id|nct_id|result_group_id|ctgov_group_code|title|period|description|count
10662246|NCT02266433|11824197|FG000|STARTED|Overall Study||127
10662247|NCT02266433|11824198|FG001|STARTED|Overall Study||118
10662248|NCT02266433|11824197|FG000|COMPLETED|Overall Study||68
10662249|NCT02266433|11824198|FG001|COMPLETED|Overall Study||65
10662250|NCT02266433|11824197|FG000|NOT COMPLETED|Overall Study||59
10662251|NCT02266433|11824198|FG001|NOT COMPLETED|Overall Study||53
10662252|NCT02266472|11824207|FG000|STARTED|Period 1+ Washout||15
10662253|NCT02266472|11824208|FG001|STARTED|Period 1+ Washout||15
10662254|NCT02266472|11824207|FG000|COMPLETED|Period 1+ Washout||15
10662255|NCT02266472|11824208|FG001|COMPLETED|Period 1+ Washout||15
10662256|NCT02266472|11824207|FG000|NOT COMPLETED|Period 1+ Washout||0
10662257|NCT02266472|11824208|FG001|NOT COMPLETED|Period 1+ Washout||0
10662258|NCT02266472|11824207|FG000|STARTED|Period 2+ Washout||15
10662259|NCT02266472|11824208|FG001|STARTED|Period 2+ Washout||15
10662260|NCT02266472|11824207|FG000|COMPLETED|Period 2+ Washout||15
10662261|NCT02266472|11824208|FG001|COMPLETED|Period 2+ Washout||15
10662262|NCT02266472|11824207|FG000|NOT COMPLETED|Period 2+ Washout||0
10662263|NCT02266472|11824208|FG001|NOT COMPLETED|Period 2+ Washout||0
10662264|NCT02266576|11824216|FG000|STARTED|Overall Study||102
10662265|NCT02266576|11824217|FG001|STARTED|Overall Study||105
10662266|NCT02266576|11824216|FG000|COMPLETED|Overall Study||85
10662267|NCT02266576|11824217|FG001|COMPLETED|Overall Study||90
10662268|NCT02266576|11824216|FG000|NOT COMPLETED|Overall Study||17
10662269|NCT02266576|11824217|FG001|NOT COMPLETED|Overall Study||15
10662270|NCT02266706|11824232|FG000|STARTED|Overall Study||6
10662271|NCT02266706|11824233|FG001|STARTED|Overall Study||7
10662272|NCT02266706|11824234|FG002|STARTED|Overall Study||4
10662273|NCT02266706|11824235|FG003|STARTED|Overall Study||4
10662274|NCT02266706|11824236|FG004|STARTED|Overall Study||1
10662275|NCT02266706|11824237|FG005|STARTED|Overall Study||7
10662276|NCT02266706|11824238|FG006|STARTED|Overall Study||8
10662277|NCT02266706|11824239|FG007|STARTED|Overall Study||2
10662278|NCT02266706|11824240|FG008|STARTED|Overall Study||4
10662279|NCT02266706|11824232|FG000|Treated|Overall Study||6
10662280|NCT02266706|11824233|FG001|Treated|Overall Study||6
10662281|NCT02266706|11824234|FG002|Treated|Overall Study||3
10662282|NCT02266706|11824235|FG003|Treated|Overall Study||3
10662283|NCT02266706|11824236|FG004|Treated|Overall Study||1
10662284|NCT02266706|11824237|FG005|Treated|Overall Study||5
10662285|NCT02266706|11824238|FG006|Treated|Overall Study||7
10662286|NCT02266706|11824239|FG007|Treated|Overall Study||2
10662287|NCT02266706|11824240|FG008|Treated|Overall Study||4
10779676|NCT03371355|11941207|FG000|STARTED|Overall Study||27
10779677|NCT03371355|11941208|FG001|STARTED|Overall Study||26
10779678|NCT03371355|11941209|FG002|STARTED|Overall Study||26
10779679|NCT03371355|11941210|FG003|STARTED|Overall Study||26
10779680|NCT03371355|11941207|FG000|COMPLETED|Overall Study||26
10779681|NCT03371355|11941208|FG001|COMPLETED|Overall Study||24
10779682|NCT03371355|11941209|FG002|COMPLETED|Overall Study||22
10779683|NCT03371355|11941210|FG003|COMPLETED|Overall Study||19
10779684|NCT03371355|11941207|FG000|NOT COMPLETED|Overall Study||1
10779685|NCT03371355|11941208|FG001|NOT COMPLETED|Overall Study||2
10779686|NCT03371355|11941209|FG002|NOT COMPLETED|Overall Study||4
10779687|NCT03371355|11941210|FG003|NOT COMPLETED|Overall Study||7
10779688|NCT03371381|11941224|FG000|STARTED|Overall Study||12
10779689|NCT03371381|11941224|FG000|COMPLETED|Overall Study||0
10779690|NCT03371381|11941224|FG000|NOT COMPLETED|Overall Study||12
10779691|NCT03371459|11941228|FG000|STARTED|Period 1||23
10779692|NCT03371459|11941229|FG001|STARTED|Period 1||23
10779693|NCT03371459|11941228|FG000|COMPLETED|Period 1||23
10779694|NCT03371459|11941229|FG001|COMPLETED|Period 1||23
10779695|NCT03371459|11941228|FG000|NOT COMPLETED|Period 1||0
10779696|NCT03371459|11941229|FG001|NOT COMPLETED|Period 1||0
10779697|NCT03371459|11941228|FG000|STARTED|Washout||23
10779698|NCT03371459|11941229|FG001|STARTED|Washout||23
10779699|NCT03371459|11941228|FG000|COMPLETED|Washout||23
10779700|NCT03371459|11941229|FG001|COMPLETED|Washout||22
10779701|NCT03371459|11941228|FG000|NOT COMPLETED|Washout||0
10779702|NCT03371459|11941229|FG001|NOT COMPLETED|Washout||1
10779703|NCT03371459|11941228|FG000|STARTED|Period 2||23
10779704|NCT03371459|11941229|FG001|STARTED|Period 2||22
10779705|NCT03371459|11941228|FG000|COMPLETED|Period 2||23
10779706|NCT03371459|11941229|FG001|COMPLETED|Period 2||22
10779707|NCT03371459|11941228|FG000|NOT COMPLETED|Period 2||0
10779708|NCT03371459|11941229|FG001|NOT COMPLETED|Period 2||0
10779709|NCT03371732|11941237|FG000|STARTED|Overall Study||51
10779710|NCT03371732|11941238|FG001|STARTED|Overall Study||53
10779711|NCT03371732|11941237|FG000|COMPLETED|Overall Study||39
10779712|NCT03371732|11941238|FG001|COMPLETED|Overall Study||46
10779713|NCT03371732|11941237|FG000|NOT COMPLETED|Overall Study||12
10779714|NCT03371732|11941238|FG001|NOT COMPLETED|Overall Study||7
10779715|NCT03371836|11941246|FG000|STARTED|Overall Study||20
10779716|NCT03371836|11941246|FG000|COMPLETED|Overall Study||18
10779717|NCT03371836|11941246|FG000|NOT COMPLETED|Overall Study||2
10779718|NCT03372083|11941250|FG000|STARTED|Overall Study||44
10779719|NCT03372083|11941250|FG000|COMPLETED|Overall Study||39
10779720|NCT03372083|11941250|FG000|NOT COMPLETED|Overall Study||5
10779721|NCT03372096|11941254|FG000|STARTED|Overall Study||18
10779722|NCT03372096|11941254|FG000|Received Intervention|Overall Study||10
10779723|NCT03372096|11941254|FG000|COMPLETED|Overall Study||10
10779724|NCT03372096|11941254|FG000|NOT COMPLETED|Overall Study||8
10779725|NCT03372369|11941263|FG000|STARTED|Qualification Period||495
10779726|NCT03372369|11941264|FG001|STARTED|Qualification Period||495
10779727|NCT03372369|11941263|FG000|COMPLETED|Qualification Period||469
10779728|NCT03372369|11941264|FG001|COMPLETED|Qualification Period||473
10779729|NCT03372369|11941263|FG000|NOT COMPLETED|Qualification Period||26
10779730|NCT03372369|11941264|FG001|NOT COMPLETED|Qualification Period||22
10779731|NCT03372369|11941263|FG000|STARTED|Intervention and Follow-Up Period||469
10779732|NCT03372369|11941264|FG001|STARTED|Intervention and Follow-Up Period||473
10779733|NCT03372369|11941263|FG000|COMPLETED|Intervention and Follow-Up Period||466
10779734|NCT03372369|11941264|FG001|COMPLETED|Intervention and Follow-Up Period||470
10779735|NCT03372369|11941263|FG000|NOT COMPLETED|Intervention and Follow-Up Period||3
10779736|NCT03372369|11941264|FG001|NOT COMPLETED|Intervention and Follow-Up Period||3
10779737|NCT03372382|11941272|FG000|STARTED|Overall Study||85
10779738|NCT03372382|11941273|FG001|STARTED|Overall Study||85
10779739|NCT03372382|11941272|FG000|COMPLETED|Overall Study||76
10779740|NCT03372382|11941273|FG001|COMPLETED|Overall Study||81
10779741|NCT03372382|11941272|FG000|NOT COMPLETED|Overall Study||9
10779742|NCT03372382|11941273|FG001|NOT COMPLETED|Overall Study||4
10779743|NCT03372434|11941284|FG000|STARTED|Overall Study||78
10779744|NCT03372434|11941285|FG001|STARTED|Overall Study||73
10779745|NCT03372434|11941286|FG002|STARTED|Overall Study||74
10779746|NCT03372434|11941284|FG000|1 Month Follow-up|Overall Study||76
10779747|NCT03372434|11941285|FG001|1 Month Follow-up|Overall Study||72
10779748|NCT03372434|11941286|FG002|1 Month Follow-up|Overall Study||73
10779749|NCT03372434|11941284|FG000|COMPLETED|Overall Study||76
10779750|NCT03372434|11941285|FG001|COMPLETED|Overall Study||70
10779751|NCT03372434|11941286|FG002|COMPLETED|Overall Study||72
10779752|NCT03372434|11941284|FG000|NOT COMPLETED|Overall Study||2
10779753|NCT03372434|11941285|FG001|NOT COMPLETED|Overall Study||3
10779754|NCT03372434|11941286|FG002|NOT COMPLETED|Overall Study||2
10779755|NCT03372551|11941294|FG000|STARTED|First Intervention (1 Week)||17
10779756|NCT03372551|11941295|FG001|STARTED|First Intervention (1 Week)||16
10779757|NCT03372551|11941294|FG000|COMPLETED|First Intervention (1 Week)||16
10779758|NCT03372551|11941295|FG001|COMPLETED|First Intervention (1 Week)||16
10779759|NCT03372551|11941294|FG000|NOT COMPLETED|First Intervention (1 Week)||1
10779760|NCT03372551|11941295|FG001|NOT COMPLETED|First Intervention (1 Week)||0
10779761|NCT03372551|11941294|FG000|STARTED|Second Intervention (1 Week)||16
10779762|NCT03372551|11941295|FG001|STARTED|Second Intervention (1 Week)||16
10779763|NCT03372551|11941294|FG000|COMPLETED|Second Intervention (1 Week)||16
10779764|NCT03372551|11941295|FG001|COMPLETED|Second Intervention (1 Week)||16
10779765|NCT03372551|11941294|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
10779766|NCT03372551|11941295|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
10779767|NCT03372603|11941308|FG000|STARTED|Treatment Period 1 (Up to 7 Days)||9
10779768|NCT03372603|11941309|FG001|STARTED|Treatment Period 1 (Up to 7 Days)||8
10779769|NCT03372603|11941308|FG000|COMPLETED|Treatment Period 1 (Up to 7 Days)||9
10779770|NCT03372603|11941309|FG001|COMPLETED|Treatment Period 1 (Up to 7 Days)||8
10779771|NCT03372603|11941308|FG000|NOT COMPLETED|Treatment Period 1 (Up to 7 Days)||0
10779772|NCT03372603|11941309|FG001|NOT COMPLETED|Treatment Period 1 (Up to 7 Days)||0
10779773|NCT03372603|11941308|FG000|STARTED|Wash-out Period (14-21 Days)||9
10779774|NCT03372603|11941309|FG001|STARTED|Wash-out Period (14-21 Days)||8
10779775|NCT03372603|11941308|FG000|COMPLETED|Wash-out Period (14-21 Days)||8
10779776|NCT03372603|11941309|FG001|COMPLETED|Wash-out Period (14-21 Days)||8
10779777|NCT03372603|11941308|FG000|NOT COMPLETED|Wash-out Period (14-21 Days)||1
10779778|NCT03372603|11941309|FG001|NOT COMPLETED|Wash-out Period (14-21 Days)||0
10779779|NCT03372603|11941308|FG000|STARTED|Treatment Period 2 (Up to 7 Days)||8
10779780|NCT03372603|11941309|FG001|STARTED|Treatment Period 2 (Up to 7 Days)||8
10779781|NCT03372603|11941308|FG000|COMPLETED|Treatment Period 2 (Up to 7 Days)||7
10779782|NCT03372603|11941309|FG001|COMPLETED|Treatment Period 2 (Up to 7 Days)||8
10779783|NCT03372603|11941308|FG000|NOT COMPLETED|Treatment Period 2 (Up to 7 Days)||1
10779784|NCT03372603|11941309|FG001|NOT COMPLETED|Treatment Period 2 (Up to 7 Days)||0
10779785|NCT03372928|11941315|FG000|STARTED|First Intervention (5 d Energy Deficit)||10
10779786|NCT03372928|11941316|FG001|STARTED|First Intervention (5 d Energy Deficit)||10
10779787|NCT03372928|11941315|FG000|COMPLETED|First Intervention (5 d Energy Deficit)||10
10779788|NCT03372928|11941316|FG001|COMPLETED|First Intervention (5 d Energy Deficit)||10
10779789|NCT03372928|11941315|FG000|NOT COMPLETED|First Intervention (5 d Energy Deficit)||0
10779790|NCT03372928|11941316|FG001|NOT COMPLETED|First Intervention (5 d Energy Deficit)||0
10779791|NCT03372928|11941315|FG000|STARTED|Washout (14 d)||10
10779792|NCT03372928|11941316|FG001|STARTED|Washout (14 d)||10
10779793|NCT03372928|11941315|FG000|COMPLETED|Washout (14 d)||10
10779794|NCT03372928|11941316|FG001|COMPLETED|Washout (14 d)||9
10779795|NCT03372928|11941315|FG000|NOT COMPLETED|Washout (14 d)||0
10779796|NCT03372928|11941316|FG001|NOT COMPLETED|Washout (14 d)||1
10779797|NCT03372928|11941315|FG000|STARTED|Second Intervention (5 d Energy Deficit)||10
10779798|NCT03372928|11941316|FG001|STARTED|Second Intervention (5 d Energy Deficit)||9
10779799|NCT03372928|11941315|FG000|COMPLETED|Second Intervention (5 d Energy Deficit)||10
10779800|NCT03372928|11941316|FG001|COMPLETED|Second Intervention (5 d Energy Deficit)||9
10779801|NCT03372928|11941315|FG000|NOT COMPLETED|Second Intervention (5 d Energy Deficit)||0
10779802|NCT03372928|11941316|FG001|NOT COMPLETED|Second Intervention (5 d Energy Deficit)||0
10779803|NCT03373162|11941327|FG000|STARTED|Overall Study||10
10779804|NCT03373162|11941327|FG000|COMPLETED|Overall Study||10
10779805|NCT03373162|11941327|FG000|NOT COMPLETED|Overall Study||0
10779806|NCT03373240|11941334|FG000|STARTED|Overall Study||22
10779807|NCT03373240|11941335|FG001|STARTED|Overall Study||24
10779808|NCT03373240|11941334|FG000|4-week Post Treatment|Overall Study||14
10779809|NCT03373240|11941335|FG001|4-week Post Treatment|Overall Study||23
10779810|NCT03373240|11941334|FG000|COMPLETED|Overall Study|This is the 1-month post follow-up|11
10779811|NCT03373240|11941335|FG001|COMPLETED|Overall Study|This is the 1-month post follow-up|20
10779812|NCT03373240|11941334|FG000|NOT COMPLETED|Overall Study||11
10779813|NCT03373240|11941335|FG001|NOT COMPLETED|Overall Study||4
10779814|NCT03373383|11941346|FG000|STARTED|Treatment Period: Wk0-16||83
10779815|NCT03373383|11941347|FG001|STARTED|Treatment Period: Wk0-16||81
10779816|NCT03373383|11941348|FG002|STARTED|Treatment Period: Wk0-16||83
10779817|NCT03373383|11941349|FG003|STARTED|Treatment Period: Wk0-16||82
10779818|NCT03373383|11941350|FG004|STARTED|Treatment Period: Wk0-16||82
10779819|NCT03373383|11941346|FG000|Completed Titration and Stabilization|Treatment Period: Wk0-16||78
10779820|NCT03373383|11941347|FG001|Completed Titration and Stabilization|Treatment Period: Wk0-16||72
10779821|NCT03373383|11941348|FG002|Completed Titration and Stabilization|Treatment Period: Wk0-16||71
10779822|NCT03373383|11941349|FG003|Completed Titration and Stabilization|Treatment Period: Wk0-16||68
10779823|NCT03373383|11941350|FG004|Completed Titration and Stabilization|Treatment Period: Wk0-16||65
10779824|NCT03373383|11941346|FG000|Completed Maintenance Period|Treatment Period: Wk0-16||70
10779825|NCT03373383|11941347|FG001|Completed Maintenance Period|Treatment Period: Wk0-16||66
10779826|NCT03373383|11941348|FG002|Completed Maintenance Period|Treatment Period: Wk0-16||68
10779827|NCT03373383|11941349|FG003|Completed Maintenance Period|Treatment Period: Wk0-16||61
10779828|NCT03373383|11941350|FG004|Completed Maintenance Period|Treatment Period: Wk0-16||58
10779829|NCT03373383|11941346|FG000|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||6
10779830|NCT03373383|11941347|FG001|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||11
10779831|NCT03373383|11941348|FG002|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||8
10779832|NCT03373383|11941349|FG003|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||18
10779833|NCT03373383|11941350|FG004|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||21
10779834|NCT03373383|11941346|FG000|COMPLETED|Treatment Period: Wk0-16||70
10779835|NCT03373383|11941347|FG001|COMPLETED|Treatment Period: Wk0-16||66
10779836|NCT03373383|11941348|FG002|COMPLETED|Treatment Period: Wk0-16||68
10779837|NCT03373383|11941349|FG003|COMPLETED|Treatment Period: Wk0-16||61
10779838|NCT03373383|11941350|FG004|COMPLETED|Treatment Period: Wk0-16||58
10779839|NCT03373383|11941346|FG000|NOT COMPLETED|Treatment Period: Wk0-16||13
10779840|NCT03373383|11941347|FG001|NOT COMPLETED|Treatment Period: Wk0-16||15
10779841|NCT03373383|11941348|FG002|NOT COMPLETED|Treatment Period: Wk0-16||15
10779842|NCT03373383|11941349|FG003|NOT COMPLETED|Treatment Period: Wk0-16||21
10779843|NCT03373383|11941350|FG004|NOT COMPLETED|Treatment Period: Wk0-16||24
10779844|NCT03373383|11941346|FG000|STARTED|Post-Treatment Period: Wk16-23||70
10779845|NCT03373383|11941347|FG001|STARTED|Post-Treatment Period: Wk16-23||66
10779846|NCT03373383|11941348|FG002|STARTED|Post-Treatment Period: Wk16-23||68
10779847|NCT03373383|11941349|FG003|STARTED|Post-Treatment Period: Wk16-23||61
10779848|NCT03373383|11941350|FG004|STARTED|Post-Treatment Period: Wk16-23||58
10779849|NCT03373383|11941346|FG000|Started Conversion Period|Post-Treatment Period: Wk16-23||69
10779850|NCT03373383|11941347|FG001|Started Conversion Period|Post-Treatment Period: Wk16-23||64
10779851|NCT03373383|11941348|FG002|Started Conversion Period|Post-Treatment Period: Wk16-23||66
10779852|NCT03373383|11941349|FG003|Started Conversion Period|Post-Treatment Period: Wk16-23||55
10779853|NCT03373383|11941350|FG004|Started Conversion Period|Post-Treatment Period: Wk16-23||57
10779854|NCT03373383|11941346|FG000|Completed Conversion Period|Post-Treatment Period: Wk16-23||68
10779855|NCT03373383|11941347|FG001|Completed Conversion Period|Post-Treatment Period: Wk16-23||64
10779856|NCT03373383|11941348|FG002|Completed Conversion Period|Post-Treatment Period: Wk16-23||66
10779857|NCT03373383|11941349|FG003|Completed Conversion Period|Post-Treatment Period: Wk16-23||55
10779858|NCT03373383|11941350|FG004|Completed Conversion Period|Post-Treatment Period: Wk16-23||57
10779859|NCT03373383|11941346|FG000|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||3
10779860|NCT03373383|11941347|FG001|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||3
10779861|NCT03373383|11941348|FG002|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||3
10779862|NCT03373383|11941349|FG003|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||6
10779863|NCT03373383|11941350|FG004|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||1
10779864|NCT03373383|11941346|FG000|Enrolled in EP0093|Post-Treatment Period: Wk16-23||67
10779865|NCT03373383|11941347|FG001|Enrolled in EP0093|Post-Treatment Period: Wk16-23||63
10779866|NCT03373383|11941348|FG002|Enrolled in EP0093|Post-Treatment Period: Wk16-23||65
10779867|NCT03373383|11941349|FG003|Enrolled in EP0093|Post-Treatment Period: Wk16-23||55
10779868|NCT03373383|11941350|FG004|Enrolled in EP0093|Post-Treatment Period: Wk16-23||57
10779869|NCT03373383|11941346|FG000|COMPLETED|Post-Treatment Period: Wk16-23||69
10779870|NCT03373383|11941347|FG001|COMPLETED|Post-Treatment Period: Wk16-23||66
10779871|NCT03373383|11941348|FG002|COMPLETED|Post-Treatment Period: Wk16-23||68
10779872|NCT03373383|11941349|FG003|COMPLETED|Post-Treatment Period: Wk16-23||61
10779873|NCT03373383|11941350|FG004|COMPLETED|Post-Treatment Period: Wk16-23||58
10779874|NCT03373383|11941346|FG000|NOT COMPLETED|Post-Treatment Period: Wk16-23||1
10779875|NCT03373383|11941347|FG001|NOT COMPLETED|Post-Treatment Period: Wk16-23||0
10779876|NCT03373383|11941348|FG002|NOT COMPLETED|Post-Treatment Period: Wk16-23||0
10779877|NCT03373383|11941349|FG003|NOT COMPLETED|Post-Treatment Period: Wk16-23||0
10779878|NCT03373383|11941350|FG004|NOT COMPLETED|Post-Treatment Period: Wk16-23||0
10779879|NCT03373591|11941380|FG000|STARTED|Overall Study||75
10779880|NCT03373591|11941381|FG001|STARTED|Overall Study||71
10779881|NCT03373591|11941382|FG002|STARTED|Overall Study||73
10779882|NCT03373591|11941380|FG000|COMPLETED|Overall Study||75
10779883|NCT03373591|11941381|FG001|COMPLETED|Overall Study||71
10779884|NCT03373591|11941382|FG002|COMPLETED|Overall Study||73
10779885|NCT03373591|11941380|FG000|NOT COMPLETED|Overall Study||0
10779886|NCT03373591|11941381|FG001|NOT COMPLETED|Overall Study||0
10779887|NCT03373591|11941382|FG002|NOT COMPLETED|Overall Study||0
10779888|NCT03373890|11941392|FG000|STARTED|Overall Study||6
10779889|NCT03373890|11941393|FG001|STARTED|Overall Study||6
10779890|NCT03373890|11941392|FG000|COMPLETED|Overall Study||6
10779891|NCT03373890|11941393|FG001|COMPLETED|Overall Study||6
10779892|NCT03373890|11941392|FG000|NOT COMPLETED|Overall Study||0
10779893|NCT03373890|11941393|FG001|NOT COMPLETED|Overall Study||0
10779894|NCT03374176|11941403|FG000|STARTED|Overall Study||21
10779895|NCT03374176|11941404|FG001|STARTED|Overall Study||21
10779896|NCT03374176|11941403|FG000|COMPLETED|Overall Study||21
10779897|NCT03374176|11941404|FG001|COMPLETED|Overall Study||21
10779898|NCT03374176|11941403|FG000|NOT COMPLETED|Overall Study||0
10779899|NCT03374176|11941404|FG001|NOT COMPLETED|Overall Study||0
10779900|NCT03374189|11941412|FG000|STARTED|Overall Study||40
10779901|NCT03374189|11941413|FG001|STARTED|Overall Study||39
10779902|NCT03374189|11941412|FG000|COMPLETED|Overall Study||39
10779903|NCT03374189|11941413|FG001|COMPLETED|Overall Study||39
10779904|NCT03374189|11941412|FG000|NOT COMPLETED|Overall Study||1
10779905|NCT03374189|11941413|FG001|NOT COMPLETED|Overall Study||0
10779906|NCT03374358|11941421|FG000|STARTED|Overall Study||24
10779907|NCT03374358|11941422|FG001|STARTED|Overall Study||21
10779908|NCT03374358|11941421|FG000|COMPLETED|Overall Study||24
10779909|NCT03374358|11941422|FG001|COMPLETED|Overall Study||19
10779910|NCT03374358|11941421|FG000|NOT COMPLETED|Overall Study||0
10779911|NCT03374358|11941422|FG001|NOT COMPLETED|Overall Study||2
10779912|NCT03374488|11941430|FG000|STARTED|Overall Study||42
10779913|NCT03374488|11941431|FG001|STARTED|Overall Study||42
10779914|NCT03374488|11941430|FG000|Intention-to-Treat (ITT)|Overall Study||42
10779915|NCT03374488|11941431|FG001|Intention-to-Treat (ITT)|Overall Study||42
10779916|NCT03374488|11941430|FG000|All Participants as Treated (APaT)|Overall Study||42
10779917|NCT03374488|11941431|FG001|All Participants as Treated (APaT)|Overall Study||41
10779918|NCT03374488|11941430|FG000|COMPLETED|Overall Study||23
10779919|NCT03374488|11941431|FG001|COMPLETED|Overall Study||28
10779920|NCT03374488|11941430|FG000|NOT COMPLETED|Overall Study||19
10779921|NCT03374488|11941431|FG001|NOT COMPLETED|Overall Study||14
10779922|NCT03374683|11941441|FG000|STARTED|Overall Study||148
10779923|NCT03374683|11941442|FG001|STARTED|Overall Study||150
10779924|NCT03374683|11941443|FG002|STARTED|Overall Study||153
10779925|NCT03374683|11941441|FG000|1-week Post-intervention|Overall Study||135
10779926|NCT03374683|11941442|FG001|1-week Post-intervention|Overall Study||113
10779927|NCT03374683|11941443|FG002|1-week Post-intervention|Overall Study||85
10779928|NCT03374683|11941441|FG000|COMPLETED|Overall Study||123
10779929|NCT03374683|11941442|FG001|COMPLETED|Overall Study||105
10779930|NCT03374683|11941443|FG002|COMPLETED|Overall Study||84
10779931|NCT03374683|11941441|FG000|NOT COMPLETED|Overall Study||25
10779932|NCT03374683|11941442|FG001|NOT COMPLETED|Overall Study||45
10779933|NCT03374683|11941443|FG002|NOT COMPLETED|Overall Study||69
10779934|NCT03374995|11941453|FG000|STARTED|Overall Study||13
10779935|NCT03374995|11941454|FG001|STARTED|Overall Study||12
10779936|NCT03374995|11941453|FG000|COMPLETED|Overall Study||13
10779937|NCT03374995|11941454|FG001|COMPLETED|Overall Study||11
10779938|NCT03374995|11941453|FG000|NOT COMPLETED|Overall Study||0
10779939|NCT03374995|11941454|FG001|NOT COMPLETED|Overall Study||1
10779940|NCT03375294|11941460|FG000|STARTED|Overall Study||3
10779941|NCT03375294|11941460|FG000|COMPLETED|Overall Study||3
10779942|NCT03375294|11941460|FG000|NOT COMPLETED|Overall Study||0
10779943|NCT03376061|11941466|FG000|STARTED|Overall Study||49
10779944|NCT03376061|11941467|FG001|STARTED|Overall Study||48
10779945|NCT03376061|11941466|FG000|COMPLETED|Overall Study||49
10779946|NCT03376061|11941467|FG001|COMPLETED|Overall Study||48
10779947|NCT03376061|11941466|FG000|NOT COMPLETED|Overall Study||0
10779948|NCT03376061|11941467|FG001|NOT COMPLETED|Overall Study||0
10779949|NCT03376256|11941476|FG000|STARTED|Overall Study||2
10779950|NCT03376256|11941477|FG001|STARTED|Overall Study||0
10779951|NCT03376256|11941476|FG000|COMPLETED|Overall Study||2
10779952|NCT03376256|11941477|FG001|COMPLETED|Overall Study||0
10779953|NCT03376256|11941476|FG000|NOT COMPLETED|Overall Study||0
10779954|NCT03376256|11941477|FG001|NOT COMPLETED|Overall Study||0
10779955|NCT03376295|11941485|FG000|STARTED|Overall Study||1977
10779956|NCT03376295|11941486|FG001|STARTED|Overall Study||1977
10779957|NCT03376295|11941485|FG000|COMPLETED|Overall Study||1977
10779958|NCT03376295|11941486|FG001|COMPLETED|Overall Study||1977
10779959|NCT03376295|11941485|FG000|NOT COMPLETED|Overall Study||0
10779960|NCT03376295|11941486|FG001|NOT COMPLETED|Overall Study||0
10779961|NCT03376321|11941494|FG000|STARTED|Overall Study||168
10779962|NCT03376321|11941495|FG001|STARTED|Overall Study||166
10779963|NCT03376321|11941494|FG000|Treated|Overall Study||163
10779964|NCT03376321|11941495|FG001|Treated|Overall Study||163
10779965|NCT03376321|11941494|FG000|COMPLETED|Overall Study||145
10779966|NCT03376321|11941495|FG001|COMPLETED|Overall Study||141
10779967|NCT03376321|11941494|FG000|NOT COMPLETED|Overall Study||23
10779968|NCT03376321|11941495|FG001|NOT COMPLETED|Overall Study||25
10779969|NCT03376516|11941501|FG000|STARTED|Overall Study||11
10779970|NCT03376516|11941501|FG000|Received Treatment|Overall Study||10
10779971|NCT03376516|11941501|FG000|SAF Population|Overall Study||10
10779972|NCT03376516|11941501|FG000|FAS Population|Overall Study||10
10779973|NCT03376516|11941501|FG000|PK Population|Overall Study||10
10779974|NCT03376516|11941501|FG000|PP Population|Overall Study||9
10779975|NCT03376516|11941501|FG000|SURG Population|Overall Study||2
10779976|NCT03376516|11941501|FG000|COMPLETED|Overall Study||9
10779977|NCT03376516|11941501|FG000|NOT COMPLETED|Overall Study||2
10779978|NCT03377127|11941518|FG000|STARTED|Overall Study||42
10779979|NCT03377127|11941519|FG001|STARTED|Overall Study||44
10779980|NCT03377127|11941518|FG000|COMPLETED|Overall Study||42
10779981|NCT03377127|11941519|FG001|COMPLETED|Overall Study||44
10779982|NCT03377127|11941518|FG000|NOT COMPLETED|Overall Study||0
10779983|NCT03377127|11941519|FG001|NOT COMPLETED|Overall Study||0
10779984|NCT03377244|11941528|FG000|STARTED|Baseline||19
10779985|NCT03377244|11941529|FG001|STARTED|Baseline||14
10779986|NCT03377244|11941530|FG002|STARTED|Baseline||69
10779987|NCT03377244|11941528|FG000|COMPLETED|Baseline||19
10779988|NCT03377244|11941529|FG001|COMPLETED|Baseline||14
10779989|NCT03377244|11941530|FG002|COMPLETED|Baseline||69
10779990|NCT03377244|11941528|FG000|NOT COMPLETED|Baseline||0
10779991|NCT03377244|11941529|FG001|NOT COMPLETED|Baseline||0
10779992|NCT03377244|11941530|FG002|NOT COMPLETED|Baseline||0
10779993|NCT03377244|11941528|FG000|STARTED|6 Months Post-intervention||19
10779994|NCT03377244|11941529|FG001|STARTED|6 Months Post-intervention||14
10779995|NCT03377244|11941530|FG002|STARTED|6 Months Post-intervention||69
10779996|NCT03377244|11941528|FG000|COMPLETED|6 Months Post-intervention||13
10779997|NCT03377244|11941529|FG001|COMPLETED|6 Months Post-intervention||7
10779998|NCT03377244|11941530|FG002|COMPLETED|6 Months Post-intervention||55
10779999|NCT03377244|11941528|FG000|NOT COMPLETED|6 Months Post-intervention||6
10780000|NCT03377244|11941529|FG001|NOT COMPLETED|6 Months Post-intervention||7
10780001|NCT03377244|11941530|FG002|NOT COMPLETED|6 Months Post-intervention||14
10780002|NCT03377556|11941538|FG000|STARTED|Overall Study||47
10780003|NCT03377556|11941538|FG000|Primary Analysis Population (HRRD-positive Per MDVN Criteria)|Overall Study||24
10780004|NCT03377556|11941538|FG000|COMPLETED|Overall Study||0
10780005|NCT03377556|11941538|FG000|NOT COMPLETED|Overall Study||47
10780006|NCT03377634|11941544|FG000|STARTED|Intervention Usability Testing Period||5
10780007|NCT03377634|11941545|FG001|STARTED|Intervention Usability Testing Period||0
10780008|NCT03377634|11941544|FG000|COMPLETED|Intervention Usability Testing Period||5
10780009|NCT03377634|11941545|FG001|COMPLETED|Intervention Usability Testing Period||0
10780010|NCT03377634|11941544|FG000|NOT COMPLETED|Intervention Usability Testing Period||0
10780011|NCT03377634|11941545|FG001|NOT COMPLETED|Intervention Usability Testing Period||0
10780012|NCT03377634|11941544|FG000|STARTED|Study Period||15
10780013|NCT03377634|11941545|FG001|STARTED|Study Period||13
10780014|NCT03377634|11941544|FG000|COMPLETED|Study Period||13
10780015|NCT03377634|11941545|FG001|COMPLETED|Study Period||13
10780016|NCT03377634|11941544|FG000|NOT COMPLETED|Study Period||2
10780017|NCT03377634|11941545|FG001|NOT COMPLETED|Study Period||0
10780018|NCT03378076|11941553|FG000|STARTED|Overall Study||12
10780019|NCT03378076|11941554|FG001|STARTED|Overall Study||12
10780020|NCT03378076|11941553|FG000|COMPLETED|Overall Study||12
10780021|NCT03378076|11941554|FG001|COMPLETED|Overall Study||12
10780022|NCT03378076|11941553|FG000|NOT COMPLETED|Overall Study||0
10780023|NCT03378076|11941554|FG001|NOT COMPLETED|Overall Study||0
10780024|NCT03378635|11941563|FG000|STARTED|Overall Study||84
10780025|NCT03378635|11941564|FG001|STARTED|Overall Study||43
10780026|NCT03378635|11941565|FG002|STARTED|Overall Study||43
10780027|NCT03378635|11941563|FG000|Randomized and Exposed to Treatment|Overall Study||82
10780028|NCT03378635|11941564|FG001|Randomized and Exposed to Treatment|Overall Study||43
10780029|NCT03378635|11941565|FG002|Randomized and Exposed to Treatment|Overall Study||43
10780030|NCT03378635|11941563|FG000|COMPLETED|Overall Study||82
10780031|NCT03378635|11941564|FG001|COMPLETED|Overall Study||43
10780032|NCT03378635|11941565|FG002|COMPLETED|Overall Study||43
10780033|NCT03378635|11941563|FG000|NOT COMPLETED|Overall Study||2
10780034|NCT03378635|11941564|FG001|NOT COMPLETED|Overall Study||0
10780035|NCT03378635|11941565|FG002|NOT COMPLETED|Overall Study||0
10780036|NCT03378921|11941576|FG000|STARTED|Overall Study||13
10780037|NCT03378921|11941577|FG001|STARTED|Overall Study||13
10780038|NCT03378921|11941576|FG000|COMPLETED|Overall Study||13
10780039|NCT03378921|11941577|FG001|COMPLETED|Overall Study||13
10780040|NCT03378921|11941576|FG000|NOT COMPLETED|Overall Study||0
10780041|NCT03378921|11941577|FG001|NOT COMPLETED|Overall Study||0
10780042|NCT03378973|11941585|FG000|STARTED|Overall Study||4
10780043|NCT03378973|11941586|FG001|STARTED|Overall Study||3
10780044|NCT03378973|11941585|FG000|COMPLETED|Overall Study||4
10780045|NCT03378973|11941586|FG001|COMPLETED|Overall Study||3
10780046|NCT03378973|11941585|FG000|NOT COMPLETED|Overall Study||0
10780047|NCT03378973|11941586|FG001|NOT COMPLETED|Overall Study||0
10780048|NCT03379259|11941598|FG000|STARTED|Overall Study||3
10780049|NCT03379259|11941599|FG001|STARTED|Overall Study||3
10780050|NCT03379259|11941600|FG002|STARTED|Overall Study||6
10780051|NCT03379259|11941601|FG003|STARTED|Overall Study||3
10780052|NCT03379259|11941602|FG004|STARTED|Overall Study||12
10780053|NCT03379259|11941603|FG005|STARTED|Overall Study||12
10780054|NCT03379259|11941598|FG000|COMPLETED|Overall Study||2
10780055|NCT03379259|11941599|FG001|COMPLETED|Overall Study||2
10780056|NCT03379259|11941600|FG002|COMPLETED|Overall Study||3
10780057|NCT03379259|11941601|FG003|COMPLETED|Overall Study||0
10780058|NCT03379259|11941602|FG004|COMPLETED|Overall Study||3
10780059|NCT03379259|11941603|FG005|COMPLETED|Overall Study||5
10780060|NCT03379259|11941598|FG000|NOT COMPLETED|Overall Study||1
10780061|NCT03379259|11941599|FG001|NOT COMPLETED|Overall Study||1
10780062|NCT03379259|11941600|FG002|NOT COMPLETED|Overall Study||3
10780063|NCT03379259|11941601|FG003|NOT COMPLETED|Overall Study||3
10780064|NCT03379259|11941602|FG004|NOT COMPLETED|Overall Study||9
10780065|NCT03379259|11941603|FG005|NOT COMPLETED|Overall Study||7
10780066|NCT03379376|11941620|FG000|STARTED|Overall Study||10
10780067|NCT03379376|11941620|FG000|COMPLETED|Overall Study||5
10780068|NCT03379376|11941620|FG000|NOT COMPLETED|Overall Study||5
10780069|NCT03379506|11941628|FG000|STARTED|Overall Study||22
10780070|NCT03379506|11941629|FG001|STARTED|Overall Study||17
10780071|NCT03379506|11941630|FG002|STARTED|Overall Study||7
10780072|NCT03379506|11941631|FG003|STARTED|Overall Study||11
10780073|NCT03379506|11941628|FG000|COMPLETED|Overall Study||22
10780074|NCT03379506|11941629|FG001|COMPLETED|Overall Study||17
10780075|NCT03379506|11941630|FG002|COMPLETED|Overall Study||7
10780076|NCT03379506|11941631|FG003|COMPLETED|Overall Study||11
10780077|NCT03379506|11941628|FG000|NOT COMPLETED|Overall Study||0
10780078|NCT03379506|11941629|FG001|NOT COMPLETED|Overall Study||0
10780079|NCT03379506|11941630|FG002|NOT COMPLETED|Overall Study||0
10780080|NCT03379506|11941631|FG003|NOT COMPLETED|Overall Study||0
10780081|NCT03379545|11941641|FG000|STARTED|Overall Study||29
10780082|NCT03379545|11941641|FG000|COMPLETED|Overall Study||29
10780083|NCT03379545|11941641|FG000|NOT COMPLETED|Overall Study||0
10780084|NCT03379662|11941648|FG000|STARTED|Overall Study||21
10780085|NCT03379662|11941649|FG001|STARTED|Overall Study||19
10780086|NCT03379662|11941648|FG000|COMPLETED|Overall Study||21
10780087|NCT03379662|11941649|FG001|COMPLETED|Overall Study||19
10780088|NCT03379662|11941648|FG000|NOT COMPLETED|Overall Study||0
10780089|NCT03379662|11941649|FG001|NOT COMPLETED|Overall Study||0
10780090|NCT03379740|11941657|FG000|STARTED|Overall Study||8
10780091|NCT03379740|11941658|FG001|STARTED|Overall Study||7
10780092|NCT03379740|11941657|FG000|COMPLETED|Overall Study||8
10780093|NCT03379740|11941658|FG001|COMPLETED|Overall Study||7
10780094|NCT03379740|11941657|FG000|NOT COMPLETED|Overall Study||0
10780095|NCT03379740|11941658|FG001|NOT COMPLETED|Overall Study||0
10780096|NCT03379753|11941673|FG000|STARTED|Overall Study||61
10780097|NCT03379753|11941674|FG001|STARTED|Overall Study||71
10780098|NCT03379753|11941673|FG000|COMPLETED|Overall Study||46
10780099|NCT03379753|11941674|FG001|COMPLETED|Overall Study||46
10780100|NCT03379753|11941673|FG000|NOT COMPLETED|Overall Study||15
10780101|NCT03379753|11941674|FG001|NOT COMPLETED|Overall Study||25
10780102|NCT03380026|11941680|FG000|STARTED|Overall Study||28
10780103|NCT03380026|11941680|FG000|Half of Body Assigned to Treatment With Valchlor Only|Overall Study||28
10780104|NCT03380026|11941680|FG000|Half of Body Assigned to Treatment With Valchlor and Triamcinolone Acetonide|Overall Study||28
10780105|NCT03380026|11941680|FG000|COMPLETED|Overall Study||25
10780106|NCT03380026|11941680|FG000|NOT COMPLETED|Overall Study||3
10780107|NCT03380091|11941689|FG000|STARTED|Overall Study||3
10780108|NCT03380091|11941690|FG001|STARTED|Overall Study||2
10780109|NCT03380091|11941689|FG000|Began Arm Treatment|Overall Study|1 participant withdrew after completing baseline measures and another withdrew just after enrolling.|1
10780110|NCT03380091|11941690|FG001|Began Arm Treatment|Overall Study|1 of the 2 participant assigned to Metformin withdrew from the study just after enrolling.|1
10780111|NCT03380091|11941689|FG000|COMPLETED|Overall Study||1
10780112|NCT03380091|11941690|FG001|COMPLETED|Overall Study||1
10780113|NCT03380091|11941689|FG000|NOT COMPLETED|Overall Study||2
10780114|NCT03380091|11941690|FG001|NOT COMPLETED|Overall Study||1
10780115|NCT03380390|11941698|FG000|STARTED|Overall Study||46
10780116|NCT03380390|11941698|FG000|COMPLETED|Overall Study||43
10780117|NCT03380390|11941698|FG000|NOT COMPLETED|Overall Study||3
10780118|NCT03380429|11941707|FG000|STARTED|Overall Study||87
10780119|NCT03380429|11941708|FG001|STARTED|Overall Study||88
10780120|NCT03380429|11941709|FG002|STARTED|Overall Study||88
10780121|NCT03380429|11941710|FG003|STARTED|Overall Study||88
10780122|NCT03380429|11941711|FG004|STARTED|Overall Study||86
10780123|NCT03380429|11941707|FG000|COMPLETED|Overall Study||82
10780124|NCT03380429|11941708|FG001|COMPLETED|Overall Study||81
10780125|NCT03380429|11941709|FG002|COMPLETED|Overall Study||77
10780126|NCT03380429|11941710|FG003|COMPLETED|Overall Study||78
10780127|NCT03380429|11941711|FG004|COMPLETED|Overall Study||81
10780128|NCT03380429|11941707|FG000|NOT COMPLETED|Overall Study||5
10780129|NCT03380429|11941708|FG001|NOT COMPLETED|Overall Study||7
10780130|NCT03380429|11941709|FG002|NOT COMPLETED|Overall Study||11
10780131|NCT03380429|11941710|FG003|NOT COMPLETED|Overall Study||10
10780132|NCT03380429|11941711|FG004|NOT COMPLETED|Overall Study||5
10780133|NCT03380572|11941730|FG000|STARTED|Overall Study||20
10780134|NCT03380572|11941731|FG001|STARTED|Overall Study||20
10780135|NCT03380572|11941730|FG000|COMPLETED|Overall Study||20
10780136|NCT03380572|11941731|FG001|COMPLETED|Overall Study||20
10780137|NCT03380572|11941730|FG000|NOT COMPLETED|Overall Study||0
10780138|NCT03380572|11941731|FG001|NOT COMPLETED|Overall Study||0
10780139|NCT03380624|11941737|FG000|STARTED|Overall Study||10
10780140|NCT03380624|11941738|FG001|STARTED|Overall Study||9
10780141|NCT03380624|11941737|FG000|COMPLETED|Overall Study||10
10780142|NCT03380624|11941738|FG001|COMPLETED|Overall Study||9
10780143|NCT03380624|11941737|FG000|NOT COMPLETED|Overall Study||0
10780144|NCT03380624|11941738|FG001|NOT COMPLETED|Overall Study||0
10780145|NCT03380780|11941744|FG000|STARTED|Overall Study||16
10780146|NCT03380780|11941744|FG000|COMPLETED|Overall Study||16
10780147|NCT03380780|11941744|FG000|NOT COMPLETED|Overall Study||0
10780148|NCT03380845|11941748|FG000|STARTED|Overall Study|Participants got bilateral face treatments with Fraxel on one side of face; Fractora on the other.|4
10780149|NCT03380845|11941748|FG000|COMPLETED|Overall Study||4
10780150|NCT03380845|11941748|FG000|NOT COMPLETED|Overall Study||0
10780151|NCT03381196|11941756|FG000|STARTED|Overall Study||276
10780152|NCT03381196|11941757|FG001|STARTED|Overall Study||277
10780153|NCT03381196|11941756|FG000|Treated|Overall Study||273
10780154|NCT03381196|11941757|FG001|Treated|Overall Study||271
10780155|NCT03381196|11941756|FG000|COMPLETED|Overall Study||260
10780156|NCT03381196|11941757|FG001|COMPLETED|Overall Study||258
10780157|NCT03381196|11941756|FG000|NOT COMPLETED|Overall Study||16
10780158|NCT03381196|11941757|FG001|NOT COMPLETED|Overall Study||19
10780159|NCT03381248|11941765|FG000|STARTED|Overall Study||89
10780160|NCT03381248|11941766|FG001|STARTED|Overall Study||88
10780161|NCT03381248|11941765|FG000|COMPLETED|Overall Study||76
10780162|NCT03381248|11941766|FG001|COMPLETED|Overall Study||82
10780163|NCT03381248|11941765|FG000|NOT COMPLETED|Overall Study||13
10780164|NCT03381248|11941766|FG001|NOT COMPLETED|Overall Study||6
10780165|NCT03381339|11941774|FG000|STARTED|Overall Study||27
10780166|NCT03381339|11941775|FG001|STARTED|Overall Study||28
10780167|NCT03381339|11941774|FG000|COMPLETED|Overall Study||23
10780168|NCT03381339|11941775|FG001|COMPLETED|Overall Study||24
10548634|NCT01520402|11702473|FG000|STARTED|Overall Study||35
10548635|NCT01520402|11702473|FG000|COMPLETED|Overall Study||30
10548636|NCT01520402|11702473|FG000|NOT COMPLETED|Overall Study||5
10548637|NCT01520454|11702488|FG000|STARTED|Overall Study||9
10548638|NCT01520454|11702489|FG001|STARTED|Overall Study||6
10548639|NCT01520454|11702490|FG002|STARTED|Overall Study||5
10548640|NCT01520454|11702491|FG003|STARTED|Overall Study||6
10548641|NCT01520454|11702488|FG000|COMPLETED|Overall Study||9
10548642|NCT01520454|11702489|FG001|COMPLETED|Overall Study||6
10548643|NCT01520454|11702490|FG002|COMPLETED|Overall Study||5
10548644|NCT01520454|11702491|FG003|COMPLETED|Overall Study||6
10548645|NCT01520454|11702488|FG000|NOT COMPLETED|Overall Study||0
10548646|NCT01520454|11702489|FG001|NOT COMPLETED|Overall Study||0
10548647|NCT01520454|11702490|FG002|NOT COMPLETED|Overall Study||0
10548648|NCT01520454|11702491|FG003|NOT COMPLETED|Overall Study||0
10548649|NCT01520506|11702504|FG000|STARTED|Overall Study||50
10548650|NCT01520506|11702504|FG000|COMPLETED|Overall Study||44
10548651|NCT01520506|11702504|FG000|NOT COMPLETED|Overall Study||6
10548652|NCT01520519|11702508|FG000|STARTED|Overall Study||40
10548653|NCT01520519|11702508|FG000|COMPLETED|Overall Study||40
10548654|NCT01520519|11702508|FG000|NOT COMPLETED|Overall Study||0
10548655|NCT01520532|11702512|FG000|STARTED|Overall Study|Subjects who underwent an ablation and had post-procedure MRI|60
10548656|NCT01520532|11702512|FG000|COMPLETED|Overall Study||60
10548657|NCT01520532|11702512|FG000|NOT COMPLETED|Overall Study||0
10548658|NCT01520558|11702519|FG000|STARTED|Overall Study||3
10548659|NCT01520558|11702520|FG001|STARTED|Overall Study||3
10548660|NCT01520558|11702521|FG002|STARTED|Overall Study||6
10548661|NCT01520558|11702519|FG000|COMPLETED|Overall Study||1
10548662|NCT01520558|11702520|FG001|COMPLETED|Overall Study||1
10548663|NCT01520558|11702521|FG002|COMPLETED|Overall Study||3
10548664|NCT01520558|11702519|FG000|NOT COMPLETED|Overall Study||2
10548665|NCT01520558|11702520|FG001|NOT COMPLETED|Overall Study||2
10548666|NCT01520558|11702521|FG002|NOT COMPLETED|Overall Study||3
10548667|NCT01520688|11702529|FG000|STARTED|Overall Study||4
10548668|NCT01520688|11702530|FG001|STARTED|Overall Study||4
10548669|NCT01520688|11702531|FG002|STARTED|Overall Study||4
10548670|NCT01520688|11702532|FG003|STARTED|Overall Study||5
10548671|NCT01520688|11702533|FG004|STARTED|Overall Study||5
10548672|NCT01520688|11702534|FG005|STARTED|Overall Study||5
10548673|NCT01520688|11702535|FG006|STARTED|Overall Study||5
10548674|NCT01520688|11702529|FG000|COMPLETED|Overall Study||4
10548675|NCT01520688|11702530|FG001|COMPLETED|Overall Study||2
10548676|NCT01520688|11702531|FG002|COMPLETED|Overall Study||4
10548677|NCT01520688|11702532|FG003|COMPLETED|Overall Study||4
10548678|NCT01520688|11702533|FG004|COMPLETED|Overall Study||4
10548679|NCT01520688|11702534|FG005|COMPLETED|Overall Study||5
10548680|NCT01520688|11702535|FG006|COMPLETED|Overall Study||0
10548681|NCT01520688|11702529|FG000|NOT COMPLETED|Overall Study||0
10548682|NCT01520688|11702530|FG001|NOT COMPLETED|Overall Study||2
10548683|NCT01520688|11702531|FG002|NOT COMPLETED|Overall Study||0
10548684|NCT01520688|11702532|FG003|NOT COMPLETED|Overall Study||1
10548685|NCT01520688|11702533|FG004|NOT COMPLETED|Overall Study||1
10548686|NCT01520688|11702534|FG005|NOT COMPLETED|Overall Study||0
10548687|NCT01520688|11702535|FG006|NOT COMPLETED|Overall Study||5
10548688|NCT01520727|11702552|FG000|STARTED|Overall Study||6
10548689|NCT01520727|11702553|FG001|STARTED|Overall Study||6
10548690|NCT01520727|11702554|FG002|STARTED|Overall Study||6
10548691|NCT01520727|11702555|FG003|STARTED|Overall Study||6
10548692|NCT01520727|11702556|FG004|STARTED|Overall Study||6
10548693|NCT01520727|11702557|FG005|STARTED|Overall Study||6
10548694|NCT01520727|11702558|FG006|STARTED|Overall Study||6
10548695|NCT01520727|11702559|FG007|STARTED|Overall Study||6
10548696|NCT01520727|11702560|FG008|STARTED|Overall Study||16
10548697|NCT01520727|11702552|FG000|COMPLETED|Overall Study||6
10548698|NCT01520727|11702553|FG001|COMPLETED|Overall Study||6
10548699|NCT01520727|11702554|FG002|COMPLETED|Overall Study||6
10548700|NCT01520727|11702555|FG003|COMPLETED|Overall Study||6
10548701|NCT01520727|11702556|FG004|COMPLETED|Overall Study||6
10548702|NCT01520727|11702557|FG005|COMPLETED|Overall Study||6
10548703|NCT01520727|11702558|FG006|COMPLETED|Overall Study||6
10548704|NCT01520727|11702559|FG007|COMPLETED|Overall Study||6
10548705|NCT01520727|11702560|FG008|COMPLETED|Overall Study||16
10548706|NCT01520727|11702552|FG000|NOT COMPLETED|Overall Study||0
10548707|NCT01520727|11702553|FG001|NOT COMPLETED|Overall Study||0
10548708|NCT01520727|11702554|FG002|NOT COMPLETED|Overall Study||0
10548709|NCT01520727|11702555|FG003|NOT COMPLETED|Overall Study||0
10548710|NCT01520727|11702556|FG004|NOT COMPLETED|Overall Study||0
10548711|NCT01520727|11702557|FG005|NOT COMPLETED|Overall Study||0
10548712|NCT01520727|11702558|FG006|NOT COMPLETED|Overall Study||0
10548713|NCT01520727|11702559|FG007|NOT COMPLETED|Overall Study||0
10548714|NCT01520727|11702560|FG008|NOT COMPLETED|Overall Study||0
10548715|NCT01520870|11702580|FG000|STARTED|Overall Study||49
10548716|NCT01520870|11702580|FG000|COMPLETED|Overall Study||47
10548717|NCT01520870|11702580|FG000|NOT COMPLETED|Overall Study||2
10548718|NCT01520909|11702586|FG000|STARTED|Part 1 (Randomized Period)||29
10548719|NCT01520909|11702587|FG001|STARTED|Part 1 (Randomized Period)||63
10548720|NCT01520909|11702588|FG002|STARTED|Part 1 (Randomized Period)||0
10548721|NCT01520909|11702586|FG000|COMPLETED|Part 1 (Randomized Period)||28
10548722|NCT01520909|11702587|FG001|COMPLETED|Part 1 (Randomized Period)||61
10548723|NCT01520909|11702588|FG002|COMPLETED|Part 1 (Randomized Period)||0
10548724|NCT01520909|11702586|FG000|NOT COMPLETED|Part 1 (Randomized Period)||1
10548725|NCT01520909|11702587|FG001|NOT COMPLETED|Part 1 (Randomized Period)||2
10548726|NCT01520909|11702588|FG002|NOT COMPLETED|Part 1 (Randomized Period)||0
10548727|NCT01520909|11702586|FG000|STARTED|Part 2 (Open-Label Period)-Eltrombopag||0
10548728|NCT01520909|11702587|FG001|STARTED|Part 2 (Open-Label Period)-Eltrombopag||0
10548729|NCT01520909|11702588|FG002|STARTED|Part 2 (Open-Label Period)-Eltrombopag|Two participants that completed Part 1 did not start Part 2 because of lack of efficacy.|87
10548730|NCT01520909|11702586|FG000|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
10548731|NCT01520909|11702587|FG001|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
10548732|NCT01520909|11702588|FG002|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||80
10548733|NCT01520909|11702586|FG000|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
10548734|NCT01520909|11702587|FG001|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
10548735|NCT01520909|11702588|FG002|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||7
10548736|NCT01520922|11702610|FG000|STARTED|Treatment Phase||44
10548737|NCT01520922|11702611|FG001|STARTED|Treatment Phase||53
10548738|NCT01520922|11702610|FG000|COMPLETED|Treatment Phase|Completed 6 Cycles of Study Treatment|39
10548739|NCT01520922|11702611|FG001|COMPLETED|Treatment Phase|Completed 6 Cycles of Study Treatment|45
10548740|NCT01520922|11702610|FG000|NOT COMPLETED|Treatment Phase||5
10548741|NCT01520922|11702611|FG001|NOT COMPLETED|Treatment Phase||8
10548742|NCT01520922|11702610|FG000|STARTED|Follow up||44
10548743|NCT01520922|11702611|FG001|STARTED|Follow up||45
10548744|NCT01520922|11702610|FG000|COMPLETED|Follow up||44
10548745|NCT01520922|11702611|FG001|COMPLETED|Follow up||44
10548746|NCT01520922|11702610|FG000|NOT COMPLETED|Follow up||0
10548747|NCT01520922|11702611|FG001|NOT COMPLETED|Follow up||1
10548748|NCT01520922|11702610|FG000|STARTED|Survival Follow-up||21
10548749|NCT01520922|11702611|FG001|STARTED|Survival Follow-up||40
10548750|NCT01520922|11702610|FG000|COMPLETED|Survival Follow-up||20
10548751|NCT01520922|11702611|FG001|COMPLETED|Survival Follow-up||40
10548752|NCT01520922|11702610|FG000|NOT COMPLETED|Survival Follow-up||1
10548753|NCT01520922|11702611|FG001|NOT COMPLETED|Survival Follow-up||0
10548754|NCT01520987|11702625|FG000|STARTED|Overall Study||13
10548755|NCT01520987|11702626|FG001|STARTED|Overall Study||12
10548756|NCT01520987|11702627|FG002|STARTED|Overall Study||11
10548757|NCT01520987|11702628|FG003|STARTED|Overall Study||15
10548758|NCT01520987|11702629|FG004|STARTED|Overall Study||14
10548759|NCT01520987|11702630|FG005|STARTED|Overall Study||14
10548760|NCT01520987|11702631|FG006|STARTED|Overall Study||12
10548761|NCT01520987|11702632|FG007|STARTED|Overall Study||14
10548762|NCT01520987|11702625|FG000|Dosed|Overall Study||13
10548763|NCT01520987|11702626|FG001|Dosed|Overall Study||12
10548764|NCT01520987|11702627|FG002|Dosed|Overall Study||11
10548765|NCT01520987|11702628|FG003|Dosed|Overall Study||15
10548766|NCT01520987|11702629|FG004|Dosed|Overall Study||14
10548767|NCT01520987|11702630|FG005|Dosed|Overall Study||14
10548768|NCT01520987|11702631|FG006|Dosed|Overall Study||12
10548769|NCT01520987|11702632|FG007|Dosed|Overall Study||14
10548770|NCT01520987|11702625|FG000|COMPLETED|Overall Study||12
10548771|NCT01520987|11702626|FG001|COMPLETED|Overall Study||12
10548772|NCT01520987|11702627|FG002|COMPLETED|Overall Study||11
10548773|NCT01520987|11702628|FG003|COMPLETED|Overall Study||15
10548774|NCT01520987|11702629|FG004|COMPLETED|Overall Study||14
10548775|NCT01520987|11702630|FG005|COMPLETED|Overall Study||13
10548776|NCT01520987|11702631|FG006|COMPLETED|Overall Study||12
10548777|NCT01520987|11702632|FG007|COMPLETED|Overall Study||14
10548778|NCT01520987|11702625|FG000|NOT COMPLETED|Overall Study||1
10548779|NCT01520987|11702626|FG001|NOT COMPLETED|Overall Study||0
10548780|NCT01520987|11702627|FG002|NOT COMPLETED|Overall Study||0
10548781|NCT01520987|11702628|FG003|NOT COMPLETED|Overall Study||0
10548782|NCT01520987|11702629|FG004|NOT COMPLETED|Overall Study||0
10548783|NCT01520987|11702630|FG005|NOT COMPLETED|Overall Study||1
10548784|NCT01520987|11702631|FG006|NOT COMPLETED|Overall Study||0
10548785|NCT01520987|11702632|FG007|NOT COMPLETED|Overall Study||0
10548786|NCT01521026|11702650|FG000|STARTED|Overall Study||38
10548787|NCT01521026|11702651|FG001|STARTED|Overall Study||31
10548788|NCT01521026|11702650|FG000|COMPLETED|Overall Study||23
10548789|NCT01521026|11702651|FG001|COMPLETED|Overall Study||28
10548790|NCT01521026|11702650|FG000|NOT COMPLETED|Overall Study||15
10548791|NCT01521026|11702651|FG001|NOT COMPLETED|Overall Study||3
10548792|NCT01521117|11702657|FG000|STARTED|First Intervention (6 Weeks)||10
10548793|NCT01521117|11702658|FG001|STARTED|First Intervention (6 Weeks)||11
10548794|NCT01521117|11702657|FG000|COMPLETED|First Intervention (6 Weeks)||5
10662288|NCT02266706|11824232|FG000|COMPLETED|Overall Study||6
10662289|NCT02266706|11824233|FG001|COMPLETED|Overall Study||6
10662290|NCT02266706|11824234|FG002|COMPLETED|Overall Study||3
10662291|NCT02266706|11824235|FG003|COMPLETED|Overall Study||3
10662292|NCT02266706|11824236|FG004|COMPLETED|Overall Study||1
10662293|NCT02266706|11824237|FG005|COMPLETED|Overall Study||5
10662294|NCT02266706|11824238|FG006|COMPLETED|Overall Study||7
10662295|NCT02266706|11824239|FG007|COMPLETED|Overall Study||2
10662296|NCT02266706|11824240|FG008|COMPLETED|Overall Study||4
10662297|NCT02266706|11824232|FG000|NOT COMPLETED|Overall Study||0
10662298|NCT02266706|11824233|FG001|NOT COMPLETED|Overall Study||1
10662299|NCT02266706|11824234|FG002|NOT COMPLETED|Overall Study||1
10662300|NCT02266706|11824235|FG003|NOT COMPLETED|Overall Study||1
10662301|NCT02266706|11824236|FG004|NOT COMPLETED|Overall Study||0
10662302|NCT02266706|11824237|FG005|NOT COMPLETED|Overall Study||2
10662303|NCT02266706|11824238|FG006|NOT COMPLETED|Overall Study||1
10662304|NCT02266706|11824239|FG007|NOT COMPLETED|Overall Study||0
10662305|NCT02266706|11824240|FG008|NOT COMPLETED|Overall Study||0
10662306|NCT02266810|11824262|FG000|STARTED|Overall Study|sinus sides|80
10662307|NCT02266810|11824263|FG001|STARTED|Overall Study|sinus sides|80
10315666|NCT00181883|11449615|FG000|STARTED|Overall Study||30
10548795|NCT01521117|11702658|FG001|COMPLETED|First Intervention (6 Weeks)||8
10548796|NCT01521117|11702657|FG000|NOT COMPLETED|First Intervention (6 Weeks)||5
10662308|NCT02266810|11824262|FG000|COMPLETED|Overall Study|sinus sides|79
10662309|NCT02266810|11824263|FG001|COMPLETED|Overall Study|sinus sides|79
10662310|NCT02266810|11824262|FG000|NOT COMPLETED|Overall Study||1
10662311|NCT02266810|11824263|FG001|NOT COMPLETED|Overall Study||1
10662312|NCT02266875|11824280|FG000|STARTED|Overall Study||40
10662313|NCT02266875|11824281|FG001|STARTED|Overall Study||30
10662314|NCT02266875|11824280|FG000|COMPLETED|Overall Study||29
10662315|NCT02266875|11824281|FG001|COMPLETED|Overall Study||30
10662316|NCT02266875|11824280|FG000|NOT COMPLETED|Overall Study||11
10662317|NCT02266875|11824281|FG001|NOT COMPLETED|Overall Study||0
10662318|NCT02266888|11824289|FG000|STARTED|Overall Study||15
10662319|NCT02266888|11824290|FG001|STARTED|Overall Study||12
10662320|NCT02266888|11824291|FG002|STARTED|Overall Study||11
10662321|NCT02266888|11824292|FG003|STARTED|Overall Study||7
10662322|NCT02266888|11824289|FG000|COMPLETED|Overall Study||8
10662323|NCT02266888|11824290|FG001|COMPLETED|Overall Study||8
10662324|NCT02266888|11824291|FG002|COMPLETED|Overall Study||0
10662325|NCT02266888|11824292|FG003|COMPLETED|Overall Study||0
10662326|NCT02266888|11824289|FG000|NOT COMPLETED|Overall Study||7
10662327|NCT02266888|11824290|FG001|NOT COMPLETED|Overall Study||4
10662328|NCT02266888|11824291|FG002|NOT COMPLETED|Overall Study||11
10662329|NCT02266888|11824292|FG003|NOT COMPLETED|Overall Study||7
10662330|NCT02267083|11824300|FG000|STARTED|Overall Study||22
10662331|NCT02267083|11824300|FG000|COMPLETED|Overall Study||3
10662332|NCT02267083|11824300|FG000|NOT COMPLETED|Overall Study||19
10662333|NCT02267135|11824306|FG000|STARTED|Period 1 (Randomized Set)||51
10662334|NCT02267135|11824307|FG001|STARTED|Period 1 (Randomized Set)||51
10662335|NCT02267135|11824306|FG000|COMPLETED|Period 1 (Randomized Set)||50
10662336|NCT02267135|11824307|FG001|COMPLETED|Period 1 (Randomized Set)||47
10662337|NCT02267135|11824306|FG000|NOT COMPLETED|Period 1 (Randomized Set)||1
10662338|NCT02267135|11824307|FG001|NOT COMPLETED|Period 1 (Randomized Set)||4
10662339|NCT02267135|11824306|FG000|STARTED|Period 2 (Randomized Set)||50
10662340|NCT02267135|11824307|FG001|STARTED|Period 2 (Randomized Set)||47
10662341|NCT02267135|11824306|FG000|COMPLETED|Period 2 (Randomized Set)||46
10662342|NCT02267135|11824307|FG001|COMPLETED|Period 2 (Randomized Set)||46
10662343|NCT02267135|11824306|FG000|NOT COMPLETED|Period 2 (Randomized Set)||4
10662344|NCT02267135|11824307|FG001|NOT COMPLETED|Period 2 (Randomized Set)||1
10662345|NCT02267187|11824316|FG000|STARTED|Overall Study||15
10662346|NCT02267187|11824316|FG000|COMPLETED|Overall Study||10
10662347|NCT02267187|11824316|FG000|NOT COMPLETED|Overall Study||5
10662348|NCT02267226|11824320|FG000|STARTED|Overall Study||25
10662349|NCT02267226|11824320|FG000|SAFETY Population|Overall Study||25
10662350|NCT02267226|11824320|FG000|FAS-Bleeding Population|Overall Study||24
10662351|NCT02267226|11824320|FG000|Surgical Prophylaxis Population|Overall Study||9
10662352|NCT02267226|11824320|FG000|COMPLETED|Overall Study||18
10662353|NCT02267226|11824320|FG000|NOT COMPLETED|Overall Study||7
10662354|NCT02267278|11824339|FG000|STARTED|Overall Study||25
10662355|NCT02267278|11824339|FG000|COMPLETED|Overall Study||20
10662356|NCT02267278|11824339|FG000|NOT COMPLETED|Overall Study||5
10662357|NCT02267317|11824346|FG000|STARTED|Infusion1||8
10662358|NCT02267317|11824347|FG001|STARTED|Infusion1||3
10662359|NCT02267317|11824348|FG002|STARTED|Infusion1||1
10662360|NCT02267317|11824349|FG003|STARTED|Infusion1||2
10662361|NCT02267317|11824350|FG004|STARTED|Infusion1||0
10662362|NCT02267317|11824351|FG005|STARTED|Infusion1||1
10662363|NCT02267317|11824346|FG000|COMPLETED|Infusion1||8
10662364|NCT02267317|11824347|FG001|COMPLETED|Infusion1||3
10662365|NCT02267317|11824348|FG002|COMPLETED|Infusion1||1
10662366|NCT02267317|11824349|FG003|COMPLETED|Infusion1||2
10662367|NCT02267317|11824350|FG004|COMPLETED|Infusion1||0
10662368|NCT02267317|11824351|FG005|COMPLETED|Infusion1||1
10662369|NCT02267317|11824346|FG000|NOT COMPLETED|Infusion1||0
10662370|NCT02267317|11824347|FG001|NOT COMPLETED|Infusion1||0
10662371|NCT02267317|11824348|FG002|NOT COMPLETED|Infusion1||0
10662372|NCT02267317|11824349|FG003|NOT COMPLETED|Infusion1||0
10662373|NCT02267317|11824350|FG004|NOT COMPLETED|Infusion1||0
10662374|NCT02267317|11824351|FG005|NOT COMPLETED|Infusion1||0
10662375|NCT02267317|11824346|FG000|STARTED|Washout (3-4weeks Between Infusions)||8
10662376|NCT02267317|11824347|FG001|STARTED|Washout (3-4weeks Between Infusions)||3
10662377|NCT02267317|11824348|FG002|STARTED|Washout (3-4weeks Between Infusions)||1
10662378|NCT02267317|11824349|FG003|STARTED|Washout (3-4weeks Between Infusions)||2
10662379|NCT02267317|11824350|FG004|STARTED|Washout (3-4weeks Between Infusions)||0
10662380|NCT02267317|11824351|FG005|STARTED|Washout (3-4weeks Between Infusions)||1
10662381|NCT02267317|11824346|FG000|COMPLETED|Washout (3-4weeks Between Infusions)||6
10662382|NCT02267317|11824347|FG001|COMPLETED|Washout (3-4weeks Between Infusions)||3
10662383|NCT02267317|11824348|FG002|COMPLETED|Washout (3-4weeks Between Infusions)||1
10662384|NCT02267317|11824349|FG003|COMPLETED|Washout (3-4weeks Between Infusions)||2
10662385|NCT02267317|11824350|FG004|COMPLETED|Washout (3-4weeks Between Infusions)||0
10662386|NCT02267317|11824351|FG005|COMPLETED|Washout (3-4weeks Between Infusions)||1
10662387|NCT02267317|11824346|FG000|NOT COMPLETED|Washout (3-4weeks Between Infusions)||2
10662388|NCT02267317|11824347|FG001|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
10662389|NCT02267317|11824348|FG002|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
10662390|NCT02267317|11824349|FG003|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
10662391|NCT02267317|11824350|FG004|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
10662392|NCT02267317|11824351|FG005|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
10662393|NCT02267317|11824346|FG000|STARTED|Infusion2||6
10662394|NCT02267317|11824347|FG001|STARTED|Infusion2||3
10662395|NCT02267317|11824348|FG002|STARTED|Infusion2||1
10662396|NCT02267317|11824349|FG003|STARTED|Infusion2||2
10662397|NCT02267317|11824350|FG004|STARTED|Infusion2||0
10662398|NCT02267317|11824351|FG005|STARTED|Infusion2||1
10662399|NCT02267317|11824346|FG000|COMPLETED|Infusion2||6
10662400|NCT02267317|11824347|FG001|COMPLETED|Infusion2||3
10662401|NCT02267317|11824348|FG002|COMPLETED|Infusion2||1
10662402|NCT02267317|11824349|FG003|COMPLETED|Infusion2||2
10662403|NCT02267317|11824350|FG004|COMPLETED|Infusion2||0
10662404|NCT02267317|11824351|FG005|COMPLETED|Infusion2||1
10662405|NCT02267317|11824346|FG000|NOT COMPLETED|Infusion2||0
10662406|NCT02267317|11824347|FG001|NOT COMPLETED|Infusion2||0
10662407|NCT02267317|11824348|FG002|NOT COMPLETED|Infusion2||0
10662408|NCT02267317|11824349|FG003|NOT COMPLETED|Infusion2||0
10662409|NCT02267317|11824350|FG004|NOT COMPLETED|Infusion2||0
10662410|NCT02267317|11824351|FG005|NOT COMPLETED|Infusion2||0
10662411|NCT02267356|11824370|FG000|STARTED|Initial Study||53
10662412|NCT02267356|11824371|FG001|STARTED|Initial Study||53
10662413|NCT02267356|11824372|FG002|STARTED|Initial Study||52
10662414|NCT02267356|11824373|FG003|STARTED|Initial Study||54
10662415|NCT02267356|11824374|FG004|STARTED|Initial Study||47
10662416|NCT02267356|11824370|FG000|COMPLETED|Initial Study||47
10662417|NCT02267356|11824371|FG001|COMPLETED|Initial Study||48
10662418|NCT02267356|11824372|FG002|COMPLETED|Initial Study||42
10662419|NCT02267356|11824373|FG003|COMPLETED|Initial Study||43
10662420|NCT02267356|11824374|FG004|COMPLETED|Initial Study||42
10662421|NCT02267356|11824370|FG000|NOT COMPLETED|Initial Study||6
10662422|NCT02267356|11824371|FG001|NOT COMPLETED|Initial Study||5
10662423|NCT02267356|11824372|FG002|NOT COMPLETED|Initial Study||10
10662424|NCT02267356|11824373|FG003|NOT COMPLETED|Initial Study||11
10662425|NCT02267356|11824374|FG004|NOT COMPLETED|Initial Study||5
10662426|NCT02267356|11824370|FG000|STARTED|Study Extension||33
10662427|NCT02267356|11824371|FG001|STARTED|Study Extension||37
10662428|NCT02267356|11824372|FG002|STARTED|Study Extension||30
10662429|NCT02267356|11824373|FG003|STARTED|Study Extension||32
10662430|NCT02267356|11824374|FG004|STARTED|Study Extension||26
10662431|NCT02267356|11824370|FG000|COMPLETED|Study Extension||32
10662432|NCT02267356|11824371|FG001|COMPLETED|Study Extension||37
10662433|NCT02267356|11824372|FG002|COMPLETED|Study Extension||29
10662434|NCT02267356|11824373|FG003|COMPLETED|Study Extension||30
10662435|NCT02267356|11824374|FG004|COMPLETED|Study Extension||26
10662436|NCT02267356|11824370|FG000|NOT COMPLETED|Study Extension||1
10662437|NCT02267356|11824371|FG001|NOT COMPLETED|Study Extension||0
10662438|NCT02267356|11824372|FG002|NOT COMPLETED|Study Extension||1
10662439|NCT02267356|11824373|FG003|NOT COMPLETED|Study Extension||2
10662440|NCT02267356|11824374|FG004|NOT COMPLETED|Study Extension||0
10662441|NCT02267382|11824391|FG000|STARTED|Overall Study||42
10662442|NCT02267382|11824392|FG001|STARTED|Overall Study||43
10662443|NCT02267382|11824393|FG002|STARTED|Overall Study||43
10662444|NCT02267382|11824394|FG003|STARTED|Overall Study||41
10662445|NCT02267382|11824395|FG004|STARTED|Overall Study||46
10662446|NCT02267382|11824391|FG000|COMPLETED|Overall Study||35
10662447|NCT02267382|11824392|FG001|COMPLETED|Overall Study||33
10662448|NCT02267382|11824393|FG002|COMPLETED|Overall Study||34
10662449|NCT02267382|11824394|FG003|COMPLETED|Overall Study||35
10662450|NCT02267382|11824395|FG004|COMPLETED|Overall Study||39
10662451|NCT02267382|11824391|FG000|NOT COMPLETED|Overall Study||7
10662452|NCT02267382|11824392|FG001|NOT COMPLETED|Overall Study||10
10662453|NCT02267382|11824393|FG002|NOT COMPLETED|Overall Study||9
10662454|NCT02267382|11824394|FG003|NOT COMPLETED|Overall Study||6
10662455|NCT02267382|11824395|FG004|NOT COMPLETED|Overall Study||7
10662456|NCT02267447|11824409|FG000|STARTED|Overall Study||77251
10662457|NCT02267447|11824410|FG001|STARTED|Overall Study||26968
10662458|NCT02267447|11824409|FG000|COMPLETED|Overall Study||77251
10662459|NCT02267447|11824410|FG001|COMPLETED|Overall Study||26968
10662460|NCT02267447|11824409|FG000|NOT COMPLETED|Overall Study||0
10662461|NCT02267447|11824410|FG001|NOT COMPLETED|Overall Study||0
10662462|NCT02267538|11824419|FG000|STARTED|Overall Study||142
10662463|NCT02267538|11824420|FG001|STARTED|Overall Study||143
10662464|NCT02267538|11824419|FG000|COMPLETED|Overall Study||142
10662465|NCT02267538|11824420|FG001|COMPLETED|Overall Study||143
10662466|NCT02267538|11824419|FG000|NOT COMPLETED|Overall Study||0
10662467|NCT02267538|11824420|FG001|NOT COMPLETED|Overall Study||0
10662468|NCT02267577|11824426|FG000|STARTED|Overall Study||85
10662469|NCT02267577|11824426|FG000|COMPLETED|Overall Study||81
10662470|NCT02267577|11824426|FG000|NOT COMPLETED|Overall Study||4
10662471|NCT02267629|11824431|FG000|STARTED|Overall Study||7
10662472|NCT02267629|11824431|FG000|COMPLETED|Overall Study||7
10662473|NCT02267629|11824431|FG000|NOT COMPLETED|Overall Study||0
10662474|NCT02267746|11824438|FG000|STARTED|Overall Study||298
10662475|NCT02267746|11824439|FG001|STARTED|Overall Study||296
10662476|NCT02267746|11824440|FG002|STARTED|Overall Study||299
10662477|NCT02267746|11824438|FG000|COMPLETED|Overall Study||277
10662478|NCT02267746|11824439|FG001|COMPLETED|Overall Study||274
10662479|NCT02267746|11824440|FG002|COMPLETED|Overall Study||278
10662480|NCT02267746|11824438|FG000|NOT COMPLETED|Overall Study||21
10662481|NCT02267746|11824439|FG001|NOT COMPLETED|Overall Study||22
10662482|NCT02267746|11824440|FG002|NOT COMPLETED|Overall Study||21
10662483|NCT02267772|11824452|FG000|STARTED|Overall Study||50
10662484|NCT02267772|11824453|FG001|STARTED|Overall Study||52
10662485|NCT02267772|11824452|FG000|Randomized|Overall Study||50
10662486|NCT02267772|11824453|FG001|Randomized|Overall Study||52
10662487|NCT02267772|11824452|FG000|Received Study Drug|Overall Study||48
10662488|NCT02267772|11824453|FG001|Received Study Drug|Overall Study||52
10780169|NCT03381339|11941774|FG000|NOT COMPLETED|Overall Study||4
10780170|NCT03381339|11941775|FG001|NOT COMPLETED|Overall Study||4
10780171|NCT03381742|11941785|FG000|STARTED|Overall Study||525
10780172|NCT03381742|11941786|FG001|STARTED|Overall Study||501
10780173|NCT03381742|11941787|FG002|STARTED|Overall Study||1511
10780174|NCT03381742|11941788|FG003|STARTED|Overall Study||506
10780175|NCT03381742|11941785|FG000|COMPLETED|Overall Study||525
10780176|NCT03381742|11941786|FG001|COMPLETED|Overall Study||501
10780177|NCT03381742|11941787|FG002|COMPLETED|Overall Study||1511
10780178|NCT03381742|11941788|FG003|COMPLETED|Overall Study||506
10780179|NCT03381742|11941785|FG000|NOT COMPLETED|Overall Study||0
10780180|NCT03381742|11941786|FG001|NOT COMPLETED|Overall Study||0
10780181|NCT03381742|11941787|FG002|NOT COMPLETED|Overall Study||0
10780182|NCT03381742|11941788|FG003|NOT COMPLETED|Overall Study||0
10662489|NCT02267772|11824452|FG000|COMPLETED|Overall Study||48
10662490|NCT02267772|11824453|FG001|COMPLETED|Overall Study||52
10662491|NCT02267772|11824452|FG000|NOT COMPLETED|Overall Study||2
10662492|NCT02267772|11824453|FG001|NOT COMPLETED|Overall Study||0
10662493|NCT02267811|11824461|FG000|STARTED|Overall Study||16
10662494|NCT02267811|11824462|FG001|STARTED|Overall Study||17
10662495|NCT02267811|11824461|FG000|COMPLETED|Overall Study||15
10662496|NCT02267811|11824462|FG001|COMPLETED|Overall Study||15
10662497|NCT02267811|11824461|FG000|NOT COMPLETED|Overall Study||1
10662498|NCT02267811|11824462|FG001|NOT COMPLETED|Overall Study||2
10662499|NCT02267824|11824472|FG000|STARTED|Overall Study||83
10662500|NCT02267824|11824473|FG001|STARTED|Overall Study||18
10662501|NCT02267824|11824472|FG000|COMPLETED|Overall Study||73
10662502|NCT02267824|11824473|FG001|COMPLETED|Overall Study||17
10662503|NCT02267824|11824472|FG000|NOT COMPLETED|Overall Study||10
10662504|NCT02267824|11824473|FG001|NOT COMPLETED|Overall Study||1
10662505|NCT02267837|11824481|FG000|STARTED|Overall Study||11
10662506|NCT02267837|11824482|FG001|STARTED|Overall Study||9
10662507|NCT02267837|11824481|FG000|COMPLETED|Overall Study||11
10662508|NCT02267837|11824482|FG001|COMPLETED|Overall Study||9
10662509|NCT02267837|11824481|FG000|NOT COMPLETED|Overall Study||0
10315667|NCT00181883|11449615|FG000|COMPLETED|Overall Study||20
10315668|NCT00181883|11449615|FG000|NOT COMPLETED|Overall Study||10
10315669|NCT00181961|11449621|FG000|STARTED|Overall Study||7
10315670|NCT00181961|11449622|FG001|STARTED|Overall Study||9
10315671|NCT00181961|11449621|FG000|COMPLETED|Overall Study||6
10315672|NCT00181961|11449622|FG001|COMPLETED|Overall Study||4
10315673|NCT00181961|11449621|FG000|NOT COMPLETED|Overall Study||1
10315674|NCT00181961|11449622|FG001|NOT COMPLETED|Overall Study||5
10315675|NCT00182000|11449630|FG000|STARTED|Overall Study||14
10315676|NCT00182000|11449631|FG001|STARTED|Overall Study||15
10315677|NCT00182000|11449630|FG000|COMPLETED|Overall Study||9
10315678|NCT00182000|11449631|FG001|COMPLETED|Overall Study||13
10315679|NCT00182000|11449630|FG000|NOT COMPLETED|Overall Study||5
10315680|NCT00182000|11449631|FG001|NOT COMPLETED|Overall Study||2
10315681|NCT00182078|11449639|FG000|STARTED|Overall Study||9
10315682|NCT00182078|11449640|FG001|STARTED|Overall Study||17
10315683|NCT00182078|11449639|FG000|COMPLETED|Overall Study||8
10315684|NCT00182078|11449640|FG001|COMPLETED|Overall Study||17
10315685|NCT00182078|11449639|FG000|NOT COMPLETED|Overall Study||1
10315686|NCT00182078|11449640|FG001|NOT COMPLETED|Overall Study||0
10315687|NCT00182091|11449650|FG000|STARTED|Overall Study||15
10315688|NCT00182091|11449651|FG001|STARTED|Overall Study||15
10315689|NCT00182091|11449652|FG002|STARTED|Overall Study||25
10315690|NCT00182091|11449653|FG003|STARTED|Overall Study||20
10315691|NCT00182091|11449650|FG000|COMPLETED|Overall Study||14
10315692|NCT00182091|11449651|FG001|COMPLETED|Overall Study||15
10315693|NCT00182091|11449652|FG002|COMPLETED|Overall Study||25
10315694|NCT00182091|11449653|FG003|COMPLETED|Overall Study||20
10315695|NCT00182091|11449650|FG000|NOT COMPLETED|Overall Study||1
10315696|NCT00182091|11449651|FG001|NOT COMPLETED|Overall Study||0
10315697|NCT00182091|11449652|FG002|NOT COMPLETED|Overall Study||0
10315698|NCT00182091|11449653|FG003|NOT COMPLETED|Overall Study||0
10662510|NCT02267837|11824482|FG001|NOT COMPLETED|Overall Study||0
10662511|NCT02267850|11824490|FG000|STARTED|Overall Study||15
10662512|NCT02267850|11824491|FG001|STARTED|Overall Study||14
10662513|NCT02267850|11824490|FG000|COMPLETED|Overall Study||14
10662514|NCT02267850|11824491|FG001|COMPLETED|Overall Study||12
10662515|NCT02267850|11824490|FG000|NOT COMPLETED|Overall Study||1
10662516|NCT02267850|11824491|FG001|NOT COMPLETED|Overall Study||2
10662517|NCT02268045|11824499|FG000|STARTED|Overall Study||136
10662518|NCT02268045|11824500|FG001|STARTED|Overall Study||136
10662519|NCT02268045|11824499|FG000|COMPLETED|Overall Study||120
10315699|NCT00182325|11449663|FG000|STARTED|Overall Study||97
10315700|NCT00182325|11449664|FG001|STARTED|Overall Study||96
10315701|NCT00182325|11449663|FG000|COMPLETED|Overall Study|63 completed survey, 85 included in intention-to-treat analysis|63
10315702|NCT00182325|11449664|FG001|COMPLETED|Overall Study|43 completed survey, 89 included in intention-to-treat analysis|43
10315703|NCT00182325|11449663|FG000|NOT COMPLETED|Overall Study||34
10315704|NCT00182325|11449664|FG001|NOT COMPLETED|Overall Study||53
10315705|NCT00182689|11449672|FG000|STARTED|Overall Study||40
10315706|NCT00182689|11449673|FG001|STARTED|Overall Study||49
10662520|NCT02268045|11824500|FG001|COMPLETED|Overall Study||116
10662521|NCT02268045|11824499|FG000|NOT COMPLETED|Overall Study||16
10662522|NCT02268045|11824500|FG001|NOT COMPLETED|Overall Study||20
10712126|NCT02667457|11877694|FG001|Dosed Participants|Overall Study||10
10662523|NCT02268058|11824512|FG000|STARTED|Overall Study||20
10662524|NCT02268058|11824513|FG001|STARTED|Overall Study||20
10662525|NCT02268058|11824514|FG002|STARTED|Overall Study||20
10662526|NCT02268058|11824515|FG003|STARTED|Overall Study||20
10662527|NCT02268058|11824512|FG000|COMPLETED|Overall Study||19
10662528|NCT02268058|11824513|FG001|COMPLETED|Overall Study||20
10662529|NCT02268058|11824514|FG002|COMPLETED|Overall Study||20
10662530|NCT02268058|11824515|FG003|COMPLETED|Overall Study||20
10662531|NCT02268058|11824512|FG000|NOT COMPLETED|Overall Study||1
10662532|NCT02268058|11824513|FG001|NOT COMPLETED|Overall Study||0
10662533|NCT02268058|11824514|FG002|NOT COMPLETED|Overall Study||0
10662534|NCT02268058|11824515|FG003|NOT COMPLETED|Overall Study||0
10662535|NCT02268084|11824527|FG000|STARTED|Overall Study||49
10662536|NCT02268084|11824528|FG001|STARTED|Overall Study||47
10662537|NCT02268084|11824527|FG000|COMPLETED|Overall Study||40
10662538|NCT02268084|11824528|FG001|COMPLETED|Overall Study||40
10662539|NCT02268084|11824527|FG000|NOT COMPLETED|Overall Study||9
10662540|NCT02268084|11824528|FG001|NOT COMPLETED|Overall Study||7
10662541|NCT02268214|11824543|FG000|STARTED|Overall Study||277
10662542|NCT02268214|11824544|FG001|STARTED|Overall Study||296
10662543|NCT02268214|11824545|FG002|STARTED|Overall Study||260
10662544|NCT02268214|11824543|FG000|COMPLETED 24 WEEK PERIOD|Overall Study||252
10662545|NCT02268214|11824544|FG001|COMPLETED 24 WEEK PERIOD|Overall Study||273
10662546|NCT02268214|11824545|FG002|COMPLETED 24 WEEK PERIOD|Overall Study||232
10662547|NCT02268214|11824543|FG000|COMPLETED|Overall Study||235
10662548|NCT02268214|11824544|FG001|COMPLETED|Overall Study||255
10662549|NCT02268214|11824545|FG002|COMPLETED|Overall Study||218
10662550|NCT02268214|11824543|FG000|NOT COMPLETED|Overall Study||42
10662551|NCT02268214|11824544|FG001|NOT COMPLETED|Overall Study||41
10662552|NCT02268214|11824545|FG002|NOT COMPLETED|Overall Study||42
10662553|NCT02268396|11824553|FG000|STARTED|Overall Study||138
10662554|NCT02268396|11824553|FG000|COMPLETED|Overall Study||126
10662555|NCT02268396|11824553|FG000|NOT COMPLETED|Overall Study||12
10662556|NCT02268500|11824559|FG000|STARTED|Overall Study||24
10662557|NCT02268500|11824560|FG001|STARTED|Overall Study||24
10662558|NCT02268500|11824559|FG000|COMPLETED|Overall Study||24
10662559|NCT02268500|11824560|FG001|COMPLETED|Overall Study||24
10662560|NCT02268500|11824559|FG000|NOT COMPLETED|Overall Study||0
10662561|NCT02268500|11824560|FG001|NOT COMPLETED|Overall Study||0
10662562|NCT02268526|11824569|FG000|STARTED|Overall Study||6
10662563|NCT02268526|11824570|FG001|STARTED|Overall Study||59
10662564|NCT02268526|11824571|FG002|STARTED|Overall Study||21
10662565|NCT02268526|11824569|FG000|PD Analysis Set (Cohort 2)|Overall Study||0
10662566|NCT02268526|11824570|FG001|PD Analysis Set (Cohort 2)|Overall Study||42
10662567|NCT02268526|11824571|FG002|PD Analysis Set (Cohort 2)|Overall Study||17
10662568|NCT02268526|11824569|FG000|COMPLETED|Overall Study||5
10662569|NCT02268526|11824570|FG001|COMPLETED|Overall Study||38
10662570|NCT02268526|11824571|FG002|COMPLETED|Overall Study||16
10662571|NCT02268526|11824569|FG000|NOT COMPLETED|Overall Study||1
10662572|NCT02268526|11824570|FG001|NOT COMPLETED|Overall Study||21
10662573|NCT02268526|11824571|FG002|NOT COMPLETED|Overall Study||5
10662574|NCT02268786|11824583|FG000|STARTED|Overall Study||330
10662575|NCT02268786|11824584|FG001|STARTED|Overall Study||331
10662576|NCT02268786|11824583|FG000|COMPLETED|Overall Study||274
10662577|NCT02268786|11824584|FG001|COMPLETED|Overall Study||313
10662578|NCT02268786|11824583|FG000|NOT COMPLETED|Overall Study||56
10662579|NCT02268786|11824584|FG001|NOT COMPLETED|Overall Study||18
10662580|NCT02268812|11824594|FG000|STARTED|Overall Study||77
10662581|NCT02268812|11824595|FG001|STARTED|Overall Study||72
10662582|NCT02268812|11824596|FG002|STARTED|Overall Study||30
10662583|NCT02268812|11824597|FG003|STARTED|Overall Study||40
10662584|NCT02268812|11824594|FG000|COMPLETED|Overall Study||61
10662585|NCT02268812|11824595|FG001|COMPLETED|Overall Study||40
10662586|NCT02268812|11824596|FG002|COMPLETED|Overall Study||21
10662587|NCT02268812|11824597|FG003|COMPLETED|Overall Study||26
10662588|NCT02268812|11824594|FG000|NOT COMPLETED|Overall Study||16
10662589|NCT02268812|11824595|FG001|NOT COMPLETED|Overall Study||32
10662590|NCT02268812|11824596|FG002|NOT COMPLETED|Overall Study||9
10662591|NCT02268812|11824597|FG003|NOT COMPLETED|Overall Study||14
10662610|NCT02268864|11824635|FG000|STARTED|Overall Study||17
10662611|NCT02268864|11824636|FG001|STARTED|Overall Study||25
10662612|NCT02268864|11824637|FG002|STARTED|Overall Study||64
10662613|NCT02268864|11824635|FG000|COMPLETED|Overall Study||15
10662614|NCT02268864|11824636|FG001|COMPLETED|Overall Study||24
10662615|NCT02268864|11824637|FG002|COMPLETED|Overall Study||64
10662616|NCT02268864|11824635|FG000|NOT COMPLETED|Overall Study||2
10662617|NCT02268864|11824636|FG001|NOT COMPLETED|Overall Study||1
10662618|NCT02268864|11824637|FG002|NOT COMPLETED|Overall Study||0
10662619|NCT02268877|11824649|FG000|STARTED|Overall Study||122
10662620|NCT02268877|11824650|FG001|STARTED|Overall Study|111 patients were randomized to this arm.|111
10662621|NCT02268877|11824649|FG000|COMPLETED|Overall Study||118
10662622|NCT02268877|11824650|FG001|COMPLETED|Overall Study|106 patients received the intervention.|106
10662623|NCT02268877|11824649|FG000|NOT COMPLETED|Overall Study||4
10662624|NCT02268877|11824650|FG001|NOT COMPLETED|Overall Study||5
10662625|NCT02268942|11824656|FG000|STARTED|Overall Study||144
10662626|NCT02268942|11824656|FG000|COMPLETED|Overall Study||144
10662627|NCT02268942|11824656|FG000|NOT COMPLETED|Overall Study||0
10662628|NCT02268955|11824662|FG000|STARTED|Overall Study||11
10662629|NCT02268955|11824663|FG001|STARTED|Overall Study||11
10662630|NCT02268955|11824662|FG000|COMPLETED|Overall Study||9
10662631|NCT02268955|11824663|FG001|COMPLETED|Overall Study||9
10662632|NCT02268955|11824662|FG000|NOT COMPLETED|Overall Study||2
10662633|NCT02268955|11824663|FG001|NOT COMPLETED|Overall Study||2
10662634|NCT02268994|11824671|FG000|STARTED|Overall Study||117
10662635|NCT02268994|11824672|FG001|STARTED|Overall Study||116
10662636|NCT02268994|11824671|FG000|COMPLETED|Overall Study||86
10662637|NCT02268994|11824672|FG001|COMPLETED|Overall Study||81
10662638|NCT02268994|11824671|FG000|NOT COMPLETED|Overall Study||31
10662639|NCT02268994|11824672|FG001|NOT COMPLETED|Overall Study||35
10662640|NCT02269098|11824683|FG000|STARTED|Overall Study||51
10662641|NCT02269098|11824684|FG001|STARTED|Overall Study||50
10662642|NCT02269098|11824683|FG000|COMPLETED|Overall Study||37
10662643|NCT02269098|11824684|FG001|COMPLETED|Overall Study||41
10662644|NCT02269098|11824683|FG000|NOT COMPLETED|Overall Study||14
10662645|NCT02269098|11824684|FG001|NOT COMPLETED|Overall Study||9
10662646|NCT02269124|11824693|FG000|STARTED|Overall Study||21
10662647|NCT02269124|11824694|FG001|STARTED|Overall Study||16
10662648|NCT02269124|11824693|FG000|Completed Survey Round 1 (Arm 1, 0 Weeks)|Overall Study||20
10662649|NCT02269124|11824694|FG001|Completed Survey Round 1 (Arm 1, 0 Weeks)|Overall Study||14
10662650|NCT02269124|11824693|FG000|Completed Survey Round 2 (Arm 1, 6 Weeks)|Overall Study||17
10662651|NCT02269124|11824694|FG001|Completed Survey Round 2 (Arm 1, 6 Weeks)|Overall Study||13
10662652|NCT02269124|11824693|FG000|Completed Survey Round 3 (Arm 1, 12 Weeks)|Overall Study||17
10662653|NCT02269124|11824694|FG001|Completed Survey Round 3 (Arm 1, 12 Weeks)|Overall Study||11
10662654|NCT02269124|11824693|FG000|Completed Survey Round 4 (Arm 2, 12 Weeks)|Overall Study||11
10662655|NCT02269124|11824694|FG001|Completed Survey Round 4 (Arm 2, 12 Weeks)|Overall Study||8
10662656|NCT02269124|11824693|FG000|Completed Survey Round 5 (Arm 2, 18 Weeks)|Overall Study||16
10662657|NCT02269124|11824694|FG001|Completed Survey Round 5 (Arm 2, 18 Weeks)|Overall Study||10
10662658|NCT02269124|11824693|FG000|Completed Survey Round 6 (Arm 2, 24 Weeks)|Overall Study||14
10662659|NCT02269124|11824694|FG001|Completed Survey Round 6 (Arm 2, 24 Weeks)|Overall Study||10
10662660|NCT02269124|11824693|FG000|COMPLETED|Overall Study|One participant from the Conventional Measures Only First arm did not return any surveys, nor did their parent/guardian or teacher, and were deemed lost to follow-up.|20
10662661|NCT02269124|11824694|FG001|COMPLETED|Overall Study|Two participants from the Conventional measures + Hearing Aid First arm withdrew from the study prior to the second arm because they did not wish to stop using the hearing aid.|14
10662662|NCT02269124|11824693|FG000|NOT COMPLETED|Overall Study||1
10662663|NCT02269124|11824694|FG001|NOT COMPLETED|Overall Study||2
10662664|NCT02269163|11824703|FG000|STARTED|Overall Study||50
10662665|NCT02269163|11824704|FG001|STARTED|Overall Study||25
10662666|NCT02269163|11824703|FG000|COMPLETED|Overall Study||47
10662667|NCT02269163|11824704|FG001|COMPLETED|Overall Study||18
10662668|NCT02269163|11824703|FG000|NOT COMPLETED|Overall Study||3
10662669|NCT02269163|11824704|FG001|NOT COMPLETED|Overall Study||7
10662670|NCT02269241|11824712|FG000|STARTED|Overall Study||1552
10662671|NCT02269241|11824712|FG000|COMPLETED|Overall Study||352
10662672|NCT02269241|11824712|FG000|NOT COMPLETED|Overall Study||1200
10662673|NCT02269423|11824721|FG000|STARTED|Overall Study||10
10662674|NCT02269423|11824722|FG001|STARTED|Overall Study||10
10662675|NCT02269423|11824723|FG002|STARTED|Overall Study||10
10662676|NCT02269423|11824724|FG003|STARTED|Overall Study||9
10662677|NCT02269423|11824721|FG000|COMPLETED|Overall Study||10
10662678|NCT02269423|11824722|FG001|COMPLETED|Overall Study||9
10662679|NCT02269423|11824723|FG002|COMPLETED|Overall Study||10
10662680|NCT02269423|11824724|FG003|COMPLETED|Overall Study||8
10662681|NCT02269423|11824721|FG000|NOT COMPLETED|Overall Study||0
10662682|NCT02269423|11824722|FG001|NOT COMPLETED|Overall Study||1
10662683|NCT02269423|11824723|FG002|NOT COMPLETED|Overall Study||0
10662684|NCT02269423|11824724|FG003|NOT COMPLETED|Overall Study||1
10662685|NCT02269475|11824736|FG000|STARTED|Overall Study||868
10662686|NCT02269475|11824737|FG001|STARTED|Overall Study||433
10662687|NCT02269475|11824736|FG000|Received IP (Safety Population)|Overall Study||868
10662688|NCT02269475|11824737|FG001|Received IP (Safety Population)|Overall Study||433
10662689|NCT02269475|11824736|FG000|Per Protocol Population|Overall Study||849
10662690|NCT02269475|11824737|FG001|Per Protocol Population|Overall Study||430
10662691|NCT02269475|11824736|FG000|COMPLETED|Overall Study||865
10662692|NCT02269475|11824737|FG001|COMPLETED|Overall Study||432
10662693|NCT02269475|11824736|FG000|NOT COMPLETED|Overall Study||3
10662694|NCT02269475|11824737|FG001|NOT COMPLETED|Overall Study||1
10662695|NCT02269488|11824744|FG000|STARTED|Overall Study||100
10662696|NCT02269488|11824744|FG000|COMPLETED|Overall Study||100
10662697|NCT02269488|11824744|FG000|NOT COMPLETED|Overall Study||0
10662698|NCT02269631|11824750|FG000|STARTED|Overall Study||7
10662699|NCT02269631|11824751|FG001|STARTED|Overall Study||5
10662700|NCT02269631|11824750|FG000|COMPLETED|Overall Study||7
10662701|NCT02269631|11824751|FG001|COMPLETED|Overall Study||5
10662702|NCT02269631|11824750|FG000|NOT COMPLETED|Overall Study||0
10662703|NCT02269631|11824751|FG001|NOT COMPLETED|Overall Study||0
10662704|NCT02269657|11824757|FG000|STARTED|Overall Study||40
10662705|NCT02269657|11824757|FG000|COMPLETED|Overall Study||37
10662706|NCT02269657|11824757|FG000|NOT COMPLETED|Overall Study||3
10662707|NCT02269709|11824763|FG000|STARTED|Time of Enrollment||21
10662708|NCT02269709|11824763|FG000|COMPLETED|Time of Enrollment||18
10662709|NCT02269709|11824763|FG000|NOT COMPLETED|Time of Enrollment||3
10662710|NCT02269709|11824763|FG000|STARTED|Follow-up #1 (24-72 Hours Post-surgery)||18
10662711|NCT02269709|11824763|FG000|COMPLETED|Follow-up #1 (24-72 Hours Post-surgery)||17
10662712|NCT02269709|11824763|FG000|NOT COMPLETED|Follow-up #1 (24-72 Hours Post-surgery)||1
10662713|NCT02269709|11824763|FG000|STARTED|Prior to Hospital Discharge||17
10662714|NCT02269709|11824763|FG000|COMPLETED|Prior to Hospital Discharge||17
10662715|NCT02269709|11824763|FG000|NOT COMPLETED|Prior to Hospital Discharge||0
10662716|NCT02269709|11824763|FG000|STARTED|Six Month Follow-up||17
10662717|NCT02269709|11824763|FG000|COMPLETED|Six Month Follow-up||5
10662718|NCT02269709|11824763|FG000|NOT COMPLETED|Six Month Follow-up||12
10662719|NCT02269787|11824770|FG000|STARTED|Overall Study||148
10662720|NCT02269787|11824771|FG001|STARTED|Overall Study||150
10662721|NCT02269787|11824770|FG000|COMPLETED|Overall Study||126
10662722|NCT02269787|11824771|FG001|COMPLETED|Overall Study||140
10662723|NCT02269787|11824770|FG000|NOT COMPLETED|Overall Study||22
10662724|NCT02269787|11824771|FG001|NOT COMPLETED|Overall Study||10
10662725|NCT02269943|11824779|FG000|STARTED|Treatment Period||6
10662726|NCT02269943|11824780|FG001|STARTED|Treatment Period||30
10662727|NCT02269943|11824779|FG000|Investigational Product (IP) Stopped|Treatment Period||6
10662728|NCT02269943|11824780|FG001|Investigational Product (IP) Stopped|Treatment Period||30
10662729|NCT02269943|11824779|FG000|COMPLETED|Treatment Period|Not applicable according to the study design|0
10662730|NCT02269943|11824780|FG001|COMPLETED|Treatment Period|Not applicable according to the study design|0
10662731|NCT02269943|11824779|FG000|NOT COMPLETED|Treatment Period||6
10662732|NCT02269943|11824780|FG001|NOT COMPLETED|Treatment Period||30
10662733|NCT02269943|11824779|FG000|STARTED|Follow-Up Survival Period||5
10662734|NCT02269943|11824780|FG001|STARTED|Follow-Up Survival Period||26
10662735|NCT02269943|11824779|FG000|COMPLETED|Follow-Up Survival Period|Not applicable according to the study design.|0
10662736|NCT02269943|11824780|FG001|COMPLETED|Follow-Up Survival Period|Not applicable according to the study design.|0
10662737|NCT02269943|11824779|FG000|NOT COMPLETED|Follow-Up Survival Period||5
10662738|NCT02269943|11824780|FG001|NOT COMPLETED|Follow-Up Survival Period||26
10662739|NCT02270060|11824789|FG000|STARTED|Overall Study||20
10662740|NCT02270060|11824790|FG001|STARTED|Overall Study||20
10662741|NCT02270060|11824791|FG002|STARTED|Overall Study||20
10662742|NCT02270060|11824789|FG000|COMPLETED|Overall Study||20
10662743|NCT02270060|11824790|FG001|COMPLETED|Overall Study||20
10662744|NCT02270060|11824791|FG002|COMPLETED|Overall Study||20
10662745|NCT02270060|11824789|FG000|NOT COMPLETED|Overall Study||0
10662746|NCT02270060|11824790|FG001|NOT COMPLETED|Overall Study||0
10662747|NCT02270060|11824791|FG002|NOT COMPLETED|Overall Study||0
10662748|NCT02270242|11824801|FG000|STARTED|Overall Study||3555
10662749|NCT02270242|11824802|FG001|STARTED|Overall Study||3564
10662750|NCT02270242|11824801|FG000|COMPLETED|Overall Study||3496
10662751|NCT02270242|11824802|FG001|COMPLETED|Overall Study||3511
10662752|NCT02270242|11824801|FG000|NOT COMPLETED|Overall Study||59
10662753|NCT02270242|11824802|FG001|NOT COMPLETED|Overall Study||53
10662754|NCT02270255|11824810|FG000|STARTED|Overall Study||22
10662755|NCT02270255|11824811|FG001|STARTED|Overall Study||22
10662756|NCT02270255|11824810|FG000|Complete Data at Discharge PACU|Overall Study||22
10780183|NCT03381989|11941798|FG000|STARTED|Overall Study||30
10662757|NCT02270255|11824811|FG001|Complete Data at Discharge PACU|Overall Study||22
10662758|NCT02270255|11824810|FG000|Complete Data From Home Survey|Overall Study||21
10662759|NCT02270255|11824811|FG001|Complete Data From Home Survey|Overall Study||22
10662760|NCT02270255|11824810|FG000|COMPLETED|Overall Study||21
10662761|NCT02270255|11824811|FG001|COMPLETED|Overall Study||22
10662762|NCT02270255|11824810|FG000|NOT COMPLETED|Overall Study||1
10662763|NCT02270255|11824811|FG001|NOT COMPLETED|Overall Study||0
10662764|NCT02270515|11824817|FG000|STARTED|Intervention Period 1: 0-6 Months||175
10662765|NCT02270515|11824817|FG000|COMPLETED|Intervention Period 1: 0-6 Months||159
10662766|NCT02270515|11824817|FG000|NOT COMPLETED|Intervention Period 1: 0-6 Months||16
10662767|NCT02270515|11824817|FG000|STARTED|Intervention Period 2: 6-12 Months||159
10662768|NCT02270515|11824817|FG000|COMPLETED|Intervention Period 2: 6-12 Months||127
10662769|NCT02270515|11824817|FG000|NOT COMPLETED|Intervention Period 2: 6-12 Months||32
10662770|NCT02270515|11824817|FG000|STARTED|Intervention Period 3: 12-18 Months||127
10662771|NCT02270515|11824817|FG000|COMPLETED|Intervention Period 3: 12-18 Months||103
10662772|NCT02270515|11824817|FG000|NOT COMPLETED|Intervention Period 3: 12-18 Months||24
10662773|NCT02270645|11824830|FG000|STARTED|Overall Study||8
10662774|NCT02270645|11824831|FG001|STARTED|Overall Study||4
10662775|NCT02270645|11824830|FG000|COMPLETED|Overall Study||6
10662776|NCT02270645|11824831|FG001|COMPLETED|Overall Study||4
10662777|NCT02270645|11824830|FG000|NOT COMPLETED|Overall Study||2
10662778|NCT02270645|11824831|FG001|NOT COMPLETED|Overall Study||0
10662779|NCT02270671|11824839|FG000|STARTED|Overall Study||64
10662780|NCT02270671|11824840|FG001|STARTED|Overall Study||66
10662781|NCT02270671|11824839|FG000|COMPLETED|Overall Study||59
10662782|NCT02270671|11824840|FG001|COMPLETED|Overall Study||61
10662783|NCT02270671|11824839|FG000|NOT COMPLETED|Overall Study||5
10662784|NCT02270671|11824840|FG001|NOT COMPLETED|Overall Study||5
10662785|NCT02270736|11824849|FG000|STARTED|Main Period (MP) (up to 16 Weeks)||72
10662786|NCT02270736|11824850|FG001|STARTED|Main Period (MP) (up to 16 Weeks)||148
10662787|NCT02270736|11824851|FG002|STARTED|Main Period (MP) (up to 16 Weeks)||36
10662788|NCT02270736|11824852|FG003|STARTED|Main Period (MP) (up to 16 Weeks)||0
10662789|NCT02270736|11824853|FG004|STARTED|Main Period (MP) (up to 16 Weeks)||0
10662790|NCT02270736|11824849|FG000|Treated|Main Period (MP) (up to 16 Weeks)||72
10662791|NCT02270736|11824850|FG001|Treated|Main Period (MP) (up to 16 Weeks)||148
10662792|NCT02270736|11824851|FG002|Treated|Main Period (MP) (up to 16 Weeks)||35
10662793|NCT02270736|11824852|FG003|Treated|Main Period (MP) (up to 16 Weeks)||0
10662794|NCT02270736|11824853|FG004|Treated|Main Period (MP) (up to 16 Weeks)||0
10662795|NCT02270736|11824849|FG000|COMPLETED|Main Period (MP) (up to 16 Weeks)||70
10662796|NCT02270736|11824850|FG001|COMPLETED|Main Period (MP) (up to 16 Weeks)||146
10662797|NCT02270736|11824851|FG002|COMPLETED|Main Period (MP) (up to 16 Weeks)||34
10662798|NCT02270736|11824852|FG003|COMPLETED|Main Period (MP) (up to 16 Weeks)||0
10662799|NCT02270736|11824853|FG004|COMPLETED|Main Period (MP) (up to 16 Weeks)||0
10662800|NCT02270736|11824849|FG000|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||2
10662801|NCT02270736|11824850|FG001|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||2
10662802|NCT02270736|11824851|FG002|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||2
10662803|NCT02270736|11824852|FG003|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||0
10662804|NCT02270736|11824853|FG004|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||0
10662805|NCT02270736|11824849|FG000|STARTED|OLEX Period (up to 48 Weeks)||0
10662806|NCT02270736|11824850|FG001|STARTED|OLEX Period (up to 48 Weeks)||0
10662807|NCT02270736|11824851|FG002|STARTED|OLEX Period (up to 48 Weeks)||0
10662808|NCT02270736|11824852|FG003|STARTED|OLEX Period (up to 48 Weeks)|2 participants from MP did not enter OLEX due to withdrawal of consent.|214
10662809|NCT02270736|11824853|FG004|STARTED|OLEX Period (up to 48 Weeks)|1 participant from MP did not enter OLEX due to adverse event.|33
10662810|NCT02270736|11824849|FG000|COMPLETED|OLEX Period (up to 48 Weeks)||0
10662811|NCT02270736|11824850|FG001|COMPLETED|OLEX Period (up to 48 Weeks)||0
10662812|NCT02270736|11824851|FG002|COMPLETED|OLEX Period (up to 48 Weeks)||0
10662813|NCT02270736|11824852|FG003|COMPLETED|OLEX Period (up to 48 Weeks)||189
10662814|NCT02270736|11824853|FG004|COMPLETED|OLEX Period (up to 48 Weeks)||33
10662815|NCT02270736|11824849|FG000|NOT COMPLETED|OLEX Period (up to 48 Weeks)||0
10662816|NCT02270736|11824850|FG001|NOT COMPLETED|OLEX Period (up to 48 Weeks)||0
10662817|NCT02270736|11824851|FG002|NOT COMPLETED|OLEX Period (up to 48 Weeks)||0
10662818|NCT02270736|11824852|FG003|NOT COMPLETED|OLEX Period (up to 48 Weeks)||25
10662819|NCT02270736|11824853|FG004|NOT COMPLETED|OLEX Period (up to 48 Weeks)||0
10662820|NCT02270944|11824868|FG000|STARTED|Overall Study||529
10662821|NCT02270944|11824869|FG001|STARTED|Overall Study||521
10662822|NCT02270944|11824868|FG000|COMPLETED|Overall Study||518
10662823|NCT02270944|11824869|FG001|COMPLETED|Overall Study||516
10662824|NCT02270944|11824868|FG000|NOT COMPLETED|Overall Study||11
10662825|NCT02270944|11824869|FG001|NOT COMPLETED|Overall Study||5
10662826|NCT02270983|11824879|FG000|STARTED|Overall Study||79
10662827|NCT02270983|11824880|FG001|STARTED|Overall Study||87
10780184|NCT03381989|11941798|FG000|COMPLETED|Overall Study||22
10780185|NCT03381989|11941798|FG000|NOT COMPLETED|Overall Study||8
10662828|NCT02270983|11824881|FG002|STARTED|Overall Study||88
10662829|NCT02270983|11824879|FG000|COMPLETED|Overall Study||70
10662830|NCT02270983|11824880|FG001|COMPLETED|Overall Study||80
10662831|NCT02270983|11824881|FG002|COMPLETED|Overall Study||76
10662832|NCT02270983|11824879|FG000|NOT COMPLETED|Overall Study||9
10662833|NCT02270983|11824880|FG001|NOT COMPLETED|Overall Study||7
10662834|NCT02270983|11824881|FG002|NOT COMPLETED|Overall Study||12
10662835|NCT02271217|11824892|FG000|STARTED|Overall Study||126
10662836|NCT02271217|11824893|FG001|STARTED|Overall Study||126
10662837|NCT02271217|11824894|FG002|STARTED|Overall Study||125
10662838|NCT02271217|11824892|FG000|COMPLETED|Overall Study||115
10662839|NCT02271217|11824893|FG001|COMPLETED|Overall Study||113
10662840|NCT02271217|11824894|FG002|COMPLETED|Overall Study||113
10662841|NCT02271217|11824892|FG000|NOT COMPLETED|Overall Study||11
10662842|NCT02271217|11824893|FG001|NOT COMPLETED|Overall Study||13
10662843|NCT02271217|11824894|FG002|NOT COMPLETED|Overall Study||12
10662844|NCT02271386|11824906|FG000|STARTED|Baseline Period- 8 Months||53
10662845|NCT02271386|11824907|FG001|STARTED|Baseline Period- 8 Months||52
10662846|NCT02271386|11824908|FG002|STARTED|Baseline Period- 8 Months||200
10662847|NCT02271386|11824909|FG003|STARTED|Baseline Period- 8 Months||191
10662848|NCT02271386|11824906|FG000|COMPLETED|Baseline Period- 8 Months||53
10662849|NCT02271386|11824907|FG001|COMPLETED|Baseline Period- 8 Months||52
10662850|NCT02271386|11824908|FG002|COMPLETED|Baseline Period- 8 Months||200
10662851|NCT02271386|11824909|FG003|COMPLETED|Baseline Period- 8 Months||191
10662852|NCT02271386|11824906|FG000|NOT COMPLETED|Baseline Period- 8 Months||0
10662853|NCT02271386|11824907|FG001|NOT COMPLETED|Baseline Period- 8 Months||0
10662854|NCT02271386|11824908|FG002|NOT COMPLETED|Baseline Period- 8 Months||0
10662855|NCT02271386|11824909|FG003|NOT COMPLETED|Baseline Period- 8 Months||0
10662856|NCT02271386|11824906|FG000|STARTED|Intervention Period- 8 Months||53
10662857|NCT02271386|11824907|FG001|STARTED|Intervention Period- 8 Months||52
10662858|NCT02271386|11824908|FG002|STARTED|Intervention Period- 8 Months||202
10662859|NCT02271386|11824909|FG003|STARTED|Intervention Period- 8 Months||197
10662860|NCT02271386|11824906|FG000|COMPLETED|Intervention Period- 8 Months||53
10662861|NCT02271386|11824907|FG001|COMPLETED|Intervention Period- 8 Months||52
10662862|NCT02271386|11824908|FG002|COMPLETED|Intervention Period- 8 Months||202
10662863|NCT02271386|11824909|FG003|COMPLETED|Intervention Period- 8 Months||197
10662864|NCT02271386|11824906|FG000|NOT COMPLETED|Intervention Period- 8 Months||0
10662865|NCT02271386|11824907|FG001|NOT COMPLETED|Intervention Period- 8 Months||0
10662866|NCT02271386|11824908|FG002|NOT COMPLETED|Intervention Period- 8 Months||0
10662867|NCT02271386|11824909|FG003|NOT COMPLETED|Intervention Period- 8 Months||0
10662868|NCT02271425|11824923|FG000|STARTED|Overall Study||8
10662869|NCT02271425|11824923|FG000|COMPLETED|Overall Study||8
10662870|NCT02271425|11824923|FG000|NOT COMPLETED|Overall Study||0
10662871|NCT02271451|11824930|FG000|STARTED|Overall Study||7
10662872|NCT02271451|11824931|FG001|STARTED|Overall Study||8
10662873|NCT02271451|11824930|FG000|COMPLETED|Overall Study||7
10662874|NCT02271451|11824931|FG001|COMPLETED|Overall Study|one subject does not have MRI data due to braces|7
10662875|NCT02271451|11824930|FG000|NOT COMPLETED|Overall Study||0
10662876|NCT02271451|11824931|FG001|NOT COMPLETED|Overall Study||1
10662877|NCT02271477|11824939|FG000|STARTED|Overall Study||80
10662878|NCT02271477|11824940|FG001|STARTED|Overall Study||80
10662879|NCT02271477|11824939|FG000|COMPLETED|Overall Study||80
10662880|NCT02271477|11824940|FG001|COMPLETED|Overall Study||80
10662881|NCT02271477|11824939|FG000|NOT COMPLETED|Overall Study||0
10662882|NCT02271477|11824940|FG001|NOT COMPLETED|Overall Study||0
10662883|NCT02271529|11824947|FG000|STARTED|Overall Study||40
10662884|NCT02271529|11824947|FG000|COMPLETED|Overall Study||39
10662885|NCT02271529|11824947|FG000|NOT COMPLETED|Overall Study||1
10662886|NCT02271698|11824955|FG000|STARTED|Overall Study||11
10662887|NCT02271698|11824956|FG001|STARTED|Overall Study||10
10662888|NCT02271698|11824957|FG002|STARTED|Overall Study||10
10662889|NCT02271698|11824958|FG003|STARTED|Overall Study||11
10662890|NCT02271698|11824955|FG000|COMPLETED|Overall Study||11
10662891|NCT02271698|11824956|FG001|COMPLETED|Overall Study||10
10662892|NCT02271698|11824957|FG002|COMPLETED|Overall Study||10
10662893|NCT02271698|11824958|FG003|COMPLETED|Overall Study||11
10662894|NCT02271698|11824955|FG000|NOT COMPLETED|Overall Study||0
10662895|NCT02271698|11824956|FG001|NOT COMPLETED|Overall Study||0
10662896|NCT02271698|11824957|FG002|NOT COMPLETED|Overall Study||0
10662897|NCT02271698|11824958|FG003|NOT COMPLETED|Overall Study||0
10662898|NCT02271854|11824968|FG000|STARTED|Overall Study||102
10662899|NCT02271854|11824968|FG000|COMPLETED|Overall Study||98
10662900|NCT02271854|11824968|FG000|NOT COMPLETED|Overall Study||4
10662901|NCT02271880|11824975|FG000|STARTED|Overall Study||3
10662902|NCT02271880|11824976|FG001|STARTED|Overall Study||4
10662903|NCT02271880|11824975|FG000|COMPLETED|Overall Study||0
10662904|NCT02271880|11824976|FG001|COMPLETED|Overall Study||0
10662905|NCT02271880|11824975|FG000|NOT COMPLETED|Overall Study||3
10662906|NCT02271880|11824976|FG001|NOT COMPLETED|Overall Study||4
10662907|NCT02271906|11824984|FG000|STARTED|Overall Study||2
10662908|NCT02271906|11824984|FG000|COMPLETED|Overall Study||2
10662909|NCT02271906|11824984|FG000|NOT COMPLETED|Overall Study||0
10662910|NCT02271945|11824990|FG000|STARTED|Overall Study||5
10662911|NCT02271945|11824991|FG001|STARTED|Overall Study||5
10662912|NCT02271945|11824990|FG000|COMPLETED|Overall Study||0
10662913|NCT02271945|11824991|FG001|COMPLETED|Overall Study||0
10662914|NCT02271945|11824990|FG000|NOT COMPLETED|Overall Study||5
10662915|NCT02271945|11824991|FG001|NOT COMPLETED|Overall Study||5
10662916|NCT02271984|11824997|FG000|STARTED|First Intervention Period (1 Day)||3
10662917|NCT02271984|11824998|FG001|STARTED|First Intervention Period (1 Day)||3
10662918|NCT02271984|11824999|FG002|STARTED|First Intervention Period (1 Day)||3
10662919|NCT02271984|11825000|FG003|STARTED|First Intervention Period (1 Day)||3
10662920|NCT02271984|11825001|FG004|STARTED|First Intervention Period (1 Day)||3
10662921|NCT02271984|11825002|FG005|STARTED|First Intervention Period (1 Day)||3
10662922|NCT02271984|11825003|FG006|STARTED|First Intervention Period (1 Day)||3
10662923|NCT02271984|11825004|FG007|STARTED|First Intervention Period (1 Day)||3
10662924|NCT02271984|11825005|FG008|STARTED|First Intervention Period (1 Day)||3
10662925|NCT02271984|11825006|FG009|STARTED|First Intervention Period (1 Day)||3
10662926|NCT02271984|11825007|FG010|STARTED|First Intervention Period (1 Day)||3
10662927|NCT02271984|11825008|FG011|STARTED|First Intervention Period (1 Day)||3
10662928|NCT02271984|11824997|FG000|COMPLETED|First Intervention Period (1 Day)||3
10662929|NCT02271984|11824998|FG001|COMPLETED|First Intervention Period (1 Day)||3
10662930|NCT02271984|11824999|FG002|COMPLETED|First Intervention Period (1 Day)||3
10662931|NCT02271984|11825000|FG003|COMPLETED|First Intervention Period (1 Day)||3
10662932|NCT02271984|11825001|FG004|COMPLETED|First Intervention Period (1 Day)||3
10662933|NCT02271984|11825002|FG005|COMPLETED|First Intervention Period (1 Day)||3
10662934|NCT02271984|11825003|FG006|COMPLETED|First Intervention Period (1 Day)||3
10548797|NCT01521117|11702658|FG001|NOT COMPLETED|First Intervention (6 Weeks)||3
10548798|NCT01521117|11702657|FG000|STARTED|Washout (4 Weeks)||5
10548799|NCT01521117|11702658|FG001|STARTED|Washout (4 Weeks)||8
10548800|NCT01521117|11702657|FG000|COMPLETED|Washout (4 Weeks)||5
10548801|NCT01521117|11702658|FG001|COMPLETED|Washout (4 Weeks)||8
10548802|NCT01521117|11702657|FG000|NOT COMPLETED|Washout (4 Weeks)||0
10548803|NCT01521117|11702658|FG001|NOT COMPLETED|Washout (4 Weeks)||0
10548804|NCT01521117|11702657|FG000|STARTED|Second Intervention (6 Weeks)||5
10548805|NCT01521117|11702658|FG001|STARTED|Second Intervention (6 Weeks)||8
10548806|NCT01521117|11702657|FG000|COMPLETED|Second Intervention (6 Weeks)||5
10548807|NCT01521117|11702658|FG001|COMPLETED|Second Intervention (6 Weeks)||5
10548808|NCT01521117|11702657|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
10548809|NCT01521117|11702658|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||3
10548810|NCT01521260|11702666|FG000|STARTED|Overall Study||15
10548811|NCT01521260|11702667|FG001|STARTED|Overall Study||15
10548812|NCT01521260|11702666|FG000|COMPLETED|Overall Study||15
10548813|NCT01521260|11702667|FG001|COMPLETED|Overall Study||15
10548814|NCT01521260|11702666|FG000|NOT COMPLETED|Overall Study||0
10548815|NCT01521260|11702667|FG001|NOT COMPLETED|Overall Study||0
10548816|NCT01521364|11702673|FG000|STARTED|Linezolid Without Clarithromycin (1 wk)||7
10548817|NCT01521364|11702673|FG000|COMPLETED|Linezolid Without Clarithromycin (1 wk)||7
10548818|NCT01521364|11702673|FG000|NOT COMPLETED|Linezolid Without Clarithromycin (1 wk)||0
10548819|NCT01521364|11702673|FG000|STARTED|Linezolid + 250mg Claritromycin (wk 2&3)||7
10548820|NCT01521364|11702673|FG000|COMPLETED|Linezolid + 250mg Claritromycin (wk 2&3)||6
10548821|NCT01521364|11702673|FG000|NOT COMPLETED|Linezolid + 250mg Claritromycin (wk 2&3)||1
10548822|NCT01521364|11702673|FG000|STARTED|Linezolid + 500mg Claritromycin (wk 4&5)||6
10548823|NCT01521364|11702673|FG000|COMPLETED|Linezolid + 500mg Claritromycin (wk 4&5)||5
10548824|NCT01521364|11702673|FG000|NOT COMPLETED|Linezolid + 500mg Claritromycin (wk 4&5)||1
10548825|NCT01521494|11702689|FG000|STARTED|Overall Study||39
10548826|NCT01521494|11702690|FG001|STARTED|Overall Study||36
10548827|NCT01521494|11702691|FG002|STARTED|Overall Study||35
10548828|NCT01521494|11702692|FG003|STARTED|Overall Study||36
10548829|NCT01521494|11702693|FG004|STARTED|Overall Study||37
10662935|NCT02271984|11825004|FG007|COMPLETED|First Intervention Period (1 Day)||3
10662936|NCT02271984|11825005|FG008|COMPLETED|First Intervention Period (1 Day)||3
10662937|NCT02271984|11825006|FG009|COMPLETED|First Intervention Period (1 Day)||3
10662938|NCT02271984|11825007|FG010|COMPLETED|First Intervention Period (1 Day)||3
10662939|NCT02271984|11825008|FG011|COMPLETED|First Intervention Period (1 Day)||3
10662940|NCT02271984|11824997|FG000|NOT COMPLETED|First Intervention Period (1 Day)||0
10662941|NCT02271984|11824998|FG001|NOT COMPLETED|First Intervention Period (1 Day)||0
10662942|NCT02271984|11824999|FG002|NOT COMPLETED|First Intervention Period (1 Day)||0
10662943|NCT02271984|11825000|FG003|NOT COMPLETED|First Intervention Period (1 Day)||0
10662944|NCT02271984|11825001|FG004|NOT COMPLETED|First Intervention Period (1 Day)||0
10662945|NCT02271984|11825002|FG005|NOT COMPLETED|First Intervention Period (1 Day)||0
10662946|NCT02271984|11825003|FG006|NOT COMPLETED|First Intervention Period (1 Day)||0
10662947|NCT02271984|11825004|FG007|NOT COMPLETED|First Intervention Period (1 Day)||0
10662948|NCT02271984|11825005|FG008|NOT COMPLETED|First Intervention Period (1 Day)||0
10662949|NCT02271984|11825006|FG009|NOT COMPLETED|First Intervention Period (1 Day)||0
10662950|NCT02271984|11825007|FG010|NOT COMPLETED|First Intervention Period (1 Day)||0
10662951|NCT02271984|11825008|FG011|NOT COMPLETED|First Intervention Period (1 Day)||0
10662952|NCT02271984|11824997|FG000|STARTED|Washout Period 1 (7 Days)||3
10662953|NCT02271984|11824998|FG001|STARTED|Washout Period 1 (7 Days)||3
10662954|NCT02271984|11824999|FG002|STARTED|Washout Period 1 (7 Days)||3
10662955|NCT02271984|11825000|FG003|STARTED|Washout Period 1 (7 Days)||3
10662956|NCT02271984|11825001|FG004|STARTED|Washout Period 1 (7 Days)||3
10662957|NCT02271984|11825002|FG005|STARTED|Washout Period 1 (7 Days)||3
10662958|NCT02271984|11825003|FG006|STARTED|Washout Period 1 (7 Days)||3
10662959|NCT02271984|11825004|FG007|STARTED|Washout Period 1 (7 Days)||3
10780186|NCT03382262|11941807|FG000|STARTED|Overall Study||12
10662960|NCT02271984|11825005|FG008|STARTED|Washout Period 1 (7 Days)||3
10662961|NCT02271984|11825006|FG009|STARTED|Washout Period 1 (7 Days)||3
10662962|NCT02271984|11825007|FG010|STARTED|Washout Period 1 (7 Days)||3
10662963|NCT02271984|11825008|FG011|STARTED|Washout Period 1 (7 Days)||3
10662964|NCT02271984|11824997|FG000|COMPLETED|Washout Period 1 (7 Days)||3
10662965|NCT02271984|11824998|FG001|COMPLETED|Washout Period 1 (7 Days)||3
10662966|NCT02271984|11824999|FG002|COMPLETED|Washout Period 1 (7 Days)||3
10662967|NCT02271984|11825000|FG003|COMPLETED|Washout Period 1 (7 Days)||3
10662968|NCT02271984|11825001|FG004|COMPLETED|Washout Period 1 (7 Days)||3
10662969|NCT02271984|11825002|FG005|COMPLETED|Washout Period 1 (7 Days)||3
10662970|NCT02271984|11825003|FG006|COMPLETED|Washout Period 1 (7 Days)||3
10662971|NCT02271984|11825004|FG007|COMPLETED|Washout Period 1 (7 Days)||3
10662972|NCT02271984|11825005|FG008|COMPLETED|Washout Period 1 (7 Days)||3
10662973|NCT02271984|11825006|FG009|COMPLETED|Washout Period 1 (7 Days)||3
10662974|NCT02271984|11825007|FG010|COMPLETED|Washout Period 1 (7 Days)||3
10662975|NCT02271984|11825008|FG011|COMPLETED|Washout Period 1 (7 Days)||3
10662976|NCT02271984|11824997|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
10662977|NCT02271984|11824998|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
10662978|NCT02271984|11824999|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
10662979|NCT02271984|11825000|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
10662980|NCT02271984|11825001|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
10662981|NCT02271984|11825002|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
10662982|NCT02271984|11825003|FG006|NOT COMPLETED|Washout Period 1 (7 Days)||0
10662983|NCT02271984|11825004|FG007|NOT COMPLETED|Washout Period 1 (7 Days)||0
10662984|NCT02271984|11825005|FG008|NOT COMPLETED|Washout Period 1 (7 Days)||0
10662985|NCT02271984|11825006|FG009|NOT COMPLETED|Washout Period 1 (7 Days)||0
10662986|NCT02271984|11825007|FG010|NOT COMPLETED|Washout Period 1 (7 Days)||0
10662987|NCT02271984|11825008|FG011|NOT COMPLETED|Washout Period 1 (7 Days)||0
10662988|NCT02271984|11824997|FG000|STARTED|Second Intervention Period (1 Day)||3
10662989|NCT02271984|11824998|FG001|STARTED|Second Intervention Period (1 Day)||3
10662990|NCT02271984|11824999|FG002|STARTED|Second Intervention Period (1 Day)||3
10662991|NCT02271984|11825000|FG003|STARTED|Second Intervention Period (1 Day)||3
10662992|NCT02271984|11825001|FG004|STARTED|Second Intervention Period (1 Day)||3
10662993|NCT02271984|11825002|FG005|STARTED|Second Intervention Period (1 Day)||3
10662994|NCT02271984|11825003|FG006|STARTED|Second Intervention Period (1 Day)||3
10662995|NCT02271984|11825004|FG007|STARTED|Second Intervention Period (1 Day)||3
10662996|NCT02271984|11825005|FG008|STARTED|Second Intervention Period (1 Day)||3
10662997|NCT02271984|11825006|FG009|STARTED|Second Intervention Period (1 Day)||3
10662998|NCT02271984|11825007|FG010|STARTED|Second Intervention Period (1 Day)||3
10662999|NCT02271984|11825008|FG011|STARTED|Second Intervention Period (1 Day)||3
10663000|NCT02271984|11824997|FG000|COMPLETED|Second Intervention Period (1 Day)||3
10663001|NCT02271984|11824998|FG001|COMPLETED|Second Intervention Period (1 Day)||3
10663002|NCT02271984|11824999|FG002|COMPLETED|Second Intervention Period (1 Day)||3
10663003|NCT02271984|11825000|FG003|COMPLETED|Second Intervention Period (1 Day)||3
10663004|NCT02271984|11825001|FG004|COMPLETED|Second Intervention Period (1 Day)||3
10663005|NCT02271984|11825002|FG005|COMPLETED|Second Intervention Period (1 Day)||3
10663006|NCT02271984|11825003|FG006|COMPLETED|Second Intervention Period (1 Day)||3
10663007|NCT02271984|11825004|FG007|COMPLETED|Second Intervention Period (1 Day)||3
10663008|NCT02271984|11825005|FG008|COMPLETED|Second Intervention Period (1 Day)||3
10663009|NCT02271984|11825006|FG009|COMPLETED|Second Intervention Period (1 Day)||3
10663010|NCT02271984|11825007|FG010|COMPLETED|Second Intervention Period (1 Day)||3
10663011|NCT02271984|11825008|FG011|COMPLETED|Second Intervention Period (1 Day)||3
10663012|NCT02271984|11824997|FG000|NOT COMPLETED|Second Intervention Period (1 Day)||0
10663013|NCT02271984|11824998|FG001|NOT COMPLETED|Second Intervention Period (1 Day)||0
10663014|NCT02271984|11824999|FG002|NOT COMPLETED|Second Intervention Period (1 Day)||0
10663015|NCT02271984|11825000|FG003|NOT COMPLETED|Second Intervention Period (1 Day)||0
10663016|NCT02271984|11825001|FG004|NOT COMPLETED|Second Intervention Period (1 Day)||0
10663017|NCT02271984|11825002|FG005|NOT COMPLETED|Second Intervention Period (1 Day)||0
10663018|NCT02271984|11825003|FG006|NOT COMPLETED|Second Intervention Period (1 Day)||0
10663019|NCT02271984|11825004|FG007|NOT COMPLETED|Second Intervention Period (1 Day)||0
10663020|NCT02271984|11825005|FG008|NOT COMPLETED|Second Intervention Period (1 Day)||0
10663021|NCT02271984|11825006|FG009|NOT COMPLETED|Second Intervention Period (1 Day)||0
10663022|NCT02271984|11825007|FG010|NOT COMPLETED|Second Intervention Period (1 Day)||0
10663023|NCT02271984|11825008|FG011|NOT COMPLETED|Second Intervention Period (1 Day)||0
10663024|NCT02271984|11824997|FG000|STARTED|Washout Period 2 (7 Days)||3
10663025|NCT02271984|11824998|FG001|STARTED|Washout Period 2 (7 Days)||3
10663026|NCT02271984|11824999|FG002|STARTED|Washout Period 2 (7 Days)||3
10663027|NCT02271984|11825000|FG003|STARTED|Washout Period 2 (7 Days)||3
10663028|NCT02271984|11825001|FG004|STARTED|Washout Period 2 (7 Days)||3
10663029|NCT02271984|11825002|FG005|STARTED|Washout Period 2 (7 Days)||3
10663030|NCT02271984|11825003|FG006|STARTED|Washout Period 2 (7 Days)||3
10663031|NCT02271984|11825004|FG007|STARTED|Washout Period 2 (7 Days)||3
10663032|NCT02271984|11825005|FG008|STARTED|Washout Period 2 (7 Days)||3
10663033|NCT02271984|11825006|FG009|STARTED|Washout Period 2 (7 Days)||3
10663034|NCT02271984|11825007|FG010|STARTED|Washout Period 2 (7 Days)||3
10663035|NCT02271984|11825008|FG011|STARTED|Washout Period 2 (7 Days)||3
10663036|NCT02271984|11824997|FG000|COMPLETED|Washout Period 2 (7 Days)||3
10663037|NCT02271984|11824998|FG001|COMPLETED|Washout Period 2 (7 Days)||3
10663038|NCT02271984|11824999|FG002|COMPLETED|Washout Period 2 (7 Days)||3
10663039|NCT02271984|11825000|FG003|COMPLETED|Washout Period 2 (7 Days)||3
10663040|NCT02271984|11825001|FG004|COMPLETED|Washout Period 2 (7 Days)||3
10663041|NCT02271984|11825002|FG005|COMPLETED|Washout Period 2 (7 Days)||3
10663042|NCT02271984|11825003|FG006|COMPLETED|Washout Period 2 (7 Days)||3
10663043|NCT02271984|11825004|FG007|COMPLETED|Washout Period 2 (7 Days)||3
10663044|NCT02271984|11825005|FG008|COMPLETED|Washout Period 2 (7 Days)||3
10663045|NCT02271984|11825006|FG009|COMPLETED|Washout Period 2 (7 Days)||3
10663046|NCT02271984|11825007|FG010|COMPLETED|Washout Period 2 (7 Days)||3
10663047|NCT02271984|11825008|FG011|COMPLETED|Washout Period 2 (7 Days)||3
10663048|NCT02271984|11824997|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
10663049|NCT02271984|11824998|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
10663050|NCT02271984|11824999|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
10663051|NCT02271984|11825000|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
10663052|NCT02271984|11825001|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
10663053|NCT02271984|11825002|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
10663054|NCT02271984|11825003|FG006|NOT COMPLETED|Washout Period 2 (7 Days)||0
10663055|NCT02271984|11825004|FG007|NOT COMPLETED|Washout Period 2 (7 Days)||0
10663056|NCT02271984|11825005|FG008|NOT COMPLETED|Washout Period 2 (7 Days)||0
10663057|NCT02271984|11825006|FG009|NOT COMPLETED|Washout Period 2 (7 Days)||0
10663058|NCT02271984|11825007|FG010|NOT COMPLETED|Washout Period 2 (7 Days)||0
10663059|NCT02271984|11825008|FG011|NOT COMPLETED|Washout Period 2 (7 Days)||0
10663060|NCT02271984|11824997|FG000|STARTED|Third Intervention Period (1 Day)||3
10663061|NCT02271984|11824998|FG001|STARTED|Third Intervention Period (1 Day)||3
10663062|NCT02271984|11824999|FG002|STARTED|Third Intervention Period (1 Day)||3
10663063|NCT02271984|11825000|FG003|STARTED|Third Intervention Period (1 Day)||3
10663064|NCT02271984|11825001|FG004|STARTED|Third Intervention Period (1 Day)||3
10663065|NCT02271984|11825002|FG005|STARTED|Third Intervention Period (1 Day)||3
10663066|NCT02271984|11825003|FG006|STARTED|Third Intervention Period (1 Day)||3
10663067|NCT02271984|11825004|FG007|STARTED|Third Intervention Period (1 Day)||3
10663068|NCT02271984|11825005|FG008|STARTED|Third Intervention Period (1 Day)||3
10663069|NCT02271984|11825006|FG009|STARTED|Third Intervention Period (1 Day)||3
10663070|NCT02271984|11825007|FG010|STARTED|Third Intervention Period (1 Day)||3
10663071|NCT02271984|11825008|FG011|STARTED|Third Intervention Period (1 Day)||3
10663072|NCT02271984|11824997|FG000|COMPLETED|Third Intervention Period (1 Day)||3
10663073|NCT02271984|11824998|FG001|COMPLETED|Third Intervention Period (1 Day)||3
10663074|NCT02271984|11824999|FG002|COMPLETED|Third Intervention Period (1 Day)||3
10663075|NCT02271984|11825000|FG003|COMPLETED|Third Intervention Period (1 Day)||3
10663076|NCT02271984|11825001|FG004|COMPLETED|Third Intervention Period (1 Day)||3
10663077|NCT02271984|11825002|FG005|COMPLETED|Third Intervention Period (1 Day)||3
10663078|NCT02271984|11825003|FG006|COMPLETED|Third Intervention Period (1 Day)||3
10663079|NCT02271984|11825004|FG007|COMPLETED|Third Intervention Period (1 Day)||3
10663080|NCT02271984|11825005|FG008|COMPLETED|Third Intervention Period (1 Day)||3
10663081|NCT02271984|11825006|FG009|COMPLETED|Third Intervention Period (1 Day)||3
10663082|NCT02271984|11825007|FG010|COMPLETED|Third Intervention Period (1 Day)||3
10663083|NCT02271984|11825008|FG011|COMPLETED|Third Intervention Period (1 Day)||3
10663084|NCT02271984|11824997|FG000|NOT COMPLETED|Third Intervention Period (1 Day)||0
10663085|NCT02271984|11824998|FG001|NOT COMPLETED|Third Intervention Period (1 Day)||0
10663086|NCT02271984|11824999|FG002|NOT COMPLETED|Third Intervention Period (1 Day)||0
10663087|NCT02271984|11825000|FG003|NOT COMPLETED|Third Intervention Period (1 Day)||0
10663088|NCT02271984|11825001|FG004|NOT COMPLETED|Third Intervention Period (1 Day)||0
10663089|NCT02271984|11825002|FG005|NOT COMPLETED|Third Intervention Period (1 Day)||0
10663090|NCT02271984|11825003|FG006|NOT COMPLETED|Third Intervention Period (1 Day)||0
10663091|NCT02271984|11825004|FG007|NOT COMPLETED|Third Intervention Period (1 Day)||0
10663092|NCT02271984|11825005|FG008|NOT COMPLETED|Third Intervention Period (1 Day)||0
10663093|NCT02271984|11825006|FG009|NOT COMPLETED|Third Intervention Period (1 Day)||0
10663094|NCT02271984|11825007|FG010|NOT COMPLETED|Third Intervention Period (1 Day)||0
10663095|NCT02271984|11825008|FG011|NOT COMPLETED|Third Intervention Period (1 Day)||0
10663096|NCT02271984|11824997|FG000|STARTED|Washout Period 3 (7 Days)||3
10663097|NCT02271984|11824998|FG001|STARTED|Washout Period 3 (7 Days)||3
10663098|NCT02271984|11824999|FG002|STARTED|Washout Period 3 (7 Days)||3
10663099|NCT02271984|11825000|FG003|STARTED|Washout Period 3 (7 Days)||3
10663100|NCT02271984|11825001|FG004|STARTED|Washout Period 3 (7 Days)||3
10663101|NCT02271984|11825002|FG005|STARTED|Washout Period 3 (7 Days)||3
10663102|NCT02271984|11825003|FG006|STARTED|Washout Period 3 (7 Days)||3
10663103|NCT02271984|11825004|FG007|STARTED|Washout Period 3 (7 Days)||3
10780187|NCT03382262|11941808|FG001|STARTED|Overall Study||13
10780188|NCT03382262|11941809|FG002|STARTED|Overall Study||15
10780189|NCT03382262|11941810|FG003|STARTED|Overall Study||15
10780190|NCT03382262|11941807|FG000|COMPLETED|Overall Study||12
10780191|NCT03382262|11941808|FG001|COMPLETED|Overall Study||13
10780192|NCT03382262|11941809|FG002|COMPLETED|Overall Study||14
10780193|NCT03382262|11941810|FG003|COMPLETED|Overall Study||14
10780194|NCT03382262|11941807|FG000|NOT COMPLETED|Overall Study||0
10780195|NCT03382262|11941808|FG001|NOT COMPLETED|Overall Study||0
10780196|NCT03382262|11941809|FG002|NOT COMPLETED|Overall Study||1
10780197|NCT03382262|11941810|FG003|NOT COMPLETED|Overall Study||1
10780198|NCT03382418|11941823|FG000|STARTED|Overall Study||25
10780199|NCT03382418|11941824|FG001|STARTED|Overall Study||15
10780200|NCT03382418|11941825|FG002|STARTED|Overall Study||5
10780201|NCT03382418|11941823|FG000|Month .5 Immunogenicity Cohort|Overall Study||25
10780202|NCT03382418|11941824|FG001|Month .5 Immunogenicity Cohort|Overall Study||14
10780203|NCT03382418|11941825|FG002|Month .5 Immunogenicity Cohort|Overall Study||5
10780204|NCT03382418|11941823|FG000|Month 6.5 Immunogenicity Cohort|Overall Study||21
10780205|NCT03382418|11941824|FG001|Month 6.5 Immunogenicity Cohort|Overall Study||13
10780206|NCT03382418|11941825|FG002|Month 6.5 Immunogenicity Cohort|Overall Study||5
10780207|NCT03382418|11941823|FG000|COMPLETED|Overall Study||22
10780208|NCT03382418|11941824|FG001|COMPLETED|Overall Study||12
10780209|NCT03382418|11941825|FG002|COMPLETED|Overall Study||5
10780210|NCT03382418|11941823|FG000|NOT COMPLETED|Overall Study||3
10780211|NCT03382418|11941824|FG001|NOT COMPLETED|Overall Study||3
10780212|NCT03382418|11941825|FG002|NOT COMPLETED|Overall Study||0
10780213|NCT03382509|11941836|FG000|STARTED|Overall Study||8
10780214|NCT03382509|11941837|FG001|STARTED|Overall Study||8
10780215|NCT03382509|11941836|FG000|COMPLETED|Overall Study||8
10780216|NCT03382509|11941837|FG001|COMPLETED|Overall Study||8
10780217|NCT03382509|11941836|FG000|NOT COMPLETED|Overall Study||0
10780218|NCT03382509|11941837|FG001|NOT COMPLETED|Overall Study||0
10780219|NCT03382665|11941844|FG000|STARTED|Overall Study||70
10780220|NCT03382665|11941844|FG000|Actual Enrollment|Overall Study||59
10780221|NCT03382665|11941844|FG000|5 Year Follow up|Overall Study||25
10780222|NCT03382665|11941844|FG000|COMPLETED|Overall Study||25
10780223|NCT03382665|11941844|FG000|NOT COMPLETED|Overall Study||45
10780224|NCT03382821|11941854|FG000|STARTED|Overall Study||60
10780225|NCT03382821|11941855|FG001|STARTED|Overall Study||60
10780226|NCT03382821|11941854|FG000|COMPLETED|Overall Study||60
10780227|NCT03382821|11941855|FG001|COMPLETED|Overall Study||57
10780228|NCT03382821|11941854|FG000|NOT COMPLETED|Overall Study||0
10780229|NCT03382821|11941855|FG001|NOT COMPLETED|Overall Study||3
10780230|NCT03382847|11941862|FG000|STARTED|Overall Study||25
10780231|NCT03382847|11941862|FG000|COMPLETED|Overall Study||25
10780232|NCT03382847|11941862|FG000|NOT COMPLETED|Overall Study||0
10780233|NCT03382899|11941868|FG000|STARTED|Overall Study||51
10780234|NCT03382899|11941869|FG001|STARTED|Overall Study||50
10780235|NCT03382899|11941868|FG000|Received at Least 1 Dose of Study Drug|Overall Study||50
10780236|NCT03382899|11941869|FG001|Received at Least 1 Dose of Study Drug|Overall Study||48
10780237|NCT03382899|11941868|FG000|COMPLETED|Overall Study||20
10780238|NCT03382899|11941869|FG001|COMPLETED|Overall Study||15
10780239|NCT03382899|11941868|FG000|NOT COMPLETED|Overall Study||31
10780240|NCT03382899|11941869|FG001|NOT COMPLETED|Overall Study||35
10780241|NCT03382912|11941877|FG000|STARTED|Overall Study||27
10780242|NCT03382912|11941878|FG001|STARTED|Overall Study||25
10780243|NCT03382912|11941877|FG000|Received at Least 1 Dose of Study Drug|Overall Study||27
10780244|NCT03382912|11941878|FG001|Received at Least 1 Dose of Study Drug|Overall Study||24
10780245|NCT03382912|11941877|FG000|COMPLETED|Overall Study||21
10780246|NCT03382912|11941878|FG001|COMPLETED|Overall Study||13
10780247|NCT03382912|11941877|FG000|NOT COMPLETED|Overall Study||6
10780248|NCT03382912|11941878|FG001|NOT COMPLETED|Overall Study||12
10780249|NCT03383146|11941886|FG000|STARTED|Overall Study||148
10780250|NCT03383146|11941887|FG001|STARTED|Overall Study||302
10780251|NCT03383146|11941886|FG000|Safety Population|Overall Study||145
10780252|NCT03383146|11941887|FG001|Safety Population|Overall Study||299
10780253|NCT03383146|11941886|FG000|Run-in Period|Overall Study||91
10780254|NCT03383146|11941887|FG001|Run-in Period|Overall Study||207
10780255|NCT03383146|11941886|FG000|COMPLETED|Overall Study||63
10780256|NCT03383146|11941887|FG001|COMPLETED|Overall Study||118
10780257|NCT03383146|11941886|FG000|NOT COMPLETED|Overall Study||85
10780258|NCT03383146|11941887|FG001|NOT COMPLETED|Overall Study||184
10780259|NCT03383198|11941896|FG000|STARTED|Overall Study||4
10780260|NCT03383198|11941897|FG001|STARTED|Overall Study||1
10780261|NCT03383198|11941896|FG000|COMPLETED|Overall Study||4
10780262|NCT03383198|11941897|FG001|COMPLETED|Overall Study||1
10780263|NCT03383198|11941896|FG000|NOT COMPLETED|Overall Study||0
10780264|NCT03383198|11941897|FG001|NOT COMPLETED|Overall Study||0
10780265|NCT03383523|11941910|FG000|STARTED|Overall Study||11
10780266|NCT03383523|11941911|FG001|STARTED|Overall Study||11
10780267|NCT03383523|11941912|FG002|STARTED|Overall Study||10
10780268|NCT03383523|11941913|FG003|STARTED|Overall Study||12
10315707|NCT00182689|11449672|FG000|Eligible|Overall Study||39
10315708|NCT00182689|11449673|FG001|Eligible|Overall Study||45
10315709|NCT00182689|11449672|FG000|Eligible and Began Protocol Therapy|Overall Study||38
10315710|NCT00182689|11449673|FG001|Eligible and Began Protocol Therapy|Overall Study||45
10315711|NCT00182689|11449672|FG000|COMPLETED|Overall Study||0
10315712|NCT00182689|11449673|FG001|COMPLETED|Overall Study||0
10315713|NCT00182689|11449672|FG000|NOT COMPLETED|Overall Study||40
10315714|NCT00182689|11449673|FG001|NOT COMPLETED|Overall Study||49
10315715|NCT00182754|11449685|FG000|STARTED|Overall Study||16
10315716|NCT00182754|11449686|FG001|STARTED|Overall Study||17
10315717|NCT00182754|11449685|FG000|COMPLETED|Overall Study||16
10315718|NCT00182754|11449686|FG001|COMPLETED|Overall Study||17
10315719|NCT00182754|11449685|FG000|NOT COMPLETED|Overall Study||0
10315720|NCT00182754|11449686|FG001|NOT COMPLETED|Overall Study||0
10315721|NCT00182767|11449692|FG000|STARTED|Overall Study||6
10315722|NCT00182767|11449693|FG001|STARTED|Overall Study||6
10315723|NCT00182767|11449694|FG002|STARTED|Overall Study||6
10315724|NCT00182767|11449695|FG003|STARTED|Overall Study||3
10315725|NCT00182767|11449696|FG004|STARTED|Overall Study||24
10315726|NCT00182767|11449692|FG000|COMPLETED|Overall Study||6
10315727|NCT00182767|11449693|FG001|COMPLETED|Overall Study||6
10315728|NCT00182767|11449694|FG002|COMPLETED|Overall Study||6
10315729|NCT00182767|11449695|FG003|COMPLETED|Overall Study||3
10315730|NCT00182767|11449696|FG004|COMPLETED|Overall Study||24
10315731|NCT00182767|11449692|FG000|NOT COMPLETED|Overall Study||0
10315732|NCT00182767|11449693|FG001|NOT COMPLETED|Overall Study||0
10315733|NCT00182767|11449694|FG002|NOT COMPLETED|Overall Study||0
10315734|NCT00182767|11449695|FG003|NOT COMPLETED|Overall Study||0
10315735|NCT00182767|11449696|FG004|NOT COMPLETED|Overall Study||0
10780269|NCT03383523|11941914|FG004|STARTED|Overall Study||11
10780270|NCT03383523|11941915|FG005|STARTED|Overall Study||12
10780271|NCT03383523|11941916|FG006|STARTED|Overall Study||10
10780272|NCT03383523|11941910|FG000|COMPLETED|Overall Study||10
10780273|NCT03383523|11941911|FG001|COMPLETED|Overall Study||11
10780274|NCT03383523|11941912|FG002|COMPLETED|Overall Study||9
10780275|NCT03383523|11941913|FG003|COMPLETED|Overall Study||12
10315736|NCT00182793|11449710|FG000|STARTED|Overall Study||32
10315737|NCT00182793|11449710|FG000|COMPLETED|Overall Study||32
10315738|NCT00182793|11449710|FG000|NOT COMPLETED|Overall Study||0
10315739|NCT00183092|11449716|FG000|STARTED|Double-blind (Baseline - Month 2)||23
10315740|NCT00183092|11449717|FG001|STARTED|Double-blind (Baseline - Month 2)||28
10315741|NCT00183092|11449718|FG002|STARTED|Double-blind (Baseline - Month 2)||0
10315742|NCT00183092|11449719|FG003|STARTED|Double-blind (Baseline - Month 2)||0
10315743|NCT00183092|11449716|FG000|Alive at Month 2|Double-blind (Baseline - Month 2)||13
10315744|NCT00183092|11449717|FG001|Alive at Month 2|Double-blind (Baseline - Month 2)||19
10315745|NCT00183092|11449718|FG002|Alive at Month 2|Double-blind (Baseline - Month 2)||0
10780276|NCT03383523|11941914|FG004|COMPLETED|Overall Study||11
10780277|NCT03383523|11941915|FG005|COMPLETED|Overall Study||12
10780278|NCT03383523|11941916|FG006|COMPLETED|Overall Study||10
10780279|NCT03383523|11941910|FG000|NOT COMPLETED|Overall Study||1
10780280|NCT03383523|11941911|FG001|NOT COMPLETED|Overall Study||0
10780281|NCT03383523|11941912|FG002|NOT COMPLETED|Overall Study||1
10780282|NCT03383523|11941913|FG003|NOT COMPLETED|Overall Study||0
10780283|NCT03383523|11941914|FG004|NOT COMPLETED|Overall Study||0
10780284|NCT03383523|11941915|FG005|NOT COMPLETED|Overall Study||0
10315746|NCT00183092|11449719|FG003|Alive at Month 2|Double-blind (Baseline - Month 2)||0
10315747|NCT00183092|11449716|FG000|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||10
10315748|NCT00183092|11449717|FG001|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||16
10315749|NCT00183092|11449718|FG002|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||0
10315750|NCT00183092|11449719|FG003|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||0
10315751|NCT00183092|11449716|FG000|COMPLETED|Double-blind (Baseline - Month 2)||11
10315752|NCT00183092|11449717|FG001|COMPLETED|Double-blind (Baseline - Month 2)||16
10315753|NCT00183092|11449718|FG002|COMPLETED|Double-blind (Baseline - Month 2)||0
10315754|NCT00183092|11449719|FG003|COMPLETED|Double-blind (Baseline - Month 2)||0
10315755|NCT00183092|11449716|FG000|NOT COMPLETED|Double-blind (Baseline - Month 2)||12
10315756|NCT00183092|11449717|FG001|NOT COMPLETED|Double-blind (Baseline - Month 2)||12
10315757|NCT00183092|11449718|FG002|NOT COMPLETED|Double-blind (Baseline - Month 2)||0
10315758|NCT00183092|11449719|FG003|NOT COMPLETED|Double-blind (Baseline - Month 2)||0
10315759|NCT00183092|11449716|FG000|STARTED|Open-label Period (Month 2 Until Death)|Participants initially assigned to Quinacrine opted to begin open-label Quinacrine at Month 2|10
10315760|NCT00183092|11449717|FG001|STARTED|Open-label Period (Month 2 Until Death)|Participants initially assigned to Placebo opted to begin open-label Quinacrine at Month 2|14
10315761|NCT00183092|11449718|FG002|STARTED|Open-label Period (Month 2 Until Death)|Participants assigned to Quinacrine opted to continue assigned drug during open-label period|1
10315762|NCT00183092|11449719|FG003|STARTED|Open-label Period (Month 2 Until Death)|Participants assigned to Placebo opted to continue assigned drug during open-label period|1
10315763|NCT00183092|11449716|FG000|COMPLETED|Open-label Period (Month 2 Until Death)||0
10315764|NCT00183092|11449717|FG001|COMPLETED|Open-label Period (Month 2 Until Death)||0
10315765|NCT00183092|11449718|FG002|COMPLETED|Open-label Period (Month 2 Until Death)||0
10315766|NCT00183092|11449719|FG003|COMPLETED|Open-label Period (Month 2 Until Death)||0
10315767|NCT00183092|11449716|FG000|NOT COMPLETED|Open-label Period (Month 2 Until Death)||10
10315768|NCT00183092|11449717|FG001|NOT COMPLETED|Open-label Period (Month 2 Until Death)||14
10315769|NCT00183092|11449718|FG002|NOT COMPLETED|Open-label Period (Month 2 Until Death)||1
10315770|NCT00183092|11449719|FG003|NOT COMPLETED|Open-label Period (Month 2 Until Death)||1
10315771|NCT00183170|11449728|FG000|STARTED|First Intervention||103
10315772|NCT00183170|11449729|FG001|STARTED|First Intervention||109
10315773|NCT00183170|11449728|FG000|COMPLETED|First Intervention||101
10315774|NCT00183170|11449729|FG001|COMPLETED|First Intervention||109
10315775|NCT00183170|11449728|FG000|NOT COMPLETED|First Intervention||2
10780285|NCT03383523|11941916|FG006|NOT COMPLETED|Overall Study||0
10780286|NCT03383588|11941935|FG000|STARTED|Overall Study||8
10780287|NCT03383588|11941936|FG001|STARTED|Overall Study||9
10780288|NCT03383588|11941937|FG002|STARTED|Overall Study||9
10780289|NCT03383588|11941935|FG000|COMPLETED|Overall Study||8
10780290|NCT03383588|11941936|FG001|COMPLETED|Overall Study||9
10315776|NCT00183170|11449729|FG001|NOT COMPLETED|First Intervention||0
10315777|NCT00183170|11449728|FG000|STARTED|Washout 1 Week||101
10315778|NCT00183170|11449729|FG001|STARTED|Washout 1 Week||109
10315779|NCT00183170|11449728|FG000|COMPLETED|Washout 1 Week||95
10315780|NCT00183170|11449729|FG001|COMPLETED|Washout 1 Week||101
10315781|NCT00183170|11449728|FG000|NOT COMPLETED|Washout 1 Week||6
10315782|NCT00183170|11449729|FG001|NOT COMPLETED|Washout 1 Week||8
10315783|NCT00183170|11449728|FG000|STARTED|Second Intervention||95
10315784|NCT00183170|11449729|FG001|STARTED|Second Intervention||101
10315785|NCT00183170|11449728|FG000|COMPLETED|Second Intervention||94
10315786|NCT00183170|11449729|FG001|COMPLETED|Second Intervention||99
10315787|NCT00183170|11449728|FG000|NOT COMPLETED|Second Intervention||1
10315788|NCT00183170|11449729|FG001|NOT COMPLETED|Second Intervention||2
10315789|NCT00183196|11449738|FG000|STARTED|Overall Study|2 subjects had no post-randomization data|50
10315790|NCT00183196|11449739|FG001|STARTED|Overall Study|1 subject had no post-randomization data|50
10315791|NCT00183196|11449740|FG002|STARTED|Overall Study|1 subject had no post-randomization data|50
10315792|NCT00183196|11449738|FG000|COMPLETED|Overall Study||30
10315793|NCT00183196|11449739|FG001|COMPLETED|Overall Study||35
10315794|NCT00183196|11449740|FG002|COMPLETED|Overall Study||32
10315795|NCT00183196|11449738|FG000|NOT COMPLETED|Overall Study||20
10315796|NCT00183196|11449739|FG001|NOT COMPLETED|Overall Study||15
10315797|NCT00183196|11449740|FG002|NOT COMPLETED|Overall Study||18
10315798|NCT00183248|11449750|FG000|STARTED|Overall Study||4
10315799|NCT00183248|11449751|FG001|STARTED|Overall Study||5
10315800|NCT00183248|11449750|FG000|COMPLETED|Overall Study||3
10315801|NCT00183248|11449751|FG001|COMPLETED|Overall Study||4
10315802|NCT00183248|11449750|FG000|NOT COMPLETED|Overall Study||1
10315803|NCT00183248|11449751|FG001|NOT COMPLETED|Overall Study||1
10315804|NCT00183274|11449757|FG000|STARTED|Phase 1: Open-Label||268
10315805|NCT00183274|11449758|FG001|STARTED|Phase 1: Open-Label||0
10315806|NCT00183274|11449759|FG002|STARTED|Phase 1: Open-Label||0
10315807|NCT00183274|11449760|FG003|STARTED|Phase 1: Open-Label||0
10780291|NCT03383588|11941937|FG002|COMPLETED|Overall Study||9
10780292|NCT03383588|11941935|FG000|NOT COMPLETED|Overall Study||0
10780293|NCT03383588|11941936|FG001|NOT COMPLETED|Overall Study||0
10780294|NCT03383588|11941937|FG002|NOT COMPLETED|Overall Study||0
10780295|NCT03383614|11941949|FG000|STARTED|Overall Study||6
10780296|NCT03383614|11941950|FG001|STARTED|Overall Study||6
10780297|NCT03383614|11941951|FG002|STARTED|Overall Study||6
10780298|NCT03383614|11941952|FG003|STARTED|Overall Study||6
10780299|NCT03383614|11941949|FG000|COMPLETED|Overall Study||6
10780300|NCT03383614|11941950|FG001|COMPLETED|Overall Study||5
10780301|NCT03383614|11941951|FG002|COMPLETED|Overall Study||6
10780302|NCT03383614|11941952|FG003|COMPLETED|Overall Study||6
10780303|NCT03383614|11941949|FG000|NOT COMPLETED|Overall Study||0
10780304|NCT03383614|11941950|FG001|NOT COMPLETED|Overall Study||1
10780305|NCT03383614|11941951|FG002|NOT COMPLETED|Overall Study||0
10780306|NCT03383614|11941952|FG003|NOT COMPLETED|Overall Study||0
10780307|NCT03383627|11941967|FG000|STARTED|Overall Study||80
10780308|NCT03383627|11941967|FG000|COMPLETED|Overall Study||80
10780309|NCT03383627|11941967|FG000|NOT COMPLETED|Overall Study||0
10780310|NCT03383757|11941971|FG000|STARTED|Overall Study||117
10780311|NCT03383757|11941971|FG000|TruSignal AllFit Sensor Subjects|Overall Study||56
10780312|NCT03383757|11941971|FG000|TruSignal Sensitive Sensor Subjects|Overall Study||59
10315808|NCT00183274|11449761|FG004|STARTED|Phase 1: Open-Label||0
10315809|NCT00183274|11449762|FG005|STARTED|Phase 1: Open-Label||0
10315810|NCT00183274|11449757|FG000|COMPLETED|Phase 1: Open-Label|110 dropouts during phase 1|158
10315811|NCT00183274|11449758|FG001|COMPLETED|Phase 1: Open-Label||0
10315812|NCT00183274|11449759|FG002|COMPLETED|Phase 1: Open-Label||0
10315813|NCT00183274|11449760|FG003|COMPLETED|Phase 1: Open-Label||0
10315814|NCT00183274|11449761|FG004|COMPLETED|Phase 1: Open-Label||0
10315815|NCT00183274|11449762|FG005|COMPLETED|Phase 1: Open-Label||0
10315816|NCT00183274|11449757|FG000|NOT COMPLETED|Phase 1: Open-Label||110
10315817|NCT00183274|11449758|FG001|NOT COMPLETED|Phase 1: Open-Label||0
10431683|NCT00876460|11577782|FG000|STARTED|Combination Therapy Phase||3
10431684|NCT00876460|11577783|FG001|STARTED|Combination Therapy Phase||7
10431685|NCT00876460|11577784|FG002|STARTED|Combination Therapy Phase||3
10431686|NCT00876460|11577785|FG003|STARTED|Combination Therapy Phase||6
10431687|NCT00876460|11577786|FG004|STARTED|Combination Therapy Phase||7
10431688|NCT00876460|11577787|FG005|STARTED|Combination Therapy Phase||3
10431689|NCT00876460|11577788|FG006|STARTED|Combination Therapy Phase||8
10431690|NCT00876460|11577789|FG007|STARTED|Combination Therapy Phase||6
10431691|NCT00876460|11577782|FG000|COMPLETED|Combination Therapy Phase||0
10431692|NCT00876460|11577783|FG001|COMPLETED|Combination Therapy Phase||0
10431693|NCT00876460|11577784|FG002|COMPLETED|Combination Therapy Phase||0
10431694|NCT00876460|11577785|FG003|COMPLETED|Combination Therapy Phase||0
10431695|NCT00876460|11577786|FG004|COMPLETED|Combination Therapy Phase||0
10431696|NCT00876460|11577787|FG005|COMPLETED|Combination Therapy Phase||0
10431697|NCT00876460|11577788|FG006|COMPLETED|Combination Therapy Phase||0
10431698|NCT00876460|11577789|FG007|COMPLETED|Combination Therapy Phase||0
10431699|NCT00876460|11577782|FG000|NOT COMPLETED|Combination Therapy Phase||3
10431700|NCT00876460|11577783|FG001|NOT COMPLETED|Combination Therapy Phase||7
10431701|NCT00876460|11577784|FG002|NOT COMPLETED|Combination Therapy Phase||3
10431702|NCT00876460|11577785|FG003|NOT COMPLETED|Combination Therapy Phase||6
10431703|NCT00876460|11577786|FG004|NOT COMPLETED|Combination Therapy Phase||7
10431704|NCT00876460|11577787|FG005|NOT COMPLETED|Combination Therapy Phase||3
10431705|NCT00876460|11577788|FG006|NOT COMPLETED|Combination Therapy Phase||8
10431706|NCT00876460|11577789|FG007|NOT COMPLETED|Combination Therapy Phase||6
10431707|NCT00876460|11577782|FG000|STARTED|Mono Therapy Phase||0
10431708|NCT00876460|11577783|FG001|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
10431709|NCT00876460|11577784|FG002|STARTED|Mono Therapy Phase||0
10431710|NCT00876460|11577785|FG003|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
10431711|NCT00876460|11577786|FG004|STARTED|Mono Therapy Phase|Two patients started mono therapy phase after discontinued from combination therapy phase.|2
10431712|NCT00876460|11577787|FG005|STARTED|Mono Therapy Phase||0
10431713|NCT00876460|11577788|FG006|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
10431714|NCT00876460|11577789|FG007|STARTED|Mono Therapy Phase|Three patients started mono therapy phase after discontinued from combination therapy phase.|3
10431715|NCT00876460|11577782|FG000|COMPLETED|Mono Therapy Phase||0
10431716|NCT00876460|11577783|FG001|COMPLETED|Mono Therapy Phase||0
10431717|NCT00876460|11577784|FG002|COMPLETED|Mono Therapy Phase||0
10431718|NCT00876460|11577785|FG003|COMPLETED|Mono Therapy Phase||0
10431719|NCT00876460|11577786|FG004|COMPLETED|Mono Therapy Phase||0
10431720|NCT00876460|11577787|FG005|COMPLETED|Mono Therapy Phase||0
10431721|NCT00876460|11577788|FG006|COMPLETED|Mono Therapy Phase||0
10431722|NCT00876460|11577789|FG007|COMPLETED|Mono Therapy Phase||0
10431723|NCT00876460|11577782|FG000|NOT COMPLETED|Mono Therapy Phase||0
10431724|NCT00876460|11577783|FG001|NOT COMPLETED|Mono Therapy Phase||1
10431725|NCT00876460|11577784|FG002|NOT COMPLETED|Mono Therapy Phase||0
10780313|NCT03383757|11941971|FG000|TruSignal AllFit Sensor Data Pairs|Overall Study||52
10780314|NCT03383757|11941971|FG000|TruSignal Sensitive Sensor Data Pairs|Overall Study||51
10780315|NCT03383757|11941971|FG000|COMPLETED|Overall Study||78
10780316|NCT03383757|11941971|FG000|NOT COMPLETED|Overall Study||39
10780317|NCT03383783|11941975|FG000|STARTED|Overall Study||27
10780318|NCT03383783|11941975|FG000|COMPLETED|Overall Study||25
10780319|NCT03383783|11941975|FG000|NOT COMPLETED|Overall Study||2
10780320|NCT03383887|11941991|FG000|STARTED|Overall Study||5
10780321|NCT03383887|11941992|FG001|STARTED|Overall Study||6
10780322|NCT03383887|11941991|FG000|COMPLETED|Overall Study||5
10780323|NCT03383887|11941992|FG001|COMPLETED|Overall Study||5
10780324|NCT03383887|11941991|FG000|NOT COMPLETED|Overall Study||0
10780325|NCT03383887|11941992|FG001|NOT COMPLETED|Overall Study||1
10780326|NCT03384173|11942000|FG000|STARTED|Overall Study||35
10780327|NCT03384173|11942000|FG000|COMPLETED|Overall Study||35
10780328|NCT03384173|11942000|FG000|NOT COMPLETED|Overall Study||0
10810492|NCT03782571|11972277|FG002|COMPLETED|Period 2||6
10810493|NCT03782571|11972278|FG003|COMPLETED|Period 2||7
10810494|NCT03782571|11972275|FG000|NOT COMPLETED|Period 2||0
10810495|NCT03782571|11972276|FG001|NOT COMPLETED|Period 2||0
10810496|NCT03782571|11972277|FG002|NOT COMPLETED|Period 2||0
10810497|NCT03782571|11972278|FG003|NOT COMPLETED|Period 2||0
10810498|NCT03782571|11972275|FG000|STARTED|Period 3||5
10810499|NCT03782571|11972276|FG001|STARTED|Period 3||6
10810500|NCT03782571|11972277|FG002|STARTED|Period 3||6
10810501|NCT03782571|11972278|FG003|STARTED|Period 3||7
10810502|NCT03782571|11972275|FG000|COMPLETED|Period 3||3
10810503|NCT03782571|11972276|FG001|COMPLETED|Period 3||6
10810504|NCT03782571|11972277|FG002|COMPLETED|Period 3||6
10810505|NCT03782571|11972278|FG003|COMPLETED|Period 3||7
10810506|NCT03782571|11972275|FG000|NOT COMPLETED|Period 3||2
10315818|NCT00183274|11449759|FG002|NOT COMPLETED|Phase 1: Open-Label||0
10315819|NCT00183274|11449760|FG003|NOT COMPLETED|Phase 1: Open-Label||0
10315820|NCT00183274|11449761|FG004|NOT COMPLETED|Phase 1: Open-Label||0
10315821|NCT00183274|11449762|FG005|NOT COMPLETED|Phase 1: Open-Label||0
10315822|NCT00183274|11449757|FG000|STARTED|Phase 2: Double-Blind|This phase ended after 6 months. There were no longer participants in this phase.|0
10315823|NCT00183274|11449758|FG001|STARTED|Phase 2: Double-Blind|22 did not enter phase 2 due to lack of efficacy and withdrawal of consent|82
10315824|NCT00183274|11449759|FG002|STARTED|Phase 2: Double-Blind|22 did not enter phase 2 due to lack of efficacy and withdrawal of consent|54
10315825|NCT00183274|11449760|FG003|STARTED|Phase 2: Double-Blind||0
10315826|NCT00183274|11449761|FG004|STARTED|Phase 2: Double-Blind||0
10315827|NCT00183274|11449762|FG005|STARTED|Phase 2: Double-Blind||0
10315828|NCT00183274|11449757|FG000|COMPLETED|Phase 2: Double-Blind||0
10315829|NCT00183274|11449758|FG001|COMPLETED|Phase 2: Double-Blind|8 lost to relapse, 18 lost to dropout|56
10315830|NCT00183274|11449759|FG002|COMPLETED|Phase 2: Double-Blind|29 lost to relapse, 14 lost to dropout|11
10315831|NCT00183274|11449760|FG003|COMPLETED|Phase 2: Double-Blind||0
10315832|NCT00183274|11449761|FG004|COMPLETED|Phase 2: Double-Blind||0
10315833|NCT00183274|11449762|FG005|COMPLETED|Phase 2: Double-Blind||0
10315834|NCT00183274|11449757|FG000|NOT COMPLETED|Phase 2: Double-Blind||0
10315835|NCT00183274|11449758|FG001|NOT COMPLETED|Phase 2: Double-Blind||26
10315836|NCT00183274|11449759|FG002|NOT COMPLETED|Phase 2: Double-Blind||43
10315837|NCT00183274|11449760|FG003|NOT COMPLETED|Phase 2: Double-Blind||0
10315838|NCT00183274|11449761|FG004|NOT COMPLETED|Phase 2: Double-Blind||0
10315839|NCT00183274|11449762|FG005|NOT COMPLETED|Phase 2: Double-Blind||0
10315840|NCT00183274|11449757|FG000|STARTED|Phase 3: Double-Blind||0
10315841|NCT00183274|11449758|FG001|STARTED|Phase 3: Double-Blind|Phase 2 ended at the end of 12 months of study.|0
10315842|NCT00183274|11449759|FG002|STARTED|Phase 3: Double-Blind|Phase 2 ended at the end of 12 months of study.|0
10315843|NCT00183274|11449760|FG003|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|15
10315844|NCT00183274|11449761|FG004|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|34
10315845|NCT00183274|11449762|FG005|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|10
10315846|NCT00183274|11449757|FG000|COMPLETED|Phase 3: Double-Blind||0
10315847|NCT00183274|11449758|FG001|COMPLETED|Phase 3: Double-Blind||0
10315848|NCT00183274|11449759|FG002|COMPLETED|Phase 3: Double-Blind||0
10315849|NCT00183274|11449760|FG003|COMPLETED|Phase 3: Double-Blind|1 lost to relapse and 1 lost to dropout|13
10315850|NCT00183274|11449761|FG004|COMPLETED|Phase 3: Double-Blind|11 lost to relapse and 9 lost to dropout|14
10315851|NCT00183274|11449762|FG005|COMPLETED|Phase 3: Double-Blind|2 lost to relapse and 2 lost to dropout|6
10315852|NCT00183274|11449757|FG000|NOT COMPLETED|Phase 3: Double-Blind||0
10315853|NCT00183274|11449758|FG001|NOT COMPLETED|Phase 3: Double-Blind||0
10315854|NCT00183274|11449759|FG002|NOT COMPLETED|Phase 3: Double-Blind||0
10315855|NCT00183274|11449760|FG003|NOT COMPLETED|Phase 3: Double-Blind||2
10315856|NCT00183274|11449761|FG004|NOT COMPLETED|Phase 3: Double-Blind||20
10315857|NCT00183274|11449762|FG005|NOT COMPLETED|Phase 3: Double-Blind||4
10315858|NCT00183339|11449779|FG000|STARTED|Overall Study||10
10315859|NCT00183339|11449780|FG001|STARTED|Overall Study||8
10315860|NCT00183339|11449779|FG000|COMPLETED|Overall Study||4
10315861|NCT00183339|11449780|FG001|COMPLETED|Overall Study||4
10315862|NCT00183339|11449779|FG000|NOT COMPLETED|Overall Study||6
10315863|NCT00183339|11449780|FG001|NOT COMPLETED|Overall Study||4
10315864|NCT00183391|11449791|FG000|STARTED|Block 1 - 5 Weeks||108
10315865|NCT00183391|11449792|FG001|STARTED|Block 1 - 5 Weeks||124
10315866|NCT00183391|11449791|FG000|COMPLETED|Block 1 - 5 Weeks||95
10315867|NCT00183391|11449792|FG001|COMPLETED|Block 1 - 5 Weeks||110
10315868|NCT00183391|11449791|FG000|NOT COMPLETED|Block 1 - 5 Weeks||13
10315869|NCT00183391|11449792|FG001|NOT COMPLETED|Block 1 - 5 Weeks||14
10810507|NCT03782571|11972276|FG001|NOT COMPLETED|Period 3||0
10810508|NCT03782571|11972277|FG002|NOT COMPLETED|Period 3||0
10810509|NCT03782571|11972278|FG003|NOT COMPLETED|Period 3||0
10810510|NCT03782571|11972275|FG000|STARTED|Period 4||3
10810511|NCT03782571|11972276|FG001|STARTED|Period 4||6
10810512|NCT03782571|11972277|FG002|STARTED|Period 4||6
10810513|NCT03782571|11972278|FG003|STARTED|Period 4||7
10810514|NCT03782571|11972275|FG000|COMPLETED|Period 4||3
10810515|NCT03782571|11972276|FG001|COMPLETED|Period 4||6
10810516|NCT03782571|11972277|FG002|COMPLETED|Period 4||6
10780329|NCT03384316|11942012|FG000|STARTED|Overall Study||6
10780330|NCT03384316|11942013|FG001|STARTED|Overall Study||5
10780331|NCT03384316|11942012|FG000|COMPLETED|Overall Study||6
10315870|NCT00183391|11449791|FG000|STARTED|Crossover Placebo - 2 Weeks||95
10315871|NCT00183391|11449792|FG001|STARTED|Crossover Placebo - 2 Weeks||110
10315872|NCT00183391|11449791|FG000|COMPLETED|Crossover Placebo - 2 Weeks||95
10315873|NCT00183391|11449792|FG001|COMPLETED|Crossover Placebo - 2 Weeks||110
10315874|NCT00183391|11449791|FG000|NOT COMPLETED|Crossover Placebo - 2 Weeks||0
10315875|NCT00183391|11449792|FG001|NOT COMPLETED|Crossover Placebo - 2 Weeks||0
10315876|NCT00183391|11449791|FG000|STARTED|Block 2 - 5 Weeks||95
10315877|NCT00183391|11449792|FG001|STARTED|Block 2 - 5 Weeks||110
10315878|NCT00183391|11449791|FG000|COMPLETED|Block 2 - 5 Weeks||91
10315879|NCT00183391|11449792|FG001|COMPLETED|Block 2 - 5 Weeks||108
10315880|NCT00183391|11449791|FG000|NOT COMPLETED|Block 2 - 5 Weeks||4
10315881|NCT00183391|11449792|FG001|NOT COMPLETED|Block 2 - 5 Weeks||2
10315882|NCT00183430|11449802|FG000|STARTED|Overall Study||9
10315883|NCT00183430|11449803|FG001|STARTED|Overall Study||11
10315884|NCT00183430|11449802|FG000|COMPLETED|Overall Study||3
10315885|NCT00183430|11449803|FG001|COMPLETED|Overall Study||11
10315886|NCT00183430|11449802|FG000|NOT COMPLETED|Overall Study||6
10315887|NCT00183430|11449803|FG001|NOT COMPLETED|Overall Study||0
10315888|NCT00183443|11449812|FG000|STARTED|Overall Study||24
10315889|NCT00183443|11449813|FG001|STARTED|Overall Study||26
10315890|NCT00183443|11449814|FG002|STARTED|Overall Study||25
10315891|NCT00183443|11449812|FG000|COMPLETED|Overall Study|13 eligible participants were offered enrollment in the continuation phase|24
10315892|NCT00183443|11449813|FG001|COMPLETED|Overall Study|8 eligible participants were offered enrollment in the continuation phase|26
10315893|NCT00183443|11449814|FG002|COMPLETED|Overall Study|4 eligible participants were offered enrollment in the continuation phase|25
10315894|NCT00183443|11449812|FG000|NOT COMPLETED|Overall Study||0
10315895|NCT00183443|11449813|FG001|NOT COMPLETED|Overall Study||0
10315896|NCT00183443|11449814|FG002|NOT COMPLETED|Overall Study||0
10315897|NCT00183456|11449826|FG000|STARTED|Overall Study||85
10315898|NCT00183456|11449827|FG001|STARTED|Overall Study||84
10315899|NCT00183456|11449828|FG002|STARTED|Overall Study||329
10315900|NCT00183456|11449829|FG003|STARTED|Overall Study||248
10315901|NCT00183456|11449826|FG000|6 Month Follow-up|Overall Study||74
10315902|NCT00183456|11449827|FG001|6 Month Follow-up|Overall Study||77
10315903|NCT00183456|11449828|FG002|6 Month Follow-up|Overall Study||278
10315904|NCT00183456|11449829|FG003|6 Month Follow-up|Overall Study||175
10315905|NCT00183456|11449826|FG000|12 Month Follow-up|Overall Study||76
10315906|NCT00183456|11449827|FG001|12 Month Follow-up|Overall Study||74
10315907|NCT00183456|11449828|FG002|12 Month Follow-up|Overall Study||267
10315908|NCT00183456|11449829|FG003|12 Month Follow-up|Overall Study||186
10315909|NCT00183456|11449826|FG000|18 Month Follow-up|Overall Study||80
10315910|NCT00183456|11449827|FG001|18 Month Follow-up|Overall Study||81
10315911|NCT00183456|11449828|FG002|18 Month Follow-up|Overall Study||303
10315912|NCT00183456|11449829|FG003|18 Month Follow-up|Overall Study||207
10315913|NCT00183456|11449826|FG000|COMPLETED|Overall Study|total # of intervention participants that completed any follow-up (6, 12, or 18 month Follow-up)|82
10315914|NCT00183456|11449827|FG001|COMPLETED|Overall Study|total # of comparison condition participants that completed any follow-up|83
10315915|NCT00183456|11449828|FG002|COMPLETED|Overall Study|total # of network participants that completed any follow-up|313
10315916|NCT00183456|11449829|FG003|COMPLETED|Overall Study|total # of non-randomized index participants that completed any follow-up|220
10315917|NCT00183456|11449826|FG000|NOT COMPLETED|Overall Study||3
10315918|NCT00183456|11449827|FG001|NOT COMPLETED|Overall Study||1
10315919|NCT00183456|11449828|FG002|NOT COMPLETED|Overall Study||16
10315920|NCT00183456|11449829|FG003|NOT COMPLETED|Overall Study||28
10431726|NCT00876460|11577785|FG003|NOT COMPLETED|Mono Therapy Phase||1
10315921|NCT00183469|11449841|FG000|STARTED|Overall Study||41
10315922|NCT00183469|11449842|FG001|STARTED|Overall Study||45
10315923|NCT00183469|11449841|FG000|COMPLETED|Overall Study||13
10780332|NCT03384316|11942013|FG001|COMPLETED|Overall Study||4
10780333|NCT03384316|11942012|FG000|NOT COMPLETED|Overall Study||0
10780334|NCT03384316|11942013|FG001|NOT COMPLETED|Overall Study||1
10780335|NCT03384329|11942023|FG000|STARTED|Overall Study||11
10780336|NCT03384329|11942024|FG001|STARTED|Overall Study||11
10780337|NCT03384329|11942023|FG000|COMPLETED|Overall Study||11
10780338|NCT03384329|11942024|FG001|COMPLETED|Overall Study||11
10780339|NCT03384329|11942023|FG000|NOT COMPLETED|Overall Study||0
10780340|NCT03384329|11942024|FG001|NOT COMPLETED|Overall Study||0
10780341|NCT03384693|11942030|FG000|STARTED|Overall Study||25
10780342|NCT03384693|11942030|FG000|COMPLETED|Overall Study||22
10780343|NCT03384693|11942030|FG000|NOT COMPLETED|Overall Study||3
10780344|NCT03384745|11942040|FG000|STARTED|Placebo Controlled Induction (W0 - W12)||52
10780345|NCT03384745|11942041|FG001|STARTED|Placebo Controlled Induction (W0 - W12)||52
10780346|NCT03384745|11942042|FG002|STARTED|Placebo Controlled Induction (W0 - W12)||53
10780347|NCT03384745|11942043|FG003|STARTED|Placebo Controlled Induction (W0 - W12)||51
10780348|NCT03384745|11942044|FG004|STARTED|Placebo Controlled Induction (W0 - W12)||52
10780349|NCT03384745|11942045|FG005|STARTED|Placebo Controlled Induction (W0 - W12)||53
10780350|NCT03384745|11942040|FG000|COMPLETED|Placebo Controlled Induction (W0 - W12)||52
10780351|NCT03384745|11942041|FG001|COMPLETED|Placebo Controlled Induction (W0 - W12)||51
10780352|NCT03384745|11942042|FG002|COMPLETED|Placebo Controlled Induction (W0 - W12)||50
10780353|NCT03384745|11942043|FG003|COMPLETED|Placebo Controlled Induction (W0 - W12)||49
10780354|NCT03384745|11942044|FG004|COMPLETED|Placebo Controlled Induction (W0 - W12)||49
10780355|NCT03384745|11942045|FG005|COMPLETED|Placebo Controlled Induction (W0 - W12)||51
10780356|NCT03384745|11942040|FG000|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||0
10780357|NCT03384745|11942041|FG001|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||1
10780358|NCT03384745|11942042|FG002|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||3
10780359|NCT03384745|11942043|FG003|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||2
10780360|NCT03384745|11942044|FG004|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||3
10780361|NCT03384745|11942045|FG005|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||2
10780362|NCT03384745|11942040|FG000|STARTED|Maintenance/Escalation (W12-W24)||52
10780363|NCT03384745|11942041|FG001|STARTED|Maintenance/Escalation (W12-W24)||51
10780364|NCT03384745|11942042|FG002|STARTED|Maintenance/Escalation (W12-W24)||50
10780365|NCT03384745|11942043|FG003|STARTED|Maintenance/Escalation (W12-W24)||49
10780366|NCT03384745|11942044|FG004|STARTED|Maintenance/Escalation (W12-W24)||49
10780367|NCT03384745|11942045|FG005|STARTED|Maintenance/Escalation (W12-W24)||51
10780368|NCT03384745|11942040|FG000|COMPLETED|Maintenance/Escalation (W12-W24)||52
10780369|NCT03384745|11942041|FG001|COMPLETED|Maintenance/Escalation (W12-W24)||51
10780370|NCT03384745|11942042|FG002|COMPLETED|Maintenance/Escalation (W12-W24)||49
10780371|NCT03384745|11942043|FG003|COMPLETED|Maintenance/Escalation (W12-W24)||47
10780372|NCT03384745|11942044|FG004|COMPLETED|Maintenance/Escalation (W12-W24)||47
10780373|NCT03384745|11942045|FG005|COMPLETED|Maintenance/Escalation (W12-W24)||51
10780374|NCT03384745|11942040|FG000|NOT COMPLETED|Maintenance/Escalation (W12-W24)||0
10780375|NCT03384745|11942041|FG001|NOT COMPLETED|Maintenance/Escalation (W12-W24)||0
10780376|NCT03384745|11942042|FG002|NOT COMPLETED|Maintenance/Escalation (W12-W24)||1
10780377|NCT03384745|11942043|FG003|NOT COMPLETED|Maintenance/Escalation (W12-W24)||2
10780378|NCT03384745|11942044|FG004|NOT COMPLETED|Maintenance/Escalation (W12-W24)||2
10780379|NCT03384745|11942045|FG005|NOT COMPLETED|Maintenance/Escalation (W12-W24)||0
10780380|NCT03384745|11942040|FG000|STARTED|Response Assess/Dose Hold (W24-W48)||52
10780381|NCT03384745|11942041|FG001|STARTED|Response Assess/Dose Hold (W24-W48)||51
10315924|NCT00183469|11449842|FG001|COMPLETED|Overall Study||16
10315925|NCT00183469|11449841|FG000|NOT COMPLETED|Overall Study||28
10315926|NCT00183469|11449842|FG001|NOT COMPLETED|Overall Study||29
10315927|NCT00183625|11449850|FG000|STARTED|Overall Study||27
10315928|NCT00183625|11449851|FG001|STARTED|Overall Study||28
10315929|NCT00183625|11449852|FG002|STARTED|Overall Study||28
10315930|NCT00183625|11449853|FG003|STARTED|Overall Study||24
10315931|NCT00183625|11449850|FG000|Obtained Employment|Overall Study||21
10315932|NCT00183625|11449851|FG001|Obtained Employment|Overall Study||18
10315933|NCT00183625|11449852|FG002|Obtained Employment|Overall Study||14
10315934|NCT00183625|11449853|FG003|Obtained Employment|Overall Study||14
10315935|NCT00183625|11449850|FG000|COMPLETED|Overall Study||9
10315936|NCT00183625|11449851|FG001|COMPLETED|Overall Study||10
10315937|NCT00183625|11449852|FG002|COMPLETED|Overall Study||9
10315938|NCT00183625|11449853|FG003|COMPLETED|Overall Study||10
10315939|NCT00183625|11449850|FG000|NOT COMPLETED|Overall Study||18
10315940|NCT00183625|11449851|FG001|NOT COMPLETED|Overall Study||18
10315941|NCT00183625|11449852|FG002|NOT COMPLETED|Overall Study||19
10431727|NCT00876460|11577786|FG004|NOT COMPLETED|Mono Therapy Phase||2
10780382|NCT03384745|11942042|FG002|STARTED|Response Assess/Dose Hold (W24-W48)||49
10780383|NCT03384745|11942043|FG003|STARTED|Response Assess/Dose Hold (W24-W48)||47
10780384|NCT03384745|11942044|FG004|STARTED|Response Assess/Dose Hold (W24-W48)||47
10780385|NCT03384745|11942045|FG005|STARTED|Response Assess/Dose Hold (W24-W48)||51
10315942|NCT00183625|11449853|FG003|NOT COMPLETED|Overall Study||14
10315943|NCT00183677|11449861|FG000|STARTED|Overall Study||97
10315944|NCT00183677|11449861|FG000|COMPLETED|Overall Study||53
10315945|NCT00183677|11449861|FG000|NOT COMPLETED|Overall Study||44
10315946|NCT00183729|11449867|FG000|STARTED|Overall Study||17
10315947|NCT00183729|11449868|FG001|STARTED|Overall Study||18
10780386|NCT03384745|11942040|FG000|COMPLETED|Response Assess/Dose Hold (W24-W48)||51
10780387|NCT03384745|11942041|FG001|COMPLETED|Response Assess/Dose Hold (W24-W48)||48
10780388|NCT03384745|11942042|FG002|COMPLETED|Response Assess/Dose Hold (W24-W48)||45
10780389|NCT03384745|11942043|FG003|COMPLETED|Response Assess/Dose Hold (W24-W48)||43
10780390|NCT03384745|11942044|FG004|COMPLETED|Response Assess/Dose Hold (W24-W48)||46
10315948|NCT00183729|11449867|FG000|COMPLETED|Overall Study||14
10315949|NCT00183729|11449868|FG001|COMPLETED|Overall Study||13
10315950|NCT00183729|11449867|FG000|NOT COMPLETED|Overall Study||3
10315951|NCT00183729|11449868|FG001|NOT COMPLETED|Overall Study||5
10315952|NCT00183794|11449874|FG000|STARTED|Overall Study||20
10315953|NCT00183794|11449874|FG000|COMPLETED|Overall Study||20
10315954|NCT00183794|11449874|FG000|NOT COMPLETED|Overall Study||0
10315955|NCT00183872|11449878|FG000|STARTED|Overall Study||40
10315956|NCT00183872|11449878|FG000|COMPLETED|Overall Study||24
10315957|NCT00183872|11449878|FG000|NOT COMPLETED|Overall Study||16
10315958|NCT00184002|11449882|FG000|STARTED|Overall Study||68
10315959|NCT00184002|11449882|FG000|COMPLETED|Overall Study||51
10315960|NCT00184002|11449882|FG000|NOT COMPLETED|Overall Study||17
10315961|NCT00184028|11449886|FG000|STARTED|Overall Study||12
10315962|NCT00184028|11449886|FG000|COMPLETED|Overall Study||2
10315963|NCT00184028|11449886|FG000|NOT COMPLETED|Overall Study||10
10315964|NCT00184054|11449891|FG000|STARTED|Overall Study||11
10315965|NCT00184054|11449891|FG000|COMPLETED|Overall Study||10
10315966|NCT00184054|11449891|FG000|NOT COMPLETED|Overall Study||1
10315967|NCT00184093|11449895|FG000|STARTED|Overall Study|Phase 1 participants = 6 Phase 2 participants = 29|35
10315968|NCT00184093|11449895|FG000|COMPLETED|Overall Study||26
10315969|NCT00184093|11449895|FG000|NOT COMPLETED|Overall Study||9
10315970|NCT00184548|11449903|FG000|STARTED|Overall Study||226
10315971|NCT00184548|11449904|FG001|STARTED|Overall Study||255
10315972|NCT00184548|11449905|FG002|STARTED|Overall Study||47
10315973|NCT00184548|11449906|FG003|STARTED|Overall Study||45
10315974|NCT00184548|11449903|FG000|Exposed|Overall Study|Two subjects withdrew due to ineligibility. Excluded from safety analysis set|224
10315975|NCT00184548|11449904|FG001|Exposed|Overall Study|Three subjects withdrew due to ineligibility, two subjects died. Excluded from safety analysis set|250
10315976|NCT00184548|11449905|FG002|Exposed|Overall Study|One subject withdrew due to ineligibility. Excluded from safety analysis set|46
10315977|NCT00184548|11449906|FG003|Exposed|Overall Study|Four subjects withdrew due to ineligibility, one subject died. Excluded from safety analysis set|40
10315978|NCT00184548|11449903|FG000|COMPLETED|Overall Study||218
10315979|NCT00184548|11449904|FG001|COMPLETED|Overall Study||242
10315980|NCT00184548|11449905|FG002|COMPLETED|Overall Study||44
10315981|NCT00184548|11449906|FG003|COMPLETED|Overall Study||38
10315982|NCT00184548|11449903|FG000|NOT COMPLETED|Overall Study||8
10315983|NCT00184548|11449904|FG001|NOT COMPLETED|Overall Study||13
10315984|NCT00184548|11449905|FG002|NOT COMPLETED|Overall Study||3
10315985|NCT00184548|11449906|FG003|NOT COMPLETED|Overall Study||7
10315986|NCT00184600|11449919|FG000|STARTED|Overall Study||234
10315987|NCT00184600|11449920|FG001|STARTED|Overall Study||239
10315988|NCT00184600|11449921|FG002|STARTED|Overall Study||235
10315989|NCT00184600|11449919|FG000|COMPLETED|Overall Study||189
10315990|NCT00184600|11449920|FG001|COMPLETED|Overall Study||188
10315991|NCT00184600|11449921|FG002|COMPLETED|Overall Study||201
10315992|NCT00184600|11449919|FG000|NOT COMPLETED|Overall Study||45
10315993|NCT00184600|11449920|FG001|NOT COMPLETED|Overall Study||51
10315994|NCT00184600|11449921|FG002|NOT COMPLETED|Overall Study||34
10315995|NCT00184717|11449932|FG000|STARTED|Main Period (GHLIQUID-1516)||39
10315996|NCT00184717|11449933|FG001|STARTED|Main Period (GHLIQUID-1516)||38
10315997|NCT00184717|11449934|FG002|STARTED|Main Period (GHLIQUID-1516)||21
10315998|NCT00184717|11449935|FG003|STARTED|Main Period (GHLIQUID-1516)||0
10315999|NCT00184717|11449936|FG004|STARTED|Main Period (GHLIQUID-1516)||0
10316000|NCT00184717|11449932|FG000|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||38
10316001|NCT00184717|11449933|FG001|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||38
10316002|NCT00184717|11449934|FG002|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||21
10316003|NCT00184717|11449935|FG003|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||0
10316004|NCT00184717|11449936|FG004|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||0
10316005|NCT00184717|11449932|FG000|COMPLETED|Main Period (GHLIQUID-1516)||36
10316006|NCT00184717|11449933|FG001|COMPLETED|Main Period (GHLIQUID-1516)||36
10316007|NCT00184717|11449934|FG002|COMPLETED|Main Period (GHLIQUID-1516)||20
10316008|NCT00184717|11449935|FG003|COMPLETED|Main Period (GHLIQUID-1516)||0
10316009|NCT00184717|11449936|FG004|COMPLETED|Main Period (GHLIQUID-1516)||0
10316010|NCT00184717|11449932|FG000|NOT COMPLETED|Main Period (GHLIQUID-1516)||3
10780391|NCT03384745|11942045|FG005|COMPLETED|Response Assess/Dose Hold (W24-W48)||49
10780392|NCT03384745|11942040|FG000|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||1
10780393|NCT03384745|11942041|FG001|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||3
10316011|NCT00184717|11449933|FG001|NOT COMPLETED|Main Period (GHLIQUID-1516)||2
10316012|NCT00184717|11449934|FG002|NOT COMPLETED|Main Period (GHLIQUID-1516)||1
10316013|NCT00184717|11449935|FG003|NOT COMPLETED|Main Period (GHLIQUID-1516)||0
10316014|NCT00184717|11449936|FG004|NOT COMPLETED|Main Period (GHLIQUID-1516)||0
10316015|NCT00184717|11449932|FG000|STARTED|Extension Period (GHLIQUID-1517)|Three subjects did not continue in extension period|33
10316016|NCT00184717|11449933|FG001|STARTED|Extension Period (GHLIQUID-1517)|Three subjects did not continue in extension period|33
10316017|NCT00184717|11449934|FG002|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised to receive 0.033 or 0.067 mg|0
10316018|NCT00184717|11449935|FG003|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised from No treatment group|10
10316019|NCT00184717|11449936|FG004|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised from No treatment group|10
10780394|NCT03384745|11942042|FG002|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||4
10780395|NCT03384745|11942043|FG003|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||4
10780396|NCT03384745|11942044|FG004|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||1
10780397|NCT03384745|11942045|FG005|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||2
10780398|NCT03384940|11942068|FG000|STARTED|Overall Study||53
10780399|NCT03384940|11942069|FG001|STARTED|Overall Study||15
10780400|NCT03384940|11942070|FG002|STARTED|Overall Study||18
10780401|NCT03384940|11942068|FG000|COMPLETED|Overall Study||0
10780402|NCT03384940|11942069|FG001|COMPLETED|Overall Study||0
10780403|NCT03384940|11942070|FG002|COMPLETED|Overall Study||0
10780404|NCT03384940|11942068|FG000|NOT COMPLETED|Overall Study||53
10780405|NCT03384940|11942069|FG001|NOT COMPLETED|Overall Study||15
10780406|NCT03384940|11942070|FG002|NOT COMPLETED|Overall Study||18
10780407|NCT03384953|11942080|FG000|STARTED|Overall Study||91
10780408|NCT03384953|11942081|FG001|STARTED|Overall Study||12
10780409|NCT03384953|11942080|FG000|Completed Treatment|Overall Study||68
10780410|NCT03384953|11942081|FG001|Completed Treatment|Overall Study||6
10780411|NCT03384953|11942080|FG000|COMPLETED|Overall Study||51
10780412|NCT03384953|11942081|FG001|COMPLETED|Overall Study||4
10780413|NCT03384953|11942080|FG000|NOT COMPLETED|Overall Study||40
10780414|NCT03384953|11942081|FG001|NOT COMPLETED|Overall Study||8
10780415|NCT03384966|11942090|FG000|STARTED|Randomized at End of Screening Period||115
10780416|NCT03384966|11942091|FG001|STARTED|Randomized at End of Screening Period||115
10780417|NCT03384966|11942092|FG002|STARTED|Randomized at End of Screening Period||116
10780418|NCT03384966|11942090|FG000|COMPLETED|Randomized at End of Screening Period||114
10780419|NCT03384966|11942091|FG001|COMPLETED|Randomized at End of Screening Period||115
10780420|NCT03384966|11942092|FG002|COMPLETED|Randomized at End of Screening Period||116
10316020|NCT00184717|11449932|FG000|COMPLETED|Extension Period (GHLIQUID-1517)||23
10316021|NCT00184717|11449933|FG001|COMPLETED|Extension Period (GHLIQUID-1517)||27
10316022|NCT00184717|11449934|FG002|COMPLETED|Extension Period (GHLIQUID-1517)||0
10316023|NCT00184717|11449935|FG003|COMPLETED|Extension Period (GHLIQUID-1517)||7
10780421|NCT03384966|11942090|FG000|NOT COMPLETED|Randomized at End of Screening Period||1
10780422|NCT03384966|11942091|FG001|NOT COMPLETED|Randomized at End of Screening Period||0
10780423|NCT03384966|11942092|FG002|NOT COMPLETED|Randomized at End of Screening Period||0
10780424|NCT03384966|11942090|FG000|STARTED|Treatment Period||114
10780425|NCT03384966|11942091|FG001|STARTED|Treatment Period||115
10780426|NCT03384966|11942092|FG002|STARTED|Treatment Period||116
10780427|NCT03384966|11942090|FG000|Thigh Administration|Treatment Period||57
10780428|NCT03384966|11942091|FG001|Thigh Administration|Treatment Period||57
10780429|NCT03384966|11942092|FG002|Thigh Administration|Treatment Period||58
10780430|NCT03384966|11942090|FG000|Abdomen Administration|Treatment Period||57
10780431|NCT03384966|11942091|FG001|Abdomen Administration|Treatment Period||58
10780432|NCT03384966|11942092|FG002|Abdomen Administration|Treatment Period||58
10780433|NCT03384966|11942090|FG000|Per-protocol Analysis Set|Treatment Period||96
10780434|NCT03384966|11942091|FG001|Per-protocol Analysis Set|Treatment Period||90
10780435|NCT03384966|11942092|FG002|Per-protocol Analysis Set|Treatment Period||93
10780436|NCT03384966|11942090|FG000|Safety Analysis Set|Treatment Period||114
10780437|NCT03384966|11942091|FG001|Safety Analysis Set|Treatment Period||115
10780438|NCT03384966|11942092|FG002|Safety Analysis Set|Treatment Period||116
10780439|NCT03384966|11942090|FG000|Pharmacokinetic Analysis Set|Treatment Period||111
10780440|NCT03384966|11942091|FG001|Pharmacokinetic Analysis Set|Treatment Period||115
10780441|NCT03384966|11942092|FG002|Pharmacokinetic Analysis Set|Treatment Period||0
10780442|NCT03384966|11942090|FG000|COMPLETED|Treatment Period||114
10780443|NCT03384966|11942091|FG001|COMPLETED|Treatment Period||115
10780444|NCT03384966|11942092|FG002|COMPLETED|Treatment Period||116
10780445|NCT03384966|11942090|FG000|NOT COMPLETED|Treatment Period||0
10780446|NCT03384966|11942091|FG001|NOT COMPLETED|Treatment Period||0
10780447|NCT03384966|11942092|FG002|NOT COMPLETED|Treatment Period||0
10780448|NCT03384966|11942090|FG000|STARTED|Follow-up Period||114
10780449|NCT03384966|11942091|FG001|STARTED|Follow-up Period||115
10780450|NCT03384966|11942092|FG002|STARTED|Follow-up Period||116
10780451|NCT03384966|11942090|FG000|COMPLETED|Follow-up Period||113
10780452|NCT03384966|11942091|FG001|COMPLETED|Follow-up Period||115
10780453|NCT03384966|11942092|FG002|COMPLETED|Follow-up Period||116
10780454|NCT03384966|11942090|FG000|NOT COMPLETED|Follow-up Period||1
10780455|NCT03384966|11942091|FG001|NOT COMPLETED|Follow-up Period||0
10780456|NCT03384966|11942092|FG002|NOT COMPLETED|Follow-up Period||0
10780457|NCT03386032|11942112|FG000|STARTED|Overall Study||36
10780458|NCT03386032|11942113|FG001|STARTED|Overall Study||18
10780459|NCT03386032|11942114|FG002|STARTED|Overall Study||11
10780460|NCT03386032|11942112|FG000|COMPLETED|Overall Study||18
10780461|NCT03386032|11942113|FG001|COMPLETED|Overall Study||11
10780462|NCT03386032|11942114|FG002|COMPLETED|Overall Study||11
10780463|NCT03386032|11942112|FG000|NOT COMPLETED|Overall Study||18
10780464|NCT03386032|11942113|FG001|NOT COMPLETED|Overall Study||7
10316024|NCT00184717|11449936|FG004|COMPLETED|Extension Period (GHLIQUID-1517)||5
10780465|NCT03386032|11942114|FG002|NOT COMPLETED|Overall Study||0
10780466|NCT03386110|11942124|FG000|STARTED|Overall Study||56
10780467|NCT03386110|11942125|FG001|STARTED|Overall Study||44
10780468|NCT03386110|11942124|FG000|COMPLETED|Overall Study||41
10780469|NCT03386110|11942125|FG001|COMPLETED|Overall Study||38
10780470|NCT03386110|11942124|FG000|NOT COMPLETED|Overall Study||15
10780471|NCT03386110|11942125|FG001|NOT COMPLETED|Overall Study||6
10780472|NCT03386344|11942134|FG000|STARTED|Overall Study||126
10780473|NCT03386344|11942135|FG001|STARTED|Overall Study||125
10780474|NCT03386344|11942136|FG002|STARTED|Overall Study||125
10780475|NCT03386344|11942134|FG000|COMPLETED|Overall Study||9
10780476|NCT03386344|11942135|FG001|COMPLETED|Overall Study||9
10780477|NCT03386344|11942136|FG002|COMPLETED|Overall Study||9
10780478|NCT03386344|11942134|FG000|NOT COMPLETED|Overall Study||117
10780479|NCT03386344|11942135|FG001|NOT COMPLETED|Overall Study||116
10780480|NCT03386344|11942136|FG002|NOT COMPLETED|Overall Study||116
10780481|NCT03386435|11942146|FG000|STARTED|Overall Study||80
10780482|NCT03386435|11942147|FG001|STARTED|Overall Study||80
10780483|NCT03386435|11942146|FG000|COMPLETED|Overall Study||75
10780484|NCT03386435|11942147|FG001|COMPLETED|Overall Study||73
10780485|NCT03386435|11942146|FG000|NOT COMPLETED|Overall Study||5
10780486|NCT03386435|11942147|FG001|NOT COMPLETED|Overall Study||7
10780487|NCT03386448|11942155|FG000|STARTED|Overall Study||6
10780488|NCT03386448|11942156|FG001|STARTED|Overall Study||8
10780489|NCT03386448|11942155|FG000|COMPLETED|Overall Study||6
10780490|NCT03386448|11942156|FG001|COMPLETED|Overall Study||6
10780491|NCT03386448|11942155|FG000|NOT COMPLETED|Overall Study||0
10780492|NCT03386448|11942156|FG001|NOT COMPLETED|Overall Study||2
10780493|NCT03386474|11942164|FG000|STARTED|Overall Study||107
10780494|NCT03386474|11942165|FG001|STARTED|Overall Study||43
10780495|NCT03386474|11942164|FG000|COMPLETED|Overall Study||106
10780496|NCT03386474|11942165|FG001|COMPLETED|Overall Study||42
10780497|NCT03386474|11942164|FG000|NOT COMPLETED|Overall Study||1
10780498|NCT03386474|11942165|FG001|NOT COMPLETED|Overall Study||1
10780499|NCT03386994|11942179|FG000|STARTED|Overall Study||204
10780500|NCT03386994|11942179|FG000|COMPLETED|Overall Study||166
10780501|NCT03386994|11942179|FG000|NOT COMPLETED|Overall Study||38
10780502|NCT03387020|11942197|FG000|STARTED|Overall Study||13
10780503|NCT03387020|11942198|FG001|STARTED|Overall Study||3
10780504|NCT03387020|11942199|FG002|STARTED|Overall Study||5
10780505|NCT03387020|11942197|FG000|Received Treatment|Overall Study||12
10780506|NCT03387020|11942198|FG001|Received Treatment|Overall Study||3
10780507|NCT03387020|11942199|FG002|Received Treatment|Overall Study||5
10780508|NCT03387020|11942197|FG000|COMPLETED|Overall Study||11
10780509|NCT03387020|11942198|FG001|COMPLETED|Overall Study||1
10780510|NCT03387020|11942199|FG002|COMPLETED|Overall Study||5
10780511|NCT03387020|11942197|FG000|NOT COMPLETED|Overall Study||2
10780512|NCT03387020|11942198|FG001|NOT COMPLETED|Overall Study||2
10780513|NCT03387020|11942199|FG002|NOT COMPLETED|Overall Study||0
10780514|NCT03387033|11942217|FG000|STARTED|Overall Study||20
10316025|NCT00184717|11449932|FG000|NOT COMPLETED|Extension Period (GHLIQUID-1517)||10
10316026|NCT00184717|11449933|FG001|NOT COMPLETED|Extension Period (GHLIQUID-1517)||6
10316027|NCT00184717|11449934|FG002|NOT COMPLETED|Extension Period (GHLIQUID-1517)||0
10316028|NCT00184717|11449935|FG003|NOT COMPLETED|Extension Period (GHLIQUID-1517)||3
10316029|NCT00184717|11449936|FG004|NOT COMPLETED|Extension Period (GHLIQUID-1517)||5
10548830|NCT01521494|11702689|FG000|COMPLETED|Overall Study||37
10548831|NCT01521494|11702690|FG001|COMPLETED|Overall Study||31
10548832|NCT01521494|11702691|FG002|COMPLETED|Overall Study||23
10780515|NCT03387033|11942217|FG000|COMPLETED|Overall Study||20
10780516|NCT03387033|11942217|FG000|NOT COMPLETED|Overall Study||0
10780517|NCT03387046|11942223|FG000|STARTED|Overall Study||5
10548833|NCT01521494|11702692|FG003|COMPLETED|Overall Study||15
10780518|NCT03387046|11942224|FG001|STARTED|Overall Study||2
10780519|NCT03387046|11942223|FG000|COMPLETED|Overall Study||4
10780520|NCT03387046|11942224|FG001|COMPLETED|Overall Study||1
10780521|NCT03387046|11942223|FG000|NOT COMPLETED|Overall Study||1
10780522|NCT03387046|11942224|FG001|NOT COMPLETED|Overall Study||1
10780523|NCT03387267|11942230|FG000|STARTED|Overall Study||452
10780524|NCT03387267|11942230|FG000|COMPLETED|Overall Study||438
10780525|NCT03387267|11942230|FG000|NOT COMPLETED|Overall Study||14
10780526|NCT03387319|11942237|FG000|STARTED|Overall Study||25
10780527|NCT03387319|11942238|FG001|STARTED|Overall Study||25
10780528|NCT03387319|11942237|FG000|COMPLETED|Overall Study||25
10548834|NCT01521494|11702693|FG004|COMPLETED|Overall Study||30
10548835|NCT01521494|11702689|FG000|NOT COMPLETED|Overall Study||2
10780529|NCT03387319|11942238|FG001|COMPLETED|Overall Study||25
10780530|NCT03387319|11942237|FG000|NOT COMPLETED|Overall Study||0
10780531|NCT03387319|11942238|FG001|NOT COMPLETED|Overall Study||0
10780532|NCT03387462|11942244|FG000|STARTED|Overall Study||20
10780533|NCT03387462|11942244|FG000|4 Weeks|Overall Study||20
10780534|NCT03387462|11942244|FG000|8 Weeks|Overall Study||19
10780535|NCT03387462|11942244|FG000|COMPLETED|Overall Study||19
10780536|NCT03387462|11942244|FG000|NOT COMPLETED|Overall Study||1
10780537|NCT03387683|11942250|FG000|STARTED|Overall Study||27
10780538|NCT03387683|11942251|FG001|STARTED|Overall Study||26
10780539|NCT03387683|11942250|FG000|COMPLETED|Overall Study||25
10780540|NCT03387683|11942251|FG001|COMPLETED|Overall Study||26
10780541|NCT03387683|11942250|FG000|NOT COMPLETED|Overall Study||2
10780542|NCT03387683|11942251|FG001|NOT COMPLETED|Overall Study||0
10780549|NCT03388164|11942268|FG000|STARTED|Overall Study||10
10780550|NCT03388164|11942269|FG001|STARTED|Overall Study||10
10780551|NCT03388164|11942268|FG000|COMPLETED|Overall Study||7
10780552|NCT03388164|11942269|FG001|COMPLETED|Overall Study||9
10780553|NCT03388164|11942268|FG000|NOT COMPLETED|Overall Study||3
10780554|NCT03388164|11942269|FG001|NOT COMPLETED|Overall Study||1
10780555|NCT03388268|11942277|FG000|STARTED|Overall Study||8
10780556|NCT03388268|11942278|FG001|STARTED|Overall Study||7
10780557|NCT03388268|11942277|FG000|COMPLETED|Overall Study||7
10780558|NCT03388268|11942278|FG001|COMPLETED|Overall Study||4
10316030|NCT00185211|11449948|FG000|STARTED|Placebo-controlled Study (92012)||292
10316031|NCT00185211|11449949|FG001|STARTED|Placebo-controlled Study (92012)||176
10316032|NCT00185211|11449948|FG000|COMPLETED|Placebo-controlled Study (92012)||271
10316033|NCT00185211|11449949|FG001|COMPLETED|Placebo-controlled Study (92012)||166
10316034|NCT00185211|11449948|FG000|NOT COMPLETED|Placebo-controlled Study (92012)||21
10316035|NCT00185211|11449949|FG001|NOT COMPLETED|Placebo-controlled Study (92012)||10
10316036|NCT00185211|11449948|FG000|STARTED|Follow-up Study (91031 - This Study)|10 of the 271 subjects completing the placebo-controlled study did not consent to the Follow-up.|261
10316037|NCT00185211|11449949|FG001|STARTED|Follow-up Study (91031 - This Study)|9 of the 166 subjects completing the placebo-controlled study did not consent to the Follow-up.|157
10316038|NCT00185211|11449948|FG000|COMPLETED|Follow-up Study (91031 - This Study)||235
10316039|NCT00185211|11449949|FG001|COMPLETED|Follow-up Study (91031 - This Study)||123
10316040|NCT00185211|11449948|FG000|NOT COMPLETED|Follow-up Study (91031 - This Study)||26
10316041|NCT00185211|11449949|FG001|NOT COMPLETED|Follow-up Study (91031 - This Study)||34
10316042|NCT00185380|11449959|FG000|STARTED|Overall Study||240
10316043|NCT00185380|11449960|FG001|STARTED|Overall Study||246
10316044|NCT00185380|11449961|FG002|STARTED|Overall Study||256
10316045|NCT00185380|11449959|FG000|Subjects Received Treatment|Overall Study||239
10316046|NCT00185380|11449960|FG001|Subjects Received Treatment|Overall Study||245
10316047|NCT00185380|11449961|FG002|Subjects Received Treatment|Overall Study||254
10316048|NCT00185380|11449959|FG000|COMPLETED|Overall Study||174
10316049|NCT00185380|11449960|FG001|COMPLETED|Overall Study||174
10316050|NCT00185380|11449961|FG002|COMPLETED|Overall Study||182
10316051|NCT00185380|11449959|FG000|NOT COMPLETED|Overall Study||66
10316052|NCT00185380|11449960|FG001|NOT COMPLETED|Overall Study||72
10316053|NCT00185380|11449961|FG002|NOT COMPLETED|Overall Study||74
10316054|NCT00185458|11449969|FG000|STARTED|Contraception Phase||394
10316055|NCT00185458|11449969|FG000|COMPLETED|Contraception Phase||336
10316056|NCT00185458|11449969|FG000|NOT COMPLETED|Contraception Phase||58
10316057|NCT00185458|11449969|FG000|STARTED|HRT Phase|168 subjects were eligible for the HRT phase out 336 who completed contraception phase.|168
10316058|NCT00185458|11449969|FG000|COMPLETED|HRT Phase||141
10316059|NCT00185458|11449969|FG000|NOT COMPLETED|HRT Phase||27
10316060|NCT00185588|11449985|FG000|STARTED|Overall Study||6
10316061|NCT00185588|11449986|FG001|STARTED|Overall Study||4
10316062|NCT00185588|11449987|FG002|STARTED|Overall Study||6
10316063|NCT00185588|11449988|FG003|STARTED|Overall Study||17
10316064|NCT00185588|11449985|FG000|COMPLETED|Overall Study||3
10316065|NCT00185588|11449986|FG001|COMPLETED|Overall Study||2
10316066|NCT00185588|11449987|FG002|COMPLETED|Overall Study||0
10316067|NCT00185588|11449988|FG003|COMPLETED|Overall Study||13
10316068|NCT00185588|11449985|FG000|NOT COMPLETED|Overall Study||3
10316069|NCT00185588|11449986|FG001|NOT COMPLETED|Overall Study||2
10316070|NCT00185588|11449987|FG002|NOT COMPLETED|Overall Study||6
10316071|NCT00185588|11449988|FG003|NOT COMPLETED|Overall Study||4
10316072|NCT00185614|11449998|FG000|STARTED|Autologous HCT (Auto-HCT)||63
10316073|NCT00185614|11449998|FG000|COMPLETED|Autologous HCT (Auto-HCT)||63
10316074|NCT00185614|11449998|FG000|NOT COMPLETED|Autologous HCT (Auto-HCT)||0
10316075|NCT00185614|11449998|FG000|STARTED|Inter-treatment Period|Not all participants who received autologous transplant continued to receive allogeneic transplant.|63
10316076|NCT00185614|11449998|FG000|COMPLETED|Inter-treatment Period||59
10316077|NCT00185614|11449998|FG000|NOT COMPLETED|Inter-treatment Period||4
10316078|NCT00185614|11449998|FG000|STARTED|Allogenic HCT (Allo-HCT)||59
10316079|NCT00185614|11449998|FG000|COMPLETED|Allogenic HCT (Allo-HCT)||59
10316080|NCT00185614|11449998|FG000|NOT COMPLETED|Allogenic HCT (Allo-HCT)||0
10316081|NCT00185640|11450002|FG000|STARTED|Overall Study||303
10316082|NCT00185640|11450002|FG000|Transplanted|Overall Study||296
10316083|NCT00185640|11450002|FG000|90 Days Post-transplant|Overall Study||161
10316084|NCT00185640|11450002|FG000|COMPLETED|Overall Study||158
10316085|NCT00185640|11450002|FG000|NOT COMPLETED|Overall Study||145
10316086|NCT00185679|11450006|FG000|STARTED|Overall Study||13
10316087|NCT00185679|11450006|FG000|COMPLETED|Overall Study||13
10316088|NCT00185679|11450006|FG000|NOT COMPLETED|Overall Study||0
10316089|NCT00185692|11450010|FG000|STARTED|Overall Study||16
10316090|NCT00185692|11450010|FG000|COMPLETED|Overall Study||0
10548836|NCT01521494|11702690|FG001|NOT COMPLETED|Overall Study||5
10780559|NCT03388268|11942277|FG000|NOT COMPLETED|Overall Study||1
10780560|NCT03388268|11942278|FG001|NOT COMPLETED|Overall Study||3
10316091|NCT00185692|11450010|FG000|NOT COMPLETED|Overall Study||16
10316092|NCT00185731|11450014|FG000|STARTED|Overall Study||25
10316093|NCT00185731|11450014|FG000|COMPLETED|Overall Study||23
10316094|NCT00185731|11450014|FG000|NOT COMPLETED|Overall Study||2
10316095|NCT00185900|11450022|FG000|STARTED|Overall Study||92
10316096|NCT00185900|11450023|FG001|STARTED|Overall Study||100
10316097|NCT00185900|11450022|FG000|COMPLETED|Overall Study||92
10316098|NCT00185900|11450023|FG001|COMPLETED|Overall Study||100
10316099|NCT00185900|11450022|FG000|NOT COMPLETED|Overall Study||0
10316100|NCT00185900|11450023|FG001|NOT COMPLETED|Overall Study||0
10316101|NCT00185965|11450031|FG000|STARTED|Overall Study||15
10780561|NCT03388294|11942286|FG000|STARTED|Overall Study||42
10780562|NCT03388294|11942287|FG001|STARTED|Overall Study||30
10780563|NCT03388294|11942286|FG000|Posttest 1|Overall Study||38
10316102|NCT00185965|11450032|FG001|STARTED|Overall Study||15
10316103|NCT00185965|11450031|FG000|COMPLETED|Overall Study||15
10316104|NCT00185965|11450032|FG001|COMPLETED|Overall Study||14
10316105|NCT00185965|11450031|FG000|NOT COMPLETED|Overall Study||0
10316106|NCT00185965|11450032|FG001|NOT COMPLETED|Overall Study||1
10316107|NCT00186017|11450040|FG000|STARTED|Overall Study||25
10316108|NCT00186017|11450041|FG001|STARTED|Overall Study||25
10316109|NCT00186017|11450040|FG000|COMPLETED|Overall Study||23
10316110|NCT00186017|11450041|FG001|COMPLETED|Overall Study||22
10316111|NCT00186017|11450040|FG000|NOT COMPLETED|Overall Study||2
10316112|NCT00186017|11450041|FG001|NOT COMPLETED|Overall Study||3
10316113|NCT00186043|11450050|FG000|STARTED|Overall Study||30
10316114|NCT00186043|11450051|FG001|STARTED|Overall Study||25
10316115|NCT00186043|11450050|FG000|COMPLETED|Overall Study||15
10316116|NCT00186043|11450051|FG001|COMPLETED|Overall Study||12
10316117|NCT00186043|11450050|FG000|NOT COMPLETED|Overall Study||15
10316118|NCT00186043|11450051|FG001|NOT COMPLETED|Overall Study||13
10316119|NCT00186056|11450059|FG000|STARTED|Overall Study||14
10316120|NCT00186056|11450060|FG001|STARTED|Overall Study||17
10316121|NCT00186056|11450059|FG000|COMPLETED|Overall Study||12
10316122|NCT00186056|11450060|FG001|COMPLETED|Overall Study||16
10316123|NCT00186056|11450059|FG000|NOT COMPLETED|Overall Study||2
10316124|NCT00186056|11450060|FG001|NOT COMPLETED|Overall Study||1
10316125|NCT00186069|11450068|FG000|STARTED|Overall Study|Enrollment goal was not reached due to the introduction of magnesium sulfate for neuroprotection|15
10316126|NCT00186069|11450069|FG001|STARTED|Overall Study|Enrollment goal was not reached due to the introduction of magnesium sulfate for neuroprotection|15
10316127|NCT00186069|11450068|FG000|COMPLETED|Overall Study||15
10316128|NCT00186069|11450069|FG001|COMPLETED|Overall Study||15
10316129|NCT00186069|11450068|FG000|NOT COMPLETED|Overall Study||0
10316130|NCT00186069|11450069|FG001|NOT COMPLETED|Overall Study||0
10338321|NCT00369486|11475225|FG001|NOT COMPLETED|8-Week Visit||1
10338322|NCT00369486|11475226|FG002|NOT COMPLETED|8-Week Visit||0
10338323|NCT00369486|11475227|FG003|NOT COMPLETED|8-Week Visit||1
10338324|NCT00369486|11475228|FG004|NOT COMPLETED|8-Week Visit||1
10338325|NCT00369486|11475224|FG000|STARTED|17-Week Visit|Number of eyes|38
10338326|NCT00369486|11475225|FG001|STARTED|17-Week Visit|Number of eyes|21
10338327|NCT00369486|11475226|FG002|STARTED|17-Week Visit|Number of eyes|23
10338328|NCT00369486|11475227|FG003|STARTED|17-Week Visit|Number of eyes|22
10338329|NCT00369486|11475228|FG004|STARTED|17-Week Visit|Number of eyes|25
10338330|NCT00369486|11475224|FG000|COMPLETED|17-Week Visit|Number of eyes|38
10338331|NCT00369486|11475225|FG001|COMPLETED|17-Week Visit|Number of eyes|21
10338332|NCT00369486|11475226|FG002|COMPLETED|17-Week Visit|Number of eyes|22
10338333|NCT00369486|11475227|FG003|COMPLETED|17-Week Visit|Number of eyes|21
10338334|NCT00369486|11475228|FG004|COMPLETED|17-Week Visit|Number of eyes|24
10338335|NCT00369486|11475224|FG000|NOT COMPLETED|17-Week Visit||0
10338336|NCT00369486|11475225|FG001|NOT COMPLETED|17-Week Visit||0
10338337|NCT00369486|11475226|FG002|NOT COMPLETED|17-Week Visit||1
10338338|NCT00369486|11475227|FG003|NOT COMPLETED|17-Week Visit||1
10338339|NCT00369486|11475228|FG004|NOT COMPLETED|17-Week Visit||1
10338340|NCT00369486|11475224|FG000|STARTED|34-Week Visit|Number of eyes|38
10338341|NCT00369486|11475225|FG001|STARTED|34-Week Visit|Number of eyes|21
10338342|NCT00369486|11475226|FG002|STARTED|34-Week Visit|Number of eyes|23
10338343|NCT00369486|11475227|FG003|STARTED|34-Week Visit|Number of eyes|22
10338344|NCT00369486|11475228|FG004|STARTED|34-Week Visit|Number of eyes that|25
10338345|NCT00369486|11475224|FG000|COMPLETED|34-Week Visit|Number of eyes|38
10780564|NCT03388294|11942287|FG001|Posttest 1|Overall Study||30
10338346|NCT00369486|11475225|FG001|COMPLETED|34-Week Visit|Number of eyes|20
10338347|NCT00369486|11475226|FG002|COMPLETED|34-Week Visit|Number of eyes|22
10338348|NCT00369486|11475227|FG003|COMPLETED|34-Week Visit|Number of eyes|19
10338349|NCT00369486|11475228|FG004|COMPLETED|34-Week Visit|Number of eyes|22
10338350|NCT00369486|11475224|FG000|NOT COMPLETED|34-Week Visit||0
10338351|NCT00369486|11475225|FG001|NOT COMPLETED|34-Week Visit||1
10338352|NCT00369486|11475226|FG002|NOT COMPLETED|34-Week Visit||1
10338353|NCT00369486|11475227|FG003|NOT COMPLETED|34-Week Visit||3
10338354|NCT00369486|11475228|FG004|NOT COMPLETED|34-Week Visit||3
10338355|NCT00369512|11475240|FG000|STARTED|Overall Study||15
10780565|NCT03388294|11942286|FG000|Posttest 2|Overall Study||38
10780566|NCT03388294|11942287|FG001|Posttest 2|Overall Study||30
10780567|NCT03388294|11942286|FG000|COMPLETED|Overall Study||38
10780568|NCT03388294|11942287|FG001|COMPLETED|Overall Study||30
10780569|NCT03388294|11942286|FG000|NOT COMPLETED|Overall Study||4
10780570|NCT03388294|11942287|FG001|NOT COMPLETED|Overall Study||0
10780571|NCT03388645|11942295|FG000|STARTED|Low Dose RSV A2||4
10780572|NCT03388645|11942296|FG001|STARTED|Low Dose RSV A2||0
10780573|NCT03388645|11942295|FG000|COMPLETED|Low Dose RSV A2||4
10780574|NCT03388645|11942296|FG001|COMPLETED|Low Dose RSV A2||0
10780575|NCT03388645|11942295|FG000|NOT COMPLETED|Low Dose RSV A2||0
10780576|NCT03388645|11942296|FG001|NOT COMPLETED|Low Dose RSV A2||0
10780577|NCT03388645|11942295|FG000|STARTED|High Dose RSV A2||0
10780578|NCT03388645|11942296|FG001|STARTED|High Dose RSV A2||8
10780579|NCT03388645|11942295|FG000|COMPLETED|High Dose RSV A2||0
10316131|NCT00186121|11450075|FG000|STARTED|Overall Study||35
10316132|NCT00186121|11450075|FG000|COMPLETED|Overall Study||32
10316133|NCT00186121|11450075|FG000|NOT COMPLETED|Overall Study||3
10316134|NCT00186186|11450079|FG000|STARTED|Overall Study||28
10316135|NCT00186186|11450079|FG000|COMPLETED|Overall Study||20
10316136|NCT00186186|11450079|FG000|NOT COMPLETED|Overall Study||8
10316137|NCT00186446|11450084|FG000|STARTED|Overall Study||20
10316138|NCT00186446|11450084|FG000|COMPLETED|Overall Study||11
10316139|NCT00186446|11450084|FG000|NOT COMPLETED|Overall Study||9
10316140|NCT00186485|11450090|FG000|STARTED|Overall Study||28
10316141|NCT00186485|11450090|FG000|COMPLETED|Overall Study||25
10316142|NCT00186485|11450090|FG000|NOT COMPLETED|Overall Study||3
10316143|NCT00186498|11450096|FG000|STARTED|Overall Study||6
10316144|NCT00186498|11450097|FG001|STARTED|Overall Study||5
10316145|NCT00186498|11450096|FG000|COMPLETED|Overall Study||4
10316146|NCT00186498|11450097|FG001|COMPLETED|Overall Study||3
10316147|NCT00186498|11450096|FG000|NOT COMPLETED|Overall Study||2
10316148|NCT00186498|11450097|FG001|NOT COMPLETED|Overall Study||2
10316149|NCT00186537|11450106|FG000|STARTED|Overall Study||19
10316150|NCT00186537|11450107|FG001|STARTED|Overall Study||12
10316151|NCT00186537|11450108|FG002|STARTED|Overall Study||16
10316152|NCT00186537|11450106|FG000|COMPLETED|Overall Study||12
10316153|NCT00186537|11450107|FG001|COMPLETED|Overall Study||12
10316154|NCT00186537|11450108|FG002|COMPLETED|Overall Study||13
10316155|NCT00186537|11450106|FG000|NOT COMPLETED|Overall Study||7
10316156|NCT00186537|11450107|FG001|NOT COMPLETED|Overall Study||0
10316157|NCT00186537|11450108|FG002|NOT COMPLETED|Overall Study||3
10316158|NCT00186628|11450116|FG000|STARTED|Overall Study||36
10316159|NCT00186628|11450116|FG000|COMPLETED|Overall Study||33
10316160|NCT00186628|11450116|FG000|NOT COMPLETED|Overall Study||3
10316161|NCT00186875|11450124|FG000|STARTED|Overall Study||26
10316162|NCT00186875|11450125|FG001|STARTED|Overall Study||14
10316163|NCT00186875|11450124|FG000|COMPLETED|Overall Study||26
10316164|NCT00186875|11450125|FG001|COMPLETED|Overall Study||14
10316165|NCT00186875|11450124|FG000|NOT COMPLETED|Overall Study||0
10316166|NCT00186875|11450125|FG001|NOT COMPLETED|Overall Study||0
10316167|NCT00186901|11450135|FG000|STARTED|Overall Study||134
10316168|NCT00186901|11450136|FG001|STARTED|Overall Study||141
10316169|NCT00186901|11450137|FG002|STARTED|Overall Study||149
10316170|NCT00186901|11450135|FG000|Baseline|Overall Study||134
10316171|NCT00186901|11450136|FG001|Baseline|Overall Study||141
10316172|NCT00186901|11450137|FG002|Baseline|Overall Study||0
10316173|NCT00186901|11450135|FG000|12 Month Follow-up|Overall Study||117
10316174|NCT00186901|11450136|FG001|12 Month Follow-up|Overall Study||122
10316175|NCT00186901|11450137|FG002|12 Month Follow-up|Overall Study||0
10316176|NCT00186901|11450135|FG000|24 Month Follow-up|Overall Study||106
10316177|NCT00186901|11450136|FG001|24 Month Follow-up|Overall Study||107
10316178|NCT00186901|11450137|FG002|24 Month Follow-up|Overall Study||0
10316179|NCT00186901|11450135|FG000|COMPLETED|Overall Study||85
10316180|NCT00186901|11450136|FG001|COMPLETED|Overall Study||96
10316181|NCT00186901|11450137|FG002|COMPLETED|Overall Study||0
10316182|NCT00186901|11450135|FG000|NOT COMPLETED|Overall Study||49
10316183|NCT00186901|11450136|FG001|NOT COMPLETED|Overall Study||45
10316184|NCT00186901|11450137|FG002|NOT COMPLETED|Overall Study||149
10316185|NCT00187096|11450177|FG000|STARTED|Overall Study||10
10316186|NCT00187096|11450178|FG001|STARTED|Overall Study||3
10316187|NCT00187096|11450179|FG002|STARTED|Overall Study||12
10316188|NCT00187096|11450177|FG000|COMPLETED|Overall Study||10
10316189|NCT00187096|11450178|FG001|COMPLETED|Overall Study||3
10316190|NCT00187096|11450179|FG002|COMPLETED|Overall Study||11
10316191|NCT00187096|11450177|FG000|NOT COMPLETED|Overall Study||0
10316192|NCT00187096|11450178|FG001|NOT COMPLETED|Overall Study||0
10316193|NCT00187096|11450179|FG002|NOT COMPLETED|Overall Study||1
10316194|NCT00187135|11450193|FG000|STARTED|Visit One||30
10316195|NCT00187135|11450194|FG001|STARTED|Visit One||28
10316196|NCT00187135|11450195|FG002|STARTED|Visit One||25
10316197|NCT00187135|11450196|FG003|STARTED|Visit One||26
10316198|NCT00187135|11450197|FG004|STARTED|Visit One||25
10316199|NCT00187135|11450198|FG005|STARTED|Visit One||28
10316200|NCT00187135|11450193|FG000|COMPLETED|Visit One||26
10780580|NCT03388645|11942296|FG001|COMPLETED|High Dose RSV A2||7
10780581|NCT03388645|11942295|FG000|NOT COMPLETED|High Dose RSV A2||0
10316201|NCT00187135|11450194|FG001|COMPLETED|Visit One||27
10316202|NCT00187135|11450195|FG002|COMPLETED|Visit One||25
10780582|NCT03388645|11942296|FG001|NOT COMPLETED|High Dose RSV A2||1
10780583|NCT03389308|11942302|FG000|STARTED|Overall Study||51
10780584|NCT03389308|11942302|FG000|COMPLETED|Overall Study||39
10316203|NCT00187135|11450196|FG003|COMPLETED|Visit One||26
10316204|NCT00187135|11450197|FG004|COMPLETED|Visit One||25
10780585|NCT03389308|11942302|FG000|NOT COMPLETED|Overall Study||12
10780586|NCT03389555|11942308|FG000|STARTED|Overall Study||103
10780587|NCT03389555|11942309|FG001|STARTED|Overall Study||102
10780588|NCT03389555|11942308|FG000|COMPLETED|Overall Study||101
10316205|NCT00187135|11450198|FG005|COMPLETED|Visit One||26
10316206|NCT00187135|11450193|FG000|NOT COMPLETED|Visit One||4
10316207|NCT00187135|11450194|FG001|NOT COMPLETED|Visit One||1
10316208|NCT00187135|11450195|FG002|NOT COMPLETED|Visit One||0
10316209|NCT00187135|11450196|FG003|NOT COMPLETED|Visit One||0
10316210|NCT00187135|11450197|FG004|NOT COMPLETED|Visit One||0
10316211|NCT00187135|11450198|FG005|NOT COMPLETED|Visit One||2
10316212|NCT00187135|11450193|FG000|STARTED|Visit Two||26
10316213|NCT00187135|11450194|FG001|STARTED|Visit Two||27
10316214|NCT00187135|11450195|FG002|STARTED|Visit Two||25
10316215|NCT00187135|11450196|FG003|STARTED|Visit Two||26
10316216|NCT00187135|11450197|FG004|STARTED|Visit Two||25
10316217|NCT00187135|11450198|FG005|STARTED|Visit Two||26
10316218|NCT00187135|11450193|FG000|COMPLETED|Visit Two||21
10316219|NCT00187135|11450194|FG001|COMPLETED|Visit Two||24
10316220|NCT00187135|11450195|FG002|COMPLETED|Visit Two||23
10316221|NCT00187135|11450196|FG003|COMPLETED|Visit Two||18
10316222|NCT00187135|11450197|FG004|COMPLETED|Visit Two||19
10316223|NCT00187135|11450198|FG005|COMPLETED|Visit Two||18
10316224|NCT00187135|11450193|FG000|NOT COMPLETED|Visit Two||5
10316225|NCT00187135|11450194|FG001|NOT COMPLETED|Visit Two||3
10316226|NCT00187135|11450195|FG002|NOT COMPLETED|Visit Two||2
10316227|NCT00187135|11450196|FG003|NOT COMPLETED|Visit Two||8
10316228|NCT00187135|11450197|FG004|NOT COMPLETED|Visit Two||6
10316229|NCT00187135|11450198|FG005|NOT COMPLETED|Visit Two||8
10316230|NCT00187135|11450193|FG000|STARTED|Visit Three||21
10316231|NCT00187135|11450194|FG001|STARTED|Visit Three||24
10316232|NCT00187135|11450195|FG002|STARTED|Visit Three||23
10316233|NCT00187135|11450196|FG003|STARTED|Visit Three||18
10316234|NCT00187135|11450197|FG004|STARTED|Visit Three||19
10316235|NCT00187135|11450198|FG005|STARTED|Visit Three||18
10316236|NCT00187135|11450193|FG000|COMPLETED|Visit Three||14
10316237|NCT00187135|11450194|FG001|COMPLETED|Visit Three||17
10316238|NCT00187135|11450195|FG002|COMPLETED|Visit Three||14
10316239|NCT00187135|11450196|FG003|COMPLETED|Visit Three||9
10316240|NCT00187135|11450197|FG004|COMPLETED|Visit Three||11
10316241|NCT00187135|11450198|FG005|COMPLETED|Visit Three||12
10316242|NCT00187135|11450193|FG000|NOT COMPLETED|Visit Three||7
10316243|NCT00187135|11450194|FG001|NOT COMPLETED|Visit Three||7
10316244|NCT00187135|11450195|FG002|NOT COMPLETED|Visit Three||9
10316245|NCT00187135|11450196|FG003|NOT COMPLETED|Visit Three||9
10316246|NCT00187135|11450197|FG004|NOT COMPLETED|Visit Three||8
10316247|NCT00187135|11450198|FG005|NOT COMPLETED|Visit Three||6
10316248|NCT00187200|11450212|FG000|STARTED|Overall Study||49
10316249|NCT00187200|11450213|FG001|STARTED|Overall Study||44
10316250|NCT00187200|11450212|FG000|COMPLETED|Overall Study||31
10316251|NCT00187200|11450213|FG001|COMPLETED|Overall Study||26
10316252|NCT00187200|11450212|FG000|NOT COMPLETED|Overall Study||18
10316253|NCT00187200|11450213|FG001|NOT COMPLETED|Overall Study||18
10316254|NCT00187278|11450223|FG000|STARTED|Overall Study||918
10316255|NCT00187278|11450224|FG001|STARTED|Overall Study||915
10316256|NCT00187278|11450223|FG000|COMPLETED|Overall Study||908
10316257|NCT00187278|11450224|FG001|COMPLETED|Overall Study||902
10316258|NCT00187278|11450223|FG000|NOT COMPLETED|Overall Study||10
10316259|NCT00187278|11450224|FG001|NOT COMPLETED|Overall Study||13
10316260|NCT00187369|11450234|FG000|STARTED|Mothers||1398
10316261|NCT00187369|11450235|FG001|STARTED|Mothers||1406
10316262|NCT00187369|11450234|FG000|Included in the Study|Mothers||1393
10316263|NCT00187369|11450235|FG001|Included in the Study|Mothers||1393
10316264|NCT00187369|11450234|FG000|COMPLETED|Mothers||1392
10316265|NCT00187369|11450235|FG001|COMPLETED|Mothers||1392
10316266|NCT00187369|11450234|FG000|NOT COMPLETED|Mothers||6
10316267|NCT00187369|11450235|FG001|NOT COMPLETED|Mothers||14
10316268|NCT00187369|11450234|FG000|STARTED|Fetuses or Infants||2795
10316269|NCT00187369|11450235|FG001|STARTED|Fetuses or Infants||2812
10316270|NCT00187369|11450234|FG000|Included in the Study|Fetuses or Infants||2785
10316271|NCT00187369|11450235|FG001|Included in the Study|Fetuses or Infants||2786
10316272|NCT00187369|11450234|FG000|COMPLETED|Fetuses or Infants||2783
10316273|NCT00187369|11450235|FG001|COMPLETED|Fetuses or Infants||2782
10316274|NCT00187369|11450234|FG000|NOT COMPLETED|Fetuses or Infants||12
10316275|NCT00187369|11450235|FG001|NOT COMPLETED|Fetuses or Infants||30
10316276|NCT00187486|11450247|FG000|STARTED|Overall Study||66
10316277|NCT00187486|11450247|FG000|COMPLETED|Overall Study||65
10316278|NCT00187486|11450247|FG000|NOT COMPLETED|Overall Study||1
10780589|NCT03389555|11942309|FG001|COMPLETED|Overall Study||99
10316279|NCT00187655|11450251|FG000|STARTED|Overall Study||24
10316280|NCT00187655|11450251|FG000|COMPLETED|Overall Study||24
10316281|NCT00187655|11450251|FG000|NOT COMPLETED|Overall Study||0
10316282|NCT00187681|11450258|FG000|STARTED|Overall Study||12
10316283|NCT00187681|11450259|FG001|STARTED|Overall Study||8
10316284|NCT00187681|11450258|FG000|COMPLETED|Overall Study||12
10316285|NCT00187681|11450259|FG001|COMPLETED|Overall Study||8
10316286|NCT00187681|11450258|FG000|NOT COMPLETED|Overall Study||0
10316287|NCT00187681|11450259|FG001|NOT COMPLETED|Overall Study||0
10316288|NCT00187720|11450269|FG000|STARTED|Overall Study||9
10316289|NCT00187720|11450270|FG001|STARTED|Overall Study||14
10316290|NCT00187720|11450269|FG000|COMPLETED|Overall Study||9
10316291|NCT00187720|11450270|FG001|COMPLETED|Overall Study||14
10316292|NCT00187720|11450269|FG000|NOT COMPLETED|Overall Study||0
10316293|NCT00187720|11450270|FG001|NOT COMPLETED|Overall Study||0
10316294|NCT00187876|11450278|FG000|STARTED|Overall Study||24
10780590|NCT03389555|11942308|FG000|NOT COMPLETED|Overall Study||2
10780591|NCT03389555|11942309|FG001|NOT COMPLETED|Overall Study||3
10780592|NCT03389854|11942319|FG000|STARTED|Overall Study||28
10780593|NCT03389854|11942320|FG001|STARTED|Overall Study||27
10780594|NCT03389854|11942321|FG002|STARTED|Overall Study||28
10780595|NCT03389854|11942322|FG003|STARTED|Overall Study||27
10780596|NCT03389854|11942319|FG000|COMPLETED|Overall Study||27
10780597|NCT03389854|11942320|FG001|COMPLETED|Overall Study||21
10780598|NCT03389854|11942321|FG002|COMPLETED|Overall Study||23
10780599|NCT03389854|11942322|FG003|COMPLETED|Overall Study||19
10780600|NCT03389854|11942319|FG000|NOT COMPLETED|Overall Study||1
10780601|NCT03389854|11942320|FG001|NOT COMPLETED|Overall Study||6
10780602|NCT03389854|11942321|FG002|NOT COMPLETED|Overall Study||5
10780603|NCT03389854|11942322|FG003|NOT COMPLETED|Overall Study||8
10780604|NCT03389893|11942338|FG000|STARTED|Randomized Double Blind Period||46
10780605|NCT03389893|11942339|FG001|STARTED|Randomized Double Blind Period||26
10780606|NCT03389893|11942340|FG002|STARTED|Randomized Double Blind Period||0
10780607|NCT03389893|11942341|FG003|STARTED|Randomized Double Blind Period||0
10780608|NCT03389893|11942338|FG000|COMPLETED|Randomized Double Blind Period||45
10316295|NCT00187876|11450279|FG001|STARTED|Overall Study||43
10316296|NCT00187876|11450278|FG000|COMPLETED|Overall Study||24
10316297|NCT00187876|11450279|FG001|COMPLETED|Overall Study||43
10316298|NCT00187876|11450278|FG000|NOT COMPLETED|Overall Study||0
10431728|NCT00876460|11577787|FG005|NOT COMPLETED|Mono Therapy Phase||0
10431729|NCT00876460|11577788|FG006|NOT COMPLETED|Mono Therapy Phase||1
10431730|NCT00876460|11577789|FG007|NOT COMPLETED|Mono Therapy Phase||3
10431731|NCT00876694|11577821|FG000|STARTED|Overall Study||125
10431732|NCT00876694|11577822|FG001|STARTED|Overall Study||61
10431733|NCT00876694|11577821|FG000|COMPLETED|Overall Study||104
10431734|NCT00876694|11577822|FG001|COMPLETED|Overall Study||49
10431735|NCT00876694|11577821|FG000|NOT COMPLETED|Overall Study||21
10431736|NCT00876694|11577822|FG001|NOT COMPLETED|Overall Study||12
10431737|NCT00876733|11577832|FG000|STARTED|Overall Study||288
10431738|NCT00876733|11577833|FG001|STARTED|Overall Study||203
10431739|NCT00876733|11577834|FG002|STARTED|Overall Study||93
10431740|NCT00876733|11577835|FG003|STARTED|Overall Study||21
10431741|NCT00876733|11577832|FG000|COMPLETED|Overall Study||197
10431742|NCT00876733|11577833|FG001|COMPLETED|Overall Study||161
10431743|NCT00876733|11577834|FG002|COMPLETED|Overall Study||63
10431744|NCT00876733|11577835|FG003|COMPLETED|Overall Study||14
10431745|NCT00876733|11577832|FG000|NOT COMPLETED|Overall Study||91
10431746|NCT00876733|11577833|FG001|NOT COMPLETED|Overall Study||42
10431747|NCT00876733|11577834|FG002|NOT COMPLETED|Overall Study||30
10431748|NCT00876733|11577835|FG003|NOT COMPLETED|Overall Study||7
10431749|NCT00876915|11577848|FG000|STARTED|Overall Study||50
10431750|NCT00876915|11577849|FG001|STARTED|Overall Study||48
10431751|NCT00876915|11577850|FG002|STARTED|Overall Study||101
10431752|NCT00876915|11577848|FG000|Week 4|Overall Study||38
10431753|NCT00876915|11577849|FG001|Week 4|Overall Study||45
10431754|NCT00876915|11577850|FG002|Week 4|Overall Study||0
10431755|NCT00876915|11577848|FG000|Week 8|Overall Study||33
10431756|NCT00876915|11577849|FG001|Week 8|Overall Study||36
10780609|NCT03389893|11942339|FG001|COMPLETED|Randomized Double Blind Period||26
10780610|NCT03389893|11942340|FG002|COMPLETED|Randomized Double Blind Period||0
10780611|NCT03389893|11942341|FG003|COMPLETED|Randomized Double Blind Period||0
10780612|NCT03389893|11942338|FG000|NOT COMPLETED|Randomized Double Blind Period||1
10780613|NCT03389893|11942339|FG001|NOT COMPLETED|Randomized Double Blind Period||0
10780614|NCT03389893|11942340|FG002|NOT COMPLETED|Randomized Double Blind Period||0
10780615|NCT03389893|11942341|FG003|NOT COMPLETED|Randomized Double Blind Period||0
10316299|NCT00187876|11450279|FG001|NOT COMPLETED|Overall Study||0
10316300|NCT00187889|11450287|FG000|STARTED|Overall Study||25
10316301|NCT00187889|11450288|FG001|STARTED|Overall Study||26
10316302|NCT00187889|11450287|FG000|COMPLETED|Overall Study||19
10316303|NCT00187889|11450288|FG001|COMPLETED|Overall Study||22
10316304|NCT00187889|11450287|FG000|NOT COMPLETED|Overall Study||6
10316305|NCT00187889|11450288|FG001|NOT COMPLETED|Overall Study||4
10316306|NCT00189098|11450297|FG000|STARTED|Overall Study||51
10316307|NCT00189098|11450298|FG001|STARTED|Overall Study||50
10316308|NCT00189098|11450297|FG000|COMPLETED|Overall Study||46
10316309|NCT00189098|11450298|FG001|COMPLETED|Overall Study||44
10316310|NCT00189098|11450297|FG000|NOT COMPLETED|Overall Study||5
10316311|NCT00189098|11450298|FG001|NOT COMPLETED|Overall Study||6
10316312|NCT00189137|11450308|FG000|STARTED|Overall Study||37
10316313|NCT00189137|11450309|FG001|STARTED|Overall Study||43
10316314|NCT00189137|11450308|FG000|COMPLETED|Overall Study||37
10316315|NCT00189137|11450309|FG001|COMPLETED|Overall Study||43
10316316|NCT00189137|11450308|FG000|NOT COMPLETED|Overall Study||0
10316317|NCT00189137|11450309|FG001|NOT COMPLETED|Overall Study||0
10316318|NCT00189202|11450315|FG000|STARTED|Overall Study||49
10316319|NCT00189202|11450315|FG000|COMPLETED|Overall Study||44
10316320|NCT00189202|11450315|FG000|NOT COMPLETED|Overall Study||5
10431757|NCT00876915|11577850|FG002|Week 8|Overall Study||0
10431758|NCT00876915|11577848|FG000|COMPLETED|Overall Study||31
10431759|NCT00876915|11577849|FG001|COMPLETED|Overall Study||34
10431760|NCT00876915|11577850|FG002|COMPLETED|Overall Study||101
10431761|NCT00876915|11577848|FG000|NOT COMPLETED|Overall Study||19
10431762|NCT00876915|11577849|FG001|NOT COMPLETED|Overall Study||14
10780616|NCT03389893|11942338|FG000|STARTED|Open Label Extension and Follow-Up||0
10780617|NCT03389893|11942339|FG001|STARTED|Open Label Extension and Follow-Up||0
10780618|NCT03389893|11942340|FG002|STARTED|Open Label Extension and Follow-Up||45
10780619|NCT03389893|11942341|FG003|STARTED|Open Label Extension and Follow-Up||26
10780620|NCT03389893|11942338|FG000|COMPLETED|Open Label Extension and Follow-Up||0
10780621|NCT03389893|11942339|FG001|COMPLETED|Open Label Extension and Follow-Up||0
10431763|NCT00876915|11577850|FG002|NOT COMPLETED|Overall Study||0
10431764|NCT00876928|11577860|FG000|STARTED|Overall Study||56
10431765|NCT00876928|11577861|FG001|STARTED|Overall Study||61
10431766|NCT00876928|11577860|FG000|COMPLETED|Overall Study||53
10431767|NCT00876928|11577861|FG001|COMPLETED|Overall Study||56
10431768|NCT00876928|11577860|FG000|NOT COMPLETED|Overall Study||3
10431769|NCT00876928|11577861|FG001|NOT COMPLETED|Overall Study||5
10431770|NCT00876993|11577872|FG000|STARTED|Overall Study||5
10431771|NCT00876993|11577873|FG001|STARTED|Overall Study||6
10431772|NCT00876993|11577874|FG002|STARTED|Overall Study||5
10431773|NCT00876993|11577875|FG003|STARTED|Overall Study||5
10431774|NCT00876993|11577876|FG004|STARTED|Overall Study||5
10431775|NCT00876993|11577872|FG000|COMPLETED|Overall Study||4
10431776|NCT00876993|11577873|FG001|COMPLETED|Overall Study||6
10431777|NCT00876993|11577874|FG002|COMPLETED|Overall Study||3
10431778|NCT00876993|11577875|FG003|COMPLETED|Overall Study||5
10431779|NCT00876993|11577876|FG004|COMPLETED|Overall Study||3
10431780|NCT00876993|11577872|FG000|NOT COMPLETED|Overall Study||1
10431781|NCT00876993|11577873|FG001|NOT COMPLETED|Overall Study||0
10431782|NCT00876993|11577874|FG002|NOT COMPLETED|Overall Study||2
10431783|NCT00876993|11577875|FG003|NOT COMPLETED|Overall Study||0
10431784|NCT00876993|11577876|FG004|NOT COMPLETED|Overall Study||2
10431785|NCT00877006|11577892|FG000|STARTED|Treatment Period||224
10431786|NCT00877006|11577893|FG001|STARTED|Treatment Period||223
10431787|NCT00877006|11577892|FG000|COMPLETED|Treatment Period||199
10431788|NCT00877006|11577893|FG001|COMPLETED|Treatment Period||196
10431789|NCT00877006|11577892|FG000|NOT COMPLETED|Treatment Period||25
10431790|NCT00877006|11577893|FG001|NOT COMPLETED|Treatment Period||27
10431791|NCT00877006|11577892|FG000|STARTED|Long-Term Follow-up Period||210
10431792|NCT00877006|11577893|FG001|STARTED|Long-Term Follow-up Period||209
10431793|NCT00877006|11577892|FG000|COMPLETED|Long-Term Follow-up Period||157
10431794|NCT00877006|11577893|FG001|COMPLETED|Long-Term Follow-up Period||154
10431795|NCT00877006|11577892|FG000|NOT COMPLETED|Long-Term Follow-up Period||53
10431796|NCT00877006|11577893|FG001|NOT COMPLETED|Long-Term Follow-up Period||55
10431797|NCT00877032|11577908|FG000|STARTED|Overall Study||6
10431798|NCT00877032|11577909|FG001|STARTED|Overall Study||6
10431799|NCT00877032|11577910|FG002|STARTED|Overall Study||6
10431800|NCT00877032|11577911|FG003|STARTED|Overall Study||7
10431801|NCT00877032|11577912|FG004|STARTED|Overall Study||6
10431802|NCT00877032|11577913|FG005|STARTED|Overall Study||6
10431803|NCT00877032|11577914|FG006|STARTED|Overall Study||20
10431804|NCT00877032|11577908|FG000|Treated|Overall Study||6
10431805|NCT00877032|11577909|FG001|Treated|Overall Study||6
10431806|NCT00877032|11577910|FG002|Treated|Overall Study||6
10431807|NCT00877032|11577911|FG003|Treated|Overall Study||6
10431808|NCT00877032|11577912|FG004|Treated|Overall Study||6
10431809|NCT00877032|11577913|FG005|Treated|Overall Study||6
10431810|NCT00877032|11577914|FG006|Treated|Overall Study||18
10431811|NCT00877032|11577908|FG000|COMPLETED|Overall Study||6
10431812|NCT00877032|11577909|FG001|COMPLETED|Overall Study||6
10431813|NCT00877032|11577910|FG002|COMPLETED|Overall Study||6
10431814|NCT00877032|11577911|FG003|COMPLETED|Overall Study||6
10431815|NCT00877032|11577912|FG004|COMPLETED|Overall Study||6
10431816|NCT00877032|11577913|FG005|COMPLETED|Overall Study||6
10431817|NCT00877032|11577914|FG006|COMPLETED|Overall Study||18
10431818|NCT00877032|11577908|FG000|NOT COMPLETED|Overall Study||0
10431819|NCT00877032|11577909|FG001|NOT COMPLETED|Overall Study||0
10431820|NCT00877032|11577910|FG002|NOT COMPLETED|Overall Study||0
10431821|NCT00877032|11577911|FG003|NOT COMPLETED|Overall Study||1
10431822|NCT00877032|11577912|FG004|NOT COMPLETED|Overall Study||0
10431823|NCT00877032|11577913|FG005|NOT COMPLETED|Overall Study||0
10431824|NCT00877032|11577914|FG006|NOT COMPLETED|Overall Study||2
10431825|NCT00877058|11577933|FG000|STARTED|Overall Study||174
10431826|NCT00877058|11577934|FG001|STARTED|Overall Study||171
10431827|NCT00877058|11577935|FG002|STARTED|Overall Study||114
10431828|NCT00877058|11577933|FG000|COMPLETED|Overall Study||137
10431829|NCT00877058|11577934|FG001|COMPLETED|Overall Study||131
10431830|NCT00877058|11577935|FG002|COMPLETED|Overall Study||75
10431831|NCT00877058|11577933|FG000|NOT COMPLETED|Overall Study||37
10431832|NCT00877058|11577934|FG001|NOT COMPLETED|Overall Study||40
10431833|NCT00877058|11577935|FG002|NOT COMPLETED|Overall Study||39
10431834|NCT00877370|11577943|FG000|STARTED|Overall Study||8
10431835|NCT00877370|11577943|FG000|COMPLETED|Overall Study||8
10431836|NCT00877370|11577943|FG000|NOT COMPLETED|Overall Study||0
10431837|NCT00877383|11577949|FG000|STARTED|Overall Study||572
10431838|NCT00877383|11577950|FG001|STARTED|Overall Study||570
10431839|NCT00877383|11577949|FG000|COMPLETED|Overall Study||543
10431840|NCT00877383|11577950|FG001|COMPLETED|Overall Study||533
10431841|NCT00877383|11577949|FG000|NOT COMPLETED|Overall Study||29
10431842|NCT00877383|11577950|FG001|NOT COMPLETED|Overall Study||37
10431843|NCT00877448|11577963|FG000|STARTED|Overall Study||10
10431844|NCT00877448|11577964|FG001|STARTED|Overall Study||10
10431845|NCT00877448|11577965|FG002|STARTED|Overall Study||10
10431846|NCT00877448|11577966|FG003|STARTED|Overall Study||10
10431847|NCT00877448|11577967|FG004|STARTED|Overall Study||10
10431848|NCT00877448|11577968|FG005|STARTED|Overall Study||10
10431849|NCT00877448|11577969|FG006|STARTED|Overall Study||3
10431850|NCT00877448|11577963|FG000|COMPLETED|Overall Study||10
10431851|NCT00877448|11577964|FG001|COMPLETED|Overall Study||9
10780622|NCT03389893|11942340|FG002|COMPLETED|Open Label Extension and Follow-Up||41
10780623|NCT03389893|11942341|FG003|COMPLETED|Open Label Extension and Follow-Up||25
10780624|NCT03389893|11942338|FG000|NOT COMPLETED|Open Label Extension and Follow-Up||0
10780625|NCT03389893|11942339|FG001|NOT COMPLETED|Open Label Extension and Follow-Up||0
10780626|NCT03389893|11942340|FG002|NOT COMPLETED|Open Label Extension and Follow-Up||4
10780627|NCT03389893|11942341|FG003|NOT COMPLETED|Open Label Extension and Follow-Up||1
10780628|NCT03390114|11942349|FG000|STARTED|Overall Study||10
10780629|NCT03390114|11942350|FG001|STARTED|Overall Study||10
10780630|NCT03390114|11942349|FG000|COMPLETED|Overall Study||6
10780631|NCT03390114|11942350|FG001|COMPLETED|Overall Study||8
10431852|NCT00877448|11577965|FG002|COMPLETED|Overall Study||10
10431853|NCT00877448|11577966|FG003|COMPLETED|Overall Study||9
10431854|NCT00877448|11577967|FG004|COMPLETED|Overall Study||10
10431855|NCT00877448|11577968|FG005|COMPLETED|Overall Study||9
10431856|NCT00877448|11577969|FG006|COMPLETED|Overall Study||3
10431857|NCT00877448|11577963|FG000|NOT COMPLETED|Overall Study||0
10431858|NCT00877448|11577964|FG001|NOT COMPLETED|Overall Study||1
10431859|NCT00877448|11577965|FG002|NOT COMPLETED|Overall Study||0
10431860|NCT00877448|11577966|FG003|NOT COMPLETED|Overall Study||1
10431861|NCT00877448|11577967|FG004|NOT COMPLETED|Overall Study||0
10431862|NCT00877448|11577968|FG005|NOT COMPLETED|Overall Study||1
10431863|NCT00877448|11577969|FG006|NOT COMPLETED|Overall Study||0
10431864|NCT00877487|11577985|FG000|STARTED|Open-label Treatment Phase||123
10431865|NCT00877487|11577986|FG001|STARTED|Open-label Treatment Phase||0
10431866|NCT00877487|11577985|FG000|COMPLETED|Open-label Treatment Phase||116
10431867|NCT00877487|11577986|FG001|COMPLETED|Open-label Treatment Phase||0
10431868|NCT00877487|11577985|FG000|NOT COMPLETED|Open-label Treatment Phase||7
10431869|NCT00877487|11577986|FG001|NOT COMPLETED|Open-label Treatment Phase||0
10431870|NCT00877487|11577985|FG000|STARTED|Double-blind Randomized Withdrawal Phase||56
10431871|NCT00877487|11577986|FG001|STARTED|Double-blind Randomized Withdrawal Phase||60
10431872|NCT00877487|11577985|FG000|COMPLETED|Double-blind Randomized Withdrawal Phase||50
10431873|NCT00877487|11577986|FG001|COMPLETED|Double-blind Randomized Withdrawal Phase||13
10431874|NCT00877487|11577985|FG000|NOT COMPLETED|Double-blind Randomized Withdrawal Phase||6
10431875|NCT00877487|11577986|FG001|NOT COMPLETED|Double-blind Randomized Withdrawal Phase||47
10431876|NCT00877604|11577994|FG000|STARTED|Overall Study||17
10431877|NCT00877604|11577995|FG001|STARTED|Overall Study||17
10431878|NCT00877604|11577994|FG000|COMPLETED|Overall Study||15
10431879|NCT00877604|11577995|FG001|COMPLETED|Overall Study||14
10431880|NCT00877604|11577994|FG000|NOT COMPLETED|Overall Study||2
10431881|NCT00877604|11577995|FG001|NOT COMPLETED|Overall Study||3
10431882|NCT00877773|11578001|FG000|STARTED|Overall Study||44
10431883|NCT00877773|11578001|FG000|COMPLETED|Overall Study|No participant reached to first restaging.|0
10431884|NCT00877773|11578001|FG000|NOT COMPLETED|Overall Study||44
10431885|NCT00877799|11578010|FG000|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||25
10431886|NCT00877799|11578011|FG001|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||22
10431887|NCT00877799|11578012|FG002|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||21
10431888|NCT00877799|11578013|FG003|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||0
10431889|NCT00877799|11578014|FG004|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||0
10431890|NCT00877799|11578010|FG000|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||22
10431891|NCT00877799|11578011|FG001|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||17
10431892|NCT00877799|11578012|FG002|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||18
10431893|NCT00877799|11578013|FG003|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
10431894|NCT00877799|11578014|FG004|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
10431895|NCT00877799|11578010|FG000|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||3
10431896|NCT00877799|11578011|FG001|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||5
10431897|NCT00877799|11578012|FG002|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||3
10431898|NCT00877799|11578013|FG003|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
10431899|NCT00877799|11578014|FG004|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
10431900|NCT00877799|11578010|FG000|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
10431901|NCT00877799|11578011|FG001|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
10431902|NCT00877799|11578012|FG002|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
10431903|NCT00877799|11578013|FG003|STARTED|Cohort 2: Immediately Post-op (Day 0)||26
10431904|NCT00877799|11578014|FG004|STARTED|Cohort 2: Immediately Post-op (Day 0)||20
10431905|NCT00877799|11578010|FG000|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
10431906|NCT00877799|11578011|FG001|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
10431907|NCT00877799|11578012|FG002|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
10548837|NCT01521494|11702691|FG002|NOT COMPLETED|Overall Study||12
10780632|NCT03390114|11942349|FG000|NOT COMPLETED|Overall Study||4
10431908|NCT00877799|11578013|FG003|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||24
10431909|NCT00877799|11578014|FG004|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||19
10431910|NCT00877799|11578010|FG000|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
10431911|NCT00877799|11578011|FG001|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
10431912|NCT00877799|11578012|FG002|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
10431913|NCT00877799|11578013|FG003|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||2
10431914|NCT00877799|11578014|FG004|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||1
10431915|NCT00877877|11578025|FG000|STARTED|Year 5||397
10431916|NCT00877877|11578025|FG000|COMPLETED|Year 5||397
10431917|NCT00877877|11578025|FG000|NOT COMPLETED|Year 5||0
10548838|NCT01521494|11702692|FG003|NOT COMPLETED|Overall Study||21
10780633|NCT03390114|11942350|FG001|NOT COMPLETED|Overall Study||2
10780634|NCT03390166|11942358|FG000|STARTED|Overall Study||630
10780635|NCT03390166|11942359|FG001|STARTED|Overall Study||315
10780636|NCT03390166|11942358|FG000|COMPLETED|Overall Study||618
10780637|NCT03390166|11942359|FG001|COMPLETED|Overall Study||305
10780638|NCT03390166|11942358|FG000|NOT COMPLETED|Overall Study||12
10780639|NCT03390166|11942359|FG001|NOT COMPLETED|Overall Study||10
10780640|NCT03390257|11942365|FG000|STARTED|Overall Study||14
10780641|NCT03390257|11942365|FG000|COMPLETED|Overall Study||14
10780642|NCT03390257|11942365|FG000|NOT COMPLETED|Overall Study||0
10780643|NCT03390426|11942373|FG000|STARTED|Overall Study||15
10780644|NCT03390426|11942374|FG001|STARTED|Overall Study||16
10780645|NCT03390426|11942373|FG000|COMPLETED|Overall Study||15
10780646|NCT03390426|11942374|FG001|COMPLETED|Overall Study||15
10780647|NCT03390426|11942373|FG000|NOT COMPLETED|Overall Study||0
10780648|NCT03390426|11942374|FG001|NOT COMPLETED|Overall Study||1
10780649|NCT03390842|11942382|FG000|STARTED|Overall Study||114
10780650|NCT03390842|11942383|FG001|STARTED|Overall Study||82
10780651|NCT03390842|11942382|FG000|COMPLETED|Overall Study||111
10780652|NCT03390842|11942383|FG001|COMPLETED|Overall Study||74
10780653|NCT03390842|11942382|FG000|NOT COMPLETED|Overall Study||3
10780654|NCT03390842|11942383|FG001|NOT COMPLETED|Overall Study||8
10780655|NCT03390907|11942389|FG000|STARTED|Overall Study||40
10780656|NCT03390907|11942389|FG000|COMPLETED|Overall Study||40
10780657|NCT03390907|11942389|FG000|NOT COMPLETED|Overall Study||0
10780658|NCT03391115|11942396|FG000|STARTED|Overall Study||20
10780659|NCT03391115|11942397|FG001|STARTED|Overall Study||18
10780660|NCT03391115|11942396|FG000|COMPLETED|Overall Study||20
10780661|NCT03391115|11942397|FG001|COMPLETED|Overall Study|Two Nurse participants in the dyadic patient-nurse enrollment were not successfully recruited.|18
10780662|NCT03391115|11942396|FG000|NOT COMPLETED|Overall Study||0
10780663|NCT03391115|11942397|FG001|NOT COMPLETED|Overall Study||0
10780664|NCT03391765|11942407|FG000|STARTED|Overall Study||51
10780665|NCT03391765|11942408|FG001|STARTED|Overall Study||45
10780666|NCT03391765|11942409|FG002|STARTED|Overall Study||23
10431918|NCT00877877|11578025|FG000|STARTED|Year 6||529
10431919|NCT00877877|11578025|FG000|COMPLETED|Year 6||529
10431920|NCT00877877|11578025|FG000|NOT COMPLETED|Year 6||0
10431921|NCT00877877|11578025|FG000|STARTED|Year 7||523
10431922|NCT00877877|11578025|FG000|COMPLETED|Year 7||523
10431923|NCT00877877|11578025|FG000|NOT COMPLETED|Year 7||0
10431924|NCT00877877|11578025|FG000|STARTED|Year 8||522
10431925|NCT00877877|11578025|FG000|COMPLETED|Year 8||522
10431926|NCT00877877|11578025|FG000|NOT COMPLETED|Year 8||0
10431927|NCT00877877|11578025|FG000|STARTED|Year 9||507
10431928|NCT00877877|11578025|FG000|COMPLETED|Year 9||507
10431929|NCT00877877|11578025|FG000|NOT COMPLETED|Year 9||0
10431930|NCT00877877|11578025|FG000|STARTED|Year 10||495
10431931|NCT00877877|11578025|FG000|COMPLETED|Year 10||495
10431932|NCT00877877|11578025|FG000|NOT COMPLETED|Year 10||0
10431933|NCT00877890|11578036|FG000|STARTED|Overall Study||129
10431934|NCT00877890|11578037|FG001|STARTED|Overall Study||125
10431935|NCT00877890|11578036|FG000|Intent to Treat (ITT)|Overall Study||129
10431936|NCT00877890|11578037|FG001|Intent to Treat (ITT)|Overall Study||123
10431937|NCT00877890|11578036|FG000|COMPLETED|Overall Study||109
10431938|NCT00877890|11578037|FG001|COMPLETED|Overall Study||95
10431939|NCT00877890|11578036|FG000|NOT COMPLETED|Overall Study||20
10431940|NCT00877890|11578037|FG001|NOT COMPLETED|Overall Study||30
10431941|NCT00877929|11578049|FG000|STARTED|Overall Study||352
10431942|NCT00877929|11578050|FG001|STARTED|Overall Study||354
10431943|NCT00877929|11578049|FG000|COMPLETED|Overall Study||332
10431944|NCT00877929|11578050|FG001|COMPLETED|Overall Study||319
10431945|NCT00877929|11578049|FG000|NOT COMPLETED|Overall Study||20
10431946|NCT00877929|11578050|FG001|NOT COMPLETED|Overall Study||35
10780667|NCT03391765|11942410|FG003|STARTED|Overall Study||23
10780668|NCT03391765|11942407|FG000|COMPLETED|Overall Study||0
10780669|NCT03391765|11942408|FG001|COMPLETED|Overall Study||0
10780670|NCT03391765|11942409|FG002|COMPLETED|Overall Study||0
10780671|NCT03391765|11942410|FG003|COMPLETED|Overall Study||0
10780672|NCT03391765|11942407|FG000|NOT COMPLETED|Overall Study||51
10780673|NCT03391765|11942408|FG001|NOT COMPLETED|Overall Study||45
10780674|NCT03391765|11942409|FG002|NOT COMPLETED|Overall Study||23
10780675|NCT03391765|11942410|FG003|NOT COMPLETED|Overall Study||23
10780676|NCT03391986|11942423|FG000|STARTED|Overall Study||53
10780677|NCT03391986|11942424|FG001|STARTED|Overall Study||50
10780678|NCT03391986|11942425|FG002|STARTED|Overall Study||50
10431947|NCT00878072|11578060|FG000|STARTED|Overall Study||53
10431948|NCT00878072|11578060|FG000|COMPLETED|Overall Study||51
10431949|NCT00878072|11578060|FG000|NOT COMPLETED|Overall Study||2
10431950|NCT00878189|11578071|FG000|STARTED|Overall Study||3
10431951|NCT00878189|11578072|FG001|STARTED|Overall Study||3
10431952|NCT00878189|11578073|FG002|STARTED|Overall Study||4
10431953|NCT00878189|11578074|FG003|STARTED|Overall Study||8
10431954|NCT00878189|11578075|FG004|STARTED|Overall Study||4
10431955|NCT00878189|11578076|FG005|STARTED|Overall Study||23
10431956|NCT00878189|11578077|FG006|STARTED|Overall Study||16
10431957|NCT00878189|11578078|FG007|STARTED|Overall Study||3
10780679|NCT03391986|11942423|FG000|COMPLETED|Overall Study||53
10780680|NCT03391986|11942424|FG001|COMPLETED|Overall Study||50
10780681|NCT03391986|11942425|FG002|COMPLETED|Overall Study||50
10780682|NCT03391986|11942423|FG000|NOT COMPLETED|Overall Study||0
10780683|NCT03391986|11942424|FG001|NOT COMPLETED|Overall Study||0
10780684|NCT03391986|11942425|FG002|NOT COMPLETED|Overall Study||0
10431958|NCT00878189|11578079|FG008|STARTED|Overall Study||8
10431959|NCT00878189|11578071|FG000|COMPLETED|Overall Study||0
10431960|NCT00878189|11578072|FG001|COMPLETED|Overall Study||0
10780709|NCT03392194|11942451|FG000|STARTED|Overall Study||16
10780710|NCT03392194|11942452|FG001|STARTED|Overall Study||17
10780711|NCT03392194|11942451|FG000|COMPLETED|Overall Study||14
10780712|NCT03392194|11942452|FG001|COMPLETED|Overall Study||15
10780713|NCT03392194|11942451|FG000|NOT COMPLETED|Overall Study||2
10780714|NCT03392194|11942452|FG001|NOT COMPLETED|Overall Study||2
10780715|NCT03392532|11942458|FG000|STARTED|Period 1, FIrst 30 Minutes of Wear||18
10780716|NCT03392532|11942459|FG001|STARTED|Period 1, FIrst 30 Minutes of Wear||18
10780717|NCT03392532|11942458|FG000|COMPLETED|Period 1, FIrst 30 Minutes of Wear||18
10780718|NCT03392532|11942459|FG001|COMPLETED|Period 1, FIrst 30 Minutes of Wear||18
10780719|NCT03392532|11942458|FG000|NOT COMPLETED|Period 1, FIrst 30 Minutes of Wear||0
10780720|NCT03392532|11942459|FG001|NOT COMPLETED|Period 1, FIrst 30 Minutes of Wear||0
10780721|NCT03392532|11942458|FG000|STARTED|Period 2, Second 30 Minutes of Wear||18
10780722|NCT03392532|11942459|FG001|STARTED|Period 2, Second 30 Minutes of Wear||18
10780723|NCT03392532|11942458|FG000|COMPLETED|Period 2, Second 30 Minutes of Wear||18
10780724|NCT03392532|11942459|FG001|COMPLETED|Period 2, Second 30 Minutes of Wear||18
10780725|NCT03392532|11942458|FG000|NOT COMPLETED|Period 2, Second 30 Minutes of Wear||0
10780726|NCT03392532|11942459|FG001|NOT COMPLETED|Period 2, Second 30 Minutes of Wear||0
10780727|NCT03392935|11942465|FG000|STARTED|Overall Study||37
10780728|NCT03392935|11942465|FG000|COMPLETED|Overall Study||35
10780729|NCT03392935|11942465|FG000|NOT COMPLETED|Overall Study||2
10780733|NCT03393000|11942474|FG000|STARTED|Overall Study|23 subjects screened|19
10780734|NCT03393000|11942474|FG000|COMPLETED|Overall Study|19 subjects treated|5
10780735|NCT03393000|11942474|FG000|NOT COMPLETED|Overall Study||14
10780736|NCT03393208|11942482|FG000|STARTED|Treatment Period 1 (Day 1-Day 3)||13
10780737|NCT03393208|11942483|FG001|STARTED|Treatment Period 1 (Day 1-Day 3)||13
10780738|NCT03393208|11942484|FG002|STARTED|Treatment Period 1 (Day 1-Day 3)||9
10780739|NCT03393208|11942485|FG003|STARTED|Treatment Period 1 (Day 1-Day 3)||9
10780740|NCT03393208|11942482|FG000|COMPLETED|Treatment Period 1 (Day 1-Day 3)||13
10780741|NCT03393208|11942483|FG001|COMPLETED|Treatment Period 1 (Day 1-Day 3)||13
10780742|NCT03393208|11942484|FG002|COMPLETED|Treatment Period 1 (Day 1-Day 3)||9
10780743|NCT03393208|11942485|FG003|COMPLETED|Treatment Period 1 (Day 1-Day 3)||9
10780744|NCT03393208|11942482|FG000|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
10780745|NCT03393208|11942483|FG001|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
10780746|NCT03393208|11942484|FG002|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
10780747|NCT03393208|11942485|FG003|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
10780748|NCT03393208|11942482|FG000|STARTED|Treatment Period 2 (Day 8- Day 10)||13
10780749|NCT03393208|11942483|FG001|STARTED|Treatment Period 2 (Day 8- Day 10)||13
10780750|NCT03393208|11942484|FG002|STARTED|Treatment Period 2 (Day 8- Day 10)||9
10780751|NCT03393208|11942485|FG003|STARTED|Treatment Period 2 (Day 8- Day 10)||9
10780752|NCT03393208|11942482|FG000|COMPLETED|Treatment Period 2 (Day 8- Day 10)||13
10780753|NCT03393208|11942483|FG001|COMPLETED|Treatment Period 2 (Day 8- Day 10)||13
10780754|NCT03393208|11942484|FG002|COMPLETED|Treatment Period 2 (Day 8- Day 10)||9
10780755|NCT03393208|11942485|FG003|COMPLETED|Treatment Period 2 (Day 8- Day 10)||9
10780756|NCT03393208|11942482|FG000|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
10780757|NCT03393208|11942483|FG001|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
10780758|NCT03393208|11942484|FG002|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
10780759|NCT03393208|11942485|FG003|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
10780760|NCT03393494|11942500|FG000|STARTED|Overall Study||329
10780761|NCT03393494|11942501|FG001|STARTED|Overall Study||331
10780762|NCT03393494|11942502|FG002|STARTED|Overall Study||165
10548839|NCT01521494|11702693|FG004|NOT COMPLETED|Overall Study||7
10780763|NCT03393494|11942500|FG000|COMPLETED|Overall Study||261
10780764|NCT03393494|11942501|FG001|COMPLETED|Overall Study||256
10780765|NCT03393494|11942502|FG002|COMPLETED|Overall Study||140
10780766|NCT03393494|11942500|FG000|NOT COMPLETED|Overall Study||68
10780767|NCT03393494|11942501|FG001|NOT COMPLETED|Overall Study||75
10780768|NCT03393494|11942502|FG002|NOT COMPLETED|Overall Study||25
10780769|NCT03393754|11942512|FG000|STARTED|Overall Study||811
10780770|NCT03393754|11942513|FG001|STARTED|Overall Study||796
10780771|NCT03393754|11942512|FG000|COMPLETED|Overall Study||785
10780772|NCT03393754|11942513|FG001|COMPLETED|Overall Study||758
10780773|NCT03393754|11942512|FG000|NOT COMPLETED|Overall Study||26
10780774|NCT03393754|11942513|FG001|NOT COMPLETED|Overall Study||38
10780775|NCT03393806|11942521|FG000|STARTED|Overall Study||9
10780776|NCT03393806|11942522|FG001|STARTED|Overall Study||8
10780777|NCT03393806|11942521|FG000|COMPLETED|Overall Study||8
10431961|NCT00878189|11578073|FG002|COMPLETED|Overall Study||0
10431962|NCT00878189|11578074|FG003|COMPLETED|Overall Study||0
10431963|NCT00878189|11578075|FG004|COMPLETED|Overall Study||0
10431964|NCT00878189|11578076|FG005|COMPLETED|Overall Study||0
10431965|NCT00878189|11578077|FG006|COMPLETED|Overall Study||0
10431966|NCT00878189|11578078|FG007|COMPLETED|Overall Study||0
10431967|NCT00878189|11578079|FG008|COMPLETED|Overall Study||0
10431968|NCT00878189|11578071|FG000|NOT COMPLETED|Overall Study||3
10431969|NCT00878189|11578072|FG001|NOT COMPLETED|Overall Study||3
10431970|NCT00878189|11578073|FG002|NOT COMPLETED|Overall Study||4
10431971|NCT00878189|11578074|FG003|NOT COMPLETED|Overall Study||8
10431972|NCT00878189|11578075|FG004|NOT COMPLETED|Overall Study||4
10431973|NCT00878189|11578076|FG005|NOT COMPLETED|Overall Study||23
10431974|NCT00878189|11578077|FG006|NOT COMPLETED|Overall Study||16
10431975|NCT00878189|11578078|FG007|NOT COMPLETED|Overall Study||3
10431976|NCT00878189|11578079|FG008|NOT COMPLETED|Overall Study||8
10525152|NCT01373450|11677012|FG004|STARTED|Crossover Period 4||2
10525153|NCT01373450|11677013|FG005|STARTED|Crossover Period 4||2
10525154|NCT01373450|11677008|FG000|COMPLETED|Crossover Period 4||2
10525155|NCT01373450|11677009|FG001|COMPLETED|Crossover Period 4||2
10525156|NCT01373450|11677010|FG002|COMPLETED|Crossover Period 4||2
10525157|NCT01373450|11677011|FG003|COMPLETED|Crossover Period 4||2
10525158|NCT01373450|11677012|FG004|COMPLETED|Crossover Period 4||2
10525159|NCT01373450|11677013|FG005|COMPLETED|Crossover Period 4||2
10525160|NCT01373450|11677008|FG000|NOT COMPLETED|Crossover Period 4||0
10525161|NCT01373450|11677009|FG001|NOT COMPLETED|Crossover Period 4||0
10525162|NCT01373450|11677010|FG002|NOT COMPLETED|Crossover Period 4||0
10525163|NCT01373450|11677011|FG003|NOT COMPLETED|Crossover Period 4||0
10525164|NCT01373450|11677012|FG004|NOT COMPLETED|Crossover Period 4||0
10525165|NCT01373450|11677013|FG005|NOT COMPLETED|Crossover Period 4||0
10525166|NCT01373489|11677029|FG000|STARTED|Overall Study||59
10525167|NCT01373489|11677030|FG001|STARTED|Overall Study||54
10525168|NCT01373489|11677029|FG000|COMPLETED|Overall Study||44
10525169|NCT01373489|11677030|FG001|COMPLETED|Overall Study||41
10525170|NCT01373489|11677029|FG000|NOT COMPLETED|Overall Study||15
10525171|NCT01373489|11677030|FG001|NOT COMPLETED|Overall Study||13
10525172|NCT01373580|11677036|FG000|STARTED|Overall Study||373
10525173|NCT01373580|11677036|FG000|COMPLETED|Overall Study||317
10525174|NCT01373580|11677036|FG000|NOT COMPLETED|Overall Study||56
10525175|NCT01373671|11677040|FG000|STARTED|Overall Study||764
10525176|NCT01373671|11677040|FG000|COMPLETED|Overall Study||672
10525177|NCT01373671|11677040|FG000|NOT COMPLETED|Overall Study||92
10525178|NCT01373918|11677047|FG000|STARTED|Overall Study||20
10525179|NCT01373918|11677048|FG001|STARTED|Overall Study||16
10525180|NCT01373918|11677047|FG000|COMPLETED|Overall Study||20
10525181|NCT01373918|11677048|FG001|COMPLETED|Overall Study||15
10525182|NCT01373918|11677047|FG000|NOT COMPLETED|Overall Study||0
10525183|NCT01373918|11677048|FG001|NOT COMPLETED|Overall Study||1
10525184|NCT01373931|11677056|FG000|STARTED|Lead-in Period||10
10525185|NCT01373931|11677057|FG001|STARTED|Lead-in Period||10
10525186|NCT01373931|11677056|FG000|Received at Least 1 Dose of Study Drug|Lead-in Period||8
10525187|NCT01373931|11677057|FG001|Received at Least 1 Dose of Study Drug|Lead-in Period||10
10525188|NCT01373931|11677056|FG000|COMPLETED|Lead-in Period||8
10525189|NCT01373931|11677057|FG001|COMPLETED|Lead-in Period||10
10525190|NCT01373931|11677056|FG000|NOT COMPLETED|Lead-in Period||2
10525191|NCT01373931|11677057|FG001|NOT COMPLETED|Lead-in Period||0
10525192|NCT01373931|11677056|FG000|STARTED|Period 1||8
10525193|NCT01373931|11677057|FG001|STARTED|Period 1||10
10525194|NCT01373931|11677056|FG000|COMPLETED|Period 1||6
10525195|NCT01373931|11677057|FG001|COMPLETED|Period 1||8
10525196|NCT01373931|11677056|FG000|NOT COMPLETED|Period 1||2
10525197|NCT01373931|11677057|FG001|NOT COMPLETED|Period 1||2
10525198|NCT01373931|11677056|FG000|STARTED|Period 2||6
10525199|NCT01373931|11677057|FG001|STARTED|Period 2||8
10525200|NCT01373931|11677056|FG000|COMPLETED|Period 2||6
10525201|NCT01373931|11677057|FG001|COMPLETED|Period 2||8
10525202|NCT01373931|11677056|FG000|NOT COMPLETED|Period 2||0
10525203|NCT01373931|11677057|FG001|NOT COMPLETED|Period 2||0
10525204|NCT01374087|11677066|FG000|STARTED|Overall Study||16
10525205|NCT01374087|11677067|FG001|STARTED|Overall Study||15
10525206|NCT01374087|11677066|FG000|COMPLETED|Overall Study||0
10525207|NCT01374087|11677067|FG001|COMPLETED|Overall Study||0
10525208|NCT01374087|11677066|FG000|NOT COMPLETED|Overall Study||16
10525209|NCT01374087|11677067|FG001|NOT COMPLETED|Overall Study||15
10525210|NCT01374178|11677073|FG000|STARTED|Period 1 (up to 24 Hours After Dosing)||11
10525211|NCT01374178|11677074|FG001|STARTED|Period 1 (up to 24 Hours After Dosing)||5
10780778|NCT03393806|11942522|FG001|COMPLETED|Overall Study||8
10780779|NCT03393806|11942521|FG000|NOT COMPLETED|Overall Study||1
10780780|NCT03393806|11942522|FG001|NOT COMPLETED|Overall Study||0
10780781|NCT03394391|11942531|FG000|STARTED|Overall Study||106
10780782|NCT03394391|11942532|FG001|STARTED|Overall Study||106
10780783|NCT03394391|11942531|FG000|COMPLETED|Overall Study||105
10780784|NCT03394391|11942532|FG001|COMPLETED|Overall Study||104
10780785|NCT03394391|11942531|FG000|NOT COMPLETED|Overall Study||1
10780786|NCT03394391|11942532|FG001|NOT COMPLETED|Overall Study||2
10780787|NCT03394508|11942540|FG000|STARTED|Overall Study||13
10780788|NCT03394508|11942541|FG001|STARTED|Overall Study||17
10780789|NCT03394508|11942540|FG000|COMPLETED|Overall Study||12
10780790|NCT03394508|11942541|FG001|COMPLETED|Overall Study||14
10780791|NCT03394508|11942540|FG000|NOT COMPLETED|Overall Study||1
10780792|NCT03394508|11942541|FG001|NOT COMPLETED|Overall Study||3
10780793|NCT03394768|11942551|FG000|STARTED|Overall Study||26
10780794|NCT03394768|11942551|FG000|COMPLETED|Overall Study||26
10780795|NCT03394768|11942551|FG000|NOT COMPLETED|Overall Study||0
10780796|NCT03394885|11942555|FG000|STARTED|Overall Study||18
10780797|NCT03394885|11942555|FG000|COMPLETED|Overall Study||3
10780798|NCT03394885|11942555|FG000|NOT COMPLETED|Overall Study||15
10780799|NCT03394924|11942562|FG000|STARTED|Overall Study||31
10780800|NCT03394924|11942563|FG001|STARTED|Overall Study||28
10780801|NCT03394924|11942564|FG002|STARTED|Overall Study||9
10780802|NCT03394924|11942562|FG000|COMPLETED|Overall Study||28
10780803|NCT03394924|11942563|FG001|COMPLETED|Overall Study||22
10780804|NCT03394924|11942564|FG002|COMPLETED|Overall Study||9
10780805|NCT03394924|11942562|FG000|NOT COMPLETED|Overall Study||3
10780806|NCT03394924|11942563|FG001|NOT COMPLETED|Overall Study||6
10780807|NCT03394924|11942564|FG002|NOT COMPLETED|Overall Study||0
10780808|NCT03395353|11942574|FG000|STARTED|Overall Study||151
10431977|NCT00878215|11578117|FG000|STARTED|Overall Study||21
10431978|NCT00878215|11578118|FG001|STARTED|Overall Study||19
10431979|NCT00878215|11578119|FG002|STARTED|Overall Study|Phase 3 not performed because the liver imaging system became commercially available|0
10431980|NCT00878215|11578120|FG003|STARTED|Overall Study|Phase 4 not performed because the liver imaging system became commercially available|0
10431981|NCT00878215|11578117|FG000|COMPLETED|Overall Study||21
10431982|NCT00878215|11578118|FG001|COMPLETED|Overall Study||9
10431983|NCT00878215|11578119|FG002|COMPLETED|Overall Study||0
10431984|NCT00878215|11578120|FG003|COMPLETED|Overall Study||0
10431985|NCT00878215|11578117|FG000|NOT COMPLETED|Overall Study||0
10431986|NCT00878215|11578118|FG001|NOT COMPLETED|Overall Study||10
10431987|NCT00878215|11578119|FG002|NOT COMPLETED|Overall Study||0
10431988|NCT00878215|11578120|FG003|NOT COMPLETED|Overall Study||0
10431989|NCT00878228|11578132|FG000|STARTED|Overall Study||49
10431990|NCT00878228|11578133|FG001|STARTED|Overall Study||49
10431991|NCT00878228|11578132|FG000|COMPLETED|Overall Study||39
10431992|NCT00878228|11578133|FG001|COMPLETED|Overall Study||37
10431993|NCT00878228|11578132|FG000|NOT COMPLETED|Overall Study||10
10431994|NCT00878228|11578133|FG001|NOT COMPLETED|Overall Study||12
10431995|NCT00878436|11578141|FG000|STARTED|Overall Study||28
10431996|NCT00878436|11578142|FG001|STARTED|Overall Study||24
10431997|NCT00878436|11578141|FG000|Completed 2 Cycles|Overall Study||21
10431998|NCT00878436|11578142|FG001|Completed 2 Cycles|Overall Study||20
10431999|NCT00878436|11578141|FG000|6 Months|Overall Study||8
10432000|NCT00878436|11578142|FG001|6 Months|Overall Study||0
10432001|NCT00878436|11578141|FG000|COMPLETED|Overall Study||5
10432002|NCT00878436|11578142|FG001|COMPLETED|Overall Study||0
10432003|NCT00878436|11578141|FG000|NOT COMPLETED|Overall Study||23
10432004|NCT00878436|11578142|FG001|NOT COMPLETED|Overall Study||24
10432005|NCT00878501|11578151|FG000|STARTED|Overall Study|One of these patients did not receive study drug since incorrectly enrolled (mis-randomisation)|104
10432006|NCT00878501|11578152|FG001|STARTED|Overall Study||44
10432007|NCT00878501|11578153|FG002|STARTED|Overall Study||93
10432008|NCT00878501|11578151|FG000|Interim Analysis|Overall Study||83
10432009|NCT00878501|11578152|FG001|Interim Analysis|Overall Study||37
10432010|NCT00878501|11578153|FG002|Interim Analysis|Overall Study||81
10432011|NCT00878501|11578151|FG000|COMPLETED|Overall Study||87
10432012|NCT00878501|11578152|FG001|COMPLETED|Overall Study||37
10432013|NCT00878501|11578153|FG002|COMPLETED|Overall Study||85
10432014|NCT00878501|11578151|FG000|NOT COMPLETED|Overall Study||17
10432015|NCT00878501|11578152|FG001|NOT COMPLETED|Overall Study||7
10432016|NCT00878501|11578153|FG002|NOT COMPLETED|Overall Study||8
10432017|NCT00878553|11578165|FG000|STARTED|Sleep Study|This Intention to Treat population includes all randomized patients; one dropped prior to treatment.|67
10432018|NCT00878553|11578166|FG001|STARTED|Sleep Study||0
10432019|NCT00878553|11578167|FG002|STARTED|Sleep Study||0
10432020|NCT00878553|11578168|FG003|STARTED|Sleep Study||0
10432021|NCT00878553|11578169|FG004|STARTED|Sleep Study||0
10432022|NCT00878553|11578165|FG000|Number of Patients Receiving Placebo|Sleep Study||66
10432023|NCT00878553|11578166|FG001|Number of Patients Receiving Placebo|Sleep Study||0
10432024|NCT00878553|11578167|FG002|Number of Patients Receiving Placebo|Sleep Study||0
10432025|NCT00878553|11578168|FG003|Number of Patients Receiving Placebo|Sleep Study||0
10432026|NCT00878553|11578169|FG004|Number of Patients Receiving Placebo|Sleep Study||0
10432027|NCT00878553|11578165|FG000|Number of Patients Receiving 10mg|Sleep Study||65
10432028|NCT00878553|11578166|FG001|Number of Patients Receiving 10mg|Sleep Study||0
10432029|NCT00878553|11578167|FG002|Number of Patients Receiving 10mg|Sleep Study||0
10432030|NCT00878553|11578168|FG003|Number of Patients Receiving 10mg|Sleep Study||0
10432031|NCT00878553|11578169|FG004|Number of Patients Receiving 10mg|Sleep Study||0
10432032|NCT00878553|11578165|FG000|Number of Patients Receiving 15mg|Sleep Study||65
10432033|NCT00878553|11578166|FG001|Number of Patients Receiving 15mg|Sleep Study||0
10432034|NCT00878553|11578167|FG002|Number of Patients Receiving 15mg|Sleep Study||0
10432035|NCT00878553|11578168|FG003|Number of Patients Receiving 15mg|Sleep Study||0
10780809|NCT03395353|11942574|FG000|Received At Least 1 Dose of Study Drug|Overall Study||150
10432036|NCT00878553|11578169|FG004|Number of Patients Receiving 15mg|Sleep Study||0
10432037|NCT00878553|11578165|FG000|Number of Patients Receiving 20mg|Sleep Study||65
10432038|NCT00878553|11578166|FG001|Number of Patients Receiving 20mg|Sleep Study||0
10432039|NCT00878553|11578167|FG002|Number of Patients Receiving 20mg|Sleep Study||0
10432040|NCT00878553|11578168|FG003|Number of Patients Receiving 20mg|Sleep Study||0
10432041|NCT00878553|11578169|FG004|Number of Patients Receiving 20mg|Sleep Study||0
10432042|NCT00878553|11578165|FG000|COMPLETED|Sleep Study|5 patient withdraws result in greater than 5 lost patient data across groups due to CROSSOVER design|62
10432043|NCT00878553|11578166|FG001|COMPLETED|Sleep Study||0
10780810|NCT03395353|11942574|FG000|COMPLETED|Overall Study||64
10780811|NCT03395353|11942574|FG000|NOT COMPLETED|Overall Study||87
10780812|NCT03395808|11942582|FG000|STARTED|Overall Study||251
10780813|NCT03395808|11942582|FG000|COMPLETED|Overall Study||251
10780814|NCT03395808|11942582|FG000|NOT COMPLETED|Overall Study||0
10780815|NCT03395886|11942588|FG000|STARTED|Overall Study||52
10780816|NCT03395886|11942589|FG001|STARTED|Overall Study||38
10780817|NCT03395886|11942588|FG000|COMPLETED|Overall Study||0
10780818|NCT03395886|11942589|FG001|COMPLETED|Overall Study||0
10780819|NCT03395886|11942588|FG000|NOT COMPLETED|Overall Study||52
10780820|NCT03395886|11942589|FG001|NOT COMPLETED|Overall Study||38
10780821|NCT03395990|11942597|FG000|STARTED|Overall Study||8
10780822|NCT03395990|11942598|FG001|STARTED|Overall Study||8
10780823|NCT03395990|11942597|FG000|COMPLETED|Overall Study||8
10780824|NCT03395990|11942598|FG001|COMPLETED|Overall Study||8
10780825|NCT03395990|11942597|FG000|NOT COMPLETED|Overall Study||0
10780826|NCT03395990|11942598|FG001|NOT COMPLETED|Overall Study||0
10780827|NCT03396432|11942606|FG000|STARTED|Overall Study||283
10780828|NCT03396432|11942607|FG001|STARTED|Overall Study||283
10780829|NCT03396432|11942606|FG000|COMPLETED|Overall Study||274
10780830|NCT03396432|11942607|FG001|COMPLETED|Overall Study||277
10780831|NCT03396432|11942606|FG000|NOT COMPLETED|Overall Study||9
10432044|NCT00878553|11578167|FG002|COMPLETED|Sleep Study||0
10432045|NCT00878553|11578168|FG003|COMPLETED|Sleep Study||0
10432046|NCT00878553|11578169|FG004|COMPLETED|Sleep Study||0
10432047|NCT00878553|11578165|FG000|NOT COMPLETED|Sleep Study||5
10432048|NCT00878553|11578166|FG001|NOT COMPLETED|Sleep Study||0
10432049|NCT00878553|11578167|FG002|NOT COMPLETED|Sleep Study||0
10432050|NCT00878553|11578168|FG003|NOT COMPLETED|Sleep Study||0
10432051|NCT00878553|11578169|FG004|NOT COMPLETED|Sleep Study||0
10432052|NCT00878553|11578165|FG000|STARTED|PK Study|A total of 62 randomized patients started this parallel group, single dose PK substudy.|0
10432053|NCT00878553|11578166|FG001|STARTED|PK Study|During the PK period, 16 randomized participants received one bedtime dose of SKP-1041 placebo.|16
10432054|NCT00878553|11578167|FG002|STARTED|PK Study|During the PK period, 17 randomized participants received one bedtime dose of 10mg SKP-1041.|17
10432055|NCT00878553|11578168|FG003|STARTED|PK Study|During the PK period, 14 participants were randomized to receive one bedtime dose of 15mg SKP-1041.|14
10432056|NCT00878553|11578169|FG004|STARTED|PK Study|During the PK period, 15 randomized participants received one bedtime dose of 20mg SKP-1041.|15
10432057|NCT00878553|11578165|FG000|COMPLETED|PK Study|A total of 61 randomized patients completed this parallel group, single dose PK substudy.|0
10432058|NCT00878553|11578166|FG001|COMPLETED|PK Study||16
10432059|NCT00878553|11578167|FG002|COMPLETED|PK Study||17
10432060|NCT00878553|11578168|FG003|COMPLETED|PK Study|One patient withdrew consent after completing the Sleep Substudy and prior to starting PK substudy.|13
10432061|NCT00878553|11578169|FG004|COMPLETED|PK Study||15
10432062|NCT00878553|11578165|FG000|NOT COMPLETED|PK Study||0
10432063|NCT00878553|11578166|FG001|NOT COMPLETED|PK Study||0
10432064|NCT00878553|11578167|FG002|NOT COMPLETED|PK Study||0
10432065|NCT00878553|11578168|FG003|NOT COMPLETED|PK Study||1
10432066|NCT00878553|11578169|FG004|NOT COMPLETED|PK Study||0
10432067|NCT00878644|11578188|FG000|STARTED|Overall Study||155
10432068|NCT00878644|11578189|FG001|STARTED|Overall Study||140
10432069|NCT00878644|11578188|FG000|COMPLETED|Overall Study||151
10432070|NCT00878644|11578189|FG001|COMPLETED|Overall Study||136
10432071|NCT00878644|11578188|FG000|NOT COMPLETED|Overall Study||4
10432072|NCT00878644|11578189|FG001|NOT COMPLETED|Overall Study||4
10432073|NCT00878709|11578197|FG000|STARTED|Overall Study||1420
10432074|NCT00878709|11578198|FG001|STARTED|Overall Study||1420
10432075|NCT00878709|11578197|FG000|COMPLETED|Overall Study||1095
10432076|NCT00878709|11578198|FG001|COMPLETED|Overall Study||1183
10432077|NCT00878709|11578197|FG000|NOT COMPLETED|Overall Study||325
10432078|NCT00878709|11578198|FG001|NOT COMPLETED|Overall Study||237
10432079|NCT00878722|11578213|FG000|STARTED|Overall Study||3
10432080|NCT00878722|11578214|FG001|STARTED|Overall Study||3
10432081|NCT00878722|11578215|FG002|STARTED|Overall Study||3
10432082|NCT00878722|11578216|FG003|STARTED|Overall Study||9
10432083|NCT00878722|11578217|FG004|STARTED|Overall Study||7
10432084|NCT00878722|11578218|FG005|STARTED|Overall Study||3
10432085|NCT00878722|11578219|FG006|STARTED|Overall Study||6
10432086|NCT00878722|11578220|FG007|STARTED|Overall Study||7
10432087|NCT00878722|11578213|FG000|COMPLETED|Overall Study||0
10432088|NCT00878722|11578214|FG001|COMPLETED|Overall Study||0
10432089|NCT00878722|11578215|FG002|COMPLETED|Overall Study||0
10432090|NCT00878722|11578216|FG003|COMPLETED|Overall Study||0
10432091|NCT00878722|11578217|FG004|COMPLETED|Overall Study||0
10432092|NCT00878722|11578218|FG005|COMPLETED|Overall Study||1
10780832|NCT03396432|11942607|FG001|NOT COMPLETED|Overall Study||6
10780833|NCT03396835|11942615|FG000|STARTED|Overall Study||16
10432093|NCT00878722|11578219|FG006|COMPLETED|Overall Study||0
10432094|NCT00878722|11578220|FG007|COMPLETED|Overall Study||0
10432095|NCT00878722|11578213|FG000|NOT COMPLETED|Overall Study||3
10432096|NCT00878722|11578214|FG001|NOT COMPLETED|Overall Study||3
10432097|NCT00878722|11578215|FG002|NOT COMPLETED|Overall Study||3
10432098|NCT00878722|11578216|FG003|NOT COMPLETED|Overall Study||9
10432099|NCT00878722|11578217|FG004|NOT COMPLETED|Overall Study||7
10432100|NCT00878722|11578218|FG005|NOT COMPLETED|Overall Study||2
10432101|NCT00878722|11578219|FG006|NOT COMPLETED|Overall Study||6
10432102|NCT00878722|11578220|FG007|NOT COMPLETED|Overall Study||7
10780834|NCT03396835|11942615|FG000|COMPLETED|Overall Study||14
10780835|NCT03396835|11942615|FG000|NOT COMPLETED|Overall Study||2
10780836|NCT03396913|11942621|FG000|STARTED|Overall Study||43
10780837|NCT03396913|11942622|FG001|STARTED|Overall Study||45
10780838|NCT03396913|11942621|FG000|COMPLETED|Overall Study||43
10780839|NCT03396913|11942622|FG001|COMPLETED|Overall Study||39
10780840|NCT03396913|11942621|FG000|NOT COMPLETED|Overall Study||0
10780841|NCT03396913|11942622|FG001|NOT COMPLETED|Overall Study||6
10780842|NCT03397121|11942630|FG000|STARTED|Overall Study||242
10780843|NCT03397121|11942631|FG001|STARTED|Overall Study||240
10780844|NCT03397121|11942630|FG000|COMPLETED|Overall Study||235
10780845|NCT03397121|11942631|FG001|COMPLETED|Overall Study||231
10780846|NCT03397121|11942630|FG000|NOT COMPLETED|Overall Study||7
10780847|NCT03397121|11942631|FG001|NOT COMPLETED|Overall Study||9
10780848|NCT03397394|11942641|FG000|STARTED|Overall Study||47
10780849|NCT03397394|11942642|FG001|STARTED|Overall Study||30
10780850|NCT03397394|11942643|FG002|STARTED|Overall Study||20
10780851|NCT03397394|11942641|FG000|COMPLETED|Overall Study||47
10780852|NCT03397394|11942642|FG001|COMPLETED|Overall Study||30
10780853|NCT03397394|11942643|FG002|COMPLETED|Overall Study||20
10780854|NCT03397394|11942641|FG000|NOT COMPLETED|Overall Study||0
10780855|NCT03397394|11942642|FG001|NOT COMPLETED|Overall Study||0
10780856|NCT03397394|11942643|FG002|NOT COMPLETED|Overall Study||0
10780857|NCT03397771|11942655|FG000|STARTED|Overall Study||53
10780858|NCT03397771|11942656|FG001|STARTED|Overall Study||29
10780859|NCT03397771|11942655|FG000|COMPLETED|Overall Study||45
10780860|NCT03397771|11942656|FG001|COMPLETED|Overall Study||22
10780861|NCT03397771|11942655|FG000|NOT COMPLETED|Overall Study||8
10780862|NCT03397771|11942656|FG001|NOT COMPLETED|Overall Study||7
10780863|NCT03398213|11942665|FG000|STARTED|Overall Study||26
10780864|NCT03398213|11942666|FG001|STARTED|Overall Study||24
10780865|NCT03398213|11942667|FG002|STARTED|Overall Study||22
10780866|NCT03398213|11942665|FG000|COMPLETED|Overall Study||26
10780867|NCT03398213|11942666|FG001|COMPLETED|Overall Study||24
10780868|NCT03398213|11942667|FG002|COMPLETED|Overall Study||22
10780869|NCT03398213|11942665|FG000|NOT COMPLETED|Overall Study||0
10780870|NCT03398213|11942666|FG001|NOT COMPLETED|Overall Study||0
10780871|NCT03398213|11942667|FG002|NOT COMPLETED|Overall Study||0
10780872|NCT03398265|11942677|FG000|STARTED|Overall Study||7
10780873|NCT03398265|11942678|FG001|STARTED|Overall Study||8
10780874|NCT03398265|11942677|FG000|COMPLETED|Overall Study||7
10780875|NCT03398265|11942678|FG001|COMPLETED|Overall Study||8
10780876|NCT03398265|11942677|FG000|NOT COMPLETED|Overall Study||0
10780877|NCT03398265|11942678|FG001|NOT COMPLETED|Overall Study||0
10780878|NCT03398278|11942687|FG000|STARTED|Period 1||19
10780879|NCT03398278|11942688|FG001|STARTED|Period 1||19
10780880|NCT03398278|11942687|FG000|COMPLETED|Period 1||18
10780881|NCT03398278|11942688|FG001|COMPLETED|Period 1||19
10780882|NCT03398278|11942687|FG000|NOT COMPLETED|Period 1||1
10780883|NCT03398278|11942688|FG001|NOT COMPLETED|Period 1||0
10780884|NCT03398278|11942687|FG000|STARTED|Period 2||18
10432103|NCT00878800|11578246|FG000|STARTED|Overall Study||3
10432104|NCT00878800|11578247|FG001|STARTED|Overall Study||7
10432105|NCT00878800|11578248|FG002|STARTED|Overall Study||9
10432106|NCT00878800|11578249|FG003|STARTED|Overall Study||6
10432107|NCT00878800|11578250|FG004|STARTED|Overall Study||16
10432108|NCT00878800|11578246|FG000|COMPLETED|Overall Study|Mean number of cycles administered: 4.0|0
10432109|NCT00878800|11578247|FG001|COMPLETED|Overall Study|Mean number of cycles administered: 4.6|0
10432110|NCT00878800|11578248|FG002|COMPLETED|Overall Study|Mean number of cycles administered: 3.0|0
10432111|NCT00878800|11578249|FG003|COMPLETED|Overall Study|Mean number of cycles administered: 5.3|0
10432112|NCT00878800|11578250|FG004|COMPLETED|Overall Study|Mean number of cycles administered: 6.4|0
10432113|NCT00878800|11578246|FG000|NOT COMPLETED|Overall Study||3
10780885|NCT03398278|11942688|FG001|STARTED|Period 2||19
10780886|NCT03398278|11942687|FG000|COMPLETED|Period 2||16
10780887|NCT03398278|11942688|FG001|COMPLETED|Period 2||17
10780888|NCT03398278|11942687|FG000|NOT COMPLETED|Period 2||2
10780889|NCT03398278|11942688|FG001|NOT COMPLETED|Period 2||2
10780890|NCT03398330|11942710|FG000|STARTED|Period 1||21
10780891|NCT03398330|11942711|FG001|STARTED|Period 1||21
10780892|NCT03398330|11942710|FG000|COMPLETED|Period 1||20
10780893|NCT03398330|11942711|FG001|COMPLETED|Period 1||17
10780894|NCT03398330|11942710|FG000|NOT COMPLETED|Period 1||1
10780895|NCT03398330|11942711|FG001|NOT COMPLETED|Period 1||4
10780896|NCT03398330|11942710|FG000|STARTED|Period 2||20
10780897|NCT03398330|11942711|FG001|STARTED|Period 2||17
10780898|NCT03398330|11942710|FG000|COMPLETED|Period 2||19
10780899|NCT03398330|11942711|FG001|COMPLETED|Period 2||17
10780900|NCT03398330|11942710|FG000|NOT COMPLETED|Period 2||1
10780901|NCT03398330|11942711|FG001|NOT COMPLETED|Period 2||0
10780902|NCT03398421|11942731|FG000|STARTED|Treatment Period 1 (Up to 6 Days)||20
10780903|NCT03398421|11942732|FG001|STARTED|Treatment Period 1 (Up to 6 Days)||0
10780904|NCT03398421|11942731|FG000|COMPLETED|Treatment Period 1 (Up to 6 Days)||20
10780905|NCT03398421|11942732|FG001|COMPLETED|Treatment Period 1 (Up to 6 Days)||0
10780906|NCT03398421|11942731|FG000|NOT COMPLETED|Treatment Period 1 (Up to 6 Days)||0
10780907|NCT03398421|11942732|FG001|NOT COMPLETED|Treatment Period 1 (Up to 6 Days)||0
10780908|NCT03398421|11942731|FG000|STARTED|Washout Period (Up to 14 Days)||20
10780909|NCT03398421|11942732|FG001|STARTED|Washout Period (Up to 14 Days)||0
10780910|NCT03398421|11942731|FG000|COMPLETED|Washout Period (Up to 14 Days)||20
10780911|NCT03398421|11942732|FG001|COMPLETED|Washout Period (Up to 14 Days)||0
10780912|NCT03398421|11942731|FG000|NOT COMPLETED|Washout Period (Up to 14 Days)||0
10780913|NCT03398421|11942732|FG001|NOT COMPLETED|Washout Period (Up to 14 Days)||0
10780914|NCT03398421|11942731|FG000|STARTED|Treatment Period 2 (Up to 11 Days)||0
10780915|NCT03398421|11942732|FG001|STARTED|Treatment Period 2 (Up to 11 Days)||20
10780916|NCT03398421|11942731|FG000|COMPLETED|Treatment Period 2 (Up to 11 Days)||0
10780917|NCT03398421|11942732|FG001|COMPLETED|Treatment Period 2 (Up to 11 Days)||20
10780918|NCT03398421|11942731|FG000|NOT COMPLETED|Treatment Period 2 (Up to 11 Days)||0
10780919|NCT03398421|11942732|FG001|NOT COMPLETED|Treatment Period 2 (Up to 11 Days)||0
10780920|NCT03398798|11942744|FG000|STARTED|Overall Study||9
10780921|NCT03398798|11942745|FG001|STARTED|Overall Study||9
10780922|NCT03398798|11942746|FG002|STARTED|Overall Study||9
10780923|NCT03398798|11942747|FG003|STARTED|Overall Study||9
10780924|NCT03398798|11942744|FG000|COMPLETED|Overall Study||9
10780925|NCT03398798|11942745|FG001|COMPLETED|Overall Study||9
10780926|NCT03398798|11942746|FG002|COMPLETED|Overall Study||9
10780927|NCT03398798|11942747|FG003|COMPLETED|Overall Study||9
10780928|NCT03398798|11942744|FG000|NOT COMPLETED|Overall Study||0
10780929|NCT03398798|11942745|FG001|NOT COMPLETED|Overall Study||0
10780930|NCT03398798|11942746|FG002|NOT COMPLETED|Overall Study||0
10780931|NCT03398798|11942747|FG003|NOT COMPLETED|Overall Study||0
10780932|NCT03398928|11942759|FG000|STARTED|Overall Study||50
10780933|NCT03398928|11942760|FG001|STARTED|Overall Study||31
10780934|NCT03398928|11942759|FG000|COMPLETED|Overall Study||50
10780935|NCT03398928|11942760|FG001|COMPLETED|Overall Study||31
10780936|NCT03398928|11942759|FG000|NOT COMPLETED|Overall Study||0
10780937|NCT03398928|11942760|FG001|NOT COMPLETED|Overall Study||0
10780938|NCT03399370|11942768|FG000|STARTED|Overall Study||781
10780939|NCT03399370|11942769|FG001|STARTED|Overall Study||780
10780940|NCT03399370|11942768|FG000|COMPLETED|Overall Study||721
10780941|NCT03399370|11942769|FG001|COMPLETED|Overall Study||694
10780942|NCT03399370|11942768|FG000|NOT COMPLETED|Overall Study||60
10780943|NCT03399370|11942769|FG001|NOT COMPLETED|Overall Study||86
10780944|NCT03399786|11942778|FG000|STARTED|Double-blind Treatment Period (DBTP)||22
10780945|NCT03399786|11942779|FG001|STARTED|Double-blind Treatment Period (DBTP)||43
10780946|NCT03399786|11942780|FG002|STARTED|Double-blind Treatment Period (DBTP)||0
10780947|NCT03399786|11942781|FG003|STARTED|Double-blind Treatment Period (DBTP)||0
10780948|NCT03399786|11942778|FG000|COMPLETED|Double-blind Treatment Period (DBTP)||21
10780949|NCT03399786|11942779|FG001|COMPLETED|Double-blind Treatment Period (DBTP)||43
10780950|NCT03399786|11942780|FG002|COMPLETED|Double-blind Treatment Period (DBTP)||0
10780951|NCT03399786|11942781|FG003|COMPLETED|Double-blind Treatment Period (DBTP)||0
10780952|NCT03399786|11942778|FG000|NOT COMPLETED|Double-blind Treatment Period (DBTP)||1
10780953|NCT03399786|11942779|FG001|NOT COMPLETED|Double-blind Treatment Period (DBTP)||0
10780954|NCT03399786|11942780|FG002|NOT COMPLETED|Double-blind Treatment Period (DBTP)||0
10780955|NCT03399786|11942781|FG003|NOT COMPLETED|Double-blind Treatment Period (DBTP)||0
10780956|NCT03399786|11942778|FG000|STARTED|Open-label Treatment Period (OLTP)||0
10780957|NCT03399786|11942779|FG001|STARTED|Open-label Treatment Period (OLTP)||0
10780958|NCT03399786|11942780|FG002|STARTED|Open-label Treatment Period (OLTP)|One participant from the placebo group received evinacumab during the DBTP|20
10780959|NCT03399786|11942781|FG003|STARTED|Open-label Treatment Period (OLTP)||44
10780960|NCT03399786|11942778|FG000|COMPLETED|Open-label Treatment Period (OLTP)||0
10432114|NCT00878800|11578247|FG001|NOT COMPLETED|Overall Study||7
10432115|NCT00878800|11578248|FG002|NOT COMPLETED|Overall Study||9
10432116|NCT00878800|11578249|FG003|NOT COMPLETED|Overall Study||6
10780961|NCT03399786|11942779|FG001|COMPLETED|Open-label Treatment Period (OLTP)||0
10780962|NCT03399786|11942780|FG002|COMPLETED|Open-label Treatment Period (OLTP)||19
10780963|NCT03399786|11942781|FG003|COMPLETED|Open-label Treatment Period (OLTP)||43
10780964|NCT03399786|11942778|FG000|NOT COMPLETED|Open-label Treatment Period (OLTP)||0
10780965|NCT03399786|11942779|FG001|NOT COMPLETED|Open-label Treatment Period (OLTP)||0
10780966|NCT03399786|11942780|FG002|NOT COMPLETED|Open-label Treatment Period (OLTP)||1
10780967|NCT03399786|11942781|FG003|NOT COMPLETED|Open-label Treatment Period (OLTP)||1
10780968|NCT03400033|11942791|FG000|STARTED|Overall Study||270
10780969|NCT03400033|11942792|FG001|STARTED|Overall Study||137
10780970|NCT03400033|11942791|FG000|COMPLETED|Overall Study||269
10780971|NCT03400033|11942792|FG001|COMPLETED|Overall Study||135
10780972|NCT03400033|11942791|FG000|NOT COMPLETED|Overall Study||1
10780973|NCT03400033|11942792|FG001|NOT COMPLETED|Overall Study||2
10780974|NCT03400163|11942809|FG000|STARTED|Treatment Period||1
10780975|NCT03400163|11942810|FG001|STARTED|Treatment Period||2
10780976|NCT03400163|11942809|FG000|COMPLETED|Treatment Period||1
10780977|NCT03400163|11942810|FG001|COMPLETED|Treatment Period||2
10780978|NCT03400163|11942809|FG000|NOT COMPLETED|Treatment Period||0
10780979|NCT03400163|11942810|FG001|NOT COMPLETED|Treatment Period||0
10780980|NCT03400163|11942809|FG000|STARTED|Follow-up Period||1
10780981|NCT03400163|11942810|FG001|STARTED|Follow-up Period||2
10780982|NCT03400163|11942809|FG000|COMPLETED|Follow-up Period||1
10780983|NCT03400163|11942810|FG001|COMPLETED|Follow-up Period||2
10780984|NCT03400163|11942809|FG000|NOT COMPLETED|Follow-up Period||0
10780985|NCT03400163|11942810|FG001|NOT COMPLETED|Follow-up Period||0
10780986|NCT03400449|11942818|FG000|STARTED|Overall Study||121
10780987|NCT03400449|11942819|FG001|STARTED|Overall Study||119
10780988|NCT03400449|11942818|FG000|COMPLETED|Overall Study||120
10780989|NCT03400449|11942819|FG001|COMPLETED|Overall Study||119
10780990|NCT03400449|11942818|FG000|NOT COMPLETED|Overall Study||1
10780991|NCT03400449|11942819|FG001|NOT COMPLETED|Overall Study||0
10780992|NCT03400475|11942829|FG000|STARTED|Overall Study||24
10780993|NCT03400475|11942830|FG001|STARTED|Overall Study||22
10780994|NCT03400475|11942829|FG000|COMPLETED|Overall Study||24
10780995|NCT03400475|11942830|FG001|COMPLETED|Overall Study||22
10780996|NCT03400475|11942829|FG000|NOT COMPLETED|Overall Study||0
10780997|NCT03400475|11942830|FG001|NOT COMPLETED|Overall Study||0
10780998|NCT03400579|11942837|FG000|STARTED|Overall Study||10
10780999|NCT03400579|11942837|FG000|COMPLETED|Overall Study||10
10781000|NCT03400579|11942837|FG000|NOT COMPLETED|Overall Study||0
10781001|NCT03400748|11942841|FG000|STARTED|Overall Study||6
10781002|NCT03400748|11942841|FG000|COMPLETED|Overall Study||6
10432117|NCT00878800|11578250|FG004|NOT COMPLETED|Overall Study||16
10432118|NCT00878826|11578264|FG000|STARTED|Overall Study||3
10432119|NCT00878826|11578265|FG001|STARTED|Overall Study||6
10432120|NCT00878826|11578266|FG002|STARTED|Overall Study||2
10432121|NCT00878826|11578264|FG000|COMPLETED|Overall Study||3
10432122|NCT00878826|11578265|FG001|COMPLETED|Overall Study||6
10432123|NCT00878826|11578266|FG002|COMPLETED|Overall Study||2
10432124|NCT00878826|11578264|FG000|NOT COMPLETED|Overall Study||0
10432125|NCT00878826|11578265|FG001|NOT COMPLETED|Overall Study||0
10432126|NCT00878826|11578266|FG002|NOT COMPLETED|Overall Study||0
10432127|NCT00878878|11578276|FG000|STARTED|Overall Study||15
10432128|NCT00878878|11578277|FG001|STARTED|Overall Study||15
10432129|NCT00878878|11578276|FG000|COMPLETED|Overall Study||15
10432130|NCT00878878|11578277|FG001|COMPLETED|Overall Study||15
10432131|NCT00878878|11578276|FG000|NOT COMPLETED|Overall Study||0
10432132|NCT00878878|11578277|FG001|NOT COMPLETED|Overall Study||0
10432133|NCT00878995|11578287|FG000|STARTED|Baseline Study - Midpoint Study||12
10432134|NCT00878995|11578288|FG001|STARTED|Baseline Study - Midpoint Study||12
10432135|NCT00878995|11578287|FG000|Baseline Study|Baseline Study - Midpoint Study||12
10432136|NCT00878995|11578288|FG001|Baseline Study|Baseline Study - Midpoint Study||12
10432137|NCT00878995|11578287|FG000|COMPLETED|Baseline Study - Midpoint Study||12
10432138|NCT00878995|11578288|FG001|COMPLETED|Baseline Study - Midpoint Study|2 subjects dropped after the baseline study. They decided to seek treatment closer to home.|10
10432139|NCT00878995|11578287|FG000|NOT COMPLETED|Baseline Study - Midpoint Study||0
10432140|NCT00878995|11578288|FG001|NOT COMPLETED|Baseline Study - Midpoint Study||2
10432141|NCT00878995|11578287|FG000|STARTED|Midpoint Study - Post Study||12
10432142|NCT00878995|11578288|FG001|STARTED|Midpoint Study - Post Study||10
10432143|NCT00878995|11578287|FG000|COMPLETED|Midpoint Study - Post Study||12
10432144|NCT00878995|11578288|FG001|COMPLETED|Midpoint Study - Post Study||10
10432145|NCT00878995|11578287|FG000|NOT COMPLETED|Midpoint Study - Post Study||0
10432146|NCT00878995|11578288|FG001|NOT COMPLETED|Midpoint Study - Post Study||0
10432147|NCT00879034|11578294|FG000|STARTED|Overall Study||5
10432148|NCT00879034|11578294|FG000|Received Treatment|Overall Study||4
10781003|NCT03400748|11942841|FG000|NOT COMPLETED|Overall Study||0
10781004|NCT03400787|11942847|FG000|STARTED|Overall Study||66
10432149|NCT00879034|11578294|FG000|COMPLETED|Overall Study||5
10781005|NCT03400787|11942848|FG001|STARTED|Overall Study||71
10781006|NCT03400787|11942847|FG000|3-Month Follow-up|Overall Study||64
10781007|NCT03400787|11942848|FG001|3-Month Follow-up|Overall Study||63
10781008|NCT03400787|11942847|FG000|COMPLETED|Overall Study||64
10781009|NCT03400787|11942848|FG001|COMPLETED|Overall Study||63
10781010|NCT03400787|11942847|FG000|NOT COMPLETED|Overall Study||2
10781011|NCT03400787|11942848|FG001|NOT COMPLETED|Overall Study||8
10781012|NCT03400800|11942856|FG000|STARTED|Overall Study||810
10781013|NCT03400800|11942857|FG001|STARTED|Overall Study||807
10781014|NCT03400800|11942856|FG000|COMPLETED|Overall Study||772
10781015|NCT03400800|11942857|FG001|COMPLETED|Overall Study||770
10781016|NCT03400800|11942856|FG000|NOT COMPLETED|Overall Study||38
10432150|NCT00879034|11578294|FG000|NOT COMPLETED|Overall Study||0
10432151|NCT00879060|11578300|FG000|STARTED|Overall Study||26
10432152|NCT00879060|11578301|FG001|STARTED|Overall Study||27
10781017|NCT03400800|11942857|FG001|NOT COMPLETED|Overall Study||37
10781018|NCT03400852|11942865|FG000|STARTED|Blinded Treatment Period||29
10781019|NCT03400852|11942866|FG001|STARTED|Blinded Treatment Period||15
10781020|NCT03400852|11942867|FG002|STARTED|Blinded Treatment Period||0
10781021|NCT03400852|11942865|FG000|COMPLETED|Blinded Treatment Period||20
10781022|NCT03400852|11942866|FG001|COMPLETED|Blinded Treatment Period||9
10781023|NCT03400852|11942867|FG002|COMPLETED|Blinded Treatment Period||0
10781024|NCT03400852|11942865|FG000|NOT COMPLETED|Blinded Treatment Period||9
10781025|NCT03400852|11942866|FG001|NOT COMPLETED|Blinded Treatment Period||6
10781026|NCT03400852|11942867|FG002|NOT COMPLETED|Blinded Treatment Period||0
10781027|NCT03400852|11942865|FG000|STARTED|Open Label Period||0
10781028|NCT03400852|11942866|FG001|STARTED|Open Label Period||0
10781029|NCT03400852|11942867|FG002|STARTED|Open Label Period||24
10781030|NCT03400852|11942865|FG000|COMPLETED|Open Label Period||0
10781031|NCT03400852|11942866|FG001|COMPLETED|Open Label Period||0
10781032|NCT03400852|11942867|FG002|COMPLETED|Open Label Period||2
10781033|NCT03400852|11942865|FG000|NOT COMPLETED|Open Label Period||0
10781034|NCT03400852|11942866|FG001|NOT COMPLETED|Open Label Period||0
10781035|NCT03400852|11942867|FG002|NOT COMPLETED|Open Label Period||22
10781036|NCT03401229|11942877|FG000|STARTED|Overall Study||207
10781037|NCT03401229|11942878|FG001|STARTED|Overall Study||203
10781038|NCT03401229|11942877|FG000|COMPLETED|Overall Study||167
10781039|NCT03401229|11942878|FG001|COMPLETED|Overall Study||166
10781040|NCT03401229|11942877|FG000|NOT COMPLETED|Overall Study||40
10781041|NCT03401229|11942878|FG001|NOT COMPLETED|Overall Study||37
10781042|NCT03401450|11942886|FG000|STARTED|Overall Study||33
10781043|NCT03401450|11942887|FG001|STARTED|Overall Study||36
10781044|NCT03401450|11942886|FG000|COMPLETED|Overall Study||21
10781045|NCT03401450|11942887|FG001|COMPLETED|Overall Study||23
10781046|NCT03401450|11942886|FG000|NOT COMPLETED|Overall Study||12
10781047|NCT03401450|11942887|FG001|NOT COMPLETED|Overall Study||13
10781048|NCT03401671|11942895|FG000|STARTED|Overall Study||16
10781049|NCT03401671|11942896|FG001|STARTED|Overall Study||16
10781050|NCT03401671|11942895|FG000|COMPLETED|Overall Study||16
10781051|NCT03401671|11942896|FG001|COMPLETED|Overall Study||16
10781052|NCT03401671|11942895|FG000|NOT COMPLETED|Overall Study||0
10781053|NCT03401671|11942896|FG001|NOT COMPLETED|Overall Study||0
10781054|NCT03402126|11942902|FG000|STARTED|Overall Study||138
10432153|NCT00879060|11578300|FG000|COMPLETED|Overall Study||26
10432154|NCT00879060|11578301|FG001|COMPLETED|Overall Study||27
10432155|NCT00879060|11578300|FG000|NOT COMPLETED|Overall Study||0
10432156|NCT00879060|11578301|FG001|NOT COMPLETED|Overall Study||0
10432157|NCT00879190|11578312|FG000|STARTED|Overall Study||43
10432158|NCT00879190|11578313|FG001|STARTED|Overall Study||49
10432159|NCT00879190|11578312|FG000|COMPLETED|Overall Study||43
10432160|NCT00879190|11578313|FG001|COMPLETED|Overall Study||49
10432161|NCT00879190|11578312|FG000|NOT COMPLETED|Overall Study||0
10432162|NCT00879190|11578313|FG001|NOT COMPLETED|Overall Study||0
10432163|NCT00879229|11578321|FG000|STARTED|Overall Study||25
10432164|NCT00879229|11578322|FG001|STARTED|Overall Study||15
10432165|NCT00879229|11578321|FG000|COMPLETED|Overall Study||3
10432166|NCT00879229|11578322|FG001|COMPLETED|Overall Study||1
10432167|NCT00879229|11578321|FG000|NOT COMPLETED|Overall Study||22
10432168|NCT00879229|11578322|FG001|NOT COMPLETED|Overall Study||14
10432169|NCT00879255|11578330|FG000|STARTED|Overall Study||61
10432170|NCT00879255|11578331|FG001|STARTED|Overall Study||64
10432171|NCT00879255|11578330|FG000|Received Allocated Intervention:|Overall Study||51
10781055|NCT03402126|11942902|FG000|COMPLETED|Overall Study||76
10781056|NCT03402126|11942902|FG000|NOT COMPLETED|Overall Study||62
10432172|NCT00879255|11578331|FG001|Received Allocated Intervention:|Overall Study||56
10432173|NCT00879255|11578330|FG000|Completed Posttreatment Follow-up|Overall Study||50
10432174|NCT00879255|11578331|FG001|Completed Posttreatment Follow-up|Overall Study||55
10432175|NCT00879255|11578330|FG000|Completed 3-mo Follow-up|Overall Study||48
10432176|NCT00879255|11578331|FG001|Completed 3-mo Follow-up|Overall Study||49
10781057|NCT03402243|11942909|FG000|STARTED|Overall Study||16
10781058|NCT03402243|11942910|FG001|STARTED|Overall Study||15
10432177|NCT00879255|11578330|FG000|COMPLETED|Overall Study|Completed 6-mo follow-up|45
10781059|NCT03402243|11942911|FG002|STARTED|Overall Study||16
10432178|NCT00879255|11578331|FG001|COMPLETED|Overall Study|Completed 6-mo follow-up|45
10781060|NCT03402243|11942909|FG000|COMPLETED|Overall Study||13
10781061|NCT03402243|11942910|FG001|COMPLETED|Overall Study||12
10781062|NCT03402243|11942911|FG002|COMPLETED|Overall Study||14
10781063|NCT03402243|11942909|FG000|NOT COMPLETED|Overall Study||3
10781064|NCT03402243|11942910|FG001|NOT COMPLETED|Overall Study||3
10781065|NCT03402243|11942911|FG002|NOT COMPLETED|Overall Study||2
10432179|NCT00879255|11578330|FG000|NOT COMPLETED|Overall Study||16
10432180|NCT00879255|11578331|FG001|NOT COMPLETED|Overall Study||19
10432181|NCT00879333|11578339|FG000|STARTED|Overall Study||439
10432182|NCT00879333|11578340|FG001|STARTED|Overall Study||217
10432183|NCT00879333|11578339|FG000|Discontinued Study Treatment|Overall Study||428
10432184|NCT00879333|11578340|FG001|Discontinued Study Treatment|Overall Study||217
10432185|NCT00879333|11578339|FG000|COMPLETED|Overall Study|Completed=Patients Still on Treatment; At data cutoff final analysis, 11 patients were on treatment|11
10432186|NCT00879333|11578340|FG001|COMPLETED|Overall Study||0
10432187|NCT00879333|11578339|FG000|NOT COMPLETED|Overall Study||428
10432188|NCT00879333|11578340|FG001|NOT COMPLETED|Overall Study||217
10432189|NCT00879359|11578348|FG000|STARTED|Overall Study||15
10432190|NCT00879359|11578348|FG000|COMPLETED|Overall Study||15
10432191|NCT00879359|11578348|FG000|NOT COMPLETED|Overall Study||0
10432192|NCT00879398|11578353|FG000|STARTED|Overall Study||3109
10432193|NCT00879398|11578353|FG000|COMPLETED|Overall Study||2434
10432194|NCT00879398|11578353|FG000|NOT COMPLETED|Overall Study||675
10432195|NCT00879411|11578357|FG000|STARTED|Overall Study||701
10432196|NCT00879411|11578357|FG000|COMPLETED|Overall Study||539
10432197|NCT00879411|11578357|FG000|NOT COMPLETED|Overall Study||162
10432198|NCT00879437|11578361|FG000|STARTED|Overall Study||20
10432199|NCT00879437|11578362|FG001|STARTED|Overall Study||18
10432200|NCT00879437|11578361|FG000|COMPLETED|Overall Study||19
10432201|NCT00879437|11578362|FG001|COMPLETED|Overall Study||17
10432202|NCT00879437|11578361|FG000|NOT COMPLETED|Overall Study||1
10432203|NCT00879437|11578362|FG001|NOT COMPLETED|Overall Study||1
10432204|NCT00879645|11578374|FG000|STARTED|Overall Study||9
10432205|NCT00879645|11578375|FG001|STARTED|Overall Study||6
10432206|NCT00879645|11578376|FG002|STARTED|Overall Study||6
10432207|NCT00879645|11578377|FG003|STARTED|Overall Study||7
10432208|NCT00879645|11578374|FG000|COMPLETED|Overall Study||8
10432209|NCT00879645|11578375|FG001|COMPLETED|Overall Study||6
10432210|NCT00879645|11578376|FG002|COMPLETED|Overall Study||6
10432211|NCT00879645|11578377|FG003|COMPLETED|Overall Study||7
10432212|NCT00879645|11578374|FG000|NOT COMPLETED|Overall Study||1
10432213|NCT00879645|11578375|FG001|NOT COMPLETED|Overall Study||0
10432214|NCT00879645|11578376|FG002|NOT COMPLETED|Overall Study||0
10432215|NCT00879645|11578377|FG003|NOT COMPLETED|Overall Study||0
10432216|NCT00879658|11578394|FG000|STARTED|Overall Study||50
10432217|NCT00879658|11578395|FG001|STARTED|Overall Study||49
10432218|NCT00879658|11578396|FG002|STARTED|Overall Study||43
10432219|NCT00879658|11578397|FG003|STARTED|Overall Study||46
10432220|NCT00879658|11578398|FG004|STARTED|Overall Study||42
10432221|NCT00879658|11578399|FG005|STARTED|Overall Study||51
10432222|NCT00879658|11578400|FG006|STARTED|Overall Study||16
10432223|NCT00879658|11578394|FG000|COMPLETED|Overall Study||35
10432224|NCT00879658|11578395|FG001|COMPLETED|Overall Study||44
10432225|NCT00879658|11578396|FG002|COMPLETED|Overall Study||36
10432226|NCT00879658|11578397|FG003|COMPLETED|Overall Study||42
10432227|NCT00879658|11578398|FG004|COMPLETED|Overall Study||40
10432228|NCT00879658|11578399|FG005|COMPLETED|Overall Study||50
10432229|NCT00879658|11578400|FG006|COMPLETED|Overall Study||16
10432230|NCT00879658|11578394|FG000|NOT COMPLETED|Overall Study||15
10432231|NCT00879658|11578395|FG001|NOT COMPLETED|Overall Study||5
10432232|NCT00879658|11578396|FG002|NOT COMPLETED|Overall Study||7
10432233|NCT00879658|11578397|FG003|NOT COMPLETED|Overall Study||4
10432234|NCT00879658|11578398|FG004|NOT COMPLETED|Overall Study||2
10432235|NCT00879658|11578399|FG005|NOT COMPLETED|Overall Study||1
10432236|NCT00879658|11578400|FG006|NOT COMPLETED|Overall Study||0
10432237|NCT00879684|11578422|FG000|STARTED|Stage 1: Dose Escalation||3
10432238|NCT00879684|11578423|FG001|STARTED|Stage 1: Dose Escalation||3
10432239|NCT00879684|11578424|FG002|STARTED|Stage 1: Dose Escalation||3
10432240|NCT00879684|11578425|FG003|STARTED|Stage 1: Dose Escalation||6
10432241|NCT00879684|11578426|FG004|STARTED|Stage 1: Dose Escalation||3
10432242|NCT00879684|11578427|FG005|STARTED|Stage 1: Dose Escalation||3
10432243|NCT00879684|11578428|FG006|STARTED|Stage 1: Dose Escalation||0
10432244|NCT00879684|11578422|FG000|COMPLETED|Stage 1: Dose Escalation||0
10432245|NCT00879684|11578423|FG001|COMPLETED|Stage 1: Dose Escalation||0
10432246|NCT00879684|11578424|FG002|COMPLETED|Stage 1: Dose Escalation||0
10432247|NCT00879684|11578425|FG003|COMPLETED|Stage 1: Dose Escalation||0
10432248|NCT00879684|11578426|FG004|COMPLETED|Stage 1: Dose Escalation||0
10432249|NCT00879684|11578427|FG005|COMPLETED|Stage 1: Dose Escalation||0
10432250|NCT00879684|11578428|FG006|COMPLETED|Stage 1: Dose Escalation||0
10432251|NCT00879684|11578422|FG000|NOT COMPLETED|Stage 1: Dose Escalation||3
10432252|NCT00879684|11578423|FG001|NOT COMPLETED|Stage 1: Dose Escalation||3
10432253|NCT00879684|11578424|FG002|NOT COMPLETED|Stage 1: Dose Escalation||3
10432254|NCT00879684|11578425|FG003|NOT COMPLETED|Stage 1: Dose Escalation||6
10432255|NCT00879684|11578426|FG004|NOT COMPLETED|Stage 1: Dose Escalation||3
10781066|NCT03402386|11942919|FG000|STARTED|Overall Study||42
10781067|NCT03402386|11942919|FG000|Correction Group|Overall Study||2
10432256|NCT00879684|11578427|FG005|NOT COMPLETED|Stage 1: Dose Escalation||3
10432257|NCT00879684|11578428|FG006|NOT COMPLETED|Stage 1: Dose Escalation||0
10432258|NCT00879684|11578422|FG000|STARTED|Stage 2: Expanded Cohort||0
10432259|NCT00879684|11578423|FG001|STARTED|Stage 2: Expanded Cohort||0
10432260|NCT00879684|11578424|FG002|STARTED|Stage 2: Expanded Cohort||0
10432261|NCT00879684|11578425|FG003|STARTED|Stage 2: Expanded Cohort||0
10432262|NCT00879684|11578426|FG004|STARTED|Stage 2: Expanded Cohort||0
10432263|NCT00879684|11578427|FG005|STARTED|Stage 2: Expanded Cohort||0
10432264|NCT00879684|11578428|FG006|STARTED|Stage 2: Expanded Cohort||13
10432265|NCT00879684|11578422|FG000|COMPLETED|Stage 2: Expanded Cohort||0
10432266|NCT00879684|11578423|FG001|COMPLETED|Stage 2: Expanded Cohort||0
10432267|NCT00879684|11578424|FG002|COMPLETED|Stage 2: Expanded Cohort||0
10432268|NCT00879684|11578425|FG003|COMPLETED|Stage 2: Expanded Cohort||0
10781068|NCT03402386|11942919|FG000|Conversion Group|Overall Study||40
10781069|NCT03402386|11942919|FG000|COMPLETED|Overall Study||36
10781070|NCT03402386|11942919|FG000|NOT COMPLETED|Overall Study||6
10781071|NCT03402555|11942923|FG000|STARTED|Overall Study||96
10781072|NCT03402555|11942923|FG000|COMPLETED|Overall Study||91
10781073|NCT03402555|11942923|FG000|NOT COMPLETED|Overall Study||5
10781074|NCT03402659|11942929|FG000|STARTED|Overall Study||83
10781075|NCT03402659|11942930|FG001|STARTED|Overall Study||78
10781076|NCT03402659|11942929|FG000|COMPLETED|Overall Study||78
10781077|NCT03402659|11942930|FG001|COMPLETED|Overall Study||73
10781078|NCT03402659|11942929|FG000|NOT COMPLETED|Overall Study||5
10781079|NCT03402659|11942930|FG001|NOT COMPLETED|Overall Study||5
10781080|NCT03402750|11942938|FG000|STARTED|Overall Study||20
10781081|NCT03402750|11942939|FG001|STARTED|Overall Study||20
10781082|NCT03402750|11942938|FG000|COMPLETED|Overall Study||18
10781083|NCT03402750|11942939|FG001|COMPLETED|Overall Study||19
10781084|NCT03402750|11942938|FG000|NOT COMPLETED|Overall Study||2
10781085|NCT03402750|11942939|FG001|NOT COMPLETED|Overall Study||1
10781086|NCT03402893|11942945|FG000|STARTED|Overall Study||21
10781087|NCT03402893|11942945|FG000|COMPLETED|Overall Study||20
10781088|NCT03402893|11942945|FG000|NOT COMPLETED|Overall Study||1
10781089|NCT03402932|11942954|FG000|STARTED|Overall Study||13
10781090|NCT03402932|11942955|FG001|STARTED|Overall Study||8
10781091|NCT03402932|11942956|FG002|STARTED|Overall Study||8
10781092|NCT03402932|11942957|FG003|STARTED|Overall Study||8
10781093|NCT03402932|11942954|FG000|COMPLETED|Overall Study||13
10781094|NCT03402932|11942955|FG001|COMPLETED|Overall Study||8
10781095|NCT03402932|11942956|FG002|COMPLETED|Overall Study||8
10781096|NCT03402932|11942957|FG003|COMPLETED|Overall Study||8
10781097|NCT03402932|11942954|FG000|NOT COMPLETED|Overall Study||0
10781098|NCT03402932|11942955|FG001|NOT COMPLETED|Overall Study||0
10781099|NCT03402932|11942956|FG002|NOT COMPLETED|Overall Study||0
10781100|NCT03402932|11942957|FG003|NOT COMPLETED|Overall Study||0
10781101|NCT03403036|11942971|FG000|STARTED|Overall Study||39
10781102|NCT03403036|11942971|FG000|COMPLETED|Overall Study||34
10781103|NCT03403036|11942971|FG000|NOT COMPLETED|Overall Study||5
10781104|NCT03403192|11942979|FG000|STARTED|Overall Study||41
10781105|NCT03403192|11942980|FG001|STARTED|Overall Study||40
10781106|NCT03403192|11942981|FG002|STARTED|Overall Study||40
10781107|NCT03403192|11942982|FG003|STARTED|Overall Study||42
10781108|NCT03403192|11942979|FG000|COMPLETED|Overall Study||37
10781109|NCT03403192|11942980|FG001|COMPLETED|Overall Study||36
10781110|NCT03403192|11942981|FG002|COMPLETED|Overall Study||37
10781111|NCT03403192|11942982|FG003|COMPLETED|Overall Study||36
10781112|NCT03403192|11942979|FG000|NOT COMPLETED|Overall Study||4
10781113|NCT03403192|11942980|FG001|NOT COMPLETED|Overall Study||4
10781114|NCT03403192|11942981|FG002|NOT COMPLETED|Overall Study||3
10781115|NCT03403192|11942982|FG003|NOT COMPLETED|Overall Study||6
10781116|NCT03403231|11943008|FG000|STARTED|Overall Study||9
10781117|NCT03403231|11943009|FG001|STARTED|Overall Study||9
10781118|NCT03403231|11943010|FG002|STARTED|Overall Study||9
10781119|NCT03403231|11943011|FG003|STARTED|Overall Study||9
10781120|NCT03403231|11943012|FG004|STARTED|Overall Study||9
10781121|NCT03403231|11943013|FG005|STARTED|Overall Study||9
10781122|NCT03403231|11943014|FG006|STARTED|Overall Study||9
10781123|NCT03403231|11943015|FG007|STARTED|Overall Study||9
10781124|NCT03403231|11943016|FG008|STARTED|Overall Study||9
10781125|NCT03403231|11943017|FG009|STARTED|Overall Study||9
10781126|NCT03403231|11943018|FG010|STARTED|Overall Study||9
10781127|NCT03403231|11943019|FG011|STARTED|Overall Study||9
10781128|NCT03403231|11943020|FG012|STARTED|Overall Study||9
10781129|NCT03403231|11943021|FG013|STARTED|Overall Study||9
10781130|NCT03403231|11943022|FG014|STARTED|Overall Study||9
10781131|NCT03403231|11943023|FG015|STARTED|Overall Study||9
10781132|NCT03403231|11943008|FG000|COMPLETED|Overall Study||9
10781133|NCT03403231|11943009|FG001|COMPLETED|Overall Study||9
10781134|NCT03403231|11943010|FG002|COMPLETED|Overall Study||9
10781135|NCT03403231|11943011|FG003|COMPLETED|Overall Study||9
10781136|NCT03403231|11943012|FG004|COMPLETED|Overall Study||9
10781137|NCT03403231|11943013|FG005|COMPLETED|Overall Study||9
10781138|NCT03403231|11943014|FG006|COMPLETED|Overall Study||9
10781139|NCT03403231|11943015|FG007|COMPLETED|Overall Study||9
10781140|NCT03403231|11943016|FG008|COMPLETED|Overall Study||9
10781141|NCT03403231|11943017|FG009|COMPLETED|Overall Study||9
10781142|NCT03403231|11943018|FG010|COMPLETED|Overall Study||9
10432269|NCT00879684|11578426|FG004|COMPLETED|Stage 2: Expanded Cohort||0
10781143|NCT03403231|11943019|FG011|COMPLETED|Overall Study||9
10781144|NCT03403231|11943020|FG012|COMPLETED|Overall Study||9
10781145|NCT03403231|11943021|FG013|COMPLETED|Overall Study||9
10781146|NCT03403231|11943022|FG014|COMPLETED|Overall Study||9
10781147|NCT03403231|11943023|FG015|COMPLETED|Overall Study||9
10781148|NCT03403231|11943008|FG000|NOT COMPLETED|Overall Study||0
10781149|NCT03403231|11943009|FG001|NOT COMPLETED|Overall Study||0
10432270|NCT00879684|11578427|FG005|COMPLETED|Stage 2: Expanded Cohort||0
10781150|NCT03403231|11943010|FG002|NOT COMPLETED|Overall Study||0
10781151|NCT03403231|11943011|FG003|NOT COMPLETED|Overall Study||0
10781152|NCT03403231|11943012|FG004|NOT COMPLETED|Overall Study||0
10781153|NCT03403231|11943013|FG005|NOT COMPLETED|Overall Study||0
10781154|NCT03403231|11943014|FG006|NOT COMPLETED|Overall Study||0
10781155|NCT03403231|11943015|FG007|NOT COMPLETED|Overall Study||0
10781156|NCT03403231|11943016|FG008|NOT COMPLETED|Overall Study||0
10781157|NCT03403231|11943017|FG009|NOT COMPLETED|Overall Study||0
10781158|NCT03403231|11943018|FG010|NOT COMPLETED|Overall Study||0
10781159|NCT03403231|11943019|FG011|NOT COMPLETED|Overall Study||0
10781160|NCT03403231|11943020|FG012|NOT COMPLETED|Overall Study||0
10432271|NCT00879684|11578428|FG006|COMPLETED|Stage 2: Expanded Cohort||0
10432272|NCT00879684|11578422|FG000|NOT COMPLETED|Stage 2: Expanded Cohort||0
10781161|NCT03403231|11943021|FG013|NOT COMPLETED|Overall Study||0
10781162|NCT03403231|11943022|FG014|NOT COMPLETED|Overall Study||0
10781163|NCT03403231|11943023|FG015|NOT COMPLETED|Overall Study||0
10781164|NCT03403374|11943057|FG000|STARTED|Overall Study||30
10781165|NCT03403374|11943057|FG000|COMPLETED|Overall Study||29
10781166|NCT03403374|11943057|FG000|NOT COMPLETED|Overall Study||1
10781167|NCT03403400|11943064|FG000|STARTED|Overall Study||5
10781168|NCT03403400|11943065|FG001|STARTED|Overall Study||6
10781169|NCT03403400|11943066|FG002|STARTED|Overall Study||6
10781170|NCT03403400|11943064|FG000|COMPLETED|Overall Study||3
10781171|NCT03403400|11943065|FG001|COMPLETED|Overall Study||6
10432273|NCT00879684|11578423|FG001|NOT COMPLETED|Stage 2: Expanded Cohort||0
10432274|NCT00879684|11578424|FG002|NOT COMPLETED|Stage 2: Expanded Cohort||0
10432275|NCT00879684|11578425|FG003|NOT COMPLETED|Stage 2: Expanded Cohort||0
10432276|NCT00879684|11578426|FG004|NOT COMPLETED|Stage 2: Expanded Cohort||0
10432277|NCT00879684|11578427|FG005|NOT COMPLETED|Stage 2: Expanded Cohort||0
10432278|NCT00879684|11578428|FG006|NOT COMPLETED|Stage 2: Expanded Cohort||13
10432279|NCT00879697|11578449|FG000|STARTED|Overall Study|Seventeen patients achieved inclusion and exclusion criteria|17
10432280|NCT00879697|11578450|FG001|STARTED|Overall Study|Seventeen patients achieved inclusion and exclusion criteria|17
10432281|NCT00879697|11578449|FG000|COMPLETED|Overall Study|Two patients did not finish the trial|15
10432282|NCT00879697|11578450|FG001|COMPLETED|Overall Study|Two patients did not finish the trial|15
10432283|NCT00879697|11578449|FG000|NOT COMPLETED|Overall Study||2
10432284|NCT00879697|11578450|FG001|NOT COMPLETED|Overall Study||2
10432285|NCT00879710|11578458|FG000|STARTED|Phase 1 - 6 Weeks|Started with simvastatin 40 mg as the starting drug|12
10432286|NCT00879710|11578459|FG001|STARTED|Phase 1 - 6 Weeks|Started with simvastatin 40 mg as the starting drug|17
10432287|NCT00879710|11578460|FG002|STARTED|Phase 1 - 6 Weeks|Started with ezetimibe 10 mg as the starting drug|11
10432288|NCT00879710|11578461|FG003|STARTED|Phase 1 - 6 Weeks|Started with ezetimibe 10 mg as the starting drug|17
10432289|NCT00879710|11578458|FG000|COMPLETED|Phase 1 - 6 Weeks||10
10432290|NCT00879710|11578459|FG001|COMPLETED|Phase 1 - 6 Weeks||14
10432291|NCT00879710|11578460|FG002|COMPLETED|Phase 1 - 6 Weeks||9
10432292|NCT00879710|11578461|FG003|COMPLETED|Phase 1 - 6 Weeks||13
10432293|NCT00879710|11578458|FG000|NOT COMPLETED|Phase 1 - 6 Weeks||2
10432294|NCT00879710|11578459|FG001|NOT COMPLETED|Phase 1 - 6 Weeks||3
10432295|NCT00879710|11578460|FG002|NOT COMPLETED|Phase 1 - 6 Weeks||2
10432296|NCT00879710|11578461|FG003|NOT COMPLETED|Phase 1 - 6 Weeks||4
10432297|NCT00879710|11578458|FG000|STARTED|Wash Out Period of 4 Weeks||10
10432298|NCT00879710|11578459|FG001|STARTED|Wash Out Period of 4 Weeks||14
10432299|NCT00879710|11578460|FG002|STARTED|Wash Out Period of 4 Weeks|The person who did not complete ezetimibe arm came back to complete simvastatin arm.|10
10432300|NCT00879710|11578461|FG003|STARTED|Wash Out Period of 4 Weeks||13
10432301|NCT00879710|11578458|FG000|COMPLETED|Wash Out Period of 4 Weeks||10
10432302|NCT00879710|11578459|FG001|COMPLETED|Wash Out Period of 4 Weeks||14
10432303|NCT00879710|11578460|FG002|COMPLETED|Wash Out Period of 4 Weeks||10
10432304|NCT00879710|11578461|FG003|COMPLETED|Wash Out Period of 4 Weeks||13
10432305|NCT00879710|11578458|FG000|NOT COMPLETED|Wash Out Period of 4 Weeks||0
10432306|NCT00879710|11578459|FG001|NOT COMPLETED|Wash Out Period of 4 Weeks||0
10432307|NCT00879710|11578460|FG002|NOT COMPLETED|Wash Out Period of 4 Weeks||0
10432308|NCT00879710|11578461|FG003|NOT COMPLETED|Wash Out Period of 4 Weeks||0
10432309|NCT00879710|11578458|FG000|STARTED|Phase 2 6 Weeks||10
10432310|NCT00879710|11578459|FG001|STARTED|Phase 2 6 Weeks||14
10432311|NCT00879710|11578460|FG002|STARTED|Phase 2 6 Weeks||10
10432312|NCT00879710|11578461|FG003|STARTED|Phase 2 6 Weeks||13
10432313|NCT00879710|11578458|FG000|COMPLETED|Phase 2 6 Weeks||10
10432314|NCT00879710|11578459|FG001|COMPLETED|Phase 2 6 Weeks||14
10432315|NCT00879710|11578460|FG002|COMPLETED|Phase 2 6 Weeks||10
10432316|NCT00879710|11578461|FG003|COMPLETED|Phase 2 6 Weeks||13
10432317|NCT00879710|11578458|FG000|NOT COMPLETED|Phase 2 6 Weeks||0
10432318|NCT00879710|11578459|FG001|NOT COMPLETED|Phase 2 6 Weeks||0
10432319|NCT00879710|11578460|FG002|NOT COMPLETED|Phase 2 6 Weeks||0
10432320|NCT00879710|11578461|FG003|NOT COMPLETED|Phase 2 6 Weeks||0
10432321|NCT00879775|11578471|FG000|STARTED|Overall Study||20
10432322|NCT00879775|11578472|FG001|STARTED|Overall Study||21
10432323|NCT00879775|11578471|FG000|COMPLETED|Overall Study||18
10432324|NCT00879775|11578472|FG001|COMPLETED|Overall Study||20
10432325|NCT00879775|11578471|FG000|NOT COMPLETED|Overall Study||2
10432326|NCT00879775|11578472|FG001|NOT COMPLETED|Overall Study||1
10432327|NCT00879814|11578482|FG000|STARTED|Overall Study||12
10432328|NCT00879814|11578483|FG001|STARTED|Overall Study||12
10781172|NCT03403400|11943066|FG002|COMPLETED|Overall Study||4
10781173|NCT03403400|11943064|FG000|NOT COMPLETED|Overall Study||2
10781174|NCT03403400|11943065|FG001|NOT COMPLETED|Overall Study||0
10781175|NCT03403400|11943066|FG002|NOT COMPLETED|Overall Study||2
10781176|NCT03403413|11943089|FG000|STARTED|Overall Study||5
10781177|NCT03403413|11943089|FG000|COMPLETED|Overall Study||3
10781178|NCT03403413|11943089|FG000|NOT COMPLETED|Overall Study||2
10432329|NCT00879814|11578484|FG002|STARTED|Overall Study||12
10781179|NCT03403426|11943095|FG000|STARTED|Overall Study||85
10781180|NCT03403426|11943095|FG000|COMPLETED|Overall Study||82
10781181|NCT03403426|11943095|FG000|NOT COMPLETED|Overall Study||3
10810517|NCT03782571|11972278|FG003|COMPLETED|Period 4||7
10810518|NCT03782571|11972275|FG000|NOT COMPLETED|Period 4||0
10432330|NCT00879814|11578485|FG003|STARTED|Overall Study||12
10432331|NCT00879814|11578482|FG000|COMPLETED|Overall Study||8
10432332|NCT00879814|11578483|FG001|COMPLETED|Overall Study||10
10432333|NCT00879814|11578484|FG002|COMPLETED|Overall Study||9
10432334|NCT00879814|11578485|FG003|COMPLETED|Overall Study||7
10432335|NCT00879814|11578482|FG000|NOT COMPLETED|Overall Study||4
10432336|NCT00879814|11578483|FG001|NOT COMPLETED|Overall Study||2
10432337|NCT00879814|11578484|FG002|NOT COMPLETED|Overall Study||3
10432338|NCT00879814|11578485|FG003|NOT COMPLETED|Overall Study||5
10432339|NCT00879879|11578495|FG000|STARTED|Overall Study||20
10432340|NCT00879879|11578495|FG000|COMPLETED|Overall Study||17
10432341|NCT00879879|11578495|FG000|NOT COMPLETED|Overall Study||3
10432342|NCT00879970|11578504|FG000|STARTED|Period 1 TZD Randomization||541
10432343|NCT00879970|11578505|FG001|STARTED|Period 1 TZD Randomization||392
10432344|NCT00879970|11578506|FG002|STARTED|Period 1 TZD Randomization||399
10432345|NCT00879970|11578507|FG003|STARTED|Period 1 TZD Randomization||0
10432346|NCT00879970|11578508|FG004|STARTED|Period 1 TZD Randomization||0
10432347|NCT00879970|11578504|FG000|COMPLETED|Period 1 TZD Randomization||533
10432348|NCT00879970|11578505|FG001|COMPLETED|Period 1 TZD Randomization||388
10432349|NCT00879970|11578506|FG002|COMPLETED|Period 1 TZD Randomization||393
10432350|NCT00879970|11578507|FG003|COMPLETED|Period 1 TZD Randomization||0
10432351|NCT00879970|11578508|FG004|COMPLETED|Period 1 TZD Randomization||0
10432352|NCT00879970|11578504|FG000|NOT COMPLETED|Period 1 TZD Randomization||8
10432353|NCT00879970|11578505|FG001|NOT COMPLETED|Period 1 TZD Randomization||4
10432354|NCT00879970|11578506|FG002|NOT COMPLETED|Period 1 TZD Randomization||6
10432355|NCT00879970|11578507|FG003|NOT COMPLETED|Period 1 TZD Randomization||0
10432356|NCT00879970|11578508|FG004|NOT COMPLETED|Period 1 TZD Randomization||0
10432357|NCT00879970|11578504|FG000|STARTED|Period 2 Vitamin D Randomization||0
10432358|NCT00879970|11578505|FG001|STARTED|Period 2 Vitamin D Randomization||0
10432359|NCT00879970|11578506|FG002|STARTED|Period 2 Vitamin D Randomization||0
10432360|NCT00879970|11578507|FG003|STARTED|Period 2 Vitamin D Randomization||614
10432361|NCT00879970|11578508|FG004|STARTED|Period 2 Vitamin D Randomization||607
10432362|NCT00879970|11578504|FG000|COMPLETED|Period 2 Vitamin D Randomization||0
10432363|NCT00879970|11578505|FG001|COMPLETED|Period 2 Vitamin D Randomization||0
10432364|NCT00879970|11578506|FG002|COMPLETED|Period 2 Vitamin D Randomization||0
10432365|NCT00879970|11578507|FG003|COMPLETED|Period 2 Vitamin D Randomization||610
10432366|NCT00879970|11578508|FG004|COMPLETED|Period 2 Vitamin D Randomization||600
10432367|NCT00879970|11578504|FG000|NOT COMPLETED|Period 2 Vitamin D Randomization||0
10432368|NCT00879970|11578505|FG001|NOT COMPLETED|Period 2 Vitamin D Randomization||0
10432369|NCT00879970|11578506|FG002|NOT COMPLETED|Period 2 Vitamin D Randomization||0
10432370|NCT00879970|11578507|FG003|NOT COMPLETED|Period 2 Vitamin D Randomization||4
10432371|NCT00879970|11578508|FG004|NOT COMPLETED|Period 2 Vitamin D Randomization||7
10432372|NCT00879996|11578528|FG000|STARTED|Overall Study||28
10432373|NCT00879996|11578529|FG001|STARTED|Overall Study||26
10432374|NCT00879996|11578528|FG000|COMPLETED|Overall Study||13
10432375|NCT00879996|11578529|FG001|COMPLETED|Overall Study||13
10432376|NCT00879996|11578528|FG000|NOT COMPLETED|Overall Study||15
10432377|NCT00879996|11578529|FG001|NOT COMPLETED|Overall Study||13
10432378|NCT00880009|11578537|FG000|STARTED|Overall Study||16
10432379|NCT00880009|11578537|FG000|COMPLETED|Overall Study||0
10432380|NCT00880009|11578537|FG000|NOT COMPLETED|Overall Study||16
10432381|NCT00880022|11578546|FG000|STARTED|Overall Study||23
10432382|NCT00880022|11578547|FG001|STARTED|Overall Study||24
10432383|NCT00880022|11578546|FG000|COMPLETED|Overall Study||21
10432384|NCT00880022|11578547|FG001|COMPLETED|Overall Study||21
10432385|NCT00880022|11578546|FG000|NOT COMPLETED|Overall Study||2
10432386|NCT00880022|11578547|FG001|NOT COMPLETED|Overall Study||3
10432387|NCT00880048|11578558|FG000|STARTED|Overall Study||116
10432388|NCT00880048|11578559|FG001|STARTED|Overall Study||115
10432389|NCT00880048|11578560|FG002|STARTED|Overall Study||112
10432390|NCT00880048|11578558|FG000|COMPLETED|Overall Study||88
10432391|NCT00880048|11578559|FG001|COMPLETED|Overall Study||82
10432392|NCT00880048|11578560|FG002|COMPLETED|Overall Study||77
10432393|NCT00880048|11578558|FG000|NOT COMPLETED|Overall Study||28
10432394|NCT00880048|11578559|FG001|NOT COMPLETED|Overall Study||33
10432395|NCT00880048|11578560|FG002|NOT COMPLETED|Overall Study||35
10432396|NCT00880087|11578570|FG000|STARTED|Overall Study|Among the 166 Started, 161 received Therapeutic Hypothermia and 5 received no treatment.|166
10432397|NCT00880087|11578571|FG001|STARTED|Overall Study|Among the 163 Started, 160 received Therapeutic Normothermia and 3 received no treatment.|163
10432398|NCT00880087|11578570|FG000|COMPLETED|Overall Study|1-year vital status available for all 166 Started patients.|166
10432399|NCT00880087|11578571|FG001|COMPLETED|Overall Study|Of 161 with 1-year vital status, 158 had received Therapeutic Normothermia, 3 received no treatment.|161
10432400|NCT00880087|11578570|FG000|NOT COMPLETED|Overall Study||0
10432401|NCT00880087|11578571|FG001|NOT COMPLETED|Overall Study||2
10432402|NCT00880100|11578577|FG000|STARTED|Baseline Phase-Usual Pancreatic Enzymes||49
10432403|NCT00880100|11578577|FG000|COMPLETED|Baseline Phase-Usual Pancreatic Enzymes||48
10432404|NCT00880100|11578577|FG000|NOT COMPLETED|Baseline Phase-Usual Pancreatic Enzymes||1
10432405|NCT00880100|11578577|FG000|STARTED|Treatment Phase With Ultrase® MT12||48
10810519|NCT03782571|11972276|FG001|NOT COMPLETED|Period 4||0
10810520|NCT03782571|11972277|FG002|NOT COMPLETED|Period 4||0
10810521|NCT03782571|11972278|FG003|NOT COMPLETED|Period 4||0
10781182|NCT03403491|11943099|FG000|STARTED|Overall Study||20
10781183|NCT03403491|11943100|FG001|STARTED|Overall Study||23
10781184|NCT03403491|11943099|FG000|COMPLETED|Overall Study||17
10781185|NCT03403491|11943100|FG001|COMPLETED|Overall Study||18
10781186|NCT03403491|11943099|FG000|NOT COMPLETED|Overall Study||3
10781187|NCT03403491|11943100|FG001|NOT COMPLETED|Overall Study||5
10781188|NCT03403504|11943109|FG000|STARTED|Period 1||12
10781189|NCT03403504|11943110|FG001|STARTED|Period 1||12
10781190|NCT03403504|11943109|FG000|COMPLETED|Period 1||12
10781191|NCT03403504|11943110|FG001|COMPLETED|Period 1||11
10781192|NCT03403504|11943109|FG000|NOT COMPLETED|Period 1||0
10781193|NCT03403504|11943110|FG001|NOT COMPLETED|Period 1||1
10781194|NCT03403504|11943109|FG000|STARTED|Period 2||12
10781195|NCT03403504|11943110|FG001|STARTED|Period 2||11
10781196|NCT03403504|11943109|FG000|COMPLETED|Period 2||12
10781197|NCT03403504|11943110|FG001|COMPLETED|Period 2||11
10432406|NCT00880100|11578577|FG000|COMPLETED|Treatment Phase With Ultrase® MT12||45
10432407|NCT00880100|11578577|FG000|NOT COMPLETED|Treatment Phase With Ultrase® MT12||3
10432408|NCT00880165|11578583|FG000|STARTED|Overall Study||148
10432409|NCT00880165|11578584|FG001|STARTED|Overall Study||148
10432410|NCT00880165|11578583|FG000|COMPLETED|Overall Study||86
10432411|NCT00880165|11578584|FG001|COMPLETED|Overall Study||98
10432412|NCT00880165|11578583|FG000|NOT COMPLETED|Overall Study||62
10432413|NCT00880165|11578584|FG001|NOT COMPLETED|Overall Study||50
10432414|NCT00880191|11578592|FG000|STARTED|Overall Study||207
10432415|NCT00880191|11578593|FG001|STARTED|Overall Study||206
10432416|NCT00880191|11578592|FG000|Available for Primary Endpoint Analysis|Overall Study||207
10432417|NCT00880191|11578593|FG001|Available for Primary Endpoint Analysis|Overall Study||206
10432418|NCT00880191|11578592|FG000|COMPLETED|Overall Study||194
10432419|NCT00880191|11578593|FG001|COMPLETED|Overall Study||198
10432420|NCT00880191|11578592|FG000|NOT COMPLETED|Overall Study||13
10432421|NCT00880191|11578593|FG001|NOT COMPLETED|Overall Study||8
10432422|NCT00880230|11578599|FG000|STARTED|Overall Study||141
10432423|NCT00880230|11578599|FG000|COMPLETED|Overall Study||134
10432424|NCT00880230|11578599|FG000|NOT COMPLETED|Overall Study||7
10432425|NCT00880256|11578603|FG000|STARTED|Overall Study||93
10432426|NCT00880256|11578603|FG000|COMPLETED|Overall Study||65
10432427|NCT00880256|11578603|FG000|NOT COMPLETED|Overall Study||28
10432428|NCT00880269|11578609|FG000|STARTED|Overall Study||32
10432429|NCT00880269|11578610|FG001|STARTED|Overall Study||27
10432430|NCT00880269|11578609|FG000|Discontinued Treatment|Overall Study||32
10432431|NCT00880269|11578610|FG001|Discontinued Treatment|Overall Study||27
10432432|NCT00880269|11578609|FG000|COMPLETED|Overall Study||0
10432433|NCT00880269|11578610|FG001|COMPLETED|Overall Study||0
10432434|NCT00880269|11578609|FG000|NOT COMPLETED|Overall Study||32
10432435|NCT00880269|11578610|FG001|NOT COMPLETED|Overall Study||27
10432436|NCT00880334|11578618|FG000|STARTED|Randomized Phase||74
10432437|NCT00880334|11578619|FG001|STARTED|Randomized Phase||75
10432438|NCT00880334|11578618|FG000|Eligible & Treated|Randomized Phase||70
10432439|NCT00880334|11578619|FG001|Eligible & Treated|Randomized Phase||72
10432440|NCT00880334|11578618|FG000|COMPLETED|Randomized Phase||70
10432441|NCT00880334|11578619|FG001|COMPLETED|Randomized Phase||35
10432442|NCT00880334|11578618|FG000|NOT COMPLETED|Randomized Phase||4
10432443|NCT00880334|11578619|FG001|NOT COMPLETED|Randomized Phase||40
10432444|NCT00880334|11578618|FG000|STARTED|Crossover Phase||0
10432445|NCT00880334|11578619|FG001|STARTED|Crossover Phase|Only participants randomized to placebo and docetaxel potentially received crossover treatment.|37
10432446|NCT00880334|11578618|FG000|COMPLETED|Crossover Phase||0
10432447|NCT00880334|11578619|FG001|COMPLETED|Crossover Phase||37
10432448|NCT00880334|11578618|FG000|NOT COMPLETED|Crossover Phase||0
10432449|NCT00880334|11578619|FG001|NOT COMPLETED|Crossover Phase||0
10432450|NCT00880360|11578629|FG000|STARTED|Overall Study||19
10432451|NCT00880360|11578629|FG000|COMPLETED|Overall Study||19
10432452|NCT00880360|11578629|FG000|NOT COMPLETED|Overall Study||0
10432453|NCT00880399|11578637|FG000|STARTED|Overall Study||108
10432454|NCT00880399|11578638|FG001|STARTED|Overall Study||113
10432455|NCT00880399|11578639|FG002|STARTED|Overall Study||107
10432456|NCT00880399|11578637|FG000|COMPLETED|Overall Study||77
10432457|NCT00880399|11578638|FG001|COMPLETED|Overall Study||84
10432458|NCT00880399|11578639|FG002|COMPLETED|Overall Study||81
10432459|NCT00880399|11578637|FG000|NOT COMPLETED|Overall Study||31
10432460|NCT00880399|11578638|FG001|NOT COMPLETED|Overall Study||29
10432461|NCT00880399|11578639|FG002|NOT COMPLETED|Overall Study||26
10432462|NCT00880425|11578647|FG000|STARTED|Overall Study||18
10432463|NCT00880425|11578648|FG001|STARTED|Overall Study||27
10432464|NCT00880425|11578647|FG000|COMPLETED|Overall Study||18
10781198|NCT03403504|11943109|FG000|NOT COMPLETED|Period 2||0
10781199|NCT03403504|11943110|FG001|NOT COMPLETED|Period 2||0
10781200|NCT03403517|11943132|FG000|STARTED|Overall Study||88
10781201|NCT03403517|11943133|FG001|STARTED|Overall Study||86
10781202|NCT03403517|11943132|FG000|COMPLETED|Overall Study||88
10781203|NCT03403517|11943133|FG001|COMPLETED|Overall Study||86
10432465|NCT00880425|11578648|FG001|COMPLETED|Overall Study||27
10432466|NCT00880425|11578647|FG000|NOT COMPLETED|Overall Study||0
10432467|NCT00880425|11578648|FG001|NOT COMPLETED|Overall Study||0
10781204|NCT03403517|11943132|FG000|NOT COMPLETED|Overall Study||0
10781205|NCT03403517|11943133|FG001|NOT COMPLETED|Overall Study||0
10432468|NCT00880464|11578654|FG000|STARTED|Overall Study||7
10432469|NCT00880464|11578654|FG000|COMPLETED|Overall Study||7
10432470|NCT00880464|11578654|FG000|NOT COMPLETED|Overall Study||0
10432471|NCT00880555|11578661|FG000|STARTED|Overall Study||23
10432472|NCT00880555|11578662|FG001|STARTED|Overall Study||40
10781206|NCT03403712|11943141|FG000|STARTED|Overall Study||200
10432473|NCT00880555|11578663|FG002|STARTED|Overall Study||11
10432474|NCT00880555|11578664|FG003|STARTED|Overall Study||2
10432475|NCT00880555|11578665|FG004|STARTED|Overall Study||1
10432476|NCT00880555|11578666|FG005|STARTED|Overall Study||1
10316321|NCT00189228|11450319|FG000|STARTED|Overall Study||18
10316322|NCT00189228|11450319|FG000|COMPLETED|Overall Study||18
10316323|NCT00189228|11450319|FG000|NOT COMPLETED|Overall Study||0
10316324|NCT00189306|11450323|FG000|STARTED|Treatment Period||169
10316325|NCT00189306|11450323|FG000|COMPLETED|Treatment Period|5 subjects discontinued during treatment - 4 subjects returned for the Posttreatment Period|164
10316326|NCT00189306|11450323|FG000|NOT COMPLETED|Treatment Period||5
10316327|NCT00189306|11450323|FG000|STARTED|Posttreatment Period|5 of the 169 discontinued, but 4 returned for the Posttreatment Period|169
10316328|NCT00189306|11450323|FG000|COMPLETED|Posttreatment Period|11 subjects discontinued during the 12-week Posttreatment Period|157
10316329|NCT00189306|11450323|FG000|NOT COMPLETED|Posttreatment Period||12
10316330|NCT00189306|11450323|FG000|STARTED|Long-Term Follow-up||157
10316331|NCT00189306|11450323|FG000|COMPLETED|Long-Term Follow-up||119
10316332|NCT00189306|11450323|FG000|NOT COMPLETED|Long-Term Follow-up||38
10316333|NCT00189423|11450329|FG000|STARTED|Overall Study||813
10316334|NCT00189423|11450330|FG001|STARTED|Overall Study||840
10781207|NCT03403712|11943142|FG001|STARTED|Overall Study||202
10781208|NCT03403712|11943141|FG000|COMPLETED|Overall Study||95
10781209|NCT03403712|11943142|FG001|COMPLETED|Overall Study||102
10781210|NCT03403712|11943141|FG000|NOT COMPLETED|Overall Study||105
10781211|NCT03403712|11943142|FG001|NOT COMPLETED|Overall Study||100
10781212|NCT03403725|11943159|FG000|STARTED|Overall Study||1
10781213|NCT03403725|11943160|FG001|STARTED|Overall Study||1
10781214|NCT03403725|11943161|FG002|STARTED|Overall Study||1
10781215|NCT03403725|11943162|FG003|STARTED|Overall Study||1
10781216|NCT03403725|11943163|FG004|STARTED|Overall Study||1
10781217|NCT03403725|11943164|FG005|STARTED|Overall Study||6
10781218|NCT03403725|11943165|FG006|STARTED|Overall Study||6
10781219|NCT03403725|11943166|FG007|STARTED|Overall Study||3
10781220|NCT03403725|11943167|FG008|STARTED|Overall Study||3
10781221|NCT03403725|11943168|FG009|STARTED|Overall Study||4
10781222|NCT03403725|11943169|FG010|STARTED|Overall Study||1
10781223|NCT03403725|11943159|FG000|COMPLETED|Overall Study||1
10781224|NCT03403725|11943160|FG001|COMPLETED|Overall Study||1
10781225|NCT03403725|11943161|FG002|COMPLETED|Overall Study||1
10781226|NCT03403725|11943162|FG003|COMPLETED|Overall Study||1
10781227|NCT03403725|11943163|FG004|COMPLETED|Overall Study||1
10781228|NCT03403725|11943164|FG005|COMPLETED|Overall Study||6
10781229|NCT03403725|11943165|FG006|COMPLETED|Overall Study||6
10781230|NCT03403725|11943166|FG007|COMPLETED|Overall Study||3
10781231|NCT03403725|11943167|FG008|COMPLETED|Overall Study||3
10781232|NCT03403725|11943168|FG009|COMPLETED|Overall Study||4
10781233|NCT03403725|11943169|FG010|COMPLETED|Overall Study||1
10781234|NCT03403725|11943159|FG000|NOT COMPLETED|Overall Study||0
10781235|NCT03403725|11943160|FG001|NOT COMPLETED|Overall Study||0
10781236|NCT03403725|11943161|FG002|NOT COMPLETED|Overall Study||0
10781237|NCT03403725|11943162|FG003|NOT COMPLETED|Overall Study||0
10781238|NCT03403725|11943163|FG004|NOT COMPLETED|Overall Study||0
10432477|NCT00880555|11578661|FG000|COMPLETED|Overall Study||13
10432478|NCT00880555|11578662|FG001|COMPLETED|Overall Study||23
10432479|NCT00880555|11578663|FG002|COMPLETED|Overall Study||6
10432480|NCT00880555|11578664|FG003|COMPLETED|Overall Study||0
10432481|NCT00880555|11578665|FG004|COMPLETED|Overall Study||0
10432482|NCT00880555|11578666|FG005|COMPLETED|Overall Study||0
10432483|NCT00880555|11578661|FG000|NOT COMPLETED|Overall Study||10
10432484|NCT00880555|11578662|FG001|NOT COMPLETED|Overall Study||17
10432485|NCT00880555|11578663|FG002|NOT COMPLETED|Overall Study||5
10432486|NCT00880555|11578664|FG003|NOT COMPLETED|Overall Study||2
10432487|NCT00880555|11578665|FG004|NOT COMPLETED|Overall Study||1
10432488|NCT00880555|11578666|FG005|NOT COMPLETED|Overall Study||1
10432489|NCT00880568|11578686|FG000|STARTED|Overall Study||3
10432490|NCT00880568|11578687|FG001|STARTED|Overall Study||3
10432491|NCT00880568|11578688|FG002|STARTED|Overall Study||3
10432492|NCT00880568|11578689|FG003|STARTED|Overall Study||1
10432493|NCT00880568|11578690|FG004|STARTED|Overall Study||3
10432494|NCT00880568|11578691|FG005|STARTED|Overall Study||3
10781239|NCT03403725|11943164|FG005|NOT COMPLETED|Overall Study||0
10781240|NCT03403725|11943165|FG006|NOT COMPLETED|Overall Study||0
10781241|NCT03403725|11943166|FG007|NOT COMPLETED|Overall Study||0
10781242|NCT03403725|11943167|FG008|NOT COMPLETED|Overall Study||0
10781243|NCT03403725|11943168|FG009|NOT COMPLETED|Overall Study||0
10432495|NCT00880568|11578692|FG006|STARTED|Overall Study||6
10432496|NCT00880568|11578693|FG007|STARTED|Overall Study||2
10432497|NCT00880568|11578694|FG008|STARTED|Overall Study||3
10432498|NCT00880568|11578686|FG000|COMPLETED|Overall Study||0
10432499|NCT00880568|11578687|FG001|COMPLETED|Overall Study||0
10432500|NCT00880568|11578688|FG002|COMPLETED|Overall Study||0
10432501|NCT00880568|11578689|FG003|COMPLETED|Overall Study||0
10432502|NCT00880568|11578690|FG004|COMPLETED|Overall Study||0
10432503|NCT00880568|11578691|FG005|COMPLETED|Overall Study||0
10432504|NCT00880568|11578692|FG006|COMPLETED|Overall Study||0
10432505|NCT00880568|11578693|FG007|COMPLETED|Overall Study||0
10432506|NCT00880568|11578694|FG008|COMPLETED|Overall Study||0
10432507|NCT00880568|11578686|FG000|NOT COMPLETED|Overall Study||3
10432508|NCT00880568|11578687|FG001|NOT COMPLETED|Overall Study||3
10432509|NCT00880568|11578688|FG002|NOT COMPLETED|Overall Study||3
10432510|NCT00880568|11578689|FG003|NOT COMPLETED|Overall Study||1
10432511|NCT00880568|11578690|FG004|NOT COMPLETED|Overall Study||3
10432512|NCT00880568|11578691|FG005|NOT COMPLETED|Overall Study||3
10432513|NCT00880568|11578692|FG006|NOT COMPLETED|Overall Study||6
10432514|NCT00880568|11578693|FG007|NOT COMPLETED|Overall Study||2
10432515|NCT00880568|11578694|FG008|NOT COMPLETED|Overall Study||3
10432516|NCT00880581|11578719|FG000|STARTED|Cycle 1||30
10432517|NCT00880581|11578719|FG000|COMPLETED|Cycle 1||30
10432518|NCT00880581|11578719|FG000|NOT COMPLETED|Cycle 1||0
10432519|NCT00880581|11578719|FG000|STARTED|Cycle 2 Re-treatment|6 subjects with progessive disease were not treated and evaluated in Cycle 2|24
10432520|NCT00880581|11578719|FG000|COMPLETED|Cycle 2 Re-treatment||24
10781244|NCT03403725|11943169|FG010|NOT COMPLETED|Overall Study||0
10781245|NCT03403751|11943197|FG000|STARTED|Overall Study||28
10781246|NCT03403751|11943198|FG001|STARTED|Overall Study||30
10781247|NCT03403751|11943197|FG000|COMPLETED|Overall Study||21
10781248|NCT03403751|11943198|FG001|COMPLETED|Overall Study||22
10781249|NCT03403751|11943197|FG000|NOT COMPLETED|Overall Study||7
10432521|NCT00880581|11578719|FG000|NOT COMPLETED|Cycle 2 Re-treatment||0
10432522|NCT00880607|11578725|FG000|STARTED|Overall Study||44
10432523|NCT00880607|11578726|FG001|STARTED|Overall Study||37
10432524|NCT00880607|11578725|FG000|Observation After Receiving Medication|Overall Study||42
10781250|NCT03403751|11943198|FG001|NOT COMPLETED|Overall Study||8
10781251|NCT03404167|11943206|FG000|STARTED|Overall Study||8
10781252|NCT03404167|11943206|FG000|COMPLETED|Overall Study||8
10781253|NCT03404167|11943206|FG000|NOT COMPLETED|Overall Study||0
10781254|NCT03404206|11943215|FG000|STARTED|Overall Study||166
10781255|NCT03404206|11943216|FG001|STARTED|Overall Study||166
10781256|NCT03404206|11943217|FG002|STARTED|Overall Study||55
10781257|NCT03404206|11943215|FG000|COMPLETED|Overall Study||162
10781258|NCT03404206|11943216|FG001|COMPLETED|Overall Study||164
10781259|NCT03404206|11943217|FG002|COMPLETED|Overall Study||55
10781260|NCT03404206|11943215|FG000|NOT COMPLETED|Overall Study||4
10781261|NCT03404206|11943216|FG001|NOT COMPLETED|Overall Study||2
10781262|NCT03404206|11943217|FG002|NOT COMPLETED|Overall Study||0
10781263|NCT03404219|11943225|FG000|STARTED|Overall Study||31
10781264|NCT03404219|11943225|FG000|COMPLETED|Overall Study||31
10781265|NCT03404219|11943225|FG000|NOT COMPLETED|Overall Study||0
10781266|NCT03404375|11943232|FG000|STARTED|Overall Study||70
10781267|NCT03404375|11943233|FG001|STARTED|Overall Study||172
10781268|NCT03404375|11943232|FG000|COMPLETED|Overall Study||70
10781269|NCT03404375|11943233|FG001|COMPLETED|Overall Study||172
10781270|NCT03404375|11943232|FG000|NOT COMPLETED|Overall Study||0
10781271|NCT03404375|11943233|FG001|NOT COMPLETED|Overall Study||0
10781272|NCT03404401|11943241|FG000|STARTED|Overall Study||281
10781273|NCT03404401|11943242|FG001|STARTED|Overall Study||271
10781274|NCT03404401|11943241|FG000|COMPLETED|Overall Study||263
10781275|NCT03404401|11943242|FG001|COMPLETED|Overall Study||252
10781276|NCT03404401|11943241|FG000|NOT COMPLETED|Overall Study||18
10781277|NCT03404401|11943242|FG001|NOT COMPLETED|Overall Study||19
10432525|NCT00880607|11578726|FG001|Observation After Receiving Medication|Overall Study||35
10432526|NCT00880607|11578725|FG000|COMPLETED|Overall Study||37
10432527|NCT00880607|11578726|FG001|COMPLETED|Overall Study||34
10432528|NCT00880607|11578725|FG000|NOT COMPLETED|Overall Study||7
10432529|NCT00880607|11578726|FG001|NOT COMPLETED|Overall Study||3
10432530|NCT00880620|11578738|FG000|STARTED|Overall Study||92
10432531|NCT00880620|11578739|FG001|STARTED|Overall Study||87
10432532|NCT00880620|11578740|FG002|STARTED|Overall Study||104
10432533|NCT00880620|11578741|FG003|STARTED|Overall Study||98
10432534|NCT00880620|11578738|FG000|Week 4|Overall Study||88
10432535|NCT00880620|11578739|FG001|Week 4|Overall Study||79
10432536|NCT00880620|11578740|FG002|Week 4|Overall Study||94
10432537|NCT00880620|11578741|FG003|Week 4|Overall Study||86
10432538|NCT00880620|11578738|FG000|Week 9|Overall Study||80
10432539|NCT00880620|11578739|FG001|Week 9|Overall Study||73
10432540|NCT00880620|11578740|FG002|Week 9|Overall Study||88
10432541|NCT00880620|11578741|FG003|Week 9|Overall Study||78
10432542|NCT00880620|11578738|FG000|Week 16|Overall Study||74
10432543|NCT00880620|11578739|FG001|Week 16|Overall Study||73
10432544|NCT00880620|11578740|FG002|Week 16|Overall Study||87
10432545|NCT00880620|11578741|FG003|Week 16|Overall Study||74
10432546|NCT00880620|11578738|FG000|Week 23|Overall Study||71
10432547|NCT00880620|11578739|FG001|Week 23|Overall Study||72
10432548|NCT00880620|11578740|FG002|Week 23|Overall Study||85
10432549|NCT00880620|11578741|FG003|Week 23|Overall Study||74
10432550|NCT00880620|11578738|FG000|COMPLETED|Overall Study||71
10432551|NCT00880620|11578739|FG001|COMPLETED|Overall Study||72
10432552|NCT00880620|11578740|FG002|COMPLETED|Overall Study||83
10432553|NCT00880620|11578741|FG003|COMPLETED|Overall Study||74
10432554|NCT00880620|11578738|FG000|NOT COMPLETED|Overall Study||21
10432555|NCT00880620|11578739|FG001|NOT COMPLETED|Overall Study||15
10432556|NCT00880620|11578740|FG002|NOT COMPLETED|Overall Study||21
10432557|NCT00880620|11578741|FG003|NOT COMPLETED|Overall Study||24
10432558|NCT00880685|11578755|FG000|STARTED|Memantine 10mg||12
10432559|NCT00880685|11578755|FG000|COMPLETED|Memantine 10mg||10
10432560|NCT00880685|11578755|FG000|NOT COMPLETED|Memantine 10mg||2
10432561|NCT00880685|11578755|FG000|STARTED|Memantine 20mg||10
10432562|NCT00880685|11578755|FG000|COMPLETED|Memantine 20mg||9
10432563|NCT00880685|11578755|FG000|NOT COMPLETED|Memantine 20mg||1
10432564|NCT00880685|11578755|FG000|STARTED|Memantine 30mg||9
10432565|NCT00880685|11578755|FG000|COMPLETED|Memantine 30mg||9
10432566|NCT00880685|11578755|FG000|NOT COMPLETED|Memantine 30mg||0
10432567|NCT00880698|11578766|FG000|STARTED|Overall Study||62
10432568|NCT00880698|11578767|FG001|STARTED|Overall Study||64
10432569|NCT00880698|11578768|FG002|STARTED|Overall Study||37
10432570|NCT00880698|11578769|FG003|STARTED|Overall Study||39
10432571|NCT00880698|11578766|FG000|COMPLETED|Overall Study||61
10432572|NCT00880698|11578767|FG001|COMPLETED|Overall Study||61
10432573|NCT00880698|11578768|FG002|COMPLETED|Overall Study||36
10432574|NCT00880698|11578769|FG003|COMPLETED|Overall Study||36
10432575|NCT00880698|11578766|FG000|NOT COMPLETED|Overall Study||1
10432576|NCT00880698|11578767|FG001|NOT COMPLETED|Overall Study||3
10432577|NCT00880698|11578768|FG002|NOT COMPLETED|Overall Study||1
10432578|NCT00880698|11578769|FG003|NOT COMPLETED|Overall Study||3
10781278|NCT03404609|11943248|FG000|STARTED|Overall Study||7
10432579|NCT00880750|11578783|FG000|STARTED|First Intervention||39
10432580|NCT00880750|11578784|FG001|STARTED|First Intervention||33
10432581|NCT00880750|11578783|FG000|COMPLETED|First Intervention||30
10432582|NCT00880750|11578784|FG001|COMPLETED|First Intervention||32
10432583|NCT00880750|11578783|FG000|NOT COMPLETED|First Intervention||9
10432584|NCT00880750|11578784|FG001|NOT COMPLETED|First Intervention||1
10432585|NCT00880750|11578783|FG000|STARTED|Washout Period||30
10432586|NCT00880750|11578784|FG001|STARTED|Washout Period||32
10781279|NCT03404609|11943248|FG000|COMPLETED|Overall Study||7
10781280|NCT03404609|11943248|FG000|NOT COMPLETED|Overall Study||0
10781281|NCT03404648|11943252|FG000|STARTED|Overall Study||19
10781282|NCT03404648|11943252|FG000|COMPLETED|Overall Study||19
10781283|NCT03404648|11943252|FG000|NOT COMPLETED|Overall Study||0
10781284|NCT03404674|11943262|FG000|STARTED|Overall Study||5
10781285|NCT03404674|11943263|FG001|STARTED|Overall Study||5
10781286|NCT03404674|11943264|FG002|STARTED|Overall Study||10
10781287|NCT03404674|11943265|FG003|STARTED|Overall Study||10
10781288|NCT03404674|11943266|FG004|STARTED|Overall Study||10
10781289|NCT03404674|11943267|FG005|STARTED|Overall Study||10
10781290|NCT03404674|11943262|FG000|Received Dose 2|Overall Study||5
10781291|NCT03404674|11943263|FG001|Received Dose 2|Overall Study||4
10781292|NCT03404674|11943264|FG002|Received Dose 2|Overall Study||10
10781293|NCT03404674|11943265|FG003|Received Dose 2|Overall Study||9
10781294|NCT03404674|11943266|FG004|Received Dose 2|Overall Study||10
10781295|NCT03404674|11943267|FG005|Received Dose 2|Overall Study||10
10781296|NCT03404674|11943262|FG000|Received Dose 3|Overall Study||5
10781297|NCT03404674|11943263|FG001|Received Dose 3|Overall Study||4
10432587|NCT00880750|11578783|FG000|COMPLETED|Washout Period||30
10432588|NCT00880750|11578784|FG001|COMPLETED|Washout Period||32
10432589|NCT00880750|11578783|FG000|NOT COMPLETED|Washout Period||0
10432590|NCT00880750|11578784|FG001|NOT COMPLETED|Washout Period||0
10432591|NCT00880750|11578783|FG000|STARTED|Second Intervention||30
10432592|NCT00880750|11578784|FG001|STARTED|Second Intervention||32
10432593|NCT00880750|11578783|FG000|COMPLETED|Second Intervention||26
10432594|NCT00880750|11578784|FG001|COMPLETED|Second Intervention||30
10432595|NCT00880750|11578783|FG000|NOT COMPLETED|Second Intervention||4
10432596|NCT00880750|11578784|FG001|NOT COMPLETED|Second Intervention||2
10432597|NCT00880763|11578794|FG000|STARTED|Initial Treatment Period (Part 1)||23
10432598|NCT00880763|11578795|FG001|STARTED|Initial Treatment Period (Part 1)||22
10432599|NCT00880763|11578796|FG002|STARTED|Initial Treatment Period (Part 1)||23
10432600|NCT00880763|11578797|FG003|STARTED|Initial Treatment Period (Part 1)||22
10432601|NCT00880763|11578794|FG000|COMPLETED|Initial Treatment Period (Part 1)||23
10432602|NCT00880763|11578795|FG001|COMPLETED|Initial Treatment Period (Part 1)||22
10432603|NCT00880763|11578796|FG002|COMPLETED|Initial Treatment Period (Part 1)||23
10432604|NCT00880763|11578797|FG003|COMPLETED|Initial Treatment Period (Part 1)||22
10432605|NCT00880763|11578794|FG000|NOT COMPLETED|Initial Treatment Period (Part 1)||0
10432606|NCT00880763|11578795|FG001|NOT COMPLETED|Initial Treatment Period (Part 1)||0
10432607|NCT00880763|11578796|FG002|NOT COMPLETED|Initial Treatment Period (Part 1)||0
10432608|NCT00880763|11578797|FG003|NOT COMPLETED|Initial Treatment Period (Part 1)||0
10432609|NCT00880763|11578794|FG000|STARTED|Extension Period (Part 2)||23
10432610|NCT00880763|11578795|FG001|STARTED|Extension Period (Part 2)||22
10432611|NCT00880763|11578796|FG002|STARTED|Extension Period (Part 2)||23
10432612|NCT00880763|11578797|FG003|STARTED|Extension Period (Part 2)||22
10432613|NCT00880763|11578794|FG000|COMPLETED|Extension Period (Part 2)||23
10432614|NCT00880763|11578795|FG001|COMPLETED|Extension Period (Part 2)||19
10432615|NCT00880763|11578796|FG002|COMPLETED|Extension Period (Part 2)||20
10432616|NCT00880763|11578797|FG003|COMPLETED|Extension Period (Part 2)||19
10432617|NCT00880763|11578794|FG000|NOT COMPLETED|Extension Period (Part 2)||0
10432618|NCT00880763|11578795|FG001|NOT COMPLETED|Extension Period (Part 2)||3
10432619|NCT00880763|11578796|FG002|NOT COMPLETED|Extension Period (Part 2)||3
10432620|NCT00880763|11578797|FG003|NOT COMPLETED|Extension Period (Part 2)||3
10432621|NCT00880906|11578809|FG000|STARTED|Overall Study||29
10432622|NCT00880906|11578810|FG001|STARTED|Overall Study||21
10432623|NCT00880906|11578809|FG000|COMPLETED|Overall Study||17
10432624|NCT00880906|11578810|FG001|COMPLETED|Overall Study||14
10432625|NCT00880906|11578809|FG000|NOT COMPLETED|Overall Study||12
10432626|NCT00880906|11578810|FG001|NOT COMPLETED|Overall Study||7
10432627|NCT00880919|11578819|FG000|STARTED|Overall Study||33
10432628|NCT00880919|11578820|FG001|STARTED|Overall Study||33
10432629|NCT00880919|11578821|FG002|STARTED|Overall Study||29
10432630|NCT00880919|11578819|FG000|COMPLETED|Overall Study||18
10432631|NCT00880919|11578820|FG001|COMPLETED|Overall Study||19
10432632|NCT00880919|11578821|FG002|COMPLETED|Overall Study||23
10432633|NCT00880919|11578819|FG000|NOT COMPLETED|Overall Study||15
10432634|NCT00880919|11578820|FG001|NOT COMPLETED|Overall Study||14
10432635|NCT00880919|11578821|FG002|NOT COMPLETED|Overall Study||6
10432636|NCT00880997|11578835|FG000|STARTED|Overall Study||9
10432637|NCT00880997|11578836|FG001|STARTED|Overall Study||8
10432638|NCT00880997|11578837|FG002|STARTED|Overall Study||13
10432639|NCT00880997|11578835|FG000|COMPLETED|Overall Study||6
10432640|NCT00880997|11578836|FG001|COMPLETED|Overall Study||6
10432641|NCT00880997|11578837|FG002|COMPLETED|Overall Study||5
10432642|NCT00880997|11578835|FG000|NOT COMPLETED|Overall Study||3
10432643|NCT00880997|11578836|FG001|NOT COMPLETED|Overall Study||2
10432644|NCT00880997|11578837|FG002|NOT COMPLETED|Overall Study||8
10432645|NCT00881335|11578847|FG000|STARTED|Overall Study||30
10432646|NCT00881335|11578848|FG001|STARTED|Overall Study||30
10432647|NCT00881335|11578847|FG000|COMPLETED|Overall Study|3 participants did not complete the period|27
10432648|NCT00881335|11578848|FG001|COMPLETED|Overall Study|2 participants did not complete the period|28
10432649|NCT00881335|11578847|FG000|NOT COMPLETED|Overall Study||3
10432650|NCT00881335|11578848|FG001|NOT COMPLETED|Overall Study||2
10781298|NCT03404674|11943264|FG002|Received Dose 3|Overall Study||9
10781299|NCT03404674|11943265|FG003|Received Dose 3|Overall Study||9
10781300|NCT03404674|11943266|FG004|Received Dose 3|Overall Study||10
10432651|NCT00881361|11578856|FG000|STARTED|Overall Study||707
10432652|NCT00881361|11578857|FG001|STARTED|Overall Study||47
10432653|NCT00881361|11578858|FG002|STARTED|Overall Study||2
10432654|NCT00881361|11578856|FG000|COMPLETED|Overall Study||663
10432655|NCT00881361|11578857|FG001|COMPLETED|Overall Study||38
10432656|NCT00881361|11578858|FG002|COMPLETED|Overall Study||0
10432657|NCT00881361|11578856|FG000|NOT COMPLETED|Overall Study||44
10781301|NCT03404674|11943267|FG005|Received Dose 3|Overall Study||9
10781302|NCT03404674|11943262|FG000|COMPLETED|Overall Study||5
10781303|NCT03404674|11943263|FG001|COMPLETED|Overall Study||4
10781304|NCT03404674|11943264|FG002|COMPLETED|Overall Study||8
10781305|NCT03404674|11943265|FG003|COMPLETED|Overall Study||9
10781306|NCT03404674|11943266|FG004|COMPLETED|Overall Study||10
10781307|NCT03404674|11943267|FG005|COMPLETED|Overall Study||9
10781308|NCT03404674|11943262|FG000|NOT COMPLETED|Overall Study||0
10781309|NCT03404674|11943263|FG001|NOT COMPLETED|Overall Study||1
10781310|NCT03404674|11943264|FG002|NOT COMPLETED|Overall Study||2
10781311|NCT03404674|11943265|FG003|NOT COMPLETED|Overall Study||1
10781312|NCT03404674|11943266|FG004|NOT COMPLETED|Overall Study||0
10781313|NCT03404674|11943267|FG005|NOT COMPLETED|Overall Study||1
10781314|NCT03404843|11943284|FG000|STARTED|Overall Study||17
10781315|NCT03404843|11943285|FG001|STARTED|Overall Study||14
10781316|NCT03404843|11943284|FG000|COMPLETED|Overall Study||13
10781317|NCT03404843|11943285|FG001|COMPLETED|Overall Study||13
10781318|NCT03404843|11943284|FG000|NOT COMPLETED|Overall Study||4
10781319|NCT03404843|11943285|FG001|NOT COMPLETED|Overall Study||1
10781320|NCT03405259|11943297|FG000|STARTED|Overall Study||11
10781321|NCT03405259|11943298|FG001|STARTED|Overall Study||11
10781322|NCT03405259|11943297|FG000|COMPLETED|Overall Study||11
10781323|NCT03405259|11943298|FG001|COMPLETED|Overall Study||11
10781324|NCT03405259|11943297|FG000|NOT COMPLETED|Overall Study||0
10781325|NCT03405259|11943298|FG001|NOT COMPLETED|Overall Study||0
10781326|NCT03405363|11943306|FG000|STARTED|Overall Study||14239
10781327|NCT03405363|11943307|FG001|STARTED|Overall Study||51167
10781328|NCT03405363|11943306|FG000|COMPLETED|Overall Study||14239
10781329|NCT03405363|11943307|FG001|COMPLETED|Overall Study||51167
10781330|NCT03405363|11943306|FG000|NOT COMPLETED|Overall Study||0
10781331|NCT03405363|11943307|FG001|NOT COMPLETED|Overall Study||0
10781332|NCT03405818|11943313|FG000|STARTED|Overall Study||55
10781333|NCT03405818|11943313|FG000|COMPLETED|Overall Study||47
10781334|NCT03405818|11943313|FG000|NOT COMPLETED|Overall Study||8
10781335|NCT03405935|11943317|FG000|STARTED|Overall Study||86
10781336|NCT03405935|11943317|FG000|COMPLETED|Overall Study||78
10781337|NCT03405935|11943317|FG000|NOT COMPLETED|Overall Study||8
10781338|NCT03406260|11943327|FG000|STARTED|Period 1||6
10781339|NCT03406260|11943328|FG001|STARTED|Period 1||6
10781340|NCT03406260|11943329|FG002|STARTED|Period 1||6
10781341|NCT03406260|11943330|FG003|STARTED|Period 1||6
10781342|NCT03406260|11943331|FG004|STARTED|Period 1||6
10781343|NCT03406260|11943332|FG005|STARTED|Period 1||6
10781344|NCT03406260|11943327|FG000|Received at Least 1 Dose of Study Drug|Period 1||6
10781345|NCT03406260|11943328|FG001|Received at Least 1 Dose of Study Drug|Period 1||6
10781346|NCT03406260|11943329|FG002|Received at Least 1 Dose of Study Drug|Period 1||6
10781347|NCT03406260|11943330|FG003|Received at Least 1 Dose of Study Drug|Period 1||6
10781348|NCT03406260|11943331|FG004|Received at Least 1 Dose of Study Drug|Period 1||6
10781349|NCT03406260|11943332|FG005|Received at Least 1 Dose of Study Drug|Period 1||6
10781350|NCT03406260|11943327|FG000|COMPLETED|Period 1||6
10781351|NCT03406260|11943328|FG001|COMPLETED|Period 1||6
10781352|NCT03406260|11943329|FG002|COMPLETED|Period 1||6
10781353|NCT03406260|11943330|FG003|COMPLETED|Period 1||6
10781354|NCT03406260|11943331|FG004|COMPLETED|Period 1||5
10781355|NCT03406260|11943332|FG005|COMPLETED|Period 1||6
10781356|NCT03406260|11943327|FG000|NOT COMPLETED|Period 1||0
10781357|NCT03406260|11943328|FG001|NOT COMPLETED|Period 1||0
10781358|NCT03406260|11943329|FG002|NOT COMPLETED|Period 1||0
10781359|NCT03406260|11943330|FG003|NOT COMPLETED|Period 1||0
10781360|NCT03406260|11943331|FG004|NOT COMPLETED|Period 1||1
10781361|NCT03406260|11943332|FG005|NOT COMPLETED|Period 1||0
10781362|NCT03406260|11943327|FG000|STARTED|Period 2||6
10781363|NCT03406260|11943328|FG001|STARTED|Period 2||6
10781364|NCT03406260|11943329|FG002|STARTED|Period 2||6
10781365|NCT03406260|11943330|FG003|STARTED|Period 2||6
10781366|NCT03406260|11943331|FG004|STARTED|Period 2||5
10781367|NCT03406260|11943332|FG005|STARTED|Period 2||6
10781368|NCT03406260|11943327|FG000|COMPLETED|Period 2||6
10781369|NCT03406260|11943328|FG001|COMPLETED|Period 2||6
10781370|NCT03406260|11943329|FG002|COMPLETED|Period 2||6
10781371|NCT03406260|11943330|FG003|COMPLETED|Period 2||6
10781372|NCT03406260|11943331|FG004|COMPLETED|Period 2||5
10781373|NCT03406260|11943332|FG005|COMPLETED|Period 2||6
10781374|NCT03406260|11943327|FG000|NOT COMPLETED|Period 2||0
10781375|NCT03406260|11943328|FG001|NOT COMPLETED|Period 2||0
10781376|NCT03406260|11943329|FG002|NOT COMPLETED|Period 2||0
10781377|NCT03406260|11943330|FG003|NOT COMPLETED|Period 2||0
10781378|NCT03406260|11943331|FG004|NOT COMPLETED|Period 2||0
10781379|NCT03406260|11943332|FG005|NOT COMPLETED|Period 2||0
10781380|NCT03406260|11943327|FG000|STARTED|Period 3||6
10781381|NCT03406260|11943328|FG001|STARTED|Period 3||6
10781382|NCT03406260|11943329|FG002|STARTED|Period 3||6
10781383|NCT03406260|11943330|FG003|STARTED|Period 3||6
10781384|NCT03406260|11943331|FG004|STARTED|Period 3||5
10781385|NCT03406260|11943332|FG005|STARTED|Period 3||6
10781386|NCT03406260|11943327|FG000|COMPLETED|Period 3||6
10781387|NCT03406260|11943328|FG001|COMPLETED|Period 3||6
10781388|NCT03406260|11943329|FG002|COMPLETED|Period 3||6
10781389|NCT03406260|11943330|FG003|COMPLETED|Period 3||6
10781390|NCT03406260|11943331|FG004|COMPLETED|Period 3||5
10781391|NCT03406260|11943332|FG005|COMPLETED|Period 3||6
10781392|NCT03406260|11943327|FG000|NOT COMPLETED|Period 3||0
10781393|NCT03406260|11943328|FG001|NOT COMPLETED|Period 3||0
10781394|NCT03406260|11943329|FG002|NOT COMPLETED|Period 3||0
10432658|NCT00881361|11578857|FG001|NOT COMPLETED|Overall Study||9
10432659|NCT00881361|11578858|FG002|NOT COMPLETED|Overall Study||2
10432660|NCT00881465|11578869|FG000|STARTED|Overall Study||16
10432661|NCT00881465|11578870|FG001|STARTED|Overall Study||15
10432662|NCT00881465|11578869|FG000|COMPLETED|Overall Study||14
10432663|NCT00881465|11578870|FG001|COMPLETED|Overall Study||15
10432664|NCT00881465|11578869|FG000|NOT COMPLETED|Overall Study||2
10432665|NCT00881465|11578870|FG001|NOT COMPLETED|Overall Study||0
10432666|NCT00881504|11578876|FG000|STARTED|Overall Study||9
10432667|NCT00881504|11578876|FG000|COMPLETED|Overall Study||8
10432668|NCT00881504|11578876|FG000|NOT COMPLETED|Overall Study||1
10432669|NCT00881530|11578886|FG000|STARTED|Overall Study||106
10432670|NCT00881530|11578887|FG001|STARTED|Overall Study||109
10432671|NCT00881530|11578888|FG002|STARTED|Overall Study||56
10432672|NCT00881530|11578889|FG003|STARTED|Overall Study||166
10432673|NCT00881530|11578890|FG004|STARTED|Overall Study||166
10432674|NCT00881530|11578891|FG005|STARTED|Overall Study||56
10432675|NCT00881530|11578886|FG000|COMPLETED|Overall Study||92
10432676|NCT00881530|11578887|FG001|COMPLETED|Overall Study||104
10432677|NCT00881530|11578888|FG002|COMPLETED|Overall Study||51
10432678|NCT00881530|11578889|FG003|COMPLETED|Overall Study||157
10432679|NCT00881530|11578890|FG004|COMPLETED|Overall Study||152
10432680|NCT00881530|11578891|FG005|COMPLETED|Overall Study||51
10432681|NCT00881530|11578886|FG000|NOT COMPLETED|Overall Study||14
10432682|NCT00881530|11578887|FG001|NOT COMPLETED|Overall Study||5
10432683|NCT00881530|11578888|FG002|NOT COMPLETED|Overall Study||5
10432684|NCT00881530|11578889|FG003|NOT COMPLETED|Overall Study||9
10432685|NCT00881530|11578890|FG004|NOT COMPLETED|Overall Study||14
10432686|NCT00881530|11578891|FG005|NOT COMPLETED|Overall Study||5
10432687|NCT00881569|11578907|FG000|STARTED|Overall Study||1
10432688|NCT00881569|11578908|FG001|STARTED|Overall Study||1
10316335|NCT00189423|11450329|FG000|COMPLETED|Overall Study||48
10316336|NCT00189423|11450330|FG001|COMPLETED|Overall Study||74
10316337|NCT00189423|11450329|FG000|NOT COMPLETED|Overall Study||765
10316338|NCT00189423|11450330|FG001|NOT COMPLETED|Overall Study||766
10316339|NCT00189436|11450338|FG000|STARTED|Overall Study||31
10316340|NCT00189436|11450339|FG001|STARTED|Overall Study||30
10316341|NCT00189436|11450338|FG000|COMPLETED|Overall Study||23
10316342|NCT00189436|11450339|FG001|COMPLETED|Overall Study||25
10316343|NCT00189436|11450338|FG000|NOT COMPLETED|Overall Study||8
10316344|NCT00189436|11450339|FG001|NOT COMPLETED|Overall Study||5
10316345|NCT00189462|11450347|FG000|STARTED|Overall Study||50
10316346|NCT00189462|11450348|FG001|STARTED|Overall Study||49
10316347|NCT00189462|11450347|FG000|COMPLETED|Overall Study||27
10316348|NCT00189462|11450348|FG001|COMPLETED|Overall Study||28
10316349|NCT00189462|11450347|FG000|NOT COMPLETED|Overall Study||23
10316350|NCT00189462|11450348|FG001|NOT COMPLETED|Overall Study||21
10316351|NCT00189475|11450356|FG000|STARTED|Overall Study||42
10316352|NCT00189475|11450357|FG001|STARTED|Overall Study||42
10316353|NCT00189475|11450356|FG000|COMPLETED|Overall Study||42
10316354|NCT00189475|11450357|FG001|COMPLETED|Overall Study||42
10432689|NCT00881569|11578907|FG000|COMPLETED|Overall Study||0
10432690|NCT00881569|11578908|FG001|COMPLETED|Overall Study||0
10432691|NCT00881569|11578907|FG000|NOT COMPLETED|Overall Study||1
10432692|NCT00881569|11578908|FG001|NOT COMPLETED|Overall Study||1
10432693|NCT00881621|11578914|FG000|STARTED|Overall Study||51
10432694|NCT00881621|11578914|FG000|COMPLETED|Overall Study||17
10432695|NCT00881621|11578914|FG000|NOT COMPLETED|Overall Study||34
10432696|NCT00881647|11578920|FG000|STARTED|Overall Study||29
10432697|NCT00881647|11578921|FG001|STARTED|Overall Study||16
10781395|NCT03406260|11943330|FG003|NOT COMPLETED|Period 3||0
10432698|NCT00881647|11578920|FG000|COMPLETED|Overall Study||27
10432699|NCT00881647|11578921|FG001|COMPLETED|Overall Study||15
10432700|NCT00881647|11578920|FG000|NOT COMPLETED|Overall Study||2
10432701|NCT00881647|11578921|FG001|NOT COMPLETED|Overall Study||1
10432702|NCT00881712|11578930|FG000|STARTED|Overall Study||15
10432703|NCT00881712|11578931|FG001|STARTED|Overall Study|This arm was non-randomized and no enrolled patients fit the inclusion criteria for this group.|0
10432704|NCT00881712|11578932|FG002|STARTED|Overall Study|This arm was non-randomized and no enrolled patients fit the inclusion criteria for this group.|0
10432705|NCT00881712|11578930|FG000|COMPLETED|Overall Study||13
10432706|NCT00881712|11578931|FG001|COMPLETED|Overall Study||0
10432707|NCT00881712|11578932|FG002|COMPLETED|Overall Study||0
10432708|NCT00881712|11578930|FG000|NOT COMPLETED|Overall Study||2
10432709|NCT00881712|11578931|FG001|NOT COMPLETED|Overall Study||0
10432710|NCT00881712|11578932|FG002|NOT COMPLETED|Overall Study||0
10432711|NCT00881751|11578942|FG000|STARTED|Overall Study||47
10432712|NCT00881751|11578943|FG001|STARTED|Overall Study||48
10432713|NCT00881751|11578942|FG000|COMPLETED|Overall Study||47
10432714|NCT00881751|11578943|FG001|COMPLETED|Overall Study||43
10432715|NCT00881751|11578942|FG000|NOT COMPLETED|Overall Study||0
10432716|NCT00881751|11578943|FG001|NOT COMPLETED|Overall Study||5
10432723|NCT00881894|11578960|FG000|STARTED|Overall Study||26
10432724|NCT00881894|11578961|FG001|STARTED|Overall Study||26
10432725|NCT00881894|11578960|FG000|Pharmacokinetic Set (PKS)|Overall Study|Patients with an insufficient patch adhesiveness were excluded from the PKS.|23
10432726|NCT00881894|11578961|FG001|Pharmacokinetic Set (PKS)|Overall Study|Patients with an insufficient patch adhesiveness were excluded from the PKS.|21
10432727|NCT00881894|11578960|FG000|COMPLETED|Overall Study||25
10432728|NCT00881894|11578961|FG001|COMPLETED|Overall Study||23
10432729|NCT00881894|11578960|FG000|NOT COMPLETED|Overall Study||1
10432730|NCT00881894|11578961|FG001|NOT COMPLETED|Overall Study||3
10432731|NCT00881959|11578969|FG000|STARTED|Overall Study||38
10432732|NCT00881959|11578970|FG001|STARTED|Overall Study||42
10432733|NCT00881959|11578969|FG000|COMPLETED|Overall Study||36
10432734|NCT00881959|11578970|FG001|COMPLETED|Overall Study||38
10432735|NCT00881959|11578969|FG000|NOT COMPLETED|Overall Study||2
10432736|NCT00881959|11578970|FG001|NOT COMPLETED|Overall Study||4
10432737|NCT00882102|11578976|FG000|STARTED|Overall Study||40
10432738|NCT00882102|11578976|FG000|COMPLETED|Overall Study||40
10432739|NCT00882102|11578976|FG000|NOT COMPLETED|Overall Study||0
10432740|NCT00882115|11578980|FG000|STARTED|Overall Study||38
10432741|NCT00882115|11578980|FG000|COMPLETED|Overall Study||29
10432742|NCT00882115|11578980|FG000|NOT COMPLETED|Overall Study||9
10432743|NCT00882206|11578984|FG000|STARTED|Overall Study||13
10432744|NCT00882206|11578984|FG000|COMPLETED|Overall Study||13
10432745|NCT00882206|11578984|FG000|NOT COMPLETED|Overall Study||0
10432746|NCT00882362|11578991|FG000|STARTED|Overall Study||122
10432747|NCT00882362|11578992|FG001|STARTED|Overall Study||33
10432748|NCT00882362|11578991|FG000|COMPLETED|Overall Study||73
10432749|NCT00882362|11578992|FG001|COMPLETED|Overall Study||10
10432750|NCT00882362|11578991|FG000|NOT COMPLETED|Overall Study||49
10432751|NCT00882362|11578992|FG001|NOT COMPLETED|Overall Study||23
10432752|NCT00882518|11579000|FG000|STARTED|Overall Study||196
10432753|NCT00882518|11579001|FG001|STARTED|Overall Study||192
10432754|NCT00882518|11579000|FG000|COMPLETED|Overall Study||158
10432755|NCT00882518|11579001|FG001|COMPLETED|Overall Study||148
10432756|NCT00882518|11579000|FG000|NOT COMPLETED|Overall Study||38
10432757|NCT00882518|11579001|FG001|NOT COMPLETED|Overall Study||44
10432758|NCT00882557|11579009|FG000|STARTED|Overall Study||8
10432759|NCT00882557|11579010|FG001|STARTED|Overall Study||8
10432760|NCT00882557|11579009|FG000|Completed Dose 1|Overall Study||8
10432761|NCT00882557|11579010|FG001|Completed Dose 1|Overall Study||7
10432762|NCT00882557|11579009|FG000|Completed Dose 2|Overall Study||6
10432763|NCT00882557|11579010|FG001|Completed Dose 2|Overall Study||7
10432764|NCT00882557|11579009|FG000|COMPLETED|Overall Study||6
10432765|NCT00882557|11579010|FG001|COMPLETED|Overall Study||7
10432766|NCT00882557|11579009|FG000|NOT COMPLETED|Overall Study||2
10432767|NCT00882557|11579010|FG001|NOT COMPLETED|Overall Study||1
10432768|NCT00882583|11579018|FG000|STARTED|Overall Study||7
10432769|NCT00882583|11579019|FG001|STARTED|Overall Study||12
10432770|NCT00882583|11579018|FG000|COMPLETED|Overall Study||6
10432771|NCT00882583|11579019|FG001|COMPLETED|Overall Study||11
10432772|NCT00882583|11579018|FG000|NOT COMPLETED|Overall Study||1
10548840|NCT01521507|11702707|FG000|STARTED|Stage 1: Randomized Design||101
10432773|NCT00882583|11579019|FG001|NOT COMPLETED|Overall Study||1
10432774|NCT00882661|11579028|FG000|STARTED|Investigational Training||89
10432775|NCT00882661|11579029|FG001|STARTED|Investigational Training||0
10432776|NCT00882661|11579028|FG000|COMPLETED|Investigational Training||79
10432777|NCT00882661|11579029|FG001|COMPLETED|Investigational Training||0
10432778|NCT00882661|11579028|FG000|NOT COMPLETED|Investigational Training||10
10432779|NCT00882661|11579029|FG001|NOT COMPLETED|Investigational Training||0
10432780|NCT00882661|11579028|FG000|STARTED|Treatment||151
10432781|NCT00882661|11579029|FG001|STARTED|Treatment||140
10432782|NCT00882661|11579028|FG000|COMPLETED|Treatment||141
10432783|NCT00882661|11579029|FG001|COMPLETED|Treatment||114
10781396|NCT03406260|11943331|FG004|NOT COMPLETED|Period 3||0
10781397|NCT03406260|11943332|FG005|NOT COMPLETED|Period 3||0
10781398|NCT03406325|11943350|FG000|STARTED|Overall Study||12
10781399|NCT03406325|11943351|FG001|STARTED|Overall Study||1
10781400|NCT03406325|11943352|FG002|STARTED|Overall Study||1
10781401|NCT03406325|11943353|FG003|STARTED|Overall Study||1
10781402|NCT03406325|11943354|FG004|STARTED|Overall Study||1
10781403|NCT03406325|11943355|FG005|STARTED|Overall Study||1
10781404|NCT03406325|11943356|FG006|STARTED|Overall Study||1
10781405|NCT03406325|11943357|FG007|STARTED|Overall Study||1
10781406|NCT03406325|11943350|FG000|COMPLETED|Overall Study||12
10781407|NCT03406325|11943351|FG001|COMPLETED|Overall Study||1
10432784|NCT00882661|11579028|FG000|NOT COMPLETED|Treatment||10
10432785|NCT00882661|11579029|FG001|NOT COMPLETED|Treatment||26
10432786|NCT00882687|11579041|FG000|STARTED|Overall Study||15
10432787|NCT00882687|11579042|FG001|STARTED|Overall Study||15
10432788|NCT00882687|11579043|FG002|STARTED|Overall Study||15
10432789|NCT00882687|11579044|FG003|STARTED|Overall Study||15
10432790|NCT00882687|11579041|FG000|COMPLETED|Overall Study||13
10432791|NCT00882687|11579042|FG001|COMPLETED|Overall Study||13
10432792|NCT00882687|11579043|FG002|COMPLETED|Overall Study||12
10432793|NCT00882687|11579044|FG003|COMPLETED|Overall Study||13
10432794|NCT00882687|11579041|FG000|NOT COMPLETED|Overall Study||2
10432795|NCT00882687|11579042|FG001|NOT COMPLETED|Overall Study||2
10432796|NCT00882687|11579043|FG002|NOT COMPLETED|Overall Study||3
10432797|NCT00882687|11579044|FG003|NOT COMPLETED|Overall Study||2
10432798|NCT00882713|11579054|FG000|STARTED|Overall Study||194
10432799|NCT00882713|11579054|FG000|COMPLETED|Overall Study||172
10432800|NCT00882713|11579054|FG000|NOT COMPLETED|Overall Study||22
10432801|NCT00882778|11579059|FG000|STARTED|Overall Study||86
10432802|NCT00882778|11579059|FG000|COMPLETED|Overall Study||86
10432803|NCT00882778|11579059|FG000|NOT COMPLETED|Overall Study||0
10432804|NCT00882908|11579068|FG000|STARTED|Overall Study||78
10432805|NCT00882908|11579069|FG001|STARTED|Overall Study||75
10432806|NCT00882908|11579070|FG002|STARTED|Overall Study||77
10432807|NCT00882908|11579071|FG003|STARTED|Overall Study||79
10432808|NCT00882908|11579072|FG004|STARTED|Overall Study||77
10432809|NCT00882908|11579068|FG000|COMPLETED|Overall Study||75
10432810|NCT00882908|11579069|FG001|COMPLETED|Overall Study||69
10432811|NCT00882908|11579070|FG002|COMPLETED|Overall Study||70
10432812|NCT00882908|11579071|FG003|COMPLETED|Overall Study||72
10432813|NCT00882908|11579072|FG004|COMPLETED|Overall Study||71
10432814|NCT00882908|11579068|FG000|NOT COMPLETED|Overall Study||3
10432815|NCT00882908|11579069|FG001|NOT COMPLETED|Overall Study||6
10432816|NCT00882908|11579070|FG002|NOT COMPLETED|Overall Study||7
10432817|NCT00882908|11579071|FG003|NOT COMPLETED|Overall Study||7
10432818|NCT00882908|11579072|FG004|NOT COMPLETED|Overall Study||6
10432819|NCT00882921|11579085|FG000|STARTED|Overall Study||26
10432820|NCT00882921|11579085|FG000|COMPLETED|Overall Study||15
10432821|NCT00882921|11579085|FG000|NOT COMPLETED|Overall Study||11
10432822|NCT00882999|11579097|FG000|STARTED|Overall Study||35
10432823|NCT00882999|11579098|FG001|STARTED|Overall Study||34
10432824|NCT00882999|11579099|FG002|STARTED|Overall Study||34
10432825|NCT00882999|11579100|FG003|STARTED|Overall Study||36
10432826|NCT00882999|11579101|FG004|STARTED|Overall Study||36
10432827|NCT00882999|11579102|FG005|STARTED|Overall Study||35
10432828|NCT00882999|11579103|FG006|STARTED|Overall Study||35
10432829|NCT00882999|11579097|FG000|Received Any Amount of Study Drug|Overall Study||35
10432830|NCT00882999|11579098|FG001|Received Any Amount of Study Drug|Overall Study||34
10432831|NCT00882999|11579099|FG002|Received Any Amount of Study Drug|Overall Study||34
10432832|NCT00882999|11579100|FG003|Received Any Amount of Study Drug|Overall Study||36
10432833|NCT00882999|11579101|FG004|Received Any Amount of Study Drug|Overall Study||36
10432834|NCT00882999|11579102|FG005|Received Any Amount of Study Drug|Overall Study||35
10432835|NCT00882999|11579103|FG006|Received Any Amount of Study Drug|Overall Study||35
10432836|NCT00882999|11579097|FG000|Completed Study Treatment|Overall Study||29
10432837|NCT00882999|11579098|FG001|Completed Study Treatment|Overall Study||29
10432838|NCT00882999|11579099|FG002|Completed Study Treatment|Overall Study||31
10432839|NCT00882999|11579100|FG003|Completed Study Treatment|Overall Study||33
10432840|NCT00882999|11579101|FG004|Completed Study Treatment|Overall Study||29
10432841|NCT00882999|11579102|FG005|Completed Study Treatment|Overall Study||30
10432842|NCT00882999|11579103|FG006|Completed Study Treatment|Overall Study||31
10432843|NCT00882999|11579097|FG000|COMPLETED|Overall Study||27
10432844|NCT00882999|11579098|FG001|COMPLETED|Overall Study||26
10432845|NCT00882999|11579099|FG002|COMPLETED|Overall Study||30
10432846|NCT00882999|11579100|FG003|COMPLETED|Overall Study||31
10432847|NCT00882999|11579101|FG004|COMPLETED|Overall Study||28
10432848|NCT00882999|11579102|FG005|COMPLETED|Overall Study||28
10432849|NCT00882999|11579103|FG006|COMPLETED|Overall Study||27
10432850|NCT00882999|11579097|FG000|NOT COMPLETED|Overall Study||8
10432851|NCT00882999|11579098|FG001|NOT COMPLETED|Overall Study||8
10432852|NCT00882999|11579099|FG002|NOT COMPLETED|Overall Study||4
10781408|NCT03406325|11943352|FG002|COMPLETED|Overall Study||1
10781409|NCT03406325|11943353|FG003|COMPLETED|Overall Study||1
10781410|NCT03406325|11943354|FG004|COMPLETED|Overall Study||1
10781411|NCT03406325|11943355|FG005|COMPLETED|Overall Study||1
10432853|NCT00882999|11579100|FG003|NOT COMPLETED|Overall Study||5
10432854|NCT00882999|11579101|FG004|NOT COMPLETED|Overall Study||8
10432855|NCT00882999|11579102|FG005|NOT COMPLETED|Overall Study||7
10432856|NCT00882999|11579103|FG006|NOT COMPLETED|Overall Study||8
10432857|NCT00883051|11579131|FG000|STARTED|Overall Study||106
10781412|NCT03406325|11943356|FG006|COMPLETED|Overall Study||1
10781413|NCT03406325|11943357|FG007|COMPLETED|Overall Study||1
10781414|NCT03406325|11943350|FG000|NOT COMPLETED|Overall Study||0
10781415|NCT03406325|11943351|FG001|NOT COMPLETED|Overall Study||0
10781416|NCT03406325|11943352|FG002|NOT COMPLETED|Overall Study||0
10781417|NCT03406325|11943353|FG003|NOT COMPLETED|Overall Study||0
10781418|NCT03406325|11943354|FG004|NOT COMPLETED|Overall Study||0
10781419|NCT03406325|11943355|FG005|NOT COMPLETED|Overall Study||0
10781420|NCT03406325|11943356|FG006|NOT COMPLETED|Overall Study||0
10781421|NCT03406325|11943357|FG007|NOT COMPLETED|Overall Study||0
10781422|NCT03406377|11943391|FG000|STARTED|Overall Study||41
10432858|NCT00883051|11579132|FG001|STARTED|Overall Study||104
10432859|NCT00883051|11579133|FG002|STARTED|Overall Study||100
10432860|NCT00883051|11579134|FG003|STARTED|Overall Study||99
10432861|NCT00883051|11579135|FG004|STARTED|Overall Study||103
10432862|NCT00883051|11579131|FG000|No Study Medication Used|Overall Study||24
10432863|NCT00883051|11579132|FG001|No Study Medication Used|Overall Study||22
10432864|NCT00883051|11579133|FG002|No Study Medication Used|Overall Study||29
10432865|NCT00883051|11579134|FG003|No Study Medication Used|Overall Study||29
10432866|NCT00883051|11579135|FG004|No Study Medication Used|Overall Study||17
10432867|NCT00883051|11579131|FG000|Received at Least 1 Dose of Study Drug|Overall Study||82
10432868|NCT00883051|11579132|FG001|Received at Least 1 Dose of Study Drug|Overall Study||82
10432869|NCT00883051|11579133|FG002|Received at Least 1 Dose of Study Drug|Overall Study||71
10432870|NCT00883051|11579134|FG003|Received at Least 1 Dose of Study Drug|Overall Study||70
10432871|NCT00883051|11579135|FG004|Received at Least 1 Dose of Study Drug|Overall Study||86
10548841|NCT01521507|11702708|FG001|STARTED|Stage 1: Randomized Design||99
10548842|NCT01521507|11702707|FG000|Received Initial Treatment (Tx)|Stage 1: Randomized Design||99
10548843|NCT01521507|11702708|FG001|Received Initial Treatment (Tx)|Stage 1: Randomized Design||98
10548844|NCT01521507|11702707|FG000|COMPLETED|Stage 1: Randomized Design||98
10548845|NCT01521507|11702708|FG001|COMPLETED|Stage 1: Randomized Design||94
10548846|NCT01521507|11702707|FG000|NOT COMPLETED|Stage 1: Randomized Design||3
10548847|NCT01521507|11702708|FG001|NOT COMPLETED|Stage 1: Randomized Design||5
10548848|NCT01521507|11702707|FG000|STARTED|Stage 2: Observational Design||98
10548849|NCT01521507|11702708|FG001|STARTED|Stage 2: Observational Design||94
10548850|NCT01521507|11702707|FG000|Received Crossover LipiFlow Tx|Stage 2: Observational Design||0
10548851|NCT01521507|11702708|FG001|Received Crossover LipiFlow Tx|Stage 2: Observational Design||93
10548852|NCT01521507|11702707|FG000|Received Only One LipiFlow Tx at 12 Mo|Stage 2: Observational Design||81
10548853|NCT01521507|11702708|FG001|Received Only One LipiFlow Tx at 12 Mo|Stage 2: Observational Design||82
10548854|NCT01521507|11702707|FG000|Received Other MGD Treatment at 12 Mo|Stage 2: Observational Design||11
10781423|NCT03406377|11943392|FG001|STARTED|Overall Study||72
10781424|NCT03406377|11943391|FG000|COMPLETED|Overall Study||25
10781425|NCT03406377|11943392|FG001|COMPLETED|Overall Study||51
10781426|NCT03406377|11943391|FG000|NOT COMPLETED|Overall Study||16
10781427|NCT03406377|11943392|FG001|NOT COMPLETED|Overall Study||21
10548855|NCT01521507|11702708|FG001|Received Other MGD Treatment at 12 Mo|Stage 2: Observational Design||9
10548856|NCT01521507|11702707|FG000|Received 2nd LipiFlow Tx at 12 Mo|Stage 2: Observational Design||2
10548857|NCT01521507|11702708|FG001|Received 2nd LipiFlow Tx at 12 Mo|Stage 2: Observational Design||1
10548858|NCT01521507|11702707|FG000|COMPLETED|Stage 2: Observational Design||94
10548859|NCT01521507|11702708|FG001|COMPLETED|Stage 2: Observational Design||92
10548860|NCT01521507|11702707|FG000|NOT COMPLETED|Stage 2: Observational Design||4
10548861|NCT01521507|11702708|FG001|NOT COMPLETED|Stage 2: Observational Design||2
10548862|NCT01521546|11702723|FG000|STARTED|Overall Study||22
10548863|NCT01521546|11702724|FG001|STARTED|Overall Study||20
10548864|NCT01521546|11702723|FG000|COMPLETED|Overall Study||20
10548865|NCT01521546|11702724|FG001|COMPLETED|Overall Study||20
10548866|NCT01521546|11702723|FG000|NOT COMPLETED|Overall Study||2
10548867|NCT01521546|11702724|FG001|NOT COMPLETED|Overall Study||0
10548868|NCT01521559|11702732|FG000|STARTED|Overall Study||92
10548869|NCT01521559|11702733|FG001|STARTED|Overall Study||91
10548870|NCT01521559|11702732|FG000|Completed Week 24|Overall Study||83
10548871|NCT01521559|11702733|FG001|Completed Week 24|Overall Study||85
10548872|NCT01521559|11702732|FG000|Completed Week 52|Overall Study||77
10548873|NCT01521559|11702733|FG001|Completed Week 52|Overall Study||73
10548874|NCT01521559|11702732|FG000|COMPLETED|Overall Study||77
10548875|NCT01521559|11702733|FG001|COMPLETED|Overall Study||73
10548876|NCT01521559|11702732|FG000|NOT COMPLETED|Overall Study||15
10548877|NCT01521559|11702733|FG001|NOT COMPLETED|Overall Study||18
10548878|NCT01521780|11702740|FG000|STARTED|Overall Study||9
10548879|NCT01521780|11702741|FG001|STARTED|Overall Study||1
10548880|NCT01521780|11702742|FG002|STARTED|Overall Study||2
10548881|NCT01521780|11702740|FG000|COMPLETED|Overall Study||9
10548882|NCT01521780|11702741|FG001|COMPLETED|Overall Study||1
10548883|NCT01521780|11702742|FG002|COMPLETED|Overall Study||2
10548884|NCT01521780|11702740|FG000|NOT COMPLETED|Overall Study||0
10548885|NCT01521780|11702741|FG001|NOT COMPLETED|Overall Study||0
10548886|NCT01521780|11702742|FG002|NOT COMPLETED|Overall Study||0
10548887|NCT01521845|11702753|FG000|STARTED|Overall Study||52
10781428|NCT03406962|11943398|FG000|STARTED|Overall Study||8
10781429|NCT03406962|11943398|FG000|COMPLETED|Overall Study||5
10781430|NCT03406962|11943398|FG000|NOT COMPLETED|Overall Study||3
10548888|NCT01521845|11702754|FG001|STARTED|Overall Study||52
10548889|NCT01521845|11702753|FG000|COMPLETED|Overall Study||43
10781431|NCT03407053|11943405|FG000|STARTED|Overall Study||10
10781432|NCT03407053|11943406|FG001|STARTED|Overall Study||10
10781433|NCT03407053|11943405|FG000|COMPLETED|Overall Study||10
10781434|NCT03407053|11943406|FG001|COMPLETED|Overall Study||10
10781435|NCT03407053|11943405|FG000|NOT COMPLETED|Overall Study||0
10781436|NCT03407053|11943406|FG001|NOT COMPLETED|Overall Study||0
10781437|NCT03407118|11943412|FG000|STARTED|Period 1||14
10781438|NCT03407118|11943413|FG001|STARTED|Period 1||17
10781439|NCT03407118|11943412|FG000|Received at Least 1 Dose of Study Drug|Period 1||14
10781440|NCT03407118|11943413|FG001|Received at Least 1 Dose of Study Drug|Period 1||17
10781441|NCT03407118|11943412|FG000|COMPLETED|Period 1||14
10781442|NCT03407118|11943413|FG001|COMPLETED|Period 1||17
10781443|NCT03407118|11943412|FG000|NOT COMPLETED|Period 1||0
10781444|NCT03407118|11943413|FG001|NOT COMPLETED|Period 1||0
10781445|NCT03407118|11943412|FG000|STARTED|Period 2||14
10781446|NCT03407118|11943413|FG001|STARTED|Period 2||17
10781447|NCT03407118|11943412|FG000|Received at Least 1 Dose of Study Drug|Period 2||13
10781448|NCT03407118|11943413|FG001|Received at Least 1 Dose of Study Drug|Period 2||17
10781449|NCT03407118|11943412|FG000|COMPLETED|Period 2||13
10781450|NCT03407118|11943413|FG001|COMPLETED|Period 2||17
10781451|NCT03407118|11943412|FG000|NOT COMPLETED|Period 2||1
10781452|NCT03407118|11943413|FG001|NOT COMPLETED|Period 2||0
10781453|NCT03407170|11943419|FG000|STARTED|Overall Study||1
10781454|NCT03407170|11943419|FG000|COMPLETED|Overall Study||0
10781455|NCT03407170|11943419|FG000|NOT COMPLETED|Overall Study||1
10781456|NCT03407313|11943423|FG000|STARTED|Overall Study||68
10781457|NCT03407313|11943423|FG000|COMPLETED|Overall Study||66
10548890|NCT01521845|11702754|FG001|COMPLETED|Overall Study||47
10548891|NCT01521845|11702753|FG000|NOT COMPLETED|Overall Study||9
10548892|NCT01521845|11702754|FG001|NOT COMPLETED|Overall Study||5
10548893|NCT01521871|11702762|FG000|STARTED|Overall Study||32
10548894|NCT01521871|11702763|FG001|STARTED|Overall Study||32
10548895|NCT01521871|11702762|FG000|COMPLETED|Overall Study||32
10548896|NCT01521871|11702763|FG001|COMPLETED|Overall Study||32
10548897|NCT01521871|11702762|FG000|NOT COMPLETED|Overall Study||0
10548898|NCT01521871|11702763|FG001|NOT COMPLETED|Overall Study||0
10548899|NCT01521884|11702769|FG000|STARTED|Overall Study||62
10548900|NCT01521884|11702769|FG000|COMPLETED|Overall Study||35
10548901|NCT01521884|11702769|FG000|NOT COMPLETED|Overall Study||27
10548902|NCT01521897|11702773|FG000|STARTED|Overall Study||1143
10548903|NCT01521897|11702773|FG000|COMPLETED|Overall Study||1120
10548904|NCT01521897|11702773|FG000|NOT COMPLETED|Overall Study||23
10548905|NCT01521923|11702781|FG000|STARTED|Overall Study||66
10548906|NCT01521923|11702782|FG001|STARTED|Overall Study||81
10548907|NCT01521923|11702783|FG002|STARTED|Overall Study||127
10548908|NCT01521923|11702784|FG003|STARTED|Overall Study||83
10548909|NCT01521923|11702781|FG000|COMPLETED|Overall Study||59
10548910|NCT01521923|11702782|FG001|COMPLETED|Overall Study||72
10548911|NCT01521923|11702783|FG002|COMPLETED|Overall Study||112
10548912|NCT01521923|11702784|FG003|COMPLETED|Overall Study||70
10548913|NCT01521923|11702781|FG000|NOT COMPLETED|Overall Study||7
10548914|NCT01521923|11702782|FG001|NOT COMPLETED|Overall Study||9
10548915|NCT01521923|11702783|FG002|NOT COMPLETED|Overall Study||15
10548916|NCT01521923|11702784|FG003|NOT COMPLETED|Overall Study||13
10548917|NCT01521949|11702797|FG000|STARTED|Overall Study||21
10548918|NCT01521949|11702797|FG000|COMPLETED|Overall Study||21
10548919|NCT01521949|11702797|FG000|NOT COMPLETED|Overall Study||0
10548920|NCT01522131|11702803|FG000|STARTED|Overall Study||16
10548921|NCT01522131|11702804|FG001|STARTED|Overall Study||17
10548922|NCT01522131|11702803|FG000|COMPLETED|Overall Study||14
10548923|NCT01522131|11702804|FG001|COMPLETED|Overall Study||17
10548924|NCT01522131|11702803|FG000|NOT COMPLETED|Overall Study||2
10548925|NCT01522131|11702804|FG001|NOT COMPLETED|Overall Study||0
10548926|NCT01522235|11702812|FG000|STARTED|Overall Study||3
10548927|NCT01522235|11702813|FG001|STARTED|Overall Study||3
10548928|NCT01522235|11702812|FG000|Randomized|Overall Study||2
10548929|NCT01522235|11702813|FG001|Randomized|Overall Study||3
10548930|NCT01522235|11702812|FG000|COMPLETED|Overall Study||2
10548931|NCT01522235|11702813|FG001|COMPLETED|Overall Study||2
10548932|NCT01522235|11702812|FG000|NOT COMPLETED|Overall Study||1
10548933|NCT01522235|11702813|FG001|NOT COMPLETED|Overall Study||1
10548934|NCT01522248|11702825|FG000|STARTED|Overall Study||10
10548935|NCT01522248|11702826|FG001|STARTED|Overall Study||10
10548936|NCT01522248|11702825|FG000|COMPLETED|Overall Study||9
10548937|NCT01522248|11702826|FG001|COMPLETED|Overall Study||10
10548938|NCT01522248|11702825|FG000|NOT COMPLETED|Overall Study||1
10548939|NCT01522248|11702826|FG001|NOT COMPLETED|Overall Study||0
10548940|NCT01522339|11702837|FG000|STARTED|Overall Study||15
10548941|NCT01522339|11702837|FG000|COMPLETED|Overall Study||15
10548942|NCT01522339|11702837|FG000|NOT COMPLETED|Overall Study||0
10548943|NCT01522391|11702844|FG000|STARTED|Overall Study||20
10548944|NCT01522391|11702845|FG001|STARTED|Overall Study||21
10548945|NCT01522391|11702844|FG000|COMPLETED|Overall Study||19
10781458|NCT03407313|11943423|FG000|NOT COMPLETED|Overall Study||2
10781459|NCT03407430|11943429|FG000|STARTED|First Intervention||5
10781460|NCT03407430|11943430|FG001|STARTED|First Intervention||3
10781461|NCT03407430|11943429|FG000|COMPLETED|First Intervention||5
10548946|NCT01522391|11702845|FG001|COMPLETED|Overall Study||20
10548947|NCT01522391|11702844|FG000|NOT COMPLETED|Overall Study||1
10548948|NCT01522391|11702845|FG001|NOT COMPLETED|Overall Study||1
10548949|NCT01522404|11702853|FG000|STARTED|First Intervention (up to Week 29)||20
10548950|NCT01522404|11702854|FG001|STARTED|First Intervention (up to Week 29)||19
10548951|NCT01522404|11702853|FG000|COMPLETED|First Intervention (up to Week 29)||18
10548952|NCT01522404|11702854|FG001|COMPLETED|First Intervention (up to Week 29)||19
10781462|NCT03407430|11943430|FG001|COMPLETED|First Intervention||3
10781463|NCT03407430|11943429|FG000|NOT COMPLETED|First Intervention||0
10781464|NCT03407430|11943430|FG001|NOT COMPLETED|First Intervention||0
10781465|NCT03407430|11943429|FG000|STARTED|Washout||5
10781466|NCT03407430|11943430|FG001|STARTED|Washout||3
10781467|NCT03407430|11943429|FG000|COMPLETED|Washout||4
10781468|NCT03407430|11943430|FG001|COMPLETED|Washout||3
10781469|NCT03407430|11943429|FG000|NOT COMPLETED|Washout||1
10781470|NCT03407430|11943430|FG001|NOT COMPLETED|Washout||0
10781471|NCT03407430|11943429|FG000|STARTED|Second Intervention||4
10781472|NCT03407430|11943430|FG001|STARTED|Second Intervention||3
10781473|NCT03407430|11943429|FG000|COMPLETED|Second Intervention||4
10781474|NCT03407430|11943430|FG001|COMPLETED|Second Intervention||3
10781475|NCT03407430|11943429|FG000|NOT COMPLETED|Second Intervention||0
10781476|NCT03407430|11943430|FG001|NOT COMPLETED|Second Intervention||0
10781477|NCT03407482|11943443|FG000|STARTED|Overall Study||160
10781478|NCT03407482|11943443|FG000|COMPLETED|Overall Study||29
10781479|NCT03407482|11943443|FG000|NOT COMPLETED|Overall Study||131
10781480|NCT03407612|11943449|FG000|STARTED|Overall Study||19
10781481|NCT03407612|11943450|FG001|STARTED|Overall Study||23
10781482|NCT03407612|11943449|FG000|COMPLETED|Overall Study||19
10781483|NCT03407612|11943450|FG001|COMPLETED|Overall Study||23
10781484|NCT03407612|11943449|FG000|NOT COMPLETED|Overall Study||0
10781485|NCT03407612|11943450|FG001|NOT COMPLETED|Overall Study||0
10781486|NCT03407625|11943458|FG000|STARTED|Overall Study||1117
10781487|NCT03407625|11943459|FG001|STARTED|Overall Study||1110
10781488|NCT03407625|11943458|FG000|COMPLETED|Overall Study||1117
10781489|NCT03407625|11943459|FG001|COMPLETED|Overall Study||1110
10781490|NCT03407625|11943458|FG000|NOT COMPLETED|Overall Study||0
10781491|NCT03407625|11943459|FG001|NOT COMPLETED|Overall Study||0
10781492|NCT03407651|11943465|FG000|STARTED|Period 1: Part 1a||11
10781493|NCT03407651|11943465|FG000|COMPLETED|Period 1: Part 1a||10
10781494|NCT03407651|11943465|FG000|NOT COMPLETED|Period 1: Part 1a||1
10781495|NCT03407651|11943465|FG000|STARTED|Period 2: Part 1b||9
10781496|NCT03407651|11943465|FG000|COMPLETED|Period 2: Part 1b||9
10781497|NCT03407651|11943465|FG000|NOT COMPLETED|Period 2: Part 1b||0
10781498|NCT03407651|11943465|FG000|STARTED|Period 3: Part 2|The subject who discontinued after 44 daily SC doses in Part 2 elected to participate in Period 3.|11
10781499|NCT03407651|11943465|FG000|COMPLETED|Period 3: Part 2||8
10781500|NCT03407651|11943465|FG000|NOT COMPLETED|Period 3: Part 2||3
10781501|NCT03408171|11943487|FG000|STARTED|Overall Study||20
10781502|NCT03408171|11943488|FG001|STARTED|Overall Study||20
10781503|NCT03408171|11943487|FG000|COMPLETED|Overall Study||20
10781504|NCT03408171|11943488|FG001|COMPLETED|Overall Study||20
10781505|NCT03408171|11943487|FG000|NOT COMPLETED|Overall Study||0
10781506|NCT03408171|11943488|FG001|NOT COMPLETED|Overall Study||0
10781507|NCT03408392|11943494|FG000|STARTED|Treatment Period 1 (16 Days)||14
10781508|NCT03408392|11943495|FG001|STARTED|Treatment Period 1 (16 Days)||14
10781509|NCT03408392|11943494|FG000|COMPLETED|Treatment Period 1 (16 Days)||14
10781510|NCT03408392|11943495|FG001|COMPLETED|Treatment Period 1 (16 Days)||14
10781511|NCT03408392|11943494|FG000|NOT COMPLETED|Treatment Period 1 (16 Days)||0
10781512|NCT03408392|11943495|FG001|NOT COMPLETED|Treatment Period 1 (16 Days)||0
10781513|NCT03408392|11943494|FG000|STARTED|Wash-out Period (14 Days)||14
10781514|NCT03408392|11943495|FG001|STARTED|Wash-out Period (14 Days)||14
10781515|NCT03408392|11943494|FG000|COMPLETED|Wash-out Period (14 Days)||14
10781516|NCT03408392|11943495|FG001|COMPLETED|Wash-out Period (14 Days)||14
10548953|NCT01522404|11702853|FG000|NOT COMPLETED|First Intervention (up to Week 29)||2
10548954|NCT01522404|11702854|FG001|NOT COMPLETED|First Intervention (up to Week 29)||0
10548955|NCT01522404|11702853|FG000|STARTED|Second Intervention (up to Week 58)||18
10548956|NCT01522404|11702854|FG001|STARTED|Second Intervention (up to Week 58)||19
10548957|NCT01522404|11702853|FG000|COMPLETED|Second Intervention (up to Week 58)||17
10548958|NCT01522404|11702854|FG001|COMPLETED|Second Intervention (up to Week 58)||19
10548959|NCT01522404|11702853|FG000|NOT COMPLETED|Second Intervention (up to Week 58)||1
10548960|NCT01522404|11702854|FG001|NOT COMPLETED|Second Intervention (up to Week 58)||0
10548961|NCT01522417|11702871|FG000|STARTED|Overall Study||209
10548962|NCT01522417|11702872|FG001|STARTED|Overall Study||202
10548963|NCT01522417|11702873|FG002|STARTED|Overall Study|Randomization into the long tirofiban arm was initiated on 14 June 2013.|124
10548964|NCT01522417|11702871|FG000|COMPLETED|Overall Study||209
10548965|NCT01522417|11702872|FG001|COMPLETED|Overall Study||202
10548966|NCT01522417|11702873|FG002|COMPLETED|Overall Study|Randomization into the long tirofiban arm was completed on 1 February 2018.|124
10548967|NCT01522417|11702871|FG000|NOT COMPLETED|Overall Study||0
10548968|NCT01522417|11702872|FG001|NOT COMPLETED|Overall Study||0
10548969|NCT01522417|11702873|FG002|NOT COMPLETED|Overall Study||0
10548970|NCT01522443|11702883|FG000|STARTED|Overall Study||61
10548971|NCT01522443|11702884|FG001|STARTED|Overall Study||58
10548972|NCT01522443|11702883|FG000|COMPLETED|Overall Study||8
10548973|NCT01522443|11702884|FG001|COMPLETED|Overall Study||3
10781517|NCT03408392|11943494|FG000|NOT COMPLETED|Wash-out Period (14 Days)||0
10781518|NCT03408392|11943495|FG001|NOT COMPLETED|Wash-out Period (14 Days)||0
10781519|NCT03408392|11943494|FG000|STARTED|Treatment Period 2 (16 Days)||14
10781520|NCT03408392|11943495|FG001|STARTED|Treatment Period 2 (16 Days)||14
10781521|NCT03408392|11943494|FG000|COMPLETED|Treatment Period 2 (16 Days)||14
10781522|NCT03408392|11943495|FG001|COMPLETED|Treatment Period 2 (16 Days)||14
10781523|NCT03408392|11943494|FG000|NOT COMPLETED|Treatment Period 2 (16 Days)||0
10781524|NCT03408392|11943495|FG001|NOT COMPLETED|Treatment Period 2 (16 Days)||0
10781525|NCT03408483|11943503|FG000|STARTED|Overall Study||42
10781526|NCT03408483|11943504|FG001|STARTED|Overall Study||38
10781527|NCT03408483|11943503|FG000|COMPLETED|Overall Study||36
10781528|NCT03408483|11943504|FG001|COMPLETED|Overall Study||35
10781529|NCT03408483|11943503|FG000|NOT COMPLETED|Overall Study||6
10781530|NCT03408483|11943504|FG001|NOT COMPLETED|Overall Study||3
10781531|NCT03408639|11943512|FG000|STARTED|Overall Study||78
10781532|NCT03408639|11943513|FG001|STARTED|Overall Study||78
10781533|NCT03408639|11943512|FG000|COMPLETED|Overall Study||67
10781534|NCT03408639|11943513|FG001|COMPLETED|Overall Study||56
10781535|NCT03408639|11943512|FG000|NOT COMPLETED|Overall Study||11
10781536|NCT03408639|11943513|FG001|NOT COMPLETED|Overall Study||22
10781537|NCT03408730|11943523|FG000|STARTED|Overall Study||712
10781538|NCT03408730|11943524|FG001|STARTED|Overall Study||711
10781539|NCT03408730|11943525|FG002|STARTED|Overall Study||709
10781540|NCT03408730|11943526|FG003|STARTED|Overall Study||706
10781541|NCT03408730|11943523|FG000|COMPLETED|Overall Study||643
10548974|NCT01522443|11702883|FG000|NOT COMPLETED|Overall Study||53
10548975|NCT01522443|11702884|FG001|NOT COMPLETED|Overall Study||55
10548979|NCT01522651|11702906|FG000|STARTED|Overall Study||26
10548980|NCT01522651|11702907|FG001|STARTED|Overall Study||27
10548981|NCT01522651|11702908|FG002|STARTED|Overall Study||26
10548982|NCT01522651|11702909|FG003|STARTED|Overall Study||28
10548983|NCT01522651|11702910|FG004|STARTED|Overall Study||27
10548984|NCT01522651|11702906|FG000|COMPLETED|Overall Study||17
10548985|NCT01522651|11702907|FG001|COMPLETED|Overall Study||19
10548986|NCT01522651|11702908|FG002|COMPLETED|Overall Study||22
10548987|NCT01522651|11702909|FG003|COMPLETED|Overall Study||20
10548988|NCT01522651|11702910|FG004|COMPLETED|Overall Study||21
10548989|NCT01522651|11702906|FG000|NOT COMPLETED|Overall Study||9
10548990|NCT01522651|11702907|FG001|NOT COMPLETED|Overall Study||8
10548991|NCT01522651|11702908|FG002|NOT COMPLETED|Overall Study||4
10548992|NCT01522651|11702909|FG003|NOT COMPLETED|Overall Study||8
10548993|NCT01522651|11702910|FG004|NOT COMPLETED|Overall Study||6
10548994|NCT01522703|11702924|FG000|STARTED|Overall Study||25
10548995|NCT01522703|11702925|FG001|STARTED|Overall Study||26
10548996|NCT01522703|11702924|FG000|COMPLETED|Overall Study||20
10548997|NCT01522703|11702925|FG001|COMPLETED|Overall Study||20
10548998|NCT01522703|11702924|FG000|NOT COMPLETED|Overall Study||5
10548999|NCT01522703|11702925|FG001|NOT COMPLETED|Overall Study||6
10549000|NCT01522755|11702931|FG000|STARTED|Overall Study||409
10549001|NCT01522755|11702931|FG000|COMPLETED|Overall Study||409
10549002|NCT01522755|11702931|FG000|NOT COMPLETED|Overall Study||0
10549003|NCT01522924|11702938|FG000|STARTED|Overall Study|There were 42 dental students in the intervention group.|42
10549004|NCT01522924|11702939|FG001|STARTED|Overall Study|There were 52 dental students in the control group.|52
10549005|NCT01522924|11702938|FG000|COMPLETED|Overall Study|There were 42 dental students who completed the second survey after the intervention.|42
10549006|NCT01522924|11702939|FG001|COMPLETED|Overall Study|There were 52 dental students who completed the second survey after the lecture.|52
10549007|NCT01522924|11702938|FG000|NOT COMPLETED|Overall Study||0
10549008|NCT01522924|11702939|FG001|NOT COMPLETED|Overall Study||0
10549009|NCT01522937|11702945|FG000|STARTED|Overall Study||146
10549010|NCT01522937|11702945|FG000|COMPLETED|Overall Study||146
10549011|NCT01522937|11702945|FG000|NOT COMPLETED|Overall Study||0
10549012|NCT01522950|11702952|FG000|STARTED|Overall Study||26
10549013|NCT01522950|11702953|FG001|STARTED|Overall Study||23
10549014|NCT01522950|11702954|FG002|STARTED|Overall Study||27
10549015|NCT01522950|11702952|FG000|COMPLETED|Overall Study||20
10549016|NCT01522950|11702953|FG001|COMPLETED|Overall Study||18
10549017|NCT01522950|11702954|FG002|COMPLETED|Overall Study||22
10549018|NCT01522950|11702952|FG000|NOT COMPLETED|Overall Study||6
10549019|NCT01522950|11702953|FG001|NOT COMPLETED|Overall Study||5
10549020|NCT01522950|11702954|FG002|NOT COMPLETED|Overall Study||5
10549021|NCT01522963|11702966|FG000|STARTED|Overall Study||24
10549022|NCT01522963|11702967|FG001|STARTED|Overall Study||25
10549023|NCT01522963|11702968|FG002|STARTED|Overall Study||25
10549024|NCT01522963|11702969|FG003|STARTED|Overall Study||24
10549025|NCT01522963|11702966|FG000|COMPLETED|Overall Study||22
10549026|NCT01522963|11702967|FG001|COMPLETED|Overall Study||22
10549027|NCT01522963|11702968|FG002|COMPLETED|Overall Study||22
10781542|NCT03408730|11943524|FG001|COMPLETED|Overall Study||636
10781543|NCT03408730|11943525|FG002|COMPLETED|Overall Study||637
10781544|NCT03408730|11943526|FG003|COMPLETED|Overall Study||625
10781545|NCT03408730|11943523|FG000|NOT COMPLETED|Overall Study||69
10781546|NCT03408730|11943524|FG001|NOT COMPLETED|Overall Study||75
10549028|NCT01522963|11702969|FG003|COMPLETED|Overall Study||18
10549029|NCT01522963|11702966|FG000|NOT COMPLETED|Overall Study||2
10549030|NCT01522963|11702967|FG001|NOT COMPLETED|Overall Study||3
10549031|NCT01522963|11702968|FG002|NOT COMPLETED|Overall Study||3
10549032|NCT01522963|11702969|FG003|NOT COMPLETED|Overall Study||6
10549033|NCT01523275|11702979|FG000|STARTED|Overall Study||6
10549034|NCT01523275|11702980|FG001|STARTED|Overall Study||9
10549035|NCT01523275|11702979|FG000|COMPLETED|Overall Study||4
10549036|NCT01523275|11702980|FG001|COMPLETED|Overall Study||7
10549037|NCT01523275|11702979|FG000|NOT COMPLETED|Overall Study||2
10549038|NCT01523275|11702980|FG001|NOT COMPLETED|Overall Study||2
10549039|NCT01523301|11702988|FG000|STARTED|Overall Study||184
10549040|NCT01523301|11702989|FG001|STARTED|Overall Study||196
10549041|NCT01523301|11702988|FG000|COMPLETED|Overall Study||149
10549042|NCT01523301|11702989|FG001|COMPLETED|Overall Study||164
10549043|NCT01523301|11702988|FG000|NOT COMPLETED|Overall Study||35
10781547|NCT03408730|11943525|FG002|NOT COMPLETED|Overall Study||72
10549044|NCT01523301|11702989|FG001|NOT COMPLETED|Overall Study||32
10549045|NCT01523366|11702997|FG000|STARTED|Treatment Period 1||20
10549046|NCT01523366|11702998|FG001|STARTED|Treatment Period 1||20
10549047|NCT01523366|11702997|FG000|COMPLETED|Treatment Period 1||19
10549048|NCT01523366|11702998|FG001|COMPLETED|Treatment Period 1||20
10549049|NCT01523366|11702997|FG000|NOT COMPLETED|Treatment Period 1||1
10549050|NCT01523366|11702998|FG001|NOT COMPLETED|Treatment Period 1||0
10549051|NCT01523366|11702997|FG000|STARTED|Washout Period - 10-14 Days||19
10549052|NCT01523366|11702998|FG001|STARTED|Washout Period - 10-14 Days||20
10549053|NCT01523366|11702997|FG000|COMPLETED|Washout Period - 10-14 Days||19
10549054|NCT01523366|11702998|FG001|COMPLETED|Washout Period - 10-14 Days||20
10549055|NCT01523366|11702997|FG000|NOT COMPLETED|Washout Period - 10-14 Days||0
10549056|NCT01523366|11702998|FG001|NOT COMPLETED|Washout Period - 10-14 Days||0
10549057|NCT01523366|11702997|FG000|STARTED|Treatment Period 2||19
10549058|NCT01523366|11702998|FG001|STARTED|Treatment Period 2||20
10549059|NCT01523366|11702997|FG000|COMPLETED|Treatment Period 2||18
10549060|NCT01523366|11702998|FG001|COMPLETED|Treatment Period 2||20
10549061|NCT01523366|11702997|FG000|NOT COMPLETED|Treatment Period 2||1
10549062|NCT01523366|11702998|FG001|NOT COMPLETED|Treatment Period 2||0
10549063|NCT01523392|11703008|FG000|STARTED|Treatment Period 1||20
10549064|NCT01523392|11703009|FG001|STARTED|Treatment Period 1||14
10549065|NCT01523392|11703008|FG000|COMPLETED|Treatment Period 1||17
10549066|NCT01523392|11703009|FG001|COMPLETED|Treatment Period 1||14
10549067|NCT01523392|11703008|FG000|NOT COMPLETED|Treatment Period 1||3
10549068|NCT01523392|11703009|FG001|NOT COMPLETED|Treatment Period 1||0
10549069|NCT01523392|11703008|FG000|STARTED|Washout Period - 10 to 14 Days|1 patient did not complete 7-9 days of Period 1 treatment but continued in the Washout and Period 2|18
10549070|NCT01523392|11703009|FG001|STARTED|Washout Period - 10 to 14 Days||14
10549071|NCT01523392|11703008|FG000|COMPLETED|Washout Period - 10 to 14 Days||17
10549072|NCT01523392|11703009|FG001|COMPLETED|Washout Period - 10 to 14 Days||14
10549073|NCT01523392|11703008|FG000|NOT COMPLETED|Washout Period - 10 to 14 Days||1
10549074|NCT01523392|11703009|FG001|NOT COMPLETED|Washout Period - 10 to 14 Days||0
10549075|NCT01523392|11703008|FG000|STARTED|Treatment Period 2||17
10549076|NCT01523392|11703009|FG001|STARTED|Treatment Period 2||14
10549077|NCT01523392|11703008|FG000|COMPLETED|Treatment Period 2||17
10549078|NCT01523392|11703009|FG001|COMPLETED|Treatment Period 2||14
10549079|NCT01523392|11703008|FG000|NOT COMPLETED|Treatment Period 2||0
10549080|NCT01523392|11703009|FG001|NOT COMPLETED|Treatment Period 2||0
10549081|NCT01523457|11703019|FG000|STARTED|Overall Study||44
10549082|NCT01523457|11703020|FG001|STARTED|Overall Study||31
10549083|NCT01523457|11703019|FG000|COMPLETED|Overall Study||37
10549084|NCT01523457|11703020|FG001|COMPLETED|Overall Study||29
10549085|NCT01523457|11703019|FG000|NOT COMPLETED|Overall Study||7
10549086|NCT01523457|11703020|FG001|NOT COMPLETED|Overall Study||2
10549087|NCT01523496|11703030|FG000|STARTED|Overall Study|The supplementation group includes medium and high dose vitamin D supplementation|66
10549088|NCT01523496|11703031|FG001|STARTED|Overall Study||36
10549089|NCT01523496|11703032|FG002|STARTED|Overall Study|The supplementation group includes medium and high dose vitamin D supplementation|58
10549090|NCT01523496|11703033|FG003|STARTED|Overall Study||30
10549091|NCT01523496|11703030|FG000|COMPLETED|Overall Study||56
10549092|NCT01523496|11703031|FG001|COMPLETED|Overall Study||32
10549093|NCT01523496|11703032|FG002|COMPLETED|Overall Study||46
10549094|NCT01523496|11703033|FG003|COMPLETED|Overall Study||27
10549095|NCT01523496|11703030|FG000|NOT COMPLETED|Overall Study||10
10549096|NCT01523496|11703031|FG001|NOT COMPLETED|Overall Study||4
10549097|NCT01523496|11703032|FG002|NOT COMPLETED|Overall Study||12
10549098|NCT01523496|11703033|FG003|NOT COMPLETED|Overall Study||3
10549099|NCT01523587|11703049|FG000|STARTED|Overall Study||398
10549100|NCT01523587|11703050|FG001|STARTED|Overall Study||397
10549101|NCT01523587|11703049|FG000|Treated|Overall Study||392
10549102|NCT01523587|11703050|FG001|Treated|Overall Study||395
10549103|NCT01523587|11703049|FG000|COMPLETED|Overall Study||0
10549104|NCT01523587|11703050|FG001|COMPLETED|Overall Study||0
10549105|NCT01523587|11703049|FG000|NOT COMPLETED|Overall Study||398
10549106|NCT01523587|11703050|FG001|NOT COMPLETED|Overall Study||397
10549107|NCT01523613|11703059|FG000|STARTED|Overall Study|- 30 single restorations (30 R)|30
10549108|NCT01523613|11703060|FG001|STARTED|Overall Study|- 30 single restorations (30 F)|30
10549109|NCT01523613|11703061|FG002|STARTED|Overall Study|- 66 paired restorations (33R + 33F)|33
10549110|NCT01523613|11703059|FG000|COMPLETED|Overall Study|- 23 single restorations (23R)|23
10549111|NCT01523613|11703060|FG001|COMPLETED|Overall Study|- 25 single restorations (25F)|25
10549112|NCT01523613|11703061|FG002|COMPLETED|Overall Study|- 42 paired restorations (21R and 21F)|21
10549113|NCT01523613|11703059|FG000|NOT COMPLETED|Overall Study||7
10549114|NCT01523613|11703060|FG001|NOT COMPLETED|Overall Study||5
10549115|NCT01523613|11703061|FG002|NOT COMPLETED|Overall Study||12
10549116|NCT01523704|11703071|FG000|STARTED|Overall Study|January 2012|636
10549117|NCT01523704|11703072|FG001|STARTED|Overall Study|January 2012|638
10549118|NCT01523704|11703071|FG000|COMPLETED|Overall Study|February 2016 (Enrollment: as of October 2013)|558
10549119|NCT01523704|11703072|FG001|COMPLETED|Overall Study|February 2016 (Enrollment: as of October 2013)|550
10549120|NCT01523704|11703071|FG000|NOT COMPLETED|Overall Study||78
10549121|NCT01523704|11703072|FG001|NOT COMPLETED|Overall Study||88
10549122|NCT01523743|11703079|FG000|STARTED|Period 1||63
10549123|NCT01523743|11703080|FG001|STARTED|Period 1||62
10549124|NCT01523743|11703079|FG000|COMPLETED|Period 1||53
10549125|NCT01523743|11703080|FG001|COMPLETED|Period 1||60
10781548|NCT03408730|11943526|FG003|NOT COMPLETED|Overall Study||81
10781549|NCT03408808|11943542|FG000|STARTED|Overall Study||8
10781550|NCT03408808|11943543|FG001|STARTED|Overall Study||9
10549126|NCT01523743|11703079|FG000|NOT COMPLETED|Period 1||10
10549127|NCT01523743|11703080|FG001|NOT COMPLETED|Period 1||2
10549128|NCT01523743|11703079|FG000|STARTED|Period 2||53
10549129|NCT01523743|11703080|FG001|STARTED|Period 2||60
10549130|NCT01523743|11703079|FG000|COMPLETED|Period 2||52
10549131|NCT01523743|11703080|FG001|COMPLETED|Period 2||58
10549132|NCT01523743|11703079|FG000|NOT COMPLETED|Period 2||1
10549133|NCT01523743|11703080|FG001|NOT COMPLETED|Period 2||2
10549134|NCT01523756|11703086|FG000|STARTED|Baseline Period||11
10549135|NCT01523756|11703087|FG001|STARTED|Baseline Period||9
10549136|NCT01523756|11703086|FG000|COMPLETED|Baseline Period||11
10549137|NCT01523756|11703087|FG001|COMPLETED|Baseline Period||8
10549138|NCT01523756|11703086|FG000|NOT COMPLETED|Baseline Period||0
10549139|NCT01523756|11703087|FG001|NOT COMPLETED|Baseline Period||1
10549140|NCT01523756|11703086|FG000|STARTED|Test Period 1||11
10549141|NCT01523756|11703087|FG001|STARTED|Test Period 1||8
10549142|NCT01523756|11703086|FG000|COMPLETED|Test Period 1||10
10549143|NCT01523756|11703087|FG001|COMPLETED|Test Period 1||8
10549144|NCT01523756|11703086|FG000|NOT COMPLETED|Test Period 1||1
10549145|NCT01523756|11703087|FG001|NOT COMPLETED|Test Period 1||0
10549146|NCT01523756|11703086|FG000|STARTED|Test Period 2||10
10549147|NCT01523756|11703087|FG001|STARTED|Test Period 2||8
10549148|NCT01523756|11703086|FG000|COMPLETED|Test Period 2||10
10549149|NCT01523756|11703087|FG001|COMPLETED|Test Period 2||7
10549150|NCT01523756|11703086|FG000|NOT COMPLETED|Test Period 2||0
10549151|NCT01523756|11703087|FG001|NOT COMPLETED|Test Period 2||1
10549152|NCT01523782|11703098|FG000|STARTED|Overall Study||3
10549153|NCT01523782|11703099|FG001|STARTED|Overall Study||13
10549154|NCT01523782|11703100|FG002|STARTED|Overall Study||14
10549155|NCT01523782|11703098|FG000|COMPLETED|Overall Study||2
10549156|NCT01523782|11703099|FG001|COMPLETED|Overall Study||13
10549157|NCT01523782|11703100|FG002|COMPLETED|Overall Study||9
10549158|NCT01523782|11703098|FG000|NOT COMPLETED|Overall Study||1
10549159|NCT01523782|11703099|FG001|NOT COMPLETED|Overall Study||0
10549160|NCT01523782|11703100|FG002|NOT COMPLETED|Overall Study||5
10549161|NCT01523808|11703112|FG000|STARTED|Overall Study||3
10549162|NCT01523808|11703113|FG001|STARTED|Overall Study||3
10549163|NCT01523808|11703114|FG002|STARTED|Overall Study||3
10549164|NCT01523808|11703115|FG003|STARTED|Overall Study||3
10549165|NCT01523808|11703112|FG000|COMPLETED|Overall Study||0
10549166|NCT01523808|11703113|FG001|COMPLETED|Overall Study||3
10549167|NCT01523808|11703114|FG002|COMPLETED|Overall Study||1
10549168|NCT01523808|11703115|FG003|COMPLETED|Overall Study||0
10549169|NCT01523808|11703112|FG000|NOT COMPLETED|Overall Study||3
10549170|NCT01523808|11703113|FG001|NOT COMPLETED|Overall Study||0
10549171|NCT01523808|11703114|FG002|NOT COMPLETED|Overall Study||2
10549172|NCT01523808|11703115|FG003|NOT COMPLETED|Overall Study||3
10549173|NCT01523821|11703137|FG000|STARTED|Overall Study||8
10549174|NCT01523821|11703138|FG001|STARTED|Overall Study||6
10549175|NCT01523821|11703139|FG002|STARTED|Overall Study||6
10549176|NCT01523821|11703137|FG000|COMPLETED|Overall Study||8
10549177|NCT01523821|11703138|FG001|COMPLETED|Overall Study||6
10549178|NCT01523821|11703139|FG002|COMPLETED|Overall Study||6
10549179|NCT01523821|11703137|FG000|NOT COMPLETED|Overall Study||0
10549180|NCT01523821|11703138|FG001|NOT COMPLETED|Overall Study||0
10549181|NCT01523821|11703139|FG002|NOT COMPLETED|Overall Study||0
10549182|NCT01523834|11703147|FG000|STARTED|Overall Study|Started Induction Phase|35
10549183|NCT01523834|11703147|FG000|Consolidation Phase|Overall Study|Started Consolidation Phase|7
10549184|NCT01523834|11703147|FG000|Maintenance Phase|Overall Study|Started Maintenance Phase|6
10549185|NCT01523834|11703147|FG000|COMPLETED|Overall Study||4
10549186|NCT01523834|11703147|FG000|NOT COMPLETED|Overall Study||31
10549187|NCT01523873|11703152|FG000|STARTED|Overall Study||35921
10549188|NCT01523873|11703152|FG000|Administered With Dotarem|Overall Study||35474
10549189|NCT01523873|11703152|FG000|COMPLETED|Overall Study||35499
10549190|NCT01523873|11703152|FG000|NOT COMPLETED|Overall Study||422
10549191|NCT01523886|11703160|FG000|STARTED|Overall Study||25
10549192|NCT01523886|11703161|FG001|STARTED|Overall Study||24
10549193|NCT01523886|11703160|FG000|COMPLETED|Overall Study||25
10549194|NCT01523886|11703161|FG001|COMPLETED|Overall Study||23
10549195|NCT01523886|11703160|FG000|NOT COMPLETED|Overall Study||0
10549196|NCT01523886|11703161|FG001|NOT COMPLETED|Overall Study||1
10549197|NCT01523899|11703169|FG000|STARTED|Overall Study||126
10549198|NCT01523899|11703170|FG001|STARTED|Overall Study||126
10549199|NCT01523899|11703169|FG000|COMPLETED|Overall Study||126
10549200|NCT01523899|11703170|FG001|COMPLETED|Overall Study||126
10549201|NCT01523899|11703169|FG000|NOT COMPLETED|Overall Study||0
10549202|NCT01523899|11703170|FG001|NOT COMPLETED|Overall Study||0
10549203|NCT01523964|11703181|FG000|STARTED|Overall Study||31
10549204|NCT01523964|11703182|FG001|STARTED|Overall Study||30
10549205|NCT01523964|11703183|FG002|STARTED|Overall Study||16
10549206|NCT01523964|11703184|FG003|STARTED|Overall Study||15
10549207|NCT01523964|11703181|FG000|COMPLETED|Overall Study||31
10549208|NCT01523964|11703182|FG001|COMPLETED|Overall Study||30
10549209|NCT01523964|11703183|FG002|COMPLETED|Overall Study||16
10549210|NCT01523964|11703184|FG003|COMPLETED|Overall Study||15
10549211|NCT01523964|11703181|FG000|NOT COMPLETED|Overall Study||0
10549212|NCT01523964|11703182|FG001|NOT COMPLETED|Overall Study||0
10549213|NCT01523964|11703183|FG002|NOT COMPLETED|Overall Study||0
10549214|NCT01523964|11703184|FG003|NOT COMPLETED|Overall Study||0
10549215|NCT01524133|11703197|FG000|STARTED|Treatment Phase||71
10549216|NCT01524133|11703198|FG001|STARTED|Treatment Phase||69
10549217|NCT01524133|11703199|FG002|STARTED|Treatment Phase||67
10549218|NCT01524133|11703197|FG000|COMPLETED|Treatment Phase|Completed Both Assigned treatment|52
10549219|NCT01524133|11703198|FG001|COMPLETED|Treatment Phase|Completed Both Assigned Treatments|37
10549220|NCT01524133|11703199|FG002|COMPLETED|Treatment Phase|Completed both assigned treatments|31
10549221|NCT01524133|11703197|FG000|NOT COMPLETED|Treatment Phase||19
10781551|NCT03408808|11943542|FG000|COMPLETED|Overall Study||8
10781552|NCT03408808|11943543|FG001|COMPLETED|Overall Study||8
10781553|NCT03408808|11943542|FG000|NOT COMPLETED|Overall Study||0
10781554|NCT03408808|11943543|FG001|NOT COMPLETED|Overall Study||1
10781555|NCT03409107|11943551|FG000|STARTED|Overall Study||307
10781556|NCT03409107|11943552|FG001|STARTED|Overall Study||307
10549222|NCT01524133|11703198|FG001|NOT COMPLETED|Treatment Phase||32
10549223|NCT01524133|11703199|FG002|NOT COMPLETED|Treatment Phase||36
10549224|NCT01524133|11703197|FG000|STARTED|Overall Study 52 Weeks||71
10781557|NCT03409107|11943551|FG000|COMPLETED|Overall Study||290
10781558|NCT03409107|11943552|FG001|COMPLETED|Overall Study||300
10781559|NCT03409107|11943551|FG000|NOT COMPLETED|Overall Study||17
10781560|NCT03409107|11943552|FG001|NOT COMPLETED|Overall Study||7
10781561|NCT03410056|11943562|FG000|STARTED|Overall Study||8
10781562|NCT03410056|11943563|FG001|STARTED|Overall Study||6
10781563|NCT03410056|11943564|FG002|STARTED|Overall Study||11
10781564|NCT03410056|11943565|FG003|STARTED|Overall Study||11
10781565|NCT03410056|11943566|FG004|STARTED|Overall Study||0
10781566|NCT03410056|11943567|FG005|STARTED|Overall Study||0
10781567|NCT03410056|11943568|FG006|STARTED|Overall Study||0
10781568|NCT03410056|11943562|FG000|Received Treatment|Overall Study||8
10781569|NCT03410056|11943563|FG001|Received Treatment|Overall Study||6
10781570|NCT03410056|11943564|FG002|Received Treatment|Overall Study||11
10781571|NCT03410056|11943565|FG003|Received Treatment|Overall Study||11
10781572|NCT03410056|11943566|FG004|Received Treatment|Overall Study||0
10781573|NCT03410056|11943567|FG005|Received Treatment|Overall Study||0
10781574|NCT03410056|11943568|FG006|Received Treatment|Overall Study||0
10781575|NCT03410056|11943562|FG000|COMPLETED|Overall Study||8
10781576|NCT03410056|11943563|FG001|COMPLETED|Overall Study||4
10781577|NCT03410056|11943564|FG002|COMPLETED|Overall Study||3
10781578|NCT03410056|11943565|FG003|COMPLETED|Overall Study||6
10781579|NCT03410056|11943566|FG004|COMPLETED|Overall Study||0
10781580|NCT03410056|11943567|FG005|COMPLETED|Overall Study||0
10781581|NCT03410056|11943568|FG006|COMPLETED|Overall Study||0
10781582|NCT03410056|11943562|FG000|NOT COMPLETED|Overall Study||0
10781583|NCT03410056|11943563|FG001|NOT COMPLETED|Overall Study||2
10549225|NCT01524133|11703198|FG001|STARTED|Overall Study 52 Weeks||69
10549226|NCT01524133|11703199|FG002|STARTED|Overall Study 52 Weeks||67
10549227|NCT01524133|11703197|FG000|COMPLETED|Overall Study 52 Weeks||50
10549228|NCT01524133|11703198|FG001|COMPLETED|Overall Study 52 Weeks||49
10549229|NCT01524133|11703199|FG002|COMPLETED|Overall Study 52 Weeks||40
10549230|NCT01524133|11703197|FG000|NOT COMPLETED|Overall Study 52 Weeks||21
10549231|NCT01524133|11703198|FG001|NOT COMPLETED|Overall Study 52 Weeks||20
10549232|NCT01524133|11703199|FG002|NOT COMPLETED|Overall Study 52 Weeks||27
10549233|NCT01524198|11703209|FG000|STARTED|Overall Study||471
10549234|NCT01524198|11703210|FG001|STARTED|Overall Study||474
10549235|NCT01524198|11703209|FG000|COMPLETED|Overall Study||448
10781584|NCT03410056|11943564|FG002|NOT COMPLETED|Overall Study||8
10781585|NCT03410056|11943565|FG003|NOT COMPLETED|Overall Study||5
10781586|NCT03410056|11943566|FG004|NOT COMPLETED|Overall Study||0
10781587|NCT03410056|11943567|FG005|NOT COMPLETED|Overall Study||0
10781588|NCT03410056|11943568|FG006|NOT COMPLETED|Overall Study||0
10781589|NCT03410628|11943584|FG000|STARTED|Overall Study||21
10781590|NCT03410628|11943584|FG000|COMPLETED|Overall Study||15
10549236|NCT01524198|11703210|FG001|COMPLETED|Overall Study||458
10549237|NCT01524198|11703209|FG000|NOT COMPLETED|Overall Study||23
10549238|NCT01524198|11703210|FG001|NOT COMPLETED|Overall Study||16
10549239|NCT01524224|11703224|FG000|STARTED|Overall Study||4
10549240|NCT01524224|11703225|FG001|STARTED|Overall Study||3
10549241|NCT01524224|11703226|FG002|STARTED|Overall Study||3
10549242|NCT01524224|11703227|FG003|STARTED|Overall Study||3
10549243|NCT01524224|11703228|FG004|STARTED|Overall Study||4
10549244|NCT01524224|11703229|FG005|STARTED|Overall Study||3
10549245|NCT01524224|11703230|FG006|STARTED|Overall Study||3
10549246|NCT01524224|11703231|FG007|STARTED|Overall Study||6
10549247|NCT01524224|11703224|FG000|Received at Least One Dose of Study Drug|Overall Study||4
10549248|NCT01524224|11703225|FG001|Received at Least One Dose of Study Drug|Overall Study||3
10549249|NCT01524224|11703226|FG002|Received at Least One Dose of Study Drug|Overall Study||3
10549250|NCT01524224|11703227|FG003|Received at Least One Dose of Study Drug|Overall Study||3
10549251|NCT01524224|11703228|FG004|Received at Least One Dose of Study Drug|Overall Study||4
10549252|NCT01524224|11703229|FG005|Received at Least One Dose of Study Drug|Overall Study||3
10549253|NCT01524224|11703230|FG006|Received at Least One Dose of Study Drug|Overall Study||3
10549254|NCT01524224|11703231|FG007|Received at Least One Dose of Study Drug|Overall Study||6
10549255|NCT01524224|11703224|FG000|COMPLETED|Overall Study||1
10549256|NCT01524224|11703225|FG001|COMPLETED|Overall Study||2
10549257|NCT01524224|11703226|FG002|COMPLETED|Overall Study||1
10549258|NCT01524224|11703227|FG003|COMPLETED|Overall Study||1
10549259|NCT01524224|11703228|FG004|COMPLETED|Overall Study||0
10549260|NCT01524224|11703229|FG005|COMPLETED|Overall Study||1
10549261|NCT01524224|11703230|FG006|COMPLETED|Overall Study||0
10549262|NCT01524224|11703231|FG007|COMPLETED|Overall Study||0
10549263|NCT01524224|11703224|FG000|NOT COMPLETED|Overall Study||3
10549264|NCT01524224|11703225|FG001|NOT COMPLETED|Overall Study||1
10549265|NCT01524224|11703226|FG002|NOT COMPLETED|Overall Study||2
10549266|NCT01524224|11703227|FG003|NOT COMPLETED|Overall Study||2
10549267|NCT01524224|11703228|FG004|NOT COMPLETED|Overall Study||4
10549268|NCT01524224|11703229|FG005|NOT COMPLETED|Overall Study||2
10549269|NCT01524224|11703230|FG006|NOT COMPLETED|Overall Study||3
10549270|NCT01524224|11703231|FG007|NOT COMPLETED|Overall Study||6
10549271|NCT01524289|11703251|FG000|STARTED|Overall Study||204
10549272|NCT01524289|11703252|FG001|STARTED|Overall Study||102
10549273|NCT01524289|11703251|FG000|Treated|Overall Study||203
10549274|NCT01524289|11703252|FG001|Treated|Overall Study||102
10549275|NCT01524289|11703251|FG000|COMPLETED|Overall Study||174
10549276|NCT01524289|11703252|FG001|COMPLETED|Overall Study||88
10549277|NCT01524289|11703251|FG000|NOT COMPLETED|Overall Study||30
10549278|NCT01524289|11703252|FG001|NOT COMPLETED|Overall Study||14
10549279|NCT01524302|11703262|FG000|STARTED|Overall Study||6
10549280|NCT01524302|11703263|FG001|STARTED|Overall Study||6
10549281|NCT01524302|11703262|FG000|COMPLETED|Overall Study||6
10549282|NCT01524302|11703263|FG001|COMPLETED|Overall Study||6
10549283|NCT01524302|11703262|FG000|NOT COMPLETED|Overall Study||0
10549284|NCT01524302|11703263|FG001|NOT COMPLETED|Overall Study||0
10549285|NCT01524627|11703275|FG000|STARTED|Overall Study||22
10549286|NCT01524627|11703276|FG001|STARTED|Overall Study||21
10549287|NCT01524627|11703275|FG000|COMPLETED|Overall Study||21
10549288|NCT01524627|11703276|FG001|COMPLETED|Overall Study||19
10549289|NCT01524627|11703275|FG000|NOT COMPLETED|Overall Study||1
10549290|NCT01524627|11703276|FG001|NOT COMPLETED|Overall Study||2
10549291|NCT01524679|11703284|FG000|STARTED|Overall Study||112
10549292|NCT01524679|11703285|FG001|STARTED|Overall Study||58
10549293|NCT01524679|11703284|FG000|COMPLETED|Overall Study||89
10549294|NCT01524679|11703285|FG001|COMPLETED|Overall Study||49
10549295|NCT01524679|11703284|FG000|NOT COMPLETED|Overall Study||23
10549296|NCT01524679|11703285|FG001|NOT COMPLETED|Overall Study||9
10549297|NCT01524692|11703291|FG000|STARTED|Overall Study||35
10549298|NCT01524692|11703291|FG000|COMPLETED|Overall Study||32
10549299|NCT01524692|11703291|FG000|NOT COMPLETED|Overall Study||3
10549300|NCT01524770|11703296|FG000|STARTED|First Intervention||26
10549301|NCT01524770|11703297|FG001|STARTED|First Intervention||24
10549302|NCT01524770|11703296|FG000|Received at Least 1 Dose of Study Drug|First Intervention||26
10549303|NCT01524770|11703297|FG001|Received at Least 1 Dose of Study Drug|First Intervention||24
10549304|NCT01524770|11703296|FG000|COMPLETED|First Intervention||23
10549305|NCT01524770|11703297|FG001|COMPLETED|First Intervention||23
10549306|NCT01524770|11703296|FG000|NOT COMPLETED|First Intervention||3
10549307|NCT01524770|11703297|FG001|NOT COMPLETED|First Intervention||1
10549308|NCT01524770|11703296|FG000|STARTED|Washout Period of at Least 28 Days||23
10549309|NCT01524770|11703297|FG001|STARTED|Washout Period of at Least 28 Days||23
10549310|NCT01524770|11703296|FG000|COMPLETED|Washout Period of at Least 28 Days||23
10549311|NCT01524770|11703297|FG001|COMPLETED|Washout Period of at Least 28 Days||23
10549312|NCT01524770|11703296|FG000|NOT COMPLETED|Washout Period of at Least 28 Days||0
10549313|NCT01524770|11703297|FG001|NOT COMPLETED|Washout Period of at Least 28 Days||0
10549314|NCT01524770|11703296|FG000|STARTED|Second Intervention||23
10549315|NCT01524770|11703297|FG001|STARTED|Second Intervention||23
10549316|NCT01524770|11703296|FG000|COMPLETED|Second Intervention||23
10549317|NCT01524770|11703297|FG001|COMPLETED|Second Intervention||23
10549318|NCT01524770|11703296|FG000|NOT COMPLETED|Second Intervention||0
10549319|NCT01524770|11703297|FG001|NOT COMPLETED|Second Intervention||0
10549320|NCT01524783|11703305|FG000|STARTED|Blinded Period||205
10549321|NCT01524783|11703306|FG001|STARTED|Blinded Period||97
10549322|NCT01524783|11703307|FG002|STARTED|Blinded Period||0
10549323|NCT01524783|11703305|FG000|COMPLETED|Blinded Period||26
10549324|NCT01524783|11703306|FG001|COMPLETED|Blinded Period||6
10549325|NCT01524783|11703307|FG002|COMPLETED|Blinded Period||0
10549326|NCT01524783|11703305|FG000|NOT COMPLETED|Blinded Period||179
10549327|NCT01524783|11703306|FG001|NOT COMPLETED|Blinded Period||91
10549328|NCT01524783|11703307|FG002|NOT COMPLETED|Blinded Period||0
10549329|NCT01524783|11703305|FG000|STARTED|Open-label Period||26
10549330|NCT01524783|11703306|FG001|STARTED|Open-label Period||0
10549331|NCT01524783|11703307|FG002|STARTED|Open-label Period||6
10549332|NCT01524783|11703305|FG000|COMPLETED|Open-label Period||0
10549333|NCT01524783|11703306|FG001|COMPLETED|Open-label Period||0
10781591|NCT03410628|11943584|FG000|NOT COMPLETED|Overall Study||6
10781592|NCT03410797|11943588|FG000|STARTED|Overall Study||11
10781593|NCT03410797|11943588|FG000|COMPLETED|Overall Study||11
10781594|NCT03410797|11943588|FG000|NOT COMPLETED|Overall Study||0
10781595|NCT03410862|11943595|FG000|STARTED|Overall Study||43
10781596|NCT03410862|11943596|FG001|STARTED|Overall Study||44
10781597|NCT03410862|11943595|FG000|COMPLETED|Overall Study||41
10781598|NCT03410862|11943596|FG001|COMPLETED|Overall Study||42
10781599|NCT03410862|11943595|FG000|NOT COMPLETED|Overall Study||2
10781600|NCT03410862|11943596|FG001|NOT COMPLETED|Overall Study||2
10781601|NCT03410914|11943602|FG000|STARTED|Overall Study||52
10781602|NCT03410914|11943602|FG000|COMPLETED|Overall Study||52
10781603|NCT03410914|11943602|FG000|NOT COMPLETED|Overall Study||0
10781604|NCT03410953|11943606|FG000|STARTED|Overall Study|First patient recruited|67
10781605|NCT03410953|11943606|FG000|COMPLETED|Overall Study|67 participants were enrolled in the Clinical Trial and included the analyses|67
10781606|NCT03410953|11943606|FG000|NOT COMPLETED|Overall Study||0
10781607|NCT03411902|11943612|FG000|STARTED|Overall Study||11
10781608|NCT03411902|11943613|FG001|STARTED|Overall Study||13
10781609|NCT03411902|11943612|FG000|COMPLETED|Overall Study||8
10781610|NCT03411902|11943613|FG001|COMPLETED|Overall Study||13
10781611|NCT03411902|11943612|FG000|NOT COMPLETED|Overall Study||3
10781612|NCT03411902|11943613|FG001|NOT COMPLETED|Overall Study||0
10781613|NCT03412019|11943621|FG000|STARTED|Overall Study||11
10781614|NCT03412019|11943622|FG001|STARTED|Overall Study||11
10781615|NCT03412019|11943621|FG000|COMPLETED|Overall Study||10
10781616|NCT03412019|11943622|FG001|COMPLETED|Overall Study||10
10781617|NCT03412019|11943621|FG000|NOT COMPLETED|Overall Study||1
10781618|NCT03412019|11943622|FG001|NOT COMPLETED|Overall Study||1
10781619|NCT03412084|11943630|FG000|STARTED|Overall Study||48
10781620|NCT03412084|11943631|FG001|STARTED|Overall Study||36
10781621|NCT03412084|11943630|FG000|COMPLETED|Overall Study||44
10781622|NCT03412084|11943631|FG001|COMPLETED|Overall Study||35
10781623|NCT03412084|11943630|FG000|NOT COMPLETED|Overall Study||4
10781624|NCT03412084|11943631|FG001|NOT COMPLETED|Overall Study||1
10781625|NCT03412734|11943639|FG000|STARTED|Overall Study||47
10781626|NCT03412734|11943640|FG001|STARTED|Overall Study||41
10781627|NCT03412734|11943639|FG000|COMPLETED|Overall Study||44
10781628|NCT03412734|11943640|FG001|COMPLETED|Overall Study||41
10781629|NCT03412734|11943639|FG000|NOT COMPLETED|Overall Study||3
10781630|NCT03412734|11943640|FG001|NOT COMPLETED|Overall Study||0
10781631|NCT03412929|11943646|FG000|STARTED|Overall Study||8
10781632|NCT03412929|11943646|FG000|COMPLETED|Overall Study||5
10781633|NCT03412929|11943646|FG000|NOT COMPLETED|Overall Study||3
10781634|NCT03413618|11943652|FG000|STARTED|Overall Study||45
10781635|NCT03413618|11943653|FG001|STARTED|Overall Study||45
10781636|NCT03413618|11943652|FG000|COMPLETED|Overall Study||45
10549334|NCT01524783|11703307|FG002|COMPLETED|Open-label Period||0
10549335|NCT01524783|11703305|FG000|NOT COMPLETED|Open-label Period||26
10549336|NCT01524783|11703306|FG001|NOT COMPLETED|Open-label Period||0
10549337|NCT01524783|11703307|FG002|NOT COMPLETED|Open-label Period||6
10549338|NCT01524796|11703319|FG000|STARTED|Overall Study||128
10549339|NCT01524796|11703319|FG000|COMPLETED|Overall Study||100
10549340|NCT01524796|11703319|FG000|NOT COMPLETED|Overall Study||28
10781637|NCT03413618|11943653|FG001|COMPLETED|Overall Study||45
10781638|NCT03413618|11943652|FG000|NOT COMPLETED|Overall Study||0
10781639|NCT03413618|11943653|FG001|NOT COMPLETED|Overall Study||0
10549341|NCT01524887|11703326|FG000|STARTED|Overall Study||85
10549342|NCT01524887|11703327|FG001|STARTED|Overall Study||90
10549343|NCT01524887|11703328|FG002|STARTED|Overall Study||86
10549344|NCT01524887|11703326|FG000|Received Treatment|Overall Study||83
10781656|NCT03414359|11943679|FG000|STARTED|Overall Study||35
10781657|NCT03414359|11943680|FG001|STARTED|Overall Study||35
10781658|NCT03414359|11943679|FG000|COMPLETED|Overall Study||34
10781659|NCT03414359|11943680|FG001|COMPLETED|Overall Study||33
10781660|NCT03414359|11943679|FG000|NOT COMPLETED|Overall Study||1
10781661|NCT03414359|11943680|FG001|NOT COMPLETED|Overall Study||2
10781662|NCT03415152|11943686|FG000|STARTED|Overall Study||3000
10781663|NCT03415152|11943686|FG000|COMPLETED|Overall Study||1975
10781664|NCT03415152|11943686|FG000|NOT COMPLETED|Overall Study||1025
10781665|NCT03415178|11943695|FG000|STARTED|Parallel-Arm Period (up to Week 4)|Randomized|34
10781666|NCT03415178|11943696|FG001|STARTED|Parallel-Arm Period (up to Week 4)|Randomized|35
10781667|NCT03415178|11943695|FG000|Treated|Parallel-Arm Period (up to Week 4)||34
10781668|NCT03415178|11943696|FG001|Treated|Parallel-Arm Period (up to Week 4)||33
10781669|NCT03415178|11943695|FG000|COMPLETED|Parallel-Arm Period (up to Week 4)|33 participants entered in single arm period & 1 participant decided not to enter single arm period.|34
10781670|NCT03415178|11943696|FG001|COMPLETED|Parallel-Arm Period (up to Week 4)|32 participants entered in single arm period & 1 participant decided not to enter single arm period.|33
10781671|NCT03415178|11943695|FG000|NOT COMPLETED|Parallel-Arm Period (up to Week 4)||0
10781672|NCT03415178|11943696|FG001|NOT COMPLETED|Parallel-Arm Period (up to Week 4)||2
10781673|NCT03415178|11943695|FG000|STARTED|Single Arm Period (up to Week 16)|Out of 34 participants from AI group, 33 participants entered entered in single arm period.|0
10781674|NCT03415178|11943696|FG001|STARTED|Single Arm Period (up to Week 16)|65 (participants completed period 1) + 1 (randomized to SYDNEY arm but not treated in period 1).|66
10781675|NCT03415178|11943695|FG000|COMPLETED|Single Arm Period (up to Week 16)||0
10781676|NCT03415178|11943696|FG001|COMPLETED|Single Arm Period (up to Week 16)||65
10781677|NCT03415178|11943695|FG000|NOT COMPLETED|Single Arm Period (up to Week 16)||0
10781678|NCT03415178|11943696|FG001|NOT COMPLETED|Single Arm Period (up to Week 16)||1
10781679|NCT03415243|11943708|FG000|STARTED|Overall Study||14
10781680|NCT03415243|11943709|FG001|STARTED|Overall Study||14
10781681|NCT03415243|11943708|FG000|COMPLETED|Overall Study||14
10781682|NCT03415243|11943709|FG001|COMPLETED|Overall Study||14
10781683|NCT03415243|11943708|FG000|NOT COMPLETED|Overall Study||0
10781684|NCT03415243|11943709|FG001|NOT COMPLETED|Overall Study||0
10781685|NCT03415581|11943717|FG000|STARTED|Overall Study||7
10781686|NCT03415581|11943718|FG001|STARTED|Overall Study||6
10781687|NCT03415581|11943717|FG000|COMPLETED|Overall Study||1
10781688|NCT03415581|11943718|FG001|COMPLETED|Overall Study||1
10781689|NCT03415581|11943717|FG000|NOT COMPLETED|Overall Study||6
10781690|NCT03415581|11943718|FG001|NOT COMPLETED|Overall Study||5
10781691|NCT03416127|11943729|FG000|STARTED|Overall Study||12
10781692|NCT03416127|11943730|FG001|STARTED|Overall Study||12
10781693|NCT03416127|11943731|FG002|STARTED|Overall Study||12
10781694|NCT03416127|11943729|FG000|COMPLETED|Overall Study||12
10781695|NCT03416127|11943730|FG001|COMPLETED|Overall Study||11
10781696|NCT03416127|11943731|FG002|COMPLETED|Overall Study||11
10781697|NCT03416127|11943729|FG000|NOT COMPLETED|Overall Study||0
10781698|NCT03416127|11943730|FG001|NOT COMPLETED|Overall Study||1
10781699|NCT03416127|11943731|FG002|NOT COMPLETED|Overall Study||1
10781700|NCT03416621|11943743|FG000|STARTED|Overall Study||13
10781701|NCT03416621|11943744|FG001|STARTED|Overall Study||12
10781702|NCT03416621|11943745|FG002|STARTED|Overall Study||6
10781703|NCT03416621|11943743|FG000|COMPLETED|Overall Study||13
10781704|NCT03416621|11943744|FG001|COMPLETED|Overall Study||11
10781705|NCT03416621|11943745|FG002|COMPLETED|Overall Study||1
10781706|NCT03416621|11943743|FG000|NOT COMPLETED|Overall Study||0
10781707|NCT03416621|11943744|FG001|NOT COMPLETED|Overall Study||1
10781708|NCT03416621|11943745|FG002|NOT COMPLETED|Overall Study||5
10781709|NCT03416946|11943757|FG000|STARTED|Overall Study||25
10781710|NCT03416946|11943758|FG001|STARTED|Overall Study||29
10781711|NCT03416946|11943757|FG000|COMPLETED|Overall Study||25
10781712|NCT03416946|11943758|FG001|COMPLETED|Overall Study||29
10781713|NCT03416946|11943757|FG000|NOT COMPLETED|Overall Study||0
10781714|NCT03416946|11943758|FG001|NOT COMPLETED|Overall Study||0
10781715|NCT03416985|11943767|FG000|STARTED|Overall Study||30
10781716|NCT03416985|11943768|FG001|STARTED|Overall Study||30
10781717|NCT03416985|11943769|FG002|STARTED|Overall Study||30
10781718|NCT03416985|11943767|FG000|COMPLETED|Overall Study||28
10781719|NCT03416985|11943768|FG001|COMPLETED|Overall Study||30
10781720|NCT03416985|11943769|FG002|COMPLETED|Overall Study||24
10781721|NCT03416985|11943767|FG000|NOT COMPLETED|Overall Study||2
10781722|NCT03416985|11943768|FG001|NOT COMPLETED|Overall Study||0
10781723|NCT03416985|11943769|FG002|NOT COMPLETED|Overall Study||6
10781724|NCT03417024|11943780|FG000|STARTED|Overall Study||13
10781725|NCT03417024|11943780|FG000|COMPLETED|Overall Study||0
10781726|NCT03417024|11943780|FG000|NOT COMPLETED|Overall Study||13
10781727|NCT03417141|11943784|FG000|STARTED|Overall Study||12
10781728|NCT03417141|11943784|FG000|COMPLETED|Overall Study||8
10781729|NCT03417141|11943784|FG000|NOT COMPLETED|Overall Study||4
10781730|NCT03417219|11943790|FG000|STARTED|Overall Study||8
10781731|NCT03417219|11943791|FG001|STARTED|Overall Study||8
10781732|NCT03417219|11943790|FG000|COMPLETED|Overall Study||8
10781733|NCT03417219|11943791|FG001|COMPLETED|Overall Study||5
10781734|NCT03417219|11943790|FG000|NOT COMPLETED|Overall Study||0
10781735|NCT03417219|11943791|FG001|NOT COMPLETED|Overall Study||3
10781736|NCT03417466|11943797|FG000|STARTED|Overall Study||66
10781737|NCT03417466|11943797|FG000|COMPLETED|Overall Study||66
10781738|NCT03417466|11943797|FG000|NOT COMPLETED|Overall Study||0
10781739|NCT03417505|11943801|FG000|STARTED|First Lens Type (30 Days)||9
10781740|NCT03417505|11943802|FG001|STARTED|First Lens Type (30 Days)||12
10781741|NCT03417505|11943801|FG000|COMPLETED|First Lens Type (30 Days)||8
10781742|NCT03417505|11943802|FG001|COMPLETED|First Lens Type (30 Days)||11
10781743|NCT03417505|11943801|FG000|NOT COMPLETED|First Lens Type (30 Days)||1
10781744|NCT03417505|11943802|FG001|NOT COMPLETED|First Lens Type (30 Days)||1
10781745|NCT03417505|11943801|FG000|STARTED|Washout Period (7 Days)||8
10781746|NCT03417505|11943802|FG001|STARTED|Washout Period (7 Days)||11
10781747|NCT03417505|11943801|FG000|COMPLETED|Washout Period (7 Days)||8
10781748|NCT03417505|11943802|FG001|COMPLETED|Washout Period (7 Days)||11
10781749|NCT03417505|11943801|FG000|NOT COMPLETED|Washout Period (7 Days)||0
10781750|NCT03417505|11943802|FG001|NOT COMPLETED|Washout Period (7 Days)||0
10781751|NCT03417505|11943801|FG000|STARTED|Second Lens Type (30 Days)||8
10781752|NCT03417505|11943802|FG001|STARTED|Second Lens Type (30 Days)||11
10781753|NCT03417505|11943801|FG000|COMPLETED|Second Lens Type (30 Days)||8
10781754|NCT03417505|11943802|FG001|COMPLETED|Second Lens Type (30 Days)||11
10781755|NCT03417505|11943801|FG000|NOT COMPLETED|Second Lens Type (30 Days)||0
10781756|NCT03417505|11943802|FG001|NOT COMPLETED|Second Lens Type (30 Days)||0
10781757|NCT03417557|11943808|FG000|STARTED|1st Intervention (3 Hours)||8
10781758|NCT03417557|11943809|FG001|STARTED|1st Intervention (3 Hours)||9
10781759|NCT03417557|11943808|FG000|COMPLETED|1st Intervention (3 Hours)||8
10781760|NCT03417557|11943809|FG001|COMPLETED|1st Intervention (3 Hours)||9
10781761|NCT03417557|11943808|FG000|NOT COMPLETED|1st Intervention (3 Hours)||0
10781762|NCT03417557|11943809|FG001|NOT COMPLETED|1st Intervention (3 Hours)||0
10781763|NCT03417557|11943808|FG000|STARTED|2nd Intervention (3 Hours)||9
10781764|NCT03417557|11943809|FG001|STARTED|2nd Intervention (3 Hours)||8
10781765|NCT03417557|11943808|FG000|COMPLETED|2nd Intervention (3 Hours)||9
10781766|NCT03417557|11943809|FG001|COMPLETED|2nd Intervention (3 Hours)||8
10781767|NCT03417557|11943808|FG000|NOT COMPLETED|2nd Intervention (3 Hours)||0
10781768|NCT03417557|11943809|FG001|NOT COMPLETED|2nd Intervention (3 Hours)||0
10781769|NCT03417713|11943815|FG000|STARTED|Overall Study||33
10781770|NCT03417713|11943815|FG000|COMPLETED|Overall Study||30
10781771|NCT03417713|11943815|FG000|NOT COMPLETED|Overall Study||3
10781772|NCT03417739|11943819|FG000|STARTED|Overall Study||13
10781773|NCT03417739|11943819|FG000|COMPLETED|Overall Study||13
10781774|NCT03417739|11943819|FG000|NOT COMPLETED|Overall Study||0
10781775|NCT03417752|11943826|FG000|STARTED|Overall Study||149
10781776|NCT03417752|11943827|FG001|STARTED|Overall Study||175
10781777|NCT03417752|11943828|FG002|STARTED|Overall Study||150
10781778|NCT03417752|11943826|FG000|COMPLETED|Overall Study||115
10781779|NCT03417752|11943827|FG001|COMPLETED|Overall Study||133
10781780|NCT03417752|11943828|FG002|COMPLETED|Overall Study||110
10781781|NCT03417752|11943826|FG000|NOT COMPLETED|Overall Study||34
10781782|NCT03417752|11943827|FG001|NOT COMPLETED|Overall Study||42
10781783|NCT03417752|11943828|FG002|NOT COMPLETED|Overall Study||40
10781784|NCT03417778|11943838|FG000|STARTED|Overall Study||10
10781785|NCT03417778|11943839|FG001|STARTED|Overall Study||10
10781786|NCT03417778|11943838|FG000|COMPLETED|Overall Study||10
10781787|NCT03417778|11943839|FG001|COMPLETED|Overall Study||10
10781788|NCT03417778|11943838|FG000|NOT COMPLETED|Overall Study||0
10781789|NCT03417778|11943839|FG001|NOT COMPLETED|Overall Study||0
10781790|NCT03417804|11943845|FG000|STARTED|Overall Study|at least 360 patients|366
10781791|NCT03417804|11943845|FG000|COMPLETED|Overall Study||366
10781792|NCT03417804|11943845|FG000|NOT COMPLETED|Overall Study||0
10781793|NCT03417830|11943852|FG000|STARTED|Part A (up to 26 Days)||2
10781794|NCT03417830|11943853|FG001|STARTED|Part A (up to 26 Days)||0
10781795|NCT03417830|11943852|FG000|COMPLETED|Part A (up to 26 Days)||1
10781796|NCT03417830|11943853|FG001|COMPLETED|Part A (up to 26 Days)||0
10781797|NCT03417830|11943852|FG000|NOT COMPLETED|Part A (up to 26 Days)||1
10781798|NCT03417830|11943853|FG001|NOT COMPLETED|Part A (up to 26 Days)||0
10781799|NCT03417830|11943852|FG000|STARTED|Part B (up to 26 Days)||0
10781800|NCT03417830|11943853|FG001|STARTED|Part B (up to 26 Days)||0
10781801|NCT03417830|11943852|FG000|COMPLETED|Part B (up to 26 Days)||0
10781802|NCT03417830|11943853|FG001|COMPLETED|Part B (up to 26 Days)||0
10781803|NCT03417830|11943852|FG000|NOT COMPLETED|Part B (up to 26 Days)||0
10781804|NCT03417830|11943853|FG001|NOT COMPLETED|Part B (up to 26 Days)||0
10781805|NCT03418051|11943863|FG000|STARTED|Overall Study||20
10781806|NCT03418051|11943864|FG001|STARTED|Overall Study||20
10781807|NCT03418051|11943865|FG002|STARTED|Overall Study||20
10781808|NCT03418051|11943863|FG000|COMPLETED|Overall Study||14
10781809|NCT03418051|11943864|FG001|COMPLETED|Overall Study||18
10781810|NCT03418051|11943865|FG002|COMPLETED|Overall Study||17
10781811|NCT03418051|11943863|FG000|NOT COMPLETED|Overall Study||6
10781812|NCT03418051|11943864|FG001|NOT COMPLETED|Overall Study||2
10781813|NCT03418051|11943865|FG002|NOT COMPLETED|Overall Study||3
10781814|NCT03418064|11943873|FG000|STARTED|First Intervention (1 Month)||21
10781815|NCT03418064|11943874|FG001|STARTED|First Intervention (1 Month)||21
10781816|NCT03418064|11943873|FG000|COMPLETED|First Intervention (1 Month)||21
10781817|NCT03418064|11943874|FG001|COMPLETED|First Intervention (1 Month)||21
10781818|NCT03418064|11943873|FG000|NOT COMPLETED|First Intervention (1 Month)||0
10781819|NCT03418064|11943874|FG001|NOT COMPLETED|First Intervention (1 Month)||0
10781820|NCT03418064|11943873|FG000|STARTED|Second Intervention (1 Month)||21
10781821|NCT03418064|11943874|FG001|STARTED|Second Intervention (1 Month)||21
10781822|NCT03418064|11943873|FG000|COMPLETED|Second Intervention (1 Month)||21
10781823|NCT03418064|11943874|FG001|COMPLETED|Second Intervention (1 Month)||21
10781824|NCT03418064|11943873|FG000|NOT COMPLETED|Second Intervention (1 Month)||0
10781825|NCT03418064|11943874|FG001|NOT COMPLETED|Second Intervention (1 Month)||0
10781826|NCT03418324|11943890|FG000|STARTED|Overall Study||3
10781827|NCT03418324|11943891|FG001|STARTED|Overall Study||8
10781828|NCT03418324|11943890|FG000|COMPLETED|Overall Study||2
10781829|NCT03418324|11943891|FG001|COMPLETED|Overall Study||6
10781830|NCT03418324|11943890|FG000|NOT COMPLETED|Overall Study||1
10781831|NCT03418324|11943891|FG001|NOT COMPLETED|Overall Study||2
10781832|NCT03418376|11943901|FG000|STARTED|Overall Study||12
10781833|NCT03418376|11943902|FG001|STARTED|Overall Study||11
10781834|NCT03418376|11943903|FG002|STARTED|Overall Study||11
10781835|NCT03418376|11943904|FG003|STARTED|Overall Study||11
10781836|NCT03418376|11943901|FG000|COMPLETED|Overall Study||11
10781837|NCT03418376|11943902|FG001|COMPLETED|Overall Study||6
10781838|NCT03418376|11943903|FG002|COMPLETED|Overall Study||8
10781839|NCT03418376|11943904|FG003|COMPLETED|Overall Study||10
10781840|NCT03418376|11943901|FG000|NOT COMPLETED|Overall Study||1
10781841|NCT03418376|11943902|FG001|NOT COMPLETED|Overall Study||5
10781842|NCT03418376|11943903|FG002|NOT COMPLETED|Overall Study||3
10781843|NCT03418376|11943904|FG003|NOT COMPLETED|Overall Study||1
10781844|NCT03418545|11943916|FG000|STARTED|Overall Study||35
10781845|NCT03418545|11943917|FG001|STARTED|Overall Study||105
10781846|NCT03418545|11943916|FG000|Safety Population|Overall Study||34
10781847|NCT03418545|11943917|FG001|Safety Population|Overall Study||105
10781848|NCT03418545|11943916|FG000|Received Optional or Repeat Treatment|Overall Study||29
10781849|NCT03418545|11943917|FG001|Received Optional or Repeat Treatment|Overall Study||37
10781850|NCT03418545|11943916|FG000|COMPLETED|Overall Study||30
10781851|NCT03418545|11943917|FG001|COMPLETED|Overall Study||94
10781852|NCT03418545|11943916|FG000|NOT COMPLETED|Overall Study||5
10781853|NCT03418545|11943917|FG001|NOT COMPLETED|Overall Study||11
10781854|NCT03418571|11943928|FG000|STARTED|Overall Study||12
10781855|NCT03418571|11943929|FG001|STARTED|Overall Study||3
10781856|NCT03418571|11943928|FG000|COMPLETED|Overall Study||11
10781857|NCT03418571|11943929|FG001|COMPLETED|Overall Study||3
10781858|NCT03418571|11943928|FG000|NOT COMPLETED|Overall Study||1
10781859|NCT03418571|11943929|FG001|NOT COMPLETED|Overall Study||0
10781860|NCT03418662|11943937|FG000|STARTED|Overall Study||287
10781861|NCT03418662|11943938|FG001|STARTED|Overall Study||282
10781862|NCT03418662|11943937|FG000|COMPLETED|Overall Study||284
10781863|NCT03418662|11943938|FG001|COMPLETED|Overall Study||278
10781864|NCT03418662|11943937|FG000|NOT COMPLETED|Overall Study||3
10781865|NCT03418662|11943938|FG001|NOT COMPLETED|Overall Study||4
10781866|NCT03418714|11943944|FG000|STARTED|Overall Study||13
10781867|NCT03418714|11943944|FG000|COMPLETED|Overall Study|One participant moved too much during the practice session and was therefore excluded from the scan.|12
10781868|NCT03418714|11943944|FG000|NOT COMPLETED|Overall Study||1
10781869|NCT03419078|11943951|FG000|STARTED|Overall Study||245
10781870|NCT03419078|11943952|FG001|STARTED|Overall Study||148
10781871|NCT03419078|11943953|FG002|STARTED|Overall Study||91
10781872|NCT03419078|11943951|FG000|COMPLETED|Overall Study||245
10781873|NCT03419078|11943952|FG001|COMPLETED|Overall Study||148
10781874|NCT03419078|11943953|FG002|COMPLETED|Overall Study||91
10781875|NCT03419078|11943951|FG000|NOT COMPLETED|Overall Study||0
10781876|NCT03419078|11943952|FG001|NOT COMPLETED|Overall Study||0
10781877|NCT03419078|11943953|FG002|NOT COMPLETED|Overall Study||0
10781878|NCT03419403|11943964|FG000|STARTED|Overall Study||14
10781879|NCT03419403|11943965|FG001|STARTED|Overall Study||12
10781880|NCT03419403|11943966|FG002|STARTED|Overall Study||12
10781881|NCT03419403|11943967|FG003|STARTED|Overall Study||2
10781882|NCT03419403|11943964|FG000|COMPLETED|Overall Study||2
10781883|NCT03419403|11943965|FG001|COMPLETED|Overall Study||3
10781884|NCT03419403|11943966|FG002|COMPLETED|Overall Study||0
10781885|NCT03419403|11943967|FG003|COMPLETED|Overall Study||0
10781886|NCT03419403|11943964|FG000|NOT COMPLETED|Overall Study||12
10781887|NCT03419403|11943965|FG001|NOT COMPLETED|Overall Study||9
10781888|NCT03419403|11943966|FG002|NOT COMPLETED|Overall Study||12
10781889|NCT03419403|11943967|FG003|NOT COMPLETED|Overall Study||2
10781890|NCT03419533|11943977|FG000|STARTED|Overall Study||4107
10781891|NCT03419533|11943978|FG001|STARTED|Overall Study||2695
10781892|NCT03419533|11943977|FG000|COMPLETED|Overall Study||4107
10781893|NCT03419533|11943978|FG001|COMPLETED|Overall Study||2695
10781894|NCT03419533|11943977|FG000|NOT COMPLETED|Overall Study||0
10781895|NCT03419533|11943978|FG001|NOT COMPLETED|Overall Study||0
10781896|NCT03419598|11943992|FG000|STARTED|Overall Study||30
10781897|NCT03419598|11943992|FG000|Subject Specific Tibia Models Created and Virtual Osteotomy Performed|Overall Study||28
10781898|NCT03419598|11943992|FG000|Virtual Cohort Duplicated Into A. Personalised and B. Generic Copies|Overall Study||28
10781899|NCT03419598|11943992|FG000|Finite Element (FE) Model Created for Cohort Copy Stabilised by Personalised HTO Plate|Overall Study||28
10781900|NCT03419598|11943992|FG000|FE Models Created for Cohort Copy Stabilised by Generic HTO Plate|Overall Study||28
10781901|NCT03419598|11943992|FG000|FE Models Solved for Personalised HTO Plate Stabilised Cohort Copy|Overall Study||28
10781902|NCT03419598|11943992|FG000|FE Models Solved for Generic HTO Plate Stabilised Cohort Copy|Overall Study||28
10781903|NCT03419598|11943992|FG000|COMPLETED|Overall Study||28
10781904|NCT03419598|11943992|FG000|NOT COMPLETED|Overall Study||2
10781905|NCT03419780|11944000|FG000|STARTED|Overall Study||33
10781906|NCT03419780|11944001|FG001|STARTED|Overall Study||33
10781907|NCT03419780|11944000|FG000|COMPLETED|Overall Study||33
10781908|NCT03419780|11944001|FG001|COMPLETED|Overall Study||33
10781909|NCT03419780|11944000|FG000|NOT COMPLETED|Overall Study||0
10781910|NCT03419780|11944001|FG001|NOT COMPLETED|Overall Study||0
10781911|NCT03419962|11944007|FG000|STARTED|Overall Study||1359
10781912|NCT03419962|11944007|FG000|COMPLETED|Overall Study||1322
10781913|NCT03419962|11944007|FG000|NOT COMPLETED|Overall Study||37
10781914|NCT03420300|11944011|FG000|STARTED|Overall Study||40
10781915|NCT03420300|11944011|FG000|COMPLETED|Overall Study||38
10781916|NCT03420300|11944011|FG000|NOT COMPLETED|Overall Study||2
10781917|NCT03420625|11944015|FG000|STARTED|Overall Study||10
10781918|NCT03420625|11944015|FG000|Baseline|Overall Study||10
10781919|NCT03420625|11944015|FG000|Foot IPC|Overall Study||10
10781920|NCT03420625|11944015|FG000|Rapid Calf IPC|Overall Study||10
10781921|NCT03420625|11944015|FG000|Slow Calf IPC|Overall Study||10
10781922|NCT03420625|11944015|FG000|Calf NMES|Overall Study||10
10781923|NCT03420625|11944015|FG000|COMPLETED|Overall Study||10
10781924|NCT03420625|11944015|FG000|NOT COMPLETED|Overall Study||0
10781925|NCT03421210|11944031|FG000|STARTED|Overall Study||88
10781926|NCT03421210|11944031|FG000|Received Functional Magnetic Resonance Imaging (fMRI)|Overall Study||42
10781927|NCT03421210|11944031|FG000|COMPLETED|Overall Study||35
10781928|NCT03421210|11944031|FG000|NOT COMPLETED|Overall Study||53
10781929|NCT03421379|11944037|FG000|STARTED|Period 1||34
10781930|NCT03421379|11944038|FG001|STARTED|Period 1||41
10781931|NCT03421379|11944037|FG000|Received at Least One Dose of Study Drug|Period 1||33
10781932|NCT03421379|11944038|FG001|Received at Least One Dose of Study Drug|Period 1||39
10781933|NCT03421379|11944037|FG000|COMPLETED|Period 1||32
10781934|NCT03421379|11944038|FG001|COMPLETED|Period 1||37
10781935|NCT03421379|11944037|FG000|NOT COMPLETED|Period 1||2
10781936|NCT03421379|11944038|FG001|NOT COMPLETED|Period 1||4
10781937|NCT03421379|11944037|FG000|STARTED|Washout Period (3 to 14 Days)||32
10781938|NCT03421379|11944038|FG001|STARTED|Washout Period (3 to 14 Days)||37
10781939|NCT03421379|11944037|FG000|COMPLETED|Washout Period (3 to 14 Days)||32
10781940|NCT03421379|11944038|FG001|COMPLETED|Washout Period (3 to 14 Days)||37
10781941|NCT03421379|11944037|FG000|NOT COMPLETED|Washout Period (3 to 14 Days)||0
10781942|NCT03421379|11944038|FG001|NOT COMPLETED|Washout Period (3 to 14 Days)||0
10781943|NCT03421379|11944037|FG000|STARTED|Period 2||32
10781944|NCT03421379|11944038|FG001|STARTED|Period 2||37
10781945|NCT03421379|11944037|FG000|COMPLETED|Period 2||32
10781946|NCT03421379|11944038|FG001|COMPLETED|Period 2||37
10781947|NCT03421379|11944037|FG000|NOT COMPLETED|Period 2||0
10781948|NCT03421379|11944038|FG001|NOT COMPLETED|Period 2||0
10781949|NCT03421431|11944047|FG000|STARTED|Overall Study||24
10781950|NCT03421431|11944048|FG001|STARTED|Overall Study||55
10781951|NCT03421431|11944049|FG002|STARTED|Overall Study||53
10781952|NCT03421431|11944047|FG000|COMPLETED|Overall Study||18
10781953|NCT03421431|11944048|FG001|COMPLETED|Overall Study||49
10781954|NCT03421431|11944049|FG002|COMPLETED|Overall Study||39
10781955|NCT03421431|11944047|FG000|NOT COMPLETED|Overall Study||6
10781956|NCT03421431|11944048|FG001|NOT COMPLETED|Overall Study||6
10781957|NCT03421431|11944049|FG002|NOT COMPLETED|Overall Study||14
10781958|NCT03421730|11944059|FG000|STARTED|First Intervention (Day 1, Visit 2)||1
10781959|NCT03421730|11944060|FG001|STARTED|First Intervention (Day 1, Visit 2)||3
10781960|NCT03421730|11944061|FG002|STARTED|First Intervention (Day 1, Visit 2)||1
10781961|NCT03421730|11944062|FG003|STARTED|First Intervention (Day 1, Visit 2)||1
10781962|NCT03421730|11944063|FG004|STARTED|First Intervention (Day 1, Visit 2)||3
10781963|NCT03421730|11944064|FG005|STARTED|First Intervention (Day 1, Visit 2)||1
10781964|NCT03421730|11944065|FG006|STARTED|First Intervention (Day 1, Visit 2)||1
10781965|NCT03421730|11944066|FG007|STARTED|First Intervention (Day 1, Visit 2)||1
10781966|NCT03421730|11944067|FG008|STARTED|First Intervention (Day 1, Visit 2)||1
10781967|NCT03421730|11944068|FG009|STARTED|First Intervention (Day 1, Visit 2)||2
10781968|NCT03421730|11944069|FG010|STARTED|First Intervention (Day 1, Visit 2)||1
10781969|NCT03421730|11944070|FG011|STARTED|First Intervention (Day 1, Visit 2)||1
10781970|NCT03421730|11944059|FG000|COMPLETED|First Intervention (Day 1, Visit 2)||1
10781971|NCT03421730|11944060|FG001|COMPLETED|First Intervention (Day 1, Visit 2)|Two subjects withdrew without receiving treatment with either A or C.|1
10781972|NCT03421730|11944061|FG002|COMPLETED|First Intervention (Day 1, Visit 2)||1
10781973|NCT03421730|11944062|FG003|COMPLETED|First Intervention (Day 1, Visit 2)||1
10781974|NCT03421730|11944063|FG004|COMPLETED|First Intervention (Day 1, Visit 2)||3
10781975|NCT03421730|11944064|FG005|COMPLETED|First Intervention (Day 1, Visit 2)||1
10781976|NCT03421730|11944065|FG006|COMPLETED|First Intervention (Day 1, Visit 2)||1
10781977|NCT03421730|11944066|FG007|COMPLETED|First Intervention (Day 1, Visit 2)||1
10781978|NCT03421730|11944067|FG008|COMPLETED|First Intervention (Day 1, Visit 2)||1
10781979|NCT03421730|11944068|FG009|COMPLETED|First Intervention (Day 1, Visit 2)||2
10781980|NCT03421730|11944069|FG010|COMPLETED|First Intervention (Day 1, Visit 2)||1
10781981|NCT03421730|11944070|FG011|COMPLETED|First Intervention (Day 1, Visit 2)||1
10781982|NCT03421730|11944059|FG000|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
10781983|NCT03421730|11944060|FG001|NOT COMPLETED|First Intervention (Day 1, Visit 2)||2
10781984|NCT03421730|11944061|FG002|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
10781985|NCT03421730|11944062|FG003|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
10781986|NCT03421730|11944063|FG004|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
10781987|NCT03421730|11944064|FG005|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
10781988|NCT03421730|11944065|FG006|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
10781989|NCT03421730|11944066|FG007|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
10781990|NCT03421730|11944067|FG008|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
10781991|NCT03421730|11944068|FG009|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
10781992|NCT03421730|11944069|FG010|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
10781993|NCT03421730|11944070|FG011|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
10781994|NCT03421730|11944059|FG000|STARTED|Washout (Days 4 to 10)||1
10781995|NCT03421730|11944060|FG001|STARTED|Washout (Days 4 to 10)||1
10781996|NCT03421730|11944061|FG002|STARTED|Washout (Days 4 to 10)||1
10781997|NCT03421730|11944062|FG003|STARTED|Washout (Days 4 to 10)||1
10781998|NCT03421730|11944063|FG004|STARTED|Washout (Days 4 to 10)||3
10781999|NCT03421730|11944064|FG005|STARTED|Washout (Days 4 to 10)||1
10782000|NCT03421730|11944065|FG006|STARTED|Washout (Days 4 to 10)||1
10782001|NCT03421730|11944066|FG007|STARTED|Washout (Days 4 to 10)||1
10782002|NCT03421730|11944067|FG008|STARTED|Washout (Days 4 to 10)||1
10782003|NCT03421730|11944068|FG009|STARTED|Washout (Days 4 to 10)||2
10782004|NCT03421730|11944069|FG010|STARTED|Washout (Days 4 to 10)||1
10782005|NCT03421730|11944070|FG011|STARTED|Washout (Days 4 to 10)||1
10782006|NCT03421730|11944059|FG000|COMPLETED|Washout (Days 4 to 10)||1
10782007|NCT03421730|11944060|FG001|COMPLETED|Washout (Days 4 to 10)||1
10782008|NCT03421730|11944061|FG002|COMPLETED|Washout (Days 4 to 10)||1
10782009|NCT03421730|11944062|FG003|COMPLETED|Washout (Days 4 to 10)||1
10782010|NCT03421730|11944063|FG004|COMPLETED|Washout (Days 4 to 10)|Two subjects withdrew after receiving treatment with B but before receiving treatment with C.|1
10782011|NCT03421730|11944064|FG005|COMPLETED|Washout (Days 4 to 10)||1
10782012|NCT03421730|11944065|FG006|COMPLETED|Washout (Days 4 to 10)||1
10782013|NCT03421730|11944066|FG007|COMPLETED|Washout (Days 4 to 10)||1
10782014|NCT03421730|11944067|FG008|COMPLETED|Washout (Days 4 to 10)||1
10782015|NCT03421730|11944068|FG009|COMPLETED|Washout (Days 4 to 10)||2
10782016|NCT03421730|11944069|FG010|COMPLETED|Washout (Days 4 to 10)||1
10782017|NCT03421730|11944070|FG011|COMPLETED|Washout (Days 4 to 10)||1
10782018|NCT03421730|11944059|FG000|NOT COMPLETED|Washout (Days 4 to 10)||0
10782019|NCT03421730|11944060|FG001|NOT COMPLETED|Washout (Days 4 to 10)||0
10782020|NCT03421730|11944061|FG002|NOT COMPLETED|Washout (Days 4 to 10)||0
10782021|NCT03421730|11944062|FG003|NOT COMPLETED|Washout (Days 4 to 10)||0
10782022|NCT03421730|11944063|FG004|NOT COMPLETED|Washout (Days 4 to 10)||2
10782023|NCT03421730|11944064|FG005|NOT COMPLETED|Washout (Days 4 to 10)||0
10782024|NCT03421730|11944065|FG006|NOT COMPLETED|Washout (Days 4 to 10)||0
10782025|NCT03421730|11944066|FG007|NOT COMPLETED|Washout (Days 4 to 10)||0
10782026|NCT03421730|11944067|FG008|NOT COMPLETED|Washout (Days 4 to 10)||0
10782027|NCT03421730|11944068|FG009|NOT COMPLETED|Washout (Days 4 to 10)||0
10782028|NCT03421730|11944069|FG010|NOT COMPLETED|Washout (Days 4 to 10)||0
10782029|NCT03421730|11944070|FG011|NOT COMPLETED|Washout (Days 4 to 10)||0
10782030|NCT03421730|11944059|FG000|STARTED|Second Intervention (Day 8±3, Visit 3)||1
10782031|NCT03421730|11944060|FG001|STARTED|Second Intervention (Day 8±3, Visit 3)||1
10782032|NCT03421730|11944061|FG002|STARTED|Second Intervention (Day 8±3, Visit 3)||1
10782033|NCT03421730|11944062|FG003|STARTED|Second Intervention (Day 8±3, Visit 3)||1
10782034|NCT03421730|11944063|FG004|STARTED|Second Intervention (Day 8±3, Visit 3)||1
10782035|NCT03421730|11944064|FG005|STARTED|Second Intervention (Day 8±3, Visit 3)||1
10782036|NCT03421730|11944065|FG006|STARTED|Second Intervention (Day 8±3, Visit 3)||1
10782037|NCT03421730|11944066|FG007|STARTED|Second Intervention (Day 8±3, Visit 3)||1
10782038|NCT03421730|11944067|FG008|STARTED|Second Intervention (Day 8±3, Visit 3)||1
10782039|NCT03421730|11944068|FG009|STARTED|Second Intervention (Day 8±3, Visit 3)||2
10782040|NCT03421730|11944069|FG010|STARTED|Second Intervention (Day 8±3, Visit 3)||1
10549345|NCT01524887|11703327|FG001|Received Treatment|Overall Study||85
10549346|NCT01524887|11703328|FG002|Received Treatment|Overall Study||83
10549347|NCT01524887|11703326|FG000|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
10549348|NCT01524887|11703327|FG001|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
10549349|NCT01524887|11703328|FG002|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
10549350|NCT01524887|11703326|FG000|NOT COMPLETED|Overall Study||85
10549351|NCT01524887|11703327|FG001|NOT COMPLETED|Overall Study||90
10549352|NCT01524887|11703328|FG002|NOT COMPLETED|Overall Study||86
10549353|NCT01524900|11703341|FG000|STARTED|Overall Study||49
10549354|NCT01524900|11703342|FG001|STARTED|Overall Study||246
10549355|NCT01524900|11703343|FG002|STARTED|Overall Study||30
10549356|NCT01524900|11703344|FG003|STARTED|Overall Study||22
10549357|NCT01524900|11703345|FG004|STARTED|Overall Study||40
10549358|NCT01524900|11703341|FG000|COMPLETED|Overall Study||43
10549359|NCT01524900|11703342|FG001|COMPLETED|Overall Study||232
10549360|NCT01524900|11703343|FG002|COMPLETED|Overall Study||29
10549361|NCT01524900|11703344|FG003|COMPLETED|Overall Study||21
10549362|NCT01524900|11703345|FG004|COMPLETED|Overall Study||40
10549363|NCT01524900|11703341|FG000|NOT COMPLETED|Overall Study||6
10549364|NCT01524900|11703342|FG001|NOT COMPLETED|Overall Study||14
10549365|NCT01524900|11703343|FG002|NOT COMPLETED|Overall Study||1
10316355|NCT00189475|11450356|FG000|NOT COMPLETED|Overall Study||0
10782041|NCT03421730|11944070|FG011|STARTED|Second Intervention (Day 8±3, Visit 3)||1
10782042|NCT03421730|11944059|FG000|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
10782043|NCT03421730|11944060|FG001|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
10782044|NCT03421730|11944061|FG002|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
10782045|NCT03421730|11944062|FG003|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
10782046|NCT03421730|11944063|FG004|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
10782047|NCT03421730|11944064|FG005|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
10782048|NCT03421730|11944065|FG006|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
10782049|NCT03421730|11944066|FG007|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
10782050|NCT03421730|11944067|FG008|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
10782051|NCT03421730|11944068|FG009|COMPLETED|Second Intervention (Day 8±3, Visit 3)||2
10782052|NCT03421730|11944069|FG010|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
10782053|NCT03421730|11944070|FG011|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
10782054|NCT03421730|11944059|FG000|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
10782055|NCT03421730|11944060|FG001|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
10782056|NCT03421730|11944061|FG002|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
10782057|NCT03421730|11944062|FG003|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
10782058|NCT03421730|11944063|FG004|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
10782059|NCT03421730|11944064|FG005|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
10782060|NCT03421730|11944065|FG006|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
10782061|NCT03421730|11944066|FG007|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
10782062|NCT03421730|11944067|FG008|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
10782063|NCT03421730|11944068|FG009|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
10782064|NCT03421730|11944069|FG010|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
10782065|NCT03421730|11944070|FG011|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
10782066|NCT03421886|11944086|FG000|STARTED|Overall Study||30
10782067|NCT03421886|11944087|FG001|STARTED|Overall Study||15
10782068|NCT03421886|11944086|FG000|COMPLETED|Overall Study||23
10782069|NCT03421886|11944087|FG001|COMPLETED|Overall Study||13
10782070|NCT03421886|11944086|FG000|NOT COMPLETED|Overall Study||7
10782071|NCT03421886|11944087|FG001|NOT COMPLETED|Overall Study||2
10782072|NCT03422159|11944095|FG000|STARTED|Overall Study||70
10782073|NCT03422159|11944096|FG001|STARTED|Overall Study||70
10782074|NCT03422159|11944095|FG000|COMPLETED|Overall Study||68
10782075|NCT03422159|11944096|FG001|COMPLETED|Overall Study||69
10782076|NCT03422159|11944095|FG000|NOT COMPLETED|Overall Study||2
10782077|NCT03422159|11944096|FG001|NOT COMPLETED|Overall Study||1
10782078|NCT03422172|11944104|FG000|STARTED|Oral lead-in Phase (4 Weeks)||48
10782079|NCT03422172|11944104|FG000|COMPLETED|Oral lead-in Phase (4 Weeks)||47
10782080|NCT03422172|11944104|FG000|NOT COMPLETED|Oral lead-in Phase (4 Weeks)||1
10782081|NCT03422172|11944104|FG000|STARTED|Washout (7 Days)||47
10782082|NCT03422172|11944104|FG000|COMPLETED|Washout (7 Days)||47
10782083|NCT03422172|11944104|FG000|NOT COMPLETED|Washout (7 Days)||0
10782084|NCT03422172|11944104|FG000|STARTED|Injection Phase (Week 5 to Week 41)||47
10782085|NCT03422172|11944104|FG000|COMPLETED|Injection Phase (Week 5 to Week 41)||43
10782086|NCT03422172|11944104|FG000|NOT COMPLETED|Injection Phase (Week 5 to Week 41)||4
10782087|NCT03422172|11944104|FG000|STARTED|Long Term Follow-up Phase(Upto Week 89)||43
10782088|NCT03422172|11944104|FG000|COMPLETED|Long Term Follow-up Phase(Upto Week 89)||43
10782089|NCT03422172|11944104|FG000|NOT COMPLETED|Long Term Follow-up Phase(Upto Week 89)||0
10782090|NCT03422250|11944117|FG000|STARTED|Intervention||11
10782091|NCT03422250|11944118|FG001|STARTED|Intervention||11
10782092|NCT03422250|11944119|FG002|STARTED|Intervention||12
10782093|NCT03422250|11944120|FG003|STARTED|Intervention||11
10782094|NCT03422250|11944117|FG000|COMPLETED|Intervention||10
10782095|NCT03422250|11944118|FG001|COMPLETED|Intervention||10
10782096|NCT03422250|11944119|FG002|COMPLETED|Intervention||10
10782097|NCT03422250|11944120|FG003|COMPLETED|Intervention||10
10782098|NCT03422250|11944117|FG000|NOT COMPLETED|Intervention||1
10782099|NCT03422250|11944118|FG001|NOT COMPLETED|Intervention||1
10782100|NCT03422250|11944119|FG002|NOT COMPLETED|Intervention||2
10782101|NCT03422250|11944120|FG003|NOT COMPLETED|Intervention||1
10782102|NCT03422250|11944117|FG000|STARTED|Follow-up||10
10782103|NCT03422250|11944118|FG001|STARTED|Follow-up||10
10782104|NCT03422250|11944119|FG002|STARTED|Follow-up||10
10782105|NCT03422250|11944120|FG003|STARTED|Follow-up||10
10782106|NCT03422250|11944117|FG000|COMPLETED|Follow-up||10
10782107|NCT03422250|11944118|FG001|COMPLETED|Follow-up||10
10782108|NCT03422250|11944119|FG002|COMPLETED|Follow-up||10
10782109|NCT03422250|11944120|FG003|COMPLETED|Follow-up||8
10782110|NCT03422250|11944117|FG000|NOT COMPLETED|Follow-up||0
10782111|NCT03422250|11944118|FG001|NOT COMPLETED|Follow-up||0
10782112|NCT03422250|11944119|FG002|NOT COMPLETED|Follow-up||0
10782113|NCT03422250|11944120|FG003|NOT COMPLETED|Follow-up||2
10782114|NCT03423082|11944132|FG000|STARTED|Overall Study||1
10782115|NCT03423082|11944132|FG000|COMPLETED|Overall Study||1
10782116|NCT03423082|11944132|FG000|NOT COMPLETED|Overall Study||0
10782117|NCT03423173|11944140|FG000|STARTED|Overall Study||132
10782118|NCT03423173|11944141|FG001|STARTED|Overall Study||263
10782119|NCT03423173|11944142|FG002|STARTED|Overall Study||264
10782120|NCT03423173|11944143|FG003|STARTED|Overall Study||264
10782121|NCT03423173|11944140|FG000|Received at Least 1 Dose of the IP|Overall Study||131
10782122|NCT03423173|11944141|FG001|Received at Least 1 Dose of the IP|Overall Study||263
10782123|NCT03423173|11944142|FG002|Received at Least 1 Dose of the IP|Overall Study|1 participant of TDV Lot 2 received vaccine of Lot 1 and was included in TDV Lot 1 in Safety Set.|262
10782124|NCT03423173|11944143|FG003|Received at Least 1 Dose of the IP|Overall Study||263
10782125|NCT03423173|11944140|FG000|COMPLETED|Overall Study||113
10782126|NCT03423173|11944141|FG001|COMPLETED|Overall Study||228
10782127|NCT03423173|11944142|FG002|COMPLETED|Overall Study||237
10782128|NCT03423173|11944143|FG003|COMPLETED|Overall Study||234
10782129|NCT03423173|11944140|FG000|NOT COMPLETED|Overall Study||19
10782130|NCT03423173|11944141|FG001|NOT COMPLETED|Overall Study||35
10782131|NCT03423173|11944142|FG002|NOT COMPLETED|Overall Study||27
10782132|NCT03423173|11944143|FG003|NOT COMPLETED|Overall Study||30
10782133|NCT03423186|11944155|FG000|STARTED|Overall Study||3
10782134|NCT03423186|11944156|FG001|STARTED|Overall Study||3
10782135|NCT03423186|11944155|FG000|COMPLETED|Overall Study||3
10782136|NCT03423186|11944156|FG001|COMPLETED|Overall Study||3
10782137|NCT03423186|11944155|FG000|NOT COMPLETED|Overall Study||0
10782138|NCT03423186|11944156|FG001|NOT COMPLETED|Overall Study||0
10810522|NCT03796260|11972292|FG000|STARTED|Period 1||7
10810523|NCT03796260|11972293|FG001|STARTED|Period 1||7
10810524|NCT03796260|11972292|FG000|COMPLETED|Period 1||7
10810525|NCT03796260|11972293|FG001|COMPLETED|Period 1||7
10810526|NCT03796260|11972292|FG000|NOT COMPLETED|Period 1||0
10810527|NCT03796260|11972293|FG001|NOT COMPLETED|Period 1||0
10810528|NCT03796260|11972292|FG000|STARTED|Period 2||7
10810529|NCT03796260|11972293|FG001|STARTED|Period 2||7
10810530|NCT03796260|11972292|FG000|COMPLETED|Period 2||7
10810531|NCT03796260|11972293|FG001|COMPLETED|Period 2||7
10810532|NCT03796260|11972292|FG000|NOT COMPLETED|Period 2||0
10810533|NCT03796260|11972293|FG001|NOT COMPLETED|Period 2||0
10810534|NCT03796039|11972301|FG000|STARTED|Overall Study||50
10810535|NCT03796039|11972302|FG001|STARTED|Overall Study||47
10810536|NCT03796039|11972301|FG000|COMPLETED|Overall Study||41
10810537|NCT03796039|11972302|FG001|COMPLETED|Overall Study||42
10810538|NCT03796039|11972301|FG000|NOT COMPLETED|Overall Study||9
10810539|NCT03796039|11972302|FG001|NOT COMPLETED|Overall Study||5
10810540|NCT03783780|11972308|FG000|STARTED|Overall Study||21
10810541|NCT03783780|11972308|FG000|COMPLETED|Overall Study||20
10810542|NCT03783780|11972308|FG000|NOT COMPLETED|Overall Study||1
10810543|NCT03780959|11972316|FG000|STARTED|Part 1||69
10810544|NCT03780959|11972317|FG001|STARTED|Part 1||0
10810545|NCT03780959|11972318|FG002|STARTED|Part 1||0
10810546|NCT03780959|11972316|FG000|COMPLETED|Part 1||64
10810547|NCT03780959|11972317|FG001|COMPLETED|Part 1||0
10810548|NCT03780959|11972318|FG002|COMPLETED|Part 1||0
10810549|NCT03780959|11972316|FG000|NOT COMPLETED|Part 1||5
10810550|NCT03780959|11972317|FG001|NOT COMPLETED|Part 1||0
10810551|NCT03780959|11972318|FG002|NOT COMPLETED|Part 1||0
10810552|NCT03780959|11972316|FG000|STARTED|Part 2||0
10810553|NCT03780959|11972317|FG001|STARTED|Part 2||26
10810554|NCT03780959|11972318|FG002|STARTED|Part 2||25
10810555|NCT03780959|11972316|FG000|COMPLETED|Part 2||0
10810556|NCT03780959|11972317|FG001|COMPLETED|Part 2||7
10810557|NCT03780959|11972318|FG002|COMPLETED|Part 2||19
10810558|NCT03780959|11972316|FG000|NOT COMPLETED|Part 2||0
10810559|NCT03780959|11972317|FG001|NOT COMPLETED|Part 2||19
10810560|NCT03780959|11972318|FG002|NOT COMPLETED|Part 2||6
10810561|NCT03796182|11972328|FG000|STARTED|Period 1||6
10782139|NCT03423238|11944164|FG000|STARTED|Overall Study||19
10782140|NCT03423238|11944165|FG001|STARTED|Overall Study||19
10782141|NCT03423238|11944164|FG000|COMPLETED|Overall Study||17
10782142|NCT03423238|11944165|FG001|COMPLETED|Overall Study||19
10782143|NCT03423238|11944164|FG000|NOT COMPLETED|Overall Study||2
10782144|NCT03423238|11944165|FG001|NOT COMPLETED|Overall Study||0
10782145|NCT03423641|11944174|FG000|STARTED|Overall Study||15524
10782146|NCT03423641|11944175|FG001|STARTED|Overall Study||18284
10782147|NCT03423641|11944174|FG000|COMPLETED|Overall Study||15193
10782148|NCT03423641|11944175|FG001|COMPLETED|Overall Study||10210
10782149|NCT03423641|11944174|FG000|NOT COMPLETED|Overall Study||331
10782150|NCT03423641|11944175|FG001|NOT COMPLETED|Overall Study||8074
10782151|NCT03424044|11944181|FG000|STARTED|Dexcom Training Visit (1 Week)||4
10782152|NCT03424044|11944182|FG001|STARTED|Dexcom Training Visit (1 Week)||3
10782153|NCT03424044|11944183|FG002|STARTED|Dexcom Training Visit (1 Week)||3
10782154|NCT03424044|11944184|FG003|STARTED|Dexcom Training Visit (1 Week)||3
10782155|NCT03424044|11944185|FG004|STARTED|Dexcom Training Visit (1 Week)||3
10782156|NCT03424044|11944186|FG005|STARTED|Dexcom Training Visit (1 Week)||4
10782157|NCT03424044|11944187|FG006|STARTED|Dexcom Training Visit (1 Week)||1
10782158|NCT03424044|11944188|FG007|STARTED|Dexcom Training Visit (1 Week)||1
10782159|NCT03424044|11944189|FG008|STARTED|Dexcom Training Visit (1 Week)||1
10782160|NCT03424044|11944181|FG000|COMPLETED|Dexcom Training Visit (1 Week)||4
10782161|NCT03424044|11944182|FG001|COMPLETED|Dexcom Training Visit (1 Week)||3
10782162|NCT03424044|11944183|FG002|COMPLETED|Dexcom Training Visit (1 Week)||3
10782163|NCT03424044|11944184|FG003|COMPLETED|Dexcom Training Visit (1 Week)||3
10782164|NCT03424044|11944185|FG004|COMPLETED|Dexcom Training Visit (1 Week)||3
10782165|NCT03424044|11944186|FG005|COMPLETED|Dexcom Training Visit (1 Week)||4
10782166|NCT03424044|11944187|FG006|COMPLETED|Dexcom Training Visit (1 Week)||1
10782167|NCT03424044|11944188|FG007|COMPLETED|Dexcom Training Visit (1 Week)||1
10782168|NCT03424044|11944189|FG008|COMPLETED|Dexcom Training Visit (1 Week)||1
10782169|NCT03424044|11944181|FG000|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
10782170|NCT03424044|11944182|FG001|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
10782323|NCT03424044|11944182|FG001|COMPLETED|Third Intervention (76 Hours)||3
10782171|NCT03424044|11944183|FG002|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
10782172|NCT03424044|11944184|FG003|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
10782173|NCT03424044|11944185|FG004|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
10782174|NCT03424044|11944186|FG005|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
10782175|NCT03424044|11944187|FG006|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
10782176|NCT03424044|11944188|FG007|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
10782177|NCT03424044|11944189|FG008|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
10782178|NCT03424044|11944181|FG000|STARTED|First Rest Period (1-12 Weeks)||4
10782179|NCT03424044|11944182|FG001|STARTED|First Rest Period (1-12 Weeks)||3
10782180|NCT03424044|11944183|FG002|STARTED|First Rest Period (1-12 Weeks)||3
10782181|NCT03424044|11944184|FG003|STARTED|First Rest Period (1-12 Weeks)||3
10782182|NCT03424044|11944185|FG004|STARTED|First Rest Period (1-12 Weeks)||3
10782183|NCT03424044|11944186|FG005|STARTED|First Rest Period (1-12 Weeks)||4
10782184|NCT03424044|11944187|FG006|STARTED|First Rest Period (1-12 Weeks)||1
10782185|NCT03424044|11944188|FG007|STARTED|First Rest Period (1-12 Weeks)||1
10782186|NCT03424044|11944189|FG008|STARTED|First Rest Period (1-12 Weeks)||1
10782187|NCT03424044|11944181|FG000|COMPLETED|First Rest Period (1-12 Weeks)||4
10782188|NCT03424044|11944182|FG001|COMPLETED|First Rest Period (1-12 Weeks)||3
10782189|NCT03424044|11944183|FG002|COMPLETED|First Rest Period (1-12 Weeks)||2
10782190|NCT03424044|11944184|FG003|COMPLETED|First Rest Period (1-12 Weeks)||3
10782191|NCT03424044|11944185|FG004|COMPLETED|First Rest Period (1-12 Weeks)||3
10782192|NCT03424044|11944186|FG005|COMPLETED|First Rest Period (1-12 Weeks)||4
10782193|NCT03424044|11944187|FG006|COMPLETED|First Rest Period (1-12 Weeks)||1
10782194|NCT03424044|11944188|FG007|COMPLETED|First Rest Period (1-12 Weeks)||1
10782195|NCT03424044|11944189|FG008|COMPLETED|First Rest Period (1-12 Weeks)||1
10782196|NCT03424044|11944181|FG000|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
10782197|NCT03424044|11944182|FG001|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
10782198|NCT03424044|11944183|FG002|NOT COMPLETED|First Rest Period (1-12 Weeks)||1
10782199|NCT03424044|11944184|FG003|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
10782200|NCT03424044|11944185|FG004|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
10782201|NCT03424044|11944186|FG005|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
10782202|NCT03424044|11944187|FG006|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
10782203|NCT03424044|11944188|FG007|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
10782204|NCT03424044|11944189|FG008|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
10782205|NCT03424044|11944181|FG000|STARTED|First Intervention (76 Hours)||4
10782206|NCT03424044|11944182|FG001|STARTED|First Intervention (76 Hours)||3
10782207|NCT03424044|11944183|FG002|STARTED|First Intervention (76 Hours)||2
10782208|NCT03424044|11944184|FG003|STARTED|First Intervention (76 Hours)||3
10782209|NCT03424044|11944185|FG004|STARTED|First Intervention (76 Hours)||3
10782210|NCT03424044|11944186|FG005|STARTED|First Intervention (76 Hours)||4
10782211|NCT03424044|11944187|FG006|STARTED|First Intervention (76 Hours)||1
10782212|NCT03424044|11944188|FG007|STARTED|First Intervention (76 Hours)||1
10782213|NCT03424044|11944189|FG008|STARTED|First Intervention (76 Hours)||1
10782214|NCT03424044|11944181|FG000|COMPLETED|First Intervention (76 Hours)||4
10782215|NCT03424044|11944182|FG001|COMPLETED|First Intervention (76 Hours)||3
10782216|NCT03424044|11944183|FG002|COMPLETED|First Intervention (76 Hours)||2
10782217|NCT03424044|11944184|FG003|COMPLETED|First Intervention (76 Hours)||3
10782218|NCT03424044|11944185|FG004|COMPLETED|First Intervention (76 Hours)||2
10782219|NCT03424044|11944186|FG005|COMPLETED|First Intervention (76 Hours)||4
10782220|NCT03424044|11944187|FG006|COMPLETED|First Intervention (76 Hours)||0
10782221|NCT03424044|11944188|FG007|COMPLETED|First Intervention (76 Hours)||0
10782222|NCT03424044|11944189|FG008|COMPLETED|First Intervention (76 Hours)||0
10782223|NCT03424044|11944181|FG000|NOT COMPLETED|First Intervention (76 Hours)||0
10782224|NCT03424044|11944182|FG001|NOT COMPLETED|First Intervention (76 Hours)||0
10782225|NCT03424044|11944183|FG002|NOT COMPLETED|First Intervention (76 Hours)||0
10782226|NCT03424044|11944184|FG003|NOT COMPLETED|First Intervention (76 Hours)||0
10782227|NCT03424044|11944185|FG004|NOT COMPLETED|First Intervention (76 Hours)||1
10782228|NCT03424044|11944186|FG005|NOT COMPLETED|First Intervention (76 Hours)||0
10782229|NCT03424044|11944187|FG006|NOT COMPLETED|First Intervention (76 Hours)||1
10782230|NCT03424044|11944188|FG007|NOT COMPLETED|First Intervention (76 Hours)||1
10782231|NCT03424044|11944189|FG008|NOT COMPLETED|First Intervention (76 Hours)||1
10782232|NCT03424044|11944181|FG000|STARTED|Second Rest Period (7-45 Days)||4
10782233|NCT03424044|11944182|FG001|STARTED|Second Rest Period (7-45 Days)||3
10782234|NCT03424044|11944183|FG002|STARTED|Second Rest Period (7-45 Days)||2
10782235|NCT03424044|11944184|FG003|STARTED|Second Rest Period (7-45 Days)||3
10782236|NCT03424044|11944185|FG004|STARTED|Second Rest Period (7-45 Days)||2
10782237|NCT03424044|11944186|FG005|STARTED|Second Rest Period (7-45 Days)||4
10782238|NCT03424044|11944187|FG006|STARTED|Second Rest Period (7-45 Days)||1
10782239|NCT03424044|11944188|FG007|STARTED|Second Rest Period (7-45 Days)||1
10782240|NCT03424044|11944189|FG008|STARTED|Second Rest Period (7-45 Days)||1
10782241|NCT03424044|11944181|FG000|COMPLETED|Second Rest Period (7-45 Days)||4
10782242|NCT03424044|11944182|FG001|COMPLETED|Second Rest Period (7-45 Days)||3
10782243|NCT03424044|11944183|FG002|COMPLETED|Second Rest Period (7-45 Days)||2
10782244|NCT03424044|11944184|FG003|COMPLETED|Second Rest Period (7-45 Days)||3
10782245|NCT03424044|11944185|FG004|COMPLETED|Second Rest Period (7-45 Days)||2
10782246|NCT03424044|11944186|FG005|COMPLETED|Second Rest Period (7-45 Days)||4
10782247|NCT03424044|11944187|FG006|COMPLETED|Second Rest Period (7-45 Days)||1
10782248|NCT03424044|11944188|FG007|COMPLETED|Second Rest Period (7-45 Days)||1
10782249|NCT03424044|11944189|FG008|COMPLETED|Second Rest Period (7-45 Days)||1
10782250|NCT03424044|11944181|FG000|NOT COMPLETED|Second Rest Period (7-45 Days)||0
10782251|NCT03424044|11944182|FG001|NOT COMPLETED|Second Rest Period (7-45 Days)||0
10782252|NCT03424044|11944183|FG002|NOT COMPLETED|Second Rest Period (7-45 Days)||0
10782253|NCT03424044|11944184|FG003|NOT COMPLETED|Second Rest Period (7-45 Days)||0
10782254|NCT03424044|11944185|FG004|NOT COMPLETED|Second Rest Period (7-45 Days)||0
10782255|NCT03424044|11944186|FG005|NOT COMPLETED|Second Rest Period (7-45 Days)||0
10782256|NCT03424044|11944187|FG006|NOT COMPLETED|Second Rest Period (7-45 Days)||0
10782257|NCT03424044|11944188|FG007|NOT COMPLETED|Second Rest Period (7-45 Days)||0
10782258|NCT03424044|11944189|FG008|NOT COMPLETED|Second Rest Period (7-45 Days)||0
10782259|NCT03424044|11944181|FG000|STARTED|Second Intervention (76 Hours)||4
10782260|NCT03424044|11944182|FG001|STARTED|Second Intervention (76 Hours)||3
10782261|NCT03424044|11944183|FG002|STARTED|Second Intervention (76 Hours)||2
10782262|NCT03424044|11944184|FG003|STARTED|Second Intervention (76 Hours)||3
10782263|NCT03424044|11944185|FG004|STARTED|Second Intervention (76 Hours)||2
10782264|NCT03424044|11944186|FG005|STARTED|Second Intervention (76 Hours)||4
10782265|NCT03424044|11944187|FG006|STARTED|Second Intervention (76 Hours)||1
10782266|NCT03424044|11944188|FG007|STARTED|Second Intervention (76 Hours)||1
10782267|NCT03424044|11944189|FG008|STARTED|Second Intervention (76 Hours)||1
10782268|NCT03424044|11944181|FG000|COMPLETED|Second Intervention (76 Hours)||4
10782269|NCT03424044|11944182|FG001|COMPLETED|Second Intervention (76 Hours)||3
10782270|NCT03424044|11944183|FG002|COMPLETED|Second Intervention (76 Hours)||2
10782271|NCT03424044|11944184|FG003|COMPLETED|Second Intervention (76 Hours)||3
10782272|NCT03424044|11944185|FG004|COMPLETED|Second Intervention (76 Hours)||2
10782273|NCT03424044|11944186|FG005|COMPLETED|Second Intervention (76 Hours)||4
10782274|NCT03424044|11944187|FG006|COMPLETED|Second Intervention (76 Hours)||1
10782275|NCT03424044|11944188|FG007|COMPLETED|Second Intervention (76 Hours)||1
10782276|NCT03424044|11944189|FG008|COMPLETED|Second Intervention (76 Hours)||1
10782277|NCT03424044|11944181|FG000|NOT COMPLETED|Second Intervention (76 Hours)||0
10782278|NCT03424044|11944182|FG001|NOT COMPLETED|Second Intervention (76 Hours)||0
10782279|NCT03424044|11944183|FG002|NOT COMPLETED|Second Intervention (76 Hours)||0
10782280|NCT03424044|11944184|FG003|NOT COMPLETED|Second Intervention (76 Hours)||0
10782281|NCT03424044|11944185|FG004|NOT COMPLETED|Second Intervention (76 Hours)||0
10782282|NCT03424044|11944186|FG005|NOT COMPLETED|Second Intervention (76 Hours)||0
10782283|NCT03424044|11944187|FG006|NOT COMPLETED|Second Intervention (76 Hours)||0
10782284|NCT03424044|11944188|FG007|NOT COMPLETED|Second Intervention (76 Hours)||0
10782285|NCT03424044|11944189|FG008|NOT COMPLETED|Second Intervention (76 Hours)||0
10782286|NCT03424044|11944181|FG000|STARTED|Third Rest Period (7-45 Days)||4
10782287|NCT03424044|11944182|FG001|STARTED|Third Rest Period (7-45 Days)||3
10782288|NCT03424044|11944183|FG002|STARTED|Third Rest Period (7-45 Days)||2
10782289|NCT03424044|11944184|FG003|STARTED|Third Rest Period (7-45 Days)||3
10782290|NCT03424044|11944185|FG004|STARTED|Third Rest Period (7-45 Days)||2
10782291|NCT03424044|11944186|FG005|STARTED|Third Rest Period (7-45 Days)||4
10782292|NCT03424044|11944187|FG006|STARTED|Third Rest Period (7-45 Days)||1
10782293|NCT03424044|11944188|FG007|STARTED|Third Rest Period (7-45 Days)||1
10782294|NCT03424044|11944189|FG008|STARTED|Third Rest Period (7-45 Days)||1
10782295|NCT03424044|11944181|FG000|COMPLETED|Third Rest Period (7-45 Days)||4
10782296|NCT03424044|11944182|FG001|COMPLETED|Third Rest Period (7-45 Days)||3
10782297|NCT03424044|11944183|FG002|COMPLETED|Third Rest Period (7-45 Days)||2
10782298|NCT03424044|11944184|FG003|COMPLETED|Third Rest Period (7-45 Days)||3
10782299|NCT03424044|11944185|FG004|COMPLETED|Third Rest Period (7-45 Days)||2
10782300|NCT03424044|11944186|FG005|COMPLETED|Third Rest Period (7-45 Days)||4
10782301|NCT03424044|11944187|FG006|COMPLETED|Third Rest Period (7-45 Days)||1
10432872|NCT00883051|11579131|FG000|COMPLETED|Overall Study||82
10432873|NCT00883051|11579132|FG001|COMPLETED|Overall Study||82
10782302|NCT03424044|11944188|FG007|COMPLETED|Third Rest Period (7-45 Days)||1
10782303|NCT03424044|11944189|FG008|COMPLETED|Third Rest Period (7-45 Days)||1
10782304|NCT03424044|11944181|FG000|NOT COMPLETED|Third Rest Period (7-45 Days)||0
10782305|NCT03424044|11944182|FG001|NOT COMPLETED|Third Rest Period (7-45 Days)||0
10782306|NCT03424044|11944183|FG002|NOT COMPLETED|Third Rest Period (7-45 Days)||0
10782307|NCT03424044|11944184|FG003|NOT COMPLETED|Third Rest Period (7-45 Days)||0
10782308|NCT03424044|11944185|FG004|NOT COMPLETED|Third Rest Period (7-45 Days)||0
10782309|NCT03424044|11944186|FG005|NOT COMPLETED|Third Rest Period (7-45 Days)||0
10782310|NCT03424044|11944187|FG006|NOT COMPLETED|Third Rest Period (7-45 Days)||0
10782311|NCT03424044|11944188|FG007|NOT COMPLETED|Third Rest Period (7-45 Days)||0
10782312|NCT03424044|11944189|FG008|NOT COMPLETED|Third Rest Period (7-45 Days)||0
10782313|NCT03424044|11944181|FG000|STARTED|Third Intervention (76 Hours)||4
10782314|NCT03424044|11944182|FG001|STARTED|Third Intervention (76 Hours)||3
10782315|NCT03424044|11944183|FG002|STARTED|Third Intervention (76 Hours)||2
10782316|NCT03424044|11944184|FG003|STARTED|Third Intervention (76 Hours)||3
10782317|NCT03424044|11944185|FG004|STARTED|Third Intervention (76 Hours)||2
10782318|NCT03424044|11944186|FG005|STARTED|Third Intervention (76 Hours)||4
10782319|NCT03424044|11944187|FG006|STARTED|Third Intervention (76 Hours)||1
10432874|NCT00883051|11579133|FG002|COMPLETED|Overall Study||71
10432875|NCT00883051|11579134|FG003|COMPLETED|Overall Study||70
10432876|NCT00883051|11579135|FG004|COMPLETED|Overall Study|One participant was lost to follow up and did not provide adverse event data.|85
10432877|NCT00883051|11579131|FG000|NOT COMPLETED|Overall Study||24
10782320|NCT03424044|11944188|FG007|STARTED|Third Intervention (76 Hours)||1
10782321|NCT03424044|11944189|FG008|STARTED|Third Intervention (76 Hours)||1
10782322|NCT03424044|11944181|FG000|COMPLETED|Third Intervention (76 Hours)||3
10316356|NCT00189475|11450357|FG001|NOT COMPLETED|Overall Study||0
10782324|NCT03424044|11944183|FG002|COMPLETED|Third Intervention (76 Hours)||2
10782325|NCT03424044|11944184|FG003|COMPLETED|Third Intervention (76 Hours)||2
10782326|NCT03424044|11944185|FG004|COMPLETED|Third Intervention (76 Hours)||2
10782327|NCT03424044|11944186|FG005|COMPLETED|Third Intervention (76 Hours)||4
10782328|NCT03424044|11944187|FG006|COMPLETED|Third Intervention (76 Hours)||0
10782329|NCT03424044|11944188|FG007|COMPLETED|Third Intervention (76 Hours)||1
10782330|NCT03424044|11944189|FG008|COMPLETED|Third Intervention (76 Hours)||1
10782331|NCT03424044|11944181|FG000|NOT COMPLETED|Third Intervention (76 Hours)||1
10782332|NCT03424044|11944182|FG001|NOT COMPLETED|Third Intervention (76 Hours)||0
10782333|NCT03424044|11944183|FG002|NOT COMPLETED|Third Intervention (76 Hours)||0
10782334|NCT03424044|11944184|FG003|NOT COMPLETED|Third Intervention (76 Hours)||1
10782335|NCT03424044|11944185|FG004|NOT COMPLETED|Third Intervention (76 Hours)||0
10782336|NCT03424044|11944186|FG005|NOT COMPLETED|Third Intervention (76 Hours)||0
10782337|NCT03424044|11944187|FG006|NOT COMPLETED|Third Intervention (76 Hours)||1
10782338|NCT03424044|11944188|FG007|NOT COMPLETED|Third Intervention (76 Hours)||0
10782339|NCT03424044|11944189|FG008|NOT COMPLETED|Third Intervention (76 Hours)||0
10782340|NCT03424044|11944181|FG000|STARTED|Optional Fourth Rest Period (7-45 Days)||0
10782341|NCT03424044|11944182|FG001|STARTED|Optional Fourth Rest Period (7-45 Days)||0
10782342|NCT03424044|11944183|FG002|STARTED|Optional Fourth Rest Period (7-45 Days)||0
10782343|NCT03424044|11944184|FG003|STARTED|Optional Fourth Rest Period (7-45 Days)||0
10782344|NCT03424044|11944185|FG004|STARTED|Optional Fourth Rest Period (7-45 Days)||0
10782345|NCT03424044|11944186|FG005|STARTED|Optional Fourth Rest Period (7-45 Days)||0
10782346|NCT03424044|11944187|FG006|STARTED|Optional Fourth Rest Period (7-45 Days)||0
10782347|NCT03424044|11944188|FG007|STARTED|Optional Fourth Rest Period (7-45 Days)||1
10782348|NCT03424044|11944189|FG008|STARTED|Optional Fourth Rest Period (7-45 Days)||1
10782349|NCT03424044|11944181|FG000|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
10782350|NCT03424044|11944182|FG001|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
10782351|NCT03424044|11944183|FG002|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
10782352|NCT03424044|11944184|FG003|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
10782353|NCT03424044|11944185|FG004|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
10782354|NCT03424044|11944186|FG005|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
10782355|NCT03424044|11944187|FG006|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
10782356|NCT03424044|11944188|FG007|COMPLETED|Optional Fourth Rest Period (7-45 Days)||1
10782357|NCT03424044|11944189|FG008|COMPLETED|Optional Fourth Rest Period (7-45 Days)||1
10782358|NCT03424044|11944181|FG000|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
10782359|NCT03424044|11944182|FG001|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
10782360|NCT03424044|11944183|FG002|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
10782361|NCT03424044|11944184|FG003|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
10782362|NCT03424044|11944185|FG004|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
10782363|NCT03424044|11944186|FG005|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
10782364|NCT03424044|11944187|FG006|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
10782365|NCT03424044|11944188|FG007|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
10782366|NCT03424044|11944189|FG008|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
10782367|NCT03424044|11944181|FG000|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
10782368|NCT03424044|11944182|FG001|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
10782369|NCT03424044|11944183|FG002|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
10782370|NCT03424044|11944184|FG003|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
10782371|NCT03424044|11944185|FG004|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
10782372|NCT03424044|11944186|FG005|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
10782373|NCT03424044|11944187|FG006|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
10782374|NCT03424044|11944188|FG007|STARTED|Fourth Intervention Repeat Visit (76 hr)||1
10782375|NCT03424044|11944189|FG008|STARTED|Fourth Intervention Repeat Visit (76 hr)||1
10782376|NCT03424044|11944181|FG000|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
10782377|NCT03424044|11944182|FG001|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
10782378|NCT03424044|11944183|FG002|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
10782379|NCT03424044|11944184|FG003|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
10782380|NCT03424044|11944185|FG004|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
10782381|NCT03424044|11944186|FG005|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
10782382|NCT03424044|11944187|FG006|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
10782383|NCT03424044|11944188|FG007|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||1
10782384|NCT03424044|11944189|FG008|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||1
10782385|NCT03424044|11944181|FG000|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
10782386|NCT03424044|11944182|FG001|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
10782387|NCT03424044|11944183|FG002|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
10782388|NCT03424044|11944184|FG003|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
10782389|NCT03424044|11944185|FG004|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
10782390|NCT03424044|11944186|FG005|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
10782391|NCT03424044|11944187|FG006|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
10782392|NCT03424044|11944188|FG007|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
10782393|NCT03424044|11944189|FG008|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
10782394|NCT03424187|11944205|FG000|STARTED|Overall Study||2
10782395|NCT03424187|11944206|FG001|STARTED|Overall Study||3
10782396|NCT03424187|11944207|FG002|STARTED|Overall Study||2
10782397|NCT03424187|11944208|FG003|STARTED|Overall Study||3
10782398|NCT03424187|11944209|FG004|STARTED|Overall Study||2
10782399|NCT03424187|11944210|FG005|STARTED|Overall Study||3
10782400|NCT03424187|11944205|FG000|COMPLETED|Overall Study||2
10782401|NCT03424187|11944206|FG001|COMPLETED|Overall Study||3
10782402|NCT03424187|11944207|FG002|COMPLETED|Overall Study||2
10782403|NCT03424187|11944208|FG003|COMPLETED|Overall Study||3
10782404|NCT03424187|11944209|FG004|COMPLETED|Overall Study||2
10782405|NCT03424187|11944210|FG005|COMPLETED|Overall Study||3
10782406|NCT03424187|11944205|FG000|NOT COMPLETED|Overall Study||0
10782407|NCT03424187|11944206|FG001|NOT COMPLETED|Overall Study||0
10782408|NCT03424187|11944207|FG002|NOT COMPLETED|Overall Study||0
10782409|NCT03424187|11944208|FG003|NOT COMPLETED|Overall Study||0
10782410|NCT03424187|11944209|FG004|NOT COMPLETED|Overall Study||0
10782411|NCT03424187|11944210|FG005|NOT COMPLETED|Overall Study||0
10782412|NCT03424239|11944223|FG000|STARTED|Overall Study||6
10782413|NCT03424239|11944223|FG000|Baseline/Zoledronic Acid Administration|Overall Study||4
10782414|NCT03424239|11944223|FG000|2 Week Post-op|Overall Study||4
10782415|NCT03424239|11944223|FG000|12 Week Post-op|Overall Study||4
10782416|NCT03424239|11944223|FG000|24 Week Post-op|Overall Study||4
10782417|NCT03424239|11944223|FG000|COMPLETED|Overall Study||4
10782418|NCT03424239|11944223|FG000|NOT COMPLETED|Overall Study||2
10782419|NCT03424265|11944229|FG000|STARTED|Overall Study||29
10782420|NCT03424265|11944230|FG001|STARTED|Overall Study||34
10782421|NCT03424265|11944229|FG000|COMPLETED|Overall Study||28
10782422|NCT03424265|11944230|FG001|COMPLETED|Overall Study||32
10782423|NCT03424265|11944229|FG000|NOT COMPLETED|Overall Study||1
10782424|NCT03424265|11944230|FG001|NOT COMPLETED|Overall Study||2
10782425|NCT03424681|11944238|FG000|STARTED|Overall Study||6
10782426|NCT03424681|11944239|FG001|STARTED|Overall Study||6
10782427|NCT03424681|11944238|FG000|COMPLETED|Overall Study||6
10782428|NCT03424681|11944239|FG001|COMPLETED|Overall Study||5
10782429|NCT03424681|11944238|FG000|NOT COMPLETED|Overall Study||0
10782430|NCT03424681|11944239|FG001|NOT COMPLETED|Overall Study||1
10782431|NCT03425019|11944245|FG000|STARTED|Overall Study||20
10782432|NCT03425019|11944245|FG000|COMPLETED|Overall Study||20
10782433|NCT03425019|11944245|FG000|NOT COMPLETED|Overall Study||0
10782434|NCT03425097|11944250|FG000|STARTED|Treatment Period 1 (2 Weeks)||6
10782435|NCT03425097|11944251|FG001|STARTED|Treatment Period 1 (2 Weeks)||5
10782436|NCT03425097|11944250|FG000|COMPLETED|Treatment Period 1 (2 Weeks)||6
10782437|NCT03425097|11944251|FG001|COMPLETED|Treatment Period 1 (2 Weeks)||5
10782438|NCT03425097|11944250|FG000|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
10782439|NCT03425097|11944251|FG001|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
10782440|NCT03425097|11944250|FG000|STARTED|Washout Period (1 Week)||6
10782441|NCT03425097|11944251|FG001|STARTED|Washout Period (1 Week)||5
10782442|NCT03425097|11944250|FG000|COMPLETED|Washout Period (1 Week)||6
10782443|NCT03425097|11944251|FG001|COMPLETED|Washout Period (1 Week)||5
10782444|NCT03425097|11944250|FG000|NOT COMPLETED|Washout Period (1 Week)||0
10782445|NCT03425097|11944251|FG001|NOT COMPLETED|Washout Period (1 Week)||0
10782446|NCT03425097|11944250|FG000|STARTED|Second Treatment Period (2 Weeks)||6
10782447|NCT03425097|11944251|FG001|STARTED|Second Treatment Period (2 Weeks)||5
10782448|NCT03425097|11944250|FG000|COMPLETED|Second Treatment Period (2 Weeks)||6
10782449|NCT03425097|11944251|FG001|COMPLETED|Second Treatment Period (2 Weeks)||5
10782450|NCT03425097|11944250|FG000|NOT COMPLETED|Second Treatment Period (2 Weeks)||0
10782451|NCT03425097|11944251|FG001|NOT COMPLETED|Second Treatment Period (2 Weeks)||0
10782452|NCT03425188|11944260|FG000|STARTED|Overall Study||53
10782453|NCT03425188|11944260|FG000|COMPLETED|Overall Study||52
10782454|NCT03425188|11944260|FG000|NOT COMPLETED|Overall Study||1
10782455|NCT03425253|11944265|FG000|STARTED|Overall Study||58
10782456|NCT03425253|11944265|FG000|Safety Analysis Set|Overall Study||53
10782457|NCT03425253|11944265|FG000|FAS|Overall Study||53
10782458|NCT03425253|11944265|FG000|Evaluable Set (ES)|Overall Study||42
10782459|NCT03425253|11944265|FG000|COMPLETED|Overall Study||42
10782460|NCT03425253|11944265|FG000|NOT COMPLETED|Overall Study||16
10782461|NCT03425396|11944275|FG000|STARTED|Overall Study||55
10782462|NCT03425396|11944276|FG001|STARTED|Overall Study||54
10782463|NCT03425396|11944277|FG002|STARTED|Overall Study||54
10782464|NCT03425396|11944278|FG003|STARTED|Overall Study||8
10782465|NCT03425396|11944279|FG004|STARTED|Overall Study||54
10782466|NCT03425396|11944275|FG000|Completed End of Treatment Visit|Overall Study||53
10782467|NCT03425396|11944276|FG001|Completed End of Treatment Visit|Overall Study||52
10782468|NCT03425396|11944277|FG002|Completed End of Treatment Visit|Overall Study||51
10782469|NCT03425396|11944278|FG003|Completed End of Treatment Visit|Overall Study||7
10782470|NCT03425396|11944279|FG004|Completed End of Treatment Visit|Overall Study||53
10782471|NCT03425396|11944275|FG000|Completed Post-therapy Evaluation Visit|Overall Study||53
10782472|NCT03425396|11944276|FG001|Completed Post-therapy Evaluation Visit|Overall Study||49
10782473|NCT03425396|11944277|FG002|Completed Post-therapy Evaluation Visit|Overall Study||51
10782474|NCT03425396|11944278|FG003|Completed Post-therapy Evaluation Visit|Overall Study||7
10782475|NCT03425396|11944279|FG004|Completed Post-therapy Evaluation Visit|Overall Study||54
10782476|NCT03425396|11944275|FG000|Completed Final Follow-up Visit|Overall Study||53
10782477|NCT03425396|11944276|FG001|Completed Final Follow-up Visit|Overall Study||47
10782478|NCT03425396|11944277|FG002|Completed Final Follow-up Visit|Overall Study||51
10782479|NCT03425396|11944278|FG003|Completed Final Follow-up Visit|Overall Study||7
10782480|NCT03425396|11944279|FG004|Completed Final Follow-up Visit|Overall Study||53
10782481|NCT03425396|11944275|FG000|COMPLETED|Overall Study||53
10782482|NCT03425396|11944276|FG001|COMPLETED|Overall Study||47
10782483|NCT03425396|11944277|FG002|COMPLETED|Overall Study||51
10782484|NCT03425396|11944278|FG003|COMPLETED|Overall Study||7
10782485|NCT03425396|11944279|FG004|COMPLETED|Overall Study||53
10782486|NCT03425396|11944275|FG000|NOT COMPLETED|Overall Study||2
10782487|NCT03425396|11944276|FG001|NOT COMPLETED|Overall Study||7
10782488|NCT03425396|11944277|FG002|NOT COMPLETED|Overall Study||3
10782489|NCT03425396|11944278|FG003|NOT COMPLETED|Overall Study||1
10782490|NCT03425396|11944279|FG004|NOT COMPLETED|Overall Study||1
10782491|NCT03426228|11944293|FG000|STARTED|Overall Study||158
10782492|NCT03426228|11944294|FG001|STARTED|Overall Study||191
10782493|NCT03426228|11944293|FG000|COMPLETED|Overall Study||117
10782494|NCT03426228|11944294|FG001|COMPLETED|Overall Study||158
10782495|NCT03426228|11944293|FG000|NOT COMPLETED|Overall Study||41
10782496|NCT03426228|11944294|FG001|NOT COMPLETED|Overall Study||33
10782497|NCT03426267|11944304|FG000|STARTED|Overall Study||163
10782498|NCT03426267|11944305|FG001|STARTED|Overall Study||162
10782499|NCT03426267|11944304|FG000|Modified Intent-to-Treat Population|Overall Study||154
10782500|NCT03426267|11944305|FG001|Modified Intent-to-Treat Population|Overall Study||144
10782501|NCT03426267|11944304|FG000|COMPLETED|Overall Study||142
10782502|NCT03426267|11944305|FG001|COMPLETED|Overall Study||90
10782503|NCT03426267|11944304|FG000|NOT COMPLETED|Overall Study||21
10782504|NCT03426267|11944305|FG001|NOT COMPLETED|Overall Study||72
10782505|NCT03426345|11944313|FG000|STARTED|Overall Study||155
10782506|NCT03426345|11944314|FG001|STARTED|Overall Study||156
10782507|NCT03426345|11944313|FG000|Safety Population|Overall Study||152
10782508|NCT03426345|11944314|FG001|Safety Population|Overall Study||155
10782509|NCT03426345|11944313|FG000|COMPLETED|Overall Study||137
10782510|NCT03426345|11944314|FG001|COMPLETED|Overall Study||139
10782511|NCT03426345|11944313|FG000|NOT COMPLETED|Overall Study||18
10782512|NCT03426345|11944314|FG001|NOT COMPLETED|Overall Study||17
10782513|NCT03426436|11944321|FG000|STARTED|Overall Study||314
10782514|NCT03426436|11944321|FG000|COMPLETED|Overall Study||295
10782515|NCT03426436|11944321|FG000|NOT COMPLETED|Overall Study||19
10782516|NCT03426631|11944325|FG000|STARTED|Overall Study||7
10782517|NCT03426631|11944326|FG001|STARTED|Overall Study||6
10782518|NCT03426631|11944325|FG000|COMPLETED|Overall Study||7
10782519|NCT03426631|11944326|FG001|COMPLETED|Overall Study||5
10782520|NCT03426631|11944325|FG000|NOT COMPLETED|Overall Study||0
10782521|NCT03426631|11944326|FG001|NOT COMPLETED|Overall Study||1
10782522|NCT03426787|11944332|FG000|STARTED|Overall Study||70
10782523|NCT03426787|11944332|FG000|COMPLETED|Overall Study||56
10782524|NCT03426787|11944332|FG000|NOT COMPLETED|Overall Study||14
10782525|NCT03426995|11944361|FG000|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
10782526|NCT03426995|11944362|FG001|STARTED|Part A: Cohort 1-Period 1 (Day1)||2
10782527|NCT03426995|11944363|FG002|STARTED|Part A: Cohort 1-Period 1 (Day1)||1
10782528|NCT03426995|11944364|FG003|STARTED|Part A: Cohort 1-Period 1 (Day1)||2
10782529|NCT03426995|11944365|FG004|STARTED|Part A: Cohort 1-Period 1 (Day1)||1
10782530|NCT03426995|11944366|FG005|STARTED|Part A: Cohort 1-Period 1 (Day1)||1
10782531|NCT03426995|11944367|FG006|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
10782532|NCT03426995|11944368|FG007|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
10782533|NCT03426995|11944369|FG008|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
10782534|NCT03426995|11944370|FG009|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
10782535|NCT03426995|11944371|FG010|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
10782536|NCT03426995|11944372|FG011|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
10782537|NCT03426995|11944373|FG012|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
10782538|NCT03426995|11944374|FG013|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
10782539|NCT03426995|11944375|FG014|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
10782540|NCT03426995|11944376|FG015|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
10782541|NCT03426995|11944377|FG016|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
10782542|NCT03426995|11944378|FG017|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
10782543|NCT03426995|11944379|FG018|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
10782544|NCT03426995|11944361|FG000|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10782545|NCT03426995|11944362|FG001|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||2
10782546|NCT03426995|11944363|FG002|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10782547|NCT03426995|11944364|FG003|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||2
10782548|NCT03426995|11944365|FG004|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||1
10782549|NCT03426995|11944366|FG005|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||1
10782550|NCT03426995|11944367|FG006|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10782551|NCT03426995|11944368|FG007|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10782552|NCT03426995|11944369|FG008|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10782553|NCT03426995|11944370|FG009|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10782554|NCT03426995|11944371|FG010|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10782555|NCT03426995|11944372|FG011|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10782556|NCT03426995|11944373|FG012|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10782557|NCT03426995|11944374|FG013|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10782558|NCT03426995|11944375|FG014|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10782559|NCT03426995|11944376|FG015|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10782560|NCT03426995|11944377|FG016|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10782561|NCT03426995|11944378|FG017|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10782562|NCT03426995|11944379|FG018|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10782563|NCT03426995|11944361|FG000|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10782564|NCT03426995|11944362|FG001|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10782565|NCT03426995|11944363|FG002|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||1
10782566|NCT03426995|11944364|FG003|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10782567|NCT03426995|11944365|FG004|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10782568|NCT03426995|11944366|FG005|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10782569|NCT03426995|11944367|FG006|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10782570|NCT03426995|11944368|FG007|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10782571|NCT03426995|11944369|FG008|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10782572|NCT03426995|11944370|FG009|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10782573|NCT03426995|11944371|FG010|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10782574|NCT03426995|11944372|FG011|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10782575|NCT03426995|11944373|FG012|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10782576|NCT03426995|11944374|FG013|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10782577|NCT03426995|11944375|FG014|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10782578|NCT03426995|11944376|FG015|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10782579|NCT03426995|11944377|FG016|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10782580|NCT03426995|11944378|FG017|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10782581|NCT03426995|11944379|FG018|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
10782582|NCT03426995|11944361|FG000|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10782583|NCT03426995|11944362|FG001|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||2
10782584|NCT03426995|11944363|FG002|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10782585|NCT03426995|11944364|FG003|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||2
10782586|NCT03426995|11944365|FG004|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||1
10782587|NCT03426995|11944366|FG005|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||1
10782588|NCT03426995|11944367|FG006|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10782589|NCT03426995|11944368|FG007|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10782590|NCT03426995|11944369|FG008|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10782591|NCT03426995|11944370|FG009|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10782592|NCT03426995|11944371|FG010|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10782593|NCT03426995|11944372|FG011|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10782594|NCT03426995|11944373|FG012|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10782595|NCT03426995|11944374|FG013|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10782596|NCT03426995|11944375|FG014|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10782597|NCT03426995|11944376|FG015|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10782598|NCT03426995|11944377|FG016|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10782599|NCT03426995|11944378|FG017|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10782600|NCT03426995|11944379|FG018|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10782601|NCT03426995|11944361|FG000|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10782602|NCT03426995|11944362|FG001|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||2
10782603|NCT03426995|11944363|FG002|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10782604|NCT03426995|11944364|FG003|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||2
10782605|NCT03426995|11944365|FG004|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||1
10782606|NCT03426995|11944366|FG005|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||1
10782607|NCT03426995|11944367|FG006|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10782608|NCT03426995|11944368|FG007|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10782609|NCT03426995|11944369|FG008|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10782610|NCT03426995|11944370|FG009|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10782611|NCT03426995|11944371|FG010|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10782612|NCT03426995|11944372|FG011|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10316357|NCT00189488|11450365|FG000|STARTED|Overall Study||78
10782613|NCT03426995|11944373|FG012|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10782614|NCT03426995|11944374|FG013|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10782615|NCT03426995|11944375|FG014|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10782616|NCT03426995|11944376|FG015|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10782617|NCT03426995|11944377|FG016|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10782618|NCT03426995|11944378|FG017|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10782619|NCT03426995|11944379|FG018|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10782620|NCT03426995|11944361|FG000|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10782621|NCT03426995|11944362|FG001|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10782622|NCT03426995|11944363|FG002|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10782623|NCT03426995|11944364|FG003|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10782624|NCT03426995|11944365|FG004|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10782625|NCT03426995|11944366|FG005|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10782626|NCT03426995|11944367|FG006|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10782627|NCT03426995|11944368|FG007|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10782628|NCT03426995|11944369|FG008|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10782629|NCT03426995|11944370|FG009|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10782630|NCT03426995|11944371|FG010|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10782631|NCT03426995|11944372|FG011|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10782632|NCT03426995|11944373|FG012|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10782633|NCT03426995|11944374|FG013|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10782634|NCT03426995|11944375|FG014|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10782635|NCT03426995|11944376|FG015|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10782636|NCT03426995|11944377|FG016|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10782637|NCT03426995|11944378|FG017|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10782638|NCT03426995|11944379|FG018|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
10782930|NCT03426995|11944367|FG006|STARTED|Part A: Cohort 2-Period 1 (Day1)||1
10782639|NCT03426995|11944361|FG000|STARTED|Part A: Cohort 1-Period 2 (Day1)|New participant enrolled and dosed.|1
10782640|NCT03426995|11944362|FG001|STARTED|Part A: Cohort 1-Period 2 (Day1)||2
10782641|NCT03426995|11944363|FG002|STARTED|Part A: Cohort 1-Period 2 (Day1)|New participant enrolled and dosed.|1
10782642|NCT03426995|11944364|FG003|STARTED|Part A: Cohort 1-Period 2 (Day1)||2
10782643|NCT03426995|11944365|FG004|STARTED|Part A: Cohort 1-Period 2 (Day1)||1
10782644|NCT03426995|11944366|FG005|STARTED|Part A: Cohort 1-Period 2 (Day1)|Two additional participants were enrolled and dosed.|3
10782645|NCT03426995|11944367|FG006|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
10782646|NCT03426995|11944368|FG007|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
10782647|NCT03426995|11944369|FG008|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
10782648|NCT03426995|11944370|FG009|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
10782649|NCT03426995|11944371|FG010|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
10782650|NCT03426995|11944372|FG011|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
10782651|NCT03426995|11944373|FG012|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
10782652|NCT03426995|11944374|FG013|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
10782653|NCT03426995|11944375|FG014|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
10782654|NCT03426995|11944376|FG015|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
10782655|NCT03426995|11944377|FG016|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
10782656|NCT03426995|11944378|FG017|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
10782657|NCT03426995|11944379|FG018|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
10316358|NCT00189488|11450366|FG001|STARTED|Overall Study||77
10316359|NCT00189488|11450365|FG000|Received Palifermin/Placebo|Overall Study||75
10316360|NCT00189488|11450366|FG001|Received Palifermin/Placebo|Overall Study||76
10316361|NCT00189488|11450365|FG000|COMPLETED|Overall Study||63
10316362|NCT00189488|11450366|FG001|COMPLETED|Overall Study||55
10782658|NCT03426995|11944361|FG000|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1
10782659|NCT03426995|11944362|FG001|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||2
10782660|NCT03426995|11944363|FG002|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1
10782661|NCT03426995|11944364|FG003|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||2
10782662|NCT03426995|11944365|FG004|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10782663|NCT03426995|11944366|FG005|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1
10782664|NCT03426995|11944367|FG006|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10782665|NCT03426995|11944368|FG007|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10782666|NCT03426995|11944369|FG008|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10782667|NCT03426995|11944370|FG009|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10782668|NCT03426995|11944371|FG010|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10782669|NCT03426995|11944372|FG011|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10782670|NCT03426995|11944373|FG012|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10782671|NCT03426995|11944374|FG013|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10782672|NCT03426995|11944375|FG014|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10782673|NCT03426995|11944376|FG015|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10782674|NCT03426995|11944377|FG016|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10782675|NCT03426995|11944378|FG017|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10782676|NCT03426995|11944379|FG018|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10782677|NCT03426995|11944361|FG000|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10782678|NCT03426995|11944362|FG001|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10782679|NCT03426995|11944363|FG002|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10782680|NCT03426995|11944364|FG003|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10782681|NCT03426995|11944365|FG004|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1
10782682|NCT03426995|11944366|FG005|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||2
10782683|NCT03426995|11944367|FG006|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10782684|NCT03426995|11944368|FG007|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10782685|NCT03426995|11944369|FG008|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10782686|NCT03426995|11944370|FG009|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10782687|NCT03426995|11944371|FG010|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10782688|NCT03426995|11944372|FG011|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10782689|NCT03426995|11944373|FG012|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10782690|NCT03426995|11944374|FG013|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10782691|NCT03426995|11944375|FG014|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10782692|NCT03426995|11944376|FG015|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10782693|NCT03426995|11944377|FG016|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10782694|NCT03426995|11944378|FG017|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10782695|NCT03426995|11944379|FG018|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
10782696|NCT03426995|11944361|FG000|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
10782697|NCT03426995|11944362|FG001|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||2
10782698|NCT03426995|11944363|FG002|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
10782699|NCT03426995|11944364|FG003|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||2
10782700|NCT03426995|11944365|FG004|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10782701|NCT03426995|11944366|FG005|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
10782702|NCT03426995|11944367|FG006|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10782703|NCT03426995|11944368|FG007|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10782704|NCT03426995|11944369|FG008|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10782705|NCT03426995|11944370|FG009|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10782706|NCT03426995|11944371|FG010|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10782707|NCT03426995|11944372|FG011|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10782708|NCT03426995|11944373|FG012|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10782709|NCT03426995|11944374|FG013|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10782710|NCT03426995|11944375|FG014|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10782711|NCT03426995|11944376|FG015|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10782712|NCT03426995|11944377|FG016|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10782713|NCT03426995|11944378|FG017|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10782714|NCT03426995|11944379|FG018|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10782715|NCT03426995|11944361|FG000|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
10782716|NCT03426995|11944362|FG001|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||2
10782717|NCT03426995|11944363|FG002|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
10782718|NCT03426995|11944364|FG003|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||2
10782719|NCT03426995|11944365|FG004|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10782720|NCT03426995|11944366|FG005|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
10782721|NCT03426995|11944367|FG006|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10782722|NCT03426995|11944368|FG007|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10782723|NCT03426995|11944369|FG008|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10782724|NCT03426995|11944370|FG009|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10782725|NCT03426995|11944371|FG010|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10782726|NCT03426995|11944372|FG011|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10782727|NCT03426995|11944373|FG012|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10782728|NCT03426995|11944374|FG013|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10782729|NCT03426995|11944375|FG014|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10782730|NCT03426995|11944376|FG015|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10782731|NCT03426995|11944377|FG016|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10782732|NCT03426995|11944378|FG017|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10782733|NCT03426995|11944379|FG018|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10782734|NCT03426995|11944361|FG000|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10782735|NCT03426995|11944362|FG001|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10782736|NCT03426995|11944363|FG002|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10782737|NCT03426995|11944364|FG003|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10782738|NCT03426995|11944365|FG004|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10782739|NCT03426995|11944366|FG005|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10782740|NCT03426995|11944367|FG006|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10782741|NCT03426995|11944368|FG007|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10782742|NCT03426995|11944369|FG008|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10782743|NCT03426995|11944370|FG009|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10782744|NCT03426995|11944371|FG010|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10782745|NCT03426995|11944372|FG011|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10782746|NCT03426995|11944373|FG012|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10782747|NCT03426995|11944374|FG013|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10782748|NCT03426995|11944375|FG014|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10782749|NCT03426995|11944376|FG015|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10782750|NCT03426995|11944377|FG016|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10782751|NCT03426995|11944378|FG017|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10782752|NCT03426995|11944379|FG018|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
10782753|NCT03426995|11944361|FG000|STARTED|Part A: Cohort 1-Period 3 (Day1)||1
10782754|NCT03426995|11944362|FG001|STARTED|Part A: Cohort 1-Period 3 (Day1)||2
10782755|NCT03426995|11944363|FG002|STARTED|Part A: Cohort 1-Period 3 (Day1)||1
10782756|NCT03426995|11944364|FG003|STARTED|Part A: Cohort 1-Period 3 (Day1)||2
10782757|NCT03426995|11944365|FG004|STARTED|Part A: Cohort 1-Period 3 (Day1)|New participant enrolled and dosed.|1
10782758|NCT03426995|11944366|FG005|STARTED|Part A: Cohort 1-Period 3 (Day1)|New participant enrolled and dosed.|2
10782759|NCT03426995|11944367|FG006|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
10782760|NCT03426995|11944368|FG007|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
10782761|NCT03426995|11944369|FG008|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
10782762|NCT03426995|11944370|FG009|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
10782763|NCT03426995|11944371|FG010|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
10782764|NCT03426995|11944372|FG011|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
10782765|NCT03426995|11944373|FG012|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
10782766|NCT03426995|11944374|FG013|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
10782767|NCT03426995|11944375|FG014|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
10782768|NCT03426995|11944376|FG015|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
10782769|NCT03426995|11944377|FG016|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
10782770|NCT03426995|11944378|FG017|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
10782771|NCT03426995|11944379|FG018|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
10782772|NCT03426995|11944361|FG000|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||1
10782773|NCT03426995|11944362|FG001|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||2
10782774|NCT03426995|11944363|FG002|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||1
10782775|NCT03426995|11944364|FG003|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||2
10782776|NCT03426995|11944365|FG004|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||1
10782777|NCT03426995|11944366|FG005|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||2
10782778|NCT03426995|11944367|FG006|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10782779|NCT03426995|11944368|FG007|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10782780|NCT03426995|11944369|FG008|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10782781|NCT03426995|11944370|FG009|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10782782|NCT03426995|11944371|FG010|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10782783|NCT03426995|11944372|FG011|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10782784|NCT03426995|11944373|FG012|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10782785|NCT03426995|11944374|FG013|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10782786|NCT03426995|11944375|FG014|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10782787|NCT03426995|11944376|FG015|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10782788|NCT03426995|11944377|FG016|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10782789|NCT03426995|11944378|FG017|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10782790|NCT03426995|11944379|FG018|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10782791|NCT03426995|11944361|FG000|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10782792|NCT03426995|11944362|FG001|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10782793|NCT03426995|11944363|FG002|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10782794|NCT03426995|11944364|FG003|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10782795|NCT03426995|11944365|FG004|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10782796|NCT03426995|11944366|FG005|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10782797|NCT03426995|11944367|FG006|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10782798|NCT03426995|11944368|FG007|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10782799|NCT03426995|11944369|FG008|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10782800|NCT03426995|11944370|FG009|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10782801|NCT03426995|11944371|FG010|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10782802|NCT03426995|11944372|FG011|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10782803|NCT03426995|11944373|FG012|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10782804|NCT03426995|11944374|FG013|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10782805|NCT03426995|11944375|FG014|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10782806|NCT03426995|11944376|FG015|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10782807|NCT03426995|11944377|FG016|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10782808|NCT03426995|11944378|FG017|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10782809|NCT03426995|11944379|FG018|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
10782810|NCT03426995|11944361|FG000|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
10782811|NCT03426995|11944362|FG001|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
10782812|NCT03426995|11944363|FG002|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
10782813|NCT03426995|11944364|FG003|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
10782814|NCT03426995|11944365|FG004|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
10782815|NCT03426995|11944366|FG005|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
10782816|NCT03426995|11944367|FG006|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10782817|NCT03426995|11944368|FG007|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10782818|NCT03426995|11944369|FG008|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10782819|NCT03426995|11944370|FG009|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10782820|NCT03426995|11944371|FG010|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10782821|NCT03426995|11944372|FG011|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10782822|NCT03426995|11944373|FG012|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10782823|NCT03426995|11944374|FG013|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10782824|NCT03426995|11944375|FG014|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10782825|NCT03426995|11944376|FG015|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10782826|NCT03426995|11944377|FG016|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10782827|NCT03426995|11944378|FG017|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10782828|NCT03426995|11944379|FG018|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10782829|NCT03426995|11944361|FG000|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
10782830|NCT03426995|11944362|FG001|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
10782831|NCT03426995|11944363|FG002|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
10782832|NCT03426995|11944364|FG003|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
10782833|NCT03426995|11944365|FG004|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
10782834|NCT03426995|11944366|FG005|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
10782835|NCT03426995|11944367|FG006|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10782836|NCT03426995|11944368|FG007|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10782837|NCT03426995|11944369|FG008|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10782838|NCT03426995|11944370|FG009|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10782839|NCT03426995|11944371|FG010|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10782840|NCT03426995|11944372|FG011|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10782841|NCT03426995|11944373|FG012|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10316363|NCT00189488|11450365|FG000|NOT COMPLETED|Overall Study||15
10316364|NCT00189488|11450366|FG001|NOT COMPLETED|Overall Study||22
10316365|NCT00189540|11450375|FG000|STARTED|Overall Study||21
10782842|NCT03426995|11944374|FG013|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10782843|NCT03426995|11944375|FG014|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10782844|NCT03426995|11944376|FG015|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10782845|NCT03426995|11944377|FG016|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10782846|NCT03426995|11944378|FG017|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10782847|NCT03426995|11944379|FG018|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10782848|NCT03426995|11944361|FG000|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10782849|NCT03426995|11944362|FG001|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10782850|NCT03426995|11944363|FG002|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10782851|NCT03426995|11944364|FG003|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10782852|NCT03426995|11944365|FG004|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10782853|NCT03426995|11944366|FG005|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10782854|NCT03426995|11944367|FG006|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10782855|NCT03426995|11944368|FG007|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10782856|NCT03426995|11944369|FG008|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10782857|NCT03426995|11944370|FG009|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10782858|NCT03426995|11944371|FG010|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10782859|NCT03426995|11944372|FG011|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10782860|NCT03426995|11944373|FG012|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10782861|NCT03426995|11944374|FG013|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10782862|NCT03426995|11944375|FG014|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10782863|NCT03426995|11944376|FG015|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10782864|NCT03426995|11944377|FG016|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10782865|NCT03426995|11944378|FG017|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10782866|NCT03426995|11944379|FG018|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
10782867|NCT03426995|11944361|FG000|STARTED|Part A: Cohort 1-Period 4 (Day1)||1
10782868|NCT03426995|11944362|FG001|STARTED|Part A: Cohort 1-Period 4 (Day1)||2
10782869|NCT03426995|11944363|FG002|STARTED|Part A: Cohort 1-Period 4 (Day1)||1
10782870|NCT03426995|11944364|FG003|STARTED|Part A: Cohort 1-Period 4 (Day1)||2
10782871|NCT03426995|11944365|FG004|STARTED|Part A: Cohort 1-Period 4 (Day1)||1
10782872|NCT03426995|11944366|FG005|STARTED|Part A: Cohort 1-Period 4 (Day1)||2
10782873|NCT03426995|11944367|FG006|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
10782874|NCT03426995|11944368|FG007|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
10782875|NCT03426995|11944369|FG008|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
10782876|NCT03426995|11944370|FG009|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
10782877|NCT03426995|11944371|FG010|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
10782878|NCT03426995|11944372|FG011|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
10782879|NCT03426995|11944373|FG012|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
10782880|NCT03426995|11944374|FG013|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
10782881|NCT03426995|11944375|FG014|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
10782882|NCT03426995|11944376|FG015|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
10782883|NCT03426995|11944377|FG016|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
10782884|NCT03426995|11944378|FG017|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
10782885|NCT03426995|11944379|FG018|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
10782886|NCT03426995|11944361|FG000|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||1
10782887|NCT03426995|11944362|FG001|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||2
10782888|NCT03426995|11944363|FG002|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||1
10782889|NCT03426995|11944364|FG003|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||2
10782890|NCT03426995|11944365|FG004|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||1
10782891|NCT03426995|11944366|FG005|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||2
10782892|NCT03426995|11944367|FG006|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10782893|NCT03426995|11944368|FG007|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10782894|NCT03426995|11944369|FG008|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10782895|NCT03426995|11944370|FG009|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10782896|NCT03426995|11944371|FG010|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10782897|NCT03426995|11944372|FG011|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10782898|NCT03426995|11944373|FG012|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10782899|NCT03426995|11944374|FG013|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10782900|NCT03426995|11944375|FG014|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10782901|NCT03426995|11944376|FG015|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10782902|NCT03426995|11944377|FG016|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10782903|NCT03426995|11944378|FG017|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10782904|NCT03426995|11944379|FG018|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10782905|NCT03426995|11944361|FG000|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10782906|NCT03426995|11944362|FG001|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10782907|NCT03426995|11944363|FG002|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10782908|NCT03426995|11944364|FG003|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10782909|NCT03426995|11944365|FG004|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10782910|NCT03426995|11944366|FG005|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10782911|NCT03426995|11944367|FG006|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10782912|NCT03426995|11944368|FG007|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10782913|NCT03426995|11944369|FG008|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10782914|NCT03426995|11944370|FG009|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10782915|NCT03426995|11944371|FG010|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10782916|NCT03426995|11944372|FG011|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10782917|NCT03426995|11944373|FG012|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10782918|NCT03426995|11944374|FG013|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10782919|NCT03426995|11944375|FG014|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10782920|NCT03426995|11944376|FG015|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10782921|NCT03426995|11944377|FG016|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10782922|NCT03426995|11944378|FG017|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10782923|NCT03426995|11944379|FG018|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
10782924|NCT03426995|11944361|FG000|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
10782925|NCT03426995|11944362|FG001|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
10782926|NCT03426995|11944363|FG002|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
10782927|NCT03426995|11944364|FG003|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
10782928|NCT03426995|11944365|FG004|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
10782929|NCT03426995|11944366|FG005|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
10782931|NCT03426995|11944368|FG007|STARTED|Part A: Cohort 2-Period 1 (Day1)||2
10782932|NCT03426995|11944369|FG008|STARTED|Part A: Cohort 2-Period 1 (Day1)||1
10316366|NCT00189540|11450376|FG001|STARTED|Overall Study||6
10316367|NCT00189540|11450375|FG000|COMPLETED|Overall Study||14
10316368|NCT00189540|11450376|FG001|COMPLETED|Overall Study||5
10316369|NCT00189540|11450375|FG000|NOT COMPLETED|Overall Study||7
10316370|NCT00189540|11450376|FG001|NOT COMPLETED|Overall Study||1
10316371|NCT00190671|11450384|FG000|STARTED|Overall Study||42
10316372|NCT00190671|11450385|FG001|STARTED|Overall Study||61
10316373|NCT00190671|11450384|FG000|COMPLETED|Overall Study||15
10316374|NCT00190671|11450385|FG001|COMPLETED|Overall Study||19
10316375|NCT00190671|11450384|FG000|NOT COMPLETED|Overall Study||27
10316376|NCT00190671|11450385|FG001|NOT COMPLETED|Overall Study||42
10316377|NCT00190684|11450392|FG000|STARTED|Overall Study||1553
10316378|NCT00190684|11450392|FG000|Received at Least 1 Dose of Study Drug|Overall Study|1553 patients entered the study; 1551 were enrolled and received study drug.|1551
10316379|NCT00190684|11450392|FG000|COMPLETED|Overall Study|Number of patients that completed overall study (through Period VI)|64
10316380|NCT00190684|11450392|FG000|NOT COMPLETED|Overall Study||1489
10316381|NCT00190749|11450398|FG000|STARTED|Overall Study||68
10316382|NCT00190749|11450399|FG001|STARTED|Overall Study||62
10316383|NCT00190749|11450398|FG000|COMPLETED|Overall Study||42
10316384|NCT00190749|11450399|FG001|COMPLETED|Overall Study||31
10316385|NCT00190749|11450398|FG000|NOT COMPLETED|Overall Study||26
10316386|NCT00190749|11450399|FG001|NOT COMPLETED|Overall Study||31
10316387|NCT00190775|11450407|FG000|STARTED|Overall Study||268
10316388|NCT00190775|11450408|FG001|STARTED|Overall Study||234
10316389|NCT00190775|11450407|FG000|Received Study Drug|Overall Study||266
10316390|NCT00190775|11450408|FG001|Received Study Drug|Overall Study||234
10316391|NCT00190775|11450407|FG000|COMPLETED|Overall Study||119
10316392|NCT00190775|11450408|FG001|COMPLETED|Overall Study||134
10316393|NCT00190775|11450407|FG000|NOT COMPLETED|Overall Study||149
10316394|NCT00190775|11450408|FG001|NOT COMPLETED|Overall Study||100
10316395|NCT00190983|11450421|FG000|STARTED|Overall Study||29
10316396|NCT00190983|11450421|FG000|COMPLETED|Overall Study|Completed means patient received treatment and was evaluable for response.|27
10316397|NCT00190983|11450421|FG000|NOT COMPLETED|Overall Study||2
10316398|NCT00191100|11450427|FG000|STARTED|Overall Study||259
10316399|NCT00191100|11450428|FG001|STARTED|Overall Study||256
10316400|NCT00191100|11450427|FG000|COMPLETED|Overall Study||217
10316401|NCT00191100|11450428|FG001|COMPLETED|Overall Study||244
10316402|NCT00191100|11450427|FG000|NOT COMPLETED|Overall Study||42
10316403|NCT00191100|11450428|FG001|NOT COMPLETED|Overall Study||12
10316404|NCT00191113|11450436|FG000|STARTED|Core Study||78
10316405|NCT00191113|11450437|FG001|STARTED|Core Study||76
10316406|NCT00191113|11450436|FG000|COMPLETED|Core Study||43
10316407|NCT00191113|11450437|FG001|COMPLETED|Core Study||61
10316408|NCT00191113|11450436|FG000|NOT COMPLETED|Core Study||35
10316409|NCT00191113|11450437|FG001|NOT COMPLETED|Core Study||15
10316410|NCT00191113|11450436|FG000|STARTED|Addendum 1||2
10316411|NCT00191113|11450437|FG001|STARTED|Addendum 1|Not Applicable -- only Control patients were eligible for Addendum 1|0
10316412|NCT00191113|11450436|FG000|COMPLETED|Addendum 1||2
10316413|NCT00191113|11450437|FG001|COMPLETED|Addendum 1|Not Applicable -- only Control patients were eligible for Addendum 1|0
10316414|NCT00191113|11450436|FG000|NOT COMPLETED|Addendum 1||0
10316415|NCT00191113|11450437|FG001|NOT COMPLETED|Addendum 1||0
10316416|NCT00191113|11450436|FG000|STARTED|Addendum 2||28
10316417|NCT00191113|11450437|FG001|STARTED|Addendum 2||48
10316418|NCT00191113|11450436|FG000|COMPLETED|Addendum 2||18
10316419|NCT00191113|11450437|FG001|COMPLETED|Addendum 2||31
10316420|NCT00191113|11450436|FG000|NOT COMPLETED|Addendum 2||10
10782933|NCT03426995|11944370|FG009|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
10782934|NCT03426995|11944371|FG010|STARTED|Part A: Cohort 2-Period 1 (Day1)||1
10782935|NCT03426995|11944372|FG011|STARTED|Part A: Cohort 2-Period 1 (Day1)||1
10782936|NCT03426995|11944373|FG012|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
10316421|NCT00191113|11450437|FG001|NOT COMPLETED|Addendum 2||17
10316422|NCT00191113|11450436|FG000|STARTED|Addendum 3||20
10316423|NCT00191113|11450437|FG001|STARTED|Addendum 3||37
10316424|NCT00191113|11450436|FG000|COMPLETED|Addendum 3||20
10316425|NCT00191113|11450437|FG001|COMPLETED|Addendum 3||37
10782937|NCT03426995|11944374|FG013|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
10316426|NCT00191113|11450436|FG000|NOT COMPLETED|Addendum 3||0
10316427|NCT00191113|11450437|FG001|NOT COMPLETED|Addendum 3||0
10316428|NCT00191139|11450451|FG000|STARTED|Overall Study||32
10316429|NCT00191139|11450452|FG001|STARTED|Overall Study||32
10316430|NCT00191139|11450451|FG000|COMPLETED|Overall Study||27
10316431|NCT00191139|11450452|FG001|COMPLETED|Overall Study||20
10316432|NCT00191139|11450451|FG000|NOT COMPLETED|Overall Study||5
10316433|NCT00191139|11450452|FG001|NOT COMPLETED|Overall Study||12
10316434|NCT00191152|11450460|FG000|STARTED|Initial Treatment||239
10316435|NCT00191152|11450461|FG001|STARTED|Initial Treatment||236
10316436|NCT00191152|11450460|FG000|Received Initial Treatment|Initial Treatment||236
10316437|NCT00191152|11450461|FG001|Received Initial Treatment|Initial Treatment||227
10316438|NCT00191152|11450460|FG000|COMPLETED|Initial Treatment||98
10316439|NCT00191152|11450461|FG001|COMPLETED|Initial Treatment||83
10316440|NCT00191152|11450460|FG000|NOT COMPLETED|Initial Treatment||141
10316441|NCT00191152|11450461|FG001|NOT COMPLETED|Initial Treatment||153
10316442|NCT00191152|11450460|FG000|STARTED|Crossover Treatment||77
10316443|NCT00191152|11450461|FG001|STARTED|Crossover Treatment||81
10316444|NCT00191152|11450460|FG000|Received Treatment|Crossover Treatment||76
10316445|NCT00191152|11450461|FG001|Received Treatment|Crossover Treatment||80
10316446|NCT00191152|11450460|FG000|COMPLETED|Crossover Treatment||50
10316447|NCT00191152|11450461|FG001|COMPLETED|Crossover Treatment||53
10316448|NCT00191152|11450460|FG000|NOT COMPLETED|Crossover Treatment||27
10316449|NCT00191152|11450461|FG001|NOT COMPLETED|Crossover Treatment||28
10316450|NCT00191165|11450481|FG000|STARTED|Overall Study||14
10316451|NCT00191165|11450482|FG001|STARTED|Overall Study||13
10316452|NCT00191165|11450481|FG000|COMPLETED|Overall Study||12
10316453|NCT00191165|11450482|FG001|COMPLETED|Overall Study||11
10316454|NCT00191165|11450481|FG000|NOT COMPLETED|Overall Study||2
10316455|NCT00191165|11450482|FG001|NOT COMPLETED|Overall Study||2
10316456|NCT00191191|11450490|FG000|STARTED|Overall Study||114
10316457|NCT00191191|11450491|FG001|STARTED|Overall Study||112
10316458|NCT00191191|11450490|FG000|Safety Analysis Population|Overall Study||114
10316459|NCT00191191|11450491|FG001|Safety Analysis Population|Overall Study||111
10316460|NCT00191191|11450490|FG000|Full Analysis Set Population|Overall Study||108
10316461|NCT00191191|11450491|FG001|Full Analysis Set Population|Overall Study||108
10316462|NCT00191191|11450490|FG000|COMPLETED|Overall Study||0
10316463|NCT00191191|11450491|FG001|COMPLETED|Overall Study||0
10316464|NCT00191191|11450490|FG000|NOT COMPLETED|Overall Study||114
10316465|NCT00191191|11450491|FG001|NOT COMPLETED|Overall Study||112
10316466|NCT00191269|11450499|FG000|STARTED|Overall Study||6
10316467|NCT00191269|11450500|FG001|STARTED|Overall Study||62
10316468|NCT00191269|11450499|FG000|COMPLETED|Overall Study||0
10316469|NCT00191269|11450500|FG001|COMPLETED|Overall Study||4
10316470|NCT00191269|11450499|FG000|NOT COMPLETED|Overall Study||6
10316471|NCT00191269|11450500|FG001|NOT COMPLETED|Overall Study||58
10316472|NCT00191282|11450509|FG000|STARTED|Overall Study||558
10316473|NCT00191282|11450510|FG001|STARTED|Overall Study||558
10316474|NCT00191282|11450509|FG000|COMPLETED|Overall Study||338
10316475|NCT00191282|11450510|FG001|COMPLETED|Overall Study||346
10316476|NCT00191282|11450509|FG000|NOT COMPLETED|Overall Study||220
10316477|NCT00191282|11450510|FG001|NOT COMPLETED|Overall Study||212
10316478|NCT00191308|11450516|FG000|STARTED|Overall Study||30
10316479|NCT00191308|11450516|FG000|COMPLETED|Overall Study||29
10316480|NCT00191308|11450516|FG000|NOT COMPLETED|Overall Study||1
10316481|NCT00191334|11450520|FG000|STARTED|Overall Study||50
10316482|NCT00191334|11450520|FG000|COMPLETED|Overall Study||33
10316483|NCT00191334|11450520|FG000|NOT COMPLETED|Overall Study||17
10782938|NCT03426995|11944375|FG014|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
10782939|NCT03426995|11944376|FG015|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
10782940|NCT03426995|11944377|FG016|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
10782941|NCT03426995|11944378|FG017|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
10782942|NCT03426995|11944379|FG018|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
10782943|NCT03426995|11944361|FG000|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10782944|NCT03426995|11944362|FG001|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10782945|NCT03426995|11944363|FG002|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10782946|NCT03426995|11944364|FG003|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10782947|NCT03426995|11944365|FG004|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10782948|NCT03426995|11944366|FG005|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10782949|NCT03426995|11944367|FG006|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1
10782950|NCT03426995|11944368|FG007|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||2
10782951|NCT03426995|11944369|FG008|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1
10782952|NCT03426995|11944370|FG009|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10316484|NCT00191386|11450524|FG000|STARTED|Overall Study||228
10316485|NCT00191386|11450524|FG000|6 Months|Overall Study||183
10316486|NCT00191386|11450524|FG000|12 Months|Overall Study||149
10316487|NCT00191386|11450524|FG000|2 Years|Overall Study||105
10316488|NCT00191386|11450524|FG000|3 Years|Overall Study||65
10316489|NCT00191386|11450524|FG000|COMPLETED|Overall Study||68
10316490|NCT00191386|11450524|FG000|NOT COMPLETED|Overall Study||160
10316491|NCT00191451|11450531|FG000|STARTED|Overall Study||50
10316492|NCT00191451|11450532|FG001|STARTED|Overall Study||51
10316493|NCT00191451|11450533|FG002|STARTED|Overall Study||49
10316494|NCT00191451|11450531|FG000|Received at Least One Dose of Study Drug|Overall Study||50
10316495|NCT00191451|11450532|FG001|Received at Least One Dose of Study Drug|Overall Study||48
10316496|NCT00191451|11450533|FG002|Received at Least One Dose of Study Drug|Overall Study||47
10316497|NCT00191451|11450531|FG000|COMPLETED|Overall Study||43
10316498|NCT00191451|11450532|FG001|COMPLETED|Overall Study||37
10316499|NCT00191451|11450533|FG002|COMPLETED|Overall Study||35
10316500|NCT00191451|11450531|FG000|NOT COMPLETED|Overall Study||7
10316501|NCT00191451|11450532|FG001|NOT COMPLETED|Overall Study||14
10316502|NCT00191451|11450533|FG002|NOT COMPLETED|Overall Study||14
10316503|NCT00191477|11450543|FG000|STARTED|Overall Study||179
10316504|NCT00191477|11450544|FG001|STARTED|Overall Study||176
10316505|NCT00191477|11450543|FG000|Received Study Drug|Overall Study||166
10432878|NCT00883051|11579132|FG001|NOT COMPLETED|Overall Study||22
10432879|NCT00883051|11579133|FG002|NOT COMPLETED|Overall Study||29
10782953|NCT03426995|11944371|FG010|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1
10782954|NCT03426995|11944372|FG011|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1
10316506|NCT00191477|11450544|FG001|Received Study Drug|Overall Study||162
10316507|NCT00191477|11450543|FG000|COMPLETED|Overall Study||41
10316508|NCT00191477|11450544|FG001|COMPLETED|Overall Study||47
10316509|NCT00191477|11450543|FG000|NOT COMPLETED|Overall Study||138
10316510|NCT00191477|11450544|FG001|NOT COMPLETED|Overall Study||129
10316511|NCT00191646|11450552|FG000|STARTED|Overall Study||417
10316512|NCT00191646|11450553|FG001|STARTED|Overall Study||414
10316513|NCT00191646|11450552|FG000|Received Induction Therapy|Overall Study||411
10316514|NCT00191646|11450553|FG001|Received Induction Therapy|Overall Study||409
10432909|NCT00883168|11579184|FG000|COMPLETED|Overall Study||434
10316515|NCT00191646|11450552|FG000|Received Consolidation Therapy|Overall Study||169
10316516|NCT00191646|11450553|FG001|Received Consolidation Therapy|Overall Study||183
10316517|NCT00191646|11450552|FG000|Received Crossover Therapy|Overall Study||77
10316518|NCT00191646|11450553|FG001|Received Crossover Therapy|Overall Study||78
10316519|NCT00191646|11450552|FG000|COMPLETED|Overall Study|Completed was defined as the patients treated in either consolidation therapy or crossover therapy.|246
10316520|NCT00191646|11450553|FG001|COMPLETED|Overall Study|Completed was defined as the patients treated in either consolidation therapy or crossover therapy.|261
10316521|NCT00191646|11450552|FG000|NOT COMPLETED|Overall Study||171
10316522|NCT00191646|11450553|FG001|NOT COMPLETED|Overall Study||153
10316523|NCT00191724|11450572|FG000|STARTED|Overall Study||6
10316524|NCT00191724|11450573|FG001|STARTED|Overall Study||9
10316525|NCT00191724|11450574|FG002|STARTED|Overall Study||9
10782955|NCT03426995|11944373|FG012|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10782956|NCT03426995|11944374|FG013|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10782957|NCT03426995|11944375|FG014|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10782958|NCT03426995|11944376|FG015|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10782959|NCT03426995|11944377|FG016|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10782960|NCT03426995|11944378|FG017|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10782961|NCT03426995|11944379|FG018|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10782962|NCT03426995|11944361|FG000|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10782963|NCT03426995|11944362|FG001|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10782964|NCT03426995|11944363|FG002|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10316526|NCT00191724|11450575|FG003|STARTED|Overall Study||8
10316527|NCT00191724|11450576|FG004|STARTED|Overall Study||15
10316528|NCT00191724|11450572|FG000|COMPLETED|Overall Study||5
10316529|NCT00191724|11450573|FG001|COMPLETED|Overall Study||8
10316530|NCT00191724|11450574|FG002|COMPLETED|Overall Study||8
10316531|NCT00191724|11450575|FG003|COMPLETED|Overall Study||5
10316532|NCT00191724|11450576|FG004|COMPLETED|Overall Study||12
10316533|NCT00191724|11450572|FG000|NOT COMPLETED|Overall Study||1
10316534|NCT00191724|11450573|FG001|NOT COMPLETED|Overall Study||1
10316535|NCT00191724|11450574|FG002|NOT COMPLETED|Overall Study||1
10316536|NCT00191724|11450575|FG003|NOT COMPLETED|Overall Study||3
10316537|NCT00191724|11450576|FG004|NOT COMPLETED|Overall Study||3
10316538|NCT00191789|11450588|FG000|STARTED|Overall Study||65
10316539|NCT00191789|11450588|FG000|COMPLETED|Overall Study||40
10316540|NCT00191789|11450588|FG000|NOT COMPLETED|Overall Study||25
10316541|NCT00191815|11450592|FG000|STARTED|Overall Study||70
10782965|NCT03426995|11944364|FG003|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10782966|NCT03426995|11944365|FG004|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10316542|NCT00191815|11450592|FG000|Treated|Overall Study||67
10316543|NCT00191815|11450592|FG000|COMPLETED|Overall Study||30
10432880|NCT00883051|11579134|FG003|NOT COMPLETED|Overall Study||29
10316544|NCT00191815|11450592|FG000|NOT COMPLETED|Overall Study||40
10316545|NCT00191854|11450599|FG000|STARTED|Overall Study||49
10316546|NCT00191854|11450600|FG001|STARTED|Overall Study||47
10316547|NCT00191854|11450601|FG002|STARTED|Overall Study||51
10316548|NCT00191854|11450599|FG000|Received at Least One Dose of Study Drug|Overall Study||49
10316549|NCT00191854|11450600|FG001|Received at Least One Dose of Study Drug|Overall Study||47
10316550|NCT00191854|11450601|FG002|Received at Least One Dose of Study Drug|Overall Study|Screen failure: discontinued prior to receiving study drug.|50
10432881|NCT00883051|11579135|FG004|NOT COMPLETED|Overall Study||18
10432882|NCT00883090|11579147|FG000|STARTED|Overall Study|Of the 15 participants started, 14 were administered FXIII|15
10432883|NCT00883090|11579147|FG000|COMPLETED|Overall Study||13
10432884|NCT00883090|11579147|FG000|NOT COMPLETED|Overall Study||2
10432885|NCT00883103|11579153|FG000|STARTED|Overall Study||69
10432886|NCT00883103|11579154|FG001|STARTED|Overall Study||68
10432887|NCT00883103|11579153|FG000|COMPLETED|Overall Study||69
10432888|NCT00883103|11579154|FG001|COMPLETED|Overall Study||68
10782967|NCT03426995|11944366|FG005|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10782968|NCT03426995|11944367|FG006|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10782969|NCT03426995|11944368|FG007|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10782970|NCT03426995|11944369|FG008|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10782971|NCT03426995|11944370|FG009|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10432889|NCT00883103|11579153|FG000|NOT COMPLETED|Overall Study||0
10432890|NCT00883103|11579154|FG001|NOT COMPLETED|Overall Study||0
10432891|NCT00883116|11579162|FG000|STARTED|Overall Study||248
10432892|NCT00883116|11579163|FG001|STARTED|Overall Study||248
10432893|NCT00883116|11579162|FG000|Received Treatment|Overall Study||248
10432894|NCT00883116|11579163|FG001|Received Treatment|Overall Study||239
10432895|NCT00883116|11579162|FG000|COMPLETED|Overall Study||39
10432896|NCT00883116|11579163|FG001|COMPLETED|Overall Study||29
10432897|NCT00883116|11579162|FG000|NOT COMPLETED|Overall Study||209
10432898|NCT00883116|11579163|FG001|NOT COMPLETED|Overall Study||219
10432899|NCT00883129|11579173|FG000|STARTED|Overall Study||69
10432900|NCT00883129|11579174|FG001|STARTED|Overall Study||73
10432901|NCT00883129|11579173|FG000|COMPLETED|Overall Study|53 subjects provided a 24 month outcome, 4 of whom had prematurely withdrawn from drug treatment.|49
10432902|NCT00883129|11579174|FG001|COMPLETED|Overall Study|53 subjects provided a 24 month outcome, 16 of whom had prematurely withdrawn from drug treatment.|37
10432903|NCT00883129|11579173|FG000|NOT COMPLETED|Overall Study||20
10432904|NCT00883129|11579174|FG001|NOT COMPLETED|Overall Study||36
10432905|NCT00883168|11579184|FG000|STARTED|Overall Study||448
10432906|NCT00883168|11579185|FG001|STARTED|Overall Study||445
10432907|NCT00883168|11579186|FG002|STARTED|Overall Study||450
10432908|NCT00883168|11579187|FG003|STARTED|Overall Study||448
10432910|NCT00883168|11579185|FG001|COMPLETED|Overall Study||430
10432911|NCT00883168|11579186|FG002|COMPLETED|Overall Study||431
10432912|NCT00883168|11579187|FG003|COMPLETED|Overall Study||433
10432913|NCT00883168|11579184|FG000|NOT COMPLETED|Overall Study||14
10432914|NCT00883168|11579185|FG001|NOT COMPLETED|Overall Study||15
10432915|NCT00883168|11579186|FG002|NOT COMPLETED|Overall Study||19
10432916|NCT00883168|11579187|FG003|NOT COMPLETED|Overall Study||15
10432917|NCT00883181|11579197|FG000|STARTED|Overall Study|Full analysis set|1347
10432918|NCT00883181|11579197|FG000|COMPLETED|Overall Study|Completed planned chemotherapy|1069
10432919|NCT00883181|11579197|FG000|NOT COMPLETED|Overall Study||278
10432920|NCT00883233|11579218|FG000|STARTED|Overall Study||32
10432921|NCT00883233|11579219|FG001|STARTED|Overall Study||32
10432922|NCT00883233|11579220|FG002|STARTED|Overall Study||29
10432923|NCT00883233|11579221|FG003|STARTED|Overall Study||30
10432924|NCT00883233|11579218|FG000|COMPLETED|Overall Study||27
10432925|NCT00883233|11579219|FG001|COMPLETED|Overall Study||28
10432926|NCT00883233|11579220|FG002|COMPLETED|Overall Study||25
10432927|NCT00883233|11579221|FG003|COMPLETED|Overall Study||25
10782972|NCT03426995|11944371|FG010|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10782973|NCT03426995|11944372|FG011|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10782974|NCT03426995|11944373|FG012|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10782975|NCT03426995|11944374|FG013|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10782976|NCT03426995|11944375|FG014|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10782977|NCT03426995|11944376|FG015|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10316551|NCT00191854|11450599|FG000|COMPLETED|Overall Study||12
10316552|NCT00191854|11450600|FG001|COMPLETED|Overall Study||17
10316553|NCT00191854|11450601|FG002|COMPLETED|Overall Study||12
10782978|NCT03426995|11944377|FG016|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10782979|NCT03426995|11944378|FG017|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10782980|NCT03426995|11944379|FG018|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
10316554|NCT00191854|11450599|FG000|NOT COMPLETED|Overall Study||37
10316555|NCT00191854|11450600|FG001|NOT COMPLETED|Overall Study||30
10316556|NCT00191854|11450601|FG002|NOT COMPLETED|Overall Study||39
10316557|NCT00191906|11450613|FG000|STARTED|Study Period II||39
10316558|NCT00191906|11450614|FG001|STARTED|Study Period II||37
10316559|NCT00191906|11450615|FG002|STARTED|Study Period II||27
10316560|NCT00191906|11450616|FG003|STARTED|Study Period II||18
10316561|NCT00191906|11450613|FG000|COMPLETED|Study Period II||39
10316562|NCT00191906|11450614|FG001|COMPLETED|Study Period II||32
10316563|NCT00191906|11450615|FG002|COMPLETED|Study Period II||26
10316564|NCT00191906|11450616|FG003|COMPLETED|Study Period II||18
10316565|NCT00191906|11450613|FG000|NOT COMPLETED|Study Period II||0
10316566|NCT00191906|11450614|FG001|NOT COMPLETED|Study Period II||5
10316567|NCT00191906|11450615|FG002|NOT COMPLETED|Study Period II||1
10316568|NCT00191906|11450616|FG003|NOT COMPLETED|Study Period II||0
10316569|NCT00191906|11450613|FG000|STARTED|Study Period III|These are patients who continued in optional open-label period (1 country). All received atomoxetine|14
10316570|NCT00191906|11450614|FG001|STARTED|Study Period III|These are patients who continued in optional open-label period (1 country). All received atomoxetine|11
10316571|NCT00191906|11450615|FG002|STARTED|Study Period III||0
10782981|NCT03426995|11944361|FG000|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10782982|NCT03426995|11944362|FG001|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10782983|NCT03426995|11944363|FG002|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10782984|NCT03426995|11944364|FG003|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10782985|NCT03426995|11944365|FG004|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10782986|NCT03426995|11944366|FG005|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10782987|NCT03426995|11944367|FG006|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
10782988|NCT03426995|11944368|FG007|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||2
10782989|NCT03426995|11944369|FG008|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
10782990|NCT03426995|11944370|FG009|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10782991|NCT03426995|11944371|FG010|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
10782992|NCT03426995|11944372|FG011|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
10782993|NCT03426995|11944373|FG012|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10782994|NCT03426995|11944374|FG013|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10782995|NCT03426995|11944375|FG014|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10782996|NCT03426995|11944376|FG015|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10782997|NCT03426995|11944377|FG016|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10782998|NCT03426995|11944378|FG017|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10782999|NCT03426995|11944379|FG018|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10783000|NCT03426995|11944361|FG000|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10783001|NCT03426995|11944362|FG001|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10783002|NCT03426995|11944363|FG002|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10783003|NCT03426995|11944364|FG003|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10783004|NCT03426995|11944365|FG004|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10783005|NCT03426995|11944366|FG005|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10783006|NCT03426995|11944367|FG006|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
10783007|NCT03426995|11944368|FG007|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||2
10316572|NCT00191906|11450616|FG003|STARTED|Study Period III||0
10316573|NCT00191906|11450613|FG000|COMPLETED|Study Period III||9
10316574|NCT00191906|11450614|FG001|COMPLETED|Study Period III||7
10316575|NCT00191906|11450615|FG002|COMPLETED|Study Period III||0
10316576|NCT00191906|11450616|FG003|COMPLETED|Study Period III||0
10316577|NCT00191906|11450613|FG000|NOT COMPLETED|Study Period III||5
10316578|NCT00191906|11450614|FG001|NOT COMPLETED|Study Period III||4
10316579|NCT00191906|11450615|FG002|NOT COMPLETED|Study Period III||0
10316580|NCT00191906|11450616|FG003|NOT COMPLETED|Study Period III||0
10316581|NCT00191945|11450634|FG000|STARTED|Double-Blind Acute Treatment||100
10316582|NCT00191945|11450635|FG001|STARTED|Double-Blind Acute Treatment||51
10316583|NCT00191945|11450634|FG000|COMPLETED|Double-Blind Acute Treatment||94
10316584|NCT00191945|11450635|FG001|COMPLETED|Double-Blind Acute Treatment||48
10316585|NCT00191945|11450634|FG000|NOT COMPLETED|Double-Blind Acute Treatment||6
10316586|NCT00191945|11450635|FG001|NOT COMPLETED|Double-Blind Acute Treatment||3
10316587|NCT00191945|11450634|FG000|STARTED|Open-Label Treatment Extension||94
10316588|NCT00191945|11450635|FG001|STARTED|Open-Label Treatment Extension||48
10316589|NCT00191945|11450634|FG000|COMPLETED|Open-Label Treatment Extension||94
10316590|NCT00191945|11450635|FG001|COMPLETED|Open-Label Treatment Extension||48
10316591|NCT00191945|11450634|FG000|NOT COMPLETED|Open-Label Treatment Extension||0
10316592|NCT00191945|11450635|FG001|NOT COMPLETED|Open-Label Treatment Extension||0
10316593|NCT00191984|11450642|FG000|STARTED|Overall Study||46
10316594|NCT00191984|11450642|FG000|COMPLETED|Overall Study||7
10316595|NCT00191984|11450642|FG000|NOT COMPLETED|Overall Study||39
10316596|NCT00192023|11450648|FG000|STARTED|Period III - Double-Blind||107
10316597|NCT00192023|11450649|FG001|STARTED|Period III - Double-Blind||32
10316598|NCT00192023|11450648|FG000|COMPLETED|Period III - Double-Blind|6 patients who completed the protocol did not enter optional open-label period.|100
10316599|NCT00192023|11450649|FG001|COMPLETED|Period III - Double-Blind|2 patients who completed the protocol did not enter the optional open-label period.|32
10316600|NCT00192023|11450648|FG000|NOT COMPLETED|Period III - Double-Blind||7
10316601|NCT00192023|11450649|FG001|NOT COMPLETED|Period III - Double-Blind||0
10316602|NCT00192023|11450648|FG000|STARTED|Period IV - Optional Open-Label||124
10316603|NCT00192023|11450649|FG001|STARTED|Period IV - Optional Open-Label|Placebo patients received atomoxetine during the optional open-label period.|0
10316604|NCT00192023|11450648|FG000|COMPLETED|Period IV - Optional Open-Label||49
10316605|NCT00192023|11450649|FG001|COMPLETED|Period IV - Optional Open-Label||0
10316606|NCT00192023|11450648|FG000|NOT COMPLETED|Period IV - Optional Open-Label||75
10783008|NCT03426995|11944369|FG008|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
10783009|NCT03426995|11944370|FG009|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10783010|NCT03426995|11944371|FG010|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
10783011|NCT03426995|11944372|FG011|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
10783012|NCT03426995|11944373|FG012|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10783013|NCT03426995|11944374|FG013|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10783014|NCT03426995|11944375|FG014|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10783015|NCT03426995|11944376|FG015|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10783016|NCT03426995|11944377|FG016|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10783017|NCT03426995|11944378|FG017|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10783018|NCT03426995|11944379|FG018|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10783019|NCT03426995|11944361|FG000|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10783020|NCT03426995|11944362|FG001|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10783021|NCT03426995|11944363|FG002|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10783022|NCT03426995|11944364|FG003|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10783023|NCT03426995|11944365|FG004|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10783024|NCT03426995|11944366|FG005|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10783025|NCT03426995|11944367|FG006|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10783026|NCT03426995|11944368|FG007|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10783027|NCT03426995|11944369|FG008|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10783028|NCT03426995|11944370|FG009|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10783029|NCT03426995|11944371|FG010|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10783030|NCT03426995|11944372|FG011|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10783031|NCT03426995|11944373|FG012|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10783032|NCT03426995|11944374|FG013|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10783033|NCT03426995|11944375|FG014|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10783034|NCT03426995|11944376|FG015|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10783035|NCT03426995|11944377|FG016|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10316607|NCT00192023|11450649|FG001|NOT COMPLETED|Period IV - Optional Open-Label||0
10316608|NCT00192036|11450655|FG000|STARTED|Overall Study||49
10316609|NCT00192036|11450655|FG000|COMPLETED|Overall Study||28
10316610|NCT00192036|11450655|FG000|NOT COMPLETED|Overall Study||21
10316611|NCT00192075|11450661|FG000|STARTED|Overall Study||42
10316612|NCT00192075|11450662|FG001|STARTED|Overall Study||42
10783036|NCT03426995|11944378|FG017|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10316613|NCT00192075|11450661|FG000|COMPLETED|Overall Study||3
10316614|NCT00192075|11450662|FG001|COMPLETED|Overall Study||23
10316615|NCT00192075|11450661|FG000|NOT COMPLETED|Overall Study||39
10316616|NCT00192075|11450662|FG001|NOT COMPLETED|Overall Study||19
10316617|NCT00192114|11450673|FG000|STARTED|Overall Study||28
10316618|NCT00192114|11450673|FG000|Received at Least 1 Dose of Study Drug|Overall Study||28
10316619|NCT00192114|11450673|FG000|COMPLETED|Overall Study||4
10316620|NCT00192114|11450673|FG000|NOT COMPLETED|Overall Study||24
10316621|NCT00192296|11450681|FG000|STARTED|Overall Study||6
10316622|NCT00192296|11450682|FG001|STARTED|Overall Study||6
10316623|NCT00192296|11450683|FG002|STARTED|Overall Study||6
10316624|NCT00192296|11450684|FG003|STARTED|Overall Study||6
10316625|NCT00192296|11450681|FG000|COMPLETED|Overall Study||6
10316626|NCT00192296|11450682|FG001|COMPLETED|Overall Study||5
10316627|NCT00192296|11450683|FG002|COMPLETED|Overall Study||6
10316628|NCT00192296|11450684|FG003|COMPLETED|Overall Study||6
10316629|NCT00192296|11450681|FG000|NOT COMPLETED|Overall Study||0
10316630|NCT00192296|11450682|FG001|NOT COMPLETED|Overall Study||1
10316631|NCT00192296|11450683|FG002|NOT COMPLETED|Overall Study||0
10316632|NCT00192296|11450684|FG003|NOT COMPLETED|Overall Study||0
10316633|NCT00192504|11450698|FG000|STARTED|Overall Study||5
10316634|NCT00192504|11450699|FG001|STARTED|Overall Study||5
10316635|NCT00192504|11450700|FG002|STARTED|Overall Study|Baseline demographics are not available on one patient who did not receive study drug.|6
10316636|NCT00192504|11450701|FG003|STARTED|Overall Study||15
10316637|NCT00192504|11450698|FG000|COMPLETED|Overall Study||4
10316638|NCT00192504|11450699|FG001|COMPLETED|Overall Study||5
10316639|NCT00192504|11450700|FG002|COMPLETED|Overall Study||5
10316640|NCT00192504|11450701|FG003|COMPLETED|Overall Study||15
10316641|NCT00192504|11450698|FG000|NOT COMPLETED|Overall Study||1
10316642|NCT00192504|11450699|FG001|NOT COMPLETED|Overall Study||0
10316643|NCT00192504|11450700|FG002|NOT COMPLETED|Overall Study||1
10316644|NCT00192504|11450701|FG003|NOT COMPLETED|Overall Study||0
10316645|NCT00192647|11450713|FG000|STARTED|Overall Study||448
10316646|NCT00192647|11450714|FG001|STARTED|Overall Study||448
10316647|NCT00192647|11450713|FG000|Treated|Overall Study||433
10316648|NCT00192647|11450714|FG001|Treated|Overall Study||438
10316649|NCT00192647|11450713|FG000|COMPLETED|Overall Study||320
10316650|NCT00192647|11450714|FG001|COMPLETED|Overall Study||302
10316651|NCT00192647|11450713|FG000|NOT COMPLETED|Overall Study||128
10316652|NCT00192647|11450714|FG001|NOT COMPLETED|Overall Study||146
10316653|NCT00193037|11450722|FG000|STARTED|Randomized Treatment||50
10316654|NCT00193037|11450723|FG001|STARTED|Randomized Treatment||52
10316655|NCT00193037|11450722|FG000|COMPLETED|Randomized Treatment||32
10316656|NCT00193037|11450723|FG001|COMPLETED|Randomized Treatment||24
10316657|NCT00193037|11450722|FG000|NOT COMPLETED|Randomized Treatment||18
10316658|NCT00193037|11450723|FG001|NOT COMPLETED|Randomized Treatment||28
10316659|NCT00193037|11450722|FG000|STARTED|Crossover Treatment||32
10316660|NCT00193037|11450723|FG001|STARTED|Crossover Treatment||24
10316661|NCT00193037|11450722|FG000|COMPLETED|Crossover Treatment||32
10316662|NCT00193037|11450723|FG001|COMPLETED|Crossover Treatment||24
10316663|NCT00193037|11450722|FG000|NOT COMPLETED|Crossover Treatment||0
10316664|NCT00193037|11450723|FG001|NOT COMPLETED|Crossover Treatment||0
10316665|NCT00193050|11450729|FG000|STARTED|Neoadjuvant Treatment||110
10316666|NCT00193050|11450729|FG000|COMPLETED|Neoadjuvant Treatment||101
10316667|NCT00193050|11450729|FG000|NOT COMPLETED|Neoadjuvant Treatment||9
10316668|NCT00193050|11450729|FG000|STARTED|Surgery|2 patients had surgery after 2 cycles of neoadjuvant treatment|103
10316669|NCT00193050|11450729|FG000|COMPLETED|Surgery||103
10316670|NCT00193050|11450729|FG000|NOT COMPLETED|Surgery||0
10316671|NCT00193050|11450729|FG000|STARTED|Adjuvant|16 patients never initiated postoperative adjuvant therapy|87
10316672|NCT00193050|11450729|FG000|COMPLETED|Adjuvant||77
10316673|NCT00193050|11450729|FG000|NOT COMPLETED|Adjuvant||10
10316674|NCT00193063|11450734|FG000|STARTED|Overall Study||41
10316675|NCT00193063|11450734|FG000|COMPLETED|Overall Study||37
10316676|NCT00193063|11450734|FG000|NOT COMPLETED|Overall Study||4
10316677|NCT00193128|11450740|FG000|STARTED|Overall Study||10
10316678|NCT00193128|11450741|FG001|STARTED|Overall Study||49
10316679|NCT00193128|11450740|FG000|COMPLETED|Overall Study||10
10316680|NCT00193128|11450741|FG001|COMPLETED|Overall Study||39
10316681|NCT00193128|11450740|FG000|NOT COMPLETED|Overall Study||0
10316682|NCT00193128|11450741|FG001|NOT COMPLETED|Overall Study||10
10316683|NCT00193180|11450749|FG000|STARTED|Overall Study||37
10316684|NCT00193180|11450749|FG000|COMPLETED|Overall Study||27
10316685|NCT00193180|11450749|FG000|NOT COMPLETED|Overall Study||10
10316686|NCT00193206|11450754|FG000|STARTED|Preoperative Therapy||123
10316687|NCT00193206|11450754|FG000|COMPLETED|Preoperative Therapy||116
10316688|NCT00193206|11450754|FG000|NOT COMPLETED|Preoperative Therapy||7
10316689|NCT00193206|11450754|FG000|STARTED|Surgery||116
10316690|NCT00193206|11450754|FG000|COMPLETED|Surgery||116
10316691|NCT00193206|11450754|FG000|NOT COMPLETED|Surgery||0
10316692|NCT00193206|11450754|FG000|STARTED|Postoperative Therapy||116
10316693|NCT00193206|11450754|FG000|COMPLETED|Postoperative Therapy||102
10316694|NCT00193206|11450754|FG000|NOT COMPLETED|Postoperative Therapy||14
10316695|NCT00193258|11450758|FG000|STARTED|Overall Study||94
10316696|NCT00193258|11450758|FG000|COMPLETED|Overall Study||94
10316697|NCT00193258|11450758|FG000|NOT COMPLETED|Overall Study||0
10316698|NCT00193375|11450762|FG000|STARTED|Overall Study||60
10316699|NCT00193375|11450762|FG000|COMPLETED|Overall Study||41
10316700|NCT00193375|11450762|FG000|NOT COMPLETED|Overall Study||19
10316701|NCT00193453|11450766|FG000|STARTED|Overall Study||69
10316702|NCT00193453|11450766|FG000|COMPLETED|Overall Study||21
10316703|NCT00193453|11450766|FG000|NOT COMPLETED|Overall Study||48
10316704|NCT00193492|11450772|FG000|STARTED|Overall Study||31
10316705|NCT00193492|11450773|FG001|STARTED|Overall Study||29
10316706|NCT00193492|11450772|FG000|COMPLETED|Overall Study||14
10316707|NCT00193492|11450773|FG001|COMPLETED|Overall Study||14
10783037|NCT03426995|11944379|FG018|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
10783038|NCT03426995|11944361|FG000|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
10316708|NCT00193492|11450772|FG000|NOT COMPLETED|Overall Study||17
10316709|NCT00193492|11450773|FG001|NOT COMPLETED|Overall Study||15
10316710|NCT00193596|11450781|FG000|STARTED|Overall Study||93
10316711|NCT00193596|11450782|FG001|STARTED|Overall Study||105
10316712|NCT00193596|11450781|FG000|COMPLETED|Overall Study||37
10783039|NCT03426995|11944362|FG001|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
10783040|NCT03426995|11944363|FG002|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
10783041|NCT03426995|11944364|FG003|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
10783042|NCT03426995|11944365|FG004|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
10783043|NCT03426995|11944366|FG005|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
10783044|NCT03426995|11944367|FG006|STARTED|Part A: Cohort 2-Period 2 (Day1)||1
10783045|NCT03426995|11944368|FG007|STARTED|Part A: Cohort 2-Period 2 (Day1)||2
10783046|NCT03426995|11944369|FG008|STARTED|Part A: Cohort 2-Period 2 (Day1)||1
10783047|NCT03426995|11944370|FG009|STARTED|Part A: Cohort 2-Period 2 (Day1)|Two additional participants were enrolled and dosed.|2
10783048|NCT03426995|11944371|FG010|STARTED|Part A: Cohort 2-Period 2 (Day1)||1
10783049|NCT03426995|11944372|FG011|STARTED|Part A: Cohort 2-Period 2 (Day1)|New participant enrolled and dosed.|2
10783050|NCT03426995|11944373|FG012|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
10783051|NCT03426995|11944374|FG013|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
10783052|NCT03426995|11944375|FG014|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
10783053|NCT03426995|11944376|FG015|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
10783054|NCT03426995|11944377|FG016|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
10783055|NCT03426995|11944378|FG017|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
10783056|NCT03426995|11944379|FG018|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
10783057|NCT03426995|11944361|FG000|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10783058|NCT03426995|11944362|FG001|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10783059|NCT03426995|11944363|FG002|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10783060|NCT03426995|11944364|FG003|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10316713|NCT00193596|11450782|FG001|COMPLETED|Overall Study||39
10316714|NCT00193596|11450781|FG000|NOT COMPLETED|Overall Study||56
10316715|NCT00193596|11450782|FG001|NOT COMPLETED|Overall Study||66
10316716|NCT00193609|11450788|FG000|STARTED|Overall Study||48
10316717|NCT00193609|11450788|FG000|COMPLETED|Overall Study||44
10316718|NCT00193609|11450788|FG000|NOT COMPLETED|Overall Study||4
10316719|NCT00194012|11450794|FG000|STARTED|Randomized Phase||31
10316720|NCT00194012|11450795|FG001|STARTED|Randomized Phase||31
10316721|NCT00194012|11450794|FG000|Received More Than One Dose|Randomized Phase||30
10316722|NCT00194012|11450795|FG001|Received More Than One Dose|Randomized Phase||29
10316723|NCT00194012|11450794|FG000|COMPLETED|Randomized Phase||15
10316724|NCT00194012|11450795|FG001|COMPLETED|Randomized Phase||6
10316725|NCT00194012|11450794|FG000|NOT COMPLETED|Randomized Phase||16
10316726|NCT00194012|11450795|FG001|NOT COMPLETED|Randomized Phase||25
10316727|NCT00194012|11450794|FG000|STARTED|Open Label Extension (OLE)|Participants from aripiprazole group started OLE (eligible even if randomized period not completed).|22
10316728|NCT00194012|11450795|FG001|STARTED|Open Label Extension (OLE)|Participants from placebo group started OLE (eligible even if randomized period not completed).|21
10316729|NCT00194012|11450794|FG000|COMPLETED|Open Label Extension (OLE)||17
10316730|NCT00194012|11450795|FG001|COMPLETED|Open Label Extension (OLE)||15
10316731|NCT00194012|11450794|FG000|NOT COMPLETED|Open Label Extension (OLE)||5
10316732|NCT00194012|11450795|FG001|NOT COMPLETED|Open Label Extension (OLE)||6
10316733|NCT00194025|11450807|FG000|STARTED|Overall Study|The intent-to-treat population received at least one dose of valproate semisodium.|20
10432928|NCT00883233|11579218|FG000|NOT COMPLETED|Overall Study||5
10432929|NCT00883233|11579219|FG001|NOT COMPLETED|Overall Study||4
10549366|NCT01524900|11703344|FG003|NOT COMPLETED|Overall Study||1
10783061|NCT03426995|11944365|FG004|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10316734|NCT00194025|11450807|FG000|COMPLETED|Overall Study|5 participants withdrew prematurely|15
10432930|NCT00883233|11579220|FG002|NOT COMPLETED|Overall Study||4
10432931|NCT00883233|11579221|FG003|NOT COMPLETED|Overall Study||5
10432932|NCT00883246|11579231|FG000|STARTED|Overall Study||799
10432933|NCT00883246|11579231|FG000|COMPLETED|Overall Study||626
10432934|NCT00883246|11579231|FG000|NOT COMPLETED|Overall Study||173
10783062|NCT03426995|11944366|FG005|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10783063|NCT03426995|11944367|FG006|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||1
10783064|NCT03426995|11944368|FG007|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||2
10783065|NCT03426995|11944369|FG008|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||1
10783066|NCT03426995|11944370|FG009|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||2
10783067|NCT03426995|11944371|FG010|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||1
10783068|NCT03426995|11944372|FG011|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||2
10783069|NCT03426995|11944373|FG012|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10783070|NCT03426995|11944374|FG013|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10783071|NCT03426995|11944375|FG014|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10783072|NCT03426995|11944376|FG015|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10783073|NCT03426995|11944377|FG016|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10783074|NCT03426995|11944378|FG017|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10783075|NCT03426995|11944379|FG018|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10783076|NCT03426995|11944361|FG000|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10783077|NCT03426995|11944362|FG001|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10783078|NCT03426995|11944363|FG002|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10783079|NCT03426995|11944364|FG003|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10783080|NCT03426995|11944365|FG004|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10783081|NCT03426995|11944366|FG005|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10783082|NCT03426995|11944367|FG006|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10783083|NCT03426995|11944368|FG007|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10783084|NCT03426995|11944369|FG008|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10783085|NCT03426995|11944370|FG009|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10783086|NCT03426995|11944371|FG010|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10783087|NCT03426995|11944372|FG011|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10783088|NCT03426995|11944373|FG012|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10783089|NCT03426995|11944374|FG013|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10783090|NCT03426995|11944375|FG014|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10783091|NCT03426995|11944376|FG015|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10783092|NCT03426995|11944377|FG016|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10783093|NCT03426995|11944378|FG017|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10783094|NCT03426995|11944379|FG018|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
10783095|NCT03426995|11944361|FG000|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10783096|NCT03426995|11944362|FG001|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10783097|NCT03426995|11944363|FG002|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10783098|NCT03426995|11944364|FG003|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10783099|NCT03426995|11944365|FG004|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10783100|NCT03426995|11944366|FG005|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10783101|NCT03426995|11944367|FG006|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
10783102|NCT03426995|11944368|FG007|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
10810562|NCT03796182|11972329|FG001|STARTED|Period 1||6
10316735|NCT00194025|11450807|FG000|NOT COMPLETED|Overall Study||5
10316736|NCT00194077|11450813|FG000|STARTED|Overall Study||30
10783103|NCT03426995|11944369|FG008|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
10783104|NCT03426995|11944370|FG009|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
10783105|NCT03426995|11944371|FG010|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
10783106|NCT03426995|11944372|FG011|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
10783107|NCT03426995|11944373|FG012|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10783108|NCT03426995|11944374|FG013|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10783109|NCT03426995|11944375|FG014|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10783110|NCT03426995|11944376|FG015|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10783111|NCT03426995|11944377|FG016|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10783112|NCT03426995|11944378|FG017|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10783113|NCT03426995|11944379|FG018|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10783114|NCT03426995|11944361|FG000|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10783115|NCT03426995|11944362|FG001|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10783116|NCT03426995|11944363|FG002|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10783117|NCT03426995|11944364|FG003|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10783118|NCT03426995|11944365|FG004|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10783119|NCT03426995|11944366|FG005|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10783120|NCT03426995|11944367|FG006|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
10783121|NCT03426995|11944368|FG007|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
10783122|NCT03426995|11944369|FG008|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
10783123|NCT03426995|11944370|FG009|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
10783124|NCT03426995|11944371|FG010|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
10783125|NCT03426995|11944372|FG011|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
10783126|NCT03426995|11944373|FG012|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10783127|NCT03426995|11944374|FG013|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10783128|NCT03426995|11944375|FG014|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10783129|NCT03426995|11944376|FG015|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10783130|NCT03426995|11944377|FG016|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10783131|NCT03426995|11944378|FG017|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10783132|NCT03426995|11944379|FG018|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10783133|NCT03426995|11944361|FG000|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10783134|NCT03426995|11944362|FG001|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10783135|NCT03426995|11944363|FG002|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10783136|NCT03426995|11944364|FG003|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10783137|NCT03426995|11944365|FG004|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10783138|NCT03426995|11944366|FG005|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10783139|NCT03426995|11944367|FG006|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10783140|NCT03426995|11944368|FG007|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10783141|NCT03426995|11944369|FG008|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10783142|NCT03426995|11944370|FG009|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10783143|NCT03426995|11944371|FG010|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10783144|NCT03426995|11944372|FG011|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10783145|NCT03426995|11944373|FG012|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10783146|NCT03426995|11944374|FG013|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10783147|NCT03426995|11944375|FG014|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10783148|NCT03426995|11944376|FG015|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10783149|NCT03426995|11944377|FG016|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10783150|NCT03426995|11944378|FG017|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10783151|NCT03426995|11944379|FG018|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
10783152|NCT03426995|11944361|FG000|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
10783153|NCT03426995|11944362|FG001|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
10783154|NCT03426995|11944363|FG002|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
10783155|NCT03426995|11944364|FG003|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
10783156|NCT03426995|11944365|FG004|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
10783157|NCT03426995|11944366|FG005|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
10783158|NCT03426995|11944367|FG006|STARTED|Part A: Cohort 2-Period 3 (Day1)||1
10783159|NCT03426995|11944368|FG007|STARTED|Part A: Cohort 2-Period 3 (Day1)||2
10783160|NCT03426995|11944369|FG008|STARTED|Part A: Cohort 2-Period 3 (Day1)||1
10783161|NCT03426995|11944370|FG009|STARTED|Part A: Cohort 2-Period 3 (Day1)||2
10783162|NCT03426995|11944371|FG010|STARTED|Part A: Cohort 2-Period 3 (Day1)||1
10783163|NCT03426995|11944372|FG011|STARTED|Part A: Cohort 2-Period 3 (Day1)||2
10783164|NCT03426995|11944373|FG012|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
10316737|NCT00194077|11450814|FG001|STARTED|Overall Study||30
10316738|NCT00194077|11450813|FG000|COMPLETED|Overall Study|"Lack of efficacy:~Hypomania n=12 Cycling n=5 Mixed state=4 Mania n=1"|6
10783165|NCT03426995|11944374|FG013|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
10783166|NCT03426995|11944375|FG014|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
10783167|NCT03426995|11944376|FG015|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
10783168|NCT03426995|11944377|FG016|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
10783169|NCT03426995|11944378|FG017|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
10783170|NCT03426995|11944379|FG018|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
10783171|NCT03426995|11944361|FG000|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10783172|NCT03426995|11944362|FG001|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10783173|NCT03426995|11944363|FG002|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10783174|NCT03426995|11944364|FG003|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10783175|NCT03426995|11944365|FG004|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10783176|NCT03426995|11944366|FG005|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10783177|NCT03426995|11944367|FG006|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||1
10783178|NCT03426995|11944368|FG007|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||2
10783179|NCT03426995|11944369|FG008|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||1
10783180|NCT03426995|11944370|FG009|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||2
10783181|NCT03426995|11944371|FG010|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||1
10783182|NCT03426995|11944372|FG011|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||2
10783183|NCT03426995|11944373|FG012|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10783184|NCT03426995|11944374|FG013|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10783185|NCT03426995|11944375|FG014|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10783186|NCT03426995|11944376|FG015|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10783187|NCT03426995|11944377|FG016|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10783188|NCT03426995|11944378|FG017|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10783189|NCT03426995|11944379|FG018|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10783190|NCT03426995|11944361|FG000|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10783191|NCT03426995|11944362|FG001|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10783192|NCT03426995|11944363|FG002|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10783193|NCT03426995|11944364|FG003|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10783194|NCT03426995|11944365|FG004|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10783195|NCT03426995|11944366|FG005|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10783196|NCT03426995|11944367|FG006|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10783197|NCT03426995|11944368|FG007|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10783198|NCT03426995|11944369|FG008|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10783199|NCT03426995|11944370|FG009|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10783200|NCT03426995|11944371|FG010|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10783201|NCT03426995|11944372|FG011|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10783202|NCT03426995|11944373|FG012|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10783203|NCT03426995|11944374|FG013|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10783204|NCT03426995|11944375|FG014|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10783205|NCT03426995|11944376|FG015|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10783206|NCT03426995|11944377|FG016|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10783207|NCT03426995|11944378|FG017|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10783208|NCT03426995|11944379|FG018|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
10783209|NCT03426995|11944361|FG000|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10783210|NCT03426995|11944362|FG001|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10783211|NCT03426995|11944363|FG002|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10783212|NCT03426995|11944364|FG003|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10783213|NCT03426995|11944365|FG004|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10783214|NCT03426995|11944366|FG005|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10783215|NCT03426995|11944367|FG006|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
10783216|NCT03426995|11944368|FG007|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
10783217|NCT03426995|11944369|FG008|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
10783218|NCT03426995|11944370|FG009|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
10783219|NCT03426995|11944371|FG010|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
10783220|NCT03426995|11944372|FG011|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
10783221|NCT03426995|11944373|FG012|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10783222|NCT03426995|11944374|FG013|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10783223|NCT03426995|11944375|FG014|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10783224|NCT03426995|11944376|FG015|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10783225|NCT03426995|11944377|FG016|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10783226|NCT03426995|11944378|FG017|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10783227|NCT03426995|11944379|FG018|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10783228|NCT03426995|11944361|FG000|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10783229|NCT03426995|11944362|FG001|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10783230|NCT03426995|11944363|FG002|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10316739|NCT00194077|11450814|FG001|COMPLETED|Overall Study|"Lack of efficacy:~hypomania n=17 Cycling n=6 Mania n=5 Mixed state n=1 Concern regarding tx n=1"|0
10316740|NCT00194077|11450813|FG000|NOT COMPLETED|Overall Study||24
10316741|NCT00194077|11450814|FG001|NOT COMPLETED|Overall Study||30
10432935|NCT00883337|11579244|FG000|STARTED|Core Treatment Period||109
10432936|NCT00883337|11579245|FG001|STARTED|Core Treatment Period||111
10432937|NCT00883337|11579246|FG002|STARTED|Core Treatment Period||104
10783231|NCT03426995|11944364|FG003|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10783232|NCT03426995|11944365|FG004|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10783233|NCT03426995|11944366|FG005|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10783234|NCT03426995|11944367|FG006|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
10783235|NCT03426995|11944368|FG007|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
10783236|NCT03426995|11944369|FG008|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
10783237|NCT03426995|11944370|FG009|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
10783238|NCT03426995|11944371|FG010|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
10783239|NCT03426995|11944372|FG011|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
10783240|NCT03426995|11944373|FG012|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10783241|NCT03426995|11944374|FG013|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10783242|NCT03426995|11944375|FG014|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10783243|NCT03426995|11944376|FG015|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10783244|NCT03426995|11944377|FG016|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10783245|NCT03426995|11944378|FG017|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10783246|NCT03426995|11944379|FG018|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10783247|NCT03426995|11944361|FG000|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10783248|NCT03426995|11944362|FG001|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10783249|NCT03426995|11944363|FG002|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10783250|NCT03426995|11944364|FG003|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10783251|NCT03426995|11944365|FG004|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10783252|NCT03426995|11944366|FG005|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10783253|NCT03426995|11944367|FG006|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10783254|NCT03426995|11944368|FG007|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10783255|NCT03426995|11944369|FG008|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10783256|NCT03426995|11944370|FG009|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10783257|NCT03426995|11944371|FG010|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10783258|NCT03426995|11944372|FG011|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10783259|NCT03426995|11944373|FG012|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10783260|NCT03426995|11944374|FG013|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10783261|NCT03426995|11944375|FG014|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10783262|NCT03426995|11944376|FG015|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10783263|NCT03426995|11944377|FG016|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10783264|NCT03426995|11944378|FG017|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10783265|NCT03426995|11944379|FG018|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
10783266|NCT03426995|11944361|FG000|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
10783267|NCT03426995|11944362|FG001|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
10783268|NCT03426995|11944363|FG002|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
10783269|NCT03426995|11944364|FG003|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
10783270|NCT03426995|11944365|FG004|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
10783271|NCT03426995|11944366|FG005|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
10783272|NCT03426995|11944367|FG006|STARTED|Part A: Cohort 2-Period 4 (Day1)||1
10783273|NCT03426995|11944368|FG007|STARTED|Part A: Cohort 2-Period 4 (Day1)|New participant enrolled and dosed.|3
10432938|NCT00883337|11579244|FG000|Treated|Core Treatment Period||109
10316742|NCT00194116|11450822|FG000|STARTED|Overall Study||26
10316743|NCT00194116|11450823|FG001|STARTED|Overall Study||28
10316744|NCT00194116|11450822|FG000|COMPLETED|Overall Study||13
10316745|NCT00194116|11450823|FG001|COMPLETED|Overall Study||13
10316746|NCT00194116|11450822|FG000|NOT COMPLETED|Overall Study||13
10316747|NCT00194116|11450823|FG001|NOT COMPLETED|Overall Study||15
10432939|NCT00883337|11579245|FG001|Treated|Core Treatment Period|One participant received teriflunomide 7 mg instead of teriflunomide 14 mg|111
10783274|NCT03426995|11944369|FG008|STARTED|Part A: Cohort 2-Period 4 (Day1)||1
10783275|NCT03426995|11944370|FG009|STARTED|Part A: Cohort 2-Period 4 (Day1)||2
10783276|NCT03426995|11944371|FG010|STARTED|Part A: Cohort 2-Period 4 (Day1)||1
10783277|NCT03426995|11944372|FG011|STARTED|Part A: Cohort 2-Period 4 (Day1)||2
10783278|NCT03426995|11944373|FG012|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
10783279|NCT03426995|11944374|FG013|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
10783280|NCT03426995|11944375|FG014|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
10783281|NCT03426995|11944376|FG015|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
10783282|NCT03426995|11944377|FG016|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
10783283|NCT03426995|11944378|FG017|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
10783284|NCT03426995|11944379|FG018|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
10783285|NCT03426995|11944361|FG000|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10783286|NCT03426995|11944362|FG001|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10783287|NCT03426995|11944363|FG002|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10783288|NCT03426995|11944364|FG003|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10783289|NCT03426995|11944365|FG004|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10783290|NCT03426995|11944366|FG005|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10316781|NCT00194896|11450889|FG003|STARTED|Overall Study||21
10783291|NCT03426995|11944367|FG006|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||1
10783292|NCT03426995|11944368|FG007|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||2
10783293|NCT03426995|11944369|FG008|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||1
10783294|NCT03426995|11944370|FG009|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||2
10783295|NCT03426995|11944371|FG010|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10783296|NCT03426995|11944372|FG011|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||2
10783297|NCT03426995|11944373|FG012|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10783298|NCT03426995|11944374|FG013|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10783299|NCT03426995|11944375|FG014|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10783300|NCT03426995|11944376|FG015|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10783301|NCT03426995|11944377|FG016|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10783302|NCT03426995|11944378|FG017|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10783303|NCT03426995|11944379|FG018|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10783304|NCT03426995|11944361|FG000|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10783305|NCT03426995|11944362|FG001|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10783306|NCT03426995|11944363|FG002|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10783307|NCT03426995|11944364|FG003|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10783308|NCT03426995|11944365|FG004|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10783309|NCT03426995|11944366|FG005|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10783310|NCT03426995|11944367|FG006|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10783311|NCT03426995|11944368|FG007|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||1
10783312|NCT03426995|11944369|FG008|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10783313|NCT03426995|11944370|FG009|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10783314|NCT03426995|11944371|FG010|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||1
10783315|NCT03426995|11944372|FG011|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10783316|NCT03426995|11944373|FG012|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10783317|NCT03426995|11944374|FG013|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10783318|NCT03426995|11944375|FG014|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10783319|NCT03426995|11944376|FG015|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10783320|NCT03426995|11944377|FG016|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10783321|NCT03426995|11944378|FG017|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10783322|NCT03426995|11944379|FG018|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
10783323|NCT03426995|11944361|FG000|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
10783324|NCT03426995|11944362|FG001|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
10783325|NCT03426995|11944363|FG002|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
10783326|NCT03426995|11944364|FG003|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
10783327|NCT03426995|11944365|FG004|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
10783328|NCT03426995|11944366|FG005|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
10783329|NCT03426995|11944367|FG006|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
10783330|NCT03426995|11944368|FG007|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
10783331|NCT03426995|11944369|FG008|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
10783332|NCT03426995|11944370|FG009|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
10783333|NCT03426995|11944371|FG010|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
10783334|NCT03426995|11944372|FG011|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
10783335|NCT03426995|11944373|FG012|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
10783336|NCT03426995|11944374|FG013|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
10783337|NCT03426995|11944375|FG014|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
10783338|NCT03426995|11944376|FG015|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
10316748|NCT00194129|11450831|FG000|STARTED|Overall Study||15
10316749|NCT00194129|11450832|FG001|STARTED|Overall Study||16
10316750|NCT00194129|11450831|FG000|COMPLETED|Overall Study||5
10528928|NCT01397448|11681299|FG001|NOT COMPLETED|Overall Study||15
10316751|NCT00194129|11450832|FG001|COMPLETED|Overall Study||3
10316752|NCT00194129|11450831|FG000|NOT COMPLETED|Overall Study||10
10316753|NCT00194129|11450832|FG001|NOT COMPLETED|Overall Study||13
10316754|NCT00194532|11450847|FG000|STARTED|Overall Study||150
10316755|NCT00194532|11450848|FG001|STARTED|Overall Study||150
10316756|NCT00194532|11450847|FG000|COMPLETED|Overall Study||150
10316757|NCT00194532|11450848|FG001|COMPLETED|Overall Study||150
10316758|NCT00194532|11450847|FG000|NOT COMPLETED|Overall Study||0
10316759|NCT00194532|11450848|FG001|NOT COMPLETED|Overall Study||0
10316760|NCT00194610|11450856|FG000|STARTED|Overall Study||11
10316761|NCT00194610|11450857|FG001|STARTED|Overall Study||9
10316762|NCT00194610|11450856|FG000|COMPLETED|Overall Study||11
10316763|NCT00194610|11450857|FG001|COMPLETED|Overall Study||9
10316764|NCT00194610|11450856|FG000|NOT COMPLETED|Overall Study||0
10316765|NCT00194610|11450857|FG001|NOT COMPLETED|Overall Study||0
10316766|NCT00194675|11450865|FG000|STARTED|Overall Study||27
10316767|NCT00194675|11450866|FG001|STARTED|Overall Study||26
10316768|NCT00194675|11450865|FG000|COMPLETED|Overall Study||22
10316769|NCT00194675|11450866|FG001|COMPLETED|Overall Study||24
10316770|NCT00194675|11450865|FG000|NOT COMPLETED|Overall Study||5
10316771|NCT00194675|11450866|FG001|NOT COMPLETED|Overall Study||2
10316772|NCT00194779|11450874|FG000|STARTED|Overall Study||50
10316773|NCT00194779|11450874|FG000|COMPLETED|Overall Study||50
10316774|NCT00194779|11450874|FG000|NOT COMPLETED|Overall Study||0
10316775|NCT00194792|11450878|FG000|STARTED|Overall Study||28
10316776|NCT00194792|11450878|FG000|COMPLETED|Overall Study||27
10316777|NCT00194792|11450878|FG000|NOT COMPLETED|Overall Study||1
10316778|NCT00194896|11450886|FG000|STARTED|Overall Study||15
10316779|NCT00194896|11450887|FG001|STARTED|Overall Study||15
10316780|NCT00194896|11450888|FG002|STARTED|Overall Study||13
10316782|NCT00194896|11450886|FG000|COMPLETED|Overall Study||4
10316783|NCT00194896|11450887|FG001|COMPLETED|Overall Study||10
10316784|NCT00194896|11450888|FG002|COMPLETED|Overall Study||7
10316785|NCT00194896|11450889|FG003|COMPLETED|Overall Study||9
10316786|NCT00194896|11450886|FG000|NOT COMPLETED|Overall Study||11
10316787|NCT00194896|11450887|FG001|NOT COMPLETED|Overall Study||5
10316788|NCT00194896|11450888|FG002|NOT COMPLETED|Overall Study||6
10316789|NCT00194896|11450889|FG003|NOT COMPLETED|Overall Study||12
10316790|NCT00194987|11450901|FG000|STARTED|Overall Study||51
10316791|NCT00194987|11450902|FG001|STARTED|Overall Study||51
10316792|NCT00194987|11450901|FG000|COMPLETED|Overall Study||51
10316793|NCT00194987|11450902|FG001|COMPLETED|Overall Study|"3 women chose to withdraw because they felt the study was too inconvenient."|48
10316794|NCT00194987|11450901|FG000|NOT COMPLETED|Overall Study||0
10316795|NCT00194987|11450902|FG001|NOT COMPLETED|Overall Study||3
10316796|NCT00195013|11450912|FG000|STARTED|Overall Study||14
10316797|NCT00195013|11450913|FG001|STARTED|Overall Study||16
10316798|NCT00195013|11450912|FG000|COMPLETED|Overall Study||12
10316799|NCT00195013|11450913|FG001|COMPLETED|Overall Study||15
10783339|NCT03426995|11944377|FG016|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
10783340|NCT03426995|11944378|FG017|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
10783341|NCT03426995|11944379|FG018|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
10783342|NCT03426995|11944361|FG000|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10783343|NCT03426995|11944362|FG001|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10783344|NCT03426995|11944363|FG002|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10783345|NCT03426995|11944364|FG003|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10783346|NCT03426995|11944365|FG004|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10783347|NCT03426995|11944366|FG005|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10783348|NCT03426995|11944367|FG006|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10783349|NCT03426995|11944368|FG007|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10316800|NCT00195013|11450912|FG000|NOT COMPLETED|Overall Study||2
10316801|NCT00195013|11450913|FG001|NOT COMPLETED|Overall Study||1
10316802|NCT00195039|11450919|FG000|STARTED|Overall Study||47
10316803|NCT00195039|11450919|FG000|COMPLETED|Overall Study||47
10316804|NCT00195039|11450919|FG000|NOT COMPLETED|Overall Study||0
10316805|NCT00195260|11450925|FG000|STARTED|Part 1: Dose Escalation||4
10316806|NCT00195260|11450926|FG001|STARTED|Part 1: Dose Escalation||4
10316807|NCT00195260|11450927|FG002|STARTED|Part 1: Dose Escalation||6
10316808|NCT00195260|11450928|FG003|STARTED|Part 1: Dose Escalation||7
10316809|NCT00195260|11450929|FG004|STARTED|Part 1: Dose Escalation||7
10316810|NCT00195260|11450930|FG005|STARTED|Part 1: Dose Escalation||7
10316811|NCT00195260|11450931|FG006|STARTED|Part 1: Dose Escalation||10
10316812|NCT00195260|11450932|FG007|STARTED|Part 1: Dose Escalation||6
10316813|NCT00195260|11450933|FG008|STARTED|Part 1: Dose Escalation||0
10316814|NCT00195260|11450934|FG009|STARTED|Part 1: Dose Escalation||0
10316815|NCT00195260|11450935|FG010|STARTED|Part 1: Dose Escalation||0
10316816|NCT00195260|11450925|FG000|COMPLETED|Part 1: Dose Escalation||0
10316817|NCT00195260|11450926|FG001|COMPLETED|Part 1: Dose Escalation||0
10316818|NCT00195260|11450927|FG002|COMPLETED|Part 1: Dose Escalation||0
10316819|NCT00195260|11450928|FG003|COMPLETED|Part 1: Dose Escalation||0
10316820|NCT00195260|11450929|FG004|COMPLETED|Part 1: Dose Escalation||0
10316821|NCT00195260|11450930|FG005|COMPLETED|Part 1: Dose Escalation||0
10316822|NCT00195260|11450931|FG006|COMPLETED|Part 1: Dose Escalation||0
10316823|NCT00195260|11450932|FG007|COMPLETED|Part 1: Dose Escalation||0
10316824|NCT00195260|11450933|FG008|COMPLETED|Part 1: Dose Escalation||0
10316825|NCT00195260|11450934|FG009|COMPLETED|Part 1: Dose Escalation||0
10316826|NCT00195260|11450935|FG010|COMPLETED|Part 1: Dose Escalation||0
10316827|NCT00195260|11450925|FG000|NOT COMPLETED|Part 1: Dose Escalation||4
10316828|NCT00195260|11450926|FG001|NOT COMPLETED|Part 1: Dose Escalation||4
10316829|NCT00195260|11450927|FG002|NOT COMPLETED|Part 1: Dose Escalation||6
10316830|NCT00195260|11450928|FG003|NOT COMPLETED|Part 1: Dose Escalation||7
10316831|NCT00195260|11450929|FG004|NOT COMPLETED|Part 1: Dose Escalation||7
10316832|NCT00195260|11450930|FG005|NOT COMPLETED|Part 1: Dose Escalation||7
10316833|NCT00195260|11450931|FG006|NOT COMPLETED|Part 1: Dose Escalation||10
10316834|NCT00195260|11450932|FG007|NOT COMPLETED|Part 1: Dose Escalation||6
10316835|NCT00195260|11450933|FG008|NOT COMPLETED|Part 1: Dose Escalation||0
10316836|NCT00195260|11450934|FG009|NOT COMPLETED|Part 1: Dose Escalation||0
10316837|NCT00195260|11450935|FG010|NOT COMPLETED|Part 1: Dose Escalation||0
10316838|NCT00195260|11450925|FG000|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10316839|NCT00195260|11450926|FG001|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10316840|NCT00195260|11450927|FG002|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10316841|NCT00195260|11450928|FG003|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10316842|NCT00195260|11450929|FG004|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10316843|NCT00195260|11450930|FG005|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10316844|NCT00195260|11450931|FG006|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10316845|NCT00195260|11450932|FG007|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10316846|NCT00195260|11450933|FG008|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||37
10316847|NCT00195260|11450934|FG009|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||38
10316848|NCT00195260|11450935|FG010|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||25
10316849|NCT00195260|11450925|FG000|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10316850|NCT00195260|11450926|FG001|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10316851|NCT00195260|11450927|FG002|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10316852|NCT00195260|11450928|FG003|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10316853|NCT00195260|11450929|FG004|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10316854|NCT00195260|11450930|FG005|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10316855|NCT00195260|11450931|FG006|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10316856|NCT00195260|11450932|FG007|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10316857|NCT00195260|11450933|FG008|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||4
10316858|NCT00195260|11450934|FG009|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10316859|NCT00195260|11450935|FG010|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||2
10316860|NCT00195260|11450925|FG000|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10338356|NCT00369512|11475240|FG000|COMPLETED|Overall Study||15
10316861|NCT00195260|11450926|FG001|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10316862|NCT00195260|11450927|FG002|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10316863|NCT00195260|11450928|FG003|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10316864|NCT00195260|11450929|FG004|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10316865|NCT00195260|11450930|FG005|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10316866|NCT00195260|11450931|FG006|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10316867|NCT00195260|11450932|FG007|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10316868|NCT00195260|11450933|FG008|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||33
10316869|NCT00195260|11450934|FG009|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||38
10316870|NCT00195260|11450935|FG010|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||23
10316871|NCT00195273|11450965|FG000|STARTED|Overall Study||31
10316872|NCT00195273|11450966|FG001|STARTED|Overall Study||30
10316873|NCT00195273|11450965|FG000|COMPLETED|Overall Study||10
10316874|NCT00195273|11450966|FG001|COMPLETED|Overall Study||16
10316875|NCT00195273|11450965|FG000|NOT COMPLETED|Overall Study||21
10316876|NCT00195273|11450966|FG001|NOT COMPLETED|Overall Study||14
10316877|NCT00195338|11450972|FG000|STARTED|Overall Study||25
10316878|NCT00195338|11450972|FG000|COMPLETED|Overall Study||13
10316879|NCT00195338|11450972|FG000|NOT COMPLETED|Overall Study||12
10316880|NCT00195351|11450978|FG000|STARTED|Overall Study||236
10316881|NCT00195351|11450979|FG001|STARTED|Overall Study||231
10316882|NCT00195351|11450978|FG000|COMPLETED|Overall Study||215
10316883|NCT00195351|11450979|FG001|COMPLETED|Overall Study||215
10316884|NCT00195351|11450978|FG000|NOT COMPLETED|Overall Study||21
10316885|NCT00195351|11450979|FG001|NOT COMPLETED|Overall Study||16
10316886|NCT00195403|11450985|FG000|STARTED|Overall Study||1014
10316887|NCT00195403|11450985|FG000|COMPLETED|Overall Study||1014
10316888|NCT00195403|11450985|FG000|NOT COMPLETED|Overall Study||0
10316889|NCT00195429|11450991|FG000|STARTED|Overall Study||24
10316890|NCT00195429|11450992|FG001|STARTED|Overall Study||23
10316891|NCT00195429|11450991|FG000|COMPLETED|Overall Study||19
10316892|NCT00195429|11450992|FG001|COMPLETED|Overall Study||18
10316893|NCT00195429|11450991|FG000|NOT COMPLETED|Overall Study||5
10316894|NCT00195429|11450992|FG001|NOT COMPLETED|Overall Study||5
10316895|NCT00195442|11450998|FG000|STARTED|Overall Study||288
10316896|NCT00195442|11450998|FG000|COMPLETED|Overall Study||152
10316897|NCT00195442|11450998|FG000|NOT COMPLETED|Overall Study||136
10316898|NCT00195494|11451004|FG000|STARTED|Year 1||0
10316899|NCT00195494|11451005|FG001|STARTED|Year 1||0
10316900|NCT00195494|11451006|FG002|STARTED|Year 1||0
10316901|NCT00195494|11451007|FG003|STARTED|Year 1||0
10316902|NCT00195494|11451008|FG004|STARTED|Year 1||268
10316903|NCT00195494|11451009|FG005|STARTED|Year 1||274
10316904|NCT00195494|11451004|FG000|COMPLETED|Year 1||0
10316905|NCT00195494|11451005|FG001|COMPLETED|Year 1||0
10316906|NCT00195494|11451006|FG002|COMPLETED|Year 1||0
10316907|NCT00195494|11451007|FG003|COMPLETED|Year 1||0
10316908|NCT00195494|11451008|FG004|COMPLETED|Year 1||189
10316909|NCT00195494|11451009|FG005|COMPLETED|Year 1||221
10316910|NCT00195494|11451004|FG000|NOT COMPLETED|Year 1||0
10316911|NCT00195494|11451005|FG001|NOT COMPLETED|Year 1||0
10316912|NCT00195494|11451006|FG002|NOT COMPLETED|Year 1||0
10316913|NCT00195494|11451007|FG003|NOT COMPLETED|Year 1||0
10316914|NCT00195494|11451008|FG004|NOT COMPLETED|Year 1||79
10316915|NCT00195494|11451009|FG005|NOT COMPLETED|Year 1||53
10316916|NCT00195494|11451004|FG000|STARTED|Year 2|A patient with Year 1 termination had taken drug briefly during Year 2 and thus counted in the data.|111
10316917|NCT00195494|11451005|FG001|STARTED|Year 2||90
10316918|NCT00195494|11451006|FG002|STARTED|Year 2|A patient with Year 1 termination had taken drug briefly during Year 2 and thus counted in the data.|111
10316919|NCT00195494|11451007|FG003|STARTED|Year 2||99
10316920|NCT00195494|11451008|FG004|STARTED|Year 2||0
10316921|NCT00195494|11451009|FG005|STARTED|Year 2||0
10316922|NCT00195494|11451004|FG000|COMPLETED|Year 2||104
10316923|NCT00195494|11451005|FG001|COMPLETED|Year 2||74
10316924|NCT00195494|11451006|FG002|COMPLETED|Year 2||93
10316925|NCT00195494|11451007|FG003|COMPLETED|Year 2||76
10316926|NCT00195494|11451008|FG004|COMPLETED|Year 2||0
10316927|NCT00195494|11451009|FG005|COMPLETED|Year 2||0
10316928|NCT00195494|11451004|FG000|NOT COMPLETED|Year 2||7
10316929|NCT00195494|11451005|FG001|NOT COMPLETED|Year 2||16
10316930|NCT00195494|11451006|FG002|NOT COMPLETED|Year 2||18
10316931|NCT00195494|11451007|FG003|NOT COMPLETED|Year 2||23
10316932|NCT00195494|11451008|FG004|NOT COMPLETED|Year 2||0
10316933|NCT00195494|11451009|FG005|NOT COMPLETED|Year 2||0
10316934|NCT00195507|11451027|FG000|STARTED|Overall Study||357
10316935|NCT00195507|11451028|FG001|STARTED|Overall Study||363
10316936|NCT00195507|11451027|FG000|COMPLETED|Overall Study||258
10316937|NCT00195507|11451028|FG001|COMPLETED|Overall Study||245
10316938|NCT00195507|11451027|FG000|NOT COMPLETED|Overall Study||99
10316939|NCT00195507|11451028|FG001|NOT COMPLETED|Overall Study||118
10316940|NCT00195624|11451036|FG000|STARTED|Overall Study||5
10316941|NCT00195624|11451037|FG001|STARTED|Overall Study||42
10316942|NCT00195624|11451036|FG000|COMPLETED|Overall Study||5
10316943|NCT00195624|11451037|FG001|COMPLETED|Overall Study||42
10316944|NCT00195624|11451036|FG000|NOT COMPLETED|Overall Study||0
10316945|NCT00195624|11451037|FG001|NOT COMPLETED|Overall Study||0
10338357|NCT00369512|11475240|FG000|NOT COMPLETED|Overall Study||0
10338358|NCT00369564|11475246|FG000|STARTED|Overall Study||127
10338359|NCT00369564|11475247|FG001|STARTED|Overall Study||123
10338360|NCT00369564|11475246|FG000|COMPLETED|Overall Study||84
10338361|NCT00369564|11475247|FG001|COMPLETED|Overall Study||100
10338362|NCT00369564|11475246|FG000|NOT COMPLETED|Overall Study||43
10316946|NCT00195650|11451043|FG000|STARTED|Overall Study|Participants who received at least 1 adalimumab dose in study;3 enrolled did not receive adalimumab.|846
10316947|NCT00195650|11451043|FG000|COMPLETED|Overall Study||321
10316948|NCT00195650|11451043|FG000|NOT COMPLETED|Overall Study||525
10316949|NCT00195663|11451050|FG000|STARTED|2-year Double-blind Treatment Period||257
10316950|NCT00195663|11451051|FG001|STARTED|2-year Double-blind Treatment Period||274
10316951|NCT00195663|11451052|FG002|STARTED|2-year Double-blind Treatment Period||268
10316952|NCT00195663|11451050|FG000|COMPLETED|2-year Double-blind Treatment Period||164
10316953|NCT00195663|11451051|FG001|COMPLETED|2-year Double-blind Treatment Period||166
10316954|NCT00195663|11451052|FG002|COMPLETED|2-year Double-blind Treatment Period||196
10316955|NCT00195663|11451050|FG000|NOT COMPLETED|2-year Double-blind Treatment Period||93
10316956|NCT00195663|11451051|FG001|NOT COMPLETED|2-year Double-blind Treatment Period||108
10316957|NCT00195663|11451052|FG002|NOT COMPLETED|2-year Double-blind Treatment Period||72
10316958|NCT00195663|11451050|FG000|STARTED|Open-Label Extension Period||155
10316959|NCT00195663|11451051|FG001|STARTED|Open-Label Extension Period||159
10316960|NCT00195663|11451052|FG002|STARTED|Open-Label Extension Period||183
10316961|NCT00195663|11451050|FG000|COMPLETED|Open-Label Extension Period||79
10316962|NCT00195663|11451051|FG001|COMPLETED|Open-Label Extension Period||85
10316963|NCT00195663|11451052|FG002|COMPLETED|Open-Label Extension Period||86
10316964|NCT00195663|11451050|FG000|NOT COMPLETED|Open-Label Extension Period||76
10316965|NCT00195663|11451051|FG001|NOT COMPLETED|Open-Label Extension Period||74
10316966|NCT00195663|11451052|FG002|NOT COMPLETED|Open-Label Extension Period||97
10316967|NCT00195676|11451070|FG000|STARTED|Period O - Open-label Treatment|Number receiving adalimumab in Period O (1 additional participant enrolled but did not receive drug)|1468
10316968|NCT00195676|11451070|FG000|COMPLETED|Period O - Open-label Treatment|254 Period O completers did not consent or were not eligible to continue into Period W and Period R.|862
10316969|NCT00195676|11451070|FG000|NOT COMPLETED|Period O - Open-label Treatment||606
10316970|NCT00195676|11451070|FG000|STARTED|Period W (Withdrawal) - No Treatment|Period O completers with a Physician's Global Assessment =<2 who continued into Periods W and R.|608
10316971|NCT00195676|11451070|FG000|COMPLETED|Period W (Withdrawal) - No Treatment|Non-completers may have entered Period R, whether or not they relapsed (PGA >= 3).|0
10316972|NCT00195676|11451070|FG000|NOT COMPLETED|Period W (Withdrawal) - No Treatment||608
10316973|NCT00195676|11451070|FG000|STARTED|Period R - Retreatment 16 Weeks|Number who entered from Period W, including those who did and did not relapse in that period.|525
10783350|NCT03426995|11944369|FG008|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10783351|NCT03426995|11944370|FG009|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10783352|NCT03426995|11944371|FG010|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10783353|NCT03426995|11944372|FG011|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10783354|NCT03426995|11944373|FG012|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10783355|NCT03426995|11944374|FG013|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10783356|NCT03426995|11944375|FG014|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10783357|NCT03426995|11944376|FG015|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10783358|NCT03426995|11944377|FG016|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10316974|NCT00195676|11451070|FG000|COMPLETED|Period R - Retreatment 16 Weeks||490
10316975|NCT00195676|11451070|FG000|NOT COMPLETED|Period R - Retreatment 16 Weeks||35
10316976|NCT00195702|11451081|FG000|STARTED|Double-blind Phase|For all groups, started indicates when the subjects entered the 52-week double-blind phase.|212
10316977|NCT00195702|11451082|FG001|STARTED|Double-blind Phase||207
10316978|NCT00195702|11451083|FG002|STARTED|Double-blind Phase||200
10316979|NCT00195702|11451084|FG003|STARTED|Double-blind Phase||0
10316980|NCT00195702|11451085|FG004|STARTED|Double-blind Phase||0
10316981|NCT00195702|11451086|FG005|STARTED|Double-blind Phase||0
10316982|NCT00195702|11451081|FG000|COMPLETED|Double-blind Phase||168
10316983|NCT00195702|11451082|FG001|COMPLETED|Double-blind Phase||159
10316984|NCT00195702|11451083|FG002|COMPLETED|Double-blind Phase||140
10316985|NCT00195702|11451084|FG003|COMPLETED|Double-blind Phase||0
10316986|NCT00195702|11451085|FG004|COMPLETED|Double-blind Phase||0
10316987|NCT00195702|11451086|FG005|COMPLETED|Double-blind Phase||0
10316988|NCT00195702|11451081|FG000|NOT COMPLETED|Double-blind Phase||44
10316989|NCT00195702|11451082|FG001|NOT COMPLETED|Double-blind Phase||48
10316990|NCT00195702|11451083|FG002|NOT COMPLETED|Double-blind Phase||60
10316991|NCT00195702|11451084|FG003|NOT COMPLETED|Double-blind Phase||0
10316992|NCT00195702|11451085|FG004|NOT COMPLETED|Double-blind Phase||0
10316993|NCT00195702|11451086|FG005|NOT COMPLETED|Double-blind Phase||0
10316994|NCT00195702|11451081|FG000|STARTED|Open-label Extension Phase||0
10316995|NCT00195702|11451082|FG001|STARTED|Open-label Extension Phase||0
10316996|NCT00195702|11451083|FG002|STARTED|Open-label Extension Phase||0
10783359|NCT03426995|11944378|FG017|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10783360|NCT03426995|11944379|FG018|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10783361|NCT03426995|11944361|FG000|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10783362|NCT03426995|11944362|FG001|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10783363|NCT03426995|11944363|FG002|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10783364|NCT03426995|11944364|FG003|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10783365|NCT03426995|11944365|FG004|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10783366|NCT03426995|11944366|FG005|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10783367|NCT03426995|11944367|FG006|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10783368|NCT03426995|11944368|FG007|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10783369|NCT03426995|11944369|FG008|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10783370|NCT03426995|11944370|FG009|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10316997|NCT00195702|11451084|FG003|STARTED|Open-label Extension Phase|3 subjects completed the double-blind phase but did not enter the open-label extension phase.|165
10316998|NCT00195702|11451085|FG004|STARTED|Open-label Extension Phase|1 subject completed the double-blind phase but did not enter the open-label extension phase.|158
10316999|NCT00195702|11451086|FG005|STARTED|Open-label Extension Phase|6 subjects completed the double-blind phase but did not enter the open-label extension phase.|134
10317000|NCT00195702|11451081|FG000|COMPLETED|Open-label Extension Phase||0
10317001|NCT00195702|11451082|FG001|COMPLETED|Open-label Extension Phase||0
10317002|NCT00195702|11451083|FG002|COMPLETED|Open-label Extension Phase||0
10317003|NCT00195702|11451084|FG003|COMPLETED|Open-label Extension Phase||66
10317004|NCT00195702|11451085|FG004|COMPLETED|Open-label Extension Phase||80
10317005|NCT00195702|11451086|FG005|COMPLETED|Open-label Extension Phase||56
10317006|NCT00195702|11451081|FG000|NOT COMPLETED|Open-label Extension Phase||0
10317007|NCT00195702|11451082|FG001|NOT COMPLETED|Open-label Extension Phase||0
10317008|NCT00195702|11451083|FG002|NOT COMPLETED|Open-label Extension Phase||0
10317009|NCT00195702|11451084|FG003|NOT COMPLETED|Open-label Extension Phase||99
10432940|NCT00883337|11579246|FG002|Treated|Core Treatment Period|3 participants refused treatment with Rebif®|101
10432941|NCT00883337|11579244|FG000|COMPLETED|Core Treatment Period||89
10432942|NCT00883337|11579245|FG001|COMPLETED|Core Treatment Period||89
10432943|NCT00883337|11579246|FG002|COMPLETED|Core Treatment Period||71
10432944|NCT00883337|11579244|FG000|NOT COMPLETED|Core Treatment Period||20
10432945|NCT00883337|11579245|FG001|NOT COMPLETED|Core Treatment Period||22
10432946|NCT00883337|11579246|FG002|NOT COMPLETED|Core Treatment Period||33
10432947|NCT00883337|11579244|FG000|STARTED|Extension Treatment Period||89
10432948|NCT00883337|11579245|FG001|STARTED|Extension Treatment Period||89
10432949|NCT00883337|11579246|FG002|STARTED|Extension Treatment Period|12 participants completed the core period but didn't enter the extension period.|59
10432950|NCT00883337|11579244|FG000|COMPLETED|Extension Treatment Period||61
10783371|NCT03426995|11944371|FG010|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10783372|NCT03426995|11944372|FG011|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10783373|NCT03426995|11944373|FG012|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10783374|NCT03426995|11944374|FG013|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10783375|NCT03426995|11944375|FG014|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10783376|NCT03426995|11944376|FG015|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10783377|NCT03426995|11944377|FG016|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10783378|NCT03426995|11944378|FG017|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10783379|NCT03426995|11944379|FG018|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
10783380|NCT03426995|11944361|FG000|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783381|NCT03426995|11944362|FG001|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783382|NCT03426995|11944363|FG002|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783383|NCT03426995|11944364|FG003|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783384|NCT03426995|11944365|FG004|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783385|NCT03426995|11944366|FG005|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783386|NCT03426995|11944367|FG006|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783387|NCT03426995|11944368|FG007|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783388|NCT03426995|11944369|FG008|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783389|NCT03426995|11944370|FG009|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783390|NCT03426995|11944371|FG010|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783391|NCT03426995|11944372|FG011|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783392|NCT03426995|11944373|FG012|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783393|NCT03426995|11944374|FG013|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783394|NCT03426995|11944375|FG014|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783395|NCT03426995|11944376|FG015|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783396|NCT03426995|11944377|FG016|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783397|NCT03426995|11944378|FG017|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783398|NCT03426995|11944379|FG018|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783399|NCT03426995|11944361|FG000|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783400|NCT03426995|11944362|FG001|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783401|NCT03426995|11944363|FG002|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783402|NCT03426995|11944364|FG003|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10810563|NCT03796182|11972328|FG000|COMPLETED|Period 1||6
10317010|NCT00195702|11451085|FG004|NOT COMPLETED|Open-label Extension Phase||78
10317011|NCT00195702|11451086|FG005|NOT COMPLETED|Open-label Extension Phase||78
10317012|NCT00195715|11451099|FG000|STARTED|Overall Study||777
10317013|NCT00195715|11451099|FG000|COMPLETED|Overall Study||400
10317014|NCT00195715|11451099|FG000|NOT COMPLETED|Overall Study||377
10317015|NCT00195819|11451103|FG000|STARTED|Double-Blind||44
10317016|NCT00195819|11451104|FG001|STARTED|Double-Blind||38
10317017|NCT00195819|11451103|FG000|COMPLETED|Double-Blind||42
10317018|NCT00195819|11451104|FG001|COMPLETED|Double-Blind||38
10317019|NCT00195819|11451103|FG000|NOT COMPLETED|Double-Blind||2
10317020|NCT00195819|11451104|FG001|NOT COMPLETED|Double-Blind||0
10317021|NCT00195819|11451103|FG000|STARTED|Open-label||0
10317022|NCT00195819|11451104|FG001|STARTED|Open-label||82
10317023|NCT00195819|11451103|FG000|COMPLETED|Open-label||0
10317024|NCT00195819|11451104|FG001|COMPLETED|Open-label||62
10317025|NCT00195819|11451103|FG000|NOT COMPLETED|Open-label||0
10317026|NCT00195819|11451104|FG001|NOT COMPLETED|Open-label||20
10317027|NCT00196105|11451119|FG000|STARTED|Overall Study||64
10317028|NCT00196105|11451120|FG001|STARTED|Overall Study||88
10317029|NCT00196105|11451121|FG002|STARTED|Overall Study||89
10317030|NCT00196105|11451119|FG000|COMPLETED|Overall Study||60
10317031|NCT00196105|11451120|FG001|COMPLETED|Overall Study||83
10317032|NCT00196105|11451121|FG002|COMPLETED|Overall Study||82
10317033|NCT00196105|11451119|FG000|NOT COMPLETED|Overall Study||4
10317034|NCT00196105|11451120|FG001|NOT COMPLETED|Overall Study||5
10317035|NCT00196105|11451121|FG002|NOT COMPLETED|Overall Study||7
10317036|NCT00196196|11451129|FG000|STARTED|Overall Study||274
10317037|NCT00196196|11451129|FG000|COMPLETED|Overall Study||267
10317038|NCT00196196|11451129|FG000|NOT COMPLETED|Overall Study||7
10317039|NCT00196313|11451135|FG000|STARTED|Overall Study||47
10317040|NCT00196313|11451136|FG001|STARTED|Overall Study||48
10317041|NCT00196313|11451135|FG000|COMPLETED|Overall Study||36
10317042|NCT00196313|11451136|FG001|COMPLETED|Overall Study||40
10317043|NCT00196313|11451135|FG000|NOT COMPLETED|Overall Study||11
10317044|NCT00196313|11451136|FG001|NOT COMPLETED|Overall Study||8
10783403|NCT03426995|11944365|FG004|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783404|NCT03426995|11944366|FG005|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783405|NCT03426995|11944367|FG006|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783406|NCT03426995|11944368|FG007|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783407|NCT03426995|11944369|FG008|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783408|NCT03426995|11944370|FG009|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783409|NCT03426995|11944371|FG010|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783410|NCT03426995|11944372|FG011|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783411|NCT03426995|11944373|FG012|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783412|NCT03426995|11944374|FG013|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783413|NCT03426995|11944375|FG014|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783414|NCT03426995|11944376|FG015|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783415|NCT03426995|11944377|FG016|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783416|NCT03426995|11944378|FG017|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783417|NCT03426995|11944379|FG018|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783418|NCT03426995|11944361|FG000|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783419|NCT03426995|11944362|FG001|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783420|NCT03426995|11944363|FG002|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783421|NCT03426995|11944364|FG003|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783422|NCT03426995|11944365|FG004|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783423|NCT03426995|11944366|FG005|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783424|NCT03426995|11944367|FG006|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783425|NCT03426995|11944368|FG007|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783426|NCT03426995|11944369|FG008|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783427|NCT03426995|11944370|FG009|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783428|NCT03426995|11944371|FG010|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783429|NCT03426995|11944372|FG011|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783430|NCT03426995|11944373|FG012|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783431|NCT03426995|11944374|FG013|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783432|NCT03426995|11944375|FG014|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783433|NCT03426995|11944376|FG015|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783434|NCT03426995|11944377|FG016|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783435|NCT03426995|11944378|FG017|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783436|NCT03426995|11944379|FG018|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
10783437|NCT03426995|11944361|FG000|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
10783438|NCT03426995|11944362|FG001|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
10783439|NCT03426995|11944363|FG002|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
10783440|NCT03426995|11944364|FG003|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
10783441|NCT03426995|11944365|FG004|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
10783442|NCT03426995|11944366|FG005|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
10783443|NCT03426995|11944367|FG006|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
10783444|NCT03426995|11944368|FG007|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
10783445|NCT03426995|11944369|FG008|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
10783446|NCT03426995|11944370|FG009|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
10783447|NCT03426995|11944371|FG010|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
10783448|NCT03426995|11944372|FG011|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
10783449|NCT03426995|11944373|FG012|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
10783450|NCT03426995|11944374|FG013|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
10783451|NCT03426995|11944375|FG014|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
10783452|NCT03426995|11944376|FG015|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
10783453|NCT03426995|11944377|FG016|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
10783454|NCT03426995|11944378|FG017|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
10783455|NCT03426995|11944379|FG018|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
10783456|NCT03426995|11944361|FG000|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10783457|NCT03426995|11944362|FG001|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10783458|NCT03426995|11944363|FG002|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10783459|NCT03426995|11944364|FG003|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10783460|NCT03426995|11944365|FG004|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10783461|NCT03426995|11944366|FG005|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10783462|NCT03426995|11944367|FG006|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10783463|NCT03426995|11944368|FG007|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10783464|NCT03426995|11944369|FG008|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10783465|NCT03426995|11944370|FG009|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10783466|NCT03426995|11944371|FG010|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10783467|NCT03426995|11944372|FG011|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10783468|NCT03426995|11944373|FG012|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10783469|NCT03426995|11944374|FG013|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10783470|NCT03426995|11944375|FG014|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10783471|NCT03426995|11944376|FG015|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10783472|NCT03426995|11944377|FG016|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10783473|NCT03426995|11944378|FG017|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10783474|NCT03426995|11944379|FG018|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10783475|NCT03426995|11944361|FG000|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10783476|NCT03426995|11944362|FG001|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10783477|NCT03426995|11944363|FG002|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10783478|NCT03426995|11944364|FG003|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10783479|NCT03426995|11944365|FG004|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10783480|NCT03426995|11944366|FG005|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10783481|NCT03426995|11944367|FG006|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10783482|NCT03426995|11944368|FG007|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10783483|NCT03426995|11944369|FG008|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10783484|NCT03426995|11944370|FG009|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10783485|NCT03426995|11944371|FG010|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10783486|NCT03426995|11944372|FG011|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10783487|NCT03426995|11944373|FG012|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10783488|NCT03426995|11944374|FG013|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10783489|NCT03426995|11944375|FG014|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10783490|NCT03426995|11944376|FG015|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10783491|NCT03426995|11944377|FG016|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10783492|NCT03426995|11944378|FG017|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10783493|NCT03426995|11944379|FG018|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
10783494|NCT03426995|11944361|FG000|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783495|NCT03426995|11944362|FG001|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783496|NCT03426995|11944363|FG002|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783497|NCT03426995|11944364|FG003|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783498|NCT03426995|11944365|FG004|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783499|NCT03426995|11944366|FG005|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783500|NCT03426995|11944367|FG006|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783501|NCT03426995|11944368|FG007|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783502|NCT03426995|11944369|FG008|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783503|NCT03426995|11944370|FG009|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783504|NCT03426995|11944371|FG010|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783505|NCT03426995|11944372|FG011|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783506|NCT03426995|11944373|FG012|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783507|NCT03426995|11944374|FG013|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783508|NCT03426995|11944375|FG014|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||11
10783509|NCT03426995|11944376|FG015|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||14
10783510|NCT03426995|11944377|FG016|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783511|NCT03426995|11944378|FG017|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783512|NCT03426995|11944379|FG018|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783513|NCT03426995|11944361|FG000|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783514|NCT03426995|11944362|FG001|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783515|NCT03426995|11944363|FG002|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783516|NCT03426995|11944364|FG003|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783517|NCT03426995|11944365|FG004|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783518|NCT03426995|11944366|FG005|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783519|NCT03426995|11944367|FG006|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783520|NCT03426995|11944368|FG007|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783521|NCT03426995|11944369|FG008|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783522|NCT03426995|11944370|FG009|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783523|NCT03426995|11944371|FG010|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783524|NCT03426995|11944372|FG011|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783525|NCT03426995|11944373|FG012|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783526|NCT03426995|11944374|FG013|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783527|NCT03426995|11944375|FG014|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||2
10783528|NCT03426995|11944376|FG015|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||2
10783529|NCT03426995|11944377|FG016|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783530|NCT03426995|11944378|FG017|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783531|NCT03426995|11944379|FG018|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783532|NCT03426995|11944361|FG000|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783533|NCT03426995|11944362|FG001|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783534|NCT03426995|11944363|FG002|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783535|NCT03426995|11944364|FG003|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783536|NCT03426995|11944365|FG004|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783537|NCT03426995|11944366|FG005|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783538|NCT03426995|11944367|FG006|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783539|NCT03426995|11944368|FG007|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783540|NCT03426995|11944369|FG008|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783541|NCT03426995|11944370|FG009|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783542|NCT03426995|11944371|FG010|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783543|NCT03426995|11944372|FG011|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783544|NCT03426995|11944373|FG012|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783545|NCT03426995|11944374|FG013|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783546|NCT03426995|11944375|FG014|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||9
10783547|NCT03426995|11944376|FG015|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||12
10783548|NCT03426995|11944377|FG016|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783549|NCT03426995|11944378|FG017|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783550|NCT03426995|11944379|FG018|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
10783551|NCT03427073|11944434|FG000|STARTED|Overall Study||1
10783552|NCT03427073|11944435|FG001|STARTED|Overall Study||1
10783553|NCT03427073|11944436|FG002|STARTED|Overall Study||1
10783554|NCT03427073|11944437|FG003|STARTED|Overall Study||3
10783555|NCT03427073|11944438|FG004|STARTED|Overall Study||3
10783556|NCT03427073|11944439|FG005|STARTED|Overall Study||4
10783557|NCT03427073|11944440|FG006|STARTED|Overall Study||3
10783558|NCT03427073|11944441|FG007|STARTED|Overall Study||4
10783559|NCT03427073|11944434|FG000|COMPLETED|Overall Study||0
10783560|NCT03427073|11944435|FG001|COMPLETED|Overall Study||0
10783561|NCT03427073|11944436|FG002|COMPLETED|Overall Study||0
10783562|NCT03427073|11944437|FG003|COMPLETED|Overall Study||0
10783563|NCT03427073|11944438|FG004|COMPLETED|Overall Study||0
10783564|NCT03427073|11944439|FG005|COMPLETED|Overall Study||0
10783565|NCT03427073|11944440|FG006|COMPLETED|Overall Study||0
10783566|NCT03427073|11944441|FG007|COMPLETED|Overall Study||0
10783567|NCT03427073|11944434|FG000|NOT COMPLETED|Overall Study||1
10783568|NCT03427073|11944435|FG001|NOT COMPLETED|Overall Study||1
10783569|NCT03427073|11944436|FG002|NOT COMPLETED|Overall Study||1
10783570|NCT03427073|11944437|FG003|NOT COMPLETED|Overall Study||3
10783571|NCT03427073|11944438|FG004|NOT COMPLETED|Overall Study||3
10783572|NCT03427073|11944439|FG005|NOT COMPLETED|Overall Study||4
10783573|NCT03427073|11944440|FG006|NOT COMPLETED|Overall Study||3
10783574|NCT03427073|11944441|FG007|NOT COMPLETED|Overall Study||4
10783575|NCT03427177|11944461|FG000|STARTED|Overall Study||125
10783576|NCT03427177|11944462|FG001|STARTED|Overall Study||132
10783577|NCT03427177|11944461|FG000|COMPLETED|Overall Study||92
10783578|NCT03427177|11944462|FG001|COMPLETED|Overall Study||105
10783579|NCT03427177|11944461|FG000|NOT COMPLETED|Overall Study||33
10783580|NCT03427177|11944462|FG001|NOT COMPLETED|Overall Study||27
10783581|NCT03427268|11944468|FG000|STARTED|Overall Study||32
10783582|NCT03427268|11944468|FG000|COMPLETED|Overall Study||0
10783583|NCT03427268|11944468|FG000|NOT COMPLETED|Overall Study||32
10783584|NCT03427619|11944472|FG000|STARTED|Overall Study||275
10783585|NCT03427619|11944472|FG000|Safety Population|Overall Study||275
10783586|NCT03427619|11944472|FG000|Modified Intention to Treat Population|Overall Study||143
10783587|NCT03427619|11944472|FG000|COMPLETED|Overall Study||209
10783588|NCT03427619|11944472|FG000|NOT COMPLETED|Overall Study||66
10783589|NCT03427892|11944476|FG000|STARTED|Overall Study||21
10783590|NCT03427892|11944476|FG000|COMPLETED|Overall Study|Of the 21 recruited, 19 completed at least one post baseline visit, included in the analysis.|19
10783591|NCT03427892|11944476|FG000|NOT COMPLETED|Overall Study||2
10783592|NCT03427931|11944480|FG000|STARTED|Overall Study||7
10783593|NCT03427931|11944480|FG000|COMPLETED|Overall Study||5
10783594|NCT03427931|11944480|FG000|NOT COMPLETED|Overall Study||2
10783595|NCT03428152|11944486|FG000|STARTED|Overall Study||37
10783596|NCT03428152|11944487|FG001|STARTED|Overall Study||41
10783597|NCT03428152|11944486|FG000|COMPLETED|Overall Study||30
10783598|NCT03428152|11944487|FG001|COMPLETED|Overall Study|exclusions: epidural / TAP / wound infiltration malignity retroperitone was opened age >65|30
10783599|NCT03428152|11944486|FG000|NOT COMPLETED|Overall Study||7
10783600|NCT03428152|11944487|FG001|NOT COMPLETED|Overall Study||11
10783601|NCT03428230|11944497|FG000|STARTED|Overall Study||15
10783602|NCT03428230|11944498|FG001|STARTED|Overall Study||15
10783603|NCT03428230|11944499|FG002|STARTED|Overall Study||15
10783604|NCT03428230|11944500|FG003|STARTED|Overall Study||15
10783605|NCT03428230|11944497|FG000|COMPLETED|Overall Study||15
10783606|NCT03428230|11944498|FG001|COMPLETED|Overall Study||15
10783607|NCT03428230|11944499|FG002|COMPLETED|Overall Study||15
10783608|NCT03428230|11944500|FG003|COMPLETED|Overall Study||15
10783609|NCT03428230|11944497|FG000|NOT COMPLETED|Overall Study||0
10783610|NCT03428230|11944498|FG001|NOT COMPLETED|Overall Study||0
10783611|NCT03428230|11944499|FG002|NOT COMPLETED|Overall Study||0
10783612|NCT03428230|11944500|FG003|NOT COMPLETED|Overall Study||0
10783613|NCT03428360|11944510|FG000|STARTED|Overall Study||130
10783614|NCT03428360|11944510|FG000|COMPLETED|Overall Study||90
10783615|NCT03428360|11944510|FG000|NOT COMPLETED|Overall Study||40
10783616|NCT03428750|11944520|FG000|STARTED|Overall Study||210
10783617|NCT03428750|11944521|FG001|STARTED|Overall Study||213
10783618|NCT03428750|11944520|FG000|COMPLETED|Overall Study||186
10783619|NCT03428750|11944521|FG001|COMPLETED|Overall Study||192
10783620|NCT03428750|11944520|FG000|NOT COMPLETED|Overall Study||24
10783621|NCT03428750|11944521|FG001|NOT COMPLETED|Overall Study||21
10783622|NCT03428815|11944552|FG000|STARTED|Overall Study||17
10783623|NCT03428815|11944553|FG001|STARTED|Overall Study||19
10783624|NCT03428815|11944552|FG000|COMPLETED|Overall Study||7
10783625|NCT03428815|11944553|FG001|COMPLETED|Overall Study||14
10783626|NCT03428815|11944552|FG000|NOT COMPLETED|Overall Study||10
10783627|NCT03428815|11944553|FG001|NOT COMPLETED|Overall Study||5
10783628|NCT03429270|11944559|FG000|STARTED|Overall Study||28
10783629|NCT03429270|11944559|FG000|COMPLETED|Overall Study||28
10783630|NCT03429270|11944559|FG000|NOT COMPLETED|Overall Study||0
10783631|NCT03429348|11944565|FG000|STARTED|Overall Study|4 participants had no additional rehab & had no corresponding sauna rehab participant to compare to.|12
10783632|NCT03429348|11944566|FG001|STARTED|Overall Study||12
10783633|NCT03429348|11944565|FG000|COMPLETED|Overall Study||12
10783634|NCT03429348|11944566|FG001|COMPLETED|Overall Study||12
10783635|NCT03429348|11944565|FG000|NOT COMPLETED|Overall Study||0
10783636|NCT03429348|11944566|FG001|NOT COMPLETED|Overall Study||0
10783637|NCT03429556|11944578|FG000|STARTED|Overall Study||12
10783638|NCT03429556|11944579|FG001|STARTED|Overall Study||4
10783639|NCT03429556|11944580|FG002|STARTED|Overall Study||4
10783640|NCT03429556|11944581|FG003|STARTED|Overall Study||3
10783641|NCT03429556|11944578|FG000|COMPLETED|Overall Study||12
10783642|NCT03429556|11944579|FG001|COMPLETED|Overall Study||3
10783643|NCT03429556|11944580|FG002|COMPLETED|Overall Study||4
10783644|NCT03429556|11944581|FG003|COMPLETED|Overall Study||3
10783645|NCT03429556|11944578|FG000|NOT COMPLETED|Overall Study||0
10783646|NCT03429556|11944579|FG001|NOT COMPLETED|Overall Study||1
10783647|NCT03429556|11944580|FG002|NOT COMPLETED|Overall Study||0
10783648|NCT03429556|11944581|FG003|NOT COMPLETED|Overall Study||0
10783649|NCT03430050|11944593|FG000|STARTED|Overall Study||3
10783650|NCT03430050|11944594|FG001|STARTED|Overall Study||5
10783651|NCT03430050|11944593|FG000|COMPLETED|Overall Study||3
10783652|NCT03430050|11944594|FG001|COMPLETED|Overall Study||5
10783653|NCT03430050|11944593|FG000|NOT COMPLETED|Overall Study||0
10783654|NCT03430050|11944594|FG001|NOT COMPLETED|Overall Study||0
10783655|NCT03430206|11944602|FG000|STARTED|Overall Study||40
10783656|NCT03430206|11944603|FG001|STARTED|Overall Study||38
10783657|NCT03430206|11944602|FG000|COMPLETED|Overall Study||18
10783658|NCT03430206|11944603|FG001|COMPLETED|Overall Study||21
10783659|NCT03430206|11944602|FG000|NOT COMPLETED|Overall Study||22
10783660|NCT03430206|11944603|FG001|NOT COMPLETED|Overall Study||17
10783661|NCT03430245|11944609|FG000|STARTED|Overall Study||16
10783662|NCT03430245|11944609|FG000|COMPLETED|Overall Study|6 subjects withdrew from study due to lengthy treatment. Treatment protocol amended.|9
10783663|NCT03430245|11944609|FG000|NOT COMPLETED|Overall Study||7
10783664|NCT03430349|11944615|FG000|STARTED|Overall Study||15
10783665|NCT03430349|11944616|FG001|STARTED|Overall Study||15
10783666|NCT03430349|11944615|FG000|Received nOPV Vaccination|Overall Study||15
10783667|NCT03430349|11944616|FG001|Received nOPV Vaccination|Overall Study||15
10783668|NCT03430349|11944615|FG000|COMPLETED|Overall Study||15
10783669|NCT03430349|11944616|FG001|COMPLETED|Overall Study||15
10783670|NCT03430349|11944615|FG000|NOT COMPLETED|Overall Study||0
10783671|NCT03430349|11944616|FG001|NOT COMPLETED|Overall Study||0
10783672|NCT03430856|11944626|FG000|STARTED|Overall Study||31
10783673|NCT03430856|11944627|FG001|STARTED|Overall Study||30
10783674|NCT03430856|11944628|FG002|STARTED|Overall Study||30
10783675|NCT03430856|11944626|FG000|Exposed|Overall Study||31
10783676|NCT03430856|11944627|FG001|Exposed|Overall Study||30
10783677|NCT03430856|11944628|FG002|Exposed|Overall Study||30
10783678|NCT03430856|11944626|FG000|COMPLETED|Overall Study||29
10783679|NCT03430856|11944627|FG001|COMPLETED|Overall Study||27
10783680|NCT03430856|11944628|FG002|COMPLETED|Overall Study||29
10783681|NCT03430856|11944626|FG000|NOT COMPLETED|Overall Study||2
10783682|NCT03430856|11944627|FG001|NOT COMPLETED|Overall Study||3
10783683|NCT03430856|11944628|FG002|NOT COMPLETED|Overall Study||1
10783684|NCT03430986|11944641|FG000|STARTED|24-week Control Period||42
10783685|NCT03430986|11944642|FG001|STARTED|24-week Control Period||122
10783686|NCT03430986|11944641|FG000|Treated as Randomized|24-week Control Period||42
10783687|NCT03430986|11944642|FG001|Treated as Randomized|24-week Control Period||120
10783688|NCT03430986|11944641|FG000|COMPLETED|24-week Control Period||34
10783689|NCT03430986|11944642|FG001|COMPLETED|24-week Control Period||118
10783690|NCT03430986|11944641|FG000|NOT COMPLETED|24-week Control Period||8
10783691|NCT03430986|11944642|FG001|NOT COMPLETED|24-week Control Period||4
10783692|NCT03430986|11944641|FG000|STARTED|24-week Post-Control Period|Not all participants received the Optional Treatment.|31
10783693|NCT03430986|11944642|FG001|STARTED|24-week Post-Control Period||118
10783694|NCT03430986|11944641|FG000|COMPLETED|24-week Post-Control Period||30
10783695|NCT03430986|11944642|FG001|COMPLETED|24-week Post-Control Period||116
10783696|NCT03430986|11944641|FG000|NOT COMPLETED|24-week Post-Control Period||1
10783697|NCT03430986|11944642|FG001|NOT COMPLETED|24-week Post-Control Period||2
10783698|NCT03431012|11944655|FG000|STARTED|Overall Study||47
10783699|NCT03431012|11944656|FG001|STARTED|Overall Study||60
10783700|NCT03431012|11944657|FG002|STARTED|Overall Study||56
10783701|NCT03431012|11944658|FG003|STARTED|Overall Study||53
10783702|NCT03431012|11944655|FG000|COMPLETED|Overall Study||47
10783703|NCT03431012|11944656|FG001|COMPLETED|Overall Study||60
10783704|NCT03431012|11944657|FG002|COMPLETED|Overall Study||56
10783705|NCT03431012|11944658|FG003|COMPLETED|Overall Study||53
10783706|NCT03431012|11944655|FG000|NOT COMPLETED|Overall Study||0
10783707|NCT03431012|11944656|FG001|NOT COMPLETED|Overall Study||0
10783708|NCT03431012|11944657|FG002|NOT COMPLETED|Overall Study||0
10783709|NCT03431012|11944658|FG003|NOT COMPLETED|Overall Study||0
10783710|NCT03431337|11944674|FG000|STARTED|Overall Study||78
10783711|NCT03431337|11944675|FG001|STARTED|Overall Study||79
10783712|NCT03431337|11944674|FG000|COMPLETED|Overall Study||49
10783713|NCT03431337|11944675|FG001|COMPLETED|Overall Study||57
10783714|NCT03431337|11944674|FG000|NOT COMPLETED|Overall Study||29
10783715|NCT03431337|11944675|FG001|NOT COMPLETED|Overall Study||22
10783716|NCT03431441|11944685|FG000|STARTED|Overall Study||24
10783717|NCT03431441|11944685|FG000|COMPLETED|Overall Study||19
10783718|NCT03431441|11944685|FG000|NOT COMPLETED|Overall Study||5
10783719|NCT03431857|11944689|FG000|STARTED|Overall Study||106
10783720|NCT03431857|11944689|FG000|COMPLETED|Overall Study|52 subjects have completed the study, and 50 had complete data (all pages of CRF visit are complete)|52
10783721|NCT03431857|11944689|FG000|NOT COMPLETED|Overall Study||54
10783722|NCT03432390|11944695|FG000|STARTED|Apnea Period||36
10783723|NCT03432390|11944696|FG001|STARTED|Apnea Period||36
10783724|NCT03432390|11944695|FG000|COMPLETED|Apnea Period||34
10783725|NCT03432390|11944696|FG001|COMPLETED|Apnea Period||34
10783726|NCT03432390|11944695|FG000|NOT COMPLETED|Apnea Period||2
10783727|NCT03432390|11944696|FG001|NOT COMPLETED|Apnea Period||2
10783728|NCT03432390|11944695|FG000|STARTED|Recovery Period||34
10783729|NCT03432390|11944696|FG001|STARTED|Recovery Period||34
10783730|NCT03432390|11944695|FG000|COMPLETED|Recovery Period||34
10783731|NCT03432390|11944696|FG001|COMPLETED|Recovery Period||34
10783732|NCT03432390|11944695|FG000|NOT COMPLETED|Recovery Period||0
10783733|NCT03432390|11944696|FG001|NOT COMPLETED|Recovery Period||0
10783734|NCT03432533|11944704|FG000|STARTED|Overall Study||141
10783735|NCT03432533|11944705|FG001|STARTED|Overall Study||142
10783736|NCT03432533|11944704|FG000|Completed 6-Month Treatment Period|Overall Study||136
10783737|NCT03432533|11944705|FG001|Completed 6-Month Treatment Period|Overall Study||137
10783738|NCT03432533|11944704|FG000|COMPLETED|Overall Study||126
10783739|NCT03432533|11944705|FG001|COMPLETED|Overall Study||131
10783740|NCT03432533|11944704|FG000|NOT COMPLETED|Overall Study||15
10783741|NCT03432533|11944705|FG001|NOT COMPLETED|Overall Study||11
10783742|NCT03432858|11944714|FG000|STARTED|Overall Study||12
10783743|NCT03432858|11944715|FG001|STARTED|Overall Study||83
10783744|NCT03432858|11944716|FG002|STARTED|Overall Study||89
10783745|NCT03432858|11944714|FG000|COMPLETED|Overall Study||10
10783746|NCT03432858|11944715|FG001|COMPLETED|Overall Study||72
10783747|NCT03432858|11944716|FG002|COMPLETED|Overall Study||72
10783748|NCT03432858|11944714|FG000|NOT COMPLETED|Overall Study||2
10783749|NCT03432858|11944715|FG001|NOT COMPLETED|Overall Study||11
10783750|NCT03432858|11944716|FG002|NOT COMPLETED|Overall Study||17
10783751|NCT03433482|11944728|FG000|STARTED|Overall Study||420
10783752|NCT03433482|11944729|FG001|STARTED|Overall Study||424
10783753|NCT03433482|11944730|FG002|STARTED|Overall Study||427
10783754|NCT03433482|11944731|FG003|STARTED|Overall Study||419
10783755|NCT03433482|11944728|FG000|COMPLETED|Overall Study||419
10783756|NCT03433482|11944729|FG001|COMPLETED|Overall Study||424
10783757|NCT03433482|11944730|FG002|COMPLETED|Overall Study||423
10783758|NCT03433482|11944731|FG003|COMPLETED|Overall Study||418
10783759|NCT03433482|11944728|FG000|NOT COMPLETED|Overall Study||1
10783760|NCT03433482|11944729|FG001|NOT COMPLETED|Overall Study||0
10783761|NCT03433482|11944730|FG002|NOT COMPLETED|Overall Study||4
10783762|NCT03433482|11944731|FG003|NOT COMPLETED|Overall Study||1
10783763|NCT03433677|11944743|FG000|STARTED|Period 1||24
10783764|NCT03433677|11944744|FG001|STARTED|Period 1||25
10783765|NCT03433677|11944743|FG000|Received at Least 1 Dose of Study Drug|Period 1||24
10783766|NCT03433677|11944744|FG001|Received at Least 1 Dose of Study Drug|Period 1||25
10783767|NCT03433677|11944743|FG000|COMPLETED|Period 1||23
10783768|NCT03433677|11944744|FG001|COMPLETED|Period 1||25
10783769|NCT03433677|11944743|FG000|NOT COMPLETED|Period 1||1
10783770|NCT03433677|11944744|FG001|NOT COMPLETED|Period 1||0
10783771|NCT03433677|11944743|FG000|STARTED|Period 2||23
10783772|NCT03433677|11944744|FG001|STARTED|Period 2||25
10783773|NCT03433677|11944743|FG000|Received at Least 1 Dose of Study Drug|Period 2||23
10783774|NCT03433677|11944744|FG001|Received at Least 1 Dose of Study Drug|Period 2||25
10783775|NCT03433677|11944743|FG000|COMPLETED|Period 2||22
10783776|NCT03433677|11944744|FG001|COMPLETED|Period 2||24
10783777|NCT03433677|11944743|FG000|NOT COMPLETED|Period 2||1
10783778|NCT03433677|11944744|FG001|NOT COMPLETED|Period 2||1
10783779|NCT03433703|11944751|FG000|STARTED|Overall Study||2
10783780|NCT03433703|11944751|FG000|COMPLETED|Overall Study||0
10783781|NCT03433703|11944751|FG000|NOT COMPLETED|Overall Study||2
10783782|NCT03433755|11944759|FG000|STARTED|Overall Study||42
10783783|NCT03433755|11944760|FG001|STARTED|Overall Study||41
10783784|NCT03433755|11944761|FG002|STARTED|Overall Study||79
10783785|NCT03433755|11944762|FG003|STARTED|Overall Study||80
10783786|NCT03433755|11944759|FG000|Randomized and Treated|Overall Study||41
10783787|NCT03433755|11944760|FG001|Randomized and Treated|Overall Study||41
10783788|NCT03433755|11944761|FG002|Randomized and Treated|Overall Study||79
10783789|NCT03433755|11944762|FG003|Randomized and Treated|Overall Study||80
10783790|NCT03433755|11944759|FG000|COMPLETED|Overall Study||40
10783791|NCT03433755|11944760|FG001|COMPLETED|Overall Study||41
10783792|NCT03433755|11944761|FG002|COMPLETED|Overall Study||79
10783793|NCT03433755|11944762|FG003|COMPLETED|Overall Study||80
10783794|NCT03433755|11944759|FG000|NOT COMPLETED|Overall Study||2
10783795|NCT03433755|11944760|FG001|NOT COMPLETED|Overall Study||0
10783796|NCT03433755|11944761|FG002|NOT COMPLETED|Overall Study||0
10783797|NCT03433755|11944762|FG003|NOT COMPLETED|Overall Study||0
10783798|NCT03433794|11944777|FG000|STARTED|Baseline||183
10783799|NCT03433794|11944778|FG001|STARTED|Baseline||173
10783800|NCT03433794|11944779|FG002|STARTED|Baseline||181
10783801|NCT03433794|11944777|FG000|COMPLETED|Baseline||183
10783802|NCT03433794|11944778|FG001|COMPLETED|Baseline||173
10783803|NCT03433794|11944779|FG002|COMPLETED|Baseline||181
10783804|NCT03433794|11944777|FG000|NOT COMPLETED|Baseline||0
10783805|NCT03433794|11944778|FG001|NOT COMPLETED|Baseline||0
10783806|NCT03433794|11944779|FG002|NOT COMPLETED|Baseline||0
10783807|NCT03433794|11944777|FG000|STARTED|2-Week Assessment||183
10783808|NCT03433794|11944778|FG001|STARTED|2-Week Assessment||173
10783809|NCT03433794|11944779|FG002|STARTED|2-Week Assessment||181
10783810|NCT03433794|11944777|FG000|COMPLETED|2-Week Assessment||117
10783811|NCT03433794|11944778|FG001|COMPLETED|2-Week Assessment||112
10783812|NCT03433794|11944779|FG002|COMPLETED|2-Week Assessment||109
10783813|NCT03433794|11944777|FG000|NOT COMPLETED|2-Week Assessment||66
10783814|NCT03433794|11944778|FG001|NOT COMPLETED|2-Week Assessment||61
10783815|NCT03433794|11944779|FG002|NOT COMPLETED|2-Week Assessment||72
10783816|NCT03433794|11944777|FG000|STARTED|4-Week Assessment||183
10783817|NCT03433794|11944778|FG001|STARTED|4-Week Assessment||173
10783818|NCT03433794|11944779|FG002|STARTED|4-Week Assessment||181
10783819|NCT03433794|11944777|FG000|COMPLETED|4-Week Assessment||98
10783820|NCT03433794|11944778|FG001|COMPLETED|4-Week Assessment||95
10783821|NCT03433794|11944779|FG002|COMPLETED|4-Week Assessment||91
10783822|NCT03433794|11944777|FG000|NOT COMPLETED|4-Week Assessment||85
10783823|NCT03433794|11944778|FG001|NOT COMPLETED|4-Week Assessment||78
10783824|NCT03433794|11944779|FG002|NOT COMPLETED|4-Week Assessment||90
10783825|NCT03433794|11944777|FG000|STARTED|6-Week Assessment||183
10783826|NCT03433794|11944778|FG001|STARTED|6-Week Assessment||173
10783827|NCT03433794|11944779|FG002|STARTED|6-Week Assessment||181
10317045|NCT00196326|11451143|FG000|STARTED|Overall Study|Took at least one dose of study medication|2235
10317046|NCT00196326|11451143|FG000|Safety Population|Overall Study|Treated participants|2185
10317047|NCT00196326|11451143|FG000|Pregnancy Intent-to-treat Cohort (PITT)|Overall Study|Completed one cycle and 18-35 years old|1735
10317048|NCT00196326|11451143|FG000|COMPLETED|Overall Study||1249
10317049|NCT00196326|11451143|FG000|NOT COMPLETED|Overall Study||986
10317050|NCT00196716|11451147|FG000|STARTED|1.0 mg/kg Period||21
10317051|NCT00196716|11451147|FG000|COMPLETED|1.0 mg/kg Period||21
10317052|NCT00196716|11451147|FG000|NOT COMPLETED|1.0 mg/kg Period||0
10317053|NCT00196716|11451147|FG000|STARTED|0.3 mg/kg Period||21
10317054|NCT00196716|11451147|FG000|COMPLETED|0.3 mg/kg Period||21
10317055|NCT00196716|11451147|FG000|NOT COMPLETED|0.3 mg/kg Period||0
10317056|NCT00196937|11451156|FG000|STARTED|Overall Study||229
10317057|NCT00196937|11451157|FG001|STARTED|Overall Study||226
10317058|NCT00196937|11451158|FG002|STARTED|Overall Study||211
10317059|NCT00196937|11451156|FG000|COMPLETED|Overall Study||220
10317060|NCT00196937|11451157|FG001|COMPLETED|Overall Study||221
10317061|NCT00196937|11451158|FG002|COMPLETED|Overall Study||204
10317062|NCT00196937|11451156|FG000|NOT COMPLETED|Overall Study||9
10317063|NCT00196937|11451157|FG001|NOT COMPLETED|Overall Study||5
10317064|NCT00196937|11451158|FG002|NOT COMPLETED|Overall Study||7
10317065|NCT00196976|11451181|FG000|STARTED|Primary Study||39
10317066|NCT00196976|11451182|FG001|STARTED|Primary Study||41
10317067|NCT00196976|11451183|FG002|STARTED|Primary Study||41
10317068|NCT00196976|11451184|FG003|STARTED|Primary Study||40
10317069|NCT00196976|11451185|FG004|STARTED|Primary Study||40
10317070|NCT00196976|11451186|FG005|STARTED|Primary Study||54
10317071|NCT00196976|11451187|FG006|STARTED|Primary Study||50
10317072|NCT00196976|11451188|FG007|STARTED|Primary Study||52
10317073|NCT00196976|11451189|FG008|STARTED|Primary Study||52
10317074|NCT00196976|11451190|FG009|STARTED|Primary Study||52
10783828|NCT03433794|11944777|FG000|COMPLETED|6-Week Assessment||94
10783829|NCT03433794|11944778|FG001|COMPLETED|6-Week Assessment||85
10783830|NCT03433794|11944779|FG002|COMPLETED|6-Week Assessment||80
10783831|NCT03433794|11944777|FG000|NOT COMPLETED|6-Week Assessment||89
10783832|NCT03433794|11944778|FG001|NOT COMPLETED|6-Week Assessment||88
10783833|NCT03433794|11944779|FG002|NOT COMPLETED|6-Week Assessment||101
10783834|NCT03433794|11944777|FG000|STARTED|3-Month Assessment||183
10783835|NCT03433794|11944778|FG001|STARTED|3-Month Assessment||173
10783836|NCT03433794|11944779|FG002|STARTED|3-Month Assessment||181
10783837|NCT03433794|11944777|FG000|COMPLETED|3-Month Assessment||69
10783838|NCT03433794|11944778|FG001|COMPLETED|3-Month Assessment||73
10783839|NCT03433794|11944779|FG002|COMPLETED|3-Month Assessment||71
10783840|NCT03433794|11944777|FG000|NOT COMPLETED|3-Month Assessment||114
10783841|NCT03433794|11944778|FG001|NOT COMPLETED|3-Month Assessment||100
10783842|NCT03433794|11944779|FG002|NOT COMPLETED|3-Month Assessment||110
10783843|NCT03433794|11944777|FG000|STARTED|6-Month Assessment||183
10783844|NCT03433794|11944778|FG001|STARTED|6-Month Assessment||173
10783845|NCT03433794|11944779|FG002|STARTED|6-Month Assessment||181
10783846|NCT03433794|11944777|FG000|COMPLETED|6-Month Assessment||65
10783847|NCT03433794|11944778|FG001|COMPLETED|6-Month Assessment||58
10783848|NCT03433794|11944779|FG002|COMPLETED|6-Month Assessment||50
10783849|NCT03433794|11944777|FG000|NOT COMPLETED|6-Month Assessment||118
10783850|NCT03433794|11944778|FG001|NOT COMPLETED|6-Month Assessment||115
10783851|NCT03433794|11944779|FG002|NOT COMPLETED|6-Month Assessment||131
10783852|NCT03433794|11944777|FG000|STARTED|9-Month Assessment||183
10783853|NCT03433794|11944778|FG001|STARTED|9-Month Assessment||173
10317075|NCT00196976|11451191|FG010|STARTED|Primary Study||0
10317076|NCT00196976|11451192|FG011|STARTED|Primary Study||0
10317077|NCT00196976|11451193|FG012|STARTED|Primary Study||0
10783854|NCT03433794|11944779|FG002|STARTED|9-Month Assessment||181
10783855|NCT03433794|11944777|FG000|COMPLETED|9-Month Assessment||49
10783856|NCT03433794|11944778|FG001|COMPLETED|9-Month Assessment||52
10783857|NCT03433794|11944779|FG002|COMPLETED|9-Month Assessment||39
10783858|NCT03433794|11944777|FG000|NOT COMPLETED|9-Month Assessment||134
10783859|NCT03433794|11944778|FG001|NOT COMPLETED|9-Month Assessment||121
10783860|NCT03433794|11944779|FG002|NOT COMPLETED|9-Month Assessment||142
10783861|NCT03434249|11944789|FG000|STARTED|Overall Study||40
10783862|NCT03434249|11944790|FG001|STARTED|Overall Study||40
10317078|NCT00196976|11451194|FG013|STARTED|Primary Study||0
10317079|NCT00196976|11451181|FG000|COMPLETED|Primary Study||38
10783863|NCT03434249|11944789|FG000|COMPLETED|Overall Study||35
10783864|NCT03434249|11944790|FG001|COMPLETED|Overall Study||37
10317080|NCT00196976|11451182|FG001|COMPLETED|Primary Study||40
10317081|NCT00196976|11451183|FG002|COMPLETED|Primary Study||37
10317082|NCT00196976|11451184|FG003|COMPLETED|Primary Study||39
10317083|NCT00196976|11451185|FG004|COMPLETED|Primary Study||37
10317084|NCT00196976|11451186|FG005|COMPLETED|Primary Study||52
10317085|NCT00196976|11451187|FG006|COMPLETED|Primary Study||50
10317086|NCT00196976|11451188|FG007|COMPLETED|Primary Study||49
10317087|NCT00196976|11451189|FG008|COMPLETED|Primary Study||52
10317088|NCT00196976|11451190|FG009|COMPLETED|Primary Study||51
10317089|NCT00196976|11451191|FG010|COMPLETED|Primary Study||0
10317090|NCT00196976|11451192|FG011|COMPLETED|Primary Study||0
10317091|NCT00196976|11451193|FG012|COMPLETED|Primary Study||0
10783865|NCT03434249|11944789|FG000|NOT COMPLETED|Overall Study||5
10783866|NCT03434249|11944790|FG001|NOT COMPLETED|Overall Study||3
10783867|NCT03434457|11944796|FG000|STARTED|Overall Study||630
10783868|NCT03434457|11944796|FG000|COMPLETED|Overall Study||630
10783869|NCT03434457|11944796|FG000|NOT COMPLETED|Overall Study||0
10783870|NCT03434834|11944800|FG000|STARTED|Overall Study||53
10783871|NCT03434834|11944800|FG000|COMPLETED|Overall Study||37
10783872|NCT03434834|11944800|FG000|NOT COMPLETED|Overall Study||16
10783873|NCT03434977|11944806|FG000|STARTED|Intervention Period 1 (6 Days)||6
10783874|NCT03434977|11944807|FG001|STARTED|Intervention Period 1 (6 Days)||6
10783875|NCT03434977|11944806|FG000|COMPLETED|Intervention Period 1 (6 Days)||6
10783876|NCT03434977|11944807|FG001|COMPLETED|Intervention Period 1 (6 Days)||6
10783877|NCT03434977|11944806|FG000|NOT COMPLETED|Intervention Period 1 (6 Days)||0
10783878|NCT03434977|11944807|FG001|NOT COMPLETED|Intervention Period 1 (6 Days)||0
10783879|NCT03434977|11944806|FG000|STARTED|Washout Period (at Least 6 Days)||6
10783880|NCT03434977|11944807|FG001|STARTED|Washout Period (at Least 6 Days)||6
10783881|NCT03434977|11944806|FG000|COMPLETED|Washout Period (at Least 6 Days)||6
10783882|NCT03434977|11944807|FG001|COMPLETED|Washout Period (at Least 6 Days)||5
10783883|NCT03434977|11944806|FG000|NOT COMPLETED|Washout Period (at Least 6 Days)||0
10783884|NCT03434977|11944807|FG001|NOT COMPLETED|Washout Period (at Least 6 Days)||1
10783885|NCT03434977|11944806|FG000|STARTED|Intervention Period 2 (6 Days)||6
10783886|NCT03434977|11944807|FG001|STARTED|Intervention Period 2 (6 Days)||5
10783887|NCT03434977|11944806|FG000|COMPLETED|Intervention Period 2 (6 Days)||6
10783888|NCT03434977|11944807|FG001|COMPLETED|Intervention Period 2 (6 Days)||5
10783889|NCT03434977|11944806|FG000|NOT COMPLETED|Intervention Period 2 (6 Days)||0
10783890|NCT03434977|11944807|FG001|NOT COMPLETED|Intervention Period 2 (6 Days)||0
10783891|NCT03435055|11944813|FG000|STARTED|Screening||21
10783892|NCT03435055|11944813|FG000|COMPLETED|Screening||19
10783893|NCT03435055|11944813|FG000|NOT COMPLETED|Screening||2
10783894|NCT03435055|11944813|FG000|STARTED|Received Intervention||19
10783895|NCT03435055|11944813|FG000|COMPLETED|Received Intervention||16
10783896|NCT03435055|11944813|FG000|NOT COMPLETED|Received Intervention||3
10783909|NCT03435211|11944838|FG000|STARTED|Overall Study||26
10783910|NCT03435211|11944838|FG000|COMPLETED|Overall Study||25
10783911|NCT03435211|11944838|FG000|NOT COMPLETED|Overall Study||1
10783912|NCT03435224|11944842|FG000|STARTED|Overall Study||29
10783913|NCT03435224|11944842|FG000|COMPLETED|Overall Study||25
10783914|NCT03435224|11944842|FG000|NOT COMPLETED|Overall Study||4
10783915|NCT03435497|11944848|FG000|STARTED|Overall Study||51
10783916|NCT03435497|11944849|FG001|STARTED|Overall Study||47
10783917|NCT03435497|11944848|FG000|COMPLETED|Overall Study||49
10783918|NCT03435497|11944849|FG001|COMPLETED|Overall Study||41
10783919|NCT03435497|11944848|FG000|NOT COMPLETED|Overall Study||2
10783920|NCT03435497|11944849|FG001|NOT COMPLETED|Overall Study||6
10783921|NCT03435562|11944855|FG000|STARTED|Overall Study||22
10783922|NCT03435562|11944855|FG000|COMPLETED|Overall Study||18
10783923|NCT03435562|11944855|FG000|NOT COMPLETED|Overall Study||4
10783924|NCT03435614|11944868|FG000|STARTED|Overall Study||6
10783925|NCT03435614|11944869|FG001|STARTED|Overall Study||23
10783926|NCT03435614|11944868|FG000|COMPLETED|Overall Study||6
10783927|NCT03435614|11944869|FG001|COMPLETED|Overall Study||23
10783928|NCT03435614|11944868|FG000|NOT COMPLETED|Overall Study||0
10783929|NCT03435614|11944869|FG001|NOT COMPLETED|Overall Study||0
10783930|NCT03435692|11944879|FG000|STARTED|Overall Study||17
10783931|NCT03435692|11944880|FG001|STARTED|Overall Study||18
10317092|NCT00196976|11451194|FG013|COMPLETED|Primary Study||0
10317093|NCT00196976|11451181|FG000|NOT COMPLETED|Primary Study||1
10317094|NCT00196976|11451182|FG001|NOT COMPLETED|Primary Study||1
10783932|NCT03435692|11944881|FG002|STARTED|Overall Study||7
10810564|NCT03796182|11972329|FG001|COMPLETED|Period 1||6
10810565|NCT03796182|11972328|FG000|NOT COMPLETED|Period 1||0
10317095|NCT00196976|11451183|FG002|NOT COMPLETED|Primary Study||4
10317096|NCT00196976|11451184|FG003|NOT COMPLETED|Primary Study||1
10317097|NCT00196976|11451185|FG004|NOT COMPLETED|Primary Study||3
10317098|NCT00196976|11451186|FG005|NOT COMPLETED|Primary Study||2
10317099|NCT00196976|11451187|FG006|NOT COMPLETED|Primary Study||0
10317100|NCT00196976|11451188|FG007|NOT COMPLETED|Primary Study||3
10317101|NCT00196976|11451189|FG008|NOT COMPLETED|Primary Study||0
10317102|NCT00196976|11451190|FG009|NOT COMPLETED|Primary Study||1
10317103|NCT00196976|11451191|FG010|NOT COMPLETED|Primary Study||0
10317104|NCT00196976|11451192|FG011|NOT COMPLETED|Primary Study||0
10317105|NCT00196976|11451193|FG012|NOT COMPLETED|Primary Study||0
10317106|NCT00196976|11451194|FG013|NOT COMPLETED|Primary Study||0
10317107|NCT00196976|11451181|FG000|STARTED|Booster Study||0
10317108|NCT00196976|11451182|FG001|STARTED|Booster Study||0
10317109|NCT00196976|11451183|FG002|STARTED|Booster Study||0
10317110|NCT00196976|11451184|FG003|STARTED|Booster Study||0
10317111|NCT00196976|11451185|FG004|STARTED|Booster Study||0
10317112|NCT00196976|11451186|FG005|STARTED|Booster Study||0
10317113|NCT00196976|11451187|FG006|STARTED|Booster Study||0
10317114|NCT00196976|11451188|FG007|STARTED|Booster Study||0
10783933|NCT03435692|11944879|FG000|COMPLETED|Overall Study|Discontinued intervention (n=2). 1) Lumbar Epidural Catheter (LEC) not working Post-Operative Day (POD) 0, Lumbar Epidural Catheter (LEC) removed and morphine infusion started - patient 1 year old. 2) Lumbar Epidural Catheter (LEC) not working Post-Operative Day (POD) 1, Lumbar Epidural Catheter (LEC) removed and Patient Controlled Analgesia (PCA) started.|15
10783934|NCT03435692|11944880|FG001|COMPLETED|Overall Study|Discontinued intervention (n=2). 1) Successful lumbar plexus injection, but unable to thread catheter, morphine infusion started (patient 1 year old). 2) Lumbar Plexus Catheter (LPC) catheter (10 cm) not long enough to reach lumbar plexus in patient weighing 136kg, Lumbar Epidural Catheter (LEC) placed instead.|16
10783935|NCT03435692|11944881|FG002|COMPLETED|Overall Study||7
10783936|NCT03435692|11944879|FG000|NOT COMPLETED|Overall Study||2
10783937|NCT03435692|11944880|FG001|NOT COMPLETED|Overall Study||2
10783938|NCT03435692|11944881|FG002|NOT COMPLETED|Overall Study||0
10783939|NCT03435783|11944895|FG000|STARTED|Overall Study||20
10783940|NCT03435783|11944896|FG001|STARTED|Overall Study||20
10783941|NCT03435783|11944895|FG000|COMPLETED|Overall Study||20
10783942|NCT03435783|11944896|FG001|COMPLETED|Overall Study||19
10783943|NCT03435783|11944895|FG000|NOT COMPLETED|Overall Study||0
10783944|NCT03435783|11944896|FG001|NOT COMPLETED|Overall Study||1
10783945|NCT03436082|11944904|FG000|STARTED|Overall Study||30
10783946|NCT03436082|11944905|FG001|STARTED|Overall Study||30
10783947|NCT03436082|11944904|FG000|COMPLETED|Overall Study|Had procedure|29
10783948|NCT03436082|11944905|FG001|COMPLETED|Overall Study|Had procedure|30
10783949|NCT03436082|11944904|FG000|NOT COMPLETED|Overall Study||1
10783950|NCT03436082|11944905|FG001|NOT COMPLETED|Overall Study||0
10783951|NCT03436147|11944913|FG000|STARTED|Overall Study||19
10783952|NCT03436147|11944914|FG001|STARTED|Overall Study||30
10783953|NCT03436147|11944913|FG000|COMPLETED|Overall Study||15
10783954|NCT03436147|11944914|FG001|COMPLETED|Overall Study||19
10783955|NCT03436147|11944913|FG000|NOT COMPLETED|Overall Study||4
10783956|NCT03436147|11944914|FG001|NOT COMPLETED|Overall Study||11
10783957|NCT03436420|11944922|FG000|STARTED|Overall Study||6
10783958|NCT03436420|11944922|FG000|COMPLETED|Overall Study||3
10783959|NCT03436420|11944922|FG000|NOT COMPLETED|Overall Study||3
10783960|NCT03436732|11944928|FG000|STARTED|Overall Study||4
10783961|NCT03436732|11944929|FG001|STARTED|Overall Study||1
10783962|NCT03436732|11944928|FG000|COMPLETED|Overall Study||0
10783963|NCT03436732|11944929|FG001|COMPLETED|Overall Study||0
10783964|NCT03436732|11944928|FG000|NOT COMPLETED|Overall Study||4
10783965|NCT03436732|11944929|FG001|NOT COMPLETED|Overall Study||1
10783966|NCT03436810|11944938|FG000|STARTED|Overall Study||20
10783967|NCT03436810|11944939|FG001|STARTED|Overall Study||20
10783968|NCT03436810|11944938|FG000|COMPLETED|Overall Study||20
10783969|NCT03436810|11944939|FG001|COMPLETED|Overall Study||20
10783970|NCT03436810|11944938|FG000|NOT COMPLETED|Overall Study||0
10783971|NCT03436810|11944939|FG001|NOT COMPLETED|Overall Study||0
10783972|NCT03437031|11944947|FG000|STARTED|Overall Study||19
10783973|NCT03437031|11944948|FG001|STARTED|Overall Study||21
10783974|NCT03437031|11944947|FG000|COMPLETED|Overall Study||19
10317115|NCT00196976|11451189|FG008|STARTED|Booster Study||0
10317116|NCT00196976|11451190|FG009|STARTED|Booster Study||0
10317117|NCT00196976|11451191|FG010|STARTED|Booster Study||33
10317118|NCT00196976|11451192|FG011|STARTED|Booster Study||32
10432951|NCT00883337|11579245|FG001|COMPLETED|Extension Treatment Period||66
10432952|NCT00883337|11579246|FG002|COMPLETED|Extension Treatment Period||40
10432953|NCT00883337|11579244|FG000|NOT COMPLETED|Extension Treatment Period||28
10432954|NCT00883337|11579245|FG001|NOT COMPLETED|Extension Treatment Period||23
10432955|NCT00883337|11579246|FG002|NOT COMPLETED|Extension Treatment Period||19
10432956|NCT00883389|11579260|FG000|STARTED|Overall Study||26
10432957|NCT00883389|11579260|FG000|COMPLETED|Overall Study||26
10432958|NCT00883389|11579260|FG000|NOT COMPLETED|Overall Study||0
10432959|NCT00883415|11579264|FG000|STARTED|Overall Study||20
10432960|NCT00883415|11579264|FG000|COMPLETED|Overall Study||18
10783975|NCT03437031|11944948|FG001|COMPLETED|Overall Study||21
10783976|NCT03437031|11944947|FG000|NOT COMPLETED|Overall Study||0
10783977|NCT03437031|11944948|FG001|NOT COMPLETED|Overall Study||0
10783978|NCT03437044|11944958|FG000|STARTED|Overall Study||20
10783979|NCT03437044|11944959|FG001|STARTED|Overall Study||20
10317119|NCT00196976|11451193|FG012|STARTED|Booster Study||45
10317120|NCT00196976|11451194|FG013|STARTED|Booster Study||43
10317121|NCT00196976|11451181|FG000|COMPLETED|Booster Study||0
10317122|NCT00196976|11451182|FG001|COMPLETED|Booster Study||0
10432961|NCT00883415|11579264|FG000|NOT COMPLETED|Overall Study||2
10432962|NCT00883493|11579270|FG000|STARTED|Overall Study||212
10432963|NCT00883493|11579271|FG001|STARTED|Overall Study||209
10317123|NCT00196976|11451183|FG002|COMPLETED|Booster Study||0
10317124|NCT00196976|11451184|FG003|COMPLETED|Booster Study||0
10317125|NCT00196976|11451185|FG004|COMPLETED|Booster Study||0
10783980|NCT03437044|11944958|FG000|COMPLETED|Overall Study||17
10783981|NCT03437044|11944959|FG001|COMPLETED|Overall Study||18
10783982|NCT03437044|11944958|FG000|NOT COMPLETED|Overall Study||3
10783983|NCT03437044|11944959|FG001|NOT COMPLETED|Overall Study||2
10783984|NCT03437265|11944965|FG000|STARTED|Overall Study||19
10783985|NCT03437265|11944965|FG000|COMPLETED|Overall Study||13
10783986|NCT03437265|11944965|FG000|NOT COMPLETED|Overall Study||6
10783987|NCT03437447|11944972|FG000|STARTED|Treatment Period 1||20
10783988|NCT03437447|11944973|FG001|STARTED|Treatment Period 1||20
10783989|NCT03437447|11944974|FG002|STARTED|Treatment Period 1||20
10783990|NCT03437447|11944972|FG000|COMPLETED|Treatment Period 1||20
10783991|NCT03437447|11944973|FG001|COMPLETED|Treatment Period 1||20
10783992|NCT03437447|11944974|FG002|COMPLETED|Treatment Period 1||19
10783993|NCT03437447|11944972|FG000|NOT COMPLETED|Treatment Period 1||0
10783994|NCT03437447|11944973|FG001|NOT COMPLETED|Treatment Period 1||0
10783995|NCT03437447|11944974|FG002|NOT COMPLETED|Treatment Period 1||1
10783996|NCT03437447|11944972|FG000|STARTED|Treatment Period 2||20
10783997|NCT03437447|11944973|FG001|STARTED|Treatment Period 2||20
10783998|NCT03437447|11944974|FG002|STARTED|Treatment Period 2||19
10783999|NCT03437447|11944972|FG000|COMPLETED|Treatment Period 2||20
10784000|NCT03437447|11944973|FG001|COMPLETED|Treatment Period 2||20
10784001|NCT03437447|11944974|FG002|COMPLETED|Treatment Period 2||19
10784002|NCT03437447|11944972|FG000|NOT COMPLETED|Treatment Period 2||0
10784003|NCT03437447|11944973|FG001|NOT COMPLETED|Treatment Period 2||0
10784004|NCT03437447|11944974|FG002|NOT COMPLETED|Treatment Period 2||0
10784005|NCT03437447|11944972|FG000|STARTED|Treatment Period 3||20
10784006|NCT03437447|11944973|FG001|STARTED|Treatment Period 3||20
10784007|NCT03437447|11944974|FG002|STARTED|Treatment Period 3||19
10784008|NCT03437447|11944972|FG000|COMPLETED|Treatment Period 3||20
10784009|NCT03437447|11944973|FG001|COMPLETED|Treatment Period 3||20
10784010|NCT03437447|11944974|FG002|COMPLETED|Treatment Period 3||19
10784011|NCT03437447|11944972|FG000|NOT COMPLETED|Treatment Period 3||0
10784012|NCT03437447|11944973|FG001|NOT COMPLETED|Treatment Period 3||0
10784013|NCT03437447|11944974|FG002|NOT COMPLETED|Treatment Period 3||0
10784014|NCT03437512|11944984|FG000|STARTED|Randomized||12
10784015|NCT03437512|11944985|FG001|STARTED|Randomized||13
10784016|NCT03437512|11944984|FG000|COMPLETED|Randomized||12
10784017|NCT03437512|11944985|FG001|COMPLETED|Randomized||11
10784018|NCT03437512|11944984|FG000|NOT COMPLETED|Randomized||0
10784019|NCT03437512|11944985|FG001|NOT COMPLETED|Randomized||2
10784020|NCT03437512|11944984|FG000|STARTED|Received First tDCS Session||12
10784021|NCT03437512|11944985|FG001|STARTED|Received First tDCS Session||11
10784022|NCT03437512|11944984|FG000|COMPLETED|Received First tDCS Session||12
10784023|NCT03437512|11944985|FG001|COMPLETED|Received First tDCS Session||11
10784024|NCT03437512|11944984|FG000|NOT COMPLETED|Received First tDCS Session||0
10784025|NCT03437512|11944985|FG001|NOT COMPLETED|Received First tDCS Session||0
10784026|NCT03437512|11944984|FG000|STARTED|Received Final tDCS Session||12
10784027|NCT03437512|11944985|FG001|STARTED|Received Final tDCS Session||11
10784028|NCT03437512|11944984|FG000|COMPLETED|Received Final tDCS Session||12
10784029|NCT03437512|11944985|FG001|COMPLETED|Received Final tDCS Session||11
10784030|NCT03437512|11944984|FG000|NOT COMPLETED|Received Final tDCS Session||0
10784031|NCT03437512|11944985|FG001|NOT COMPLETED|Received Final tDCS Session||0
10784032|NCT03437512|11944984|FG000|STARTED|Completed Study Follow up||12
10784033|NCT03437512|11944985|FG001|STARTED|Completed Study Follow up||11
10784034|NCT03437512|11944984|FG000|COMPLETED|Completed Study Follow up||10
10784035|NCT03437512|11944985|FG001|COMPLETED|Completed Study Follow up||10
10784036|NCT03437512|11944984|FG000|NOT COMPLETED|Completed Study Follow up||2
10784037|NCT03437512|11944985|FG001|NOT COMPLETED|Completed Study Follow up||1
10784038|NCT03437564|11944993|FG000|STARTED|Overall Study||14
10784039|NCT03437564|11944994|FG001|STARTED|Overall Study||14
10784040|NCT03437564|11944993|FG000|COMPLETED|Overall Study||14
10784041|NCT03437564|11944994|FG001|COMPLETED|Overall Study||14
10784042|NCT03437564|11944993|FG000|NOT COMPLETED|Overall Study||0
10784043|NCT03437564|11944994|FG001|NOT COMPLETED|Overall Study||0
10784044|NCT03437577|11945003|FG000|STARTED|Pre-Randomization||0
10784045|NCT03437577|11945004|FG001|STARTED|Pre-Randomization||0
10784046|NCT03437577|11945005|FG002|STARTED|Pre-Randomization||10
10784047|NCT03437577|11945003|FG000|COMPLETED|Pre-Randomization||0
10784048|NCT03437577|11945004|FG001|COMPLETED|Pre-Randomization||0
10784049|NCT03437577|11945005|FG002|COMPLETED|Pre-Randomization||0
10784050|NCT03437577|11945003|FG000|NOT COMPLETED|Pre-Randomization||0
10784051|NCT03437577|11945004|FG001|NOT COMPLETED|Pre-Randomization||0
10784052|NCT03437577|11945005|FG002|NOT COMPLETED|Pre-Randomization||10
10784053|NCT03437577|11945003|FG000|STARTED|Post-Randomization||3
10784054|NCT03437577|11945004|FG001|STARTED|Post-Randomization||5
10784055|NCT03437577|11945005|FG002|STARTED|Post-Randomization||0
10784056|NCT03437577|11945003|FG000|COMPLETED|Post-Randomization||3
10784057|NCT03437577|11945004|FG001|COMPLETED|Post-Randomization||3
10317126|NCT00196976|11451186|FG005|COMPLETED|Booster Study||0
10784058|NCT03437577|11945005|FG002|COMPLETED|Post-Randomization||0
10784059|NCT03437577|11945003|FG000|NOT COMPLETED|Post-Randomization||0
10317127|NCT00196976|11451187|FG006|COMPLETED|Booster Study||0
10784060|NCT03437577|11945004|FG001|NOT COMPLETED|Post-Randomization||2
10784061|NCT03437577|11945005|FG002|NOT COMPLETED|Post-Randomization||0
10784062|NCT03437733|11945013|FG000|STARTED|Overall Study||8
10784063|NCT03437733|11945014|FG001|STARTED|Overall Study||90
10317128|NCT00196976|11451188|FG007|COMPLETED|Booster Study||0
10317129|NCT00196976|11451189|FG008|COMPLETED|Booster Study||0
10317130|NCT00196976|11451190|FG009|COMPLETED|Booster Study||0
10317131|NCT00196976|11451191|FG010|COMPLETED|Booster Study||31
10317132|NCT00196976|11451192|FG011|COMPLETED|Booster Study||30
10317133|NCT00196976|11451193|FG012|COMPLETED|Booster Study||45
10317134|NCT00196976|11451194|FG013|COMPLETED|Booster Study||43
10784064|NCT03437733|11945013|FG000|Safety|Overall Study||8
10784065|NCT03437733|11945014|FG001|Safety|Overall Study||87
10784066|NCT03437733|11945013|FG000|COMPLETED|Overall Study||8
10784067|NCT03437733|11945014|FG001|COMPLETED|Overall Study||87
10784068|NCT03437733|11945013|FG000|NOT COMPLETED|Overall Study||0
10784069|NCT03437733|11945014|FG001|NOT COMPLETED|Overall Study||3
10784070|NCT03437863|11945019|FG000|STARTED|Overall Study||12
10784071|NCT03437863|11945019|FG000|COMPLETED|Overall Study||12
10784072|NCT03437863|11945019|FG000|NOT COMPLETED|Overall Study||0
10784073|NCT03438006|11945023|FG000|STARTED|Overall Study||3013
10784074|NCT03438006|11945023|FG000|COMPLETED|Overall Study||2895
10784075|NCT03438006|11945023|FG000|NOT COMPLETED|Overall Study||118
10784076|NCT03438045|11945027|FG000|STARTED|Overall Study||75
10784077|NCT03438045|11945027|FG000|COMPLETED|Overall Study||75
10784078|NCT03438045|11945027|FG000|NOT COMPLETED|Overall Study||0
10784079|NCT03438266|11945031|FG000|STARTED|Overall Study||60
10784080|NCT03438266|11945031|FG000|COMPLETED|Overall Study||60
10784081|NCT03438266|11945031|FG000|NOT COMPLETED|Overall Study||0
10784082|NCT03438383|11945039|FG000|STARTED|Overall Study||23
10784083|NCT03438383|11945040|FG001|STARTED|Overall Study||24
10784084|NCT03438383|11945039|FG000|COMPLETED|Overall Study||14
10784085|NCT03438383|11945040|FG001|COMPLETED|Overall Study||21
10784086|NCT03438383|11945039|FG000|NOT COMPLETED|Overall Study||9
10784087|NCT03438383|11945040|FG001|NOT COMPLETED|Overall Study||3
10784092|NCT03438539|11945056|FG000|STARTED|Overall Study||76
10784093|NCT03438539|11945057|FG001|STARTED|Overall Study||72
10784094|NCT03438539|11945058|FG002|STARTED|Overall Study||76
10784095|NCT03438539|11945059|FG003|STARTED|Overall Study||73
10784096|NCT03438539|11945060|FG004|STARTED|Overall Study||73
10784097|NCT03438539|11945061|FG005|STARTED|Overall Study||74
10784098|NCT03438539|11945056|FG000|COMPLETED|Overall Study||68
10784099|NCT03438539|11945057|FG001|COMPLETED|Overall Study||68
10784100|NCT03438539|11945058|FG002|COMPLETED|Overall Study||66
10784101|NCT03438539|11945059|FG003|COMPLETED|Overall Study||64
10784102|NCT03438539|11945060|FG004|COMPLETED|Overall Study||70
10784103|NCT03438539|11945061|FG005|COMPLETED|Overall Study||66
10784104|NCT03438539|11945056|FG000|NOT COMPLETED|Overall Study||8
10784105|NCT03438539|11945057|FG001|NOT COMPLETED|Overall Study||4
10784106|NCT03438539|11945058|FG002|NOT COMPLETED|Overall Study||10
10784107|NCT03438539|11945059|FG003|NOT COMPLETED|Overall Study||9
10784108|NCT03438539|11945060|FG004|NOT COMPLETED|Overall Study||3
10784109|NCT03438539|11945061|FG005|NOT COMPLETED|Overall Study||8
10784110|NCT03438578|11945077|FG000|STARTED|Overall Study||100
10784111|NCT03438578|11945078|FG001|STARTED|Overall Study||100
10784112|NCT03438578|11945077|FG000|COMPLETED|Overall Study||99
10784113|NCT03438578|11945078|FG001|COMPLETED|Overall Study||96
10784114|NCT03438578|11945077|FG000|NOT COMPLETED|Overall Study||1
10784115|NCT03438578|11945078|FG001|NOT COMPLETED|Overall Study||4
10784116|NCT03439072|11945084|FG000|STARTED|Overall Study||41
10784117|NCT03439072|11945085|FG001|STARTED|Overall Study||40
10784118|NCT03439072|11945084|FG000|COMPLETED|Overall Study|1 subject dropped before G-Pen; another after G-Pen (n=40 G-Pen; N=39 Lilly Glucagon)|39
10784119|NCT03439072|11945085|FG001|COMPLETED|Overall Study|1 subject dropped before Lilly Glucagon; 3 others after Lilly Glucagon (N=39 Lilly; N=36 G-Pen)|36
10784120|NCT03439072|11945084|FG000|NOT COMPLETED|Overall Study||2
10784121|NCT03439072|11945085|FG001|NOT COMPLETED|Overall Study||4
10784122|NCT03439137|11945093|FG000|STARTED|Overall Study||162
10784123|NCT03439137|11945094|FG001|STARTED|Overall Study||161
10784124|NCT03439137|11945093|FG000|COMPLETED|Overall Study||120
10784125|NCT03439137|11945094|FG001|COMPLETED|Overall Study||135
10784126|NCT03439137|11945093|FG000|NOT COMPLETED|Overall Study||42
10784127|NCT03439137|11945094|FG001|NOT COMPLETED|Overall Study||26
10784128|NCT03439189|11945100|FG000|STARTED|Overall Study|Subjects performed at least one Methacetin Breath Test (MBT)|343
10784129|NCT03439189|11945100|FG000|COMPLETED|Overall Study||261
10784130|NCT03439189|11945100|FG000|NOT COMPLETED|Overall Study||82
10784131|NCT03440229|11945107|FG000|STARTED|Overall Study||9
10784132|NCT03440229|11945108|FG001|STARTED|Overall Study||7
10784133|NCT03440229|11945107|FG000|COMPLETED|Overall Study||9
10784134|NCT03440229|11945108|FG001|COMPLETED|Overall Study||7
10784135|NCT03440229|11945107|FG000|NOT COMPLETED|Overall Study||0
10784136|NCT03440229|11945108|FG001|NOT COMPLETED|Overall Study||0
10784137|NCT03440320|11945118|FG000|STARTED|Overall Study||18
10784138|NCT03440320|11945119|FG001|STARTED|Overall Study||14
10784139|NCT03440320|11945118|FG000|COMPLETED|Overall Study||18
10784140|NCT03440320|11945119|FG001|COMPLETED|Overall Study||13
10784141|NCT03440320|11945118|FG000|NOT COMPLETED|Overall Study||0
10784142|NCT03440320|11945119|FG001|NOT COMPLETED|Overall Study||1
10784143|NCT03440411|11945131|FG000|STARTED|Overall Study||3
10784144|NCT03440411|11945132|FG001|STARTED|Overall Study||1
10784145|NCT03440411|11945133|FG002|STARTED|Overall Study||2
10784146|NCT03440411|11945134|FG003|STARTED|Overall Study||2
10784147|NCT03440411|11945131|FG000|COMPLETED|Overall Study||0
10317135|NCT00196976|11451181|FG000|NOT COMPLETED|Booster Study||0
10317136|NCT00196976|11451182|FG001|NOT COMPLETED|Booster Study||0
10317137|NCT00196976|11451183|FG002|NOT COMPLETED|Booster Study||0
10317138|NCT00196976|11451184|FG003|NOT COMPLETED|Booster Study||0
10317139|NCT00196976|11451185|FG004|NOT COMPLETED|Booster Study||0
10784148|NCT03440411|11945132|FG001|COMPLETED|Overall Study||0
10784149|NCT03440411|11945133|FG002|COMPLETED|Overall Study||0
10784150|NCT03440411|11945134|FG003|COMPLETED|Overall Study||0
10784151|NCT03440411|11945131|FG000|NOT COMPLETED|Overall Study||3
10784152|NCT03440411|11945132|FG001|NOT COMPLETED|Overall Study||1
10784153|NCT03440411|11945133|FG002|NOT COMPLETED|Overall Study||2
10784154|NCT03440411|11945134|FG003|NOT COMPLETED|Overall Study||2
10784155|NCT03440424|11945152|FG000|STARTED|Overall Study||8
10784156|NCT03440424|11945153|FG001|STARTED|Overall Study||8
10784157|NCT03440424|11945154|FG002|STARTED|Overall Study||8
10784158|NCT03440424|11945152|FG000|COMPLETED|Overall Study||8
10784159|NCT03440424|11945153|FG001|COMPLETED|Overall Study||8
10784160|NCT03440424|11945154|FG002|COMPLETED|Overall Study||8
10784161|NCT03440424|11945152|FG000|NOT COMPLETED|Overall Study||0
10784162|NCT03440424|11945153|FG001|NOT COMPLETED|Overall Study||0
10784163|NCT03440424|11945154|FG002|NOT COMPLETED|Overall Study||0
10784164|NCT03440619|11945162|FG000|STARTED|Overall Study||28
10784165|NCT03440619|11945162|FG000|COMPLETED|Overall Study||28
10784166|NCT03440619|11945162|FG000|NOT COMPLETED|Overall Study||0
10784167|NCT03440723|11945168|FG000|STARTED|Overall Study||21
10784168|NCT03440723|11945169|FG001|STARTED|Overall Study||21
10784169|NCT03440723|11945168|FG000|COMPLETED|Overall Study||21
10784170|NCT03440723|11945169|FG001|COMPLETED|Overall Study||21
10784171|NCT03440723|11945168|FG000|NOT COMPLETED|Overall Study||0
10784172|NCT03440723|11945169|FG001|NOT COMPLETED|Overall Study||0
10784173|NCT03440918|11945178|FG000|STARTED|Overall Study||133
10784174|NCT03440918|11945179|FG001|STARTED|Overall Study||138
10784175|NCT03440918|11945178|FG000|COMPLETED|Overall Study||133
10784176|NCT03440918|11945179|FG001|COMPLETED|Overall Study||122
10784177|NCT03440918|11945178|FG000|NOT COMPLETED|Overall Study||0
10784178|NCT03440918|11945179|FG001|NOT COMPLETED|Overall Study||16
10784179|NCT03440944|11945187|FG000|STARTED|Overall Study||9
10784180|NCT03440944|11945188|FG001|STARTED|Overall Study||9
10784181|NCT03440944|11945187|FG000|COMPLETED|Overall Study||8
10784182|NCT03440944|11945188|FG001|COMPLETED|Overall Study||8
10784183|NCT03440944|11945187|FG000|NOT COMPLETED|Overall Study||1
10784184|NCT03440944|11945188|FG001|NOT COMPLETED|Overall Study||1
10784185|NCT03441178|11945195|FG000|STARTED|Overall Study||36
10784186|NCT03441178|11945196|FG001|STARTED|Overall Study||44
10784187|NCT03441178|11945197|FG002|STARTED|Overall Study||21
10784188|NCT03441178|11945195|FG000|COMPLETED|Overall Study||36
10784189|NCT03441178|11945196|FG001|COMPLETED|Overall Study||43
10784190|NCT03441178|11945197|FG002|COMPLETED|Overall Study||20
10784191|NCT03441178|11945195|FG000|NOT COMPLETED|Overall Study||0
10784192|NCT03441178|11945196|FG001|NOT COMPLETED|Overall Study||1
10784193|NCT03441178|11945197|FG002|NOT COMPLETED|Overall Study||1
10784194|NCT03441269|11945210|FG000|STARTED|Overall Study||75
10784195|NCT03441269|11945211|FG001|STARTED|Overall Study||75
10784196|NCT03441269|11945212|FG002|STARTED|Overall Study||75
10784197|NCT03441269|11945210|FG000|COMPLETED|Overall Study||75
10784198|NCT03441269|11945211|FG001|COMPLETED|Overall Study||74
10784199|NCT03441269|11945212|FG002|COMPLETED|Overall Study||74
10784200|NCT03441269|11945210|FG000|NOT COMPLETED|Overall Study||0
10784201|NCT03441269|11945211|FG001|NOT COMPLETED|Overall Study||1
10784202|NCT03441269|11945212|FG002|NOT COMPLETED|Overall Study||1
10784203|NCT03441581|11945222|FG000|STARTED|Overall Study||12
10784204|NCT03441581|11945223|FG001|STARTED|Overall Study||12
10784205|NCT03441581|11945222|FG000|COMPLETED|Overall Study||12
10784206|NCT03441581|11945223|FG001|COMPLETED|Overall Study||12
10784207|NCT03441581|11945222|FG000|NOT COMPLETED|Overall Study||0
10317140|NCT00196976|11451186|FG005|NOT COMPLETED|Booster Study||0
10317141|NCT00196976|11451187|FG006|NOT COMPLETED|Booster Study||0
10784208|NCT03441581|11945223|FG001|NOT COMPLETED|Overall Study||0
10784209|NCT03441594|11945229|FG000|STARTED|Overall Study||56
10784210|NCT03441594|11945229|FG000|COMPLETED|Overall Study||56
10784211|NCT03441594|11945229|FG000|NOT COMPLETED|Overall Study||0
10810566|NCT03796182|11972329|FG001|NOT COMPLETED|Period 1||0
10810567|NCT03796182|11972328|FG000|STARTED|Washout Period||6
10810568|NCT03796182|11972329|FG001|STARTED|Washout Period||6
10810569|NCT03796182|11972328|FG000|COMPLETED|Washout Period||6
10810570|NCT03796182|11972329|FG001|COMPLETED|Washout Period||6
10810571|NCT03796182|11972328|FG000|NOT COMPLETED|Washout Period||0
10810572|NCT03796182|11972329|FG001|NOT COMPLETED|Washout Period||0
10810573|NCT03796182|11972328|FG000|STARTED|Period 2||6
10810574|NCT03796182|11972329|FG001|STARTED|Period 2||6
10784212|NCT03441633|11945243|FG000|STARTED|Overall Study||4712
10784213|NCT03441633|11945244|FG001|STARTED|Overall Study||1423
10784214|NCT03441633|11945245|FG002|STARTED|Overall Study||32212
10784215|NCT03441633|11945246|FG003|STARTED|Overall Study||192
10784216|NCT03441633|11945247|FG004|STARTED|Overall Study||2286
10317142|NCT00196976|11451188|FG007|NOT COMPLETED|Booster Study||0
10317143|NCT00196976|11451189|FG008|NOT COMPLETED|Booster Study||0
10317144|NCT00196976|11451190|FG009|NOT COMPLETED|Booster Study||0
10317145|NCT00196976|11451191|FG010|NOT COMPLETED|Booster Study||2
10317146|NCT00196976|11451192|FG011|NOT COMPLETED|Booster Study||2
10317147|NCT00196976|11451193|FG012|NOT COMPLETED|Booster Study||0
10317148|NCT00196976|11451194|FG013|NOT COMPLETED|Booster Study||0
10317149|NCT00197002|11451237|FG000|STARTED|Overall Study||147
10317150|NCT00197002|11451238|FG001|STARTED|Overall Study||137
10317151|NCT00197002|11451239|FG002|STARTED|Overall Study||149
10317152|NCT00197002|11451237|FG000|COMPLETED|Overall Study||125
10317153|NCT00197002|11451238|FG001|COMPLETED|Overall Study||119
10317154|NCT00197002|11451239|FG002|COMPLETED|Overall Study||132
10317155|NCT00197002|11451237|FG000|NOT COMPLETED|Overall Study||22
10317156|NCT00197002|11451238|FG001|NOT COMPLETED|Overall Study||18
10317157|NCT00197002|11451239|FG002|NOT COMPLETED|Overall Study||17
10317158|NCT00197015|11451253|FG000|STARTED|Overall Study||324
10317159|NCT00197015|11451254|FG001|STARTED|Overall Study||455
10317160|NCT00197015|11451255|FG002|STARTED|Overall Study||462
10317161|NCT00197015|11451253|FG000|COMPLETED|Overall Study||274
10317162|NCT00197015|11451254|FG001|COMPLETED|Overall Study||366
10317163|NCT00197015|11451255|FG002|COMPLETED|Overall Study||385
10317164|NCT00197015|11451253|FG000|NOT COMPLETED|Overall Study||50
10317165|NCT00197015|11451254|FG001|NOT COMPLETED|Overall Study||89
10317166|NCT00197015|11451255|FG002|NOT COMPLETED|Overall Study||77
10317167|NCT00197028|11451265|FG000|STARTED|Overall Study||107
10317168|NCT00197028|11451266|FG001|STARTED|Overall Study||107
10317169|NCT00197028|11451265|FG000|COMPLETED|Overall Study||91
10317170|NCT00197028|11451266|FG001|COMPLETED|Overall Study||86
10317171|NCT00197028|11451265|FG000|NOT COMPLETED|Overall Study||16
10317172|NCT00197028|11451266|FG001|NOT COMPLETED|Overall Study||21
10317173|NCT00197054|11451275|FG000|STARTED|Overall Study||85
10317174|NCT00197054|11451276|FG001|STARTED|Overall Study||85
10317175|NCT00197054|11451277|FG002|STARTED|Overall Study||85
10317176|NCT00197054|11451275|FG000|COMPLETED|Overall Study||68
10317177|NCT00197054|11451276|FG001|COMPLETED|Overall Study||64
10317178|NCT00197054|11451277|FG002|COMPLETED|Overall Study||73
10317179|NCT00197054|11451275|FG000|NOT COMPLETED|Overall Study||17
10317180|NCT00197054|11451276|FG001|NOT COMPLETED|Overall Study||21
10317181|NCT00197054|11451277|FG002|NOT COMPLETED|Overall Study||12
10317182|NCT00197106|11451297|FG000|STARTED|4-Week Run-In Period||257
10317183|NCT00197106|11451298|FG001|STARTED|4-Week Run-In Period||0
10317184|NCT00197106|11451299|FG002|STARTED|4-Week Run-In Period||0
10317185|NCT00197106|11451297|FG000|COMPLETED|4-Week Run-In Period||158
10317186|NCT00197106|11451298|FG001|COMPLETED|4-Week Run-In Period||0
10317187|NCT00197106|11451299|FG002|COMPLETED|4-Week Run-In Period||0
10317188|NCT00197106|11451297|FG000|NOT COMPLETED|4-Week Run-In Period||99
10317189|NCT00197106|11451298|FG001|NOT COMPLETED|4-Week Run-In Period||0
10317190|NCT00197106|11451299|FG002|NOT COMPLETED|4-Week Run-In Period||0
10317191|NCT00197106|11451297|FG000|STARTED|Overall Treatment Period||0
10317192|NCT00197106|11451298|FG001|STARTED|Overall Treatment Period||78
10317193|NCT00197106|11451299|FG002|STARTED|Overall Treatment Period||80
10317194|NCT00197106|11451297|FG000|COMPLETED|Overall Treatment Period||0
10317195|NCT00197106|11451298|FG001|COMPLETED|Overall Treatment Period||77
10317196|NCT00197106|11451299|FG002|COMPLETED|Overall Treatment Period||74
10317197|NCT00197106|11451297|FG000|NOT COMPLETED|Overall Treatment Period||0
10317198|NCT00197106|11451298|FG001|NOT COMPLETED|Overall Treatment Period||1
10317199|NCT00197106|11451299|FG002|NOT COMPLETED|Overall Treatment Period||6
10317200|NCT00197119|11451307|FG000|STARTED|Year 6||126
10317201|NCT00197119|11451308|FG001|STARTED|Year 6||118
10317202|NCT00197119|11451307|FG000|COMPLETED|Year 6||126
10317203|NCT00197119|11451308|FG001|COMPLETED|Year 6||118
10317204|NCT00197119|11451307|FG000|NOT COMPLETED|Year 6||0
10317205|NCT00197119|11451308|FG001|NOT COMPLETED|Year 6||0
10317206|NCT00197119|11451307|FG000|STARTED|Year 7|4 subjects who participated in the Year 6 follow-up time point did not return for this time point.|122
10317207|NCT00197119|11451308|FG001|STARTED|Year 7|4 subjects who participated in the Year 6 follow-up time point did not return for this time point.|114
10317208|NCT00197119|11451307|FG000|COMPLETED|Year 7||122
10317209|NCT00197119|11451308|FG001|COMPLETED|Year 7||114
10317210|NCT00197119|11451307|FG000|NOT COMPLETED|Year 7||0
10317211|NCT00197119|11451308|FG001|NOT COMPLETED|Year 7||0
10317212|NCT00197119|11451307|FG000|STARTED|Year 8||122
10317213|NCT00197119|11451308|FG001|STARTED|Year 8|One additional subject (compared to Year 7) participated in the current follow-up time point.|115
10317214|NCT00197119|11451307|FG000|COMPLETED|Year 8||122
10317215|NCT00197119|11451308|FG001|COMPLETED|Year 8||115
10317216|NCT00197119|11451307|FG000|NOT COMPLETED|Year 8||0
10784217|NCT03441633|11945248|FG005|STARTED|Overall Study||363
10784218|NCT03441633|11945249|FG006|STARTED|Overall Study||2855
10784219|NCT03441633|11945250|FG007|STARTED|Overall Study||953
10784220|NCT03441633|11945251|FG008|STARTED|Overall Study||5132
10317217|NCT00197119|11451308|FG001|NOT COMPLETED|Year 8||0
10317218|NCT00197119|11451307|FG000|STARTED|Year 9|One subject participating in the Year 8 time point did not return for the current time point.|121
10338363|NCT00369564|11475247|FG001|NOT COMPLETED|Overall Study||23
10784221|NCT03441633|11945252|FG009|STARTED|Overall Study||1562
10784222|NCT03441633|11945243|FG000|COMPLETED|Overall Study||4712
10317219|NCT00197119|11451308|FG001|STARTED|Year 9|One subject participating in the Year 8 time point did not return for the current time point.|114
10432964|NCT00883493|11579270|FG000|Intention To Treat Analysis Population|Overall Study||204
10432965|NCT00883493|11579271|FG001|Intention To Treat Analysis Population|Overall Study||195
10432966|NCT00883493|11579270|FG000|Per Protocol Analysis Population|Overall Study||162
10432967|NCT00883493|11579271|FG001|Per Protocol Analysis Population|Overall Study||155
10432968|NCT00883493|11579270|FG000|COMPLETED|Overall Study||166
10432969|NCT00883493|11579271|FG001|COMPLETED|Overall Study||159
10432970|NCT00883493|11579270|FG000|NOT COMPLETED|Overall Study||46
10432971|NCT00883493|11579271|FG001|NOT COMPLETED|Overall Study||50
10432972|NCT00883558|11579277|FG000|STARTED|Titration Period (Weeks 0 to 4)||48
10432973|NCT00883558|11579278|FG001|STARTED|Titration Period (Weeks 0 to 4)||0
10432974|NCT00883558|11579279|FG002|STARTED|Titration Period (Weeks 0 to 4)||0
10432975|NCT00883558|11579277|FG000|COMPLETED|Titration Period (Weeks 0 to 4)||46
10432976|NCT00883558|11579278|FG001|COMPLETED|Titration Period (Weeks 0 to 4)||0
10432977|NCT00883558|11579279|FG002|COMPLETED|Titration Period (Weeks 0 to 4)||0
10432978|NCT00883558|11579277|FG000|NOT COMPLETED|Titration Period (Weeks 0 to 4)||2
10432979|NCT00883558|11579278|FG001|NOT COMPLETED|Titration Period (Weeks 0 to 4)||0
10432980|NCT00883558|11579279|FG002|NOT COMPLETED|Titration Period (Weeks 0 to 4)||0
10432981|NCT00883558|11579277|FG000|STARTED|First Treatment Cycle (Weeks 4 to 16)||0
10432982|NCT00883558|11579278|FG001|STARTED|First Treatment Cycle (Weeks 4 to 16)||22
10432983|NCT00883558|11579279|FG002|STARTED|First Treatment Cycle (Weeks 4 to 16)||24
10432984|NCT00883558|11579277|FG000|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||0
10432985|NCT00883558|11579278|FG001|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||22
10432986|NCT00883558|11579279|FG002|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||24
10432987|NCT00883558|11579277|FG000|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||0
10432988|NCT00883558|11579278|FG001|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||19
10432989|NCT00883558|11579279|FG002|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||23
10432990|NCT00883558|11579277|FG000|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||0
10432991|NCT00883558|11579278|FG001|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||3
10432992|NCT00883558|11579279|FG002|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||1
10432993|NCT00883558|11579277|FG000|STARTED|Second Treatment Cycle (Weeks 16 to 28)||0
10432994|NCT00883558|11579278|FG001|STARTED|Second Treatment Cycle (Weeks 16 to 28)||19
10432995|NCT00883558|11579279|FG002|STARTED|Second Treatment Cycle (Weeks 16 to 28)||23
10432996|NCT00883558|11579277|FG000|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||0
10432997|NCT00883558|11579278|FG001|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||19
10432998|NCT00883558|11579279|FG002|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||23
10432999|NCT00883558|11579277|FG000|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
10433000|NCT00883558|11579278|FG001|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||19
10433001|NCT00883558|11579279|FG002|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||22
10433002|NCT00883558|11579277|FG000|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
10433003|NCT00883558|11579278|FG001|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
10433004|NCT00883558|11579279|FG002|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||1
10525212|NCT01374178|11677073|FG000|Received at Least 1 Dose of LY2963016|Period 1 (up to 24 Hours After Dosing)||11
10525213|NCT01374178|11677074|FG001|Received at Least 1 Dose of LY2963016|Period 1 (up to 24 Hours After Dosing)||5
10525214|NCT01374178|11677073|FG000|COMPLETED|Period 1 (up to 24 Hours After Dosing)||11
10525215|NCT01374178|11677074|FG001|COMPLETED|Period 1 (up to 24 Hours After Dosing)||5
10525216|NCT01374178|11677073|FG000|NOT COMPLETED|Period 1 (up to 24 Hours After Dosing)||0
10525217|NCT01374178|11677074|FG001|NOT COMPLETED|Period 1 (up to 24 Hours After Dosing)||0
10525218|NCT01374178|11677073|FG000|STARTED|Washout Period of at Least 7 Days||11
10525219|NCT01374178|11677074|FG001|STARTED|Washout Period of at Least 7 Days||5
10525220|NCT01374178|11677073|FG000|COMPLETED|Washout Period of at Least 7 Days||10
10525221|NCT01374178|11677074|FG001|COMPLETED|Washout Period of at Least 7 Days||5
10525222|NCT01374178|11677073|FG000|NOT COMPLETED|Washout Period of at Least 7 Days||1
10525223|NCT01374178|11677074|FG001|NOT COMPLETED|Washout Period of at Least 7 Days||0
10317220|NCT00197119|11451307|FG000|COMPLETED|Year 9||121
10317221|NCT00197119|11451308|FG001|COMPLETED|Year 9||114
10317222|NCT00197119|11451307|FG000|NOT COMPLETED|Year 9||0
10317223|NCT00197119|11451308|FG001|NOT COMPLETED|Year 9||0
10317224|NCT00197119|11451307|FG000|STARTED|Year 10|One subject participating in the Year 9 time point did not return for the current time point.|120
10317225|NCT00197119|11451308|FG001|STARTED|Year 10|Six subjects participating in the Year 9 time point did not return for the current time point.|108
10317226|NCT00197119|11451307|FG000|COMPLETED|Year 10||120
10317227|NCT00197119|11451308|FG001|COMPLETED|Year 10||108
10317228|NCT00197119|11451307|FG000|NOT COMPLETED|Year 10||0
10317229|NCT00197119|11451308|FG001|NOT COMPLETED|Year 10||0
10317230|NCT00197145|11451316|FG000|STARTED|Period 1: Randomized Treatment Phase||13
10317231|NCT00197145|11451317|FG001|STARTED|Period 1: Randomized Treatment Phase||11
10317232|NCT00197145|11451316|FG000|COMPLETED|Period 1: Randomized Treatment Phase||0
10317233|NCT00197145|11451317|FG001|COMPLETED|Period 1: Randomized Treatment Phase||0
10317234|NCT00197145|11451316|FG000|NOT COMPLETED|Period 1: Randomized Treatment Phase||13
10317235|NCT00197145|11451317|FG001|NOT COMPLETED|Period 1: Randomized Treatment Phase||11
10317236|NCT00197145|11451316|FG000|STARTED|Period 2 : Open Label Phase||10
10317237|NCT00197145|11451317|FG001|STARTED|Period 2 : Open Label Phase||0
10317238|NCT00197145|11451316|FG000|COMPLETED|Period 2 : Open Label Phase||0
10317239|NCT00197145|11451317|FG001|COMPLETED|Period 2 : Open Label Phase||0
10317240|NCT00197145|11451316|FG000|NOT COMPLETED|Period 2 : Open Label Phase||10
10317241|NCT00197145|11451317|FG001|NOT COMPLETED|Period 2 : Open Label Phase||0
10317242|NCT00197184|11451326|FG000|STARTED|Overall Study||139
10317243|NCT00197184|11451327|FG001|STARTED|Overall Study||137
10317244|NCT00197184|11451326|FG000|COMPLETED|Overall Study||139
10317245|NCT00197184|11451327|FG001|COMPLETED|Overall Study||137
10317246|NCT00197184|11451326|FG000|NOT COMPLETED|Overall Study||0
10317247|NCT00197184|11451327|FG001|NOT COMPLETED|Overall Study||0
10317248|NCT00197236|11451336|FG000|STARTED|Overall Study||135
10317249|NCT00197236|11451337|FG001|STARTED|Overall Study||127
10317250|NCT00197236|11451338|FG002|STARTED|Overall Study||132
10317251|NCT00197236|11451336|FG000|COMPLETED|Overall Study||121
10317252|NCT00197236|11451337|FG001|COMPLETED|Overall Study||110
10317253|NCT00197236|11451338|FG002|COMPLETED|Overall Study||109
10317254|NCT00197236|11451336|FG000|NOT COMPLETED|Overall Study||14
10317255|NCT00197236|11451337|FG001|NOT COMPLETED|Overall Study||17
10317256|NCT00197236|11451338|FG002|NOT COMPLETED|Overall Study||23
10317257|NCT00197392|11451351|FG000|STARTED|Overall Study||214
10317258|NCT00197392|11451352|FG001|STARTED|Overall Study||220
10317259|NCT00197392|11451351|FG000|Safety Population|Overall Study||214
10317260|NCT00197392|11451352|FG001|Safety Population|Overall Study||220
10317261|NCT00197392|11451351|FG000|Modified Intent to Treat|Overall Study||209
10317262|NCT00197392|11451352|FG001|Modified Intent to Treat|Overall Study||210
10317263|NCT00197392|11451351|FG000|Evaluable|Overall Study||176
10317264|NCT00197392|11451352|FG001|Evaluable|Overall Study||181
10317265|NCT00197392|11451351|FG000|Per Protocol|Overall Study||126
10317266|NCT00197392|11451352|FG001|Per Protocol|Overall Study||134
10317267|NCT00197392|11451351|FG000|COMPLETED|Overall Study||126
10317268|NCT00197392|11451352|FG001|COMPLETED|Overall Study||134
10317269|NCT00197392|11451351|FG000|NOT COMPLETED|Overall Study||88
10317270|NCT00197392|11451352|FG001|NOT COMPLETED|Overall Study||86
10317271|NCT00197496|11451376|FG000|STARTED|Baseline to Discharge||14
10317272|NCT00197496|11451377|FG001|STARTED|Baseline to Discharge||7
10317273|NCT00197496|11451376|FG000|COMPLETED|Baseline to Discharge||12
10317274|NCT00197496|11451377|FG001|COMPLETED|Baseline to Discharge||5
10317275|NCT00197496|11451376|FG000|NOT COMPLETED|Baseline to Discharge||2
10317276|NCT00197496|11451377|FG001|NOT COMPLETED|Baseline to Discharge||2
10317277|NCT00197496|11451376|FG000|STARTED|Follow-up||12
10317278|NCT00197496|11451377|FG001|STARTED|Follow-up||5
10317279|NCT00197496|11451376|FG000|COMPLETED|Follow-up||10
10317280|NCT00197496|11451377|FG001|COMPLETED|Follow-up||4
10317281|NCT00197496|11451376|FG000|NOT COMPLETED|Follow-up||2
10317282|NCT00197496|11451377|FG001|NOT COMPLETED|Follow-up||1
10317283|NCT00198029|11451383|FG000|STARTED|Overall Study||32
10317284|NCT00198029|11451383|FG000|COMPLETED|Overall Study||28
10317285|NCT00198029|11451383|FG000|NOT COMPLETED|Overall Study||4
10317286|NCT00198042|11451387|FG000|STARTED|Overall Study||18
10317287|NCT00198042|11451387|FG000|COMPLETED|Overall Study||18
10317288|NCT00198042|11451387|FG000|NOT COMPLETED|Overall Study||0
10317289|NCT00198081|11451393|FG000|STARTED|Overall Study|Eight (8) persons consented to participate but 3 withdrew prior to beginning protocol treatment.|5
10317290|NCT00198081|11451394|FG001|STARTED|Overall Study|No enrollment on this arm.|0
10317291|NCT00198081|11451393|FG000|COMPLETED|Overall Study||4
10317292|NCT00198081|11451394|FG001|COMPLETED|Overall Study|No enrollment on this arm.|0
10317293|NCT00198081|11451393|FG000|NOT COMPLETED|Overall Study||1
10317294|NCT00198081|11451394|FG001|NOT COMPLETED|Overall Study||0
10317295|NCT00198107|11451407|FG000|STARTED|Double-Blind Period||41
10317296|NCT00198107|11451408|FG001|STARTED|Double-Blind Period||40
10317297|NCT00198107|11451409|FG002|STARTED|Double-Blind Period||0
10317298|NCT00198107|11451407|FG000|1 or More Follow-up Visits|Double-Blind Period||40
10317299|NCT00198107|11451408|FG001|1 or More Follow-up Visits|Double-Blind Period||38
10317300|NCT00198107|11451409|FG002|1 or More Follow-up Visits|Double-Blind Period||0
10317301|NCT00198107|11451407|FG000|COMPLETED|Double-Blind Period||35
10317302|NCT00198107|11451408|FG001|COMPLETED|Double-Blind Period||37
10317303|NCT00198107|11451409|FG002|COMPLETED|Double-Blind Period||0
10317304|NCT00198107|11451407|FG000|NOT COMPLETED|Double-Blind Period||6
10317305|NCT00198107|11451408|FG001|NOT COMPLETED|Double-Blind Period||3
10317306|NCT00198107|11451409|FG002|NOT COMPLETED|Double-Blind Period||0
10317307|NCT00198107|11451407|FG000|STARTED|Pilot Add-On Aripiprazole +D-cycloserine||0
10317308|NCT00198107|11451408|FG001|STARTED|Pilot Add-On Aripiprazole +D-cycloserine||0
10317309|NCT00198107|11451409|FG002|STARTED|Pilot Add-On Aripiprazole +D-cycloserine||10
10317310|NCT00198107|11451407|FG000|COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
10317311|NCT00198107|11451408|FG001|COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
10317312|NCT00198107|11451409|FG002|COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||8
10317313|NCT00198107|11451407|FG000|NOT COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
10317314|NCT00198107|11451408|FG001|NOT COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
10317315|NCT00198107|11451409|FG002|NOT COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||2
10317316|NCT00198133|11451419|FG000|STARTED|Overall Study||16
10317317|NCT00198133|11451420|FG001|STARTED|Overall Study||11
10317318|NCT00198133|11451419|FG000|COMPLETED|Overall Study||11
10317319|NCT00198133|11451420|FG001|COMPLETED|Overall Study||3
10317320|NCT00198133|11451419|FG000|NOT COMPLETED|Overall Study||5
10317321|NCT00198133|11451420|FG001|NOT COMPLETED|Overall Study||8
10317322|NCT00198822|11451429|FG000|STARTED|Overall Study|No. of consenting pregnant women in the placebo arm of trial cohort|19876
10317323|NCT00198822|11451430|FG001|STARTED|Overall Study|No. of consenting pregnant women in the vitamin A arm of trial cohort|19826
10317324|NCT00198822|11451431|FG002|STARTED|Overall Study|No. of consenting pregnant women in the beta-catorene arm of trial cohort|20019
10317325|NCT00198822|11451429|FG000|COMPLETED|Overall Study|No. of consented pregnant women in placebo arm with vital status known at 12 weeks postpartum|19862
10317326|NCT00198822|11451430|FG001|COMPLETED|Overall Study|No. of consented pregnant women in vitamin A arm with vital status known at 12 weeks postpartum|19806
10317327|NCT00198822|11451431|FG002|COMPLETED|Overall Study|No. of consented pregnant women in beta-catorene arm with vital status known at 12 weeks postpartum|19998
10317328|NCT00198822|11451429|FG000|NOT COMPLETED|Overall Study||14
10317329|NCT00198822|11451430|FG001|NOT COMPLETED|Overall Study||20
10317330|NCT00198822|11451431|FG002|NOT COMPLETED|Overall Study||21
10317331|NCT00199381|11451439|FG000|STARTED|Overall Study||504
10317332|NCT00199381|11451439|FG000|COMPLETED|Overall Study|Premature study termination by the Sponsor.|0
10317333|NCT00199381|11451439|FG000|NOT COMPLETED|Overall Study||504
10317334|NCT00199797|11451443|FG000|STARTED|Overall Study||20
10317335|NCT00199797|11451443|FG000|COMPLETED|Overall Study||17
10317336|NCT00199797|11451443|FG000|NOT COMPLETED|Overall Study||3
10317337|NCT00199836|11451448|FG000|STARTED|Overall Study||14
10317338|NCT00199836|11451448|FG000|COMPLETED|Overall Study||8
10317339|NCT00199836|11451448|FG000|NOT COMPLETED|Overall Study||6
10317340|NCT00199849|11451456|FG000|STARTED|Overall Study||3
10317341|NCT00199849|11451457|FG001|STARTED|Overall Study||7
10317342|NCT00199849|11451458|FG002|STARTED|Overall Study||8
10317343|NCT00199849|11451456|FG000|COMPLETED|Overall Study||3
10317344|NCT00199849|11451457|FG001|COMPLETED|Overall Study||6
10317345|NCT00199849|11451458|FG002|COMPLETED|Overall Study||6
10317346|NCT00199849|11451456|FG000|NOT COMPLETED|Overall Study||0
10317347|NCT00199849|11451457|FG001|NOT COMPLETED|Overall Study||1
10317348|NCT00199849|11451458|FG002|NOT COMPLETED|Overall Study||2
10317349|NCT00199875|11451471|FG000|STARTED|Overall Study||3
10317350|NCT00199875|11451472|FG001|STARTED|Overall Study||3
10317351|NCT00199875|11451473|FG002|STARTED|Overall Study||6
10317352|NCT00199875|11451474|FG003|STARTED|Overall Study||3
10317353|NCT00199875|11451475|FG004|STARTED|Overall Study||3
10317354|NCT00199875|11451471|FG000|COMPLETED|Overall Study||3
10317355|NCT00199875|11451472|FG001|COMPLETED|Overall Study||3
10433005|NCT00883675|11579285|FG000|STARTED|Overall Study||133
10433006|NCT00883675|11579285|FG000|COMPLETED|Overall Study||133
10433007|NCT00883675|11579285|FG000|NOT COMPLETED|Overall Study||0
10433008|NCT00883688|11579289|FG000|STARTED|Overall Study||24
10433009|NCT00883688|11579289|FG000|COMPLETED|Overall Study||22
10433010|NCT00883688|11579289|FG000|NOT COMPLETED|Overall Study||2
10433011|NCT00883740|11579293|FG000|STARTED|First Intervention||60
10433012|NCT00883740|11579294|FG001|STARTED|First Intervention||59
10433013|NCT00883740|11579293|FG000|COMPLETED|First Intervention|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|53
10433014|NCT00883740|11579294|FG001|COMPLETED|First Intervention||51
10433015|NCT00883740|11579293|FG000|NOT COMPLETED|First Intervention||7
10433016|NCT00883740|11579294|FG001|NOT COMPLETED|First Intervention||8
10433017|NCT00883740|11579293|FG000|STARTED|Taper and Washout Period (2 Weeks)|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|54
10433018|NCT00883740|11579294|FG001|STARTED|Taper and Washout Period (2 Weeks)||51
10433019|NCT00883740|11579293|FG000|COMPLETED|Taper and Washout Period (2 Weeks)||54
10433020|NCT00883740|11579294|FG001|COMPLETED|Taper and Washout Period (2 Weeks)||51
10433021|NCT00883740|11579293|FG000|NOT COMPLETED|Taper and Washout Period (2 Weeks)||0
10433022|NCT00883740|11579294|FG001|NOT COMPLETED|Taper and Washout Period (2 Weeks)||0
10433023|NCT00883740|11579293|FG000|STARTED|Second Intervention|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|53
10433024|NCT00883740|11579294|FG001|STARTED|Second Intervention||51
10433025|NCT00883740|11579293|FG000|COMPLETED|Second Intervention||52
10784223|NCT03441633|11945244|FG001|COMPLETED|Overall Study||1423
10784224|NCT03441633|11945245|FG002|COMPLETED|Overall Study||32212
10784225|NCT03441633|11945246|FG003|COMPLETED|Overall Study||192
10784226|NCT03441633|11945247|FG004|COMPLETED|Overall Study||2286
10784227|NCT03441633|11945248|FG005|COMPLETED|Overall Study||363
10784228|NCT03441633|11945249|FG006|COMPLETED|Overall Study||2855
10784229|NCT03441633|11945250|FG007|COMPLETED|Overall Study||953
10784230|NCT03441633|11945251|FG008|COMPLETED|Overall Study||5132
10784231|NCT03441633|11945252|FG009|COMPLETED|Overall Study||1562
10784232|NCT03441633|11945243|FG000|NOT COMPLETED|Overall Study||0
10784233|NCT03441633|11945244|FG001|NOT COMPLETED|Overall Study||0
10784234|NCT03441633|11945245|FG002|NOT COMPLETED|Overall Study||0
10317356|NCT00199875|11451473|FG002|COMPLETED|Overall Study||6
10317357|NCT00199875|11451474|FG003|COMPLETED|Overall Study||3
10317358|NCT00199875|11451475|FG004|COMPLETED|Overall Study||2
10317359|NCT00199875|11451471|FG000|NOT COMPLETED|Overall Study||0
10317360|NCT00199875|11451472|FG001|NOT COMPLETED|Overall Study||0
10317361|NCT00199875|11451473|FG002|NOT COMPLETED|Overall Study||0
10317362|NCT00199875|11451474|FG003|NOT COMPLETED|Overall Study||0
10433026|NCT00883740|11579294|FG001|COMPLETED|Second Intervention||50
10784235|NCT03441633|11945246|FG003|NOT COMPLETED|Overall Study||0
10784236|NCT03441633|11945247|FG004|NOT COMPLETED|Overall Study||0
10784237|NCT03441633|11945248|FG005|NOT COMPLETED|Overall Study||0
10317363|NCT00199875|11451475|FG004|NOT COMPLETED|Overall Study||1
10317364|NCT00199888|11451487|FG000|STARTED|Overall Study||26
10784238|NCT03441633|11945249|FG006|NOT COMPLETED|Overall Study||0
10784239|NCT03441633|11945250|FG007|NOT COMPLETED|Overall Study||0
10784240|NCT03441633|11945251|FG008|NOT COMPLETED|Overall Study||0
10317365|NCT00199888|11451487|FG000|COMPLETED|Overall Study||25
10317366|NCT00199888|11451487|FG000|NOT COMPLETED|Overall Study||1
10317367|NCT00199901|11451493|FG000|STARTED|Overall Study||56
10317368|NCT00199901|11451494|FG001|STARTED|Overall Study||54
10317369|NCT00199901|11451493|FG000|COMPLETED|Overall Study||29
10317370|NCT00199901|11451494|FG001|COMPLETED|Overall Study||30
10317371|NCT00199901|11451493|FG000|NOT COMPLETED|Overall Study||27
10317372|NCT00199901|11451494|FG001|NOT COMPLETED|Overall Study||24
10317373|NCT00199914|11451504|FG000|STARTED|Overall Study||53
10317374|NCT00199914|11451505|FG001|STARTED|Overall Study||60
10317375|NCT00199914|11451504|FG000|COMPLETED|Overall Study||50
10317376|NCT00199914|11451505|FG001|COMPLETED|Overall Study||54
10317377|NCT00199914|11451504|FG000|NOT COMPLETED|Overall Study||3
10317378|NCT00199914|11451505|FG001|NOT COMPLETED|Overall Study||6
10317379|NCT00200057|11451511|FG000|STARTED|Overall Study||120
10317380|NCT00200057|11451511|FG000|1 Month Follow-up|Overall Study||117
10317381|NCT00200057|11451511|FG000|3 Month Follow-up|Overall Study||116
10317382|NCT00200057|11451511|FG000|6 Month Follow-up|Overall Study||114
10317383|NCT00200057|11451511|FG000|12 Month Follow-up|Overall Study||111
10317384|NCT00200057|11451511|FG000|COMPLETED|Overall Study||111
10317385|NCT00200057|11451511|FG000|NOT COMPLETED|Overall Study||9
10317386|NCT00200161|11451517|FG000|STARTED|Overall Study||43
10317387|NCT00200161|11451518|FG001|STARTED|Overall Study||42
10317388|NCT00200161|11451517|FG000|COMPLETED|Overall Study||43
10317389|NCT00200161|11451518|FG001|COMPLETED|Overall Study||42
10317390|NCT00200161|11451517|FG000|NOT COMPLETED|Overall Study||0
10317391|NCT00200161|11451518|FG001|NOT COMPLETED|Overall Study||0
10317392|NCT00200343|11451527|FG000|STARTED|Overall Study||199
10317393|NCT00200343|11451528|FG001|STARTED|Overall Study||200
10317394|NCT00200343|11451529|FG002|STARTED|Overall Study||197
10317395|NCT00200343|11451527|FG000|COMPLETED|Overall Study||183
10317396|NCT00200343|11451528|FG001|COMPLETED|Overall Study||192
10317397|NCT00200343|11451529|FG002|COMPLETED|Overall Study||184
10317398|NCT00200343|11451527|FG000|NOT COMPLETED|Overall Study||16
10317399|NCT00200343|11451528|FG001|NOT COMPLETED|Overall Study||8
10317400|NCT00200343|11451529|FG002|NOT COMPLETED|Overall Study||13
10317401|NCT00200356|11451539|FG000|STARTED|Overall Study||199
10317402|NCT00200356|11451540|FG001|STARTED|Overall Study||202
10317403|NCT00200356|11451539|FG000|Safety Analysis Set|Overall Study||194
10317404|NCT00200356|11451540|FG001|Safety Analysis Set|Overall Study||198
10317405|NCT00200356|11451539|FG000|COMPLETED|Overall Study||191
10317406|NCT00200356|11451540|FG001|COMPLETED|Overall Study||195
10317407|NCT00200356|11451539|FG000|NOT COMPLETED|Overall Study||8
10317408|NCT00200356|11451540|FG001|NOT COMPLETED|Overall Study||7
10784241|NCT03441633|11945252|FG009|NOT COMPLETED|Overall Study||0
10784242|NCT03441789|11945280|FG000|STARTED|Overall Study||14
10784243|NCT03441789|11945281|FG001|STARTED|Overall Study||14
10784244|NCT03441789|11945280|FG000|COMPLETED|Overall Study||13
10784245|NCT03441789|11945281|FG001|COMPLETED|Overall Study||10
10784246|NCT03441789|11945280|FG000|NOT COMPLETED|Overall Study||1
10784247|NCT03441789|11945281|FG001|NOT COMPLETED|Overall Study||4
10784248|NCT03441984|11945289|FG000|STARTED|Part 1: Period 1 (Up to Day 4)||3
10784249|NCT03441984|11945290|FG001|STARTED|Part 1: Period 1 (Up to Day 4)||3
10784250|NCT03441984|11945291|FG002|STARTED|Part 1: Period 1 (Up to Day 4)||3
10784251|NCT03441984|11945292|FG003|STARTED|Part 1: Period 1 (Up to Day 4)||3
10784252|NCT03441984|11945293|FG004|STARTED|Part 1: Period 1 (Up to Day 4)||3
10784253|NCT03441984|11945294|FG005|STARTED|Part 1: Period 1 (Up to Day 4)||3
10784254|NCT03441984|11945295|FG006|STARTED|Part 1: Period 1 (Up to Day 4)||0
10784255|NCT03441984|11945296|FG007|STARTED|Part 1: Period 1 (Up to Day 4)||0
10784256|NCT03441984|11945297|FG008|STARTED|Part 1: Period 1 (Up to Day 4)||0
10784257|NCT03441984|11945298|FG009|STARTED|Part 1: Period 1 (Up to Day 4)||0
10784258|NCT03441984|11945299|FG010|STARTED|Part 1: Period 1 (Up to Day 4)||0
10784259|NCT03441984|11945300|FG011|STARTED|Part 1: Period 1 (Up to Day 4)||0
10784260|NCT03441984|11945289|FG000|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
10784261|NCT03441984|11945290|FG001|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
10784262|NCT03441984|11945291|FG002|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
10784263|NCT03441984|11945292|FG003|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
10784264|NCT03441984|11945293|FG004|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
10784265|NCT03441984|11945294|FG005|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
10784266|NCT03441984|11945295|FG006|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
10784267|NCT03441984|11945296|FG007|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
10784268|NCT03441984|11945297|FG008|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
10784269|NCT03441984|11945298|FG009|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
10317409|NCT00200785|11451548|FG000|STARTED|First Intervention||9
10784270|NCT03441984|11945299|FG010|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
10784271|NCT03441984|11945300|FG011|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
10784272|NCT03441984|11945289|FG000|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
10317410|NCT00200785|11451549|FG001|STARTED|First Intervention||6
10317411|NCT00200785|11451548|FG000|COMPLETED|First Intervention||9
10317412|NCT00200785|11451549|FG001|COMPLETED|First Intervention||6
10317413|NCT00200785|11451548|FG000|NOT COMPLETED|First Intervention||0
10317414|NCT00200785|11451549|FG001|NOT COMPLETED|First Intervention||0
10317415|NCT00200785|11451548|FG000|STARTED|Washout Period of 1 Week||9
10317416|NCT00200785|11451549|FG001|STARTED|Washout Period of 1 Week||6
10317417|NCT00200785|11451548|FG000|COMPLETED|Washout Period of 1 Week||9
10317418|NCT00200785|11451549|FG001|COMPLETED|Washout Period of 1 Week||6
10317419|NCT00200785|11451548|FG000|NOT COMPLETED|Washout Period of 1 Week||0
10317420|NCT00200785|11451549|FG001|NOT COMPLETED|Washout Period of 1 Week||0
10317421|NCT00200785|11451548|FG000|STARTED|Second Intervention||9
10317422|NCT00200785|11451549|FG001|STARTED|Second Intervention||6
10317423|NCT00200785|11451548|FG000|COMPLETED|Second Intervention||9
10317424|NCT00200785|11451549|FG001|COMPLETED|Second Intervention||6
10317425|NCT00200785|11451548|FG000|NOT COMPLETED|Second Intervention||0
10317426|NCT00200785|11451549|FG001|NOT COMPLETED|Second Intervention||0
10317427|NCT00200850|11451558|FG000|STARTED|Overall Study||10
10317428|NCT00200850|11451559|FG001|STARTED|Overall Study||10
10317429|NCT00200850|11451560|FG002|STARTED|Overall Study||11
10317430|NCT00200850|11451558|FG000|COMPLETED|Overall Study||7
10317431|NCT00200850|11451559|FG001|COMPLETED|Overall Study||9
10317432|NCT00200850|11451560|FG002|COMPLETED|Overall Study||5
10317433|NCT00200850|11451558|FG000|NOT COMPLETED|Overall Study||3
10317434|NCT00200850|11451559|FG001|NOT COMPLETED|Overall Study||1
10317435|NCT00200850|11451560|FG002|NOT COMPLETED|Overall Study||6
10317436|NCT00200902|11451571|FG000|STARTED|Overall Study||39
10317437|NCT00200902|11451572|FG001|STARTED|Overall Study||29
10317438|NCT00200902|11451573|FG002|STARTED|Overall Study||20
10317439|NCT00200902|11451571|FG000|COMPLETED|Overall Study||29
10317440|NCT00200902|11451572|FG001|COMPLETED|Overall Study||26
10317441|NCT00200902|11451573|FG002|COMPLETED|Overall Study||12
10317442|NCT00200902|11451571|FG000|NOT COMPLETED|Overall Study||10
10317443|NCT00200902|11451572|FG001|NOT COMPLETED|Overall Study||3
10317444|NCT00200902|11451573|FG002|NOT COMPLETED|Overall Study||8
10317445|NCT00200967|11451589|FG000|STARTED|First Treatment Period||42
10317446|NCT00200967|11451590|FG001|STARTED|First Treatment Period||45
10317447|NCT00200967|11451589|FG000|First Treatment Period|First Treatment Period||42
10317448|NCT00200967|11451590|FG001|First Treatment Period|First Treatment Period||45
10317449|NCT00200967|11451589|FG000|COMPLETED|First Treatment Period||36
10317450|NCT00200967|11451590|FG001|COMPLETED|First Treatment Period||44
10784273|NCT03441984|11945290|FG001|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
10784274|NCT03441984|11945291|FG002|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
10784275|NCT03441984|11945292|FG003|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
10784276|NCT03441984|11945293|FG004|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
10784277|NCT03441984|11945294|FG005|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
10784278|NCT03441984|11945295|FG006|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
10784279|NCT03441984|11945296|FG007|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
10784280|NCT03441984|11945297|FG008|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
10784281|NCT03441984|11945298|FG009|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
10784282|NCT03441984|11945299|FG010|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
10784283|NCT03441984|11945300|FG011|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
10784284|NCT03441984|11945289|FG000|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
10784285|NCT03441984|11945290|FG001|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
10784286|NCT03441984|11945291|FG002|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
10784287|NCT03441984|11945292|FG003|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
10784288|NCT03441984|11945293|FG004|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
10784289|NCT03441984|11945294|FG005|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
10784290|NCT03441984|11945295|FG006|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
10784291|NCT03441984|11945296|FG007|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
10784292|NCT03441984|11945297|FG008|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
10784293|NCT03441984|11945298|FG009|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
10784294|NCT03441984|11945299|FG010|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
10784295|NCT03441984|11945300|FG011|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
10784296|NCT03441984|11945289|FG000|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
10784297|NCT03441984|11945290|FG001|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
10784298|NCT03441984|11945291|FG002|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
10784299|NCT03441984|11945292|FG003|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
10784300|NCT03441984|11945293|FG004|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
10784301|NCT03441984|11945294|FG005|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
10784302|NCT03441984|11945295|FG006|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
10784303|NCT03441984|11945296|FG007|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
10784304|NCT03441984|11945297|FG008|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
10784305|NCT03441984|11945298|FG009|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
10784306|NCT03441984|11945299|FG010|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
10784307|NCT03441984|11945300|FG011|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
10784308|NCT03441984|11945289|FG000|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
10784309|NCT03441984|11945290|FG001|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
10317451|NCT00200967|11451589|FG000|NOT COMPLETED|First Treatment Period||6
10317452|NCT00200967|11451590|FG001|NOT COMPLETED|First Treatment Period||1
10317453|NCT00200967|11451589|FG000|STARTED|Wash-out Period||36
10317454|NCT00200967|11451590|FG001|STARTED|Wash-out Period||44
10317455|NCT00200967|11451589|FG000|COMPLETED|Wash-out Period||36
10317456|NCT00200967|11451590|FG001|COMPLETED|Wash-out Period||43
10317457|NCT00200967|11451589|FG000|NOT COMPLETED|Wash-out Period||0
10317458|NCT00200967|11451590|FG001|NOT COMPLETED|Wash-out Period||1
10317459|NCT00200967|11451589|FG000|STARTED|Second Treatment Period||36
10317460|NCT00200967|11451590|FG001|STARTED|Second Treatment Period||43
10784310|NCT03441984|11945291|FG002|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
10784311|NCT03441984|11945292|FG003|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
10784312|NCT03441984|11945293|FG004|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
10317461|NCT00200967|11451589|FG000|COMPLETED|Second Treatment Period||35
10317462|NCT00200967|11451590|FG001|COMPLETED|Second Treatment Period||41
10317463|NCT00200967|11451589|FG000|NOT COMPLETED|Second Treatment Period||1
10317464|NCT00200967|11451590|FG001|NOT COMPLETED|Second Treatment Period||2
10317465|NCT00200967|11451589|FG000|STARTED|Run-out Period||35
10317466|NCT00200967|11451590|FG001|STARTED|Run-out Period||41
10317467|NCT00200967|11451589|FG000|COMPLETED|Run-out Period||34
10317468|NCT00200967|11451590|FG001|COMPLETED|Run-out Period||41
10317469|NCT00200967|11451589|FG000|NOT COMPLETED|Run-out Period||1
10317470|NCT00200967|11451590|FG001|NOT COMPLETED|Run-out Period||0
10317471|NCT00201006|11451599|FG000|STARTED|Overall Study||83
10317472|NCT00201006|11451600|FG001|STARTED|Overall Study||72
10317473|NCT00201006|11451601|FG002|STARTED|Overall Study||79
10317474|NCT00201006|11451599|FG000|COMPLETED|Overall Study||75
10317475|NCT00201006|11451600|FG001|COMPLETED|Overall Study||70
10317476|NCT00201006|11451601|FG002|COMPLETED|Overall Study||75
10317477|NCT00201006|11451599|FG000|NOT COMPLETED|Overall Study||8
10317478|NCT00201006|11451600|FG001|NOT COMPLETED|Overall Study||2
10317479|NCT00201006|11451601|FG002|NOT COMPLETED|Overall Study||4
10317480|NCT00201123|11451612|FG000|STARTED|Overall Study||32
10317481|NCT00201123|11451613|FG001|STARTED|Overall Study||32
10317482|NCT00201123|11451614|FG002|STARTED|Overall Study||32
10317483|NCT00201123|11451612|FG000|Did Not Meet Continuation Criteria|Overall Study||2
10317484|NCT00201123|11451613|FG001|Did Not Meet Continuation Criteria|Overall Study||0
10317485|NCT00201123|11451614|FG002|Did Not Meet Continuation Criteria|Overall Study||5
10317486|NCT00201123|11451612|FG000|COMPLETED|Overall Study||26
10317487|NCT00201123|11451613|FG001|COMPLETED|Overall Study||28
10317488|NCT00201123|11451614|FG002|COMPLETED|Overall Study||23
10317489|NCT00201123|11451612|FG000|NOT COMPLETED|Overall Study||6
10317490|NCT00201123|11451613|FG001|NOT COMPLETED|Overall Study||4
10317491|NCT00201123|11451614|FG002|NOT COMPLETED|Overall Study||9
10317492|NCT00201201|11451628|FG000|STARTED|Overall Study||87
10317493|NCT00201201|11451629|FG001|STARTED|Overall Study||73
10317494|NCT00201201|11451628|FG000|COMPLETED|Overall Study||82
10317495|NCT00201201|11451629|FG001|COMPLETED|Overall Study||66
10317496|NCT00201201|11451628|FG000|NOT COMPLETED|Overall Study||5
10317497|NCT00201201|11451629|FG001|NOT COMPLETED|Overall Study||7
10317498|NCT00201240|11451635|FG000|STARTED|Overall Study||47
10317499|NCT00201240|11451635|FG000|COMPLETED|Overall Study||44
10317500|NCT00201240|11451635|FG000|NOT COMPLETED|Overall Study||3
10317501|NCT00201409|11451642|FG000|STARTED|Overall Study||65
10317502|NCT00201409|11451643|FG001|STARTED|Overall Study||67
10317503|NCT00201409|11451642|FG000|COMPLETED|Overall Study||64
10317504|NCT00201409|11451643|FG001|COMPLETED|Overall Study||66
10317505|NCT00201409|11451642|FG000|NOT COMPLETED|Overall Study||1
10317506|NCT00201409|11451643|FG001|NOT COMPLETED|Overall Study||1
10317507|NCT00201448|11451651|FG000|STARTED|Overall Study||42
10317508|NCT00201448|11451652|FG001|STARTED|Overall Study||40
10317509|NCT00201448|11451651|FG000|COMPLETED|Overall Study||42
10317510|NCT00201448|11451652|FG001|COMPLETED|Overall Study||40
10317511|NCT00201448|11451651|FG000|NOT COMPLETED|Overall Study||0
10317512|NCT00201448|11451652|FG001|NOT COMPLETED|Overall Study||0
10317513|NCT00201643|11451662|FG000|STARTED|Overall Study||223
10317514|NCT00201643|11451663|FG001|STARTED|Overall Study||214
10317515|NCT00201643|11451662|FG000|COMPLETED|Overall Study||218
10317516|NCT00201643|11451663|FG001|COMPLETED|Overall Study||210
10317517|NCT00201643|11451662|FG000|NOT COMPLETED|Overall Study||5
10317518|NCT00201643|11451663|FG001|NOT COMPLETED|Overall Study||4
10317519|NCT00201734|11451671|FG000|STARTED|Overall Study||32
10317520|NCT00201734|11451672|FG001|STARTED|Overall Study||25
10317521|NCT00201734|11451671|FG000|Patients Not Evaluable|Overall Study||3
10317522|NCT00201734|11451672|FG001|Patients Not Evaluable|Overall Study||0
10317523|NCT00201734|11451671|FG000|COMPLETED|Overall Study||29
10317524|NCT00201734|11451672|FG001|COMPLETED|Overall Study||25
10317525|NCT00201734|11451671|FG000|NOT COMPLETED|Overall Study||3
10317526|NCT00201734|11451672|FG001|NOT COMPLETED|Overall Study||0
10317527|NCT00201760|11451681|FG000|STARTED|Overall Study||5
10317528|NCT00201760|11451682|FG001|STARTED|Overall Study||5
10317529|NCT00201760|11451681|FG000|COMPLETED|Overall Study||5
10317530|NCT00201760|11451682|FG001|COMPLETED|Overall Study||5
10317531|NCT00201760|11451681|FG000|NOT COMPLETED|Overall Study||0
10317532|NCT00201760|11451682|FG001|NOT COMPLETED|Overall Study||0
10317533|NCT00201773|11451688|FG000|STARTED|Overall Study||22
10317534|NCT00201773|11451688|FG000|Completed 8 Weeks of Planned Therapy|Overall Study||16
10317535|NCT00201773|11451688|FG000|Received All Exemestane Therapy|Overall Study||5
10317536|NCT00201773|11451688|FG000|Stopped Exemestane After 4 Weeks|Overall Study||1
10317537|NCT00201773|11451688|FG000|COMPLETED|Overall Study||16
10317538|NCT00201773|11451688|FG000|NOT COMPLETED|Overall Study||6
10317539|NCT00201825|11451695|FG000|STARTED|Overall Study||29
10317540|NCT00201825|11451695|FG000|COMPLETED|Overall Study||29
10317541|NCT00201825|11451695|FG000|NOT COMPLETED|Overall Study||0
10317542|NCT00201838|11451701|FG000|STARTED|Overall Study||30
10317543|NCT00201838|11451702|FG001|STARTED|Overall Study||8
10317544|NCT00201838|11451701|FG000|Treatment Cohort|Overall Study||30
10317545|NCT00201838|11451702|FG001|Treatment Cohort|Overall Study||8
10317546|NCT00201838|11451701|FG000|COMPLETED|Overall Study||30
10317547|NCT00201838|11451702|FG001|COMPLETED|Overall Study||8
10317548|NCT00201838|11451701|FG000|NOT COMPLETED|Overall Study||0
10317549|NCT00201838|11451702|FG001|NOT COMPLETED|Overall Study||0
10317550|NCT00201851|11451717|FG000|STARTED|Overall Study||252
10317551|NCT00201851|11451718|FG001|STARTED|Overall Study||257
10317552|NCT00201851|11451719|FG002|STARTED|Overall Study||231
10317553|NCT00201851|11451717|FG000|COMPLETED|Overall Study||244
10784313|NCT03441984|11945294|FG005|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
10784314|NCT03441984|11945295|FG006|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
10784315|NCT03441984|11945296|FG007|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
10784316|NCT03441984|11945297|FG008|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
10784317|NCT03441984|11945298|FG009|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
10784318|NCT03441984|11945299|FG010|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
10784319|NCT03441984|11945300|FG011|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
10784320|NCT03441984|11945289|FG000|STARTED|Part 1: Period 2 (Up to Day 4 )||3
10784321|NCT03441984|11945290|FG001|STARTED|Part 1: Period 2 (Up to Day 4 )||3
10784322|NCT03441984|11945291|FG002|STARTED|Part 1: Period 2 (Up to Day 4 )||3
10784323|NCT03441984|11945292|FG003|STARTED|Part 1: Period 2 (Up to Day 4 )||3
10784324|NCT03441984|11945293|FG004|STARTED|Part 1: Period 2 (Up to Day 4 )||3
10784325|NCT03441984|11945294|FG005|STARTED|Part 1: Period 2 (Up to Day 4 )||3
10784326|NCT03441984|11945295|FG006|STARTED|Part 1: Period 2 (Up to Day 4 )||0
10784327|NCT03441984|11945296|FG007|STARTED|Part 1: Period 2 (Up to Day 4 )||0
10784328|NCT03441984|11945297|FG008|STARTED|Part 1: Period 2 (Up to Day 4 )||0
10784329|NCT03441984|11945298|FG009|STARTED|Part 1: Period 2 (Up to Day 4 )||0
10784330|NCT03441984|11945299|FG010|STARTED|Part 1: Period 2 (Up to Day 4 )||0
10784331|NCT03441984|11945300|FG011|STARTED|Part 1: Period 2 (Up to Day 4 )||0
10784332|NCT03441984|11945289|FG000|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
10784333|NCT03441984|11945290|FG001|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
10784334|NCT03441984|11945291|FG002|COMPLETED|Part 1: Period 2 (Up to Day 4 )||2
10784335|NCT03441984|11945292|FG003|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
10784336|NCT03441984|11945293|FG004|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
10784337|NCT03441984|11945294|FG005|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
10784338|NCT03441984|11945295|FG006|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
10784339|NCT03441984|11945296|FG007|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
10784340|NCT03441984|11945297|FG008|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
10784341|NCT03441984|11945298|FG009|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
10784342|NCT03441984|11945299|FG010|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
10784343|NCT03441984|11945300|FG011|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
10784344|NCT03441984|11945289|FG000|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
10784345|NCT03441984|11945290|FG001|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
10784346|NCT03441984|11945291|FG002|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||1
10784347|NCT03441984|11945292|FG003|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
10784348|NCT03441984|11945293|FG004|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
10784349|NCT03441984|11945294|FG005|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
10784350|NCT03441984|11945295|FG006|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
10784351|NCT03441984|11945296|FG007|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
10784352|NCT03441984|11945297|FG008|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
10784353|NCT03441984|11945298|FG009|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
10784354|NCT03441984|11945299|FG010|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
10784355|NCT03441984|11945300|FG011|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
10784356|NCT03441984|11945289|FG000|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
10784357|NCT03441984|11945290|FG001|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
10784358|NCT03441984|11945291|FG002|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||2
10784359|NCT03441984|11945292|FG003|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
10784360|NCT03441984|11945293|FG004|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
10784361|NCT03441984|11945294|FG005|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
10784362|NCT03441984|11945295|FG006|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
10784363|NCT03441984|11945296|FG007|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
10784364|NCT03441984|11945297|FG008|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
10784365|NCT03441984|11945298|FG009|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
10784366|NCT03441984|11945299|FG010|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
10784367|NCT03441984|11945300|FG011|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
10784368|NCT03441984|11945289|FG000|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
10784369|NCT03441984|11945290|FG001|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
10784370|NCT03441984|11945291|FG002|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||2
10784371|NCT03441984|11945292|FG003|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
10784372|NCT03441984|11945293|FG004|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
10784373|NCT03441984|11945294|FG005|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
10784374|NCT03441984|11945295|FG006|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
10784375|NCT03441984|11945296|FG007|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
10784376|NCT03441984|11945297|FG008|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
10784377|NCT03441984|11945298|FG009|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
10784378|NCT03441984|11945299|FG010|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
10784379|NCT03441984|11945300|FG011|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
10784380|NCT03441984|11945289|FG000|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
10784381|NCT03441984|11945290|FG001|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
10784382|NCT03441984|11945291|FG002|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
10317554|NCT00201851|11451718|FG001|COMPLETED|Overall Study||255
10317555|NCT00201851|11451719|FG002|COMPLETED|Overall Study||230
10317556|NCT00201851|11451717|FG000|NOT COMPLETED|Overall Study||8
10317557|NCT00201851|11451718|FG001|NOT COMPLETED|Overall Study||2
10317558|NCT00201851|11451719|FG002|NOT COMPLETED|Overall Study||1
10317559|NCT00201864|11451727|FG000|STARTED|Overall Study||40
10317560|NCT00201864|11451727|FG000|COMPLETED|Overall Study||40
10317561|NCT00201864|11451727|FG000|NOT COMPLETED|Overall Study||0
10317562|NCT00201877|11451733|FG000|STARTED|Overall Study||25
10317563|NCT00201877|11451733|FG000|COMPLETED|Overall Study||25
10317564|NCT00201877|11451733|FG000|NOT COMPLETED|Overall Study||0
10317565|NCT00202449|11451741|FG000|STARTED|Overall Study||18
10317566|NCT00202449|11451742|FG001|STARTED|Overall Study||20
10784383|NCT03441984|11945292|FG003|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
10784384|NCT03441984|11945293|FG004|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
10784385|NCT03441984|11945294|FG005|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
10784386|NCT03441984|11945295|FG006|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
10784387|NCT03441984|11945296|FG007|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
10784388|NCT03441984|11945297|FG008|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
10784389|NCT03441984|11945298|FG009|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
10784390|NCT03441984|11945299|FG010|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
10784391|NCT03441984|11945300|FG011|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
10784392|NCT03441984|11945289|FG000|STARTED|Part 1: Period 3 (Up to Day 4 )||3
10784393|NCT03441984|11945290|FG001|STARTED|Part 1: Period 3 (Up to Day 4 )||3
10784394|NCT03441984|11945291|FG002|STARTED|Part 1: Period 3 (Up to Day 4 )||2
10784395|NCT03441984|11945292|FG003|STARTED|Part 1: Period 3 (Up to Day 4 )||3
10784396|NCT03441984|11945293|FG004|STARTED|Part 1: Period 3 (Up to Day 4 )||3
10784397|NCT03441984|11945294|FG005|STARTED|Part 1: Period 3 (Up to Day 4 )||3
10784398|NCT03441984|11945295|FG006|STARTED|Part 1: Period 3 (Up to Day 4 )||0
10784399|NCT03441984|11945296|FG007|STARTED|Part 1: Period 3 (Up to Day 4 )||0
10784400|NCT03441984|11945297|FG008|STARTED|Part 1: Period 3 (Up to Day 4 )||0
10784401|NCT03441984|11945298|FG009|STARTED|Part 1: Period 3 (Up to Day 4 )||0
10784402|NCT03441984|11945299|FG010|STARTED|Part 1: Period 3 (Up to Day 4 )||0
10784403|NCT03441984|11945300|FG011|STARTED|Part 1: Period 3 (Up to Day 4 )||0
10784404|NCT03441984|11945289|FG000|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
10784405|NCT03441984|11945290|FG001|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
10784406|NCT03441984|11945291|FG002|COMPLETED|Part 1: Period 3 (Up to Day 4 )||2
10784407|NCT03441984|11945292|FG003|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
10784408|NCT03441984|11945293|FG004|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
10784409|NCT03441984|11945294|FG005|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
10784410|NCT03441984|11945295|FG006|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
10784411|NCT03441984|11945296|FG007|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
10784412|NCT03441984|11945297|FG008|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
10784413|NCT03441984|11945298|FG009|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
10784414|NCT03441984|11945299|FG010|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
10784415|NCT03441984|11945300|FG011|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
10784416|NCT03441984|11945289|FG000|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
10784417|NCT03441984|11945290|FG001|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
10784418|NCT03441984|11945291|FG002|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
10784419|NCT03441984|11945292|FG003|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
10784420|NCT03441984|11945293|FG004|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
10784421|NCT03441984|11945294|FG005|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
10784422|NCT03441984|11945295|FG006|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
10784423|NCT03441984|11945296|FG007|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
10784424|NCT03441984|11945297|FG008|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
10784425|NCT03441984|11945298|FG009|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
10784426|NCT03441984|11945299|FG010|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
10784427|NCT03441984|11945300|FG011|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
10784428|NCT03441984|11945289|FG000|STARTED|Part 2: Period 1(Up to Day 4)||0
10784429|NCT03441984|11945290|FG001|STARTED|Part 2: Period 1(Up to Day 4)||0
10784430|NCT03441984|11945291|FG002|STARTED|Part 2: Period 1(Up to Day 4)||0
10784431|NCT03441984|11945292|FG003|STARTED|Part 2: Period 1(Up to Day 4)||0
10784432|NCT03441984|11945293|FG004|STARTED|Part 2: Period 1(Up to Day 4)||0
10784433|NCT03441984|11945294|FG005|STARTED|Part 2: Period 1(Up to Day 4)||0
10784434|NCT03441984|11945295|FG006|STARTED|Part 2: Period 1(Up to Day 4)||3
10784435|NCT03441984|11945296|FG007|STARTED|Part 2: Period 1(Up to Day 4)||3
10784436|NCT03441984|11945297|FG008|STARTED|Part 2: Period 1(Up to Day 4)||3
10784437|NCT03441984|11945298|FG009|STARTED|Part 2: Period 1(Up to Day 4)||3
10784438|NCT03441984|11945299|FG010|STARTED|Part 2: Period 1(Up to Day 4)||3
10784439|NCT03441984|11945300|FG011|STARTED|Part 2: Period 1(Up to Day 4)||3
10784440|NCT03441984|11945289|FG000|COMPLETED|Part 2: Period 1(Up to Day 4)||0
10784441|NCT03441984|11945290|FG001|COMPLETED|Part 2: Period 1(Up to Day 4)||0
10784442|NCT03441984|11945291|FG002|COMPLETED|Part 2: Period 1(Up to Day 4)||0
10784443|NCT03441984|11945292|FG003|COMPLETED|Part 2: Period 1(Up to Day 4)||0
10784444|NCT03441984|11945293|FG004|COMPLETED|Part 2: Period 1(Up to Day 4)||0
10784445|NCT03441984|11945294|FG005|COMPLETED|Part 2: Period 1(Up to Day 4)||0
10784446|NCT03441984|11945295|FG006|COMPLETED|Part 2: Period 1(Up to Day 4)||3
10317567|NCT00202449|11451743|FG002|STARTED|Overall Study||21
10317568|NCT00202449|11451741|FG000|COMPLETED|Overall Study||7
10317569|NCT00202449|11451742|FG001|COMPLETED|Overall Study||9
10317570|NCT00202449|11451743|FG002|COMPLETED|Overall Study||9
10317571|NCT00202449|11451741|FG000|NOT COMPLETED|Overall Study||11
10317572|NCT00202449|11451742|FG001|NOT COMPLETED|Overall Study||11
10317573|NCT00202449|11451743|FG002|NOT COMPLETED|Overall Study||12
10317574|NCT00202644|11451753|FG000|STARTED|Overall Study|One participant not randomized but treated.|76
10317575|NCT00202644|11451754|FG001|STARTED|Overall Study||70
10784447|NCT03441984|11945296|FG007|COMPLETED|Part 2: Period 1(Up to Day 4)||3
10784448|NCT03441984|11945297|FG008|COMPLETED|Part 2: Period 1(Up to Day 4)||3
10784449|NCT03441984|11945298|FG009|COMPLETED|Part 2: Period 1(Up to Day 4)||3
10784450|NCT03441984|11945299|FG010|COMPLETED|Part 2: Period 1(Up to Day 4)||3
10784451|NCT03441984|11945300|FG011|COMPLETED|Part 2: Period 1(Up to Day 4)||3
10784452|NCT03441984|11945289|FG000|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
10784453|NCT03441984|11945290|FG001|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
10784454|NCT03441984|11945291|FG002|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
10784455|NCT03441984|11945292|FG003|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
10784456|NCT03441984|11945293|FG004|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
10784457|NCT03441984|11945294|FG005|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
10784458|NCT03441984|11945295|FG006|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
10784459|NCT03441984|11945296|FG007|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
10784460|NCT03441984|11945297|FG008|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
10784461|NCT03441984|11945298|FG009|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
10784462|NCT03441984|11945299|FG010|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
10784463|NCT03441984|11945300|FG011|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
10784464|NCT03441984|11945289|FG000|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
10784465|NCT03441984|11945290|FG001|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
10784466|NCT03441984|11945291|FG002|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
10784467|NCT03441984|11945292|FG003|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
10784468|NCT03441984|11945293|FG004|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
10784469|NCT03441984|11945294|FG005|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
10784470|NCT03441984|11945295|FG006|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
10784471|NCT03441984|11945296|FG007|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
10784472|NCT03441984|11945297|FG008|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
10784473|NCT03441984|11945298|FG009|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
10784474|NCT03441984|11945299|FG010|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
10784475|NCT03441984|11945300|FG011|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
10784476|NCT03441984|11945289|FG000|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
10784477|NCT03441984|11945290|FG001|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
10784478|NCT03441984|11945291|FG002|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
10784479|NCT03441984|11945292|FG003|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
10784480|NCT03441984|11945293|FG004|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
10784481|NCT03441984|11945294|FG005|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
10784482|NCT03441984|11945295|FG006|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
10784483|NCT03441984|11945296|FG007|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
10784484|NCT03441984|11945297|FG008|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
10784485|NCT03441984|11945298|FG009|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
10784486|NCT03441984|11945299|FG010|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
10784487|NCT03441984|11945300|FG011|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
10784488|NCT03441984|11945289|FG000|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
10784489|NCT03441984|11945290|FG001|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
10784490|NCT03441984|11945291|FG002|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
10784491|NCT03441984|11945292|FG003|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
10784492|NCT03441984|11945293|FG004|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
10784493|NCT03441984|11945294|FG005|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
10784494|NCT03441984|11945295|FG006|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
10784495|NCT03441984|11945296|FG007|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
10784496|NCT03441984|11945297|FG008|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
10784497|NCT03441984|11945298|FG009|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
10784498|NCT03441984|11945299|FG010|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
10784499|NCT03441984|11945300|FG011|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
10784500|NCT03441984|11945289|FG000|STARTED|Part 2: Period 2 (Up to Day 4)||0
10784501|NCT03441984|11945290|FG001|STARTED|Part 2: Period 2 (Up to Day 4)||0
10784502|NCT03441984|11945291|FG002|STARTED|Part 2: Period 2 (Up to Day 4)||0
10784503|NCT03441984|11945292|FG003|STARTED|Part 2: Period 2 (Up to Day 4)||0
10784504|NCT03441984|11945293|FG004|STARTED|Part 2: Period 2 (Up to Day 4)||0
10784505|NCT03441984|11945294|FG005|STARTED|Part 2: Period 2 (Up to Day 4)||0
10784506|NCT03441984|11945295|FG006|STARTED|Part 2: Period 2 (Up to Day 4)||3
10784507|NCT03441984|11945296|FG007|STARTED|Part 2: Period 2 (Up to Day 4)||3
10784508|NCT03441984|11945297|FG008|STARTED|Part 2: Period 2 (Up to Day 4)||3
10317576|NCT00202644|11451753|FG000|COMPLETED|Overall Study||41
10317577|NCT00202644|11451754|FG001|COMPLETED|Overall Study||43
10317578|NCT00202644|11451753|FG000|NOT COMPLETED|Overall Study||35
10317579|NCT00202644|11451754|FG001|NOT COMPLETED|Overall Study||27
10784509|NCT03441984|11945298|FG009|STARTED|Part 2: Period 2 (Up to Day 4)||3
10784510|NCT03441984|11945299|FG010|STARTED|Part 2: Period 2 (Up to Day 4)||3
10784511|NCT03441984|11945300|FG011|STARTED|Part 2: Period 2 (Up to Day 4)||3
10317580|NCT00202722|11451760|FG000|STARTED|Overall Study||41
10317581|NCT00202722|11451760|FG000|COMPLETED|Overall Study||41
10317582|NCT00202722|11451760|FG000|NOT COMPLETED|Overall Study||0
10317583|NCT00202839|11451767|FG000|STARTED|Overall Study||78
10317584|NCT00202839|11451768|FG001|STARTED|Overall Study||82
10317585|NCT00202839|11451767|FG000|COMPLETED|Overall Study||54
10317586|NCT00202839|11451768|FG001|COMPLETED|Overall Study||72
10317587|NCT00202839|11451767|FG000|NOT COMPLETED|Overall Study||24
10317588|NCT00202839|11451768|FG001|NOT COMPLETED|Overall Study||10
10317589|NCT00202930|11451774|FG000|STARTED|Overall Study||4
10317590|NCT00202930|11451774|FG000|COMPLETED|Overall Study||4
10317591|NCT00202930|11451774|FG000|NOT COMPLETED|Overall Study||0
10317592|NCT00203021|11451780|FG000|STARTED|Overall Study||107
10317593|NCT00203021|11451781|FG001|STARTED|Overall Study||101
10317594|NCT00203021|11451780|FG000|Received at Least 1 Dose of Study Drug|Overall Study||107
10317595|NCT00203021|11451781|FG001|Received at Least 1 Dose of Study Drug|Overall Study||101
10317596|NCT00203021|11451780|FG000|COMPLETED|Overall Study||28
10317597|NCT00203021|11451781|FG001|COMPLETED|Overall Study||24
10317598|NCT00203021|11451780|FG000|NOT COMPLETED|Overall Study||79
10317599|NCT00203021|11451781|FG001|NOT COMPLETED|Overall Study||77
10317600|NCT00203047|11451789|FG000|STARTED|Overall Study||204
10317601|NCT00203047|11451790|FG001|STARTED|Overall Study||210
10317602|NCT00203047|11451789|FG000|In Database as of January 29, 2009|Overall Study||199
10317603|NCT00203047|11451790|FG001|In Database as of January 29, 2009|Overall Study||209
10784512|NCT03441984|11945289|FG000|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
10784513|NCT03441984|11945290|FG001|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
10784514|NCT03441984|11945291|FG002|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
10784515|NCT03441984|11945292|FG003|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
10784516|NCT03441984|11945293|FG004|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
10784517|NCT03441984|11945294|FG005|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
10784518|NCT03441984|11945295|FG006|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
10784519|NCT03441984|11945296|FG007|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
10784520|NCT03441984|11945297|FG008|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
10784521|NCT03441984|11945298|FG009|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
10784522|NCT03441984|11945299|FG010|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
10784523|NCT03441984|11945300|FG011|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
10784524|NCT03441984|11945289|FG000|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
10784525|NCT03441984|11945290|FG001|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
10784526|NCT03441984|11945291|FG002|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
10784527|NCT03441984|11945292|FG003|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
10784528|NCT03441984|11945293|FG004|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
10784529|NCT03441984|11945294|FG005|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
10784530|NCT03441984|11945295|FG006|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
10784531|NCT03441984|11945296|FG007|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
10784532|NCT03441984|11945297|FG008|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
10784533|NCT03441984|11945298|FG009|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
10784534|NCT03441984|11945299|FG010|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
10784535|NCT03441984|11945300|FG011|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
10784536|NCT03441984|11945289|FG000|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
10784537|NCT03441984|11945290|FG001|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
10784538|NCT03441984|11945291|FG002|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
10784539|NCT03441984|11945292|FG003|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
10784540|NCT03441984|11945293|FG004|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
10784541|NCT03441984|11945294|FG005|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
10784542|NCT03441984|11945295|FG006|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
10784543|NCT03441984|11945296|FG007|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
10784544|NCT03441984|11945297|FG008|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
10784545|NCT03441984|11945298|FG009|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
10784546|NCT03441984|11945299|FG010|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
10784547|NCT03441984|11945300|FG011|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
10784548|NCT03441984|11945289|FG000|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
10784549|NCT03441984|11945290|FG001|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
10784550|NCT03441984|11945291|FG002|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
10784551|NCT03441984|11945292|FG003|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
10784552|NCT03441984|11945293|FG004|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
10784553|NCT03441984|11945294|FG005|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
10784554|NCT03441984|11945295|FG006|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
10784555|NCT03441984|11945296|FG007|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
10784556|NCT03441984|11945297|FG008|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
10317604|NCT00203047|11451789|FG000|COMPLETED|Overall Study||13
10317605|NCT00203047|11451790|FG001|COMPLETED|Overall Study||7
10317606|NCT00203047|11451789|FG000|NOT COMPLETED|Overall Study||191
10317607|NCT00203047|11451790|FG001|NOT COMPLETED|Overall Study||203
10317608|NCT00203203|11451798|FG000|STARTED|Overall Study||10
10784557|NCT03441984|11945298|FG009|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
10784558|NCT03441984|11945299|FG010|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
10784559|NCT03441984|11945300|FG011|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
10784560|NCT03441984|11945289|FG000|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
10810575|NCT03796182|11972328|FG000|COMPLETED|Period 2||6
10317609|NCT00203203|11451799|FG001|STARTED|Overall Study||20
10317610|NCT00203203|11451798|FG000|COMPLETED|Overall Study||9
10317611|NCT00203203|11451799|FG001|COMPLETED|Overall Study||20
10317612|NCT00203203|11451798|FG000|NOT COMPLETED|Overall Study||1
10317613|NCT00203203|11451799|FG001|NOT COMPLETED|Overall Study||0
10317614|NCT00203216|11451805|FG000|STARTED|Overall Study||31
10317615|NCT00203216|11451805|FG000|COMPLETED|Overall Study||27
10317616|NCT00203216|11451805|FG000|NOT COMPLETED|Overall Study||4
10317617|NCT00203229|11451811|FG000|STARTED|Overall Study||10
10784561|NCT03441984|11945290|FG001|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
10784562|NCT03441984|11945291|FG002|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
10784563|NCT03441984|11945292|FG003|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
10784564|NCT03441984|11945293|FG004|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
10784565|NCT03441984|11945294|FG005|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
10784566|NCT03441984|11945295|FG006|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
10784567|NCT03441984|11945296|FG007|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
10784568|NCT03441984|11945297|FG008|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
10784569|NCT03441984|11945298|FG009|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
10784570|NCT03441984|11945299|FG010|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
10784682|NCT03443024|11945401|FG001|NOT COMPLETED|Overall Study||31
10784571|NCT03441984|11945300|FG011|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
10784572|NCT03441984|11945289|FG000|STARTED|Part 2: Period 3 (Up to Day 4)||0
10784573|NCT03441984|11945290|FG001|STARTED|Part 2: Period 3 (Up to Day 4)||0
10784574|NCT03441984|11945291|FG002|STARTED|Part 2: Period 3 (Up to Day 4)||0
10784575|NCT03441984|11945292|FG003|STARTED|Part 2: Period 3 (Up to Day 4)||0
10784576|NCT03441984|11945293|FG004|STARTED|Part 2: Period 3 (Up to Day 4)||0
10784577|NCT03441984|11945294|FG005|STARTED|Part 2: Period 3 (Up to Day 4)||0
10784578|NCT03441984|11945295|FG006|STARTED|Part 2: Period 3 (Up to Day 4)||3
10784579|NCT03441984|11945296|FG007|STARTED|Part 2: Period 3 (Up to Day 4)||3
10784580|NCT03441984|11945297|FG008|STARTED|Part 2: Period 3 (Up to Day 4)||3
10784581|NCT03441984|11945298|FG009|STARTED|Part 2: Period 3 (Up to Day 4)||3
10784582|NCT03441984|11945299|FG010|STARTED|Part 2: Period 3 (Up to Day 4)||3
10784583|NCT03441984|11945300|FG011|STARTED|Part 2: Period 3 (Up to Day 4)||3
10784584|NCT03441984|11945289|FG000|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
10784585|NCT03441984|11945290|FG001|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
10784586|NCT03441984|11945291|FG002|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
10784587|NCT03441984|11945292|FG003|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
10784588|NCT03441984|11945293|FG004|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
10784589|NCT03441984|11945294|FG005|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
10784590|NCT03441984|11945295|FG006|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
10784591|NCT03441984|11945296|FG007|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
10784592|NCT03441984|11945297|FG008|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
10784593|NCT03441984|11945298|FG009|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
10784594|NCT03441984|11945299|FG010|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
10784595|NCT03441984|11945300|FG011|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
10784596|NCT03441984|11945289|FG000|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
10784597|NCT03441984|11945290|FG001|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
10784598|NCT03441984|11945291|FG002|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
10784599|NCT03441984|11945292|FG003|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
10784600|NCT03441984|11945293|FG004|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
10784601|NCT03441984|11945294|FG005|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
10784602|NCT03441984|11945295|FG006|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
10784603|NCT03441984|11945296|FG007|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
10784604|NCT03441984|11945297|FG008|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
10784605|NCT03441984|11945298|FG009|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
10784606|NCT03441984|11945299|FG010|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
10784607|NCT03441984|11945300|FG011|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
10784608|NCT03442036|11945317|FG000|STARTED|Overall Study||35
10784609|NCT03442036|11945318|FG001|STARTED|Overall Study||35
10784610|NCT03442036|11945317|FG000|COMPLETED|Overall Study||35
10784611|NCT03442036|11945318|FG001|COMPLETED|Overall Study||35
10784612|NCT03442036|11945317|FG000|NOT COMPLETED|Overall Study||0
10784613|NCT03442036|11945318|FG001|NOT COMPLETED|Overall Study||0
10784614|NCT03442296|11945328|FG000|STARTED|3 Month Follow-up||78
10784615|NCT03442296|11945329|FG001|STARTED|3 Month Follow-up||73
10784616|NCT03442296|11945328|FG000|COMPLETED|3 Month Follow-up||73
10784617|NCT03442296|11945329|FG001|COMPLETED|3 Month Follow-up||70
10784618|NCT03442296|11945328|FG000|NOT COMPLETED|3 Month Follow-up||5
10317618|NCT00203229|11451812|FG001|STARTED|Overall Study||10
10317619|NCT00203229|11451811|FG000|COMPLETED|Overall Study||7
10317620|NCT00203229|11451812|FG001|COMPLETED|Overall Study||7
10317621|NCT00203229|11451811|FG000|NOT COMPLETED|Overall Study||3
10317622|NCT00203229|11451812|FG001|NOT COMPLETED|Overall Study||3
10784619|NCT03442296|11945329|FG001|NOT COMPLETED|3 Month Follow-up||3
10784620|NCT03442296|11945328|FG000|STARTED|12 Month Follow-up|15 participants in the immediate group did not start the 12month visit due to: death unrelated to study (3), loss to follow up (6), or withdrew consent (6)|58
10784621|NCT03442296|11945329|FG001|STARTED|12 Month Follow-up|18 participants in the delayed group did not start the 12month visit due to: death unrelated to study (3), loss to follow up (5), or withdrew consent (10)|52
10784622|NCT03442296|11945328|FG000|COMPLETED|12 Month Follow-up||57
10784623|NCT03442296|11945329|FG001|COMPLETED|12 Month Follow-up||51
10784624|NCT03442296|11945328|FG000|NOT COMPLETED|12 Month Follow-up||1
10317623|NCT00203242|11451818|FG000|STARTED|Overall Study||15
10317624|NCT00203242|11451818|FG000|COMPLETED|Overall Study||14
10317625|NCT00203242|11451818|FG000|NOT COMPLETED|Overall Study||1
10317626|NCT00203268|11451822|FG000|STARTED|Early Treatment||13
10317627|NCT00203268|11451822|FG000|COMPLETED|Early Treatment||9
10317628|NCT00203268|11451822|FG000|NOT COMPLETED|Early Treatment||4
10317629|NCT00203268|11451822|FG000|STARTED|Late Treatment||9
10317630|NCT00203268|11451822|FG000|COMPLETED|Late Treatment||9
10317631|NCT00203268|11451822|FG000|NOT COMPLETED|Late Treatment||0
10317632|NCT00203294|11451830|FG000|STARTED|Overall Study||22
10317633|NCT00203294|11451831|FG001|STARTED|Overall Study||23
10317634|NCT00203294|11451830|FG000|COMPLETED|Overall Study||14
10317635|NCT00203294|11451831|FG001|COMPLETED|Overall Study||10
10317636|NCT00203294|11451830|FG000|NOT COMPLETED|Overall Study||8
10317637|NCT00203294|11451831|FG001|NOT COMPLETED|Overall Study||13
10317638|NCT00203307|11451839|FG000|STARTED|First Intervention|Double-blind cross-over design. Study terminated early. Results not analyzed.|3
10317639|NCT00203307|11451840|FG001|STARTED|First Intervention||0
10317640|NCT00203307|11451839|FG000|COMPLETED|First Intervention||1
10317641|NCT00203307|11451840|FG001|COMPLETED|First Intervention||0
10317642|NCT00203307|11451839|FG000|NOT COMPLETED|First Intervention||2
10317643|NCT00203307|11451840|FG001|NOT COMPLETED|First Intervention||0
10784683|NCT03443024|11945402|FG002|NOT COMPLETED|Overall Study||19
10317644|NCT00203307|11451839|FG000|STARTED|Second Intervention|2 subjects dropped out of the 1st intervention period, due to fatugue.|1
10317645|NCT00203307|11451840|FG001|STARTED|Second Intervention||0
10317646|NCT00203307|11451839|FG000|COMPLETED|Second Intervention||1
10317647|NCT00203307|11451840|FG001|COMPLETED|Second Intervention||0
10317648|NCT00203307|11451839|FG000|NOT COMPLETED|Second Intervention||0
10317649|NCT00203307|11451840|FG001|NOT COMPLETED|Second Intervention||0
10317650|NCT00203411|11451846|FG000|STARTED|Treatment Period||45
10317651|NCT00203411|11451846|FG000|COMPLETED|Treatment Period||45
10317652|NCT00203411|11451846|FG000|NOT COMPLETED|Treatment Period||0
10317653|NCT00203411|11451846|FG000|STARTED|Follow-up||45
10784625|NCT03442296|11945329|FG001|NOT COMPLETED|12 Month Follow-up||1
10784626|NCT03442569|11945335|FG000|STARTED|Overall Study||56
10784627|NCT03442569|11945335|FG000|Started Treatment|Overall Study||55
10784628|NCT03442569|11945335|FG000|COMPLETED|Overall Study||55
10784629|NCT03442569|11945335|FG000|NOT COMPLETED|Overall Study||1
10784630|NCT03442595|11945341|FG000|STARTED|Overall Study||460
10784631|NCT03442595|11945342|FG001|STARTED|Overall Study||366
10784632|NCT03442595|11945341|FG000|COMPLETED|Overall Study||366
10784633|NCT03442595|11945342|FG001|COMPLETED|Overall Study||366
10784634|NCT03442595|11945341|FG000|NOT COMPLETED|Overall Study||94
10784635|NCT03442595|11945342|FG001|NOT COMPLETED|Overall Study||0
10784636|NCT03442699|11945347|FG000|STARTED|Overall Study||6
10784637|NCT03442699|11945347|FG000|COMPLETED|Overall Study||6
10784638|NCT03442699|11945347|FG000|NOT COMPLETED|Overall Study||0
10784639|NCT03442725|11945355|FG000|STARTED|Overall Study||8
10784640|NCT03442725|11945356|FG001|STARTED|Overall Study||8
10784641|NCT03442725|11945355|FG000|COMPLETED|Overall Study||8
10784642|NCT03442725|11945356|FG001|COMPLETED|Overall Study||8
10784643|NCT03442725|11945355|FG000|NOT COMPLETED|Overall Study||0
10784644|NCT03442725|11945356|FG001|NOT COMPLETED|Overall Study||0
10784645|NCT03442777|11945365|FG000|STARTED|Overall Study|All participants received at least 1 dressing|542
10784646|NCT03442777|11945366|FG001|STARTED|Overall Study|One participant received one Allevyn® Life dressing (wrong brand by mistake), besides 13 Mepilex® Border on sacrum, (0.2%) All participants received at least 1 dressing|545
10784647|NCT03442777|11945367|FG002|STARTED|Overall Study|No participants received dressings|546
10784648|NCT03442777|11945365|FG000|COMPLETED|Overall Study||534
10784649|NCT03442777|11945366|FG001|COMPLETED|Overall Study||532
10784650|NCT03442777|11945367|FG002|COMPLETED|Overall Study||539
10784651|NCT03442777|11945365|FG000|NOT COMPLETED|Overall Study||8
10784652|NCT03442777|11945366|FG001|NOT COMPLETED|Overall Study||13
10784653|NCT03442777|11945367|FG002|NOT COMPLETED|Overall Study||7
10784654|NCT03442829|11945375|FG000|STARTED|Overall Study||27
10784655|NCT03442829|11945376|FG001|STARTED|Overall Study||27
10784656|NCT03442829|11945375|FG000|COMPLETED|Overall Study||23
10784657|NCT03442829|11945376|FG001|COMPLETED|Overall Study||25
10784658|NCT03442829|11945375|FG000|NOT COMPLETED|Overall Study||4
10784659|NCT03442829|11945376|FG001|NOT COMPLETED|Overall Study||2
10784660|NCT03442868|11945382|FG000|STARTED|Overall Study||15
10784661|NCT03442868|11945382|FG000|COMPLETED|Overall Study||15
10784662|NCT03442868|11945382|FG000|NOT COMPLETED|Overall Study||0
10784663|NCT03442933|11945386|FG000|STARTED|Overall Study||20
10784664|NCT03442933|11945387|FG001|STARTED|Overall Study||20
10784665|NCT03442933|11945386|FG000|COMPLETED|Overall Study||20
10784666|NCT03442933|11945387|FG001|COMPLETED|Overall Study||20
10784667|NCT03442933|11945386|FG000|NOT COMPLETED|Overall Study||0
10317654|NCT00203411|11451846|FG000|COMPLETED|Follow-up||41
10317655|NCT00203411|11451846|FG000|NOT COMPLETED|Follow-up||4
10317656|NCT00203424|11451851|FG000|STARTED|Treatment Period|23 subjects registered for treatment, 1 withdrew consent after registration,22 received treatment.|22
10338364|NCT00369577|11475260|FG000|STARTED|Overall Study||43
10784668|NCT03442933|11945387|FG001|NOT COMPLETED|Overall Study||0
10784669|NCT03443024|11945400|FG000|STARTED|Overall Study||73
10784670|NCT03443024|11945401|FG001|STARTED|Overall Study||80
10784671|NCT03443024|11945402|FG002|STARTED|Overall Study||75
10784672|NCT03443024|11945403|FG003|STARTED|Overall Study||52
10784673|NCT03443024|11945400|FG000|Received at Least One Dose of Study Drug|Overall Study||73
10784674|NCT03443024|11945401|FG001|Received at Least One Dose of Study Drug|Overall Study||80
10784675|NCT03443024|11945402|FG002|Received at Least One Dose of Study Drug|Overall Study||75
10810576|NCT03796182|11972329|FG001|COMPLETED|Period 2||6
10338365|NCT00369577|11475261|FG001|STARTED|Overall Study||45
10317657|NCT00203424|11451851|FG000|COMPLETED|Treatment Period|Of 11 pts that did not complete treatment,5 stopped due to adverse event and entered followup period|11
10317658|NCT00203424|11451851|FG000|NOT COMPLETED|Treatment Period||11
10317659|NCT00203424|11451851|FG000|STARTED|Follow-up Period|followup includes 11 pts that completed treatment + 5 pts who stopped treatment due to adverse event|16
10317660|NCT00203424|11451851|FG000|COMPLETED|Follow-up Period||10
10317661|NCT00203424|11451851|FG000|NOT COMPLETED|Follow-up Period||6
10317662|NCT00203476|11451858|FG000|STARTED|Overall Study||10
10317663|NCT00203476|11451859|FG001|STARTED|Overall Study||10
10317664|NCT00203476|11451860|FG002|STARTED|Overall Study||10
10317665|NCT00203476|11451858|FG000|COMPLETED|Overall Study||9
10317666|NCT00203476|11451859|FG001|COMPLETED|Overall Study||9
10317667|NCT00203476|11451860|FG002|COMPLETED|Overall Study||10
10317668|NCT00203476|11451858|FG000|NOT COMPLETED|Overall Study||1
10784676|NCT03443024|11945403|FG003|Received at Least One Dose of Study Drug|Overall Study||52
10784677|NCT03443024|11945400|FG000|COMPLETED|Overall Study||52
10784678|NCT03443024|11945401|FG001|COMPLETED|Overall Study||49
10784679|NCT03443024|11945402|FG002|COMPLETED|Overall Study||56
10784680|NCT03443024|11945403|FG003|COMPLETED|Overall Study||20
10784681|NCT03443024|11945400|FG000|NOT COMPLETED|Overall Study||21
10784684|NCT03443024|11945403|FG003|NOT COMPLETED|Overall Study||32
10784685|NCT03443063|11945415|FG000|STARTED|Overall Study||8
10784686|NCT03443063|11945416|FG001|STARTED|Overall Study||8
10784687|NCT03443063|11945415|FG000|COMPLETED|Overall Study||8
10784688|NCT03443063|11945416|FG001|COMPLETED|Overall Study||8
10784689|NCT03443063|11945415|FG000|NOT COMPLETED|Overall Study||0
10784690|NCT03443063|11945416|FG001|NOT COMPLETED|Overall Study||0
10784691|NCT03443414|11945429|FG000|STARTED|Overall Study||82
10784692|NCT03443414|11945430|FG001|STARTED|Overall Study||81
10784693|NCT03443414|11945431|FG002|STARTED|Overall Study||82
10784694|NCT03443414|11945432|FG003|STARTED|Overall Study||80
10784695|NCT03443414|11945433|FG004|STARTED|Overall Study||80
10784696|NCT03443414|11945429|FG000|Received Treatment|Overall Study||81
10784697|NCT03443414|11945430|FG001|Received Treatment|Overall Study||81
10784698|NCT03443414|11945431|FG002|Received Treatment|Overall Study||82
10784699|NCT03443414|11945432|FG003|Received Treatment|Overall Study||80
10784700|NCT03443414|11945433|FG004|Received Treatment|Overall Study||79
10784701|NCT03443414|11945429|FG000|COMPLETED|Overall Study||71
10784702|NCT03443414|11945430|FG001|COMPLETED|Overall Study||78
10784703|NCT03443414|11945431|FG002|COMPLETED|Overall Study||76
10784704|NCT03443414|11945432|FG003|COMPLETED|Overall Study||75
10784705|NCT03443414|11945433|FG004|COMPLETED|Overall Study||75
10784706|NCT03443414|11945429|FG000|NOT COMPLETED|Overall Study||11
10784707|NCT03443414|11945430|FG001|NOT COMPLETED|Overall Study||3
10784708|NCT03443414|11945431|FG002|NOT COMPLETED|Overall Study||6
10784709|NCT03443414|11945432|FG003|NOT COMPLETED|Overall Study||5
10784710|NCT03443414|11945433|FG004|NOT COMPLETED|Overall Study||5
10784711|NCT03443427|11945447|FG000|STARTED|Overall Study||100
10784712|NCT03443427|11945448|FG001|STARTED|Overall Study||100
10784713|NCT03443427|11945447|FG000|COMPLETED|Overall Study||88
10784714|NCT03443427|11945448|FG001|COMPLETED|Overall Study||89
10784715|NCT03443427|11945447|FG000|NOT COMPLETED|Overall Study||12
10784716|NCT03443427|11945448|FG001|NOT COMPLETED|Overall Study||11
10784717|NCT03443713|11945457|FG000|STARTED|Start up Visit (2 Hours)||8
10784718|NCT03443713|11945458|FG001|STARTED|Start up Visit (2 Hours)||8
10784719|NCT03443713|11945459|FG002|STARTED|Start up Visit (2 Hours)||9
10784720|NCT03443713|11945457|FG000|COMPLETED|Start up Visit (2 Hours)||8
10784721|NCT03443713|11945458|FG001|COMPLETED|Start up Visit (2 Hours)||8
10784722|NCT03443713|11945459|FG002|COMPLETED|Start up Visit (2 Hours)||9
10784723|NCT03443713|11945457|FG000|NOT COMPLETED|Start up Visit (2 Hours)||0
10784724|NCT03443713|11945458|FG001|NOT COMPLETED|Start up Visit (2 Hours)||0
10784725|NCT03443713|11945459|FG002|NOT COMPLETED|Start up Visit (2 Hours)||0
10784726|NCT03443713|11945457|FG000|STARTED|First at Home Period (9-14 Days)||8
10784727|NCT03443713|11945458|FG001|STARTED|First at Home Period (9-14 Days)||8
10317669|NCT00203476|11451859|FG001|NOT COMPLETED|Overall Study||1
10317670|NCT00203476|11451860|FG002|NOT COMPLETED|Overall Study||0
10317671|NCT00203502|11451868|FG000|STARTED|Overall Study||40
10317672|NCT00203502|11451868|FG000|COMPLETED|Overall Study||39
10317673|NCT00203502|11451868|FG000|NOT COMPLETED|Overall Study||1
10317674|NCT00203892|11451875|FG000|STARTED|Overall Study||7
10317675|NCT00203892|11451876|FG001|STARTED|Overall Study||10
10317676|NCT00203892|11451877|FG002|STARTED|Overall Study||6
10317677|NCT00203892|11451875|FG000|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|5
10317678|NCT00203892|11451876|FG001|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|5
10317679|NCT00203892|11451877|FG002|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|4
10317680|NCT00203892|11451875|FG000|COMPLETED|Overall Study|2 patients not completing study were randomized but never treated|5
10317681|NCT00203892|11451876|FG001|COMPLETED|Overall Study|2 patients not completing study were randomized but never treated|8
10317682|NCT00203892|11451877|FG002|COMPLETED|Overall Study||6
10317683|NCT00203892|11451875|FG000|NOT COMPLETED|Overall Study||2
10784728|NCT03443713|11945459|FG002|STARTED|First at Home Period (9-14 Days)||9
10784729|NCT03443713|11945457|FG000|COMPLETED|First at Home Period (9-14 Days)||8
10784730|NCT03443713|11945458|FG001|COMPLETED|First at Home Period (9-14 Days)||8
10317684|NCT00203892|11451876|FG001|NOT COMPLETED|Overall Study||2
10317685|NCT00203892|11451877|FG002|NOT COMPLETED|Overall Study||0
10317686|NCT00203931|11451887|FG000|STARTED|Overall Study||27
10317687|NCT00203931|11451888|FG001|STARTED|Overall Study||28
10317688|NCT00203931|11451887|FG000|COMPLETED|Overall Study|These are the evaluable patients who received at least 3 doses of cetuximab.|20
10317689|NCT00203931|11451888|FG001|COMPLETED|Overall Study|These are the evaluable patients who received at least 3 doses of cetuximab.|23
10317690|NCT00203931|11451887|FG000|NOT COMPLETED|Overall Study||7
10317691|NCT00203931|11451888|FG001|NOT COMPLETED|Overall Study||5
10317692|NCT00203996|11451904|FG000|STARTED|Overall Study||0
10317693|NCT00203996|11451905|FG001|STARTED|Overall Study||0
10317694|NCT00203996|11451906|FG002|STARTED|Overall Study||0
10317695|NCT00203996|11451907|FG003|STARTED|Overall Study||19
10317696|NCT00203996|11451908|FG004|STARTED|Overall Study||4
10317697|NCT00203996|11451909|FG005|STARTED|Overall Study||3
10317698|NCT00203996|11451910|FG006|STARTED|Overall Study||2
10317699|NCT00203996|11451911|FG007|STARTED|Overall Study||4
10317700|NCT00203996|11451912|FG008|STARTED|Overall Study||2
10317701|NCT00203996|11451913|FG009|STARTED|Overall Study||3
10317702|NCT00203996|11451904|FG000|Aim 3 Only: First Intervention|Overall Study||0
10317703|NCT00203996|11451905|FG001|Aim 3 Only: First Intervention|Overall Study||0
10317704|NCT00203996|11451906|FG002|Aim 3 Only: First Intervention|Overall Study||0
10317705|NCT00203996|11451907|FG003|Aim 3 Only: First Intervention|Overall Study||0
10317706|NCT00203996|11451908|FG004|Aim 3 Only: First Intervention|Overall Study||0
10317707|NCT00203996|11451909|FG005|Aim 3 Only: First Intervention|Overall Study||3
10317708|NCT00203996|11451910|FG006|Aim 3 Only: First Intervention|Overall Study||2
10317709|NCT00203996|11451911|FG007|Aim 3 Only: First Intervention|Overall Study||4
10317710|NCT00203996|11451912|FG008|Aim 3 Only: First Intervention|Overall Study||2
10317711|NCT00203996|11451913|FG009|Aim 3 Only: First Intervention|Overall Study||3
10317712|NCT00203996|11451904|FG000|Aim 3 Only: Washout|Overall Study||0
10317713|NCT00203996|11451905|FG001|Aim 3 Only: Washout|Overall Study||0
10317714|NCT00203996|11451906|FG002|Aim 3 Only: Washout|Overall Study||0
10317715|NCT00203996|11451907|FG003|Aim 3 Only: Washout|Overall Study||0
10317716|NCT00203996|11451908|FG004|Aim 3 Only: Washout|Overall Study||0
10317717|NCT00203996|11451909|FG005|Aim 3 Only: Washout|Overall Study||3
10317718|NCT00203996|11451910|FG006|Aim 3 Only: Washout|Overall Study||2
10317719|NCT00203996|11451911|FG007|Aim 3 Only: Washout|Overall Study||2
10317720|NCT00203996|11451912|FG008|Aim 3 Only: Washout|Overall Study||2
10317721|NCT00203996|11451913|FG009|Aim 3 Only: Washout|Overall Study||2
10317722|NCT00203996|11451904|FG000|Aim 3 Only: Second Intervention|Overall Study||0
10317723|NCT00203996|11451905|FG001|Aim 3 Only: Second Intervention|Overall Study||0
10317724|NCT00203996|11451906|FG002|Aim 3 Only: Second Intervention|Overall Study||0
10433027|NCT00883740|11579293|FG000|NOT COMPLETED|Second Intervention||1
10433028|NCT00883740|11579294|FG001|NOT COMPLETED|Second Intervention||1
10784731|NCT03443713|11945459|FG002|COMPLETED|First at Home Period (9-14 Days)||8
10784732|NCT03443713|11945457|FG000|NOT COMPLETED|First at Home Period (9-14 Days)||0
10784733|NCT03443713|11945458|FG001|NOT COMPLETED|First at Home Period (9-14 Days)||0
10784734|NCT03443713|11945459|FG002|NOT COMPLETED|First at Home Period (9-14 Days)||1
10784735|NCT03443713|11945457|FG000|STARTED|First Exercise Visit (1 Hour)||8
10784736|NCT03443713|11945458|FG001|STARTED|First Exercise Visit (1 Hour)||8
10317725|NCT00203996|11451907|FG003|Aim 3 Only: Second Intervention|Overall Study||0
10317726|NCT00203996|11451908|FG004|Aim 3 Only: Second Intervention|Overall Study||0
10317727|NCT00203996|11451909|FG005|Aim 3 Only: Second Intervention|Overall Study||3
10317728|NCT00203996|11451910|FG006|Aim 3 Only: Second Intervention|Overall Study||2
10317729|NCT00203996|11451911|FG007|Aim 3 Only: Second Intervention|Overall Study||2
10317730|NCT00203996|11451912|FG008|Aim 3 Only: Second Intervention|Overall Study||2
10317731|NCT00203996|11451913|FG009|Aim 3 Only: Second Intervention|Overall Study||2
10317732|NCT00203996|11451904|FG000|Aim 3 Only: Second Washout|Overall Study||0
10317733|NCT00203996|11451905|FG001|Aim 3 Only: Second Washout|Overall Study||0
10784737|NCT03443713|11945459|FG002|STARTED|First Exercise Visit (1 Hour)||8
10784738|NCT03443713|11945457|FG000|COMPLETED|First Exercise Visit (1 Hour)||8
10784739|NCT03443713|11945458|FG001|COMPLETED|First Exercise Visit (1 Hour)||8
10784740|NCT03443713|11945459|FG002|COMPLETED|First Exercise Visit (1 Hour)||8
10433029|NCT00883753|11579300|FG000|STARTED|Overall Study||934
10433030|NCT00883753|11579300|FG000|COMPLETED|Overall Study||827
10433031|NCT00883753|11579300|FG000|NOT COMPLETED|Overall Study||107
10433032|NCT00883779|11579309|FG000|STARTED|Primary Study Treatment Phase||225
10433033|NCT00883779|11579310|FG001|STARTED|Primary Study Treatment Phase||226
10433034|NCT00883779|11579309|FG000|COMPLETED|Primary Study Treatment Phase||120
10433035|NCT00883779|11579310|FG001|COMPLETED|Primary Study Treatment Phase||140
10433036|NCT00883779|11579309|FG000|NOT COMPLETED|Primary Study Treatment Phase||105
10433037|NCT00883779|11579310|FG001|NOT COMPLETED|Primary Study Treatment Phase||86
10433038|NCT00883779|11579309|FG000|STARTED|Post-Study Treatment Phase||112
10433039|NCT00883779|11579310|FG001|STARTED|Post-Study Treatment Phase||135
10433040|NCT00883779|11579309|FG000|COMPLETED|Post-Study Treatment Phase||0
10433041|NCT00883779|11579310|FG001|COMPLETED|Post-Study Treatment Phase||0
10433042|NCT00883779|11579309|FG000|NOT COMPLETED|Post-Study Treatment Phase||112
10784741|NCT03443713|11945457|FG000|NOT COMPLETED|First Exercise Visit (1 Hour)||0
10317734|NCT00203996|11451906|FG002|Aim 3 Only: Second Washout|Overall Study||0
10317735|NCT00203996|11451907|FG003|Aim 3 Only: Second Washout|Overall Study||0
10317736|NCT00203996|11451908|FG004|Aim 3 Only: Second Washout|Overall Study||0
10317737|NCT00203996|11451909|FG005|Aim 3 Only: Second Washout|Overall Study||3
10317738|NCT00203996|11451910|FG006|Aim 3 Only: Second Washout|Overall Study||2
10317739|NCT00203996|11451911|FG007|Aim 3 Only: Second Washout|Overall Study||2
10317740|NCT00203996|11451912|FG008|Aim 3 Only: Second Washout|Overall Study||2
10317741|NCT00203996|11451913|FG009|Aim 3 Only: Second Washout|Overall Study||2
10317742|NCT00203996|11451904|FG000|Aim 3 Only: Third Intervention|Overall Study||0
10317743|NCT00203996|11451905|FG001|Aim 3 Only: Third Intervention|Overall Study||0
10317744|NCT00203996|11451906|FG002|Aim 3 Only: Third Intervention|Overall Study||0
10317745|NCT00203996|11451907|FG003|Aim 3 Only: Third Intervention|Overall Study||0
10317746|NCT00203996|11451908|FG004|Aim 3 Only: Third Intervention|Overall Study||0
10317747|NCT00203996|11451909|FG005|Aim 3 Only: Third Intervention|Overall Study||3
10317748|NCT00203996|11451910|FG006|Aim 3 Only: Third Intervention|Overall Study||2
10317749|NCT00203996|11451911|FG007|Aim 3 Only: Third Intervention|Overall Study||2
10317750|NCT00203996|11451912|FG008|Aim 3 Only: Third Intervention|Overall Study||2
10317751|NCT00203996|11451913|FG009|Aim 3 Only: Third Intervention|Overall Study||2
10317752|NCT00203996|11451904|FG000|COMPLETED|Overall Study||0
10317753|NCT00203996|11451905|FG001|COMPLETED|Overall Study||0
10317754|NCT00203996|11451906|FG002|COMPLETED|Overall Study||0
10784742|NCT03443713|11945458|FG001|NOT COMPLETED|First Exercise Visit (1 Hour)||0
10784743|NCT03443713|11945459|FG002|NOT COMPLETED|First Exercise Visit (1 Hour)||0
10784744|NCT03443713|11945457|FG000|STARTED|Dexcom Insertion Visit (30 Minutes)||8
10784745|NCT03443713|11945458|FG001|STARTED|Dexcom Insertion Visit (30 Minutes)||8
10784746|NCT03443713|11945459|FG002|STARTED|Dexcom Insertion Visit (30 Minutes)||8
10784747|NCT03443713|11945457|FG000|COMPLETED|Dexcom Insertion Visit (30 Minutes)||8
10317755|NCT00203996|11451907|FG003|COMPLETED|Overall Study||9
10317756|NCT00203996|11451908|FG004|COMPLETED|Overall Study||3
10317757|NCT00203996|11451909|FG005|COMPLETED|Overall Study||3
10317758|NCT00203996|11451910|FG006|COMPLETED|Overall Study||2
10317759|NCT00203996|11451911|FG007|COMPLETED|Overall Study||2
10317760|NCT00203996|11451912|FG008|COMPLETED|Overall Study||2
10317761|NCT00203996|11451913|FG009|COMPLETED|Overall Study||2
10317762|NCT00203996|11451904|FG000|NOT COMPLETED|Overall Study||0
10317763|NCT00203996|11451905|FG001|NOT COMPLETED|Overall Study||0
10317764|NCT00203996|11451906|FG002|NOT COMPLETED|Overall Study||0
10317765|NCT00203996|11451907|FG003|NOT COMPLETED|Overall Study||10
10317766|NCT00203996|11451908|FG004|NOT COMPLETED|Overall Study||1
10317767|NCT00203996|11451909|FG005|NOT COMPLETED|Overall Study||0
10317768|NCT00203996|11451910|FG006|NOT COMPLETED|Overall Study||0
10317769|NCT00203996|11451911|FG007|NOT COMPLETED|Overall Study||2
10317770|NCT00203996|11451912|FG008|NOT COMPLETED|Overall Study||0
10317771|NCT00203996|11451913|FG009|NOT COMPLETED|Overall Study||1
10317772|NCT00204373|11451929|FG000|STARTED|Overall Study||72
10317773|NCT00204373|11451929|FG000|COMPLETED|Overall Study||72
10317774|NCT00204373|11451929|FG000|NOT COMPLETED|Overall Study||0
10317775|NCT00204932|11451935|FG000|STARTED|Overall Study||24
10317776|NCT00204932|11451936|FG001|STARTED|Overall Study||24
10784748|NCT03443713|11945458|FG001|COMPLETED|Dexcom Insertion Visit (30 Minutes)||8
10784749|NCT03443713|11945459|FG002|COMPLETED|Dexcom Insertion Visit (30 Minutes)||8
10784750|NCT03443713|11945457|FG000|NOT COMPLETED|Dexcom Insertion Visit (30 Minutes)||0
10317777|NCT00204932|11451935|FG000|COMPLETED|Overall Study||22
10317778|NCT00204932|11451936|FG001|COMPLETED|Overall Study||18
10317779|NCT00204932|11451935|FG000|NOT COMPLETED|Overall Study||2
10317780|NCT00204932|11451936|FG001|NOT COMPLETED|Overall Study||6
10317781|NCT00205179|11451944|FG000|STARTED|Overall Study||32
10317782|NCT00205179|11451945|FG001|STARTED|Overall Study||33
10317783|NCT00205179|11451944|FG000|COMPLETED|Overall Study||30
10317784|NCT00205179|11451945|FG001|COMPLETED|Overall Study||29
10317785|NCT00205179|11451944|FG000|NOT COMPLETED|Overall Study||2
10317786|NCT00205179|11451945|FG001|NOT COMPLETED|Overall Study||4
10317787|NCT00205348|11451952|FG000|STARTED|Overall Study||146
10433043|NCT00883779|11579310|FG001|NOT COMPLETED|Post-Study Treatment Phase||135
10433044|NCT00883779|11579309|FG000|STARTED|Off-study Phase||209
10433045|NCT00883779|11579310|FG001|STARTED|Off-study Phase||202
10433046|NCT00883779|11579309|FG000|COMPLETED|Off-study Phase||0
10317788|NCT00205348|11451952|FG000|COMPLETED|Overall Study||116
10317789|NCT00205348|11451952|FG000|NOT COMPLETED|Overall Study||30
10317790|NCT00205374|11451958|FG000|STARTED|Overall Study||10
10317791|NCT00205374|11451959|FG001|STARTED|Overall Study||9
10317792|NCT00205374|11451958|FG000|COMPLETED|Overall Study||10
10317793|NCT00205374|11451959|FG001|COMPLETED|Overall Study||9
10317794|NCT00205374|11451958|FG000|NOT COMPLETED|Overall Study||0
10317795|NCT00205374|11451959|FG001|NOT COMPLETED|Overall Study||0
10317796|NCT00205504|11451967|FG000|STARTED|Overall Study||21
10317797|NCT00205504|11451968|FG001|STARTED|Overall Study||15
10317798|NCT00205504|11451967|FG000|COMPLETED|Overall Study||14
10317799|NCT00205504|11451968|FG001|COMPLETED|Overall Study||15
10317800|NCT00205504|11451967|FG000|NOT COMPLETED|Overall Study||7
10317801|NCT00205504|11451968|FG001|NOT COMPLETED|Overall Study||0
10317802|NCT00205660|11451980|FG000|STARTED|Overall Study||14
10317803|NCT00205660|11451981|FG001|STARTED|Overall Study||37
10317804|NCT00205660|11451980|FG000|COMPLETED|Overall Study||12
10317805|NCT00205660|11451981|FG001|COMPLETED|Overall Study||35
10317806|NCT00205660|11451980|FG000|NOT COMPLETED|Overall Study||2
10317807|NCT00205660|11451981|FG001|NOT COMPLETED|Overall Study||2
10317808|NCT00205699|11451991|FG000|STARTED|Overall Study||49
10317809|NCT00205699|11451992|FG001|STARTED|Overall Study||46
10317810|NCT00205699|11451993|FG002|STARTED|Overall Study||49
10317811|NCT00205699|11451991|FG000|COMPLETED|Overall Study||46
10317812|NCT00205699|11451992|FG001|COMPLETED|Overall Study||40
10317813|NCT00205699|11451993|FG002|COMPLETED|Overall Study||43
10317814|NCT00205699|11451991|FG000|NOT COMPLETED|Overall Study||3
10317815|NCT00205699|11451992|FG001|NOT COMPLETED|Overall Study||6
10317816|NCT00205699|11451993|FG002|NOT COMPLETED|Overall Study||6
10317817|NCT00205712|11452006|FG000|STARTED|Overall Study||20
10317818|NCT00205712|11452007|FG001|STARTED|Overall Study||20
10317819|NCT00205712|11452006|FG000|COMPLETED|Overall Study||20
10317820|NCT00205712|11452007|FG001|COMPLETED|Overall Study||19
10317821|NCT00205712|11452006|FG000|NOT COMPLETED|Overall Study||0
10317822|NCT00205712|11452007|FG001|NOT COMPLETED|Overall Study||1
10317823|NCT00205777|11452019|FG000|STARTED|Core Study (Up to 3 Years)||1907
10317824|NCT00205777|11452020|FG001|STARTED|Core Study (Up to 3 Years)||1904
10317825|NCT00205777|11452021|FG002|STARTED|Core Study (Up to 3 Years)||1884
10317826|NCT00205777|11452022|FG003|STARTED|Core Study (Up to 3 Years)||1914
10317827|NCT00205777|11452023|FG004|STARTED|Core Study (Up to 3 Years)||0
10317828|NCT00205777|11452024|FG005|STARTED|Core Study (Up to 3 Years)||0
10317829|NCT00205777|11452019|FG000|TREATED|Core Study (Up to 3 Years)||1886
10317830|NCT00205777|11452020|FG001|TREATED|Core Study (Up to 3 Years)||1872
10317831|NCT00205777|11452021|FG002|TREATED|Core Study (Up to 3 Years)||1849
10317832|NCT00205777|11452022|FG003|TREATED|Core Study (Up to 3 Years)||1885
10317833|NCT00205777|11452023|FG004|TREATED|Core Study (Up to 3 Years)||0
10317834|NCT00205777|11452024|FG005|TREATED|Core Study (Up to 3 Years)||0
10317835|NCT00205777|11452019|FG000|COMPLETED|Core Study (Up to 3 Years)||1279
10317836|NCT00205777|11452020|FG001|COMPLETED|Core Study (Up to 3 Years)||1245
10317837|NCT00205777|11452021|FG002|COMPLETED|Core Study (Up to 3 Years)||1277
10317838|NCT00205777|11452022|FG003|COMPLETED|Core Study (Up to 3 Years)||1282
10317839|NCT00205777|11452023|FG004|COMPLETED|Core Study (Up to 3 Years)||0
10317840|NCT00205777|11452024|FG005|COMPLETED|Core Study (Up to 3 Years)||0
10317841|NCT00205777|11452019|FG000|NOT COMPLETED|Core Study (Up to 3 Years)||628
10317842|NCT00205777|11452020|FG001|NOT COMPLETED|Core Study (Up to 3 Years)||659
10317843|NCT00205777|11452021|FG002|NOT COMPLETED|Core Study (Up to 3 Years)||607
10317844|NCT00205777|11452022|FG003|NOT COMPLETED|Core Study (Up to 3 Years)||632
10317845|NCT00205777|11452023|FG004|NOT COMPLETED|Core Study (Up to 3 Years)||0
10317846|NCT00205777|11452024|FG005|NOT COMPLETED|Core Study (Up to 3 Years)||0
10317847|NCT00205777|11452019|FG000|STARTED|Completed Core Study, Entered SE I||1279
10317848|NCT00205777|11452020|FG001|STARTED|Completed Core Study, Entered SE I||1245
10317849|NCT00205777|11452021|FG002|STARTED|Completed Core Study, Entered SE I||1277
10317850|NCT00205777|11452022|FG003|STARTED|Completed Core Study, Entered SE I||1282
10317851|NCT00205777|11452023|FG004|STARTED|Completed Core Study, Entered SE I||0
10317852|NCT00205777|11452024|FG005|STARTED|Completed Core Study, Entered SE I||0
10317853|NCT00205777|11452019|FG000|COMPLETED|Completed Core Study, Entered SE I||1047
10317854|NCT00205777|11452020|FG001|COMPLETED|Completed Core Study, Entered SE I||1041
10317855|NCT00205777|11452021|FG002|COMPLETED|Completed Core Study, Entered SE I||1070
10317856|NCT00205777|11452022|FG003|COMPLETED|Completed Core Study, Entered SE I||1058
10317857|NCT00205777|11452023|FG004|COMPLETED|Completed Core Study, Entered SE I||0
10317858|NCT00205777|11452024|FG005|COMPLETED|Completed Core Study, Entered SE I||0
10784751|NCT03443713|11945458|FG001|NOT COMPLETED|Dexcom Insertion Visit (30 Minutes)||0
10784752|NCT03443713|11945459|FG002|NOT COMPLETED|Dexcom Insertion Visit (30 Minutes)||0
10784753|NCT03443713|11945457|FG000|STARTED|Second at Home Period (2-11 Days)||8
10784754|NCT03443713|11945458|FG001|STARTED|Second at Home Period (2-11 Days)||8
10784755|NCT03443713|11945459|FG002|STARTED|Second at Home Period (2-11 Days)||8
10784756|NCT03443713|11945457|FG000|COMPLETED|Second at Home Period (2-11 Days)||8
10784757|NCT03443713|11945458|FG001|COMPLETED|Second at Home Period (2-11 Days)||8
10317859|NCT00205777|11452019|FG000|NOT COMPLETED|Completed Core Study, Entered SE I||232
10317860|NCT00205777|11452020|FG001|NOT COMPLETED|Completed Core Study, Entered SE I||204
10317861|NCT00205777|11452021|FG002|NOT COMPLETED|Completed Core Study, Entered SE I||207
10317862|NCT00205777|11452022|FG003|NOT COMPLETED|Completed Core Study, Entered SE I||224
10317863|NCT00205777|11452023|FG004|NOT COMPLETED|Completed Core Study, Entered SE I||0
10317864|NCT00205777|11452024|FG005|NOT COMPLETED|Completed Core Study, Entered SE I||0
10784758|NCT03443713|11945459|FG002|COMPLETED|Second at Home Period (2-11 Days)||8
10784759|NCT03443713|11945457|FG000|NOT COMPLETED|Second at Home Period (2-11 Days)||0
10784760|NCT03443713|11945458|FG001|NOT COMPLETED|Second at Home Period (2-11 Days)||0
10784761|NCT03443713|11945459|FG002|NOT COMPLETED|Second at Home Period (2-11 Days)||0
10784762|NCT03443713|11945457|FG000|STARTED|Second Exercise Visit (1 Hour)||8
10784763|NCT03443713|11945458|FG001|STARTED|Second Exercise Visit (1 Hour)||8
10784764|NCT03443713|11945459|FG002|STARTED|Second Exercise Visit (1 Hour)||8
10784765|NCT03443713|11945457|FG000|COMPLETED|Second Exercise Visit (1 Hour)||8
10784766|NCT03443713|11945458|FG001|COMPLETED|Second Exercise Visit (1 Hour)||8
10784767|NCT03443713|11945459|FG002|COMPLETED|Second Exercise Visit (1 Hour)||8
10784768|NCT03443713|11945457|FG000|NOT COMPLETED|Second Exercise Visit (1 Hour)||0
10784769|NCT03443713|11945458|FG001|NOT COMPLETED|Second Exercise Visit (1 Hour)||0
10784770|NCT03443713|11945459|FG002|NOT COMPLETED|Second Exercise Visit (1 Hour)||0
10784771|NCT03443713|11945457|FG000|STARTED|Third at Home Period (8-12 Days)||8
10784772|NCT03443713|11945458|FG001|STARTED|Third at Home Period (8-12 Days)||8
10784773|NCT03443713|11945459|FG002|STARTED|Third at Home Period (8-12 Days)||8
10784774|NCT03443713|11945457|FG000|COMPLETED|Third at Home Period (8-12 Days)||8
10784775|NCT03443713|11945458|FG001|COMPLETED|Third at Home Period (8-12 Days)||8
10784776|NCT03443713|11945459|FG002|COMPLETED|Third at Home Period (8-12 Days)||8
10784777|NCT03443713|11945457|FG000|NOT COMPLETED|Third at Home Period (8-12 Days)||0
10317865|NCT00205777|11452019|FG000|STARTED|Study Extension I||1047
10784778|NCT03443713|11945458|FG001|NOT COMPLETED|Third at Home Period (8-12 Days)||0
10784779|NCT03443713|11945459|FG002|NOT COMPLETED|Third at Home Period (8-12 Days)||0
10784780|NCT03443713|11945457|FG000|STARTED|Close-out Visit (30 Minutes)||8
10784781|NCT03443713|11945458|FG001|STARTED|Close-out Visit (30 Minutes)||8
10784782|NCT03443713|11945459|FG002|STARTED|Close-out Visit (30 Minutes)||8
10784783|NCT03443713|11945457|FG000|COMPLETED|Close-out Visit (30 Minutes)||8
10784784|NCT03443713|11945458|FG001|COMPLETED|Close-out Visit (30 Minutes)||8
10784785|NCT03443713|11945459|FG002|COMPLETED|Close-out Visit (30 Minutes)||8
10784786|NCT03443713|11945457|FG000|NOT COMPLETED|Close-out Visit (30 Minutes)||0
10784787|NCT03443713|11945458|FG001|NOT COMPLETED|Close-out Visit (30 Minutes)||0
10784788|NCT03443713|11945459|FG002|NOT COMPLETED|Close-out Visit (30 Minutes)||0
10784789|NCT03444090|11945473|FG000|STARTED|Overall Study||214
10784790|NCT03444090|11945474|FG001|STARTED|Overall Study||214
10784791|NCT03444090|11945473|FG000|COMPLETED|Overall Study||211
10784792|NCT03444090|11945474|FG001|COMPLETED|Overall Study||210
10784793|NCT03444090|11945473|FG000|NOT COMPLETED|Overall Study||3
10784794|NCT03444090|11945474|FG001|NOT COMPLETED|Overall Study||4
10784795|NCT03444155|11945482|FG000|STARTED|First Intervention (6 Weeks)||15
10784796|NCT03444155|11945483|FG001|STARTED|First Intervention (6 Weeks)||15
10784797|NCT03444155|11945482|FG000|COMPLETED|First Intervention (6 Weeks)||14
10784798|NCT03444155|11945483|FG001|COMPLETED|First Intervention (6 Weeks)||15
10784799|NCT03444155|11945482|FG000|NOT COMPLETED|First Intervention (6 Weeks)||1
10784800|NCT03444155|11945483|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
10784801|NCT03444155|11945482|FG000|STARTED|Washout (2 Weeks)||14
10784802|NCT03444155|11945483|FG001|STARTED|Washout (2 Weeks)||15
10784803|NCT03444155|11945482|FG000|COMPLETED|Washout (2 Weeks)||14
10784804|NCT03444155|11945483|FG001|COMPLETED|Washout (2 Weeks)||15
10784805|NCT03444155|11945482|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10784806|NCT03444155|11945483|FG001|NOT COMPLETED|Washout (2 Weeks)||0
10784807|NCT03444155|11945482|FG000|STARTED|Second Intervention (6 Weeks)||14
10784808|NCT03444155|11945483|FG001|STARTED|Second Intervention (6 Weeks)||15
10784809|NCT03444155|11945482|FG000|COMPLETED|Second Intervention (6 Weeks)||14
10784810|NCT03444155|11945483|FG001|COMPLETED|Second Intervention (6 Weeks)||15
10784811|NCT03444155|11945482|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
10784812|NCT03444155|11945483|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
10784813|NCT03444584|11945491|FG000|STARTED|Overall Study||24
10784814|NCT03444584|11945492|FG001|STARTED|Overall Study||25
10784815|NCT03444584|11945491|FG000|COMPLETED|Overall Study||24
10784816|NCT03444584|11945492|FG001|COMPLETED|Overall Study||23
10784817|NCT03444584|11945491|FG000|NOT COMPLETED|Overall Study||0
10784818|NCT03444584|11945492|FG001|NOT COMPLETED|Overall Study||2
10784819|NCT03444766|11945499|FG000|STARTED|Overall Study||100
10784820|NCT03444766|11945499|FG000|COMPLETED|Overall Study||34
10784821|NCT03444766|11945499|FG000|NOT COMPLETED|Overall Study||66
10784822|NCT03444961|11945503|FG000|STARTED|Overall Study||4
10784823|NCT03444961|11945503|FG000|COMPLETED|Overall Study||4
10784824|NCT03444961|11945503|FG000|NOT COMPLETED|Overall Study||0
10784825|NCT03445065|11945515|FG000|STARTED|Overall Study||97
10784826|NCT03445065|11945516|FG001|STARTED|Overall Study||52
10784827|NCT03445065|11945517|FG002|STARTED|Overall Study||62
10784828|NCT03445065|11945518|FG003|STARTED|Overall Study||28
10784829|NCT03445065|11945515|FG000|COMPLETED|Overall Study||90
10784830|NCT03445065|11945516|FG001|COMPLETED|Overall Study||43
10784831|NCT03445065|11945517|FG002|COMPLETED|Overall Study||57
10784832|NCT03445065|11945518|FG003|COMPLETED|Overall Study||25
10784833|NCT03445065|11945515|FG000|NOT COMPLETED|Overall Study||7
10784834|NCT03445065|11945516|FG001|NOT COMPLETED|Overall Study||9
10784835|NCT03445065|11945517|FG002|NOT COMPLETED|Overall Study||5
10784836|NCT03445065|11945518|FG003|NOT COMPLETED|Overall Study||3
10784837|NCT03445156|11945543|FG000|STARTED|Pilot Study||20
10784838|NCT03445156|11945544|FG001|STARTED|Pilot Study||20
10784839|NCT03445156|11945545|FG002|STARTED|Pilot Study||0
10784840|NCT03445156|11945543|FG000|COMPLETED|Pilot Study||20
10784841|NCT03445156|11945544|FG001|COMPLETED|Pilot Study||20
10317866|NCT00205777|11452020|FG001|STARTED|Study Extension I||0
10317867|NCT00205777|11452021|FG002|STARTED|Study Extension I||1070
10317868|NCT00205777|11452022|FG003|STARTED|Study Extension I||1058
10317869|NCT00205777|11452023|FG004|STARTED|Study Extension I||1041
10317870|NCT00205777|11452024|FG005|STARTED|Study Extension I||0
10317871|NCT00205777|11452019|FG000|COMPLETED|Study Extension I||833
10317872|NCT00205777|11452020|FG001|COMPLETED|Study Extension I||0
10317873|NCT00205777|11452021|FG002|COMPLETED|Study Extension I||0
10317874|NCT00205777|11452022|FG003|COMPLETED|Study Extension I||830
10317875|NCT00205777|11452023|FG004|COMPLETED|Study Extension I||840
10317876|NCT00205777|11452024|FG005|COMPLETED|Study Extension I||0
10317877|NCT00205777|11452019|FG000|NOT COMPLETED|Study Extension I||214
10317878|NCT00205777|11452020|FG001|NOT COMPLETED|Study Extension I||0
10317879|NCT00205777|11452021|FG002|NOT COMPLETED|Study Extension I||1070
10317880|NCT00205777|11452022|FG003|NOT COMPLETED|Study Extension I||228
10317881|NCT00205777|11452023|FG004|NOT COMPLETED|Study Extension I||201
10317882|NCT00205777|11452024|FG005|NOT COMPLETED|Study Extension I||0
10317883|NCT00205777|11452019|FG000|STARTED|Completed SE I, Entered Extension SE II||833
10317884|NCT00205777|11452020|FG001|STARTED|Completed SE I, Entered Extension SE II||0
10317885|NCT00205777|11452021|FG002|STARTED|Completed SE I, Entered Extension SE II||0
10317886|NCT00205777|11452022|FG003|STARTED|Completed SE I, Entered Extension SE II||830
10317887|NCT00205777|11452023|FG004|STARTED|Completed SE I, Entered Extension SE II||840
10317888|NCT00205777|11452024|FG005|STARTED|Completed SE I, Entered Extension SE II||0
10317889|NCT00205777|11452019|FG000|COMPLETED|Completed SE I, Entered Extension SE II||560
10317890|NCT00205777|11452020|FG001|COMPLETED|Completed SE I, Entered Extension SE II||0
10317891|NCT00205777|11452021|FG002|COMPLETED|Completed SE I, Entered Extension SE II||0
10317892|NCT00205777|11452022|FG003|COMPLETED|Completed SE I, Entered Extension SE II||590
10317893|NCT00205777|11452023|FG004|COMPLETED|Completed SE I, Entered Extension SE II||582
10317894|NCT00205777|11452024|FG005|COMPLETED|Completed SE I, Entered Extension SE II||0
10317895|NCT00205777|11452019|FG000|NOT COMPLETED|Completed SE I, Entered Extension SE II||273
10317896|NCT00205777|11452020|FG001|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
10317897|NCT00205777|11452021|FG002|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
10317898|NCT00205777|11452022|FG003|NOT COMPLETED|Completed SE I, Entered Extension SE II||240
10317899|NCT00205777|11452023|FG004|NOT COMPLETED|Completed SE I, Entered Extension SE II||258
10317900|NCT00205777|11452024|FG005|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
10317901|NCT00205777|11452019|FG000|STARTED|Study Extension II||0
10317902|NCT00205777|11452020|FG001|STARTED|Study Extension II||0
10317903|NCT00205777|11452021|FG002|STARTED|Study Extension II||0
10317904|NCT00205777|11452022|FG003|STARTED|Study Extension II||590
10317905|NCT00205777|11452023|FG004|STARTED|Study Extension II||0
10317906|NCT00205777|11452024|FG005|STARTED|Study Extension II||1142
10317907|NCT00205777|11452019|FG000|TREATED|Study Extension II||0
10317908|NCT00205777|11452020|FG001|TREATED|Study Extension II||0
10317909|NCT00205777|11452021|FG002|TREATED|Study Extension II||0
10317910|NCT00205777|11452022|FG003|TREATED|Study Extension II||519
10317911|NCT00205777|11452023|FG004|TREATED|Study Extension II||0
10317912|NCT00205777|11452024|FG005|TREATED|Study Extension II||1011
10317913|NCT00205777|11452019|FG000|COMPLETED|Study Extension II||0
10317914|NCT00205777|11452020|FG001|COMPLETED|Study Extension II||0
10317915|NCT00205777|11452021|FG002|COMPLETED|Study Extension II||0
10317916|NCT00205777|11452022|FG003|COMPLETED|Study Extension II||441
10317917|NCT00205777|11452023|FG004|COMPLETED|Study Extension II||0
10317918|NCT00205777|11452024|FG005|COMPLETED|Study Extension II||860
10317919|NCT00205777|11452019|FG000|NOT COMPLETED|Study Extension II||0
10317920|NCT00205777|11452020|FG001|NOT COMPLETED|Study Extension II||0
10317921|NCT00205777|11452021|FG002|NOT COMPLETED|Study Extension II||0
10317922|NCT00205777|11452022|FG003|NOT COMPLETED|Study Extension II||149
10317923|NCT00205777|11452023|FG004|NOT COMPLETED|Study Extension II||0
10317924|NCT00205777|11452024|FG005|NOT COMPLETED|Study Extension II||282
10317925|NCT00205803|11452041|FG000|STARTED|Infant Series||122
10317926|NCT00205803|11452042|FG001|STARTED|Infant Series||127
10317927|NCT00205803|11452041|FG000|Vaccinated Dose 1|Infant Series||121
10317928|NCT00205803|11452042|FG001|Vaccinated Dose 1|Infant Series||126
10317929|NCT00205803|11452041|FG000|Vaccinated Dose 2|Infant Series||115
10317930|NCT00205803|11452042|FG001|Vaccinated Dose 2|Infant Series||122
10317931|NCT00205803|11452041|FG000|Vaccinated Dose 3|Infant Series||110
10317932|NCT00205803|11452042|FG001|Vaccinated Dose 3|Infant Series||118
10317933|NCT00205803|11452041|FG000|COMPLETED|Infant Series||104
10317934|NCT00205803|11452042|FG001|COMPLETED|Infant Series||116
10317935|NCT00205803|11452041|FG000|NOT COMPLETED|Infant Series||18
10317936|NCT00205803|11452042|FG001|NOT COMPLETED|Infant Series||11
10317937|NCT00205803|11452041|FG000|STARTED|After Infant Series||104
10317938|NCT00205803|11452042|FG001|STARTED|After Infant Series||116
10317939|NCT00205803|11452041|FG000|COMPLETED|After Infant Series||86
10317940|NCT00205803|11452042|FG001|COMPLETED|After Infant Series||103
10317941|NCT00205803|11452041|FG000|NOT COMPLETED|After Infant Series||18
10317942|NCT00205803|11452042|FG001|NOT COMPLETED|After Infant Series||13
10317943|NCT00205803|11452041|FG000|STARTED|Toddler Dose||86
10317944|NCT00205803|11452042|FG001|STARTED|Toddler Dose||103
10317945|NCT00205803|11452041|FG000|COMPLETED|Toddler Dose||84
10317946|NCT00205803|11452042|FG001|COMPLETED|Toddler Dose||100
10317947|NCT00205803|11452041|FG000|NOT COMPLETED|Toddler Dose||2
10317948|NCT00205803|11452042|FG001|NOT COMPLETED|Toddler Dose||3
10317949|NCT00205855|11452066|FG000|STARTED|Overall Study||65
10317950|NCT00205855|11452066|FG000|COMPLETED|Overall Study||44
10317951|NCT00205855|11452066|FG000|NOT COMPLETED|Overall Study||21
10317952|NCT00205881|11452070|FG000|STARTED|Overall Study||32
10317953|NCT00205881|11452070|FG000|COMPLETED|Overall Study|32 enrolled. 1 unilateral. 25 bilateral for data analysis at 8 months. 16 completed study.|16
10317954|NCT00205881|11452070|FG000|NOT COMPLETED|Overall Study||16
10317955|NCT00206076|11452077|FG000|STARTED|Overall Study||9
10317956|NCT00206076|11452078|FG001|STARTED|Overall Study||10
10317957|NCT00206076|11452077|FG000|COMPLETED|Overall Study||6
10317958|NCT00206076|11452078|FG001|COMPLETED|Overall Study||9
10317959|NCT00206076|11452077|FG000|NOT COMPLETED|Overall Study||3
10317960|NCT00206076|11452078|FG001|NOT COMPLETED|Overall Study||1
10317961|NCT00206102|11452088|FG000|STARTED|Overall Study||596
10317962|NCT00206102|11452089|FG001|STARTED|Overall Study||502
10317963|NCT00206102|11452088|FG000|COMPLETED|Overall Study||188
10317964|NCT00206102|11452089|FG001|COMPLETED|Overall Study||187
10317965|NCT00206102|11452088|FG000|NOT COMPLETED|Overall Study||408
10317966|NCT00206102|11452089|FG001|NOT COMPLETED|Overall Study||315
10317967|NCT00206323|11452097|FG000|STARTED|Overall Study||14
10317968|NCT00206323|11452098|FG001|STARTED|Overall Study||15
10317969|NCT00206323|11452097|FG000|COMPLETED|Overall Study||8
10317970|NCT00206323|11452098|FG001|COMPLETED|Overall Study||12
10317971|NCT00206323|11452097|FG000|NOT COMPLETED|Overall Study||6
10317972|NCT00206323|11452098|FG001|NOT COMPLETED|Overall Study||3
10317973|NCT00206336|11452104|FG000|STARTED|Overall Study||20
10317974|NCT00206336|11452104|FG000|COMPLETED|Overall Study||20
10317975|NCT00206336|11452104|FG000|NOT COMPLETED|Overall Study||0
10317976|NCT00206427|11452108|FG000|STARTED|Overall Study|Received First Dose|49
10317977|NCT00206427|11452108|FG000|COMPLETED|Overall Study|Complete 6-week therapy|47
10317978|NCT00206427|11452108|FG000|NOT COMPLETED|Overall Study||2
10338366|NCT00369577|11475262|FG002|STARTED|Overall Study||41
10338367|NCT00369577|11475260|FG000|COMPLETED|Overall Study||43
10338368|NCT00369577|11475261|FG001|COMPLETED|Overall Study||45
10338369|NCT00369577|11475262|FG002|COMPLETED|Overall Study||40
10338370|NCT00369577|11475260|FG000|NOT COMPLETED|Overall Study||0
10338371|NCT00369577|11475261|FG001|NOT COMPLETED|Overall Study||0
10338372|NCT00369577|11475262|FG002|NOT COMPLETED|Overall Study||1
10338373|NCT00369590|11475272|FG000|STARTED|Overall Study||16
10338374|NCT00369590|11475273|FG001|STARTED|Overall Study||42
10338375|NCT00369590|11475272|FG000|COMPLETED|Overall Study||16
10338376|NCT00369590|11475273|FG001|COMPLETED|Overall Study||42
10338377|NCT00369590|11475272|FG000|NOT COMPLETED|Overall Study||0
10338378|NCT00369590|11475273|FG001|NOT COMPLETED|Overall Study||0
10338379|NCT00369629|11475278|FG000|STARTED|Treated 2 Cycles/Reached First Response||6
10338380|NCT00369629|11475279|FG001|STARTED|Treated 2 Cycles/Reached First Response||3
10338381|NCT00369629|11475280|FG002|STARTED|Treated 2 Cycles/Reached First Response||5
10338382|NCT00369629|11475281|FG003|STARTED|Treated 2 Cycles/Reached First Response|No patients were enrolled at this dose level as the study closed early due to lack of funding.|0
10338383|NCT00369629|11475278|FG000|COMPLETED|Treated 2 Cycles/Reached First Response||4
10338384|NCT00369629|11475279|FG001|COMPLETED|Treated 2 Cycles/Reached First Response||2
10338385|NCT00369629|11475280|FG002|COMPLETED|Treated 2 Cycles/Reached First Response||3
10338386|NCT00369629|11475281|FG003|COMPLETED|Treated 2 Cycles/Reached First Response||0
10338387|NCT00369629|11475278|FG000|NOT COMPLETED|Treated 2 Cycles/Reached First Response||2
10338388|NCT00369629|11475279|FG001|NOT COMPLETED|Treated 2 Cycles/Reached First Response||1
10338389|NCT00369629|11475280|FG002|NOT COMPLETED|Treated 2 Cycles/Reached First Response||2
10338390|NCT00369629|11475281|FG003|NOT COMPLETED|Treated 2 Cycles/Reached First Response||0
10338391|NCT00369629|11475278|FG000|STARTED|Moved on to 4 More Cycles||4
10338392|NCT00369629|11475279|FG001|STARTED|Moved on to 4 More Cycles||2
10338393|NCT00369629|11475280|FG002|STARTED|Moved on to 4 More Cycles||3
10338394|NCT00369629|11475281|FG003|STARTED|Moved on to 4 More Cycles||0
10338395|NCT00369629|11475278|FG000|COMPLETED|Moved on to 4 More Cycles||4
10338396|NCT00369629|11475279|FG001|COMPLETED|Moved on to 4 More Cycles||2
10338397|NCT00369629|11475280|FG002|COMPLETED|Moved on to 4 More Cycles||2
10338398|NCT00369629|11475281|FG003|COMPLETED|Moved on to 4 More Cycles||0
10338399|NCT00369629|11475278|FG000|NOT COMPLETED|Moved on to 4 More Cycles||0
10338400|NCT00369629|11475279|FG001|NOT COMPLETED|Moved on to 4 More Cycles||0
10338401|NCT00369629|11475280|FG002|NOT COMPLETED|Moved on to 4 More Cycles||1
10338402|NCT00369629|11475281|FG003|NOT COMPLETED|Moved on to 4 More Cycles||0
10338403|NCT00369629|11475278|FG000|STARTED|Completed 4 More Cycles||4
10338404|NCT00369629|11475279|FG001|STARTED|Completed 4 More Cycles||2
10338405|NCT00369629|11475280|FG002|STARTED|Completed 4 More Cycles||2
10338406|NCT00369629|11475281|FG003|STARTED|Completed 4 More Cycles||0
10338407|NCT00369629|11475278|FG000|COMPLETED|Completed 4 More Cycles||0
10338408|NCT00369629|11475279|FG001|COMPLETED|Completed 4 More Cycles||0
10338409|NCT00369629|11475280|FG002|COMPLETED|Completed 4 More Cycles||0
10338410|NCT00369629|11475281|FG003|COMPLETED|Completed 4 More Cycles||0
10338411|NCT00369629|11475278|FG000|NOT COMPLETED|Completed 4 More Cycles||4
10338412|NCT00369629|11475279|FG001|NOT COMPLETED|Completed 4 More Cycles||2
10338413|NCT00369629|11475280|FG002|NOT COMPLETED|Completed 4 More Cycles||2
10338414|NCT00369629|11475281|FG003|NOT COMPLETED|Completed 4 More Cycles||0
10338415|NCT00369629|11475278|FG000|STARTED|Follow up for 1 Year|All patients treated on study go into the follow up period|6
10338416|NCT00369629|11475279|FG001|STARTED|Follow up for 1 Year||3
10338417|NCT00369629|11475280|FG002|STARTED|Follow up for 1 Year||5
10338418|NCT00369629|11475281|FG003|STARTED|Follow up for 1 Year||0
10338419|NCT00369629|11475278|FG000|COMPLETED|Follow up for 1 Year||4
10338420|NCT00369629|11475279|FG001|COMPLETED|Follow up for 1 Year||1
10338421|NCT00369629|11475280|FG002|COMPLETED|Follow up for 1 Year||2
10317979|NCT00206440|11452114|FG000|STARTED|Overall Study||21
10317980|NCT00206440|11452115|FG001|STARTED|Overall Study||22
10317981|NCT00206440|11452114|FG000|COMPLETED|Overall Study||16
10317982|NCT00206440|11452115|FG001|COMPLETED|Overall Study||18
10317983|NCT00206440|11452114|FG000|NOT COMPLETED|Overall Study||5
10317984|NCT00206440|11452115|FG001|NOT COMPLETED|Overall Study||4
10317985|NCT00206518|11452123|FG000|STARTED|Overall Study||83
10317986|NCT00206518|11452124|FG001|STARTED|Overall Study||84
10317987|NCT00206518|11452123|FG000|COMPLETED|Overall Study||73
10317988|NCT00206518|11452124|FG001|COMPLETED|Overall Study||78
10317989|NCT00206518|11452123|FG000|NOT COMPLETED|Overall Study||10
10317990|NCT00206518|11452124|FG001|NOT COMPLETED|Overall Study||6
10317991|NCT00206726|11452130|FG000|STARTED|Overall Study||60
10317992|NCT00206726|11452130|FG000|Treatment Started|Overall Study|Safety population (3 withdrew consent prior to receiving study drug)|57
10317993|NCT00206726|11452130|FG000|4 Cycles Completed|Overall Study|per protocol population|41
10317994|NCT00206726|11452130|FG000|COMPLETED|Overall Study|4-6 cycles of treatment with assessments at 2, 6, and 9 months post last dose|9
10317995|NCT00206726|11452130|FG000|NOT COMPLETED|Overall Study||51
10317996|NCT00207090|11452134|FG000|STARTED|Overall Study|Number of participants treated|15
10317997|NCT00207090|11452134|FG000|COMPLETED|Overall Study||8
10317998|NCT00207090|11452134|FG000|NOT COMPLETED|Overall Study||7
10317999|NCT00207142|11452146|FG000|STARTED|Induction Phase||252
10318000|NCT00207142|11452147|FG001|STARTED|Induction Phase||0
10318001|NCT00207142|11452148|FG002|STARTED|Induction Phase||0
10318002|NCT00207142|11452149|FG003|STARTED|Induction Phase||0
10318003|NCT00207142|11452146|FG000|COMPLETED|Induction Phase|Subjects randomized into Maintenance Phase=172 (87 ATV +85 ATV/RTV); Rescue Phase subjects=50|222
10318004|NCT00207142|11452147|FG001|COMPLETED|Induction Phase||0
10318005|NCT00207142|11452148|FG002|COMPLETED|Induction Phase||0
10318006|NCT00207142|11452149|FG003|COMPLETED|Induction Phase||0
10318007|NCT00207142|11452146|FG000|NOT COMPLETED|Induction Phase||30
10318008|NCT00207142|11452147|FG001|NOT COMPLETED|Induction Phase||0
10318009|NCT00207142|11452148|FG002|NOT COMPLETED|Induction Phase||0
10318010|NCT00207142|11452149|FG003|NOT COMPLETED|Induction Phase||0
10318011|NCT00207142|11452146|FG000|STARTED|Maintenance Phase/Rescue Phase||0
10318012|NCT00207142|11452147|FG001|STARTED|Maintenance Phase/Rescue Phase||87
10318013|NCT00207142|11452148|FG002|STARTED|Maintenance Phase/Rescue Phase||85
10318014|NCT00207142|11452149|FG003|STARTED|Maintenance Phase/Rescue Phase||50
10318015|NCT00207142|11452146|FG000|COMPLETED|Maintenance Phase/Rescue Phase||0
10318016|NCT00207142|11452147|FG001|COMPLETED|Maintenance Phase/Rescue Phase||78
10318017|NCT00207142|11452148|FG002|COMPLETED|Maintenance Phase/Rescue Phase||72
10318018|NCT00207142|11452149|FG003|COMPLETED|Maintenance Phase/Rescue Phase||41
10318019|NCT00207142|11452146|FG000|NOT COMPLETED|Maintenance Phase/Rescue Phase||0
10318020|NCT00207142|11452147|FG001|NOT COMPLETED|Maintenance Phase/Rescue Phase||9
10318021|NCT00207142|11452148|FG002|NOT COMPLETED|Maintenance Phase/Rescue Phase||13
10318022|NCT00207142|11452149|FG003|NOT COMPLETED|Maintenance Phase/Rescue Phase||9
10318023|NCT00207714|11452169|FG000|STARTED|Overall Study||35
10318024|NCT00207714|11452170|FG001|STARTED|Overall Study||35
10318025|NCT00207714|11452171|FG002|STARTED|Overall Study||34
10318026|NCT00207714|11452172|FG003|STARTED|Overall Study||34
10318027|NCT00207714|11452173|FG004|STARTED|Overall Study||34
10318028|NCT00207714|11452169|FG000|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|21
10318029|NCT00207714|11452170|FG001|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|28
10318030|NCT00207714|11452171|FG002|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|24
10318031|NCT00207714|11452172|FG003|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|26
10318032|NCT00207714|11452173|FG004|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|29
10318033|NCT00207714|11452169|FG000|NOT COMPLETED|Overall Study||14
10318034|NCT00207714|11452170|FG001|NOT COMPLETED|Overall Study||7
10318035|NCT00207714|11452171|FG002|NOT COMPLETED|Overall Study||10
10318036|NCT00207714|11452172|FG003|NOT COMPLETED|Overall Study||8
10318037|NCT00207714|11452173|FG004|NOT COMPLETED|Overall Study||5
10318038|NCT00207727|11452197|FG000|STARTED|Overall Study||49
10318039|NCT00207727|11452198|FG001|STARTED|Overall Study||50
10318040|NCT00207727|11452199|FG002|STARTED|Overall Study||50
10318041|NCT00207727|11452200|FG003|STARTED|Overall Study||50
10318042|NCT00207727|11452201|FG004|STARTED|Overall Study||50
10318043|NCT00207727|11452197|FG000|COMPLETED|Overall Study||11
10784842|NCT03445156|11945545|FG002|COMPLETED|Pilot Study||0
10784843|NCT03445156|11945543|FG000|NOT COMPLETED|Pilot Study||0
10784844|NCT03445156|11945544|FG001|NOT COMPLETED|Pilot Study||0
10784845|NCT03445156|11945545|FG002|NOT COMPLETED|Pilot Study||0
10784846|NCT03445156|11945543|FG000|STARTED|Experiment Proper||113
10318044|NCT00207727|11452198|FG001|COMPLETED|Overall Study||8
10318045|NCT00207727|11452199|FG002|COMPLETED|Overall Study||9
10318046|NCT00207727|11452200|FG003|COMPLETED|Overall Study||13
10318047|NCT00207727|11452201|FG004|COMPLETED|Overall Study||16
10318048|NCT00207727|11452197|FG000|NOT COMPLETED|Overall Study||38
10318049|NCT00207727|11452198|FG001|NOT COMPLETED|Overall Study||42
10784847|NCT03445156|11945544|FG001|STARTED|Experiment Proper||115
10318050|NCT00207727|11452199|FG002|NOT COMPLETED|Overall Study||41
10318051|NCT00207727|11452200|FG003|NOT COMPLETED|Overall Study||37
10318052|NCT00207727|11452201|FG004|NOT COMPLETED|Overall Study||34
10318053|NCT00207740|11452217|FG000|STARTED|Overall Study||78
10784848|NCT03445156|11945545|FG002|STARTED|Experiment Proper||59
10784849|NCT03445156|11945543|FG000|COMPLETED|Experiment Proper||113
10318054|NCT00207740|11452218|FG001|STARTED|Overall Study||77
10318055|NCT00207740|11452219|FG002|STARTED|Overall Study||76
10318056|NCT00207740|11452220|FG003|STARTED|Overall Study||78
10318057|NCT00207740|11452217|FG000|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|49
10318058|NCT00207740|11452218|FG001|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|36
10318059|NCT00207740|11452219|FG002|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|36
10318060|NCT00207740|11452220|FG003|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|35
10318061|NCT00207740|11452217|FG000|NOT COMPLETED|Overall Study||29
10318062|NCT00207740|11452218|FG001|NOT COMPLETED|Overall Study||41
10318063|NCT00207740|11452219|FG002|NOT COMPLETED|Overall Study||40
10318064|NCT00207740|11452220|FG003|NOT COMPLETED|Overall Study||43
10318065|NCT00207883|11452236|FG000|STARTED|Overall Study||93
10784850|NCT03445156|11945544|FG001|COMPLETED|Experiment Proper||115
10784851|NCT03445156|11945545|FG002|COMPLETED|Experiment Proper||59
10784852|NCT03445156|11945543|FG000|NOT COMPLETED|Experiment Proper||0
10318066|NCT00207883|11452237|FG001|STARTED|Overall Study||119
10318067|NCT00207883|11452236|FG000|COMPLETED|Overall Study||93
10318068|NCT00207883|11452237|FG001|COMPLETED|Overall Study||119
10318069|NCT00207883|11452236|FG000|NOT COMPLETED|Overall Study||0
10318070|NCT00207883|11452237|FG001|NOT COMPLETED|Overall Study||0
10318071|NCT00208026|11452243|FG000|STARTED|Overall Study||3
10318072|NCT00208026|11452243|FG000|COMPLETED|Overall Study||3
10784853|NCT03445156|11945544|FG001|NOT COMPLETED|Experiment Proper||0
10784854|NCT03445156|11945545|FG002|NOT COMPLETED|Experiment Proper||0
10784855|NCT03445195|11945559|FG000|STARTED|Overall Study||53
10784856|NCT03445195|11945560|FG001|STARTED|Overall Study||27
10784857|NCT03445195|11945559|FG000|COMPLETED|Overall Study||51
10784858|NCT03445195|11945560|FG001|COMPLETED|Overall Study||27
10784859|NCT03445195|11945559|FG000|NOT COMPLETED|Overall Study||2
10784860|NCT03445195|11945560|FG001|NOT COMPLETED|Overall Study||0
10784861|NCT03445390|11945566|FG000|STARTED|First Intervention||14
10784862|NCT03445390|11945567|FG001|STARTED|First Intervention||13
10784863|NCT03445390|11945566|FG000|COMPLETED|First Intervention||12
10784864|NCT03445390|11945567|FG001|COMPLETED|First Intervention||11
10784865|NCT03445390|11945566|FG000|NOT COMPLETED|First Intervention||2
10784866|NCT03445390|11945567|FG001|NOT COMPLETED|First Intervention||2
10784867|NCT03445390|11945566|FG000|STARTED|Second Intervention||12
10784868|NCT03445390|11945567|FG001|STARTED|Second Intervention||11
10784869|NCT03445390|11945566|FG000|COMPLETED|Second Intervention||10
10784870|NCT03445390|11945567|FG001|COMPLETED|Second Intervention||10
10784871|NCT03445390|11945566|FG000|NOT COMPLETED|Second Intervention||2
10784872|NCT03445390|11945567|FG001|NOT COMPLETED|Second Intervention||1
10784873|NCT03445793|11945573|FG000|STARTED|Overall Study||5
10784874|NCT03445793|11945573|FG000|COMPLETED|Overall Study||5
10784875|NCT03445793|11945573|FG000|NOT COMPLETED|Overall Study||0
10784876|NCT03446053|11945582|FG000|STARTED|Overall Study||2
10784877|NCT03446053|11945583|FG001|STARTED|Overall Study||6
10784878|NCT03446053|11945584|FG002|STARTED|Overall Study||6
10784879|NCT03446053|11945585|FG003|STARTED|Overall Study||7
10784880|NCT03446053|11945586|FG004|STARTED|Overall Study||6
10784881|NCT03446053|11945587|FG005|STARTED|Overall Study||6
10784882|NCT03446053|11945582|FG000|Randomized Set|Overall Study||2
10784883|NCT03446053|11945583|FG001|Randomized Set|Overall Study||6
10784884|NCT03446053|11945584|FG002|Randomized Set|Overall Study||6
10784885|NCT03446053|11945585|FG003|Randomized Set|Overall Study||7
10784886|NCT03446053|11945586|FG004|Randomized Set|Overall Study||6
10784887|NCT03446053|11945587|FG005|Randomized Set|Overall Study||6
10784888|NCT03446053|11945582|FG000|Safety Analysis Set|Overall Study||2
10784889|NCT03446053|11945583|FG001|Safety Analysis Set|Overall Study||6
10784890|NCT03446053|11945584|FG002|Safety Analysis Set|Overall Study||6
10784891|NCT03446053|11945585|FG003|Safety Analysis Set|Overall Study||6
10784892|NCT03446053|11945586|FG004|Safety Analysis Set|Overall Study||6
10784893|NCT03446053|11945587|FG005|Safety Analysis Set|Overall Study||6
10784894|NCT03446053|11945582|FG000|PK/PD Analysis Set|Overall Study||2
10784895|NCT03446053|11945583|FG001|PK/PD Analysis Set|Overall Study||6
10784896|NCT03446053|11945584|FG002|PK/PD Analysis Set|Overall Study||6
10784897|NCT03446053|11945585|FG003|PK/PD Analysis Set|Overall Study||6
10784898|NCT03446053|11945586|FG004|PK/PD Analysis Set|Overall Study||6
10784899|NCT03446053|11945587|FG005|PK/PD Analysis Set|Overall Study||5
10784900|NCT03446053|11945582|FG000|COMPLETED|Overall Study||2
10784901|NCT03446053|11945583|FG001|COMPLETED|Overall Study||5
10318073|NCT00208026|11452243|FG000|NOT COMPLETED|Overall Study||0
10784902|NCT03446053|11945584|FG002|COMPLETED|Overall Study||6
10784903|NCT03446053|11945585|FG003|COMPLETED|Overall Study||6
10784904|NCT03446053|11945586|FG004|COMPLETED|Overall Study||6
10784905|NCT03446053|11945587|FG005|COMPLETED|Overall Study||5
10784906|NCT03446053|11945582|FG000|NOT COMPLETED|Overall Study||0
10784907|NCT03446053|11945583|FG001|NOT COMPLETED|Overall Study||1
10784908|NCT03446053|11945584|FG002|NOT COMPLETED|Overall Study||0
10784909|NCT03446053|11945585|FG003|NOT COMPLETED|Overall Study||1
10784910|NCT03446053|11945586|FG004|NOT COMPLETED|Overall Study||0
10784911|NCT03446053|11945587|FG005|NOT COMPLETED|Overall Study||1
10784912|NCT03446690|11945616|FG000|STARTED|Overall Study||33
10784913|NCT03446690|11945617|FG001|STARTED|Overall Study||29
10784914|NCT03446690|11945616|FG000|COMPLETED|Overall Study||26
10784915|NCT03446690|11945617|FG001|COMPLETED|Overall Study||29
10784916|NCT03446690|11945616|FG000|NOT COMPLETED|Overall Study||7
10318074|NCT00208091|11452249|FG000|STARTED|Overall Study||16
10318075|NCT00208091|11452249|FG000|COMPLETED|Overall Study||16
10318076|NCT00208091|11452249|FG000|NOT COMPLETED|Overall Study||0
10318077|NCT00208325|11452261|FG000|STARTED|Overall Study||193
10318078|NCT00208325|11452262|FG001|STARTED|Overall Study||196
10318079|NCT00208325|11452263|FG002|STARTED|Overall Study||170
10318080|NCT00208325|11452264|FG003|STARTED|Overall Study||161
10318081|NCT00208325|11452261|FG000|COMPLETED|Overall Study||142
10318082|NCT00208325|11452262|FG001|COMPLETED|Overall Study||142
10318083|NCT00208325|11452263|FG002|COMPLETED|Overall Study||156
10318084|NCT00208325|11452264|FG003|COMPLETED|Overall Study||147
10318085|NCT00208325|11452261|FG000|NOT COMPLETED|Overall Study||51
10318086|NCT00208325|11452262|FG001|NOT COMPLETED|Overall Study||54
10318087|NCT00208325|11452263|FG002|NOT COMPLETED|Overall Study||14
10318088|NCT00208325|11452264|FG003|NOT COMPLETED|Overall Study||14
10318089|NCT00208494|11452276|FG000|STARTED|Overall Study||194
10318090|NCT00208494|11452277|FG001|STARTED|Overall Study||196
10318091|NCT00208494|11452276|FG000|COMPLETED|Overall Study||164
10318092|NCT00208494|11452277|FG001|COMPLETED|Overall Study||162
10318093|NCT00208494|11452276|FG000|NOT COMPLETED|Overall Study||30
10318094|NCT00208494|11452277|FG001|NOT COMPLETED|Overall Study||34
10318095|NCT00208507|11452285|FG000|STARTED|Overall Study||177
10318096|NCT00208507|11452286|FG001|STARTED|Overall Study||87
10318097|NCT00208507|11452285|FG000|COMPLETED|Overall Study||163
10318098|NCT00208507|11452286|FG001|COMPLETED|Overall Study||79
10318099|NCT00208507|11452285|FG000|NOT COMPLETED|Overall Study||14
10318100|NCT00208507|11452286|FG001|NOT COMPLETED|Overall Study||8
10318101|NCT00208767|11452294|FG000|STARTED|Overall Study||80
10318102|NCT00208767|11452295|FG001|STARTED|Overall Study||40
10318103|NCT00208767|11452294|FG000|COMPLETED|Overall Study||53
10318104|NCT00208767|11452295|FG001|COMPLETED|Overall Study||33
10318105|NCT00208767|11452294|FG000|NOT COMPLETED|Overall Study||27
10318106|NCT00208767|11452295|FG001|NOT COMPLETED|Overall Study||7
10318107|NCT00208949|11452303|FG000|STARTED|Overall Study||25
10318108|NCT00208949|11452304|FG001|STARTED|Overall Study||25
10318109|NCT00208949|11452303|FG000|COMPLETED|Overall Study||25
10318110|NCT00208949|11452304|FG001|COMPLETED|Overall Study||25
10318111|NCT00208949|11452303|FG000|NOT COMPLETED|Overall Study||0
10318112|NCT00208949|11452304|FG001|NOT COMPLETED|Overall Study||0
10318113|NCT00208975|11452310|FG000|STARTED|Overall Study||15
10318114|NCT00208975|11452310|FG000|COMPLETED|Overall Study||15
10318115|NCT00208975|11452310|FG000|NOT COMPLETED|Overall Study||0
10318116|NCT00209092|11452317|FG000|STARTED|Overall Study||25
10318117|NCT00209092|11452318|FG001|STARTED|Overall Study||26
10318118|NCT00209092|11452317|FG000|COMPLETED|Overall Study||17
10318119|NCT00209092|11452318|FG001|COMPLETED|Overall Study||24
10318120|NCT00209092|11452317|FG000|NOT COMPLETED|Overall Study||8
10318121|NCT00209092|11452318|FG001|NOT COMPLETED|Overall Study||2
10784917|NCT03446690|11945617|FG001|NOT COMPLETED|Overall Study||0
10784918|NCT03446781|11945625|FG000|STARTED|Overall Study||214
10784919|NCT03446781|11945626|FG001|STARTED|Overall Study||208
10784920|NCT03446781|11945625|FG000|COMPLETED|Overall Study||186
10784921|NCT03446781|11945626|FG001|COMPLETED|Overall Study||191
10784922|NCT03446781|11945625|FG000|NOT COMPLETED|Overall Study||28
10784923|NCT03446781|11945626|FG001|NOT COMPLETED|Overall Study||17
10784924|NCT03446846|11945657|FG000|STARTED|Overall Study||90
10784925|NCT03446846|11945658|FG001|STARTED|Overall Study||92
10784926|NCT03446846|11945659|FG002|STARTED|Overall Study||178
10784927|NCT03446846|11945657|FG000|COMPLETED|Overall Study||83
10784928|NCT03446846|11945658|FG001|COMPLETED|Overall Study||87
10784929|NCT03446846|11945659|FG002|COMPLETED|Overall Study||162
10784930|NCT03446846|11945657|FG000|NOT COMPLETED|Overall Study||7
10784931|NCT03446846|11945658|FG001|NOT COMPLETED|Overall Study||5
10784932|NCT03446846|11945659|FG002|NOT COMPLETED|Overall Study||16
10784933|NCT03446885|11945667|FG000|STARTED|Overall Study||12
10318122|NCT00209170|11452326|FG000|STARTED|Overall Study||7
10318123|NCT00209170|11452327|FG001|STARTED|Overall Study||7
10318124|NCT00209170|11452326|FG000|COMPLETED|Overall Study||5
10318125|NCT00209170|11452327|FG001|COMPLETED|Overall Study||4
10318126|NCT00209170|11452326|FG000|NOT COMPLETED|Overall Study||2
10784934|NCT03446885|11945668|FG001|STARTED|Overall Study||10
10784935|NCT03446885|11945667|FG000|COMPLETED|Overall Study||10
10784936|NCT03446885|11945668|FG001|COMPLETED|Overall Study||10
10784937|NCT03446885|11945667|FG000|NOT COMPLETED|Overall Study||2
10784938|NCT03446885|11945668|FG001|NOT COMPLETED|Overall Study||0
10784939|NCT03447015|11945678|FG000|STARTED|Overall Study||140
10784940|NCT03447015|11945679|FG001|STARTED|Overall Study||150
10318127|NCT00209170|11452327|FG001|NOT COMPLETED|Overall Study||3
10318128|NCT00209274|11452335|FG000|STARTED|Overall Study||184
10318129|NCT00209274|11452336|FG001|STARTED|Overall Study||95
10318130|NCT00209274|11452335|FG000|COMPLETED|Overall Study||113
10784941|NCT03447015|11945678|FG000|COMPLETED|Overall Study||95
10784942|NCT03447015|11945679|FG001|COMPLETED|Overall Study||106
10784943|NCT03447015|11945678|FG000|NOT COMPLETED|Overall Study||45
10318131|NCT00209274|11452336|FG001|COMPLETED|Overall Study||48
10318132|NCT00209274|11452335|FG000|NOT COMPLETED|Overall Study||71
10318133|NCT00209274|11452336|FG001|NOT COMPLETED|Overall Study||47
10318134|NCT00209339|11452342|FG000|STARTED|At 12 Months Follow-up||55
10318135|NCT00209339|11452342|FG000|COMPLETED|At 12 Months Follow-up||40
10318136|NCT00209339|11452342|FG000|NOT COMPLETED|At 12 Months Follow-up||15
10784944|NCT03447015|11945679|FG001|NOT COMPLETED|Overall Study||44
10784945|NCT03447249|11945687|FG000|STARTED|Overall Study||190
10784946|NCT03447249|11945688|FG001|STARTED|Overall Study||192
10784947|NCT03447249|11945687|FG000|Safety Set|Overall Study||189
10318137|NCT00209339|11452342|FG000|STARTED|At 24 Months Follow-up||40
10318138|NCT00209339|11452342|FG000|COMPLETED|At 24 Months Follow-up||29
10318139|NCT00209339|11452342|FG000|NOT COMPLETED|At 24 Months Follow-up||11
10318140|NCT00209339|11452342|FG000|STARTED|At 3 Years Follow-up||29
10318141|NCT00209339|11452342|FG000|COMPLETED|At 3 Years Follow-up||28
10318142|NCT00209339|11452342|FG000|NOT COMPLETED|At 3 Years Follow-up||1
10318143|NCT00209339|11452342|FG000|STARTED|At 4 Years Follow-up||28
10318144|NCT00209339|11452342|FG000|COMPLETED|At 4 Years Follow-up||23
10318145|NCT00209339|11452342|FG000|NOT COMPLETED|At 4 Years Follow-up||5
10318146|NCT00209339|11452342|FG000|STARTED|At 5 Years Follow-up||23
10784948|NCT03447249|11945688|FG001|Safety Set|Overall Study||193
10784949|NCT03447249|11945687|FG000|COMPLETED|Overall Study||185
10784950|NCT03447249|11945688|FG001|COMPLETED|Overall Study||192
10784951|NCT03447249|11945687|FG000|NOT COMPLETED|Overall Study||5
10784952|NCT03447249|11945688|FG001|NOT COMPLETED|Overall Study||0
10784953|NCT03447353|11945696|FG000|STARTED|Overall Study||18
10784954|NCT03447353|11945696|FG000|COMPLETED|Overall Study||8
10784955|NCT03447353|11945696|FG000|NOT COMPLETED|Overall Study||10
10784956|NCT03447730|11945709|FG000|STARTED|Overall Study||6
10784957|NCT03447730|11945710|FG001|STARTED|Overall Study||9
10784958|NCT03447730|11945711|FG002|STARTED|Overall Study||8
10784959|NCT03447730|11945709|FG000|COMPLETED|Overall Study||6
10784960|NCT03447730|11945710|FG001|COMPLETED|Overall Study||7
10784961|NCT03447730|11945711|FG002|COMPLETED|Overall Study||8
10784962|NCT03447730|11945709|FG000|NOT COMPLETED|Overall Study||0
10784963|NCT03447730|11945710|FG001|NOT COMPLETED|Overall Study||2
10784964|NCT03447730|11945711|FG002|NOT COMPLETED|Overall Study||0
10784965|NCT03447821|11945722|FG000|STARTED|Overall Study||14
10784966|NCT03447821|11945723|FG001|STARTED|Overall Study||13
10784967|NCT03447821|11945724|FG002|STARTED|Overall Study||13
10784968|NCT03447821|11945722|FG000|COMPLETED|Overall Study||13
10784969|NCT03447821|11945723|FG001|COMPLETED|Overall Study||12
10784970|NCT03447821|11945724|FG002|COMPLETED|Overall Study||12
10784971|NCT03447821|11945722|FG000|NOT COMPLETED|Overall Study||1
10784972|NCT03447821|11945723|FG001|NOT COMPLETED|Overall Study||1
10784973|NCT03447821|11945724|FG002|NOT COMPLETED|Overall Study||1
10784974|NCT03448068|11945734|FG000|STARTED|Overall Study||17
10784975|NCT03448068|11945735|FG001|STARTED|Overall Study||17
10784976|NCT03448068|11945734|FG000|COMPLETED|Overall Study||17
10784977|NCT03448068|11945735|FG001|COMPLETED|Overall Study||17
10784978|NCT03448068|11945734|FG000|NOT COMPLETED|Overall Study||0
10784979|NCT03448068|11945735|FG001|NOT COMPLETED|Overall Study||0
10784980|NCT03448224|11945743|FG000|STARTED|Overall Study||28
10784981|NCT03448224|11945744|FG001|STARTED|Overall Study||26
10784982|NCT03448224|11945743|FG000|COMPLETED|Overall Study||27
10784983|NCT03448224|11945744|FG001|COMPLETED|Overall Study||26
10784984|NCT03448224|11945743|FG000|NOT COMPLETED|Overall Study||1
10784985|NCT03448224|11945744|FG001|NOT COMPLETED|Overall Study||0
10784986|NCT03448406|11945752|FG000|STARTED|Overall Study||158
10784987|NCT03448406|11945753|FG001|STARTED|Overall Study||157
10784988|NCT03448406|11945752|FG000|COMPLETED|Overall Study||147
10784989|NCT03448406|11945753|FG001|COMPLETED|Overall Study||144
10784990|NCT03448406|11945752|FG000|NOT COMPLETED|Overall Study||11
10784991|NCT03448406|11945753|FG001|NOT COMPLETED|Overall Study||13
10784992|NCT03448419|11945761|FG000|STARTED|Overall Study||156
10784993|NCT03448419|11945762|FG001|STARTED|Overall Study||156
10784994|NCT03448419|11945761|FG000|Treated|Overall Study||156
10784995|NCT03448419|11945762|FG001|Treated|Overall Study||155
10784996|NCT03448419|11945761|FG000|COMPLETED|Overall Study||143
10784997|NCT03448419|11945762|FG001|COMPLETED|Overall Study||140
10784998|NCT03448419|11945761|FG000|NOT COMPLETED|Overall Study||13
10784999|NCT03448419|11945762|FG001|NOT COMPLETED|Overall Study||16
10785000|NCT03448536|11945772|FG000|STARTED|Overall Study||100
10785001|NCT03448536|11945773|FG001|STARTED|Overall Study||101
10785002|NCT03448536|11945772|FG000|Completed First Intervention|Overall Study||83
10785003|NCT03448536|11945773|FG001|Completed First Intervention|Overall Study||78
10785004|NCT03448536|11945772|FG000|Completed First Intervention|Overall Study||95
10785005|NCT03448536|11945773|FG001|Completed First Intervention|Overall Study||97
10785006|NCT03448536|11945772|FG000|Completed Second Intervention|Overall Study||82
10785007|NCT03448536|11945773|FG001|Completed Second Intervention|Overall Study||87
10785008|NCT03448536|11945772|FG000|COMPLETED|Overall Study||88
10785009|NCT03448536|11945773|FG001|COMPLETED|Overall Study||97
10785010|NCT03448536|11945772|FG000|NOT COMPLETED|Overall Study||12
10785011|NCT03448536|11945773|FG001|NOT COMPLETED|Overall Study||4
10785012|NCT03449030|11945789|FG000|STARTED|Overall Study||1
10785013|NCT03449030|11945790|FG001|STARTED|Overall Study||1
10785014|NCT03449030|11945791|FG002|STARTED|Overall Study||1
10785015|NCT03449030|11945792|FG003|STARTED|Overall Study||5
10785016|NCT03449030|11945793|FG004|STARTED|Overall Study||7
10785017|NCT03449030|11945794|FG005|STARTED|Overall Study||7
10318147|NCT00209339|11452342|FG000|COMPLETED|At 5 Years Follow-up||15
10318148|NCT00209339|11452342|FG000|NOT COMPLETED|At 5 Years Follow-up||8
10785018|NCT03449030|11945795|FG006|STARTED|Overall Study||2
10318149|NCT00209417|11452348|FG000|STARTED|Overall Study||321
10785019|NCT03449030|11945796|FG007|STARTED|Overall Study||3
10785020|NCT03449030|11945797|FG008|STARTED|Overall Study||3
10785021|NCT03449030|11945798|FG009|STARTED|Overall Study||1
10318150|NCT00209417|11452349|FG001|STARTED|Overall Study||327
10785022|NCT03449030|11945789|FG000|COMPLETED|Overall Study||0
10785023|NCT03449030|11945790|FG001|COMPLETED|Overall Study||0
10785024|NCT03449030|11945791|FG002|COMPLETED|Overall Study||0
10785025|NCT03449030|11945792|FG003|COMPLETED|Overall Study||0
10318151|NCT00209417|11452348|FG000|COMPLETED|Overall Study||321
10318152|NCT00209417|11452349|FG001|COMPLETED|Overall Study||327
10318153|NCT00209417|11452348|FG000|NOT COMPLETED|Overall Study||0
10318154|NCT00209417|11452349|FG001|NOT COMPLETED|Overall Study||0
10318155|NCT00209560|11452357|FG000|STARTED|Overall Study||121
10318156|NCT00209560|11452358|FG001|STARTED|Overall Study||42
10318157|NCT00209560|11452357|FG000|COMPLETED|Overall Study||120
10318158|NCT00209560|11452358|FG001|COMPLETED|Overall Study||42
10318159|NCT00209560|11452357|FG000|NOT COMPLETED|Overall Study||1
10318160|NCT00209560|11452358|FG001|NOT COMPLETED|Overall Study||0
10318161|NCT00210106|11452364|FG000|STARTED|Overall Study||52
10785026|NCT03449030|11945793|FG004|COMPLETED|Overall Study||0
10785027|NCT03449030|11945794|FG005|COMPLETED|Overall Study||0
10785028|NCT03449030|11945795|FG006|COMPLETED|Overall Study||0
10785029|NCT03449030|11945796|FG007|COMPLETED|Overall Study||0
10785030|NCT03449030|11945797|FG008|COMPLETED|Overall Study||0
10785031|NCT03449030|11945798|FG009|COMPLETED|Overall Study||0
10785032|NCT03449030|11945789|FG000|NOT COMPLETED|Overall Study||1
10785033|NCT03449030|11945790|FG001|NOT COMPLETED|Overall Study||1
10785034|NCT03449030|11945791|FG002|NOT COMPLETED|Overall Study||1
10785035|NCT03449030|11945792|FG003|NOT COMPLETED|Overall Study||5
10785036|NCT03449030|11945793|FG004|NOT COMPLETED|Overall Study||7
10785037|NCT03449030|11945794|FG005|NOT COMPLETED|Overall Study||7
10785038|NCT03449030|11945795|FG006|NOT COMPLETED|Overall Study||2
10785039|NCT03449030|11945796|FG007|NOT COMPLETED|Overall Study||3
10785040|NCT03449030|11945797|FG008|NOT COMPLETED|Overall Study||3
10785041|NCT03449030|11945798|FG009|NOT COMPLETED|Overall Study||1
10785042|NCT03449134|11945824|FG000|STARTED|52-Week Treatment Period||244
10785043|NCT03449134|11945825|FG001|STARTED|52-Week Treatment Period||244
10785044|NCT03449134|11945826|FG002|STARTED|52-Week Treatment Period||244
10785045|NCT03449134|11945824|FG000|Treated|52-Week Treatment Period||243
10785046|NCT03449134|11945825|FG001|Treated|52-Week Treatment Period||244
10785047|NCT03449134|11945826|FG002|Treated|52-Week Treatment Period||243
10785048|NCT03449134|11945824|FG000|COMPLETED|52-Week Treatment Period||199
10785049|NCT03449134|11945825|FG001|COMPLETED|52-Week Treatment Period||200
10785050|NCT03449134|11945826|FG002|COMPLETED|52-Week Treatment Period||184
10785051|NCT03449134|11945824|FG000|NOT COMPLETED|52-Week Treatment Period||45
10785052|NCT03449134|11945825|FG001|NOT COMPLETED|52-Week Treatment Period||44
10785053|NCT03449134|11945826|FG002|NOT COMPLETED|52-Week Treatment Period||60
10785054|NCT03449134|11945824|FG000|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|10
10785055|NCT03449134|11945825|FG001|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|18
10785056|NCT03449134|11945826|FG002|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|13
10785057|NCT03449134|11945824|FG000|COMPLETED|12-Week Off-Treatment Durability Period||10
10785058|NCT03449134|11945825|FG001|COMPLETED|12-Week Off-Treatment Durability Period||18
10785059|NCT03449134|11945826|FG002|COMPLETED|12-Week Off-Treatment Durability Period||13
10785191|NCT03449979|11945919|FG003|STARTED|Overall Study||22
10785060|NCT03449134|11945824|FG000|NOT COMPLETED|12-Week Off-Treatment Durability Period||0
10785061|NCT03449134|11945825|FG001|NOT COMPLETED|12-Week Off-Treatment Durability Period||0
10785062|NCT03449134|11945826|FG002|NOT COMPLETED|12-Week Off-Treatment Durability Period||0
10785063|NCT03449147|11945840|FG000|STARTED|52-week Treatment Period||436
10785064|NCT03449147|11945841|FG001|STARTED|52-week Treatment Period||442
10785065|NCT03449147|11945842|FG002|STARTED|52-week Treatment Period||439
10785066|NCT03449147|11945840|FG000|COMPLETED|52-week Treatment Period||382
10785067|NCT03449147|11945841|FG001|COMPLETED|52-week Treatment Period||368
10785068|NCT03449147|11945842|FG002|COMPLETED|52-week Treatment Period||355
10785069|NCT03449147|11945840|FG000|NOT COMPLETED|52-week Treatment Period||54
10785070|NCT03449147|11945841|FG001|NOT COMPLETED|52-week Treatment Period||74
10785071|NCT03449147|11945842|FG002|NOT COMPLETED|52-week Treatment Period||84
10785072|NCT03449147|11945840|FG000|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|48
10785073|NCT03449147|11945841|FG001|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|37
10785074|NCT03449147|11945842|FG002|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|37
10785075|NCT03449147|11945840|FG000|COMPLETED|12-Week Off-Treatment Durability Period||47
10785076|NCT03449147|11945841|FG001|COMPLETED|12-Week Off-Treatment Durability Period||36
10785077|NCT03449147|11945842|FG002|COMPLETED|12-Week Off-Treatment Durability Period||37
10785078|NCT03449147|11945840|FG000|NOT COMPLETED|12-Week Off-Treatment Durability Period||1
10785079|NCT03449147|11945841|FG001|NOT COMPLETED|12-Week Off-Treatment Durability Period||1
10785080|NCT03449147|11945842|FG002|NOT COMPLETED|12-Week Off-Treatment Durability Period||0
10785081|NCT03449342|11945856|FG000|STARTED|Overall Study||10
10785082|NCT03449342|11945857|FG001|STARTED|Overall Study||50
10785083|NCT03449342|11945856|FG000|COMPLETED|Overall Study||10
10785084|NCT03449342|11945857|FG001|COMPLETED|Overall Study||50
10785085|NCT03449342|11945856|FG000|NOT COMPLETED|Overall Study||0
10785086|NCT03449342|11945857|FG001|NOT COMPLETED|Overall Study||0
10785087|NCT03449433|11945865|FG000|STARTED|Period 1||17
10785088|NCT03449433|11945866|FG001|STARTED|Period 1||16
10785089|NCT03449433|11945867|FG002|STARTED|Period 1||18
10785090|NCT03449433|11945868|FG003|STARTED|Period 1||17
10785091|NCT03449433|11945869|FG004|STARTED|Period 1||12
10785092|NCT03449433|11945865|FG000|Received at Least 1 Dose of Study Drug|Period 1||17
10785093|NCT03449433|11945866|FG001|Received at Least 1 Dose of Study Drug|Period 1||16
10318162|NCT00210106|11452364|FG000|Safety Population|Overall Study||49
10318163|NCT00210106|11452364|FG000|COMPLETED|Overall Study||38
10318164|NCT00210106|11452364|FG000|NOT COMPLETED|Overall Study||14
10318165|NCT00210119|11452369|FG000|STARTED|Overall Study||19
10318166|NCT00210119|11452369|FG000|COMPLETED|Overall Study||17
10318167|NCT00210119|11452369|FG000|NOT COMPLETED|Overall Study||2
10318168|NCT00210184|11452373|FG000|STARTED|Overall Study||42
10318169|NCT00210184|11452373|FG000|COMPLETED|Overall Study||40
10318170|NCT00210184|11452373|FG000|NOT COMPLETED|Overall Study||2
10433047|NCT00883779|11579310|FG001|COMPLETED|Off-study Phase||0
10785094|NCT03449433|11945867|FG002|Received at Least 1 Dose of Study Drug|Period 1||18
10785095|NCT03449433|11945868|FG003|Received at Least 1 Dose of Study Drug|Period 1||17
10785096|NCT03449433|11945869|FG004|Received at Least 1 Dose of Study Drug|Period 1||0
10785097|NCT03449433|11945865|FG000|COMPLETED|Period 1||17
10785098|NCT03449433|11945866|FG001|COMPLETED|Period 1||16
10785099|NCT03449433|11945867|FG002|COMPLETED|Period 1||18
10785100|NCT03449433|11945868|FG003|COMPLETED|Period 1||17
10785101|NCT03449433|11945869|FG004|COMPLETED|Period 1||12
10785102|NCT03449433|11945865|FG000|NOT COMPLETED|Period 1||0
10785103|NCT03449433|11945866|FG001|NOT COMPLETED|Period 1||0
10785104|NCT03449433|11945867|FG002|NOT COMPLETED|Period 1||0
10785105|NCT03449433|11945868|FG003|NOT COMPLETED|Period 1||0
10785106|NCT03449433|11945869|FG004|NOT COMPLETED|Period 1||0
10785107|NCT03449433|11945865|FG000|STARTED|Period 2||17
10785108|NCT03449433|11945866|FG001|STARTED|Period 2||16
10785109|NCT03449433|11945867|FG002|STARTED|Period 2||18
10785110|NCT03449433|11945868|FG003|STARTED|Period 2||17
10785111|NCT03449433|11945869|FG004|STARTED|Period 2||12
10785112|NCT03449433|11945865|FG000|Received at Least 1 Dose of Study Drug|Period 2||17
10785113|NCT03449433|11945866|FG001|Received at Least 1 Dose of Study Drug|Period 2||16
10785114|NCT03449433|11945867|FG002|Received at Least 1 Dose of Study Drug|Period 2||18
10785115|NCT03449433|11945868|FG003|Received at Least 1 Dose of Study Drug|Period 2||17
10785116|NCT03449433|11945869|FG004|Received at Least 1 Dose of Study Drug|Period 2||0
10785117|NCT03449433|11945865|FG000|COMPLETED|Period 2||17
10785118|NCT03449433|11945866|FG001|COMPLETED|Period 2||16
10785119|NCT03449433|11945867|FG002|COMPLETED|Period 2||18
10785120|NCT03449433|11945868|FG003|COMPLETED|Period 2||17
10785121|NCT03449433|11945869|FG004|COMPLETED|Period 2||12
10785122|NCT03449433|11945865|FG000|NOT COMPLETED|Period 2||0
10785123|NCT03449433|11945866|FG001|NOT COMPLETED|Period 2||0
10785124|NCT03449433|11945867|FG002|NOT COMPLETED|Period 2||0
10785125|NCT03449433|11945868|FG003|NOT COMPLETED|Period 2||0
10785126|NCT03449433|11945869|FG004|NOT COMPLETED|Period 2||0
10785127|NCT03449433|11945865|FG000|STARTED|Period 3||17
10785128|NCT03449433|11945866|FG001|STARTED|Period 3||16
10785129|NCT03449433|11945867|FG002|STARTED|Period 3||18
10785130|NCT03449433|11945868|FG003|STARTED|Period 3||17
10785131|NCT03449433|11945869|FG004|STARTED|Period 3||12
10785132|NCT03449433|11945865|FG000|Received at Least 1 Dose of Study Drug|Period 3||17
10785133|NCT03449433|11945866|FG001|Received at Least 1 Dose of Study Drug|Period 3||15
10785134|NCT03449433|11945867|FG002|Received at Least 1 Dose of Study Drug|Period 3||18
10785135|NCT03449433|11945868|FG003|Received at Least 1 Dose of Study Drug|Period 3||17
10785136|NCT03449433|11945869|FG004|Received at Least 1 Dose of Study Drug|Period 3||0
10785137|NCT03449433|11945865|FG000|COMPLETED|Period 3||17
10785138|NCT03449433|11945866|FG001|COMPLETED|Period 3||15
10785139|NCT03449433|11945867|FG002|COMPLETED|Period 3||18
10785140|NCT03449433|11945868|FG003|COMPLETED|Period 3||17
10785141|NCT03449433|11945869|FG004|COMPLETED|Period 3||12
10785142|NCT03449433|11945865|FG000|NOT COMPLETED|Period 3||0
10785143|NCT03449433|11945866|FG001|NOT COMPLETED|Period 3||1
10785144|NCT03449433|11945867|FG002|NOT COMPLETED|Period 3||0
10785145|NCT03449433|11945868|FG003|NOT COMPLETED|Period 3||0
10785146|NCT03449433|11945869|FG004|NOT COMPLETED|Period 3||0
10785147|NCT03449433|11945865|FG000|STARTED|Period 4||17
10785148|NCT03449433|11945866|FG001|STARTED|Period 4||15
10785149|NCT03449433|11945867|FG002|STARTED|Period 4||18
10785150|NCT03449433|11945868|FG003|STARTED|Period 4||17
10785151|NCT03449433|11945869|FG004|STARTED|Period 4||12
10785152|NCT03449433|11945865|FG000|Received at Least 1 Dose of Study Drug|Period 4||17
10785153|NCT03449433|11945866|FG001|Received at Least 1 Dose of Study Drug|Period 4||15
10785154|NCT03449433|11945867|FG002|Received at Least 1 Dose of Study Drug|Period 4||18
10785155|NCT03449433|11945868|FG003|Received at Least 1 Dose of Study Drug|Period 4||17
10785156|NCT03449433|11945869|FG004|Received at Least 1 Dose of Study Drug|Period 4||0
10785157|NCT03449433|11945865|FG000|COMPLETED|Period 4||17
10785158|NCT03449433|11945866|FG001|COMPLETED|Period 4||15
10785159|NCT03449433|11945867|FG002|COMPLETED|Period 4||18
10785160|NCT03449433|11945868|FG003|COMPLETED|Period 4||17
10785161|NCT03449433|11945869|FG004|COMPLETED|Period 4||12
10785162|NCT03449433|11945865|FG000|NOT COMPLETED|Period 4||0
10785163|NCT03449433|11945866|FG001|NOT COMPLETED|Period 4||0
10318171|NCT00210353|11452380|FG000|STARTED|Overall Study||151
10318172|NCT00210353|11452381|FG001|STARTED|Overall Study||152
10318173|NCT00210353|11452382|FG002|STARTED|Overall Study||151
10785164|NCT03449433|11945867|FG002|NOT COMPLETED|Period 4||0
10785165|NCT03449433|11945868|FG003|NOT COMPLETED|Period 4||0
10785166|NCT03449433|11945869|FG004|NOT COMPLETED|Period 4||0
10785167|NCT03449446|11945890|FG000|STARTED|Overall Study||39
10318174|NCT00210353|11452380|FG000|COMPLETED|Overall Study||113
10785168|NCT03449446|11945891|FG001|STARTED|Overall Study||40
10785169|NCT03449446|11945892|FG002|STARTED|Overall Study||41
10318175|NCT00210353|11452381|FG001|COMPLETED|Overall Study||107
10785170|NCT03449446|11945893|FG003|STARTED|Overall Study||80
10785171|NCT03449446|11945894|FG004|STARTED|Overall Study||78
10785172|NCT03449446|11945895|FG005|STARTED|Overall Study||78
10318176|NCT00210353|11452382|FG002|COMPLETED|Overall Study||125
10318177|NCT00210353|11452380|FG000|NOT COMPLETED|Overall Study||38
10318178|NCT00210353|11452381|FG001|NOT COMPLETED|Overall Study||45
10318179|NCT00210353|11452382|FG002|NOT COMPLETED|Overall Study||26
10318180|NCT00210470|11452395|FG000|STARTED|Overall Study||27
10318181|NCT00210470|11452395|FG000|COMPLETED|Overall Study||27
10318182|NCT00210470|11452395|FG000|NOT COMPLETED|Overall Study||0
10318183|NCT00210626|11452404|FG000|STARTED|Overall Study||97
10318184|NCT00210626|11452405|FG001|STARTED|Overall Study||95
10318185|NCT00210626|11452404|FG000|COMPLETED|Overall Study||49
10318186|NCT00210626|11452405|FG001|COMPLETED|Overall Study||50
10318187|NCT00210626|11452404|FG000|NOT COMPLETED|Overall Study||48
10318188|NCT00210626|11452405|FG001|NOT COMPLETED|Overall Study||45
10318189|NCT00210639|11452413|FG000|STARTED|Overall Study||124
10318190|NCT00210639|11452414|FG001|STARTED|Overall Study||83
10318191|NCT00210639|11452413|FG000|COMPLETED|Overall Study||61
10318192|NCT00210639|11452414|FG001|COMPLETED|Overall Study||41
10318193|NCT00210639|11452413|FG000|NOT COMPLETED|Overall Study||63
10318194|NCT00210639|11452414|FG001|NOT COMPLETED|Overall Study||42
10318195|NCT00211081|11452420|FG000|STARTED|Overall Study||12
10318196|NCT00211081|11452420|FG000|COMPLETED|Overall Study||10
10318197|NCT00211081|11452420|FG000|NOT COMPLETED|Overall Study||2
10318198|NCT00211172|11452426|FG000|STARTED|Overall Study||449
10318199|NCT00211172|11452427|FG001|STARTED|Overall Study||458
10318200|NCT00211172|11452426|FG000|COMPLETED|Overall Study|39 patients died or lost health plan eligibility|410
10318201|NCT00211172|11452427|FG001|COMPLETED|Overall Study|32 patients died or lost health plan eligibility|426
10318202|NCT00211172|11452426|FG000|NOT COMPLETED|Overall Study||39
10318203|NCT00211172|11452427|FG001|NOT COMPLETED|Overall Study||32
10318204|NCT00211185|11452433|FG000|STARTED|Overall Study||49
10318205|NCT00211185|11452433|FG000|COMPLETED|Overall Study||29
10318206|NCT00211185|11452433|FG000|NOT COMPLETED|Overall Study||20
10318207|NCT00211237|11452439|FG000|STARTED|Baseline||70
10318208|NCT00211237|11452440|FG001|STARTED|Baseline||64
10785173|NCT03449446|11945896|FG006|STARTED|Overall Study||39
10785174|NCT03449446|11945890|FG000|COMPLETED|Overall Study||3
10785175|NCT03449446|11945891|FG001|COMPLETED|Overall Study||33
10785176|NCT03449446|11945892|FG002|COMPLETED|Overall Study||34
10785177|NCT03449446|11945893|FG003|COMPLETED|Overall Study||71
10785178|NCT03449446|11945894|FG004|COMPLETED|Overall Study||66
10785179|NCT03449446|11945895|FG005|COMPLETED|Overall Study||69
10785180|NCT03449446|11945896|FG006|COMPLETED|Overall Study||38
10785181|NCT03449446|11945890|FG000|NOT COMPLETED|Overall Study||36
10785182|NCT03449446|11945891|FG001|NOT COMPLETED|Overall Study||7
10785183|NCT03449446|11945892|FG002|NOT COMPLETED|Overall Study||7
10785184|NCT03449446|11945893|FG003|NOT COMPLETED|Overall Study||9
10785185|NCT03449446|11945894|FG004|NOT COMPLETED|Overall Study||12
10785186|NCT03449446|11945895|FG005|NOT COMPLETED|Overall Study||9
10785187|NCT03449446|11945896|FG006|NOT COMPLETED|Overall Study||1
10785188|NCT03449979|11945916|FG000|STARTED|Overall Study||21
10785189|NCT03449979|11945917|FG001|STARTED|Overall Study||20
10785190|NCT03449979|11945918|FG002|STARTED|Overall Study||21
10785192|NCT03449979|11945916|FG000|COMPLETED|Overall Study||21
10785193|NCT03449979|11945917|FG001|COMPLETED|Overall Study||20
10785194|NCT03449979|11945918|FG002|COMPLETED|Overall Study||21
10785195|NCT03449979|11945919|FG003|COMPLETED|Overall Study||21
10785196|NCT03449979|11945916|FG000|NOT COMPLETED|Overall Study||0
10785197|NCT03449979|11945917|FG001|NOT COMPLETED|Overall Study||0
10785198|NCT03449979|11945918|FG002|NOT COMPLETED|Overall Study||0
10785199|NCT03449979|11945919|FG003|NOT COMPLETED|Overall Study||1
10785200|NCT03450070|11945929|FG000|STARTED|Overall Study||118
10785201|NCT03450070|11945929|FG000|COMPLETED|Overall Study||110
10785202|NCT03450070|11945929|FG000|NOT COMPLETED|Overall Study||8
10785203|NCT03450083|11945935|FG000|STARTED|Overall Study||12
10785204|NCT03450083|11945936|FG001|STARTED|Overall Study||12
10785205|NCT03450083|11945935|FG000|COMPLETED|Overall Study||12
10785206|NCT03450083|11945936|FG001|COMPLETED|Overall Study||12
10785207|NCT03450083|11945935|FG000|NOT COMPLETED|Overall Study||0
10785208|NCT03450083|11945936|FG001|NOT COMPLETED|Overall Study||0
10785209|NCT03450369|11945944|FG000|STARTED|Overall Study||5
10785210|NCT03450369|11945945|FG001|STARTED|Overall Study||5
10785211|NCT03450369|11945944|FG000|COMPLETED|Overall Study||5
10785212|NCT03450369|11945945|FG001|COMPLETED|Overall Study||5
10785213|NCT03450369|11945944|FG000|NOT COMPLETED|Overall Study||0
10785214|NCT03450369|11945945|FG001|NOT COMPLETED|Overall Study||0
10785215|NCT03450915|11945953|FG000|STARTED|Overall Study||6230
10318209|NCT00211237|11452441|FG002|STARTED|Baseline||0
10318210|NCT00211237|11452439|FG000|COMPLETED|Baseline||68
10785216|NCT03450915|11945954|FG001|STARTED|Overall Study||6230
10785217|NCT03450915|11945953|FG000|COMPLETED|Overall Study||5827
10785218|NCT03450915|11945954|FG001|COMPLETED|Overall Study||5855
10785219|NCT03450915|11945953|FG000|NOT COMPLETED|Overall Study||403
10785220|NCT03450915|11945954|FG001|NOT COMPLETED|Overall Study||375
10785221|NCT03451071|11945960|FG000|STARTED|First Vaccine||56
10785222|NCT03451071|11945960|FG000|COMPLETED|First Vaccine||55
10318211|NCT00211237|11452440|FG001|COMPLETED|Baseline||61
10318212|NCT00211237|11452441|FG002|COMPLETED|Baseline||0
10318213|NCT00211237|11452439|FG000|NOT COMPLETED|Baseline||2
10785223|NCT03451071|11945960|FG000|NOT COMPLETED|First Vaccine||1
10785224|NCT03451071|11945960|FG000|STARTED|Second Vaccine||55
10785225|NCT03451071|11945960|FG000|COMPLETED|Second Vaccine||36
10785226|NCT03451071|11945960|FG000|NOT COMPLETED|Second Vaccine||19
10785227|NCT03451071|11945960|FG000|STARTED|Third Vaccine||36
10318214|NCT00211237|11452440|FG001|NOT COMPLETED|Baseline||3
10318215|NCT00211237|11452441|FG002|NOT COMPLETED|Baseline||0
10318216|NCT00211237|11452439|FG000|STARTED|1 Month||68
10318217|NCT00211237|11452440|FG001|STARTED|1 Month||61
10318218|NCT00211237|11452441|FG002|STARTED|1 Month||0
10318219|NCT00211237|11452439|FG000|COMPLETED|1 Month||65
10318220|NCT00211237|11452440|FG001|COMPLETED|1 Month||52
10318221|NCT00211237|11452441|FG002|COMPLETED|1 Month||0
10318222|NCT00211237|11452439|FG000|NOT COMPLETED|1 Month||3
10318223|NCT00211237|11452440|FG001|NOT COMPLETED|1 Month||9
10318224|NCT00211237|11452441|FG002|NOT COMPLETED|1 Month||0
10318225|NCT00211237|11452439|FG000|STARTED|3 Months||65
10318226|NCT00211237|11452440|FG001|STARTED|3 Months|34 patients crossed over to Balloon Kyphoplasty.|18
10318227|NCT00211237|11452441|FG002|STARTED|3 Months||34
10318228|NCT00211237|11452439|FG000|COMPLETED|3 Months||57
10318229|NCT00211237|11452440|FG001|COMPLETED|3 Months||14
10318230|NCT00211237|11452441|FG002|COMPLETED|3 Months||33
10318231|NCT00211237|11452439|FG000|NOT COMPLETED|3 Months||8
10318232|NCT00211237|11452440|FG001|NOT COMPLETED|3 Months||4
10318233|NCT00211237|11452441|FG002|NOT COMPLETED|3 Months||1
10318234|NCT00211237|11452439|FG000|STARTED|6 Months||57
10318235|NCT00211237|11452440|FG001|STARTED|6 Months|3 patients crossed over Balloon Kyphoplasty|11
10318236|NCT00211237|11452441|FG002|STARTED|6 Months||36
10785228|NCT03451071|11945960|FG000|COMPLETED|Third Vaccine||14
10785229|NCT03451071|11945960|FG000|NOT COMPLETED|Third Vaccine||22
10785230|NCT03451071|11945960|FG000|STARTED|Final Questionnaire and Blood Draw||14
10785231|NCT03451071|11945960|FG000|COMPLETED|Final Questionnaire and Blood Draw||10
10785232|NCT03451071|11945960|FG000|NOT COMPLETED|Final Questionnaire and Blood Draw||4
10785233|NCT03451084|11945968|FG000|STARTED|Overall Study||6
10785234|NCT03451084|11945969|FG001|STARTED|Overall Study||6
10785235|NCT03451084|11945970|FG002|STARTED|Overall Study||6
10785236|NCT03451084|11945971|FG003|STARTED|Overall Study||6
10785237|NCT03451084|11945968|FG000|COMPLETED|Overall Study||0
10785238|NCT03451084|11945969|FG001|COMPLETED|Overall Study||0
10785239|NCT03451084|11945970|FG002|COMPLETED|Overall Study||0
10785240|NCT03451084|11945971|FG003|COMPLETED|Overall Study||0
10785241|NCT03451084|11945968|FG000|NOT COMPLETED|Overall Study||6
10785242|NCT03451084|11945969|FG001|NOT COMPLETED|Overall Study||6
10785243|NCT03451084|11945970|FG002|NOT COMPLETED|Overall Study||6
10785244|NCT03451084|11945971|FG003|NOT COMPLETED|Overall Study||6
10785245|NCT03451721|11945981|FG000|STARTED|Overall Study||20
10785246|NCT03451721|11945981|FG000|COMPLETED|Overall Study||19
10785247|NCT03451721|11945981|FG000|NOT COMPLETED|Overall Study||1
10785248|NCT03451773|11945987|FG000|STARTED|Overall Study||1
10785249|NCT03451773|11945988|FG001|STARTED|Overall Study||6
10785250|NCT03451773|11945987|FG000|COMPLETED|Overall Study||0
10785251|NCT03451773|11945988|FG001|COMPLETED|Overall Study||0
10785252|NCT03451773|11945987|FG000|NOT COMPLETED|Overall Study||1
10785253|NCT03451773|11945988|FG001|NOT COMPLETED|Overall Study||6
10785254|NCT03452176|11945997|FG000|STARTED|Overall Study||11
10785255|NCT03452176|11945998|FG001|STARTED|Overall Study||11
10785256|NCT03452176|11945997|FG000|COMPLETED|Overall Study||11
10785257|NCT03452176|11945998|FG001|COMPLETED|Overall Study||11
10785258|NCT03452176|11945997|FG000|NOT COMPLETED|Overall Study||0
10785259|NCT03452176|11945998|FG001|NOT COMPLETED|Overall Study||0
10785260|NCT03452189|11946012|FG000|STARTED|First Intervention (3 Months)||10
10785261|NCT03452189|11946013|FG001|STARTED|First Intervention (3 Months)||5
10785262|NCT03452189|11946012|FG000|COMPLETED|First Intervention (3 Months)||5
10785263|NCT03452189|11946013|FG001|COMPLETED|First Intervention (3 Months)||5
10785264|NCT03452189|11946012|FG000|NOT COMPLETED|First Intervention (3 Months)||5
10785265|NCT03452189|11946013|FG001|NOT COMPLETED|First Intervention (3 Months)||0
10785266|NCT03452189|11946012|FG000|STARTED|Intervention 2 (3 Months)||5
10785267|NCT03452189|11946013|FG001|STARTED|Intervention 2 (3 Months)||5
10785268|NCT03452189|11946012|FG000|COMPLETED|Intervention 2 (3 Months)||5
10785269|NCT03452189|11946013|FG001|COMPLETED|Intervention 2 (3 Months)||5
10785270|NCT03452189|11946012|FG000|NOT COMPLETED|Intervention 2 (3 Months)||0
10785271|NCT03452189|11946013|FG001|NOT COMPLETED|Intervention 2 (3 Months)||0
10785272|NCT03452371|11946021|FG000|STARTED|Overall Study||21
10785273|NCT03452371|11946022|FG001|STARTED|Overall Study||23
10785274|NCT03452371|11946021|FG000|COMPLETED|Overall Study||21
10785275|NCT03452371|11946022|FG001|COMPLETED|Overall Study||23
10785276|NCT03452371|11946021|FG000|NOT COMPLETED|Overall Study||0
10785277|NCT03452371|11946022|FG001|NOT COMPLETED|Overall Study||0
10785278|NCT03452527|11946030|FG000|STARTED|Overall Study||7
10785279|NCT03452527|11946031|FG001|STARTED|Overall Study||8
10318237|NCT00211237|11452439|FG000|COMPLETED|6 Months||49
10318238|NCT00211237|11452440|FG001|COMPLETED|6 Months||9
10785280|NCT03452527|11946030|FG000|COMPLETED|Overall Study||4
10785281|NCT03452527|11946031|FG001|COMPLETED|Overall Study||4
10785282|NCT03452527|11946030|FG000|NOT COMPLETED|Overall Study||3
10785283|NCT03452527|11946031|FG001|NOT COMPLETED|Overall Study||4
10785284|NCT03452943|11946039|FG000|STARTED|Titration Period (7 Weeks)||59
10785285|NCT03452943|11946040|FG001|STARTED|Titration Period (7 Weeks)||60
10318239|NCT00211237|11452441|FG002|COMPLETED|6 Months||33
10318240|NCT00211237|11452439|FG000|NOT COMPLETED|6 Months||8
10318241|NCT00211237|11452440|FG001|NOT COMPLETED|6 Months||2
10318242|NCT00211237|11452441|FG002|NOT COMPLETED|6 Months||3
10785286|NCT03452943|11946039|FG000|Safety Analysis Set|Titration Period (7 Weeks)||58
10785287|NCT03452943|11946040|FG001|Safety Analysis Set|Titration Period (7 Weeks)||59
10318243|NCT00211237|11452439|FG000|STARTED|12 Months||49
10318244|NCT00211237|11452440|FG001|STARTED|12 Months|1 patient crossed over Balloon Kyphoplasty|8
10318245|NCT00211237|11452441|FG002|STARTED|12 Months||34
10318246|NCT00211237|11452439|FG000|COMPLETED|12 Months||40
10318247|NCT00211237|11452440|FG001|COMPLETED|12 Months||6
10318248|NCT00211237|11452441|FG002|COMPLETED|12 Months||28
10318249|NCT00211237|11452439|FG000|NOT COMPLETED|12 Months||9
10318250|NCT00211237|11452440|FG001|NOT COMPLETED|12 Months||2
10318251|NCT00211237|11452441|FG002|NOT COMPLETED|12 Months||6
10318252|NCT00211510|11452460|FG000|STARTED|Overall Study||72
10318253|NCT00211510|11452461|FG001|STARTED|Overall Study||74
10318254|NCT00211510|11452460|FG000|COMPLETED|Overall Study||66
10318255|NCT00211510|11452461|FG001|COMPLETED|Overall Study||72
10318256|NCT00211510|11452460|FG000|NOT COMPLETED|Overall Study||6
10318257|NCT00211510|11452461|FG001|NOT COMPLETED|Overall Study||2
10318258|NCT00211536|11452472|FG000|STARTED|Overall Study||53
10318259|NCT00211536|11452473|FG001|STARTED|Overall Study||54
10318260|NCT00211536|11452472|FG000|As Treated Data Analysis Set|Overall Study|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|52
10318261|NCT00211536|11452473|FG001|As Treated Data Analysis Set|Overall Study||48
10318262|NCT00211536|11452472|FG000|COMPLETED|Overall Study||49
10318263|NCT00211536|11452473|FG001|COMPLETED|Overall Study|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|47
10318264|NCT00211536|11452472|FG000|NOT COMPLETED|Overall Study||4
10318265|NCT00211536|11452473|FG001|NOT COMPLETED|Overall Study||7
10318266|NCT00211692|11452481|FG000|STARTED|Overall Study||33
10318267|NCT00211692|11452482|FG001|STARTED|Overall Study||31
10318268|NCT00211692|11452481|FG000|COMPLETED|Overall Study||33
10318269|NCT00211692|11452482|FG001|COMPLETED|Overall Study||31
10318270|NCT00211692|11452481|FG000|NOT COMPLETED|Overall Study||0
10318271|NCT00211692|11452482|FG001|NOT COMPLETED|Overall Study||0
10318272|NCT00211757|11452490|FG000|STARTED|Overall Study||11
10318273|NCT00211757|11452491|FG001|STARTED|Overall Study||16
10318274|NCT00211757|11452490|FG000|COMPLETED|Overall Study||10
10318275|NCT00211757|11452491|FG001|COMPLETED|Overall Study||14
10318276|NCT00211757|11452490|FG000|NOT COMPLETED|Overall Study||1
10785288|NCT03452943|11946039|FG000|Modified ITT (mITT) Analysis Set|Titration Period (7 Weeks)||58
10785289|NCT03452943|11946040|FG001|Modified ITT (mITT) Analysis Set|Titration Period (7 Weeks)||59
10785290|NCT03452943|11946039|FG000|COMPLETED|Titration Period (7 Weeks)||54
10785291|NCT03452943|11946040|FG001|COMPLETED|Titration Period (7 Weeks)||56
10785292|NCT03452943|11946039|FG000|NOT COMPLETED|Titration Period (7 Weeks)||5
10785293|NCT03452943|11946040|FG001|NOT COMPLETED|Titration Period (7 Weeks)||4
10785294|NCT03452943|11946039|FG000|STARTED|Maintenance Period (5 Weeks)||54
10785295|NCT03452943|11946040|FG001|STARTED|Maintenance Period (5 Weeks)||56
10785296|NCT03452943|11946039|FG000|COMPLETED|Maintenance Period (5 Weeks)||51
10785297|NCT03452943|11946040|FG001|COMPLETED|Maintenance Period (5 Weeks)||56
10785298|NCT03452943|11946039|FG000|NOT COMPLETED|Maintenance Period (5 Weeks)||3
10785299|NCT03452943|11946040|FG001|NOT COMPLETED|Maintenance Period (5 Weeks)||0
10785300|NCT03453060|11946051|FG000|STARTED|Overall Study||4
10785301|NCT03453060|11946052|FG001|STARTED|Overall Study||4
10785302|NCT03453060|11946053|FG002|STARTED|Overall Study||4
10785303|NCT03453060|11946054|FG003|STARTED|Overall Study||4
10785304|NCT03453060|11946055|FG004|STARTED|Overall Study||5
10785305|NCT03453060|11946051|FG000|COMPLETED|Overall Study||4
10785306|NCT03453060|11946052|FG001|COMPLETED|Overall Study||4
10785307|NCT03453060|11946053|FG002|COMPLETED|Overall Study||4
10785308|NCT03453060|11946054|FG003|COMPLETED|Overall Study||4
10785309|NCT03453060|11946055|FG004|COMPLETED|Overall Study||5
10785310|NCT03453060|11946051|FG000|NOT COMPLETED|Overall Study||0
10785311|NCT03453060|11946052|FG001|NOT COMPLETED|Overall Study||0
10785312|NCT03453060|11946053|FG002|NOT COMPLETED|Overall Study||0
10785313|NCT03453060|11946054|FG003|NOT COMPLETED|Overall Study||0
10785314|NCT03453060|11946055|FG004|NOT COMPLETED|Overall Study||0
10785315|NCT03453151|11946067|FG000|STARTED|Overall Study||19
10785316|NCT03453151|11946067|FG000|COMPLETED|Overall Study||15
10785317|NCT03453151|11946067|FG000|NOT COMPLETED|Overall Study||4
10785318|NCT03453515|11946073|FG000|STARTED|Overall Study||113
10785319|NCT03453515|11946074|FG001|STARTED|Overall Study||113
10785320|NCT03453515|11946073|FG000|COMPLETED|Overall Study||107
10785321|NCT03453515|11946074|FG001|COMPLETED|Overall Study||100
10785322|NCT03453515|11946073|FG000|NOT COMPLETED|Overall Study||6
10785323|NCT03453515|11946074|FG001|NOT COMPLETED|Overall Study||13
10785324|NCT03454048|11946084|FG000|STARTED|Overall Study||6
10785325|NCT03454048|11946085|FG001|STARTED|Overall Study||6
10785326|NCT03454048|11946086|FG002|STARTED|Overall Study||6
10785327|NCT03454048|11946087|FG003|STARTED|Overall Study||6
10785328|NCT03454048|11946084|FG000|COMPLETED|Overall Study||6
10785329|NCT03454048|11946085|FG001|COMPLETED|Overall Study||6
10785330|NCT03454048|11946086|FG002|COMPLETED|Overall Study||6
10785331|NCT03454048|11946087|FG003|COMPLETED|Overall Study||6
10785332|NCT03454048|11946084|FG000|NOT COMPLETED|Overall Study||0
10785333|NCT03454048|11946085|FG001|NOT COMPLETED|Overall Study||0
10785334|NCT03454048|11946086|FG002|NOT COMPLETED|Overall Study||0
10785335|NCT03454048|11946087|FG003|NOT COMPLETED|Overall Study||0
10785336|NCT03454412|11946099|FG000|STARTED|Baseline Assesment||44
10785337|NCT03454412|11946099|FG000|COMPLETED|Baseline Assesment||32
10785338|NCT03454412|11946099|FG000|NOT COMPLETED|Baseline Assesment||12
10318277|NCT00211757|11452491|FG001|NOT COMPLETED|Overall Study||2
10318278|NCT00211809|11452499|FG000|STARTED|Overall Study||17
10318279|NCT00211809|11452499|FG000|COMPLETED|Overall Study||11
10318280|NCT00211809|11452499|FG000|NOT COMPLETED|Overall Study||6
10318281|NCT00211887|11452508|FG000|STARTED|Overall Study||499
10318282|NCT00211887|11452509|FG001|STARTED|Overall Study||250
10318283|NCT00211887|11452510|FG002|STARTED|Overall Study||259
10318284|NCT00211887|11452508|FG000|COMPLETED|Overall Study||397
10318285|NCT00211887|11452509|FG001|COMPLETED|Overall Study||194
10318286|NCT00211887|11452510|FG002|COMPLETED|Overall Study||223
10318287|NCT00211887|11452508|FG000|NOT COMPLETED|Overall Study||102
10318288|NCT00211887|11452509|FG001|NOT COMPLETED|Overall Study||56
10318289|NCT00211887|11452510|FG002|NOT COMPLETED|Overall Study||36
10785339|NCT03454412|11946099|FG000|STARTED|Treatment Course||32
10785340|NCT03454412|11946099|FG000|COMPLETED|Treatment Course||32
10785341|NCT03454412|11946099|FG000|NOT COMPLETED|Treatment Course||0
10785342|NCT03454412|11946099|FG000|STARTED|Final Assesment||32
10785343|NCT03454412|11946099|FG000|COMPLETED|Final Assesment||32
10785344|NCT03454412|11946099|FG000|NOT COMPLETED|Final Assesment||0
10785345|NCT03454581|11946106|FG000|STARTED|Overall Study||18
10785346|NCT03454581|11946107|FG001|STARTED|Overall Study||16
10785347|NCT03454581|11946108|FG002|STARTED|Overall Study||17
10785348|NCT03454581|11946106|FG000|COMPLETED|Overall Study||14
10785349|NCT03454581|11946107|FG001|COMPLETED|Overall Study||13
10785350|NCT03454581|11946108|FG002|COMPLETED|Overall Study||14
10785351|NCT03454581|11946106|FG000|NOT COMPLETED|Overall Study||4
10785352|NCT03454581|11946107|FG001|NOT COMPLETED|Overall Study||3
10785353|NCT03454581|11946108|FG002|NOT COMPLETED|Overall Study||3
10785354|NCT03455218|11946119|FG000|STARTED|Overall Study||18
10785355|NCT03455218|11946120|FG001|STARTED|Overall Study||22
10785356|NCT03455218|11946119|FG000|COMPLETED|Overall Study||18
10785357|NCT03455218|11946120|FG001|COMPLETED|Overall Study||22
10785358|NCT03455218|11946119|FG000|NOT COMPLETED|Overall Study||0
10785359|NCT03455218|11946120|FG001|NOT COMPLETED|Overall Study||0
10785360|NCT03455491|11946129|FG000|STARTED|Overall Study||40
10785361|NCT03455491|11946130|FG001|STARTED|Overall Study||40
10785362|NCT03455491|11946131|FG002|STARTED|Overall Study||40
10785363|NCT03455491|11946129|FG000|COMPLETED|Overall Study||40
10785364|NCT03455491|11946130|FG001|COMPLETED|Overall Study||40
10785365|NCT03455491|11946131|FG002|COMPLETED|Overall Study||40
10433048|NCT00883779|11579309|FG000|NOT COMPLETED|Off-study Phase||209
10433049|NCT00883779|11579310|FG001|NOT COMPLETED|Off-study Phase||202
10433050|NCT00884039|11579318|FG000|STARTED|Overall Study||5
10785366|NCT03455491|11946129|FG000|NOT COMPLETED|Overall Study||0
10785367|NCT03455491|11946130|FG001|NOT COMPLETED|Overall Study||0
10785368|NCT03455491|11946131|FG002|NOT COMPLETED|Overall Study||0
10785369|NCT03455543|11946141|FG000|STARTED|Part A: Randomized Treatment (17 Weeks)||92
10785370|NCT03455543|11946142|FG001|STARTED|Part A: Randomized Treatment (17 Weeks)||90
10785371|NCT03455543|11946143|FG002|STARTED|Part A: Randomized Treatment (17 Weeks)||0
10785372|NCT03455543|11946141|FG000|COMPLETED|Part A: Randomized Treatment (17 Weeks)||81
10785373|NCT03455543|11946142|FG001|COMPLETED|Part A: Randomized Treatment (17 Weeks)||83
10785374|NCT03455543|11946143|FG002|COMPLETED|Part A: Randomized Treatment (17 Weeks)||0
10785375|NCT03455543|11946141|FG000|NOT COMPLETED|Part A: Randomized Treatment (17 Weeks)||11
10785376|NCT03455543|11946142|FG001|NOT COMPLETED|Part A: Randomized Treatment (17 Weeks)||7
10785377|NCT03455543|11946143|FG002|NOT COMPLETED|Part A: Randomized Treatment (17 Weeks)||0
10785433|NCT03456960|11946171|FG001|STARTED|Period 2 (1 Day)||12
10785378|NCT03455543|11946141|FG000|STARTED|Part B: Open-label Extension (24 Weeks)||0
10785379|NCT03455543|11946142|FG001|STARTED|Part B: Open-label Extension (24 Weeks)||0
10785380|NCT03455543|11946143|FG002|STARTED|Part B: Open-label Extension (24 Weeks)||152
10785381|NCT03455543|11946141|FG000|COMPLETED|Part B: Open-label Extension (24 Weeks)||0
10785382|NCT03455543|11946142|FG001|COMPLETED|Part B: Open-label Extension (24 Weeks)||0
10785383|NCT03455543|11946143|FG002|COMPLETED|Part B: Open-label Extension (24 Weeks)||115
10785384|NCT03455543|11946141|FG000|NOT COMPLETED|Part B: Open-label Extension (24 Weeks)||0
10785385|NCT03455543|11946142|FG001|NOT COMPLETED|Part B: Open-label Extension (24 Weeks)||0
10785386|NCT03455543|11946143|FG002|NOT COMPLETED|Part B: Open-label Extension (24 Weeks)||37
10785387|NCT03456245|11946151|FG000|STARTED|Overall Study||205
10785388|NCT03456245|11946151|FG000|COMPLETED|Overall Study||190
10785389|NCT03456245|11946151|FG000|NOT COMPLETED|Overall Study||15
10785390|NCT03456427|11946155|FG000|STARTED|Overall Study||36
10785391|NCT03456427|11946155|FG000|COMPLETED|Overall Study||33
10785392|NCT03456427|11946155|FG000|NOT COMPLETED|Overall Study||3
10785393|NCT03456856|11946160|FG000|STARTED|Overall Study||30
10785394|NCT03456856|11946160|FG000|COMPLETED|Overall Study||27
10785395|NCT03456856|11946160|FG000|NOT COMPLETED|Overall Study||3
10785396|NCT03456960|11946170|FG000|STARTED|Period 1 (1 Day)||12
10785397|NCT03456960|11946171|FG001|STARTED|Period 1 (1 Day)||12
10785398|NCT03456960|11946172|FG002|STARTED|Period 1 (1 Day)||120
10785399|NCT03456960|11946173|FG003|STARTED|Period 1 (1 Day)||120
10785400|NCT03456960|11946174|FG004|STARTED|Period 1 (1 Day)||6
10785401|NCT03456960|11946175|FG005|STARTED|Period 1 (1 Day)||6
10785402|NCT03456960|11946170|FG000|COMPLETED|Period 1 (1 Day)||12
10785403|NCT03456960|11946171|FG001|COMPLETED|Period 1 (1 Day)||12
10785404|NCT03456960|11946172|FG002|COMPLETED|Period 1 (1 Day)||120
10785405|NCT03456960|11946173|FG003|COMPLETED|Period 1 (1 Day)||120
10785406|NCT03456960|11946174|FG004|COMPLETED|Period 1 (1 Day)||6
10785407|NCT03456960|11946175|FG005|COMPLETED|Period 1 (1 Day)||6
10785408|NCT03456960|11946170|FG000|NOT COMPLETED|Period 1 (1 Day)||0
10785409|NCT03456960|11946171|FG001|NOT COMPLETED|Period 1 (1 Day)||0
10785410|NCT03456960|11946172|FG002|NOT COMPLETED|Period 1 (1 Day)||0
10785411|NCT03456960|11946173|FG003|NOT COMPLETED|Period 1 (1 Day)||0
10785412|NCT03456960|11946174|FG004|NOT COMPLETED|Period 1 (1 Day)||0
10785413|NCT03456960|11946175|FG005|NOT COMPLETED|Period 1 (1 Day)||0
10785414|NCT03456960|11946170|FG000|STARTED|Washout Period (at Least 14 Days)||12
10785415|NCT03456960|11946171|FG001|STARTED|Washout Period (at Least 14 Days)||12
10785416|NCT03456960|11946172|FG002|STARTED|Washout Period (at Least 14 Days)||120
10785417|NCT03456960|11946173|FG003|STARTED|Washout Period (at Least 14 Days)||120
10785418|NCT03456960|11946174|FG004|STARTED|Washout Period (at Least 14 Days)||6
10785419|NCT03456960|11946175|FG005|STARTED|Washout Period (at Least 14 Days)||6
10785420|NCT03456960|11946170|FG000|COMPLETED|Washout Period (at Least 14 Days)||12
10785421|NCT03456960|11946171|FG001|COMPLETED|Washout Period (at Least 14 Days)||12
10785422|NCT03456960|11946172|FG002|COMPLETED|Washout Period (at Least 14 Days)||119
10785423|NCT03456960|11946173|FG003|COMPLETED|Washout Period (at Least 14 Days)||118
10785424|NCT03456960|11946174|FG004|COMPLETED|Washout Period (at Least 14 Days)||6
10785425|NCT03456960|11946175|FG005|COMPLETED|Washout Period (at Least 14 Days)||6
10785426|NCT03456960|11946170|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10318310|NCT00212264|11452534|FG000|STARTED|Overall Study||70
10318311|NCT00212264|11452535|FG001|STARTED|Overall Study||70
10318312|NCT00212264|11452536|FG002|STARTED|Overall Study||68
10318313|NCT00212264|11452534|FG000|COMPLETED|Overall Study||58
10318314|NCT00212264|11452535|FG001|COMPLETED|Overall Study||54
10318315|NCT00212264|11452536|FG002|COMPLETED|Overall Study||64
10318316|NCT00212264|11452534|FG000|NOT COMPLETED|Overall Study||12
10318317|NCT00212264|11452535|FG001|NOT COMPLETED|Overall Study||16
10318318|NCT00212264|11452536|FG002|NOT COMPLETED|Overall Study||4
10318319|NCT00212355|11452544|FG000|STARTED|Overall Study||37
10318320|NCT00212355|11452544|FG000|COMPLETED|Overall Study||34
10318321|NCT00212355|11452544|FG000|NOT COMPLETED|Overall Study||3
10318322|NCT00212446|11452548|FG000|STARTED|Overall Study||8
10318323|NCT00212446|11452548|FG000|COMPLETED|Overall Study||8
10318324|NCT00212446|11452548|FG000|NOT COMPLETED|Overall Study||0
10318325|NCT00212758|11452552|FG000|STARTED|First Intervention (7 Days)||8
10318326|NCT00212758|11452553|FG001|STARTED|First Intervention (7 Days)||9
10318327|NCT00212758|11452552|FG000|COMPLETED|First Intervention (7 Days)||8
10318328|NCT00212758|11452553|FG001|COMPLETED|First Intervention (7 Days)||9
10318329|NCT00212758|11452552|FG000|NOT COMPLETED|First Intervention (7 Days)||0
10318330|NCT00212758|11452553|FG001|NOT COMPLETED|First Intervention (7 Days)||0
10318331|NCT00212758|11452552|FG000|STARTED|Wash Out Period (2 Weeks)||8
10318332|NCT00212758|11452553|FG001|STARTED|Wash Out Period (2 Weeks)||9
10318333|NCT00212758|11452552|FG000|COMPLETED|Wash Out Period (2 Weeks)||8
10318334|NCT00212758|11452553|FG001|COMPLETED|Wash Out Period (2 Weeks)||9
10318335|NCT00212758|11452552|FG000|NOT COMPLETED|Wash Out Period (2 Weeks)||0
10318336|NCT00212758|11452553|FG001|NOT COMPLETED|Wash Out Period (2 Weeks)||0
10433051|NCT00884039|11579319|FG001|STARTED|Overall Study||2
10433052|NCT00884039|11579318|FG000|COMPLETED|Overall Study||3
10433053|NCT00884039|11579319|FG001|COMPLETED|Overall Study||1
10785427|NCT03456960|11946171|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10785428|NCT03456960|11946172|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||1
10785429|NCT03456960|11946173|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||2
10785430|NCT03456960|11946174|FG004|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10785431|NCT03456960|11946175|FG005|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10785432|NCT03456960|11946170|FG000|STARTED|Period 2 (1 Day)||12
10785434|NCT03456960|11946172|FG002|STARTED|Period 2 (1 Day)||119
10785435|NCT03456960|11946173|FG003|STARTED|Period 2 (1 Day)||118
10785436|NCT03456960|11946174|FG004|STARTED|Period 2 (1 Day)||6
10785437|NCT03456960|11946175|FG005|STARTED|Period 2 (1 Day)||6
10785438|NCT03456960|11946170|FG000|COMPLETED|Period 2 (1 Day)||11
10785439|NCT03456960|11946171|FG001|COMPLETED|Period 2 (1 Day)||12
10785440|NCT03456960|11946172|FG002|COMPLETED|Period 2 (1 Day)||119
10785441|NCT03456960|11946173|FG003|COMPLETED|Period 2 (1 Day)||117
10785442|NCT03456960|11946174|FG004|COMPLETED|Period 2 (1 Day)||6
10785443|NCT03456960|11946175|FG005|COMPLETED|Period 2 (1 Day)||6
10785444|NCT03456960|11946170|FG000|NOT COMPLETED|Period 2 (1 Day)||1
10785445|NCT03456960|11946171|FG001|NOT COMPLETED|Period 2 (1 Day)||0
10785446|NCT03456960|11946172|FG002|NOT COMPLETED|Period 2 (1 Day)||0
10785447|NCT03456960|11946173|FG003|NOT COMPLETED|Period 2 (1 Day)||1
10785448|NCT03456960|11946174|FG004|NOT COMPLETED|Period 2 (1 Day)||0
10785449|NCT03456960|11946175|FG005|NOT COMPLETED|Period 2 (1 Day)||0
10785450|NCT03457103|11946193|FG000|STARTED|Overall Study||22
10785451|NCT03457103|11946194|FG001|STARTED|Overall Study||9
10785452|NCT03457103|11946193|FG000|COMPLETED|Overall Study||14
10785453|NCT03457103|11946194|FG001|COMPLETED|Overall Study||3
10318337|NCT00212758|11452552|FG000|STARTED|Second Intervention (7 Days)||8
10433054|NCT00884039|11579318|FG000|NOT COMPLETED|Overall Study||2
10433055|NCT00884039|11579319|FG001|NOT COMPLETED|Overall Study||1
10785454|NCT03457103|11946193|FG000|NOT COMPLETED|Overall Study||8
10785455|NCT03457103|11946194|FG001|NOT COMPLETED|Overall Study||6
10785456|NCT03457116|11946202|FG000|STARTED|Overall Study||41
10785457|NCT03457116|11946203|FG001|STARTED|Overall Study||29
10785458|NCT03457116|11946202|FG000|COMPLETED|Overall Study||41
10785459|NCT03457116|11946203|FG001|COMPLETED|Overall Study||29
10785460|NCT03457116|11946202|FG000|NOT COMPLETED|Overall Study||0
10785461|NCT03457116|11946203|FG001|NOT COMPLETED|Overall Study||0
10785462|NCT03457636|11946209|FG000|STARTED|Overall Study||22
10318338|NCT00212758|11452553|FG001|STARTED|Second Intervention (7 Days)||9
10318339|NCT00212758|11452552|FG000|COMPLETED|Second Intervention (7 Days)||8
10318340|NCT00212758|11452553|FG001|COMPLETED|Second Intervention (7 Days)||9
10318341|NCT00212758|11452552|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
10318342|NCT00212758|11452553|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
10318343|NCT00212758|11452552|FG000|STARTED|Standard Therapy of GH (12 Months)||8
10433056|NCT00884052|11579325|FG000|STARTED|Overall Study||6
10433057|NCT00884052|11579326|FG001|STARTED|Overall Study||12
10433058|NCT00884052|11579325|FG000|COMPLETED|Overall Study||6
10433059|NCT00884052|11579326|FG001|COMPLETED|Overall Study||12
10433060|NCT00884052|11579325|FG000|NOT COMPLETED|Overall Study||0
10433061|NCT00884052|11579326|FG001|NOT COMPLETED|Overall Study||0
10433062|NCT00884065|11579334|FG000|STARTED|Overall Study||25
10433063|NCT00884065|11579335|FG001|STARTED|Overall Study||25
10433064|NCT00884065|11579334|FG000|COMPLETED|Overall Study||25
10433065|NCT00884065|11579335|FG001|COMPLETED|Overall Study||25
10433066|NCT00884065|11579334|FG000|NOT COMPLETED|Overall Study||0
10433067|NCT00884065|11579335|FG001|NOT COMPLETED|Overall Study||0
10433068|NCT00884117|11579341|FG000|STARTED|Overall Study||4561
10433069|NCT00884117|11579341|FG000|COMPLETED|Overall Study|Defined as Day 6 visit for those enrolled before Amendment D; thereafter defined as Day 10 visit.|4312
10433070|NCT00884117|11579341|FG000|NOT COMPLETED|Overall Study||249
10433071|NCT00884221|11579360|FG000|STARTED|Overall Study||374
10433072|NCT00884221|11579361|FG001|STARTED|Overall Study||375
10433073|NCT00884221|11579360|FG000|COMPLETED|Overall Study||340
10433074|NCT00884221|11579361|FG001|COMPLETED|Overall Study||343
10433075|NCT00884221|11579360|FG000|NOT COMPLETED|Overall Study||34
10433076|NCT00884221|11579361|FG001|NOT COMPLETED|Overall Study||32
10433077|NCT00884273|11579371|FG000|STARTED|Overall Study|Intention-to-treat (ITT) population.|84
10433078|NCT00884273|11579372|FG001|STARTED|Overall Study|ITT population.|98
10433079|NCT00884273|11579371|FG000|Full Analysis Set (FAS)|Overall Study|Two participants did not have any post-dose efficacy assessment and were excluded from the FAS.|82
10433080|NCT00884273|11579372|FG001|Full Analysis Set (FAS)|Overall Study|One participant did not have any post-dose efficacy assessment and was excluded from the FAS.|97
10433081|NCT00884273|11579371|FG000|Per Protocol (PP) Analysis Set|Overall Study||81
10433082|NCT00884273|11579372|FG001|Per Protocol (PP) Analysis Set|Overall Study||92
10433083|NCT00884273|11579371|FG000|Safety Analysis Set|Overall Study||84
10433084|NCT00884273|11579372|FG001|Safety Analysis Set|Overall Study||98
10433085|NCT00884273|11579371|FG000|COMPLETED|Overall Study||82
10433086|NCT00884273|11579372|FG001|COMPLETED|Overall Study||93
10433087|NCT00884273|11579371|FG000|NOT COMPLETED|Overall Study||2
10433088|NCT00884273|11579372|FG001|NOT COMPLETED|Overall Study||5
10433089|NCT00884286|11579380|FG000|STARTED|Overall Study||34
10433090|NCT00884286|11579381|FG001|STARTED|Overall Study||33
10433091|NCT00884286|11579380|FG000|COMPLETED|Overall Study||2
10433092|NCT00884286|11579381|FG001|COMPLETED|Overall Study||0
10433093|NCT00884286|11579380|FG000|NOT COMPLETED|Overall Study||32
10433094|NCT00884286|11579381|FG001|NOT COMPLETED|Overall Study||33
10433095|NCT00884312|11579390|FG000|STARTED|Overall Study||9
10433096|NCT00884312|11579391|FG001|STARTED|Overall Study||92
10433097|NCT00884312|11579390|FG000|Received Treatment|Overall Study||9
10433098|NCT00884312|11579391|FG001|Received Treatment|Overall Study||91
10433099|NCT00884312|11579390|FG000|COMPLETED|Overall Study||7
10433100|NCT00884312|11579391|FG001|COMPLETED|Overall Study||67
10433101|NCT00884312|11579390|FG000|NOT COMPLETED|Overall Study||2
10433102|NCT00884312|11579391|FG001|NOT COMPLETED|Overall Study||25
10433103|NCT00884325|11579399|FG000|STARTED|Overall Study||20
10433104|NCT00884325|11579400|FG001|STARTED|Overall Study||20
10433105|NCT00884325|11579399|FG000|COMPLETED|Overall Study||17
10433106|NCT00884325|11579400|FG001|COMPLETED|Overall Study||16
10433107|NCT00884325|11579399|FG000|NOT COMPLETED|Overall Study||3
10433108|NCT00884325|11579400|FG001|NOT COMPLETED|Overall Study||4
10433109|NCT00884377|11579408|FG000|STARTED|Overall Study|1 not treated because infecting parasite could not be confirmed as L. major on rapid PCR testing,|28
10433110|NCT00884377|11579409|FG001|STARTED|Overall Study|1 was not treated due to concerns arising from the location of cutaneous leishmaniasis lesion|28
10433111|NCT00884377|11579408|FG000|COMPLETED|Overall Study|1 received full course of therapy,withdrew consent before completion of the 12 month follow up|26
10433112|NCT00884377|11579409|FG001|COMPLETED|Overall Study||27
10433113|NCT00884377|11579408|FG000|NOT COMPLETED|Overall Study||2
10433114|NCT00884377|11579409|FG001|NOT COMPLETED|Overall Study||1
10785463|NCT03457636|11946209|FG000|COMPLETED|Overall Study||20
10785464|NCT03457636|11946209|FG000|NOT COMPLETED|Overall Study||2
10785465|NCT03457727|11946217|FG000|STARTED|Part 1, Period 1 (1 Day)||8
10785466|NCT03457727|11946218|FG001|STARTED|Part 1, Period 1 (1 Day)||8
10785467|NCT03457727|11946219|FG002|STARTED|Part 1, Period 1 (1 Day)||0
10785468|NCT03457727|11946220|FG003|STARTED|Part 1, Period 1 (1 Day)||0
10785469|NCT03457727|11946217|FG000|COMPLETED|Part 1, Period 1 (1 Day)||8
10785470|NCT03457727|11946218|FG001|COMPLETED|Part 1, Period 1 (1 Day)||8
10318344|NCT00212758|11452553|FG001|STARTED|Standard Therapy of GH (12 Months)||9
10318345|NCT00212758|11452552|FG000|COMPLETED|Standard Therapy of GH (12 Months)||6
10318346|NCT00212758|11452553|FG001|COMPLETED|Standard Therapy of GH (12 Months)||8
10318347|NCT00212758|11452552|FG000|NOT COMPLETED|Standard Therapy of GH (12 Months)||2
10318348|NCT00212758|11452553|FG001|NOT COMPLETED|Standard Therapy of GH (12 Months)||1
10318349|NCT00212888|11452562|FG000|STARTED|Overall Study||19
10318350|NCT00212888|11452563|FG001|STARTED|Overall Study||18
10318351|NCT00212888|11452564|FG002|STARTED|Overall Study||15
10318352|NCT00212888|11452562|FG000|COMPLETED|Overall Study||16
10318353|NCT00212888|11452563|FG001|COMPLETED|Overall Study||18
10433115|NCT00884390|11579423|FG000|STARTED|Overall Study||146
10785471|NCT03457727|11946219|FG002|COMPLETED|Part 1, Period 1 (1 Day)||0
10318354|NCT00212888|11452564|FG002|COMPLETED|Overall Study||14
10318355|NCT00212888|11452562|FG000|NOT COMPLETED|Overall Study||3
10318356|NCT00212888|11452563|FG001|NOT COMPLETED|Overall Study||0
10318357|NCT00212888|11452564|FG002|NOT COMPLETED|Overall Study||1
10318358|NCT00213135|11452577|FG000|STARTED|Overall Study||456
10318359|NCT00213135|11452578|FG001|STARTED|Overall Study||433
10318360|NCT00213135|11452579|FG002|STARTED|Overall Study||437
10318361|NCT00213135|11452577|FG000|COMPLETED|Overall Study||406
10318362|NCT00213135|11452578|FG001|COMPLETED|Overall Study||398
10318363|NCT00213135|11452579|FG002|COMPLETED|Overall Study||380
10318364|NCT00213135|11452577|FG000|NOT COMPLETED|Overall Study||50
10318365|NCT00213135|11452578|FG001|NOT COMPLETED|Overall Study||35
10318366|NCT00213135|11452579|FG002|NOT COMPLETED|Overall Study||57
10318367|NCT00213148|11452591|FG000|STARTED|Cycle 1 (1 Month)||77
10318368|NCT00213148|11452592|FG001|STARTED|Cycle 1 (1 Month)||0
10318369|NCT00213148|11452593|FG002|STARTED|Cycle 1 (1 Month)||79
10318370|NCT00213148|11452594|FG003|STARTED|Cycle 1 (1 Month)||76
10318371|NCT00213148|11452595|FG004|STARTED|Cycle 1 (1 Month)||39
10318372|NCT00213148|11452591|FG000|COMPLETED|Cycle 1 (1 Month)||53
10318373|NCT00213148|11452592|FG001|COMPLETED|Cycle 1 (1 Month)||0
10318374|NCT00213148|11452593|FG002|COMPLETED|Cycle 1 (1 Month)||60
10318375|NCT00213148|11452594|FG003|COMPLETED|Cycle 1 (1 Month)||58
10318376|NCT00213148|11452595|FG004|COMPLETED|Cycle 1 (1 Month)||17
10318377|NCT00213148|11452591|FG000|NOT COMPLETED|Cycle 1 (1 Month)||24
10318378|NCT00213148|11452592|FG001|NOT COMPLETED|Cycle 1 (1 Month)||0
10318379|NCT00213148|11452593|FG002|NOT COMPLETED|Cycle 1 (1 Month)||19
10318380|NCT00213148|11452594|FG003|NOT COMPLETED|Cycle 1 (1 Month)||18
10318381|NCT00213148|11452595|FG004|NOT COMPLETED|Cycle 1 (1 Month)||22
10318382|NCT00213148|11452591|FG000|STARTED|Cycle 2 (1 Month)||43
10318383|NCT00213148|11452592|FG001|STARTED|Cycle 2 (1 Month)||10
10318384|NCT00213148|11452593|FG002|STARTED|Cycle 2 (1 Month)||42
10318385|NCT00213148|11452594|FG003|STARTED|Cycle 2 (1 Month)||52
10318386|NCT00213148|11452595|FG004|STARTED|Cycle 2 (1 Month)||41
10318387|NCT00213148|11452591|FG000|COMPLETED|Cycle 2 (1 Month)||29
10318388|NCT00213148|11452592|FG001|COMPLETED|Cycle 2 (1 Month)||4
10318389|NCT00213148|11452593|FG002|COMPLETED|Cycle 2 (1 Month)||28
10318390|NCT00213148|11452594|FG003|COMPLETED|Cycle 2 (1 Month)||33
10318391|NCT00213148|11452595|FG004|COMPLETED|Cycle 2 (1 Month)||11
10318392|NCT00213148|11452591|FG000|NOT COMPLETED|Cycle 2 (1 Month)||14
10318393|NCT00213148|11452592|FG001|NOT COMPLETED|Cycle 2 (1 Month)||6
10318394|NCT00213148|11452593|FG002|NOT COMPLETED|Cycle 2 (1 Month)||14
10318395|NCT00213148|11452594|FG003|NOT COMPLETED|Cycle 2 (1 Month)||19
10318396|NCT00213148|11452595|FG004|NOT COMPLETED|Cycle 2 (1 Month)||30
10318397|NCT00213148|11452591|FG000|STARTED|Cycle 3 (1 Month)||23
10318398|NCT00213148|11452592|FG001|STARTED|Cycle 3 (1 Month)||10
10318399|NCT00213148|11452593|FG002|STARTED|Cycle 3 (1 Month)||26
10318400|NCT00213148|11452594|FG003|STARTED|Cycle 3 (1 Month)||24
10318401|NCT00213148|11452595|FG004|STARTED|Cycle 3 (1 Month)||22
10318402|NCT00213148|11452591|FG000|COMPLETED|Cycle 3 (1 Month)||23
10318403|NCT00213148|11452592|FG001|COMPLETED|Cycle 3 (1 Month)||8
10318404|NCT00213148|11452593|FG002|COMPLETED|Cycle 3 (1 Month)||25
10318405|NCT00213148|11452594|FG003|COMPLETED|Cycle 3 (1 Month)||23
10318406|NCT00213148|11452595|FG004|COMPLETED|Cycle 3 (1 Month)||21
10318407|NCT00213148|11452591|FG000|NOT COMPLETED|Cycle 3 (1 Month)||0
10318408|NCT00213148|11452592|FG001|NOT COMPLETED|Cycle 3 (1 Month)||2
10318409|NCT00213148|11452593|FG002|NOT COMPLETED|Cycle 3 (1 Month)||1
10318410|NCT00213148|11452594|FG003|NOT COMPLETED|Cycle 3 (1 Month)||1
10318411|NCT00213148|11452595|FG004|NOT COMPLETED|Cycle 3 (1 Month)||1
10318412|NCT00213239|11452617|FG000|STARTED|Overall Study||32
10318413|NCT00213239|11452618|FG001|STARTED|Overall Study||32
10318414|NCT00213239|11452617|FG000|COMPLETED|Overall Study||32
10318415|NCT00213239|11452618|FG001|COMPLETED|Overall Study||32
10318416|NCT00213239|11452617|FG000|NOT COMPLETED|Overall Study||0
10318417|NCT00213239|11452618|FG001|NOT COMPLETED|Overall Study||0
10318418|NCT00213980|11452626|FG000|STARTED|Overall Study||32
10433116|NCT00884390|11579424|FG001|STARTED|Overall Study||62
10433117|NCT00884390|11579423|FG000|COMPLETED|Overall Study||123
10433118|NCT00884390|11579424|FG001|COMPLETED|Overall Study||54
10433119|NCT00884390|11579423|FG000|NOT COMPLETED|Overall Study||23
10433120|NCT00884390|11579424|FG001|NOT COMPLETED|Overall Study||8
10433121|NCT00884585|11579440|FG000|STARTED|Double-Masked Phase (Day 1-Month 3)||89
10433122|NCT00884585|11579441|FG001|STARTED|Double-Masked Phase (Day 1-Month 3)||87
10433123|NCT00884585|11579440|FG000|COMPLETED|Double-Masked Phase (Day 1-Month 3)||79
10433124|NCT00884585|11579441|FG001|COMPLETED|Double-Masked Phase (Day 1-Month 3)|All placebo patients who completed the double-masked phase received COS in the open-label phase.|83
10433125|NCT00884585|11579440|FG000|NOT COMPLETED|Double-Masked Phase (Day 1-Month 3)||10
10433126|NCT00884585|11579441|FG001|NOT COMPLETED|Double-Masked Phase (Day 1-Month 3)||4
10318419|NCT00213980|11452627|FG001|STARTED|Overall Study||36
10318420|NCT00213980|11452626|FG000|COMPLETED|Overall Study||26
10318421|NCT00213980|11452627|FG001|COMPLETED|Overall Study||29
10318422|NCT00213980|11452626|FG000|NOT COMPLETED|Overall Study||6
10318423|NCT00213980|11452627|FG001|NOT COMPLETED|Overall Study||7
10318424|NCT00214019|11452633|FG000|STARTED|Overall Study||36
10318425|NCT00214019|11452633|FG000|Placebo/Placebo Arm|Overall Study||6
10318426|NCT00214019|11452633|FG000|Placebo/Salmeterol Arm|Overall Study||6
10318427|NCT00214019|11452633|FG000|Fluticasone/Placebo Arm|Overall Study||6
10318428|NCT00214019|11452633|FG000|Fluticason/Salmeterol Arm|Overall Study||6
10318429|NCT00214019|11452633|FG000|COMPLETED|Overall Study||6
10318430|NCT00214019|11452633|FG000|NOT COMPLETED|Overall Study||30
10318431|NCT00214045|11452642|FG000|STARTED|Overall Study||18
10318432|NCT00214045|11452643|FG001|STARTED|Overall Study||18
10318433|NCT00214045|11452642|FG000|COMPLETED|Overall Study||18
10318434|NCT00214045|11452643|FG001|COMPLETED|Overall Study||18
10318435|NCT00214045|11452642|FG000|NOT COMPLETED|Overall Study||0
10318436|NCT00214045|11452643|FG001|NOT COMPLETED|Overall Study||0
10318437|NCT00214097|11452652|FG000|STARTED|Overall Study|Escalation to the next higher level will occur when > 20 pt yrs of F/U and > 5 pts followed >1 yr|101
10785472|NCT03457727|11946220|FG003|COMPLETED|Part 1, Period 1 (1 Day)||0
10785473|NCT03457727|11946217|FG000|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
10785474|NCT03457727|11946218|FG001|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
10785475|NCT03457727|11946219|FG002|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
10785476|NCT03457727|11946220|FG003|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
10785477|NCT03457727|11946217|FG000|STARTED|Part 1, Washout Period 1 (5 Days)||8
10785478|NCT03457727|11946218|FG001|STARTED|Part 1, Washout Period 1 (5 Days)||8
10785479|NCT03457727|11946219|FG002|STARTED|Part 1, Washout Period 1 (5 Days)||0
10785480|NCT03457727|11946220|FG003|STARTED|Part 1, Washout Period 1 (5 Days)||0
10785481|NCT03457727|11946217|FG000|COMPLETED|Part 1, Washout Period 1 (5 Days)||8
10785482|NCT03457727|11946218|FG001|COMPLETED|Part 1, Washout Period 1 (5 Days)||8
10785483|NCT03457727|11946219|FG002|COMPLETED|Part 1, Washout Period 1 (5 Days)||0
10785484|NCT03457727|11946220|FG003|COMPLETED|Part 1, Washout Period 1 (5 Days)||0
10785485|NCT03457727|11946217|FG000|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
10785486|NCT03457727|11946218|FG001|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
10785487|NCT03457727|11946219|FG002|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
10785488|NCT03457727|11946220|FG003|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
10785489|NCT03457727|11946217|FG000|STARTED|Part 1, Period 2 (1 Day)||8
10785490|NCT03457727|11946218|FG001|STARTED|Part 1, Period 2 (1 Day)||8
10785491|NCT03457727|11946219|FG002|STARTED|Part 1, Period 2 (1 Day)||0
10785492|NCT03457727|11946220|FG003|STARTED|Part 1, Period 2 (1 Day)||0
10785493|NCT03457727|11946217|FG000|COMPLETED|Part 1, Period 2 (1 Day)||8
10785494|NCT03457727|11946218|FG001|COMPLETED|Part 1, Period 2 (1 Day)||8
10785495|NCT03457727|11946219|FG002|COMPLETED|Part 1, Period 2 (1 Day)||0
10785496|NCT03457727|11946220|FG003|COMPLETED|Part 1, Period 2 (1 Day)||0
10785497|NCT03457727|11946217|FG000|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
10785498|NCT03457727|11946218|FG001|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
10785499|NCT03457727|11946219|FG002|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
10785500|NCT03457727|11946220|FG003|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
10785501|NCT03457727|11946217|FG000|STARTED|Part 1, Washout Period 2 (5 Days)||8
10785502|NCT03457727|11946218|FG001|STARTED|Part 1, Washout Period 2 (5 Days)||8
10785503|NCT03457727|11946219|FG002|STARTED|Part 1, Washout Period 2 (5 Days)||0
10785504|NCT03457727|11946220|FG003|STARTED|Part 1, Washout Period 2 (5 Days)||0
10785505|NCT03457727|11946217|FG000|COMPLETED|Part 1, Washout Period 2 (5 Days)||8
10785506|NCT03457727|11946218|FG001|COMPLETED|Part 1, Washout Period 2 (5 Days)||8
10785507|NCT03457727|11946219|FG002|COMPLETED|Part 1, Washout Period 2 (5 Days)||0
10785508|NCT03457727|11946220|FG003|COMPLETED|Part 1, Washout Period 2 (5 Days)||0
10785509|NCT03457727|11946217|FG000|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
10785510|NCT03457727|11946218|FG001|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
10785511|NCT03457727|11946219|FG002|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
10785512|NCT03457727|11946220|FG003|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
10785513|NCT03457727|11946217|FG000|STARTED|Part 1, Period 3 (1 Day)||8
10785514|NCT03457727|11946218|FG001|STARTED|Part 1, Period 3 (1 Day)||8
10785515|NCT03457727|11946219|FG002|STARTED|Part 1, Period 3 (1 Day)||0
10785516|NCT03457727|11946220|FG003|STARTED|Part 1, Period 3 (1 Day)||0
10785517|NCT03457727|11946217|FG000|COMPLETED|Part 1, Period 3 (1 Day)||8
10785518|NCT03457727|11946218|FG001|COMPLETED|Part 1, Period 3 (1 Day)||8
10785519|NCT03457727|11946219|FG002|COMPLETED|Part 1, Period 3 (1 Day)||0
10785520|NCT03457727|11946220|FG003|COMPLETED|Part 1, Period 3 (1 Day)||0
10785521|NCT03457727|11946217|FG000|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
10785522|NCT03457727|11946218|FG001|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
10785523|NCT03457727|11946219|FG002|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
10785524|NCT03457727|11946220|FG003|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
10785525|NCT03457727|11946217|FG000|STARTED|Part 1, Washout Period 3 (5 Days)||8
10785526|NCT03457727|11946218|FG001|STARTED|Part 1, Washout Period 3 (5 Days)||8
10785527|NCT03457727|11946219|FG002|STARTED|Part 1, Washout Period 3 (5 Days)||0
10785528|NCT03457727|11946220|FG003|STARTED|Part 1, Washout Period 3 (5 Days)||0
10785529|NCT03457727|11946217|FG000|COMPLETED|Part 1, Washout Period 3 (5 Days)||8
10785530|NCT03457727|11946218|FG001|COMPLETED|Part 1, Washout Period 3 (5 Days)||8
10785531|NCT03457727|11946219|FG002|COMPLETED|Part 1, Washout Period 3 (5 Days)||0
10785532|NCT03457727|11946220|FG003|COMPLETED|Part 1, Washout Period 3 (5 Days)||0
10785533|NCT03457727|11946217|FG000|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
10785534|NCT03457727|11946218|FG001|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
10785535|NCT03457727|11946219|FG002|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
10785536|NCT03457727|11946220|FG003|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
10785537|NCT03457727|11946217|FG000|STARTED|Part 1, Period 4 (1 Day)||8
10785538|NCT03457727|11946218|FG001|STARTED|Part 1, Period 4 (1 Day)||8
10785539|NCT03457727|11946219|FG002|STARTED|Part 1, Period 4 (1 Day)||0
10785540|NCT03457727|11946220|FG003|STARTED|Part 1, Period 4 (1 Day)||0
10785541|NCT03457727|11946217|FG000|COMPLETED|Part 1, Period 4 (1 Day)||8
10785542|NCT03457727|11946218|FG001|COMPLETED|Part 1, Period 4 (1 Day)||8
10785543|NCT03457727|11946219|FG002|COMPLETED|Part 1, Period 4 (1 Day)||0
10785544|NCT03457727|11946220|FG003|COMPLETED|Part 1, Period 4 (1 Day)||0
10785545|NCT03457727|11946217|FG000|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
10338422|NCT00369629|11475281|FG003|COMPLETED|Follow up for 1 Year||0
10318438|NCT00214097|11452653|FG001|STARTED|Overall Study|Escalation to the next higher level will occur when > 20 pt yrs of F/U and > 5 pts followed >1 yr|111
10318439|NCT00214097|11452654|FG002|STARTED|Overall Study||135
10318440|NCT00214097|11452652|FG000|COMPLETED|Overall Study||101
10318441|NCT00214097|11452653|FG001|COMPLETED|Overall Study||111
10318442|NCT00214097|11452654|FG002|COMPLETED|Overall Study||135
10318443|NCT00214097|11452652|FG000|NOT COMPLETED|Overall Study||0
10318444|NCT00214097|11452653|FG001|NOT COMPLETED|Overall Study||0
10318445|NCT00214097|11452654|FG002|NOT COMPLETED|Overall Study||0
10318446|NCT00214136|11452668|FG000|STARTED|Overall Study||30
10318447|NCT00214136|11452668|FG000|COMPLETED|Overall Study||25
10318448|NCT00214136|11452668|FG000|NOT COMPLETED|Overall Study||5
10318449|NCT00214201|11452674|FG000|STARTED|Overall Study||20
10318450|NCT00214201|11452675|FG001|STARTED|Overall Study||20
10318451|NCT00214201|11452674|FG000|COMPLETED|Overall Study||18
10318452|NCT00214201|11452675|FG001|COMPLETED|Overall Study||18
10318453|NCT00214201|11452674|FG000|NOT COMPLETED|Overall Study||2
10318454|NCT00214201|11452675|FG001|NOT COMPLETED|Overall Study||2
10318455|NCT00214383|11452684|FG000|STARTED|Overall Study||148
10318456|NCT00214383|11452685|FG001|STARTED|Overall Study||153
10318457|NCT00214383|11452684|FG000|COMPLETED|Overall Study||132
10318458|NCT00214383|11452685|FG001|COMPLETED|Overall Study||127
10318459|NCT00214383|11452684|FG000|NOT COMPLETED|Overall Study||16
10318460|NCT00214383|11452685|FG001|NOT COMPLETED|Overall Study||26
10318461|NCT00214422|11452694|FG000|STARTED|Overall Study||12
10318462|NCT00214422|11452695|FG001|STARTED|Overall Study||3
10318463|NCT00214422|11452696|FG002|STARTED|Overall Study||4
10318464|NCT00214422|11452694|FG000|COMPLETED|Overall Study||7
10318465|NCT00214422|11452695|FG001|COMPLETED|Overall Study||2
10318466|NCT00214422|11452696|FG002|COMPLETED|Overall Study||3
10318467|NCT00214422|11452694|FG000|NOT COMPLETED|Overall Study||5
10318468|NCT00214422|11452695|FG001|NOT COMPLETED|Overall Study||1
10318469|NCT00214422|11452696|FG002|NOT COMPLETED|Overall Study||1
10318470|NCT00214461|11452712|FG000|STARTED|Overall Study||12
10318471|NCT00214461|11452713|FG001|STARTED|Overall Study||12
10318472|NCT00214461|11452714|FG002|STARTED|Overall Study||12
10318473|NCT00214461|11452715|FG003|STARTED|Overall Study||12
10318474|NCT00214461|11452712|FG000|COMPLETED|Overall Study||12
10318475|NCT00214461|11452713|FG001|COMPLETED|Overall Study||12
10318476|NCT00214461|11452714|FG002|COMPLETED|Overall Study||10
10318477|NCT00214461|11452715|FG003|COMPLETED|Overall Study||11
10318478|NCT00214461|11452712|FG000|NOT COMPLETED|Overall Study||0
10318479|NCT00214461|11452713|FG001|NOT COMPLETED|Overall Study||0
10318480|NCT00214461|11452714|FG002|NOT COMPLETED|Overall Study||2
10318481|NCT00214461|11452715|FG003|NOT COMPLETED|Overall Study||1
10318482|NCT00214487|11452727|FG000|STARTED|Overall Study||43
10318483|NCT00214487|11452728|FG001|STARTED|Overall Study||43
10318484|NCT00214487|11452727|FG000|COMPLETED|Overall Study||38
10318485|NCT00214487|11452728|FG001|COMPLETED|Overall Study||40
10318486|NCT00214487|11452727|FG000|NOT COMPLETED|Overall Study||5
10318487|NCT00214487|11452728|FG001|NOT COMPLETED|Overall Study||3
10318488|NCT00214526|11452736|FG000|STARTED|Randomized||56
10318489|NCT00214526|11452737|FG001|STARTED|Randomized||56
10318490|NCT00214526|11452736|FG000|COMPLETED|Randomized||55
10785546|NCT03457727|11946218|FG001|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
10785547|NCT03457727|11946219|FG002|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
10785548|NCT03457727|11946220|FG003|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
10785549|NCT03457727|11946217|FG000|STARTED|Part 2, Period 1 (1 Day)||0
10785550|NCT03457727|11946218|FG001|STARTED|Part 2, Period 1 (1 Day)||0
10785551|NCT03457727|11946219|FG002|STARTED|Part 2, Period 1 (1 Day)||12
10785552|NCT03457727|11946220|FG003|STARTED|Part 2, Period 1 (1 Day)||12
10785553|NCT03457727|11946217|FG000|COMPLETED|Part 2, Period 1 (1 Day)||0
10785554|NCT03457727|11946218|FG001|COMPLETED|Part 2, Period 1 (1 Day)||0
10785555|NCT03457727|11946219|FG002|COMPLETED|Part 2, Period 1 (1 Day)||12
10785556|NCT03457727|11946220|FG003|COMPLETED|Part 2, Period 1 (1 Day)||12
10785557|NCT03457727|11946217|FG000|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
10785558|NCT03457727|11946218|FG001|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
10785559|NCT03457727|11946219|FG002|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
10785560|NCT03457727|11946220|FG003|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
10785561|NCT03457727|11946217|FG000|STARTED|Part 2, Washout Period 1 (5 Days)||0
10785562|NCT03457727|11946218|FG001|STARTED|Part 2, Washout Period 1 (5 Days)||0
10785563|NCT03457727|11946219|FG002|STARTED|Part 2, Washout Period 1 (5 Days)||12
10785564|NCT03457727|11946220|FG003|STARTED|Part 2, Washout Period 1 (5 Days)||12
10318491|NCT00214526|11452737|FG001|COMPLETED|Randomized||54
10318492|NCT00214526|11452736|FG000|NOT COMPLETED|Randomized||1
10318493|NCT00214526|11452737|FG001|NOT COMPLETED|Randomized||2
10318494|NCT00214526|11452736|FG000|STARTED|Treatment Period||55
10318495|NCT00214526|11452737|FG001|STARTED|Treatment Period||54
10318496|NCT00214526|11452736|FG000|COMPLETED|Treatment Period||53
10318497|NCT00214526|11452737|FG001|COMPLETED|Treatment Period||49
10318498|NCT00214526|11452736|FG000|NOT COMPLETED|Treatment Period||2
10318499|NCT00214526|11452737|FG001|NOT COMPLETED|Treatment Period||5
10318500|NCT00214526|11452736|FG000|STARTED|Post-Treatment Period||53
10318501|NCT00214526|11452737|FG001|STARTED|Post-Treatment Period||49
10318502|NCT00214526|11452736|FG000|COMPLETED|Post-Treatment Period||52
10318503|NCT00214526|11452737|FG001|COMPLETED|Post-Treatment Period||49
10318504|NCT00214526|11452736|FG000|NOT COMPLETED|Post-Treatment Period||1
10318505|NCT00214526|11452737|FG001|NOT COMPLETED|Post-Treatment Period||0
10318506|NCT00214539|11452747|FG000|STARTED|Randomized||17
10785565|NCT03457727|11946217|FG000|COMPLETED|Part 2, Washout Period 1 (5 Days)||0
10318507|NCT00214539|11452748|FG001|STARTED|Randomized||17
10318508|NCT00214539|11452747|FG000|COMPLETED|Randomized||15
10433127|NCT00884585|11579440|FG000|STARTED|Open-Label Phase (Months 3-9)|All patients who completed the double-masked phase received COS in the open-label phase.|162
10433128|NCT00884585|11579441|FG001|STARTED|Open-Label Phase (Months 3-9)|All placebo patients who completed the double-masked phase received COS in the open-label phase.|0
10433129|NCT00884585|11579440|FG000|COMPLETED|Open-Label Phase (Months 3-9)||147
10433130|NCT00884585|11579441|FG001|COMPLETED|Open-Label Phase (Months 3-9)||0
10433131|NCT00884585|11579440|FG000|NOT COMPLETED|Open-Label Phase (Months 3-9)||15
10433132|NCT00884585|11579441|FG001|NOT COMPLETED|Open-Label Phase (Months 3-9)||0
10433133|NCT00884585|11579440|FG000|STARTED|Open-Label Maintenance (Months 9-12)||147
10433134|NCT00884585|11579441|FG001|STARTED|Open-Label Maintenance (Months 9-12)||0
10433135|NCT00884585|11579440|FG000|COMPLETED|Open-Label Maintenance (Months 9-12)||144
10433136|NCT00884585|11579441|FG001|COMPLETED|Open-Label Maintenance (Months 9-12)||0
10549367|NCT01524900|11703345|FG004|NOT COMPLETED|Overall Study||0
10549368|NCT01524913|11703361|FG000|STARTED|Overall Study||35
10785566|NCT03457727|11946218|FG001|COMPLETED|Part 2, Washout Period 1 (5 Days)||0
10549369|NCT01524913|11703362|FG001|STARTED|Overall Study||36
10549370|NCT01524913|11703363|FG002|STARTED|Overall Study||31
10549371|NCT01524913|11703361|FG000|COMPLETED|Overall Study||31
10549372|NCT01524913|11703362|FG001|COMPLETED|Overall Study||36
10549373|NCT01524913|11703363|FG002|COMPLETED|Overall Study||31
10549374|NCT01524913|11703361|FG000|NOT COMPLETED|Overall Study||4
10549375|NCT01524913|11703362|FG001|NOT COMPLETED|Overall Study||0
10549376|NCT01524913|11703363|FG002|NOT COMPLETED|Overall Study||0
10549377|NCT01524978|11703382|FG000|STARTED|Overall Study||62
10549378|NCT01524978|11703383|FG001|STARTED|Overall Study||4
10785567|NCT03457727|11946219|FG002|COMPLETED|Part 2, Washout Period 1 (5 Days)||12
10785568|NCT03457727|11946220|FG003|COMPLETED|Part 2, Washout Period 1 (5 Days)||11
10785569|NCT03457727|11946217|FG000|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||0
10785570|NCT03457727|11946218|FG001|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||0
10785571|NCT03457727|11946219|FG002|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||0
10785572|NCT03457727|11946220|FG003|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||1
10785573|NCT03457727|11946217|FG000|STARTED|Part 2, Period 2 (1 Day)||0
10785574|NCT03457727|11946218|FG001|STARTED|Part 2, Period 2 (1 Day)||0
10785575|NCT03457727|11946219|FG002|STARTED|Part 2, Period 2 (1 Day)||12
10785576|NCT03457727|11946220|FG003|STARTED|Part 2, Period 2 (1 Day)||11
10318509|NCT00214539|11452748|FG001|COMPLETED|Randomized||17
10318510|NCT00214539|11452747|FG000|NOT COMPLETED|Randomized||2
10318511|NCT00214539|11452748|FG001|NOT COMPLETED|Randomized||0
10318512|NCT00214539|11452747|FG000|STARTED|Treatment Period||15
10318513|NCT00214539|11452748|FG001|STARTED|Treatment Period||17
10318514|NCT00214539|11452747|FG000|COMPLETED|Treatment Period||15
10318515|NCT00214539|11452748|FG001|COMPLETED|Treatment Period||17
10318516|NCT00214539|11452747|FG000|NOT COMPLETED|Treatment Period||0
10318517|NCT00214539|11452748|FG001|NOT COMPLETED|Treatment Period||0
10318518|NCT00214539|11452747|FG000|STARTED|Steroid Stable (Post-Tx to 22-Weeks)||15
10318519|NCT00214539|11452748|FG001|STARTED|Steroid Stable (Post-Tx to 22-Weeks)||17
10318520|NCT00214539|11452747|FG000|COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||15
10318521|NCT00214539|11452748|FG001|COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||17
10318522|NCT00214539|11452747|FG000|NOT COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||0
10318523|NCT00214539|11452748|FG001|NOT COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||0
10318524|NCT00214539|11452747|FG000|STARTED|Reduced Steroid (Post-SS to 52-Weeks)||15
10318525|NCT00214539|11452748|FG001|STARTED|Reduced Steroid (Post-SS to 52-Weeks)||17
10318526|NCT00214539|11452747|FG000|COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||15
10318527|NCT00214539|11452748|FG001|COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||17
10318528|NCT00214539|11452747|FG000|NOT COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||0
10318529|NCT00214539|11452748|FG001|NOT COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||0
10318530|NCT00214786|11452758|FG000|STARTED|Overall Study||4
10318531|NCT00214786|11452758|FG000|COMPLETED|Overall Study||1
10318532|NCT00214786|11452758|FG000|NOT COMPLETED|Overall Study||3
10318533|NCT00214890|11452764|FG000|STARTED|Overall Study||10
10318534|NCT00214890|11452765|FG001|STARTED|Overall Study||11
10318535|NCT00214890|11452764|FG000|COMPLETED|Overall Study||10
10318536|NCT00214890|11452765|FG001|COMPLETED|Overall Study||11
10318537|NCT00214890|11452764|FG000|NOT COMPLETED|Overall Study||0
10318538|NCT00214890|11452765|FG001|NOT COMPLETED|Overall Study||0
10318539|NCT00214903|11452775|FG000|STARTED|Overall Study||10043
10318540|NCT00214903|11452776|FG001|STARTED|Overall Study||13384
10318541|NCT00214903|11452777|FG002|STARTED|Overall Study||4113
10318542|NCT00214903|11452778|FG003|STARTED|Overall Study||3057
10318543|NCT00214903|11452775|FG000|COMPLETED|Overall Study||10043
10318544|NCT00214903|11452776|FG001|COMPLETED|Overall Study||13384
10318545|NCT00214903|11452777|FG002|COMPLETED|Overall Study||4113
10318546|NCT00214903|11452778|FG003|COMPLETED|Overall Study||3057
10549379|NCT01524978|11703384|FG002|STARTED|Overall Study||10
10549380|NCT01524978|11703385|FG003|STARTED|Overall Study||27
10549381|NCT01524978|11703386|FG004|STARTED|Overall Study||9
10549382|NCT01524978|11703387|FG005|STARTED|Overall Study||9
10318547|NCT00214903|11452775|FG000|NOT COMPLETED|Overall Study||0
10318548|NCT00214903|11452776|FG001|NOT COMPLETED|Overall Study||0
10318549|NCT00214903|11452777|FG002|NOT COMPLETED|Overall Study||0
10318550|NCT00214903|11452778|FG003|NOT COMPLETED|Overall Study||0
10318551|NCT00215137|11452788|FG000|STARTED|Open Label Escitalopram||14
10318552|NCT00215137|11452789|FG001|STARTED|Open Label Escitalopram||0
10318553|NCT00215137|11452790|FG002|STARTED|Open Label Escitalopram||0
10318554|NCT00215137|11452788|FG000|COMPLETED|Open Label Escitalopram||13
10318555|NCT00215137|11452789|FG001|COMPLETED|Open Label Escitalopram||0
10318556|NCT00215137|11452790|FG002|COMPLETED|Open Label Escitalopram||0
10318557|NCT00215137|11452788|FG000|NOT COMPLETED|Open Label Escitalopram||1
10318558|NCT00215137|11452789|FG001|NOT COMPLETED|Open Label Escitalopram||0
10318559|NCT00215137|11452790|FG002|NOT COMPLETED|Open Label Escitalopram||0
10785577|NCT03457727|11946217|FG000|COMPLETED|Part 2, Period 2 (1 Day)||0
10785578|NCT03457727|11946218|FG001|COMPLETED|Part 2, Period 2 (1 Day)||0
10785579|NCT03457727|11946219|FG002|COMPLETED|Part 2, Period 2 (1 Day)||12
10785580|NCT03457727|11946220|FG003|COMPLETED|Part 2, Period 2 (1 Day)||11
10785581|NCT03457727|11946217|FG000|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
10785582|NCT03457727|11946218|FG001|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
10785583|NCT03457727|11946219|FG002|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
10785584|NCT03457727|11946220|FG003|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
10785585|NCT03457727|11946217|FG000|STARTED|Part 2, Washout Period 2 (5 Days)||0
10785586|NCT03457727|11946218|FG001|STARTED|Part 2, Washout Period 2 (5 Days)||0
10785587|NCT03457727|11946219|FG002|STARTED|Part 2, Washout Period 2 (5 Days)||12
10785588|NCT03457727|11946220|FG003|STARTED|Part 2, Washout Period 2 (5 Days)||11
10785589|NCT03457727|11946217|FG000|COMPLETED|Part 2, Washout Period 2 (5 Days)||0
10785590|NCT03457727|11946218|FG001|COMPLETED|Part 2, Washout Period 2 (5 Days)||0
10785591|NCT03457727|11946219|FG002|COMPLETED|Part 2, Washout Period 2 (5 Days)||12
10785592|NCT03457727|11946220|FG003|COMPLETED|Part 2, Washout Period 2 (5 Days)||11
10785593|NCT03457727|11946217|FG000|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
10785594|NCT03457727|11946218|FG001|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
10785595|NCT03457727|11946219|FG002|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
10785596|NCT03457727|11946220|FG003|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
10785597|NCT03457727|11946217|FG000|STARTED|Part 2, Period 3 (1 Day)||0
10785598|NCT03457727|11946218|FG001|STARTED|Part 2, Period 3 (1 Day)||0
10785599|NCT03457727|11946219|FG002|STARTED|Part 2, Period 3 (1 Day)||12
10785600|NCT03457727|11946220|FG003|STARTED|Part 2, Period 3 (1 Day)||11
10785601|NCT03457727|11946217|FG000|COMPLETED|Part 2, Period 3 (1 Day)||0
10785602|NCT03457727|11946218|FG001|COMPLETED|Part 2, Period 3 (1 Day)||0
10785603|NCT03457727|11946219|FG002|COMPLETED|Part 2, Period 3 (1 Day)||12
10785604|NCT03457727|11946220|FG003|COMPLETED|Part 2, Period 3 (1 Day)||11
10785605|NCT03457727|11946217|FG000|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
10785606|NCT03457727|11946218|FG001|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
10785607|NCT03457727|11946219|FG002|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
10785608|NCT03457727|11946220|FG003|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
10785609|NCT03457727|11946217|FG000|STARTED|Part 2, Washout Period 3 (5 Days)||0
10785610|NCT03457727|11946218|FG001|STARTED|Part 2, Washout Period 3 (5 Days)||0
10785611|NCT03457727|11946219|FG002|STARTED|Part 2, Washout Period 3 (5 Days)||12
10785612|NCT03457727|11946220|FG003|STARTED|Part 2, Washout Period 3 (5 Days)||11
10785613|NCT03457727|11946217|FG000|COMPLETED|Part 2, Washout Period 3 (5 Days)||0
10785614|NCT03457727|11946218|FG001|COMPLETED|Part 2, Washout Period 3 (5 Days)||0
10785615|NCT03457727|11946219|FG002|COMPLETED|Part 2, Washout Period 3 (5 Days)||12
10785616|NCT03457727|11946220|FG003|COMPLETED|Part 2, Washout Period 3 (5 Days)||11
10785617|NCT03457727|11946217|FG000|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
10785618|NCT03457727|11946218|FG001|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
10785619|NCT03457727|11946219|FG002|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
10785620|NCT03457727|11946220|FG003|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
10785621|NCT03457727|11946217|FG000|STARTED|Part 2, Period 4 (1 Day)||0
10785622|NCT03457727|11946218|FG001|STARTED|Part 2, Period 4 (1 Day)||0
10318560|NCT00215137|11452788|FG000|STARTED|Randomization Period||0
10318561|NCT00215137|11452789|FG001|STARTED|Randomization Period||7
10318562|NCT00215137|11452790|FG002|STARTED|Randomization Period||5
10318563|NCT00215137|11452788|FG000|COMPLETED|Randomization Period||0
10318564|NCT00215137|11452789|FG001|COMPLETED|Randomization Period||5
10318565|NCT00215137|11452790|FG002|COMPLETED|Randomization Period||5
10318566|NCT00215137|11452788|FG000|NOT COMPLETED|Randomization Period||0
10318567|NCT00215137|11452789|FG001|NOT COMPLETED|Randomization Period||2
10318568|NCT00215137|11452790|FG002|NOT COMPLETED|Randomization Period||0
10433137|NCT00884585|11579440|FG000|NOT COMPLETED|Open-Label Maintenance (Months 9-12)||3
10433138|NCT00884585|11579441|FG001|NOT COMPLETED|Open-Label Maintenance (Months 9-12)||0
10433139|NCT00884611|11579447|FG000|STARTED|Overall Study||20
10433140|NCT00884611|11579447|FG000|Enrolled, Not Treated|Overall Study||1
10433141|NCT00884611|11579447|FG000|COMPLETED|Overall Study||19
10785623|NCT03457727|11946219|FG002|STARTED|Part 2, Period 4 (1 Day)||12
10785624|NCT03457727|11946220|FG003|STARTED|Part 2, Period 4 (1 Day)||0
10785625|NCT03457727|11946217|FG000|COMPLETED|Part 2, Period 4 (1 Day)||0
10785626|NCT03457727|11946218|FG001|COMPLETED|Part 2, Period 4 (1 Day)||0
10785627|NCT03457727|11946219|FG002|COMPLETED|Part 2, Period 4 (1 Day)||12
10785628|NCT03457727|11946220|FG003|COMPLETED|Part 2, Period 4 (1 Day)||0
10785629|NCT03457727|11946217|FG000|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
10785630|NCT03457727|11946218|FG001|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
10785631|NCT03457727|11946219|FG002|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
10785632|NCT03457727|11946220|FG003|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
10785633|NCT03457909|11946252|FG000|STARTED|Overall Study||25
10785634|NCT03457909|11946252|FG000|COMPLETED|Overall Study||25
10785635|NCT03457909|11946252|FG000|NOT COMPLETED|Overall Study||0
10785636|NCT03458702|11946256|FG000|STARTED|Study Condition A (Yoga or Rest)||28
10785637|NCT03458702|11946257|FG001|STARTED|Study Condition A (Yoga or Rest)||28
10785638|NCT03458702|11946256|FG000|COMPLETED|Study Condition A (Yoga or Rest)||24
10785639|NCT03458702|11946257|FG001|COMPLETED|Study Condition A (Yoga or Rest)||22
10785640|NCT03458702|11946256|FG000|NOT COMPLETED|Study Condition A (Yoga or Rest)||4
10785641|NCT03458702|11946257|FG001|NOT COMPLETED|Study Condition A (Yoga or Rest)||6
10785642|NCT03458702|11946256|FG000|STARTED|Study Condition B (Yoga or Rest)||24
10785643|NCT03458702|11946257|FG001|STARTED|Study Condition B (Yoga or Rest)||22
10785644|NCT03458702|11946256|FG000|COMPLETED|Study Condition B (Yoga or Rest)||20
10785645|NCT03458702|11946257|FG001|COMPLETED|Study Condition B (Yoga or Rest)||20
10785646|NCT03458702|11946256|FG000|NOT COMPLETED|Study Condition B (Yoga or Rest)||4
10785647|NCT03458702|11946257|FG001|NOT COMPLETED|Study Condition B (Yoga or Rest)||2
10785648|NCT03458702|11946256|FG000|STARTED|Picture Rating/Body Composition||20
10785649|NCT03458702|11946257|FG001|STARTED|Picture Rating/Body Composition||20
10785650|NCT03458702|11946256|FG000|COMPLETED|Picture Rating/Body Composition||20
10785651|NCT03458702|11946257|FG001|COMPLETED|Picture Rating/Body Composition||20
10785652|NCT03458702|11946256|FG000|NOT COMPLETED|Picture Rating/Body Composition||0
10785653|NCT03458702|11946257|FG001|NOT COMPLETED|Picture Rating/Body Composition||0
10785654|NCT03458871|11946263|FG000|STARTED|Overall Study||16
10785655|NCT03458871|11946263|FG000|COMPLETED|Overall Study||16
10785656|NCT03458871|11946263|FG000|NOT COMPLETED|Overall Study||0
10785657|NCT03459040|11946267|FG000|STARTED|Overall Study||30
10785658|NCT03459040|11946267|FG000|COMPLETED|Overall Study||21
10785659|NCT03459040|11946267|FG000|NOT COMPLETED|Overall Study||9
10785660|NCT03459131|11946272|FG000|STARTED|Period 1, First 7 Days of Wear||7
10785661|NCT03459131|11946273|FG001|STARTED|Period 1, First 7 Days of Wear||8
10785662|NCT03459131|11946272|FG000|COMPLETED|Period 1, First 7 Days of Wear||7
10785663|NCT03459131|11946273|FG001|COMPLETED|Period 1, First 7 Days of Wear||8
10785664|NCT03459131|11946272|FG000|NOT COMPLETED|Period 1, First 7 Days of Wear||0
10785665|NCT03459131|11946273|FG001|NOT COMPLETED|Period 1, First 7 Days of Wear||0
10785666|NCT03459131|11946272|FG000|STARTED|Period 2, Second 7 Days of Wear||7
10785667|NCT03459131|11946273|FG001|STARTED|Period 2, Second 7 Days of Wear||8
10785668|NCT03459131|11946272|FG000|COMPLETED|Period 2, Second 7 Days of Wear||7
10785669|NCT03459131|11946273|FG001|COMPLETED|Period 2, Second 7 Days of Wear||8
10785670|NCT03459131|11946272|FG000|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
10785671|NCT03459131|11946273|FG001|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
10785672|NCT03459196|11946279|FG000|STARTED|Overall Study||54
10785673|NCT03459196|11946279|FG000|COMPLETED|Overall Study||52
10785674|NCT03459196|11946279|FG000|NOT COMPLETED|Overall Study||2
10785675|NCT03459612|11946287|FG000|STARTED|Period 1||17
10785676|NCT03459612|11946288|FG001|STARTED|Period 1||17
10785677|NCT03459612|11946289|FG002|STARTED|Period 1||17
10785678|NCT03459612|11946290|FG003|STARTED|Period 1||17
10785679|NCT03459612|11946287|FG000|Received at Least 1 Dose of Study Drug|Period 1||17
10785680|NCT03459612|11946288|FG001|Received at Least 1 Dose of Study Drug|Period 1||17
10785681|NCT03459612|11946289|FG002|Received at Least 1 Dose of Study Drug|Period 1||17
10785682|NCT03459612|11946290|FG003|Received at Least 1 Dose of Study Drug|Period 1||17
10433142|NCT00884611|11579447|FG000|NOT COMPLETED|Overall Study||1
10433143|NCT00884650|11579459|FG000|STARTED|Overall Study||25
10785683|NCT03459612|11946287|FG000|COMPLETED|Period 1||17
10785684|NCT03459612|11946288|FG001|COMPLETED|Period 1||17
10785685|NCT03459612|11946289|FG002|COMPLETED|Period 1||17
10785686|NCT03459612|11946290|FG003|COMPLETED|Period 1||17
10785687|NCT03459612|11946287|FG000|NOT COMPLETED|Period 1||0
10785688|NCT03459612|11946288|FG001|NOT COMPLETED|Period 1||0
10785689|NCT03459612|11946289|FG002|NOT COMPLETED|Period 1||0
10785690|NCT03459612|11946290|FG003|NOT COMPLETED|Period 1||0
10318569|NCT00215150|11452798|FG000|STARTED|Open Label Phase|Number of subjects consented|51
10785691|NCT03459612|11946287|FG000|STARTED|Period 2||17
10785692|NCT03459612|11946288|FG001|STARTED|Period 2||17
10785693|NCT03459612|11946289|FG002|STARTED|Period 2||17
10785694|NCT03459612|11946290|FG003|STARTED|Period 2||17
10318570|NCT00215150|11452798|FG000|COMPLETED|Open Label Phase||21
10318571|NCT00215150|11452798|FG000|NOT COMPLETED|Open Label Phase||30
10318572|NCT00215150|11452798|FG000|STARTED|Randomization Phase Ziprasidone||10
10318573|NCT00215150|11452798|FG000|COMPLETED|Randomization Phase Ziprasidone||7
10318574|NCT00215150|11452798|FG000|NOT COMPLETED|Randomization Phase Ziprasidone||3
10318575|NCT00215150|11452798|FG000|STARTED|Randomization Phase Placebo||11
10318576|NCT00215150|11452798|FG000|COMPLETED|Randomization Phase Placebo||10
10318577|NCT00215150|11452798|FG000|NOT COMPLETED|Randomization Phase Placebo||1
10318578|NCT00215540|11452809|FG000|STARTED|Overall Study||45
10318579|NCT00215540|11452810|FG001|STARTED|Overall Study||47
10318580|NCT00215540|11452811|FG002|STARTED|Overall Study||44
10318581|NCT00215540|11452809|FG000|COMPLETED|Overall Study||44
10318582|NCT00215540|11452810|FG001|COMPLETED|Overall Study||47
10318583|NCT00215540|11452811|FG002|COMPLETED|Overall Study||44
10318584|NCT00215540|11452809|FG000|NOT COMPLETED|Overall Study||1
10318585|NCT00215540|11452810|FG001|NOT COMPLETED|Overall Study||0
10318586|NCT00215540|11452811|FG002|NOT COMPLETED|Overall Study||0
10318587|NCT00215553|11452826|FG000|STARTED|Overall Study||5
10318588|NCT00215553|11452827|FG001|STARTED|Overall Study||6
10318589|NCT00215553|11452828|FG002|STARTED|Overall Study||6
10318590|NCT00215553|11452829|FG003|STARTED|Overall Study||5
10318591|NCT00215553|11452830|FG004|STARTED|Overall Study||28
10318592|NCT00215553|11452831|FG005|STARTED|Overall Study||38
10318593|NCT00215553|11452832|FG006|STARTED|Overall Study||36
10318594|NCT00215553|11452826|FG000|COMPLETED|Overall Study||5
10318595|NCT00215553|11452827|FG001|COMPLETED|Overall Study||5
10318596|NCT00215553|11452828|FG002|COMPLETED|Overall Study||4
10318597|NCT00215553|11452829|FG003|COMPLETED|Overall Study||4
10318598|NCT00215553|11452830|FG004|COMPLETED|Overall Study||26
10318599|NCT00215553|11452831|FG005|COMPLETED|Overall Study||32
10318600|NCT00215553|11452832|FG006|COMPLETED|Overall Study||36
10318601|NCT00215553|11452826|FG000|NOT COMPLETED|Overall Study||0
10318602|NCT00215553|11452827|FG001|NOT COMPLETED|Overall Study||1
10318603|NCT00215553|11452828|FG002|NOT COMPLETED|Overall Study||2
10318604|NCT00215553|11452829|FG003|NOT COMPLETED|Overall Study||1
10318605|NCT00215553|11452830|FG004|NOT COMPLETED|Overall Study||2
10318606|NCT00215553|11452831|FG005|NOT COMPLETED|Overall Study||6
10318607|NCT00215553|11452832|FG006|NOT COMPLETED|Overall Study||0
10318608|NCT00215644|11452850|FG000|STARTED|Overall Study||36
10318609|NCT00215644|11452851|FG001|STARTED|Overall Study||36
10318610|NCT00215644|11452850|FG000|Treated|Overall Study||35
10318611|NCT00215644|11452851|FG001|Treated|Overall Study||36
10318612|NCT00215644|11452850|FG000|COMPLETED|Overall Study||0
10318613|NCT00215644|11452851|FG001|COMPLETED|Overall Study||0
10318614|NCT00215644|11452850|FG000|NOT COMPLETED|Overall Study||36
10318615|NCT00215644|11452851|FG001|NOT COMPLETED|Overall Study||36
10318616|NCT00215657|11452865|FG000|STARTED|Overall Study||26
10318617|NCT00215657|11452866|FG001|STARTED|Overall Study||12
10433144|NCT00884650|11579460|FG001|STARTED|Overall Study||29
10433145|NCT00884650|11579459|FG000|COMPLETED|Overall Study||16
10433146|NCT00884650|11579460|FG001|COMPLETED|Overall Study||21
10433147|NCT00884650|11579459|FG000|NOT COMPLETED|Overall Study||9
10433148|NCT00884650|11579460|FG001|NOT COMPLETED|Overall Study||8
10433149|NCT00884741|11579470|FG000|STARTED|Step 1 Registration: Tissue Screening||978
10433150|NCT00884741|11579471|FG001|STARTED|Step 1 Registration: Tissue Screening||0
10433151|NCT00884741|11579472|FG002|STARTED|Step 1 Registration: Tissue Screening||0
10433152|NCT00884741|11579473|FG003|STARTED|Step 1 Registration: Tissue Screening||0
10433153|NCT00884741|11579470|FG000|COMPLETED|Step 1 Registration: Tissue Screening||666
10433154|NCT00884741|11579471|FG001|COMPLETED|Step 1 Registration: Tissue Screening||0
10433155|NCT00884741|11579472|FG002|COMPLETED|Step 1 Registration: Tissue Screening||0
10433156|NCT00884741|11579473|FG003|COMPLETED|Step 1 Registration: Tissue Screening||0
10433157|NCT00884741|11579470|FG000|NOT COMPLETED|Step 1 Registration: Tissue Screening||312
10433158|NCT00884741|11579471|FG001|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
10433159|NCT00884741|11579472|FG002|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
10433160|NCT00884741|11579473|FG003|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
10433161|NCT00884741|11579470|FG000|STARTED|Step 2 Registration: Tissue Analysis|Step 1 Registration Arm goes to Step 2 Registration Arm|0
10525224|NCT01374178|11677073|FG000|STARTED|Period 2 (up to 24 Hours After Dosing)||10
10785695|NCT03459612|11946287|FG000|Received at Least 1 Dose of Study Drug|Period 2||17
10785696|NCT03459612|11946288|FG001|Received at Least 1 Dose of Study Drug|Period 2||17
10785697|NCT03459612|11946289|FG002|Received at Least 1 Dose of Study Drug|Period 2||17
10318618|NCT00215657|11452867|FG002|STARTED|Overall Study||13
10318619|NCT00215657|11452868|FG003|STARTED|Overall Study||24
10318620|NCT00215657|11452869|FG004|STARTED|Overall Study||27
10318621|NCT00215657|11452870|FG005|STARTED|Overall Study||24
10318622|NCT00215657|11452871|FG006|STARTED|Overall Study||27
10318623|NCT00215657|11452872|FG007|STARTED|Overall Study||27
10318624|NCT00215657|11452865|FG000|Intention-to-treat Population|Overall Study||25
10318625|NCT00215657|11452866|FG001|Intention-to-treat Population|Overall Study||12
10318626|NCT00215657|11452867|FG002|Intention-to-treat Population|Overall Study||12
10318627|NCT00215657|11452868|FG003|Intention-to-treat Population|Overall Study||24
10318628|NCT00215657|11452869|FG004|Intention-to-treat Population|Overall Study||24
10318629|NCT00215657|11452870|FG005|Intention-to-treat Population|Overall Study||24
10433162|NCT00884741|11579471|FG001|STARTED|Step 2 Registration: Tissue Analysis|These patients completed the previous period on the Step 1 Registration arm.|666
10433163|NCT00884741|11579472|FG002|STARTED|Step 2 Registration: Tissue Analysis||0
10433164|NCT00884741|11579473|FG003|STARTED|Step 2 Registration: Tissue Analysis||0
10785698|NCT03459612|11946290|FG003|Received at Least 1 Dose of Study Drug|Period 2||17
10785699|NCT03459612|11946287|FG000|COMPLETED|Period 2||17
10785700|NCT03459612|11946288|FG001|COMPLETED|Period 2||17
10785701|NCT03459612|11946289|FG002|COMPLETED|Period 2||17
10785702|NCT03459612|11946290|FG003|COMPLETED|Period 2||17
10433165|NCT00884741|11579470|FG000|COMPLETED|Step 2 Registration: Tissue Analysis||0
10433166|NCT00884741|11579471|FG001|COMPLETED|Step 2 Registration: Tissue Analysis||637
10433167|NCT00884741|11579472|FG002|COMPLETED|Step 2 Registration: Tissue Analysis||0
10433168|NCT00884741|11579473|FG003|COMPLETED|Step 2 Registration: Tissue Analysis||0
10433169|NCT00884741|11579470|FG000|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
10433170|NCT00884741|11579471|FG001|NOT COMPLETED|Step 2 Registration: Tissue Analysis||29
10433171|NCT00884741|11579472|FG002|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
10433172|NCT00884741|11579473|FG003|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
10433173|NCT00884741|11579470|FG000|STARTED|Randomization||0
10433174|NCT00884741|11579471|FG001|STARTED|Randomization|Step 2 Registration Arm goes to a randomized arm.|0
10433175|NCT00884741|11579472|FG002|STARTED|Randomization|These patients completed the previous period on the Step 2 Registration arm.|317
10433176|NCT00884741|11579473|FG003|STARTED|Randomization|These patients completed the previous period on the Step 2 Registration arm.|320
10433177|NCT00884741|11579470|FG000|COMPLETED|Randomization||0
10433178|NCT00884741|11579471|FG001|COMPLETED|Randomization||0
10433179|NCT00884741|11579472|FG002|COMPLETED|Randomization|Patients with data available for the primary analysis are considered to have completed the study.|309
10433180|NCT00884741|11579473|FG003|COMPLETED|Randomization|Patients with data available for the primary analysis are considered to have completed the study.|312
10433181|NCT00884741|11579470|FG000|NOT COMPLETED|Randomization||0
10433182|NCT00884741|11579471|FG001|NOT COMPLETED|Randomization||0
10433183|NCT00884741|11579472|FG002|NOT COMPLETED|Randomization||8
10433184|NCT00884741|11579473|FG003|NOT COMPLETED|Randomization||8
10433185|NCT00884754|11579482|FG000|STARTED|Overall Study||30
10433186|NCT00884754|11579483|FG001|STARTED|Overall Study||30
10785703|NCT03459612|11946287|FG000|NOT COMPLETED|Period 2||0
10785704|NCT03459612|11946288|FG001|NOT COMPLETED|Period 2||0
10785705|NCT03459612|11946289|FG002|NOT COMPLETED|Period 2||0
10785706|NCT03459612|11946290|FG003|NOT COMPLETED|Period 2||0
10785707|NCT03459612|11946287|FG000|STARTED|Period 3||17
10785708|NCT03459612|11946288|FG001|STARTED|Period 3||17
10785709|NCT03459612|11946289|FG002|STARTED|Period 3||17
10785710|NCT03459612|11946290|FG003|STARTED|Period 3||17
10785711|NCT03459612|11946287|FG000|Received at Least 1 Dose of Study Drug|Period 3||17
10785712|NCT03459612|11946288|FG001|Received at Least 1 Dose of Study Drug|Period 3||17
10785713|NCT03459612|11946289|FG002|Received at Least 1 Dose of Study Drug|Period 3||17
10785714|NCT03459612|11946290|FG003|Received at Least 1 Dose of Study Drug|Period 3||17
10785715|NCT03459612|11946287|FG000|COMPLETED|Period 3||17
10785716|NCT03459612|11946288|FG001|COMPLETED|Period 3||17
10785717|NCT03459612|11946289|FG002|COMPLETED|Period 3||17
10785718|NCT03459612|11946290|FG003|COMPLETED|Period 3||17
10785719|NCT03459612|11946287|FG000|NOT COMPLETED|Period 3||0
10785720|NCT03459612|11946288|FG001|NOT COMPLETED|Period 3||0
10785721|NCT03459612|11946289|FG002|NOT COMPLETED|Period 3||0
10785722|NCT03459612|11946290|FG003|NOT COMPLETED|Period 3||0
10785723|NCT03459612|11946287|FG000|STARTED|Period 4||17
10785724|NCT03459612|11946288|FG001|STARTED|Period 4||17
10785725|NCT03459612|11946289|FG002|STARTED|Period 4|One participant completed period 3 and withdrew for personal reasons prior to Period 4.|16
10785726|NCT03459612|11946290|FG003|STARTED|Period 4||17
10785727|NCT03459612|11946287|FG000|Received at Least 1 Dose of Study Drug|Period 4||17
10785728|NCT03459612|11946288|FG001|Received at Least 1 Dose of Study Drug|Period 4||17
10785729|NCT03459612|11946289|FG002|Received at Least 1 Dose of Study Drug|Period 4||16
10785730|NCT03459612|11946290|FG003|Received at Least 1 Dose of Study Drug|Period 4||17
10785731|NCT03459612|11946287|FG000|COMPLETED|Period 4||17
10785732|NCT03459612|11946288|FG001|COMPLETED|Period 4||17
10785733|NCT03459612|11946289|FG002|COMPLETED|Period 4||16
10785734|NCT03459612|11946290|FG003|COMPLETED|Period 4||17
10785735|NCT03459612|11946287|FG000|NOT COMPLETED|Period 4||0
10785736|NCT03459612|11946288|FG001|NOT COMPLETED|Period 4||0
10785737|NCT03459612|11946289|FG002|NOT COMPLETED|Period 4||0
10785738|NCT03459612|11946290|FG003|NOT COMPLETED|Period 4||0
10785739|NCT03459794|11946305|FG000|STARTED|Overall Study||8
10785740|NCT03459794|11946306|FG001|STARTED|Overall Study||4
10785741|NCT03459794|11946305|FG000|COMPLETED|Overall Study||8
10785742|NCT03459794|11946306|FG001|COMPLETED|Overall Study||4
10433187|NCT00884754|11579482|FG000|COMPLETED|Overall Study||30
10433188|NCT00884754|11579483|FG001|COMPLETED|Overall Study||30
10433189|NCT00884754|11579482|FG000|NOT COMPLETED|Overall Study||0
10433190|NCT00884754|11579483|FG001|NOT COMPLETED|Overall Study||0
10433191|NCT00884793|11579489|FG000|STARTED|Overall Study||8
10433192|NCT00884793|11579489|FG000|COMPLETED|Overall Study||7
10433193|NCT00884793|11579489|FG000|NOT COMPLETED|Overall Study||1
10785743|NCT03459794|11946305|FG000|NOT COMPLETED|Overall Study||0
10785744|NCT03459794|11946306|FG001|NOT COMPLETED|Overall Study||0
10785745|NCT03460587|11946318|FG000|STARTED|Overall Study||13
10785746|NCT03460587|11946318|FG000|COMPLETED|Overall Study||13
10785747|NCT03460587|11946318|FG000|NOT COMPLETED|Overall Study||0
10785748|NCT03460652|11946322|FG000|STARTED|Overall Study||282
10433194|NCT00884806|11579493|FG000|STARTED|Overall Study||110
10433195|NCT00884806|11579493|FG000|COMPLETED|Overall Study||110
10433196|NCT00884806|11579493|FG000|NOT COMPLETED|Overall Study||0
10433197|NCT00884832|11579499|FG000|STARTED|Overall Study||22
10433198|NCT00884832|11579500|FG001|STARTED|Overall Study||22
10433199|NCT00884832|11579499|FG000|COMPLETED|Overall Study||22
10433200|NCT00884832|11579500|FG001|COMPLETED|Overall Study||21
10433201|NCT00884832|11579499|FG000|NOT COMPLETED|Overall Study||0
10433202|NCT00884832|11579500|FG001|NOT COMPLETED|Overall Study||1
10433203|NCT00884897|11579508|FG000|STARTED|Overall Study||13
10433204|NCT00884897|11579509|FG001|STARTED|Overall Study||15
10433205|NCT00884897|11579508|FG000|COMPLETED|Overall Study||13
10433206|NCT00884897|11579509|FG001|COMPLETED|Overall Study||15
10433207|NCT00884897|11579508|FG000|NOT COMPLETED|Overall Study||0
10433208|NCT00884897|11579509|FG001|NOT COMPLETED|Overall Study||0
10433209|NCT00884910|11579515|FG000|STARTED|Overall Study||33
10433210|NCT00884910|11579515|FG000|COMPLETED|Overall Study|patient diagnosed with primary pulmonary tumor during study|32
10433211|NCT00884910|11579515|FG000|NOT COMPLETED|Overall Study||1
10433212|NCT00884949|11579519|FG000|STARTED|Weeks 1-12: 0.1 mg/kg/Week||20
10433213|NCT00884949|11579519|FG000|COMPLETED|Weeks 1-12: 0.1 mg/kg/Week||18
10433214|NCT00884949|11579519|FG000|NOT COMPLETED|Weeks 1-12: 0.1 mg/kg/Week||2
10433215|NCT00884949|11579519|FG000|STARTED|Weeks 13-24: 1.0 mg/kg/Week||18
10433216|NCT00884949|11579519|FG000|COMPLETED|Weeks 13-24: 1.0 mg/kg/Week||18
10433217|NCT00884949|11579519|FG000|NOT COMPLETED|Weeks 13-24: 1.0 mg/kg/Week||0
10433218|NCT00884949|11579519|FG000|STARTED|Weeks 25-36: 2.0 mg/kg/Week||18
10433219|NCT00884949|11579519|FG000|COMPLETED|Weeks 25-36: 2.0 mg/kg/Week||18
10433220|NCT00884949|11579519|FG000|NOT COMPLETED|Weeks 25-36: 2.0 mg/kg/Week||0
10433221|NCT00884949|11579519|FG000|STARTED|Continuation Period||18
10433222|NCT00884949|11579519|FG000|COMPLETED|Continuation Period||18
10433223|NCT00884949|11579519|FG000|NOT COMPLETED|Continuation Period||0
10433224|NCT00885079|11579534|FG000|STARTED|Overall Study||93
10433225|NCT00885079|11579535|FG001|STARTED|Overall Study||95
10433226|NCT00885079|11579534|FG000|COMPLETED|Overall Study||91
10433227|NCT00885079|11579535|FG001|COMPLETED|Overall Study||91
10433228|NCT00885079|11579534|FG000|NOT COMPLETED|Overall Study||2
10433229|NCT00885079|11579535|FG001|NOT COMPLETED|Overall Study||4
10433230|NCT00885092|11579543|FG000|STARTED|Period 1, 7 Days||20
10433231|NCT00885092|11579544|FG001|STARTED|Period 1, 7 Days||20
10433232|NCT00885092|11579543|FG000|COMPLETED|Period 1, 7 Days||20
10433233|NCT00885092|11579544|FG001|COMPLETED|Period 1, 7 Days||20
10433234|NCT00885092|11579543|FG000|NOT COMPLETED|Period 1, 7 Days||0
10433235|NCT00885092|11579544|FG001|NOT COMPLETED|Period 1, 7 Days||0
10433236|NCT00885092|11579543|FG000|STARTED|Period 2, 7 Days||20
10433237|NCT00885092|11579544|FG001|STARTED|Period 2, 7 Days||20
10433238|NCT00885092|11579543|FG000|COMPLETED|Period 2, 7 Days||20
10433239|NCT00885092|11579544|FG001|COMPLETED|Period 2, 7 Days||20
10433240|NCT00885092|11579543|FG000|NOT COMPLETED|Period 2, 7 Days||0
10433241|NCT00885092|11579544|FG001|NOT COMPLETED|Period 2, 7 Days||0
10433242|NCT00885105|11579552|FG000|STARTED|Overall Study||112
10433243|NCT00885105|11579553|FG001|STARTED|Overall Study||130
10433244|NCT00885105|11579552|FG000|COMPLETED|Overall Study||111
10433245|NCT00885105|11579553|FG001|COMPLETED|Overall Study||120
10433246|NCT00885105|11579552|FG000|NOT COMPLETED|Overall Study||1
10433247|NCT00885105|11579553|FG001|NOT COMPLETED|Overall Study||10
10433248|NCT00885118|11579564|FG000|STARTED|Overall Study||21
10433249|NCT00885118|11579565|FG001|STARTED|Overall Study||19
10433250|NCT00885118|11579566|FG002|STARTED|Overall Study||21
10433251|NCT00885118|11579567|FG003|STARTED|Overall Study||20
10433252|NCT00885118|11579568|FG004|STARTED|Overall Study||19
10433253|NCT00885118|11579564|FG000|COMPLETED|Overall Study||20
10433254|NCT00885118|11579565|FG001|COMPLETED|Overall Study||19
10433255|NCT00885118|11579566|FG002|COMPLETED|Overall Study||20
10433256|NCT00885118|11579567|FG003|COMPLETED|Overall Study||20
10433257|NCT00885118|11579568|FG004|COMPLETED|Overall Study||18
10433258|NCT00885118|11579564|FG000|NOT COMPLETED|Overall Study||1
10433259|NCT00885118|11579565|FG001|NOT COMPLETED|Overall Study||0
10433260|NCT00885118|11579566|FG002|NOT COMPLETED|Overall Study||1
10433261|NCT00885118|11579567|FG003|NOT COMPLETED|Overall Study||0
10433262|NCT00885118|11579568|FG004|NOT COMPLETED|Overall Study||1
10433263|NCT00885170|11579586|FG000|STARTED|Overall Study||124
10433264|NCT00885170|11579587|FG001|STARTED|Overall Study||122
10433265|NCT00885170|11579586|FG000|Treated|Overall Study||122
10433266|NCT00885170|11579587|FG001|Treated|Overall Study||121
10433267|NCT00885170|11579586|FG000|COMPLETED|Overall Study||86
10433268|NCT00885170|11579587|FG001|COMPLETED|Overall Study||99
10433269|NCT00885170|11579586|FG000|NOT COMPLETED|Overall Study||38
10433270|NCT00885170|11579587|FG001|NOT COMPLETED|Overall Study||23
10433271|NCT00885352|11579595|FG000|STARTED|Overall Study||157
10433272|NCT00885352|11579596|FG001|STARTED|Overall Study||156
10433273|NCT00885352|11579595|FG000|COMPLETED|Overall Study||149
10433274|NCT00885352|11579596|FG001|COMPLETED|Overall Study||136
10433275|NCT00885352|11579595|FG000|NOT COMPLETED|Overall Study||8
10433276|NCT00885352|11579596|FG001|NOT COMPLETED|Overall Study||20
10433277|NCT00885365|11579604|FG000|STARTED|4 Weeks ON Treatment||159
10433278|NCT00885365|11579605|FG001|STARTED|4 Weeks ON Treatment||165
10433279|NCT00885365|11579604|FG000|Intent-to-Treat Population|4 Weeks ON Treatment|Participants who took 1 dose of study medication and had baseline and at least 1 post-treatment FEV1|158
10433280|NCT00885365|11579605|FG001|Intent-to-Treat Population|4 Weeks ON Treatment||163
10433281|NCT00885365|11579604|FG000|Safety Population|4 Weeks ON Treatment|Nine participants randomized to Bramitob were administered TOBI.|156
10433282|NCT00885365|11579605|FG001|Safety Population|4 Weeks ON Treatment|Six participants randomized to TOBI were administered Bramitob|168
10433283|NCT00885365|11579604|FG000|COMPLETED|4 Weeks ON Treatment||155
10433284|NCT00885365|11579605|FG001|COMPLETED|4 Weeks ON Treatment||159
10433285|NCT00885365|11579604|FG000|NOT COMPLETED|4 Weeks ON Treatment||4
10433286|NCT00885365|11579605|FG001|NOT COMPLETED|4 Weeks ON Treatment||6
10433287|NCT00885365|11579604|FG000|STARTED|4 Weeks OFF Treatment||155
10433288|NCT00885365|11579605|FG001|STARTED|4 Weeks OFF Treatment||159
10433289|NCT00885365|11579604|FG000|COMPLETED|4 Weeks OFF Treatment||155
10433290|NCT00885365|11579605|FG001|COMPLETED|4 Weeks OFF Treatment||159
10433291|NCT00885365|11579604|FG000|NOT COMPLETED|4 Weeks OFF Treatment||0
10433292|NCT00885365|11579605|FG001|NOT COMPLETED|4 Weeks OFF Treatment||0
10433293|NCT00885378|11579613|FG000|STARTED|Overall Study|Number randomized.|74
10433294|NCT00885378|11579614|FG001|STARTED|Overall Study|Number randomized.|86
10433295|NCT00885378|11579613|FG000|COMPLETED|Overall Study||66
10433296|NCT00885378|11579614|FG001|COMPLETED|Overall Study||78
10549383|NCT01524978|11703388|FG006|STARTED|Overall Study||26
10549384|NCT01524978|11703389|FG007|STARTED|Overall Study||12
10785749|NCT03460652|11946322|FG000|Entered Treatment Phase|Overall Study||238
10785750|NCT03460652|11946322|FG000|COMPLETED|Overall Study||155
10785751|NCT03460652|11946322|FG000|NOT COMPLETED|Overall Study||127
10785752|NCT03460899|11946327|FG000|STARTED|Euglycaemic Clamp|First Euglycaemic Clamp completed: 05. March 2018|14
10785753|NCT03460899|11946327|FG000|COMPLETED|Euglycaemic Clamp|Last Euglycaemic clamp completed: 23. May 2018|14
10785754|NCT03460899|11946327|FG000|NOT COMPLETED|Euglycaemic Clamp||0
10785755|NCT03460899|11946327|FG000|STARTED|Hyperinsulinaemic/Hypoglycaemic Clamp|First Hyperinsulinaemic/Hypoglycaemic Clamp completed: 15. March 2018|14
10785756|NCT03460899|11946327|FG000|COMPLETED|Hyperinsulinaemic/Hypoglycaemic Clamp|Last Hyperinsulinaemic/Hypoglycaemic Clamp completed: 05. June 2018|14
10785757|NCT03460899|11946327|FG000|NOT COMPLETED|Hyperinsulinaemic/Hypoglycaemic Clamp||0
10549385|NCT01524978|11703390|FG008|STARTED|Overall Study||12
10549386|NCT01524978|11703391|FG009|STARTED|Overall Study||9
10549387|NCT01524978|11703392|FG010|STARTED|Overall Study||28
10549388|NCT01524978|11703382|FG000|COMPLETED|Overall Study||0
10549389|NCT01524978|11703383|FG001|COMPLETED|Overall Study||0
10549390|NCT01524978|11703384|FG002|COMPLETED|Overall Study||0
10549391|NCT01524978|11703385|FG003|COMPLETED|Overall Study||0
10549392|NCT01524978|11703386|FG004|COMPLETED|Overall Study||0
10549393|NCT01524978|11703387|FG005|COMPLETED|Overall Study||0
10549394|NCT01524978|11703388|FG006|COMPLETED|Overall Study||0
10549395|NCT01524978|11703389|FG007|COMPLETED|Overall Study||0
10549396|NCT01524978|11703390|FG008|COMPLETED|Overall Study||0
10549397|NCT01524978|11703391|FG009|COMPLETED|Overall Study||0
10549398|NCT01524978|11703392|FG010|COMPLETED|Overall Study||0
10549399|NCT01524978|11703382|FG000|NOT COMPLETED|Overall Study||62
10549400|NCT01524978|11703383|FG001|NOT COMPLETED|Overall Study||4
10549401|NCT01524978|11703384|FG002|NOT COMPLETED|Overall Study||10
10549402|NCT01524978|11703385|FG003|NOT COMPLETED|Overall Study||27
10549403|NCT01524978|11703386|FG004|NOT COMPLETED|Overall Study||9
10549404|NCT01524978|11703387|FG005|NOT COMPLETED|Overall Study||9
10549405|NCT01524978|11703388|FG006|NOT COMPLETED|Overall Study||26
10549406|NCT01524978|11703389|FG007|NOT COMPLETED|Overall Study||12
10549407|NCT01524978|11703390|FG008|NOT COMPLETED|Overall Study||12
10549408|NCT01524978|11703391|FG009|NOT COMPLETED|Overall Study||9
10549409|NCT01524978|11703392|FG010|NOT COMPLETED|Overall Study||28
10785758|NCT03460990|11946333|FG000|STARTED|Overall Study||57
10785759|NCT03460990|11946334|FG001|STARTED|Overall Study||54
10785760|NCT03460990|11946333|FG000|COMPLETED|Overall Study||57
10549413|NCT01525082|11703411|FG000|STARTED|Overall Study||20
10785761|NCT03460990|11946334|FG001|COMPLETED|Overall Study||54
10785762|NCT03460990|11946333|FG000|NOT COMPLETED|Overall Study||0
10785763|NCT03460990|11946334|FG001|NOT COMPLETED|Overall Study||0
10785764|NCT03461146|11946340|FG000|STARTED|Overall Study||24
10785765|NCT03461146|11946340|FG000|COMPLETED|Overall Study||21
10785766|NCT03461146|11946340|FG000|NOT COMPLETED|Overall Study||3
10785767|NCT03461757|11946346|FG000|STARTED|Overall Study||732
10785768|NCT03461757|11946347|FG001|STARTED|Overall Study||734
10785769|NCT03461757|11946346|FG000|Treated|Overall Study||682
10785770|NCT03461757|11946347|FG001|Treated|Overall Study||693
10785771|NCT03461757|11946346|FG000|COMPLETED|Overall Study||679
10785772|NCT03461757|11946347|FG001|COMPLETED|Overall Study||689
10785773|NCT03461757|11946346|FG000|NOT COMPLETED|Overall Study||53
10785774|NCT03461757|11946347|FG001|NOT COMPLETED|Overall Study||45
10785775|NCT03461965|11946355|FG000|STARTED|Overall Study||42
10785776|NCT03461965|11946356|FG001|STARTED|Overall Study||40
10785777|NCT03461965|11946355|FG000|COMPLETED|Overall Study||42
10785778|NCT03461965|11946356|FG001|COMPLETED|Overall Study||40
10785779|NCT03461965|11946355|FG000|NOT COMPLETED|Overall Study||0
10785780|NCT03461965|11946356|FG001|NOT COMPLETED|Overall Study||0
10785781|NCT03462082|11946362|FG000|STARTED|Study Phase (Randomized, Blinded Period)||3
10785782|NCT03462082|11946363|FG001|STARTED|Study Phase (Randomized, Blinded Period)||4
10549414|NCT01525082|11703411|FG000|COMPLETED|Overall Study||19
10549415|NCT01525082|11703411|FG000|NOT COMPLETED|Overall Study||1
10549416|NCT01525173|11703420|FG000|STARTED|Overall Study||70
10549417|NCT01525173|11703421|FG001|STARTED|Overall Study||67
10549418|NCT01525173|11703420|FG000|COMPLETED|Overall Study||63
10549419|NCT01525173|11703421|FG001|COMPLETED|Overall Study||62
10549420|NCT01525173|11703420|FG000|NOT COMPLETED|Overall Study||7
10549421|NCT01525173|11703421|FG001|NOT COMPLETED|Overall Study||5
10549422|NCT01525225|11703427|FG000|STARTED|Enrollment||4
10549423|NCT01525225|11703427|FG000|COMPLETED|Enrollment||2
10433297|NCT00885378|11579613|FG000|NOT COMPLETED|Overall Study||8
10433298|NCT00885378|11579614|FG001|NOT COMPLETED|Overall Study||8
10433299|NCT00885482|11579620|FG000|STARTED|Overall Study||40
10433300|NCT00885482|11579620|FG000|COMPLETED|Overall Study||36
10433301|NCT00885482|11579620|FG000|NOT COMPLETED|Overall Study||4
10433302|NCT00885534|11579624|FG000|STARTED|Overall Study||7
10433303|NCT00885534|11579624|FG000|COMPLETED|Overall Study||6
10433304|NCT00885534|11579624|FG000|NOT COMPLETED|Overall Study||1
10433305|NCT00885638|11579628|FG000|STARTED|Overall Study||6
10433306|NCT00885638|11579629|FG001|STARTED|Overall Study||6
10433307|NCT00885638|11579628|FG000|COMPLETED|Overall Study||6
10433308|NCT00885638|11579629|FG001|COMPLETED|Overall Study||6
10433309|NCT00885638|11579628|FG000|NOT COMPLETED|Overall Study||0
10433310|NCT00885638|11579629|FG001|NOT COMPLETED|Overall Study||0
10433311|NCT00885677|11579638|FG000|STARTED|Overall Study||462
10785783|NCT03462082|11946364|FG002|STARTED|Study Phase (Randomized, Blinded Period)||4
10785784|NCT03462082|11946365|FG003|STARTED|Study Phase (Randomized, Blinded Period)||3
10785785|NCT03462082|11946366|FG004|STARTED|Study Phase (Randomized, Blinded Period)||3
10433312|NCT00885677|11579639|FG001|STARTED|Overall Study||455
10433313|NCT00885677|11579638|FG000|Intention To Treat|Overall Study||437
10433314|NCT00885677|11579639|FG001|Intention To Treat|Overall Study||428
10433315|NCT00885677|11579638|FG000|COMPLETED|Overall Study||279
10433316|NCT00885677|11579639|FG001|COMPLETED|Overall Study||277
10433317|NCT00885677|11579638|FG000|NOT COMPLETED|Overall Study||183
10433318|NCT00885677|11579639|FG001|NOT COMPLETED|Overall Study||178
10433319|NCT00885703|11579652|FG000|STARTED|Overall Study||22
10433320|NCT00885703|11579653|FG001|STARTED|Overall Study||26
10433321|NCT00885703|11579654|FG002|STARTED|Overall Study||24
10433322|NCT00885703|11579655|FG003|STARTED|Overall Study||24
10433323|NCT00885703|11579656|FG004|STARTED|Overall Study||24
10433324|NCT00885703|11579657|FG005|STARTED|Overall Study||24
10433325|NCT00885703|11579658|FG006|STARTED|Overall Study||24
10433326|NCT00885703|11579652|FG000|COMPLETED|Overall Study||12
10433327|NCT00885703|11579653|FG001|COMPLETED|Overall Study||16
10433328|NCT00885703|11579654|FG002|COMPLETED|Overall Study||13
10433329|NCT00885703|11579655|FG003|COMPLETED|Overall Study||15
10433330|NCT00885703|11579656|FG004|COMPLETED|Overall Study||12
10433331|NCT00885703|11579657|FG005|COMPLETED|Overall Study||11
10433332|NCT00885703|11579658|FG006|COMPLETED|Overall Study||18
10433333|NCT00885703|11579652|FG000|NOT COMPLETED|Overall Study||10
10433334|NCT00885703|11579653|FG001|NOT COMPLETED|Overall Study||10
10433335|NCT00885703|11579654|FG002|NOT COMPLETED|Overall Study||11
10433336|NCT00885703|11579655|FG003|NOT COMPLETED|Overall Study||9
10433337|NCT00885703|11579656|FG004|NOT COMPLETED|Overall Study||12
10433338|NCT00885703|11579657|FG005|NOT COMPLETED|Overall Study||13
10433339|NCT00885703|11579658|FG006|NOT COMPLETED|Overall Study||6
10433340|NCT00885742|11579678|FG000|STARTED|Overall Study||41
10433341|NCT00885742|11579678|FG000|COMPLETED|Overall Study||41
10433342|NCT00885742|11579678|FG000|NOT COMPLETED|Overall Study||0
10433343|NCT00885755|11579685|FG000|STARTED|Part I: Trastuzumab+Taxane||31
10433344|NCT00885755|11579686|FG001|STARTED|Part I: Trastuzumab+Taxane||1
10785786|NCT03462082|11946367|FG005|STARTED|Study Phase (Randomized, Blinded Period)||5
10785787|NCT03462082|11946368|FG006|STARTED|Study Phase (Randomized, Blinded Period)||0
10785788|NCT03462082|11946369|FG007|STARTED|Study Phase (Randomized, Blinded Period)||0
10785789|NCT03462082|11946362|FG000|COMPLETED|Study Phase (Randomized, Blinded Period)||3
10785790|NCT03462082|11946363|FG001|COMPLETED|Study Phase (Randomized, Blinded Period)||4
10785791|NCT03462082|11946364|FG002|COMPLETED|Study Phase (Randomized, Blinded Period)||4
10785792|NCT03462082|11946365|FG003|COMPLETED|Study Phase (Randomized, Blinded Period)||3
10785793|NCT03462082|11946366|FG004|COMPLETED|Study Phase (Randomized, Blinded Period)||3
10785794|NCT03462082|11946367|FG005|COMPLETED|Study Phase (Randomized, Blinded Period)||5
10433345|NCT00885755|11579687|FG002|STARTED|Part I: Trastuzumab+Taxane||1
10433346|NCT00885755|11579685|FG000|COMPLETED|Part I: Trastuzumab+Taxane||13
10433347|NCT00885755|11579686|FG001|COMPLETED|Part I: Trastuzumab+Taxane||1
10433348|NCT00885755|11579687|FG002|COMPLETED|Part I: Trastuzumab+Taxane||0
10433349|NCT00885755|11579685|FG000|NOT COMPLETED|Part I: Trastuzumab+Taxane||18
10433350|NCT00885755|11579686|FG001|NOT COMPLETED|Part I: Trastuzumab+Taxane||0
10433351|NCT00885755|11579687|FG002|NOT COMPLETED|Part I: Trastuzumab+Taxane||1
10433352|NCT00885755|11579685|FG000|STARTED|Part II: Trastuzumab + Capecitabine.||13
10433353|NCT00885755|11579686|FG001|STARTED|Part II: Trastuzumab + Capecitabine.||1
10785795|NCT03462082|11946368|FG006|COMPLETED|Study Phase (Randomized, Blinded Period)||0
10785796|NCT03462082|11946369|FG007|COMPLETED|Study Phase (Randomized, Blinded Period)||0
10785797|NCT03462082|11946362|FG000|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
10785798|NCT03462082|11946363|FG001|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
10785799|NCT03462082|11946364|FG002|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
10785800|NCT03462082|11946365|FG003|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
10785801|NCT03462082|11946366|FG004|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
10433354|NCT00885755|11579687|FG002|STARTED|Part II: Trastuzumab + Capecitabine.||0
10433355|NCT00885755|11579685|FG000|COMPLETED|Part II: Trastuzumab + Capecitabine.||8
10433356|NCT00885755|11579686|FG001|COMPLETED|Part II: Trastuzumab + Capecitabine.||1
10433357|NCT00885755|11579687|FG002|COMPLETED|Part II: Trastuzumab + Capecitabine.||0
10433358|NCT00885755|11579685|FG000|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||5
10433359|NCT00885755|11579686|FG001|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||0
10433360|NCT00885755|11579687|FG002|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||0
10433361|NCT00885768|11579695|FG000|STARTED|Overall Study|all patients with coronary artery stenosis on angiography entered the study|146
10433362|NCT00885768|11579695|FG000|COMPLETED|Overall Study|all patients with including criteria completed the study|146
10433363|NCT00885768|11579695|FG000|NOT COMPLETED|Overall Study||0
10433364|NCT00885846|11579702|FG000|STARTED|Overall Study|Cohort 1 = 5 Cohort 2 = 6|11
10433365|NCT00885846|11579703|FG001|STARTED|Overall Study|Cohort 1 = 6 Cohort 2 = 5|11
10433366|NCT00885846|11579704|FG002|STARTED|Overall Study|Cohort 1 = 4 Cohort 2 = 6|10
10433367|NCT00885846|11579702|FG000|COMPLETED|Overall Study|Cohort 1 = 3 Cohort 2 = 6|9
10433368|NCT00885846|11579703|FG001|COMPLETED|Overall Study|Cohort 1 = 1 Cohort 2 = 5|6
10433369|NCT00885846|11579704|FG002|COMPLETED|Overall Study|Cohort 1 = 4 Cohort 2 = 6|8
10433370|NCT00885846|11579702|FG000|NOT COMPLETED|Overall Study||2
10433371|NCT00885846|11579703|FG001|NOT COMPLETED|Overall Study||5
10433372|NCT00885846|11579704|FG002|NOT COMPLETED|Overall Study||2
10433373|NCT00886015|11579714|FG000|STARTED|Overall Study|1674 eyes; 960 participants|1674
10433374|NCT00886015|11579715|FG001|STARTED|Overall Study|1671 eyes; 957 participants|1671
10433375|NCT00886015|11579714|FG000|COMPLETED|Overall Study|1674 eyes; 960 participants|1674
10433376|NCT00886015|11579715|FG001|COMPLETED|Overall Study|1669 eyes; 956 participants|1669
10433377|NCT00886015|11579714|FG000|NOT COMPLETED|Overall Study||0
10433378|NCT00886015|11579715|FG001|NOT COMPLETED|Overall Study||2
10433379|NCT00886119|11579721|FG000|STARTED|Period 1||24
10785802|NCT03462082|11946367|FG005|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
10785803|NCT03462082|11946368|FG006|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
10785804|NCT03462082|11946369|FG007|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
10785805|NCT03462082|11946362|FG000|STARTED|Open Label Phase||0
10785806|NCT03462082|11946363|FG001|STARTED|Open Label Phase||0
10785807|NCT03462082|11946364|FG002|STARTED|Open Label Phase||0
10785808|NCT03462082|11946365|FG003|STARTED|Open Label Phase||0
10785809|NCT03462082|11946366|FG004|STARTED|Open Label Phase||0
10785810|NCT03462082|11946367|FG005|STARTED|Open Label Phase||0
10785811|NCT03462082|11946368|FG006|STARTED|Open Label Phase||7
10785812|NCT03462082|11946369|FG007|STARTED|Open Label Phase||10
10785813|NCT03462082|11946362|FG000|COMPLETED|Open Label Phase||0
10785814|NCT03462082|11946363|FG001|COMPLETED|Open Label Phase||0
10785815|NCT03462082|11946364|FG002|COMPLETED|Open Label Phase||0
10785816|NCT03462082|11946365|FG003|COMPLETED|Open Label Phase||0
10785817|NCT03462082|11946366|FG004|COMPLETED|Open Label Phase||0
10785818|NCT03462082|11946367|FG005|COMPLETED|Open Label Phase||0
10785819|NCT03462082|11946368|FG006|COMPLETED|Open Label Phase||6
10785820|NCT03462082|11946369|FG007|COMPLETED|Open Label Phase||8
10785821|NCT03462082|11946362|FG000|NOT COMPLETED|Open Label Phase||0
10785822|NCT03462082|11946363|FG001|NOT COMPLETED|Open Label Phase||0
10785823|NCT03462082|11946364|FG002|NOT COMPLETED|Open Label Phase||0
10785824|NCT03462082|11946365|FG003|NOT COMPLETED|Open Label Phase||0
10785825|NCT03462082|11946366|FG004|NOT COMPLETED|Open Label Phase||0
10785826|NCT03462082|11946367|FG005|NOT COMPLETED|Open Label Phase||0
10785827|NCT03462082|11946368|FG006|NOT COMPLETED|Open Label Phase||1
10785828|NCT03462082|11946369|FG007|NOT COMPLETED|Open Label Phase||2
10785829|NCT03462576|11946382|FG000|STARTED|Overall Study||46
10785830|NCT03462576|11946383|FG001|STARTED|Overall Study||48
10433380|NCT00886119|11579722|FG001|STARTED|Period 1||22
10433381|NCT00886119|11579721|FG000|COMPLETED|Period 1||23
10433382|NCT00886119|11579722|FG001|COMPLETED|Period 1||22
10433383|NCT00886119|11579721|FG000|NOT COMPLETED|Period 1||1
10433384|NCT00886119|11579722|FG001|NOT COMPLETED|Period 1||0
10433385|NCT00886119|11579721|FG000|STARTED|Period 2||23
10433386|NCT00886119|11579722|FG001|STARTED|Period 2||22
10433387|NCT00886119|11579721|FG000|COMPLETED|Period 2||23
10433388|NCT00886119|11579722|FG001|COMPLETED|Period 2||22
10785831|NCT03462576|11946384|FG002|STARTED|Overall Study||45
10785832|NCT03462576|11946382|FG000|COMPLETED|Overall Study||41
10785833|NCT03462576|11946383|FG001|COMPLETED|Overall Study||37
10785834|NCT03462576|11946384|FG002|COMPLETED|Overall Study||37
10785835|NCT03462576|11946382|FG000|NOT COMPLETED|Overall Study||5
10785836|NCT03462576|11946383|FG001|NOT COMPLETED|Overall Study||11
10785837|NCT03462576|11946384|FG002|NOT COMPLETED|Overall Study||8
10785838|NCT03462680|11946394|FG000|STARTED|Overall Study||21
10785839|NCT03462680|11946395|FG001|STARTED|Overall Study||26
10785840|NCT03462680|11946394|FG000|COMPLETED|Overall Study||18
10785841|NCT03462680|11946395|FG001|COMPLETED|Overall Study||21
10785842|NCT03462680|11946394|FG000|NOT COMPLETED|Overall Study||3
10785843|NCT03462680|11946395|FG001|NOT COMPLETED|Overall Study||5
10785844|NCT03462745|11946403|FG000|STARTED|Overall Study||92
10785845|NCT03462745|11946404|FG001|STARTED|Overall Study||92
10785846|NCT03462745|11946403|FG000|COMPLETED|Overall Study||92
10785847|NCT03462745|11946404|FG001|COMPLETED|Overall Study||92
10785848|NCT03462745|11946403|FG000|NOT COMPLETED|Overall Study||0
10785849|NCT03462745|11946404|FG001|NOT COMPLETED|Overall Study||0
10785850|NCT03462927|11946412|FG000|STARTED|Overall Study||32
10785851|NCT03462927|11946413|FG001|STARTED|Overall Study||31
10785852|NCT03462927|11946412|FG000|COMPLETED|Overall Study||26
10785853|NCT03462927|11946413|FG001|COMPLETED|Overall Study||29
10785854|NCT03462927|11946412|FG000|NOT COMPLETED|Overall Study||6
10785855|NCT03462927|11946413|FG001|NOT COMPLETED|Overall Study||2
10810577|NCT03796182|11972328|FG000|NOT COMPLETED|Period 2||0
10810578|NCT03796182|11972329|FG001|NOT COMPLETED|Period 2||0
10810579|NCT03796013|11972337|FG000|STARTED|Period 1||14
10810580|NCT03796013|11972338|FG001|STARTED|Period 1||14
10810581|NCT03796013|11972337|FG000|COMPLETED|Period 1||14
10810582|NCT03796013|11972338|FG001|COMPLETED|Period 1||14
10810583|NCT03796013|11972337|FG000|NOT COMPLETED|Period 1||0
10810584|NCT03796013|11972338|FG001|NOT COMPLETED|Period 1||0
10810585|NCT03796013|11972337|FG000|STARTED|Period 2||14
10810586|NCT03796013|11972338|FG001|STARTED|Period 2||14
10810587|NCT03796013|11972337|FG000|COMPLETED|Period 2||14
10810588|NCT03796013|11972338|FG001|COMPLETED|Period 2||14
10810589|NCT03796013|11972337|FG000|NOT COMPLETED|Period 2||0
10810590|NCT03796013|11972338|FG001|NOT COMPLETED|Period 2||0
10810591|NCT03795753|11972346|FG000|STARTED|Overall Study||23
10810592|NCT03795753|11972347|FG001|STARTED|Overall Study||13
10810593|NCT03795753|11972346|FG000|COMPLETED|Overall Study||23
10810594|NCT03795753|11972347|FG001|COMPLETED|Overall Study||13
10810595|NCT03795753|11972346|FG000|NOT COMPLETED|Overall Study||0
10810596|NCT03795753|11972347|FG001|NOT COMPLETED|Overall Study||0
10810597|NCT03792477|11972358|FG000|STARTED|Overall Study||6
10810598|NCT03792477|11972359|FG001|STARTED|Overall Study||6
10810599|NCT03792477|11972360|FG002|STARTED|Overall Study||21
10810600|NCT03792477|11972361|FG003|STARTED|Overall Study||21
10810601|NCT03792477|11972362|FG004|STARTED|Overall Study||20
10810602|NCT03792477|11972358|FG000|COMPLETED|Overall Study||6
10810603|NCT03792477|11972359|FG001|COMPLETED|Overall Study||6
10810604|NCT03792477|11972360|FG002|COMPLETED|Overall Study||19
10810605|NCT03792477|11972361|FG003|COMPLETED|Overall Study||20
10810606|NCT03792477|11972362|FG004|COMPLETED|Overall Study||19
10810607|NCT03792477|11972358|FG000|NOT COMPLETED|Overall Study||0
10810608|NCT03792477|11972359|FG001|NOT COMPLETED|Overall Study||0
10810609|NCT03792477|11972360|FG002|NOT COMPLETED|Overall Study||2
10810610|NCT03792477|11972361|FG003|NOT COMPLETED|Overall Study||1
10810611|NCT03792477|11972362|FG004|NOT COMPLETED|Overall Study||1
10810612|NCT03783962|11972370|FG000|STARTED|Overall Study||28
10810613|NCT03783962|11972371|FG001|STARTED|Overall Study||28
10810614|NCT03783962|11972370|FG000|COMPLETED|Overall Study||25
10810615|NCT03783962|11972371|FG001|COMPLETED|Overall Study||21
10810616|NCT03783962|11972370|FG000|NOT COMPLETED|Overall Study||3
10810617|NCT03783962|11972371|FG001|NOT COMPLETED|Overall Study||7
10810618|NCT03782272|11972379|FG000|STARTED|Overall Study||6
10810619|NCT03782272|11972380|FG001|STARTED|Overall Study||6
10810620|NCT03782272|11972379|FG000|COMPLETED|Overall Study||6
10810621|NCT03782272|11972380|FG001|COMPLETED|Overall Study||6
10810622|NCT03782272|11972379|FG000|NOT COMPLETED|Overall Study||0
10810623|NCT03782272|11972380|FG001|NOT COMPLETED|Overall Study||0
10810624|NCT03779724|11972389|FG000|STARTED|Overall Study||25
10810625|NCT03779724|11972390|FG001|STARTED|Overall Study||25
10810626|NCT03779724|11972389|FG000|COMPLETED|Overall Study||19
10810627|NCT03779724|11972390|FG001|COMPLETED|Overall Study||21
10810628|NCT03779724|11972389|FG000|NOT COMPLETED|Overall Study||6
10810629|NCT03779724|11972390|FG001|NOT COMPLETED|Overall Study||4
10433389|NCT00886119|11579721|FG000|NOT COMPLETED|Period 2||0
10810630|NCT03775915|11972400|FG000|STARTED|Overall Study||12
10810631|NCT03775915|11972401|FG001|STARTED|Overall Study||12
10810632|NCT03775915|11972400|FG000|COMPLETED|Overall Study||12
10810633|NCT03775915|11972401|FG001|COMPLETED|Overall Study||12
10810634|NCT03775915|11972400|FG000|NOT COMPLETED|Overall Study||0
10810635|NCT03775915|11972401|FG001|NOT COMPLETED|Overall Study||0
10810636|NCT03794752|11972407|FG000|STARTED|Overall Study||8
10433390|NCT00886119|11579722|FG001|NOT COMPLETED|Period 2||0
10433391|NCT00886145|11579728|FG000|STARTED|Overall Study||1
10433392|NCT00886145|11579728|FG000|COMPLETED|Overall Study||1
10433393|NCT00886145|11579728|FG000|NOT COMPLETED|Overall Study||0
10433394|NCT00886236|11579737|FG000|STARTED|Overall Study||20
10433395|NCT00886236|11579738|FG001|STARTED|Overall Study||21
10433396|NCT00886236|11579739|FG002|STARTED|Overall Study||21
10433397|NCT00886236|11579737|FG000|COMPLETED|Overall Study||18
10433398|NCT00886236|11579738|FG001|COMPLETED|Overall Study||17
10433399|NCT00886236|11579739|FG002|COMPLETED|Overall Study||17
10433400|NCT00886236|11579737|FG000|NOT COMPLETED|Overall Study||2
10433401|NCT00886236|11579738|FG001|NOT COMPLETED|Overall Study||4
10433402|NCT00886236|11579739|FG002|NOT COMPLETED|Overall Study||4
10433403|NCT00886262|11579749|FG000|STARTED|Overall Study||8
10433404|NCT00886262|11579750|FG001|STARTED|Overall Study||10
10433405|NCT00886262|11579749|FG000|COMPLETED|Overall Study||8
10433406|NCT00886262|11579750|FG001|COMPLETED|Overall Study||7
10433407|NCT00886262|11579749|FG000|NOT COMPLETED|Overall Study||0
10433408|NCT00886262|11579750|FG001|NOT COMPLETED|Overall Study||3
10433409|NCT00886288|11579758|FG000|STARTED|Overall Study|Baseline Population|2027
10433410|NCT00886288|11579759|FG001|STARTED|Overall Study|Baseline Population|684
10433411|NCT00886288|11579758|FG000|COMPLETED|Overall Study||1284
10433412|NCT00886288|11579759|FG001|COMPLETED|Overall Study||457
10433413|NCT00886288|11579758|FG000|NOT COMPLETED|Overall Study||743
10433414|NCT00886288|11579759|FG001|NOT COMPLETED|Overall Study||227
10433415|NCT00886340|11579769|FG000|STARTED|Overall Study||27
10433416|NCT00886340|11579770|FG001|STARTED|Overall Study||31
10433417|NCT00886340|11579769|FG000|COMPLETED|Overall Study||27
10433418|NCT00886340|11579770|FG001|COMPLETED|Overall Study||24
10433419|NCT00886340|11579769|FG000|NOT COMPLETED|Overall Study||0
10433420|NCT00886340|11579770|FG001|NOT COMPLETED|Overall Study||7
10433421|NCT00886379|11579781|FG000|STARTED|Overall Study||104
10433422|NCT00886379|11579782|FG001|STARTED|Overall Study||143
10433423|NCT00886379|11579783|FG002|STARTED|Overall Study||143
10433424|NCT00886379|11579784|FG003|STARTED|Overall Study||112
10433425|NCT00886379|11579785|FG004|STARTED|Overall Study||95
10433426|NCT00886379|11579781|FG000|COMPLETED|Overall Study||101
10785856|NCT03463031|11946423|FG000|STARTED|Overall Study||225
10785857|NCT03463031|11946424|FG001|STARTED|Overall Study||221
10785858|NCT03463031|11946423|FG000|COMPLETED|Overall Study||215
10785859|NCT03463031|11946424|FG001|COMPLETED|Overall Study||216
10785860|NCT03463031|11946423|FG000|NOT COMPLETED|Overall Study||10
10785861|NCT03463031|11946424|FG001|NOT COMPLETED|Overall Study||5
10785862|NCT03463161|11946430|FG000|STARTED|Overall Study||2
10785863|NCT03463161|11946430|FG000|COMPLETED|Overall Study||2
10785864|NCT03463161|11946430|FG000|NOT COMPLETED|Overall Study||0
10785865|NCT03463512|11946436|FG000|STARTED|Overall Study||62
10785866|NCT03463512|11946437|FG001|STARTED|Overall Study||62
10785867|NCT03463512|11946436|FG000|COMPLETED|Overall Study||62
10785868|NCT03463512|11946437|FG001|COMPLETED|Overall Study||62
10785869|NCT03463512|11946436|FG000|NOT COMPLETED|Overall Study||0
10785870|NCT03463512|11946437|FG001|NOT COMPLETED|Overall Study||0
10785871|NCT03463889|11946443|FG000|STARTED|Overall Study||12
10785872|NCT03463889|11946443|FG000|COMPLETED|Overall Study||12
10785873|NCT03463889|11946443|FG000|NOT COMPLETED|Overall Study||0
10785874|NCT03463915|11946449|FG000|STARTED|Overall Study||45
10785875|NCT03463915|11946450|FG001|STARTED|Overall Study||45
10785876|NCT03463915|11946449|FG000|COMPLETED|Overall Study||35
10785877|NCT03463915|11946450|FG001|COMPLETED|Overall Study||36
10785878|NCT03463915|11946449|FG000|NOT COMPLETED|Overall Study||10
10785879|NCT03463915|11946450|FG001|NOT COMPLETED|Overall Study||9
10785880|NCT03463941|11946458|FG000|STARTED|Overall Study||80
10785881|NCT03463941|11946458|FG000|COMPLETED|Overall Study||62
10785882|NCT03463941|11946458|FG000|NOT COMPLETED|Overall Study||18
10785883|NCT03464383|11946466|FG000|STARTED|Overall Study||3
10785884|NCT03464383|11946467|FG001|STARTED|Overall Study||3
10785885|NCT03464383|11946468|FG002|STARTED|Overall Study||63
10785886|NCT03464383|11946466|FG000|COMPLETED|Overall Study||2
10785887|NCT03464383|11946467|FG001|COMPLETED|Overall Study||2
10785888|NCT03464383|11946468|FG002|COMPLETED|Overall Study||63
10785889|NCT03464383|11946466|FG000|NOT COMPLETED|Overall Study||1
10785890|NCT03464383|11946467|FG001|NOT COMPLETED|Overall Study||1
10785891|NCT03464383|11946468|FG002|NOT COMPLETED|Overall Study||0
10433427|NCT00886379|11579782|FG001|COMPLETED|Overall Study||140
10433428|NCT00886379|11579783|FG002|COMPLETED|Overall Study||137
10433429|NCT00886379|11579784|FG003|COMPLETED|Overall Study||109
10433430|NCT00886379|11579785|FG004|COMPLETED|Overall Study||92
10433431|NCT00886379|11579781|FG000|NOT COMPLETED|Overall Study||3
10433432|NCT00886379|11579782|FG001|NOT COMPLETED|Overall Study||3
10433433|NCT00886379|11579783|FG002|NOT COMPLETED|Overall Study||6
10433434|NCT00886379|11579784|FG003|NOT COMPLETED|Overall Study||3
10433435|NCT00886379|11579785|FG004|NOT COMPLETED|Overall Study||3
10433436|NCT00886483|11579799|FG000|STARTED|Overall Study||26
10785892|NCT03464422|11946477|FG000|STARTED|Overall Study||21
10433437|NCT00886483|11579800|FG001|STARTED|Overall Study||13
10433438|NCT00886483|11579799|FG000|Completed 20 Treatments|Overall Study||25
10433439|NCT00886483|11579800|FG001|Completed 20 Treatments|Overall Study||11
10433440|NCT00886483|11579799|FG000|COMPLETED|Overall Study||24
10433441|NCT00886483|11579800|FG001|COMPLETED|Overall Study||10
10785893|NCT03464422|11946477|FG000|COMPLETED|Overall Study||17
10785894|NCT03464422|11946477|FG000|NOT COMPLETED|Overall Study||4
10785895|NCT03465436|11946487|FG000|STARTED|Period 1||14
10785896|NCT03465436|11946488|FG001|STARTED|Period 1||14
10785897|NCT03465436|11946489|FG002|STARTED|Period 1||14
10433442|NCT00886483|11579799|FG000|NOT COMPLETED|Overall Study||2
10433443|NCT00886483|11579800|FG001|NOT COMPLETED|Overall Study||3
10433444|NCT00886587|11579816|FG000|STARTED|Overall Study||41
10433445|NCT00886587|11579817|FG001|STARTED|Overall Study||41
10433446|NCT00886587|11579816|FG000|COMPLETED|Overall Study||37
10433447|NCT00886587|11579817|FG001|COMPLETED|Overall Study||39
10433448|NCT00886587|11579816|FG000|NOT COMPLETED|Overall Study||4
10433449|NCT00886587|11579817|FG001|NOT COMPLETED|Overall Study||2
10433450|NCT00886613|11579826|FG000|STARTED|Overall Study||41
10433451|NCT00886613|11579827|FG001|STARTED|Overall Study||39
10433452|NCT00886613|11579828|FG002|STARTED|Overall Study||40
10433453|NCT00886613|11579826|FG000|COMPLETED|Overall Study||39
10433454|NCT00886613|11579827|FG001|COMPLETED|Overall Study||39
10433455|NCT00886613|11579828|FG002|COMPLETED|Overall Study||37
10433456|NCT00886613|11579826|FG000|NOT COMPLETED|Overall Study||2
10433457|NCT00886613|11579827|FG001|NOT COMPLETED|Overall Study||0
10785898|NCT03465436|11946490|FG003|STARTED|Period 1||14
10785899|NCT03465436|11946487|FG000|Received at Least 1 Dose of Study Drug|Period 1||14
10785900|NCT03465436|11946488|FG001|Received at Least 1 Dose of Study Drug|Period 1||14
10785901|NCT03465436|11946489|FG002|Received at Least 1 Dose of Study Drug|Period 1||14
10785902|NCT03465436|11946490|FG003|Received at Least 1 Dose of Study Drug|Period 1||14
10785903|NCT03465436|11946487|FG000|COMPLETED|Period 1||14
10785904|NCT03465436|11946488|FG001|COMPLETED|Period 1||14
10785905|NCT03465436|11946489|FG002|COMPLETED|Period 1||13
10785906|NCT03465436|11946490|FG003|COMPLETED|Period 1||14
10785907|NCT03465436|11946487|FG000|NOT COMPLETED|Period 1||0
10785908|NCT03465436|11946488|FG001|NOT COMPLETED|Period 1||0
10785909|NCT03465436|11946489|FG002|NOT COMPLETED|Period 1||1
10785910|NCT03465436|11946490|FG003|NOT COMPLETED|Period 1||0
10785911|NCT03465436|11946487|FG000|STARTED|Period 2||14
10785912|NCT03465436|11946488|FG001|STARTED|Period 2||14
10785913|NCT03465436|11946489|FG002|STARTED|Period 2||13
10785914|NCT03465436|11946490|FG003|STARTED|Period 2||14
10785915|NCT03465436|11946487|FG000|Received at Least 1 Dose of Study Drug|Period 2||14
10785916|NCT03465436|11946488|FG001|Received at Least 1 Dose of Study Drug|Period 2||13
10785917|NCT03465436|11946489|FG002|Received at Least 1 Dose of Study Drug|Period 2||13
10785918|NCT03465436|11946490|FG003|Received at Least 1 Dose of Study Drug|Period 2||14
10785919|NCT03465436|11946487|FG000|COMPLETED|Period 2||14
10785920|NCT03465436|11946488|FG001|COMPLETED|Period 2||13
10785921|NCT03465436|11946489|FG002|COMPLETED|Period 2||13
10785922|NCT03465436|11946490|FG003|COMPLETED|Period 2||14
10785923|NCT03465436|11946487|FG000|NOT COMPLETED|Period 2||0
10785924|NCT03465436|11946488|FG001|NOT COMPLETED|Period 2||1
10785925|NCT03465436|11946489|FG002|NOT COMPLETED|Period 2||0
10785926|NCT03465436|11946490|FG003|NOT COMPLETED|Period 2||0
10785927|NCT03465436|11946487|FG000|STARTED|Period 3||14
10785928|NCT03465436|11946488|FG001|STARTED|Period 3||13
10785929|NCT03465436|11946489|FG002|STARTED|Period 3||13
10785930|NCT03465436|11946490|FG003|STARTED|Period 3||14
10785931|NCT03465436|11946487|FG000|Received at Least One Dose of Study Drug|Period 3||13
10785932|NCT03465436|11946488|FG001|Received at Least One Dose of Study Drug|Period 3||12
10785933|NCT03465436|11946489|FG002|Received at Least One Dose of Study Drug|Period 3||13
10785934|NCT03465436|11946490|FG003|Received at Least One Dose of Study Drug|Period 3||14
10785935|NCT03465436|11946487|FG000|COMPLETED|Period 3||13
10785936|NCT03465436|11946488|FG001|COMPLETED|Period 3||12
10785937|NCT03465436|11946489|FG002|COMPLETED|Period 3||13
10785938|NCT03465436|11946490|FG003|COMPLETED|Period 3||14
10785939|NCT03465436|11946487|FG000|NOT COMPLETED|Period 3||1
10785940|NCT03465436|11946488|FG001|NOT COMPLETED|Period 3||1
10785941|NCT03465436|11946489|FG002|NOT COMPLETED|Period 3||0
10785942|NCT03465436|11946490|FG003|NOT COMPLETED|Period 3||0
10785943|NCT03465436|11946487|FG000|STARTED|Period 4||13
10785944|NCT03465436|11946488|FG001|STARTED|Period 4||12
10785945|NCT03465436|11946489|FG002|STARTED|Period 4||13
10785946|NCT03465436|11946490|FG003|STARTED|Period 4||14
10785947|NCT03465436|11946487|FG000|Received at Least 1 Dose of Study Drug|Period 4||13
10785948|NCT03465436|11946488|FG001|Received at Least 1 Dose of Study Drug|Period 4||12
10785949|NCT03465436|11946489|FG002|Received at Least 1 Dose of Study Drug|Period 4||13
10785950|NCT03465436|11946490|FG003|Received at Least 1 Dose of Study Drug|Period 4||14
10785951|NCT03465436|11946487|FG000|COMPLETED|Period 4||13
10785952|NCT03465436|11946488|FG001|COMPLETED|Period 4||12
10785953|NCT03465436|11946489|FG002|COMPLETED|Period 4||12
10785954|NCT03465436|11946490|FG003|COMPLETED|Period 4||14
10433458|NCT00886613|11579828|FG002|NOT COMPLETED|Overall Study||3
10433459|NCT00886626|11579839|FG000|STARTED|Period 1 (90 Days)||6
10433460|NCT00886626|11579840|FG001|STARTED|Period 1 (90 Days)||6
10433461|NCT00886626|11579839|FG000|COMPLETED|Period 1 (90 Days)||5
10433462|NCT00886626|11579840|FG001|COMPLETED|Period 1 (90 Days)||6
10433463|NCT00886626|11579839|FG000|NOT COMPLETED|Period 1 (90 Days)||1
10433464|NCT00886626|11579840|FG001|NOT COMPLETED|Period 1 (90 Days)||0
10433465|NCT00886626|11579839|FG000|STARTED|Period 2 (90 Days)||5
10785955|NCT03465436|11946487|FG000|NOT COMPLETED|Period 4||0
10785956|NCT03465436|11946488|FG001|NOT COMPLETED|Period 4||0
10785957|NCT03465436|11946489|FG002|NOT COMPLETED|Period 4||1
10785958|NCT03465436|11946490|FG003|NOT COMPLETED|Period 4||0
10785959|NCT03465709|11946502|FG000|STARTED|Overall Study||17
10785960|NCT03465709|11946502|FG000|COMPLETED|Overall Study||0
10785961|NCT03465709|11946502|FG000|NOT COMPLETED|Overall Study||17
10785962|NCT03465722|11946510|FG000|STARTED|End of Treatment||240
10785963|NCT03465722|11946511|FG001|STARTED|End of Treatment||236
10785964|NCT03465722|11946510|FG000|COMPLETED|End of Treatment||0
10785965|NCT03465722|11946511|FG001|COMPLETED|End of Treatment||0
10549424|NCT01525225|11703427|FG000|NOT COMPLETED|Enrollment||2
10549425|NCT01525225|11703427|FG000|STARTED|Treated||2
10549426|NCT01525225|11703427|FG000|COMPLETED|Treated||2
10549427|NCT01525225|11703427|FG000|NOT COMPLETED|Treated||0
10549428|NCT01525238|11703434|FG000|STARTED|Overall Study||8
10549429|NCT01525238|11703435|FG001|STARTED|Overall Study||8
10549430|NCT01525238|11703436|FG002|STARTED|Overall Study||8
10549431|NCT01525238|11703434|FG000|COMPLETED|Overall Study||7
10549432|NCT01525238|11703435|FG001|COMPLETED|Overall Study||8
10549433|NCT01525238|11703436|FG002|COMPLETED|Overall Study||8
10549434|NCT01525238|11703434|FG000|NOT COMPLETED|Overall Study||1
10549435|NCT01525238|11703435|FG001|NOT COMPLETED|Overall Study||0
10785966|NCT03465722|11946510|FG000|NOT COMPLETED|End of Treatment||240
10785967|NCT03465722|11946511|FG001|NOT COMPLETED|End of Treatment||236
10785968|NCT03465722|11946510|FG000|STARTED|End of Study||240
10785969|NCT03465722|11946511|FG001|STARTED|End of Study||236
10785970|NCT03465722|11946510|FG000|COMPLETED|End of Study||0
10785971|NCT03465722|11946511|FG001|COMPLETED|End of Study||0
10785972|NCT03465722|11946510|FG000|NOT COMPLETED|End of Study||240
10785973|NCT03465722|11946511|FG001|NOT COMPLETED|End of Study||236
10785974|NCT03465878|11946519|FG000|STARTED|Period 1-Part A First Intervention Day 1||21
10785975|NCT03465878|11946520|FG001|STARTED|Period 1-Part A First Intervention Day 1||21
10785976|NCT03465878|11946521|FG002|STARTED|Period 1-Part A First Intervention Day 1||0
10785977|NCT03465878|11946522|FG003|STARTED|Period 1-Part A First Intervention Day 1||0
10785978|NCT03465878|11946519|FG000|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||21
10785979|NCT03465878|11946520|FG001|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||21
10785980|NCT03465878|11946521|FG002|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||0
10785981|NCT03465878|11946522|FG003|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||0
10785982|NCT03465878|11946519|FG000|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||7
10785983|NCT03465878|11946520|FG001|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||6
10785984|NCT03465878|11946521|FG002|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||0
10785985|NCT03465878|11946522|FG003|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||0
10785986|NCT03465878|11946519|FG000|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||7
10785987|NCT03465878|11946520|FG001|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||7
10785988|NCT03465878|11946521|FG002|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||0
10785989|NCT03465878|11946522|FG003|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||0
10785990|NCT03465878|11946519|FG000|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||7
10785991|NCT03465878|11946520|FG001|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||8
10785992|NCT03465878|11946521|FG002|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||0
10785993|NCT03465878|11946522|FG003|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||0
10785994|NCT03465878|11946519|FG000|COMPLETED|Period 1-Part A First Intervention Day 1||21
10785995|NCT03465878|11946520|FG001|COMPLETED|Period 1-Part A First Intervention Day 1||20
10785996|NCT03465878|11946521|FG002|COMPLETED|Period 1-Part A First Intervention Day 1||0
10785997|NCT03465878|11946522|FG003|COMPLETED|Period 1-Part A First Intervention Day 1||0
10785998|NCT03465878|11946519|FG000|NOT COMPLETED|Period 1-Part A First Intervention Day 1||0
10785999|NCT03465878|11946520|FG001|NOT COMPLETED|Period 1-Part A First Intervention Day 1||1
10786000|NCT03465878|11946521|FG002|NOT COMPLETED|Period 1-Part A First Intervention Day 1||0
10786001|NCT03465878|11946522|FG003|NOT COMPLETED|Period 1-Part A First Intervention Day 1||0
10786002|NCT03465878|11946519|FG000|STARTED|Period2-Part A Second Intervention Day 1||21
10786003|NCT03465878|11946520|FG001|STARTED|Period2-Part A Second Intervention Day 1||20
10786004|NCT03465878|11946521|FG002|STARTED|Period2-Part A Second Intervention Day 1||0
10786005|NCT03465878|11946522|FG003|STARTED|Period2-Part A Second Intervention Day 1||0
10786006|NCT03465878|11946519|FG000|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||7
10318630|NCT00215657|11452871|FG006|Intention-to-treat Population|Overall Study||24
10318631|NCT00215657|11452872|FG007|Intention-to-treat Population|Overall Study||27
10318632|NCT00215657|11452865|FG000|Started FE200486 CS07A|Overall Study||20
10549436|NCT01525238|11703436|FG002|NOT COMPLETED|Overall Study||0
10786007|NCT03465878|11946520|FG001|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||6
10786008|NCT03465878|11946521|FG002|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||0
10786009|NCT03465878|11946522|FG003|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||0
10786010|NCT03465878|11946519|FG000|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||7
10786011|NCT03465878|11946520|FG001|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||7
10786012|NCT03465878|11946521|FG002|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||0
10786013|NCT03465878|11946522|FG003|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||0
10786014|NCT03465878|11946519|FG000|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||7
10786015|NCT03465878|11946520|FG001|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||7
10786016|NCT03465878|11946521|FG002|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||0
10786017|NCT03465878|11946522|FG003|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||0
10786018|NCT03465878|11946519|FG000|COMPLETED|Period2-Part A Second Intervention Day 1||21
10650472|NCT02169466|11810733|FG002|NOT COMPLETED|Overall Study||0
10650473|NCT02169466|11810734|FG003|NOT COMPLETED|Overall Study||0
10650474|NCT02169479|11810752|FG000|STARTED|Overall Study||4
10650475|NCT02169479|11810753|FG001|STARTED|Overall Study||4
10650476|NCT02169479|11810754|FG002|STARTED|Overall Study||4
10786019|NCT03465878|11946520|FG001|COMPLETED|Period2-Part A Second Intervention Day 1||20
10786020|NCT03465878|11946521|FG002|COMPLETED|Period2-Part A Second Intervention Day 1||0
10786021|NCT03465878|11946522|FG003|COMPLETED|Period2-Part A Second Intervention Day 1||0
10786022|NCT03465878|11946519|FG000|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0
10786023|NCT03465878|11946520|FG001|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0
10786024|NCT03465878|11946521|FG002|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0
10786025|NCT03465878|11946522|FG003|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0
10786026|NCT03465878|11946519|FG000|STARTED|Period 1-Part B First Intervention Day 1|This period is for Part B group.|0
10786027|NCT03465878|11946520|FG001|STARTED|Period 1-Part B First Intervention Day 1|This period is for Part B group.|0
10786028|NCT03465878|11946521|FG002|STARTED|Period 1-Part B First Intervention Day 1|25 pts from Part A were re-randomized to Part B, 14 new pts were randomized in Part B.|20
10786029|NCT03465878|11946522|FG003|STARTED|Period 1-Part B First Intervention Day 1|25 pts from Part A were re-randomized to Part B, 14 new pts were randomized in Part B.|19
10786030|NCT03465878|11946519|FG000|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||0
10786031|NCT03465878|11946520|FG001|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||0
10786032|NCT03465878|11946521|FG002|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||20
10786033|NCT03465878|11946522|FG003|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||17
10786034|NCT03465878|11946519|FG000|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||0
10786035|NCT03465878|11946520|FG001|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||0
10786036|NCT03465878|11946521|FG002|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||6
10786037|NCT03465878|11946522|FG003|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||6
10786038|NCT03465878|11946519|FG000|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||0
10786039|NCT03465878|11946520|FG001|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||0
10786040|NCT03465878|11946521|FG002|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||7
10786041|NCT03465878|11946522|FG003|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||6
10786042|NCT03465878|11946519|FG000|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||0
10786043|NCT03465878|11946520|FG001|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||0
10433486|NCT00886769|11579868|FG001|COMPLETED|Overall Study||4
10786044|NCT03465878|11946521|FG002|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||7
10786045|NCT03465878|11946522|FG003|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||5
10786046|NCT03465878|11946519|FG000|COMPLETED|Period 1-Part B First Intervention Day 1||0
10433466|NCT00886626|11579840|FG001|STARTED|Period 2 (90 Days)||6
10433467|NCT00886626|11579839|FG000|COMPLETED|Period 2 (90 Days)||5
10433468|NCT00886626|11579840|FG001|COMPLETED|Period 2 (90 Days)||6
10433469|NCT00886626|11579839|FG000|NOT COMPLETED|Period 2 (90 Days)||0
10433470|NCT00886626|11579840|FG001|NOT COMPLETED|Period 2 (90 Days)||0
10433471|NCT00886639|11579846|FG000|STARTED|Overall Study||127
10433472|NCT00886639|11579846|FG000|COMPLETED|Overall Study||111
10433473|NCT00886639|11579846|FG000|NOT COMPLETED|Overall Study||16
10433474|NCT00886704|11579852|FG000|STARTED|Overall Study||40
10433475|NCT00886704|11579853|FG001|STARTED|Overall Study||10
10433476|NCT00886704|11579852|FG000|COMPLETED|Overall Study||40
10433477|NCT00886704|11579853|FG001|COMPLETED|Overall Study||10
10433478|NCT00886704|11579852|FG000|NOT COMPLETED|Overall Study||0
10433479|NCT00886704|11579853|FG001|NOT COMPLETED|Overall Study||0
10433480|NCT00886743|11579861|FG000|STARTED|Overall Study|Received treatment|19
10786047|NCT03465878|11946520|FG001|COMPLETED|Period 1-Part B First Intervention Day 1||0
10786048|NCT03465878|11946521|FG002|COMPLETED|Period 1-Part B First Intervention Day 1||20
10786049|NCT03465878|11946522|FG003|COMPLETED|Period 1-Part B First Intervention Day 1||17
10786050|NCT03465878|11946519|FG000|NOT COMPLETED|Period 1-Part B First Intervention Day 1||0
10786051|NCT03465878|11946520|FG001|NOT COMPLETED|Period 1-Part B First Intervention Day 1||0
10786052|NCT03465878|11946521|FG002|NOT COMPLETED|Period 1-Part B First Intervention Day 1||0
10786053|NCT03465878|11946522|FG003|NOT COMPLETED|Period 1-Part B First Intervention Day 1||2
10786054|NCT03465878|11946519|FG000|STARTED|Period2-Part B Second Intervention Day 1||0
10786055|NCT03465878|11946520|FG001|STARTED|Period2-Part B Second Intervention Day 1||0
10786056|NCT03465878|11946521|FG002|STARTED|Period2-Part B Second Intervention Day 1||20
10786057|NCT03465878|11946522|FG003|STARTED|Period2-Part B Second Intervention Day 1||17
10786058|NCT03465878|11946519|FG000|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||0
10786059|NCT03465878|11946520|FG001|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||0
10786060|NCT03465878|11946521|FG002|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||6
10786061|NCT03465878|11946522|FG003|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||6
10786062|NCT03465878|11946519|FG000|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||0
10786063|NCT03465878|11946520|FG001|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||0
10786064|NCT03465878|11946521|FG002|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||7
10786065|NCT03465878|11946522|FG003|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||6
10786066|NCT03465878|11946519|FG000|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||0
10786067|NCT03465878|11946520|FG001|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||0
10786068|NCT03465878|11946521|FG002|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||7
10786069|NCT03465878|11946522|FG003|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||5
10786070|NCT03465878|11946519|FG000|COMPLETED|Period2-Part B Second Intervention Day 1||0
10786071|NCT03465878|11946520|FG001|COMPLETED|Period2-Part B Second Intervention Day 1||0
10786072|NCT03465878|11946521|FG002|COMPLETED|Period2-Part B Second Intervention Day 1||20
10786073|NCT03465878|11946522|FG003|COMPLETED|Period2-Part B Second Intervention Day 1||17
10786074|NCT03465878|11946519|FG000|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0
10786075|NCT03465878|11946520|FG001|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0
10786076|NCT03465878|11946521|FG002|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0
10786077|NCT03465878|11946522|FG003|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0
10786078|NCT03465904|11946550|FG000|STARTED|Overall Study||298
10786079|NCT03465904|11946551|FG001|STARTED|Overall Study||303
10786080|NCT03465904|11946550|FG000|COMPLETED|Overall Study||209
10786081|NCT03465904|11946551|FG001|COMPLETED|Overall Study||237
10786082|NCT03465904|11946550|FG000|NOT COMPLETED|Overall Study||89
10786083|NCT03465904|11946551|FG001|NOT COMPLETED|Overall Study||66
10786084|NCT03466047|11946557|FG000|STARTED|Protein Stomach (1day)|The same 8 patients were studied in all interventions|8
10786085|NCT03466047|11946557|FG000|COMPLETED|Protein Stomach (1day)|The same 8 patients were studied in all interventions|8
10786086|NCT03466047|11946557|FG000|NOT COMPLETED|Protein Stomach (1day)||0
10786087|NCT03466047|11946557|FG000|STARTED|Protein Small Intestine (1 Day)||8
10786088|NCT03466047|11946557|FG000|COMPLETED|Protein Small Intestine (1 Day)||8
10786089|NCT03466047|11946557|FG000|NOT COMPLETED|Protein Small Intestine (1 Day)||0
10786090|NCT03466047|11946557|FG000|STARTED|CHO Stomach (1 Day)||8
10786091|NCT03466047|11946557|FG000|COMPLETED|CHO Stomach (1 Day)||8
10786092|NCT03466047|11946557|FG000|NOT COMPLETED|CHO Stomach (1 Day)||0
10786093|NCT03466047|11946557|FG000|STARTED|CHO Small Intestine (1 Day)||8
10786094|NCT03466047|11946557|FG000|COMPLETED|CHO Small Intestine (1 Day)||8
10786095|NCT03466047|11946557|FG000|NOT COMPLETED|CHO Small Intestine (1 Day)||0
10786096|NCT03466047|11946557|FG000|STARTED|Fat Stomach (1 Day)||8
10786097|NCT03466047|11946557|FG000|COMPLETED|Fat Stomach (1 Day)||8
10786098|NCT03466047|11946557|FG000|NOT COMPLETED|Fat Stomach (1 Day)||0
10786099|NCT03466047|11946557|FG000|STARTED|Fat Small Intestine (1 Day)||8
10786100|NCT03466047|11946557|FG000|COMPLETED|Fat Small Intestine (1 Day)||8
10433481|NCT00886743|11579861|FG000|COMPLETED|Overall Study||15
10433482|NCT00886743|11579861|FG000|NOT COMPLETED|Overall Study||4
10433483|NCT00886769|11579867|FG000|STARTED|Overall Study||43
10433484|NCT00886769|11579868|FG001|STARTED|Overall Study||41
10433485|NCT00886769|11579867|FG000|COMPLETED|Overall Study||37
10433487|NCT00886769|11579867|FG000|NOT COMPLETED|Overall Study||6
10433488|NCT00886769|11579868|FG001|NOT COMPLETED|Overall Study||37
10433489|NCT00886795|11579874|FG000|STARTED|Overall Study||4
10433490|NCT00886795|11579874|FG000|COMPLETED|Overall Study||3
10433491|NCT00886795|11579874|FG000|NOT COMPLETED|Overall Study||1
10433492|NCT00886821|11579893|FG000|STARTED|Stage 1||7
10433493|NCT00886821|11579894|FG001|STARTED|Stage 1||6
10433494|NCT00886821|11579895|FG002|STARTED|Stage 1||6
10433495|NCT00886821|11579896|FG003|STARTED|Stage 1||7
10433496|NCT00886821|11579897|FG004|STARTED|Stage 1||6
10433497|NCT00886821|11579898|FG005|STARTED|Stage 1||6
10433498|NCT00886821|11579899|FG006|STARTED|Stage 1||6
10433499|NCT00886821|11579900|FG007|STARTED|Stage 1||6
10433500|NCT00886821|11579901|FG008|STARTED|Stage 1||6
10433501|NCT00886821|11579902|FG009|STARTED|Stage 1||18
10433502|NCT00886821|11579903|FG010|STARTED|Stage 1||0
10433503|NCT00886821|11579904|FG011|STARTED|Stage 1||0
10433504|NCT00886821|11579905|FG012|STARTED|Stage 1||0
10433505|NCT00886821|11579906|FG013|STARTED|Stage 1||0
10433506|NCT00886821|11579893|FG000|COMPLETED|Stage 1||7
10433507|NCT00886821|11579894|FG001|COMPLETED|Stage 1||6
10433508|NCT00886821|11579895|FG002|COMPLETED|Stage 1||6
10433509|NCT00886821|11579896|FG003|COMPLETED|Stage 1||7
10433510|NCT00886821|11579897|FG004|COMPLETED|Stage 1||6
10433511|NCT00886821|11579898|FG005|COMPLETED|Stage 1||6
10433512|NCT00886821|11579899|FG006|COMPLETED|Stage 1||6
10433513|NCT00886821|11579900|FG007|COMPLETED|Stage 1||6
10433514|NCT00886821|11579901|FG008|COMPLETED|Stage 1||6
10433515|NCT00886821|11579902|FG009|COMPLETED|Stage 1||18
10433516|NCT00886821|11579903|FG010|COMPLETED|Stage 1||0
10433517|NCT00886821|11579904|FG011|COMPLETED|Stage 1||0
10433518|NCT00886821|11579905|FG012|COMPLETED|Stage 1||0
10433519|NCT00886821|11579906|FG013|COMPLETED|Stage 1||0
10433520|NCT00886821|11579893|FG000|NOT COMPLETED|Stage 1||0
10433521|NCT00886821|11579894|FG001|NOT COMPLETED|Stage 1||0
10433522|NCT00886821|11579895|FG002|NOT COMPLETED|Stage 1||0
10433523|NCT00886821|11579896|FG003|NOT COMPLETED|Stage 1||0
10433524|NCT00886821|11579897|FG004|NOT COMPLETED|Stage 1||0
10433525|NCT00886821|11579898|FG005|NOT COMPLETED|Stage 1||0
10433526|NCT00886821|11579899|FG006|NOT COMPLETED|Stage 1||0
10433527|NCT00886821|11579900|FG007|NOT COMPLETED|Stage 1||0
10786101|NCT03466047|11946557|FG000|NOT COMPLETED|Fat Small Intestine (1 Day)||0
10786102|NCT03466060|11946586|FG000|STARTED|Period 1||19
10786103|NCT03466060|11946587|FG001|STARTED|Period 1||18
10786104|NCT03466060|11946588|FG002|STARTED|Period 1||20
10786105|NCT03466060|11946589|FG003|STARTED|Period 1||18
10786106|NCT03466060|11946590|FG004|STARTED|Period 1||20
10786107|NCT03466060|11946591|FG005|STARTED|Period 1||18
10786108|NCT03466060|11946586|FG000|COMPLETED|Period 1||19
10786109|NCT03466060|11946587|FG001|COMPLETED|Period 1||16
10786110|NCT03466060|11946588|FG002|COMPLETED|Period 1||17
10786111|NCT03466060|11946589|FG003|COMPLETED|Period 1||17
10786112|NCT03466060|11946590|FG004|COMPLETED|Period 1||20
10786113|NCT03466060|11946591|FG005|COMPLETED|Period 1||18
10786114|NCT03466060|11946586|FG000|NOT COMPLETED|Period 1||0
10786115|NCT03466060|11946587|FG001|NOT COMPLETED|Period 1||2
10786116|NCT03466060|11946588|FG002|NOT COMPLETED|Period 1||3
10786117|NCT03466060|11946589|FG003|NOT COMPLETED|Period 1||1
10786118|NCT03466060|11946590|FG004|NOT COMPLETED|Period 1||0
10786119|NCT03466060|11946591|FG005|NOT COMPLETED|Period 1||0
10786120|NCT03466060|11946586|FG000|STARTED|Period 2||19
10786121|NCT03466060|11946587|FG001|STARTED|Period 2||16
10786122|NCT03466060|11946588|FG002|STARTED|Period 2||17
10786123|NCT03466060|11946589|FG003|STARTED|Period 2||17
10786124|NCT03466060|11946590|FG004|STARTED|Period 2||20
10786125|NCT03466060|11946591|FG005|STARTED|Period 2||18
10786126|NCT03466060|11946586|FG000|COMPLETED|Period 2||19
10786127|NCT03466060|11946587|FG001|COMPLETED|Period 2||16
10786128|NCT03466060|11946588|FG002|COMPLETED|Period 2||16
10786129|NCT03466060|11946589|FG003|COMPLETED|Period 2||17
10786130|NCT03466060|11946590|FG004|COMPLETED|Period 2||20
10786131|NCT03466060|11946591|FG005|COMPLETED|Period 2||18
10786132|NCT03466060|11946586|FG000|NOT COMPLETED|Period 2||0
10786133|NCT03466060|11946587|FG001|NOT COMPLETED|Period 2||0
10786134|NCT03466060|11946588|FG002|NOT COMPLETED|Period 2||1
10786135|NCT03466060|11946589|FG003|NOT COMPLETED|Period 2||0
10786136|NCT03466060|11946590|FG004|NOT COMPLETED|Period 2||0
10786137|NCT03466060|11946591|FG005|NOT COMPLETED|Period 2||0
10786138|NCT03466073|11946611|FG000|STARTED|Overall Study||6
10786139|NCT03466073|11946612|FG001|STARTED|Overall Study||2
10786140|NCT03466073|11946613|FG002|STARTED|Overall Study||6
10786141|NCT03466073|11946614|FG003|STARTED|Overall Study||6
10786142|NCT03466073|11946615|FG004|STARTED|Overall Study||6
10786143|NCT03466073|11946616|FG005|STARTED|Overall Study||7
10786144|NCT03466073|11946611|FG000|COMPLETED|Overall Study||5
10786145|NCT03466073|11946612|FG001|COMPLETED|Overall Study||2
10786146|NCT03466073|11946613|FG002|COMPLETED|Overall Study||6
10786147|NCT03466073|11946614|FG003|COMPLETED|Overall Study||6
10786148|NCT03466073|11946615|FG004|COMPLETED|Overall Study||6
10433528|NCT00886821|11579901|FG008|NOT COMPLETED|Stage 1||0
10433529|NCT00886821|11579902|FG009|NOT COMPLETED|Stage 1||0
10433530|NCT00886821|11579903|FG010|NOT COMPLETED|Stage 1||0
10433531|NCT00886821|11579904|FG011|NOT COMPLETED|Stage 1||0
10433532|NCT00886821|11579905|FG012|NOT COMPLETED|Stage 1||0
10433533|NCT00886821|11579906|FG013|NOT COMPLETED|Stage 1||0
10433534|NCT00886821|11579893|FG000|STARTED|Stage 2||0
10433535|NCT00886821|11579894|FG001|STARTED|Stage 2||0
10433536|NCT00886821|11579895|FG002|STARTED|Stage 2||0
10433537|NCT00886821|11579896|FG003|STARTED|Stage 2||0
10433538|NCT00886821|11579897|FG004|STARTED|Stage 2||0
10433539|NCT00886821|11579898|FG005|STARTED|Stage 2||0
10786149|NCT03466073|11946616|FG005|COMPLETED|Overall Study||6
10786150|NCT03466073|11946611|FG000|NOT COMPLETED|Overall Study||1
10786151|NCT03466073|11946612|FG001|NOT COMPLETED|Overall Study||0
10786152|NCT03466073|11946613|FG002|NOT COMPLETED|Overall Study||0
10786153|NCT03466073|11946614|FG003|NOT COMPLETED|Overall Study||0
10786154|NCT03466073|11946615|FG004|NOT COMPLETED|Overall Study||0
10786155|NCT03466073|11946616|FG005|NOT COMPLETED|Overall Study||1
10786156|NCT03466086|11946637|FG000|STARTED|Period 1||28
10786157|NCT03466086|11946638|FG001|STARTED|Period 1||27
10786158|NCT03466086|11946637|FG000|COMPLETED|Period 1||26
10786159|NCT03466086|11946638|FG001|COMPLETED|Period 1||27
10786160|NCT03466086|11946637|FG000|NOT COMPLETED|Period 1||2
10786161|NCT03466086|11946638|FG001|NOT COMPLETED|Period 1||0
10786162|NCT03466086|11946637|FG000|STARTED|Period 2||26
10786163|NCT03466086|11946638|FG001|STARTED|Period 2||27
10786164|NCT03466086|11946637|FG000|COMPLETED|Period 2||26
10786165|NCT03466086|11946638|FG001|COMPLETED|Period 2||27
10786166|NCT03466086|11946637|FG000|NOT COMPLETED|Period 2||0
10786167|NCT03466086|11946638|FG001|NOT COMPLETED|Period 2||0
10786168|NCT03466099|11946647|FG000|STARTED|Overall Study||41
10786169|NCT03466099|11946648|FG001|STARTED|Overall Study||44
10786170|NCT03466099|11946649|FG002|STARTED|Overall Study|One study subject consented and was randomized, but withdrew prior to receiving any study treatments|45
10786171|NCT03466099|11946647|FG000|Treated|Overall Study||41
10786172|NCT03466099|11946648|FG001|Treated|Overall Study||44
10786173|NCT03466099|11946649|FG002|Treated|Overall Study||44
10786174|NCT03466099|11946647|FG000|COMPLETED|Overall Study||24
10786175|NCT03466099|11946648|FG001|COMPLETED|Overall Study||30
10786176|NCT03466099|11946649|FG002|COMPLETED|Overall Study||28
10786177|NCT03466099|11946647|FG000|NOT COMPLETED|Overall Study||17
10786178|NCT03466099|11946648|FG001|NOT COMPLETED|Overall Study||14
10786179|NCT03466099|11946649|FG002|NOT COMPLETED|Overall Study||17
10786184|NCT03467048|11946664|FG000|STARTED|Overall Study||66
10786185|NCT03467048|11946665|FG001|STARTED|Overall Study||64
10786186|NCT03467048|11946664|FG000|COMPLETED|Overall Study||66
10786187|NCT03467048|11946665|FG001|COMPLETED|Overall Study||63
10786188|NCT03467048|11946664|FG000|NOT COMPLETED|Overall Study||0
10786189|NCT03467048|11946665|FG001|NOT COMPLETED|Overall Study||1
10786190|NCT03467217|11946673|FG000|STARTED|Overall Study||43
10786191|NCT03467217|11946674|FG001|STARTED|Overall Study||40
10786192|NCT03467217|11946673|FG000|COMPLETED|Overall Study||33
10786193|NCT03467217|11946674|FG001|COMPLETED|Overall Study||34
10786194|NCT03467217|11946673|FG000|NOT COMPLETED|Overall Study||10
10786195|NCT03467217|11946674|FG001|NOT COMPLETED|Overall Study||6
10786196|NCT03467412|11946680|FG000|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|25
10786197|NCT03467412|11946681|FG001|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|25
10786198|NCT03467412|11946682|FG002|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|25
10786199|NCT03467412|11946683|FG003|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|25
10786200|NCT03467412|11946684|FG004|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|20
10786201|NCT03467412|11946680|FG000|COMPLETED|Overall Study||22
10786202|NCT03467412|11946681|FG001|COMPLETED|Overall Study||24
10786203|NCT03467412|11946682|FG002|COMPLETED|Overall Study||20
10786204|NCT03467412|11946683|FG003|COMPLETED|Overall Study||23
10786205|NCT03467412|11946684|FG004|COMPLETED|Overall Study||17
10786206|NCT03467412|11946680|FG000|NOT COMPLETED|Overall Study||3
10786207|NCT03467412|11946681|FG001|NOT COMPLETED|Overall Study||1
10786208|NCT03467412|11946682|FG002|NOT COMPLETED|Overall Study||5
10786209|NCT03467412|11946683|FG003|NOT COMPLETED|Overall Study||2
10786210|NCT03467412|11946684|FG004|NOT COMPLETED|Overall Study||3
10786211|NCT03467425|11946705|FG000|STARTED|Overall Study||1545
10786212|NCT03467425|11946706|FG001|STARTED|Overall Study||1547
10786213|NCT03467425|11946705|FG000|Randomized But Did Not Start IP|Overall Study||1
10786214|NCT03467425|11946706|FG001|Randomized But Did Not Start IP|Overall Study||0
10786215|NCT03467425|11946705|FG000|Completed IP|Overall Study||1256
10786216|NCT03467425|11946706|FG001|Completed IP|Overall Study||1359
10786217|NCT03467425|11946705|FG000|Not Completed IP|Overall Study||288
10786218|NCT03467425|11946706|FG001|Not Completed IP|Overall Study||188
10786219|NCT03467425|11946705|FG000|Withdrew IP (WIP): Lost to Follow-up|Overall Study||15
10786220|NCT03467425|11946706|FG001|Withdrew IP (WIP): Lost to Follow-up|Overall Study||24
10786221|NCT03467425|11946705|FG000|WIP: Protocol Deviation|Overall Study||0
10786222|NCT03467425|11946706|FG001|WIP: Protocol Deviation|Overall Study||2
10786223|NCT03467425|11946705|FG000|WIP: Adverse Event|Overall Study||112
10786224|NCT03467425|11946706|FG001|WIP: Adverse Event|Overall Study||29
10786225|NCT03467425|11946705|FG000|WIP: Lack of Efficacy|Overall Study||56
10786226|NCT03467425|11946706|FG001|WIP: Lack of Efficacy|Overall Study||28
10786227|NCT03467425|11946705|FG000|WIP: Physician Decision|Overall Study||14
10786228|NCT03467425|11946706|FG001|WIP: Physician Decision|Overall Study||27
10786229|NCT03467425|11946705|FG000|WIP: Withdrawal by Participant|Overall Study||91
10786230|NCT03467425|11946706|FG001|WIP: Withdrawal by Participant|Overall Study||78
10786231|NCT03467425|11946705|FG000|COMPLETED|Overall Study||1498
10786232|NCT03467425|11946706|FG001|COMPLETED|Overall Study||1493
10786233|NCT03467425|11946705|FG000|NOT COMPLETED|Overall Study||47
10786234|NCT03467425|11946706|FG001|NOT COMPLETED|Overall Study||54
10786235|NCT03467477|11946712|FG000|STARTED|Overall Study||161
10433540|NCT00886821|11579899|FG006|STARTED|Stage 2||0
10433541|NCT00886821|11579900|FG007|STARTED|Stage 2||0
10433542|NCT00886821|11579901|FG008|STARTED|Stage 2||0
10433543|NCT00886821|11579902|FG009|STARTED|Stage 2||0
10433544|NCT00886821|11579903|FG010|STARTED|Stage 2||9
10786236|NCT03467477|11946712|FG000|COMPLETED|Overall Study||161
10786237|NCT03467477|11946712|FG000|NOT COMPLETED|Overall Study||0
10786238|NCT03467685|11946721|FG000|STARTED|Overall Study||52
10786239|NCT03467685|11946722|FG001|STARTED|Overall Study||49
10786240|NCT03467685|11946721|FG000|COMPLETED|Overall Study||52
10786241|NCT03467685|11946722|FG001|COMPLETED|Overall Study||49
10786242|NCT03467685|11946721|FG000|NOT COMPLETED|Overall Study||0
10786243|NCT03467685|11946722|FG001|NOT COMPLETED|Overall Study||0
10786244|NCT03467763|11946728|FG000|STARTED|Overall Study||13
10786245|NCT03467763|11946728|FG000|Weeks 1-2|Overall Study||13
10786246|NCT03467763|11946728|FG000|Weeks 3-4|Overall Study||10
10786247|NCT03467763|11946728|FG000|Weeks 5-6|Overall Study||8
10786248|NCT03467763|11946728|FG000|Weeks 7-8|Overall Study||7
10786249|NCT03467763|11946728|FG000|Weeks 9 - 10|Overall Study||6
10786250|NCT03467763|11946728|FG000|Week 11-12|Overall Study||6
10786251|NCT03467763|11946728|FG000|Weeks 13-14|Overall Study||2
10786252|NCT03467763|11946728|FG000|Weeks 15-16|Overall Study||2
10786253|NCT03467763|11946728|FG000|COMPLETED|Overall Study||10
10786254|NCT03467763|11946728|FG000|NOT COMPLETED|Overall Study||3
10786255|NCT03467945|11946738|FG000|STARTED|Treatment Period 1||10
10786256|NCT03467945|11946739|FG001|STARTED|Treatment Period 1||10
10786257|NCT03467945|11946740|FG002|STARTED|Treatment Period 1||10
10786258|NCT03467945|11946741|FG003|STARTED|Treatment Period 1||10
10786259|NCT03467945|11946738|FG000|COMPLETED|Treatment Period 1||10
10786260|NCT03467945|11946739|FG001|COMPLETED|Treatment Period 1||10
10786261|NCT03467945|11946740|FG002|COMPLETED|Treatment Period 1||10
10786262|NCT03467945|11946741|FG003|COMPLETED|Treatment Period 1||10
10786263|NCT03467945|11946738|FG000|NOT COMPLETED|Treatment Period 1||0
10786264|NCT03467945|11946739|FG001|NOT COMPLETED|Treatment Period 1||0
10786265|NCT03467945|11946740|FG002|NOT COMPLETED|Treatment Period 1||0
10786266|NCT03467945|11946741|FG003|NOT COMPLETED|Treatment Period 1||0
10786267|NCT03467945|11946738|FG000|STARTED|Treatment Period 2||10
10786268|NCT03467945|11946739|FG001|STARTED|Treatment Period 2||10
10786269|NCT03467945|11946740|FG002|STARTED|Treatment Period 2||10
10786270|NCT03467945|11946741|FG003|STARTED|Treatment Period 2||10
10786271|NCT03467945|11946738|FG000|COMPLETED|Treatment Period 2||10
10786272|NCT03467945|11946739|FG001|COMPLETED|Treatment Period 2||9
10786273|NCT03467945|11946740|FG002|COMPLETED|Treatment Period 2||10
10786274|NCT03467945|11946741|FG003|COMPLETED|Treatment Period 2||10
10786275|NCT03467945|11946738|FG000|NOT COMPLETED|Treatment Period 2||0
10786276|NCT03467945|11946739|FG001|NOT COMPLETED|Treatment Period 2||1
10786277|NCT03467945|11946740|FG002|NOT COMPLETED|Treatment Period 2||0
10786278|NCT03467945|11946741|FG003|NOT COMPLETED|Treatment Period 2||0
10786279|NCT03467945|11946738|FG000|STARTED|Treatment Period 3||10
10786280|NCT03467945|11946739|FG001|STARTED|Treatment Period 3||9
10786281|NCT03467945|11946740|FG002|STARTED|Treatment Period 3||10
10433545|NCT00886821|11579904|FG011|STARTED|Stage 2||9
10786282|NCT03467945|11946741|FG003|STARTED|Treatment Period 3||10
10786283|NCT03467945|11946738|FG000|COMPLETED|Treatment Period 3||9
10786284|NCT03467945|11946739|FG001|COMPLETED|Treatment Period 3||9
10786285|NCT03467945|11946740|FG002|COMPLETED|Treatment Period 3||8
10786286|NCT03467945|11946741|FG003|COMPLETED|Treatment Period 3||9
10433546|NCT00886821|11579905|FG012|STARTED|Stage 2||13
10433547|NCT00886821|11579906|FG013|STARTED|Stage 2||9
10786287|NCT03467945|11946738|FG000|NOT COMPLETED|Treatment Period 3||1
10433548|NCT00886821|11579893|FG000|COMPLETED|Stage 2||0
10433549|NCT00886821|11579894|FG001|COMPLETED|Stage 2||0
10433550|NCT00886821|11579895|FG002|COMPLETED|Stage 2||0
10433551|NCT00886821|11579896|FG003|COMPLETED|Stage 2||0
10433552|NCT00886821|11579897|FG004|COMPLETED|Stage 2||0
10433553|NCT00886821|11579898|FG005|COMPLETED|Stage 2||0
10433554|NCT00886821|11579899|FG006|COMPLETED|Stage 2||0
10433555|NCT00886821|11579900|FG007|COMPLETED|Stage 2||0
10786288|NCT03467945|11946739|FG001|NOT COMPLETED|Treatment Period 3||0
10786289|NCT03467945|11946740|FG002|NOT COMPLETED|Treatment Period 3||2
10786290|NCT03467945|11946741|FG003|NOT COMPLETED|Treatment Period 3||1
10786291|NCT03467945|11946738|FG000|STARTED|Treatment Period 4||9
10786292|NCT03467945|11946739|FG001|STARTED|Treatment Period 4||9
10786293|NCT03467945|11946740|FG002|STARTED|Treatment Period 4||8
10786294|NCT03467945|11946741|FG003|STARTED|Treatment Period 4||9
10786295|NCT03467945|11946738|FG000|COMPLETED|Treatment Period 4||9
10786296|NCT03467945|11946739|FG001|COMPLETED|Treatment Period 4||9
10786297|NCT03467945|11946740|FG002|COMPLETED|Treatment Period 4||8
10786298|NCT03467945|11946741|FG003|COMPLETED|Treatment Period 4||9
10786299|NCT03467945|11946738|FG000|NOT COMPLETED|Treatment Period 4||0
10786300|NCT03467945|11946739|FG001|NOT COMPLETED|Treatment Period 4||0
10786301|NCT03467945|11946740|FG002|NOT COMPLETED|Treatment Period 4||0
10786302|NCT03467945|11946741|FG003|NOT COMPLETED|Treatment Period 4||0
10786303|NCT03467971|11946754|FG000|STARTED|Treatment Period 1||10
10786304|NCT03467971|11946755|FG001|STARTED|Treatment Period 1||11
10786305|NCT03467971|11946754|FG000|COMPLETED|Treatment Period 1||10
10786306|NCT03467971|11946755|FG001|COMPLETED|Treatment Period 1||11
10786307|NCT03467971|11946754|FG000|NOT COMPLETED|Treatment Period 1||0
10786308|NCT03467971|11946755|FG001|NOT COMPLETED|Treatment Period 1||0
10786309|NCT03467971|11946754|FG000|STARTED|Treatment Period 2||10
10786310|NCT03467971|11946755|FG001|STARTED|Treatment Period 2||11
10786311|NCT03467971|11946754|FG000|COMPLETED|Treatment Period 2||10
10786312|NCT03467971|11946755|FG001|COMPLETED|Treatment Period 2||10
10786313|NCT03467971|11946754|FG000|NOT COMPLETED|Treatment Period 2||0
10786314|NCT03467971|11946755|FG001|NOT COMPLETED|Treatment Period 2||1
10786315|NCT03468075|11946762|FG000|STARTED|Overall Study||10
10786316|NCT03468075|11946762|FG000|COMPLETED|Overall Study||10
10786317|NCT03468075|11946762|FG000|NOT COMPLETED|Overall Study||0
10786318|NCT03468179|11946766|FG000|STARTED|Overall Study||10
10786319|NCT03468179|11946766|FG000|COMPLETED|Overall Study||10
10786320|NCT03468179|11946766|FG000|NOT COMPLETED|Overall Study||0
10786321|NCT03468543|11946773|FG000|STARTED|Overall Study||3
10786322|NCT03468543|11946773|FG000|COMPLETED|Overall Study||0
10786323|NCT03468543|11946773|FG000|NOT COMPLETED|Overall Study||3
10786324|NCT03468816|11946779|FG000|STARTED|Overall Study||2
10786325|NCT03468816|11946780|FG001|STARTED|Overall Study||3
10786326|NCT03468816|11946779|FG000|COMPLETED|Overall Study||2
10786327|NCT03468816|11946780|FG001|COMPLETED|Overall Study||3
10786328|NCT03468816|11946779|FG000|NOT COMPLETED|Overall Study||0
10786329|NCT03468816|11946780|FG001|NOT COMPLETED|Overall Study||0
10786330|NCT03468855|11946788|FG000|STARTED|Overall Study||34
10786331|NCT03468855|11946788|FG000|COMPLETED|Overall Study||23
10786332|NCT03468855|11946788|FG000|NOT COMPLETED|Overall Study||11
10786333|NCT03468920|11946794|FG000|STARTED|Overall Study||60
10786334|NCT03468920|11946795|FG001|STARTED|Overall Study||60
10786335|NCT03468920|11946794|FG000|COMPLETED|Overall Study||60
10786336|NCT03468920|11946795|FG001|COMPLETED|Overall Study||60
10786337|NCT03468920|11946794|FG000|NOT COMPLETED|Overall Study||0
10786338|NCT03468920|11946795|FG001|NOT COMPLETED|Overall Study||0
10786339|NCT03468933|11946803|FG000|STARTED|Overall Study||16
10786340|NCT03468933|11946804|FG001|STARTED|Overall Study||16
10786341|NCT03468933|11946803|FG000|COMPLETED|Overall Study||16
10786342|NCT03468933|11946804|FG001|COMPLETED|Overall Study||16
10786343|NCT03468933|11946803|FG000|NOT COMPLETED|Overall Study||0
10786344|NCT03468933|11946804|FG001|NOT COMPLETED|Overall Study||0
10786345|NCT03469336|11946810|FG000|STARTED|Overall Study||18
10786346|NCT03469336|11946810|FG000|COMPLETED|Overall Study||17
10786347|NCT03469336|11946810|FG000|NOT COMPLETED|Overall Study||1
10786348|NCT03469349|11946822|FG000|STARTED|Overall Study||182
10786349|NCT03469349|11946823|FG001|STARTED|Overall Study||184
10786350|NCT03469349|11946822|FG000|COMPLETED|Overall Study||177
10786351|NCT03469349|11946823|FG001|COMPLETED|Overall Study||174
10786352|NCT03469349|11946822|FG000|NOT COMPLETED|Overall Study||5
10786353|NCT03469349|11946823|FG001|NOT COMPLETED|Overall Study||10
10786354|NCT03470012|11946829|FG000|STARTED|Overall Study||24
10786355|NCT03470012|11946829|FG000|COMPLETED|Overall Study||24
10786356|NCT03470012|11946829|FG000|NOT COMPLETED|Overall Study||0
10433556|NCT00886821|11579901|FG008|COMPLETED|Stage 2||0
10786357|NCT03470194|11946835|FG000|STARTED|Overall Study||49
10786358|NCT03470194|11946836|FG001|STARTED|Overall Study||57
10786359|NCT03470194|11946835|FG000|COMPLETED|Overall Study||38
10786360|NCT03470194|11946836|FG001|COMPLETED|Overall Study||40
10786361|NCT03470194|11946835|FG000|NOT COMPLETED|Overall Study||11
10786362|NCT03470194|11946836|FG001|NOT COMPLETED|Overall Study||17
10786363|NCT03470493|11946842|FG000|STARTED|Overall Study||130
10433557|NCT00886821|11579902|FG009|COMPLETED|Stage 2||0
10786364|NCT03470493|11946842|FG000|Met Primary Endpoint|Overall Study||80
10786365|NCT03470493|11946842|FG000|COMPLETED|Overall Study||130
10786366|NCT03470493|11946842|FG000|NOT COMPLETED|Overall Study||0
10786367|NCT03470545|11946848|FG000|STARTED|Overall Study||123
10786368|NCT03470545|11946849|FG001|STARTED|Overall Study||128
10433558|NCT00886821|11579903|FG010|COMPLETED|Stage 2||9
10433559|NCT00886821|11579904|FG011|COMPLETED|Stage 2||8
10433560|NCT00886821|11579905|FG012|COMPLETED|Stage 2||8
10433561|NCT00886821|11579906|FG013|COMPLETED|Stage 2||8
10433562|NCT00886821|11579893|FG000|NOT COMPLETED|Stage 2||0
10433563|NCT00886821|11579894|FG001|NOT COMPLETED|Stage 2||0
10433564|NCT00886821|11579895|FG002|NOT COMPLETED|Stage 2||0
10433565|NCT00886821|11579896|FG003|NOT COMPLETED|Stage 2||0
10433566|NCT00886821|11579897|FG004|NOT COMPLETED|Stage 2||0
10433567|NCT00886821|11579898|FG005|NOT COMPLETED|Stage 2||0
10433568|NCT00886821|11579899|FG006|NOT COMPLETED|Stage 2||0
10433569|NCT00886821|11579900|FG007|NOT COMPLETED|Stage 2||0
10433570|NCT00886821|11579901|FG008|NOT COMPLETED|Stage 2||0
10433571|NCT00886821|11579902|FG009|NOT COMPLETED|Stage 2||0
10786369|NCT03470545|11946848|FG000|COMPLETED|Overall Study||119
10786370|NCT03470545|11946849|FG001|COMPLETED|Overall Study||125
10786371|NCT03470545|11946848|FG000|NOT COMPLETED|Overall Study||4
10786372|NCT03470545|11946849|FG001|NOT COMPLETED|Overall Study||3
10786373|NCT03470740|11946858|FG000|STARTED|Overall Study||112
10786374|NCT03470740|11946859|FG001|STARTED|Overall Study||112
10786375|NCT03470740|11946858|FG000|COMPLETED|Overall Study||108
10786376|NCT03470740|11946859|FG001|COMPLETED|Overall Study||106
10786377|NCT03470740|11946858|FG000|NOT COMPLETED|Overall Study||4
10786378|NCT03470740|11946859|FG001|NOT COMPLETED|Overall Study||6
10786379|NCT03471065|11946866|FG000|STARTED|Overall Study||100
10786380|NCT03471065|11946866|FG000|COMPLETED|Overall Study||100
10786381|NCT03471065|11946866|FG000|NOT COMPLETED|Overall Study||0
10786382|NCT03471078|11946872|FG000|STARTED|Overall Study||82
10786383|NCT03471078|11946873|FG001|STARTED|Overall Study||40
10786384|NCT03471078|11946872|FG000|COMPLETED|Overall Study||61
10786385|NCT03471078|11946873|FG001|COMPLETED|Overall Study||34
10786386|NCT03471078|11946872|FG000|NOT COMPLETED|Overall Study||21
10786387|NCT03471078|11946873|FG001|NOT COMPLETED|Overall Study||6
10786388|NCT03471832|11946879|FG000|STARTED|Overall Study||40
10786389|NCT03471832|11946880|FG001|STARTED|Overall Study||40
10786390|NCT03471832|11946879|FG000|COMPLETED|Overall Study||40
10786391|NCT03471832|11946880|FG001|COMPLETED|Overall Study||40
10786392|NCT03471832|11946879|FG000|NOT COMPLETED|Overall Study||0
10786393|NCT03471832|11946880|FG001|NOT COMPLETED|Overall Study||0
10786394|NCT03471871|11946890|FG000|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
10786395|NCT03471871|11946891|FG001|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
10786396|NCT03471871|11946892|FG002|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
10786397|NCT03471871|11946893|FG003|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||19
10786398|NCT03471871|11946894|FG004|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||20
10786399|NCT03471871|11946890|FG000|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
10786400|NCT03471871|11946891|FG001|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
10786401|NCT03471871|11946892|FG002|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
10786402|NCT03471871|11946893|FG003|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||18
10786403|NCT03471871|11946894|FG004|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||20
10786404|NCT03471871|11946890|FG000|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
10786405|NCT03471871|11946891|FG001|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
10786406|NCT03471871|11946892|FG002|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
10786407|NCT03471871|11946893|FG003|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||18
10786408|NCT03471871|11946894|FG004|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||19
10786409|NCT03471871|11946890|FG000|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||0
10786410|NCT03471871|11946891|FG001|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||0
10786411|NCT03471871|11946892|FG002|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||1
10786412|NCT03471871|11946893|FG003|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||1
10786413|NCT03471871|11946894|FG004|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||1
10786414|NCT03471871|11946890|FG000|STARTED|Washout Period 1 (14 Days)||6
10786415|NCT03471871|11946891|FG001|STARTED|Washout Period 1 (14 Days)||5
10786416|NCT03471871|11946892|FG002|STARTED|Washout Period 1 (14 Days)||5
10786417|NCT03471871|11946893|FG003|STARTED|Washout Period 1 (14 Days)||18
10786418|NCT03471871|11946894|FG004|STARTED|Washout Period 1 (14 Days)||19
10786419|NCT03471871|11946890|FG000|COMPLETED|Washout Period 1 (14 Days)||6
10786420|NCT03471871|11946891|FG001|COMPLETED|Washout Period 1 (14 Days)||5
10786421|NCT03471871|11946892|FG002|COMPLETED|Washout Period 1 (14 Days)||5
10786422|NCT03471871|11946893|FG003|COMPLETED|Washout Period 1 (14 Days)||18
10786423|NCT03471871|11946894|FG004|COMPLETED|Washout Period 1 (14 Days)||19
10433572|NCT00886821|11579903|FG010|NOT COMPLETED|Stage 2||0
10433573|NCT00886821|11579904|FG011|NOT COMPLETED|Stage 2||1
10433574|NCT00886821|11579905|FG012|NOT COMPLETED|Stage 2||5
10433575|NCT00886821|11579906|FG013|NOT COMPLETED|Stage 2||1
10433576|NCT00886834|11579952|FG000|STARTED|Overall Study||54
10433577|NCT00886834|11579953|FG001|STARTED|Overall Study||54
10433578|NCT00886834|11579952|FG000|COMPLETED|Overall Study||54
10433579|NCT00886834|11579953|FG001|COMPLETED|Overall Study||51
10433580|NCT00886834|11579952|FG000|NOT COMPLETED|Overall Study||0
10433581|NCT00886834|11579953|FG001|NOT COMPLETED|Overall Study||3
10433582|NCT00886899|11579959|FG000|STARTED|Overall Study||147
10433583|NCT00886899|11579959|FG000|COMPLETED|Overall Study||147
10433584|NCT00886899|11579959|FG000|NOT COMPLETED|Overall Study||0
10433585|NCT00886938|11579963|FG000|STARTED|Overall Study||12
10433586|NCT00886938|11579963|FG000|COMPLETED|Overall Study||10
10433587|NCT00886938|11579963|FG000|NOT COMPLETED|Overall Study||2
10433588|NCT00887068|11579969|FG000|STARTED|Overall Study||93
10433589|NCT00887068|11579970|FG001|STARTED|Overall Study||94
10433590|NCT00887068|11579969|FG000|COMPLETED|Overall Study||87
10433591|NCT00887068|11579970|FG001|COMPLETED|Overall Study||94
10433592|NCT00887068|11579969|FG000|NOT COMPLETED|Overall Study||6
10433593|NCT00887068|11579970|FG001|NOT COMPLETED|Overall Study||0
10433594|NCT00887159|11579979|FG000|STARTED|Overall Study||56
10433595|NCT00887159|11579980|FG001|STARTED|Overall Study||56
10433596|NCT00887159|11579981|FG002|STARTED|Overall Study||56
10433597|NCT00887159|11579979|FG000|Patients Who Started Assigned Treatment|Overall Study||53
10433598|NCT00887159|11579980|FG001|Patients Who Started Assigned Treatment|Overall Study||53
10433599|NCT00887159|11579981|FG002|Patients Who Started Assigned Treatment|Overall Study||52
10433600|NCT00887159|11579979|FG000|Eligible and Treated Patients|Overall Study||48
10433601|NCT00887159|11579980|FG001|Eligible and Treated Patients|Overall Study||52
10433602|NCT00887159|11579981|FG002|Eligible and Treated Patients|Overall Study||52
10433603|NCT00887159|11579979|FG000|Eligible/Treated Pts With CTCs Results|Overall Study||40
10433604|NCT00887159|11579980|FG001|Eligible/Treated Pts With CTCs Results|Overall Study||42
10433605|NCT00887159|11579981|FG002|Eligible/Treated Pts With CTCs Results|Overall Study||38
10433606|NCT00887159|11579979|FG000|COMPLETED|Overall Study||27
10433607|NCT00887159|11579980|FG001|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicity.|0
10433608|NCT00887159|11579981|FG002|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicity.|0
10433609|NCT00887159|11579979|FG000|NOT COMPLETED|Overall Study||29
10433610|NCT00887159|11579980|FG001|NOT COMPLETED|Overall Study||56
10433611|NCT00887159|11579981|FG002|NOT COMPLETED|Overall Study||56
10433612|NCT00887198|11579993|FG000|STARTED|Randomized Period||546
10433613|NCT00887198|11579994|FG001|STARTED|Randomized Period||542
10433614|NCT00887198|11579995|FG002|STARTED|Randomized Period||0
10433615|NCT00887198|11579993|FG000|Treated|Randomized Period||542
10433616|NCT00887198|11579994|FG001|Treated|Randomized Period||540
10433617|NCT00887198|11579995|FG002|Treated|Randomized Period||0
10433618|NCT00887198|11579993|FG000|COMPLETED|Randomized Period||0
10433619|NCT00887198|11579994|FG001|COMPLETED|Randomized Period||0
10433620|NCT00887198|11579995|FG002|COMPLETED|Randomized Period||0
10433621|NCT00887198|11579993|FG000|NOT COMPLETED|Randomized Period||546
10433622|NCT00887198|11579994|FG001|NOT COMPLETED|Randomized Period||542
10433623|NCT00887198|11579995|FG002|NOT COMPLETED|Randomized Period||0
10433624|NCT00887198|11579993|FG000|STARTED|Cross Over (Placebo to AA)||0
10433625|NCT00887198|11579994|FG001|STARTED|Cross Over (Placebo to AA)||0
10433626|NCT00887198|11579995|FG002|STARTED|Cross Over (Placebo to AA)|93= 51 participants(crossed over under amendment 3)+42 participants (crossed over under amendment 4)|93
10433627|NCT00887198|11579993|FG000|COMPLETED|Cross Over (Placebo to AA)||0
10433628|NCT00887198|11579994|FG001|COMPLETED|Cross Over (Placebo to AA)||0
10433629|NCT00887198|11579995|FG002|COMPLETED|Cross Over (Placebo to AA)||0
10433630|NCT00887198|11579993|FG000|NOT COMPLETED|Cross Over (Placebo to AA)||0
10433631|NCT00887198|11579994|FG001|NOT COMPLETED|Cross Over (Placebo to AA)||0
10433632|NCT00887198|11579995|FG002|NOT COMPLETED|Cross Over (Placebo to AA)||93
10433633|NCT00887224|11580006|FG000|STARTED|Open-label Response (OLR) Phase||874
10433634|NCT00887224|11580007|FG001|STARTED|Open-label Response (OLR) Phase||0
10433635|NCT00887224|11580008|FG002|STARTED|Open-label Response (OLR) Phase||0
10433636|NCT00887224|11580006|FG000|COMPLETED|Open-label Response (OLR) Phase||752
10433637|NCT00887224|11580007|FG001|COMPLETED|Open-label Response (OLR) Phase||0
10433638|NCT00887224|11580008|FG002|COMPLETED|Open-label Response (OLR) Phase||0
10433639|NCT00887224|11580006|FG000|NOT COMPLETED|Open-label Response (OLR) Phase||122
10433640|NCT00887224|11580007|FG001|NOT COMPLETED|Open-label Response (OLR) Phase||0
10433641|NCT00887224|11580008|FG002|NOT COMPLETED|Open-label Response (OLR) Phase||0
10433642|NCT00887224|11580006|FG000|STARTED|Between OLR and OLS Phases||752
10433643|NCT00887224|11580007|FG001|STARTED|Between OLR and OLS Phases||0
10433644|NCT00887224|11580008|FG002|STARTED|Between OLR and OLS Phases||0
10433645|NCT00887224|11580006|FG000|COMPLETED|Between OLR and OLS Phases||659
10433646|NCT00887224|11580007|FG001|COMPLETED|Between OLR and OLS Phases||0
10433647|NCT00887224|11580008|FG002|COMPLETED|Between OLR and OLS Phases||0
10433648|NCT00887224|11580006|FG000|NOT COMPLETED|Between OLR and OLS Phases||93
10433649|NCT00887224|11580007|FG001|NOT COMPLETED|Between OLR and OLS Phases||0
10433650|NCT00887224|11580008|FG002|NOT COMPLETED|Between OLR and OLS Phases||0
10433651|NCT00887224|11580006|FG000|STARTED|Open-label Stability (OLS) Phase||659
10433652|NCT00887224|11580007|FG001|STARTED|Open-label Stability (OLS) Phase||0
10433653|NCT00887224|11580008|FG002|STARTED|Open-label Stability (OLS) Phase||0
10433654|NCT00887224|11580006|FG000|COMPLETED|Open-label Stability (OLS) Phase||576
10433655|NCT00887224|11580007|FG001|COMPLETED|Open-label Stability (OLS) Phase||0
10433656|NCT00887224|11580008|FG002|COMPLETED|Open-label Stability (OLS) Phase||0
10549437|NCT01525407|11703446|FG000|STARTED|Overall Study||41
10549438|NCT01525407|11703447|FG001|STARTED|Overall Study||42
10433657|NCT00887224|11580006|FG000|NOT COMPLETED|Open-label Stability (OLS) Phase||83
10433658|NCT00887224|11580007|FG001|NOT COMPLETED|Open-label Stability (OLS) Phase||0
10433659|NCT00887224|11580008|FG002|NOT COMPLETED|Open-label Stability (OLS) Phase||0
10433660|NCT00887224|11580006|FG000|STARTED|Between OLS and DB Phases||576
10433661|NCT00887224|11580007|FG001|STARTED|Between OLS and DB Phases||0
10433662|NCT00887224|11580008|FG002|STARTED|Between OLS and DB Phases||0
10433663|NCT00887224|11580006|FG000|COMPLETED|Between OLS and DB Phases||548
10433664|NCT00887224|11580007|FG001|COMPLETED|Between OLS and DB Phases||0
10433665|NCT00887224|11580008|FG002|COMPLETED|Between OLS and DB Phases||0
10433666|NCT00887224|11580006|FG000|NOT COMPLETED|Between OLS and DB Phases||28
10433667|NCT00887224|11580007|FG001|NOT COMPLETED|Between OLS and DB Phases||0
10433668|NCT00887224|11580008|FG002|NOT COMPLETED|Between OLS and DB Phases||0
10433669|NCT00887224|11580006|FG000|STARTED|OL Taper Phase / OL Follow Up|Could have entered 7-day taper period at any time during either the OLR phase or OLS phase.|307
10433670|NCT00887224|11580007|FG001|STARTED|OL Taper Phase / OL Follow Up||0
10433671|NCT00887224|11580008|FG002|STARTED|OL Taper Phase / OL Follow Up||0
10433672|NCT00887224|11580006|FG000|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up|Could have discontinued at any time during OL taper phase or OL Follow-up (7 days after last dose).|144
10433673|NCT00887224|11580007|FG001|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up||0
10433674|NCT00887224|11580008|FG002|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up||0
10433675|NCT00887224|11580006|FG000|COMPLETED|OL Taper Phase / OL Follow Up||163
10433676|NCT00887224|11580007|FG001|COMPLETED|OL Taper Phase / OL Follow Up||0
10433677|NCT00887224|11580008|FG002|COMPLETED|OL Taper Phase / OL Follow Up||0
10433678|NCT00887224|11580006|FG000|NOT COMPLETED|OL Taper Phase / OL Follow Up||144
10433679|NCT00887224|11580007|FG001|NOT COMPLETED|OL Taper Phase / OL Follow Up||0
10433680|NCT00887224|11580008|FG002|NOT COMPLETED|OL Taper Phase / OL Follow Up||0
10433681|NCT00887224|11580006|FG000|STARTED|Double-blind (DB) Phase||0
10433682|NCT00887224|11580007|FG001|STARTED|Double-blind (DB) Phase|2 participants randomized in error to DB, then entered OL Taper; counted in OL Taper and DB phases.|276
10433683|NCT00887224|11580008|FG002|STARTED|Double-blind (DB) Phase||272
10433684|NCT00887224|11580006|FG000|COMPLETED|Double-blind (DB) Phase||0
10786424|NCT03471871|11946890|FG000|NOT COMPLETED|Washout Period 1 (14 Days)||0
10786425|NCT03471871|11946891|FG001|NOT COMPLETED|Washout Period 1 (14 Days)||0
10786426|NCT03471871|11946892|FG002|NOT COMPLETED|Washout Period 1 (14 Days)||0
10786427|NCT03471871|11946893|FG003|NOT COMPLETED|Washout Period 1 (14 Days)||0
10786428|NCT03471871|11946894|FG004|NOT COMPLETED|Washout Period 1 (14 Days)||0
10786429|NCT03471871|11946890|FG000|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||6
10786430|NCT03471871|11946891|FG001|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
10786431|NCT03471871|11946892|FG002|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
10786432|NCT03471871|11946893|FG003|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||18
10786433|NCT03471871|11946894|FG004|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||19
10786434|NCT03471871|11946890|FG000|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||6
10786435|NCT03471871|11946891|FG001|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
10786436|NCT03471871|11946892|FG002|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
10786437|NCT03471871|11946893|FG003|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||18
10786438|NCT03471871|11946894|FG004|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||18
10786439|NCT03471871|11946890|FG000|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
10786440|NCT03471871|11946891|FG001|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
10786441|NCT03471871|11946892|FG002|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
10786442|NCT03471871|11946893|FG003|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
10786443|NCT03471871|11946894|FG004|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||1
10786444|NCT03471871|11946890|FG000|STARTED|Washout Period 2 (14 Days)||6
10786445|NCT03471871|11946891|FG001|STARTED|Washout Period 2 (14 Days)||5
10786446|NCT03471871|11946892|FG002|STARTED|Washout Period 2 (14 Days)||5
10786447|NCT03471871|11946893|FG003|STARTED|Washout Period 2 (14 Days)|0=not applicable, as OSA cohort was treated till Treatment Period 2, then directly followed up.|0
10786448|NCT03471871|11946894|FG004|STARTED|Washout Period 2 (14 Days)|0=not applicable, as OSA cohort was treated till Treatment Period 2, then directly followed up.|0
10786449|NCT03471871|11946890|FG000|COMPLETED|Washout Period 2 (14 Days)||6
10786450|NCT03471871|11946891|FG001|COMPLETED|Washout Period 2 (14 Days)||5
10786451|NCT03471871|11946892|FG002|COMPLETED|Washout Period 2 (14 Days)||5
10786452|NCT03471871|11946893|FG003|COMPLETED|Washout Period 2 (14 Days)||0
10786453|NCT03471871|11946894|FG004|COMPLETED|Washout Period 2 (14 Days)||0
10786454|NCT03471871|11946890|FG000|NOT COMPLETED|Washout Period 2 (14 Days)||0
10786455|NCT03471871|11946891|FG001|NOT COMPLETED|Washout Period 2 (14 Days)||0
10786456|NCT03471871|11946892|FG002|NOT COMPLETED|Washout Period 2 (14 Days)||0
10786457|NCT03471871|11946893|FG003|NOT COMPLETED|Washout Period 2 (14 Days)||0
10786458|NCT03471871|11946894|FG004|NOT COMPLETED|Washout Period 2 (14 Days)||0
10786459|NCT03471871|11946890|FG000|STARTED|Treatment Period 3: ( HV:1 Day)||6
10786460|NCT03471871|11946891|FG001|STARTED|Treatment Period 3: ( HV:1 Day)||5
10786461|NCT03471871|11946892|FG002|STARTED|Treatment Period 3: ( HV:1 Day)||5
10786462|NCT03471871|11946893|FG003|STARTED|Treatment Period 3: ( HV:1 Day)||0
10786463|NCT03471871|11946894|FG004|STARTED|Treatment Period 3: ( HV:1 Day)||0
10786464|NCT03471871|11946890|FG000|COMPLETED|Treatment Period 3: ( HV:1 Day)||6
10786465|NCT03471871|11946891|FG001|COMPLETED|Treatment Period 3: ( HV:1 Day)||5
10786466|NCT03471871|11946892|FG002|COMPLETED|Treatment Period 3: ( HV:1 Day)||5
10786467|NCT03471871|11946893|FG003|COMPLETED|Treatment Period 3: ( HV:1 Day)||0
10786468|NCT03471871|11946894|FG004|COMPLETED|Treatment Period 3: ( HV:1 Day)||0
10433685|NCT00887224|11580007|FG001|COMPLETED|Double-blind (DB) Phase||176
10433686|NCT00887224|11580008|FG002|COMPLETED|Double-blind (DB) Phase||210
10433687|NCT00887224|11580006|FG000|NOT COMPLETED|Double-blind (DB) Phase||0
10433688|NCT00887224|11580007|FG001|NOT COMPLETED|Double-blind (DB) Phase||100
10433689|NCT00887224|11580008|FG002|NOT COMPLETED|Double-blind (DB) Phase||62
10433690|NCT00887224|11580006|FG000|STARTED|DB Taper Phase / Post Study Follow Up||0
10433691|NCT00887224|11580007|FG001|STARTED|DB Taper Phase / Post Study Follow Up|Double-blind participants (DBp) could have entered 7-day taper period at any time during DB phase.|267
10433692|NCT00887224|11580008|FG002|STARTED|DB Taper Phase / Post Study Follow Up||265
10433693|NCT00887224|11580006|FG000|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||0
10433694|NCT00887224|11580007|FG001|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||9
10433695|NCT00887224|11580008|FG002|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||7
10433696|NCT00887224|11580006|FG000|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up||0
10433697|NCT00887224|11580007|FG001|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up|DBp could have discontinued at anytime during DB taper period or Follow-up (7 days after last dose).|41
10433698|NCT00887224|11580008|FG002|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up||30
10433699|NCT00887224|11580006|FG000|COMPLETED|DB Taper Phase / Post Study Follow Up||0
10433700|NCT00887224|11580007|FG001|COMPLETED|DB Taper Phase / Post Study Follow Up||226
10433701|NCT00887224|11580008|FG002|COMPLETED|DB Taper Phase / Post Study Follow Up||235
10433702|NCT00887224|11580006|FG000|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||0
10433703|NCT00887224|11580007|FG001|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||41
10433704|NCT00887224|11580008|FG002|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||30
10433705|NCT00887289|11580020|FG000|STARTED|Overall Study||1504
10433706|NCT00887289|11580020|FG000|COMPLETED|Overall Study||1409
10433707|NCT00887289|11580020|FG000|NOT COMPLETED|Overall Study||95
10433708|NCT00887341|11580026|FG000|STARTED|Overall Study||37
10433709|NCT00887341|11580027|FG001|STARTED|Overall Study||39
10433710|NCT00887341|11580026|FG000|COMPLETED|Overall Study||35
10433711|NCT00887341|11580027|FG001|COMPLETED|Overall Study||36
10433712|NCT00887341|11580026|FG000|NOT COMPLETED|Overall Study||2
10433713|NCT00887341|11580027|FG001|NOT COMPLETED|Overall Study||3
10433714|NCT00887354|11580035|FG000|STARTED|Treatment Phase (Week 0 to Week 26)||111
10433715|NCT00887354|11580036|FG001|STARTED|Treatment Phase (Week 0 to Week 26)||113
10433716|NCT00887354|11580035|FG000|Received at Least 1 Dose of Study Drug|Treatment Phase (Week 0 to Week 26)||106
10433717|NCT00887354|11580036|FG001|Received at Least 1 Dose of Study Drug|Treatment Phase (Week 0 to Week 26)||110
10433718|NCT00887354|11580035|FG000|Included in Full Analysis Set|Treatment Phase (Week 0 to Week 26)||86
10433719|NCT00887354|11580036|FG001|Included in Full Analysis Set|Treatment Phase (Week 0 to Week 26)||85
10433720|NCT00887354|11580035|FG000|COMPLETED|Treatment Phase (Week 0 to Week 26)||60
10433721|NCT00887354|11580036|FG001|COMPLETED|Treatment Phase (Week 0 to Week 26)||65
10433722|NCT00887354|11580035|FG000|NOT COMPLETED|Treatment Phase (Week 0 to Week 26)||51
10433723|NCT00887354|11580036|FG001|NOT COMPLETED|Treatment Phase (Week 0 to Week 26)||48
10433724|NCT00887354|11580035|FG000|STARTED|Open Label Phase (Week 26 to Week 78)||60
10433725|NCT00887354|11580036|FG001|STARTED|Open Label Phase (Week 26 to Week 78)||65
10433726|NCT00887354|11580035|FG000|COMPLETED|Open Label Phase (Week 26 to Week 78)||57
10433727|NCT00887354|11580036|FG001|COMPLETED|Open Label Phase (Week 26 to Week 78)||59
10433728|NCT00887354|11580035|FG000|NOT COMPLETED|Open Label Phase (Week 26 to Week 78)||3
10433729|NCT00887354|11580036|FG001|NOT COMPLETED|Open Label Phase (Week 26 to Week 78)||6
10433730|NCT00887432|11580045|FG000|STARTED|Overall Study||58
10433731|NCT00887432|11580046|FG001|STARTED|Overall Study||74
10433732|NCT00887432|11580045|FG000|COMPLETED|Overall Study||43
10433733|NCT00887432|11580046|FG001|COMPLETED|Overall Study||60
10433734|NCT00887432|11580045|FG000|NOT COMPLETED|Overall Study||15
10433735|NCT00887432|11580046|FG001|NOT COMPLETED|Overall Study||14
10433736|NCT00887458|11580054|FG000|STARTED|Overall Study||17
10433737|NCT00887458|11580055|FG001|STARTED|Overall Study||29
10433738|NCT00887458|11580054|FG000|COMPLETED|Overall Study||17
10433739|NCT00887458|11580055|FG001|COMPLETED|Overall Study||25
10433740|NCT00887458|11580054|FG000|NOT COMPLETED|Overall Study||0
10433741|NCT00887458|11580055|FG001|NOT COMPLETED|Overall Study||4
10433742|NCT00887471|11580065|FG000|STARTED|Overall Study||15
10433743|NCT00887471|11580066|FG001|STARTED|Overall Study||15
10433744|NCT00887471|11580065|FG000|COMPLETED|Overall Study||15
10433745|NCT00887471|11580066|FG001|COMPLETED|Overall Study||15
10433746|NCT00887471|11580065|FG000|NOT COMPLETED|Overall Study||0
10433747|NCT00887471|11580066|FG001|NOT COMPLETED|Overall Study||0
10433748|NCT00887484|11580072|FG000|STARTED|Split Face Treatment (Weeks 1 and 2)||48
10433749|NCT00887484|11580072|FG000|COMPLETED|Split Face Treatment (Weeks 1 and 2)||48
10433750|NCT00887484|11580072|FG000|NOT COMPLETED|Split Face Treatment (Weeks 1 and 2)||0
10433751|NCT00887484|11580072|FG000|STARTED|Full Face Treatment (Weeks 5 and 8)||48
10433752|NCT00887484|11580072|FG000|COMPLETED|Full Face Treatment (Weeks 5 and 8)||45
10433753|NCT00887484|11580072|FG000|NOT COMPLETED|Full Face Treatment (Weeks 5 and 8)||3
10433754|NCT00887510|11580083|FG000|STARTED|Overall Study||12
10433755|NCT00887510|11580084|FG001|STARTED|Overall Study||12
10433756|NCT00887510|11580083|FG000|COMPLETED|Overall Study||12
10433757|NCT00887510|11580084|FG001|COMPLETED|Overall Study||12
10433758|NCT00887510|11580083|FG000|NOT COMPLETED|Overall Study||0
10433759|NCT00887510|11580084|FG001|NOT COMPLETED|Overall Study||0
10786469|NCT03471871|11946890|FG000|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
10786470|NCT03471871|11946891|FG001|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
10433760|NCT00887549|11580090|FG000|STARTED|Induction Therapy||70
10433761|NCT00887549|11580090|FG000|COMPLETED|Induction Therapy||43
10433762|NCT00887549|11580090|FG000|NOT COMPLETED|Induction Therapy||27
10433763|NCT00887549|11580090|FG000|STARTED|Maintenance Therapy||43
10433764|NCT00887549|11580090|FG000|COMPLETED|Maintenance Therapy||0
10433765|NCT00887549|11580090|FG000|NOT COMPLETED|Maintenance Therapy||43
10433766|NCT00887562|11580097|FG000|STARTED|Overall Study||10
10433767|NCT00887562|11580098|FG001|STARTED|Overall Study||9
10433768|NCT00887562|11580099|FG002|STARTED|Overall Study||8
10433769|NCT00887562|11580097|FG000|COMPLETED|Overall Study||7
10433770|NCT00887562|11580098|FG001|COMPLETED|Overall Study||7
10433771|NCT00887562|11580099|FG002|COMPLETED|Overall Study||7
10433772|NCT00887562|11580097|FG000|NOT COMPLETED|Overall Study||3
10433773|NCT00887562|11580098|FG001|NOT COMPLETED|Overall Study||2
10433774|NCT00887562|11580099|FG002|NOT COMPLETED|Overall Study||1
10433775|NCT00887575|11580109|FG000|STARTED|Phase I||6
10433776|NCT00887575|11580110|FG001|STARTED|Phase I||6
10433777|NCT00887575|11580111|FG002|STARTED|Phase I||3
10433778|NCT00887575|11580109|FG000|COMPLETED|Phase I||6
10433779|NCT00887575|11580110|FG001|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
10433780|NCT00887575|11580111|FG002|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
10433781|NCT00887575|11580109|FG000|NOT COMPLETED|Phase I||0
10433782|NCT00887575|11580110|FG001|NOT COMPLETED|Phase I||6
10433783|NCT00887575|11580111|FG002|NOT COMPLETED|Phase I||3
10433784|NCT00887575|11580109|FG000|STARTED|Phase II - Neoadjuvant Therapy|Includes patients treated at MTD during Phase I, 39 additional patients enrolled, 4 were not treated|41
10433785|NCT00887575|11580110|FG001|STARTED|Phase II - Neoadjuvant Therapy||0
10433786|NCT00887575|11580111|FG002|STARTED|Phase II - Neoadjuvant Therapy||0
10433787|NCT00887575|11580109|FG000|COMPLETED|Phase II - Neoadjuvant Therapy||16
10433788|NCT00887575|11580110|FG001|COMPLETED|Phase II - Neoadjuvant Therapy||0
10433789|NCT00887575|11580111|FG002|COMPLETED|Phase II - Neoadjuvant Therapy||0
10433790|NCT00887575|11580109|FG000|NOT COMPLETED|Phase II - Neoadjuvant Therapy||25
10433791|NCT00887575|11580110|FG001|NOT COMPLETED|Phase II - Neoadjuvant Therapy||0
10433792|NCT00887575|11580111|FG002|NOT COMPLETED|Phase II - Neoadjuvant Therapy||0
10433793|NCT00887575|11580109|FG000|STARTED|Phase II - Maintenance Therapy|Pts who completed 6 cycles of Neoadjuvant Therapy & underwent surgery were eligible for maintenance|8
10433794|NCT00887575|11580110|FG001|STARTED|Phase II - Maintenance Therapy||0
10433795|NCT00887575|11580111|FG002|STARTED|Phase II - Maintenance Therapy||0
10433796|NCT00887575|11580109|FG000|COMPLETED|Phase II - Maintenance Therapy||6
10433797|NCT00887575|11580110|FG001|COMPLETED|Phase II - Maintenance Therapy||0
10433798|NCT00887575|11580111|FG002|COMPLETED|Phase II - Maintenance Therapy||0
10433799|NCT00887575|11580109|FG000|NOT COMPLETED|Phase II - Maintenance Therapy||2
10433800|NCT00887575|11580110|FG001|NOT COMPLETED|Phase II - Maintenance Therapy||0
10433801|NCT00887575|11580111|FG002|NOT COMPLETED|Phase II - Maintenance Therapy||0
10433802|NCT00887588|11580118|FG000|STARTED|Core Period||149
10433803|NCT00887588|11580119|FG001|STARTED|Core Period||152
10433804|NCT00887588|11580118|FG000|Extension Efficacy Set|Core Period||127
10433805|NCT00887588|11580119|FG001|Extension Efficacy Set|Core Period||125
10433806|NCT00887588|11580118|FG000|Full Analysis Set|Core Period||148
10433807|NCT00887588|11580119|FG001|Full Analysis Set|Core Period||146
10433808|NCT00887588|11580118|FG000|Arterial Stiffness Set|Core Period||86
10433809|NCT00887588|11580119|FG001|Arterial Stiffness Set|Core Period||94
10433810|NCT00887588|11580118|FG000|COMPLETED|Core Period||130
10433811|NCT00887588|11580119|FG001|COMPLETED|Core Period||131
10433812|NCT00887588|11580118|FG000|NOT COMPLETED|Core Period||19
10433813|NCT00887588|11580119|FG001|NOT COMPLETED|Core Period||21
10433814|NCT00887588|11580118|FG000|STARTED|Extension Period||127
10433815|NCT00887588|11580119|FG001|STARTED|Extension Period||125
10433816|NCT00887588|11580118|FG000|Arterial Stiffness Set|Extension Period||86
10433817|NCT00887588|11580119|FG001|Arterial Stiffness Set|Extension Period||94
10433818|NCT00887588|11580118|FG000|COMPLETED|Extension Period||121
10433819|NCT00887588|11580119|FG001|COMPLETED|Extension Period||120
10433820|NCT00887588|11580118|FG000|NOT COMPLETED|Extension Period||6
10433821|NCT00887588|11580119|FG001|NOT COMPLETED|Extension Period||5
10433822|NCT00887640|11580125|FG000|STARTED|Overall Study||11
10433823|NCT00887640|11580125|FG000|COMPLETED|Overall Study||11
10433824|NCT00887640|11580125|FG000|NOT COMPLETED|Overall Study||0
10433825|NCT00887653|11580129|FG000|STARTED|Overall Study||20
10433826|NCT00887653|11580129|FG000|COMPLETED|Overall Study||20
10433827|NCT00887653|11580129|FG000|NOT COMPLETED|Overall Study||0
10433828|NCT00887679|11580133|FG000|STARTED|Overall Study||30
10433829|NCT00887679|11580133|FG000|COMPLETED|Overall Study|20 subjects completed the study.|20
10433830|NCT00887679|11580133|FG000|NOT COMPLETED|Overall Study||10
10433831|NCT00887744|11580138|FG000|STARTED|Overall Study|162 patients signed an informed consent but only 157 patients were treated with the Aperius.|162
10433832|NCT00887744|11580138|FG000|COMPLETED|Overall Study||128
10433833|NCT00887744|11580138|FG000|NOT COMPLETED|Overall Study||34
10433834|NCT00887809|11580144|FG000|STARTED|Overall Study||37
10433835|NCT00887809|11580145|FG001|STARTED|Overall Study||10
10433836|NCT00887809|11580144|FG000|COMPLETED|Overall Study||33
10433837|NCT00887809|11580145|FG001|COMPLETED|Overall Study||10
10433838|NCT00887809|11580144|FG000|NOT COMPLETED|Overall Study||4
10433839|NCT00887809|11580145|FG001|NOT COMPLETED|Overall Study||0
10433840|NCT00887822|11580153|FG000|STARTED|Overall Study||100
10433841|NCT00887822|11580154|FG001|STARTED|Overall Study||102
10433842|NCT00887822|11580153|FG000|Treated (Safety Population)|Overall Study||100
10433843|NCT00887822|11580154|FG001|Treated (Safety Population)|Overall Study||101
10433844|NCT00887822|11580153|FG000|COMPLETED|Overall Study||3
10433845|NCT00887822|11580154|FG001|COMPLETED|Overall Study||0
10433846|NCT00887822|11580153|FG000|NOT COMPLETED|Overall Study||97
10433847|NCT00887822|11580154|FG001|NOT COMPLETED|Overall Study||102
10433848|NCT00887913|11580160|FG000|STARTED|Overall Study||69
10433849|NCT00887913|11580160|FG000|COMPLETED|Overall Study||63
10433850|NCT00887913|11580160|FG000|NOT COMPLETED|Overall Study||6
10433851|NCT00887926|11580168|FG000|STARTED|Overall Study||3
10433852|NCT00887926|11580169|FG001|STARTED|Overall Study||14
10433853|NCT00887926|11580170|FG002|STARTED|Overall Study||3
10433854|NCT00887926|11580171|FG003|STARTED|Overall Study||5
10433855|NCT00887926|11580168|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
10433856|NCT00887926|11580169|FG001|Received at Least 1 Dose of Study Drug|Overall Study||13
10433857|NCT00887926|11580170|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
10433858|NCT00887926|11580171|FG003|Received at Least 1 Dose of Study Drug|Overall Study||5
10433859|NCT00887926|11580168|FG000|COMPLETED|Overall Study||3
10433860|NCT00887926|11580169|FG001|COMPLETED|Overall Study||13
10433861|NCT00887926|11580170|FG002|COMPLETED|Overall Study||3
10786471|NCT03471871|11946892|FG002|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
10786472|NCT03471871|11946893|FG003|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
10786473|NCT03471871|11946894|FG004|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
10786474|NCT03471871|11946890|FG000|STARTED|Follow Up (14 Days for Both HV and OSA)||6
10786475|NCT03471871|11946891|FG001|STARTED|Follow Up (14 Days for Both HV and OSA)||5
10786476|NCT03471871|11946892|FG002|STARTED|Follow Up (14 Days for Both HV and OSA)||5
10786477|NCT03471871|11946893|FG003|STARTED|Follow Up (14 Days for Both HV and OSA)|OSA cohort was treated till Treatment Period 2 only and then entered in follow up period.|18
10786478|NCT03471871|11946894|FG004|STARTED|Follow Up (14 Days for Both HV and OSA)|OSA cohort was treated till Treatment Period 2 only and then entered in follow up period.|18
10786479|NCT03471871|11946890|FG000|COMPLETED|Follow Up (14 Days for Both HV and OSA)||6
10786480|NCT03471871|11946891|FG001|COMPLETED|Follow Up (14 Days for Both HV and OSA)||5
10786481|NCT03471871|11946892|FG002|COMPLETED|Follow Up (14 Days for Both HV and OSA)||5
10786482|NCT03471871|11946893|FG003|COMPLETED|Follow Up (14 Days for Both HV and OSA)||17
10786483|NCT03471871|11946894|FG004|COMPLETED|Follow Up (14 Days for Both HV and OSA)||17
10786484|NCT03471871|11946890|FG000|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||0
10786485|NCT03471871|11946891|FG001|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||0
10786486|NCT03471871|11946892|FG002|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||0
10786487|NCT03471871|11946893|FG003|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||1
10786488|NCT03471871|11946894|FG004|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||1
10786489|NCT03471975|11946908|FG000|STARTED|Overall Study||17
10786490|NCT03471975|11946909|FG001|STARTED|Overall Study||20
10786491|NCT03471975|11946908|FG000|COMPLETED|Overall Study||17
10786492|NCT03471975|11946909|FG001|COMPLETED|Overall Study||20
10786493|NCT03471975|11946908|FG000|NOT COMPLETED|Overall Study||0
10786494|NCT03471975|11946909|FG001|NOT COMPLETED|Overall Study||0
10786495|NCT03472014|11946915|FG000|STARTED|Overall Study||22
10786496|NCT03472014|11946915|FG000|COMPLETED|Overall Study||18
10786497|NCT03472014|11946915|FG000|NOT COMPLETED|Overall Study||4
10786498|NCT03472287|11946921|FG000|STARTED|Overall Study||8
10786499|NCT03472287|11946922|FG001|STARTED|Overall Study||3
10786500|NCT03472287|11946921|FG000|COMPLETED|Overall Study||8
10786501|NCT03472287|11946922|FG001|COMPLETED|Overall Study||3
10786502|NCT03472287|11946921|FG000|NOT COMPLETED|Overall Study||0
10786503|NCT03472287|11946922|FG001|NOT COMPLETED|Overall Study||0
10786504|NCT03472326|11946930|FG000|STARTED|Part 1: GS-9131 Functional Monotherapy||11
10786505|NCT03472326|11946931|FG001|STARTED|Part 1: GS-9131 Functional Monotherapy||10
10786506|NCT03472326|11946932|FG002|STARTED|Part 1: GS-9131 Functional Monotherapy||0
10786507|NCT03472326|11946933|FG003|STARTED|Part 1: GS-9131 Functional Monotherapy||0
10786508|NCT03472326|11946930|FG000|COMPLETED|Part 1: GS-9131 Functional Monotherapy||11
10786509|NCT03472326|11946931|FG001|COMPLETED|Part 1: GS-9131 Functional Monotherapy||10
10786510|NCT03472326|11946932|FG002|COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
10786511|NCT03472326|11946933|FG003|COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
10786512|NCT03472326|11946930|FG000|NOT COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
10786513|NCT03472326|11946931|FG001|NOT COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
10786514|NCT03472326|11946932|FG002|NOT COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
10786515|NCT03472326|11946933|FG003|NOT COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
10786516|NCT03472326|11946930|FG000|STARTED|Part 2: Combination Therapy||0
10786517|NCT03472326|11946931|FG001|STARTED|Part 2: Combination Therapy||0
10786518|NCT03472326|11946932|FG002|STARTED|Part 2: Combination Therapy|Of the participants who completed Part 1, only 1 participant entered in Part 2.|1
10786519|NCT03472326|11946933|FG003|STARTED|Part 2: Combination Therapy|Of the participants who completed Part 1, only 3 participants entered in Part 2.|3
10786520|NCT03472326|11946930|FG000|COMPLETED|Part 2: Combination Therapy||0
10786521|NCT03472326|11946931|FG001|COMPLETED|Part 2: Combination Therapy||0
10433862|NCT00887926|11580171|FG003|COMPLETED|Overall Study||5
10433863|NCT00887926|11580168|FG000|NOT COMPLETED|Overall Study||0
10433864|NCT00887926|11580169|FG001|NOT COMPLETED|Overall Study||1
10433865|NCT00887926|11580170|FG002|NOT COMPLETED|Overall Study||0
10433866|NCT00887926|11580171|FG003|NOT COMPLETED|Overall Study||0
10433867|NCT00887965|11580183|FG000|STARTED|Overall Study||15
10433868|NCT00887965|11580183|FG000|COMPLETED|Overall Study||15
10433869|NCT00887965|11580183|FG000|NOT COMPLETED|Overall Study||0
10433870|NCT00887978|11580189|FG000|STARTED|Overall Study||157
10433871|NCT00887978|11580190|FG001|STARTED|Overall Study||153
10433872|NCT00887978|11580189|FG000|COMPLETED|Overall Study||132
10433873|NCT00887978|11580190|FG001|COMPLETED|Overall Study||138
10433874|NCT00887978|11580189|FG000|NOT COMPLETED|Overall Study||25
10433875|NCT00887978|11580190|FG001|NOT COMPLETED|Overall Study||15
10433876|NCT00888134|11580196|FG000|STARTED|Treatment With Study Drug||28
10433877|NCT00888134|11580196|FG000|COMPLETED|Treatment With Study Drug|21 had progressive disease; 5 had unacceptable toxicity; 1 finished treatment|27
10433878|NCT00888134|11580196|FG000|NOT COMPLETED|Treatment With Study Drug||1
10433879|NCT00888134|11580196|FG000|STARTED|Follow-up||27
10433880|NCT00888134|11580196|FG000|COMPLETED|Follow-up|23 died; 3 were lost-to-follow-up|26
10433881|NCT00888134|11580196|FG000|NOT COMPLETED|Follow-up||1
10433882|NCT00888173|11580201|FG000|STARTED|Overall Study||45
10433883|NCT00888173|11580201|FG000|COMPLETED|Overall Study||43
10433884|NCT00888173|11580201|FG000|NOT COMPLETED|Overall Study||2
10433885|NCT00888238|11580205|FG000|STARTED|First Period of Treatment Intervention||4
10433886|NCT00888238|11580206|FG001|STARTED|First Period of Treatment Intervention||4
10433887|NCT00888238|11580207|FG002|STARTED|First Period of Treatment Intervention||4
10433888|NCT00888238|11580205|FG000|COMPLETED|First Period of Treatment Intervention||4
10433889|NCT00888238|11580206|FG001|COMPLETED|First Period of Treatment Intervention||4
10433890|NCT00888238|11580207|FG002|COMPLETED|First Period of Treatment Intervention||4
10433891|NCT00888238|11580205|FG000|NOT COMPLETED|First Period of Treatment Intervention||0
10433892|NCT00888238|11580206|FG001|NOT COMPLETED|First Period of Treatment Intervention||0
10786522|NCT03472326|11946932|FG002|COMPLETED|Part 2: Combination Therapy||0
10786523|NCT03472326|11946933|FG003|COMPLETED|Part 2: Combination Therapy||0
10786524|NCT03472326|11946930|FG000|NOT COMPLETED|Part 2: Combination Therapy||0
10786525|NCT03472326|11946931|FG001|NOT COMPLETED|Part 2: Combination Therapy||0
10786526|NCT03472326|11946932|FG002|NOT COMPLETED|Part 2: Combination Therapy||1
10786527|NCT03472326|11946933|FG003|NOT COMPLETED|Part 2: Combination Therapy||3
10786528|NCT03472469|11946944|FG000|STARTED|Overall Study||787
10786529|NCT03472469|11946945|FG001|STARTED|Overall Study||774
10786530|NCT03472469|11946944|FG000|COMPLETED|Overall Study||787
10786531|NCT03472469|11946945|FG001|COMPLETED|Overall Study||774
10786532|NCT03472469|11946944|FG000|NOT COMPLETED|Overall Study||0
10786533|NCT03472469|11946945|FG001|NOT COMPLETED|Overall Study||0
10786534|NCT03472534|11946951|FG000|STARTED|Overall Study|Each participant receives all 4 unit interventions.|46
10786535|NCT03472534|11946951|FG000|Diacerein 1% Ointment|Overall Study||46
10786536|NCT03472534|11946951|FG000|Vehicle Ointment|Overall Study||46
10786537|NCT03472534|11946951|FG000|0.2% Sodium Lauryl Sulfate (SLS)|Overall Study||46
10786538|NCT03472534|11946951|FG000|0.9% Saline|Overall Study||46
10786539|NCT03472534|11946951|FG000|COMPLETED|Overall Study||35
10786540|NCT03472534|11946951|FG000|NOT COMPLETED|Overall Study||11
10786541|NCT03472547|11946955|FG000|STARTED|Overall Study||234
10786542|NCT03472547|11946955|FG000|COMPLETED|Overall Study||204
10786543|NCT03472547|11946955|FG000|NOT COMPLETED|Overall Study||30
10786544|NCT03473171|11946959|FG000|STARTED|Overall Study||5
10786545|NCT03473171|11946959|FG000|COMPLETED|Overall Study||5
10786546|NCT03473171|11946959|FG000|NOT COMPLETED|Overall Study||0
10786547|NCT03473184|11946963|FG000|STARTED|Overall Study||34
10786548|NCT03473184|11946963|FG000|Diacerein 1% Ointment Irradiated|Overall Study||34
10786549|NCT03473184|11946963|FG000|Vehicle Ointment Irradiated|Overall Study||34
10786550|NCT03473184|11946963|FG000|Diacerein 1% Ointment Non-irradiated|Overall Study||34
10786551|NCT03473184|11946963|FG000|Vehicle Ointment Non-irradiated|Overall Study||34
10786552|NCT03473184|11946963|FG000|Untreated Irradiated|Overall Study||34
10786553|NCT03473184|11946963|FG000|COMPLETED|Overall Study||34
10786554|NCT03473184|11946963|FG000|NOT COMPLETED|Overall Study||0
10786555|NCT03473197|11946967|FG000|STARTED|Overall Study||61
10786556|NCT03473197|11946967|FG000|Diacerein 1% Ointment Irradiated|Overall Study||51
10786557|NCT03473197|11946967|FG000|Vehicle Ointment Irradiated|Overall Study||51
10786558|NCT03473197|11946967|FG000|Diacerein 1% Ointment Non-irradiated|Overall Study||51
10786559|NCT03473197|11946967|FG000|Vehicle Ointment Non-irradiated|Overall Study||51
10786560|NCT03473197|11946967|FG000|Untreated Irradiated|Overall Study||51
10786561|NCT03473197|11946967|FG000|COMPLETED|Overall Study||51
10786562|NCT03473197|11946967|FG000|NOT COMPLETED|Overall Study||10
10786563|NCT03473236|11946981|FG000|STARTED|Overall Study||10
10786564|NCT03473236|11946982|FG001|STARTED|Overall Study||6
10786565|NCT03473236|11946983|FG002|STARTED|Overall Study||6
10786566|NCT03473236|11946984|FG003|STARTED|Overall Study||6
10786567|NCT03473236|11946985|FG004|STARTED|Overall Study||6
10786568|NCT03473236|11946986|FG005|STARTED|Overall Study||7
10786569|NCT03473236|11946987|FG006|STARTED|Overall Study||6
10786570|NCT03473236|11946988|FG007|STARTED|Overall Study||6
10786571|NCT03473236|11946989|FG008|STARTED|Overall Study||7
10433893|NCT00888238|11580207|FG002|NOT COMPLETED|First Period of Treatment Intervention||0
10433894|NCT00888238|11580205|FG000|STARTED|Washout Period After Period 1||4
10433895|NCT00888238|11580206|FG001|STARTED|Washout Period After Period 1||4
10549439|NCT01525407|11703446|FG000|COMPLETED|Overall Study||38
10549440|NCT01525407|11703447|FG001|COMPLETED|Overall Study||38
10786572|NCT03473236|11946990|FG009|STARTED|Overall Study||6
10786573|NCT03473236|11946981|FG000|COMPLETED|Overall Study||10
10786574|NCT03473236|11946982|FG001|COMPLETED|Overall Study||6
10786575|NCT03473236|11946983|FG002|COMPLETED|Overall Study||6
10786576|NCT03473236|11946984|FG003|COMPLETED|Overall Study||6
10786577|NCT03473236|11946985|FG004|COMPLETED|Overall Study||6
10786578|NCT03473236|11946986|FG005|COMPLETED|Overall Study||6
10786579|NCT03473236|11946987|FG006|COMPLETED|Overall Study||6
10786580|NCT03473236|11946988|FG007|COMPLETED|Overall Study||6
10786581|NCT03473236|11946989|FG008|COMPLETED|Overall Study||6
10786582|NCT03473236|11946990|FG009|COMPLETED|Overall Study||6
10786583|NCT03473236|11946981|FG000|NOT COMPLETED|Overall Study||0
10786584|NCT03473236|11946982|FG001|NOT COMPLETED|Overall Study||0
10786585|NCT03473236|11946983|FG002|NOT COMPLETED|Overall Study||0
10786586|NCT03473236|11946984|FG003|NOT COMPLETED|Overall Study||0
10786587|NCT03473236|11946985|FG004|NOT COMPLETED|Overall Study||0
10433896|NCT00888238|11580207|FG002|STARTED|Washout Period After Period 1||4
10433897|NCT00888238|11580205|FG000|COMPLETED|Washout Period After Period 1||4
10433898|NCT00888238|11580206|FG001|COMPLETED|Washout Period After Period 1||4
10433899|NCT00888238|11580207|FG002|COMPLETED|Washout Period After Period 1||4
10433900|NCT00888238|11580205|FG000|NOT COMPLETED|Washout Period After Period 1||0
10433901|NCT00888238|11580206|FG001|NOT COMPLETED|Washout Period After Period 1||0
10433902|NCT00888238|11580207|FG002|NOT COMPLETED|Washout Period After Period 1||0
10433903|NCT00888238|11580205|FG000|STARTED|Second Period of Treatment Intervention||4
10433904|NCT00888238|11580206|FG001|STARTED|Second Period of Treatment Intervention||4
10433905|NCT00888238|11580207|FG002|STARTED|Second Period of Treatment Intervention||4
10433906|NCT00888238|11580205|FG000|COMPLETED|Second Period of Treatment Intervention||4
10433907|NCT00888238|11580206|FG001|COMPLETED|Second Period of Treatment Intervention||4
10433908|NCT00888238|11580207|FG002|COMPLETED|Second Period of Treatment Intervention||4
10433909|NCT00888238|11580205|FG000|NOT COMPLETED|Second Period of Treatment Intervention||0
10433910|NCT00888238|11580206|FG001|NOT COMPLETED|Second Period of Treatment Intervention||0
10433911|NCT00888238|11580207|FG002|NOT COMPLETED|Second Period of Treatment Intervention||0
10433912|NCT00888238|11580205|FG000|STARTED|Washout Period After Period 2||4
10433913|NCT00888238|11580206|FG001|STARTED|Washout Period After Period 2||4
10433914|NCT00888238|11580207|FG002|STARTED|Washout Period After Period 2||4
10433915|NCT00888238|11580205|FG000|COMPLETED|Washout Period After Period 2||4
10433916|NCT00888238|11580206|FG001|COMPLETED|Washout Period After Period 2||4
10433917|NCT00888238|11580207|FG002|COMPLETED|Washout Period After Period 2||3
10433918|NCT00888238|11580205|FG000|NOT COMPLETED|Washout Period After Period 2||0
10433919|NCT00888238|11580206|FG001|NOT COMPLETED|Washout Period After Period 2||0
10433920|NCT00888238|11580207|FG002|NOT COMPLETED|Washout Period After Period 2||1
10433921|NCT00888238|11580205|FG000|STARTED|Third Period of Treatment Intervention||4
10433922|NCT00888238|11580206|FG001|STARTED|Third Period of Treatment Intervention||4
10433923|NCT00888238|11580207|FG002|STARTED|Third Period of Treatment Intervention||3
10433924|NCT00888238|11580205|FG000|COMPLETED|Third Period of Treatment Intervention||4
10433925|NCT00888238|11580206|FG001|COMPLETED|Third Period of Treatment Intervention||4
10433926|NCT00888238|11580207|FG002|COMPLETED|Third Period of Treatment Intervention||3
10433927|NCT00888238|11580205|FG000|NOT COMPLETED|Third Period of Treatment Intervention||0
10433928|NCT00888238|11580206|FG001|NOT COMPLETED|Third Period of Treatment Intervention||0
10433929|NCT00888238|11580207|FG002|NOT COMPLETED|Third Period of Treatment Intervention||0
10433930|NCT00888329|11580215|FG000|STARTED|Overall Study||125
10433931|NCT00888329|11580216|FG001|STARTED|Overall Study||131
10433932|NCT00888329|11580215|FG000|COMPLETED|Overall Study||119
10433933|NCT00888329|11580216|FG001|COMPLETED|Overall Study||122
10433934|NCT00888329|11580215|FG000|NOT COMPLETED|Overall Study||6
10433935|NCT00888329|11580216|FG001|NOT COMPLETED|Overall Study||9
10433936|NCT00888381|11580224|FG000|STARTED|Overall Study||60
10433937|NCT00888381|11580225|FG001|STARTED|Overall Study||60
10433938|NCT00888381|11580224|FG000|COMPLETED|Overall Study||60
10433939|NCT00888381|11580225|FG001|COMPLETED|Overall Study||59
10433940|NCT00888381|11580224|FG000|NOT COMPLETED|Overall Study||0
10433941|NCT00888381|11580225|FG001|NOT COMPLETED|Overall Study||1
10433942|NCT00888433|11580233|FG000|STARTED|Overall Study||52
10433943|NCT00888433|11580234|FG001|STARTED|Overall Study||54
10433944|NCT00888433|11580233|FG000|COMPLETED|Overall Study||49
10433945|NCT00888433|11580234|FG001|COMPLETED|Overall Study||51
10433946|NCT00888433|11580233|FG000|NOT COMPLETED|Overall Study||3
10433947|NCT00888433|11580234|FG001|NOT COMPLETED|Overall Study||3
10433948|NCT00888459|11580242|FG000|STARTED|Overall Study||30
10433949|NCT00888459|11580243|FG001|STARTED|Overall Study||30
10433950|NCT00888459|11580242|FG000|COMPLETED|Overall Study||30
10433951|NCT00888459|11580243|FG001|COMPLETED|Overall Study||30
10433952|NCT00888459|11580242|FG000|NOT COMPLETED|Overall Study||0
10433953|NCT00888459|11580243|FG001|NOT COMPLETED|Overall Study||0
10433954|NCT00888511|11580249|FG000|STARTED|Overall Study||15
10433955|NCT00888511|11580249|FG000|COMPLETED|Overall Study||15
10433956|NCT00888511|11580249|FG000|NOT COMPLETED|Overall Study||0
10433957|NCT00888615|11580253|FG000|STARTED|Overall Study||58
10433958|NCT00888615|11580253|FG000|COMPLETED|Overall Study||56
10433959|NCT00888615|11580253|FG000|NOT COMPLETED|Overall Study||2
10525225|NCT01374178|11677074|FG001|STARTED|Period 2 (up to 24 Hours After Dosing)||5
10525226|NCT01374178|11677073|FG000|COMPLETED|Period 2 (up to 24 Hours After Dosing)||8
10525227|NCT01374178|11677074|FG001|COMPLETED|Period 2 (up to 24 Hours After Dosing)||5
10525228|NCT01374178|11677073|FG000|NOT COMPLETED|Period 2 (up to 24 Hours After Dosing)||2
10525229|NCT01374178|11677074|FG001|NOT COMPLETED|Period 2 (up to 24 Hours After Dosing)||0
10525230|NCT01374217|11677080|FG000|STARTED|Overall Study||13
10525231|NCT01374217|11677080|FG000|COMPLETED|Overall Study||0
10525232|NCT01374217|11677080|FG000|NOT COMPLETED|Overall Study||13
10525233|NCT01374269|11677086|FG000|STARTED|Overall Study||46
10525234|NCT01374269|11677087|FG001|STARTED|Overall Study||44
10525235|NCT01374269|11677086|FG000|COMPLETED|Overall Study||40
10525236|NCT01374269|11677087|FG001|COMPLETED|Overall Study||39
10786588|NCT03473236|11946986|FG005|NOT COMPLETED|Overall Study||1
10433960|NCT00888628|11580257|FG000|STARTED|Overall Study||7
10433961|NCT00888628|11580257|FG000|Enrolled|Overall Study||7
10433962|NCT00888628|11580257|FG000|Screen Failure|Overall Study||2
10433963|NCT00888628|11580257|FG000|Withdrawn|Overall Study||1
10433964|NCT00888628|11580257|FG000|Transplanted|Overall Study||4
10433965|NCT00888628|11580257|FG000|COMPLETED|Overall Study||4
10433966|NCT00888628|11580257|FG000|NOT COMPLETED|Overall Study||3
10433967|NCT00888654|11580261|FG000|STARTED|Overall Study||41
10433968|NCT00888654|11580261|FG000|COMPLETED|Overall Study||31
10433969|NCT00888654|11580261|FG000|NOT COMPLETED|Overall Study||10
10433970|NCT00888849|11580267|FG000|STARTED|Overall Study||142
10433971|NCT00888849|11580268|FG001|STARTED|Overall Study||138
10433972|NCT00888849|11580267|FG000|COMPLETED|Overall Study||137
10433973|NCT00888849|11580268|FG001|COMPLETED|Overall Study||129
10433974|NCT00888849|11580267|FG000|NOT COMPLETED|Overall Study||5
10433975|NCT00888849|11580268|FG001|NOT COMPLETED|Overall Study||9
10433976|NCT00888927|11580278|FG000|STARTED|Overall Study||3
10549441|NCT01525407|11703446|FG000|NOT COMPLETED|Overall Study||3
10549442|NCT01525407|11703447|FG001|NOT COMPLETED|Overall Study||4
10549443|NCT01525420|11703455|FG000|STARTED|Overall Study||59
10549444|NCT01525420|11703456|FG001|STARTED|Overall Study||62
10549445|NCT01525420|11703455|FG000|COMPLETED|Overall Study||43
10549446|NCT01525420|11703456|FG001|COMPLETED|Overall Study||38
10549447|NCT01525420|11703455|FG000|NOT COMPLETED|Overall Study||16
10549448|NCT01525420|11703456|FG001|NOT COMPLETED|Overall Study||24
10549449|NCT01525550|11703464|FG000|STARTED|Overall Study||61
10549450|NCT01525550|11703465|FG001|STARTED|Overall Study||45
10549451|NCT01525550|11703464|FG000|COMPLETED|Overall Study||0
10549452|NCT01525550|11703465|FG001|COMPLETED|Overall Study||0
10549453|NCT01525550|11703464|FG000|NOT COMPLETED|Overall Study||61
10786589|NCT03473236|11946987|FG006|NOT COMPLETED|Overall Study||0
10786590|NCT03473236|11946988|FG007|NOT COMPLETED|Overall Study||0
10786591|NCT03473236|11946989|FG008|NOT COMPLETED|Overall Study||1
10786592|NCT03473236|11946990|FG009|NOT COMPLETED|Overall Study||0
10786593|NCT03473301|11947023|FG000|STARTED|Overall Study||31
10786594|NCT03473301|11947024|FG001|STARTED|Overall Study||29
10786595|NCT03473301|11947025|FG002|STARTED|Overall Study||31
10786596|NCT03473301|11947023|FG000|COMPLETED|Overall Study||20
10786597|NCT03473301|11947024|FG001|COMPLETED|Overall Study||23
10786598|NCT03473301|11947025|FG002|COMPLETED|Overall Study||25
10786599|NCT03473301|11947023|FG000|NOT COMPLETED|Overall Study||11
10786600|NCT03473301|11947024|FG001|NOT COMPLETED|Overall Study||6
10786601|NCT03473301|11947025|FG002|NOT COMPLETED|Overall Study||6
10786602|NCT03473665|11947035|FG000|STARTED|Overall Study||9
10786603|NCT03473665|11947035|FG000|COMPLETED|Overall Study||9
10786604|NCT03473665|11947035|FG000|NOT COMPLETED|Overall Study||0
10786605|NCT03473808|11947044|FG000|STARTED|Overall Study||5
10786606|NCT03473808|11947044|FG000|COMPLETED|Overall Study||4
10786607|NCT03473808|11947044|FG000|NOT COMPLETED|Overall Study||1
10786608|NCT03473886|11947048|FG000|STARTED|Overall Study||8
10786609|NCT03473886|11947048|FG000|COMPLETED|Overall Study||7
10786610|NCT03473886|11947048|FG000|NOT COMPLETED|Overall Study||1
10786611|NCT03474081|11947054|FG000|STARTED|Overall Study||400
10786612|NCT03474081|11947055|FG001|STARTED|Overall Study||400
10786613|NCT03474081|11947054|FG000|Received Study Treatment|Overall Study||400
10786614|NCT03474081|11947055|FG001|Received Study Treatment|Overall Study|One randomized participant withdrew consent and never received study treatment.|399
10786615|NCT03474081|11947054|FG000|COMPLETED|Overall Study||383
10786616|NCT03474081|11947055|FG001|COMPLETED|Overall Study||387
10786617|NCT03474081|11947054|FG000|NOT COMPLETED|Overall Study||17
10786618|NCT03474081|11947055|FG001|NOT COMPLETED|Overall Study||13
10786619|NCT03474172|11947063|FG000|STARTED|Overall Study||30
10786620|NCT03474172|11947064|FG001|STARTED|Overall Study||30
10786621|NCT03474172|11947063|FG000|COMPLETED|Overall Study||30
10786622|NCT03474172|11947064|FG001|COMPLETED|Overall Study||30
10786623|NCT03474172|11947063|FG000|NOT COMPLETED|Overall Study||0
10786624|NCT03474172|11947064|FG001|NOT COMPLETED|Overall Study||0
10786625|NCT03474406|11947073|FG000|STARTED|Overall Study||150
10786626|NCT03474406|11947073|FG000|COMPLETED|Overall Study||72
10786627|NCT03474406|11947073|FG000|NOT COMPLETED|Overall Study||78
10433977|NCT00888927|11580279|FG001|STARTED|Overall Study||3
10549454|NCT01525550|11703465|FG001|NOT COMPLETED|Overall Study||45
10549455|NCT01525563|11703471|FG000|STARTED|Overall Study||1000
10549456|NCT01525563|11703471|FG000|End of Treatment|Overall Study|Only patients who had cycle regularization at end of treatment were allowed to continue.|910
10549457|NCT01525563|11703471|FG000|3 Months Follow-up|Overall Study|Only patients who had cycle regularization at end of treatment were allowed to continue.|838
10549458|NCT01525563|11703471|FG000|COMPLETED|Overall Study|6 Months Follow-up|788
10549459|NCT01525563|11703471|FG000|NOT COMPLETED|Overall Study||212
10786628|NCT03474874|11947077|FG000|STARTED|Overall Study||68
10433978|NCT00888927|11580280|FG002|STARTED|Overall Study||3
10433979|NCT00888927|11580281|FG003|STARTED|Overall Study||33
10433980|NCT00888927|11580278|FG000|COMPLETED|Overall Study||3
10433981|NCT00888927|11580279|FG001|COMPLETED|Overall Study||3
10433982|NCT00888927|11580280|FG002|COMPLETED|Overall Study||3
10433983|NCT00888927|11580281|FG003|COMPLETED|Overall Study||31
10433984|NCT00888927|11580278|FG000|NOT COMPLETED|Overall Study||0
10433985|NCT00888927|11580279|FG001|NOT COMPLETED|Overall Study||0
10786629|NCT03474874|11947077|FG000|COMPLETED|Overall Study||54
10786630|NCT03474874|11947077|FG000|NOT COMPLETED|Overall Study||14
10433986|NCT00888927|11580280|FG002|NOT COMPLETED|Overall Study||0
10433987|NCT00888927|11580281|FG003|NOT COMPLETED|Overall Study||2
10433988|NCT00888940|11580293|FG000|STARTED|Overall Study||120
10433989|NCT00888940|11580294|FG001|STARTED|Overall Study||122
10433990|NCT00888940|11580293|FG000|Completed Therapy|Overall Study||107
10433991|NCT00888940|11580294|FG001|Completed Therapy|Overall Study||106
10433992|NCT00888940|11580293|FG000|COMPLETED|Overall Study||92
10433993|NCT00888940|11580294|FG001|COMPLETED|Overall Study||101
10433994|NCT00888940|11580293|FG000|NOT COMPLETED|Overall Study||28
10433995|NCT00888940|11580294|FG001|NOT COMPLETED|Overall Study||21
10433996|NCT00888979|11580300|FG000|STARTED|Overall Study||10
10433997|NCT00888979|11580300|FG000|Received the Inhaler/Counseling|Overall Study||8
10433998|NCT00888979|11580300|FG000|COMPLETED|Overall Study||6
10433999|NCT00888979|11580300|FG000|NOT COMPLETED|Overall Study||4
10434000|NCT00889005|11580306|FG000|STARTED|Overall Study||65
10434001|NCT00889005|11580307|FG001|STARTED|Overall Study||74
10434002|NCT00889005|11580306|FG000|COMPLETED|Overall Study||57
10434003|NCT00889005|11580307|FG001|COMPLETED|Overall Study||72
10434004|NCT00889005|11580306|FG000|NOT COMPLETED|Overall Study||8
10434005|NCT00889005|11580307|FG001|NOT COMPLETED|Overall Study||2
10434006|NCT00889187|11580313|FG000|STARTED|Overall Study||3
10434007|NCT00889187|11580314|FG001|STARTED|Overall Study||3
10434008|NCT00889187|11580315|FG002|STARTED|Overall Study||4
10434009|NCT00889187|11580316|FG003|STARTED|Overall Study||0
10434010|NCT00889187|11580313|FG000|COMPLETED|Overall Study||3
10434011|NCT00889187|11580314|FG001|COMPLETED|Overall Study||3
10434012|NCT00889187|11580315|FG002|COMPLETED|Overall Study||4
10434013|NCT00889187|11580316|FG003|COMPLETED|Overall Study||0
10434014|NCT00889187|11580313|FG000|NOT COMPLETED|Overall Study||0
10434015|NCT00889187|11580314|FG001|NOT COMPLETED|Overall Study||0
10434016|NCT00889187|11580315|FG002|NOT COMPLETED|Overall Study||0
10434017|NCT00889187|11580316|FG003|NOT COMPLETED|Overall Study||0
10434018|NCT00889200|11580326|FG000|STARTED|Overall Study||12
10434019|NCT00889200|11580326|FG000|COMPLETED|Overall Study||12
10434020|NCT00889200|11580326|FG000|NOT COMPLETED|Overall Study||0
10434021|NCT00889226|11580332|FG000|STARTED|Overall Study||83
10434022|NCT00889226|11580333|FG001|STARTED|Overall Study||78
10434023|NCT00889226|11580332|FG000|COMPLETED|Overall Study||58
10434024|NCT00889226|11580333|FG001|COMPLETED|Overall Study||43
10434025|NCT00889226|11580332|FG000|NOT COMPLETED|Overall Study||25
10434026|NCT00889226|11580333|FG001|NOT COMPLETED|Overall Study||35
10434027|NCT00889252|11580341|FG000|STARTED|Overall Study||168
10786639|NCT03475316|11947095|FG000|STARTED|6 Month Intervention||13
10786640|NCT03475316|11947096|FG001|STARTED|6 Month Intervention||12
10786641|NCT03475316|11947095|FG000|COMPLETED|6 Month Intervention||8
10786642|NCT03475316|11947096|FG001|COMPLETED|6 Month Intervention||8
10786643|NCT03475316|11947095|FG000|NOT COMPLETED|6 Month Intervention||5
10786644|NCT03475316|11947096|FG001|NOT COMPLETED|6 Month Intervention||4
10786645|NCT03475316|11947095|FG000|STARTED|9 Months||8
10786646|NCT03475316|11947096|FG001|STARTED|9 Months||8
10786647|NCT03475316|11947095|FG000|COMPLETED|9 Months||5
10786648|NCT03475316|11947096|FG001|COMPLETED|9 Months||4
10786649|NCT03475316|11947095|FG000|NOT COMPLETED|9 Months||3
10786650|NCT03475316|11947096|FG001|NOT COMPLETED|9 Months||4
10786651|NCT03475875|11947102|FG000|STARTED|Period 1||46
10786652|NCT03475875|11947103|FG001|STARTED|Period 1||45
10786653|NCT03475875|11947102|FG000|COMPLETED|Period 1||43
10786654|NCT03475875|11947103|FG001|COMPLETED|Period 1||44
10786655|NCT03475875|11947102|FG000|NOT COMPLETED|Period 1||3
10786656|NCT03475875|11947103|FG001|NOT COMPLETED|Period 1||1
10786657|NCT03475875|11947102|FG000|STARTED|Period 2||43
10786658|NCT03475875|11947103|FG001|STARTED|Period 2||44
10786659|NCT03475875|11947102|FG000|COMPLETED|Period 2||40
10786660|NCT03475875|11947103|FG001|COMPLETED|Period 2||43
10786661|NCT03475875|11947102|FG000|NOT COMPLETED|Period 2||3
10786662|NCT03475875|11947103|FG001|NOT COMPLETED|Period 2||1
10786663|NCT03475875|11947102|FG000|STARTED|Period 3||40
10786664|NCT03475875|11947103|FG001|STARTED|Period 3||43
10786665|NCT03475875|11947102|FG000|COMPLETED|Period 3||40
10434028|NCT00889252|11580342|FG001|STARTED|Overall Study||82
10434029|NCT00889252|11580341|FG000|COMPLETED|Overall Study||161
10434030|NCT00889252|11580342|FG001|COMPLETED|Overall Study||78
10434031|NCT00889252|11580341|FG000|NOT COMPLETED|Overall Study||7
10434032|NCT00889252|11580342|FG001|NOT COMPLETED|Overall Study||4
10434033|NCT00889265|11580348|FG000|STARTED|Overall Study|Date Enrollment Started: 07/21/2009 Date Enrollment Completed: 02/15/2011 Total enrolled: 51|51
10434034|NCT00889265|11580348|FG000|COMPLETED|Overall Study||44
10434035|NCT00889265|11580348|FG000|NOT COMPLETED|Overall Study||7
10434036|NCT00889330|11580354|FG000|STARTED|Overall Study||30
10786666|NCT03475875|11947103|FG001|COMPLETED|Period 3||43
10786667|NCT03475875|11947102|FG000|NOT COMPLETED|Period 3||0
10786668|NCT03475875|11947103|FG001|NOT COMPLETED|Period 3||0
10786669|NCT03475992|11947112|FG000|STARTED|Overall Study||11
10786670|NCT03475992|11947113|FG001|STARTED|Overall Study||9
10786671|NCT03475992|11947114|FG002|STARTED|Overall Study||5
10786672|NCT03475992|11947112|FG000|COMPLETED|Overall Study||11
10786673|NCT03475992|11947113|FG001|COMPLETED|Overall Study||9
10786674|NCT03475992|11947114|FG002|COMPLETED|Overall Study||5
10786675|NCT03475992|11947112|FG000|NOT COMPLETED|Overall Study||0
10434037|NCT00889330|11580355|FG001|STARTED|Overall Study||30
10434038|NCT00889330|11580354|FG000|COMPLETED|Overall Study||30
10434039|NCT00889330|11580355|FG001|COMPLETED|Overall Study||30
10434040|NCT00889330|11580354|FG000|NOT COMPLETED|Overall Study||0
10434041|NCT00889330|11580355|FG001|NOT COMPLETED|Overall Study||0
10434042|NCT00889512|11580363|FG000|STARTED|Overall Study||5
10434043|NCT00889512|11580364|FG001|STARTED|Overall Study||9
10434044|NCT00889512|11580363|FG000|COMPLETED|Overall Study||5
10434045|NCT00889512|11580364|FG001|COMPLETED|Overall Study||9
10434046|NCT00889512|11580363|FG000|NOT COMPLETED|Overall Study||0
10434047|NCT00889512|11580364|FG001|NOT COMPLETED|Overall Study||0
10434048|NCT00889603|11580370|FG000|STARTED|Overall Study||370
10434049|NCT00889603|11580370|FG000|COMPLETED|Overall Study||333
10434050|NCT00889603|11580370|FG000|NOT COMPLETED|Overall Study||37
10434051|NCT00889681|11580374|FG000|STARTED|Overall Study||81
10434052|NCT00889681|11580374|FG000|Received Treatment|Overall Study||78
10434053|NCT00889681|11580374|FG000|COMPLETED|Overall Study||78
10434054|NCT00889681|11580374|FG000|NOT COMPLETED|Overall Study||3
10434055|NCT00889707|11580380|FG000|STARTED|Overall Study||61
10434056|NCT00889707|11580381|FG001|STARTED|Overall Study||31
10434057|NCT00889707|11580380|FG000|COMPLETED|Overall Study||54
10434058|NCT00889707|11580381|FG001|COMPLETED|Overall Study||21
10434059|NCT00889707|11580380|FG000|NOT COMPLETED|Overall Study||7
10434060|NCT00889707|11580381|FG001|NOT COMPLETED|Overall Study||10
10434061|NCT00889720|11580387|FG000|STARTED|Overall Study||16
10434062|NCT00889720|11580387|FG000|Surgical Population|Overall Study||12
10434063|NCT00889720|11580387|FG000|COMPLETED|Overall Study||8
10434064|NCT00889720|11580387|FG000|NOT COMPLETED|Overall Study||8
10434065|NCT00889824|11580391|FG000|STARTED|Overall Study||5
10434066|NCT00889824|11580391|FG000|COMPLETED|Overall Study||5
10434067|NCT00889824|11580391|FG000|NOT COMPLETED|Overall Study||0
10434068|NCT00889863|11580395|FG000|STARTED|Part I: Open Label||177
10434069|NCT00889863|11580396|FG001|STARTED|Part I: Open Label|No participants received placebo in Part I.|0
10434070|NCT00889863|11580395|FG000|Entered Part Ia|Part I: Open Label||145
10434071|NCT00889863|11580396|FG001|Entered Part Ia|Part I: Open Label||0
10434072|NCT00889863|11580395|FG000|Entered Part Ib|Part I: Open Label||142
10434073|NCT00889863|11580396|FG001|Entered Part Ib|Part I: Open Label||0
10434074|NCT00889863|11580395|FG000|Entered Part Ic|Part I: Open Label|Patients steroid free at study entry entered Part Id directly and did not participate in Part Ic.|92
10434075|NCT00889863|11580396|FG001|Entered Part Ic|Part I: Open Label||0
10434076|NCT00889863|11580395|FG000|Entered Part 1d|Part I: Open Label||103
10434077|NCT00889863|11580396|FG001|Entered Part 1d|Part I: Open Label||0
10786676|NCT03475992|11947113|FG001|NOT COMPLETED|Overall Study||0
10786677|NCT03475992|11947114|FG002|NOT COMPLETED|Overall Study||0
10786678|NCT03476278|11947122|FG000|STARTED|Overall Study||300
10786679|NCT03476278|11947122|FG000|COMPLETED|Overall Study||300
10786680|NCT03476278|11947122|FG000|NOT COMPLETED|Overall Study||0
10786684|NCT03476850|11947142|FG000|STARTED|Overall Study||24
10786685|NCT03476850|11947143|FG001|STARTED|Overall Study||24
10786686|NCT03476850|11947142|FG000|COMPLETED|Overall Study||24
10786687|NCT03476850|11947143|FG001|COMPLETED|Overall Study||24
10786688|NCT03476850|11947142|FG000|NOT COMPLETED|Overall Study||0
10786689|NCT03476850|11947143|FG001|NOT COMPLETED|Overall Study||0
10786690|NCT03477006|11947151|FG000|STARTED|Overall Study||40
10786691|NCT03477006|11947152|FG001|STARTED|Overall Study||46
10786692|NCT03477006|11947151|FG000|COMPLETED|Overall Study||40
10786693|NCT03477006|11947152|FG001|COMPLETED|Overall Study||46
10786694|NCT03477006|11947151|FG000|NOT COMPLETED|Overall Study||0
10786695|NCT03477006|11947152|FG001|NOT COMPLETED|Overall Study||0
10786696|NCT03477279|11947163|FG000|STARTED|Overall Study||250
10786697|NCT03477279|11947164|FG001|STARTED|Overall Study||250
10786698|NCT03477279|11947165|FG002|STARTED|Overall Study||98
10786699|NCT03477279|11947166|FG003|STARTED|Overall Study||168
10786700|NCT03477279|11947167|FG004|STARTED|Overall Study||350
10786701|NCT03477279|11947163|FG000|COMPLETED|Overall Study||203
10786702|NCT03477279|11947164|FG001|COMPLETED|Overall Study||202
10786703|NCT03477279|11947165|FG002|COMPLETED|Overall Study||98
10786704|NCT03477279|11947166|FG003|COMPLETED|Overall Study||136
10786705|NCT03477279|11947167|FG004|COMPLETED|Overall Study||349
10434078|NCT00889863|11580395|FG000|COMPLETED|Part I: Open Label||100
10434079|NCT00889863|11580396|FG001|COMPLETED|Part I: Open Label||0
10434080|NCT00889863|11580395|FG000|NOT COMPLETED|Part I: Open Label||77
10434081|NCT00889863|11580396|FG001|NOT COMPLETED|Part I: Open Label||0
10434082|NCT00889863|11580395|FG000|STARTED|Part II: Randomized Double Blind||50
10434083|NCT00889863|11580396|FG001|STARTED|Part II: Randomized Double Blind||50
10434084|NCT00889863|11580395|FG000|COMPLETED|Part II: Randomized Double Blind||39
10434085|NCT00889863|11580396|FG001|COMPLETED|Part II: Randomized Double Blind||24
10434086|NCT00889863|11580395|FG000|NOT COMPLETED|Part II: Randomized Double Blind||11
10434087|NCT00889863|11580396|FG001|NOT COMPLETED|Part II: Randomized Double Blind||26
10434088|NCT00889915|11580408|FG000|STARTED|Overall Study||37
10786706|NCT03477279|11947163|FG000|NOT COMPLETED|Overall Study||47
10786707|NCT03477279|11947164|FG001|NOT COMPLETED|Overall Study||48
10786708|NCT03477279|11947165|FG002|NOT COMPLETED|Overall Study||0
10434089|NCT00889915|11580409|FG001|STARTED|Overall Study||76
10434090|NCT00889915|11580410|FG002|STARTED|Overall Study||67
10434091|NCT00889915|11580411|FG003|STARTED|Overall Study||48
10434092|NCT00889915|11580408|FG000|COMPLETED|Overall Study||35
10786709|NCT03477279|11947166|FG003|NOT COMPLETED|Overall Study||32
10786710|NCT03477279|11947167|FG004|NOT COMPLETED|Overall Study||1
10786711|NCT03477838|11947180|FG000|STARTED|Overall Study||28
10786712|NCT03477838|11947180|FG000|COMPLETED|Overall Study||14
10786713|NCT03477838|11947180|FG000|NOT COMPLETED|Overall Study||14
10786714|NCT03478163|11947186|FG000|STARTED|Overall Study||5
10434093|NCT00889915|11580409|FG001|COMPLETED|Overall Study||71
10434094|NCT00889915|11580410|FG002|COMPLETED|Overall Study||54
10434095|NCT00889915|11580411|FG003|COMPLETED|Overall Study||40
10434096|NCT00889915|11580408|FG000|NOT COMPLETED|Overall Study||2
10434097|NCT00889915|11580409|FG001|NOT COMPLETED|Overall Study||5
10434098|NCT00889915|11580410|FG002|NOT COMPLETED|Overall Study||13
10434099|NCT00889915|11580411|FG003|NOT COMPLETED|Overall Study||8
10434100|NCT00889928|11580421|FG000|STARTED|Overall Study||7
10434101|NCT00889928|11580421|FG000|COMPLETED|Overall Study||7
10434102|NCT00889928|11580421|FG000|NOT COMPLETED|Overall Study||0
10434103|NCT00890045|11580427|FG000|STARTED|Overall Study||20
10434104|NCT00890045|11580428|FG001|STARTED|Overall Study|Of the 52 subjects randomized to the HeRO Graft, two implants were abandoned.|52
10434105|NCT00890045|11580427|FG000|COMPLETED|Overall Study||15
10434106|NCT00890045|11580428|FG001|COMPLETED|Overall Study||42
10434107|NCT00890045|11580427|FG000|NOT COMPLETED|Overall Study||5
10434108|NCT00890045|11580428|FG001|NOT COMPLETED|Overall Study||10
10434109|NCT00890084|11580434|FG000|STARTED|Overall Study||2913
10434110|NCT00890084|11580434|FG000|COMPLETED|Overall Study||2771
10434111|NCT00890084|11580434|FG000|NOT COMPLETED|Overall Study||142
10434112|NCT00890097|11580441|FG000|STARTED|Overall Study||252
10434113|NCT00890097|11580442|FG001|STARTED|Overall Study||259
10434114|NCT00890097|11580443|FG002|STARTED|Overall Study||261
10434115|NCT00890097|11580441|FG000|COMPLETED|Overall Study||184
10434116|NCT00890097|11580442|FG001|COMPLETED|Overall Study||173
10434117|NCT00890097|11580443|FG002|COMPLETED|Overall Study||184
10434118|NCT00890097|11580441|FG000|NOT COMPLETED|Overall Study||68
10434119|NCT00890097|11580442|FG001|NOT COMPLETED|Overall Study||86
10786715|NCT03478163|11947187|FG001|STARTED|Overall Study||6
10786716|NCT03478163|11947186|FG000|COMPLETED|Overall Study||5
10786717|NCT03478163|11947187|FG001|COMPLETED|Overall Study||6
10786718|NCT03478163|11947186|FG000|NOT COMPLETED|Overall Study||0
10786719|NCT03478163|11947187|FG001|NOT COMPLETED|Overall Study||0
10786720|NCT03478254|11947193|FG000|STARTED|Overall Study||300
10786721|NCT03478254|11947193|FG000|COMPLETED|Overall Study||300
10786722|NCT03478254|11947193|FG000|NOT COMPLETED|Overall Study||0
10786723|NCT03478371|11947198|FG000|STARTED|Overall Study||94
10786724|NCT03478371|11947198|FG000|Received Tampon D|Overall Study||91
10786725|NCT03478371|11947198|FG000|Received Tampon M|Overall Study||92
10786726|NCT03478371|11947198|FG000|Recived Tampon T|Overall Study||90
10786727|NCT03478371|11947198|FG000|Received Tampon V|Overall Study||91
10786728|NCT03478371|11947198|FG000|COMPLETED|Overall Study||89
10786729|NCT03478371|11947198|FG000|NOT COMPLETED|Overall Study||5
10786730|NCT03478644|11947210|FG000|STARTED|Phase 1|In Phase 1, only the wipe treatment was administered to eligible participants.|31
10786731|NCT03478644|11947211|FG001|STARTED|Phase 1||0
10786732|NCT03478644|11947210|FG000|COMPLETED|Phase 1|In Phase 1, only the wipe treatment was administered to eligible participants.|31
10786733|NCT03478644|11947211|FG001|COMPLETED|Phase 1||0
10786734|NCT03478644|11947210|FG000|NOT COMPLETED|Phase 1||0
10786735|NCT03478644|11947211|FG001|NOT COMPLETED|Phase 1||0
10786736|NCT03478644|11947210|FG000|STARTED|Phase 2||76
10786737|NCT03478644|11947211|FG001|STARTED|Phase 2||76
10786738|NCT03478644|11947210|FG000|COMPLETED|Phase 2||73
10786739|NCT03478644|11947211|FG001|COMPLETED|Phase 2||75
10786740|NCT03478644|11947210|FG000|NOT COMPLETED|Phase 2||3
10786741|NCT03478644|11947211|FG001|NOT COMPLETED|Phase 2||1
10786742|NCT03478657|11947219|FG000|STARTED|Overall Study||88
10786743|NCT03478657|11947220|FG001|STARTED|Overall Study||134
10786744|NCT03478657|11947219|FG000|COMPLETED|Overall Study||88
10786745|NCT03478657|11947220|FG001|COMPLETED|Overall Study||133
10786746|NCT03478657|11947219|FG000|NOT COMPLETED|Overall Study||0
10786747|NCT03478657|11947220|FG001|NOT COMPLETED|Overall Study||1
10786748|NCT03478683|11947228|FG000|STARTED|Overall Study||363
10786749|NCT03478683|11947229|FG001|STARTED|Overall Study||365
10786750|NCT03478683|11947228|FG000|COMPLETED|Overall Study||350
10786751|NCT03478683|11947229|FG001|COMPLETED|Overall Study||347
10786752|NCT03478683|11947228|FG000|NOT COMPLETED|Overall Study||13
10434120|NCT00890097|11580443|FG002|NOT COMPLETED|Overall Study||77
10434121|NCT00890162|11580453|FG000|STARTED|Overall Study||8
10434122|NCT00890162|11580454|FG001|STARTED|Overall Study||8
10434123|NCT00890162|11580453|FG000|COMPLETED|Overall Study||6
10434124|NCT00890162|11580454|FG001|COMPLETED|Overall Study||7
10434125|NCT00890162|11580453|FG000|NOT COMPLETED|Overall Study||2
10434126|NCT00890162|11580454|FG001|NOT COMPLETED|Overall Study||1
10434127|NCT00890201|11580462|FG000|STARTED|Overall Study|5 patients with gastric cancer and gallstone disease|38
10434128|NCT00890201|11580463|FG001|STARTED|Overall Study|41 patients with acute cholecystitis and 15 patients with common bile duct stones|159
10786753|NCT03478683|11947229|FG001|NOT COMPLETED|Overall Study||18
10786754|NCT03478696|11947237|FG000|STARTED|Overall Study||366
10786755|NCT03478696|11947238|FG001|STARTED|Overall Study||366
10786756|NCT03478696|11947237|FG000|COMPLETED|Overall Study||349
10786757|NCT03478696|11947238|FG001|COMPLETED|Overall Study||354
10786758|NCT03478696|11947237|FG000|NOT COMPLETED|Overall Study||17
10786759|NCT03478696|11947238|FG001|NOT COMPLETED|Overall Study||12
10786760|NCT03478787|11947246|FG000|STARTED|Overall Study||163
10786761|NCT03478787|11947247|FG001|STARTED|Overall Study||164
10786762|NCT03478787|11947246|FG000|COMPLETED|Overall Study||134
10434129|NCT00890201|11580462|FG000|COMPLETED|Overall Study|33 patients with gastric cancer and without gallstone disease|33
10434130|NCT00890201|11580463|FG001|COMPLETED|Overall Study|103 patients without acute cholecystitis or common bile duct stones|103
10434131|NCT00890201|11580462|FG000|NOT COMPLETED|Overall Study||5
10434132|NCT00890201|11580463|FG001|NOT COMPLETED|Overall Study||56
10434133|NCT00890396|11580471|FG000|STARTED|Overall Study||127
10434134|NCT00890396|11580472|FG001|STARTED|Overall Study||36
10434135|NCT00890396|11580471|FG000|COMPLETED|Overall Study||122
10434136|NCT00890396|11580472|FG001|COMPLETED|Overall Study||34
10434137|NCT00890396|11580471|FG000|NOT COMPLETED|Overall Study||5
10434138|NCT00890396|11580472|FG001|NOT COMPLETED|Overall Study||2
10434139|NCT00890552|11580481|FG000|STARTED|Enrollment and Pre-treatment||25
10434140|NCT00890552|11580481|FG000|COMPLETED|Enrollment and Pre-treatment||24
10434141|NCT00890552|11580481|FG000|NOT COMPLETED|Enrollment and Pre-treatment||1
10434142|NCT00890552|11580481|FG000|STARTED|On-treatment||24
10434143|NCT00890552|11580481|FG000|COMPLETED|On-treatment||14
10434144|NCT00890552|11580481|FG000|NOT COMPLETED|On-treatment||10
10434145|NCT00890617|11580485|FG000|STARTED|Overall Study||9
10434146|NCT00890617|11580485|FG000|COMPLETED|Overall Study||9
10434147|NCT00890617|11580485|FG000|NOT COMPLETED|Overall Study||0
10434148|NCT00890656|11580489|FG000|STARTED|Overall Study||90
10434149|NCT00890656|11580489|FG000|COMPLETED|Overall Study||90
10434150|NCT00890656|11580489|FG000|NOT COMPLETED|Overall Study||0
10434151|NCT00890682|11580495|FG000|STARTED|Overall Study||97
10434152|NCT00890682|11580496|FG001|STARTED|Overall Study||96
10434153|NCT00890682|11580495|FG000|COMPLETED|Overall Study||93
10434154|NCT00890682|11580496|FG001|COMPLETED|Overall Study||94
10434155|NCT00890682|11580495|FG000|NOT COMPLETED|Overall Study||4
10434156|NCT00890682|11580496|FG001|NOT COMPLETED|Overall Study||2
10434157|NCT00890695|11580504|FG000|STARTED|Overall Study||32
10434158|NCT00890695|11580505|FG001|STARTED|Overall Study||33
10786763|NCT03478787|11947247|FG001|COMPLETED|Overall Study||151
10786764|NCT03478787|11947246|FG000|NOT COMPLETED|Overall Study||29
10786765|NCT03478787|11947247|FG001|NOT COMPLETED|Overall Study||13
10434159|NCT00890695|11580504|FG000|COMPLETED|Overall Study||31
10434160|NCT00890695|11580505|FG001|COMPLETED|Overall Study||33
10786766|NCT03478891|11947256|FG000|STARTED|Overall Study||3
10786767|NCT03478891|11947257|FG001|STARTED|Overall Study||5
10786768|NCT03478891|11947258|FG002|STARTED|Overall Study||11
10786769|NCT03478891|11947256|FG000|Received MAb114|Overall Study||3
10786770|NCT03478891|11947257|FG001|Received MAb114|Overall Study||5
10786771|NCT03478891|11947258|FG002|Received MAb114|Overall Study|One Group 3 subject discontinued prior to MAb114 infusion due to inadequate venous access|10
10786772|NCT03478891|11947256|FG000|COMPLETED|Overall Study||2
10786773|NCT03478891|11947257|FG001|COMPLETED|Overall Study||5
10786774|NCT03478891|11947258|FG002|COMPLETED|Overall Study||8
10786775|NCT03478891|11947256|FG000|NOT COMPLETED|Overall Study||1
10786776|NCT03478891|11947257|FG001|NOT COMPLETED|Overall Study||0
10786777|NCT03478891|11947258|FG002|NOT COMPLETED|Overall Study||3
10786778|NCT03478904|11947270|FG000|STARTED|Overall Study||1
10786779|NCT03478904|11947270|FG000|COMPLETED|Overall Study||1
10786780|NCT03478904|11947270|FG000|NOT COMPLETED|Overall Study||0
10786781|NCT03478969|11947284|FG000|STARTED|Overall Study||62
10786782|NCT03478969|11947285|FG001|STARTED|Overall Study||61
10786783|NCT03478969|11947286|FG002|STARTED|Overall Study||58
10786784|NCT03478969|11947284|FG000|Participants at End of Parallel Phase|Overall Study||55
10786785|NCT03478969|11947285|FG001|Participants at End of Parallel Phase|Overall Study||58
10786786|NCT03478969|11947286|FG002|Participants at End of Parallel Phase|Overall Study||52
10786787|NCT03478969|11947284|FG000|COMPLETED|Overall Study||53
10786788|NCT03478969|11947285|FG001|COMPLETED|Overall Study||49
10786789|NCT03478969|11947286|FG002|COMPLETED|Overall Study||40
10786790|NCT03478969|11947284|FG000|NOT COMPLETED|Overall Study||9
10786791|NCT03478969|11947285|FG001|NOT COMPLETED|Overall Study||12
10786792|NCT03478969|11947286|FG002|NOT COMPLETED|Overall Study||18
10786793|NCT03478982|11947300|FG000|STARTED|Overall Study||11
10786794|NCT03478982|11947301|FG001|STARTED|Overall Study||50
10786795|NCT03478982|11947302|FG002|STARTED|Overall Study||47
10786796|NCT03478982|11947303|FG003|STARTED|Overall Study||48
10786797|NCT03478982|11947300|FG000|Enrolled Participants But Not Treated|Overall Study||3
10786798|NCT03478982|11947301|FG001|Enrolled Participants But Not Treated|Overall Study||10
10786799|NCT03478982|11947302|FG002|Enrolled Participants But Not Treated|Overall Study||9
10786800|NCT03478982|11947303|FG003|Enrolled Participants But Not Treated|Overall Study||10
10434161|NCT00890695|11580504|FG000|NOT COMPLETED|Overall Study||1
10786801|NCT03478982|11947300|FG000|Intent-to-treat (ITT) Population|Overall Study||8
10786802|NCT03478982|11947301|FG001|Intent-to-treat (ITT) Population|Overall Study||40
10786803|NCT03478982|11947302|FG002|Intent-to-treat (ITT) Population|Overall Study||38
10786804|NCT03478982|11947303|FG003|Intent-to-treat (ITT) Population|Overall Study||38
10786805|NCT03478982|11947300|FG000|COMPLETED|Overall Study||11
10786806|NCT03478982|11947301|FG001|COMPLETED|Overall Study||50
10434162|NCT00890695|11580505|FG001|NOT COMPLETED|Overall Study||0
10434163|NCT00890721|11580513|FG000|STARTED|Overall Study||95
10434164|NCT00890721|11580514|FG001|STARTED|Overall Study||94
10434165|NCT00890721|11580513|FG000|COMPLETED|Overall Study||94
10434166|NCT00890721|11580514|FG001|COMPLETED|Overall Study||93
10434167|NCT00890721|11580513|FG000|NOT COMPLETED|Overall Study||1
10434168|NCT00890721|11580514|FG001|NOT COMPLETED|Overall Study||1
10434169|NCT00890825|11580522|FG000|STARTED|Overall Study||44
10525237|NCT01374269|11677086|FG000|NOT COMPLETED|Overall Study||6
10786807|NCT03478982|11947302|FG002|COMPLETED|Overall Study||47
10525238|NCT01374269|11677087|FG001|NOT COMPLETED|Overall Study||5
10786808|NCT03478982|11947303|FG003|COMPLETED|Overall Study||48
10786809|NCT03478982|11947300|FG000|NOT COMPLETED|Overall Study||0
10786810|NCT03478982|11947301|FG001|NOT COMPLETED|Overall Study||0
10786811|NCT03478982|11947302|FG002|NOT COMPLETED|Overall Study||0
10786812|NCT03478982|11947303|FG003|NOT COMPLETED|Overall Study||0
10786813|NCT03479216|11947315|FG000|STARTED|Overall Study||31
10786814|NCT03479216|11947316|FG001|STARTED|Overall Study||31
10786815|NCT03479216|11947315|FG000|COMPLETED|Overall Study||26
10786816|NCT03479216|11947316|FG001|COMPLETED|Overall Study||26
10786817|NCT03479216|11947315|FG000|NOT COMPLETED|Overall Study||5
10786818|NCT03479216|11947316|FG001|NOT COMPLETED|Overall Study||5
10786819|NCT03479944|11947322|FG000|STARTED|Overall Study||55
10786820|NCT03479944|11947322|FG000|FLACS|Overall Study||55
10786821|NCT03479944|11947322|FG000|Conventional|Overall Study||55
10786822|NCT03479944|11947322|FG000|Full Analysis Set|Overall Study||53
10786823|NCT03479944|11947322|FG000|COMPLETED|Overall Study||55
10786824|NCT03479944|11947322|FG000|NOT COMPLETED|Overall Study||0
10786825|NCT03480009|11947334|FG000|STARTED|Overall Study||62
10786826|NCT03480009|11947335|FG001|STARTED|Overall Study||62
10786827|NCT03480009|11947336|FG002|STARTED|Overall Study||16
10786828|NCT03480009|11947337|FG003|STARTED|Overall Study||16
10786829|NCT03480009|11947334|FG000|COMPLETED|Overall Study||58
10786830|NCT03480009|11947335|FG001|COMPLETED|Overall Study||57
10786831|NCT03480009|11947336|FG002|COMPLETED|Overall Study||12
10786832|NCT03480009|11947337|FG003|COMPLETED|Overall Study||16
10786833|NCT03480009|11947334|FG000|NOT COMPLETED|Overall Study||4
10786834|NCT03480009|11947335|FG001|NOT COMPLETED|Overall Study||5
10786835|NCT03480009|11947336|FG002|NOT COMPLETED|Overall Study||4
10786836|NCT03480009|11947337|FG003|NOT COMPLETED|Overall Study||0
10786837|NCT03480022|11947352|FG000|STARTED|Overall Study||55
10786838|NCT03480022|11947353|FG001|STARTED|Overall Study||27
10786839|NCT03480022|11947352|FG000|COMPLETED|Overall Study||44
10786840|NCT03480022|11947353|FG001|COMPLETED|Overall Study||23
10786841|NCT03480022|11947352|FG000|NOT COMPLETED|Overall Study||11
10786842|NCT03480022|11947353|FG001|NOT COMPLETED|Overall Study||4
10786843|NCT03480048|11947361|FG000|STARTED|Overall Study||28
10786844|NCT03480048|11947362|FG001|STARTED|Overall Study||25
10786845|NCT03480048|11947361|FG000|COMPLETED|Overall Study||18
10786846|NCT03480048|11947362|FG001|COMPLETED|Overall Study||17
10786847|NCT03480048|11947361|FG000|NOT COMPLETED|Overall Study||10
10786848|NCT03480048|11947362|FG001|NOT COMPLETED|Overall Study||8
10786849|NCT03480152|11947370|FG000|STARTED|Phase I||3
10786850|NCT03480152|11947371|FG001|STARTED|Phase I||2
10786851|NCT03480152|11947372|FG002|STARTED|Phase I||0
10786852|NCT03480152|11947370|FG000|Received Intervention|Phase I||2
10786853|NCT03480152|11947371|FG001|Received Intervention|Phase I||2
10786854|NCT03480152|11947372|FG002|Received Intervention|Phase I||0
10786855|NCT03480152|11947370|FG000|COMPLETED|Phase I||2
10786856|NCT03480152|11947371|FG001|COMPLETED|Phase I||2
10786857|NCT03480152|11947372|FG002|COMPLETED|Phase I||0
10786858|NCT03480152|11947370|FG000|NOT COMPLETED|Phase I||1
10786859|NCT03480152|11947371|FG001|NOT COMPLETED|Phase I||0
10786860|NCT03480152|11947372|FG002|NOT COMPLETED|Phase I||0
10786861|NCT03480152|11947370|FG000|STARTED|Phase II||0
10434170|NCT00890825|11580523|FG001|STARTED|Overall Study|A patient randomized to this arm was excluded from the safety population for not receiving treatment|43
10434171|NCT00890825|11580522|FG000|COMPLETED|Overall Study||30
10434172|NCT00890825|11580523|FG001|COMPLETED|Overall Study||29
10434173|NCT00890825|11580522|FG000|NOT COMPLETED|Overall Study||14
10434174|NCT00890825|11580523|FG001|NOT COMPLETED|Overall Study||14
10434175|NCT00890916|11580529|FG000|STARTED|"Rehab - Neuroprosthesis (NP) On"|First Implanted Stimulator-Telemeter (IST-12) Implant.|10
10434176|NCT00890916|11580529|FG000|"Grasp Release Pre-Test ON"|"Rehab - Neuroprosthesis (NP) On"||10
10434177|NCT00890916|11580529|FG000|COMPLETED|"Rehab - Neuroprosthesis (NP) On"||10
10434178|NCT00890916|11580529|FG000|NOT COMPLETED|"Rehab - Neuroprosthesis (NP) On"||0
10434179|NCT00890916|11580529|FG000|STARTED|"Rehab - NP Off"||10
10434180|NCT00890916|11580529|FG000|"Grasp Release Pre-Test OFF"|"Rehab - NP Off"||10
10434181|NCT00890916|11580529|FG000|COMPLETED|"Rehab - NP Off"||10
10434182|NCT00890916|11580529|FG000|NOT COMPLETED|"Rehab - NP Off"||0
10434183|NCT00890929|11580533|FG000|STARTED|Overall Study||45
10434184|NCT00890929|11580533|FG000|Consented & Enrolled|Overall Study||45
10434185|NCT00890929|11580533|FG000|Initiated Treatment|Overall Study||43
10434186|NCT00890929|11580533|FG000|COMPLETED|Overall Study||39
10434187|NCT00890929|11580533|FG000|NOT COMPLETED|Overall Study||6
10434188|NCT00890981|11580539|FG000|STARTED|Overall Study||39
10434189|NCT00890981|11580540|FG001|STARTED|Overall Study||40
10434190|NCT00890981|11580539|FG000|COMPLETED|Overall Study||39
10434191|NCT00890981|11580540|FG001|COMPLETED|Overall Study||40
10434192|NCT00890981|11580539|FG000|NOT COMPLETED|Overall Study||0
10434193|NCT00890981|11580540|FG001|NOT COMPLETED|Overall Study||0
10434194|NCT00891020|11580549|FG000|STARTED|24 Week Treatment Period||163
10434195|NCT00891020|11580550|FG001|STARTED|24 Week Treatment Period||363
10434196|NCT00891020|11580551|FG002|STARTED|24 Week Treatment Period||360
10434197|NCT00891020|11580549|FG000|Intent-to-Treat (ITT)|24 Week Treatment Period||163
10434198|NCT00891020|11580550|FG001|Intent-to-Treat (ITT)|24 Week Treatment Period||362
10434199|NCT00891020|11580551|FG002|Intent-to-Treat (ITT)|24 Week Treatment Period||358
10434200|NCT00891020|11580549|FG000|Safety Set|24 Week Treatment Period|4 patients from 8 mg/kg +DMARD arm did not receive DMARD, included in Monotherapy arm for safety.|138
10434201|NCT00891020|11580550|FG001|Safety Set|24 Week Treatment Period|1 patient from Monotherapy arm and 1 from 8 mg/kg +DMARD, included in 4 mg/kg +DMARD arm for safety.|364
10434202|NCT00891020|11580551|FG002|Safety Set|24 Week Treatment Period|28 patients from Monotherapy arm received DMARD, included in 8 mg/kg +DMARD arm for safety.|381
10786862|NCT03480152|11947371|FG001|STARTED|Phase II||0
10786863|NCT03480152|11947372|FG002|STARTED|Phase II||0
10786864|NCT03480152|11947370|FG000|COMPLETED|Phase II||0
10786865|NCT03480152|11947371|FG001|COMPLETED|Phase II||0
10786866|NCT03480152|11947372|FG002|COMPLETED|Phase II||0
10786867|NCT03480152|11947370|FG000|NOT COMPLETED|Phase II||0
10786868|NCT03480152|11947371|FG001|NOT COMPLETED|Phase II||0
10786869|NCT03480152|11947372|FG002|NOT COMPLETED|Phase II||0
10786870|NCT03480243|11947380|FG000|STARTED|Padsevonil (Period 1)||28
10786871|NCT03480243|11947380|FG000|COMPLETED|Padsevonil (Period 1)||28
10786872|NCT03480243|11947380|FG000|NOT COMPLETED|Padsevonil (Period 1)||0
10786873|NCT03480243|11947380|FG000|STARTED|Padsevonil (Period 2)||28
10786874|NCT03480243|11947380|FG000|COMPLETED|Padsevonil (Period 2)||27
10786875|NCT03480243|11947380|FG000|NOT COMPLETED|Padsevonil (Period 2)||1
10786876|NCT03480243|11947380|FG000|STARTED|Erythromycin (Period 3a)||27
10786877|NCT03480243|11947380|FG000|COMPLETED|Erythromycin (Period 3a)||27
10786878|NCT03480243|11947380|FG000|NOT COMPLETED|Erythromycin (Period 3a)||0
10786879|NCT03480243|11947380|FG000|STARTED|Padsevonil and Erythromycin (Period 3b)||27
10786880|NCT03480243|11947380|FG000|COMPLETED|Padsevonil and Erythromycin (Period 3b)||26
10786881|NCT03480243|11947380|FG000|NOT COMPLETED|Padsevonil and Erythromycin (Period 3b)||1
10786882|NCT03480243|11947380|FG000|STARTED|Erythromycin (Period 3c)||26
10786883|NCT03480243|11947380|FG000|COMPLETED|Erythromycin (Period 3c)||26
10786884|NCT03480243|11947380|FG000|NOT COMPLETED|Erythromycin (Period 3c)||0
10786885|NCT03480425|11947393|FG000|STARTED|Overall Study||11
10786886|NCT03480425|11947393|FG000|COMPLETED|Overall Study||10
10786887|NCT03480425|11947393|FG000|NOT COMPLETED|Overall Study||1
10786888|NCT03480685|11947397|FG000|STARTED|Overall Study||12
10786889|NCT03480685|11947397|FG000|COMPLETED|Overall Study||12
10786890|NCT03480685|11947397|FG000|NOT COMPLETED|Overall Study||0
10786891|NCT03480750|11947409|FG000|STARTED|Overall Study||3
10786892|NCT03480750|11947410|FG001|STARTED|Overall Study||4
10786893|NCT03480750|11947411|FG002|STARTED|Overall Study||3
10786894|NCT03480750|11947412|FG003|STARTED|Overall Study||3
10786895|NCT03480750|11947413|FG004|STARTED|Overall Study||3
10786896|NCT03480750|11947414|FG005|STARTED|Overall Study||2
10786897|NCT03480750|11947409|FG000|COMPLETED|Overall Study||3
10786898|NCT03480750|11947410|FG001|COMPLETED|Overall Study||3
10786899|NCT03480750|11947411|FG002|COMPLETED|Overall Study||3
10786900|NCT03480750|11947412|FG003|COMPLETED|Overall Study||3
10434203|NCT00891020|11580549|FG000|COMPLETED|24 Week Treatment Period||126
10434204|NCT00891020|11580550|FG001|COMPLETED|24 Week Treatment Period||303
10434205|NCT00891020|11580551|FG002|COMPLETED|24 Week Treatment Period||302
10434206|NCT00891020|11580549|FG000|NOT COMPLETED|24 Week Treatment Period||37
10786901|NCT03480750|11947413|FG004|COMPLETED|Overall Study||3
10786902|NCT03480750|11947414|FG005|COMPLETED|Overall Study||1
10786903|NCT03480750|11947409|FG000|NOT COMPLETED|Overall Study||0
10786904|NCT03480750|11947410|FG001|NOT COMPLETED|Overall Study||1
10786905|NCT03480750|11947411|FG002|NOT COMPLETED|Overall Study||0
10786906|NCT03480750|11947412|FG003|NOT COMPLETED|Overall Study||0
10786907|NCT03480750|11947413|FG004|NOT COMPLETED|Overall Study||0
10434207|NCT00891020|11580550|FG001|NOT COMPLETED|24 Week Treatment Period||60
10434208|NCT00891020|11580551|FG002|NOT COMPLETED|24 Week Treatment Period||58
10434209|NCT00891020|11580549|FG000|STARTED|Long-term Extension Period||55
10434210|NCT00891020|11580550|FG001|STARTED|Long-term Extension Period||196
10434211|NCT00891020|11580551|FG002|STARTED|Long-term Extension Period||193
10434212|NCT00891020|11580549|FG000|COMPLETED|Long-term Extension Period||49
10549460|NCT01525589|11703478|FG000|STARTED|Overall Study||56
10549461|NCT01525589|11703479|FG001|STARTED|Overall Study||20
10786908|NCT03480750|11947414|FG005|NOT COMPLETED|Overall Study||1
10786909|NCT03480763|11947439|FG000|STARTED|Overall Study||327
10786910|NCT03480763|11947440|FG001|STARTED|Overall Study||325
10786911|NCT03480763|11947439|FG000|Vaccination 1 - (V114 or Prevnar 13™, Day 1)|Overall Study||326
10786912|NCT03480763|11947440|FG001|Vaccination 1 - (V114 or Prevnar 13™, Day 1)|Overall Study||325
10786913|NCT03480763|11947439|FG000|Vaccination 2 - (PNEUMOVAX™23, Month 12)|Overall Study||298
10786914|NCT03480763|11947440|FG001|Vaccination 2 - (PNEUMOVAX™23, Month 12)|Overall Study||302
10786915|NCT03480763|11947439|FG000|COMPLETED|Overall Study||303
10786916|NCT03480763|11947440|FG001|COMPLETED|Overall Study||306
10786917|NCT03480763|11947439|FG000|NOT COMPLETED|Overall Study||24
10786918|NCT03480763|11947440|FG001|NOT COMPLETED|Overall Study||19
10786919|NCT03480841|11947452|FG000|STARTED|Overall Study||10
10786920|NCT03480841|11947452|FG000|Time 1 Data Collection (T1)|Overall Study||10
10786921|NCT03480841|11947452|FG000|LENA Baseline|Overall Study||10
10786922|NCT03480841|11947452|FG000|LENA Time 1|Overall Study||10
10434213|NCT00891020|11580550|FG001|COMPLETED|Long-term Extension Period||172
10434214|NCT00891020|11580551|FG002|COMPLETED|Long-term Extension Period||170
10786923|NCT03480841|11947452|FG000|LENA Time 2|Overall Study||10
10434215|NCT00891020|11580549|FG000|NOT COMPLETED|Long-term Extension Period||6
10434216|NCT00891020|11580550|FG001|NOT COMPLETED|Long-term Extension Period||24
10434217|NCT00891020|11580551|FG002|NOT COMPLETED|Long-term Extension Period||23
10434218|NCT00891046|11580566|FG000|STARTED|Overall Study||33
10434219|NCT00891046|11580567|FG001|STARTED|Overall Study||63
10434220|NCT00891046|11580568|FG002|STARTED|Overall Study||40
10434221|NCT00891046|11580569|FG003|STARTED|Overall Study||11
10434222|NCT00891046|11580570|FG004|STARTED|Overall Study||123
10434223|NCT00891046|11580566|FG000|COMPLETED|Overall Study||21
10434224|NCT00891046|11580567|FG001|COMPLETED|Overall Study||54
10434225|NCT00891046|11580568|FG002|COMPLETED|Overall Study||17
10786924|NCT03480841|11947452|FG000|LENA Time 3|Overall Study||10
10786925|NCT03480841|11947452|FG000|LENA Time 4|Overall Study||9
10786926|NCT03480841|11947452|FG000|LENA Time 5|Overall Study||8
10786927|NCT03480841|11947452|FG000|Time 2 Data Collection (T2)|Overall Study||8
10786928|NCT03480841|11947452|FG000|COMPLETED|Overall Study||8
10786929|NCT03480841|11947452|FG000|NOT COMPLETED|Overall Study||2
10786930|NCT03480919|11947459|FG000|STARTED|Overall Study||1
10786931|NCT03480919|11947460|FG001|STARTED|Overall Study||2
10786932|NCT03480919|11947461|FG002|STARTED|Overall Study||1
10434226|NCT00891046|11580569|FG003|COMPLETED|Overall Study||8
10434227|NCT00891046|11580570|FG004|COMPLETED|Overall Study||84
10434228|NCT00891046|11580566|FG000|NOT COMPLETED|Overall Study||12
10434229|NCT00891046|11580567|FG001|NOT COMPLETED|Overall Study||9
10434230|NCT00891046|11580568|FG002|NOT COMPLETED|Overall Study||23
10434231|NCT00891046|11580569|FG003|NOT COMPLETED|Overall Study||3
10434232|NCT00891046|11580570|FG004|NOT COMPLETED|Overall Study||39
10434233|NCT00891176|11580601|FG000|STARTED|At 3 Years of Age||144
10434234|NCT00891176|11580602|FG001|STARTED|At 3 Years of Age||147
10786933|NCT03480919|11947459|FG000|COMPLETED|Overall Study||1
10434235|NCT00891176|11580603|FG002|STARTED|At 3 Years of Age||149
10434236|NCT00891176|11580604|FG003|STARTED|At 3 Years of Age||141
10434237|NCT00891176|11580601|FG000|COMPLETED|At 3 Years of Age||144
10434238|NCT00891176|11580602|FG001|COMPLETED|At 3 Years of Age||147
10434239|NCT00891176|11580603|FG002|COMPLETED|At 3 Years of Age||149
10434240|NCT00891176|11580604|FG003|COMPLETED|At 3 Years of Age||141
10434241|NCT00891176|11580601|FG000|NOT COMPLETED|At 3 Years of Age||0
10434242|NCT00891176|11580602|FG001|NOT COMPLETED|At 3 Years of Age||0
10434243|NCT00891176|11580603|FG002|NOT COMPLETED|At 3 Years of Age||0
10434244|NCT00891176|11580604|FG003|NOT COMPLETED|At 3 Years of Age||0
10434245|NCT00891176|11580601|FG000|STARTED|At 4 Years of Age||140
10434246|NCT00891176|11580602|FG001|STARTED|At 4 Years of Age||142
10434247|NCT00891176|11580603|FG002|STARTED|At 4 Years of Age||142
10434248|NCT00891176|11580604|FG003|STARTED|At 4 Years of Age||137
10434249|NCT00891176|11580601|FG000|COMPLETED|At 4 Years of Age||140
10434250|NCT00891176|11580602|FG001|COMPLETED|At 4 Years of Age||142
10434251|NCT00891176|11580603|FG002|COMPLETED|At 4 Years of Age||142
10434252|NCT00891176|11580604|FG003|COMPLETED|At 4 Years of Age||137
10434253|NCT00891176|11580601|FG000|NOT COMPLETED|At 4 Years of Age||0
10434254|NCT00891176|11580602|FG001|NOT COMPLETED|At 4 Years of Age||0
10434255|NCT00891176|11580603|FG002|NOT COMPLETED|At 4 Years of Age||0
10434256|NCT00891176|11580604|FG003|NOT COMPLETED|At 4 Years of Age||0
10434257|NCT00891176|11580601|FG000|STARTED|At 6 Years of Age||131
10434258|NCT00891176|11580602|FG001|STARTED|At 6 Years of Age||138
10434259|NCT00891176|11580603|FG002|STARTED|At 6 Years of Age||135
10434260|NCT00891176|11580604|FG003|STARTED|At 6 Years of Age||135
10434261|NCT00891176|11580601|FG000|COMPLETED|At 6 Years of Age||131
10434262|NCT00891176|11580602|FG001|COMPLETED|At 6 Years of Age||138
10434263|NCT00891176|11580603|FG002|COMPLETED|At 6 Years of Age||135
10434264|NCT00891176|11580604|FG003|COMPLETED|At 6 Years of Age||135
10434265|NCT00891176|11580601|FG000|NOT COMPLETED|At 6 Years of Age||0
10434266|NCT00891176|11580602|FG001|NOT COMPLETED|At 6 Years of Age||0
10434267|NCT00891176|11580603|FG002|NOT COMPLETED|At 6 Years of Age||0
10434268|NCT00891176|11580604|FG003|NOT COMPLETED|At 6 Years of Age||0
10434269|NCT00891202|11580622|FG000|STARTED|PAP (Up To Week 39)||20
10434270|NCT00891202|11580623|FG001|STARTED|PAP (Up To Week 39)||20
10434271|NCT00891202|11580624|FG002|STARTED|PAP (Up To Week 39)||0
10434272|NCT00891202|11580625|FG003|STARTED|PAP (Up To Week 39)||0
10434273|NCT00891202|11580622|FG000|COMPLETED|PAP (Up To Week 39)||19
10434274|NCT00891202|11580623|FG001|COMPLETED|PAP (Up To Week 39)||20
10434275|NCT00891202|11580624|FG002|COMPLETED|PAP (Up To Week 39)||0
10434276|NCT00891202|11580625|FG003|COMPLETED|PAP (Up To Week 39)||0
10434277|NCT00891202|11580622|FG000|NOT COMPLETED|PAP (Up To Week 39)||1
10434278|NCT00891202|11580623|FG001|NOT COMPLETED|PAP (Up To Week 39)||0
10434279|NCT00891202|11580624|FG002|NOT COMPLETED|PAP (Up To Week 39)||0
10786934|NCT03480919|11947460|FG001|COMPLETED|Overall Study||2
10786935|NCT03480919|11947461|FG002|COMPLETED|Overall Study||1
10786936|NCT03480919|11947459|FG000|NOT COMPLETED|Overall Study||0
10786937|NCT03480919|11947460|FG001|NOT COMPLETED|Overall Study||0
10786938|NCT03480919|11947461|FG002|NOT COMPLETED|Overall Study||0
10810637|NCT03794752|11972407|FG000|COMPLETED|Overall Study||8
10810638|NCT03794752|11972407|FG000|NOT COMPLETED|Overall Study||0
10810639|NCT03793751|11972417|FG000|STARTED|Overall Study||60
10810640|NCT03793751|11972418|FG001|STARTED|Overall Study||60
10810641|NCT03793751|11972417|FG000|COMPLETED|Overall Study||60
10810642|NCT03793751|11972418|FG001|COMPLETED|Overall Study||60
10810643|NCT03793751|11972417|FG000|NOT COMPLETED|Overall Study||0
10810644|NCT03793751|11972418|FG001|NOT COMPLETED|Overall Study||0
10810645|NCT03793556|11972426|FG000|STARTED|Overall Study||35
10810646|NCT03793556|11972427|FG001|STARTED|Overall Study||36
10810647|NCT03793556|11972426|FG000|COMPLETED|Overall Study||22
10810648|NCT03793556|11972427|FG001|COMPLETED|Overall Study||34
10810649|NCT03793556|11972426|FG000|NOT COMPLETED|Overall Study||13
10810650|NCT03793556|11972427|FG001|NOT COMPLETED|Overall Study||2
10810651|NCT03785548|11972438|FG000|STARTED|Overall Study||73
10810652|NCT03785548|11972439|FG001|STARTED|Overall Study||74
10810653|NCT03785548|11972438|FG000|COMPLETED|Overall Study||71
10810654|NCT03785548|11972439|FG001|COMPLETED|Overall Study||74
10810655|NCT03785548|11972438|FG000|NOT COMPLETED|Overall Study||2
10810656|NCT03785548|11972439|FG001|NOT COMPLETED|Overall Study||0
10810657|NCT03782701|11972445|FG000|STARTED|Overall Study||43
10810658|NCT03782701|11972445|FG000|Lumify|Overall Study||43
10810659|NCT03782701|11972445|FG000|Saline Solution|Overall Study||43
10810660|NCT03782701|11972445|FG000|COMPLETED|Overall Study||43
10810661|NCT03782701|11972445|FG000|NOT COMPLETED|Overall Study||0
10810667|NCT03792672|11972456|FG000|STARTED|Treatment Period 1 (1 Day)||4
10810668|NCT03792672|11972457|FG001|STARTED|Treatment Period 1 (1 Day)||4
10810669|NCT03792672|11972458|FG002|STARTED|Treatment Period 1 (1 Day)||4
10434280|NCT00891202|11580625|FG003|NOT COMPLETED|PAP (Up To Week 39)||0
10434281|NCT00891202|11580622|FG000|STARTED|LTTP (Post-Week 39 up to Week 312)||0
10434282|NCT00891202|11580623|FG001|STARTED|LTTP (Post-Week 39 up to Week 312)||0
10434283|NCT00891202|11580624|FG002|STARTED|LTTP (Post-Week 39 up to Week 312)||19
10434284|NCT00891202|11580625|FG003|STARTED|LTTP (Post-Week 39 up to Week 312)||20
10810670|NCT03792672|11972459|FG003|STARTED|Treatment Period 1 (1 Day)||4
10434285|NCT00891202|11580622|FG000|COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
10434286|NCT00891202|11580623|FG001|COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
10434287|NCT00891202|11580624|FG002|COMPLETED|LTTP (Post-Week 39 up to Week 312)||12
10786939|NCT03480932|11947472|FG000|STARTED|Overall Study||50
10786940|NCT03480932|11947473|FG001|STARTED|Overall Study||50
10786941|NCT03480932|11947474|FG002|STARTED|Overall Study||50
10786942|NCT03480932|11947472|FG000|COMPLETED|Overall Study||47
10786943|NCT03480932|11947473|FG001|COMPLETED|Overall Study||45
10786944|NCT03480932|11947474|FG002|COMPLETED|Overall Study||45
10786945|NCT03480932|11947472|FG000|NOT COMPLETED|Overall Study||3
10786946|NCT03480932|11947473|FG001|NOT COMPLETED|Overall Study||5
10786947|NCT03480932|11947474|FG002|NOT COMPLETED|Overall Study||5
10786948|NCT03481270|11947484|FG000|STARTED|Overall Study||324
10786949|NCT03481270|11947485|FG001|STARTED|Overall Study||313
10786950|NCT03481270|11947484|FG000|COMPLETED|Overall Study||324
10786951|NCT03481270|11947485|FG001|COMPLETED|Overall Study||313
10786952|NCT03481270|11947484|FG000|NOT COMPLETED|Overall Study||0
10786953|NCT03481270|11947485|FG001|NOT COMPLETED|Overall Study||0
10786954|NCT03481309|11947497|FG000|STARTED|First Intervention (1 Day)||4
10786955|NCT03481309|11947498|FG001|STARTED|First Intervention (1 Day)||3
10786956|NCT03481309|11947499|FG002|STARTED|First Intervention (1 Day)||3
10786957|NCT03481309|11947500|FG003|STARTED|First Intervention (1 Day)||3
10786958|NCT03481309|11947501|FG004|STARTED|First Intervention (1 Day)||3
10786959|NCT03481309|11947502|FG005|STARTED|First Intervention (1 Day)||3
10786960|NCT03481309|11947497|FG000|COMPLETED|First Intervention (1 Day)||4
10786961|NCT03481309|11947498|FG001|COMPLETED|First Intervention (1 Day)||3
10786962|NCT03481309|11947499|FG002|COMPLETED|First Intervention (1 Day)||3
10786963|NCT03481309|11947500|FG003|COMPLETED|First Intervention (1 Day)||3
10786964|NCT03481309|11947501|FG004|COMPLETED|First Intervention (1 Day)||3
10786965|NCT03481309|11947502|FG005|COMPLETED|First Intervention (1 Day)||3
10786966|NCT03481309|11947497|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10786967|NCT03481309|11947498|FG001|NOT COMPLETED|First Intervention (1 Day)||0
10786968|NCT03481309|11947499|FG002|NOT COMPLETED|First Intervention (1 Day)||0
10786969|NCT03481309|11947500|FG003|NOT COMPLETED|First Intervention (1 Day)||0
10786970|NCT03481309|11947501|FG004|NOT COMPLETED|First Intervention (1 Day)||0
10786971|NCT03481309|11947502|FG005|NOT COMPLETED|First Intervention (1 Day)||0
10786972|NCT03481309|11947497|FG000|STARTED|Washout (at Least 3 Days)||4
10786973|NCT03481309|11947498|FG001|STARTED|Washout (at Least 3 Days)||3
10786974|NCT03481309|11947499|FG002|STARTED|Washout (at Least 3 Days)||3
10786975|NCT03481309|11947500|FG003|STARTED|Washout (at Least 3 Days)||3
10786976|NCT03481309|11947501|FG004|STARTED|Washout (at Least 3 Days)||3
10786977|NCT03481309|11947502|FG005|STARTED|Washout (at Least 3 Days)||3
10786978|NCT03481309|11947497|FG000|COMPLETED|Washout (at Least 3 Days)||3
10786979|NCT03481309|11947498|FG001|COMPLETED|Washout (at Least 3 Days)||3
10786980|NCT03481309|11947499|FG002|COMPLETED|Washout (at Least 3 Days)||3
10786981|NCT03481309|11947500|FG003|COMPLETED|Washout (at Least 3 Days)||3
10786982|NCT03481309|11947501|FG004|COMPLETED|Washout (at Least 3 Days)||3
10786983|NCT03481309|11947502|FG005|COMPLETED|Washout (at Least 3 Days)||3
10786984|NCT03481309|11947497|FG000|NOT COMPLETED|Washout (at Least 3 Days)||1
10434288|NCT00891202|11580625|FG003|COMPLETED|LTTP (Post-Week 39 up to Week 312)||15
10434289|NCT00891202|11580622|FG000|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
10434290|NCT00891202|11580623|FG001|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
10434291|NCT00891202|11580624|FG002|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||7
10434292|NCT00891202|11580625|FG003|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||5
10434293|NCT00891228|11580636|FG000|STARTED|Overall Study||32
10434294|NCT00891228|11580637|FG001|STARTED|Overall Study||33
10434295|NCT00891228|11580638|FG002|STARTED|Overall Study||34
10434296|NCT00891228|11580636|FG000|COMPLETED|Overall Study||21
10434297|NCT00891228|11580637|FG001|COMPLETED|Overall Study||20
10786985|NCT03481309|11947498|FG001|NOT COMPLETED|Washout (at Least 3 Days)||0
10786986|NCT03481309|11947499|FG002|NOT COMPLETED|Washout (at Least 3 Days)||0
10786987|NCT03481309|11947500|FG003|NOT COMPLETED|Washout (at Least 3 Days)||0
10786988|NCT03481309|11947501|FG004|NOT COMPLETED|Washout (at Least 3 Days)||0
10786989|NCT03481309|11947502|FG005|NOT COMPLETED|Washout (at Least 3 Days)||0
10786990|NCT03481309|11947497|FG000|STARTED|Second Intervention (1 Day)||3
10786991|NCT03481309|11947498|FG001|STARTED|Second Intervention (1 Day)||3
10786992|NCT03481309|11947499|FG002|STARTED|Second Intervention (1 Day)||3
10786993|NCT03481309|11947500|FG003|STARTED|Second Intervention (1 Day)||3
10786994|NCT03481309|11947501|FG004|STARTED|Second Intervention (1 Day)||3
10786995|NCT03481309|11947502|FG005|STARTED|Second Intervention (1 Day)||3
10786996|NCT03481309|11947497|FG000|COMPLETED|Second Intervention (1 Day)||3
10786997|NCT03481309|11947498|FG001|COMPLETED|Second Intervention (1 Day)||3
10786998|NCT03481309|11947499|FG002|COMPLETED|Second Intervention (1 Day)||3
10786999|NCT03481309|11947500|FG003|COMPLETED|Second Intervention (1 Day)||3
10787000|NCT03481309|11947501|FG004|COMPLETED|Second Intervention (1 Day)||3
10787001|NCT03481309|11947502|FG005|COMPLETED|Second Intervention (1 Day)||3
10787002|NCT03481309|11947497|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10787003|NCT03481309|11947498|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10787004|NCT03481309|11947499|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
10787005|NCT03481309|11947500|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
10787006|NCT03481309|11947501|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
10787007|NCT03481309|11947502|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
10787008|NCT03481309|11947497|FG000|STARTED|Washout (at Least 3 Days)||3
10787009|NCT03481309|11947498|FG001|STARTED|Washout (at Least 3 Days)||3
10787010|NCT03481309|11947499|FG002|STARTED|Washout (at Least 3 Days)||3
10787011|NCT03481309|11947500|FG003|STARTED|Washout (at Least 3 Days)||3
10787012|NCT03481309|11947501|FG004|STARTED|Washout (at Least 3 Days)||3
10787013|NCT03481309|11947502|FG005|STARTED|Washout (at Least 3 Days)||3
10787014|NCT03481309|11947497|FG000|COMPLETED|Washout (at Least 3 Days)||3
10787015|NCT03481309|11947498|FG001|COMPLETED|Washout (at Least 3 Days)||3
10787016|NCT03481309|11947499|FG002|COMPLETED|Washout (at Least 3 Days)||3
10787017|NCT03481309|11947500|FG003|COMPLETED|Washout (at Least 3 Days)||3
10787018|NCT03481309|11947501|FG004|COMPLETED|Washout (at Least 3 Days)||3
10787019|NCT03481309|11947502|FG005|COMPLETED|Washout (at Least 3 Days)||3
10787020|NCT03481309|11947497|FG000|NOT COMPLETED|Washout (at Least 3 Days)||0
10787021|NCT03481309|11947498|FG001|NOT COMPLETED|Washout (at Least 3 Days)||0
10787022|NCT03481309|11947499|FG002|NOT COMPLETED|Washout (at Least 3 Days)||0
10787023|NCT03481309|11947500|FG003|NOT COMPLETED|Washout (at Least 3 Days)||0
10787024|NCT03481309|11947501|FG004|NOT COMPLETED|Washout (at Least 3 Days)||0
10787025|NCT03481309|11947502|FG005|NOT COMPLETED|Washout (at Least 3 Days)||0
10787026|NCT03481309|11947497|FG000|STARTED|Third Intervention (1 Day)||3
10787027|NCT03481309|11947498|FG001|STARTED|Third Intervention (1 Day)||3
10787028|NCT03481309|11947499|FG002|STARTED|Third Intervention (1 Day)||3
10787029|NCT03481309|11947500|FG003|STARTED|Third Intervention (1 Day)||3
10787030|NCT03481309|11947501|FG004|STARTED|Third Intervention (1 Day)||3
10787031|NCT03481309|11947502|FG005|STARTED|Third Intervention (1 Day)||3
10787032|NCT03481309|11947497|FG000|COMPLETED|Third Intervention (1 Day)||3
10787033|NCT03481309|11947498|FG001|COMPLETED|Third Intervention (1 Day)||3
10787034|NCT03481309|11947499|FG002|COMPLETED|Third Intervention (1 Day)||3
10787035|NCT03481309|11947500|FG003|COMPLETED|Third Intervention (1 Day)||3
10787036|NCT03481309|11947501|FG004|COMPLETED|Third Intervention (1 Day)||3
10787037|NCT03481309|11947502|FG005|COMPLETED|Third Intervention (1 Day)||3
10787038|NCT03481309|11947497|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
10787039|NCT03481309|11947498|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
10787040|NCT03481309|11947499|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
10787041|NCT03481309|11947500|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
10787042|NCT03481309|11947501|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
10787043|NCT03481309|11947502|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
10787044|NCT03481595|11947512|FG000|STARTED|Overall Study||146
10787045|NCT03481595|11947513|FG001|STARTED|Overall Study||148
10787046|NCT03481595|11947512|FG000|COMPLETED|Overall Study||143
10787047|NCT03481595|11947513|FG001|COMPLETED|Overall Study||127
10787048|NCT03481595|11947512|FG000|NOT COMPLETED|Overall Study||3
10787049|NCT03481595|11947513|FG001|NOT COMPLETED|Overall Study||21
10787050|NCT03481725|11947521|FG000|STARTED|Overall Study||31
10787051|NCT03481725|11947522|FG001|STARTED|Overall Study||34
10434298|NCT00891228|11580638|FG002|COMPLETED|Overall Study||19
10434299|NCT00891228|11580636|FG000|NOT COMPLETED|Overall Study||11
10434300|NCT00891228|11580637|FG001|NOT COMPLETED|Overall Study||13
10434301|NCT00891228|11580638|FG002|NOT COMPLETED|Overall Study||15
10787052|NCT03481725|11947521|FG000|COMPLETED|Overall Study||30
10787053|NCT03481725|11947522|FG001|COMPLETED|Overall Study||34
10434302|NCT00891293|11580646|FG000|STARTED|Overall Study|93 participants were enrolled; baseline data are provided for 89 participants (Safety Population).|93
10434303|NCT00891293|11580646|FG000|COMPLETED|Overall Study||9
10434304|NCT00891293|11580646|FG000|NOT COMPLETED|Overall Study||84
10434305|NCT00891319|11580652|FG000|STARTED|Overall Study||40
10434306|NCT00891319|11580653|FG001|STARTED|Overall Study||40
10434307|NCT00891319|11580652|FG000|COMPLETED|Overall Study||32
10434308|NCT00891319|11580653|FG001|COMPLETED|Overall Study||40
10787054|NCT03481725|11947521|FG000|NOT COMPLETED|Overall Study||1
10787055|NCT03481725|11947522|FG001|NOT COMPLETED|Overall Study||0
10787056|NCT03481816|11947532|FG000|STARTED|Starting Dose||6
10787057|NCT03481816|11947533|FG001|STARTED|Starting Dose||0
10787058|NCT03481816|11947532|FG000|COMPLETED|Starting Dose||5
10787059|NCT03481816|11947533|FG001|COMPLETED|Starting Dose||0
10787060|NCT03481816|11947532|FG000|NOT COMPLETED|Starting Dose||1
10787061|NCT03481816|11947533|FG001|NOT COMPLETED|Starting Dose||0
10787062|NCT03481816|11947532|FG000|STARTED|Dose Expansion||0
10787063|NCT03481816|11947533|FG001|STARTED|Dose Expansion||12
10787064|NCT03481816|11947532|FG000|COMPLETED|Dose Expansion||0
10787065|NCT03481816|11947533|FG001|COMPLETED|Dose Expansion||0
10787066|NCT03481816|11947532|FG000|NOT COMPLETED|Dose Expansion||0
10787067|NCT03481816|11947533|FG001|NOT COMPLETED|Dose Expansion||12
10787068|NCT03482011|11947543|FG000|STARTED|Induction Period (16 Weeks)||107
10787069|NCT03482011|11947544|FG001|STARTED|Induction Period (16 Weeks)||423
10787070|NCT03482011|11947545|FG002|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
10787071|NCT03482011|11947546|FG003|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
10787072|NCT03482011|11947547|FG004|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
10787073|NCT03482011|11947548|FG005|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
10787074|NCT03482011|11947549|FG006|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
10787075|NCT03482011|11947550|FG007|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
10787076|NCT03482011|11947543|FG000|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||107
10787077|NCT03482011|11947544|FG001|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||422
10787078|NCT03482011|11947545|FG002|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
10787079|NCT03482011|11947546|FG003|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
10787080|NCT03482011|11947547|FG004|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
10787081|NCT03482011|11947548|FG005|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
10787082|NCT03482011|11947549|FG006|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
10787083|NCT03482011|11947550|FG007|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
10787084|NCT03482011|11947543|FG000|COMPLETED|Induction Period (16 Weeks)||101
10787085|NCT03482011|11947544|FG001|COMPLETED|Induction Period (16 Weeks)||412
10787086|NCT03482011|11947545|FG002|COMPLETED|Induction Period (16 Weeks)||0
10787087|NCT03482011|11947546|FG003|COMPLETED|Induction Period (16 Weeks)||0
10787088|NCT03482011|11947547|FG004|COMPLETED|Induction Period (16 Weeks)||0
10787089|NCT03482011|11947548|FG005|COMPLETED|Induction Period (16 Weeks)||0
10787090|NCT03482011|11947549|FG006|COMPLETED|Induction Period (16 Weeks)||0
10787091|NCT03482011|11947550|FG007|COMPLETED|Induction Period (16 Weeks)||0
10787092|NCT03482011|11947543|FG000|NOT COMPLETED|Induction Period (16 Weeks)||6
10787093|NCT03482011|11947544|FG001|NOT COMPLETED|Induction Period (16 Weeks)||11
10787094|NCT03482011|11947545|FG002|NOT COMPLETED|Induction Period (16 Weeks)||0
10787095|NCT03482011|11947546|FG003|NOT COMPLETED|Induction Period (16 Weeks)||0
10787096|NCT03482011|11947547|FG004|NOT COMPLETED|Induction Period (16 Weeks)||0
10787097|NCT03482011|11947548|FG005|NOT COMPLETED|Induction Period (16 Weeks)||0
10787098|NCT03482011|11947549|FG006|NOT COMPLETED|Induction Period (16 Weeks)||0
10787099|NCT03482011|11947550|FG007|NOT COMPLETED|Induction Period (16 Weeks)||0
10787100|NCT03482011|11947543|FG000|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
10787101|NCT03482011|11947544|FG001|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
10787102|NCT03482011|11947545|FG002|STARTED|Maintenance Period (36 Weeks)||7
10787103|NCT03482011|11947546|FG003|STARTED|Maintenance Period (36 Weeks)||94
10787104|NCT03482011|11947547|FG004|STARTED|Maintenance Period (36 Weeks)||91
10787105|NCT03482011|11947548|FG005|STARTED|Maintenance Period (36 Weeks)||90
10787106|NCT03482011|11947549|FG006|STARTED|Maintenance Period (36 Weeks)||91
10787107|NCT03482011|11947550|FG007|STARTED|Maintenance Period (36 Weeks)||140
10787108|NCT03482011|11947543|FG000|Relapse|Maintenance Period (36 Weeks)||0
10787109|NCT03482011|11947544|FG001|Relapse|Maintenance Period (36 Weeks)||0
10787110|NCT03482011|11947545|FG002|Relapse|Maintenance Period (36 Weeks)||1
10787111|NCT03482011|11947546|FG003|Relapse|Maintenance Period (36 Weeks)||0
10787112|NCT03482011|11947547|FG004|Relapse|Maintenance Period (36 Weeks)||41
10787113|NCT03482011|11947548|FG005|Relapse|Maintenance Period (36 Weeks)||3
10787114|NCT03482011|11947549|FG006|Relapse|Maintenance Period (36 Weeks)||2
10787115|NCT03482011|11947550|FG007|Relapse|Maintenance Period (36 Weeks)||0
10787116|NCT03482011|11947543|FG000|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||0
10787117|NCT03482011|11947544|FG001|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||0
10787118|NCT03482011|11947545|FG002|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||6
10434309|NCT00891319|11580652|FG000|NOT COMPLETED|Overall Study||8
10434310|NCT00891319|11580653|FG001|NOT COMPLETED|Overall Study||0
10434311|NCT00891371|11580659|FG000|STARTED|Pre-assignment||42
10434312|NCT00891371|11580659|FG000|COMPLETED|Pre-assignment||36
10434313|NCT00891371|11580659|FG000|NOT COMPLETED|Pre-assignment||6
10434314|NCT00891371|11580659|FG000|STARTED|Treatment||36
10434315|NCT00891371|11580659|FG000|COMPLETED|Treatment||27
10434316|NCT00891371|11580659|FG000|NOT COMPLETED|Treatment||9
10434317|NCT00891436|11580665|FG000|STARTED|Overall Study||10
10434318|NCT00891436|11580666|FG001|STARTED|Overall Study||10
10434319|NCT00891436|11580665|FG000|COMPLETED|Overall Study||10
10434320|NCT00891436|11580666|FG001|COMPLETED|Overall Study||10
10434321|NCT00891436|11580665|FG000|NOT COMPLETED|Overall Study||0
10434322|NCT00891436|11580666|FG001|NOT COMPLETED|Overall Study||0
10434323|NCT00891462|11580675|FG000|STARTED|Overall Study||186
10434324|NCT00891462|11580676|FG001|STARTED|Overall Study||185
10434325|NCT00891462|11580677|FG002|STARTED|Overall Study||190
10434326|NCT00891462|11580675|FG000|COMPLETED|Overall Study||149
10434327|NCT00891462|11580676|FG001|COMPLETED|Overall Study||152
10434328|NCT00891462|11580677|FG002|COMPLETED|Overall Study||166
10434329|NCT00891462|11580675|FG000|NOT COMPLETED|Overall Study||37
10434330|NCT00891462|11580676|FG001|NOT COMPLETED|Overall Study||33
10434331|NCT00891462|11580677|FG002|NOT COMPLETED|Overall Study||24
10434332|NCT00891527|11580687|FG000|STARTED|Overall Study||50
10434333|NCT00891527|11580687|FG000|COMPLETED|Overall Study||48
10434334|NCT00891527|11580687|FG000|NOT COMPLETED|Overall Study||2
10434335|NCT00891618|11580692|FG000|STARTED|Overall Study||21
10434336|NCT00891618|11580692|FG000|COMPLETED|Overall Study||20
10434337|NCT00891618|11580692|FG000|NOT COMPLETED|Overall Study||1
10434338|NCT00891657|11580698|FG000|STARTED|Overall Study||9
10434339|NCT00891657|11580699|FG001|STARTED|Overall Study||6
10434340|NCT00891657|11580698|FG000|COMPLETED|Overall Study||8
10787119|NCT03482011|11947546|FG003|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||88
10787120|NCT03482011|11947547|FG004|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||86
10787121|NCT03482011|11947548|FG005|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||85
10787122|NCT03482011|11947549|FG006|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||87
10787123|NCT03482011|11947550|FG007|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||121
10787124|NCT03482011|11947543|FG000|COMPLETED|Maintenance Period (36 Weeks)||0
10787125|NCT03482011|11947544|FG001|COMPLETED|Maintenance Period (36 Weeks)||0
10787126|NCT03482011|11947545|FG002|COMPLETED|Maintenance Period (36 Weeks)||6
10787127|NCT03482011|11947546|FG003|COMPLETED|Maintenance Period (36 Weeks)||90
10787128|NCT03482011|11947547|FG004|COMPLETED|Maintenance Period (36 Weeks)||86
10787129|NCT03482011|11947548|FG005|COMPLETED|Maintenance Period (36 Weeks)||86
10787130|NCT03482011|11947549|FG006|COMPLETED|Maintenance Period (36 Weeks)||87
10787131|NCT03482011|11947550|FG007|COMPLETED|Maintenance Period (36 Weeks)||123
10787132|NCT03482011|11947543|FG000|NOT COMPLETED|Maintenance Period (36 Weeks)||0
10787133|NCT03482011|11947544|FG001|NOT COMPLETED|Maintenance Period (36 Weeks)||0
10787134|NCT03482011|11947545|FG002|NOT COMPLETED|Maintenance Period (36 Weeks)||1
10787135|NCT03482011|11947546|FG003|NOT COMPLETED|Maintenance Period (36 Weeks)||4
10787136|NCT03482011|11947547|FG004|NOT COMPLETED|Maintenance Period (36 Weeks)||5
10787137|NCT03482011|11947548|FG005|NOT COMPLETED|Maintenance Period (36 Weeks)||4
10787138|NCT03482011|11947549|FG006|NOT COMPLETED|Maintenance Period (36 Weeks)||4
10787139|NCT03482011|11947550|FG007|NOT COMPLETED|Maintenance Period (36 Weeks)||17
10787140|NCT03482011|11947543|FG000|STARTED|Follow-up Period (12 Weeks)|Participants were assigned to this arm during induction period.|0
10787141|NCT03482011|11947544|FG001|STARTED|Follow-up Period (12 Weeks)|Participants were assigned to this arm during induction period.|0
10787142|NCT03482011|11947545|FG002|STARTED|Follow-up Period (12 Weeks)||1
10787143|NCT03482011|11947546|FG003|STARTED|Follow-up Period (12 Weeks)||10
10787144|NCT03482011|11947547|FG004|STARTED|Follow-up Period (12 Weeks)||2
10787145|NCT03482011|11947548|FG005|STARTED|Follow-up Period (12 Weeks)||4
10787146|NCT03482011|11947549|FG006|STARTED|Follow-up Period (12 Weeks)||4
10787147|NCT03482011|11947550|FG007|STARTED|Follow-up Period (12 Weeks)||21
10787148|NCT03482011|11947543|FG000|COMPLETED|Follow-up Period (12 Weeks)||0
10787149|NCT03482011|11947544|FG001|COMPLETED|Follow-up Period (12 Weeks)||0
10787150|NCT03482011|11947545|FG002|COMPLETED|Follow-up Period (12 Weeks)||0
10787151|NCT03482011|11947546|FG003|COMPLETED|Follow-up Period (12 Weeks)||5
10787152|NCT03482011|11947547|FG004|COMPLETED|Follow-up Period (12 Weeks)||2
10787153|NCT03482011|11947548|FG005|COMPLETED|Follow-up Period (12 Weeks)||3
10787154|NCT03482011|11947549|FG006|COMPLETED|Follow-up Period (12 Weeks)||2
10787155|NCT03482011|11947550|FG007|COMPLETED|Follow-up Period (12 Weeks)||4
10787156|NCT03482011|11947543|FG000|NOT COMPLETED|Follow-up Period (12 Weeks)||0
10787157|NCT03482011|11947544|FG001|NOT COMPLETED|Follow-up Period (12 Weeks)||0
10787158|NCT03482011|11947545|FG002|NOT COMPLETED|Follow-up Period (12 Weeks)||1
10787159|NCT03482011|11947546|FG003|NOT COMPLETED|Follow-up Period (12 Weeks)||5
10787160|NCT03482011|11947547|FG004|NOT COMPLETED|Follow-up Period (12 Weeks)||0
10787161|NCT03482011|11947548|FG005|NOT COMPLETED|Follow-up Period (12 Weeks)||1
10787162|NCT03482011|11947549|FG006|NOT COMPLETED|Follow-up Period (12 Weeks)||2
10434341|NCT00891657|11580699|FG001|COMPLETED|Overall Study||5
10434342|NCT00891657|11580698|FG000|NOT COMPLETED|Overall Study||1
10434343|NCT00891657|11580699|FG001|NOT COMPLETED|Overall Study||1
10434344|NCT00891735|11580709|FG000|STARTED|Overall Study||275
10434345|NCT00891735|11580710|FG001|STARTED|Overall Study||274
10434346|NCT00891735|11580711|FG002|STARTED|Overall Study||275
10434347|NCT00891735|11580712|FG003|STARTED|Overall Study||273
10434348|NCT00891735|11580709|FG000|COMPLETED|Overall Study||258
10434349|NCT00891735|11580710|FG001|COMPLETED|Overall Study||258
10434350|NCT00891735|11580711|FG002|COMPLETED|Overall Study||263
10434351|NCT00891735|11580712|FG003|COMPLETED|Overall Study||258
10434352|NCT00891735|11580709|FG000|NOT COMPLETED|Overall Study||17
10434353|NCT00891735|11580710|FG001|NOT COMPLETED|Overall Study||16
10434354|NCT00891735|11580711|FG002|NOT COMPLETED|Overall Study||12
10434355|NCT00891735|11580712|FG003|NOT COMPLETED|Overall Study||15
10434356|NCT00891774|11580722|FG000|STARTED|Overall Study||172
10787163|NCT03482011|11947550|FG007|NOT COMPLETED|Follow-up Period (12 Weeks)||17
10787164|NCT03482453|11947587|FG000|STARTED|Part 1 (1 Day)||10
10787165|NCT03482453|11947588|FG001|STARTED|Part 1 (1 Day)||6
10787166|NCT03482453|11947589|FG002|STARTED|Part 1 (1 Day)||6
10787167|NCT03482453|11947590|FG003|STARTED|Part 1 (1 Day)||6
10787168|NCT03482453|11947591|FG004|STARTED|Part 1 (1 Day)||6
10787169|NCT03482453|11947592|FG005|STARTED|Part 1 (1 Day)||6
10787170|NCT03482453|11947593|FG006|STARTED|Part 1 (1 Day)||0
10787171|NCT03482453|11947594|FG007|STARTED|Part 1 (1 Day)||0
10787172|NCT03482453|11947595|FG008|STARTED|Part 1 (1 Day)||0
10787173|NCT03482453|11947596|FG009|STARTED|Part 1 (1 Day)||0
10787174|NCT03482453|11947597|FG010|STARTED|Part 1 (1 Day)||0
10787175|NCT03482453|11947598|FG011|STARTED|Part 1 (1 Day)||0
10787176|NCT03482453|11947587|FG000|COMPLETED|Part 1 (1 Day)||10
10787177|NCT03482453|11947588|FG001|COMPLETED|Part 1 (1 Day)||6
10787178|NCT03482453|11947589|FG002|COMPLETED|Part 1 (1 Day)||6
10787179|NCT03482453|11947590|FG003|COMPLETED|Part 1 (1 Day)||6
10787180|NCT03482453|11947591|FG004|COMPLETED|Part 1 (1 Day)||6
10787181|NCT03482453|11947592|FG005|COMPLETED|Part 1 (1 Day)||6
10787182|NCT03482453|11947593|FG006|COMPLETED|Part 1 (1 Day)||0
10787183|NCT03482453|11947594|FG007|COMPLETED|Part 1 (1 Day)||0
10787184|NCT03482453|11947595|FG008|COMPLETED|Part 1 (1 Day)||0
10434357|NCT00891774|11580722|FG000|COMPLETED|Overall Study||158
10434358|NCT00891774|11580722|FG000|NOT COMPLETED|Overall Study||14
10787185|NCT03482453|11947596|FG009|COMPLETED|Part 1 (1 Day)||0
10787186|NCT03482453|11947597|FG010|COMPLETED|Part 1 (1 Day)||0
10787187|NCT03482453|11947598|FG011|COMPLETED|Part 1 (1 Day)||0
10787188|NCT03482453|11947587|FG000|NOT COMPLETED|Part 1 (1 Day)||0
10787189|NCT03482453|11947588|FG001|NOT COMPLETED|Part 1 (1 Day)||0
10787190|NCT03482453|11947589|FG002|NOT COMPLETED|Part 1 (1 Day)||0
10787191|NCT03482453|11947590|FG003|NOT COMPLETED|Part 1 (1 Day)||0
10787192|NCT03482453|11947591|FG004|NOT COMPLETED|Part 1 (1 Day)||0
10787193|NCT03482453|11947592|FG005|NOT COMPLETED|Part 1 (1 Day)||0
10787194|NCT03482453|11947593|FG006|NOT COMPLETED|Part 1 (1 Day)||0
10787195|NCT03482453|11947594|FG007|NOT COMPLETED|Part 1 (1 Day)||0
10787196|NCT03482453|11947595|FG008|NOT COMPLETED|Part 1 (1 Day)||0
10787197|NCT03482453|11947596|FG009|NOT COMPLETED|Part 1 (1 Day)||0
10787198|NCT03482453|11947597|FG010|NOT COMPLETED|Part 1 (1 Day)||0
10787199|NCT03482453|11947598|FG011|NOT COMPLETED|Part 1 (1 Day)||0
10787200|NCT03482453|11947587|FG000|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
10787201|NCT03482453|11947588|FG001|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
10787202|NCT03482453|11947589|FG002|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
10787203|NCT03482453|11947590|FG003|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
10787204|NCT03482453|11947591|FG004|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
10787205|NCT03482453|11947592|FG005|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
10787206|NCT03482453|11947593|FG006|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||3
10787207|NCT03482453|11947594|FG007|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||3
10787208|NCT03482453|11947595|FG008|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||5
10787209|NCT03482453|11947596|FG009|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||5
10787210|NCT03482453|11947597|FG010|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||7
10787211|NCT03482453|11947598|FG011|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||6
10787212|NCT03482453|11947587|FG000|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
10787213|NCT03482453|11947588|FG001|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
10787214|NCT03482453|11947589|FG002|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
10787215|NCT03482453|11947590|FG003|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
10787216|NCT03482453|11947591|FG004|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
10787217|NCT03482453|11947592|FG005|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
10787218|NCT03482453|11947593|FG006|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||3
10787219|NCT03482453|11947594|FG007|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||3
10787220|NCT03482453|11947595|FG008|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||5
10787221|NCT03482453|11947596|FG009|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||5
10787222|NCT03482453|11947597|FG010|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||6
10787223|NCT03482453|11947598|FG011|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||6
10787224|NCT03482453|11947587|FG000|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
10787225|NCT03482453|11947588|FG001|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
10787226|NCT03482453|11947589|FG002|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
10787227|NCT03482453|11947590|FG003|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
10787228|NCT03482453|11947591|FG004|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
10434359|NCT00891813|11580726|FG000|STARTED|Overall Study||100
10787229|NCT03482453|11947592|FG005|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
10787230|NCT03482453|11947593|FG006|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
10787231|NCT03482453|11947594|FG007|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
10787232|NCT03482453|11947595|FG008|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
10787233|NCT03482453|11947596|FG009|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
10787234|NCT03482453|11947597|FG010|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||1
10434360|NCT00891813|11580726|FG000|COMPLETED|Overall Study||88
10434361|NCT00891813|11580726|FG000|NOT COMPLETED|Overall Study||12
10434362|NCT00891839|11580730|FG000|STARTED|Overall Study||45
10434363|NCT00891839|11580730|FG000|COMPLETED|Overall Study|completed treatment|38
10434364|NCT00891839|11580730|FG000|NOT COMPLETED|Overall Study||7
10434365|NCT00891878|11580736|FG000|STARTED|Overall Study||6
10434366|NCT00891878|11580737|FG001|STARTED|Overall Study||6
10434367|NCT00891878|11580736|FG000|COMPLETED|Overall Study||6
10434368|NCT00891878|11580737|FG001|COMPLETED|Overall Study||6
10434369|NCT00891878|11580736|FG000|NOT COMPLETED|Overall Study||0
10434370|NCT00891878|11580737|FG001|NOT COMPLETED|Overall Study||0
10434371|NCT00891930|11580743|FG000|STARTED|Part 1: Panitumumab +Irinotecan||76
10434372|NCT00891930|11580743|FG000|Received Treatment|Part 1: Panitumumab +Irinotecan||74
10434373|NCT00891930|11580743|FG000|COMPLETED|Part 1: Panitumumab +Irinotecan||36
10787235|NCT03482453|11947598|FG011|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
10787236|NCT03482453|11947587|FG000|STARTED|Parts 2, 3 Washout Period (7 Days)||0
10787237|NCT03482453|11947588|FG001|STARTED|Parts 2, 3 Washout Period (7 Days)||0
10787238|NCT03482453|11947589|FG002|STARTED|Parts 2, 3 Washout Period (7 Days)||0
10787239|NCT03482453|11947590|FG003|STARTED|Parts 2, 3 Washout Period (7 Days)||0
10787240|NCT03482453|11947591|FG004|STARTED|Parts 2, 3 Washout Period (7 Days)||0
10787241|NCT03482453|11947592|FG005|STARTED|Parts 2, 3 Washout Period (7 Days)||0
10787242|NCT03482453|11947593|FG006|STARTED|Parts 2, 3 Washout Period (7 Days)||3
10787243|NCT03482453|11947594|FG007|STARTED|Parts 2, 3 Washout Period (7 Days)||3
10787244|NCT03482453|11947595|FG008|STARTED|Parts 2, 3 Washout Period (7 Days)||5
10787245|NCT03482453|11947596|FG009|STARTED|Parts 2, 3 Washout Period (7 Days)||5
10787246|NCT03482453|11947597|FG010|STARTED|Parts 2, 3 Washout Period (7 Days)||6
10787247|NCT03482453|11947598|FG011|STARTED|Parts 2, 3 Washout Period (7 Days)||6
10787248|NCT03482453|11947587|FG000|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
10787249|NCT03482453|11947588|FG001|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
10787250|NCT03482453|11947589|FG002|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
10787251|NCT03482453|11947590|FG003|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
10787252|NCT03482453|11947591|FG004|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
10787253|NCT03482453|11947592|FG005|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
10787254|NCT03482453|11947593|FG006|COMPLETED|Parts 2, 3 Washout Period (7 Days)||3
10787255|NCT03482453|11947594|FG007|COMPLETED|Parts 2, 3 Washout Period (7 Days)||3
10787256|NCT03482453|11947595|FG008|COMPLETED|Parts 2, 3 Washout Period (7 Days)||5
10787257|NCT03482453|11947596|FG009|COMPLETED|Parts 2, 3 Washout Period (7 Days)||5
10787258|NCT03482453|11947597|FG010|COMPLETED|Parts 2, 3 Washout Period (7 Days)||6
10787259|NCT03482453|11947598|FG011|COMPLETED|Parts 2, 3 Washout Period (7 Days)||6
10787260|NCT03482453|11947587|FG000|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
10787261|NCT03482453|11947588|FG001|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
10787262|NCT03482453|11947589|FG002|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
10787263|NCT03482453|11947590|FG003|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
10787264|NCT03482453|11947591|FG004|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
10787265|NCT03482453|11947592|FG005|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
10787266|NCT03482453|11947593|FG006|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
10787267|NCT03482453|11947594|FG007|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
10787268|NCT03482453|11947595|FG008|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
10787269|NCT03482453|11947596|FG009|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
10787270|NCT03482453|11947597|FG010|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
10787271|NCT03482453|11947598|FG011|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
10787272|NCT03482453|11947587|FG000|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
10787273|NCT03482453|11947588|FG001|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
10787274|NCT03482453|11947589|FG002|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
10787275|NCT03482453|11947590|FG003|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
10787276|NCT03482453|11947591|FG004|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
10787277|NCT03482453|11947592|FG005|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
10787278|NCT03482453|11947593|FG006|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||3
10787279|NCT03482453|11947594|FG007|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||3
10787280|NCT03482453|11947595|FG008|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||5
10787281|NCT03482453|11947596|FG009|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||5
10787282|NCT03482453|11947597|FG010|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||6
10787283|NCT03482453|11947598|FG011|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||6
10787284|NCT03482453|11947587|FG000|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
10787285|NCT03482453|11947588|FG001|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
10787286|NCT03482453|11947589|FG002|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
10787287|NCT03482453|11947590|FG003|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
10787288|NCT03482453|11947591|FG004|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
10787289|NCT03482453|11947592|FG005|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
10787290|NCT03482453|11947593|FG006|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||3
10787291|NCT03482453|11947594|FG007|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||3
10787292|NCT03482453|11947595|FG008|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||5
10787293|NCT03482453|11947596|FG009|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||5
10434374|NCT00891930|11580743|FG000|NOT COMPLETED|Part 1: Panitumumab +Irinotecan||40
10434375|NCT00891930|11580743|FG000|STARTED|Part 2: Panitumumab + Ganitumab||36
10434376|NCT00891930|11580743|FG000|COMPLETED|Part 2: Panitumumab + Ganitumab||5
10434377|NCT00891930|11580743|FG000|NOT COMPLETED|Part 2: Panitumumab + Ganitumab||31
10434378|NCT00891982|11580753|FG000|STARTED|Overall Study||30
10434379|NCT00891982|11580754|FG001|STARTED|Overall Study||31
10434380|NCT00891982|11580753|FG000|COMPLETED|Overall Study||28
10434381|NCT00891982|11580754|FG001|COMPLETED|Overall Study||30
10434382|NCT00891982|11580753|FG000|NOT COMPLETED|Overall Study||2
10434383|NCT00891982|11580754|FG001|NOT COMPLETED|Overall Study||1
10434384|NCT00891995|11580762|FG000|STARTED|Overall Study||50
10787294|NCT03482453|11947597|FG010|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||6
10787295|NCT03482453|11947598|FG011|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||6
10787296|NCT03482453|11947587|FG000|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
10787297|NCT03482453|11947588|FG001|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
10787298|NCT03482453|11947589|FG002|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
10787299|NCT03482453|11947590|FG003|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
10787300|NCT03482453|11947591|FG004|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
10787301|NCT03482453|11947592|FG005|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
10787302|NCT03482453|11947593|FG006|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
10787303|NCT03482453|11947594|FG007|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
10787304|NCT03482453|11947595|FG008|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
10787305|NCT03482453|11947596|FG009|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
10787306|NCT03482453|11947597|FG010|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
10787307|NCT03482453|11947598|FG011|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
10787308|NCT03482583|11947637|FG000|STARTED|Overall Study||37
10787309|NCT03482583|11947638|FG001|STARTED|Overall Study||14
10787310|NCT03482583|11947639|FG002|STARTED|Overall Study||39
10787311|NCT03482583|11947637|FG000|COMPLETED|Overall Study||12
10787312|NCT03482583|11947638|FG001|COMPLETED|Overall Study||5
10787313|NCT03482583|11947639|FG002|COMPLETED|Overall Study||18
10787314|NCT03482583|11947637|FG000|NOT COMPLETED|Overall Study||25
10787315|NCT03482583|11947638|FG001|NOT COMPLETED|Overall Study||9
10787316|NCT03482583|11947639|FG002|NOT COMPLETED|Overall Study||21
10787317|NCT03482635|11947652|FG000|STARTED|Overall Study||23
10787318|NCT03482635|11947653|FG001|STARTED|Overall Study||24
10787319|NCT03482635|11947654|FG002|STARTED|Overall Study||23
10787320|NCT03482635|11947655|FG003|STARTED|Overall Study||28
10787321|NCT03482635|11947652|FG000|Treated|Overall Study||23
10787322|NCT03482635|11947653|FG001|Treated|Overall Study||24
10787323|NCT03482635|11947654|FG002|Treated|Overall Study||23
10787324|NCT03482635|11947655|FG003|Treated|Overall Study||27
10787325|NCT03482635|11947652|FG000|COMPLETED|Overall Study||18
10787326|NCT03482635|11947653|FG001|COMPLETED|Overall Study||21
10787327|NCT03482635|11947654|FG002|COMPLETED|Overall Study||22
10787328|NCT03482635|11947655|FG003|COMPLETED|Overall Study||20
10787329|NCT03482635|11947652|FG000|NOT COMPLETED|Overall Study||5
10787330|NCT03482635|11947653|FG001|NOT COMPLETED|Overall Study||3
10787331|NCT03482635|11947654|FG002|NOT COMPLETED|Overall Study||1
10787332|NCT03482635|11947655|FG003|NOT COMPLETED|Overall Study||8
10787333|NCT03482713|11947667|FG000|STARTED|Overall Study||11
10787334|NCT03482713|11947668|FG001|STARTED|Overall Study||12
10787335|NCT03482713|11947667|FG000|COMPLETED|Overall Study||11
10787336|NCT03482713|11947668|FG001|COMPLETED|Overall Study||12
10787337|NCT03482713|11947667|FG000|NOT COMPLETED|Overall Study||0
10787338|NCT03482713|11947668|FG001|NOT COMPLETED|Overall Study||0
10787339|NCT03482882|11947674|FG000|STARTED|Overall Study||47
10787340|NCT03482882|11947674|FG000|COMPLETED|Overall Study||40
10787341|NCT03482882|11947674|FG000|NOT COMPLETED|Overall Study||7
10787342|NCT03482973|11947680|FG000|STARTED|Overall Study||40
10787343|NCT03482973|11947681|FG001|STARTED|Overall Study||40
10787344|NCT03482973|11947680|FG000|COMPLETED|Overall Study||40
10787345|NCT03482973|11947681|FG001|COMPLETED|Overall Study||40
10787346|NCT03482973|11947680|FG000|NOT COMPLETED|Overall Study||0
10787347|NCT03482973|11947681|FG001|NOT COMPLETED|Overall Study||0
10787348|NCT03483506|11947687|FG000|STARTED|Overall Study||12
10787349|NCT03483506|11947687|FG000|COMPLETED|Overall Study||12
10787350|NCT03483506|11947687|FG000|NOT COMPLETED|Overall Study||0
10787351|NCT03483623|11947693|FG000|STARTED|Overall Study||44
10787352|NCT03483623|11947693|FG000|Started NATO WELP|Overall Study||44
10787353|NCT03483623|11947693|FG000|Completeded NATO WELP|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
10787354|NCT03483623|11947693|FG000|Started NATO FIS|Overall Study||44
10434459|NCT00892177|11580804|FG000|NOT COMPLETED|Phase I: Dose Level 2||0
10787355|NCT03483623|11947693|FG000|Completed NATO FIS|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
10787356|NCT03483623|11947693|FG000|Started RAVEN WELP|Overall Study||44
10787357|NCT03483623|11947693|FG000|Completed RAVEN WELP|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
10787358|NCT03483623|11947693|FG000|Started RAVEN FIS|Overall Study||44
10787359|NCT03483623|11947693|FG000|Completed RAVEN FIS|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
10787360|NCT03483623|11947693|FG000|COMPLETED|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
10787361|NCT03483623|11947693|FG000|NOT COMPLETED|Overall Study||1
10787362|NCT03483675|11947699|FG000|STARTED|Overall Study||9
10787363|NCT03483675|11947700|FG001|STARTED|Overall Study||8
10434385|NCT00891995|11580763|FG001|STARTED|Overall Study||21
10787364|NCT03483675|11947699|FG000|COMPLETED|Overall Study||9
10787365|NCT03483675|11947700|FG001|COMPLETED|Overall Study||8
10434386|NCT00891995|11580762|FG000|COMPLETED|Overall Study||50
10434387|NCT00891995|11580763|FG001|COMPLETED|Overall Study||21
10787366|NCT03483675|11947699|FG000|NOT COMPLETED|Overall Study||0
10434388|NCT00891995|11580762|FG000|NOT COMPLETED|Overall Study||0
10434389|NCT00891995|11580763|FG001|NOT COMPLETED|Overall Study||0
10434390|NCT00892008|11580769|FG000|STARTED|Overall Study||2278
10434391|NCT00892008|11580769|FG000|COMPLETED|Overall Study||1713
10434392|NCT00892008|11580769|FG000|NOT COMPLETED|Overall Study||565
10434393|NCT00892047|11580775|FG000|STARTED|Overall Study||91
10434394|NCT00892047|11580776|FG001|STARTED|Overall Study||90
10434395|NCT00892047|11580775|FG000|COMPLETED|Overall Study||87
10434396|NCT00892047|11580776|FG001|COMPLETED|Overall Study||83
10434397|NCT00892047|11580775|FG000|NOT COMPLETED|Overall Study||4
10434398|NCT00892047|11580776|FG001|NOT COMPLETED|Overall Study||7
10434399|NCT00892099|11580787|FG000|STARTED|Overall Study||36
10434400|NCT00892099|11580788|FG001|STARTED|Overall Study||33
10434401|NCT00892099|11580789|FG002|STARTED|Overall Study||36
10434402|NCT00892099|11580787|FG000|COMPLETED|Overall Study||31
10434403|NCT00892099|11580788|FG001|COMPLETED|Overall Study||32
10434404|NCT00892099|11580789|FG002|COMPLETED|Overall Study||29
10434405|NCT00892099|11580787|FG000|NOT COMPLETED|Overall Study||5
10434406|NCT00892099|11580788|FG001|NOT COMPLETED|Overall Study||1
10434407|NCT00892099|11580789|FG002|NOT COMPLETED|Overall Study||7
10434408|NCT00892151|11580797|FG000|STARTED|Overall Study||51
10434409|NCT00892151|11580797|FG000|COMPLETED|Overall Study||50
10434410|NCT00892151|11580797|FG000|NOT COMPLETED|Overall Study||1
10434411|NCT00892177|11580804|FG000|STARTED|Phase I: Dose Level 0||3
10434412|NCT00892177|11580805|FG001|STARTED|Phase I: Dose Level 0||0
10434413|NCT00892177|11580806|FG002|STARTED|Phase I: Dose Level 0||0
10434414|NCT00892177|11580807|FG003|STARTED|Phase I: Dose Level 0||0
10434415|NCT00892177|11580808|FG004|STARTED|Phase I: Dose Level 0||0
10434416|NCT00892177|11580809|FG005|STARTED|Phase I: Dose Level 0||0
10434417|NCT00892177|11580804|FG000|COMPLETED|Phase I: Dose Level 0||3
10434418|NCT00892177|11580805|FG001|COMPLETED|Phase I: Dose Level 0||0
10434419|NCT00892177|11580806|FG002|COMPLETED|Phase I: Dose Level 0||0
10434420|NCT00892177|11580807|FG003|COMPLETED|Phase I: Dose Level 0||0
10434421|NCT00892177|11580808|FG004|COMPLETED|Phase I: Dose Level 0||0
10434422|NCT00892177|11580809|FG005|COMPLETED|Phase I: Dose Level 0||0
10434423|NCT00892177|11580804|FG000|NOT COMPLETED|Phase I: Dose Level 0||0
10434424|NCT00892177|11580805|FG001|NOT COMPLETED|Phase I: Dose Level 0||0
10434425|NCT00892177|11580806|FG002|NOT COMPLETED|Phase I: Dose Level 0||0
10434426|NCT00892177|11580807|FG003|NOT COMPLETED|Phase I: Dose Level 0||0
10434427|NCT00892177|11580808|FG004|NOT COMPLETED|Phase I: Dose Level 0||0
10434428|NCT00892177|11580809|FG005|NOT COMPLETED|Phase I: Dose Level 0||0
10434429|NCT00892177|11580804|FG000|STARTED|Phase I: Dose Level 1||0
10434430|NCT00892177|11580805|FG001|STARTED|Phase I: Dose Level 1||4
10434431|NCT00892177|11580806|FG002|STARTED|Phase I: Dose Level 1||0
10434432|NCT00892177|11580807|FG003|STARTED|Phase I: Dose Level 1||0
10434433|NCT00892177|11580808|FG004|STARTED|Phase I: Dose Level 1||0
10434434|NCT00892177|11580809|FG005|STARTED|Phase I: Dose Level 1||0
10434435|NCT00892177|11580804|FG000|COMPLETED|Phase I: Dose Level 1||0
10434436|NCT00892177|11580805|FG001|COMPLETED|Phase I: Dose Level 1||4
10434437|NCT00892177|11580806|FG002|COMPLETED|Phase I: Dose Level 1||0
10434438|NCT00892177|11580807|FG003|COMPLETED|Phase I: Dose Level 1||0
10434439|NCT00892177|11580808|FG004|COMPLETED|Phase I: Dose Level 1||0
10434440|NCT00892177|11580809|FG005|COMPLETED|Phase I: Dose Level 1||0
10434441|NCT00892177|11580804|FG000|NOT COMPLETED|Phase I: Dose Level 1||0
10434442|NCT00892177|11580805|FG001|NOT COMPLETED|Phase I: Dose Level 1||0
10434443|NCT00892177|11580806|FG002|NOT COMPLETED|Phase I: Dose Level 1||0
10434444|NCT00892177|11580807|FG003|NOT COMPLETED|Phase I: Dose Level 1||0
10434445|NCT00892177|11580808|FG004|NOT COMPLETED|Phase I: Dose Level 1||0
10434446|NCT00892177|11580809|FG005|NOT COMPLETED|Phase I: Dose Level 1||0
10434447|NCT00892177|11580804|FG000|STARTED|Phase I: Dose Level 2||0
10434448|NCT00892177|11580805|FG001|STARTED|Phase I: Dose Level 2||0
10434449|NCT00892177|11580806|FG002|STARTED|Phase I: Dose Level 2||3
10434450|NCT00892177|11580807|FG003|STARTED|Phase I: Dose Level 2||0
10434451|NCT00892177|11580808|FG004|STARTED|Phase I: Dose Level 2||0
10434452|NCT00892177|11580809|FG005|STARTED|Phase I: Dose Level 2||0
10434453|NCT00892177|11580804|FG000|COMPLETED|Phase I: Dose Level 2||0
10434454|NCT00892177|11580805|FG001|COMPLETED|Phase I: Dose Level 2||0
10434455|NCT00892177|11580806|FG002|COMPLETED|Phase I: Dose Level 2||3
10434456|NCT00892177|11580807|FG003|COMPLETED|Phase I: Dose Level 2||0
10434457|NCT00892177|11580808|FG004|COMPLETED|Phase I: Dose Level 2||0
10434458|NCT00892177|11580809|FG005|COMPLETED|Phase I: Dose Level 2||0
10434460|NCT00892177|11580805|FG001|NOT COMPLETED|Phase I: Dose Level 2||0
10434461|NCT00892177|11580806|FG002|NOT COMPLETED|Phase I: Dose Level 2||0
10434462|NCT00892177|11580807|FG003|NOT COMPLETED|Phase I: Dose Level 2||0
10434463|NCT00892177|11580808|FG004|NOT COMPLETED|Phase I: Dose Level 2||0
10434464|NCT00892177|11580809|FG005|NOT COMPLETED|Phase I: Dose Level 2||0
10434465|NCT00892177|11580804|FG000|STARTED|Phase I: Dose Level 3||0
10434466|NCT00892177|11580805|FG001|STARTED|Phase I: Dose Level 3||0
10434467|NCT00892177|11580806|FG002|STARTED|Phase I: Dose Level 3||0
10434468|NCT00892177|11580807|FG003|STARTED|Phase I: Dose Level 3||6
10434469|NCT00892177|11580808|FG004|STARTED|Phase I: Dose Level 3||0
10434470|NCT00892177|11580809|FG005|STARTED|Phase I: Dose Level 3||0
10434471|NCT00892177|11580804|FG000|COMPLETED|Phase I: Dose Level 3||0
10434472|NCT00892177|11580805|FG001|COMPLETED|Phase I: Dose Level 3||0
10434473|NCT00892177|11580806|FG002|COMPLETED|Phase I: Dose Level 3||0
10434474|NCT00892177|11580807|FG003|COMPLETED|Phase I: Dose Level 3||6
10434475|NCT00892177|11580808|FG004|COMPLETED|Phase I: Dose Level 3||0
10434476|NCT00892177|11580809|FG005|COMPLETED|Phase I: Dose Level 3||0
10434477|NCT00892177|11580804|FG000|NOT COMPLETED|Phase I: Dose Level 3||0
10434478|NCT00892177|11580805|FG001|NOT COMPLETED|Phase I: Dose Level 3||0
10434479|NCT00892177|11580806|FG002|NOT COMPLETED|Phase I: Dose Level 3||0
10434480|NCT00892177|11580807|FG003|NOT COMPLETED|Phase I: Dose Level 3||0
10434481|NCT00892177|11580808|FG004|NOT COMPLETED|Phase I: Dose Level 3||0
10434482|NCT00892177|11580809|FG005|NOT COMPLETED|Phase I: Dose Level 3||0
10434483|NCT00892177|11580804|FG000|STARTED|Phase II||0
10434484|NCT00892177|11580805|FG001|STARTED|Phase II||0
10434485|NCT00892177|11580806|FG002|STARTED|Phase II||0
10434486|NCT00892177|11580807|FG003|STARTED|Phase II||0
10434487|NCT00892177|11580808|FG004|STARTED|Phase II||88
10434488|NCT00892177|11580809|FG005|STARTED|Phase II||40
10434489|NCT00892177|11580804|FG000|COMPLETED|Phase II||0
10434490|NCT00892177|11580805|FG001|COMPLETED|Phase II||0
10434491|NCT00892177|11580806|FG002|COMPLETED|Phase II||0
10434492|NCT00892177|11580807|FG003|COMPLETED|Phase II||0
10434493|NCT00892177|11580808|FG004|COMPLETED|Phase II||83
10434494|NCT00892177|11580809|FG005|COMPLETED|Phase II||38
10434495|NCT00892177|11580804|FG000|NOT COMPLETED|Phase II||0
10434496|NCT00892177|11580805|FG001|NOT COMPLETED|Phase II||0
10434497|NCT00892177|11580806|FG002|NOT COMPLETED|Phase II||0
10434498|NCT00892177|11580807|FG003|NOT COMPLETED|Phase II||0
10434499|NCT00892177|11580808|FG004|NOT COMPLETED|Phase II||5
10434500|NCT00892177|11580809|FG005|NOT COMPLETED|Phase II||2
10787367|NCT03483675|11947700|FG001|NOT COMPLETED|Overall Study||0
10787368|NCT03483896|11947709|FG000|STARTED|Overall Study||33
10787369|NCT03483896|11947710|FG001|STARTED|Overall Study||50
10787370|NCT03483896|11947709|FG000|COMPLETED|Overall Study||31
10787371|NCT03483896|11947710|FG001|COMPLETED|Overall Study||46
10787372|NCT03483896|11947709|FG000|NOT COMPLETED|Overall Study||2
10787373|NCT03483896|11947710|FG001|NOT COMPLETED|Overall Study||4
10787374|NCT03483935|11947718|FG000|STARTED|Stage 1: Dose Setting Study||7
10787375|NCT03483935|11947718|FG000|COMPLETED|Stage 1: Dose Setting Study||7
10787376|NCT03483935|11947718|FG000|NOT COMPLETED|Stage 1: Dose Setting Study||0
10434507|NCT00892437|11580835|FG000|STARTED|Randomized Phase||56
10434508|NCT00892437|11580836|FG001|STARTED|Randomized Phase||29
10434509|NCT00892437|11580835|FG000|Randomized and Treated|Randomized Phase||50
10434510|NCT00892437|11580836|FG001|Randomized and Treated|Randomized Phase||29
10434511|NCT00892437|11580835|FG000|COMPLETED|Randomized Phase||45
10434512|NCT00892437|11580836|FG001|COMPLETED|Randomized Phase||24
10434513|NCT00892437|11580835|FG000|NOT COMPLETED|Randomized Phase||11
10434514|NCT00892437|11580836|FG001|NOT COMPLETED|Randomized Phase||5
10434515|NCT00892437|11580835|FG000|STARTED|Open-Label Extension Phase|1 participant completed the randomized phase but did not enter the open-label extension phase.|44
10434516|NCT00892437|11580836|FG001|STARTED|Open-Label Extension Phase|5 participants completed the randomized phase but did not enter the open-label extension phase.|19
10434517|NCT00892437|11580835|FG000|COMPLETED|Open-Label Extension Phase||32
10434518|NCT00892437|11580836|FG001|COMPLETED|Open-Label Extension Phase||15
10434519|NCT00892437|11580835|FG000|NOT COMPLETED|Open-Label Extension Phase||12
10434520|NCT00892437|11580836|FG001|NOT COMPLETED|Open-Label Extension Phase||4
10434521|NCT00892606|11580845|FG000|STARTED|Overall Study||38
10434522|NCT00892606|11580846|FG001|STARTED|Overall Study||37
10434523|NCT00892606|11580845|FG000|COMPLETED|Overall Study||33
10434524|NCT00892606|11580846|FG001|COMPLETED|Overall Study||33
10434525|NCT00892606|11580845|FG000|NOT COMPLETED|Overall Study||5
10434526|NCT00892606|11580846|FG001|NOT COMPLETED|Overall Study||4
10434527|NCT00892697|11580852|FG000|STARTED|Overall Study||15
10434528|NCT00892697|11580852|FG000|COMPLETED|Overall Study||15
10434529|NCT00892697|11580852|FG000|NOT COMPLETED|Overall Study||0
10434530|NCT00892710|11580860|FG000|STARTED|Overall Study||48
10434531|NCT00892710|11580861|FG001|STARTED|Overall Study||59
10434532|NCT00892710|11580862|FG002|STARTED|Overall Study||55
10434533|NCT00892710|11580860|FG000|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
10434534|NCT00892710|11580861|FG001|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
10434535|NCT00892710|11580862|FG002|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
10434536|NCT00892710|11580860|FG000|NOT COMPLETED|Overall Study||48
10434537|NCT00892710|11580861|FG001|NOT COMPLETED|Overall Study||59
10434538|NCT00892710|11580862|FG002|NOT COMPLETED|Overall Study||55
10434539|NCT00892723|11580873|FG000|STARTED|Overall Study||21
10434540|NCT00892723|11580874|FG001|STARTED|Overall Study||19
10434541|NCT00892723|11580875|FG002|STARTED|Overall Study||19
10434542|NCT00892723|11580873|FG000|COMPLETED|Overall Study||19
10434543|NCT00892723|11580874|FG001|COMPLETED|Overall Study||15
10434544|NCT00892723|11580875|FG002|COMPLETED|Overall Study||17
10434545|NCT00892723|11580873|FG000|NOT COMPLETED|Overall Study||2
10434546|NCT00892723|11580874|FG001|NOT COMPLETED|Overall Study||4
10434547|NCT00892723|11580875|FG002|NOT COMPLETED|Overall Study||2
10434548|NCT00892775|11580918|FG000|STARTED|Overall Study||332
10434549|NCT00892775|11580919|FG001|STARTED|Overall Study||166
10810671|NCT03792672|11972460|FG004|STARTED|Treatment Period 1 (1 Day)||4
10434550|NCT00892775|11580918|FG000|COMPLETED|Overall Study||327
10434551|NCT00892775|11580919|FG001|COMPLETED|Overall Study||165
10434552|NCT00892775|11580918|FG000|NOT COMPLETED|Overall Study||5
10434553|NCT00892775|11580919|FG001|NOT COMPLETED|Overall Study||1
10434554|NCT00892957|11580927|FG000|STARTED|Intraoperative Day 0||70
10434555|NCT00892957|11580928|FG001|STARTED|Intraoperative Day 0||70
10434556|NCT00892957|11580927|FG000|COMPLETED|Intraoperative Day 0||70
10434557|NCT00892957|11580928|FG001|COMPLETED|Intraoperative Day 0||70
10787377|NCT03483935|11947718|FG000|STARTED|Stage 2: Randomised Controlled Trial|Participants were randomised to receiving treatment on the left or right side.|11
10787378|NCT03483935|11947718|FG000|AKs Treated|Stage 2: Randomised Controlled Trial||11
10787379|NCT03483935|11947718|FG000|AKs Not Treated|Stage 2: Randomised Controlled Trial||11
10434558|NCT00892957|11580927|FG000|NOT COMPLETED|Intraoperative Day 0||0
10434559|NCT00892957|11580928|FG001|NOT COMPLETED|Intraoperative Day 0||0
10434560|NCT00892957|11580927|FG000|STARTED|Postoperative Day 1 Assessment||70
10434561|NCT00892957|11580928|FG001|STARTED|Postoperative Day 1 Assessment||70
10434562|NCT00892957|11580927|FG000|COMPLETED|Postoperative Day 1 Assessment||70
10434563|NCT00892957|11580928|FG001|COMPLETED|Postoperative Day 1 Assessment||70
10434564|NCT00892957|11580927|FG000|NOT COMPLETED|Postoperative Day 1 Assessment||0
10434565|NCT00892957|11580928|FG001|NOT COMPLETED|Postoperative Day 1 Assessment||0
10434566|NCT00892957|11580927|FG000|STARTED|Between Postoperative Day 1 and Day 14||70
10434567|NCT00892957|11580928|FG001|STARTED|Between Postoperative Day 1 and Day 14||70
10434568|NCT00892957|11580927|FG000|COMPLETED|Between Postoperative Day 1 and Day 14||70
10434569|NCT00892957|11580928|FG001|COMPLETED|Between Postoperative Day 1 and Day 14||66
10434570|NCT00892957|11580927|FG000|NOT COMPLETED|Between Postoperative Day 1 and Day 14||0
10434571|NCT00892957|11580928|FG001|NOT COMPLETED|Between Postoperative Day 1 and Day 14||4
10434572|NCT00892957|11580927|FG000|STARTED|Postoperative Day 14 Assessment|Two participants missed postoperative Day 14 assessment, both returned for Day 30 postop assessment|68
10434573|NCT00892957|11580928|FG001|STARTED|Postoperative Day 14 Assessment||66
10434574|NCT00892957|11580927|FG000|COMPLETED|Postoperative Day 14 Assessment||68
10434575|NCT00892957|11580928|FG001|COMPLETED|Postoperative Day 14 Assessment||66
10434576|NCT00892957|11580927|FG000|NOT COMPLETED|Postoperative Day 14 Assessment||0
10434577|NCT00892957|11580928|FG001|NOT COMPLETED|Postoperative Day 14 Assessment||0
10434578|NCT00892957|11580927|FG000|STARTED|Postoperative Day 30 Assessment|Two participants missed postoperative Day 14 assessment, both returned for Day 30 postop assessment|70
10434579|NCT00892957|11580928|FG001|STARTED|Postoperative Day 30 Assessment||66
10434580|NCT00892957|11580927|FG000|COMPLETED|Postoperative Day 30 Assessment||70
10787380|NCT03483935|11947718|FG000|COMPLETED|Stage 2: Randomised Controlled Trial||11
10787381|NCT03483935|11947718|FG000|NOT COMPLETED|Stage 2: Randomised Controlled Trial||0
10787382|NCT03483961|11947736|FG000|STARTED|Overall Study||53
10787383|NCT03483961|11947737|FG001|STARTED|Overall Study||52
10787384|NCT03483961|11947738|FG002|STARTED|Overall Study||51
10787385|NCT03483961|11947739|FG003|STARTED|Overall Study||50
10787386|NCT03483961|11947740|FG004|STARTED|Overall Study||53
10787387|NCT03483961|11947741|FG005|STARTED|Overall Study||53
10787388|NCT03483961|11947742|FG006|STARTED|Overall Study||51
10787389|NCT03483961|11947743|FG007|STARTED|Overall Study||52
10787390|NCT03483961|11947744|FG008|STARTED|Overall Study||20
10787391|NCT03483961|11947745|FG009|STARTED|Overall Study||10
10787392|NCT03483961|11947736|FG000|Exposed / Safety|Overall Study||53
10434581|NCT00892957|11580928|FG001|COMPLETED|Postoperative Day 30 Assessment||66
10434582|NCT00892957|11580927|FG000|NOT COMPLETED|Postoperative Day 30 Assessment||0
10434583|NCT00892957|11580928|FG001|NOT COMPLETED|Postoperative Day 30 Assessment||0
10434584|NCT00893074|11580948|FG000|STARTED|Overall Study||24
10434585|NCT00893074|11580948|FG000|COMPLETED|Overall Study||13
10434586|NCT00893074|11580948|FG000|NOT COMPLETED|Overall Study||11
10434587|NCT00893113|11580965|FG000|STARTED|Overall Study||36
10434588|NCT00893113|11580966|FG001|STARTED|Overall Study||38
10434589|NCT00893113|11580965|FG000|COMPLETED|Overall Study||23
10434590|NCT00893113|11580966|FG001|COMPLETED|Overall Study||22
10434591|NCT00893113|11580965|FG000|NOT COMPLETED|Overall Study||13
10434592|NCT00893113|11580966|FG001|NOT COMPLETED|Overall Study||16
10434593|NCT00893152|11580974|FG000|STARTED|Overall Study||47
10434594|NCT00893152|11580975|FG001|STARTED|Overall Study||36
10434595|NCT00893152|11580974|FG000|COMPLETED|Overall Study||47
10434596|NCT00893152|11580975|FG001|COMPLETED|Overall Study||36
10434597|NCT00893152|11580974|FG000|NOT COMPLETED|Overall Study||0
10434598|NCT00893152|11580975|FG001|NOT COMPLETED|Overall Study||0
10434599|NCT00893464|11580989|FG000|STARTED|Overall Study||1
10434600|NCT00893464|11580990|FG001|STARTED|Overall Study||1
10434601|NCT00893464|11580991|FG002|STARTED|Overall Study||1
10434602|NCT00893464|11580992|FG003|STARTED|Overall Study||1
10434603|NCT00893464|11580993|FG004|STARTED|Overall Study||4
10434604|NCT00893464|11580994|FG005|STARTED|Overall Study||7
10434605|NCT00893464|11580995|FG006|STARTED|Overall Study||10
10434606|NCT00893464|11580996|FG007|STARTED|Overall Study||5
10434607|NCT00893464|11580989|FG000|COMPLETED|Overall Study||1
10434608|NCT00893464|11580990|FG001|COMPLETED|Overall Study||1
10434609|NCT00893464|11580991|FG002|COMPLETED|Overall Study||1
10434610|NCT00893464|11580992|FG003|COMPLETED|Overall Study||1
10434611|NCT00893464|11580993|FG004|COMPLETED|Overall Study||4
10434612|NCT00893464|11580994|FG005|COMPLETED|Overall Study||7
10434613|NCT00893464|11580995|FG006|COMPLETED|Overall Study||8
10434614|NCT00893464|11580996|FG007|COMPLETED|Overall Study||3
10434615|NCT00893464|11580989|FG000|NOT COMPLETED|Overall Study||0
10434616|NCT00893464|11580990|FG001|NOT COMPLETED|Overall Study||0
10434617|NCT00893464|11580991|FG002|NOT COMPLETED|Overall Study||0
10434618|NCT00893464|11580992|FG003|NOT COMPLETED|Overall Study||0
10434619|NCT00893464|11580993|FG004|NOT COMPLETED|Overall Study||0
10434620|NCT00893464|11580994|FG005|NOT COMPLETED|Overall Study||0
10434621|NCT00893464|11580995|FG006|NOT COMPLETED|Overall Study||2
10434622|NCT00893464|11580996|FG007|NOT COMPLETED|Overall Study||2
10434623|NCT00893737|11581019|FG000|STARTED|Overall Study||147
10434624|NCT00893737|11581019|FG000|COMPLETED|Overall Study||135
10434625|NCT00893737|11581019|FG000|NOT COMPLETED|Overall Study||12
10434626|NCT00893763|11581025|FG000|STARTED|Overall Study||157
10434627|NCT00893763|11581026|FG001|STARTED|Overall Study||157
10434628|NCT00893763|11581025|FG000|COMPLETED|Overall Study||47
10434629|NCT00893763|11581026|FG001|COMPLETED|Overall Study||47
10434630|NCT00893763|11581025|FG000|NOT COMPLETED|Overall Study||110
10434631|NCT00893763|11581026|FG001|NOT COMPLETED|Overall Study||110
10434632|NCT00893971|11581034|FG000|STARTED|Overall Study||16
10434633|NCT00893971|11581034|FG000|Placebo + GP MDI (PT001)|Overall Study||15
10434634|NCT00893971|11581034|FG000|Placebo + GFF MDI (PT003)|Overall Study||15
10434635|NCT00893971|11581034|FG000|Placebo + FF MDI (PT005)|Overall Study||13
10434636|NCT00893971|11581034|FG000|GP MDI (PT001) + FF MDI (PT005)|Overall Study||16
10434637|NCT00893971|11581034|FG000|COMPLETED|Overall Study||13
10434638|NCT00893971|11581034|FG000|NOT COMPLETED|Overall Study||3
10434639|NCT00893984|11581047|FG000|STARTED|Overall Study||6
10434640|NCT00893984|11581047|FG000|COMPLETED|Overall Study||0
10434641|NCT00893984|11581047|FG000|NOT COMPLETED|Overall Study||6
10434642|NCT00893997|11581051|FG000|STARTED|Overall Study||10
10434643|NCT00893997|11581051|FG000|COMPLETED|Overall Study||10
10434644|NCT00893997|11581051|FG000|NOT COMPLETED|Overall Study||0
10434645|NCT00894127|11581055|FG000|STARTED|Overall Study||128
10434646|NCT00894127|11581055|FG000|COMPLETED|Overall Study||128
10434647|NCT00894127|11581055|FG000|NOT COMPLETED|Overall Study||0
10434648|NCT00894166|11581067|FG000|STARTED|Overall Study||132
10434649|NCT00894166|11581068|FG001|STARTED|Overall Study||109
10434650|NCT00894166|11581069|FG002|STARTED|Overall Study||112
10434651|NCT00894166|11581070|FG003|STARTED|Overall Study||114
10434652|NCT00894166|11581071|FG004|STARTED|Overall Study||34
10434653|NCT00894166|11581072|FG005|STARTED|Overall Study||36
10434654|NCT00894166|11581073|FG006|STARTED|Overall Study||35
10434655|NCT00894166|11581074|FG007|STARTED|Overall Study||34
10434656|NCT00894166|11581067|FG000|COMPLETED|Overall Study||71
10434657|NCT00894166|11581068|FG001|COMPLETED|Overall Study||46
10434658|NCT00894166|11581069|FG002|COMPLETED|Overall Study||50
10434659|NCT00894166|11581070|FG003|COMPLETED|Overall Study||45
10434660|NCT00894166|11581071|FG004|COMPLETED|Overall Study||10
10434661|NCT00894166|11581072|FG005|COMPLETED|Overall Study||20
10434662|NCT00894166|11581073|FG006|COMPLETED|Overall Study||19
10434663|NCT00894166|11581074|FG007|COMPLETED|Overall Study||0
10434664|NCT00894166|11581067|FG000|NOT COMPLETED|Overall Study||61
10434665|NCT00894166|11581068|FG001|NOT COMPLETED|Overall Study||63
10434666|NCT00894166|11581069|FG002|NOT COMPLETED|Overall Study||62
10434667|NCT00894166|11581070|FG003|NOT COMPLETED|Overall Study||69
10434668|NCT00894166|11581071|FG004|NOT COMPLETED|Overall Study||24
10434669|NCT00894166|11581072|FG005|NOT COMPLETED|Overall Study||16
10434670|NCT00894166|11581073|FG006|NOT COMPLETED|Overall Study||16
10434671|NCT00894166|11581074|FG007|NOT COMPLETED|Overall Study||34
10434672|NCT00894322|11581100|FG000|STARTED|Overall Study||30
10434673|NCT00894322|11581101|FG001|STARTED|Overall Study||23
10434674|NCT00894322|11581102|FG002|STARTED|Overall Study||12
10434675|NCT00894322|11581100|FG000|COMPLETED|Overall Study||29
10434676|NCT00894322|11581101|FG001|COMPLETED|Overall Study||23
10434677|NCT00894322|11581102|FG002|COMPLETED|Overall Study||12
10434678|NCT00894322|11581100|FG000|NOT COMPLETED|Overall Study||1
10434679|NCT00894322|11581101|FG001|NOT COMPLETED|Overall Study||0
10434680|NCT00894322|11581102|FG002|NOT COMPLETED|Overall Study||0
10434681|NCT00894361|11581114|FG000|STARTED|Overall Study||200
10434682|NCT00894361|11581115|FG001|STARTED|Overall Study||200
10434683|NCT00894361|11581114|FG000|COMPLETED|Overall Study||176
10434684|NCT00894361|11581115|FG001|COMPLETED|Overall Study||136
10434685|NCT00894361|11581114|FG000|NOT COMPLETED|Overall Study||24
10434686|NCT00894361|11581115|FG001|NOT COMPLETED|Overall Study||64
10434687|NCT00894387|11581125|FG000|STARTED|Overall Study|"Started indicates all randomized patients"|821
10434688|NCT00894387|11581126|FG001|STARTED|Overall Study||818
10434689|NCT00894387|11581125|FG000|Safety Set|Overall Study||808
10434690|NCT00894387|11581126|FG001|Safety Set|Overall Study||810
10434691|NCT00894387|11581125|FG000|Full Analysis Set|Overall Study||808
10434692|NCT00894387|11581126|FG001|Full Analysis Set|Overall Study||807
10434693|NCT00894387|11581125|FG000|Completed Primary Efficacy Phase (6 m)|Overall Study||717
10434694|NCT00894387|11581126|FG001|Completed Primary Efficacy Phase (6 m)|Overall Study||707
10434695|NCT00894387|11581125|FG000|Completed Secondary Efficacy Phase (12m)|Overall Study||654
10434696|NCT00894387|11581126|FG001|Completed Secondary Efficacy Phase (12m)|Overall Study||640
10434697|NCT00894387|11581125|FG000|COMPLETED|Overall Study|"Completed indicates patients whose treatment duration completed as per protocol"|646
10434698|NCT00894387|11581126|FG001|COMPLETED|Overall Study||643
10434699|NCT00894387|11581125|FG000|NOT COMPLETED|Overall Study||175
10434700|NCT00894387|11581126|FG001|NOT COMPLETED|Overall Study||175
10434701|NCT00894413|11581134|FG000|STARTED|Overall Study||15
10434702|NCT00894413|11581135|FG001|STARTED|Overall Study||25
10434703|NCT00894413|11581134|FG000|COMPLETED|Overall Study||15
10434704|NCT00894413|11581135|FG001|COMPLETED|Overall Study||17
10434705|NCT00894413|11581134|FG000|NOT COMPLETED|Overall Study||0
10434706|NCT00894413|11581135|FG001|NOT COMPLETED|Overall Study||8
10434707|NCT00894465|11581143|FG000|STARTED|Overall Study||22
10434708|NCT00894465|11581144|FG001|STARTED|Overall Study||22
10434709|NCT00894465|11581143|FG000|COMPLETED|Overall Study||22
10434710|NCT00894465|11581144|FG001|COMPLETED|Overall Study||22
10434711|NCT00894465|11581143|FG000|NOT COMPLETED|Overall Study||0
10434712|NCT00894465|11581144|FG001|NOT COMPLETED|Overall Study||0
10434713|NCT00894504|11581152|FG000|STARTED|Overall Study||71
10787393|NCT03483961|11947737|FG001|Exposed / Safety|Overall Study||52
10787394|NCT03483961|11947738|FG002|Exposed / Safety|Overall Study|One subject was randomized to Group 3 but treated in Group 4 due to a dispensing error.|50
10787395|NCT03483961|11947739|FG003|Exposed / Safety|Overall Study|One subject was randomized to Group 3 but treated in Group 4 due to a dispensing error.|51
10787396|NCT03483961|11947740|FG004|Exposed / Safety|Overall Study|One subject did not receive PXVX0317 but is in the Exposed / Safety population because of receipt of placebo.|53
10787397|NCT03483961|11947741|FG005|Exposed / Safety|Overall Study||53
10787398|NCT03483961|11947742|FG006|Exposed / Safety|Overall Study|One subject did not receive PXVX0317 but is in the Exposed / Safety population because of receipt of placebo.|51
10787399|NCT03483961|11947743|FG007|Exposed / Safety|Overall Study|Two subjects did not receive PXVX0317 but are in the Exposed / Safety population because of receipt of placebo.|52
10787400|NCT03483961|11947744|FG008|Exposed / Safety|Overall Study||20
10787401|NCT03483961|11947745|FG009|Exposed / Safety|Overall Study||10
10787402|NCT03483961|11947736|FG000|Immunogenicity-evaluable|Overall Study||47
10787403|NCT03483961|11947737|FG001|Immunogenicity-evaluable|Overall Study||44
10787404|NCT03483961|11947738|FG002|Immunogenicity-evaluable|Overall Study||44
10787405|NCT03483961|11947739|FG003|Immunogenicity-evaluable|Overall Study||45
10787406|NCT03483961|11947740|FG004|Immunogenicity-evaluable|Overall Study||48
10787407|NCT03483961|11947741|FG005|Immunogenicity-evaluable|Overall Study||48
10787408|NCT03483961|11947742|FG006|Immunogenicity-evaluable|Overall Study||47
10787409|NCT03483961|11947743|FG007|Immunogenicity-evaluable|Overall Study||50
10787410|NCT03483961|11947744|FG008|Immunogenicity-evaluable|Overall Study||20
10434714|NCT00894504|11581152|FG000|COMPLETED|Overall Study||0
10434715|NCT00894504|11581152|FG000|NOT COMPLETED|Overall Study||71
10434716|NCT00894517|11581168|FG000|STARTED|Overall Study||30
10434717|NCT00894517|11581169|FG001|STARTED|Overall Study||31
10434718|NCT00894517|11581168|FG000|COMPLETED|Overall Study||28
10434719|NCT00894517|11581169|FG001|COMPLETED|Overall Study||26
10434720|NCT00894517|11581168|FG000|NOT COMPLETED|Overall Study||2
10434721|NCT00894517|11581169|FG001|NOT COMPLETED|Overall Study||5
10787411|NCT03483961|11947745|FG009|Immunogenicity-evaluable|Overall Study||10
10787412|NCT03483961|11947736|FG000|COMPLETED|Overall Study||42
10787413|NCT03483961|11947737|FG001|COMPLETED|Overall Study||42
10787414|NCT03483961|11947738|FG002|COMPLETED|Overall Study||39
10787415|NCT03483961|11947739|FG003|COMPLETED|Overall Study||41
10787416|NCT03483961|11947740|FG004|COMPLETED|Overall Study||43
10787417|NCT03483961|11947741|FG005|COMPLETED|Overall Study||47
10787418|NCT03483961|11947742|FG006|COMPLETED|Overall Study||46
10787419|NCT03483961|11947743|FG007|COMPLETED|Overall Study||39
10787420|NCT03483961|11947744|FG008|COMPLETED|Overall Study||18
10434722|NCT00894543|11581177|FG000|STARTED|Baseline||104
10434723|NCT00894543|11581178|FG001|STARTED|Baseline||101
10434724|NCT00894543|11581177|FG000|COMPLETED|Baseline||104
10434725|NCT00894543|11581178|FG001|COMPLETED|Baseline||101
10434726|NCT00894543|11581177|FG000|NOT COMPLETED|Baseline||0
10434727|NCT00894543|11581178|FG001|NOT COMPLETED|Baseline||0
10434728|NCT00894543|11581177|FG000|STARTED|Baseline to Week 4||104
10434729|NCT00894543|11581178|FG001|STARTED|Baseline to Week 4||101
10434730|NCT00894543|11581177|FG000|COMPLETED|Baseline to Week 4||101
10434731|NCT00894543|11581178|FG001|COMPLETED|Baseline to Week 4||99
10434732|NCT00894543|11581177|FG000|NOT COMPLETED|Baseline to Week 4||3
10434733|NCT00894543|11581178|FG001|NOT COMPLETED|Baseline to Week 4||2
10434734|NCT00894543|11581177|FG000|STARTED|Week 4 to Week 8||101
10434735|NCT00894543|11581178|FG001|STARTED|Week 4 to Week 8||99
10434736|NCT00894543|11581177|FG000|COMPLETED|Week 4 to Week 8||97
10434737|NCT00894543|11581178|FG001|COMPLETED|Week 4 to Week 8||97
10434738|NCT00894543|11581177|FG000|NOT COMPLETED|Week 4 to Week 8||4
10434739|NCT00894543|11581178|FG001|NOT COMPLETED|Week 4 to Week 8||2
10434740|NCT00894647|11581186|FG000|STARTED|Overall Study||121
10434741|NCT00894647|11581187|FG001|STARTED|Overall Study||126
10434742|NCT00894647|11581186|FG000|COMPLETED|Overall Study||111
10434743|NCT00894647|11581187|FG001|COMPLETED|Overall Study||112
10434744|NCT00894647|11581186|FG000|NOT COMPLETED|Overall Study||10
10434745|NCT00894647|11581187|FG001|NOT COMPLETED|Overall Study||14
10434746|NCT00894686|11581193|FG000|STARTED|Overall Study||179
10434747|NCT00894686|11581193|FG000|COMPLETED|Overall Study||123
10434748|NCT00894686|11581193|FG000|NOT COMPLETED|Overall Study||56
10434749|NCT00894699|11581199|FG000|STARTED|Overall Study||21
10434750|NCT00894699|11581200|FG001|STARTED|Overall Study||19
10434751|NCT00894699|11581199|FG000|COMPLETED|Overall Study||21
10434752|NCT00894699|11581200|FG001|COMPLETED|Overall Study||19
10434753|NCT00894699|11581199|FG000|NOT COMPLETED|Overall Study||0
10434754|NCT00894699|11581200|FG001|NOT COMPLETED|Overall Study||0
10434755|NCT00894738|11581208|FG000|STARTED|Overall Study||25
10434756|NCT00894738|11581209|FG001|STARTED|Overall Study||19
10434757|NCT00894738|11581208|FG000|COMPLETED|Overall Study||25
10434758|NCT00894738|11581209|FG001|COMPLETED|Overall Study||19
10434759|NCT00894738|11581208|FG000|NOT COMPLETED|Overall Study||0
10434760|NCT00894738|11581209|FG001|NOT COMPLETED|Overall Study||0
10434761|NCT00894803|11581217|FG000|STARTED|Overall Study||101
10434762|NCT00894803|11581218|FG001|STARTED|Overall Study||25
10787421|NCT03483961|11947745|FG009|COMPLETED|Overall Study||10
10787422|NCT03483961|11947736|FG000|NOT COMPLETED|Overall Study||11
10434763|NCT00894803|11581217|FG000|COMPLETED|Overall Study||81
10434764|NCT00894803|11581218|FG001|COMPLETED|Overall Study||20
10434765|NCT00894803|11581217|FG000|NOT COMPLETED|Overall Study||20
10434766|NCT00894803|11581218|FG001|NOT COMPLETED|Overall Study||5
10434767|NCT00894933|11581224|FG000|STARTED|Overall Study||33
10434768|NCT00894933|11581224|FG000|COMPLETED|Overall Study||29
10434769|NCT00894933|11581224|FG000|NOT COMPLETED|Overall Study||4
10434770|NCT00895011|11581231|FG000|STARTED|Overall Study||100
10434771|NCT00895011|11581232|FG001|STARTED|Overall Study||99
10434772|NCT00895011|11581233|FG002|STARTED|Overall Study||99
10434773|NCT00895011|11581231|FG000|COMPLETED|Overall Study||76
10434774|NCT00895011|11581232|FG001|COMPLETED|Overall Study||85
10434775|NCT00895011|11581233|FG002|COMPLETED|Overall Study||91
10434776|NCT00895011|11581231|FG000|NOT COMPLETED|Overall Study||24
10434777|NCT00895011|11581232|FG001|NOT COMPLETED|Overall Study||14
10434778|NCT00895011|11581233|FG002|NOT COMPLETED|Overall Study||8
10434779|NCT00895037|11581245|FG000|STARTED|Overall Study||22
10434780|NCT00895037|11581246|FG001|STARTED|Overall Study||77
10434781|NCT00895037|11581247|FG002|STARTED|Overall Study||2
10434782|NCT00895037|11581245|FG000|COMPLETED|Overall Study||22
10434783|NCT00895037|11581246|FG001|COMPLETED|Overall Study||75
10434784|NCT00895037|11581247|FG002|COMPLETED|Overall Study||1
10434785|NCT00895037|11581245|FG000|NOT COMPLETED|Overall Study||0
10434786|NCT00895037|11581246|FG001|NOT COMPLETED|Overall Study||2
10434787|NCT00895037|11581247|FG002|NOT COMPLETED|Overall Study||1
10434788|NCT00895154|11581257|FG000|STARTED|Overall Study||8
10434789|NCT00895154|11581258|FG001|STARTED|Overall Study||10
10434790|NCT00895154|11581257|FG000|Follow Up|Overall Study||7
10434791|NCT00895154|11581258|FG001|Follow Up|Overall Study||8
10434792|NCT00895154|11581257|FG000|COMPLETED|Overall Study||7
10434793|NCT00895154|11581258|FG001|COMPLETED|Overall Study||8
10434794|NCT00895154|11581257|FG000|NOT COMPLETED|Overall Study||1
10434795|NCT00895154|11581258|FG001|NOT COMPLETED|Overall Study||2
10525239|NCT01374425|11677095|FG000|STARTED|Overall Study||188
10525240|NCT01374425|11677096|FG001|STARTED|Overall Study||188
10525241|NCT01374425|11677095|FG000|COMPLETED|Overall Study||0
10525242|NCT01374425|11677096|FG001|COMPLETED|Overall Study||0
10525243|NCT01374425|11677095|FG000|NOT COMPLETED|Overall Study||188
10525244|NCT01374425|11677096|FG001|NOT COMPLETED|Overall Study||188
10525245|NCT01374438|11677125|FG000|STARTED|Overall Study||16
10525246|NCT01374438|11677126|FG001|STARTED|Overall Study||13
10525247|NCT01374438|11677125|FG000|COMPLETED|Overall Study||16
10525248|NCT01374438|11677126|FG001|COMPLETED|Overall Study||13
10525249|NCT01374438|11677125|FG000|NOT COMPLETED|Overall Study||0
10525250|NCT01374438|11677126|FG001|NOT COMPLETED|Overall Study||0
10525251|NCT01374451|11677134|FG000|STARTED|Overall Study||79
10525252|NCT01374451|11677135|FG001|STARTED|Overall Study||81
10525253|NCT01374451|11677134|FG000|COMPLETED|Overall Study||78
10525254|NCT01374451|11677135|FG001|COMPLETED|Overall Study||81
10525255|NCT01374451|11677134|FG000|NOT COMPLETED|Overall Study||1
10525256|NCT01374451|11677135|FG001|NOT COMPLETED|Overall Study||0
10525257|NCT01374490|11677141|FG000|STARTED|Overall Study||250
10525258|NCT01374490|11677141|FG000|COMPLETED|Overall Study||190
10525259|NCT01374490|11677141|FG000|NOT COMPLETED|Overall Study||60
10525260|NCT01374568|11677147|FG000|STARTED|Overall Study||2
10525261|NCT01374568|11677148|FG001|STARTED|Overall Study||3
10525262|NCT01374568|11677147|FG000|COMPLETED|Overall Study||2
10525263|NCT01374568|11677148|FG001|COMPLETED|Overall Study||1
10434796|NCT00895180|11581266|FG000|STARTED|Overall Study||40
10434797|NCT00895180|11581267|FG001|STARTED|Overall Study||40
10434798|NCT00895180|11581266|FG000|Received at Least 1 Dose of Study Drug|Overall Study||40
10434799|NCT00895180|11581267|FG001|Received at Least 1 Dose of Study Drug|Overall Study||40
10434800|NCT00895180|11581266|FG000|COMPLETED|Overall Study||40
10434801|NCT00895180|11581267|FG001|COMPLETED|Overall Study||40
10434802|NCT00895180|11581266|FG000|NOT COMPLETED|Overall Study||0
10434803|NCT00895180|11581267|FG001|NOT COMPLETED|Overall Study||0
10434804|NCT00895193|11581279|FG000|STARTED|Overall Study||25
10434805|NCT00895193|11581280|FG001|STARTED|Overall Study||25
10434806|NCT00895193|11581281|FG002|STARTED|Overall Study||25
10434807|NCT00895193|11581282|FG003|STARTED|Overall Study||25
10434808|NCT00895193|11581279|FG000|COMPLETED|Overall Study||25
10434809|NCT00895193|11581280|FG001|COMPLETED|Overall Study||25
10434810|NCT00895193|11581281|FG002|COMPLETED|Overall Study||25
10434811|NCT00895193|11581282|FG003|COMPLETED|Overall Study||25
10434812|NCT00895193|11581279|FG000|NOT COMPLETED|Overall Study||0
10434813|NCT00895193|11581280|FG001|NOT COMPLETED|Overall Study||0
10434814|NCT00895193|11581281|FG002|NOT COMPLETED|Overall Study||0
10434815|NCT00895193|11581282|FG003|NOT COMPLETED|Overall Study||0
10434816|NCT00895232|11581295|FG000|STARTED|Overall Study||7
10434817|NCT00895232|11581296|FG001|STARTED|Overall Study||6
10434818|NCT00895232|11581297|FG002|STARTED|Overall Study||8
10434819|NCT00895232|11581295|FG000|COMPLETED|Overall Study||4
10434820|NCT00895232|11581296|FG001|COMPLETED|Overall Study||2
10434821|NCT00895232|11581297|FG002|COMPLETED|Overall Study||3
10434822|NCT00895232|11581295|FG000|NOT COMPLETED|Overall Study||3
10434823|NCT00895232|11581296|FG001|NOT COMPLETED|Overall Study||4
10434824|NCT00895232|11581297|FG002|NOT COMPLETED|Overall Study||5
10434825|NCT00895245|11581305|FG000|STARTED|Overall Study||6
10434826|NCT00895245|11581305|FG000|COMPLETED|Overall Study||0
10434827|NCT00895245|11581305|FG000|NOT COMPLETED|Overall Study||6
10434828|NCT00895310|11581309|FG000|STARTED|Overall Study||30
10434829|NCT00895310|11581309|FG000|COMPLETED|Overall Study||29
10434830|NCT00895310|11581309|FG000|NOT COMPLETED|Overall Study||1
10434831|NCT00895414|11581313|FG000|STARTED|First Intervention (14 Days)||9
10434832|NCT00895414|11581314|FG001|STARTED|First Intervention (14 Days)||10
10434833|NCT00895414|11581313|FG000|COMPLETED|First Intervention (14 Days)||8
10434834|NCT00895414|11581314|FG001|COMPLETED|First Intervention (14 Days)||9
10434835|NCT00895414|11581313|FG000|NOT COMPLETED|First Intervention (14 Days)||1
10434836|NCT00895414|11581314|FG001|NOT COMPLETED|First Intervention (14 Days)||1
10434837|NCT00895414|11581313|FG000|STARTED|Second Intervention (14 Days)||8
10434838|NCT00895414|11581314|FG001|STARTED|Second Intervention (14 Days)||9
10434839|NCT00895414|11581313|FG000|COMPLETED|Second Intervention (14 Days)||8
10434840|NCT00895414|11581314|FG001|COMPLETED|Second Intervention (14 Days)||9
10434841|NCT00895414|11581313|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
10434842|NCT00895414|11581314|FG001|NOT COMPLETED|Second Intervention (14 Days)||0
10434843|NCT00895453|11581323|FG000|STARTED|Overall Study||48
10434844|NCT00895453|11581324|FG001|STARTED|Overall Study||50
10434845|NCT00895453|11581325|FG002|STARTED|Overall Study||46
10434846|NCT00895453|11581323|FG000|COMPLETED|Overall Study||23
10434847|NCT00895453|11581324|FG001|COMPLETED|Overall Study||25
10434848|NCT00895453|11581325|FG002|COMPLETED|Overall Study||23
10434849|NCT00895453|11581323|FG000|NOT COMPLETED|Overall Study||25
10434850|NCT00895453|11581324|FG001|NOT COMPLETED|Overall Study||25
10434851|NCT00895453|11581325|FG002|NOT COMPLETED|Overall Study||23
10434852|NCT00895531|11581335|FG000|STARTED|Overall Study||38
10434853|NCT00895531|11581336|FG001|STARTED|Overall Study||37
10434854|NCT00895531|11581335|FG000|COMPLETED|Overall Study||38
10434855|NCT00895531|11581336|FG001|COMPLETED|Overall Study||37
10434856|NCT00895531|11581335|FG000|NOT COMPLETED|Overall Study||0
10434857|NCT00895531|11581336|FG001|NOT COMPLETED|Overall Study||0
10787423|NCT03483961|11947737|FG001|NOT COMPLETED|Overall Study||10
10787424|NCT03483961|11947738|FG002|NOT COMPLETED|Overall Study||12
10787425|NCT03483961|11947739|FG003|NOT COMPLETED|Overall Study||9
10787426|NCT03483961|11947740|FG004|NOT COMPLETED|Overall Study||10
10787427|NCT03483961|11947741|FG005|NOT COMPLETED|Overall Study||6
10787428|NCT03483961|11947742|FG006|NOT COMPLETED|Overall Study||5
10787429|NCT03483961|11947743|FG007|NOT COMPLETED|Overall Study||13
10787430|NCT03483961|11947744|FG008|NOT COMPLETED|Overall Study||2
10787431|NCT03483961|11947745|FG009|NOT COMPLETED|Overall Study||0
10787432|NCT03484273|11947766|FG000|STARTED|Overall Study|This was a crossover trial. A total of 32 participants were enrolled in this study.|32
10787433|NCT03484273|11947766|FG000|COMPLETED|Overall Study|This was a crossover trial. A total of 30 participants completed all 4 arms.|30
10787434|NCT03484273|11947766|FG000|NOT COMPLETED|Overall Study||2
10434858|NCT00895583|11581344|FG000|STARTED|Overall Study||131
10787435|NCT03484429|11947780|FG000|STARTED|Overall Study||8
10787436|NCT03484429|11947781|FG001|STARTED|Overall Study||8
10787437|NCT03484429|11947780|FG000|Postamputation Week 1-4|Overall Study||8
10787438|NCT03484429|11947781|FG001|Postamputation Week 1-4|Overall Study||8
10787439|NCT03484429|11947780|FG000|Postamputation Week 5-8|Overall Study||5
10787440|NCT03484429|11947781|FG001|Postamputation Week 5-8|Overall Study||8
10434859|NCT00895583|11581345|FG001|STARTED|Overall Study||123
10434860|NCT00895583|11581344|FG000|COMPLETED|Overall Study||87
10434861|NCT00895583|11581345|FG001|COMPLETED|Overall Study||111
10434862|NCT00895583|11581344|FG000|NOT COMPLETED|Overall Study||44
10434863|NCT00895583|11581345|FG001|NOT COMPLETED|Overall Study||12
10434864|NCT00895622|11581354|FG000|STARTED|Overall Study||65
10434865|NCT00895622|11581355|FG001|STARTED|Overall Study||56
10434866|NCT00895622|11581356|FG002|STARTED|Overall Study||57
10434867|NCT00895622|11581354|FG000|COMPLETED|Overall Study||60
10434868|NCT00895622|11581355|FG001|COMPLETED|Overall Study||52
10434869|NCT00895622|11581356|FG002|COMPLETED|Overall Study||53
10434870|NCT00895622|11581354|FG000|NOT COMPLETED|Overall Study||5
10434871|NCT00895622|11581355|FG001|NOT COMPLETED|Overall Study||4
10434872|NCT00895622|11581356|FG002|NOT COMPLETED|Overall Study||4
10434873|NCT00895661|11581372|FG000|STARTED|Overall Study||40
10434874|NCT00895661|11581372|FG000|COMPLETED|Overall Study||37
10434875|NCT00895661|11581372|FG000|NOT COMPLETED|Overall Study||3
10434876|NCT00895752|11581376|FG000|STARTED|Overall Study||6
10434877|NCT00895752|11581376|FG000|COMPLETED|Overall Study||6
10434878|NCT00895752|11581376|FG000|NOT COMPLETED|Overall Study||0
10434879|NCT00895817|11581384|FG000|STARTED|Overall Study||21
10434880|NCT00895817|11581385|FG001|STARTED|Overall Study||21
10434881|NCT00895817|11581384|FG000|COMPLETED|Overall Study||21
10434882|NCT00895817|11581385|FG001|COMPLETED|Overall Study||21
10434883|NCT00895817|11581384|FG000|NOT COMPLETED|Overall Study||0
10434884|NCT00895817|11581385|FG001|NOT COMPLETED|Overall Study||0
10434885|NCT00895830|11581396|FG000|STARTED|Overall Study||51
10434886|NCT00895830|11581397|FG001|STARTED|Overall Study||50
10434887|NCT00895830|11581398|FG002|STARTED|Overall Study||49
10434888|NCT00895830|11581399|FG003|STARTED|Overall Study||52
10434889|NCT00895830|11581400|FG004|STARTED|Overall Study||55
10434890|NCT00895830|11581396|FG000|COMPLETED|Overall Study||51
10434891|NCT00895830|11581397|FG001|COMPLETED|Overall Study||50
10434892|NCT00895830|11581398|FG002|COMPLETED|Overall Study||49
10434893|NCT00895830|11581399|FG003|COMPLETED|Overall Study||52
10434894|NCT00895830|11581400|FG004|COMPLETED|Overall Study||55
10434895|NCT00895830|11581396|FG000|NOT COMPLETED|Overall Study||0
10434896|NCT00895830|11581397|FG001|NOT COMPLETED|Overall Study||0
10434897|NCT00895830|11581398|FG002|NOT COMPLETED|Overall Study||0
10434898|NCT00895830|11581399|FG003|NOT COMPLETED|Overall Study||0
10434899|NCT00895830|11581400|FG004|NOT COMPLETED|Overall Study||0
10434900|NCT00895843|11581414|FG000|STARTED|Overall Study||60
10434901|NCT00895843|11581415|FG001|STARTED|Overall Study||62
10434902|NCT00895843|11581414|FG000|COMPLETED|Overall Study||48
10434903|NCT00895843|11581415|FG001|COMPLETED|Overall Study||50
10434904|NCT00895843|11581414|FG000|NOT COMPLETED|Overall Study||12
10434905|NCT00895843|11581415|FG001|NOT COMPLETED|Overall Study||12
10434906|NCT00895895|11581426|FG000|STARTED|Period 1||107
10434907|NCT00895895|11581427|FG001|STARTED|Period 1||105
10434908|NCT00895895|11581428|FG002|STARTED|Period 1||104
10434909|NCT00895895|11581429|FG003|STARTED|Period 1||104
10434910|NCT00895895|11581430|FG004|STARTED|Period 1||106
10434911|NCT00895895|11581426|FG000|Randomized But Not Treated|Period 1||1
10434912|NCT00895895|11581427|FG001|Randomized But Not Treated|Period 1||3
10434913|NCT00895895|11581428|FG002|Randomized But Not Treated|Period 1||1
10434914|NCT00895895|11581429|FG003|Randomized But Not Treated|Period 1||1
10434915|NCT00895895|11581430|FG004|Randomized But Not Treated|Period 1||2
10434916|NCT00895895|11581426|FG000|COMPLETED|Period 1||86
10434917|NCT00895895|11581427|FG001|COMPLETED|Period 1||84
10434918|NCT00895895|11581428|FG002|COMPLETED|Period 1||84
10434919|NCT00895895|11581429|FG003|COMPLETED|Period 1||91
10434920|NCT00895895|11581430|FG004|COMPLETED|Period 1||86
10434921|NCT00895895|11581426|FG000|NOT COMPLETED|Period 1||21
10434922|NCT00895895|11581427|FG001|NOT COMPLETED|Period 1||21
10434923|NCT00895895|11581428|FG002|NOT COMPLETED|Period 1||20
10434924|NCT00895895|11581429|FG003|NOT COMPLETED|Period 1||13
10434925|NCT00895895|11581430|FG004|NOT COMPLETED|Period 1||20
10434926|NCT00895895|11581426|FG000|STARTED|After Period 1, Prior to Period 2||86
10434927|NCT00895895|11581427|FG001|STARTED|After Period 1, Prior to Period 2||84
10434928|NCT00895895|11581428|FG002|STARTED|After Period 1, Prior to Period 2||84
10434929|NCT00895895|11581429|FG003|STARTED|After Period 1, Prior to Period 2||91
10434930|NCT00895895|11581430|FG004|STARTED|After Period 1, Prior to Period 2||86
10434931|NCT00895895|11581426|FG000|COMPLETED|After Period 1, Prior to Period 2||86
10434932|NCT00895895|11581427|FG001|COMPLETED|After Period 1, Prior to Period 2||84
10434933|NCT00895895|11581428|FG002|COMPLETED|After Period 1, Prior to Period 2||82
10434934|NCT00895895|11581429|FG003|COMPLETED|After Period 1, Prior to Period 2||91
10434935|NCT00895895|11581430|FG004|COMPLETED|After Period 1, Prior to Period 2||84
10434936|NCT00895895|11581426|FG000|NOT COMPLETED|After Period 1, Prior to Period 2||0
10434937|NCT00895895|11581427|FG001|NOT COMPLETED|After Period 1, Prior to Period 2||0
10434938|NCT00895895|11581428|FG002|NOT COMPLETED|After Period 1, Prior to Period 2||2
10434939|NCT00895895|11581429|FG003|NOT COMPLETED|After Period 1, Prior to Period 2||0
10434940|NCT00895895|11581430|FG004|NOT COMPLETED|After Period 1, Prior to Period 2||2
10434941|NCT00895895|11581426|FG000|STARTED|Period 2||86
10549462|NCT01525589|11703480|FG002|STARTED|Overall Study||35
10434942|NCT00895895|11581427|FG001|STARTED|Period 2||84
10434943|NCT00895895|11581428|FG002|STARTED|Period 2||82
10434944|NCT00895895|11581429|FG003|STARTED|Period 2||91
10434945|NCT00895895|11581430|FG004|STARTED|Period 2||84
10434946|NCT00895895|11581426|FG000|COMPLETED|Period 2||30
10434947|NCT00895895|11581427|FG001|COMPLETED|Period 2||31
10434948|NCT00895895|11581428|FG002|COMPLETED|Period 2||33
10434949|NCT00895895|11581429|FG003|COMPLETED|Period 2||37
10434950|NCT00895895|11581430|FG004|COMPLETED|Period 2||35
10434951|NCT00895895|11581426|FG000|NOT COMPLETED|Period 2||56
10434952|NCT00895895|11581427|FG001|NOT COMPLETED|Period 2||53
10434953|NCT00895895|11581428|FG002|NOT COMPLETED|Period 2||49
10434954|NCT00895895|11581429|FG003|NOT COMPLETED|Period 2||54
10434955|NCT00895895|11581430|FG004|NOT COMPLETED|Period 2||49
10434956|NCT00895921|11581450|FG000|STARTED|Overall Study||15
10434957|NCT00895921|11581451|FG001|STARTED|Overall Study||15
10434958|NCT00895921|11581450|FG000|COMPLETED|Overall Study||15
10434959|NCT00895921|11581451|FG001|COMPLETED|Overall Study||15
10434960|NCT00895921|11581450|FG000|NOT COMPLETED|Overall Study||0
10434961|NCT00895921|11581451|FG001|NOT COMPLETED|Overall Study||0
10434962|NCT00895934|11581459|FG000|STARTED|Dose Escalation||3
10434963|NCT00895934|11581460|FG001|STARTED|Dose Escalation||3
10434964|NCT00895934|11581461|FG002|STARTED|Dose Escalation||3
10549463|NCT01525589|11703478|FG000|COMPLETED|Overall Study||0
10549464|NCT01525589|11703479|FG001|COMPLETED|Overall Study||0
10549465|NCT01525589|11703480|FG002|COMPLETED|Overall Study||0
10549466|NCT01525589|11703478|FG000|NOT COMPLETED|Overall Study||56
10549467|NCT01525589|11703479|FG001|NOT COMPLETED|Overall Study||20
10549468|NCT01525589|11703480|FG002|NOT COMPLETED|Overall Study||35
10549469|NCT01525602|11703496|FG000|STARTED|Overall Study||9
10549470|NCT01525602|11703497|FG001|STARTED|Overall Study||3
10549471|NCT01525602|11703498|FG002|STARTED|Overall Study||3
10549472|NCT01525602|11703499|FG003|STARTED|Overall Study||6
10549473|NCT01525602|11703500|FG004|STARTED|Overall Study||33
10549474|NCT01525602|11703501|FG005|STARTED|Overall Study||7
10549475|NCT01525602|11703502|FG006|STARTED|Overall Study||6
10549476|NCT01525602|11703503|FG007|STARTED|Overall Study||7
10549477|NCT01525602|11703496|FG000|COMPLETED|Overall Study||0
10549478|NCT01525602|11703497|FG001|COMPLETED|Overall Study||0
10549479|NCT01525602|11703498|FG002|COMPLETED|Overall Study||0
10549480|NCT01525602|11703499|FG003|COMPLETED|Overall Study||0
10549481|NCT01525602|11703500|FG004|COMPLETED|Overall Study||0
10549482|NCT01525602|11703501|FG005|COMPLETED|Overall Study||0
10549483|NCT01525602|11703502|FG006|COMPLETED|Overall Study||0
10549484|NCT01525602|11703503|FG007|COMPLETED|Overall Study||0
10549485|NCT01525602|11703496|FG000|NOT COMPLETED|Overall Study||9
10549486|NCT01525602|11703497|FG001|NOT COMPLETED|Overall Study||3
10549487|NCT01525602|11703498|FG002|NOT COMPLETED|Overall Study||3
10549488|NCT01525602|11703499|FG003|NOT COMPLETED|Overall Study||6
10549489|NCT01525602|11703500|FG004|NOT COMPLETED|Overall Study||33
10549490|NCT01525602|11703501|FG005|NOT COMPLETED|Overall Study||7
10549491|NCT01525602|11703502|FG006|NOT COMPLETED|Overall Study||6
10549492|NCT01525602|11703503|FG007|NOT COMPLETED|Overall Study||7
10549493|NCT01525615|11703531|FG000|STARTED|Overall Study||132
10549494|NCT01525615|11703532|FG001|STARTED|Overall Study||133
10549495|NCT01525615|11703533|FG002|STARTED|Overall Study||139
10549496|NCT01525615|11703531|FG000|COMPLETED|Overall Study||118
10549497|NCT01525615|11703532|FG001|COMPLETED|Overall Study||126
10549498|NCT01525615|11703533|FG002|COMPLETED|Overall Study||133
10549499|NCT01525615|11703531|FG000|NOT COMPLETED|Overall Study||14
10549500|NCT01525615|11703532|FG001|NOT COMPLETED|Overall Study||7
10549501|NCT01525615|11703533|FG002|NOT COMPLETED|Overall Study||6
10549502|NCT01525628|11703546|FG000|STARTED|Overall Study||16
10549503|NCT01525628|11703547|FG001|STARTED|Overall Study||19
10549504|NCT01525628|11703548|FG002|STARTED|Overall Study||16
10549505|NCT01525628|11703549|FG003|STARTED|Overall Study||14
10549506|NCT01525628|11703550|FG004|STARTED|Overall Study||7
10549507|NCT01525628|11703546|FG000|COMPLETED|Overall Study||14
10549508|NCT01525628|11703547|FG001|COMPLETED|Overall Study||14
10549509|NCT01525628|11703548|FG002|COMPLETED|Overall Study||11
10549510|NCT01525628|11703549|FG003|COMPLETED|Overall Study||10
10549511|NCT01525628|11703550|FG004|COMPLETED|Overall Study||4
10549512|NCT01525628|11703546|FG000|NOT COMPLETED|Overall Study||2
10549513|NCT01525628|11703547|FG001|NOT COMPLETED|Overall Study||5
10549514|NCT01525628|11703548|FG002|NOT COMPLETED|Overall Study||5
10549515|NCT01525628|11703549|FG003|NOT COMPLETED|Overall Study||4
10549516|NCT01525628|11703550|FG004|NOT COMPLETED|Overall Study||3
10549517|NCT01525641|11703564|FG000|STARTED|Overall Study||615
10549518|NCT01525641|11703564|FG000|COMPLETED|Overall Study||435
10549519|NCT01525641|11703564|FG000|NOT COMPLETED|Overall Study||180
10549520|NCT01525667|11703571|FG000|STARTED|Overall Study||7
10549521|NCT01525667|11703572|FG001|STARTED|Overall Study||6
10549522|NCT01525667|11703573|FG002|STARTED|Overall Study||7
10549523|NCT01525667|11703571|FG000|COMPLETED|Overall Study||7
10549524|NCT01525667|11703572|FG001|COMPLETED|Overall Study||6
10549525|NCT01525667|11703573|FG002|COMPLETED|Overall Study||7
10549526|NCT01525667|11703571|FG000|NOT COMPLETED|Overall Study||0
10549527|NCT01525667|11703572|FG001|NOT COMPLETED|Overall Study||0
10549528|NCT01525667|11703573|FG002|NOT COMPLETED|Overall Study||0
10549529|NCT01525849|11703585|FG000|STARTED|Overall Study||76
10549530|NCT01525849|11703586|FG001|STARTED|Overall Study||75
10434965|NCT00895934|11581462|FG003|STARTED|Dose Escalation||6
10549531|NCT01525849|11703585|FG000|Treated|Overall Study|2 withdrew before treatment: 1 didn't want balloon dilation, 1 unrelated medical issue.|74
10549532|NCT01525849|11703586|FG001|Treated|Overall Study|14 withdrew before treatment: 8 didn't want FESS, 1 too busy, 2 medical issues, 3 excl. criteria.|61
10549533|NCT01525849|11703585|FG000|6-Months|Overall Study||73
10549534|NCT01525849|11703586|FG001|6-Months|Overall Study||60
10549535|NCT01525849|11703585|FG000|COMPLETED|Overall Study||71
10549536|NCT01525849|11703586|FG001|COMPLETED|Overall Study||59
10549537|NCT01525849|11703585|FG000|NOT COMPLETED|Overall Study||5
10549538|NCT01525849|11703586|FG001|NOT COMPLETED|Overall Study||16
10549539|NCT01525862|11703592|FG000|STARTED|Overall Study||21
10549540|NCT01525862|11703592|FG000|COMPLETED|Overall Study||21
10549541|NCT01525862|11703592|FG000|NOT COMPLETED|Overall Study||0
10434966|NCT00895934|11581459|FG000|COMPLETED|Dose Escalation||3
10434967|NCT00895934|11581460|FG001|COMPLETED|Dose Escalation||3
10434968|NCT00895934|11581461|FG002|COMPLETED|Dose Escalation||3
10434969|NCT00895934|11581462|FG003|COMPLETED|Dose Escalation||6
10434970|NCT00895934|11581459|FG000|NOT COMPLETED|Dose Escalation||0
10434971|NCT00895934|11581460|FG001|NOT COMPLETED|Dose Escalation||0
10434972|NCT00895934|11581461|FG002|NOT COMPLETED|Dose Escalation||0
10434973|NCT00895934|11581462|FG003|NOT COMPLETED|Dose Escalation||0
10434974|NCT00895934|11581459|FG000|STARTED|Efficacy of Most Tolerated Dose||0
10434975|NCT00895934|11581460|FG001|STARTED|Efficacy of Most Tolerated Dose||0
10434976|NCT00895934|11581461|FG002|STARTED|Efficacy of Most Tolerated Dose||0
10434977|NCT00895934|11581462|FG003|STARTED|Efficacy of Most Tolerated Dose||37
10434978|NCT00895934|11581459|FG000|COMPLETED|Efficacy of Most Tolerated Dose||0
10434979|NCT00895934|11581460|FG001|COMPLETED|Efficacy of Most Tolerated Dose||0
10434980|NCT00895934|11581461|FG002|COMPLETED|Efficacy of Most Tolerated Dose||0
10434981|NCT00895934|11581462|FG003|COMPLETED|Efficacy of Most Tolerated Dose||37
10434982|NCT00895934|11581459|FG000|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
10434983|NCT00895934|11581460|FG001|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
10434984|NCT00895934|11581461|FG002|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
10434985|NCT00895934|11581462|FG003|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
10434986|NCT00895947|11581475|FG000|STARTED|Overall Study||100
10434987|NCT00895947|11581476|FG001|STARTED|Overall Study||100
10434988|NCT00895947|11581475|FG000|COMPLETED|Overall Study||88
10434989|NCT00895947|11581476|FG001|COMPLETED|Overall Study||90
10434990|NCT00895947|11581475|FG000|NOT COMPLETED|Overall Study||12
10434991|NCT00895947|11581476|FG001|NOT COMPLETED|Overall Study||10
10434992|NCT00896012|11581484|FG000|STARTED|Overall Study||29
10434993|NCT00896012|11581485|FG001|STARTED|Overall Study||23
10434994|NCT00896012|11581484|FG000|COMPLETED|Overall Study||18
10434995|NCT00896012|11581485|FG001|COMPLETED|Overall Study||12
10434996|NCT00896012|11581484|FG000|NOT COMPLETED|Overall Study||11
10434997|NCT00896012|11581485|FG001|NOT COMPLETED|Overall Study||11
10434998|NCT00896038|11581493|FG000|STARTED|Overall Study||30
10434999|NCT00896038|11581494|FG001|STARTED|Overall Study||28
10435000|NCT00896038|11581493|FG000|COMPLETED|Overall Study||26
10435001|NCT00896038|11581494|FG001|COMPLETED|Overall Study||27
10435002|NCT00896038|11581493|FG000|NOT COMPLETED|Overall Study||4
10549542|NCT01525875|11703598|FG000|STARTED|Placebo-controlled Period||22
10549543|NCT01525875|11703599|FG001|STARTED|Placebo-controlled Period||22
10549544|NCT01525875|11703598|FG000|COMPLETED|Placebo-controlled Period||21
10787441|NCT03484429|11947780|FG000|Postamputation Month 3|Overall Study||5
10435003|NCT00896038|11581494|FG001|NOT COMPLETED|Overall Study||1
10435004|NCT00896051|11581502|FG000|STARTED|Overall Study||25
10435005|NCT00896051|11581503|FG001|STARTED|Overall Study||25
10435006|NCT00896051|11581502|FG000|COMPLETED|Overall Study||15
10435007|NCT00896051|11581503|FG001|COMPLETED|Overall Study||16
10435008|NCT00896051|11581502|FG000|NOT COMPLETED|Overall Study||10
10435009|NCT00896051|11581503|FG001|NOT COMPLETED|Overall Study||9
10435010|NCT00896064|11581520|FG000|STARTED|Overall Study||22
10435011|NCT00896064|11581521|FG001|STARTED|Overall Study||21
10435012|NCT00896064|11581520|FG000|COMPLETED|Overall Study||22
10435013|NCT00896064|11581521|FG001|COMPLETED|Overall Study||21
10435014|NCT00896064|11581520|FG000|NOT COMPLETED|Overall Study||0
10435015|NCT00896064|11581521|FG001|NOT COMPLETED|Overall Study||0
10435016|NCT00896168|11581529|FG000|STARTED|Overall Study||104
10435017|NCT00896168|11581530|FG001|STARTED|Overall Study||130
10435018|NCT00896168|11581529|FG000|COMPLETED|Overall Study||90
10435019|NCT00896168|11581530|FG001|COMPLETED|Overall Study||111
10435020|NCT00896168|11581529|FG000|NOT COMPLETED|Overall Study||14
10435021|NCT00896168|11581530|FG001|NOT COMPLETED|Overall Study||19
10435022|NCT00896181|11581536|FG000|STARTED|Overall Study||26
10435023|NCT00896181|11581536|FG000|COMPLETED|Overall Study||26
10435024|NCT00896181|11581536|FG000|NOT COMPLETED|Overall Study||0
10435025|NCT00896233|11581540|FG000|STARTED|Overall Study||10
10435026|NCT00896233|11581540|FG000|COMPLETED|Overall Study||9
10435027|NCT00896233|11581540|FG000|NOT COMPLETED|Overall Study||1
10435028|NCT00896298|11581547|FG000|STARTED|Overall Study||13
10435029|NCT00896298|11581548|FG001|STARTED|Overall Study||12
10435030|NCT00896298|11581547|FG000|COMPLETED|Overall Study||10
10435031|NCT00896298|11581548|FG001|COMPLETED|Overall Study||9
10435032|NCT00896298|11581547|FG000|NOT COMPLETED|Overall Study||3
10549545|NCT01525875|11703599|FG001|COMPLETED|Placebo-controlled Period||20
10549546|NCT01525875|11703598|FG000|NOT COMPLETED|Placebo-controlled Period||1
10549547|NCT01525875|11703599|FG001|NOT COMPLETED|Placebo-controlled Period||2
10549548|NCT01525875|11703598|FG000|STARTED|Open-label Period||21
10549549|NCT01525875|11703599|FG001|STARTED|Open-label Period||20
10549550|NCT01525875|11703598|FG000|COMPLETED|Open-label Period||21
10549551|NCT01525875|11703599|FG001|COMPLETED|Open-label Period||18
10549552|NCT01525875|11703598|FG000|NOT COMPLETED|Open-label Period||0
10787442|NCT03484429|11947781|FG001|Postamputation Month 3|Overall Study||7
10549553|NCT01525875|11703599|FG001|NOT COMPLETED|Open-label Period||2
10549554|NCT01526057|11703608|FG000|STARTED|Overall Study||73
10549555|NCT01526057|11703609|FG001|STARTED|Overall Study||74
10549556|NCT01526057|11703610|FG002|STARTED|Overall Study||73
10787443|NCT03484429|11947780|FG000|COMPLETED|Overall Study||5
10435033|NCT00896298|11581548|FG001|NOT COMPLETED|Overall Study||3
10435034|NCT00896337|11581554|FG000|STARTED|Overall Study||125
10435035|NCT00896337|11581554|FG000|COMPLETED|Overall Study||100
10435036|NCT00896337|11581554|FG000|NOT COMPLETED|Overall Study||25
10435037|NCT00896363|11581566|FG000|STARTED|Overall Study||31
10435038|NCT00896363|11581567|FG001|STARTED|Overall Study||36
10435039|NCT00896363|11581568|FG002|STARTED|Overall Study||32
10435040|NCT00896363|11581566|FG000|COMPLETED|Overall Study||25
10435041|NCT00896363|11581567|FG001|COMPLETED|Overall Study||25
10435042|NCT00896363|11581568|FG002|COMPLETED|Overall Study||24
10435043|NCT00896363|11581566|FG000|NOT COMPLETED|Overall Study||6
10435044|NCT00896363|11581567|FG001|NOT COMPLETED|Overall Study||11
10435045|NCT00896363|11581568|FG002|NOT COMPLETED|Overall Study||8
10435046|NCT00896441|11581581|FG000|STARTED|Overall Study||17
10435047|NCT00896441|11581582|FG001|STARTED|Overall Study||9
10435048|NCT00896441|11581581|FG000|COMPLETED|Overall Study||15
10435049|NCT00896441|11581582|FG001|COMPLETED|Overall Study||9
10435050|NCT00896441|11581581|FG000|NOT COMPLETED|Overall Study||2
10435051|NCT00896441|11581582|FG001|NOT COMPLETED|Overall Study||0
10435052|NCT00896454|11581587|FG000|STARTED|Overall Study||33
10435053|NCT00896454|11581587|FG000|COMPLETED|Overall Study||0
10435054|NCT00896454|11581587|FG000|NOT COMPLETED|Overall Study||33
10435055|NCT00896480|11581591|FG000|STARTED|Overall Study||24
10435056|NCT00896480|11581591|FG000|COMPLETED|Overall Study||3
10435057|NCT00896480|11581591|FG000|NOT COMPLETED|Overall Study||21
10787444|NCT03484429|11947781|FG001|COMPLETED|Overall Study||8
10787445|NCT03484429|11947780|FG000|NOT COMPLETED|Overall Study||3
10787446|NCT03484429|11947781|FG001|NOT COMPLETED|Overall Study||0
10787447|NCT03485222|11947789|FG000|STARTED|Overall Study||42
10787448|NCT03485222|11947790|FG001|STARTED|Overall Study||42
10787449|NCT03485222|11947789|FG000|COMPLETED|Overall Study||40
10787450|NCT03485222|11947790|FG001|COMPLETED|Overall Study||40
10787451|NCT03485222|11947789|FG000|NOT COMPLETED|Overall Study||2
10787452|NCT03485222|11947790|FG001|NOT COMPLETED|Overall Study||2
10787453|NCT03485495|11947798|FG000|STARTED|Overall Study||65
10787454|NCT03485495|11947799|FG001|STARTED|Overall Study||59
10787455|NCT03485495|11947798|FG000|COMPLETED|Overall Study||64
10787456|NCT03485495|11947799|FG001|COMPLETED|Overall Study||59
10787457|NCT03485495|11947798|FG000|NOT COMPLETED|Overall Study||1
10787458|NCT03485495|11947799|FG001|NOT COMPLETED|Overall Study||0
10787459|NCT03485976|11947805|FG000|STARTED|Overall Study||12
10787460|NCT03485976|11947805|FG000|COMPLETED|Overall Study||11
10787461|NCT03485976|11947805|FG000|NOT COMPLETED|Overall Study||1
10787462|NCT03486392|11947814|FG000|STARTED|Overall Study||60
10787463|NCT03486392|11947815|FG001|STARTED|Overall Study||59
10787464|NCT03486392|11947816|FG002|STARTED|Overall Study||118
10787465|NCT03486392|11947817|FG003|STARTED|Overall Study||118
10787466|NCT03486392|11947818|FG004|STARTED|Overall Study||119
10787467|NCT03486392|11947814|FG000|COMPLETED|Overall Study||57
10787468|NCT03486392|11947815|FG001|COMPLETED|Overall Study||59
10787469|NCT03486392|11947816|FG002|COMPLETED|Overall Study||104
10787470|NCT03486392|11947817|FG003|COMPLETED|Overall Study||109
10787471|NCT03486392|11947818|FG004|COMPLETED|Overall Study||115
10787472|NCT03486392|11947814|FG000|NOT COMPLETED|Overall Study||3
10787473|NCT03486392|11947815|FG001|NOT COMPLETED|Overall Study||0
10787474|NCT03486392|11947816|FG002|NOT COMPLETED|Overall Study||14
10787475|NCT03486392|11947817|FG003|NOT COMPLETED|Overall Study||9
10787476|NCT03486392|11947818|FG004|NOT COMPLETED|Overall Study||4
10787477|NCT03486834|11947833|FG000|STARTED|Overall Study||733
10787478|NCT03486834|11947834|FG001|STARTED|Overall Study||733
10787479|NCT03486834|11947835|FG002|STARTED|Overall Study||734
10787480|NCT03486834|11947833|FG000|Treatment 1|Overall Study||729
10787481|NCT03486834|11947834|FG001|Treatment 1|Overall Study||729
10787482|NCT03486834|11947835|FG002|Treatment 1|Overall Study||733
10787483|NCT03486834|11947833|FG000|Treatment 2|Overall Study||680
10787484|NCT03486834|11947834|FG001|Treatment 2|Overall Study||680
10787485|NCT03486834|11947835|FG002|Treatment 2|Overall Study||679
10787486|NCT03486834|11947833|FG000|Treatment 3|Overall Study||614
10787487|NCT03486834|11947834|FG001|Treatment 3|Overall Study||631
10787488|NCT03486834|11947835|FG002|Treatment 3|Overall Study||622
10787489|NCT03486834|11947833|FG000|COMPLETED|Overall Study||614
10787490|NCT03486834|11947834|FG001|COMPLETED|Overall Study||631
10787491|NCT03486834|11947835|FG002|COMPLETED|Overall Study||622
10787492|NCT03486834|11947833|FG000|NOT COMPLETED|Overall Study||119
10787493|NCT03486834|11947834|FG001|NOT COMPLETED|Overall Study||102
10787494|NCT03486834|11947835|FG002|NOT COMPLETED|Overall Study||112
10787495|NCT03486990|11947854|FG000|STARTED|Overall Study||2
10787496|NCT03486990|11947855|FG001|STARTED|Overall Study||2
10787497|NCT03486990|11947856|FG002|STARTED|Overall Study||3
10787498|NCT03486990|11947857|FG003|STARTED|Overall Study||3
10787499|NCT03486990|11947858|FG004|STARTED|Overall Study||3
10787500|NCT03486990|11947859|FG005|STARTED|Overall Study||4
10787501|NCT03486990|11947860|FG006|STARTED|Overall Study||2
10787502|NCT03486990|11947861|FG007|STARTED|Overall Study||2
10787503|NCT03486990|11947862|FG008|STARTED|Overall Study||2
10787504|NCT03486990|11947854|FG000|COMPLETED|Overall Study||2
10787505|NCT03486990|11947855|FG001|COMPLETED|Overall Study||2
10787506|NCT03486990|11947856|FG002|COMPLETED|Overall Study||3
10787507|NCT03486990|11947857|FG003|COMPLETED|Overall Study||3
10787508|NCT03486990|11947858|FG004|COMPLETED|Overall Study||3
10787509|NCT03486990|11947859|FG005|COMPLETED|Overall Study||4
10787510|NCT03486990|11947860|FG006|COMPLETED|Overall Study||2
10787511|NCT03486990|11947861|FG007|COMPLETED|Overall Study||2
10787512|NCT03486990|11947862|FG008|COMPLETED|Overall Study||2
10787513|NCT03486990|11947854|FG000|NOT COMPLETED|Overall Study||0
10787514|NCT03486990|11947855|FG001|NOT COMPLETED|Overall Study||0
10787515|NCT03486990|11947856|FG002|NOT COMPLETED|Overall Study||0
10787516|NCT03486990|11947857|FG003|NOT COMPLETED|Overall Study||0
10787517|NCT03486990|11947858|FG004|NOT COMPLETED|Overall Study||0
10787518|NCT03486990|11947859|FG005|NOT COMPLETED|Overall Study||0
10525264|NCT01374568|11677147|FG000|NOT COMPLETED|Overall Study||0
10787519|NCT03486990|11947860|FG006|NOT COMPLETED|Overall Study||0
10787520|NCT03486990|11947861|FG007|NOT COMPLETED|Overall Study||0
10787521|NCT03486990|11947862|FG008|NOT COMPLETED|Overall Study||0
10787522|NCT03487276|11947903|FG000|STARTED|Main Period (16 Weeks)||37
10787523|NCT03487276|11947904|FG001|STARTED|Main Period (16 Weeks)||34
10787524|NCT03487276|11947905|FG002|STARTED|Main Period (16 Weeks)||36
10787525|NCT03487276|11947906|FG003|STARTED|Main Period (16 Weeks)||36
10787526|NCT03487276|11947907|FG004|STARTED|Main Period (16 Weeks)||36
10787527|NCT03487276|11947903|FG000|COMPLETED|Main Period (16 Weeks)||34
10787528|NCT03487276|11947904|FG001|COMPLETED|Main Period (16 Weeks)||30
10787529|NCT03487276|11947905|FG002|COMPLETED|Main Period (16 Weeks)||32
10787530|NCT03487276|11947906|FG003|COMPLETED|Main Period (16 Weeks)||30
10787531|NCT03487276|11947907|FG004|COMPLETED|Main Period (16 Weeks)|One patient completed the Main Period but was lost to follow-up afterwards and not treated in the Extension Period|31
10787532|NCT03487276|11947903|FG000|NOT COMPLETED|Main Period (16 Weeks)||3
10787533|NCT03487276|11947904|FG001|NOT COMPLETED|Main Period (16 Weeks)||4
10787534|NCT03487276|11947905|FG002|NOT COMPLETED|Main Period (16 Weeks)||4
10787535|NCT03487276|11947906|FG003|NOT COMPLETED|Main Period (16 Weeks)||6
10787536|NCT03487276|11947907|FG004|NOT COMPLETED|Main Period (16 Weeks)||5
10787537|NCT03487276|11947903|FG000|STARTED|Extension Period (28 Weeks)||0
10787538|NCT03487276|11947904|FG001|STARTED|Extension Period (28 Weeks)||0
10787539|NCT03487276|11947905|FG002|STARTED|Extension Period (28 Weeks)||72
10787540|NCT03487276|11947906|FG003|STARTED|Extension Period (28 Weeks)||84
10787541|NCT03487276|11947907|FG004|STARTED|Extension Period (28 Weeks)||0
10787542|NCT03487276|11947903|FG000|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
10787543|NCT03487276|11947904|FG001|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
10787544|NCT03487276|11947905|FG002|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||16
10787545|NCT03487276|11947906|FG003|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||18
10787546|NCT03487276|11947907|FG004|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
10787547|NCT03487276|11947903|FG000|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
10787548|NCT03487276|11947904|FG001|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
10787549|NCT03487276|11947905|FG002|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||12
10787550|NCT03487276|11947906|FG003|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||18
10787551|NCT03487276|11947907|FG004|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
10787552|NCT03487276|11947903|FG000|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
10787553|NCT03487276|11947904|FG001|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
10787554|NCT03487276|11947905|FG002|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||17
10787555|NCT03487276|11947906|FG003|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||15
10787556|NCT03487276|11947907|FG004|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
10787557|NCT03487276|11947903|FG000|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
10787558|NCT03487276|11947904|FG001|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
10787559|NCT03487276|11947905|FG002|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||12
10787560|NCT03487276|11947906|FG003|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||18
10787561|NCT03487276|11947907|FG004|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
10787562|NCT03487276|11947903|FG000|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
10787563|NCT03487276|11947904|FG001|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
10787564|NCT03487276|11947905|FG002|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||15
10810672|NCT03792672|11972461|FG005|STARTED|Treatment Period 1 (1 Day)||4
10787565|NCT03487276|11947906|FG003|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||16
10787566|NCT03487276|11947907|FG004|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
10787567|NCT03487276|11947903|FG000|COMPLETED|Extension Period (28 Weeks)||0
10787568|NCT03487276|11947904|FG001|COMPLETED|Extension Period (28 Weeks)||0
10787569|NCT03487276|11947905|FG002|COMPLETED|Extension Period (28 Weeks)||67
10787570|NCT03487276|11947906|FG003|COMPLETED|Extension Period (28 Weeks)||54
10787571|NCT03487276|11947907|FG004|COMPLETED|Extension Period (28 Weeks)||0
10787572|NCT03487276|11947903|FG000|NOT COMPLETED|Extension Period (28 Weeks)||0
10787573|NCT03487276|11947904|FG001|NOT COMPLETED|Extension Period (28 Weeks)||0
10787574|NCT03487276|11947905|FG002|NOT COMPLETED|Extension Period (28 Weeks)||5
10787575|NCT03487276|11947906|FG003|NOT COMPLETED|Extension Period (28 Weeks)||30
10787576|NCT03487276|11947907|FG004|NOT COMPLETED|Extension Period (28 Weeks)||0
10787577|NCT03487445|11947930|FG000|STARTED|Randomization||25
10787578|NCT03487445|11947931|FG001|STARTED|Randomization||23
10787579|NCT03487445|11947930|FG000|COMPLETED|Randomization||24
10787580|NCT03487445|11947931|FG001|COMPLETED|Randomization||23
10787581|NCT03487445|11947930|FG000|NOT COMPLETED|Randomization||1
10787582|NCT03487445|11947931|FG001|NOT COMPLETED|Randomization||0
10787583|NCT03487445|11947930|FG000|STARTED|Treatment Period||24
10787584|NCT03487445|11947931|FG001|STARTED|Treatment Period||23
10787585|NCT03487445|11947930|FG000|Modified Full Analysis Set (mFAS)|Treatment Period||23
10787586|NCT03487445|11947931|FG001|Modified Full Analysis Set (mFAS)|Treatment Period||22
10787587|NCT03487445|11947930|FG000|Per Protocol Set|Treatment Period||20
10787588|NCT03487445|11947931|FG001|Per Protocol Set|Treatment Period||20
10787589|NCT03487445|11947930|FG000|COMPLETED|Treatment Period||24
10787590|NCT03487445|11947931|FG001|COMPLETED|Treatment Period||23
10787591|NCT03487445|11947930|FG000|NOT COMPLETED|Treatment Period||0
10787592|NCT03487445|11947931|FG001|NOT COMPLETED|Treatment Period||0
10787593|NCT03487549|11947939|FG000|STARTED|Overall Study||21
10787594|NCT03487549|11947940|FG001|STARTED|Overall Study||35
10787595|NCT03487549|11947939|FG000|COMPLETED|Overall Study||17
10787596|NCT03487549|11947940|FG001|COMPLETED|Overall Study||33
10787597|NCT03487549|11947939|FG000|NOT COMPLETED|Overall Study||4
10787598|NCT03487549|11947940|FG001|NOT COMPLETED|Overall Study||2
10787599|NCT03487588|11947946|FG000|STARTED|Overall Study||41
10787600|NCT03487588|11947946|FG000|COMPLETED|Overall Study||41
10787601|NCT03487588|11947946|FG000|NOT COMPLETED|Overall Study||0
10787602|NCT03487718|11947952|FG000|STARTED|Overall Study||12
10787603|NCT03487718|11947953|FG001|STARTED|Overall Study||15
10787604|NCT03487718|11947952|FG000|COMPLETED|Overall Study||11
10787605|NCT03487718|11947953|FG001|COMPLETED|Overall Study||11
10787606|NCT03487718|11947952|FG000|NOT COMPLETED|Overall Study||1
10787607|NCT03487718|11947953|FG001|NOT COMPLETED|Overall Study||4
10787608|NCT03487848|11947959|FG000|STARTED|Overall Study||5
10787609|NCT03487848|11947959|FG000|COMPLETED|Overall Study||4
10787610|NCT03487848|11947959|FG000|NOT COMPLETED|Overall Study||1
10787611|NCT03488108|11947965|FG000|STARTED|First Intervention (12 Weeks)||10
10787612|NCT03488108|11947966|FG001|STARTED|First Intervention (12 Weeks)||10
10787613|NCT03488108|11947965|FG000|COMPLETED|First Intervention (12 Weeks)||10
10787614|NCT03488108|11947966|FG001|COMPLETED|First Intervention (12 Weeks)||9
10787615|NCT03488108|11947965|FG000|NOT COMPLETED|First Intervention (12 Weeks)||0
10787616|NCT03488108|11947966|FG001|NOT COMPLETED|First Intervention (12 Weeks)||1
10787617|NCT03488108|11947965|FG000|STARTED|Washout (2 Months)||10
10787618|NCT03488108|11947966|FG001|STARTED|Washout (2 Months)||9
10787619|NCT03488108|11947965|FG000|COMPLETED|Washout (2 Months)||10
10787620|NCT03488108|11947966|FG001|COMPLETED|Washout (2 Months)||9
10787621|NCT03488108|11947965|FG000|NOT COMPLETED|Washout (2 Months)||0
10787622|NCT03488108|11947966|FG001|NOT COMPLETED|Washout (2 Months)||0
10787623|NCT03488108|11947965|FG000|STARTED|Second Intervention (12 Weeks)||10
10787624|NCT03488108|11947966|FG001|STARTED|Second Intervention (12 Weeks)||9
10787625|NCT03488108|11947965|FG000|COMPLETED|Second Intervention (12 Weeks)||9
10787626|NCT03488108|11947966|FG001|COMPLETED|Second Intervention (12 Weeks)||9
10787627|NCT03488108|11947965|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||1
10787628|NCT03488108|11947966|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||0
10787629|NCT03488225|11947974|FG000|STARTED|Overall Study||4
10787630|NCT03488225|11947974|FG000|COMPLETED|Overall Study||0
10787631|NCT03488225|11947974|FG000|NOT COMPLETED|Overall Study||4
10787632|NCT03488238|11947978|FG000|STARTED|Overall Study||31
10787633|NCT03488238|11947978|FG000|COMPLETED|Overall Study||29
10787634|NCT03488238|11947978|FG000|NOT COMPLETED|Overall Study||2
10549557|NCT01526057|11703608|FG000|COMPLETED|Overall Study||64
10549558|NCT01526057|11703609|FG001|COMPLETED|Overall Study||71
10549559|NCT01526057|11703610|FG002|COMPLETED|Overall Study||67
10549560|NCT01526057|11703608|FG000|NOT COMPLETED|Overall Study||9
10549561|NCT01526057|11703609|FG001|NOT COMPLETED|Overall Study||3
10549562|NCT01526057|11703610|FG002|NOT COMPLETED|Overall Study||6
10549563|NCT01526148|11703620|FG000|STARTED|Overall Study||18
10549564|NCT01526148|11703621|FG001|STARTED|Overall Study||24
10549565|NCT01526148|11703620|FG000|COMPLETED|Overall Study||4
10549566|NCT01526148|11703621|FG001|COMPLETED|Overall Study||11
10549567|NCT01526148|11703620|FG000|NOT COMPLETED|Overall Study||14
10549568|NCT01526148|11703621|FG001|NOT COMPLETED|Overall Study||13
10549569|NCT01526213|11703633|FG000|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
10549570|NCT01526213|11703634|FG001|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
10549571|NCT01526213|11703635|FG002|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
10549572|NCT01526213|11703636|FG003|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
10549573|NCT01526213|11703637|FG004|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
10549574|NCT01526213|11703638|FG005|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to (and completed) one of six sequences.|3
10549575|NCT01526213|11703633|FG000|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
10549576|NCT01526213|11703634|FG001|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
10549577|NCT01526213|11703635|FG002|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
10549578|NCT01526213|11703636|FG003|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
10549579|NCT01526213|11703637|FG004|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
10549580|NCT01526213|11703638|FG005|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
10549581|NCT01526213|11703633|FG000|NOT COMPLETED|Period 1 (5 Days)||0
10549582|NCT01526213|11703634|FG001|NOT COMPLETED|Period 1 (5 Days)||0
10549583|NCT01526213|11703635|FG002|NOT COMPLETED|Period 1 (5 Days)||0
10549584|NCT01526213|11703636|FG003|NOT COMPLETED|Period 1 (5 Days)||0
10549585|NCT01526213|11703637|FG004|NOT COMPLETED|Period 1 (5 Days)||0
10549586|NCT01526213|11703638|FG005|NOT COMPLETED|Period 1 (5 Days)||0
10549587|NCT01526213|11703633|FG000|STARTED|Washout 1 (10 Days)||3
10549588|NCT01526213|11703634|FG001|STARTED|Washout 1 (10 Days)||3
10549589|NCT01526213|11703635|FG002|STARTED|Washout 1 (10 Days)||3
10549590|NCT01526213|11703636|FG003|STARTED|Washout 1 (10 Days)||3
10549591|NCT01526213|11703637|FG004|STARTED|Washout 1 (10 Days)||3
10549592|NCT01526213|11703638|FG005|STARTED|Washout 1 (10 Days)||3
10549593|NCT01526213|11703633|FG000|COMPLETED|Washout 1 (10 Days)||3
10549594|NCT01526213|11703634|FG001|COMPLETED|Washout 1 (10 Days)||3
10549595|NCT01526213|11703635|FG002|COMPLETED|Washout 1 (10 Days)||3
10549596|NCT01526213|11703636|FG003|COMPLETED|Washout 1 (10 Days)||3
10549597|NCT01526213|11703637|FG004|COMPLETED|Washout 1 (10 Days)||3
10549598|NCT01526213|11703638|FG005|COMPLETED|Washout 1 (10 Days)||3
10549599|NCT01526213|11703633|FG000|NOT COMPLETED|Washout 1 (10 Days)||0
10549600|NCT01526213|11703634|FG001|NOT COMPLETED|Washout 1 (10 Days)||0
10549601|NCT01526213|11703635|FG002|NOT COMPLETED|Washout 1 (10 Days)||0
10549602|NCT01526213|11703636|FG003|NOT COMPLETED|Washout 1 (10 Days)||0
10549603|NCT01526213|11703637|FG004|NOT COMPLETED|Washout 1 (10 Days)||0
10549604|NCT01526213|11703638|FG005|NOT COMPLETED|Washout 1 (10 Days)||0
10549605|NCT01526213|11703633|FG000|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
10549606|NCT01526213|11703634|FG001|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
10549607|NCT01526213|11703635|FG002|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
10549608|NCT01526213|11703636|FG003|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
10549609|NCT01526213|11703637|FG004|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
10549610|NCT01526213|11703638|FG005|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
10549611|NCT01526213|11703633|FG000|COMPLETED|Period 2 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
10787635|NCT03488849|11947985|FG000|STARTED|Overall Study||10
10787636|NCT03488849|11947986|FG001|STARTED|Overall Study||8
10787637|NCT03488849|11947987|FG002|STARTED|Overall Study||6
10787638|NCT03488849|11947985|FG000|COMPLETED|Overall Study||10
10787639|NCT03488849|11947986|FG001|COMPLETED|Overall Study||8
10787640|NCT03488849|11947987|FG002|COMPLETED|Overall Study||6
10787729|NCT03490110|11948118|FG001|STARTED|Overall Study||9
10525265|NCT01374568|11677148|FG001|NOT COMPLETED|Overall Study||2
10787641|NCT03488849|11947985|FG000|NOT COMPLETED|Overall Study||0
10787642|NCT03488849|11947986|FG001|NOT COMPLETED|Overall Study||0
10787643|NCT03488849|11947987|FG002|NOT COMPLETED|Overall Study||0
10787644|NCT03488927|11947998|FG000|STARTED|Overall Study||305
10787645|NCT03488927|11947999|FG001|STARTED|Overall Study||432
10787646|NCT03488927|11948000|FG002|STARTED|Overall Study||531
10787647|NCT03488927|11947998|FG000|COMPLETED|Overall Study||261
10787648|NCT03488927|11947999|FG001|COMPLETED|Overall Study||314
10787649|NCT03488927|11948000|FG002|COMPLETED|Overall Study||314
10787650|NCT03488927|11947998|FG000|NOT COMPLETED|Overall Study||44
10787651|NCT03488927|11947999|FG001|NOT COMPLETED|Overall Study||118
10787652|NCT03488927|11948000|FG002|NOT COMPLETED|Overall Study||217
10787653|NCT03489304|11948008|FG000|STARTED|Overall Study||20
10787654|NCT03489304|11948008|FG000|COMPLETED|Overall Study||16
10787655|NCT03489304|11948008|FG000|NOT COMPLETED|Overall Study||4
10787656|NCT03489343|11948019|FG000|STARTED|Overall Study||1
10787657|NCT03489343|11948020|FG001|STARTED|Overall Study||1
10787658|NCT03489343|11948021|FG002|STARTED|Overall Study||3
10787659|NCT03489343|11948022|FG003|STARTED|Overall Study||3
10787660|NCT03489343|11948023|FG004|STARTED|Overall Study||3
10787661|NCT03489343|11948024|FG005|STARTED|Overall Study||7
10787662|NCT03489343|11948025|FG006|STARTED|Overall Study||6
10787663|NCT03489343|11948019|FG000|COMPLETED|Overall Study||0
10787664|NCT03489343|11948020|FG001|COMPLETED|Overall Study||0
10787665|NCT03489343|11948021|FG002|COMPLETED|Overall Study||0
10787666|NCT03489343|11948022|FG003|COMPLETED|Overall Study||0
10787667|NCT03489343|11948023|FG004|COMPLETED|Overall Study||0
10787668|NCT03489343|11948024|FG005|COMPLETED|Overall Study||0
10787669|NCT03489343|11948025|FG006|COMPLETED|Overall Study||0
10787670|NCT03489343|11948019|FG000|NOT COMPLETED|Overall Study||1
10787671|NCT03489343|11948020|FG001|NOT COMPLETED|Overall Study||1
10787672|NCT03489343|11948021|FG002|NOT COMPLETED|Overall Study||3
10787673|NCT03489343|11948022|FG003|NOT COMPLETED|Overall Study||3
10787674|NCT03489343|11948023|FG004|NOT COMPLETED|Overall Study||3
10787675|NCT03489343|11948024|FG005|NOT COMPLETED|Overall Study||7
10787676|NCT03489343|11948025|FG006|NOT COMPLETED|Overall Study||6
10787677|NCT03489369|11948045|FG000|STARTED|Overall Study||3
10787678|NCT03489369|11948046|FG001|STARTED|Overall Study||3
10787679|NCT03489369|11948047|FG002|STARTED|Overall Study||3
10787680|NCT03489369|11948048|FG003|STARTED|Overall Study||6
10787681|NCT03489369|11948045|FG000|COMPLETED|Overall Study||0
10787682|NCT03489369|11948046|FG001|COMPLETED|Overall Study||0
10787683|NCT03489369|11948047|FG002|COMPLETED|Overall Study||0
10787684|NCT03489369|11948048|FG003|COMPLETED|Overall Study||0
10787685|NCT03489369|11948045|FG000|NOT COMPLETED|Overall Study||3
10787686|NCT03489369|11948046|FG001|NOT COMPLETED|Overall Study||3
10787687|NCT03489369|11948047|FG002|NOT COMPLETED|Overall Study||3
10787688|NCT03489369|11948048|FG003|NOT COMPLETED|Overall Study||6
10787689|NCT03489551|11948058|FG000|STARTED|Overall Study||17
10787690|NCT03489551|11948058|FG000|COMPLETED|Overall Study||15
10787691|NCT03489551|11948058|FG000|NOT COMPLETED|Overall Study||2
10787692|NCT03489720|11948064|FG000|STARTED|Overall Study||24
10787693|NCT03489720|11948065|FG001|STARTED|Overall Study||22
10787694|NCT03489720|11948064|FG000|COMPLETED|Overall Study||22
10787695|NCT03489720|11948065|FG001|COMPLETED|Overall Study||22
10787696|NCT03489720|11948064|FG000|NOT COMPLETED|Overall Study||2
10787697|NCT03489720|11948065|FG001|NOT COMPLETED|Overall Study||0
10787698|NCT03489850|11948077|FG000|STARTED|Overall Study||24
10787699|NCT03489850|11948078|FG001|STARTED|Overall Study||28
10787700|NCT03489850|11948077|FG000|COMPLETED|Overall Study||23
10787701|NCT03489850|11948078|FG001|COMPLETED|Overall Study||27
10787702|NCT03489850|11948077|FG000|NOT COMPLETED|Overall Study||1
10787703|NCT03489850|11948078|FG001|NOT COMPLETED|Overall Study||1
10787704|NCT03489863|11948086|FG000|STARTED|Overall Study||7
10525266|NCT01374802|11677154|FG000|STARTED|Overall Study||14
10787705|NCT03489863|11948087|FG001|STARTED|Overall Study||7
10787706|NCT03489863|11948086|FG000|COMPLETED|Overall Study||7
10787707|NCT03489863|11948087|FG001|COMPLETED|Overall Study||6
10787708|NCT03489863|11948086|FG000|NOT COMPLETED|Overall Study||0
10787709|NCT03489863|11948087|FG001|NOT COMPLETED|Overall Study||1
10787710|NCT03489941|11948093|FG000|STARTED|Overall Study||51
10787711|NCT03489941|11948094|FG001|STARTED|Overall Study||52
10787712|NCT03489941|11948095|FG002|STARTED|Overall Study||27
10787713|NCT03489941|11948093|FG000|COMPLETED|Overall Study||51
10787714|NCT03489941|11948094|FG001|COMPLETED|Overall Study||52
10787715|NCT03489941|11948095|FG002|COMPLETED|Overall Study||27
10787716|NCT03489941|11948093|FG000|NOT COMPLETED|Overall Study||0
10787717|NCT03489941|11948094|FG001|NOT COMPLETED|Overall Study||0
10787718|NCT03489941|11948095|FG002|NOT COMPLETED|Overall Study||0
10787719|NCT03490032|11948104|FG000|STARTED|Overall Study||6
10787720|NCT03490032|11948105|FG001|STARTED|Overall Study||12
10787721|NCT03490032|11948106|FG002|STARTED|Overall Study||12
10787722|NCT03490032|11948104|FG000|COMPLETED|Overall Study||5
10787723|NCT03490032|11948105|FG001|COMPLETED|Overall Study||12
10787724|NCT03490032|11948106|FG002|COMPLETED|Overall Study||12
10787725|NCT03490032|11948104|FG000|NOT COMPLETED|Overall Study||1
10787726|NCT03490032|11948105|FG001|NOT COMPLETED|Overall Study||0
10787727|NCT03490032|11948106|FG002|NOT COMPLETED|Overall Study||0
10787728|NCT03490110|11948117|FG000|STARTED|Overall Study||9
10787730|NCT03490110|11948117|FG000|COMPLETED|Overall Study||6
10787731|NCT03490110|11948118|FG001|COMPLETED|Overall Study||6
10787732|NCT03490110|11948117|FG000|NOT COMPLETED|Overall Study||3
10787733|NCT03490110|11948118|FG001|NOT COMPLETED|Overall Study||3
10787734|NCT03490942|11948127|FG000|STARTED|Overall Study||15
10787735|NCT03490942|11948128|FG001|STARTED|Overall Study||18
10787736|NCT03490942|11948129|FG002|STARTED|Overall Study||16
10787737|NCT03490942|11948127|FG000|COMPLETED|Overall Study||5
10787738|NCT03490942|11948128|FG001|COMPLETED|Overall Study||8
10787739|NCT03490942|11948129|FG002|COMPLETED|Overall Study||9
10787740|NCT03490942|11948127|FG000|NOT COMPLETED|Overall Study||10
10787741|NCT03490942|11948128|FG001|NOT COMPLETED|Overall Study||10
10787742|NCT03490942|11948129|FG002|NOT COMPLETED|Overall Study||7
10787743|NCT03490981|11948139|FG000|STARTED|Overall Study||15
10787744|NCT03490981|11948140|FG001|STARTED|Overall Study||15
10787745|NCT03490981|11948139|FG000|COMPLETED|Overall Study||14
10787746|NCT03490981|11948140|FG001|COMPLETED|Overall Study||13
10787747|NCT03490981|11948139|FG000|NOT COMPLETED|Overall Study||1
10787748|NCT03490981|11948140|FG001|NOT COMPLETED|Overall Study||2
10787749|NCT03491150|11948148|FG000|STARTED|Overall Study||76
10787750|NCT03491150|11948149|FG001|STARTED|Overall Study||73
10787751|NCT03491150|11948148|FG000|COMPLETED|Overall Study||0
10787752|NCT03491150|11948149|FG001|COMPLETED|Overall Study||0
10787753|NCT03491150|11948148|FG000|NOT COMPLETED|Overall Study||76
10787754|NCT03491150|11948149|FG001|NOT COMPLETED|Overall Study||73
10787755|NCT03491228|11948155|FG000|STARTED|Overall Study||107
10787756|NCT03491228|11948155|FG000|COMPLETED|Overall Study||107
10787757|NCT03491228|11948155|FG000|NOT COMPLETED|Overall Study||0
10787758|NCT03491553|11948165|FG000|STARTED|Main Study (Up to Week 48)||9
10787759|NCT03491553|11948166|FG001|STARTED|Main Study (Up to Week 48)||10
10787760|NCT03491553|11948167|FG002|STARTED|Main Study (Up to Week 48)||10
10787761|NCT03491553|11948168|FG003|STARTED|Main Study (Up to Week 48)||10
10787762|NCT03491553|11948169|FG004|STARTED|Main Study (Up to Week 48)||5
10787763|NCT03491553|11948170|FG005|STARTED|Main Study (Up to Week 48)||4
10787764|NCT03491553|11948165|FG000|COMPLETED|Main Study (Up to Week 48)||8
10787765|NCT03491553|11948166|FG001|COMPLETED|Main Study (Up to Week 48)||9
10787766|NCT03491553|11948167|FG002|COMPLETED|Main Study (Up to Week 48)||10
10787767|NCT03491553|11948168|FG003|COMPLETED|Main Study (Up to Week 48)||9
10787768|NCT03491553|11948169|FG004|COMPLETED|Main Study (Up to Week 48)||5
10787769|NCT03491553|11948170|FG005|COMPLETED|Main Study (Up to Week 48)||4
10787770|NCT03491553|11948165|FG000|NOT COMPLETED|Main Study (Up to Week 48)||1
10787771|NCT03491553|11948166|FG001|NOT COMPLETED|Main Study (Up to Week 48)||1
10787772|NCT03491553|11948167|FG002|NOT COMPLETED|Main Study (Up to Week 48)||0
10787773|NCT03491553|11948168|FG003|NOT COMPLETED|Main Study (Up to Week 48)||1
10787774|NCT03491553|11948169|FG004|NOT COMPLETED|Main Study (Up to Week 48)||0
10787775|NCT03491553|11948170|FG005|NOT COMPLETED|Main Study (Up to Week 48)||0
10787776|NCT03491553|11948165|FG000|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|8 participants completed the study period up to Week 48 but did not continue in the TFFU phase.|0
10787777|NCT03491553|11948166|FG001|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|9 participants completed the study period up to Week 48 but only 1 participant continued in the TFFU phase.|1
10787778|NCT03491553|11948167|FG002|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|10 participants completed the study period up to Week 48 but did not continue in the TFFU phase.|0
10787779|NCT03491553|11948168|FG003|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|9 participants completed the study period up to Week 48 but did not continue in the TFFU phase.|0
10787780|NCT03491553|11948169|FG004|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|5 participants completed the study period up to Week 48 but did not continue in the TFFU phase.|0
10787781|NCT03491553|11948170|FG005|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|4 participants completed the study period up to Week 48 but did not continue in the TFFU phase.|0
10787782|NCT03491553|11948165|FG000|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
10787783|NCT03491553|11948166|FG001|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||1
10787784|NCT03491553|11948167|FG002|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
10787785|NCT03491553|11948168|FG003|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
10787786|NCT03491553|11948169|FG004|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
10787787|NCT03491553|11948170|FG005|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
10787788|NCT03491553|11948165|FG000|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
10787789|NCT03491553|11948166|FG001|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
10787790|NCT03491553|11948167|FG002|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
10787791|NCT03491553|11948168|FG003|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
10787792|NCT03491553|11948169|FG004|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
10787793|NCT03491553|11948170|FG005|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
10787794|NCT03491800|11948189|FG000|STARTED|Overall Study||23
10787795|NCT03491800|11948190|FG001|STARTED|Overall Study||23
10787796|NCT03491800|11948191|FG002|STARTED|Overall Study||7
10787797|NCT03491800|11948189|FG000|COMPLETED|Overall Study||23
10787798|NCT03491800|11948190|FG001|COMPLETED|Overall Study||23
10787799|NCT03491800|11948191|FG002|COMPLETED|Overall Study||7
10787800|NCT03491800|11948189|FG000|NOT COMPLETED|Overall Study||0
10787801|NCT03491800|11948190|FG001|NOT COMPLETED|Overall Study||0
10787802|NCT03491800|11948191|FG002|NOT COMPLETED|Overall Study||0
10787803|NCT03491891|11948202|FG000|STARTED|Overall Study||6038
10787804|NCT03491891|11948203|FG001|STARTED|Overall Study||2438
10787805|NCT03491891|11948202|FG000|COMPLETED|Overall Study||5185
10787806|NCT03491891|11948203|FG001|COMPLETED|Overall Study||2058
10787807|NCT03491891|11948202|FG000|NOT COMPLETED|Overall Study||853
10787808|NCT03491891|11948203|FG001|NOT COMPLETED|Overall Study||380
10787809|NCT03491917|11948209|FG000|STARTED|First Reading Session||50
10787810|NCT03491917|11948210|FG001|STARTED|First Reading Session||50
10787811|NCT03491917|11948209|FG000|COMPLETED|First Reading Session||50
10787812|NCT03491917|11948210|FG001|COMPLETED|First Reading Session||50
10787813|NCT03491917|11948209|FG000|NOT COMPLETED|First Reading Session||0
10787814|NCT03491917|11948210|FG001|NOT COMPLETED|First Reading Session||0
10787815|NCT03491917|11948209|FG000|STARTED|4 Week Memory Washout Period||50
10787816|NCT03491917|11948210|FG001|STARTED|4 Week Memory Washout Period||50
10787817|NCT03491917|11948209|FG000|COMPLETED|4 Week Memory Washout Period||50
10787818|NCT03491917|11948210|FG001|COMPLETED|4 Week Memory Washout Period||50
10787819|NCT03491917|11948209|FG000|NOT COMPLETED|4 Week Memory Washout Period||0
10787820|NCT03491917|11948210|FG001|NOT COMPLETED|4 Week Memory Washout Period||0
10787821|NCT03491917|11948209|FG000|STARTED|Second Reading Session||50
10787822|NCT03491917|11948210|FG001|STARTED|Second Reading Session||50
10787823|NCT03491917|11948209|FG000|COMPLETED|Second Reading Session||50
10787824|NCT03491917|11948210|FG001|COMPLETED|Second Reading Session||50
10787825|NCT03491917|11948209|FG000|NOT COMPLETED|Second Reading Session||0
10787826|NCT03491917|11948210|FG001|NOT COMPLETED|Second Reading Session||0
10787827|NCT03492281|11948219|FG000|STARTED|Overall Study||540
10787828|NCT03492281|11948220|FG001|STARTED|Overall Study||547
10787829|NCT03492281|11948221|FG002|STARTED|Overall Study||431
10787830|NCT03492281|11948219|FG000|COMPLETED|Overall Study||486
10787831|NCT03492281|11948220|FG001|COMPLETED|Overall Study||502
10787832|NCT03492281|11948221|FG002|COMPLETED|Overall Study||385
10787833|NCT03492281|11948219|FG000|NOT COMPLETED|Overall Study||54
10787834|NCT03492281|11948220|FG001|NOT COMPLETED|Overall Study||45
10787835|NCT03492281|11948221|FG002|NOT COMPLETED|Overall Study||46
10787836|NCT03492398|11948241|FG000|STARTED|Overall Study||8
10787837|NCT03492398|11948242|FG001|STARTED|Overall Study||6
10787838|NCT03492398|11948243|FG002|STARTED|Overall Study||6
10787839|NCT03492398|11948244|FG003|STARTED|Overall Study||6
10787840|NCT03492398|11948245|FG004|STARTED|Overall Study||6
10787841|NCT03492398|11948246|FG005|STARTED|Overall Study||6
10787842|NCT03492398|11948247|FG006|STARTED|Overall Study||6
10787843|NCT03492398|11948248|FG007|STARTED|Overall Study||6
10787844|NCT03492398|11948249|FG008|STARTED|Overall Study||6
10787845|NCT03492398|11948241|FG000|COMPLETED|Overall Study||8
10787846|NCT03492398|11948242|FG001|COMPLETED|Overall Study||6
10787847|NCT03492398|11948243|FG002|COMPLETED|Overall Study||6
10787848|NCT03492398|11948244|FG003|COMPLETED|Overall Study||6
10787849|NCT03492398|11948245|FG004|COMPLETED|Overall Study||6
10787850|NCT03492398|11948246|FG005|COMPLETED|Overall Study||6
10787851|NCT03492398|11948247|FG006|COMPLETED|Overall Study||5
10787852|NCT03492398|11948248|FG007|COMPLETED|Overall Study||5
10787853|NCT03492398|11948249|FG008|COMPLETED|Overall Study||6
10787854|NCT03492398|11948241|FG000|NOT COMPLETED|Overall Study||0
10787855|NCT03492398|11948242|FG001|NOT COMPLETED|Overall Study||0
10787856|NCT03492398|11948243|FG002|NOT COMPLETED|Overall Study||0
10787857|NCT03492398|11948244|FG003|NOT COMPLETED|Overall Study||0
10787858|NCT03492398|11948245|FG004|NOT COMPLETED|Overall Study||0
10787859|NCT03492398|11948246|FG005|NOT COMPLETED|Overall Study||0
10787860|NCT03492398|11948247|FG006|NOT COMPLETED|Overall Study||1
10787861|NCT03492398|11948248|FG007|NOT COMPLETED|Overall Study||1
10787862|NCT03492398|11948249|FG008|NOT COMPLETED|Overall Study||0
10787863|NCT03492554|11948271|FG000|STARTED|Overall Study||301
10787864|NCT03492554|11948272|FG001|STARTED|Overall Study||301
10787865|NCT03492554|11948271|FG000|COMPLETED|Overall Study||301
10787866|NCT03492554|11948272|FG001|COMPLETED|Overall Study||287
10787867|NCT03492554|11948271|FG000|NOT COMPLETED|Overall Study||0
10787868|NCT03492554|11948272|FG001|NOT COMPLETED|Overall Study||14
10787869|NCT03493386|11948281|FG000|STARTED|Part 1, Intervention Period 1 (2 Days)||26
10787870|NCT03493386|11948282|FG001|STARTED|Part 1, Intervention Period 1 (2 Days)||26
10787871|NCT03493386|11948283|FG002|STARTED|Part 1, Intervention Period 1 (2 Days)||0
10787872|NCT03493386|11948284|FG003|STARTED|Part 1, Intervention Period 1 (2 Days)||0
10787873|NCT03493386|11948281|FG000|COMPLETED|Part 1, Intervention Period 1 (2 Days)||26
10787874|NCT03493386|11948282|FG001|COMPLETED|Part 1, Intervention Period 1 (2 Days)||26
10787875|NCT03493386|11948283|FG002|COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
10787876|NCT03493386|11948284|FG003|COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
10787877|NCT03493386|11948281|FG000|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
10787878|NCT03493386|11948282|FG001|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
10787879|NCT03493386|11948283|FG002|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
10787880|NCT03493386|11948284|FG003|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
10787881|NCT03493386|11948281|FG000|STARTED|Part 1, Washout Period (at Least 5 Days)||26
10787882|NCT03493386|11948282|FG001|STARTED|Part 1, Washout Period (at Least 5 Days)||26
10787883|NCT03493386|11948283|FG002|STARTED|Part 1, Washout Period (at Least 5 Days)||0
10787884|NCT03493386|11948284|FG003|STARTED|Part 1, Washout Period (at Least 5 Days)||0
10787885|NCT03493386|11948281|FG000|COMPLETED|Part 1, Washout Period (at Least 5 Days)||26
10787886|NCT03493386|11948282|FG001|COMPLETED|Part 1, Washout Period (at Least 5 Days)||25
10787887|NCT03493386|11948283|FG002|COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
10787888|NCT03493386|11948284|FG003|COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
10787889|NCT03493386|11948281|FG000|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
10787890|NCT03493386|11948282|FG001|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||1
10787891|NCT03493386|11948283|FG002|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
10787892|NCT03493386|11948284|FG003|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
10787893|NCT03493386|11948281|FG000|STARTED|Part 1, Intervention Period 2 (2 Days)||26
10787894|NCT03493386|11948282|FG001|STARTED|Part 1, Intervention Period 2 (2 Days)||25
10787895|NCT03493386|11948283|FG002|STARTED|Part 1, Intervention Period 2 (2 Days)||0
10787896|NCT03493386|11948284|FG003|STARTED|Part 1, Intervention Period 2 (2 Days)||0
10787897|NCT03493386|11948281|FG000|COMPLETED|Part 1, Intervention Period 2 (2 Days)||26
10787898|NCT03493386|11948282|FG001|COMPLETED|Part 1, Intervention Period 2 (2 Days)||25
10787899|NCT03493386|11948283|FG002|COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
10787900|NCT03493386|11948284|FG003|COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
10787901|NCT03493386|11948281|FG000|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
10787902|NCT03493386|11948282|FG001|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
10787903|NCT03493386|11948283|FG002|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
10787904|NCT03493386|11948284|FG003|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
10787905|NCT03493386|11948281|FG000|STARTED|Part 2, Intervention Period 1 (2 Days)||0
10787906|NCT03493386|11948282|FG001|STARTED|Part 2, Intervention Period 1 (2 Days)||0
10787907|NCT03493386|11948283|FG002|STARTED|Part 2, Intervention Period 1 (2 Days)||6
10787908|NCT03493386|11948284|FG003|STARTED|Part 2, Intervention Period 1 (2 Days)||6
10787909|NCT03493386|11948281|FG000|COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
10787910|NCT03493386|11948282|FG001|COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
10787911|NCT03493386|11948283|FG002|COMPLETED|Part 2, Intervention Period 1 (2 Days)||6
10787912|NCT03493386|11948284|FG003|COMPLETED|Part 2, Intervention Period 1 (2 Days)||6
10787913|NCT03493386|11948281|FG000|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
10787914|NCT03493386|11948282|FG001|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
10787915|NCT03493386|11948283|FG002|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
10787916|NCT03493386|11948284|FG003|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
10787917|NCT03493386|11948281|FG000|STARTED|Part 2, Washout Period (at Least 5 Days)||0
10787918|NCT03493386|11948282|FG001|STARTED|Part 2, Washout Period (at Least 5 Days)||0
10787919|NCT03493386|11948283|FG002|STARTED|Part 2, Washout Period (at Least 5 Days)||6
10787920|NCT03493386|11948284|FG003|STARTED|Part 2, Washout Period (at Least 5 Days)||6
10787921|NCT03493386|11948281|FG000|COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
10787922|NCT03493386|11948282|FG001|COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
10787923|NCT03493386|11948283|FG002|COMPLETED|Part 2, Washout Period (at Least 5 Days)||6
10787924|NCT03493386|11948284|FG003|COMPLETED|Part 2, Washout Period (at Least 5 Days)||6
10787925|NCT03493386|11948281|FG000|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
10787926|NCT03493386|11948282|FG001|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
10787927|NCT03493386|11948283|FG002|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
10787928|NCT03493386|11948284|FG003|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
10787929|NCT03493386|11948281|FG000|STARTED|Part 2, Intervention Period 2 (2 Days)||0
10787930|NCT03493386|11948282|FG001|STARTED|Part 2, Intervention Period 2 (2 Days)||0
10787931|NCT03493386|11948283|FG002|STARTED|Part 2, Intervention Period 2 (2 Days)||6
10787932|NCT03493386|11948284|FG003|STARTED|Part 2, Intervention Period 2 (2 Days)||6
10787933|NCT03493386|11948281|FG000|COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
10787934|NCT03493386|11948282|FG001|COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
10787935|NCT03493386|11948283|FG002|COMPLETED|Part 2, Intervention Period 2 (2 Days)||6
10787936|NCT03493386|11948284|FG003|COMPLETED|Part 2, Intervention Period 2 (2 Days)||6
10787937|NCT03493386|11948281|FG000|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
10787938|NCT03493386|11948282|FG001|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
10787939|NCT03493386|11948283|FG002|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
10787940|NCT03493386|11948284|FG003|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
10787941|NCT03493542|11948303|FG000|STARTED|Overall Study||383
10787942|NCT03493542|11948304|FG001|STARTED|Overall Study||383
10787943|NCT03493542|11948303|FG000|Vaccination 1|Overall Study||383
10787944|NCT03493542|11948304|FG001|Vaccination 1|Overall Study||383
10787945|NCT03493542|11948303|FG000|Vaccination 2|Overall Study||379
10787946|NCT03493542|11948304|FG001|Vaccination 2|Overall Study||378
10787947|NCT03493542|11948303|FG000|Vaccination 3|Overall Study||376
10787948|NCT03493542|11948304|FG001|Vaccination 3|Overall Study||374
10787949|NCT03493542|11948303|FG000|COMPLETED|Overall Study||376
10787950|NCT03493542|11948304|FG001|COMPLETED|Overall Study||374
10787951|NCT03493542|11948303|FG000|NOT COMPLETED|Overall Study||7
10787952|NCT03493542|11948304|FG001|NOT COMPLETED|Overall Study||9
10787953|NCT03493607|11948310|FG000|STARTED|Overall Study||6
10787954|NCT03493607|11948310|FG000|COMPLETED|Overall Study||6
10787955|NCT03493607|11948310|FG000|NOT COMPLETED|Overall Study||0
10787956|NCT03493698|11948314|FG000|STARTED|Treatment Period A||17
10787957|NCT03493698|11948314|FG000|COMPLETED|Treatment Period A||17
10787958|NCT03493698|11948314|FG000|NOT COMPLETED|Treatment Period A||0
10787959|NCT03493698|11948314|FG000|STARTED|Treatment Period B||17
10787960|NCT03493698|11948314|FG000|COMPLETED|Treatment Period B||17
10787961|NCT03493698|11948314|FG000|NOT COMPLETED|Treatment Period B||0
10787962|NCT03493698|11948314|FG000|STARTED|Treatment Period C||17
10787963|NCT03493698|11948314|FG000|COMPLETED|Treatment Period C||15
10787964|NCT03493698|11948314|FG000|NOT COMPLETED|Treatment Period C||2
10787965|NCT03493698|11948314|FG000|STARTED|Treatment Period D||15
10787966|NCT03493698|11948314|FG000|COMPLETED|Treatment Period D||15
10787967|NCT03493698|11948314|FG000|NOT COMPLETED|Treatment Period D||0
10787968|NCT03493815|11948330|FG000|STARTED|Overall Study||42
10787969|NCT03493815|11948331|FG001|STARTED|Overall Study||43
10787970|NCT03493815|11948330|FG000|COMPLETED|Overall Study||33
10787971|NCT03493815|11948331|FG001|COMPLETED|Overall Study||32
10787972|NCT03493815|11948330|FG000|NOT COMPLETED|Overall Study||9
10787973|NCT03493815|11948331|FG001|NOT COMPLETED|Overall Study||11
10787974|NCT03493828|11948340|FG000|STARTED|Overall Study||20
10787975|NCT03493828|11948341|FG001|STARTED|Overall Study||20
10787976|NCT03493828|11948342|FG002|STARTED|Overall Study||20
10787977|NCT03493828|11948340|FG000|COMPLETED|Overall Study||20
10787978|NCT03493828|11948341|FG001|COMPLETED|Overall Study||20
10787979|NCT03493828|11948342|FG002|COMPLETED|Overall Study||20
10787980|NCT03493828|11948340|FG000|NOT COMPLETED|Overall Study||0
10787981|NCT03493828|11948341|FG001|NOT COMPLETED|Overall Study||0
10787982|NCT03493828|11948342|FG002|NOT COMPLETED|Overall Study||0
10787983|NCT03494725|11948352|FG000|STARTED|Overall Study||60
10787984|NCT03494725|11948353|FG001|STARTED|Overall Study||60
10787985|NCT03494725|11948352|FG000|Intervention (Post 2 Weeks run-in)|Overall Study||59
10787986|NCT03494725|11948353|FG001|Intervention (Post 2 Weeks run-in)|Overall Study||59
10787987|NCT03494725|11948352|FG000|COMPLETED|Overall Study||59
10787988|NCT03494725|11948353|FG001|COMPLETED|Overall Study||58
10787989|NCT03494725|11948352|FG000|NOT COMPLETED|Overall Study||1
10787990|NCT03494725|11948353|FG001|NOT COMPLETED|Overall Study||2
10787991|NCT03494816|11948365|FG000|STARTED|Overall Study||24
10787992|NCT03494816|11948365|FG000|COMPLETED|Overall Study||18
10787993|NCT03494816|11948365|FG000|NOT COMPLETED|Overall Study||6
10787994|NCT03494985|11948377|FG000|STARTED|Overall Study||101
10787995|NCT03494985|11948378|FG001|STARTED|Overall Study||98
10787996|NCT03494985|11948379|FG002|STARTED|Overall Study||98
10787997|NCT03494985|11948380|FG003|STARTED|Overall Study||99
10787998|NCT03494985|11948377|FG000|COMPLETED|Overall Study||96
10787999|NCT03494985|11948378|FG001|COMPLETED|Overall Study||92
10788000|NCT03494985|11948379|FG002|COMPLETED|Overall Study||92
10788001|NCT03494985|11948380|FG003|COMPLETED|Overall Study||94
10788002|NCT03494985|11948377|FG000|NOT COMPLETED|Overall Study||5
10788003|NCT03494985|11948378|FG001|NOT COMPLETED|Overall Study||6
10788004|NCT03494985|11948379|FG002|NOT COMPLETED|Overall Study||6
10788005|NCT03494985|11948380|FG003|NOT COMPLETED|Overall Study||5
10788006|NCT03495102|11948393|FG000|STARTED|Overall Study||612
10788007|NCT03495102|11948394|FG001|STARTED|Overall Study||616
10788008|NCT03495102|11948395|FG002|STARTED|Overall Study||614
10788009|NCT03495102|11948393|FG000|Received at Least One Dose of Study Drug|Overall Study||612
10788010|NCT03495102|11948394|FG001|Received at Least One Dose of Study Drug|Overall Study||616
10788011|NCT03495102|11948395|FG002|Received at Least One Dose of Study Drug|Overall Study||614
10788012|NCT03495102|11948393|FG000|COMPLETED|Overall Study||556
10788013|NCT03495102|11948394|FG001|COMPLETED|Overall Study||549
10788014|NCT03495102|11948395|FG002|COMPLETED|Overall Study||560
10788015|NCT03495102|11948393|FG000|NOT COMPLETED|Overall Study||56
10788016|NCT03495102|11948394|FG001|NOT COMPLETED|Overall Study||67
10788017|NCT03495102|11948395|FG002|NOT COMPLETED|Overall Study||54
10788018|NCT03495648|11948405|FG000|STARTED|Overall Study||60
10788019|NCT03495648|11948406|FG001|STARTED|Overall Study||61
10788020|NCT03495648|11948405|FG000|COMPLETED|Overall Study||60
10788021|NCT03495648|11948406|FG001|COMPLETED|Overall Study||61
10788022|NCT03495648|11948405|FG000|NOT COMPLETED|Overall Study||0
10788023|NCT03495648|11948406|FG001|NOT COMPLETED|Overall Study||0
10788024|NCT03495817|11948412|FG000|STARTED|26 Week Open Label||31
10788025|NCT03495817|11948412|FG000|COMPLETED|26 Week Open Label||23
10788026|NCT03495817|11948412|FG000|NOT COMPLETED|26 Week Open Label||8
10788027|NCT03495817|11948412|FG000|STARTED|26 Week Extension||19
10788028|NCT03495817|11948412|FG000|COMPLETED|26 Week Extension||17
10788029|NCT03495817|11948412|FG000|NOT COMPLETED|26 Week Extension||2
10788030|NCT03495856|11948416|FG000|STARTED|Overall Study||23
10788031|NCT03495856|11948416|FG000|COMPLETED|Overall Study||22
10788032|NCT03495856|11948416|FG000|NOT COMPLETED|Overall Study||1
10788033|NCT03495869|11948424|FG000|STARTED|Overall Study||54
10788034|NCT03495869|11948425|FG001|STARTED|Overall Study||124
10788035|NCT03495869|11948426|FG002|STARTED|Overall Study||61
10788036|NCT03495869|11948427|FG003|STARTED|Overall Study||129
10788037|NCT03495869|11948424|FG000|COMPLETED|Overall Study||50
10788038|NCT03495869|11948425|FG001|COMPLETED|Overall Study||97
10788039|NCT03495869|11948426|FG002|COMPLETED|Overall Study||51
10788040|NCT03495869|11948427|FG003|COMPLETED|Overall Study||108
10788041|NCT03495869|11948424|FG000|NOT COMPLETED|Overall Study||4
10788042|NCT03495869|11948425|FG001|NOT COMPLETED|Overall Study||27
10788043|NCT03495869|11948426|FG002|NOT COMPLETED|Overall Study||10
10788044|NCT03495869|11948427|FG003|NOT COMPLETED|Overall Study||21
10788045|NCT03495908|11948439|FG000|STARTED|Overall Study||69
10788046|NCT03495908|11948440|FG001|STARTED|Overall Study||67
10788047|NCT03495908|11948439|FG000|COMPLETED|Overall Study||59
10788048|NCT03495908|11948440|FG001|COMPLETED|Overall Study||54
10788049|NCT03495908|11948439|FG000|NOT COMPLETED|Overall Study||10
10788050|NCT03495908|11948440|FG001|NOT COMPLETED|Overall Study||13
10788051|NCT03496220|11948448|FG000|STARTED|First Intervention||15
10788052|NCT03496220|11948449|FG001|STARTED|First Intervention||4
10788053|NCT03496220|11948450|FG002|STARTED|First Intervention||10
10788054|NCT03496220|11948448|FG000|COMPLETED|First Intervention||15
10788055|NCT03496220|11948449|FG001|COMPLETED|First Intervention||4
10788056|NCT03496220|11948450|FG002|COMPLETED|First Intervention||10
10788057|NCT03496220|11948448|FG000|NOT COMPLETED|First Intervention||0
10435449|NCT00896649|11581675|FG000|STARTED|Overall Study||193
10435450|NCT00896649|11581675|FG000|COMPLETED|Overall Study||188
10435451|NCT00896649|11581675|FG000|NOT COMPLETED|Overall Study||5
10435452|NCT00896779|11581682|FG000|STARTED|Overall Study||8
10435453|NCT00896779|11581683|FG001|STARTED|Overall Study||12
10435454|NCT00896779|11581682|FG000|COMPLETED|Overall Study||8
10435455|NCT00896779|11581683|FG001|COMPLETED|Overall Study||11
10435456|NCT00896779|11581682|FG000|NOT COMPLETED|Overall Study||0
10435457|NCT00896779|11581683|FG001|NOT COMPLETED|Overall Study||1
10435458|NCT00897390|11581689|FG000|STARTED|Overall Study||24
10435459|NCT00897390|11581689|FG000|COMPLETED|Overall Study||18
10435460|NCT00897390|11581689|FG000|NOT COMPLETED|Overall Study||6
10435461|NCT00897676|11581700|FG000|STARTED|Intervention 1(6 Hours)||9
10435462|NCT00897676|11581701|FG001|STARTED|Intervention 1(6 Hours)||7
10435463|NCT00897676|11581700|FG000|COMPLETED|Intervention 1(6 Hours)||9
10435464|NCT00897676|11581701|FG001|COMPLETED|Intervention 1(6 Hours)||7
10435465|NCT00897676|11581700|FG000|NOT COMPLETED|Intervention 1(6 Hours)||0
10435466|NCT00897676|11581701|FG001|NOT COMPLETED|Intervention 1(6 Hours)||0
10435467|NCT00897676|11581700|FG000|STARTED|Intervention 2(6 Hours)||9
10435468|NCT00897676|11581701|FG001|STARTED|Intervention 2(6 Hours)||7
10435469|NCT00897676|11581700|FG000|COMPLETED|Intervention 2(6 Hours)||9
10435470|NCT00897676|11581701|FG001|COMPLETED|Intervention 2(6 Hours)||7
10435471|NCT00897676|11581700|FG000|NOT COMPLETED|Intervention 2(6 Hours)||0
10435472|NCT00897676|11581701|FG001|NOT COMPLETED|Intervention 2(6 Hours)||0
10788058|NCT03496220|11948449|FG001|NOT COMPLETED|First Intervention||0
10788059|NCT03496220|11948450|FG002|NOT COMPLETED|First Intervention||0
10788060|NCT03496220|11948448|FG000|STARTED|Second Intervention||17
10788061|NCT03496220|11948449|FG001|STARTED|Second Intervention||9
10788062|NCT03496220|11948450|FG002|STARTED|Second Intervention||11
10788063|NCT03496220|11948448|FG000|COMPLETED|Second Intervention||17
10788064|NCT03496220|11948449|FG001|COMPLETED|Second Intervention||9
10788065|NCT03496220|11948450|FG002|COMPLETED|Second Intervention||11
10788066|NCT03496220|11948448|FG000|NOT COMPLETED|Second Intervention||0
10788067|NCT03496220|11948449|FG001|NOT COMPLETED|Second Intervention||0
10788068|NCT03496220|11948450|FG002|NOT COMPLETED|Second Intervention||0
10788069|NCT03496220|11948448|FG000|STARTED|Third Intervention||11
10788070|NCT03496220|11948449|FG001|STARTED|Third Intervention||8
10788071|NCT03496220|11948450|FG002|STARTED|Third Intervention||5
10788072|NCT03496220|11948448|FG000|COMPLETED|Third Intervention||11
10788073|NCT03496220|11948449|FG001|COMPLETED|Third Intervention||8
10788074|NCT03496220|11948450|FG002|COMPLETED|Third Intervention||5
10788075|NCT03496220|11948448|FG000|NOT COMPLETED|Third Intervention||0
10788076|NCT03496220|11948449|FG001|NOT COMPLETED|Third Intervention||0
10788077|NCT03496220|11948450|FG002|NOT COMPLETED|Third Intervention||0
10788078|NCT03496298|11948459|FG000|STARTED|Overall Study||1359
10788079|NCT03496298|11948460|FG001|STARTED|Overall Study||1359
10788080|NCT03496298|11948461|FG002|STARTED|Overall Study||1358
10788081|NCT03496298|11948459|FG000|Randomized and Treated|Overall Study||1358
10788082|NCT03496298|11948460|FG001|Randomized and Treated|Overall Study||1358
10788083|NCT03496298|11948461|FG002|Randomized and Treated|Overall Study||1357
10788084|NCT03496298|11948459|FG000|Safety Population|Overall Study|2 participants of Placebo arm received Efpeglenatide 4 mg treatment and 1 participant received Efpeglenatide 6 mg treatment. Hence, they were counted in the respective arm for safety analysis.|1355
10788085|NCT03496298|11948460|FG001|Safety Population|Overall Study|2 participants of Placebo arm received Efpeglenatide 4 mg treatment and thus counted in the 4 mg treatment arm for safety analysis.|1360
10788086|NCT03496298|11948461|FG002|Safety Population|Overall Study|1 participant of Placebo arm received Efpeglenatide 6 mg treatment and thus counted in the 6 mg treatment arm for safety analysis.|1358
10788087|NCT03496298|11948459|FG000|COMPLETED|Overall Study||42
10788088|NCT03496298|11948460|FG001|COMPLETED|Overall Study||36
10788089|NCT03496298|11948461|FG002|COMPLETED|Overall Study||23
10788090|NCT03496298|11948459|FG000|NOT COMPLETED|Overall Study||1317
10788091|NCT03496298|11948460|FG001|NOT COMPLETED|Overall Study||1323
10788092|NCT03496298|11948461|FG002|NOT COMPLETED|Overall Study||1335
10788093|NCT03496324|11948468|FG000|STARTED|Period 1||6
10788094|NCT03496324|11948469|FG001|STARTED|Period 1||6
10435473|NCT00897715|11581716|FG000|STARTED|Overall Study||8
10435474|NCT00897715|11581717|FG001|STARTED|Overall Study||7
10435475|NCT00897715|11581716|FG000|COMPLETED|Overall Study||6
10435476|NCT00897715|11581717|FG001|COMPLETED|Overall Study||6
10435477|NCT00897715|11581716|FG000|NOT COMPLETED|Overall Study||2
10435478|NCT00897715|11581717|FG001|NOT COMPLETED|Overall Study||1
10435479|NCT00897897|11581723|FG000|STARTED|Overall Study||33
10435480|NCT00897897|11581723|FG000|COMPLETED|Overall Study||33
10435481|NCT00897897|11581723|FG000|NOT COMPLETED|Overall Study||0
10435482|NCT00898222|11581727|FG000|STARTED|Overall Study||4
10435483|NCT00898222|11581727|FG000|COMPLETED|Overall Study||4
10435484|NCT00898222|11581727|FG000|NOT COMPLETED|Overall Study||0
10435485|NCT00898443|11581733|FG000|STARTED|Overall Study||10
10788095|NCT03496324|11948470|FG002|STARTED|Period 1||6
10788096|NCT03496324|11948471|FG003|STARTED|Period 1||6
10788097|NCT03496324|11948468|FG000|COMPLETED|Period 1||6
10788098|NCT03496324|11948469|FG001|COMPLETED|Period 1||6
10788099|NCT03496324|11948470|FG002|COMPLETED|Period 1||6
10435486|NCT00898443|11581734|FG001|STARTED|Overall Study||8
10435487|NCT00898443|11581733|FG000|COMPLETED|Overall Study||9
10435488|NCT00898443|11581734|FG001|COMPLETED|Overall Study||8
10435489|NCT00898443|11581733|FG000|NOT COMPLETED|Overall Study||1
10435490|NCT00898443|11581734|FG001|NOT COMPLETED|Overall Study||0
10435491|NCT00898560|11581740|FG000|STARTED|Overall Study||20
10435492|NCT00898560|11581740|FG000|COMPLETED|Overall Study||19
10435493|NCT00898560|11581740|FG000|NOT COMPLETED|Overall Study||1
10435494|NCT00898807|11581748|FG000|STARTED|Overall Study||94
10435495|NCT00898807|11581749|FG001|STARTED|Overall Study||92
10435496|NCT00898807|11581748|FG000|COMPLETED|Overall Study||86
10435497|NCT00898807|11581749|FG001|COMPLETED|Overall Study||83
10435498|NCT00898807|11581748|FG000|NOT COMPLETED|Overall Study||8
10435499|NCT00898807|11581749|FG001|NOT COMPLETED|Overall Study||9
10435500|NCT00898937|11581758|FG000|STARTED|Overall Study||25
10435501|NCT00898937|11581759|FG001|STARTED|Overall Study||21
10435502|NCT00898937|11581760|FG002|STARTED|Overall Study||9
10435503|NCT00898937|11581758|FG000|COMPLETED|Overall Study||25
10435504|NCT00898937|11581759|FG001|COMPLETED|Overall Study||21
10435505|NCT00898937|11581760|FG002|COMPLETED|Overall Study||9
10435506|NCT00898937|11581758|FG000|NOT COMPLETED|Overall Study||0
10435507|NCT00898937|11581759|FG001|NOT COMPLETED|Overall Study||0
10435508|NCT00898937|11581760|FG002|NOT COMPLETED|Overall Study||0
10435509|NCT00899353|11581768|FG000|STARTED|Overall Study||16
10435510|NCT00899353|11581768|FG000|COMPLETED|Overall Study||11
10435511|NCT00899353|11581768|FG000|NOT COMPLETED|Overall Study||5
10435512|NCT00899392|11581791|FG000|STARTED|Overall Study||68
10435513|NCT00899392|11581792|FG001|STARTED|Overall Study||74
10435514|NCT00899392|11581791|FG000|COMPLETED|Overall Study|Subjects:PerVariableStudied Consent:47-EAC 50-FBC Anxiety:60-EAC 3-FBC Satisfaction:63-EAC 67-FBC|47
10435515|NCT00899392|11581792|FG001|COMPLETED|Overall Study|Subjects:PerVariableStudied Consent:47-EAC 50-FBC Anxiety:60-EAC 3-FBC Satisfaction:63-EAC 67-FBC|50
10435516|NCT00899392|11581791|FG000|NOT COMPLETED|Overall Study||21
10435517|NCT00899392|11581792|FG001|NOT COMPLETED|Overall Study||24
10435518|NCT00899431|11581801|FG000|STARTED|Overall Study||22
10435519|NCT00899431|11581802|FG001|STARTED|Overall Study||8
10435520|NCT00899431|11581803|FG002|STARTED|Overall Study||9
10788100|NCT03496324|11948471|FG003|COMPLETED|Period 1||6
10788101|NCT03496324|11948468|FG000|NOT COMPLETED|Period 1||0
10435521|NCT00899431|11581801|FG000|COMPLETED|Overall Study||21
10435522|NCT00899431|11581802|FG001|COMPLETED|Overall Study||8
10435523|NCT00899431|11581803|FG002|COMPLETED|Overall Study||9
10435524|NCT00899431|11581801|FG000|NOT COMPLETED|Overall Study||1
10435525|NCT00899431|11581802|FG001|NOT COMPLETED|Overall Study||0
10435526|NCT00899431|11581803|FG002|NOT COMPLETED|Overall Study||0
10435527|NCT00899470|11581814|FG000|STARTED|First Therapy||6
10435528|NCT00899470|11581815|FG001|STARTED|First Therapy||6
10435529|NCT00899470|11581816|FG002|STARTED|First Therapy||6
10435530|NCT00899470|11581817|FG003|STARTED|First Therapy||6
10435531|NCT00899470|11581814|FG000|COMPLETED|First Therapy||6
10435532|NCT00899470|11581815|FG001|COMPLETED|First Therapy||6
10435533|NCT00899470|11581816|FG002|COMPLETED|First Therapy||6
10435534|NCT00899470|11581817|FG003|COMPLETED|First Therapy||6
10435535|NCT00899470|11581814|FG000|NOT COMPLETED|First Therapy||0
10435536|NCT00899470|11581815|FG001|NOT COMPLETED|First Therapy||0
10435537|NCT00899470|11581816|FG002|NOT COMPLETED|First Therapy||0
10435538|NCT00899470|11581817|FG003|NOT COMPLETED|First Therapy||0
10435539|NCT00899470|11581814|FG000|STARTED|First Washout Period||6
10435540|NCT00899470|11581815|FG001|STARTED|First Washout Period||6
10435541|NCT00899470|11581816|FG002|STARTED|First Washout Period||6
10435542|NCT00899470|11581817|FG003|STARTED|First Washout Period||6
10435543|NCT00899470|11581814|FG000|COMPLETED|First Washout Period||6
10435544|NCT00899470|11581815|FG001|COMPLETED|First Washout Period||6
10435545|NCT00899470|11581816|FG002|COMPLETED|First Washout Period||6
10435546|NCT00899470|11581817|FG003|COMPLETED|First Washout Period||6
10435547|NCT00899470|11581814|FG000|NOT COMPLETED|First Washout Period||0
10435548|NCT00899470|11581815|FG001|NOT COMPLETED|First Washout Period||0
10435549|NCT00899470|11581816|FG002|NOT COMPLETED|First Washout Period||0
10435550|NCT00899470|11581817|FG003|NOT COMPLETED|First Washout Period||0
10435551|NCT00899470|11581814|FG000|STARTED|Second Therapy||6
10435552|NCT00899470|11581815|FG001|STARTED|Second Therapy||6
10435553|NCT00899470|11581816|FG002|STARTED|Second Therapy||6
10435554|NCT00899470|11581817|FG003|STARTED|Second Therapy||6
10435555|NCT00899470|11581814|FG000|COMPLETED|Second Therapy||6
10435556|NCT00899470|11581815|FG001|COMPLETED|Second Therapy||6
10435557|NCT00899470|11581816|FG002|COMPLETED|Second Therapy||6
10435558|NCT00899470|11581817|FG003|COMPLETED|Second Therapy||6
10435559|NCT00899470|11581814|FG000|NOT COMPLETED|Second Therapy||0
10435560|NCT00899470|11581815|FG001|NOT COMPLETED|Second Therapy||0
10435561|NCT00899470|11581816|FG002|NOT COMPLETED|Second Therapy||0
10435562|NCT00899470|11581817|FG003|NOT COMPLETED|Second Therapy||0
10435563|NCT00899470|11581814|FG000|STARTED|Second Washout||6
10435564|NCT00899470|11581815|FG001|STARTED|Second Washout||6
10435565|NCT00899470|11581816|FG002|STARTED|Second Washout||6
10435566|NCT00899470|11581817|FG003|STARTED|Second Washout||6
10435567|NCT00899470|11581814|FG000|COMPLETED|Second Washout||6
10788102|NCT03496324|11948469|FG001|NOT COMPLETED|Period 1||0
10435568|NCT00899470|11581815|FG001|COMPLETED|Second Washout||6
10435569|NCT00899470|11581816|FG002|COMPLETED|Second Washout||6
10435570|NCT00899470|11581817|FG003|COMPLETED|Second Washout||6
10435571|NCT00899470|11581814|FG000|NOT COMPLETED|Second Washout||0
10435572|NCT00899470|11581815|FG001|NOT COMPLETED|Second Washout||0
10435573|NCT00899470|11581816|FG002|NOT COMPLETED|Second Washout||0
10435574|NCT00899470|11581817|FG003|NOT COMPLETED|Second Washout||0
10435575|NCT00899470|11581814|FG000|STARTED|Third Therapy||6
10435576|NCT00899470|11581815|FG001|STARTED|Third Therapy||6
10435577|NCT00899470|11581816|FG002|STARTED|Third Therapy||6
10435578|NCT00899470|11581817|FG003|STARTED|Third Therapy||6
10435579|NCT00899470|11581814|FG000|COMPLETED|Third Therapy||6
10435580|NCT00899470|11581815|FG001|COMPLETED|Third Therapy||6
10435581|NCT00899470|11581816|FG002|COMPLETED|Third Therapy||6
10435582|NCT00899470|11581817|FG003|COMPLETED|Third Therapy||6
10788103|NCT03496324|11948470|FG002|NOT COMPLETED|Period 1||0
10435583|NCT00899470|11581814|FG000|NOT COMPLETED|Third Therapy||0
10435584|NCT00899470|11581815|FG001|NOT COMPLETED|Third Therapy||0
10435585|NCT00899470|11581816|FG002|NOT COMPLETED|Third Therapy||0
10435586|NCT00899470|11581817|FG003|NOT COMPLETED|Third Therapy||0
10435587|NCT00899470|11581814|FG000|STARTED|Third Washout||6
10788104|NCT03496324|11948471|FG003|NOT COMPLETED|Period 1||0
10788105|NCT03496324|11948468|FG000|STARTED|Period 1: Washout (3 to 7 Days)||6
10788106|NCT03496324|11948469|FG001|STARTED|Period 1: Washout (3 to 7 Days)||6
10788107|NCT03496324|11948470|FG002|STARTED|Period 1: Washout (3 to 7 Days)||6
10788108|NCT03496324|11948471|FG003|STARTED|Period 1: Washout (3 to 7 Days)||6
10788109|NCT03496324|11948468|FG000|COMPLETED|Period 1: Washout (3 to 7 Days)||6
10788110|NCT03496324|11948469|FG001|COMPLETED|Period 1: Washout (3 to 7 Days)||6
10788111|NCT03496324|11948470|FG002|COMPLETED|Period 1: Washout (3 to 7 Days)||6
10788112|NCT03496324|11948471|FG003|COMPLETED|Period 1: Washout (3 to 7 Days)||6
10788113|NCT03496324|11948468|FG000|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
10788114|NCT03496324|11948469|FG001|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
10788115|NCT03496324|11948470|FG002|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
10788116|NCT03496324|11948471|FG003|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
10788117|NCT03496324|11948468|FG000|STARTED|Period 2||6
10788118|NCT03496324|11948469|FG001|STARTED|Period 2||6
10788119|NCT03496324|11948470|FG002|STARTED|Period 2||6
10788120|NCT03496324|11948471|FG003|STARTED|Period 2||6
10788121|NCT03496324|11948468|FG000|COMPLETED|Period 2||6
10788122|NCT03496324|11948469|FG001|COMPLETED|Period 2||6
10788123|NCT03496324|11948470|FG002|COMPLETED|Period 2||6
10435588|NCT00899470|11581815|FG001|STARTED|Third Washout||6
10788124|NCT03496324|11948471|FG003|COMPLETED|Period 2||6
10788125|NCT03496324|11948468|FG000|NOT COMPLETED|Period 2||0
10788126|NCT03496324|11948469|FG001|NOT COMPLETED|Period 2||0
10788127|NCT03496324|11948470|FG002|NOT COMPLETED|Period 2||0
10788128|NCT03496324|11948471|FG003|NOT COMPLETED|Period 2||0
10788129|NCT03496324|11948468|FG000|STARTED|Period 2: Washout (3 to 7 Days)||6
10435589|NCT00899470|11581816|FG002|STARTED|Third Washout||6
10435590|NCT00899470|11581817|FG003|STARTED|Third Washout||6
10788130|NCT03496324|11948469|FG001|STARTED|Period 2: Washout (3 to 7 Days)||6
10788131|NCT03496324|11948470|FG002|STARTED|Period 2: Washout (3 to 7 Days)||6
10435591|NCT00899470|11581814|FG000|COMPLETED|Third Washout||6
10435592|NCT00899470|11581815|FG001|COMPLETED|Third Washout||6
10435593|NCT00899470|11581816|FG002|COMPLETED|Third Washout||6
10435594|NCT00899470|11581817|FG003|COMPLETED|Third Washout||6
10435595|NCT00899470|11581814|FG000|NOT COMPLETED|Third Washout||0
10435596|NCT00899470|11581815|FG001|NOT COMPLETED|Third Washout||0
10435597|NCT00899470|11581816|FG002|NOT COMPLETED|Third Washout||0
10435598|NCT00899470|11581817|FG003|NOT COMPLETED|Third Washout||0
10435599|NCT00899470|11581814|FG000|STARTED|Fourth Therapy||6
10435600|NCT00899470|11581815|FG001|STARTED|Fourth Therapy||6
10435601|NCT00899470|11581816|FG002|STARTED|Fourth Therapy||6
10435602|NCT00899470|11581817|FG003|STARTED|Fourth Therapy||6
10435603|NCT00899470|11581814|FG000|COMPLETED|Fourth Therapy||6
10435604|NCT00899470|11581815|FG001|COMPLETED|Fourth Therapy||6
10435605|NCT00899470|11581816|FG002|COMPLETED|Fourth Therapy||6
10435606|NCT00899470|11581817|FG003|COMPLETED|Fourth Therapy||6
10435607|NCT00899470|11581814|FG000|NOT COMPLETED|Fourth Therapy||0
10435608|NCT00899470|11581815|FG001|NOT COMPLETED|Fourth Therapy||0
10435609|NCT00899470|11581816|FG002|NOT COMPLETED|Fourth Therapy||0
10435610|NCT00899470|11581817|FG003|NOT COMPLETED|Fourth Therapy||0
10435611|NCT00899548|11581832|FG000|STARTED|Overall Study||182
10435612|NCT00899548|11581832|FG000|COMPLETED|Overall Study||179
10435613|NCT00899548|11581832|FG000|NOT COMPLETED|Overall Study||3
10435614|NCT00899574|11581840|FG000|STARTED|Overall Study||10
10435615|NCT00899574|11581840|FG000|COMPLETED|Overall Study||10
10435616|NCT00899574|11581840|FG000|NOT COMPLETED|Overall Study||0
10435617|NCT00899600|11581846|FG000|STARTED|Overall Study||50
10435618|NCT00899600|11581847|FG001|STARTED|Overall Study||52
10435619|NCT00899600|11581846|FG000|COMPLETED|Overall Study||50
10435620|NCT00899600|11581847|FG001|COMPLETED|Overall Study||52
10435621|NCT00899600|11581846|FG000|NOT COMPLETED|Overall Study||0
10435622|NCT00899600|11581847|FG001|NOT COMPLETED|Overall Study||0
10435623|NCT00899678|11581856|FG000|STARTED|Induction Period (Weeks 0 to 6)|Induction only includes subjects that discontinued before Maintenance Period.|27
10435624|NCT00899678|11581857|FG001|STARTED|Induction Period (Weeks 0 to 6)||37
10435625|NCT00899678|11581858|FG002|STARTED|Induction Period (Weeks 0 to 6)||35
10435626|NCT00899678|11581856|FG000|COMPLETED|Induction Period (Weeks 0 to 6)|2 subjects completed the Induction Phase, but discontinued prior to receiving any Maintenance doses.|2
10435627|NCT00899678|11581857|FG001|COMPLETED|Induction Period (Weeks 0 to 6)||37
10435628|NCT00899678|11581858|FG002|COMPLETED|Induction Period (Weeks 0 to 6)||35
10435629|NCT00899678|11581856|FG000|NOT COMPLETED|Induction Period (Weeks 0 to 6)||25
10435630|NCT00899678|11581857|FG001|NOT COMPLETED|Induction Period (Weeks 0 to 6)||0
10435631|NCT00899678|11581858|FG002|NOT COMPLETED|Induction Period (Weeks 0 to 6)||0
10435632|NCT00899678|11581856|FG000|STARTED|Maintenance Period (Weeks 8 to 62)|Induction only includes subjects that discontinued before Maintenance Period.|0
10435633|NCT00899678|11581857|FG001|STARTED|Maintenance Period (Weeks 8 to 62)||37
10435634|NCT00899678|11581858|FG002|STARTED|Maintenance Period (Weeks 8 to 62)||35
10435635|NCT00899678|11581856|FG000|COMPLETED|Maintenance Period (Weeks 8 to 62)||0
10435636|NCT00899678|11581857|FG001|COMPLETED|Maintenance Period (Weeks 8 to 62)||12
10435637|NCT00899678|11581858|FG002|COMPLETED|Maintenance Period (Weeks 8 to 62)||7
10435638|NCT00899678|11581856|FG000|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||0
10435639|NCT00899678|11581857|FG001|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||25
10435640|NCT00899678|11581858|FG002|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||28
10435641|NCT00899717|11581868|FG000|STARTED|Overall Study||10
10435642|NCT00899717|11581869|FG001|STARTED|Overall Study||11
10435643|NCT00899717|11581868|FG000|COMPLETED|Overall Study||10
10435644|NCT00899717|11581869|FG001|COMPLETED|Overall Study||11
10435645|NCT00899717|11581868|FG000|NOT COMPLETED|Overall Study||0
10435646|NCT00899717|11581869|FG001|NOT COMPLETED|Overall Study||0
10435647|NCT00899847|11581881|FG000|STARTED|Overall Study||9
10435648|NCT00899847|11581881|FG000|COMPLETED|Overall Study||7
10435649|NCT00899847|11581881|FG000|NOT COMPLETED|Overall Study||2
10435650|NCT00900029|11581892|FG000|STARTED|Overall Study||38
10435651|NCT00900029|11581893|FG001|STARTED|Overall Study||41
10435652|NCT00900029|11581894|FG002|STARTED|Overall Study||41
10435653|NCT00900029|11581895|FG003|STARTED|Overall Study||42
10435654|NCT00900029|11581896|FG004|STARTED|Overall Study||44
10435655|NCT00900029|11581892|FG000|COMPLETED|Overall Study||35
10435656|NCT00900029|11581893|FG001|COMPLETED|Overall Study||37
10435657|NCT00900029|11581894|FG002|COMPLETED|Overall Study||38
10435658|NCT00900029|11581895|FG003|COMPLETED|Overall Study||35
10435659|NCT00900029|11581896|FG004|COMPLETED|Overall Study||38
10435660|NCT00900029|11581892|FG000|NOT COMPLETED|Overall Study||3
10435661|NCT00900029|11581893|FG001|NOT COMPLETED|Overall Study||4
10435662|NCT00900029|11581894|FG002|NOT COMPLETED|Overall Study||3
10435663|NCT00900029|11581895|FG003|NOT COMPLETED|Overall Study||7
10435664|NCT00900029|11581896|FG004|NOT COMPLETED|Overall Study||6
10435665|NCT00900146|11581913|FG000|STARTED|Dose Finding: Period II (4 Months)||93
10435666|NCT00900146|11581914|FG001|STARTED|Dose Finding: Period II (4 Months)||95
10435667|NCT00900146|11581915|FG002|STARTED|Dose Finding: Period II (4 Months)||92
10435668|NCT00900146|11581916|FG003|STARTED|Dose Finding: Period II (4 Months)||92
10435669|NCT00900146|11581917|FG004|STARTED|Dose Finding: Period II (4 Months)||179
10435670|NCT00900146|11581913|FG000|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||93
10435671|NCT00900146|11581914|FG001|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||95
10525267|NCT01374802|11677154|FG000|COMPLETED|Overall Study||14
10525268|NCT01374802|11677154|FG000|NOT COMPLETED|Overall Study||0
10525269|NCT01374906|11677162|FG000|STARTED|Overall Study||74
10435672|NCT00900146|11581915|FG002|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||92
10435673|NCT00900146|11581916|FG003|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||92
10435674|NCT00900146|11581917|FG004|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||179
10435675|NCT00900146|11581913|FG000|COMPLETED|Dose Finding: Period II (4 Months)||88
10435676|NCT00900146|11581914|FG001|COMPLETED|Dose Finding: Period II (4 Months)||93
10435677|NCT00900146|11581915|FG002|COMPLETED|Dose Finding: Period II (4 Months)||87
10435678|NCT00900146|11581916|FG003|COMPLETED|Dose Finding: Period II (4 Months)||90
10435679|NCT00900146|11581917|FG004|COMPLETED|Dose Finding: Period II (4 Months)|Placebo also included 1 patient with no study completion page.|167
10435680|NCT00900146|11581913|FG000|NOT COMPLETED|Dose Finding: Period II (4 Months)||5
10435681|NCT00900146|11581914|FG001|NOT COMPLETED|Dose Finding: Period II (4 Months)||2
10435682|NCT00900146|11581915|FG002|NOT COMPLETED|Dose Finding: Period II (4 Months)||5
10435683|NCT00900146|11581916|FG003|NOT COMPLETED|Dose Finding: Period II (4 Months)||2
10435684|NCT00900146|11581917|FG004|NOT COMPLETED|Dose Finding: Period II (4 Months)||12
10435685|NCT00900146|11581913|FG000|STARTED|Intermediate: Period III||87
10435686|NCT00900146|11581914|FG001|STARTED|Intermediate: Period III||93
10435687|NCT00900146|11581915|FG002|STARTED|Intermediate: Period III||84
10435688|NCT00900146|11581916|FG003|STARTED|Intermediate: Period III||90
10435689|NCT00900146|11581917|FG004|STARTED|Intermediate: Period III||167
10435690|NCT00900146|11581913|FG000|Safety Set|Intermediate: Period III||86
10435691|NCT00900146|11581914|FG001|Safety Set|Intermediate: Period III||92
10435692|NCT00900146|11581915|FG002|Safety Set|Intermediate: Period III||84
10435693|NCT00900146|11581916|FG003|Safety Set|Intermediate: Period III||90
10435694|NCT00900146|11581917|FG004|Safety Set|Intermediate: Period III||166
10435695|NCT00900146|11581913|FG000|COMPLETED|Intermediate: Period III||0
10435696|NCT00900146|11581914|FG001|COMPLETED|Intermediate: Period III||0
10435697|NCT00900146|11581915|FG002|COMPLETED|Intermediate: Period III||0
10435698|NCT00900146|11581916|FG003|COMPLETED|Intermediate: Period III||0
10435699|NCT00900146|11581917|FG004|COMPLETED|Intermediate: Period III||0
10435700|NCT00900146|11581913|FG000|NOT COMPLETED|Intermediate: Period III||87
10435701|NCT00900146|11581914|FG001|NOT COMPLETED|Intermediate: Period III||93
10435702|NCT00900146|11581915|FG002|NOT COMPLETED|Intermediate: Period III||84
10435703|NCT00900146|11581916|FG003|NOT COMPLETED|Intermediate: Period III||90
10435704|NCT00900146|11581917|FG004|NOT COMPLETED|Intermediate: Period III||167
10435705|NCT00900159|11581931|FG000|STARTED|First Intervention||11
10435706|NCT00900159|11581932|FG001|STARTED|First Intervention||13
10435707|NCT00900159|11581931|FG000|COMPLETED|First Intervention||11
10435708|NCT00900159|11581932|FG001|COMPLETED|First Intervention||13
10435709|NCT00900159|11581931|FG000|NOT COMPLETED|First Intervention||0
10435710|NCT00900159|11581932|FG001|NOT COMPLETED|First Intervention||0
10435711|NCT00900159|11581931|FG000|STARTED|Washout||11
10435712|NCT00900159|11581932|FG001|STARTED|Washout||13
10435713|NCT00900159|11581931|FG000|COMPLETED|Washout||11
10435714|NCT00900159|11581932|FG001|COMPLETED|Washout||13
10435715|NCT00900159|11581931|FG000|NOT COMPLETED|Washout||0
10435716|NCT00900159|11581932|FG001|NOT COMPLETED|Washout||0
10435717|NCT00900159|11581931|FG000|STARTED|Second Intervention||11
10435718|NCT00900159|11581932|FG001|STARTED|Second Intervention||13
10435719|NCT00900159|11581931|FG000|COMPLETED|Second Intervention||10
10435720|NCT00900159|11581932|FG001|COMPLETED|Second Intervention||13
10435721|NCT00900159|11581931|FG000|NOT COMPLETED|Second Intervention||1
10435722|NCT00900159|11581932|FG001|NOT COMPLETED|Second Intervention||0
10435723|NCT00900237|11581940|FG000|STARTED|Overall Study||7
10435724|NCT00900237|11581941|FG001|STARTED|Overall Study||7
10435725|NCT00900237|11581940|FG000|COMPLETED|Overall Study||7
10435726|NCT00900237|11581941|FG001|COMPLETED|Overall Study||7
10435727|NCT00900237|11581940|FG000|NOT COMPLETED|Overall Study||0
10435728|NCT00900237|11581941|FG001|NOT COMPLETED|Overall Study||0
10435729|NCT00900562|11581949|FG000|STARTED|Overall Study||12
10435730|NCT00900562|11581950|FG001|STARTED|Overall Study||7
10435731|NCT00900562|11581949|FG000|COMPLETED|Overall Study||0
10435732|NCT00900562|11581950|FG001|COMPLETED|Overall Study||0
10435733|NCT00900562|11581949|FG000|NOT COMPLETED|Overall Study||12
10435734|NCT00900562|11581950|FG001|NOT COMPLETED|Overall Study||7
10435735|NCT00900601|11581957|FG000|STARTED|Overall Study||9
10435736|NCT00900601|11581957|FG000|COMPLETED|Overall Study||8
10435737|NCT00900601|11581957|FG000|NOT COMPLETED|Overall Study||1
10435738|NCT00900627|11581967|FG000|STARTED|Overall Study||6
10435739|NCT00900627|11581968|FG001|STARTED|Overall Study||2
10435740|NCT00900627|11581969|FG002|STARTED|Overall Study||6
10435741|NCT00900627|11581970|FG003|STARTED|Overall Study||6
10435742|NCT00900627|11581971|FG004|STARTED|Overall Study|The values under 'Not Completed' are based on the time of the primary analysis|94
10435743|NCT00900627|11581972|FG005|STARTED|Overall Study|The values under 'Not Completed' are based on the time of the primary analysis|96
10435744|NCT00900627|11581967|FG000|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
10435745|NCT00900627|11581968|FG001|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
10435746|NCT00900627|11581969|FG002|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
10435747|NCT00900627|11581970|FG003|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
10435748|NCT00900627|11581971|FG004|COMPLETED|Overall Study|No set completion, pts were to remain in study until withdrawn|65
10435749|NCT00900627|11581972|FG005|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|70
10435750|NCT00900627|11581967|FG000|NOT COMPLETED|Overall Study||6
10435751|NCT00900627|11581968|FG001|NOT COMPLETED|Overall Study||2
10435752|NCT00900627|11581969|FG002|NOT COMPLETED|Overall Study||6
10435753|NCT00900627|11581970|FG003|NOT COMPLETED|Overall Study||6
10435754|NCT00900627|11581971|FG004|NOT COMPLETED|Overall Study||29
10435755|NCT00900627|11581972|FG005|NOT COMPLETED|Overall Study||26
10435756|NCT00900666|11581988|FG000|STARTED|Overall Study||10
10435757|NCT00900666|11581989|FG001|STARTED|Overall Study||9
10435758|NCT00900666|11581988|FG000|COMPLETED|Overall Study||10
10435759|NCT00900666|11581989|FG001|COMPLETED|Overall Study||9
10435760|NCT00900666|11581988|FG000|NOT COMPLETED|Overall Study||0
10435761|NCT00900666|11581989|FG001|NOT COMPLETED|Overall Study||0
10435762|NCT00900731|11581997|FG000|STARTED|Overall Study|Randomized participants|797
10435763|NCT00900731|11581998|FG001|STARTED|Overall Study||801
10435764|NCT00900731|11581997|FG000|Safety Set: Received Study Drug|Overall Study||794
10435765|NCT00900731|11581998|FG001|Safety Set: Received Study Drug|Overall Study||799
10435766|NCT00900731|11581997|FG000|COMPLETED|Overall Study||737
10435767|NCT00900731|11581998|FG001|COMPLETED|Overall Study||740
10435768|NCT00900731|11581997|FG000|NOT COMPLETED|Overall Study||60
10435769|NCT00900731|11581998|FG001|NOT COMPLETED|Overall Study||61
10435770|NCT00900757|11582004|FG000|STARTED|Overall Study||57
10435771|NCT00900757|11582004|FG000|COMPLETED|Overall Study||38
10435772|NCT00900757|11582004|FG000|NOT COMPLETED|Overall Study||19
10435773|NCT00900796|11582008|FG000|STARTED|Phase 1||132
10435774|NCT00900796|11582008|FG000|COMPLETED|Phase 1||121
10435775|NCT00900796|11582008|FG000|NOT COMPLETED|Phase 1||11
10435776|NCT00900796|11582008|FG000|STARTED|Between Phase 1 and Phase 2||121
10435777|NCT00900796|11582008|FG000|COMPLETED|Between Phase 1 and Phase 2||11
10435778|NCT00900796|11582008|FG000|NOT COMPLETED|Between Phase 1 and Phase 2||110
10788132|NCT03496324|11948471|FG003|STARTED|Period 2: Washout (3 to 7 Days)||6
10788133|NCT03496324|11948468|FG000|COMPLETED|Period 2: Washout (3 to 7 Days)||6
10788134|NCT03496324|11948469|FG001|COMPLETED|Period 2: Washout (3 to 7 Days)||6
10788135|NCT03496324|11948470|FG002|COMPLETED|Period 2: Washout (3 to 7 Days)||6
10788136|NCT03496324|11948471|FG003|COMPLETED|Period 2: Washout (3 to 7 Days)||6
10788137|NCT03496324|11948468|FG000|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
10788138|NCT03496324|11948469|FG001|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
10435779|NCT00900796|11582008|FG000|STARTED|Phase 2||11
10435780|NCT00900796|11582008|FG000|COMPLETED|Phase 2||6
10435781|NCT00900796|11582008|FG000|NOT COMPLETED|Phase 2||5
10435782|NCT00900822|11582013|FG000|STARTED|9 Months Histological Evaluation||11
10435783|NCT00900822|11582013|FG000|COMPLETED|9 Months Histological Evaluation||11
10435784|NCT00900822|11582013|FG000|NOT COMPLETED|9 Months Histological Evaluation||0
10435785|NCT00900822|11582013|FG000|STARTED|12 Months Clinical Evaluation||11
10435786|NCT00900822|11582013|FG000|COMPLETED|12 Months Clinical Evaluation||11
10435787|NCT00900822|11582013|FG000|NOT COMPLETED|12 Months Clinical Evaluation||0
10435788|NCT00901017|11582020|FG000|STARTED|Overall Study||14
10435789|NCT00901017|11582020|FG000|COMPLETED|Overall Study||14
10435790|NCT00901017|11582020|FG000|NOT COMPLETED|Overall Study||0
10435791|NCT00901186|11582029|FG000|STARTED|Overall Study||40
10435792|NCT00901186|11582030|FG001|STARTED|Overall Study||43
10435793|NCT00901186|11582029|FG000|Safety Set|Overall Study|One participant did not receive one intravitreal RFB002 injection.|39
10435794|NCT00901186|11582030|FG001|Safety Set|Overall Study||43
10435795|NCT00901186|11582029|FG000|Intent to Treat|Overall Study|Four treated participants did not have at least a baseline and one post-treatment BCVA.|35
10435796|NCT00901186|11582030|FG001|Intent to Treat|Overall Study|Five treated participants did not have at least a baseline and one post-treatment BCVA.|38
10435797|NCT00901186|11582029|FG000|COMPLETED|Overall Study||31
10435798|NCT00901186|11582030|FG001|COMPLETED|Overall Study||32
10435799|NCT00901186|11582029|FG000|NOT COMPLETED|Overall Study||9
10435800|NCT00901186|11582030|FG001|NOT COMPLETED|Overall Study||11
10435801|NCT00901199|11582036|FG000|STARTED|Overall Study||22
10435802|NCT00901199|11582036|FG000|COMPLETED|Overall Study||18
10435803|NCT00901199|11582036|FG000|NOT COMPLETED|Overall Study||4
10435804|NCT00901225|11582040|FG000|STARTED|Overall Study||21
10435805|NCT00901225|11582040|FG000|COMPLETED|Overall Study||20
10435806|NCT00901225|11582040|FG000|NOT COMPLETED|Overall Study||1
10435807|NCT00901316|11582046|FG000|STARTED|Overall Study||492
10435808|NCT00901316|11582047|FG001|STARTED|Overall Study||495
10435809|NCT00901316|11582046|FG000|COMPLETED|Overall Study||492
10435810|NCT00901316|11582047|FG001|COMPLETED|Overall Study||495
10435811|NCT00901316|11582046|FG000|NOT COMPLETED|Overall Study||0
10435812|NCT00901316|11582047|FG001|NOT COMPLETED|Overall Study||0
10435813|NCT00901342|11582053|FG000|STARTED|Overall Study||104
10435814|NCT00901342|11582053|FG000|Received at Least 1 Infusion|Overall Study||98
10435815|NCT00901342|11582053|FG000|COMPLETED|Overall Study|89 subjects completed the study completion visit|89
10435816|NCT00901342|11582053|FG000|NOT COMPLETED|Overall Study||15
10435817|NCT00901394|11582060|FG000|STARTED|Overall Study||21
10435818|NCT00901394|11582061|FG001|STARTED|Overall Study||20
10788139|NCT03496324|11948470|FG002|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
10435819|NCT00901394|11582062|FG002|STARTED|Overall Study||22
10435820|NCT00901394|11582060|FG000|COMPLETED|Overall Study||20
10435821|NCT00901394|11582061|FG001|COMPLETED|Overall Study||19
10435822|NCT00901394|11582062|FG002|COMPLETED|Overall Study||20
10435823|NCT00901394|11582060|FG000|NOT COMPLETED|Overall Study||1
10435824|NCT00901394|11582061|FG001|NOT COMPLETED|Overall Study||1
10435825|NCT00901394|11582062|FG002|NOT COMPLETED|Overall Study||2
10435826|NCT00901459|11582070|FG000|STARTED|Overall Study||21
10435827|NCT00901459|11582070|FG000|COMPLETED|Overall Study||15
10435828|NCT00901459|11582070|FG000|NOT COMPLETED|Overall Study||6
10788140|NCT03496324|11948471|FG003|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
10788141|NCT03496324|11948468|FG000|STARTED|Period 3||6
10788142|NCT03496324|11948469|FG001|STARTED|Period 3||6
10435829|NCT00901485|11582081|FG000|STARTED|Overall Study||10
10435830|NCT00901485|11582082|FG001|STARTED|Overall Study||13
10435831|NCT00901485|11582081|FG000|COMPLETED|Overall Study||9
10435832|NCT00901485|11582082|FG001|COMPLETED|Overall Study||9
10435833|NCT00901485|11582081|FG000|NOT COMPLETED|Overall Study||1
10435834|NCT00901485|11582082|FG001|NOT COMPLETED|Overall Study||4
10435835|NCT00901576|11582094|FG000|STARTED|First Intervention||6
10435836|NCT00901576|11582095|FG001|STARTED|First Intervention||7
10435837|NCT00901576|11582096|FG002|STARTED|First Intervention||7
10435838|NCT00901576|11582097|FG003|STARTED|First Intervention||6
10435839|NCT00901576|11582098|FG004|STARTED|First Intervention||6
10435840|NCT00901576|11582099|FG005|STARTED|First Intervention||6
10435841|NCT00901576|11582094|FG000|COMPLETED|First Intervention||6
10435842|NCT00901576|11582095|FG001|COMPLETED|First Intervention||7
10435843|NCT00901576|11582096|FG002|COMPLETED|First Intervention||7
10435844|NCT00901576|11582097|FG003|COMPLETED|First Intervention||6
10435845|NCT00901576|11582098|FG004|COMPLETED|First Intervention||6
10435846|NCT00901576|11582099|FG005|COMPLETED|First Intervention||6
10435847|NCT00901576|11582094|FG000|NOT COMPLETED|First Intervention||0
10435848|NCT00901576|11582095|FG001|NOT COMPLETED|First Intervention||0
10435849|NCT00901576|11582096|FG002|NOT COMPLETED|First Intervention||0
10435850|NCT00901576|11582097|FG003|NOT COMPLETED|First Intervention||0
10435851|NCT00901576|11582098|FG004|NOT COMPLETED|First Intervention||0
10435852|NCT00901576|11582099|FG005|NOT COMPLETED|First Intervention||0
10435853|NCT00901576|11582094|FG000|STARTED|Washout||6
10435854|NCT00901576|11582095|FG001|STARTED|Washout||7
10435855|NCT00901576|11582096|FG002|STARTED|Washout||7
10435856|NCT00901576|11582097|FG003|STARTED|Washout||6
10435857|NCT00901576|11582098|FG004|STARTED|Washout||6
10435858|NCT00901576|11582099|FG005|STARTED|Washout||6
10435859|NCT00901576|11582094|FG000|COMPLETED|Washout||6
10435860|NCT00901576|11582095|FG001|COMPLETED|Washout||7
10435861|NCT00901576|11582096|FG002|COMPLETED|Washout||7
10435862|NCT00901576|11582097|FG003|COMPLETED|Washout||6
10435863|NCT00901576|11582098|FG004|COMPLETED|Washout||6
10435864|NCT00901576|11582099|FG005|COMPLETED|Washout||6
10788143|NCT03496324|11948470|FG002|STARTED|Period 3||6
10788144|NCT03496324|11948471|FG003|STARTED|Period 3||6
10788145|NCT03496324|11948468|FG000|COMPLETED|Period 3||6
10788146|NCT03496324|11948469|FG001|COMPLETED|Period 3||6
10788147|NCT03496324|11948470|FG002|COMPLETED|Period 3||6
10788148|NCT03496324|11948471|FG003|COMPLETED|Period 3||6
10788149|NCT03496324|11948468|FG000|NOT COMPLETED|Period 3||0
10788150|NCT03496324|11948469|FG001|NOT COMPLETED|Period 3||0
10788151|NCT03496324|11948470|FG002|NOT COMPLETED|Period 3||0
10788152|NCT03496324|11948471|FG003|NOT COMPLETED|Period 3||0
10788153|NCT03496324|11948468|FG000|STARTED|Period 3: Washout (3 to 7 Days)||6
10788154|NCT03496324|11948469|FG001|STARTED|Period 3: Washout (3 to 7 Days)||6
10788155|NCT03496324|11948470|FG002|STARTED|Period 3: Washout (3 to 7 Days)||6
10788156|NCT03496324|11948471|FG003|STARTED|Period 3: Washout (3 to 7 Days)||6
10788157|NCT03496324|11948468|FG000|COMPLETED|Period 3: Washout (3 to 7 Days)||6
10788158|NCT03496324|11948469|FG001|COMPLETED|Period 3: Washout (3 to 7 Days)||6
10788159|NCT03496324|11948470|FG002|COMPLETED|Period 3: Washout (3 to 7 Days)||6
10788160|NCT03496324|11948471|FG003|COMPLETED|Period 3: Washout (3 to 7 Days)||6
10788161|NCT03496324|11948468|FG000|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
10788162|NCT03496324|11948469|FG001|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
10788163|NCT03496324|11948470|FG002|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
10788164|NCT03496324|11948471|FG003|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
10788165|NCT03496324|11948468|FG000|STARTED|Period 7: Period 4||6
10788166|NCT03496324|11948469|FG001|STARTED|Period 7: Period 4||6
10788167|NCT03496324|11948470|FG002|STARTED|Period 7: Period 4||6
10788168|NCT03496324|11948471|FG003|STARTED|Period 7: Period 4||6
10788169|NCT03496324|11948468|FG000|COMPLETED|Period 7: Period 4||6
10788170|NCT03496324|11948469|FG001|COMPLETED|Period 7: Period 4||6
10788171|NCT03496324|11948470|FG002|COMPLETED|Period 7: Period 4||6
10788172|NCT03496324|11948471|FG003|COMPLETED|Period 7: Period 4||6
10788173|NCT03496324|11948468|FG000|NOT COMPLETED|Period 7: Period 4||0
10788174|NCT03496324|11948469|FG001|NOT COMPLETED|Period 7: Period 4||0
10788175|NCT03496324|11948470|FG002|NOT COMPLETED|Period 7: Period 4||0
10788176|NCT03496324|11948471|FG003|NOT COMPLETED|Period 7: Period 4||0
10788177|NCT03496428|11948481|FG000|STARTED|Overall Study|304 locations distributed for the analyzed teeth 108 locations distributed for the implant spots|6
10788178|NCT03496428|11948481|FG000|COMPLETED|Overall Study|304 locations distributed for the analyzed teeth 108 locations distributed for the implant spots|6
10788179|NCT03496428|11948481|FG000|NOT COMPLETED|Overall Study||0
10788180|NCT03496467|11948487|FG000|STARTED|Overall Study||38
10788181|NCT03496467|11948488|FG001|STARTED|Overall Study||18
10435865|NCT00901576|11582094|FG000|NOT COMPLETED|Washout||0
10435866|NCT00901576|11582095|FG001|NOT COMPLETED|Washout||0
10435867|NCT00901576|11582096|FG002|NOT COMPLETED|Washout||0
10435868|NCT00901576|11582097|FG003|NOT COMPLETED|Washout||0
10435869|NCT00901576|11582098|FG004|NOT COMPLETED|Washout||0
10435870|NCT00901576|11582099|FG005|NOT COMPLETED|Washout||0
10435871|NCT00901576|11582094|FG000|STARTED|Second Intervention||6
10435872|NCT00901576|11582095|FG001|STARTED|Second Intervention||7
10788182|NCT03496467|11948487|FG000|COMPLETED|Overall Study||34
10788183|NCT03496467|11948488|FG001|COMPLETED|Overall Study||14
10788184|NCT03496467|11948487|FG000|NOT COMPLETED|Overall Study||4
10435873|NCT00901576|11582096|FG002|STARTED|Second Intervention||7
10435874|NCT00901576|11582097|FG003|STARTED|Second Intervention||6
10435875|NCT00901576|11582098|FG004|STARTED|Second Intervention||6
10435876|NCT00901576|11582099|FG005|STARTED|Second Intervention||6
10435877|NCT00901576|11582094|FG000|COMPLETED|Second Intervention||5
10435878|NCT00901576|11582095|FG001|COMPLETED|Second Intervention||7
10435879|NCT00901576|11582096|FG002|COMPLETED|Second Intervention||7
10435880|NCT00901576|11582097|FG003|COMPLETED|Second Intervention||5
10435881|NCT00901576|11582098|FG004|COMPLETED|Second Intervention||6
10435882|NCT00901576|11582099|FG005|COMPLETED|Second Intervention||5
10435883|NCT00901576|11582094|FG000|NOT COMPLETED|Second Intervention||1
10435884|NCT00901576|11582095|FG001|NOT COMPLETED|Second Intervention||0
10435885|NCT00901576|11582096|FG002|NOT COMPLETED|Second Intervention||0
10435886|NCT00901576|11582097|FG003|NOT COMPLETED|Second Intervention||1
10435887|NCT00901576|11582098|FG004|NOT COMPLETED|Second Intervention||0
10435888|NCT00901576|11582099|FG005|NOT COMPLETED|Second Intervention||1
10435889|NCT00901576|11582094|FG000|STARTED|Washout||5
10435890|NCT00901576|11582095|FG001|STARTED|Washout||7
10435891|NCT00901576|11582096|FG002|STARTED|Washout||7
10435892|NCT00901576|11582097|FG003|STARTED|Washout||5
10435893|NCT00901576|11582098|FG004|STARTED|Washout||6
10435894|NCT00901576|11582099|FG005|STARTED|Washout||5
10435895|NCT00901576|11582094|FG000|COMPLETED|Washout||5
10435896|NCT00901576|11582095|FG001|COMPLETED|Washout||7
10435897|NCT00901576|11582096|FG002|COMPLETED|Washout||7
10435898|NCT00901576|11582097|FG003|COMPLETED|Washout||5
10435899|NCT00901576|11582098|FG004|COMPLETED|Washout||6
10435900|NCT00901576|11582099|FG005|COMPLETED|Washout||5
10435901|NCT00901576|11582094|FG000|NOT COMPLETED|Washout||0
10435902|NCT00901576|11582095|FG001|NOT COMPLETED|Washout||0
10435903|NCT00901576|11582096|FG002|NOT COMPLETED|Washout||0
10435904|NCT00901576|11582097|FG003|NOT COMPLETED|Washout||0
10435905|NCT00901576|11582098|FG004|NOT COMPLETED|Washout||0
10435906|NCT00901576|11582099|FG005|NOT COMPLETED|Washout||0
10435907|NCT00901576|11582094|FG000|STARTED|Third Intervention||5
10435908|NCT00901576|11582095|FG001|STARTED|Third Intervention||7
10435909|NCT00901576|11582096|FG002|STARTED|Third Intervention||7
10435910|NCT00901576|11582097|FG003|STARTED|Third Intervention||5
10435911|NCT00901576|11582098|FG004|STARTED|Third Intervention||6
10435912|NCT00901576|11582099|FG005|STARTED|Third Intervention||5
10435913|NCT00901576|11582094|FG000|COMPLETED|Third Intervention||5
10435914|NCT00901576|11582095|FG001|COMPLETED|Third Intervention||7
10435915|NCT00901576|11582096|FG002|COMPLETED|Third Intervention||7
10435916|NCT00901576|11582097|FG003|COMPLETED|Third Intervention||5
10435917|NCT00901576|11582098|FG004|COMPLETED|Third Intervention||6
10435918|NCT00901576|11582099|FG005|COMPLETED|Third Intervention||5
10435919|NCT00901576|11582094|FG000|NOT COMPLETED|Third Intervention||0
10435920|NCT00901576|11582095|FG001|NOT COMPLETED|Third Intervention||0
10435921|NCT00901576|11582096|FG002|NOT COMPLETED|Third Intervention||0
10435922|NCT00901576|11582097|FG003|NOT COMPLETED|Third Intervention||0
10435923|NCT00901576|11582098|FG004|NOT COMPLETED|Third Intervention||0
10435924|NCT00901576|11582099|FG005|NOT COMPLETED|Third Intervention||0
10435925|NCT00901628|11582109|FG000|STARTED|Overall Study||49
10435926|NCT00901628|11582110|FG001|STARTED|Overall Study||52
10435927|NCT00901628|11582109|FG000|COMPLETED|Overall Study||45
10435928|NCT00901628|11582110|FG001|COMPLETED|Overall Study||42
10435929|NCT00901628|11582109|FG000|NOT COMPLETED|Overall Study||4
10788185|NCT03496467|11948488|FG001|NOT COMPLETED|Overall Study||4
10788186|NCT03496545|11948496|FG000|STARTED|Overall Study||21
10788187|NCT03496545|11948497|FG001|STARTED|Overall Study||26
10788188|NCT03496545|11948496|FG000|COMPLETED|Overall Study||20
10788189|NCT03496545|11948497|FG001|COMPLETED|Overall Study||24
10788190|NCT03496545|11948496|FG000|NOT COMPLETED|Overall Study||1
10788191|NCT03496545|11948497|FG001|NOT COMPLETED|Overall Study||2
10788192|NCT03496701|11948503|FG000|STARTED|Overall Study||77
10788193|NCT03496701|11948503|FG000|COMPLETED|Overall Study||77
10788194|NCT03496701|11948503|FG000|NOT COMPLETED|Overall Study||0
10788195|NCT03496974|11948511|FG000|STARTED|Overall Study||10
10788196|NCT03496974|11948512|FG001|STARTED|Overall Study||28
10788197|NCT03496974|11948511|FG000|COMPLETED|Overall Study||9
10788198|NCT03496974|11948512|FG001|COMPLETED|Overall Study||20
10788199|NCT03496974|11948511|FG000|NOT COMPLETED|Overall Study||1
10788200|NCT03496974|11948512|FG001|NOT COMPLETED|Overall Study||8
10435930|NCT00901628|11582110|FG001|NOT COMPLETED|Overall Study||10
10435931|NCT00901901|11582118|FG000|STARTED|Treatment Period||362
10435932|NCT00901901|11582119|FG001|STARTED|Treatment Period||358
10435933|NCT00901901|11582118|FG000|Participants Received Treatment|Treatment Period||362
10435934|NCT00901901|11582119|FG001|Participants Received Treatment|Treatment Period||355
10435935|NCT00901901|11582118|FG000|COMPLETED|Treatment Period||193
10435936|NCT00901901|11582119|FG001|COMPLETED|Treatment Period||181
10435937|NCT00901901|11582118|FG000|NOT COMPLETED|Treatment Period||169
10435938|NCT00901901|11582119|FG001|NOT COMPLETED|Treatment Period||177
10435939|NCT00901901|11582118|FG000|STARTED|Follow-up Period||340
10435940|NCT00901901|11582119|FG001|STARTED|Follow-up Period||341
10435941|NCT00901901|11582118|FG000|COMPLETED|Follow-up Period||0
10435942|NCT00901901|11582119|FG001|COMPLETED|Follow-up Period||0
10435943|NCT00901901|11582118|FG000|NOT COMPLETED|Follow-up Period||340
10435944|NCT00901901|11582119|FG001|NOT COMPLETED|Follow-up Period||341
10435945|NCT00901927|11582127|FG000|STARTED|Overall Study||14
10788201|NCT03496987|11948520|FG000|STARTED|Overall Study||49
10788202|NCT03496987|11948521|FG001|STARTED|Overall Study||51
10788203|NCT03496987|11948520|FG000|COMPLETED|Overall Study||49
10435946|NCT00901927|11582127|FG000|COMPLETED|Overall Study||8
10435947|NCT00901927|11582127|FG000|NOT COMPLETED|Overall Study||6
10435948|NCT00902018|11582134|FG000|STARTED|Overall Study||7
10435949|NCT00902018|11582135|FG001|STARTED|Overall Study||3
10435950|NCT00902018|11582136|FG002|STARTED|Overall Study||10
10435951|NCT00902018|11582134|FG000|COMPLETED|Overall Study||7
10435952|NCT00902018|11582135|FG001|COMPLETED|Overall Study||3
10435953|NCT00902018|11582136|FG002|COMPLETED|Overall Study||10
10435954|NCT00902018|11582134|FG000|NOT COMPLETED|Overall Study||0
10435955|NCT00902018|11582135|FG001|NOT COMPLETED|Overall Study||0
10435956|NCT00902018|11582136|FG002|NOT COMPLETED|Overall Study||0
10435957|NCT00902161|11582152|FG000|STARTED|Pre-study Washout/Propanolol Run-in||0
10435958|NCT00902161|11582153|FG001|STARTED|Pre-study Washout/Propanolol Run-in||0
10435959|NCT00902161|11582154|FG002|STARTED|Pre-study Washout/Propanolol Run-in||22
10435960|NCT00902161|11582152|FG000|COMPLETED|Pre-study Washout/Propanolol Run-in||0
10435961|NCT00902161|11582153|FG001|COMPLETED|Pre-study Washout/Propanolol Run-in||0
10435962|NCT00902161|11582154|FG002|COMPLETED|Pre-study Washout/Propanolol Run-in||22
10435963|NCT00902161|11582152|FG000|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
10435964|NCT00902161|11582153|FG001|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
10435965|NCT00902161|11582154|FG002|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
10435966|NCT00902161|11582152|FG000|STARTED|Period 1||12
10435967|NCT00902161|11582153|FG001|STARTED|Period 1||10
10435968|NCT00902161|11582154|FG002|STARTED|Period 1||0
10435969|NCT00902161|11582152|FG000|COMPLETED|Period 1||12
10435970|NCT00902161|11582153|FG001|COMPLETED|Period 1||10
10435971|NCT00902161|11582154|FG002|COMPLETED|Period 1||0
10435972|NCT00902161|11582152|FG000|NOT COMPLETED|Period 1||0
10435973|NCT00902161|11582153|FG001|NOT COMPLETED|Period 1||0
10435974|NCT00902161|11582154|FG002|NOT COMPLETED|Period 1||0
10435975|NCT00902161|11582152|FG000|STARTED|Post-clamp Washout||0
10435976|NCT00902161|11582153|FG001|STARTED|Post-clamp Washout||0
10435977|NCT00902161|11582154|FG002|STARTED|Post-clamp Washout||22
10435978|NCT00902161|11582152|FG000|COMPLETED|Post-clamp Washout||0
10435979|NCT00902161|11582153|FG001|COMPLETED|Post-clamp Washout||0
10435980|NCT00902161|11582154|FG002|COMPLETED|Post-clamp Washout|2 participants discontinued washout and were replaced; 1 due to an AE and 1 due to lack of efficacy|22
10435981|NCT00902161|11582152|FG000|NOT COMPLETED|Post-clamp Washout||0
10788204|NCT03496987|11948521|FG001|COMPLETED|Overall Study||51
10788205|NCT03496987|11948520|FG000|NOT COMPLETED|Overall Study||0
10788206|NCT03496987|11948521|FG001|NOT COMPLETED|Overall Study||0
10788207|NCT03497026|11948527|FG000|STARTED|Overall Study||4
10788208|NCT03497026|11948527|FG000|COMPLETED|Overall Study||4
10788209|NCT03497026|11948527|FG000|NOT COMPLETED|Overall Study||0
10788210|NCT03497039|11948533|FG000|STARTED|Overall Study||30
10788211|NCT03497039|11948534|FG001|STARTED|Overall Study||17
10788212|NCT03497039|11948533|FG000|Treated|Overall Study||29
10788213|NCT03497039|11948534|FG001|Treated|Overall Study||17
10788214|NCT03497039|11948533|FG000|COMPLETED|Overall Study||29
10788215|NCT03497039|11948534|FG001|COMPLETED|Overall Study||16
10788216|NCT03497039|11948533|FG000|NOT COMPLETED|Overall Study||1
10788217|NCT03497039|11948534|FG001|NOT COMPLETED|Overall Study||1
10788218|NCT03497130|11948542|FG000|STARTED|Overall Study||40
10788219|NCT03497130|11948543|FG001|STARTED|Overall Study||14
10788220|NCT03497130|11948542|FG000|COMPLETED|Overall Study||39
10788221|NCT03497130|11948543|FG001|COMPLETED|Overall Study||13
10788222|NCT03497130|11948542|FG000|NOT COMPLETED|Overall Study||1
10788223|NCT03497130|11948543|FG001|NOT COMPLETED|Overall Study||1
10788224|NCT03497429|11948551|FG000|STARTED|Overall Study||3
10788225|NCT03497429|11948552|FG001|STARTED|Overall Study||6
10788226|NCT03497429|11948551|FG000|Started|Overall Study||3
10788227|NCT03497429|11948552|FG001|Started|Overall Study||6
10788228|NCT03497429|11948551|FG000|Completed|Overall Study||0
10788229|NCT03497429|11948552|FG001|Completed|Overall Study||0
10788230|NCT03497429|11948551|FG000|COMPLETED|Overall Study||0
10788231|NCT03497429|11948552|FG001|COMPLETED|Overall Study||0
10788232|NCT03497429|11948551|FG000|NOT COMPLETED|Overall Study||3
10788233|NCT03497429|11948552|FG001|NOT COMPLETED|Overall Study||6
10788234|NCT03497585|11948558|FG000|STARTED|Overall Study|112 participants were recruited: 107 patients, plus 5 HCPs for the acceptability interviews.|112
10788235|NCT03497585|11948558|FG000|COMPLETED|Overall Study||57
10788236|NCT03497585|11948558|FG000|NOT COMPLETED|Overall Study||55
10788237|NCT03497845|11948574|FG000|STARTED|Overall Study||60
10788238|NCT03497845|11948575|FG001|STARTED|Overall Study||58
10788239|NCT03497845|11948576|FG002|STARTED|Overall Study||61
10788240|NCT03497845|11948577|FG003|STARTED|Overall Study||60
10788241|NCT03497845|11948578|FG004|STARTED|Overall Study||59
10788242|NCT03497845|11948579|FG005|STARTED|Overall Study||62
10435982|NCT00902161|11582153|FG001|NOT COMPLETED|Post-clamp Washout||0
10435983|NCT00902161|11582154|FG002|NOT COMPLETED|Post-clamp Washout||0
10435984|NCT00902161|11582152|FG000|STARTED|Period 2||8
10435985|NCT00902161|11582153|FG001|STARTED|Period 2||9
10435986|NCT00902161|11582154|FG002|STARTED|Period 2||0
10435987|NCT00902161|11582152|FG000|COMPLETED|Period 2|2 participants discontinued and were replaced; 1 due to protocol deviation and 1 withdrew consent|8
10435988|NCT00902161|11582153|FG001|COMPLETED|Period 2||9
10788243|NCT03497845|11948580|FG006|STARTED|Overall Study||59
10788244|NCT03497845|11948581|FG007|STARTED|Overall Study||60
10788245|NCT03497845|11948582|FG008|STARTED|Overall Study||61
10788246|NCT03497845|11948583|FG009|STARTED|Overall Study||59
10788247|NCT03497845|11948584|FG010|STARTED|Overall Study||61
10788248|NCT03497845|11948585|FG011|STARTED|Overall Study||60
10788249|NCT03497845|11948574|FG000|COMPLETED|Overall Study|Day 142|55
10435989|NCT00902161|11582154|FG002|COMPLETED|Period 2||0
10435990|NCT00902161|11582152|FG000|NOT COMPLETED|Period 2||0
10435991|NCT00902161|11582153|FG001|NOT COMPLETED|Period 2||0
10435992|NCT00902161|11582154|FG002|NOT COMPLETED|Period 2||0
10435993|NCT00902174|11582166|FG000|STARTED|Overall Study||103
10435994|NCT00902174|11582167|FG001|STARTED|Overall Study||99
10435995|NCT00902174|11582166|FG000|COMPLETED|Overall Study||69
10435996|NCT00902174|11582167|FG001|COMPLETED|Overall Study||81
10435997|NCT00902174|11582166|FG000|NOT COMPLETED|Overall Study||34
10435998|NCT00902174|11582167|FG001|NOT COMPLETED|Overall Study||18
10435999|NCT00902226|11582176|FG000|STARTED|Overall Study||30
10436000|NCT00902226|11582176|FG000|COMPLETED|Overall Study||30
10436001|NCT00902226|11582176|FG000|NOT COMPLETED|Overall Study||0
10436002|NCT00902265|11582180|FG000|STARTED|Overall Study||138
10436003|NCT00902265|11582180|FG000|Participants Who Received Treatment|Overall Study||137
10436004|NCT00902265|11582180|FG000|COMPLETED|Overall Study||132
10436005|NCT00902265|11582180|FG000|NOT COMPLETED|Overall Study||6
10436006|NCT00902278|11582189|FG000|STARTED|Overall Study||54
10436007|NCT00902278|11582190|FG001|STARTED|Overall Study||36
10436008|NCT00902278|11582191|FG002|STARTED|Overall Study||54
10436009|NCT00902278|11582192|FG003|STARTED|Overall Study||12
10436010|NCT00902278|11582193|FG004|STARTED|Overall Study||37
10436011|NCT00902278|11582189|FG000|COMPLETED|Overall Study||50
10436012|NCT00902278|11582190|FG001|COMPLETED|Overall Study||34
10436013|NCT00902278|11582191|FG002|COMPLETED|Overall Study||49
10436014|NCT00902278|11582192|FG003|COMPLETED|Overall Study||12
10788250|NCT03497845|11948575|FG001|COMPLETED|Overall Study|Day 142|45
10788251|NCT03497845|11948576|FG002|COMPLETED|Overall Study|Day 142|50
10788252|NCT03497845|11948577|FG003|COMPLETED|Overall Study|Day 142|50
10788253|NCT03497845|11948578|FG004|COMPLETED|Overall Study|Day 262|38
10788254|NCT03497845|11948579|FG005|COMPLETED|Overall Study|Day 262|44
10788255|NCT03497845|11948580|FG006|COMPLETED|Overall Study|Day 142|51
10788256|NCT03497845|11948581|FG007|COMPLETED|Overall Study|Day 142|50
10788257|NCT03497845|11948582|FG008|COMPLETED|Overall Study|Day 142|47
10788258|NCT03497845|11948583|FG009|COMPLETED|Overall Study|Day 142|53
10788259|NCT03497845|11948584|FG010|COMPLETED|Overall Study|Day 262|46
10788260|NCT03497845|11948585|FG011|COMPLETED|Overall Study|Day 262|38
10788261|NCT03497845|11948574|FG000|NOT COMPLETED|Overall Study||5
10788262|NCT03497845|11948575|FG001|NOT COMPLETED|Overall Study||13
10788263|NCT03497845|11948576|FG002|NOT COMPLETED|Overall Study||11
10788264|NCT03497845|11948577|FG003|NOT COMPLETED|Overall Study||10
10788265|NCT03497845|11948578|FG004|NOT COMPLETED|Overall Study||21
10788266|NCT03497845|11948579|FG005|NOT COMPLETED|Overall Study||18
10788267|NCT03497845|11948580|FG006|NOT COMPLETED|Overall Study||8
10788268|NCT03497845|11948581|FG007|NOT COMPLETED|Overall Study||10
10788269|NCT03497845|11948582|FG008|NOT COMPLETED|Overall Study||14
10788270|NCT03497845|11948583|FG009|NOT COMPLETED|Overall Study||6
10788271|NCT03497845|11948584|FG010|NOT COMPLETED|Overall Study||15
10788272|NCT03497845|11948585|FG011|NOT COMPLETED|Overall Study||22
10788273|NCT03498196|11948617|FG000|STARTED|Overall Study||1
10788274|NCT03498196|11948617|FG000|COMPLETED|Overall Study||1
10788275|NCT03498196|11948617|FG000|NOT COMPLETED|Overall Study||0
10788276|NCT03498287|11948623|FG000|STARTED|Overall Study||45
10788277|NCT03498287|11948624|FG001|STARTED|Overall Study||43
10788278|NCT03498287|11948623|FG000|COMPLETED|Overall Study||42
10788279|NCT03498287|11948624|FG001|COMPLETED|Overall Study||38
10788280|NCT03498287|11948623|FG000|NOT COMPLETED|Overall Study||3
10788281|NCT03498287|11948624|FG001|NOT COMPLETED|Overall Study||5
10788282|NCT03498300|11948632|FG000|STARTED|Overall Study||21
10788283|NCT03498300|11948633|FG001|STARTED|Overall Study||21
10788284|NCT03498300|11948632|FG000|COMPLETED|Overall Study||18
10788285|NCT03498300|11948633|FG001|COMPLETED|Overall Study||13
10788286|NCT03498300|11948632|FG000|NOT COMPLETED|Overall Study||3
10788287|NCT03498300|11948633|FG001|NOT COMPLETED|Overall Study||8
10788288|NCT03499028|11948642|FG000|STARTED|Overall Study||226
10788289|NCT03499028|11948643|FG001|STARTED|Overall Study||220
10788290|NCT03499028|11948642|FG000|COMPLETED|Overall Study||204
10788291|NCT03499028|11948643|FG001|COMPLETED|Overall Study||195
10788292|NCT03499028|11948642|FG000|NOT COMPLETED|Overall Study||22
10788293|NCT03499028|11948643|FG001|NOT COMPLETED|Overall Study||25
10788294|NCT03499067|11948651|FG000|STARTED|First Intervention||27
10788295|NCT03499067|11948652|FG001|STARTED|First Intervention||31
10788296|NCT03499067|11948651|FG000|COMPLETED|First Intervention||22
10788297|NCT03499067|11948652|FG001|COMPLETED|First Intervention||24
10788298|NCT03499067|11948651|FG000|NOT COMPLETED|First Intervention||5
10788299|NCT03499067|11948652|FG001|NOT COMPLETED|First Intervention||7
10788300|NCT03499067|11948651|FG000|STARTED|Second Intervention||22
10436015|NCT00902278|11582193|FG004|COMPLETED|Overall Study||35
10436016|NCT00902278|11582189|FG000|NOT COMPLETED|Overall Study||4
10436017|NCT00902278|11582190|FG001|NOT COMPLETED|Overall Study||2
10436018|NCT00902278|11582191|FG002|NOT COMPLETED|Overall Study||5
10436019|NCT00902278|11582192|FG003|NOT COMPLETED|Overall Study||0
10436020|NCT00902278|11582193|FG004|NOT COMPLETED|Overall Study||2
10788301|NCT03499067|11948652|FG001|STARTED|Second Intervention||24
10788302|NCT03499067|11948651|FG000|COMPLETED|Second Intervention||22
10788303|NCT03499067|11948652|FG001|COMPLETED|Second Intervention||24
10788304|NCT03499067|11948651|FG000|NOT COMPLETED|Second Intervention||0
10788305|NCT03499067|11948652|FG001|NOT COMPLETED|Second Intervention||0
10788306|NCT03499353|11948658|FG000|STARTED|Treatment||61
10788307|NCT03499353|11948658|FG000|COMPLETED|Treatment||45
10788308|NCT03499353|11948658|FG000|NOT COMPLETED|Treatment||16
10436021|NCT00902304|11582208|FG000|STARTED|Overall Study||524
10436022|NCT00902304|11582209|FG001|STARTED|Overall Study||360
10436023|NCT00902304|11582210|FG002|STARTED|Overall Study||678
10436024|NCT00902304|11582208|FG000|COMPLETED|Overall Study||466
10436025|NCT00902304|11582209|FG001|COMPLETED|Overall Study||289
10436026|NCT00902304|11582210|FG002|COMPLETED|Overall Study||568
10436027|NCT00902304|11582208|FG000|NOT COMPLETED|Overall Study||58
10436028|NCT00902304|11582209|FG001|NOT COMPLETED|Overall Study||71
10436029|NCT00902304|11582210|FG002|NOT COMPLETED|Overall Study||110
10436030|NCT00902330|11582221|FG000|STARTED|Overall Study||81
10436031|NCT00902330|11582222|FG001|STARTED|Overall Study||80
10436032|NCT00902330|11582221|FG000|COMPLETED|Overall Study||77
10436033|NCT00902330|11582222|FG001|COMPLETED|Overall Study||75
10436034|NCT00902330|11582221|FG000|NOT COMPLETED|Overall Study||4
10436035|NCT00902330|11582222|FG001|NOT COMPLETED|Overall Study||5
10436036|NCT00902486|11582235|FG000|STARTED|Treatment Period (Weeks 0 Through 12)||31
10436037|NCT00902486|11582236|FG001|STARTED|Treatment Period (Weeks 0 Through 12)||0
10436038|NCT00902486|11582237|FG002|STARTED|Treatment Period (Weeks 0 Through 12)||0
10436039|NCT00902486|11582238|FG003|STARTED|Treatment Period (Weeks 0 Through 12)||32
10436040|NCT00902486|11582239|FG004|STARTED|Treatment Period (Weeks 0 Through 12)||32
10436041|NCT00902486|11582240|FG005|STARTED|Treatment Period (Weeks 0 Through 12)||32
10436042|NCT00902486|11582235|FG000|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31
10436043|NCT00902486|11582236|FG001|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||0
10436044|NCT00902486|11582237|FG002|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||0
10436045|NCT00902486|11582238|FG003|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31
10436046|NCT00902486|11582239|FG004|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||32
10436047|NCT00902486|11582240|FG005|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31
10436048|NCT00902486|11582235|FG000|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||31
10436049|NCT00902486|11582236|FG001|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||0
10436050|NCT00902486|11582237|FG002|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||0
10436051|NCT00902486|11582238|FG003|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||31
10788309|NCT03499353|11948658|FG000|STARTED|Safety Follow-up||49
10788310|NCT03499353|11948658|FG000|Received Treatment|Safety Follow-up||0
10788311|NCT03499353|11948658|FG000|COMPLETED|Safety Follow-up||49
10788312|NCT03499353|11948658|FG000|NOT COMPLETED|Safety Follow-up||0
10788313|NCT03499353|11948658|FG000|STARTED|Long-Term Follow-up||58
10788314|NCT03499353|11948658|FG000|Received Treatment|Long-Term Follow-up||0
10788315|NCT03499353|11948658|FG000|COMPLETED|Long-Term Follow-up||0
10788316|NCT03499353|11948658|FG000|NOT COMPLETED|Long-Term Follow-up||58
10788317|NCT03499873|11948665|FG000|STARTED|Overall Study||183
10788318|NCT03499873|11948666|FG001|STARTED|Overall Study||182
10788319|NCT03499873|11948667|FG002|STARTED|Overall Study||83
10788320|NCT03499873|11948665|FG000|Safety Population|Overall Study||175
10788321|NCT03499873|11948666|FG001|Safety Population|Overall Study||174
10788322|NCT03499873|11948667|FG002|Safety Population|Overall Study||80
10788323|NCT03499873|11948665|FG000|Per-Protocol Population|Overall Study||144
10788324|NCT03499873|11948666|FG001|Per-Protocol Population|Overall Study||143
10788325|NCT03499873|11948667|FG002|Per-Protocol Population|Overall Study||58
10788326|NCT03499873|11948665|FG000|Modified-Intent-to-Treat|Overall Study||170
10788327|NCT03499873|11948666|FG001|Modified-Intent-to-Treat|Overall Study||168
10788328|NCT03499873|11948667|FG002|Modified-Intent-to-Treat|Overall Study||77
10788329|NCT03499873|11948665|FG000|COMPLETED|Overall Study||163
10788330|NCT03499873|11948666|FG001|COMPLETED|Overall Study||162
10788331|NCT03499873|11948667|FG002|COMPLETED|Overall Study||56
10788332|NCT03499873|11948665|FG000|NOT COMPLETED|Overall Study||20
10788333|NCT03499873|11948666|FG001|NOT COMPLETED|Overall Study||20
10788334|NCT03499873|11948667|FG002|NOT COMPLETED|Overall Study||27
10788335|NCT03500094|11948675|FG000|STARTED|Overall Study||22
10788336|NCT03500094|11948675|FG000|Received At Least 1 Dose of Study Drug|Overall Study||21
10788337|NCT03500094|11948675|FG000|COMPLETED|Overall Study||19
10788338|NCT03500094|11948675|FG000|NOT COMPLETED|Overall Study||3
10788339|NCT03500198|11948683|FG000|STARTED|Overall Study||110
10788340|NCT03500198|11948684|FG001|STARTED|Overall Study||108
10788341|NCT03500198|11948683|FG000|First Eye|Overall Study||110
10788342|NCT03500198|11948684|FG001|First Eye|Overall Study||108
10788343|NCT03500198|11948683|FG000|Second Eye|Overall Study||109
10788344|NCT03500198|11948684|FG001|Second Eye|Overall Study||108
10788345|NCT03500198|11948683|FG000|COMPLETED|Overall Study||110
10788346|NCT03500198|11948684|FG001|COMPLETED|Overall Study||107
10788347|NCT03500198|11948683|FG000|NOT COMPLETED|Overall Study||0
10788348|NCT03500198|11948684|FG001|NOT COMPLETED|Overall Study||1
10788349|NCT03500211|11948694|FG000|STARTED|Overall Study||25
10788350|NCT03500211|11948695|FG001|STARTED|Overall Study||25
10788351|NCT03500211|11948694|FG000|COMPLETED|Overall Study||24
10788352|NCT03500211|11948695|FG001|COMPLETED|Overall Study||24
10436052|NCT00902486|11582239|FG004|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||32
10436053|NCT00902486|11582240|FG005|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||30
10788353|NCT03500211|11948694|FG000|NOT COMPLETED|Overall Study||1
10788354|NCT03500211|11948695|FG001|NOT COMPLETED|Overall Study||1
10788355|NCT03500224|11948701|FG000|STARTED|Overall Study||6
10788356|NCT03500224|11948701|FG000|COMPLETED|Overall Study||4
10788357|NCT03500224|11948701|FG000|NOT COMPLETED|Overall Study||2
10810673|NCT03792672|11972456|FG000|COMPLETED|Treatment Period 1 (1 Day)||4
10436054|NCT00902486|11582235|FG000|COMPLETED|Treatment Period (Weeks 0 Through 12)||29
10436055|NCT00902486|11582236|FG001|COMPLETED|Treatment Period (Weeks 0 Through 12)||0
10436056|NCT00902486|11582237|FG002|COMPLETED|Treatment Period (Weeks 0 Through 12)||0
10436057|NCT00902486|11582238|FG003|COMPLETED|Treatment Period (Weeks 0 Through 12)||29
10436058|NCT00902486|11582239|FG004|COMPLETED|Treatment Period (Weeks 0 Through 12)||30
10436059|NCT00902486|11582240|FG005|COMPLETED|Treatment Period (Weeks 0 Through 12)||27
10436060|NCT00902486|11582235|FG000|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||2
10436061|NCT00902486|11582236|FG001|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||0
10436062|NCT00902486|11582237|FG002|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||0
10436063|NCT00902486|11582238|FG003|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||3
10436064|NCT00902486|11582239|FG004|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||2
10436065|NCT00902486|11582240|FG005|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||5
10436066|NCT00902486|11582235|FG000|STARTED|Extension Period (Weeks 12 Through 24)||0
10436067|NCT00902486|11582236|FG001|STARTED|Extension Period (Weeks 12 Through 24)||14
10436068|NCT00902486|11582237|FG002|STARTED|Extension Period (Weeks 12 Through 24)||15
10436069|NCT00902486|11582238|FG003|STARTED|Extension Period (Weeks 12 Through 24)||29
10436070|NCT00902486|11582239|FG004|STARTED|Extension Period (Weeks 12 Through 24)||30
10436071|NCT00902486|11582240|FG005|STARTED|Extension Period (Weeks 12 Through 24)||27
10436072|NCT00902486|11582235|FG000|COMPLETED|Extension Period (Weeks 12 Through 24)||0
10436073|NCT00902486|11582236|FG001|COMPLETED|Extension Period (Weeks 12 Through 24)||14
10788358|NCT03500289|11948707|FG000|STARTED|Overall Study||12
10788359|NCT03500289|11948708|FG001|STARTED|Overall Study||6
10788360|NCT03500289|11948707|FG000|COMPLETED|Overall Study||12
10788361|NCT03500289|11948708|FG001|COMPLETED|Overall Study||6
10788362|NCT03500289|11948707|FG000|NOT COMPLETED|Overall Study||0
10788363|NCT03500289|11948708|FG001|NOT COMPLETED|Overall Study||0
10788364|NCT03500302|11948714|FG000|STARTED|Overall Study||19
10788365|NCT03500302|11948714|FG000|COMPLETED|Overall Study||19
10788366|NCT03500302|11948714|FG000|NOT COMPLETED|Overall Study||0
10788367|NCT03500419|11948720|FG000|STARTED|Overall Study||27
10788368|NCT03500419|11948721|FG001|STARTED|Overall Study||55
10788369|NCT03500419|11948720|FG000|COMPLETED|Overall Study||25
10788370|NCT03500419|11948721|FG001|COMPLETED|Overall Study||30
10788371|NCT03500419|11948720|FG000|NOT COMPLETED|Overall Study||2
10788372|NCT03500419|11948721|FG001|NOT COMPLETED|Overall Study||25
10788373|NCT03500679|11948729|FG000|STARTED|Overall Study||75
10788374|NCT03500679|11948730|FG001|STARTED|Overall Study||25
10788375|NCT03500679|11948729|FG000|COMPLETED|Overall Study||66
10788376|NCT03500679|11948730|FG001|COMPLETED|Overall Study||22
10788377|NCT03500679|11948729|FG000|NOT COMPLETED|Overall Study||9
10788378|NCT03500679|11948730|FG001|NOT COMPLETED|Overall Study||3
10788379|NCT03501043|11948736|FG000|STARTED|Overall Study||11
10788380|NCT03501043|11948736|FG000|COMPLETED|Overall Study||10
10788381|NCT03501043|11948736|FG000|NOT COMPLETED|Overall Study||1
10788382|NCT03501069|11948760|FG000|STARTED|Period A||2
10788383|NCT03501069|11948761|FG001|STARTED|Period A||4
10788384|NCT03501069|11948762|FG002|STARTED|Period A||2
10788385|NCT03501069|11948763|FG003|STARTED|Period A||5
10788386|NCT03501069|11948764|FG004|STARTED|Period A||1
10788387|NCT03501069|11948765|FG005|STARTED|Period A||6
10788388|NCT03501069|11948766|FG006|STARTED|Period A||6
10788389|NCT03501069|11948767|FG007|STARTED|Period A||3
10788390|NCT03501069|11948768|FG008|STARTED|Period A||3
10788391|NCT03501069|11948760|FG000|COMPLETED|Period A||2
10788392|NCT03501069|11948761|FG001|COMPLETED|Period A||4
10788393|NCT03501069|11948762|FG002|COMPLETED|Period A||2
10788394|NCT03501069|11948763|FG003|COMPLETED|Period A||5
10788395|NCT03501069|11948764|FG004|COMPLETED|Period A||1
10788396|NCT03501069|11948765|FG005|COMPLETED|Period A||6
10788397|NCT03501069|11948766|FG006|COMPLETED|Period A||6
10788398|NCT03501069|11948767|FG007|COMPLETED|Period A||3
10788399|NCT03501069|11948768|FG008|COMPLETED|Period A||3
10788400|NCT03501069|11948760|FG000|NOT COMPLETED|Period A||0
10788401|NCT03501069|11948761|FG001|NOT COMPLETED|Period A||0
10788402|NCT03501069|11948762|FG002|NOT COMPLETED|Period A||0
10788403|NCT03501069|11948763|FG003|NOT COMPLETED|Period A||0
10788404|NCT03501069|11948764|FG004|NOT COMPLETED|Period A||0
10788405|NCT03501069|11948765|FG005|NOT COMPLETED|Period A||0
10788406|NCT03501069|11948766|FG006|NOT COMPLETED|Period A||0
10788407|NCT03501069|11948767|FG007|NOT COMPLETED|Period A||0
10788408|NCT03501069|11948768|FG008|NOT COMPLETED|Period A||0
10788409|NCT03501069|11948760|FG000|STARTED|Washout Period (at Least 14 Days)||2
10788410|NCT03501069|11948761|FG001|STARTED|Washout Period (at Least 14 Days)||4
10788411|NCT03501069|11948762|FG002|STARTED|Washout Period (at Least 14 Days)||2
10788412|NCT03501069|11948763|FG003|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
10788413|NCT03501069|11948764|FG004|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
10788414|NCT03501069|11948765|FG005|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
10788415|NCT03501069|11948766|FG006|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
10788416|NCT03501069|11948767|FG007|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
10788417|NCT03501069|11948768|FG008|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
10436074|NCT00902486|11582237|FG002|COMPLETED|Extension Period (Weeks 12 Through 24)||13
10436075|NCT00902486|11582238|FG003|COMPLETED|Extension Period (Weeks 12 Through 24)||27
10436076|NCT00902486|11582239|FG004|COMPLETED|Extension Period (Weeks 12 Through 24)||29
10436077|NCT00902486|11582240|FG005|COMPLETED|Extension Period (Weeks 12 Through 24)||24
10436236|NCT00903331|11582370|FG001|NOT COMPLETED|Overall Study||18
10436078|NCT00902486|11582235|FG000|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||0
10436079|NCT00902486|11582236|FG001|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||0
10436080|NCT00902486|11582237|FG002|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||2
10436081|NCT00902486|11582238|FG003|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||2
10436082|NCT00902486|11582239|FG004|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||1
10436083|NCT00902486|11582240|FG005|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||3
10436084|NCT00902486|11582235|FG000|STARTED|Follow-up (After Week 24)||0
10436085|NCT00902486|11582236|FG001|STARTED|Follow-up (After Week 24)||14
10436086|NCT00902486|11582237|FG002|STARTED|Follow-up (After Week 24)||13
10436087|NCT00902486|11582238|FG003|STARTED|Follow-up (After Week 24)||27
10436088|NCT00902486|11582239|FG004|STARTED|Follow-up (After Week 24)||29
10436089|NCT00902486|11582240|FG005|STARTED|Follow-up (After Week 24)||24
10436090|NCT00902486|11582235|FG000|Safety Evaluable Participants|Follow-up (After Week 24)||0
10436091|NCT00902486|11582236|FG001|Safety Evaluable Participants|Follow-up (After Week 24)||14
10436092|NCT00902486|11582237|FG002|Safety Evaluable Participants|Follow-up (After Week 24)||15
10436093|NCT00902486|11582238|FG003|Safety Evaluable Participants|Follow-up (After Week 24)||29
10436094|NCT00902486|11582239|FG004|Safety Evaluable Participants|Follow-up (After Week 24)||30
10436095|NCT00902486|11582240|FG005|Safety Evaluable Participants|Follow-up (After Week 24)||27
10436096|NCT00902486|11582235|FG000|COMPLETED|Follow-up (After Week 24)||0
10436097|NCT00902486|11582236|FG001|COMPLETED|Follow-up (After Week 24)||14
10436098|NCT00902486|11582237|FG002|COMPLETED|Follow-up (After Week 24)||13
10436099|NCT00902486|11582238|FG003|COMPLETED|Follow-up (After Week 24)||26
10436100|NCT00902486|11582239|FG004|COMPLETED|Follow-up (After Week 24)||29
10436101|NCT00902486|11582240|FG005|COMPLETED|Follow-up (After Week 24)||24
10436102|NCT00902486|11582235|FG000|NOT COMPLETED|Follow-up (After Week 24)||0
10436103|NCT00902486|11582236|FG001|NOT COMPLETED|Follow-up (After Week 24)||0
10436104|NCT00902486|11582237|FG002|NOT COMPLETED|Follow-up (After Week 24)||0
10436105|NCT00902486|11582238|FG003|NOT COMPLETED|Follow-up (After Week 24)||1
10436106|NCT00902486|11582239|FG004|NOT COMPLETED|Follow-up (After Week 24)||0
10436107|NCT00902486|11582240|FG005|NOT COMPLETED|Follow-up (After Week 24)||0
10436108|NCT00902538|11582273|FG000|STARTED|1-Single-blind, Run-in, Single-Treatment||2204
10436109|NCT00902538|11582274|FG001|STARTED|1-Single-blind, Run-in, Single-Treatment||0
10436110|NCT00902538|11582275|FG002|STARTED|1-Single-blind, Run-in, Single-Treatment||0
10436111|NCT00902538|11582276|FG003|STARTED|1-Single-blind, Run-in, Single-Treatment||0
10436112|NCT00902538|11582277|FG004|STARTED|1-Single-blind, Run-in, Single-Treatment||0
10436113|NCT00902538|11582278|FG005|STARTED|1-Single-blind, Run-in, Single-Treatment||0
10436114|NCT00902538|11582273|FG000|COMPLETED|1-Single-blind, Run-in, Single-Treatment||2086
10436115|NCT00902538|11582274|FG001|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
10436116|NCT00902538|11582275|FG002|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
10788418|NCT03501069|11948760|FG000|COMPLETED|Washout Period (at Least 14 Days)||2
10788419|NCT03501069|11948761|FG001|COMPLETED|Washout Period (at Least 14 Days)||4
10788420|NCT03501069|11948762|FG002|COMPLETED|Washout Period (at Least 14 Days)||2
10788421|NCT03501069|11948763|FG003|COMPLETED|Washout Period (at Least 14 Days)||0
10788422|NCT03501069|11948764|FG004|COMPLETED|Washout Period (at Least 14 Days)||0
10788423|NCT03501069|11948765|FG005|COMPLETED|Washout Period (at Least 14 Days)||0
10788424|NCT03501069|11948766|FG006|COMPLETED|Washout Period (at Least 14 Days)||0
10788425|NCT03501069|11948767|FG007|COMPLETED|Washout Period (at Least 14 Days)||0
10788426|NCT03501069|11948768|FG008|COMPLETED|Washout Period (at Least 14 Days)||0
10788427|NCT03501069|11948760|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10788428|NCT03501069|11948761|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10788429|NCT03501069|11948762|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10788430|NCT03501069|11948763|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10788431|NCT03501069|11948764|FG004|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10788432|NCT03501069|11948765|FG005|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10788433|NCT03501069|11948766|FG006|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10788434|NCT03501069|11948767|FG007|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10788435|NCT03501069|11948768|FG008|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10788436|NCT03501069|11948760|FG000|STARTED|Period B||2
10788437|NCT03501069|11948761|FG001|STARTED|Period B||4
10788438|NCT03501069|11948762|FG002|STARTED|Period B||2
10788439|NCT03501069|11948763|FG003|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
10436117|NCT00902538|11582276|FG003|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
10788440|NCT03501069|11948764|FG004|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
10788441|NCT03501069|11948765|FG005|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
10788442|NCT03501069|11948766|FG006|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
10788443|NCT03501069|11948767|FG007|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
10788444|NCT03501069|11948768|FG008|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
10788445|NCT03501069|11948760|FG000|COMPLETED|Period B||2
10788446|NCT03501069|11948761|FG001|COMPLETED|Period B||4
10788447|NCT03501069|11948762|FG002|COMPLETED|Period B||2
10436118|NCT00902538|11582277|FG004|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
10436119|NCT00902538|11582278|FG005|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
10436120|NCT00902538|11582273|FG000|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||118
10436237|NCT00903344|11582378|FG000|STARTED|Overall Study||12
10436121|NCT00902538|11582274|FG001|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
10436122|NCT00902538|11582275|FG002|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
10436123|NCT00902538|11582276|FG003|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
10436124|NCT00902538|11582277|FG004|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
10436125|NCT00902538|11582278|FG005|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
10436126|NCT00902538|11582273|FG000|STARTED|2-Randomized Double-blind 3 Treatments|Only 808 began Period 2 because the others finishing Period 1 did not meet the entry criteria.|269
10436127|NCT00902538|11582274|FG001|STARTED|2-Randomized Double-blind 3 Treatments||269
10436128|NCT00902538|11582275|FG002|STARTED|2-Randomized Double-blind 3 Treatments||270
10436129|NCT00902538|11582276|FG003|STARTED|2-Randomized Double-blind 3 Treatments||0
10436130|NCT00902538|11582277|FG004|STARTED|2-Randomized Double-blind 3 Treatments||0
10436131|NCT00902538|11582278|FG005|STARTED|2-Randomized Double-blind 3 Treatments||0
10436132|NCT00902538|11582273|FG000|COMPLETED|2-Randomized Double-blind 3 Treatments||260
10788448|NCT03501069|11948763|FG003|COMPLETED|Period B||0
10788449|NCT03501069|11948764|FG004|COMPLETED|Period B||0
10788450|NCT03501069|11948765|FG005|COMPLETED|Period B||0
10788451|NCT03501069|11948766|FG006|COMPLETED|Period B||0
10788452|NCT03501069|11948767|FG007|COMPLETED|Period B||0
10788453|NCT03501069|11948768|FG008|COMPLETED|Period B||0
10788454|NCT03501069|11948760|FG000|NOT COMPLETED|Period B||0
10788455|NCT03501069|11948761|FG001|NOT COMPLETED|Period B||0
10788456|NCT03501069|11948762|FG002|NOT COMPLETED|Period B||0
10788457|NCT03501069|11948763|FG003|NOT COMPLETED|Period B||0
10788458|NCT03501069|11948764|FG004|NOT COMPLETED|Period B||0
10788459|NCT03501069|11948765|FG005|NOT COMPLETED|Period B||0
10788460|NCT03501069|11948766|FG006|NOT COMPLETED|Period B||0
10788461|NCT03501069|11948767|FG007|NOT COMPLETED|Period B||0
10788462|NCT03501069|11948768|FG008|NOT COMPLETED|Period B||0
10788463|NCT03501264|11948798|FG000|STARTED|Overall Study||120
10788464|NCT03501264|11948799|FG001|STARTED|Overall Study||120
10788465|NCT03501264|11948798|FG000|COMPLETED|Overall Study||120
10788466|NCT03501264|11948799|FG001|COMPLETED|Overall Study||120
10788467|NCT03501264|11948798|FG000|NOT COMPLETED|Overall Study||0
10788468|NCT03501264|11948799|FG001|NOT COMPLETED|Overall Study||0
10788469|NCT03501277|11948809|FG000|STARTED|Intervention Period 1 (4 Days)||18
10788470|NCT03501277|11948810|FG001|STARTED|Intervention Period 1 (4 Days)||18
10788471|NCT03501277|11948811|FG002|STARTED|Intervention Period 1 (4 Days)||18
10788472|NCT03501277|11948812|FG003|STARTED|Intervention Period 1 (4 Days)||18
10788473|NCT03501277|11948809|FG000|Safety Analysis Set|Intervention Period 1 (4 Days)||18
10788474|NCT03501277|11948810|FG001|Safety Analysis Set|Intervention Period 1 (4 Days)||18
10788475|NCT03501277|11948811|FG002|Safety Analysis Set|Intervention Period 1 (4 Days)||17
10788476|NCT03501277|11948812|FG003|Safety Analysis Set|Intervention Period 1 (4 Days)||17
10788477|NCT03501277|11948809|FG000|COMPLETED|Intervention Period 1 (4 Days)||18
10788478|NCT03501277|11948810|FG001|COMPLETED|Intervention Period 1 (4 Days)||18
10788479|NCT03501277|11948811|FG002|COMPLETED|Intervention Period 1 (4 Days)||17
10788480|NCT03501277|11948812|FG003|COMPLETED|Intervention Period 1 (4 Days)||17
10788481|NCT03501277|11948809|FG000|NOT COMPLETED|Intervention Period 1 (4 Days)||0
10788482|NCT03501277|11948810|FG001|NOT COMPLETED|Intervention Period 1 (4 Days)||0
10788483|NCT03501277|11948811|FG002|NOT COMPLETED|Intervention Period 1 (4 Days)||1
10788484|NCT03501277|11948812|FG003|NOT COMPLETED|Intervention Period 1 (4 Days)||1
10788485|NCT03501277|11948809|FG000|STARTED|Washout Period 1 (7 Days)||18
10788486|NCT03501277|11948810|FG001|STARTED|Washout Period 1 (7 Days)||18
10788487|NCT03501277|11948811|FG002|STARTED|Washout Period 1 (7 Days)||17
10788488|NCT03501277|11948812|FG003|STARTED|Washout Period 1 (7 Days)||17
10788489|NCT03501277|11948809|FG000|COMPLETED|Washout Period 1 (7 Days)||18
10788490|NCT03501277|11948810|FG001|COMPLETED|Washout Period 1 (7 Days)||18
10788491|NCT03501277|11948811|FG002|COMPLETED|Washout Period 1 (7 Days)||17
10788492|NCT03501277|11948812|FG003|COMPLETED|Washout Period 1 (7 Days)||17
10788493|NCT03501277|11948809|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
10788494|NCT03501277|11948810|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
10788495|NCT03501277|11948811|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
10788496|NCT03501277|11948812|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
10788497|NCT03501277|11948809|FG000|STARTED|Intervention Period 2 (4 Days)||18
10436133|NCT00902538|11582274|FG001|COMPLETED|2-Randomized Double-blind 3 Treatments||263
10436134|NCT00902538|11582275|FG002|COMPLETED|2-Randomized Double-blind 3 Treatments||262
10788498|NCT03501277|11948810|FG001|STARTED|Intervention Period 2 (4 Days)||18
10788499|NCT03501277|11948811|FG002|STARTED|Intervention Period 2 (4 Days)||17
10788500|NCT03501277|11948812|FG003|STARTED|Intervention Period 2 (4 Days)||17
10788501|NCT03501277|11948809|FG000|COMPLETED|Intervention Period 2 (4 Days)||18
10788502|NCT03501277|11948810|FG001|COMPLETED|Intervention Period 2 (4 Days)||18
10788503|NCT03501277|11948811|FG002|COMPLETED|Intervention Period 2 (4 Days)||17
10788504|NCT03501277|11948812|FG003|COMPLETED|Intervention Period 2 (4 Days)||16
10788505|NCT03501277|11948809|FG000|NOT COMPLETED|Intervention Period 2 (4 Days)||0
10788506|NCT03501277|11948810|FG001|NOT COMPLETED|Intervention Period 2 (4 Days)||0
10788507|NCT03501277|11948811|FG002|NOT COMPLETED|Intervention Period 2 (4 Days)||0
10788508|NCT03501277|11948812|FG003|NOT COMPLETED|Intervention Period 2 (4 Days)||1
10788509|NCT03501277|11948809|FG000|STARTED|Washout Period 2 (7 Days)||18
10788510|NCT03501277|11948810|FG001|STARTED|Washout Period 2 (7 Days)||18
10436135|NCT00902538|11582276|FG003|COMPLETED|2-Randomized Double-blind 3 Treatments||0
10436136|NCT00902538|11582277|FG004|COMPLETED|2-Randomized Double-blind 3 Treatments||0
10436137|NCT00902538|11582278|FG005|COMPLETED|2-Randomized Double-blind 3 Treatments||0
10436138|NCT00902538|11582273|FG000|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||9
10436139|NCT00902538|11582274|FG001|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||6
10436140|NCT00902538|11582275|FG002|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||8
10436141|NCT00902538|11582276|FG003|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
10436142|NCT00902538|11582277|FG004|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
10436143|NCT00902538|11582278|FG005|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
10788511|NCT03501277|11948811|FG002|STARTED|Washout Period 2 (7 Days)||17
10788512|NCT03501277|11948812|FG003|STARTED|Washout Period 2 (7 Days)||16
10788513|NCT03501277|11948809|FG000|COMPLETED|Washout Period 2 (7 Days)||18
10788514|NCT03501277|11948810|FG001|COMPLETED|Washout Period 2 (7 Days)||18
10788515|NCT03501277|11948811|FG002|COMPLETED|Washout Period 2 (7 Days)||17
10788516|NCT03501277|11948812|FG003|COMPLETED|Washout Period 2 (7 Days)||16
10436144|NCT00902538|11582273|FG000|STARTED|3-Single-blind, Single Treatment||0
10436145|NCT00902538|11582274|FG001|STARTED|3-Single-blind, Single Treatment|Number starting is < total completing previous arm since 3 subjects did not receive at least 1 dose.|782
10436146|NCT00902538|11582275|FG002|STARTED|3-Single-blind, Single Treatment||0
10436147|NCT00902538|11582276|FG003|STARTED|3-Single-blind, Single Treatment||0
10436148|NCT00902538|11582277|FG004|STARTED|3-Single-blind, Single Treatment||0
10436149|NCT00902538|11582278|FG005|STARTED|3-Single-blind, Single Treatment||0
10788517|NCT03501277|11948809|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
10788518|NCT03501277|11948810|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
10788519|NCT03501277|11948811|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
10788520|NCT03501277|11948812|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
10788521|NCT03501277|11948809|FG000|STARTED|Intervention Period 3 (4 Days)||18
10788522|NCT03501277|11948810|FG001|STARTED|Intervention Period 3 (4 Days)||18
10788523|NCT03501277|11948811|FG002|STARTED|Intervention Period 3 (4 Days)||17
10788524|NCT03501277|11948812|FG003|STARTED|Intervention Period 3 (4 Days)||16
10788525|NCT03501277|11948809|FG000|COMPLETED|Intervention Period 3 (4 Days)||18
10788526|NCT03501277|11948810|FG001|COMPLETED|Intervention Period 3 (4 Days)||18
10788527|NCT03501277|11948811|FG002|COMPLETED|Intervention Period 3 (4 Days)||17
10788528|NCT03501277|11948812|FG003|COMPLETED|Intervention Period 3 (4 Days)||15
10788529|NCT03501277|11948809|FG000|NOT COMPLETED|Intervention Period 3 (4 Days)||0
10788530|NCT03501277|11948810|FG001|NOT COMPLETED|Intervention Period 3 (4 Days)||0
10788531|NCT03501277|11948811|FG002|NOT COMPLETED|Intervention Period 3 (4 Days)||0
10788532|NCT03501277|11948812|FG003|NOT COMPLETED|Intervention Period 3 (4 Days)||1
10788533|NCT03501277|11948809|FG000|STARTED|Washout Period 3 (7 Days)||18
10788534|NCT03501277|11948810|FG001|STARTED|Washout Period 3 (7 Days)||18
10788535|NCT03501277|11948811|FG002|STARTED|Washout Period 3 (7 Days)||17
10788536|NCT03501277|11948812|FG003|STARTED|Washout Period 3 (7 Days)||15
10788537|NCT03501277|11948809|FG000|COMPLETED|Washout Period 3 (7 Days)||18
10788538|NCT03501277|11948810|FG001|COMPLETED|Washout Period 3 (7 Days)||18
10788539|NCT03501277|11948811|FG002|COMPLETED|Washout Period 3 (7 Days)||17
10788540|NCT03501277|11948812|FG003|COMPLETED|Washout Period 3 (7 Days)||15
10788541|NCT03501277|11948809|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
10788542|NCT03501277|11948810|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
10788543|NCT03501277|11948811|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
10788544|NCT03501277|11948812|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
10788545|NCT03501277|11948809|FG000|STARTED|Intervention Period 4 (4 Days)||18
10788546|NCT03501277|11948810|FG001|STARTED|Intervention Period 4 (4 Days)||18
10788547|NCT03501277|11948811|FG002|STARTED|Intervention Period 4 (4 Days)||17
10788548|NCT03501277|11948812|FG003|STARTED|Intervention Period 4 (4 Days)||15
10788549|NCT03501277|11948809|FG000|COMPLETED|Intervention Period 4 (4 Days)||18
10788550|NCT03501277|11948810|FG001|COMPLETED|Intervention Period 4 (4 Days)||18
10788551|NCT03501277|11948811|FG002|COMPLETED|Intervention Period 4 (4 Days)||17
10788552|NCT03501277|11948812|FG003|COMPLETED|Intervention Period 4 (4 Days)||15
10788553|NCT03501277|11948809|FG000|NOT COMPLETED|Intervention Period 4 (4 Days)||0
10788554|NCT03501277|11948810|FG001|NOT COMPLETED|Intervention Period 4 (4 Days)||0
10788555|NCT03501277|11948811|FG002|NOT COMPLETED|Intervention Period 4 (4 Days)||0
10788556|NCT03501277|11948812|FG003|NOT COMPLETED|Intervention Period 4 (4 Days)||0
10788557|NCT03501550|11948822|FG000|STARTED|Overall Study||12
10788558|NCT03501550|11948822|FG000|COMPLETED|Overall Study||12
10788559|NCT03501550|11948822|FG000|NOT COMPLETED|Overall Study||0
10788560|NCT03501693|11948826|FG000|STARTED|First Reading Session||75
10788561|NCT03501693|11948827|FG001|STARTED|First Reading Session||75
10788562|NCT03501693|11948826|FG000|COMPLETED|First Reading Session||75
10788563|NCT03501693|11948827|FG001|COMPLETED|First Reading Session||75
10436150|NCT00902538|11582273|FG000|COMPLETED|3-Single-blind, Single Treatment||0
10436151|NCT00902538|11582274|FG001|COMPLETED|3-Single-blind, Single Treatment||767
10788564|NCT03501693|11948826|FG000|NOT COMPLETED|First Reading Session||0
10788565|NCT03501693|11948827|FG001|NOT COMPLETED|First Reading Session||0
10788566|NCT03501693|11948826|FG000|STARTED|4 Week Memory Washout Period||75
10788567|NCT03501693|11948827|FG001|STARTED|4 Week Memory Washout Period||75
10788568|NCT03501693|11948826|FG000|COMPLETED|4 Week Memory Washout Period||75
10788569|NCT03501693|11948827|FG001|COMPLETED|4 Week Memory Washout Period||75
10788570|NCT03501693|11948826|FG000|NOT COMPLETED|4 Week Memory Washout Period||0
10788571|NCT03501693|11948827|FG001|NOT COMPLETED|4 Week Memory Washout Period||0
10788572|NCT03501693|11948826|FG000|STARTED|Second Reading Session||75
10436152|NCT00902538|11582275|FG002|COMPLETED|3-Single-blind, Single Treatment||0
10436153|NCT00902538|11582276|FG003|COMPLETED|3-Single-blind, Single Treatment||0
10436154|NCT00902538|11582277|FG004|COMPLETED|3-Single-blind, Single Treatment||0
10436155|NCT00902538|11582278|FG005|COMPLETED|3-Single-blind, Single Treatment||0
10436156|NCT00902538|11582273|FG000|NOT COMPLETED|3-Single-blind, Single Treatment||0
10436157|NCT00902538|11582274|FG001|NOT COMPLETED|3-Single-blind, Single Treatment||15
10436158|NCT00902538|11582275|FG002|NOT COMPLETED|3-Single-blind, Single Treatment||0
10436159|NCT00902538|11582276|FG003|NOT COMPLETED|3-Single-blind, Single Treatment||0
10436160|NCT00902538|11582277|FG004|NOT COMPLETED|3-Single-blind, Single Treatment||0
10436161|NCT00902538|11582278|FG005|NOT COMPLETED|3-Single-blind, Single Treatment||0
10436162|NCT00902538|11582273|FG000|STARTED|4-Randomized Double-blind 2 Treatments||0
10436163|NCT00902538|11582274|FG001|STARTED|4-Randomized Double-blind 2 Treatments||0
10436164|NCT00902538|11582275|FG002|STARTED|4-Randomized Double-blind 2 Treatments||0
10436165|NCT00902538|11582276|FG003|STARTED|4-Randomized Double-blind 2 Treatments|Period 3 responders were continued on OLM 40-AML 10-HCTZ 12.5|467
10436166|NCT00902538|11582277|FG004|STARTED|4-Randomized Double-blind 2 Treatments|Period 3 non-responders were randomized to OLM 40-AML 10-HCTZ 12.5 or 25 in a 2:1 ratio|97
10436167|NCT00902538|11582278|FG005|STARTED|4-Randomized Double-blind 2 Treatments||197
10436168|NCT00902538|11582273|FG000|COMPLETED|4-Randomized Double-blind 2 Treatments||0
10436169|NCT00902538|11582274|FG001|COMPLETED|4-Randomized Double-blind 2 Treatments||0
10436170|NCT00902538|11582275|FG002|COMPLETED|4-Randomized Double-blind 2 Treatments||0
10436171|NCT00902538|11582276|FG003|COMPLETED|4-Randomized Double-blind 2 Treatments||458
10436172|NCT00902538|11582277|FG004|COMPLETED|4-Randomized Double-blind 2 Treatments||95
10436173|NCT00902538|11582278|FG005|COMPLETED|4-Randomized Double-blind 2 Treatments||196
10436174|NCT00902538|11582273|FG000|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
10436175|NCT00902538|11582274|FG001|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
10436176|NCT00902538|11582275|FG002|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
10436177|NCT00902538|11582276|FG003|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||9
10436178|NCT00902538|11582277|FG004|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||2
10436179|NCT00902538|11582278|FG005|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||1
10436180|NCT00902564|11582290|FG000|STARTED|Overall Study||30
10436181|NCT00902564|11582290|FG000|COMPLETED|Overall Study||28
10436182|NCT00902564|11582290|FG000|NOT COMPLETED|Overall Study||2
10436183|NCT00902577|11582294|FG000|STARTED|Overall Study||50
10436184|NCT00902577|11582294|FG000|FMISO/PET|Overall Study||38
10436185|NCT00902577|11582294|FG000|DCE MRI|Overall Study||31
10436186|NCT00902577|11582294|FG000|DSE MRI|Overall Study||37
10436187|NCT00902577|11582294|FG000|DWI MRI|Overall Study||39
10436188|NCT00902577|11582294|FG000|COMPLETED|Overall Study||42
10436189|NCT00902577|11582294|FG000|NOT COMPLETED|Overall Study||8
10436190|NCT00902746|11582317|FG000|STARTED|Overall Study||149
10436191|NCT00902746|11582317|FG000|Initiation of Study Drug Administration|Overall Study||148
10436192|NCT00902746|11582317|FG000|Transfer to Step 2|Overall Study||133
10436193|NCT00902746|11582317|FG000|COMPLETED|Overall Study||113
10436194|NCT00902746|11582317|FG000|NOT COMPLETED|Overall Study||36
10436195|NCT00902850|11582323|FG000|STARTED|Overall Study||14
10436196|NCT00902850|11582324|FG001|STARTED|Overall Study||14
10436197|NCT00902850|11582323|FG000|COMPLETED|Overall Study||12
10436198|NCT00902850|11582324|FG001|COMPLETED|Overall Study||12
10436199|NCT00902850|11582323|FG000|NOT COMPLETED|Overall Study||2
10436200|NCT00902850|11582324|FG001|NOT COMPLETED|Overall Study||2
10436201|NCT00903032|11582332|FG000|STARTED|Overall Study||129
10436202|NCT00903032|11582333|FG001|STARTED|Overall Study||124
10436203|NCT00903032|11582332|FG000|COMPLETED|Overall Study||122
10436204|NCT00903032|11582333|FG001|COMPLETED|Overall Study||119
10436205|NCT00903032|11582332|FG000|NOT COMPLETED|Overall Study||7
10436206|NCT00903032|11582333|FG001|NOT COMPLETED|Overall Study||5
10436207|NCT00903162|11582339|FG000|STARTED|Overall Study||16
10436208|NCT00903162|11582339|FG000|COMPLETED|Overall Study||12
10436209|NCT00903162|11582339|FG000|NOT COMPLETED|Overall Study||4
10436210|NCT00903175|11582345|FG000|STARTED|Period 1 - First Line||238
10436211|NCT00903175|11582346|FG001|STARTED|Period 1 - First Line||231
10436212|NCT00903175|11582345|FG000|COMPLETED|Period 1 - First Line|Completed = Disease progression (completed 1L)|161
10436213|NCT00903175|11582346|FG001|COMPLETED|Period 1 - First Line|Completed = Disease progression (completed 1L)|142
10436214|NCT00903175|11582345|FG000|NOT COMPLETED|Period 1 - First Line||77
10436215|NCT00903175|11582346|FG001|NOT COMPLETED|Period 1 - First Line||89
10436216|NCT00903175|11582345|FG000|STARTED|Period 2 - Second Line|139 from everolimus 1L planned to enter 2L period and cross over to sunitinib but only 128 did.|128
10436217|NCT00903175|11582346|FG001|STARTED|Period 2 - Second Line|130 from Sunitinib 1L planned to enter 2L period and cross over to everolimus but only 116 did.|116
10436218|NCT00903175|11582345|FG000|COMPLETED|Period 2 - Second Line|Completed = Disease progression - (completed 2L)|79
10436219|NCT00903175|11582346|FG001|COMPLETED|Period 2 - Second Line|Completed = Disease progression - (completed 2L)|80
10436220|NCT00903175|11582345|FG000|NOT COMPLETED|Period 2 - Second Line||49
10436221|NCT00903175|11582346|FG001|NOT COMPLETED|Period 2 - Second Line||36
10436222|NCT00903201|11582355|FG000|STARTED|Overall Study||61
10436223|NCT00903201|11582356|FG001|STARTED|Overall Study||44
10436224|NCT00903201|11582357|FG002|STARTED|Overall Study||41
10436225|NCT00903201|11582355|FG000|COMPLETED|Overall Study||56
10436226|NCT00903201|11582356|FG001|COMPLETED|Overall Study||38
10436227|NCT00903201|11582357|FG002|COMPLETED|Overall Study||39
10436228|NCT00903201|11582355|FG000|NOT COMPLETED|Overall Study||5
10436229|NCT00903201|11582356|FG001|NOT COMPLETED|Overall Study||6
10436230|NCT00903201|11582357|FG002|NOT COMPLETED|Overall Study||2
10436231|NCT00903331|11582369|FG000|STARTED|Overall Study||59
10436232|NCT00903331|11582370|FG001|STARTED|Overall Study||119
10436233|NCT00903331|11582369|FG000|COMPLETED|Overall Study||54
10436234|NCT00903331|11582370|FG001|COMPLETED|Overall Study||101
10436235|NCT00903331|11582369|FG000|NOT COMPLETED|Overall Study||5
10436238|NCT00903344|11582379|FG001|STARTED|Overall Study||10
10436239|NCT00903344|11582378|FG000|3 Month Visit|Overall Study||10
10436240|NCT00903344|11582379|FG001|3 Month Visit|Overall Study||10
10436241|NCT00903344|11582378|FG000|6 Month Visit|Overall Study||9
10436242|NCT00903344|11582379|FG001|6 Month Visit|Overall Study||10
10436243|NCT00903344|11582378|FG000|COMPLETED|Overall Study||7
10436244|NCT00903344|11582379|FG001|COMPLETED|Overall Study||7
10436245|NCT00903344|11582378|FG000|NOT COMPLETED|Overall Study||5
10436246|NCT00903344|11582379|FG001|NOT COMPLETED|Overall Study||3
10436247|NCT00903357|11582385|FG000|STARTED|First Intervention||27
10436248|NCT00903357|11582386|FG001|STARTED|First Intervention||27
10436249|NCT00903357|11582385|FG000|COMPLETED|First Intervention||22
10436250|NCT00903357|11582386|FG001|COMPLETED|First Intervention||23
10436251|NCT00903357|11582385|FG000|NOT COMPLETED|First Intervention||5
10436252|NCT00903357|11582386|FG001|NOT COMPLETED|First Intervention||4
10436253|NCT00903357|11582385|FG000|STARTED|Wash Out Period of 2 Weeks||22
10436254|NCT00903357|11582386|FG001|STARTED|Wash Out Period of 2 Weeks||23
10436255|NCT00903357|11582385|FG000|COMPLETED|Wash Out Period of 2 Weeks||22
10436256|NCT00903357|11582386|FG001|COMPLETED|Wash Out Period of 2 Weeks||22
10436257|NCT00903357|11582385|FG000|NOT COMPLETED|Wash Out Period of 2 Weeks||0
10436258|NCT00903357|11582386|FG001|NOT COMPLETED|Wash Out Period of 2 Weeks||1
10436259|NCT00903357|11582385|FG000|STARTED|Second Intervention||22
10436260|NCT00903357|11582386|FG001|STARTED|Second Intervention||22
10436261|NCT00903357|11582385|FG000|COMPLETED|Second Intervention||21
10436262|NCT00903357|11582386|FG001|COMPLETED|Second Intervention||22
10436263|NCT00903357|11582385|FG000|NOT COMPLETED|Second Intervention||1
10436264|NCT00903357|11582386|FG001|NOT COMPLETED|Second Intervention||0
10525270|NCT01374906|11677163|FG001|STARTED|Overall Study||76
10525271|NCT01374906|11677162|FG000|DC Dur Core Phs at/Prior to Data Cutoff|Overall Study||24
10525272|NCT01374906|11677163|FG001|DC Dur Core Phs at/Prior to Data Cutoff|Overall Study||22
10525273|NCT01374906|11677162|FG000|Completed Core Phase|Overall Study||50
10525274|NCT01374906|11677163|FG001|Completed Core Phase|Overall Study||54
10525275|NCT01374906|11677162|FG000|Completed Core/Did Not Enter Ext. Phase|Overall Study||10
10525276|NCT01374906|11677163|FG001|Completed Core/Did Not Enter Ext. Phase|Overall Study||13
10525277|NCT01374906|11677162|FG000|Completed Core Phase/Entered Ext. Phase|Overall Study||40
10525278|NCT01374906|11677163|FG001|Completed Core Phase/Entered Ext. Phase|Overall Study||41
10525279|NCT01374906|11677162|FG000|DC Dur Ext Phs at/Prior to Data Cutoff|Overall Study||16
10525280|NCT01374906|11677163|FG001|DC Dur Ext Phs at/Prior to Data Cutoff|Overall Study||26
10525281|NCT01374906|11677162|FG000|Completed Extension Phase|Overall Study||24
10525282|NCT01374906|11677163|FG001|Completed Extension Phase|Overall Study||15
10525283|NCT01374906|11677162|FG000|COMPLETED|Overall Study||34
10525284|NCT01374906|11677163|FG001|COMPLETED|Overall Study||28
10525285|NCT01374906|11677162|FG000|NOT COMPLETED|Overall Study||40
10525286|NCT01374906|11677163|FG001|NOT COMPLETED|Overall Study||48
10525287|NCT01374919|11677173|FG000|STARTED|Overall Study||60
10525288|NCT01374919|11677173|FG000|COMPLETED|Overall Study||58
10525289|NCT01374919|11677173|FG000|NOT COMPLETED|Overall Study||2
10525290|NCT01374971|11677177|FG000|STARTED|Overall Study||12
10525291|NCT01374971|11677177|FG000|COMPLETED|Overall Study||11
10525292|NCT01374971|11677177|FG000|NOT COMPLETED|Overall Study||1
10525293|NCT01375010|11677183|FG000|STARTED|Overall Study||43
10525294|NCT01375010|11677184|FG001|STARTED|Overall Study||42
10525295|NCT01375010|11677183|FG000|COMPLETED|Overall Study||31
10525296|NCT01375010|11677184|FG001|COMPLETED|Overall Study||38
10525297|NCT01375010|11677183|FG000|NOT COMPLETED|Overall Study||12
10525298|NCT01375010|11677184|FG001|NOT COMPLETED|Overall Study||4
10525299|NCT01375049|11677190|FG000|STARTED|Overall Study||105
10525300|NCT01375049|11677190|FG000|COMPLETED|Overall Study||55
10549612|NCT01526213|11703634|FG001|COMPLETED|Period 2 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
10549613|NCT01526213|11703635|FG002|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
10549614|NCT01526213|11703636|FG003|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
10549615|NCT01526213|11703637|FG004|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
10525301|NCT01375049|11677190|FG000|NOT COMPLETED|Overall Study||50
10525302|NCT01375075|11677204|FG000|STARTED|Overall Study||27
10525303|NCT01375075|11677205|FG001|STARTED|Overall Study||28
10525304|NCT01375075|11677206|FG002|STARTED|Overall Study||27
10525305|NCT01375075|11677207|FG003|STARTED|Overall Study||28
10525306|NCT01375075|11677208|FG004|STARTED|Overall Study||27
10525307|NCT01375075|11677209|FG005|STARTED|Overall Study||28
10525308|NCT01375075|11677204|FG000|Received at Least One Dose of Study Drug|Overall Study||27
10525309|NCT01375075|11677205|FG001|Received at Least One Dose of Study Drug|Overall Study||28
10525310|NCT01375075|11677206|FG002|Received at Least One Dose of Study Drug|Overall Study||27
10436265|NCT00903370|11582398|FG000|STARTED|Overall Study||127
10436266|NCT00903370|11582399|FG001|STARTED|Overall Study||133
10436267|NCT00903370|11582398|FG000|COMPLETED|Overall Study||99
10436268|NCT00903370|11582399|FG001|COMPLETED|Overall Study||109
10436269|NCT00903370|11582398|FG000|NOT COMPLETED|Overall Study||28
10436270|NCT00903370|11582399|FG001|NOT COMPLETED|Overall Study||24
10436271|NCT00903383|11582409|FG000|STARTED|Overall Study||55
10788573|NCT03501693|11948827|FG001|STARTED|Second Reading Session||75
10788574|NCT03501693|11948826|FG000|COMPLETED|Second Reading Session||75
10788575|NCT03501693|11948827|FG001|COMPLETED|Second Reading Session||75
10788576|NCT03501693|11948826|FG000|NOT COMPLETED|Second Reading Session||0
10788577|NCT03501693|11948827|FG001|NOT COMPLETED|Second Reading Session||0
10788578|NCT03502265|11948833|FG000|STARTED|Overall Study||4
10788579|NCT03502265|11948833|FG000|COMPLETED|Overall Study||4
10788580|NCT03502265|11948833|FG000|NOT COMPLETED|Overall Study||0
10788581|NCT03502616|11948839|FG000|STARTED|Up to Week 16||134
10788582|NCT03502616|11948840|FG001|STARTED|Up to Week 16||136
10788583|NCT03502616|11948839|FG000|Treated|Up to Week 16||133
10788584|NCT03502616|11948840|FG001|Treated|Up to Week 16||136
10788585|NCT03502616|11948839|FG000|COMPLETED|Up to Week 16||132
10788586|NCT03502616|11948840|FG001|COMPLETED|Up to Week 16||133
10788587|NCT03502616|11948839|FG000|NOT COMPLETED|Up to Week 16||2
10788588|NCT03502616|11948840|FG001|NOT COMPLETED|Up to Week 16||3
10788589|NCT03502616|11948839|FG000|STARTED|Week 16 to Week 48||132
10788590|NCT03502616|11948840|FG001|STARTED|Week 16 to Week 48||133
10788591|NCT03502616|11948839|FG000|Treated|Week 16 to Week 48||132
10788592|NCT03502616|11948840|FG001|Treated|Week 16 to Week 48||133
10788593|NCT03502616|11948839|FG000|COMPLETED|Week 16 to Week 48||125
10788594|NCT03502616|11948840|FG001|COMPLETED|Week 16 to Week 48||127
10788595|NCT03502616|11948839|FG000|NOT COMPLETED|Week 16 to Week 48||7
10788596|NCT03502616|11948840|FG001|NOT COMPLETED|Week 16 to Week 48||6
10788597|NCT03502798|11948850|FG000|STARTED|Overall Study||5
10788598|NCT03502798|11948851|FG001|STARTED|Overall Study||40
10788599|NCT03502798|11948850|FG000|COMPLETED|Overall Study||5
10788600|NCT03502798|11948851|FG001|COMPLETED|Overall Study||33
10788601|NCT03502798|11948850|FG000|NOT COMPLETED|Overall Study||0
10788602|NCT03502798|11948851|FG001|NOT COMPLETED|Overall Study||7
10788603|NCT03502915|11948859|FG000|STARTED|Overall Study||24
10788604|NCT03502915|11948860|FG001|STARTED|Overall Study||24
10788605|NCT03502915|11948859|FG000|COMPLETED|Overall Study||24
10788606|NCT03502915|11948860|FG001|COMPLETED|Overall Study||24
10788607|NCT03502915|11948859|FG000|NOT COMPLETED|Overall Study||0
10788608|NCT03502915|11948860|FG001|NOT COMPLETED|Overall Study||0
10788609|NCT03502941|11948869|FG000|STARTED|Overall Study||3
10788610|NCT03502941|11948870|FG001|STARTED|Overall Study||5
10788611|NCT03502941|11948871|FG002|STARTED|Overall Study||8
10788612|NCT03502941|11948869|FG000|COMPLETED|Overall Study||3
10788613|NCT03502941|11948870|FG001|COMPLETED|Overall Study||5
10788614|NCT03502941|11948871|FG002|COMPLETED|Overall Study||8
10788615|NCT03502941|11948869|FG000|NOT COMPLETED|Overall Study||0
10788616|NCT03502941|11948870|FG001|NOT COMPLETED|Overall Study||0
10788617|NCT03502941|11948871|FG002|NOT COMPLETED|Overall Study||0
10788618|NCT03503162|11948879|FG000|STARTED|Overall Study||95
10788619|NCT03503162|11948879|FG000|COMPLETED|Overall Study||94
10788620|NCT03503162|11948879|FG000|NOT COMPLETED|Overall Study||1
10788621|NCT03503188|11948885|FG000|STARTED|Overall Study||128
10788622|NCT03503188|11948886|FG001|STARTED|Overall Study||146
10788623|NCT03503188|11948885|FG000|Entered in the Entire Study|Overall Study||128
10788624|NCT03503188|11948886|FG001|Entered in the Entire Study|Overall Study||145
10788625|NCT03503188|11948885|FG000|Main Study|Overall Study||99
10788626|NCT03503188|11948886|FG001|Main Study|Overall Study||101
10788627|NCT03503188|11948885|FG000|Sub-study|Overall Study||29
10788628|NCT03503188|11948886|FG001|Sub-study|Overall Study||44
10788629|NCT03503188|11948885|FG000|COMPLETED|Overall Study||128
10788630|NCT03503188|11948886|FG001|COMPLETED|Overall Study||145
10788631|NCT03503188|11948885|FG000|NOT COMPLETED|Overall Study||0
10788632|NCT03503188|11948886|FG001|NOT COMPLETED|Overall Study||1
10788633|NCT03503292|11948894|FG000|STARTED|Overall Study||2
10788634|NCT03503292|11948895|FG001|STARTED|Overall Study||90
10436272|NCT00903383|11582410|FG001|STARTED|Overall Study||54
10436273|NCT00903383|11582411|FG002|STARTED|Overall Study||50
10436274|NCT00903383|11582412|FG003|STARTED|Overall Study||49
10436275|NCT00903383|11582409|FG000|COMPLETED|Overall Study||48
10436276|NCT00903383|11582410|FG001|COMPLETED|Overall Study||48
10788635|NCT03503292|11948894|FG000|COMPLETED|Overall Study||2
10788636|NCT03503292|11948895|FG001|COMPLETED|Overall Study||90
10788637|NCT03503292|11948894|FG000|NOT COMPLETED|Overall Study||0
10788638|NCT03503292|11948895|FG001|NOT COMPLETED|Overall Study||0
10788639|NCT03503565|11948903|FG000|STARTED|Overall Study||59
10788640|NCT03503565|11948904|FG001|STARTED|Overall Study||58
10788641|NCT03503565|11948903|FG000|COMPLETED|Overall Study||59
10788642|NCT03503565|11948904|FG001|COMPLETED|Overall Study||58
10788643|NCT03503565|11948903|FG000|NOT COMPLETED|Overall Study||0
10788644|NCT03503565|11948904|FG001|NOT COMPLETED|Overall Study||0
10788645|NCT03503578|11948910|FG000|STARTED|Overall Study||12
10788646|NCT03503578|11948910|FG000|COMPLETED|Overall Study||12
10788647|NCT03503578|11948910|FG000|NOT COMPLETED|Overall Study||0
10788648|NCT03504189|11948914|FG000|STARTED|Overall Study||151
10788649|NCT03504189|11948914|FG000|COMPLETED|Overall Study||147
10788650|NCT03504189|11948914|FG000|NOT COMPLETED|Overall Study||4
10788651|NCT03504839|11948923|FG000|STARTED|Overall Study||53
10788652|NCT03504839|11948923|FG000|COMPLETED|Overall Study||49
10788653|NCT03504839|11948923|FG000|NOT COMPLETED|Overall Study||4
10436277|NCT00903383|11582411|FG002|COMPLETED|Overall Study||47
10436278|NCT00903383|11582412|FG003|COMPLETED|Overall Study||44
10436279|NCT00903383|11582409|FG000|NOT COMPLETED|Overall Study||7
10436280|NCT00903383|11582410|FG001|NOT COMPLETED|Overall Study||6
10436281|NCT00903383|11582411|FG002|NOT COMPLETED|Overall Study||3
10436282|NCT00903383|11582412|FG003|NOT COMPLETED|Overall Study||5
10436283|NCT00903409|11582424|FG000|STARTED|Overall Study||88
10436284|NCT00903409|11582425|FG001|STARTED|Overall Study||100
10436285|NCT00903409|11582424|FG000|COMPLETED|Overall Study||62
10436286|NCT00903409|11582425|FG001|COMPLETED|Overall Study||73
10436287|NCT00903409|11582424|FG000|NOT COMPLETED|Overall Study||26
10436288|NCT00903409|11582425|FG001|NOT COMPLETED|Overall Study||27
10436289|NCT00903448|11582433|FG000|STARTED|Period 1: 5 Days Then 10 Day Washout||20
10436290|NCT00903448|11582434|FG001|STARTED|Period 1: 5 Days Then 10 Day Washout||20
10436291|NCT00903448|11582433|FG000|COMPLETED|Period 1: 5 Days Then 10 Day Washout||20
10436292|NCT00903448|11582434|FG001|COMPLETED|Period 1: 5 Days Then 10 Day Washout||20
10436293|NCT00903448|11582433|FG000|NOT COMPLETED|Period 1: 5 Days Then 10 Day Washout||0
10436294|NCT00903448|11582434|FG001|NOT COMPLETED|Period 1: 5 Days Then 10 Day Washout||0
10436295|NCT00903448|11582433|FG000|STARTED|Period 2: 5 Days Then 10 Day Washout||20
10436296|NCT00903448|11582434|FG001|STARTED|Period 2: 5 Days Then 10 Day Washout||20
10436297|NCT00903448|11582433|FG000|COMPLETED|Period 2: 5 Days Then 10 Day Washout||20
10436298|NCT00903448|11582434|FG001|COMPLETED|Period 2: 5 Days Then 10 Day Washout||20
10436299|NCT00903448|11582433|FG000|NOT COMPLETED|Period 2: 5 Days Then 10 Day Washout||0
10436300|NCT00903448|11582434|FG001|NOT COMPLETED|Period 2: 5 Days Then 10 Day Washout||0
10436301|NCT00903448|11582433|FG000|STARTED|Period 3: 5 Days||20
10436302|NCT00903448|11582434|FG001|STARTED|Period 3: 5 Days||20
10436303|NCT00903448|11582433|FG000|COMPLETED|Period 3: 5 Days||20
10436304|NCT00903448|11582434|FG001|COMPLETED|Period 3: 5 Days||20
10436305|NCT00903448|11582433|FG000|NOT COMPLETED|Period 3: 5 Days||0
10436306|NCT00903448|11582434|FG001|NOT COMPLETED|Period 3: 5 Days||0
10436307|NCT00903617|11582444|FG000|STARTED|Overall Study||19
10436308|NCT00903617|11582445|FG001|STARTED|Overall Study||20
10436309|NCT00903617|11582446|FG002|STARTED|Overall Study||20
10436310|NCT00903617|11582447|FG003|STARTED|Overall Study||21
10436311|NCT00903617|11582444|FG000|COMPLETED|Overall Study||16
10436312|NCT00903617|11582445|FG001|COMPLETED|Overall Study||15
10436313|NCT00903617|11582446|FG002|COMPLETED|Overall Study||15
10436314|NCT00903617|11582447|FG003|COMPLETED|Overall Study||20
10436315|NCT00903617|11582444|FG000|NOT COMPLETED|Overall Study||3
10436316|NCT00903617|11582445|FG001|NOT COMPLETED|Overall Study||5
10436317|NCT00903617|11582446|FG002|NOT COMPLETED|Overall Study||5
10436318|NCT00903617|11582447|FG003|NOT COMPLETED|Overall Study||1
10436319|NCT00903630|11582461|FG000|STARTED|Phase l||6
10436320|NCT00903630|11582462|FG001|STARTED|Phase l||5
10436321|NCT00903630|11582463|FG002|STARTED|Phase l||0
10436322|NCT00903630|11582461|FG000|COMPLETED|Phase l||6
10436323|NCT00903630|11582462|FG001|COMPLETED|Phase l||5
10436324|NCT00903630|11582463|FG002|COMPLETED|Phase l||0
10436325|NCT00903630|11582461|FG000|NOT COMPLETED|Phase l||0
10788654|NCT03504852|11948930|FG000|STARTED|Overall Study||165
10788655|NCT03504852|11948931|FG001|STARTED|Overall Study||135
10788656|NCT03504852|11948932|FG002|STARTED|Overall Study||31
10788657|NCT03504852|11948930|FG000|COMPLETED|Overall Study||148
10788658|NCT03504852|11948931|FG001|COMPLETED|Overall Study||117
10788659|NCT03504852|11948932|FG002|COMPLETED|Overall Study||28
10788660|NCT03504852|11948930|FG000|NOT COMPLETED|Overall Study||17
10788661|NCT03504852|11948931|FG001|NOT COMPLETED|Overall Study||18
10788662|NCT03504852|11948932|FG002|NOT COMPLETED|Overall Study||3
10788663|NCT03504917|11948944|FG000|STARTED|Blinded Treatment Period||163
10788664|NCT03504917|11948945|FG001|STARTED|Blinded Treatment Period||158
10788665|NCT03504917|11948944|FG000|COMPLETED|Blinded Treatment Period||103
10788666|NCT03504917|11948945|FG001|COMPLETED|Blinded Treatment Period||102
10788667|NCT03504917|11948944|FG000|NOT COMPLETED|Blinded Treatment Period||60
10788668|NCT03504917|11948945|FG001|NOT COMPLETED|Blinded Treatment Period||56
10788669|NCT03504917|11948944|FG000|STARTED|Open Label Extension Treatment Period||100
10788670|NCT03504917|11948945|FG001|STARTED|Open Label Extension Treatment Period||97
10788671|NCT03504917|11948944|FG000|COMPLETED|Open Label Extension Treatment Period||0
10788672|NCT03504917|11948945|FG001|COMPLETED|Open Label Extension Treatment Period||0
10788673|NCT03504917|11948944|FG000|NOT COMPLETED|Open Label Extension Treatment Period||100
10788674|NCT03504917|11948945|FG001|NOT COMPLETED|Open Label Extension Treatment Period||97
10788675|NCT03505190|11948962|FG000|STARTED|Overall Study||9
10436326|NCT00903630|11582462|FG001|NOT COMPLETED|Phase l||0
10436327|NCT00903630|11582463|FG002|NOT COMPLETED|Phase l||0
10436328|NCT00903630|11582461|FG000|STARTED|Phase 2||6
10436329|NCT00903630|11582462|FG001|STARTED|Phase 2||0
10436330|NCT00903630|11582463|FG002|STARTED|Phase 2||4
10436331|NCT00903630|11582461|FG000|COMPLETED|Phase 2||6
10788676|NCT03505190|11948963|FG001|STARTED|Overall Study||8
10788677|NCT03505190|11948964|FG002|STARTED|Overall Study||8
10436332|NCT00903630|11582462|FG001|COMPLETED|Phase 2||0
10436333|NCT00903630|11582463|FG002|COMPLETED|Phase 2|One participant was removed from the study after 2 weeks of treatment due to skin toxicity.|3
10436334|NCT00903630|11582461|FG000|NOT COMPLETED|Phase 2||0
10436335|NCT00903630|11582462|FG001|NOT COMPLETED|Phase 2||0
10788678|NCT03505190|11948965|FG003|STARTED|Overall Study||8
10788679|NCT03505190|11948966|FG004|STARTED|Overall Study||8
10788680|NCT03505190|11948962|FG000|COMPLETED|Overall Study||9
10788681|NCT03505190|11948963|FG001|COMPLETED|Overall Study||8
10788682|NCT03505190|11948964|FG002|COMPLETED|Overall Study||8
10436336|NCT00903630|11582463|FG002|NOT COMPLETED|Phase 2||1
10436337|NCT00903682|11582475|FG000|STARTED|Overall Study||79
10436338|NCT00903682|11582476|FG001|STARTED|Overall Study||78
10788683|NCT03505190|11948965|FG003|COMPLETED|Overall Study||8
10788684|NCT03505190|11948966|FG004|COMPLETED|Overall Study||8
10788685|NCT03505190|11948962|FG000|NOT COMPLETED|Overall Study||0
10788686|NCT03505190|11948963|FG001|NOT COMPLETED|Overall Study||0
10788687|NCT03505190|11948964|FG002|NOT COMPLETED|Overall Study||0
10788688|NCT03505190|11948965|FG003|NOT COMPLETED|Overall Study||0
10788689|NCT03505190|11948966|FG004|NOT COMPLETED|Overall Study||0
10788690|NCT03505593|11948978|FG000|STARTED|Overall Study||48
10788691|NCT03505593|11948978|FG000|COMPLETED|Overall Study||43
10788692|NCT03505593|11948978|FG000|NOT COMPLETED|Overall Study||5
10788693|NCT03506295|11948982|FG000|STARTED|Overall Study||10
10788694|NCT03506295|11948982|FG000|COMPLETED|Overall Study||10
10788695|NCT03506295|11948982|FG000|NOT COMPLETED|Overall Study||0
10788696|NCT03506347|11948990|FG000|STARTED|Overall Study||12
10788697|NCT03506347|11948991|FG001|STARTED|Overall Study||12
10788698|NCT03506347|11948990|FG000|COMPLETED|Overall Study||12
10788699|NCT03506347|11948991|FG001|COMPLETED|Overall Study||12
10788700|NCT03506347|11948990|FG000|NOT COMPLETED|Overall Study||0
10788701|NCT03506347|11948991|FG001|NOT COMPLETED|Overall Study||0
10788702|NCT03506386|11948997|FG000|STARTED|Overall Study||943
10788703|NCT03506386|11948997|FG000|COMPLETED|Overall Study||943
10788704|NCT03506386|11948997|FG000|NOT COMPLETED|Overall Study||0
10788705|NCT03506425|11949004|FG000|STARTED|Overall Study||5
10788706|NCT03506425|11949005|FG001|STARTED|Overall Study||5
10788707|NCT03506425|11949006|FG002|STARTED|Overall Study||5
10788708|NCT03506425|11949004|FG000|COMPLETED|Overall Study||3
10788709|NCT03506425|11949005|FG001|COMPLETED|Overall Study||2
10788710|NCT03506425|11949006|FG002|COMPLETED|Overall Study||4
10788711|NCT03506425|11949004|FG000|NOT COMPLETED|Overall Study||2
10788712|NCT03506425|11949005|FG001|NOT COMPLETED|Overall Study||3
10788713|NCT03506425|11949006|FG002|NOT COMPLETED|Overall Study||1
10788714|NCT03506477|11949017|FG000|STARTED|Overall Study||20
10788715|NCT03506477|11949018|FG001|STARTED|Overall Study||5
10788716|NCT03506477|11949017|FG000|COMPLETED|Overall Study||19
10788717|NCT03506477|11949018|FG001|COMPLETED|Overall Study||5
10788718|NCT03506477|11949017|FG000|NOT COMPLETED|Overall Study||1
10788719|NCT03506477|11949018|FG001|NOT COMPLETED|Overall Study||0
10788720|NCT03506724|11949026|FG000|STARTED|Overall Study||54
10788721|NCT03506724|11949027|FG001|STARTED|Overall Study||55
10788722|NCT03506724|11949026|FG000|COMPLETED|Overall Study||54
10788723|NCT03506724|11949027|FG001|COMPLETED|Overall Study||55
10788724|NCT03506724|11949026|FG000|NOT COMPLETED|Overall Study||0
10788725|NCT03506724|11949027|FG001|NOT COMPLETED|Overall Study||0
10788726|NCT03507036|11949033|FG000|STARTED|Overall Study||20
10788727|NCT03507036|11949033|FG000|COMPLETED|Overall Study||15
10788728|NCT03507036|11949033|FG000|NOT COMPLETED|Overall Study||5
10788729|NCT03507569|11949044|FG000|STARTED|Overall Study||2
10788730|NCT03507569|11949045|FG001|STARTED|Overall Study||1
10788731|NCT03507569|11949046|FG002|STARTED|Overall Study||2
10788732|NCT03507569|11949047|FG003|STARTED|Overall Study||1
10788733|NCT03507569|11949044|FG000|COMPLETED|Overall Study||2
10788734|NCT03507569|11949045|FG001|COMPLETED|Overall Study||1
10788735|NCT03507569|11949046|FG002|COMPLETED|Overall Study||2
10788736|NCT03507569|11949047|FG003|COMPLETED|Overall Study||1
10788737|NCT03507569|11949044|FG000|NOT COMPLETED|Overall Study||0
10788738|NCT03507569|11949045|FG001|NOT COMPLETED|Overall Study||0
10788739|NCT03507569|11949046|FG002|NOT COMPLETED|Overall Study||0
10788740|NCT03507569|11949047|FG003|NOT COMPLETED|Overall Study||0
10788741|NCT03508050|11949059|FG000|STARTED|Overall Study||20
10788742|NCT03508050|11949060|FG001|STARTED|Overall Study||17
10788743|NCT03508050|11949059|FG000|COMPLETED|Overall Study||15
10788744|NCT03508050|11949060|FG001|COMPLETED|Overall Study||15
10788745|NCT03508050|11949059|FG000|NOT COMPLETED|Overall Study||5
10436339|NCT00903682|11582475|FG000|COMPLETED|Overall Study||63
10436340|NCT00903682|11582476|FG001|COMPLETED|Overall Study||63
10436341|NCT00903682|11582475|FG000|NOT COMPLETED|Overall Study||16
10436342|NCT00903682|11582476|FG001|NOT COMPLETED|Overall Study||15
10436343|NCT00903695|11582484|FG000|STARTED|Overall Study||8
10788746|NCT03508050|11949060|FG001|NOT COMPLETED|Overall Study||2
10788747|NCT03508609|11949067|FG000|STARTED|Overall Study||20
10788748|NCT03508609|11949067|FG000|COMPLETED|Overall Study||19
10788749|NCT03508609|11949067|FG000|NOT COMPLETED|Overall Study||1
10788750|NCT03508661|11949071|FG000|STARTED|Overall Study||10
10788751|NCT03508661|11949071|FG000|COMPLETED|Overall Study||10
10788752|NCT03508661|11949071|FG000|NOT COMPLETED|Overall Study||0
10788753|NCT03508687|11949077|FG000|STARTED|Overall Study||2
10788754|NCT03508687|11949078|FG001|STARTED|Overall Study||3
10788755|NCT03508687|11949077|FG000|COMPLETED|Overall Study||2
10788756|NCT03508687|11949078|FG001|COMPLETED|Overall Study||3
10788757|NCT03508687|11949077|FG000|NOT COMPLETED|Overall Study||0
10788758|NCT03508687|11949078|FG001|NOT COMPLETED|Overall Study||0
10788759|NCT03508830|11949088|FG000|STARTED|Overall Study||46
10788760|NCT03508830|11949089|FG001|STARTED|Overall Study||45
10788761|NCT03508830|11949088|FG000|COMPLETED|Overall Study||41
10788762|NCT03508830|11949089|FG001|COMPLETED|Overall Study||39
10788763|NCT03508830|11949088|FG000|NOT COMPLETED|Overall Study||5
10788764|NCT03508830|11949089|FG001|NOT COMPLETED|Overall Study||6
10788765|NCT03508843|11949095|FG000|STARTED|Overall Study||150
10788766|NCT03508843|11949095|FG000|COMPLETED|Overall Study||147
10788767|NCT03508843|11949095|FG000|NOT COMPLETED|Overall Study||3
10788768|NCT03509350|11949101|FG000|STARTED|Overall Study||252
10436344|NCT00903695|11582485|FG001|STARTED|Overall Study||2
10436345|NCT00903695|11582484|FG000|COMPLETED|Overall Study||6
10436346|NCT00903695|11582485|FG001|COMPLETED|Overall Study||2
10436347|NCT00903695|11582484|FG000|NOT COMPLETED|Overall Study||2
10788769|NCT03509350|11949102|FG001|STARTED|Overall Study||249
10788770|NCT03509350|11949101|FG000|COMPLETED|Overall Study||252
10788771|NCT03509350|11949102|FG001|COMPLETED|Overall Study||247
10788772|NCT03509350|11949101|FG000|NOT COMPLETED|Overall Study||0
10788773|NCT03509350|11949102|FG001|NOT COMPLETED|Overall Study||2
10788774|NCT03509675|11949110|FG000|STARTED|First Intervention (7 Days)||11
10788775|NCT03509675|11949111|FG001|STARTED|First Intervention (7 Days)||12
10788776|NCT03509675|11949110|FG000|COMPLETED|First Intervention (7 Days)||6
10788777|NCT03509675|11949111|FG001|COMPLETED|First Intervention (7 Days)||8
10788778|NCT03509675|11949110|FG000|NOT COMPLETED|First Intervention (7 Days)||5
10788779|NCT03509675|11949111|FG001|NOT COMPLETED|First Intervention (7 Days)||4
10788780|NCT03509675|11949110|FG000|STARTED|Washout Period (7 Days)||6
10788781|NCT03509675|11949111|FG001|STARTED|Washout Period (7 Days)||8
10788782|NCT03509675|11949110|FG000|COMPLETED|Washout Period (7 Days)||6
10788783|NCT03509675|11949111|FG001|COMPLETED|Washout Period (7 Days)||8
10788784|NCT03509675|11949110|FG000|NOT COMPLETED|Washout Period (7 Days)||0
10788785|NCT03509675|11949111|FG001|NOT COMPLETED|Washout Period (7 Days)||0
10788786|NCT03509675|11949110|FG000|STARTED|Second Intervention )7 Days)||6
10788787|NCT03509675|11949111|FG001|STARTED|Second Intervention )7 Days)||8
10788788|NCT03509675|11949110|FG000|COMPLETED|Second Intervention )7 Days)||4
10788789|NCT03509675|11949111|FG001|COMPLETED|Second Intervention )7 Days)||8
10788790|NCT03509675|11949110|FG000|NOT COMPLETED|Second Intervention )7 Days)||2
10788791|NCT03509675|11949111|FG001|NOT COMPLETED|Second Intervention )7 Days)||0
10788792|NCT03509766|11949117|FG000|STARTED|Overall Study||24
10788793|NCT03509766|11949117|FG000|COMPLETED|Overall Study||24
10788794|NCT03509766|11949117|FG000|NOT COMPLETED|Overall Study||0
10788795|NCT03509883|11949124|FG000|STARTED|Initial Treatment||15
10788796|NCT03509883|11949125|FG001|STARTED|Initial Treatment||15
10788797|NCT03509883|11949124|FG000|COMPLETED|Initial Treatment||15
10788798|NCT03509883|11949125|FG001|COMPLETED|Initial Treatment||15
10788799|NCT03509883|11949124|FG000|NOT COMPLETED|Initial Treatment||0
10788800|NCT03509883|11949125|FG001|NOT COMPLETED|Initial Treatment||0
10788801|NCT03509883|11949124|FG000|STARTED|Initial Treatment Washout||15
10788802|NCT03509883|11949125|FG001|STARTED|Initial Treatment Washout||15
10788803|NCT03509883|11949124|FG000|COMPLETED|Initial Treatment Washout||15
10788804|NCT03509883|11949125|FG001|COMPLETED|Initial Treatment Washout||15
10788805|NCT03509883|11949124|FG000|NOT COMPLETED|Initial Treatment Washout||0
10788806|NCT03509883|11949125|FG001|NOT COMPLETED|Initial Treatment Washout||0
10788807|NCT03509883|11949124|FG000|STARTED|Cross-over and Treatment||15
10788808|NCT03509883|11949125|FG001|STARTED|Cross-over and Treatment||15
10788809|NCT03509883|11949124|FG000|COMPLETED|Cross-over and Treatment||15
10788810|NCT03509883|11949125|FG001|COMPLETED|Cross-over and Treatment||15
10788811|NCT03509883|11949124|FG000|NOT COMPLETED|Cross-over and Treatment||0
10788812|NCT03509883|11949125|FG001|NOT COMPLETED|Cross-over and Treatment||0
10788813|NCT03509948|11949132|FG000|STARTED|Overall Study||6
10788814|NCT03509948|11949133|FG001|STARTED|Overall Study||7
10788815|NCT03509948|11949132|FG000|COMPLETED|Overall Study||6
10788816|NCT03509948|11949133|FG001|COMPLETED|Overall Study||6
10788817|NCT03509948|11949132|FG000|NOT COMPLETED|Overall Study||0
10788818|NCT03509948|11949133|FG001|NOT COMPLETED|Overall Study||1
10788819|NCT03509974|11949139|FG000|STARTED|Overall Study||14
10788820|NCT03509974|11949139|FG000|COMPLETED|Overall Study||14
10788821|NCT03509974|11949139|FG000|NOT COMPLETED|Overall Study||0
10788822|NCT03510182|11949143|FG000|STARTED|Overall Study||25
10788823|NCT03510182|11949143|FG000|COMPLETED|Overall Study||23
10788824|NCT03510182|11949143|FG000|NOT COMPLETED|Overall Study||2
10788825|NCT03510195|11949147|FG000|STARTED|Overall Study||267
10788826|NCT03510195|11949147|FG000|COMPLETED|Overall Study||101
10788827|NCT03510195|11949147|FG000|NOT COMPLETED|Overall Study||166
10788828|NCT03510273|11949161|FG000|STARTED|Overall Study||319
10788829|NCT03510273|11949161|FG000|Treated With Thermal Coagulation|Overall Study||319
10788830|NCT03510273|11949161|FG000|Completed 1-mth Follow-up Visit & Exited|Overall Study||192
10788831|NCT03510273|11949161|FG000|Completed 1-mth Follow-up Visit & Cont'd|Overall Study||126
10788832|NCT03510273|11949161|FG000|Completed All One-year Follow up Visits|Overall Study||118
10788833|NCT03510273|11949161|FG000|COMPLETED|Overall Study||310
10436348|NCT00903695|11582485|FG001|NOT COMPLETED|Overall Study||0
10788834|NCT03510273|11949161|FG000|NOT COMPLETED|Overall Study||9
10788835|NCT03510455|11949169|FG000|STARTED|Overall Study||4
10788836|NCT03510455|11949169|FG000|Treated|Overall Study||4
10788837|NCT03510455|11949169|FG000|Extension Phase|Overall Study||1
10788838|NCT03510455|11949169|FG000|Screening Failures|Overall Study||0
10788839|NCT03510455|11949169|FG000|COMPLETED|Overall Study|3 of 4 patients completed the 24 week treatment phase of the study|3
10788840|NCT03510455|11949169|FG000|NOT COMPLETED|Overall Study||1
10788841|NCT03510481|11949179|FG000|STARTED|Year 1||69
10788842|NCT03510481|11949180|FG001|STARTED|Year 1||70
10788843|NCT03510481|11949181|FG002|STARTED|Year 1||36
10788844|NCT03510481|11949182|FG003|STARTED|Year 1||35
10788845|NCT03510481|11949179|FG000|COMPLETED|Year 1||56
10788846|NCT03510481|11949180|FG001|COMPLETED|Year 1||61
10788847|NCT03510481|11949181|FG002|COMPLETED|Year 1||34
10788848|NCT03510481|11949182|FG003|COMPLETED|Year 1||31
10788849|NCT03510481|11949179|FG000|NOT COMPLETED|Year 1||13
10788850|NCT03510481|11949180|FG001|NOT COMPLETED|Year 1||9
10788851|NCT03510481|11949181|FG002|NOT COMPLETED|Year 1||2
10436349|NCT00903760|11582495|FG000|STARTED|Overall Study||19
10436350|NCT00903760|11582496|FG001|STARTED|Overall Study||18
10436351|NCT00903760|11582495|FG000|COMPLETED|Overall Study|Completed all 24 courses|0
10436352|NCT00903760|11582496|FG001|COMPLETED|Overall Study|Completed all 24 courses|2
10436353|NCT00903760|11582495|FG000|NOT COMPLETED|Overall Study||19
10436354|NCT00903760|11582496|FG001|NOT COMPLETED|Overall Study||16
10436355|NCT00903786|11582502|FG000|STARTED|Overall Study||21
10436356|NCT00903786|11582502|FG000|COMPLETED|Overall Study||6
10436357|NCT00903786|11582502|FG000|NOT COMPLETED|Overall Study||15
10436358|NCT00903877|11582507|FG000|STARTED|Overall Study||51
10436359|NCT00903877|11582507|FG000|COMPLETED|Overall Study||8
10436360|NCT00903877|11582507|FG000|NOT COMPLETED|Overall Study||43
10436361|NCT00903929|11582511|FG000|STARTED|Overall Study||3
10436362|NCT00903929|11582512|FG001|STARTED|Overall Study||3
10436363|NCT00903929|11582513|FG002|STARTED|Overall Study|Participants who did not complete the study were replaced with additional participants.|4
10436364|NCT00903929|11582514|FG003|STARTED|Overall Study|Participants who did not complete the study were replaced with additional participants.|9
10436365|NCT00903929|11582511|FG000|COMPLETED|Overall Study||3
10436366|NCT00903929|11582512|FG001|COMPLETED|Overall Study||3
10436367|NCT00903929|11582513|FG002|COMPLETED|Overall Study||3
10436368|NCT00903929|11582514|FG003|COMPLETED|Overall Study||6
10436369|NCT00903929|11582511|FG000|NOT COMPLETED|Overall Study||0
10436370|NCT00903929|11582512|FG001|NOT COMPLETED|Overall Study||0
10436371|NCT00903929|11582513|FG002|NOT COMPLETED|Overall Study||1
10436372|NCT00903929|11582514|FG003|NOT COMPLETED|Overall Study||3
10436373|NCT00903968|11582521|FG000|STARTED|Overall Study||3
10436374|NCT00903968|11582522|FG001|STARTED|Overall Study||3
10436375|NCT00903968|11582523|FG002|STARTED|Overall Study||3
10436376|NCT00903968|11582524|FG003|STARTED|Overall Study||3
10436377|NCT00903968|11582525|FG004|STARTED|Overall Study||4
10436378|NCT00903968|11582526|FG005|STARTED|Overall Study||6
10436379|NCT00903968|11582527|FG006|STARTED|Overall Study||3
10436380|NCT00903968|11582528|FG007|STARTED|Overall Study||33
10436381|NCT00903968|11582521|FG000|COMPLETED|Overall Study||0
10436382|NCT00903968|11582522|FG001|COMPLETED|Overall Study||0
10436383|NCT00903968|11582523|FG002|COMPLETED|Overall Study||0
10436384|NCT00903968|11582524|FG003|COMPLETED|Overall Study||0
10436385|NCT00903968|11582525|FG004|COMPLETED|Overall Study||0
10436386|NCT00903968|11582526|FG005|COMPLETED|Overall Study||0
10436387|NCT00903968|11582527|FG006|COMPLETED|Overall Study||0
10436388|NCT00903968|11582528|FG007|COMPLETED|Overall Study||0
10788852|NCT03510481|11949182|FG003|NOT COMPLETED|Year 1||4
10788853|NCT03510481|11949179|FG000|STARTED|Year 2 - Booster Dose|10 participants who completed Period 1 did not re-consent for Period 2.|46
10788854|NCT03510481|11949180|FG001|STARTED|Year 2 - Booster Dose|9 participants who completed Period 1 did not re-consent for Period 2.|52
10788855|NCT03510481|11949181|FG002|STARTED|Year 2 - Booster Dose|9 participants who completed Period 1 did not re-consent for Period 2.|25
10788856|NCT03510481|11949182|FG003|STARTED|Year 2 - Booster Dose|12 participants who completed Period 1 did not re-consent for Period 2.|19
10788857|NCT03510481|11949179|FG000|COMPLETED|Year 2 - Booster Dose||42
10788858|NCT03510481|11949180|FG001|COMPLETED|Year 2 - Booster Dose||49
10788859|NCT03510481|11949181|FG002|COMPLETED|Year 2 - Booster Dose||23
10788860|NCT03510481|11949182|FG003|COMPLETED|Year 2 - Booster Dose||18
10788861|NCT03510481|11949179|FG000|NOT COMPLETED|Year 2 - Booster Dose||4
10788862|NCT03510481|11949180|FG001|NOT COMPLETED|Year 2 - Booster Dose||3
10788863|NCT03510481|11949181|FG002|NOT COMPLETED|Year 2 - Booster Dose||2
10788864|NCT03510481|11949182|FG003|NOT COMPLETED|Year 2 - Booster Dose||1
10788865|NCT03510663|11949202|FG000|STARTED|Overall Study||6
10788866|NCT03510663|11949203|FG001|STARTED|Overall Study||6
10788867|NCT03510663|11949204|FG002|STARTED|Overall Study||6
10788868|NCT03510663|11949205|FG003|STARTED|Overall Study||6
10788869|NCT03510663|11949206|FG004|STARTED|Overall Study||6
10788870|NCT03510663|11949207|FG005|STARTED|Overall Study||6
10788871|NCT03510663|11949208|FG006|STARTED|Overall Study||6
10788872|NCT03510663|11949209|FG007|STARTED|Overall Study||6
10788873|NCT03510663|11949202|FG000|COMPLETED|Overall Study||6
10788874|NCT03510663|11949203|FG001|COMPLETED|Overall Study||5
10788875|NCT03510663|11949204|FG002|COMPLETED|Overall Study||6
10788876|NCT03510663|11949205|FG003|COMPLETED|Overall Study||6
10788877|NCT03510663|11949206|FG004|COMPLETED|Overall Study||6
10788878|NCT03510663|11949207|FG005|COMPLETED|Overall Study||6
10788879|NCT03510663|11949208|FG006|COMPLETED|Overall Study||6
10788880|NCT03510663|11949209|FG007|COMPLETED|Overall Study||6
10788881|NCT03510663|11949202|FG000|NOT COMPLETED|Overall Study||0
10788882|NCT03510663|11949203|FG001|NOT COMPLETED|Overall Study||1
10788883|NCT03510663|11949204|FG002|NOT COMPLETED|Overall Study||0
10436389|NCT00903968|11582521|FG000|NOT COMPLETED|Overall Study||3
10436390|NCT00903968|11582522|FG001|NOT COMPLETED|Overall Study||3
10436391|NCT00903968|11582523|FG002|NOT COMPLETED|Overall Study||3
10436392|NCT00903968|11582524|FG003|NOT COMPLETED|Overall Study||3
10436393|NCT00903968|11582525|FG004|NOT COMPLETED|Overall Study||4
10436394|NCT00903968|11582526|FG005|NOT COMPLETED|Overall Study||6
10436395|NCT00903968|11582527|FG006|NOT COMPLETED|Overall Study||3
10436396|NCT00903968|11582528|FG007|NOT COMPLETED|Overall Study||33
10436397|NCT00904007|11582551|FG000|STARTED|Overall Study||55
10436398|NCT00904007|11582552|FG001|STARTED|Overall Study||56
10788884|NCT03510663|11949205|FG003|NOT COMPLETED|Overall Study||0
10788885|NCT03510663|11949206|FG004|NOT COMPLETED|Overall Study||0
10788886|NCT03510663|11949207|FG005|NOT COMPLETED|Overall Study||0
10788887|NCT03510663|11949208|FG006|NOT COMPLETED|Overall Study||0
10788888|NCT03510663|11949209|FG007|NOT COMPLETED|Overall Study||0
10436399|NCT00904007|11582551|FG000|COMPLETED|Overall Study||55
10436400|NCT00904007|11582552|FG001|COMPLETED|Overall Study||56
10436401|NCT00904007|11582551|FG000|NOT COMPLETED|Overall Study||0
10436402|NCT00904007|11582552|FG001|NOT COMPLETED|Overall Study||0
10436403|NCT00904033|11582564|FG000|STARTED|Overall Study||10
10436404|NCT00904033|11582565|FG001|STARTED|Overall Study||10
10436405|NCT00904033|11582566|FG002|STARTED|Overall Study||10
10436406|NCT00904033|11582567|FG003|STARTED|Overall Study||11
10436407|NCT00904033|11582564|FG000|COMPLETED|Overall Study||9
10788889|NCT03510715|11949221|FG000|STARTED|Overall Study||9
10788890|NCT03510715|11949222|FG001|STARTED|Overall Study||9
10788891|NCT03510715|11949221|FG000|COMPLETED|Overall Study||8
10788892|NCT03510715|11949222|FG001|COMPLETED|Overall Study||9
10788893|NCT03510715|11949221|FG000|NOT COMPLETED|Overall Study||1
10788894|NCT03510715|11949222|FG001|NOT COMPLETED|Overall Study||0
10788895|NCT03510910|11949231|FG000|STARTED|Overall Study||42
10788896|NCT03510910|11949232|FG001|STARTED|Overall Study||43
10788897|NCT03510910|11949231|FG000|COMPLETED|Overall Study||40
10788898|NCT03510910|11949232|FG001|COMPLETED|Overall Study||40
10788899|NCT03510910|11949231|FG000|NOT COMPLETED|Overall Study||2
10788900|NCT03510910|11949232|FG001|NOT COMPLETED|Overall Study||3
10788901|NCT03511001|11949240|FG000|STARTED|Overall Study||126
10788902|NCT03511001|11949241|FG001|STARTED|Overall Study||61
10788903|NCT03511001|11949240|FG000|Completers Analyzed|Overall Study|1 participant was excluded post-randomization due to not meeting race/ethnicity inclusion criteria.|114
10788904|NCT03511001|11949241|FG001|Completers Analyzed|Overall Study||61
10788905|NCT03511001|11949240|FG000|COMPLETED|Overall Study||115
10788906|NCT03511001|11949241|FG001|COMPLETED|Overall Study||54
10788907|NCT03511001|11949240|FG000|NOT COMPLETED|Overall Study||11
10788908|NCT03511001|11949241|FG001|NOT COMPLETED|Overall Study||7
10788909|NCT03511053|11949247|FG000|STARTED|Overall Study||11
10788910|NCT03511053|11949247|FG000|COMPLETED|Overall Study||10
10788911|NCT03511053|11949247|FG000|NOT COMPLETED|Overall Study||1
10788912|NCT03511105|11949253|FG000|STARTED|Overall Study||25
10788913|NCT03511105|11949254|FG001|STARTED|Overall Study||22
10788914|NCT03511105|11949253|FG000|COMPLETED|Overall Study||23
10788915|NCT03511105|11949254|FG001|COMPLETED|Overall Study||22
10788916|NCT03511105|11949253|FG000|NOT COMPLETED|Overall Study||2
10788917|NCT03511105|11949254|FG001|NOT COMPLETED|Overall Study||0
10788918|NCT03511326|11949261|FG000|STARTED|Overall Study||50
10788919|NCT03511326|11949261|FG000|COMPLETED|Overall Study||49
10788920|NCT03511326|11949261|FG000|NOT COMPLETED|Overall Study||1
10788921|NCT03511378|11949267|FG000|STARTED|Overall Study||70
10788922|NCT03511378|11949268|FG001|STARTED|Overall Study||68
10788923|NCT03511378|11949267|FG000|COMPLETED|Overall Study||67
10788924|NCT03511378|11949268|FG001|COMPLETED|Overall Study||66
10788925|NCT03511378|11949267|FG000|NOT COMPLETED|Overall Study||3
10788926|NCT03511378|11949268|FG001|NOT COMPLETED|Overall Study||2
10788927|NCT03511521|11949276|FG000|STARTED|Overall Study||2
10788928|NCT03511521|11949277|FG001|STARTED|Overall Study||1
10788929|NCT03511521|11949276|FG000|COMPLETED|Overall Study||2
10788930|NCT03511521|11949277|FG001|COMPLETED|Overall Study||1
10788931|NCT03511521|11949276|FG000|NOT COMPLETED|Overall Study||0
10788932|NCT03511521|11949277|FG001|NOT COMPLETED|Overall Study||0
10788933|NCT03511638|11949285|FG000|STARTED|Overall Study||184
10788934|NCT03511638|11949286|FG001|STARTED|Overall Study||188
10788935|NCT03511638|11949285|FG000|COMPLETED|Overall Study||182
10788936|NCT03511638|11949286|FG001|COMPLETED|Overall Study||187
10788937|NCT03511638|11949285|FG000|NOT COMPLETED|Overall Study||2
10788938|NCT03511638|11949286|FG001|NOT COMPLETED|Overall Study||1
10788939|NCT03511937|11949294|FG000|STARTED|Overall Study||200
10788940|NCT03511937|11949295|FG001|STARTED|Overall Study||200
10788941|NCT03511937|11949294|FG000|COMPLETED|Overall Study||200
10788942|NCT03511937|11949295|FG001|COMPLETED|Overall Study||200
10788943|NCT03511937|11949294|FG000|NOT COMPLETED|Overall Study||0
10788944|NCT03511937|11949295|FG001|NOT COMPLETED|Overall Study||0
10788945|NCT03512028|11949305|FG000|STARTED|Overall Study||19
10788946|NCT03512028|11949306|FG001|STARTED|Overall Study||15
10788947|NCT03512028|11949305|FG000|COMPLETED|Overall Study||15
10788948|NCT03512028|11949306|FG001|COMPLETED|Overall Study||15
10788949|NCT03512028|11949305|FG000|NOT COMPLETED|Overall Study||4
10788950|NCT03512028|11949306|FG001|NOT COMPLETED|Overall Study||0
10788951|NCT03512041|11949316|FG000|STARTED|Overall Study||10
10788952|NCT03512041|11949317|FG001|STARTED|Overall Study||10
10788953|NCT03512041|11949318|FG002|STARTED|Overall Study||11
10788954|NCT03512041|11949319|FG003|STARTED|Overall Study||9
10788955|NCT03512041|11949316|FG000|COMPLETED|Overall Study||10
10788956|NCT03512041|11949317|FG001|COMPLETED|Overall Study||10
10788957|NCT03512041|11949318|FG002|COMPLETED|Overall Study||11
10788958|NCT03512041|11949319|FG003|COMPLETED|Overall Study||9
10788959|NCT03512041|11949316|FG000|NOT COMPLETED|Overall Study||0
10788960|NCT03512041|11949317|FG001|NOT COMPLETED|Overall Study||0
10436408|NCT00904033|11582565|FG001|COMPLETED|Overall Study||9
10788961|NCT03512041|11949318|FG002|NOT COMPLETED|Overall Study||0
10788962|NCT03512041|11949319|FG003|NOT COMPLETED|Overall Study||0
10788963|NCT03512067|11949329|FG000|STARTED|Overall Study||1
10788964|NCT03512067|11949329|FG000|COMPLETED|Overall Study||1
10436409|NCT00904033|11582566|FG002|COMPLETED|Overall Study||9
10436410|NCT00904033|11582567|FG003|COMPLETED|Overall Study||9
10788965|NCT03512067|11949329|FG000|NOT COMPLETED|Overall Study||0
10788966|NCT03512288|11949335|FG000|STARTED|Overall Study||232
10788967|NCT03512288|11949336|FG001|STARTED|Overall Study||228
10788968|NCT03512288|11949335|FG000|Vaccination 1|Overall Study||231
10436411|NCT00904033|11582564|FG000|NOT COMPLETED|Overall Study||1
10436412|NCT00904033|11582565|FG001|NOT COMPLETED|Overall Study||1
10436413|NCT00904033|11582566|FG002|NOT COMPLETED|Overall Study||1
10436414|NCT00904033|11582567|FG003|NOT COMPLETED|Overall Study||2
10436415|NCT00904150|11582580|FG000|STARTED|Saliva Samples (DNA)||285
10788969|NCT03512288|11949336|FG001|Vaccination 1|Overall Study||227
10788970|NCT03512288|11949335|FG000|Vaccination 2|Overall Study||222
10788971|NCT03512288|11949336|FG001|Vaccination 2|Overall Study||213
10788972|NCT03512288|11949335|FG000|Vaccination 3|Overall Study||210
10788973|NCT03512288|11949336|FG001|Vaccination 3|Overall Study||206
10788974|NCT03512288|11949335|FG000|Vaccination 4|Overall Study||197
10788975|NCT03512288|11949336|FG001|Vaccination 4|Overall Study||194
10788976|NCT03512288|11949335|FG000|COMPLETED|Overall Study||191
10788977|NCT03512288|11949336|FG001|COMPLETED|Overall Study||185
10788978|NCT03512288|11949335|FG000|NOT COMPLETED|Overall Study||41
10788979|NCT03512288|11949336|FG001|NOT COMPLETED|Overall Study||43
10788980|NCT03512353|11949342|FG000|STARTED|Overall Study||7
10788981|NCT03512353|11949342|FG000|Received Treatment|Overall Study||6
10788982|NCT03512353|11949342|FG000|COMPLETED|Overall Study||3
10788983|NCT03512353|11949342|FG000|NOT COMPLETED|Overall Study||4
10788984|NCT03512457|11949350|FG000|STARTED|Overall Study||195
10788985|NCT03512457|11949351|FG001|STARTED|Overall Study||225
10788986|NCT03512457|11949350|FG000|COMPLETED|Overall Study||161
10788987|NCT03512457|11949351|FG001|COMPLETED|Overall Study||185
10788988|NCT03512457|11949350|FG000|NOT COMPLETED|Overall Study||34
10788989|NCT03512457|11949351|FG001|NOT COMPLETED|Overall Study||40
10788990|NCT03513588|11949362|FG000|STARTED|Overall Study||16
10788991|NCT03513588|11949363|FG001|STARTED|Overall Study||17
10788992|NCT03513588|11949364|FG002|STARTED|Overall Study||15
10788993|NCT03513588|11949362|FG000|COMPLETED|Overall Study||15
10788994|NCT03513588|11949363|FG001|COMPLETED|Overall Study||15
10788995|NCT03513588|11949364|FG002|COMPLETED|Overall Study||13
10788996|NCT03513588|11949362|FG000|NOT COMPLETED|Overall Study||1
10788997|NCT03513588|11949363|FG001|NOT COMPLETED|Overall Study||2
10788998|NCT03513588|11949364|FG002|NOT COMPLETED|Overall Study||2
10788999|NCT03513757|11949376|FG000|STARTED|Overall Study||22
10789000|NCT03513757|11949377|FG001|STARTED|Overall Study||18
10789001|NCT03513757|11949376|FG000|COMPLETED|Overall Study||22
10789002|NCT03513757|11949377|FG001|COMPLETED|Overall Study||18
10789003|NCT03513757|11949376|FG000|NOT COMPLETED|Overall Study||0
10789004|NCT03513757|11949377|FG001|NOT COMPLETED|Overall Study||0
10789005|NCT03513848|11949388|FG000|STARTED|Overall Study||9
10789006|NCT03513848|11949389|FG001|STARTED|Overall Study||6
10789007|NCT03513848|11949388|FG000|COMPLETED|Overall Study||9
10789008|NCT03513848|11949389|FG001|COMPLETED|Overall Study||6
10789009|NCT03513848|11949388|FG000|NOT COMPLETED|Overall Study||0
10789010|NCT03513848|11949389|FG001|NOT COMPLETED|Overall Study||0
10789011|NCT03514277|11949398|FG000|STARTED|Overall Study||11
10789012|NCT03514277|11949399|FG001|STARTED|Overall Study||4
10789013|NCT03514277|11949400|FG002|STARTED|Overall Study||4
10789014|NCT03514277|11949398|FG000|COMPLETED|Overall Study||11
10789015|NCT03514277|11949399|FG001|COMPLETED|Overall Study||4
10789016|NCT03514277|11949400|FG002|COMPLETED|Overall Study||4
10789017|NCT03514277|11949398|FG000|NOT COMPLETED|Overall Study||0
10789018|NCT03514277|11949399|FG001|NOT COMPLETED|Overall Study||0
10789019|NCT03514277|11949400|FG002|NOT COMPLETED|Overall Study||0
10789020|NCT03514420|11949408|FG000|STARTED|Overall Study||4
10789021|NCT03514420|11949408|FG000|COMPLETED|Overall Study||4
10789022|NCT03514420|11949408|FG000|NOT COMPLETED|Overall Study||0
10789023|NCT03514641|11949416|FG000|STARTED|603A: 0-12 Week Study Period||334
10789024|NCT03514641|11949417|FG001|STARTED|603A: 0-12 Week Study Period||339
10789025|NCT03514641|11949418|FG002|STARTED|603A: 0-12 Week Study Period||0
10789026|NCT03514641|11949419|FG003|STARTED|603A: 0-12 Week Study Period||0
10789027|NCT03514641|11949416|FG000|COMPLETED|603A: 0-12 Week Study Period||307
10789028|NCT03514641|11949417|FG001|COMPLETED|603A: 0-12 Week Study Period||319
10789029|NCT03514641|11949418|FG002|COMPLETED|603A: 0-12 Week Study Period||0
10789030|NCT03514641|11949419|FG003|COMPLETED|603A: 0-12 Week Study Period||0
10789031|NCT03514641|11949416|FG000|NOT COMPLETED|603A: 0-12 Week Study Period||27
10789032|NCT03514641|11949417|FG001|NOT COMPLETED|603A: 0-12 Week Study Period||20
10789033|NCT03514641|11949418|FG002|NOT COMPLETED|603A: 0-12 Week Study Period||0
10789034|NCT03514641|11949419|FG003|NOT COMPLETED|603A: 0-12 Week Study Period||0
10789035|NCT03514641|11949416|FG000|STARTED|603B: 24-36 Week Study Period|The second part of study only applies to subjects in 603B|0
10789036|NCT03514641|11949417|FG001|STARTED|603B: 24-36 Week Study Period|The second part of study only applies to subjects in 603B|0
10789037|NCT03514641|11949418|FG002|STARTED|603B: 24-36 Week Study Period|The subjects were re-randomized in 603B|281
10789038|NCT03514641|11949419|FG003|STARTED|603B: 24-36 Week Study Period|The subjects were re-randomized in 603B|281
10789039|NCT03514641|11949416|FG000|COMPLETED|603B: 24-36 Week Study Period||0
10789040|NCT03514641|11949417|FG001|COMPLETED|603B: 24-36 Week Study Period||0
10436416|NCT00904150|11582581|FG001|STARTED|Saliva Samples (DNA)||300
10436417|NCT00904150|11582580|FG000|COMPLETED|Saliva Samples (DNA)||282
10789041|NCT03514641|11949418|FG002|COMPLETED|603B: 24-36 Week Study Period||267
10789042|NCT03514641|11949419|FG003|COMPLETED|603B: 24-36 Week Study Period||266
10789043|NCT03514641|11949416|FG000|NOT COMPLETED|603B: 24-36 Week Study Period||0
10789044|NCT03514641|11949417|FG001|NOT COMPLETED|603B: 24-36 Week Study Period||0
10789045|NCT03514641|11949418|FG002|NOT COMPLETED|603B: 24-36 Week Study Period||14
10436418|NCT00904150|11582581|FG001|COMPLETED|Saliva Samples (DNA)||155
10436419|NCT00904150|11582580|FG000|NOT COMPLETED|Saliva Samples (DNA)||3
10436420|NCT00904150|11582581|FG001|NOT COMPLETED|Saliva Samples (DNA)||145
10789046|NCT03514641|11949419|FG003|NOT COMPLETED|603B: 24-36 Week Study Period||15
10789047|NCT03514966|11949433|FG000|STARTED|Overall Study||40
10789048|NCT03514966|11949434|FG001|STARTED|Overall Study||43
10789049|NCT03514966|11949433|FG000|COMPLETED|Overall Study||40
10789050|NCT03514966|11949434|FG001|COMPLETED|Overall Study||43
10789051|NCT03514966|11949433|FG000|NOT COMPLETED|Overall Study||0
10789052|NCT03514966|11949434|FG001|NOT COMPLETED|Overall Study||0
10789053|NCT03515681|11949442|FG000|STARTED|Overall Study||70
10789054|NCT03515681|11949443|FG001|STARTED|Overall Study||70
10789055|NCT03515681|11949442|FG000|Randomized|Overall Study||70
10789056|NCT03515681|11949443|FG001|Randomized|Overall Study||70
10789057|NCT03515681|11949442|FG000|Completed at 6 Months|Overall Study||61
10789058|NCT03515681|11949443|FG001|Completed at 6 Months|Overall Study||62
10789059|NCT03515681|11949442|FG000|COMPLETED|Overall Study||37
10789060|NCT03515681|11949443|FG001|COMPLETED|Overall Study||25
10789061|NCT03515681|11949442|FG000|NOT COMPLETED|Overall Study||33
10789062|NCT03515681|11949443|FG001|NOT COMPLETED|Overall Study||45
10789063|NCT03515824|11949452|FG000|STARTED|Overall Study||3
10789064|NCT03515824|11949453|FG001|STARTED|Overall Study||4
10789065|NCT03515824|11949454|FG002|STARTED|Overall Study||15
10789066|NCT03515824|11949455|FG003|STARTED|Overall Study||0
10789067|NCT03515824|11949452|FG000|COMPLETED|Overall Study||0
10789068|NCT03515824|11949453|FG001|COMPLETED|Overall Study||0
10789069|NCT03515824|11949454|FG002|COMPLETED|Overall Study||0
10789070|NCT03515824|11949455|FG003|COMPLETED|Overall Study||0
10789071|NCT03515824|11949452|FG000|NOT COMPLETED|Overall Study||3
10789072|NCT03515824|11949453|FG001|NOT COMPLETED|Overall Study||4
10789073|NCT03515824|11949454|FG002|NOT COMPLETED|Overall Study||15
10789074|NCT03515824|11949455|FG003|NOT COMPLETED|Overall Study||0
10789075|NCT03515941|11949465|FG000|STARTED|Overall Study||4
10789076|NCT03515941|11949466|FG001|STARTED|Overall Study||2
10789077|NCT03515941|11949465|FG000|COMPLETED|Overall Study||3
10789078|NCT03515941|11949466|FG001|COMPLETED|Overall Study||2
10789079|NCT03515941|11949465|FG000|NOT COMPLETED|Overall Study||1
10789080|NCT03515941|11949466|FG001|NOT COMPLETED|Overall Study||0
10789081|NCT03516227|11949474|FG000|STARTED|Overall Study||20
10789082|NCT03516227|11949475|FG001|STARTED|Overall Study||20
10789083|NCT03516227|11949474|FG000|COMPLETED|Overall Study||19
10789084|NCT03516227|11949475|FG001|COMPLETED|Overall Study||16
10789085|NCT03516227|11949474|FG000|NOT COMPLETED|Overall Study||1
10789086|NCT03516227|11949475|FG001|NOT COMPLETED|Overall Study||4
10789087|NCT03517436|11949482|FG000|STARTED|Overall Study||101
10789088|NCT03517436|11949482|FG000|COMPLETED|Overall Study||93
10789089|NCT03517436|11949482|FG000|NOT COMPLETED|Overall Study||8
10789090|NCT03517566|11949491|FG000|STARTED|Overall Study||74
10789091|NCT03517566|11949492|FG001|STARTED|Overall Study||37
10789092|NCT03517566|11949493|FG002|STARTED|Overall Study||36
10789093|NCT03517566|11949494|FG003|STARTED|Overall Study||73
10789094|NCT03517566|11949495|FG004|STARTED|Overall Study||73
10789095|NCT03517566|11949491|FG000|COMPLETED|Overall Study||42
10789096|NCT03517566|11949492|FG001|COMPLETED|Overall Study||16
10789097|NCT03517566|11949493|FG002|COMPLETED|Overall Study||21
10789098|NCT03517566|11949494|FG003|COMPLETED|Overall Study||39
10789099|NCT03517566|11949495|FG004|COMPLETED|Overall Study||41
10789100|NCT03517566|11949491|FG000|NOT COMPLETED|Overall Study||32
10789101|NCT03517566|11949492|FG001|NOT COMPLETED|Overall Study||21
10789102|NCT03517566|11949493|FG002|NOT COMPLETED|Overall Study||15
10789103|NCT03517566|11949494|FG003|NOT COMPLETED|Overall Study||34
10789104|NCT03517566|11949495|FG004|NOT COMPLETED|Overall Study||32
10789105|NCT03518008|11949508|FG000|STARTED|Period 1, First Week of Wear||11
10789106|NCT03518008|11949509|FG001|STARTED|Period 1, First Week of Wear||11
10789107|NCT03518008|11949508|FG000|COMPLETED|Period 1, First Week of Wear||11
10789108|NCT03518008|11949509|FG001|COMPLETED|Period 1, First Week of Wear||11
10789109|NCT03518008|11949508|FG000|NOT COMPLETED|Period 1, First Week of Wear||0
10789110|NCT03518008|11949509|FG001|NOT COMPLETED|Period 1, First Week of Wear||0
10789111|NCT03518008|11949508|FG000|STARTED|Period 2, Second Week of Wear||11
10789112|NCT03518008|11949509|FG001|STARTED|Period 2, Second Week of Wear||11
10789113|NCT03518008|11949508|FG000|COMPLETED|Period 2, Second Week of Wear||11
10789114|NCT03518008|11949509|FG001|COMPLETED|Period 2, Second Week of Wear||10
10789115|NCT03518008|11949508|FG000|NOT COMPLETED|Period 2, Second Week of Wear||0
10789116|NCT03518008|11949509|FG001|NOT COMPLETED|Period 2, Second Week of Wear||1
10789117|NCT03518125|11949521|FG000|STARTED|Overall Study||50
10789118|NCT03518125|11949522|FG001|STARTED|Overall Study||50
10789119|NCT03518125|11949523|FG002|STARTED|Overall Study||49
10789120|NCT03518125|11949524|FG003|STARTED|Overall Study||52
10789121|NCT03518125|11949525|FG004|STARTED|Overall Study||52
10789122|NCT03518125|11949526|FG005|STARTED|Overall Study||52
10789123|NCT03518125|11949521|FG000|COMPLETED|Overall Study||48
10789124|NCT03518125|11949522|FG001|COMPLETED|Overall Study||46
10789125|NCT03518125|11949523|FG002|COMPLETED|Overall Study||49
10789126|NCT03518125|11949524|FG003|COMPLETED|Overall Study||51
10789127|NCT03518125|11949525|FG004|COMPLETED|Overall Study||48
10789128|NCT03518125|11949526|FG005|COMPLETED|Overall Study||44
10789129|NCT03518125|11949521|FG000|NOT COMPLETED|Overall Study||2
10789130|NCT03518125|11949522|FG001|NOT COMPLETED|Overall Study||4
10789131|NCT03518125|11949523|FG002|NOT COMPLETED|Overall Study||0
10789132|NCT03518125|11949524|FG003|NOT COMPLETED|Overall Study||1
10789133|NCT03518125|11949525|FG004|NOT COMPLETED|Overall Study||4
10789134|NCT03518125|11949526|FG005|NOT COMPLETED|Overall Study||8
10810674|NCT03792672|11972457|FG001|COMPLETED|Treatment Period 1 (1 Day)||4
10436421|NCT00904150|11582580|FG000|STARTED|Blood Samples (RNA): Follicular Phase||37
10436422|NCT00904150|11582581|FG001|STARTED|Blood Samples (RNA): Follicular Phase||32
10436423|NCT00904150|11582580|FG000|COMPLETED|Blood Samples (RNA): Follicular Phase||37
10436424|NCT00904150|11582581|FG001|COMPLETED|Blood Samples (RNA): Follicular Phase||32
10436425|NCT00904150|11582580|FG000|NOT COMPLETED|Blood Samples (RNA): Follicular Phase||0
10436426|NCT00904150|11582581|FG001|NOT COMPLETED|Blood Samples (RNA): Follicular Phase||0
10436427|NCT00904150|11582580|FG000|STARTED|Blood Samples (RNA): Luteal Phase||34
10436428|NCT00904150|11582581|FG001|STARTED|Blood Samples (RNA): Luteal Phase||30
10436429|NCT00904150|11582580|FG000|COMPLETED|Blood Samples (RNA): Luteal Phase||34
10436430|NCT00904150|11582581|FG001|COMPLETED|Blood Samples (RNA): Luteal Phase||30
10436431|NCT00904150|11582580|FG000|NOT COMPLETED|Blood Samples (RNA): Luteal Phase||0
10436432|NCT00904150|11582581|FG001|NOT COMPLETED|Blood Samples (RNA): Luteal Phase||0
10436433|NCT00904215|11582587|FG000|STARTED|Overall Study||1095
10436434|NCT00904215|11582587|FG000|COMPLETED|Overall Study||960
10436435|NCT00904215|11582587|FG000|NOT COMPLETED|Overall Study||135
10436436|NCT00904345|11582591|FG000|STARTED|Overall Study||21
10436437|NCT00904345|11582591|FG000|Stopped or Modified Treatment Due to Toxicity|Overall Study||3
10436438|NCT00904345|11582591|FG000|COMPLETED|Overall Study||18
10436439|NCT00904345|11582591|FG000|NOT COMPLETED|Overall Study||3
10436440|NCT00904371|11582595|FG000|STARTED|Overall Study||211
10436441|NCT00904371|11582595|FG000|COMPLETED|Overall Study||202
10436442|NCT00904371|11582595|FG000|NOT COMPLETED|Overall Study||9
10436443|NCT00904488|11582601|FG000|STARTED|Overall Study||5
10436444|NCT00904488|11582602|FG001|STARTED|Overall Study||6
10436445|NCT00904488|11582601|FG000|COMPLETED|Overall Study||5
10436446|NCT00904488|11582602|FG001|COMPLETED|Overall Study||6
10436447|NCT00904488|11582601|FG000|NOT COMPLETED|Overall Study||0
10436448|NCT00904488|11582602|FG001|NOT COMPLETED|Overall Study||0
10436449|NCT00904618|11582608|FG000|STARTED|Overall Study||48
10436450|NCT00904618|11582608|FG000|COMPLETED|Overall Study||48
10436451|NCT00904618|11582608|FG000|NOT COMPLETED|Overall Study||0
10436452|NCT00904670|11582615|FG000|STARTED|Open Label Phase||23
10436453|NCT00904670|11582616|FG001|STARTED|Open Label Phase||22
10436454|NCT00904670|11582615|FG000|COMPLETED|Open Label Phase||17
10436455|NCT00904670|11582616|FG001|COMPLETED|Open Label Phase||22
10436456|NCT00904670|11582615|FG000|NOT COMPLETED|Open Label Phase||6
10436457|NCT00904670|11582616|FG001|NOT COMPLETED|Open Label Phase||0
10436458|NCT00904670|11582615|FG000|STARTED|First Intervention Period||17
10436459|NCT00904670|11582616|FG001|STARTED|First Intervention Period||22
10436460|NCT00904670|11582615|FG000|COMPLETED|First Intervention Period||17
10436461|NCT00904670|11582616|FG001|COMPLETED|First Intervention Period||22
10436462|NCT00904670|11582615|FG000|NOT COMPLETED|First Intervention Period||0
10436463|NCT00904670|11582616|FG001|NOT COMPLETED|First Intervention Period||0
10436464|NCT00904670|11582615|FG000|STARTED|Second Intervention Period||17
10436465|NCT00904670|11582616|FG001|STARTED|Second Intervention Period||22
10436466|NCT00904670|11582615|FG000|COMPLETED|Second Intervention Period||17
10436467|NCT00904670|11582616|FG001|COMPLETED|Second Intervention Period||22
10436468|NCT00904670|11582615|FG000|NOT COMPLETED|Second Intervention Period||0
10436469|NCT00904670|11582616|FG001|NOT COMPLETED|Second Intervention Period||0
10436470|NCT00904722|11582624|FG000|STARTED|Overall Study||30
10436471|NCT00904722|11582624|FG000|COMPLETED|Overall Study||29
10436472|NCT00904722|11582624|FG000|NOT COMPLETED|Overall Study||1
10436473|NCT00904748|11582628|FG000|STARTED|Overall Study||8
10436474|NCT00904748|11582629|FG001|STARTED|Overall Study||8
10436475|NCT00904748|11582630|FG002|STARTED|Overall Study||8
10436476|NCT00904748|11582631|FG003|STARTED|Overall Study||8
10436477|NCT00904748|11582632|FG004|STARTED|Overall Study|1 participant randomized to this sequence discontinued prior to receipt of study medication.|8
10436478|NCT00904748|11582633|FG005|STARTED|Overall Study||8
10436479|NCT00904748|11582628|FG000|Received Treatment|Overall Study||8
10436480|NCT00904748|11582629|FG001|Received Treatment|Overall Study||8
10436481|NCT00904748|11582630|FG002|Received Treatment|Overall Study||8
10436482|NCT00904748|11582631|FG003|Received Treatment|Overall Study||8
10436483|NCT00904748|11582632|FG004|Received Treatment|Overall Study||7
10436484|NCT00904748|11582633|FG005|Received Treatment|Overall Study||8
10436485|NCT00904748|11582628|FG000|COMPLETED|Overall Study||7
10436486|NCT00904748|11582629|FG001|COMPLETED|Overall Study||7
10436487|NCT00904748|11582630|FG002|COMPLETED|Overall Study||7
10436488|NCT00904748|11582631|FG003|COMPLETED|Overall Study||6
10436489|NCT00904748|11582632|FG004|COMPLETED|Overall Study||7
10436490|NCT00904748|11582633|FG005|COMPLETED|Overall Study||8
10436491|NCT00904748|11582628|FG000|NOT COMPLETED|Overall Study||1
10436492|NCT00904748|11582629|FG001|NOT COMPLETED|Overall Study||1
10436493|NCT00904748|11582630|FG002|NOT COMPLETED|Overall Study||1
10436494|NCT00904748|11582631|FG003|NOT COMPLETED|Overall Study||2
10436495|NCT00904748|11582632|FG004|NOT COMPLETED|Overall Study||1
10436496|NCT00904748|11582633|FG005|NOT COMPLETED|Overall Study||0
10436497|NCT00904813|11582647|FG000|STARTED|Overall Study||129
10436498|NCT00904813|11582648|FG001|STARTED|Overall Study||128
10436499|NCT00904813|11582649|FG002|STARTED|Overall Study||128
10436500|NCT00904813|11582650|FG003|STARTED|Overall Study||228
10436501|NCT00904813|11582651|FG004|STARTED|Overall Study||227
10436502|NCT00904813|11582647|FG000|COMPLETED|Overall Study||129
10436503|NCT00904813|11582648|FG001|COMPLETED|Overall Study||128
10436504|NCT00904813|11582649|FG002|COMPLETED|Overall Study||128
10436505|NCT00904813|11582650|FG003|COMPLETED|Overall Study||228
10436506|NCT00904813|11582651|FG004|COMPLETED|Overall Study||227
10436507|NCT00904813|11582647|FG000|NOT COMPLETED|Overall Study||0
10436508|NCT00904813|11582648|FG001|NOT COMPLETED|Overall Study||0
10436509|NCT00904813|11582649|FG002|NOT COMPLETED|Overall Study||0
10436510|NCT00904813|11582650|FG003|NOT COMPLETED|Overall Study||0
10436511|NCT00904813|11582651|FG004|NOT COMPLETED|Overall Study||0
10436512|NCT00904826|11582674|FG000|STARTED|Overall Study||14
10436513|NCT00904826|11582674|FG000|COMPLETED|Overall Study||14
10436514|NCT00904826|11582674|FG000|NOT COMPLETED|Overall Study||0
10436515|NCT00904839|11582680|FG000|STARTED|Overall Study|All 4 patients were randomised to Maximum Tolerable Dose analysis set.|4
10436516|NCT00904839|11582681|FG001|STARTED|Overall Study|11 patients were randomised to Maximum Tolerable Dose analysis set.|82
10436517|NCT00904839|11582682|FG002|STARTED|Overall Study|Randomised|42
10436518|NCT00904839|11582680|FG000|COMPLETED|Overall Study||3
10436519|NCT00904839|11582681|FG001|COMPLETED|Overall Study||64
10436520|NCT00904839|11582682|FG002|COMPLETED|Overall Study||27
10436521|NCT00904839|11582680|FG000|NOT COMPLETED|Overall Study||1
10436522|NCT00904839|11582681|FG001|NOT COMPLETED|Overall Study||18
10436523|NCT00904839|11582682|FG002|NOT COMPLETED|Overall Study||15
10436524|NCT00904917|11582697|FG000|STARTED|Overall Study||7
10436525|NCT00904917|11582698|FG001|STARTED|Overall Study||11
10436526|NCT00904917|11582699|FG002|STARTED|Overall Study||8
10436527|NCT00904917|11582700|FG003|STARTED|Overall Study||8
10436528|NCT00904917|11582697|FG000|COMPLETED|Overall Study||5
10436529|NCT00904917|11582698|FG001|COMPLETED|Overall Study||9
10436530|NCT00904917|11582699|FG002|COMPLETED|Overall Study||6
10436531|NCT00904917|11582700|FG003|COMPLETED|Overall Study||6
10436532|NCT00904917|11582697|FG000|NOT COMPLETED|Overall Study||2
10436533|NCT00904917|11582698|FG001|NOT COMPLETED|Overall Study||2
10436534|NCT00904917|11582699|FG002|NOT COMPLETED|Overall Study||2
10436535|NCT00904917|11582700|FG003|NOT COMPLETED|Overall Study||2
10436536|NCT00904969|11582713|FG000|STARTED|Overall Study|Number of patients with an attempted implant; 1 subject with procedure aborted|50
10436537|NCT00904969|11582713|FG000|COMPLETED|Overall Study|# of Implanted Subjects Who Completed the Study|31
10436538|NCT00904969|11582713|FG000|NOT COMPLETED|Overall Study||19
10436539|NCT00904982|11582736|FG000|STARTED|Overall Study||68
10436540|NCT00904982|11582737|FG001|STARTED|Overall Study||67
10436541|NCT00904982|11582738|FG002|STARTED|Overall Study||67
10436542|NCT00904982|11582739|FG003|STARTED|Overall Study||68
10436543|NCT00904982|11582736|FG000|COMPLETED|Overall Study||66
10436544|NCT00904982|11582737|FG001|COMPLETED|Overall Study||67
10436545|NCT00904982|11582738|FG002|COMPLETED|Overall Study||67
10436546|NCT00904982|11582739|FG003|COMPLETED|Overall Study||68
10436547|NCT00904982|11582736|FG000|NOT COMPLETED|Overall Study||2
10436548|NCT00904982|11582737|FG001|NOT COMPLETED|Overall Study||0
10436549|NCT00904982|11582738|FG002|NOT COMPLETED|Overall Study||0
10436550|NCT00904982|11582739|FG003|NOT COMPLETED|Overall Study||0
10436551|NCT00904995|11582751|FG000|STARTED|Overall Study||10
10436552|NCT00904995|11582752|FG001|STARTED|Overall Study||11
10436553|NCT00904995|11582751|FG000|COMPLETED|Overall Study||10
10436554|NCT00904995|11582752|FG001|COMPLETED|Overall Study||11
10436555|NCT00904995|11582751|FG000|NOT COMPLETED|Overall Study||0
10436556|NCT00904995|11582752|FG001|NOT COMPLETED|Overall Study||0
10436557|NCT00905021|11582758|FG000|STARTED|Overall Study||4
10436558|NCT00905021|11582758|FG000|COMPLETED|Overall Study|2 patients were off study due to AE.|2
10436559|NCT00905021|11582758|FG000|NOT COMPLETED|Overall Study||2
10436560|NCT00905034|11582763|FG000|STARTED|Overall Study||37
10789135|NCT03518658|11949543|FG000|STARTED|Overall Study|Number of patients completing device pairing survey|257
10789136|NCT03518658|11949544|FG001|STARTED|Overall Study||128607
10789137|NCT03518658|11949543|FG000|COMPLETED|Overall Study|Number of patients completing annual survey|206
10789138|NCT03518658|11949544|FG001|COMPLETED|Overall Study||128607
10789139|NCT03518658|11949543|FG000|NOT COMPLETED|Overall Study||51
10789140|NCT03518658|11949544|FG001|NOT COMPLETED|Overall Study||0
10789141|NCT03518840|11949552|FG000|STARTED|Overall Study||63
10789142|NCT03518840|11949552|FG000|COMPLETED|Overall Study||57
10789143|NCT03518840|11949552|FG000|NOT COMPLETED|Overall Study||6
10789144|NCT03519087|11949561|FG000|STARTED|Clinic Evaluation||55
10789145|NCT03519087|11949562|FG001|STARTED|Clinic Evaluation||57
10789146|NCT03519087|11949563|FG002|STARTED|Clinic Evaluation||0
10789147|NCT03519087|11949564|FG003|STARTED|Clinic Evaluation||0
10789148|NCT03519087|11949565|FG004|STARTED|Clinic Evaluation||0
10789149|NCT03519087|11949561|FG000|Received Assigned Intervention|Clinic Evaluation||54
10789150|NCT03519087|11949562|FG001|Received Assigned Intervention|Clinic Evaluation||57
10789151|NCT03519087|11949563|FG002|Received Assigned Intervention|Clinic Evaluation||0
10789152|NCT03519087|11949564|FG003|Received Assigned Intervention|Clinic Evaluation||0
10789153|NCT03519087|11949565|FG004|Received Assigned Intervention|Clinic Evaluation||0
10789154|NCT03519087|11949561|FG000|Confirmed Diagnosis by Physician|Clinic Evaluation||39
10789155|NCT03519087|11949562|FG001|Confirmed Diagnosis by Physician|Clinic Evaluation||39
10436561|NCT00905034|11582763|FG000|COMPLETED|Overall Study||36
10436562|NCT00905034|11582763|FG000|NOT COMPLETED|Overall Study||1
10436563|NCT00905060|11582767|FG000|STARTED|Surgical Resection||70
10436564|NCT00905060|11582767|FG000|COMPLETED|Surgical Resection||46
10436565|NCT00905060|11582767|FG000|NOT COMPLETED|Surgical Resection||24
10436566|NCT00905060|11582767|FG000|STARTED|Vaccination Treatment Period||46
10436567|NCT00905060|11582767|FG000|COMPLETED|Vaccination Treatment Period||46
10436568|NCT00905060|11582767|FG000|NOT COMPLETED|Vaccination Treatment Period||0
10436569|NCT00905125|11582773|FG000|STARTED|Overall Study||46
10436570|NCT00905125|11582774|FG001|STARTED|Overall Study||56
10436571|NCT00905125|11582773|FG000|COMPLETED|Overall Study||42
10436572|NCT00905125|11582774|FG001|COMPLETED|Overall Study||53
10789156|NCT03519087|11949563|FG002|Confirmed Diagnosis by Physician|Clinic Evaluation||0
10789157|NCT03519087|11949564|FG003|Confirmed Diagnosis by Physician|Clinic Evaluation||0
10789158|NCT03519087|11949565|FG004|Confirmed Diagnosis by Physician|Clinic Evaluation||0
10789159|NCT03519087|11949561|FG000|COMPLETED|Clinic Evaluation||39
10789160|NCT03519087|11949562|FG001|COMPLETED|Clinic Evaluation||39
10789161|NCT03519087|11949563|FG002|COMPLETED|Clinic Evaluation||0
10789162|NCT03519087|11949564|FG003|COMPLETED|Clinic Evaluation||0
10789163|NCT03519087|11949565|FG004|COMPLETED|Clinic Evaluation||0
10436573|NCT00905125|11582773|FG000|NOT COMPLETED|Overall Study||4
10436574|NCT00905125|11582774|FG001|NOT COMPLETED|Overall Study||3
10436575|NCT00905151|11582780|FG000|STARTED|Overall Study||206
10436576|NCT00905151|11582780|FG000|COMPLETED|Overall Study||200
10436577|NCT00905151|11582780|FG000|NOT COMPLETED|Overall Study||6
10436578|NCT00905255|11582786|FG000|STARTED|Overall Study|Randomized.|33
10436579|NCT00905255|11582787|FG001|STARTED|Overall Study||36
10436580|NCT00905255|11582786|FG000|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|33
10436581|NCT00905255|11582787|FG001|Safety Population|Overall Study||36
10436582|NCT00905255|11582786|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|33
10436583|NCT00905255|11582787|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||36
10436584|NCT00905255|11582786|FG000|COMPLETED|Overall Study||20
10436585|NCT00905255|11582787|FG001|COMPLETED|Overall Study||27
10436586|NCT00905255|11582786|FG000|NOT COMPLETED|Overall Study||13
10436587|NCT00905255|11582787|FG001|NOT COMPLETED|Overall Study||9
10436588|NCT00905268|11582798|FG000|STARTED|Overall Study||57
10436589|NCT00905268|11582799|FG001|STARTED|Overall Study||57
10436590|NCT00905268|11582800|FG002|STARTED|Overall Study||59
10436591|NCT00905268|11582801|FG003|STARTED|Overall Study||59
10436592|NCT00905268|11582798|FG000|COMPLETED|Overall Study||53
10436593|NCT00905268|11582799|FG001|COMPLETED|Overall Study||56
10436594|NCT00905268|11582800|FG002|COMPLETED|Overall Study||59
10436595|NCT00905268|11582801|FG003|COMPLETED|Overall Study||57
10436596|NCT00905268|11582798|FG000|NOT COMPLETED|Overall Study||4
10436597|NCT00905268|11582799|FG001|NOT COMPLETED|Overall Study||1
10436598|NCT00905268|11582800|FG002|NOT COMPLETED|Overall Study||0
10436599|NCT00905268|11582801|FG003|NOT COMPLETED|Overall Study||2
10436600|NCT00905307|11582817|FG000|STARTED|Overall Study||42
10436601|NCT00905307|11582818|FG001|STARTED|Overall Study||89
10436602|NCT00905307|11582819|FG002|STARTED|Overall Study||90
10436603|NCT00905307|11582820|FG003|STARTED|Overall Study||93
10436604|NCT00905307|11582821|FG004|STARTED|Overall Study||50
10436605|NCT00905307|11582822|FG005|STARTED|Overall Study||95
10436606|NCT00905307|11582817|FG000|COMPLETED|Overall Study||20
10436607|NCT00905307|11582818|FG001|COMPLETED|Overall Study||52
10436608|NCT00905307|11582819|FG002|COMPLETED|Overall Study||53
10436609|NCT00905307|11582820|FG003|COMPLETED|Overall Study||56
10436610|NCT00905307|11582821|FG004|COMPLETED|Overall Study||34
10436611|NCT00905307|11582822|FG005|COMPLETED|Overall Study||53
10436612|NCT00905307|11582817|FG000|NOT COMPLETED|Overall Study||22
10436613|NCT00905307|11582818|FG001|NOT COMPLETED|Overall Study||37
10436614|NCT00905307|11582819|FG002|NOT COMPLETED|Overall Study||37
10436615|NCT00905307|11582820|FG003|NOT COMPLETED|Overall Study||37
10436616|NCT00905307|11582821|FG004|NOT COMPLETED|Overall Study||16
10436617|NCT00905307|11582822|FG005|NOT COMPLETED|Overall Study||42
10436618|NCT00905359|11582851|FG000|STARTED|Overall Study||82
10436619|NCT00905359|11582852|FG001|STARTED|Overall Study||81
10436620|NCT00905359|11582851|FG000|12 Months Follow up|Overall Study||68
10436621|NCT00905359|11582852|FG001|12 Months Follow up|Overall Study||72
10436622|NCT00905359|11582851|FG000|24 Months Follow up|Overall Study||58
10436623|NCT00905359|11582852|FG001|24 Months Follow up|Overall Study||65
10436624|NCT00905359|11582851|FG000|COMPLETED|Overall Study||58
10436625|NCT00905359|11582852|FG001|COMPLETED|Overall Study||65
10436626|NCT00905359|11582851|FG000|NOT COMPLETED|Overall Study||24
10436627|NCT00905359|11582852|FG001|NOT COMPLETED|Overall Study||16
10436628|NCT00905424|11582860|FG000|STARTED|Overall Study||89
10436629|NCT00905424|11582861|FG001|STARTED|Overall Study||88
10436630|NCT00905424|11582860|FG000|COMPLETED|Overall Study||78
10436631|NCT00905424|11582861|FG001|COMPLETED|Overall Study||79
10436632|NCT00905424|11582860|FG000|NOT COMPLETED|Overall Study||11
10436633|NCT00905424|11582861|FG001|NOT COMPLETED|Overall Study||9
10436634|NCT00905437|11582871|FG000|STARTED|Overall Study||35
10436635|NCT00905437|11582872|FG001|STARTED|Overall Study||37
10436636|NCT00905437|11582871|FG000|COMPLETED|Overall Study||27
10436637|NCT00905437|11582872|FG001|COMPLETED|Overall Study||27
10436638|NCT00905437|11582871|FG000|NOT COMPLETED|Overall Study||8
10436639|NCT00905437|11582872|FG001|NOT COMPLETED|Overall Study||10
10436640|NCT00905450|11582886|FG000|STARTED|Overall Study||60
10789164|NCT03519087|11949561|FG000|NOT COMPLETED|Clinic Evaluation||16
10789165|NCT03519087|11949562|FG001|NOT COMPLETED|Clinic Evaluation||18
10436641|NCT00905450|11582887|FG001|STARTED|Overall Study||28
10436642|NCT00905450|11582888|FG002|STARTED|Overall Study||28
10436643|NCT00905450|11582889|FG003|STARTED|Overall Study||60
10436644|NCT00905450|11582890|FG004|STARTED|Overall Study||59
10436645|NCT00905450|11582891|FG005|STARTED|Overall Study||60
10436646|NCT00905450|11582892|FG006|STARTED|Overall Study||60
10436647|NCT00905450|11582893|FG007|STARTED|Overall Study||60
10436648|NCT00905450|11582886|FG000|COMPLETED|Overall Study||59
10436649|NCT00905450|11582887|FG001|COMPLETED|Overall Study||27
10436650|NCT00905450|11582888|FG002|COMPLETED|Overall Study||28
10436651|NCT00905450|11582889|FG003|COMPLETED|Overall Study||60
10436652|NCT00905450|11582890|FG004|COMPLETED|Overall Study||59
10436653|NCT00905450|11582891|FG005|COMPLETED|Overall Study||58
10436654|NCT00905450|11582892|FG006|COMPLETED|Overall Study||58
10436655|NCT00905450|11582893|FG007|COMPLETED|Overall Study||59
10436656|NCT00905450|11582886|FG000|NOT COMPLETED|Overall Study||1
10436657|NCT00905450|11582887|FG001|NOT COMPLETED|Overall Study||1
10436658|NCT00905450|11582888|FG002|NOT COMPLETED|Overall Study||0
10436659|NCT00905450|11582889|FG003|NOT COMPLETED|Overall Study||0
10436660|NCT00905450|11582890|FG004|NOT COMPLETED|Overall Study||0
10436661|NCT00905450|11582891|FG005|NOT COMPLETED|Overall Study||2
10436662|NCT00905450|11582892|FG006|NOT COMPLETED|Overall Study||2
10436663|NCT00905450|11582893|FG007|NOT COMPLETED|Overall Study||1
10436664|NCT00905489|11582911|FG000|STARTED|Pharmaco-kinetic (PK) Phase||85
10436665|NCT00905489|11582911|FG000|COMPLETED|Pharmaco-kinetic (PK) Phase||80
10436666|NCT00905489|11582911|FG000|NOT COMPLETED|Pharmaco-kinetic (PK) Phase||5
10436667|NCT00905489|11582911|FG000|STARTED|Optional Extension Phase (OEP)|Includes only subjects who chose to continue trt with nevirapine XR after completing the PK phase.|40
10436668|NCT00905489|11582911|FG000|COMPLETED|Optional Extension Phase (OEP)||39
10436669|NCT00905489|11582911|FG000|NOT COMPLETED|Optional Extension Phase (OEP)||1
10436670|NCT00905515|11582923|FG000|STARTED|Overall Study||21
10436671|NCT00905515|11582924|FG001|STARTED|Overall Study||20
10436672|NCT00905515|11582925|FG002|STARTED|Overall Study||22
10436673|NCT00905515|11582923|FG000|COMPLETED|Overall Study||19
10436674|NCT00905515|11582924|FG001|COMPLETED|Overall Study||20
10436675|NCT00905515|11582925|FG002|COMPLETED|Overall Study||20
10436676|NCT00905515|11582923|FG000|NOT COMPLETED|Overall Study||2
10436677|NCT00905515|11582924|FG001|NOT COMPLETED|Overall Study||0
10436678|NCT00905515|11582925|FG002|NOT COMPLETED|Overall Study||2
10436679|NCT00905554|11582935|FG000|STARTED|Overall Study||116
10436680|NCT00905554|11582936|FG001|STARTED|Overall Study||114
10436681|NCT00905554|11582935|FG000|COMPLETED|Overall Study||116
10436682|NCT00905554|11582936|FG001|COMPLETED|Overall Study||114
10436683|NCT00905554|11582935|FG000|NOT COMPLETED|Overall Study||0
10436684|NCT00905554|11582936|FG001|NOT COMPLETED|Overall Study||0
10436685|NCT00905580|11582944|FG000|STARTED|Overall Study||49
10436686|NCT00905580|11582945|FG001|STARTED|Overall Study||50
10436687|NCT00905580|11582944|FG000|COMPLETED|Overall Study||47
10436688|NCT00905580|11582945|FG001|COMPLETED|Overall Study||47
10436689|NCT00905580|11582944|FG000|NOT COMPLETED|Overall Study||2
10436690|NCT00905580|11582945|FG001|NOT COMPLETED|Overall Study||3
10436691|NCT00905632|11582958|FG000|STARTED|Overall Study||8
10436692|NCT00905632|11582959|FG001|STARTED|Overall Study||6
10436693|NCT00905632|11582960|FG002|STARTED|Overall Study||7
10436694|NCT00905632|11582961|FG003|STARTED|Overall Study||6
10436695|NCT00905632|11582962|FG004|STARTED|Overall Study||10
10436696|NCT00905632|11582963|FG005|STARTED|Overall Study||9
10436697|NCT00905632|11582964|FG006|STARTED|Overall Study||11
10436698|NCT00905632|11582958|FG000|COMPLETED|Overall Study||8
10436699|NCT00905632|11582959|FG001|COMPLETED|Overall Study||6
10436700|NCT00905632|11582960|FG002|COMPLETED|Overall Study||7
10436701|NCT00905632|11582961|FG003|COMPLETED|Overall Study||6
10436702|NCT00905632|11582962|FG004|COMPLETED|Overall Study||10
10436703|NCT00905632|11582963|FG005|COMPLETED|Overall Study||8
10436704|NCT00905632|11582964|FG006|COMPLETED|Overall Study||7
10436705|NCT00905632|11582958|FG000|NOT COMPLETED|Overall Study||0
10436706|NCT00905632|11582959|FG001|NOT COMPLETED|Overall Study||0
10436707|NCT00905632|11582960|FG002|NOT COMPLETED|Overall Study||0
10436708|NCT00905632|11582961|FG003|NOT COMPLETED|Overall Study||0
10436709|NCT00905632|11582962|FG004|NOT COMPLETED|Overall Study||0
10436710|NCT00905632|11582963|FG005|NOT COMPLETED|Overall Study||1
10436711|NCT00905632|11582964|FG006|NOT COMPLETED|Overall Study||4
10436712|NCT00905827|11582990|FG000|STARTED|Overall Study||70
10436713|NCT00905827|11582991|FG001|STARTED|Overall Study||69
10436714|NCT00905827|11582992|FG002|STARTED|Overall Study||73
10436715|NCT00905827|11582990|FG000|COMPLETED|Overall Study||70
10436716|NCT00905827|11582991|FG001|COMPLETED|Overall Study||69
10436717|NCT00905827|11582992|FG002|COMPLETED|Overall Study||73
10436718|NCT00905827|11582990|FG000|NOT COMPLETED|Overall Study||0
10436719|NCT00905827|11582991|FG001|NOT COMPLETED|Overall Study||0
10436720|NCT00905827|11582992|FG002|NOT COMPLETED|Overall Study||0
10436721|NCT00905840|11583000|FG000|STARTED|Overall Study||91
10436722|NCT00905840|11583000|FG000|COMPLETED|Overall Study||75
10436723|NCT00905840|11583000|FG000|NOT COMPLETED|Overall Study||16
10436724|NCT00906074|11583009|FG000|STARTED|Overall Study||90
10436725|NCT00906074|11583010|FG001|STARTED|Overall Study||90
10436726|NCT00906074|11583009|FG000|COMPLETED|Overall Study||90
10436727|NCT00906074|11583010|FG001|COMPLETED|Overall Study||90
10436728|NCT00906074|11583009|FG000|NOT COMPLETED|Overall Study||0
10436729|NCT00906074|11583010|FG001|NOT COMPLETED|Overall Study||0
10436730|NCT00906087|11583016|FG000|STARTED|Initial Washout||14
10436731|NCT00906087|11583016|FG000|Completed Screening|Initial Washout||14
10436732|NCT00906087|11583016|FG000|Begin Washout|Initial Washout||13
10436733|NCT00906087|11583016|FG000|Completed Washout and Continue Protocol|Initial Washout||12
10436734|NCT00906087|11583016|FG000|COMPLETED|Initial Washout||12
10436735|NCT00906087|11583016|FG000|NOT COMPLETED|Initial Washout||2
10436736|NCT00906087|11583016|FG000|STARTED|Cosopt Treatment 6 Weeks||12
10436737|NCT00906087|11583016|FG000|COMPLETED|Cosopt Treatment 6 Weeks||12
10436738|NCT00906087|11583016|FG000|NOT COMPLETED|Cosopt Treatment 6 Weeks||0
10436739|NCT00906087|11583016|FG000|STARTED|Final Washout Period 4 Weeks||12
10436740|NCT00906087|11583016|FG000|COMPLETED|Final Washout Period 4 Weeks||12
10436741|NCT00906087|11583016|FG000|NOT COMPLETED|Final Washout Period 4 Weeks||0
10436742|NCT00906165|11583025|FG000|STARTED|Overall Study||14
10436743|NCT00906165|11583026|FG001|STARTED|Overall Study||14
10436744|NCT00906165|11583025|FG000|COMPLETED|Overall Study||10
10436745|NCT00906165|11583026|FG001|COMPLETED|Overall Study||14
10436746|NCT00906165|11583025|FG000|NOT COMPLETED|Overall Study||4
10436747|NCT00906165|11583026|FG001|NOT COMPLETED|Overall Study||0
10436748|NCT00906178|11583034|FG000|STARTED|Overall Study||183
10436749|NCT00906178|11583035|FG001|STARTED|Overall Study||183
10436750|NCT00906178|11583034|FG000|COMPLETED|Overall Study||168
10436751|NCT00906178|11583035|FG001|COMPLETED|Overall Study||167
10436752|NCT00906178|11583034|FG000|NOT COMPLETED|Overall Study||15
10436753|NCT00906178|11583035|FG001|NOT COMPLETED|Overall Study||16
10436754|NCT00906204|11583043|FG000|STARTED|Primary Endpoint (Early Safety)||45
10789166|NCT03519087|11949563|FG002|NOT COMPLETED|Clinic Evaluation||0
10789167|NCT03519087|11949564|FG003|NOT COMPLETED|Clinic Evaluation||0
10789168|NCT03519087|11949565|FG004|NOT COMPLETED|Clinic Evaluation||0
10789169|NCT03519087|11949561|FG000|STARTED|Re-randomization for Treatment||39
10789170|NCT03519087|11949562|FG001|STARTED|Re-randomization for Treatment||39
10789171|NCT03519087|11949563|FG002|STARTED|Re-randomization for Treatment||0
10789172|NCT03519087|11949564|FG003|STARTED|Re-randomization for Treatment||0
10789173|NCT03519087|11949565|FG004|STARTED|Re-randomization for Treatment||0
10789174|NCT03519087|11949561|FG000|COMPLETED|Re-randomization for Treatment||12
10789175|NCT03519087|11949562|FG001|COMPLETED|Re-randomization for Treatment||7
10789176|NCT03519087|11949563|FG002|COMPLETED|Re-randomization for Treatment||0
10789177|NCT03519087|11949564|FG003|COMPLETED|Re-randomization for Treatment||0
10789178|NCT03519087|11949565|FG004|COMPLETED|Re-randomization for Treatment||0
10789179|NCT03519087|11949561|FG000|NOT COMPLETED|Re-randomization for Treatment||27
10789180|NCT03519087|11949562|FG001|NOT COMPLETED|Re-randomization for Treatment||32
10789181|NCT03519087|11949563|FG002|NOT COMPLETED|Re-randomization for Treatment||0
10789182|NCT03519087|11949564|FG003|NOT COMPLETED|Re-randomization for Treatment||0
10789183|NCT03519087|11949565|FG004|NOT COMPLETED|Re-randomization for Treatment||0
10789184|NCT03519087|11949561|FG000|STARTED|Laboratory Testing||0
10789185|NCT03519087|11949562|FG001|STARTED|Laboratory Testing||0
10789186|NCT03519087|11949563|FG002|STARTED|Laboratory Testing|From interdisciplinary (4) or standard (2) evaluation from Period 1|6
10789187|NCT03519087|11949564|FG003|STARTED|Laboratory Testing|From interdisciplinary (4) or standard (2) evaluation from Period 1|6
10789188|NCT03519087|11949565|FG004|STARTED|Laboratory Testing|From interdisciplinary (4) or standard (3) evaluation from Period 1|7
10789189|NCT03519087|11949561|FG000|Baseline Lab Testing|Laboratory Testing||0
10789190|NCT03519087|11949562|FG001|Baseline Lab Testing|Laboratory Testing||0
10789191|NCT03519087|11949563|FG002|Baseline Lab Testing|Laboratory Testing||5
10789192|NCT03519087|11949564|FG003|Baseline Lab Testing|Laboratory Testing||4
10789193|NCT03519087|11949565|FG004|Baseline Lab Testing|Laboratory Testing||3
10789194|NCT03519087|11949561|FG000|COMPLETED|Laboratory Testing||0
10789195|NCT03519087|11949562|FG001|COMPLETED|Laboratory Testing||0
10789196|NCT03519087|11949563|FG002|COMPLETED|Laboratory Testing||4
10789197|NCT03519087|11949564|FG003|COMPLETED|Laboratory Testing||2
10789198|NCT03519087|11949565|FG004|COMPLETED|Laboratory Testing||1
10789199|NCT03519087|11949561|FG000|NOT COMPLETED|Laboratory Testing||0
10789200|NCT03519087|11949562|FG001|NOT COMPLETED|Laboratory Testing||0
10789201|NCT03519087|11949563|FG002|NOT COMPLETED|Laboratory Testing||2
10789202|NCT03519087|11949564|FG003|NOT COMPLETED|Laboratory Testing||4
10789203|NCT03519087|11949565|FG004|NOT COMPLETED|Laboratory Testing||6
10789204|NCT03519204|11949583|FG000|STARTED|Overall Study|3 control participants were treated in error; 29 participants received treatment after 3 months.|43
10789205|NCT03519204|11949584|FG001|STARTED|Overall Study||133
10789206|NCT03519204|11949583|FG000|mITT Population|Overall Study||33
10789207|NCT03519204|11949584|FG001|mITT Population|Overall Study||130
10789208|NCT03519204|11949583|FG000|Safety Population|Overall Study||40
10789209|NCT03519204|11949584|FG001|Safety Population|Overall Study||136
10789210|NCT03519204|11949583|FG000|COMPLETED|Overall Study||30
10789211|NCT03519204|11949584|FG001|COMPLETED|Overall Study||118
10436755|NCT00906204|11583044|FG001|STARTED|Primary Endpoint (Early Safety)||52
10436756|NCT00906204|11583043|FG000|COMPLETED|Primary Endpoint (Early Safety)||43
10436757|NCT00906204|11583044|FG001|COMPLETED|Primary Endpoint (Early Safety)||51
10436758|NCT00906204|11583043|FG000|NOT COMPLETED|Primary Endpoint (Early Safety)||2
10436759|NCT00906204|11583044|FG001|NOT COMPLETED|Primary Endpoint (Early Safety)||1
10436760|NCT00906204|11583043|FG000|STARTED|Secondary Endpoints (Long-term Safety)||43
10436761|NCT00906204|11583044|FG001|STARTED|Secondary Endpoints (Long-term Safety)||51
10436762|NCT00906204|11583043|FG000|COMPLETED|Secondary Endpoints (Long-term Safety)||41
10436763|NCT00906204|11583044|FG001|COMPLETED|Secondary Endpoints (Long-term Safety)||48
10436764|NCT00906204|11583043|FG000|NOT COMPLETED|Secondary Endpoints (Long-term Safety)||2
10789212|NCT03519204|11949583|FG000|NOT COMPLETED|Overall Study||13
10789213|NCT03519204|11949584|FG001|NOT COMPLETED|Overall Study||15
10789214|NCT03519243|11949597|FG000|STARTED|Overall Study||25
10789215|NCT03519243|11949598|FG001|STARTED|Overall Study||25
10810675|NCT03792672|11972458|FG002|COMPLETED|Treatment Period 1 (1 Day)||4
10436765|NCT00906204|11583044|FG001|NOT COMPLETED|Secondary Endpoints (Long-term Safety)||3
10436766|NCT00906243|11583050|FG000|STARTED|Overall Study||6
10436767|NCT00906243|11583050|FG000|COMPLETED|Overall Study||6
10436768|NCT00906243|11583050|FG000|NOT COMPLETED|Overall Study||0
10436769|NCT00906282|11583054|FG000|STARTED|Preoperative Chemotherapy||46
10436770|NCT00906282|11583054|FG000|COMPLETED|Preoperative Chemotherapy|2 of 27 patients completed less than 4 cycles and were deemed surgical candidates.|27
10436771|NCT00906282|11583054|FG000|NOT COMPLETED|Preoperative Chemotherapy||19
10436772|NCT00906282|11583054|FG000|STARTED|Surgical Resection||27
10436773|NCT00906282|11583054|FG000|COMPLETED|Surgical Resection||27
10436774|NCT00906282|11583054|FG000|NOT COMPLETED|Surgical Resection||0
10436775|NCT00906347|11583061|FG000|STARTED|Randomized||176
10436776|NCT00906347|11583062|FG001|STARTED|Randomized||174
10436777|NCT00906347|11583061|FG000|COMPLETED|Randomized||176
10436778|NCT00906347|11583062|FG001|COMPLETED|Randomized||174
10436779|NCT00906347|11583061|FG000|NOT COMPLETED|Randomized||0
10436780|NCT00906347|11583062|FG001|NOT COMPLETED|Randomized||0
10436781|NCT00906347|11583061|FG000|STARTED|Received Study Drug||176
10436782|NCT00906347|11583062|FG001|STARTED|Received Study Drug||174
10436783|NCT00906347|11583061|FG000|COMPLETED|Received Study Drug||136
10436784|NCT00906347|11583062|FG001|COMPLETED|Received Study Drug||143
10436785|NCT00906347|11583061|FG000|NOT COMPLETED|Received Study Drug||40
10436786|NCT00906347|11583062|FG001|NOT COMPLETED|Received Study Drug||31
10436787|NCT00906373|11583070|FG000|STARTED|Overall Study||6
10436788|NCT00906373|11583071|FG001|STARTED|Overall Study||41
10436789|NCT00906373|11583070|FG000|Received Any Amount of Study Drug|Overall Study||6
10436790|NCT00906373|11583071|FG001|Received Any Amount of Study Drug|Overall Study||41
10436791|NCT00906373|11583070|FG000|COMPLETED|Overall Study||6
10436792|NCT00906373|11583071|FG001|COMPLETED|Overall Study||33
10436793|NCT00906373|11583070|FG000|NOT COMPLETED|Overall Study||0
10436794|NCT00906373|11583071|FG001|NOT COMPLETED|Overall Study||8
10436795|NCT00906399|11583081|FG000|STARTED|Year 1||500
10436796|NCT00906399|11583082|FG001|STARTED|Year 1||501
10436797|NCT00906399|11583083|FG002|STARTED|Year 1||515
10436798|NCT00906399|11583084|FG003|STARTED|Year 1||0
10436799|NCT00906399|11583085|FG004|STARTED|Year 1||0
10436800|NCT00906399|11583086|FG005|STARTED|Year 1||0
10436801|NCT00906399|11583087|FG006|STARTED|Year 1||0
10436802|NCT00906399|11583081|FG000|Completed Year 1 Study Treatment|Year 1||456
10436803|NCT00906399|11583082|FG001|Completed Year 1 Study Treatment|Year 1||438
10436804|NCT00906399|11583083|FG002|Completed Year 1 Study Treatment|Year 1||438
10436805|NCT00906399|11583084|FG003|Completed Year 1 Study Treatment|Year 1||0
10436806|NCT00906399|11583085|FG004|Completed Year 1 Study Treatment|Year 1||0
10436807|NCT00906399|11583086|FG005|Completed Year 1 Study Treatment|Year 1||0
10436808|NCT00906399|11583087|FG006|Completed Year 1 Study Treatment|Year 1||0
10436809|NCT00906399|11583081|FG000|COMPLETED|Year 1||456
10436810|NCT00906399|11583082|FG001|COMPLETED|Year 1||438
10436811|NCT00906399|11583083|FG002|COMPLETED|Year 1|1 participant discontinued treatment before end of study period but remained to complete follow-up.|439
10436812|NCT00906399|11583084|FG003|COMPLETED|Year 1||0
10436813|NCT00906399|11583085|FG004|COMPLETED|Year 1||0
10436814|NCT00906399|11583086|FG005|COMPLETED|Year 1||0
10436815|NCT00906399|11583087|FG006|COMPLETED|Year 1||0
10436816|NCT00906399|11583081|FG000|NOT COMPLETED|Year 1||44
10436817|NCT00906399|11583082|FG001|NOT COMPLETED|Year 1||63
10436818|NCT00906399|11583083|FG002|NOT COMPLETED|Year 1||76
10436819|NCT00906399|11583084|FG003|NOT COMPLETED|Year 1||0
10436820|NCT00906399|11583085|FG004|NOT COMPLETED|Year 1||0
10436821|NCT00906399|11583086|FG005|NOT COMPLETED|Year 1||0
10436822|NCT00906399|11583087|FG006|NOT COMPLETED|Year 1||0
10436823|NCT00906399|11583081|FG000|STARTED|Year 2||0
10436824|NCT00906399|11583082|FG001|STARTED|Year 2||0
10789216|NCT03519243|11949599|FG002|STARTED|Overall Study|The dose level was not studied due to the dose level l.7 µg/kg demonstrated the sufficient PD effect|0
10789217|NCT03519243|11949600|FG003|STARTED|Overall Study||25
10436825|NCT00906399|11583083|FG002|STARTED|Year 2||0
10436826|NCT00906399|11583084|FG003|STARTED|Year 2||228
10436827|NCT00906399|11583085|FG004|STARTED|Year 2||228
10436828|NCT00906399|11583086|FG005|STARTED|Year 2||438
10436829|NCT00906399|11583087|FG006|STARTED|Year 2||438
10436830|NCT00906399|11583081|FG000|Completed Year 2 Study Treatment|Year 2||0
10436831|NCT00906399|11583082|FG001|Completed Year 2 Study Treatment|Year 2||0
10436832|NCT00906399|11583083|FG002|Completed Year 2 Study Treatment|Year 2||0
10436833|NCT00906399|11583084|FG003|Completed Year 2 Study Treatment|Year 2||200
10436834|NCT00906399|11583085|FG004|Completed Year 2 Study Treatment|Year 2||196
10436835|NCT00906399|11583086|FG005|Completed Year 2 Study Treatment|Year 2||391
10436836|NCT00906399|11583087|FG006|Completed Year 2 Study Treatment|Year 2||411
10436837|NCT00906399|11583081|FG000|COMPLETED|Year 2||0
10436838|NCT00906399|11583082|FG001|COMPLETED|Year 2||0
10436839|NCT00906399|11583083|FG002|COMPLETED|Year 2||0
10436840|NCT00906399|11583084|FG003|COMPLETED|Year 2||198
10436841|NCT00906399|11583085|FG004|COMPLETED|Year 2||193
10436842|NCT00906399|11583086|FG005|COMPLETED|Year 2||391
10436843|NCT00906399|11583087|FG006|COMPLETED|Year 2||409
10436844|NCT00906399|11583081|FG000|NOT COMPLETED|Year 2||0
10436845|NCT00906399|11583082|FG001|NOT COMPLETED|Year 2||0
10436846|NCT00906399|11583083|FG002|NOT COMPLETED|Year 2||0
10436847|NCT00906399|11583084|FG003|NOT COMPLETED|Year 2||30
10436848|NCT00906399|11583085|FG004|NOT COMPLETED|Year 2||35
10436849|NCT00906399|11583086|FG005|NOT COMPLETED|Year 2||47
10436850|NCT00906399|11583087|FG006|NOT COMPLETED|Year 2||29
10436851|NCT00906425|11583101|FG000|STARTED|Overall Study||73
10436852|NCT00906425|11583102|FG001|STARTED|Overall Study||72
10436853|NCT00906425|11583101|FG000|6 Months|Overall Study|ITT population|69
10436854|NCT00906425|11583102|FG001|6 Months|Overall Study|ITT population|64
10436855|NCT00906425|11583101|FG000|1 Year|Overall Study|ITT population|67
10436856|NCT00906425|11583102|FG001|1 Year|Overall Study|ITT population|60
10436857|NCT00906425|11583101|FG000|2 Year|Overall Study|ITT population|62
10436858|NCT00906425|11583102|FG001|2 Year|Overall Study|ITT population|58
10436859|NCT00906425|11583101|FG000|COMPLETED|Overall Study|Clinical Trial expected to be completed in 2013|0
10436860|NCT00906425|11583102|FG001|COMPLETED|Overall Study|Clinical Trial expected to be completed in 2013|0
10436861|NCT00906425|11583101|FG000|NOT COMPLETED|Overall Study||73
10436862|NCT00906425|11583102|FG001|NOT COMPLETED|Overall Study||72
10436863|NCT00906503|11583108|FG000|STARTED|Overall Study||9
10436864|NCT00906503|11583108|FG000|COMPLETED|Overall Study||9
10436865|NCT00906503|11583108|FG000|NOT COMPLETED|Overall Study||0
10436866|NCT00906698|11583118|FG000|STARTED|Overall Study||3
10436867|NCT00906698|11583119|FG001|STARTED|Overall Study||19
10436868|NCT00906698|11583120|FG002|STARTED|Overall Study||6
10436869|NCT00906698|11583121|FG003|STARTED|Overall Study||4
10436870|NCT00906698|11583122|FG004|STARTED|Overall Study||18
10436871|NCT00906698|11583123|FG005|STARTED|Overall Study||5
10436872|NCT00906698|11583118|FG000|COMPLETED|Overall Study||0
10436873|NCT00906698|11583119|FG001|COMPLETED|Overall Study||0
10436874|NCT00906698|11583120|FG002|COMPLETED|Overall Study||0
10436875|NCT00906698|11583121|FG003|COMPLETED|Overall Study||0
10436876|NCT00906698|11583122|FG004|COMPLETED|Overall Study||0
10436877|NCT00906698|11583123|FG005|COMPLETED|Overall Study||0
10436878|NCT00906698|11583118|FG000|NOT COMPLETED|Overall Study||3
10436879|NCT00906698|11583119|FG001|NOT COMPLETED|Overall Study||19
10436880|NCT00906698|11583120|FG002|NOT COMPLETED|Overall Study||6
10436881|NCT00906698|11583121|FG003|NOT COMPLETED|Overall Study||4
10436882|NCT00906698|11583122|FG004|NOT COMPLETED|Overall Study||18
10436883|NCT00906698|11583123|FG005|NOT COMPLETED|Overall Study||5
10436884|NCT00906776|11583157|FG000|STARTED|Overall Study||11
10436885|NCT00906776|11583158|FG001|STARTED|Overall Study||8
10436886|NCT00906776|11583157|FG000|COMPLETED|Overall Study||11
10436887|NCT00906776|11583158|FG001|COMPLETED|Overall Study||8
10436888|NCT00906776|11583157|FG000|NOT COMPLETED|Overall Study||0
10436889|NCT00906776|11583158|FG001|NOT COMPLETED|Overall Study||0
10436890|NCT00906789|11583164|FG000|STARTED|Overall Study|Radiologists served as own control. Total enrollment is 15 radiologists.|15
10436891|NCT00906789|11583164|FG000|COMPLETED|Overall Study||15
10436892|NCT00906789|11583164|FG000|NOT COMPLETED|Overall Study||0
10436893|NCT00906945|11583175|FG000|STARTED|Overall Study||3
10436894|NCT00906945|11583176|FG001|STARTED|Overall Study||3
10436895|NCT00906945|11583177|FG002|STARTED|Overall Study||3
10436896|NCT00906945|11583178|FG003|STARTED|Overall Study||7
10436897|NCT00906945|11583179|FG004|STARTED|Overall Study||7
10436898|NCT00906945|11583180|FG005|STARTED|Overall Study||16
10436899|NCT00906945|11583175|FG000|COMPLETED|Overall Study||3
10436900|NCT00906945|11583176|FG001|COMPLETED|Overall Study||3
10436901|NCT00906945|11583177|FG002|COMPLETED|Overall Study||3
10436902|NCT00906945|11583178|FG003|COMPLETED|Overall Study||6
10436903|NCT00906945|11583179|FG004|COMPLETED|Overall Study||6
10436904|NCT00906945|11583180|FG005|COMPLETED|Overall Study||14
10436905|NCT00906945|11583175|FG000|NOT COMPLETED|Overall Study||0
10436906|NCT00906945|11583176|FG001|NOT COMPLETED|Overall Study||0
10436907|NCT00906945|11583177|FG002|NOT COMPLETED|Overall Study||0
10436908|NCT00906945|11583178|FG003|NOT COMPLETED|Overall Study||1
10436909|NCT00906945|11583179|FG004|NOT COMPLETED|Overall Study||1
10436910|NCT00906945|11583180|FG005|NOT COMPLETED|Overall Study||2
10436911|NCT00906958|11583196|FG000|STARTED|Overall Study||10
10436912|NCT00906958|11583197|FG001|STARTED|Overall Study||10
10436913|NCT00906958|11583196|FG000|COMPLETED|Overall Study||10
10436914|NCT00906958|11583197|FG001|COMPLETED|Overall Study||10
10789218|NCT03519243|11949597|FG000|COMPLETED|Overall Study||20
10789219|NCT03519243|11949598|FG001|COMPLETED|Overall Study||21
10789220|NCT03519243|11949599|FG002|COMPLETED|Overall Study||0
10789221|NCT03519243|11949600|FG003|COMPLETED|Overall Study||24
10789222|NCT03519243|11949597|FG000|NOT COMPLETED|Overall Study||5
10789223|NCT03519243|11949598|FG001|NOT COMPLETED|Overall Study||4
10436915|NCT00906958|11583196|FG000|NOT COMPLETED|Overall Study||0
10436916|NCT00906958|11583197|FG001|NOT COMPLETED|Overall Study||0
10436917|NCT00906971|11583207|FG000|STARTED|Overall Study||36
10436918|NCT00906971|11583208|FG001|STARTED|Overall Study||36
10436919|NCT00906971|11583207|FG000|COMPLETED|Overall Study||28
10789224|NCT03519243|11949599|FG002|NOT COMPLETED|Overall Study||0
10789225|NCT03519243|11949600|FG003|NOT COMPLETED|Overall Study||1
10789226|NCT03519282|11949608|FG000|STARTED|First Intervention||5
10789227|NCT03519282|11949609|FG001|STARTED|First Intervention||5
10789228|NCT03519282|11949608|FG000|COMPLETED|First Intervention||5
10789229|NCT03519282|11949609|FG001|COMPLETED|First Intervention||5
10789230|NCT03519282|11949608|FG000|NOT COMPLETED|First Intervention||0
10789231|NCT03519282|11949609|FG001|NOT COMPLETED|First Intervention||0
10789232|NCT03519282|11949608|FG000|STARTED|Second Intervention||5
10789233|NCT03519282|11949609|FG001|STARTED|Second Intervention||5
10789234|NCT03519282|11949608|FG000|COMPLETED|Second Intervention||5
10789235|NCT03519282|11949609|FG001|COMPLETED|Second Intervention||5
10436920|NCT00906971|11583208|FG001|COMPLETED|Overall Study||33
10436921|NCT00906971|11583207|FG000|NOT COMPLETED|Overall Study||8
10436922|NCT00906971|11583208|FG001|NOT COMPLETED|Overall Study||3
10436923|NCT00907088|11583216|FG000|STARTED|Overall Study||122
10436924|NCT00907088|11583217|FG001|STARTED|Overall Study||129
10789236|NCT03519282|11949608|FG000|NOT COMPLETED|Second Intervention||0
10789237|NCT03519282|11949609|FG001|NOT COMPLETED|Second Intervention||0
10789238|NCT03519516|11949617|FG000|STARTED|Overall Study||15
10436925|NCT00907088|11583216|FG000|COMPLETED|Overall Study||102
10436926|NCT00907088|11583217|FG001|COMPLETED|Overall Study||99
10436927|NCT00907088|11583216|FG000|NOT COMPLETED|Overall Study||20
10789239|NCT03519516|11949618|FG001|STARTED|Overall Study||15
10436928|NCT00907088|11583217|FG001|NOT COMPLETED|Overall Study||30
10436932|NCT00907153|11583229|FG000|STARTED|Overall Study||13
10436933|NCT00907153|11583230|FG001|STARTED|Overall Study||15
10436934|NCT00907153|11583229|FG000|COMPLETED|Overall Study||11
10436935|NCT00907153|11583230|FG001|COMPLETED|Overall Study||11
10436936|NCT00907153|11583229|FG000|NOT COMPLETED|Overall Study||2
10436937|NCT00907153|11583230|FG001|NOT COMPLETED|Overall Study||4
10436938|NCT00907257|11583238|FG000|STARTED|Overall Study||123
10436939|NCT00907257|11583239|FG001|STARTED|Overall Study||124
10436940|NCT00907257|11583238|FG000|COMPLETED|Overall Study||110
10436941|NCT00907257|11583239|FG001|COMPLETED|Overall Study||112
10436942|NCT00907257|11583238|FG000|NOT COMPLETED|Overall Study||13
10436943|NCT00907257|11583239|FG001|NOT COMPLETED|Overall Study||12
10436984|NCT00907335|11583288|FG000|STARTED|Overall Study||55
10436985|NCT00907335|11583289|FG001|STARTED|Overall Study||55
10436986|NCT00907335|11583288|FG000|COMPLETED|Overall Study||47
10436987|NCT00907335|11583289|FG001|COMPLETED|Overall Study||54
10436988|NCT00907335|11583288|FG000|NOT COMPLETED|Overall Study||8
10436989|NCT00907335|11583289|FG001|NOT COMPLETED|Overall Study||1
10436990|NCT00907374|11583297|FG000|STARTED|Overall Study||14
10436991|NCT00907374|11583298|FG001|STARTED|Overall Study||13
10436992|NCT00907374|11583297|FG000|COMPLETED|Overall Study||12
10436993|NCT00907374|11583298|FG001|COMPLETED|Overall Study||11
10436994|NCT00907374|11583297|FG000|NOT COMPLETED|Overall Study||2
10436995|NCT00907374|11583298|FG001|NOT COMPLETED|Overall Study||2
10436996|NCT00907426|11583307|FG000|STARTED|Treatment Period 1 (0 to 6 Months)||215
10436997|NCT00907426|11583308|FG001|STARTED|Treatment Period 1 (0 to 6 Months)||60
10436998|NCT00907426|11583309|FG002|STARTED|Treatment Period 1 (0 to 6 Months)||93
10436999|NCT00907426|11583307|FG000|COMPLETED|Treatment Period 1 (0 to 6 Months)||195
10437000|NCT00907426|11583308|FG001|COMPLETED|Treatment Period 1 (0 to 6 Months)||55
10437001|NCT00907426|11583309|FG002|COMPLETED|Treatment Period 1 (0 to 6 Months)||84
10437002|NCT00907426|11583307|FG000|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||20
10437003|NCT00907426|11583308|FG001|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||5
10437004|NCT00907426|11583309|FG002|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||9
10437005|NCT00907426|11583307|FG000|STARTED|Treatment Period 2 (6 to 12 Months)||195
10437006|NCT00907426|11583308|FG001|STARTED|Treatment Period 2 (6 to 12 Months)||55
10437007|NCT00907426|11583309|FG002|STARTED|Treatment Period 2 (6 to 12 Months)||84
10437008|NCT00907426|11583307|FG000|COMPLETED|Treatment Period 2 (6 to 12 Months)||184
10437009|NCT00907426|11583308|FG001|COMPLETED|Treatment Period 2 (6 to 12 Months)||52
10437010|NCT00907426|11583309|FG002|COMPLETED|Treatment Period 2 (6 to 12 Months)||77
10437011|NCT00907426|11583307|FG000|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||11
10437012|NCT00907426|11583308|FG001|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||3
10437013|NCT00907426|11583309|FG002|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||7
10437023|NCT00907517|11583336|FG000|STARTED|Overall Study||3
10437024|NCT00907517|11583337|FG001|STARTED|Overall Study||3
10437025|NCT00907517|11583338|FG002|STARTED|Overall Study||6
10437026|NCT00907517|11583339|FG003|STARTED|Overall Study||6
10437027|NCT00907517|11583340|FG004|STARTED|Overall Study||6
10437028|NCT00907517|11583336|FG000|COMPLETED|Overall Study||0
10437029|NCT00907517|11583337|FG001|COMPLETED|Overall Study||0
10437030|NCT00907517|11583338|FG002|COMPLETED|Overall Study||2
10437031|NCT00907517|11583339|FG003|COMPLETED|Overall Study||2
10437032|NCT00907517|11583340|FG004|COMPLETED|Overall Study||1
10437033|NCT00907517|11583336|FG000|NOT COMPLETED|Overall Study||3
10437034|NCT00907517|11583337|FG001|NOT COMPLETED|Overall Study||3
10437035|NCT00907517|11583338|FG002|NOT COMPLETED|Overall Study||4
10437036|NCT00907517|11583339|FG003|NOT COMPLETED|Overall Study||4
10437037|NCT00907517|11583340|FG004|NOT COMPLETED|Overall Study||5
10437038|NCT00907621|11583354|FG000|STARTED|Overall Study||45
10437039|NCT00907621|11583355|FG001|STARTED|Overall Study||45
10437040|NCT00907621|11583354|FG000|COMPLETED|Overall Study||38
10437041|NCT00907621|11583355|FG001|COMPLETED|Overall Study||41
10437042|NCT00907621|11583354|FG000|NOT COMPLETED|Overall Study||7
10437043|NCT00907621|11583355|FG001|NOT COMPLETED|Overall Study||4
10437044|NCT00907738|11583366|FG000|STARTED|Overall Study||13
10437045|NCT00907738|11583367|FG001|STARTED|Overall Study||1
10437046|NCT00907738|11583368|FG002|STARTED|Overall Study||7
10437047|NCT00907738|11583369|FG003|STARTED|Overall Study||4
10437048|NCT00907738|11583370|FG004|STARTED|Overall Study||2
10437049|NCT00907738|11583366|FG000|COMPLETED|Overall Study||0
10437050|NCT00907738|11583367|FG001|COMPLETED|Overall Study||0
10437051|NCT00907738|11583368|FG002|COMPLETED|Overall Study||0
10437052|NCT00907738|11583369|FG003|COMPLETED|Overall Study||0
10437053|NCT00907738|11583370|FG004|COMPLETED|Overall Study||0
10437054|NCT00907738|11583366|FG000|NOT COMPLETED|Overall Study||13
10437055|NCT00907738|11583367|FG001|NOT COMPLETED|Overall Study||1
10437056|NCT00907738|11583368|FG002|NOT COMPLETED|Overall Study||7
10437057|NCT00907738|11583369|FG003|NOT COMPLETED|Overall Study||4
10437058|NCT00907738|11583370|FG004|NOT COMPLETED|Overall Study||2
10437059|NCT00907777|11583388|FG000|STARTED|Overall Study||25
10437060|NCT00907777|11583389|FG001|STARTED|Overall Study||27
10437061|NCT00907777|11583388|FG000|COMPLETED|Overall Study||25
10437062|NCT00907777|11583389|FG001|COMPLETED|Overall Study||26
10437063|NCT00907777|11583388|FG000|NOT COMPLETED|Overall Study||0
10437064|NCT00907777|11583389|FG001|NOT COMPLETED|Overall Study||1
10437065|NCT00907803|11583398|FG000|STARTED|Overall Study||45
10437066|NCT00907803|11583399|FG001|STARTED|Overall Study||46
10437067|NCT00907803|11583400|FG002|STARTED|Overall Study||16
10437068|NCT00907803|11583398|FG000|COMPLETED|Overall Study||42
10437069|NCT00907803|11583399|FG001|COMPLETED|Overall Study||43
10437070|NCT00907803|11583400|FG002|COMPLETED|Overall Study||16
10437071|NCT00907803|11583398|FG000|NOT COMPLETED|Overall Study||3
10437072|NCT00907803|11583399|FG001|NOT COMPLETED|Overall Study||3
10437073|NCT00907803|11583400|FG002|NOT COMPLETED|Overall Study||0
10437074|NCT00907881|11583408|FG000|STARTED|Overall Study||1069
10437075|NCT00907881|11583408|FG000|COMPLETED|Overall Study||984
10437076|NCT00907881|11583408|FG000|NOT COMPLETED|Overall Study||85
10437077|NCT00908011|11583414|FG000|STARTED|Overall Study||23
10437078|NCT00908011|11583415|FG001|STARTED|Overall Study||20
10437079|NCT00908011|11583414|FG000|COMPLETED|Overall Study||21
10437080|NCT00908011|11583415|FG001|COMPLETED|Overall Study||18
10437081|NCT00908011|11583414|FG000|NOT COMPLETED|Overall Study||2
10437082|NCT00908011|11583415|FG001|NOT COMPLETED|Overall Study||2
10437083|NCT00908037|11583428|FG000|STARTED|Part1 (24 Week Dose-Finding Period)||5
10437084|NCT00908037|11583429|FG001|STARTED|Part1 (24 Week Dose-Finding Period)||5
10437085|NCT00908037|11583430|FG002|STARTED|Part1 (24 Week Dose-Finding Period)||5
10437086|NCT00908037|11583431|FG003|STARTED|Part1 (24 Week Dose-Finding Period)||0
10437087|NCT00908037|11583432|FG004|STARTED|Part1 (24 Week Dose-Finding Period)||0
10437088|NCT00908037|11583433|FG005|STARTED|Part1 (24 Week Dose-Finding Period)||0
10437089|NCT00908037|11583434|FG006|STARTED|Part1 (24 Week Dose-Finding Period)||0
10437090|NCT00908037|11583435|FG007|STARTED|Part1 (24 Week Dose-Finding Period)||0
10437091|NCT00908037|11583436|FG008|STARTED|Part1 (24 Week Dose-Finding Period)||0
10437092|NCT00908037|11583437|FG009|STARTED|Part1 (24 Week Dose-Finding Period)||0
10437093|NCT00908037|11583438|FG010|STARTED|Part1 (24 Week Dose-Finding Period)||0
10437094|NCT00908037|11583439|FG011|STARTED|Part1 (24 Week Dose-Finding Period)||0
10437095|NCT00908037|11583428|FG000|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
10437096|NCT00908037|11583429|FG001|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
10437097|NCT00908037|11583430|FG002|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
10437098|NCT00908037|11583431|FG003|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
10437099|NCT00908037|11583432|FG004|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
10437100|NCT00908037|11583433|FG005|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
10437101|NCT00908037|11583434|FG006|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
10789240|NCT03519516|11949617|FG000|COMPLETED|Overall Study||15
10437102|NCT00908037|11583435|FG007|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
10437103|NCT00908037|11583436|FG008|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
10437104|NCT00908037|11583437|FG009|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
10437105|NCT00908037|11583438|FG010|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
10437106|NCT00908037|11583439|FG011|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
10437107|NCT00908037|11583428|FG000|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
10437108|NCT00908037|11583429|FG001|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
10437109|NCT00908037|11583430|FG002|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
10437110|NCT00908037|11583431|FG003|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
10437111|NCT00908037|11583432|FG004|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
10437112|NCT00908037|11583433|FG005|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
10437113|NCT00908037|11583434|FG006|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
10437114|NCT00908037|11583435|FG007|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
10437115|NCT00908037|11583436|FG008|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
10437116|NCT00908037|11583437|FG009|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
10437117|NCT00908037|11583438|FG010|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
10437118|NCT00908037|11583439|FG011|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
10437119|NCT00908037|11583428|FG000|STARTED|Part 2 (7 Week Randomized Period)||0
10437120|NCT00908037|11583429|FG001|STARTED|Part 2 (7 Week Randomized Period)||0
10437121|NCT00908037|11583430|FG002|STARTED|Part 2 (7 Week Randomized Period)||0
10437122|NCT00908037|11583431|FG003|STARTED|Part 2 (7 Week Randomized Period)||8
10437123|NCT00908037|11583432|FG004|STARTED|Part 2 (7 Week Randomized Period)||16
10437124|NCT00908037|11583433|FG005|STARTED|Part 2 (7 Week Randomized Period)||9
10437125|NCT00908037|11583434|FG006|STARTED|Part 2 (7 Week Randomized Period)||19
10789241|NCT03519516|11949618|FG001|COMPLETED|Overall Study||14
10437126|NCT00908037|11583435|FG007|STARTED|Part 2 (7 Week Randomized Period)||5
10437127|NCT00908037|11583436|FG008|STARTED|Part 2 (7 Week Randomized Period)||10
10437128|NCT00908037|11583437|FG009|STARTED|Part 2 (7 Week Randomized Period)||0
10437129|NCT00908037|11583438|FG010|STARTED|Part 2 (7 Week Randomized Period)||0
10437130|NCT00908037|11583439|FG011|STARTED|Part 2 (7 Week Randomized Period)||0
10437131|NCT00908037|11583428|FG000|COMPLETED|Part 2 (7 Week Randomized Period)||0
10437132|NCT00908037|11583429|FG001|COMPLETED|Part 2 (7 Week Randomized Period)||0
10437133|NCT00908037|11583430|FG002|COMPLETED|Part 2 (7 Week Randomized Period)||0
10437134|NCT00908037|11583431|FG003|COMPLETED|Part 2 (7 Week Randomized Period)||7
10437135|NCT00908037|11583432|FG004|COMPLETED|Part 2 (7 Week Randomized Period)||13
10437136|NCT00908037|11583433|FG005|COMPLETED|Part 2 (7 Week Randomized Period)||9
10437137|NCT00908037|11583434|FG006|COMPLETED|Part 2 (7 Week Randomized Period)||15
10437138|NCT00908037|11583435|FG007|COMPLETED|Part 2 (7 Week Randomized Period)||5
10437139|NCT00908037|11583436|FG008|COMPLETED|Part 2 (7 Week Randomized Period)||5
10437140|NCT00908037|11583437|FG009|COMPLETED|Part 2 (7 Week Randomized Period)||0
10437141|NCT00908037|11583438|FG010|COMPLETED|Part 2 (7 Week Randomized Period)||0
10437142|NCT00908037|11583439|FG011|COMPLETED|Part 2 (7 Week Randomized Period)||0
10437143|NCT00908037|11583428|FG000|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
10437144|NCT00908037|11583429|FG001|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
10437145|NCT00908037|11583430|FG002|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
10437146|NCT00908037|11583431|FG003|NOT COMPLETED|Part 2 (7 Week Randomized Period)||1
10437147|NCT00908037|11583432|FG004|NOT COMPLETED|Part 2 (7 Week Randomized Period)||3
10437148|NCT00908037|11583433|FG005|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
10437149|NCT00908037|11583434|FG006|NOT COMPLETED|Part 2 (7 Week Randomized Period)||4
10437150|NCT00908037|11583435|FG007|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
10437151|NCT00908037|11583436|FG008|NOT COMPLETED|Part 2 (7 Week Randomized Period)||5
10437152|NCT00908037|11583437|FG009|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
10437153|NCT00908037|11583438|FG010|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
10437154|NCT00908037|11583439|FG011|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
10437155|NCT00908037|11583428|FG000|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
10437156|NCT00908037|11583429|FG001|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
10437157|NCT00908037|11583430|FG002|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
10437158|NCT00908037|11583431|FG003|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
10437159|NCT00908037|11583432|FG004|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
10437160|NCT00908037|11583433|FG005|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
10437161|NCT00908037|11583434|FG006|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
10437162|NCT00908037|11583435|FG007|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
10437163|NCT00908037|11583436|FG008|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
10437164|NCT00908037|11583437|FG009|STARTED|Part 2/3(Eltrombopag Open-Label Period)||24
10437165|NCT00908037|11583438|FG010|STARTED|Part 2/3(Eltrombopag Open-Label Period)|Two participants were randomized but did not receive treatment.|28
10437166|NCT00908037|11583439|FG011|STARTED|Part 2/3(Eltrombopag Open-Label Period)||15
10437167|NCT00908037|11583428|FG000|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
10437168|NCT00908037|11583429|FG001|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
10437169|NCT00908037|11583430|FG002|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
10437170|NCT00908037|11583431|FG003|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
10789242|NCT03519516|11949617|FG000|NOT COMPLETED|Overall Study||0
10789243|NCT03519516|11949618|FG001|NOT COMPLETED|Overall Study||1
10437171|NCT00908037|11583432|FG004|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
10437172|NCT00908037|11583433|FG005|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
10437173|NCT00908037|11583434|FG006|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
10437174|NCT00908037|11583435|FG007|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
10437175|NCT00908037|11583436|FG008|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
10437176|NCT00908037|11583437|FG009|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||21
10437177|NCT00908037|11583438|FG010|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)|Two participants were randomized but did not receive treatment.|24
10437178|NCT00908037|11583439|FG011|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||12
10437179|NCT00908037|11583428|FG000|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
10437180|NCT00908037|11583429|FG001|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
10437181|NCT00908037|11583430|FG002|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
10437182|NCT00908037|11583431|FG003|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
10437183|NCT00908037|11583432|FG004|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
10437184|NCT00908037|11583433|FG005|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
10437185|NCT00908037|11583434|FG006|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
10437186|NCT00908037|11583435|FG007|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
10437187|NCT00908037|11583436|FG008|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
10437188|NCT00908037|11583437|FG009|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||3
10437189|NCT00908037|11583438|FG010|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||4
10437190|NCT00908037|11583439|FG011|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||3
10437191|NCT00908076|11583493|FG000|STARTED|Overall Study||27
10437192|NCT00908076|11583494|FG001|STARTED|Overall Study||27
10437193|NCT00908076|11583493|FG000|COMPLETED|Overall Study||26
10437194|NCT00908076|11583494|FG001|COMPLETED|Overall Study||26
10437195|NCT00908076|11583493|FG000|NOT COMPLETED|Overall Study||1
10789244|NCT03519854|11949642|FG000|STARTED|Overall Study|N=3 randomized to Arm A. An additional N=1 (randomized to Arm C) is counted as Started in Arm A|4
10789245|NCT03519854|11949643|FG001|STARTED|Overall Study||6
10789246|NCT03519854|11949644|FG002|STARTED|Overall Study||5
10437196|NCT00908076|11583494|FG001|NOT COMPLETED|Overall Study||1
10437197|NCT00908115|11583500|FG000|STARTED|Overall Study||1258
10437198|NCT00908115|11583500|FG000|COMPLETED|Overall Study||1244
10437199|NCT00908115|11583500|FG000|NOT COMPLETED|Overall Study||14
10437200|NCT00908141|11583506|FG000|STARTED|Overall Study||8
10437201|NCT00908141|11583507|FG001|STARTED|Overall Study||9
10437202|NCT00908141|11583506|FG000|COMPLETED|Overall Study||8
10789247|NCT03519854|11949645|FG003|STARTED|Overall Study||6
10789248|NCT03519854|11949646|FG004|STARTED|Overall Study||6
10789249|NCT03519854|11949647|FG005|STARTED|Overall Study||6
10789250|NCT03519854|11949648|FG006|STARTED|Overall Study||3
10789251|NCT03519854|11949649|FG007|STARTED|Overall Study||6
10789252|NCT03519854|11949650|FG008|STARTED|Overall Study||6
10789253|NCT03519854|11949651|FG009|STARTED|Overall Study||6
10789254|NCT03519854|11949652|FG010|STARTED|Overall Study||6
10789255|NCT03519854|11949653|FG011|STARTED|Overall Study||6
10789256|NCT03519854|11949654|FG012|STARTED|Overall Study||3
10789257|NCT03519854|11949655|FG013|STARTED|Overall Study||6
10789258|NCT03519854|11949656|FG014|STARTED|Overall Study||6
10789259|NCT03519854|11949657|FG015|STARTED|Overall Study||6
10789260|NCT03519854|11949658|FG016|STARTED|Overall Study||6
10789261|NCT03519854|11949659|FG017|STARTED|Overall Study||6
10789262|NCT03519854|11949642|FG000|Treated|Overall Study|N=1 (randomized to Arm C) received placebo, 3 min after 1.2 mg/kg Esmeron®|4
10789263|NCT03519854|11949643|FG001|Treated|Overall Study||6
10789264|NCT03519854|11949644|FG002|Treated|Overall Study||4
10789265|NCT03519854|11949645|FG003|Treated|Overall Study||6
10789266|NCT03519854|11949646|FG004|Treated|Overall Study||6
10789267|NCT03519854|11949647|FG005|Treated|Overall Study||6
10789268|NCT03519854|11949648|FG006|Treated|Overall Study||3
10789269|NCT03519854|11949649|FG007|Treated|Overall Study||6
10789270|NCT03519854|11949650|FG008|Treated|Overall Study||6
10789271|NCT03519854|11949651|FG009|Treated|Overall Study||6
10789272|NCT03519854|11949652|FG010|Treated|Overall Study||6
10437203|NCT00908141|11583507|FG001|COMPLETED|Overall Study||8
10437204|NCT00908141|11583506|FG000|NOT COMPLETED|Overall Study||0
10437205|NCT00908141|11583507|FG001|NOT COMPLETED|Overall Study||1
10437206|NCT00908232|11583513|FG000|STARTED|Cycle 1 to 4|All participants started VD treatment for 4 cycles prior to local site response assessments|163
10437207|NCT00908232|11583514|FG001|STARTED|Cycle 1 to 4||0
10437208|NCT00908232|11583515|FG002|STARTED|Cycle 1 to 4||0
10437209|NCT00908232|11583516|FG003|STARTED|Cycle 1 to 4||0
10437210|NCT00908232|11583513|FG000|COMPLETED|Cycle 1 to 4|Of those completed, 120 subjects were assessed for response, 117 w/ Response or SD continued.|135
10437211|NCT00908232|11583514|FG001|COMPLETED|Cycle 1 to 4||0
10437212|NCT00908232|11583515|FG002|COMPLETED|Cycle 1 to 4||0
10437213|NCT00908232|11583516|FG003|COMPLETED|Cycle 1 to 4||0
10437214|NCT00908232|11583513|FG000|NOT COMPLETED|Cycle 1 to 4||28
10650477|NCT02169479|11810755|FG003|STARTED|Overall Study||4
10437215|NCT00908232|11583514|FG001|NOT COMPLETED|Cycle 1 to 4||0
10650478|NCT02169479|11810752|FG000|25 mg BIA 9-1067|Overall Study||4
10789273|NCT03519854|11949653|FG011|Treated|Overall Study||6
10789274|NCT03519854|11949654|FG012|Treated|Overall Study||3
10789275|NCT03519854|11949655|FG013|Treated|Overall Study||6
10789276|NCT03519854|11949656|FG014|Treated|Overall Study||6
10789277|NCT03519854|11949657|FG015|Treated|Overall Study||6
10789278|NCT03519854|11949658|FG016|Treated|Overall Study||6
10789279|NCT03519854|11949659|FG017|Treated|Overall Study||6
10789280|NCT03519854|11949642|FG000|COMPLETED|Overall Study||4
10437216|NCT00908232|11583515|FG002|NOT COMPLETED|Cycle 1 to 4||0
10437217|NCT00908232|11583516|FG003|NOT COMPLETED|Cycle 1 to 4||0
10437218|NCT00908232|11583513|FG000|STARTED|Randomization (Cycle 5) to Cycle 8|Responding patients (not randomized) who received 4 more cycles of VD|98
10437219|NCT00908232|11583514|FG001|STARTED|Randomization (Cycle 5) to Cycle 8||7
10437220|NCT00908232|11583515|FG002|STARTED|Randomization (Cycle 5) to Cycle 8||8
10437221|NCT00908232|11583516|FG003|STARTED|Randomization (Cycle 5) to Cycle 8||4
10437222|NCT00908232|11583513|FG000|COMPLETED|Randomization (Cycle 5) to Cycle 8||63
10437223|NCT00908232|11583514|FG001|COMPLETED|Randomization (Cycle 5) to Cycle 8||4
10437224|NCT00908232|11583515|FG002|COMPLETED|Randomization (Cycle 5) to Cycle 8||7
10437225|NCT00908232|11583516|FG003|COMPLETED|Randomization (Cycle 5) to Cycle 8||4
10437226|NCT00908232|11583513|FG000|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||35
10437227|NCT00908232|11583514|FG001|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||3
10437228|NCT00908232|11583515|FG002|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||1
10437229|NCT00908232|11583516|FG003|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||0
10437230|NCT00908310|11583522|FG000|STARTED|Overall Study||213
10437231|NCT00908310|11583522|FG000|COMPLETED|Overall Study||153
10437232|NCT00908310|11583522|FG000|NOT COMPLETED|Overall Study||60
10437233|NCT00908349|11583526|FG000|STARTED|Overall Study||214
10437234|NCT00908349|11583526|FG000|COMPLETED|Overall Study||179
10437235|NCT00908349|11583526|FG000|NOT COMPLETED|Overall Study||35
10437236|NCT00908375|11583532|FG000|STARTED|Overall Study||20
10437237|NCT00908375|11583533|FG001|STARTED|Overall Study||19
10437238|NCT00908375|11583532|FG000|COMPLETED|Overall Study||10
10437239|NCT00908375|11583533|FG001|COMPLETED|Overall Study||9
10437240|NCT00908375|11583532|FG000|NOT COMPLETED|Overall Study||10
10437241|NCT00908375|11583533|FG001|NOT COMPLETED|Overall Study||10
10437242|NCT00908388|11583539|FG000|STARTED|Overall Study||50
10437243|NCT00908388|11583539|FG000|COMPLETED|Overall Study||40
10437244|NCT00908388|11583539|FG000|NOT COMPLETED|Overall Study||10
10437245|NCT00908466|11583545|FG000|STARTED|Overall Study||15
10437246|NCT00908466|11583546|FG001|STARTED|Overall Study||15
10437247|NCT00908466|11583545|FG000|COMPLETED|Overall Study||14
10437248|NCT00908466|11583546|FG001|COMPLETED|Overall Study||14
10437249|NCT00908466|11583545|FG000|NOT COMPLETED|Overall Study||1
10437250|NCT00908466|11583546|FG001|NOT COMPLETED|Overall Study||1
10437251|NCT00908544|11583554|FG000|STARTED|Overall Study||20
10437252|NCT00908544|11583555|FG001|STARTED|Overall Study||22
10437253|NCT00908544|11583554|FG000|COMPLETED|Overall Study||15
10437254|NCT00908544|11583555|FG001|COMPLETED|Overall Study||16
10437255|NCT00908544|11583554|FG000|NOT COMPLETED|Overall Study||5
10437256|NCT00908544|11583555|FG001|NOT COMPLETED|Overall Study||6
10437257|NCT00908583|11583561|FG000|STARTED|Phase 1||20
10437258|NCT00908583|11583561|FG000|COMPLETED|Phase 1||15
10437259|NCT00908583|11583561|FG000|NOT COMPLETED|Phase 1||5
10437260|NCT00908583|11583561|FG000|STARTED|Phase 2||12
10437261|NCT00908583|11583561|FG000|COMPLETED|Phase 2||10
10437262|NCT00908583|11583561|FG000|NOT COMPLETED|Phase 2||2
10437263|NCT00908583|11583561|FG000|STARTED|Phase 3||10
10437264|NCT00908583|11583561|FG000|COMPLETED|Phase 3||8
10437265|NCT00908583|11583561|FG000|NOT COMPLETED|Phase 3||2
10437266|NCT00908583|11583561|FG000|STARTED|Phase 4||5
10437267|NCT00908583|11583561|FG000|COMPLETED|Phase 4||3
10437268|NCT00908583|11583561|FG000|NOT COMPLETED|Phase 4||2
10437269|NCT00908583|11583561|FG000|STARTED|Phase 5||5
10437270|NCT00908583|11583561|FG000|COMPLETED|Phase 5||2
10437271|NCT00908583|11583561|FG000|NOT COMPLETED|Phase 5||3
10437272|NCT00908596|11583583|FG000|STARTED|Overall Study||47
10437273|NCT00908596|11583584|FG001|STARTED|Overall Study||32
10437274|NCT00908596|11583585|FG002|STARTED|Overall Study||193
10437275|NCT00908596|11583586|FG003|STARTED|Overall Study||85
10437276|NCT00908596|11583583|FG000|COMPLETED|Overall Study||0
10437277|NCT00908596|11583584|FG001|COMPLETED|Overall Study||19
10437278|NCT00908596|11583585|FG002|COMPLETED|Overall Study||119
10437279|NCT00908596|11583586|FG003|COMPLETED|Overall Study||48
10437280|NCT00908596|11583583|FG000|NOT COMPLETED|Overall Study||47
10437281|NCT00908596|11583584|FG001|NOT COMPLETED|Overall Study||13
10437282|NCT00908596|11583585|FG002|NOT COMPLETED|Overall Study||74
10437283|NCT00908596|11583586|FG003|NOT COMPLETED|Overall Study||37
10437284|NCT00908791|11583596|FG000|STARTED|Overall Study||24
10437285|NCT00908791|11583596|FG000|COMPLETED|Overall Study||24
10437286|NCT00908791|11583596|FG000|NOT COMPLETED|Overall Study||0
10437287|NCT00908830|11583611|FG000|STARTED|Overall Study||5
10437288|NCT00908830|11583612|FG001|STARTED|Overall Study||5
10437289|NCT00908830|11583611|FG000|COMPLETED|Overall Study||5
10437290|NCT00908830|11583612|FG001|COMPLETED|Overall Study||5
10437291|NCT00908830|11583611|FG000|NOT COMPLETED|Overall Study||0
10437292|NCT00908830|11583612|FG001|NOT COMPLETED|Overall Study||0
10437293|NCT00908882|11583620|FG000|STARTED|Overall Study||89
10437294|NCT00908882|11583621|FG001|STARTED|Overall Study||89
10437295|NCT00908882|11583620|FG000|COMPLETED|Overall Study||61
10437296|NCT00908882|11583621|FG001|COMPLETED|Overall Study||59
10437297|NCT00908882|11583620|FG000|NOT COMPLETED|Overall Study||28
10437298|NCT00908882|11583621|FG001|NOT COMPLETED|Overall Study||30
10525311|NCT01375075|11677207|FG003|Received at Least One Dose of Study Drug|Overall Study||28
10525312|NCT01375075|11677208|FG004|Received at Least One Dose of Study Drug|Overall Study||27
10525313|NCT01375075|11677209|FG005|Received at Least One Dose of Study Drug|Overall Study||28
10525314|NCT01375075|11677204|FG000|COMPLETED|Overall Study||26
10525315|NCT01375075|11677205|FG001|COMPLETED|Overall Study||27
10525316|NCT01375075|11677206|FG002|COMPLETED|Overall Study||24
10525317|NCT01375075|11677207|FG003|COMPLETED|Overall Study||27
10437299|NCT00908895|11583629|FG000|STARTED|Overall Study||57
10437300|NCT00908895|11583630|FG001|STARTED|Overall Study||63
10437301|NCT00908895|11583629|FG000|COMPLETED|Overall Study||53
10437302|NCT00908895|11583630|FG001|COMPLETED|Overall Study||57
10437303|NCT00908895|11583629|FG000|NOT COMPLETED|Overall Study||4
10437304|NCT00908895|11583630|FG001|NOT COMPLETED|Overall Study||6
10437305|NCT00908908|11583636|FG000|STARTED|Overall Study||6
10437306|NCT00908908|11583636|FG000|Adverse Event|Overall Study||0
10437307|NCT00908908|11583636|FG000|Withdrawl by Subject|Overall Study||0
10437308|NCT00908908|11583636|FG000|Administrative/Other|Overall Study||0
10437309|NCT00908908|11583636|FG000|Physician Decision|Overall Study||0
10437310|NCT00908908|11583636|FG000|COMPLETED|Overall Study||6
10437311|NCT00908908|11583636|FG000|NOT COMPLETED|Overall Study||0
10437312|NCT00908947|11583640|FG000|STARTED|Overall Study||173
10437313|NCT00908947|11583640|FG000|COMPLETED|Overall Study||83
10437314|NCT00908947|11583640|FG000|NOT COMPLETED|Overall Study||90
10437315|NCT00908960|11583648|FG000|STARTED|Overall Study||24
10437316|NCT00908960|11583649|FG001|STARTED|Overall Study||12
10437317|NCT00908960|11583650|FG002|STARTED|Overall Study||34
10437318|NCT00908960|11583648|FG000|Evaluable|Overall Study||23
10437319|NCT00908960|11583649|FG001|Evaluable|Overall Study||11
10437320|NCT00908960|11583650|FG002|Evaluable|Overall Study||32
10437321|NCT00908960|11583648|FG000|COMPLETED|Overall Study||23
10437322|NCT00908960|11583649|FG001|COMPLETED|Overall Study||11
10437323|NCT00908960|11583650|FG002|COMPLETED|Overall Study||32
10437324|NCT00908960|11583648|FG000|NOT COMPLETED|Overall Study||1
10437325|NCT00908960|11583649|FG001|NOT COMPLETED|Overall Study||1
10437326|NCT00908960|11583650|FG002|NOT COMPLETED|Overall Study||2
10437327|NCT00909038|11583658|FG000|STARTED|Overall Study||2411
10437328|NCT00909038|11583658|FG000|COMPLETED|Overall Study||1994
10437329|NCT00909038|11583658|FG000|NOT COMPLETED|Overall Study||417
10437330|NCT00909064|11583662|FG000|STARTED|Overall Study||114
10437331|NCT00909064|11583662|FG000|COMPLETED|Overall Study||114
10437332|NCT00909064|11583662|FG000|NOT COMPLETED|Overall Study||0
10437333|NCT00909090|11583668|FG000|STARTED|Overall Study||53
10437334|NCT00909090|11583669|FG001|STARTED|Overall Study||56
10437335|NCT00909090|11583668|FG000|COMPLETED|Overall Study||36
10437336|NCT00909090|11583669|FG001|COMPLETED|Overall Study||39
10437337|NCT00909090|11583668|FG000|NOT COMPLETED|Overall Study||17
10437338|NCT00909090|11583669|FG001|NOT COMPLETED|Overall Study||17
10437339|NCT00909155|11583681|FG000|STARTED|Overall Study||15
10437340|NCT00909155|11583682|FG001|STARTED|Overall Study||14
10437341|NCT00909155|11583683|FG002|STARTED|Overall Study||21
10437342|NCT00909155|11583681|FG000|COMPLETED|Overall Study||12
10437343|NCT00909155|11583682|FG001|COMPLETED|Overall Study||9
10437344|NCT00909155|11583683|FG002|COMPLETED|Overall Study||14
10437345|NCT00909155|11583681|FG000|NOT COMPLETED|Overall Study||3
10437346|NCT00909155|11583682|FG001|NOT COMPLETED|Overall Study||5
10437347|NCT00909155|11583683|FG002|NOT COMPLETED|Overall Study||7
10437348|NCT00909181|11583697|FG000|STARTED|Overall Study||210
10437349|NCT00909181|11583698|FG001|STARTED|Overall Study||214
10437350|NCT00909181|11583699|FG002|STARTED|Overall Study||202
10437351|NCT00909181|11583697|FG000|COMPLETED|Overall Study||171
10437352|NCT00909181|11583698|FG001|COMPLETED|Overall Study||196
10437353|NCT00909181|11583699|FG002|COMPLETED|Overall Study||169
10437354|NCT00909181|11583697|FG000|NOT COMPLETED|Overall Study||39
10437355|NCT00909181|11583698|FG001|NOT COMPLETED|Overall Study||18
10437356|NCT00909181|11583699|FG002|NOT COMPLETED|Overall Study||33
10437357|NCT00909220|11583709|FG000|STARTED|Overall Study|Started enrolling participants May 2009|41
10437358|NCT00909220|11583710|FG001|STARTED|Overall Study|Started enrolling participants May 2009|36
10437359|NCT00909220|11583709|FG000|Data Entry|Overall Study||41
10437360|NCT00909220|11583710|FG001|Data Entry|Overall Study||36
10437361|NCT00909220|11583709|FG000|Data Analyses|Overall Study||41
10437362|NCT00909220|11583710|FG001|Data Analyses|Overall Study||36
10437363|NCT00909220|11583709|FG000|Submission for Publication|Overall Study||41
10437364|NCT00909220|11583710|FG001|Submission for Publication|Overall Study||36
10437365|NCT00909220|11583709|FG000|COMPLETED|Overall Study||41
10437366|NCT00909220|11583710|FG001|COMPLETED|Overall Study||36
10789281|NCT03519854|11949643|FG001|COMPLETED|Overall Study||6
10437367|NCT00909220|11583709|FG000|NOT COMPLETED|Overall Study||0
10437368|NCT00909220|11583710|FG001|NOT COMPLETED|Overall Study||0
10437369|NCT00909324|11583720|FG000|STARTED|Overall Study||72
10437370|NCT00909324|11583721|FG001|STARTED|Overall Study||90
10437371|NCT00909324|11583720|FG000|COMPLETED|Overall Study||72
10789282|NCT03519854|11949644|FG002|COMPLETED|Overall Study||4
10437372|NCT00909324|11583721|FG001|COMPLETED|Overall Study||90
10437373|NCT00909324|11583720|FG000|NOT COMPLETED|Overall Study||0
10437374|NCT00909324|11583721|FG001|NOT COMPLETED|Overall Study||0
10437375|NCT00909363|11583730|FG000|STARTED|Overall Study||11
10437376|NCT00909363|11583731|FG001|STARTED|Overall Study||8
10437377|NCT00909363|11583732|FG002|STARTED|Overall Study||5
10437378|NCT00909363|11583730|FG000|COMPLETED|Overall Study|1 patient started bleeding 3 days after starting eltrombopag; he underwent bone marrow transplant|9
10437379|NCT00909363|11583731|FG001|COMPLETED|Overall Study||8
10437380|NCT00909363|11583732|FG002|COMPLETED|Overall Study||5
10437381|NCT00909363|11583730|FG000|NOT COMPLETED|Overall Study||2
10437382|NCT00909363|11583731|FG001|NOT COMPLETED|Overall Study||0
10437383|NCT00909363|11583732|FG002|NOT COMPLETED|Overall Study||0
10437384|NCT00909428|11583746|FG000|STARTED|Overall Study||18
10437385|NCT00909428|11583747|FG001|STARTED|Overall Study||15
10437386|NCT00909428|11583748|FG002|STARTED|Overall Study||9
10437387|NCT00909428|11583746|FG000|COMPLETED|Overall Study||5
10437388|NCT00909428|11583747|FG001|COMPLETED|Overall Study||5
10437389|NCT00909428|11583748|FG002|COMPLETED|Overall Study||0
10437390|NCT00909428|11583746|FG000|NOT COMPLETED|Overall Study||13
10437391|NCT00909428|11583747|FG001|NOT COMPLETED|Overall Study||10
10437392|NCT00909428|11583748|FG002|NOT COMPLETED|Overall Study||9
10437393|NCT00909480|11583757|FG000|STARTED|Overall Study||228
10437394|NCT00909480|11583758|FG001|STARTED|Overall Study||229
10437395|NCT00909480|11583757|FG000|Exposed|Overall Study|2 subjects withdrew before exposure to trial insulin|226
10437396|NCT00909480|11583758|FG001|Exposed|Overall Study|2 subjects withdrew before exposure to trial insulin|227
10437397|NCT00909480|11583757|FG000|COMPLETED|Overall Study||190
10437398|NCT00909480|11583758|FG001|COMPLETED|Overall Study||188
10437399|NCT00909480|11583757|FG000|NOT COMPLETED|Overall Study||38
10437400|NCT00909480|11583758|FG001|NOT COMPLETED|Overall Study||41
10789283|NCT03519854|11949645|FG003|COMPLETED|Overall Study||6
10789284|NCT03519854|11949646|FG004|COMPLETED|Overall Study||6
10789285|NCT03519854|11949647|FG005|COMPLETED|Overall Study||6
10789286|NCT03519854|11949648|FG006|COMPLETED|Overall Study||3
10789287|NCT03519854|11949649|FG007|COMPLETED|Overall Study||6
10789288|NCT03519854|11949650|FG008|COMPLETED|Overall Study||6
10789289|NCT03519854|11949651|FG009|COMPLETED|Overall Study||6
10789290|NCT03519854|11949652|FG010|COMPLETED|Overall Study||6
10789291|NCT03519854|11949653|FG011|COMPLETED|Overall Study||6
10789292|NCT03519854|11949654|FG012|COMPLETED|Overall Study||3
10789293|NCT03519854|11949655|FG013|COMPLETED|Overall Study||6
10437401|NCT00909532|11583766|FG000|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (placebo).|78
10437402|NCT00909532|11583767|FG001|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (ivacaftor).|83
10437403|NCT00909532|11583766|FG000|Completed Treatment Period, Week 24|Overall Study||71
10437404|NCT00909532|11583767|FG001|Completed Treatment Period, Week 24|Overall Study||80
10549616|NCT01526213|11703638|FG005|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
10549617|NCT01526213|11703633|FG000|NOT COMPLETED|Period 2 (5 Days)||0
10549618|NCT01526213|11703634|FG001|NOT COMPLETED|Period 2 (5 Days)||0
10549619|NCT01526213|11703635|FG002|NOT COMPLETED|Period 2 (5 Days)||0
10549620|NCT01526213|11703636|FG003|NOT COMPLETED|Period 2 (5 Days)||0
10549621|NCT01526213|11703637|FG004|NOT COMPLETED|Period 2 (5 Days)||0
10549622|NCT01526213|11703638|FG005|NOT COMPLETED|Period 2 (5 Days)||0
10549623|NCT01526213|11703633|FG000|STARTED|Washout 2 (10 Days)||3
10549624|NCT01526213|11703634|FG001|STARTED|Washout 2 (10 Days)||3
10549625|NCT01526213|11703635|FG002|STARTED|Washout 2 (10 Days)||3
10549626|NCT01526213|11703636|FG003|STARTED|Washout 2 (10 Days)||3
10549627|NCT01526213|11703637|FG004|STARTED|Washout 2 (10 Days)||3
10549628|NCT01526213|11703638|FG005|STARTED|Washout 2 (10 Days)||3
10549629|NCT01526213|11703633|FG000|COMPLETED|Washout 2 (10 Days)||3
10549630|NCT01526213|11703634|FG001|COMPLETED|Washout 2 (10 Days)||3
10549631|NCT01526213|11703635|FG002|COMPLETED|Washout 2 (10 Days)||3
10549632|NCT01526213|11703636|FG003|COMPLETED|Washout 2 (10 Days)||3
10549633|NCT01526213|11703637|FG004|COMPLETED|Washout 2 (10 Days)||3
10549634|NCT01526213|11703638|FG005|COMPLETED|Washout 2 (10 Days)||3
10549635|NCT01526213|11703633|FG000|NOT COMPLETED|Washout 2 (10 Days)||0
10549636|NCT01526213|11703634|FG001|NOT COMPLETED|Washout 2 (10 Days)||0
10549637|NCT01526213|11703635|FG002|NOT COMPLETED|Washout 2 (10 Days)||0
10549638|NCT01526213|11703636|FG003|NOT COMPLETED|Washout 2 (10 Days)||0
10549639|NCT01526213|11703637|FG004|NOT COMPLETED|Washout 2 (10 Days)||0
10549640|NCT01526213|11703638|FG005|NOT COMPLETED|Washout 2 (10 Days)||0
10549641|NCT01526213|11703633|FG000|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
10549642|NCT01526213|11703634|FG001|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
10549643|NCT01526213|11703635|FG002|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
10549644|NCT01526213|11703636|FG003|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
10549645|NCT01526213|11703637|FG004|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
10549646|NCT01526213|11703638|FG005|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
10549647|NCT01526213|11703633|FG000|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
10549648|NCT01526213|11703634|FG001|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
10549649|NCT01526213|11703635|FG002|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
10549650|NCT01526213|11703636|FG003|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
10549651|NCT01526213|11703637|FG004|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
10549652|NCT01526213|11703638|FG005|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
10549653|NCT01526213|11703633|FG000|NOT COMPLETED|Period 3 (5 Days)||0
10789294|NCT03519854|11949656|FG014|COMPLETED|Overall Study||6
10789295|NCT03519854|11949657|FG015|COMPLETED|Overall Study||6
10789296|NCT03519854|11949658|FG016|COMPLETED|Overall Study||6
10789297|NCT03519854|11949659|FG017|COMPLETED|Overall Study||6
10789298|NCT03519854|11949642|FG000|NOT COMPLETED|Overall Study||0
10789299|NCT03519854|11949643|FG001|NOT COMPLETED|Overall Study||0
10437405|NCT00909532|11583766|FG000|COMPLETED|Overall Study|Completed Treatment and Extension Periods (Through Week 48)|68
10437406|NCT00909532|11583767|FG001|COMPLETED|Overall Study|Completed Treatment and Extension Periods (Through Week 48)|77
10437407|NCT00909532|11583766|FG000|NOT COMPLETED|Overall Study||10
10437408|NCT00909532|11583767|FG001|NOT COMPLETED|Overall Study||6
10437409|NCT00909545|11583778|FG000|STARTED|Overall Study||26
10437410|NCT00909545|11583779|FG001|STARTED|Overall Study||23
10437411|NCT00909545|11583780|FG002|STARTED|Overall Study||26
10437412|NCT00909545|11583781|FG003|STARTED|Overall Study||24
10437413|NCT00909545|11583778|FG000|COMPLETED|Overall Study||25
10437414|NCT00909545|11583779|FG001|COMPLETED|Overall Study||22
10437415|NCT00909545|11583780|FG002|COMPLETED|Overall Study||25
10437416|NCT00909545|11583781|FG003|COMPLETED|Overall Study||19
10437417|NCT00909545|11583778|FG000|NOT COMPLETED|Overall Study||1
10437418|NCT00909545|11583779|FG001|NOT COMPLETED|Overall Study||1
10789300|NCT03519854|11949644|FG002|NOT COMPLETED|Overall Study||1
10789301|NCT03519854|11949645|FG003|NOT COMPLETED|Overall Study||0
10789302|NCT03519854|11949646|FG004|NOT COMPLETED|Overall Study||0
10789303|NCT03519854|11949647|FG005|NOT COMPLETED|Overall Study||0
10789304|NCT03519854|11949648|FG006|NOT COMPLETED|Overall Study||0
10789305|NCT03519854|11949649|FG007|NOT COMPLETED|Overall Study||0
10789306|NCT03519854|11949650|FG008|NOT COMPLETED|Overall Study||0
10789307|NCT03519854|11949651|FG009|NOT COMPLETED|Overall Study||0
10789308|NCT03519854|11949652|FG010|NOT COMPLETED|Overall Study||0
10789309|NCT03519854|11949653|FG011|NOT COMPLETED|Overall Study||0
10789310|NCT03519854|11949654|FG012|NOT COMPLETED|Overall Study||0
10437419|NCT00909545|11583780|FG002|NOT COMPLETED|Overall Study||1
10437420|NCT00909545|11583781|FG003|NOT COMPLETED|Overall Study||5
10437421|NCT00909727|11583794|FG000|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (placebo)|26
10437422|NCT00909727|11583795|FG001|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (ivacaftor)|26
10437423|NCT00909727|11583794|FG000|Completed Treatment Period, Week 24|Overall Study||23
10437424|NCT00909727|11583795|FG001|Completed Treatment Period, Week 24|Overall Study||26
10437425|NCT00909727|11583794|FG000|COMPLETED|Overall Study|Completed Treatment and Extension Periods (through Week 48)|22
10437426|NCT00909727|11583795|FG001|COMPLETED|Overall Study|Completed Treatment and Extension Periods (through Week 48)|26
10437427|NCT00909727|11583794|FG000|NOT COMPLETED|Overall Study||4
10437428|NCT00909727|11583795|FG001|NOT COMPLETED|Overall Study||0
10437429|NCT00909779|11583803|FG000|STARTED|Overall Study||421
10437430|NCT00909779|11583804|FG001|STARTED|Overall Study||420
10437431|NCT00909779|11583803|FG000|COMPLETED|Overall Study|All subjects but 47 were followed for 12 months/until death (whichever was earlier).|211
10437432|NCT00909779|11583804|FG001|COMPLETED|Overall Study|All subjects but 42 were followed for 12 months/until death (whichever was earlier).|255
10437433|NCT00909779|11583803|FG000|NOT COMPLETED|Overall Study||210
10437434|NCT00909779|11583804|FG001|NOT COMPLETED|Overall Study||165
10437435|NCT00909792|11583812|FG000|STARTED|Period 1||130
10437436|NCT00909792|11583813|FG001|STARTED|Period 1||128
10437437|NCT00909792|11583812|FG000|COMPLETED|Period 1||130
10437438|NCT00909792|11583813|FG001|COMPLETED|Period 1||127
10437439|NCT00909792|11583812|FG000|NOT COMPLETED|Period 1||0
10437440|NCT00909792|11583813|FG001|NOT COMPLETED|Period 1||1
10437441|NCT00909792|11583812|FG000|STARTED|Period 2|One participant discontinued between Period 1 and Period 2 due to lack of efficacy.|129
10437442|NCT00909792|11583813|FG001|STARTED|Period 2|Two discontinuations between P1 & P2: 1 for fail inc/exc criteria; 1 for lack of efficacy.|125
10437443|NCT00909792|11583812|FG000|COMPLETED|Period 2||128
10437444|NCT00909792|11583813|FG001|COMPLETED|Period 2||124
10437445|NCT00909792|11583812|FG000|NOT COMPLETED|Period 2||1
10437446|NCT00909792|11583813|FG001|NOT COMPLETED|Period 2||1
10437447|NCT00909844|11583819|FG000|STARTED|Overall Study||35
10437448|NCT00909844|11583819|FG000|COMPLETED|Overall Study||31
10437449|NCT00909844|11583819|FG000|NOT COMPLETED|Overall Study||4
10437450|NCT00909857|11583826|FG000|STARTED|Overall Study||253
10437451|NCT00909857|11583827|FG001|STARTED|Overall Study||254
10437452|NCT00909857|11583826|FG000|Treated|Overall Study||234
10437453|NCT00909857|11583827|FG001|Treated|Overall Study||230
10437454|NCT00909857|11583826|FG000|COMPLETED|Overall Study||217
10437455|NCT00909857|11583827|FG001|COMPLETED|Overall Study||209
10437456|NCT00909857|11583826|FG000|NOT COMPLETED|Overall Study||36
10437457|NCT00909857|11583827|FG001|NOT COMPLETED|Overall Study||45
10437458|NCT00909870|11583835|FG000|STARTED|Overall Study||274
10437459|NCT00909870|11583836|FG001|STARTED|Overall Study||263
10437460|NCT00909870|11583835|FG000|COMPLETED|Overall Study||251
10437461|NCT00909870|11583836|FG001|COMPLETED|Overall Study||236
10437462|NCT00909870|11583835|FG000|NOT COMPLETED|Overall Study||23
10437463|NCT00909870|11583836|FG001|NOT COMPLETED|Overall Study||27
10437464|NCT00910000|11583849|FG000|STARTED|Overall Study||3
10437465|NCT00910000|11583850|FG001|STARTED|Overall Study||3
10437466|NCT00910000|11583851|FG002|STARTED|Overall Study||3
10437467|NCT00910000|11583852|FG003|STARTED|Overall Study||2
10437468|NCT00910000|11583853|FG004|STARTED|Overall Study||3
10437469|NCT00910000|11583854|FG005|STARTED|Overall Study||1
10437470|NCT00910000|11583849|FG000|COMPLETED|Overall Study||3
10437471|NCT00910000|11583850|FG001|COMPLETED|Overall Study||0
10437472|NCT00910000|11583851|FG002|COMPLETED|Overall Study||0
10437473|NCT00910000|11583852|FG003|COMPLETED|Overall Study||0
10437474|NCT00910000|11583853|FG004|COMPLETED|Overall Study||2
10437475|NCT00910000|11583854|FG005|COMPLETED|Overall Study||0
10437476|NCT00910000|11583849|FG000|NOT COMPLETED|Overall Study||0
10437477|NCT00910000|11583850|FG001|NOT COMPLETED|Overall Study||3
10789311|NCT03519854|11949655|FG013|NOT COMPLETED|Overall Study||0
10789312|NCT03519854|11949656|FG014|NOT COMPLETED|Overall Study||0
10789313|NCT03519854|11949657|FG015|NOT COMPLETED|Overall Study||0
10789314|NCT03519854|11949658|FG016|NOT COMPLETED|Overall Study||0
10789315|NCT03519854|11949659|FG017|NOT COMPLETED|Overall Study||0
10437478|NCT00910000|11583851|FG002|NOT COMPLETED|Overall Study||3
10437479|NCT00910000|11583852|FG003|NOT COMPLETED|Overall Study||2
10437480|NCT00910000|11583853|FG004|NOT COMPLETED|Overall Study||1
10437481|NCT00910000|11583854|FG005|NOT COMPLETED|Overall Study||1
10437482|NCT00910039|11583864|FG000|STARTED|Overall Study||14
10437483|NCT00910039|11583864|FG000|COMPLETED|Overall Study||13
10437484|NCT00910039|11583864|FG000|NOT COMPLETED|Overall Study||1
10437485|NCT00910091|11583871|FG000|STARTED|Pre-assignment||36
10437486|NCT00910091|11583872|FG001|STARTED|Pre-assignment||37
10437487|NCT00910091|11583871|FG000|COMPLETED|Pre-assignment||36
10437488|NCT00910091|11583872|FG001|COMPLETED|Pre-assignment||35
10437489|NCT00910091|11583871|FG000|NOT COMPLETED|Pre-assignment||0
10437490|NCT00910091|11583872|FG001|NOT COMPLETED|Pre-assignment||2
10437491|NCT00910091|11583871|FG000|STARTED|Treatment and Survival||36
10437492|NCT00910091|11583872|FG001|STARTED|Treatment and Survival||35
10437493|NCT00910091|11583871|FG000|COMPLETED|Treatment and Survival||32
10437494|NCT00910091|11583872|FG001|COMPLETED|Treatment and Survival||31
10437495|NCT00910091|11583871|FG000|NOT COMPLETED|Treatment and Survival||4
10437496|NCT00910091|11583872|FG001|NOT COMPLETED|Treatment and Survival||4
10437497|NCT00910208|11583882|FG000|STARTED|Overall Study||69
10437498|NCT00910208|11583883|FG001|STARTED|Overall Study||72
10437499|NCT00910208|11583884|FG002|STARTED|Overall Study||70
10437500|NCT00910208|11583882|FG000|COMPLETED|Overall Study||67
10437501|NCT00910208|11583883|FG001|COMPLETED|Overall Study||70
10437502|NCT00910208|11583884|FG002|COMPLETED|Overall Study||69
10437503|NCT00910208|11583882|FG000|NOT COMPLETED|Overall Study||2
10437504|NCT00910208|11583883|FG001|NOT COMPLETED|Overall Study||2
10437505|NCT00910208|11583884|FG002|NOT COMPLETED|Overall Study||1
10437506|NCT00910247|11583892|FG000|STARTED|Overall Study||274
10437507|NCT00910247|11583892|FG000|COMPLETED|Overall Study||205
10437508|NCT00910247|11583892|FG000|NOT COMPLETED|Overall Study||69
10437509|NCT00910273|11583898|FG000|STARTED|Overall Study||18
10437510|NCT00910273|11583899|FG001|STARTED|Overall Study||16
10437511|NCT00910273|11583898|FG000|COMPLETED|Overall Study||0
10437512|NCT00910273|11583899|FG001|COMPLETED|Overall Study||3
10437513|NCT00910273|11583898|FG000|NOT COMPLETED|Overall Study||18
10437514|NCT00910273|11583899|FG001|NOT COMPLETED|Overall Study||13
10437515|NCT00910299|11583907|FG000|STARTED|Overall Study||212
10437516|NCT00910299|11583908|FG001|STARTED|Overall Study||211
10437517|NCT00910299|11583907|FG000|Received at Least 1 Dose of Study Drug|Overall Study||210
10437518|NCT00910299|11583908|FG001|Received at Least 1 Dose of Study Drug|Overall Study||210
10437519|NCT00910299|11583907|FG000|COMPLETED|Overall Study||136
10437520|NCT00910299|11583908|FG001|COMPLETED|Overall Study|"1 participant died of sepsis while on study drug and was considered a protocol completer."|137
10437521|NCT00910299|11583907|FG000|NOT COMPLETED|Overall Study||76
10437522|NCT00910299|11583908|FG001|NOT COMPLETED|Overall Study||74
10437523|NCT00910429|11583916|FG000|STARTED|Overall Study||155
10437524|NCT00910429|11583917|FG001|STARTED|Overall Study||82
10437525|NCT00910429|11583916|FG000|COMPLETED|Overall Study|Completed treatment|116
10437526|NCT00910429|11583917|FG001|COMPLETED|Overall Study|Completed treatment|61
10437527|NCT00910429|11583916|FG000|NOT COMPLETED|Overall Study||39
10437528|NCT00910429|11583917|FG001|NOT COMPLETED|Overall Study||21
10437529|NCT00910481|11583925|FG000|STARTED|Overall Study||151
10437530|NCT00910481|11583926|FG001|STARTED|Overall Study||150
10437531|NCT00910481|11583925|FG000|COMPLETED|Overall Study||151
10437532|NCT00910481|11583926|FG001|COMPLETED|Overall Study||150
10437533|NCT00910481|11583925|FG000|NOT COMPLETED|Overall Study||0
10437534|NCT00910481|11583926|FG001|NOT COMPLETED|Overall Study||0
10437535|NCT00910520|11583934|FG000|STARTED|Treatment Cycle 1||277
10437536|NCT00910520|11583935|FG001|STARTED|Treatment Cycle 1||271
10437537|NCT00910520|11583934|FG000|COMPLETED|Treatment Cycle 1||257
10437538|NCT00910520|11583935|FG001|COMPLETED|Treatment Cycle 1||247
10437539|NCT00910520|11583934|FG000|NOT COMPLETED|Treatment Cycle 1||20
10437540|NCT00910520|11583935|FG001|NOT COMPLETED|Treatment Cycle 1||24
10437541|NCT00910520|11583934|FG000|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|163
10437542|NCT00910520|11583935|FG001|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|223
10437543|NCT00910520|11583934|FG000|COMPLETED|Treatment Cycle 2||156
10437544|NCT00910520|11583935|FG001|COMPLETED|Treatment Cycle 2||215
10437545|NCT00910520|11583934|FG000|NOT COMPLETED|Treatment Cycle 2||7
10437546|NCT00910520|11583935|FG001|NOT COMPLETED|Treatment Cycle 2||8
10437547|NCT00910624|11583945|FG000|STARTED|Treatment Phase||52
10437548|NCT00910624|11583946|FG001|STARTED|Treatment Phase||85
10437549|NCT00910624|11583947|FG002|STARTED|Treatment Phase||29
10437550|NCT00910624|11583948|FG003|STARTED|Treatment Phase||2
10437551|NCT00910624|11583945|FG000|COMPLETED|Treatment Phase||22
10437552|NCT00910624|11583946|FG001|COMPLETED|Treatment Phase||64
10437553|NCT00910624|11583947|FG002|COMPLETED|Treatment Phase||20
10437554|NCT00910624|11583948|FG003|COMPLETED|Treatment Phase||2
10437555|NCT00910624|11583945|FG000|NOT COMPLETED|Treatment Phase||30
10437556|NCT00910624|11583946|FG001|NOT COMPLETED|Treatment Phase||21
10437557|NCT00910624|11583947|FG002|NOT COMPLETED|Treatment Phase||9
10437558|NCT00910624|11583948|FG003|NOT COMPLETED|Treatment Phase||0
10437559|NCT00910624|11583945|FG000|STARTED|Follow-Up Phase||48
10437560|NCT00910624|11583946|FG001|STARTED|Follow-Up Phase||80
10437561|NCT00910624|11583947|FG002|STARTED|Follow-Up Phase||29
10437562|NCT00910624|11583948|FG003|STARTED|Follow-Up Phase||2
10437563|NCT00910624|11583945|FG000|COMPLETED|Follow-Up Phase||42
10437564|NCT00910624|11583946|FG001|COMPLETED|Follow-Up Phase||76
10437565|NCT00910624|11583947|FG002|COMPLETED|Follow-Up Phase||25
10437566|NCT00910624|11583948|FG003|COMPLETED|Follow-Up Phase||2
10437567|NCT00910624|11583945|FG000|NOT COMPLETED|Follow-Up Phase||6
10437568|NCT00910624|11583946|FG001|NOT COMPLETED|Follow-Up Phase||4
10437569|NCT00910624|11583947|FG002|NOT COMPLETED|Follow-Up Phase||4
10437570|NCT00910624|11583948|FG003|NOT COMPLETED|Follow-Up Phase||0
10437571|NCT00910663|11583958|FG000|STARTED|Period 1||30
10437572|NCT00910663|11583959|FG001|STARTED|Period 1||30
10437573|NCT00910663|11583958|FG000|COMPLETED|Period 1||30
10437574|NCT00910663|11583959|FG001|COMPLETED|Period 1||29
10437575|NCT00910663|11583958|FG000|NOT COMPLETED|Period 1||0
10437576|NCT00910663|11583959|FG001|NOT COMPLETED|Period 1||1
10437577|NCT00910663|11583958|FG000|STARTED|Period 2||30
10437578|NCT00910663|11583959|FG001|STARTED|Period 2||29
10437579|NCT00910663|11583958|FG000|COMPLETED|Period 2||30
10437580|NCT00910663|11583959|FG001|COMPLETED|Period 2||29
10437581|NCT00910663|11583958|FG000|NOT COMPLETED|Period 2||0
10437582|NCT00910663|11583959|FG001|NOT COMPLETED|Period 2||0
10437583|NCT00910689|11583969|FG000|STARTED|Month 1: Optimal Acute Therapy Run in||55
10437584|NCT00910689|11583970|FG001|STARTED|Month 1: Optimal Acute Therapy Run in||53
10437585|NCT00910689|11583971|FG002|STARTED|Month 1: Optimal Acute Therapy Run in||55
10437586|NCT00910689|11583972|FG003|STARTED|Month 1: Optimal Acute Therapy Run in||69
10437587|NCT00910689|11583969|FG000|COMPLETED|Month 1: Optimal Acute Therapy Run in||53
10437588|NCT00910689|11583970|FG001|COMPLETED|Month 1: Optimal Acute Therapy Run in||52
10437589|NCT00910689|11583971|FG002|COMPLETED|Month 1: Optimal Acute Therapy Run in||50
10437590|NCT00910689|11583972|FG003|COMPLETED|Month 1: Optimal Acute Therapy Run in||59
10437591|NCT00910689|11583969|FG000|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||2
10437592|NCT00910689|11583970|FG001|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||1
10437593|NCT00910689|11583971|FG002|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||5
10437594|NCT00910689|11583972|FG003|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||10
10437595|NCT00910689|11583969|FG000|STARTED|Month 2- 4: Treatment Period||53
10437596|NCT00910689|11583970|FG001|STARTED|Month 2- 4: Treatment Period||52
10437597|NCT00910689|11583971|FG002|STARTED|Month 2- 4: Treatment Period||50
10437598|NCT00910689|11583972|FG003|STARTED|Month 2- 4: Treatment Period||59
10437599|NCT00910689|11583969|FG000|COMPLETED|Month 2- 4: Treatment Period||44
10437600|NCT00910689|11583970|FG001|COMPLETED|Month 2- 4: Treatment Period||42
10437601|NCT00910689|11583971|FG002|COMPLETED|Month 2- 4: Treatment Period||42
10437602|NCT00910689|11583972|FG003|COMPLETED|Month 2- 4: Treatment Period||48
10437603|NCT00910689|11583969|FG000|NOT COMPLETED|Month 2- 4: Treatment Period||9
10437604|NCT00910689|11583970|FG001|NOT COMPLETED|Month 2- 4: Treatment Period||10
10437605|NCT00910689|11583971|FG002|NOT COMPLETED|Month 2- 4: Treatment Period||8
10437606|NCT00910689|11583972|FG003|NOT COMPLETED|Month 2- 4: Treatment Period||11
10437607|NCT00910689|11583969|FG000|STARTED|Months 5 - 10: Evaluation Period I||44
10437608|NCT00910689|11583970|FG001|STARTED|Months 5 - 10: Evaluation Period I||42
10437609|NCT00910689|11583971|FG002|STARTED|Months 5 - 10: Evaluation Period I||42
10437610|NCT00910689|11583972|FG003|STARTED|Months 5 - 10: Evaluation Period I||48
10437611|NCT00910689|11583969|FG000|COMPLETED|Months 5 - 10: Evaluation Period I||40
10437612|NCT00910689|11583970|FG001|COMPLETED|Months 5 - 10: Evaluation Period I||35
10437613|NCT00910689|11583971|FG002|COMPLETED|Months 5 - 10: Evaluation Period I||35
10437614|NCT00910689|11583972|FG003|COMPLETED|Months 5 - 10: Evaluation Period I||41
10437615|NCT00910689|11583969|FG000|NOT COMPLETED|Months 5 - 10: Evaluation Period I||4
10437616|NCT00910689|11583970|FG001|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
10437617|NCT00910689|11583971|FG002|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
10549654|NCT01526213|11703634|FG001|NOT COMPLETED|Period 3 (5 Days)||0
10549655|NCT01526213|11703635|FG002|NOT COMPLETED|Period 3 (5 Days)||0
10549656|NCT01526213|11703636|FG003|NOT COMPLETED|Period 3 (5 Days)||0
10549657|NCT01526213|11703637|FG004|NOT COMPLETED|Period 3 (5 Days)||0
10549658|NCT01526213|11703638|FG005|NOT COMPLETED|Period 3 (5 Days)||0
10549659|NCT01526343|11703649|FG000|STARTED|Overall Study||47
10549660|NCT01526343|11703649|FG000|COMPLETED|Overall Study||47
10549661|NCT01526343|11703649|FG000|NOT COMPLETED|Overall Study||0
10549662|NCT01526356|11703656|FG000|STARTED|Overall Study||59
10549663|NCT01526356|11703657|FG001|STARTED|Overall Study||63
10549664|NCT01526356|11703658|FG002|STARTED|Overall Study||57
10549665|NCT01526356|11703656|FG000|COMPLETED|Overall Study||51
10437618|NCT00910689|11583972|FG003|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
10437619|NCT00910689|11583969|FG000|STARTED|Months 11- 16: Evaluation Period II||40
10437620|NCT00910689|11583970|FG001|STARTED|Months 11- 16: Evaluation Period II||35
10437621|NCT00910689|11583971|FG002|STARTED|Months 11- 16: Evaluation Period II||35
10437622|NCT00910689|11583972|FG003|STARTED|Months 11- 16: Evaluation Period II||41
10437623|NCT00910689|11583969|FG000|COMPLETED|Months 11- 16: Evaluation Period II||30
10437624|NCT00910689|11583970|FG001|COMPLETED|Months 11- 16: Evaluation Period II||25
10437625|NCT00910689|11583971|FG002|COMPLETED|Months 11- 16: Evaluation Period II||28
10437626|NCT00910689|11583972|FG003|COMPLETED|Months 11- 16: Evaluation Period II||35
10437627|NCT00910689|11583969|FG000|NOT COMPLETED|Months 11- 16: Evaluation Period II||10
10549666|NCT01526356|11703657|FG001|COMPLETED|Overall Study||53
10437628|NCT00910689|11583970|FG001|NOT COMPLETED|Months 11- 16: Evaluation Period II||10
10437629|NCT00910689|11583971|FG002|NOT COMPLETED|Months 11- 16: Evaluation Period II||7
10437630|NCT00910689|11583972|FG003|NOT COMPLETED|Months 11- 16: Evaluation Period II||6
10437631|NCT00910715|11583985|FG000|STARTED|Overall Study||108
10549667|NCT01526356|11703658|FG002|COMPLETED|Overall Study||45
10549668|NCT01526356|11703656|FG000|NOT COMPLETED|Overall Study||8
10437632|NCT00910715|11583986|FG001|STARTED|Overall Study||117
10437633|NCT00910715|11583987|FG002|STARTED|Overall Study||81
10437634|NCT00910715|11583985|FG000|COMPLETED|Overall Study||86
10437635|NCT00910715|11583986|FG001|COMPLETED|Overall Study||91
10437636|NCT00910715|11583987|FG002|COMPLETED|Overall Study||81
10437637|NCT00910715|11583985|FG000|NOT COMPLETED|Overall Study||22
10437638|NCT00910715|11583986|FG001|NOT COMPLETED|Overall Study||26
10437639|NCT00910715|11583987|FG002|NOT COMPLETED|Overall Study||0
10437640|NCT00910728|11584006|FG000|STARTED|Overall Study||6
10437641|NCT00910728|11584007|FG001|STARTED|Overall Study||3
10437642|NCT00910728|11584008|FG002|STARTED|Overall Study||3
10437643|NCT00910728|11584009|FG003|STARTED|Overall Study||3
10437644|NCT00910728|11584010|FG004|STARTED|Overall Study||6
10437645|NCT00910728|11584011|FG005|STARTED|Overall Study||1
10437646|NCT00910728|11584012|FG006|STARTED|Overall Study||6
10437647|NCT00910728|11584013|FG007|STARTED|Overall Study||4
10437648|NCT00910728|11584014|FG008|STARTED|Overall Study||3
10437649|NCT00910728|11584006|FG000|COMPLETED|Overall Study||0
10437650|NCT00910728|11584007|FG001|COMPLETED|Overall Study||0
10437651|NCT00910728|11584008|FG002|COMPLETED|Overall Study||0
10437652|NCT00910728|11584009|FG003|COMPLETED|Overall Study||0
10437653|NCT00910728|11584010|FG004|COMPLETED|Overall Study||1
10437654|NCT00910728|11584011|FG005|COMPLETED|Overall Study||0
10437655|NCT00910728|11584012|FG006|COMPLETED|Overall Study||0
10437656|NCT00910728|11584013|FG007|COMPLETED|Overall Study||1
10437657|NCT00910728|11584014|FG008|COMPLETED|Overall Study||0
10437658|NCT00910728|11584006|FG000|NOT COMPLETED|Overall Study||6
10437659|NCT00910728|11584007|FG001|NOT COMPLETED|Overall Study||3
10437660|NCT00910728|11584008|FG002|NOT COMPLETED|Overall Study||3
10437661|NCT00910728|11584009|FG003|NOT COMPLETED|Overall Study||3
10437662|NCT00910728|11584010|FG004|NOT COMPLETED|Overall Study||5
10437663|NCT00910728|11584011|FG005|NOT COMPLETED|Overall Study||1
10437664|NCT00910728|11584012|FG006|NOT COMPLETED|Overall Study||6
10437665|NCT00910728|11584013|FG007|NOT COMPLETED|Overall Study||3
10437666|NCT00910728|11584014|FG008|NOT COMPLETED|Overall Study||3
10437667|NCT00910845|11584036|FG000|STARTED|Treatment Cycle 1||280
10437668|NCT00910845|11584037|FG001|STARTED|Treatment Cycle 1||277
10437669|NCT00910845|11584036|FG000|COMPLETED|Treatment Cycle 1||249
10437670|NCT00910845|11584037|FG001|COMPLETED|Treatment Cycle 1||243
10437671|NCT00910845|11584036|FG000|NOT COMPLETED|Treatment Cycle 1||31
10437672|NCT00910845|11584037|FG001|NOT COMPLETED|Treatment Cycle 1||34
10437673|NCT00910845|11584036|FG000|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|141
10437674|NCT00910845|11584037|FG001|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|212
10437675|NCT00910845|11584036|FG000|COMPLETED|Treatment Cycle 2||136
10437676|NCT00910845|11584037|FG001|COMPLETED|Treatment Cycle 2||203
10437677|NCT00910845|11584036|FG000|NOT COMPLETED|Treatment Cycle 2||5
10437678|NCT00910845|11584037|FG001|NOT COMPLETED|Treatment Cycle 2||9
10437679|NCT00910858|11584046|FG000|STARTED|Pharmacokinetic Phase||9
10437680|NCT00910858|11584047|FG001|STARTED|Pharmacokinetic Phase||0
10437681|NCT00910858|11584048|FG002|STARTED|Pharmacokinetic Phase||3
10437682|NCT00910858|11584046|FG000|COMPLETED|Pharmacokinetic Phase||8
10437683|NCT00910858|11584047|FG001|COMPLETED|Pharmacokinetic Phase||0
10437684|NCT00910858|11584048|FG002|COMPLETED|Pharmacokinetic Phase||3
10437685|NCT00910858|11584046|FG000|NOT COMPLETED|Pharmacokinetic Phase||1
10437686|NCT00910858|11584047|FG001|NOT COMPLETED|Pharmacokinetic Phase||0
10437687|NCT00910858|11584048|FG002|NOT COMPLETED|Pharmacokinetic Phase||0
10437688|NCT00910858|11584046|FG000|STARTED|Monotherapy Phase|Includes 8 participants from the PK Phase and 9 newly enrolled participants.|17
10437689|NCT00910858|11584047|FG001|STARTED|Monotherapy Phase|All 15 participants were newly enrolled into the Monotherapy Phase.|15
10437690|NCT00910858|11584048|FG002|STARTED|Monotherapy Phase|Includes 3 participants from the PK Phase and 4 newly enrolled participants.|7
10437691|NCT00910858|11584046|FG000|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|17
10437692|NCT00910858|11584047|FG001|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|15
10437693|NCT00910858|11584048|FG002|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|7
10437694|NCT00910858|11584046|FG000|Pharmacokinetic Population|Monotherapy Phase||17
10437695|NCT00910858|11584047|FG001|Pharmacokinetic Population|Monotherapy Phase|Patients in the 15 mg Non-del 5q group were not included in the pharmacokinetic assessment.|0
10437696|NCT00910858|11584048|FG002|Pharmacokinetic Population|Monotherapy Phase||7
10437697|NCT00910858|11584046|FG000|COMPLETED|Monotherapy Phase||0
10437698|NCT00910858|11584047|FG001|COMPLETED|Monotherapy Phase||0
10437699|NCT00910858|11584048|FG002|COMPLETED|Monotherapy Phase||0
10437700|NCT00910858|11584046|FG000|NOT COMPLETED|Monotherapy Phase||17
10437701|NCT00910858|11584047|FG001|NOT COMPLETED|Monotherapy Phase||15
10437702|NCT00910858|11584048|FG002|NOT COMPLETED|Monotherapy Phase||7
10437703|NCT00910858|11584046|FG000|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|9
10437704|NCT00910858|11584047|FG001|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|10
10437705|NCT00910858|11584048|FG002|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|4
10437706|NCT00910858|11584046|FG000|COMPLETED|Combined Treatment Phase||0
10437707|NCT00910858|11584047|FG001|COMPLETED|Combined Treatment Phase||0
10437708|NCT00910858|11584048|FG002|COMPLETED|Combined Treatment Phase||0
10437709|NCT00910858|11584046|FG000|NOT COMPLETED|Combined Treatment Phase||9
10437710|NCT00910858|11584047|FG001|NOT COMPLETED|Combined Treatment Phase||10
10437711|NCT00910858|11584048|FG002|NOT COMPLETED|Combined Treatment Phase||4
10437712|NCT00910871|11584064|FG000|STARTED|Overall Study||233
10437713|NCT00910871|11584064|FG000|COMPLETED|Overall Study||179
10437714|NCT00910871|11584064|FG000|NOT COMPLETED|Overall Study||54
10437715|NCT00910910|11584070|FG000|STARTED|Overall Study||225
10437716|NCT00910910|11584071|FG001|STARTED|Overall Study||225
10437717|NCT00910910|11584070|FG000|Safety Population|Overall Study|All randomized participants who received at least 1 dose of the either lenalidomide or chlorambucil|224
10437718|NCT00910910|11584071|FG001|Safety Population|Overall Study|All randomized participants who received at least 1 dose of the either lenalidomide or chlorambucil|223
10437719|NCT00910910|11584070|FG000|COMPLETED|Overall Study|Completed includes participants who continued with ongoing treatment|0
10437720|NCT00910910|11584071|FG001|COMPLETED|Overall Study|Completed includes participants who continued with ongoing treatment|1
10437721|NCT00910910|11584070|FG000|NOT COMPLETED|Overall Study||225
10437722|NCT00910910|11584071|FG001|NOT COMPLETED|Overall Study||224
10437723|NCT00910962|11584080|FG000|STARTED|Overall Study||135
10437724|NCT00910962|11584081|FG001|STARTED|Overall Study||199
10437725|NCT00910962|11584082|FG002|STARTED|Overall Study||192
10437726|NCT00910962|11584080|FG000|COMPLETED|Overall Study||92
10437727|NCT00910962|11584081|FG001|COMPLETED|Overall Study||121
10437728|NCT00910962|11584082|FG002|COMPLETED|Overall Study||116
10437729|NCT00910962|11584080|FG000|NOT COMPLETED|Overall Study||43
10437730|NCT00910962|11584081|FG001|NOT COMPLETED|Overall Study||78
10437731|NCT00910962|11584082|FG002|NOT COMPLETED|Overall Study||76
10437732|NCT00910988|11584096|FG000|STARTED|Overall Study||16
10437733|NCT00910988|11584097|FG001|STARTED|Overall Study||16
10437734|NCT00910988|11584098|FG002|STARTED|Overall Study||8
10437735|NCT00910988|11584099|FG003|STARTED|Overall Study||6
10437736|NCT00910988|11584096|FG000|COMPLETED|Overall Study||14
10437737|NCT00910988|11584097|FG001|COMPLETED|Overall Study||12
10437738|NCT00910988|11584098|FG002|COMPLETED|Overall Study||5
10437739|NCT00910988|11584099|FG003|COMPLETED|Overall Study||6
10437740|NCT00910988|11584096|FG000|NOT COMPLETED|Overall Study||2
10437741|NCT00910988|11584097|FG001|NOT COMPLETED|Overall Study||4
10437742|NCT00910988|11584098|FG002|NOT COMPLETED|Overall Study||3
10437743|NCT00910988|11584099|FG003|NOT COMPLETED|Overall Study||0
10437744|NCT00911144|11584127|FG000|STARTED|Overall Study||335
10437745|NCT00911144|11584128|FG001|STARTED|Overall Study||113
10789316|NCT03519867|11949707|FG000|STARTED|Overall Study||6
10789317|NCT03519867|11949708|FG001|STARTED|Overall Study|One participant randomized to receive MK-8616 8.0 mg/kg received MK-8616 0.8 mg/kg.|7
10789318|NCT03519867|11949709|FG002|STARTED|Overall Study||6
10437746|NCT00911144|11584127|FG000|COMPLETED|Overall Study||319
10437747|NCT00911144|11584128|FG001|COMPLETED|Overall Study||108
10437748|NCT00911144|11584127|FG000|NOT COMPLETED|Overall Study||16
10437749|NCT00911144|11584128|FG001|NOT COMPLETED|Overall Study||5
10437750|NCT00911157|11584136|FG000|STARTED|Overall Study||29
10437751|NCT00911157|11584137|FG001|STARTED|Overall Study||10
10437752|NCT00911157|11584136|FG000|COMPLETED|Overall Study||22
10437753|NCT00911157|11584137|FG001|COMPLETED|Overall Study||8
10437754|NCT00911157|11584136|FG000|NOT COMPLETED|Overall Study||7
10437755|NCT00911157|11584137|FG001|NOT COMPLETED|Overall Study||2
10437756|NCT00911170|11584145|FG000|STARTED|Treatment Period||424
10437757|NCT00911170|11584146|FG001|STARTED|Treatment Period||423
10437758|NCT00911170|11584145|FG000|Received Chemotherapy|Treatment Period|Primary Analysis Set|423
10437759|NCT00911170|11584146|FG001|Received Chemotherapy|Treatment Period|Primary Analysis Set|422
10437760|NCT00911170|11584145|FG000|Received Bevacizumab|Treatment Period||423
10437761|NCT00911170|11584146|FG001|Received Bevacizumab|Treatment Period||420
10437762|NCT00911170|11584145|FG000|Received Investigational Product|Treatment Period|Includes one participant who received pegfilgrastim in error.|422
10437763|NCT00911170|11584146|FG001|Received Investigational Product|Treatment Period||419
10437764|NCT00911170|11584145|FG000|COMPLETED|Treatment Period|Completed 4 cycles of treatment including chemotherapy, bevacizumab and investigational product.|397
10437765|NCT00911170|11584146|FG001|COMPLETED|Treatment Period|Completed 4 cycles of treatment including chemotherapy, bevacizumab and investigational product.|386
10437766|NCT00911170|11584145|FG000|NOT COMPLETED|Treatment Period||27
10437767|NCT00911170|11584146|FG001|NOT COMPLETED|Treatment Period||37
10437768|NCT00911170|11584145|FG000|STARTED|Long Term Follow-Up|Participants who received treatment in the Treatment Period|423
10437769|NCT00911170|11584146|FG001|STARTED|Long Term Follow-Up|Participants who received treatment in the Treatment Period|422
10437770|NCT00911170|11584145|FG000|COMPLETED|Long Term Follow-Up|As of the data cut-off date of 8 June 2012|0
10437771|NCT00911170|11584146|FG001|COMPLETED|Long Term Follow-Up|As of the data cut-off date of 8 June 2012|0
10437772|NCT00911170|11584145|FG000|NOT COMPLETED|Long Term Follow-Up||423
10437773|NCT00911170|11584146|FG001|NOT COMPLETED|Long Term Follow-Up||422
10437774|NCT00911300|11584154|FG000|STARTED|Overall Study||175
10437775|NCT00911300|11584155|FG001|STARTED|Overall Study||174
10437776|NCT00911300|11584154|FG000|COMPLETED|Overall Study||140
10437777|NCT00911300|11584155|FG001|COMPLETED|Overall Study||131
10437778|NCT00911300|11584154|FG000|NOT COMPLETED|Overall Study||35
10437779|NCT00911300|11584155|FG001|NOT COMPLETED|Overall Study||43
10789319|NCT03519867|11949710|FG003|STARTED|Overall Study||4
10789320|NCT03519867|11949711|FG004|STARTED|Overall Study||5
10437780|NCT00911326|11584162|FG000|STARTED|Overall Study||101
10437781|NCT00911326|11584162|FG000|COMPLETED|Overall Study||85
10437782|NCT00911326|11584162|FG000|NOT COMPLETED|Overall Study||16
10437783|NCT00911495|11584166|FG000|STARTED|Overall Study||15
10437784|NCT00911495|11584166|FG000|COMPLETED|Overall Study||14
10437785|NCT00911495|11584166|FG000|NOT COMPLETED|Overall Study||1
10437786|NCT00911508|11584172|FG000|STARTED|Overall Study||1108
10437787|NCT00911508|11584173|FG001|STARTED|Overall Study||1096
10437788|NCT00911508|11584172|FG000|COMPLETED|Overall Study||1002
10437789|NCT00911508|11584173|FG001|COMPLETED|Overall Study||966
10437790|NCT00911508|11584172|FG000|NOT COMPLETED|Overall Study||106
10437791|NCT00911508|11584173|FG001|NOT COMPLETED|Overall Study||130
10437792|NCT00911534|11584181|FG000|STARTED|Overall Study|Randomized (treated)|147
10437793|NCT00911534|11584182|FG001|STARTED|Overall Study|Randomized (treated)|153
10437794|NCT00911534|11584181|FG000|COMPLETED|Overall Study||132
10437795|NCT00911534|11584182|FG001|COMPLETED|Overall Study||137
10437796|NCT00911534|11584181|FG000|NOT COMPLETED|Overall Study||15
10437797|NCT00911534|11584182|FG001|NOT COMPLETED|Overall Study||16
10437798|NCT00911586|11584188|FG000|STARTED|Overall Study||15
10437799|NCT00911586|11584188|FG000|COMPLETED|Overall Study||15
10437800|NCT00911586|11584188|FG000|NOT COMPLETED|Overall Study||0
10437801|NCT00911612|11584195|FG000|STARTED|Overall Study||12
10437802|NCT00911612|11584196|FG001|STARTED|Overall Study||12
10437803|NCT00911612|11584195|FG000|COMPLETED|Overall Study||12
10437804|NCT00911612|11584196|FG001|COMPLETED|Overall Study||12
10437805|NCT00911612|11584195|FG000|NOT COMPLETED|Overall Study||0
10437806|NCT00911612|11584196|FG001|NOT COMPLETED|Overall Study||0
10437807|NCT00911625|11584204|FG000|STARTED|Overall Study||57
10437808|NCT00911625|11584205|FG001|STARTED|Overall Study||57
10437809|NCT00911625|11584204|FG000|COMPLETED|Overall Study||50
10437810|NCT00911625|11584205|FG001|COMPLETED|Overall Study||57
10437811|NCT00911625|11584204|FG000|NOT COMPLETED|Overall Study||7
10437812|NCT00911625|11584205|FG001|NOT COMPLETED|Overall Study||0
10437813|NCT00911742|11584213|FG000|STARTED|Treatment Phase I||13
10437814|NCT00911742|11584214|FG001|STARTED|Treatment Phase I||13
10437815|NCT00911742|11584213|FG000|COMPLETED|Treatment Phase I||13
10437816|NCT00911742|11584214|FG001|COMPLETED|Treatment Phase I||13
10437817|NCT00911742|11584213|FG000|NOT COMPLETED|Treatment Phase I||0
10437818|NCT00911742|11584214|FG001|NOT COMPLETED|Treatment Phase I||0
10437819|NCT00911742|11584213|FG000|STARTED|Treatment Phase II||13
10437820|NCT00911742|11584214|FG001|STARTED|Treatment Phase II||13
10437821|NCT00911742|11584213|FG000|COMPLETED|Treatment Phase II||13
10437822|NCT00911742|11584214|FG001|COMPLETED|Treatment Phase II||13
10437823|NCT00911742|11584213|FG000|NOT COMPLETED|Treatment Phase II||0
10437824|NCT00911742|11584214|FG001|NOT COMPLETED|Treatment Phase II||0
10437825|NCT00911768|11584222|FG000|STARTED|Overall Study||50
10437826|NCT00911768|11584223|FG001|STARTED|Overall Study||50
10437827|NCT00911768|11584222|FG000|COMPLETED|Overall Study||44
10437828|NCT00911768|11584223|FG001|COMPLETED|Overall Study||46
10437829|NCT00911768|11584222|FG000|NOT COMPLETED|Overall Study||6
10437830|NCT00911768|11584223|FG001|NOT COMPLETED|Overall Study||4
10437831|NCT00911807|11584232|FG000|STARTED|Overall Study||72
10437832|NCT00911807|11584233|FG001|STARTED|Overall Study||70
10437833|NCT00911807|11584234|FG002|STARTED|Overall Study||75
10437834|NCT00911807|11584232|FG000|COMPLETED|Overall Study||55
10437835|NCT00911807|11584233|FG001|COMPLETED|Overall Study||52
10437836|NCT00911807|11584234|FG002|COMPLETED|Overall Study||52
10437837|NCT00911807|11584232|FG000|NOT COMPLETED|Overall Study||17
10437838|NCT00911807|11584233|FG001|NOT COMPLETED|Overall Study||18
10437839|NCT00911807|11584234|FG002|NOT COMPLETED|Overall Study||23
10437840|NCT00911820|11584244|FG000|STARTED|Overall Study||45
10437841|NCT00911820|11584245|FG001|STARTED|Overall Study||43
10437842|NCT00911820|11584244|FG000|Treated|Overall Study|Randomized patients not treated: unable to confirm pathology (n=1)|44
10437843|NCT00911820|11584245|FG001|Treated|Overall Study|Randomized patients not treated: withdrew consent (n=2)|41
10437844|NCT00911820|11584244|FG000|COMPLETED|Overall Study||0
10437845|NCT00911820|11584245|FG001|COMPLETED|Overall Study||0
10437846|NCT00911820|11584244|FG000|NOT COMPLETED|Overall Study||45
10437847|NCT00911820|11584245|FG001|NOT COMPLETED|Overall Study||43
10437848|NCT00911859|11584254|FG000|STARTED|Treatment Period||12
10437849|NCT00911859|11584255|FG001|STARTED|Treatment Period||54
10437850|NCT00911859|11584256|FG002|STARTED|Treatment Period||52
10437851|NCT00911859|11584254|FG000|Received Treatment|Treatment Period||12
10437852|NCT00911859|11584255|FG001|Received Treatment|Treatment Period||53
10437853|NCT00911859|11584256|FG002|Received Treatment|Treatment Period||52
10437854|NCT00911859|11584254|FG000|COMPLETED|Treatment Period||4
10437855|NCT00911859|11584255|FG001|COMPLETED|Treatment Period||33
10437856|NCT00911859|11584256|FG002|COMPLETED|Treatment Period||27
10437857|NCT00911859|11584254|FG000|NOT COMPLETED|Treatment Period||8
10437858|NCT00911859|11584255|FG001|NOT COMPLETED|Treatment Period||21
10437859|NCT00911859|11584256|FG002|NOT COMPLETED|Treatment Period||25
10437860|NCT00911859|11584254|FG000|STARTED|Maintainance Period||0
10437861|NCT00911859|11584255|FG001|STARTED|Maintainance Period||0
10437862|NCT00911859|11584256|FG002|STARTED|Maintainance Period|Participants who received siltuximab only during the 18-month maintenance period|21
10437863|NCT00911859|11584254|FG000|COMPLETED|Maintainance Period||0
10437864|NCT00911859|11584255|FG001|COMPLETED|Maintainance Period||0
10437865|NCT00911859|11584256|FG002|COMPLETED|Maintainance Period||0
10437866|NCT00911859|11584254|FG000|NOT COMPLETED|Maintainance Period||0
10437867|NCT00911859|11584255|FG001|NOT COMPLETED|Maintainance Period||0
10437868|NCT00911859|11584256|FG002|NOT COMPLETED|Maintainance Period||21
10437869|NCT00911859|11584254|FG000|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|12
10525318|NCT01375075|11677208|FG004|COMPLETED|Overall Study||27
10525319|NCT01375075|11677209|FG005|COMPLETED|Overall Study||25
10437870|NCT00911859|11584255|FG001|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|53
10437871|NCT00911859|11584256|FG002|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|52
10437872|NCT00911859|11584254|FG000|COMPLETED|Follow-up Period||1
10437873|NCT00911859|11584255|FG001|COMPLETED|Follow-up Period||7
10437874|NCT00911859|11584256|FG002|COMPLETED|Follow-up Period||11
10437875|NCT00911859|11584254|FG000|NOT COMPLETED|Follow-up Period||11
10437876|NCT00911859|11584255|FG001|NOT COMPLETED|Follow-up Period||46
10437877|NCT00911859|11584256|FG002|NOT COMPLETED|Follow-up Period||41
10437878|NCT00911898|11584264|FG000|STARTED|Overall Study||20
10437879|NCT00911898|11584264|FG000|COMPLETED|Overall Study||20
10437880|NCT00911898|11584264|FG000|NOT COMPLETED|Overall Study||0
10437881|NCT00911937|11584270|FG000|STARTED|Overall Study||487
10437882|NCT00911937|11584271|FG001|STARTED|Overall Study||476
10437883|NCT00911937|11584270|FG000|Treated|Overall Study||474
10437884|NCT00911937|11584271|FG001|Treated|Overall Study||463
10437885|NCT00911937|11584270|FG000|COMPLETED|Overall Study||400
10437886|NCT00911937|11584271|FG001|COMPLETED|Overall Study||381
10437887|NCT00911937|11584270|FG000|NOT COMPLETED|Overall Study||87
10437888|NCT00911937|11584271|FG001|NOT COMPLETED|Overall Study||95
10437889|NCT00911989|11584277|FG000|STARTED|Overall Study||4
10437890|NCT00911989|11584277|FG000|COMPLETED|Overall Study||3
10437891|NCT00911989|11584277|FG000|NOT COMPLETED|Overall Study||1
10437892|NCT00912002|11584281|FG000|STARTED|Overall Study||6
10437893|NCT00912002|11584281|FG000|COMPLETED|Overall Study||6
10437894|NCT00912002|11584281|FG000|NOT COMPLETED|Overall Study||0
10437895|NCT00912015|11584290|FG000|STARTED|Overall Study|Dose at which a patient spent the longest time.|141
10437896|NCT00912015|11584291|FG001|STARTED|Overall Study|Dose at which a patient spent the longest time.|70
10437897|NCT00912015|11584292|FG002|STARTED|Overall Study|Dose at which a patient spent the longest time.|25
10437898|NCT00912015|11584293|FG003|STARTED|Overall Study|Two patients took 100 mg against instructions in protocol that the minimum daily dose was 200 mg.|2
10437899|NCT00912015|11584290|FG000|COMPLETED|Overall Study||125
10437900|NCT00912015|11584291|FG001|COMPLETED|Overall Study||62
10437901|NCT00912015|11584292|FG002|COMPLETED|Overall Study||22
10437902|NCT00912015|11584293|FG003|COMPLETED|Overall Study||0
10437903|NCT00912015|11584290|FG000|NOT COMPLETED|Overall Study||16
10437904|NCT00912015|11584291|FG001|NOT COMPLETED|Overall Study||8
10437905|NCT00912015|11584292|FG002|NOT COMPLETED|Overall Study||3
10437906|NCT00912015|11584293|FG003|NOT COMPLETED|Overall Study||2
10437907|NCT00912028|11584306|FG000|STARTED|Overall Study||35
10437908|NCT00912028|11584307|FG001|STARTED|Overall Study||3
10437909|NCT00912028|11584308|FG002|STARTED|Overall Study||13
10437910|NCT00912028|11584309|FG003|STARTED|Overall Study||17
10437911|NCT00912028|11584310|FG004|STARTED|Overall Study||3
10437912|NCT00912028|11584306|FG000|COMPLETED|Overall Study||30
10437913|NCT00912028|11584307|FG001|COMPLETED|Overall Study||0
10437914|NCT00912028|11584308|FG002|COMPLETED|Overall Study||13
10437915|NCT00912028|11584309|FG003|COMPLETED|Overall Study||16
10437916|NCT00912028|11584310|FG004|COMPLETED|Overall Study||0
10789321|NCT03519867|11949712|FG005|STARTED|Overall Study||5
10789322|NCT03519867|11949713|FG006|STARTED|Overall Study||4
10437917|NCT00912028|11584306|FG000|NOT COMPLETED|Overall Study||5
10437918|NCT00912028|11584307|FG001|NOT COMPLETED|Overall Study||3
10437919|NCT00912028|11584308|FG002|NOT COMPLETED|Overall Study||0
10437920|NCT00912028|11584309|FG003|NOT COMPLETED|Overall Study||1
10437921|NCT00912028|11584310|FG004|NOT COMPLETED|Overall Study||3
10437922|NCT00912093|11584325|FG000|STARTED|The Controlled Phase||43
10789323|NCT03519867|11949714|FG007|STARTED|Overall Study||5
10789324|NCT03519867|11949715|FG008|STARTED|Overall Study||4
10789325|NCT03519867|11949716|FG009|STARTED|Overall Study||4
10437923|NCT00912093|11584326|FG001|STARTED|The Controlled Phase||45
10437924|NCT00912093|11584327|FG002|STARTED|The Controlled Phase||3
10437925|NCT00912093|11584328|FG003|STARTED|The Controlled Phase||2
10437926|NCT00912093|11584329|FG004|STARTED|The Controlled Phase||5
10437927|NCT00912093|11584325|FG000|COMPLETED|The Controlled Phase||43
10437928|NCT00912093|11584326|FG001|COMPLETED|The Controlled Phase||43
10437929|NCT00912093|11584327|FG002|COMPLETED|The Controlled Phase||3
10437930|NCT00912093|11584328|FG003|COMPLETED|The Controlled Phase||2
10437931|NCT00912093|11584329|FG004|COMPLETED|The Controlled Phase||4
10437932|NCT00912093|11584325|FG000|NOT COMPLETED|The Controlled Phase||0
10437933|NCT00912093|11584326|FG001|NOT COMPLETED|The Controlled Phase||2
10437934|NCT00912093|11584327|FG002|NOT COMPLETED|The Controlled Phase||0
10437935|NCT00912093|11584328|FG003|NOT COMPLETED|The Controlled Phase||0
10437936|NCT00912093|11584329|FG004|NOT COMPLETED|The Controlled Phase||1
10437937|NCT00912093|11584325|FG000|STARTED|The Open Label Extension (OLE) Phase||38
10437938|NCT00912093|11584326|FG001|STARTED|The Open Label Extension (OLE) Phase||35
10437939|NCT00912093|11584327|FG002|STARTED|The Open Label Extension (OLE) Phase||3
10437940|NCT00912093|11584328|FG003|STARTED|The Open Label Extension (OLE) Phase||2
10437941|NCT00912093|11584329|FG004|STARTED|The Open Label Extension (OLE) Phase||4
10437942|NCT00912093|11584325|FG000|COMPLETED|The Open Label Extension (OLE) Phase||38
10437943|NCT00912093|11584326|FG001|COMPLETED|The Open Label Extension (OLE) Phase||35
10437944|NCT00912093|11584327|FG002|COMPLETED|The Open Label Extension (OLE) Phase||3
10437945|NCT00912093|11584328|FG003|COMPLETED|The Open Label Extension (OLE) Phase||2
10437946|NCT00912093|11584329|FG004|COMPLETED|The Open Label Extension (OLE) Phase||4
10525320|NCT01375075|11677204|FG000|NOT COMPLETED|Overall Study||1
10789326|NCT03519867|11949707|FG000|Treated|Overall Study||5
10437947|NCT00912093|11584325|FG000|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
10437948|NCT00912093|11584326|FG001|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
10437949|NCT00912093|11584327|FG002|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
10437950|NCT00912093|11584328|FG003|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
10437951|NCT00912093|11584329|FG004|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
10437952|NCT00912197|11584339|FG000|STARTED|Overall Study||15
10437953|NCT00912197|11584340|FG001|STARTED|Overall Study||13
10437954|NCT00912197|11584339|FG000|COMPLETED|Overall Study||12
10437955|NCT00912197|11584340|FG001|COMPLETED|Overall Study||10
10437956|NCT00912197|11584339|FG000|NOT COMPLETED|Overall Study||3
10437957|NCT00912197|11584340|FG001|NOT COMPLETED|Overall Study||3
10437958|NCT00912288|11584350|FG000|STARTED|Overall Study||44
10437959|NCT00912288|11584351|FG001|STARTED|Overall Study||42
10437960|NCT00912288|11584350|FG000|COMPLETED|Overall Study||3
10437961|NCT00912288|11584351|FG001|COMPLETED|Overall Study||2
10437962|NCT00912288|11584350|FG000|NOT COMPLETED|Overall Study||41
10437963|NCT00912288|11584351|FG001|NOT COMPLETED|Overall Study||40
10437964|NCT00912301|11584360|FG000|STARTED|Overall Study||11
10437965|NCT00912301|11584361|FG001|STARTED|Overall Study||12
10437966|NCT00912301|11584362|FG002|STARTED|Overall Study||13
10437967|NCT00912301|11584360|FG000|COMPLETED|Overall Study||11
10437968|NCT00912301|11584361|FG001|COMPLETED|Overall Study||12
10437969|NCT00912301|11584362|FG002|COMPLETED|Overall Study||13
10437970|NCT00912301|11584360|FG000|NOT COMPLETED|Overall Study||0
10437971|NCT00912301|11584361|FG001|NOT COMPLETED|Overall Study||0
10437972|NCT00912301|11584362|FG002|NOT COMPLETED|Overall Study||0
10437973|NCT00912340|11584373|FG000|STARTED|Overall Study||24
10437974|NCT00912340|11584374|FG001|STARTED|Overall Study||30
10437975|NCT00912340|11584375|FG002|STARTED|Overall Study||4
10437976|NCT00912340|11584373|FG000|COMPLETED|Overall Study||22
10437977|NCT00912340|11584374|FG001|COMPLETED|Overall Study||26
10437978|NCT00912340|11584375|FG002|COMPLETED|Overall Study||0
10437979|NCT00912340|11584373|FG000|NOT COMPLETED|Overall Study||2
10437980|NCT00912340|11584374|FG001|NOT COMPLETED|Overall Study||4
10437981|NCT00912340|11584375|FG002|NOT COMPLETED|Overall Study||4
10437982|NCT00912405|11584383|FG000|STARTED|Overall Study||50
10437983|NCT00912405|11584383|FG000|COMPLETED|Overall Study||45
10437984|NCT00912405|11584383|FG000|NOT COMPLETED|Overall Study||5
10437985|NCT00912509|11584389|FG000|STARTED|Overall Study||20
10437986|NCT00912509|11584390|FG001|STARTED|Overall Study||10
10437987|NCT00912509|11584389|FG000|COMPLETED|Overall Study||15
10437988|NCT00912509|11584390|FG001|COMPLETED|Overall Study||7
10437989|NCT00912509|11584389|FG000|NOT COMPLETED|Overall Study||5
10437990|NCT00912509|11584390|FG001|NOT COMPLETED|Overall Study||3
10437991|NCT00912743|11584399|FG000|STARTED|Overall Study||13
10437992|NCT00912743|11584400|FG001|STARTED|Overall Study||20
10789327|NCT03519867|11949708|FG001|Treated|Overall Study||6
10789328|NCT03519867|11949709|FG002|Treated|Overall Study||5
10789329|NCT03519867|11949710|FG003|Treated|Overall Study||3
10789330|NCT03519867|11949711|FG004|Treated|Overall Study||5
10437993|NCT00912743|11584399|FG000|COMPLETED|Overall Study||0
10437994|NCT00912743|11584400|FG001|COMPLETED|Overall Study||0
10437995|NCT00912743|11584399|FG000|NOT COMPLETED|Overall Study||13
10437996|NCT00912743|11584400|FG001|NOT COMPLETED|Overall Study||20
10437997|NCT00912782|11584408|FG000|STARTED|Overall Study||27
10437998|NCT00912782|11584409|FG001|STARTED|Overall Study||25
10437999|NCT00912782|11584408|FG000|COMPLETED|Overall Study||24
10438000|NCT00912782|11584409|FG001|COMPLETED|Overall Study||20
10438001|NCT00912782|11584408|FG000|NOT COMPLETED|Overall Study||3
10438002|NCT00912782|11584409|FG001|NOT COMPLETED|Overall Study||5
10438003|NCT00912795|11584417|FG000|STARTED|Overall Study||76
10438004|NCT00912795|11584418|FG001|STARTED|Overall Study||75
10438005|NCT00912795|11584417|FG000|COMPLETED|Overall Study||29
10438006|NCT00912795|11584418|FG001|COMPLETED|Overall Study||17
10438007|NCT00912795|11584417|FG000|NOT COMPLETED|Overall Study||47
10438008|NCT00912795|11584418|FG001|NOT COMPLETED|Overall Study||58
10438009|NCT00912808|11584426|FG000|STARTED|First Intervention (6 Weeks)||11
10438010|NCT00912808|11584427|FG001|STARTED|First Intervention (6 Weeks)||12
10438011|NCT00912808|11584426|FG000|Received Intervention|First Intervention (6 Weeks)||11
10438012|NCT00912808|11584427|FG001|Received Intervention|First Intervention (6 Weeks)||12
10438013|NCT00912808|11584426|FG000|COMPLETED|First Intervention (6 Weeks)||9
10789331|NCT03519867|11949712|FG005|Treated|Overall Study||4
10438014|NCT00912808|11584427|FG001|COMPLETED|First Intervention (6 Weeks)||11
10438015|NCT00912808|11584426|FG000|NOT COMPLETED|First Intervention (6 Weeks)||2
10438016|NCT00912808|11584427|FG001|NOT COMPLETED|First Intervention (6 Weeks)||1
10438017|NCT00912808|11584426|FG000|STARTED|Washout||9
10438018|NCT00912808|11584427|FG001|STARTED|Washout||11
10438019|NCT00912808|11584426|FG000|COMPLETED|Washout||9
10438020|NCT00912808|11584427|FG001|COMPLETED|Washout||10
10438021|NCT00912808|11584426|FG000|NOT COMPLETED|Washout||0
10438022|NCT00912808|11584427|FG001|NOT COMPLETED|Washout||1
10438023|NCT00912808|11584426|FG000|STARTED|Second Intervention (6 Weeks)||9
10438024|NCT00912808|11584427|FG001|STARTED|Second Intervention (6 Weeks)||10
10438025|NCT00912808|11584426|FG000|Received Intervention|Second Intervention (6 Weeks)||9
10438026|NCT00912808|11584427|FG001|Received Intervention|Second Intervention (6 Weeks)||10
10438027|NCT00912808|11584426|FG000|COMPLETED|Second Intervention (6 Weeks)||8
10438028|NCT00912808|11584427|FG001|COMPLETED|Second Intervention (6 Weeks)||9
10789332|NCT03519867|11949713|FG006|Treated|Overall Study||4
10789333|NCT03519867|11949714|FG007|Treated|Overall Study||4
10438029|NCT00912808|11584426|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||1
10438030|NCT00912808|11584427|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||1
10438031|NCT00912873|11584436|FG000|STARTED|Overall Study||26
10438032|NCT00912873|11584437|FG001|STARTED|Overall Study||24
10438033|NCT00912873|11584436|FG000|COMPLETED|Overall Study||26
10438034|NCT00912873|11584437|FG001|COMPLETED|Overall Study||24
10438035|NCT00912873|11584436|FG000|NOT COMPLETED|Overall Study||0
10438036|NCT00912873|11584437|FG001|NOT COMPLETED|Overall Study||0
10438037|NCT00912912|11584447|FG000|STARTED|Overall Study||5
10438038|NCT00912912|11584447|FG000|COMPLETED|Overall Study||1
10438039|NCT00912912|11584447|FG000|NOT COMPLETED|Overall Study||4
10438040|NCT00912925|11584453|FG000|STARTED|Overall Study||23
10438041|NCT00912925|11584454|FG001|STARTED|Overall Study||22
10438042|NCT00912925|11584453|FG000|COMPLETED|Overall Study||23
10438043|NCT00912925|11584454|FG001|COMPLETED|Overall Study||22
10438044|NCT00912925|11584453|FG000|NOT COMPLETED|Overall Study||0
10438045|NCT00912925|11584454|FG001|NOT COMPLETED|Overall Study||0
10438046|NCT00912964|11584463|FG000|STARTED|Overall Study||433
10438047|NCT00912964|11584464|FG001|STARTED|Overall Study||433
10438048|NCT00912964|11584465|FG002|STARTED|Overall Study||440
10438049|NCT00912964|11584463|FG000|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|433
10438050|NCT00912964|11584464|FG001|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|432
10438051|NCT00912964|11584465|FG002|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|440
10438220|NCT00913770|11584605|FG000|COMPLETED|Overall Study||69
10438052|NCT00912964|11584463|FG000|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|415
10438053|NCT00912964|11584464|FG001|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|410
10438054|NCT00912964|11584465|FG002|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|426
10438055|NCT00912964|11584463|FG000|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|262
10438056|NCT00912964|11584464|FG001|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|254
10438057|NCT00912964|11584465|FG002|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|257
10438058|NCT00912964|11584463|FG000|COMPLETED|Overall Study||367
10438059|NCT00912964|11584464|FG001|COMPLETED|Overall Study||387
10438060|NCT00912964|11584465|FG002|COMPLETED|Overall Study||386
10438061|NCT00912964|11584463|FG000|NOT COMPLETED|Overall Study||66
10438062|NCT00912964|11584464|FG001|NOT COMPLETED|Overall Study||46
10438063|NCT00912964|11584465|FG002|NOT COMPLETED|Overall Study||54
10438064|NCT00912990|11584475|FG000|STARTED|Overall Study||16
10438065|NCT00912990|11584476|FG001|STARTED|Overall Study||18
10438066|NCT00912990|11584475|FG000|COMPLETED|Overall Study||16
10438067|NCT00912990|11584476|FG001|COMPLETED|Overall Study||18
10438068|NCT00912990|11584475|FG000|NOT COMPLETED|Overall Study||0
10438069|NCT00912990|11584476|FG001|NOT COMPLETED|Overall Study||0
10438070|NCT00913003|11584484|FG000|STARTED|Overall Study||11
10438071|NCT00913003|11584485|FG001|STARTED|Overall Study||11
10438072|NCT00913003|11584484|FG000|COMPLETED|Overall Study||11
10438073|NCT00913003|11584485|FG001|COMPLETED|Overall Study||11
10438074|NCT00913003|11584484|FG000|NOT COMPLETED|Overall Study||0
10438075|NCT00913003|11584485|FG001|NOT COMPLETED|Overall Study||0
10438076|NCT00913068|11584493|FG000|STARTED|Overall Study||56
10438077|NCT00913068|11584494|FG001|STARTED|Overall Study||54
10438078|NCT00913068|11584493|FG000|COMPLETED|Overall Study||48
10438079|NCT00913068|11584494|FG001|COMPLETED|Overall Study||46
10438080|NCT00913068|11584493|FG000|NOT COMPLETED|Overall Study||8
10438081|NCT00913068|11584494|FG001|NOT COMPLETED|Overall Study||8
10438082|NCT00913081|11584500|FG000|STARTED|Quercetin 500 mg + Niacin 500 mg (1day)||17
10438083|NCT00913081|11584500|FG000|COMPLETED|Quercetin 500 mg + Niacin 500 mg (1day)||17
10438084|NCT00913081|11584500|FG000|NOT COMPLETED|Quercetin 500 mg + Niacin 500 mg (1day)||0
10438085|NCT00913081|11584500|FG000|STARTED|Washout #1 (7 Days)||17
10438086|NCT00913081|11584500|FG000|COMPLETED|Washout #1 (7 Days)||17
10438087|NCT00913081|11584500|FG000|NOT COMPLETED|Washout #1 (7 Days)||0
10438088|NCT00913081|11584500|FG000|STARTED|Quercetin 1000 mg + Niacin 500 mg (1day)||17
10438089|NCT00913081|11584500|FG000|COMPLETED|Quercetin 1000 mg + Niacin 500 mg (1day)||17
10438090|NCT00913081|11584500|FG000|NOT COMPLETED|Quercetin 1000 mg + Niacin 500 mg (1day)||0
10438091|NCT00913081|11584500|FG000|STARTED|Washout #2 (7 Days)||17
10438092|NCT00913081|11584500|FG000|COMPLETED|Washout #2 (7 Days)||17
10438093|NCT00913081|11584500|FG000|NOT COMPLETED|Washout #2 (7 Days)||0
10438094|NCT00913081|11584500|FG000|STARTED|Quercetin 2000 mg + Niacin 500 mg (1day)||17
10438095|NCT00913081|11584500|FG000|COMPLETED|Quercetin 2000 mg + Niacin 500 mg (1day)||17
10438096|NCT00913081|11584500|FG000|NOT COMPLETED|Quercetin 2000 mg + Niacin 500 mg (1day)||0
10438097|NCT00913081|11584500|FG000|STARTED|Washout #3 (7days)||17
10438098|NCT00913081|11584500|FG000|COMPLETED|Washout #3 (7days)||17
10438099|NCT00913081|11584500|FG000|NOT COMPLETED|Washout #3 (7days)||0
10438100|NCT00913081|11584500|FG000|STARTED|Placebo + Niacin 500 mg (1day)||17
10438101|NCT00913081|11584500|FG000|COMPLETED|Placebo + Niacin 500 mg (1day)||17
10438102|NCT00913081|11584500|FG000|NOT COMPLETED|Placebo + Niacin 500 mg (1day)||0
10438103|NCT00913133|11584510|FG000|STARTED|Overall Study||516
10438104|NCT00913133|11584510|FG000|COMPLETED|Overall Study||516
10438105|NCT00913133|11584510|FG000|NOT COMPLETED|Overall Study||0
10438106|NCT00913263|11584514|FG000|STARTED|Overall Study||24
10438107|NCT00913263|11584514|FG000|COMPLETED|Overall Study||24
10438108|NCT00913263|11584514|FG000|NOT COMPLETED|Overall Study||0
10549669|NCT01526356|11703657|FG001|NOT COMPLETED|Overall Study||10
10438109|NCT00913380|11584524|FG000|STARTED|CT Examination||444
10438110|NCT00913380|11584525|FG001|STARTED|CT Examination||447
10438111|NCT00913380|11584524|FG000|COMPLETED|CT Examination||444
10438112|NCT00913380|11584525|FG001|COMPLETED|CT Examination||447
10438113|NCT00913380|11584524|FG000|NOT COMPLETED|CT Examination||0
10438114|NCT00913380|11584525|FG001|NOT COMPLETED|CT Examination||0
10438115|NCT00913380|11584524|FG000|STARTED|Clinical Outcomes||444
10438116|NCT00913380|11584525|FG001|STARTED|Clinical Outcomes||447
10438117|NCT00913380|11584524|FG000|COMPLETED|Clinical Outcomes||438
10438118|NCT00913380|11584525|FG001|COMPLETED|Clinical Outcomes||441
10438119|NCT00913380|11584524|FG000|NOT COMPLETED|Clinical Outcomes||6
10438120|NCT00913380|11584525|FG001|NOT COMPLETED|Clinical Outcomes||6
10438121|NCT00913458|11584531|FG000|STARTED|Phase 1||306
10438122|NCT00913458|11584532|FG001|STARTED|Phase 1|This arm is part of Phase 2 study|0
10438123|NCT00913458|11584533|FG002|STARTED|Phase 1|This arm is part of Phase 2 study|0
10438124|NCT00913458|11584534|FG003|STARTED|Phase 1|This arm is part of Phase 2 study|0
10438125|NCT00913458|11584535|FG004|STARTED|Phase 1|This arm is part of Phase 3 study|0
10438126|NCT00913458|11584536|FG005|STARTED|Phase 1|This arm is part of Phase 3 study|0
10438127|NCT00913458|11584537|FG006|STARTED|Phase 1|This arm is part of Phase 3 study|0
10438128|NCT00913458|11584531|FG000|COMPLETED|Phase 1|194 continued to Phase 2 but 1 was randomized in error leaving 193 in the phase 2 analysis.|194
10438129|NCT00913458|11584532|FG001|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
10438221|NCT00913770|11584606|FG001|COMPLETED|Overall Study||82
10438130|NCT00913458|11584533|FG002|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
10438131|NCT00913458|11584534|FG003|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
10438132|NCT00913458|11584535|FG004|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
10438133|NCT00913458|11584536|FG005|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
10438134|NCT00913458|11584537|FG006|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
10438135|NCT00913458|11584531|FG000|NOT COMPLETED|Phase 1||112
10438136|NCT00913458|11584532|FG001|NOT COMPLETED|Phase 1||0
10438137|NCT00913458|11584533|FG002|NOT COMPLETED|Phase 1||0
10438138|NCT00913458|11584534|FG003|NOT COMPLETED|Phase 1||0
10438139|NCT00913458|11584535|FG004|NOT COMPLETED|Phase 1||0
10438140|NCT00913458|11584536|FG005|NOT COMPLETED|Phase 1||0
10438141|NCT00913458|11584537|FG006|NOT COMPLETED|Phase 1||0
10438142|NCT00913458|11584531|FG000|STARTED|Phase 2|This arm is part of Phase 1 of the study.|0
10438143|NCT00913458|11584532|FG001|STARTED|Phase 2||63
10438144|NCT00913458|11584533|FG002|STARTED|Phase 2||65
10438145|NCT00913458|11584534|FG003|STARTED|Phase 2||65
10438146|NCT00913458|11584535|FG004|STARTED|Phase 2||0
10438147|NCT00913458|11584536|FG005|STARTED|Phase 2||0
10438148|NCT00913458|11584537|FG006|STARTED|Phase 2||0
10438149|NCT00913458|11584531|FG000|COMPLETED|Phase 2|This arm is part of Phase 1 of the study.|0
10438150|NCT00913458|11584532|FG001|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|53
10438151|NCT00913458|11584533|FG002|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|46
10438152|NCT00913458|11584534|FG003|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|32
10438153|NCT00913458|11584535|FG004|COMPLETED|Phase 2||0
10438154|NCT00913458|11584536|FG005|COMPLETED|Phase 2||0
10438155|NCT00913458|11584537|FG006|COMPLETED|Phase 2||0
10438156|NCT00913458|11584531|FG000|NOT COMPLETED|Phase 2||0
10438157|NCT00913458|11584532|FG001|NOT COMPLETED|Phase 2||10
10438158|NCT00913458|11584533|FG002|NOT COMPLETED|Phase 2||19
10438159|NCT00913458|11584534|FG003|NOT COMPLETED|Phase 2||33
10438160|NCT00913458|11584535|FG004|NOT COMPLETED|Phase 2||0
10438161|NCT00913458|11584536|FG005|NOT COMPLETED|Phase 2||0
10438162|NCT00913458|11584537|FG006|NOT COMPLETED|Phase 2||0
10438163|NCT00913458|11584531|FG000|STARTED|Phase 3|This arm is part of Phase 1 of the study.|0
10438164|NCT00913458|11584532|FG001|STARTED|Phase 3||0
10438165|NCT00913458|11584533|FG002|STARTED|Phase 3||0
10438166|NCT00913458|11584534|FG003|STARTED|Phase 3||0
10438167|NCT00913458|11584535|FG004|STARTED|Phase 3|Participants who completed Phase 2 study|53
10438168|NCT00913458|11584536|FG005|STARTED|Phase 3|Participants who completed Phase 2 study|46
10438169|NCT00913458|11584537|FG006|STARTED|Phase 3|Participants who completed Phase 2 study|32
10438170|NCT00913458|11584531|FG000|COMPLETED|Phase 3|This arm is part of Phase 1 of the study.|0
10438171|NCT00913458|11584532|FG001|COMPLETED|Phase 3||0
10438172|NCT00913458|11584533|FG002|COMPLETED|Phase 3||0
10438173|NCT00913458|11584534|FG003|COMPLETED|Phase 3||0
10438174|NCT00913458|11584535|FG004|COMPLETED|Phase 3||31
10438175|NCT00913458|11584536|FG005|COMPLETED|Phase 3||28
10438176|NCT00913458|11584537|FG006|COMPLETED|Phase 3||24
10438177|NCT00913458|11584531|FG000|NOT COMPLETED|Phase 3||0
10438178|NCT00913458|11584532|FG001|NOT COMPLETED|Phase 3||0
10438179|NCT00913458|11584533|FG002|NOT COMPLETED|Phase 3||0
10438180|NCT00913458|11584534|FG003|NOT COMPLETED|Phase 3||0
10438181|NCT00913458|11584535|FG004|NOT COMPLETED|Phase 3||22
10438182|NCT00913458|11584536|FG005|NOT COMPLETED|Phase 3||18
10438183|NCT00913458|11584537|FG006|NOT COMPLETED|Phase 3||8
10438184|NCT00913510|11584556|FG000|STARTED|Overall Study||13
10438185|NCT00913510|11584557|FG001|STARTED|Overall Study||7
10549670|NCT01526356|11703658|FG002|NOT COMPLETED|Overall Study||12
10438186|NCT00913510|11584556|FG000|COMPLETED|Overall Study||5
10438187|NCT00913510|11584557|FG001|COMPLETED|Overall Study||3
10438188|NCT00913510|11584556|FG000|NOT COMPLETED|Overall Study||8
10438189|NCT00913510|11584557|FG001|NOT COMPLETED|Overall Study||4
10438190|NCT00913523|11584566|FG000|STARTED|Overall Study||162
10438191|NCT00913523|11584567|FG001|STARTED|Overall Study||159
10438192|NCT00913523|11584568|FG002|STARTED|Overall Study||161
10438193|NCT00913523|11584566|FG000|COMPLETED|Overall Study||144
10438194|NCT00913523|11584567|FG001|COMPLETED|Overall Study||143
10438195|NCT00913523|11584568|FG002|COMPLETED|Overall Study||147
10438196|NCT00913523|11584566|FG000|NOT COMPLETED|Overall Study||18
10438197|NCT00913523|11584567|FG001|NOT COMPLETED|Overall Study||16
10438198|NCT00913523|11584568|FG002|NOT COMPLETED|Overall Study||14
10438199|NCT00913627|11584580|FG000|STARTED|Overall Study||29
10438200|NCT00913627|11584581|FG001|STARTED|Overall Study||53
10438201|NCT00913627|11584582|FG002|STARTED|Overall Study||56
10438202|NCT00913627|11584583|FG003|STARTED|Overall Study||58
10438203|NCT00913627|11584580|FG000|COMPLETED|Overall Study||29
10438204|NCT00913627|11584581|FG001|COMPLETED|Overall Study||53
10438205|NCT00913627|11584582|FG002|COMPLETED|Overall Study||56
10438206|NCT00913627|11584583|FG003|COMPLETED|Overall Study||58
10438207|NCT00913627|11584580|FG000|NOT COMPLETED|Overall Study||0
10438208|NCT00913627|11584581|FG001|NOT COMPLETED|Overall Study||0
10438209|NCT00913627|11584582|FG002|NOT COMPLETED|Overall Study||0
10438210|NCT00913627|11584583|FG003|NOT COMPLETED|Overall Study||0
10438211|NCT00913744|11584595|FG000|STARTED|Overall Study||75
10438212|NCT00913744|11584596|FG001|STARTED|Overall Study||25
10438213|NCT00913744|11584595|FG000|COMPLETED|Overall Study||70
10438214|NCT00913744|11584596|FG001|COMPLETED|Overall Study||24
10438215|NCT00913744|11584595|FG000|NOT COMPLETED|Overall Study||5
10438216|NCT00913744|11584596|FG001|NOT COMPLETED|Overall Study||1
10438217|NCT00913770|11584605|FG000|STARTED|Overall Study||104
10438218|NCT00913770|11584606|FG001|STARTED|Overall Study||111
10438219|NCT00913770|11584607|FG002|STARTED|Overall Study||114
10438222|NCT00913770|11584607|FG002|COMPLETED|Overall Study||93
10438223|NCT00913770|11584605|FG000|NOT COMPLETED|Overall Study||35
10438224|NCT00913770|11584606|FG001|NOT COMPLETED|Overall Study||29
10438225|NCT00913770|11584607|FG002|NOT COMPLETED|Overall Study||21
10438226|NCT00913835|11584617|FG000|STARTED|Olara+Lip Dox and Lip Dox Monotherapy||63
10438227|NCT00913835|11584618|FG001|STARTED|Olara+Lip Dox and Lip Dox Monotherapy||62
10438228|NCT00913835|11584617|FG000|Received Any Study Drug|Olara+Lip Dox and Lip Dox Monotherapy||62
10549671|NCT01526538|11703670|FG000|STARTED|Overall Study||30
10549672|NCT01526538|11703671|FG001|STARTED|Overall Study||22
10549673|NCT01526538|11703670|FG000|COMPLETED|Overall Study||21
10549674|NCT01526538|11703671|FG001|COMPLETED|Overall Study||18
10549675|NCT01526538|11703670|FG000|NOT COMPLETED|Overall Study||9
10549676|NCT01526538|11703671|FG001|NOT COMPLETED|Overall Study||4
10789334|NCT03519867|11949715|FG008|Treated|Overall Study||3
10549677|NCT01526551|11703679|FG000|STARTED|Overall Study||935
10549678|NCT01526551|11703679|FG000|COMPLETED|Overall Study||511
10549679|NCT01526551|11703679|FG000|NOT COMPLETED|Overall Study||424
10549680|NCT01526577|11703688|FG000|STARTED|Overall Study|1 more subject enrolled as a substitute for 1 withdrawn subject before the administration.|49
10549681|NCT01526577|11703689|FG001|STARTED|Overall Study||12
10549682|NCT01526577|11703690|FG002|STARTED|Overall Study|1 more subject enrolled as a substitute for 1 withdrawn subject before the administration.|33
10549683|NCT01526577|11703691|FG003|STARTED|Overall Study|1 more subject enrolled as a substitute for 1 withdrawn subject before the administration.|9
10549684|NCT01526577|11703692|FG004|STARTED|Overall Study|2 more subjects were enrolled as the substitutes for 2 withdrawn subjects before the administration.|10
10549685|NCT01526577|11703688|FG000|COMPLETED|Overall Study||48
10549686|NCT01526577|11703689|FG001|COMPLETED|Overall Study||12
10549687|NCT01526577|11703690|FG002|COMPLETED|Overall Study||32
10549688|NCT01526577|11703691|FG003|COMPLETED|Overall Study||8
10438229|NCT00913835|11584618|FG001|Received Any Study Drug|Olara+Lip Dox and Lip Dox Monotherapy||61
10438230|NCT00913835|11584617|FG000|COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||55
10438231|NCT00913835|11584618|FG001|COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||55
10438232|NCT00913835|11584617|FG000|NOT COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||8
10438233|NCT00913835|11584618|FG001|NOT COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||7
10438234|NCT00913835|11584617|FG000|STARTED|Lip Dox: Olaratumab Monotherapy||0
10438235|NCT00913835|11584618|FG001|STARTED|Lip Dox: Olaratumab Monotherapy||28
10438236|NCT00913835|11584617|FG000|Received at Least 1 Dose of Study Drug|Lip Dox: Olaratumab Monotherapy||0
10438237|NCT00913835|11584618|FG001|Received at Least 1 Dose of Study Drug|Lip Dox: Olaratumab Monotherapy||28
10438238|NCT00913835|11584617|FG000|COMPLETED|Lip Dox: Olaratumab Monotherapy||0
10438239|NCT00913835|11584618|FG001|COMPLETED|Lip Dox: Olaratumab Monotherapy||25
10438240|NCT00913835|11584617|FG000|NOT COMPLETED|Lip Dox: Olaratumab Monotherapy||0
10438241|NCT00913835|11584618|FG001|NOT COMPLETED|Lip Dox: Olaratumab Monotherapy||3
10438242|NCT00913913|11584631|FG000|STARTED|Overall Study||8
10438243|NCT00913913|11584631|FG000|COMPLETED|Overall Study||0
10438244|NCT00913913|11584631|FG000|NOT COMPLETED|Overall Study||8
10438245|NCT00913978|11584637|FG000|STARTED|Overall Study||26
10438246|NCT00913978|11584638|FG001|STARTED|Overall Study||24
10438247|NCT00913978|11584637|FG000|COMPLETED|Overall Study||25
10438248|NCT00913978|11584638|FG001|COMPLETED|Overall Study||21
10438249|NCT00913978|11584637|FG000|NOT COMPLETED|Overall Study||1
10438250|NCT00913978|11584638|FG001|NOT COMPLETED|Overall Study||3
10438251|NCT00914069|11584646|FG000|STARTED|Overall Study||84
10438252|NCT00914069|11584647|FG001|STARTED|Overall Study||88
10438253|NCT00914069|11584646|FG000|COMPLETED|Overall Study||84
10438254|NCT00914069|11584647|FG001|COMPLETED|Overall Study||88
10438255|NCT00914069|11584646|FG000|NOT COMPLETED|Overall Study||0
10438256|NCT00914069|11584647|FG001|NOT COMPLETED|Overall Study||0
10438257|NCT00914186|11584657|FG000|STARTED|Overall Study||31
10438258|NCT00914186|11584658|FG001|STARTED|Overall Study||30
10438259|NCT00914186|11584659|FG002|STARTED|Overall Study||31
10438260|NCT00914186|11584660|FG003|STARTED|Overall Study||30
10438261|NCT00914186|11584657|FG000|COMPLETED|Overall Study||28
10438262|NCT00914186|11584658|FG001|COMPLETED|Overall Study||28
10438263|NCT00914186|11584659|FG002|COMPLETED|Overall Study||29
10438264|NCT00914186|11584660|FG003|COMPLETED|Overall Study||20
10438265|NCT00914186|11584657|FG000|NOT COMPLETED|Overall Study||3
10438266|NCT00914186|11584658|FG001|NOT COMPLETED|Overall Study||2
10438267|NCT00914186|11584659|FG002|NOT COMPLETED|Overall Study||2
10438268|NCT00914186|11584660|FG003|NOT COMPLETED|Overall Study||10
10438269|NCT00914316|11584675|FG000|STARTED|Phase 1||7
10438270|NCT00914316|11584676|FG001|STARTED|Phase 1||6
10438271|NCT00914316|11584677|FG002|STARTED|Phase 1||8
10438272|NCT00914316|11584678|FG003|STARTED|Phase 1||8
10438273|NCT00914316|11584675|FG000|COMPLETED|Phase 1||2
10438274|NCT00914316|11584676|FG001|COMPLETED|Phase 1||4
10438275|NCT00914316|11584677|FG002|COMPLETED|Phase 1||3
10438276|NCT00914316|11584678|FG003|COMPLETED|Phase 1||6
10789335|NCT03519867|11949716|FG009|Treated|Overall Study||4
10789336|NCT03519867|11949707|FG000|COMPLETED|Overall Study||3
10789337|NCT03519867|11949708|FG001|COMPLETED|Overall Study||4
10789338|NCT03519867|11949709|FG002|COMPLETED|Overall Study||5
10789339|NCT03519867|11949710|FG003|COMPLETED|Overall Study||3
10789340|NCT03519867|11949711|FG004|COMPLETED|Overall Study||5
10438277|NCT00914316|11584675|FG000|NOT COMPLETED|Phase 1||5
10438278|NCT00914316|11584676|FG001|NOT COMPLETED|Phase 1||2
10438279|NCT00914316|11584677|FG002|NOT COMPLETED|Phase 1||5
10438280|NCT00914316|11584678|FG003|NOT COMPLETED|Phase 1||2
10438281|NCT00914316|11584675|FG000|STARTED|Phase 2||2
10438282|NCT00914316|11584676|FG001|STARTED|Phase 2||4
10789341|NCT03519867|11949712|FG005|COMPLETED|Overall Study||2
10789342|NCT03519867|11949713|FG006|COMPLETED|Overall Study||3
10789343|NCT03519867|11949714|FG007|COMPLETED|Overall Study||4
10789344|NCT03519867|11949715|FG008|COMPLETED|Overall Study||3
10789345|NCT03519867|11949716|FG009|COMPLETED|Overall Study||4
10789346|NCT03519867|11949707|FG000|NOT COMPLETED|Overall Study||3
10789347|NCT03519867|11949708|FG001|NOT COMPLETED|Overall Study||3
10789348|NCT03519867|11949709|FG002|NOT COMPLETED|Overall Study||1
10789349|NCT03519867|11949710|FG003|NOT COMPLETED|Overall Study||1
10789350|NCT03519867|11949711|FG004|NOT COMPLETED|Overall Study||0
10789351|NCT03519867|11949712|FG005|NOT COMPLETED|Overall Study||3
10438283|NCT00914316|11584677|FG002|STARTED|Phase 2||3
10438284|NCT00914316|11584678|FG003|STARTED|Phase 2||6
10438285|NCT00914316|11584675|FG000|COMPLETED|Phase 2||1
10438286|NCT00914316|11584676|FG001|COMPLETED|Phase 2||4
10438287|NCT00914316|11584677|FG002|COMPLETED|Phase 2||2
10438288|NCT00914316|11584678|FG003|COMPLETED|Phase 2||6
10438289|NCT00914316|11584675|FG000|NOT COMPLETED|Phase 2||1
10438290|NCT00914316|11584676|FG001|NOT COMPLETED|Phase 2||0
10438291|NCT00914316|11584677|FG002|NOT COMPLETED|Phase 2||1
10438292|NCT00914316|11584678|FG003|NOT COMPLETED|Phase 2||0
10438293|NCT00914459|11584690|FG000|STARTED|Overall Study||18
10438294|NCT00914459|11584691|FG001|STARTED|Overall Study||19
10438295|NCT00914459|11584690|FG000|COMPLETED|Overall Study||17
10789352|NCT03519867|11949713|FG006|NOT COMPLETED|Overall Study||1
10789353|NCT03519867|11949714|FG007|NOT COMPLETED|Overall Study||1
10789354|NCT03519867|11949715|FG008|NOT COMPLETED|Overall Study||1
10789355|NCT03519867|11949716|FG009|NOT COMPLETED|Overall Study||0
10789356|NCT03519919|11949738|FG000|STARTED|Overall Study||51
10438296|NCT00914459|11584691|FG001|COMPLETED|Overall Study||18
10438297|NCT00914459|11584690|FG000|NOT COMPLETED|Overall Study||1
10438298|NCT00914459|11584691|FG001|NOT COMPLETED|Overall Study||1
10525321|NCT01375075|11677205|FG001|NOT COMPLETED|Overall Study||1
10525322|NCT01375075|11677206|FG002|NOT COMPLETED|Overall Study||3
10525323|NCT01375075|11677207|FG003|NOT COMPLETED|Overall Study||1
10525324|NCT01375075|11677208|FG004|NOT COMPLETED|Overall Study||0
10525325|NCT01375075|11677209|FG005|NOT COMPLETED|Overall Study||3
10525326|NCT01375127|11677233|FG000|STARTED|Overall Study||1
10525327|NCT01375127|11677234|FG001|STARTED|Overall Study||1
10525328|NCT01375127|11677235|FG002|STARTED|Overall Study||40
10525329|NCT01375127|11677236|FG003|STARTED|Overall Study||33
10525330|NCT01375127|11677237|FG004|STARTED|Overall Study||5
10525331|NCT01375127|11677238|FG005|STARTED|Overall Study||3
10525332|NCT01375127|11677233|FG000|COMPLETED|Overall Study||1
10525333|NCT01375127|11677234|FG001|COMPLETED|Overall Study||1
10525334|NCT01375127|11677235|FG002|COMPLETED|Overall Study||40
10525335|NCT01375127|11677236|FG003|COMPLETED|Overall Study||33
10525336|NCT01375127|11677237|FG004|COMPLETED|Overall Study||5
10525337|NCT01375127|11677238|FG005|COMPLETED|Overall Study||3
10525338|NCT01375127|11677233|FG000|NOT COMPLETED|Overall Study||0
10525339|NCT01375127|11677234|FG001|NOT COMPLETED|Overall Study||0
10789357|NCT03519919|11949738|FG000|COMPLETED|Overall Study||48
10789358|NCT03519919|11949738|FG000|NOT COMPLETED|Overall Study||3
10789359|NCT03519932|11949768|FG000|STARTED|First Intervention||24
10525340|NCT01375127|11677235|FG002|NOT COMPLETED|Overall Study||0
10525341|NCT01375127|11677236|FG003|NOT COMPLETED|Overall Study||0
10525342|NCT01375127|11677237|FG004|NOT COMPLETED|Overall Study||0
10525343|NCT01375127|11677238|FG005|NOT COMPLETED|Overall Study||0
10525344|NCT01375140|11677252|FG000|STARTED|Overall Study||31
10525345|NCT01375140|11677252|FG000|COMPLETED|Overall Study||31
10525346|NCT01375140|11677252|FG000|NOT COMPLETED|Overall Study||0
10525347|NCT01375205|11677258|FG000|STARTED|Overall Study||54
10525348|NCT01375205|11677259|FG001|STARTED|Overall Study||46
10525349|NCT01375205|11677258|FG000|COMPLETED|Overall Study||33
10438299|NCT00914485|11584699|FG000|STARTED|Overall Study||369
10438300|NCT00914485|11584699|FG000|COMPLETED|Overall Study||369
10438301|NCT00914485|11584699|FG000|NOT COMPLETED|Overall Study||0
10438302|NCT00914589|11584706|FG000|STARTED|Overall Study||128
10438303|NCT00914589|11584707|FG001|STARTED|Overall Study||143
10438304|NCT00914589|11584708|FG002|STARTED|Overall Study||138
10438305|NCT00914589|11584706|FG000|COMPLETED|Overall Study||103
10438306|NCT00914589|11584707|FG001|COMPLETED|Overall Study||127
10438307|NCT00914589|11584708|FG002|COMPLETED|Overall Study||126
10438308|NCT00914589|11584706|FG000|NOT COMPLETED|Overall Study||25
10438309|NCT00914589|11584707|FG001|NOT COMPLETED|Overall Study||16
10438310|NCT00914589|11584708|FG002|NOT COMPLETED|Overall Study||12
10438311|NCT00914628|11584718|FG000|STARTED|Overall Study|Referred to all randomized patient|64
10549689|NCT01526577|11703692|FG004|COMPLETED|Overall Study||8
10549690|NCT01526577|11703688|FG000|NOT COMPLETED|Overall Study||1
10549691|NCT01526577|11703689|FG001|NOT COMPLETED|Overall Study||0
10549692|NCT01526577|11703690|FG002|NOT COMPLETED|Overall Study||1
10549693|NCT01526577|11703691|FG003|NOT COMPLETED|Overall Study||1
10549694|NCT01526577|11703692|FG004|NOT COMPLETED|Overall Study||2
10549695|NCT01526629|11703700|FG000|STARTED|Overall Study||354
10549696|NCT01526629|11703700|FG000|COMPLETED|Overall Study||308
10549697|NCT01526629|11703700|FG000|NOT COMPLETED|Overall Study||46
10549698|NCT01526733|11703704|FG000|STARTED|Phase 1||12
10549699|NCT01526733|11703705|FG001|STARTED|Phase 1|One participant discontinued after receiving insulin-sham and before receiving insulin-rHuPH20.|13
10549700|NCT01526733|11703704|FG000|Received at Least 1 Dose of Study Drug|Phase 1||12
10549701|NCT01526733|11703705|FG001|Received at Least 1 Dose of Study Drug|Phase 1||13
10318633|NCT00215657|11452866|FG001|Started FE200486 CS07A|Overall Study||6
10318634|NCT00215657|11452867|FG002|Started FE200486 CS07A|Overall Study||7
10318635|NCT00215657|11452868|FG003|Started FE200486 CS07A|Overall Study||24
10318636|NCT00215657|11452869|FG004|Started FE200486 CS07A|Overall Study||17
10318637|NCT00215657|11452870|FG005|Started FE200486 CS07A|Overall Study||20
10318638|NCT00215657|11452871|FG006|Started FE200486 CS07A|Overall Study||14
10549702|NCT01526733|11703704|FG000|COMPLETED|Phase 1||10
10549703|NCT01526733|11703705|FG001|COMPLETED|Phase 1||12
10549704|NCT01526733|11703704|FG000|NOT COMPLETED|Phase 1||2
10549705|NCT01526733|11703705|FG001|NOT COMPLETED|Phase 1||1
10549706|NCT01526733|11703704|FG000|STARTED|Washout Period of 5 to 21 Days||10
10549707|NCT01526733|11703705|FG001|STARTED|Washout Period of 5 to 21 Days||12
10549708|NCT01526733|11703704|FG000|COMPLETED|Washout Period of 5 to 21 Days||10
10549709|NCT01526733|11703705|FG001|COMPLETED|Washout Period of 5 to 21 Days||12
10549710|NCT01526733|11703704|FG000|NOT COMPLETED|Washout Period of 5 to 21 Days||0
10549711|NCT01526733|11703705|FG001|NOT COMPLETED|Washout Period of 5 to 21 Days||0
10549712|NCT01526733|11703704|FG000|STARTED|Phase 2||10
10549713|NCT01526733|11703705|FG001|STARTED|Phase 2||12
10549714|NCT01526733|11703704|FG000|COMPLETED|Phase 2||10
10549715|NCT01526733|11703705|FG001|COMPLETED|Phase 2||12
10549716|NCT01526733|11703704|FG000|NOT COMPLETED|Phase 2||0
10549717|NCT01526733|11703705|FG001|NOT COMPLETED|Phase 2||0
10549718|NCT01526785|11703712|FG000|STARTED|Overall Study||113
10318639|NCT00215657|11452872|FG007|Started FE200486 CS07A|Overall Study||23
10318640|NCT00215657|11452865|FG000|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study.|4
10549719|NCT01526785|11703712|FG000|COMPLETED|Overall Study||100
10549720|NCT01526785|11703712|FG000|NOT COMPLETED|Overall Study||13
10549721|NCT01526889|11703718|FG000|STARTED|Treatment Period||18
10549722|NCT01526889|11703719|FG001|STARTED|Treatment Period||7
10549723|NCT01526889|11703718|FG000|COMPLETED|Treatment Period||16
10549724|NCT01526889|11703719|FG001|COMPLETED|Treatment Period||7
10549725|NCT01526889|11703718|FG000|NOT COMPLETED|Treatment Period||2
10549726|NCT01526889|11703719|FG001|NOT COMPLETED|Treatment Period||0
10549727|NCT01526889|11703718|FG000|STARTED|Treatment Extension Period||5
10549728|NCT01526889|11703719|FG001|STARTED|Treatment Extension Period||0
10549729|NCT01526889|11703718|FG000|COMPLETED|Treatment Extension Period||4
10549730|NCT01526889|11703719|FG001|COMPLETED|Treatment Extension Period||0
10549731|NCT01526889|11703718|FG000|NOT COMPLETED|Treatment Extension Period||1
10318641|NCT00215657|11452866|FG001|COMPLETED|Overall Study||1
10318642|NCT00215657|11452867|FG002|COMPLETED|Overall Study||2
10318643|NCT00215657|11452868|FG003|COMPLETED|Overall Study||6
10318644|NCT00215657|11452869|FG004|COMPLETED|Overall Study||4
10318645|NCT00215657|11452870|FG005|COMPLETED|Overall Study||4
10318646|NCT00215657|11452871|FG006|COMPLETED|Overall Study||4
10318647|NCT00215657|11452872|FG007|COMPLETED|Overall Study||11
10318648|NCT00215657|11452865|FG000|NOT COMPLETED|Overall Study||22
10318649|NCT00215657|11452866|FG001|NOT COMPLETED|Overall Study||11
10318650|NCT00215657|11452867|FG002|NOT COMPLETED|Overall Study||11
10318651|NCT00215657|11452868|FG003|NOT COMPLETED|Overall Study||18
10318652|NCT00215657|11452869|FG004|NOT COMPLETED|Overall Study||23
10318653|NCT00215657|11452870|FG005|NOT COMPLETED|Overall Study||20
10318654|NCT00215657|11452871|FG006|NOT COMPLETED|Overall Study||23
10318655|NCT00215657|11452872|FG007|NOT COMPLETED|Overall Study||16
10318656|NCT00215683|11452893|FG000|STARTED|Overall Study|Safety analysis set|45
10318657|NCT00215683|11452894|FG001|STARTED|Overall Study||48
10318658|NCT00215683|11452895|FG002|STARTED|Overall Study||44
10318659|NCT00215683|11452893|FG000|Switched to 160 mg|Overall Study|A protocol amendment changed the dosage to 160 mg (40 mg/mL) for all participants|32
10318660|NCT00215683|11452894|FG001|Switched to 160 mg|Overall Study||41
10318661|NCT00215683|11452895|FG002|Switched to 160 mg|Overall Study||36
10549732|NCT01526889|11703719|FG001|NOT COMPLETED|Treatment Extension Period||0
10438312|NCT00914628|11584719|FG001|STARTED|Overall Study|Referred to all randomized patient|28
10438313|NCT00914628|11584718|FG000|COMPLETED|Overall Study|Early termination of the Study|0
10438314|NCT00914628|11584719|FG001|COMPLETED|Overall Study|Early termination of the Study|0
10438315|NCT00914628|11584718|FG000|NOT COMPLETED|Overall Study||64
10438316|NCT00914628|11584719|FG001|NOT COMPLETED|Overall Study||28
10438317|NCT00914732|11584732|FG000|STARTED|Overall Study||165
10438318|NCT00914732|11584733|FG001|STARTED|Overall Study||167
10438319|NCT00914732|11584734|FG002|STARTED|Overall Study||191
10438320|NCT00914732|11584732|FG000|Received Second Vaccination|Overall Study||150
10438321|NCT00914732|11584733|FG001|Received Second Vaccination|Overall Study||157
10438322|NCT00914732|11584734|FG002|Received Second Vaccination|Overall Study||153
10438323|NCT00914732|11584732|FG000|COMPLETED|Overall Study||155
10438324|NCT00914732|11584733|FG001|COMPLETED|Overall Study||160
10438325|NCT00914732|11584734|FG002|COMPLETED|Overall Study||180
10438326|NCT00914732|11584732|FG000|NOT COMPLETED|Overall Study||10
10438327|NCT00914732|11584733|FG001|NOT COMPLETED|Overall Study||7
10438328|NCT00914732|11584734|FG002|NOT COMPLETED|Overall Study||11
10438329|NCT00914810|11584745|FG000|STARTED|Overall Study||20
10438330|NCT00914810|11584746|FG001|STARTED|Overall Study||19
10438331|NCT00914810|11584745|FG000|COMPLETED|Overall Study||18
10438332|NCT00914810|11584746|FG001|COMPLETED|Overall Study||18
10438333|NCT00914810|11584745|FG000|NOT COMPLETED|Overall Study||2
10438334|NCT00914810|11584746|FG001|NOT COMPLETED|Overall Study||1
10438335|NCT00914849|11584754|FG000|STARTED|Overall Study||34
10438336|NCT00914849|11584755|FG001|STARTED|Overall Study||34
10438337|NCT00914849|11584754|FG000|COMPLETED|Overall Study||33
10438338|NCT00914849|11584755|FG001|COMPLETED|Overall Study||33
10438339|NCT00914849|11584754|FG000|NOT COMPLETED|Overall Study||1
10438340|NCT00914849|11584755|FG001|NOT COMPLETED|Overall Study||1
10438341|NCT00914862|11584766|FG000|STARTED|Overall Study||6
10438342|NCT00914862|11584767|FG001|STARTED|Overall Study||6
10438343|NCT00914862|11584768|FG002|STARTED|Overall Study||8
10438344|NCT00914862|11584769|FG003|STARTED|Overall Study||8
10438345|NCT00914862|11584770|FG004|STARTED|Overall Study||28
10438346|NCT00914862|11584766|FG000|COMPLETED|Overall Study||6
10438347|NCT00914862|11584767|FG001|COMPLETED|Overall Study||6
10438348|NCT00914862|11584768|FG002|COMPLETED|Overall Study||8
10438349|NCT00914862|11584769|FG003|COMPLETED|Overall Study||8
10438350|NCT00914862|11584770|FG004|COMPLETED|Overall Study||28
10438351|NCT00914862|11584766|FG000|NOT COMPLETED|Overall Study||0
10438352|NCT00914862|11584767|FG001|NOT COMPLETED|Overall Study||0
10438353|NCT00914862|11584768|FG002|NOT COMPLETED|Overall Study||0
10438354|NCT00914862|11584769|FG003|NOT COMPLETED|Overall Study||0
10438355|NCT00914862|11584770|FG004|NOT COMPLETED|Overall Study||0
10438356|NCT00914927|11584789|FG000|STARTED|Overall Study||18
10438357|NCT00914927|11584790|FG001|STARTED|Overall Study||16
10438358|NCT00914927|11584791|FG002|STARTED|Overall Study||17
10438359|NCT00914927|11584792|FG003|STARTED|Overall Study||16
10438360|NCT00914927|11584793|FG004|STARTED|Overall Study||21
10438361|NCT00914927|11584794|FG005|STARTED|Overall Study||21
10438362|NCT00914927|11584795|FG006|STARTED|Overall Study||21
10438363|NCT00914927|11584789|FG000|COMPLETED|Overall Study||16
10438364|NCT00914927|11584790|FG001|COMPLETED|Overall Study||14
10438365|NCT00914927|11584791|FG002|COMPLETED|Overall Study||17
10438366|NCT00914927|11584792|FG003|COMPLETED|Overall Study||14
10438367|NCT00914927|11584793|FG004|COMPLETED|Overall Study||19
10438368|NCT00914927|11584794|FG005|COMPLETED|Overall Study||21
10438369|NCT00914927|11584795|FG006|COMPLETED|Overall Study||21
10438370|NCT00914927|11584789|FG000|NOT COMPLETED|Overall Study||2
10438371|NCT00914927|11584790|FG001|NOT COMPLETED|Overall Study||2
10438372|NCT00914927|11584791|FG002|NOT COMPLETED|Overall Study||0
10438373|NCT00914927|11584792|FG003|NOT COMPLETED|Overall Study||2
10438374|NCT00914927|11584793|FG004|NOT COMPLETED|Overall Study||2
10438375|NCT00914927|11584794|FG005|NOT COMPLETED|Overall Study||0
10438376|NCT00914927|11584795|FG006|NOT COMPLETED|Overall Study||0
10438377|NCT00914940|11584820|FG000|STARTED|D0 to D100 Post-transplant||41
10438378|NCT00914940|11584820|FG000|COMPLETED|D0 to D100 Post-transplant||39
10438379|NCT00914940|11584820|FG000|NOT COMPLETED|D0 to D100 Post-transplant||2
10438380|NCT00914940|11584820|FG000|STARTED|D101 to 2 Years Post-transplant||39
10438381|NCT00914940|11584820|FG000|COMPLETED|D101 to 2 Years Post-transplant||31
10438382|NCT00914940|11584820|FG000|NOT COMPLETED|D101 to 2 Years Post-transplant||8
10438383|NCT00914940|11584820|FG000|STARTED|2 Years to 5 Years Post-transplant||31
10438384|NCT00914940|11584820|FG000|COMPLETED|2 Years to 5 Years Post-transplant||28
10438385|NCT00914940|11584820|FG000|NOT COMPLETED|2 Years to 5 Years Post-transplant||3
10438386|NCT00914966|11584824|FG000|STARTED|Step 1: 1500 Units||20
10438387|NCT00914966|11584824|FG000|COMPLETED|Step 1: 1500 Units|5/18 subjects completing Step 1 (1500 Units) entered the 3 month follow-up and did not dose escalate|18
10438388|NCT00914966|11584824|FG000|NOT COMPLETED|Step 1: 1500 Units||2
10438389|NCT00914966|11584824|FG000|STARTED|Step 2: 2000 Units||13
10438390|NCT00914966|11584824|FG000|COMPLETED|Step 2: 2000 Units||12
10438391|NCT00914966|11584824|FG000|NOT COMPLETED|Step 2: 2000 Units||1
10438392|NCT00914966|11584824|FG000|STARTED|Step 3: 2500 Units||12
10438393|NCT00914966|11584824|FG000|COMPLETED|Step 3: 2500 Units||12
10438394|NCT00914966|11584824|FG000|NOT COMPLETED|Step 3: 2500 Units||0
10438395|NCT00915005|11584835|FG000|STARTED|Overall Study||105
10438396|NCT00915005|11584836|FG001|STARTED|Overall Study||76
10438397|NCT00915005|11584835|FG000|COMPLETED|Overall Study||92
10438398|NCT00915005|11584836|FG001|COMPLETED|Overall Study||57
10438399|NCT00915005|11584835|FG000|NOT COMPLETED|Overall Study||13
10438400|NCT00915005|11584836|FG001|NOT COMPLETED|Overall Study||19
10438401|NCT00915018|11584844|FG000|STARTED|Overall Study||242
10438402|NCT00915018|11584845|FG001|STARTED|Overall Study||237
10789360|NCT03519932|11949769|FG001|STARTED|First Intervention||25
10789361|NCT03519932|11949768|FG000|COMPLETED|First Intervention|One subject had non-significant adverse event and data not included in the analysis|23
10438403|NCT00915018|11584844|FG000|Received Treatment|Overall Study||240
10438404|NCT00915018|11584845|FG001|Received Treatment|Overall Study||234
10438405|NCT00915018|11584844|FG000|COMPLETED|Overall Study||27
10438406|NCT00915018|11584845|FG001|COMPLETED|Overall Study||30
10438407|NCT00915018|11584844|FG000|NOT COMPLETED|Overall Study||215
10438408|NCT00915018|11584845|FG001|NOT COMPLETED|Overall Study||207
10438409|NCT00915031|11584853|FG000|STARTED|Overall Study||714
10438410|NCT00915031|11584854|FG001|STARTED|Overall Study||24
10438411|NCT00915031|11584853|FG000|COMPLETED|Overall Study||714
10438412|NCT00915031|11584854|FG001|COMPLETED|Overall Study||24
10438413|NCT00915031|11584853|FG000|NOT COMPLETED|Overall Study||0
10438414|NCT00915031|11584854|FG001|NOT COMPLETED|Overall Study||0
10438415|NCT00915148|11584859|FG000|STARTED|Overall Study|October 2009|110
10438416|NCT00915148|11584859|FG000|COMPLETED|Overall Study|August 2010|110
10438417|NCT00915148|11584859|FG000|NOT COMPLETED|Overall Study||0
10438418|NCT00915278|11584870|FG000|STARTED|Overall Study||8
10438419|NCT00915278|11584871|FG001|STARTED|Overall Study||5
10438420|NCT00915278|11584872|FG002|STARTED|Overall Study||3
10438421|NCT00915278|11584873|FG003|STARTED|Overall Study||5
10438422|NCT00915278|11584874|FG004|STARTED|Overall Study||3
10438423|NCT00915278|11584875|FG005|STARTED|Overall Study||9
10438424|NCT00915278|11584870|FG000|COMPLETED|Overall Study||3
10438425|NCT00915278|11584871|FG001|COMPLETED|Overall Study||2
10438426|NCT00915278|11584872|FG002|COMPLETED|Overall Study||2
10438427|NCT00915278|11584873|FG003|COMPLETED|Overall Study||2
10438428|NCT00915278|11584874|FG004|COMPLETED|Overall Study||1
10438429|NCT00915278|11584875|FG005|COMPLETED|Overall Study||1
10438430|NCT00915278|11584870|FG000|NOT COMPLETED|Overall Study||5
10438431|NCT00915278|11584871|FG001|NOT COMPLETED|Overall Study||3
10438432|NCT00915278|11584872|FG002|NOT COMPLETED|Overall Study||1
10438433|NCT00915278|11584873|FG003|NOT COMPLETED|Overall Study||3
10438434|NCT00915278|11584874|FG004|NOT COMPLETED|Overall Study||2
10438435|NCT00915278|11584875|FG005|NOT COMPLETED|Overall Study||8
10438436|NCT00915343|11584889|FG000|STARTED|Part A - First Intervention Period||32
10438437|NCT00915343|11584890|FG001|STARTED|Part A - First Intervention Period||32
10438438|NCT00915343|11584891|FG002|STARTED|Part A - First Intervention Period||0
10438439|NCT00915343|11584889|FG000|COMPLETED|Part A - First Intervention Period||32
10438440|NCT00915343|11584890|FG001|COMPLETED|Part A - First Intervention Period||32
10438441|NCT00915343|11584891|FG002|COMPLETED|Part A - First Intervention Period||0
10438442|NCT00915343|11584889|FG000|NOT COMPLETED|Part A - First Intervention Period||0
10438443|NCT00915343|11584890|FG001|NOT COMPLETED|Part A - First Intervention Period||0
10438444|NCT00915343|11584891|FG002|NOT COMPLETED|Part A - First Intervention Period||0
10438445|NCT00915343|11584889|FG000|STARTED|Part A - Second Intervention Period||32
10438446|NCT00915343|11584890|FG001|STARTED|Part A - Second Intervention Period||32
10438447|NCT00915343|11584891|FG002|STARTED|Part A - Second Intervention Period||0
10438448|NCT00915343|11584889|FG000|COMPLETED|Part A - Second Intervention Period||32
10438449|NCT00915343|11584890|FG001|COMPLETED|Part A - Second Intervention Period||32
10438450|NCT00915343|11584891|FG002|COMPLETED|Part A - Second Intervention Period||0
10438451|NCT00915343|11584889|FG000|NOT COMPLETED|Part A - Second Intervention Period||0
10438452|NCT00915343|11584890|FG001|NOT COMPLETED|Part A - Second Intervention Period||0
10438453|NCT00915343|11584891|FG002|NOT COMPLETED|Part A - Second Intervention Period||0
10438454|NCT00915343|11584889|FG000|STARTED|Part B - Open Label Period||0
10438455|NCT00915343|11584890|FG001|STARTED|Part B - Open Label Period||0
10438456|NCT00915343|11584891|FG002|STARTED|Part B - Open Label Period||59
10438457|NCT00915343|11584889|FG000|COMPLETED|Part B - Open Label Period||0
10438458|NCT00915343|11584890|FG001|COMPLETED|Part B - Open Label Period||0
10438459|NCT00915343|11584891|FG002|COMPLETED|Part B - Open Label Period||57
10438460|NCT00915343|11584889|FG000|NOT COMPLETED|Part B - Open Label Period||0
10438461|NCT00915343|11584890|FG001|NOT COMPLETED|Part B - Open Label Period||0
10438462|NCT00915343|11584891|FG002|NOT COMPLETED|Part B - Open Label Period||2
10438463|NCT00915356|11584908|FG000|STARTED|Overall Study||26
10438464|NCT00915356|11584909|FG001|STARTED|Overall Study||45
10438465|NCT00915356|11584910|FG002|STARTED|Overall Study||45
10438466|NCT00915356|11584911|FG003|STARTED|Overall Study||12
10438467|NCT00915356|11584912|FG004|STARTED|Overall Study||43
10438468|NCT00915356|11584908|FG000|COMPLETED|Overall Study||25
10789362|NCT03519932|11949769|FG001|COMPLETED|First Intervention|3 subjects had non-significant adverse events and data not included in analysis.|22
10438469|NCT00915356|11584909|FG001|COMPLETED|Overall Study||45
10438470|NCT00915356|11584910|FG002|COMPLETED|Overall Study||45
10438471|NCT00915356|11584911|FG003|COMPLETED|Overall Study||12
10438472|NCT00915356|11584912|FG004|COMPLETED|Overall Study||43
10438473|NCT00915356|11584908|FG000|NOT COMPLETED|Overall Study||1
10438474|NCT00915356|11584909|FG001|NOT COMPLETED|Overall Study||0
10438475|NCT00915356|11584910|FG002|NOT COMPLETED|Overall Study||0
10438476|NCT00915356|11584911|FG003|NOT COMPLETED|Overall Study||0
10438477|NCT00915356|11584912|FG004|NOT COMPLETED|Overall Study||0
10438478|NCT00915473|11584926|FG000|STARTED|Screening||35
10438479|NCT00915473|11584927|FG001|STARTED|Screening||35
10438480|NCT00915473|11584926|FG000|COMPLETED|Screening||34
10438481|NCT00915473|11584927|FG001|COMPLETED|Screening||35
10438482|NCT00915473|11584926|FG000|NOT COMPLETED|Screening||1
10438483|NCT00915473|11584927|FG001|NOT COMPLETED|Screening||0
10438484|NCT00915473|11584926|FG000|STARTED|Injection||34
10438485|NCT00915473|11584927|FG001|STARTED|Injection||35
10438486|NCT00915473|11584926|FG000|COMPLETED|Injection||34
10438487|NCT00915473|11584927|FG001|COMPLETED|Injection||35
10438488|NCT00915473|11584926|FG000|NOT COMPLETED|Injection||0
10438489|NCT00915473|11584927|FG001|NOT COMPLETED|Injection||0
10438490|NCT00915473|11584926|FG000|STARTED|4-week Follow Up||34
10438491|NCT00915473|11584927|FG001|STARTED|4-week Follow Up||35
10438492|NCT00915473|11584926|FG000|COMPLETED|4-week Follow Up||33
10438493|NCT00915473|11584927|FG001|COMPLETED|4-week Follow Up||30
10438494|NCT00915473|11584926|FG000|NOT COMPLETED|4-week Follow Up||1
10438495|NCT00915473|11584927|FG001|NOT COMPLETED|4-week Follow Up||5
10438496|NCT00915499|11584935|FG000|STARTED|Overall Study||33
10438497|NCT00915499|11584936|FG001|STARTED|Overall Study||33
10438498|NCT00915499|11584935|FG000|COMPLETED|Overall Study||29
10438499|NCT00915499|11584936|FG001|COMPLETED|Overall Study||31
10438500|NCT00915499|11584935|FG000|NOT COMPLETED|Overall Study||4
10438501|NCT00915499|11584936|FG001|NOT COMPLETED|Overall Study||2
10438502|NCT00915525|11584944|FG000|STARTED|Overall Study||543
10438503|NCT00915525|11584945|FG001|STARTED|Overall Study||286
10438504|NCT00915525|11584944|FG000|COMPLETED|Overall Study||278
10438505|NCT00915525|11584945|FG001|COMPLETED|Overall Study||151
10438506|NCT00915525|11584944|FG000|NOT COMPLETED|Overall Study||265
10438507|NCT00915525|11584945|FG001|NOT COMPLETED|Overall Study||135
10438508|NCT00915538|11584973|FG000|STARTED|Overall Study||8
10438509|NCT00915538|11584974|FG001|STARTED|Overall Study||8
10438510|NCT00915538|11584973|FG000|COMPLETED|Overall Study||8
10438511|NCT00915538|11584974|FG001|COMPLETED|Overall Study||8
10438512|NCT00915538|11584973|FG000|NOT COMPLETED|Overall Study||0
10438513|NCT00915538|11584974|FG001|NOT COMPLETED|Overall Study||0
10438514|NCT00915551|11584984|FG000|STARTED|Overall Study||142
10438515|NCT00915551|11584985|FG001|STARTED|Overall Study||136
10438516|NCT00915551|11584984|FG000|COMPLETED|Overall Study||142
10438517|NCT00915551|11584985|FG001|COMPLETED|Overall Study||135
10438518|NCT00915551|11584984|FG000|NOT COMPLETED|Overall Study||0
10438519|NCT00915551|11584985|FG001|NOT COMPLETED|Overall Study||1
10438520|NCT00915590|11584993|FG000|STARTED|Overall Study||5
10438521|NCT00915590|11584994|FG001|STARTED|Overall Study||5
10438522|NCT00915590|11584993|FG000|COMPLETED|Overall Study||3
10438523|NCT00915590|11584994|FG001|COMPLETED|Overall Study||4
10438524|NCT00915590|11584993|FG000|NOT COMPLETED|Overall Study||2
10438525|NCT00915590|11584994|FG001|NOT COMPLETED|Overall Study||1
10438526|NCT00915603|11585007|FG000|STARTED|Overall Study|One patient enrolled/randomized but did not start treatment|56
10438527|NCT00915603|11585008|FG001|STARTED|Overall Study|One patient enrolled/randomized but did not start treatment|55
10438528|NCT00915603|11585007|FG000|COMPLETED|Overall Study||0
10438529|NCT00915603|11585008|FG001|COMPLETED|Overall Study||0
10438530|NCT00915603|11585007|FG000|NOT COMPLETED|Overall Study||56
10438531|NCT00915603|11585008|FG001|NOT COMPLETED|Overall Study||55
10438532|NCT00915655|11585014|FG000|STARTED|Overall Study||12
10438533|NCT00915655|11585014|FG000|COMPLETED|Overall Study|'Completed' represents patients who have not discontinued at time of cut-off for Week 24 analysis|12
10438534|NCT00915655|11585014|FG000|NOT COMPLETED|Overall Study||0
10438535|NCT00915759|11585018|FG000|STARTED|Overall Study|number of participants|40
10438536|NCT00915759|11585018|FG000|COMPLETED|Overall Study|number of participants|40
10438537|NCT00915759|11585018|FG000|NOT COMPLETED|Overall Study||0
10438538|NCT00915772|11585031|FG000|STARTED|Overall Study||170
10438539|NCT00915772|11585032|FG001|STARTED|Overall Study||225
10438540|NCT00915772|11585033|FG002|STARTED|Overall Study||171
10438541|NCT00915772|11585031|FG000|COMPLETED|Overall Study||134
10438542|NCT00915772|11585032|FG001|COMPLETED|Overall Study||179
10438543|NCT00915772|11585033|FG002|COMPLETED|Overall Study||142
10438544|NCT00915772|11585031|FG000|NOT COMPLETED|Overall Study||36
10438545|NCT00915772|11585032|FG001|NOT COMPLETED|Overall Study||46
10438546|NCT00915772|11585033|FG002|NOT COMPLETED|Overall Study||29
10438547|NCT00915798|11585046|FG000|STARTED|Overall Study||19
10438548|NCT00915798|11585047|FG001|STARTED|Overall Study||21
10438549|NCT00915798|11585048|FG002|STARTED|Overall Study||23
10438550|NCT00915798|11585049|FG003|STARTED|Overall Study||26
10438551|NCT00915798|11585046|FG000|COMPLETED|Overall Study||19
10438552|NCT00915798|11585047|FG001|COMPLETED|Overall Study||21
10438553|NCT00915798|11585048|FG002|COMPLETED|Overall Study||23
10438554|NCT00915798|11585049|FG003|COMPLETED|Overall Study||26
10438555|NCT00915798|11585046|FG000|NOT COMPLETED|Overall Study||0
10438556|NCT00915798|11585047|FG001|NOT COMPLETED|Overall Study||0
10438557|NCT00915798|11585048|FG002|NOT COMPLETED|Overall Study||0
10438558|NCT00915798|11585049|FG003|NOT COMPLETED|Overall Study||0
10438559|NCT00915876|11585071|FG000|STARTED|Overall Study||20
10438560|NCT00915876|11585072|FG001|STARTED|Overall Study||21
10438561|NCT00915876|11585071|FG000|Moving Beyond First Dose|Overall Study||20
10438562|NCT00915876|11585072|FG001|Moving Beyond First Dose|Overall Study||20
10438563|NCT00915876|11585071|FG000|COMPLETED|Overall Study||20
10438564|NCT00915876|11585072|FG001|COMPLETED|Overall Study||20
10438565|NCT00915876|11585071|FG000|NOT COMPLETED|Overall Study||0
10438566|NCT00915876|11585072|FG001|NOT COMPLETED|Overall Study||1
10438567|NCT00915902|11585080|FG000|STARTED|1st Treatment Period||20
10438568|NCT00915902|11585081|FG001|STARTED|1st Treatment Period||22
10438569|NCT00915902|11585080|FG000|COMPLETED|1st Treatment Period||19
10438570|NCT00915902|11585081|FG001|COMPLETED|1st Treatment Period||22
10438571|NCT00915902|11585080|FG000|NOT COMPLETED|1st Treatment Period||1
10438572|NCT00915902|11585081|FG001|NOT COMPLETED|1st Treatment Period||0
10438573|NCT00915902|11585080|FG000|STARTED|Washout (4 Weeks)||19
10438574|NCT00915902|11585081|FG001|STARTED|Washout (4 Weeks)||22
10438575|NCT00915902|11585080|FG000|COMPLETED|Washout (4 Weeks)||19
10438576|NCT00915902|11585081|FG001|COMPLETED|Washout (4 Weeks)||21
10438577|NCT00915902|11585080|FG000|NOT COMPLETED|Washout (4 Weeks)||0
10438578|NCT00915902|11585081|FG001|NOT COMPLETED|Washout (4 Weeks)||1
10438579|NCT00915902|11585080|FG000|STARTED|2nd Treatment Period||19
10438580|NCT00915902|11585081|FG001|STARTED|2nd Treatment Period||21
10438581|NCT00915902|11585080|FG000|COMPLETED|2nd Treatment Period||19
10438582|NCT00915902|11585081|FG001|COMPLETED|2nd Treatment Period||20
10438583|NCT00915902|11585080|FG000|NOT COMPLETED|2nd Treatment Period||0
10438584|NCT00915902|11585081|FG001|NOT COMPLETED|2nd Treatment Period||1
10438585|NCT00915928|11585091|FG000|STARTED|Overall Study||25
10438586|NCT00915928|11585092|FG001|STARTED|Overall Study||22
10438587|NCT00915928|11585091|FG000|COMPLETED|Overall Study||25
10438588|NCT00915928|11585092|FG001|COMPLETED|Overall Study||22
10438589|NCT00915928|11585091|FG000|NOT COMPLETED|Overall Study||0
10438590|NCT00915928|11585092|FG001|NOT COMPLETED|Overall Study||0
10438591|NCT00915954|11585102|FG000|STARTED|Overall Study||10
10438592|NCT00915954|11585103|FG001|STARTED|Overall Study||8
10438593|NCT00915954|11585104|FG002|STARTED|Overall Study||10
10438594|NCT00915954|11585102|FG000|COMPLETED|Overall Study||10
10438595|NCT00915954|11585103|FG001|COMPLETED|Overall Study||8
10438596|NCT00915954|11585104|FG002|COMPLETED|Overall Study||10
10438597|NCT00915954|11585102|FG000|NOT COMPLETED|Overall Study||0
10438598|NCT00915954|11585103|FG001|NOT COMPLETED|Overall Study||0
10438599|NCT00915954|11585104|FG002|NOT COMPLETED|Overall Study||0
10438600|NCT00915967|11585114|FG000|STARTED|Overall Study||98
10438601|NCT00915967|11585115|FG001|STARTED|Overall Study||100
10438602|NCT00915967|11585114|FG000|COMPLETED|Overall Study||97
10438603|NCT00915967|11585115|FG001|COMPLETED|Overall Study||98
10438604|NCT00915967|11585114|FG000|NOT COMPLETED|Overall Study||1
10438605|NCT00915967|11585115|FG001|NOT COMPLETED|Overall Study||2
10438606|NCT00916006|11585123|FG000|STARTED|Overall Study||135
10438607|NCT00916006|11585124|FG001|STARTED|Overall Study||134
10438608|NCT00916006|11585123|FG000|COMPLETED|Overall Study||132
10438609|NCT00916006|11585124|FG001|COMPLETED|Overall Study||127
10438610|NCT00916006|11585123|FG000|NOT COMPLETED|Overall Study||3
10438611|NCT00916006|11585124|FG001|NOT COMPLETED|Overall Study||7
10438612|NCT00916032|11585130|FG000|STARTED|Overall Study||12
10438613|NCT00916032|11585131|FG001|STARTED|Overall Study||11
10438614|NCT00916032|11585130|FG000|COMPLETED|Overall Study||12
10438615|NCT00916032|11585131|FG001|COMPLETED|Overall Study||11
10438616|NCT00916032|11585130|FG000|NOT COMPLETED|Overall Study||0
10438617|NCT00916032|11585131|FG001|NOT COMPLETED|Overall Study||0
10438618|NCT00916058|11585144|FG000|STARTED|Phase 1||3
10438619|NCT00916058|11585145|FG001|STARTED|Phase 1||6
10549733|NCT01526902|11703725|FG000|STARTED|Overall Study||25
10549734|NCT01526902|11703726|FG001|STARTED|Overall Study||24
10549735|NCT01526902|11703725|FG000|COMPLETED|Overall Study||25
10549736|NCT01526902|11703726|FG001|COMPLETED|Overall Study||24
10549737|NCT01526902|11703725|FG000|NOT COMPLETED|Overall Study||0
10549738|NCT01526902|11703726|FG001|NOT COMPLETED|Overall Study||0
10549739|NCT01526928|11703738|FG000|STARTED|Overall Study||38
10549740|NCT01526928|11703739|FG001|STARTED|Overall Study||19
10549741|NCT01526928|11703740|FG002|STARTED|Overall Study||209
10549742|NCT01526928|11703741|FG003|STARTED|Overall Study||245
10549743|NCT01526928|11703742|FG004|STARTED|Overall Study||95
10549744|NCT01526928|11703743|FG005|STARTED|Overall Study||6
10549745|NCT01526928|11703738|FG000|Started Phase 1|Overall Study||38
10549746|NCT01526928|11703739|FG001|Started Phase 1|Overall Study||19
10549747|NCT01526928|11703740|FG002|Started Phase 1|Overall Study||18
10549748|NCT01526928|11703741|FG003|Started Phase 1|Overall Study||17
10549749|NCT01526928|11703742|FG004|Started Phase 1|Overall Study||13
10549750|NCT01526928|11703743|FG005|Started Phase 1|Overall Study||6
10549751|NCT01526928|11703738|FG000|Started Phase 2|Overall Study||0
10549752|NCT01526928|11703739|FG001|Started Phase 2|Overall Study||0
10549753|NCT01526928|11703740|FG002|Started Phase 2|Overall Study||191
10549754|NCT01526928|11703741|FG003|Started Phase 2|Overall Study||228
10549755|NCT01526928|11703742|FG004|Started Phase 2|Overall Study||82
10549756|NCT01526928|11703743|FG005|Started Phase 2|Overall Study||0
10549757|NCT01526928|11703738|FG000|COMPLETED|Overall Study||0
10549758|NCT01526928|11703739|FG001|COMPLETED|Overall Study||0
10549759|NCT01526928|11703740|FG002|COMPLETED|Overall Study||0
10549760|NCT01526928|11703741|FG003|COMPLETED|Overall Study||0
10549761|NCT01526928|11703742|FG004|COMPLETED|Overall Study||0
10549762|NCT01526928|11703743|FG005|COMPLETED|Overall Study||0
10549763|NCT01526928|11703738|FG000|NOT COMPLETED|Overall Study||38
10549764|NCT01526928|11703739|FG001|NOT COMPLETED|Overall Study||19
10549765|NCT01526928|11703740|FG002|NOT COMPLETED|Overall Study||209
10549766|NCT01526928|11703741|FG003|NOT COMPLETED|Overall Study||245
10549767|NCT01526928|11703742|FG004|NOT COMPLETED|Overall Study||95
10549768|NCT01526928|11703743|FG005|NOT COMPLETED|Overall Study||6
10549769|NCT01527006|11703801|FG000|STARTED|Core Study||22
10438620|NCT00916058|11585146|FG002|STARTED|Phase 1||3
10438621|NCT00916058|11585147|FG003|STARTED|Phase 1||3
10438622|NCT00916058|11585148|FG004|STARTED|Phase 1||3
10438623|NCT00916058|11585149|FG005|STARTED|Phase 1||8
10438624|NCT00916058|11585150|FG006|STARTED|Phase 1||0
10438625|NCT00916058|11585144|FG000|COMPLETED|Phase 1||3
10438626|NCT00916058|11585145|FG001|COMPLETED|Phase 1||6
10438627|NCT00916058|11585146|FG002|COMPLETED|Phase 1||3
10438628|NCT00916058|11585147|FG003|COMPLETED|Phase 1||3
10438629|NCT00916058|11585148|FG004|COMPLETED|Phase 1||3
10438630|NCT00916058|11585149|FG005|COMPLETED|Phase 1||7
10438631|NCT00916058|11585150|FG006|COMPLETED|Phase 1||0
10438632|NCT00916058|11585144|FG000|NOT COMPLETED|Phase 1||0
10438633|NCT00916058|11585145|FG001|NOT COMPLETED|Phase 1||0
10438634|NCT00916058|11585146|FG002|NOT COMPLETED|Phase 1||0
10438635|NCT00916058|11585147|FG003|NOT COMPLETED|Phase 1||0
10438636|NCT00916058|11585148|FG004|NOT COMPLETED|Phase 1||0
10438637|NCT00916058|11585149|FG005|NOT COMPLETED|Phase 1||1
10438638|NCT00916058|11585150|FG006|NOT COMPLETED|Phase 1||0
10438639|NCT00916058|11585144|FG000|STARTED|Phase 2||0
10438640|NCT00916058|11585145|FG001|STARTED|Phase 2||0
10438641|NCT00916058|11585146|FG002|STARTED|Phase 2||0
10438642|NCT00916058|11585147|FG003|STARTED|Phase 2||0
10438643|NCT00916058|11585148|FG004|STARTED|Phase 2||0
10438644|NCT00916058|11585149|FG005|STARTED|Phase 2||0
10438645|NCT00916058|11585150|FG006|STARTED|Phase 2||31
10438646|NCT00916058|11585144|FG000|COMPLETED|Phase 2||0
10438647|NCT00916058|11585145|FG001|COMPLETED|Phase 2||0
10438648|NCT00916058|11585146|FG002|COMPLETED|Phase 2||0
10438649|NCT00916058|11585147|FG003|COMPLETED|Phase 2||0
10438650|NCT00916058|11585148|FG004|COMPLETED|Phase 2||0
10438651|NCT00916058|11585149|FG005|COMPLETED|Phase 2||0
10438652|NCT00916058|11585150|FG006|COMPLETED|Phase 2||28
10438653|NCT00916058|11585144|FG000|NOT COMPLETED|Phase 2||0
10438654|NCT00916058|11585145|FG001|NOT COMPLETED|Phase 2||0
10438655|NCT00916058|11585146|FG002|NOT COMPLETED|Phase 2||0
10438656|NCT00916058|11585147|FG003|NOT COMPLETED|Phase 2||0
10438657|NCT00916058|11585148|FG004|NOT COMPLETED|Phase 2||0
10438658|NCT00916058|11585149|FG005|NOT COMPLETED|Phase 2||0
10438659|NCT00916058|11585150|FG006|NOT COMPLETED|Phase 2||3
10438660|NCT00916136|11585170|FG000|STARTED|Overall Study||37
10438661|NCT00916136|11585171|FG001|STARTED|Overall Study||29
10438662|NCT00916136|11585170|FG000|COMPLETED|Overall Study||37
10438663|NCT00916136|11585171|FG001|COMPLETED|Overall Study||29
10438664|NCT00916136|11585170|FG000|NOT COMPLETED|Overall Study||0
10438665|NCT00916136|11585171|FG001|NOT COMPLETED|Overall Study||0
10438666|NCT00916149|11585180|FG000|STARTED|Overall Study||16
10438667|NCT00916149|11585181|FG001|STARTED|Overall Study||10
10438668|NCT00916149|11585182|FG002|STARTED|Overall Study||5
10438669|NCT00916149|11585180|FG000|COMPLETED|Overall Study||12
10438670|NCT00916149|11585181|FG001|COMPLETED|Overall Study||8
10438671|NCT00916149|11585182|FG002|COMPLETED|Overall Study||5
10438672|NCT00916149|11585180|FG000|NOT COMPLETED|Overall Study||4
10438673|NCT00916149|11585181|FG001|NOT COMPLETED|Overall Study||2
10438674|NCT00916149|11585182|FG002|NOT COMPLETED|Overall Study||0
10438675|NCT00916279|11585189|FG000|STARTED|Overall Study||41
10438676|NCT00916279|11585189|FG000|30 Days|Overall Study||41
10438677|NCT00916279|11585189|FG000|6 Months|Overall Study||41
10438678|NCT00916279|11585189|FG000|24 Months|Overall Study||37
10438679|NCT00916279|11585189|FG000|COMPLETED|Overall Study||37
10438680|NCT00916279|11585189|FG000|NOT COMPLETED|Overall Study||4
10438681|NCT00916305|11585198|FG000|STARTED|Overall Study||28
10438682|NCT00916305|11585199|FG001|STARTED|Overall Study||37
10438683|NCT00916305|11585198|FG000|COMPLETED|Overall Study||7
10438684|NCT00916305|11585199|FG001|COMPLETED|Overall Study||9
10438685|NCT00916305|11585198|FG000|NOT COMPLETED|Overall Study||21
10438686|NCT00916305|11585199|FG001|NOT COMPLETED|Overall Study||28
10438687|NCT00916344|11585205|FG000|STARTED|Overall Study||175
10438688|NCT00916344|11585205|FG000|COMPLETED|Overall Study||167
10438689|NCT00916344|11585205|FG000|NOT COMPLETED|Overall Study||8
10438690|NCT00916357|11585209|FG000|STARTED|Period 1||4
10438691|NCT00916357|11585210|FG001|STARTED|Period 1||4
10789363|NCT03519932|11949768|FG000|NOT COMPLETED|First Intervention||1
10789364|NCT03519932|11949769|FG001|NOT COMPLETED|First Intervention||3
10789365|NCT03519932|11949768|FG000|STARTED|Second Intervention|Subjects who wore samfilcon A toric at 1st intervention wear comfilcon A toric at 2nd intervention|22
10789366|NCT03519932|11949769|FG001|STARTED|Second Intervention|Subjects who wore comfilcon A toric at 1st intervention wear Samfilcon A toric at 2nd intervention|23
10789367|NCT03519932|11949768|FG000|COMPLETED|Second Intervention||22
10789368|NCT03519932|11949769|FG001|COMPLETED|Second Intervention||23
10438692|NCT00916357|11585211|FG002|STARTED|Period 1||4
10438693|NCT00916357|11585212|FG003|STARTED|Period 1||4
10438694|NCT00916357|11585213|FG004|STARTED|Period 1||3
10438695|NCT00916357|11585214|FG005|STARTED|Period 1||4
10438696|NCT00916357|11585209|FG000|Received at Least 1 Dose of Study Drug|Period 1||4
10438697|NCT00916357|11585210|FG001|Received at Least 1 Dose of Study Drug|Period 1||4
10438698|NCT00916357|11585211|FG002|Received at Least 1 Dose of Study Drug|Period 1||4
10438699|NCT00916357|11585212|FG003|Received at Least 1 Dose of Study Drug|Period 1||4
10438700|NCT00916357|11585213|FG004|Received at Least 1 Dose of Study Drug|Period 1||3
10438701|NCT00916357|11585214|FG005|Received at Least 1 Dose of Study Drug|Period 1||4
10438702|NCT00916357|11585209|FG000|COMPLETED|Period 1||3
10438703|NCT00916357|11585210|FG001|COMPLETED|Period 1||4
10438704|NCT00916357|11585211|FG002|COMPLETED|Period 1||4
10438705|NCT00916357|11585212|FG003|COMPLETED|Period 1||4
10438706|NCT00916357|11585213|FG004|COMPLETED|Period 1||3
10438707|NCT00916357|11585214|FG005|COMPLETED|Period 1||4
10438708|NCT00916357|11585209|FG000|NOT COMPLETED|Period 1||1
10438709|NCT00916357|11585210|FG001|NOT COMPLETED|Period 1||0
10438710|NCT00916357|11585211|FG002|NOT COMPLETED|Period 1||0
10438711|NCT00916357|11585212|FG003|NOT COMPLETED|Period 1||0
10438712|NCT00916357|11585213|FG004|NOT COMPLETED|Period 1||0
10438713|NCT00916357|11585214|FG005|NOT COMPLETED|Period 1||0
10438714|NCT00916357|11585209|FG000|STARTED|Washout (3 to 14 Days)||3
10438715|NCT00916357|11585210|FG001|STARTED|Washout (3 to 14 Days)||4
10789369|NCT03519932|11949768|FG000|NOT COMPLETED|Second Intervention||0
10789370|NCT03519932|11949769|FG001|NOT COMPLETED|Second Intervention||0
10789371|NCT03520283|11949782|FG000|STARTED|Overall Study||24
10789372|NCT03520283|11949783|FG001|STARTED|Overall Study||42
10789373|NCT03520283|11949782|FG000|COMPLETED|Overall Study||24
10789374|NCT03520283|11949783|FG001|COMPLETED|Overall Study||42
10789375|NCT03520283|11949782|FG000|NOT COMPLETED|Overall Study||0
10789376|NCT03520283|11949783|FG001|NOT COMPLETED|Overall Study||0
10789377|NCT03520348|11949800|FG000|STARTED|Overall Study||12
10438716|NCT00916357|11585211|FG002|STARTED|Washout (3 to 14 Days)||4
10438717|NCT00916357|11585212|FG003|STARTED|Washout (3 to 14 Days)||4
10438718|NCT00916357|11585213|FG004|STARTED|Washout (3 to 14 Days)||3
10438719|NCT00916357|11585214|FG005|STARTED|Washout (3 to 14 Days)||4
10438720|NCT00916357|11585209|FG000|COMPLETED|Washout (3 to 14 Days)||3
10438721|NCT00916357|11585210|FG001|COMPLETED|Washout (3 to 14 Days)||4
10438722|NCT00916357|11585211|FG002|COMPLETED|Washout (3 to 14 Days)||4
10438723|NCT00916357|11585212|FG003|COMPLETED|Washout (3 to 14 Days)||4
10438724|NCT00916357|11585213|FG004|COMPLETED|Washout (3 to 14 Days)||3
10438725|NCT00916357|11585214|FG005|COMPLETED|Washout (3 to 14 Days)||4
10438726|NCT00916357|11585209|FG000|NOT COMPLETED|Washout (3 to 14 Days)||0
10438727|NCT00916357|11585210|FG001|NOT COMPLETED|Washout (3 to 14 Days)||0
10438728|NCT00916357|11585211|FG002|NOT COMPLETED|Washout (3 to 14 Days)||0
10438729|NCT00916357|11585212|FG003|NOT COMPLETED|Washout (3 to 14 Days)||0
10438730|NCT00916357|11585213|FG004|NOT COMPLETED|Washout (3 to 14 Days)||0
10438731|NCT00916357|11585214|FG005|NOT COMPLETED|Washout (3 to 14 Days)||0
10438732|NCT00916357|11585209|FG000|STARTED|Period 2||3
10438733|NCT00916357|11585210|FG001|STARTED|Period 2||4
10438734|NCT00916357|11585211|FG002|STARTED|Period 2||4
10438735|NCT00916357|11585212|FG003|STARTED|Period 2||4
10438736|NCT00916357|11585213|FG004|STARTED|Period 2||3
10438737|NCT00916357|11585214|FG005|STARTED|Period 2||4
10438738|NCT00916357|11585209|FG000|COMPLETED|Period 2||3
10438739|NCT00916357|11585210|FG001|COMPLETED|Period 2||4
10438740|NCT00916357|11585211|FG002|COMPLETED|Period 2||4
10438741|NCT00916357|11585212|FG003|COMPLETED|Period 2||3
10438742|NCT00916357|11585213|FG004|COMPLETED|Period 2||3
10438743|NCT00916357|11585214|FG005|COMPLETED|Period 2||4
10438744|NCT00916357|11585209|FG000|NOT COMPLETED|Period 2||0
10438745|NCT00916357|11585210|FG001|NOT COMPLETED|Period 2||0
10438746|NCT00916357|11585211|FG002|NOT COMPLETED|Period 2||0
10438747|NCT00916357|11585212|FG003|NOT COMPLETED|Period 2||1
10438748|NCT00916357|11585213|FG004|NOT COMPLETED|Period 2||0
10438749|NCT00916357|11585214|FG005|NOT COMPLETED|Period 2||0
10438750|NCT00916357|11585209|FG000|STARTED|Washout (3 to 14 Days)||3
10438751|NCT00916357|11585210|FG001|STARTED|Washout (3 to 14 Days)||4
10438752|NCT00916357|11585211|FG002|STARTED|Washout (3 to 14 Days)||4
10438753|NCT00916357|11585212|FG003|STARTED|Washout (3 to 14 Days)||3
10438754|NCT00916357|11585213|FG004|STARTED|Washout (3 to 14 Days)||3
10438755|NCT00916357|11585214|FG005|STARTED|Washout (3 to 14 Days)||4
10438756|NCT00916357|11585209|FG000|COMPLETED|Washout (3 to 14 Days)||3
10438757|NCT00916357|11585210|FG001|COMPLETED|Washout (3 to 14 Days)||4
10438758|NCT00916357|11585211|FG002|COMPLETED|Washout (3 to 14 Days)||4
10438759|NCT00916357|11585212|FG003|COMPLETED|Washout (3 to 14 Days)||3
10438760|NCT00916357|11585213|FG004|COMPLETED|Washout (3 to 14 Days)||3
10438761|NCT00916357|11585214|FG005|COMPLETED|Washout (3 to 14 Days)||4
10438762|NCT00916357|11585209|FG000|NOT COMPLETED|Washout (3 to 14 Days)||0
10438763|NCT00916357|11585210|FG001|NOT COMPLETED|Washout (3 to 14 Days)||0
10438764|NCT00916357|11585211|FG002|NOT COMPLETED|Washout (3 to 14 Days)||0
10438765|NCT00916357|11585212|FG003|NOT COMPLETED|Washout (3 to 14 Days)||0
10438766|NCT00916357|11585213|FG004|NOT COMPLETED|Washout (3 to 14 Days)||0
10438767|NCT00916357|11585214|FG005|NOT COMPLETED|Washout (3 to 14 Days)||0
10438768|NCT00916357|11585209|FG000|STARTED|Period 3||3
10438769|NCT00916357|11585210|FG001|STARTED|Period 3||4
10438770|NCT00916357|11585211|FG002|STARTED|Period 3||4
10438771|NCT00916357|11585212|FG003|STARTED|Period 3||3
10438772|NCT00916357|11585213|FG004|STARTED|Period 3||3
10438773|NCT00916357|11585214|FG005|STARTED|Period 3||4
10438774|NCT00916357|11585209|FG000|COMPLETED|Period 3||3
10438775|NCT00916357|11585210|FG001|COMPLETED|Period 3||4
10438776|NCT00916357|11585211|FG002|COMPLETED|Period 3||4
10438777|NCT00916357|11585212|FG003|COMPLETED|Period 3||3
10438778|NCT00916357|11585213|FG004|COMPLETED|Period 3||3
10438779|NCT00916357|11585214|FG005|COMPLETED|Period 3||4
10438780|NCT00916357|11585209|FG000|NOT COMPLETED|Period 3||0
10438781|NCT00916357|11585210|FG001|NOT COMPLETED|Period 3||0
10438782|NCT00916357|11585211|FG002|NOT COMPLETED|Period 3||0
10438783|NCT00916357|11585212|FG003|NOT COMPLETED|Period 3||0
10789378|NCT03520348|11949801|FG001|STARTED|Overall Study||12
10789379|NCT03520348|11949800|FG000|COMPLETED|Overall Study||12
10438784|NCT00916357|11585213|FG004|NOT COMPLETED|Period 3||0
10438785|NCT00916357|11585214|FG005|NOT COMPLETED|Period 3||0
10438786|NCT00916370|11585225|FG000|STARTED|Overall Study||401
10438787|NCT00916370|11585226|FG001|STARTED|Overall Study||104
10789380|NCT03520348|11949801|FG001|COMPLETED|Overall Study||12
10438788|NCT00916370|11585225|FG000|COMPLETED|Overall Study||396
10438789|NCT00916370|11585226|FG001|COMPLETED|Overall Study||102
10438790|NCT00916370|11585225|FG000|NOT COMPLETED|Overall Study||5
10438791|NCT00916370|11585226|FG001|NOT COMPLETED|Overall Study||2
10438792|NCT00916383|11585233|FG000|STARTED|Overall Study||49
10438793|NCT00916383|11585233|FG000|COMPLETED|Overall Study||46
10438794|NCT00916383|11585233|FG000|NOT COMPLETED|Overall Study||3
10438795|NCT00916539|11585243|FG000|STARTED|Overall Study||31
10438796|NCT00916539|11585244|FG001|STARTED|Overall Study||31
10438797|NCT00916539|11585243|FG000|COMPLETED|Overall Study||31
10438798|NCT00916539|11585244|FG001|COMPLETED|Overall Study||31
10438799|NCT00916539|11585243|FG000|NOT COMPLETED|Overall Study||0
10438800|NCT00916539|11585244|FG001|NOT COMPLETED|Overall Study||0
10438801|NCT00916578|11585250|FG000|STARTED|Overall Study||33
10438802|NCT00916578|11585250|FG000|COMPLETED|Overall Study||26
10438803|NCT00916578|11585250|FG000|NOT COMPLETED|Overall Study||7
10438804|NCT00916617|11585258|FG000|STARTED|Overall Study||24
10438805|NCT00916617|11585259|FG001|STARTED|Overall Study||21
10438806|NCT00916617|11585260|FG002|STARTED|Overall Study||10
10438807|NCT00916617|11585261|FG003|STARTED|Overall Study||7
10438808|NCT00916617|11585258|FG000|COMPLETED|Overall Study||1
10438809|NCT00916617|11585259|FG001|COMPLETED|Overall Study||0
10438810|NCT00916617|11585260|FG002|COMPLETED|Overall Study||0
10438811|NCT00916617|11585261|FG003|COMPLETED|Overall Study||0
10438812|NCT00916617|11585258|FG000|NOT COMPLETED|Overall Study||23
10438813|NCT00916617|11585259|FG001|NOT COMPLETED|Overall Study||21
10438814|NCT00916617|11585260|FG002|NOT COMPLETED|Overall Study||10
10438815|NCT00916617|11585261|FG003|NOT COMPLETED|Overall Study||7
10438816|NCT00916643|11585271|FG000|STARTED|Overall Study||113
10438817|NCT00916643|11585271|FG000|COMPLETED|Overall Study||113
10438818|NCT00916643|11585271|FG000|NOT COMPLETED|Overall Study||0
10438819|NCT00916721|11585277|FG000|STARTED|Overall Study||35
10438820|NCT00916721|11585278|FG001|STARTED|Overall Study||39
10438821|NCT00916721|11585277|FG000|COMPLETED|Overall Study||25
10438822|NCT00916721|11585278|FG001|COMPLETED|Overall Study||29
10438823|NCT00916721|11585277|FG000|NOT COMPLETED|Overall Study||10
10438824|NCT00916721|11585278|FG001|NOT COMPLETED|Overall Study||10
10438825|NCT00916929|11585286|FG000|STARTED|Overall Study||80
10438826|NCT00916929|11585287|FG001|STARTED|Overall Study||82
10438827|NCT00916929|11585286|FG000|COMPLETED|Overall Study||70
10438828|NCT00916929|11585287|FG001|COMPLETED|Overall Study||53
10438829|NCT00916929|11585286|FG000|NOT COMPLETED|Overall Study||10
10438830|NCT00916929|11585287|FG001|NOT COMPLETED|Overall Study||29
10438831|NCT00917124|11585297|FG000|STARTED|Overall Study||100
10438832|NCT00917124|11585298|FG001|STARTED|Overall Study||100
10438833|NCT00917124|11585297|FG000|COMPLETED|Overall Study||96
10438834|NCT00917124|11585298|FG001|COMPLETED|Overall Study||94
10438835|NCT00917124|11585297|FG000|NOT COMPLETED|Overall Study||4
10438836|NCT00917124|11585298|FG001|NOT COMPLETED|Overall Study||6
10438837|NCT00917150|11585308|FG000|STARTED|Overall Study||192
10438838|NCT00917150|11585309|FG001|STARTED|Overall Study||198
10438839|NCT00917150|11585310|FG002|STARTED|Overall Study||191
10438840|NCT00917150|11585311|FG003|STARTED|Overall Study||190
10438841|NCT00917150|11585308|FG000|COMPLETED|Overall Study||155
10438842|NCT00917150|11585309|FG001|COMPLETED|Overall Study||161
10438843|NCT00917150|11585310|FG002|COMPLETED|Overall Study||149
10438844|NCT00917150|11585311|FG003|COMPLETED|Overall Study||156
10438845|NCT00917150|11585308|FG000|NOT COMPLETED|Overall Study||37
10438846|NCT00917150|11585309|FG001|NOT COMPLETED|Overall Study||37
10438847|NCT00917150|11585310|FG002|NOT COMPLETED|Overall Study||42
10438848|NCT00917150|11585311|FG003|NOT COMPLETED|Overall Study||34
10438849|NCT00917267|11585323|FG000|STARTED|Overall Study||346
10438850|NCT00917267|11585324|FG001|STARTED|Overall Study||345
10438851|NCT00917267|11585323|FG000|Intent to Treat (ITT)|Overall Study||340
10438852|NCT00917267|11585324|FG001|Intent to Treat (ITT)|Overall Study||338
10438853|NCT00917267|11585323|FG000|COMPLETED|Overall Study||307
10438854|NCT00917267|11585324|FG001|COMPLETED|Overall Study||266
10438855|NCT00917267|11585323|FG000|NOT COMPLETED|Overall Study||39
10438856|NCT00917267|11585324|FG001|NOT COMPLETED|Overall Study||79
10438857|NCT00917384|11585336|FG000|STARTED|Overall Study||238
10438858|NCT00917384|11585337|FG001|STARTED|Overall Study||117
10438859|NCT00917384|11585336|FG000|Received at Least 1 Dose of Study Drug|Overall Study||236
10438860|NCT00917384|11585337|FG001|Received at Least 1 Dose of Study Drug|Overall Study||115
10789381|NCT03520348|11949800|FG000|NOT COMPLETED|Overall Study||0
10789382|NCT03520348|11949801|FG001|NOT COMPLETED|Overall Study||0
10438861|NCT00917384|11585336|FG000|COMPLETED|Overall Study||224
10438862|NCT00917384|11585337|FG001|COMPLETED|Overall Study||113
10789383|NCT03520387|11949812|FG000|STARTED|Pre-Randomization||16
10438863|NCT00917384|11585336|FG000|NOT COMPLETED|Overall Study||14
10438864|NCT00917384|11585337|FG001|NOT COMPLETED|Overall Study||4
10438865|NCT00917462|11585343|FG000|STARTED|Overall Study||35
10438866|NCT00917462|11585343|FG000|COMPLETED|Overall Study||34
10438867|NCT00917462|11585343|FG000|NOT COMPLETED|Overall Study||1
10438868|NCT00917501|11585349|FG000|STARTED|Overall Study||29
10438869|NCT00917501|11585350|FG001|STARTED|Overall Study||26
10438870|NCT00917501|11585349|FG000|COMPLETED|Overall Study||21
10438871|NCT00917501|11585350|FG001|COMPLETED|Overall Study||21
10438872|NCT00917501|11585349|FG000|NOT COMPLETED|Overall Study||8
10438873|NCT00917501|11585350|FG001|NOT COMPLETED|Overall Study||5
10438874|NCT00917553|11585358|FG000|STARTED|Overall Study||17
10438875|NCT00917553|11585359|FG001|STARTED|Overall Study||16
10438876|NCT00917553|11585358|FG000|COMPLETED|Overall Study||15
10438877|NCT00917553|11585359|FG001|COMPLETED|Overall Study||15
10438878|NCT00917553|11585358|FG000|NOT COMPLETED|Overall Study||2
10438879|NCT00917553|11585359|FG001|NOT COMPLETED|Overall Study||1
10438880|NCT00917579|11585365|FG000|STARTED|Period 1: 1st Intervention||39
10438881|NCT00917579|11585366|FG001|STARTED|Period 1: 1st Intervention||37
10438882|NCT00917579|11585365|FG000|COMPLETED|Period 1: 1st Intervention||39
10438883|NCT00917579|11585366|FG001|COMPLETED|Period 1: 1st Intervention||37
10438884|NCT00917579|11585365|FG000|NOT COMPLETED|Period 1: 1st Intervention||0
10438885|NCT00917579|11585366|FG001|NOT COMPLETED|Period 1: 1st Intervention||0
10438886|NCT00917579|11585365|FG000|STARTED|Washout >= 2 Weeks||39
10438887|NCT00917579|11585366|FG001|STARTED|Washout >= 2 Weeks||37
10438888|NCT00917579|11585365|FG000|COMPLETED|Washout >= 2 Weeks||37
10438889|NCT00917579|11585366|FG001|COMPLETED|Washout >= 2 Weeks||37
10438890|NCT00917579|11585365|FG000|NOT COMPLETED|Washout >= 2 Weeks||2
10438891|NCT00917579|11585366|FG001|NOT COMPLETED|Washout >= 2 Weeks||0
10438892|NCT00917579|11585365|FG000|STARTED|Period 2: 2nd Intervention||37
10438893|NCT00917579|11585366|FG001|STARTED|Period 2: 2nd Intervention||37
10438894|NCT00917579|11585365|FG000|COMPLETED|Period 2: 2nd Intervention||37
10438895|NCT00917579|11585366|FG001|COMPLETED|Period 2: 2nd Intervention||37
10438896|NCT00917579|11585365|FG000|NOT COMPLETED|Period 2: 2nd Intervention||0
10438897|NCT00917579|11585366|FG001|NOT COMPLETED|Period 2: 2nd Intervention||0
10438898|NCT00917644|11585372|FG000|STARTED|Period 1: First Intervention||39
10438899|NCT00917644|11585373|FG001|STARTED|Period 1: First Intervention||37
10438900|NCT00917644|11585372|FG000|COMPLETED|Period 1: First Intervention||39
10438901|NCT00917644|11585373|FG001|COMPLETED|Period 1: First Intervention||37
10438902|NCT00917644|11585372|FG000|NOT COMPLETED|Period 1: First Intervention||0
10438903|NCT00917644|11585373|FG001|NOT COMPLETED|Period 1: First Intervention||0
10438904|NCT00917644|11585372|FG000|STARTED|Period: Washout Period of > = 2 Weeks||39
10438905|NCT00917644|11585373|FG001|STARTED|Period: Washout Period of > = 2 Weeks||37
10438906|NCT00917644|11585372|FG000|COMPLETED|Period: Washout Period of > = 2 Weeks||37
10438907|NCT00917644|11585373|FG001|COMPLETED|Period: Washout Period of > = 2 Weeks||37
10438908|NCT00917644|11585372|FG000|NOT COMPLETED|Period: Washout Period of > = 2 Weeks||2
10438909|NCT00917644|11585373|FG001|NOT COMPLETED|Period: Washout Period of > = 2 Weeks||0
10438910|NCT00917644|11585372|FG000|STARTED|Period 2: Second Intervention|Washout: Test drug 1st, completed = 37; 2nd period: Test drug 2nd, completed = 37.|37
10439071|NCT00918866|11585548|FG001|NOT COMPLETED|Overall Study||0
10438911|NCT00917644|11585373|FG001|STARTED|Period 2: Second Intervention|Washout: Reference drug (Ref) 1st, completed = 37; 2nd period: Ref drug 2nd, completed = 36.|37
10438912|NCT00917644|11585372|FG000|COMPLETED|Period 2: Second Intervention|Total number of subjects completed Test drug = 74.|36
10438913|NCT00917644|11585373|FG001|COMPLETED|Period 2: Second Intervention|Total number of subjects completed Ref drug = 73.|37
10438914|NCT00917644|11585372|FG000|NOT COMPLETED|Period 2: Second Intervention||1
10438915|NCT00917644|11585373|FG001|NOT COMPLETED|Period 2: Second Intervention||0
10438916|NCT00917735|11585381|FG000|STARTED|Overall Study||538
10438917|NCT00917735|11585382|FG001|STARTED|Overall Study||537
10438918|NCT00917735|11585381|FG000|COMPLETED|Overall Study||463
10438919|NCT00917735|11585382|FG001|COMPLETED|Overall Study||474
10438920|NCT00917735|11585381|FG000|NOT COMPLETED|Overall Study||75
10438921|NCT00917735|11585382|FG001|NOT COMPLETED|Overall Study||63
10438922|NCT00917852|11585388|FG000|STARTED|Overall Study||51
10438923|NCT00917852|11585388|FG000|COMPLETED|Overall Study||45
10438924|NCT00917852|11585388|FG000|NOT COMPLETED|Overall Study||6
10438925|NCT00917865|11585393|FG000|STARTED|Overall Study||11
10438926|NCT00917865|11585393|FG000|COMPLETED|Overall Study||11
10438927|NCT00917865|11585393|FG000|NOT COMPLETED|Overall Study||0
10438928|NCT00918125|11585406|FG000|STARTED|Overall Study||20
10438929|NCT00918125|11585407|FG001|STARTED|Overall Study||39
10438930|NCT00918125|11585406|FG000|COMPLETED|Overall Study||20
10438931|NCT00918125|11585407|FG001|COMPLETED|Overall Study||39
10438932|NCT00918125|11585406|FG000|NOT COMPLETED|Overall Study||0
10438933|NCT00918125|11585407|FG001|NOT COMPLETED|Overall Study||0
10438934|NCT00918138|11585418|FG000|STARTED|Overall Study||46
10438935|NCT00918138|11585419|FG001|STARTED|Overall Study||47
10438936|NCT00918138|11585418|FG000|COMPLETED|Overall Study||44
10438937|NCT00918138|11585419|FG001|COMPLETED|Overall Study||46
10438938|NCT00918138|11585418|FG000|NOT COMPLETED|Overall Study||2
10438939|NCT00918138|11585419|FG001|NOT COMPLETED|Overall Study||1
10438940|NCT00918203|11585427|FG000|STARTED|Treatment With or Without Olaratumab||70
10438941|NCT00918203|11585428|FG001|STARTED|Treatment With or Without Olaratumab||67
10438942|NCT00918203|11585429|FG002|STARTED|Treatment With or Without Olaratumab||0
10438943|NCT00918203|11585427|FG000|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||67
10438944|NCT00918203|11585428|FG001|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||64
10438945|NCT00918203|11585429|FG002|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||0
10438946|NCT00918203|11585427|FG000|Death Due to Any Cause|Treatment With or Without Olaratumab||53
10438947|NCT00918203|11585428|FG001|Death Due to Any Cause|Treatment With or Without Olaratumab||47
10438948|NCT00918203|11585429|FG002|Death Due to Any Cause|Treatment With or Without Olaratumab||0
10438949|NCT00918203|11585427|FG000|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||11
10438950|NCT00918203|11585428|FG001|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||10
10438951|NCT00918203|11585429|FG002|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||0
10438952|NCT00918203|11585427|FG000|COMPLETED|Treatment With or Without Olaratumab||64
10438953|NCT00918203|11585428|FG001|COMPLETED|Treatment With or Without Olaratumab||57
10438954|NCT00918203|11585429|FG002|COMPLETED|Treatment With or Without Olaratumab||0
10438955|NCT00918203|11585427|FG000|NOT COMPLETED|Treatment With or Without Olaratumab||6
10438956|NCT00918203|11585428|FG001|NOT COMPLETED|Treatment With or Without Olaratumab||10
10438957|NCT00918203|11585429|FG002|NOT COMPLETED|Treatment With or Without Olaratumab||0
10438958|NCT00918203|11585427|FG000|STARTED|Crossover to Olaratumab Monotherapy||0
10438959|NCT00918203|11585428|FG001|STARTED|Crossover to Olaratumab Monotherapy||0
10438960|NCT00918203|11585429|FG002|STARTED|Crossover to Olaratumab Monotherapy|18 participants who had progressive disease crossed over to monotherapy.|18
10438961|NCT00918203|11585427|FG000|COMPLETED|Crossover to Olaratumab Monotherapy||0
10438962|NCT00918203|11585428|FG001|COMPLETED|Crossover to Olaratumab Monotherapy||0
10438963|NCT00918203|11585429|FG002|COMPLETED|Crossover to Olaratumab Monotherapy||18
10438964|NCT00918203|11585427|FG000|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
10438965|NCT00918203|11585428|FG001|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
10438966|NCT00918203|11585429|FG002|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
10438967|NCT00918229|11585441|FG000|STARTED|Overall Study||24
10438968|NCT00918229|11585441|FG000|COMPLETED|Overall Study||24
10438969|NCT00918229|11585441|FG000|NOT COMPLETED|Overall Study||0
10438970|NCT00918255|11585448|FG000|STARTED|Overall Study||51
10438971|NCT00918255|11585449|FG001|STARTED|Overall Study||52
10438972|NCT00918255|11585450|FG002|STARTED|Overall Study||51
10438973|NCT00918255|11585448|FG000|COMPLETED|Overall Study||45
10438974|NCT00918255|11585449|FG001|COMPLETED|Overall Study||52
10438975|NCT00918255|11585450|FG002|COMPLETED|Overall Study||46
10438976|NCT00918255|11585448|FG000|NOT COMPLETED|Overall Study||6
10438977|NCT00918255|11585449|FG001|NOT COMPLETED|Overall Study||0
10438978|NCT00918255|11585450|FG002|NOT COMPLETED|Overall Study||5
10438979|NCT00918281|11585458|FG000|STARTED|Overall Study||70
10438980|NCT00918281|11585458|FG000|COMPLETED|Overall Study||41
10438981|NCT00918281|11585458|FG000|NOT COMPLETED|Overall Study||29
10438982|NCT00918333|11585467|FG000|STARTED|Overall Study||26
10438983|NCT00918333|11585468|FG001|STARTED|Overall Study||98
10438984|NCT00918333|11585467|FG000|COMPLETED|Overall Study||23
10438985|NCT00918333|11585468|FG001|COMPLETED|Overall Study||93
10438986|NCT00918333|11585467|FG000|NOT COMPLETED|Overall Study||3
10438987|NCT00918333|11585468|FG001|NOT COMPLETED|Overall Study||5
10438988|NCT00918346|11585477|FG000|STARTED|First Treatment Period (4 Weeks)||21
10438989|NCT00918346|11585478|FG001|STARTED|First Treatment Period (4 Weeks)||22
10438990|NCT00918346|11585477|FG000|COMPLETED|First Treatment Period (4 Weeks)||21
10438991|NCT00918346|11585478|FG001|COMPLETED|First Treatment Period (4 Weeks)|A patient completed the first treatment period but discontinued thereafter (did not start washout).|21
10438992|NCT00918346|11585477|FG000|NOT COMPLETED|First Treatment Period (4 Weeks)||0
10438993|NCT00918346|11585478|FG001|NOT COMPLETED|First Treatment Period (4 Weeks)||1
10438994|NCT00918346|11585477|FG000|STARTED|Washout (at Least 4 Weeks)||21
10438995|NCT00918346|11585478|FG001|STARTED|Washout (at Least 4 Weeks)||21
10438996|NCT00918346|11585477|FG000|COMPLETED|Washout (at Least 4 Weeks)||21
10438997|NCT00918346|11585478|FG001|COMPLETED|Washout (at Least 4 Weeks)||21
10438998|NCT00918346|11585477|FG000|NOT COMPLETED|Washout (at Least 4 Weeks)||0
10438999|NCT00918346|11585478|FG001|NOT COMPLETED|Washout (at Least 4 Weeks)||0
10439000|NCT00918346|11585477|FG000|STARTED|Second Treatment Period (4 Weeks)||21
10439001|NCT00918346|11585478|FG001|STARTED|Second Treatment Period (4 Weeks)||21
10439002|NCT00918346|11585477|FG000|COMPLETED|Second Treatment Period (4 Weeks)||21
10439003|NCT00918346|11585478|FG001|COMPLETED|Second Treatment Period (4 Weeks)||21
10439004|NCT00918346|11585477|FG000|NOT COMPLETED|Second Treatment Period (4 Weeks)||0
10439005|NCT00918346|11585478|FG001|NOT COMPLETED|Second Treatment Period (4 Weeks)||0
10439006|NCT00918346|11585477|FG000|STARTED|Post Study Period||21
10439007|NCT00918346|11585478|FG001|STARTED|Post Study Period||21
10439008|NCT00918346|11585477|FG000|COMPLETED|Post Study Period||21
10439009|NCT00918346|11585478|FG001|COMPLETED|Post Study Period||21
10439010|NCT00918346|11585477|FG000|NOT COMPLETED|Post Study Period||0
10439011|NCT00918346|11585478|FG001|NOT COMPLETED|Post Study Period||0
10439012|NCT00918385|11585489|FG000|STARTED|Monotherapy||14
10439013|NCT00918385|11585490|FG001|STARTED|Monotherapy||17
10439014|NCT00918385|11585489|FG000|COMPLETED|Monotherapy|Completed = received treatment until first disease progression on single agent.|12
10439015|NCT00918385|11585490|FG001|COMPLETED|Monotherapy|Completed = received treatment until first disease progression on single agent.|11
10439016|NCT00918385|11585489|FG000|NOT COMPLETED|Monotherapy||2
10439017|NCT00918385|11585490|FG001|NOT COMPLETED|Monotherapy||6
10439018|NCT00918385|11585489|FG000|STARTED|Combination Nilutamide and Dasatinib||12
10439019|NCT00918385|11585490|FG001|STARTED|Combination Nilutamide and Dasatinib||11
10439020|NCT00918385|11585489|FG000|COMPLETED|Combination Nilutamide and Dasatinib||6
10439021|NCT00918385|11585490|FG001|COMPLETED|Combination Nilutamide and Dasatinib||3
10439022|NCT00918385|11585489|FG000|NOT COMPLETED|Combination Nilutamide and Dasatinib||6
10439023|NCT00918385|11585490|FG001|NOT COMPLETED|Combination Nilutamide and Dasatinib||8
10439024|NCT00918567|11585500|FG000|STARTED|Overall Study||29
10439025|NCT00918567|11585501|FG001|STARTED|Overall Study||27
10439026|NCT00918567|11585500|FG000|COMPLETED|Overall Study||24
10439027|NCT00918567|11585501|FG001|COMPLETED|Overall Study||25
10439028|NCT00918567|11585500|FG000|NOT COMPLETED|Overall Study||5
10439029|NCT00918567|11585501|FG001|NOT COMPLETED|Overall Study||2
10439030|NCT00918580|11585507|FG000|STARTED|Up to 6-month Follow-up(FU)||158
10439031|NCT00918580|11585507|FG000|Vaccinated Dose 1|Up to 6-month Follow-up(FU)||158
10439032|NCT00918580|11585507|FG000|Vaccinated Dose 2|Up to 6-month Follow-up(FU)||146
10439033|NCT00918580|11585507|FG000|COMPLETED|Up to 6-month Follow-up(FU)|Completed include 1 participant:withdrew before Dose 2 (protocol violation) but completed 6-month FU|147
10439034|NCT00918580|11585507|FG000|NOT COMPLETED|Up to 6-month Follow-up(FU)||11
10439035|NCT00918580|11585507|FG000|STARTED|After 6-month FU to 1-year FU||147
10439036|NCT00918580|11585507|FG000|Continued After 6-Month FU|After 6-month FU to 1-year FU||89
10439037|NCT00918580|11585507|FG000|COMPLETED|After 6-month FU to 1-year FU||87
10439038|NCT00918580|11585507|FG000|NOT COMPLETED|After 6-month FU to 1-year FU||60
10439039|NCT00918671|11585514|FG000|STARTED|Overall Study||60
10439040|NCT00918671|11585514|FG000|COMPLETED|Overall Study||60
10439041|NCT00918671|11585514|FG000|NOT COMPLETED|Overall Study||0
10439042|NCT00918684|11585518|FG000|STARTED|Two Week Drug Washout and Placebo Phase||106
10439043|NCT00918684|11585518|FG000|COMPLETED|Two Week Drug Washout and Placebo Phase||90
10439044|NCT00918684|11585518|FG000|NOT COMPLETED|Two Week Drug Washout and Placebo Phase||16
10439045|NCT00918684|11585518|FG000|STARTED|Treatment Phase||90
10439046|NCT00918684|11585518|FG000|COMPLETED|Treatment Phase||65
10439047|NCT00918684|11585518|FG000|NOT COMPLETED|Treatment Phase||25
10439048|NCT00918723|11585522|FG000|STARTED|Overall Study||40
10439049|NCT00918723|11585522|FG000|COMPLETED|Overall Study||40
10439050|NCT00918723|11585522|FG000|NOT COMPLETED|Overall Study||0
10439051|NCT00918736|11585528|FG000|STARTED|Overall Study|October, 2007|50
10439052|NCT00918736|11585528|FG000|COMPLETED|Overall Study|October, 2008|46
10439053|NCT00918736|11585528|FG000|NOT COMPLETED|Overall Study||4
10439054|NCT00918749|11585535|FG000|STARTED|Overall Study||70
10439055|NCT00918749|11585536|FG001|STARTED|Overall Study||66
10439056|NCT00918749|11585537|FG002|STARTED|Overall Study||69
10439057|NCT00918749|11585535|FG000|ITT (Intent to Treat) Population|Overall Study|One subject took no study drug and was not included in ITT Population|69
10439058|NCT00918749|11585536|FG001|ITT (Intent to Treat) Population|Overall Study||66
10439059|NCT00918749|11585537|FG002|ITT (Intent to Treat) Population|Overall Study||69
10439060|NCT00918749|11585535|FG000|COMPLETED|Overall Study||63
10439061|NCT00918749|11585536|FG001|COMPLETED|Overall Study||63
10439062|NCT00918749|11585537|FG002|COMPLETED|Overall Study||62
10439063|NCT00918749|11585535|FG000|NOT COMPLETED|Overall Study||7
10439064|NCT00918749|11585536|FG001|NOT COMPLETED|Overall Study||3
10439065|NCT00918749|11585537|FG002|NOT COMPLETED|Overall Study||7
10439066|NCT00918866|11585547|FG000|STARTED|Overall Study||16
10439067|NCT00918866|11585548|FG001|STARTED|Overall Study||16
10439068|NCT00918866|11585547|FG000|COMPLETED|Overall Study||16
10439069|NCT00918866|11585548|FG001|COMPLETED|Overall Study||16
10439070|NCT00918866|11585547|FG000|NOT COMPLETED|Overall Study||0
10439072|NCT00918879|11585556|FG000|STARTED|Overall Study|Randomized and treated|107
10439073|NCT00918879|11585557|FG001|STARTED|Overall Study|Randomized and treated|106
10439074|NCT00918879|11585556|FG000|COMPLETED|Overall Study|Completed 24 weeks of treatment|101
10439075|NCT00918879|11585557|FG001|COMPLETED|Overall Study|Completed 24 weeks of treatment|100
10439076|NCT00918879|11585556|FG000|NOT COMPLETED|Overall Study||6
10439077|NCT00918879|11585557|FG001|NOT COMPLETED|Overall Study||6
10439078|NCT00918931|11585563|FG000|STARTED|Overall Study||3
10439079|NCT00918931|11585563|FG000|COMPLETED|Overall Study||3
10439080|NCT00918931|11585563|FG000|NOT COMPLETED|Overall Study||0
10439081|NCT00918957|11585569|FG000|STARTED|Overall Study||32
10439082|NCT00918957|11585570|FG001|STARTED|Overall Study||30
10439083|NCT00918957|11585569|FG000|COMPLETED|Overall Study||29
10439084|NCT00918957|11585570|FG001|COMPLETED|Overall Study||30
10439085|NCT00918957|11585569|FG000|NOT COMPLETED|Overall Study||3
10439086|NCT00918957|11585570|FG001|NOT COMPLETED|Overall Study||0
10439087|NCT00919035|11585576|FG000|STARTED|Overall Study||21
10439088|NCT00919035|11585576|FG000|COMPLETED|Overall Study||21
10439089|NCT00919035|11585576|FG000|NOT COMPLETED|Overall Study||0
10439090|NCT00919061|11585580|FG000|STARTED|Overall Study||39
10439091|NCT00919061|11585580|FG000|COMPLETED|Overall Study||37
10439092|NCT00919061|11585580|FG000|NOT COMPLETED|Overall Study||2
10439093|NCT00919100|11585586|FG000|STARTED|Overall Study||40
10439094|NCT00919100|11585587|FG001|STARTED|Overall Study||41
10439095|NCT00919100|11585586|FG000|COMPLETED|Overall Study||40
10439096|NCT00919100|11585587|FG001|COMPLETED|Overall Study||41
10439097|NCT00919100|11585586|FG000|NOT COMPLETED|Overall Study||0
10439098|NCT00919100|11585587|FG001|NOT COMPLETED|Overall Study||0
10439099|NCT00919113|11585595|FG000|STARTED|Overall Study||50
10439100|NCT00919113|11585596|FG001|STARTED|Overall Study||48
10439101|NCT00919113|11585595|FG000|Received Uracyst|Overall Study|One subject was misrandomized. Actual treatment was used for Demographic and Safety analysis.|49
10439102|NCT00919113|11585596|FG001|Received Uracyst|Overall Study||0
10439103|NCT00919113|11585595|FG000|Received Placebo|Overall Study||0
10439104|NCT00919113|11585596|FG001|Received Placebo|Overall Study|One subject was misrandomized. Actual treatment was used for Demographic and Safety analysis.|49
10439105|NCT00919113|11585595|FG000|COMPLETED|Overall Study||41
10439106|NCT00919113|11585596|FG001|COMPLETED|Overall Study||40
10439107|NCT00919113|11585595|FG000|NOT COMPLETED|Overall Study||9
10439108|NCT00919113|11585596|FG001|NOT COMPLETED|Overall Study||8
10439109|NCT00919126|11585605|FG000|STARTED|Overall Study||32
10439110|NCT00919126|11585606|FG001|STARTED|Overall Study||37
10439111|NCT00919126|11585607|FG002|STARTED|Overall Study||33
10439112|NCT00919126|11585605|FG000|COMPLETED|Overall Study||31
10439113|NCT00919126|11585606|FG001|COMPLETED|Overall Study||32
10439114|NCT00919126|11585607|FG002|COMPLETED|Overall Study||32
10439115|NCT00919126|11585605|FG000|NOT COMPLETED|Overall Study||1
10439116|NCT00919126|11585606|FG001|NOT COMPLETED|Overall Study||5
10439117|NCT00919126|11585607|FG002|NOT COMPLETED|Overall Study||1
10439118|NCT00919191|11585616|FG000|STARTED|Overall Study||26
10439119|NCT00919191|11585616|FG000|COMPLETED|Overall Study||26
10439120|NCT00919191|11585616|FG000|NOT COMPLETED|Overall Study||0
10439121|NCT00919503|11585624|FG000|STARTED|Overall Study||84
10439122|NCT00919503|11585625|FG001|STARTED|Overall Study||14
10439123|NCT00919503|11585624|FG000|COMPLETED|Overall Study||84
10439124|NCT00919503|11585625|FG001|COMPLETED|Overall Study||14
10439125|NCT00919503|11585624|FG000|NOT COMPLETED|Overall Study||0
10439126|NCT00919503|11585625|FG001|NOT COMPLETED|Overall Study||0
10439127|NCT00919633|11585635|FG000|STARTED|Overall Study||28
10439128|NCT00919633|11585636|FG001|STARTED|Overall Study||25
10439129|NCT00919633|11585637|FG002|STARTED|Overall Study||27
10439130|NCT00919633|11585638|FG003|STARTED|Overall Study||26
10439131|NCT00919633|11585635|FG000|COMPLETED|Overall Study||6
10439132|NCT00919633|11585636|FG001|COMPLETED|Overall Study||10
10439133|NCT00919633|11585637|FG002|COMPLETED|Overall Study||4
10439134|NCT00919633|11585638|FG003|COMPLETED|Overall Study||5
10439135|NCT00919633|11585635|FG000|NOT COMPLETED|Overall Study||22
10439136|NCT00919633|11585636|FG001|NOT COMPLETED|Overall Study||15
10439137|NCT00919633|11585637|FG002|NOT COMPLETED|Overall Study||23
10439138|NCT00919633|11585638|FG003|NOT COMPLETED|Overall Study||21
10439139|NCT00919711|11585650|FG000|STARTED|Overall Study||435
10439140|NCT00919711|11585651|FG001|STARTED|Overall Study||435
10439141|NCT00919711|11585650|FG000|COMPLETED|Overall Study||402
10439142|NCT00919711|11585651|FG001|COMPLETED|Overall Study||422
10439143|NCT00919711|11585650|FG000|NOT COMPLETED|Overall Study||33
10439144|NCT00919711|11585651|FG001|NOT COMPLETED|Overall Study||13
10439145|NCT00919724|11585659|FG000|STARTED|Overall Study||45
10439146|NCT00919724|11585660|FG001|STARTED|Overall Study||44
10439147|NCT00919724|11585659|FG000|COMPLETED|Overall Study||45
10439148|NCT00919724|11585660|FG001|COMPLETED|Overall Study||44
10439149|NCT00919724|11585659|FG000|NOT COMPLETED|Overall Study||0
10439150|NCT00919724|11585660|FG001|NOT COMPLETED|Overall Study||0
10439157|NCT00919802|11585675|FG000|STARTED|First Intervention - (24 Hours)||12
10439158|NCT00919802|11585676|FG001|STARTED|First Intervention - (24 Hours)||13
10439159|NCT00919802|11585675|FG000|COMPLETED|First Intervention - (24 Hours)||12
10549770|NCT01527006|11703802|FG001|STARTED|Core Study||28
10549771|NCT01527006|11703801|FG000|COMPLETED|Core Study||20
10549772|NCT01527006|11703802|FG001|COMPLETED|Core Study||22
10549773|NCT01527006|11703801|FG000|NOT COMPLETED|Core Study||2
10549774|NCT01527006|11703802|FG001|NOT COMPLETED|Core Study||6
10549775|NCT01527006|11703801|FG000|STARTED|Extension Phase|Of the 20 subjects who completed the Core Study, 19 subjects continued into the Extension Phase.|19
10549776|NCT01527006|11703802|FG001|STARTED|Extension Phase||22
10549777|NCT01527006|11703801|FG000|COMPLETED|Extension Phase||13
10549778|NCT01527006|11703802|FG001|COMPLETED|Extension Phase||14
10549779|NCT01527006|11703801|FG000|NOT COMPLETED|Extension Phase||6
10549780|NCT01527006|11703802|FG001|NOT COMPLETED|Extension Phase||8
10549781|NCT01527045|11703817|FG000|STARTED|Overall Study||30
10549782|NCT01527045|11703818|FG001|STARTED|Overall Study||5
10549783|NCT01527045|11703819|FG002|STARTED|Overall Study||12
10549784|NCT01527045|11703817|FG000|COMPLETED|Overall Study||29
10549785|NCT01527045|11703818|FG001|COMPLETED|Overall Study||5
10549786|NCT01527045|11703819|FG002|COMPLETED|Overall Study||12
10549787|NCT01527045|11703817|FG000|NOT COMPLETED|Overall Study||1
10549788|NCT01527045|11703818|FG001|NOT COMPLETED|Overall Study||0
10549789|NCT01527045|11703819|FG002|NOT COMPLETED|Overall Study||0
10789384|NCT03520387|11949813|FG001|STARTED|Pre-Randomization|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment. There are no participants in this group until the randomization period (until after the pre-randomization run-in period has ended).|0
10810676|NCT03792672|11972459|FG003|COMPLETED|Treatment Period 1 (1 Day)||4
10810677|NCT03792672|11972460|FG004|COMPLETED|Treatment Period 1 (1 Day)||4
10810678|NCT03792672|11972461|FG005|COMPLETED|Treatment Period 1 (1 Day)||4
10439160|NCT00919802|11585676|FG001|COMPLETED|First Intervention - (24 Hours)||13
10439161|NCT00919802|11585675|FG000|NOT COMPLETED|First Intervention - (24 Hours)||0
10439162|NCT00919802|11585676|FG001|NOT COMPLETED|First Intervention - (24 Hours)||0
10439163|NCT00919802|11585675|FG000|STARTED|Second Intervention - (24 Hours)||12
10439164|NCT00919802|11585676|FG001|STARTED|Second Intervention - (24 Hours)||13
10439165|NCT00919802|11585675|FG000|COMPLETED|Second Intervention - (24 Hours)||12
10439166|NCT00919802|11585676|FG001|COMPLETED|Second Intervention - (24 Hours)||13
10439167|NCT00919802|11585675|FG000|NOT COMPLETED|Second Intervention - (24 Hours)||0
10549790|NCT01527110|11703827|FG000|STARTED|Overall Study||21
10439168|NCT00919802|11585676|FG001|NOT COMPLETED|Second Intervention - (24 Hours)||0
10439169|NCT00919854|11585682|FG000|STARTED|Overall Study||21
10439170|NCT00919854|11585682|FG000|COMPLETED|Overall Study|'Completed' represents the patients that are ongoing at the time of cut-off for the Week 24 analysis|20
10439171|NCT00919854|11585682|FG000|NOT COMPLETED|Overall Study||1
10439172|NCT00919867|11585692|FG000|STARTED|First Intervention||7
10439173|NCT00919867|11585693|FG001|STARTED|First Intervention||7
10439174|NCT00919867|11585694|FG002|STARTED|First Intervention||7
10439175|NCT00919867|11585695|FG003|STARTED|First Intervention||7
10439176|NCT00919867|11585696|FG004|STARTED|First Intervention||7
10439177|NCT00919867|11585697|FG005|STARTED|First Intervention||7
10439178|NCT00919867|11585692|FG000|COMPLETED|First Intervention||7
10439179|NCT00919867|11585693|FG001|COMPLETED|First Intervention||7
10439180|NCT00919867|11585694|FG002|COMPLETED|First Intervention||6
10439181|NCT00919867|11585695|FG003|COMPLETED|First Intervention||7
10439182|NCT00919867|11585696|FG004|COMPLETED|First Intervention||7
10439183|NCT00919867|11585697|FG005|COMPLETED|First Intervention||6
10439184|NCT00919867|11585692|FG000|NOT COMPLETED|First Intervention||0
10439185|NCT00919867|11585693|FG001|NOT COMPLETED|First Intervention||0
10439186|NCT00919867|11585694|FG002|NOT COMPLETED|First Intervention||1
10439187|NCT00919867|11585695|FG003|NOT COMPLETED|First Intervention||0
10439188|NCT00919867|11585696|FG004|NOT COMPLETED|First Intervention||0
10439189|NCT00919867|11585697|FG005|NOT COMPLETED|First Intervention||1
10439190|NCT00919867|11585692|FG000|STARTED|Washout||7
10439191|NCT00919867|11585693|FG001|STARTED|Washout||7
10439192|NCT00919867|11585694|FG002|STARTED|Washout||6
10439193|NCT00919867|11585695|FG003|STARTED|Washout||7
10439194|NCT00919867|11585696|FG004|STARTED|Washout||7
10439195|NCT00919867|11585697|FG005|STARTED|Washout||6
10439196|NCT00919867|11585692|FG000|COMPLETED|Washout||7
10439197|NCT00919867|11585693|FG001|COMPLETED|Washout||7
10439198|NCT00919867|11585694|FG002|COMPLETED|Washout||6
10439199|NCT00919867|11585695|FG003|COMPLETED|Washout||7
10439200|NCT00919867|11585696|FG004|COMPLETED|Washout||7
10439201|NCT00919867|11585697|FG005|COMPLETED|Washout||6
10439202|NCT00919867|11585692|FG000|NOT COMPLETED|Washout||0
10439203|NCT00919867|11585693|FG001|NOT COMPLETED|Washout||0
10439204|NCT00919867|11585694|FG002|NOT COMPLETED|Washout||0
10439205|NCT00919867|11585695|FG003|NOT COMPLETED|Washout||0
10439206|NCT00919867|11585696|FG004|NOT COMPLETED|Washout||0
10439207|NCT00919867|11585697|FG005|NOT COMPLETED|Washout||0
10439208|NCT00919867|11585692|FG000|STARTED|Second Intervention||7
10439209|NCT00919867|11585693|FG001|STARTED|Second Intervention||7
10439210|NCT00919867|11585694|FG002|STARTED|Second Intervention||6
10439211|NCT00919867|11585695|FG003|STARTED|Second Intervention||7
10439212|NCT00919867|11585696|FG004|STARTED|Second Intervention||7
10439213|NCT00919867|11585697|FG005|STARTED|Second Intervention||6
10439214|NCT00919867|11585692|FG000|COMPLETED|Second Intervention||7
10439215|NCT00919867|11585693|FG001|COMPLETED|Second Intervention||7
10439216|NCT00919867|11585694|FG002|COMPLETED|Second Intervention||6
10439217|NCT00919867|11585695|FG003|COMPLETED|Second Intervention||7
10439218|NCT00919867|11585696|FG004|COMPLETED|Second Intervention||7
10439219|NCT00919867|11585697|FG005|COMPLETED|Second Intervention||6
10439220|NCT00919867|11585692|FG000|NOT COMPLETED|Second Intervention||0
10439221|NCT00919867|11585693|FG001|NOT COMPLETED|Second Intervention||0
10439222|NCT00919867|11585694|FG002|NOT COMPLETED|Second Intervention||0
10439223|NCT00919867|11585695|FG003|NOT COMPLETED|Second Intervention||0
10439224|NCT00919867|11585696|FG004|NOT COMPLETED|Second Intervention||0
10439225|NCT00919867|11585697|FG005|NOT COMPLETED|Second Intervention||0
10439226|NCT00919867|11585692|FG000|STARTED|Washout||7
10439227|NCT00919867|11585693|FG001|STARTED|Washout||7
10439228|NCT00919867|11585694|FG002|STARTED|Washout||6
10439229|NCT00919867|11585695|FG003|STARTED|Washout||7
10439230|NCT00919867|11585696|FG004|STARTED|Washout||7
10439231|NCT00919867|11585697|FG005|STARTED|Washout||6
10439232|NCT00919867|11585692|FG000|COMPLETED|Washout||7
10439233|NCT00919867|11585693|FG001|COMPLETED|Washout||7
10439234|NCT00919867|11585694|FG002|COMPLETED|Washout||6
10439235|NCT00919867|11585695|FG003|COMPLETED|Washout||7
10439236|NCT00919867|11585696|FG004|COMPLETED|Washout||7
10439237|NCT00919867|11585697|FG005|COMPLETED|Washout||6
10439238|NCT00919867|11585692|FG000|NOT COMPLETED|Washout||0
10439239|NCT00919867|11585693|FG001|NOT COMPLETED|Washout||0
10439240|NCT00919867|11585694|FG002|NOT COMPLETED|Washout||0
10439241|NCT00919867|11585695|FG003|NOT COMPLETED|Washout||0
10439242|NCT00919867|11585696|FG004|NOT COMPLETED|Washout||0
10439243|NCT00919867|11585697|FG005|NOT COMPLETED|Washout||0
10439244|NCT00919867|11585692|FG000|STARTED|Third Intervention||7
10439245|NCT00919867|11585693|FG001|STARTED|Third Intervention||7
10439246|NCT00919867|11585694|FG002|STARTED|Third Intervention||6
10439247|NCT00919867|11585695|FG003|STARTED|Third Intervention||7
10439248|NCT00919867|11585696|FG004|STARTED|Third Intervention||7
10439249|NCT00919867|11585697|FG005|STARTED|Third Intervention||6
10439250|NCT00919867|11585692|FG000|COMPLETED|Third Intervention||7
10439251|NCT00919867|11585693|FG001|COMPLETED|Third Intervention||7
10439252|NCT00919867|11585694|FG002|COMPLETED|Third Intervention||6
10439253|NCT00919867|11585695|FG003|COMPLETED|Third Intervention||7
10439254|NCT00919867|11585696|FG004|COMPLETED|Third Intervention||7
10439255|NCT00919867|11585697|FG005|COMPLETED|Third Intervention||6
10439256|NCT00919867|11585692|FG000|NOT COMPLETED|Third Intervention||0
10439257|NCT00919867|11585693|FG001|NOT COMPLETED|Third Intervention||0
10439258|NCT00919867|11585694|FG002|NOT COMPLETED|Third Intervention||0
10439259|NCT00919867|11585695|FG003|NOT COMPLETED|Third Intervention||0
10439260|NCT00919867|11585696|FG004|NOT COMPLETED|Third Intervention||0
10439261|NCT00919867|11585697|FG005|NOT COMPLETED|Third Intervention||0
10439262|NCT00919932|11585707|FG000|STARTED|Overall Study||4
10439263|NCT00919932|11585708|FG001|STARTED|Overall Study||5
10439264|NCT00919932|11585707|FG000|COMPLETED|Overall Study||4
10439265|NCT00919932|11585708|FG001|COMPLETED|Overall Study||5
10439266|NCT00919932|11585707|FG000|NOT COMPLETED|Overall Study||0
10439267|NCT00919932|11585708|FG001|NOT COMPLETED|Overall Study||0
10439268|NCT00920023|11585714|FG000|STARTED|Overall Study||15
10439269|NCT00920023|11585714|FG000|COMPLETED|Overall Study||15
10439270|NCT00920023|11585714|FG000|NOT COMPLETED|Overall Study||0
10439271|NCT00920075|11585718|FG000|STARTED|Last Study, 25 Pts Invited,11 Responded||11
10439272|NCT00920075|11585718|FG000|COMPLETED|Last Study, 25 Pts Invited,11 Responded||11
10439273|NCT00920075|11585718|FG000|NOT COMPLETED|Last Study, 25 Pts Invited,11 Responded||0
10439274|NCT00920075|11585718|FG000|STARTED|Post Study, 11 Pts Responded||11
10439275|NCT00920075|11585718|FG000|COMPLETED|Post Study, 11 Pts Responded||11
10439276|NCT00920075|11585718|FG000|NOT COMPLETED|Post Study, 11 Pts Responded||0
10439277|NCT00920140|11585727|FG000|STARTED|Phase 1 (Dose Escalation)||5
10439278|NCT00920140|11585728|FG001|STARTED|Phase 1 (Dose Escalation)||9
10439279|NCT00920140|11585729|FG002|STARTED|Phase 1 (Dose Escalation)||0
10439280|NCT00920140|11585730|FG003|STARTED|Phase 1 (Dose Escalation)||0
10439281|NCT00920140|11585731|FG004|STARTED|Phase 1 (Dose Escalation)||0
10439282|NCT00920140|11585727|FG000|COMPLETED|Phase 1 (Dose Escalation)||0
10439283|NCT00920140|11585728|FG001|COMPLETED|Phase 1 (Dose Escalation)||0
10439284|NCT00920140|11585729|FG002|COMPLETED|Phase 1 (Dose Escalation)||0
10439285|NCT00920140|11585730|FG003|COMPLETED|Phase 1 (Dose Escalation)||0
10439286|NCT00920140|11585731|FG004|COMPLETED|Phase 1 (Dose Escalation)||0
10439287|NCT00920140|11585727|FG000|NOT COMPLETED|Phase 1 (Dose Escalation)||5
10439288|NCT00920140|11585728|FG001|NOT COMPLETED|Phase 1 (Dose Escalation)||9
10439289|NCT00920140|11585729|FG002|NOT COMPLETED|Phase 1 (Dose Escalation)||0
10439290|NCT00920140|11585730|FG003|NOT COMPLETED|Phase 1 (Dose Escalation)||0
10439291|NCT00920140|11585731|FG004|NOT COMPLETED|Phase 1 (Dose Escalation)||0
10439292|NCT00920140|11585727|FG000|STARTED|Phase 2||0
10439293|NCT00920140|11585728|FG001|STARTED|Phase 2||0
10439294|NCT00920140|11585729|FG002|STARTED|Phase 2||50
10439295|NCT00920140|11585730|FG003|STARTED|Phase 2||22
10439296|NCT00920140|11585731|FG004|STARTED|Phase 2||11
10439297|NCT00920140|11585727|FG000|COMPLETED|Phase 2||0
10439298|NCT00920140|11585728|FG001|COMPLETED|Phase 2||0
10439299|NCT00920140|11585729|FG002|COMPLETED|Phase 2||0
10439300|NCT00920140|11585730|FG003|COMPLETED|Phase 2||0
10439301|NCT00920140|11585731|FG004|COMPLETED|Phase 2||0
10439302|NCT00920140|11585727|FG000|NOT COMPLETED|Phase 2||0
10439303|NCT00920140|11585728|FG001|NOT COMPLETED|Phase 2||0
10439304|NCT00920140|11585729|FG002|NOT COMPLETED|Phase 2||50
10439305|NCT00920140|11585730|FG003|NOT COMPLETED|Phase 2||22
10439306|NCT00920140|11585731|FG004|NOT COMPLETED|Phase 2||11
10525350|NCT01375205|11677259|FG001|COMPLETED|Overall Study||33
10789385|NCT03520387|11949814|FG002|STARTED|Pre-Randomization|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment. There are no participants in this group until the randomization period (until after the pre-randomization run-in period has ended).|0
10810679|NCT03792672|11972456|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0
10810680|NCT03792672|11972457|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0
10810681|NCT03792672|11972458|FG002|NOT COMPLETED|Treatment Period 1 (1 Day)||0
10810682|NCT03792672|11972459|FG003|NOT COMPLETED|Treatment Period 1 (1 Day)||0
10810683|NCT03792672|11972460|FG004|NOT COMPLETED|Treatment Period 1 (1 Day)||0
10525351|NCT01375205|11677258|FG000|NOT COMPLETED|Overall Study||21
10525352|NCT01375205|11677259|FG001|NOT COMPLETED|Overall Study||13
10525353|NCT01375374|11677265|FG000|STARTED|Overall Study||11
10525354|NCT01375374|11677265|FG000|COMPLETED|Overall Study||10
10525355|NCT01375374|11677265|FG000|NOT COMPLETED|Overall Study||1
10525356|NCT01375491|11677272|FG000|STARTED|Overall Study||11
10525357|NCT01375491|11677273|FG001|STARTED|Overall Study||13
10525358|NCT01375491|11677274|FG002|STARTED|Overall Study||15
10525359|NCT01375491|11677272|FG000|COMPLETED|Overall Study||9
10525360|NCT01375491|11677273|FG001|COMPLETED|Overall Study||12
10525361|NCT01375491|11677274|FG002|COMPLETED|Overall Study||15
10525362|NCT01375491|11677272|FG000|NOT COMPLETED|Overall Study||2
10525363|NCT01375491|11677273|FG001|NOT COMPLETED|Overall Study||1
10525364|NCT01375491|11677274|FG002|NOT COMPLETED|Overall Study||0
10525365|NCT01375569|11677281|FG000|STARTED|Overall Study||11
10525366|NCT01375569|11677281|FG000|COMPLETED|Overall Study||11
10525367|NCT01375569|11677281|FG000|NOT COMPLETED|Overall Study||0
10525368|NCT01375608|11677285|FG000|STARTED|Overall Study||10
10525369|NCT01375608|11677285|FG000|COMPLETED|Overall Study||8
10525370|NCT01375608|11677285|FG000|NOT COMPLETED|Overall Study||2
10525371|NCT01375660|11677291|FG000|STARTED|Overall Study||102
10525372|NCT01375660|11677292|FG001|STARTED|Overall Study||103
10525373|NCT01375660|11677291|FG000|COMPLETED|Overall Study||86
10525374|NCT01375660|11677292|FG001|COMPLETED|Overall Study||87
10525375|NCT01375660|11677291|FG000|NOT COMPLETED|Overall Study||16
10525376|NCT01375660|11677292|FG001|NOT COMPLETED|Overall Study||16
10525377|NCT01375673|11677301|FG000|STARTED|Overall Study||7
10525378|NCT01375673|11677302|FG001|STARTED|Overall Study||7
10525379|NCT01375673|11677301|FG000|COMPLETED|Overall Study||7
10525380|NCT01375673|11677302|FG001|COMPLETED|Overall Study||6
10525381|NCT01375673|11677301|FG000|NOT COMPLETED|Overall Study||0
10525382|NCT01375673|11677302|FG001|NOT COMPLETED|Overall Study||1
10525383|NCT01375751|11677311|FG000|STARTED|Overall Study||56
10525384|NCT01375751|11677312|FG001|STARTED|Overall Study||56
10525385|NCT01375751|11677313|FG002|STARTED|Overall Study||56
10525386|NCT01375751|11677311|FG000|Received Treatment|Overall Study||56
10439307|NCT00920218|11585748|FG000|STARTED|Overall Study||30
10439308|NCT00920218|11585749|FG001|STARTED|Overall Study||29
10439309|NCT00920218|11585750|FG002|STARTED|Overall Study||31
10439310|NCT00920218|11585751|FG003|STARTED|Overall Study||30
10439311|NCT00920218|11585748|FG000|COMPLETED|Overall Study||28
10439312|NCT00920218|11585749|FG001|COMPLETED|Overall Study||24
10439313|NCT00920218|11585750|FG002|COMPLETED|Overall Study||23
10439314|NCT00920218|11585751|FG003|COMPLETED|Overall Study||23
10439315|NCT00920218|11585748|FG000|NOT COMPLETED|Overall Study||2
10439316|NCT00920218|11585749|FG001|NOT COMPLETED|Overall Study||5
10439317|NCT00920218|11585750|FG002|NOT COMPLETED|Overall Study||8
10439318|NCT00920218|11585751|FG003|NOT COMPLETED|Overall Study||7
10439319|NCT00920231|11585767|FG000|STARTED|Overall Study||8
10439320|NCT00920231|11585768|FG001|STARTED|Overall Study||8
10439321|NCT00920231|11585767|FG000|COMPLETED|Overall Study||8
10439322|NCT00920231|11585768|FG001|COMPLETED|Overall Study||8
10439323|NCT00920231|11585767|FG000|NOT COMPLETED|Overall Study||0
10439324|NCT00920231|11585768|FG001|NOT COMPLETED|Overall Study||0
10439325|NCT00920374|11585778|FG000|STARTED|Overall Study||61
10439326|NCT00920374|11585779|FG001|STARTED|Overall Study||57
10439327|NCT00920374|11585778|FG000|COMPLETED|Overall Study||61
10439328|NCT00920374|11585779|FG001|COMPLETED|Overall Study||57
10439329|NCT00920374|11585778|FG000|NOT COMPLETED|Overall Study||0
10439330|NCT00920374|11585779|FG001|NOT COMPLETED|Overall Study||0
10439331|NCT00920426|11585788|FG000|STARTED|ITZ111451||8
10439332|NCT00920426|11585789|FG001|STARTED|ITZ111451||0
10439333|NCT00920426|11585790|FG002|STARTED|ITZ111451||0
10439334|NCT00920426|11585791|FG003|STARTED|ITZ111451||0
10439335|NCT00920426|11585788|FG000|COMPLETED|ITZ111451||7
10439336|NCT00920426|11585789|FG001|COMPLETED|ITZ111451||0
10439337|NCT00920426|11585790|FG002|COMPLETED|ITZ111451||0
10439338|NCT00920426|11585791|FG003|COMPLETED|ITZ111451||0
10439339|NCT00920426|11585788|FG000|NOT COMPLETED|ITZ111451||1
10439340|NCT00920426|11585789|FG001|NOT COMPLETED|ITZ111451||0
10439341|NCT00920426|11585790|FG002|NOT COMPLETED|ITZ111451||0
10439342|NCT00920426|11585791|FG003|NOT COMPLETED|ITZ111451||0
10439343|NCT00920426|11585788|FG000|STARTED|ITZ112929: Randomized Regimen||0
10439344|NCT00920426|11585789|FG001|STARTED|ITZ112929: Randomized Regimen||7
10439345|NCT00920426|11585790|FG002|STARTED|ITZ112929: Randomized Regimen||2
10439346|NCT00920426|11585791|FG003|STARTED|ITZ112929: Randomized Regimen||0
10439347|NCT00920426|11585788|FG000|COMPLETED|ITZ112929: Randomized Regimen||0
10439348|NCT00920426|11585789|FG001|COMPLETED|ITZ112929: Randomized Regimen||7
10439349|NCT00920426|11585790|FG002|COMPLETED|ITZ112929: Randomized Regimen||2
10439350|NCT00920426|11585791|FG003|COMPLETED|ITZ112929: Randomized Regimen||0
10439351|NCT00920426|11585788|FG000|NOT COMPLETED|ITZ112929: Randomized Regimen||0
10439352|NCT00920426|11585789|FG001|NOT COMPLETED|ITZ112929: Randomized Regimen||0
10439353|NCT00920426|11585790|FG002|NOT COMPLETED|ITZ112929: Randomized Regimen||0
10439354|NCT00920426|11585791|FG003|NOT COMPLETED|ITZ112929: Randomized Regimen||0
10439355|NCT00920426|11585788|FG000|STARTED|ITZ112929: Optimized Therapy (OT)||0
10439356|NCT00920426|11585789|FG001|STARTED|ITZ112929: Optimized Therapy (OT)||0
10439357|NCT00920426|11585790|FG002|STARTED|ITZ112929: Optimized Therapy (OT)||0
10439358|NCT00920426|11585791|FG003|STARTED|ITZ112929: Optimized Therapy (OT)|Out of 9 participants receiving randomized regimen, 8 participants continued to receive OT.|8
10439359|NCT00920426|11585788|FG000|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
10439360|NCT00920426|11585789|FG001|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
10439361|NCT00920426|11585790|FG002|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
10439362|NCT00920426|11585791|FG003|COMPLETED|ITZ112929: Optimized Therapy (OT)||8
10439363|NCT00920426|11585788|FG000|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
10439364|NCT00920426|11585789|FG001|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
10439365|NCT00920426|11585790|FG002|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
10439366|NCT00920426|11585791|FG003|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
10439367|NCT00920439|11585803|FG000|STARTED|Overall Study||25
10439368|NCT00920439|11585803|FG000|COMPLETED|Overall Study||25
10439369|NCT00920439|11585803|FG000|NOT COMPLETED|Overall Study||0
10439370|NCT00920556|11585807|FG000|STARTED|Overall Study||24
10439371|NCT00920556|11585807|FG000|COMPLETED|Overall Study||0
10439372|NCT00920556|11585807|FG000|NOT COMPLETED|Overall Study||24
10439373|NCT00920647|11585819|FG000|STARTED|Overall Study||4
10439374|NCT00920647|11585820|FG001|STARTED|Overall Study||4
10439375|NCT00920647|11585821|FG002|STARTED|Overall Study||4
10439376|NCT00920647|11585822|FG003|STARTED|Overall Study||4
10439377|NCT00920647|11585819|FG000|COMPLETED|Overall Study||4
10439378|NCT00920647|11585820|FG001|COMPLETED|Overall Study||4
10439379|NCT00920647|11585821|FG002|COMPLETED|Overall Study||4
10439380|NCT00920647|11585822|FG003|COMPLETED|Overall Study||4
10439381|NCT00920647|11585819|FG000|NOT COMPLETED|Overall Study||0
10439382|NCT00920647|11585820|FG001|NOT COMPLETED|Overall Study||0
10439383|NCT00920647|11585821|FG002|NOT COMPLETED|Overall Study||0
10439384|NCT00920647|11585822|FG003|NOT COMPLETED|Overall Study||0
10439385|NCT00920686|11585845|FG000|STARTED|Overall Study||82
10439386|NCT00920686|11585846|FG001|STARTED|Overall Study||82
10439387|NCT00920686|11585847|FG002|STARTED|Overall Study||75
10439388|NCT00920686|11585845|FG000|COMPLETED|Overall Study||63
10439389|NCT00920686|11585846|FG001|COMPLETED|Overall Study||60
10439390|NCT00920686|11585847|FG002|COMPLETED|Overall Study||62
10439391|NCT00920686|11585845|FG000|NOT COMPLETED|Overall Study||19
10439392|NCT00920686|11585846|FG001|NOT COMPLETED|Overall Study||22
10439393|NCT00920686|11585847|FG002|NOT COMPLETED|Overall Study||13
10439394|NCT00920699|11585862|FG000|STARTED|Overall Study||29
10439395|NCT00920699|11585863|FG001|STARTED|Overall Study||30
10439396|NCT00920699|11585864|FG002|STARTED|Overall Study||32
10439397|NCT00920699|11585862|FG000|COMPLETED|Overall Study||27
10439398|NCT00920699|11585863|FG001|COMPLETED|Overall Study||29
10439399|NCT00920699|11585864|FG002|COMPLETED|Overall Study||28
10439400|NCT00920699|11585862|FG000|NOT COMPLETED|Overall Study||2
10789386|NCT03520387|11949815|FG003|STARTED|Pre-Randomization|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment. There are no participants in this group until the randomization period (until after the pre-randomization run-in period has ended).|0
10439401|NCT00920699|11585863|FG001|NOT COMPLETED|Overall Study||1
10439402|NCT00920699|11585864|FG002|NOT COMPLETED|Overall Study||4
10439403|NCT00920790|11585872|FG000|STARTED|Overall Study||27
10439404|NCT00920790|11585872|FG000|COMPLETED|Overall Study||13
10439405|NCT00920790|11585872|FG000|NOT COMPLETED|Overall Study||14
10439406|NCT00920829|11585880|FG000|STARTED|Allocation||38
10439407|NCT00920829|11585881|FG001|STARTED|Allocation||39
10439408|NCT00920829|11585882|FG002|STARTED|Allocation||38
10439409|NCT00920829|11585883|FG003|STARTED|Allocation||37
10439410|NCT00920829|11585880|FG000|COMPLETED|Allocation||35
10439411|NCT00920829|11585881|FG001|COMPLETED|Allocation||38
10439412|NCT00920829|11585882|FG002|COMPLETED|Allocation||38
10439413|NCT00920829|11585883|FG003|COMPLETED|Allocation||35
10439414|NCT00920829|11585880|FG000|NOT COMPLETED|Allocation||3
10439415|NCT00920829|11585881|FG001|NOT COMPLETED|Allocation||1
10439416|NCT00920829|11585882|FG002|NOT COMPLETED|Allocation||0
10439417|NCT00920829|11585883|FG003|NOT COMPLETED|Allocation||2
10439418|NCT00920829|11585880|FG000|STARTED|Available for Analysis||35
10439419|NCT00920829|11585881|FG001|STARTED|Available for Analysis||38
10439420|NCT00920829|11585882|FG002|STARTED|Available for Analysis||38
10439421|NCT00920829|11585883|FG003|STARTED|Available for Analysis||35
10439422|NCT00920829|11585880|FG000|COMPLETED|Available for Analysis||27
10439423|NCT00920829|11585881|FG001|COMPLETED|Available for Analysis||27
10439424|NCT00920829|11585882|FG002|COMPLETED|Available for Analysis||28
10439425|NCT00920829|11585883|FG003|COMPLETED|Available for Analysis||24
10439426|NCT00920829|11585880|FG000|NOT COMPLETED|Available for Analysis||8
10439427|NCT00920829|11585881|FG001|NOT COMPLETED|Available for Analysis||11
10439428|NCT00920829|11585882|FG002|NOT COMPLETED|Available for Analysis||10
10439429|NCT00920829|11585883|FG003|NOT COMPLETED|Available for Analysis||11
10439430|NCT00920855|11585896|FG000|STARTED|Overall Study||5
10439431|NCT00920855|11585897|FG001|STARTED|Overall Study||4
10439432|NCT00920855|11585898|FG002|STARTED|Overall Study||31
10439433|NCT00920855|11585896|FG000|Safety and Efficacy Populations|Overall Study||5
10439434|NCT00920855|11585897|FG001|Safety and Efficacy Populations|Overall Study||4
10439435|NCT00920855|11585898|FG002|Safety and Efficacy Populations|Overall Study||31
10439436|NCT00920855|11585896|FG000|COMPLETED|Overall Study|completed eight cycles of treatment|0
10439437|NCT00920855|11585897|FG001|COMPLETED|Overall Study|completed eight cycles of treatment|1
10439438|NCT00920855|11585898|FG002|COMPLETED|Overall Study|completed eight cycles of treatment|9
10439439|NCT00920855|11585896|FG000|NOT COMPLETED|Overall Study||5
10439440|NCT00920855|11585897|FG001|NOT COMPLETED|Overall Study||3
10439441|NCT00920855|11585898|FG002|NOT COMPLETED|Overall Study||22
10439442|NCT00920907|11585909|FG000|STARTED|Induction Period||37
10439443|NCT00920907|11585910|FG001|STARTED|Induction Period||38
10439444|NCT00920907|11585909|FG000|COMPLETED|Induction Period||15
10439445|NCT00920907|11585910|FG001|COMPLETED|Induction Period||16
10439446|NCT00920907|11585909|FG000|NOT COMPLETED|Induction Period||22
10439447|NCT00920907|11585910|FG001|NOT COMPLETED|Induction Period||22
10439448|NCT00920907|11585909|FG000|STARTED|Maintenance Period||15
10439449|NCT00920907|11585910|FG001|STARTED|Maintenance Period|1 patient completed Induction phase but discontinued the study prior to start of maintenance phase.|15
10439450|NCT00920907|11585909|FG000|COMPLETED|Maintenance Period|All participants who entered Maintenance were treated with study drug.|3
10439451|NCT00920907|11585910|FG001|COMPLETED|Maintenance Period|2 participants who entered Maintenance Period did not receive study drug during the period.|2
10439452|NCT00920907|11585909|FG000|NOT COMPLETED|Maintenance Period||12
10439453|NCT00920907|11585910|FG001|NOT COMPLETED|Maintenance Period||13
10439454|NCT00921024|11585920|FG000|STARTED|Overall Study||85
10439455|NCT00921024|11585921|FG001|STARTED|Overall Study||42
10439456|NCT00921024|11585920|FG000|COMPLETED|Overall Study||81
10439457|NCT00921024|11585921|FG001|COMPLETED|Overall Study||39
10439458|NCT00921024|11585920|FG000|NOT COMPLETED|Overall Study||4
10439459|NCT00921024|11585921|FG001|NOT COMPLETED|Overall Study||3
10439460|NCT00921310|11585929|FG000|STARTED|Overall Study||2
10439461|NCT00921310|11585930|FG001|STARTED|Overall Study||6
10439462|NCT00921310|11585931|FG002|STARTED|Overall Study||4
10439463|NCT00921310|11585929|FG000|COMPLETED|Overall Study||2
10439464|NCT00921310|11585930|FG001|COMPLETED|Overall Study||6
10439465|NCT00921310|11585931|FG002|COMPLETED|Overall Study||4
10439466|NCT00921310|11585929|FG000|NOT COMPLETED|Overall Study||0
10439467|NCT00921310|11585930|FG001|NOT COMPLETED|Overall Study||0
10439468|NCT00921310|11585931|FG002|NOT COMPLETED|Overall Study||0
10439469|NCT00921518|11585945|FG000|STARTED|Overall Study||48
10439470|NCT00921518|11585946|FG001|STARTED|Overall Study||44
10439471|NCT00921518|11585945|FG000|COMPLETED|Overall Study||48
10439472|NCT00921518|11585946|FG001|COMPLETED|Overall Study||44
10439473|NCT00921518|11585945|FG000|NOT COMPLETED|Overall Study||0
10439474|NCT00921518|11585946|FG001|NOT COMPLETED|Overall Study||0
10439475|NCT00921557|11585955|FG000|STARTED|Weeks 0-48 (on Study Treatment)||17
10439476|NCT00921557|11585956|FG001|STARTED|Weeks 0-48 (on Study Treatment)||17
10439477|NCT00921557|11585957|FG002|STARTED|Weeks 0-48 (on Study Treatment)||18
10439478|NCT00921557|11585955|FG000|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|15
10439479|NCT00921557|11585956|FG001|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|17
10439480|NCT00921557|11585957|FG002|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|18
10439481|NCT00921557|11585955|FG000|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||2
10439482|NCT00921557|11585956|FG001|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||0
10439483|NCT00921557|11585957|FG002|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||0
10439484|NCT00921557|11585955|FG000|STARTED|Weeks 48-96 (on Study Treatment)||15
10439485|NCT00921557|11585956|FG001|STARTED|Weeks 48-96 (on Study Treatment)||17
10439486|NCT00921557|11585957|FG002|STARTED|Weeks 48-96 (on Study Treatment)||18
10439487|NCT00921557|11585955|FG000|COMPLETED|Weeks 48-96 (on Study Treatment)||15
10439488|NCT00921557|11585956|FG001|COMPLETED|Weeks 48-96 (on Study Treatment)||16
10439489|NCT00921557|11585957|FG002|COMPLETED|Weeks 48-96 (on Study Treatment)||17
10439490|NCT00921557|11585955|FG000|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||0
10439491|NCT00921557|11585956|FG001|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||1
10439492|NCT00921557|11585957|FG002|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||1
10439493|NCT00921557|11585955|FG000|STARTED|Weeks 96-144 (Off Study Treatment)||15
10439494|NCT00921557|11585956|FG001|STARTED|Weeks 96-144 (Off Study Treatment)||16
10439495|NCT00921557|11585957|FG002|STARTED|Weeks 96-144 (Off Study Treatment)||17
10439496|NCT00921557|11585955|FG000|COMPLETED|Weeks 96-144 (Off Study Treatment)||12
10439497|NCT00921557|11585956|FG001|COMPLETED|Weeks 96-144 (Off Study Treatment)||15
10439498|NCT00921557|11585957|FG002|COMPLETED|Weeks 96-144 (Off Study Treatment)||16
10439499|NCT00921557|11585955|FG000|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||3
10439500|NCT00921557|11585956|FG001|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||1
10439501|NCT00921557|11585957|FG002|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||1
10439502|NCT00921687|11585972|FG000|STARTED|Overall Study|eligible patients seen in clinic between 1/1/09 and 1/1/10|418
10439503|NCT00921687|11585973|FG001|STARTED|Overall Study||363
10439504|NCT00921687|11585972|FG000|COMPLETED|Overall Study||418
10439505|NCT00921687|11585973|FG001|COMPLETED|Overall Study||363
10439506|NCT00921687|11585972|FG000|NOT COMPLETED|Overall Study||0
10439507|NCT00921687|11585973|FG001|NOT COMPLETED|Overall Study||0
10439508|NCT00921843|11585983|FG000|STARTED|Overall Study||10
10439509|NCT00921843|11585984|FG001|STARTED|Overall Study||10
10439510|NCT00921843|11585985|FG002|STARTED|Overall Study||11
10439511|NCT00921843|11585986|FG003|STARTED|Overall Study||30
10439512|NCT00921843|11585983|FG000|COMPLETED|Overall Study||10
10439513|NCT00921843|11585984|FG001|COMPLETED|Overall Study||10
10439514|NCT00921843|11585985|FG002|COMPLETED|Overall Study||11
10439515|NCT00921843|11585986|FG003|COMPLETED|Overall Study||30
10439516|NCT00921843|11585983|FG000|NOT COMPLETED|Overall Study||0
10439517|NCT00921843|11585984|FG001|NOT COMPLETED|Overall Study||0
10439518|NCT00921843|11585985|FG002|NOT COMPLETED|Overall Study||0
10439519|NCT00921843|11585986|FG003|NOT COMPLETED|Overall Study||0
10439520|NCT00921895|11585996|FG000|STARTED|Overall Study||128
10439521|NCT00921895|11585996|FG000|COMPLETED|Overall Study||128
10439522|NCT00921895|11585996|FG000|NOT COMPLETED|Overall Study||0
10439523|NCT00921934|11586001|FG000|STARTED|Overall Study||68
10439524|NCT00921934|11586001|FG000|COMPLETED|Overall Study||68
10439525|NCT00921934|11586001|FG000|NOT COMPLETED|Overall Study||0
10439526|NCT00921947|11586007|FG000|STARTED|Day 0||30
10439527|NCT00921947|11586008|FG001|STARTED|Day 0||30
10439528|NCT00921947|11586007|FG000|COMPLETED|Day 0||30
10439529|NCT00921947|11586008|FG001|COMPLETED|Day 0||30
10439530|NCT00921947|11586007|FG000|NOT COMPLETED|Day 0||0
10439531|NCT00921947|11586008|FG001|NOT COMPLETED|Day 0||0
10439532|NCT00921947|11586007|FG000|STARTED|Day 28|2 subjects were lost to follow-up and did not receive the 2nd vaccination of 1.0 ug i.m.|28
10439533|NCT00921947|11586008|FG001|STARTED|Day 28||30
10439534|NCT00921947|11586007|FG000|COMPLETED|Day 28||28
10439535|NCT00921947|11586008|FG001|COMPLETED|Day 28||30
10439536|NCT00921947|11586007|FG000|NOT COMPLETED|Day 28||0
10439537|NCT00921947|11586008|FG001|NOT COMPLETED|Day 28||0
10439538|NCT00922116|11586014|FG000|STARTED|Overall Study||191
10439539|NCT00922116|11586014|FG000|COMPLETED|Overall Study||176
10439540|NCT00922116|11586014|FG000|NOT COMPLETED|Overall Study||15
10439541|NCT00922194|11586018|FG000|STARTED|Metformin in Maximum Tolerated Dose|February 2006|102
10439542|NCT00922194|11586018|FG000|COMPLETED|Metformin in Maximum Tolerated Dose|June 2009|102
10439543|NCT00922194|11586018|FG000|NOT COMPLETED|Metformin in Maximum Tolerated Dose||0
10439544|NCT00922194|11586018|FG000|STARTED|Metformin for 12 Months or More|Gradually increasing dose of Extended Release Metformin|102
10439545|NCT00922194|11586018|FG000|COMPLETED|Metformin for 12 Months or More||102
10439546|NCT00922194|11586018|FG000|NOT COMPLETED|Metformin for 12 Months or More||0
10439547|NCT00922207|11586025|FG000|STARTED|Overall Study||91
10439548|NCT00922207|11586026|FG001|STARTED|Overall Study||95
10439549|NCT00922207|11586027|FG002|STARTED|Overall Study||94
10439550|NCT00922207|11586025|FG000|COMPLETED|Overall Study||85
10439551|NCT00922207|11586026|FG001|COMPLETED|Overall Study||88
10439552|NCT00922207|11586027|FG002|COMPLETED|Overall Study||90
10439553|NCT00922207|11586025|FG000|NOT COMPLETED|Overall Study||6
10439554|NCT00922207|11586026|FG001|NOT COMPLETED|Overall Study||7
10439555|NCT00922207|11586027|FG002|NOT COMPLETED|Overall Study||4
10439556|NCT00922233|11586035|FG000|STARTED|Overall Study||72
10439557|NCT00922233|11586035|FG000|COMPLETED|Overall Study||68
10439558|NCT00922233|11586035|FG000|NOT COMPLETED|Overall Study||4
10439559|NCT00922272|11586040|FG000|STARTED|Open-label Phase||92
10439560|NCT00922272|11586041|FG001|STARTED|Open-label Phase||0
10439561|NCT00922272|11586040|FG000|COMPLETED|Open-label Phase||69
10439562|NCT00922272|11586041|FG001|COMPLETED|Open-label Phase||0
10439563|NCT00922272|11586040|FG000|NOT COMPLETED|Open-label Phase||23
10439564|NCT00922272|11586041|FG001|NOT COMPLETED|Open-label Phase||0
10439565|NCT00922272|11586040|FG000|STARTED|Double-blind Phase||34
10439566|NCT00922272|11586041|FG001|STARTED|Double-blind Phase||35
10439567|NCT00922272|11586040|FG000|COMPLETED|Double-blind Phase||27
10439568|NCT00922272|11586041|FG001|COMPLETED|Double-blind Phase||29
10439569|NCT00922272|11586040|FG000|NOT COMPLETED|Double-blind Phase||7
10439570|NCT00922272|11586041|FG001|NOT COMPLETED|Double-blind Phase||6
10439571|NCT00922428|11586049|FG000|STARTED|Overall Study|13 patients were completely not analysed, 2 not for demographic or efficacy but for safety|1389
10439572|NCT00922428|11586049|FG000|COMPLETED|Overall Study|for 11 participants no gender was given|1374
10439573|NCT00922428|11586049|FG000|NOT COMPLETED|Overall Study||15
10439574|NCT00922441|11586062|FG000|STARTED|Overall Study||30
10439575|NCT00922441|11586063|FG001|STARTED|Overall Study||30
10439576|NCT00922441|11586064|FG002|STARTED|Overall Study||32
10439577|NCT00922441|11586062|FG000|COMPLETED|Overall Study||30
10439578|NCT00922441|11586063|FG001|COMPLETED|Overall Study||30
10439579|NCT00922441|11586064|FG002|COMPLETED|Overall Study||29
10439580|NCT00922441|11586062|FG000|NOT COMPLETED|Overall Study||0
10439581|NCT00922441|11586063|FG001|NOT COMPLETED|Overall Study||0
10439582|NCT00922441|11586064|FG002|NOT COMPLETED|Overall Study||3
10439583|NCT00922480|11586074|FG000|STARTED|Main Study||250
10439584|NCT00922480|11586075|FG001|STARTED|Main Study||255
10439585|NCT00922480|11586074|FG000|COMPLETED|Main Study||213
10439586|NCT00922480|11586075|FG001|COMPLETED|Main Study||226
10439587|NCT00922480|11586074|FG000|NOT COMPLETED|Main Study||37
10439588|NCT00922480|11586075|FG001|NOT COMPLETED|Main Study||29
10439589|NCT00922480|11586074|FG000|STARTED|Extension Study||73
10439590|NCT00922480|11586075|FG001|STARTED|Extension Study||85
10439591|NCT00922480|11586074|FG000|COMPLETED|Extension Study||68
10439592|NCT00922480|11586075|FG001|COMPLETED|Extension Study||82
10439593|NCT00922480|11586074|FG000|NOT COMPLETED|Extension Study||5
10439594|NCT00922480|11586075|FG001|NOT COMPLETED|Extension Study||3
10439595|NCT00922623|11586083|FG000|STARTED|Overall Study||93
10439596|NCT00922623|11586083|FG000|COMPLETED|Overall Study||88
10439597|NCT00922623|11586083|FG000|NOT COMPLETED|Overall Study||5
10439598|NCT00922636|11586094|FG000|STARTED|Overall Study||36
10439599|NCT00922636|11586095|FG001|STARTED|Overall Study||78
10439600|NCT00922636|11586096|FG002|STARTED|Overall Study||76
10439601|NCT00922636|11586097|FG003|STARTED|Overall Study||75
10439602|NCT00922636|11586098|FG004|STARTED|Overall Study||75
10439603|NCT00922636|11586094|FG000|Entered Optional Taper Phase|Overall Study||4
10439604|NCT00922636|11586095|FG001|Entered Optional Taper Phase|Overall Study||10
10439605|NCT00922636|11586096|FG002|Entered Optional Taper Phase|Overall Study||15
10439606|NCT00922636|11586097|FG003|Entered Optional Taper Phase|Overall Study||7
10439607|NCT00922636|11586098|FG004|Entered Optional Taper Phase|Overall Study||12
10439608|NCT00922636|11586094|FG000|COMPLETED|Overall Study||29
10439609|NCT00922636|11586095|FG001|COMPLETED|Overall Study||62
10439610|NCT00922636|11586096|FG002|COMPLETED|Overall Study||56
10439611|NCT00922636|11586097|FG003|COMPLETED|Overall Study||58
10439612|NCT00922636|11586098|FG004|COMPLETED|Overall Study||59
10439613|NCT00922636|11586094|FG000|NOT COMPLETED|Overall Study||7
10439614|NCT00922636|11586095|FG001|NOT COMPLETED|Overall Study||16
10439615|NCT00922636|11586096|FG002|NOT COMPLETED|Overall Study||20
10439616|NCT00922636|11586097|FG003|NOT COMPLETED|Overall Study||17
10810684|NCT03792672|11972461|FG005|NOT COMPLETED|Treatment Period 1 (1 Day)||0
10810685|NCT03792672|11972456|FG000|STARTED|Washout Period 1 (10 Days)||4
10810686|NCT03792672|11972457|FG001|STARTED|Washout Period 1 (10 Days)||4
10439617|NCT00922636|11586098|FG004|NOT COMPLETED|Overall Study||16
10439618|NCT00922701|11586115|FG000|STARTED|Overall Study||4
10439619|NCT00922701|11586115|FG000|COMPLETED|Overall Study||4
10439620|NCT00922701|11586115|FG000|NOT COMPLETED|Overall Study||0
10439621|NCT00922766|11586119|FG000|STARTED|Overall Study||617
10439622|NCT00922766|11586119|FG000|COMPLETED|Overall Study||610
10439623|NCT00922766|11586119|FG000|NOT COMPLETED|Overall Study||7
10439624|NCT00922779|11586123|FG000|STARTED|Overall Study||6661
10439625|NCT00922779|11586123|FG000|COMPLETED|Overall Study||4334
10439626|NCT00922779|11586123|FG000|NOT COMPLETED|Overall Study||2327
10439627|NCT00922883|11586127|FG000|STARTED|Overall Study||43
10439628|NCT00922883|11586127|FG000|COMPLETED|Overall Study||43
10439629|NCT00922883|11586127|FG000|NOT COMPLETED|Overall Study||0
10439630|NCT00922935|11586134|FG000|STARTED|Overall Study||10
10439631|NCT00922935|11586135|FG001|STARTED|Overall Study||16
10439632|NCT00922935|11586136|FG002|STARTED|Overall Study||10
10439633|NCT00922935|11586134|FG000|COMPLETED|Overall Study||9
10439634|NCT00922935|11586135|FG001|COMPLETED|Overall Study||11
10810687|NCT03792672|11972458|FG002|STARTED|Washout Period 1 (10 Days)||4
10810688|NCT03792672|11972459|FG003|STARTED|Washout Period 1 (10 Days)||4
10439635|NCT00922935|11586136|FG002|COMPLETED|Overall Study||10
10439636|NCT00922935|11586134|FG000|NOT COMPLETED|Overall Study||1
10439637|NCT00922935|11586135|FG001|NOT COMPLETED|Overall Study||5
10439638|NCT00922935|11586136|FG002|NOT COMPLETED|Overall Study||0
10439639|NCT00922974|11586147|FG000|STARTED|Phase II Component||46
10439640|NCT00922974|11586148|FG001|STARTED|Phase II Component||0
10439641|NCT00922974|11586147|FG000|Eligible|Phase II Component||44
10439642|NCT00922974|11586148|FG001|Eligible|Phase II Component||0
10789387|NCT03520387|11949816|FG004|STARTED|Pre-Randomization|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment. There are no participants in this group until the randomization period (until after the pre-randomization run-in period has ended).|0
10439643|NCT00922974|11586147|FG000|Eligible and Started Treatment|Phase II Component||39
10439644|NCT00922974|11586148|FG001|Eligible and Started Treatment|Phase II Component||0
10439645|NCT00922974|11586147|FG000|Eligible, Treated, Adverse Event Data|Phase II Component||34
10439646|NCT00922974|11586148|FG001|Eligible, Treated, Adverse Event Data|Phase II Component||0
10439647|NCT00922974|11586147|FG000|COMPLETED|Phase II Component|These subjects do not participate in the phase III component.|39
10439648|NCT00922974|11586148|FG001|COMPLETED|Phase II Component||0
10439649|NCT00922974|11586147|FG000|NOT COMPLETED|Phase II Component||7
10439650|NCT00922974|11586148|FG001|NOT COMPLETED|Phase II Component||0
10439651|NCT00922974|11586147|FG000|STARTED|Phase III Component|The phase III component accrues new subjects; these are not continuing phase II subjects.|217
10439652|NCT00922974|11586148|FG001|STARTED|Phase III Component||136
10439653|NCT00922974|11586147|FG000|Eligible|Phase III Component||209
10439654|NCT00922974|11586148|FG001|Eligible|Phase III Component||130
10439655|NCT00922974|11586147|FG000|Eligible With 3 mo. NRPS Data|Phase III Component||139
10439656|NCT00922974|11586148|FG001|Eligible With 3 mo. NRPS Data|Phase III Component||76
10439657|NCT00922974|11586147|FG000|Eligible With 3 mo. FACT-G Data|Phase III Component||87
10439658|NCT00922974|11586148|FG001|Eligible With 3 mo. FACT-G Data|Phase III Component||58
10439659|NCT00922974|11586147|FG000|Eligible With Adverse Event Data|Phase III Component||202
10439660|NCT00922974|11586148|FG001|Eligible With Adverse Event Data|Phase III Component||117
10439661|NCT00922974|11586147|FG000|Eligible, Treated, Adverse Event Data|Phase III Component||148
10439662|NCT00922974|11586148|FG001|Eligible, Treated, Adverse Event Data|Phase III Component||83
10439663|NCT00922974|11586147|FG000|Eligible and Consented to Quality of Life Participate in Quality of Life (QOL) Study Component|Phase III Component||152
10439664|NCT00922974|11586148|FG001|Eligible and Consented to Quality of Life Participate in Quality of Life (QOL) Study Component|Phase III Component||100
10439665|NCT00922974|11586147|FG000|COMPLETED|Phase III Component||209
10439666|NCT00922974|11586148|FG001|COMPLETED|Phase III Component||130
10439667|NCT00922974|11586147|FG000|NOT COMPLETED|Phase III Component||8
10439668|NCT00922974|11586148|FG001|NOT COMPLETED|Phase III Component||6
10439669|NCT00922987|11586156|FG000|STARTED|Overall Study||281
10439670|NCT00922987|11586156|FG000|COMPLETED|Overall Study||277
10439671|NCT00922987|11586156|FG000|NOT COMPLETED|Overall Study||4
10439672|NCT00923078|11586163|FG000|STARTED|First Intervention (Weeks 1-4)||20
10439673|NCT00923078|11586164|FG001|STARTED|First Intervention (Weeks 1-4)||20
10439674|NCT00923078|11586165|FG002|STARTED|First Intervention (Weeks 1-4)||20
10439675|NCT00923078|11586163|FG000|COMPLETED|First Intervention (Weeks 1-4)||19
10439676|NCT00923078|11586164|FG001|COMPLETED|First Intervention (Weeks 1-4)||19
10439677|NCT00923078|11586165|FG002|COMPLETED|First Intervention (Weeks 1-4)||0
10439678|NCT00923078|11586163|FG000|NOT COMPLETED|First Intervention (Weeks 1-4)||1
10439679|NCT00923078|11586164|FG001|NOT COMPLETED|First Intervention (Weeks 1-4)||1
10439680|NCT00923078|11586165|FG002|NOT COMPLETED|First Intervention (Weeks 1-4)||20
10439681|NCT00923078|11586163|FG000|STARTED|Second Intervention (Weeks 5-8)||19
10439682|NCT00923078|11586164|FG001|STARTED|Second Intervention (Weeks 5-8)||19
10439683|NCT00923078|11586165|FG002|STARTED|Second Intervention (Weeks 5-8)|Healthy Comparison sample subjects completed only a single test session (baseline)|0
10439684|NCT00923078|11586163|FG000|COMPLETED|Second Intervention (Weeks 5-8)||19
10439685|NCT00923078|11586164|FG001|COMPLETED|Second Intervention (Weeks 5-8)||19
10439686|NCT00923078|11586165|FG002|COMPLETED|Second Intervention (Weeks 5-8)||0
10439687|NCT00923078|11586163|FG000|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
10439688|NCT00923078|11586164|FG001|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
10439689|NCT00923078|11586165|FG002|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
10439690|NCT00923091|11586180|FG000|STARTED|PeriodI-II (Randomized, Double-Blind)||335
10439691|NCT00923091|11586181|FG001|STARTED|PeriodI-II (Randomized, Double-Blind)||336
10439692|NCT00923091|11586182|FG002|STARTED|PeriodI-II (Randomized, Double-Blind)||336
10439693|NCT00923091|11586183|FG003|STARTED|PeriodI-II (Randomized, Double-Blind)||336
10439694|NCT00923091|11586184|FG004|STARTED|PeriodI-II (Randomized, Double-Blind)||336
10439695|NCT00923091|11586185|FG005|STARTED|PeriodI-II (Randomized, Double-Blind)||337
10439696|NCT00923091|11586186|FG006|STARTED|PeriodI-II (Randomized, Double-Blind)||337
10439697|NCT00923091|11586187|FG007|STARTED|PeriodI-II (Randomized, Double-Blind)||336
10439698|NCT00923091|11586188|FG008|STARTED|PeriodI-II (Randomized, Double-Blind)||0
10439699|NCT00923091|11586189|FG009|STARTED|PeriodI-II (Randomized, Double-Blind)||0
10439700|NCT00923091|11586190|FG010|STARTED|PeriodI-II (Randomized, Double-Blind)||0
10439701|NCT00923091|11586191|FG011|STARTED|PeriodI-II (Randomized, Double-Blind)||0
10439702|NCT00923091|11586192|FG012|STARTED|PeriodI-II (Randomized, Double-Blind)||0
10439703|NCT00923091|11586180|FG000|COMPLETED|PeriodI-II (Randomized, Double-Blind)||319
10439704|NCT00923091|11586181|FG001|COMPLETED|PeriodI-II (Randomized, Double-Blind)||325
10439705|NCT00923091|11586182|FG002|COMPLETED|PeriodI-II (Randomized, Double-Blind)||323
10439706|NCT00923091|11586183|FG003|COMPLETED|PeriodI-II (Randomized, Double-Blind)||309
10439707|NCT00923091|11586184|FG004|COMPLETED|PeriodI-II (Randomized, Double-Blind)||315
10439708|NCT00923091|11586185|FG005|COMPLETED|PeriodI-II (Randomized, Double-Blind)||322
10439709|NCT00923091|11586186|FG006|COMPLETED|PeriodI-II (Randomized, Double-Blind)||319
10439710|NCT00923091|11586187|FG007|COMPLETED|PeriodI-II (Randomized, Double-Blind)||311
10439711|NCT00923091|11586188|FG008|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
10439712|NCT00923091|11586189|FG009|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
10439713|NCT00923091|11586190|FG010|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
10439714|NCT00923091|11586191|FG011|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
10439715|NCT00923091|11586192|FG012|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
10439716|NCT00923091|11586180|FG000|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||16
10439717|NCT00923091|11586181|FG001|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||11
10439718|NCT00923091|11586182|FG002|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||13
10439719|NCT00923091|11586183|FG003|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||27
10439720|NCT00923091|11586184|FG004|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||21
10439721|NCT00923091|11586185|FG005|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||15
10439722|NCT00923091|11586186|FG006|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||18
10439723|NCT00923091|11586187|FG007|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||25
10439724|NCT00923091|11586188|FG008|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
10439725|NCT00923091|11586189|FG009|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
10439726|NCT00923091|11586190|FG010|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
10439727|NCT00923091|11586191|FG011|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
10439728|NCT00923091|11586192|FG012|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
10439729|NCT00923091|11586180|FG000|STARTED|Period III (Single-Blind)|2543 completed Period 2. Three decided not to continue in the study=2540.|2540
10439730|NCT00923091|11586181|FG001|STARTED|Period III (Single-Blind)||0
10439731|NCT00923091|11586182|FG002|STARTED|Period III (Single-Blind)||0
10439732|NCT00923091|11586183|FG003|STARTED|Period III (Single-Blind)||0
10439733|NCT00923091|11586184|FG004|STARTED|Period III (Single-Blind)||0
10439734|NCT00923091|11586185|FG005|STARTED|Period III (Single-Blind)||0
10439735|NCT00923091|11586186|FG006|STARTED|Period III (Single-Blind)||0
10439736|NCT00923091|11586187|FG007|STARTED|Period III (Single-Blind)||0
10439737|NCT00923091|11586188|FG008|STARTED|Period III (Single-Blind)||0
10439738|NCT00923091|11586189|FG009|STARTED|Period III (Single-Blind)||0
10439739|NCT00923091|11586190|FG010|STARTED|Period III (Single-Blind)||0
10439740|NCT00923091|11586191|FG011|STARTED|Period III (Single-Blind)||0
10439741|NCT00923091|11586192|FG012|STARTED|Period III (Single-Blind)||0
10439742|NCT00923091|11586180|FG000|COMPLETED|Period III (Single-Blind)||2520
10439743|NCT00923091|11586181|FG001|COMPLETED|Period III (Single-Blind)||0
10439744|NCT00923091|11586182|FG002|COMPLETED|Period III (Single-Blind)||0
10439745|NCT00923091|11586183|FG003|COMPLETED|Period III (Single-Blind)||0
10439746|NCT00923091|11586184|FG004|COMPLETED|Period III (Single-Blind)||0
10439747|NCT00923091|11586185|FG005|COMPLETED|Period III (Single-Blind)||0
10439748|NCT00923091|11586186|FG006|COMPLETED|Period III (Single-Blind)||0
10439749|NCT00923091|11586187|FG007|COMPLETED|Period III (Single-Blind)||0
10439750|NCT00923091|11586188|FG008|COMPLETED|Period III (Single-Blind)||0
10439751|NCT00923091|11586189|FG009|COMPLETED|Period III (Single-Blind)||0
10439752|NCT00923091|11586190|FG010|COMPLETED|Period III (Single-Blind)||0
10439753|NCT00923091|11586191|FG011|COMPLETED|Period III (Single-Blind)||0
10439754|NCT00923091|11586192|FG012|COMPLETED|Period III (Single-Blind)||0
10439755|NCT00923091|11586180|FG000|NOT COMPLETED|Period III (Single-Blind)||20
10439756|NCT00923091|11586181|FG001|NOT COMPLETED|Period III (Single-Blind)||0
10439757|NCT00923091|11586182|FG002|NOT COMPLETED|Period III (Single-Blind)||0
10439758|NCT00923091|11586183|FG003|NOT COMPLETED|Period III (Single-Blind)||0
10439759|NCT00923091|11586184|FG004|NOT COMPLETED|Period III (Single-Blind)||0
10439760|NCT00923091|11586185|FG005|NOT COMPLETED|Period III (Single-Blind)||0
10439761|NCT00923091|11586186|FG006|NOT COMPLETED|Period III (Single-Blind)||0
10439762|NCT00923091|11586187|FG007|NOT COMPLETED|Period III (Single-Blind)||0
10439763|NCT00923091|11586188|FG008|NOT COMPLETED|Period III (Single-Blind)||0
10439764|NCT00923091|11586189|FG009|NOT COMPLETED|Period III (Single-Blind)||0
10439765|NCT00923091|11586190|FG010|NOT COMPLETED|Period III (Single-Blind)||0
10439766|NCT00923091|11586191|FG011|NOT COMPLETED|Period III (Single-Blind)||0
10439767|NCT00923091|11586192|FG012|NOT COMPLETED|Period III (Single-Blind)||0
10439768|NCT00923091|11586180|FG000|STARTED|Period IV (Double-Blind)|2 did not continue in the study and 1837 responders went directly to Period VI. 228+453+2+1837=2520|228
10439769|NCT00923091|11586181|FG001|STARTED|Period IV (Double-Blind)||453
10439770|NCT00923091|11586182|FG002|STARTED|Period IV (Double-Blind)||0
10439771|NCT00923091|11586183|FG003|STARTED|Period IV (Double-Blind)||0
10439772|NCT00923091|11586184|FG004|STARTED|Period IV (Double-Blind)||0
10439773|NCT00923091|11586185|FG005|STARTED|Period IV (Double-Blind)||0
10439774|NCT00923091|11586186|FG006|STARTED|Period IV (Double-Blind)||0
10439775|NCT00923091|11586187|FG007|STARTED|Period IV (Double-Blind)||0
10439776|NCT00923091|11586188|FG008|STARTED|Period IV (Double-Blind)||0
10439777|NCT00923091|11586189|FG009|STARTED|Period IV (Double-Blind)||0
10439778|NCT00923091|11586190|FG010|STARTED|Period IV (Double-Blind)||0
10439779|NCT00923091|11586191|FG011|STARTED|Period IV (Double-Blind)||0
10439780|NCT00923091|11586192|FG012|STARTED|Period IV (Double-Blind)||0
10439781|NCT00923091|11586180|FG000|COMPLETED|Period IV (Double-Blind)||226
10439782|NCT00923091|11586181|FG001|COMPLETED|Period IV (Double-Blind)||451
10439783|NCT00923091|11586182|FG002|COMPLETED|Period IV (Double-Blind)||0
10439784|NCT00923091|11586183|FG003|COMPLETED|Period IV (Double-Blind)||0
10439785|NCT00923091|11586184|FG004|COMPLETED|Period IV (Double-Blind)||0
10439786|NCT00923091|11586185|FG005|COMPLETED|Period IV (Double-Blind)||0
10439787|NCT00923091|11586186|FG006|COMPLETED|Period IV (Double-Blind)||0
10439788|NCT00923091|11586187|FG007|COMPLETED|Period IV (Double-Blind)||0
10439789|NCT00923091|11586188|FG008|COMPLETED|Period IV (Double-Blind)||0
10439790|NCT00923091|11586189|FG009|COMPLETED|Period IV (Double-Blind)||0
10439791|NCT00923091|11586190|FG010|COMPLETED|Period IV (Double-Blind)||0
10439792|NCT00923091|11586191|FG011|COMPLETED|Period IV (Double-Blind)||0
10439793|NCT00923091|11586192|FG012|COMPLETED|Period IV (Double-Blind)||0
10439794|NCT00923091|11586180|FG000|NOT COMPLETED|Period IV (Double-Blind)||2
10439795|NCT00923091|11586181|FG001|NOT COMPLETED|Period IV (Double-Blind)||2
10439796|NCT00923091|11586182|FG002|NOT COMPLETED|Period IV (Double-Blind)||0
10439797|NCT00923091|11586183|FG003|NOT COMPLETED|Period IV (Double-Blind)||0
10439798|NCT00923091|11586184|FG004|NOT COMPLETED|Period IV (Double-Blind)||0
10439799|NCT00923091|11586185|FG005|NOT COMPLETED|Period IV (Double-Blind)||0
10439800|NCT00923091|11586186|FG006|NOT COMPLETED|Period IV (Double-Blind)||0
10439801|NCT00923091|11586187|FG007|NOT COMPLETED|Period IV (Double-Blind)||0
10439802|NCT00923091|11586188|FG008|NOT COMPLETED|Period IV (Double-Blind)||0
10439803|NCT00923091|11586189|FG009|NOT COMPLETED|Period IV (Double-Blind)||0
10439804|NCT00923091|11586190|FG010|NOT COMPLETED|Period IV (Double-Blind)||0
10439805|NCT00923091|11586191|FG011|NOT COMPLETED|Period IV (Double-Blind)||0
10439806|NCT00923091|11586192|FG012|NOT COMPLETED|Period IV (Double-Blind)||0
10439807|NCT00923091|11586180|FG000|STARTED|Period V (Double -Blind)|677 completed Period 4. 1 did not continue and 2 erroneously responders were not counted = 674|0
10439808|NCT00923091|11586181|FG001|STARTED|Period V (Double -Blind)||0
10439809|NCT00923091|11586182|FG002|STARTED|Period V (Double -Blind)||0
10439810|NCT00923091|11586183|FG003|STARTED|Period V (Double -Blind)||0
10439811|NCT00923091|11586184|FG004|STARTED|Period V (Double -Blind)||0
10439812|NCT00923091|11586185|FG005|STARTED|Period V (Double -Blind)||0
10439813|NCT00923091|11586186|FG006|STARTED|Period V (Double -Blind)||0
10439814|NCT00923091|11586187|FG007|STARTED|Period V (Double -Blind)||0
10439815|NCT00923091|11586188|FG008|STARTED|Period V (Double -Blind)||135
10439816|NCT00923091|11586189|FG009|STARTED|Period V (Double -Blind)||119
10439817|NCT00923091|11586190|FG010|STARTED|Period V (Double -Blind)||194
10439818|NCT00923091|11586191|FG011|STARTED|Period V (Double -Blind)||151
10439819|NCT00923091|11586192|FG012|STARTED|Period V (Double -Blind)||75
10439820|NCT00923091|11586180|FG000|COMPLETED|Period V (Double -Blind)||0
10439821|NCT00923091|11586181|FG001|COMPLETED|Period V (Double -Blind)||0
10439822|NCT00923091|11586182|FG002|COMPLETED|Period V (Double -Blind)||0
10439823|NCT00923091|11586183|FG003|COMPLETED|Period V (Double -Blind)||0
10439824|NCT00923091|11586184|FG004|COMPLETED|Period V (Double -Blind)||0
10439825|NCT00923091|11586185|FG005|COMPLETED|Period V (Double -Blind)||0
10439826|NCT00923091|11586186|FG006|COMPLETED|Period V (Double -Blind)||0
10439827|NCT00923091|11586187|FG007|COMPLETED|Period V (Double -Blind)||0
10439828|NCT00923091|11586188|FG008|COMPLETED|Period V (Double -Blind)||134
10439829|NCT00923091|11586189|FG009|COMPLETED|Period V (Double -Blind)||119
10439830|NCT00923091|11586190|FG010|COMPLETED|Period V (Double -Blind)||193
10439831|NCT00923091|11586191|FG011|COMPLETED|Period V (Double -Blind)||151
10439832|NCT00923091|11586192|FG012|COMPLETED|Period V (Double -Blind)||73
10439833|NCT00923091|11586180|FG000|NOT COMPLETED|Period V (Double -Blind)||0
10439834|NCT00923091|11586181|FG001|NOT COMPLETED|Period V (Double -Blind)||0
10439835|NCT00923091|11586182|FG002|NOT COMPLETED|Period V (Double -Blind)||0
10439836|NCT00923091|11586183|FG003|NOT COMPLETED|Period V (Double -Blind)||0
10439837|NCT00923091|11586184|FG004|NOT COMPLETED|Period V (Double -Blind)||0
10439838|NCT00923091|11586185|FG005|NOT COMPLETED|Period V (Double -Blind)||0
10439839|NCT00923091|11586186|FG006|NOT COMPLETED|Period V (Double -Blind)||0
10439840|NCT00923091|11586187|FG007|NOT COMPLETED|Period V (Double -Blind)||0
10439841|NCT00923091|11586188|FG008|NOT COMPLETED|Period V (Double -Blind)||1
10439842|NCT00923091|11586189|FG009|NOT COMPLETED|Period V (Double -Blind)||0
10439843|NCT00923091|11586190|FG010|NOT COMPLETED|Period V (Double -Blind)||1
10439844|NCT00923091|11586191|FG011|NOT COMPLETED|Period V (Double -Blind)||0
10439845|NCT00923091|11586192|FG012|NOT COMPLETED|Period V (Double -Blind)||2
10439846|NCT00923091|11586180|FG000|STARTED|Period VI (Open-Label)|1837 from Period III+2 from Period IV + 670 from Period 5 = 2509|1447
10439847|NCT00923091|11586181|FG001|STARTED|Period VI (Open-Label)||272
10439848|NCT00923091|11586182|FG002|STARTED|Period VI (Open-Label)||480
10439849|NCT00923091|11586183|FG003|STARTED|Period VI (Open-Label)||146
10439850|NCT00923091|11586184|FG004|STARTED|Period VI (Open-Label)||164
10549791|NCT01527110|11703827|FG000|COMPLETED|Overall Study||20
10549792|NCT01527110|11703827|FG000|NOT COMPLETED|Overall Study||1
10549793|NCT01527162|11703831|FG000|STARTED|Overall Study||6
10549794|NCT01527162|11703832|FG001|STARTED|Overall Study||5
10549795|NCT01527162|11703831|FG000|COMPLETED|Overall Study||6
10549796|NCT01527162|11703832|FG001|COMPLETED|Overall Study||5
10549797|NCT01527162|11703831|FG000|NOT COMPLETED|Overall Study||0
10549798|NCT01527162|11703832|FG001|NOT COMPLETED|Overall Study||0
10549799|NCT01527357|11703842|FG000|STARTED|Overall Study||482
10549800|NCT01527357|11703843|FG001|STARTED|Overall Study||239
10439851|NCT00923091|11586185|FG005|STARTED|Period VI (Open-Label)||0
10439852|NCT00923091|11586186|FG006|STARTED|Period VI (Open-Label)||0
10439853|NCT00923091|11586187|FG007|STARTED|Period VI (Open-Label)||0
10439854|NCT00923091|11586188|FG008|STARTED|Period VI (Open-Label)||0
10439855|NCT00923091|11586189|FG009|STARTED|Period VI (Open-Label)||0
10439856|NCT00923091|11586190|FG010|STARTED|Period VI (Open-Label)||0
10439857|NCT00923091|11586191|FG011|STARTED|Period VI (Open-Label)||0
10439858|NCT00923091|11586192|FG012|STARTED|Period VI (Open-Label)||0
10439859|NCT00923091|11586180|FG000|COMPLETED|Period VI (Open-Label)||1408
10549801|NCT01527357|11703842|FG000|Efficacy Population|Overall Study|Two participants did not receive study treatment.|480
10439860|NCT00923091|11586181|FG001|COMPLETED|Period VI (Open-Label)||264
10439861|NCT00923091|11586182|FG002|COMPLETED|Period VI (Open-Label)||467
10439862|NCT00923091|11586183|FG003|COMPLETED|Period VI (Open-Label)||143
10439863|NCT00923091|11586184|FG004|COMPLETED|Period VI (Open-Label)||157
10439864|NCT00923091|11586185|FG005|COMPLETED|Period VI (Open-Label)||0
10439865|NCT00923091|11586186|FG006|COMPLETED|Period VI (Open-Label)||0
10439866|NCT00923091|11586187|FG007|COMPLETED|Period VI (Open-Label)||0
10439867|NCT00923091|11586188|FG008|COMPLETED|Period VI (Open-Label)||0
10439868|NCT00923091|11586189|FG009|COMPLETED|Period VI (Open-Label)||0
10439869|NCT00923091|11586190|FG010|COMPLETED|Period VI (Open-Label)||0
10439870|NCT00923091|11586191|FG011|COMPLETED|Period VI (Open-Label)||0
10439871|NCT00923091|11586192|FG012|COMPLETED|Period VI (Open-Label)||0
10439872|NCT00923091|11586180|FG000|NOT COMPLETED|Period VI (Open-Label)||39
10439873|NCT00923091|11586181|FG001|NOT COMPLETED|Period VI (Open-Label)||8
10439874|NCT00923091|11586182|FG002|NOT COMPLETED|Period VI (Open-Label)||13
10439875|NCT00923091|11586183|FG003|NOT COMPLETED|Period VI (Open-Label)||3
10439876|NCT00923091|11586184|FG004|NOT COMPLETED|Period VI (Open-Label)||7
10439877|NCT00923091|11586185|FG005|NOT COMPLETED|Period VI (Open-Label)||0
10439878|NCT00923091|11586186|FG006|NOT COMPLETED|Period VI (Open-Label)||0
10439879|NCT00923091|11586187|FG007|NOT COMPLETED|Period VI (Open-Label)||0
10439880|NCT00923091|11586188|FG008|NOT COMPLETED|Period VI (Open-Label)||0
10439881|NCT00923091|11586189|FG009|NOT COMPLETED|Period VI (Open-Label)||0
10439882|NCT00923091|11586190|FG010|NOT COMPLETED|Period VI (Open-Label)||0
10439883|NCT00923091|11586191|FG011|NOT COMPLETED|Period VI (Open-Label)||0
10439884|NCT00923091|11586192|FG012|NOT COMPLETED|Period VI (Open-Label)||0
10439885|NCT00923117|11586219|FG000|STARTED|Overall Study||44
10439886|NCT00923117|11586220|FG001|STARTED|Overall Study||43
10439887|NCT00923117|11586219|FG000|COMPLETED|Overall Study||44
10439888|NCT00923117|11586220|FG001|COMPLETED|Overall Study||43
10439889|NCT00923117|11586219|FG000|NOT COMPLETED|Overall Study||0
10439890|NCT00923117|11586220|FG001|NOT COMPLETED|Overall Study||0
10439891|NCT00923130|11586226|FG000|STARTED|Overall Study||30
10439892|NCT00923130|11586226|FG000|COMPLETED|Overall Study||5
10439893|NCT00923130|11586226|FG000|NOT COMPLETED|Overall Study||25
10439894|NCT00923156|11586233|FG000|STARTED|Overall Study|"Started indicates randomized, safety and pharmacodynamic population"|40
10439895|NCT00923156|11586234|FG001|STARTED|Overall Study||42
10439896|NCT00923156|11586235|FG002|STARTED|Overall Study||41
10439897|NCT00923156|11586233|FG000|COMPLETED|Overall Study||40
10439898|NCT00923156|11586234|FG001|COMPLETED|Overall Study||38
10439899|NCT00923156|11586235|FG002|COMPLETED|Overall Study||38
10439900|NCT00923156|11586233|FG000|NOT COMPLETED|Overall Study||0
10439901|NCT00923156|11586234|FG001|NOT COMPLETED|Overall Study||4
10439902|NCT00923156|11586235|FG002|NOT COMPLETED|Overall Study||3
10439903|NCT00923195|11586245|FG000|STARTED|Overall Study||2
10439904|NCT00923195|11586246|FG001|STARTED|Overall Study||2
10439905|NCT00923195|11586245|FG000|COMPLETED|Overall Study||2
10439906|NCT00923195|11586246|FG001|COMPLETED|Overall Study||1
10439907|NCT00923195|11586245|FG000|NOT COMPLETED|Overall Study||0
10439908|NCT00923195|11586246|FG001|NOT COMPLETED|Overall Study||1
10439909|NCT00923260|11586254|FG000|STARTED|Overall Study||12
10439910|NCT00923260|11586255|FG001|STARTED|Overall Study||12
10439911|NCT00923260|11586254|FG000|COMPLETED|Overall Study|Patient didn't complete the follow-up period after surgery|11
10439912|NCT00923260|11586255|FG001|COMPLETED|Overall Study|Patient didn't complete the follow-up period after surgery|11
10439913|NCT00923260|11586254|FG000|NOT COMPLETED|Overall Study||1
10439914|NCT00923260|11586255|FG001|NOT COMPLETED|Overall Study||1
10439915|NCT00923273|11586266|FG000|STARTED|Phase I Treatment Period|The phase I portion will establish the maximum tolerated dose. 4 subjects peme naive.|4
10439916|NCT00923273|11586267|FG001|STARTED|Phase I Treatment Period|3 subjects peme naive.|3
10439917|NCT00923273|11586268|FG002|STARTED|Phase I Treatment Period|3 subjects peme naive.|3
10439918|NCT00923273|11586269|FG003|STARTED|Phase I Treatment Period|3 subjects initially enrolled and 4 subjects added after dose level 5; peme naive.|7
10439919|NCT00923273|11586270|FG004|STARTED|Phase I Treatment Period|5 subjects peme naive.|5
10439920|NCT00923273|11586266|FG000|COMPLETED|Phase I Treatment Period||4
10439921|NCT00923273|11586267|FG001|COMPLETED|Phase I Treatment Period||3
10439922|NCT00923273|11586268|FG002|COMPLETED|Phase I Treatment Period||3
10439923|NCT00923273|11586269|FG003|COMPLETED|Phase I Treatment Period||7
10439924|NCT00923273|11586270|FG004|COMPLETED|Phase I Treatment Period||5
10439925|NCT00923273|11586266|FG000|NOT COMPLETED|Phase I Treatment Period||0
10439926|NCT00923273|11586267|FG001|NOT COMPLETED|Phase I Treatment Period||0
10439927|NCT00923273|11586268|FG002|NOT COMPLETED|Phase I Treatment Period||0
10439928|NCT00923273|11586269|FG003|NOT COMPLETED|Phase I Treatment Period||0
10439929|NCT00923273|11586270|FG004|NOT COMPLETED|Phase I Treatment Period||0
10439930|NCT00923273|11586266|FG000|STARTED|Phase II Treatment Period|The phase II portion will utilize the MTD from the phase I portion.|0
10439931|NCT00923273|11586267|FG001|STARTED|Phase II Treatment Period||0
10439932|NCT00923273|11586268|FG002|STARTED|Phase II Treatment Period||0
10439933|NCT00923273|11586269|FG003|STARTED|Phase II Treatment Period|Includes 8 subjects with prior peme;12 subjects who were peme naive; 7 subjects rolled over from phI|27
10439934|NCT00923273|11586270|FG004|STARTED|Phase II Treatment Period||0
10439935|NCT00923273|11586266|FG000|COMPLETED|Phase II Treatment Period||0
10439936|NCT00923273|11586267|FG001|COMPLETED|Phase II Treatment Period||0
10439937|NCT00923273|11586268|FG002|COMPLETED|Phase II Treatment Period||0
10439938|NCT00923273|11586269|FG003|COMPLETED|Phase II Treatment Period||20
10439939|NCT00923273|11586270|FG004|COMPLETED|Phase II Treatment Period||0
10439940|NCT00923273|11586266|FG000|NOT COMPLETED|Phase II Treatment Period||0
10439941|NCT00923273|11586267|FG001|NOT COMPLETED|Phase II Treatment Period||0
10439942|NCT00923273|11586268|FG002|NOT COMPLETED|Phase II Treatment Period||0
10439943|NCT00923273|11586269|FG003|NOT COMPLETED|Phase II Treatment Period||7
10439944|NCT00923273|11586270|FG004|NOT COMPLETED|Phase II Treatment Period||0
10439945|NCT00923351|11586290|FG000|STARTED|Overall Study||6
10439946|NCT00923351|11586291|FG001|STARTED|Overall Study||26
10439947|NCT00923351|11586292|FG002|STARTED|Overall Study||12
10439948|NCT00923351|11586290|FG000|COMPLETED|Overall Study||6
10439949|NCT00923351|11586291|FG001|COMPLETED|Overall Study||26
10439950|NCT00923351|11586292|FG002|COMPLETED|Overall Study||0
10439951|NCT00923351|11586290|FG000|NOT COMPLETED|Overall Study||0
10439952|NCT00923351|11586291|FG001|NOT COMPLETED|Overall Study||0
10439953|NCT00923351|11586292|FG002|NOT COMPLETED|Overall Study||12
10439954|NCT00923364|11586298|FG000|STARTED|Overall Study||14
10439955|NCT00923364|11586299|FG001|STARTED|Overall Study||5
10439956|NCT00923364|11586298|FG000|COMPLETED|Overall Study||10
10439957|NCT00923364|11586299|FG001|COMPLETED|Overall Study||5
10439958|NCT00923364|11586298|FG000|NOT COMPLETED|Overall Study||4
10439959|NCT00923364|11586299|FG001|NOT COMPLETED|Overall Study||0
10439960|NCT00923481|11586304|FG000|STARTED|Overall Study||37
10439961|NCT00923481|11586304|FG000|COMPLETED|Overall Study||37
10439962|NCT00923481|11586304|FG000|NOT COMPLETED|Overall Study||0
10439963|NCT00923559|11586310|FG000|STARTED|Overall Study||40
10439964|NCT00923559|11586311|FG001|STARTED|Overall Study||40
10439965|NCT00923559|11586310|FG000|COMPLETED|Overall Study||38
10439966|NCT00923559|11586311|FG001|COMPLETED|Overall Study||37
10439967|NCT00923559|11586310|FG000|NOT COMPLETED|Overall Study||2
10439968|NCT00923559|11586311|FG001|NOT COMPLETED|Overall Study||3
10439969|NCT00923598|11586321|FG000|STARTED|Overall Study||23
10439970|NCT00923598|11586322|FG001|STARTED|Overall Study||22
10439971|NCT00923598|11586321|FG000|COMPLETED|Overall Study||19
10439972|NCT00923598|11586322|FG001|COMPLETED|Overall Study||17
10439973|NCT00923598|11586321|FG000|NOT COMPLETED|Overall Study||4
10439974|NCT00923598|11586322|FG001|NOT COMPLETED|Overall Study||5
10439975|NCT00923845|11586330|FG000|STARTED|Donor Lymphocyte Harvest||13
10439976|NCT00923845|11586331|FG001|STARTED|Donor Lymphocyte Harvest||0
10439977|NCT00923845|11586330|FG000|COMPLETED|Donor Lymphocyte Harvest||13
10439978|NCT00923845|11586331|FG001|COMPLETED|Donor Lymphocyte Harvest||0
10439979|NCT00923845|11586330|FG000|NOT COMPLETED|Donor Lymphocyte Harvest||0
10439980|NCT00923845|11586331|FG001|NOT COMPLETED|Donor Lymphocyte Harvest||0
10439981|NCT00923845|11586330|FG000|STARTED|Donor Hematopoietic Stem Cell Harvest||13
10439982|NCT00923845|11586331|FG001|STARTED|Donor Hematopoietic Stem Cell Harvest||0
10439983|NCT00923845|11586330|FG000|COMPLETED|Donor Hematopoietic Stem Cell Harvest||13
10439984|NCT00923845|11586331|FG001|COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
10439985|NCT00923845|11586330|FG000|NOT COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
10439986|NCT00923845|11586331|FG001|NOT COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
10439987|NCT00923845|11586330|FG000|STARTED|Induction Therapy||0
10439988|NCT00923845|11586331|FG001|STARTED|Induction Therapy||12
10439989|NCT00923845|11586330|FG000|COMPLETED|Induction Therapy||0
10439990|NCT00923845|11586331|FG001|COMPLETED|Induction Therapy||10
10439991|NCT00923845|11586330|FG000|NOT COMPLETED|Induction Therapy||0
10439992|NCT00923845|11586331|FG001|NOT COMPLETED|Induction Therapy||2
10439993|NCT00923845|11586330|FG000|STARTED|Allogeneic Stem Cell Therapy||0
10439994|NCT00923845|11586331|FG001|STARTED|Allogeneic Stem Cell Therapy||10
10439995|NCT00923845|11586330|FG000|Received Each of 3 Planned T-Rapa DLI|Allogeneic Stem Cell Therapy||0
10439996|NCT00923845|11586331|FG001|Received Each of 3 Planned T-Rapa DLI|Allogeneic Stem Cell Therapy||8
10439997|NCT00923845|11586330|FG000|Received More Unmanipulated DLI for PD|Allogeneic Stem Cell Therapy||0
10439998|NCT00923845|11586331|FG001|Received More Unmanipulated DLI for PD|Allogeneic Stem Cell Therapy||6
10439999|NCT00923845|11586330|FG000|COMPLETED|Allogeneic Stem Cell Therapy||0
10440000|NCT00923845|11586331|FG001|COMPLETED|Allogeneic Stem Cell Therapy||10
10440001|NCT00923845|11586330|FG000|NOT COMPLETED|Allogeneic Stem Cell Therapy||0
10440002|NCT00923845|11586331|FG001|NOT COMPLETED|Allogeneic Stem Cell Therapy||0
10440003|NCT00923910|11586340|FG000|STARTED|Period 1||5
10440004|NCT00923910|11586341|FG001|STARTED|Period 1||5
10440005|NCT00923910|11586340|FG000|COMPLETED|Period 1||5
10440006|NCT00923910|11586341|FG001|COMPLETED|Period 1||5
10440007|NCT00923910|11586340|FG000|NOT COMPLETED|Period 1||0
10440008|NCT00923910|11586341|FG001|NOT COMPLETED|Period 1||0
10440009|NCT00923910|11586340|FG000|STARTED|Period 2||5
10440010|NCT00923910|11586341|FG001|STARTED|Period 2||5
10440011|NCT00923910|11586340|FG000|COMPLETED|Period 2||5
10440012|NCT00923910|11586341|FG001|COMPLETED|Period 2||5
10440013|NCT00923910|11586340|FG000|NOT COMPLETED|Period 2||0
10440014|NCT00923910|11586341|FG001|NOT COMPLETED|Period 2||0
10440015|NCT00923936|11586348|FG000|STARTED|Overall Study||10
10440016|NCT00923936|11586349|FG001|STARTED|Overall Study||6
10440017|NCT00923936|11586348|FG000|COMPLETED|Overall Study||2
10440018|NCT00923936|11586349|FG001|COMPLETED|Overall Study||3
10440019|NCT00923936|11586348|FG000|NOT COMPLETED|Overall Study||8
10440020|NCT00923936|11586349|FG001|NOT COMPLETED|Overall Study||3
10440021|NCT00923949|11586357|FG000|STARTED|Overall Study||1
10440022|NCT00923949|11586357|FG000|COMPLETED|Overall Study||1
10440023|NCT00923949|11586357|FG000|NOT COMPLETED|Overall Study||0
10440024|NCT00923975|11586361|FG000|STARTED|Overall Study||51
10440025|NCT00923975|11586361|FG000|COMPLETED|Overall Study|One subject did not meet inclusion criteria; the data was not used in analysis.|50
10440026|NCT00923975|11586361|FG000|NOT COMPLETED|Overall Study||1
10440027|NCT00924001|11586365|FG000|STARTED|Overall Study||1
10440028|NCT00924001|11586365|FG000|COMPLETED|Overall Study||1
10440029|NCT00924001|11586365|FG000|NOT COMPLETED|Overall Study||0
10440030|NCT00924040|11586369|FG000|STARTED|Overall Study||1
10440031|NCT00924040|11586369|FG000|COMPLETED|Overall Study||1
10440032|NCT00924040|11586369|FG000|NOT COMPLETED|Overall Study||0
10440033|NCT00924053|11586377|FG000|STARTED|Overall Study||6
10440034|NCT00924053|11586378|FG001|STARTED|Overall Study||6
10440035|NCT00924053|11586379|FG002|STARTED|Overall Study||6
10440036|NCT00924053|11586380|FG003|STARTED|Overall Study||6
10440037|NCT00924053|11586377|FG000|COMPLETED|Overall Study||6
10440038|NCT00924053|11586378|FG001|COMPLETED|Overall Study||6
10440039|NCT00924053|11586379|FG002|COMPLETED|Overall Study||6
10440040|NCT00924053|11586380|FG003|COMPLETED|Overall Study||6
10440041|NCT00924053|11586377|FG000|NOT COMPLETED|Overall Study||0
10440042|NCT00924053|11586378|FG001|NOT COMPLETED|Overall Study||0
10440043|NCT00924053|11586379|FG002|NOT COMPLETED|Overall Study||0
10440044|NCT00924053|11586380|FG003|NOT COMPLETED|Overall Study||0
10440045|NCT00924066|11586390|FG000|STARTED|Overall Study||41
10440046|NCT00924066|11586390|FG000|COMPLETED|Overall Study||41
10440047|NCT00924066|11586390|FG000|NOT COMPLETED|Overall Study||0
10440048|NCT00924118|11586397|FG000|STARTED|Overall Study||15
10440049|NCT00924118|11586398|FG001|STARTED|Overall Study||15
10440050|NCT00924118|11586397|FG000|COMPLETED|Overall Study||15
10440051|NCT00924118|11586398|FG001|COMPLETED|Overall Study||15
10440052|NCT00924118|11586397|FG000|NOT COMPLETED|Overall Study||0
10440053|NCT00924118|11586398|FG001|NOT COMPLETED|Overall Study||0
10440054|NCT00924209|11586404|FG000|STARTED|Overall Study||7
10440055|NCT00924209|11586404|FG000|COMPLETED|Overall Study||7
10440056|NCT00924209|11586404|FG000|NOT COMPLETED|Overall Study||0
10440057|NCT00924287|11586408|FG000|STARTED|Overall Study||1
10440058|NCT00924287|11586408|FG000|COMPLETED|Overall Study||0
10440059|NCT00924287|11586408|FG000|NOT COMPLETED|Overall Study||1
10440060|NCT00924313|11586412|FG000|STARTED|Overall Study||40
10440061|NCT00924313|11586412|FG000|COMPLETED|Overall Study||39
10440062|NCT00924313|11586412|FG000|NOT COMPLETED|Overall Study||1
10440063|NCT00924352|11586416|FG000|STARTED|Overall Study||12
10440064|NCT00924352|11586417|FG001|STARTED|Overall Study||44
10440065|NCT00924352|11586416|FG000|COMPLETED|Overall Study||12
10440066|NCT00924352|11586417|FG001|COMPLETED|Overall Study||44
10440067|NCT00924352|11586416|FG000|NOT COMPLETED|Overall Study||0
10440068|NCT00924352|11586417|FG001|NOT COMPLETED|Overall Study||0
10549802|NCT01527357|11703843|FG001|Efficacy Population|Overall Study||239
10549803|NCT01527357|11703842|FG000|COMPLETED|Overall Study||465
10549804|NCT01527357|11703843|FG001|COMPLETED|Overall Study||230
10549805|NCT01527357|11703842|FG000|NOT COMPLETED|Overall Study||17
10549806|NCT01527357|11703843|FG001|NOT COMPLETED|Overall Study||9
10549807|NCT01527370|11703849|FG000|STARTED|Overall Study||250
10549808|NCT01527370|11703849|FG000|COMPLETED|Overall Study||244
10549809|NCT01527370|11703849|FG000|NOT COMPLETED|Overall Study||6
10549810|NCT01527383|11703855|FG000|STARTED|Overall Study||292
10549811|NCT01527383|11703856|FG001|STARTED|Overall Study||62
10549812|NCT01527383|11703855|FG000|Vaccination 1 (Day 1)|Overall Study||291
10549813|NCT01527383|11703856|FG001|Vaccination 1 (Day 1)|Overall Study||62
10549814|NCT01527383|11703855|FG000|Vaccination 2 (~Day 30)|Overall Study||283
10549815|NCT01527383|11703856|FG001|Vaccination 2 (~Day 30)|Overall Study||61
10549816|NCT01527383|11703855|FG000|Vaccination 3 (~Day 60)|Overall Study||278
10549817|NCT01527383|11703856|FG001|Vaccination 3 (~Day 60)|Overall Study||58
10549818|NCT01527383|11703855|FG000|Vaccination 4 (~Day 90)|Overall Study||277
10549819|NCT01527383|11703856|FG001|Vaccination 4 (~Day 90)|Overall Study||58
10549820|NCT01527383|11703855|FG000|COMPLETED|Overall Study||277
10549821|NCT01527383|11703856|FG001|COMPLETED|Overall Study||58
10549822|NCT01527383|11703855|FG000|NOT COMPLETED|Overall Study||15
10549823|NCT01527383|11703856|FG001|NOT COMPLETED|Overall Study||4
10549824|NCT01527487|11703864|FG000|STARTED|Overall Study|Includes 10 patients from safety lead-in.|54
10549825|NCT01527487|11703865|FG001|STARTED|Overall Study||22
10549826|NCT01527487|11703864|FG000|COMPLETED|Overall Study|Patients who completed 6 cycles plus surgery.|46
10549827|NCT01527487|11703865|FG001|COMPLETED|Overall Study||15
10549828|NCT01527487|11703864|FG000|NOT COMPLETED|Overall Study||8
10549829|NCT01527487|11703865|FG001|NOT COMPLETED|Overall Study||7
10549830|NCT01527500|11703880|FG000|STARTED|Part A||99
10789388|NCT03520387|11949812|FG000|COMPLETED|Pre-Randomization||13
10789389|NCT03520387|11949813|FG001|COMPLETED|Pre-Randomization||0
10789390|NCT03520387|11949814|FG002|COMPLETED|Pre-Randomization||0
10440069|NCT00924404|11586426|FG000|STARTED|Overall Study||27
10440070|NCT00924404|11586427|FG001|STARTED|Overall Study||26
10549831|NCT01527500|11703881|FG001|STARTED|Part A||51
10549832|NCT01527500|11703880|FG000|COMPLETED|Part A||69
10549833|NCT01527500|11703881|FG001|COMPLETED|Part A||38
10440071|NCT00924404|11586426|FG000|COMPLETED|Overall Study||21
10440072|NCT00924404|11586427|FG001|COMPLETED|Overall Study||22
10440073|NCT00924404|11586426|FG000|NOT COMPLETED|Overall Study||6
10440074|NCT00924404|11586427|FG001|NOT COMPLETED|Overall Study||4
10440075|NCT00924443|11586433|FG000|STARTED|Overall Study||69
10440076|NCT00924443|11586433|FG000|Full Analysis Set (Received Study Drug)|Overall Study||66
10440077|NCT00924443|11586433|FG000|COMPLETED|Overall Study||66
10440078|NCT00924443|11586433|FG000|NOT COMPLETED|Overall Study||3
10440079|NCT00924469|11586439|FG000|STARTED|Overall Study||30
10440080|NCT00924469|11586440|FG001|STARTED|Overall Study||28
10440081|NCT00924469|11586439|FG000|COMPLETED|Overall Study||28
10549834|NCT01527500|11703880|FG000|NOT COMPLETED|Part A||30
10440082|NCT00924469|11586440|FG001|COMPLETED|Overall Study||26
10440083|NCT00924469|11586439|FG000|NOT COMPLETED|Overall Study||2
10440084|NCT00924469|11586440|FG001|NOT COMPLETED|Overall Study||2
10440085|NCT00924482|11586446|FG000|STARTED|Overall Study||261
10440086|NCT00924482|11586446|FG000|COMPLETED|Overall Study||261
10440087|NCT00924482|11586446|FG000|NOT COMPLETED|Overall Study||0
10440088|NCT00924508|11586451|FG000|STARTED|Overall Study||23
10440089|NCT00924508|11586451|FG000|COMPLETED|Overall Study||20
10440090|NCT00924508|11586451|FG000|NOT COMPLETED|Overall Study||3
10440091|NCT00924560|11586461|FG000|STARTED|Overall Study||458
10440092|NCT00924560|11586462|FG001|STARTED|Overall Study||448
10440093|NCT00924560|11586463|FG002|STARTED|Overall Study||455
10440094|NCT00924560|11586461|FG000|Received Treatment|Overall Study|Excludes 7 participants at 1 site that was closed. One participant received 28-day OC in error.|422
10440095|NCT00924560|11586462|FG001|Received Treatment|Overall Study|Excludes 9 participants from one site that was closed due to audit findings.|411
10440096|NCT00924560|11586463|FG002|Received Treatment|Overall Study||0
10440097|NCT00924560|11586461|FG000|COMPLETED|Overall Study||247
10440098|NCT00924560|11586462|FG001|COMPLETED|Overall Study||240
10440099|NCT00924560|11586463|FG002|COMPLETED|Overall Study||372
10440100|NCT00924560|11586461|FG000|NOT COMPLETED|Overall Study||211
10440101|NCT00924560|11586462|FG001|NOT COMPLETED|Overall Study||208
10440102|NCT00924560|11586463|FG002|NOT COMPLETED|Overall Study||83
10440103|NCT00924612|11586473|FG000|STARTED|Overall Study||4
10440104|NCT00924612|11586474|FG001|STARTED|Overall Study||4
10440105|NCT00924612|11586475|FG002|STARTED|Overall Study||4
10440106|NCT00924612|11586476|FG003|STARTED|Overall Study||4
10440107|NCT00924612|11586473|FG000|COMPLETED|Overall Study||4
10440108|NCT00924612|11586474|FG001|COMPLETED|Overall Study||4
10440109|NCT00924612|11586475|FG002|COMPLETED|Overall Study||4
10440110|NCT00924612|11586476|FG003|COMPLETED|Overall Study||4
10440111|NCT00924612|11586473|FG000|NOT COMPLETED|Overall Study||0
10440112|NCT00924612|11586474|FG001|NOT COMPLETED|Overall Study||0
10440113|NCT00924612|11586475|FG002|NOT COMPLETED|Overall Study||0
10440114|NCT00924612|11586476|FG003|NOT COMPLETED|Overall Study||0
10440115|NCT00924638|11586490|FG000|STARTED|Overall Study|Randomized to Continuous Monitoring Arm|221
10440116|NCT00924638|11586491|FG001|STARTED|Overall Study|Randomized to Control Arm|220
10440117|NCT00924638|11586490|FG000|COMPLETED|Overall Study|Completed 6 months of follow-up|209
10440118|NCT00924638|11586491|FG001|COMPLETED|Overall Study|Completed 6 months of follow-up|207
10440119|NCT00924638|11586490|FG000|NOT COMPLETED|Overall Study||12
10440120|NCT00924638|11586491|FG001|NOT COMPLETED|Overall Study||13
10440121|NCT00924651|11586499|FG000|STARTED|Overall Study||356
10440122|NCT00924651|11586500|FG001|STARTED|Overall Study||337
10440123|NCT00924651|11586499|FG000|COMPLETED|Overall Study||331
10440124|NCT00924651|11586500|FG001|COMPLETED|Overall Study||312
10440125|NCT00924651|11586499|FG000|NOT COMPLETED|Overall Study||25
10440126|NCT00924651|11586500|FG001|NOT COMPLETED|Overall Study||25
10440127|NCT00924664|11586508|FG000|STARTED|Overall Study||322
10440128|NCT00924664|11586509|FG001|STARTED|Overall Study||527
10440129|NCT00924664|11586508|FG000|Treated|Overall Study||321
10440130|NCT00924664|11586509|FG001|Treated|Overall Study||527
10440131|NCT00924664|11586508|FG000|COMPLETED|Overall Study||0
10440132|NCT00924664|11586509|FG001|COMPLETED|Overall Study||0
10440133|NCT00924664|11586508|FG000|NOT COMPLETED|Overall Study||322
10440134|NCT00924664|11586509|FG001|NOT COMPLETED|Overall Study||527
10440135|NCT00924703|11586515|FG000|STARTED|Overall Study||68
10440136|NCT00924703|11586515|FG000|COMPLETED|Overall Study||46
10440137|NCT00924703|11586515|FG000|NOT COMPLETED|Overall Study||22
10440138|NCT00924729|11586521|FG000|STARTED|Overall Study||25
10440139|NCT00924729|11586522|FG001|STARTED|Overall Study||25
10440140|NCT00924729|11586521|FG000|COMPLETED|Overall Study||23
10440141|NCT00924729|11586522|FG001|COMPLETED|Overall Study||25
10440142|NCT00924729|11586521|FG000|NOT COMPLETED|Overall Study||2
10440143|NCT00924729|11586522|FG001|NOT COMPLETED|Overall Study||0
10440144|NCT00924781|11586534|FG000|STARTED|Overall Study||20
10440145|NCT00924781|11586535|FG001|STARTED|Overall Study||19
10440146|NCT00924781|11586534|FG000|COMPLETED|Overall Study||8
10440147|NCT00924781|11586535|FG001|COMPLETED|Overall Study||9
10440148|NCT00924781|11586534|FG000|NOT COMPLETED|Overall Study||12
10440149|NCT00924781|11586535|FG001|NOT COMPLETED|Overall Study||10
10440150|NCT00924820|11586551|FG000|STARTED|Overall Study||20
10440151|NCT00924820|11586551|FG000|COMPLETED|Overall Study||13
10440152|NCT00924820|11586551|FG000|NOT COMPLETED|Overall Study||7
10440153|NCT00924885|11586557|FG000|STARTED|Overall Study||129
10440154|NCT00924885|11586558|FG001|STARTED|Overall Study||128
10440155|NCT00924885|11586557|FG000|COMPLETED|Overall Study||126
10440156|NCT00924885|11586558|FG001|COMPLETED|Overall Study||124
10440157|NCT00924885|11586557|FG000|NOT COMPLETED|Overall Study||3
10440158|NCT00924885|11586558|FG001|NOT COMPLETED|Overall Study||4
10440159|NCT00924898|11586566|FG000|STARTED|Overall Study||92
10440160|NCT00924898|11586566|FG000|COMPLETED|Overall Study||90
10440161|NCT00924898|11586566|FG000|NOT COMPLETED|Overall Study||2
10440162|NCT00924950|11586575|FG000|STARTED|Overall Study||30
10440163|NCT00924950|11586575|FG000|COMPLETED|Overall Study||28
10440164|NCT00924950|11586575|FG000|NOT COMPLETED|Overall Study||2
10440165|NCT00925002|11586585|FG000|STARTED|Overall Study||38
10440166|NCT00925002|11586586|FG001|STARTED|Overall Study||37
10440167|NCT00925002|11586587|FG002|STARTED|Overall Study||18
10440168|NCT00925002|11586585|FG000|Treated|Overall Study||38
10440169|NCT00925002|11586586|FG001|Treated|Overall Study||37
10440170|NCT00925002|11586587|FG002|Treated|Overall Study||18
10440171|NCT00925002|11586585|FG000|COMPLETED|Overall Study||32
10440172|NCT00925002|11586586|FG001|COMPLETED|Overall Study||28
10440173|NCT00925002|11586587|FG002|COMPLETED|Overall Study||8
10440174|NCT00925002|11586585|FG000|NOT COMPLETED|Overall Study||6
10440175|NCT00925002|11586586|FG001|NOT COMPLETED|Overall Study||9
10440176|NCT00925002|11586587|FG002|NOT COMPLETED|Overall Study||10
10440177|NCT00925015|11586599|FG000|STARTED|Overall Study||8
10440178|NCT00925015|11586600|FG001|STARTED|Overall Study||6
10440179|NCT00925015|11586601|FG002|STARTED|Overall Study||6
10440180|NCT00925015|11586599|FG000|COMPLETED|Overall Study||0
10440181|NCT00925015|11586600|FG001|COMPLETED|Overall Study||0
10440182|NCT00925015|11586601|FG002|COMPLETED|Overall Study||0
10440183|NCT00925015|11586599|FG000|NOT COMPLETED|Overall Study||8
10440184|NCT00925015|11586600|FG001|NOT COMPLETED|Overall Study||6
10440185|NCT00925015|11586601|FG002|NOT COMPLETED|Overall Study||6
10440186|NCT00925054|11586618|FG000|STARTED|Overall Study||7
10440187|NCT00925054|11586619|FG001|STARTED|Overall Study||9
10440188|NCT00925054|11586620|FG002|STARTED|Overall Study||13
10440189|NCT00925054|11586621|FG003|STARTED|Overall Study||1
10440190|NCT00925054|11586622|FG004|STARTED|Overall Study||10
10440191|NCT00925054|11586618|FG000|COMPLETED|Overall Study||7
10440192|NCT00925054|11586619|FG001|COMPLETED|Overall Study||8
10440193|NCT00925054|11586620|FG002|COMPLETED|Overall Study||12
10440194|NCT00925054|11586621|FG003|COMPLETED|Overall Study||0
10440195|NCT00925054|11586622|FG004|COMPLETED|Overall Study||10
10440196|NCT00925054|11586618|FG000|NOT COMPLETED|Overall Study||0
10440197|NCT00925054|11586619|FG001|NOT COMPLETED|Overall Study||1
10440198|NCT00925054|11586620|FG002|NOT COMPLETED|Overall Study||1
10440199|NCT00925054|11586621|FG003|NOT COMPLETED|Overall Study||1
10440200|NCT00925054|11586622|FG004|NOT COMPLETED|Overall Study||0
10440201|NCT00925119|11586635|FG000|STARTED|Overall Study||31
10440202|NCT00925119|11586635|FG000|COMPLETED|Overall Study||19
10440203|NCT00925119|11586635|FG000|NOT COMPLETED|Overall Study||12
10440204|NCT00925132|11586639|FG000|STARTED|Overall Study||5
10440205|NCT00925132|11586640|FG001|STARTED|Overall Study||4
10440206|NCT00925132|11586641|FG002|STARTED|Overall Study||4
10440207|NCT00925132|11586642|FG003|STARTED|Overall Study||4
10440208|NCT00925132|11586643|FG004|STARTED|Overall Study||22
10440209|NCT00925132|11586639|FG000|COMPLETED|Overall Study||3
10440210|NCT00925132|11586640|FG001|COMPLETED|Overall Study||4
10440211|NCT00925132|11586641|FG002|COMPLETED|Overall Study||4
10440212|NCT00925132|11586642|FG003|COMPLETED|Overall Study||4
10440213|NCT00925132|11586643|FG004|COMPLETED|Overall Study||17
10440214|NCT00925132|11586639|FG000|NOT COMPLETED|Overall Study||2
10440215|NCT00925132|11586640|FG001|NOT COMPLETED|Overall Study||0
10440216|NCT00925132|11586641|FG002|NOT COMPLETED|Overall Study||0
10440217|NCT00925132|11586642|FG003|NOT COMPLETED|Overall Study||0
10440218|NCT00925132|11586643|FG004|NOT COMPLETED|Overall Study||5
10440219|NCT00925288|11586651|FG000|STARTED|Overall Study||100
10440220|NCT00925288|11586652|FG001|STARTED|Overall Study||100
10440221|NCT00925288|11586651|FG000|COMPLETED|Overall Study||91
10440222|NCT00925288|11586652|FG001|COMPLETED|Overall Study||93
10440223|NCT00925288|11586651|FG000|NOT COMPLETED|Overall Study||9
10440224|NCT00925288|11586652|FG001|NOT COMPLETED|Overall Study||7
10440225|NCT00925301|11586662|FG000|STARTED|6-Month Double-blind (Stage 1)||34
10440226|NCT00925301|11586663|FG001|STARTED|6-Month Double-blind (Stage 1)||33
10440227|NCT00925301|11586664|FG002|STARTED|6-Month Double-blind (Stage 1)|Zero participants noted because participants did not start Stage 2 yet.|0
10440228|NCT00925301|11586665|FG003|STARTED|6-Month Double-blind (Stage 1)|Zero participants noted because participants did not start the OLE yet.|0
10440229|NCT00925301|11586662|FG000|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||34
10440230|NCT00925301|11586663|FG001|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||33
10440231|NCT00925301|11586664|FG002|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||0
10440232|NCT00925301|11586665|FG003|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||0
10440233|NCT00925301|11586662|FG000|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||34
10440234|NCT00925301|11586663|FG001|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||33
10440235|NCT00925301|11586664|FG002|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||0
10440236|NCT00925301|11586665|FG003|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||0
10440237|NCT00925301|11586662|FG000|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||30
10440238|NCT00925301|11586663|FG001|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||30
10440239|NCT00925301|11586664|FG002|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||0
10440240|NCT00925301|11586665|FG003|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||0
10440241|NCT00925301|11586662|FG000|COMPLETED|6-Month Double-blind (Stage 1)||34
10440242|NCT00925301|11586663|FG001|COMPLETED|6-Month Double-blind (Stage 1)||30
10440243|NCT00925301|11586664|FG002|COMPLETED|6-Month Double-blind (Stage 1)||0
10440244|NCT00925301|11586665|FG003|COMPLETED|6-Month Double-blind (Stage 1)||0
10440245|NCT00925301|11586662|FG000|NOT COMPLETED|6-Month Double-blind (Stage 1)||0
10440246|NCT00925301|11586663|FG001|NOT COMPLETED|6-Month Double-blind (Stage 1)||3
10440247|NCT00925301|11586664|FG002|NOT COMPLETED|6-Month Double-blind (Stage 1)||0
10440248|NCT00925301|11586665|FG003|NOT COMPLETED|6-Month Double-blind (Stage 1)||0
10440249|NCT00925301|11586662|FG000|STARTED|6-Month Open-label (Stage 2)|Zero participants noted because participants had completed Stage 1.|0
10440250|NCT00925301|11586663|FG001|STARTED|6-Month Open-label (Stage 2)|Zero participants noted because participants had completed Stage 1.|0
10440251|NCT00925301|11586664|FG002|STARTED|6-Month Open-label (Stage 2)|One participant (Migalastat [0-6 Months]) withdrew consent after completing Month 6.|63
10525387|NCT01375751|11677312|FG001|Received Treatment|Overall Study||55
10440252|NCT00925301|11586665|FG003|STARTED|6-Month Open-label (Stage 2)|Zero participants noted because participants did not start the OLE yet.|0
10440253|NCT00925301|11586662|FG000|ITT-amenable|6-Month Open-label (Stage 2)||0
10440254|NCT00925301|11586663|FG001|ITT-amenable|6-Month Open-label (Stage 2)||0
10440255|NCT00925301|11586664|FG002|ITT-amenable|6-Month Open-label (Stage 2)||47
10440256|NCT00925301|11586665|FG003|ITT-amenable|6-Month Open-label (Stage 2)||0
10440257|NCT00925301|11586662|FG000|COMPLETED|6-Month Open-label (Stage 2)||0
10440258|NCT00925301|11586663|FG001|COMPLETED|6-Month Open-label (Stage 2)||0
10440259|NCT00925301|11586664|FG002|COMPLETED|6-Month Open-label (Stage 2)||60
10440260|NCT00925301|11586665|FG003|COMPLETED|6-Month Open-label (Stage 2)||0
10440261|NCT00925301|11586662|FG000|NOT COMPLETED|6-Month Open-label (Stage 2)||0
10440262|NCT00925301|11586663|FG001|NOT COMPLETED|6-Month Open-label (Stage 2)||0
10440263|NCT00925301|11586664|FG002|NOT COMPLETED|6-Month Open-label (Stage 2)||3
10440264|NCT00925301|11586665|FG003|NOT COMPLETED|6-Month Open-label (Stage 2)||0
10440265|NCT00925301|11586662|FG000|STARTED|12-Month Open-label Extension (Optional)|Zero participants noted because participants had completed Stage 1.|0
10440266|NCT00925301|11586663|FG001|STARTED|12-Month Open-label Extension (Optional)|Zero participants noted because participants had completed Stage 1.|0
10440267|NCT00925301|11586664|FG002|STARTED|12-Month Open-label Extension (Optional)|Zero participants noted because participants had completed Stage 2.|0
10440268|NCT00925301|11586665|FG003|STARTED|12-Month Open-label Extension (Optional)|The OLE was optional for those who completed Stage 2. Reasons for not entering were not recorded.|57
10440269|NCT00925301|11586662|FG000|ITT-amenable|12-Month Open-label Extension (Optional)||0
10440270|NCT00925301|11586663|FG001|ITT-amenable|12-Month Open-label Extension (Optional)||0
10440271|NCT00925301|11586664|FG002|ITT-amenable|12-Month Open-label Extension (Optional)||0
10440272|NCT00925301|11586665|FG003|ITT-amenable|12-Month Open-label Extension (Optional)||42
10440273|NCT00925301|11586662|FG000|COMPLETED|12-Month Open-label Extension (Optional)||0
10440274|NCT00925301|11586663|FG001|COMPLETED|12-Month Open-label Extension (Optional)||0
10440275|NCT00925301|11586664|FG002|COMPLETED|12-Month Open-label Extension (Optional)||0
10440276|NCT00925301|11586665|FG003|COMPLETED|12-Month Open-label Extension (Optional)||54
10440277|NCT00925301|11586662|FG000|NOT COMPLETED|12-Month Open-label Extension (Optional)||0
10440278|NCT00925301|11586663|FG001|NOT COMPLETED|12-Month Open-label Extension (Optional)||0
10440279|NCT00925301|11586664|FG002|NOT COMPLETED|12-Month Open-label Extension (Optional)||0
10440280|NCT00925301|11586665|FG003|NOT COMPLETED|12-Month Open-label Extension (Optional)||3
10440281|NCT00925353|11586676|FG000|STARTED|Overall Study||13
10440282|NCT00925353|11586676|FG000|COMPLETED|Overall Study||10
10440283|NCT00925353|11586676|FG000|NOT COMPLETED|Overall Study||3
10440284|NCT00925522|11586680|FG000|STARTED|Overall Study||20
10440285|NCT00925522|11586680|FG000|COMPLETED|Overall Study||0
10440286|NCT00925522|11586680|FG000|NOT COMPLETED|Overall Study||20
10440287|NCT00925587|11586686|FG000|STARTED|Overall Study||178
10440288|NCT00925587|11586687|FG001|STARTED|Overall Study||180
10440289|NCT00925587|11586686|FG000|COMPLETED|Overall Study||142
10440290|NCT00925587|11586687|FG001|COMPLETED|Overall Study||155
10549835|NCT01527500|11703881|FG001|NOT COMPLETED|Part A||13
10549836|NCT01527500|11703880|FG000|STARTED|Part B||7
10440291|NCT00925587|11586686|FG000|NOT COMPLETED|Overall Study||36
10440292|NCT00925587|11586687|FG001|NOT COMPLETED|Overall Study||25
10440293|NCT00925600|11586695|FG000|STARTED|Overall Study||386
10440294|NCT00925600|11586696|FG001|STARTED|Overall Study||383
10440295|NCT00925600|11586695|FG000|Received Treatment|Overall Study|Three participants received at least 1 dose of denosumab in error|383
10440296|NCT00925600|11586696|FG001|Received Treatment|Overall Study||382
10440297|NCT00925600|11586695|FG000|COMPLETED|Overall Study||354
10440298|NCT00925600|11586696|FG001|COMPLETED|Overall Study||355
10440299|NCT00925600|11586695|FG000|NOT COMPLETED|Overall Study||32
10440300|NCT00925600|11586696|FG001|NOT COMPLETED|Overall Study||28
10440301|NCT00925704|11586712|FG000|STARTED|First Intervention||6
10440302|NCT00925704|11586713|FG001|STARTED|First Intervention||7
10440303|NCT00925704|11586714|FG002|STARTED|First Intervention||7
10440304|NCT00925704|11586715|FG003|STARTED|First Intervention||7
10440305|NCT00925704|11586716|FG004|STARTED|First Intervention||7
10440306|NCT00925704|11586717|FG005|STARTED|First Intervention||7
10440307|NCT00925704|11586712|FG000|COMPLETED|First Intervention||6
10440308|NCT00925704|11586713|FG001|COMPLETED|First Intervention||7
10440309|NCT00925704|11586714|FG002|COMPLETED|First Intervention||7
10440310|NCT00925704|11586715|FG003|COMPLETED|First Intervention||6
10440311|NCT00925704|11586716|FG004|COMPLETED|First Intervention||6
10440312|NCT00925704|11586717|FG005|COMPLETED|First Intervention||7
10440313|NCT00925704|11586712|FG000|NOT COMPLETED|First Intervention||0
10440314|NCT00925704|11586713|FG001|NOT COMPLETED|First Intervention||0
10440315|NCT00925704|11586714|FG002|NOT COMPLETED|First Intervention||0
10440316|NCT00925704|11586715|FG003|NOT COMPLETED|First Intervention||1
10440317|NCT00925704|11586716|FG004|NOT COMPLETED|First Intervention||1
10440318|NCT00925704|11586717|FG005|NOT COMPLETED|First Intervention||0
10440319|NCT00925704|11586712|FG000|STARTED|Washout||6
10440320|NCT00925704|11586713|FG001|STARTED|Washout||7
10440321|NCT00925704|11586714|FG002|STARTED|Washout||7
10440322|NCT00925704|11586715|FG003|STARTED|Washout||6
10440323|NCT00925704|11586716|FG004|STARTED|Washout||6
10440324|NCT00925704|11586717|FG005|STARTED|Washout||7
10440325|NCT00925704|11586712|FG000|COMPLETED|Washout||6
10440326|NCT00925704|11586713|FG001|COMPLETED|Washout||7
10440327|NCT00925704|11586714|FG002|COMPLETED|Washout||7
10549837|NCT01527500|11703881|FG001|STARTED|Part B||1
10549838|NCT01527500|11703880|FG000|COMPLETED|Part B||6
10549839|NCT01527500|11703881|FG001|COMPLETED|Part B||1
10440328|NCT00925704|11586715|FG003|COMPLETED|Washout||6
10440329|NCT00925704|11586716|FG004|COMPLETED|Washout||6
10440330|NCT00925704|11586717|FG005|COMPLETED|Washout||7
10440331|NCT00925704|11586712|FG000|NOT COMPLETED|Washout||0
10440332|NCT00925704|11586713|FG001|NOT COMPLETED|Washout||0
10440333|NCT00925704|11586714|FG002|NOT COMPLETED|Washout||0
10440334|NCT00925704|11586715|FG003|NOT COMPLETED|Washout||0
10440335|NCT00925704|11586716|FG004|NOT COMPLETED|Washout||0
10440336|NCT00925704|11586717|FG005|NOT COMPLETED|Washout||0
10440337|NCT00925704|11586712|FG000|STARTED|Second Intervention||6
10440338|NCT00925704|11586713|FG001|STARTED|Second Intervention||7
10440339|NCT00925704|11586714|FG002|STARTED|Second Intervention||7
10440340|NCT00925704|11586715|FG003|STARTED|Second Intervention||6
10440341|NCT00925704|11586716|FG004|STARTED|Second Intervention||6
10440342|NCT00925704|11586717|FG005|STARTED|Second Intervention||7
10440343|NCT00925704|11586712|FG000|COMPLETED|Second Intervention||5
10440344|NCT00925704|11586713|FG001|COMPLETED|Second Intervention||7
10440345|NCT00925704|11586714|FG002|COMPLETED|Second Intervention||7
10440346|NCT00925704|11586715|FG003|COMPLETED|Second Intervention||6
10440347|NCT00925704|11586716|FG004|COMPLETED|Second Intervention||5
10440348|NCT00925704|11586717|FG005|COMPLETED|Second Intervention||7
10440349|NCT00925704|11586712|FG000|NOT COMPLETED|Second Intervention||1
10440350|NCT00925704|11586713|FG001|NOT COMPLETED|Second Intervention||0
10440351|NCT00925704|11586714|FG002|NOT COMPLETED|Second Intervention||0
10440352|NCT00925704|11586715|FG003|NOT COMPLETED|Second Intervention||0
10440353|NCT00925704|11586716|FG004|NOT COMPLETED|Second Intervention||1
10440354|NCT00925704|11586717|FG005|NOT COMPLETED|Second Intervention||0
10440355|NCT00925704|11586712|FG000|STARTED|Washout||5
10440356|NCT00925704|11586713|FG001|STARTED|Washout||7
10440357|NCT00925704|11586714|FG002|STARTED|Washout||7
10440358|NCT00925704|11586715|FG003|STARTED|Washout||6
10440359|NCT00925704|11586716|FG004|STARTED|Washout||5
10440360|NCT00925704|11586717|FG005|STARTED|Washout||7
10440361|NCT00925704|11586712|FG000|COMPLETED|Washout||5
10440362|NCT00925704|11586713|FG001|COMPLETED|Washout||7
10440363|NCT00925704|11586714|FG002|COMPLETED|Washout||7
10440364|NCT00925704|11586715|FG003|COMPLETED|Washout||6
10440365|NCT00925704|11586716|FG004|COMPLETED|Washout||5
10440366|NCT00925704|11586717|FG005|COMPLETED|Washout||7
10440367|NCT00925704|11586712|FG000|NOT COMPLETED|Washout||0
10440368|NCT00925704|11586713|FG001|NOT COMPLETED|Washout||0
10440369|NCT00925704|11586714|FG002|NOT COMPLETED|Washout||0
10440370|NCT00925704|11586715|FG003|NOT COMPLETED|Washout||0
10440371|NCT00925704|11586716|FG004|NOT COMPLETED|Washout||0
10440372|NCT00925704|11586717|FG005|NOT COMPLETED|Washout||0
10440373|NCT00925704|11586712|FG000|STARTED|Third Intervention||5
10440374|NCT00925704|11586713|FG001|STARTED|Third Intervention||7
10440375|NCT00925704|11586714|FG002|STARTED|Third Intervention||7
10440376|NCT00925704|11586715|FG003|STARTED|Third Intervention||6
10440377|NCT00925704|11586716|FG004|STARTED|Third Intervention||5
10440378|NCT00925704|11586717|FG005|STARTED|Third Intervention||7
10440379|NCT00925704|11586712|FG000|COMPLETED|Third Intervention||5
10440380|NCT00925704|11586713|FG001|COMPLETED|Third Intervention||7
10440381|NCT00925704|11586714|FG002|COMPLETED|Third Intervention||7
10440382|NCT00925704|11586715|FG003|COMPLETED|Third Intervention||6
10440383|NCT00925704|11586716|FG004|COMPLETED|Third Intervention||5
10440384|NCT00925704|11586717|FG005|COMPLETED|Third Intervention||6
10440385|NCT00925704|11586712|FG000|NOT COMPLETED|Third Intervention||0
10440386|NCT00925704|11586713|FG001|NOT COMPLETED|Third Intervention||0
10440387|NCT00925704|11586714|FG002|NOT COMPLETED|Third Intervention||0
10440388|NCT00925704|11586715|FG003|NOT COMPLETED|Third Intervention||0
10440389|NCT00925704|11586716|FG004|NOT COMPLETED|Third Intervention||0
10440390|NCT00925704|11586717|FG005|NOT COMPLETED|Third Intervention||1
10440391|NCT00925756|11586728|FG000|STARTED|Overall Study||32
10440392|NCT00925756|11586728|FG000|COMPLETED|Overall Study||32
10440393|NCT00925756|11586728|FG000|NOT COMPLETED|Overall Study||0
10440394|NCT00925769|11586732|FG000|STARTED|Overall Study||6
10440395|NCT00925769|11586733|FG001|STARTED|Overall Study||6
10440396|NCT00925769|11586734|FG002|STARTED|Overall Study||6
10440397|NCT00925769|11586735|FG003|STARTED|Overall Study||6
10440398|NCT00925769|11586736|FG004|STARTED|Overall Study||3
10440399|NCT00925769|11586737|FG005|STARTED|Overall Study||3
10440400|NCT00925769|11586732|FG000|COMPLETED|Overall Study||0
10440401|NCT00925769|11586733|FG001|COMPLETED|Overall Study||0
10440402|NCT00925769|11586734|FG002|COMPLETED|Overall Study||0
10440403|NCT00925769|11586735|FG003|COMPLETED|Overall Study||0
10440404|NCT00925769|11586736|FG004|COMPLETED|Overall Study||0
10440405|NCT00925769|11586737|FG005|COMPLETED|Overall Study||0
10440406|NCT00925769|11586732|FG000|NOT COMPLETED|Overall Study||6
10440407|NCT00925769|11586733|FG001|NOT COMPLETED|Overall Study||6
10440408|NCT00925769|11586734|FG002|NOT COMPLETED|Overall Study||6
10440409|NCT00925769|11586735|FG003|NOT COMPLETED|Overall Study||6
10440410|NCT00925769|11586736|FG004|NOT COMPLETED|Overall Study||3
10440411|NCT00925769|11586737|FG005|NOT COMPLETED|Overall Study||3
10440412|NCT00925782|11586753|FG000|STARTED|Pretreatment (Day -30 to Day -3)||12
10440413|NCT00925782|11586754|FG001|STARTED|Pretreatment (Day -30 to Day -3)||12
10440414|NCT00925782|11586753|FG000|COMPLETED|Pretreatment (Day -30 to Day -3)||12
10440415|NCT00925782|11586754|FG001|COMPLETED|Pretreatment (Day -30 to Day -3)||12
10440416|NCT00925782|11586753|FG000|NOT COMPLETED|Pretreatment (Day -30 to Day -3)||0
10440417|NCT00925782|11586754|FG001|NOT COMPLETED|Pretreatment (Day -30 to Day -3)||0
10440418|NCT00925782|11586753|FG000|STARTED|Study Period (Day -3 to Day 0)||12
10440419|NCT00925782|11586754|FG001|STARTED|Study Period (Day -3 to Day 0)||12
10440420|NCT00925782|11586753|FG000|COMPLETED|Study Period (Day -3 to Day 0)||12
10440421|NCT00925782|11586754|FG001|COMPLETED|Study Period (Day -3 to Day 0)||12
10440422|NCT00925782|11586753|FG000|NOT COMPLETED|Study Period (Day -3 to Day 0)||0
10440423|NCT00925782|11586754|FG001|NOT COMPLETED|Study Period (Day -3 to Day 0)||0
10440424|NCT00925782|11586753|FG000|STARTED|Follow-up(Day +1 to Date of Engraftment)||12
10440425|NCT00925782|11586754|FG001|STARTED|Follow-up(Day +1 to Date of Engraftment)||12
10440426|NCT00925782|11586753|FG000|COMPLETED|Follow-up(Day +1 to Date of Engraftment)||12
10440427|NCT00925782|11586754|FG001|COMPLETED|Follow-up(Day +1 to Date of Engraftment)||12
10440428|NCT00925782|11586753|FG000|NOT COMPLETED|Follow-up(Day +1 to Date of Engraftment)||0
10440429|NCT00925782|11586754|FG001|NOT COMPLETED|Follow-up(Day +1 to Date of Engraftment)||0
10440430|NCT00925899|11586763|FG000|STARTED|Part 1||34
10440431|NCT00925899|11586764|FG001|STARTED|Part 1||38
10440432|NCT00925899|11586763|FG000|COMPLETED|Part 1||23
10440433|NCT00925899|11586764|FG001|COMPLETED|Part 1||27
10440434|NCT00925899|11586763|FG000|NOT COMPLETED|Part 1||11
10440435|NCT00925899|11586764|FG001|NOT COMPLETED|Part 1||11
10440436|NCT00925899|11586763|FG000|STARTED|Part 2|All patients received the same intervention in the second part of the study (20 mg melatonin)|15
10440437|NCT00925899|11586764|FG001|STARTED|Part 2|Nine patients withdrew because they did not wish to continue in the study|21
10440438|NCT00925899|11586763|FG000|COMPLETED|Part 2||9
10440439|NCT00925899|11586764|FG001|COMPLETED|Part 2||9
10440440|NCT00925899|11586763|FG000|NOT COMPLETED|Part 2||6
10440441|NCT00925899|11586764|FG001|NOT COMPLETED|Part 2||12
10440442|NCT00925938|11586774|FG000|STARTED|Overall Study||9
10440443|NCT00925938|11586775|FG001|STARTED|Overall Study||25
10440444|NCT00925938|11586776|FG002|STARTED|Overall Study||17
10440445|NCT00925938|11586774|FG000|COMPLETED|Overall Study||9
10440446|NCT00925938|11586775|FG001|COMPLETED|Overall Study||25
10440447|NCT00925938|11586776|FG002|COMPLETED|Overall Study||17
10440448|NCT00925938|11586774|FG000|NOT COMPLETED|Overall Study||0
10440449|NCT00925938|11586775|FG001|NOT COMPLETED|Overall Study||0
10440450|NCT00925938|11586776|FG002|NOT COMPLETED|Overall Study||0
10525388|NCT01375751|11677313|FG002|Received Treatment|Overall Study||56
10525389|NCT01375751|11677311|FG000|COMPLETED|Overall Study||56
10525390|NCT01375751|11677312|FG001|COMPLETED|Overall Study||55
10525391|NCT01375751|11677313|FG002|COMPLETED|Overall Study||56
10525392|NCT01375751|11677311|FG000|NOT COMPLETED|Overall Study||0
10525393|NCT01375751|11677312|FG001|NOT COMPLETED|Overall Study||1
10525394|NCT01375751|11677313|FG002|NOT COMPLETED|Overall Study||0
10525395|NCT01375764|11677326|FG000|STARTED|Overall Study||33
10525396|NCT01375764|11677327|FG001|STARTED|Overall Study||31
10525397|NCT01375764|11677328|FG002|STARTED|Overall Study||32
10525398|NCT01375764|11677329|FG003|STARTED|Overall Study||32
10525399|NCT01375764|11677330|FG004|STARTED|Overall Study||32
10525400|NCT01375764|11677326|FG000|Received Treatment|Overall Study||32
10525401|NCT01375764|11677327|FG001|Received Treatment|Overall Study||30
10525402|NCT01375764|11677328|FG002|Received Treatment|Overall Study||32
10525403|NCT01375764|11677329|FG003|Received Treatment|Overall Study||31
10525404|NCT01375764|11677330|FG004|Received Treatment|Overall Study||32
10525405|NCT01375764|11677326|FG000|COMPLETED|Overall Study||31
10525406|NCT01375764|11677327|FG001|COMPLETED|Overall Study||30
10525407|NCT01375764|11677328|FG002|COMPLETED|Overall Study||32
10525408|NCT01375764|11677329|FG003|COMPLETED|Overall Study||31
10525409|NCT01375764|11677330|FG004|COMPLETED|Overall Study||31
10525410|NCT01375764|11677326|FG000|NOT COMPLETED|Overall Study||2
10525411|NCT01375764|11677327|FG001|NOT COMPLETED|Overall Study||1
10525412|NCT01375764|11677328|FG002|NOT COMPLETED|Overall Study||0
10525413|NCT01375764|11677329|FG003|NOT COMPLETED|Overall Study||1
10525414|NCT01375764|11677330|FG004|NOT COMPLETED|Overall Study||1
10525415|NCT01375777|11677351|FG000|STARTED|Overall Study||46
10525416|NCT01375777|11677352|FG001|STARTED|Overall Study||45
10525417|NCT01375777|11677353|FG002|STARTED|Overall Study||46
10525418|NCT01375777|11677354|FG003|STARTED|Overall Study||45
10525419|NCT01375777|11677355|FG004|STARTED|Overall Study||46
10525420|NCT01375777|11677356|FG005|STARTED|Overall Study||45
10525421|NCT01375777|11677357|FG006|STARTED|Overall Study||46
10525422|NCT01375777|11677358|FG007|STARTED|Overall Study||46
10525423|NCT01375777|11677359|FG008|STARTED|Overall Study||46
10525424|NCT01375777|11677351|FG000|Received Treatment|Overall Study||45
10525425|NCT01375777|11677352|FG001|Received Treatment|Overall Study||45
10525426|NCT01375777|11677353|FG002|Received Treatment|Overall Study||45
10525427|NCT01375777|11677354|FG003|Received Treatment|Overall Study||45
10525428|NCT01375777|11677355|FG004|Received Treatment|Overall Study||46
10525429|NCT01375777|11677356|FG005|Received Treatment|Overall Study||45
10525430|NCT01375777|11677357|FG006|Received Treatment|Overall Study||45
10525431|NCT01375777|11677358|FG007|Received Treatment|Overall Study||45
10525432|NCT01375777|11677359|FG008|Received Treatment|Overall Study||45
10525433|NCT01375777|11677351|FG000|COMPLETED|Overall Study||44
10525434|NCT01375777|11677352|FG001|COMPLETED|Overall Study||42
10525435|NCT01375777|11677353|FG002|COMPLETED|Overall Study||45
10525436|NCT01375777|11677354|FG003|COMPLETED|Overall Study||45
10525437|NCT01375777|11677355|FG004|COMPLETED|Overall Study||45
10525438|NCT01375777|11677356|FG005|COMPLETED|Overall Study||44
10525439|NCT01375777|11677357|FG006|COMPLETED|Overall Study||44
10525440|NCT01375777|11677358|FG007|COMPLETED|Overall Study||44
10525441|NCT01375777|11677359|FG008|COMPLETED|Overall Study||44
10525442|NCT01375777|11677351|FG000|NOT COMPLETED|Overall Study||2
10525443|NCT01375777|11677352|FG001|NOT COMPLETED|Overall Study||3
10525444|NCT01375777|11677353|FG002|NOT COMPLETED|Overall Study||1
10525445|NCT01375777|11677354|FG003|NOT COMPLETED|Overall Study||0
10440451|NCT00925990|11586786|FG000|STARTED|Overall Study||35
10440452|NCT00925990|11586787|FG001|STARTED|Overall Study||35
10440453|NCT00925990|11586786|FG000|COMPLETED|Overall Study||30
10440454|NCT00925990|11586787|FG001|COMPLETED|Overall Study||24
10440455|NCT00925990|11586786|FG000|NOT COMPLETED|Overall Study||5
10440456|NCT00925990|11586787|FG001|NOT COMPLETED|Overall Study||11
10440457|NCT00926003|11586796|FG000|STARTED|Baseline||53
10440458|NCT00926003|11586797|FG001|STARTED|Baseline||54
10440459|NCT00926003|11586798|FG002|STARTED|Baseline||52
10440460|NCT00926003|11586796|FG000|COMPLETED|Baseline||53
10440461|NCT00926003|11586797|FG001|COMPLETED|Baseline||54
10440462|NCT00926003|11586798|FG002|COMPLETED|Baseline||52
10440463|NCT00926003|11586796|FG000|NOT COMPLETED|Baseline||0
10440464|NCT00926003|11586797|FG001|NOT COMPLETED|Baseline||0
10440465|NCT00926003|11586798|FG002|NOT COMPLETED|Baseline||0
10440466|NCT00926003|11586796|FG000|STARTED|Post-Training Evaluation||53
10440467|NCT00926003|11586797|FG001|STARTED|Post-Training Evaluation||54
10440468|NCT00926003|11586798|FG002|STARTED|Post-Training Evaluation||52
10440469|NCT00926003|11586796|FG000|COMPLETED|Post-Training Evaluation||52
10440470|NCT00926003|11586797|FG001|COMPLETED|Post-Training Evaluation||54
10440471|NCT00926003|11586798|FG002|COMPLETED|Post-Training Evaluation||52
10440472|NCT00926003|11586796|FG000|NOT COMPLETED|Post-Training Evaluation||1
10440473|NCT00926003|11586797|FG001|NOT COMPLETED|Post-Training Evaluation||0
10440474|NCT00926003|11586798|FG002|NOT COMPLETED|Post-Training Evaluation||0
10440475|NCT00926003|11586796|FG000|STARTED|Post-Training 3-month Follow-up||52
10440476|NCT00926003|11586797|FG001|STARTED|Post-Training 3-month Follow-up||54
10440477|NCT00926003|11586798|FG002|STARTED|Post-Training 3-month Follow-up||52
10440478|NCT00926003|11586796|FG000|COMPLETED|Post-Training 3-month Follow-up||51
10440479|NCT00926003|11586797|FG001|COMPLETED|Post-Training 3-month Follow-up||54
10440480|NCT00926003|11586798|FG002|COMPLETED|Post-Training 3-month Follow-up||52
10440481|NCT00926003|11586796|FG000|NOT COMPLETED|Post-Training 3-month Follow-up||1
10440482|NCT00926003|11586797|FG001|NOT COMPLETED|Post-Training 3-month Follow-up||0
10440483|NCT00926003|11586798|FG002|NOT COMPLETED|Post-Training 3-month Follow-up||0
10440484|NCT00926029|11586809|FG000|STARTED|Overall Study||34
10440485|NCT00926029|11586810|FG001|STARTED|Overall Study||34
10440486|NCT00926029|11586811|FG002|STARTED|Overall Study||34
10440487|NCT00926029|11586809|FG000|COMPLETED|Overall Study||32
10440488|NCT00926029|11586810|FG001|COMPLETED|Overall Study||33
10440489|NCT00926029|11586811|FG002|COMPLETED|Overall Study||33
10440490|NCT00926029|11586809|FG000|NOT COMPLETED|Overall Study||2
10440491|NCT00926029|11586810|FG001|NOT COMPLETED|Overall Study||1
10440492|NCT00926029|11586811|FG002|NOT COMPLETED|Overall Study||1
10440493|NCT00926185|11586825|FG000|STARTED|Overall Study||57
10440494|NCT00926185|11586826|FG001|STARTED|Overall Study||57
10440495|NCT00926185|11586827|FG002|STARTED|Overall Study||58
10440496|NCT00926185|11586828|FG003|STARTED|Overall Study||58
10440497|NCT00926185|11586825|FG000|COMPLETED|Overall Study||54
10440498|NCT00926185|11586826|FG001|COMPLETED|Overall Study||51
10440499|NCT00926185|11586827|FG002|COMPLETED|Overall Study||48
10440500|NCT00926185|11586828|FG003|COMPLETED|Overall Study||48
10440501|NCT00926185|11586825|FG000|NOT COMPLETED|Overall Study||3
10440502|NCT00926185|11586826|FG001|NOT COMPLETED|Overall Study||6
10440503|NCT00926185|11586827|FG002|NOT COMPLETED|Overall Study||10
10440504|NCT00926185|11586828|FG003|NOT COMPLETED|Overall Study||10
10440505|NCT00926211|11586838|FG000|STARTED|Overall Study|One additional subject was not randomized and did not receive the treatment procedure.|36
10440506|NCT00926211|11586838|FG000|COMPLETED|Overall Study||35
10440507|NCT00926211|11586838|FG000|NOT COMPLETED|Overall Study||1
10440508|NCT00926237|11586843|FG000|STARTED|Overall Study|Two subjects withdrew after receiving sham rTMS but before receiving active rTMS.|19
10440509|NCT00926237|11586844|FG001|STARTED|Overall Study|One subjects withdrew after receiving sham rTMS but before receiving active rTMS.|20
10440510|NCT00926237|11586843|FG000|COMPLETED|Overall Study||17
10440511|NCT00926237|11586844|FG001|COMPLETED|Overall Study||19
10440512|NCT00926237|11586843|FG000|NOT COMPLETED|Overall Study||2
10440513|NCT00926237|11586844|FG001|NOT COMPLETED|Overall Study||1
10440514|NCT00926263|11586856|FG000|STARTED|Overall Study||16
10440515|NCT00926263|11586857|FG001|STARTED|Overall Study||12
10440516|NCT00926263|11586856|FG000|COMPLETED|Overall Study||16
10440517|NCT00926263|11586857|FG001|COMPLETED|Overall Study||12
10440518|NCT00926263|11586856|FG000|NOT COMPLETED|Overall Study||0
10440519|NCT00926263|11586857|FG001|NOT COMPLETED|Overall Study||0
10440520|NCT00926289|11586866|FG000|STARTED|Overall Study|Number of treated patients|294
10440521|NCT00926289|11586867|FG001|STARTED|Overall Study|Number of treated patients|594
10440522|NCT00926289|11586866|FG000|COMPLETED|Overall Study||269
10440523|NCT00926289|11586867|FG001|COMPLETED|Overall Study||558
10440524|NCT00926289|11586866|FG000|NOT COMPLETED|Overall Study||25
10440525|NCT00926289|11586867|FG001|NOT COMPLETED|Overall Study||36
10440526|NCT00926328|11586875|FG000|STARTED|Overall Study||60
10440527|NCT00926328|11586876|FG001|STARTED|Overall Study||60
10440528|NCT00926328|11586875|FG000|COMPLETED|Overall Study||48
10440529|NCT00926328|11586876|FG001|COMPLETED|Overall Study||46
10440530|NCT00926328|11586875|FG000|NOT COMPLETED|Overall Study||12
10440531|NCT00926328|11586876|FG001|NOT COMPLETED|Overall Study||14
10440532|NCT00926367|11586884|FG000|STARTED|Overall Study||25
10440533|NCT00926367|11586885|FG001|STARTED|Overall Study||27
10440534|NCT00926367|11586884|FG000|COMPLETED|Overall Study||23
10440535|NCT00926367|11586885|FG001|COMPLETED|Overall Study||24
10440536|NCT00926367|11586884|FG000|NOT COMPLETED|Overall Study||2
10440537|NCT00926367|11586885|FG001|NOT COMPLETED|Overall Study||3
10440538|NCT00926380|11586896|FG000|STARTED|Year 1||33
10440539|NCT00926380|11586897|FG001|STARTED|Year 1||31
10440540|NCT00926380|11586898|FG002|STARTED|Year 1||30
10440541|NCT00926380|11586896|FG000|COMPLETED|Year 1||33
10440542|NCT00926380|11586897|FG001|COMPLETED|Year 1||30
10440543|NCT00926380|11586898|FG002|COMPLETED|Year 1||29
10440544|NCT00926380|11586896|FG000|NOT COMPLETED|Year 1||0
10440545|NCT00926380|11586897|FG001|NOT COMPLETED|Year 1||1
10440546|NCT00926380|11586898|FG002|NOT COMPLETED|Year 1||1
10440547|NCT00926380|11586896|FG000|STARTED|Year 2||33
10440548|NCT00926380|11586897|FG001|STARTED|Year 2||30
10440549|NCT00926380|11586898|FG002|STARTED|Year 2||29
10440550|NCT00926380|11586896|FG000|COMPLETED|Year 2||31
10440551|NCT00926380|11586897|FG001|COMPLETED|Year 2||28
10440552|NCT00926380|11586898|FG002|COMPLETED|Year 2||24
10440553|NCT00926380|11586896|FG000|NOT COMPLETED|Year 2||2
10440554|NCT00926380|11586897|FG001|NOT COMPLETED|Year 2||2
10440555|NCT00926380|11586898|FG002|NOT COMPLETED|Year 2||5
10440556|NCT00926393|11586908|FG000|STARTED|Overall Study||69
10440557|NCT00926393|11586909|FG001|STARTED|Overall Study||70
10440558|NCT00926393|11586908|FG000|COMPLETED|Overall Study||67
10440559|NCT00926393|11586909|FG001|COMPLETED|Overall Study||67
10440560|NCT00926393|11586908|FG000|NOT COMPLETED|Overall Study||2
10440561|NCT00926393|11586909|FG001|NOT COMPLETED|Overall Study||3
10440562|NCT00926497|11586917|FG000|STARTED|Overall Study||60
10440563|NCT00926497|11586918|FG001|STARTED|Overall Study||61
10440564|NCT00926497|11586917|FG000|COMPLETED|Overall Study||60
10440565|NCT00926497|11586918|FG001|COMPLETED|Overall Study||61
10440566|NCT00926497|11586917|FG000|NOT COMPLETED|Overall Study||0
10440567|NCT00926497|11586918|FG001|NOT COMPLETED|Overall Study||0
10440568|NCT00926536|11586926|FG000|STARTED|Overall Study||44
10440569|NCT00926536|11586927|FG001|STARTED|Overall Study||43
10440570|NCT00926536|11586926|FG000|COMPLETED|Overall Study||43
10440571|NCT00926536|11586927|FG001|COMPLETED|Overall Study||41
10440572|NCT00926536|11586926|FG000|NOT COMPLETED|Overall Study||1
10440573|NCT00926536|11586927|FG001|NOT COMPLETED|Overall Study||2
10440574|NCT00926588|11586935|FG000|STARTED|Overall Study||124
10440575|NCT00926588|11586936|FG001|STARTED|Overall Study||126
10440576|NCT00926588|11586935|FG000|COMPLETED|Overall Study||116
10440577|NCT00926588|11586936|FG001|COMPLETED|Overall Study||122
10440578|NCT00926588|11586935|FG000|NOT COMPLETED|Overall Study||8
10440579|NCT00926588|11586936|FG001|NOT COMPLETED|Overall Study||4
10440580|NCT00926783|11586944|FG000|STARTED|Overall Study||42
10440581|NCT00926783|11586945|FG001|STARTED|Overall Study||41
10440582|NCT00926783|11586944|FG000|COMPLETED|Overall Study||39
10440583|NCT00926783|11586945|FG001|COMPLETED|Overall Study||38
10440584|NCT00926783|11586944|FG000|NOT COMPLETED|Overall Study||3
10440585|NCT00926783|11586945|FG001|NOT COMPLETED|Overall Study||3
10440586|NCT00926796|11586953|FG000|STARTED|Overall Study|Number randomized|309
10440587|NCT00926796|11586954|FG001|STARTED|Overall Study|Number randomized|305
10440588|NCT00926796|11586953|FG000|COMPLETED|Overall Study|Number eligible and in the full analysis set|202
10440589|NCT00926796|11586954|FG001|COMPLETED|Overall Study|Number eligible and in the full analysis set|199
10440590|NCT00926796|11586953|FG000|NOT COMPLETED|Overall Study||107
10440591|NCT00926796|11586954|FG001|NOT COMPLETED|Overall Study||106
10440592|NCT00926848|11586964|FG000|STARTED|Overall Study||34
10440593|NCT00926848|11586965|FG001|STARTED|Overall Study||34
10440594|NCT00926848|11586964|FG000|COMPLETED|Overall Study||34
10440595|NCT00926848|11586965|FG001|COMPLETED|Overall Study||34
10440596|NCT00926848|11586964|FG000|NOT COMPLETED|Overall Study||0
10440597|NCT00926848|11586965|FG001|NOT COMPLETED|Overall Study||0
10440598|NCT00926887|11586983|FG000|STARTED|Overall Study||54
10440599|NCT00926887|11586984|FG001|STARTED|Overall Study||50
10440600|NCT00926887|11586983|FG000|COMPLETED|Overall Study||54
10440601|NCT00926887|11586984|FG001|COMPLETED|Overall Study||50
10440602|NCT00926887|11586983|FG000|NOT COMPLETED|Overall Study||0
10440603|NCT00926887|11586984|FG001|NOT COMPLETED|Overall Study||0
10440604|NCT00926952|11586990|FG000|STARTED|Overall Study||20
10440605|NCT00926952|11586990|FG000|COMPLETED|Overall Study||20
10440606|NCT00926952|11586990|FG000|NOT COMPLETED|Overall Study||0
10440607|NCT00927069|11586996|FG000|STARTED|Week 0 to Week 12||50
10440608|NCT00927069|11586997|FG001|STARTED|Week 0 to Week 12||35
10440609|NCT00927069|11586998|FG002|STARTED|Week 0 to Week 12||0
10440610|NCT00927069|11586999|FG003|STARTED|Week 0 to Week 12||0
10440611|NCT00927069|11586996|FG000|COMPLETED|Week 0 to Week 12||49
10440612|NCT00927069|11586997|FG001|COMPLETED|Week 0 to Week 12||34
10440613|NCT00927069|11586998|FG002|COMPLETED|Week 0 to Week 12||0
10440614|NCT00927069|11586999|FG003|COMPLETED|Week 0 to Week 12||0
10440615|NCT00927069|11586996|FG000|NOT COMPLETED|Week 0 to Week 12||1
10440616|NCT00927069|11586997|FG001|NOT COMPLETED|Week 0 to Week 12||1
10440617|NCT00927069|11586998|FG002|NOT COMPLETED|Week 0 to Week 12||0
10440618|NCT00927069|11586999|FG003|NOT COMPLETED|Week 0 to Week 12||0
10440619|NCT00927069|11586996|FG000|STARTED|Week 12 to Week 24|17 patients stayed at the same dose. One patient withdrew at Week 12 and also had no dose increase|18
10440620|NCT00927069|11586997|FG001|STARTED|Week 12 to Week 24|11 patients stayed at the same dose of 40 mg Adalimumab every other week|11
10440621|NCT00927069|11586998|FG002|STARTED|Week 12 to Week 24|31 Pts. from Group A had a dose incr. since they did not respond to 40mg adalimumab every other week|31
10440622|NCT00927069|11586999|FG003|STARTED|Week 12 to Week 24|23 Pts. from Group B had a dose incr. since they did not respond to 40mg adalimumab every other week|23
10440623|NCT00927069|11586996|FG000|COMPLETED|Week 12 to Week 24||16
10440624|NCT00927069|11586997|FG001|COMPLETED|Week 12 to Week 24||11
10440625|NCT00927069|11586998|FG002|COMPLETED|Week 12 to Week 24||28
10440626|NCT00927069|11586999|FG003|COMPLETED|Week 12 to Week 24||20
10440627|NCT00927069|11586996|FG000|NOT COMPLETED|Week 12 to Week 24||2
10440628|NCT00927069|11586997|FG001|NOT COMPLETED|Week 12 to Week 24||0
10440629|NCT00927069|11586998|FG002|NOT COMPLETED|Week 12 to Week 24||3
10440630|NCT00927069|11586999|FG003|NOT COMPLETED|Week 12 to Week 24||3
10440631|NCT00927082|11587013|FG000|STARTED|Overall Study||91
10440632|NCT00927082|11587014|FG001|STARTED|Overall Study||87
10440633|NCT00927082|11587015|FG002|STARTED|Overall Study||108
10440634|NCT00927082|11587016|FG003|STARTED|Overall Study||97
10440635|NCT00927082|11587013|FG000|COMPLETED|Overall Study||79
10440636|NCT00927082|11587014|FG001|COMPLETED|Overall Study||77
10440637|NCT00927082|11587015|FG002|COMPLETED|Overall Study||86
10440638|NCT00927082|11587016|FG003|COMPLETED|Overall Study||78
10440639|NCT00927082|11587013|FG000|NOT COMPLETED|Overall Study||12
10440640|NCT00927082|11587014|FG001|NOT COMPLETED|Overall Study||10
10440641|NCT00927082|11587015|FG002|NOT COMPLETED|Overall Study||22
10440642|NCT00927082|11587016|FG003|NOT COMPLETED|Overall Study||19
10440643|NCT00927095|11587033|FG000|STARTED|Overall Study||22
10440644|NCT00927095|11587034|FG001|STARTED|Overall Study||21
10440645|NCT00927095|11587035|FG002|STARTED|Overall Study||24
10440646|NCT00927095|11587033|FG000|COMPLETED|Overall Study||16
10440647|NCT00927095|11587034|FG001|COMPLETED|Overall Study||17
10440648|NCT00927095|11587035|FG002|COMPLETED|Overall Study||22
10440649|NCT00927095|11587033|FG000|NOT COMPLETED|Overall Study||6
10440650|NCT00927095|11587034|FG001|NOT COMPLETED|Overall Study||4
10440651|NCT00927095|11587035|FG002|NOT COMPLETED|Overall Study||2
10440652|NCT00927160|11587045|FG000|STARTED|Overall Study||173
10440653|NCT00927160|11587046|FG001|STARTED|Overall Study||173
10440654|NCT00927160|11587045|FG000|COMPLETED|Overall Study||173
10440655|NCT00927160|11587046|FG001|COMPLETED|Overall Study||173
10440656|NCT00927160|11587045|FG000|NOT COMPLETED|Overall Study||0
10440657|NCT00927160|11587046|FG001|NOT COMPLETED|Overall Study||0
10440658|NCT00927186|11587054|FG000|STARTED|12 Months Primary Study||34
10440659|NCT00927186|11587055|FG001|STARTED|12 Months Primary Study||35
10440660|NCT00927186|11587054|FG000|Completed 6 Months Double Blind Phase|12 Months Primary Study||28
10440661|NCT00927186|11587055|FG001|Completed 6 Months Double Blind Phase|12 Months Primary Study||31
10440662|NCT00927186|11587054|FG000|COMPLETED|12 Months Primary Study||27
10440663|NCT00927186|11587055|FG001|COMPLETED|12 Months Primary Study||31
10440664|NCT00927186|11587054|FG000|NOT COMPLETED|12 Months Primary Study||7
10440665|NCT00927186|11587055|FG001|NOT COMPLETED|12 Months Primary Study||4
10440666|NCT00927186|11587054|FG000|STARTED|12 - 24 Months Extension Treatment|Not all participants who completed 12 months of primary study chose to enter 12-month extension.|10
10440667|NCT00927186|11587055|FG001|STARTED|12 - 24 Months Extension Treatment|Not all participants who completed 12 months of primary study chose to enter 12-month extension.|11
10440668|NCT00927186|11587054|FG000|COMPLETED|12 - 24 Months Extension Treatment||10
10440669|NCT00927186|11587055|FG001|COMPLETED|12 - 24 Months Extension Treatment||11
10440670|NCT00927186|11587054|FG000|NOT COMPLETED|12 - 24 Months Extension Treatment||0
10440671|NCT00927186|11587055|FG001|NOT COMPLETED|12 - 24 Months Extension Treatment||0
10440672|NCT00927251|11587064|FG000|STARTED|Overall Study||90
10440673|NCT00927251|11587064|FG000|COMPLETED|Overall Study||82
10440674|NCT00927251|11587064|FG000|NOT COMPLETED|Overall Study||8
10440675|NCT00927264|11587070|FG000|STARTED|Overall Study||165
10440676|NCT00927264|11587071|FG001|STARTED|Overall Study||165
10440677|NCT00927264|11587070|FG000|COMPLETED|Overall Study||109
10440678|NCT00927264|11587071|FG001|COMPLETED|Overall Study||140
10440679|NCT00927264|11587070|FG000|NOT COMPLETED|Overall Study||56
10440680|NCT00927264|11587071|FG001|NOT COMPLETED|Overall Study||25
10440681|NCT00927355|11587081|FG000|STARTED|Overall Study||5
10440682|NCT00927355|11587082|FG001|STARTED|Overall Study||5
10440683|NCT00927355|11587081|FG000|COMPLETED|Overall Study||4
10440684|NCT00927355|11587082|FG001|COMPLETED|Overall Study||4
10440685|NCT00927355|11587081|FG000|NOT COMPLETED|Overall Study||1
10440686|NCT00927355|11587082|FG001|NOT COMPLETED|Overall Study||1
10440687|NCT00927368|11587103|FG000|STARTED|Overall Study||153
10440688|NCT00927368|11587104|FG001|STARTED|Overall Study||157
10440689|NCT00927368|11587105|FG002|STARTED|Overall Study||143
10440690|NCT00927368|11587103|FG000|COMPLETED|Overall Study||147
10440691|NCT00927368|11587104|FG001|COMPLETED|Overall Study||152
10440692|NCT00927368|11587105|FG002|COMPLETED|Overall Study||138
10440693|NCT00927368|11587103|FG000|NOT COMPLETED|Overall Study||6
10440694|NCT00927368|11587104|FG001|NOT COMPLETED|Overall Study||5
10440695|NCT00927368|11587105|FG002|NOT COMPLETED|Overall Study||5
10440696|NCT00927394|11587115|FG000|STARTED|Overall Study||575
10440697|NCT00927394|11587116|FG001|STARTED|Overall Study|One patient was randomized in error and was discontinued by site.|568
10440698|NCT00927394|11587115|FG000|Cohort 1 (Randomized)|Overall Study|Cohort 1 includes patients with specific eligibility criteria mentioned in protocol section|157
10440699|NCT00927394|11587116|FG001|Cohort 1 (Randomized)|Overall Study||165
10440700|NCT00927394|11587115|FG000|Cohort 2 (Randomized)|Overall Study|Cohort 2 includes patients with specific eligibility criteria mentioned in protocol section|418
10440701|NCT00927394|11587116|FG001|Cohort 2 (Randomized)|Overall Study||403
10440702|NCT00927394|11587115|FG000|Combined Safety Set (Cohort 1 and 2)|Overall Study||574
10440703|NCT00927394|11587116|FG001|Combined Safety Set (Cohort 1 and 2)|Overall Study||565
10440704|NCT00927394|11587115|FG000|Cohort 1: Full Analysis Set 1 (FAS 1)|Overall Study|FAS 1 includes all patients in Cohort 1 to whom study treatments were given through randomization.|157
10440705|NCT00927394|11587116|FG001|Cohort 1: Full Analysis Set 1 (FAS 1)|Overall Study||164
10440706|NCT00927394|11587115|FG000|Cohort 2: Full Analysis Set 2 (FAS 2)|Overall Study|FAS 2= all patients randomized to Cohort 2 and who had a valid baseline assessment of 24 hours ABPM.|417
10440707|NCT00927394|11587116|FG001|Cohort 2: Full Analysis Set 2 (FAS 2)|Overall Study||398
10440708|NCT00927394|11587115|FG000|FAS 2 :Ambulatory Blood Pressure Monitor|Overall Study|consists of all patients in FAS 2 who had both valid baseline and post-baseline ABPM assessments.|342
10440709|NCT00927394|11587116|FG001|FAS 2 :Ambulatory Blood Pressure Monitor|Overall Study||323
10440710|NCT00927394|11587115|FG000|Combined Full Analysis Set (FAS 1+FAS 2)|Overall Study||574
10440711|NCT00927394|11587116|FG001|Combined Full Analysis Set (FAS 1+FAS 2)|Overall Study||562
10440712|NCT00927394|11587115|FG000|COMPLETED|Overall Study||498
10440713|NCT00927394|11587116|FG001|COMPLETED|Overall Study||483
10440714|NCT00927394|11587115|FG000|NOT COMPLETED|Overall Study||77
10440715|NCT00927394|11587116|FG001|NOT COMPLETED|Overall Study||85
10440716|NCT00927472|11587125|FG000|STARTED|Overall Study||126
10440717|NCT00927472|11587126|FG001|STARTED|Overall Study||128
10440718|NCT00927472|11587125|FG000|COMPLETED|Overall Study||115
10440719|NCT00927472|11587126|FG001|COMPLETED|Overall Study||106
10440720|NCT00927472|11587125|FG000|NOT COMPLETED|Overall Study||11
10440721|NCT00927472|11587126|FG001|NOT COMPLETED|Overall Study||22
10440722|NCT00927485|11587134|FG000|STARTED|Overall Study||21
10440723|NCT00927485|11587135|FG001|STARTED|Overall Study||23
10440724|NCT00927485|11587134|FG000|COMPLETED|Overall Study||15
10440725|NCT00927485|11587135|FG001|COMPLETED|Overall Study||19
10440726|NCT00927485|11587134|FG000|NOT COMPLETED|Overall Study||6
10440727|NCT00927485|11587135|FG001|NOT COMPLETED|Overall Study||4
10440728|NCT00927563|11587141|FG000|STARTED|Overall Study||24
10440729|NCT00927563|11587141|FG000|COMPLETED|Overall Study||22
10440730|NCT00927563|11587141|FG000|NOT COMPLETED|Overall Study||2
10440731|NCT00927576|11587147|FG000|STARTED|Overall Study||237
10440732|NCT00927576|11587148|FG001|STARTED|Overall Study||28
10440733|NCT00927576|11587147|FG000|Cognitive Testing|Overall Study||237
10440734|NCT00927576|11587148|FG001|Cognitive Testing|Overall Study||28
10440735|NCT00927576|11587147|FG000|COMPLETED|Overall Study||237
10440736|NCT00927576|11587148|FG001|COMPLETED|Overall Study||28
10440737|NCT00927576|11587147|FG000|NOT COMPLETED|Overall Study||0
10440738|NCT00927576|11587148|FG001|NOT COMPLETED|Overall Study||0
10440739|NCT00927589|11587153|FG000|STARTED|Overall Study||59
10440740|NCT00927589|11587153|FG000|COMPLETED|Overall Study|Participants were considered to have completed the study after receiving 3 cycles of treatment.|43
10440741|NCT00927589|11587153|FG000|NOT COMPLETED|Overall Study||16
10440742|NCT00927758|11587157|FG000|STARTED|Treatment Cycle 1 (Day 1 - Day 7)|"Started  indicates randomized as well as safety set."|4
10440743|NCT00927758|11587158|FG001|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
10440744|NCT00927758|11587159|FG002|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
10440745|NCT00927758|11587160|FG003|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||3
10440746|NCT00927758|11587161|FG004|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||3
10440747|NCT00927758|11587162|FG005|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
10440748|NCT00927758|11587157|FG000|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
10440749|NCT00927758|11587158|FG001|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
10440750|NCT00927758|11587159|FG002|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
10440751|NCT00927758|11587160|FG003|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||2
10440752|NCT00927758|11587161|FG004|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||3
10440753|NCT00927758|11587162|FG005|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||3
10440754|NCT00927758|11587157|FG000|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
10440755|NCT00927758|11587158|FG001|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
10440756|NCT00927758|11587159|FG002|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
10440757|NCT00927758|11587160|FG003|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||2
10440758|NCT00927758|11587161|FG004|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||3
10440759|NCT00927758|11587162|FG005|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||3
10440760|NCT00927758|11587157|FG000|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
10440761|NCT00927758|11587158|FG001|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
10440762|NCT00927758|11587159|FG002|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
10440763|NCT00927758|11587160|FG003|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||1
10440764|NCT00927758|11587161|FG004|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
10440765|NCT00927758|11587162|FG005|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||1
10440766|NCT00927758|11587157|FG000|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
10440767|NCT00927758|11587158|FG001|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
10440768|NCT00927758|11587159|FG002|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
10440769|NCT00927758|11587160|FG003|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||2
10440770|NCT00927758|11587161|FG004|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||3
10549840|NCT01527500|11703880|FG000|NOT COMPLETED|Part B||1
10549841|NCT01527500|11703881|FG001|NOT COMPLETED|Part B||0
10549842|NCT01527513|11703899|FG000|STARTED|Double Blind Period (DB) - Part I||40
10549843|NCT01527513|11703900|FG001|STARTED|Double Blind Period (DB) - Part I||83
10549844|NCT01527513|11703899|FG000|Randomized|Double Blind Period (DB) - Part I||40
10549845|NCT01527513|11703900|FG001|Randomized|Double Blind Period (DB) - Part I||83
10549846|NCT01527513|11703899|FG000|Safety Population|Double Blind Period (DB) - Part I||40
10549847|NCT01527513|11703900|FG001|Safety Population|Double Blind Period (DB) - Part I||83
10549848|NCT01527513|11703899|FG000|Entered Maintenance Period|Double Blind Period (DB) - Part I||40
10549849|NCT01527513|11703900|FG001|Entered Maintenance Period|Double Blind Period (DB) - Part I||76
10549850|NCT01527513|11703899|FG000|Completed the Double Blind (DB)- Part I|Double Blind Period (DB) - Part I||37
10549851|NCT01527513|11703900|FG001|Completed the Double Blind (DB)- Part I|Double Blind Period (DB) - Part I||75
10549852|NCT01527513|11703899|FG000|Eligible for Open Label Period (OL)|Double Blind Period (DB) - Part I||37
10440771|NCT00927758|11587162|FG005|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||3
10440772|NCT00927758|11587157|FG000|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||4
10440773|NCT00927758|11587158|FG001|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||4
10440774|NCT00927758|11587159|FG002|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||3
10440775|NCT00927758|11587160|FG003|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||1
10440776|NCT00927758|11587161|FG004|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||3
10440777|NCT00927758|11587162|FG005|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||2
10440778|NCT00927758|11587157|FG000|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||4
10440779|NCT00927758|11587158|FG001|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||4
10440780|NCT00927758|11587159|FG002|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||3
10440781|NCT00927758|11587160|FG003|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
10440782|NCT00927758|11587161|FG004|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||3
10440783|NCT00927758|11587162|FG005|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||2
10440784|NCT00927758|11587157|FG000|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
10440785|NCT00927758|11587158|FG001|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
10440786|NCT00927758|11587159|FG002|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
10440787|NCT00927758|11587160|FG003|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
10440788|NCT00927758|11587161|FG004|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
10440789|NCT00927758|11587162|FG005|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
10440790|NCT00927758|11587157|FG000|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||4
10440791|NCT00927758|11587158|FG001|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||4
10440792|NCT00927758|11587159|FG002|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||3
10440793|NCT00927758|11587160|FG003|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||1
10440794|NCT00927758|11587161|FG004|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||3
10440795|NCT00927758|11587162|FG005|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||2
10440796|NCT00927758|11587157|FG000|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||4
10440797|NCT00927758|11587158|FG001|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||4
10440798|NCT00927758|11587159|FG002|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||3
10440799|NCT00927758|11587160|FG003|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||1
10440800|NCT00927758|11587161|FG004|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||3
10440801|NCT00927758|11587162|FG005|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||2
10440802|NCT00927758|11587157|FG000|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
10440803|NCT00927758|11587158|FG001|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
10440804|NCT00927758|11587159|FG002|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
10440805|NCT00927758|11587160|FG003|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
10440806|NCT00927758|11587161|FG004|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
10440807|NCT00927758|11587162|FG005|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
10440808|NCT00927784|11587172|FG000|STARTED|Overall Study||8
10440809|NCT00927784|11587173|FG001|STARTED|Overall Study||2
10440810|NCT00927784|11587172|FG000|COMPLETED|Overall Study||6
10440811|NCT00927784|11587173|FG001|COMPLETED|Overall Study||2
10440812|NCT00927784|11587172|FG000|NOT COMPLETED|Overall Study||2
10440813|NCT00927784|11587173|FG001|NOT COMPLETED|Overall Study||0
10440814|NCT00927810|11587183|FG000|STARTED|Overall Study||75
10440815|NCT00927810|11587184|FG001|STARTED|Overall Study||181
10440816|NCT00927810|11587185|FG002|STARTED|Overall Study||25
10440817|NCT00927810|11587186|FG003|STARTED|Overall Study||60
10440818|NCT00927810|11587183|FG000|COMPLETED|Overall Study||75
10440819|NCT00927810|11587184|FG001|COMPLETED|Overall Study||173
10789391|NCT03520387|11949815|FG003|COMPLETED|Pre-Randomization||0
10789392|NCT03520387|11949816|FG004|COMPLETED|Pre-Randomization||0
10440820|NCT00927810|11587185|FG002|COMPLETED|Overall Study||24
10440821|NCT00927810|11587186|FG003|COMPLETED|Overall Study||58
10440822|NCT00927810|11587183|FG000|NOT COMPLETED|Overall Study||0
10440823|NCT00927810|11587184|FG001|NOT COMPLETED|Overall Study||8
10440824|NCT00927810|11587185|FG002|NOT COMPLETED|Overall Study||1
10440825|NCT00927810|11587186|FG003|NOT COMPLETED|Overall Study||2
10440826|NCT00927823|11587204|FG000|STARTED|Lead-In Period||3
10440827|NCT00927823|11587205|FG001|STARTED|Lead-In Period||3
10440828|NCT00927823|11587206|FG002|STARTED|Lead-In Period||26
10440829|NCT00927823|11587207|FG003|STARTED|Lead-In Period||5
10440830|NCT00927823|11587204|FG000|COMPLETED|Lead-In Period||3
10440831|NCT00927823|11587205|FG001|COMPLETED|Lead-In Period||3
10440832|NCT00927823|11587206|FG002|COMPLETED|Lead-In Period||26
10440833|NCT00927823|11587207|FG003|COMPLETED|Lead-In Period||5
10440834|NCT00927823|11587204|FG000|NOT COMPLETED|Lead-In Period||0
10440835|NCT00927823|11587205|FG001|NOT COMPLETED|Lead-In Period||0
10440836|NCT00927823|11587206|FG002|NOT COMPLETED|Lead-In Period||0
10440837|NCT00927823|11587207|FG003|NOT COMPLETED|Lead-In Period||0
10440838|NCT00927823|11587204|FG000|STARTED|Continuous Dosing Period||3
10440839|NCT00927823|11587205|FG001|STARTED|Continuous Dosing Period||3
10440840|NCT00927823|11587206|FG002|STARTED|Continuous Dosing Period||26
10440841|NCT00927823|11587207|FG003|STARTED|Continuous Dosing Period||5
10440842|NCT00927823|11587204|FG000|Treated|Continuous Dosing Period||3
10440843|NCT00927823|11587205|FG001|Treated|Continuous Dosing Period||3
10440844|NCT00927823|11587206|FG002|Treated|Continuous Dosing Period||23
10440845|NCT00927823|11587207|FG003|Treated|Continuous Dosing Period||5
10440846|NCT00927823|11587204|FG000|COMPLETED|Continuous Dosing Period||0
10789393|NCT03520387|11949812|FG000|NOT COMPLETED|Pre-Randomization||3
10789394|NCT03520387|11949813|FG001|NOT COMPLETED|Pre-Randomization||0
10440847|NCT00927823|11587205|FG001|COMPLETED|Continuous Dosing Period||0
10440848|NCT00927823|11587206|FG002|COMPLETED|Continuous Dosing Period||0
10440849|NCT00927823|11587207|FG003|COMPLETED|Continuous Dosing Period||0
10440850|NCT00927823|11587204|FG000|NOT COMPLETED|Continuous Dosing Period||3
10440851|NCT00927823|11587205|FG001|NOT COMPLETED|Continuous Dosing Period||3
10440852|NCT00927823|11587206|FG002|NOT COMPLETED|Continuous Dosing Period||26
10440853|NCT00927823|11587207|FG003|NOT COMPLETED|Continuous Dosing Period||5
10440854|NCT00927849|11587227|FG000|STARTED|Overall Study||21
10440855|NCT00927849|11587228|FG001|STARTED|Overall Study||21
10440856|NCT00927849|11587229|FG002|STARTED|Overall Study||21
10440857|NCT00927849|11587227|FG000|COMPLETED|Overall Study||21
10440858|NCT00927849|11587228|FG001|COMPLETED|Overall Study||21
10440859|NCT00927849|11587229|FG002|COMPLETED|Overall Study||21
10440860|NCT00927849|11587227|FG000|NOT COMPLETED|Overall Study||0
10440861|NCT00927849|11587228|FG001|NOT COMPLETED|Overall Study||0
10440862|NCT00927849|11587229|FG002|NOT COMPLETED|Overall Study||0
10440863|NCT00927862|11587239|FG000|STARTED|Overall Study||504
10440864|NCT00927862|11587240|FG001|STARTED|Overall Study||1911
10440865|NCT00927862|11587239|FG000|COMPLETED|Overall Study|477 patients evaluated in primary analyses and 488 evaluated in secondary analyses.|477
10440866|NCT00927862|11587240|FG001|COMPLETED|Overall Study||1866
10440867|NCT00927862|11587239|FG000|NOT COMPLETED|Overall Study||27
10440868|NCT00927862|11587240|FG001|NOT COMPLETED|Overall Study||45
10440869|NCT00927888|11587250|FG000|STARTED|Overall Study||29
10440870|NCT00927888|11587251|FG001|STARTED|Overall Study||27
10440871|NCT00927888|11587250|FG000|COMPLETED|Overall Study||29
10440872|NCT00927888|11587251|FG001|COMPLETED|Overall Study||27
10440873|NCT00927888|11587250|FG000|NOT COMPLETED|Overall Study||0
10440874|NCT00927888|11587251|FG001|NOT COMPLETED|Overall Study||0
10440875|NCT00927901|11587259|FG000|STARTED|Treatment Period 1||7
10440876|NCT00927901|11587260|FG001|STARTED|Treatment Period 1||7
10440877|NCT00927901|11587261|FG002|STARTED|Treatment Period 1||7
10440878|NCT00927901|11587262|FG003|STARTED|Treatment Period 1||9
10440879|NCT00927901|11587259|FG000|COMPLETED|Treatment Period 1||7
10440880|NCT00927901|11587260|FG001|COMPLETED|Treatment Period 1||7
10440881|NCT00927901|11587261|FG002|COMPLETED|Treatment Period 1||6
10440882|NCT00927901|11587262|FG003|COMPLETED|Treatment Period 1||9
10440883|NCT00927901|11587259|FG000|NOT COMPLETED|Treatment Period 1||0
10440884|NCT00927901|11587260|FG001|NOT COMPLETED|Treatment Period 1||0
10440885|NCT00927901|11587261|FG002|NOT COMPLETED|Treatment Period 1||1
10440886|NCT00927901|11587262|FG003|NOT COMPLETED|Treatment Period 1||0
10440887|NCT00927901|11587259|FG000|STARTED|Treatment Period 2||7
10440888|NCT00927901|11587260|FG001|STARTED|Treatment Period 2||7
10440889|NCT00927901|11587261|FG002|STARTED|Treatment Period 2||6
10440890|NCT00927901|11587262|FG003|STARTED|Treatment Period 2||9
10440891|NCT00927901|11587259|FG000|COMPLETED|Treatment Period 2||7
10440892|NCT00927901|11587260|FG001|COMPLETED|Treatment Period 2||7
10440893|NCT00927901|11587261|FG002|COMPLETED|Treatment Period 2||6
10440894|NCT00927901|11587262|FG003|COMPLETED|Treatment Period 2||9
10440895|NCT00927901|11587259|FG000|NOT COMPLETED|Treatment Period 2||0
10440896|NCT00927901|11587260|FG001|NOT COMPLETED|Treatment Period 2||0
10440897|NCT00927901|11587261|FG002|NOT COMPLETED|Treatment Period 2||0
10440898|NCT00927901|11587262|FG003|NOT COMPLETED|Treatment Period 2||0
10440899|NCT00927901|11587259|FG000|STARTED|Treatment Period 3||7
10440900|NCT00927901|11587260|FG001|STARTED|Treatment Period 3||7
10440901|NCT00927901|11587261|FG002|STARTED|Treatment Period 3||6
10440902|NCT00927901|11587262|FG003|STARTED|Treatment Period 3||9
10440903|NCT00927901|11587259|FG000|COMPLETED|Treatment Period 3||7
10440904|NCT00927901|11587260|FG001|COMPLETED|Treatment Period 3||7
10440905|NCT00927901|11587261|FG002|COMPLETED|Treatment Period 3||6
10440906|NCT00927901|11587262|FG003|COMPLETED|Treatment Period 3||9
10440907|NCT00927901|11587259|FG000|NOT COMPLETED|Treatment Period 3||0
10440908|NCT00927901|11587260|FG001|NOT COMPLETED|Treatment Period 3||0
10440909|NCT00927901|11587261|FG002|NOT COMPLETED|Treatment Period 3||0
10440910|NCT00927901|11587262|FG003|NOT COMPLETED|Treatment Period 3||0
10440911|NCT00927901|11587259|FG000|STARTED|Treatment Period 4||7
10440912|NCT00927901|11587260|FG001|STARTED|Treatment Period 4||7
10440913|NCT00927901|11587261|FG002|STARTED|Treatment Period 4||6
10440914|NCT00927901|11587262|FG003|STARTED|Treatment Period 4||9
10440915|NCT00927901|11587259|FG000|COMPLETED|Treatment Period 4||7
10440916|NCT00927901|11587260|FG001|COMPLETED|Treatment Period 4||7
10440917|NCT00927901|11587261|FG002|COMPLETED|Treatment Period 4||5
10440918|NCT00927901|11587262|FG003|COMPLETED|Treatment Period 4||8
10440919|NCT00927901|11587259|FG000|NOT COMPLETED|Treatment Period 4||0
10440920|NCT00927901|11587260|FG001|NOT COMPLETED|Treatment Period 4||0
10440921|NCT00927901|11587261|FG002|NOT COMPLETED|Treatment Period 4||1
10440922|NCT00927901|11587262|FG003|NOT COMPLETED|Treatment Period 4||1
10440923|NCT00927927|11587290|FG000|STARTED|Overall Study||3
10440924|NCT00927927|11587291|FG001|STARTED|Overall Study||3
10440925|NCT00927927|11587292|FG002|STARTED|Overall Study||3
10440926|NCT00927927|11587293|FG003|STARTED|Overall Study||3
10440927|NCT00927927|11587294|FG004|STARTED|Overall Study||3
10440928|NCT00927927|11587295|FG005|STARTED|Overall Study||3
10440929|NCT00927927|11587296|FG006|STARTED|Overall Study||3
10440930|NCT00927927|11587297|FG007|STARTED|Overall Study||3
10440931|NCT00927927|11587298|FG008|STARTED|Overall Study||8
10440932|NCT00927927|11587299|FG009|STARTED|Overall Study||3
10440933|NCT00927927|11587300|FG010|STARTED|Overall Study||5
10440934|NCT00927927|11587301|FG011|STARTED|Overall Study||6
10440935|NCT00927927|11587302|FG012|STARTED|Overall Study||5
10440936|NCT00927927|11587303|FG013|STARTED|Overall Study||5
10440937|NCT00927927|11587304|FG014|STARTED|Overall Study||9
10440938|NCT00927927|11587290|FG000|Exposed|Overall Study||3
10440939|NCT00927927|11587291|FG001|Exposed|Overall Study||3
10440940|NCT00927927|11587292|FG002|Exposed|Overall Study||3
10440941|NCT00927927|11587293|FG003|Exposed|Overall Study||3
10440942|NCT00927927|11587294|FG004|Exposed|Overall Study||3
10440943|NCT00927927|11587295|FG005|Exposed|Overall Study||3
10440944|NCT00927927|11587296|FG006|Exposed|Overall Study||3
10440945|NCT00927927|11587297|FG007|Exposed|Overall Study||3
10440946|NCT00927927|11587298|FG008|Exposed|Overall Study||8
10440947|NCT00927927|11587299|FG009|Exposed|Overall Study||3
10440948|NCT00927927|11587300|FG010|Exposed|Overall Study||5
10440949|NCT00927927|11587301|FG011|Exposed|Overall Study||5
10440950|NCT00927927|11587302|FG012|Exposed|Overall Study||5
10440951|NCT00927927|11587303|FG013|Exposed|Overall Study||5
10440952|NCT00927927|11587304|FG014|Exposed|Overall Study||9
10440953|NCT00927927|11587290|FG000|COMPLETED|Overall Study||3
10440954|NCT00927927|11587291|FG001|COMPLETED|Overall Study||3
10440955|NCT00927927|11587292|FG002|COMPLETED|Overall Study||3
10440956|NCT00927927|11587293|FG003|COMPLETED|Overall Study||3
10440957|NCT00927927|11587294|FG004|COMPLETED|Overall Study||3
10440958|NCT00927927|11587295|FG005|COMPLETED|Overall Study||3
10440959|NCT00927927|11587296|FG006|COMPLETED|Overall Study||3
10440960|NCT00927927|11587297|FG007|COMPLETED|Overall Study||1
10440961|NCT00927927|11587298|FG008|COMPLETED|Overall Study||8
10440962|NCT00927927|11587299|FG009|COMPLETED|Overall Study||3
10440963|NCT00927927|11587300|FG010|COMPLETED|Overall Study||5
10440964|NCT00927927|11587301|FG011|COMPLETED|Overall Study|One subject withdrew consent after being randomised but before receiving any trial product.|4
10440965|NCT00927927|11587302|FG012|COMPLETED|Overall Study||5
10440966|NCT00927927|11587303|FG013|COMPLETED|Overall Study||5
10440967|NCT00927927|11587304|FG014|COMPLETED|Overall Study||9
10440968|NCT00927927|11587290|FG000|NOT COMPLETED|Overall Study||0
10440969|NCT00927927|11587291|FG001|NOT COMPLETED|Overall Study||0
10440970|NCT00927927|11587292|FG002|NOT COMPLETED|Overall Study||0
10440971|NCT00927927|11587293|FG003|NOT COMPLETED|Overall Study||0
10440972|NCT00927927|11587294|FG004|NOT COMPLETED|Overall Study||0
10440973|NCT00927927|11587295|FG005|NOT COMPLETED|Overall Study||0
10440974|NCT00927927|11587296|FG006|NOT COMPLETED|Overall Study||0
10440975|NCT00927927|11587297|FG007|NOT COMPLETED|Overall Study||2
10440976|NCT00927927|11587298|FG008|NOT COMPLETED|Overall Study||0
10440977|NCT00927927|11587299|FG009|NOT COMPLETED|Overall Study||0
10440978|NCT00927927|11587300|FG010|NOT COMPLETED|Overall Study||0
10440979|NCT00927927|11587301|FG011|NOT COMPLETED|Overall Study||2
10440980|NCT00927927|11587302|FG012|NOT COMPLETED|Overall Study||0
10440981|NCT00927927|11587303|FG013|NOT COMPLETED|Overall Study||0
10440982|NCT00927927|11587304|FG014|NOT COMPLETED|Overall Study||0
10440983|NCT00927940|11587336|FG000|STARTED|Overall Study||100
10440984|NCT00927940|11587336|FG000|COMPLETED|Overall Study|A patient died before 30 days follow up. This pasitent is excluded from primary analysis.|99
10440985|NCT00927940|11587336|FG000|NOT COMPLETED|Overall Study||1
10440986|NCT00927992|11587341|FG000|STARTED|Overall Study||11
10440987|NCT00927992|11587341|FG000|COMPLETED|Overall Study||11
10440988|NCT00927992|11587341|FG000|NOT COMPLETED|Overall Study||0
10440989|NCT00928018|11587347|FG000|STARTED|Overall Study|One Arm A patient withdrew consent, treated as Arm B, but analyzed on Arm A based on intent-to-treat|66
10440990|NCT00928018|11587348|FG001|STARTED|Overall Study||73
10440991|NCT00928018|11587347|FG000|COMPLETED|Overall Study||65
10440992|NCT00928018|11587348|FG001|COMPLETED|Overall Study||73
10440993|NCT00928018|11587347|FG000|NOT COMPLETED|Overall Study||1
10440994|NCT00928018|11587348|FG001|NOT COMPLETED|Overall Study||0
10440995|NCT00928057|11587360|FG000|STARTED|Overall Study||84
10440996|NCT00928057|11587361|FG001|STARTED|Overall Study||89
10440997|NCT00928057|11587360|FG000|COMPLETED|Overall Study||82
10440998|NCT00928057|11587361|FG001|COMPLETED|Overall Study||85
10440999|NCT00928057|11587360|FG000|NOT COMPLETED|Overall Study||2
10441000|NCT00928057|11587361|FG001|NOT COMPLETED|Overall Study||4
10441001|NCT00928070|11587379|FG000|STARTED|Overall Study||283
10441002|NCT00928070|11587380|FG001|STARTED|Overall Study||283
10441003|NCT00928070|11587379|FG000|Treated|Overall Study||281
10441004|NCT00928070|11587380|FG001|Treated|Overall Study||281
10441005|NCT00928070|11587379|FG000|COMPLETED|Overall Study||220
10441006|NCT00928070|11587380|FG001|COMPLETED|Overall Study||226
10441007|NCT00928070|11587379|FG000|NOT COMPLETED|Overall Study||63
10441008|NCT00928070|11587380|FG001|NOT COMPLETED|Overall Study||57
10441009|NCT00928083|11587389|FG000|STARTED|Overall Study||10
10441010|NCT00928083|11587390|FG001|STARTED|Overall Study||8
10441011|NCT00928083|11587391|FG002|STARTED|Overall Study||8
10441012|NCT00928083|11587392|FG003|STARTED|Overall Study||6
10441013|NCT00928083|11587393|FG004|STARTED|Overall Study||7
10441014|NCT00928083|11587394|FG005|STARTED|Overall Study||6
10441015|NCT00928083|11587395|FG006|STARTED|Overall Study||6
10441016|NCT00928083|11587396|FG007|STARTED|Overall Study||6
10441017|NCT00928083|11587397|FG008|STARTED|Overall Study||6
10441018|NCT00928083|11587389|FG000|COMPLETED|Overall Study||6
10441019|NCT00928083|11587390|FG001|COMPLETED|Overall Study||8
10441020|NCT00928083|11587391|FG002|COMPLETED|Overall Study||8
10441021|NCT00928083|11587392|FG003|COMPLETED|Overall Study||5
10441022|NCT00928083|11587393|FG004|COMPLETED|Overall Study||6
10441023|NCT00928083|11587394|FG005|COMPLETED|Overall Study||6
10441024|NCT00928083|11587395|FG006|COMPLETED|Overall Study||6
10441025|NCT00928083|11587396|FG007|COMPLETED|Overall Study||6
10441026|NCT00928083|11587397|FG008|COMPLETED|Overall Study||6
10441027|NCT00928083|11587389|FG000|NOT COMPLETED|Overall Study||4
10441028|NCT00928083|11587390|FG001|NOT COMPLETED|Overall Study||0
10441029|NCT00928083|11587391|FG002|NOT COMPLETED|Overall Study||0
10441030|NCT00928083|11587392|FG003|NOT COMPLETED|Overall Study||1
10441031|NCT00928083|11587393|FG004|NOT COMPLETED|Overall Study||1
10441032|NCT00928083|11587394|FG005|NOT COMPLETED|Overall Study||0
10441033|NCT00928083|11587395|FG006|NOT COMPLETED|Overall Study||0
10441034|NCT00928083|11587396|FG007|NOT COMPLETED|Overall Study||0
10441035|NCT00928083|11587397|FG008|NOT COMPLETED|Overall Study||0
10441036|NCT00928135|11587448|FG000|STARTED|Overall Study||30
10441037|NCT00928135|11587449|FG001|STARTED|Overall Study||30
10549853|NCT01527513|11703900|FG001|Eligible for Open Label Period (OL)|Double Blind Period (DB) - Part I||75
10441038|NCT00928135|11587448|FG000|COMPLETED|Overall Study||29
10441039|NCT00928135|11587449|FG001|COMPLETED|Overall Study||30
10441040|NCT00928135|11587448|FG000|NOT COMPLETED|Overall Study||1
10441041|NCT00928135|11587449|FG001|NOT COMPLETED|Overall Study||0
10441042|NCT00928174|11587455|FG000|STARTED|Overall Study||27
10441043|NCT00928174|11587455|FG000|COMPLETED|Overall Study|3 withdrawn before start of participation|22
10441044|NCT00928174|11587455|FG000|NOT COMPLETED|Overall Study||5
10441045|NCT00928187|11587462|FG000|STARTED|Overall Study||152
10441046|NCT00928187|11587463|FG001|STARTED|Overall Study||147
10441047|NCT00928187|11587464|FG002|STARTED|Overall Study||155
10441048|NCT00928187|11587462|FG000|Analysed|Overall Study||152
10441049|NCT00928187|11587463|FG001|Analysed|Overall Study||145
10441050|NCT00928187|11587464|FG002|Analysed|Overall Study||154
10441051|NCT00928187|11587462|FG000|COMPLETED|Overall Study||150
10441052|NCT00928187|11587463|FG001|COMPLETED|Overall Study||141
10441053|NCT00928187|11587464|FG002|COMPLETED|Overall Study||150
10441054|NCT00928187|11587462|FG000|NOT COMPLETED|Overall Study||2
10441055|NCT00928187|11587463|FG001|NOT COMPLETED|Overall Study||6
10441056|NCT00928187|11587464|FG002|NOT COMPLETED|Overall Study||5
10441057|NCT00928200|11587472|FG000|STARTED|Overall Study||1
10441058|NCT00928200|11587472|FG000|COMPLETED|Overall Study||1
10441059|NCT00928200|11587472|FG000|NOT COMPLETED|Overall Study||0
10441060|NCT00928252|11587476|FG000|STARTED|Overall Study||45
10441061|NCT00928252|11587476|FG000|COMPLETED|Overall Study||42
10441062|NCT00928252|11587476|FG000|NOT COMPLETED|Overall Study||3
10441063|NCT00928304|11587482|FG000|STARTED|Overall Study||39
10441064|NCT00928304|11587483|FG001|STARTED|Overall Study||70
10441065|NCT00928304|11587482|FG000|COMPLETED|Overall Study||39
10441066|NCT00928304|11587483|FG001|COMPLETED|Overall Study||70
10441067|NCT00928304|11587482|FG000|NOT COMPLETED|Overall Study||0
10441068|NCT00928304|11587483|FG001|NOT COMPLETED|Overall Study||0
10441069|NCT00928395|11587495|FG000|STARTED|Overall Study||50
10441070|NCT00928395|11587495|FG000|COMPLETED|Overall Study||29
10441071|NCT00928395|11587495|FG000|NOT COMPLETED|Overall Study||21
10441072|NCT00928408|11587499|FG000|STARTED|Overall Study|Number Enrolled|305
10441073|NCT00928408|11587499|FG000|Full Analysis Set|Overall Study|All enrolled participants who fulfilled the study inclusion/exclusion criteria|303
10441074|NCT00928408|11587499|FG000|COMPLETED|Overall Study||282
10441075|NCT00928408|11587499|FG000|NOT COMPLETED|Overall Study||23
10441076|NCT00928421|11587503|FG000|STARTED|Overall Study||16
10441077|NCT00928421|11587503|FG000|Treated With Study Drug|Overall Study||16
10441078|NCT00928421|11587503|FG000|COMPLETED|Overall Study||16
10441079|NCT00928421|11587503|FG000|NOT COMPLETED|Overall Study||0
10441080|NCT00928434|11587510|FG000|STARTED|Overall Study|Full Analysis Set Patients|175
10441081|NCT00928434|11587511|FG001|STARTED|Overall Study|Full Analysis Set Patients|50
10441082|NCT00928434|11587512|FG002|STARTED|Overall Study|Full Analysis Set Patients|178
10441083|NCT00928434|11587510|FG000|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|137
10441084|NCT00928434|11587511|FG001|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|41
10441085|NCT00928434|11587512|FG002|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|150
10441086|NCT00928434|11587510|FG000|COMPLETED|Overall Study||131
10441087|NCT00928434|11587511|FG001|COMPLETED|Overall Study||36
10441088|NCT00928434|11587512|FG002|COMPLETED|Overall Study||134
10441089|NCT00928434|11587510|FG000|NOT COMPLETED|Overall Study||44
10441090|NCT00928434|11587511|FG001|NOT COMPLETED|Overall Study||14
10441091|NCT00928434|11587512|FG002|NOT COMPLETED|Overall Study||44
10441092|NCT00928486|11587528|FG000|STARTED|Overall Study||25
10441093|NCT00928486|11587528|FG000|Efficacy Evaluable (EE)|Overall Study|EE population = given at least 1 dose of study drug, evaluated for efficacy and met eligibility|24
10441094|NCT00928486|11587528|FG000|COMPLETED|Overall Study|Completed = those who continued responding to treatment; upon marketing approval, given lenalidomide|15
10441095|NCT00928486|11587528|FG000|NOT COMPLETED|Overall Study||10
10441096|NCT00928512|11587537|FG000|STARTED|Overall Study||41
10441097|NCT00928512|11587538|FG001|STARTED|Overall Study||43
10441098|NCT00928512|11587539|FG002|STARTED|Overall Study||49
10441099|NCT00928512|11587540|FG003|STARTED|Overall Study||54
10441100|NCT00928512|11587541|FG004|STARTED|Overall Study||50
10441101|NCT00928512|11587537|FG000|Discontinued Prior to Week 16|Overall Study||3
10441102|NCT00928512|11587538|FG001|Discontinued Prior to Week 16|Overall Study||0
10441103|NCT00928512|11587539|FG002|Discontinued Prior to Week 16|Overall Study||2
10441104|NCT00928512|11587540|FG003|Discontinued Prior to Week 16|Overall Study||6
10441105|NCT00928512|11587541|FG004|Discontinued Prior to Week 16|Overall Study||5
10441106|NCT00928512|11587537|FG000|Reassigned at Week 20 (Non-responders)|Overall Study|All patients in the 300 mg group at Week 20 remained at this dose in this group.|0
10441107|NCT00928512|11587538|FG001|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 150 mg group were reassigned treatment to the 300 mg group.|23
10441108|NCT00928512|11587539|FG002|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 75 mg group were reassigned treatment to the 150 mg group.|23
10441109|NCT00928512|11587540|FG003|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 25 mg group were reassigned treatment to the 150 mg group.|27
10441110|NCT00928512|11587541|FG004|Reassigned at Week 20 (Non-responders)|Overall Study|All placebo patients (responders & non-responders) were reassigned treatment to the 150 mg group.|45
10441111|NCT00928512|11587537|FG000|Not Reassigned at Week 20 (Responders)|Overall Study||37
10441112|NCT00928512|11587538|FG001|Not Reassigned at Week 20 (Responders)|Overall Study||20
10441113|NCT00928512|11587539|FG002|Not Reassigned at Week 20 (Responders)|Overall Study||23
10441114|NCT00928512|11587540|FG003|Not Reassigned at Week 20 (Responders)|Overall Study||18
10441115|NCT00928512|11587541|FG004|Not Reassigned at Week 20 (Responders)|Overall Study||0
10441116|NCT00928512|11587537|FG000|New Groups After Reassignment|Overall Study|1 patient in this group continued at Week 16 but did not receive any study drug at Week 20.|60
10441117|NCT00928512|11587538|FG001|New Groups After Reassignment|Overall Study||115
10441118|NCT00928512|11587539|FG002|New Groups After Reassignment|Overall Study|1 patient in this group continued at Week 16 but did not receive any study drug at Week 20.|23
10441119|NCT00928512|11587540|FG003|New Groups After Reassignment|Overall Study|2 patients in this group continued at Week 16 but did not receive any study drug at Week 20|18
10441120|NCT00928512|11587541|FG004|New Groups After Reassignment|Overall Study||0
10441121|NCT00928512|11587537|FG000|Completed Week 16|Overall Study||38
10441122|NCT00928512|11587538|FG001|Completed Week 16|Overall Study||43
10441123|NCT00928512|11587539|FG002|Completed Week 16|Overall Study||47
10441124|NCT00928512|11587540|FG003|Completed Week 16|Overall Study||48
10441125|NCT00928512|11587541|FG004|Completed Week 16|Overall Study||45
10441126|NCT00928512|11587537|FG000|Entered/Continued to Week 20 (All)|Overall Study||37
10441127|NCT00928512|11587538|FG001|Entered/Continued to Week 20 (All)|Overall Study||43
10441128|NCT00928512|11587539|FG002|Entered/Continued to Week 20 (All)|Overall Study||46
10441129|NCT00928512|11587540|FG003|Entered/Continued to Week 20 (All)|Overall Study||45
10441130|NCT00928512|11587541|FG004|Entered/Continued to Week 20 (All)|Overall Study||45
10441131|NCT00928512|11587537|FG000|COMPLETED|Overall Study||31
10441132|NCT00928512|11587538|FG001|COMPLETED|Overall Study||37
10441133|NCT00928512|11587539|FG002|COMPLETED|Overall Study||38
10441134|NCT00928512|11587540|FG003|COMPLETED|Overall Study||33
10441135|NCT00928512|11587541|FG004|COMPLETED|Overall Study||35
10441136|NCT00928512|11587537|FG000|NOT COMPLETED|Overall Study||10
10441137|NCT00928512|11587538|FG001|NOT COMPLETED|Overall Study||6
10441138|NCT00928512|11587539|FG002|NOT COMPLETED|Overall Study||11
10441139|NCT00928512|11587540|FG003|NOT COMPLETED|Overall Study||21
10441140|NCT00928512|11587541|FG004|NOT COMPLETED|Overall Study||15
10441141|NCT00928564|11587559|FG000|STARTED|Overall Study||28
10441142|NCT00928564|11587560|FG001|STARTED|Overall Study||12
10441143|NCT00928564|11587559|FG000|COMPLETED|Overall Study||22
10441144|NCT00928564|11587560|FG001|COMPLETED|Overall Study||12
10441145|NCT00928564|11587559|FG000|NOT COMPLETED|Overall Study||6
10441146|NCT00928564|11587560|FG001|NOT COMPLETED|Overall Study||0
10441147|NCT00928642|11587566|FG000|STARTED|Overall Study||8
10525446|NCT01375777|11677355|FG004|NOT COMPLETED|Overall Study||1
10525447|NCT01375777|11677356|FG005|NOT COMPLETED|Overall Study||1
10525448|NCT01375777|11677357|FG006|NOT COMPLETED|Overall Study||2
10525449|NCT01375777|11677358|FG007|NOT COMPLETED|Overall Study||2
10525450|NCT01375777|11677359|FG008|NOT COMPLETED|Overall Study||2
10525451|NCT01375946|11677379|FG000|STARTED|Overall Study||4
10525452|NCT01375946|11677380|FG001|STARTED|Overall Study||4
10525453|NCT01375946|11677381|FG002|STARTED|Overall Study||4
10525454|NCT01375946|11677382|FG003|STARTED|Overall Study||4
10525455|NCT01375946|11677383|FG004|STARTED|Overall Study||4
10525456|NCT01375946|11677384|FG005|STARTED|Overall Study||4
10525457|NCT01375946|11677379|FG000|COMPLETED|Overall Study||4
10525458|NCT01375946|11677380|FG001|COMPLETED|Overall Study||4
10525459|NCT01375946|11677381|FG002|COMPLETED|Overall Study||4
10525460|NCT01375946|11677382|FG003|COMPLETED|Overall Study||4
10525461|NCT01375946|11677383|FG004|COMPLETED|Overall Study||4
10525462|NCT01375946|11677384|FG005|COMPLETED|Overall Study||4
10525463|NCT01375946|11677379|FG000|NOT COMPLETED|Overall Study||0
10525464|NCT01375946|11677380|FG001|NOT COMPLETED|Overall Study||0
10525465|NCT01375946|11677381|FG002|NOT COMPLETED|Overall Study||0
10525466|NCT01375946|11677382|FG003|NOT COMPLETED|Overall Study||0
10525467|NCT01375946|11677383|FG004|NOT COMPLETED|Overall Study||0
10525468|NCT01375946|11677384|FG005|NOT COMPLETED|Overall Study||0
10525469|NCT01376037|11677390|FG000|STARTED|Overall Study||31
10525470|NCT01376037|11677391|FG001|STARTED|Overall Study||31
10525471|NCT01376037|11677390|FG000|COMPLETED|Overall Study||31
10525472|NCT01376037|11677391|FG001|COMPLETED|Overall Study||29
10525473|NCT01376037|11677390|FG000|NOT COMPLETED|Overall Study||0
10525474|NCT01376037|11677391|FG001|NOT COMPLETED|Overall Study||2
10525475|NCT01376050|11677399|FG000|STARTED|Overall Study||13
10525476|NCT01376050|11677400|FG001|STARTED|Overall Study||11
10525477|NCT01376050|11677399|FG000|COMPLETED|Overall Study||13
10525478|NCT01376050|11677400|FG001|COMPLETED|Overall Study||11
10525479|NCT01376050|11677399|FG000|NOT COMPLETED|Overall Study||0
10525480|NCT01376050|11677400|FG001|NOT COMPLETED|Overall Study||0
10525481|NCT01376089|11677408|FG000|STARTED|Overall Study||151
10525482|NCT01376089|11677409|FG001|STARTED|Overall Study||148
10549854|NCT01527513|11703899|FG000|Efficacy PP Population|Double Blind Period (DB) - Part I||37
10549855|NCT01527513|11703900|FG001|Efficacy PP Population|Double Blind Period (DB) - Part I||67
10549856|NCT01527513|11703899|FG000|Per-protocol (PP) Population|Double Blind Period (DB) - Part I||36
10549857|NCT01527513|11703900|FG001|Per-protocol (PP) Population|Double Blind Period (DB) - Part I||66
10549858|NCT01527513|11703899|FG000|COMPLETED|Double Blind Period (DB) - Part I||37
10549859|NCT01527513|11703900|FG001|COMPLETED|Double Blind Period (DB) - Part I||75
10549860|NCT01527513|11703899|FG000|NOT COMPLETED|Double Blind Period (DB) - Part I||3
10549861|NCT01527513|11703900|FG001|NOT COMPLETED|Double Blind Period (DB) - Part I||8
10549862|NCT01527513|11703899|FG000|STARTED|Eligible for 1-Year Open Label Period||0
10549863|NCT01527513|11703900|FG001|STARTED|Eligible for 1-Year Open Label Period|Participants that were eligible to participate in for 1-Year Open Label Period - Part II|112
10549864|NCT01527513|11703899|FG000|COMPLETED|Eligible for 1-Year Open Label Period||0
10549865|NCT01527513|11703900|FG001|COMPLETED|Eligible for 1-Year Open Label Period||95
10549866|NCT01527513|11703899|FG000|NOT COMPLETED|Eligible for 1-Year Open Label Period||0
10549867|NCT01527513|11703900|FG001|NOT COMPLETED|Eligible for 1-Year Open Label Period||17
10549868|NCT01527682|11703908|FG000|STARTED|Overall Study||37
10549869|NCT01527682|11703908|FG000|COMPLETED|Overall Study||29
10549870|NCT01527682|11703908|FG000|NOT COMPLETED|Overall Study||8
10549871|NCT01528033|11703914|FG000|STARTED|Primary Endpoint Assessment ITT||273
10549872|NCT01528033|11703915|FG001|STARTED|Primary Endpoint Assessment ITT||266
10549873|NCT01528033|11703914|FG000|COMPLETED|Primary Endpoint Assessment ITT||256
10549874|NCT01528033|11703915|FG001|COMPLETED|Primary Endpoint Assessment ITT||251
10549875|NCT01528033|11703914|FG000|NOT COMPLETED|Primary Endpoint Assessment ITT||17
10549876|NCT01528033|11703915|FG001|NOT COMPLETED|Primary Endpoint Assessment ITT||15
10549877|NCT01528033|11703914|FG000|STARTED|Follow Up||256
10549878|NCT01528033|11703915|FG001|STARTED|Follow Up||251
10549879|NCT01528033|11703914|FG000|COMPLETED|Follow Up||210
10549880|NCT01528033|11703915|FG001|COMPLETED|Follow Up||207
10549881|NCT01528033|11703914|FG000|NOT COMPLETED|Follow Up||46
10549882|NCT01528033|11703915|FG001|NOT COMPLETED|Follow Up||44
10549883|NCT01528072|11703921|FG000|STARTED|Overall Study||140
10549884|NCT01528072|11703921|FG000|COMPLETED|Overall Study||66
10549885|NCT01528072|11703921|FG000|NOT COMPLETED|Overall Study||74
10549886|NCT01528124|11703932|FG000|STARTED|Overall Study||6
10549887|NCT01528124|11703933|FG001|STARTED|Overall Study||6
10549888|NCT01528124|11703934|FG002|STARTED|Overall Study||6
10549889|NCT01528124|11703935|FG003|STARTED|Overall Study||6
10549890|NCT01528124|11703936|FG004|STARTED|Overall Study||5
10549891|NCT01528124|11703937|FG005|STARTED|Overall Study||6
10549892|NCT01528124|11703938|FG006|STARTED|Overall Study||6
10549893|NCT01528124|11703932|FG000|Received Study Drug|Overall Study||6
10549894|NCT01528124|11703933|FG001|Received Study Drug|Overall Study||6
10549895|NCT01528124|11703934|FG002|Received Study Drug|Overall Study||6
10549896|NCT01528124|11703935|FG003|Received Study Drug|Overall Study||6
10549897|NCT01528124|11703936|FG004|Received Study Drug|Overall Study||5
10549898|NCT01528124|11703937|FG005|Received Study Drug|Overall Study||6
10549899|NCT01528124|11703938|FG006|Received Study Drug|Overall Study||6
10549900|NCT01528124|11703932|FG000|COMPLETED|Overall Study||6
10549901|NCT01528124|11703933|FG001|COMPLETED|Overall Study||6
10549902|NCT01528124|11703934|FG002|COMPLETED|Overall Study||6
10549903|NCT01528124|11703935|FG003|COMPLETED|Overall Study||6
10549904|NCT01528124|11703936|FG004|COMPLETED|Overall Study||5
10549905|NCT01528124|11703937|FG005|COMPLETED|Overall Study||6
10549906|NCT01528124|11703938|FG006|COMPLETED|Overall Study||6
10549907|NCT01528124|11703932|FG000|NOT COMPLETED|Overall Study||0
10549908|NCT01528124|11703933|FG001|NOT COMPLETED|Overall Study||0
10549909|NCT01528124|11703934|FG002|NOT COMPLETED|Overall Study||0
10549910|NCT01528124|11703935|FG003|NOT COMPLETED|Overall Study||0
10549911|NCT01528124|11703936|FG004|NOT COMPLETED|Overall Study||0
10549912|NCT01528124|11703937|FG005|NOT COMPLETED|Overall Study||0
10549913|NCT01528124|11703938|FG006|NOT COMPLETED|Overall Study||0
10549914|NCT01528150|11703960|FG000|STARTED|Overall Study||466
10549915|NCT01528150|11703960|FG000|COMPLETED|Overall Study||422
10549916|NCT01528150|11703960|FG000|NOT COMPLETED|Overall Study||44
10549917|NCT01528215|11703966|FG000|STARTED|Enrollment to 1 Year Follow-up||59
10549918|NCT01528215|11703967|FG001|STARTED|Enrollment to 1 Year Follow-up||61
10549919|NCT01528215|11703966|FG000|COMPLETED|Enrollment to 1 Year Follow-up||55
10549920|NCT01528215|11703967|FG001|COMPLETED|Enrollment to 1 Year Follow-up||60
10549921|NCT01528215|11703966|FG000|NOT COMPLETED|Enrollment to 1 Year Follow-up||4
10549922|NCT01528215|11703967|FG001|NOT COMPLETED|Enrollment to 1 Year Follow-up||1
10549923|NCT01528215|11703966|FG000|STARTED|1 Year Follow-up to 5 Year Follow-up||55
10549924|NCT01528215|11703967|FG001|STARTED|1 Year Follow-up to 5 Year Follow-up||60
10549925|NCT01528215|11703966|FG000|COMPLETED|1 Year Follow-up to 5 Year Follow-up||40
10549926|NCT01528215|11703967|FG001|COMPLETED|1 Year Follow-up to 5 Year Follow-up||45
10549927|NCT01528215|11703966|FG000|NOT COMPLETED|1 Year Follow-up to 5 Year Follow-up||15
10549928|NCT01528215|11703967|FG001|NOT COMPLETED|1 Year Follow-up to 5 Year Follow-up||15
10549929|NCT01528228|11703975|FG000|STARTED|Overall Study||10
10549930|NCT01528228|11703976|FG001|STARTED|Overall Study||10
10549931|NCT01528228|11703975|FG000|COMPLETED|Overall Study||9
10549932|NCT01528228|11703976|FG001|COMPLETED|Overall Study||9
10549933|NCT01528228|11703975|FG000|NOT COMPLETED|Overall Study||1
10549934|NCT01528228|11703976|FG001|NOT COMPLETED|Overall Study||1
10549935|NCT01528254|11703984|FG000|STARTED|Overall Study||998
10549936|NCT01528254|11703985|FG001|STARTED|Overall Study||1003
10549937|NCT01528254|11703984|FG000|Safety Set|Overall Study||998
10549938|NCT01528254|11703985|FG001|Safety Set|Overall Study||1001
10549939|NCT01528254|11703984|FG000|Full Analysis Set (FAS)|Overall Study||983
10549940|NCT01528254|11703985|FG001|Full Analysis Set (FAS)|Overall Study||989
10549941|NCT01528254|11703984|FG000|Completed Treatment Period 1|Overall Study||458
10549942|NCT01528254|11703985|FG001|Completed Treatment Period 1|Overall Study||273
10549943|NCT01528254|11703984|FG000|Completed Treatment Period 2|Overall Study||244
10549944|NCT01528254|11703985|FG001|Completed Treatment Period 2|Overall Study||399
10549945|NCT01528254|11703984|FG000|Completed Treatment Period 3|Overall Study||109
10549946|NCT01528254|11703985|FG001|Completed Treatment Period 3|Overall Study||115
10549947|NCT01528254|11703984|FG000|COMPLETED|Overall Study||811
10549948|NCT01528254|11703985|FG001|COMPLETED|Overall Study||787
10549949|NCT01528254|11703984|FG000|NOT COMPLETED|Overall Study||187
10549950|NCT01528254|11703985|FG001|NOT COMPLETED|Overall Study||216
10549951|NCT01528319|11703992|FG000|STARTED|Overall Study||24
10549952|NCT01528319|11703992|FG000|12 Weeks After Surgery|Overall Study||24
10549953|NCT01528319|11703992|FG000|COMPLETED|Overall Study||23
10549954|NCT01528319|11703992|FG000|NOT COMPLETED|Overall Study||1
10549955|NCT01528332|11703998|FG000|STARTED|Overall Study||85
10549956|NCT01528332|11703999|FG001|STARTED|Overall Study||86
10549957|NCT01528332|11703998|FG000|COMPLETED|Overall Study||81
10549958|NCT01528332|11703999|FG001|COMPLETED|Overall Study||84
10549959|NCT01528332|11703998|FG000|NOT COMPLETED|Overall Study||4
10549960|NCT01528332|11703999|FG001|NOT COMPLETED|Overall Study||2
10549961|NCT01528345|11704007|FG000|STARTED|Overall Study||47
10549962|NCT01528345|11704008|FG001|STARTED|Overall Study||50
10549963|NCT01528345|11704007|FG000|COMPLETED|Overall Study||0
10549964|NCT01528345|11704008|FG001|COMPLETED|Overall Study||0
10549965|NCT01528345|11704007|FG000|NOT COMPLETED|Overall Study||47
10549966|NCT01528345|11704008|FG001|NOT COMPLETED|Overall Study||50
10549967|NCT01528592|11704014|FG000|STARTED|Overall Study||18
10549968|NCT01528592|11704014|FG000|COMPLETED|Overall Study||18
10549969|NCT01528592|11704014|FG000|NOT COMPLETED|Overall Study||0
10549970|NCT01528605|11704024|FG000|STARTED|Overall Study||28
10549971|NCT01528605|11704025|FG001|STARTED|Overall Study||28
10549972|NCT01528605|11704026|FG002|STARTED|Overall Study||28
10549973|NCT01528605|11704027|FG003|STARTED|Overall Study||28
10549974|NCT01528605|11704028|FG004|STARTED|Overall Study||28
10549975|NCT01528605|11704029|FG005|STARTED|Overall Study||28
10549976|NCT01528605|11704024|FG000|COMPLETED|Overall Study||26
10549977|NCT01528605|11704025|FG001|COMPLETED|Overall Study||28
10549978|NCT01528605|11704026|FG002|COMPLETED|Overall Study||27
10549979|NCT01528605|11704027|FG003|COMPLETED|Overall Study||27
10549980|NCT01528605|11704028|FG004|COMPLETED|Overall Study||28
10549981|NCT01528605|11704029|FG005|COMPLETED|Overall Study||28
10549982|NCT01528605|11704024|FG000|NOT COMPLETED|Overall Study||2
10549983|NCT01528605|11704025|FG001|NOT COMPLETED|Overall Study||0
10549984|NCT01528605|11704026|FG002|NOT COMPLETED|Overall Study||1
10549985|NCT01528605|11704027|FG003|NOT COMPLETED|Overall Study||1
10549986|NCT01528605|11704028|FG004|NOT COMPLETED|Overall Study||0
10549987|NCT01528605|11704029|FG005|NOT COMPLETED|Overall Study||0
10549988|NCT01528709|11704045|FG000|STARTED|Overall Study||86
10549989|NCT01528709|11704046|FG001|STARTED|Overall Study||87
10549990|NCT01528709|11704045|FG000|COMPLETED|Overall Study||73
10549991|NCT01528709|11704046|FG001|COMPLETED|Overall Study||72
10549992|NCT01528709|11704045|FG000|NOT COMPLETED|Overall Study||13
10549993|NCT01528709|11704046|FG001|NOT COMPLETED|Overall Study||15
10549994|NCT01528735|11704054|FG000|STARTED|Treatment Period 1: Faldap/Del/RBV||12
10549995|NCT01528735|11704055|FG001|STARTED|Treatment Period 1: Faldap/Del/RBV||13
10549996|NCT01528735|11704054|FG000|COMPLETED|Treatment Period 1: Faldap/Del/RBV||11
10549997|NCT01528735|11704055|FG001|COMPLETED|Treatment Period 1: Faldap/Del/RBV||12
10549998|NCT01528735|11704054|FG000|NOT COMPLETED|Treatment Period 1: Faldap/Del/RBV||1
10549999|NCT01528735|11704055|FG001|NOT COMPLETED|Treatment Period 1: Faldap/Del/RBV||1
10550000|NCT01528735|11704054|FG000|STARTED|Treatment Period 2: Faldap/PegIFN/RBV||11
10550001|NCT01528735|11704055|FG001|STARTED|Treatment Period 2: Faldap/PegIFN/RBV|One patient was treated with only PegIFN/RBV, as faldaprevir was discontinued due to adverse events|12
10550002|NCT01528735|11704054|FG000|COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||10
10550003|NCT01528735|11704055|FG001|COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||12
10550004|NCT01528735|11704054|FG000|NOT COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||1
10441242|NCT00929201|11587690|FG000|STARTED|7-day Washout||30
10550005|NCT01528735|11704055|FG001|NOT COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||0
10550006|NCT01528787|11704067|FG000|STARTED|Overall Study||22
10550007|NCT01528787|11704068|FG001|STARTED|Overall Study||21
10550008|NCT01528787|11704069|FG002|STARTED|Overall Study||19
10550009|NCT01528787|11704070|FG003|STARTED|Overall Study||23
10550010|NCT01528787|11704067|FG000|COMPLETED|Overall Study||22
10550011|NCT01528787|11704068|FG001|COMPLETED|Overall Study||21
10550012|NCT01528787|11704069|FG002|COMPLETED|Overall Study||18
10550013|NCT01528787|11704070|FG003|COMPLETED|Overall Study||22
10550014|NCT01528787|11704067|FG000|NOT COMPLETED|Overall Study||0
10550015|NCT01528787|11704068|FG001|NOT COMPLETED|Overall Study||0
10550016|NCT01528787|11704069|FG002|NOT COMPLETED|Overall Study||1
10550017|NCT01528787|11704070|FG003|NOT COMPLETED|Overall Study||1
10550018|NCT01528878|11704080|FG000|STARTED|Overall Study||30
10550019|NCT01528878|11704080|FG000|COMPLETED|Overall Study||30
10550020|NCT01528878|11704080|FG000|NOT COMPLETED|Overall Study||0
10550021|NCT01528891|11704088|FG000|STARTED|Overall Study||200
10550022|NCT01528891|11704089|FG001|STARTED|Overall Study||200
10550023|NCT01528891|11704088|FG000|COMPLETED|Overall Study||200
10550024|NCT01528891|11704089|FG001|COMPLETED|Overall Study||200
10550025|NCT01528891|11704088|FG000|NOT COMPLETED|Overall Study||0
10550026|NCT01528891|11704089|FG001|NOT COMPLETED|Overall Study||0
10550027|NCT01528969|11704099|FG000|STARTED|Overall Study||37
10550028|NCT01528969|11704100|FG001|STARTED|Overall Study||38
10550029|NCT01528969|11704099|FG000|COMPLETED|Overall Study||35
10550030|NCT01528969|11704100|FG001|COMPLETED|Overall Study||38
10550031|NCT01528969|11704099|FG000|NOT COMPLETED|Overall Study||2
10550032|NCT01528969|11704100|FG001|NOT COMPLETED|Overall Study||0
10441148|NCT00928642|11587566|FG000|COMPLETED|Overall Study|1 subject withdrew after 1st cycle but before disease assessment. 7 of 8 are evaluable for response|8
10441149|NCT00928642|11587566|FG000|NOT COMPLETED|Overall Study||0
10441150|NCT00928668|11587573|FG000|STARTED|Overall Study||7
10441151|NCT00928668|11587574|FG001|STARTED|Overall Study||7
10441152|NCT00928668|11587575|FG002|STARTED|Overall Study||7
10441153|NCT00928668|11587576|FG003|STARTED|Overall Study||4
10441154|NCT00928668|11587577|FG004|STARTED|Overall Study||6
10441155|NCT00928668|11587573|FG000|COMPLETED|Overall Study||6
10441156|NCT00928668|11587574|FG001|COMPLETED|Overall Study||6
10441157|NCT00928668|11587575|FG002|COMPLETED|Overall Study||6
10441158|NCT00928668|11587576|FG003|COMPLETED|Overall Study||3
10441159|NCT00928668|11587577|FG004|COMPLETED|Overall Study||5
10441160|NCT00928668|11587573|FG000|NOT COMPLETED|Overall Study||1
10441161|NCT00928668|11587574|FG001|NOT COMPLETED|Overall Study||1
10441162|NCT00928668|11587575|FG002|NOT COMPLETED|Overall Study||1
10550033|NCT01529034|11704106|FG000|STARTED|Overall Study|Completed Study P261-401 and rolled over to Study P261-402|175
10550034|NCT01529034|11704106|FG000|Exposed|Overall Study|Treated at least 1 seizure cluster with USL261|161
10550035|NCT01529034|11704106|FG000|COMPLETED|Overall Study|Completed under initial protocol duration of 2 years; amended protocol open-ended duration|1
10550036|NCT01529034|11704106|FG000|NOT COMPLETED|Overall Study||174
10550037|NCT01529060|11704113|FG000|STARTED|Overall Study||10
10550038|NCT01529060|11704114|FG001|STARTED|Overall Study||10
10550039|NCT01529060|11704113|FG000|COMPLETED|Overall Study||10
10550040|NCT01529060|11704114|FG001|COMPLETED|Overall Study||10
10550041|NCT01529060|11704113|FG000|NOT COMPLETED|Overall Study||0
10550042|NCT01529060|11704114|FG001|NOT COMPLETED|Overall Study||0
10550043|NCT01529112|11704123|FG000|STARTED|Overall Study||89
10550044|NCT01529112|11704124|FG001|STARTED|Overall Study||46
10550045|NCT01529112|11704123|FG000|COMPLETED|Overall Study|On treatment=2, Discontinued treatment-continued follow-up=18 (data cut-off date 21 January 2014)|20
10550046|NCT01529112|11704124|FG001|COMPLETED|Overall Study|Discontinued treatment-continued follow-up=5 (data cut-off date 21 January 2014)|5
10550047|NCT01529112|11704123|FG000|NOT COMPLETED|Overall Study||69
10550048|NCT01529112|11704124|FG001|NOT COMPLETED|Overall Study||41
10550049|NCT01529203|11704130|FG000|STARTED|Overall Study||60
10550050|NCT01529203|11704130|FG000|COMPLETED|Overall Study||57
10550051|NCT01529203|11704130|FG000|NOT COMPLETED|Overall Study||3
10550052|NCT01529268|11704136|FG000|STARTED|Overall Study||88
10550053|NCT01529268|11704137|FG001|STARTED|Overall Study||81
10550054|NCT01529268|11704136|FG000|Completed 52-week Biopsy|Overall Study||71
10550055|NCT01529268|11704137|FG001|Completed 52-week Biopsy|Overall Study||75
10550056|NCT01529268|11704136|FG000|COMPLETED|Overall Study||76
10550057|NCT01529268|11704137|FG001|COMPLETED|Overall Study||78
10550058|NCT01529268|11704136|FG000|NOT COMPLETED|Overall Study||12
10550059|NCT01529268|11704137|FG001|NOT COMPLETED|Overall Study||3
10550060|NCT01529346|11704148|FG000|STARTED|Overall Study||55
10550061|NCT01529346|11704149|FG001|STARTED|Overall Study||54
10550062|NCT01529346|11704150|FG002|STARTED|Overall Study||54
10550063|NCT01529346|11704151|FG003|STARTED|Overall Study||36
10550064|NCT01529346|11704152|FG004|STARTED|Overall Study||36
10550065|NCT01529346|11704148|FG000|COMPLETED|Overall Study||53
10550066|NCT01529346|11704149|FG001|COMPLETED|Overall Study||53
10550067|NCT01529346|11704150|FG002|COMPLETED|Overall Study||52
10550068|NCT01529346|11704151|FG003|COMPLETED|Overall Study||36
10550069|NCT01529346|11704152|FG004|COMPLETED|Overall Study||36
10550070|NCT01529346|11704148|FG000|NOT COMPLETED|Overall Study||2
10550071|NCT01529346|11704149|FG001|NOT COMPLETED|Overall Study||1
10550072|NCT01529346|11704150|FG002|NOT COMPLETED|Overall Study||2
10550073|NCT01529346|11704151|FG003|NOT COMPLETED|Overall Study||0
10550074|NCT01529346|11704152|FG004|NOT COMPLETED|Overall Study||0
10550075|NCT01529385|11704167|FG000|STARTED|Overall Study||40
10550076|NCT01529385|11704168|FG001|STARTED|Overall Study||40
10441243|NCT00929201|11587691|FG001|STARTED|7-day Washout||30
10550077|NCT01529385|11704167|FG000|Received Intervention|Overall Study|1 participant failed to show up to treatment allocation visit and was subsequently lost to follow up|39
10550078|NCT01529385|11704168|FG001|Received Intervention|Overall Study||40
10550079|NCT01529385|11704167|FG000|COMPLETED|Overall Study||38
10550080|NCT01529385|11704168|FG001|COMPLETED|Overall Study||39
10550081|NCT01529385|11704167|FG000|NOT COMPLETED|Overall Study||2
10550082|NCT01529385|11704168|FG001|NOT COMPLETED|Overall Study||1
10550083|NCT01529450|11704176|FG000|STARTED|Overall Study||3
10550084|NCT01529450|11704177|FG001|STARTED|Overall Study||8
10550085|NCT01529450|11704176|FG000|COMPLETED|Overall Study||3
10441163|NCT00928668|11587576|FG003|NOT COMPLETED|Overall Study||1
10441164|NCT00928668|11587577|FG004|NOT COMPLETED|Overall Study||1
10550086|NCT01529450|11704177|FG001|COMPLETED|Overall Study||6
10550087|NCT01529450|11704176|FG000|NOT COMPLETED|Overall Study||0
10550088|NCT01529450|11704177|FG001|NOT COMPLETED|Overall Study||2
10441165|NCT00928694|11587594|FG000|STARTED|First Intervention||7
10441166|NCT00928694|11587595|FG001|STARTED|First Intervention||7
10441167|NCT00928694|11587594|FG000|COMPLETED|First Intervention||7
10441168|NCT00928694|11587595|FG001|COMPLETED|First Intervention||7
10441169|NCT00928694|11587594|FG000|NOT COMPLETED|First Intervention||0
10441170|NCT00928694|11587595|FG001|NOT COMPLETED|First Intervention||0
10441171|NCT00928694|11587594|FG000|STARTED|Second Intervention||7
10441172|NCT00928694|11587595|FG001|STARTED|Second Intervention||7
10441173|NCT00928694|11587594|FG000|COMPLETED|Second Intervention||7
10441174|NCT00928694|11587595|FG001|COMPLETED|Second Intervention||7
10441175|NCT00928694|11587594|FG000|NOT COMPLETED|Second Intervention||0
10441176|NCT00928694|11587595|FG001|NOT COMPLETED|Second Intervention||0
10441177|NCT00928707|11587603|FG000|STARTED|Overall Study||23
10441178|NCT00928707|11587604|FG001|STARTED|Overall Study||22
10441179|NCT00928707|11587603|FG000|COMPLETED|Overall Study||22
10441180|NCT00928707|11587604|FG001|COMPLETED|Overall Study||22
10441181|NCT00928707|11587603|FG000|NOT COMPLETED|Overall Study||1
10441182|NCT00928707|11587604|FG001|NOT COMPLETED|Overall Study||0
10441183|NCT00928720|11587613|FG000|STARTED|Overall Study||19
10441184|NCT00928720|11587614|FG001|STARTED|Overall Study||20
10441185|NCT00928720|11587615|FG002|STARTED|Overall Study||18
10441186|NCT00928720|11587613|FG000|COMPLETED|Overall Study||17
10441187|NCT00928720|11587614|FG001|COMPLETED|Overall Study||14
10441188|NCT00928720|11587615|FG002|COMPLETED|Overall Study||15
10441189|NCT00928720|11587613|FG000|NOT COMPLETED|Overall Study||2
10441190|NCT00928720|11587614|FG001|NOT COMPLETED|Overall Study||6
10441191|NCT00928720|11587615|FG002|NOT COMPLETED|Overall Study||3
10441192|NCT00928746|11587626|FG000|STARTED|Overall Study||142
10441193|NCT00928746|11587626|FG000|COMPLETED|Overall Study||136
10441194|NCT00928746|11587626|FG000|NOT COMPLETED|Overall Study||6
10441195|NCT00928772|11587635|FG000|STARTED|Overall Study||39
10441196|NCT00928772|11587636|FG001|STARTED|Overall Study||38
10441197|NCT00928772|11587637|FG002|STARTED|Overall Study||38
10441198|NCT00928772|11587635|FG000|COMPLETED|Overall Study||39
10441199|NCT00928772|11587636|FG001|COMPLETED|Overall Study||38
10441200|NCT00928772|11587637|FG002|COMPLETED|Overall Study||38
10441201|NCT00928772|11587635|FG000|NOT COMPLETED|Overall Study||0
10441202|NCT00928772|11587636|FG001|NOT COMPLETED|Overall Study||0
10441203|NCT00928772|11587637|FG002|NOT COMPLETED|Overall Study||0
10441204|NCT00928889|11587647|FG000|STARTED|Overall Study||80
10441205|NCT00928889|11587648|FG001|STARTED|Overall Study||80
10441206|NCT00928889|11587647|FG000|COMPLETED|Overall Study||75
10441207|NCT00928889|11587648|FG001|COMPLETED|Overall Study||78
10441208|NCT00928889|11587647|FG000|NOT COMPLETED|Overall Study||5
10441209|NCT00928889|11587648|FG001|NOT COMPLETED|Overall Study||2
10441210|NCT00928954|11587654|FG000|STARTED|Overall Study||4
10441211|NCT00928954|11587655|FG001|STARTED|Overall Study||6
10441212|NCT00928954|11587654|FG000|COMPLETED|Overall Study||4
10441213|NCT00928954|11587655|FG001|COMPLETED|Overall Study||6
10441214|NCT00928954|11587654|FG000|NOT COMPLETED|Overall Study||0
10441215|NCT00928954|11587655|FG001|NOT COMPLETED|Overall Study||0
10441216|NCT00929071|11587661|FG000|STARTED|Overall Study||10
10441217|NCT00929071|11587661|FG000|COMPLETED|Overall Study||10
10441218|NCT00929071|11587661|FG000|NOT COMPLETED|Overall Study||0
10441219|NCT00929110|11587671|FG000|STARTED|Overall Study||529
10441220|NCT00929110|11587672|FG001|STARTED|Overall Study||269
10441221|NCT00929110|11587673|FG002|STARTED|Overall Study||268
10441222|NCT00929110|11587671|FG000|COMPLETED|Overall Study||411
10441223|NCT00929110|11587672|FG001|COMPLETED|Overall Study||193
10441224|NCT00929110|11587673|FG002|COMPLETED|Overall Study||206
10441225|NCT00929110|11587671|FG000|NOT COMPLETED|Overall Study||118
10441226|NCT00929110|11587672|FG001|NOT COMPLETED|Overall Study||76
10441227|NCT00929110|11587673|FG002|NOT COMPLETED|Overall Study||62
10441228|NCT00929162|11587683|FG000|STARTED|Overall Study||59
10441229|NCT00929162|11587684|FG001|STARTED|Overall Study||61
10441230|NCT00929162|11587683|FG000|Patients Who Received Treatment|Overall Study||58
10441231|NCT00929162|11587684|FG001|Patients Who Received Treatment|Overall Study||58
10441232|NCT00929162|11587683|FG000|COMPLETED|Overall Study||11
10441233|NCT00929162|11587684|FG001|COMPLETED|Overall Study||19
10441234|NCT00929162|11587683|FG000|NOT COMPLETED|Overall Study||48
10441235|NCT00929162|11587684|FG001|NOT COMPLETED|Overall Study||42
10441236|NCT00929201|11587690|FG000|STARTED|Period 1||30
10441237|NCT00929201|11587691|FG001|STARTED|Period 1||31
10441238|NCT00929201|11587690|FG000|COMPLETED|Period 1||30
10441239|NCT00929201|11587691|FG001|COMPLETED|Period 1||30
10441240|NCT00929201|11587690|FG000|NOT COMPLETED|Period 1||0
10441241|NCT00929201|11587691|FG001|NOT COMPLETED|Period 1||1
10441244|NCT00929201|11587690|FG000|COMPLETED|7-day Washout||30
10441245|NCT00929201|11587691|FG001|COMPLETED|7-day Washout||30
10441246|NCT00929201|11587690|FG000|NOT COMPLETED|7-day Washout||0
10441247|NCT00929201|11587691|FG001|NOT COMPLETED|7-day Washout||0
10441248|NCT00929201|11587690|FG000|STARTED|Period 2||30
10441249|NCT00929201|11587691|FG001|STARTED|Period 2||30
10441250|NCT00929201|11587690|FG000|COMPLETED|Period 2||30
10441251|NCT00929201|11587691|FG001|COMPLETED|Period 2||30
10441252|NCT00929201|11587690|FG000|NOT COMPLETED|Period 2||0
10441253|NCT00929201|11587691|FG001|NOT COMPLETED|Period 2||0
10441254|NCT00929240|11587698|FG000|STARTED|Initial Treatment Phase|Includes only the participants that received Initial Phase Treatment.|284
10441255|NCT00929240|11587699|FG001|STARTED|Initial Treatment Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|0
10550089|NCT01529502|11704190|FG000|STARTED|Overall Study||2
10550090|NCT01529502|11704191|FG001|STARTED|Overall Study||3
10550091|NCT01529502|11704192|FG002|STARTED|Overall Study||2
10550092|NCT01529502|11704193|FG003|STARTED|Overall Study||3
10441256|NCT00929240|11587700|FG002|STARTED|Initial Treatment Phase||0
10441257|NCT00929240|11587698|FG000|COMPLETED|Initial Treatment Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|185
10441258|NCT00929240|11587699|FG001|COMPLETED|Initial Treatment Phase||0
10441259|NCT00929240|11587700|FG002|COMPLETED|Initial Treatment Phase||0
10441260|NCT00929240|11587698|FG000|NOT COMPLETED|Initial Treatment Phase||99
10441261|NCT00929240|11587699|FG001|NOT COMPLETED|Initial Treatment Phase||0
10441262|NCT00929240|11587700|FG002|NOT COMPLETED|Initial Treatment Phase||0
10441263|NCT00929240|11587698|FG000|STARTED|Maintenance Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|0
10441264|NCT00929240|11587699|FG001|STARTED|Maintenance Phase||94
10441265|NCT00929240|11587700|FG002|STARTED|Maintenance Phase||91
10441266|NCT00929240|11587698|FG000|COMPLETED|Maintenance Phase||0
10441267|NCT00929240|11587699|FG001|COMPLETED|Maintenance Phase||0
10441268|NCT00929240|11587700|FG002|COMPLETED|Maintenance Phase||0
10441269|NCT00929240|11587698|FG000|NOT COMPLETED|Maintenance Phase||0
10550093|NCT01529502|11704194|FG004|STARTED|Overall Study||2
10550094|NCT01529502|11704195|FG005|STARTED|Overall Study||2
10550095|NCT01529502|11704190|FG000|COMPLETED|Overall Study||2
10550096|NCT01529502|11704191|FG001|COMPLETED|Overall Study||3
10550097|NCT01529502|11704192|FG002|COMPLETED|Overall Study||2
10550098|NCT01529502|11704193|FG003|COMPLETED|Overall Study||1
10550099|NCT01529502|11704194|FG004|COMPLETED|Overall Study||2
10550100|NCT01529502|11704195|FG005|COMPLETED|Overall Study||2
10550101|NCT01529502|11704190|FG000|NOT COMPLETED|Overall Study||0
10550102|NCT01529502|11704191|FG001|NOT COMPLETED|Overall Study||0
10550103|NCT01529502|11704192|FG002|NOT COMPLETED|Overall Study||0
10550104|NCT01529502|11704193|FG003|NOT COMPLETED|Overall Study||2
10550105|NCT01529502|11704194|FG004|NOT COMPLETED|Overall Study||0
10550106|NCT01529502|11704195|FG005|NOT COMPLETED|Overall Study||0
10550107|NCT01529515|11704205|FG000|STARTED|TRANSITION PHASE||506
10550108|NCT01529515|11704206|FG001|STARTED|TRANSITION PHASE||0
10550109|NCT01529515|11704207|FG002|STARTED|TRANSITION PHASE||0
10550110|NCT01529515|11704208|FG003|STARTED|TRANSITION PHASE||0
10550111|NCT01529515|11704205|FG000|COMPLETED|TRANSITION PHASE||379
10550112|NCT01529515|11704206|FG001|COMPLETED|TRANSITION PHASE||0
10789395|NCT03520387|11949814|FG002|NOT COMPLETED|Pre-Randomization||0
10789396|NCT03520387|11949815|FG003|NOT COMPLETED|Pre-Randomization||0
10441270|NCT00929240|11587699|FG001|NOT COMPLETED|Maintenance Phase||94
10441271|NCT00929240|11587700|FG002|NOT COMPLETED|Maintenance Phase||91
10441272|NCT00929305|11587711|FG000|STARTED|Overall Study||43
10441273|NCT00929305|11587712|FG001|STARTED|Overall Study||43
10441274|NCT00929305|11587711|FG000|COMPLETED|Overall Study||43
10441275|NCT00929305|11587712|FG001|COMPLETED|Overall Study||43
10441276|NCT00929305|11587711|FG000|NOT COMPLETED|Overall Study||0
10441277|NCT00929305|11587712|FG001|NOT COMPLETED|Overall Study||0
10441278|NCT00929331|11587721|FG000|STARTED|Overall Study||55
10441279|NCT00929331|11587722|FG001|STARTED|Overall Study||55
10441280|NCT00929331|11587721|FG000|COMPLETED|Overall Study||55
10441281|NCT00929331|11587722|FG001|COMPLETED|Overall Study||55
10441282|NCT00929331|11587721|FG000|NOT COMPLETED|Overall Study||0
10441283|NCT00929331|11587722|FG001|NOT COMPLETED|Overall Study||0
10441284|NCT00929344|11587731|FG000|STARTED|Overall Study||50
10441285|NCT00929344|11587732|FG001|STARTED|Overall Study||50
10789397|NCT03520387|11949816|FG004|NOT COMPLETED|Pre-Randomization||0
10789398|NCT03520387|11949812|FG000|STARTED|Randomized|There are no participants in this group during this period, because the pre-randomization run-in period has ended.|0
10810689|NCT03792672|11972460|FG004|STARTED|Washout Period 1 (10 Days)||4
10810690|NCT03792672|11972461|FG005|STARTED|Washout Period 1 (10 Days)||4
10441286|NCT00929344|11587733|FG002|STARTED|Overall Study||50
10441287|NCT00929344|11587731|FG000|COMPLETED|Overall Study||28
10441288|NCT00929344|11587732|FG001|COMPLETED|Overall Study||37
10441289|NCT00929344|11587733|FG002|COMPLETED|Overall Study||29
10441290|NCT00929344|11587731|FG000|NOT COMPLETED|Overall Study||22
10441291|NCT00929344|11587732|FG001|NOT COMPLETED|Overall Study||13
10441292|NCT00929344|11587733|FG002|NOT COMPLETED|Overall Study||21
10441293|NCT00929357|11587743|FG000|STARTED|Overall Study||92
10441294|NCT00929357|11587744|FG001|STARTED|Overall Study||64
10441295|NCT00929357|11587743|FG000|COMPLETED|Overall Study||92
10441296|NCT00929357|11587744|FG001|COMPLETED|Overall Study||64
10441297|NCT00929357|11587743|FG000|NOT COMPLETED|Overall Study||0
10441298|NCT00929357|11587744|FG001|NOT COMPLETED|Overall Study||0
10550113|NCT01529515|11704207|FG002|COMPLETED|TRANSITION PHASE||0
10550114|NCT01529515|11704208|FG003|COMPLETED|TRANSITION PHASE||0
10550115|NCT01529515|11704205|FG000|NOT COMPLETED|TRANSITION PHASE||127
10550116|NCT01529515|11704206|FG001|NOT COMPLETED|TRANSITION PHASE||0
10550117|NCT01529515|11704207|FG002|NOT COMPLETED|TRANSITION PHASE||0
10810691|NCT03792672|11972456|FG000|COMPLETED|Washout Period 1 (10 Days)||4
10810692|NCT03792672|11972457|FG001|COMPLETED|Washout Period 1 (10 Days)||4
10441299|NCT00929383|11587750|FG000|STARTED|Overall Study||82
10441300|NCT00929383|11587750|FG000|COMPLETED|Overall Study||67
10441301|NCT00929383|11587750|FG000|NOT COMPLETED|Overall Study||15
10441302|NCT00929500|11587756|FG000|STARTED|Overall Study||8
10550118|NCT01529515|11704208|FG003|NOT COMPLETED|TRANSITION PHASE||0
10550119|NCT01529515|11704205|FG000|STARTED|MAINTENANCE PHASE||0
10550120|NCT01529515|11704206|FG001|STARTED|MAINTENANCE PHASE||379
10550121|NCT01529515|11704207|FG002|STARTED|MAINTENANCE PHASE||0
10550122|NCT01529515|11704208|FG003|STARTED|MAINTENANCE PHASE||0
10550123|NCT01529515|11704205|FG000|COMPLETED|MAINTENANCE PHASE||0
10789399|NCT03520387|11949813|FG001|STARTED|Randomized|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment.|4
10810693|NCT03792672|11972458|FG002|COMPLETED|Washout Period 1 (10 Days)||4
10810694|NCT03792672|11972459|FG003|COMPLETED|Washout Period 1 (10 Days)||4
10441303|NCT00929500|11587757|FG001|STARTED|Overall Study||4
10441304|NCT00929500|11587756|FG000|COMPLETED|Overall Study||4
10441305|NCT00929500|11587757|FG001|COMPLETED|Overall Study||4
10441306|NCT00929500|11587756|FG000|NOT COMPLETED|Overall Study||4
10441307|NCT00929500|11587757|FG001|NOT COMPLETED|Overall Study||0
10441308|NCT00929526|11587765|FG000|STARTED|Overall Study||375
10441309|NCT00929526|11587766|FG001|STARTED|Overall Study||377
10441310|NCT00929526|11587765|FG000|COMPLETED|Overall Study||358
10441311|NCT00929526|11587766|FG001|COMPLETED|Overall Study||348
10441312|NCT00929526|11587765|FG000|NOT COMPLETED|Overall Study||17
10441313|NCT00929526|11587766|FG001|NOT COMPLETED|Overall Study||29
10441314|NCT00929578|11587772|FG000|STARTED|Overall Study||15
10441315|NCT00929578|11587772|FG000|COMPLETED|Overall Study||15
10441316|NCT00929578|11587772|FG000|NOT COMPLETED|Overall Study||0
10441317|NCT00929643|11587781|FG000|STARTED|Overall Study||203
10441318|NCT00929643|11587781|FG000|COMPLETED|Overall Study||201
10441319|NCT00929643|11587781|FG000|NOT COMPLETED|Overall Study||2
10441320|NCT00929656|11587787|FG000|STARTED|Overall Study||13
10441321|NCT00929656|11587788|FG001|STARTED|Overall Study||9
10441322|NCT00929656|11587787|FG000|COMPLETED|Overall Study||13
10441323|NCT00929656|11587788|FG001|COMPLETED|Overall Study||8
10441324|NCT00929656|11587787|FG000|NOT COMPLETED|Overall Study||0
10441325|NCT00929656|11587788|FG001|NOT COMPLETED|Overall Study||1
10441326|NCT00929669|11587794|FG000|STARTED|Overall Study||2
10441327|NCT00929669|11587794|FG000|COMPLETED|Overall Study||1
10441328|NCT00929669|11587794|FG000|NOT COMPLETED|Overall Study||1
10441329|NCT00929695|11587800|FG000|STARTED|Overall Study||81
10441330|NCT00929695|11587801|FG001|STARTED|Overall Study||83
10441331|NCT00929695|11587800|FG000|COMPLETED|Overall Study||73
10441332|NCT00929695|11587801|FG001|COMPLETED|Overall Study||77
10441333|NCT00929695|11587800|FG000|NOT COMPLETED|Overall Study||8
10441334|NCT00929695|11587801|FG001|NOT COMPLETED|Overall Study||6
10441335|NCT00929708|11587817|FG000|STARTED|Overall Study||65
10441336|NCT00929708|11587818|FG001|STARTED|Overall Study||69
10441337|NCT00929708|11587819|FG002|STARTED|Overall Study||65
10441338|NCT00929708|11587820|FG003|STARTED|Overall Study||67
10441339|NCT00929708|11587821|FG004|STARTED|Overall Study||63
10441340|NCT00929708|11587817|FG000|COMPLETED|Overall Study||61
10441341|NCT00929708|11587818|FG001|COMPLETED|Overall Study||66
10441342|NCT00929708|11587819|FG002|COMPLETED|Overall Study||62
10441343|NCT00929708|11587820|FG003|COMPLETED|Overall Study||61
10441344|NCT00929708|11587821|FG004|COMPLETED|Overall Study||57
10441345|NCT00929708|11587817|FG000|NOT COMPLETED|Overall Study||4
10441346|NCT00929708|11587818|FG001|NOT COMPLETED|Overall Study||3
10441347|NCT00929708|11587819|FG002|NOT COMPLETED|Overall Study||3
10441348|NCT00929708|11587820|FG003|NOT COMPLETED|Overall Study||6
10441349|NCT00929708|11587821|FG004|NOT COMPLETED|Overall Study||6
10441350|NCT00929734|11587835|FG000|STARTED|Overall Study||49
10441351|NCT00929734|11587836|FG001|STARTED|Overall Study||50
10441352|NCT00929734|11587835|FG000|COMPLETED|Overall Study||47
10441353|NCT00929734|11587836|FG001|COMPLETED|Overall Study||47
10441354|NCT00929734|11587835|FG000|NOT COMPLETED|Overall Study||2
10441355|NCT00929734|11587836|FG001|NOT COMPLETED|Overall Study||3
10441356|NCT00929773|11587844|FG000|STARTED|Overall Study||50
10441357|NCT00929773|11587845|FG001|STARTED|Overall Study||50
10441358|NCT00929773|11587844|FG000|COMPLETED|Overall Study||50
10441359|NCT00929773|11587845|FG001|COMPLETED|Overall Study||50
10441360|NCT00929773|11587844|FG000|NOT COMPLETED|Overall Study||0
10441361|NCT00929773|11587845|FG001|NOT COMPLETED|Overall Study||0
10441362|NCT00929838|11587856|FG000|STARTED|Overall Study||63
10441363|NCT00929838|11587857|FG001|STARTED|Overall Study||65
10441364|NCT00929838|11587858|FG002|STARTED|Overall Study||63
10441365|NCT00929838|11587859|FG003|STARTED|Overall Study||64
10441366|NCT00929838|11587856|FG000|COMPLETED|Overall Study||53
10441367|NCT00929838|11587857|FG001|COMPLETED|Overall Study||56
10441368|NCT00929838|11587858|FG002|COMPLETED|Overall Study||53
10441369|NCT00929838|11587859|FG003|COMPLETED|Overall Study||55
10441370|NCT00929838|11587856|FG000|NOT COMPLETED|Overall Study||10
10441371|NCT00929838|11587857|FG001|NOT COMPLETED|Overall Study||9
10441372|NCT00929838|11587858|FG002|NOT COMPLETED|Overall Study||10
10441373|NCT00929838|11587859|FG003|NOT COMPLETED|Overall Study||9
10441374|NCT00929864|11587871|FG000|STARTED|Overall Study||318
10441375|NCT00929864|11587872|FG001|STARTED|Overall Study||328
10441376|NCT00929864|11587871|FG000|COMPLETED|Overall Study||252
10441377|NCT00929864|11587872|FG001|COMPLETED|Overall Study||245
10550124|NCT01529515|11704206|FG001|COMPLETED|MAINTENANCE PHASE||305
10441378|NCT00929864|11587871|FG000|NOT COMPLETED|Overall Study||66
10441379|NCT00929864|11587872|FG001|NOT COMPLETED|Overall Study||83
10441380|NCT00929981|11587878|FG000|STARTED|Overall Study||80
10441381|NCT00929981|11587878|FG000|COMPLETED|Overall Study||80
10441382|NCT00929981|11587878|FG000|NOT COMPLETED|Overall Study||0
10441383|NCT00929994|11587882|FG000|STARTED|Overall Study||20
10441384|NCT00929994|11587882|FG000|COMPLETED|Overall Study||14
10441385|NCT00929994|11587882|FG000|NOT COMPLETED|Overall Study||6
10441386|NCT00930046|11587891|FG000|STARTED|Overall Study||8
10441387|NCT00930046|11587892|FG001|STARTED|Overall Study||7
10441388|NCT00930046|11587891|FG000|COMPLETED|Overall Study||7
10441389|NCT00930046|11587892|FG001|COMPLETED|Overall Study||5
10441390|NCT00930046|11587891|FG000|NOT COMPLETED|Overall Study||1
10441391|NCT00930046|11587892|FG001|NOT COMPLETED|Overall Study||2
10441392|NCT00930059|11587900|FG000|STARTED|Overall Study||100
10441393|NCT00930059|11587901|FG001|STARTED|Overall Study||91
10441394|NCT00930059|11587900|FG000|COMPLETED|Overall Study||92
10441395|NCT00930059|11587901|FG001|COMPLETED|Overall Study||79
10441396|NCT00930059|11587900|FG000|NOT COMPLETED|Overall Study||8
10789400|NCT03520387|11949814|FG002|STARTED|Randomized|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment.|3
10789401|NCT03520387|11949815|FG003|STARTED|Randomized|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment.|3
10789402|NCT03520387|11949816|FG004|STARTED|Randomized|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment.|3
10789403|NCT03520387|11949812|FG000|COMPLETED|Randomized||0
10789404|NCT03520387|11949813|FG001|COMPLETED|Randomized||4
10789405|NCT03520387|11949814|FG002|COMPLETED|Randomized||3
10441397|NCT00930059|11587901|FG001|NOT COMPLETED|Overall Study||12
10441398|NCT00930176|11587907|FG000|STARTED|Overall Study||16
10441399|NCT00930176|11587907|FG000|COMPLETED|Overall Study||15
10441400|NCT00930176|11587907|FG000|NOT COMPLETED|Overall Study||1
10441401|NCT00930293|11587913|FG000|STARTED|Overall Study||24
10441402|NCT00930293|11587914|FG001|STARTED|Overall Study||26
10441403|NCT00930293|11587913|FG000|COMPLETED|Overall Study||17
10441404|NCT00930293|11587914|FG001|COMPLETED|Overall Study||19
10441405|NCT00930293|11587913|FG000|NOT COMPLETED|Overall Study||7
10441406|NCT00930293|11587914|FG001|NOT COMPLETED|Overall Study||7
10525483|NCT01376089|11677408|FG000|COMPLETED|Overall Study||148
10525484|NCT01376089|11677409|FG001|COMPLETED|Overall Study||144
10525485|NCT01376089|11677408|FG000|NOT COMPLETED|Overall Study||3
10525486|NCT01376089|11677409|FG001|NOT COMPLETED|Overall Study||4
10525487|NCT01376167|11677422|FG000|STARTED|Overall Study||133
10525488|NCT01376167|11677423|FG001|STARTED|Overall Study||260
10525489|NCT01376167|11677424|FG002|STARTED|Overall Study||129
10525490|NCT01376167|11677422|FG000|COMPLETED|Overall Study||129
10525491|NCT01376167|11677423|FG001|COMPLETED|Overall Study||250
10525492|NCT01376167|11677424|FG002|COMPLETED|Overall Study||123
10525493|NCT01376167|11677422|FG000|NOT COMPLETED|Overall Study||4
10525494|NCT01376167|11677423|FG001|NOT COMPLETED|Overall Study||10
10525495|NCT01376167|11677424|FG002|NOT COMPLETED|Overall Study||6
10525496|NCT01376245|11677439|FG000|STARTED|2-wk Single-blind Placebo Run-in Period||744
10525497|NCT01376245|11677440|FG001|STARTED|2-wk Single-blind Placebo Run-in Period||0
10525498|NCT01376245|11677441|FG002|STARTED|2-wk Single-blind Placebo Run-in Period||0
10525499|NCT01376245|11677442|FG003|STARTED|2-wk Single-blind Placebo Run-in Period||0
10525500|NCT01376245|11677443|FG004|STARTED|2-wk Single-blind Placebo Run-in Period||0
10789406|NCT03520387|11949815|FG003|COMPLETED|Randomized||3
10789407|NCT03520387|11949816|FG004|COMPLETED|Randomized||3
10789408|NCT03520387|11949812|FG000|NOT COMPLETED|Randomized||0
10789409|NCT03520387|11949813|FG001|NOT COMPLETED|Randomized||0
10789410|NCT03520387|11949814|FG002|NOT COMPLETED|Randomized||0
10789411|NCT03520387|11949815|FG003|NOT COMPLETED|Randomized||0
10789412|NCT03520387|11949816|FG004|NOT COMPLETED|Randomized||0
10789413|NCT03520400|11949829|FG000|STARTED|Overall Study||37
10789414|NCT03520400|11949830|FG001|STARTED|Overall Study||14
10789415|NCT03520400|11949829|FG000|COMPLETED|Overall Study||22
10789416|NCT03520400|11949830|FG001|COMPLETED|Overall Study||7
10789417|NCT03520400|11949829|FG000|NOT COMPLETED|Overall Study||15
10789418|NCT03520400|11949830|FG001|NOT COMPLETED|Overall Study||7
10789419|NCT03520920|11949839|FG000|STARTED|Overall Study||20
10789420|NCT03520920|11949840|FG001|STARTED|Overall Study||16
10789421|NCT03520920|11949841|FG002|STARTED|Overall Study||5
10789422|NCT03520920|11949839|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20
10789423|NCT03520920|11949840|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16
10789424|NCT03520920|11949841|FG002|Received at Least 1 Dose of Study Drug|Overall Study||5
10525501|NCT01376245|11677439|FG000|COMPLETED|2-wk Single-blind Placebo Run-in Period||643
10525502|NCT01376245|11677440|FG001|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
10525503|NCT01376245|11677441|FG002|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
10789425|NCT03520920|11949839|FG000|COMPLETED|Overall Study||0
10789426|NCT03520920|11949840|FG001|COMPLETED|Overall Study||0
10789427|NCT03520920|11949841|FG002|COMPLETED|Overall Study||0
10525504|NCT01376245|11677442|FG003|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
10525505|NCT01376245|11677443|FG004|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
10525506|NCT01376245|11677439|FG000|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||101
10525507|NCT01376245|11677440|FG001|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
10525508|NCT01376245|11677441|FG002|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
10525509|NCT01376245|11677442|FG003|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
10525510|NCT01376245|11677443|FG004|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
10441407|NCT00930553|11587920|FG000|STARTED|Overall Study||1314
10441408|NCT00930553|11587920|FG000|Participants Entered From CAMMS223|Overall Study||141
10441409|NCT00930553|11587920|FG000|Participants Entered From CAMMS323|Overall Study||488
10441410|NCT00930553|11587920|FG000|Participants Entered From CAMMS324|Overall Study||685
10441411|NCT00930553|11587920|FG000|COMPLETED|Overall Study||1091
10441412|NCT00930553|11587920|FG000|NOT COMPLETED|Overall Study||223
10441413|NCT00930644|11587942|FG000|STARTED|Overall Study||88
10441414|NCT00930644|11587942|FG000|COMPLETED|Overall Study||65
10441415|NCT00930644|11587942|FG000|NOT COMPLETED|Overall Study||23
10441416|NCT00930761|11587951|FG000|STARTED|Overall Study||50
10441417|NCT00930761|11587952|FG001|STARTED|Overall Study||51
10441418|NCT00930761|11587951|FG000|COMPLETED|Overall Study||46
10441419|NCT00930761|11587952|FG001|COMPLETED|Overall Study||48
10441420|NCT00930761|11587951|FG000|NOT COMPLETED|Overall Study||4
10441421|NCT00930761|11587952|FG001|NOT COMPLETED|Overall Study||3
10441422|NCT00930774|11587962|FG000|STARTED|Overall Study||25
10441423|NCT00930774|11587963|FG001|STARTED|Overall Study||25
10441424|NCT00930774|11587964|FG002|STARTED|Overall Study||24
10441425|NCT00930774|11587965|FG003|STARTED|Overall Study||25
10441426|NCT00930774|11587962|FG000|COMPLETED|Overall Study||24
10441427|NCT00930774|11587963|FG001|COMPLETED|Overall Study||16
10441428|NCT00930774|11587964|FG002|COMPLETED|Overall Study||22
10441429|NCT00930774|11587965|FG003|COMPLETED|Overall Study||25
10441430|NCT00930774|11587962|FG000|NOT COMPLETED|Overall Study||1
10441431|NCT00930774|11587963|FG001|NOT COMPLETED|Overall Study||9
10441432|NCT00930774|11587964|FG002|NOT COMPLETED|Overall Study||2
10441433|NCT00930774|11587965|FG003|NOT COMPLETED|Overall Study||0
10441434|NCT00930813|11587978|FG000|STARTED|Overall Study||49
10441435|NCT00930813|11587979|FG001|STARTED|Overall Study||52
10441436|NCT00930813|11587978|FG000|COMPLETED|Overall Study||41
10441437|NCT00930813|11587979|FG001|COMPLETED|Overall Study||38
10441438|NCT00930813|11587978|FG000|NOT COMPLETED|Overall Study||8
10441439|NCT00930813|11587979|FG001|NOT COMPLETED|Overall Study||14
10441440|NCT00930930|11587989|FG000|STARTED|Overall Study||96
10441441|NCT00930930|11587990|FG001|STARTED|Overall Study||49
10441442|NCT00930930|11587989|FG000|COMPLETED|Overall Study||75
10441443|NCT00930930|11587990|FG001|COMPLETED|Overall Study||40
10441444|NCT00930930|11587989|FG000|NOT COMPLETED|Overall Study||21
10441445|NCT00930930|11587990|FG001|NOT COMPLETED|Overall Study||9
10441446|NCT00930969|11587996|FG000|STARTED|Overall Study||175
10441447|NCT00930969|11587996|FG000|COMPLETED|Overall Study||137
10441448|NCT00930969|11587996|FG000|NOT COMPLETED|Overall Study||38
10441449|NCT00930982|11588002|FG000|STARTED|Overall Study||60
10441450|NCT00930982|11588003|FG001|STARTED|Overall Study||64
10441451|NCT00930982|11588002|FG000|COMPLETED|Overall Study||39
10441452|NCT00930982|11588003|FG001|COMPLETED|Overall Study||35
10441453|NCT00930982|11588002|FG000|NOT COMPLETED|Overall Study||21
10441454|NCT00930982|11588003|FG001|NOT COMPLETED|Overall Study||29
10441455|NCT00931164|11588009|FG000|STARTED|Overall Study||6
10441456|NCT00931164|11588009|FG000|COMPLETED|Overall Study||6
10441457|NCT00931164|11588009|FG000|NOT COMPLETED|Overall Study||0
10441458|NCT00931242|11588015|FG000|STARTED|Overall Study||10
10441459|NCT00931242|11588016|FG001|STARTED|Overall Study||2
10441460|NCT00931242|11588015|FG000|COMPLETED|Overall Study||5
10441461|NCT00931242|11588016|FG001|COMPLETED|Overall Study||0
10441462|NCT00931242|11588015|FG000|NOT COMPLETED|Overall Study||5
10441463|NCT00931242|11588016|FG001|NOT COMPLETED|Overall Study||2
10441467|NCT00931307|11588024|FG000|STARTED|Overall Study||22
10441468|NCT00931307|11588024|FG000|COMPLETED|Overall Study||9
10441469|NCT00931307|11588024|FG000|NOT COMPLETED|Overall Study||13
10441470|NCT00931359|11588030|FG000|STARTED|Overall Study||39
10441471|NCT00931359|11588031|FG001|STARTED|Overall Study||81
10441472|NCT00931359|11588030|FG000|COMPLETED|Overall Study||33
10441473|NCT00931359|11588031|FG001|COMPLETED|Overall Study||68
10441474|NCT00931359|11588030|FG000|NOT COMPLETED|Overall Study||6
10441475|NCT00931359|11588031|FG001|NOT COMPLETED|Overall Study||13
10441476|NCT00931385|11588037|FG000|STARTED|Overall Study||25
10441477|NCT00931385|11588038|FG001|STARTED|Overall Study||23
10441478|NCT00931385|11588039|FG002|STARTED|Overall Study||25
10441479|NCT00931385|11588040|FG003|STARTED|Overall Study||26
10441480|NCT00931385|11588037|FG000|COMPLETED|Overall Study||23
10441481|NCT00931385|11588038|FG001|COMPLETED|Overall Study||21
10441482|NCT00931385|11588039|FG002|COMPLETED|Overall Study||24
10441483|NCT00931385|11588040|FG003|COMPLETED|Overall Study||21
10441484|NCT00931385|11588037|FG000|NOT COMPLETED|Overall Study||2
10441485|NCT00931385|11588038|FG001|NOT COMPLETED|Overall Study||2
10441486|NCT00931385|11588039|FG002|NOT COMPLETED|Overall Study||1
10441487|NCT00931385|11588040|FG003|NOT COMPLETED|Overall Study||5
10441488|NCT00931411|11588056|FG000|STARTED|First Intervention - 42 Days||35
10441489|NCT00931411|11588057|FG001|STARTED|First Intervention - 42 Days||38
10441490|NCT00931411|11588056|FG000|COMPLETED|First Intervention - 42 Days||31
10441491|NCT00931411|11588057|FG001|COMPLETED|First Intervention - 42 Days||35
10441492|NCT00931411|11588056|FG000|NOT COMPLETED|First Intervention - 42 Days||4
10441493|NCT00931411|11588057|FG001|NOT COMPLETED|First Intervention - 42 Days||3
10441494|NCT00931411|11588056|FG000|STARTED|After Crossover - 14 Days (up to Day 56)||31
10441495|NCT00931411|11588057|FG001|STARTED|After Crossover - 14 Days (up to Day 56)||35
10441496|NCT00931411|11588056|FG000|COMPLETED|After Crossover - 14 Days (up to Day 56)||31
10528929|NCT01397448|11681300|FG002|NOT COMPLETED|Overall Study||18
10441497|NCT00931411|11588057|FG001|COMPLETED|After Crossover - 14 Days (up to Day 56)||34
10441498|NCT00931411|11588056|FG000|NOT COMPLETED|After Crossover - 14 Days (up to Day 56)||0
10441499|NCT00931411|11588057|FG001|NOT COMPLETED|After Crossover - 14 Days (up to Day 56)||1
10441500|NCT00931463|11588069|FG000|STARTED|Overall Study||271
10441501|NCT00931463|11588070|FG001|STARTED|Overall Study||270
10441502|NCT00931463|11588069|FG000|COMPLETED|Overall Study||254
10441503|NCT00931463|11588070|FG001|COMPLETED|Overall Study||265
10441504|NCT00931463|11588069|FG000|NOT COMPLETED|Overall Study||17
10441505|NCT00931463|11588070|FG001|NOT COMPLETED|Overall Study||5
10441506|NCT00931489|11588081|FG000|STARTED|Overall Study||40
10441507|NCT00931489|11588082|FG001|STARTED|Overall Study||40
10441508|NCT00931489|11588083|FG002|STARTED|Overall Study||5
10441509|NCT00931489|11588084|FG003|STARTED|Overall Study||39
10441510|NCT00931489|11588085|FG004|STARTED|Overall Study||7
10441511|NCT00931489|11588081|FG000|COMPLETED|Overall Study||40
10441512|NCT00931489|11588082|FG001|COMPLETED|Overall Study||40
10441513|NCT00931489|11588083|FG002|COMPLETED|Overall Study|3 subjects enrolled in Group 1 (responders) were moved to Group 3 (non-responders)|5
10441514|NCT00931489|11588084|FG003|COMPLETED|Overall Study||39
10441515|NCT00931489|11588085|FG004|COMPLETED|Overall Study||7
10441516|NCT00931489|11588081|FG000|NOT COMPLETED|Overall Study||0
10441517|NCT00931489|11588082|FG001|NOT COMPLETED|Overall Study||0
10441518|NCT00931489|11588083|FG002|NOT COMPLETED|Overall Study||0
10441519|NCT00931489|11588084|FG003|NOT COMPLETED|Overall Study||0
10441520|NCT00931489|11588085|FG004|NOT COMPLETED|Overall Study||0
10441521|NCT00931515|11588098|FG000|STARTED|Overall Study||15
10441522|NCT00931515|11588099|FG001|STARTED|Overall Study||15
10441523|NCT00931515|11588098|FG000|COMPLETED|Overall Study||13
10441524|NCT00931515|11588099|FG001|COMPLETED|Overall Study||10
10441525|NCT00931515|11588098|FG000|NOT COMPLETED|Overall Study||2
10441526|NCT00931515|11588099|FG001|NOT COMPLETED|Overall Study||5
10441527|NCT00931528|11588107|FG000|STARTED|Overall Study||121
10441528|NCT00931528|11588108|FG001|STARTED|Overall Study||121
10441529|NCT00931528|11588107|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|80
10441530|NCT00931528|11588108|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|61
10441531|NCT00931528|11588107|FG000|NOT COMPLETED|Overall Study||41
10441532|NCT00931528|11588108|FG001|NOT COMPLETED|Overall Study||60
10441533|NCT00931632|11588117|FG000|STARTED|Overall Study|Randomized|229
10441534|NCT00931632|11588118|FG001|STARTED|Overall Study|Randomized|222
10441535|NCT00931632|11588117|FG000|COMPLETED|Overall Study|Completed at 36 weeks Postmenstrual Age (PMA)|208
10441536|NCT00931632|11588118|FG001|COMPLETED|Overall Study|Completed at 36 weeks Postmenstrual Age (PMA)|204
10441537|NCT00931632|11588117|FG000|NOT COMPLETED|Overall Study||21
10441538|NCT00931632|11588118|FG001|NOT COMPLETED|Overall Study||18
10441539|NCT00931710|11588126|FG000|STARTED|Overall Study||241
10441540|NCT00931710|11588127|FG001|STARTED|Overall Study||247
10441541|NCT00931710|11588126|FG000|COMPLETED|Overall Study||207
10441542|NCT00931710|11588127|FG001|COMPLETED|Overall Study||209
10441543|NCT00931710|11588126|FG000|NOT COMPLETED|Overall Study||34
10441544|NCT00931710|11588127|FG001|NOT COMPLETED|Overall Study||38
10441545|NCT00931723|11588135|FG000|STARTED|Overall Study||173
10441546|NCT00931723|11588136|FG001|STARTED|Overall Study||183
10441547|NCT00931723|11588135|FG000|COMPLETED|Overall Study||147
10441548|NCT00931723|11588136|FG001|COMPLETED|Overall Study||144
10441549|NCT00931723|11588135|FG000|NOT COMPLETED|Overall Study||26
10441550|NCT00931723|11588136|FG001|NOT COMPLETED|Overall Study||39
10441551|NCT00931762|11588142|FG000|STARTED|Overall Study||35
10441552|NCT00931762|11588142|FG000|COMPLETED|Overall Study||0
10441553|NCT00931762|11588142|FG000|NOT COMPLETED|Overall Study||35
10441554|NCT00931801|11588149|FG000|STARTED|Overall Study||14
10441555|NCT00931801|11588150|FG001|STARTED|Overall Study||15
10441556|NCT00931801|11588151|FG002|STARTED|Overall Study||14
10441557|NCT00931801|11588149|FG000|COMPLETED|Overall Study||13
10441558|NCT00931801|11588150|FG001|COMPLETED|Overall Study||14
10441559|NCT00931801|11588151|FG002|COMPLETED|Overall Study||10
10441560|NCT00931801|11588149|FG000|NOT COMPLETED|Overall Study||1
10441561|NCT00931801|11588150|FG001|NOT COMPLETED|Overall Study||1
10441562|NCT00931801|11588151|FG002|NOT COMPLETED|Overall Study||4
10441563|NCT00931879|11588165|FG000|STARTED|Overall Study||22
10441564|NCT00931879|11588166|FG001|STARTED|Overall Study||22
10441565|NCT00931879|11588165|FG000|COMPLETED|Overall Study||19
10441566|NCT00931879|11588166|FG001|COMPLETED|Overall Study||19
10441567|NCT00931879|11588165|FG000|NOT COMPLETED|Overall Study||3
10441568|NCT00931879|11588166|FG001|NOT COMPLETED|Overall Study||3
10441569|NCT00931892|11588175|FG000|STARTED|Completed Gluten Challenge||10
10441570|NCT00931892|11588176|FG001|STARTED|Completed Gluten Challenge||10
10441571|NCT00931892|11588175|FG000|COMPLETED|Completed Gluten Challenge||10
10441572|NCT00931892|11588176|FG001|COMPLETED|Completed Gluten Challenge||10
10441573|NCT00931892|11588175|FG000|NOT COMPLETED|Completed Gluten Challenge||0
10441574|NCT00931892|11588176|FG001|NOT COMPLETED|Completed Gluten Challenge||0
10441575|NCT00931892|11588175|FG000|STARTED|Completed Endoscopies||10
10441576|NCT00931892|11588176|FG001|STARTED|Completed Endoscopies||10
10441577|NCT00931892|11588175|FG000|First Endoscopy|Completed Endoscopies||10
10441578|NCT00931892|11588176|FG001|First Endoscopy|Completed Endoscopies||10
10441579|NCT00931892|11588175|FG000|Second Endoscopy|Completed Endoscopies||10
10441580|NCT00931892|11588176|FG001|Second Endoscopy|Completed Endoscopies||10
10441581|NCT00931892|11588175|FG000|Third Endoscopy|Completed Endoscopies||10
10441582|NCT00931892|11588176|FG001|Third Endoscopy|Completed Endoscopies||9
10441583|NCT00931892|11588175|FG000|COMPLETED|Completed Endoscopies||10
10441584|NCT00931892|11588176|FG001|COMPLETED|Completed Endoscopies||9
10441585|NCT00931892|11588175|FG000|NOT COMPLETED|Completed Endoscopies||0
10441586|NCT00931892|11588176|FG001|NOT COMPLETED|Completed Endoscopies||1
10441587|NCT00931918|11588224|FG000|STARTED|Overall Study||103
10441588|NCT00931918|11588225|FG001|STARTED|Overall Study||103
10441589|NCT00931918|11588224|FG000|Safety Population: Received Study Drug|Overall Study||100
10441590|NCT00931918|11588225|FG001|Safety Population: Received Study Drug|Overall Study||101
10441591|NCT00931918|11588224|FG000|COMPLETED|Overall Study|Completed the maximum of 6 cycles.|86
10441592|NCT00931918|11588225|FG001|COMPLETED|Overall Study|Completed the maximum of 6 cycles.|86
10441593|NCT00931918|11588224|FG000|NOT COMPLETED|Overall Study||17
10441594|NCT00931918|11588225|FG001|NOT COMPLETED|Overall Study||17
10441595|NCT00931944|11588231|FG000|STARTED|Overall Study||74
10441596|NCT00931944|11588231|FG000|COMPLETED|Overall Study||19
10441597|NCT00931944|11588231|FG000|NOT COMPLETED|Overall Study||55
10550125|NCT01529515|11704207|FG002|COMPLETED|MAINTENANCE PHASE||0
10550126|NCT01529515|11704208|FG003|COMPLETED|MAINTENANCE PHASE||0
10550127|NCT01529515|11704205|FG000|NOT COMPLETED|MAINTENANCE PHASE||0
10441598|NCT00931996|11588235|FG000|STARTED|Overall Study||12
10441599|NCT00931996|11588235|FG000|COMPLETED|Overall Study||5
10441600|NCT00931996|11588235|FG000|NOT COMPLETED|Overall Study||7
10441601|NCT00932022|11588241|FG000|STARTED|Overall Study||64
10441602|NCT00932022|11588242|FG001|STARTED|Overall Study||63
10441603|NCT00932022|11588241|FG000|COMPLETED|Overall Study||59
10441604|NCT00932022|11588242|FG001|COMPLETED|Overall Study||59
10441605|NCT00932022|11588241|FG000|NOT COMPLETED|Overall Study||5
10441606|NCT00932022|11588242|FG001|NOT COMPLETED|Overall Study||4
10441607|NCT00932035|11588250|FG000|STARTED|Overall Study||18
10441608|NCT00932035|11588251|FG001|STARTED|Overall Study||21
10441609|NCT00932035|11588250|FG000|COMPLETED|Overall Study||18
10441610|NCT00932035|11588251|FG001|COMPLETED|Overall Study||21
10441611|NCT00932035|11588250|FG000|NOT COMPLETED|Overall Study||0
10441612|NCT00932035|11588251|FG001|NOT COMPLETED|Overall Study||0
10441613|NCT00932113|11588259|FG000|STARTED|Overall Study||15
10441614|NCT00932113|11588260|FG001|STARTED|Overall Study||15
10441615|NCT00932113|11588259|FG000|COMPLETED|Overall Study||14
10441616|NCT00932113|11588260|FG001|COMPLETED|Overall Study||15
10441617|NCT00932113|11588259|FG000|NOT COMPLETED|Overall Study||1
10441618|NCT00932113|11588260|FG001|NOT COMPLETED|Overall Study||0
10441619|NCT00932126|11588266|FG000|STARTED|Overall Study||3
10441620|NCT00932126|11588267|FG001|STARTED|Overall Study||3
10441621|NCT00932126|11588268|FG002|STARTED|Overall Study||3
10441622|NCT00932126|11588269|FG003|STARTED|Overall Study||3
10441623|NCT00932126|11588270|FG004|STARTED|Overall Study||5
10441624|NCT00932126|11588271|FG005|STARTED|Overall Study||3
10441625|NCT00932126|11588272|FG006|STARTED|Overall Study||5
10441626|NCT00932126|11588273|FG007|STARTED|Overall Study||10
10441627|NCT00932126|11588266|FG000|COMPLETED|Overall Study||0
10441628|NCT00932126|11588267|FG001|COMPLETED|Overall Study||0
10441629|NCT00932126|11588268|FG002|COMPLETED|Overall Study||0
10441630|NCT00932126|11588269|FG003|COMPLETED|Overall Study||0
10441631|NCT00932126|11588270|FG004|COMPLETED|Overall Study||0
10441632|NCT00932126|11588271|FG005|COMPLETED|Overall Study||0
10441633|NCT00932126|11588272|FG006|COMPLETED|Overall Study||0
10441634|NCT00932126|11588273|FG007|COMPLETED|Overall Study||0
10441635|NCT00932126|11588266|FG000|NOT COMPLETED|Overall Study||3
10441636|NCT00932126|11588267|FG001|NOT COMPLETED|Overall Study||3
10441637|NCT00932126|11588268|FG002|NOT COMPLETED|Overall Study||3
10441638|NCT00932126|11588269|FG003|NOT COMPLETED|Overall Study||3
10441639|NCT00932126|11588270|FG004|NOT COMPLETED|Overall Study||5
10441640|NCT00932126|11588271|FG005|NOT COMPLETED|Overall Study||3
10441641|NCT00932126|11588272|FG006|NOT COMPLETED|Overall Study||5
10441642|NCT00932126|11588273|FG007|NOT COMPLETED|Overall Study||10
10441643|NCT00932165|11588293|FG000|STARTED|Overall Study||451
10550128|NCT01529515|11704206|FG001|NOT COMPLETED|MAINTENANCE PHASE||74
10550129|NCT01529515|11704207|FG002|NOT COMPLETED|MAINTENANCE PHASE||0
10550130|NCT01529515|11704208|FG003|NOT COMPLETED|MAINTENANCE PHASE||0
10550131|NCT01529515|11704205|FG000|STARTED|DOUBLE BLIND PHASE||0
10550132|NCT01529515|11704206|FG001|STARTED|DOUBLE BLIND PHASE||0
10550133|NCT01529515|11704207|FG002|STARTED|DOUBLE BLIND PHASE||145
10550134|NCT01529515|11704208|FG003|STARTED|DOUBLE BLIND PHASE||160
10550135|NCT01529515|11704205|FG000|COMPLETED|DOUBLE BLIND PHASE||0
10550136|NCT01529515|11704206|FG001|COMPLETED|DOUBLE BLIND PHASE||0
10441644|NCT00932165|11588293|FG000|COMPLETED|Overall Study||450
10441645|NCT00932165|11588293|FG000|NOT COMPLETED|Overall Study||1
10441646|NCT00932282|11588300|FG000|STARTED|Pre-OIT Anti-IgE Therapy Phase||7
10441647|NCT00932282|11588301|FG001|STARTED|Pre-OIT Anti-IgE Therapy Phase||6
10441648|NCT00932282|11588300|FG000|COMPLETED|Pre-OIT Anti-IgE Therapy Phase||6
10441649|NCT00932282|11588301|FG001|COMPLETED|Pre-OIT Anti-IgE Therapy Phase||5
10441650|NCT00932282|11588300|FG000|NOT COMPLETED|Pre-OIT Anti-IgE Therapy Phase||1
10441651|NCT00932282|11588301|FG001|NOT COMPLETED|Pre-OIT Anti-IgE Therapy Phase||1
10441652|NCT00932282|11588300|FG000|STARTED|Modified OIT Rush Desensitization Phase||6
10441653|NCT00932282|11588301|FG001|STARTED|Modified OIT Rush Desensitization Phase||5
10441654|NCT00932282|11588300|FG000|COMPLETED|Modified OIT Rush Desensitization Phase||6
10441655|NCT00932282|11588301|FG001|COMPLETED|Modified OIT Rush Desensitization Phase||5
10441656|NCT00932282|11588300|FG000|NOT COMPLETED|Modified OIT Rush Desensitization Phase||0
10550137|NCT01529515|11704207|FG002|COMPLETED|DOUBLE BLIND PHASE||122
10550138|NCT01529515|11704208|FG003|COMPLETED|DOUBLE BLIND PHASE||148
10441657|NCT00932282|11588301|FG001|NOT COMPLETED|Modified OIT Rush Desensitization Phase||0
10441658|NCT00932282|11588300|FG000|STARTED|Biweekly OIT Buildup Phase||6
10441659|NCT00932282|11588301|FG001|STARTED|Biweekly OIT Buildup Phase||5
10441660|NCT00932282|11588300|FG000|COMPLETED|Biweekly OIT Buildup Phase||5
10441661|NCT00932282|11588301|FG001|COMPLETED|Biweekly OIT Buildup Phase||4
10441662|NCT00932282|11588300|FG000|NOT COMPLETED|Biweekly OIT Buildup Phase||1
10441663|NCT00932282|11588301|FG001|NOT COMPLETED|Biweekly OIT Buildup Phase||1
10441664|NCT00932282|11588300|FG000|STARTED|OIT Maintenance Phase||5
10441665|NCT00932282|11588301|FG001|STARTED|OIT Maintenance Phase||4
10441666|NCT00932282|11588300|FG000|COMPLETED|OIT Maintenance Phase||4
10441667|NCT00932282|11588301|FG001|COMPLETED|OIT Maintenance Phase||2
10441668|NCT00932282|11588300|FG000|NOT COMPLETED|OIT Maintenance Phase||1
10441669|NCT00932282|11588301|FG001|NOT COMPLETED|OIT Maintenance Phase||2
10441670|NCT00932321|11588309|FG000|STARTED|Overall Study||751
10441671|NCT00932321|11588310|FG001|STARTED|Overall Study||187
10441672|NCT00932321|11588309|FG000|MITT Population|Overall Study||705
10441673|NCT00932321|11588310|FG001|MITT Population|Overall Study||181
10441674|NCT00932321|11588309|FG000|COMPLETED|Overall Study||580
10789428|NCT03520920|11949839|FG000|NOT COMPLETED|Overall Study||20
10789429|NCT03520920|11949840|FG001|NOT COMPLETED|Overall Study||16
10789430|NCT03520920|11949841|FG002|NOT COMPLETED|Overall Study||5
10789431|NCT03520959|11949857|FG000|STARTED|Overall Study||0
10789432|NCT03520959|11949858|FG001|STARTED|Overall Study||1
10441675|NCT00932321|11588310|FG001|COMPLETED|Overall Study||141
10441676|NCT00932321|11588309|FG000|NOT COMPLETED|Overall Study||171
10441677|NCT00932321|11588310|FG001|NOT COMPLETED|Overall Study||46
10441678|NCT00932360|11588316|FG000|STARTED|1: Visit 1/Week1||10
10441679|NCT00932360|11588317|FG001|STARTED|1: Visit 1/Week1||6
10441680|NCT00932360|11588318|FG002|STARTED|1: Visit 1/Week1||3
10441681|NCT00932360|11588319|FG003|STARTED|1: Visit 1/Week1||13
10441682|NCT00932360|11588320|FG004|STARTED|1: Visit 1/Week1||4
10441683|NCT00932360|11588321|FG005|STARTED|1: Visit 1/Week1||7
10441684|NCT00932360|11588316|FG000|COMPLETED|1: Visit 1/Week1||10
10441685|NCT00932360|11588317|FG001|COMPLETED|1: Visit 1/Week1||6
10441686|NCT00932360|11588318|FG002|COMPLETED|1: Visit 1/Week1||3
10441687|NCT00932360|11588319|FG003|COMPLETED|1: Visit 1/Week1||13
10441688|NCT00932360|11588320|FG004|COMPLETED|1: Visit 1/Week1||4
10441689|NCT00932360|11588321|FG005|COMPLETED|1: Visit 1/Week1||7
10441690|NCT00932360|11588316|FG000|NOT COMPLETED|1: Visit 1/Week1||0
10441691|NCT00932360|11588317|FG001|NOT COMPLETED|1: Visit 1/Week1||0
10441692|NCT00932360|11588318|FG002|NOT COMPLETED|1: Visit 1/Week1||0
10441693|NCT00932360|11588319|FG003|NOT COMPLETED|1: Visit 1/Week1||0
10441694|NCT00932360|11588320|FG004|NOT COMPLETED|1: Visit 1/Week1||0
10441695|NCT00932360|11588321|FG005|NOT COMPLETED|1: Visit 1/Week1||0
10441696|NCT00932360|11588316|FG000|STARTED|Washout (One Week)||10
10441697|NCT00932360|11588317|FG001|STARTED|Washout (One Week)||6
10441698|NCT00932360|11588318|FG002|STARTED|Washout (One Week)||3
10441699|NCT00932360|11588319|FG003|STARTED|Washout (One Week)||13
10441700|NCT00932360|11588320|FG004|STARTED|Washout (One Week)||4
10441701|NCT00932360|11588321|FG005|STARTED|Washout (One Week)||7
10441702|NCT00932360|11588316|FG000|COMPLETED|Washout (One Week)||10
10441703|NCT00932360|11588317|FG001|COMPLETED|Washout (One Week)||6
10441704|NCT00932360|11588318|FG002|COMPLETED|Washout (One Week)||3
10441705|NCT00932360|11588319|FG003|COMPLETED|Washout (One Week)||13
10441706|NCT00932360|11588320|FG004|COMPLETED|Washout (One Week)||2
10441707|NCT00932360|11588321|FG005|COMPLETED|Washout (One Week)||7
10441708|NCT00932360|11588316|FG000|NOT COMPLETED|Washout (One Week)||0
10441709|NCT00932360|11588317|FG001|NOT COMPLETED|Washout (One Week)||0
10441710|NCT00932360|11588318|FG002|NOT COMPLETED|Washout (One Week)||0
10441711|NCT00932360|11588319|FG003|NOT COMPLETED|Washout (One Week)||0
10441712|NCT00932360|11588320|FG004|NOT COMPLETED|Washout (One Week)||2
10441713|NCT00932360|11588321|FG005|NOT COMPLETED|Washout (One Week)||0
10441714|NCT00932360|11588316|FG000|STARTED|Visit 2/Week 2||10
10441715|NCT00932360|11588317|FG001|STARTED|Visit 2/Week 2||6
10441716|NCT00932360|11588318|FG002|STARTED|Visit 2/Week 2||3
10441717|NCT00932360|11588319|FG003|STARTED|Visit 2/Week 2||13
10441718|NCT00932360|11588320|FG004|STARTED|Visit 2/Week 2||2
10441719|NCT00932360|11588321|FG005|STARTED|Visit 2/Week 2||7
10441720|NCT00932360|11588316|FG000|COMPLETED|Visit 2/Week 2||10
10441721|NCT00932360|11588317|FG001|COMPLETED|Visit 2/Week 2||6
10441722|NCT00932360|11588318|FG002|COMPLETED|Visit 2/Week 2||3
10550139|NCT01529515|11704205|FG000|NOT COMPLETED|DOUBLE BLIND PHASE||0
10550140|NCT01529515|11704206|FG001|NOT COMPLETED|DOUBLE BLIND PHASE||0
10550141|NCT01529515|11704207|FG002|NOT COMPLETED|DOUBLE BLIND PHASE||23
10550142|NCT01529515|11704208|FG003|NOT COMPLETED|DOUBLE BLIND PHASE||12
10550143|NCT01529606|11704217|FG000|STARTED|Overall Study||55
10550144|NCT01529606|11704218|FG001|STARTED|Overall Study||47
10550145|NCT01529606|11704217|FG000|COMPLETED|Overall Study||34
10789433|NCT03520959|11949857|FG000|COMPLETED|Overall Study||0
10789434|NCT03520959|11949858|FG001|COMPLETED|Overall Study||0
10441723|NCT00932360|11588319|FG003|COMPLETED|Visit 2/Week 2||13
10441724|NCT00932360|11588320|FG004|COMPLETED|Visit 2/Week 2||2
10441725|NCT00932360|11588321|FG005|COMPLETED|Visit 2/Week 2||7
10441726|NCT00932360|11588316|FG000|NOT COMPLETED|Visit 2/Week 2||0
10441727|NCT00932360|11588317|FG001|NOT COMPLETED|Visit 2/Week 2||0
10441728|NCT00932360|11588318|FG002|NOT COMPLETED|Visit 2/Week 2||0
10441729|NCT00932360|11588319|FG003|NOT COMPLETED|Visit 2/Week 2||0
10550146|NCT01529606|11704218|FG001|COMPLETED|Overall Study||29
10550147|NCT01529606|11704217|FG000|NOT COMPLETED|Overall Study||21
10550148|NCT01529606|11704218|FG001|NOT COMPLETED|Overall Study||18
10441730|NCT00932360|11588320|FG004|NOT COMPLETED|Visit 2/Week 2||0
10441731|NCT00932360|11588321|FG005|NOT COMPLETED|Visit 2/Week 2||0
10441732|NCT00932360|11588316|FG000|STARTED|Washout (One Week)||10
10441733|NCT00932360|11588317|FG001|STARTED|Washout (One Week)||6
10441734|NCT00932360|11588318|FG002|STARTED|Washout (One Week)||3
10441735|NCT00932360|11588319|FG003|STARTED|Washout (One Week)||13
10441736|NCT00932360|11588320|FG004|STARTED|Washout (One Week)||2
10441737|NCT00932360|11588321|FG005|STARTED|Washout (One Week)||7
10441738|NCT00932360|11588316|FG000|COMPLETED|Washout (One Week)||10
10441739|NCT00932360|11588317|FG001|COMPLETED|Washout (One Week)||6
10441740|NCT00932360|11588318|FG002|COMPLETED|Washout (One Week)||3
10441741|NCT00932360|11588319|FG003|COMPLETED|Washout (One Week)||13
10441742|NCT00932360|11588320|FG004|COMPLETED|Washout (One Week)||2
10441743|NCT00932360|11588321|FG005|COMPLETED|Washout (One Week)||7
10441744|NCT00932360|11588316|FG000|NOT COMPLETED|Washout (One Week)||0
10441745|NCT00932360|11588317|FG001|NOT COMPLETED|Washout (One Week)||0
10441746|NCT00932360|11588318|FG002|NOT COMPLETED|Washout (One Week)||0
10441747|NCT00932360|11588319|FG003|NOT COMPLETED|Washout (One Week)||0
10441748|NCT00932360|11588320|FG004|NOT COMPLETED|Washout (One Week)||0
10441749|NCT00932360|11588321|FG005|NOT COMPLETED|Washout (One Week)||0
10441750|NCT00932360|11588316|FG000|STARTED|Visit 3/Week 3||10
10441751|NCT00932360|11588317|FG001|STARTED|Visit 3/Week 3||6
10441752|NCT00932360|11588318|FG002|STARTED|Visit 3/Week 3||3
10441753|NCT00932360|11588319|FG003|STARTED|Visit 3/Week 3||13
10441754|NCT00932360|11588320|FG004|STARTED|Visit 3/Week 3||2
10441755|NCT00932360|11588321|FG005|STARTED|Visit 3/Week 3||7
10441756|NCT00932360|11588316|FG000|COMPLETED|Visit 3/Week 3||10
10441757|NCT00932360|11588317|FG001|COMPLETED|Visit 3/Week 3||6
10441758|NCT00932360|11588318|FG002|COMPLETED|Visit 3/Week 3||3
10441759|NCT00932360|11588319|FG003|COMPLETED|Visit 3/Week 3||13
10441760|NCT00932360|11588320|FG004|COMPLETED|Visit 3/Week 3||2
10441761|NCT00932360|11588321|FG005|COMPLETED|Visit 3/Week 3||7
10441762|NCT00932360|11588316|FG000|NOT COMPLETED|Visit 3/Week 3||0
10441763|NCT00932360|11588317|FG001|NOT COMPLETED|Visit 3/Week 3||0
10441764|NCT00932360|11588318|FG002|NOT COMPLETED|Visit 3/Week 3||0
10441765|NCT00932360|11588319|FG003|NOT COMPLETED|Visit 3/Week 3||0
10441766|NCT00932360|11588320|FG004|NOT COMPLETED|Visit 3/Week 3||0
10441767|NCT00932360|11588321|FG005|NOT COMPLETED|Visit 3/Week 3||0
10441768|NCT00932373|11588346|FG000|STARTED|Overall Study||3
10441769|NCT00932373|11588347|FG001|STARTED|Overall Study||1
10441770|NCT00932373|11588348|FG002|STARTED|Overall Study||1
10441771|NCT00932373|11588349|FG003|STARTED|Overall Study||1
10441772|NCT00932373|11588350|FG004|STARTED|Overall Study||15
10441773|NCT00932373|11588351|FG005|STARTED|Overall Study||3
10441774|NCT00932373|11588352|FG006|STARTED|Overall Study||3
10441775|NCT00932373|11588353|FG007|STARTED|Overall Study||3
10441776|NCT00932373|11588354|FG008|STARTED|Overall Study||3
10441777|NCT00932373|11588355|FG009|STARTED|Overall Study||16
10441778|NCT00932373|11588356|FG010|STARTED|Overall Study||3
10441779|NCT00932373|11588346|FG000|COMPLETED|Overall Study||0
10441780|NCT00932373|11588347|FG001|COMPLETED|Overall Study||0
10441781|NCT00932373|11588348|FG002|COMPLETED|Overall Study||0
10441782|NCT00932373|11588349|FG003|COMPLETED|Overall Study||1
10441783|NCT00932373|11588350|FG004|COMPLETED|Overall Study||1
10441784|NCT00932373|11588351|FG005|COMPLETED|Overall Study||0
10441785|NCT00932373|11588352|FG006|COMPLETED|Overall Study||2
10441786|NCT00932373|11588353|FG007|COMPLETED|Overall Study||0
10441787|NCT00932373|11588354|FG008|COMPLETED|Overall Study||1
10441788|NCT00932373|11588355|FG009|COMPLETED|Overall Study||3
10441789|NCT00932373|11588356|FG010|COMPLETED|Overall Study||0
10441790|NCT00932373|11588346|FG000|NOT COMPLETED|Overall Study||3
10550149|NCT01529632|11704226|FG000|STARTED|Overall Study||90
10550150|NCT01529632|11704227|FG001|STARTED|Overall Study||103
10441791|NCT00932373|11588347|FG001|NOT COMPLETED|Overall Study||1
10441792|NCT00932373|11588348|FG002|NOT COMPLETED|Overall Study||1
10441793|NCT00932373|11588349|FG003|NOT COMPLETED|Overall Study||0
10441794|NCT00932373|11588350|FG004|NOT COMPLETED|Overall Study||14
10441795|NCT00932373|11588351|FG005|NOT COMPLETED|Overall Study||3
10441796|NCT00932373|11588352|FG006|NOT COMPLETED|Overall Study||1
10441797|NCT00932373|11588353|FG007|NOT COMPLETED|Overall Study||3
10441798|NCT00932373|11588354|FG008|NOT COMPLETED|Overall Study||2
10441799|NCT00932373|11588355|FG009|NOT COMPLETED|Overall Study||13
10441800|NCT00932373|11588356|FG010|NOT COMPLETED|Overall Study||3
10441801|NCT00932399|11588390|FG000|STARTED|Overall Study||759
10441802|NCT00932399|11588391|FG001|STARTED|Overall Study||3790
10441803|NCT00932399|11588390|FG000|COMPLETED|Overall Study||759
10441804|NCT00932399|11588391|FG001|COMPLETED|Overall Study||3790
10441805|NCT00932399|11588390|FG000|NOT COMPLETED|Overall Study||0
10441806|NCT00932399|11588391|FG001|NOT COMPLETED|Overall Study||0
10441807|NCT00932425|11588399|FG000|STARTED|Overall Study||20
10441808|NCT00932425|11588400|FG001|STARTED|Overall Study||20
10441809|NCT00932425|11588399|FG000|COMPLETED|Overall Study||20
10441810|NCT00932425|11588400|FG001|COMPLETED|Overall Study||18
10441811|NCT00932425|11588399|FG000|NOT COMPLETED|Overall Study||0
10441812|NCT00932425|11588400|FG001|NOT COMPLETED|Overall Study||2
10441813|NCT00932438|11588408|FG000|STARTED|Overall Study||40
10441814|NCT00932438|11588409|FG001|STARTED|Overall Study||30
10441815|NCT00932438|11588408|FG000|COMPLETED|Overall Study||39
10441816|NCT00932438|11588409|FG001|COMPLETED|Overall Study||30
10441817|NCT00932438|11588408|FG000|NOT COMPLETED|Overall Study||1
10441818|NCT00932438|11588409|FG001|NOT COMPLETED|Overall Study||0
10550151|NCT01529632|11704226|FG000|COMPLETED|Overall Study||87
10441819|NCT00932451|11588417|FG000|STARTED|Overall Study||1066
10441820|NCT00932451|11588417|FG000|COMPLETED|Overall Study||244
10441821|NCT00932451|11588417|FG000|NOT COMPLETED|Overall Study||822
10441822|NCT00932477|11588425|FG000|STARTED|Treatment 1||7
10441823|NCT00932477|11588426|FG001|STARTED|Treatment 1||8
10441824|NCT00932477|11588427|FG002|STARTED|Treatment 1||9
10441825|NCT00932477|11588428|FG003|STARTED|Treatment 1||7
10441826|NCT00932477|11588429|FG004|STARTED|Treatment 1||8
10441827|NCT00932477|11588430|FG005|STARTED|Treatment 1||8
10441828|NCT00932477|11588425|FG000|COMPLETED|Treatment 1||7
10441829|NCT00932477|11588426|FG001|COMPLETED|Treatment 1||8
10441830|NCT00932477|11588427|FG002|COMPLETED|Treatment 1||9
10441831|NCT00932477|11588428|FG003|COMPLETED|Treatment 1||7
10441832|NCT00932477|11588429|FG004|COMPLETED|Treatment 1||8
10441833|NCT00932477|11588430|FG005|COMPLETED|Treatment 1||8
10441834|NCT00932477|11588425|FG000|NOT COMPLETED|Treatment 1||0
10441835|NCT00932477|11588426|FG001|NOT COMPLETED|Treatment 1||0
10441836|NCT00932477|11588427|FG002|NOT COMPLETED|Treatment 1||0
10441837|NCT00932477|11588428|FG003|NOT COMPLETED|Treatment 1||0
10441838|NCT00932477|11588429|FG004|NOT COMPLETED|Treatment 1||0
10441839|NCT00932477|11588430|FG005|NOT COMPLETED|Treatment 1||0
10441840|NCT00932477|11588425|FG000|STARTED|Treatment 2||7
10441841|NCT00932477|11588426|FG001|STARTED|Treatment 2||8
10441842|NCT00932477|11588427|FG002|STARTED|Treatment 2||9
10441843|NCT00932477|11588428|FG003|STARTED|Treatment 2||7
10441844|NCT00932477|11588429|FG004|STARTED|Treatment 2||8
10441845|NCT00932477|11588430|FG005|STARTED|Treatment 2||8
10441846|NCT00932477|11588425|FG000|COMPLETED|Treatment 2||7
10441847|NCT00932477|11588426|FG001|COMPLETED|Treatment 2||8
10441848|NCT00932477|11588427|FG002|COMPLETED|Treatment 2||9
10441849|NCT00932477|11588428|FG003|COMPLETED|Treatment 2||7
10441850|NCT00932477|11588429|FG004|COMPLETED|Treatment 2||8
10441851|NCT00932477|11588430|FG005|COMPLETED|Treatment 2||8
10441852|NCT00932477|11588425|FG000|NOT COMPLETED|Treatment 2||0
10441853|NCT00932477|11588426|FG001|NOT COMPLETED|Treatment 2||0
10441854|NCT00932477|11588427|FG002|NOT COMPLETED|Treatment 2||0
10441855|NCT00932477|11588428|FG003|NOT COMPLETED|Treatment 2||0
10441856|NCT00932477|11588429|FG004|NOT COMPLETED|Treatment 2||0
10441857|NCT00932477|11588430|FG005|NOT COMPLETED|Treatment 2||0
10441858|NCT00932477|11588425|FG000|STARTED|Treatment 3||7
10441859|NCT00932477|11588426|FG001|STARTED|Treatment 3||8
10441860|NCT00932477|11588427|FG002|STARTED|Treatment 3||9
10441861|NCT00932477|11588428|FG003|STARTED|Treatment 3||7
10789435|NCT03520959|11949857|FG000|NOT COMPLETED|Overall Study||0
10789436|NCT03520959|11949858|FG001|NOT COMPLETED|Overall Study||1
10810695|NCT03792672|11972460|FG004|COMPLETED|Washout Period 1 (10 Days)||4
10810696|NCT03792672|11972461|FG005|COMPLETED|Washout Period 1 (10 Days)||4
10810697|NCT03792672|11972456|FG000|NOT COMPLETED|Washout Period 1 (10 Days)||0
10810698|NCT03792672|11972457|FG001|NOT COMPLETED|Washout Period 1 (10 Days)||0
10810699|NCT03792672|11972458|FG002|NOT COMPLETED|Washout Period 1 (10 Days)||0
10810700|NCT03792672|11972459|FG003|NOT COMPLETED|Washout Period 1 (10 Days)||0
10810701|NCT03792672|11972460|FG004|NOT COMPLETED|Washout Period 1 (10 Days)||0
10810702|NCT03792672|11972461|FG005|NOT COMPLETED|Washout Period 1 (10 Days)||0
10550152|NCT01529632|11704227|FG001|COMPLETED|Overall Study||100
10550153|NCT01529632|11704226|FG000|NOT COMPLETED|Overall Study||3
10550154|NCT01529632|11704227|FG001|NOT COMPLETED|Overall Study||3
10550155|NCT01529645|11704243|FG000|STARTED|Overall Study||42
10550156|NCT01529645|11704244|FG001|STARTED|Overall Study||42
10550157|NCT01529645|11704245|FG002|STARTED|Overall Study||42
10550158|NCT01529645|11704246|FG003|STARTED|Overall Study||42
10550159|NCT01529645|11704247|FG004|STARTED|Overall Study||42
10550160|NCT01529645|11704248|FG005|STARTED|Overall Study||42
10550161|NCT01529645|11704249|FG006|STARTED|Overall Study||42
10550162|NCT01529645|11704250|FG007|STARTED|Overall Study||42
10550163|NCT01529645|11704251|FG008|STARTED|Overall Study||42
10550164|NCT01529645|11704252|FG009|STARTED|Overall Study||42
10550165|NCT01529645|11704243|FG000|COMPLETED|Overall Study||40
10550166|NCT01529645|11704244|FG001|COMPLETED|Overall Study||41
10550167|NCT01529645|11704245|FG002|COMPLETED|Overall Study||40
10550168|NCT01529645|11704246|FG003|COMPLETED|Overall Study||40
10550169|NCT01529645|11704247|FG004|COMPLETED|Overall Study||40
10550170|NCT01529645|11704248|FG005|COMPLETED|Overall Study||41
10550171|NCT01529645|11704249|FG006|COMPLETED|Overall Study||40
10550172|NCT01529645|11704250|FG007|COMPLETED|Overall Study||42
10550173|NCT01529645|11704251|FG008|COMPLETED|Overall Study||41
10810703|NCT03792672|11972456|FG000|STARTED|Treatment Period 2 (1 Day)||4
10810704|NCT03792672|11972457|FG001|STARTED|Treatment Period 2 (1 Day)||4
10810705|NCT03792672|11972458|FG002|STARTED|Treatment Period 2 (1 Day)||4
10441862|NCT00932477|11588429|FG004|STARTED|Treatment 3||8
10441863|NCT00932477|11588430|FG005|STARTED|Treatment 3||8
10441864|NCT00932477|11588425|FG000|COMPLETED|Treatment 3||7
10550174|NCT01529645|11704252|FG009|COMPLETED|Overall Study||42
10810706|NCT03792672|11972459|FG003|STARTED|Treatment Period 2 (1 Day)||4
10810707|NCT03792672|11972460|FG004|STARTED|Treatment Period 2 (1 Day)||4
10441865|NCT00932477|11588426|FG001|COMPLETED|Treatment 3||8
10441866|NCT00932477|11588427|FG002|COMPLETED|Treatment 3||9
10441867|NCT00932477|11588428|FG003|COMPLETED|Treatment 3||7
10441868|NCT00932477|11588429|FG004|COMPLETED|Treatment 3||8
10550175|NCT01529645|11704243|FG000|NOT COMPLETED|Overall Study||2
10550176|NCT01529645|11704244|FG001|NOT COMPLETED|Overall Study||1
10550177|NCT01529645|11704245|FG002|NOT COMPLETED|Overall Study||2
10550178|NCT01529645|11704246|FG003|NOT COMPLETED|Overall Study||2
10550179|NCT01529645|11704247|FG004|NOT COMPLETED|Overall Study||2
10441869|NCT00932477|11588430|FG005|COMPLETED|Treatment 3||8
10441870|NCT00932477|11588425|FG000|NOT COMPLETED|Treatment 3||0
10441871|NCT00932477|11588426|FG001|NOT COMPLETED|Treatment 3||0
10441872|NCT00932477|11588427|FG002|NOT COMPLETED|Treatment 3||0
10441873|NCT00932477|11588428|FG003|NOT COMPLETED|Treatment 3||0
10441874|NCT00932477|11588429|FG004|NOT COMPLETED|Treatment 3||0
10441875|NCT00932477|11588430|FG005|NOT COMPLETED|Treatment 3||0
10441876|NCT00932620|11588440|FG000|STARTED|Overall Study||50
10441877|NCT00932620|11588441|FG001|STARTED|Overall Study||50
10441878|NCT00932620|11588440|FG000|COMPLETED|Overall Study||50
10441879|NCT00932620|11588441|FG001|COMPLETED|Overall Study||50
10441880|NCT00932620|11588440|FG000|NOT COMPLETED|Overall Study||0
10441881|NCT00932620|11588441|FG001|NOT COMPLETED|Overall Study||0
10441882|NCT00932646|11588449|FG000|STARTED|Overall Study||25
10441883|NCT00932646|11588450|FG001|STARTED|Overall Study||25
10441884|NCT00932646|11588451|FG002|STARTED|Overall Study||25
10441885|NCT00932646|11588452|FG003|STARTED|Overall Study||25
10441886|NCT00932646|11588449|FG000|COMPLETED|Overall Study||20
10441887|NCT00932646|11588450|FG001|COMPLETED|Overall Study||22
10441888|NCT00932646|11588451|FG002|COMPLETED|Overall Study||21
10441889|NCT00932646|11588452|FG003|COMPLETED|Overall Study||24
10441890|NCT00932646|11588449|FG000|NOT COMPLETED|Overall Study||5
10441891|NCT00932646|11588450|FG001|NOT COMPLETED|Overall Study||3
10441892|NCT00932646|11588451|FG002|NOT COMPLETED|Overall Study||4
10441893|NCT00932646|11588452|FG003|NOT COMPLETED|Overall Study||1
10441894|NCT00932659|11588466|FG000|STARTED|Overall Study||8
10441895|NCT00932659|11588466|FG000|COMPLETED|Overall Study||8
10441896|NCT00932659|11588466|FG000|NOT COMPLETED|Overall Study||0
10441897|NCT00932698|11588481|FG000|STARTED|Part 1 (Dose Escalation)||3
10441898|NCT00932698|11588482|FG001|STARTED|Part 1 (Dose Escalation)||3
10441899|NCT00932698|11588483|FG002|STARTED|Part 1 (Dose Escalation)||3
10441900|NCT00932698|11588484|FG003|STARTED|Part 1 (Dose Escalation)||3
10441901|NCT00932698|11588485|FG004|STARTED|Part 1 (Dose Escalation)||3
10441902|NCT00932698|11588486|FG005|STARTED|Part 1 (Dose Escalation)||7
10441903|NCT00932698|11588487|FG006|STARTED|Part 1 (Dose Escalation)||4
10441904|NCT00932698|11588488|FG007|STARTED|Part 1 (Dose Escalation)||0
10441905|NCT00932698|11588489|FG008|STARTED|Part 1 (Dose Escalation)||0
10441906|NCT00932698|11588490|FG009|STARTED|Part 1 (Dose Escalation)||0
10441907|NCT00932698|11588491|FG010|STARTED|Part 1 (Dose Escalation)||0
10441908|NCT00932698|11588481|FG000|COMPLETED|Part 1 (Dose Escalation)||0
10441909|NCT00932698|11588482|FG001|COMPLETED|Part 1 (Dose Escalation)||0
10441910|NCT00932698|11588483|FG002|COMPLETED|Part 1 (Dose Escalation)||0
10441911|NCT00932698|11588484|FG003|COMPLETED|Part 1 (Dose Escalation)||0
10441912|NCT00932698|11588485|FG004|COMPLETED|Part 1 (Dose Escalation)||0
10441913|NCT00932698|11588486|FG005|COMPLETED|Part 1 (Dose Escalation)|6 participants from 2.0 mg/m^2 dose cohort transitioned to dose expansion cohort: 5 in RR, 1 in VR.|0
10441914|NCT00932698|11588487|FG006|COMPLETED|Part 1 (Dose Escalation)||0
10441915|NCT00932698|11588488|FG007|COMPLETED|Part 1 (Dose Escalation)||0
10441916|NCT00932698|11588489|FG008|COMPLETED|Part 1 (Dose Escalation)||0
10441917|NCT00932698|11588490|FG009|COMPLETED|Part 1 (Dose Escalation)||0
10441918|NCT00932698|11588491|FG010|COMPLETED|Part 1 (Dose Escalation)||0
10441919|NCT00932698|11588481|FG000|NOT COMPLETED|Part 1 (Dose Escalation)||3
10441920|NCT00932698|11588482|FG001|NOT COMPLETED|Part 1 (Dose Escalation)||3
10441921|NCT00932698|11588483|FG002|NOT COMPLETED|Part 1 (Dose Escalation)||3
10441922|NCT00932698|11588484|FG003|NOT COMPLETED|Part 1 (Dose Escalation)||3
10441923|NCT00932698|11588485|FG004|NOT COMPLETED|Part 1 (Dose Escalation)||3
10441924|NCT00932698|11588486|FG005|NOT COMPLETED|Part 1 (Dose Escalation)||7
10441925|NCT00932698|11588487|FG006|NOT COMPLETED|Part 1 (Dose Escalation)||4
10441926|NCT00932698|11588488|FG007|NOT COMPLETED|Part 1 (Dose Escalation)||0
10441927|NCT00932698|11588489|FG008|NOT COMPLETED|Part 1 (Dose Escalation)||0
10441928|NCT00932698|11588490|FG009|NOT COMPLETED|Part 1 (Dose Escalation)||0
10441929|NCT00932698|11588491|FG010|NOT COMPLETED|Part 1 (Dose Escalation)||0
10441930|NCT00932698|11588481|FG000|STARTED|Part 2 (Dose Expansion)||0
10441931|NCT00932698|11588482|FG001|STARTED|Part 2 (Dose Expansion)||0
10441932|NCT00932698|11588483|FG002|STARTED|Part 2 (Dose Expansion)||0
10441933|NCT00932698|11588484|FG003|STARTED|Part 2 (Dose Expansion)||0
10441934|NCT00932698|11588485|FG004|STARTED|Part 2 (Dose Expansion)||0
10441935|NCT00932698|11588486|FG005|STARTED|Part 2 (Dose Expansion)||0
10441936|NCT00932698|11588487|FG006|STARTED|Part 2 (Dose Expansion)||0
10441937|NCT00932698|11588488|FG007|STARTED|Part 2 (Dose Expansion)||20
10441938|NCT00932698|11588489|FG008|STARTED|Part 2 (Dose Expansion)||12
10441939|NCT00932698|11588490|FG009|STARTED|Part 2 (Dose Expansion)||6
10441940|NCT00932698|11588491|FG010|STARTED|Part 2 (Dose Expansion)||2
10441941|NCT00932698|11588481|FG000|COMPLETED|Part 2 (Dose Expansion)||0
10441942|NCT00932698|11588482|FG001|COMPLETED|Part 2 (Dose Expansion)||0
10441943|NCT00932698|11588483|FG002|COMPLETED|Part 2 (Dose Expansion)||0
10441944|NCT00932698|11588484|FG003|COMPLETED|Part 2 (Dose Expansion)||0
10441945|NCT00932698|11588485|FG004|COMPLETED|Part 2 (Dose Expansion)||0
10441946|NCT00932698|11588486|FG005|COMPLETED|Part 2 (Dose Expansion)||0
10441947|NCT00932698|11588487|FG006|COMPLETED|Part 2 (Dose Expansion)||0
10441948|NCT00932698|11588488|FG007|COMPLETED|Part 2 (Dose Expansion)||0
10441949|NCT00932698|11588489|FG008|COMPLETED|Part 2 (Dose Expansion)||0
10441950|NCT00932698|11588490|FG009|COMPLETED|Part 2 (Dose Expansion)||0
10441951|NCT00932698|11588491|FG010|COMPLETED|Part 2 (Dose Expansion)||0
10441952|NCT00932698|11588481|FG000|NOT COMPLETED|Part 2 (Dose Expansion)||0
10441953|NCT00932698|11588482|FG001|NOT COMPLETED|Part 2 (Dose Expansion)||0
10441954|NCT00932698|11588483|FG002|NOT COMPLETED|Part 2 (Dose Expansion)||0
10441955|NCT00932698|11588484|FG003|NOT COMPLETED|Part 2 (Dose Expansion)||0
10441956|NCT00932698|11588485|FG004|NOT COMPLETED|Part 2 (Dose Expansion)||0
10441957|NCT00932698|11588486|FG005|NOT COMPLETED|Part 2 (Dose Expansion)||0
10441958|NCT00932698|11588487|FG006|NOT COMPLETED|Part 2 (Dose Expansion)||0
10441959|NCT00932698|11588488|FG007|NOT COMPLETED|Part 2 (Dose Expansion)||20
10441960|NCT00932698|11588489|FG008|NOT COMPLETED|Part 2 (Dose Expansion)||12
10441961|NCT00932698|11588490|FG009|NOT COMPLETED|Part 2 (Dose Expansion)||6
10441962|NCT00932698|11588491|FG010|NOT COMPLETED|Part 2 (Dose Expansion)||2
10441963|NCT00932828|11588517|FG000|STARTED|Overall Study||37
10441964|NCT00932828|11588517|FG000|COMPLETED|Overall Study|5 subjects who did not complete the protocol were considered in an ITT analysis.|32
10441965|NCT00932828|11588517|FG000|NOT COMPLETED|Overall Study||5
10441966|NCT00932893|11588523|FG000|STARTED|Overall Study||173
10441967|NCT00932893|11588524|FG001|STARTED|Overall Study||174
10441968|NCT00932893|11588523|FG000|Treated|Overall Study||172
10441969|NCT00932893|11588524|FG001|Treated|Overall Study||171
10441970|NCT00932893|11588523|FG000|COMPLETED|Overall Study||40
10441971|NCT00932893|11588524|FG001|COMPLETED|Overall Study||4
10441972|NCT00932893|11588523|FG000|NOT COMPLETED|Overall Study||133
10441973|NCT00932893|11588524|FG001|NOT COMPLETED|Overall Study||170
10441974|NCT00933166|11588531|FG000|STARTED|Overall Study||169
10441975|NCT00933166|11588531|FG000|COMPLETED|Overall Study||151
10441976|NCT00933166|11588531|FG000|NOT COMPLETED|Overall Study||18
10441977|NCT00933244|11588538|FG000|STARTED|Overall Study||79
10441978|NCT00933244|11588539|FG001|STARTED|Overall Study||75
10441979|NCT00933244|11588540|FG002|STARTED|Overall Study||76
10441980|NCT00933244|11588538|FG000|COMPLETED|Overall Study||74
10441981|NCT00933244|11588539|FG001|COMPLETED|Overall Study||74
10441982|NCT00933244|11588540|FG002|COMPLETED|Overall Study||73
10441983|NCT00933244|11588538|FG000|NOT COMPLETED|Overall Study||5
10441984|NCT00933244|11588539|FG001|NOT COMPLETED|Overall Study||1
10441985|NCT00933244|11588540|FG002|NOT COMPLETED|Overall Study||3
10441986|NCT00933270|11588548|FG000|STARTED|Overall Study|ITT population|264
10441987|NCT00933270|11588548|FG000|COMPLETED|Overall Study||177
10441988|NCT00933270|11588548|FG000|NOT COMPLETED|Overall Study||87
10441989|NCT00933335|11588555|FG000|STARTED|Overall Study||2
10441990|NCT00933335|11588556|FG001|STARTED|Overall Study|35/36 participants who received 3 cycles of fludarabine later received a DD and TD of TST/I 131 TST.|36
10441991|NCT00933335|11588555|FG000|COMPLETED|Overall Study||0
10441992|NCT00933335|11588556|FG001|COMPLETED|Overall Study||20
10441993|NCT00933335|11588555|FG000|NOT COMPLETED|Overall Study||2
10441994|NCT00933335|11588556|FG001|NOT COMPLETED|Overall Study||16
10441995|NCT00933491|11588570|FG000|STARTED|Overall Study||14
10441996|NCT00933491|11588571|FG001|STARTED|Overall Study||18
10441997|NCT00933491|11588570|FG000|COMPLETED|Overall Study||14
10441998|NCT00933491|11588571|FG001|COMPLETED|Overall Study||18
10441999|NCT00933491|11588570|FG000|NOT COMPLETED|Overall Study||0
10442000|NCT00933491|11588571|FG001|NOT COMPLETED|Overall Study||0
10442001|NCT00933543|11588579|FG000|STARTED|Overall Study||54
10442002|NCT00933543|11588580|FG001|STARTED|Overall Study||53
10442003|NCT00933543|11588579|FG000|COMPLETED|Overall Study||51
10442004|NCT00933543|11588580|FG001|COMPLETED|Overall Study||46
10442005|NCT00933543|11588579|FG000|NOT COMPLETED|Overall Study||3
10442006|NCT00933543|11588580|FG001|NOT COMPLETED|Overall Study||7
10442007|NCT00933608|11588588|FG000|STARTED|Overall Study||7
10442008|NCT00933608|11588589|FG001|STARTED|Overall Study||10
10442009|NCT00933608|11588588|FG000|COMPLETED|Overall Study||2
10442010|NCT00933608|11588589|FG001|COMPLETED|Overall Study||8
10442011|NCT00933608|11588588|FG000|NOT COMPLETED|Overall Study||5
10442012|NCT00933608|11588589|FG001|NOT COMPLETED|Overall Study||2
10442013|NCT00933686|11588597|FG000|STARTED|Overall Study||55
10789437|NCT03520998|11949866|FG000|STARTED|Overall Study||24
10789438|NCT03520998|11949867|FG001|STARTED|Overall Study||23
10789439|NCT03520998|11949866|FG000|COMPLETED|Overall Study||18
10789440|NCT03520998|11949867|FG001|COMPLETED|Overall Study||21
10789441|NCT03520998|11949866|FG000|NOT COMPLETED|Overall Study||6
10789442|NCT03520998|11949867|FG001|NOT COMPLETED|Overall Study||2
10789443|NCT03521089|11949875|FG000|STARTED|Overall Study||8
10789444|NCT03521089|11949876|FG001|STARTED|Overall Study||8
10789445|NCT03521089|11949875|FG000|COMPLETED|Overall Study||8
10789446|NCT03521089|11949876|FG001|COMPLETED|Overall Study||8
10442014|NCT00933686|11588598|FG001|STARTED|Overall Study||58
10442015|NCT00933686|11588597|FG000|COMPLETED|Overall Study||45
10442016|NCT00933686|11588598|FG001|COMPLETED|Overall Study||47
10789447|NCT03521089|11949875|FG000|NOT COMPLETED|Overall Study||0
10789448|NCT03521089|11949876|FG001|NOT COMPLETED|Overall Study||0
10442017|NCT00933686|11588597|FG000|NOT COMPLETED|Overall Study||10
10442018|NCT00933686|11588598|FG001|NOT COMPLETED|Overall Study||11
10442019|NCT00933933|11588609|FG000|STARTED|General Population From 16 to 89 Years||6164
10442020|NCT00933933|11588610|FG001|STARTED|General Population From 16 to 89 Years||1287
10442021|NCT00933933|11588611|FG002|STARTED|General Population From 16 to 89 Years||1206
10442168|NCT00934440|11588721|FG000|STARTED|Overall Study||11
10442022|NCT00933933|11588609|FG000|COMPLETED|General Population From 16 to 89 Years||6164
10442023|NCT00933933|11588610|FG001|COMPLETED|General Population From 16 to 89 Years||1267
10789449|NCT03521115|11949884|FG000|STARTED|Time 0 Baseline Surveys||206
10789450|NCT03521115|11949885|FG001|STARTED|Time 0 Baseline Surveys||205
10442024|NCT00933933|11588611|FG002|COMPLETED|General Population From 16 to 89 Years||1206
10442025|NCT00933933|11588609|FG000|NOT COMPLETED|General Population From 16 to 89 Years||0
10442026|NCT00933933|11588610|FG001|NOT COMPLETED|General Population From 16 to 89 Years||20
10442027|NCT00933933|11588611|FG002|NOT COMPLETED|General Population From 16 to 89 Years||0
10442028|NCT00933933|11588609|FG000|STARTED|Pregnant Females Between 16-44 Years||448
10442029|NCT00933933|11588610|FG001|STARTED|Pregnant Females Between 16-44 Years||67
10442030|NCT00933933|11588611|FG002|STARTED|Pregnant Females Between 16-44 Years||203
10442031|NCT00933933|11588609|FG000|COMPLETED|Pregnant Females Between 16-44 Years||448
10442032|NCT00933933|11588610|FG001|COMPLETED|Pregnant Females Between 16-44 Years||65
10442033|NCT00933933|11588611|FG002|COMPLETED|Pregnant Females Between 16-44 Years||203
10442034|NCT00933933|11588609|FG000|NOT COMPLETED|Pregnant Females Between 16-44 Years||0
10442035|NCT00933933|11588610|FG001|NOT COMPLETED|Pregnant Females Between 16-44 Years||2
10442036|NCT00933933|11588611|FG002|NOT COMPLETED|Pregnant Females Between 16-44 Years||0
10442037|NCT00933933|11588609|FG000|STARTED|Pediatric From 2 to 21 Years||588
10442038|NCT00933933|11588610|FG001|STARTED|Pediatric From 2 to 21 Years||64
10442039|NCT00933933|11588611|FG002|STARTED|Pediatric From 2 to 21 Years|Specimens from individuals 16-21 years included reactivity for general population or pregnant women.|0
10442040|NCT00933933|11588609|FG000|COMPLETED|Pediatric From 2 to 21 Years||588
10442041|NCT00933933|11588610|FG001|COMPLETED|Pediatric From 2 to 21 Years||64
10442042|NCT00933933|11588611|FG002|COMPLETED|Pediatric From 2 to 21 Years|Specimens from individuals 16-21 years included reactivity for general population or pregnant women|0
10442043|NCT00933933|11588609|FG000|NOT COMPLETED|Pediatric From 2 to 21 Years||0
10442044|NCT00933933|11588610|FG001|NOT COMPLETED|Pediatric From 2 to 21 Years||0
10442045|NCT00933933|11588611|FG002|NOT COMPLETED|Pediatric From 2 to 21 Years||0
10442046|NCT00934024|11588629|FG000|STARTED|Overall Study||10
10442047|NCT00934024|11588630|FG001|STARTED|Overall Study||11
10442048|NCT00934024|11588629|FG000|COMPLETED|Overall Study||10
10442049|NCT00934024|11588630|FG001|COMPLETED|Overall Study||6
10442050|NCT00934024|11588629|FG000|NOT COMPLETED|Overall Study||0
10442051|NCT00934024|11588630|FG001|NOT COMPLETED|Overall Study||5
10442052|NCT00934050|11588641|FG000|STARTED|Enrolled Prior to 15 Dec 2009||12
10442053|NCT00934050|11588642|FG001|STARTED|Enrolled Prior to 15 Dec 2009||12
10442054|NCT00934050|11588643|FG002|STARTED|Enrolled Prior to 15 Dec 2009||12
10442055|NCT00934050|11588644|FG003|STARTED|Enrolled Prior to 15 Dec 2009||14
10442056|NCT00934050|11588645|FG004|STARTED|Enrolled Prior to 15 Dec 2009||0
10442057|NCT00934050|11588646|FG005|STARTED|Enrolled Prior to 15 Dec 2009||0
10442058|NCT00934050|11588641|FG000|COMPLETED|Enrolled Prior to 15 Dec 2009||0
10442059|NCT00934050|11588642|FG001|COMPLETED|Enrolled Prior to 15 Dec 2009||0
10442060|NCT00934050|11588643|FG002|COMPLETED|Enrolled Prior to 15 Dec 2009||0
10442061|NCT00934050|11588644|FG003|COMPLETED|Enrolled Prior to 15 Dec 2009||0
10442062|NCT00934050|11588645|FG004|COMPLETED|Enrolled Prior to 15 Dec 2009||0
10442063|NCT00934050|11588646|FG005|COMPLETED|Enrolled Prior to 15 Dec 2009||0
10442064|NCT00934050|11588641|FG000|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
10442065|NCT00934050|11588642|FG001|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
10442066|NCT00934050|11588643|FG002|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
10442067|NCT00934050|11588644|FG003|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||14
10442068|NCT00934050|11588645|FG004|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||0
10550180|NCT01529645|11704248|FG005|NOT COMPLETED|Overall Study||1
10550181|NCT01529645|11704249|FG006|NOT COMPLETED|Overall Study||2
10550182|NCT01529645|11704250|FG007|NOT COMPLETED|Overall Study||0
10550183|NCT01529645|11704251|FG008|NOT COMPLETED|Overall Study||1
10442069|NCT00934050|11588646|FG005|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||0
10442070|NCT00934050|11588641|FG000|STARTED|Enrolled After 15 Dec 2009||0
10442071|NCT00934050|11588642|FG001|STARTED|Enrolled After 15 Dec 2009||0
10442072|NCT00934050|11588643|FG002|STARTED|Enrolled After 15 Dec 2009||0
10442073|NCT00934050|11588644|FG003|STARTED|Enrolled After 15 Dec 2009||0
10442074|NCT00934050|11588645|FG004|STARTED|Enrolled After 15 Dec 2009||26
10442075|NCT00934050|11588646|FG005|STARTED|Enrolled After 15 Dec 2009||27
10442076|NCT00934050|11588641|FG000|COMPLETED|Enrolled After 15 Dec 2009||0
10442077|NCT00934050|11588642|FG001|COMPLETED|Enrolled After 15 Dec 2009||0
10442078|NCT00934050|11588643|FG002|COMPLETED|Enrolled After 15 Dec 2009||0
10442079|NCT00934050|11588644|FG003|COMPLETED|Enrolled After 15 Dec 2009||0
10442080|NCT00934050|11588645|FG004|COMPLETED|Enrolled After 15 Dec 2009||19
10442081|NCT00934050|11588646|FG005|COMPLETED|Enrolled After 15 Dec 2009||23
10442082|NCT00934050|11588641|FG000|NOT COMPLETED|Enrolled After 15 Dec 2009||0
10442083|NCT00934050|11588642|FG001|NOT COMPLETED|Enrolled After 15 Dec 2009||0
10442084|NCT00934050|11588643|FG002|NOT COMPLETED|Enrolled After 15 Dec 2009||0
10442085|NCT00934050|11588644|FG003|NOT COMPLETED|Enrolled After 15 Dec 2009||0
10442086|NCT00934050|11588645|FG004|NOT COMPLETED|Enrolled After 15 Dec 2009||7
10442087|NCT00934050|11588646|FG005|NOT COMPLETED|Enrolled After 15 Dec 2009||4
10442088|NCT00934089|11588658|FG000|STARTED|First Intervention Period (14 Days)||15
10442089|NCT00934089|11588659|FG001|STARTED|First Intervention Period (14 Days)||16
10442090|NCT00934089|11588658|FG000|Treated|First Intervention Period (14 Days)||14
10442091|NCT00934089|11588659|FG001|Treated|First Intervention Period (14 Days)||16
10442092|NCT00934089|11588658|FG000|COMPLETED|First Intervention Period (14 Days)||13
10442093|NCT00934089|11588659|FG001|COMPLETED|First Intervention Period (14 Days)||16
10442094|NCT00934089|11588658|FG000|NOT COMPLETED|First Intervention Period (14 Days)||2
10442095|NCT00934089|11588659|FG001|NOT COMPLETED|First Intervention Period (14 Days)||0
10442096|NCT00934089|11588658|FG000|STARTED|Washout Period (28 Days)||13
10442097|NCT00934089|11588659|FG001|STARTED|Washout Period (28 Days)||16
10442098|NCT00934089|11588658|FG000|COMPLETED|Washout Period (28 Days)||13
10442099|NCT00934089|11588659|FG001|COMPLETED|Washout Period (28 Days)||16
10442100|NCT00934089|11588658|FG000|NOT COMPLETED|Washout Period (28 Days)||0
10442101|NCT00934089|11588659|FG001|NOT COMPLETED|Washout Period (28 Days)||0
10442102|NCT00934089|11588658|FG000|STARTED|Second Intervention Period (14 Days)||13
10442103|NCT00934089|11588659|FG001|STARTED|Second Intervention Period (14 Days)||16
10442104|NCT00934089|11588658|FG000|COMPLETED|Second Intervention Period (14 Days)||13
10442105|NCT00934089|11588659|FG001|COMPLETED|Second Intervention Period (14 Days)||16
10442106|NCT00934089|11588658|FG000|NOT COMPLETED|Second Intervention Period (14 Days)||0
10442107|NCT00934089|11588659|FG001|NOT COMPLETED|Second Intervention Period (14 Days)||0
10442108|NCT00934102|11588665|FG000|STARTED|Period 1, One Night of Wear||16
10442109|NCT00934102|11588666|FG001|STARTED|Period 1, One Night of Wear||15
10789451|NCT03521115|11949884|FG000|COMPLETED|Time 0 Baseline Surveys||206
10442110|NCT00934102|11588667|FG002|STARTED|Period 1, One Night of Wear||15
10442111|NCT00934102|11588665|FG000|COMPLETED|Period 1, One Night of Wear||15
10442112|NCT00934102|11588666|FG001|COMPLETED|Period 1, One Night of Wear||15
10442113|NCT00934102|11588667|FG002|COMPLETED|Period 1, One Night of Wear||15
10442114|NCT00934102|11588665|FG000|NOT COMPLETED|Period 1, One Night of Wear||1
10442115|NCT00934102|11588666|FG001|NOT COMPLETED|Period 1, One Night of Wear||0
10442116|NCT00934102|11588667|FG002|NOT COMPLETED|Period 1, One Night of Wear||0
10442117|NCT00934102|11588665|FG000|STARTED|Period 2, 7 Days/6 Nights of Wear||15
10442118|NCT00934102|11588666|FG001|STARTED|Period 2, 7 Days/6 Nights of Wear||15
10442119|NCT00934102|11588667|FG002|STARTED|Period 2, 7 Days/6 Nights of Wear||15
10442120|NCT00934102|11588665|FG000|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
10442121|NCT00934102|11588666|FG001|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
10442122|NCT00934102|11588667|FG002|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
10442123|NCT00934102|11588665|FG000|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
10442124|NCT00934102|11588666|FG001|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
10442125|NCT00934102|11588667|FG002|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
10442126|NCT00934128|11588677|FG000|STARTED|First Intervention (2 Hours)||15
10442127|NCT00934128|11588678|FG001|STARTED|First Intervention (2 Hours)||15
10442128|NCT00934128|11588677|FG000|COMPLETED|First Intervention (2 Hours)||10
10442129|NCT00934128|11588678|FG001|COMPLETED|First Intervention (2 Hours)||13
10442130|NCT00934128|11588677|FG000|NOT COMPLETED|First Intervention (2 Hours)||5
10442131|NCT00934128|11588678|FG001|NOT COMPLETED|First Intervention (2 Hours)||2
10442132|NCT00934128|11588677|FG000|STARTED|Washout Period (1 Hour)||10
10442133|NCT00934128|11588678|FG001|STARTED|Washout Period (1 Hour)||13
10442134|NCT00934128|11588677|FG000|COMPLETED|Washout Period (1 Hour)||3
10442135|NCT00934128|11588678|FG001|COMPLETED|Washout Period (1 Hour)||8
10442136|NCT00934128|11588677|FG000|NOT COMPLETED|Washout Period (1 Hour)||7
10442137|NCT00934128|11588678|FG001|NOT COMPLETED|Washout Period (1 Hour)||5
10442138|NCT00934128|11588677|FG000|STARTED|Second Intervention (2 Hours)||3
10442139|NCT00934128|11588678|FG001|STARTED|Second Intervention (2 Hours)||8
10550184|NCT01529645|11704252|FG009|NOT COMPLETED|Overall Study||0
10550185|NCT01529749|11704286|FG000|STARTED|Overall Study||12
10550186|NCT01529749|11704287|FG001|STARTED|Overall Study||12
10550187|NCT01529749|11704288|FG002|STARTED|Overall Study||12
10550188|NCT01529749|11704289|FG003|STARTED|Overall Study||12
10550189|NCT01529749|11704286|FG000|COMPLETED|Overall Study||12
10550190|NCT01529749|11704287|FG001|COMPLETED|Overall Study||10
10550191|NCT01529749|11704288|FG002|COMPLETED|Overall Study||10
10550192|NCT01529749|11704289|FG003|COMPLETED|Overall Study||10
10550193|NCT01529749|11704286|FG000|NOT COMPLETED|Overall Study||0
10442140|NCT00934128|11588677|FG000|COMPLETED|Second Intervention (2 Hours)||3
10442141|NCT00934128|11588678|FG001|COMPLETED|Second Intervention (2 Hours)||5
10442142|NCT00934128|11588677|FG000|NOT COMPLETED|Second Intervention (2 Hours)||0
10442143|NCT00934128|11588678|FG001|NOT COMPLETED|Second Intervention (2 Hours)||3
10442144|NCT00934141|11588688|FG000|STARTED|Overall Study||49
10442145|NCT00934141|11588689|FG001|STARTED|Overall Study||50
10442146|NCT00934141|11588690|FG002|STARTED|Overall Study||48
10442147|NCT00934141|11588691|FG003|STARTED|Overall Study||54
10442148|NCT00934141|11588688|FG000|COMPLETED|Overall Study||45
10442149|NCT00934141|11588689|FG001|COMPLETED|Overall Study||47
10442150|NCT00934141|11588690|FG002|COMPLETED|Overall Study||48
10442151|NCT00934141|11588691|FG003|COMPLETED|Overall Study||51
10442152|NCT00934141|11588688|FG000|NOT COMPLETED|Overall Study||4
10442153|NCT00934141|11588689|FG001|NOT COMPLETED|Overall Study||3
10442154|NCT00934141|11588690|FG002|NOT COMPLETED|Overall Study||0
10442155|NCT00934141|11588691|FG003|NOT COMPLETED|Overall Study||3
10442156|NCT00934362|11588705|FG000|STARTED|Overall Study||8
10442157|NCT00934362|11588706|FG001|STARTED|Overall Study||8
10442158|NCT00934362|11588705|FG000|COMPLETED|Overall Study||7
10442159|NCT00934362|11588706|FG001|COMPLETED|Overall Study||8
10442160|NCT00934362|11588705|FG000|NOT COMPLETED|Overall Study||1
10442161|NCT00934362|11588706|FG001|NOT COMPLETED|Overall Study||0
10442162|NCT00934375|11588714|FG000|STARTED|Overall Study||68
10442163|NCT00934375|11588715|FG001|STARTED|Overall Study||77
10442164|NCT00934375|11588714|FG000|COMPLETED|Overall Study||55
10442165|NCT00934375|11588715|FG001|COMPLETED|Overall Study||55
10442166|NCT00934375|11588714|FG000|NOT COMPLETED|Overall Study||13
10442167|NCT00934375|11588715|FG001|NOT COMPLETED|Overall Study||22
10442169|NCT00934440|11588721|FG000|COMPLETED|Overall Study||10
10442170|NCT00934440|11588721|FG000|NOT COMPLETED|Overall Study||1
10442171|NCT00934544|11588728|FG000|STARTED|Primary Endpoint Analysis (Interim)||146
10550194|NCT01529749|11704287|FG001|NOT COMPLETED|Overall Study||2
10550195|NCT01529749|11704288|FG002|NOT COMPLETED|Overall Study||2
10550196|NCT01529749|11704289|FG003|NOT COMPLETED|Overall Study||2
10550197|NCT01529827|11704299|FG000|STARTED|Overall Study||94
10442172|NCT00934544|11588729|FG001|STARTED|Primary Endpoint Analysis (Interim)||73
10442173|NCT00934544|11588730|FG002|STARTED|Primary Endpoint Analysis (Interim)||0
10442174|NCT00934544|11588728|FG000|COMPLETED|Primary Endpoint Analysis (Interim)||91
10442175|NCT00934544|11588729|FG001|COMPLETED|Primary Endpoint Analysis (Interim)||31
10442176|NCT00934544|11588730|FG002|COMPLETED|Primary Endpoint Analysis (Interim)||0
10442177|NCT00934544|11588728|FG000|NOT COMPLETED|Primary Endpoint Analysis (Interim)||55
10442178|NCT00934544|11588729|FG001|NOT COMPLETED|Primary Endpoint Analysis (Interim)||42
10442179|NCT00934544|11588730|FG002|NOT COMPLETED|Primary Endpoint Analysis (Interim)||0
10442180|NCT00934544|11588728|FG000|STARTED|Overall Disposition at 5 Year Follow-up||146
10442181|NCT00934544|11588729|FG001|STARTED|Overall Disposition at 5 Year Follow-up||28
10442182|NCT00934544|11588730|FG002|STARTED|Overall Disposition at 5 Year Follow-up||45
10442183|NCT00934544|11588728|FG000|Crossed Over After Qualifying Event|Overall Disposition at 5 Year Follow-up||0
10442184|NCT00934544|11588729|FG001|Crossed Over After Qualifying Event|Overall Disposition at 5 Year Follow-up||0
10442185|NCT00934544|11588730|FG002|Crossed Over After Qualifying Event|Overall Disposition at 5 Year Follow-up||27
10442186|NCT00934544|11588728|FG000|Crossed Over After AMEND 5|Overall Disposition at 5 Year Follow-up||0
10442187|NCT00934544|11588729|FG001|Crossed Over After AMEND 5|Overall Disposition at 5 Year Follow-up||0
10442188|NCT00934544|11588730|FG002|Crossed Over After AMEND 5|Overall Disposition at 5 Year Follow-up||12
10442189|NCT00934544|11588728|FG000|Crossed Over: Other|Overall Disposition at 5 Year Follow-up||0
10442190|NCT00934544|11588729|FG001|Crossed Over: Other|Overall Disposition at 5 Year Follow-up||0
10442191|NCT00934544|11588730|FG002|Crossed Over: Other|Overall Disposition at 5 Year Follow-up||6
10442192|NCT00934544|11588728|FG000|COMPLETED|Overall Disposition at 5 Year Follow-up||39
10442193|NCT00934544|11588729|FG001|COMPLETED|Overall Disposition at 5 Year Follow-up||0
10442194|NCT00934544|11588730|FG002|COMPLETED|Overall Disposition at 5 Year Follow-up||11
10442195|NCT00934544|11588728|FG000|NOT COMPLETED|Overall Disposition at 5 Year Follow-up||107
10442196|NCT00934544|11588729|FG001|NOT COMPLETED|Overall Disposition at 5 Year Follow-up||28
10442197|NCT00934544|11588730|FG002|NOT COMPLETED|Overall Disposition at 5 Year Follow-up||34
10442198|NCT00934596|11588749|FG000|STARTED|Overall Study|Twenty patients were prospectively randomly assigned to the two arms|10
10442199|NCT00934596|11588750|FG001|STARTED|Overall Study||10
10442200|NCT00934596|11588749|FG000|COMPLETED|Overall Study||10
10442201|NCT00934596|11588750|FG001|COMPLETED|Overall Study||10
10442202|NCT00934596|11588749|FG000|NOT COMPLETED|Overall Study||0
10442203|NCT00934596|11588750|FG001|NOT COMPLETED|Overall Study||0
10442204|NCT00934622|11588760|FG000|STARTED|Overall Study||76
10442205|NCT00934622|11588760|FG000|COMPLETED|Overall Study||68
10442206|NCT00934622|11588760|FG000|NOT COMPLETED|Overall Study||8
10442207|NCT00934635|11588773|FG000|STARTED|Overall Study||0
10442208|NCT00934635|11588774|FG001|STARTED|Overall Study||1
10442209|NCT00934635|11588775|FG002|STARTED|Overall Study||0
10442210|NCT00934635|11588776|FG003|STARTED|Overall Study||0
10442211|NCT00934635|11588777|FG004|STARTED|Overall Study||0
10442212|NCT00934635|11588778|FG005|STARTED|Overall Study||0
10442213|NCT00934635|11588779|FG006|STARTED|Overall Study||0
10442214|NCT00934635|11588780|FG007|STARTED|Overall Study||0
10442215|NCT00934635|11588781|FG008|STARTED|Overall Study||1
10442216|NCT00934635|11588773|FG000|COMPLETED|Overall Study||0
10442217|NCT00934635|11588774|FG001|COMPLETED|Overall Study||1
10442218|NCT00934635|11588775|FG002|COMPLETED|Overall Study||0
10442219|NCT00934635|11588776|FG003|COMPLETED|Overall Study||0
10442220|NCT00934635|11588777|FG004|COMPLETED|Overall Study||0
10442221|NCT00934635|11588778|FG005|COMPLETED|Overall Study||0
10442222|NCT00934635|11588779|FG006|COMPLETED|Overall Study||0
10442223|NCT00934635|11588780|FG007|COMPLETED|Overall Study||0
10442224|NCT00934635|11588781|FG008|COMPLETED|Overall Study||1
10442225|NCT00934635|11588773|FG000|NOT COMPLETED|Overall Study||0
10442226|NCT00934635|11588774|FG001|NOT COMPLETED|Overall Study||0
10442227|NCT00934635|11588775|FG002|NOT COMPLETED|Overall Study||0
10442228|NCT00934635|11588776|FG003|NOT COMPLETED|Overall Study||0
10442229|NCT00934635|11588777|FG004|NOT COMPLETED|Overall Study||0
10442230|NCT00934635|11588778|FG005|NOT COMPLETED|Overall Study||0
10442231|NCT00934635|11588779|FG006|NOT COMPLETED|Overall Study||0
10442232|NCT00934635|11588780|FG007|NOT COMPLETED|Overall Study||0
10442233|NCT00934635|11588781|FG008|NOT COMPLETED|Overall Study||0
10442234|NCT00934648|11588801|FG000|STARTED|Overall Study||15
10442235|NCT00934648|11588801|FG000|COMPLETED|Overall Study||6
10442236|NCT00934648|11588801|FG000|NOT COMPLETED|Overall Study||9
10442237|NCT00934661|11588807|FG000|STARTED|Overall Study||20
10442238|NCT00934661|11588808|FG001|STARTED|Overall Study||20
10442239|NCT00934661|11588807|FG000|COMPLETED|Overall Study||19
10442240|NCT00934661|11588808|FG001|COMPLETED|Overall Study||20
10442241|NCT00934661|11588807|FG000|NOT COMPLETED|Overall Study||1
10442242|NCT00934661|11588808|FG001|NOT COMPLETED|Overall Study||0
10442243|NCT00934843|11588816|FG000|STARTED|Overall Study||37
10442244|NCT00934843|11588817|FG001|STARTED|Overall Study||40
10442245|NCT00934843|11588816|FG000|COMPLETED|Overall Study||37
10442246|NCT00934843|11588817|FG001|COMPLETED|Overall Study|1 subject discontinued intervention, surgery plan changed and did not require CPB|39
10442247|NCT00934843|11588816|FG000|NOT COMPLETED|Overall Study||0
10442248|NCT00934843|11588817|FG001|NOT COMPLETED|Overall Study||1
10442249|NCT00934856|11588829|FG000|STARTED|Feasibility Part||6
10442250|NCT00934856|11588830|FG001|STARTED|Feasibility Part||6
10442251|NCT00934856|11588831|FG002|STARTED|Feasibility Part||3
10442252|NCT00934856|11588832|FG003|STARTED|Feasibility Part||6
10442253|NCT00934856|11588833|FG004|STARTED|Feasibility Part||12
10442254|NCT00934856|11588834|FG005|STARTED|Feasibility Part||9
10442255|NCT00934856|11588829|FG000|COMPLETED|Feasibility Part||1
10442256|NCT00934856|11588830|FG001|COMPLETED|Feasibility Part||1
10442257|NCT00934856|11588831|FG002|COMPLETED|Feasibility Part||0
10442258|NCT00934856|11588832|FG003|COMPLETED|Feasibility Part||1
10442259|NCT00934856|11588833|FG004|COMPLETED|Feasibility Part||12
10442260|NCT00934856|11588834|FG005|COMPLETED|Feasibility Part||6
10442261|NCT00934856|11588829|FG000|NOT COMPLETED|Feasibility Part||5
10442262|NCT00934856|11588830|FG001|NOT COMPLETED|Feasibility Part||5
10442263|NCT00934856|11588831|FG002|NOT COMPLETED|Feasibility Part||3
10442264|NCT00934856|11588832|FG003|NOT COMPLETED|Feasibility Part||5
10442265|NCT00934856|11588833|FG004|NOT COMPLETED|Feasibility Part||0
10442266|NCT00934856|11588834|FG005|NOT COMPLETED|Feasibility Part||3
10442267|NCT00934856|11588829|FG000|STARTED|Extension Part||0
10442268|NCT00934856|11588830|FG001|STARTED|Extension Part||0
10442269|NCT00934856|11588831|FG002|STARTED|Extension Part||0
10442270|NCT00934856|11588832|FG003|STARTED|Extension Part|New participants were enrolled in the extension part.|4
10442271|NCT00934856|11588833|FG004|STARTED|Extension Part|New participants were enrolled in the extension part.|28
10550198|NCT01529827|11704299|FG000|COMPLETED|Overall Study||94
10550199|NCT01529827|11704299|FG000|NOT COMPLETED|Overall Study||0
10550200|NCT01530178|11704305|FG000|STARTED|Overall Study||2
10550201|NCT01530178|11704306|FG001|STARTED|Overall Study||6
10442272|NCT00934856|11588834|FG005|STARTED|Extension Part|New participants were enrolled in the extension part.|24
10442273|NCT00934856|11588829|FG000|COMPLETED|Extension Part||0
10442274|NCT00934856|11588830|FG001|COMPLETED|Extension Part||0
10442275|NCT00934856|11588831|FG002|COMPLETED|Extension Part||0
10442276|NCT00934856|11588832|FG003|COMPLETED|Extension Part||2
10442277|NCT00934856|11588833|FG004|COMPLETED|Extension Part||24
10442278|NCT00934856|11588834|FG005|COMPLETED|Extension Part||19
10442279|NCT00934856|11588829|FG000|NOT COMPLETED|Extension Part||0
10442280|NCT00934856|11588830|FG001|NOT COMPLETED|Extension Part||0
10442281|NCT00934856|11588831|FG002|NOT COMPLETED|Extension Part||0
10442282|NCT00934856|11588832|FG003|NOT COMPLETED|Extension Part||2
10442283|NCT00934856|11588833|FG004|NOT COMPLETED|Extension Part||4
10442284|NCT00934856|11588834|FG005|NOT COMPLETED|Extension Part||5
10550202|NCT01530178|11704305|FG000|COMPLETED|Overall Study||2
10550203|NCT01530178|11704306|FG001|COMPLETED|Overall Study||6
10550204|NCT01530178|11704305|FG000|NOT COMPLETED|Overall Study||0
10550205|NCT01530178|11704306|FG001|NOT COMPLETED|Overall Study||0
10550206|NCT01530243|11704320|FG000|STARTED|Overall Study||26
10550207|NCT01530243|11704321|FG001|STARTED|Overall Study||26
10550208|NCT01530243|11704322|FG002|STARTED|Overall Study||26
10550209|NCT01530243|11704323|FG003|STARTED|Overall Study||26
10550210|NCT01530243|11704320|FG000|COMPLETED|Overall Study||24
10550211|NCT01530243|11704321|FG001|COMPLETED|Overall Study||23
10550212|NCT01530243|11704322|FG002|COMPLETED|Overall Study||23
10550213|NCT01530243|11704323|FG003|COMPLETED|Overall Study||24
10550214|NCT01530243|11704320|FG000|NOT COMPLETED|Overall Study||2
10550215|NCT01530243|11704321|FG001|NOT COMPLETED|Overall Study||3
10550216|NCT01530243|11704322|FG002|NOT COMPLETED|Overall Study||3
10550217|NCT01530243|11704323|FG003|NOT COMPLETED|Overall Study||2
10550218|NCT01530256|11704334|FG000|STARTED|Overall Study||3
10550219|NCT01530256|11704334|FG000|COMPLETED|Overall Study||1
10550220|NCT01530256|11704334|FG000|NOT COMPLETED|Overall Study||2
10550221|NCT01530334|11704338|FG000|STARTED|Overall Study||61
10550222|NCT01530334|11704338|FG000|COMPLETED|Overall Study||10
10550223|NCT01530334|11704338|FG000|NOT COMPLETED|Overall Study||51
10550224|NCT01530399|11704348|FG000|STARTED|Overall Study||8
10550225|NCT01530399|11704349|FG001|STARTED|Overall Study||10
10550226|NCT01530399|11704350|FG002|STARTED|Overall Study||8
10550227|NCT01530399|11704351|FG003|STARTED|Overall Study||10
10550228|NCT01530399|11704352|FG004|STARTED|Overall Study||6
10550229|NCT01530399|11704353|FG005|STARTED|Overall Study||7
10550230|NCT01530399|11704348|FG000|COMPLETED|Overall Study||7
10550231|NCT01530399|11704349|FG001|COMPLETED|Overall Study||8
10550232|NCT01530399|11704350|FG002|COMPLETED|Overall Study||7
10550233|NCT01530399|11704351|FG003|COMPLETED|Overall Study||10
10550234|NCT01530399|11704352|FG004|COMPLETED|Overall Study||6
10550235|NCT01530399|11704353|FG005|COMPLETED|Overall Study||6
10550236|NCT01530399|11704348|FG000|NOT COMPLETED|Overall Study||1
10550237|NCT01530399|11704349|FG001|NOT COMPLETED|Overall Study||2
10550238|NCT01530399|11704350|FG002|NOT COMPLETED|Overall Study||1
10550239|NCT01530399|11704351|FG003|NOT COMPLETED|Overall Study||0
10550240|NCT01530399|11704352|FG004|NOT COMPLETED|Overall Study||0
10550241|NCT01530399|11704353|FG005|NOT COMPLETED|Overall Study||1
10550242|NCT01530464|11704369|FG000|STARTED|First Intervention (24h)||10
10550243|NCT01530464|11704370|FG001|STARTED|First Intervention (24h)||8
10550244|NCT01530464|11704369|FG000|COMPLETED|First Intervention (24h)||10
10550245|NCT01530464|11704370|FG001|COMPLETED|First Intervention (24h)||8
10442285|NCT00934934|11588868|FG000|STARTED|Overall Study||30
10442286|NCT00934934|11588869|FG001|STARTED|Overall Study||31
10442287|NCT00934934|11588868|FG000|COMPLETED|Overall Study||29
10442288|NCT00934934|11588869|FG001|COMPLETED|Overall Study||31
10442289|NCT00934934|11588868|FG000|NOT COMPLETED|Overall Study||1
10550246|NCT01530464|11704369|FG000|NOT COMPLETED|First Intervention (24h)||0
10550247|NCT01530464|11704370|FG001|NOT COMPLETED|First Intervention (24h)||0
10550248|NCT01530464|11704369|FG000|STARTED|Washout (24h)||10
10550249|NCT01530464|11704370|FG001|STARTED|Washout (24h)||8
10550250|NCT01530464|11704369|FG000|COMPLETED|Washout (24h)||10
10550251|NCT01530464|11704370|FG001|COMPLETED|Washout (24h)||8
10550252|NCT01530464|11704369|FG000|NOT COMPLETED|Washout (24h)||0
10442290|NCT00934934|11588869|FG001|NOT COMPLETED|Overall Study||0
10442291|NCT00934947|11588880|FG000|STARTED|Overall Study||23
10442292|NCT00934947|11588881|FG001|STARTED|Overall Study||22
10442293|NCT00934947|11588880|FG000|COMPLETED|Overall Study||23
10442294|NCT00934947|11588881|FG001|COMPLETED|Overall Study||20
10442295|NCT00934947|11588880|FG000|NOT COMPLETED|Overall Study||0
10442296|NCT00934947|11588881|FG001|NOT COMPLETED|Overall Study||2
10442297|NCT00935012|11588889|FG000|STARTED|Overall Study||31
10442298|NCT00935012|11588889|FG000|COMPLETED|Overall Study||2
10442299|NCT00935012|11588889|FG000|NOT COMPLETED|Overall Study||29
10442300|NCT00935064|11588895|FG000|STARTED|Overall Study||30
10442301|NCT00935064|11588896|FG001|STARTED|Overall Study||30
10442302|NCT00935064|11588895|FG000|COMPLETED|Overall Study||30
10442303|NCT00935064|11588896|FG001|COMPLETED|Overall Study||30
10442304|NCT00935064|11588895|FG000|NOT COMPLETED|Overall Study||0
10442305|NCT00935064|11588896|FG001|NOT COMPLETED|Overall Study||0
10442306|NCT00935220|11588902|FG000|STARTED|Overall Study||41
10442307|NCT00935220|11588902|FG000|COMPLETED|Overall Study||39
10442308|NCT00935220|11588902|FG000|NOT COMPLETED|Overall Study||2
10442309|NCT00935259|11588906|FG000|STARTED|Period 1||16
10442310|NCT00935259|11588907|FG001|STARTED|Period 1||15
10442311|NCT00935259|11588906|FG000|COMPLETED|Period 1||15
10442312|NCT00935259|11588907|FG001|COMPLETED|Period 1||14
10442313|NCT00935259|11588906|FG000|NOT COMPLETED|Period 1||1
10442314|NCT00935259|11588907|FG001|NOT COMPLETED|Period 1||1
10442315|NCT00935259|11588906|FG000|STARTED|Period 2||15
10442316|NCT00935259|11588907|FG001|STARTED|Period 2||14
10442317|NCT00935259|11588906|FG000|COMPLETED|Period 2||15
10442318|NCT00935259|11588907|FG001|COMPLETED|Period 2||14
10442319|NCT00935259|11588906|FG000|NOT COMPLETED|Period 2||0
10442320|NCT00935259|11588907|FG001|NOT COMPLETED|Period 2||0
10442321|NCT00935272|11588917|FG000|STARTED|Overall Study||135
10442322|NCT00935272|11588918|FG001|STARTED|Overall Study||45
10442323|NCT00935272|11588917|FG000|COMPLETED|Overall Study||116
10442324|NCT00935272|11588918|FG001|COMPLETED|Overall Study||39
10442325|NCT00935272|11588917|FG000|NOT COMPLETED|Overall Study||19
10442326|NCT00935272|11588918|FG001|NOT COMPLETED|Overall Study||6
10442327|NCT00935311|11588928|FG000|STARTED|Overall Study||43
10442328|NCT00935311|11588929|FG001|STARTED|Overall Study||39
10442329|NCT00935311|11588930|FG002|STARTED|Overall Study||40
10442330|NCT00935311|11588928|FG000|COMPLETED|Overall Study||43
10442331|NCT00935311|11588929|FG001|COMPLETED|Overall Study||39
10442332|NCT00935311|11588930|FG002|COMPLETED|Overall Study||40
10442333|NCT00935311|11588928|FG000|NOT COMPLETED|Overall Study||0
10442334|NCT00935311|11588929|FG001|NOT COMPLETED|Overall Study||0
10442335|NCT00935311|11588930|FG002|NOT COMPLETED|Overall Study||0
10442336|NCT00935428|11588938|FG000|STARTED|Overall Study||231
10442337|NCT00935428|11588938|FG000|COMPLETED|Overall Study||231
10442338|NCT00935428|11588938|FG000|NOT COMPLETED|Overall Study||0
10442339|NCT00935493|11588951|FG000|STARTED|Overall Study||41
10442340|NCT00935493|11588952|FG001|STARTED|Overall Study||41
10442341|NCT00935493|11588953|FG002|STARTED|Overall Study||41
10442342|NCT00935493|11588951|FG000|COMPLETED|Overall Study||40
10442343|NCT00935493|11588952|FG001|COMPLETED|Overall Study||39
10442344|NCT00935493|11588953|FG002|COMPLETED|Overall Study||40
10442345|NCT00935493|11588951|FG000|NOT COMPLETED|Overall Study||1
10442346|NCT00935493|11588952|FG001|NOT COMPLETED|Overall Study||2
10442347|NCT00935493|11588953|FG002|NOT COMPLETED|Overall Study||1
10442348|NCT00935532|11588963|FG000|STARTED|Overall Study||215
10442349|NCT00935532|11588964|FG001|STARTED|Overall Study||212
10442350|NCT00935532|11588963|FG000|COMPLETED|Overall Study||193
10442351|NCT00935532|11588964|FG001|COMPLETED|Overall Study||201
10442352|NCT00935532|11588963|FG000|NOT COMPLETED|Overall Study||22
10442353|NCT00935532|11588964|FG001|NOT COMPLETED|Overall Study||11
10442354|NCT00935584|11588972|FG000|STARTED|Overall Study|Out of 128 participants consented, 2 patients had no data collected, as the clinic was cancelled.|126
10442355|NCT00935584|11588973|FG001|STARTED|Overall Study||23
10442356|NCT00935584|11588972|FG000|COMPLETED|Overall Study||77
10442357|NCT00935584|11588973|FG001|COMPLETED|Overall Study||19
10442358|NCT00935584|11588972|FG000|NOT COMPLETED|Overall Study||49
10442359|NCT00935584|11588973|FG001|NOT COMPLETED|Overall Study||4
10442360|NCT00935701|11588977|FG000|STARTED|Overall Study||10
10442361|NCT00935701|11588977|FG000|Transition Acupressure to Acupuncture|Overall Study||9
10442362|NCT00935701|11588977|FG000|COMPLETED|Overall Study||9
10442363|NCT00935701|11588977|FG000|NOT COMPLETED|Overall Study||1
10442364|NCT00935766|11588984|FG000|STARTED|Overall Study||42
10442365|NCT00935766|11588985|FG001|STARTED|Overall Study||34
10442366|NCT00935766|11588984|FG000|COMPLETED|Overall Study||35
10442367|NCT00935766|11588985|FG001|COMPLETED|Overall Study||27
10442368|NCT00935766|11588984|FG000|NOT COMPLETED|Overall Study||7
10442369|NCT00935766|11588985|FG001|NOT COMPLETED|Overall Study||7
10442370|NCT00935792|11588994|FG000|STARTED|Overall Study||7
10442371|NCT00935792|11588995|FG001|STARTED|Overall Study||9
10442372|NCT00935792|11588996|FG002|STARTED|Overall Study||12
10442373|NCT00935792|11588994|FG000|COMPLETED|Overall Study||6
10442374|NCT00935792|11588995|FG001|COMPLETED|Overall Study||6
10442375|NCT00935792|11588996|FG002|COMPLETED|Overall Study||12
10442376|NCT00935792|11588994|FG000|NOT COMPLETED|Overall Study||1
10442377|NCT00935792|11588995|FG001|NOT COMPLETED|Overall Study||3
10442378|NCT00935792|11588996|FG002|NOT COMPLETED|Overall Study||0
10442379|NCT00935818|11589008|FG000|STARTED|Overall Study||249
10442380|NCT00935818|11589009|FG001|STARTED|Overall Study||257
10442381|NCT00935818|11589008|FG000|End of Medication Phase|Overall Study||182
10442382|NCT00935818|11589009|FG001|End of Medication Phase|Overall Study||184
10442383|NCT00935818|11589008|FG000|COMPLETED|Overall Study||158
10442384|NCT00935818|11589009|FG001|COMPLETED|Overall Study||157
10442385|NCT00935818|11589008|FG000|NOT COMPLETED|Overall Study||91
10442386|NCT00935818|11589009|FG001|NOT COMPLETED|Overall Study||100
10442387|NCT00935857|11589017|FG000|STARTED|Overall Study||14
10442388|NCT00935857|11589018|FG001|STARTED|Overall Study||16
10442389|NCT00935857|11589017|FG000|COMPLETED|Overall Study||14
10442390|NCT00935857|11589018|FG001|COMPLETED|Overall Study||16
10442391|NCT00935857|11589017|FG000|NOT COMPLETED|Overall Study||0
10442392|NCT00935857|11589018|FG001|NOT COMPLETED|Overall Study||0
10442393|NCT00935883|11589026|FG000|STARTED|Treatment Period||20
10442394|NCT00935883|11589027|FG001|STARTED|Treatment Period||40
10442395|NCT00935883|11589026|FG000|COMPLETED|Treatment Period||19
10442396|NCT00935883|11589027|FG001|COMPLETED|Treatment Period||38
10442397|NCT00935883|11589026|FG000|NOT COMPLETED|Treatment Period||1
10442398|NCT00935883|11589027|FG001|NOT COMPLETED|Treatment Period||2
10442399|NCT00935883|11589026|FG000|STARTED|Follow-Up Period||19
10442400|NCT00935883|11589027|FG001|STARTED|Follow-Up Period||38
10442401|NCT00935883|11589026|FG000|COMPLETED|Follow-Up Period||19
10442402|NCT00935883|11589027|FG001|COMPLETED|Follow-Up Period||38
10442403|NCT00935883|11589026|FG000|NOT COMPLETED|Follow-Up Period||0
10442404|NCT00935883|11589027|FG001|NOT COMPLETED|Follow-Up Period||0
10442405|NCT00936065|11589036|FG000|STARTED|Overall Study||21
10442406|NCT00936065|11589037|FG001|STARTED|Overall Study||20
10442407|NCT00936065|11589038|FG002|STARTED|Overall Study||19
10442408|NCT00936065|11589036|FG000|Received Treatment|Overall Study||21
10442409|NCT00936065|11589037|FG001|Received Treatment|Overall Study||20
10442410|NCT00936065|11589038|FG002|Received Treatment|Overall Study||18
10442411|NCT00936065|11589036|FG000|Study Assessments Performed|Overall Study||21
10442412|NCT00936065|11589037|FG001|Study Assessments Performed|Overall Study||19
10442413|NCT00936065|11589038|FG002|Study Assessments Performed|Overall Study||18
10442414|NCT00936065|11589036|FG000|COMPLETED|Overall Study||17
10442415|NCT00936065|11589037|FG001|COMPLETED|Overall Study||16
10442416|NCT00936065|11589038|FG002|COMPLETED|Overall Study||12
10442417|NCT00936065|11589036|FG000|NOT COMPLETED|Overall Study||4
10442418|NCT00936065|11589037|FG001|NOT COMPLETED|Overall Study||4
10442419|NCT00936065|11589038|FG002|NOT COMPLETED|Overall Study||7
10442420|NCT00936117|11589046|FG000|STARTED|Overall Study||20
10442421|NCT00936117|11589046|FG000|COMPLETED|Overall Study|Completed 42 days on study drug|10
10442422|NCT00936117|11589046|FG000|NOT COMPLETED|Overall Study||10
10442423|NCT00936208|11589053|FG000|STARTED|Overall Study||1499
10442424|NCT00936208|11589054|FG001|STARTED|Overall Study||1596
10442425|NCT00936208|11589053|FG000|COMPLETED|Overall Study||1462
10442426|NCT00936208|11589054|FG001|COMPLETED|Overall Study||1574
10442427|NCT00936208|11589053|FG000|NOT COMPLETED|Overall Study||37
10442428|NCT00936208|11589054|FG001|NOT COMPLETED|Overall Study||22
10442429|NCT00936221|11589062|FG000|STARTED|Overall Study||45
10442430|NCT00936221|11589063|FG001|STARTED|Overall Study||46
10442431|NCT00936221|11589062|FG000|Received Treatment|Overall Study||44
10442432|NCT00936221|11589063|FG001|Received Treatment|Overall Study||45
10442433|NCT00936221|11589062|FG000|COMPLETED|Overall Study|13 patients ongoing cutoff + 31 patients who had died.|44
10442434|NCT00936221|11589063|FG001|COMPLETED|Overall Study|10 patients ongoing at data cutoff + 35 patients who had died.|45
10442435|NCT00936221|11589062|FG000|NOT COMPLETED|Overall Study||1
10442436|NCT00936221|11589063|FG001|NOT COMPLETED|Overall Study||1
10442437|NCT00936299|11589071|FG000|STARTED|Overall Study||53
10442438|NCT00936299|11589072|FG001|STARTED|Overall Study||52
10442439|NCT00936299|11589071|FG000|COMPLETED|Overall Study||40
10442440|NCT00936299|11589072|FG001|COMPLETED|Overall Study||40
10442441|NCT00936299|11589071|FG000|NOT COMPLETED|Overall Study||13
10442442|NCT00936299|11589072|FG001|NOT COMPLETED|Overall Study||12
10442443|NCT00936351|11589082|FG000|STARTED|Overall Study||18
10442444|NCT00936351|11589083|FG001|STARTED|Overall Study||16
10442445|NCT00936351|11589082|FG000|COMPLETED|Overall Study||15
10442446|NCT00936351|11589083|FG001|COMPLETED|Overall Study||14
10442447|NCT00936351|11589082|FG000|NOT COMPLETED|Overall Study||3
10442448|NCT00936351|11589083|FG001|NOT COMPLETED|Overall Study||2
10442449|NCT00936377|11589092|FG000|STARTED|Overall Study||8
10442450|NCT00936377|11589093|FG001|STARTED|Overall Study||8
10442451|NCT00936377|11589094|FG002|STARTED|Overall Study||8
10442452|NCT00936377|11589092|FG000|COMPLETED|Overall Study||8
10442453|NCT00936377|11589093|FG001|COMPLETED|Overall Study||8
10442454|NCT00936377|11589094|FG002|COMPLETED|Overall Study||8
10442455|NCT00936377|11589092|FG000|NOT COMPLETED|Overall Study||0
10442456|NCT00936377|11589093|FG001|NOT COMPLETED|Overall Study||0
10442457|NCT00936377|11589094|FG002|NOT COMPLETED|Overall Study||0
10525511|NCT01376245|11677439|FG000|STARTED|24-week, Double-blind Treatment Period||0
10525512|NCT01376245|11677440|FG001|STARTED|24-week, Double-blind Treatment Period||162
10525513|NCT01376245|11677441|FG002|STARTED|24-week, Double-blind Treatment Period||160
10525514|NCT01376245|11677442|FG003|STARTED|24-week, Double-blind Treatment Period||161
10525515|NCT01376245|11677443|FG004|STARTED|24-week, Double-blind Treatment Period||160
10525516|NCT01376245|11677439|FG000|COMPLETED|24-week, Double-blind Treatment Period||0
10525517|NCT01376245|11677440|FG001|COMPLETED|24-week, Double-blind Treatment Period||130
10525518|NCT01376245|11677441|FG002|COMPLETED|24-week, Double-blind Treatment Period||135
10525519|NCT01376245|11677442|FG003|COMPLETED|24-week, Double-blind Treatment Period||138
10525520|NCT01376245|11677443|FG004|COMPLETED|24-week, Double-blind Treatment Period||134
10525521|NCT01376245|11677439|FG000|NOT COMPLETED|24-week, Double-blind Treatment Period||0
10550253|NCT01530464|11704370|FG001|NOT COMPLETED|Washout (24h)||0
10550254|NCT01530464|11704369|FG000|STARTED|Second Intervention (24h)||10
10550255|NCT01530464|11704370|FG001|STARTED|Second Intervention (24h)||8
10550256|NCT01530464|11704369|FG000|COMPLETED|Second Intervention (24h)||10
10550257|NCT01530464|11704370|FG001|COMPLETED|Second Intervention (24h)||8
10442458|NCT00936455|11589104|FG000|STARTED|Overall Study||37
10442459|NCT00936455|11589105|FG001|STARTED|Overall Study||38
10442460|NCT00936455|11589104|FG000|COMPLETED|Overall Study||37
10442461|NCT00936455|11589105|FG001|COMPLETED|Overall Study||38
10442462|NCT00936455|11589104|FG000|NOT COMPLETED|Overall Study||0
10442463|NCT00936455|11589105|FG001|NOT COMPLETED|Overall Study||0
10442464|NCT00936481|11589119|FG000|STARTED|Overall Study||17
10442465|NCT00936481|11589120|FG001|STARTED|Overall Study||17
10442466|NCT00936481|11589119|FG000|COMPLETED|Overall Study||17
10442467|NCT00936481|11589120|FG001|COMPLETED|Overall Study||17
10442468|NCT00936481|11589119|FG000|NOT COMPLETED|Overall Study||0
10442469|NCT00936481|11589120|FG001|NOT COMPLETED|Overall Study||0
10442470|NCT00936611|11589126|FG000|STARTED|Overall Study||39
10442471|NCT00936611|11589126|FG000|Treated|Overall Study||36
10442472|NCT00936611|11589126|FG000|Starting Dose Reduction: 30 mg to 25 mg|Overall Study||12
10442473|NCT00936611|11589126|FG000|COMPLETED|Overall Study||0
10442474|NCT00936611|11589126|FG000|NOT COMPLETED|Overall Study||39
10442475|NCT00936663|11589132|FG000|STARTED|Overall Study||1
10550258|NCT01530464|11704369|FG000|NOT COMPLETED|Second Intervention (24h)||0
10550259|NCT01530464|11704370|FG001|NOT COMPLETED|Second Intervention (24h)||0
10550260|NCT01530464|11704369|FG000|STARTED|Washout (24h)||10
10550261|NCT01530464|11704370|FG001|STARTED|Washout (24h)||8
10550262|NCT01530464|11704369|FG000|COMPLETED|Washout (24h)|1 subject withdrew consent and left due to family emergencies|9
10550263|NCT01530464|11704370|FG001|COMPLETED|Washout (24h)||8
10442476|NCT00936663|11589133|FG001|STARTED|Overall Study||2
10442477|NCT00936663|11589132|FG000|COMPLETED|Overall Study||1
10442478|NCT00936663|11589133|FG001|COMPLETED|Overall Study||2
10442479|NCT00936663|11589132|FG000|NOT COMPLETED|Overall Study||0
10442480|NCT00936663|11589133|FG001|NOT COMPLETED|Overall Study||0
10442481|NCT00936702|11589139|FG000|STARTED|Overall Study||46
10442482|NCT00936702|11589139|FG000|COMPLETED|Overall Study||0
10442483|NCT00936702|11589139|FG000|NOT COMPLETED|Overall Study||46
10442484|NCT00936715|11589143|FG000|STARTED|Overall Study||24
10442485|NCT00936715|11589143|FG000|COMPLETED|Overall Study||18
10442486|NCT00936715|11589143|FG000|NOT COMPLETED|Overall Study||6
10442487|NCT00936741|11589147|FG000|STARTED|Overall Study||30
10442488|NCT00936741|11589147|FG000|COMPLETED|Overall Study||21
10442489|NCT00936741|11589147|FG000|NOT COMPLETED|Overall Study||9
10442490|NCT00936858|11589151|FG000|STARTED|Overall Study||50
10442491|NCT00936858|11589151|FG000|Participants With Medullary Thyroid Cancer|Overall Study||10
10442492|NCT00936858|11589151|FG000|COMPLETED|Overall Study||0
10442493|NCT00936858|11589151|FG000|NOT COMPLETED|Overall Study||50
10442494|NCT00936884|11589158|FG000|STARTED|Double-blind|Twenty-five subjects received MNTX, and 24 had ≥ 1 post baseline diary assessment.|25
10442495|NCT00936884|11589159|FG001|STARTED|Double-blind|Twenty-four subjects received placebo, and 23 had ≥ 1 post baseline diary assessment.|25
10442496|NCT00936884|11589160|FG002|STARTED|Double-blind|Thirteen subjects from the MNTX group and 18 from the placebo group entered the 12-week extension.|0
10442497|NCT00936884|11589158|FG000|COMPLETED|Double-blind||13
10442498|NCT00936884|11589159|FG001|COMPLETED|Double-blind||18
10550264|NCT01530464|11704369|FG000|NOT COMPLETED|Washout (24h)||1
10550265|NCT01530464|11704370|FG001|NOT COMPLETED|Washout (24h)||0
10550266|NCT01530464|11704369|FG000|STARTED|Third Intervention (24h)||9
10550267|NCT01530464|11704370|FG001|STARTED|Third Intervention (24h)||8
10550268|NCT01530464|11704369|FG000|COMPLETED|Third Intervention (24h)||9
10550269|NCT01530464|11704370|FG001|COMPLETED|Third Intervention (24h)||8
10550270|NCT01530464|11704369|FG000|NOT COMPLETED|Third Intervention (24h)||0
10550271|NCT01530464|11704370|FG001|NOT COMPLETED|Third Intervention (24h)||0
10550272|NCT01530464|11704369|FG000|STARTED|Washout (24h)||9
10550273|NCT01530464|11704370|FG001|STARTED|Washout (24h)||8
10550274|NCT01530464|11704369|FG000|COMPLETED|Washout (24h)||9
10550275|NCT01530464|11704370|FG001|COMPLETED|Washout (24h)|1 subject withdrew consent and left due to family emergencies|7
10550276|NCT01530464|11704369|FG000|NOT COMPLETED|Washout (24h)||0
10550277|NCT01530464|11704370|FG001|NOT COMPLETED|Washout (24h)||1
10550278|NCT01530477|11704384|FG000|STARTED|Overall Study|17 subjects consented to the Skeletal cohort only.|17
10550279|NCT01530477|11704385|FG001|STARTED|Overall Study|12 subjects consented to the Body Composition cohort only.|12
10550280|NCT01530477|11704386|FG002|STARTED|Overall Study|53 subjects consented to both the Skeletal and body Composition cohorts.|53
10550281|NCT01530477|11704384|FG000|COMPLETED|Overall Study|17 subjects completed imaging in the Skeletal cohort only.|17
10550282|NCT01530477|11704385|FG001|COMPLETED|Overall Study|12 subjects completed imaging in the Body Composition cohort only.|12
10789452|NCT03521115|11949885|FG001|COMPLETED|Time 0 Baseline Surveys||205
10789453|NCT03521115|11949884|FG000|NOT COMPLETED|Time 0 Baseline Surveys||0
10789454|NCT03521115|11949885|FG001|NOT COMPLETED|Time 0 Baseline Surveys||0
10810708|NCT03792672|11972461|FG005|STARTED|Treatment Period 2 (1 Day)||4
10442499|NCT00936884|11589160|FG002|COMPLETED|Double-blind||0
10442500|NCT00936884|11589158|FG000|NOT COMPLETED|Double-blind||12
10442501|NCT00936884|11589159|FG001|NOT COMPLETED|Double-blind||7
10442502|NCT00936884|11589160|FG002|NOT COMPLETED|Double-blind||0
10442503|NCT00936884|11589158|FG000|STARTED|Open-label||0
10442504|NCT00936884|11589159|FG001|STARTED|Open-label||0
10442505|NCT00936884|11589160|FG002|STARTED|Open-label||31
10442506|NCT00936884|11589158|FG000|COMPLETED|Open-label||0
10550283|NCT01530477|11704386|FG002|COMPLETED|Overall Study|53 subjects completed the imaging in both the Skeletal and Body Composition cohorts.|53
10550284|NCT01530477|11704384|FG000|NOT COMPLETED|Overall Study||0
10550285|NCT01530477|11704385|FG001|NOT COMPLETED|Overall Study||0
10550286|NCT01530477|11704386|FG002|NOT COMPLETED|Overall Study||0
10550287|NCT01531153|11704395|FG000|STARTED|Overall Study||32
10550288|NCT01531153|11704396|FG001|STARTED|Overall Study||31
10550289|NCT01531153|11704397|FG002|STARTED|Overall Study||30
10550290|NCT01531153|11704395|FG000|COMPLETED|Overall Study||22
10550291|NCT01531153|11704396|FG001|COMPLETED|Overall Study||22
10550292|NCT01531153|11704397|FG002|COMPLETED|Overall Study||15
10550293|NCT01531153|11704395|FG000|NOT COMPLETED|Overall Study||10
10550294|NCT01531153|11704396|FG001|NOT COMPLETED|Overall Study||9
10550295|NCT01531153|11704397|FG002|NOT COMPLETED|Overall Study||15
10550296|NCT01531205|11704408|FG000|STARTED|Overall Study||2
10550297|NCT01531205|11704408|FG000|COMPLETED|Overall Study||1
10550298|NCT01531205|11704408|FG000|NOT COMPLETED|Overall Study||1
10550299|NCT01531335|11704416|FG000|STARTED|Overall Study||40
10550300|NCT01531335|11704417|FG001|STARTED|Overall Study||40
10550301|NCT01531335|11704416|FG000|COMPLETED|Overall Study||40
10550302|NCT01531335|11704417|FG001|COMPLETED|Overall Study||40
10550303|NCT01531335|11704416|FG000|NOT COMPLETED|Overall Study||0
10550304|NCT01531335|11704417|FG001|NOT COMPLETED|Overall Study||0
10550305|NCT01531439|11704425|FG000|STARTED|Overall Study||41
10550306|NCT01531439|11704426|FG001|STARTED|Overall Study||43
10550307|NCT01531439|11704425|FG000|COMPLETED|Overall Study||37
10550308|NCT01531439|11704426|FG001|COMPLETED|Overall Study||42
10550309|NCT01531439|11704425|FG000|NOT COMPLETED|Overall Study||4
10550310|NCT01531439|11704426|FG001|NOT COMPLETED|Overall Study||1
10550311|NCT01531673|11704445|FG000|STARTED|Overall Study||33
10550312|NCT01531673|11704446|FG001|STARTED|Overall Study||8
10550313|NCT01531673|11704447|FG002|STARTED|Overall Study||8
10550314|NCT01531673|11704448|FG003|STARTED|Overall Study||18
10550315|NCT01531673|11704449|FG004|STARTED|Overall Study||8
10550316|NCT01531673|11704450|FG005|STARTED|Overall Study||19
10550317|NCT01531673|11704451|FG006|STARTED|Overall Study||17
10550318|NCT01531673|11704452|FG007|STARTED|Overall Study||9
10550319|NCT01531673|11704453|FG008|STARTED|Overall Study||17
10550320|NCT01531673|11704454|FG009|STARTED|Overall Study||19
10550321|NCT01531673|11704455|FG010|STARTED|Overall Study||16
10550322|NCT01531673|11704456|FG011|STARTED|Overall Study||4
10550323|NCT01531673|11704457|FG012|STARTED|Overall Study||14
10550324|NCT01531673|11704445|FG000|COMPLETED|Overall Study||33
10550325|NCT01531673|11704446|FG001|COMPLETED|Overall Study||7
10550326|NCT01531673|11704447|FG002|COMPLETED|Overall Study||8
10550327|NCT01531673|11704448|FG003|COMPLETED|Overall Study||17
10550328|NCT01531673|11704449|FG004|COMPLETED|Overall Study||7
10550329|NCT01531673|11704450|FG005|COMPLETED|Overall Study||18
10550330|NCT01531673|11704451|FG006|COMPLETED|Overall Study||17
10550331|NCT01531673|11704452|FG007|COMPLETED|Overall Study||9
10550332|NCT01531673|11704453|FG008|COMPLETED|Overall Study||17
10550333|NCT01531673|11704454|FG009|COMPLETED|Overall Study||18
10550334|NCT01531673|11704455|FG010|COMPLETED|Overall Study||16
10550335|NCT01531673|11704456|FG011|COMPLETED|Overall Study||4
10550336|NCT01531673|11704457|FG012|COMPLETED|Overall Study||14
10550337|NCT01531673|11704445|FG000|NOT COMPLETED|Overall Study||0
10550338|NCT01531673|11704446|FG001|NOT COMPLETED|Overall Study||1
10550339|NCT01531673|11704447|FG002|NOT COMPLETED|Overall Study||0
10550340|NCT01531673|11704448|FG003|NOT COMPLETED|Overall Study||1
10550341|NCT01531673|11704449|FG004|NOT COMPLETED|Overall Study||1
10550342|NCT01531673|11704450|FG005|NOT COMPLETED|Overall Study||1
10550343|NCT01531673|11704451|FG006|NOT COMPLETED|Overall Study||0
10550344|NCT01531673|11704452|FG007|NOT COMPLETED|Overall Study||0
10550345|NCT01531673|11704453|FG008|NOT COMPLETED|Overall Study||0
10550346|NCT01531673|11704454|FG009|NOT COMPLETED|Overall Study||1
10550347|NCT01531673|11704455|FG010|NOT COMPLETED|Overall Study||0
10550348|NCT01531673|11704456|FG011|NOT COMPLETED|Overall Study||0
10550349|NCT01531673|11704457|FG012|NOT COMPLETED|Overall Study||0
10550350|NCT01531725|11704509|FG000|STARTED|Overall Study|5 patients with protocol violation were excluded.|202
10550351|NCT01531725|11704509|FG000|COMPLETED|Overall Study||197
10550352|NCT01531725|11704509|FG000|NOT COMPLETED|Overall Study||5
10550353|NCT01531738|11704515|FG000|STARTED|Overall Study||11
10550354|NCT01531738|11704516|FG001|STARTED|Overall Study||11
10550355|NCT01531738|11704515|FG000|COMPLETED|Overall Study||11
10550356|NCT01531738|11704516|FG001|COMPLETED|Overall Study||11
10550357|NCT01531738|11704515|FG000|NOT COMPLETED|Overall Study||0
10550358|NCT01531738|11704516|FG001|NOT COMPLETED|Overall Study||0
10550359|NCT01531803|11704524|FG000|STARTED|Overall Study||1
10550360|NCT01531803|11704525|FG001|STARTED|Overall Study||2
10550361|NCT01531803|11704524|FG000|COMPLETED|Overall Study||1
10550362|NCT01531803|11704525|FG001|COMPLETED|Overall Study||2
10550363|NCT01531803|11704524|FG000|NOT COMPLETED|Overall Study||0
10550364|NCT01531803|11704525|FG001|NOT COMPLETED|Overall Study||0
10550365|NCT01531894|11704531|FG000|STARTED|Overall Study||11
10550366|NCT01531894|11704531|FG000|COMPLETED|Overall Study||2
10550367|NCT01531894|11704531|FG000|NOT COMPLETED|Overall Study||9
10550368|NCT01531959|11704537|FG000|STARTED|Overall Study||68
10550369|NCT01531959|11704538|FG001|STARTED|Overall Study||68
10550370|NCT01531959|11704537|FG000|COMPLETED|Overall Study||66
10550371|NCT01531959|11704538|FG001|COMPLETED|Overall Study||66
10550372|NCT01531959|11704537|FG000|NOT COMPLETED|Overall Study||2
10550373|NCT01531959|11704538|FG001|NOT COMPLETED|Overall Study||2
10550374|NCT01531998|11704544|FG000|STARTED|Overall Study||11
10442507|NCT00936884|11589159|FG001|COMPLETED|Open-label||0
10442508|NCT00936884|11589160|FG002|COMPLETED|Open-label||12
10442509|NCT00936884|11589158|FG000|NOT COMPLETED|Open-label||0
10442510|NCT00936884|11589159|FG001|NOT COMPLETED|Open-label||0
10442511|NCT00936884|11589160|FG002|NOT COMPLETED|Open-label||19
10442512|NCT00936897|11589169|FG000|STARTED|Overall Study|Randomized|417
10442513|NCT00936897|11589170|FG001|STARTED|Overall Study|Randomized|416
10442514|NCT00936897|11589169|FG000|COMPLETED|Overall Study||398
10442515|NCT00936897|11589170|FG001|COMPLETED|Overall Study||356
10442516|NCT00936897|11589169|FG000|NOT COMPLETED|Overall Study||19
10442517|NCT00936897|11589170|FG001|NOT COMPLETED|Overall Study||60
10442518|NCT00936910|11589176|FG000|STARTED|Overall Study||13
10442519|NCT00936910|11589176|FG000|COMPLETED|Overall Study|The primary endpt. of 2 (-) cultures within 5 d of lock therapy was met for 10 patients|10
10442520|NCT00936910|11589176|FG000|NOT COMPLETED|Overall Study||3
10442521|NCT00936975|11589181|FG000|STARTED|Overall Study||18
10442522|NCT00936975|11589181|FG000|COMPLETED|Overall Study||12
10442523|NCT00936975|11589181|FG000|NOT COMPLETED|Overall Study||6
10442524|NCT00937040|11589188|FG000|STARTED|Overall Study||179
10442525|NCT00937040|11589189|FG001|STARTED|Overall Study||178
10442526|NCT00937040|11589188|FG000|COMPLETED|Overall Study||138
10442527|NCT00937040|11589189|FG001|COMPLETED|Overall Study||141
10442528|NCT00937040|11589188|FG000|NOT COMPLETED|Overall Study||41
10442529|NCT00937040|11589189|FG001|NOT COMPLETED|Overall Study||37
10442530|NCT00937105|11589197|FG000|STARTED|Overall Study||109
10442531|NCT00937105|11589198|FG001|STARTED|Overall Study||109
10442532|NCT00937105|11589197|FG000|COMPLETED|Overall Study||69
10442533|NCT00937105|11589198|FG001|COMPLETED|Overall Study||70
10442534|NCT00937105|11589197|FG000|NOT COMPLETED|Overall Study||40
10442535|NCT00937105|11589198|FG001|NOT COMPLETED|Overall Study||39
10442536|NCT00937118|11589213|FG000|STARTED|Overall Study||41
10442537|NCT00937118|11589213|FG000|COMPLETED|Overall Study||41
10442538|NCT00937118|11589213|FG000|NOT COMPLETED|Overall Study||0
10442539|NCT00937157|11589220|FG000|STARTED|Overall Study||12
10442540|NCT00937157|11589220|FG000|COMPLETED|Overall Study||8
10442541|NCT00937157|11589220|FG000|NOT COMPLETED|Overall Study||4
10442542|NCT00937235|11589226|FG000|STARTED|Overall Study||72
10442543|NCT00937235|11589227|FG001|STARTED|Overall Study||70
10442544|NCT00937235|11589226|FG000|COMPLETED|Overall Study||72
10442545|NCT00937235|11589227|FG001|COMPLETED|Overall Study||70
10442546|NCT00937235|11589226|FG000|NOT COMPLETED|Overall Study||0
10442547|NCT00937235|11589227|FG001|NOT COMPLETED|Overall Study||0
10442548|NCT00937326|11589238|FG000|STARTED|Overall Study||46
10442549|NCT00937326|11589239|FG001|STARTED|Overall Study||45
10442550|NCT00937326|11589240|FG002|STARTED|Overall Study||46
10442551|NCT00937326|11589241|FG003|STARTED|Overall Study||45
10442552|NCT00937326|11589242|FG004|STARTED|Overall Study||45
10442553|NCT00937326|11589238|FG000|COMPLETED|Overall Study||43
10442554|NCT00937326|11589239|FG001|COMPLETED|Overall Study||38
10442555|NCT00937326|11589240|FG002|COMPLETED|Overall Study||42
10442556|NCT00937326|11589241|FG003|COMPLETED|Overall Study||40
10442557|NCT00937326|11589242|FG004|COMPLETED|Overall Study||40
10442558|NCT00937326|11589238|FG000|NOT COMPLETED|Overall Study||3
10442559|NCT00937326|11589239|FG001|NOT COMPLETED|Overall Study||7
10442560|NCT00937326|11589240|FG002|NOT COMPLETED|Overall Study||4
10442561|NCT00937326|11589241|FG003|NOT COMPLETED|Overall Study||5
10442562|NCT00937326|11589242|FG004|NOT COMPLETED|Overall Study||5
10442563|NCT00937378|11589261|FG000|STARTED|Overall Study||167
10442564|NCT00937378|11589262|FG001|STARTED|Overall Study||159
10442565|NCT00937378|11589261|FG000|COMPLETED|Overall Study||149
10442566|NCT00937378|11589262|FG001|COMPLETED|Overall Study||141
10442567|NCT00937378|11589261|FG000|NOT COMPLETED|Overall Study||18
10442568|NCT00937378|11589262|FG001|NOT COMPLETED|Overall Study||18
10442569|NCT00937391|11589270|FG000|STARTED|Stage 1||20
10442570|NCT00937391|11589270|FG000|Treated|Stage 1|Valid for Full Analysis Set (FAS); includes all participants administered Magnevist Injection|20
10442571|NCT00937391|11589270|FG000|COMPLETED|Stage 1||20
10442572|NCT00937391|11589270|FG000|NOT COMPLETED|Stage 1||0
10442573|NCT00937391|11589270|FG000|STARTED|Stage 2|Stage 1 and Stage 2 are independent each enrolling a different set of participants|34
10442574|NCT00937391|11589270|FG000|Treated|Stage 2|Valid for Full Analysis Set; participants administered correct Magnevist dose based on body weight|34
10442575|NCT00937391|11589270|FG000|COMPLETED|Stage 2|The number completed includes participants within the FAS and Per Protocol Set (PPS)|33
10442576|NCT00937391|11589270|FG000|NOT COMPLETED|Stage 2||1
10442577|NCT00937404|11589287|FG000|STARTED|Overall Study||25
10442578|NCT00937404|11589287|FG000|COMPLETED|Overall Study||23
10442579|NCT00937404|11589287|FG000|NOT COMPLETED|Overall Study||2
10442580|NCT00937495|11589291|FG000|STARTED|Overall Study||16
10442581|NCT00937495|11589291|FG000|COMPLETED|Overall Study||14
10442582|NCT00937495|11589291|FG000|NOT COMPLETED|Overall Study||2
10442583|NCT00937521|11589303|FG000|STARTED|Overall Study - Prior to Booster Dose||188
10442584|NCT00937521|11589304|FG001|STARTED|Overall Study - Prior to Booster Dose||190
10442585|NCT00937521|11589305|FG002|STARTED|Overall Study - Prior to Booster Dose||192
10442586|NCT00937521|11589306|FG003|STARTED|Overall Study - Prior to Booster Dose||188
10442587|NCT00937521|11589307|FG004|STARTED|Overall Study - Prior to Booster Dose||191
10442588|NCT00937521|11589308|FG005|STARTED|Overall Study - Prior to Booster Dose||188
10442644|NCT00937521|11589308|FG005|NOT COMPLETED|Booster Phase||5
10442589|NCT00937521|11589309|FG006|STARTED|Overall Study - Prior to Booster Dose||186
10442590|NCT00937521|11589310|FG007|STARTED|Overall Study - Prior to Booster Dose||184
10442591|NCT00937521|11589303|FG000|Premature Withdrawal|Overall Study - Prior to Booster Dose||3
10528930|NCT01397461|11681311|FG000|STARTED|Overall Study||155
10442592|NCT00937521|11589304|FG001|Premature Withdrawal|Overall Study - Prior to Booster Dose||5
10442593|NCT00937521|11589305|FG002|Premature Withdrawal|Overall Study - Prior to Booster Dose||6
10442594|NCT00937521|11589306|FG003|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
10442595|NCT00937521|11589307|FG004|Premature Withdrawal|Overall Study - Prior to Booster Dose||3
10442596|NCT00937521|11589308|FG005|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
10442597|NCT00937521|11589309|FG006|Premature Withdrawal|Overall Study - Prior to Booster Dose||5
10442598|NCT00937521|11589310|FG007|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
10442599|NCT00937521|11589303|FG000|COMPLETED|Overall Study - Prior to Booster Dose||185
10442600|NCT00937521|11589304|FG001|COMPLETED|Overall Study - Prior to Booster Dose||185
10442601|NCT00937521|11589305|FG002|COMPLETED|Overall Study - Prior to Booster Dose||186
10442602|NCT00937521|11589306|FG003|COMPLETED|Overall Study - Prior to Booster Dose||187
10442603|NCT00937521|11589307|FG004|COMPLETED|Overall Study - Prior to Booster Dose||188
10442604|NCT00937521|11589308|FG005|COMPLETED|Overall Study - Prior to Booster Dose||187
10442605|NCT00937521|11589309|FG006|COMPLETED|Overall Study - Prior to Booster Dose||181
10442606|NCT00937521|11589310|FG007|COMPLETED|Overall Study - Prior to Booster Dose||183
10442607|NCT00937521|11589303|FG000|NOT COMPLETED|Overall Study - Prior to Booster Dose||3
10442608|NCT00937521|11589304|FG001|NOT COMPLETED|Overall Study - Prior to Booster Dose||5
10442609|NCT00937521|11589305|FG002|NOT COMPLETED|Overall Study - Prior to Booster Dose||6
10550375|NCT01531998|11704544|FG000|COMPLETED|Overall Study||8
10550376|NCT01531998|11704544|FG000|NOT COMPLETED|Overall Study||3
10550377|NCT01532089|11704550|FG000|STARTED|Overall Study||45
10550378|NCT01532089|11704551|FG001|STARTED|Overall Study||43
10550379|NCT01532089|11704550|FG000|COMPLETED|Overall Study||45
10550380|NCT01532089|11704551|FG001|COMPLETED|Overall Study||43
10550381|NCT01532089|11704550|FG000|NOT COMPLETED|Overall Study||0
10550382|NCT01532089|11704551|FG001|NOT COMPLETED|Overall Study||0
10550383|NCT01532128|11704562|FG000|STARTED|Overall Study||8
10550384|NCT01532128|11704563|FG001|STARTED|Overall Study||8
10550385|NCT01532128|11704564|FG002|STARTED|Overall Study||8
10550386|NCT01532128|11704562|FG000|COMPLETED|Overall Study||8
10442610|NCT00937521|11589306|FG003|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
10442611|NCT00937521|11589307|FG004|NOT COMPLETED|Overall Study - Prior to Booster Dose||3
10442612|NCT00937521|11589308|FG005|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
10550387|NCT01532128|11704563|FG001|COMPLETED|Overall Study||8
10789455|NCT03521115|11949884|FG000|STARTED|Time 1 Survey (6 Months Post Baseline)||206
10789456|NCT03521115|11949885|FG001|STARTED|Time 1 Survey (6 Months Post Baseline)||205
10789457|NCT03521115|11949884|FG000|COMPLETED|Time 1 Survey (6 Months Post Baseline)||150
10789458|NCT03521115|11949885|FG001|COMPLETED|Time 1 Survey (6 Months Post Baseline)||165
10789459|NCT03521115|11949884|FG000|NOT COMPLETED|Time 1 Survey (6 Months Post Baseline)||56
10789460|NCT03521115|11949885|FG001|NOT COMPLETED|Time 1 Survey (6 Months Post Baseline)||40
10789461|NCT03521115|11949884|FG000|STARTED|Time 2 Survey (12 Months Post Baseline)||150
10789462|NCT03521115|11949885|FG001|STARTED|Time 2 Survey (12 Months Post Baseline)||165
10789463|NCT03521115|11949884|FG000|COMPLETED|Time 2 Survey (12 Months Post Baseline)||147
10789464|NCT03521115|11949885|FG001|COMPLETED|Time 2 Survey (12 Months Post Baseline)||164
10789465|NCT03521115|11949884|FG000|NOT COMPLETED|Time 2 Survey (12 Months Post Baseline)||3
10789466|NCT03521115|11949885|FG001|NOT COMPLETED|Time 2 Survey (12 Months Post Baseline)||1
10442613|NCT00937521|11589309|FG006|NOT COMPLETED|Overall Study - Prior to Booster Dose||5
10442614|NCT00937521|11589310|FG007|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
10442615|NCT00937521|11589303|FG000|STARTED|Booster Phase||155
10442616|NCT00937521|11589304|FG001|STARTED|Booster Phase||163
10442617|NCT00937521|11589305|FG002|STARTED|Booster Phase||169
10442618|NCT00937521|11589306|FG003|STARTED|Booster Phase||170
10442619|NCT00937521|11589307|FG004|STARTED|Booster Phase||168
10442620|NCT00937521|11589308|FG005|STARTED|Booster Phase||165
10442621|NCT00937521|11589309|FG006|STARTED|Booster Phase||165
10442622|NCT00937521|11589310|FG007|STARTED|Booster Phase||161
10442623|NCT00937521|11589303|FG000|Premature Withdrawal|Booster Phase||3
10442624|NCT00937521|11589304|FG001|Premature Withdrawal|Booster Phase||2
10442625|NCT00937521|11589305|FG002|Premature Withdrawal|Booster Phase||5
10442626|NCT00937521|11589306|FG003|Premature Withdrawal|Booster Phase||3
10442627|NCT00937521|11589307|FG004|Premature Withdrawal|Booster Phase||5
10442628|NCT00937521|11589308|FG005|Premature Withdrawal|Booster Phase||5
10442629|NCT00937521|11589309|FG006|Premature Withdrawal|Booster Phase||5
10442630|NCT00937521|11589310|FG007|Premature Withdrawal|Booster Phase||2
10442631|NCT00937521|11589303|FG000|COMPLETED|Booster Phase||152
10442632|NCT00937521|11589304|FG001|COMPLETED|Booster Phase||161
10442633|NCT00937521|11589305|FG002|COMPLETED|Booster Phase||164
10442634|NCT00937521|11589306|FG003|COMPLETED|Booster Phase||167
10442635|NCT00937521|11589307|FG004|COMPLETED|Booster Phase||163
10442636|NCT00937521|11589308|FG005|COMPLETED|Booster Phase||160
10442637|NCT00937521|11589309|FG006|COMPLETED|Booster Phase||160
10442638|NCT00937521|11589310|FG007|COMPLETED|Booster Phase||159
10442639|NCT00937521|11589303|FG000|NOT COMPLETED|Booster Phase||3
10442640|NCT00937521|11589304|FG001|NOT COMPLETED|Booster Phase||2
10442641|NCT00937521|11589305|FG002|NOT COMPLETED|Booster Phase||5
10442642|NCT00937521|11589306|FG003|NOT COMPLETED|Booster Phase||3
10442643|NCT00937521|11589307|FG004|NOT COMPLETED|Booster Phase||5
10550388|NCT01532128|11704564|FG002|COMPLETED|Overall Study||8
10550389|NCT01532128|11704562|FG000|NOT COMPLETED|Overall Study||0
10550390|NCT01532128|11704563|FG001|NOT COMPLETED|Overall Study||0
10442645|NCT00937521|11589309|FG006|NOT COMPLETED|Booster Phase||5
10442646|NCT00937521|11589310|FG007|NOT COMPLETED|Booster Phase||2
10442647|NCT00937547|11589346|FG000|STARTED|Overall Study||96
10550391|NCT01532128|11704564|FG002|NOT COMPLETED|Overall Study||0
10550392|NCT01532141|11704576|FG000|STARTED|Overall Study||9
10550393|NCT01532141|11704577|FG001|STARTED|Overall Study||8
10789467|NCT03521115|11949884|FG000|STARTED|Time 3 Survey (18 Months Post Baseline)||147
10789468|NCT03521115|11949885|FG001|STARTED|Time 3 Survey (18 Months Post Baseline)||164
10789469|NCT03521115|11949884|FG000|COMPLETED|Time 3 Survey (18 Months Post Baseline)||145
10442648|NCT00937547|11589347|FG001|STARTED|Overall Study||84
10442649|NCT00937547|11589348|FG002|STARTED|Overall Study||149
10442650|NCT00937547|11589346|FG000|Histological Samples|Overall Study||95
10442651|NCT00937547|11589347|FG001|Histological Samples|Overall Study||78
10442652|NCT00937547|11589348|FG002|Histological Samples|Overall Study||142
10442653|NCT00937547|11589346|FG000|COMPLETED|Overall Study||95
10442654|NCT00937547|11589347|FG001|COMPLETED|Overall Study||78
10442655|NCT00937547|11589348|FG002|COMPLETED|Overall Study||142
10442656|NCT00937547|11589346|FG000|NOT COMPLETED|Overall Study||1
10442657|NCT00937547|11589347|FG001|NOT COMPLETED|Overall Study||6
10442658|NCT00937547|11589348|FG002|NOT COMPLETED|Overall Study||7
10442659|NCT00937560|11589356|FG000|STARTED|Initial Treatment||189
10442660|NCT00937560|11589356|FG000|Received Treatment|Initial Treatment||189
10442661|NCT00937560|11589356|FG000|COMPLETED|Initial Treatment||168
10442662|NCT00937560|11589356|FG000|NOT COMPLETED|Initial Treatment||21
10442663|NCT00937560|11589356|FG000|STARTED|Maintenance Treatment||168
10442664|NCT00937560|11589356|FG000|COMPLETED|Maintenance Treatment||150
10442665|NCT00937560|11589356|FG000|NOT COMPLETED|Maintenance Treatment||18
10442666|NCT00937768|11589362|FG000|STARTED|Overall Study||8
10442667|NCT00937768|11589363|FG001|STARTED|Overall Study||8
10442668|NCT00937768|11589362|FG000|COMPLETED|Overall Study||0
10442669|NCT00937768|11589363|FG001|COMPLETED|Overall Study||0
10442670|NCT00937768|11589362|FG000|NOT COMPLETED|Overall Study||8
10442671|NCT00937768|11589363|FG001|NOT COMPLETED|Overall Study||8
10442672|NCT00937794|11589369|FG000|STARTED|Overall Study||33
10442673|NCT00937794|11589369|FG000|COMPLETED|Overall Study||33
10442674|NCT00937794|11589369|FG000|NOT COMPLETED|Overall Study||0
10442675|NCT00937833|11589375|FG000|STARTED|Overall Study||73
10442676|NCT00937833|11589376|FG001|STARTED|Overall Study||77
10442677|NCT00937833|11589375|FG000|COMPLETED|Overall Study||58
10442678|NCT00937833|11589376|FG001|COMPLETED|Overall Study||60
10442679|NCT00937833|11589375|FG000|NOT COMPLETED|Overall Study||15
10442680|NCT00937833|11589376|FG001|NOT COMPLETED|Overall Study||17
10442681|NCT00937859|11589384|FG000|STARTED|Overall Study||148
10442682|NCT00937859|11589385|FG001|STARTED|Overall Study||153
10442683|NCT00937859|11589384|FG000|COMPLETED|Overall Study||129
10442684|NCT00937859|11589385|FG001|COMPLETED|Overall Study||134
10442685|NCT00937859|11589384|FG000|NOT COMPLETED|Overall Study||19
10442686|NCT00937859|11589385|FG001|NOT COMPLETED|Overall Study||19
10442687|NCT00937950|11589391|FG000|STARTED|Overall Study||2003
10442688|NCT00937950|11589391|FG000|COMPLETED|Overall Study||1787
10442689|NCT00937950|11589391|FG000|NOT COMPLETED|Overall Study||216
10442690|NCT00938015|11589395|FG000|STARTED|Overall Study||303
10442691|NCT00938015|11589395|FG000|COMPLETED|Overall Study||156
10442692|NCT00938015|11589395|FG000|NOT COMPLETED|Overall Study||147
10442693|NCT00938041|11589399|FG000|STARTED|Overall Study||32
10442694|NCT00938041|11589399|FG000|COMPLETED|Overall Study||5
10442695|NCT00938041|11589399|FG000|NOT COMPLETED|Overall Study||27
10442696|NCT00938314|11589407|FG000|STARTED|Cohort 1||24
10442697|NCT00938314|11589408|FG001|STARTED|Cohort 1||0
10442698|NCT00938314|11589409|FG002|STARTED|Cohort 1||0
10442699|NCT00938314|11589410|FG003|STARTED|Cohort 1||8
10442700|NCT00938314|11589407|FG000|COMPLETED|Cohort 1||22
10442701|NCT00938314|11589408|FG001|COMPLETED|Cohort 1||0
10442702|NCT00938314|11589409|FG002|COMPLETED|Cohort 1||0
10442703|NCT00938314|11589410|FG003|COMPLETED|Cohort 1||6
10442704|NCT00938314|11589407|FG000|NOT COMPLETED|Cohort 1||2
10442705|NCT00938314|11589408|FG001|NOT COMPLETED|Cohort 1||0
10442706|NCT00938314|11589409|FG002|NOT COMPLETED|Cohort 1||0
10442707|NCT00938314|11589410|FG003|NOT COMPLETED|Cohort 1||2
10442708|NCT00938314|11589407|FG000|STARTED|Cohort 2||0
10442709|NCT00938314|11589408|FG001|STARTED|Cohort 2||24
10442710|NCT00938314|11589409|FG002|STARTED|Cohort 2||0
10442711|NCT00938314|11589410|FG003|STARTED|Cohort 2||8
10442712|NCT00938314|11589407|FG000|COMPLETED|Cohort 2||0
10442713|NCT00938314|11589408|FG001|COMPLETED|Cohort 2||18
10442714|NCT00938314|11589409|FG002|COMPLETED|Cohort 2||0
10442715|NCT00938314|11589410|FG003|COMPLETED|Cohort 2||6
10442716|NCT00938314|11589407|FG000|NOT COMPLETED|Cohort 2||0
10442717|NCT00938314|11589408|FG001|NOT COMPLETED|Cohort 2||6
10442718|NCT00938314|11589409|FG002|NOT COMPLETED|Cohort 2||0
10442719|NCT00938314|11589410|FG003|NOT COMPLETED|Cohort 2||2
10442720|NCT00938314|11589407|FG000|STARTED|Cohort 3||0
10442721|NCT00938314|11589408|FG001|STARTED|Cohort 3||0
10442722|NCT00938314|11589409|FG002|STARTED|Cohort 3||24
10442723|NCT00938314|11589410|FG003|STARTED|Cohort 3||8
10442724|NCT00938314|11589407|FG000|COMPLETED|Cohort 3||0
10442725|NCT00938314|11589408|FG001|COMPLETED|Cohort 3||0
10442726|NCT00938314|11589409|FG002|COMPLETED|Cohort 3||20
10442727|NCT00938314|11589410|FG003|COMPLETED|Cohort 3||7
10442728|NCT00938314|11589407|FG000|NOT COMPLETED|Cohort 3||0
10442729|NCT00938314|11589408|FG001|NOT COMPLETED|Cohort 3||0
10442730|NCT00938314|11589409|FG002|NOT COMPLETED|Cohort 3||4
10550394|NCT01532141|11704578|FG002|STARTED|Overall Study||8
10550395|NCT01532141|11704576|FG000|Period 1|Overall Study||9
10442731|NCT00938314|11589410|FG003|NOT COMPLETED|Cohort 3||1
10442732|NCT00938327|11589420|FG000|STARTED|Overall Study||332
10442733|NCT00938327|11589420|FG000|COMPLETED|Overall Study||272
10442734|NCT00938327|11589420|FG000|NOT COMPLETED|Overall Study||60
10442735|NCT00938340|11589424|FG000|STARTED|Overall Study||20
10442736|NCT00938340|11589424|FG000|Received Whole Walnut Intervention|Overall Study||16
10442737|NCT00938340|11589424|FG000|Received Walnut Nutmeat Intervention|Overall Study||19
10550396|NCT01532141|11704577|FG001|Period 1|Overall Study||8
10550397|NCT01532141|11704578|FG002|Period 1|Overall Study||8
10550398|NCT01532141|11704576|FG000|Period 2|Overall Study||8
10442738|NCT00938340|11589424|FG000|Received Walnut Skins Intervention|Overall Study||15
10442739|NCT00938340|11589424|FG000|Received Walnut Oil Intervention|Overall Study||15
10442740|NCT00938340|11589424|FG000|COMPLETED|Overall Study||15
10442741|NCT00938340|11589424|FG000|NOT COMPLETED|Overall Study||5
10442742|NCT00938366|11589472|FG000|STARTED|Overall Study||9
10442743|NCT00938366|11589473|FG001|STARTED|Overall Study||9
10442744|NCT00938366|11589472|FG000|COMPLETED|Overall Study||8
10442745|NCT00938366|11589473|FG001|COMPLETED|Overall Study||9
10442746|NCT00938366|11589472|FG000|NOT COMPLETED|Overall Study||1
10442747|NCT00938366|11589473|FG001|NOT COMPLETED|Overall Study||0
10442748|NCT00938392|11589481|FG000|STARTED|Overall Study||362
10442749|NCT00938392|11589482|FG001|STARTED|Overall Study||362
10442750|NCT00938392|11589481|FG000|COMPLETED|Overall Study||360
10442751|NCT00938392|11589482|FG001|COMPLETED|Overall Study||358
10442752|NCT00938392|11589481|FG000|NOT COMPLETED|Overall Study||2
10442753|NCT00938392|11589482|FG001|NOT COMPLETED|Overall Study||4
10442754|NCT00938431|11589491|FG000|STARTED|Overall Study||15
10442755|NCT00938431|11589492|FG001|STARTED|Overall Study||23
10442756|NCT00938431|11589493|FG002|STARTED|Overall Study||9
10442757|NCT00938431|11589491|FG000|COMPLETED|Overall Study||9
10442758|NCT00938431|11589492|FG001|COMPLETED|Overall Study||14
10442759|NCT00938431|11589493|FG002|COMPLETED|Overall Study||1
10442760|NCT00938431|11589491|FG000|NOT COMPLETED|Overall Study||6
10442761|NCT00938431|11589492|FG001|NOT COMPLETED|Overall Study||9
10442762|NCT00938431|11589493|FG002|NOT COMPLETED|Overall Study||8
10442763|NCT00938457|11589505|FG000|STARTED|Overall Study||3
10442764|NCT00938457|11589505|FG000|COMPLETED|Overall Study||3
10442765|NCT00938457|11589505|FG000|NOT COMPLETED|Overall Study||0
10442766|NCT00938470|11589511|FG000|STARTED|Overall Study||34
10442767|NCT00938470|11589512|FG001|STARTED|Overall Study||28
10442768|NCT00938470|11589511|FG000|COMPLETED|Overall Study||27
10442769|NCT00938470|11589512|FG001|COMPLETED|Overall Study||25
10442770|NCT00938470|11589511|FG000|NOT COMPLETED|Overall Study||7
10442771|NCT00938470|11589512|FG001|NOT COMPLETED|Overall Study||3
10442772|NCT00938548|11589520|FG000|STARTED|Overall Study||35
10442773|NCT00938548|11589521|FG001|STARTED|Overall Study||35
10442774|NCT00938548|11589520|FG000|COMPLETED|Overall Study||35
10442775|NCT00938548|11589521|FG001|COMPLETED|Overall Study||35
10442776|NCT00938548|11589520|FG000|NOT COMPLETED|Overall Study||0
10550399|NCT01532141|11704577|FG001|Period 2|Overall Study||8
10789470|NCT03521115|11949885|FG001|COMPLETED|Time 3 Survey (18 Months Post Baseline)||164
10789471|NCT03521115|11949884|FG000|NOT COMPLETED|Time 3 Survey (18 Months Post Baseline)||2
10789472|NCT03521115|11949885|FG001|NOT COMPLETED|Time 3 Survey (18 Months Post Baseline)||0
10789473|NCT03521141|11949900|FG000|STARTED|Overall Study||19
10789474|NCT03521141|11949901|FG001|STARTED|Overall Study||19
10789475|NCT03521141|11949902|FG002|STARTED|Overall Study||20
10789476|NCT03521141|11949900|FG000|COMPLETED|Overall Study||18
10789477|NCT03521141|11949901|FG001|COMPLETED|Overall Study||19
10789478|NCT03521141|11949902|FG002|COMPLETED|Overall Study||19
10789479|NCT03521141|11949900|FG000|NOT COMPLETED|Overall Study||1
10789480|NCT03521141|11949901|FG001|NOT COMPLETED|Overall Study||0
10789481|NCT03521141|11949902|FG002|NOT COMPLETED|Overall Study||1
10442777|NCT00938548|11589521|FG001|NOT COMPLETED|Overall Study||0
10442778|NCT00938639|11589529|FG000|STARTED|Overall Study||120
10442779|NCT00938639|11589530|FG001|STARTED|Overall Study||120
10442780|NCT00938639|11589529|FG000|COMPLETED|Overall Study||117
10442781|NCT00938639|11589530|FG001|COMPLETED|Overall Study||116
10442782|NCT00938639|11589529|FG000|NOT COMPLETED|Overall Study||3
10442783|NCT00938639|11589530|FG001|NOT COMPLETED|Overall Study||4
10442784|NCT00938704|11589542|FG000|STARTED|Overall Study||33
10442785|NCT00938704|11589543|FG001|STARTED|Overall Study||37
10442786|NCT00938704|11589542|FG000|COMPLETED|Overall Study||33
10442787|NCT00938704|11589543|FG001|COMPLETED|Overall Study||37
10442788|NCT00938704|11589542|FG000|NOT COMPLETED|Overall Study||0
10442789|NCT00938704|11589543|FG001|NOT COMPLETED|Overall Study||0
10442790|NCT00938717|11589551|FG000|STARTED|Overall Study||403
10442791|NCT00938717|11589552|FG001|STARTED|Overall Study||402
10442792|NCT00938717|11589551|FG000|COMPLETED|Overall Study||305
10442793|NCT00938717|11589552|FG001|COMPLETED|Overall Study||294
10442794|NCT00938717|11589551|FG000|NOT COMPLETED|Overall Study||98
10442795|NCT00938717|11589552|FG001|NOT COMPLETED|Overall Study||108
10442796|NCT00938782|11589560|FG000|STARTED|Overall Study|Pre-induction of anesthesia|32
10550400|NCT01532141|11704578|FG002|Period 2|Overall Study||8
10789488|NCT03521479|11949924|FG000|STARTED|Overall Study||10
10789489|NCT03521479|11949925|FG001|STARTED|Overall Study||10
10789490|NCT03521479|11949926|FG002|STARTED|Overall Study||10
10789491|NCT03521479|11949927|FG003|STARTED|Overall Study||10
10789492|NCT03521479|11949924|FG000|COMPLETED|Overall Study||10
10789493|NCT03521479|11949925|FG001|COMPLETED|Overall Study||10
10789494|NCT03521479|11949926|FG002|COMPLETED|Overall Study||10
10789495|NCT03521479|11949927|FG003|COMPLETED|Overall Study||10
10789496|NCT03521479|11949924|FG000|NOT COMPLETED|Overall Study||0
10789497|NCT03521479|11949925|FG001|NOT COMPLETED|Overall Study||0
10789498|NCT03521479|11949926|FG002|NOT COMPLETED|Overall Study||0
10442797|NCT00938782|11589561|FG001|STARTED|Overall Study|Monitoring started pre-induction of anesthesia|35
10442798|NCT00938782|11589560|FG000|COMPLETED|Overall Study|Upon discharge from PACU|32
10442799|NCT00938782|11589561|FG001|COMPLETED|Overall Study|Upon discharge from PACU|35
10442800|NCT00938782|11589560|FG000|NOT COMPLETED|Overall Study||0
10442801|NCT00938782|11589561|FG001|NOT COMPLETED|Overall Study||0
10442802|NCT00938860|11589569|FG000|STARTED|Overall Study|Intent-to-Treat (ITT) population. ITT population consisted of all randomized patients|50
10442803|NCT00938860|11589570|FG001|STARTED|Overall Study||42
10442804|NCT00938860|11589569|FG000|Efficacy Population|Overall Study||40
10442805|NCT00938860|11589570|FG001|Efficacy Population|Overall Study||41
10442806|NCT00938860|11589569|FG000|COMPLETED|Overall Study||25
10442807|NCT00938860|11589570|FG001|COMPLETED|Overall Study||25
10442808|NCT00938860|11589569|FG000|NOT COMPLETED|Overall Study||25
10442809|NCT00938860|11589570|FG001|NOT COMPLETED|Overall Study||17
10442810|NCT00938886|11589578|FG000|STARTED|Overall Study||75
10442811|NCT00938886|11589579|FG001|STARTED|Overall Study||75
10442812|NCT00938886|11589578|FG000|Attended 1 Counseling Session|Overall Study||70
10442813|NCT00938886|11589579|FG001|Attended 1 Counseling Session|Overall Study||70
10442814|NCT00938886|11589578|FG000|COMPLETED|Overall Study||68
10442815|NCT00938886|11589579|FG001|COMPLETED|Overall Study||65
10442816|NCT00938886|11589578|FG000|NOT COMPLETED|Overall Study||7
10442817|NCT00938886|11589579|FG001|NOT COMPLETED|Overall Study||10
10442818|NCT00938964|11589587|FG000|STARTED|Overall Study||241
10442819|NCT00938964|11589588|FG001|STARTED|Overall Study||237
10442820|NCT00938964|11589587|FG000|COMPLETED|Overall Study||211
10442821|NCT00938964|11589588|FG001|COMPLETED|Overall Study||209
10442822|NCT00938964|11589587|FG000|NOT COMPLETED|Overall Study||30
10442823|NCT00938964|11589588|FG001|NOT COMPLETED|Overall Study||28
10442824|NCT00939003|11589596|FG000|STARTED|Double-blind Treatment Period||97
10442825|NCT00939003|11589597|FG001|STARTED|Double-blind Treatment Period||95
10442826|NCT00939003|11589596|FG000|COMPLETED|Double-blind Treatment Period||95
10442827|NCT00939003|11589597|FG001|COMPLETED|Double-blind Treatment Period||91
10442828|NCT00939003|11589596|FG000|NOT COMPLETED|Double-blind Treatment Period||2
10442829|NCT00939003|11589597|FG001|NOT COMPLETED|Double-blind Treatment Period||4
10442830|NCT00939003|11589596|FG000|STARTED|Open-label Treatment Period||95
10442831|NCT00939003|11589597|FG001|STARTED|Open-label Treatment Period||91
10442832|NCT00939003|11589596|FG000|COMPLETED|Open-label Treatment Period||66
10442833|NCT00939003|11589597|FG001|COMPLETED|Open-label Treatment Period||62
10442834|NCT00939003|11589596|FG000|NOT COMPLETED|Open-label Treatment Period||29
10442835|NCT00939003|11589597|FG001|NOT COMPLETED|Open-label Treatment Period||29
10442836|NCT00939029|11589608|FG000|STARTED|Overall Study||25
10442837|NCT00939029|11589609|FG001|STARTED|Overall Study||27
10442838|NCT00939029|11589608|FG000|COMPLETED|Overall Study||19
10442839|NCT00939029|11589609|FG001|COMPLETED|Overall Study||15
10442840|NCT00939029|11589608|FG000|NOT COMPLETED|Overall Study||6
10442841|NCT00939029|11589609|FG001|NOT COMPLETED|Overall Study||12
10442842|NCT00939055|11589617|FG000|STARTED|Overall Study||73
10442843|NCT00939055|11589618|FG001|STARTED|Overall Study||39
10442844|NCT00939055|11589617|FG000|COMPLETED|Overall Study||69
10442845|NCT00939055|11589618|FG001|COMPLETED|Overall Study||39
10442846|NCT00939055|11589617|FG000|NOT COMPLETED|Overall Study||4
10442847|NCT00939055|11589618|FG001|NOT COMPLETED|Overall Study||0
10442848|NCT00939094|11589627|FG000|STARTED|Overall Study||42
10442849|NCT00939094|11589628|FG001|STARTED|Overall Study||45
10442850|NCT00939094|11589627|FG000|COMPLETED|Overall Study||28
10442851|NCT00939094|11589628|FG001|COMPLETED|Overall Study||35
10442852|NCT00939094|11589627|FG000|NOT COMPLETED|Overall Study||14
10442853|NCT00939094|11589628|FG001|NOT COMPLETED|Overall Study||10
10442854|NCT00939107|11589636|FG000|STARTED|Overall Study||175
10442855|NCT00939107|11589637|FG001|STARTED|Overall Study||175
10442856|NCT00939107|11589636|FG000|12 Months Follow-up|Overall Study||161
10442857|NCT00939107|11589637|FG001|12 Months Follow-up|Overall Study||163
10442858|NCT00939107|11589636|FG000|COMPLETED|Overall Study||161
10442859|NCT00939107|11589637|FG001|COMPLETED|Overall Study||163
10442860|NCT00939107|11589636|FG000|NOT COMPLETED|Overall Study||14
10442861|NCT00939107|11589637|FG001|NOT COMPLETED|Overall Study||12
10442862|NCT00939120|11589645|FG000|STARTED|Overall Study||23
10442863|NCT00939120|11589646|FG001|STARTED|Overall Study||23
10442864|NCT00939120|11589645|FG000|COMPLETED|Overall Study||15
10442865|NCT00939120|11589646|FG001|COMPLETED|Overall Study||18
10442866|NCT00939120|11589645|FG000|NOT COMPLETED|Overall Study||8
10442867|NCT00939120|11589646|FG001|NOT COMPLETED|Overall Study||5
10442868|NCT00939159|11589652|FG000|STARTED|Overall Study||13
10442869|NCT00939159|11589652|FG000|COMPLETED|Overall Study||13
10442870|NCT00939159|11589652|FG000|NOT COMPLETED|Overall Study||0
10789499|NCT03521479|11949927|FG003|NOT COMPLETED|Overall Study||0
10789500|NCT03521505|11949939|FG000|STARTED|Overall Study||25
10789501|NCT03521505|11949940|FG001|STARTED|Overall Study||25
10789502|NCT03521505|11949939|FG000|COMPLETED|Overall Study||25
10789503|NCT03521505|11949940|FG001|COMPLETED|Overall Study||25
10442871|NCT00939185|11589656|FG000|STARTED|Overall Study||400
10442872|NCT00939185|11589656|FG000|Received Treatment|Overall Study||390
10442873|NCT00939185|11589656|FG000|COMPLETED|Overall Study||375
10442874|NCT00939185|11589656|FG000|NOT COMPLETED|Overall Study||25
10442875|NCT00939198|11589660|FG000|STARTED|Overall Study||87
10442876|NCT00939198|11589660|FG000|COMPLETED|Overall Study||87
10442877|NCT00939198|11589660|FG000|NOT COMPLETED|Overall Study||0
10550401|NCT01532141|11704576|FG000|Period 3|Overall Study||8
10550402|NCT01532141|11704577|FG001|Period 3|Overall Study||8
10550403|NCT01532141|11704578|FG002|Period 3|Overall Study||8
10550404|NCT01532141|11704576|FG000|COMPLETED|Overall Study||8
10550405|NCT01532141|11704577|FG001|COMPLETED|Overall Study||8
10550406|NCT01532141|11704578|FG002|COMPLETED|Overall Study||8
10550407|NCT01532141|11704576|FG000|NOT COMPLETED|Overall Study||1
10550408|NCT01532141|11704577|FG001|NOT COMPLETED|Overall Study||0
10550409|NCT01532141|11704578|FG002|NOT COMPLETED|Overall Study||0
10550410|NCT01532349|11704589|FG000|STARTED|Overall Study||17
10550411|NCT01532349|11704590|FG001|STARTED|Overall Study||17
10550412|NCT01532349|11704589|FG000|COMPLETED|Overall Study||15
10550413|NCT01532349|11704590|FG001|COMPLETED|Overall Study||12
10550414|NCT01532349|11704589|FG000|NOT COMPLETED|Overall Study||2
10550415|NCT01532349|11704590|FG001|NOT COMPLETED|Overall Study||5
10550416|NCT01532388|11704598|FG000|STARTED|3-month Follow-up||101
10550417|NCT01532388|11704599|FG001|STARTED|3-month Follow-up||101
10550418|NCT01532388|11704598|FG000|COMPLETED|3-month Follow-up||33
10550419|NCT01532388|11704599|FG001|COMPLETED|3-month Follow-up||33
10550420|NCT01532388|11704598|FG000|NOT COMPLETED|3-month Follow-up||68
10550421|NCT01532388|11704599|FG001|NOT COMPLETED|3-month Follow-up||68
10550422|NCT01532388|11704598|FG000|STARTED|6-month Follow-up|All participants registered in the trial were contacted for follow-ups at 3, 6 and 12 months.|101
10550423|NCT01532388|11704599|FG001|STARTED|6-month Follow-up|All participants registered in the trial were contacted for follow-ups at 3, 6 and 12 months.|101
10550424|NCT01532388|11704598|FG000|COMPLETED|6-month Follow-up||27
10550425|NCT01532388|11704599|FG001|COMPLETED|6-month Follow-up||35
10550426|NCT01532388|11704598|FG000|NOT COMPLETED|6-month Follow-up||74
10550427|NCT01532388|11704599|FG001|NOT COMPLETED|6-month Follow-up||66
10550428|NCT01532388|11704598|FG000|STARTED|12-month Follow-up|All participants registered in the trial were contacted for follow-ups at 3, 6 and 12 months.|101
10550429|NCT01532388|11704599|FG001|STARTED|12-month Follow-up|All participants registered in the trial were contacted for follow-ups at 3, 6 and 12 months.|101
10550430|NCT01532388|11704598|FG000|COMPLETED|12-month Follow-up||32
10550431|NCT01532388|11704599|FG001|COMPLETED|12-month Follow-up||34
10550432|NCT01532388|11704598|FG000|NOT COMPLETED|12-month Follow-up||69
10550433|NCT01532388|11704599|FG001|NOT COMPLETED|12-month Follow-up||67
10550434|NCT01532414|11704608|FG000|STARTED|Overall Study||92
10550435|NCT01532414|11704609|FG001|STARTED|Overall Study|Up-titrated at 6 weeks from a starting dose of 12.5 mg due to morning testosterone <300 ng/dL|21
10550436|NCT01532414|11704610|FG002|STARTED|Overall Study||38
10550437|NCT01532414|11704608|FG000|COMPLETED|Overall Study||85
10550438|NCT01532414|11704609|FG001|COMPLETED|Overall Study||19
10550439|NCT01532414|11704610|FG002|COMPLETED|Overall Study||35
10550440|NCT01532414|11704608|FG000|NOT COMPLETED|Overall Study||7
10550441|NCT01532414|11704609|FG001|NOT COMPLETED|Overall Study||2
10550442|NCT01532414|11704610|FG002|NOT COMPLETED|Overall Study||3
10550443|NCT01532453|11704620|FG000|STARTED|Overall Study||81
10550444|NCT01532453|11704621|FG001|STARTED|Overall Study||160
10550445|NCT01532453|11704620|FG000|COMPLETED|Overall Study||54
10550446|NCT01532453|11704621|FG001|COMPLETED|Overall Study||90
10550447|NCT01532453|11704620|FG000|NOT COMPLETED|Overall Study||27
10550448|NCT01532453|11704621|FG001|NOT COMPLETED|Overall Study||70
10550449|NCT01532570|11704631|FG000|STARTED|Overall Study||11
10550450|NCT01532570|11704632|FG001|STARTED|Overall Study||2
10550451|NCT01532570|11704633|FG002|STARTED|Overall Study||1
10550452|NCT01532570|11704634|FG003|STARTED|Overall Study||4
10550453|NCT01532570|11704631|FG000|COMPLETED|Overall Study||10
10550454|NCT01532570|11704632|FG001|COMPLETED|Overall Study||1
10550455|NCT01532570|11704633|FG002|COMPLETED|Overall Study||1
10550456|NCT01532570|11704634|FG003|COMPLETED|Overall Study||4
10550457|NCT01532570|11704631|FG000|NOT COMPLETED|Overall Study||1
10550458|NCT01532570|11704632|FG001|NOT COMPLETED|Overall Study||1
10550459|NCT01532570|11704633|FG002|NOT COMPLETED|Overall Study||0
10550460|NCT01532570|11704634|FG003|NOT COMPLETED|Overall Study||0
10550461|NCT01532648|11704653|FG000|STARTED|Overall Study||255
10550462|NCT01532648|11704654|FG001|STARTED|Overall Study||255
10550463|NCT01532648|11704653|FG000|Safety Population|Overall Study||255
10550464|NCT01532648|11704654|FG001|Safety Population|Overall Study||255
10550465|NCT01532648|11704653|FG000|Intent-To-Treat Population|Overall Study||230
10550466|NCT01532648|11704654|FG001|Intent-To-Treat Population|Overall Study||228
10550467|NCT01532648|11704653|FG000|COMPLETED|Overall Study||219
10550468|NCT01532648|11704654|FG001|COMPLETED|Overall Study||238
10550469|NCT01532648|11704653|FG000|NOT COMPLETED|Overall Study||36
10550470|NCT01532648|11704654|FG001|NOT COMPLETED|Overall Study||17
10550471|NCT01532687|11704662|FG000|STARTED|Overall Study||29
10550472|NCT01532687|11704663|FG001|STARTED|Overall Study||25
10550473|NCT01532687|11704662|FG000|Crossover to Open-label Pazopanib|Overall Study||0
10550474|NCT01532687|11704663|FG001|Crossover to Open-label Pazopanib|Overall Study||14
10442878|NCT00939211|11589665|FG000|STARTED|AZD9164 100 Mcg First, Then Placebo|Cross-over study|28
10442879|NCT00939211|11589665|FG000|COMPLETED|AZD9164 100 Mcg First, Then Placebo||28
10442880|NCT00939211|11589665|FG000|NOT COMPLETED|AZD9164 100 Mcg First, Then Placebo||0
10442881|NCT00939211|11589665|FG000|STARTED|AZD9164 400 Mcg First, Then Placebo||28
10550475|NCT01532687|11704662|FG000|COMPLETED|Overall Study|Participants remain on treatment until time of progression and through the AE assessment period|15
10550476|NCT01532687|11704663|FG001|COMPLETED|Overall Study|Participants remain on treatment until time of progression|23
10550477|NCT01532687|11704662|FG000|NOT COMPLETED|Overall Study||14
10550478|NCT01532687|11704663|FG001|NOT COMPLETED|Overall Study||2
10550479|NCT01532700|11704671|FG000|STARTED|Overall Study||28
10550480|NCT01532700|11704671|FG000|COMPLETED|Overall Study||28
10550481|NCT01532700|11704671|FG000|NOT COMPLETED|Overall Study||0
10650479|NCT02169479|11810753|FG001|25 mg BIA 9-1067|Overall Study||3
10650480|NCT02169479|11810754|FG002|25 mg BIA 9-1067|Overall Study||4
10650481|NCT02169479|11810755|FG003|25 mg BIA 9-1067|Overall Study||4
10650482|NCT02169479|11810752|FG000|50 mg BIA 9-1067|Overall Study||4
10789504|NCT03521505|11949939|FG000|NOT COMPLETED|Overall Study||0
10789505|NCT03521505|11949940|FG001|NOT COMPLETED|Overall Study||0
10789506|NCT03521635|11949948|FG000|STARTED|Overall Study||49
10789507|NCT03521635|11949949|FG001|STARTED|Overall Study||49
10789508|NCT03521635|11949948|FG000|COMPLETED|Overall Study||45
10442882|NCT00939211|11589665|FG000|COMPLETED|AZD9164 400 Mcg First, Then Placebo||28
10442883|NCT00939211|11589665|FG000|NOT COMPLETED|AZD9164 400 Mcg First, Then Placebo||0
10442884|NCT00939211|11589665|FG000|STARTED|AZD9164 1200 Mcg First, Then Placebo||28
10442885|NCT00939211|11589665|FG000|COMPLETED|AZD9164 1200 Mcg First, Then Placebo||28
10442886|NCT00939211|11589665|FG000|NOT COMPLETED|AZD9164 1200 Mcg First, Then Placebo||0
10442887|NCT00939211|11589665|FG000|STARTED|Spiriva 18 Mcg First, Then Placebo||28
10442888|NCT00939211|11589665|FG000|COMPLETED|Spiriva 18 Mcg First, Then Placebo||28
10442889|NCT00939211|11589665|FG000|NOT COMPLETED|Spiriva 18 Mcg First, Then Placebo||0
10442890|NCT00939211|11589665|FG000|STARTED|Placebo||28
10442891|NCT00939211|11589665|FG000|COMPLETED|Placebo||28
10442892|NCT00939211|11589665|FG000|NOT COMPLETED|Placebo||0
10442893|NCT00939341|11589677|FG000|STARTED|Overall Study|1022 participants were enrolled. There were 160 screen failures, 862 proceeded to treatment period.|862
10442894|NCT00939341|11589677|FG000|COMPLETED|Overall Study|862 participants entered into the 12-week treatment,66 discontinued, 796 completed the treatment.|796
10442895|NCT00939341|11589677|FG000|NOT COMPLETED|Overall Study||66
10442896|NCT00939367|11589681|FG000|STARTED|First Intervention||15
10442897|NCT00939367|11589682|FG001|STARTED|First Intervention||15
10442898|NCT00939367|11589681|FG000|COMPLETED|First Intervention||15
10442899|NCT00939367|11589682|FG001|COMPLETED|First Intervention||15
10442900|NCT00939367|11589681|FG000|NOT COMPLETED|First Intervention||0
10442901|NCT00939367|11589682|FG001|NOT COMPLETED|First Intervention||0
10442902|NCT00939367|11589681|FG000|STARTED|Second Intervention||15
10442903|NCT00939367|11589682|FG001|STARTED|Second Intervention||15
10442904|NCT00939367|11589681|FG000|COMPLETED|Second Intervention||15
10442905|NCT00939367|11589682|FG001|COMPLETED|Second Intervention||15
10442906|NCT00939367|11589681|FG000|NOT COMPLETED|Second Intervention||0
10442907|NCT00939367|11589682|FG001|NOT COMPLETED|Second Intervention||0
10442908|NCT00939393|11589690|FG000|STARTED|Overall Study||37
10442909|NCT00939393|11589691|FG001|STARTED|Overall Study||35
10442910|NCT00939393|11589690|FG000|COMPLETED|Overall Study||33
10442911|NCT00939393|11589691|FG001|COMPLETED|Overall Study||35
10442912|NCT00939393|11589690|FG000|NOT COMPLETED|Overall Study||4
10442913|NCT00939393|11589691|FG001|NOT COMPLETED|Overall Study||0
10442914|NCT00939471|11589699|FG000|STARTED|Overall Study||44
10442915|NCT00939471|11589699|FG000|COMPLETED|Overall Study||33
10442916|NCT00939471|11589699|FG000|NOT COMPLETED|Overall Study||11
10442917|NCT00939484|11589706|FG000|STARTED|Overall Study||8
10442918|NCT00939484|11589707|FG001|STARTED|Overall Study||20
10442919|NCT00939484|11589708|FG002|STARTED|Overall Study||3
10442920|NCT00939484|11589706|FG000|COMPLETED|Overall Study||0
10442921|NCT00939484|11589707|FG001|COMPLETED|Overall Study||0
10442922|NCT00939484|11589708|FG002|COMPLETED|Overall Study||0
10442923|NCT00939484|11589706|FG000|NOT COMPLETED|Overall Study||8
10442924|NCT00939484|11589707|FG001|NOT COMPLETED|Overall Study||20
10442925|NCT00939484|11589708|FG002|NOT COMPLETED|Overall Study||3
10442926|NCT00939510|11589718|FG000|STARTED|Overall Study||32
10442927|NCT00939510|11589718|FG000|COMPLETED|Overall Study||31
10442928|NCT00939510|11589718|FG000|NOT COMPLETED|Overall Study||1
10442929|NCT00939523|11589722|FG000|STARTED|Overall Study||9
10442930|NCT00939523|11589722|FG000|COMPLETED|Overall Study||6
10442931|NCT00939523|11589722|FG000|NOT COMPLETED|Overall Study||3
10442932|NCT00939536|11589728|FG000|STARTED|First Intervention||12
10442933|NCT00939536|11589729|FG001|STARTED|First Intervention||12
10442934|NCT00939536|11589728|FG000|COMPLETED|First Intervention||12
10442935|NCT00939536|11589729|FG001|COMPLETED|First Intervention||12
10442936|NCT00939536|11589728|FG000|NOT COMPLETED|First Intervention||0
10442937|NCT00939536|11589729|FG001|NOT COMPLETED|First Intervention||0
10442938|NCT00939536|11589728|FG000|STARTED|Second Intervention||12
10442939|NCT00939536|11589729|FG001|STARTED|Second Intervention||12
10650483|NCT02169479|11810753|FG001|50 mg BIA 9-1067|Overall Study||4
10650484|NCT02169479|11810754|FG002|50 mg BIA 9-1067|Overall Study||4
10650485|NCT02169479|11810755|FG003|50 mg BIA 9-1067|Overall Study||4
10789509|NCT03521635|11949949|FG001|COMPLETED|Overall Study||43
10789510|NCT03521635|11949948|FG000|NOT COMPLETED|Overall Study||4
10442940|NCT00939536|11589728|FG000|COMPLETED|Second Intervention||12
10442941|NCT00939536|11589729|FG001|COMPLETED|Second Intervention||12
10442942|NCT00939536|11589728|FG000|NOT COMPLETED|Second Intervention||0
10442943|NCT00939536|11589729|FG001|NOT COMPLETED|Second Intervention||0
10442944|NCT00939562|11589735|FG000|STARTED|Period 1||12
10442945|NCT00939562|11589736|FG001|STARTED|Period 1||12
10442946|NCT00939562|11589735|FG000|COMPLETED|Period 1||12
10442947|NCT00939562|11589736|FG001|COMPLETED|Period 1||12
10442948|NCT00939562|11589735|FG000|NOT COMPLETED|Period 1||0
10442949|NCT00939562|11589736|FG001|NOT COMPLETED|Period 1||0
10442950|NCT00939562|11589735|FG000|STARTED|Period 2||12
10442951|NCT00939562|11589736|FG001|STARTED|Period 2||12
10442952|NCT00939562|11589735|FG000|COMPLETED|Period 2||12
10442953|NCT00939562|11589736|FG001|COMPLETED|Period 2||12
10442954|NCT00939562|11589735|FG000|NOT COMPLETED|Period 2||0
10442955|NCT00939562|11589736|FG001|NOT COMPLETED|Period 2||0
10442956|NCT00939627|11589744|FG000|STARTED|Overall Study||27
10442957|NCT00939627|11589745|FG001|STARTED|Overall Study||28
10442958|NCT00939627|11589746|FG002|STARTED|Overall Study||0
10442959|NCT00939627|11589744|FG000|COMPLETED|Overall Study||0
10442960|NCT00939627|11589745|FG001|COMPLETED|Overall Study||0
10442961|NCT00939627|11589746|FG002|COMPLETED|Overall Study||0
10442962|NCT00939627|11589744|FG000|NOT COMPLETED|Overall Study||27
10442963|NCT00939627|11589745|FG001|NOT COMPLETED|Overall Study||28
10442964|NCT00939627|11589746|FG002|NOT COMPLETED|Overall Study||0
10442965|NCT00939640|11589752|FG000|STARTED|Overall Study||14
10442966|NCT00939640|11589752|FG000|COMPLETED|Overall Study||13
10442967|NCT00939640|11589752|FG000|NOT COMPLETED|Overall Study||1
10442968|NCT00939653|11589761|FG000|STARTED|Treatment Course 1||6
10442969|NCT00939653|11589761|FG000|COMPLETED|Treatment Course 1||6
10442970|NCT00939653|11589761|FG000|NOT COMPLETED|Treatment Course 1||0
10442971|NCT00939653|11589761|FG000|STARTED|Treatment Course 2||2
10442972|NCT00939653|11589761|FG000|COMPLETED|Treatment Course 2||2
10442973|NCT00939653|11589761|FG000|NOT COMPLETED|Treatment Course 2||0
10442974|NCT00939653|11589761|FG000|STARTED|Treatment Course 3||0
10442975|NCT00939653|11589761|FG000|COMPLETED|Treatment Course 3||0
10442976|NCT00939653|11589761|FG000|NOT COMPLETED|Treatment Course 3||0
10442977|NCT00939653|11589761|FG000|STARTED|Treatment Course 4||0
10442978|NCT00939653|11589761|FG000|COMPLETED|Treatment Course 4||0
10442979|NCT00939653|11589761|FG000|NOT COMPLETED|Treatment Course 4||0
10442980|NCT00939692|11589768|FG000|STARTED|Period 1 - First Intervention - 5 Days||13
10442981|NCT00939692|11589769|FG001|STARTED|Period 1 - First Intervention - 5 Days||13
10442982|NCT00939692|11589768|FG000|COMPLETED|Period 1 - First Intervention - 5 Days||12
10442983|NCT00939692|11589769|FG001|COMPLETED|Period 1 - First Intervention - 5 Days||13
10442984|NCT00939692|11589768|FG000|NOT COMPLETED|Period 1 - First Intervention - 5 Days||1
10442985|NCT00939692|11589769|FG001|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
10442986|NCT00939692|11589768|FG000|STARTED|Period 2 - Second Intervent - 5 Days||12
10442987|NCT00939692|11589769|FG001|STARTED|Period 2 - Second Intervent - 5 Days||13
10442988|NCT00939692|11589768|FG000|COMPLETED|Period 2 - Second Intervent - 5 Days||12
10442989|NCT00939692|11589769|FG001|COMPLETED|Period 2 - Second Intervent - 5 Days||12
10442990|NCT00939692|11589768|FG000|NOT COMPLETED|Period 2 - Second Intervent - 5 Days||0
10550482|NCT01532817|11704675|FG000|STARTED|Overall Study||30
10550483|NCT01532817|11704675|FG000|COMPLETED|Overall Study||30
10550484|NCT01532817|11704675|FG000|NOT COMPLETED|Overall Study||0
10550485|NCT01532830|11704679|FG000|STARTED|Overall Study||30
10550486|NCT01532830|11704679|FG000|COMPLETED|Overall Study||26
10550487|NCT01532830|11704679|FG000|NOT COMPLETED|Overall Study||4
10442991|NCT00939692|11589769|FG001|NOT COMPLETED|Period 2 - Second Intervent - 5 Days||1
10442992|NCT00939705|11589777|FG000|STARTED|Period 1 - First Intervention - 5 Days||9
10442993|NCT00939705|11589778|FG001|STARTED|Period 1 - First Intervention - 5 Days||9
10442994|NCT00939705|11589777|FG000|COMPLETED|Period 1 - First Intervention - 5 Days||9
10442995|NCT00939705|11589778|FG001|COMPLETED|Period 1 - First Intervention - 5 Days||9
10442996|NCT00939705|11589777|FG000|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
10442997|NCT00939705|11589778|FG001|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
10442998|NCT00939705|11589777|FG000|STARTED|Period 2 - Washout Period - 21 Days||9
10442999|NCT00939705|11589778|FG001|STARTED|Period 2 - Washout Period - 21 Days||9
10443000|NCT00939705|11589777|FG000|COMPLETED|Period 2 - Washout Period - 21 Days||9
10443001|NCT00939705|11589778|FG001|COMPLETED|Period 2 - Washout Period - 21 Days||9
10443002|NCT00939705|11589777|FG000|NOT COMPLETED|Period 2 - Washout Period - 21 Days||0
10443003|NCT00939705|11589778|FG001|NOT COMPLETED|Period 2 - Washout Period - 21 Days||0
10443004|NCT00939705|11589777|FG000|STARTED|Period 3 - Second Intervent - 5 Days||9
10443005|NCT00939705|11589778|FG001|STARTED|Period 3 - Second Intervent - 5 Days||9
10443006|NCT00939705|11589777|FG000|COMPLETED|Period 3 - Second Intervent - 5 Days||9
10443007|NCT00939705|11589778|FG001|COMPLETED|Period 3 - Second Intervent - 5 Days||9
10443008|NCT00939705|11589777|FG000|NOT COMPLETED|Period 3 - Second Intervent - 5 Days||0
10443009|NCT00939705|11589778|FG001|NOT COMPLETED|Period 3 - Second Intervent - 5 Days||0
10443010|NCT00939731|11589784|FG000|STARTED|First Intervention Period||12
10443011|NCT00939731|11589785|FG001|STARTED|First Intervention Period||12
10443012|NCT00939731|11589784|FG000|COMPLETED|First Intervention Period||12
10443013|NCT00939731|11589785|FG001|COMPLETED|First Intervention Period||12
10443014|NCT00939731|11589784|FG000|NOT COMPLETED|First Intervention Period||0
10443015|NCT00939731|11589785|FG001|NOT COMPLETED|First Intervention Period||0
10443016|NCT00939731|11589784|FG000|STARTED|Washout Period (at Least 14 Days)||12
10443017|NCT00939731|11589785|FG001|STARTED|Washout Period (at Least 14 Days)||12
10443018|NCT00939731|11589784|FG000|COMPLETED|Washout Period (at Least 14 Days)||12
10443019|NCT00939731|11589785|FG001|COMPLETED|Washout Period (at Least 14 Days)||12
10550488|NCT01532869|11704685|FG000|STARTED|Blinded-Treatment Period (Up to Week 24)||44
10550489|NCT01532869|11704686|FG001|STARTED|Blinded-Treatment Period (Up to Week 24)||43
10443020|NCT00939731|11589784|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10443021|NCT00939731|11589785|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10443022|NCT00939731|11589784|FG000|STARTED|Second Intervention Period||12
10443023|NCT00939731|11589785|FG001|STARTED|Second Intervention Period||12
10443024|NCT00939731|11589784|FG000|COMPLETED|Second Intervention Period||12
10443025|NCT00939731|11589785|FG001|COMPLETED|Second Intervention Period||12
10443026|NCT00939731|11589784|FG000|NOT COMPLETED|Second Intervention Period||0
10443027|NCT00939731|11589785|FG001|NOT COMPLETED|Second Intervention Period||0
10443028|NCT00939770|11589799|FG000|STARTED|Overall Study||6
10443029|NCT00939770|11589800|FG001|STARTED|Overall Study||8
10443030|NCT00939770|11589801|FG002|STARTED|Overall Study||23
10443031|NCT00939770|11589802|FG003|STARTED|Overall Study||12
10443032|NCT00939770|11589803|FG004|STARTED|Overall Study||38
10443033|NCT00939770|11589804|FG005|STARTED|Overall Study||11
10443034|NCT00939770|11589805|FG006|STARTED|Overall Study||14
10443035|NCT00939770|11589806|FG007|STARTED|Overall Study||10
10443036|NCT00939770|11589799|FG000|COMPLETED|Overall Study||1
10443037|NCT00939770|11589800|FG001|COMPLETED|Overall Study||0
10443038|NCT00939770|11589801|FG002|COMPLETED|Overall Study||3
10443039|NCT00939770|11589802|FG003|COMPLETED|Overall Study||1
10443040|NCT00939770|11589803|FG004|COMPLETED|Overall Study||1
10443041|NCT00939770|11589804|FG005|COMPLETED|Overall Study||0
10443042|NCT00939770|11589805|FG006|COMPLETED|Overall Study||0
10443043|NCT00939770|11589806|FG007|COMPLETED|Overall Study||0
10443044|NCT00939770|11589799|FG000|NOT COMPLETED|Overall Study||5
10443045|NCT00939770|11589800|FG001|NOT COMPLETED|Overall Study||8
10443046|NCT00939770|11589801|FG002|NOT COMPLETED|Overall Study||20
10443047|NCT00939770|11589802|FG003|NOT COMPLETED|Overall Study||11
10443048|NCT00939770|11589803|FG004|NOT COMPLETED|Overall Study||37
10443049|NCT00939770|11589804|FG005|NOT COMPLETED|Overall Study||11
10443050|NCT00939770|11589805|FG006|NOT COMPLETED|Overall Study||14
10443051|NCT00939770|11589806|FG007|NOT COMPLETED|Overall Study||10
10443052|NCT00939783|11589837|FG000|STARTED|Overall Study||649
10443053|NCT00939783|11589837|FG000|Treated|Overall Study||648
10443054|NCT00939783|11589837|FG000|COMPLETED|Overall Study||0
10443055|NCT00939783|11589837|FG000|NOT COMPLETED|Overall Study||649
10443056|NCT00939796|11589841|FG000|STARTED|Overall Study||16
10443057|NCT00939796|11589841|FG000|COMPLETED|Overall Study||16
10443058|NCT00939796|11589841|FG000|NOT COMPLETED|Overall Study||0
10443059|NCT00939809|11589845|FG000|STARTED|Overall Study||31
10443060|NCT00939809|11589845|FG000|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|28
10443061|NCT00939809|11589845|FG000|NOT COMPLETED|Overall Study||3
10443062|NCT00939822|11589851|FG000|STARTED|Overall Study||44
10443063|NCT00939822|11589852|FG001|STARTED|Overall Study||44
10443064|NCT00939822|11589851|FG000|COMPLETED|Overall Study||42
10443065|NCT00939822|11589852|FG001|COMPLETED|Overall Study||41
10443066|NCT00939822|11589851|FG000|NOT COMPLETED|Overall Study||2
10443067|NCT00939822|11589852|FG001|NOT COMPLETED|Overall Study||3
10443068|NCT00939874|11589858|FG000|STARTED|Overall Study||52
10443069|NCT00939874|11589858|FG000|Completed Week 48|Overall Study||37
10443070|NCT00939874|11589858|FG000|COMPLETED|Overall Study||32
10443071|NCT00939874|11589858|FG000|NOT COMPLETED|Overall Study||20
10443072|NCT00939900|11589864|FG000|STARTED|Overall Study||55
10443073|NCT00939900|11589865|FG001|STARTED|Overall Study||55
10443074|NCT00939900|11589864|FG000|COMPLETED|Overall Study||53
10443075|NCT00939900|11589865|FG001|COMPLETED|Overall Study||48
10443076|NCT00939900|11589864|FG000|NOT COMPLETED|Overall Study||2
10443077|NCT00939900|11589865|FG001|NOT COMPLETED|Overall Study||7
10443078|NCT00939952|11589871|FG000|STARTED|Overall Study||7
10443079|NCT00939952|11589871|FG000|COMPLETED|Overall Study||7
10443080|NCT00939952|11589871|FG000|NOT COMPLETED|Overall Study||0
10443081|NCT00939991|11589877|FG000|STARTED|Overall Study||9
10443082|NCT00939991|11589878|FG001|STARTED|Overall Study||39
10443083|NCT00939991|11589877|FG000|COMPLETED|Overall Study||9
10443084|NCT00939991|11589878|FG001|COMPLETED|Overall Study||39
10443085|NCT00939991|11589877|FG000|NOT COMPLETED|Overall Study||0
10443086|NCT00939991|11589878|FG001|NOT COMPLETED|Overall Study||0
10443087|NCT00940017|11589884|FG000|STARTED|Overall Study||24
10443088|NCT00940017|11589884|FG000|Subjects Treated|Overall Study||21
10443089|NCT00940017|11589884|FG000|COMPLETED|Overall Study||20
10443090|NCT00940017|11589884|FG000|NOT COMPLETED|Overall Study||4
10443091|NCT00940108|11589892|FG000|STARTED|Overall Study||82
10443092|NCT00940108|11589893|FG001|STARTED|Overall Study||80
10443093|NCT00940108|11589894|FG002|STARTED|Overall Study||103
10443094|NCT00940108|11589895|FG003|STARTED|Overall Study||104
10443095|NCT00940108|11589892|FG000|COMPLETED|Overall Study||77
10443096|NCT00940108|11589893|FG001|COMPLETED|Overall Study||71
10443097|NCT00940108|11589894|FG002|COMPLETED|Overall Study||100
10443098|NCT00940108|11589895|FG003|COMPLETED|Overall Study||99
10443099|NCT00940108|11589892|FG000|NOT COMPLETED|Overall Study||5
10443100|NCT00940108|11589893|FG001|NOT COMPLETED|Overall Study||9
10443101|NCT00940108|11589894|FG002|NOT COMPLETED|Overall Study||3
10443102|NCT00940108|11589895|FG003|NOT COMPLETED|Overall Study||5
10443103|NCT00940290|11589909|FG000|STARTED|Overall Study||54
10443104|NCT00940290|11589910|FG001|STARTED|Overall Study||53
10443105|NCT00940290|11589911|FG002|STARTED|Overall Study||55
10443106|NCT00940290|11589912|FG003|STARTED|Overall Study||54
10443107|NCT00940290|11589909|FG000|COMPLETED|Overall Study||54
10443108|NCT00940290|11589910|FG001|COMPLETED|Overall Study||53
10443109|NCT00940290|11589911|FG002|COMPLETED|Overall Study||55
10443110|NCT00940290|11589912|FG003|COMPLETED|Overall Study||54
10443111|NCT00940290|11589909|FG000|NOT COMPLETED|Overall Study||0
10443112|NCT00940290|11589910|FG001|NOT COMPLETED|Overall Study||0
10443113|NCT00940290|11589911|FG002|NOT COMPLETED|Overall Study||0
10443114|NCT00940290|11589912|FG003|NOT COMPLETED|Overall Study||0
10443115|NCT00940316|11589925|FG000|STARTED|Reached First Response at 8 Weeks||13
10443116|NCT00940316|11589926|FG001|STARTED|Reached First Response at 8 Weeks||13
10443117|NCT00940316|11589927|FG002|STARTED|Reached First Response at 8 Weeks||2
10443118|NCT00940316|11589925|FG000|COMPLETED|Reached First Response at 8 Weeks||10
10443119|NCT00940316|11589926|FG001|COMPLETED|Reached First Response at 8 Weeks||9
10443120|NCT00940316|11589927|FG002|COMPLETED|Reached First Response at 8 Weeks||2
10443121|NCT00940316|11589925|FG000|NOT COMPLETED|Reached First Response at 8 Weeks||3
10443122|NCT00940316|11589926|FG001|NOT COMPLETED|Reached First Response at 8 Weeks||4
10443123|NCT00940316|11589927|FG002|NOT COMPLETED|Reached First Response at 8 Weeks||0
10443124|NCT00940316|11589925|FG000|STARTED|Moved on to be Treated Cycle 5||10
10443125|NCT00940316|11589926|FG001|STARTED|Moved on to be Treated Cycle 5||9
10443126|NCT00940316|11589927|FG002|STARTED|Moved on to be Treated Cycle 5||2
10550490|NCT01532869|11704685|FG000|COMPLETED|Blinded-Treatment Period (Up to Week 24)|Number of participants who completed the first 24 weeks of full 48 weeks blinded-treatment period.|36
10550491|NCT01532869|11704686|FG001|COMPLETED|Blinded-Treatment Period (Up to Week 24)|Number of participants who completed the first 24 weeks of full 48 weeks blinded-treatment period.|35
10550492|NCT01532869|11704685|FG000|NOT COMPLETED|Blinded-Treatment Period (Up to Week 24)||8
10443127|NCT00940316|11589925|FG000|COMPLETED|Moved on to be Treated Cycle 5||8
10443128|NCT00940316|11589926|FG001|COMPLETED|Moved on to be Treated Cycle 5||9
10443129|NCT00940316|11589927|FG002|COMPLETED|Moved on to be Treated Cycle 5||2
10443130|NCT00940316|11589925|FG000|NOT COMPLETED|Moved on to be Treated Cycle 5||2
10443131|NCT00940316|11589926|FG001|NOT COMPLETED|Moved on to be Treated Cycle 5||0
10443132|NCT00940316|11589927|FG002|NOT COMPLETED|Moved on to be Treated Cycle 5||0
10443133|NCT00940316|11589925|FG000|STARTED|Treated After Cycle 5||8
10443134|NCT00940316|11589926|FG001|STARTED|Treated After Cycle 5||9
10443135|NCT00940316|11589927|FG002|STARTED|Treated After Cycle 5||2
10443136|NCT00940316|11589925|FG000|COMPLETED|Treated After Cycle 5||8
10443137|NCT00940316|11589926|FG001|COMPLETED|Treated After Cycle 5||8
10443138|NCT00940316|11589927|FG002|COMPLETED|Treated After Cycle 5||1
10443139|NCT00940316|11589925|FG000|NOT COMPLETED|Treated After Cycle 5||0
10443140|NCT00940316|11589926|FG001|NOT COMPLETED|Treated After Cycle 5||1
10443141|NCT00940316|11589927|FG002|NOT COMPLETED|Treated After Cycle 5||1
10443142|NCT00940316|11589925|FG000|STARTED|Crossed Over to Arm A After Progression||0
10443143|NCT00940316|11589926|FG001|STARTED|Crossed Over to Arm A After Progression||3
10443144|NCT00940316|11589927|FG002|STARTED|Crossed Over to Arm A After Progression||0
10443145|NCT00940316|11589925|FG000|Treated for Cycle One|Crossed Over to Arm A After Progression||0
10443146|NCT00940316|11589926|FG001|Treated for Cycle One|Crossed Over to Arm A After Progression||3
10443147|NCT00940316|11589927|FG002|Treated for Cycle One|Crossed Over to Arm A After Progression||0
10443148|NCT00940316|11589925|FG000|COMPLETED|Crossed Over to Arm A After Progression||0
10443149|NCT00940316|11589926|FG001|COMPLETED|Crossed Over to Arm A After Progression||3
10443150|NCT00940316|11589927|FG002|COMPLETED|Crossed Over to Arm A After Progression||0
10443151|NCT00940316|11589925|FG000|NOT COMPLETED|Crossed Over to Arm A After Progression||0
10443152|NCT00940316|11589926|FG001|NOT COMPLETED|Crossed Over to Arm A After Progression||0
10443153|NCT00940316|11589927|FG002|NOT COMPLETED|Crossed Over to Arm A After Progression||0
10443154|NCT00940316|11589925|FG000|STARTED|Follow up Every 3 Months||13
10443155|NCT00940316|11589926|FG001|STARTED|Follow up Every 3 Months||13
10443156|NCT00940316|11589927|FG002|STARTED|Follow up Every 3 Months||2
10443157|NCT00940316|11589925|FG000|COMPLETED|Follow up Every 3 Months||13
10443158|NCT00940316|11589926|FG001|COMPLETED|Follow up Every 3 Months||13
10443159|NCT00940316|11589927|FG002|COMPLETED|Follow up Every 3 Months||2
10443160|NCT00940316|11589925|FG000|NOT COMPLETED|Follow up Every 3 Months||0
10443161|NCT00940316|11589926|FG001|NOT COMPLETED|Follow up Every 3 Months||0
10443162|NCT00940316|11589927|FG002|NOT COMPLETED|Follow up Every 3 Months||0
10443163|NCT00940342|11589946|FG000|STARTED|Overall Study||50
10443164|NCT00940342|11589947|FG001|STARTED|Overall Study||40
10443165|NCT00940342|11589948|FG002|STARTED|Overall Study||40
10443166|NCT00940342|11589946|FG000|COMPLETED|Overall Study||50
10443167|NCT00940342|11589947|FG001|COMPLETED|Overall Study||38
10443168|NCT00940342|11589948|FG002|COMPLETED|Overall Study||39
10443169|NCT00940342|11589946|FG000|NOT COMPLETED|Overall Study||0
10443170|NCT00940342|11589947|FG001|NOT COMPLETED|Overall Study||2
10443171|NCT00940342|11589948|FG002|NOT COMPLETED|Overall Study||1
10443172|NCT00940446|11589958|FG000|STARTED|Overall Study||30
10443173|NCT00940446|11589959|FG001|STARTED|Overall Study||30
10443174|NCT00940446|11589958|FG000|COMPLETED|Overall Study||30
10443175|NCT00940446|11589959|FG001|COMPLETED|Overall Study||30
10443176|NCT00940446|11589958|FG000|NOT COMPLETED|Overall Study||0
10443177|NCT00940446|11589959|FG001|NOT COMPLETED|Overall Study||0
10550493|NCT01532869|11704686|FG001|NOT COMPLETED|Blinded-Treatment Period (Up to Week 24)||8
10550494|NCT01532869|11704685|FG000|STARTED|Blinded-Treatment Period (Up to Week 48)||44
10550495|NCT01532869|11704686|FG001|STARTED|Blinded-Treatment Period (Up to Week 48)||43
10550496|NCT01532869|11704685|FG000|COMPLETED|Blinded-Treatment Period (Up to Week 48)|Number of participants who completed 48 weeks of blinded-treatment period.|33
10550497|NCT01532869|11704686|FG001|COMPLETED|Blinded-Treatment Period (Up to Week 48)|Number of participants who completed 48 weeks of blinded-treatment period.|30
10550498|NCT01532869|11704685|FG000|NOT COMPLETED|Blinded-Treatment Period (Up to Week 48)||11
10443178|NCT00940485|11589969|FG000|STARTED|Overall Study||97
10443179|NCT00940485|11589970|FG001|STARTED|Overall Study||100
10443180|NCT00940485|11589969|FG000|COMPLETED|Overall Study||82
10443181|NCT00940485|11589970|FG001|COMPLETED|Overall Study||93
10443182|NCT00940485|11589969|FG000|NOT COMPLETED|Overall Study||15
10443183|NCT00940485|11589970|FG001|NOT COMPLETED|Overall Study||7
10443184|NCT00940537|11589978|FG000|STARTED|Overall Study||5
10443185|NCT00940537|11589979|FG001|STARTED|Overall Study||9
10443186|NCT00940537|11589978|FG000|COMPLETED|Overall Study||5
10443187|NCT00940537|11589979|FG001|COMPLETED|Overall Study||9
10443188|NCT00940537|11589978|FG000|NOT COMPLETED|Overall Study||0
10443189|NCT00940537|11589979|FG001|NOT COMPLETED|Overall Study||0
10443190|NCT00940576|11589986|FG000|STARTED|Overall Study||8
10443191|NCT00940576|11589987|FG001|STARTED|Overall Study||9
10443192|NCT00940576|11589986|FG000|COMPLETED|Overall Study||8
10443193|NCT00940576|11589987|FG001|COMPLETED|Overall Study||9
10443194|NCT00940576|11589986|FG000|NOT COMPLETED|Overall Study||0
10443195|NCT00940576|11589987|FG001|NOT COMPLETED|Overall Study||0
10443196|NCT00940589|11589996|FG000|STARTED|Overall Study||39
10443197|NCT00940589|11589997|FG001|STARTED|Overall Study||34
10443198|NCT00940589|11589996|FG000|COMPLETED|Overall Study||31
10443199|NCT00940589|11589997|FG001|COMPLETED|Overall Study||29
10443200|NCT00940589|11589996|FG000|NOT COMPLETED|Overall Study||8
10443201|NCT00940589|11589997|FG001|NOT COMPLETED|Overall Study||5
10443202|NCT00940602|11590005|FG000|STARTED|Overall Study||149
10443203|NCT00940602|11590006|FG001|STARTED|Overall Study||76
10443204|NCT00940602|11590005|FG000|Safety Analysis Set|Overall Study||148
10443205|NCT00940602|11590006|FG001|Safety Analysis Set|Overall Study||76
10443206|NCT00940602|11590005|FG000|Full Analysis Set|Overall Study||149
10443207|NCT00940602|11590006|FG001|Full Analysis Set|Overall Study||76
10443208|NCT00940602|11590005|FG000|Treated|Overall Study||148
10443209|NCT00940602|11590006|FG001|Treated|Overall Study||76
10443210|NCT00940602|11590005|FG000|Untreated|Overall Study||1
10443211|NCT00940602|11590006|FG001|Untreated|Overall Study||0
10443212|NCT00940602|11590005|FG000|COMPLETED|Overall Study||0
10443213|NCT00940602|11590006|FG001|COMPLETED|Overall Study||0
10443214|NCT00940602|11590005|FG000|NOT COMPLETED|Overall Study||149
10443215|NCT00940602|11590006|FG001|NOT COMPLETED|Overall Study||76
10443216|NCT00940771|11590013|FG000|STARTED|Pre-Entry||10
10443217|NCT00940771|11590013|FG000|COMPLETED|Pre-Entry||10
10443218|NCT00940771|11590013|FG000|NOT COMPLETED|Pre-Entry||0
10443219|NCT00940771|11590013|FG000|STARTED|4 Weeks||10
10443220|NCT00940771|11590013|FG000|COMPLETED|4 Weeks||10
10443221|NCT00940771|11590013|FG000|NOT COMPLETED|4 Weeks||0
10443222|NCT00940771|11590013|FG000|STARTED|12 Weeks||10
10443223|NCT00940771|11590013|FG000|COMPLETED|12 Weeks||10
10443224|NCT00940771|11590013|FG000|NOT COMPLETED|12 Weeks||0
10443225|NCT00940771|11590013|FG000|STARTED|24 Weeks||10
10443226|NCT00940771|11590013|FG000|COMPLETED|24 Weeks||10
10443227|NCT00940771|11590013|FG000|NOT COMPLETED|24 Weeks||0
10443228|NCT00940823|11590019|FG000|STARTED|Overall Study||124
10443229|NCT00940823|11590020|FG001|STARTED|Overall Study||114
10443230|NCT00940823|11590019|FG000|COMPLETED|Overall Study||89
10443231|NCT00940823|11590020|FG001|COMPLETED|Overall Study||82
10443232|NCT00940823|11590019|FG000|NOT COMPLETED|Overall Study||35
10443233|NCT00940823|11590020|FG001|NOT COMPLETED|Overall Study||32
10443234|NCT00940875|11590030|FG000|STARTED|Treatment Phase|Disposition analysis includes 3 participants randomized to G+E but received only gemcitabine|31
10443235|NCT00940875|11590031|FG001|STARTED|Treatment Phase|3 participants randomized to G+E arm received only gemcitabine and were analyzed in Gemcitabine arm|23
10443236|NCT00940875|11590030|FG000|COMPLETED|Treatment Phase||5
10443237|NCT00940875|11590031|FG001|COMPLETED|Treatment Phase||4
10550499|NCT01532869|11704686|FG001|NOT COMPLETED|Blinded-Treatment Period (Up to Week 48)||13
10550500|NCT01532869|11704685|FG000|STARTED|Open-label Period (Week 48 to Week 96)|Two participants did not start the open label extension period.|31
10550501|NCT01532869|11704686|FG001|STARTED|Open-label Period (Week 48 to Week 96)||30
10550502|NCT01532869|11704685|FG000|COMPLETED|Open-label Period (Week 48 to Week 96)|Number of participants who completed study to Week 96.|24
10550503|NCT01532869|11704686|FG001|COMPLETED|Open-label Period (Week 48 to Week 96)|Number of participants who completed study to Week 96.|27
10550504|NCT01532869|11704685|FG000|NOT COMPLETED|Open-label Period (Week 48 to Week 96)||7
10550505|NCT01532869|11704686|FG001|NOT COMPLETED|Open-label Period (Week 48 to Week 96)||3
10550506|NCT01532908|11704699|FG000|STARTED|Overall Study||9
10443238|NCT00940875|11590030|FG000|NOT COMPLETED|Treatment Phase||26
10443239|NCT00940875|11590031|FG001|NOT COMPLETED|Treatment Phase||19
10550507|NCT01532908|11704700|FG001|STARTED|Overall Study||2
10550508|NCT01532908|11704699|FG000|Infused|Overall Study||9
10550509|NCT01532908|11704700|FG001|Infused|Overall Study||2
10443240|NCT00940875|11590030|FG000|STARTED|Post-Study Treatment||0
10443241|NCT00940875|11590031|FG001|STARTED|Post-Study Treatment||4
10443242|NCT00940875|11590030|FG000|COMPLETED|Post-Study Treatment||0
10443243|NCT00940875|11590031|FG001|COMPLETED|Post-Study Treatment||1
10443244|NCT00940875|11590030|FG000|NOT COMPLETED|Post-Study Treatment||0
10443245|NCT00940875|11590031|FG001|NOT COMPLETED|Post-Study Treatment||3
10443246|NCT00940888|11590038|FG000|STARTED|Overall Study|Total number of subjects consented|1701
10443247|NCT00940888|11590038|FG000|COMPLETED|Overall Study|Subjects that completed the 60 month follow up visit|866
10443248|NCT00940888|11590038|FG000|NOT COMPLETED|Overall Study||835
10443249|NCT00940901|11590044|FG000|STARTED|Weeks 1-8 (Phase 1)||6
10443250|NCT00940901|11590045|FG001|STARTED|Weeks 1-8 (Phase 1)||7
10443251|NCT00940901|11590044|FG000|COMPLETED|Weeks 1-8 (Phase 1)||6
10443252|NCT00940901|11590045|FG001|COMPLETED|Weeks 1-8 (Phase 1)||7
10443253|NCT00940901|11590044|FG000|NOT COMPLETED|Weeks 1-8 (Phase 1)||0
10443254|NCT00940901|11590045|FG001|NOT COMPLETED|Weeks 1-8 (Phase 1)||0
10443255|NCT00940901|11590044|FG000|STARTED|Week 9-16 (Phase 2)||6
10443256|NCT00940901|11590045|FG001|STARTED|Week 9-16 (Phase 2)||7
10443257|NCT00940901|11590044|FG000|COMPLETED|Week 9-16 (Phase 2)||4
10443258|NCT00940901|11590045|FG001|COMPLETED|Week 9-16 (Phase 2)||4
10443259|NCT00940901|11590044|FG000|NOT COMPLETED|Week 9-16 (Phase 2)||2
10443260|NCT00940901|11590045|FG001|NOT COMPLETED|Week 9-16 (Phase 2)||3
10443261|NCT00940927|11590053|FG000|STARTED|Overall Study||81
10443262|NCT00940927|11590053|FG000|COMPLETED|Overall Study||81
10443263|NCT00940927|11590053|FG000|NOT COMPLETED|Overall Study||0
10443264|NCT00940992|11590060|FG000|STARTED|Overall Study||32
10443265|NCT00940992|11590061|FG001|STARTED|Overall Study||30
10443266|NCT00940992|11590062|FG002|STARTED|Overall Study||30
10443267|NCT00940992|11590060|FG000|COMPLETED|Overall Study||28
10443268|NCT00940992|11590061|FG001|COMPLETED|Overall Study||28
10443269|NCT00940992|11590062|FG002|COMPLETED|Overall Study||28
10443270|NCT00940992|11590060|FG000|NOT COMPLETED|Overall Study||4
10443271|NCT00940992|11590061|FG001|NOT COMPLETED|Overall Study||2
10443272|NCT00940992|11590062|FG002|NOT COMPLETED|Overall Study||2
10525522|NCT01376245|11677440|FG001|NOT COMPLETED|24-week, Double-blind Treatment Period||32
10525523|NCT01376245|11677441|FG002|NOT COMPLETED|24-week, Double-blind Treatment Period||25
10525524|NCT01376245|11677442|FG003|NOT COMPLETED|24-week, Double-blind Treatment Period||23
10525525|NCT01376245|11677443|FG004|NOT COMPLETED|24-week, Double-blind Treatment Period||26
10525526|NCT01376297|11677455|FG000|STARTED|Overall Study|number of randomised patients|309
10525527|NCT01376297|11677456|FG001|STARTED|Overall Study|number of randomised patients|104
10525528|NCT01376297|11677455|FG000|COMPLETED|Overall Study|number of patients completing planned/unplanned chemotherapy cycles|181
10525529|NCT01376297|11677456|FG001|COMPLETED|Overall Study|number of patients completing planned/unplanned chemotherapy cycles|55
10550510|NCT01532908|11704699|FG000|Transplanted|Overall Study||8
10550511|NCT01532908|11704700|FG001|Transplanted|Overall Study||2
10550512|NCT01532908|11704699|FG000|COMPLETED|Overall Study||8
10550513|NCT01532908|11704700|FG001|COMPLETED|Overall Study||2
10550514|NCT01532908|11704699|FG000|NOT COMPLETED|Overall Study||1
10550515|NCT01532908|11704700|FG001|NOT COMPLETED|Overall Study||0
10550516|NCT01532921|11704706|FG000|STARTED|Overall Study||85
10550517|NCT01532921|11704706|FG000|Implantation Procedure|Overall Study||76
10550518|NCT01532921|11704706|FG000|Discharge|Overall Study||75
10550519|NCT01532921|11704706|FG000|6 Months Follow Up|Overall Study||68
10550520|NCT01532921|11704706|FG000|COMPLETED|Overall Study||69
10550521|NCT01532921|11704706|FG000|NOT COMPLETED|Overall Study||16
10550522|NCT01532934|11704716|FG000|STARTED|Overall Study||53
10550523|NCT01532934|11704717|FG001|STARTED|Overall Study||52
10550524|NCT01532934|11704716|FG000|COMPLETED|Overall Study||39
10550525|NCT01532934|11704717|FG001|COMPLETED|Overall Study||39
10525530|NCT01376297|11677455|FG000|NOT COMPLETED|Overall Study||128
10525531|NCT01376297|11677456|FG001|NOT COMPLETED|Overall Study||49
10525532|NCT01376310|11677464|FG000|STARTED|Overall Study||126
10525533|NCT01376310|11677465|FG001|STARTED|Overall Study||33
10525534|NCT01376310|11677464|FG000|COMPLETED|Overall Study||90
10525535|NCT01376310|11677465|FG001|COMPLETED|Overall Study||22
10525536|NCT01376310|11677464|FG000|NOT COMPLETED|Overall Study||36
10525537|NCT01376310|11677465|FG001|NOT COMPLETED|Overall Study||11
10525538|NCT01376349|11677474|FG000|STARTED|Raondomized Treatment||147
10525539|NCT01376349|11677475|FG001|STARTED|Raondomized Treatment||149
10525540|NCT01376349|11677476|FG002|STARTED|Raondomized Treatment||147
10525541|NCT01376349|11677474|FG000|COMPLETED|Raondomized Treatment||123
10525542|NCT01376349|11677475|FG001|COMPLETED|Raondomized Treatment||114
10525543|NCT01376349|11677476|FG002|COMPLETED|Raondomized Treatment||118
10525544|NCT01376349|11677474|FG000|NOT COMPLETED|Raondomized Treatment||24
10525545|NCT01376349|11677475|FG001|NOT COMPLETED|Raondomized Treatment||35
10525546|NCT01376349|11677476|FG002|NOT COMPLETED|Raondomized Treatment||29
10525547|NCT01376349|11677474|FG000|STARTED|Optional Continuation Phase||0
10525548|NCT01376349|11677475|FG001|STARTED|Optional Continuation Phase||0
10525549|NCT01376349|11677476|FG002|STARTED|Optional Continuation Phase|Patients completing Arm III Placebo were offered the option of continuing High Dose DHEA|94
10525550|NCT01376349|11677474|FG000|COMPLETED|Optional Continuation Phase||0
10525551|NCT01376349|11677475|FG001|COMPLETED|Optional Continuation Phase||0
10525552|NCT01376349|11677476|FG002|COMPLETED|Optional Continuation Phase||94
10525553|NCT01376349|11677474|FG000|NOT COMPLETED|Optional Continuation Phase||0
10525554|NCT01376349|11677475|FG001|NOT COMPLETED|Optional Continuation Phase||0
10525555|NCT01376349|11677476|FG002|NOT COMPLETED|Optional Continuation Phase||0
10528931|NCT01397461|11681312|FG001|STARTED|Overall Study||156
10528932|NCT01397461|11681313|FG002|STARTED|Overall Study||154
10528933|NCT01397461|11681311|FG000|COMPLETED|Overall Study||153
10528934|NCT01397461|11681312|FG001|COMPLETED|Overall Study||150
10528935|NCT01397461|11681313|FG002|COMPLETED|Overall Study||152
10528936|NCT01397461|11681311|FG000|NOT COMPLETED|Overall Study||2
10528937|NCT01397461|11681312|FG001|NOT COMPLETED|Overall Study||6
10550526|NCT01532934|11704716|FG000|NOT COMPLETED|Overall Study||14
10550527|NCT01532934|11704717|FG001|NOT COMPLETED|Overall Study||13
10550528|NCT01532973|11704734|FG000|STARTED|Part 1||6
10550529|NCT01532973|11704735|FG001|STARTED|Part 1||6
10528938|NCT01397461|11681313|FG002|NOT COMPLETED|Overall Study||2
10528939|NCT01397591|11681321|FG000|STARTED|Overall Study||2
10528940|NCT01397591|11681321|FG000|COMPLETED|Overall Study||2
10550530|NCT01532973|11704736|FG002|STARTED|Part 1||6
10650486|NCT02169479|11810752|FG000|100 mg BIA 9-1067|Overall Study||3
10443273|NCT00941005|11590072|FG000|STARTED|Overall Study||61
10443274|NCT00941005|11590073|FG001|STARTED|Overall Study||61
10443275|NCT00941005|11590072|FG000|COMPLETED|Overall Study||61
10443276|NCT00941005|11590073|FG001|COMPLETED|Overall Study||61
10443277|NCT00941005|11590072|FG000|NOT COMPLETED|Overall Study||0
10443278|NCT00941005|11590073|FG001|NOT COMPLETED|Overall Study||0
10443279|NCT00941031|11590085|FG000|STARTED|Induction Period||66
10443280|NCT00941031|11590086|FG001|STARTED|Induction Period||138
10443281|NCT00941031|11590087|FG002|STARTED|Induction Period||133
10443282|NCT00941031|11590088|FG003|STARTED|Induction Period||67
10443283|NCT00941031|11590089|FG004|STARTED|Induction Period||0
10443284|NCT00941031|11590090|FG005|STARTED|Induction Period||0
10443285|NCT00941031|11590091|FG006|STARTED|Induction Period||0
10443286|NCT00941031|11590085|FG000|COMPLETED|Induction Period||61
10443287|NCT00941031|11590086|FG001|COMPLETED|Induction Period||134
10443288|NCT00941031|11590087|FG002|COMPLETED|Induction Period||127
10443289|NCT00941031|11590088|FG003|COMPLETED|Induction Period||58
10443290|NCT00941031|11590089|FG004|COMPLETED|Induction Period||0
10443291|NCT00941031|11590090|FG005|COMPLETED|Induction Period||0
10443292|NCT00941031|11590091|FG006|COMPLETED|Induction Period||0
10443293|NCT00941031|11590085|FG000|NOT COMPLETED|Induction Period||5
10443294|NCT00941031|11590086|FG001|NOT COMPLETED|Induction Period||4
10443295|NCT00941031|11590087|FG002|NOT COMPLETED|Induction Period||6
10443296|NCT00941031|11590088|FG003|NOT COMPLETED|Induction Period||9
10443297|NCT00941031|11590089|FG004|NOT COMPLETED|Induction Period||0
10443298|NCT00941031|11590090|FG005|NOT COMPLETED|Induction Period||0
10443299|NCT00941031|11590091|FG006|NOT COMPLETED|Induction Period||0
10443300|NCT00941031|11590085|FG000|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
10443301|NCT00941031|11590086|FG001|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
10443302|NCT00941031|11590087|FG002|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
10443303|NCT00941031|11590088|FG003|STARTED|Maintenance Period|Non Responders treated with an open label regimen.|0
10443304|NCT00941031|11590089|FG004|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|65
10443305|NCT00941031|11590090|FG005|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|67
10443306|NCT00941031|11590091|FG006|STARTED|Maintenance Period|Non Responders treated with an open label regimen.|247
10443307|NCT00941031|11590085|FG000|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
10443308|NCT00941031|11590086|FG001|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
10443309|NCT00941031|11590087|FG002|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
10443310|NCT00941031|11590088|FG003|COMPLETED|Maintenance Period|Non Responders treated with an open label regimen.|0
10443311|NCT00941031|11590089|FG004|COMPLETED|Maintenance Period||56
10443312|NCT00941031|11590090|FG005|COMPLETED|Maintenance Period||61
10443313|NCT00941031|11590091|FG006|COMPLETED|Maintenance Period||204
10443314|NCT00941031|11590085|FG000|NOT COMPLETED|Maintenance Period||0
10443315|NCT00941031|11590086|FG001|NOT COMPLETED|Maintenance Period||0
10443316|NCT00941031|11590087|FG002|NOT COMPLETED|Maintenance Period||0
10789511|NCT03521635|11949949|FG001|NOT COMPLETED|Overall Study||6
10789512|NCT03521791|11949957|FG000|STARTED|Overall Study||76
10789513|NCT03521791|11949958|FG001|STARTED|Overall Study||90
10789514|NCT03521791|11949957|FG000|COMPLETED|Overall Study||69
10789515|NCT03521791|11949958|FG001|COMPLETED|Overall Study||73
10789516|NCT03521791|11949957|FG000|NOT COMPLETED|Overall Study||7
10789517|NCT03521791|11949958|FG001|NOT COMPLETED|Overall Study||17
10789518|NCT03521817|11949966|FG000|STARTED|Overall Study||7
10789519|NCT03521817|11949967|FG001|STARTED|Overall Study||5
10789520|NCT03521817|11949966|FG000|COMPLETED|Overall Study||7
10789521|NCT03521817|11949967|FG001|COMPLETED|Overall Study|1 completer was non adherent based on weekly intervention body weight|4
10443317|NCT00941031|11590088|FG003|NOT COMPLETED|Maintenance Period||0
10443318|NCT00941031|11590089|FG004|NOT COMPLETED|Maintenance Period||9
10443319|NCT00941031|11590090|FG005|NOT COMPLETED|Maintenance Period||6
10443320|NCT00941031|11590091|FG006|NOT COMPLETED|Maintenance Period||43
10443321|NCT00941070|11590110|FG000|STARTED|Overall Study||26
10443322|NCT00941070|11590110|FG000|COMPLETED|Overall Study||25
10443323|NCT00941070|11590110|FG000|NOT COMPLETED|Overall Study||1
10443324|NCT00941304|11590121|FG000|STARTED|Overall Study||31
10443325|NCT00941304|11590122|FG001|STARTED|Overall Study||30
10443326|NCT00941304|11590123|FG002|STARTED|Overall Study||31
10443327|NCT00941304|11590124|FG003|STARTED|Overall Study||30
10443328|NCT00941304|11590125|FG004|STARTED|Overall Study||31
10443329|NCT00941304|11590121|FG000|COMPLETED|Overall Study||30
10443330|NCT00941304|11590122|FG001|COMPLETED|Overall Study||30
10443331|NCT00941304|11590123|FG002|COMPLETED|Overall Study||31
10443332|NCT00941304|11590124|FG003|COMPLETED|Overall Study||30
10443333|NCT00941304|11590125|FG004|COMPLETED|Overall Study||31
10789522|NCT03521817|11949966|FG000|NOT COMPLETED|Overall Study||0
10789523|NCT03521817|11949967|FG001|NOT COMPLETED|Overall Study||1
10789524|NCT03522350|11949973|FG000|STARTED|Overall Study||18
10789525|NCT03522350|11949974|FG001|STARTED|Overall Study||18
10789526|NCT03522350|11949973|FG000|COMPLETED|Overall Study||18
10789527|NCT03522350|11949974|FG001|COMPLETED|Overall Study||18
10789528|NCT03522350|11949973|FG000|NOT COMPLETED|Overall Study||0
10789529|NCT03522350|11949974|FG001|NOT COMPLETED|Overall Study||0
10443334|NCT00941304|11590121|FG000|NOT COMPLETED|Overall Study||1
10443335|NCT00941304|11590122|FG001|NOT COMPLETED|Overall Study||0
10443336|NCT00941304|11590123|FG002|NOT COMPLETED|Overall Study||0
10443337|NCT00941304|11590124|FG003|NOT COMPLETED|Overall Study||0
10443338|NCT00941304|11590125|FG004|NOT COMPLETED|Overall Study||0
10443339|NCT00941330|11590139|FG000|STARTED|Overall Study||15
10443340|NCT00941330|11590140|FG001|STARTED|Overall Study||11
10443341|NCT00941330|11590139|FG000|COMPLETED|Overall Study||14
10443342|NCT00941330|11590140|FG001|COMPLETED|Overall Study||9
10443343|NCT00941330|11590139|FG000|NOT COMPLETED|Overall Study||1
10443344|NCT00941330|11590140|FG001|NOT COMPLETED|Overall Study||2
10443345|NCT00941603|11590152|FG000|STARTED|Overall Study||104
10443346|NCT00941603|11590153|FG001|STARTED|Overall Study||105
10443347|NCT00941603|11590154|FG002|STARTED|Overall Study||104
10443348|NCT00941603|11590155|FG003|STARTED|Overall Study||104
10443349|NCT00941603|11590156|FG004|STARTED|Overall Study||105
10443350|NCT00941603|11590157|FG005|STARTED|Overall Study||97
10443351|NCT00941603|11590152|FG000|COMPLETED|Overall Study||93
10443352|NCT00941603|11590153|FG001|COMPLETED|Overall Study||89
10443353|NCT00941603|11590154|FG002|COMPLETED|Overall Study||99
10443354|NCT00941603|11590155|FG003|COMPLETED|Overall Study||100
10443355|NCT00941603|11590156|FG004|COMPLETED|Overall Study||101
10443356|NCT00941603|11590157|FG005|COMPLETED|Overall Study||94
10443357|NCT00941603|11590152|FG000|NOT COMPLETED|Overall Study||11
10443358|NCT00941603|11590153|FG001|NOT COMPLETED|Overall Study||16
10443359|NCT00941603|11590154|FG002|NOT COMPLETED|Overall Study||5
10443360|NCT00941603|11590155|FG003|NOT COMPLETED|Overall Study||4
10443361|NCT00941603|11590156|FG004|NOT COMPLETED|Overall Study||4
10443362|NCT00941603|11590157|FG005|NOT COMPLETED|Overall Study||3
10443363|NCT00941655|11590173|FG000|STARTED|Overall Study||8
10443364|NCT00941655|11590174|FG001|STARTED|Overall Study||7
10443365|NCT00941655|11590173|FG000|COMPLETED|Overall Study||3
10443366|NCT00941655|11590174|FG001|COMPLETED|Overall Study||2
10443367|NCT00941655|11590173|FG000|NOT COMPLETED|Overall Study||5
10443368|NCT00941655|11590174|FG001|NOT COMPLETED|Overall Study||5
10443369|NCT00941668|11590183|FG000|STARTED|Overall Study||24
10443370|NCT00941668|11590184|FG001|STARTED|Overall Study||25
10443371|NCT00941668|11590183|FG000|COMPLETED|Overall Study||0
10443372|NCT00941668|11590184|FG001|COMPLETED|Overall Study||0
10443373|NCT00941668|11590183|FG000|NOT COMPLETED|Overall Study||24
10443374|NCT00941668|11590184|FG001|NOT COMPLETED|Overall Study||25
10443375|NCT00941681|11590193|FG000|STARTED|Overall Study||12
10443376|NCT00941681|11590194|FG001|STARTED|Overall Study||11
10443377|NCT00941681|11590195|FG002|STARTED|Overall Study||12
10443378|NCT00941681|11590193|FG000|COMPLETED|Overall Study||12
10443379|NCT00941681|11590194|FG001|COMPLETED|Overall Study||10
10443380|NCT00941681|11590195|FG002|COMPLETED|Overall Study||12
10443381|NCT00941681|11590193|FG000|NOT COMPLETED|Overall Study||0
10443382|NCT00941681|11590194|FG001|NOT COMPLETED|Overall Study||1
10443383|NCT00941681|11590195|FG002|NOT COMPLETED|Overall Study||0
10443384|NCT00941720|11590203|FG000|STARTED|Overall Study||71
10443385|NCT00941720|11590203|FG000|COMPLETED|Overall Study||57
10443386|NCT00941720|11590203|FG000|NOT COMPLETED|Overall Study||14
10443387|NCT00941733|11590209|FG000|STARTED|Overall Study||239
10443388|NCT00941733|11590210|FG001|STARTED|Overall Study||119
10443389|NCT00941733|11590209|FG000|COMPLETED|Overall Study|1 year follow-up|165
10443390|NCT00941733|11590210|FG001|COMPLETED|Overall Study|1 year follow-up|91
10443391|NCT00941733|11590209|FG000|NOT COMPLETED|Overall Study||74
10443392|NCT00941733|11590210|FG001|NOT COMPLETED|Overall Study||28
10443393|NCT00941798|11590218|FG000|STARTED|Overall Study||755
10443394|NCT00941798|11590219|FG001|STARTED|Overall Study||763
10443395|NCT00941798|11590218|FG000|Full Analysis Set|Overall Study||749
10443396|NCT00941798|11590219|FG001|Full Analysis Set|Overall Study||759
10443397|NCT00941798|11590218|FG000|COMPLETED|Overall Study||561
10443398|NCT00941798|11590219|FG001|COMPLETED|Overall Study||578
10443399|NCT00941798|11590218|FG000|NOT COMPLETED|Overall Study||194
10443400|NCT00941798|11590219|FG001|NOT COMPLETED|Overall Study||185
10443401|NCT00941863|11590230|FG000|STARTED|Until Primary Completion Date (PCD)||7
10443402|NCT00941863|11590231|FG001|STARTED|Until Primary Completion Date (PCD)||3
10443403|NCT00941863|11590232|FG002|STARTED|Until Primary Completion Date (PCD)||12
10443404|NCT00941863|11590233|FG003|STARTED|Until Primary Completion Date (PCD)||17
10443405|NCT00941863|11590234|FG004|STARTED|Until Primary Completion Date (PCD)||119
10443406|NCT00941863|11590230|FG000|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||7
10443407|NCT00941863|11590231|FG001|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||3
10443408|NCT00941863|11590232|FG002|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||12
10443409|NCT00941863|11590233|FG003|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||17
10443410|NCT00941863|11590234|FG004|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||94
10443411|NCT00941863|11590230|FG000|COMPLETED|Until Primary Completion Date (PCD)||0
10443412|NCT00941863|11590231|FG001|COMPLETED|Until Primary Completion Date (PCD)||0
10443413|NCT00941863|11590232|FG002|COMPLETED|Until Primary Completion Date (PCD)||0
10443414|NCT00941863|11590233|FG003|COMPLETED|Until Primary Completion Date (PCD)||0
10443415|NCT00941863|11590234|FG004|COMPLETED|Until Primary Completion Date (PCD)||25
10443416|NCT00941863|11590230|FG000|NOT COMPLETED|Until Primary Completion Date (PCD)||7
10443417|NCT00941863|11590231|FG001|NOT COMPLETED|Until Primary Completion Date (PCD)||3
10443418|NCT00941863|11590232|FG002|NOT COMPLETED|Until Primary Completion Date (PCD)||12
10443419|NCT00941863|11590233|FG003|NOT COMPLETED|Until Primary Completion Date (PCD)||17
10443420|NCT00941863|11590234|FG004|NOT COMPLETED|Until Primary Completion Date (PCD)||94
10443421|NCT00941863|11590230|FG000|STARTED|Continued After PCD||0
10443422|NCT00941863|11590231|FG001|STARTED|Continued After PCD||0
10443423|NCT00941863|11590232|FG002|STARTED|Continued After PCD||0
10443424|NCT00941863|11590233|FG003|STARTED|Continued After PCD||0
10443425|NCT00941863|11590234|FG004|STARTED|Continued After PCD|25 of 119 participants from the Expansion Phase, were still on the treatment as of 31 May 2005.|25
10443426|NCT00941863|11590230|FG000|COMPLETED|Continued After PCD||0
10443427|NCT00941863|11590231|FG001|COMPLETED|Continued After PCD||0
10443428|NCT00941863|11590232|FG002|COMPLETED|Continued After PCD||0
10443429|NCT00941863|11590233|FG003|COMPLETED|Continued After PCD||0
10443430|NCT00941863|11590234|FG004|COMPLETED|Continued After PCD||6
10443431|NCT00941863|11590230|FG000|NOT COMPLETED|Continued After PCD||0
10443432|NCT00941863|11590231|FG001|NOT COMPLETED|Continued After PCD||0
10789530|NCT03522441|11949982|FG000|STARTED|Overall Study||450
10789531|NCT03522441|11949983|FG001|STARTED|Overall Study||450
10789532|NCT03522441|11949984|FG002|STARTED|Overall Study||225
10789533|NCT03522441|11949982|FG000|COMPLETED|Overall Study||424
10789534|NCT03522441|11949983|FG001|COMPLETED|Overall Study||431
10443433|NCT00941863|11590232|FG002|NOT COMPLETED|Continued After PCD||0
10443434|NCT00941863|11590233|FG003|NOT COMPLETED|Continued After PCD||0
10443435|NCT00941863|11590234|FG004|NOT COMPLETED|Continued After PCD||19
10443436|NCT00941889|11590252|FG000|STARTED|Overall Study||17
10443437|NCT00941889|11590253|FG001|STARTED|Overall Study||15
10443438|NCT00941889|11590252|FG000|COMPLETED|Overall Study||5
10443439|NCT00941889|11590253|FG001|COMPLETED|Overall Study||3
10443440|NCT00941889|11590252|FG000|NOT COMPLETED|Overall Study||12
10443441|NCT00941889|11590253|FG001|NOT COMPLETED|Overall Study||12
10443442|NCT00941993|11590259|FG000|STARTED|Overall Study||109
10443443|NCT00941993|11590259|FG000|COMPLETED|Overall Study||109
10443444|NCT00941993|11590259|FG000|NOT COMPLETED|Overall Study||0
10443445|NCT00942084|11590264|FG000|STARTED|Overall Study||32
10443446|NCT00942084|11590264|FG000|COMPLETED|Overall Study|There were 2 infant deaths. None determined to be related to study drug.|30
10443447|NCT00942084|11590264|FG000|NOT COMPLETED|Overall Study||2
10443448|NCT00942149|11590268|FG000|STARTED|Overall Study||20
10443449|NCT00942149|11590268|FG000|COMPLETED|Overall Study||20
10443450|NCT00942149|11590268|FG000|NOT COMPLETED|Overall Study||0
10443451|NCT00942162|11590275|FG000|STARTED|Overall Study||71
10443452|NCT00942162|11590276|FG001|STARTED|Overall Study||50
10443453|NCT00942162|11590277|FG002|STARTED|Overall Study||2
10443454|NCT00942162|11590275|FG000|COMPLETED|Overall Study||1
10443455|NCT00942162|11590276|FG001|COMPLETED|Overall Study||0
10443456|NCT00942162|11590277|FG002|COMPLETED|Overall Study||0
10443457|NCT00942162|11590275|FG000|NOT COMPLETED|Overall Study||70
10443458|NCT00942162|11590276|FG001|NOT COMPLETED|Overall Study||50
10443459|NCT00942162|11590277|FG002|NOT COMPLETED|Overall Study||2
10443460|NCT00942175|11590291|FG000|STARTED|Overall Study||40
10443461|NCT00942175|11590292|FG001|STARTED|Overall Study||40
10443462|NCT00942175|11590293|FG002|STARTED|Overall Study||40
10443463|NCT00942175|11590294|FG003|STARTED|Overall Study||40
10443464|NCT00942175|11590291|FG000|COMPLETED|Overall Study||38
10443465|NCT00942175|11590292|FG001|COMPLETED|Overall Study||36
10443466|NCT00942175|11590293|FG002|COMPLETED|Overall Study||38
10443467|NCT00942175|11590294|FG003|COMPLETED|Overall Study||38
10443468|NCT00942175|11590291|FG000|NOT COMPLETED|Overall Study||2
10443469|NCT00942175|11590292|FG001|NOT COMPLETED|Overall Study||4
10443470|NCT00942175|11590293|FG002|NOT COMPLETED|Overall Study||2
10443471|NCT00942175|11590294|FG003|NOT COMPLETED|Overall Study||2
10443472|NCT00942188|11590316|FG000|STARTED|Overall Study||26
10443473|NCT00942188|11590317|FG001|STARTED|Overall Study||26
10443474|NCT00942188|11590318|FG002|STARTED|Overall Study||27
10443475|NCT00942188|11590319|FG003|STARTED|Overall Study||27
10443476|NCT00942188|11590316|FG000|COMPLETED|Overall Study||22
10443477|NCT00942188|11590317|FG001|COMPLETED|Overall Study||16
10443478|NCT00942188|11590318|FG002|COMPLETED|Overall Study||18
10443479|NCT00942188|11590319|FG003|COMPLETED|Overall Study||23
10443480|NCT00942188|11590316|FG000|NOT COMPLETED|Overall Study||4
10443481|NCT00942188|11590317|FG001|NOT COMPLETED|Overall Study||10
10443482|NCT00942188|11590318|FG002|NOT COMPLETED|Overall Study||9
10443483|NCT00942188|11590319|FG003|NOT COMPLETED|Overall Study||4
10443484|NCT00942266|11590331|FG000|STARTED|Overall Study||43
10443485|NCT00942266|11590332|FG001|STARTED|Overall Study||15
10443486|NCT00942266|11590331|FG000|COMPLETED|Overall Study||0
10443487|NCT00942266|11590332|FG001|COMPLETED|Overall Study||0
10443488|NCT00942266|11590331|FG000|NOT COMPLETED|Overall Study||43
10443489|NCT00942266|11590332|FG001|NOT COMPLETED|Overall Study||15
10443490|NCT00942305|11590348|FG000|STARTED|Overall Study||30
10443491|NCT00942305|11590349|FG001|STARTED|Overall Study||10
10443492|NCT00942305|11590350|FG002|STARTED|Overall Study||29
10789535|NCT03522441|11949984|FG002|COMPLETED|Overall Study||214
10443493|NCT00942305|11590351|FG003|STARTED|Overall Study||10
10443494|NCT00942305|11590352|FG004|STARTED|Overall Study||39
10443495|NCT00942305|11590353|FG005|STARTED|Overall Study||14
10443496|NCT00942305|11590354|FG006|STARTED|Overall Study||30
10443497|NCT00942305|11590355|FG007|STARTED|Overall Study||10
10443498|NCT00942305|11590356|FG008|STARTED|Overall Study||50
10443499|NCT00942305|11590357|FG009|STARTED|Overall Study||17
10443500|NCT00942305|11590348|FG000|COMPLETED|Overall Study||7
10443501|NCT00942305|11590349|FG001|COMPLETED|Overall Study||5
10443502|NCT00942305|11590350|FG002|COMPLETED|Overall Study||14
10443503|NCT00942305|11590351|FG003|COMPLETED|Overall Study||4
10443504|NCT00942305|11590352|FG004|COMPLETED|Overall Study||14
10443505|NCT00942305|11590353|FG005|COMPLETED|Overall Study||9
10443506|NCT00942305|11590354|FG006|COMPLETED|Overall Study||6
10443507|NCT00942305|11590355|FG007|COMPLETED|Overall Study||5
10443508|NCT00942305|11590356|FG008|COMPLETED|Overall Study||25
10443509|NCT00942305|11590357|FG009|COMPLETED|Overall Study||7
10443510|NCT00942305|11590348|FG000|NOT COMPLETED|Overall Study||23
10443511|NCT00942305|11590349|FG001|NOT COMPLETED|Overall Study||5
10443512|NCT00942305|11590350|FG002|NOT COMPLETED|Overall Study||15
10443513|NCT00942305|11590351|FG003|NOT COMPLETED|Overall Study||6
10443514|NCT00942305|11590352|FG004|NOT COMPLETED|Overall Study||25
10443515|NCT00942305|11590353|FG005|NOT COMPLETED|Overall Study||5
10443516|NCT00942305|11590354|FG006|NOT COMPLETED|Overall Study||24
10443517|NCT00942305|11590355|FG007|NOT COMPLETED|Overall Study||5
10443518|NCT00942305|11590356|FG008|NOT COMPLETED|Overall Study||25
10443519|NCT00942305|11590357|FG009|NOT COMPLETED|Overall Study||10
10443520|NCT00942357|11590381|FG000|STARTED|Overall Study||407
10443521|NCT00942357|11590382|FG001|STARTED|Overall Study||406
10443522|NCT00942357|11590381|FG000|COMPLETED|Overall Study||370
10443523|NCT00942357|11590382|FG001|COMPLETED|Overall Study||366
10443524|NCT00942357|11590381|FG000|NOT COMPLETED|Overall Study||37
10443525|NCT00942357|11590382|FG001|NOT COMPLETED|Overall Study||40
10443526|NCT00942422|11590388|FG000|STARTED|Overall Study||8
10443527|NCT00942422|11590388|FG000|COMPLETED|Overall Study||5
10443528|NCT00942422|11590388|FG000|NOT COMPLETED|Overall Study||3
10443529|NCT00942448|11590396|FG000|STARTED|Overall Study||77
10443530|NCT00942448|11590397|FG001|STARTED|Overall Study||76
10443531|NCT00942448|11590398|FG002|STARTED|Overall Study||78
10443532|NCT00942448|11590399|FG003|STARTED|Overall Study||75
10443533|NCT00942448|11590396|FG000|COMPLETED|Overall Study||77
10443534|NCT00942448|11590397|FG001|COMPLETED|Overall Study||76
10443535|NCT00942448|11590398|FG002|COMPLETED|Overall Study||78
10443536|NCT00942448|11590399|FG003|COMPLETED|Overall Study||75
10443537|NCT00942448|11590396|FG000|NOT COMPLETED|Overall Study||0
10443538|NCT00942448|11590397|FG001|NOT COMPLETED|Overall Study||0
10443539|NCT00942448|11590398|FG002|NOT COMPLETED|Overall Study||0
10443540|NCT00942448|11590399|FG003|NOT COMPLETED|Overall Study||0
10443541|NCT00942578|11590416|FG000|STARTED|Dose Escalation Phase||3
10443542|NCT00942578|11590417|FG001|STARTED|Dose Escalation Phase||3
10443543|NCT00942578|11590418|FG002|STARTED|Dose Escalation Phase||3
10443544|NCT00942578|11590416|FG000|COMPLETED|Dose Escalation Phase||3
10443545|NCT00942578|11590417|FG001|COMPLETED|Dose Escalation Phase||3
10443546|NCT00942578|11590418|FG002|COMPLETED|Dose Escalation Phase||3
10443547|NCT00942578|11590416|FG000|NOT COMPLETED|Dose Escalation Phase||0
10443548|NCT00942578|11590417|FG001|NOT COMPLETED|Dose Escalation Phase||0
10443549|NCT00942578|11590418|FG002|NOT COMPLETED|Dose Escalation Phase||0
10443550|NCT00942578|11590416|FG000|STARTED|Expansion Phase||11
10443551|NCT00942578|11590417|FG001|STARTED|Expansion Phase||0
10443552|NCT00942578|11590418|FG002|STARTED|Expansion Phase||43
10443553|NCT00942578|11590416|FG000|COMPLETED|Expansion Phase||11
10443554|NCT00942578|11590417|FG001|COMPLETED|Expansion Phase||0
10443555|NCT00942578|11590418|FG002|COMPLETED|Expansion Phase||43
10443556|NCT00942578|11590416|FG000|NOT COMPLETED|Expansion Phase||0
10443557|NCT00942578|11590417|FG001|NOT COMPLETED|Expansion Phase||0
10443558|NCT00942578|11590418|FG002|NOT COMPLETED|Expansion Phase||0
10443559|NCT00942604|11590433|FG000|STARTED|Overall Study||100
10443560|NCT00942604|11590434|FG001|STARTED|Overall Study||103
10443561|NCT00942604|11590433|FG000|COMPLETED|Overall Study||98
10443562|NCT00942604|11590434|FG001|COMPLETED|Overall Study||99
10443563|NCT00942604|11590433|FG000|NOT COMPLETED|Overall Study||2
10443564|NCT00942604|11590434|FG001|NOT COMPLETED|Overall Study||4
10443565|NCT00942708|11590440|FG000|STARTED|Overall Study||6
10443566|NCT00942708|11590440|FG000|COMPLETED|Overall Study||5
10443567|NCT00942708|11590440|FG000|NOT COMPLETED|Overall Study||1
10443568|NCT00942734|11590445|FG000|STARTED|Overall Study||43
10443569|NCT00942734|11590445|FG000|COMPLETED|Overall Study||35
10443570|NCT00942734|11590445|FG000|NOT COMPLETED|Overall Study||8
10443571|NCT00942786|11590449|FG000|STARTED|Overall Study||297
10443572|NCT00942786|11590449|FG000|COMPLETED|Overall Study|date of last follow-up|297
10443573|NCT00942786|11590449|FG000|NOT COMPLETED|Overall Study||0
10443574|NCT00942825|11590458|FG000|STARTED|Overall Study||97
10443575|NCT00942825|11590459|FG001|STARTED|Overall Study||98
10443576|NCT00942825|11590458|FG000|COMPLETED|Overall Study||97
10443577|NCT00942825|11590459|FG001|COMPLETED|Overall Study||98
10443578|NCT00942825|11590458|FG000|NOT COMPLETED|Overall Study||0
10443579|NCT00942825|11590459|FG001|NOT COMPLETED|Overall Study||0
10443580|NCT00942851|11590467|FG000|STARTED|Overall Study||12
10443581|NCT00942851|11590468|FG001|STARTED|Overall Study||12
10443582|NCT00942851|11590467|FG000|COMPLETED|Overall Study||12
10443583|NCT00942851|11590468|FG001|COMPLETED|Overall Study||11
10443584|NCT00942851|11590467|FG000|NOT COMPLETED|Overall Study||0
10443585|NCT00942851|11590468|FG001|NOT COMPLETED|Overall Study||1
10443586|NCT00942890|11590480|FG000|STARTED|Overall Study||21
10443587|NCT00942890|11590481|FG001|STARTED|Overall Study||23
10443588|NCT00942890|11590480|FG000|COMPLETED|Overall Study||21
10443589|NCT00942890|11590481|FG001|COMPLETED|Overall Study||23
10443590|NCT00942890|11590480|FG000|NOT COMPLETED|Overall Study||0
10443591|NCT00942890|11590481|FG001|NOT COMPLETED|Overall Study||0
10443592|NCT00942903|11590488|FG000|STARTED|Overall Study||20
10443593|NCT00942903|11590488|FG000|COMPLETED|Overall Study||20
10443594|NCT00942903|11590488|FG000|NOT COMPLETED|Overall Study||0
10443595|NCT00942968|11590492|FG000|STARTED|Overall Study||338
10443596|NCT00942968|11590492|FG000|Treated|Overall Study||334
10443597|NCT00942968|11590492|FG000|COMPLETED|Overall Study||109
10443598|NCT00942968|11590492|FG000|NOT COMPLETED|Overall Study||229
10443599|NCT00942994|11590498|FG000|STARTED|Overall Study||203
10443600|NCT00942994|11590499|FG001|STARTED|Overall Study||209
10443601|NCT00942994|11590498|FG000|COMPLETED|Overall Study||187
10443602|NCT00942994|11590499|FG001|COMPLETED|Overall Study||190
10443603|NCT00942994|11590498|FG000|NOT COMPLETED|Overall Study||16
10443604|NCT00942994|11590499|FG001|NOT COMPLETED|Overall Study||19
10443605|NCT00943072|11590507|FG000|STARTED|Overall Study||115
10443606|NCT00943072|11590508|FG001|STARTED|Overall Study||74
10443607|NCT00943072|11590507|FG000|Participants Received Treatment|Overall Study|Safety population (SAF)|114
10443608|NCT00943072|11590508|FG001|Participants Received Treatment|Overall Study||74
10443609|NCT00943072|11590507|FG000|Full Analysis Set (FAS) Population|Overall Study|FAS population used for analysis of Primary and Secondary Outcome Measures|114
10443610|NCT00943072|11590508|FG001|Full Analysis Set (FAS) Population|Overall Study||73
10443611|NCT00943072|11590507|FG000|COMPLETED|Overall Study|110 Participants completed Week 24, From FAS; 102 Participants completed up to Week 100, From SAF|110
10443612|NCT00943072|11590508|FG001|COMPLETED|Overall Study|60 Participants completed Week 24, From FAS; 50 Participants completed up to Week 100, From SAF|60
10443613|NCT00943072|11590507|FG000|NOT COMPLETED|Overall Study||5
10443614|NCT00943072|11590508|FG001|NOT COMPLETED|Overall Study||14
10443615|NCT00943098|11590518|FG000|STARTED|Overall Study||70
10443616|NCT00943098|11590519|FG001|STARTED|Overall Study|1 patient was excluded from the ITT and therefore the baseline population is 71|72
10443617|NCT00943098|11590518|FG000|COMPLETED|Overall Study||70
10443618|NCT00943098|11590519|FG001|COMPLETED|Overall Study||72
10443619|NCT00943098|11590518|FG000|NOT COMPLETED|Overall Study||0
10443620|NCT00943098|11590519|FG001|NOT COMPLETED|Overall Study||0
10443621|NCT00943111|11590527|FG000|STARTED|52-Weeks Primary Analysis Period||106
10443622|NCT00943111|11590528|FG001|STARTED|52-Weeks Primary Analysis Period||54
10443623|NCT00943111|11590529|FG002|STARTED|52-Weeks Primary Analysis Period||0
10443624|NCT00943111|11590527|FG000|Treated|52-Weeks Primary Analysis Period||106
10650487|NCT02169479|11810753|FG001|100 mg BIA 9-1067|Overall Study||4
10443625|NCT00943111|11590528|FG001|Treated|52-Weeks Primary Analysis Period||53
10443626|NCT00943111|11590529|FG002|Treated|52-Weeks Primary Analysis Period||0
10443627|NCT00943111|11590527|FG000|COMPLETED|52-Weeks Primary Analysis Period||104
10443628|NCT00943111|11590528|FG001|COMPLETED|52-Weeks Primary Analysis Period||52
10443629|NCT00943111|11590529|FG002|COMPLETED|52-Weeks Primary Analysis Period||0
10443630|NCT00943111|11590527|FG000|NOT COMPLETED|52-Weeks Primary Analysis Period||2
10443631|NCT00943111|11590528|FG001|NOT COMPLETED|52-Weeks Primary Analysis Period||2
10443632|NCT00943111|11590529|FG002|NOT COMPLETED|52-Weeks Primary Analysis Period||0
10443633|NCT00943111|11590527|FG000|STARTED|5 Years Long-term Treatment Period||0
10443634|NCT00943111|11590528|FG001|STARTED|5 Years Long-term Treatment Period||0
10443635|NCT00943111|11590529|FG002|STARTED|5 Years Long-term Treatment Period|Participants from both the arms of PAP who completed PAP and remained on-study|152
10443636|NCT00943111|11590527|FG000|COMPLETED|5 Years Long-term Treatment Period||0
10443637|NCT00943111|11590528|FG001|COMPLETED|5 Years Long-term Treatment Period||0
10443638|NCT00943111|11590529|FG002|COMPLETED|5 Years Long-term Treatment Period||77
10443639|NCT00943111|11590527|FG000|NOT COMPLETED|5 Years Long-term Treatment Period||0
10443640|NCT00943111|11590528|FG001|NOT COMPLETED|5 Years Long-term Treatment Period||0
10443641|NCT00943111|11590529|FG002|NOT COMPLETED|5 Years Long-term Treatment Period||75
10443642|NCT00943124|11590536|FG000|STARTED|Period 1||110
10443643|NCT00943124|11590537|FG001|STARTED|Period 1||110
10443644|NCT00943124|11590536|FG000|COMPLETED|Period 1||108
10443645|NCT00943124|11590537|FG001|COMPLETED|Period 1||108
10443646|NCT00943124|11590536|FG000|NOT COMPLETED|Period 1||2
10443647|NCT00943124|11590537|FG001|NOT COMPLETED|Period 1||2
10443648|NCT00943124|11590536|FG000|STARTED|Period 2||108
10443649|NCT00943124|11590537|FG001|STARTED|Period 2||108
10443650|NCT00943124|11590536|FG000|COMPLETED|Period 2||108
10443651|NCT00943124|11590537|FG001|COMPLETED|Period 2||108
10443652|NCT00943124|11590536|FG000|NOT COMPLETED|Period 2||0
10443653|NCT00943124|11590537|FG001|NOT COMPLETED|Period 2||0
10443654|NCT00943150|11590545|FG000|STARTED|Overall Study||10
10443655|NCT00943150|11590546|FG001|STARTED|Overall Study||10
10443656|NCT00943150|11590545|FG000|COMPLETED|Overall Study||10
10443657|NCT00943150|11590546|FG001|COMPLETED|Overall Study||10
10443658|NCT00943150|11590545|FG000|NOT COMPLETED|Overall Study||0
10443659|NCT00943150|11590546|FG001|NOT COMPLETED|Overall Study||0
10443660|NCT00943202|11590560|FG000|STARTED|Overall Study||133
10443661|NCT00943202|11590561|FG001|STARTED|Overall Study||133
10443662|NCT00943202|11590562|FG002|STARTED|Overall Study||133
10443663|NCT00943202|11590563|FG003|STARTED|Overall Study||132
10443664|NCT00943202|11590560|FG000|COMPLETED|Overall Study||132
10443665|NCT00943202|11590561|FG001|COMPLETED|Overall Study||131
10443666|NCT00943202|11590562|FG002|COMPLETED|Overall Study||133
10443667|NCT00943202|11590563|FG003|COMPLETED|Overall Study||131
10443668|NCT00943202|11590560|FG000|NOT COMPLETED|Overall Study||1
10443669|NCT00943202|11590561|FG001|NOT COMPLETED|Overall Study||2
10443670|NCT00943202|11590562|FG002|NOT COMPLETED|Overall Study||0
10443671|NCT00943202|11590563|FG003|NOT COMPLETED|Overall Study||1
10443672|NCT00943306|11590574|FG000|STARTED|Overall Study||19
10443673|NCT00943306|11590574|FG000|COMPLETED|Overall Study||16
10443674|NCT00943306|11590574|FG000|NOT COMPLETED|Overall Study||3
10443675|NCT00943319|11590578|FG000|STARTED|Overall Study||50
10443676|NCT00943319|11590578|FG000|COMPLETED|Overall Study||49
10443677|NCT00943319|11590578|FG000|NOT COMPLETED|Overall Study||1
10443678|NCT00943384|11590582|FG000|STARTED|Overall Study|104 subjects consented and underwent additional screening to determine eligibility to participate|104
10443679|NCT00943384|11590582|FG000|Treated|Overall Study|81 subjects were eligible and willing to participate in the study and were treated|81
10443731|NCT00943761|11590651|FG001|COMPLETED|Overall Study||23
10443732|NCT00943761|11590650|FG000|NOT COMPLETED|Overall Study||4
10443680|NCT00943384|11590582|FG000|Treated on Protocol|Overall Study|5 subjects were treated off protocol due to intraoperative decisions made by the surgeon|76
10443681|NCT00943384|11590582|FG000|COMPLETED|Overall Study|evaluated at the Month 24 visit with complete or partial data|55
10443682|NCT00943384|11590582|FG000|NOT COMPLETED|Overall Study||49
10443683|NCT00943436|11590588|FG000|STARTED|Exercise Session: 45 Minutes of Activity||10
10443684|NCT00943436|11590589|FG001|STARTED|Exercise Session: 45 Minutes of Activity||10
10443685|NCT00943436|11590588|FG000|COMPLETED|Exercise Session: 45 Minutes of Activity||10
10443686|NCT00943436|11590589|FG001|COMPLETED|Exercise Session: 45 Minutes of Activity||10
10443687|NCT00943436|11590588|FG000|NOT COMPLETED|Exercise Session: 45 Minutes of Activity||0
10443688|NCT00943436|11590589|FG001|NOT COMPLETED|Exercise Session: 45 Minutes of Activity||0
10443689|NCT00943436|11590588|FG000|STARTED|Rest Session: 45 Minutes of Reading||10
10443690|NCT00943436|11590589|FG001|STARTED|Rest Session: 45 Minutes of Reading||10
10443691|NCT00943436|11590588|FG000|COMPLETED|Rest Session: 45 Minutes of Reading||10
10443692|NCT00943436|11590589|FG001|COMPLETED|Rest Session: 45 Minutes of Reading||10
10443693|NCT00943436|11590588|FG000|NOT COMPLETED|Rest Session: 45 Minutes of Reading||0
10443694|NCT00943436|11590589|FG001|NOT COMPLETED|Rest Session: 45 Minutes of Reading||0
10443695|NCT00943488|11590597|FG000|STARTED|Overall Study||204
10443696|NCT00943488|11590598|FG001|STARTED|Overall Study||204
10443697|NCT00943488|11590597|FG000|COMPLETED|Overall Study||203
10443698|NCT00943488|11590598|FG001|COMPLETED|Overall Study||202
10443699|NCT00943488|11590597|FG000|NOT COMPLETED|Overall Study||1
10443700|NCT00943488|11590598|FG001|NOT COMPLETED|Overall Study||2
10443701|NCT00943579|11590606|FG000|STARTED|Overall Study||21
10443702|NCT00943579|11590607|FG001|STARTED|Overall Study||20
10443703|NCT00943579|11590606|FG000|COMPLETED|Overall Study||15
10443704|NCT00943579|11590607|FG001|COMPLETED|Overall Study||15
10443705|NCT00943579|11590606|FG000|NOT COMPLETED|Overall Study||6
10443706|NCT00943579|11590607|FG001|NOT COMPLETED|Overall Study||5
10443707|NCT00943592|11590616|FG000|STARTED|Overall Study||82
10443708|NCT00943592|11590616|FG000|Maximum Tolerated Dose|Overall Study|74 patients received the Maximum Tolerated Dose|74
10443709|NCT00943592|11590616|FG000|COMPLETED|Overall Study|None of the three deaths were attributed to the conditioning regimen|79
10443710|NCT00943592|11590616|FG000|NOT COMPLETED|Overall Study||3
10443711|NCT00943631|11590622|FG000|STARTED|Overall Study||202
10443712|NCT00943631|11590623|FG001|STARTED|Overall Study||204
10443713|NCT00943631|11590622|FG000|COMPLETED|Overall Study||198
10443714|NCT00943631|11590623|FG001|COMPLETED|Overall Study||202
10443715|NCT00943631|11590622|FG000|NOT COMPLETED|Overall Study||4
10550531|NCT01532973|11704737|FG003|STARTED|Part 1|Planned panel not performed. No participants were enrolled.|0
10550532|NCT01532973|11704738|FG004|STARTED|Part 1||0
10550533|NCT01532973|11704739|FG005|STARTED|Part 1||0
10550534|NCT01532973|11704740|FG006|STARTED|Part 1||0
10443716|NCT00943631|11590623|FG001|NOT COMPLETED|Overall Study||2
10443717|NCT00943670|11590629|FG000|STARTED|Single-agent Trastuzumab Emtansine||51
10443718|NCT00943670|11590629|FG000|Treated|Single-agent Trastuzumab Emtansine||51
10443719|NCT00943670|11590629|FG000|COMPLETED|Single-agent Trastuzumab Emtansine|Completed single-agent treatment defined as receiving 17 cycles of trastuzumab emtansine therapy.|9
10443720|NCT00943670|11590629|FG000|NOT COMPLETED|Single-agent Trastuzumab Emtansine||42
10443721|NCT00943670|11590629|FG000|STARTED|Trastuzumab Emtansine + Pertuzumab|Patients with early progressive disease who elected to receive T-DM1 and pertuzumab.|20
10443722|NCT00943670|11590629|FG000|COMPLETED|Trastuzumab Emtansine + Pertuzumab|Completed treatment defined as receiving a total of 17 cycles of therapy in both treatment periods.|2
10443723|NCT00943670|11590629|FG000|NOT COMPLETED|Trastuzumab Emtansine + Pertuzumab||18
10443724|NCT00943735|11590644|FG000|STARTED|Overall Study||774
10443725|NCT00943735|11590644|FG000|Per Protocol Population|Overall Study||500
10443726|NCT00943735|11590644|FG000|COMPLETED|Overall Study||742
10550535|NCT01532973|11704741|FG007|STARTED|Part 1||0
10550536|NCT01532973|11704742|FG008|STARTED|Part 1||0
10550537|NCT01532973|11704743|FG009|STARTED|Part 1||0
10550538|NCT01532973|11704734|FG000|COMPLETED|Part 1||6
10550539|NCT01532973|11704735|FG001|COMPLETED|Part 1||6
10550540|NCT01532973|11704736|FG002|COMPLETED|Part 1||6
10550541|NCT01532973|11704737|FG003|COMPLETED|Part 1||0
10550542|NCT01532973|11704738|FG004|COMPLETED|Part 1||0
10550543|NCT01532973|11704739|FG005|COMPLETED|Part 1||0
10550544|NCT01532973|11704740|FG006|COMPLETED|Part 1||0
10550545|NCT01532973|11704741|FG007|COMPLETED|Part 1||0
10550546|NCT01532973|11704742|FG008|COMPLETED|Part 1||0
10550547|NCT01532973|11704743|FG009|COMPLETED|Part 1||0
10550548|NCT01532973|11704734|FG000|NOT COMPLETED|Part 1||0
10550549|NCT01532973|11704735|FG001|NOT COMPLETED|Part 1||0
10550550|NCT01532973|11704736|FG002|NOT COMPLETED|Part 1||0
10550551|NCT01532973|11704737|FG003|NOT COMPLETED|Part 1||0
10550552|NCT01532973|11704738|FG004|NOT COMPLETED|Part 1||0
10550553|NCT01532973|11704739|FG005|NOT COMPLETED|Part 1||0
10550554|NCT01532973|11704740|FG006|NOT COMPLETED|Part 1||0
10550555|NCT01532973|11704741|FG007|NOT COMPLETED|Part 1||0
10550556|NCT01532973|11704742|FG008|NOT COMPLETED|Part 1||0
10443727|NCT00943735|11590644|FG000|NOT COMPLETED|Overall Study||32
10550557|NCT01532973|11704743|FG009|NOT COMPLETED|Part 1||0
10550558|NCT01532973|11704734|FG000|STARTED|Part 2||0
10550559|NCT01532973|11704735|FG001|STARTED|Part 2||0
10550560|NCT01532973|11704736|FG002|STARTED|Part 2||0
10550561|NCT01532973|11704737|FG003|STARTED|Part 2||0
10550562|NCT01532973|11704738|FG004|STARTED|Part 2||6
10550563|NCT01532973|11704739|FG005|STARTED|Part 2||6
10550564|NCT01532973|11704740|FG006|STARTED|Part 2||6
10443728|NCT00943761|11590650|FG000|STARTED|Overall Study||21
10443729|NCT00943761|11590651|FG001|STARTED|Overall Study||24
10443730|NCT00943761|11590650|FG000|COMPLETED|Overall Study||17
10443733|NCT00943761|11590651|FG001|NOT COMPLETED|Overall Study||1
10443734|NCT00943787|11590657|FG000|STARTED|Overall Study||41
10443735|NCT00943787|11590657|FG000|COMPLETED|Overall Study||34
10443736|NCT00943787|11590657|FG000|NOT COMPLETED|Overall Study||7
10443737|NCT00943800|11590661|FG000|STARTED|Overall Study||87
10443738|NCT00943800|11590661|FG000|COMPLETED|Overall Study||87
10443739|NCT00943800|11590661|FG000|NOT COMPLETED|Overall Study||0
10443740|NCT00943826|11590667|FG000|STARTED|Concurrent Phase||458
10443741|NCT00943826|11590668|FG001|STARTED|Concurrent Phase||463
10443742|NCT00943826|11590667|FG000|Treated|Concurrent Phase||452
10443743|NCT00943826|11590668|FG001|Treated|Concurrent Phase||459
10443744|NCT00943826|11590667|FG000|COMPLETED|Concurrent Phase||397
10443745|NCT00943826|11590668|FG001|COMPLETED|Concurrent Phase||421
10443746|NCT00943826|11590667|FG000|NOT COMPLETED|Concurrent Phase||61
10443747|NCT00943826|11590668|FG001|NOT COMPLETED|Concurrent Phase||42
10443748|NCT00943826|11590667|FG000|STARTED|Maintenance Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|396
10443749|NCT00943826|11590668|FG001|STARTED|Maintenance Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|370
10443750|NCT00943826|11590667|FG000|COMPLETED|Maintenance Phase||353
10443751|NCT00943826|11590668|FG001|COMPLETED|Maintenance Phase||331
10443752|NCT00943826|11590667|FG000|NOT COMPLETED|Maintenance Phase||43
10443753|NCT00943826|11590668|FG001|NOT COMPLETED|Maintenance Phase||39
10443754|NCT00943826|11590667|FG000|STARTED|Monotherapy Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|269
10443755|NCT00943826|11590668|FG001|STARTED|Monotherapy Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|159
10443756|NCT00943826|11590667|FG000|COMPLETED|Monotherapy Phase||204
10443757|NCT00943826|11590668|FG001|COMPLETED|Monotherapy Phase||143
10443758|NCT00943826|11590667|FG000|NOT COMPLETED|Monotherapy Phase||65
10443759|NCT00943826|11590668|FG001|NOT COMPLETED|Monotherapy Phase||16
10443760|NCT00943826|11590667|FG000|STARTED|After Primary Overall Survival Analysis|Some who completed previous period had discontinued, progressed, or died prior to this period.|27
10443761|NCT00943826|11590668|FG001|STARTED|After Primary Overall Survival Analysis|Some who completed previous period had discontinued, progressed, or died prior to this period.|20
10443762|NCT00943826|11590667|FG000|COMPLETED|After Primary Overall Survival Analysis||0
10443763|NCT00943826|11590668|FG001|COMPLETED|After Primary Overall Survival Analysis||0
10443764|NCT00943826|11590667|FG000|NOT COMPLETED|After Primary Overall Survival Analysis||27
10443765|NCT00943826|11590668|FG001|NOT COMPLETED|After Primary Overall Survival Analysis||20
10443766|NCT00943878|11590679|FG000|STARTED|Overall Study||202
10443767|NCT00943878|11590680|FG001|STARTED|Overall Study||200
10443768|NCT00943878|11590681|FG002|STARTED|Overall Study||203
10443769|NCT00943878|11590682|FG003|STARTED|Overall Study||200
10443770|NCT00943878|11590679|FG000|COMPLETED|Overall Study||200
10443771|NCT00943878|11590680|FG001|COMPLETED|Overall Study||198
10443772|NCT00943878|11590681|FG002|COMPLETED|Overall Study||197
10443773|NCT00943878|11590682|FG003|COMPLETED|Overall Study||198
10443774|NCT00943878|11590679|FG000|NOT COMPLETED|Overall Study||2
10443775|NCT00943878|11590680|FG001|NOT COMPLETED|Overall Study||2
10443776|NCT00943878|11590681|FG002|NOT COMPLETED|Overall Study||6
10443777|NCT00943878|11590682|FG003|NOT COMPLETED|Overall Study||2
10443778|NCT00943904|11590692|FG000|STARTED|Overall Study||31
10443779|NCT00943904|11590692|FG000|COMPLETED|Overall Study||31
10443780|NCT00943904|11590692|FG000|NOT COMPLETED|Overall Study||0
10443781|NCT00943917|11590711|FG000|STARTED|Stage I||51
10443782|NCT00943917|11590712|FG001|STARTED|Stage I||51
10443783|NCT00943917|11590713|FG002|STARTED|Stage I||53
10443784|NCT00943917|11590714|FG003|STARTED|Stage I||0
10443785|NCT00943917|11590715|FG004|STARTED|Stage I||0
10443786|NCT00943917|11590716|FG005|STARTED|Stage I||0
10443787|NCT00943917|11590717|FG006|STARTED|Stage I||0
10443788|NCT00943917|11590718|FG007|STARTED|Stage I||0
10443789|NCT00943917|11590719|FG008|STARTED|Stage I||0
10443790|NCT00943917|11590720|FG009|STARTED|Stage I||0
10443791|NCT00943917|11590721|FG010|STARTED|Stage I||0
10443792|NCT00943917|11590722|FG011|STARTED|Stage I||0
10443793|NCT00943917|11590723|FG012|STARTED|Stage I||0
10443794|NCT00943917|11590724|FG013|STARTED|Stage I||0
10443795|NCT00943917|11590725|FG014|STARTED|Stage I||0
10443796|NCT00943917|11590711|FG000|COMPLETED|Stage I||47
10443797|NCT00943917|11590712|FG001|COMPLETED|Stage I||48
10443798|NCT00943917|11590713|FG002|COMPLETED|Stage I||47
10443799|NCT00943917|11590714|FG003|COMPLETED|Stage I||0
10443800|NCT00943917|11590715|FG004|COMPLETED|Stage I||0
10443801|NCT00943917|11590716|FG005|COMPLETED|Stage I||0
10443802|NCT00943917|11590717|FG006|COMPLETED|Stage I||0
10443803|NCT00943917|11590718|FG007|COMPLETED|Stage I||0
10443804|NCT00943917|11590719|FG008|COMPLETED|Stage I||0
10443805|NCT00943917|11590720|FG009|COMPLETED|Stage I||0
10443806|NCT00943917|11590721|FG010|COMPLETED|Stage I||0
10443807|NCT00943917|11590722|FG011|COMPLETED|Stage I||0
10443808|NCT00943917|11590723|FG012|COMPLETED|Stage I||0
10443809|NCT00943917|11590724|FG013|COMPLETED|Stage I||0
10443810|NCT00943917|11590725|FG014|COMPLETED|Stage I||0
10443811|NCT00943917|11590711|FG000|NOT COMPLETED|Stage I||4
10443812|NCT00943917|11590712|FG001|NOT COMPLETED|Stage I||3
10443813|NCT00943917|11590713|FG002|NOT COMPLETED|Stage I||6
10443814|NCT00943917|11590714|FG003|NOT COMPLETED|Stage I||0
10443815|NCT00943917|11590715|FG004|NOT COMPLETED|Stage I||0
10443816|NCT00943917|11590716|FG005|NOT COMPLETED|Stage I||0
10443817|NCT00943917|11590717|FG006|NOT COMPLETED|Stage I||0
10443818|NCT00943917|11590718|FG007|NOT COMPLETED|Stage I||0
10443819|NCT00943917|11590719|FG008|NOT COMPLETED|Stage I||0
10443820|NCT00943917|11590720|FG009|NOT COMPLETED|Stage I||0
10443821|NCT00943917|11590721|FG010|NOT COMPLETED|Stage I||0
10443822|NCT00943917|11590722|FG011|NOT COMPLETED|Stage I||0
10443823|NCT00943917|11590723|FG012|NOT COMPLETED|Stage I||0
10443824|NCT00943917|11590724|FG013|NOT COMPLETED|Stage I||0
10443825|NCT00943917|11590725|FG014|NOT COMPLETED|Stage I||0
10443826|NCT00943917|11590711|FG000|STARTED|Stage II||0
10443827|NCT00943917|11590712|FG001|STARTED|Stage II||0
10443828|NCT00943917|11590713|FG002|STARTED|Stage II||0
10443829|NCT00943917|11590714|FG003|STARTED|Stage II||20
10443830|NCT00943917|11590715|FG004|STARTED|Stage II||21
10443831|NCT00943917|11590716|FG005|STARTED|Stage II||23
10443832|NCT00943917|11590717|FG006|STARTED|Stage II||23
10443833|NCT00943917|11590718|FG007|STARTED|Stage II||23
10443834|NCT00943917|11590719|FG008|STARTED|Stage II||21
10443835|NCT00943917|11590720|FG009|STARTED|Stage II||0
10443836|NCT00943917|11590721|FG010|STARTED|Stage II||0
10443837|NCT00943917|11590722|FG011|STARTED|Stage II||0
10443838|NCT00943917|11590723|FG012|STARTED|Stage II||0
10443839|NCT00943917|11590724|FG013|STARTED|Stage II||0
10443840|NCT00943917|11590725|FG014|STARTED|Stage II||0
10443841|NCT00943917|11590711|FG000|COMPLETED|Stage II||0
10443842|NCT00943917|11590712|FG001|COMPLETED|Stage II||0
10443843|NCT00943917|11590713|FG002|COMPLETED|Stage II||0
10443844|NCT00943917|11590714|FG003|COMPLETED|Stage II||20
10443845|NCT00943917|11590715|FG004|COMPLETED|Stage II||21
10443846|NCT00943917|11590716|FG005|COMPLETED|Stage II||20
10443847|NCT00943917|11590717|FG006|COMPLETED|Stage II||20
10443848|NCT00943917|11590718|FG007|COMPLETED|Stage II||23
10443849|NCT00943917|11590719|FG008|COMPLETED|Stage II||20
10443850|NCT00943917|11590720|FG009|COMPLETED|Stage II||0
10443851|NCT00943917|11590721|FG010|COMPLETED|Stage II||0
10443852|NCT00943917|11590722|FG011|COMPLETED|Stage II||0
10443853|NCT00943917|11590723|FG012|COMPLETED|Stage II||0
10443854|NCT00943917|11590724|FG013|COMPLETED|Stage II||0
10443855|NCT00943917|11590725|FG014|COMPLETED|Stage II||0
10443856|NCT00943917|11590711|FG000|NOT COMPLETED|Stage II||0
10443857|NCT00943917|11590712|FG001|NOT COMPLETED|Stage II||0
10443858|NCT00943917|11590713|FG002|NOT COMPLETED|Stage II||0
10443859|NCT00943917|11590714|FG003|NOT COMPLETED|Stage II||0
10443860|NCT00943917|11590715|FG004|NOT COMPLETED|Stage II||0
10443861|NCT00943917|11590716|FG005|NOT COMPLETED|Stage II||3
10443862|NCT00943917|11590717|FG006|NOT COMPLETED|Stage II||3
10443863|NCT00943917|11590718|FG007|NOT COMPLETED|Stage II||0
10789536|NCT03522441|11949982|FG000|NOT COMPLETED|Overall Study||26
10789537|NCT03522441|11949983|FG001|NOT COMPLETED|Overall Study||19
10789538|NCT03522441|11949984|FG002|NOT COMPLETED|Overall Study||11
10443864|NCT00943917|11590719|FG008|NOT COMPLETED|Stage II||1
10443865|NCT00943917|11590720|FG009|NOT COMPLETED|Stage II||0
10443866|NCT00943917|11590721|FG010|NOT COMPLETED|Stage II||0
10443867|NCT00943917|11590722|FG011|NOT COMPLETED|Stage II||0
10443868|NCT00943917|11590723|FG012|NOT COMPLETED|Stage II||0
10443869|NCT00943917|11590724|FG013|NOT COMPLETED|Stage II||0
10443870|NCT00943917|11590725|FG014|NOT COMPLETED|Stage II||0
10443871|NCT00943917|11590711|FG000|STARTED|Stage II Continuation||0
10443872|NCT00943917|11590712|FG001|STARTED|Stage II Continuation||0
10443873|NCT00943917|11590713|FG002|STARTED|Stage II Continuation||0
10443874|NCT00943917|11590714|FG003|STARTED|Stage II Continuation||0
10443875|NCT00943917|11590715|FG004|STARTED|Stage II Continuation||0
10443876|NCT00943917|11590716|FG005|STARTED|Stage II Continuation||0
10443877|NCT00943917|11590717|FG006|STARTED|Stage II Continuation||0
10443878|NCT00943917|11590718|FG007|STARTED|Stage II Continuation||0
10443879|NCT00943917|11590719|FG008|STARTED|Stage II Continuation||0
10443880|NCT00943917|11590720|FG009|STARTED|Stage II Continuation||15
10789539|NCT03522506|11949996|FG000|STARTED|Treatment Period 1 (2 Days)||5
10789540|NCT03522506|11949997|FG001|STARTED|Treatment Period 1 (2 Days)||5
10443881|NCT00943917|11590721|FG010|STARTED|Stage II Continuation||15
10443882|NCT00943917|11590722|FG011|STARTED|Stage II Continuation||13
10443883|NCT00943917|11590723|FG012|STARTED|Stage II Continuation||16
10443884|NCT00943917|11590724|FG013|STARTED|Stage II Continuation||15
10443885|NCT00943917|11590725|FG014|STARTED|Stage II Continuation||12
10443886|NCT00943917|11590711|FG000|COMPLETED|Stage II Continuation||0
10443887|NCT00943917|11590712|FG001|COMPLETED|Stage II Continuation||0
10443888|NCT00943917|11590713|FG002|COMPLETED|Stage II Continuation||0
10443889|NCT00943917|11590714|FG003|COMPLETED|Stage II Continuation||0
10443890|NCT00943917|11590715|FG004|COMPLETED|Stage II Continuation||0
10443891|NCT00943917|11590716|FG005|COMPLETED|Stage II Continuation||0
10443892|NCT00943917|11590717|FG006|COMPLETED|Stage II Continuation||0
10443893|NCT00943917|11590718|FG007|COMPLETED|Stage II Continuation||0
10443894|NCT00943917|11590719|FG008|COMPLETED|Stage II Continuation||0
10443895|NCT00943917|11590720|FG009|COMPLETED|Stage II Continuation||14
10443896|NCT00943917|11590721|FG010|COMPLETED|Stage II Continuation||15
10443897|NCT00943917|11590722|FG011|COMPLETED|Stage II Continuation||11
10443898|NCT00943917|11590723|FG012|COMPLETED|Stage II Continuation||13
10443899|NCT00943917|11590724|FG013|COMPLETED|Stage II Continuation||12
10443900|NCT00943917|11590725|FG014|COMPLETED|Stage II Continuation||8
10443901|NCT00943917|11590711|FG000|NOT COMPLETED|Stage II Continuation||0
10443902|NCT00943917|11590712|FG001|NOT COMPLETED|Stage II Continuation||0
10443903|NCT00943917|11590713|FG002|NOT COMPLETED|Stage II Continuation||0
10443904|NCT00943917|11590714|FG003|NOT COMPLETED|Stage II Continuation||0
10443905|NCT00943917|11590715|FG004|NOT COMPLETED|Stage II Continuation||0
10443906|NCT00943917|11590716|FG005|NOT COMPLETED|Stage II Continuation||0
10443907|NCT00943917|11590717|FG006|NOT COMPLETED|Stage II Continuation||0
10443908|NCT00943917|11590718|FG007|NOT COMPLETED|Stage II Continuation||0
10443909|NCT00943917|11590719|FG008|NOT COMPLETED|Stage II Continuation||0
10443910|NCT00943917|11590720|FG009|NOT COMPLETED|Stage II Continuation||1
10550565|NCT01532973|11704741|FG007|STARTED|Part 2|Planned panel not performed. No participants were enrolled.|0
10550566|NCT01532973|11704742|FG008|STARTED|Part 2||0
10550567|NCT01532973|11704743|FG009|STARTED|Part 2||0
10550568|NCT01532973|11704734|FG000|COMPLETED|Part 2||0
10550569|NCT01532973|11704735|FG001|COMPLETED|Part 2||0
10550570|NCT01532973|11704736|FG002|COMPLETED|Part 2||0
10443911|NCT00943917|11590721|FG010|NOT COMPLETED|Stage II Continuation||0
10443912|NCT00943917|11590722|FG011|NOT COMPLETED|Stage II Continuation||2
10443913|NCT00943917|11590723|FG012|NOT COMPLETED|Stage II Continuation||3
10443914|NCT00943917|11590724|FG013|NOT COMPLETED|Stage II Continuation||3
10443915|NCT00943917|11590725|FG014|NOT COMPLETED|Stage II Continuation||4
10443916|NCT00944021|11590763|FG000|STARTED|Overall Study||15
10443917|NCT00944021|11590764|FG001|STARTED|Overall Study||15
10443918|NCT00944021|11590765|FG002|STARTED|Overall Study||15
10443919|NCT00944021|11590766|FG003|STARTED|Overall Study||16
10443920|NCT00944021|11590767|FG004|STARTED|Overall Study||8
10443921|NCT00944021|11590763|FG000|COMPLETED|Overall Study||14
10443922|NCT00944021|11590764|FG001|COMPLETED|Overall Study||15
10550571|NCT01532973|11704737|FG003|COMPLETED|Part 2||0
10550572|NCT01532973|11704738|FG004|COMPLETED|Part 2||6
10550573|NCT01532973|11704739|FG005|COMPLETED|Part 2||6
10443923|NCT00944021|11590765|FG002|COMPLETED|Overall Study||15
10443924|NCT00944021|11590766|FG003|COMPLETED|Overall Study||16
10443925|NCT00944021|11590767|FG004|COMPLETED|Overall Study||8
10443926|NCT00944021|11590763|FG000|NOT COMPLETED|Overall Study||1
10443927|NCT00944021|11590764|FG001|NOT COMPLETED|Overall Study||0
10443928|NCT00944021|11590765|FG002|NOT COMPLETED|Overall Study||0
10443929|NCT00944021|11590766|FG003|NOT COMPLETED|Overall Study||0
10443930|NCT00944021|11590767|FG004|NOT COMPLETED|Overall Study||0
10443931|NCT00944034|11590791|FG000|STARTED|Overall Study||188
10443932|NCT00944034|11590792|FG001|STARTED|Overall Study||157
10443933|NCT00944034|11590793|FG002|STARTED|Overall Study||152
10443934|NCT00944034|11590794|FG003|STARTED|Overall Study||174
10443935|NCT00944034|11590795|FG004|STARTED|Overall Study||164
10443936|NCT00944034|11590796|FG005|STARTED|Overall Study||143
10443937|NCT00944034|11590797|FG006|STARTED|Overall Study||106
10550574|NCT01532973|11704740|FG006|COMPLETED|Part 2||6
10550575|NCT01532973|11704741|FG007|COMPLETED|Part 2||0
10550576|NCT01532973|11704742|FG008|COMPLETED|Part 2||0
10550577|NCT01532973|11704743|FG009|COMPLETED|Part 2||0
10550578|NCT01532973|11704734|FG000|NOT COMPLETED|Part 2||0
10550579|NCT01532973|11704735|FG001|NOT COMPLETED|Part 2||0
10550580|NCT01532973|11704736|FG002|NOT COMPLETED|Part 2||0
10443938|NCT00944034|11590798|FG007|STARTED|Overall Study||78
10443939|NCT00944034|11590799|FG008|STARTED|Overall Study||73
10443940|NCT00944034|11590800|FG009|STARTED|Overall Study||246
10443941|NCT00944034|11590801|FG010|STARTED|Overall Study||51
10443942|NCT00944034|11590802|FG011|STARTED|Overall Study||56
10443943|NCT00944034|11590791|FG000|COMPLETED|Overall Study||183
10443944|NCT00944034|11590792|FG001|COMPLETED|Overall Study||150
10443945|NCT00944034|11590793|FG002|COMPLETED|Overall Study||143
10443946|NCT00944034|11590794|FG003|COMPLETED|Overall Study||170
10443947|NCT00944034|11590795|FG004|COMPLETED|Overall Study||150
10443948|NCT00944034|11590796|FG005|COMPLETED|Overall Study||123
10443949|NCT00944034|11590797|FG006|COMPLETED|Overall Study||102
10443950|NCT00944034|11590798|FG007|COMPLETED|Overall Study||73
10443951|NCT00944034|11590799|FG008|COMPLETED|Overall Study||63
10443952|NCT00944034|11590800|FG009|COMPLETED|Overall Study||236
10443953|NCT00944034|11590801|FG010|COMPLETED|Overall Study||50
10443954|NCT00944034|11590802|FG011|COMPLETED|Overall Study||52
10443955|NCT00944034|11590791|FG000|NOT COMPLETED|Overall Study||5
10443956|NCT00944034|11590792|FG001|NOT COMPLETED|Overall Study||7
10443957|NCT00944034|11590793|FG002|NOT COMPLETED|Overall Study||9
10443958|NCT00944034|11590794|FG003|NOT COMPLETED|Overall Study||4
10443959|NCT00944034|11590795|FG004|NOT COMPLETED|Overall Study||14
10443960|NCT00944034|11590796|FG005|NOT COMPLETED|Overall Study||20
10443961|NCT00944034|11590797|FG006|NOT COMPLETED|Overall Study||4
10443962|NCT00944034|11590798|FG007|NOT COMPLETED|Overall Study||5
10443963|NCT00944034|11590799|FG008|NOT COMPLETED|Overall Study||10
10443964|NCT00944034|11590800|FG009|NOT COMPLETED|Overall Study||10
10443965|NCT00944034|11590801|FG010|NOT COMPLETED|Overall Study||1
10443966|NCT00944034|11590802|FG011|NOT COMPLETED|Overall Study||4
10443967|NCT00944047|11590845|FG000|STARTED|Overall Study||32
10443968|NCT00944047|11590845|FG000|COMPLETED|Overall Study||27
10443969|NCT00944047|11590845|FG000|NOT COMPLETED|Overall Study||5
10443970|NCT00944073|11590851|FG000|STARTED|Overall Study||292
10443971|NCT00944073|11590852|FG001|STARTED|Overall Study||291
10443972|NCT00944073|11590851|FG000|COMPLETED|Overall Study||287
10443973|NCT00944073|11590852|FG001|COMPLETED|Overall Study||287
10443974|NCT00944073|11590851|FG000|NOT COMPLETED|Overall Study||5
10443975|NCT00944073|11590852|FG001|NOT COMPLETED|Overall Study||4
10550581|NCT01532973|11704737|FG003|NOT COMPLETED|Part 2||0
10550582|NCT01532973|11704738|FG004|NOT COMPLETED|Part 2||0
10550583|NCT01532973|11704739|FG005|NOT COMPLETED|Part 2||0
10550584|NCT01532973|11704740|FG006|NOT COMPLETED|Part 2||0
10550585|NCT01532973|11704741|FG007|NOT COMPLETED|Part 2||0
10550586|NCT01532973|11704742|FG008|NOT COMPLETED|Part 2||0
10443976|NCT00944125|11590858|FG000|STARTED|Baseline to 3 Months||19
10443977|NCT00944125|11590859|FG001|STARTED|Baseline to 3 Months||22
10443978|NCT00944125|11590858|FG000|COMPLETED|Baseline to 3 Months||19
10443979|NCT00944125|11590859|FG001|COMPLETED|Baseline to 3 Months||22
10443980|NCT00944125|11590858|FG000|NOT COMPLETED|Baseline to 3 Months||0
10443981|NCT00944125|11590859|FG001|NOT COMPLETED|Baseline to 3 Months||0
10443982|NCT00944125|11590858|FG000|STARTED|3 to 6 Months||19
10443983|NCT00944125|11590859|FG001|STARTED|3 to 6 Months||22
10443984|NCT00944125|11590858|FG000|COMPLETED|3 to 6 Months||19
10443985|NCT00944125|11590859|FG001|COMPLETED|3 to 6 Months||20
10443986|NCT00944125|11590858|FG000|NOT COMPLETED|3 to 6 Months||0
10443987|NCT00944125|11590859|FG001|NOT COMPLETED|3 to 6 Months||2
10443988|NCT00944125|11590858|FG000|STARTED|6 Months to Study Completion||19
10443989|NCT00944125|11590859|FG001|STARTED|6 Months to Study Completion||20
10443990|NCT00944125|11590858|FG000|COMPLETED|6 Months to Study Completion||19
10443991|NCT00944125|11590859|FG001|COMPLETED|6 Months to Study Completion||18
10443992|NCT00944125|11590858|FG000|NOT COMPLETED|6 Months to Study Completion||0
10443993|NCT00944125|11590859|FG001|NOT COMPLETED|6 Months to Study Completion||2
10443994|NCT00944450|11590865|FG000|STARTED|Period 1||6
10443995|NCT00944450|11590866|FG001|STARTED|Period 1||6
10443996|NCT00944450|11590865|FG000|COMPLETED|Period 1||6
10443997|NCT00944450|11590866|FG001|COMPLETED|Period 1||6
10443998|NCT00944450|11590865|FG000|NOT COMPLETED|Period 1||0
10443999|NCT00944450|11590866|FG001|NOT COMPLETED|Period 1||0
10444000|NCT00944450|11590865|FG000|STARTED|Period 2||6
10444001|NCT00944450|11590866|FG001|STARTED|Period 2||6
10444002|NCT00944450|11590865|FG000|COMPLETED|Period 2||6
10444003|NCT00944450|11590866|FG001|COMPLETED|Period 2||6
10444004|NCT00944450|11590865|FG000|NOT COMPLETED|Period 2||0
10444005|NCT00944450|11590866|FG001|NOT COMPLETED|Period 2||0
10444006|NCT00944554|11590874|FG000|STARTED|Overall Study||50
10444007|NCT00944554|11590875|FG001|STARTED|Overall Study||54
10444008|NCT00944554|11590874|FG000|COMPLETED|Overall Study||22
10444009|NCT00944554|11590875|FG001|COMPLETED|Overall Study||25
10444010|NCT00944554|11590874|FG000|NOT COMPLETED|Overall Study||28
10444011|NCT00944554|11590875|FG001|NOT COMPLETED|Overall Study||29
10444012|NCT00944645|11590881|FG000|STARTED|Period 1||94
10444013|NCT00944645|11590882|FG001|STARTED|Period 1||94
10444014|NCT00944645|11590881|FG000|COMPLETED|Period 1||94
10444015|NCT00944645|11590882|FG001|COMPLETED|Period 1||94
10444016|NCT00944645|11590881|FG000|NOT COMPLETED|Period 1||0
10444017|NCT00944645|11590882|FG001|NOT COMPLETED|Period 1||0
10444018|NCT00944645|11590881|FG000|STARTED|Period 2||94
10444019|NCT00944645|11590882|FG001|STARTED|Period 2||94
10444020|NCT00944645|11590881|FG000|COMPLETED|Period 2||86
10444021|NCT00944645|11590882|FG001|COMPLETED|Period 2||85
10444022|NCT00944645|11590881|FG000|NOT COMPLETED|Period 2||8
10444023|NCT00944645|11590882|FG001|NOT COMPLETED|Period 2||9
10550587|NCT01532973|11704743|FG009|NOT COMPLETED|Part 2||0
10550588|NCT01532973|11704734|FG000|STARTED|Part 3||0
10550589|NCT01532973|11704735|FG001|STARTED|Part 3||0
10550590|NCT01532973|11704736|FG002|STARTED|Part 3||0
10550591|NCT01532973|11704737|FG003|STARTED|Part 3||0
10444024|NCT00944658|11590890|FG000|STARTED|Treatment 12 Weeks||19
10444025|NCT00944658|11590891|FG001|STARTED|Treatment 12 Weeks||19
10444026|NCT00944658|11590890|FG000|COMPLETED|Treatment 12 Weeks||19
10444027|NCT00944658|11590891|FG001|COMPLETED|Treatment 12 Weeks||17
10444028|NCT00944658|11590890|FG000|NOT COMPLETED|Treatment 12 Weeks||0
10444029|NCT00944658|11590891|FG001|NOT COMPLETED|Treatment 12 Weeks||2
10444030|NCT00944658|11590890|FG000|STARTED|Follow up 4 Weeks||19
10444031|NCT00944658|11590891|FG001|STARTED|Follow up 4 Weeks||17
10444032|NCT00944658|11590890|FG000|COMPLETED|Follow up 4 Weeks||19
10444033|NCT00944658|11590891|FG001|COMPLETED|Follow up 4 Weeks||17
10444034|NCT00944658|11590890|FG000|NOT COMPLETED|Follow up 4 Weeks||0
10444035|NCT00944658|11590891|FG001|NOT COMPLETED|Follow up 4 Weeks||0
10444036|NCT00944671|11590903|FG000|STARTED|Period I||4
10444037|NCT00944671|11590904|FG001|STARTED|Period I||4
10444038|NCT00944671|11590905|FG002|STARTED|Period I||4
10444039|NCT00944671|11590906|FG003|STARTED|Period I||4
10444040|NCT00944671|11590907|FG004|STARTED|Period I||4
10444041|NCT00944671|11590908|FG005|STARTED|Period I||4
10444042|NCT00944671|11590903|FG000|COMPLETED|Period I||4
10444043|NCT00944671|11590904|FG001|COMPLETED|Period I||4
10444044|NCT00944671|11590905|FG002|COMPLETED|Period I||4
10444045|NCT00944671|11590906|FG003|COMPLETED|Period I||4
10444046|NCT00944671|11590907|FG004|COMPLETED|Period I||4
10550592|NCT01532973|11704738|FG004|STARTED|Part 3||0
10550593|NCT01532973|11704739|FG005|STARTED|Part 3||0
10444047|NCT00944671|11590908|FG005|COMPLETED|Period I||4
10444048|NCT00944671|11590903|FG000|NOT COMPLETED|Period I||0
10444049|NCT00944671|11590904|FG001|NOT COMPLETED|Period I||0
10444050|NCT00944671|11590905|FG002|NOT COMPLETED|Period I||0
10444051|NCT00944671|11590906|FG003|NOT COMPLETED|Period I||0
10444052|NCT00944671|11590907|FG004|NOT COMPLETED|Period I||0
10444053|NCT00944671|11590908|FG005|NOT COMPLETED|Period I||0
10444054|NCT00944671|11590903|FG000|STARTED|Period II||4
10444055|NCT00944671|11590904|FG001|STARTED|Period II||4
10444056|NCT00944671|11590905|FG002|STARTED|Period II||4
10550594|NCT01532973|11704740|FG006|STARTED|Part 3||0
10550595|NCT01532973|11704741|FG007|STARTED|Part 3||0
10444057|NCT00944671|11590906|FG003|STARTED|Period II||4
10444058|NCT00944671|11590907|FG004|STARTED|Period II||4
10444059|NCT00944671|11590908|FG005|STARTED|Period II||4
10444060|NCT00944671|11590903|FG000|COMPLETED|Period II||4
10444061|NCT00944671|11590904|FG001|COMPLETED|Period II||4
10550596|NCT01532973|11704742|FG008|STARTED|Part 3||6
10444062|NCT00944671|11590905|FG002|COMPLETED|Period II||4
10444063|NCT00944671|11590906|FG003|COMPLETED|Period II||4
10444064|NCT00944671|11590907|FG004|COMPLETED|Period II||4
10444065|NCT00944671|11590908|FG005|COMPLETED|Period II||4
10444066|NCT00944671|11590903|FG000|NOT COMPLETED|Period II||0
10444067|NCT00944671|11590904|FG001|NOT COMPLETED|Period II||0
10444068|NCT00944671|11590905|FG002|NOT COMPLETED|Period II||0
10444069|NCT00944671|11590906|FG003|NOT COMPLETED|Period II||0
10444070|NCT00944671|11590907|FG004|NOT COMPLETED|Period II||0
10444071|NCT00944671|11590908|FG005|NOT COMPLETED|Period II||0
10444072|NCT00944671|11590903|FG000|STARTED|Period III||4
10444073|NCT00944671|11590904|FG001|STARTED|Period III||4
10444074|NCT00944671|11590905|FG002|STARTED|Period III||4
10444075|NCT00944671|11590906|FG003|STARTED|Period III||4
10444076|NCT00944671|11590907|FG004|STARTED|Period III||4
10444077|NCT00944671|11590908|FG005|STARTED|Period III||4
10444078|NCT00944671|11590903|FG000|COMPLETED|Period III||4
10444079|NCT00944671|11590904|FG001|COMPLETED|Period III||4
10444080|NCT00944671|11590905|FG002|COMPLETED|Period III||4
10444081|NCT00944671|11590906|FG003|COMPLETED|Period III||4
10789541|NCT03522506|11949998|FG002|STARTED|Treatment Period 1 (2 Days)||5
10789542|NCT03522506|11949999|FG003|STARTED|Treatment Period 1 (2 Days)||5
10789543|NCT03522506|11949996|FG000|COMPLETED|Treatment Period 1 (2 Days)||5
10789544|NCT03522506|11949997|FG001|COMPLETED|Treatment Period 1 (2 Days)||5
10444082|NCT00944671|11590907|FG004|COMPLETED|Period III||4
10444083|NCT00944671|11590908|FG005|COMPLETED|Period III||4
10444084|NCT00944671|11590903|FG000|NOT COMPLETED|Period III||0
10444085|NCT00944671|11590904|FG001|NOT COMPLETED|Period III||0
10444086|NCT00944671|11590905|FG002|NOT COMPLETED|Period III||0
10444087|NCT00944671|11590906|FG003|NOT COMPLETED|Period III||0
10444088|NCT00944671|11590907|FG004|NOT COMPLETED|Period III||0
10444089|NCT00944671|11590908|FG005|NOT COMPLETED|Period III||0
10444090|NCT00944697|11590918|FG000|STARTED|Overall Study||50
10444091|NCT00944697|11590919|FG001|STARTED|Overall Study||48
10444092|NCT00944697|11590918|FG000|COMPLETED|Overall Study||48
10444093|NCT00944697|11590919|FG001|COMPLETED|Overall Study||43
10444094|NCT00944697|11590918|FG000|NOT COMPLETED|Overall Study||2
10444095|NCT00944697|11590919|FG001|NOT COMPLETED|Overall Study||5
10444096|NCT00944710|11590927|FG000|STARTED|10-week Primary Outcome||40
10444097|NCT00944710|11590928|FG001|STARTED|10-week Primary Outcome||33
10444098|NCT00944710|11590927|FG000|COMPLETED|10-week Primary Outcome||40
10444099|NCT00944710|11590928|FG001|COMPLETED|10-week Primary Outcome||33
10444100|NCT00944710|11590927|FG000|NOT COMPLETED|10-week Primary Outcome||0
10444101|NCT00944710|11590928|FG001|NOT COMPLETED|10-week Primary Outcome||0
10444102|NCT00944710|11590927|FG000|STARTED|12-week Visit (Off-treatment)||40
10444103|NCT00944710|11590928|FG001|STARTED|12-week Visit (Off-treatment)||33
10444104|NCT00944710|11590927|FG000|COMPLETED|12-week Visit (Off-treatment)||40
10444105|NCT00944710|11590928|FG001|COMPLETED|12-week Visit (Off-treatment)||33
10444106|NCT00944710|11590927|FG000|NOT COMPLETED|12-week Visit (Off-treatment)||0
10444107|NCT00944710|11590928|FG001|NOT COMPLETED|12-week Visit (Off-treatment)||0
10444108|NCT00944710|11590927|FG000|STARTED|Additional Post 10-week Primary Outcome||40
10444109|NCT00944710|11590928|FG001|STARTED|Additional Post 10-week Primary Outcome||33
10550597|NCT01532973|11704743|FG009|STARTED|Part 3||6
10550598|NCT01532973|11704734|FG000|COMPLETED|Part 3||0
10550599|NCT01532973|11704735|FG001|COMPLETED|Part 3||0
10550600|NCT01532973|11704736|FG002|COMPLETED|Part 3||0
10550601|NCT01532973|11704737|FG003|COMPLETED|Part 3||0
10550602|NCT01532973|11704738|FG004|COMPLETED|Part 3||0
10550603|NCT01532973|11704739|FG005|COMPLETED|Part 3||0
10550604|NCT01532973|11704740|FG006|COMPLETED|Part 3||0
10550605|NCT01532973|11704741|FG007|COMPLETED|Part 3||0
10550606|NCT01532973|11704742|FG008|COMPLETED|Part 3||6
10550607|NCT01532973|11704743|FG009|COMPLETED|Part 3||6
10550608|NCT01532973|11704734|FG000|NOT COMPLETED|Part 3||0
10550609|NCT01532973|11704735|FG001|NOT COMPLETED|Part 3||0
10789545|NCT03522506|11949998|FG002|COMPLETED|Treatment Period 1 (2 Days)||5
10789546|NCT03522506|11949999|FG003|COMPLETED|Treatment Period 1 (2 Days)||5
10789547|NCT03522506|11949996|FG000|NOT COMPLETED|Treatment Period 1 (2 Days)||0
10789548|NCT03522506|11949997|FG001|NOT COMPLETED|Treatment Period 1 (2 Days)||0
10789549|NCT03522506|11949998|FG002|NOT COMPLETED|Treatment Period 1 (2 Days)||0
10789550|NCT03522506|11949999|FG003|NOT COMPLETED|Treatment Period 1 (2 Days)||0
10789551|NCT03522506|11949996|FG000|STARTED|Washout Period 1 (7 Days)||5
10444110|NCT00944710|11590927|FG000|Eligible to Enter Post 10-week Phase|Additional Post 10-week Primary Outcome||24
10444111|NCT00944710|11590928|FG001|Eligible to Enter Post 10-week Phase|Additional Post 10-week Primary Outcome||26
10444112|NCT00944710|11590927|FG000|COMPLETED|Additional Post 10-week Primary Outcome||23
10444113|NCT00944710|11590928|FG001|COMPLETED|Additional Post 10-week Primary Outcome||22
10444114|NCT00944710|11590927|FG000|NOT COMPLETED|Additional Post 10-week Primary Outcome||17
10444115|NCT00944710|11590928|FG001|NOT COMPLETED|Additional Post 10-week Primary Outcome||11
10444116|NCT00944749|11590934|FG000|STARTED|Overall Study||23
10444117|NCT00944749|11590934|FG000|COMPLETED|Overall Study||22
10444118|NCT00944749|11590934|FG000|NOT COMPLETED|Overall Study||1
10444119|NCT00945061|11590940|FG000|STARTED|Overall Study||12
10789552|NCT03522506|11949997|FG001|STARTED|Washout Period 1 (7 Days)||5
10444120|NCT00945061|11590941|FG001|STARTED|Overall Study||1
10444121|NCT00945061|11590940|FG000|COMPLETED|Overall Study||12
10550610|NCT01532973|11704736|FG002|NOT COMPLETED|Part 3||0
10550611|NCT01532973|11704737|FG003|NOT COMPLETED|Part 3||0
10550612|NCT01532973|11704738|FG004|NOT COMPLETED|Part 3||0
10550613|NCT01532973|11704739|FG005|NOT COMPLETED|Part 3||0
10550614|NCT01532973|11704740|FG006|NOT COMPLETED|Part 3||0
10444122|NCT00945061|11590941|FG001|COMPLETED|Overall Study||1
10444123|NCT00945061|11590940|FG000|NOT COMPLETED|Overall Study||0
10444124|NCT00945061|11590941|FG001|NOT COMPLETED|Overall Study||0
10444125|NCT00945100|11590958|FG000|STARTED|10-week Primary Outcome||83
10444126|NCT00945100|11590959|FG001|STARTED|10-week Primary Outcome||86
10550618|NCT01532986|11704769|FG000|STARTED|Overall Study||166
10444127|NCT00945100|11590958|FG000|Completed, Eligible|10-week Primary Outcome|Eligible for Post-10 week phase|55
10444128|NCT00945100|11590959|FG001|Completed, Eligible|10-week Primary Outcome|Eligible for Post-10 week phase|63
10444129|NCT00945100|11590958|FG000|Completed, Not Eligible|10-week Primary Outcome|Not Eligible for Post-10 week phase|27
10444130|NCT00945100|11590959|FG001|Completed, Not Eligible|10-week Primary Outcome|Not Eligible for Post-10 week phase|20
10444131|NCT00945100|11590958|FG000|COMPLETED|10-week Primary Outcome||82
10444132|NCT00945100|11590959|FG001|COMPLETED|10-week Primary Outcome||83
10444133|NCT00945100|11590958|FG000|NOT COMPLETED|10-week Primary Outcome||1
10444134|NCT00945100|11590959|FG001|NOT COMPLETED|10-week Primary Outcome||3
10444135|NCT00945100|11590958|FG000|STARTED|Post-10 Week Primary Outcome|27 participants were not eligible for Post 10 week Primary Outcome phase|55
10444136|NCT00945100|11590959|FG001|STARTED|Post-10 Week Primary Outcome|20 participants were not eligible for Post 10 week Primary Outcome phase|63
10444137|NCT00945100|11590958|FG000|COMPLETED|Post-10 Week Primary Outcome||51
10444138|NCT00945100|11590959|FG001|COMPLETED|Post-10 Week Primary Outcome||56
10444139|NCT00945100|11590958|FG000|NOT COMPLETED|Post-10 Week Primary Outcome||4
10444140|NCT00945100|11590959|FG001|NOT COMPLETED|Post-10 Week Primary Outcome||7
10444141|NCT00945139|11590965|FG000|STARTED|Overall Study||46
10444142|NCT00945139|11590965|FG000|COMPLETED|Overall Study||46
10444143|NCT00945139|11590965|FG000|NOT COMPLETED|Overall Study||0
10444144|NCT00945191|11590970|FG000|STARTED|Overall Study||24
10444145|NCT00945191|11590970|FG000|COMPLETED|Overall Study||0
10444146|NCT00945191|11590970|FG000|NOT COMPLETED|Overall Study||24
10444147|NCT00945243|11590974|FG000|STARTED|Overall Study|Enrolled and Treated Per Protocol|11
10444148|NCT00945243|11590974|FG000|COMPLETED|Overall Study||8
10444149|NCT00945243|11590974|FG000|NOT COMPLETED|Overall Study||3
10444150|NCT00945256|11590983|FG000|STARTED|Overall Study||13
10444151|NCT00945256|11590984|FG001|STARTED|Overall Study||10
10444152|NCT00945256|11590985|FG002|STARTED|Overall Study||15
10444153|NCT00945256|11590986|FG003|STARTED|Overall Study||16
10444154|NCT00945256|11590987|FG004|STARTED|Overall Study||8
10444155|NCT00945256|11590983|FG000|COMPLETED|Overall Study||9
10444156|NCT00945256|11590984|FG001|COMPLETED|Overall Study||8
10444157|NCT00945256|11590985|FG002|COMPLETED|Overall Study||7
10444158|NCT00945256|11590986|FG003|COMPLETED|Overall Study||7
10444159|NCT00945256|11590987|FG004|COMPLETED|Overall Study||7
10444160|NCT00945256|11590983|FG000|NOT COMPLETED|Overall Study||4
10444161|NCT00945256|11590984|FG001|NOT COMPLETED|Overall Study||2
10444162|NCT00945256|11590985|FG002|NOT COMPLETED|Overall Study||8
10444163|NCT00945256|11590986|FG003|NOT COMPLETED|Overall Study||9
10444164|NCT00945256|11590987|FG004|NOT COMPLETED|Overall Study||1
10444165|NCT00945282|11591001|FG000|STARTED|Overall Study||6
10444166|NCT00945282|11591002|FG001|STARTED|Overall Study||2
10444167|NCT00945282|11591001|FG000|COMPLETED|Overall Study||6
10444168|NCT00945282|11591002|FG001|COMPLETED|Overall Study||2
10444169|NCT00945282|11591001|FG000|NOT COMPLETED|Overall Study||0
10444170|NCT00945282|11591002|FG001|NOT COMPLETED|Overall Study||0
10444171|NCT00945295|11591018|FG000|STARTED|Overall Study||15
10444172|NCT00945295|11591019|FG001|STARTED|Overall Study||16
10444173|NCT00945295|11591018|FG000|COMPLETED|Overall Study||15
10444174|NCT00945295|11591019|FG001|COMPLETED|Overall Study||14
10444175|NCT00945295|11591018|FG000|NOT COMPLETED|Overall Study||0
10444176|NCT00945295|11591019|FG001|NOT COMPLETED|Overall Study||2
10444177|NCT00945321|11591025|FG000|STARTED|Period 1||7
10444178|NCT00945321|11591026|FG001|STARTED|Period 1||7
10444179|NCT00945321|11591027|FG002|STARTED|Period 1||7
10444180|NCT00945321|11591028|FG003|STARTED|Period 1||7
10444181|NCT00945321|11591029|FG004|STARTED|Period 1||7
10444182|NCT00945321|11591030|FG005|STARTED|Period 1||7
10444183|NCT00945321|11591025|FG000|COMPLETED|Period 1||7
10444184|NCT00945321|11591026|FG001|COMPLETED|Period 1||7
10444185|NCT00945321|11591027|FG002|COMPLETED|Period 1||7
10444186|NCT00945321|11591028|FG003|COMPLETED|Period 1||7
10444187|NCT00945321|11591029|FG004|COMPLETED|Period 1||6
10444188|NCT00945321|11591030|FG005|COMPLETED|Period 1||7
10444189|NCT00945321|11591025|FG000|NOT COMPLETED|Period 1||0
10444190|NCT00945321|11591026|FG001|NOT COMPLETED|Period 1||0
10444191|NCT00945321|11591027|FG002|NOT COMPLETED|Period 1||0
10444192|NCT00945321|11591028|FG003|NOT COMPLETED|Period 1||0
10444193|NCT00945321|11591029|FG004|NOT COMPLETED|Period 1||1
10444194|NCT00945321|11591030|FG005|NOT COMPLETED|Period 1||0
10444195|NCT00945321|11591025|FG000|STARTED|Period 2||7
10444196|NCT00945321|11591026|FG001|STARTED|Period 2||7
10444197|NCT00945321|11591027|FG002|STARTED|Period 2||7
10444198|NCT00945321|11591028|FG003|STARTED|Period 2||7
10444199|NCT00945321|11591029|FG004|STARTED|Period 2||6
10444200|NCT00945321|11591030|FG005|STARTED|Period 2||7
10444201|NCT00945321|11591025|FG000|COMPLETED|Period 2||7
10444202|NCT00945321|11591026|FG001|COMPLETED|Period 2||7
10444203|NCT00945321|11591027|FG002|COMPLETED|Period 2||7
10444204|NCT00945321|11591028|FG003|COMPLETED|Period 2||7
10444205|NCT00945321|11591029|FG004|COMPLETED|Period 2||6
10444206|NCT00945321|11591030|FG005|COMPLETED|Period 2||7
10444207|NCT00945321|11591025|FG000|NOT COMPLETED|Period 2||0
10444208|NCT00945321|11591026|FG001|NOT COMPLETED|Period 2||0
10444209|NCT00945321|11591027|FG002|NOT COMPLETED|Period 2||0
10444210|NCT00945321|11591028|FG003|NOT COMPLETED|Period 2||0
10444211|NCT00945321|11591029|FG004|NOT COMPLETED|Period 2||0
10444212|NCT00945321|11591030|FG005|NOT COMPLETED|Period 2||0
10444213|NCT00945321|11591025|FG000|STARTED|Period 3||7
10550615|NCT01532973|11704741|FG007|NOT COMPLETED|Part 3||0
10550616|NCT01532973|11704742|FG008|NOT COMPLETED|Part 3||0
10550617|NCT01532973|11704743|FG009|NOT COMPLETED|Part 3||0
10550619|NCT01532986|11704770|FG001|STARTED|Overall Study||162
10550620|NCT01532986|11704769|FG000|COMPLETED|Overall Study||143
10444214|NCT00945321|11591026|FG001|STARTED|Period 3||7
10444215|NCT00945321|11591027|FG002|STARTED|Period 3||7
10444216|NCT00945321|11591028|FG003|STARTED|Period 3||7
10444217|NCT00945321|11591029|FG004|STARTED|Period 3||6
10444218|NCT00945321|11591030|FG005|STARTED|Period 3||7
10444219|NCT00945321|11591025|FG000|COMPLETED|Period 3||7
10444220|NCT00945321|11591026|FG001|COMPLETED|Period 3||7
10444221|NCT00945321|11591027|FG002|COMPLETED|Period 3||7
10444222|NCT00945321|11591028|FG003|COMPLETED|Period 3||7
10444223|NCT00945321|11591029|FG004|COMPLETED|Period 3||6
10444224|NCT00945321|11591030|FG005|COMPLETED|Period 3||7
10444225|NCT00945321|11591025|FG000|NOT COMPLETED|Period 3||0
10444226|NCT00945321|11591026|FG001|NOT COMPLETED|Period 3||0
10444227|NCT00945321|11591027|FG002|NOT COMPLETED|Period 3||0
10444228|NCT00945321|11591028|FG003|NOT COMPLETED|Period 3||0
10444229|NCT00945321|11591029|FG004|NOT COMPLETED|Period 3||0
10444230|NCT00945321|11591030|FG005|NOT COMPLETED|Period 3||0
10444231|NCT00945321|11591025|FG000|STARTED|Period 4||7
10550621|NCT01532986|11704770|FG001|COMPLETED|Overall Study||138
10550622|NCT01532986|11704769|FG000|NOT COMPLETED|Overall Study||23
10550623|NCT01532986|11704770|FG001|NOT COMPLETED|Overall Study||24
10789553|NCT03522506|11949998|FG002|STARTED|Washout Period 1 (7 Days)||5
10444232|NCT00945321|11591026|FG001|STARTED|Period 4||7
10444233|NCT00945321|11591027|FG002|STARTED|Period 4||7
10444234|NCT00945321|11591028|FG003|STARTED|Period 4||7
10444235|NCT00945321|11591029|FG004|STARTED|Period 4||6
10444236|NCT00945321|11591030|FG005|STARTED|Period 4||7
10444237|NCT00945321|11591025|FG000|COMPLETED|Period 4||7
10444238|NCT00945321|11591026|FG001|COMPLETED|Period 4||7
10444239|NCT00945321|11591027|FG002|COMPLETED|Period 4||7
10444240|NCT00945321|11591028|FG003|COMPLETED|Period 4||7
10444241|NCT00945321|11591029|FG004|COMPLETED|Period 4||6
10444242|NCT00945321|11591030|FG005|COMPLETED|Period 4||6
10444243|NCT00945321|11591025|FG000|NOT COMPLETED|Period 4||0
10444244|NCT00945321|11591026|FG001|NOT COMPLETED|Period 4||0
10444245|NCT00945321|11591027|FG002|NOT COMPLETED|Period 4||0
10444246|NCT00945321|11591028|FG003|NOT COMPLETED|Period 4||0
10444247|NCT00945321|11591029|FG004|NOT COMPLETED|Period 4||0
10444248|NCT00945321|11591030|FG005|NOT COMPLETED|Period 4||1
10444249|NCT00945334|11591050|FG000|STARTED|Overall Study||19
10444250|NCT00945334|11591051|FG001|STARTED|Overall Study||18
10444251|NCT00945334|11591050|FG000|COMPLETED|Overall Study||16
10444252|NCT00945334|11591051|FG001|COMPLETED|Overall Study||15
10444253|NCT00945334|11591050|FG000|NOT COMPLETED|Overall Study||3
10444254|NCT00945334|11591051|FG001|NOT COMPLETED|Overall Study||3
10444255|NCT00945477|11591057|FG000|STARTED|Overall Study||11
10444256|NCT00945477|11591057|FG000|COMPLETED|Overall Study||5
10444257|NCT00945477|11591057|FG000|NOT COMPLETED|Overall Study||6
10444258|NCT00945555|11591062|FG000|STARTED|Overall Study||264
10444259|NCT00945555|11591062|FG000|COMPLETED|Overall Study||236
10444260|NCT00945555|11591062|FG000|NOT COMPLETED|Overall Study||28
10444261|NCT00945594|11591068|FG000|STARTED|Overall Study||50
10444262|NCT00945594|11591069|FG001|STARTED|Overall Study||50
10444263|NCT00945594|11591068|FG000|COMPLETED|Overall Study||50
10444264|NCT00945594|11591069|FG001|COMPLETED|Overall Study||50
10444265|NCT00945594|11591068|FG000|NOT COMPLETED|Overall Study||0
10444266|NCT00945594|11591069|FG001|NOT COMPLETED|Overall Study||0
10444267|NCT00945659|11591080|FG000|STARTED|Overall Study||39
10444268|NCT00945659|11591081|FG001|STARTED|Overall Study||40
10444269|NCT00945659|11591082|FG002|STARTED|Overall Study||37
10550624|NCT01532999|11704779|FG000|STARTED|Overall Study||96
10550625|NCT01532999|11704780|FG001|STARTED|Overall Study||95
10550626|NCT01532999|11704779|FG000|COMPLETED|Overall Study||65
10550627|NCT01532999|11704780|FG001|COMPLETED|Overall Study||77
10550628|NCT01532999|11704779|FG000|NOT COMPLETED|Overall Study||31
10789554|NCT03522506|11949999|FG003|STARTED|Washout Period 1 (7 Days)||5
10444270|NCT00945659|11591080|FG000|Baseline|Overall Study||39
10444271|NCT00945659|11591081|FG001|Baseline|Overall Study||40
10444272|NCT00945659|11591082|FG002|Baseline|Overall Study||37
10444273|NCT00945659|11591080|FG000|3-Months|Overall Study||38
10444274|NCT00945659|11591081|FG001|3-Months|Overall Study||39
10444275|NCT00945659|11591082|FG002|3-Months|Overall Study||35
10444276|NCT00945659|11591080|FG000|6-Months|Overall Study||31
10444277|NCT00945659|11591081|FG001|6-Months|Overall Study||29
10444278|NCT00945659|11591082|FG002|6-Months|Overall Study||25
10444279|NCT00945659|11591080|FG000|9-Months|Overall Study||32
10550629|NCT01532999|11704780|FG001|NOT COMPLETED|Overall Study||18
10550630|NCT01533038|11704788|FG000|STARTED|Overall Study||45
10789555|NCT03522506|11949996|FG000|COMPLETED|Washout Period 1 (7 Days)||5
10444280|NCT00945659|11591081|FG001|9-Months|Overall Study||20
10444281|NCT00945659|11591082|FG002|9-Months|Overall Study||20
10444282|NCT00945659|11591080|FG000|12-Months|Overall Study||32
10444283|NCT00945659|11591081|FG001|12-Months|Overall Study||20
10444284|NCT00945659|11591082|FG002|12-Months|Overall Study||20
10444285|NCT00945659|11591080|FG000|COMPLETED|Overall Study||32
10444286|NCT00945659|11591081|FG001|COMPLETED|Overall Study||20
10444287|NCT00945659|11591082|FG002|COMPLETED|Overall Study||20
10550631|NCT01533038|11704789|FG001|STARTED|Overall Study||35
10444288|NCT00945659|11591080|FG000|NOT COMPLETED|Overall Study||7
10444289|NCT00945659|11591081|FG001|NOT COMPLETED|Overall Study||20
10444290|NCT00945659|11591082|FG002|NOT COMPLETED|Overall Study||17
10444291|NCT00945750|11591096|FG000|STARTED|Period I||5
10444292|NCT00945750|11591097|FG001|STARTED|Period I||5
10444293|NCT00945750|11591098|FG002|STARTED|Period I||5
10444294|NCT00945750|11591099|FG003|STARTED|Period I||5
10444295|NCT00945750|11591100|FG004|STARTED|Period I||5
10444296|NCT00945750|11591101|FG005|STARTED|Period I||5
10444297|NCT00945750|11591096|FG000|COMPLETED|Period I||5
10444298|NCT00945750|11591097|FG001|COMPLETED|Period I||5
10444299|NCT00945750|11591098|FG002|COMPLETED|Period I||5
10444300|NCT00945750|11591099|FG003|COMPLETED|Period I||5
10444301|NCT00945750|11591100|FG004|COMPLETED|Period I||5
10444302|NCT00945750|11591101|FG005|COMPLETED|Period I||5
10444303|NCT00945750|11591096|FG000|NOT COMPLETED|Period I||0
10444304|NCT00945750|11591097|FG001|NOT COMPLETED|Period I||0
10444305|NCT00945750|11591098|FG002|NOT COMPLETED|Period I||0
10444306|NCT00945750|11591099|FG003|NOT COMPLETED|Period I||0
10444307|NCT00945750|11591100|FG004|NOT COMPLETED|Period I||0
10444308|NCT00945750|11591101|FG005|NOT COMPLETED|Period I||0
10444309|NCT00945750|11591096|FG000|STARTED|Period II||5
10444310|NCT00945750|11591097|FG001|STARTED|Period II||5
10444311|NCT00945750|11591098|FG002|STARTED|Period II||5
10444312|NCT00945750|11591099|FG003|STARTED|Period II||5
10444313|NCT00945750|11591100|FG004|STARTED|Period II||5
10444314|NCT00945750|11591101|FG005|STARTED|Period II||5
10444315|NCT00945750|11591096|FG000|COMPLETED|Period II||5
10444316|NCT00945750|11591097|FG001|COMPLETED|Period II||5
10444317|NCT00945750|11591098|FG002|COMPLETED|Period II||5
10444318|NCT00945750|11591099|FG003|COMPLETED|Period II||5
10444319|NCT00945750|11591100|FG004|COMPLETED|Period II||5
10444320|NCT00945750|11591101|FG005|COMPLETED|Period II||5
10444321|NCT00945750|11591096|FG000|NOT COMPLETED|Period II||0
10444322|NCT00945750|11591097|FG001|NOT COMPLETED|Period II||0
10444323|NCT00945750|11591098|FG002|NOT COMPLETED|Period II||0
10444324|NCT00945750|11591099|FG003|NOT COMPLETED|Period II||0
10444325|NCT00945750|11591100|FG004|NOT COMPLETED|Period II||0
10444326|NCT00945750|11591101|FG005|NOT COMPLETED|Period II||0
10444327|NCT00945750|11591096|FG000|STARTED|Period III||5
10444328|NCT00945750|11591097|FG001|STARTED|Period III||5
10444329|NCT00945750|11591098|FG002|STARTED|Period III||5
10444330|NCT00945750|11591099|FG003|STARTED|Period III||5
10444331|NCT00945750|11591100|FG004|STARTED|Period III||5
10444332|NCT00945750|11591101|FG005|STARTED|Period III||5
10444333|NCT00945750|11591096|FG000|COMPLETED|Period III||5
10789556|NCT03522506|11949997|FG001|COMPLETED|Washout Period 1 (7 Days)||5
10789557|NCT03522506|11949998|FG002|COMPLETED|Washout Period 1 (7 Days)||5
10789558|NCT03522506|11949999|FG003|COMPLETED|Washout Period 1 (7 Days)||4
10789559|NCT03522506|11949996|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
10789560|NCT03522506|11949997|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
10789561|NCT03522506|11949998|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
10444334|NCT00945750|11591097|FG001|COMPLETED|Period III||5
10444335|NCT00945750|11591098|FG002|COMPLETED|Period III||5
10444336|NCT00945750|11591099|FG003|COMPLETED|Period III||5
10444337|NCT00945750|11591100|FG004|COMPLETED|Period III||5
10444338|NCT00945750|11591101|FG005|COMPLETED|Period III||5
10444339|NCT00945750|11591096|FG000|NOT COMPLETED|Period III||0
10789562|NCT03522506|11949999|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||1
10789563|NCT03522506|11949996|FG000|STARTED|Treatment Period 2 (2 Days)||5
10789564|NCT03522506|11949997|FG001|STARTED|Treatment Period 2 (2 Days)||5
10789565|NCT03522506|11949998|FG002|STARTED|Treatment Period 2 (2 Days)||5
10789566|NCT03522506|11949999|FG003|STARTED|Treatment Period 2 (2 Days)||4
10789567|NCT03522506|11949996|FG000|COMPLETED|Treatment Period 2 (2 Days)||5
10789568|NCT03522506|11949997|FG001|COMPLETED|Treatment Period 2 (2 Days)||5
10789569|NCT03522506|11949998|FG002|COMPLETED|Treatment Period 2 (2 Days)||5
10789570|NCT03522506|11949999|FG003|COMPLETED|Treatment Period 2 (2 Days)||4
10444340|NCT00945750|11591097|FG001|NOT COMPLETED|Period III||0
10444341|NCT00945750|11591098|FG002|NOT COMPLETED|Period III||0
10444342|NCT00945750|11591099|FG003|NOT COMPLETED|Period III||0
10444343|NCT00945750|11591100|FG004|NOT COMPLETED|Period III||0
10550632|NCT01533038|11704788|FG000|COMPLETED|Overall Study||45
10550633|NCT01533038|11704789|FG001|COMPLETED|Overall Study||34
10550634|NCT01533038|11704788|FG000|NOT COMPLETED|Overall Study||0
10444344|NCT00945750|11591101|FG005|NOT COMPLETED|Period III||0
10789571|NCT03522506|11949996|FG000|NOT COMPLETED|Treatment Period 2 (2 Days)||0
10789572|NCT03522506|11949997|FG001|NOT COMPLETED|Treatment Period 2 (2 Days)||0
10789573|NCT03522506|11949998|FG002|NOT COMPLETED|Treatment Period 2 (2 Days)||0
10444345|NCT00945815|11591109|FG000|STARTED|Overall Study||35
10444346|NCT00945815|11591109|FG000|Eligible|Overall Study||32
10444347|NCT00945815|11591109|FG000|Eligible and Began Protocol Therapy|Overall Study||31
10444348|NCT00945815|11591109|FG000|COMPLETED|Overall Study||27
10444349|NCT00945815|11591109|FG000|NOT COMPLETED|Overall Study||8
10444350|NCT00945854|11591115|FG000|STARTED|Overall Study||30
10444351|NCT00945854|11591116|FG001|STARTED|Overall Study||30
10444352|NCT00945854|11591115|FG000|COMPLETED|Overall Study||28
10444353|NCT00945854|11591116|FG001|COMPLETED|Overall Study||26
10444354|NCT00945854|11591115|FG000|NOT COMPLETED|Overall Study||2
10444355|NCT00945854|11591116|FG001|NOT COMPLETED|Overall Study||4
10444356|NCT00945893|11591124|FG000|STARTED|Overall Study||60
10444357|NCT00945893|11591125|FG001|STARTED|Overall Study||240
10444358|NCT00945893|11591124|FG000|Day 15 Post Dose 1|Overall Study||60
10444359|NCT00945893|11591125|FG001|Day 15 Post Dose 1|Overall Study||238
10444360|NCT00945893|11591124|FG000|Day 15 Post Dose 2|Overall Study||54
10444361|NCT00945893|11591125|FG001|Day 15 Post Dose 2|Overall Study||226
10444362|NCT00945893|11591124|FG000|COMPLETED|Overall Study||57
10444363|NCT00945893|11591125|FG001|COMPLETED|Overall Study||230
10444364|NCT00945893|11591124|FG000|NOT COMPLETED|Overall Study||3
10444365|NCT00945893|11591125|FG001|NOT COMPLETED|Overall Study||10
10444366|NCT00945906|11591135|FG000|STARTED|Overall Study||61
10444367|NCT00945906|11591135|FG000|COMPLETED|Overall Study||54
10444368|NCT00945906|11591135|FG000|NOT COMPLETED|Overall Study||7
10444369|NCT00945945|11591141|FG000|STARTED|Overall Study||207
10444370|NCT00945945|11591142|FG001|STARTED|Overall Study||217
10444371|NCT00945945|11591141|FG000|COMPLETED|Overall Study||171
10444372|NCT00945945|11591142|FG001|COMPLETED|Overall Study||162
10444373|NCT00945945|11591141|FG000|NOT COMPLETED|Overall Study||36
10444374|NCT00945945|11591142|FG001|NOT COMPLETED|Overall Study||55
10444375|NCT00945958|11591148|FG000|STARTED|Overall Study||161
10444376|NCT00945958|11591148|FG000|COMPLETED|Overall Study||149
10444377|NCT00945958|11591148|FG000|NOT COMPLETED|Overall Study||12
10444378|NCT00946023|11591153|FG000|STARTED|Overall Study||83
10444379|NCT00946023|11591153|FG000|COMPLETED|Overall Study||83
10444380|NCT00946023|11591153|FG000|NOT COMPLETED|Overall Study||0
10444381|NCT00946088|11591159|FG000|STARTED|Overall Study||4
10444382|NCT00946088|11591160|FG001|STARTED|Overall Study||3
10444383|NCT00946088|11591159|FG000|COMPLETED|Overall Study|At least one dose administered and pre-term birth status known.|4
10444384|NCT00946088|11591160|FG001|COMPLETED|Overall Study|At least one dose administered and pre-term birth status known.|2
10444385|NCT00946088|11591159|FG000|NOT COMPLETED|Overall Study||0
10444386|NCT00946088|11591160|FG001|NOT COMPLETED|Overall Study||1
10444387|NCT00946101|11591170|FG000|STARTED|Overall Study|Intent to Treat population, enrolled and randomized|261
10444388|NCT00946101|11591171|FG001|STARTED|Overall Study||65
10444389|NCT00946101|11591170|FG000|Day 15 Post Dose 1|Overall Study||260
10444390|NCT00946101|11591171|FG001|Day 15 Post Dose 1|Overall Study||64
10444391|NCT00946101|11591170|FG000|Day 15 Post Dose 2|Overall Study||254
10444392|NCT00946101|11591171|FG001|Day 15 Post Dose 2|Overall Study||63
10444393|NCT00946101|11591170|FG000|COMPLETED|Overall Study||257
10444394|NCT00946101|11591171|FG001|COMPLETED|Overall Study||63
10444395|NCT00946101|11591170|FG000|NOT COMPLETED|Overall Study||4
10444396|NCT00946101|11591171|FG001|NOT COMPLETED|Overall Study||2
10444397|NCT00946114|11591183|FG000|STARTED|Overall Study||20
10444398|NCT00946114|11591184|FG001|STARTED|Overall Study||12
10444399|NCT00946114|11591183|FG000|COMPLETED|Overall Study||12
10444400|NCT00946114|11591184|FG001|COMPLETED|Overall Study||10
10444401|NCT00946114|11591183|FG000|NOT COMPLETED|Overall Study||8
10444402|NCT00946114|11591184|FG001|NOT COMPLETED|Overall Study||2
10444403|NCT00946153|11591195|FG000|STARTED|Phase 1||6
10444404|NCT00946153|11591196|FG001|STARTED|Phase 1||3
10444405|NCT00946153|11591197|FG002|STARTED|Phase 1||6
10444406|NCT00946153|11591198|FG003|STARTED|Phase 1||5
10444407|NCT00946153|11591199|FG004|STARTED|Phase 1||0
10444408|NCT00946153|11591195|FG000|COMPLETED|Phase 1||6
10444409|NCT00946153|11591196|FG001|COMPLETED|Phase 1||3
10444410|NCT00946153|11591197|FG002|COMPLETED|Phase 1||6
10444411|NCT00946153|11591198|FG003|COMPLETED|Phase 1||5
10444412|NCT00946153|11591199|FG004|COMPLETED|Phase 1||0
10444413|NCT00946153|11591195|FG000|NOT COMPLETED|Phase 1||0
10444414|NCT00946153|11591196|FG001|NOT COMPLETED|Phase 1||0
10444415|NCT00946153|11591197|FG002|NOT COMPLETED|Phase 1||0
10444416|NCT00946153|11591198|FG003|NOT COMPLETED|Phase 1||0
10444417|NCT00946153|11591199|FG004|NOT COMPLETED|Phase 1||0
10444418|NCT00946153|11591195|FG000|STARTED|Phase 2||0
10444419|NCT00946153|11591196|FG001|STARTED|Phase 2||0
10444420|NCT00946153|11591197|FG002|STARTED|Phase 2||0
10444421|NCT00946153|11591198|FG003|STARTED|Phase 2||0
10444422|NCT00946153|11591199|FG004|STARTED|Phase 2||46
10444423|NCT00946153|11591195|FG000|COMPLETED|Phase 2||0
10444424|NCT00946153|11591196|FG001|COMPLETED|Phase 2||0
10444425|NCT00946153|11591197|FG002|COMPLETED|Phase 2||0
10444426|NCT00946153|11591198|FG003|COMPLETED|Phase 2||0
10444427|NCT00946153|11591199|FG004|COMPLETED|Phase 2||33
10444428|NCT00946153|11591195|FG000|NOT COMPLETED|Phase 2||0
10444429|NCT00946153|11591196|FG001|NOT COMPLETED|Phase 2||0
10444430|NCT00946153|11591197|FG002|NOT COMPLETED|Phase 2||0
10444431|NCT00946153|11591198|FG003|NOT COMPLETED|Phase 2||0
10444432|NCT00946153|11591199|FG004|NOT COMPLETED|Phase 2||13
10444433|NCT00946192|11591219|FG000|STARTED|Overall Study||43
10444434|NCT00946192|11591220|FG001|STARTED|Overall Study||40
10444435|NCT00946192|11591221|FG002|STARTED|Overall Study||38
10444436|NCT00946192|11591219|FG000|COMPLETED|Overall Study||25
10444437|NCT00946192|11591220|FG001|COMPLETED|Overall Study||22
10444438|NCT00946192|11591221|FG002|COMPLETED|Overall Study||26
10444439|NCT00946192|11591219|FG000|NOT COMPLETED|Overall Study||18
10444440|NCT00946192|11591220|FG001|NOT COMPLETED|Overall Study||18
10444441|NCT00946192|11591221|FG002|NOT COMPLETED|Overall Study||12
10444442|NCT00946270|11591232|FG000|STARTED|Overall Study||21
10444443|NCT00946270|11591233|FG001|STARTED|Overall Study||20
10444444|NCT00946270|11591234|FG002|STARTED|Overall Study||29
10444445|NCT00946270|11591232|FG000|COMPLETED|Overall Study||21
10444446|NCT00946270|11591233|FG001|COMPLETED|Overall Study||20
10444447|NCT00946270|11591234|FG002|COMPLETED|Overall Study||29
10444448|NCT00946270|11591232|FG000|NOT COMPLETED|Overall Study||0
10444449|NCT00946270|11591233|FG001|NOT COMPLETED|Overall Study||0
10444450|NCT00946270|11591234|FG002|NOT COMPLETED|Overall Study||0
10525556|NCT01376362|11677485|FG000|STARTED|Overall Study||5
10525557|NCT01376362|11677485|FG000|COMPLETED|Overall Study||5
10525558|NCT01376362|11677485|FG000|NOT COMPLETED|Overall Study||0
10444451|NCT00946296|11591244|FG000|STARTED|Overall Study||21
10444452|NCT00946296|11591245|FG001|STARTED|Overall Study||15
10444453|NCT00946296|11591244|FG000|COMPLETED|Overall Study||18
10444454|NCT00946296|11591245|FG001|COMPLETED|Overall Study||15
10444455|NCT00946296|11591244|FG000|NOT COMPLETED|Overall Study||3
10444456|NCT00946296|11591245|FG001|NOT COMPLETED|Overall Study||0
10444457|NCT00946309|11591253|FG000|STARTED|Overall Study||22
10444458|NCT00946309|11591254|FG001|STARTED|Overall Study||23
10444459|NCT00946309|11591253|FG000|COMPLETED|Overall Study||21
10444460|NCT00946309|11591254|FG001|COMPLETED|Overall Study||19
10444461|NCT00946309|11591253|FG000|NOT COMPLETED|Overall Study||1
10444462|NCT00946309|11591254|FG001|NOT COMPLETED|Overall Study||4
10444463|NCT00946322|11591261|FG000|STARTED|Pre-treatment||12
10444464|NCT00946322|11591261|FG000|COMPLETED|Pre-treatment||11
10444465|NCT00946322|11591261|FG000|NOT COMPLETED|Pre-treatment||1
10444466|NCT00946322|11591261|FG000|STARTED|Post-treatment||11
10444467|NCT00946322|11591261|FG000|COMPLETED|Post-treatment||9
10444468|NCT00946322|11591261|FG000|NOT COMPLETED|Post-treatment||2
10444469|NCT00946348|11591267|FG000|STARTED|Overall Study||6
10444470|NCT00946348|11591268|FG001|STARTED|Overall Study||6
10444471|NCT00946348|11591267|FG000|COMPLETED|Overall Study||6
10444472|NCT00946348|11591268|FG001|COMPLETED|Overall Study||6
10444473|NCT00946348|11591267|FG000|NOT COMPLETED|Overall Study||0
10444474|NCT00946348|11591268|FG001|NOT COMPLETED|Overall Study||0
10444475|NCT00946478|11591276|FG000|STARTED|Overall Study||20
10444476|NCT00946478|11591277|FG001|STARTED|Overall Study||20
10444477|NCT00946478|11591276|FG000|COMPLETED|Overall Study||20
10444478|NCT00946478|11591277|FG001|COMPLETED|Overall Study||20
10444479|NCT00946478|11591276|FG000|NOT COMPLETED|Overall Study||0
10444480|NCT00946478|11591277|FG001|NOT COMPLETED|Overall Study||0
10444481|NCT00946530|11591287|FG000|STARTED|Overall Study|32 dyads consisting of 1 AD patient and 1 caregiver were assigned the Bright Light Arm|32
10444482|NCT00946530|11591288|FG001|STARTED|Overall Study|27 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|27
10444483|NCT00946530|11591289|FG002|STARTED|Overall Study|32 dyads consisting of 1 AD patient and 1 caregiver were assigned the Bright Light Arm|32
10444484|NCT00946530|11591290|FG003|STARTED|Overall Study|27 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|27
10550635|NCT01533038|11704789|FG001|NOT COMPLETED|Overall Study||1
10550636|NCT01533077|11704799|FG000|STARTED|Overall Study||5
10550637|NCT01533077|11704800|FG001|STARTED|Overall Study||5
10550638|NCT01533077|11704801|FG002|STARTED|Overall Study||4
10550639|NCT01533077|11704802|FG003|STARTED|Overall Study||4
10550640|NCT01533077|11704799|FG000|BIA 9-1067 50 mg|Overall Study||5
10550641|NCT01533077|11704800|FG001|BIA 9-1067 50 mg|Overall Study||5
10550642|NCT01533077|11704801|FG002|BIA 9-1067 50 mg|Overall Study||4
10550643|NCT01533077|11704802|FG003|BIA 9-1067 50 mg|Overall Study||4
10550644|NCT01533077|11704799|FG000|Sinemet® 100/25|Overall Study||4
10550645|NCT01533077|11704800|FG001|Sinemet® 100/25|Overall Study||5
10550646|NCT01533077|11704801|FG002|Sinemet® 100/25|Overall Study||4
10550647|NCT01533077|11704802|FG003|Sinemet® 100/25|Overall Study||4
10550648|NCT01533077|11704799|FG000|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
10550649|NCT01533077|11704800|FG001|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
10550650|NCT01533077|11704801|FG002|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
10550651|NCT01533077|11704802|FG003|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
10550652|NCT01533077|11704799|FG000|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||5
10550653|NCT01533077|11704800|FG001|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||5
10550654|NCT01533077|11704801|FG002|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||4
10550655|NCT01533077|11704802|FG003|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||4
10550656|NCT01533077|11704799|FG000|COMPLETED|Overall Study||4
10550657|NCT01533077|11704800|FG001|COMPLETED|Overall Study||4
10550658|NCT01533077|11704801|FG002|COMPLETED|Overall Study||4
10550659|NCT01533077|11704802|FG003|COMPLETED|Overall Study||4
10550660|NCT01533077|11704799|FG000|NOT COMPLETED|Overall Study||1
10550661|NCT01533077|11704800|FG001|NOT COMPLETED|Overall Study||1
10550662|NCT01533077|11704801|FG002|NOT COMPLETED|Overall Study||0
10550663|NCT01533077|11704802|FG003|NOT COMPLETED|Overall Study||0
10550664|NCT01533116|11704816|FG000|STARTED|Overall Study||14
10789574|NCT03522506|11949999|FG003|NOT COMPLETED|Treatment Period 2 (2 Days)||0
10789575|NCT03522506|11949996|FG000|STARTED|Washout Period 2 (7 Days)||5
10789576|NCT03522506|11949997|FG001|STARTED|Washout Period 2 (7 Days)||5
10789577|NCT03522506|11949998|FG002|STARTED|Washout Period 2 (7 Days)||5
10789578|NCT03522506|11949999|FG003|STARTED|Washout Period 2 (7 Days)||4
10789579|NCT03522506|11949996|FG000|COMPLETED|Washout Period 2 (7 Days)||5
10789580|NCT03522506|11949997|FG001|COMPLETED|Washout Period 2 (7 Days)||5
10444485|NCT00946530|11591287|FG000|COMPLETED|Overall Study|31 dyads consisting of 1 AD patient and 1 caregiver completed the Bright Light Arm|31
10444486|NCT00946530|11591288|FG001|COMPLETED|Overall Study|23 dyads consisting of 1 AD patient and 1 caregiver completed to the Dim Light (Control) arm|23
10550665|NCT01533116|11704817|FG001|STARTED|Overall Study||13
10550666|NCT01533116|11704818|FG002|STARTED|Overall Study||13
10550667|NCT01533116|11704819|FG003|STARTED|Overall Study||12
10550668|NCT01533116|11704816|FG000|COMPLETED|Overall Study||12
10550669|NCT01533116|11704817|FG001|COMPLETED|Overall Study||12
10550670|NCT01533116|11704818|FG002|COMPLETED|Overall Study||12
10550671|NCT01533116|11704819|FG003|COMPLETED|Overall Study||12
10550672|NCT01533116|11704816|FG000|NOT COMPLETED|Overall Study||2
10550673|NCT01533116|11704817|FG001|NOT COMPLETED|Overall Study||1
10550674|NCT01533116|11704818|FG002|NOT COMPLETED|Overall Study||1
10550675|NCT01533116|11704819|FG003|NOT COMPLETED|Overall Study||0
10550676|NCT01533181|11704831|FG000|STARTED|Overall Study||15
10550677|NCT01533181|11704832|FG001|STARTED|Overall Study||29
10550678|NCT01533181|11704831|FG000|COMPLETED|Overall Study||14
10550679|NCT01533181|11704832|FG001|COMPLETED|Overall Study||28
10550680|NCT01533181|11704831|FG000|NOT COMPLETED|Overall Study||1
10444487|NCT00946530|11591289|FG002|COMPLETED|Overall Study|31 dyads consisting of 1 AD patient and 1 caregiver completed the Bright Light Arm|31
10444488|NCT00946530|11591290|FG003|COMPLETED|Overall Study|23 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|23
10444489|NCT00946530|11591287|FG000|NOT COMPLETED|Overall Study||1
10444490|NCT00946530|11591288|FG001|NOT COMPLETED|Overall Study||4
10444491|NCT00946530|11591289|FG002|NOT COMPLETED|Overall Study||1
10444492|NCT00946530|11591290|FG003|NOT COMPLETED|Overall Study||4
10444493|NCT00946647|11591309|FG000|STARTED|Phase 1 Part||6
10444494|NCT00946647|11591310|FG001|STARTED|Phase 1 Part||18
10444495|NCT00946647|11591311|FG002|STARTED|Phase 1 Part||7
10444496|NCT00946647|11591312|FG003|STARTED|Phase 1 Part||0
10444497|NCT00946647|11591313|FG004|STARTED|Phase 1 Part||0
10444498|NCT00946647|11591309|FG000|COMPLETED|Phase 1 Part||0
10444499|NCT00946647|11591310|FG001|COMPLETED|Phase 1 Part||0
10444500|NCT00946647|11591311|FG002|COMPLETED|Phase 1 Part||0
10444501|NCT00946647|11591312|FG003|COMPLETED|Phase 1 Part||0
10444502|NCT00946647|11591313|FG004|COMPLETED|Phase 1 Part||0
10444503|NCT00946647|11591309|FG000|NOT COMPLETED|Phase 1 Part||6
10444504|NCT00946647|11591310|FG001|NOT COMPLETED|Phase 1 Part||18
10444505|NCT00946647|11591311|FG002|NOT COMPLETED|Phase 1 Part||7
10444506|NCT00946647|11591312|FG003|NOT COMPLETED|Phase 1 Part||0
10444507|NCT00946647|11591313|FG004|NOT COMPLETED|Phase 1 Part||0
10444508|NCT00946647|11591309|FG000|STARTED|Phase ll Part||0
10444509|NCT00946647|11591310|FG001|STARTED|Phase ll Part||0
10444510|NCT00946647|11591311|FG002|STARTED|Phase ll Part||0
10444511|NCT00946647|11591312|FG003|STARTED|Phase ll Part||40
10444512|NCT00946647|11591313|FG004|STARTED|Phase ll Part||42
10444513|NCT00946647|11591309|FG000|Safety Set|Phase ll Part||0
10550681|NCT01533181|11704832|FG001|NOT COMPLETED|Overall Study||1
10550682|NCT01533207|11704840|FG000|STARTED|Overall Study||20
10550683|NCT01533207|11704841|FG001|STARTED|Overall Study||18
10550684|NCT01533207|11704840|FG000|COMPLETED|Overall Study||20
10550685|NCT01533207|11704841|FG001|COMPLETED|Overall Study||18
10550686|NCT01533207|11704840|FG000|NOT COMPLETED|Overall Study||0
10550687|NCT01533207|11704841|FG001|NOT COMPLETED|Overall Study||0
10444514|NCT00946647|11591310|FG001|Safety Set|Phase ll Part||0
10444515|NCT00946647|11591311|FG002|Safety Set|Phase ll Part||0
10444516|NCT00946647|11591312|FG003|Safety Set|Phase ll Part|2 pts rand. to this grp did not receive PAN|38
10444517|NCT00946647|11591313|FG004|Safety Set|Phase ll Part|2 pts rand. to PAN+5AZA, did not receive PAN but received 5AZA|42
10444518|NCT00946647|11591309|FG000|COMPLETED|Phase ll Part||0
10444519|NCT00946647|11591310|FG001|COMPLETED|Phase ll Part||0
10444520|NCT00946647|11591311|FG002|COMPLETED|Phase ll Part||0
10444521|NCT00946647|11591312|FG003|COMPLETED|Phase ll Part||0
10444522|NCT00946647|11591313|FG004|COMPLETED|Phase ll Part||0
10444523|NCT00946647|11591309|FG000|NOT COMPLETED|Phase ll Part||0
10444524|NCT00946647|11591310|FG001|NOT COMPLETED|Phase ll Part||0
10444525|NCT00946647|11591311|FG002|NOT COMPLETED|Phase ll Part||0
10444526|NCT00946647|11591312|FG003|NOT COMPLETED|Phase ll Part||40
10444527|NCT00946647|11591313|FG004|NOT COMPLETED|Phase ll Part||42
10444528|NCT00946712|11591328|FG000|STARTED|Overall Study||671
10444529|NCT00946712|11591329|FG001|STARTED|Overall Study||662
10444530|NCT00946712|11591328|FG000|COMPLETED|Overall Study||124
10444531|NCT00946712|11591329|FG001|COMPLETED|Overall Study||0
10444532|NCT00946712|11591328|FG000|NOT COMPLETED|Overall Study||547
10444533|NCT00946712|11591329|FG001|NOT COMPLETED|Overall Study||662
10444534|NCT00946881|11591336|FG000|STARTED|First Treatment||30
10444535|NCT00946881|11591336|FG000|COMPLETED|First Treatment||28
10444536|NCT00946881|11591336|FG000|NOT COMPLETED|First Treatment||2
10444537|NCT00946881|11591336|FG000|STARTED|Retreatment||8
10444538|NCT00946881|11591336|FG000|COMPLETED|Retreatment||7
10444539|NCT00946881|11591336|FG000|NOT COMPLETED|Retreatment||1
10444540|NCT00946920|11591363|FG000|STARTED|Overall Study|Received at least one dose of degarelix.|565
10444541|NCT00946920|11591364|FG001|STARTED|Overall Study|Received at least one dose of goserelin acetate.|283
10444542|NCT00946920|11591363|FG000|Full Analysis Set (FAS)|Overall Study|Received at least one dose of degarelix and had at least one post-dosing efficacy assessment.|565
10444543|NCT00946920|11591364|FG001|Full Analysis Set (FAS)|Overall Study|Received at least one dose of goserelin and had at least one post-dosing efficacy assessment.|282
10444544|NCT00946920|11591363|FG000|COMPLETED|Overall Study||455
10444545|NCT00946920|11591364|FG001|COMPLETED|Overall Study||239
10444546|NCT00946920|11591363|FG000|NOT COMPLETED|Overall Study||110
10444547|NCT00946920|11591364|FG001|NOT COMPLETED|Overall Study||44
10444548|NCT00946998|11591372|FG000|STARTED|Overall Study||102
10444549|NCT00946998|11591373|FG001|STARTED|Overall Study||99
10444550|NCT00946998|11591372|FG000|Received Treatment as Randomized|Overall Study||102
10444551|NCT00946998|11591373|FG001|Received Treatment as Randomized|Overall Study||99
10444552|NCT00946998|11591372|FG000|COMPLETED|Overall Study||97
10444553|NCT00946998|11591373|FG001|COMPLETED|Overall Study||96
10444554|NCT00946998|11591372|FG000|NOT COMPLETED|Overall Study||5
10550688|NCT01533246|11704847|FG000|STARTED|Overall Study||17
10550689|NCT01533246|11704847|FG000|COMPLETED|Overall Study||15
10550690|NCT01533246|11704847|FG000|NOT COMPLETED|Overall Study||2
10550691|NCT01533259|11704851|FG000|STARTED|Overall Study||48
10550692|NCT01533259|11704851|FG000|COMPLETED|Overall Study||48
10444555|NCT00946998|11591373|FG001|NOT COMPLETED|Overall Study||3
10444556|NCT00947115|11591382|FG000|STARTED|Overall Study||159
10444557|NCT00947115|11591383|FG001|STARTED|Overall Study||194
10444558|NCT00947115|11591384|FG002|STARTED|Overall Study||171
10444559|NCT00947115|11591382|FG000|COMPLETED|Overall Study||142
10444560|NCT00947115|11591383|FG001|COMPLETED|Overall Study||172
10444561|NCT00947115|11591384|FG002|COMPLETED|Overall Study||156
10444562|NCT00947115|11591382|FG000|NOT COMPLETED|Overall Study||17
10444563|NCT00947115|11591383|FG001|NOT COMPLETED|Overall Study||22
10444564|NCT00947115|11591384|FG002|NOT COMPLETED|Overall Study||15
10444565|NCT00947154|11591392|FG000|STARTED|Overall Study||12
10444566|NCT00947154|11591392|FG000|COMPLETED|Overall Study||11
10444567|NCT00947154|11591392|FG000|NOT COMPLETED|Overall Study||1
10444568|NCT00947167|11591397|FG000|STARTED|Pertuzumab Alone||4
10444569|NCT00947167|11591397|FG000|COMPLETED|Pertuzumab Alone||4
10444570|NCT00947167|11591397|FG000|NOT COMPLETED|Pertuzumab Alone||0
10444571|NCT00947167|11591397|FG000|STARTED|Erlotinib Added to Pertuzumab||3
10444572|NCT00947167|11591397|FG000|COMPLETED|Erlotinib Added to Pertuzumab||3
10444573|NCT00947167|11591397|FG000|NOT COMPLETED|Erlotinib Added to Pertuzumab||0
10444574|NCT00947193|11591401|FG000|STARTED|Overall Study||3
10444575|NCT00947193|11591402|FG001|STARTED|Overall Study||10
10444576|NCT00947193|11591401|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
10444577|NCT00947193|11591402|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
10444578|NCT00947193|11591401|FG000|COMPLETED|Overall Study||0
10444579|NCT00947193|11591402|FG001|COMPLETED|Overall Study||10
10444580|NCT00947193|11591401|FG000|NOT COMPLETED|Overall Study||3
10444581|NCT00947193|11591402|FG001|NOT COMPLETED|Overall Study||0
10444582|NCT00947219|11591410|FG000|STARTED|Overall Study||28
10444583|NCT00947219|11591411|FG001|STARTED|Overall Study||25
10444584|NCT00947219|11591412|FG002|STARTED|Overall Study||26
10444585|NCT00947219|11591410|FG000|COMPLETED|Overall Study||22
10444586|NCT00947219|11591411|FG001|COMPLETED|Overall Study||21
10444587|NCT00947219|11591412|FG002|COMPLETED|Overall Study||22
10444588|NCT00947219|11591410|FG000|NOT COMPLETED|Overall Study||6
10444589|NCT00947219|11591411|FG001|NOT COMPLETED|Overall Study||4
10444590|NCT00947219|11591412|FG002|NOT COMPLETED|Overall Study||4
10444591|NCT00947271|11591424|FG000|STARTED|3 Months Post Intervention||254
10444592|NCT00947271|11591425|FG001|STARTED|3 Months Post Intervention||252
10444593|NCT00947271|11591426|FG002|STARTED|3 Months Post Intervention||254
10444594|NCT00947271|11591427|FG003|STARTED|3 Months Post Intervention||250
10444595|NCT00947271|11591424|FG000|COMPLETED|3 Months Post Intervention||202
10444596|NCT00947271|11591425|FG001|COMPLETED|3 Months Post Intervention||204
10444597|NCT00947271|11591426|FG002|COMPLETED|3 Months Post Intervention||218
10444598|NCT00947271|11591427|FG003|COMPLETED|3 Months Post Intervention||206
10444599|NCT00947271|11591424|FG000|NOT COMPLETED|3 Months Post Intervention||52
10444600|NCT00947271|11591425|FG001|NOT COMPLETED|3 Months Post Intervention||48
10444601|NCT00947271|11591426|FG002|NOT COMPLETED|3 Months Post Intervention||36
10444602|NCT00947271|11591427|FG003|NOT COMPLETED|3 Months Post Intervention||44
10444603|NCT00947271|11591424|FG000|STARTED|6 Months Post Intervention||254
10444604|NCT00947271|11591425|FG001|STARTED|6 Months Post Intervention||252
10444605|NCT00947271|11591426|FG002|STARTED|6 Months Post Intervention||254
10444606|NCT00947271|11591427|FG003|STARTED|6 Months Post Intervention||250
10444607|NCT00947271|11591424|FG000|COMPLETED|6 Months Post Intervention||199
10444608|NCT00947271|11591425|FG001|COMPLETED|6 Months Post Intervention||199
10444609|NCT00947271|11591426|FG002|COMPLETED|6 Months Post Intervention||196
10444610|NCT00947271|11591427|FG003|COMPLETED|6 Months Post Intervention||196
10444611|NCT00947271|11591424|FG000|NOT COMPLETED|6 Months Post Intervention||55
10444612|NCT00947271|11591425|FG001|NOT COMPLETED|6 Months Post Intervention||53
10444613|NCT00947271|11591426|FG002|NOT COMPLETED|6 Months Post Intervention||58
10444614|NCT00947271|11591427|FG003|NOT COMPLETED|6 Months Post Intervention||54
10444615|NCT00947271|11591424|FG000|STARTED|9 Months Post Intervention||254
10444616|NCT00947271|11591425|FG001|STARTED|9 Months Post Intervention||252
10444617|NCT00947271|11591426|FG002|STARTED|9 Months Post Intervention||254
10444618|NCT00947271|11591427|FG003|STARTED|9 Months Post Intervention||250
10444619|NCT00947271|11591424|FG000|COMPLETED|9 Months Post Intervention||184
10444620|NCT00947271|11591425|FG001|COMPLETED|9 Months Post Intervention||192
10444621|NCT00947271|11591426|FG002|COMPLETED|9 Months Post Intervention||193
10444622|NCT00947271|11591427|FG003|COMPLETED|9 Months Post Intervention||191
10444623|NCT00947271|11591424|FG000|NOT COMPLETED|9 Months Post Intervention||70
10444624|NCT00947271|11591425|FG001|NOT COMPLETED|9 Months Post Intervention||60
10444625|NCT00947271|11591426|FG002|NOT COMPLETED|9 Months Post Intervention||61
10444626|NCT00947271|11591427|FG003|NOT COMPLETED|9 Months Post Intervention||59
10444627|NCT00947271|11591424|FG000|STARTED|12 Months Post Intervention||254
10444628|NCT00947271|11591425|FG001|STARTED|12 Months Post Intervention||252
10444629|NCT00947271|11591426|FG002|STARTED|12 Months Post Intervention||254
10444630|NCT00947271|11591427|FG003|STARTED|12 Months Post Intervention||250
10444631|NCT00947271|11591424|FG000|COMPLETED|12 Months Post Intervention||183
10444632|NCT00947271|11591425|FG001|COMPLETED|12 Months Post Intervention||192
10444633|NCT00947271|11591426|FG002|COMPLETED|12 Months Post Intervention||195
10444634|NCT00947271|11591427|FG003|COMPLETED|12 Months Post Intervention||188
10444635|NCT00947271|11591424|FG000|NOT COMPLETED|12 Months Post Intervention||71
10444636|NCT00947271|11591425|FG001|NOT COMPLETED|12 Months Post Intervention||60
10444637|NCT00947271|11591426|FG002|NOT COMPLETED|12 Months Post Intervention||59
10444638|NCT00947271|11591427|FG003|NOT COMPLETED|12 Months Post Intervention||62
10444639|NCT00947297|11591437|FG000|STARTED|Overall Study||60
10444640|NCT00947297|11591437|FG000|COMPLETED|Overall Study||53
10444641|NCT00947297|11591437|FG000|NOT COMPLETED|Overall Study||7
10444642|NCT00947310|11591445|FG000|STARTED|Overall Study||514
10444643|NCT00947310|11591446|FG001|STARTED|Overall Study||500
10444644|NCT00947310|11591447|FG002|STARTED|Overall Study||486
10444645|NCT00947310|11591445|FG000|COMPLETED|Overall Study||514
10444646|NCT00947310|11591446|FG001|COMPLETED|Overall Study||500
10444647|NCT00947310|11591447|FG002|COMPLETED|Overall Study||486
10444648|NCT00947310|11591445|FG000|NOT COMPLETED|Overall Study||0
10444649|NCT00947310|11591446|FG001|NOT COMPLETED|Overall Study||0
10444650|NCT00947310|11591447|FG002|NOT COMPLETED|Overall Study||0
10444651|NCT00947349|11591459|FG000|STARTED|Triple Treatment Combination Period||4
10444652|NCT00947349|11591460|FG001|STARTED|Triple Treatment Combination Period||6
10444653|NCT00947349|11591461|FG002|STARTED|Triple Treatment Combination Period||6
10444654|NCT00947349|11591462|FG003|STARTED|Triple Treatment Combination Period||6
10444655|NCT00947349|11591459|FG000|COMPLETED|Triple Treatment Combination Period||4
10444656|NCT00947349|11591460|FG001|COMPLETED|Triple Treatment Combination Period||5
10444657|NCT00947349|11591461|FG002|COMPLETED|Triple Treatment Combination Period||6
10444658|NCT00947349|11591462|FG003|COMPLETED|Triple Treatment Combination Period||6
10444659|NCT00947349|11591459|FG000|NOT COMPLETED|Triple Treatment Combination Period||0
10444660|NCT00947349|11591460|FG001|NOT COMPLETED|Triple Treatment Combination Period||1
10444661|NCT00947349|11591461|FG002|NOT COMPLETED|Triple Treatment Combination Period||0
10444662|NCT00947349|11591462|FG003|NOT COMPLETED|Triple Treatment Combination Period||0
10444663|NCT00947349|11591459|FG000|STARTED|Overall Study Standard of Care||4
10444664|NCT00947349|11591460|FG001|STARTED|Overall Study Standard of Care||5
10444665|NCT00947349|11591461|FG002|STARTED|Overall Study Standard of Care||6
10444666|NCT00947349|11591462|FG003|STARTED|Overall Study Standard of Care||6
10444667|NCT00947349|11591459|FG000|COMPLETED|Overall Study Standard of Care||4
10444668|NCT00947349|11591460|FG001|COMPLETED|Overall Study Standard of Care||5
10444669|NCT00947349|11591461|FG002|COMPLETED|Overall Study Standard of Care||4
10444670|NCT00947349|11591462|FG003|COMPLETED|Overall Study Standard of Care||4
10444671|NCT00947349|11591459|FG000|NOT COMPLETED|Overall Study Standard of Care||0
10444672|NCT00947349|11591460|FG001|NOT COMPLETED|Overall Study Standard of Care||0
10444673|NCT00947349|11591461|FG002|NOT COMPLETED|Overall Study Standard of Care||2
10444674|NCT00947349|11591462|FG003|NOT COMPLETED|Overall Study Standard of Care||2
10444675|NCT00947427|11591492|FG000|STARTED|Overall Study||22
10444676|NCT00947427|11591493|FG001|STARTED|Overall Study|2 participants discontinued prior to any study drug administration|49
10444677|NCT00947427|11591492|FG000|COMPLETED|Overall Study||21
10444678|NCT00947427|11591493|FG001|COMPLETED|Overall Study||45
10444679|NCT00947427|11591492|FG000|NOT COMPLETED|Overall Study||1
10444680|NCT00947427|11591493|FG001|NOT COMPLETED|Overall Study||4
10444681|NCT00947505|11591501|FG000|STARTED|Overall Study||33
10444682|NCT00947505|11591502|FG001|STARTED|Overall Study||16
10444683|NCT00947505|11591501|FG000|COMPLETED|Overall Study||24
10444684|NCT00947505|11591502|FG001|COMPLETED|Overall Study||14
10444685|NCT00947505|11591501|FG000|NOT COMPLETED|Overall Study||9
10444686|NCT00947505|11591502|FG001|NOT COMPLETED|Overall Study||2
10318662|NCT00215683|11452893|FG000|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study|16
10318663|NCT00215683|11452894|FG001|COMPLETED|Overall Study||22
10318664|NCT00215683|11452895|FG002|COMPLETED|Overall Study||12
10444687|NCT00947531|11591510|FG000|STARTED|Overall Study||121
10444688|NCT00947531|11591511|FG001|STARTED|Overall Study||121
10444689|NCT00947531|11591510|FG000|COMPLETED|Overall Study||107
10444690|NCT00947531|11591511|FG001|COMPLETED|Overall Study||110
10444691|NCT00947531|11591510|FG000|NOT COMPLETED|Overall Study||14
10444692|NCT00947531|11591511|FG001|NOT COMPLETED|Overall Study||11
10318665|NCT00215683|11452893|FG000|NOT COMPLETED|Overall Study||29
10444693|NCT00947544|11591517|FG000|STARTED|Switch-Over Period (2 Weeks)||11
10444694|NCT00947544|11591518|FG001|STARTED|Switch-Over Period (2 Weeks)||0
10444695|NCT00947544|11591517|FG000|COMPLETED|Switch-Over Period (2 Weeks)||11
10444696|NCT00947544|11591518|FG001|COMPLETED|Switch-Over Period (2 Weeks)||0
10444697|NCT00947544|11591517|FG000|NOT COMPLETED|Switch-Over Period (2 Weeks)||0
10444698|NCT00947544|11591518|FG001|NOT COMPLETED|Switch-Over Period (2 Weeks)||0
10444699|NCT00947544|11591517|FG000|STARTED|Safety-Extension Period (12 Months)||11
10525559|NCT01376388|11677489|FG000|STARTED|Overall Study||130
10525560|NCT01376388|11677489|FG000|COMPLETED|Overall Study||112
10525561|NCT01376388|11677489|FG000|NOT COMPLETED|Overall Study||18
10525562|NCT01376557|11677498|FG000|STARTED|Overall Study||59
10525563|NCT01376557|11677499|FG001|STARTED|Overall Study||60
10525564|NCT01376557|11677500|FG002|STARTED|Overall Study||60
10525565|NCT01376557|11677501|FG003|STARTED|Overall Study||60
10525566|NCT01376557|11677502|FG004|STARTED|Overall Study||60
10525567|NCT01376557|11677498|FG000|COMPLETED|Overall Study||51
10525568|NCT01376557|11677499|FG001|COMPLETED|Overall Study||54
10525569|NCT01376557|11677500|FG002|COMPLETED|Overall Study||55
10525570|NCT01376557|11677501|FG003|COMPLETED|Overall Study||54
10525571|NCT01376557|11677502|FG004|COMPLETED|Overall Study||53
10525572|NCT01376557|11677498|FG000|NOT COMPLETED|Overall Study||8
10525573|NCT01376557|11677499|FG001|NOT COMPLETED|Overall Study||6
10525574|NCT01376557|11677500|FG002|NOT COMPLETED|Overall Study||5
10525575|NCT01376557|11677501|FG003|NOT COMPLETED|Overall Study||6
10525576|NCT01376557|11677502|FG004|NOT COMPLETED|Overall Study||7
10525577|NCT01376700|11677514|FG000|STARTED|Overall Study||19
10525578|NCT01376700|11677514|FG000|COMPLETED|Overall Study||3
10444700|NCT00947544|11591518|FG001|STARTED|Safety-Extension Period (12 Months)|New participants were enrolled due to DSMB approval.|6
10444701|NCT00947544|11591517|FG000|COMPLETED|Safety-Extension Period (12 Months)||10
10444702|NCT00947544|11591518|FG001|COMPLETED|Safety-Extension Period (12 Months)||6
10444703|NCT00947544|11591517|FG000|NOT COMPLETED|Safety-Extension Period (12 Months)||1
10444704|NCT00947544|11591518|FG001|NOT COMPLETED|Safety-Extension Period (12 Months)||0
10444705|NCT00947661|11591530|FG000|STARTED|Overall Study||289
10444706|NCT00947661|11591531|FG001|STARTED|Overall Study||289
10444707|NCT00947661|11591530|FG000|COMPLETED|Overall Study||276
10550693|NCT01533259|11704851|FG000|NOT COMPLETED|Overall Study||0
10550694|NCT01533428|11704857|FG000|STARTED|Overall Study||186
10550695|NCT01533428|11704858|FG001|STARTED|Overall Study||183
10550696|NCT01533428|11704857|FG000|COMPLETED|Overall Study||177
10550697|NCT01533428|11704858|FG001|COMPLETED|Overall Study||175
10550698|NCT01533428|11704857|FG000|NOT COMPLETED|Overall Study||9
10550699|NCT01533428|11704858|FG001|NOT COMPLETED|Overall Study||8
10550700|NCT01533493|11704866|FG000|STARTED|Overall Study||12
10550701|NCT01533493|11704867|FG001|STARTED|Overall Study||14
10789581|NCT03522506|11949998|FG002|COMPLETED|Washout Period 2 (7 Days)||5
10789582|NCT03522506|11949999|FG003|COMPLETED|Washout Period 2 (7 Days)||3
10789583|NCT03522506|11949996|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
10789584|NCT03522506|11949997|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
10789585|NCT03522506|11949998|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
10789586|NCT03522506|11949999|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||1
10789587|NCT03522506|11949996|FG000|STARTED|Treatment Period 3 (2 Days)||5
10444708|NCT00947661|11591531|FG001|COMPLETED|Overall Study||274
10444709|NCT00947661|11591530|FG000|NOT COMPLETED|Overall Study||13
10444710|NCT00947661|11591531|FG001|NOT COMPLETED|Overall Study||15
10444711|NCT00947752|11591539|FG000|STARTED|7-Day Run-in Treatment Period|All subjects started with a daily does of F1 for 7 days|147
10444712|NCT00947752|11591540|FG001|STARTED|7-Day Run-in Treatment Period||0
10444713|NCT00947752|11591539|FG000|COMPLETED|7-Day Run-in Treatment Period||147
10444714|NCT00947752|11591540|FG001|COMPLETED|7-Day Run-in Treatment Period||0
10444715|NCT00947752|11591539|FG000|NOT COMPLETED|7-Day Run-in Treatment Period||0
10444716|NCT00947752|11591540|FG001|NOT COMPLETED|7-Day Run-in Treatment Period||0
10444717|NCT00947752|11591539|FG000|STARTED|1st 14-day Treatment Period||76
10444718|NCT00947752|11591540|FG001|STARTED|1st 14-day Treatment Period||71
10444719|NCT00947752|11591539|FG000|COMPLETED|1st 14-day Treatment Period||76
10444720|NCT00947752|11591540|FG001|COMPLETED|1st 14-day Treatment Period||71
10444721|NCT00947752|11591539|FG000|NOT COMPLETED|1st 14-day Treatment Period||0
10444722|NCT00947752|11591540|FG001|NOT COMPLETED|1st 14-day Treatment Period||0
10444723|NCT00947752|11591539|FG000|STARTED|Crossover to 2nd 14-day Treatment Period||71
10444724|NCT00947752|11591540|FG001|STARTED|Crossover to 2nd 14-day Treatment Period||76
10444725|NCT00947752|11591539|FG000|COMPLETED|Crossover to 2nd 14-day Treatment Period||71
10444726|NCT00947752|11591540|FG001|COMPLETED|Crossover to 2nd 14-day Treatment Period||76
10444727|NCT00947752|11591539|FG000|NOT COMPLETED|Crossover to 2nd 14-day Treatment Period||0
10444728|NCT00947752|11591540|FG001|NOT COMPLETED|Crossover to 2nd 14-day Treatment Period||0
10444729|NCT00947765|11591548|FG000|STARTED|Overall Study||30
10444730|NCT00947765|11591549|FG001|STARTED|Overall Study||30
10444731|NCT00947765|11591548|FG000|COMPLETED|Overall Study||30
10444732|NCT00947765|11591549|FG001|COMPLETED|Overall Study||30
10444733|NCT00947765|11591548|FG000|NOT COMPLETED|Overall Study||0
10444734|NCT00947765|11591549|FG001|NOT COMPLETED|Overall Study||0
10444735|NCT00947856|11591557|FG000|STARTED|Treatment Period||78
10444736|NCT00947856|11591558|FG001|STARTED|Treatment Period|Two patients in extension arm re-enrolled in retreatment arm and are represented in both arms|32
10444737|NCT00947856|11591557|FG000|COMPLETED|Treatment Period||0
10444738|NCT00947856|11591558|FG001|COMPLETED|Treatment Period|Patients treated until disease progression, unacceptable toxicity or study closure|0
10444739|NCT00947856|11591557|FG000|NOT COMPLETED|Treatment Period||78
10444740|NCT00947856|11591558|FG001|NOT COMPLETED|Treatment Period||32
10444741|NCT00947856|11591557|FG000|STARTED|Follow-up Period||78
10444742|NCT00947856|11591558|FG001|STARTED|Follow-up Period|All participants were followed after treatment; thus, number started will not match number completed|32
10444743|NCT00947856|11591557|FG000|COMPLETED|Follow-up Period||27
10444744|NCT00947856|11591558|FG001|COMPLETED|Follow-up Period|Completed survival follow-up due to death|9
10444745|NCT00947856|11591557|FG000|NOT COMPLETED|Follow-up Period||51
10444746|NCT00947856|11591558|FG001|NOT COMPLETED|Follow-up Period||23
10444747|NCT00947882|11591577|FG000|STARTED|Overall Study|Started: Randomised.|100
10444748|NCT00947882|11591578|FG001|STARTED|Overall Study||101
10444749|NCT00947882|11591579|FG002|STARTED|Overall Study||101
10444750|NCT00947882|11591580|FG003|STARTED|Overall Study||102
10444751|NCT00947882|11591577|FG000|Full Analysis Set (FAS)|Overall Study|FAS: Received a dose of IMP and completed at least one post-baseline IPSS questionnaire.|100
10444752|NCT00947882|11591578|FG001|Full Analysis Set (FAS)|Overall Study||101
10444753|NCT00947882|11591579|FG002|Full Analysis Set (FAS)|Overall Study|1 patient received 20 mg degarelix but had no post-baseline IPSS value and was excluded from the FAS|100
10444754|NCT00947882|11591580|FG003|Full Analysis Set (FAS)|Overall Study||102
10550702|NCT01533493|11704866|FG000|COMPLETED|Overall Study||7
10550703|NCT01533493|11704867|FG001|COMPLETED|Overall Study||11
10550704|NCT01533493|11704866|FG000|NOT COMPLETED|Overall Study||5
10550705|NCT01533493|11704867|FG001|NOT COMPLETED|Overall Study||3
10789588|NCT03522506|11949997|FG001|STARTED|Treatment Period 3 (2 Days)||5
10789589|NCT03522506|11949998|FG002|STARTED|Treatment Period 3 (2 Days)||5
10550706|NCT01533597|11704875|FG000|STARTED|Overall Study||35
10444755|NCT00947882|11591577|FG000|Actual Treatment|Overall Study|2 placebo patients received 30 mg degarelix|98
10444756|NCT00947882|11591578|FG001|Actual Treatment|Overall Study||101
10789590|NCT03522506|11949999|FG003|STARTED|Treatment Period 3 (2 Days)||3
10550707|NCT01533597|11704876|FG001|STARTED|Overall Study||35
10550708|NCT01533597|11704875|FG000|COMPLETED|Overall Study||29
10550709|NCT01533597|11704876|FG001|COMPLETED|Overall Study||25
10550710|NCT01533597|11704875|FG000|NOT COMPLETED|Overall Study||6
10550711|NCT01533597|11704876|FG001|NOT COMPLETED|Overall Study||10
10550712|NCT01533688|11704885|FG000|STARTED|Overall Study||71
10550713|NCT01533688|11704886|FG001|STARTED|Overall Study||70
10550714|NCT01533688|11704887|FG002|STARTED|Overall Study||71
10550715|NCT01533688|11704885|FG000|COMPLETED|Overall Study||63
10550716|NCT01533688|11704886|FG001|COMPLETED|Overall Study||60
10550717|NCT01533688|11704887|FG002|COMPLETED|Overall Study||63
10550718|NCT01533688|11704885|FG000|NOT COMPLETED|Overall Study||8
10550719|NCT01533688|11704886|FG001|NOT COMPLETED|Overall Study||10
10550720|NCT01533688|11704887|FG002|NOT COMPLETED|Overall Study||8
10550721|NCT01533922|11704897|FG000|STARTED|Overall Study||59
10550722|NCT01533922|11704898|FG001|STARTED|Overall Study||59
10550723|NCT01533922|11704899|FG002|STARTED|Overall Study||60
10550724|NCT01533922|11704900|FG003|STARTED|Overall Study||58
10550725|NCT01533922|11704901|FG004|STARTED|Overall Study||59
10550726|NCT01533922|11704897|FG000|Received Placebo|Overall Study||0
10444757|NCT00947882|11591579|FG002|Actual Treatment|Overall Study|1 patient randomised to 20 mg degarelix received 30 mg degarelix|100
10444758|NCT00947882|11591580|FG003|Actual Treatment|Overall Study||105
10444759|NCT00947882|11591577|FG000|Safety Analysis Set|Overall Study|Safety Analysis Set: Received a dose of Investigational Medicinal Product (IMP).|98
10444760|NCT00947882|11591578|FG001|Safety Analysis Set|Overall Study||101
10444761|NCT00947882|11591579|FG002|Safety Analysis Set|Overall Study||100
10444762|NCT00947882|11591580|FG003|Safety Analysis Set|Overall Study||105
10444763|NCT00947882|11591577|FG000|Visit 12, Month 6|Overall Study|The trial was stopped when all patients had completed Visit 12, scheduled 6 months after the dosing.|93
10444764|NCT00947882|11591578|FG001|Visit 12, Month 6|Overall Study||91
10444765|NCT00947882|11591579|FG002|Visit 12, Month 6|Overall Study||90
10444766|NCT00947882|11591580|FG003|Visit 12, Month 6|Overall Study||95
10444767|NCT00947882|11591577|FG000|COMPLETED|Overall Study|End of Trial, Month 12: Patients who had completed the 12-month period when the trial was stopped.|26
10444768|NCT00947882|11591578|FG001|COMPLETED|Overall Study||24
10444769|NCT00947882|11591579|FG002|COMPLETED|Overall Study||22
10444770|NCT00947882|11591580|FG003|COMPLETED|Overall Study||20
10444771|NCT00947882|11591577|FG000|NOT COMPLETED|Overall Study||74
10444772|NCT00947882|11591578|FG001|NOT COMPLETED|Overall Study||77
10444773|NCT00947882|11591579|FG002|NOT COMPLETED|Overall Study||79
10444774|NCT00947882|11591580|FG003|NOT COMPLETED|Overall Study||82
10444775|NCT00948025|11591593|FG000|STARTED|Phase 1 (Pilot Phase)||14
10444776|NCT00948025|11591594|FG001|STARTED|Phase 1 (Pilot Phase)||9
10444777|NCT00948025|11591593|FG000|COMPLETED|Phase 1 (Pilot Phase)||5
10444778|NCT00948025|11591594|FG001|COMPLETED|Phase 1 (Pilot Phase)||6
10444779|NCT00948025|11591593|FG000|NOT COMPLETED|Phase 1 (Pilot Phase)||9
10444780|NCT00948025|11591594|FG001|NOT COMPLETED|Phase 1 (Pilot Phase)||3
10444781|NCT00948025|11591593|FG000|STARTED|Phase 2 (Comparative Phase)||0
10444782|NCT00948025|11591594|FG001|STARTED|Phase 2 (Comparative Phase)||0
10444783|NCT00948025|11591593|FG000|COMPLETED|Phase 2 (Comparative Phase)||0
10444784|NCT00948025|11591594|FG001|COMPLETED|Phase 2 (Comparative Phase)||0
10444785|NCT00948025|11591593|FG000|NOT COMPLETED|Phase 2 (Comparative Phase)||0
10444786|NCT00948025|11591594|FG001|NOT COMPLETED|Phase 2 (Comparative Phase)||0
10444787|NCT00948064|11591604|FG000|STARTED|Phase I||31
10444788|NCT00948064|11591605|FG001|STARTED|Phase I||0
10444789|NCT00948064|11591606|FG002|STARTED|Phase I||0
10444790|NCT00948064|11591604|FG000|COMPLETED|Phase I||30
10444791|NCT00948064|11591605|FG001|COMPLETED|Phase I||0
10444792|NCT00948064|11591606|FG002|COMPLETED|Phase I||0
10444793|NCT00948064|11591604|FG000|NOT COMPLETED|Phase I||1
10444794|NCT00948064|11591605|FG001|NOT COMPLETED|Phase I||0
10444795|NCT00948064|11591606|FG002|NOT COMPLETED|Phase I||0
10444796|NCT00948064|11591604|FG000|STARTED|Phase II||0
10444797|NCT00948064|11591605|FG001|STARTED|Phase II||52
10444798|NCT00948064|11591606|FG002|STARTED|Phase II||27
10444799|NCT00948064|11591604|FG000|COMPLETED|Phase II||0
10444800|NCT00948064|11591605|FG001|COMPLETED|Phase II||51
10444801|NCT00948064|11591606|FG002|COMPLETED|Phase II||26
10444802|NCT00948064|11591604|FG000|NOT COMPLETED|Phase II||0
10444803|NCT00948064|11591605|FG001|NOT COMPLETED|Phase II||1
10444804|NCT00948064|11591606|FG002|NOT COMPLETED|Phase II||1
10550727|NCT01533922|11704898|FG001|Received Placebo|Overall Study||49
10550728|NCT01533922|11704899|FG002|Received Placebo|Overall Study||57
10550729|NCT01533922|11704900|FG003|Received Placebo|Overall Study||57
10550730|NCT01533922|11704901|FG004|Received Placebo|Overall Study||59
10444805|NCT00948090|11591618|FG000|STARTED|Overall Study||65
10444806|NCT00948090|11591619|FG001|STARTED|Overall Study||1
10444807|NCT00948090|11591620|FG002|STARTED|Overall Study||123
10444808|NCT00948090|11591621|FG003|STARTED|Overall Study||18
10444809|NCT00948090|11591618|FG000|COMPLETED|Overall Study||22
10444810|NCT00948090|11591619|FG001|COMPLETED|Overall Study||0
10444811|NCT00948090|11591620|FG002|COMPLETED|Overall Study||67
10550731|NCT01533922|11704897|FG000|Received Olo 5|Overall Study||51
10550732|NCT01533922|11704898|FG001|Received Olo 5|Overall Study||52
10550733|NCT01533922|11704899|FG002|Received Olo 5|Overall Study||57
10550734|NCT01533922|11704900|FG003|Received Olo 5|Overall Study||57
10550735|NCT01533922|11704901|FG004|Received Olo 5|Overall Study||0
10444812|NCT00948090|11591621|FG003|COMPLETED|Overall Study||7
10444813|NCT00948090|11591618|FG000|NOT COMPLETED|Overall Study||43
10444814|NCT00948090|11591619|FG001|NOT COMPLETED|Overall Study||1
10444815|NCT00948090|11591620|FG002|NOT COMPLETED|Overall Study||56
10444816|NCT00948090|11591621|FG003|NOT COMPLETED|Overall Study||11
10444817|NCT00948155|11591630|FG000|STARTED|First Intervention 21 Days||14
10444818|NCT00948155|11591631|FG001|STARTED|First Intervention 21 Days||15
10444819|NCT00948155|11591630|FG000|COMPLETED|First Intervention 21 Days||12
10444820|NCT00948155|11591631|FG001|COMPLETED|First Intervention 21 Days||13
10444821|NCT00948155|11591630|FG000|NOT COMPLETED|First Intervention 21 Days||2
10444822|NCT00948155|11591631|FG001|NOT COMPLETED|First Intervention 21 Days||2
10444823|NCT00948155|11591630|FG000|STARTED|Washout 14 Days||12
10444824|NCT00948155|11591631|FG001|STARTED|Washout 14 Days||13
10444825|NCT00948155|11591630|FG000|COMPLETED|Washout 14 Days||11
10444826|NCT00948155|11591631|FG001|COMPLETED|Washout 14 Days||11
10444827|NCT00948155|11591630|FG000|NOT COMPLETED|Washout 14 Days||1
10550736|NCT01533922|11704897|FG000|Received Tio 5|Overall Study||54
10550737|NCT01533922|11704898|FG001|Received Tio 5|Overall Study||58
10550738|NCT01533922|11704899|FG002|Received Tio 5|Overall Study||59
10550739|NCT01533922|11704900|FG003|Received Tio 5|Overall Study|One patient received Tio 5 instead of Olo 5 by mistake.|1
10550740|NCT01533922|11704901|FG004|Received Tio 5|Overall Study||54
10550741|NCT01533922|11704897|FG000|Received Tio+Olo 2.5/5|Overall Study||59
10550742|NCT01533922|11704898|FG001|Received Tio+Olo 2.5/5|Overall Study||0
10550743|NCT01533922|11704899|FG002|Received Tio+Olo 2.5/5|Overall Study||52
10550744|NCT01533922|11704900|FG003|Received Tio+Olo 2.5/5|Overall Study||55
10550745|NCT01533922|11704901|FG004|Received Tio+Olo 2.5/5|Overall Study||56
10550746|NCT01533922|11704897|FG000|Received Tio+Olo 5/5|Overall Study||58
10550747|NCT01533922|11704898|FG001|Received Tio+Olo 5/5|Overall Study||59
10550748|NCT01533922|11704899|FG002|Received Tio+Olo 5/5|Overall Study||0
10550749|NCT01533922|11704900|FG003|Received Tio+Olo 5/5|Overall Study||53
10550750|NCT01533922|11704901|FG004|Received Tio+Olo 5/5|Overall Study||56
10550751|NCT01533922|11704897|FG000|COMPLETED|Overall Study|Completed all treatment arms|49
10550752|NCT01533922|11704898|FG001|COMPLETED|Overall Study|Completed all treatment arms|47
10550753|NCT01533922|11704899|FG002|COMPLETED|Overall Study|Completed all treatment arms|50
10444828|NCT00948155|11591631|FG001|NOT COMPLETED|Washout 14 Days||2
10444829|NCT00948155|11591630|FG000|STARTED|Second Intervention 21 Days||11
10444830|NCT00948155|11591631|FG001|STARTED|Second Intervention 21 Days||11
10444831|NCT00948155|11591630|FG000|COMPLETED|Second Intervention 21 Days||9
10444832|NCT00948155|11591631|FG001|COMPLETED|Second Intervention 21 Days||8
10444833|NCT00948155|11591630|FG000|NOT COMPLETED|Second Intervention 21 Days||2
10444834|NCT00948155|11591631|FG001|NOT COMPLETED|Second Intervention 21 Days||3
10444835|NCT00948246|11591639|FG000|STARTED|Overall Study||110
10444836|NCT00948246|11591639|FG000|COMPLETED|Overall Study||86
10444837|NCT00948246|11591639|FG000|NOT COMPLETED|Overall Study||24
10444838|NCT00948298|11591645|FG000|STARTED|Overall Study||65
10444839|NCT00948298|11591646|FG001|STARTED|Overall Study||65
10444840|NCT00948298|11591645|FG000|COMPLETED|Overall Study||55
10444841|NCT00948298|11591646|FG001|COMPLETED|Overall Study||60
10444842|NCT00948298|11591645|FG000|NOT COMPLETED|Overall Study||10
10444843|NCT00948298|11591646|FG001|NOT COMPLETED|Overall Study||5
10444844|NCT00948389|11591657|FG000|STARTED|Overall Study||6
10444845|NCT00948389|11591658|FG001|STARTED|Overall Study||3
10444846|NCT00948389|11591659|FG002|STARTED|Overall Study||7
10444847|NCT00948389|11591660|FG003|STARTED|Overall Study||9
10444848|NCT00948389|11591661|FG004|STARTED|Overall Study||1
10444849|NCT00948389|11591657|FG000|COMPLETED|Overall Study||0
10444850|NCT00948389|11591658|FG001|COMPLETED|Overall Study||0
10444851|NCT00948389|11591659|FG002|COMPLETED|Overall Study||0
10444852|NCT00948389|11591660|FG003|COMPLETED|Overall Study||0
10444853|NCT00948389|11591661|FG004|COMPLETED|Overall Study||0
10444854|NCT00948389|11591657|FG000|NOT COMPLETED|Overall Study||6
10444855|NCT00948389|11591658|FG001|NOT COMPLETED|Overall Study||3
10444856|NCT00948389|11591659|FG002|NOT COMPLETED|Overall Study||7
10444857|NCT00948389|11591660|FG003|NOT COMPLETED|Overall Study||9
10444858|NCT00948389|11591661|FG004|NOT COMPLETED|Overall Study||1
10444859|NCT00948428|11591678|FG000|STARTED|Overall Study||185
10444860|NCT00948428|11591679|FG001|STARTED|Overall Study||185
10444861|NCT00948428|11591680|FG002|STARTED|Overall Study||92
10444862|NCT00948428|11591678|FG000|COMPLETED|Overall Study||167
10444863|NCT00948428|11591679|FG001|COMPLETED|Overall Study||167
10444864|NCT00948428|11591680|FG002|COMPLETED|Overall Study||84
10550754|NCT01533922|11704900|FG003|COMPLETED|Overall Study|Completed all treatment arms|53
10550755|NCT01533922|11704901|FG004|COMPLETED|Overall Study|Completed all treatment arms|53
10444865|NCT00948428|11591678|FG000|NOT COMPLETED|Overall Study||18
10444866|NCT00948428|11591679|FG001|NOT COMPLETED|Overall Study||18
10444867|NCT00948428|11591680|FG002|NOT COMPLETED|Overall Study||8
10444868|NCT00948441|11591690|FG000|STARTED|Overall Study||8
10444869|NCT00948441|11591691|FG001|STARTED|Overall Study||8
10444870|NCT00948441|11591690|FG000|COMPLETED|Overall Study||7
10444871|NCT00948441|11591691|FG001|COMPLETED|Overall Study||4
10444872|NCT00948441|11591690|FG000|NOT COMPLETED|Overall Study||1
10444873|NCT00948441|11591691|FG001|NOT COMPLETED|Overall Study||4
10444874|NCT00948506|11591701|FG000|STARTED|Overall Study||11
10444875|NCT00948506|11591702|FG001|STARTED|Overall Study||9
10444876|NCT00948506|11591701|FG000|COMPLETED|Overall Study||8
10444877|NCT00948506|11591702|FG001|COMPLETED|Overall Study||8
10444878|NCT00948506|11591701|FG000|NOT COMPLETED|Overall Study||3
10444879|NCT00948506|11591702|FG001|NOT COMPLETED|Overall Study||1
10444880|NCT00948610|11591713|FG000|STARTED|Overall Study||10
10444881|NCT00948610|11591714|FG001|STARTED|Overall Study||10
10444882|NCT00948610|11591713|FG000|COMPLETED|Overall Study||9
10444883|NCT00948610|11591714|FG001|COMPLETED|Overall Study||9
10444884|NCT00948610|11591713|FG000|NOT COMPLETED|Overall Study||1
10444885|NCT00948610|11591714|FG001|NOT COMPLETED|Overall Study||1
10444886|NCT00948675|11591722|FG000|STARTED|Overall Study||182
10444887|NCT00948675|11591723|FG001|STARTED|Overall Study||179
10444888|NCT00948675|11591722|FG000|Received Any Amount of Study Drug|Overall Study||171
10444889|NCT00948675|11591723|FG001|Received Any Amount of Study Drug|Overall Study||166
10444890|NCT00948675|11591722|FG000|COMPLETED|Overall Study||181
10444891|NCT00948675|11591723|FG001|COMPLETED|Overall Study||179
10444892|NCT00948675|11591722|FG000|NOT COMPLETED|Overall Study||1
10444893|NCT00948675|11591723|FG001|NOT COMPLETED|Overall Study||0
10444894|NCT00948688|11591729|FG000|STARTED|Period 1: 200 mg Vorinostat||4
10444895|NCT00948688|11591730|FG001|STARTED|Period 1: 200 mg Vorinostat||0
10444896|NCT00948688|11591729|FG000|COMPLETED|Period 1: 200 mg Vorinostat||2
10444897|NCT00948688|11591730|FG001|COMPLETED|Period 1: 200 mg Vorinostat||0
10444898|NCT00948688|11591729|FG000|NOT COMPLETED|Period 1: 200 mg Vorinostat||2
10444899|NCT00948688|11591730|FG001|NOT COMPLETED|Period 1: 200 mg Vorinostat||0
10444900|NCT00948688|11591729|FG000|STARTED|Period 2: 100 mg Vorinostat||0
10444901|NCT00948688|11591730|FG001|STARTED|Period 2: 100 mg Vorinostat||6
10444902|NCT00948688|11591729|FG000|COMPLETED|Period 2: 100 mg Vorinostat||0
10444903|NCT00948688|11591730|FG001|COMPLETED|Period 2: 100 mg Vorinostat||5
10444904|NCT00948688|11591729|FG000|NOT COMPLETED|Period 2: 100 mg Vorinostat||0
10444905|NCT00948688|11591730|FG001|NOT COMPLETED|Period 2: 100 mg Vorinostat||1
10444906|NCT00948766|11591739|FG000|STARTED|Core Study||356
10444907|NCT00948766|11591740|FG001|STARTED|Core Study||360
10444908|NCT00948766|11591739|FG000|Exposed to Study Medication|Core Study||355
10444909|NCT00948766|11591740|FG001|Exposed to Study Medication|Core Study||359
10444910|NCT00948766|11591739|FG000|COMPLETED|Core Study||229
10444911|NCT00948766|11591740|FG001|COMPLETED|Core Study||234
10444912|NCT00948766|11591739|FG000|NOT COMPLETED|Core Study||127
10550756|NCT01533922|11704897|FG000|NOT COMPLETED|Overall Study||10
10550757|NCT01533922|11704898|FG001|NOT COMPLETED|Overall Study||12
10550758|NCT01533922|11704899|FG002|NOT COMPLETED|Overall Study||10
10550759|NCT01533922|11704900|FG003|NOT COMPLETED|Overall Study||5
10550760|NCT01533922|11704901|FG004|NOT COMPLETED|Overall Study||6
10789591|NCT03522506|11949996|FG000|COMPLETED|Treatment Period 3 (2 Days)||5
10444913|NCT00948766|11591740|FG001|NOT COMPLETED|Core Study||126
10444914|NCT00948766|11591739|FG000|STARTED|Extension Study|397 of the 463 patients who completed the core study entered the extension study.|397
10444915|NCT00948766|11591740|FG001|STARTED|Extension Study|No patients received this treatment in the extension study.|0
10444916|NCT00948766|11591739|FG000|Exposed to Study Medication|Extension Study||396
10444917|NCT00948766|11591740|FG001|Exposed to Study Medication|Extension Study||0
10444918|NCT00948766|11591739|FG000|COMPLETED|Extension Study||306
10444919|NCT00948766|11591740|FG001|COMPLETED|Extension Study||0
10444920|NCT00948766|11591739|FG000|NOT COMPLETED|Extension Study||91
10444921|NCT00948766|11591740|FG001|NOT COMPLETED|Extension Study||0
10444922|NCT00948792|11591747|FG000|STARTED|Overall Study||21
10444923|NCT00948792|11591747|FG000|COMPLETED|Overall Study||21
10444924|NCT00948792|11591747|FG000|NOT COMPLETED|Overall Study||0
10444925|NCT00948818|11591755|FG000|STARTED|Overall Study||397
10444926|NCT00948818|11591756|FG001|STARTED|Overall Study||406
10789592|NCT03522506|11949997|FG001|COMPLETED|Treatment Period 3 (2 Days)||5
10789593|NCT03522506|11949998|FG002|COMPLETED|Treatment Period 3 (2 Days)||5
10789594|NCT03522506|11949999|FG003|COMPLETED|Treatment Period 3 (2 Days)||3
10789595|NCT03522506|11949996|FG000|NOT COMPLETED|Treatment Period 3 (2 Days)||0
10444927|NCT00948818|11591755|FG000|COMPLETED|Overall Study||335
10444928|NCT00948818|11591756|FG001|COMPLETED|Overall Study||312
10444929|NCT00948818|11591755|FG000|NOT COMPLETED|Overall Study||62
10444930|NCT00948818|11591756|FG001|NOT COMPLETED|Overall Study||94
10444931|NCT00948857|11591767|FG000|STARTED|Overall Study||3
10444932|NCT00948857|11591768|FG001|STARTED|Overall Study||2
10444933|NCT00948857|11591767|FG000|COMPLETED|Overall Study|3 completed and 1 dropped out.|2
10444934|NCT00948857|11591768|FG001|COMPLETED|Overall Study||2
10444935|NCT00948857|11591767|FG000|NOT COMPLETED|Overall Study||1
10444936|NCT00948857|11591768|FG001|NOT COMPLETED|Overall Study||0
10444937|NCT00948896|11591782|FG000|STARTED|Randomization to 24 Months of Age||98
10444938|NCT00948896|11591783|FG001|STARTED|Randomization to 24 Months of Age||98
10550761|NCT01533935|11704913|FG000|STARTED|Overall Study||58
10550762|NCT01533935|11704914|FG001|STARTED|Overall Study||58
10550763|NCT01533935|11704915|FG002|STARTED|Overall Study||58
10789596|NCT03522506|11949997|FG001|NOT COMPLETED|Treatment Period 3 (2 Days)||0
10444939|NCT00948896|11591784|FG002|STARTED|Randomization to 24 Months of Age||99
10444940|NCT00948896|11591785|FG003|STARTED|Randomization to 24 Months of Age||98
10444941|NCT00948896|11591786|FG004|STARTED|Randomization to 24 Months of Age||46
10444942|NCT00948896|11591787|FG005|STARTED|Randomization to 24 Months of Age||46
10444943|NCT00948896|11591788|FG006|STARTED|Randomization to 24 Months of Age||47
10444944|NCT00948896|11591789|FG007|STARTED|Randomization to 24 Months of Age||47
10444945|NCT00948896|11591782|FG000|COMPLETED|Randomization to 24 Months of Age||90
10444946|NCT00948896|11591783|FG001|COMPLETED|Randomization to 24 Months of Age||85
10444947|NCT00948896|11591784|FG002|COMPLETED|Randomization to 24 Months of Age||90
10444948|NCT00948896|11591785|FG003|COMPLETED|Randomization to 24 Months of Age||87
10550764|NCT01533935|11704916|FG003|STARTED|Overall Study||59
10550765|NCT01533935|11704917|FG004|STARTED|Overall Study||58
10550766|NCT01533935|11704913|FG000|Received Placebo|Overall Study||0
10550767|NCT01533935|11704914|FG001|Received Placebo|Overall Study||47
10550768|NCT01533935|11704915|FG002|Received Placebo|Overall Study||52
10550769|NCT01533935|11704916|FG003|Received Placebo|Overall Study||57
10789597|NCT03522506|11949998|FG002|NOT COMPLETED|Treatment Period 3 (2 Days)||0
10789598|NCT03522506|11949999|FG003|NOT COMPLETED|Treatment Period 3 (2 Days)||0
10789599|NCT03522506|11949996|FG000|STARTED|Washout Period 3 (7 Days)||5
10789600|NCT03522506|11949997|FG001|STARTED|Washout Period 3 (7 Days)||5
10789601|NCT03522506|11949998|FG002|STARTED|Washout Period 3 (7 Days)||5
10444949|NCT00948896|11591786|FG004|COMPLETED|Randomization to 24 Months of Age||44
10444950|NCT00948896|11591787|FG005|COMPLETED|Randomization to 24 Months of Age||42
10444951|NCT00948896|11591788|FG006|COMPLETED|Randomization to 24 Months of Age||43
10444952|NCT00948896|11591789|FG007|COMPLETED|Randomization to 24 Months of Age||45
10444953|NCT00948896|11591782|FG000|NOT COMPLETED|Randomization to 24 Months of Age||8
10444954|NCT00948896|11591783|FG001|NOT COMPLETED|Randomization to 24 Months of Age||13
10444955|NCT00948896|11591784|FG002|NOT COMPLETED|Randomization to 24 Months of Age||9
10444956|NCT00948896|11591785|FG003|NOT COMPLETED|Randomization to 24 Months of Age||11
10444957|NCT00948896|11591786|FG004|NOT COMPLETED|Randomization to 24 Months of Age||2
10444958|NCT00948896|11591787|FG005|NOT COMPLETED|Randomization to 24 Months of Age||4
10444959|NCT00948896|11591788|FG006|NOT COMPLETED|Randomization to 24 Months of Age||4
10444960|NCT00948896|11591789|FG007|NOT COMPLETED|Randomization to 24 Months of Age||2
10444961|NCT00948896|11591782|FG000|STARTED|24 Months of Age to 36 Months of Age||90
10444962|NCT00948896|11591783|FG001|STARTED|24 Months of Age to 36 Months of Age||85
10444963|NCT00948896|11591784|FG002|STARTED|24 Months of Age to 36 Months of Age||90
10444964|NCT00948896|11591785|FG003|STARTED|24 Months of Age to 36 Months of Age||87
10444965|NCT00948896|11591786|FG004|STARTED|24 Months of Age to 36 Months of Age||44
10444966|NCT00948896|11591787|FG005|STARTED|24 Months of Age to 36 Months of Age||42
10444967|NCT00948896|11591788|FG006|STARTED|24 Months of Age to 36 Months of Age||43
10444968|NCT00948896|11591789|FG007|STARTED|24 Months of Age to 36 Months of Age||45
10444969|NCT00948896|11591782|FG000|COMPLETED|24 Months of Age to 36 Months of Age||87
10444970|NCT00948896|11591783|FG001|COMPLETED|24 Months of Age to 36 Months of Age||83
10444971|NCT00948896|11591784|FG002|COMPLETED|24 Months of Age to 36 Months of Age||85
10444972|NCT00948896|11591785|FG003|COMPLETED|24 Months of Age to 36 Months of Age||85
10444973|NCT00948896|11591786|FG004|COMPLETED|24 Months of Age to 36 Months of Age||43
10444974|NCT00948896|11591787|FG005|COMPLETED|24 Months of Age to 36 Months of Age||40
10444975|NCT00948896|11591788|FG006|COMPLETED|24 Months of Age to 36 Months of Age||43
10444976|NCT00948896|11591789|FG007|COMPLETED|24 Months of Age to 36 Months of Age||45
10444977|NCT00948896|11591782|FG000|NOT COMPLETED|24 Months of Age to 36 Months of Age||3
10444978|NCT00948896|11591783|FG001|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
10444979|NCT00948896|11591784|FG002|NOT COMPLETED|24 Months of Age to 36 Months of Age||5
10444980|NCT00948896|11591785|FG003|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
10444981|NCT00948896|11591786|FG004|NOT COMPLETED|24 Months of Age to 36 Months of Age||1
10444982|NCT00948896|11591787|FG005|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
10444983|NCT00948896|11591788|FG006|NOT COMPLETED|24 Months of Age to 36 Months of Age||0
10444984|NCT00948896|11591789|FG007|NOT COMPLETED|24 Months of Age to 36 Months of Age||0
10444985|NCT00948922|11591814|FG000|STARTED|Overall Study||34
10444986|NCT00948922|11591815|FG001|STARTED|Overall Study||51
10444987|NCT00948922|11591816|FG002|STARTED|Overall Study||39
10444988|NCT00948922|11591814|FG000|COMPLETED|Overall Study||26
10444989|NCT00948922|11591815|FG001|COMPLETED|Overall Study||37
10444990|NCT00948922|11591816|FG002|COMPLETED|Overall Study||38
10444991|NCT00948922|11591814|FG000|NOT COMPLETED|Overall Study||8
10444992|NCT00948922|11591815|FG001|NOT COMPLETED|Overall Study||14
10444993|NCT00948922|11591816|FG002|NOT COMPLETED|Overall Study||1
10444994|NCT00948935|11591828|FG000|STARTED|Overall Study||35
10444995|NCT00948935|11591828|FG000|COMPLETED|Overall Study||35
10444996|NCT00948935|11591828|FG000|NOT COMPLETED|Overall Study||0
10444997|NCT00948974|11591834|FG000|STARTED|Overall Study||40
10444998|NCT00948974|11591835|FG001|STARTED|Overall Study||48
10444999|NCT00948974|11591834|FG000|COMPLETED|Overall Study||17
10445000|NCT00948974|11591835|FG001|COMPLETED|Overall Study||28
10550770|NCT01533935|11704917|FG004|Received Placebo|Overall Study||58
10550771|NCT01533935|11704913|FG000|Received Olo 5|Overall Study||52
10550772|NCT01533935|11704914|FG001|Received Olo 5|Overall Study||52
10550773|NCT01533935|11704915|FG002|Received Olo 5|Overall Study||55
10550774|NCT01533935|11704916|FG003|Received Olo 5|Overall Study||59
10550775|NCT01533935|11704917|FG004|Received Olo 5|Overall Study||0
10789602|NCT03522506|11949999|FG003|STARTED|Washout Period 3 (7 Days)||3
10789603|NCT03522506|11949996|FG000|COMPLETED|Washout Period 3 (7 Days)||5
10789604|NCT03522506|11949997|FG001|COMPLETED|Washout Period 3 (7 Days)||5
10550776|NCT01533935|11704913|FG000|Received Tio 5|Overall Study||54
10550777|NCT01533935|11704914|FG001|Received Tio 5|Overall Study||54
10550778|NCT01533935|11704915|FG002|Received Tio 5|Overall Study||58
10550779|NCT01533935|11704916|FG003|Received Tio 5|Overall Study||0
10789605|NCT03522506|11949998|FG002|COMPLETED|Washout Period 3 (7 Days)||5
10445001|NCT00948974|11591834|FG000|NOT COMPLETED|Overall Study||23
10445002|NCT00948974|11591835|FG001|NOT COMPLETED|Overall Study||20
10445003|NCT00949078|11591843|FG000|STARTED|Overall Study||5
10445004|NCT00949078|11591844|FG001|STARTED|Overall Study||9
10445005|NCT00949078|11591843|FG000|COMPLETED|Overall Study||5
10445006|NCT00949078|11591844|FG001|COMPLETED|Overall Study||9
10445007|NCT00949078|11591843|FG000|NOT COMPLETED|Overall Study||0
10445008|NCT00949078|11591844|FG001|NOT COMPLETED|Overall Study||0
10445009|NCT00949117|11591852|FG000|STARTED|Overall Study||4
10445010|NCT00949117|11591853|FG001|STARTED|Overall Study||5
10445011|NCT00949117|11591852|FG000|COMPLETED|Overall Study||1
10445012|NCT00949117|11591853|FG001|COMPLETED|Overall Study||0
10445013|NCT00949117|11591852|FG000|NOT COMPLETED|Overall Study||3
10445014|NCT00949117|11591853|FG001|NOT COMPLETED|Overall Study||5
10445015|NCT00949234|11591861|FG000|STARTED|Overall Study||267
10445016|NCT00949234|11591861|FG000|COMPLETED|Overall Study||225
10445017|NCT00949234|11591861|FG000|NOT COMPLETED|Overall Study||42
10445018|NCT00949325|11591865|FG000|STARTED|Overall Study||3
10445019|NCT00949325|11591866|FG001|STARTED|Overall Study||18
10445020|NCT00949325|11591867|FG002|STARTED|Overall Study||3
10445021|NCT00949325|11591865|FG000|COMPLETED|Overall Study||3
10445022|NCT00949325|11591866|FG001|COMPLETED|Overall Study||16
10445023|NCT00949325|11591867|FG002|COMPLETED|Overall Study||3
10445024|NCT00949325|11591865|FG000|NOT COMPLETED|Overall Study||0
10445025|NCT00949325|11591866|FG001|NOT COMPLETED|Overall Study||2
10445026|NCT00949325|11591867|FG002|NOT COMPLETED|Overall Study||0
10445027|NCT00949533|11591885|FG000|STARTED|Overall Study||19
10445028|NCT00949533|11591886|FG001|STARTED|Overall Study||18
10445029|NCT00949533|11591885|FG000|COMPLETED|Overall Study||19
10445030|NCT00949533|11591886|FG001|COMPLETED|Overall Study||17
10445031|NCT00949533|11591885|FG000|NOT COMPLETED|Overall Study||0
10445032|NCT00949533|11591886|FG001|NOT COMPLETED|Overall Study||1
10445033|NCT00949650|11591894|FG000|STARTED|Overall Study|Treated patients.|230
10445034|NCT00949650|11591895|FG001|STARTED|Overall Study|Treated patients.|115
10445035|NCT00949650|11591894|FG000|COMPLETED|Overall Study|On treatment at the cut-off date 17MAR2017.|0
10445036|NCT00949650|11591895|FG001|COMPLETED|Overall Study||0
10445037|NCT00949650|11591894|FG000|NOT COMPLETED|Overall Study||230
10445038|NCT00949650|11591895|FG001|NOT COMPLETED|Overall Study||115
10445039|NCT00949702|11591905|FG000|STARTED|Overall Study||132
10445040|NCT00949702|11591905|FG000|COMPLETED|Overall Study||84
10445041|NCT00949702|11591905|FG000|NOT COMPLETED|Overall Study||48
10445042|NCT00949715|11591911|FG000|STARTED|Overall Study||32
10445043|NCT00949715|11591912|FG001|STARTED|Overall Study||33
10445044|NCT00949715|11591911|FG000|COMPLETED|Overall Study||28
10445045|NCT00949715|11591912|FG001|COMPLETED|Overall Study||33
10445046|NCT00949715|11591911|FG000|NOT COMPLETED|Overall Study||4
10445047|NCT00949715|11591912|FG001|NOT COMPLETED|Overall Study||0
10445048|NCT00949884|11591920|FG000|STARTED|Overall Study||420
10445049|NCT00949884|11591921|FG001|STARTED|Overall Study||52
10445050|NCT00949884|11591922|FG002|STARTED|Overall Study||469
10445051|NCT00949884|11591920|FG000|COMPLETED|Overall Study||370
10445052|NCT00949884|11591921|FG001|COMPLETED|Overall Study||37
10445053|NCT00949884|11591922|FG002|COMPLETED|Overall Study||411
10445054|NCT00949884|11591920|FG000|NOT COMPLETED|Overall Study||50
10445055|NCT00949884|11591921|FG001|NOT COMPLETED|Overall Study||15
10445056|NCT00949884|11591922|FG002|NOT COMPLETED|Overall Study||58
10445057|NCT00949910|11591931|FG000|STARTED|Overall Study||6586
10445058|NCT00949910|11591931|FG000|COMPLETED|Overall Study||10
10445059|NCT00949910|11591931|FG000|NOT COMPLETED|Overall Study||6576
10445060|NCT00949975|11591939|FG000|STARTED|Overall Study||212
10445061|NCT00949975|11591940|FG001|STARTED|Overall Study||206
10445062|NCT00949975|11591941|FG002|STARTED|Overall Study||202
10445063|NCT00949975|11591942|FG003|STARTED|Overall Study||218
10445064|NCT00949975|11591939|FG000|COMPLETED|Overall Study||185
10445065|NCT00949975|11591940|FG001|COMPLETED|Overall Study||177
10445066|NCT00949975|11591941|FG002|COMPLETED|Overall Study||183
10445067|NCT00949975|11591942|FG003|COMPLETED|Overall Study||190
10445068|NCT00949975|11591939|FG000|NOT COMPLETED|Overall Study||27
10445069|NCT00949975|11591940|FG001|NOT COMPLETED|Overall Study||29
10445070|NCT00949975|11591941|FG002|NOT COMPLETED|Overall Study||19
10445071|NCT00949975|11591942|FG003|NOT COMPLETED|Overall Study||28
10445072|NCT00950170|11591952|FG000|STARTED|Overall Study||23
10445073|NCT00950170|11591952|FG000|COMPLETED|Overall Study||19
10445074|NCT00950170|11591952|FG000|NOT COMPLETED|Overall Study||4
10445075|NCT00950235|11591976|FG000|STARTED|Overall Study||60
10445076|NCT00950235|11591977|FG001|STARTED|Overall Study||58
10445077|NCT00950235|11591976|FG000|COMPLETED|Overall Study||58
10445078|NCT00950235|11591977|FG001|COMPLETED|Overall Study||54
10445079|NCT00950235|11591976|FG000|NOT COMPLETED|Overall Study||2
10445080|NCT00950235|11591977|FG001|NOT COMPLETED|Overall Study||4
10445081|NCT00950248|11591985|FG000|STARTED|Year 1: Baseline||85
10445082|NCT00950248|11591986|FG001|STARTED|Year 1: Baseline||0
10445083|NCT00950248|11591987|FG002|STARTED|Year 1: Baseline||0
10445084|NCT00950248|11591985|FG000|COMPLETED|Year 1: Baseline||77
10445085|NCT00950248|11591986|FG001|COMPLETED|Year 1: Baseline||0
10445086|NCT00950248|11591987|FG002|COMPLETED|Year 1: Baseline||0
10445087|NCT00950248|11591985|FG000|NOT COMPLETED|Year 1: Baseline||8
10445088|NCT00950248|11591986|FG001|NOT COMPLETED|Year 1: Baseline||0
10445089|NCT00950248|11591987|FG002|NOT COMPLETED|Year 1: Baseline||0
10445090|NCT00950248|11591985|FG000|STARTED|Year 2&3 Treatment Randomization||0
10445091|NCT00950248|11591986|FG001|STARTED|Year 2&3 Treatment Randomization||39
10445092|NCT00950248|11591987|FG002|STARTED|Year 2&3 Treatment Randomization||38
10445093|NCT00950248|11591985|FG000|COMPLETED|Year 2&3 Treatment Randomization||0
10445094|NCT00950248|11591986|FG001|COMPLETED|Year 2&3 Treatment Randomization||33
10445095|NCT00950248|11591987|FG002|COMPLETED|Year 2&3 Treatment Randomization||33
10445096|NCT00950248|11591985|FG000|NOT COMPLETED|Year 2&3 Treatment Randomization||0
10445097|NCT00950248|11591986|FG001|NOT COMPLETED|Year 2&3 Treatment Randomization||6
10445098|NCT00950248|11591987|FG002|NOT COMPLETED|Year 2&3 Treatment Randomization||5
10445099|NCT00950300|11591996|FG000|STARTED|Neoadjuvant/Adjuvant Treatment Periods||299
10445100|NCT00950300|11591997|FG001|STARTED|Neoadjuvant/Adjuvant Treatment Periods||297
10445101|NCT00950300|11591996|FG000|Received Neoadjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||298
10445102|NCT00950300|11591997|FG001|Received Neoadjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||297
10445103|NCT00950300|11591996|FG000|Underwent Surgery|Neoadjuvant/Adjuvant Treatment Periods||277
10445104|NCT00950300|11591997|FG001|Underwent Surgery|Neoadjuvant/Adjuvant Treatment Periods||273
10445105|NCT00950300|11591996|FG000|Entered Adjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||277
10445106|NCT00950300|11591997|FG001|Entered Adjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||274
10445107|NCT00950300|11591996|FG000|COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||257
10445108|NCT00950300|11591997|FG001|COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||255
10789606|NCT03522506|11949999|FG003|COMPLETED|Washout Period 3 (7 Days)||3
10789607|NCT03522506|11949996|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
10789608|NCT03522506|11949997|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
10789609|NCT03522506|11949998|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
10789610|NCT03522506|11949999|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
10789611|NCT03522506|11949996|FG000|STARTED|Treatment Period 4 (2 Days)||5
10789612|NCT03522506|11949997|FG001|STARTED|Treatment Period 4 (2 Days)||5
10789613|NCT03522506|11949998|FG002|STARTED|Treatment Period 4 (2 Days)||5
10789614|NCT03522506|11949999|FG003|STARTED|Treatment Period 4 (2 Days)||3
10789615|NCT03522506|11949996|FG000|COMPLETED|Treatment Period 4 (2 Days)||5
10445109|NCT00950300|11591996|FG000|NOT COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||42
10445110|NCT00950300|11591997|FG001|NOT COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||42
10445111|NCT00950300|11591996|FG000|STARTED|TFFU Period|Participants could withdraw from the study entirely or advance directly to the TFFU or SFU Period.|265
10445112|NCT00950300|11591997|FG001|STARTED|TFFU Period|Participants could withdraw from the study entirely or advance directly to the TFFU or SFU Period.|268
10445113|NCT00950300|11591996|FG000|COMPLETED|TFFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|165
10445114|NCT00950300|11591997|FG001|COMPLETED|TFFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|161
10445115|NCT00950300|11591996|FG000|NOT COMPLETED|TFFU Period||100
10445116|NCT00950300|11591997|FG001|NOT COMPLETED|TFFU Period||107
10445117|NCT00950300|11591996|FG000|STARTED|SFU Period|Participants could withdraw from the study entirely or advance directly to the SFU Period.|118
10445118|NCT00950300|11591997|FG001|STARTED|SFU Period|Participants could withdraw from the study entirely or advance directly to the SFU Period.|123
10445119|NCT00950300|11591996|FG000|COMPLETED|SFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|40
10445120|NCT00950300|11591997|FG001|COMPLETED|SFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|45
10445121|NCT00950300|11591996|FG000|NOT COMPLETED|SFU Period||78
10445122|NCT00950300|11591997|FG001|NOT COMPLETED|SFU Period||78
10445123|NCT00950352|11592006|FG000|STARTED|Overall Study||72
10445124|NCT00950352|11592007|FG001|STARTED|Overall Study||32
10445125|NCT00950352|11592006|FG000|COMPLETED|Overall Study||30
10445126|NCT00950352|11592007|FG001|COMPLETED|Overall Study||21
10445127|NCT00950352|11592006|FG000|NOT COMPLETED|Overall Study||42
10445128|NCT00950352|11592007|FG001|NOT COMPLETED|Overall Study||11
10445129|NCT00950365|11592015|FG000|STARTED|Overall Study||27
10445130|NCT00950365|11592016|FG001|STARTED|Overall Study||52
10445131|NCT00950365|11592015|FG000|COMPLETED|Overall Study||25
10445132|NCT00950365|11592016|FG001|COMPLETED|Overall Study||50
10445133|NCT00950365|11592015|FG000|NOT COMPLETED|Overall Study||2
10445134|NCT00950365|11592016|FG001|NOT COMPLETED|Overall Study||2
10445135|NCT00950599|11592030|FG000|STARTED|Double-Blind Treatment Period||55
10445136|NCT00950599|11592031|FG001|STARTED|Double-Blind Treatment Period||47
10445137|NCT00950599|11592032|FG002|STARTED|Double-Blind Treatment Period||63
10445138|NCT00950599|11592033|FG003|STARTED|Double-Blind Treatment Period||54
10445139|NCT00950599|11592034|FG004|STARTED|Double-Blind Treatment Period||52
10445140|NCT00950599|11592035|FG005|STARTED|Double-Blind Treatment Period||67
10445141|NCT00950599|11592036|FG006|STARTED|Double-Blind Treatment Period||44
10445142|NCT00950599|11592037|FG007|STARTED|Double-Blind Treatment Period||41
10445143|NCT00950599|11592038|FG008|STARTED|Double-Blind Treatment Period||0
10445144|NCT00950599|11592039|FG009|STARTED|Double-Blind Treatment Period||0
10445145|NCT00950599|11592030|FG000|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|48
10445146|NCT00950599|11592031|FG001|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|37
10445147|NCT00950599|11592032|FG002|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|54
10445148|NCT00950599|11592033|FG003|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|43
10445149|NCT00950599|11592034|FG004|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|45
10445150|NCT00950599|11592035|FG005|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|55
10445151|NCT00950599|11592036|FG006|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|44
10445152|NCT00950599|11592037|FG007|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|35
10445153|NCT00950599|11592038|FG008|COMPLETED|Double-Blind Treatment Period||0
10445154|NCT00950599|11592039|FG009|COMPLETED|Double-Blind Treatment Period||0
10445155|NCT00950599|11592030|FG000|NOT COMPLETED|Double-Blind Treatment Period||7
10789616|NCT03522506|11949997|FG001|COMPLETED|Treatment Period 4 (2 Days)||5
10789617|NCT03522506|11949998|FG002|COMPLETED|Treatment Period 4 (2 Days)||5
10789618|NCT03522506|11949999|FG003|COMPLETED|Treatment Period 4 (2 Days)||3
10445156|NCT00950599|11592031|FG001|NOT COMPLETED|Double-Blind Treatment Period||10
10445157|NCT00950599|11592032|FG002|NOT COMPLETED|Double-Blind Treatment Period||9
10445158|NCT00950599|11592033|FG003|NOT COMPLETED|Double-Blind Treatment Period||11
10445159|NCT00950599|11592034|FG004|NOT COMPLETED|Double-Blind Treatment Period||7
10445160|NCT00950599|11592035|FG005|NOT COMPLETED|Double-Blind Treatment Period||12
10445161|NCT00950599|11592036|FG006|NOT COMPLETED|Double-Blind Treatment Period||0
10445162|NCT00950599|11592037|FG007|NOT COMPLETED|Double-Blind Treatment Period||6
10445163|NCT00950599|11592038|FG008|NOT COMPLETED|Double-Blind Treatment Period||0
10445164|NCT00950599|11592039|FG009|NOT COMPLETED|Double-Blind Treatment Period||0
10445165|NCT00950599|11592030|FG000|STARTED|Follow-Up Period||0
10445166|NCT00950599|11592031|FG001|STARTED|Follow-Up Period||0
10445167|NCT00950599|11592032|FG002|STARTED|Follow-Up Period||0
10445168|NCT00950599|11592033|FG003|STARTED|Follow-Up Period||0
10445169|NCT00950599|11592034|FG004|STARTED|Follow-Up Period||0
10445170|NCT00950599|11592035|FG005|STARTED|Follow-Up Period||0
10445171|NCT00950599|11592036|FG006|STARTED|Follow-Up Period||0
10445172|NCT00950599|11592037|FG007|STARTED|Follow-Up Period||0
10445173|NCT00950599|11592038|FG008|STARTED|Follow-Up Period|those completing double blind period (DB) + those rescued/discontinued from DB due to hyperglycemia|309
10445174|NCT00950599|11592039|FG009|STARTED|Follow-Up Period|those completing double blind period (DB) + those rescued/discontinued from DB due to hyperglycemia|80
10445175|NCT00950599|11592030|FG000|COMPLETED|Follow-Up Period||0
10445176|NCT00950599|11592031|FG001|COMPLETED|Follow-Up Period||0
10445177|NCT00950599|11592032|FG002|COMPLETED|Follow-Up Period||0
10445178|NCT00950599|11592033|FG003|COMPLETED|Follow-Up Period||0
10445179|NCT00950599|11592034|FG004|COMPLETED|Follow-Up Period||0
10445180|NCT00950599|11592035|FG005|COMPLETED|Follow-Up Period||0
10445181|NCT00950599|11592036|FG006|COMPLETED|Follow-Up Period||0
10445182|NCT00950599|11592037|FG007|COMPLETED|Follow-Up Period||0
10445183|NCT00950599|11592038|FG008|COMPLETED|Follow-Up Period||296
10445184|NCT00950599|11592039|FG009|COMPLETED|Follow-Up Period||78
10445185|NCT00950599|11592030|FG000|NOT COMPLETED|Follow-Up Period||0
10445186|NCT00950599|11592031|FG001|NOT COMPLETED|Follow-Up Period||0
10445187|NCT00950599|11592032|FG002|NOT COMPLETED|Follow-Up Period||0
10445188|NCT00950599|11592033|FG003|NOT COMPLETED|Follow-Up Period||0
10445189|NCT00950599|11592034|FG004|NOT COMPLETED|Follow-Up Period||0
10445190|NCT00950599|11592035|FG005|NOT COMPLETED|Follow-Up Period||0
10445191|NCT00950599|11592036|FG006|NOT COMPLETED|Follow-Up Period||0
10445192|NCT00950599|11592037|FG007|NOT COMPLETED|Follow-Up Period||0
10445193|NCT00950599|11592038|FG008|NOT COMPLETED|Follow-Up Period||13
10445194|NCT00950599|11592039|FG009|NOT COMPLETED|Follow-Up Period||2
10445195|NCT00950612|11592064|FG000|STARTED|Overall Study||40
10445196|NCT00950612|11592065|FG001|STARTED|Overall Study||20
10445197|NCT00950612|11592064|FG000|COMPLETED|Overall Study||40
10445198|NCT00950612|11592065|FG001|COMPLETED|Overall Study||20
10445199|NCT00950612|11592064|FG000|NOT COMPLETED|Overall Study||0
10445200|NCT00950612|11592065|FG001|NOT COMPLETED|Overall Study||0
10445201|NCT00950651|11592073|FG000|STARTED|Overall Study||215
10445202|NCT00950651|11592074|FG001|STARTED|Overall Study|216 patients randomized but one never took study medication|216
10445203|NCT00950651|11592073|FG000|COMPLETED|Overall Study||184
10445204|NCT00950651|11592074|FG001|COMPLETED|Overall Study||181
10445205|NCT00950651|11592073|FG000|NOT COMPLETED|Overall Study||31
10445206|NCT00950651|11592074|FG001|NOT COMPLETED|Overall Study||35
10445207|NCT00950664|11592082|FG000|STARTED|First Intervention||49
10445208|NCT00950664|11592083|FG001|STARTED|First Intervention||53
10445209|NCT00950664|11592082|FG000|COMPLETED|First Intervention||46
10445210|NCT00950664|11592083|FG001|COMPLETED|First Intervention||48
10445211|NCT00950664|11592082|FG000|NOT COMPLETED|First Intervention||3
10445212|NCT00950664|11592083|FG001|NOT COMPLETED|First Intervention||5
10445213|NCT00950664|11592082|FG000|STARTED|Washout Period of 4 Weeks||46
10445214|NCT00950664|11592083|FG001|STARTED|Washout Period of 4 Weeks||48
10445215|NCT00950664|11592082|FG000|COMPLETED|Washout Period of 4 Weeks||46
10445216|NCT00950664|11592083|FG001|COMPLETED|Washout Period of 4 Weeks||48
10445217|NCT00950664|11592082|FG000|NOT COMPLETED|Washout Period of 4 Weeks||0
10445218|NCT00950664|11592083|FG001|NOT COMPLETED|Washout Period of 4 Weeks||0
10445219|NCT00950664|11592082|FG000|STARTED|Second Intervention||46
10445220|NCT00950664|11592083|FG001|STARTED|Second Intervention||48
10445221|NCT00950664|11592082|FG000|COMPLETED|Second Intervention||0
10445222|NCT00950664|11592083|FG001|COMPLETED|Second Intervention||0
10445223|NCT00950664|11592082|FG000|NOT COMPLETED|Second Intervention||46
10445224|NCT00950664|11592083|FG001|NOT COMPLETED|Second Intervention||48
10445225|NCT00950729|11592089|FG000|STARTED|Driving With Running Shoes|March 2007|48
10445226|NCT00950729|11592089|FG000|COMPLETED|Driving With Running Shoes|June 2007|48
10445227|NCT00950729|11592089|FG000|NOT COMPLETED|Driving With Running Shoes||0
10445228|NCT00950729|11592089|FG000|STARTED|Driving With Plaster Cast||48
10445229|NCT00950729|11592089|FG000|COMPLETED|Driving With Plaster Cast||48
10445230|NCT00950729|11592089|FG000|NOT COMPLETED|Driving With Plaster Cast||0
10445231|NCT00950729|11592089|FG000|STARTED|Driving With Aircast||48
10445232|NCT00950729|11592089|FG000|COMPLETED|Driving With Aircast||48
10445233|NCT00950729|11592089|FG000|NOT COMPLETED|Driving With Aircast||0
10445234|NCT00950742|11592095|FG000|STARTED|Overall Study|entered and treated|16
10445235|NCT00950742|11592096|FG001|STARTED|Overall Study|entered and treated|2
10445236|NCT00950742|11592095|FG000|COMPLETED|Overall Study||0
10445237|NCT00950742|11592096|FG001|COMPLETED|Overall Study||0
10445238|NCT00950742|11592095|FG000|NOT COMPLETED|Overall Study||16
10445239|NCT00950742|11592096|FG001|NOT COMPLETED|Overall Study||2
10550780|NCT01533935|11704917|FG004|Received Tio 5|Overall Study||52
10550781|NCT01533935|11704913|FG000|Received Tio+Olo 2.5/5|Overall Study||58
10550782|NCT01533935|11704914|FG001|Received Tio+Olo 2.5/5|Overall Study||0
10550783|NCT01533935|11704915|FG002|Received Tio+Olo 2.5/5|Overall Study||49
10550784|NCT01533935|11704916|FG003|Received Tio+Olo 2.5/5|Overall Study||56
10550785|NCT01533935|11704917|FG004|Received Tio+Olo 2.5/5|Overall Study||56
10550786|NCT01533935|11704913|FG000|Received Tio+Olo 5/5|Overall Study||56
10550787|NCT01533935|11704914|FG001|Received Tio+Olo 5/5|Overall Study||58
10550788|NCT01533935|11704915|FG002|Received Tio+Olo 5/5|Overall Study|One patient received Tio+Olo 5/5 instead of Tio+Olo 2.5/5 by mistake.|1
10550789|NCT01533935|11704916|FG003|Received Tio+Olo 5/5|Overall Study||54
10445240|NCT00950755|11592106|FG000|STARTED|Dosimetric and Therapeutic Treatment||41
10445241|NCT00950755|11592106|FG000|COMPLETED|Dosimetric and Therapeutic Treatment||0
10445242|NCT00950755|11592106|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||41
10445243|NCT00950755|11592106|FG000|STARTED|Long-Term Follow-Up|18 of the 41 participants withdrawing from Study BEX104505 enrolled in the LTFU study.|18
10445244|NCT00950755|11592106|FG000|COMPLETED|Long-Term Follow-Up||9
10445245|NCT00950755|11592106|FG000|NOT COMPLETED|Long-Term Follow-Up||9
10445246|NCT00950807|11592110|FG000|STARTED|Treatment Period 1||59
10445247|NCT00950807|11592111|FG001|STARTED|Treatment Period 1||13
10445248|NCT00950807|11592112|FG002|STARTED|Treatment Period 1||14
10445249|NCT00950807|11592113|FG003|STARTED|Treatment Period 1||12
10445250|NCT00950807|11592114|FG004|STARTED|Treatment Period 1||13
10445251|NCT00950807|11592115|FG005|STARTED|Treatment Period 1||13
10445252|NCT00950807|11592116|FG006|STARTED|Treatment Period 1||12
10445253|NCT00950807|11592117|FG007|STARTED|Treatment Period 1||14
10445254|NCT00950807|11592118|FG008|STARTED|Treatment Period 1||13
10445255|NCT00950807|11592119|FG009|STARTED|Treatment Period 1||13
10445256|NCT00950807|11592110|FG000|COMPLETED|Treatment Period 1||56
10445257|NCT00950807|11592111|FG001|COMPLETED|Treatment Period 1||13
10445258|NCT00950807|11592112|FG002|COMPLETED|Treatment Period 1||13
10445259|NCT00950807|11592113|FG003|COMPLETED|Treatment Period 1||12
10445260|NCT00950807|11592114|FG004|COMPLETED|Treatment Period 1||12
10445261|NCT00950807|11592115|FG005|COMPLETED|Treatment Period 1||11
10445262|NCT00950807|11592116|FG006|COMPLETED|Treatment Period 1||12
10445263|NCT00950807|11592117|FG007|COMPLETED|Treatment Period 1||14
10445264|NCT00950807|11592118|FG008|COMPLETED|Treatment Period 1||12
10445265|NCT00950807|11592119|FG009|COMPLETED|Treatment Period 1||13
10445266|NCT00950807|11592110|FG000|NOT COMPLETED|Treatment Period 1||3
10445267|NCT00950807|11592111|FG001|NOT COMPLETED|Treatment Period 1||0
10445268|NCT00950807|11592112|FG002|NOT COMPLETED|Treatment Period 1||1
10445269|NCT00950807|11592113|FG003|NOT COMPLETED|Treatment Period 1||0
10445270|NCT00950807|11592114|FG004|NOT COMPLETED|Treatment Period 1||1
10445271|NCT00950807|11592115|FG005|NOT COMPLETED|Treatment Period 1||2
10445272|NCT00950807|11592116|FG006|NOT COMPLETED|Treatment Period 1||0
10445273|NCT00950807|11592117|FG007|NOT COMPLETED|Treatment Period 1||0
10445274|NCT00950807|11592118|FG008|NOT COMPLETED|Treatment Period 1||1
10445275|NCT00950807|11592119|FG009|NOT COMPLETED|Treatment Period 1||0
10445276|NCT00950807|11592110|FG000|STARTED|Washout Period 1||56
10445277|NCT00950807|11592111|FG001|STARTED|Washout Period 1||13
10445278|NCT00950807|11592112|FG002|STARTED|Washout Period 1||13
10445279|NCT00950807|11592113|FG003|STARTED|Washout Period 1||12
10445280|NCT00950807|11592114|FG004|STARTED|Washout Period 1||12
10445281|NCT00950807|11592115|FG005|STARTED|Washout Period 1||11
10445282|NCT00950807|11592116|FG006|STARTED|Washout Period 1||12
10445283|NCT00950807|11592117|FG007|STARTED|Washout Period 1||14
10445284|NCT00950807|11592118|FG008|STARTED|Washout Period 1||12
10445285|NCT00950807|11592119|FG009|STARTED|Washout Period 1||13
10445286|NCT00950807|11592110|FG000|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|51
10445287|NCT00950807|11592111|FG001|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
10445288|NCT00950807|11592112|FG002|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
10445289|NCT00950807|11592113|FG003|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
10445290|NCT00950807|11592114|FG004|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
10445291|NCT00950807|11592115|FG005|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
10445292|NCT00950807|11592116|FG006|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|10
10445293|NCT00950807|11592117|FG007|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
10445294|NCT00950807|11592118|FG008|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
10445295|NCT00950807|11592119|FG009|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
10445296|NCT00950807|11592110|FG000|NOT COMPLETED|Washout Period 1||5
10445297|NCT00950807|11592111|FG001|NOT COMPLETED|Washout Period 1||0
10445298|NCT00950807|11592112|FG002|NOT COMPLETED|Washout Period 1||0
10445299|NCT00950807|11592113|FG003|NOT COMPLETED|Washout Period 1||1
10445300|NCT00950807|11592114|FG004|NOT COMPLETED|Washout Period 1||1
10445301|NCT00950807|11592115|FG005|NOT COMPLETED|Washout Period 1||0
10445302|NCT00950807|11592116|FG006|NOT COMPLETED|Washout Period 1||2
10445303|NCT00950807|11592117|FG007|NOT COMPLETED|Washout Period 1||1
10445304|NCT00950807|11592118|FG008|NOT COMPLETED|Washout Period 1||1
10550790|NCT01533935|11704917|FG004|Received Tio+Olo 5/5|Overall Study||55
10445305|NCT00950807|11592119|FG009|NOT COMPLETED|Washout Period 1||0
10445306|NCT00950807|11592110|FG000|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|53
10445307|NCT00950807|11592111|FG001|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
10445308|NCT00950807|11592112|FG002|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
10445309|NCT00950807|11592113|FG003|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
10445310|NCT00950807|11592114|FG004|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
10445311|NCT00950807|11592115|FG005|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
10445312|NCT00950807|11592116|FG006|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
10445313|NCT00950807|11592117|FG007|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
10445314|NCT00950807|11592118|FG008|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|11
10445315|NCT00950807|11592119|FG009|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|11
10445316|NCT00950807|11592110|FG000|COMPLETED|Treatment Period 2||51
10445317|NCT00950807|11592111|FG001|COMPLETED|Treatment Period 2||12
10445318|NCT00950807|11592112|FG002|COMPLETED|Treatment Period 2||10
10445319|NCT00950807|11592113|FG003|COMPLETED|Treatment Period 2||12
10445320|NCT00950807|11592114|FG004|COMPLETED|Treatment Period 2||13
10445321|NCT00950807|11592115|FG005|COMPLETED|Treatment Period 2||9
10445322|NCT00950807|11592116|FG006|COMPLETED|Treatment Period 2||9
10445323|NCT00950807|11592117|FG007|COMPLETED|Treatment Period 2||10
10445324|NCT00950807|11592118|FG008|COMPLETED|Treatment Period 2||11
10445325|NCT00950807|11592119|FG009|COMPLETED|Treatment Period 2||11
10445326|NCT00950807|11592110|FG000|NOT COMPLETED|Treatment Period 2||2
10445327|NCT00950807|11592111|FG001|NOT COMPLETED|Treatment Period 2||1
10445328|NCT00950807|11592112|FG002|NOT COMPLETED|Treatment Period 2||0
10445329|NCT00950807|11592113|FG003|NOT COMPLETED|Treatment Period 2||1
10445330|NCT00950807|11592114|FG004|NOT COMPLETED|Treatment Period 2||0
10445331|NCT00950807|11592115|FG005|NOT COMPLETED|Treatment Period 2||1
10445332|NCT00950807|11592116|FG006|NOT COMPLETED|Treatment Period 2||1
10445333|NCT00950807|11592117|FG007|NOT COMPLETED|Treatment Period 2||3
10445334|NCT00950807|11592118|FG008|NOT COMPLETED|Treatment Period 2||0
10445335|NCT00950807|11592119|FG009|NOT COMPLETED|Treatment Period 2||0
10445336|NCT00950807|11592110|FG000|STARTED|Washout Period 2||51
10445337|NCT00950807|11592111|FG001|STARTED|Washout Period 2||12
10445338|NCT00950807|11592112|FG002|STARTED|Washout Period 2||10
10445339|NCT00950807|11592113|FG003|STARTED|Washout Period 2||12
10445340|NCT00950807|11592114|FG004|STARTED|Washout Period 2||13
10445341|NCT00950807|11592115|FG005|STARTED|Washout Period 2||9
10445342|NCT00950807|11592116|FG006|STARTED|Washout Period 2||9
10445343|NCT00950807|11592117|FG007|STARTED|Washout Period 2||10
10445344|NCT00950807|11592118|FG008|STARTED|Washout Period 2||11
10445345|NCT00950807|11592119|FG009|STARTED|Washout Period 2||11
10445346|NCT00950807|11592110|FG000|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|47
10445347|NCT00950807|11592111|FG001|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
10445348|NCT00950807|11592112|FG002|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|10
10445349|NCT00950807|11592113|FG003|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
10445350|NCT00950807|11592114|FG004|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|12
10445351|NCT00950807|11592115|FG005|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|9
10445352|NCT00950807|11592116|FG006|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|8
10445353|NCT00950807|11592117|FG007|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|9
10445354|NCT00950807|11592118|FG008|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
10445355|NCT00950807|11592119|FG009|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
10445356|NCT00950807|11592110|FG000|NOT COMPLETED|Washout Period 2||4
10445357|NCT00950807|11592111|FG001|NOT COMPLETED|Washout Period 2||1
10445358|NCT00950807|11592112|FG002|NOT COMPLETED|Washout Period 2||0
10445359|NCT00950807|11592113|FG003|NOT COMPLETED|Washout Period 2||1
10445360|NCT00950807|11592114|FG004|NOT COMPLETED|Washout Period 2||1
10445361|NCT00950807|11592115|FG005|NOT COMPLETED|Washout Period 2||0
10445362|NCT00950807|11592116|FG006|NOT COMPLETED|Washout Period 2||1
10445363|NCT00950807|11592117|FG007|NOT COMPLETED|Washout Period 2||1
10445364|NCT00950807|11592118|FG008|NOT COMPLETED|Washout Period 2||0
10445365|NCT00950807|11592119|FG009|NOT COMPLETED|Washout Period 2||0
10445366|NCT00950807|11592110|FG000|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|46
10445367|NCT00950807|11592111|FG001|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
10445368|NCT00950807|11592112|FG002|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|10
10445369|NCT00950807|11592113|FG003|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|11
10525579|NCT01376700|11677514|FG000|NOT COMPLETED|Overall Study||16
10445370|NCT00950807|11592114|FG004|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|12
10445371|NCT00950807|11592115|FG005|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
10445372|NCT00950807|11592116|FG006|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|12
10445373|NCT00950807|11592117|FG007|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|10
10445374|NCT00950807|11592118|FG008|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
10445375|NCT00950807|11592119|FG009|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|11
10445376|NCT00950807|11592110|FG000|COMPLETED|Treatment Period 3||45
10445377|NCT00950807|11592111|FG001|COMPLETED|Treatment Period 3||9
10550791|NCT01533935|11704913|FG000|COMPLETED|Overall Study|All treatment periods|52
10550792|NCT01533935|11704914|FG001|COMPLETED|Overall Study|All treatment periods|45
10550793|NCT01533935|11704915|FG002|COMPLETED|Overall Study|All treatment periods|50
10445378|NCT00950807|11592112|FG002|COMPLETED|Treatment Period 3||10
10445379|NCT00950807|11592113|FG003|COMPLETED|Treatment Period 3||11
10445380|NCT00950807|11592114|FG004|COMPLETED|Treatment Period 3||12
10445381|NCT00950807|11592115|FG005|COMPLETED|Treatment Period 3||9
10445382|NCT00950807|11592116|FG006|COMPLETED|Treatment Period 3||11
10445383|NCT00950807|11592117|FG007|COMPLETED|Treatment Period 3||9
10445384|NCT00950807|11592118|FG008|COMPLETED|Treatment Period 3||9
10445385|NCT00950807|11592119|FG009|COMPLETED|Treatment Period 3||10
10445386|NCT00950807|11592110|FG000|NOT COMPLETED|Treatment Period 3||1
10445387|NCT00950807|11592111|FG001|NOT COMPLETED|Treatment Period 3||0
10445388|NCT00950807|11592112|FG002|NOT COMPLETED|Treatment Period 3||0
10445389|NCT00950807|11592113|FG003|NOT COMPLETED|Treatment Period 3||0
10550794|NCT01533935|11704916|FG003|COMPLETED|Overall Study|All treatment periods|52
10550795|NCT01533935|11704917|FG004|COMPLETED|Overall Study|All treatment periods|50
10550796|NCT01533935|11704913|FG000|NOT COMPLETED|Overall Study||6
10550797|NCT01533935|11704914|FG001|NOT COMPLETED|Overall Study||13
10550798|NCT01533935|11704915|FG002|NOT COMPLETED|Overall Study||8
10550799|NCT01533935|11704916|FG003|NOT COMPLETED|Overall Study||7
10550800|NCT01533935|11704917|FG004|NOT COMPLETED|Overall Study||8
10550801|NCT01533948|11704929|FG000|STARTED|Overall Study||25
10550802|NCT01533948|11704929|FG000|COMPLETED|Overall Study||25
10550803|NCT01533948|11704929|FG000|NOT COMPLETED|Overall Study||0
10550804|NCT01533974|11704935|FG000|STARTED|Overall Study||224
10550805|NCT01533974|11704936|FG001|STARTED|Overall Study||226
10445390|NCT00950807|11592114|FG004|NOT COMPLETED|Treatment Period 3||0
10445391|NCT00950807|11592115|FG005|NOT COMPLETED|Treatment Period 3||0
10445392|NCT00950807|11592116|FG006|NOT COMPLETED|Treatment Period 3||1
10445393|NCT00950807|11592117|FG007|NOT COMPLETED|Treatment Period 3||1
10445394|NCT00950807|11592118|FG008|NOT COMPLETED|Treatment Period 3||0
10445395|NCT00950807|11592119|FG009|NOT COMPLETED|Treatment Period 3||1
10445396|NCT00950833|11592144|FG000|STARTED|Overall Study||112
10445397|NCT00950833|11592145|FG001|STARTED|Overall Study||108
10445398|NCT00950833|11592146|FG002|STARTED|Overall Study||223
10445399|NCT00950833|11592144|FG000|COMPLETED|Overall Study||112
10445400|NCT00950833|11592145|FG001|COMPLETED|Overall Study||108
10445401|NCT00950833|11592146|FG002|COMPLETED|Overall Study||223
10445402|NCT00950833|11592144|FG000|NOT COMPLETED|Overall Study||0
10445403|NCT00950833|11592145|FG001|NOT COMPLETED|Overall Study||0
10445404|NCT00950833|11592146|FG002|NOT COMPLETED|Overall Study||0
10445405|NCT00950859|11592158|FG000|STARTED|Overall Study||27
10445406|NCT00950859|11592159|FG001|STARTED|Overall Study||24
10445407|NCT00950859|11592158|FG000|COMPLETED|Overall Study||11
10445408|NCT00950859|11592159|FG001|COMPLETED|Overall Study||14
10445409|NCT00950859|11592158|FG000|NOT COMPLETED|Overall Study||16
10550806|NCT01533974|11704935|FG000|COMPLETED|Overall Study||173
10550807|NCT01533974|11704936|FG001|COMPLETED|Overall Study||176
10550808|NCT01533974|11704935|FG000|NOT COMPLETED|Overall Study||51
10550809|NCT01533974|11704936|FG001|NOT COMPLETED|Overall Study||50
10550810|NCT01534013|11704944|FG000|STARTED|Overall Study||8
10550811|NCT01534013|11704945|FG001|STARTED|Overall Study||6
10550812|NCT01534013|11704944|FG000|COMPLETED|Overall Study||6
10550813|NCT01534013|11704945|FG001|COMPLETED|Overall Study||6
10550814|NCT01534013|11704944|FG000|NOT COMPLETED|Overall Study||2
10550815|NCT01534013|11704945|FG001|NOT COMPLETED|Overall Study||0
10550816|NCT01534052|11704951|FG000|STARTED|Overall Study||52
10550817|NCT01534052|11704951|FG000|Treatment Received|Overall Study||52
10550818|NCT01534052|11704951|FG000|COMPLETED|Overall Study||52
10550819|NCT01534052|11704951|FG000|NOT COMPLETED|Overall Study||0
10445410|NCT00950859|11592159|FG001|NOT COMPLETED|Overall Study||10
10445411|NCT00950872|11592165|FG000|STARTED|Overall Study||29
10445412|NCT00950872|11592165|FG000|COMPLETED|Overall Study||26
10445413|NCT00950872|11592165|FG000|NOT COMPLETED|Overall Study||3
10445414|NCT00950911|11592171|FG000|STARTED|Overall Study||17
10445415|NCT00950911|11592172|FG001|STARTED|Overall Study||18
10445416|NCT00950911|11592171|FG000|COMPLETED|Overall Study||5
10445417|NCT00950911|11592172|FG001|COMPLETED|Overall Study||3
10445418|NCT00950911|11592171|FG000|NOT COMPLETED|Overall Study||12
10550820|NCT01534078|11704955|FG000|STARTED|Overall Study||34
10550821|NCT01534078|11704955|FG000|COMPLETED|Overall Study||32
10550822|NCT01534078|11704955|FG000|NOT COMPLETED|Overall Study||2
10550823|NCT01534182|11704961|FG000|STARTED|Overall Study||230
10550824|NCT01534182|11704962|FG001|STARTED|Overall Study||68
10550825|NCT01534182|11704961|FG000|Safety Set|Overall Study||230
10550826|NCT01534182|11704962|FG001|Safety Set|Overall Study||64
10550827|NCT01534182|11704961|FG000|Full Analysis Set|Overall Study||229
10550828|NCT01534182|11704962|FG001|Full Analysis Set|Overall Study||62
10550829|NCT01534182|11704961|FG000|COMPLETED|Overall Study||218
10550830|NCT01534182|11704962|FG001|COMPLETED|Overall Study||58
10550831|NCT01534182|11704961|FG000|NOT COMPLETED|Overall Study||12
10550832|NCT01534182|11704962|FG001|NOT COMPLETED|Overall Study||10
10550833|NCT01534195|11704971|FG000|STARTED|Overall Study||5
10550834|NCT01534195|11704972|FG001|STARTED|Overall Study||6
10550835|NCT01534195|11704971|FG000|COMPLETED|Overall Study||4
10550836|NCT01534195|11704972|FG001|COMPLETED|Overall Study||5
10550837|NCT01534195|11704971|FG000|NOT COMPLETED|Overall Study||1
10550838|NCT01534195|11704972|FG001|NOT COMPLETED|Overall Study||1
10445419|NCT00950911|11592172|FG001|NOT COMPLETED|Overall Study||15
10445420|NCT00950950|11592180|FG000|STARTED|Overall Study||12
10445421|NCT00950950|11592181|FG001|STARTED|Overall Study||12
10445422|NCT00950950|11592180|FG000|COMPLETED|Overall Study||11
10445423|NCT00950950|11592181|FG001|COMPLETED|Overall Study||11
10445424|NCT00950950|11592180|FG000|NOT COMPLETED|Overall Study||1
10445425|NCT00950950|11592181|FG001|NOT COMPLETED|Overall Study||1
10445426|NCT00950963|11592190|FG000|STARTED|Overall Study|Patients were randomized from a diabetes registry and were followed as intent to treat|381
10445427|NCT00950963|11592191|FG001|STARTED|Overall Study|Patients were randomized from a diabetes registry and were followed as intent to treat|381
10445428|NCT00950963|11592190|FG000|COMPLETED|Overall Study||352
10445429|NCT00950963|11592191|FG001|COMPLETED|Overall Study||357
10445430|NCT00950963|11592190|FG000|NOT COMPLETED|Overall Study||29
10445431|NCT00950963|11592191|FG001|NOT COMPLETED|Overall Study||24
10445432|NCT00951015|11592201|FG000|STARTED|Randomization Phase 96 Week||53
10445433|NCT00951015|11592202|FG001|STARTED|Randomization Phase 96 Week||51
10445434|NCT00951015|11592203|FG002|STARTED|Randomization Phase 96 Week||51
10445435|NCT00951015|11592204|FG003|STARTED|Randomization Phase 96 Week||50
10445436|NCT00951015|11592205|FG004|STARTED|Randomization Phase 96 Week||0
10445437|NCT00951015|11592201|FG000|COMPLETED|Randomization Phase 96 Week||48
10445438|NCT00951015|11592202|FG001|COMPLETED|Randomization Phase 96 Week||44
10445439|NCT00951015|11592203|FG002|COMPLETED|Randomization Phase 96 Week||46
10445440|NCT00951015|11592204|FG003|COMPLETED|Randomization Phase 96 Week||40
10445441|NCT00951015|11592205|FG004|COMPLETED|Randomization Phase 96 Week||0
10445442|NCT00951015|11592201|FG000|NOT COMPLETED|Randomization Phase 96 Week||5
10445443|NCT00951015|11592202|FG001|NOT COMPLETED|Randomization Phase 96 Week||7
10445444|NCT00951015|11592203|FG002|NOT COMPLETED|Randomization Phase 96 Week||5
10445445|NCT00951015|11592204|FG003|NOT COMPLETED|Randomization Phase 96 Week||10
10445446|NCT00951015|11592205|FG004|NOT COMPLETED|Randomization Phase 96 Week||0
10445447|NCT00951015|11592201|FG000|STARTED|Open-label Phase||0
10445448|NCT00951015|11592202|FG001|STARTED|Open-label Phase||0
10445449|NCT00951015|11592203|FG002|STARTED|Open-label Phase||0
10445450|NCT00951015|11592204|FG003|STARTED|Open-label Phase||0
10445451|NCT00951015|11592205|FG004|STARTED|Open-label Phase||138
10445452|NCT00951015|11592201|FG000|COMPLETED|Open-label Phase||0
10445453|NCT00951015|11592202|FG001|COMPLETED|Open-label Phase||0
10445454|NCT00951015|11592203|FG002|COMPLETED|Open-label Phase||0
10445455|NCT00951015|11592204|FG003|COMPLETED|Open-label Phase||0
10445456|NCT00951015|11592205|FG004|COMPLETED|Open-label Phase||88
10445457|NCT00951015|11592201|FG000|NOT COMPLETED|Open-label Phase||0
10445458|NCT00951015|11592202|FG001|NOT COMPLETED|Open-label Phase||0
10445459|NCT00951015|11592203|FG002|NOT COMPLETED|Open-label Phase||0
10550839|NCT01534208|11704980|FG000|STARTED|Overall Study||216
10550840|NCT01534208|11704981|FG001|STARTED|Overall Study||283
10445460|NCT00951015|11592204|FG003|NOT COMPLETED|Open-label Phase||0
10445461|NCT00951015|11592205|FG004|NOT COMPLETED|Open-label Phase||50
10445462|NCT00951041|11592230|FG000|STARTED|Overall Study||64
10445463|NCT00951041|11592231|FG001|STARTED|Overall Study||66
10445464|NCT00951041|11592230|FG000|COMPLETED|Overall Study||59
10445465|NCT00951041|11592231|FG001|COMPLETED|Overall Study||65
10445466|NCT00951041|11592230|FG000|NOT COMPLETED|Overall Study||5
10445467|NCT00951041|11592231|FG001|NOT COMPLETED|Overall Study||1
10445474|NCT00951093|11592247|FG000|STARTED|Before GBP||53
10550841|NCT01534208|11704980|FG000|COMPLETED|Overall Study||159
10550842|NCT01534208|11704981|FG001|COMPLETED|Overall Study||234
10445475|NCT00951093|11592247|FG000|COMPLETED|Before GBP||53
10550843|NCT01534208|11704980|FG000|NOT COMPLETED|Overall Study||57
10550844|NCT01534208|11704981|FG001|NOT COMPLETED|Overall Study||49
10550845|NCT01534260|11704989|FG000|STARTED|Overall Study||17
10550846|NCT01534260|11704990|FG001|STARTED|Overall Study||20
10550847|NCT01534260|11704989|FG000|COMPLETED|Overall Study||1
10445476|NCT00951093|11592247|FG000|NOT COMPLETED|Before GBP||0
10445477|NCT00951093|11592247|FG000|STARTED|6 Months After GBP||53
10445478|NCT00951093|11592247|FG000|COMPLETED|6 Months After GBP||53
10445479|NCT00951093|11592247|FG000|NOT COMPLETED|6 Months After GBP||0
10445480|NCT00951171|11592255|FG000|STARTED|Overall Study||40
10445481|NCT00951171|11592256|FG001|STARTED|Overall Study||55
10445482|NCT00951171|11592255|FG000|Pregnancy|Overall Study||1
10445483|NCT00951171|11592256|FG001|Pregnancy|Overall Study||7
10445484|NCT00951171|11592255|FG000|COMPLETED|Overall Study||38
10550848|NCT01534260|11704990|FG001|COMPLETED|Overall Study||0
10445485|NCT00951171|11592256|FG001|COMPLETED|Overall Study|2 of the cervical occlusion group transferred to standard group because of pain during attempted IUI|55
10445486|NCT00951171|11592255|FG000|NOT COMPLETED|Overall Study||2
10445487|NCT00951171|11592256|FG001|NOT COMPLETED|Overall Study||0
10445488|NCT00951275|11592262|FG000|STARTED|Overall Study||105
10445489|NCT00951275|11592262|FG000|COMPLETED|Overall Study||92
10445490|NCT00951275|11592262|FG000|NOT COMPLETED|Overall Study||13
10445491|NCT00951379|11592268|FG000|STARTED|Overall Study||27
10445492|NCT00951379|11592269|FG001|STARTED|Overall Study||25
10445493|NCT00951379|11592268|FG000|COMPLETED|Overall Study||21
10445494|NCT00951379|11592269|FG001|COMPLETED|Overall Study||23
10445495|NCT00951379|11592268|FG000|NOT COMPLETED|Overall Study||6
10445496|NCT00951379|11592269|FG001|NOT COMPLETED|Overall Study||2
10445497|NCT00951483|11592285|FG000|STARTED|Overall Study||47
10445498|NCT00951483|11592286|FG001|STARTED|Overall Study||44
10445499|NCT00951483|11592285|FG000|COMPLETED|Overall Study||28
10445500|NCT00951483|11592286|FG001|COMPLETED|Overall Study||44
10445501|NCT00951483|11592285|FG000|NOT COMPLETED|Overall Study||19
10445502|NCT00951483|11592286|FG001|NOT COMPLETED|Overall Study||0
10445503|NCT00951496|11592297|FG000|STARTED|Overall Study||521
10445504|NCT00951496|11592298|FG001|STARTED|Overall Study||518
10445505|NCT00951496|11592299|FG002|STARTED|Overall Study||521
10445506|NCT00951496|11592297|FG000|COMPLETED|Overall Study||511
10445507|NCT00951496|11592298|FG001|COMPLETED|Overall Study||510
10445508|NCT00951496|11592299|FG002|COMPLETED|Overall Study||508
10445509|NCT00951496|11592297|FG000|NOT COMPLETED|Overall Study||10
10445510|NCT00951496|11592298|FG001|NOT COMPLETED|Overall Study||8
10445511|NCT00951496|11592299|FG002|NOT COMPLETED|Overall Study||13
10445512|NCT00951509|11592310|FG000|STARTED|Overall Study||31
10445513|NCT00951509|11592310|FG000|Driving Condition 1|Overall Study||29
10445514|NCT00951509|11592310|FG000|Driving Condition 2|Overall Study||29
10445515|NCT00951509|11592310|FG000|Driving Condition 3|Overall Study||25
10445516|NCT00951509|11592310|FG000|Driving Condition 4|Overall Study||28
10445517|NCT00951509|11592310|FG000|Driving Condition 5|Overall Study||30
10445518|NCT00951509|11592310|FG000|COMPLETED|Overall Study||29
10445519|NCT00951509|11592310|FG000|NOT COMPLETED|Overall Study||2
10445520|NCT00951561|11592318|FG000|STARTED|Overall Study|Randomized Vipon or Ibuprofen period 1, crossover period 2, randomized period 3, crossover period 4|25
10445521|NCT00951561|11592319|FG001|STARTED|Overall Study||29
10445522|NCT00951561|11592320|FG002|STARTED|Overall Study|1 subject used Vipon periods 1 & 2 instead of Ibuprofen period 2.|21
10445523|NCT00951561|11592321|FG003|STARTED|Overall Study||27
10445524|NCT00951561|11592318|FG000|COMPLETED|Overall Study||25
10445525|NCT00951561|11592319|FG001|COMPLETED|Overall Study||29
10445526|NCT00951561|11592320|FG002|COMPLETED|Overall Study|3 subjects dropped after period 2|18
10445527|NCT00951561|11592321|FG003|COMPLETED|Overall Study|1 subject dropped after period 2|26
10445528|NCT00951561|11592318|FG000|NOT COMPLETED|Overall Study||0
10445529|NCT00951561|11592319|FG001|NOT COMPLETED|Overall Study||0
10445530|NCT00951561|11592320|FG002|NOT COMPLETED|Overall Study||3
10445531|NCT00951561|11592321|FG003|NOT COMPLETED|Overall Study||1
10445532|NCT00951665|11592332|FG000|STARTED|Phase 1b||29
10445533|NCT00951665|11592333|FG001|STARTED|Phase 1b||10
10550849|NCT01534260|11704989|FG000|NOT COMPLETED|Overall Study||16
10550850|NCT01534260|11704990|FG001|NOT COMPLETED|Overall Study||20
10550851|NCT01534273|11705000|FG000|STARTED|Period 1||3
10550852|NCT01534273|11705001|FG001|STARTED|Period 1||6
10550853|NCT01534273|11705002|FG002|STARTED|Period 1||2
10550854|NCT01534273|11705003|FG003|STARTED|Period 1||7
10550855|NCT01534273|11705004|FG004|STARTED|Period 1||3
10445534|NCT00951665|11592334|FG002|STARTED|Phase 1b||21
10445535|NCT00951665|11592335|FG003|STARTED|Phase 1b||3
10445536|NCT00951665|11592336|FG004|STARTED|Phase 1b||0
10445537|NCT00951665|11592337|FG005|STARTED|Phase 1b||0
10445538|NCT00951665|11592332|FG000|Started Treatment|Phase 1b||26
10445539|NCT00951665|11592333|FG001|Started Treatment|Phase 1b||10
10445540|NCT00951665|11592334|FG002|Started Treatment|Phase 1b||21
10445541|NCT00951665|11592335|FG003|Started Treatment|Phase 1b||3
10445542|NCT00951665|11592336|FG004|Started Treatment|Phase 1b||0
10445543|NCT00951665|11592337|FG005|Started Treatment|Phase 1b||0
10445544|NCT00951665|11592332|FG000|COMPLETED|Phase 1b||7
10445545|NCT00951665|11592333|FG001|COMPLETED|Phase 1b||6
10445546|NCT00951665|11592334|FG002|COMPLETED|Phase 1b||4
10550856|NCT01534273|11705005|FG005|STARTED|Period 1||3
10550857|NCT01534273|11705006|FG006|STARTED|Period 1||6
10550858|NCT01534273|11705000|FG000|Received at Least 1 Dose of Study Drug|Period 1||3
10550859|NCT01534273|11705001|FG001|Received at Least 1 Dose of Study Drug|Period 1||6
10550860|NCT01534273|11705002|FG002|Received at Least 1 Dose of Study Drug|Period 1||2
10550861|NCT01534273|11705003|FG003|Received at Least 1 Dose of Study Drug|Period 1||7
10445547|NCT00951665|11592335|FG003|COMPLETED|Phase 1b||2
10445548|NCT00951665|11592336|FG004|COMPLETED|Phase 1b||0
10445549|NCT00951665|11592337|FG005|COMPLETED|Phase 1b||0
10445550|NCT00951665|11592332|FG000|NOT COMPLETED|Phase 1b||22
10445551|NCT00951665|11592333|FG001|NOT COMPLETED|Phase 1b||4
10445552|NCT00951665|11592334|FG002|NOT COMPLETED|Phase 1b||17
10445553|NCT00951665|11592335|FG003|NOT COMPLETED|Phase 1b||1
10445554|NCT00951665|11592336|FG004|NOT COMPLETED|Phase 1b||0
10445555|NCT00951665|11592337|FG005|NOT COMPLETED|Phase 1b||0
10445556|NCT00951665|11592332|FG000|STARTED|Phase 2a||0
10445557|NCT00951665|11592333|FG001|STARTED|Phase 2a||0
10445558|NCT00951665|11592334|FG002|STARTED|Phase 2a||0
10445559|NCT00951665|11592335|FG003|STARTED|Phase 2a||0
10445560|NCT00951665|11592336|FG004|STARTED|Phase 2a||22
10550862|NCT01534273|11705004|FG004|Received at Least 1 Dose of Study Drug|Period 1||3
10445561|NCT00951665|11592337|FG005|STARTED|Phase 2a||22
10445562|NCT00951665|11592332|FG000|COMPLETED|Phase 2a||0
10445563|NCT00951665|11592333|FG001|COMPLETED|Phase 2a||0
10445564|NCT00951665|11592334|FG002|COMPLETED|Phase 2a||0
10445565|NCT00951665|11592335|FG003|COMPLETED|Phase 2a||0
10445566|NCT00951665|11592336|FG004|COMPLETED|Phase 2a||10
10445567|NCT00951665|11592337|FG005|COMPLETED|Phase 2a||15
10445568|NCT00951665|11592332|FG000|NOT COMPLETED|Phase 2a||0
10445569|NCT00951665|11592333|FG001|NOT COMPLETED|Phase 2a||0
10445570|NCT00951665|11592334|FG002|NOT COMPLETED|Phase 2a||0
10445571|NCT00951665|11592335|FG003|NOT COMPLETED|Phase 2a||0
10445572|NCT00951665|11592336|FG004|NOT COMPLETED|Phase 2a||12
10445573|NCT00951665|11592337|FG005|NOT COMPLETED|Phase 2a||7
10445574|NCT00951808|11592371|FG000|STARTED|Overall Study||4
10445575|NCT00951808|11592372|FG001|STARTED|Overall Study||6
10445576|NCT00951808|11592373|FG002|STARTED|Overall Study||227
10445577|NCT00951808|11592371|FG000|COMPLETED|Overall Study||4
10445578|NCT00951808|11592372|FG001|COMPLETED|Overall Study||6
10445579|NCT00951808|11592373|FG002|COMPLETED|Overall Study|Four subjects withdrew from the study.|223
10445580|NCT00951808|11592371|FG000|NOT COMPLETED|Overall Study||0
10445581|NCT00951808|11592372|FG001|NOT COMPLETED|Overall Study||0
10445582|NCT00951808|11592373|FG002|NOT COMPLETED|Overall Study||4
10445583|NCT00951821|11592381|FG000|STARTED|Overall Study||16
10445584|NCT00951821|11592382|FG001|STARTED|Overall Study||8
10445585|NCT00951821|11592381|FG000|COMPLETED|Overall Study||16
10445586|NCT00951821|11592382|FG001|COMPLETED|Overall Study||8
10445587|NCT00951821|11592381|FG000|NOT COMPLETED|Overall Study||0
10445588|NCT00951821|11592382|FG001|NOT COMPLETED|Overall Study||0
10445589|NCT00951899|11592390|FG000|STARTED|Overall Study||19
10445590|NCT00951899|11592391|FG001|STARTED|Overall Study||19
10445591|NCT00951899|11592390|FG000|COMPLETED|Overall Study||19
10445592|NCT00951899|11592391|FG001|COMPLETED|Overall Study||19
10445593|NCT00951899|11592390|FG000|NOT COMPLETED|Overall Study||0
10445594|NCT00951899|11592391|FG001|NOT COMPLETED|Overall Study||0
10445595|NCT00951912|11592400|FG000|STARTED|Overall Study||54
10445596|NCT00951912|11592401|FG001|STARTED|Overall Study||55
10445597|NCT00951912|11592402|FG002|STARTED|Overall Study||56
10445598|NCT00951912|11592400|FG000|COMPLETED|Overall Study||47
10445599|NCT00951912|11592401|FG001|COMPLETED|Overall Study||50
10445600|NCT00951912|11592402|FG002|COMPLETED|Overall Study||54
10445601|NCT00951912|11592400|FG000|NOT COMPLETED|Overall Study||7
10650488|NCT02169479|11810754|FG002|100 mg BIA 9-1067|Overall Study||4
10445602|NCT00951912|11592401|FG001|NOT COMPLETED|Overall Study||5
10445603|NCT00951912|11592402|FG002|NOT COMPLETED|Overall Study||2
10445604|NCT00952068|11592410|FG000|STARTED|Overall Study||47
10445605|NCT00952068|11592410|FG000|COMPLETED|Overall Study||40
10445606|NCT00952068|11592410|FG000|NOT COMPLETED|Overall Study||7
10445607|NCT00952081|11592414|FG000|STARTED|Overall Study||22
10445608|NCT00952081|11592414|FG000|COMPLETED|Overall Study||22
10445609|NCT00952081|11592414|FG000|NOT COMPLETED|Overall Study||0
10445610|NCT00952120|11592421|FG000|STARTED|Overall Study||52
10445611|NCT00952120|11592422|FG001|STARTED|Overall Study||47
10445612|NCT00952120|11592423|FG002|STARTED|Overall Study||5
10445613|NCT00952120|11592421|FG000|COMPLETED|Overall Study||52
10445614|NCT00952120|11592422|FG001|COMPLETED|Overall Study||47
10445615|NCT00952120|11592423|FG002|COMPLETED|Overall Study||5
10445616|NCT00952120|11592421|FG000|NOT COMPLETED|Overall Study||0
10445617|NCT00952120|11592422|FG001|NOT COMPLETED|Overall Study||0
10445618|NCT00952120|11592423|FG002|NOT COMPLETED|Overall Study||0
10525580|NCT01376804|11677521|FG000|STARTED|Treatment Period||57
10525581|NCT01376804|11677521|FG000|Received Study Drug|Treatment Period||56
10525582|NCT01376804|11677521|FG000|COMPLETED|Treatment Period||49
10525583|NCT01376804|11677521|FG000|NOT COMPLETED|Treatment Period||8
10525584|NCT01376804|11677521|FG000|STARTED|Follow-up Period|6 of the 7 patients who withdrew from treatment continued to the Follow-up Period.|55
10525585|NCT01376804|11677521|FG000|COMPLETED|Follow-up Period||55
10525586|NCT01376804|11677521|FG000|NOT COMPLETED|Follow-up Period||0
10525587|NCT01376908|11677527|FG000|STARTED|Overall Study||27
10525588|NCT01376908|11677528|FG001|STARTED|Overall Study||29
10525589|NCT01376908|11677527|FG000|COMPLETED|Overall Study||25
10525590|NCT01376908|11677528|FG001|COMPLETED|Overall Study||26
10525591|NCT01376908|11677527|FG000|NOT COMPLETED|Overall Study||2
10525592|NCT01376908|11677528|FG001|NOT COMPLETED|Overall Study||3
10525593|NCT01377012|11677544|FG000|STARTED|Core Study||210
10525594|NCT01377012|11677545|FG001|STARTED|Core Study||213
10525595|NCT01377012|11677546|FG002|STARTED|Core Study||214
10525596|NCT01377012|11677544|FG000|wk16 Re-randomized to AIN 75mg NR|Core Study||0
10525597|NCT01377012|11677545|FG001|wk16 Re-randomized to AIN 75mg NR|Core Study||0
10525598|NCT01377012|11677546|FG002|wk16 Re-randomized to AIN 75mg NR|Core Study|NR=Non-responder|56
10525599|NCT01377012|11677544|FG000|wk16 Re-randomized to AIN 150mg NR|Core Study||0
10525600|NCT01377012|11677545|FG001|wk16 Re-randomized to AIN 150mg NR|Core Study||0
10525601|NCT01377012|11677546|FG002|wk16 Re-randomized to AIN 150mg NR|Core Study||53
10525602|NCT01377012|11677544|FG000|wk 24 Re-randomized to AIN 75 mg Res|Core Study||0
10525603|NCT01377012|11677545|FG001|wk 24 Re-randomized to AIN 75 mg Res|Core Study||0
10525604|NCT01377012|11677546|FG002|wk 24 Re-randomized to AIN 75 mg Res|Core Study|Res= responder|38
10525605|NCT01377012|11677544|FG000|wk 24 Re-randomized to AIN 150 mg Res|Core Study||0
10525606|NCT01377012|11677545|FG001|wk 24 Re-randomized to AIN 150 mg Res|Core Study||0
10525607|NCT01377012|11677546|FG002|wk 24 Re-randomized to AIN 150 mg Res|Core Study||34
10525608|NCT01377012|11677544|FG000|COMPLETED|Core Study||76
10525609|NCT01377012|11677545|FG001|COMPLETED|Core Study||81
10445619|NCT00952133|11592431|FG000|STARTED|Overall Study||59
10445620|NCT00952133|11592432|FG001|STARTED|Overall Study||59
10445621|NCT00952133|11592431|FG000|COMPLETED|Overall Study||59
10445622|NCT00952133|11592432|FG001|COMPLETED|Overall Study||59
10445623|NCT00952133|11592431|FG000|NOT COMPLETED|Overall Study||0
10445624|NCT00952133|11592432|FG001|NOT COMPLETED|Overall Study||0
10445625|NCT00952211|11592442|FG000|STARTED|Overall Study||3
10445626|NCT00952211|11592443|FG001|STARTED|Overall Study||0
10445627|NCT00952211|11592442|FG000|COMPLETED|Overall Study||3
10445628|NCT00952211|11592443|FG001|COMPLETED|Overall Study||0
10445629|NCT00952211|11592442|FG000|NOT COMPLETED|Overall Study||0
10445630|NCT00952211|11592443|FG001|NOT COMPLETED|Overall Study||0
10445631|NCT00952276|11592454|FG000|STARTED|Overall Study||127
10445632|NCT00952276|11592455|FG001|STARTED|Overall Study||115
10445633|NCT00952276|11592456|FG002|STARTED|Overall Study||122
10445634|NCT00952276|11592457|FG003|STARTED|Overall Study||121
10445635|NCT00952276|11592458|FG004|STARTED|Overall Study||63
10445636|NCT00952276|11592454|FG000|COMPLETED|Overall Study||126
10445637|NCT00952276|11592455|FG001|COMPLETED|Overall Study||115
10445638|NCT00952276|11592456|FG002|COMPLETED|Overall Study||122
10445639|NCT00952276|11592457|FG003|COMPLETED|Overall Study||120
10445640|NCT00952276|11592458|FG004|COMPLETED|Overall Study||63
10445641|NCT00952276|11592454|FG000|NOT COMPLETED|Overall Study||1
10445642|NCT00952276|11592455|FG001|NOT COMPLETED|Overall Study||0
10445643|NCT00952276|11592456|FG002|NOT COMPLETED|Overall Study||0
10445644|NCT00952276|11592457|FG003|NOT COMPLETED|Overall Study||1
10445645|NCT00952276|11592458|FG004|NOT COMPLETED|Overall Study||0
10445646|NCT00952289|11592472|FG000|STARTED|All Participants||155
10445647|NCT00952289|11592473|FG001|STARTED|All Participants||154
10445648|NCT00952289|11592472|FG000|Safety Population|All Participants||155
10445649|NCT00952289|11592473|FG001|Safety Population|All Participants|Randomized patients who are documented to have received at least 1 dose of study medication.|151
10445650|NCT00952289|11592472|FG000|COMPLETED|All Participants|Represents the number of patients who were still in the study as of 02 November 2010|134
10445651|NCT00952289|11592473|FG001|COMPLETED|All Participants|Includes patients in the study as of 2 November 2010 (78) + those who crossed over to Ruxolitinib.|114
10445652|NCT00952289|11592472|FG000|NOT COMPLETED|All Participants||21
10445653|NCT00952289|11592473|FG001|NOT COMPLETED|All Participants||40
10445654|NCT00952289|11592472|FG000|STARTED|Patients Who Crossed Over to Ruxolitinib||0
10445655|NCT00952289|11592473|FG001|STARTED|Patients Who Crossed Over to Ruxolitinib||111
10445656|NCT00952289|11592472|FG000|COMPLETED|Patients Who Crossed Over to Ruxolitinib||0
10445657|NCT00952289|11592473|FG001|COMPLETED|Patients Who Crossed Over to Ruxolitinib|Number of cross over subjects who were still in the study as of 25 JAN 2013|57
10445658|NCT00952289|11592472|FG000|NOT COMPLETED|Patients Who Crossed Over to Ruxolitinib||0
10445659|NCT00952289|11592473|FG001|NOT COMPLETED|Patients Who Crossed Over to Ruxolitinib||54
10445660|NCT00952315|11592482|FG000|STARTED|Overall Study||90
10445661|NCT00952315|11592483|FG001|STARTED|Overall Study||90
10445662|NCT00952315|11592484|FG002|STARTED|Overall Study||90
10445663|NCT00952315|11592482|FG000|COMPLETED|Overall Study||64
10445664|NCT00952315|11592483|FG001|COMPLETED|Overall Study||66
10445665|NCT00952315|11592484|FG002|COMPLETED|Overall Study||71
10445666|NCT00952315|11592482|FG000|NOT COMPLETED|Overall Study||26
10445667|NCT00952315|11592483|FG001|NOT COMPLETED|Overall Study||24
10445668|NCT00952315|11592484|FG002|NOT COMPLETED|Overall Study||19
10445669|NCT00952341|11592497|FG000|STARTED|Cycle 1||209
10445670|NCT00952341|11592498|FG001|STARTED|Cycle 1||212
10445671|NCT00952341|11592497|FG000|COMPLETED|Cycle 1||189
10445672|NCT00952341|11592498|FG001|COMPLETED|Cycle 1||199
10445673|NCT00952341|11592497|FG000|NOT COMPLETED|Cycle 1||20
10445674|NCT00952341|11592498|FG001|NOT COMPLETED|Cycle 1||13
10445675|NCT00952341|11592497|FG000|STARTED|Cycle 2||110
10445676|NCT00952341|11592498|FG001|STARTED|Cycle 2||130
10445677|NCT00952341|11592497|FG000|COMPLETED|Cycle 2||101
10445678|NCT00952341|11592498|FG001|COMPLETED|Cycle 2||118
10445679|NCT00952341|11592497|FG000|NOT COMPLETED|Cycle 2||9
10445680|NCT00952341|11592498|FG001|NOT COMPLETED|Cycle 2||12
10445681|NCT00952367|11592504|FG000|STARTED|Overall Study||3641
10445682|NCT00952367|11592504|FG000|COMPLETED|Overall Study||3635
10445683|NCT00952367|11592504|FG000|NOT COMPLETED|Overall Study||6
10445684|NCT00952380|11592513|FG000|STARTED|Overall Study||1
10445685|NCT00952380|11592514|FG001|STARTED|Overall Study||2
10445686|NCT00952380|11592515|FG002|STARTED|Overall Study||8
10445687|NCT00952380|11592516|FG003|STARTED|Overall Study||7
10445688|NCT00952380|11592517|FG004|STARTED|Overall Study||20
10445689|NCT00952380|11592513|FG000|COMPLETED|Overall Study||1
10445690|NCT00952380|11592514|FG001|COMPLETED|Overall Study||1
10445691|NCT00952380|11592515|FG002|COMPLETED|Overall Study||6
10445692|NCT00952380|11592516|FG003|COMPLETED|Overall Study||4
10445693|NCT00952380|11592517|FG004|COMPLETED|Overall Study||14
10445694|NCT00952380|11592513|FG000|NOT COMPLETED|Overall Study||0
10445695|NCT00952380|11592514|FG001|NOT COMPLETED|Overall Study||1
10445696|NCT00952380|11592515|FG002|NOT COMPLETED|Overall Study||2
10445697|NCT00952380|11592516|FG003|NOT COMPLETED|Overall Study||3
10445698|NCT00952380|11592517|FG004|NOT COMPLETED|Overall Study||6
10445699|NCT00952393|11592534|FG000|STARTED|Overall Study|10|10
10445700|NCT00952393|11592534|FG000|COMPLETED|Overall Study||10
10445701|NCT00952393|11592534|FG000|NOT COMPLETED|Overall Study||0
10445702|NCT00952419|11592541|FG000|STARTED|Overall Study||215
10445703|NCT00952419|11592542|FG001|STARTED|Overall Study||208
10445704|NCT00952419|11592543|FG002|STARTED|Overall Study||51
10445705|NCT00952419|11592541|FG000|COMPLETED|Overall Study||209
10445706|NCT00952419|11592542|FG001|COMPLETED|Overall Study||198
10445707|NCT00952419|11592543|FG002|COMPLETED|Overall Study||51
10445708|NCT00952419|11592541|FG000|NOT COMPLETED|Overall Study||6
10445709|NCT00952419|11592542|FG001|NOT COMPLETED|Overall Study||10
10445710|NCT00952419|11592543|FG002|NOT COMPLETED|Overall Study||0
10445711|NCT00952484|11592554|FG000|STARTED|Overall Study||6
10445712|NCT00952484|11592555|FG001|STARTED|Overall Study||7
10445713|NCT00952484|11592556|FG002|STARTED|Overall Study||16
10445714|NCT00952484|11592554|FG000|COMPLETED|Overall Study||6
10445715|NCT00952484|11592555|FG001|COMPLETED|Overall Study||6
10445716|NCT00952484|11592556|FG002|COMPLETED|Overall Study||16
10445717|NCT00952484|11592554|FG000|NOT COMPLETED|Overall Study||0
10445718|NCT00952484|11592555|FG001|NOT COMPLETED|Overall Study||1
10445719|NCT00952484|11592556|FG002|NOT COMPLETED|Overall Study||0
10445720|NCT00952523|11592565|FG000|STARTED|Overall Study||162
10445721|NCT00952523|11592565|FG000|COMPLETED|Overall Study||155
10445722|NCT00952523|11592565|FG000|NOT COMPLETED|Overall Study||7
10445723|NCT00952588|11592573|FG000|STARTED|Overall Study||48
10445724|NCT00952588|11592574|FG001|STARTED|Overall Study||26
10445725|NCT00952588|11592573|FG000|COMPLETED|Overall Study||12
10445726|NCT00952588|11592574|FG001|COMPLETED|Overall Study||2
10445727|NCT00952588|11592573|FG000|NOT COMPLETED|Overall Study||36
10445728|NCT00952588|11592574|FG001|NOT COMPLETED|Overall Study||24
10445729|NCT00952614|11592580|FG000|STARTED|Overall Study||30
10445730|NCT00952614|11592580|FG000|Participants Started Treatment|Overall Study|29 subjects signed consent; 1 agreed for both eyes to enroll. 30 eyes rec'd drug delivery implant|30
10445731|NCT00952614|11592580|FG000|COMPLETED|Overall Study|3 subjects died from unrelated causes, 3 were lost to follow-up & 1 had both eyes included in study.|23
10445732|NCT00952614|11592580|FG000|NOT COMPLETED|Overall Study||7
10445733|NCT00952653|11592585|FG000|STARTED|Period 1: MDZ Alone||28
10445734|NCT00952653|11592585|FG000|COMPLETED|Period 1: MDZ Alone||28
10445735|NCT00952653|11592585|FG000|NOT COMPLETED|Period 1: MDZ Alone||0
10445736|NCT00952653|11592585|FG000|STARTED|Period 2: Coadministration DVS SR, MDZ||28
10445737|NCT00952653|11592585|FG000|COMPLETED|Period 2: Coadministration DVS SR, MDZ||28
10445738|NCT00952653|11592585|FG000|NOT COMPLETED|Period 2: Coadministration DVS SR, MDZ||0
10445739|NCT00952705|11592595|FG000|STARTED|Overall Study|Three not treated with Q/LAIV-BFS (1 treated with FluMist/B/Yamagata; 2 withdrew prior to dosing).|1202
10445740|NCT00952705|11592596|FG001|STARTED|Overall Study||300
10445741|NCT00952705|11592597|FG002|STARTED|Overall Study||298
10445742|NCT00952705|11592595|FG000|COMPLETED|Overall Study||1169
10445743|NCT00952705|11592596|FG001|COMPLETED|Overall Study||290
10445744|NCT00952705|11592597|FG002|COMPLETED|Overall Study||288
10445745|NCT00952705|11592595|FG000|NOT COMPLETED|Overall Study||33
10445746|NCT00952705|11592596|FG001|NOT COMPLETED|Overall Study||10
10445747|NCT00952705|11592597|FG002|NOT COMPLETED|Overall Study||10
10445748|NCT00952718|11592611|FG000|STARTED|Overall Study||19
10445749|NCT00952718|11592612|FG001|STARTED|Overall Study||19
10445750|NCT00952718|11592611|FG000|COMPLETED|Overall Study||13
10445751|NCT00952718|11592612|FG001|COMPLETED|Overall Study||13
10445752|NCT00952718|11592611|FG000|NOT COMPLETED|Overall Study||6
10445753|NCT00952718|11592612|FG001|NOT COMPLETED|Overall Study||6
10445754|NCT00952731|11592622|FG000|STARTED|Overall Study||13
10445755|NCT00952731|11592623|FG001|STARTED|Overall Study||14
10445756|NCT00952731|11592622|FG000|Randomization|Overall Study||13
10445757|NCT00952731|11592623|FG001|Randomization|Overall Study||14
10445758|NCT00952731|11592622|FG000|Treatment & Pre-Surgery|Overall Study||12
10445759|NCT00952731|11592623|FG001|Treatment & Pre-Surgery|Overall Study||14
10445760|NCT00952731|11592622|FG000|Surgery|Overall Study||12
10445761|NCT00952731|11592623|FG001|Surgery|Overall Study||14
10445762|NCT00952731|11592622|FG000|Follow-up|Overall Study||12
10445763|NCT00952731|11592623|FG001|Follow-up|Overall Study||14
10445764|NCT00952731|11592622|FG000|COMPLETED|Overall Study||12
10445765|NCT00952731|11592623|FG001|COMPLETED|Overall Study||14
10445766|NCT00952731|11592622|FG000|NOT COMPLETED|Overall Study||1
10445767|NCT00952731|11592623|FG001|NOT COMPLETED|Overall Study||0
10445768|NCT00952822|11592629|FG000|STARTED|1st Pharmacokinetic Evaluation||9
10445769|NCT00952822|11592630|FG001|STARTED|1st Pharmacokinetic Evaluation||18
10445770|NCT00952822|11592631|FG002|STARTED|1st Pharmacokinetic Evaluation||11
10445771|NCT00952822|11592632|FG003|STARTED|1st Pharmacokinetic Evaluation||4
10445772|NCT00952822|11592629|FG000|COMPLETED|1st Pharmacokinetic Evaluation||9
10445773|NCT00952822|11592630|FG001|COMPLETED|1st Pharmacokinetic Evaluation||17
10445774|NCT00952822|11592631|FG002|COMPLETED|1st Pharmacokinetic Evaluation||11
10445775|NCT00952822|11592632|FG003|COMPLETED|1st Pharmacokinetic Evaluation||4
10445776|NCT00952822|11592629|FG000|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
10445777|NCT00952822|11592630|FG001|NOT COMPLETED|1st Pharmacokinetic Evaluation||1
10445778|NCT00952822|11592631|FG002|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
10445779|NCT00952822|11592632|FG003|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
10445780|NCT00952822|11592629|FG000|STARTED|2nd Pharmacokinetic Evaluation||9
10445781|NCT00952822|11592630|FG001|STARTED|2nd Pharmacokinetic Evaluation||17
10445782|NCT00952822|11592631|FG002|STARTED|2nd Pharmacokinetic Evaluation||11
10445783|NCT00952822|11592632|FG003|STARTED|2nd Pharmacokinetic Evaluation||4
10445784|NCT00952822|11592629|FG000|COMPLETED|2nd Pharmacokinetic Evaluation||9
10445785|NCT00952822|11592630|FG001|COMPLETED|2nd Pharmacokinetic Evaluation||17
10445786|NCT00952822|11592631|FG002|COMPLETED|2nd Pharmacokinetic Evaluation||10
10445787|NCT00952822|11592632|FG003|COMPLETED|2nd Pharmacokinetic Evaluation||4
10445788|NCT00952822|11592629|FG000|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
10445789|NCT00952822|11592630|FG001|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
10445790|NCT00952822|11592631|FG002|NOT COMPLETED|2nd Pharmacokinetic Evaluation||1
10550863|NCT01534273|11705005|FG005|Received at Least 1 Dose of Study Drug|Period 1||3
10550864|NCT01534273|11705006|FG006|Received at Least 1 Dose of Study Drug|Period 1||6
10550865|NCT01534273|11705000|FG000|COMPLETED|Period 1||3
10550866|NCT01534273|11705001|FG001|COMPLETED|Period 1||6
10550867|NCT01534273|11705002|FG002|COMPLETED|Period 1||2
10789619|NCT03522506|11949996|FG000|NOT COMPLETED|Treatment Period 4 (2 Days)||0
10445791|NCT00952822|11592632|FG003|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
10445792|NCT00952848|11592643|FG000|STARTED|Overall Study||18
10445793|NCT00952848|11592643|FG000|COMPLETED|Overall Study||14
10445794|NCT00952848|11592643|FG000|NOT COMPLETED|Overall Study||4
10445795|NCT00953017|11592651|FG000|STARTED|Overall Study||106
10445796|NCT00953017|11592652|FG001|STARTED|Overall Study||107
10445797|NCT00953017|11592653|FG002|STARTED|Overall Study||106
10445798|NCT00953017|11592654|FG003|STARTED|Overall Study||106
10445799|NCT00953017|11592651|FG000|COMPLETED|Overall Study||101
10445800|NCT00953017|11592652|FG001|COMPLETED|Overall Study||101
10445801|NCT00953017|11592653|FG002|COMPLETED|Overall Study||100
10445802|NCT00953017|11592654|FG003|COMPLETED|Overall Study||101
10445803|NCT00953017|11592651|FG000|NOT COMPLETED|Overall Study||5
10445804|NCT00953017|11592652|FG001|NOT COMPLETED|Overall Study||6
10445805|NCT00953017|11592653|FG002|NOT COMPLETED|Overall Study||6
10445806|NCT00953017|11592654|FG003|NOT COMPLETED|Overall Study||5
10789620|NCT03522506|11949997|FG001|NOT COMPLETED|Treatment Period 4 (2 Days)||0
10789621|NCT03522506|11949998|FG002|NOT COMPLETED|Treatment Period 4 (2 Days)||0
10789622|NCT03522506|11949999|FG003|NOT COMPLETED|Treatment Period 4 (2 Days)||0
10789623|NCT03522675|11950013|FG000|STARTED|Overall Study||22
10789624|NCT03522675|11950013|FG000|COMPLETED|Overall Study||20
10789625|NCT03522675|11950013|FG000|NOT COMPLETED|Overall Study||2
10789626|NCT03522948|11950021|FG000|STARTED|Overall Study||8
10789627|NCT03522948|11950021|FG000|COMPLETED|Overall Study||7
10789628|NCT03522948|11950021|FG000|NOT COMPLETED|Overall Study||1
10789629|NCT03523715|11950027|FG000|STARTED|Overall Study||38
10789630|NCT03523715|11950028|FG001|STARTED|Overall Study||39
10789631|NCT03523715|11950027|FG000|COMPLETED|Overall Study||26
10789632|NCT03523715|11950028|FG001|COMPLETED|Overall Study||23
10789633|NCT03523715|11950027|FG000|NOT COMPLETED|Overall Study||12
10789634|NCT03523715|11950028|FG001|NOT COMPLETED|Overall Study||16
10789635|NCT03523871|11950034|FG000|STARTED|Overall Study||20
10789636|NCT03523871|11950034|FG000|COMPLETED|Overall Study||19
10445807|NCT00953043|11592666|FG000|STARTED|Overall Study||30
10445808|NCT00953043|11592667|FG001|STARTED|Overall Study||30
10445809|NCT00953043|11592666|FG000|COMPLETED|Overall Study||26
10445810|NCT00953043|11592667|FG001|COMPLETED|Overall Study||28
10445811|NCT00953043|11592666|FG000|NOT COMPLETED|Overall Study||4
10445812|NCT00953043|11592667|FG001|NOT COMPLETED|Overall Study||2
10445813|NCT00953056|11592679|FG000|STARTED|Overall Study||24
10445814|NCT00953056|11592680|FG001|STARTED|Overall Study||24
10445815|NCT00953056|11592681|FG002|STARTED|Overall Study||24
10445816|NCT00953056|11592682|FG003|STARTED|Overall Study||24
10445817|NCT00953056|11592683|FG004|STARTED|Overall Study||24
10445818|NCT00953056|11592684|FG005|STARTED|Overall Study||24
10445819|NCT00953056|11592679|FG000|COMPLETED|Overall Study||24
10445820|NCT00953056|11592680|FG001|COMPLETED|Overall Study||24
10445821|NCT00953056|11592681|FG002|COMPLETED|Overall Study||24
10445822|NCT00953056|11592682|FG003|COMPLETED|Overall Study||24
10445823|NCT00953056|11592683|FG004|COMPLETED|Overall Study|One participant received placebo at the second dose in error, but completed the study.|22
10445824|NCT00953056|11592684|FG005|COMPLETED|Overall Study||20
10445825|NCT00953056|11592679|FG000|NOT COMPLETED|Overall Study||0
10445826|NCT00953056|11592680|FG001|NOT COMPLETED|Overall Study||0
10445827|NCT00953056|11592681|FG002|NOT COMPLETED|Overall Study||0
10445828|NCT00953056|11592682|FG003|NOT COMPLETED|Overall Study||0
10445829|NCT00953056|11592683|FG004|NOT COMPLETED|Overall Study||2
10445830|NCT00953056|11592684|FG005|NOT COMPLETED|Overall Study||4
10445831|NCT00953121|11592703|FG000|STARTED|Overall Study||40
10445832|NCT00953121|11592704|FG001|STARTED|Overall Study||39
10445833|NCT00953121|11592705|FG002|STARTED|Overall Study||25
10445834|NCT00953121|11592703|FG000|COMPLETED|Overall Study||40
10445835|NCT00953121|11592704|FG001|COMPLETED|Overall Study||39
10445836|NCT00953121|11592705|FG002|COMPLETED|Overall Study||25
10445837|NCT00953121|11592703|FG000|NOT COMPLETED|Overall Study||0
10445838|NCT00953121|11592704|FG001|NOT COMPLETED|Overall Study||0
10445839|NCT00953121|11592705|FG002|NOT COMPLETED|Overall Study||0
10445840|NCT00953147|11592716|FG000|STARTED|Overall Study||298
10445841|NCT00953147|11592717|FG001|STARTED|Overall Study||505
10445842|NCT00953147|11592718|FG002|STARTED|Overall Study||307
10445843|NCT00953147|11592716|FG000|COMPLETED|Overall Study||261
10445844|NCT00953147|11592717|FG001|COMPLETED|Overall Study||439
10445845|NCT00953147|11592718|FG002|COMPLETED|Overall Study||265
10445846|NCT00953147|11592716|FG000|NOT COMPLETED|Overall Study||37
10445847|NCT00953147|11592717|FG001|NOT COMPLETED|Overall Study||66
10445848|NCT00953147|11592718|FG002|NOT COMPLETED|Overall Study||42
10550868|NCT01534273|11705003|FG003|COMPLETED|Period 1||6
10550869|NCT01534273|11705004|FG004|COMPLETED|Period 1||3
10550870|NCT01534273|11705005|FG005|COMPLETED|Period 1||3
10789637|NCT03523871|11950034|FG000|NOT COMPLETED|Overall Study||1
10789638|NCT03523988|11950041|FG000|STARTED|Overall Study||24
10789639|NCT03523988|11950042|FG001|STARTED|Overall Study||24
10789640|NCT03523988|11950043|FG002|STARTED|Overall Study||25
10789641|NCT03523988|11950041|FG000|COMPLETED|Overall Study||7
10445849|NCT00953160|11592726|FG000|STARTED|Overall Study||76
10445850|NCT00953160|11592726|FG000|COMPLETED|Overall Study||49
10445851|NCT00953160|11592726|FG000|NOT COMPLETED|Overall Study||27
10789642|NCT03523988|11950042|FG001|COMPLETED|Overall Study||8
10789643|NCT03523988|11950043|FG002|COMPLETED|Overall Study||7
10789644|NCT03523988|11950041|FG000|NOT COMPLETED|Overall Study||17
10789645|NCT03523988|11950042|FG001|NOT COMPLETED|Overall Study||16
10789646|NCT03523988|11950043|FG002|NOT COMPLETED|Overall Study||18
10789647|NCT03524157|11950054|FG000|STARTED|Overall Study||10
10789648|NCT03524157|11950055|FG001|STARTED|Overall Study||10
10789649|NCT03524157|11950056|FG002|STARTED|Overall Study||10
10789650|NCT03524157|11950054|FG000|COMPLETED|Overall Study||10
10789651|NCT03524157|11950055|FG001|COMPLETED|Overall Study||10
10789652|NCT03524157|11950056|FG002|COMPLETED|Overall Study||9
10789653|NCT03524157|11950054|FG000|NOT COMPLETED|Overall Study||0
10789654|NCT03524157|11950055|FG001|NOT COMPLETED|Overall Study||0
10445852|NCT00953173|11592730|FG000|STARTED|Overall Study||671
10445853|NCT00953173|11592730|FG000|COMPLETED|Overall Study||389
10445854|NCT00953173|11592730|FG000|NOT COMPLETED|Overall Study||282
10445855|NCT00953199|11592736|FG000|STARTED|Overall Study||254
10445856|NCT00953199|11592737|FG001|STARTED|Overall Study||252
10445857|NCT00953199|11592736|FG000|COMPLETED|Overall Study||254
10445858|NCT00953199|11592737|FG001|COMPLETED|Overall Study||252
10445859|NCT00953199|11592736|FG000|NOT COMPLETED|Overall Study||0
10445860|NCT00953199|11592737|FG001|NOT COMPLETED|Overall Study||0
10445861|NCT00953212|11592749|FG000|STARTED|Overall Study||76
10445862|NCT00953212|11592750|FG001|STARTED|Overall Study||74
10445863|NCT00953212|11592751|FG002|STARTED|Overall Study||78
10445864|NCT00953212|11592752|FG003|STARTED|Overall Study||76
10445865|NCT00953212|11592749|FG000|COMPLETED|Overall Study||76
10445866|NCT00953212|11592750|FG001|COMPLETED|Overall Study||74
10445867|NCT00953212|11592751|FG002|COMPLETED|Overall Study||78
10445868|NCT00953212|11592752|FG003|COMPLETED|Overall Study||76
10445869|NCT00953212|11592749|FG000|NOT COMPLETED|Overall Study||0
10445870|NCT00953212|11592750|FG001|NOT COMPLETED|Overall Study||0
10445871|NCT00953212|11592751|FG002|NOT COMPLETED|Overall Study||0
10445872|NCT00953212|11592752|FG003|NOT COMPLETED|Overall Study||0
10445873|NCT00953225|11592768|FG000|STARTED|Overall Study||46
10445874|NCT00953225|11592769|FG001|STARTED|Overall Study||37
10445875|NCT00953225|11592768|FG000|COMPLETED|Overall Study||44
10445876|NCT00953225|11592769|FG001|COMPLETED|Overall Study||37
10445877|NCT00953225|11592768|FG000|NOT COMPLETED|Overall Study||2
10445878|NCT00953225|11592769|FG001|NOT COMPLETED|Overall Study||0
10445879|NCT00953290|11592775|FG000|STARTED|Overall Study||4
10445880|NCT00953290|11592775|FG000|COMPLETED|Overall Study||4
10445881|NCT00953290|11592775|FG000|NOT COMPLETED|Overall Study||0
10445882|NCT00953407|11592787|FG000|STARTED|Overall Study||26
10445883|NCT00953407|11592788|FG001|STARTED|Overall Study||25
10445884|NCT00953407|11592789|FG002|STARTED|Overall Study||26
10445885|NCT00953407|11592790|FG003|STARTED|Overall Study||25
10445886|NCT00953407|11592791|FG004|STARTED|Overall Study||24
10445887|NCT00953407|11592787|FG000|COMPLETED|Overall Study||25
10445888|NCT00953407|11592788|FG001|COMPLETED|Overall Study||24
10445889|NCT00953407|11592789|FG002|COMPLETED|Overall Study||25
10445890|NCT00953407|11592790|FG003|COMPLETED|Overall Study||23
10445891|NCT00953407|11592791|FG004|COMPLETED|Overall Study||23
10445892|NCT00953407|11592787|FG000|NOT COMPLETED|Overall Study||1
10445893|NCT00953407|11592788|FG001|NOT COMPLETED|Overall Study||1
10445894|NCT00953407|11592789|FG002|NOT COMPLETED|Overall Study||1
10445895|NCT00953407|11592790|FG003|NOT COMPLETED|Overall Study||2
10445896|NCT00953407|11592791|FG004|NOT COMPLETED|Overall Study||1
10445897|NCT00953524|11592807|FG000|STARTED|Overall Study||249
10445898|NCT00953524|11592808|FG001|STARTED|Overall Study||254
10445899|NCT00953524|11592809|FG002|STARTED|Overall Study||247
10445900|NCT00953524|11592810|FG003|STARTED|Overall Study||99
10445901|NCT00953524|11592807|FG000|COMPLETED|Overall Study||227
10445902|NCT00953524|11592808|FG001|COMPLETED|Overall Study||239
10445903|NCT00953524|11592809|FG002|COMPLETED|Overall Study||233
10445904|NCT00953524|11592810|FG003|COMPLETED|Overall Study||91
10445905|NCT00953524|11592807|FG000|NOT COMPLETED|Overall Study||22
10445906|NCT00953524|11592808|FG001|NOT COMPLETED|Overall Study||15
10445907|NCT00953524|11592809|FG002|NOT COMPLETED|Overall Study||14
10445908|NCT00953524|11592810|FG003|NOT COMPLETED|Overall Study||8
10445909|NCT00953576|11592822|FG000|STARTED|Overall Study||6
10445910|NCT00953576|11592823|FG001|STARTED|Overall Study||5
10445911|NCT00953576|11592822|FG000|DLT Evaluable|Overall Study||3
10445912|NCT00953576|11592823|FG001|DLT Evaluable|Overall Study||5
10445913|NCT00953576|11592822|FG000|Treated|Overall Study||4
10445914|NCT00953576|11592823|FG001|Treated|Overall Study||5
10445915|NCT00953576|11592822|FG000|Pharmacokinetic (PK) Evaluable|Overall Study||4
10445916|NCT00953576|11592823|FG001|Pharmacokinetic (PK) Evaluable|Overall Study||3
10445917|NCT00953576|11592822|FG000|COMPLETED|Overall Study|One participant enrolled on dose level 1 did not receive full dose ketoconazole and was replaced.|4
10445918|NCT00953576|11592823|FG001|COMPLETED|Overall Study||4
10445919|NCT00953576|11592822|FG000|NOT COMPLETED|Overall Study||2
10445920|NCT00953576|11592823|FG001|NOT COMPLETED|Overall Study||1
10445921|NCT00953654|11592835|FG000|STARTED|Overall Study||10
10445922|NCT00953654|11592836|FG001|STARTED|Overall Study||10
10445923|NCT00953654|11592837|FG002|STARTED|Overall Study||10
10445924|NCT00953654|11592835|FG000|COMPLETED|Overall Study||10
10789655|NCT03524157|11950056|FG002|NOT COMPLETED|Overall Study||1
10789656|NCT03524339|11950066|FG000|STARTED|Overall Study||66
10789657|NCT03524339|11950067|FG001|STARTED|Overall Study||66
10789658|NCT03524339|11950066|FG000|COMPLETED|Overall Study||57
10445925|NCT00953654|11592836|FG001|COMPLETED|Overall Study||10
10445926|NCT00953654|11592837|FG002|COMPLETED|Overall Study||10
10445927|NCT00953654|11592835|FG000|NOT COMPLETED|Overall Study||0
10445928|NCT00953654|11592836|FG001|NOT COMPLETED|Overall Study||0
10445929|NCT00953654|11592837|FG002|NOT COMPLETED|Overall Study||0
10445930|NCT00953667|11592845|FG000|STARTED|Overall Study||400
10445931|NCT00953667|11592845|FG000|COMPLETED|Overall Study||277
10445932|NCT00953667|11592845|FG000|NOT COMPLETED|Overall Study||123
10445933|NCT00953706|11592851|FG000|STARTED|Part A (16-Week Double-Blind Treatment)|All subjects who received at least 1 dose of study drug (placebo)|28
10445934|NCT00953706|11592852|FG001|STARTED|Part A (16-Week Double-Blind Treatment)|All subjects who received at least 1 dose of study drug (ivacaftor)|112
10445935|NCT00953706|11592853|FG002|STARTED|Part A (16-Week Double-Blind Treatment)||0
10445936|NCT00953706|11592854|FG003|STARTED|Part A (16-Week Double-Blind Treatment)||0
10445937|NCT00953706|11592851|FG000|COMPLETED|Part A (16-Week Double-Blind Treatment)|Only 5 participants continued in Part B.|26
10445938|NCT00953706|11592852|FG001|COMPLETED|Part A (16-Week Double-Blind Treatment)|Only 33 participants continued in Part B.|104
10445939|NCT00953706|11592853|FG002|COMPLETED|Part A (16-Week Double-Blind Treatment)||0
10445940|NCT00953706|11592854|FG003|COMPLETED|Part A (16-Week Double-Blind Treatment)||0
10445941|NCT00953706|11592851|FG000|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||2
10445942|NCT00953706|11592852|FG001|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||8
10445943|NCT00953706|11592853|FG002|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||0
10445944|NCT00953706|11592854|FG003|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||0
10445945|NCT00953706|11592851|FG000|STARTED|Part B (96-Week Open-Label Extension)||0
10445946|NCT00953706|11592852|FG001|STARTED|Part B (96-Week Open-Label Extension)||0
10445947|NCT00953706|11592853|FG002|STARTED|Part B (96-Week Open-Label Extension)||5
10445948|NCT00953706|11592854|FG003|STARTED|Part B (96-Week Open-Label Extension)||33
10445949|NCT00953706|11592851|FG000|COMPLETED|Part B (96-Week Open-Label Extension)||0
10445950|NCT00953706|11592852|FG001|COMPLETED|Part B (96-Week Open-Label Extension)||0
10445951|NCT00953706|11592853|FG002|COMPLETED|Part B (96-Week Open-Label Extension)||0
10445952|NCT00953706|11592854|FG003|COMPLETED|Part B (96-Week Open-Label Extension)||0
10445953|NCT00953706|11592851|FG000|NOT COMPLETED|Part B (96-Week Open-Label Extension)||0
10445954|NCT00953706|11592852|FG001|NOT COMPLETED|Part B (96-Week Open-Label Extension)||0
10445955|NCT00953706|11592853|FG002|NOT COMPLETED|Part B (96-Week Open-Label Extension)||5
10445956|NCT00953706|11592854|FG003|NOT COMPLETED|Part B (96-Week Open-Label Extension)||33
10445957|NCT00953719|11592866|FG000|STARTED|Overall Study||169
10445958|NCT00953719|11592867|FG001|STARTED|Overall Study||74
10445959|NCT00953719|11592866|FG000|COMPLETED|Overall Study||150
10445960|NCT00953719|11592867|FG001|COMPLETED|Overall Study||69
10445961|NCT00953719|11592866|FG000|NOT COMPLETED|Overall Study||19
10445962|NCT00953719|11592867|FG001|NOT COMPLETED|Overall Study||5
10445963|NCT00953745|11592875|FG000|STARTED|Phase 1: 8 Weeks Escitalopram + Placebo||37
10445964|NCT00953745|11592876|FG001|STARTED|Phase 1: 8 Weeks Escitalopram + Placebo||6
10445965|NCT00953745|11592875|FG000|COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||24
10445966|NCT00953745|11592876|FG001|COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||6
10445967|NCT00953745|11592875|FG000|NOT COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||13
10445968|NCT00953745|11592876|FG001|NOT COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||0
10445969|NCT00953745|11592875|FG000|STARTED|Phase 2: 2 Weeks Escitalopram + Placebo||18
10445970|NCT00953745|11592876|FG001|STARTED|Phase 2: 2 Weeks Escitalopram + Placebo||0
10445971|NCT00953745|11592875|FG000|COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||17
10445972|NCT00953745|11592876|FG001|COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||0
10445973|NCT00953745|11592875|FG000|NOT COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||1
10445974|NCT00953745|11592876|FG001|NOT COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||0
10445975|NCT00953745|11592875|FG000|STARTED|ARP Phase: 6 Weeks Escitalopram + ARP||17
10445976|NCT00953745|11592876|FG001|STARTED|ARP Phase: 6 Weeks Escitalopram + ARP||0
10445977|NCT00953745|11592875|FG000|COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||17
10445978|NCT00953745|11592876|FG001|COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
10445979|NCT00953745|11592875|FG000|NOT COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
10445980|NCT00953745|11592876|FG001|NOT COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
10445981|NCT00953849|11592888|FG000|STARTED|Overall Study||6
10445982|NCT00953849|11592889|FG001|STARTED|Overall Study||6
10445983|NCT00953849|11592890|FG002|STARTED|Overall Study||4
10445984|NCT00953849|11592891|FG003|STARTED|Overall Study||5
10445985|NCT00953849|11592888|FG000|COMPLETED|Overall Study||6
10445986|NCT00953849|11592889|FG001|COMPLETED|Overall Study||6
10445987|NCT00953849|11592890|FG002|COMPLETED|Overall Study||4
10445988|NCT00953849|11592891|FG003|COMPLETED|Overall Study||5
10445989|NCT00953849|11592888|FG000|NOT COMPLETED|Overall Study||0
10445990|NCT00953849|11592889|FG001|NOT COMPLETED|Overall Study||0
10445991|NCT00953849|11592890|FG002|NOT COMPLETED|Overall Study||0
10445992|NCT00953849|11592891|FG003|NOT COMPLETED|Overall Study||0
10445993|NCT00953862|11592905|FG000|STARTED|Overall Study||18
10445994|NCT00953862|11592905|FG000|COMPLETED|Overall Study||12
10445995|NCT00953862|11592905|FG000|NOT COMPLETED|Overall Study||6
10445996|NCT00953927|11592913|FG000|STARTED|Overall Study||1399
10445997|NCT00953927|11592914|FG001|STARTED|Overall Study||1398
10445998|NCT00953927|11592913|FG000|COMPLETED|Overall Study||1294
10445999|NCT00953927|11592914|FG001|COMPLETED|Overall Study||1303
10446000|NCT00953927|11592913|FG000|NOT COMPLETED|Overall Study||105
10446001|NCT00953927|11592914|FG001|NOT COMPLETED|Overall Study||95
10446002|NCT00954109|11592920|FG000|STARTED|Overall Study||11
10446003|NCT00954109|11592920|FG000|COMPLETED|Overall Study||11
10446004|NCT00954109|11592920|FG000|NOT COMPLETED|Overall Study||0
10446005|NCT00954122|11592924|FG000|STARTED|Overall Study||35
10446006|NCT00954122|11592924|FG000|COMPLETED|Overall Study||28
10446007|NCT00954122|11592924|FG000|NOT COMPLETED|Overall Study||7
10446008|NCT00954174|11592933|FG000|STARTED|Overall Study||268
10446009|NCT00954174|11592934|FG001|STARTED|Overall Study||268
10446010|NCT00954174|11592935|FG002|STARTED|Overall Study||51
10446011|NCT00954174|11592936|FG003|STARTED|Overall Study||50
10446012|NCT00954174|11592933|FG000|COMPLETED|Overall Study||142
10446013|NCT00954174|11592934|FG001|COMPLETED|Overall Study||145
10446014|NCT00954174|11592935|FG002|COMPLETED|Overall Study||27
10446015|NCT00954174|11592936|FG003|COMPLETED|Overall Study||25
10446016|NCT00954174|11592933|FG000|NOT COMPLETED|Overall Study||126
10446017|NCT00954174|11592934|FG001|NOT COMPLETED|Overall Study||123
10446018|NCT00954174|11592935|FG002|NOT COMPLETED|Overall Study||24
10446019|NCT00954174|11592936|FG003|NOT COMPLETED|Overall Study||25
10446020|NCT00954356|11592951|FG000|STARTED|Overall Study||41
10446021|NCT00954356|11592952|FG001|STARTED|Overall Study||20
10446022|NCT00954356|11592951|FG000|COMPLETED|Overall Study||41
10446023|NCT00954356|11592952|FG001|COMPLETED|Overall Study||20
10446024|NCT00954356|11592951|FG000|NOT COMPLETED|Overall Study||0
10446025|NCT00954356|11592952|FG001|NOT COMPLETED|Overall Study||0
10446026|NCT00954421|11592958|FG000|STARTED|Screening||16
10446027|NCT00954421|11592958|FG000|COMPLETED|Screening||13
10446028|NCT00954421|11592958|FG000|NOT COMPLETED|Screening||3
10446029|NCT00954421|11592958|FG000|STARTED|Baseline||13
10446030|NCT00954421|11592958|FG000|COMPLETED|Baseline||13
10446031|NCT00954421|11592958|FG000|NOT COMPLETED|Baseline||0
10446032|NCT00954421|11592958|FG000|STARTED|6 Months of DBS||13
10446033|NCT00954421|11592958|FG000|COMPLETED|6 Months of DBS||12
10446034|NCT00954421|11592958|FG000|NOT COMPLETED|6 Months of DBS||1
10446035|NCT00954421|11592958|FG000|STARTED|VIM=ON VO=ON at 6 Months|This is the point of evaluation: Order of assessment was random for periods 4-7|12
10446036|NCT00954421|11592958|FG000|COMPLETED|VIM=ON VO=ON at 6 Months||12
10446037|NCT00954421|11592958|FG000|NOT COMPLETED|VIM=ON VO=ON at 6 Months||0
10446038|NCT00954421|11592958|FG000|STARTED|VIM=OFF VO=OFF at 6 Months||12
10446039|NCT00954421|11592958|FG000|COMPLETED|VIM=OFF VO=OFF at 6 Months||12
10446040|NCT00954421|11592958|FG000|NOT COMPLETED|VIM=OFF VO=OFF at 6 Months||0
10446041|NCT00954421|11592958|FG000|STARTED|VIM=OFF VO=ON at 6 Months||12
10446042|NCT00954421|11592958|FG000|COMPLETED|VIM=OFF VO=ON at 6 Months||12
10446043|NCT00954421|11592958|FG000|NOT COMPLETED|VIM=OFF VO=ON at 6 Months||0
10446044|NCT00954421|11592958|FG000|STARTED|VIM=ON VO=OFF at 6 Months||12
10446045|NCT00954421|11592958|FG000|COMPLETED|VIM=ON VO=OFF at 6 Months||11
10446046|NCT00954421|11592958|FG000|NOT COMPLETED|VIM=ON VO=OFF at 6 Months||1
10550871|NCT01534273|11705006|FG006|COMPLETED|Period 1||6
10550872|NCT01534273|11705000|FG000|NOT COMPLETED|Period 1||0
10550873|NCT01534273|11705001|FG001|NOT COMPLETED|Period 1||0
10550874|NCT01534273|11705002|FG002|NOT COMPLETED|Period 1||0
10789659|NCT03524339|11950067|FG001|COMPLETED|Overall Study||62
10789660|NCT03524339|11950066|FG000|NOT COMPLETED|Overall Study||9
10446047|NCT00954447|11592966|FG000|STARTED|Overall Study||630
10446048|NCT00954447|11592967|FG001|STARTED|Overall Study||631
10446049|NCT00954447|11592966|FG000|COMPLETED|Overall Study||520
10446050|NCT00954447|11592967|FG001|COMPLETED|Overall Study||543
10446051|NCT00954447|11592966|FG000|NOT COMPLETED|Overall Study||110
10446052|NCT00954447|11592967|FG001|NOT COMPLETED|Overall Study||88
10446053|NCT00954512|11592979|FG000|STARTED|Overall Study||2
10446054|NCT00954512|11592980|FG001|STARTED|Overall Study||3
10446055|NCT00954512|11592981|FG002|STARTED|Overall Study||0
10446056|NCT00954512|11592982|FG003|STARTED|Overall Study||2
10446057|NCT00954512|11592983|FG004|STARTED|Overall Study||4
10446058|NCT00954512|11592984|FG005|STARTED|Overall Study||4
10446059|NCT00954512|11592979|FG000|COMPLETED|Overall Study||0
10446060|NCT00954512|11592980|FG001|COMPLETED|Overall Study||0
10446061|NCT00954512|11592981|FG002|COMPLETED|Overall Study||0
10446062|NCT00954512|11592982|FG003|COMPLETED|Overall Study||0
10446063|NCT00954512|11592983|FG004|COMPLETED|Overall Study||0
10550875|NCT01534273|11705003|FG003|NOT COMPLETED|Period 1||1
10550876|NCT01534273|11705004|FG004|NOT COMPLETED|Period 1||0
10550877|NCT01534273|11705005|FG005|NOT COMPLETED|Period 1||0
10550878|NCT01534273|11705006|FG006|NOT COMPLETED|Period 1||0
10789661|NCT03524339|11950067|FG001|NOT COMPLETED|Overall Study||4
10446064|NCT00954512|11592984|FG005|COMPLETED|Overall Study||0
10446065|NCT00954512|11592979|FG000|NOT COMPLETED|Overall Study||2
10446066|NCT00954512|11592980|FG001|NOT COMPLETED|Overall Study||3
10446067|NCT00954512|11592981|FG002|NOT COMPLETED|Overall Study||0
10446068|NCT00954512|11592982|FG003|NOT COMPLETED|Overall Study||2
10446069|NCT00954512|11592983|FG004|NOT COMPLETED|Overall Study||4
10446070|NCT00954512|11592984|FG005|NOT COMPLETED|Overall Study||4
10446071|NCT00954538|11592999|FG000|STARTED|Part I|These subjects did not participate in Part II or III|3
10446072|NCT00954538|11593000|FG001|STARTED|Part I||0
10446073|NCT00954538|11593001|FG002|STARTED|Part I||0
10446074|NCT00954538|11593002|FG003|STARTED|Part I||0
10446075|NCT00954538|11593003|FG004|STARTED|Part I||0
10446076|NCT00954538|11593004|FG005|STARTED|Part I||0
10446077|NCT00954538|11592999|FG000|COMPLETED|Part I||3
10446078|NCT00954538|11593000|FG001|COMPLETED|Part I||0
10446079|NCT00954538|11593001|FG002|COMPLETED|Part I||0
10446080|NCT00954538|11593002|FG003|COMPLETED|Part I||0
10446081|NCT00954538|11593003|FG004|COMPLETED|Part I||0
10446082|NCT00954538|11593004|FG005|COMPLETED|Part I||0
10550879|NCT01534273|11705000|FG000|STARTED|Period 2|Participants in Cohort A participated in only 1 treatment period.|0
10446083|NCT00954538|11592999|FG000|NOT COMPLETED|Part I||0
10446084|NCT00954538|11593000|FG001|NOT COMPLETED|Part I||0
10446085|NCT00954538|11593001|FG002|NOT COMPLETED|Part I||0
10446086|NCT00954538|11593002|FG003|NOT COMPLETED|Part I||0
10446087|NCT00954538|11593003|FG004|NOT COMPLETED|Part I||0
10446088|NCT00954538|11593004|FG005|NOT COMPLETED|Part I||0
10446089|NCT00954538|11592999|FG000|STARTED|Part II||0
10446090|NCT00954538|11593000|FG001|STARTED|Part II|This subject did not participate in Part I or III|1
10446091|NCT00954538|11593001|FG002|STARTED|Part II|These subjects did not participate in Part I or III|3
10446092|NCT00954538|11593002|FG003|STARTED|Part II||0
10446093|NCT00954538|11593003|FG004|STARTED|Part II||0
10446094|NCT00954538|11593004|FG005|STARTED|Part II|These subjects did not participate in Part I and did participate in Part II and III|2
10446095|NCT00954538|11592999|FG000|COMPLETED|Part II||0
10446096|NCT00954538|11593000|FG001|COMPLETED|Part II||1
10446097|NCT00954538|11593001|FG002|COMPLETED|Part II||3
10446098|NCT00954538|11593002|FG003|COMPLETED|Part II||0
10446099|NCT00954538|11593003|FG004|COMPLETED|Part II||0
10446100|NCT00954538|11593004|FG005|COMPLETED|Part II||2
10446101|NCT00954538|11592999|FG000|NOT COMPLETED|Part II||0
10446102|NCT00954538|11593000|FG001|NOT COMPLETED|Part II||0
10446103|NCT00954538|11593001|FG002|NOT COMPLETED|Part II||0
10446104|NCT00954538|11593002|FG003|NOT COMPLETED|Part II||0
10446105|NCT00954538|11593003|FG004|NOT COMPLETED|Part II||0
10446106|NCT00954538|11593004|FG005|NOT COMPLETED|Part II||0
10446107|NCT00954538|11592999|FG000|STARTED|Part III||0
10446108|NCT00954538|11593000|FG001|STARTED|Part III||0
10446109|NCT00954538|11593001|FG002|STARTED|Part III||0
10446110|NCT00954538|11593002|FG003|STARTED|Part III|These subjects did not participate in Part I or II|4
10446111|NCT00954538|11593003|FG004|STARTED|Part III|These subjects did not participate in Part I or II|6
10446112|NCT00954538|11593004|FG005|STARTED|Part III|These subjects did not participate in Part I and did participate in Part II and III|2
10446113|NCT00954538|11592999|FG000|COMPLETED|Part III||0
10446114|NCT00954538|11593000|FG001|COMPLETED|Part III||0
10446115|NCT00954538|11593001|FG002|COMPLETED|Part III||0
10446116|NCT00954538|11593002|FG003|COMPLETED|Part III||4
10446117|NCT00954538|11593003|FG004|COMPLETED|Part III|The subject who did not complete received 1 dose of study drug|5
10446118|NCT00954538|11593004|FG005|COMPLETED|Part III||2
10446119|NCT00954538|11592999|FG000|NOT COMPLETED|Part III||0
10446120|NCT00954538|11593000|FG001|NOT COMPLETED|Part III||0
10446121|NCT00954538|11593001|FG002|NOT COMPLETED|Part III||0
10446122|NCT00954538|11593002|FG003|NOT COMPLETED|Part III||0
10446123|NCT00954538|11593003|FG004|NOT COMPLETED|Part III||1
10446124|NCT00954538|11593004|FG005|NOT COMPLETED|Part III||0
10446125|NCT00954681|11593013|FG000|STARTED|Overall Study||15
10446126|NCT00954681|11593013|FG000|COMPLETED|Overall Study||10
10446127|NCT00954681|11593013|FG000|NOT COMPLETED|Overall Study||5
10446128|NCT00954707|11593017|FG000|STARTED|Overall Study||2509
10446129|NCT00954707|11593017|FG000|COMPLETED|Overall Study|2342 Subjects completed 12-month Phase 1 follow-up; 167 subjects didn't complete the Phase 1.|2342
10446130|NCT00954707|11593017|FG000|NOT COMPLETED|Overall Study||167
10446131|NCT00954733|11593021|FG000|STARTED|Overall Study||40
10446132|NCT00954733|11593021|FG000|COMPLETED|Overall Study||39
10446133|NCT00954733|11593021|FG000|NOT COMPLETED|Overall Study||1
10446134|NCT00954824|11593025|FG000|STARTED|Overall Study||100
10446135|NCT00954824|11593025|FG000|COMPLETED|Overall Study||50
10446136|NCT00954824|11593025|FG000|NOT COMPLETED|Overall Study||50
10446137|NCT00954941|11593031|FG000|STARTED|Overall Study||50
10446138|NCT00954941|11593032|FG001|STARTED|Overall Study||48
10446139|NCT00954941|11593031|FG000|COMPLETED|Overall Study||42
10446140|NCT00954941|11593032|FG001|COMPLETED|Overall Study||41
10446141|NCT00954941|11593031|FG000|NOT COMPLETED|Overall Study||8
10446142|NCT00954941|11593032|FG001|NOT COMPLETED|Overall Study||7
10446143|NCT00954993|11593038|FG000|STARTED|Period 1||3
10446144|NCT00954993|11593038|FG000|COMPLETED|Period 1||3
10446145|NCT00954993|11593038|FG000|NOT COMPLETED|Period 1||0
10446146|NCT00954993|11593038|FG000|STARTED|Washout||3
10446147|NCT00954993|11593038|FG000|COMPLETED|Washout||3
10446148|NCT00954993|11593038|FG000|NOT COMPLETED|Washout||0
10446149|NCT00954993|11593038|FG000|STARTED|Period 2||3
10446150|NCT00954993|11593038|FG000|COMPLETED|Period 2||3
10446151|NCT00954993|11593038|FG000|NOT COMPLETED|Period 2||0
10446152|NCT00955032|11593046|FG000|STARTED|Overall Study||16
10446153|NCT00955032|11593047|FG001|STARTED|Overall Study||8
10446154|NCT00955032|11593046|FG000|COMPLETED|Overall Study||16
10446155|NCT00955032|11593047|FG001|COMPLETED|Overall Study||8
10446156|NCT00955032|11593046|FG000|NOT COMPLETED|Overall Study||0
10446157|NCT00955032|11593047|FG001|NOT COMPLETED|Overall Study||0
10446158|NCT00955110|11593062|FG000|STARTED|Qualification Phase||78
10446159|NCT00955110|11593062|FG000|COMPLETED|Qualification Phase||54
10446160|NCT00955110|11593062|FG000|NOT COMPLETED|Qualification Phase||24
10446161|NCT00955110|11593062|FG000|STARTED|Treatment Phase||41
10446162|NCT00955110|11593062|FG000|Placebo|Treatment Phase||38
10446163|NCT00955110|11593062|FG000|Oxymorphone ER 15 mg|Treatment Phase||37
10446164|NCT00955110|11593062|FG000|Oxymorphone ER 30 mg|Treatment Phase||38
10446165|NCT00955110|11593062|FG000|Oxycodone CR 30 mg|Treatment Phase||40
10446166|NCT00955110|11593062|FG000|Oxycodone CR 60 mg|Treatment Phase||40
10446167|NCT00955110|11593062|FG000|COMPLETED|Treatment Phase||35
10446168|NCT00955110|11593062|FG000|NOT COMPLETED|Treatment Phase||6
10446169|NCT00955201|11593078|FG000|STARTED|Overall Study||12
10446170|NCT00955201|11593079|FG001|STARTED|Overall Study||11
10446171|NCT00955201|11593080|FG002|STARTED|Overall Study||11
10446172|NCT00955201|11593081|FG003|STARTED|Overall Study||11
10446173|NCT00955201|11593078|FG000|COMPLETED|Overall Study||8
10446174|NCT00955201|11593079|FG001|COMPLETED|Overall Study||11
10446175|NCT00955201|11593080|FG002|COMPLETED|Overall Study||10
10446176|NCT00955201|11593081|FG003|COMPLETED|Overall Study||7
10446177|NCT00955201|11593078|FG000|NOT COMPLETED|Overall Study||4
10446178|NCT00955201|11593079|FG001|NOT COMPLETED|Overall Study||0
10446179|NCT00955201|11593080|FG002|NOT COMPLETED|Overall Study||1
10446180|NCT00955201|11593081|FG003|NOT COMPLETED|Overall Study||4
10446181|NCT00955253|11593100|FG000|STARTED|First Intervention (Day 2)||7
10446182|NCT00955253|11593101|FG001|STARTED|First Intervention (Day 2)||6
10789674|NCT03525210|11950088|FG000|STARTED|Overall Study||100
10789675|NCT03525210|11950089|FG001|STARTED|Overall Study||171
10789676|NCT03525210|11950088|FG000|COMPLETED|Overall Study||96
10789677|NCT03525210|11950089|FG001|COMPLETED|Overall Study||169
10446183|NCT00955253|11593100|FG000|COMPLETED|First Intervention (Day 2)||7
10789678|NCT03525210|11950088|FG000|NOT COMPLETED|Overall Study||4
10789679|NCT03525210|11950089|FG001|NOT COMPLETED|Overall Study||2
10789680|NCT03525444|11950099|FG000|STARTED|Overall Study||203
10789681|NCT03525444|11950100|FG001|STARTED|Overall Study||200
10446184|NCT00955253|11593101|FG001|COMPLETED|First Intervention (Day 2)||6
10446185|NCT00955253|11593100|FG000|NOT COMPLETED|First Intervention (Day 2)||0
10789682|NCT03525444|11950099|FG000|Safety Set|Overall Study||201
10789683|NCT03525444|11950100|FG001|Safety Set|Overall Study||202
10789684|NCT03525444|11950099|FG000|COMPLETED|Overall Study||203
10446186|NCT00955253|11593101|FG001|NOT COMPLETED|First Intervention (Day 2)||0
10446187|NCT00955253|11593100|FG000|STARTED|Second Intervention (Day 4)||7
10446188|NCT00955253|11593101|FG001|STARTED|Second Intervention (Day 4)||6
10446189|NCT00955253|11593100|FG000|COMPLETED|Second Intervention (Day 4)||7
10446190|NCT00955253|11593101|FG001|COMPLETED|Second Intervention (Day 4)||6
10446191|NCT00955253|11593100|FG000|NOT COMPLETED|Second Intervention (Day 4)||0
10446192|NCT00955253|11593101|FG001|NOT COMPLETED|Second Intervention (Day 4)||0
10446193|NCT00955266|11593108|FG000|STARTED|Overall Study||4
10446194|NCT00955266|11593109|FG001|STARTED|Overall Study||4
10446195|NCT00955266|11593108|FG000|COMPLETED|Overall Study||4
10446196|NCT00955266|11593109|FG001|COMPLETED|Overall Study||4
10446197|NCT00955266|11593108|FG000|NOT COMPLETED|Overall Study||0
10446198|NCT00955266|11593109|FG001|NOT COMPLETED|Overall Study||0
10446199|NCT00955279|11593118|FG000|STARTED|Overall Study||58
10446200|NCT00955279|11593119|FG001|STARTED|Overall Study||55
10446201|NCT00955279|11593120|FG002|STARTED|Overall Study||60
10446202|NCT00955279|11593118|FG000|COMPLETED|Overall Study||55
10446203|NCT00955279|11593119|FG001|COMPLETED|Overall Study||51
10446204|NCT00955279|11593120|FG002|COMPLETED|Overall Study||52
10446205|NCT00955279|11593118|FG000|NOT COMPLETED|Overall Study||3
10446206|NCT00955279|11593119|FG001|NOT COMPLETED|Overall Study||4
10446207|NCT00955279|11593120|FG002|NOT COMPLETED|Overall Study||8
10446208|NCT00955305|11593130|FG000|STARTED|Overall Study||88
10446209|NCT00955305|11593131|FG001|STARTED|Overall Study||87
10446210|NCT00955305|11593130|FG000|Treated|Overall Study||83
10446211|NCT00955305|11593131|FG001|Treated|Overall Study||82
10446212|NCT00955305|11593130|FG000|Eligible and Treated|Overall Study||78
10446213|NCT00955305|11593131|FG001|Eligible and Treated|Overall Study||75
10446214|NCT00955305|11593130|FG000|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
10446215|NCT00955305|11593131|FG001|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
10446216|NCT00955305|11593130|FG000|NOT COMPLETED|Overall Study||88
10446217|NCT00955305|11593131|FG001|NOT COMPLETED|Overall Study||87
10446218|NCT00955357|11593139|FG000|STARTED|Titration Phase||96
10446219|NCT00955357|11593140|FG001|STARTED|Titration Phase||360
10446220|NCT00955357|11593139|FG000|COMPLETED|Titration Phase||80
10446221|NCT00955357|11593140|FG001|COMPLETED|Titration Phase||294
10446222|NCT00955357|11593139|FG000|NOT COMPLETED|Titration Phase||16
10446223|NCT00955357|11593140|FG001|NOT COMPLETED|Titration Phase||66
10446224|NCT00955357|11593139|FG000|STARTED|Maintenance Phase||80
10446225|NCT00955357|11593140|FG001|STARTED|Maintenance Phase||294
10446226|NCT00955357|11593139|FG000|COMPLETED|Maintenance Phase||68
10446227|NCT00955357|11593140|FG001|COMPLETED|Maintenance Phase||249
10446228|NCT00955357|11593139|FG000|NOT COMPLETED|Maintenance Phase||12
10446229|NCT00955357|11593140|FG001|NOT COMPLETED|Maintenance Phase||45
10446230|NCT00955409|11593156|FG000|STARTED|Overall Study|Started=Randomized|21
10446231|NCT00955409|11593157|FG001|STARTED|Overall Study|Started=Randomized|6
10446232|NCT00955409|11593158|FG002|STARTED|Overall Study|Started=Randomized|41
10446233|NCT00955409|11593159|FG003|STARTED|Overall Study|Started=Randomized.|25
10446234|NCT00955409|11593160|FG004|STARTED|Overall Study|Started=Randomized|5
10446235|NCT00955409|11593161|FG005|STARTED|Overall Study|Started=Randomized|9
10446236|NCT00955409|11593162|FG006|STARTED|Overall Study|Started=Randomized|27
10789685|NCT03525444|11950100|FG001|COMPLETED|Overall Study||197
10446237|NCT00955409|11593163|FG007|STARTED|Overall Study|Started=Randomized|6
10446238|NCT00955409|11593164|FG008|STARTED|Overall Study|Started=Randomized|16
10446239|NCT00955409|11593165|FG009|STARTED|Overall Study|Started=Randomized|4
10446240|NCT00955409|11593156|FG000|Treated|Overall Study||21
10446241|NCT00955409|11593157|FG001|Treated|Overall Study||6
10446242|NCT00955409|11593158|FG002|Treated|Overall Study||41
10446243|NCT00955409|11593159|FG003|Treated|Overall Study||24
10446244|NCT00955409|11593160|FG004|Treated|Overall Study||5
10446245|NCT00955409|11593161|FG005|Treated|Overall Study||9
10446246|NCT00955409|11593162|FG006|Treated|Overall Study||27
10446247|NCT00955409|11593163|FG007|Treated|Overall Study||6
10446248|NCT00955409|11593164|FG008|Treated|Overall Study||16
10446249|NCT00955409|11593165|FG009|Treated|Overall Study||4
10446250|NCT00955409|11593156|FG000|Completed Treatment|Overall Study||12
10446251|NCT00955409|11593157|FG001|Completed Treatment|Overall Study||5
10446252|NCT00955409|11593158|FG002|Completed Treatment|Overall Study||15
10446253|NCT00955409|11593159|FG003|Completed Treatment|Overall Study||17
10446254|NCT00955409|11593160|FG004|Completed Treatment|Overall Study||3
10446255|NCT00955409|11593161|FG005|Completed Treatment|Overall Study||7
10446256|NCT00955409|11593162|FG006|Completed Treatment|Overall Study||4
10446257|NCT00955409|11593163|FG007|Completed Treatment|Overall Study||3
10446258|NCT00955409|11593164|FG008|Completed Treatment|Overall Study||2
10446259|NCT00955409|11593165|FG009|Completed Treatment|Overall Study||4
10446260|NCT00955409|11593156|FG000|COMPLETED|Overall Study|Completed study|11
10446261|NCT00955409|11593157|FG001|COMPLETED|Overall Study|Completed study|5
10446262|NCT00955409|11593158|FG002|COMPLETED|Overall Study|Completed study|15
10446263|NCT00955409|11593159|FG003|COMPLETED|Overall Study|Completed study|17
10446264|NCT00955409|11593160|FG004|COMPLETED|Overall Study|Completed study|3
10446265|NCT00955409|11593161|FG005|COMPLETED|Overall Study|Completed study|6
10446266|NCT00955409|11593162|FG006|COMPLETED|Overall Study|Completed study|3
10446267|NCT00955409|11593163|FG007|COMPLETED|Overall Study|Completed study|2
10446268|NCT00955409|11593164|FG008|COMPLETED|Overall Study|Completed study|2
10446269|NCT00955409|11593165|FG009|COMPLETED|Overall Study|Completed study|3
10446270|NCT00955409|11593156|FG000|NOT COMPLETED|Overall Study||10
10446271|NCT00955409|11593157|FG001|NOT COMPLETED|Overall Study||1
10446272|NCT00955409|11593158|FG002|NOT COMPLETED|Overall Study||26
10446273|NCT00955409|11593159|FG003|NOT COMPLETED|Overall Study||8
10446274|NCT00955409|11593160|FG004|NOT COMPLETED|Overall Study||2
10446275|NCT00955409|11593161|FG005|NOT COMPLETED|Overall Study||3
10446276|NCT00955409|11593162|FG006|NOT COMPLETED|Overall Study||24
10446277|NCT00955409|11593163|FG007|NOT COMPLETED|Overall Study||4
10446278|NCT00955409|11593164|FG008|NOT COMPLETED|Overall Study||14
10446279|NCT00955409|11593165|FG009|NOT COMPLETED|Overall Study||1
10446280|NCT00955474|11593193|FG000|STARTED|Overall Study||12
10446281|NCT00955474|11593194|FG001|STARTED|Overall Study||13
10446282|NCT00955474|11593193|FG000|COMPLETED|Overall Study||5
10446283|NCT00955474|11593194|FG001|COMPLETED|Overall Study||8
10446284|NCT00955474|11593193|FG000|NOT COMPLETED|Overall Study||7
10446285|NCT00955474|11593194|FG001|NOT COMPLETED|Overall Study||5
10446286|NCT00955487|11593204|FG000|STARTED|Overall Study||10
10446287|NCT00955487|11593205|FG001|STARTED|Overall Study||9
10446288|NCT00955487|11593206|FG002|STARTED|Overall Study||17
10446289|NCT00955487|11593207|FG003|STARTED|Overall Study||21
10446290|NCT00955487|11593208|FG004|STARTED|Overall Study||32
10446291|NCT00955487|11593209|FG005|STARTED|Overall Study||35
10446292|NCT00955487|11593204|FG000|COMPLETED|Overall Study||10
10446293|NCT00955487|11593205|FG001|COMPLETED|Overall Study||9
10446294|NCT00955487|11593206|FG002|COMPLETED|Overall Study||17
10446295|NCT00955487|11593207|FG003|COMPLETED|Overall Study||21
10446296|NCT00955487|11593208|FG004|COMPLETED|Overall Study||32
10446297|NCT00955487|11593209|FG005|COMPLETED|Overall Study||35
10446298|NCT00955487|11593204|FG000|NOT COMPLETED|Overall Study||0
10446299|NCT00955487|11593205|FG001|NOT COMPLETED|Overall Study||0
10446300|NCT00955487|11593206|FG002|NOT COMPLETED|Overall Study||0
10446301|NCT00955487|11593207|FG003|NOT COMPLETED|Overall Study||0
10446302|NCT00955487|11593208|FG004|NOT COMPLETED|Overall Study||0
10446303|NCT00955487|11593209|FG005|NOT COMPLETED|Overall Study||0
10446304|NCT00955513|11593224|FG000|STARTED|Overall Study||80
10446305|NCT00955513|11593225|FG001|STARTED|Overall Study||80
10446306|NCT00955513|11593226|FG002|STARTED|Overall Study||82
10446307|NCT00955513|11593224|FG000|COMPLETED|Overall Study||79
10446308|NCT00955513|11593225|FG001|COMPLETED|Overall Study||78
10446309|NCT00955513|11593226|FG002|COMPLETED|Overall Study||79
10446310|NCT00955513|11593224|FG000|NOT COMPLETED|Overall Study||1
10446311|NCT00955513|11593225|FG001|NOT COMPLETED|Overall Study||2
10446312|NCT00955513|11593226|FG002|NOT COMPLETED|Overall Study||3
10446313|NCT00955617|11593234|FG000|STARTED|First MRA (Between Day0 and Day21)||10
10446314|NCT00955617|11593235|FG001|STARTED|First MRA (Between Day0 and Day21)||10
10446315|NCT00955617|11593234|FG000|COMPLETED|First MRA (Between Day0 and Day21)||10
10446316|NCT00955617|11593235|FG001|COMPLETED|First MRA (Between Day0 and Day21)||10
10446317|NCT00955617|11593234|FG000|NOT COMPLETED|First MRA (Between Day0 and Day21)||0
10446318|NCT00955617|11593235|FG001|NOT COMPLETED|First MRA (Between Day0 and Day21)||0
10446319|NCT00955617|11593234|FG000|STARTED|Second MRA (Between Day 1 and Day 51)||10
10446320|NCT00955617|11593235|FG001|STARTED|Second MRA (Between Day 1 and Day 51)||10
10446321|NCT00955617|11593234|FG000|COMPLETED|Second MRA (Between Day 1 and Day 51)||7
10446322|NCT00955617|11593235|FG001|COMPLETED|Second MRA (Between Day 1 and Day 51)||7
10446323|NCT00955617|11593234|FG000|NOT COMPLETED|Second MRA (Between Day 1 and Day 51)||3
10525610|NCT01377012|11677546|FG002|COMPLETED|Core Study||80
10446324|NCT00955617|11593235|FG001|NOT COMPLETED|Second MRA (Between Day 1 and Day 51)||3
10789686|NCT03525444|11950099|FG000|NOT COMPLETED|Overall Study||0
10789687|NCT03525444|11950100|FG001|NOT COMPLETED|Overall Study||3
10789688|NCT03525548|11950109|FG000|STARTED|Overall Study||52
10789689|NCT03525548|11950110|FG001|STARTED|Overall Study||55
10789690|NCT03525548|11950109|FG000|COMPLETED|Overall Study||52
10789691|NCT03525548|11950110|FG001|COMPLETED|Overall Study||55
10789692|NCT03525548|11950109|FG000|NOT COMPLETED|Overall Study||0
10789693|NCT03525548|11950110|FG001|NOT COMPLETED|Overall Study||0
10446325|NCT00955682|11593243|FG000|STARTED|Year 2 Period||253
10446326|NCT00955682|11593244|FG001|STARTED|Year 2 Period||42
10446327|NCT00955682|11593243|FG000|COMPLETED|Year 2 Period||253
10446328|NCT00955682|11593244|FG001|COMPLETED|Year 2 Period||42
10446329|NCT00955682|11593243|FG000|NOT COMPLETED|Year 2 Period||0
10446330|NCT00955682|11593244|FG001|NOT COMPLETED|Year 2 Period||0
10446331|NCT00955682|11593243|FG000|STARTED|Year 3 Period||273
10446332|NCT00955682|11593244|FG001|STARTED|Year 3 Period||47
10446333|NCT00955682|11593243|FG000|COMPLETED|Year 3 Period||273
10446334|NCT00955682|11593244|FG001|COMPLETED|Year 3 Period||47
10446335|NCT00955682|11593243|FG000|NOT COMPLETED|Year 3 Period||0
10446336|NCT00955682|11593244|FG001|NOT COMPLETED|Year 3 Period||0
10446337|NCT00955682|11593243|FG000|STARTED|Year 4 Period||246
10446338|NCT00955682|11593244|FG001|STARTED|Year 4 Period||48
10446339|NCT00955682|11593243|FG000|COMPLETED|Year 4 Period||246
10789694|NCT03525834|11950116|FG000|STARTED|Overall Study||40
10789695|NCT03525834|11950116|FG000|COMPLETED|Overall Study||39
10789696|NCT03525834|11950116|FG000|NOT COMPLETED|Overall Study||1
10789697|NCT03526055|11950120|FG000|STARTED|Initial Program||5
10446340|NCT00955682|11593244|FG001|COMPLETED|Year 4 Period||48
10446341|NCT00955682|11593243|FG000|NOT COMPLETED|Year 4 Period||0
10446342|NCT00955682|11593244|FG001|NOT COMPLETED|Year 4 Period||0
10446343|NCT00955682|11593243|FG000|STARTED|Booster Period (Month 48- 49)||245
10446344|NCT00955682|11593244|FG001|STARTED|Booster Period (Month 48- 49)||48
10446345|NCT00955682|11593243|FG000|COMPLETED|Booster Period (Month 48- 49)||244
10446346|NCT00955682|11593244|FG001|COMPLETED|Booster Period (Month 48- 49)||47
10446347|NCT00955682|11593243|FG000|NOT COMPLETED|Booster Period (Month 48- 49)||1
10446348|NCT00955682|11593244|FG001|NOT COMPLETED|Booster Period (Month 48- 49)||1
10446349|NCT00955682|11593243|FG000|STARTED|Year 5 Period||239
10446350|NCT00955682|11593244|FG001|STARTED|Year 5 Period||47
10446351|NCT00955682|11593243|FG000|COMPLETED|Year 5 Period||239
10446352|NCT00955682|11593244|FG001|COMPLETED|Year 5 Period||47
10789698|NCT03526055|11950121|FG001|STARTED|Initial Program||5
10789699|NCT03526055|11950120|FG000|COMPLETED|Initial Program||5
10789700|NCT03526055|11950121|FG001|COMPLETED|Initial Program||5
10446353|NCT00955682|11593243|FG000|NOT COMPLETED|Year 5 Period||0
10446354|NCT00955682|11593244|FG001|NOT COMPLETED|Year 5 Period||0
10446355|NCT00955708|11593258|FG000|STARTED|Overall Study||1308
10446356|NCT00955708|11593258|FG000|COMPLETED|Overall Study||250
10446357|NCT00955708|11593258|FG000|NOT COMPLETED|Overall Study||1058
10446358|NCT00955721|11593264|FG000|STARTED|Overall Study||9
10446359|NCT00955721|11593265|FG001|STARTED|Overall Study||0
10446360|NCT00955721|11593264|FG000|COMPLETED|Overall Study||6
10446361|NCT00955721|11593265|FG001|COMPLETED|Overall Study||0
10446362|NCT00955721|11593264|FG000|NOT COMPLETED|Overall Study||3
10446363|NCT00955721|11593265|FG001|NOT COMPLETED|Overall Study||0
10446364|NCT00955747|11593274|FG000|STARTED|Overall Study||253
10446365|NCT00955747|11593275|FG001|STARTED|Overall Study||241
10446366|NCT00955747|11593274|FG000|COMPLETED|Overall Study||184
10446367|NCT00955747|11593275|FG001|COMPLETED|Overall Study||172
10446368|NCT00955747|11593274|FG000|NOT COMPLETED|Overall Study||69
10446369|NCT00955747|11593275|FG001|NOT COMPLETED|Overall Study||69
10446370|NCT00955825|11593283|FG000|STARTED|Overall Study||233
10446371|NCT00955825|11593284|FG001|STARTED|Overall Study||240
10446372|NCT00955825|11593283|FG000|COMPLETED|Overall Study||207
10446373|NCT00955825|11593284|FG001|COMPLETED|Overall Study||223
10446374|NCT00955825|11593283|FG000|NOT COMPLETED|Overall Study||26
10446375|NCT00955825|11593284|FG001|NOT COMPLETED|Overall Study||17
10446376|NCT00955877|11593293|FG000|STARTED|Overall Study|Drug manufacturer ceased producing the drug prior to completion of 10 enrolled in this arm.|6
10446377|NCT00955877|11593294|FG001|STARTED|Overall Study|No patients were enrolled because analysis of previous arm wasn't completed.|0
10789701|NCT03526055|11950120|FG000|NOT COMPLETED|Initial Program||0
10446378|NCT00955877|11593295|FG002|STARTED|Overall Study||7
10446379|NCT00955877|11593293|FG000|COMPLETED|Overall Study||6
10446380|NCT00955877|11593294|FG001|COMPLETED|Overall Study||0
10446381|NCT00955877|11593295|FG002|COMPLETED|Overall Study||7
10446382|NCT00955877|11593293|FG000|NOT COMPLETED|Overall Study||0
10446383|NCT00955877|11593294|FG001|NOT COMPLETED|Overall Study||0
10446384|NCT00955877|11593295|FG002|NOT COMPLETED|Overall Study||0
10446385|NCT00955903|11593306|FG000|STARTED|Overall Study||55
10446386|NCT00955903|11593307|FG001|STARTED|Overall Study||54
10446387|NCT00955903|11593308|FG002|STARTED|Overall Study||55
10446388|NCT00955903|11593306|FG000|COMPLETED|Overall Study||49
10446389|NCT00955903|11593307|FG001|COMPLETED|Overall Study||51
10446390|NCT00955903|11593308|FG002|COMPLETED|Overall Study||48
10446391|NCT00955903|11593306|FG000|NOT COMPLETED|Overall Study||6
10446392|NCT00955903|11593307|FG001|NOT COMPLETED|Overall Study||3
10446393|NCT00955903|11593308|FG002|NOT COMPLETED|Overall Study||7
10446394|NCT00955916|11593316|FG000|STARTED|Overall Study||38
10446395|NCT00955916|11593316|FG000|COMPLETED|Overall Study||38
10446396|NCT00955916|11593316|FG000|NOT COMPLETED|Overall Study||0
10446397|NCT00955955|11593323|FG000|STARTED|Overall Study||19
10446398|NCT00955955|11593324|FG001|STARTED|Overall Study||28
10446399|NCT00955955|11593325|FG002|STARTED|Overall Study||28
10446400|NCT00955955|11593323|FG000|COMPLETED|Overall Study||17
10446401|NCT00955955|11593324|FG001|COMPLETED|Overall Study||28
10446402|NCT00955955|11593325|FG002|COMPLETED|Overall Study||28
10446403|NCT00955955|11593323|FG000|NOT COMPLETED|Overall Study||2
10446404|NCT00955955|11593324|FG001|NOT COMPLETED|Overall Study||0
10446405|NCT00955955|11593325|FG002|NOT COMPLETED|Overall Study||0
10446406|NCT00955968|11593341|FG000|STARTED|Overall Study||828
10446407|NCT00955968|11593342|FG001|STARTED|Overall Study||825
10446408|NCT00955968|11593341|FG000|COMPLETED|Overall Study||691
10446409|NCT00955968|11593342|FG001|COMPLETED|Overall Study||699
10446410|NCT00955968|11593341|FG000|NOT COMPLETED|Overall Study||137
10446411|NCT00955968|11593342|FG001|NOT COMPLETED|Overall Study||126
10446412|NCT00956020|11593351|FG000|STARTED|Overall Study||4
10446413|NCT00956020|11593351|FG000|COMPLETED|Overall Study||4
10446414|NCT00956020|11593351|FG000|NOT COMPLETED|Overall Study||0
10446415|NCT00956085|11593364|FG000|STARTED|Overall Study||12
10446416|NCT00956085|11593364|FG000|COMPLETED|Overall Study||12
10446417|NCT00956085|11593364|FG000|NOT COMPLETED|Overall Study||0
10446418|NCT00956254|11593368|FG000|STARTED|Overall Study||18
10446419|NCT00956254|11593368|FG000|COMPLETED|Overall Study||18
10550880|NCT01534273|11705001|FG001|STARTED|Period 2|Participants in Cohort A participated in only 1 treatment period.|0
10550881|NCT01534273|11705002|FG002|STARTED|Period 2||2
10550882|NCT01534273|11705003|FG003|STARTED|Period 2||6
10550883|NCT01534273|11705004|FG004|STARTED|Period 2|Participants in Cohort C participated in only 1 treatment period.|0
10550884|NCT01534273|11705005|FG005|STARTED|Period 2|Participants in Cohort C participated in only 1 treatment period.|0
10550885|NCT01534273|11705006|FG006|STARTED|Period 2|Participants in Cohort C participated in only 1 treatment period.|0
10550886|NCT01534273|11705000|FG000|COMPLETED|Period 2||0
10550887|NCT01534273|11705001|FG001|COMPLETED|Period 2||0
10550888|NCT01534273|11705002|FG002|COMPLETED|Period 2||2
10550889|NCT01534273|11705003|FG003|COMPLETED|Period 2||6
10550890|NCT01534273|11705004|FG004|COMPLETED|Period 2||0
10550891|NCT01534273|11705005|FG005|COMPLETED|Period 2||0
10550892|NCT01534273|11705006|FG006|COMPLETED|Period 2||0
10550893|NCT01534273|11705000|FG000|NOT COMPLETED|Period 2||0
10550894|NCT01534273|11705001|FG001|NOT COMPLETED|Period 2||0
10550895|NCT01534273|11705002|FG002|NOT COMPLETED|Period 2||0
10550896|NCT01534273|11705003|FG003|NOT COMPLETED|Period 2||0
10550897|NCT01534273|11705004|FG004|NOT COMPLETED|Period 2||0
10550898|NCT01534273|11705005|FG005|NOT COMPLETED|Period 2||0
10550899|NCT01534273|11705006|FG006|NOT COMPLETED|Period 2||0
10550900|NCT01534351|11705030|FG000|STARTED|Overall Study||1
10550901|NCT01534351|11705031|FG001|STARTED|Overall Study||0
10550902|NCT01534351|11705032|FG002|STARTED|Overall Study||0
10550903|NCT01534351|11705030|FG000|COMPLETED|Overall Study||0
10550904|NCT01534351|11705031|FG001|COMPLETED|Overall Study||0
10550905|NCT01534351|11705032|FG002|COMPLETED|Overall Study||0
10550906|NCT01534351|11705030|FG000|NOT COMPLETED|Overall Study||1
10550907|NCT01534351|11705031|FG001|NOT COMPLETED|Overall Study||0
10550908|NCT01534351|11705032|FG002|NOT COMPLETED|Overall Study||0
10550909|NCT01534416|11705042|FG000|STARTED|Overall Study||68
10550910|NCT01534416|11705043|FG001|STARTED|Overall Study||64
10550911|NCT01534416|11705042|FG000|COMPLETED|Overall Study||68
10550912|NCT01534416|11705043|FG001|COMPLETED|Overall Study||64
10550913|NCT01534416|11705042|FG000|NOT COMPLETED|Overall Study||0
10446420|NCT00956254|11593368|FG000|NOT COMPLETED|Overall Study||0
10446421|NCT00956293|11593376|FG000|STARTED|Main Period (Pre-randomization)||0
10446422|NCT00956293|11593377|FG001|STARTED|Main Period (Pre-randomization)||0
10446423|NCT00956293|11593378|FG002|STARTED|Main Period (Pre-randomization)||207
10446424|NCT00956293|11593376|FG000|Enrolled Safety Set|Main Period (Pre-randomization)||0
10446425|NCT00956293|11593377|FG001|Enrolled Safety Set|Main Period (Pre-randomization)||0
10446426|NCT00956293|11593378|FG002|Enrolled Safety Set|Main Period (Pre-randomization)||203
10446427|NCT00956293|11593376|FG000|COMPLETED|Main Period (Pre-randomization)||0
10446428|NCT00956293|11593377|FG001|COMPLETED|Main Period (Pre-randomization)||0
10446429|NCT00956293|11593378|FG002|COMPLETED|Main Period (Pre-randomization)||77
10446430|NCT00956293|11593376|FG000|NOT COMPLETED|Main Period (Pre-randomization)||0
10550914|NCT01534416|11705043|FG001|NOT COMPLETED|Overall Study||0
10550915|NCT01534520|11705061|FG000|STARTED|Overall Study||30
10446431|NCT00956293|11593377|FG001|NOT COMPLETED|Main Period (Pre-randomization)||0
10446432|NCT00956293|11593378|FG002|NOT COMPLETED|Main Period (Pre-randomization)||130
10446433|NCT00956293|11593376|FG000|STARTED|Main Period (Randomization)||24
10446434|NCT00956293|11593377|FG001|STARTED|Main Period (Randomization)||53
10446435|NCT00956293|11593378|FG002|STARTED|Main Period (Randomization)||0
10446436|NCT00956293|11593376|FG000|Full Analysis Set|Main Period (Randomization)||24
10446437|NCT00956293|11593377|FG001|Full Analysis Set|Main Period (Randomization)|Two participants, randomized to this arm, did not receive everolimus.|51
10446438|NCT00956293|11593378|FG002|Full Analysis Set|Main Period (Randomization)||0
10446439|NCT00956293|11593376|FG000|Randomized Safety Set|Main Period (Randomization)||24
10446440|NCT00956293|11593377|FG001|Randomized Safety Set|Main Period (Randomization)||51
10446441|NCT00956293|11593378|FG002|Randomized Safety Set|Main Period (Randomization)||0
10446442|NCT00956293|11593376|FG000|COMPLETED|Main Period (Randomization)||23
10446443|NCT00956293|11593377|FG001|COMPLETED|Main Period (Randomization)||26
10446444|NCT00956293|11593378|FG002|COMPLETED|Main Period (Randomization)||0
10446445|NCT00956293|11593376|FG000|NOT COMPLETED|Main Period (Randomization)||1
10446446|NCT00956293|11593377|FG001|NOT COMPLETED|Main Period (Randomization)||27
10446447|NCT00956293|11593378|FG002|NOT COMPLETED|Main Period (Randomization)||0
10446448|NCT00956293|11593376|FG000|STARTED|Follow-up Period||20
10446449|NCT00956293|11593377|FG001|STARTED|Follow-up Period||32
10446450|NCT00956293|11593378|FG002|STARTED|Follow-up Period||0
10446451|NCT00956293|11593376|FG000|COMPLETED|Follow-up Period||0
10446452|NCT00956293|11593377|FG001|COMPLETED|Follow-up Period||0
10446453|NCT00956293|11593378|FG002|COMPLETED|Follow-up Period||0
10446454|NCT00956293|11593376|FG000|NOT COMPLETED|Follow-up Period||20
10446455|NCT00956293|11593377|FG001|NOT COMPLETED|Follow-up Period||32
10446456|NCT00956293|11593378|FG002|NOT COMPLETED|Follow-up Period||0
10446457|NCT00956540|11593388|FG000|STARTED|Overall Study||54
10446458|NCT00956540|11593389|FG001|STARTED|Overall Study||50
10446459|NCT00956540|11593390|FG002|STARTED|Overall Study||46
10446460|NCT00956540|11593391|FG003|STARTED|Overall Study||45
10446461|NCT00956540|11593388|FG000|COMPLETED|Overall Study||51
10446462|NCT00956540|11593389|FG001|COMPLETED|Overall Study||46
10446463|NCT00956540|11593390|FG002|COMPLETED|Overall Study||43
10446464|NCT00956540|11593391|FG003|COMPLETED|Overall Study||41
10446465|NCT00956540|11593388|FG000|NOT COMPLETED|Overall Study||3
10446466|NCT00956540|11593389|FG001|NOT COMPLETED|Overall Study||4
10446467|NCT00956540|11593390|FG002|NOT COMPLETED|Overall Study||3
10446468|NCT00956540|11593391|FG003|NOT COMPLETED|Overall Study||4
10446469|NCT00956592|11593403|FG000|STARTED|Overall Study||150
10446470|NCT00956592|11593404|FG001|STARTED|Overall Study||150
10446471|NCT00956592|11593403|FG000|COMPLETED|Overall Study||149
10446472|NCT00956592|11593404|FG001|COMPLETED|Overall Study||147
10446473|NCT00956592|11593403|FG000|NOT COMPLETED|Overall Study||1
10446474|NCT00956592|11593404|FG001|NOT COMPLETED|Overall Study||3
10446475|NCT00956631|11593412|FG000|STARTED|Overall Study||78
10446476|NCT00956631|11593412|FG000|COMPLETED|Overall Study||62
10446477|NCT00956631|11593412|FG000|NOT COMPLETED|Overall Study||16
10446478|NCT00956657|11593420|FG000|STARTED|Overall Study||18
10446479|NCT00956657|11593421|FG001|STARTED|Overall Study||13
10789702|NCT03526055|11950121|FG001|NOT COMPLETED|Initial Program||0
10789703|NCT03526055|11950120|FG000|STARTED|Second Program||5
10789704|NCT03526055|11950121|FG001|STARTED|Second Program||5
10789705|NCT03526055|11950120|FG000|COMPLETED|Second Program||5
10789706|NCT03526055|11950121|FG001|COMPLETED|Second Program||5
10789707|NCT03526055|11950120|FG000|NOT COMPLETED|Second Program||0
10789708|NCT03526055|11950121|FG001|NOT COMPLETED|Second Program||0
10789709|NCT03526458|11950130|FG000|STARTED|Overall Study||20
10446480|NCT00956657|11593420|FG000|COMPLETED|Overall Study||18
10446481|NCT00956657|11593421|FG001|COMPLETED|Overall Study||13
10446482|NCT00956657|11593420|FG000|NOT COMPLETED|Overall Study||0
10446483|NCT00956657|11593421|FG001|NOT COMPLETED|Overall Study||0
10446484|NCT00956709|11593429|FG000|STARTED|Overall Study||16
10446485|NCT00956709|11593430|FG001|STARTED|Overall Study||19
10446486|NCT00956709|11593429|FG000|COMPLETED|Overall Study||16
10446487|NCT00956709|11593430|FG001|COMPLETED|Overall Study||19
10446488|NCT00956709|11593429|FG000|NOT COMPLETED|Overall Study||0
10789710|NCT03526458|11950131|FG001|STARTED|Overall Study||20
10789711|NCT03526458|11950130|FG000|COMPLETED|Overall Study||12
10446489|NCT00956709|11593430|FG001|NOT COMPLETED|Overall Study||0
10446490|NCT00956761|11593436|FG000|STARTED|Overall Study||63
10446491|NCT00956761|11593436|FG000|COMPLETED|Overall Study||63
10446492|NCT00956761|11593436|FG000|NOT COMPLETED|Overall Study||0
10446493|NCT00956813|11593443|FG000|STARTED|Flaxseed and Placebo||105
10446494|NCT00956813|11593444|FG001|STARTED|Flaxseed and Placebo||105
10446495|NCT00956813|11593443|FG000|COMPLETED|Flaxseed and Placebo||97
10446496|NCT00956813|11593444|FG001|COMPLETED|Flaxseed and Placebo||100
10446497|NCT00956813|11593443|FG000|NOT COMPLETED|Flaxseed and Placebo||8
10446498|NCT00956813|11593444|FG001|NOT COMPLETED|Flaxseed and Placebo||5
10446499|NCT00956813|11593443|FG000|STARTED|Continuation Phase||80
10446500|NCT00956813|11593444|FG001|STARTED|Continuation Phase||0
10446501|NCT00956813|11593443|FG000|COMPLETED|Continuation Phase||80
10446502|NCT00956813|11593444|FG001|COMPLETED|Continuation Phase||0
10446503|NCT00956813|11593443|FG000|NOT COMPLETED|Continuation Phase||0
10446504|NCT00956813|11593444|FG001|NOT COMPLETED|Continuation Phase||0
10446505|NCT00956839|11593454|FG000|STARTED|Overall Study||14
10446506|NCT00956839|11593455|FG001|STARTED|Overall Study||13
10446507|NCT00956839|11593456|FG002|STARTED|Overall Study||13
10446508|NCT00956839|11593454|FG000|COMPLETED|Overall Study||11
10446509|NCT00956839|11593455|FG001|COMPLETED|Overall Study||13
10446510|NCT00956839|11593456|FG002|COMPLETED|Overall Study||10
10446511|NCT00956839|11593454|FG000|NOT COMPLETED|Overall Study||3
10446512|NCT00956839|11593455|FG001|NOT COMPLETED|Overall Study||0
10446513|NCT00956839|11593456|FG002|NOT COMPLETED|Overall Study||3
10446514|NCT00956930|11593466|FG000|STARTED|Overall Study||24
10446515|NCT00956930|11593467|FG001|STARTED|Overall Study||21
10446516|NCT00956930|11593466|FG000|COMPLETED|Overall Study||24
10446517|NCT00956930|11593467|FG001|COMPLETED|Overall Study||21
10446518|NCT00956930|11593466|FG000|NOT COMPLETED|Overall Study||0
10446519|NCT00956930|11593467|FG001|NOT COMPLETED|Overall Study||0
10446520|NCT00956943|11593477|FG000|STARTED|Overall Study||43
10446521|NCT00956943|11593478|FG001|STARTED|Overall Study||44
10446522|NCT00956943|11593477|FG000|Baseline|Overall Study||43
10446523|NCT00956943|11593478|FG001|Baseline|Overall Study||44
10446524|NCT00956943|11593477|FG000|COMPLETED|Overall Study||34
10446525|NCT00956943|11593478|FG001|COMPLETED|Overall Study||34
10446526|NCT00956943|11593477|FG000|NOT COMPLETED|Overall Study||9
10446527|NCT00956943|11593478|FG001|NOT COMPLETED|Overall Study||10
10446528|NCT00957008|11593488|FG000|STARTED|Overall Study||49
10446529|NCT00957008|11593489|FG001|STARTED|Overall Study||49
10446530|NCT00957008|11593490|FG002|STARTED|Overall Study||49
10446531|NCT00957008|11593491|FG003|STARTED|Overall Study||50
10446532|NCT00957008|11593488|FG000|COMPLETED|Overall Study||28
10446533|NCT00957008|11593489|FG001|COMPLETED|Overall Study||37
10446534|NCT00957008|11593490|FG002|COMPLETED|Overall Study||32
10446535|NCT00957008|11593491|FG003|COMPLETED|Overall Study||26
10446536|NCT00957008|11593488|FG000|NOT COMPLETED|Overall Study||21
10446537|NCT00957008|11593489|FG001|NOT COMPLETED|Overall Study||12
10446538|NCT00957008|11593490|FG002|NOT COMPLETED|Overall Study||17
10446539|NCT00957008|11593491|FG003|NOT COMPLETED|Overall Study||24
10446540|NCT00957021|11593505|FG000|STARTED|Overall Study||354
10446541|NCT00957021|11593505|FG000|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2 yr primary outcome interval.|237
10446542|NCT00957021|11593505|FG000|NOT COMPLETED|Overall Study||117
10446543|NCT00957047|11593514|FG000|STARTED|PART I||100
10446544|NCT00957047|11593515|FG001|STARTED|PART I||96
10446545|NCT00957047|11593516|FG002|STARTED|PART I||101
10446546|NCT00957047|11593517|FG003|STARTED|PART I||98
10446547|NCT00957047|11593518|FG004|STARTED|PART I||0
10446548|NCT00957047|11593514|FG000|Randomized/Safety Population|PART I||100
10446549|NCT00957047|11593515|FG001|Randomized/Safety Population|PART I||96
10446550|NCT00957047|11593516|FG002|Randomized/Safety Population|PART I||101
10446551|NCT00957047|11593517|FG003|Randomized/Safety Population|PART I||98
10446552|NCT00957047|11593518|FG004|Randomized/Safety Population|PART I||0
10446553|NCT00957047|11593514|FG000|Intention-to-treat (ITT) Population|PART I||100
10446554|NCT00957047|11593515|FG001|Intention-to-treat (ITT) Population|PART I||96
10446555|NCT00957047|11593516|FG002|Intention-to-treat (ITT) Population|PART I||100
10446556|NCT00957047|11593517|FG003|Intention-to-treat (ITT) Population|PART I||97
10446557|NCT00957047|11593518|FG004|Intention-to-treat (ITT) Population|PART I||0
10446558|NCT00957047|11593514|FG000|Per-Protocol Population|PART I||81
10446559|NCT00957047|11593515|FG001|Per-Protocol Population|PART I||70
10446560|NCT00957047|11593516|FG002|Per-Protocol Population|PART I||75
10446561|NCT00957047|11593517|FG003|Per-Protocol Population|PART I||54
10446562|NCT00957047|11593518|FG004|Per-Protocol Population|PART I||0
10446563|NCT00957047|11593514|FG000|COMPLETED|PART I||94
10446564|NCT00957047|11593515|FG001|COMPLETED|PART I||83
10446565|NCT00957047|11593516|FG002|COMPLETED|PART I||80
10446566|NCT00957047|11593517|FG003|COMPLETED|PART I||68
10446567|NCT00957047|11593518|FG004|COMPLETED|PART I||0
10446568|NCT00957047|11593514|FG000|NOT COMPLETED|PART I||6
10446569|NCT00957047|11593515|FG001|NOT COMPLETED|PART I||13
10446570|NCT00957047|11593516|FG002|NOT COMPLETED|PART I||21
10446571|NCT00957047|11593517|FG003|NOT COMPLETED|PART I||30
10446572|NCT00957047|11593518|FG004|NOT COMPLETED|PART I||0
10446573|NCT00957047|11593514|FG000|STARTED|PART II||0
10446574|NCT00957047|11593515|FG001|STARTED|PART II||0
10446575|NCT00957047|11593516|FG002|STARTED|PART II||0
10446576|NCT00957047|11593517|FG003|STARTED|PART II||0
10446577|NCT00957047|11593518|FG004|STARTED|PART II|325 patients who completed Part I were enrolled in Part II.|325
10446578|NCT00957047|11593514|FG000|Terminated Prematurely|PART II||0
10446579|NCT00957047|11593515|FG001|Terminated Prematurely|PART II||0
10446580|NCT00957047|11593516|FG002|Terminated Prematurely|PART II||0
10446581|NCT00957047|11593517|FG003|Terminated Prematurely|PART II||0
10446582|NCT00957047|11593518|FG004|Terminated Prematurely|PART II|Terminated Prematurely during 1-year Open-Label Period|102
10446583|NCT00957047|11593514|FG000|COMPLETED|PART II||0
10446584|NCT00957047|11593515|FG001|COMPLETED|PART II||0
10446585|NCT00957047|11593516|FG002|COMPLETED|PART II||0
10446586|NCT00957047|11593517|FG003|COMPLETED|PART II||0
10446587|NCT00957047|11593518|FG004|COMPLETED|PART II||223
10446588|NCT00957047|11593514|FG000|NOT COMPLETED|PART II||0
10446589|NCT00957047|11593515|FG001|NOT COMPLETED|PART II||0
10446590|NCT00957047|11593516|FG002|NOT COMPLETED|PART II||0
10446591|NCT00957047|11593517|FG003|NOT COMPLETED|PART II||0
10446592|NCT00957047|11593518|FG004|NOT COMPLETED|PART II||102
10446593|NCT00957229|11593538|FG000|STARTED|Study Start||15
10446594|NCT00957229|11593539|FG001|STARTED|Study Start||26
10446595|NCT00957229|11593538|FG000|COMPLETED|Study Start||14
10446596|NCT00957229|11593539|FG001|COMPLETED|Study Start||23
10446597|NCT00957229|11593538|FG000|NOT COMPLETED|Study Start||1
10446598|NCT00957229|11593539|FG001|NOT COMPLETED|Study Start||3
10446599|NCT00957229|11593538|FG000|STARTED|Reallocated to or Continued Vismodegib||14
10446600|NCT00957229|11593539|FG001|STARTED|Reallocated to or Continued Vismodegib||23
10446601|NCT00957229|11593538|FG000|COMPLETED|Reallocated to or Continued Vismodegib||11
10446602|NCT00957229|11593539|FG001|COMPLETED|Reallocated to or Continued Vismodegib||21
10446603|NCT00957229|11593538|FG000|NOT COMPLETED|Reallocated to or Continued Vismodegib||3
10446604|NCT00957229|11593539|FG001|NOT COMPLETED|Reallocated to or Continued Vismodegib||2
10446605|NCT00957242|11593547|FG000|STARTED|Overall Study||73
10446606|NCT00957242|11593548|FG001|STARTED|Overall Study||72
10550916|NCT01534520|11705062|FG001|STARTED|Overall Study||29
10550917|NCT01534520|11705061|FG000|COMPLETED|Overall Study||30
10550918|NCT01534520|11705062|FG001|COMPLETED|Overall Study|1 subject withdrew consent at time of uterine sound attempt due to intolerable pain|28
10550919|NCT01534520|11705061|FG000|NOT COMPLETED|Overall Study||0
10550920|NCT01534520|11705062|FG001|NOT COMPLETED|Overall Study||1
10550921|NCT01534533|11705076|FG000|STARTED|Overall Study||48
10550922|NCT01534533|11705077|FG001|STARTED|Overall Study||48
10550923|NCT01534533|11705078|FG002|STARTED|Overall Study||48
10446607|NCT00957242|11593547|FG000|COMPLETED|Overall Study||73
10446608|NCT00957242|11593548|FG001|COMPLETED|Overall Study||72
10446609|NCT00957242|11593547|FG000|NOT COMPLETED|Overall Study||0
10446610|NCT00957242|11593548|FG001|NOT COMPLETED|Overall Study||0
10446611|NCT00957268|11593561|FG000|STARTED|Overall Study||5
10446612|NCT00957268|11593562|FG001|STARTED|Overall Study||4
10446613|NCT00957268|11593563|FG002|STARTED|Overall Study||8
10446614|NCT00957268|11593564|FG003|STARTED|Overall Study||7
10446615|NCT00957268|11593565|FG004|STARTED|Overall Study||22
10446616|NCT00957268|11593561|FG000|COMPLETED|Overall Study||5
10446617|NCT00957268|11593562|FG001|COMPLETED|Overall Study||4
10446618|NCT00957268|11593563|FG002|COMPLETED|Overall Study||7
10446619|NCT00957268|11593564|FG003|COMPLETED|Overall Study||7
10446620|NCT00957268|11593565|FG004|COMPLETED|Overall Study||22
10446621|NCT00957268|11593561|FG000|NOT COMPLETED|Overall Study||0
10446622|NCT00957268|11593562|FG001|NOT COMPLETED|Overall Study||0
10446623|NCT00957268|11593563|FG002|NOT COMPLETED|Overall Study||1
10446624|NCT00957268|11593564|FG003|NOT COMPLETED|Overall Study||0
10446625|NCT00957268|11593565|FG004|NOT COMPLETED|Overall Study||0
10446626|NCT00957333|11593577|FG000|STARTED|Overall Study||44
10446627|NCT00957333|11593577|FG000|COMPLETED|Overall Study||44
10446628|NCT00957333|11593577|FG000|NOT COMPLETED|Overall Study||0
10525611|NCT01377012|11677544|FG000|NOT COMPLETED|Core Study||134
10525612|NCT01377012|11677545|FG001|NOT COMPLETED|Core Study||132
10525613|NCT01377012|11677546|FG002|NOT COMPLETED|Core Study||134
10525614|NCT01377012|11677544|FG000|STARTED|Extension Study, Weeks 104-260||57
10525615|NCT01377012|11677545|FG001|STARTED|Extension Study, Weeks 104-260||71
10525616|NCT01377012|11677546|FG002|STARTED|Extension Study, Weeks 104-260||68
10525617|NCT01377012|11677544|FG000|COMPLETED|Extension Study, Weeks 104-260||0
10525618|NCT01377012|11677545|FG001|COMPLETED|Extension Study, Weeks 104-260||0
10525619|NCT01377012|11677546|FG002|COMPLETED|Extension Study, Weeks 104-260||0
10525620|NCT01377012|11677544|FG000|NOT COMPLETED|Extension Study, Weeks 104-260||57
10525621|NCT01377012|11677545|FG001|NOT COMPLETED|Extension Study, Weeks 104-260||71
10525622|NCT01377012|11677546|FG002|NOT COMPLETED|Extension Study, Weeks 104-260||68
10525623|NCT01377194|11677557|FG000|STARTED|Overall Study||186
10525624|NCT01377194|11677558|FG001|STARTED|Overall Study||188
10525625|NCT01377194|11677559|FG002|STARTED|Overall Study||188
10525626|NCT01377194|11677557|FG000|COMPLETED|Overall Study||154
10525627|NCT01377194|11677558|FG001|COMPLETED|Overall Study||145
10525628|NCT01377194|11677559|FG002|COMPLETED|Overall Study||142
10525629|NCT01377194|11677557|FG000|NOT COMPLETED|Overall Study||32
10525630|NCT01377194|11677558|FG001|NOT COMPLETED|Overall Study||43
10525631|NCT01377194|11677559|FG002|NOT COMPLETED|Overall Study||46
10525632|NCT01377233|11677575|FG000|STARTED|Open-label||46
10525633|NCT01377233|11677576|FG001|STARTED|Open-label||0
10525634|NCT01377233|11677577|FG002|STARTED|Open-label||0
10525635|NCT01377233|11677578|FG003|STARTED|Open-label||0
10525636|NCT01377233|11677579|FG004|STARTED|Open-label||0
10525637|NCT01377233|11677575|FG000|COMPLETED|Open-label||42
10525638|NCT01377233|11677576|FG001|COMPLETED|Open-label||0
10525639|NCT01377233|11677577|FG002|COMPLETED|Open-label||0
10525640|NCT01377233|11677578|FG003|COMPLETED|Open-label||0
10525641|NCT01377233|11677579|FG004|COMPLETED|Open-label||0
10525642|NCT01377233|11677575|FG000|NOT COMPLETED|Open-label||4
10525643|NCT01377233|11677576|FG001|NOT COMPLETED|Open-label||0
10525644|NCT01377233|11677577|FG002|NOT COMPLETED|Open-label||0
10550924|NCT01534533|11705079|FG003|STARTED|Overall Study||48
10550925|NCT01534533|11705076|FG000|COMPLETED|Overall Study||40
10550926|NCT01534533|11705077|FG001|COMPLETED|Overall Study||45
10525645|NCT01377233|11677578|FG003|NOT COMPLETED|Open-label||0
10525646|NCT01377233|11677579|FG004|NOT COMPLETED|Open-label||0
10525647|NCT01377233|11677575|FG000|STARTED|Double-blind||0
10525648|NCT01377233|11677576|FG001|STARTED|Double-blind||11
10525649|NCT01377233|11677577|FG002|STARTED|Double-blind||10
10525650|NCT01377233|11677578|FG003|STARTED|Double-blind||11
10525651|NCT01377233|11677579|FG004|STARTED|Double-blind||10
10525652|NCT01377233|11677575|FG000|COMPLETED|Double-blind||0
10525653|NCT01377233|11677576|FG001|COMPLETED|Double-blind||10
10525654|NCT01377233|11677577|FG002|COMPLETED|Double-blind||8
10525655|NCT01377233|11677578|FG003|COMPLETED|Double-blind||7
10525656|NCT01377233|11677579|FG004|COMPLETED|Double-blind||8
10525657|NCT01377233|11677575|FG000|NOT COMPLETED|Double-blind||0
10525658|NCT01377233|11677576|FG001|NOT COMPLETED|Double-blind||1
10525659|NCT01377233|11677577|FG002|NOT COMPLETED|Double-blind||2
10550927|NCT01534533|11705078|FG002|COMPLETED|Overall Study||40
10446629|NCT00957359|11593583|FG000|STARTED|Overall Study||14
10446630|NCT00957359|11593584|FG001|STARTED|Overall Study||15
10446631|NCT00957359|11593583|FG000|COMPLETED|Overall Study||14
10446632|NCT00957359|11593584|FG001|COMPLETED|Overall Study||15
10446633|NCT00957359|11593583|FG000|NOT COMPLETED|Overall Study||0
10446634|NCT00957359|11593584|FG001|NOT COMPLETED|Overall Study||0
10446635|NCT00957372|11593593|FG000|STARTED|PART I||80
10446636|NCT00957372|11593594|FG001|STARTED|PART I||85
10446637|NCT00957372|11593595|FG002|STARTED|PART I||88
10446638|NCT00957372|11593596|FG003|STARTED|PART I||0
10446639|NCT00957372|11593593|FG000|Safety Population|PART I||80
10446640|NCT00957372|11593594|FG001|Safety Population|PART I||85
10446641|NCT00957372|11593595|FG002|Safety Population|PART I||87
10446642|NCT00957372|11593596|FG003|Safety Population|PART I||0
10446643|NCT00957372|11593593|FG000|Intention-to-Treat Population|PART I||77
10446644|NCT00957372|11593594|FG001|Intention-to-Treat Population|PART I||84
10446645|NCT00957372|11593595|FG002|Intention-to-Treat Population|PART I||84
10446646|NCT00957372|11593596|FG003|Intention-to-Treat Population|PART I||0
10446647|NCT00957372|11593593|FG000|Per-Protocol Population|PART I||35
10446648|NCT00957372|11593594|FG001|Per-Protocol Population|PART I||47
10446649|NCT00957372|11593595|FG002|Per-Protocol Population|PART I||51
10446650|NCT00957372|11593596|FG003|Per-Protocol Population|PART I||0
10446651|NCT00957372|11593593|FG000|Randomized But Not Treated|PART I||0
10446652|NCT00957372|11593594|FG001|Randomized But Not Treated|PART I||0
10446653|NCT00957372|11593595|FG002|Randomized But Not Treated|PART I||1
10446654|NCT00957372|11593596|FG003|Randomized But Not Treated|PART I||0
10446655|NCT00957372|11593593|FG000|COMPLETED|PART I||80
10446656|NCT00957372|11593594|FG001|COMPLETED|PART I||85
10446657|NCT00957372|11593595|FG002|COMPLETED|PART I||87
10446658|NCT00957372|11593596|FG003|COMPLETED|PART I||0
10446659|NCT00957372|11593593|FG000|NOT COMPLETED|PART I||0
10446660|NCT00957372|11593594|FG001|NOT COMPLETED|PART I||0
10446661|NCT00957372|11593595|FG002|NOT COMPLETED|PART I||1
10446662|NCT00957372|11593596|FG003|NOT COMPLETED|PART I||0
10446663|NCT00957372|11593593|FG000|STARTED|PART II||0
10446664|NCT00957372|11593594|FG001|STARTED|PART II||0
10446665|NCT00957372|11593595|FG002|STARTED|PART II||0
10446666|NCT00957372|11593596|FG003|STARTED|PART II||194
10446667|NCT00957372|11593593|FG000|Safety Population|PART II||0
10446668|NCT00957372|11593594|FG001|Safety Population|PART II||0
10446669|NCT00957372|11593595|FG002|Safety Population|PART II||0
10446670|NCT00957372|11593596|FG003|Safety Population|PART II||194
10446671|NCT00957372|11593593|FG000|Intention-to-treat (ITT) Population|PART II||0
10446672|NCT00957372|11593594|FG001|Intention-to-treat (ITT) Population|PART II||0
10446673|NCT00957372|11593595|FG002|Intention-to-treat (ITT) Population|PART II||0
10446674|NCT00957372|11593596|FG003|Intention-to-treat (ITT) Population|PART II||191
10446675|NCT00957372|11593593|FG000|Per-Protocol Population|PART II||0
10446676|NCT00957372|11593594|FG001|Per-Protocol Population|PART II||0
10446677|NCT00957372|11593595|FG002|Per-Protocol Population|PART II||0
10446678|NCT00957372|11593596|FG003|Per-Protocol Population|PART II||108
10446679|NCT00957372|11593593|FG000|COMPLETED|PART II||0
10446680|NCT00957372|11593594|FG001|COMPLETED|PART II||0
10446681|NCT00957372|11593595|FG002|COMPLETED|PART II||0
10446682|NCT00957372|11593596|FG003|COMPLETED|PART II||150
10446683|NCT00957372|11593593|FG000|NOT COMPLETED|PART II||0
10446684|NCT00957372|11593594|FG001|NOT COMPLETED|PART II||0
10446685|NCT00957372|11593595|FG002|NOT COMPLETED|PART II||0
10446686|NCT00957372|11593596|FG003|NOT COMPLETED|PART II||44
10446687|NCT00957424|11593612|FG000|STARTED|Overall Study||67
10446688|NCT00957424|11593612|FG000|Follow-up #1|Overall Study||59
10446689|NCT00957424|11593612|FG000|Follow-up #2|Overall Study||50
10446690|NCT00957424|11593612|FG000|COMPLETED|Overall Study||44
10446691|NCT00957424|11593612|FG000|NOT COMPLETED|Overall Study||23
10446692|NCT00957528|11593619|FG000|STARTED|Overall Study||8
10446693|NCT00957528|11593620|FG001|STARTED|Overall Study||9
10446694|NCT00957528|11593621|FG002|STARTED|Overall Study||9
10446695|NCT00957528|11593619|FG000|COMPLETED|Overall Study||8
10446696|NCT00957528|11593620|FG001|COMPLETED|Overall Study||8
10446697|NCT00957528|11593621|FG002|COMPLETED|Overall Study||8
10446698|NCT00957528|11593619|FG000|NOT COMPLETED|Overall Study||0
10446699|NCT00957528|11593620|FG001|NOT COMPLETED|Overall Study||1
10446700|NCT00957528|11593621|FG002|NOT COMPLETED|Overall Study||1
10446701|NCT00957580|11593632|FG000|STARTED|Overall Study||33
10446702|NCT00957580|11593633|FG001|STARTED|Overall Study||33
10446703|NCT00957580|11593634|FG002|STARTED|Overall Study||15
10446704|NCT00957580|11593632|FG000|Treated|Overall Study||33
10446705|NCT00957580|11593633|FG001|Treated|Overall Study||32
10446706|NCT00957580|11593634|FG002|Treated|Overall Study||15
10446707|NCT00957580|11593632|FG000|COMPLETED|Overall Study||33
10446708|NCT00957580|11593633|FG001|COMPLETED|Overall Study||31
10446709|NCT00957580|11593634|FG002|COMPLETED|Overall Study||15
10446710|NCT00957580|11593632|FG000|NOT COMPLETED|Overall Study||0
10446711|NCT00957580|11593633|FG001|NOT COMPLETED|Overall Study||2
10446712|NCT00957580|11593634|FG002|NOT COMPLETED|Overall Study||0
10446713|NCT00957593|11593657|FG000|STARTED|Overall Study||127
10446714|NCT00957593|11593658|FG001|STARTED|Overall Study||125
10446715|NCT00957593|11593657|FG000|COMPLETED|Overall Study||127
10446716|NCT00957593|11593658|FG001|COMPLETED|Overall Study||125
10446717|NCT00957593|11593657|FG000|NOT COMPLETED|Overall Study||0
10446718|NCT00957593|11593658|FG001|NOT COMPLETED|Overall Study||0
10446719|NCT00957658|11593666|FG000|STARTED|Overall Study||234
10446720|NCT00957658|11593666|FG000|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2yr primary outcome interval.|169
10446721|NCT00957658|11593666|FG000|NOT COMPLETED|Overall Study||65
10446722|NCT00957671|11593672|FG000|STARTED|Overall Study|15 subjects began the treatment phase.|15
10789712|NCT03526458|11950131|FG001|COMPLETED|Overall Study||15
10789713|NCT03526458|11950130|FG000|NOT COMPLETED|Overall Study||8
10789714|NCT03526458|11950131|FG001|NOT COMPLETED|Overall Study||5
10446723|NCT00957671|11593672|FG000|COMPLETED|Overall Study|15 subjects completed the treatment phase of the study.|15
10446724|NCT00957671|11593672|FG000|NOT COMPLETED|Overall Study||0
10446725|NCT00957684|11593681|FG000|STARTED|PART I||102
10446726|NCT00957684|11593682|FG001|STARTED|PART I||98
10446727|NCT00957684|11593683|FG002|STARTED|PART I||100
10446728|NCT00957684|11593684|FG003|STARTED|PART I||102
10446729|NCT00957684|11593685|FG004|STARTED|PART I||0
10446730|NCT00957684|11593681|FG000|Randomised (Safety Population)|PART I||102
10446731|NCT00957684|11593682|FG001|Randomised (Safety Population)|PART I||98
10446732|NCT00957684|11593683|FG002|Randomised (Safety Population)|PART I||100
10446733|NCT00957684|11593684|FG003|Randomised (Safety Population)|PART I||102
10446734|NCT00957684|11593685|FG004|Randomised (Safety Population)|PART I||0
10446735|NCT00957684|11593681|FG000|Intention-to-treat (ITT) Population|PART I||98
10446736|NCT00957684|11593682|FG001|Intention-to-treat (ITT) Population|PART I||98
10446737|NCT00957684|11593683|FG002|Intention-to-treat (ITT) Population|PART I||99
10446738|NCT00957684|11593684|FG003|Intention-to-treat (ITT) Population|PART I||102
10446739|NCT00957684|11593685|FG004|Intention-to-treat (ITT) Population|PART I||0
10446740|NCT00957684|11593681|FG000|Per-protocol (PP)Population|PART I||72
10446741|NCT00957684|11593682|FG001|Per-protocol (PP)Population|PART I||86
10446742|NCT00957684|11593683|FG002|Per-protocol (PP)Population|PART I||94
10446743|NCT00957684|11593684|FG003|Per-protocol (PP)Population|PART I||91
10446744|NCT00957684|11593685|FG004|Per-protocol (PP)Population|PART I||0
10446745|NCT00957684|11593681|FG000|COMPLETED|PART I||71
10446746|NCT00957684|11593682|FG001|COMPLETED|PART I||85
10446747|NCT00957684|11593683|FG002|COMPLETED|PART I||90
10446748|NCT00957684|11593684|FG003|COMPLETED|PART I||84
10446749|NCT00957684|11593685|FG004|COMPLETED|PART I||0
10446750|NCT00957684|11593681|FG000|NOT COMPLETED|PART I||31
10446751|NCT00957684|11593682|FG001|NOT COMPLETED|PART I||13
10446752|NCT00957684|11593683|FG002|NOT COMPLETED|PART I||10
10446753|NCT00957684|11593684|FG003|NOT COMPLETED|PART I||18
10446754|NCT00957684|11593685|FG004|NOT COMPLETED|PART I||0
10446755|NCT00957684|11593681|FG000|STARTED|PART II||0
10446756|NCT00957684|11593682|FG001|STARTED|PART II||0
10446757|NCT00957684|11593683|FG002|STARTED|PART II||0
10446758|NCT00957684|11593684|FG003|STARTED|PART II||0
10446759|NCT00957684|11593685|FG004|STARTED|PART II||314
10446760|NCT00957684|11593681|FG000|Patients Entered Part II|PART II||0
10446761|NCT00957684|11593682|FG001|Patients Entered Part II|PART II||0
10446762|NCT00957684|11593683|FG002|Patients Entered Part II|PART II||0
10446763|NCT00957684|11593684|FG003|Patients Entered Part II|PART II||0
10446764|NCT00957684|11593685|FG004|Patients Entered Part II|PART II||314
10446765|NCT00957684|11593681|FG000|COMPLETED|PART II||0
10446766|NCT00957684|11593682|FG001|COMPLETED|PART II||0
10446767|NCT00957684|11593683|FG002|COMPLETED|PART II||0
10446768|NCT00957684|11593684|FG003|COMPLETED|PART II||0
10446769|NCT00957684|11593685|FG004|COMPLETED|PART II||239
10446770|NCT00957684|11593681|FG000|NOT COMPLETED|PART II||0
10446771|NCT00957684|11593682|FG001|NOT COMPLETED|PART II||0
10446772|NCT00957684|11593683|FG002|NOT COMPLETED|PART II||0
10446773|NCT00957684|11593684|FG003|NOT COMPLETED|PART II||0
10446774|NCT00957684|11593685|FG004|NOT COMPLETED|PART II||75
10446775|NCT00957723|11593695|FG000|STARTED|Overall Study||411
10446776|NCT00957723|11593695|FG000|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2yr primary outcome interval.|298
10446777|NCT00957723|11593695|FG000|NOT COMPLETED|Overall Study||113
10550928|NCT01534533|11705079|FG003|COMPLETED|Overall Study||44
10550929|NCT01534533|11705076|FG000|NOT COMPLETED|Overall Study||8
10550930|NCT01534533|11705077|FG001|NOT COMPLETED|Overall Study||3
10550931|NCT01534533|11705078|FG002|NOT COMPLETED|Overall Study||8
10550932|NCT01534533|11705079|FG003|NOT COMPLETED|Overall Study||4
10550933|NCT01534637|11705091|FG000|STARTED|Overall Study||22
10446778|NCT00957801|11593705|FG000|STARTED|Overall Study||7
10446779|NCT00957801|11593706|FG001|STARTED|Overall Study||7
10446780|NCT00957801|11593707|FG002|STARTED|Overall Study||7
10446781|NCT00957801|11593708|FG003|STARTED|Overall Study||8
10446782|NCT00957801|11593705|FG000|COMPLETED|Overall Study||7
10446783|NCT00957801|11593706|FG001|COMPLETED|Overall Study||7
10446784|NCT00957801|11593707|FG002|COMPLETED|Overall Study||7
10446785|NCT00957801|11593708|FG003|COMPLETED|Overall Study||7
10446786|NCT00957801|11593705|FG000|NOT COMPLETED|Overall Study||0
10446787|NCT00957801|11593706|FG001|NOT COMPLETED|Overall Study||0
10446788|NCT00957801|11593707|FG002|NOT COMPLETED|Overall Study||0
10446789|NCT00957801|11593708|FG003|NOT COMPLETED|Overall Study||1
10446790|NCT00957853|11593721|FG000|STARTED|Overall Study||4
10550934|NCT01534637|11705091|FG000|COMPLETED|Overall Study||13
10446791|NCT00957853|11593722|FG001|STARTED|Overall Study||6
10446792|NCT00957853|11593723|FG002|STARTED|Overall Study||5
10446793|NCT00957853|11593721|FG000|Randomization|Overall Study||4
10446794|NCT00957853|11593722|FG001|Randomization|Overall Study||6
10446795|NCT00957853|11593723|FG002|Randomization|Overall Study||5
10446796|NCT00957853|11593721|FG000|Neoadjuvant Tx Completion|Overall Study||3
10446797|NCT00957853|11593722|FG001|Neoadjuvant Tx Completion|Overall Study||6
10446798|NCT00957853|11593723|FG002|Neoadjuvant Tx Completion|Overall Study||5
10446799|NCT00957853|11593721|FG000|COMPLETED|Overall Study||3
10446800|NCT00957853|11593722|FG001|COMPLETED|Overall Study||6
10446801|NCT00957853|11593723|FG002|COMPLETED|Overall Study||5
10446802|NCT00957853|11593721|FG000|NOT COMPLETED|Overall Study||1
10446803|NCT00957853|11593722|FG001|NOT COMPLETED|Overall Study||0
10446804|NCT00957853|11593723|FG002|NOT COMPLETED|Overall Study||0
10446805|NCT00957905|11593733|FG000|STARTED|Part A||7
10446806|NCT00957905|11593734|FG001|STARTED|Part A||0
10446807|NCT00957905|11593733|FG000|COMPLETED|Part A||7
10446808|NCT00957905|11593734|FG001|COMPLETED|Part A||0
10446809|NCT00957905|11593733|FG000|NOT COMPLETED|Part A||0
10446810|NCT00957905|11593734|FG001|NOT COMPLETED|Part A||0
10446811|NCT00957905|11593733|FG000|STARTED|Part B||0
10446812|NCT00957905|11593734|FG001|STARTED|Part B||29
10446813|NCT00957905|11593733|FG000|COMPLETED|Part B||0
10446814|NCT00957905|11593734|FG001|COMPLETED|Part B||25
10446815|NCT00957905|11593733|FG000|NOT COMPLETED|Part B||0
10446816|NCT00957905|11593734|FG001|NOT COMPLETED|Part B||4
10446817|NCT00957931|11593740|FG000|STARTED|Overall Study||6
10446818|NCT00957931|11593740|FG000|COMPLETED|Overall Study||2
10446819|NCT00957931|11593740|FG000|NOT COMPLETED|Overall Study||4
10446820|NCT00957944|11593746|FG000|STARTED|First Intervention- 24 Hours||20
10446821|NCT00957944|11593747|FG001|STARTED|First Intervention- 24 Hours||20
10446822|NCT00957944|11593746|FG000|COMPLETED|First Intervention- 24 Hours||20
10446823|NCT00957944|11593747|FG001|COMPLETED|First Intervention- 24 Hours||19
10446824|NCT00957944|11593746|FG000|NOT COMPLETED|First Intervention- 24 Hours||0
10446825|NCT00957944|11593747|FG001|NOT COMPLETED|First Intervention- 24 Hours||1
10446826|NCT00957944|11593746|FG000|STARTED|Washout Period of at Least 5 Days||20
10446827|NCT00957944|11593747|FG001|STARTED|Washout Period of at Least 5 Days||19
10446828|NCT00957944|11593746|FG000|COMPLETED|Washout Period of at Least 5 Days||20
10446829|NCT00957944|11593747|FG001|COMPLETED|Washout Period of at Least 5 Days||19
10446830|NCT00957944|11593746|FG000|NOT COMPLETED|Washout Period of at Least 5 Days||0
10446831|NCT00957944|11593747|FG001|NOT COMPLETED|Washout Period of at Least 5 Days||0
10446832|NCT00957944|11593746|FG000|STARTED|Second Intervention- 24 Hours||20
10446833|NCT00957944|11593747|FG001|STARTED|Second Intervention- 24 Hours||19
10446834|NCT00957944|11593746|FG000|Pharmacokinetic Set (PKS)|Second Intervention- 24 Hours||20
10446835|NCT00957944|11593747|FG001|Pharmacokinetic Set (PKS)|Second Intervention- 24 Hours|One subject that fullfilled predefined criteria for patch adhesiveness was excluded from the PKS|18
10446836|NCT00957944|11593746|FG000|COMPLETED|Second Intervention- 24 Hours||20
10446837|NCT00957944|11593747|FG001|COMPLETED|Second Intervention- 24 Hours||19
10446838|NCT00957944|11593746|FG000|NOT COMPLETED|Second Intervention- 24 Hours||0
10446839|NCT00957944|11593747|FG001|NOT COMPLETED|Second Intervention- 24 Hours||0
10446840|NCT00957996|11593755|FG000|STARTED|Overall Study||117
10446841|NCT00957996|11593756|FG001|STARTED|Overall Study||117
10446842|NCT00957996|11593755|FG000|COMPLETED|Overall Study||91
10446843|NCT00957996|11593756|FG001|COMPLETED|Overall Study||89
10446844|NCT00957996|11593755|FG000|NOT COMPLETED|Overall Study||26
10446845|NCT00957996|11593756|FG001|NOT COMPLETED|Overall Study||28
10446846|NCT00958009|11593764|FG000|STARTED|Overall Study||109
10446847|NCT00958009|11593764|FG000|COMPLETED|Overall Study||107
10446848|NCT00958009|11593764|FG000|NOT COMPLETED|Overall Study||2
10446849|NCT00958035|11593770|FG000|STARTED|Overall Study||46
10446850|NCT00958035|11593771|FG001|STARTED|Overall Study||43
10446851|NCT00958035|11593770|FG000|COMPLETED|Overall Study||43
10446852|NCT00958035|11593771|FG001|COMPLETED|Overall Study||39
10446853|NCT00958035|11593770|FG000|NOT COMPLETED|Overall Study||3
10446854|NCT00958035|11593771|FG001|NOT COMPLETED|Overall Study||4
10446855|NCT00958074|11593779|FG000|STARTED|Overall Study||4
10446856|NCT00958074|11593780|FG001|STARTED|Overall Study||7
10446857|NCT00958074|11593779|FG000|COMPLETED|Overall Study||4
10446858|NCT00958074|11593780|FG001|COMPLETED|Overall Study||6
10446859|NCT00958074|11593779|FG000|NOT COMPLETED|Overall Study||0
10446860|NCT00958074|11593780|FG001|NOT COMPLETED|Overall Study||1
10446861|NCT00958126|11593794|FG000|STARTED|Overall Study||49
10446862|NCT00958126|11593795|FG001|STARTED|Overall Study||205
10446863|NCT00958126|11593796|FG002|STARTED|Overall Study||201
10446864|NCT00958126|11593797|FG003|STARTED|Overall Study||203
10446865|NCT00958126|11593798|FG004|STARTED|Overall Study||50
10446866|NCT00958126|11593799|FG005|STARTED|Overall Study||203
10446867|NCT00958126|11593800|FG006|STARTED|Overall Study||200
10446868|NCT00958126|11593801|FG007|STARTED|Overall Study||202
10446869|NCT00958126|11593794|FG000|COMPLETED|Overall Study||48
10446870|NCT00958126|11593795|FG001|COMPLETED|Overall Study||196
10446871|NCT00958126|11593796|FG002|COMPLETED|Overall Study||191
10446872|NCT00958126|11593797|FG003|COMPLETED|Overall Study||192
10446873|NCT00958126|11593798|FG004|COMPLETED|Overall Study||50
10446874|NCT00958126|11593799|FG005|COMPLETED|Overall Study||202
10446875|NCT00958126|11593800|FG006|COMPLETED|Overall Study||199
10446876|NCT00958126|11593801|FG007|COMPLETED|Overall Study||202
10446877|NCT00958126|11593794|FG000|NOT COMPLETED|Overall Study||1
10446878|NCT00958126|11593795|FG001|NOT COMPLETED|Overall Study||9
10446879|NCT00958126|11593796|FG002|NOT COMPLETED|Overall Study||10
10446880|NCT00958126|11593797|FG003|NOT COMPLETED|Overall Study||11
10446881|NCT00958126|11593798|FG004|NOT COMPLETED|Overall Study||0
10446882|NCT00958126|11593799|FG005|NOT COMPLETED|Overall Study||1
10446883|NCT00958126|11593800|FG006|NOT COMPLETED|Overall Study||1
10446884|NCT00958126|11593801|FG007|NOT COMPLETED|Overall Study||0
10446885|NCT00958165|11593823|FG000|STARTED|Overall Study|81 enrolled participants resulted in 72 eligible participants that were treated.|81
10446886|NCT00958165|11593823|FG000|Treated|Overall Study||72
10446887|NCT00958165|11593823|FG000|COMPLETED|Overall Study|Of the 72 treated participants, 67 completed follow-up and were evaluable for effectiveness.|67
10446888|NCT00958165|11593823|FG000|NOT COMPLETED|Overall Study||14
10446889|NCT00958191|11593827|FG000|STARTED|Overall Study||221
10446890|NCT00958191|11593827|FG000|COMPLETED|Overall Study||110
10446891|NCT00958191|11593827|FG000|NOT COMPLETED|Overall Study||111
10446892|NCT00958217|11593835|FG000|STARTED|Overall Study||61
10446893|NCT00958217|11593836|FG001|STARTED|Overall Study||62
10446894|NCT00958217|11593835|FG000|End of Treatment|Overall Study|Participants had a maximum of 16 weeks to complete 12 individual psychotherapy sessions|56
10446895|NCT00958217|11593836|FG001|End of Treatment|Overall Study|Participants had a maximum of 16 weeks to complete 12 individual psychotherapy sessions|57
10446896|NCT00958217|11593835|FG000|COMPLETED|Overall Study|Participants were assessed quarterly for one year following end of treatment|37
10446897|NCT00958217|11593836|FG001|COMPLETED|Overall Study|Participants were assessed quarterly for one year following end of treatment|37
10446898|NCT00958217|11593835|FG000|NOT COMPLETED|Overall Study||24
10446899|NCT00958217|11593836|FG001|NOT COMPLETED|Overall Study||25
10446900|NCT00958243|11593849|FG000|STARTED|Overall Study||26
10446901|NCT00958243|11593850|FG001|STARTED|Overall Study||105
10446902|NCT00958243|11593851|FG002|STARTED|Overall Study||96
10446903|NCT00958243|11593852|FG003|STARTED|Overall Study||28
10446904|NCT00958243|11593853|FG004|STARTED|Overall Study||109
10446905|NCT00958243|11593854|FG005|STARTED|Overall Study||109
10446906|NCT00958243|11593849|FG000|COMPLETED|Overall Study||24
10446907|NCT00958243|11593850|FG001|COMPLETED|Overall Study||99
10446908|NCT00958243|11593851|FG002|COMPLETED|Overall Study||82
10446909|NCT00958243|11593852|FG003|COMPLETED|Overall Study||25
10446910|NCT00958243|11593853|FG004|COMPLETED|Overall Study||100
10446911|NCT00958243|11593854|FG005|COMPLETED|Overall Study||99
10446912|NCT00958243|11593849|FG000|NOT COMPLETED|Overall Study||2
10446913|NCT00958243|11593850|FG001|NOT COMPLETED|Overall Study||6
10446914|NCT00958243|11593851|FG002|NOT COMPLETED|Overall Study||14
10446915|NCT00958243|11593852|FG003|NOT COMPLETED|Overall Study||3
10446916|NCT00958243|11593853|FG004|NOT COMPLETED|Overall Study||9
10446917|NCT00958243|11593854|FG005|NOT COMPLETED|Overall Study||10
10446918|NCT00958256|11593874|FG000|STARTED|Overall Study||21
10550935|NCT01534637|11705091|FG000|NOT COMPLETED|Overall Study||9
10550936|NCT01534663|11705097|FG000|STARTED|Overall Study||14
10550937|NCT01534663|11705098|FG001|STARTED|Overall Study||17
10550938|NCT01534663|11705097|FG000|COMPLETED|Overall Study||12
10550939|NCT01534663|11705098|FG001|COMPLETED|Overall Study||14
10550940|NCT01534663|11705097|FG000|NOT COMPLETED|Overall Study||2
10550941|NCT01534663|11705098|FG001|NOT COMPLETED|Overall Study||3
10550942|NCT01534689|11705104|FG000|STARTED|Overall Study||105
10550943|NCT01534689|11705104|FG000|COMPLETED|Overall Study||105
10550944|NCT01534689|11705104|FG000|NOT COMPLETED|Overall Study||0
10550945|NCT01534897|11705108|FG000|STARTED|Overall Study||10
10550946|NCT01534897|11705108|FG000|Day 25 Iodine-131 Scan|Overall Study||10
10550947|NCT01534897|11705108|FG000|Day 37 Iodine-131 Treatment|Overall Study||6
10550948|NCT01534897|11705108|FG000|COMPLETED|Overall Study||10
10550949|NCT01534897|11705108|FG000|NOT COMPLETED|Overall Study||0
10550950|NCT01534910|11705115|FG000|STARTED|Overall Study||33
10550951|NCT01534910|11705116|FG001|STARTED|Overall Study||32
10550952|NCT01534910|11705115|FG000|COMPLETED|Overall Study||29
10550953|NCT01534910|11705116|FG001|COMPLETED|Overall Study||28
10550954|NCT01534910|11705115|FG000|NOT COMPLETED|Overall Study||4
10550955|NCT01534910|11705116|FG001|NOT COMPLETED|Overall Study||4
10550956|NCT01534962|11705128|FG000|STARTED|Overall Study||67
10550957|NCT01534962|11705129|FG001|STARTED|Overall Study||60
10550958|NCT01534962|11705130|FG002|STARTED|Overall Study||58
10550959|NCT01534962|11705131|FG003|STARTED|Overall Study||56
10550960|NCT01534962|11705128|FG000|COMPLETED|Overall Study||30
10550961|NCT01534962|11705129|FG001|COMPLETED|Overall Study||34
10550962|NCT01534962|11705130|FG002|COMPLETED|Overall Study||34
10550963|NCT01534962|11705131|FG003|COMPLETED|Overall Study||24
10550964|NCT01534962|11705128|FG000|NOT COMPLETED|Overall Study||37
10550965|NCT01534962|11705129|FG001|NOT COMPLETED|Overall Study||26
10550966|NCT01534962|11705130|FG002|NOT COMPLETED|Overall Study||24
10550967|NCT01534962|11705131|FG003|NOT COMPLETED|Overall Study||32
10550968|NCT01534975|11705145|FG000|STARTED|Overall Study||136
10550969|NCT01534975|11705146|FG001|STARTED|Overall Study||133
10550970|NCT01534975|11705147|FG002|STARTED|Overall Study||160
10446919|NCT00958256|11593874|FG000|COMPLETED|Overall Study||18
10446920|NCT00958256|11593874|FG000|NOT COMPLETED|Overall Study||3
10446921|NCT00958282|11593880|FG000|STARTED|Overall Study||22
10446922|NCT00958282|11593881|FG001|STARTED|Overall Study||21
10446923|NCT00958282|11593880|FG000|COMPLETED|Overall Study||12
10446924|NCT00958282|11593881|FG001|COMPLETED|Overall Study||15
10550971|NCT01534975|11705148|FG003|STARTED|Overall Study||84
10550972|NCT01534975|11705145|FG000|COMPLETED|Overall Study||136
10550973|NCT01534975|11705146|FG001|COMPLETED|Overall Study||133
10550974|NCT01534975|11705147|FG002|COMPLETED|Overall Study||160
10550975|NCT01534975|11705148|FG003|COMPLETED|Overall Study||84
10550976|NCT01534975|11705145|FG000|NOT COMPLETED|Overall Study||0
10446925|NCT00958282|11593880|FG000|NOT COMPLETED|Overall Study||10
10446926|NCT00958282|11593881|FG001|NOT COMPLETED|Overall Study||6
10446927|NCT00958308|11593890|FG000|STARTED|Overall Study||84
10446928|NCT00958308|11593891|FG001|STARTED|Overall Study||85
10446929|NCT00958308|11593892|FG002|STARTED|Overall Study||86
10446930|NCT00958308|11593890|FG000|COMPLETED|Overall Study||84
10446931|NCT00958308|11593891|FG001|COMPLETED|Overall Study||85
10446932|NCT00958308|11593892|FG002|COMPLETED|Overall Study||86
10446933|NCT00958308|11593890|FG000|NOT COMPLETED|Overall Study||0
10446934|NCT00958308|11593891|FG001|NOT COMPLETED|Overall Study||0
10446935|NCT00958308|11593892|FG002|NOT COMPLETED|Overall Study||0
10446936|NCT00958334|11593903|FG000|STARTED|Overall Study||22
10446937|NCT00958334|11593904|FG001|STARTED|Overall Study||22
10446938|NCT00958334|11593905|FG002|STARTED|Overall Study||21
10446939|NCT00958334|11593903|FG000|COMPLETED|Overall Study||8
10446940|NCT00958334|11593904|FG001|COMPLETED|Overall Study||5
10446941|NCT00958334|11593905|FG002|COMPLETED|Overall Study||8
10446942|NCT00958334|11593903|FG000|NOT COMPLETED|Overall Study||14
10446943|NCT00958334|11593904|FG001|NOT COMPLETED|Overall Study||17
10446944|NCT00958334|11593905|FG002|NOT COMPLETED|Overall Study||13
10446945|NCT00958360|11593915|FG000|STARTED|Overall Study||163
10446946|NCT00958360|11593916|FG001|STARTED|Overall Study||160
10446947|NCT00958360|11593915|FG000|COMPLETED|Overall Study||152
10446948|NCT00958360|11593916|FG001|COMPLETED|Overall Study||150
10446949|NCT00958360|11593915|FG000|NOT COMPLETED|Overall Study||11
10446950|NCT00958360|11593916|FG001|NOT COMPLETED|Overall Study||10
10446951|NCT00958412|11593922|FG000|STARTED|Overall Study||18
10446952|NCT00958412|11593922|FG000|COMPLETED|Overall Study||0
10446953|NCT00958412|11593922|FG000|NOT COMPLETED|Overall Study||18
10446954|NCT00958438|11593929|FG000|STARTED|Overall Study||82
10446955|NCT00958438|11593930|FG001|STARTED|Overall Study||82
10446956|NCT00958438|11593931|FG002|STARTED|Overall Study||84
10446957|NCT00958438|11593929|FG000|COMPLETED|Overall Study||72
10446958|NCT00958438|11593930|FG001|COMPLETED|Overall Study||72
10446959|NCT00958438|11593931|FG002|COMPLETED|Overall Study||78
10446960|NCT00958438|11593929|FG000|NOT COMPLETED|Overall Study||10
10446961|NCT00958438|11593930|FG001|NOT COMPLETED|Overall Study||10
10446962|NCT00958438|11593931|FG002|NOT COMPLETED|Overall Study||6
10446963|NCT00958477|11593943|FG000|STARTED|Overall Study||8
10446964|NCT00958477|11593944|FG001|STARTED|Overall Study||6
10446965|NCT00958477|11593945|FG002|STARTED|Overall Study||6
10446966|NCT00958477|11593946|FG003|STARTED|Overall Study||6
10446967|NCT00958477|11593943|FG000|COMPLETED|Overall Study||8
10446968|NCT00958477|11593944|FG001|COMPLETED|Overall Study||6
10446969|NCT00958477|11593945|FG002|COMPLETED|Overall Study||6
10446970|NCT00958477|11593946|FG003|COMPLETED|Overall Study||6
10446971|NCT00958477|11593943|FG000|NOT COMPLETED|Overall Study||0
10446972|NCT00958477|11593944|FG001|NOT COMPLETED|Overall Study||0
10446973|NCT00958477|11593945|FG002|NOT COMPLETED|Overall Study||0
10446974|NCT00958477|11593946|FG003|NOT COMPLETED|Overall Study||0
10446975|NCT00958568|11593962|FG000|STARTED|SPII (Wk 0-8, Acute Open-label)||892
10446976|NCT00958568|11593963|FG001|STARTED|SPII (Wk 0-8, Acute Open-label)||0
10446977|NCT00958568|11593964|FG002|STARTED|SPII (Wk 0-8, Acute Open-label)||0
10446978|NCT00958568|11593965|FG003|STARTED|SPII (Wk 0-8, Acute Open-label)||0
10446979|NCT00958568|11593962|FG000|COMPLETED|SPII (Wk 0-8, Acute Open-label)||655
10446980|NCT00958568|11593963|FG001|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
10446981|NCT00958568|11593964|FG002|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
10446982|NCT00958568|11593965|FG003|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
10446983|NCT00958568|11593962|FG000|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||237
10446984|NCT00958568|11593963|FG001|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
10446985|NCT00958568|11593964|FG002|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
10446986|NCT00958568|11593965|FG003|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
10446987|NCT00958568|11593962|FG000|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
10446988|NCT00958568|11593963|FG001|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||655
10446989|NCT00958568|11593964|FG002|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
10446990|NCT00958568|11593965|FG003|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
10446991|NCT00958568|11593962|FG000|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
10446992|NCT00958568|11593963|FG001|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||444
10446993|NCT00958568|11593964|FG002|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
10446994|NCT00958568|11593965|FG003|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
10446995|NCT00958568|11593962|FG000|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
10446996|NCT00958568|11593963|FG001|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||211
10446997|NCT00958568|11593964|FG002|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
10446998|NCT00958568|11593965|FG003|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
10446999|NCT00958568|11593962|FG000|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||0
10447000|NCT00958568|11593963|FG001|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||0
10447001|NCT00958568|11593964|FG002|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||221
10447002|NCT00958568|11593965|FG003|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||223
10447003|NCT00958568|11593962|FG000|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
10447004|NCT00958568|11593963|FG001|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
10447005|NCT00958568|11593964|FG002|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||139
10447006|NCT00958568|11593965|FG003|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||117
10525660|NCT01377233|11677578|FG003|NOT COMPLETED|Double-blind||4
10447007|NCT00958568|11593962|FG000|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
10550977|NCT01534975|11705146|FG001|NOT COMPLETED|Overall Study||0
10550978|NCT01534975|11705147|FG002|NOT COMPLETED|Overall Study||0
10550979|NCT01534975|11705148|FG003|NOT COMPLETED|Overall Study||0
10550980|NCT01535001|11705160|FG000|STARTED|Overall Study||50
10550981|NCT01535001|11705161|FG001|STARTED|Overall Study||50
10550982|NCT01535001|11705160|FG000|COMPLETED|Overall Study||47
10447008|NCT00958568|11593963|FG001|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
10447009|NCT00958568|11593964|FG002|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||82
10447010|NCT00958568|11593965|FG003|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||106
10447011|NCT00958581|11593979|FG000|STARTED|Overall Study||61
10447012|NCT00958581|11593980|FG001|STARTED|Overall Study||61
10447013|NCT00958581|11593981|FG002|STARTED|Overall Study||55
10447014|NCT00958581|11593979|FG000|COMPLETED|Overall Study||61
10447015|NCT00958581|11593980|FG001|COMPLETED|Overall Study||61
10447016|NCT00958581|11593981|FG002|COMPLETED|Overall Study||55
10447017|NCT00958581|11593979|FG000|NOT COMPLETED|Overall Study||0
10447018|NCT00958581|11593980|FG001|NOT COMPLETED|Overall Study||0
10550983|NCT01535001|11705161|FG001|COMPLETED|Overall Study||44
10550984|NCT01535001|11705160|FG000|NOT COMPLETED|Overall Study||3
10550985|NCT01535001|11705161|FG001|NOT COMPLETED|Overall Study||6
10550986|NCT01535014|11705171|FG000|STARTED|Overall Study||210
10550987|NCT01535014|11705172|FG001|STARTED|Overall Study||200
10550988|NCT01535014|11705173|FG002|STARTED|Overall Study||50
10550989|NCT01535014|11705174|FG003|STARTED|Overall Study||33
10550990|NCT01535014|11705171|FG000|COMPLETED|Overall Study||208
10550991|NCT01535014|11705172|FG001|COMPLETED|Overall Study||194
10550992|NCT01535014|11705173|FG002|COMPLETED|Overall Study||49
10550993|NCT01535014|11705174|FG003|COMPLETED|Overall Study||33
10550994|NCT01535014|11705171|FG000|NOT COMPLETED|Overall Study||2
10447019|NCT00958581|11593981|FG002|NOT COMPLETED|Overall Study||0
10447020|NCT00958711|11593994|FG000|STARTED|Overall Study||42
10447021|NCT00958711|11593995|FG001|STARTED|Overall Study||48
10447022|NCT00958711|11593994|FG000|COMPLETED|Overall Study||29
10447023|NCT00958711|11593995|FG001|COMPLETED|Overall Study||27
10447024|NCT00958711|11593994|FG000|NOT COMPLETED|Overall Study||13
10447025|NCT00958711|11593995|FG001|NOT COMPLETED|Overall Study||21
10447026|NCT00958724|11594001|FG000|STARTED|Overall Study||6
10447027|NCT00958724|11594001|FG000|COMPLETED|Overall Study||0
10447028|NCT00958724|11594001|FG000|NOT COMPLETED|Overall Study||6
10447029|NCT00958776|11594007|FG000|STARTED|Overall Study||137
10447030|NCT00958776|11594008|FG001|STARTED|Overall Study||268
10447031|NCT00958776|11594007|FG000|COMPLETED|Overall Study||121
10447032|NCT00958776|11594008|FG001|COMPLETED|Overall Study||239
10447033|NCT00958776|11594007|FG000|NOT COMPLETED|Overall Study||16
10447034|NCT00958776|11594008|FG001|NOT COMPLETED|Overall Study||29
10447035|NCT00958789|11594015|FG000|STARTED|Overall Study||180
10447036|NCT00958789|11594015|FG000|COMPLETED|Overall Study|Participant status at the 2 year primary outcome interval determined Completed/Not Completed counts.|130
10447037|NCT00958789|11594015|FG000|NOT COMPLETED|Overall Study||50
10447038|NCT00958828|11594024|FG000|STARTED|Period 1, 1 Week of Wear||89
10447039|NCT00958828|11594025|FG001|STARTED|Period 1, 1 Week of Wear||89
10447040|NCT00958828|11594024|FG000|COMPLETED|Period 1, 1 Week of Wear||89
10447041|NCT00958828|11594025|FG001|COMPLETED|Period 1, 1 Week of Wear||88
10447042|NCT00958828|11594024|FG000|NOT COMPLETED|Period 1, 1 Week of Wear||0
10447043|NCT00958828|11594025|FG001|NOT COMPLETED|Period 1, 1 Week of Wear||1
10447044|NCT00958828|11594024|FG000|STARTED|Period 2, 1 Week of Wear||89
10447045|NCT00958828|11594025|FG001|STARTED|Period 2, 1 Week of Wear||88
10447046|NCT00958828|11594024|FG000|COMPLETED|Period 2, 1 Week of Wear||89
10447047|NCT00958828|11594025|FG001|COMPLETED|Period 2, 1 Week of Wear||87
10447048|NCT00958828|11594024|FG000|NOT COMPLETED|Period 2, 1 Week of Wear||0
10447049|NCT00958828|11594025|FG001|NOT COMPLETED|Period 2, 1 Week of Wear||1
10447050|NCT00958841|11594031|FG000|STARTED|Overall Study||118
10447051|NCT00958841|11594031|FG000|Completed Month 6 (M6)|Overall Study||90
10447052|NCT00958841|11594031|FG000|Entered in Extension|Overall Study||63
10447053|NCT00958841|11594031|FG000|COMPLETED|Overall Study|Completed = Completed extension|22
10447054|NCT00958841|11594031|FG000|NOT COMPLETED|Overall Study||96
10447055|NCT00958880|11594047|FG000|STARTED|Overall Study||20
10550995|NCT01535014|11705172|FG001|NOT COMPLETED|Overall Study||6
10550996|NCT01535014|11705173|FG002|NOT COMPLETED|Overall Study||1
10550997|NCT01535014|11705174|FG003|NOT COMPLETED|Overall Study||0
10550998|NCT01535040|11705184|FG000|STARTED|Overall Study||65
10447056|NCT00958880|11594048|FG001|STARTED|Overall Study||20
10550999|NCT01535040|11705185|FG001|STARTED|Overall Study||65
10551000|NCT01535040|11705184|FG000|COMPLETED|Overall Study||35
10551001|NCT01535040|11705185|FG001|COMPLETED|Overall Study||44
10551002|NCT01535040|11705184|FG000|NOT COMPLETED|Overall Study||30
10551003|NCT01535040|11705185|FG001|NOT COMPLETED|Overall Study||21
10447057|NCT00958880|11594047|FG000|COMPLETED|Overall Study||18
10447058|NCT00958880|11594048|FG001|COMPLETED|Overall Study||18
10447059|NCT00958880|11594047|FG000|NOT COMPLETED|Overall Study||2
10447060|NCT00958880|11594048|FG001|NOT COMPLETED|Overall Study||2
10447061|NCT00958919|11594054|FG000|STARTED|First Intervention||7
10447062|NCT00958919|11594055|FG001|STARTED|First Intervention||7
10447063|NCT00958919|11594054|FG000|COMPLETED|First Intervention||7
10447064|NCT00958919|11594055|FG001|COMPLETED|First Intervention||7
10447065|NCT00958919|11594054|FG000|NOT COMPLETED|First Intervention||0
10447066|NCT00958919|11594055|FG001|NOT COMPLETED|First Intervention||0
10447067|NCT00958919|11594054|FG000|STARTED|Second Intervention||7
10447068|NCT00958919|11594055|FG001|STARTED|Second Intervention||7
10447069|NCT00958919|11594054|FG000|COMPLETED|Second Intervention||7
10447070|NCT00958919|11594055|FG001|COMPLETED|Second Intervention||7
10447071|NCT00958919|11594054|FG000|NOT COMPLETED|Second Intervention||0
10447072|NCT00958919|11594055|FG001|NOT COMPLETED|Second Intervention||0
10447073|NCT00959049|11594074|FG000|STARTED|Overall Study||231
10447074|NCT00959049|11594075|FG001|STARTED|Overall Study||254
10447075|NCT00959049|11594076|FG002|STARTED|Overall Study||254
10447076|NCT00959049|11594077|FG003|STARTED|Overall Study||228
10447077|NCT00959049|11594078|FG004|STARTED|Overall Study||257
10447078|NCT00959049|11594079|FG005|STARTED|Overall Study||250
10447079|NCT00959049|11594074|FG000|COMPLETED|Overall Study||213
10447080|NCT00959049|11594075|FG001|COMPLETED|Overall Study||247
10447081|NCT00959049|11594076|FG002|COMPLETED|Overall Study||253
10447082|NCT00959049|11594077|FG003|COMPLETED|Overall Study||217
10447083|NCT00959049|11594078|FG004|COMPLETED|Overall Study||248
10447084|NCT00959049|11594079|FG005|COMPLETED|Overall Study||249
10447085|NCT00959049|11594074|FG000|NOT COMPLETED|Overall Study||18
10447086|NCT00959049|11594075|FG001|NOT COMPLETED|Overall Study||7
10447087|NCT00959049|11594076|FG002|NOT COMPLETED|Overall Study||1
10447088|NCT00959049|11594077|FG003|NOT COMPLETED|Overall Study||11
10447089|NCT00959049|11594078|FG004|NOT COMPLETED|Overall Study||9
10447090|NCT00959049|11594079|FG005|NOT COMPLETED|Overall Study||1
10447091|NCT00959166|11594106|FG000|STARTED|Overall Study||24
10447092|NCT00959166|11594107|FG001|STARTED|Overall Study||57
10447093|NCT00959166|11594106|FG000|COMPLETED|Overall Study||24
10447094|NCT00959166|11594107|FG001|COMPLETED|Overall Study||57
10447095|NCT00959166|11594106|FG000|NOT COMPLETED|Overall Study||0
10447096|NCT00959166|11594107|FG001|NOT COMPLETED|Overall Study||0
10447097|NCT00959192|11594117|FG000|STARTED|Overall Study||6
10447098|NCT00959192|11594118|FG001|STARTED|Overall Study||9
10447099|NCT00959192|11594119|FG002|STARTED|Overall Study||9
10447100|NCT00959192|11594120|FG003|STARTED|Overall Study||8
10447101|NCT00959192|11594117|FG000|COMPLETED|Overall Study||4
10447102|NCT00959192|11594118|FG001|COMPLETED|Overall Study||8
10447103|NCT00959192|11594119|FG002|COMPLETED|Overall Study||6
10447104|NCT00959192|11594120|FG003|COMPLETED|Overall Study||7
10447105|NCT00959192|11594117|FG000|NOT COMPLETED|Overall Study||2
10447106|NCT00959192|11594118|FG001|NOT COMPLETED|Overall Study||1
10447107|NCT00959192|11594119|FG002|NOT COMPLETED|Overall Study||3
10447108|NCT00959192|11594120|FG003|NOT COMPLETED|Overall Study||1
10447109|NCT00959374|11594131|FG000|STARTED|Overall Study|Of the 241 enrolled subjects, 229 were randomized and treated|241
10447110|NCT00959374|11594131|FG000|COMPLETED|Overall Study||218
10447111|NCT00959374|11594131|FG000|NOT COMPLETED|Overall Study||23
10447112|NCT00959647|11594139|FG000|STARTED|Overall Study||19
10447113|NCT00959647|11594139|FG000|COMPLETED|Overall Study||0
10447114|NCT00959647|11594139|FG000|NOT COMPLETED|Overall Study||19
10447115|NCT00959660|11594147|FG000|STARTED|Overall Study||26
10447116|NCT00959660|11594148|FG001|STARTED|Overall Study||24
10447117|NCT00959660|11594149|FG002|STARTED|Overall Study||25
10447118|NCT00959660|11594150|FG003|STARTED|Overall Study||25
10447119|NCT00959660|11594147|FG000|COMPLETED|Overall Study||24
10447120|NCT00959660|11594148|FG001|COMPLETED|Overall Study||24
10447121|NCT00959660|11594149|FG002|COMPLETED|Overall Study||22
10447122|NCT00959660|11594150|FG003|COMPLETED|Overall Study||22
10447123|NCT00959660|11594147|FG000|NOT COMPLETED|Overall Study||2
10447124|NCT00959660|11594148|FG001|NOT COMPLETED|Overall Study||0
10447125|NCT00959660|11594149|FG002|NOT COMPLETED|Overall Study||3
10447126|NCT00959660|11594150|FG003|NOT COMPLETED|Overall Study||3
10447127|NCT00959699|11594162|FG000|STARTED|Treatment Period||34
10447128|NCT00959699|11594163|FG001|STARTED|Treatment Period||65
10447129|NCT00959699|11594162|FG000|Treated|Treatment Period||34
10447130|NCT00959699|11594163|FG001|Treated|Treatment Period||64
10447131|NCT00959699|11594162|FG000|COMPLETED|Treatment Period|At TW24, 4 participants not achieving undetectable HCV-RNA crossed-over and received boceprevir.|11
10447132|NCT00959699|11594163|FG001|COMPLETED|Treatment Period||40
10447133|NCT00959699|11594162|FG000|NOT COMPLETED|Treatment Period||23
10447134|NCT00959699|11594163|FG001|NOT COMPLETED|Treatment Period||25
10447135|NCT00959699|11594162|FG000|STARTED|Follow-up Period|1 participant didn't enter Follow-up; participants discontinuing treatment could enter Follow-up.|33
10447136|NCT00959699|11594163|FG001|STARTED|Follow-up Period|2 participants didn't enter Follow-up; participants discontinuing treatment could enter Follow-up.|62
10447137|NCT00959699|11594162|FG000|COMPLETED|Follow-up Period||27
10447138|NCT00959699|11594163|FG001|COMPLETED|Follow-up Period||56
10447139|NCT00959699|11594162|FG000|NOT COMPLETED|Follow-up Period||6
10447140|NCT00959699|11594163|FG001|NOT COMPLETED|Follow-up Period||6
10447141|NCT00959751|11594172|FG000|STARTED|Overall Study||97
10447142|NCT00959751|11594173|FG001|STARTED|Overall Study||98
10447143|NCT00959751|11594172|FG000|COMPLETED|Overall Study||88
10447144|NCT00959751|11594173|FG001|COMPLETED|Overall Study||86
10447145|NCT00959751|11594172|FG000|NOT COMPLETED|Overall Study||9
10447146|NCT00959751|11594173|FG001|NOT COMPLETED|Overall Study||12
10447147|NCT00959764|11594182|FG000|STARTED|Overall Study||271
10447148|NCT00959764|11594183|FG001|STARTED|Overall Study||185
10447149|NCT00959764|11594184|FG002|STARTED|Overall Study||109
10447150|NCT00959764|11594182|FG000|COMPLETED|Overall Study||176
10447151|NCT00959764|11594183|FG001|COMPLETED|Overall Study||128
10447152|NCT00959764|11594184|FG002|COMPLETED|Overall Study||73
10447153|NCT00959764|11594182|FG000|NOT COMPLETED|Overall Study||95
10447154|NCT00959764|11594183|FG001|NOT COMPLETED|Overall Study||57
10447155|NCT00959764|11594184|FG002|NOT COMPLETED|Overall Study||36
10447156|NCT00959842|11594195|FG000|STARTED|Overall Study|17 were recruited and at baseline. 2 dropped out before starting the study drug. 15 finished|15
10447157|NCT00959842|11594195|FG000|COMPLETED|Overall Study||15
10447158|NCT00959842|11594195|FG000|NOT COMPLETED|Overall Study||0
10447159|NCT00959894|11594199|FG000|STARTED|Overall Study|One (1) additional subject became ineligible on the day of entry and never started study medication.|79
10447160|NCT00959894|11594199|FG000|COMPLETED|Overall Study||63
10447161|NCT00959894|11594199|FG000|NOT COMPLETED|Overall Study||16
10447162|NCT00959907|11594206|FG000|STARTED|Overall Study||30
10447163|NCT00959907|11594207|FG001|STARTED|Overall Study||29
10447164|NCT00959907|11594206|FG000|COMPLETED|Overall Study||27
10447165|NCT00959907|11594207|FG001|COMPLETED|Overall Study||28
10447166|NCT00959907|11594206|FG000|NOT COMPLETED|Overall Study||3
10447167|NCT00959907|11594207|FG001|NOT COMPLETED|Overall Study||1
10447168|NCT00959920|11594215|FG000|STARTED|Overall Study||72
10447169|NCT00959920|11594216|FG001|STARTED|Overall Study||67
10447170|NCT00959920|11594215|FG000|COMPLETED|Overall Study||72
10447171|NCT00959920|11594216|FG001|COMPLETED|Overall Study||66
10447172|NCT00959920|11594215|FG000|NOT COMPLETED|Overall Study||0
10447173|NCT00959920|11594216|FG001|NOT COMPLETED|Overall Study||1
10447174|NCT00959946|11594232|FG000|STARTED|Overall Study||2
10447175|NCT00959946|11594233|FG001|STARTED|Overall Study||4
10447176|NCT00959946|11594234|FG002|STARTED|Overall Study||4
10447177|NCT00959946|11594235|FG003|STARTED|Overall Study||5
10447178|NCT00959946|11594236|FG004|STARTED|Overall Study||4
10447179|NCT00959946|11594237|FG005|STARTED|Overall Study||9
10447180|NCT00959946|11594238|FG006|STARTED|Overall Study||2
10447181|NCT00959946|11594239|FG007|STARTED|Overall Study||2
10447182|NCT00959946|11594232|FG000|COMPLETED|Overall Study||0
10447183|NCT00959946|11594233|FG001|COMPLETED|Overall Study||0
10447184|NCT00959946|11594234|FG002|COMPLETED|Overall Study||0
10447185|NCT00959946|11594235|FG003|COMPLETED|Overall Study||0
10447186|NCT00959946|11594236|FG004|COMPLETED|Overall Study||0
10447187|NCT00959946|11594237|FG005|COMPLETED|Overall Study||0
10447188|NCT00959946|11594238|FG006|COMPLETED|Overall Study||0
10447189|NCT00959946|11594239|FG007|COMPLETED|Overall Study||0
10447190|NCT00959946|11594232|FG000|NOT COMPLETED|Overall Study||2
10447191|NCT00959946|11594233|FG001|NOT COMPLETED|Overall Study||4
10447192|NCT00959946|11594234|FG002|NOT COMPLETED|Overall Study||4
10447193|NCT00959946|11594235|FG003|NOT COMPLETED|Overall Study||5
10447194|NCT00959946|11594236|FG004|NOT COMPLETED|Overall Study||4
10447195|NCT00959946|11594237|FG005|NOT COMPLETED|Overall Study||9
10447196|NCT00959946|11594238|FG006|NOT COMPLETED|Overall Study||2
10447197|NCT00959946|11594239|FG007|NOT COMPLETED|Overall Study||2
10447198|NCT00959985|11594266|FG000|STARTED|Overall Study||8
10447199|NCT00959985|11594267|FG001|STARTED|Overall Study||7
10447200|NCT00959985|11594268|FG002|STARTED|Overall Study||4
10447201|NCT00959985|11594269|FG003|STARTED|Overall Study||4
10447202|NCT00959985|11594266|FG000|COMPLETED|Overall Study||8
10447203|NCT00959985|11594267|FG001|COMPLETED|Overall Study||7
10447204|NCT00959985|11594268|FG002|COMPLETED|Overall Study||4
10447205|NCT00959985|11594269|FG003|COMPLETED|Overall Study||4
10447206|NCT00959985|11594266|FG000|NOT COMPLETED|Overall Study||0
10447207|NCT00959985|11594267|FG001|NOT COMPLETED|Overall Study||0
10447208|NCT00959985|11594268|FG002|NOT COMPLETED|Overall Study||0
10447209|NCT00959985|11594269|FG003|NOT COMPLETED|Overall Study||0
10447210|NCT00960011|11594281|FG000|STARTED|Overall Study||33
10447211|NCT00960011|11594282|FG001|STARTED|Overall Study||25
10447212|NCT00960011|11594281|FG000|COMPLETED|Overall Study||22
10447213|NCT00960011|11594282|FG001|COMPLETED|Overall Study||23
10551010|NCT01535118|11705200|FG000|STARTED|Overall Study||2765
10551011|NCT01535118|11705200|FG000|COMPLETED|Overall Study||2765
10551012|NCT01535118|11705200|FG000|NOT COMPLETED|Overall Study||0
10551013|NCT01535222|11705210|FG000|STARTED|Overall Study||3
10551014|NCT01535222|11705211|FG001|STARTED|Overall Study||3
10551015|NCT01535222|11705212|FG002|STARTED|Overall Study|Patient randomized but did not meet inclusion/exclusion criteria and did not receive study drug|7
10551016|NCT01535222|11705213|FG003|STARTED|Overall Study||6
10551017|NCT01535222|11705214|FG004|STARTED|Overall Study||6
10551018|NCT01535222|11705215|FG005|STARTED|Overall Study||8
10551019|NCT01535222|11705210|FG000|COMPLETED|Overall Study||3
10551020|NCT01535222|11705211|FG001|COMPLETED|Overall Study||3
10551021|NCT01535222|11705212|FG002|COMPLETED|Overall Study||6
10551022|NCT01535222|11705213|FG003|COMPLETED|Overall Study||6
10447214|NCT00960011|11594281|FG000|NOT COMPLETED|Overall Study||11
10447215|NCT00960011|11594282|FG001|NOT COMPLETED|Overall Study||2
10447216|NCT00960063|11594325|FG000|STARTED|Overall Study||1
10447217|NCT00960063|11594326|FG001|STARTED|Overall Study||0
10447218|NCT00960063|11594327|FG002|STARTED|Overall Study||3
10447219|NCT00960063|11594325|FG000|COMPLETED|Overall Study||0
10447220|NCT00960063|11594326|FG001|COMPLETED|Overall Study||0
10447221|NCT00960063|11594327|FG002|COMPLETED|Overall Study||0
10447222|NCT00960063|11594325|FG000|NOT COMPLETED|Overall Study||1
10447223|NCT00960063|11594326|FG001|NOT COMPLETED|Overall Study||0
10447224|NCT00960063|11594327|FG002|NOT COMPLETED|Overall Study||3
10447225|NCT00960076|11594337|FG000|STARTED|Overall Study|Randomized and treated|138
10447226|NCT00960076|11594338|FG001|STARTED|Overall Study|Randomized and treated|144
10447227|NCT00960076|11594337|FG000|COMPLETED|Overall Study|Completing 18 weeks of treatment|130
10447228|NCT00960076|11594338|FG001|COMPLETED|Overall Study|Completing 18 weeks of treatment|119
10447229|NCT00960076|11594337|FG000|NOT COMPLETED|Overall Study||8
10447230|NCT00960076|11594338|FG001|NOT COMPLETED|Overall Study||25
10447231|NCT00960115|11594346|FG000|STARTED|Overall Study||114
10447232|NCT00960115|11594347|FG001|STARTED|Overall Study||58
10447233|NCT00960115|11594346|FG000|COMPLETED|Overall Study||95
10447234|NCT00960115|11594347|FG001|COMPLETED|Overall Study||43
10447235|NCT00960115|11594346|FG000|NOT COMPLETED|Overall Study||19
10447236|NCT00960115|11594347|FG001|NOT COMPLETED|Overall Study||15
10447237|NCT00960193|11594353|FG000|STARTED|Colchicine Alone||24
10447238|NCT00960193|11594353|FG000|COMPLETED|Colchicine Alone||24
10447239|NCT00960193|11594353|FG000|NOT COMPLETED|Colchicine Alone||0
10447240|NCT00960193|11594353|FG000|STARTED|14 Day Washout Period||24
10447241|NCT00960193|11594353|FG000|COMPLETED|14 Day Washout Period||23
10447242|NCT00960193|11594353|FG000|NOT COMPLETED|14 Day Washout Period||1
10447243|NCT00960193|11594353|FG000|STARTED|Seville Orange Juice Alone||23
10447244|NCT00960193|11594353|FG000|COMPLETED|Seville Orange Juice Alone||23
10447245|NCT00960193|11594353|FG000|NOT COMPLETED|Seville Orange Juice Alone||0
10447246|NCT00960193|11594353|FG000|STARTED|Colchicine With Seville Orange Juice||23
10447247|NCT00960193|11594353|FG000|COMPLETED|Colchicine With Seville Orange Juice||23
10447248|NCT00960193|11594353|FG000|NOT COMPLETED|Colchicine With Seville Orange Juice||0
10447249|NCT00960206|11594363|FG000|STARTED|Overall Study||190
10447250|NCT00960206|11594364|FG001|STARTED|Overall Study||185
10447251|NCT00960206|11594365|FG002|STARTED|Overall Study||89
10447252|NCT00960206|11594363|FG000|COMPLETED|Overall Study||150
10447253|NCT00960206|11594364|FG001|COMPLETED|Overall Study||158
10447254|NCT00960206|11594365|FG002|COMPLETED|Overall Study||77
10447255|NCT00960206|11594363|FG000|NOT COMPLETED|Overall Study||40
10447256|NCT00960206|11594364|FG001|NOT COMPLETED|Overall Study||27
10447257|NCT00960206|11594365|FG002|NOT COMPLETED|Overall Study||12
10447258|NCT00960323|11594374|FG000|STARTED|Colchicine Alone||24
10447259|NCT00960323|11594374|FG000|COMPLETED|Colchicine Alone||24
10447260|NCT00960323|11594374|FG000|NOT COMPLETED|Colchicine Alone||0
10447261|NCT00960323|11594374|FG000|STARTED|14 Day Washout Period||24
10447262|NCT00960323|11594374|FG000|COMPLETED|14 Day Washout Period||24
10447263|NCT00960323|11594374|FG000|NOT COMPLETED|14 Day Washout Period||0
10447264|NCT00960323|11594374|FG000|STARTED|Atorvastatin Alone||24
10447265|NCT00960323|11594374|FG000|COMPLETED|Atorvastatin Alone||23
10447266|NCT00960323|11594374|FG000|NOT COMPLETED|Atorvastatin Alone||1
10447267|NCT00960323|11594374|FG000|STARTED|Colchicine and Atorvastatin||23
10447268|NCT00960323|11594374|FG000|COMPLETED|Colchicine and Atorvastatin||23
10447269|NCT00960323|11594374|FG000|NOT COMPLETED|Colchicine and Atorvastatin||0
10447270|NCT00960375|11594384|FG000|STARTED|Overall Study||92
10447271|NCT00960375|11594385|FG001|STARTED|Overall Study||87
10447272|NCT00960375|11594384|FG000|COMPLETED|Overall Study||72
10447273|NCT00960375|11594385|FG001|COMPLETED|Overall Study||65
10447274|NCT00960375|11594384|FG000|NOT COMPLETED|Overall Study||20
10447275|NCT00960375|11594385|FG001|NOT COMPLETED|Overall Study||22
10447276|NCT00960440|11594395|FG000|STARTED|Overall Study||133
10447277|NCT00960440|11594396|FG001|STARTED|Overall Study||134
10447278|NCT00960440|11594397|FG002|STARTED|Overall Study||66
10447279|NCT00960440|11594398|FG003|STARTED|Overall Study||66
10447280|NCT00960440|11594395|FG000|COMPLETED|Overall Study||107
10447281|NCT00960440|11594396|FG001|COMPLETED|Overall Study||103
10447282|NCT00960440|11594397|FG002|COMPLETED|Overall Study||53
10447283|NCT00960440|11594398|FG003|COMPLETED|Overall Study||48
10447284|NCT00960440|11594395|FG000|NOT COMPLETED|Overall Study||26
10447285|NCT00960440|11594396|FG001|NOT COMPLETED|Overall Study||31
10447286|NCT00960440|11594397|FG002|NOT COMPLETED|Overall Study||13
10447287|NCT00960440|11594398|FG003|NOT COMPLETED|Overall Study||18
10447288|NCT00960505|11594413|FG000|STARTED|Overall Study||34
10447289|NCT00960505|11594414|FG001|STARTED|Overall Study||35
10447290|NCT00960505|11594415|FG002|STARTED|Overall Study||31
10447291|NCT00960505|11594413|FG000|COMPLETED|Overall Study||21
10447292|NCT00960505|11594414|FG001|COMPLETED|Overall Study||25
10447293|NCT00960505|11594415|FG002|COMPLETED|Overall Study||23
10447294|NCT00960505|11594413|FG000|NOT COMPLETED|Overall Study||13
10447295|NCT00960505|11594414|FG001|NOT COMPLETED|Overall Study||10
10447296|NCT00960505|11594415|FG002|NOT COMPLETED|Overall Study||8
10447297|NCT00960531|11594433|FG000|STARTED|Overall Study|Started=Randomized|21
10447298|NCT00960531|11594434|FG001|STARTED|Overall Study|Started=Randomized|6
10447299|NCT00960531|11594435|FG002|STARTED|Overall Study|Started=Randomized|41
10447300|NCT00960531|11594436|FG003|STARTED|Overall Study|Started=Randomized.|25
10447301|NCT00960531|11594437|FG004|STARTED|Overall Study|Started=Randomized|5
10551023|NCT01535222|11705214|FG004|COMPLETED|Overall Study||6
10551024|NCT01535222|11705215|FG005|COMPLETED|Overall Study||8
10551025|NCT01535222|11705210|FG000|NOT COMPLETED|Overall Study||0
10447302|NCT00960531|11594438|FG005|STARTED|Overall Study|Started=Randomized|9
10447303|NCT00960531|11594439|FG006|STARTED|Overall Study|Started=Randomized|27
10447304|NCT00960531|11594440|FG007|STARTED|Overall Study|Started=Randomized|6
10551026|NCT01535222|11705211|FG001|NOT COMPLETED|Overall Study||0
10551027|NCT01535222|11705212|FG002|NOT COMPLETED|Overall Study||1
10551028|NCT01535222|11705213|FG003|NOT COMPLETED|Overall Study||0
10551029|NCT01535222|11705214|FG004|NOT COMPLETED|Overall Study||0
10447305|NCT00960531|11594441|FG008|STARTED|Overall Study|Started=Randomized|16
10447306|NCT00960531|11594442|FG009|STARTED|Overall Study|Started=Randomized|4
10447307|NCT00960531|11594433|FG000|Treated|Overall Study||21
10447308|NCT00960531|11594434|FG001|Treated|Overall Study||6
10447309|NCT00960531|11594435|FG002|Treated|Overall Study||41
10447310|NCT00960531|11594436|FG003|Treated|Overall Study||24
10447311|NCT00960531|11594437|FG004|Treated|Overall Study||5
10447312|NCT00960531|11594438|FG005|Treated|Overall Study||9
10447313|NCT00960531|11594439|FG006|Treated|Overall Study||27
10447314|NCT00960531|11594440|FG007|Treated|Overall Study||6
10447315|NCT00960531|11594441|FG008|Treated|Overall Study||16
10447316|NCT00960531|11594442|FG009|Treated|Overall Study||4
10447317|NCT00960531|11594433|FG000|Completed Treatment|Overall Study||12
10447318|NCT00960531|11594434|FG001|Completed Treatment|Overall Study||5
10447319|NCT00960531|11594435|FG002|Completed Treatment|Overall Study||15
10447320|NCT00960531|11594436|FG003|Completed Treatment|Overall Study||17
10447321|NCT00960531|11594437|FG004|Completed Treatment|Overall Study||3
10447322|NCT00960531|11594438|FG005|Completed Treatment|Overall Study||7
10447323|NCT00960531|11594439|FG006|Completed Treatment|Overall Study||4
10447324|NCT00960531|11594440|FG007|Completed Treatment|Overall Study||3
10447325|NCT00960531|11594441|FG008|Completed Treatment|Overall Study||2
10447326|NCT00960531|11594442|FG009|Completed Treatment|Overall Study||4
10447327|NCT00960531|11594433|FG000|COMPLETED|Overall Study|Completed study|11
10447328|NCT00960531|11594434|FG001|COMPLETED|Overall Study|Completed study|5
10447329|NCT00960531|11594435|FG002|COMPLETED|Overall Study|Completed study|15
10447330|NCT00960531|11594436|FG003|COMPLETED|Overall Study|Completed study|17
10447331|NCT00960531|11594437|FG004|COMPLETED|Overall Study|Completed study|3
10447332|NCT00960531|11594438|FG005|COMPLETED|Overall Study|Completed study|6
10447333|NCT00960531|11594439|FG006|COMPLETED|Overall Study|Completed study|3
10447334|NCT00960531|11594440|FG007|COMPLETED|Overall Study|Completed study|2
10447335|NCT00960531|11594441|FG008|COMPLETED|Overall Study|Completed study|2
10447336|NCT00960531|11594442|FG009|COMPLETED|Overall Study|Completed study|3
10447337|NCT00960531|11594433|FG000|NOT COMPLETED|Overall Study||10
10447338|NCT00960531|11594434|FG001|NOT COMPLETED|Overall Study||1
10447339|NCT00960531|11594435|FG002|NOT COMPLETED|Overall Study||26
10447340|NCT00960531|11594436|FG003|NOT COMPLETED|Overall Study||8
10447341|NCT00960531|11594437|FG004|NOT COMPLETED|Overall Study||2
10447342|NCT00960531|11594438|FG005|NOT COMPLETED|Overall Study||3
10447343|NCT00960531|11594439|FG006|NOT COMPLETED|Overall Study||24
10447344|NCT00960531|11594440|FG007|NOT COMPLETED|Overall Study||4
10447345|NCT00960531|11594441|FG008|NOT COMPLETED|Overall Study||14
10447346|NCT00960531|11594442|FG009|NOT COMPLETED|Overall Study||1
10447347|NCT00960570|11594468|FG000|STARTED|Efavirenz Alone||30
10447348|NCT00960570|11594468|FG000|COMPLETED|Efavirenz Alone||30
10447349|NCT00960570|11594468|FG000|NOT COMPLETED|Efavirenz Alone||0
10447350|NCT00960570|11594468|FG000|STARTED|21 Day Washout Period||30
10447351|NCT00960570|11594468|FG000|COMPLETED|21 Day Washout Period||28
10447352|NCT00960570|11594468|FG000|NOT COMPLETED|21 Day Washout Period||2
10447353|NCT00960570|11594468|FG000|STARTED|Fenofibric Acid Alone||28
10447354|NCT00960570|11594468|FG000|COMPLETED|Fenofibric Acid Alone||28
10447355|NCT00960570|11594468|FG000|NOT COMPLETED|Fenofibric Acid Alone||0
10447356|NCT00960570|11594468|FG000|STARTED|1 Day Period Between Dosing||28
10447357|NCT00960570|11594468|FG000|COMPLETED|1 Day Period Between Dosing||25
10447358|NCT00960570|11594468|FG000|NOT COMPLETED|1 Day Period Between Dosing||3
10447359|NCT00960570|11594468|FG000|STARTED|Efavirenz and Fenofibric Acid||25
10447360|NCT00960570|11594468|FG000|COMPLETED|Efavirenz and Fenofibric Acid||25
10447361|NCT00960570|11594468|FG000|NOT COMPLETED|Efavirenz and Fenofibric Acid||0
10447362|NCT00960622|11594477|FG000|STARTED|Overall Study||10
10447363|NCT00960622|11594478|FG001|STARTED|Overall Study||10
10551030|NCT01535222|11705215|FG005|NOT COMPLETED|Overall Study||0
10551031|NCT01535235|11705231|FG000|STARTED|Overall Study||16
10551032|NCT01535235|11705232|FG001|STARTED|Overall Study||15
10551033|NCT01535235|11705231|FG000|COMPLETED|Overall Study||15
10447364|NCT00960622|11594477|FG000|COMPLETED|Overall Study||10
10447365|NCT00960622|11594478|FG001|COMPLETED|Overall Study||7
10447366|NCT00960622|11594477|FG000|NOT COMPLETED|Overall Study||0
10447367|NCT00960622|11594478|FG001|NOT COMPLETED|Overall Study||3
10447368|NCT00960661|11594486|FG000|STARTED|Basal Insulin Optimization Phase (BIO)||1036
10447369|NCT00960661|11594487|FG001|STARTED|Basal Insulin Optimization Phase (BIO)||0
10447370|NCT00960661|11594488|FG002|STARTED|Basal Insulin Optimization Phase (BIO)||0
10447371|NCT00960661|11594486|FG000|COMPLETED|Basal Insulin Optimization Phase (BIO)||637
10447372|NCT00960661|11594487|FG001|COMPLETED|Basal Insulin Optimization Phase (BIO)||0
10447373|NCT00960661|11594488|FG002|COMPLETED|Basal Insulin Optimization Phase (BIO)||0
10447374|NCT00960661|11594486|FG000|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||399
10447375|NCT00960661|11594487|FG001|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||0
10447376|NCT00960661|11594488|FG002|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||0
10447377|NCT00960661|11594486|FG000|STARTED|Interventional Phase||0
10447378|NCT00960661|11594487|FG001|STARTED|Interventional Phase||316
10447379|NCT00960661|11594488|FG002|STARTED|Interventional Phase||321
10447380|NCT00960661|11594486|FG000|Intent to Treat Population|Interventional Phase||0
10447381|NCT00960661|11594487|FG001|Intent to Treat Population|Interventional Phase|all randomized participants who took at least one dose of study drug|315
10447382|NCT00960661|11594488|FG002|Intent to Treat Population|Interventional Phase|all randomized participants who took at least one dose of study drug|312
10447383|NCT00960661|11594486|FG000|Per Protocol Population|Interventional Phase||0
10447384|NCT00960661|11594487|FG001|Per Protocol Population|Interventional Phase|all randomized participants who completed study and had no violations|247
10447385|NCT00960661|11594488|FG002|Per Protocol Population|Interventional Phase|all randomized participants who completed study and had no violations|263
10447386|NCT00960661|11594486|FG000|COMPLETED|Interventional Phase||0
10447387|NCT00960661|11594487|FG001|COMPLETED|Interventional Phase||264
10447388|NCT00960661|11594488|FG002|COMPLETED|Interventional Phase||275
10447389|NCT00960661|11594486|FG000|NOT COMPLETED|Interventional Phase||0
10447390|NCT00960661|11594487|FG001|NOT COMPLETED|Interventional Phase||52
10447391|NCT00960661|11594488|FG002|NOT COMPLETED|Interventional Phase||46
10447392|NCT00960687|11594494|FG000|STARTED|First Intervention||27
10447393|NCT00960687|11594495|FG001|STARTED|First Intervention||27
10447394|NCT00960687|11594494|FG000|COMPLETED|First Intervention||27
10447395|NCT00960687|11594495|FG001|COMPLETED|First Intervention||27
10447396|NCT00960687|11594494|FG000|NOT COMPLETED|First Intervention||0
10447397|NCT00960687|11594495|FG001|NOT COMPLETED|First Intervention||0
10447398|NCT00960687|11594494|FG000|STARTED|Washout Period of 7 Days||27
10447399|NCT00960687|11594495|FG001|STARTED|Washout Period of 7 Days||27
10447400|NCT00960687|11594494|FG000|COMPLETED|Washout Period of 7 Days|three subjects withdrew due to adverse events and one subject withdrew for personal reasons.|23
10447401|NCT00960687|11594495|FG001|COMPLETED|Washout Period of 7 Days|two subjects withdrew due to adverse events and one subject withdrew for personal reasons.|24
10447402|NCT00960687|11594494|FG000|NOT COMPLETED|Washout Period of 7 Days||4
10447403|NCT00960687|11594495|FG001|NOT COMPLETED|Washout Period of 7 Days||3
10447404|NCT00960687|11594494|FG000|STARTED|Second Intervention||23
10447405|NCT00960687|11594495|FG001|STARTED|Second Intervention||24
10447406|NCT00960687|11594494|FG000|COMPLETED|Second Intervention||23
10447407|NCT00960687|11594495|FG001|COMPLETED|Second Intervention||24
10447408|NCT00960687|11594494|FG000|NOT COMPLETED|Second Intervention||0
10447409|NCT00960687|11594495|FG001|NOT COMPLETED|Second Intervention||0
10447410|NCT00960778|11594503|FG000|STARTED|Overall Study||17
10447411|NCT00960778|11594504|FG001|STARTED|Overall Study||16
10447412|NCT00960778|11594503|FG000|COMPLETED|Overall Study||8
10447413|NCT00960778|11594504|FG001|COMPLETED|Overall Study||13
10447414|NCT00960778|11594503|FG000|NOT COMPLETED|Overall Study||9
10447415|NCT00960778|11594504|FG001|NOT COMPLETED|Overall Study||3
10447416|NCT00960804|11594513|FG000|STARTED|Overall Study||7
10447417|NCT00960804|11594514|FG001|STARTED|Overall Study||4
10447418|NCT00960804|11594515|FG002|STARTED|Overall Study||10
10447419|NCT00960804|11594513|FG000|COMPLETED|Overall Study||0
10447420|NCT00960804|11594514|FG001|COMPLETED|Overall Study||0
10447421|NCT00960804|11594515|FG002|COMPLETED|Overall Study||0
10447422|NCT00960804|11594513|FG000|NOT COMPLETED|Overall Study||7
10447423|NCT00960804|11594514|FG001|NOT COMPLETED|Overall Study||4
10447424|NCT00960804|11594515|FG002|NOT COMPLETED|Overall Study||10
10447425|NCT00960843|11594525|FG000|STARTED|Overall Study||25
10447426|NCT00960843|11594526|FG001|STARTED|Overall Study||26
10447427|NCT00960843|11594525|FG000|COMPLETED|Overall Study||23
10447428|NCT00960843|11594526|FG001|COMPLETED|Overall Study||21
10447429|NCT00960843|11594525|FG000|NOT COMPLETED|Overall Study||2
10447430|NCT00960843|11594526|FG001|NOT COMPLETED|Overall Study||5
10447431|NCT00960856|11594532|FG000|STARTED|Period I||10
10447432|NCT00960856|11594533|FG001|STARTED|Period I||9
10447433|NCT00960856|11594534|FG002|STARTED|Period I||9
10447434|NCT00960856|11594535|FG003|STARTED|Period I||9
10447435|NCT00960856|11594532|FG000|COMPLETED|Period I||10
10447436|NCT00960856|11594533|FG001|COMPLETED|Period I||9
10447437|NCT00960856|11594534|FG002|COMPLETED|Period I||9
10447438|NCT00960856|11594535|FG003|COMPLETED|Period I||9
10447439|NCT00960856|11594532|FG000|NOT COMPLETED|Period I||0
10447440|NCT00960856|11594533|FG001|NOT COMPLETED|Period I||0
10447441|NCT00960856|11594534|FG002|NOT COMPLETED|Period I||0
10447442|NCT00960856|11594535|FG003|NOT COMPLETED|Period I||0
10447443|NCT00960856|11594532|FG000|STARTED|Washout Period of 7 Days||10
10447444|NCT00960856|11594533|FG001|STARTED|Washout Period of 7 Days||9
10447445|NCT00960856|11594534|FG002|STARTED|Washout Period of 7 Days||9
10447446|NCT00960856|11594535|FG003|STARTED|Washout Period of 7 Days||9
10447447|NCT00960856|11594532|FG000|COMPLETED|Washout Period of 7 Days||10
10447448|NCT00960856|11594533|FG001|COMPLETED|Washout Period of 7 Days|personal reasons|7
10447449|NCT00960856|11594534|FG002|COMPLETED|Washout Period of 7 Days||9
10447450|NCT00960856|11594535|FG003|COMPLETED|Washout Period of 7 Days||9
10447451|NCT00960856|11594532|FG000|NOT COMPLETED|Washout Period of 7 Days||0
10447452|NCT00960856|11594533|FG001|NOT COMPLETED|Washout Period of 7 Days||2
10447453|NCT00960856|11594534|FG002|NOT COMPLETED|Washout Period of 7 Days||0
10447454|NCT00960856|11594535|FG003|NOT COMPLETED|Washout Period of 7 Days||0
10447455|NCT00960856|11594532|FG000|STARTED|Period II||10
10447456|NCT00960856|11594533|FG001|STARTED|Period II||7
10447457|NCT00960856|11594534|FG002|STARTED|Period II||9
10447458|NCT00960856|11594535|FG003|STARTED|Period II||9
10447459|NCT00960856|11594532|FG000|COMPLETED|Period II||10
10447460|NCT00960856|11594533|FG001|COMPLETED|Period II||7
10447461|NCT00960856|11594534|FG002|COMPLETED|Period II||9
10447462|NCT00960856|11594535|FG003|COMPLETED|Period II||9
10447463|NCT00960856|11594532|FG000|NOT COMPLETED|Period II||0
10447464|NCT00960856|11594533|FG001|NOT COMPLETED|Period II||0
10447465|NCT00960856|11594534|FG002|NOT COMPLETED|Period II||0
10447466|NCT00960856|11594535|FG003|NOT COMPLETED|Period II||0
10447467|NCT00960856|11594532|FG000|STARTED|Washout Period of 7 Days||10
10447468|NCT00960856|11594533|FG001|STARTED|Washout Period of 7 Days||7
10447469|NCT00960856|11594534|FG002|STARTED|Washout Period of 7 Days||9
10447470|NCT00960856|11594535|FG003|STARTED|Washout Period of 7 Days||9
10447471|NCT00960856|11594532|FG000|COMPLETED|Washout Period of 7 Days||10
10447472|NCT00960856|11594533|FG001|COMPLETED|Washout Period of 7 Days||7
10447473|NCT00960856|11594534|FG002|COMPLETED|Washout Period of 7 Days||9
10447474|NCT00960856|11594535|FG003|COMPLETED|Washout Period of 7 Days||9
10447475|NCT00960856|11594532|FG000|NOT COMPLETED|Washout Period of 7 Days||0
10447476|NCT00960856|11594533|FG001|NOT COMPLETED|Washout Period of 7 Days||0
10447477|NCT00960856|11594534|FG002|NOT COMPLETED|Washout Period of 7 Days||0
10447478|NCT00960856|11594535|FG003|NOT COMPLETED|Washout Period of 7 Days||0
10447479|NCT00960856|11594532|FG000|STARTED|Period III||10
10447480|NCT00960856|11594533|FG001|STARTED|Period III||7
10447481|NCT00960856|11594534|FG002|STARTED|Period III||9
10447482|NCT00960856|11594535|FG003|STARTED|Period III||9
10447483|NCT00960856|11594532|FG000|COMPLETED|Period III||10
10447484|NCT00960856|11594533|FG001|COMPLETED|Period III||7
10447485|NCT00960856|11594534|FG002|COMPLETED|Period III||9
10447486|NCT00960856|11594535|FG003|COMPLETED|Period III||9
10447487|NCT00960856|11594532|FG000|NOT COMPLETED|Period III||0
10447488|NCT00960856|11594533|FG001|NOT COMPLETED|Period III||0
10447489|NCT00960856|11594534|FG002|NOT COMPLETED|Period III||0
10447490|NCT00960856|11594535|FG003|NOT COMPLETED|Period III||0
10447491|NCT00960856|11594532|FG000|STARTED|Washout Period of 7 Days||10
10447492|NCT00960856|11594533|FG001|STARTED|Washout Period of 7 Days||7
10447493|NCT00960856|11594534|FG002|STARTED|Washout Period of 7 Days||9
10447494|NCT00960856|11594535|FG003|STARTED|Washout Period of 7 Days||9
10447495|NCT00960856|11594532|FG000|COMPLETED|Washout Period of 7 Days||10
10447496|NCT00960856|11594533|FG001|COMPLETED|Washout Period of 7 Days||7
10447497|NCT00960856|11594534|FG002|COMPLETED|Washout Period of 7 Days||8
10447498|NCT00960856|11594535|FG003|COMPLETED|Washout Period of 7 Days||9
10447499|NCT00960856|11594532|FG000|NOT COMPLETED|Washout Period of 7 Days||0
10447500|NCT00960856|11594533|FG001|NOT COMPLETED|Washout Period of 7 Days||0
10447501|NCT00960856|11594534|FG002|NOT COMPLETED|Washout Period of 7 Days||1
10447502|NCT00960856|11594535|FG003|NOT COMPLETED|Washout Period of 7 Days||0
10447503|NCT00960856|11594532|FG000|STARTED|Period IV||10
10447504|NCT00960856|11594533|FG001|STARTED|Period IV||7
10447505|NCT00960856|11594534|FG002|STARTED|Period IV||8
10447506|NCT00960856|11594535|FG003|STARTED|Period IV||9
10447507|NCT00960856|11594532|FG000|COMPLETED|Period IV||10
10447508|NCT00960856|11594533|FG001|COMPLETED|Period IV||7
10447509|NCT00960856|11594534|FG002|COMPLETED|Period IV||8
10447510|NCT00960856|11594535|FG003|COMPLETED|Period IV||9
10447511|NCT00960856|11594532|FG000|NOT COMPLETED|Period IV||0
10447512|NCT00960856|11594533|FG001|NOT COMPLETED|Period IV||0
10447513|NCT00960856|11594534|FG002|NOT COMPLETED|Period IV||0
10447514|NCT00960856|11594535|FG003|NOT COMPLETED|Period IV||0
10447515|NCT00960869|11594547|FG000|STARTED|Overall Study||259
10447516|NCT00960869|11594548|FG001|STARTED|Overall Study||260
10447517|NCT00960869|11594547|FG000|Intent-to-Treat Population (ITT)|Overall Study||259
10447518|NCT00960869|11594548|FG001|Intent-to-Treat Population (ITT)|Overall Study||260
10447519|NCT00960869|11594547|FG000|Safety Popluation|Overall Study|3 rand to PA32540 took EC-ASA 325mg/3 rand to EC-ASA 325mg took PA32540 counted by actual treatment.|257
10447520|NCT00960869|11594548|FG001|Safety Popluation|Overall Study|3 rand to PA32540 took EC-ASA 325mg/3 rand to EC-ASA 325mg took PA32540 counted by actual treatment.|259
10447521|NCT00960869|11594547|FG000|COMPLETED|Overall Study||206
10447522|NCT00960869|11594548|FG001|COMPLETED|Overall Study||198
10447523|NCT00960869|11594547|FG000|NOT COMPLETED|Overall Study||53
10447524|NCT00960869|11594548|FG001|NOT COMPLETED|Overall Study||62
10447525|NCT00960934|11594560|FG000|STARTED|Overall Study||64
10447526|NCT00960934|11594561|FG001|STARTED|Overall Study||63
10447527|NCT00960934|11594562|FG002|STARTED|Overall Study||64
10447528|NCT00960934|11594563|FG003|STARTED|Overall Study||64
10447529|NCT00960934|11594564|FG004|STARTED|Overall Study||64
10447530|NCT00960934|11594565|FG005|STARTED|Overall Study||64
10447531|NCT00960934|11594560|FG000|Number Treated|Overall Study||64
10447532|NCT00960934|11594561|FG001|Number Treated|Overall Study|1 participant was randomized but not treated|62
10447533|NCT00960934|11594562|FG002|Number Treated|Overall Study||64
10447534|NCT00960934|11594563|FG003|Number Treated|Overall Study||64
10447535|NCT00960934|11594564|FG004|Number Treated|Overall Study|1 participant was randomized but not treated|63
10447536|NCT00960934|11594565|FG005|Number Treated|Overall Study|1 participant was randomized but not treated|63
10447537|NCT00960934|11594560|FG000|COMPLETED|Overall Study||0
10447538|NCT00960934|11594561|FG001|COMPLETED|Overall Study||0
10447539|NCT00960934|11594562|FG002|COMPLETED|Overall Study||0
10447540|NCT00960934|11594563|FG003|COMPLETED|Overall Study||0
10447541|NCT00960934|11594564|FG004|COMPLETED|Overall Study||0
10447542|NCT00960934|11594565|FG005|COMPLETED|Overall Study||0
10447543|NCT00960934|11594560|FG000|NOT COMPLETED|Overall Study||64
10447544|NCT00960934|11594561|FG001|NOT COMPLETED|Overall Study||63
10447545|NCT00960934|11594562|FG002|NOT COMPLETED|Overall Study||64
10447546|NCT00960934|11594563|FG003|NOT COMPLETED|Overall Study||64
10447547|NCT00960934|11594564|FG004|NOT COMPLETED|Overall Study||64
10447548|NCT00960934|11594565|FG005|NOT COMPLETED|Overall Study||64
10447549|NCT00960986|11594583|FG000|STARTED|Period 1 (Screening and Washout)||59
10447550|NCT00960986|11594584|FG001|STARTED|Period 1 (Screening and Washout)||63
10318666|NCT00215683|11452894|FG001|NOT COMPLETED|Overall Study||26
10318667|NCT00215683|11452895|FG002|NOT COMPLETED|Overall Study||32
10318668|NCT00215787|11452903|FG000|STARTED|Overall Study||20
10318669|NCT00215787|11452903|FG000|COMPLETED|Overall Study||20
10318670|NCT00215787|11452903|FG000|NOT COMPLETED|Overall Study||0
10318671|NCT00215930|11452907|FG000|STARTED|Overall Study||53
10318672|NCT00215930|11452907|FG000|COMPLETED|Overall Study||53
10318673|NCT00215930|11452907|FG000|NOT COMPLETED|Overall Study||0
10318674|NCT00215943|11452914|FG000|STARTED|Overall Study||36
10318675|NCT00215943|11452915|FG001|STARTED|Overall Study||37
10318676|NCT00215943|11452914|FG000|COMPLETED|Overall Study||27
10318677|NCT00215943|11452915|FG001|COMPLETED|Overall Study||23
10318678|NCT00215943|11452914|FG000|NOT COMPLETED|Overall Study||9
10318679|NCT00215943|11452915|FG001|NOT COMPLETED|Overall Study||14
10447551|NCT00960986|11594585|FG002|STARTED|Period 1 (Screening and Washout)||63
10447552|NCT00960986|11594586|FG003|STARTED|Period 1 (Screening and Washout)||64
10447553|NCT00960986|11594583|FG000|COMPLETED|Period 1 (Screening and Washout)||56
10447554|NCT00960986|11594584|FG001|COMPLETED|Period 1 (Screening and Washout)||59
10447555|NCT00960986|11594585|FG002|COMPLETED|Period 1 (Screening and Washout)||59
10447556|NCT00960986|11594586|FG003|COMPLETED|Period 1 (Screening and Washout)||61
10447557|NCT00960986|11594583|FG000|NOT COMPLETED|Period 1 (Screening and Washout)||3
10447558|NCT00960986|11594584|FG001|NOT COMPLETED|Period 1 (Screening and Washout)||4
10447559|NCT00960986|11594585|FG002|NOT COMPLETED|Period 1 (Screening and Washout)||4
10447560|NCT00960986|11594586|FG003|NOT COMPLETED|Period 1 (Screening and Washout)||3
10447561|NCT00960986|11594583|FG000|STARTED|Period 2 (1-week Initial Dosing Period)||56
10447562|NCT00960986|11594584|FG001|STARTED|Period 2 (1-week Initial Dosing Period)||59
10447563|NCT00960986|11594585|FG002|STARTED|Period 2 (1-week Initial Dosing Period)||59
10447564|NCT00960986|11594586|FG003|STARTED|Period 2 (1-week Initial Dosing Period)||61
10447565|NCT00960986|11594583|FG000|COMPLETED|Period 2 (1-week Initial Dosing Period)||56
10447566|NCT00960986|11594584|FG001|COMPLETED|Period 2 (1-week Initial Dosing Period)||59
10447567|NCT00960986|11594585|FG002|COMPLETED|Period 2 (1-week Initial Dosing Period)||59
10447568|NCT00960986|11594586|FG003|COMPLETED|Period 2 (1-week Initial Dosing Period)||61
10447569|NCT00960986|11594583|FG000|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
10447570|NCT00960986|11594584|FG001|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
10447571|NCT00960986|11594585|FG002|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
10447572|NCT00960986|11594586|FG003|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
10447573|NCT00960986|11594583|FG000|STARTED|Period 3 (7-week Therapy Period)||56
10447574|NCT00960986|11594584|FG001|STARTED|Period 3 (7-week Therapy Period)||59
10447575|NCT00960986|11594585|FG002|STARTED|Period 3 (7-week Therapy Period)||59
10447576|NCT00960986|11594586|FG003|STARTED|Period 3 (7-week Therapy Period)||61
10447577|NCT00960986|11594583|FG000|COMPLETED|Period 3 (7-week Therapy Period)||26
10447578|NCT00960986|11594584|FG001|COMPLETED|Period 3 (7-week Therapy Period)||36
10447579|NCT00960986|11594585|FG002|COMPLETED|Period 3 (7-week Therapy Period)||39
10447580|NCT00960986|11594586|FG003|COMPLETED|Period 3 (7-week Therapy Period)||36
10447581|NCT00960986|11594583|FG000|NOT COMPLETED|Period 3 (7-week Therapy Period)||30
10447582|NCT00960986|11594584|FG001|NOT COMPLETED|Period 3 (7-week Therapy Period)||23
10447583|NCT00960986|11594585|FG002|NOT COMPLETED|Period 3 (7-week Therapy Period)||20
10447584|NCT00960986|11594586|FG003|NOT COMPLETED|Period 3 (7-week Therapy Period)||25
10447585|NCT00960999|11594598|FG000|STARTED|Overall Study||47
10447586|NCT00960999|11594599|FG001|STARTED|Overall Study||47
10447587|NCT00960999|11594598|FG000|Eligible|Overall Study||39
10447588|NCT00960999|11594599|FG001|Eligible|Overall Study||45
10447589|NCT00960999|11594598|FG000|Started Protocol Treatment|Overall Study||39
10447590|NCT00960999|11594599|FG001|Started Protocol Treatment|Overall Study||45
10447591|NCT00960999|11594598|FG000|Primary Endpoint Population|Overall Study||38
10447592|NCT00960999|11594599|FG001|Primary Endpoint Population|Overall Study||38
10447593|NCT00960999|11594598|FG000|Peak SUV at 8 Weeks|Overall Study||3
10447594|NCT00960999|11594599|FG001|Peak SUV at 8 Weeks|Overall Study||11
10447595|NCT00960999|11594598|FG000|Peak SUV at 1 Year|Overall Study||4
10447596|NCT00960999|11594599|FG001|Peak SUV at 1 Year|Overall Study||7
10447597|NCT00960999|11594598|FG000|Normalized SUV at 8 Weeks|Overall Study||3
10447598|NCT00960999|11594599|FG001|Normalized SUV at 8 Weeks|Overall Study||9
10447599|NCT00960999|11594598|FG000|Normalized SUV at 1 Year|Overall Study||4
10447600|NCT00960999|11594599|FG001|Normalized SUV at 1 Year|Overall Study||7
10447601|NCT00960999|11594598|FG000|FEV1 by Best Response|Overall Study||26
10447602|NCT00960999|11594599|FG001|FEV1 by Best Response|Overall Study||33
10447603|NCT00960999|11594598|FG000|DLCO by Best Response|Overall Study||23
10447604|NCT00960999|11594599|FG001|DLCO by Best Response|Overall Study||28
10447605|NCT00960999|11594598|FG000|COMPLETED|Overall Study||39
10447606|NCT00960999|11594599|FG001|COMPLETED|Overall Study||45
10318680|NCT00216060|11452923|FG000|STARTED|Overall Study||32
10318681|NCT00216060|11452924|FG001|STARTED|Overall Study||31
10318682|NCT00216060|11452923|FG000|COMPLETED|Overall Study||32
10447607|NCT00960999|11594598|FG000|NOT COMPLETED|Overall Study||8
10447608|NCT00960999|11594599|FG001|NOT COMPLETED|Overall Study||2
10447609|NCT00961051|11594607|FG000|STARTED|Overall Study||177
10447610|NCT00961051|11594608|FG001|STARTED|Overall Study||93
10447611|NCT00961051|11594607|FG000|COMPLETED|Overall Study||165
10447612|NCT00961051|11594608|FG001|COMPLETED|Overall Study||79
10447613|NCT00961051|11594607|FG000|NOT COMPLETED|Overall Study||12
10447614|NCT00961051|11594608|FG001|NOT COMPLETED|Overall Study||14
10447615|NCT00961116|11594614|FG000|STARTED|First Intervention||27
10447616|NCT00961116|11594615|FG001|STARTED|First Intervention||27
10447617|NCT00961116|11594614|FG000|COMPLETED|First Intervention||27
10447618|NCT00961116|11594615|FG001|COMPLETED|First Intervention||27
10447619|NCT00961116|11594614|FG000|NOT COMPLETED|First Intervention||0
10447620|NCT00961116|11594615|FG001|NOT COMPLETED|First Intervention||0
10447621|NCT00961116|11594614|FG000|STARTED|Washout Period of 7 Days||27
10447622|NCT00961116|11594615|FG001|STARTED|Washout Period of 7 Days||27
10447623|NCT00961116|11594614|FG000|COMPLETED|Washout Period of 7 Days||25
10447624|NCT00961116|11594615|FG001|COMPLETED|Washout Period of 7 Days||24
10447625|NCT00961116|11594614|FG000|NOT COMPLETED|Washout Period of 7 Days||2
10447626|NCT00961116|11594615|FG001|NOT COMPLETED|Washout Period of 7 Days||3
10447627|NCT00961116|11594614|FG000|STARTED|Second Intervention||25
10447628|NCT00961116|11594615|FG001|STARTED|Second Intervention||24
10447629|NCT00961116|11594614|FG000|COMPLETED|Second Intervention||25
10447630|NCT00961116|11594615|FG001|COMPLETED|Second Intervention||24
10447631|NCT00961116|11594614|FG000|NOT COMPLETED|Second Intervention||0
10447632|NCT00961116|11594615|FG001|NOT COMPLETED|Second Intervention||0
10551034|NCT01535235|11705232|FG001|COMPLETED|Overall Study||15
10551035|NCT01535235|11705231|FG000|NOT COMPLETED|Overall Study||1
10551036|NCT01535235|11705232|FG001|NOT COMPLETED|Overall Study||0
10551037|NCT01535261|11705238|FG000|STARTED|Overall Study||357
10551038|NCT01535261|11705238|FG000|COMPLETED|Overall Study||307
10551039|NCT01535261|11705238|FG000|NOT COMPLETED|Overall Study||50
10551040|NCT01535287|11705244|FG000|STARTED|Overall Study||70
10551041|NCT01535287|11705245|FG001|STARTED|Overall Study||70
10551042|NCT01535287|11705244|FG000|COMPLETED|Overall Study||65
10551043|NCT01535287|11705245|FG001|COMPLETED|Overall Study||64
10551044|NCT01535287|11705244|FG000|NOT COMPLETED|Overall Study||5
10551045|NCT01535287|11705245|FG001|NOT COMPLETED|Overall Study||6
10551046|NCT01535326|11705254|FG000|STARTED|Overall Study||90
10551047|NCT01535326|11705255|FG001|STARTED|Overall Study||90
10551048|NCT01535326|11705256|FG002|STARTED|Overall Study||90
10551049|NCT01535326|11705254|FG000|COMPLETED|Overall Study||90
10447633|NCT00961181|11594622|FG000|STARTED|Overall Study||81
10447634|NCT00961181|11594622|FG000|COMPLETED|Overall Study||76
10447635|NCT00961181|11594622|FG000|NOT COMPLETED|Overall Study||5
10447636|NCT00961220|11594626|FG000|STARTED|Overall Study||17
10447637|NCT00961220|11594626|FG000|COMPLETED|Overall Study||10
10447638|NCT00961220|11594626|FG000|NOT COMPLETED|Overall Study||7
10447639|NCT00961233|11594634|FG000|STARTED|Overall Study||13
10447640|NCT00961233|11594635|FG001|STARTED|Overall Study||12
10447641|NCT00961233|11594634|FG000|COMPLETED|Overall Study||11
10447642|NCT00961233|11594635|FG001|COMPLETED|Overall Study||11
10447643|NCT00961233|11594634|FG000|NOT COMPLETED|Overall Study||2
10447644|NCT00961233|11594635|FG001|NOT COMPLETED|Overall Study||1
10447645|NCT00961259|11594643|FG000|STARTED|First Intervention||18
10447646|NCT00961259|11594644|FG001|STARTED|First Intervention||18
10447647|NCT00961259|11594645|FG002|STARTED|First Intervention||18
10447648|NCT00961259|11594643|FG000|COMPLETED|First Intervention||18
10447649|NCT00961259|11594644|FG001|COMPLETED|First Intervention||18
10447650|NCT00961259|11594645|FG002|COMPLETED|First Intervention||18
10447651|NCT00961259|11594643|FG000|NOT COMPLETED|First Intervention||0
10447652|NCT00961259|11594644|FG001|NOT COMPLETED|First Intervention||0
10447653|NCT00961259|11594645|FG002|NOT COMPLETED|First Intervention||0
10447654|NCT00961259|11594643|FG000|STARTED|Washout Period of 7 Days||18
10447655|NCT00961259|11594644|FG001|STARTED|Washout Period of 7 Days||18
10447656|NCT00961259|11594645|FG002|STARTED|Washout Period of 7 Days||18
10447657|NCT00961259|11594643|FG000|COMPLETED|Washout Period of 7 Days||18
10447658|NCT00961259|11594644|FG001|COMPLETED|Washout Period of 7 Days|dropped due to concomitant medication used prior to admission.|17
10447659|NCT00961259|11594645|FG002|COMPLETED|Washout Period of 7 Days||18
10447660|NCT00961259|11594643|FG000|NOT COMPLETED|Washout Period of 7 Days||0
10447661|NCT00961259|11594644|FG001|NOT COMPLETED|Washout Period of 7 Days||1
10551050|NCT01535326|11705255|FG001|COMPLETED|Overall Study||90
10447662|NCT00961259|11594645|FG002|NOT COMPLETED|Washout Period of 7 Days||0
10447663|NCT00961259|11594643|FG000|STARTED|Second Intervention||18
10447664|NCT00961259|11594644|FG001|STARTED|Second Intervention||17
10447665|NCT00961259|11594645|FG002|STARTED|Second Intervention||18
10447666|NCT00961259|11594643|FG000|COMPLETED|Second Intervention||18
10447667|NCT00961259|11594644|FG001|COMPLETED|Second Intervention||17
10447668|NCT00961259|11594645|FG002|COMPLETED|Second Intervention||18
10447669|NCT00961259|11594643|FG000|NOT COMPLETED|Second Intervention||0
10447670|NCT00961259|11594644|FG001|NOT COMPLETED|Second Intervention||0
10447671|NCT00961259|11594645|FG002|NOT COMPLETED|Second Intervention||0
10447672|NCT00961259|11594643|FG000|STARTED|Washout Period of 7 Days||18
10447673|NCT00961259|11594644|FG001|STARTED|Washout Period of 7 Days||17
10551051|NCT01535326|11705256|FG002|COMPLETED|Overall Study||90
10551052|NCT01535326|11705254|FG000|NOT COMPLETED|Overall Study||0
10551053|NCT01535326|11705255|FG001|NOT COMPLETED|Overall Study||0
10447674|NCT00961259|11594645|FG002|STARTED|Washout Period of 7 Days||18
10447675|NCT00961259|11594643|FG000|COMPLETED|Washout Period of 7 Days||18
10447676|NCT00961259|11594644|FG001|COMPLETED|Washout Period of 7 Days||17
10447677|NCT00961259|11594645|FG002|COMPLETED|Washout Period of 7 Days||18
10447678|NCT00961259|11594643|FG000|NOT COMPLETED|Washout Period of 7 Days||0
10447679|NCT00961259|11594644|FG001|NOT COMPLETED|Washout Period of 7 Days||0
10447680|NCT00961259|11594645|FG002|NOT COMPLETED|Washout Period of 7 Days||0
10447681|NCT00961259|11594643|FG000|STARTED|Third Intervention||18
10447682|NCT00961259|11594644|FG001|STARTED|Third Intervention||17
10447683|NCT00961259|11594645|FG002|STARTED|Third Intervention||18
10447684|NCT00961259|11594643|FG000|COMPLETED|Third Intervention||18
10447685|NCT00961259|11594644|FG001|COMPLETED|Third Intervention||17
10447686|NCT00961259|11594645|FG002|COMPLETED|Third Intervention||18
10447687|NCT00961259|11594643|FG000|NOT COMPLETED|Third Intervention||0
10447688|NCT00961259|11594644|FG001|NOT COMPLETED|Third Intervention||0
10447689|NCT00961259|11594645|FG002|NOT COMPLETED|Third Intervention||0
10447690|NCT00961298|11594654|FG000|STARTED|Two Week Placebo Run in||15
10447691|NCT00961298|11594654|FG000|COMPLETED|Two Week Placebo Run in||14
10447692|NCT00961298|11594654|FG000|NOT COMPLETED|Two Week Placebo Run in||1
10447693|NCT00961298|11594654|FG000|STARTED|12 Weeks Duloxetine Treatment Phase||14
10447694|NCT00961298|11594654|FG000|COMPLETED|12 Weeks Duloxetine Treatment Phase||11
10447695|NCT00961298|11594654|FG000|NOT COMPLETED|12 Weeks Duloxetine Treatment Phase||3
10447696|NCT00961311|11594658|FG000|STARTED|Overall Study||51
10447697|NCT00961311|11594658|FG000|COMPLETED|Overall Study||51
10447698|NCT00961311|11594658|FG000|NOT COMPLETED|Overall Study||0
10447699|NCT00961350|11594664|FG000|STARTED|Overall Study||265
10447700|NCT00961350|11594665|FG001|STARTED|Overall Study||265
10447701|NCT00961350|11594664|FG000|Intent-to-Treat Population (ITT)|Overall Study||265
10447702|NCT00961350|11594665|FG001|Intent-to-Treat Population (ITT)|Overall Study||265
10447703|NCT00961350|11594664|FG000|Safety Population|Overall Study|1. One sub rand to PA32540 took EC-Aspirin|264
10447704|NCT00961350|11594665|FG001|Safety Population|Overall Study||265
10447705|NCT00961350|11594664|FG000|COMPLETED|Overall Study||218
10447706|NCT00961350|11594665|FG001|COMPLETED|Overall Study||198
10447707|NCT00961350|11594664|FG000|NOT COMPLETED|Overall Study||47
10447708|NCT00961350|11594665|FG001|NOT COMPLETED|Overall Study||67
10447709|NCT00961402|11594673|FG000|STARTED|Overall Study||64
10447710|NCT00961402|11594674|FG001|STARTED|Overall Study||66
10447711|NCT00961402|11594673|FG000|Randomized|Overall Study||64
10447712|NCT00961402|11594674|FG001|Randomized|Overall Study||66
10447713|NCT00961402|11594673|FG000|COMPLETED|Overall Study||63
10447714|NCT00961402|11594674|FG001|COMPLETED|Overall Study||61
10447715|NCT00961402|11594673|FG000|NOT COMPLETED|Overall Study||1
10447716|NCT00961402|11594674|FG001|NOT COMPLETED|Overall Study||5
10447717|NCT00961415|11594682|FG000|STARTED|Induction Treatment Phase||376
10447718|NCT00961415|11594683|FG001|STARTED|Induction Treatment Phase||0
10447719|NCT00961415|11594684|FG002|STARTED|Induction Treatment Phase||0
10447720|NCT00961415|11594682|FG000|COMPLETED|Induction Treatment Phase||253
10447721|NCT00961415|11594683|FG001|COMPLETED|Induction Treatment Phase||0
10447722|NCT00961415|11594684|FG002|COMPLETED|Induction Treatment Phase||0
10447723|NCT00961415|11594682|FG000|NOT COMPLETED|Induction Treatment Phase||123
10447724|NCT00961415|11594683|FG001|NOT COMPLETED|Induction Treatment Phase||0
10447725|NCT00961415|11594684|FG002|NOT COMPLETED|Induction Treatment Phase||0
10447726|NCT00961415|11594682|FG000|STARTED|Maintenance Treatment Phase||0
10447727|NCT00961415|11594683|FG001|STARTED|Maintenance Treatment Phase||125
10447728|NCT00961415|11594684|FG002|STARTED|Maintenance Treatment Phase||128
10447729|NCT00961415|11594682|FG000|COMPLETED|Maintenance Treatment Phase||0
10447730|NCT00961415|11594683|FG001|COMPLETED|Maintenance Treatment Phase||77
10447731|NCT00961415|11594684|FG002|COMPLETED|Maintenance Treatment Phase||83
10447732|NCT00961415|11594682|FG000|NOT COMPLETED|Maintenance Treatment Phase||0
10447733|NCT00961415|11594683|FG001|NOT COMPLETED|Maintenance Treatment Phase||48
10447734|NCT00961415|11594684|FG002|NOT COMPLETED|Maintenance Treatment Phase||45
10447735|NCT00961441|11594700|FG000|STARTED|Overall Study||12
10447736|NCT00961441|11594701|FG001|STARTED|Overall Study||13
10447737|NCT00961441|11594700|FG000|Pharmacokinetic (PK-PP) Population|Overall Study||12
10447738|NCT00961441|11594701|FG001|Pharmacokinetic (PK-PP) Population|Overall Study|Two subjects were excluded due to study medication noncompliance, one due to wrong dosing regimen.|10
10447739|NCT00961441|11594700|FG000|COMPLETED|Overall Study||12
10447740|NCT00961441|11594701|FG001|COMPLETED|Overall Study||13
10447741|NCT00961441|11594700|FG000|NOT COMPLETED|Overall Study||0
10447742|NCT00961441|11594701|FG001|NOT COMPLETED|Overall Study||0
10447743|NCT00961532|11594707|FG000|STARTED|Overall Study||14
10447744|NCT00961532|11594707|FG000|COMPLETED|Overall Study||14
10447745|NCT00961532|11594707|FG000|NOT COMPLETED|Overall Study||0
10447746|NCT00961571|11594711|FG000|STARTED|Overall Study||50
10447747|NCT00961571|11594711|FG000|COMPLETED|Overall Study|high percentage of patient drop-off study prior cancer progression|11
10447748|NCT00961571|11594711|FG000|NOT COMPLETED|Overall Study||39
10447749|NCT00961636|11594718|FG000|STARTED|Overall Study||463
10447750|NCT00961636|11594719|FG001|STARTED|Overall Study||456
10447751|NCT00961636|11594720|FG002|STARTED|Overall Study||233
10447752|NCT00961636|11594718|FG000|COMPLETED|Overall Study||356
10447753|NCT00961636|11594719|FG001|COMPLETED|Overall Study||325
10447754|NCT00961636|11594720|FG002|COMPLETED|Overall Study||201
10447755|NCT00961636|11594718|FG000|NOT COMPLETED|Overall Study||107
10447756|NCT00961636|11594719|FG001|NOT COMPLETED|Overall Study||131
10447757|NCT00961636|11594720|FG002|NOT COMPLETED|Overall Study||32
10447758|NCT00961649|11594732|FG000|STARTED|Overall Study||41
10447759|NCT00961649|11594733|FG001|STARTED|Overall Study||44
10447760|NCT00961649|11594734|FG002|STARTED|Overall Study||44
10447761|NCT00961649|11594735|FG003|STARTED|Overall Study||41
10447762|NCT00961649|11594732|FG000|COMPLETED|Overall Study||32
10447763|NCT00961649|11594733|FG001|COMPLETED|Overall Study||40
10447764|NCT00961649|11594734|FG002|COMPLETED|Overall Study||39
10447765|NCT00961649|11594735|FG003|COMPLETED|Overall Study||37
10447766|NCT00961649|11594732|FG000|NOT COMPLETED|Overall Study||9
10447767|NCT00961649|11594733|FG001|NOT COMPLETED|Overall Study||4
10447768|NCT00961649|11594734|FG002|NOT COMPLETED|Overall Study||5
10447769|NCT00961649|11594735|FG003|NOT COMPLETED|Overall Study||4
10447770|NCT00961662|11594748|FG000|STARTED|Overall Study||57
10447771|NCT00961662|11594749|FG001|STARTED|Overall Study||51
10447772|NCT00961662|11594750|FG002|STARTED|Overall Study||53
10447773|NCT00961662|11594748|FG000|COMPLETED|Overall Study||35
10447774|NCT00961662|11594749|FG001|COMPLETED|Overall Study||32
10447775|NCT00961662|11594750|FG002|COMPLETED|Overall Study||34
10447776|NCT00961662|11594748|FG000|NOT COMPLETED|Overall Study||22
10447777|NCT00961662|11594749|FG001|NOT COMPLETED|Overall Study||19
10447778|NCT00961662|11594750|FG002|NOT COMPLETED|Overall Study||19
10447779|NCT00961896|11594761|FG000|STARTED|Overall Study||8
10447780|NCT00961896|11594762|FG001|STARTED|Overall Study||3
10447781|NCT00961896|11594763|FG002|STARTED|Overall Study||7
10447782|NCT00961896|11594761|FG000|COMPLETED|Overall Study||8
10447783|NCT00961896|11594762|FG001|COMPLETED|Overall Study||3
10447784|NCT00961896|11594763|FG002|COMPLETED|Overall Study||6
10447785|NCT00961896|11594761|FG000|NOT COMPLETED|Overall Study||0
10447786|NCT00961896|11594762|FG001|NOT COMPLETED|Overall Study||0
10447787|NCT00961896|11594763|FG002|NOT COMPLETED|Overall Study||1
10447788|NCT00961961|11594778|FG000|STARTED|Phase I||177
10447789|NCT00961961|11594779|FG001|STARTED|Phase I||0
10447790|NCT00961961|11594780|FG002|STARTED|Phase I||0
10447791|NCT00961961|11594781|FG003|STARTED|Phase I||0
10447792|NCT00961961|11594778|FG000|COMPLETED|Phase I||51
10447793|NCT00961961|11594779|FG001|COMPLETED|Phase I||0
10447794|NCT00961961|11594780|FG002|COMPLETED|Phase I||0
10447795|NCT00961961|11594781|FG003|COMPLETED|Phase I||0
10447796|NCT00961961|11594778|FG000|NOT COMPLETED|Phase I||126
10447797|NCT00961961|11594779|FG001|NOT COMPLETED|Phase I||0
10447798|NCT00961961|11594780|FG002|NOT COMPLETED|Phase I||0
10447799|NCT00961961|11594781|FG003|NOT COMPLETED|Phase I||0
10447800|NCT00961961|11594778|FG000|STARTED|Phase II|This is a Phase I category. Not relevant in Phase II.|0
10447801|NCT00961961|11594779|FG001|STARTED|Phase II|This is a Phase I category. Not relevant in Phase II.|0
10447802|NCT00961961|11594780|FG002|STARTED|Phase II||29
10447803|NCT00961961|11594781|FG003|STARTED|Phase II||22
10447804|NCT00961961|11594778|FG000|COMPLETED|Phase II||0
10447805|NCT00961961|11594779|FG001|COMPLETED|Phase II||0
10447806|NCT00961961|11594780|FG002|COMPLETED|Phase II||17
10447807|NCT00961961|11594781|FG003|COMPLETED|Phase II||14
10447808|NCT00961961|11594778|FG000|NOT COMPLETED|Phase II||0
10447809|NCT00961961|11594779|FG001|NOT COMPLETED|Phase II||0
10447810|NCT00961961|11594780|FG002|NOT COMPLETED|Phase II||12
10447811|NCT00961961|11594781|FG003|NOT COMPLETED|Phase II||8
10447812|NCT00962000|11594801|FG000|STARTED|Period 1 - 1 Week||21
10447813|NCT00962000|11594802|FG001|STARTED|Period 1 - 1 Week||21
10447814|NCT00962000|11594801|FG000|COMPLETED|Period 1 - 1 Week||21
10447815|NCT00962000|11594802|FG001|COMPLETED|Period 1 - 1 Week||21
10447816|NCT00962000|11594801|FG000|NOT COMPLETED|Period 1 - 1 Week||0
10447817|NCT00962000|11594802|FG001|NOT COMPLETED|Period 1 - 1 Week||0
10447818|NCT00962000|11594801|FG000|STARTED|Period 2 - 1 Week||21
10447819|NCT00962000|11594802|FG001|STARTED|Period 2 - 1 Week||21
10447820|NCT00962000|11594801|FG000|COMPLETED|Period 2 - 1 Week||21
10447821|NCT00962000|11594802|FG001|COMPLETED|Period 2 - 1 Week||21
10447822|NCT00962000|11594801|FG000|NOT COMPLETED|Period 2 - 1 Week||0
10447823|NCT00962000|11594802|FG001|NOT COMPLETED|Period 2 - 1 Week||0
10447824|NCT00962000|11594801|FG000|STARTED|Period 3 - 1 Week||21
10447825|NCT00962000|11594802|FG001|STARTED|Period 3 - 1 Week||21
10447826|NCT00962000|11594801|FG000|COMPLETED|Period 3 - 1 Week||21
10447827|NCT00962000|11594802|FG001|COMPLETED|Period 3 - 1 Week||21
10447828|NCT00962000|11594801|FG000|NOT COMPLETED|Period 3 - 1 Week||0
10447829|NCT00962000|11594802|FG001|NOT COMPLETED|Period 3 - 1 Week||0
10447830|NCT00962000|11594801|FG000|STARTED|Period 4 - 1 Week||21
10447831|NCT00962000|11594802|FG001|STARTED|Period 4 - 1 Week||21
10447832|NCT00962000|11594801|FG000|COMPLETED|Period 4 - 1 Week||21
10447833|NCT00962000|11594802|FG001|COMPLETED|Period 4 - 1 Week||21
10447834|NCT00962000|11594801|FG000|NOT COMPLETED|Period 4 - 1 Week||0
10447835|NCT00962000|11594802|FG001|NOT COMPLETED|Period 4 - 1 Week||0
10525661|NCT01377233|11677579|FG004|NOT COMPLETED|Double-blind||2
10525662|NCT01377389|11677595|FG000|STARTED|Overall Study||30
10525663|NCT01377389|11677595|FG000|COMPLETED|Overall Study||27
10525664|NCT01377389|11677595|FG000|NOT COMPLETED|Overall Study||3
10525665|NCT01377402|11677599|FG000|STARTED|Overall Study||982
10525666|NCT01377402|11677599|FG000|COMPLETED|Overall Study||982
10525667|NCT01377402|11677599|FG000|NOT COMPLETED|Overall Study||0
10525668|NCT01377467|11677607|FG000|STARTED|Overall Study||46
10525669|NCT01377467|11677608|FG001|STARTED|Overall Study||44
10525670|NCT01377467|11677607|FG000|COMPLETED|Overall Study||46
10525671|NCT01377467|11677608|FG001|COMPLETED|Overall Study||44
10525672|NCT01377467|11677607|FG000|NOT COMPLETED|Overall Study||0
10525673|NCT01377467|11677608|FG001|NOT COMPLETED|Overall Study||0
10525674|NCT01377480|11677618|FG000|STARTED|Overall Study|Includes 2 participants randomized to POS + BNZ but who only received POS|32
10525675|NCT01377480|11677619|FG001|STARTED|Overall Study||30
10525676|NCT01377480|11677620|FG002|STARTED|Overall Study|2 participants received only POS and were analyzed as part of the posaconazole group|28
10447836|NCT00962013|11594808|FG000|STARTED|Overall Study||120
10447837|NCT00962013|11594808|FG000|COMPLETED|Overall Study|Number of participants with 5 year primary endpoint data|52
10447838|NCT00962013|11594808|FG000|NOT COMPLETED|Overall Study||68
10447839|NCT00962039|11594814|FG000|STARTED|Overall Study||40
10447840|NCT00962039|11594815|FG001|STARTED|Overall Study||41
10447841|NCT00962039|11594814|FG000|COMPLETED|Overall Study||35
10447842|NCT00962039|11594815|FG001|COMPLETED|Overall Study||37
10447843|NCT00962039|11594814|FG000|NOT COMPLETED|Overall Study||5
10447844|NCT00962039|11594815|FG001|NOT COMPLETED|Overall Study||4
10447845|NCT00962065|11594824|FG000|STARTED|Overall Study||12
10447846|NCT00962065|11594825|FG001|STARTED|Overall Study||12
10447847|NCT00962065|11594826|FG002|STARTED|Overall Study||12
10447848|NCT00962065|11594824|FG000|COMPLETED|Overall Study||12
10447849|NCT00962065|11594825|FG001|COMPLETED|Overall Study||12
10447850|NCT00962065|11594826|FG002|COMPLETED|Overall Study||12
10447851|NCT00962065|11594824|FG000|NOT COMPLETED|Overall Study||0
10447852|NCT00962065|11594825|FG001|NOT COMPLETED|Overall Study||0
10447853|NCT00962065|11594826|FG002|NOT COMPLETED|Overall Study||0
10447854|NCT00962078|11594836|FG000|STARTED|Overall Study||35
10447855|NCT00962078|11594837|FG001|STARTED|Overall Study||36
10447856|NCT00962078|11594836|FG000|COMPLETED|Overall Study||30
10447857|NCT00962078|11594837|FG001|COMPLETED|Overall Study||30
10447858|NCT00962078|11594836|FG000|NOT COMPLETED|Overall Study||5
10447859|NCT00962078|11594837|FG001|NOT COMPLETED|Overall Study||6
10447860|NCT00962091|11594850|FG000|STARTED|Overall Study||4
10447861|NCT00962091|11594851|FG001|STARTED|Overall Study||9
10447862|NCT00962091|11594852|FG002|STARTED|Overall Study||10
10447863|NCT00962091|11594853|FG003|STARTED|Overall Study||3
10447864|NCT00962091|11594854|FG004|STARTED|Overall Study||3
10447865|NCT00962091|11594855|FG005|STARTED|Overall Study||12
10447866|NCT00962091|11594856|FG006|STARTED|Overall Study||12
10447867|NCT00962091|11594850|FG000|COMPLETED|Overall Study||3
10447868|NCT00962091|11594851|FG001|COMPLETED|Overall Study||7
10447869|NCT00962091|11594852|FG002|COMPLETED|Overall Study||9
10447870|NCT00962091|11594853|FG003|COMPLETED|Overall Study||2
10447871|NCT00962091|11594854|FG004|COMPLETED|Overall Study||3
10447872|NCT00962091|11594855|FG005|COMPLETED|Overall Study||11
10447873|NCT00962091|11594856|FG006|COMPLETED|Overall Study||11
10447874|NCT00962091|11594850|FG000|NOT COMPLETED|Overall Study||1
10447875|NCT00962091|11594851|FG001|NOT COMPLETED|Overall Study||2
10447876|NCT00962091|11594852|FG002|NOT COMPLETED|Overall Study||1
10447877|NCT00962091|11594853|FG003|NOT COMPLETED|Overall Study||1
10447878|NCT00962091|11594854|FG004|NOT COMPLETED|Overall Study||0
10447879|NCT00962091|11594855|FG005|NOT COMPLETED|Overall Study||1
10447880|NCT00962091|11594856|FG006|NOT COMPLETED|Overall Study||1
10447881|NCT00962104|11594882|FG000|STARTED|Overall Study||195
10447882|NCT00962104|11594883|FG001|STARTED|Overall Study||196
10447883|NCT00962104|11594882|FG000|Full Analysis Set|Overall Study|2 participants were excluded because they failed to take the assigned study medication.|193
10447884|NCT00962104|11594883|FG001|Full Analysis Set|Overall Study|1 participant was excluded because that participant failed to take the assigned study medication.|195
10447885|NCT00962104|11594882|FG000|COMPLETED|Overall Study||155
10447886|NCT00962104|11594883|FG001|COMPLETED|Overall Study||171
10447887|NCT00962104|11594882|FG000|NOT COMPLETED|Overall Study||40
10447888|NCT00962104|11594883|FG001|NOT COMPLETED|Overall Study||25
10447889|NCT00962208|11594891|FG000|STARTED|Overall Study||51
10447890|NCT00962208|11594892|FG001|STARTED|Overall Study||51
10447891|NCT00962208|11594891|FG000|COMPLETED|Overall Study||37
10447892|NCT00962208|11594892|FG001|COMPLETED|Overall Study||41
10447893|NCT00962208|11594891|FG000|NOT COMPLETED|Overall Study||14
10447894|NCT00962208|11594892|FG001|NOT COMPLETED|Overall Study||10
10447895|NCT00962247|11594898|FG000|STARTED|Usual Sedentary||61
10447896|NCT00962247|11594898|FG000|COMPLETED|Usual Sedentary||61
10447897|NCT00962247|11594898|FG000|NOT COMPLETED|Usual Sedentary||0
10447898|NCT00962247|11594898|FG000|STARTED|25% Reduction of Sedentary Activity||61
10447899|NCT00962247|11594898|FG000|COMPLETED|25% Reduction of Sedentary Activity||56
10447900|NCT00962247|11594898|FG000|NOT COMPLETED|25% Reduction of Sedentary Activity||5
10447901|NCT00962247|11594898|FG000|STARTED|50% Reduction of Sedentary Activity||56
10447902|NCT00962247|11594898|FG000|COMPLETED|50% Reduction of Sedentary Activity||56
10447903|NCT00962247|11594898|FG000|NOT COMPLETED|50% Reduction of Sedentary Activity||0
10447904|NCT00962390|11594908|FG000|STARTED|Overall Study||29
10447905|NCT00962390|11594909|FG001|STARTED|Overall Study||29
10447906|NCT00962390|11594910|FG002|STARTED|Overall Study||29
10447907|NCT00962390|11594911|FG003|STARTED|Overall Study||29
10447908|NCT00962390|11594908|FG000|COMPLETED|Overall Study||25
10447909|NCT00962390|11594909|FG001|COMPLETED|Overall Study||26
10447910|NCT00962390|11594910|FG002|COMPLETED|Overall Study||25
10447911|NCT00962390|11594911|FG003|COMPLETED|Overall Study||28
10447912|NCT00962390|11594908|FG000|NOT COMPLETED|Overall Study||4
10447913|NCT00962390|11594909|FG001|NOT COMPLETED|Overall Study||3
10447914|NCT00962390|11594910|FG002|NOT COMPLETED|Overall Study||4
10447915|NCT00962390|11594911|FG003|NOT COMPLETED|Overall Study||1
10447916|NCT00962585|11594925|FG000|STARTED|Overall Study||43
10447917|NCT00962585|11594926|FG001|STARTED|Overall Study||42
10447918|NCT00962585|11594927|FG002|STARTED|Overall Study||42
10447919|NCT00962585|11594928|FG003|STARTED|Overall Study||42
10447920|NCT00962585|11594925|FG000|COMPLETED|Overall Study||37
10447921|NCT00962585|11594926|FG001|COMPLETED|Overall Study||40
10447922|NCT00962585|11594927|FG002|COMPLETED|Overall Study||39
10447923|NCT00962585|11594928|FG003|COMPLETED|Overall Study||42
10447924|NCT00962585|11594925|FG000|NOT COMPLETED|Overall Study||6
10447925|NCT00962585|11594926|FG001|NOT COMPLETED|Overall Study||2
10447926|NCT00962585|11594927|FG002|NOT COMPLETED|Overall Study||3
10447927|NCT00962585|11594928|FG003|NOT COMPLETED|Overall Study||0
10447928|NCT00962598|11594942|FG000|STARTED|Overall Study||7
10447929|NCT00962598|11594943|FG001|STARTED|Overall Study||9
10447930|NCT00962598|11594942|FG000|COMPLETED|Overall Study||7
10447931|NCT00962598|11594943|FG001|COMPLETED|Overall Study||9
10447932|NCT00962598|11594942|FG000|NOT COMPLETED|Overall Study||0
10447933|NCT00962598|11594943|FG001|NOT COMPLETED|Overall Study||0
10447934|NCT00962650|11594949|FG000|STARTED|Overall Study||10
10447935|NCT00962650|11594949|FG000|COMPLETED|Overall Study||8
10447936|NCT00962650|11594949|FG000|NOT COMPLETED|Overall Study||2
10447937|NCT00962741|11594953|FG000|STARTED|Overall Study||127
10447938|NCT00962741|11594953|FG000|COMPLETED|Overall Study||119
10447939|NCT00962741|11594953|FG000|NOT COMPLETED|Overall Study||8
10447940|NCT00962754|11594959|FG000|STARTED|Overall Study||86
10447941|NCT00962754|11594960|FG001|STARTED|Overall Study||84
10447942|NCT00962754|11594959|FG000|COMPLETED|Overall Study||86
10447943|NCT00962754|11594960|FG001|COMPLETED|Overall Study||84
10447944|NCT00962754|11594959|FG000|NOT COMPLETED|Overall Study||0
10447945|NCT00962754|11594960|FG001|NOT COMPLETED|Overall Study||0
10447946|NCT00962780|11594972|FG000|STARTED|Overall Study||151
10447947|NCT00962780|11594973|FG001|STARTED|Overall Study||152
10447948|NCT00962780|11594972|FG000|Vaccinated 13vPnC Dose 1|Overall Study||150
10447949|NCT00962780|11594973|FG001|Vaccinated 13vPnC Dose 1|Overall Study||151
10447950|NCT00962780|11594972|FG000|Vaccinated 13vPnC Dose 2|Overall Study||145
10447951|NCT00962780|11594973|FG001|Vaccinated 13vPnC Dose 2|Overall Study||145
10447952|NCT00962780|11594972|FG000|Vaccinated 13vPnC Dose 3|Overall Study||144
10447953|NCT00962780|11594973|FG001|Vaccinated 13vPnC Dose 3|Overall Study||142
10447954|NCT00962780|11594972|FG000|Vaccinated 23vPS Dose|Overall Study||143
10447955|NCT00962780|11594973|FG001|Vaccinated 23vPS Dose|Overall Study||139
10447956|NCT00962780|11594972|FG000|COMPLETED|Overall Study||141
10447957|NCT00962780|11594973|FG001|COMPLETED|Overall Study||138
10447958|NCT00962780|11594972|FG000|NOT COMPLETED|Overall Study||10
10447959|NCT00962780|11594973|FG001|NOT COMPLETED|Overall Study||14
10447960|NCT00962871|11594989|FG000|STARTED|Overall Study||6
10447961|NCT00962871|11594990|FG001|STARTED|Overall Study||6
10447962|NCT00962871|11594991|FG002|STARTED|Overall Study||12
10447963|NCT00962871|11594992|FG003|STARTED|Overall Study||6
10447964|NCT00962871|11594989|FG000|COMPLETED|Overall Study||6
10447965|NCT00962871|11594990|FG001|COMPLETED|Overall Study||6
10447966|NCT00962871|11594991|FG002|COMPLETED|Overall Study||12
10447967|NCT00962871|11594992|FG003|COMPLETED|Overall Study||6
10551054|NCT01535326|11705256|FG002|NOT COMPLETED|Overall Study||0
10551055|NCT01535365|11705269|FG000|STARTED|Overall Study||31
10551056|NCT01535365|11705270|FG001|STARTED|Overall Study||29
10447968|NCT00962871|11594989|FG000|NOT COMPLETED|Overall Study||0
10447969|NCT00962871|11594990|FG001|NOT COMPLETED|Overall Study||0
10447970|NCT00962871|11594991|FG002|NOT COMPLETED|Overall Study||0
10447971|NCT00962871|11594992|FG003|NOT COMPLETED|Overall Study||0
10447972|NCT00962949|11595004|FG000|STARTED|Overall Study||13
10551057|NCT01535365|11705269|FG000|COMPLETED|Overall Study||31
10551058|NCT01535365|11705270|FG001|COMPLETED|Overall Study||29
10551059|NCT01535365|11705269|FG000|NOT COMPLETED|Overall Study||0
10551060|NCT01535365|11705270|FG001|NOT COMPLETED|Overall Study||0
10551061|NCT01535443|11705278|FG000|STARTED|Overall Study||35
10551062|NCT01535443|11705278|FG000|COMPLETED|Overall Study||32
10447973|NCT00962949|11595005|FG001|STARTED|Overall Study||15
10447974|NCT00962949|11595004|FG000|COMPLETED|Overall Study||13
10447975|NCT00962949|11595005|FG001|COMPLETED|Overall Study||15
10447976|NCT00962949|11595004|FG000|NOT COMPLETED|Overall Study||0
10447977|NCT00962949|11595005|FG001|NOT COMPLETED|Overall Study||0
10447978|NCT00963105|11595014|FG000|STARTED|Overall Study||34
10447979|NCT00963105|11595015|FG001|STARTED|Overall Study||35
10447980|NCT00963105|11595016|FG002|STARTED|Overall Study||35
10447981|NCT00963105|11595014|FG000|Received Treatment|Overall Study||34
10447982|NCT00963105|11595015|FG001|Received Treatment|Overall Study||34
10447983|NCT00963105|11595016|FG002|Received Treatment|Overall Study||35
10447984|NCT00963105|11595014|FG000|COMPLETED|Overall Study||34
10447985|NCT00963105|11595015|FG001|COMPLETED|Overall Study||35
10447986|NCT00963105|11595016|FG002|COMPLETED|Overall Study||35
10447987|NCT00963105|11595014|FG000|NOT COMPLETED|Overall Study||0
10447988|NCT00963105|11595015|FG001|NOT COMPLETED|Overall Study||0
10447989|NCT00963105|11595016|FG002|NOT COMPLETED|Overall Study||0
10447990|NCT00963157|11595029|FG000|STARTED|Overall Study||156
10447991|NCT00963157|11595030|FG001|STARTED|Overall Study||163
10447992|NCT00963157|11595031|FG002|STARTED|Overall Study||160
10447993|NCT00963157|11595032|FG003|STARTED|Overall Study||157
10447994|NCT00963157|11595033|FG004|STARTED|Overall Study||153
10447995|NCT00963157|11595029|FG000|COMPLETED|Overall Study||151
10447996|NCT00963157|11595030|FG001|COMPLETED|Overall Study||159
10447997|NCT00963157|11595031|FG002|COMPLETED|Overall Study||155
10447998|NCT00963157|11595032|FG003|COMPLETED|Overall Study||150
10447999|NCT00963157|11595033|FG004|COMPLETED|Overall Study||151
10448000|NCT00963157|11595029|FG000|NOT COMPLETED|Overall Study||5
10448001|NCT00963157|11595030|FG001|NOT COMPLETED|Overall Study||4
10448002|NCT00963157|11595031|FG002|NOT COMPLETED|Overall Study||5
10448003|NCT00963157|11595032|FG003|NOT COMPLETED|Overall Study||7
10448004|NCT00963157|11595033|FG004|NOT COMPLETED|Overall Study||2
10448005|NCT00963235|11595045|FG000|STARTED|Overall Study||331
10448006|NCT00963235|11595045|FG000|Vaccinated Dose 1|Overall Study||329
10448007|NCT00963235|11595045|FG000|Vaccinated Dose 2|Overall Study||300
10448008|NCT00963235|11595045|FG000|Vaccinated Dose 3|Overall Study||279
10448009|NCT00963235|11595045|FG000|Completed Dose 3 1-month Blood Draw|Overall Study||277
10448010|NCT00963235|11595045|FG000|COMPLETED|Overall Study||271
10448011|NCT00963235|11595045|FG000|NOT COMPLETED|Overall Study||60
10448012|NCT00963430|11595054|FG000|STARTED|Overall Study||60
10448013|NCT00963430|11595055|FG001|STARTED|Overall Study||60
10448014|NCT00963430|11595054|FG000|COMPLETED|Overall Study||59
10448015|NCT00963430|11595055|FG001|COMPLETED|Overall Study||57
10448016|NCT00963430|11595054|FG000|NOT COMPLETED|Overall Study||1
10551063|NCT01535443|11705278|FG000|NOT COMPLETED|Overall Study||3
10551064|NCT01535560|11705285|FG000|STARTED|Overall Study||274
10448017|NCT00963430|11595055|FG001|NOT COMPLETED|Overall Study||3
10448018|NCT00963482|11595063|FG000|STARTED|Overall Study||53
10448019|NCT00963482|11595064|FG001|STARTED|Overall Study||50
10448020|NCT00963482|11595063|FG000|COMPLETED|Overall Study||25
10448021|NCT00963482|11595064|FG001|COMPLETED|Overall Study||33
10448022|NCT00963482|11595063|FG000|NOT COMPLETED|Overall Study||28
10448023|NCT00963482|11595064|FG001|NOT COMPLETED|Overall Study||17
10448024|NCT00963508|11595072|FG000|STARTED|Overall Study||206
10448025|NCT00963508|11595073|FG001|STARTED|Overall Study||197
10448026|NCT00963508|11595072|FG000|COMPLETED|Overall Study||196
10448027|NCT00963508|11595073|FG001|COMPLETED|Overall Study||169
10448028|NCT00963508|11595072|FG000|NOT COMPLETED|Overall Study||10
10448029|NCT00963508|11595073|FG001|NOT COMPLETED|Overall Study||28
10448030|NCT00963547|11595083|FG000|STARTED|Overall Study||4
10448031|NCT00963547|11595084|FG001|STARTED|Overall Study||11
10448032|NCT00963547|11595085|FG002|STARTED|Overall Study||12
10448033|NCT00963547|11595086|FG003|STARTED|Overall Study||6
10448034|NCT00963547|11595087|FG004|STARTED|Overall Study|Study terminated before Part 2 enrollment.|0
10448035|NCT00963547|11595088|FG005|STARTED|Overall Study|Study terminated before Part 2 enrollment.|0
10448036|NCT00963547|11595089|FG006|STARTED|Overall Study|Study terminated before Part 2 enrollment.|0
10448037|NCT00963547|11595083|FG000|Treated|Overall Study||3
10448038|NCT00963547|11595084|FG001|Treated|Overall Study||11
10448039|NCT00963547|11595085|FG002|Treated|Overall Study||11
10448040|NCT00963547|11595086|FG003|Treated|Overall Study||6
10448041|NCT00963547|11595087|FG004|Treated|Overall Study|Study terminated before Part 2 enrollment.|0
10448042|NCT00963547|11595088|FG005|Treated|Overall Study|Study terminated before Part 2 enrollment.|0
10448043|NCT00963547|11595089|FG006|Treated|Overall Study|Study terminated before Part 2 enrollment.|0
10448044|NCT00963547|11595083|FG000|COMPLETED|Overall Study||0
10448045|NCT00963547|11595084|FG001|COMPLETED|Overall Study||0
10448046|NCT00963547|11595085|FG002|COMPLETED|Overall Study||0
10448047|NCT00963547|11595086|FG003|COMPLETED|Overall Study||0
10448048|NCT00963547|11595087|FG004|COMPLETED|Overall Study|Study terminated before Part 2 enrollment.|0
10448049|NCT00963547|11595088|FG005|COMPLETED|Overall Study|Study terminated before Part 2 enrollment.|0
10448050|NCT00963547|11595089|FG006|COMPLETED|Overall Study|Study terminated before Part 2 enrollment.|0
10448051|NCT00963547|11595083|FG000|NOT COMPLETED|Overall Study||4
10448052|NCT00963547|11595084|FG001|NOT COMPLETED|Overall Study||11
10448053|NCT00963547|11595085|FG002|NOT COMPLETED|Overall Study||12
10448054|NCT00963547|11595086|FG003|NOT COMPLETED|Overall Study||6
10448055|NCT00963547|11595087|FG004|NOT COMPLETED|Overall Study||0
10551065|NCT01535560|11705286|FG001|STARTED|Overall Study||275
10448056|NCT00963547|11595088|FG005|NOT COMPLETED|Overall Study||0
10448057|NCT00963547|11595089|FG006|NOT COMPLETED|Overall Study||0
10448058|NCT00963560|11595105|FG000|STARTED|Overall Study||47
10448059|NCT00963560|11595106|FG001|STARTED|Overall Study||44
10448060|NCT00963560|11595107|FG002|STARTED|Overall Study||41
10448061|NCT00963560|11595105|FG000|COMPLETED|Overall Study||44
10551066|NCT01535560|11705285|FG000|COMPLETED|Overall Study||237
10551067|NCT01535560|11705286|FG001|COMPLETED|Overall Study||179
10448062|NCT00963560|11595106|FG001|COMPLETED|Overall Study||41
10448063|NCT00963560|11595107|FG002|COMPLETED|Overall Study||41
10448064|NCT00963560|11595105|FG000|NOT COMPLETED|Overall Study||3
10448065|NCT00963560|11595106|FG001|NOT COMPLETED|Overall Study||3
10448066|NCT00963560|11595107|FG002|NOT COMPLETED|Overall Study||0
10448067|NCT00963638|11595117|FG000|STARTED|Overall Study||20
10448068|NCT00963638|11595118|FG001|STARTED|Overall Study||20
10448069|NCT00963638|11595117|FG000|COMPLETED|Overall Study||20
10448070|NCT00963638|11595118|FG001|COMPLETED|Overall Study||20
10448071|NCT00963638|11595117|FG000|NOT COMPLETED|Overall Study||0
10448072|NCT00963638|11595118|FG001|NOT COMPLETED|Overall Study||0
10448073|NCT00963677|11595126|FG000|STARTED|Overall Study|Patients without predicted difficult intubation|35
10448074|NCT00963677|11595127|FG001|STARTED|Overall Study|Patients with predicted difficult intubation but not ventilation|20
10448075|NCT00963677|11595126|FG000|COMPLETED|Overall Study||35
10448076|NCT00963677|11595127|FG001|COMPLETED|Overall Study|Two patients were excluded from the study due to the difficult ventilation with facemask ventilation|18
10448077|NCT00963677|11595126|FG000|NOT COMPLETED|Overall Study||0
10448078|NCT00963677|11595127|FG001|NOT COMPLETED|Overall Study||2
10448079|NCT00963807|11595133|FG000|STARTED|Overall Study||26
10448080|NCT00963807|11595133|FG000|Completed Baseline Imaging|Overall Study||11
10448081|NCT00963807|11595133|FG000|Completed Post-Cycle 1 Imaging|Overall Study||9
10448082|NCT00963807|11595133|FG000|Completed Post-Cycle 2 FLT Imaging|Overall Study||9
10448083|NCT00963807|11595133|FG000|Completed Post-Cycle 2 FDG Imaging|Overall Study||8
10448084|NCT00963807|11595133|FG000|COMPLETED|Overall Study||8
10448085|NCT00963807|11595133|FG000|NOT COMPLETED|Overall Study||18
10448086|NCT00963820|11595139|FG000|STARTED|Dose Escalation Phase||3
10448087|NCT00963820|11595140|FG001|STARTED|Dose Escalation Phase||3
10448088|NCT00963820|11595141|FG002|STARTED|Dose Escalation Phase||3
10448089|NCT00963820|11595142|FG003|STARTED|Dose Escalation Phase||3
10448090|NCT00963820|11595143|FG004|STARTED|Dose Escalation Phase||4
10448091|NCT00963820|11595144|FG005|STARTED|Dose Escalation Phase||3
10448092|NCT00963820|11595145|FG006|STARTED|Dose Escalation Phase||8
10448093|NCT00963820|11595146|FG007|STARTED|Dose Escalation Phase||5
10448094|NCT00963820|11595147|FG008|STARTED|Dose Escalation Phase|Expansion cohorts were not part of Dose Escalation except as noted in comments.|0
10448095|NCT00963820|11595148|FG009|STARTED|Dose Escalation Phase||0
10448096|NCT00963820|11595149|FG010|STARTED|Dose Escalation Phase||0
10448097|NCT00963820|11595150|FG011|STARTED|Dose Escalation Phase||0
10448098|NCT00963820|11595139|FG000|COMPLETED|Dose Escalation Phase||0
10448099|NCT00963820|11595140|FG001|COMPLETED|Dose Escalation Phase||0
10448100|NCT00963820|11595141|FG002|COMPLETED|Dose Escalation Phase||0
10448101|NCT00963820|11595142|FG003|COMPLETED|Dose Escalation Phase||0
10448102|NCT00963820|11595143|FG004|COMPLETED|Dose Escalation Phase||0
10448103|NCT00963820|11595144|FG005|COMPLETED|Dose Escalation Phase||0
10448104|NCT00963820|11595145|FG006|COMPLETED|Dose Escalation Phase||0
10448105|NCT00963820|11595146|FG007|COMPLETED|Dose Escalation Phase||0
10448106|NCT00963820|11595147|FG008|COMPLETED|Dose Escalation Phase||0
10448107|NCT00963820|11595148|FG009|COMPLETED|Dose Escalation Phase||0
10448108|NCT00963820|11595149|FG010|COMPLETED|Dose Escalation Phase||0
10448109|NCT00963820|11595150|FG011|COMPLETED|Dose Escalation Phase||0
10448110|NCT00963820|11595139|FG000|NOT COMPLETED|Dose Escalation Phase||3
10448111|NCT00963820|11595140|FG001|NOT COMPLETED|Dose Escalation Phase||3
10448112|NCT00963820|11595141|FG002|NOT COMPLETED|Dose Escalation Phase||3
10448113|NCT00963820|11595142|FG003|NOT COMPLETED|Dose Escalation Phase||3
10448114|NCT00963820|11595143|FG004|NOT COMPLETED|Dose Escalation Phase||4
10448115|NCT00963820|11595144|FG005|NOT COMPLETED|Dose Escalation Phase||3
10448116|NCT00963820|11595145|FG006|NOT COMPLETED|Dose Escalation Phase||8
10448117|NCT00963820|11595146|FG007|NOT COMPLETED|Dose Escalation Phase||5
10448118|NCT00963820|11595147|FG008|NOT COMPLETED|Dose Escalation Phase||0
10448119|NCT00963820|11595148|FG009|NOT COMPLETED|Dose Escalation Phase||0
10448120|NCT00963820|11595149|FG010|NOT COMPLETED|Dose Escalation Phase||0
10448121|NCT00963820|11595150|FG011|NOT COMPLETED|Dose Escalation Phase||0
10448122|NCT00963820|11595139|FG000|STARTED|Expansion Phase|Dose escalation cohorts were not part of the Expansion Phase except as noted in comments.|0
10448123|NCT00963820|11595140|FG001|STARTED|Expansion Phase||0
10448124|NCT00963820|11595141|FG002|STARTED|Expansion Phase||0
10448125|NCT00963820|11595142|FG003|STARTED|Expansion Phase||0
10448126|NCT00963820|11595143|FG004|STARTED|Expansion Phase||0
10448127|NCT00963820|11595144|FG005|STARTED|Expansion Phase||0
10448128|NCT00963820|11595145|FG006|STARTED|Expansion Phase||0
10448129|NCT00963820|11595146|FG007|STARTED|Expansion Phase||0
10448130|NCT00963820|11595147|FG008|STARTED|Expansion Phase|Includes 2 participants from the dose escalation cohort 2.97 mg/m^2.|11
10551068|NCT01535560|11705285|FG000|NOT COMPLETED|Overall Study||37
10448131|NCT00963820|11595148|FG009|STARTED|Expansion Phase|Includes 1 participant from the dose escalation cohort 2.97 mg/m^2.|10
10448132|NCT00963820|11595149|FG010|STARTED|Expansion Phase|Includes only participants who are proteasome inhibitor (PI)-naïve.|6
10448133|NCT00963820|11595150|FG011|STARTED|Expansion Phase|Includes participants with last dose of carfilzomib 21 to 60 days before 1st ixazomib citrate dose.|4
10448134|NCT00963820|11595139|FG000|COMPLETED|Expansion Phase||0
10448135|NCT00963820|11595140|FG001|COMPLETED|Expansion Phase||0
10448136|NCT00963820|11595141|FG002|COMPLETED|Expansion Phase||0
10448137|NCT00963820|11595142|FG003|COMPLETED|Expansion Phase||0
10448138|NCT00963820|11595143|FG004|COMPLETED|Expansion Phase||0
10551069|NCT01535560|11705286|FG001|NOT COMPLETED|Overall Study||96
10551070|NCT01535573|11705295|FG000|STARTED|Overall Study||21
10448139|NCT00963820|11595144|FG005|COMPLETED|Expansion Phase||0
10448140|NCT00963820|11595145|FG006|COMPLETED|Expansion Phase||0
10448141|NCT00963820|11595146|FG007|COMPLETED|Expansion Phase||0
10448142|NCT00963820|11595147|FG008|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
10448143|NCT00963820|11595148|FG009|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
10448144|NCT00963820|11595149|FG010|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
10448145|NCT00963820|11595150|FG011|COMPLETED|Expansion Phase||0
10448146|NCT00963820|11595139|FG000|NOT COMPLETED|Expansion Phase||0
10448147|NCT00963820|11595140|FG001|NOT COMPLETED|Expansion Phase||0
10448148|NCT00963820|11595141|FG002|NOT COMPLETED|Expansion Phase||0
10448149|NCT00963820|11595142|FG003|NOT COMPLETED|Expansion Phase||0
10448150|NCT00963820|11595143|FG004|NOT COMPLETED|Expansion Phase||0
10448151|NCT00963820|11595144|FG005|NOT COMPLETED|Expansion Phase||0
10448152|NCT00963820|11595145|FG006|NOT COMPLETED|Expansion Phase||0
10448153|NCT00963820|11595146|FG007|NOT COMPLETED|Expansion Phase||0
10448154|NCT00963820|11595147|FG008|NOT COMPLETED|Expansion Phase||10
10448155|NCT00963820|11595148|FG009|NOT COMPLETED|Expansion Phase||9
10448156|NCT00963820|11595149|FG010|NOT COMPLETED|Expansion Phase||5
10448157|NCT00963820|11595150|FG011|NOT COMPLETED|Expansion Phase||4
10448158|NCT00963859|11595167|FG000|STARTED|Overall Study||11
10448159|NCT00963859|11595167|FG000|COMPLETED|Overall Study||11
10448160|NCT00963859|11595167|FG000|NOT COMPLETED|Overall Study||0
10448161|NCT00963872|11595173|FG000|STARTED|Overall Study||25
10448162|NCT00963872|11595174|FG001|STARTED|Overall Study||6
10448163|NCT00963872|11595173|FG000|COMPLETED|Overall Study||24
10448164|NCT00963872|11595174|FG001|COMPLETED|Overall Study||5
10448165|NCT00963872|11595173|FG000|NOT COMPLETED|Overall Study||1
10448166|NCT00963872|11595174|FG001|NOT COMPLETED|Overall Study||1
10448167|NCT00963911|11595180|FG000|STARTED|Overall Study||1674
10448168|NCT00963911|11595180|FG000|COMPLETED|Overall Study||1674
10448169|NCT00963911|11595180|FG000|NOT COMPLETED|Overall Study||0
10448170|NCT00963924|11595186|FG000|STARTED|Overall Study||18
10448171|NCT00963924|11595187|FG001|STARTED|Overall Study||18
10448172|NCT00963924|11595186|FG000|COMPLETED|Overall Study||17
10448173|NCT00963924|11595187|FG001|COMPLETED|Overall Study||15
10448174|NCT00963924|11595186|FG000|NOT COMPLETED|Overall Study||1
10448175|NCT00963924|11595187|FG001|NOT COMPLETED|Overall Study||3
10448176|NCT00963937|11595198|FG000|STARTED|Overall Study||89
10448177|NCT00963937|11595199|FG001|STARTED|Overall Study||44
10448178|NCT00963937|11595200|FG002|STARTED|Overall Study||45
10448179|NCT00963937|11595198|FG000|COMPLETED|Overall Study||70
10448180|NCT00963937|11595199|FG001|COMPLETED|Overall Study||33
10551071|NCT01535573|11705296|FG001|STARTED|Overall Study||44
10551072|NCT01535573|11705297|FG002|STARTED|Overall Study||43
10551073|NCT01535573|11705295|FG000|COMPLETED|Overall Study||13
10551074|NCT01535573|11705296|FG001|COMPLETED|Overall Study||23
10551075|NCT01535573|11705297|FG002|COMPLETED|Overall Study||24
10551076|NCT01535573|11705295|FG000|NOT COMPLETED|Overall Study||8
10551077|NCT01535573|11705296|FG001|NOT COMPLETED|Overall Study||21
10551078|NCT01535573|11705297|FG002|NOT COMPLETED|Overall Study||19
10551079|NCT01535599|11705307|FG000|STARTED|Overall Study||347
10551080|NCT01535599|11705308|FG001|STARTED|Overall Study||346
10448181|NCT00963937|11595200|FG002|COMPLETED|Overall Study||41
10448182|NCT00963937|11595198|FG000|NOT COMPLETED|Overall Study||19
10448183|NCT00963937|11595199|FG001|NOT COMPLETED|Overall Study||11
10448184|NCT00963937|11595200|FG002|NOT COMPLETED|Overall Study||4
10448185|NCT00963989|11595211|FG000|STARTED|Overall Study||146
10448186|NCT00963989|11595211|FG000|COMPLETED|Overall Study||127
10448187|NCT00963989|11595211|FG000|NOT COMPLETED|Overall Study||19
10448188|NCT00964028|11595217|FG000|STARTED|Overall Study||25
10448189|NCT00964028|11595218|FG001|STARTED|Overall Study||25
10448190|NCT00964028|11595217|FG000|COMPLETED|Overall Study||25
10448191|NCT00964028|11595218|FG001|COMPLETED|Overall Study||24
10448192|NCT00964028|11595217|FG000|NOT COMPLETED|Overall Study||0
10448193|NCT00964028|11595218|FG001|NOT COMPLETED|Overall Study||1
10448194|NCT00964119|11595224|FG000|STARTED|Overall Study||15
10448195|NCT00964119|11595224|FG000|COMPLETED|Overall Study||15
10448196|NCT00964119|11595224|FG000|NOT COMPLETED|Overall Study||0
10448197|NCT00964158|11595231|FG000|STARTED|Overall Study||53
10551081|NCT01535599|11705307|FG000|COMPLETED|Overall Study||297
10448198|NCT00964158|11595232|FG001|STARTED|Overall Study||57
10448199|NCT00964158|11595233|FG002|STARTED|Overall Study||100
10448200|NCT00964158|11595231|FG000|COMPLETED|Overall Study||53
10448201|NCT00964158|11595232|FG001|COMPLETED|Overall Study||56
10551082|NCT01535599|11705308|FG001|COMPLETED|Overall Study||250
10448202|NCT00964158|11595233|FG002|COMPLETED|Overall Study||92
10448203|NCT00964158|11595231|FG000|NOT COMPLETED|Overall Study||0
10448204|NCT00964158|11595232|FG001|NOT COMPLETED|Overall Study||1
10448205|NCT00964158|11595233|FG002|NOT COMPLETED|Overall Study||8
10448206|NCT00964223|11595244|FG000|STARTED|Split Face Treatment (Weeks 1 and 2)||28
10448207|NCT00964223|11595244|FG000|COMPLETED|Split Face Treatment (Weeks 1 and 2)||28
10448208|NCT00964223|11595244|FG000|NOT COMPLETED|Split Face Treatment (Weeks 1 and 2)||0
10448209|NCT00964223|11595244|FG000|STARTED|Full Face Treatment (Weeks 5 and 8)||28
10448210|NCT00964223|11595244|FG000|COMPLETED|Full Face Treatment (Weeks 5 and 8)||27
10448211|NCT00964223|11595244|FG000|NOT COMPLETED|Full Face Treatment (Weeks 5 and 8)||1
10448212|NCT00964353|11595251|FG000|STARTED|Overall Study||181
10448213|NCT00964353|11595252|FG001|STARTED|Overall Study||178
10448214|NCT00964353|11595251|FG000|COMPLETED|Overall Study||181
10448215|NCT00964353|11595252|FG001|COMPLETED|Overall Study||178
10448216|NCT00964353|11595251|FG000|NOT COMPLETED|Overall Study||0
10448217|NCT00964353|11595252|FG001|NOT COMPLETED|Overall Study||0
10448218|NCT00964366|11595260|FG000|STARTED|Overall Study|27 of the 28 enrolled were eligible after screening.|28
10448219|NCT00964366|11595261|FG001|STARTED|Overall Study||25
10448220|NCT00964366|11595260|FG000|COMPLETED|Overall Study||27
10448221|NCT00964366|11595261|FG001|COMPLETED|Overall Study||24
10448222|NCT00964366|11595260|FG000|NOT COMPLETED|Overall Study||1
10448223|NCT00964366|11595261|FG001|NOT COMPLETED|Overall Study||1
10448224|NCT00964392|11595269|FG000|STARTED|Overall Study|Both safety and efficacy cohort: Total 128 (3 MEP Excluded)|125
10448225|NCT00964392|11595270|FG001|STARTED|Overall Study|Both safety and efficacy cohort: Total 292 (10 LEP Excluded)|282
10448226|NCT00964392|11595269|FG000|COMPLETED|Overall Study||72
10448227|NCT00964392|11595270|FG001|COMPLETED|Overall Study||92
10448228|NCT00964392|11595269|FG000|NOT COMPLETED|Overall Study||53
10448229|NCT00964392|11595270|FG001|NOT COMPLETED|Overall Study||190
10448230|NCT00964431|11595280|FG000|STARTED|Overall Study||50
10448231|NCT00964431|11595281|FG001|STARTED|Overall Study||51
10448232|NCT00964431|11595282|FG002|STARTED|Overall Study||51
10448233|NCT00964431|11595283|FG003|STARTED|Overall Study||51
10448234|NCT00964431|11595280|FG000|COMPLETED|Overall Study||50
10448235|NCT00964431|11595281|FG001|COMPLETED|Overall Study||51
10551083|NCT01535599|11705307|FG000|NOT COMPLETED|Overall Study||50
10551084|NCT01535599|11705308|FG001|NOT COMPLETED|Overall Study||96
10551085|NCT01535638|11705314|FG000|STARTED|Treatment 1 (Single Dose)||3
10551086|NCT01535638|11705315|FG001|STARTED|Treatment 1 (Single Dose)||3
10551087|NCT01535638|11705316|FG002|STARTED|Treatment 1 (Single Dose)||3
10551088|NCT01535638|11705317|FG003|STARTED|Treatment 1 (Single Dose)||3
10551089|NCT01535638|11705318|FG004|STARTED|Treatment 1 (Single Dose)||3
10551090|NCT01535638|11705319|FG005|STARTED|Treatment 1 (Single Dose)||3
10551091|NCT01535638|11705314|FG000|COMPLETED|Treatment 1 (Single Dose)||3
10551092|NCT01535638|11705315|FG001|COMPLETED|Treatment 1 (Single Dose)||3
10551093|NCT01535638|11705316|FG002|COMPLETED|Treatment 1 (Single Dose)||3
10551094|NCT01535638|11705317|FG003|COMPLETED|Treatment 1 (Single Dose)||3
10551095|NCT01535638|11705318|FG004|COMPLETED|Treatment 1 (Single Dose)||3
10551096|NCT01535638|11705319|FG005|COMPLETED|Treatment 1 (Single Dose)||2
10551097|NCT01535638|11705314|FG000|NOT COMPLETED|Treatment 1 (Single Dose)||0
10551098|NCT01535638|11705315|FG001|NOT COMPLETED|Treatment 1 (Single Dose)||0
10551099|NCT01535638|11705316|FG002|NOT COMPLETED|Treatment 1 (Single Dose)||0
10551100|NCT01535638|11705317|FG003|NOT COMPLETED|Treatment 1 (Single Dose)||0
10551101|NCT01535638|11705318|FG004|NOT COMPLETED|Treatment 1 (Single Dose)||0
10551102|NCT01535638|11705319|FG005|NOT COMPLETED|Treatment 1 (Single Dose)||1
10551103|NCT01535638|11705314|FG000|STARTED|Treatment 2 (Single Dose)||3
10551104|NCT01535638|11705315|FG001|STARTED|Treatment 2 (Single Dose)||3
10551105|NCT01535638|11705316|FG002|STARTED|Treatment 2 (Single Dose)||3
10551106|NCT01535638|11705317|FG003|STARTED|Treatment 2 (Single Dose)||3
10551107|NCT01535638|11705318|FG004|STARTED|Treatment 2 (Single Dose)||3
10551108|NCT01535638|11705319|FG005|STARTED|Treatment 2 (Single Dose)||2
10551109|NCT01535638|11705314|FG000|COMPLETED|Treatment 2 (Single Dose)||3
10551110|NCT01535638|11705315|FG001|COMPLETED|Treatment 2 (Single Dose)||3
10551111|NCT01535638|11705316|FG002|COMPLETED|Treatment 2 (Single Dose)||3
10551112|NCT01535638|11705317|FG003|COMPLETED|Treatment 2 (Single Dose)||3
10551113|NCT01535638|11705318|FG004|COMPLETED|Treatment 2 (Single Dose)||3
10551114|NCT01535638|11705319|FG005|COMPLETED|Treatment 2 (Single Dose)||2
10551115|NCT01535638|11705314|FG000|NOT COMPLETED|Treatment 2 (Single Dose)||0
10551116|NCT01535638|11705315|FG001|NOT COMPLETED|Treatment 2 (Single Dose)||0
10551117|NCT01535638|11705316|FG002|NOT COMPLETED|Treatment 2 (Single Dose)||0
10551118|NCT01535638|11705317|FG003|NOT COMPLETED|Treatment 2 (Single Dose)||0
10551119|NCT01535638|11705318|FG004|NOT COMPLETED|Treatment 2 (Single Dose)||0
10551120|NCT01535638|11705319|FG005|NOT COMPLETED|Treatment 2 (Single Dose)||0
10551121|NCT01535638|11705314|FG000|STARTED|Treatment 3 (Single Dose)||3
10551122|NCT01535638|11705315|FG001|STARTED|Treatment 3 (Single Dose)||3
10448236|NCT00964431|11595282|FG002|COMPLETED|Overall Study||51
10448237|NCT00964431|11595283|FG003|COMPLETED|Overall Study||51
10448238|NCT00964431|11595280|FG000|NOT COMPLETED|Overall Study||0
10448239|NCT00964431|11595281|FG001|NOT COMPLETED|Overall Study||0
10551123|NCT01535638|11705316|FG002|STARTED|Treatment 3 (Single Dose)||3
10551124|NCT01535638|11705317|FG003|STARTED|Treatment 3 (Single Dose)||3
10551125|NCT01535638|11705318|FG004|STARTED|Treatment 3 (Single Dose)||3
10551126|NCT01535638|11705319|FG005|STARTED|Treatment 3 (Single Dose)||2
10448240|NCT00964431|11595282|FG002|NOT COMPLETED|Overall Study||0
10448241|NCT00964431|11595283|FG003|NOT COMPLETED|Overall Study||0
10448242|NCT00964444|11595293|FG000|STARTED|Overall Study||10
10448243|NCT00964444|11595293|FG000|COMPLETED|Overall Study||10
10448244|NCT00964444|11595293|FG000|NOT COMPLETED|Overall Study||0
10448245|NCT00964496|11595299|FG000|STARTED|Overall Study||28
10448246|NCT00964496|11595300|FG001|STARTED|Overall Study||27
10448247|NCT00964496|11595299|FG000|COMPLETED|Overall Study||26
10448248|NCT00964496|11595300|FG001|COMPLETED|Overall Study||26
10448249|NCT00964496|11595299|FG000|NOT COMPLETED|Overall Study||2
10448250|NCT00964496|11595300|FG001|NOT COMPLETED|Overall Study||1
10448251|NCT00964548|11595308|FG000|STARTED|Overall Study||5
10448252|NCT00964548|11595309|FG001|STARTED|Overall Study||5
10448253|NCT00964548|11595308|FG000|COMPLETED|Overall Study||5
10448254|NCT00964548|11595309|FG001|COMPLETED|Overall Study||5
10448255|NCT00964548|11595308|FG000|NOT COMPLETED|Overall Study||0
10448256|NCT00964548|11595309|FG001|NOT COMPLETED|Overall Study||0
10448257|NCT00964678|11595315|FG000|STARTED|Overall Study||10
10448258|NCT00964678|11595315|FG000|COMPLETED|Overall Study||6
10448259|NCT00964678|11595315|FG000|NOT COMPLETED|Overall Study||4
10448260|NCT00964743|11595320|FG000|STARTED|Overall Study||2
10448261|NCT00964743|11595320|FG000|COMPLETED|Overall Study||0
10448262|NCT00964743|11595320|FG000|NOT COMPLETED|Overall Study||2
10448263|NCT00964782|11595326|FG000|STARTED|Overall Study||8
10448264|NCT00964782|11595327|FG001|STARTED|Overall Study||8
10448265|NCT00964782|11595326|FG000|COMPLETED|Overall Study||7
10448266|NCT00964782|11595327|FG001|COMPLETED|Overall Study||8
10448267|NCT00964782|11595326|FG000|NOT COMPLETED|Overall Study||1
10448268|NCT00964782|11595327|FG001|NOT COMPLETED|Overall Study||0
10448269|NCT00964795|11595335|FG000|STARTED|Overall Study|randomized|323
10448270|NCT00964795|11595335|FG000|Number of Participants Treated|Overall Study||320
10789796|NCT03527160|11950170|FG000|STARTED|Overall Study||134
10789797|NCT03527160|11950170|FG000|COMPLETED|Overall Study||113
10789798|NCT03527160|11950170|FG000|NOT COMPLETED|Overall Study||21
10789799|NCT03527173|11950179|FG000|STARTED|Overall Study||36
10789800|NCT03527173|11950180|FG001|STARTED|Overall Study||35
10789801|NCT03527173|11950179|FG000|COMPLETED|Overall Study||29
10789802|NCT03527173|11950180|FG001|COMPLETED|Overall Study||28
10789803|NCT03527173|11950179|FG000|NOT COMPLETED|Overall Study||7
10789804|NCT03527173|11950180|FG001|NOT COMPLETED|Overall Study||7
10789805|NCT03527550|11950188|FG000|STARTED|Overall Study||24
10789806|NCT03527550|11950189|FG001|STARTED|Overall Study||22
10789807|NCT03527550|11950188|FG000|COMPLETED|Overall Study||15
10789808|NCT03527550|11950189|FG001|COMPLETED|Overall Study||19
10448271|NCT00964795|11595335|FG000|COMPLETED|Overall Study|Prior to amendment 4, 16 participants completed up to Week 120. No participants completed Week 180.|16
10448272|NCT00964795|11595335|FG000|NOT COMPLETED|Overall Study||307
10448273|NCT00964860|11595342|FG000|STARTED|Overall Study||30
10551127|NCT01535638|11705314|FG000|COMPLETED|Treatment 3 (Single Dose)||3
10551128|NCT01535638|11705315|FG001|COMPLETED|Treatment 3 (Single Dose)||3
10551129|NCT01535638|11705316|FG002|COMPLETED|Treatment 3 (Single Dose)||3
10551130|NCT01535638|11705317|FG003|COMPLETED|Treatment 3 (Single Dose)||2
10551131|NCT01535638|11705318|FG004|COMPLETED|Treatment 3 (Single Dose)||3
10551132|NCT01535638|11705319|FG005|COMPLETED|Treatment 3 (Single Dose)||2
10448274|NCT00964860|11595343|FG001|STARTED|Overall Study||30
10448275|NCT00964860|11595342|FG000|COMPLETED|Overall Study||30
10448276|NCT00964860|11595343|FG001|COMPLETED|Overall Study||29
10789809|NCT03527550|11950188|FG000|NOT COMPLETED|Overall Study||9
10789810|NCT03527550|11950189|FG001|NOT COMPLETED|Overall Study||3
10448277|NCT00964860|11595342|FG000|NOT COMPLETED|Overall Study||0
10448278|NCT00964860|11595343|FG001|NOT COMPLETED|Overall Study||1
10448279|NCT00964886|11595353|FG000|STARTED|Overall Study||38
10448280|NCT00964886|11595354|FG001|STARTED|Overall Study||34
10448281|NCT00964886|11595355|FG002|STARTED|Overall Study||37
10448282|NCT00964886|11595356|FG003|STARTED|Overall Study||33
10551133|NCT01535638|11705314|FG000|NOT COMPLETED|Treatment 3 (Single Dose)||0
10789811|NCT03527745|11950223|FG000|STARTED|Overall Study||27
10789812|NCT03527745|11950224|FG001|STARTED|Overall Study||27
10448283|NCT00964886|11595353|FG000|COMPLETED|Overall Study||27
10448284|NCT00964886|11595354|FG001|COMPLETED|Overall Study||27
10448285|NCT00964886|11595355|FG002|COMPLETED|Overall Study||21
10448286|NCT00964886|11595356|FG003|COMPLETED|Overall Study||24
10448287|NCT00964886|11595353|FG000|NOT COMPLETED|Overall Study||11
10448288|NCT00964886|11595354|FG001|NOT COMPLETED|Overall Study||7
10448289|NCT00964886|11595355|FG002|NOT COMPLETED|Overall Study||16
10448290|NCT00964886|11595356|FG003|NOT COMPLETED|Overall Study||9
10448291|NCT00965081|11595372|FG000|STARTED|Overall Study|2 randomized participants had no post-baseline measures and are not included in outcome measures.|155
10448292|NCT00965081|11595373|FG001|STARTED|Overall Study||153
10448293|NCT00965081|11595372|FG000|COMPLETED|Overall Study|In addition, 16/17 rescue participants completed study on protocol-specified study medication.|121
10448294|NCT00965081|11595373|FG001|COMPLETED|Overall Study||110
10448295|NCT00965081|11595372|FG000|NOT COMPLETED|Overall Study||34
10448296|NCT00965081|11595373|FG001|NOT COMPLETED|Overall Study||43
10448297|NCT00965094|11595382|FG000|STARTED|Overall Study||19
10448298|NCT00965094|11595383|FG001|STARTED|Overall Study||17
10448299|NCT00965094|11595382|FG000|COMPLETED|Overall Study||14
10448300|NCT00965094|11595383|FG001|COMPLETED|Overall Study||16
10448301|NCT00965094|11595382|FG000|NOT COMPLETED|Overall Study||5
10448302|NCT00965094|11595383|FG001|NOT COMPLETED|Overall Study||1
10448303|NCT00965185|11595392|FG000|STARTED|Overall Study||19
10448304|NCT00965185|11595393|FG001|STARTED|Overall Study||21
10448305|NCT00965185|11595392|FG000|1 Month Visit|Overall Study||18
10448306|NCT00965185|11595393|FG001|1 Month Visit|Overall Study||21
10448307|NCT00965185|11595392|FG000|3 Month Visit|Overall Study||18
10448308|NCT00965185|11595393|FG001|3 Month Visit|Overall Study||21
10448309|NCT00965185|11595392|FG000|6 Month Visit|Overall Study||18
10448310|NCT00965185|11595393|FG001|6 Month Visit|Overall Study||21
10448311|NCT00965185|11595392|FG000|9 Month Visit|Overall Study||18
10448312|NCT00965185|11595393|FG001|9 Month Visit|Overall Study||21
10448313|NCT00965185|11595392|FG000|COMPLETED|Overall Study||17
10448314|NCT00965185|11595393|FG001|COMPLETED|Overall Study||20
10448315|NCT00965185|11595392|FG000|NOT COMPLETED|Overall Study||2
10448316|NCT00965185|11595393|FG001|NOT COMPLETED|Overall Study||1
10448317|NCT00965237|11595401|FG000|STARTED|Period 1, One Week of Wear||8
10448318|NCT00965237|11595402|FG001|STARTED|Period 1, One Week of Wear||8
10448319|NCT00965237|11595401|FG000|COMPLETED|Period 1, One Week of Wear||8
10448320|NCT00965237|11595402|FG001|COMPLETED|Period 1, One Week of Wear||8
10448321|NCT00965237|11595401|FG000|NOT COMPLETED|Period 1, One Week of Wear||0
10448322|NCT00965237|11595402|FG001|NOT COMPLETED|Period 1, One Week of Wear||0
10448323|NCT00965237|11595401|FG000|STARTED|Period 2, One Week of Wear||8
10448324|NCT00965237|11595402|FG001|STARTED|Period 2, One Week of Wear||8
10448325|NCT00965237|11595401|FG000|COMPLETED|Period 2, One Week of Wear||8
10448326|NCT00965237|11595402|FG001|COMPLETED|Period 2, One Week of Wear||8
10448327|NCT00965237|11595401|FG000|NOT COMPLETED|Period 2, One Week of Wear||0
10448328|NCT00965237|11595402|FG001|NOT COMPLETED|Period 2, One Week of Wear||0
10448329|NCT00965250|11595410|FG000|STARTED|Overall Study||37
10448330|NCT00965250|11595411|FG001|STARTED|Overall Study||12
10448331|NCT00965250|11595410|FG000|COMPLETED|Overall Study||37
10448332|NCT00965250|11595411|FG001|COMPLETED|Overall Study||12
10448333|NCT00965250|11595410|FG000|NOT COMPLETED|Overall Study||0
10448334|NCT00965250|11595411|FG001|NOT COMPLETED|Overall Study||0
10448335|NCT00965263|11595419|FG000|STARTED|Overall Study||6
10448336|NCT00965263|11595420|FG001|STARTED|Overall Study||9
10448337|NCT00965263|11595419|FG000|COMPLETED|Overall Study||4
10448338|NCT00965263|11595420|FG001|COMPLETED|Overall Study||6
10448339|NCT00965263|11595419|FG000|NOT COMPLETED|Overall Study||2
10448340|NCT00965263|11595420|FG001|NOT COMPLETED|Overall Study||3
10448341|NCT00965341|11595446|FG000|STARTED|Overall Study||19
10448342|NCT00965341|11595447|FG001|STARTED|Overall Study||24
10448343|NCT00965341|11595446|FG000|COMPLETED|Overall Study||13
10448344|NCT00965341|11595447|FG001|COMPLETED|Overall Study||16
10448345|NCT00965341|11595446|FG000|NOT COMPLETED|Overall Study||6
10448346|NCT00965341|11595447|FG001|NOT COMPLETED|Overall Study||8
10448347|NCT00965419|11595453|FG000|STARTED|Open Label Treatment for Responders||267
10448348|NCT00965419|11595453|FG000|Not Lost to f/u at First Post-baseline|Open Label Treatment for Responders||264
10448349|NCT00965419|11595453|FG000|COMPLETED|Open Label Treatment for Responders||20
10448350|NCT00965419|11595453|FG000|NOT COMPLETED|Open Label Treatment for Responders||247
10448351|NCT00965419|11595453|FG000|STARTED|Follow-up Phase||80
10448352|NCT00965419|11595453|FG000|COMPLETED|Follow-up Phase||18
10448353|NCT00965419|11595453|FG000|NOT COMPLETED|Follow-up Phase||62
10448354|NCT00965458|11595460|FG000|STARTED|Overall Study||33
10448355|NCT00965458|11595461|FG001|STARTED|Overall Study||16
10448356|NCT00965458|11595460|FG000|COMPLETED|Overall Study||31
10448357|NCT00965458|11595461|FG001|COMPLETED|Overall Study||12
10448358|NCT00965458|11595460|FG000|NOT COMPLETED|Overall Study||2
10448359|NCT00965458|11595461|FG001|NOT COMPLETED|Overall Study||4
10448360|NCT00965484|11595469|FG000|STARTED|Overall Study||136
10448361|NCT00965484|11595469|FG000|COMPLETED|Overall Study||134
10448362|NCT00965484|11595469|FG000|NOT COMPLETED|Overall Study||2
10448363|NCT00965497|11595473|FG000|STARTED|Overall Study||14
10448364|NCT00965497|11595473|FG000|COMPLETED|Overall Study||13
10448365|NCT00965497|11595473|FG000|NOT COMPLETED|Overall Study||1
10448366|NCT00965523|11595477|FG000|STARTED|Study 221|Study 221 (Safety Analysis Set).|81
10448367|NCT00965523|11595477|FG000|COMPLETED|Study 221||74
10448368|NCT00965523|11595477|FG000|NOT COMPLETED|Study 221||7
10448369|NCT00965523|11595477|FG000|STARTED|Study 224|Six subjects continued into Study 224 from Study 221.|6
10448370|NCT00965523|11595477|FG000|COMPLETED|Study 224||0
10448371|NCT00965523|11595477|FG000|NOT COMPLETED|Study 224||6
10448372|NCT00965562|11595484|FG000|STARTED|Overall Study||16
10448373|NCT00965562|11595485|FG001|STARTED|Overall Study||17
10448374|NCT00965562|11595486|FG002|STARTED|Overall Study||16
10448375|NCT00965562|11595484|FG000|Women With at Least 2 Follow up Visits|Overall Study|3 patients with no follow up visits: 1 out of contact, 2 patient requests|13
10448376|NCT00965562|11595485|FG001|Women With at Least 2 Follow up Visits|Overall Study|4 patients with no follow up visits: 2 out of contact, 2 patient requests|13
10448377|NCT00965562|11595486|FG002|Women With at Least 2 Follow up Visits|Overall Study|3 patients with no follow up visits: 3 out of contact|13
10448378|NCT00965562|11595484|FG000|Women Who Participated Full Follow up|Overall Study|7 patients discontinued intervention: 2 out of contact, 4 patient requests, 1 suspended by IRB|6
10448379|NCT00965562|11595485|FG001|Women Who Participated Full Follow up|Overall Study|3 patients discontinued intervention: 1 out of contact, 2 patient requests|10
10448380|NCT00965562|11595486|FG002|Women Who Participated Full Follow up|Overall Study|2 patients discontinued intervention: 2 patient requests|11
10448381|NCT00965562|11595484|FG000|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
10448382|NCT00965562|11595485|FG001|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
10448383|NCT00965562|11595486|FG002|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
10448384|NCT00965562|11595484|FG000|NOT COMPLETED|Overall Study||3
10448385|NCT00965562|11595485|FG001|NOT COMPLETED|Overall Study||4
10448386|NCT00965562|11595486|FG002|NOT COMPLETED|Overall Study||3
10448387|NCT00965575|11595497|FG000|STARTED|Overall Study|cross over, total enrolled 11|6
10448388|NCT00965575|11595498|FG001|STARTED|Overall Study|cross over, total enrolled 11|5
10448389|NCT00965575|11595497|FG000|COMPLETED|Overall Study||5
10448390|NCT00965575|11595498|FG001|COMPLETED|Overall Study||5
10448391|NCT00965575|11595497|FG000|NOT COMPLETED|Overall Study||1
10448392|NCT00965575|11595498|FG001|NOT COMPLETED|Overall Study||0
10448393|NCT00965718|11595506|FG000|STARTED|Overall Study||20
10448394|NCT00965718|11595506|FG000|COMPLETED|Overall Study||16
10448395|NCT00965718|11595506|FG000|NOT COMPLETED|Overall Study||4
10448396|NCT00965731|11595512|FG000|STARTED|Overall Study||7
10448397|NCT00965731|11595513|FG001|STARTED|Overall Study|Dose level given only after lower dose was successfully administered|20
10448398|NCT00965731|11595512|FG000|COMPLETED|Overall Study||0
10448399|NCT00965731|11595513|FG001|COMPLETED|Overall Study||0
10448400|NCT00965731|11595512|FG000|NOT COMPLETED|Overall Study||7
10448401|NCT00965731|11595513|FG001|NOT COMPLETED|Overall Study||20
10448402|NCT00965848|11595524|FG000|STARTED|Overall Study||107
10448403|NCT00965848|11595525|FG001|STARTED|Overall Study||34
10448404|NCT00965848|11595526|FG002|STARTED|Overall Study||127
10448405|NCT00965848|11595524|FG000|COMPLETED|Overall Study||78
10448406|NCT00965848|11595525|FG001|COMPLETED|Overall Study||32
10448407|NCT00965848|11595526|FG002|COMPLETED|Overall Study||117
10448408|NCT00965848|11595524|FG000|NOT COMPLETED|Overall Study||29
10448409|NCT00965848|11595525|FG001|NOT COMPLETED|Overall Study||2
10448410|NCT00965848|11595526|FG002|NOT COMPLETED|Overall Study||10
10448411|NCT00966186|11595536|FG000|STARTED|Overall Study||60
10448412|NCT00966186|11595537|FG001|STARTED|Overall Study||60
10448413|NCT00966186|11595536|FG000|COMPLETED|Overall Study||60
10448414|NCT00966186|11595537|FG001|COMPLETED|Overall Study||60
10448415|NCT00966186|11595536|FG000|NOT COMPLETED|Overall Study||0
10448416|NCT00966186|11595537|FG001|NOT COMPLETED|Overall Study||0
10448417|NCT00966238|11595549|FG000|STARTED|Overall Study||20
10448418|NCT00966238|11595550|FG001|STARTED|Overall Study||20
10448419|NCT00966238|11595551|FG002|STARTED|Overall Study||20
10448420|NCT00966238|11595552|FG003|STARTED|Overall Study||20
10448421|NCT00966238|11595553|FG004|STARTED|Overall Study||20
10448422|NCT00966238|11595554|FG005|STARTED|Overall Study||20
10448423|NCT00966238|11595549|FG000|COMPLETED|Overall Study||20
10448424|NCT00966238|11595550|FG001|COMPLETED|Overall Study||20
10448425|NCT00966238|11595551|FG002|COMPLETED|Overall Study||20
10448426|NCT00966238|11595552|FG003|COMPLETED|Overall Study||20
10448427|NCT00966238|11595553|FG004|COMPLETED|Overall Study||20
10448428|NCT00966238|11595554|FG005|COMPLETED|Overall Study||20
10448429|NCT00966238|11595549|FG000|NOT COMPLETED|Overall Study||0
10448430|NCT00966238|11595550|FG001|NOT COMPLETED|Overall Study||0
10448431|NCT00966238|11595551|FG002|NOT COMPLETED|Overall Study||0
10448432|NCT00966238|11595552|FG003|NOT COMPLETED|Overall Study||0
10448433|NCT00966238|11595553|FG004|NOT COMPLETED|Overall Study||0
10448434|NCT00966238|11595554|FG005|NOT COMPLETED|Overall Study||0
10448435|NCT00966264|11595570|FG000|STARTED|Overall Study||119
10448436|NCT00966264|11595571|FG001|STARTED|Overall Study||117
10448437|NCT00966264|11595570|FG000|COMPLETED|Overall Study|5 years results|115
10448438|NCT00966264|11595571|FG001|COMPLETED|Overall Study|5 years results|114
10448439|NCT00966264|11595570|FG000|NOT COMPLETED|Overall Study||4
10448440|NCT00966264|11595571|FG001|NOT COMPLETED|Overall Study||3
10448441|NCT00966277|11595579|FG000|STARTED|Overall Study||38
10448442|NCT00966277|11595580|FG001|STARTED|Overall Study||37
10448443|NCT00966277|11595579|FG000|COMPLETED|Overall Study|Four participants did not receive study treatment, see 'Reasons Not Completed.'|34
10448444|NCT00966277|11595580|FG001|COMPLETED|Overall Study|Four participants did not receive study treatment, see 'Reasons Not Completed.'|33
10448445|NCT00966277|11595579|FG000|NOT COMPLETED|Overall Study||4
10448446|NCT00966277|11595580|FG001|NOT COMPLETED|Overall Study||4
10448447|NCT00966355|11595589|FG000|STARTED|Overall Study||344
10448448|NCT00966355|11595590|FG001|STARTED|Overall Study||345
10448449|NCT00966355|11595591|FG002|STARTED|Overall Study||345
10448450|NCT00966355|11595589|FG000|COMPLETED|Overall Study||260
10448451|NCT00966355|11595590|FG001|COMPLETED|Overall Study||259
10448452|NCT00966355|11595591|FG002|COMPLETED|Overall Study||261
10448453|NCT00966355|11595589|FG000|NOT COMPLETED|Overall Study||84
10448454|NCT00966355|11595590|FG001|NOT COMPLETED|Overall Study||86
10448455|NCT00966355|11595591|FG002|NOT COMPLETED|Overall Study||84
10448456|NCT00966433|11595602|FG000|STARTED|Overall Study||11
10448457|NCT00966433|11595603|FG001|STARTED|Overall Study||11
10448458|NCT00966433|11595604|FG002|STARTED|Overall Study||11
10448459|NCT00966433|11595602|FG000|COMPLETED|Overall Study||10
10448460|NCT00966433|11595603|FG001|COMPLETED|Overall Study||10
10448461|NCT00966433|11595604|FG002|COMPLETED|Overall Study||11
10448462|NCT00966433|11595602|FG000|NOT COMPLETED|Overall Study||1
10448463|NCT00966433|11595603|FG001|NOT COMPLETED|Overall Study||1
10448464|NCT00966433|11595604|FG002|NOT COMPLETED|Overall Study||0
10448465|NCT00966446|11595617|FG000|STARTED|Overall Study||76
10448466|NCT00966446|11595618|FG001|STARTED|Overall Study||74
10448467|NCT00966446|11595619|FG002|STARTED|Overall Study||73
10448468|NCT00966446|11595617|FG000|COMPLETED|Overall Study||48
10448469|NCT00966446|11595618|FG001|COMPLETED|Overall Study||49
10448470|NCT00966446|11595619|FG002|COMPLETED|Overall Study||52
10448471|NCT00966446|11595617|FG000|NOT COMPLETED|Overall Study||28
10448472|NCT00966446|11595618|FG001|NOT COMPLETED|Overall Study||25
10448473|NCT00966446|11595619|FG002|NOT COMPLETED|Overall Study||21
10448474|NCT00966550|11595629|FG000|STARTED|Overall Study||13
10448475|NCT00966550|11595630|FG001|STARTED|Overall Study||12
10448476|NCT00966550|11595629|FG000|COMPLETED|Overall Study||13
10448477|NCT00966550|11595630|FG001|COMPLETED|Overall Study||12
10448478|NCT00966550|11595629|FG000|NOT COMPLETED|Overall Study||0
10448479|NCT00966550|11595630|FG001|NOT COMPLETED|Overall Study||0
10448480|NCT00966641|11595636|FG000|STARTED|First Intervention||17
10448481|NCT00966641|11595637|FG001|STARTED|First Intervention||17
10448482|NCT00966641|11595636|FG000|COMPLETED|First Intervention||17
10448483|NCT00966641|11595637|FG001|COMPLETED|First Intervention||17
10448484|NCT00966641|11595636|FG000|NOT COMPLETED|First Intervention||0
10448485|NCT00966641|11595637|FG001|NOT COMPLETED|First Intervention||0
10448486|NCT00966641|11595636|FG000|STARTED|Second Intervention||17
10448487|NCT00966641|11595637|FG001|STARTED|Second Intervention||17
10448488|NCT00966641|11595636|FG000|COMPLETED|Second Intervention||17
10448489|NCT00966641|11595637|FG001|COMPLETED|Second Intervention||17
10448490|NCT00966641|11595636|FG000|NOT COMPLETED|Second Intervention||0
10448491|NCT00966641|11595637|FG001|NOT COMPLETED|Second Intervention||0
10448492|NCT00966693|11595647|FG000|STARTED|Overall Study||3
10448493|NCT00966693|11595648|FG001|STARTED|Overall Study||3
10448494|NCT00966693|11595649|FG002|STARTED|Overall Study||9
10448495|NCT00966693|11595650|FG003|STARTED|Overall Study||49
10448496|NCT00966693|11595647|FG000|Phase 1 Completed|Overall Study||2
10448497|NCT00966693|11595648|FG001|Phase 1 Completed|Overall Study||3
10448498|NCT00966693|11595649|FG002|Phase 1 Completed|Overall Study||6
10448499|NCT00966693|11595650|FG003|Phase 1 Completed|Overall Study||0
10448500|NCT00966693|11595647|FG000|Phase 2 Completed|Overall Study||0
10448501|NCT00966693|11595648|FG001|Phase 2 Completed|Overall Study||0
10448502|NCT00966693|11595649|FG002|Phase 2 Completed|Overall Study||0
10448503|NCT00966693|11595650|FG003|Phase 2 Completed|Overall Study||46
10448504|NCT00966693|11595647|FG000|COMPLETED|Overall Study||2
10448505|NCT00966693|11595648|FG001|COMPLETED|Overall Study||3
10448506|NCT00966693|11595649|FG002|COMPLETED|Overall Study||6
10448507|NCT00966693|11595650|FG003|COMPLETED|Overall Study||26
10448508|NCT00966693|11595647|FG000|NOT COMPLETED|Overall Study||1
10448509|NCT00966693|11595648|FG001|NOT COMPLETED|Overall Study||0
10448510|NCT00966693|11595649|FG002|NOT COMPLETED|Overall Study||3
10448511|NCT00966693|11595650|FG003|NOT COMPLETED|Overall Study||23
10448512|NCT00966719|11595662|FG000|STARTED|Overall Study||50
10448513|NCT00966719|11595663|FG001|STARTED|Overall Study||49
10448514|NCT00966719|11595662|FG000|COMPLETED|Overall Study||44
10448515|NCT00966719|11595663|FG001|COMPLETED|Overall Study||38
10448516|NCT00966719|11595662|FG000|NOT COMPLETED|Overall Study||6
10448517|NCT00966719|11595663|FG001|NOT COMPLETED|Overall Study||11
10448518|NCT00966823|11595669|FG000|STARTED|Overall Study||3
10448519|NCT00966823|11595669|FG000|COMPLETED|Overall Study||2
10448520|NCT00966823|11595669|FG000|NOT COMPLETED|Overall Study||1
10448521|NCT00966849|11595676|FG000|STARTED|Overall Study||3660
10448522|NCT00966849|11595677|FG001|STARTED|Overall Study||3976
10448523|NCT00966849|11595678|FG002|STARTED|Overall Study||3169
10448524|NCT00966849|11595676|FG000|COMPLETED|Overall Study||2119
10448525|NCT00966849|11595677|FG001|COMPLETED|Overall Study||2498
10448526|NCT00966849|11595678|FG002|COMPLETED|Overall Study||1876
10448527|NCT00966849|11595676|FG000|NOT COMPLETED|Overall Study||1541
10448528|NCT00966849|11595677|FG001|NOT COMPLETED|Overall Study||1478
10448529|NCT00966849|11595678|FG002|NOT COMPLETED|Overall Study||1293
10448530|NCT00966875|11595695|FG000|STARTED|Part A||54
10448531|NCT00966875|11595696|FG001|STARTED|Part A||40
10448532|NCT00966875|11595697|FG002|STARTED|Part A||35
10448533|NCT00966875|11595698|FG003|STARTED|Part A||37
10448534|NCT00966875|11595699|FG004|STARTED|Part A||57
10448535|NCT00966875|11595700|FG005|STARTED|Part A||37
10448536|NCT00966875|11595701|FG006|STARTED|Part A||64
10448537|NCT00966875|11595702|FG007|STARTED|Part A||65
10448538|NCT00966875|11595703|FG008|STARTED|Part A||59
10448539|NCT00966875|11595695|FG000|Received ≥1 Doses of Study Drug|Part A||54
10448540|NCT00966875|11595696|FG001|Received ≥1 Doses of Study Drug|Part A||40
10448541|NCT00966875|11595697|FG002|Received ≥1 Doses of Study Drug|Part A||35
10448542|NCT00966875|11595698|FG003|Received ≥1 Doses of Study Drug|Part A||37
10448543|NCT00966875|11595699|FG004|Received ≥1 Doses of Study Drug|Part A||57
10448544|NCT00966875|11595700|FG005|Received ≥1 Doses of Study Drug|Part A||37
10448545|NCT00966875|11595701|FG006|Received ≥1 Doses of Study Drug|Part A||64
10448546|NCT00966875|11595702|FG007|Received ≥1 Doses of Study Drug|Part A||65
10448547|NCT00966875|11595703|FG008|Received ≥1 Doses of Study Drug|Part A||59
10448548|NCT00966875|11595695|FG000|COMPLETED|Part A||48
10448549|NCT00966875|11595696|FG001|COMPLETED|Part A||36
10448550|NCT00966875|11595697|FG002|COMPLETED|Part A||33
10448551|NCT00966875|11595698|FG003|COMPLETED|Part A||34
10448552|NCT00966875|11595699|FG004|COMPLETED|Part A||52
10448553|NCT00966875|11595700|FG005|COMPLETED|Part A||33
10448554|NCT00966875|11595701|FG006|COMPLETED|Part A||52
10448555|NCT00966875|11595702|FG007|COMPLETED|Part A||58
10448556|NCT00966875|11595703|FG008|COMPLETED|Part A||51
10448557|NCT00966875|11595695|FG000|NOT COMPLETED|Part A||6
10448558|NCT00966875|11595696|FG001|NOT COMPLETED|Part A||4
10448559|NCT00966875|11595697|FG002|NOT COMPLETED|Part A||2
10448560|NCT00966875|11595698|FG003|NOT COMPLETED|Part A||3
10448561|NCT00966875|11595699|FG004|NOT COMPLETED|Part A||5
10448562|NCT00966875|11595700|FG005|NOT COMPLETED|Part A||4
10448563|NCT00966875|11595701|FG006|NOT COMPLETED|Part A||12
10448564|NCT00966875|11595702|FG007|NOT COMPLETED|Part A||7
10448565|NCT00966875|11595703|FG008|NOT COMPLETED|Part A||8
10448566|NCT00966875|11595695|FG000|STARTED|Part B|Two (2) participants who completed Part A did not enter Part B.|46
10448567|NCT00966875|11595696|FG001|STARTED|Part B||36
10448568|NCT00966875|11595697|FG002|STARTED|Part B||33
10448569|NCT00966875|11595698|FG003|STARTED|Part B||34
10448570|NCT00966875|11595699|FG004|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|51
10448571|NCT00966875|11595700|FG005|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|32
10448572|NCT00966875|11595701|FG006|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|51
10448573|NCT00966875|11595702|FG007|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|57
10448574|NCT00966875|11595703|FG008|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|50
10448575|NCT00966875|11595695|FG000|COMPLETED|Part B||41
10448576|NCT00966875|11595696|FG001|COMPLETED|Part B||33
10448577|NCT00966875|11595697|FG002|COMPLETED|Part B||27
10448578|NCT00966875|11595698|FG003|COMPLETED|Part B||31
10448579|NCT00966875|11595699|FG004|COMPLETED|Part B||44
10448580|NCT00966875|11595700|FG005|COMPLETED|Part B||26
10448581|NCT00966875|11595701|FG006|COMPLETED|Part B||29
10448582|NCT00966875|11595702|FG007|COMPLETED|Part B||38
10448583|NCT00966875|11595703|FG008|COMPLETED|Part B||32
10448584|NCT00966875|11595695|FG000|NOT COMPLETED|Part B||5
10448585|NCT00966875|11595696|FG001|NOT COMPLETED|Part B||3
10448586|NCT00966875|11595697|FG002|NOT COMPLETED|Part B||6
10448587|NCT00966875|11595698|FG003|NOT COMPLETED|Part B||3
10448588|NCT00966875|11595699|FG004|NOT COMPLETED|Part B||7
10448589|NCT00966875|11595700|FG005|NOT COMPLETED|Part B||6
10448590|NCT00966875|11595701|FG006|NOT COMPLETED|Part B||22
10448591|NCT00966875|11595702|FG007|NOT COMPLETED|Part B||19
10448592|NCT00966875|11595703|FG008|NOT COMPLETED|Part B||18
10448593|NCT00966940|11595778|FG000|STARTED|Period 1, First 6 Weeks||28
10448594|NCT00966940|11595779|FG001|STARTED|Period 1, First 6 Weeks||23
10448595|NCT00966940|11595778|FG000|COMPLETED|Period 1, First 6 Weeks||25
10448596|NCT00966940|11595779|FG001|COMPLETED|Period 1, First 6 Weeks||23
10448597|NCT00966940|11595778|FG000|NOT COMPLETED|Period 1, First 6 Weeks||3
10448598|NCT00966940|11595779|FG001|NOT COMPLETED|Period 1, First 6 Weeks||0
10448599|NCT00966940|11595778|FG000|STARTED|Period 2, Second 6 Weeks||25
10448600|NCT00966940|11595779|FG001|STARTED|Period 2, Second 6 Weeks||23
10448601|NCT00966940|11595778|FG000|COMPLETED|Period 2, Second 6 Weeks||25
10448602|NCT00966940|11595779|FG001|COMPLETED|Period 2, Second 6 Weeks||23
10448603|NCT00966940|11595778|FG000|NOT COMPLETED|Period 2, Second 6 Weeks||0
10448604|NCT00966940|11595779|FG001|NOT COMPLETED|Period 2, Second 6 Weeks||0
10448605|NCT00967005|11595787|FG000|STARTED|Overall Study||13
10448606|NCT00967005|11595788|FG001|STARTED|Overall Study||15
10448607|NCT00967005|11595787|FG000|Treatment Completion|Overall Study||10
10448608|NCT00967005|11595788|FG001|Treatment Completion|Overall Study||10
10448609|NCT00967005|11595787|FG000|COMPLETED|Overall Study||6
10448610|NCT00967005|11595788|FG001|COMPLETED|Overall Study||5
10448611|NCT00967005|11595787|FG000|NOT COMPLETED|Overall Study||7
10448612|NCT00967005|11595788|FG001|NOT COMPLETED|Overall Study||10
10448613|NCT00967018|11595794|FG000|STARTED|Overall Study||77
10448614|NCT00967018|11595794|FG000|COMPLETED|Overall Study||56
10448615|NCT00967018|11595794|FG000|NOT COMPLETED|Overall Study||21
10448616|NCT00967044|11595798|FG000|STARTED|Overall Study||30
10448617|NCT00967044|11595798|FG000|COMPLETED|Overall Study||30
10448618|NCT00967044|11595798|FG000|NOT COMPLETED|Overall Study||0
10448619|NCT00967226|11595804|FG000|STARTED|Overall Study||11
10448620|NCT00967226|11595805|FG001|STARTED|Overall Study||8
10448621|NCT00967226|11595804|FG000|COMPLETED|Overall Study||9
10448622|NCT00967226|11595805|FG001|COMPLETED|Overall Study||2
10448623|NCT00967226|11595804|FG000|NOT COMPLETED|Overall Study||2
10448624|NCT00967226|11595805|FG001|NOT COMPLETED|Overall Study||6
10448625|NCT00967330|11595837|FG000|STARTED|Overall Study||122
10448626|NCT00967330|11595838|FG001|STARTED|Overall Study||60
10448627|NCT00967330|11595837|FG000|COMPLETED|Overall Study||0
10448628|NCT00967330|11595838|FG001|COMPLETED|Overall Study||0
10448629|NCT00967330|11595837|FG000|NOT COMPLETED|Overall Study||122
10448630|NCT00967330|11595838|FG001|NOT COMPLETED|Overall Study||60
10448631|NCT00967343|11595844|FG000|STARTED|Overall Study||40
10448632|NCT00967343|11595844|FG000|COMPLETED|Overall Study||2
10448633|NCT00967343|11595844|FG000|NOT COMPLETED|Overall Study||38
10448634|NCT00967369|11595850|FG000|STARTED|Overall Study||10
10448635|NCT00967369|11595851|FG001|STARTED|Overall Study||10
10448636|NCT00967369|11595850|FG000|Relapsed|Overall Study||4
10448637|NCT00967369|11595851|FG001|Relapsed|Overall Study||7
10448638|NCT00967369|11595850|FG000|Refractory|Overall Study||6
10448639|NCT00967369|11595851|FG001|Refractory|Overall Study||3
10448640|NCT00967369|11595850|FG000|COMPLETED|Overall Study||10
10448641|NCT00967369|11595851|FG001|COMPLETED|Overall Study||10
10448642|NCT00967369|11595850|FG000|NOT COMPLETED|Overall Study||0
10448643|NCT00967369|11595851|FG001|NOT COMPLETED|Overall Study||0
10448644|NCT00967473|11595857|FG000|STARTED|Overall Study||15
10448645|NCT00967473|11595857|FG000|COMPLETED|Overall Study||15
10448646|NCT00967473|11595857|FG000|NOT COMPLETED|Overall Study||0
10448647|NCT00967486|11595863|FG000|STARTED|Overall Study||98
10448648|NCT00967486|11595864|FG001|STARTED|Overall Study||102
10448649|NCT00967486|11595863|FG000|COMPLETED|Overall Study||98
10448650|NCT00967486|11595864|FG001|COMPLETED|Overall Study||102
10448651|NCT00967486|11595863|FG000|NOT COMPLETED|Overall Study||0
10448652|NCT00967486|11595864|FG001|NOT COMPLETED|Overall Study||0
10448653|NCT00967499|11595872|FG000|STARTED|Overall Study||111
10448654|NCT00967499|11595873|FG001|STARTED|Overall Study||109
10448655|NCT00967499|11595872|FG000|Treated (Full Analysis Set)|Overall Study||48
10448656|NCT00967499|11595873|FG001|Treated (Full Analysis Set)|Overall Study||50
10448657|NCT00967499|11595872|FG000|COMPLETED|Overall Study||46
10448658|NCT00967499|11595873|FG001|COMPLETED|Overall Study||49
10448659|NCT00967499|11595872|FG000|NOT COMPLETED|Overall Study||65
10448660|NCT00967499|11595873|FG001|NOT COMPLETED|Overall Study||60
10448661|NCT00967551|11595881|FG000|STARTED|Overall Study||68
10448662|NCT00967551|11595882|FG001|STARTED|Overall Study||75
10448663|NCT00967551|11595881|FG000|COMPLETED|Overall Study||68
10448664|NCT00967551|11595882|FG001|COMPLETED|Overall Study||75
10448665|NCT00967551|11595881|FG000|NOT COMPLETED|Overall Study||0
10448666|NCT00967551|11595882|FG001|NOT COMPLETED|Overall Study||0
10448667|NCT00967616|11595890|FG000|STARTED|Overall Study||50
10448668|NCT00967616|11595891|FG001|STARTED|Overall Study||50
10448669|NCT00967616|11595890|FG000|COMPLETED|Overall Study||0
10448670|NCT00967616|11595891|FG001|COMPLETED|Overall Study||0
10448671|NCT00967616|11595890|FG000|NOT COMPLETED|Overall Study||50
10448672|NCT00967616|11595891|FG001|NOT COMPLETED|Overall Study||50
10448673|NCT00967668|11595900|FG000|STARTED|Overall Study||162
10448674|NCT00967668|11595901|FG001|STARTED|Overall Study||160
10448675|NCT00967668|11595902|FG002|STARTED|Overall Study||159
10448676|NCT00967668|11595900|FG000|3-mo Assessment|Overall Study||131
10448677|NCT00967668|11595901|FG001|3-mo Assessment|Overall Study||127
10448678|NCT00967668|11595902|FG002|3-mo Assessment|Overall Study||115
10448679|NCT00967668|11595900|FG000|Completed Year 1 - 12-mo Assessment|Overall Study||120
10448680|NCT00967668|11595901|FG001|Completed Year 1 - 12-mo Assessment|Overall Study||122
10448681|NCT00967668|11595902|FG002|Completed Year 1 - 12-mo Assessment|Overall Study||119
10448682|NCT00967668|11595900|FG000|18-mo Assessment|Overall Study||95
10448683|NCT00967668|11595901|FG001|18-mo Assessment|Overall Study||102
10448684|NCT00967668|11595902|FG002|18-mo Assessment|Overall Study||92
10448685|NCT00967668|11595900|FG000|COMPLETED|Overall Study||91
10448686|NCT00967668|11595901|FG001|COMPLETED|Overall Study||104
10448687|NCT00967668|11595902|FG002|COMPLETED|Overall Study||90
10448688|NCT00967668|11595900|FG000|NOT COMPLETED|Overall Study||71
10448689|NCT00967668|11595901|FG001|NOT COMPLETED|Overall Study||56
10448690|NCT00967668|11595902|FG002|NOT COMPLETED|Overall Study||69
10448691|NCT00967694|11595913|FG000|STARTED|Overall Study||26
10448692|NCT00967694|11595913|FG000|COMPLETED|Overall Study|5 discontinued during N2O administration due to agitation ⁄ dysphoria, one due to nausea⁄vomiting.|20
10448693|NCT00967694|11595913|FG000|NOT COMPLETED|Overall Study||6
10448694|NCT00967798|11595919|FG000|STARTED|Overall Study||17
10448695|NCT00967798|11595920|FG001|STARTED|Overall Study||16
10448696|NCT00967798|11595919|FG000|COMPLETED|Overall Study||8
10448697|NCT00967798|11595920|FG001|COMPLETED|Overall Study||13
10448698|NCT00967798|11595919|FG000|NOT COMPLETED|Overall Study||9
10448699|NCT00967798|11595920|FG001|NOT COMPLETED|Overall Study||3
10448700|NCT00967941|11595929|FG000|STARTED|Overall Study||67
10448701|NCT00967941|11595930|FG001|STARTED|Overall Study||54
10448702|NCT00967941|11595931|FG002|STARTED|Overall Study||60
10448703|NCT00967941|11595929|FG000|COMPLETED|Overall Study||62
10448704|NCT00967941|11595930|FG001|COMPLETED|Overall Study||51
10448705|NCT00967941|11595931|FG002|COMPLETED|Overall Study||56
10448706|NCT00967941|11595929|FG000|NOT COMPLETED|Overall Study||5
10448707|NCT00967941|11595930|FG001|NOT COMPLETED|Overall Study||3
10448708|NCT00967941|11595931|FG002|NOT COMPLETED|Overall Study||4
10525677|NCT01377480|11677621|FG003|STARTED|Overall Study||30
10525678|NCT01377480|11677618|FG000|COMPLETED|Overall Study||32
10525679|NCT01377480|11677619|FG001|COMPLETED|Overall Study||29
10525680|NCT01377480|11677620|FG002|COMPLETED|Overall Study||18
10525681|NCT01377480|11677621|FG003|COMPLETED|Overall Study||19
10525682|NCT01377480|11677618|FG000|NOT COMPLETED|Overall Study||0
10525683|NCT01377480|11677619|FG001|NOT COMPLETED|Overall Study||1
10525684|NCT01377480|11677620|FG002|NOT COMPLETED|Overall Study||10
10525685|NCT01377480|11677621|FG003|NOT COMPLETED|Overall Study||11
10525686|NCT01377584|11677637|FG000|STARTED|Overall Study||8
10525687|NCT01377584|11677638|FG001|STARTED|Overall Study||8
10525688|NCT01377584|11677639|FG002|STARTED|Overall Study||10
10525689|NCT01377584|11677640|FG003|STARTED|Overall Study||10
10525690|NCT01377584|11677641|FG004|STARTED|Overall Study||12
10525691|NCT01377584|11677642|FG005|STARTED|Overall Study||12
10525692|NCT01377584|11677637|FG000|COMPLETED|Overall Study||5
10525693|NCT01377584|11677638|FG001|COMPLETED|Overall Study||5
10525694|NCT01377584|11677639|FG002|COMPLETED|Overall Study||6
10448709|NCT00967993|11595939|FG000|STARTED|Overall Study||22
10448710|NCT00967993|11595939|FG000|COMPLETED|Overall Study||18
10448711|NCT00967993|11595939|FG000|NOT COMPLETED|Overall Study||4
10448712|NCT00968019|11595943|FG000|STARTED|Overall Study||318
10448713|NCT00968019|11595943|FG000|COMPLETED|Overall Study||303
10448714|NCT00968019|11595943|FG000|NOT COMPLETED|Overall Study||15
10448715|NCT00968032|11595947|FG000|STARTED|Overall Study||63
10448716|NCT00968032|11595947|FG000|COMPLETED|Overall Study|"1 patient not receiving investigational device due to failure in usage~1 patient denied latest FU"|61
10448717|NCT00968032|11595947|FG000|NOT COMPLETED|Overall Study||2
10448718|NCT00968071|11595951|FG000|STARTED|Overall Study||71
10448719|NCT00968071|11595951|FG000|COMPLETED|Overall Study||71
10448720|NCT00968071|11595951|FG000|NOT COMPLETED|Overall Study||0
10448721|NCT00968227|11595955|FG000|STARTED|Overall Study||56
10448722|NCT00968227|11595955|FG000|COMPLETED|Overall Study||56
10448723|NCT00968227|11595955|FG000|NOT COMPLETED|Overall Study||0
10448724|NCT00968253|11595962|FG000|STARTED|Overall Study||3
10448725|NCT00968253|11595963|FG001|STARTED|Overall Study||9
10448726|NCT00968253|11595964|FG002|STARTED|Overall Study||12
10448727|NCT00968253|11595962|FG000|COMPLETED|Overall Study||3
10448728|NCT00968253|11595963|FG001|COMPLETED|Overall Study||6
10448729|NCT00968253|11595964|FG002|COMPLETED|Overall Study||5
10448730|NCT00968253|11595962|FG000|NOT COMPLETED|Overall Study||0
10448731|NCT00968253|11595963|FG001|NOT COMPLETED|Overall Study||3
10448732|NCT00968253|11595964|FG002|NOT COMPLETED|Overall Study||7
10448733|NCT00968344|11595975|FG000|STARTED|Overall Study|Includes screen fails|20
10448734|NCT00968344|11595976|FG001|STARTED|Overall Study|Includes screen fails|20
10448735|NCT00968344|11595975|FG000|COMPLETED|Overall Study||10
10448736|NCT00968344|11595976|FG001|COMPLETED|Overall Study||9
10448737|NCT00968344|11595975|FG000|NOT COMPLETED|Overall Study||10
10448738|NCT00968344|11595976|FG001|NOT COMPLETED|Overall Study||11
10448739|NCT00968526|11595984|FG000|STARTED|Overall Study||138
10448740|NCT00968526|11595985|FG001|STARTED|Overall Study||102
10448741|NCT00968526|11595984|FG000|COMPLETED|Overall Study||135
10448742|NCT00968526|11595985|FG001|COMPLETED|Overall Study||102
10448743|NCT00968526|11595984|FG000|NOT COMPLETED|Overall Study||3
10448744|NCT00968526|11595985|FG001|NOT COMPLETED|Overall Study||0
10448745|NCT00968539|11596002|FG000|STARTED|Overall Study||64
10448746|NCT00968539|11596003|FG001|STARTED|Overall Study||66
10448747|NCT00968539|11596002|FG000|COMPLETED|Overall Study||63
10448748|NCT00968539|11596003|FG001|COMPLETED|Overall Study||66
10448749|NCT00968539|11596002|FG000|NOT COMPLETED|Overall Study||1
10448750|NCT00968539|11596003|FG001|NOT COMPLETED|Overall Study||0
10448751|NCT00968617|11596010|FG000|STARTED|Overall Study||7
10448752|NCT00968617|11596010|FG000|COMPLETED|Overall Study||1
10448753|NCT00968617|11596010|FG000|NOT COMPLETED|Overall Study||6
10448754|NCT00968669|11596018|FG000|STARTED|Overall Study||82
10448755|NCT00968669|11596019|FG001|STARTED|Overall Study||81
10448756|NCT00968669|11596020|FG002|STARTED|Overall Study||83
10448757|NCT00968669|11596021|FG003|STARTED|Overall Study||81
10448758|NCT00968669|11596018|FG000|COMPLETED|Overall Study||64
10448759|NCT00968669|11596019|FG001|COMPLETED|Overall Study||63
10448760|NCT00968669|11596020|FG002|COMPLETED|Overall Study||72
10448761|NCT00968669|11596021|FG003|COMPLETED|Overall Study||72
10448762|NCT00968669|11596018|FG000|NOT COMPLETED|Overall Study||18
10448763|NCT00968669|11596019|FG001|NOT COMPLETED|Overall Study||18
10448764|NCT00968669|11596020|FG002|NOT COMPLETED|Overall Study||11
10448765|NCT00968669|11596021|FG003|NOT COMPLETED|Overall Study||9
10448766|NCT00968708|11596033|FG000|STARTED|Overall Study||2679
10448767|NCT00968708|11596034|FG001|STARTED|Overall Study||2701
10448768|NCT00968708|11596033|FG000|Treated|Overall Study||2676
10448769|NCT00968708|11596034|FG001|Treated|Overall Study||2698
10448770|NCT00968708|11596033|FG000|COMPLETED|Overall Study||2361
10448771|NCT00968708|11596034|FG001|COMPLETED|Overall Study||2403
10448772|NCT00968708|11596033|FG000|NOT COMPLETED|Overall Study||318
10448773|NCT00968708|11596034|FG001|NOT COMPLETED|Overall Study||298
10448774|NCT00968799|11596040|FG000|STARTED|Overall Study||6
10448775|NCT00968799|11596040|FG000|COMPLETED|Overall Study||4
10448776|NCT00968799|11596040|FG000|NOT COMPLETED|Overall Study||2
10448777|NCT00968812|11596047|FG000|STARTED|Overall Study||483
10448778|NCT00968812|11596048|FG001|STARTED|Overall Study||485
10448779|NCT00968812|11596049|FG002|STARTED|Overall Study||482
10448780|NCT00968812|11596047|FG000|COMPLETED|Overall Study||343
10448781|NCT00968812|11596048|FG001|COMPLETED|Overall Study||323
10448782|NCT00968812|11596049|FG002|COMPLETED|Overall Study||314
10448783|NCT00968812|11596047|FG000|NOT COMPLETED|Overall Study||140
10448784|NCT00968812|11596048|FG001|NOT COMPLETED|Overall Study||162
10448785|NCT00968812|11596049|FG002|NOT COMPLETED|Overall Study||168
10448786|NCT00968838|11596062|FG000|STARTED|Overall Study||50
10448787|NCT00968838|11596063|FG001|STARTED|Overall Study||58
10448788|NCT00968838|11596062|FG000|COMPLETED|Overall Study||50
10448789|NCT00968838|11596063|FG001|COMPLETED|Overall Study||58
10448790|NCT00968838|11596062|FG000|NOT COMPLETED|Overall Study||0
10448791|NCT00968838|11596063|FG001|NOT COMPLETED|Overall Study||0
10448792|NCT00968890|11596071|FG000|STARTED|Overall Study||84
10448793|NCT00968890|11596072|FG001|STARTED|Overall Study||84
10448794|NCT00968890|11596071|FG000|COMPLETED|Overall Study||84
10448795|NCT00968890|11596072|FG001|COMPLETED|Overall Study||84
10448796|NCT00968890|11596071|FG000|NOT COMPLETED|Overall Study||0
10448797|NCT00968890|11596072|FG001|NOT COMPLETED|Overall Study||0
10448798|NCT00968968|11596080|FG000|STARTED|Overall Study||20
10448799|NCT00968968|11596081|FG001|STARTED|Overall Study||17
10448800|NCT00968968|11596080|FG000|COMPLETED|Overall Study||4
10448801|NCT00968968|11596081|FG001|COMPLETED|Overall Study||3
10448802|NCT00968968|11596080|FG000|NOT COMPLETED|Overall Study||16
10448803|NCT00968968|11596081|FG001|NOT COMPLETED|Overall Study||14
10448804|NCT00968981|11596091|FG000|STARTED|Overall Study||23
10448805|NCT00968981|11596092|FG001|STARTED|Overall Study||22
10448806|NCT00968981|11596093|FG002|STARTED|Overall Study||22
10448807|NCT00968981|11596091|FG000|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|20
10448808|NCT00968981|11596092|FG001|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|21
10448809|NCT00968981|11596093|FG002|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|22
10448810|NCT00968981|11596091|FG000|COMPLETED|Overall Study||1
10448811|NCT00968981|11596092|FG001|COMPLETED|Overall Study||0
10448812|NCT00968981|11596093|FG002|COMPLETED|Overall Study||0
10448813|NCT00968981|11596091|FG000|NOT COMPLETED|Overall Study||22
10448814|NCT00968981|11596092|FG001|NOT COMPLETED|Overall Study||22
10448815|NCT00968981|11596093|FG002|NOT COMPLETED|Overall Study||22
10448816|NCT00969124|11596102|FG000|STARTED|Overall Study||328
10448817|NCT00969124|11596102|FG000|COMPLETED|Overall Study||298
10448818|NCT00969124|11596102|FG000|NOT COMPLETED|Overall Study||30
10448819|NCT00969150|11596109|FG000|STARTED|Overall Study||182
10448820|NCT00969150|11596110|FG001|STARTED|Overall Study||175
10448821|NCT00969150|11596109|FG000|COMPLETED|Overall Study||149
10448822|NCT00969150|11596110|FG001|COMPLETED|Overall Study||135
10448823|NCT00969150|11596109|FG000|NOT COMPLETED|Overall Study||33
10448824|NCT00969150|11596110|FG001|NOT COMPLETED|Overall Study||40
10448825|NCT00969228|11596118|FG000|STARTED|Overall Study||508
10448826|NCT00969228|11596119|FG001|STARTED|Overall Study||176
10448827|NCT00969228|11596118|FG000|COMPLETED|Overall Study||465
10448828|NCT00969228|11596119|FG001|COMPLETED|Overall Study||162
10448829|NCT00969228|11596118|FG000|NOT COMPLETED|Overall Study||43
10448830|NCT00969228|11596119|FG001|NOT COMPLETED|Overall Study||14
10789813|NCT03527745|11950225|FG002|STARTED|Overall Study||30
10789814|NCT03527745|11950226|FG003|STARTED|Overall Study||27
10789815|NCT03527745|11950227|FG004|STARTED|Overall Study||46
10789816|NCT03527745|11950228|FG005|STARTED|Overall Study||45
10448831|NCT00969280|11596127|FG000|STARTED|Overall Study||21
10448832|NCT00969280|11596128|FG001|STARTED|Overall Study||21
10448833|NCT00969280|11596127|FG000|COMPLETED|Overall Study||19
10448834|NCT00969280|11596128|FG001|COMPLETED|Overall Study||18
10448835|NCT00969280|11596127|FG000|NOT COMPLETED|Overall Study||2
10448836|NCT00969280|11596128|FG001|NOT COMPLETED|Overall Study||3
10448837|NCT00969332|11596134|FG000|STARTED|Overall Study||62
10448838|NCT00969332|11596134|FG000|COMPLETED|Overall Study||51
10448839|NCT00969332|11596134|FG000|NOT COMPLETED|Overall Study||11
10448840|NCT00969436|11596142|FG000|STARTED|Overall Study||180
10448841|NCT00969436|11596143|FG001|STARTED|Overall Study||180
10448842|NCT00969436|11596144|FG002|STARTED|Overall Study||90
10448843|NCT00969436|11596142|FG000|COMPLETED|Overall Study||155
10448844|NCT00969436|11596143|FG001|COMPLETED|Overall Study||159
10448845|NCT00969436|11596144|FG002|COMPLETED|Overall Study||79
10448846|NCT00969436|11596142|FG000|NOT COMPLETED|Overall Study||25
10448847|NCT00969436|11596143|FG001|NOT COMPLETED|Overall Study||21
10448848|NCT00969436|11596144|FG002|NOT COMPLETED|Overall Study||11
10448849|NCT00969501|11596152|FG000|STARTED|Overall Study||32
10448850|NCT00969501|11596152|FG000|COMPLETED|Overall Study||27
10448851|NCT00969501|11596152|FG000|NOT COMPLETED|Overall Study||5
10448852|NCT00969540|11596158|FG000|STARTED|Overall Study||4
10448853|NCT00969540|11596159|FG001|STARTED|Overall Study||4
10448854|NCT00969540|11596158|FG000|COMPLETED|Overall Study||3
10448855|NCT00969540|11596159|FG001|COMPLETED|Overall Study||3
10448856|NCT00969540|11596158|FG000|NOT COMPLETED|Overall Study||1
10448857|NCT00969540|11596159|FG001|NOT COMPLETED|Overall Study||1
10448858|NCT00969553|11596186|FG000|STARTED|Overall Study||3
10448859|NCT00969553|11596187|FG001|STARTED|Overall Study||3
10448860|NCT00969553|11596188|FG002|STARTED|Overall Study||6
10448861|NCT00969553|11596189|FG003|STARTED|Overall Study||17
10448862|NCT00969553|11596190|FG004|STARTED|Overall Study||3
10448863|NCT00969553|11596191|FG005|STARTED|Overall Study||4
10448864|NCT00969553|11596192|FG006|STARTED|Overall Study||4
10448865|NCT00969553|11596193|FG007|STARTED|Overall Study||16
10448866|NCT00969553|11596194|FG008|STARTED|Overall Study||3
10448867|NCT00969553|11596186|FG000|COMPLETED|Overall Study||0
10448868|NCT00969553|11596187|FG001|COMPLETED|Overall Study||0
10448869|NCT00969553|11596188|FG002|COMPLETED|Overall Study||0
10789817|NCT03527745|11950229|FG006|STARTED|Overall Study||46
10789818|NCT03527745|11950230|FG007|STARTED|Overall Study||43
10789819|NCT03527745|11950231|FG008|STARTED|Overall Study||10
10789820|NCT03527745|11950232|FG009|STARTED|Overall Study||11
10789821|NCT03527745|11950233|FG010|STARTED|Overall Study||9
10789822|NCT03527745|11950234|FG011|STARTED|Overall Study||12
10789823|NCT03527745|11950235|FG012|STARTED|Overall Study|During screening, the principal investigator decided to remove the this arm due to recruitment.|0
10789824|NCT03527745|11950236|FG013|STARTED|Overall Study||13
10789825|NCT03527745|11950237|FG014|STARTED|Overall Study||13
10789826|NCT03527745|11950238|FG015|STARTED|Overall Study||12
10448870|NCT00969553|11596189|FG003|COMPLETED|Overall Study|on-treatment at analysis data base lock date (27-Oct-2011)|1
10448871|NCT00969553|11596190|FG004|COMPLETED|Overall Study||0
10448872|NCT00969553|11596191|FG005|COMPLETED|Overall Study||0
10448873|NCT00969553|11596192|FG006|COMPLETED|Overall Study||0
10789827|NCT03527745|11950239|FG016|STARTED|Overall Study||24
10789828|NCT03527745|11950240|FG017|STARTED|Overall Study||27
10789829|NCT03527745|11950241|FG018|STARTED|Overall Study||27
10789830|NCT03527745|11950242|FG019|STARTED|Overall Study||29
10789831|NCT03527745|11950243|FG020|STARTED|Overall Study||26
10789832|NCT03527745|11950244|FG021|STARTED|Overall Study||40
10789833|NCT03527745|11950245|FG022|STARTED|Overall Study||41
10789834|NCT03527745|11950246|FG023|STARTED|Overall Study||38
10789835|NCT03527745|11950247|FG024|STARTED|Overall Study||40
10789836|NCT03527745|11950248|FG025|STARTED|Overall Study||37
10789837|NCT03527745|11950223|FG000|COMPLETED|Overall Study||24
10789838|NCT03527745|11950224|FG001|COMPLETED|Overall Study||21
10789839|NCT03527745|11950225|FG002|COMPLETED|Overall Study||23
10789840|NCT03527745|11950226|FG003|COMPLETED|Overall Study||18
10789841|NCT03527745|11950227|FG004|COMPLETED|Overall Study||46
10789842|NCT03527745|11950228|FG005|COMPLETED|Overall Study||43
10789843|NCT03527745|11950229|FG006|COMPLETED|Overall Study||43
10789844|NCT03527745|11950230|FG007|COMPLETED|Overall Study||41
10448874|NCT00969553|11596193|FG007|COMPLETED|Overall Study|on-treatment at analysis data base lock date (27-Oct-2011)|2
10448875|NCT00969553|11596194|FG008|COMPLETED|Overall Study||0
10448876|NCT00969553|11596186|FG000|NOT COMPLETED|Overall Study||3
10448877|NCT00969553|11596187|FG001|NOT COMPLETED|Overall Study||3
10448878|NCT00969553|11596188|FG002|NOT COMPLETED|Overall Study||6
10448879|NCT00969553|11596189|FG003|NOT COMPLETED|Overall Study||16
10448880|NCT00969553|11596190|FG004|NOT COMPLETED|Overall Study||3
10448881|NCT00969553|11596191|FG005|NOT COMPLETED|Overall Study||4
10448882|NCT00969553|11596192|FG006|NOT COMPLETED|Overall Study||4
10448883|NCT00969553|11596193|FG007|NOT COMPLETED|Overall Study||14
10448884|NCT00969553|11596194|FG008|NOT COMPLETED|Overall Study||3
10448885|NCT00969618|11596222|FG000|STARTED|Overall Study||211
10448886|NCT00969618|11596222|FG000|COMPLETED|Overall Study||133
10448887|NCT00969618|11596222|FG000|NOT COMPLETED|Overall Study||78
10448888|NCT00969709|11596230|FG000|STARTED|Overall Study||176
10448889|NCT00969709|11596231|FG001|STARTED|Overall Study||178
10448890|NCT00969709|11596232|FG002|STARTED|Overall Study||179
10448891|NCT00969709|11596233|FG003|STARTED|Overall Study||180
10551134|NCT01535638|11705315|FG001|NOT COMPLETED|Treatment 3 (Single Dose)||0
10551135|NCT01535638|11705316|FG002|NOT COMPLETED|Treatment 3 (Single Dose)||0
10551136|NCT01535638|11705317|FG003|NOT COMPLETED|Treatment 3 (Single Dose)||1
10551137|NCT01535638|11705318|FG004|NOT COMPLETED|Treatment 3 (Single Dose)||0
10551138|NCT01535638|11705319|FG005|NOT COMPLETED|Treatment 3 (Single Dose)||0
10551139|NCT01535664|11705328|FG000|STARTED|Overall Study||20
10551140|NCT01535664|11705328|FG000|COMPLETED|Overall Study||20
10551141|NCT01535664|11705328|FG000|NOT COMPLETED|Overall Study||0
10551142|NCT01535729|11705336|FG000|STARTED|Overall Study||465
10551143|NCT01535729|11705336|FG000|Treated|Overall Study||385
10551144|NCT01535729|11705336|FG000|COMPLETED|Overall Study||49
10551145|NCT01535729|11705336|FG000|NOT COMPLETED|Overall Study||416
10551146|NCT01535924|11705346|FG000|STARTED|Overall Study||3
10551147|NCT01535924|11705347|FG001|STARTED|Overall Study||3
10551148|NCT01535924|11705348|FG002|STARTED|Overall Study||3
10551149|NCT01535924|11705349|FG003|STARTED|Overall Study||4
10551150|NCT01535924|11705350|FG004|STARTED|Overall Study||6
10551151|NCT01535924|11705351|FG005|STARTED|Overall Study||7
10551152|NCT01535924|11705346|FG000|COMPLETED|Overall Study||3
10551153|NCT01535924|11705347|FG001|COMPLETED|Overall Study||3
10551154|NCT01535924|11705348|FG002|COMPLETED|Overall Study||3
10551155|NCT01535924|11705349|FG003|COMPLETED|Overall Study||4
10551156|NCT01535924|11705350|FG004|COMPLETED|Overall Study||6
10551157|NCT01535924|11705351|FG005|COMPLETED|Overall Study||7
10551158|NCT01535924|11705346|FG000|NOT COMPLETED|Overall Study||0
10551159|NCT01535924|11705347|FG001|NOT COMPLETED|Overall Study||0
10551160|NCT01535924|11705348|FG002|NOT COMPLETED|Overall Study||0
10551161|NCT01535924|11705349|FG003|NOT COMPLETED|Overall Study||0
10551162|NCT01535924|11705350|FG004|NOT COMPLETED|Overall Study||0
10551163|NCT01535924|11705351|FG005|NOT COMPLETED|Overall Study||0
10551164|NCT01535937|11705368|FG000|STARTED|Overall Study||27
10551165|NCT01535937|11705369|FG001|STARTED|Overall Study||28
10551166|NCT01535937|11705368|FG000|COMPLETED|Overall Study||27
10551167|NCT01535937|11705369|FG001|COMPLETED|Overall Study||28
10551168|NCT01535937|11705368|FG000|NOT COMPLETED|Overall Study||0
10551169|NCT01535937|11705369|FG001|NOT COMPLETED|Overall Study||0
10551170|NCT01535976|11705377|FG000|STARTED|Overall Study||27
10551171|NCT01535976|11705378|FG001|STARTED|Overall Study||27
10551172|NCT01535976|11705377|FG000|COMPLETED|Overall Study||26
10551173|NCT01535976|11705378|FG001|COMPLETED|Overall Study||26
10789845|NCT03527745|11950231|FG008|COMPLETED|Overall Study||7
10789846|NCT03527745|11950232|FG009|COMPLETED|Overall Study||9
10789847|NCT03527745|11950233|FG010|COMPLETED|Overall Study||8
10789848|NCT03527745|11950234|FG011|COMPLETED|Overall Study||11
10789849|NCT03527745|11950235|FG012|COMPLETED|Overall Study||0
10448892|NCT00969709|11596230|FG000|COMPLETED|Overall Study||138
10448893|NCT00969709|11596231|FG001|COMPLETED|Overall Study||130
10448894|NCT00969709|11596232|FG002|COMPLETED|Overall Study||121
10448895|NCT00969709|11596233|FG003|COMPLETED|Overall Study||117
10448896|NCT00969709|11596230|FG000|NOT COMPLETED|Overall Study||38
10448897|NCT00969709|11596231|FG001|NOT COMPLETED|Overall Study||48
10448898|NCT00969709|11596232|FG002|NOT COMPLETED|Overall Study||58
10448899|NCT00969709|11596233|FG003|NOT COMPLETED|Overall Study||63
10551174|NCT01535976|11705377|FG000|NOT COMPLETED|Overall Study||1
10551175|NCT01535976|11705378|FG001|NOT COMPLETED|Overall Study||1
10551176|NCT01536067|11705384|FG000|STARTED|Overall Study||3
10551177|NCT01536067|11705384|FG000|COMPLETED|Overall Study||2
10448900|NCT00969761|11596259|FG000|STARTED|Discont. Before Start of Treat. Cycle 2||3
10448901|NCT00969761|11596260|FG001|STARTED|Discont. Before Start of Treat. Cycle 2||3
10448902|NCT00969761|11596261|FG002|STARTED|Discont. Before Start of Treat. Cycle 2||12
10448903|NCT00969761|11596262|FG003|STARTED|Discont. Before Start of Treat. Cycle 2||6
10448904|NCT00969761|11596263|FG004|STARTED|Discont. Before Start of Treat. Cycle 2||3
10448905|NCT00969761|11596264|FG005|STARTED|Discont. Before Start of Treat. Cycle 2||3
10448906|NCT00969761|11596265|FG006|STARTED|Discont. Before Start of Treat. Cycle 2||3
10448907|NCT00969761|11596266|FG007|STARTED|Discont. Before Start of Treat. Cycle 2||6
10448908|NCT00969761|11596267|FG008|STARTED|Discont. Before Start of Treat. Cycle 2||13
10448909|NCT00969761|11596268|FG009|STARTED|Discont. Before Start of Treat. Cycle 2||3
10448910|NCT00969761|11596269|FG010|STARTED|Discont. Before Start of Treat. Cycle 2||3
10448911|NCT00969761|11596270|FG011|STARTED|Discont. Before Start of Treat. Cycle 2||3
10448912|NCT00969761|11596259|FG000|COMPLETED|Discont. Before Start of Treat. Cycle 2||2
10448913|NCT00969761|11596260|FG001|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
10448914|NCT00969761|11596261|FG002|COMPLETED|Discont. Before Start of Treat. Cycle 2||10
10448915|NCT00969761|11596262|FG003|COMPLETED|Discont. Before Start of Treat. Cycle 2||5
10448916|NCT00969761|11596263|FG004|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
10448917|NCT00969761|11596264|FG005|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
10448918|NCT00969761|11596265|FG006|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
10448919|NCT00969761|11596266|FG007|COMPLETED|Discont. Before Start of Treat. Cycle 2||6
10448920|NCT00969761|11596267|FG008|COMPLETED|Discont. Before Start of Treat. Cycle 2||11
10448921|NCT00969761|11596268|FG009|COMPLETED|Discont. Before Start of Treat. Cycle 2||2
10789850|NCT03527745|11950236|FG013|COMPLETED|Overall Study||13
10789851|NCT03527745|11950237|FG014|COMPLETED|Overall Study||13
10789852|NCT03527745|11950238|FG015|COMPLETED|Overall Study||12
10789853|NCT03527745|11950239|FG016|COMPLETED|Overall Study||23
10448922|NCT00969761|11596269|FG010|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
10448923|NCT00969761|11596270|FG011|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
10448924|NCT00969761|11596259|FG000|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||1
10448925|NCT00969761|11596260|FG001|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
10448926|NCT00969761|11596261|FG002|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||2
10448927|NCT00969761|11596262|FG003|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||1
10448928|NCT00969761|11596263|FG004|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
10448929|NCT00969761|11596264|FG005|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
10448930|NCT00969761|11596265|FG006|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
10448931|NCT00969761|11596266|FG007|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
10448932|NCT00969761|11596267|FG008|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||2
10448933|NCT00969761|11596268|FG009|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||1
10448934|NCT00969761|11596269|FG010|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
10448935|NCT00969761|11596270|FG011|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
10448936|NCT00969761|11596259|FG000|STARTED|Treated in and Beyond Treat. Cycle 2||2
10448937|NCT00969761|11596260|FG001|STARTED|Treated in and Beyond Treat. Cycle 2||3
10448938|NCT00969761|11596261|FG002|STARTED|Treated in and Beyond Treat. Cycle 2||10
10448939|NCT00969761|11596262|FG003|STARTED|Treated in and Beyond Treat. Cycle 2||5
10448940|NCT00969761|11596263|FG004|STARTED|Treated in and Beyond Treat. Cycle 2||3
10448941|NCT00969761|11596264|FG005|STARTED|Treated in and Beyond Treat. Cycle 2||3
10448942|NCT00969761|11596265|FG006|STARTED|Treated in and Beyond Treat. Cycle 2||3
10448943|NCT00969761|11596266|FG007|STARTED|Treated in and Beyond Treat. Cycle 2||6
10448944|NCT00969761|11596267|FG008|STARTED|Treated in and Beyond Treat. Cycle 2||11
10448945|NCT00969761|11596268|FG009|STARTED|Treated in and Beyond Treat. Cycle 2||2
10448946|NCT00969761|11596269|FG010|STARTED|Treated in and Beyond Treat. Cycle 2||3
10448947|NCT00969761|11596270|FG011|STARTED|Treated in and Beyond Treat. Cycle 2||3
10448948|NCT00969761|11596259|FG000|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
10448949|NCT00969761|11596260|FG001|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
10448950|NCT00969761|11596261|FG002|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
10448951|NCT00969761|11596262|FG003|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
10448952|NCT00969761|11596263|FG004|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
10448953|NCT00969761|11596264|FG005|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
10448954|NCT00969761|11596265|FG006|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
10448955|NCT00969761|11596266|FG007|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
10448956|NCT00969761|11596267|FG008|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
10448957|NCT00969761|11596268|FG009|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
10448958|NCT00969761|11596269|FG010|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
10448959|NCT00969761|11596270|FG011|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
10448960|NCT00969761|11596259|FG000|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||2
10448961|NCT00969761|11596260|FG001|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
10448962|NCT00969761|11596261|FG002|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||10
10448963|NCT00969761|11596262|FG003|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||5
10448964|NCT00969761|11596263|FG004|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
10448965|NCT00969761|11596264|FG005|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
10448966|NCT00969761|11596265|FG006|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
10448967|NCT00969761|11596266|FG007|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||6
10448968|NCT00969761|11596267|FG008|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||11
10789854|NCT03527745|11950240|FG017|COMPLETED|Overall Study||27
10448969|NCT00969761|11596268|FG009|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||2
10448970|NCT00969761|11596269|FG010|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
10448971|NCT00969761|11596270|FG011|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
10448972|NCT00969878|11596298|FG000|STARTED|Overall Study||148
10448973|NCT00969878|11596299|FG001|STARTED|Overall Study||152
10448974|NCT00969878|11596298|FG000|COMPLETED|Overall Study||118
10448975|NCT00969878|11596299|FG001|COMPLETED|Overall Study||126
10448976|NCT00969878|11596298|FG000|NOT COMPLETED|Overall Study||30
10448977|NCT00969878|11596299|FG001|NOT COMPLETED|Overall Study||26
10448978|NCT00970073|11596310|FG000|STARTED|Overall Study||10
10448979|NCT00970073|11596311|FG001|STARTED|Overall Study||10
10448980|NCT00970073|11596312|FG002|STARTED|Overall Study||10
10448981|NCT00970073|11596310|FG000|COMPLETED|Overall Study||10
10448982|NCT00970073|11596311|FG001|COMPLETED|Overall Study||10
10448983|NCT00970073|11596312|FG002|COMPLETED|Overall Study||10
10448984|NCT00970073|11596310|FG000|NOT COMPLETED|Overall Study||0
10448985|NCT00970073|11596311|FG001|NOT COMPLETED|Overall Study||0
10448986|NCT00970073|11596312|FG002|NOT COMPLETED|Overall Study||0
10448987|NCT00970203|11596322|FG000|STARTED|Overall Study||7
10448988|NCT00970203|11596323|FG001|STARTED|Overall Study||6
10448989|NCT00970203|11596322|FG000|COMPLETED|Overall Study||7
10448990|NCT00970203|11596323|FG001|COMPLETED|Overall Study||6
10448991|NCT00970203|11596322|FG000|NOT COMPLETED|Overall Study||0
10448992|NCT00970203|11596323|FG001|NOT COMPLETED|Overall Study||0
10448993|NCT00970216|11596329|FG000|STARTED|Overall Study||160
10448994|NCT00970216|11596329|FG000|COMPLETED|Overall Study||80
10448995|NCT00970216|11596329|FG000|NOT COMPLETED|Overall Study||80
10448996|NCT00970268|11596335|FG000|STARTED|Overall Study||139
10448997|NCT00970268|11596336|FG001|STARTED|Overall Study||152
10448998|NCT00970268|11596335|FG000|COMPLETED|Overall Study||96
10448999|NCT00970268|11596336|FG001|COMPLETED|Overall Study||103
10449000|NCT00970268|11596335|FG000|NOT COMPLETED|Overall Study||43
10449001|NCT00970268|11596336|FG001|NOT COMPLETED|Overall Study||49
10449002|NCT00970281|11596350|FG000|STARTED|Overall Study||46
10449003|NCT00970281|11596351|FG001|STARTED|Overall Study||45
10449004|NCT00970281|11596350|FG000|Full Analysis Set|Overall Study|1 participant in the olanzapine arm discontinued before the first intramuscular (IM) injection.|45
10449005|NCT00970281|11596351|FG001|Full Analysis Set|Overall Study||45
10449006|NCT00970281|11596350|FG000|COMPLETED|Overall Study||44
10449007|NCT00970281|11596351|FG001|COMPLETED|Overall Study||29
10449008|NCT00970281|11596350|FG000|NOT COMPLETED|Overall Study||2
10449009|NCT00970281|11596351|FG001|NOT COMPLETED|Overall Study||16
10449010|NCT00970294|11596357|FG000|STARTED|Overall Study||11
10449011|NCT00970294|11596357|FG000|COMPLETED|Overall Study||6
10449012|NCT00970294|11596357|FG000|NOT COMPLETED|Overall Study||5
10449013|NCT00970307|11596364|FG000|STARTED|Overall Study||141
10551178|NCT01536067|11705384|FG000|NOT COMPLETED|Overall Study||1
10551179|NCT01536093|11705390|FG000|STARTED|Overall Study||24
10551180|NCT01536093|11705391|FG001|STARTED|Overall Study||24
10551181|NCT01536093|11705390|FG000|COMPLETED|Overall Study||21
10551182|NCT01536093|11705391|FG001|COMPLETED|Overall Study||21
10551183|NCT01536093|11705390|FG000|NOT COMPLETED|Overall Study||3
10551184|NCT01536093|11705391|FG001|NOT COMPLETED|Overall Study||3
10551185|NCT01536119|11705399|FG000|STARTED|Overall Study|(107*2= 214) (107 mothers and 107 fathers)|214
10551186|NCT01536119|11705400|FG001|STARTED|Overall Study|(107*2=214) (107 mothers and 107 fathers)|214
10551187|NCT01536119|11705399|FG000|COMPLETED|Overall Study|104 Mothers + 93 fathers = 197 participants 3 mothers + 14 fathers = 17 did not complete the study|197
10551188|NCT01536119|11705400|FG001|COMPLETED|Overall Study|105 mothers + 95 fathers = 200 participants 2 mothers + 12 fathers = 14 did not complete the study|200
10551189|NCT01536119|11705399|FG000|NOT COMPLETED|Overall Study||17
10551190|NCT01536119|11705400|FG001|NOT COMPLETED|Overall Study||14
10551191|NCT01536145|11705406|FG000|STARTED|Overall Study||3
10551192|NCT01536145|11705407|FG001|STARTED|Overall Study||4
10551193|NCT01536145|11705408|FG002|STARTED|Overall Study||3
10551194|NCT01536145|11705409|FG003|STARTED|Overall Study||3
10551195|NCT01536145|11705410|FG004|STARTED|Overall Study||4
10551196|NCT01536145|11705411|FG005|STARTED|Overall Study||3
10551197|NCT01536145|11705412|FG006|STARTED|Overall Study||3
10551198|NCT01536145|11705413|FG007|STARTED|Overall Study||4
10551199|NCT01536145|11705414|FG008|STARTED|Overall Study||3
10551200|NCT01536145|11705415|FG009|STARTED|Overall Study||7
10551201|NCT01536145|11705416|FG010|STARTED|Overall Study||10
10789855|NCT03527745|11950241|FG018|COMPLETED|Overall Study||27
10789856|NCT03527745|11950242|FG019|COMPLETED|Overall Study||28
10789857|NCT03527745|11950243|FG020|COMPLETED|Overall Study||25
10789858|NCT03527745|11950244|FG021|COMPLETED|Overall Study||35
10449014|NCT00970307|11596365|FG001|STARTED|Overall Study||139
10449015|NCT00970307|11596366|FG002|STARTED|Overall Study||141
10449016|NCT00970307|11596364|FG000|COMPLETED|Overall Study||138
10449017|NCT00970307|11596365|FG001|COMPLETED|Overall Study||136
10449018|NCT00970307|11596366|FG002|COMPLETED|Overall Study||139
10449019|NCT00970307|11596364|FG000|NOT COMPLETED|Overall Study||3
10449020|NCT00970307|11596365|FG001|NOT COMPLETED|Overall Study||3
10449021|NCT00970307|11596366|FG002|NOT COMPLETED|Overall Study||2
10449022|NCT00970320|11596379|FG000|STARTED|Overall Study||25
10449023|NCT00970320|11596380|FG001|STARTED|Overall Study||24
10551202|NCT01536145|11705406|FG000|COMPLETED|Overall Study||0
10551203|NCT01536145|11705407|FG001|COMPLETED|Overall Study||0
10449024|NCT00970320|11596381|FG002|STARTED|Overall Study||48
10449025|NCT00970320|11596382|FG003|STARTED|Overall Study||50
10449026|NCT00970320|11596383|FG004|STARTED|Overall Study||1571
10789859|NCT03527745|11950245|FG022|COMPLETED|Overall Study||35
10449027|NCT00970320|11596379|FG000|COMPLETED|Overall Study||25
10449028|NCT00970320|11596380|FG001|COMPLETED|Overall Study||13
10449029|NCT00970320|11596381|FG002|COMPLETED|Overall Study||35
10449030|NCT00970320|11596382|FG003|COMPLETED|Overall Study||36
10449031|NCT00970320|11596383|FG004|COMPLETED|Overall Study||1031
10449032|NCT00970320|11596379|FG000|NOT COMPLETED|Overall Study||0
10449033|NCT00970320|11596380|FG001|NOT COMPLETED|Overall Study||11
10449034|NCT00970320|11596381|FG002|NOT COMPLETED|Overall Study||13
10449035|NCT00970320|11596382|FG003|NOT COMPLETED|Overall Study||14
10449036|NCT00970320|11596383|FG004|NOT COMPLETED|Overall Study||540
10449037|NCT00970359|11596395|FG000|STARTED|Overall Study||24
10449038|NCT00970359|11596395|FG000|COMPLETED|Overall Study||20
10449039|NCT00970359|11596395|FG000|NOT COMPLETED|Overall Study||4
10449040|NCT00970489|11596401|FG000|STARTED|Overall Study||758
10449041|NCT00970489|11596402|FG001|STARTED|Overall Study||758
10449042|NCT00970489|11596401|FG000|COMPLETED|Overall Study||704
10449043|NCT00970489|11596402|FG001|COMPLETED|Overall Study||717
10449044|NCT00970489|11596401|FG000|NOT COMPLETED|Overall Study||54
10449045|NCT00970489|11596402|FG001|NOT COMPLETED|Overall Study||41
10449046|NCT00970502|11596408|FG000|STARTED|Overall Study||15
10449047|NCT00970502|11596408|FG000|COMPLETED|Overall Study||14
10449048|NCT00970502|11596408|FG000|NOT COMPLETED|Overall Study||1
10449049|NCT00970593|11596423|FG000|STARTED|Overall Study||11
10449050|NCT00970593|11596424|FG001|STARTED|Overall Study||15
10449051|NCT00970593|11596425|FG002|STARTED|Overall Study||13
10449052|NCT00970593|11596426|FG003|STARTED|Overall Study||12
10449053|NCT00970593|11596427|FG004|STARTED|Overall Study||20
10449054|NCT00970593|11596428|FG005|STARTED|Overall Study||5
10449055|NCT00970593|11596429|FG006|STARTED|Overall Study||16
10449056|NCT00970593|11596423|FG000|COMPLETED|Overall Study||10
10449057|NCT00970593|11596424|FG001|COMPLETED|Overall Study||14
10449058|NCT00970593|11596425|FG002|COMPLETED|Overall Study||7
10449059|NCT00970593|11596426|FG003|COMPLETED|Overall Study||12
10449060|NCT00970593|11596427|FG004|COMPLETED|Overall Study||20
10449061|NCT00970593|11596428|FG005|COMPLETED|Overall Study||5
10449062|NCT00970593|11596429|FG006|COMPLETED|Overall Study||14
10449063|NCT00970593|11596423|FG000|NOT COMPLETED|Overall Study||1
10449064|NCT00970593|11596424|FG001|NOT COMPLETED|Overall Study||1
10449065|NCT00970593|11596425|FG002|NOT COMPLETED|Overall Study||6
10449066|NCT00970593|11596426|FG003|NOT COMPLETED|Overall Study||0
10449067|NCT00970593|11596427|FG004|NOT COMPLETED|Overall Study||0
10449068|NCT00970593|11596428|FG005|NOT COMPLETED|Overall Study||0
10449069|NCT00970593|11596429|FG006|NOT COMPLETED|Overall Study||2
10449070|NCT00970632|11596452|FG000|STARTED|Overall Study||172
10449071|NCT00970632|11596453|FG001|STARTED|Overall Study||171
10449072|NCT00970632|11596454|FG002|STARTED|Overall Study||168
10449073|NCT00970632|11596452|FG000|COMPLETED|Overall Study||148
10449074|NCT00970632|11596453|FG001|COMPLETED|Overall Study||156
10449075|NCT00970632|11596454|FG002|COMPLETED|Overall Study||150
10449076|NCT00970632|11596452|FG000|NOT COMPLETED|Overall Study||24
10449077|NCT00970632|11596453|FG001|NOT COMPLETED|Overall Study||15
10789860|NCT03527745|11950246|FG023|COMPLETED|Overall Study||30
10789861|NCT03527745|11950247|FG024|COMPLETED|Overall Study||39
10789862|NCT03527745|11950248|FG025|COMPLETED|Overall Study||34
10789863|NCT03527745|11950223|FG000|NOT COMPLETED|Overall Study||3
10789864|NCT03527745|11950224|FG001|NOT COMPLETED|Overall Study||6
10789865|NCT03527745|11950225|FG002|NOT COMPLETED|Overall Study||7
10789866|NCT03527745|11950226|FG003|NOT COMPLETED|Overall Study||9
10789867|NCT03527745|11950227|FG004|NOT COMPLETED|Overall Study||0
10789868|NCT03527745|11950228|FG005|NOT COMPLETED|Overall Study||2
10789869|NCT03527745|11950229|FG006|NOT COMPLETED|Overall Study||3
10789870|NCT03527745|11950230|FG007|NOT COMPLETED|Overall Study||2
10789871|NCT03527745|11950231|FG008|NOT COMPLETED|Overall Study||3
10789872|NCT03527745|11950232|FG009|NOT COMPLETED|Overall Study||2
10789873|NCT03527745|11950233|FG010|NOT COMPLETED|Overall Study||1
10789874|NCT03527745|11950234|FG011|NOT COMPLETED|Overall Study||1
10789875|NCT03527745|11950235|FG012|NOT COMPLETED|Overall Study||0
10789876|NCT03527745|11950236|FG013|NOT COMPLETED|Overall Study||0
10789877|NCT03527745|11950237|FG014|NOT COMPLETED|Overall Study||0
10789878|NCT03527745|11950238|FG015|NOT COMPLETED|Overall Study||0
10789879|NCT03527745|11950239|FG016|NOT COMPLETED|Overall Study||1
10789880|NCT03527745|11950240|FG017|NOT COMPLETED|Overall Study||0
10789881|NCT03527745|11950241|FG018|NOT COMPLETED|Overall Study||0
10449078|NCT00970632|11596454|FG002|NOT COMPLETED|Overall Study||18
10789882|NCT03527745|11950242|FG019|NOT COMPLETED|Overall Study||1
10789883|NCT03527745|11950243|FG020|NOT COMPLETED|Overall Study||1
10789884|NCT03527745|11950244|FG021|NOT COMPLETED|Overall Study||5
10789885|NCT03527745|11950245|FG022|NOT COMPLETED|Overall Study||6
10789886|NCT03527745|11950246|FG023|NOT COMPLETED|Overall Study||8
10449082|NCT00970814|11596468|FG000|STARTED|Overall Study||66
10449083|NCT00970814|11596469|FG001|STARTED|Overall Study||64
10449084|NCT00970814|11596468|FG000|COMPLETED|Overall Study||58
10449085|NCT00970814|11596469|FG001|COMPLETED|Overall Study||50
10449086|NCT00970814|11596468|FG000|NOT COMPLETED|Overall Study||8
10449087|NCT00970814|11596469|FG001|NOT COMPLETED|Overall Study||14
10449088|NCT00970853|11596477|FG000|STARTED|Overall Study||89
10449089|NCT00970853|11596478|FG001|STARTED|Overall Study||98
10449090|NCT00970853|11596477|FG000|COMPLETED|Overall Study||89
10789887|NCT03527745|11950247|FG024|NOT COMPLETED|Overall Study||1
10449091|NCT00970853|11596478|FG001|COMPLETED|Overall Study||98
10449092|NCT00970853|11596477|FG000|NOT COMPLETED|Overall Study||0
10449093|NCT00970853|11596478|FG001|NOT COMPLETED|Overall Study||0
10449094|NCT00970944|11596486|FG000|STARTED|Overall Study||87
10449095|NCT00970944|11596487|FG001|STARTED|Overall Study||97
10449096|NCT00970944|11596486|FG000|COMPLETED|Overall Study||86
10449097|NCT00970944|11596487|FG001|COMPLETED|Overall Study||95
10449098|NCT00970944|11596486|FG000|NOT COMPLETED|Overall Study||1
10449099|NCT00970944|11596487|FG001|NOT COMPLETED|Overall Study||2
10449100|NCT00971048|11596498|FG000|STARTED|Overall Study||30
10449101|NCT00971048|11596499|FG001|STARTED|Overall Study||33
10449102|NCT00971048|11596500|FG002|STARTED|Overall Study||12
10449103|NCT00971048|11596501|FG003|STARTED|Overall Study||13
10449104|NCT00971048|11596498|FG000|COMPLETED|Overall Study||29
10449105|NCT00971048|11596499|FG001|COMPLETED|Overall Study||31
10449106|NCT00971048|11596500|FG002|COMPLETED|Overall Study||11
10449107|NCT00971048|11596501|FG003|COMPLETED|Overall Study||11
10449108|NCT00971048|11596498|FG000|NOT COMPLETED|Overall Study||1
10449109|NCT00971048|11596499|FG001|NOT COMPLETED|Overall Study||2
10449110|NCT00971048|11596500|FG002|NOT COMPLETED|Overall Study||1
10449111|NCT00971048|11596501|FG003|NOT COMPLETED|Overall Study||2
10449112|NCT00971178|11596516|FG000|STARTED|Overall Study||35
10449113|NCT00971178|11596517|FG001|STARTED|Overall Study||35
10449114|NCT00971178|11596518|FG002|STARTED|Overall Study||35
10449115|NCT00971178|11596516|FG000|COMPLETED|Overall Study||33
10449116|NCT00971178|11596517|FG001|COMPLETED|Overall Study||33
10449117|NCT00971178|11596518|FG002|COMPLETED|Overall Study||33
10449118|NCT00971178|11596516|FG000|NOT COMPLETED|Overall Study||2
10449119|NCT00971178|11596517|FG001|NOT COMPLETED|Overall Study||2
10449120|NCT00971178|11596518|FG002|NOT COMPLETED|Overall Study||2
10449121|NCT00971204|11596526|FG000|STARTED|Overall Study|100 enrolled participants|100
10449122|NCT00971204|11596526|FG000|Treated|Overall Study||86
10449123|NCT00971204|11596526|FG000|COMPLETED|Overall Study|86 participants were treated and of these 86, 76 completed the study.|76
10449124|NCT00971204|11596526|FG000|NOT COMPLETED|Overall Study||24
10449125|NCT00971243|11596535|FG000|STARTED|Double Blind Period||87
10449126|NCT00971243|11596536|FG001|STARTED|Double Blind Period||93
10449127|NCT00971243|11596537|FG002|STARTED|Double Blind Period||91
10449128|NCT00971243|11596538|FG003|STARTED|Double Blind Period|One subject who did not receive any study drug was excluded from the ITT|88
10449129|NCT00971243|11596539|FG004|STARTED|Double Blind Period||88
10449130|NCT00971243|11596535|FG000|COMPLETED|Double Blind Period||68
10449131|NCT00971243|11596536|FG001|COMPLETED|Double Blind Period||82
10449132|NCT00971243|11596537|FG002|COMPLETED|Double Blind Period||72
10449133|NCT00971243|11596538|FG003|COMPLETED|Double Blind Period||74
10449134|NCT00971243|11596539|FG004|COMPLETED|Double Blind Period||70
10449135|NCT00971243|11596535|FG000|NOT COMPLETED|Double Blind Period||19
10449136|NCT00971243|11596536|FG001|NOT COMPLETED|Double Blind Period||11
10449137|NCT00971243|11596537|FG002|NOT COMPLETED|Double Blind Period||19
10449138|NCT00971243|11596538|FG003|NOT COMPLETED|Double Blind Period||14
10449139|NCT00971243|11596539|FG004|NOT COMPLETED|Double Blind Period||18
10449140|NCT00971243|11596535|FG000|STARTED|Open-label Period||68
10449141|NCT00971243|11596536|FG001|STARTED|Open-label Period|One Subject did not entered because of the failure of inclusion/exclusion criteria.|81
10449142|NCT00971243|11596537|FG002|STARTED|Open-label Period|One Subject did not entered the Open-label Period because of the withdrawal of consent.|71
10449143|NCT00971243|11596538|FG003|STARTED|Open-label Period||74
10449144|NCT00971243|11596539|FG004|STARTED|Open-label Period||70
10449145|NCT00971243|11596535|FG000|COMPLETED|Open-label Period||60
10449146|NCT00971243|11596536|FG001|COMPLETED|Open-label Period||71
10449147|NCT00971243|11596537|FG002|COMPLETED|Open-label Period||66
10449148|NCT00971243|11596538|FG003|COMPLETED|Open-label Period||64
10449149|NCT00971243|11596539|FG004|COMPLETED|Open-label Period||64
10449150|NCT00971243|11596535|FG000|NOT COMPLETED|Open-label Period||8
10449151|NCT00971243|11596536|FG001|NOT COMPLETED|Open-label Period||10
10449152|NCT00971243|11596537|FG002|NOT COMPLETED|Open-label Period||5
10449153|NCT00971243|11596538|FG003|NOT COMPLETED|Open-label Period||10
10449154|NCT00971243|11596539|FG004|NOT COMPLETED|Open-label Period||6
10449155|NCT00971282|11596551|FG000|STARTED|Overall Study||30
10449156|NCT00971282|11596551|FG000|COMPLETED|Overall Study||30
10449157|NCT00971282|11596551|FG000|NOT COMPLETED|Overall Study||0
10449158|NCT00971295|11596557|FG000|STARTED|Overall Study||10
10449159|NCT00971295|11596558|FG001|STARTED|Overall Study||10
10449160|NCT00971295|11596557|FG000|COMPLETED|Overall Study||10
10449161|NCT00971295|11596558|FG001|COMPLETED|Overall Study||9
10449162|NCT00971295|11596557|FG000|NOT COMPLETED|Overall Study||0
10449163|NCT00971295|11596558|FG001|NOT COMPLETED|Overall Study||1
10449164|NCT00971321|11596566|FG000|STARTED|Up to Day 42||104
10449165|NCT00971321|11596567|FG001|STARTED|Up to Day 42||53
10449166|NCT00971321|11596566|FG000|COMPLETED|Up to Day 42||104
10449167|NCT00971321|11596567|FG001|COMPLETED|Up to Day 42||53
10449168|NCT00971321|11596566|FG000|NOT COMPLETED|Up to Day 42||0
10449169|NCT00971321|11596567|FG001|NOT COMPLETED|Up to Day 42||0
10449170|NCT00971321|11596566|FG000|STARTED|Up to Month 7||104
10449171|NCT00971321|11596567|FG001|STARTED|Up to Month 7||53
10449172|NCT00971321|11596566|FG000|COMPLETED|Up to Month 7||100
10449173|NCT00971321|11596567|FG001|COMPLETED|Up to Month 7||51
10449174|NCT00971321|11596566|FG000|NOT COMPLETED|Up to Month 7||4
10449175|NCT00971321|11596567|FG001|NOT COMPLETED|Up to Month 7||2
10449176|NCT00971321|11596566|FG000|STARTED|Up to Month 11-12||104
10789888|NCT03527745|11950248|FG025|NOT COMPLETED|Overall Study||3
10449177|NCT00971321|11596567|FG001|STARTED|Up to Month 11-12||53
10449178|NCT00971321|11596566|FG000|COMPLETED|Up to Month 11-12||99
10449179|NCT00971321|11596567|FG001|COMPLETED|Up to Month 11-12||50
10449180|NCT00971321|11596566|FG000|NOT COMPLETED|Up to Month 11-12||5
10449181|NCT00971321|11596567|FG001|NOT COMPLETED|Up to Month 11-12||3
10449182|NCT00971425|11596575|FG000|STARTED|Overall Study||72
10449183|NCT00971425|11596576|FG001|STARTED|Overall Study||73
10449184|NCT00971425|11596575|FG000|COMPLETED|Overall Study||71
10449185|NCT00971425|11596576|FG001|COMPLETED|Overall Study||71
10449186|NCT00971425|11596575|FG000|NOT COMPLETED|Overall Study||1
10449187|NCT00971425|11596576|FG001|NOT COMPLETED|Overall Study||2
10449188|NCT00971620|11596584|FG000|STARTED|Overall Study||9
10449189|NCT00971620|11596585|FG001|STARTED|Overall Study||9
10449190|NCT00971620|11596584|FG000|COMPLETED|Overall Study||9
10449191|NCT00971620|11596585|FG001|COMPLETED|Overall Study||9
10449192|NCT00971620|11596584|FG000|NOT COMPLETED|Overall Study||0
10449193|NCT00971620|11596585|FG001|NOT COMPLETED|Overall Study||0
10449194|NCT00971633|11596591|FG000|STARTED|Period 1||2
10449195|NCT00971633|11596592|FG001|STARTED|Period 1||2
10449196|NCT00971633|11596593|FG002|STARTED|Period 1||2
10449197|NCT00971633|11596594|FG003|STARTED|Period 1||2
10449198|NCT00971633|11596595|FG004|STARTED|Period 1||2
10449199|NCT00971633|11596596|FG005|STARTED|Period 1||2
10449200|NCT00971633|11596591|FG000|COMPLETED|Period 1||2
10449201|NCT00971633|11596592|FG001|COMPLETED|Period 1||2
10449202|NCT00971633|11596593|FG002|COMPLETED|Period 1||2
10449203|NCT00971633|11596594|FG003|COMPLETED|Period 1||2
10449204|NCT00971633|11596595|FG004|COMPLETED|Period 1||2
10449205|NCT00971633|11596596|FG005|COMPLETED|Period 1||2
10449206|NCT00971633|11596591|FG000|NOT COMPLETED|Period 1||0
10449207|NCT00971633|11596592|FG001|NOT COMPLETED|Period 1||0
10449208|NCT00971633|11596593|FG002|NOT COMPLETED|Period 1||0
10449209|NCT00971633|11596594|FG003|NOT COMPLETED|Period 1||0
10449210|NCT00971633|11596595|FG004|NOT COMPLETED|Period 1||0
10449211|NCT00971633|11596596|FG005|NOT COMPLETED|Period 1||0
10449212|NCT00971633|11596591|FG000|STARTED|Period 2||2
10449213|NCT00971633|11596592|FG001|STARTED|Period 2||2
10449214|NCT00971633|11596593|FG002|STARTED|Period 2||2
10449215|NCT00971633|11596594|FG003|STARTED|Period 2||2
10449216|NCT00971633|11596595|FG004|STARTED|Period 2||2
10449217|NCT00971633|11596596|FG005|STARTED|Period 2||2
10449218|NCT00971633|11596591|FG000|COMPLETED|Period 2||2
10449219|NCT00971633|11596592|FG001|COMPLETED|Period 2||2
10449220|NCT00971633|11596593|FG002|COMPLETED|Period 2||2
10449221|NCT00971633|11596594|FG003|COMPLETED|Period 2||2
10449222|NCT00971633|11596595|FG004|COMPLETED|Period 2||2
10449223|NCT00971633|11596596|FG005|COMPLETED|Period 2||2
10449224|NCT00971633|11596591|FG000|NOT COMPLETED|Period 2||0
10449225|NCT00971633|11596592|FG001|NOT COMPLETED|Period 2||0
10449226|NCT00971633|11596593|FG002|NOT COMPLETED|Period 2||0
10449227|NCT00971633|11596594|FG003|NOT COMPLETED|Period 2||0
10449228|NCT00971633|11596595|FG004|NOT COMPLETED|Period 2||0
10449229|NCT00971633|11596596|FG005|NOT COMPLETED|Period 2||0
10449230|NCT00971633|11596591|FG000|STARTED|Period 3||2
10449231|NCT00971633|11596592|FG001|STARTED|Period 3||2
10449232|NCT00971633|11596593|FG002|STARTED|Period 3||2
10449233|NCT00971633|11596594|FG003|STARTED|Period 3||2
10449234|NCT00971633|11596595|FG004|STARTED|Period 3||2
10449235|NCT00971633|11596596|FG005|STARTED|Period 3||2
10449236|NCT00971633|11596591|FG000|COMPLETED|Period 3||2
10449237|NCT00971633|11596592|FG001|COMPLETED|Period 3||2
10449238|NCT00971633|11596593|FG002|COMPLETED|Period 3||2
10449239|NCT00971633|11596594|FG003|COMPLETED|Period 3||2
10449240|NCT00971633|11596595|FG004|COMPLETED|Period 3||2
10449241|NCT00971633|11596596|FG005|COMPLETED|Period 3||2
10449242|NCT00971633|11596591|FG000|NOT COMPLETED|Period 3||0
10449243|NCT00971633|11596592|FG001|NOT COMPLETED|Period 3||0
10449244|NCT00971633|11596593|FG002|NOT COMPLETED|Period 3||0
10449245|NCT00971633|11596594|FG003|NOT COMPLETED|Period 3||0
10449246|NCT00971633|11596595|FG004|NOT COMPLETED|Period 3||0
10449247|NCT00971633|11596596|FG005|NOT COMPLETED|Period 3||0
10449248|NCT00971737|11596606|FG000|STARTED|Overall Study||30
10449249|NCT00971737|11596607|FG001|STARTED|Overall Study||30
10449250|NCT00971737|11596606|FG000|COMPLETED|Overall Study||30
10449251|NCT00971737|11596607|FG001|COMPLETED|Overall Study||30
10449252|NCT00971737|11596606|FG000|NOT COMPLETED|Overall Study||0
10449253|NCT00971737|11596607|FG001|NOT COMPLETED|Overall Study||0
10449254|NCT00971750|11596613|FG000|STARTED|Overall Study||253
10449255|NCT00971750|11596613|FG000|COMPLETED|Overall Study||253
10449256|NCT00971750|11596613|FG000|NOT COMPLETED|Overall Study||0
10449257|NCT00971789|11596619|FG000|STARTED|Overall Study||18
10449258|NCT00971789|11596619|FG000|COMPLETED|Overall Study||18
10449259|NCT00971789|11596619|FG000|NOT COMPLETED|Overall Study||0
10449260|NCT00971841|11596623|FG000|STARTED|Overall Study||1
10449261|NCT00971841|11596623|FG000|COMPLETED|Overall Study||1
10449262|NCT00971841|11596623|FG000|NOT COMPLETED|Overall Study||0
10449263|NCT00971932|11596627|FG000|STARTED|Overall Study|Number of participants treated.|33
10449264|NCT00971932|11596627|FG000|COMPLETED|Overall Study||26
10449265|NCT00971932|11596627|FG000|NOT COMPLETED|Overall Study||7
10449266|NCT00971945|11596631|FG000|STARTED|Overall Study||6
10449267|NCT00971945|11596631|FG000|COMPLETED|Overall Study||0
10449268|NCT00971945|11596631|FG000|NOT COMPLETED|Overall Study||6
10449269|NCT00971997|11596635|FG000|STARTED|Overall Study||135
10449270|NCT00971997|11596635|FG000|COMPLETED|Overall Study||116
10449271|NCT00971997|11596635|FG000|NOT COMPLETED|Overall Study||19
10449272|NCT00972088|11596642|FG000|STARTED|Overall Study||26
10449273|NCT00972088|11596642|FG000|COMPLETED|Overall Study||26
10449274|NCT00972088|11596642|FG000|NOT COMPLETED|Overall Study||0
10449275|NCT00972153|11596649|FG000|STARTED|Overall Study||12
10449276|NCT00972153|11596650|FG001|STARTED|Overall Study||12
10449277|NCT00972153|11596651|FG002|STARTED|Overall Study||12
10449278|NCT00972153|11596649|FG000|COMPLETED|Overall Study||12
10449279|NCT00972153|11596650|FG001|COMPLETED|Overall Study|One case excluded due to technical problem with measuring equipment.|11
10449280|NCT00972153|11596651|FG002|COMPLETED|Overall Study||12
10449281|NCT00972153|11596649|FG000|NOT COMPLETED|Overall Study||0
10449282|NCT00972153|11596650|FG001|NOT COMPLETED|Overall Study||1
10449283|NCT00972153|11596651|FG002|NOT COMPLETED|Overall Study||0
10449284|NCT00972205|11596659|FG000|STARTED|Overall Study||12
10449285|NCT00972205|11596659|FG000|COMPLETED|Overall Study||12
10449286|NCT00972205|11596659|FG000|NOT COMPLETED|Overall Study||0
10449287|NCT00972244|11596668|FG000|STARTED|Overall Study||59
10449288|NCT00972244|11596669|FG001|STARTED|Overall Study||56
10449289|NCT00972244|11596670|FG002|STARTED|Overall Study||58
10449290|NCT00972244|11596671|FG003|STARTED|Overall Study||52
10449291|NCT00972244|11596672|FG004|STARTED|Overall Study||54
10449292|NCT00972244|11596668|FG000|COMPLETED|Overall Study||54
10449293|NCT00972244|11596669|FG001|COMPLETED|Overall Study||51
10449294|NCT00972244|11596670|FG002|COMPLETED|Overall Study||56
10449295|NCT00972244|11596671|FG003|COMPLETED|Overall Study||52
10449296|NCT00972244|11596672|FG004|COMPLETED|Overall Study||45
10449297|NCT00972244|11596668|FG000|NOT COMPLETED|Overall Study||5
10449298|NCT00972244|11596669|FG001|NOT COMPLETED|Overall Study||5
10449299|NCT00972244|11596670|FG002|NOT COMPLETED|Overall Study||2
10449300|NCT00972244|11596671|FG003|NOT COMPLETED|Overall Study||0
10449301|NCT00972244|11596672|FG004|NOT COMPLETED|Overall Study||9
10449302|NCT00972283|11596686|FG000|STARTED|Main: Week 0 to 52 (NN1250-3582)||755
10449303|NCT00972283|11596687|FG001|STARTED|Main: Week 0 to 52 (NN1250-3582)||251
10449304|NCT00972283|11596686|FG000|Full Analysis Set|Main: Week 0 to 52 (NN1250-3582)|11 subjects were excluded due to closure of a site|744
10449305|NCT00972283|11596687|FG001|Full Analysis Set|Main: Week 0 to 52 (NN1250-3582)|3 subjects were excluded due to closure of a site|248
10449306|NCT00972283|11596686|FG000|Exposed|Main: Week 0 to 52 (NN1250-3582)|2 subjects were withdrawn prior to exposure to trial products|753
10449307|NCT00972283|11596687|FG001|Exposed|Main: Week 0 to 52 (NN1250-3582)||251
10449308|NCT00972283|11596686|FG000|COMPLETED|Main: Week 0 to 52 (NN1250-3582)||618
10449309|NCT00972283|11596687|FG001|COMPLETED|Main: Week 0 to 52 (NN1250-3582)||211
10449310|NCT00972283|11596686|FG000|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3582)||137
10449311|NCT00972283|11596687|FG001|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3582)||40
10449312|NCT00972283|11596686|FG000|STARTED|Extension: Week 53 to 78 (NN1250-3667)|52 subjects did not continue into the extension from main trial|566
10449313|NCT00972283|11596687|FG001|STARTED|Extension: Week 53 to 78 (NN1250-3667)|20 subjects did not continue into the extension from main trial|191
10449314|NCT00972283|11596686|FG000|COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||539
10449315|NCT00972283|11596687|FG001|COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||183
10449316|NCT00972283|11596686|FG000|NOT COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||27
10449317|NCT00972283|11596687|FG001|NOT COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||8
10449318|NCT00972322|11596695|FG000|STARTED|Overall Study||28
10449319|NCT00972322|11596696|FG001|STARTED|Overall Study||28
10449320|NCT00972322|11596695|FG000|COMPLETED|Overall Study||25
10449321|NCT00972322|11596696|FG001|COMPLETED|Overall Study||25
10449322|NCT00972322|11596695|FG000|NOT COMPLETED|Overall Study||3
10449323|NCT00972322|11596696|FG001|NOT COMPLETED|Overall Study||3
10449324|NCT00972335|11596702|FG000|STARTED|Overall Study|One patient was enrolled but showed no evidence of disease at study entry and was not treated|17
10449325|NCT00972335|11596702|FG000|COMPLETED|Overall Study|Patients were on study until an event or condition occured which required them to come off study|0
10449326|NCT00972335|11596702|FG000|NOT COMPLETED|Overall Study||17
10449327|NCT00972374|11596709|FG000|STARTED|Overall Study||15
10449328|NCT00972374|11596710|FG001|STARTED|Overall Study||15
10449329|NCT00972374|11596711|FG002|STARTED|Overall Study||14
10449330|NCT00972374|11596709|FG000|COMPLETED|Overall Study||13
10449331|NCT00972374|11596710|FG001|COMPLETED|Overall Study||15
10449332|NCT00972374|11596711|FG002|COMPLETED|Overall Study||13
10449333|NCT00972374|11596709|FG000|NOT COMPLETED|Overall Study||2
10449334|NCT00972374|11596710|FG001|NOT COMPLETED|Overall Study||0
10449335|NCT00972374|11596711|FG002|NOT COMPLETED|Overall Study||1
10449336|NCT00972439|11596721|FG000|STARTED|Overall Study||17
10449337|NCT00972439|11596722|FG001|STARTED|Overall Study||16
10449338|NCT00972439|11596721|FG000|COMPLETED|Overall Study||17
10449339|NCT00972439|11596722|FG001|COMPLETED|Overall Study||16
10449340|NCT00972439|11596721|FG000|NOT COMPLETED|Overall Study||0
10449341|NCT00972439|11596722|FG001|NOT COMPLETED|Overall Study||0
10449342|NCT00972504|11596728|FG000|STARTED|Overall Study||54
10449343|NCT00972504|11596728|FG000|COMPLETED|Overall Study||51
10449344|NCT00972504|11596728|FG000|NOT COMPLETED|Overall Study||3
10449345|NCT00972517|11596738|FG000|STARTED|Overall Study||31
10449346|NCT00972517|11596739|FG001|STARTED|Overall Study||31
10449347|NCT00972517|11596740|FG002|STARTED|Overall Study||60
10449348|NCT00972517|11596741|FG003|STARTED|Overall Study||30
10449349|NCT00972517|11596742|FG004|STARTED|Overall Study||34
10449350|NCT00972517|11596743|FG005|STARTED|Overall Study||58
10449351|NCT00972517|11596738|FG000|COMPLETED|Overall Study||31
10449352|NCT00972517|11596739|FG001|COMPLETED|Overall Study||30
10449353|NCT00972517|11596740|FG002|COMPLETED|Overall Study||60
10449354|NCT00972517|11596741|FG003|COMPLETED|Overall Study||27
10449355|NCT00972517|11596742|FG004|COMPLETED|Overall Study||33
10449356|NCT00972517|11596743|FG005|COMPLETED|Overall Study||58
10449357|NCT00972517|11596738|FG000|NOT COMPLETED|Overall Study||0
10449358|NCT00972517|11596739|FG001|NOT COMPLETED|Overall Study||1
10449359|NCT00972517|11596740|FG002|NOT COMPLETED|Overall Study||0
10449360|NCT00972517|11596741|FG003|NOT COMPLETED|Overall Study||3
10449361|NCT00972517|11596742|FG004|NOT COMPLETED|Overall Study||1
10449362|NCT00972517|11596743|FG005|NOT COMPLETED|Overall Study||0
10449363|NCT00972530|11596765|FG000|STARTED|Overall Study||44
10449364|NCT00972530|11596766|FG001|STARTED|Overall Study||46
10449365|NCT00972530|11596765|FG000|COMPLETED|Overall Study||44
10449366|NCT00972530|11596766|FG001|COMPLETED|Overall Study||46
10449367|NCT00972530|11596765|FG000|NOT COMPLETED|Overall Study||0
10449368|NCT00972530|11596766|FG001|NOT COMPLETED|Overall Study||0
10449369|NCT00972543|11596774|FG000|STARTED|Overall Study||5
10449370|NCT00972543|11596775|FG001|STARTED|Overall Study||1
10449371|NCT00972543|11596774|FG000|COMPLETED|Overall Study||0
10449372|NCT00972543|11596775|FG001|COMPLETED|Overall Study||0
10449373|NCT00972543|11596774|FG000|NOT COMPLETED|Overall Study||5
10449374|NCT00972543|11596775|FG001|NOT COMPLETED|Overall Study||1
10449375|NCT00972595|11596781|FG000|STARTED|Period 1||23
10449376|NCT00972595|11596782|FG001|STARTED|Period 1||22
10449377|NCT00972595|11596781|FG000|COMPLETED|Period 1||22
10449378|NCT00972595|11596782|FG001|COMPLETED|Period 1||22
10449379|NCT00972595|11596781|FG000|NOT COMPLETED|Period 1||1
10449380|NCT00972595|11596782|FG001|NOT COMPLETED|Period 1||0
10449381|NCT00972595|11596781|FG000|STARTED|Period 2||22
10449382|NCT00972595|11596782|FG001|STARTED|Period 2||22
10449383|NCT00972595|11596781|FG000|COMPLETED|Period 2||22
10449384|NCT00972595|11596782|FG001|COMPLETED|Period 2||22
10449385|NCT00972595|11596781|FG000|NOT COMPLETED|Period 2||0
10449386|NCT00972595|11596782|FG001|NOT COMPLETED|Period 2||0
10449387|NCT00972621|11596790|FG000|STARTED|Overall Study||200
10449388|NCT00972621|11596791|FG001|STARTED|Overall Study||200
10449389|NCT00972621|11596790|FG000|COMPLETED|Overall Study||200
10449390|NCT00972621|11596791|FG001|COMPLETED|Overall Study|One subject discontinued due to lens exchange.|199
10449391|NCT00972621|11596790|FG000|NOT COMPLETED|Overall Study||0
10449392|NCT00972621|11596791|FG001|NOT COMPLETED|Overall Study||1
10449393|NCT00972725|11596799|FG000|STARTED|Overall Study||13
10449394|NCT00972725|11596800|FG001|STARTED|Overall Study||15
10449395|NCT00972725|11596799|FG000|COMPLETED|Overall Study||13
10449396|NCT00972725|11596800|FG001|COMPLETED|Overall Study||15
10449397|NCT00972725|11596799|FG000|NOT COMPLETED|Overall Study||0
10449398|NCT00972725|11596800|FG001|NOT COMPLETED|Overall Study||0
10449399|NCT00972777|11596808|FG000|STARTED|Overall Study||231
10449400|NCT00972777|11596809|FG001|STARTED|Overall Study||243
10449401|NCT00972777|11596808|FG000|COMPLETED|Overall Study||217
10449402|NCT00972777|11596809|FG001|COMPLETED|Overall Study||229
10449403|NCT00972777|11596808|FG000|NOT COMPLETED|Overall Study||14
10449404|NCT00972777|11596809|FG001|NOT COMPLETED|Overall Study||14
10449405|NCT00972816|11596823|FG000|STARTED|Overall Study||173
10449406|NCT00972816|11596824|FG001|STARTED|Overall Study||169
10449407|NCT00972816|11596825|FG002|STARTED|Overall Study||169
10449408|NCT00972816|11596826|FG003|STARTED|Overall Study||169
10449409|NCT00972816|11596827|FG004|STARTED|Overall Study||169
10449410|NCT00972816|11596828|FG005|STARTED|Overall Study||169
10449411|NCT00972816|11596829|FG006|STARTED|Overall Study||169
10449412|NCT00972816|11596830|FG007|STARTED|Overall Study||170
10449413|NCT00972816|11596823|FG000|COMPLETED|Overall Study||156
10449414|NCT00972816|11596824|FG001|COMPLETED|Overall Study||158
10449415|NCT00972816|11596825|FG002|COMPLETED|Overall Study||160
10449416|NCT00972816|11596826|FG003|COMPLETED|Overall Study||161
10449417|NCT00972816|11596827|FG004|COMPLETED|Overall Study||157
10449418|NCT00972816|11596828|FG005|COMPLETED|Overall Study||158
10449419|NCT00972816|11596829|FG006|COMPLETED|Overall Study||159
10449420|NCT00972816|11596830|FG007|COMPLETED|Overall Study||161
10449421|NCT00972816|11596823|FG000|NOT COMPLETED|Overall Study||17
10449422|NCT00972816|11596824|FG001|NOT COMPLETED|Overall Study||11
10449423|NCT00972816|11596825|FG002|NOT COMPLETED|Overall Study||9
10449424|NCT00972816|11596826|FG003|NOT COMPLETED|Overall Study||8
10449425|NCT00972816|11596827|FG004|NOT COMPLETED|Overall Study||12
10449426|NCT00972816|11596828|FG005|NOT COMPLETED|Overall Study||11
10449427|NCT00972816|11596829|FG006|NOT COMPLETED|Overall Study||10
10449428|NCT00972816|11596830|FG007|NOT COMPLETED|Overall Study||9
10449429|NCT00972959|11596848|FG000|STARTED|Overall Study||17
10449430|NCT00972959|11596848|FG000|COMPLETED|Overall Study||17
10551204|NCT01536145|11705408|FG002|COMPLETED|Overall Study||1
10551205|NCT01536145|11705409|FG003|COMPLETED|Overall Study||1
10551206|NCT01536145|11705410|FG004|COMPLETED|Overall Study||2
10551207|NCT01536145|11705411|FG005|COMPLETED|Overall Study||0
10449431|NCT00972959|11596848|FG000|NOT COMPLETED|Overall Study||0
10449432|NCT00973102|11596854|FG000|STARTED|Overall Study||24
10449433|NCT00973102|11596855|FG001|STARTED|Overall Study||26
10449434|NCT00973102|11596854|FG000|COMPLETED|Overall Study||23
10449435|NCT00973102|11596855|FG001|COMPLETED|Overall Study||25
10449436|NCT00973102|11596854|FG000|NOT COMPLETED|Overall Study||1
10551208|NCT01536145|11705412|FG006|COMPLETED|Overall Study||1
10551209|NCT01536145|11705413|FG007|COMPLETED|Overall Study||0
10551210|NCT01536145|11705414|FG008|COMPLETED|Overall Study||0
10449437|NCT00973102|11596855|FG001|NOT COMPLETED|Overall Study||1
10449438|NCT00973349|11596877|FG000|STARTED|Overall Study||170
10449439|NCT00973349|11596878|FG001|STARTED|Overall Study||168
10449440|NCT00973349|11596879|FG002|STARTED|Overall Study||171
10449441|NCT00973349|11596880|FG003|STARTED|Overall Study||168
10449442|NCT00973349|11596881|FG004|STARTED|Overall Study||170
10449443|NCT00973349|11596882|FG005|STARTED|Overall Study||169
10449444|NCT00973349|11596883|FG006|STARTED|Overall Study||174
10449445|NCT00973349|11596884|FG007|STARTED|Overall Study||169
10449446|NCT00973349|11596885|FG008|STARTED|Overall Study||171
10449447|NCT00973349|11596886|FG009|STARTED|Overall Study||169
10449448|NCT00973349|11596887|FG010|STARTED|Overall Study||174
10449449|NCT00973349|11596888|FG011|STARTED|Overall Study||169
10449450|NCT00973349|11596889|FG012|STARTED|Overall Study||169
10449451|NCT00973349|11596890|FG013|STARTED|Overall Study||171
10449452|NCT00973349|11596891|FG014|STARTED|Overall Study||170
10449453|NCT00973349|11596892|FG015|STARTED|Overall Study||167
10449454|NCT00973349|11596877|FG000|COMPLETED|Overall Study||166
10449455|NCT00973349|11596878|FG001|COMPLETED|Overall Study||165
10449456|NCT00973349|11596879|FG002|COMPLETED|Overall Study||166
10449457|NCT00973349|11596880|FG003|COMPLETED|Overall Study||163
10449458|NCT00973349|11596881|FG004|COMPLETED|Overall Study||165
10449459|NCT00973349|11596882|FG005|COMPLETED|Overall Study||165
10449460|NCT00973349|11596883|FG006|COMPLETED|Overall Study||172
10449461|NCT00973349|11596884|FG007|COMPLETED|Overall Study||166
10449462|NCT00973349|11596885|FG008|COMPLETED|Overall Study||167
10449463|NCT00973349|11596886|FG009|COMPLETED|Overall Study||163
10449464|NCT00973349|11596887|FG010|COMPLETED|Overall Study||174
10449465|NCT00973349|11596888|FG011|COMPLETED|Overall Study||167
10449466|NCT00973349|11596889|FG012|COMPLETED|Overall Study||168
10449467|NCT00973349|11596890|FG013|COMPLETED|Overall Study||171
10449468|NCT00973349|11596891|FG014|COMPLETED|Overall Study||168
10449469|NCT00973349|11596892|FG015|COMPLETED|Overall Study||165
10449470|NCT00973349|11596877|FG000|NOT COMPLETED|Overall Study||4
10449471|NCT00973349|11596878|FG001|NOT COMPLETED|Overall Study||3
10449472|NCT00973349|11596879|FG002|NOT COMPLETED|Overall Study||5
10449473|NCT00973349|11596880|FG003|NOT COMPLETED|Overall Study||5
10449474|NCT00973349|11596881|FG004|NOT COMPLETED|Overall Study||5
10449475|NCT00973349|11596882|FG005|NOT COMPLETED|Overall Study||4
10449476|NCT00973349|11596883|FG006|NOT COMPLETED|Overall Study||2
10449477|NCT00973349|11596884|FG007|NOT COMPLETED|Overall Study||3
10449478|NCT00973349|11596885|FG008|NOT COMPLETED|Overall Study||4
10449479|NCT00973349|11596886|FG009|NOT COMPLETED|Overall Study||6
10449480|NCT00973349|11596887|FG010|NOT COMPLETED|Overall Study||0
10449481|NCT00973349|11596888|FG011|NOT COMPLETED|Overall Study||2
10449482|NCT00973349|11596889|FG012|NOT COMPLETED|Overall Study||1
10449483|NCT00973349|11596890|FG013|NOT COMPLETED|Overall Study||0
10449484|NCT00973349|11596891|FG014|NOT COMPLETED|Overall Study||2
10449485|NCT00973349|11596892|FG015|NOT COMPLETED|Overall Study||2
10449486|NCT00973362|11596920|FG000|STARTED|Baseline Evaluation||11644
10449487|NCT00973362|11596921|FG001|STARTED|Baseline Evaluation||1252
10449488|NCT00973362|11596920|FG000|Evaluable for Analysis|Baseline Evaluation||10871
10449489|NCT00973362|11596921|FG001|Evaluable for Analysis|Baseline Evaluation||958
10449490|NCT00973362|11596920|FG000|Conclusive Disease Status|Baseline Evaluation||819
10449491|NCT00973362|11596921|FG001|Conclusive Disease Status|Baseline Evaluation||939
10449492|NCT00973362|11596920|FG000|COMPLETED|Baseline Evaluation||10871
10449493|NCT00973362|11596921|FG001|COMPLETED|Baseline Evaluation||1029
10449494|NCT00973362|11596920|FG000|NOT COMPLETED|Baseline Evaluation||773
10449495|NCT00973362|11596921|FG001|NOT COMPLETED|Baseline Evaluation||223
10449496|NCT00973362|11596920|FG000|STARTED|3-Year Follow-up||10871
10449497|NCT00973362|11596921|FG001|STARTED|3-Year Follow-up|ASC-US study arm did not have a follow-up period|0
10449498|NCT00973362|11596920|FG000|COMPLETED|3-Year Follow-up||10854
10449499|NCT00973362|11596921|FG001|COMPLETED|3-Year Follow-up||0
10449500|NCT00973362|11596920|FG000|NOT COMPLETED|3-Year Follow-up||17
10449501|NCT00973362|11596921|FG001|NOT COMPLETED|3-Year Follow-up||0
10449502|NCT00973479|11596932|FG000|STARTED|Overall Study||197
10449503|NCT00973479|11596933|FG001|STARTED|Overall Study||395
10449504|NCT00973479|11596932|FG000|COMPLETED|Overall Study||160
10449505|NCT00973479|11596933|FG001|COMPLETED|Overall Study||326
10449506|NCT00973479|11596932|FG000|NOT COMPLETED|Overall Study||37
10449507|NCT00973479|11596933|FG001|NOT COMPLETED|Overall Study||69
10449508|NCT00973622|11596943|FG000|STARTED|Overall Study|75 passed telephone interview; 28 passed in-person interview, were enrolled, and sent for MRI.|47
10449509|NCT00973622|11596944|FG001|STARTED|Overall Study|21 passed telephone interview; 19 passed the in-person interview, were enrolled, and sent for MRI.|19
10449510|NCT00973622|11596943|FG000|COMPLETED|Overall Study|Completed three sessions of rTMS|16
10449511|NCT00973622|11596944|FG001|COMPLETED|Overall Study|Completed three sessions of rTMS|14
10449512|NCT00973622|11596943|FG000|NOT COMPLETED|Overall Study||31
10449513|NCT00973622|11596944|FG001|NOT COMPLETED|Overall Study||5
10449514|NCT00973674|11596952|FG000|STARTED|Overall Study||24
10449515|NCT00973674|11596953|FG001|STARTED|Overall Study||26
10449516|NCT00973674|11596952|FG000|COMPLETED|Overall Study||22
10449517|NCT00973674|11596953|FG001|COMPLETED|Overall Study||26
10449518|NCT00973674|11596952|FG000|NOT COMPLETED|Overall Study||2
10449519|NCT00973674|11596953|FG001|NOT COMPLETED|Overall Study||0
10449520|NCT00973700|11596965|FG000|STARTED|Overall Study||56
10449521|NCT00973700|11596966|FG001|STARTED|Overall Study||56
10449522|NCT00973700|11596967|FG002|STARTED|Overall Study||168
10449523|NCT00973700|11596968|FG003|STARTED|Overall Study||336
10449524|NCT00973700|11596969|FG004|STARTED|Overall Study||168
10449525|NCT00973700|11596965|FG000|COMPLETED|Overall Study||49
10449526|NCT00973700|11596966|FG001|COMPLETED|Overall Study||54
10449527|NCT00973700|11596967|FG002|COMPLETED|Overall Study||158
10449528|NCT00973700|11596968|FG003|COMPLETED|Overall Study||318
10449529|NCT00973700|11596969|FG004|COMPLETED|Overall Study||158
10449530|NCT00973700|11596965|FG000|NOT COMPLETED|Overall Study||7
10449531|NCT00973700|11596966|FG001|NOT COMPLETED|Overall Study||2
10449532|NCT00973700|11596967|FG002|NOT COMPLETED|Overall Study||10
10449533|NCT00973700|11596968|FG003|NOT COMPLETED|Overall Study||18
10449534|NCT00973700|11596969|FG004|NOT COMPLETED|Overall Study||10
10449535|NCT00973739|11596996|FG000|STARTED|Overall Study||21
10449536|NCT00973739|11596996|FG000|COMPLETED|Overall Study||17
10449537|NCT00973739|11596996|FG000|NOT COMPLETED|Overall Study||4
10449538|NCT00973752|11597000|FG000|STARTED|Overall Study||30
10449539|NCT00973752|11597000|FG000|COMPLETED|Overall Study||30
10449540|NCT00973752|11597000|FG000|NOT COMPLETED|Overall Study||0
10449541|NCT00973765|11597006|FG000|STARTED|Overall Study|96|96
10449542|NCT00973765|11597007|FG001|STARTED|Overall Study|116|116
10449543|NCT00973765|11597006|FG000|COMPLETED|Overall Study|88|88
10449544|NCT00973765|11597007|FG001|COMPLETED|Overall Study|102|102
10449545|NCT00973765|11597006|FG000|NOT COMPLETED|Overall Study||8
10449546|NCT00973765|11597007|FG001|NOT COMPLETED|Overall Study||14
10449547|NCT00973921|11597013|FG000|STARTED|Overall Study||40
10449548|NCT00973921|11597013|FG000|COMPLETED|Overall Study||31
10449549|NCT00973921|11597013|FG000|NOT COMPLETED|Overall Study||9
10449550|NCT00973973|11597019|FG000|STARTED|Double-blind Treatment Phase (Weeks 1-8)||69
10449551|NCT00973973|11597020|FG001|STARTED|Double-blind Treatment Phase (Weeks 1-8)||68
10449552|NCT00973973|11597019|FG000|Received Study Drug|Double-blind Treatment Phase (Weeks 1-8)||69
10449553|NCT00973973|11597020|FG001|Received Study Drug|Double-blind Treatment Phase (Weeks 1-8)||68
10449554|NCT00973973|11597019|FG000|COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||63
10449555|NCT00973973|11597020|FG001|COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||60
10449556|NCT00973973|11597019|FG000|NOT COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||6
10449557|NCT00973973|11597020|FG001|NOT COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||8
10449558|NCT00973973|11597019|FG000|STARTED|Open-label Treatment Phase (Weeks 8-24)||63
10449559|NCT00973973|11597020|FG001|STARTED|Open-label Treatment Phase (Weeks 8-24)||60
10449560|NCT00973973|11597019|FG000|COMPLETED|Open-label Treatment Phase (Weeks 8-24)||57
10449561|NCT00973973|11597020|FG001|COMPLETED|Open-label Treatment Phase (Weeks 8-24)||55
10449562|NCT00973973|11597019|FG000|NOT COMPLETED|Open-label Treatment Phase (Weeks 8-24)||6
10449563|NCT00973973|11597020|FG001|NOT COMPLETED|Open-label Treatment Phase (Weeks 8-24)||5
10449564|NCT00974051|11597026|FG000|STARTED|Overall Study||6
10449565|NCT00974051|11597027|FG001|STARTED|Overall Study||4
10449566|NCT00974051|11597028|FG002|STARTED|Overall Study||6
10449567|NCT00974051|11597026|FG000|COMPLETED|Overall Study||6
10449568|NCT00974051|11597027|FG001|COMPLETED|Overall Study||4
10449569|NCT00974051|11597028|FG002|COMPLETED|Overall Study||6
10449570|NCT00974051|11597026|FG000|NOT COMPLETED|Overall Study||0
10449571|NCT00974051|11597027|FG001|NOT COMPLETED|Overall Study||0
10449572|NCT00974051|11597028|FG002|NOT COMPLETED|Overall Study||0
10449573|NCT00974090|11597039|FG000|STARTED|Period 1: Double Blind Period||98
10449574|NCT00974090|11597040|FG001|STARTED|Period 1: Double Blind Period||96
10449575|NCT00974090|11597039|FG000|COMPLETED|Period 1: Double Blind Period||95
10449576|NCT00974090|11597040|FG001|COMPLETED|Period 1: Double Blind Period||95
10449577|NCT00974090|11597039|FG000|NOT COMPLETED|Period 1: Double Blind Period||3
10449578|NCT00974090|11597040|FG001|NOT COMPLETED|Period 1: Double Blind Period||1
10449579|NCT00974090|11597039|FG000|STARTED|Period 2: Open-label Period||95
10449580|NCT00974090|11597040|FG001|STARTED|Period 2: Open-label Period||95
10449581|NCT00974090|11597039|FG000|COMPLETED|Period 2: Open-label Period||87
10449582|NCT00974090|11597040|FG001|COMPLETED|Period 2: Open-label Period||85
10449583|NCT00974090|11597039|FG000|NOT COMPLETED|Period 2: Open-label Period||8
10449584|NCT00974090|11597040|FG001|NOT COMPLETED|Period 2: Open-label Period||10
10449585|NCT00974142|11597050|FG000|STARTED|Overall Study||8
10449586|NCT00974142|11597051|FG001|STARTED|Overall Study||9
10449587|NCT00974142|11597050|FG000|COMPLETED|Overall Study||8
10449588|NCT00974142|11597051|FG001|COMPLETED|Overall Study||9
10449589|NCT00974142|11597050|FG000|NOT COMPLETED|Overall Study||0
10449590|NCT00974142|11597051|FG001|NOT COMPLETED|Overall Study||0
10449591|NCT00974220|11597059|FG000|STARTED|Treatment Period 1||9
10449592|NCT00974220|11597060|FG001|STARTED|Treatment Period 1||7
10449593|NCT00974220|11597059|FG000|COMPLETED|Treatment Period 1||7
10449594|NCT00974220|11597060|FG001|COMPLETED|Treatment Period 1||5
10449595|NCT00974220|11597059|FG000|NOT COMPLETED|Treatment Period 1||2
10449596|NCT00974220|11597060|FG001|NOT COMPLETED|Treatment Period 1||2
10449597|NCT00974220|11597059|FG000|STARTED|Treatment Period 2||7
10449598|NCT00974220|11597060|FG001|STARTED|Treatment Period 2||5
10449599|NCT00974220|11597059|FG000|COMPLETED|Treatment Period 2||7
10449600|NCT00974220|11597060|FG001|COMPLETED|Treatment Period 2||5
10449601|NCT00974220|11597059|FG000|NOT COMPLETED|Treatment Period 2||0
10449602|NCT00974220|11597060|FG001|NOT COMPLETED|Treatment Period 2||0
10525695|NCT01377584|11677640|FG003|COMPLETED|Overall Study||6
10525696|NCT01377584|11677641|FG004|COMPLETED|Overall Study||9
10525697|NCT01377584|11677642|FG005|COMPLETED|Overall Study||9
10525698|NCT01377584|11677637|FG000|NOT COMPLETED|Overall Study||3
10525699|NCT01377584|11677638|FG001|NOT COMPLETED|Overall Study||3
10525700|NCT01377584|11677639|FG002|NOT COMPLETED|Overall Study||4
10525701|NCT01377584|11677640|FG003|NOT COMPLETED|Overall Study||4
10525702|NCT01377584|11677641|FG004|NOT COMPLETED|Overall Study||3
10525703|NCT01377584|11677642|FG005|NOT COMPLETED|Overall Study||3
10525704|NCT01377623|11677661|FG000|STARTED|Overall Study||33
10525705|NCT01377623|11677662|FG001|STARTED|Overall Study||33
10525706|NCT01377623|11677661|FG000|COMPLETED|Overall Study||26
10525707|NCT01377623|11677662|FG001|COMPLETED|Overall Study||28
10525708|NCT01377623|11677661|FG000|NOT COMPLETED|Overall Study||7
10525709|NCT01377623|11677662|FG001|NOT COMPLETED|Overall Study||5
10449603|NCT00974233|11597066|FG000|STARTED|Induction Chemoimmunotherapy||34
10449604|NCT00974233|11597066|FG000|COMPLETED|Induction Chemoimmunotherapy||19
10449605|NCT00974233|11597066|FG000|NOT COMPLETED|Induction Chemoimmunotherapy||15
10449606|NCT00974233|11597066|FG000|STARTED|Maintenance Lenalidomide||19
10449607|NCT00974233|11597066|FG000|COMPLETED|Maintenance Lenalidomide||6
10449608|NCT00974233|11597066|FG000|NOT COMPLETED|Maintenance Lenalidomide||13
10449609|NCT00974246|11597078|FG000|STARTED|Overall Study||27
10449610|NCT00974246|11597078|FG000|COMPLETED|Overall Study||27
10449611|NCT00974246|11597078|FG000|NOT COMPLETED|Overall Study||0
10449612|NCT00974259|11597085|FG000|STARTED|Overall Study||59
10449613|NCT00974259|11597086|FG001|STARTED|Overall Study||63
10449614|NCT00974259|11597085|FG000|COMPLETED|Overall Study||57
10449615|NCT00974259|11597086|FG001|COMPLETED|Overall Study||62
10449616|NCT00974259|11597085|FG000|NOT COMPLETED|Overall Study||2
10449617|NCT00974259|11597086|FG001|NOT COMPLETED|Overall Study||1
10449618|NCT00974311|11597094|FG000|STARTED|DB Phase (up to 24 Months)||800
10449619|NCT00974311|11597095|FG001|STARTED|DB Phase (up to 24 Months)||399
10449620|NCT00974311|11597094|FG000|COMPLETED|DB Phase (up to 24 Months)||109
10449621|NCT00974311|11597095|FG001|COMPLETED|DB Phase (up to 24 Months)||50
10449622|NCT00974311|11597094|FG000|NOT COMPLETED|DB Phase (up to 24 Months)||691
10449623|NCT00974311|11597095|FG001|NOT COMPLETED|DB Phase (up to 24 Months)||349
10449624|NCT00974311|11597094|FG000|STARTED|OLE Phase (up to 77 Months)||109
10449625|NCT00974311|11597095|FG001|STARTED|OLE Phase (up to 77 Months)||50
10449626|NCT00974311|11597094|FG000|COMPLETED|OLE Phase (up to 77 Months)||0
10449627|NCT00974311|11597095|FG001|COMPLETED|OLE Phase (up to 77 Months)||0
10449628|NCT00974311|11597094|FG000|NOT COMPLETED|OLE Phase (up to 77 Months)||109
10449629|NCT00974311|11597095|FG001|NOT COMPLETED|OLE Phase (up to 77 Months)||50
10449630|NCT00974350|11597107|FG000|STARTED|Overall Study||45
10449631|NCT00974350|11597108|FG001|STARTED|Overall Study||47
10449632|NCT00974350|11597109|FG002|STARTED|Overall Study||32
10449633|NCT00974350|11597107|FG000|COMPLETED|Overall Study||42
10449634|NCT00974350|11597108|FG001|COMPLETED|Overall Study||47
10449635|NCT00974350|11597109|FG002|COMPLETED|Overall Study||31
10449636|NCT00974350|11597107|FG000|NOT COMPLETED|Overall Study||3
10449637|NCT00974350|11597108|FG001|NOT COMPLETED|Overall Study||0
10449638|NCT00974350|11597109|FG002|NOT COMPLETED|Overall Study||1
10449639|NCT00974363|11597120|FG000|STARTED|Overall Study||521
10449640|NCT00974363|11597121|FG001|STARTED|Overall Study||168
10449641|NCT00974363|11597120|FG000|COMPLETED|Overall Study||521
10449642|NCT00974363|11597121|FG001|COMPLETED|Overall Study||168
10449643|NCT00974363|11597120|FG000|NOT COMPLETED|Overall Study||0
10449644|NCT00974363|11597121|FG001|NOT COMPLETED|Overall Study||0
10449645|NCT00974376|11597129|FG000|STARTED|Overall Study||75
10449646|NCT00974376|11597130|FG001|STARTED|Overall Study||75
10449647|NCT00974376|11597129|FG000|COMPLETED|Overall Study||41
10449648|NCT00974376|11597130|FG001|COMPLETED|Overall Study||42
10449649|NCT00974376|11597129|FG000|NOT COMPLETED|Overall Study||34
10449650|NCT00974376|11597130|FG001|NOT COMPLETED|Overall Study||33
10449651|NCT00974480|11597139|FG000|STARTED|Overall Study||40
10449652|NCT00974480|11597140|FG001|STARTED|Overall Study||40
10449653|NCT00974480|11597141|FG002|STARTED|Overall Study||40
10449654|NCT00974480|11597139|FG000|COMPLETED|Overall Study||29
10449655|NCT00974480|11597140|FG001|COMPLETED|Overall Study||33
10449656|NCT00974480|11597141|FG002|COMPLETED|Overall Study||30
10449657|NCT00974480|11597139|FG000|NOT COMPLETED|Overall Study||11
10449658|NCT00974480|11597140|FG001|NOT COMPLETED|Overall Study||7
10449659|NCT00974480|11597141|FG002|NOT COMPLETED|Overall Study||10
10449660|NCT00974493|11597157|FG000|STARTED|Overall Study||527
10449661|NCT00974493|11597158|FG001|STARTED|Overall Study||527
10449662|NCT00974493|11597157|FG000|COMPLETED|Overall Study||509
10449663|NCT00974493|11597158|FG001|COMPLETED|Overall Study||506
10449664|NCT00974493|11597157|FG000|NOT COMPLETED|Overall Study||18
10449665|NCT00974493|11597158|FG001|NOT COMPLETED|Overall Study||21
10449666|NCT00974675|11597168|FG000|STARTED|Overall Study||8
10449667|NCT00974675|11597169|FG001|STARTED|Overall Study||8
10449668|NCT00974675|11597170|FG002|STARTED|Overall Study||3
10449669|NCT00974675|11597171|FG003|STARTED|Overall Study||4
10449670|NCT00974675|11597168|FG000|COMPLETED|Overall Study||6
10449671|NCT00974675|11597169|FG001|COMPLETED|Overall Study||7
10449672|NCT00974675|11597170|FG002|COMPLETED|Overall Study||1
10449673|NCT00974675|11597171|FG003|COMPLETED|Overall Study||2
10449674|NCT00974675|11597168|FG000|NOT COMPLETED|Overall Study||2
10449675|NCT00974675|11597169|FG001|NOT COMPLETED|Overall Study||1
10449676|NCT00974675|11597170|FG002|NOT COMPLETED|Overall Study||2
10449677|NCT00974675|11597171|FG003|NOT COMPLETED|Overall Study||2
10449678|NCT00974818|11597183|FG000|STARTED|Overall Study||25
10449679|NCT00974818|11597184|FG001|STARTED|Overall Study||25
10449680|NCT00974818|11597183|FG000|COMPLETED|Overall Study||25
10449681|NCT00974818|11597184|FG001|COMPLETED|Overall Study||25
10449682|NCT00974818|11597183|FG000|NOT COMPLETED|Overall Study||0
10449683|NCT00974818|11597184|FG001|NOT COMPLETED|Overall Study||0
10449684|NCT00974974|11597192|FG000|STARTED|IR CD-LD Dose Adjustment||0
10449685|NCT00974974|11597193|FG001|STARTED|IR CD-LD Dose Adjustment||471
10449686|NCT00974974|11597192|FG000|COMPLETED|IR CD-LD Dose Adjustment||0
10449687|NCT00974974|11597193|FG001|COMPLETED|IR CD-LD Dose Adjustment||450
10449688|NCT00974974|11597192|FG000|NOT COMPLETED|IR CD-LD Dose Adjustment||0
10449689|NCT00974974|11597193|FG001|NOT COMPLETED|IR CD-LD Dose Adjustment||21
10449690|NCT00974974|11597192|FG000|STARTED|IPX066 Dose Conversion|All subjects who completed IR Dose adjustment entered into IPX066 dose conversion.|450
10525710|NCT01377636|11677668|FG000|STARTED|Overall Study||20
10449691|NCT00974974|11597193|FG001|STARTED|IPX066 Dose Conversion|IR is not applicable in IPX066 dose conversion.|0
10449692|NCT00974974|11597192|FG000|COMPLETED|IPX066 Dose Conversion||393
10449693|NCT00974974|11597193|FG001|COMPLETED|IPX066 Dose Conversion||0
10449694|NCT00974974|11597192|FG000|NOT COMPLETED|IPX066 Dose Conversion||57
10449695|NCT00974974|11597193|FG001|NOT COMPLETED|IPX066 Dose Conversion||0
10449696|NCT00974974|11597192|FG000|STARTED|Maintenance - Double Blind Treatment|All subjects who completed IPX066 Dose Conversion were randomized to either IPX066 or IR.|201
10449697|NCT00974974|11597193|FG001|STARTED|Maintenance - Double Blind Treatment|All subjects who completed IPX066 Dose Conversion were randomized to either IPX066 or IR.|192
10449698|NCT00974974|11597192|FG000|COMPLETED|Maintenance - Double Blind Treatment||186
10449699|NCT00974974|11597193|FG001|COMPLETED|Maintenance - Double Blind Treatment||182
10449700|NCT00974974|11597192|FG000|NOT COMPLETED|Maintenance - Double Blind Treatment||15
10449701|NCT00974974|11597193|FG001|NOT COMPLETED|Maintenance - Double Blind Treatment||10
10449702|NCT00975000|11597201|FG000|STARTED|Overall Study||57
10449703|NCT00975000|11597202|FG001|STARTED|Overall Study||57
10449704|NCT00975000|11597201|FG000|Completed Titration Phase|Overall Study||54
10449705|NCT00975000|11597202|FG001|Completed Titration Phase|Overall Study||55
10449706|NCT00975000|11597201|FG000|Completed Efficacy Assessment Phase|Overall Study||54
10449707|NCT00975000|11597202|FG001|Completed Efficacy Assessment Phase|Overall Study||54
10449708|NCT00975000|11597201|FG000|Completed Maintenance Phase|Overall Study||52
10449709|NCT00975000|11597202|FG001|Completed Maintenance Phase|Overall Study||52
10449710|NCT00975000|11597201|FG000|COMPLETED|Overall Study|Completed post-treatment follow-up phase|52
10449711|NCT00975000|11597202|FG001|COMPLETED|Overall Study|Completed post-treatment follow-up phase|52
10449712|NCT00975000|11597201|FG000|NOT COMPLETED|Overall Study||5
10449713|NCT00975000|11597202|FG001|NOT COMPLETED|Overall Study||5
10449714|NCT00975130|11597208|FG000|STARTED|Study Part 1||3366
10449715|NCT00975130|11597209|FG001|STARTED|Study Part 1||0
10449716|NCT00975130|11597210|FG002|STARTED|Study Part 1||0
10449717|NCT00975130|11597208|FG000|COMPLETED|Study Part 1||3086
10449718|NCT00975130|11597209|FG001|COMPLETED|Study Part 1||0
10449719|NCT00975130|11597210|FG002|COMPLETED|Study Part 1||0
10449720|NCT00975130|11597208|FG000|NOT COMPLETED|Study Part 1||280
10449721|NCT00975130|11597209|FG001|NOT COMPLETED|Study Part 1||0
10449722|NCT00975130|11597210|FG002|NOT COMPLETED|Study Part 1||0
10449723|NCT00975130|11597208|FG000|STARTED|Study Part 2||0
10449724|NCT00975130|11597209|FG001|STARTED|Study Part 2|Good/moderate responders without remission at the end of Part 1 were invited to enroll in Part 2.|250
10449725|NCT00975130|11597210|FG002|STARTED|Study Part 2|Good/moderate responders without remission at the end of Part 1 were invited to enroll in Part 2.|255
10449726|NCT00975130|11597208|FG000|COMPLETED|Study Part 2||0
10449727|NCT00975130|11597209|FG001|COMPLETED|Study Part 2||212
10449728|NCT00975130|11597210|FG002|COMPLETED|Study Part 2||238
10449729|NCT00975130|11597208|FG000|NOT COMPLETED|Study Part 2||0
10449730|NCT00975130|11597209|FG001|NOT COMPLETED|Study Part 2||38
10449731|NCT00975130|11597210|FG002|NOT COMPLETED|Study Part 2||17
10449732|NCT00975143|11597225|FG000|STARTED|Overall Study||464
10449733|NCT00975143|11597226|FG001|STARTED|Overall Study||461
10449734|NCT00975143|11597225|FG000|Completed Treatment (Week 20)|Overall Study||403
10449735|NCT00975143|11597226|FG001|Completed Treatment (Week 20)|Overall Study||410
10449736|NCT00975143|11597225|FG000|COMPLETED|Overall Study||394
10449737|NCT00975143|11597226|FG001|COMPLETED|Overall Study||401
10449738|NCT00975143|11597225|FG000|NOT COMPLETED|Overall Study||70
10449739|NCT00975143|11597226|FG001|NOT COMPLETED|Overall Study||60
10449740|NCT00975156|11597234|FG000|STARTED|Overall Study||11
10449741|NCT00975156|11597235|FG001|STARTED|Overall Study||10
10449742|NCT00975156|11597234|FG000|COMPLETED|Overall Study||11
10449743|NCT00975156|11597235|FG001|COMPLETED|Overall Study||9
10449744|NCT00975156|11597234|FG000|NOT COMPLETED|Overall Study||0
10449745|NCT00975156|11597235|FG001|NOT COMPLETED|Overall Study||1
10449746|NCT00975195|11597247|FG000|STARTED|Overall Study||1244
10449747|NCT00975195|11597248|FG001|STARTED|Overall Study||1244
10449748|NCT00975195|11597247|FG000|COMPLETED|Overall Study|Includes open-label treatment if appropriate|1016
10449749|NCT00975195|11597248|FG001|COMPLETED|Overall Study|Includes open-label treatment if appropriate|1011
10449750|NCT00975195|11597247|FG000|NOT COMPLETED|Overall Study||228
10449751|NCT00975195|11597248|FG001|NOT COMPLETED|Overall Study||233
10449752|NCT00975221|11597256|FG000|STARTED|Titration Phase (Weeks 1-12)||34
10449753|NCT00975221|11597257|FG001|STARTED|Titration Phase (Weeks 1-12)||33
10449754|NCT00975221|11597256|FG000|Received Study Drug|Titration Phase (Weeks 1-12)||34
10449755|NCT00975221|11597257|FG001|Received Study Drug|Titration Phase (Weeks 1-12)||33
10449756|NCT00975221|11597256|FG000|COMPLETED|Titration Phase (Weeks 1-12)||31
10449757|NCT00975221|11597257|FG001|COMPLETED|Titration Phase (Weeks 1-12)||29
10449758|NCT00975221|11597256|FG000|NOT COMPLETED|Titration Phase (Weeks 1-12)||3
10449759|NCT00975221|11597257|FG001|NOT COMPLETED|Titration Phase (Weeks 1-12)||4
10449760|NCT00975221|11597256|FG000|STARTED|Efficacy Assessment Phase (Weeks 13-28)|1 participant who completed the Titration Phase did not enter the EAP|30
10449761|NCT00975221|11597257|FG001|STARTED|Efficacy Assessment Phase (Weeks 13-28)||29
10449762|NCT00975221|11597256|FG000|COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||30
10449763|NCT00975221|11597257|FG001|COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||28
10449764|NCT00975221|11597256|FG000|NOT COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||0
10449765|NCT00975221|11597257|FG001|NOT COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||1
10449766|NCT00975221|11597256|FG000|STARTED|Open-label Extension Phase (Weeks 29-52)|1 participant who completed the EAP did not enter the open-label phase|29
10449767|NCT00975221|11597257|FG001|STARTED|Open-label Extension Phase (Weeks 29-52)||28
10449768|NCT00975221|11597256|FG000|COMPLETED|Open-label Extension Phase (Weeks 29-52)||27
10449769|NCT00975221|11597257|FG001|COMPLETED|Open-label Extension Phase (Weeks 29-52)||27
10449770|NCT00975221|11597256|FG000|NOT COMPLETED|Open-label Extension Phase (Weeks 29-52)||2
10449771|NCT00975221|11597257|FG001|NOT COMPLETED|Open-label Extension Phase (Weeks 29-52)||1
10449772|NCT00975286|11597267|FG000|STARTED|Overall Study|Randomized.|223
10449773|NCT00975286|11597268|FG001|STARTED|Overall Study||223
10449774|NCT00975286|11597267|FG000|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|223
10449775|NCT00975286|11597268|FG001|Safety Population|Overall Study||223
10449776|NCT00975286|11597267|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|223
10449777|NCT00975286|11597268|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||223
10449778|NCT00975286|11597267|FG000|COMPLETED|Overall Study||211
10449779|NCT00975286|11597268|FG001|COMPLETED|Overall Study||194
10449780|NCT00975286|11597267|FG000|NOT COMPLETED|Overall Study||12
10449781|NCT00975286|11597268|FG001|NOT COMPLETED|Overall Study||29
10449782|NCT00975416|11597276|FG000|STARTED|Overall Study||14
10449783|NCT00975416|11597277|FG001|STARTED|Overall Study||16
10449784|NCT00975416|11597276|FG000|COMPLETED|Overall Study||11
10449785|NCT00975416|11597277|FG001|COMPLETED|Overall Study||11
10449786|NCT00975416|11597276|FG000|NOT COMPLETED|Overall Study||3
10449787|NCT00975416|11597277|FG001|NOT COMPLETED|Overall Study||5
10449788|NCT00975481|11597284|FG000|STARTED|First Intervention Period||6
10449789|NCT00975481|11597285|FG001|STARTED|First Intervention Period||6
10449790|NCT00975481|11597286|FG002|STARTED|First Intervention Period||6
10449791|NCT00975481|11597287|FG003|STARTED|First Intervention Period||6
10449792|NCT00975481|11597288|FG004|STARTED|First Intervention Period||6
10449793|NCT00975481|11597289|FG005|STARTED|First Intervention Period||6
10449794|NCT00975481|11597284|FG000|COMPLETED|First Intervention Period||6
10449795|NCT00975481|11597285|FG001|COMPLETED|First Intervention Period||6
10449796|NCT00975481|11597286|FG002|COMPLETED|First Intervention Period||6
10449797|NCT00975481|11597287|FG003|COMPLETED|First Intervention Period||6
10449798|NCT00975481|11597288|FG004|COMPLETED|First Intervention Period||6
10449799|NCT00975481|11597289|FG005|COMPLETED|First Intervention Period||6
10551211|NCT01536145|11705415|FG009|COMPLETED|Overall Study||1
10551212|NCT01536145|11705416|FG010|COMPLETED|Overall Study||0
10551213|NCT01536145|11705406|FG000|NOT COMPLETED|Overall Study||3
10551214|NCT01536145|11705407|FG001|NOT COMPLETED|Overall Study||4
10551215|NCT01536145|11705408|FG002|NOT COMPLETED|Overall Study||2
10551216|NCT01536145|11705409|FG003|NOT COMPLETED|Overall Study||2
10551217|NCT01536145|11705410|FG004|NOT COMPLETED|Overall Study||2
10551218|NCT01536145|11705411|FG005|NOT COMPLETED|Overall Study||3
10551219|NCT01536145|11705412|FG006|NOT COMPLETED|Overall Study||2
10551220|NCT01536145|11705413|FG007|NOT COMPLETED|Overall Study||4
10551221|NCT01536145|11705414|FG008|NOT COMPLETED|Overall Study||3
10551222|NCT01536145|11705415|FG009|NOT COMPLETED|Overall Study||6
10551223|NCT01536145|11705416|FG010|NOT COMPLETED|Overall Study||10
10551224|NCT01536171|11705447|FG000|STARTED|Overall Study||22
10551225|NCT01536171|11705447|FG000|COMPLETED|Overall Study||21
10551226|NCT01536171|11705447|FG000|NOT COMPLETED|Overall Study||1
10551227|NCT01536184|11705454|FG000|STARTED|Overall Study||8
10551228|NCT01536184|11705455|FG001|STARTED|Overall Study||4
10551229|NCT01536184|11705454|FG000|COMPLETED|Overall Study||8
10551230|NCT01536184|11705455|FG001|COMPLETED|Overall Study||4
10551231|NCT01536184|11705454|FG000|NOT COMPLETED|Overall Study||0
10551232|NCT01536184|11705455|FG001|NOT COMPLETED|Overall Study||0
10551233|NCT01536197|11705463|FG000|STARTED|Overall Study||23
10551234|NCT01536197|11705464|FG001|STARTED|Overall Study||10
10551235|NCT01536197|11705463|FG000|COMPLETED|Overall Study||23
10551236|NCT01536197|11705464|FG001|COMPLETED|Overall Study||10
10551237|NCT01536197|11705463|FG000|NOT COMPLETED|Overall Study||0
10551238|NCT01536197|11705464|FG001|NOT COMPLETED|Overall Study||0
10551239|NCT01536262|11705473|FG000|STARTED|Overall Study||41
10551240|NCT01536262|11705474|FG001|STARTED|Overall Study||40
10551241|NCT01536262|11705475|FG002|STARTED|Overall Study||41
10551242|NCT01536262|11705473|FG000|COMPLETED|Overall Study||33
10551243|NCT01536262|11705474|FG001|COMPLETED|Overall Study||38
10551244|NCT01536262|11705475|FG002|COMPLETED|Overall Study||39
10551245|NCT01536262|11705473|FG000|NOT COMPLETED|Overall Study||8
10551246|NCT01536262|11705474|FG001|NOT COMPLETED|Overall Study||2
10551247|NCT01536262|11705475|FG002|NOT COMPLETED|Overall Study||2
10551248|NCT01536366|11705486|FG000|STARTED|Overall Study||14
10551249|NCT01536366|11705487|FG001|STARTED|Overall Study||13
10551250|NCT01536366|11705486|FG000|BIA 9-1067 + Repaglinide|Overall Study||14
10551251|NCT01536366|11705487|FG001|BIA 9-1067 + Repaglinide|Overall Study||10
10551252|NCT01536366|11705486|FG000|Repaglinide|Overall Study||14
10449800|NCT00975481|11597284|FG000|NOT COMPLETED|First Intervention Period||0
10449801|NCT00975481|11597285|FG001|NOT COMPLETED|First Intervention Period||0
10449802|NCT00975481|11597286|FG002|NOT COMPLETED|First Intervention Period||0
10551253|NCT01536366|11705487|FG001|Repaglinide|Overall Study||13
10551254|NCT01536366|11705486|FG000|Follow-up|Overall Study||13
10551255|NCT01536366|11705487|FG001|Follow-up|Overall Study||9
10551256|NCT01536366|11705486|FG000|COMPLETED|Overall Study||1
10551257|NCT01536366|11705487|FG001|COMPLETED|Overall Study||9
10551258|NCT01536366|11705486|FG000|NOT COMPLETED|Overall Study||13
10551259|NCT01536366|11705487|FG001|NOT COMPLETED|Overall Study||4
10551260|NCT01536379|11705495|FG000|STARTED|Overall Study||13
10551261|NCT01536379|11705496|FG001|STARTED|Overall Study||12
10449803|NCT00975481|11597287|FG003|NOT COMPLETED|First Intervention Period||0
10449804|NCT00975481|11597288|FG004|NOT COMPLETED|First Intervention Period||0
10449805|NCT00975481|11597289|FG005|NOT COMPLETED|First Intervention Period||0
10449806|NCT00975481|11597284|FG000|STARTED|Washout Period (at Least 7 Days)||6
10449807|NCT00975481|11597285|FG001|STARTED|Washout Period (at Least 7 Days)||6
10449808|NCT00975481|11597286|FG002|STARTED|Washout Period (at Least 7 Days)||6
10449809|NCT00975481|11597287|FG003|STARTED|Washout Period (at Least 7 Days)||6
10449810|NCT00975481|11597288|FG004|STARTED|Washout Period (at Least 7 Days)||6
10449811|NCT00975481|11597289|FG005|STARTED|Washout Period (at Least 7 Days)||6
10449812|NCT00975481|11597284|FG000|COMPLETED|Washout Period (at Least 7 Days)||6
10449813|NCT00975481|11597285|FG001|COMPLETED|Washout Period (at Least 7 Days)||6
10449814|NCT00975481|11597286|FG002|COMPLETED|Washout Period (at Least 7 Days)||6
10449815|NCT00975481|11597287|FG003|COMPLETED|Washout Period (at Least 7 Days)||6
10449816|NCT00975481|11597288|FG004|COMPLETED|Washout Period (at Least 7 Days)||6
10449817|NCT00975481|11597289|FG005|COMPLETED|Washout Period (at Least 7 Days)||6
10449818|NCT00975481|11597284|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
10449819|NCT00975481|11597285|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
10449820|NCT00975481|11597286|FG002|NOT COMPLETED|Washout Period (at Least 7 Days)||0
10449821|NCT00975481|11597287|FG003|NOT COMPLETED|Washout Period (at Least 7 Days)||0
10449822|NCT00975481|11597288|FG004|NOT COMPLETED|Washout Period (at Least 7 Days)||0
10449823|NCT00975481|11597289|FG005|NOT COMPLETED|Washout Period (at Least 7 Days)||0
10449824|NCT00975481|11597284|FG000|STARTED|Second Intervention Period||6
10449825|NCT00975481|11597285|FG001|STARTED|Second Intervention Period||6
10449826|NCT00975481|11597286|FG002|STARTED|Second Intervention Period||6
10449827|NCT00975481|11597287|FG003|STARTED|Second Intervention Period||6
10449828|NCT00975481|11597288|FG004|STARTED|Second Intervention Period||6
10449829|NCT00975481|11597289|FG005|STARTED|Second Intervention Period||6
10449830|NCT00975481|11597284|FG000|COMPLETED|Second Intervention Period||4
10449831|NCT00975481|11597285|FG001|COMPLETED|Second Intervention Period||5
10449832|NCT00975481|11597286|FG002|COMPLETED|Second Intervention Period||5
10449833|NCT00975481|11597287|FG003|COMPLETED|Second Intervention Period||6
10449834|NCT00975481|11597288|FG004|COMPLETED|Second Intervention Period||6
10449835|NCT00975481|11597289|FG005|COMPLETED|Second Intervention Period||6
10449836|NCT00975481|11597284|FG000|NOT COMPLETED|Second Intervention Period||2
10449837|NCT00975481|11597285|FG001|NOT COMPLETED|Second Intervention Period||1
10449838|NCT00975481|11597286|FG002|NOT COMPLETED|Second Intervention Period||1
10449839|NCT00975481|11597287|FG003|NOT COMPLETED|Second Intervention Period||0
10449840|NCT00975481|11597288|FG004|NOT COMPLETED|Second Intervention Period||0
10449841|NCT00975481|11597289|FG005|NOT COMPLETED|Second Intervention Period||0
10449842|NCT00975481|11597284|FG000|STARTED|Washout Period (at Least 7 Days)||4
10449843|NCT00975481|11597285|FG001|STARTED|Washout Period (at Least 7 Days)||5
10449844|NCT00975481|11597286|FG002|STARTED|Washout Period (at Least 7 Days)||5
10449845|NCT00975481|11597287|FG003|STARTED|Washout Period (at Least 7 Days)||6
10449846|NCT00975481|11597288|FG004|STARTED|Washout Period (at Least 7 Days)||6
10449847|NCT00975481|11597289|FG005|STARTED|Washout Period (at Least 7 Days)||6
10449848|NCT00975481|11597284|FG000|COMPLETED|Washout Period (at Least 7 Days)||4
10449849|NCT00975481|11597285|FG001|COMPLETED|Washout Period (at Least 7 Days)||5
10449850|NCT00975481|11597286|FG002|COMPLETED|Washout Period (at Least 7 Days)||5
10449851|NCT00975481|11597287|FG003|COMPLETED|Washout Period (at Least 7 Days)||6
10449852|NCT00975481|11597288|FG004|COMPLETED|Washout Period (at Least 7 Days)||6
10449853|NCT00975481|11597289|FG005|COMPLETED|Washout Period (at Least 7 Days)||6
10449854|NCT00975481|11597284|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
10449855|NCT00975481|11597285|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
10449856|NCT00975481|11597286|FG002|NOT COMPLETED|Washout Period (at Least 7 Days)||0
10449857|NCT00975481|11597287|FG003|NOT COMPLETED|Washout Period (at Least 7 Days)||0
10449858|NCT00975481|11597288|FG004|NOT COMPLETED|Washout Period (at Least 7 Days)||0
10449859|NCT00975481|11597289|FG005|NOT COMPLETED|Washout Period (at Least 7 Days)||0
10449860|NCT00975481|11597284|FG000|STARTED|Third Intervention Period||4
10449861|NCT00975481|11597285|FG001|STARTED|Third Intervention Period||5
10449862|NCT00975481|11597286|FG002|STARTED|Third Intervention Period||5
10449863|NCT00975481|11597287|FG003|STARTED|Third Intervention Period||6
10449864|NCT00975481|11597288|FG004|STARTED|Third Intervention Period||6
10449865|NCT00975481|11597289|FG005|STARTED|Third Intervention Period||6
10449866|NCT00975481|11597284|FG000|COMPLETED|Third Intervention Period||4
10449867|NCT00975481|11597285|FG001|COMPLETED|Third Intervention Period||5
10449868|NCT00975481|11597286|FG002|COMPLETED|Third Intervention Period||5
10449869|NCT00975481|11597287|FG003|COMPLETED|Third Intervention Period||6
10449870|NCT00975481|11597288|FG004|COMPLETED|Third Intervention Period||6
10449871|NCT00975481|11597289|FG005|COMPLETED|Third Intervention Period||6
10449872|NCT00975481|11597284|FG000|NOT COMPLETED|Third Intervention Period||0
10449873|NCT00975481|11597285|FG001|NOT COMPLETED|Third Intervention Period||0
10449874|NCT00975481|11597286|FG002|NOT COMPLETED|Third Intervention Period||0
10449875|NCT00975481|11597287|FG003|NOT COMPLETED|Third Intervention Period||0
10449876|NCT00975481|11597288|FG004|NOT COMPLETED|Third Intervention Period||0
10449877|NCT00975481|11597289|FG005|NOT COMPLETED|Third Intervention Period||0
10449878|NCT00975481|11597284|FG000|STARTED|Washout Period (at Least 7 Days)||4
10449879|NCT00975481|11597285|FG001|STARTED|Washout Period (at Least 7 Days)||5
10449880|NCT00975481|11597286|FG002|STARTED|Washout Period (at Least 7 Days)||5
10449881|NCT00975481|11597287|FG003|STARTED|Washout Period (at Least 7 Days)||6
10449882|NCT00975481|11597288|FG004|STARTED|Washout Period (at Least 7 Days)||6
10449883|NCT00975481|11597289|FG005|STARTED|Washout Period (at Least 7 Days)||6
10449884|NCT00975481|11597284|FG000|COMPLETED|Washout Period (at Least 7 Days)||4
10449885|NCT00975481|11597285|FG001|COMPLETED|Washout Period (at Least 7 Days)||5
10449886|NCT00975481|11597286|FG002|COMPLETED|Washout Period (at Least 7 Days)||5
10449887|NCT00975481|11597287|FG003|COMPLETED|Washout Period (at Least 7 Days)||6
10449888|NCT00975481|11597288|FG004|COMPLETED|Washout Period (at Least 7 Days)||6
10449889|NCT00975481|11597289|FG005|COMPLETED|Washout Period (at Least 7 Days)||6
10449890|NCT00975481|11597284|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
10449891|NCT00975481|11597285|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
10449892|NCT00975481|11597286|FG002|NOT COMPLETED|Washout Period (at Least 7 Days)||0
10449893|NCT00975481|11597287|FG003|NOT COMPLETED|Washout Period (at Least 7 Days)||0
10449894|NCT00975481|11597288|FG004|NOT COMPLETED|Washout Period (at Least 7 Days)||0
10449895|NCT00975481|11597289|FG005|NOT COMPLETED|Washout Period (at Least 7 Days)||0
10449896|NCT00975481|11597284|FG000|STARTED|Fourth Intervention Period||4
10449897|NCT00975481|11597285|FG001|STARTED|Fourth Intervention Period||5
10449898|NCT00975481|11597286|FG002|STARTED|Fourth Intervention Period||5
10449899|NCT00975481|11597287|FG003|STARTED|Fourth Intervention Period||6
10449900|NCT00975481|11597288|FG004|STARTED|Fourth Intervention Period||6
10449901|NCT00975481|11597289|FG005|STARTED|Fourth Intervention Period||6
10449902|NCT00975481|11597284|FG000|COMPLETED|Fourth Intervention Period||4
10449903|NCT00975481|11597285|FG001|COMPLETED|Fourth Intervention Period||5
10449904|NCT00975481|11597286|FG002|COMPLETED|Fourth Intervention Period||4
10449905|NCT00975481|11597287|FG003|COMPLETED|Fourth Intervention Period||5
10449906|NCT00975481|11597288|FG004|COMPLETED|Fourth Intervention Period||6
10449907|NCT00975481|11597289|FG005|COMPLETED|Fourth Intervention Period||6
10449908|NCT00975481|11597284|FG000|NOT COMPLETED|Fourth Intervention Period||0
10449909|NCT00975481|11597285|FG001|NOT COMPLETED|Fourth Intervention Period||0
10449910|NCT00975481|11597286|FG002|NOT COMPLETED|Fourth Intervention Period||1
10449911|NCT00975481|11597287|FG003|NOT COMPLETED|Fourth Intervention Period||1
10449912|NCT00975481|11597288|FG004|NOT COMPLETED|Fourth Intervention Period||0
10449913|NCT00975481|11597289|FG005|NOT COMPLETED|Fourth Intervention Period||0
10449914|NCT00975481|11597284|FG000|STARTED|Washout Period (at Least 7 Days)||4
10449915|NCT00975481|11597285|FG001|STARTED|Washout Period (at Least 7 Days)||5
10449916|NCT00975481|11597286|FG002|STARTED|Washout Period (at Least 7 Days)||4
10449917|NCT00975481|11597287|FG003|STARTED|Washout Period (at Least 7 Days)||5
10449918|NCT00975481|11597288|FG004|STARTED|Washout Period (at Least 7 Days)||6
10449919|NCT00975481|11597289|FG005|STARTED|Washout Period (at Least 7 Days)||6
10449920|NCT00975481|11597284|FG000|COMPLETED|Washout Period (at Least 7 Days)||4
10449921|NCT00975481|11597285|FG001|COMPLETED|Washout Period (at Least 7 Days)||5
10449922|NCT00975481|11597286|FG002|COMPLETED|Washout Period (at Least 7 Days)||4
10449923|NCT00975481|11597287|FG003|COMPLETED|Washout Period (at Least 7 Days)||5
10449924|NCT00975481|11597288|FG004|COMPLETED|Washout Period (at Least 7 Days)||6
10449925|NCT00975481|11597289|FG005|COMPLETED|Washout Period (at Least 7 Days)||6
10449926|NCT00975481|11597284|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
10449927|NCT00975481|11597285|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
10449928|NCT00975481|11597286|FG002|NOT COMPLETED|Washout Period (at Least 7 Days)||0
10449929|NCT00975481|11597287|FG003|NOT COMPLETED|Washout Period (at Least 7 Days)||0
10449930|NCT00975481|11597288|FG004|NOT COMPLETED|Washout Period (at Least 7 Days)||0
10449931|NCT00975481|11597289|FG005|NOT COMPLETED|Washout Period (at Least 7 Days)||0
10449932|NCT00975481|11597284|FG000|STARTED|Fifth Intervention Period||4
10449933|NCT00975481|11597285|FG001|STARTED|Fifth Intervention Period||5
10449934|NCT00975481|11597286|FG002|STARTED|Fifth Intervention Period||4
10449935|NCT00975481|11597287|FG003|STARTED|Fifth Intervention Period||5
10449936|NCT00975481|11597288|FG004|STARTED|Fifth Intervention Period||6
10449937|NCT00975481|11597289|FG005|STARTED|Fifth Intervention Period||6
10449938|NCT00975481|11597284|FG000|COMPLETED|Fifth Intervention Period||4
10449939|NCT00975481|11597285|FG001|COMPLETED|Fifth Intervention Period||5
10449940|NCT00975481|11597286|FG002|COMPLETED|Fifth Intervention Period||4
10449941|NCT00975481|11597287|FG003|COMPLETED|Fifth Intervention Period||5
10449942|NCT00975481|11597288|FG004|COMPLETED|Fifth Intervention Period||5
10449943|NCT00975481|11597289|FG005|COMPLETED|Fifth Intervention Period||6
10449944|NCT00975481|11597284|FG000|NOT COMPLETED|Fifth Intervention Period||0
10449945|NCT00975481|11597285|FG001|NOT COMPLETED|Fifth Intervention Period||0
10449946|NCT00975481|11597286|FG002|NOT COMPLETED|Fifth Intervention Period||0
10449947|NCT00975481|11597287|FG003|NOT COMPLETED|Fifth Intervention Period||0
10449948|NCT00975481|11597288|FG004|NOT COMPLETED|Fifth Intervention Period||1
10449949|NCT00975481|11597289|FG005|NOT COMPLETED|Fifth Intervention Period||0
10449950|NCT00975481|11597284|FG000|STARTED|Washout Period (at Least 7 Days)||4
10449951|NCT00975481|11597285|FG001|STARTED|Washout Period (at Least 7 Days)||5
10449952|NCT00975481|11597286|FG002|STARTED|Washout Period (at Least 7 Days)||4
10449953|NCT00975481|11597287|FG003|STARTED|Washout Period (at Least 7 Days)||5
10449954|NCT00975481|11597288|FG004|STARTED|Washout Period (at Least 7 Days)||5
10449955|NCT00975481|11597289|FG005|STARTED|Washout Period (at Least 7 Days)||6
10449956|NCT00975481|11597284|FG000|COMPLETED|Washout Period (at Least 7 Days)||4
10449957|NCT00975481|11597285|FG001|COMPLETED|Washout Period (at Least 7 Days)||5
10449958|NCT00975481|11597286|FG002|COMPLETED|Washout Period (at Least 7 Days)||4
10449959|NCT00975481|11597287|FG003|COMPLETED|Washout Period (at Least 7 Days)||5
10449960|NCT00975481|11597288|FG004|COMPLETED|Washout Period (at Least 7 Days)||5
10449961|NCT00975481|11597289|FG005|COMPLETED|Washout Period (at Least 7 Days)||6
10449962|NCT00975481|11597284|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
10449963|NCT00975481|11597285|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
10449964|NCT00975481|11597286|FG002|NOT COMPLETED|Washout Period (at Least 7 Days)||0
10449965|NCT00975481|11597287|FG003|NOT COMPLETED|Washout Period (at Least 7 Days)||0
10449966|NCT00975481|11597288|FG004|NOT COMPLETED|Washout Period (at Least 7 Days)||0
10449967|NCT00975481|11597289|FG005|NOT COMPLETED|Washout Period (at Least 7 Days)||0
10449968|NCT00975481|11597284|FG000|STARTED|Sixth Intervention Period||4
10449969|NCT00975481|11597285|FG001|STARTED|Sixth Intervention Period||5
10449970|NCT00975481|11597286|FG002|STARTED|Sixth Intervention Period||4
10449971|NCT00975481|11597287|FG003|STARTED|Sixth Intervention Period||5
10449972|NCT00975481|11597288|FG004|STARTED|Sixth Intervention Period||5
10449973|NCT00975481|11597289|FG005|STARTED|Sixth Intervention Period||6
10449974|NCT00975481|11597284|FG000|COMPLETED|Sixth Intervention Period||4
10449975|NCT00975481|11597285|FG001|COMPLETED|Sixth Intervention Period||5
10449976|NCT00975481|11597286|FG002|COMPLETED|Sixth Intervention Period||4
10449977|NCT00975481|11597287|FG003|COMPLETED|Sixth Intervention Period||5
10449978|NCT00975481|11597288|FG004|COMPLETED|Sixth Intervention Period||5
10449979|NCT00975481|11597289|FG005|COMPLETED|Sixth Intervention Period||6
10449980|NCT00975481|11597284|FG000|NOT COMPLETED|Sixth Intervention Period||0
10449981|NCT00975481|11597285|FG001|NOT COMPLETED|Sixth Intervention Period||0
10449982|NCT00975481|11597286|FG002|NOT COMPLETED|Sixth Intervention Period||0
10449983|NCT00975481|11597287|FG003|NOT COMPLETED|Sixth Intervention Period||0
10449984|NCT00975481|11597288|FG004|NOT COMPLETED|Sixth Intervention Period||0
10449985|NCT00975481|11597289|FG005|NOT COMPLETED|Sixth Intervention Period||0
10449986|NCT00975507|11597309|FG000|STARTED|Overall Study||323
10449987|NCT00975507|11597310|FG001|STARTED|Overall Study||157
10449988|NCT00975507|11597309|FG000|Vaccinated at Visit 1|Overall Study||323
10449989|NCT00975507|11597310|FG001|Vaccinated at Visit 1|Overall Study||157
10449990|NCT00975507|11597309|FG000|Vaccinated at Visit 2|Overall Study||310
10449991|NCT00975507|11597310|FG001|Vaccinated at Visit 2|Overall Study|Per-protocol, subjects receiving M-M-R™ II + VARIVAX™ at Visit 1 were not vaccinated at Visit 2|0
10449992|NCT00975507|11597309|FG000|COMPLETED|Overall Study||303
10449993|NCT00975507|11597310|FG001|COMPLETED|Overall Study||153
10449994|NCT00975507|11597309|FG000|NOT COMPLETED|Overall Study||20
10449995|NCT00975507|11597310|FG001|NOT COMPLETED|Overall Study||4
10449996|NCT00975585|11597320|FG000|STARTED|Overall Study||184
10449997|NCT00975585|11597321|FG001|STARTED|Overall Study||195
10449998|NCT00975585|11597320|FG000|COMPLETED|Overall Study||177
10449999|NCT00975585|11597321|FG001|COMPLETED|Overall Study||183
10450000|NCT00975585|11597320|FG000|NOT COMPLETED|Overall Study||7
10450001|NCT00975585|11597321|FG001|NOT COMPLETED|Overall Study||12
10450002|NCT00975637|11597334|FG000|STARTED|Overall Study||40
10450003|NCT00975637|11597335|FG001|STARTED|Overall Study||39
10450004|NCT00975637|11597336|FG002|STARTED|Overall Study||42
10450005|NCT00975637|11597337|FG003|STARTED|Overall Study||38
10450006|NCT00975637|11597338|FG004|STARTED|Overall Study||39
10450007|NCT00975637|11597334|FG000|COMPLETED|Overall Study||37
10450008|NCT00975637|11597335|FG001|COMPLETED|Overall Study||38
10450009|NCT00975637|11597336|FG002|COMPLETED|Overall Study||40
10450010|NCT00975637|11597337|FG003|COMPLETED|Overall Study||32
10450011|NCT00975637|11597338|FG004|COMPLETED|Overall Study||37
10450012|NCT00975637|11597334|FG000|NOT COMPLETED|Overall Study||3
10450013|NCT00975637|11597335|FG001|NOT COMPLETED|Overall Study||1
10450014|NCT00975637|11597336|FG002|NOT COMPLETED|Overall Study||2
10450015|NCT00975637|11597337|FG003|NOT COMPLETED|Overall Study||6
10450016|NCT00975637|11597338|FG004|NOT COMPLETED|Overall Study||2
10450017|NCT00975650|11597350|FG000|STARTED|Period 1||13
10450018|NCT00975650|11597351|FG001|STARTED|Period 1||16
10450019|NCT00975650|11597352|FG002|STARTED|Period 1||14
10450020|NCT00975650|11597353|FG003|STARTED|Period 1||14
10450021|NCT00975650|11597350|FG000|COMPLETED|Period 1||13
10450022|NCT00975650|11597351|FG001|COMPLETED|Period 1||16
10450023|NCT00975650|11597352|FG002|COMPLETED|Period 1||14
10450024|NCT00975650|11597353|FG003|COMPLETED|Period 1||14
10450025|NCT00975650|11597350|FG000|NOT COMPLETED|Period 1||0
10450026|NCT00975650|11597351|FG001|NOT COMPLETED|Period 1||0
10450027|NCT00975650|11597352|FG002|NOT COMPLETED|Period 1||0
10450028|NCT00975650|11597353|FG003|NOT COMPLETED|Period 1||0
10450029|NCT00975650|11597350|FG000|STARTED|Period 2||13
10450030|NCT00975650|11597351|FG001|STARTED|Period 2||16
10450031|NCT00975650|11597352|FG002|STARTED|Period 2||14
10450032|NCT00975650|11597353|FG003|STARTED|Period 2||14
10450033|NCT00975650|11597350|FG000|COMPLETED|Period 2||12
10450034|NCT00975650|11597351|FG001|COMPLETED|Period 2||14
10450035|NCT00975650|11597352|FG002|COMPLETED|Period 2||14
10450036|NCT00975650|11597353|FG003|COMPLETED|Period 2||14
10450037|NCT00975650|11597350|FG000|NOT COMPLETED|Period 2||1
10450038|NCT00975650|11597351|FG001|NOT COMPLETED|Period 2||2
10450039|NCT00975650|11597352|FG002|NOT COMPLETED|Period 2||0
10450040|NCT00975650|11597353|FG003|NOT COMPLETED|Period 2||0
10450041|NCT00975650|11597350|FG000|STARTED|Period 3||12
10450042|NCT00975650|11597351|FG001|STARTED|Period 3||14
10450043|NCT00975650|11597352|FG002|STARTED|Period 3||14
10450044|NCT00975650|11597353|FG003|STARTED|Period 3||14
10450045|NCT00975650|11597350|FG000|COMPLETED|Period 3||12
10450046|NCT00975650|11597351|FG001|COMPLETED|Period 3||14
10450047|NCT00975650|11597352|FG002|COMPLETED|Period 3||14
10450048|NCT00975650|11597353|FG003|COMPLETED|Period 3||14
10450049|NCT00975650|11597350|FG000|NOT COMPLETED|Period 3||0
10450050|NCT00975650|11597351|FG001|NOT COMPLETED|Period 3||0
10450051|NCT00975650|11597352|FG002|NOT COMPLETED|Period 3||0
10450052|NCT00975650|11597353|FG003|NOT COMPLETED|Period 3||0
10450053|NCT00975650|11597350|FG000|STARTED|Period 4||12
10450054|NCT00975650|11597351|FG001|STARTED|Period 4||14
10450055|NCT00975650|11597352|FG002|STARTED|Period 4||14
10450056|NCT00975650|11597353|FG003|STARTED|Period 4||14
10450057|NCT00975650|11597350|FG000|COMPLETED|Period 4||12
10450058|NCT00975650|11597351|FG001|COMPLETED|Period 4||14
10450059|NCT00975650|11597352|FG002|COMPLETED|Period 4||14
10450060|NCT00975650|11597353|FG003|COMPLETED|Period 4||14
10450061|NCT00975650|11597350|FG000|NOT COMPLETED|Period 4||0
10450062|NCT00975650|11597351|FG001|NOT COMPLETED|Period 4||0
10450063|NCT00975650|11597352|FG002|NOT COMPLETED|Period 4||0
10450064|NCT00975650|11597353|FG003|NOT COMPLETED|Period 4||0
10450065|NCT00975676|11597365|FG000|STARTED|Overall Study||32
10450066|NCT00975676|11597366|FG001|STARTED|Overall Study||91
10450067|NCT00975676|11597365|FG000|COMPLETED|Overall Study||26
10450068|NCT00975676|11597366|FG001|COMPLETED|Overall Study||83
10450069|NCT00975676|11597365|FG000|NOT COMPLETED|Overall Study||6
10450070|NCT00975676|11597366|FG001|NOT COMPLETED|Overall Study||8
10450071|NCT00975689|11597379|FG000|STARTED|Overall Study||17
10450072|NCT00975689|11597380|FG001|STARTED|Overall Study||18
10450073|NCT00975689|11597379|FG000|COMPLETED|Overall Study||15
10450074|NCT00975689|11597380|FG001|COMPLETED|Overall Study||15
10450075|NCT00975689|11597379|FG000|NOT COMPLETED|Overall Study||2
10450076|NCT00975689|11597380|FG001|NOT COMPLETED|Overall Study||3
10450077|NCT00975715|11597388|FG000|STARTED|Titration Period||48
10450078|NCT00975715|11597389|FG001|STARTED|Titration Period||51
10450079|NCT00975715|11597388|FG000|COMPLETED|Titration Period||41
10450080|NCT00975715|11597389|FG001|COMPLETED|Titration Period||51
10450081|NCT00975715|11597388|FG000|NOT COMPLETED|Titration Period||7
10450082|NCT00975715|11597389|FG001|NOT COMPLETED|Titration Period||0
10450083|NCT00975715|11597388|FG000|STARTED|Maintenance Period||41
10450084|NCT00975715|11597389|FG001|STARTED|Maintenance Period||51
10450085|NCT00975715|11597388|FG000|COMPLETED|Maintenance Period||39
10450086|NCT00975715|11597389|FG001|COMPLETED|Maintenance Period||50
10450087|NCT00975715|11597388|FG000|NOT COMPLETED|Maintenance Period||2
10450088|NCT00975715|11597389|FG001|NOT COMPLETED|Maintenance Period||1
10450089|NCT00975780|11597397|FG000|STARTED|Allocation||400
10450090|NCT00975780|11597398|FG001|STARTED|Allocation||434
10450091|NCT00975780|11597397|FG000|COMPLETED|Allocation||400
10450092|NCT00975780|11597398|FG001|COMPLETED|Allocation||434
10450093|NCT00975780|11597397|FG000|NOT COMPLETED|Allocation||0
10450094|NCT00975780|11597398|FG001|NOT COMPLETED|Allocation||0
10450095|NCT00975780|11597397|FG000|STARTED|Follow Up||400
10450096|NCT00975780|11597398|FG001|STARTED|Follow Up||434
10450097|NCT00975780|11597397|FG000|COMPLETED|Follow Up||298
10450098|NCT00975780|11597398|FG001|COMPLETED|Follow Up||277
10450099|NCT00975780|11597397|FG000|NOT COMPLETED|Follow Up||102
10450100|NCT00975780|11597398|FG001|NOT COMPLETED|Follow Up||157
10450101|NCT00975806|11597407|FG000|STARTED|Overall Study||5
10450102|NCT00975806|11597408|FG001|STARTED|Overall Study||7
10450103|NCT00975806|11597409|FG002|STARTED|Overall Study||4
10450104|NCT00975806|11597407|FG000|COMPLETED|Overall Study|Participants were prematurely discontinued|0
10450105|NCT00975806|11597408|FG001|COMPLETED|Overall Study|Participants were prematurely discontinued|0
10450106|NCT00975806|11597409|FG002|COMPLETED|Overall Study|Participants were prematurely discontinued|0
10450107|NCT00975806|11597407|FG000|NOT COMPLETED|Overall Study||5
10551262|NCT01536379|11705495|FG000|COMPLETED|Overall Study||11
10551263|NCT01536379|11705496|FG001|COMPLETED|Overall Study||9
10551264|NCT01536379|11705495|FG000|NOT COMPLETED|Overall Study||2
10551265|NCT01536379|11705496|FG001|NOT COMPLETED|Overall Study||3
10551266|NCT01536392|11705504|FG000|STARTED|Overall Study||41
10551267|NCT01536392|11705505|FG001|STARTED|Overall Study||34
10551268|NCT01536392|11705504|FG000|COMPLETED|Overall Study||28
10551269|NCT01536392|11705505|FG001|COMPLETED|Overall Study||19
10551270|NCT01536392|11705504|FG000|NOT COMPLETED|Overall Study||13
10551271|NCT01536392|11705505|FG001|NOT COMPLETED|Overall Study||15
10551272|NCT01536405|11705513|FG000|STARTED|Randomization to Visit 1 (Vaccination 1)||706
10551273|NCT01536405|11705514|FG001|STARTED|Randomization to Visit 1 (Vaccination 1)||706
10551274|NCT01536405|11705513|FG000|COMPLETED|Randomization to Visit 1 (Vaccination 1)||698
10551275|NCT01536405|11705514|FG001|COMPLETED|Randomization to Visit 1 (Vaccination 1)||702
10551276|NCT01536405|11705513|FG000|NOT COMPLETED|Randomization to Visit 1 (Vaccination 1)||8
10551277|NCT01536405|11705514|FG001|NOT COMPLETED|Randomization to Visit 1 (Vaccination 1)||4
10551278|NCT01536405|11705513|FG000|STARTED|Visit 1 (Vaccination 1) to Visit 2||698
10551279|NCT01536405|11705514|FG001|STARTED|Visit 1 (Vaccination 1) to Visit 2||702
10551280|NCT01536405|11705513|FG000|Received Vaccination 1|Visit 1 (Vaccination 1) to Visit 2||698
10551281|NCT01536405|11705514|FG001|Received Vaccination 1|Visit 1 (Vaccination 1) to Visit 2||702
10551282|NCT01536405|11705513|FG000|COMPLETED|Visit 1 (Vaccination 1) to Visit 2||666
10551283|NCT01536405|11705514|FG001|COMPLETED|Visit 1 (Vaccination 1) to Visit 2||662
10450108|NCT00975806|11597408|FG001|NOT COMPLETED|Overall Study||7
10450109|NCT00975806|11597409|FG002|NOT COMPLETED|Overall Study||4
10450110|NCT00975884|11597421|FG000|STARTED|Overall Study||184
10450111|NCT00975884|11597422|FG001|STARTED|Overall Study||122
10450112|NCT00975884|11597421|FG000|COMPLETED|Overall Study||168
10450113|NCT00975884|11597422|FG001|COMPLETED|Overall Study||107
10450114|NCT00975884|11597421|FG000|NOT COMPLETED|Overall Study||16
10450115|NCT00975884|11597422|FG001|NOT COMPLETED|Overall Study||15
10450116|NCT00975923|11597440|FG000|STARTED|Overall Study||30
10450117|NCT00975923|11597441|FG001|STARTED|Overall Study||30
10450118|NCT00975923|11597440|FG000|COMPLETED|Overall Study||30
10450119|NCT00975923|11597441|FG001|COMPLETED|Overall Study|1 hospital was sold, yielding 29 hospitals in the Tool Kit Group|29
10450120|NCT00975923|11597440|FG000|NOT COMPLETED|Overall Study||0
10450121|NCT00975923|11597441|FG001|NOT COMPLETED|Overall Study||1
10450122|NCT00975975|11597448|FG000|STARTED|Overall Study||17
10450123|NCT00975975|11597448|FG000|COMPLETED|Overall Study||11
10450124|NCT00975975|11597448|FG000|NOT COMPLETED|Overall Study||6
10450125|NCT00976027|11597454|FG000|STARTED|Overall Study||6108
10450126|NCT00976027|11597455|FG001|STARTED|Overall Study||3050
10450127|NCT00976027|11597454|FG000|COMPLETED|Overall Study||5697
10450128|NCT00976027|11597455|FG001|COMPLETED|Overall Study||2835
10450129|NCT00976027|11597454|FG000|NOT COMPLETED|Overall Study||411
10450130|NCT00976027|11597455|FG001|NOT COMPLETED|Overall Study||215
10450131|NCT00976183|11597461|FG000|STARTED|Overall Study||18
10551284|NCT01536405|11705513|FG000|NOT COMPLETED|Visit 1 (Vaccination 1) to Visit 2||32
10551285|NCT01536405|11705514|FG001|NOT COMPLETED|Visit 1 (Vaccination 1) to Visit 2||40
10551286|NCT01536405|11705513|FG000|STARTED|Visit 2 to Visit 3 (Vaccination 2)||666
10551287|NCT01536405|11705514|FG001|STARTED|Visit 2 to Visit 3 (Vaccination 2)||662
10551288|NCT01536405|11705513|FG000|COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||635
10551289|NCT01536405|11705514|FG001|COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||634
10551290|NCT01536405|11705513|FG000|NOT COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||31
10551291|NCT01536405|11705514|FG001|NOT COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||28
10450132|NCT00976183|11597461|FG000|COMPLETED|Overall Study|The study was closed on 05/30/12 due to adverse events. We did not complete enrollment|18
10450133|NCT00976183|11597461|FG000|NOT COMPLETED|Overall Study||0
10450134|NCT00976209|11597467|FG000|STARTED|Treatment Period 1||165
10450135|NCT00976209|11597468|FG001|STARTED|Treatment Period 1||166
10450136|NCT00976209|11597467|FG000|COMPLETED|Treatment Period 1||162
10450137|NCT00976209|11597468|FG001|COMPLETED|Treatment Period 1||165
10450138|NCT00976209|11597467|FG000|NOT COMPLETED|Treatment Period 1||3
10450139|NCT00976209|11597468|FG001|NOT COMPLETED|Treatment Period 1||1
10450140|NCT00976209|11597467|FG000|STARTED|Wash-out Period||162
10450141|NCT00976209|11597468|FG001|STARTED|Wash-out Period||165
10450142|NCT00976209|11597467|FG000|COMPLETED|Wash-out Period||158
10450143|NCT00976209|11597468|FG001|COMPLETED|Wash-out Period||163
10450144|NCT00976209|11597467|FG000|NOT COMPLETED|Wash-out Period||4
10450145|NCT00976209|11597468|FG001|NOT COMPLETED|Wash-out Period||2
10450146|NCT00976209|11597467|FG000|STARTED|Treatment Period 2||158
10450147|NCT00976209|11597468|FG001|STARTED|Treatment Period 2||163
10450148|NCT00976209|11597467|FG000|COMPLETED|Treatment Period 2||158
10450149|NCT00976209|11597468|FG001|COMPLETED|Treatment Period 2||161
10450150|NCT00976209|11597467|FG000|NOT COMPLETED|Treatment Period 2||0
10450151|NCT00976209|11597468|FG001|NOT COMPLETED|Treatment Period 2||2
10450152|NCT00976248|11597473|FG000|STARTED|Overall Study||33
10450153|NCT00976248|11597473|FG000|COMPLETED|Overall Study||33
10450154|NCT00976248|11597473|FG000|NOT COMPLETED|Overall Study||0
10450155|NCT00976274|11597480|FG000|STARTED|Overall Study||31
10450156|NCT00976274|11597481|FG001|STARTED|Overall Study||29
10450157|NCT00976274|11597480|FG000|COMPLETED|Overall Study||24
10450158|NCT00976274|11597481|FG001|COMPLETED|Overall Study||21
10450159|NCT00976274|11597480|FG000|NOT COMPLETED|Overall Study||7
10450160|NCT00976274|11597481|FG001|NOT COMPLETED|Overall Study||8
10450161|NCT00976352|11597489|FG000|STARTED|Overall Study||3
10450162|NCT00976352|11597490|FG001|STARTED|Overall Study||10
10450163|NCT00976352|11597489|FG000|COMPLETED|Overall Study||3
10450164|NCT00976352|11597490|FG001|COMPLETED|Overall Study|Last evaluation of last subject in cohort.|6
10450165|NCT00976352|11597489|FG000|NOT COMPLETED|Overall Study||0
10450166|NCT00976352|11597490|FG001|NOT COMPLETED|Overall Study||4
10450167|NCT00976391|11597502|FG000|STARTED|Treatment Period (52 Weeks)||285
10450168|NCT00976391|11597503|FG001|STARTED|Treatment Period (52 Weeks)||281
10450169|NCT00976391|11597502|FG000|COMPLETED|Treatment Period (52 Weeks)||243
10450170|NCT00976391|11597503|FG001|COMPLETED|Treatment Period (52 Weeks)||242
10450171|NCT00976391|11597502|FG000|NOT COMPLETED|Treatment Period (52 Weeks)||42
10450172|NCT00976391|11597503|FG001|NOT COMPLETED|Treatment Period (52 Weeks)||39
10450173|NCT00976391|11597502|FG000|STARTED|Follow-up Period (8 Weeks)||285
10450174|NCT00976391|11597503|FG001|STARTED|Follow-up Period (8 Weeks)||281
10450175|NCT00976391|11597502|FG000|COMPLETED|Follow-up Period (8 Weeks)||256
10450176|NCT00976391|11597503|FG001|COMPLETED|Follow-up Period (8 Weeks)||247
10450177|NCT00976391|11597502|FG000|NOT COMPLETED|Follow-up Period (8 Weeks)||29
10450178|NCT00976391|11597503|FG001|NOT COMPLETED|Follow-up Period (8 Weeks)||34
10450179|NCT00976404|11597511|FG000|STARTED|Overall Study||14
10450180|NCT00976404|11597512|FG001|STARTED|Overall Study||14
10450181|NCT00976404|11597511|FG000|COMPLETED|Overall Study||14
10450182|NCT00976404|11597512|FG001|COMPLETED|Overall Study||14
10450183|NCT00976404|11597511|FG000|NOT COMPLETED|Overall Study||0
10450184|NCT00976404|11597512|FG001|NOT COMPLETED|Overall Study||0
10450185|NCT00976456|11597522|FG000|STARTED|Overall Study||135
10450186|NCT00976456|11597523|FG001|STARTED|Overall Study||136
10450187|NCT00976456|11597522|FG000|COMPLETED|Overall Study||92
10450188|NCT00976456|11597523|FG001|COMPLETED|Overall Study||98
10450189|NCT00976456|11597522|FG000|NOT COMPLETED|Overall Study||43
10450190|NCT00976456|11597523|FG001|NOT COMPLETED|Overall Study||38
10450191|NCT00976482|11597529|FG000|STARTED|Overall Study||1745
10450192|NCT00976482|11597529|FG000|Eligible for Last Follow up|Overall Study||1487
10450193|NCT00976482|11597529|FG000|COMPLETED|Overall Study||1486
10450194|NCT00976482|11597529|FG000|NOT COMPLETED|Overall Study||259
10450195|NCT00976495|11597536|FG000|STARTED|Overall Study||25
10450196|NCT00976495|11597537|FG001|STARTED|Overall Study||24
10450197|NCT00976495|11597538|FG002|STARTED|Overall Study||26
10450198|NCT00976495|11597536|FG000|COMPLETED|Overall Study||25
10450199|NCT00976495|11597537|FG001|COMPLETED|Overall Study||23
10450200|NCT00976495|11597538|FG002|COMPLETED|Overall Study||26
10450201|NCT00976495|11597536|FG000|NOT COMPLETED|Overall Study||0
10450202|NCT00976495|11597537|FG001|NOT COMPLETED|Overall Study||1
10450203|NCT00976495|11597538|FG002|NOT COMPLETED|Overall Study||0
10450204|NCT00976508|11597548|FG000|STARTED|Overall Study|18 subjects were enrolled; 17 subjects were treated; 1 subject was not eligible.|17
10450205|NCT00976508|11597549|FG001|STARTED|Overall Study||6
10450206|NCT00976508|11597548|FG000|COMPLETED|Overall Study|These subjects withdrew from last study treatment due to progressive disease.|3
10450207|NCT00976508|11597549|FG001|COMPLETED|Overall Study||0
10450208|NCT00976508|11597548|FG000|NOT COMPLETED|Overall Study||14
10450209|NCT00976508|11597549|FG001|NOT COMPLETED|Overall Study||6
10450210|NCT00976521|11597562|FG000|STARTED|Overall Study||118
10450211|NCT00976521|11597563|FG001|STARTED|Overall Study||111
10450212|NCT00976521|11597564|FG002|STARTED|Overall Study||111
10450213|NCT00976521|11597565|FG003|STARTED|Overall Study||112
10450214|NCT00976521|11597562|FG000|COMPLETED|Overall Study||109
10450215|NCT00976521|11597563|FG001|COMPLETED|Overall Study||99
10450216|NCT00976521|11597564|FG002|COMPLETED|Overall Study||102
10450217|NCT00976521|11597565|FG003|COMPLETED|Overall Study||93
10450218|NCT00976521|11597562|FG000|NOT COMPLETED|Overall Study||9
10450219|NCT00976521|11597563|FG001|NOT COMPLETED|Overall Study||12
10450220|NCT00976521|11597564|FG002|NOT COMPLETED|Overall Study||9
10450221|NCT00976521|11597565|FG003|NOT COMPLETED|Overall Study||19
10450222|NCT00976560|11597578|FG000|STARTED|Overall Study||64
10450223|NCT00976560|11597579|FG001|STARTED|Overall Study||64
10450224|NCT00976560|11597578|FG000|COMPLETED|Overall Study||50
10450225|NCT00976560|11597579|FG001|COMPLETED|Overall Study||51
10450226|NCT00976560|11597578|FG000|NOT COMPLETED|Overall Study||14
10450227|NCT00976560|11597579|FG001|NOT COMPLETED|Overall Study||13
10450228|NCT00976573|11597587|FG000|STARTED|Overall Study||75
10450229|NCT00976573|11597588|FG001|STARTED|Overall Study||74
10450230|NCT00976573|11597587|FG000|COMPLETED|Overall Study||71
10450231|NCT00976573|11597588|FG001|COMPLETED|Overall Study||71
10450232|NCT00976573|11597587|FG000|NOT COMPLETED|Overall Study||4
10450233|NCT00976573|11597588|FG001|NOT COMPLETED|Overall Study||3
10450234|NCT00976599|11597596|FG000|STARTED|Overall Study||15
10450235|NCT00976599|11597597|FG001|STARTED|Overall Study||14
10450236|NCT00976599|11597596|FG000|COMPLETED|Overall Study||15
10450237|NCT00976599|11597597|FG001|COMPLETED|Overall Study||14
10450238|NCT00976599|11597596|FG000|NOT COMPLETED|Overall Study||0
10551292|NCT01536405|11705513|FG000|STARTED|Visit 3 (Vaccination 2) to Visit 4||635
10551293|NCT01536405|11705514|FG001|STARTED|Visit 3 (Vaccination 2) to Visit 4||634
10551294|NCT01536405|11705513|FG000|Received Vaccination 2|Visit 3 (Vaccination 2) to Visit 4||634
10450239|NCT00976599|11597597|FG001|NOT COMPLETED|Overall Study||0
10450240|NCT00976664|11597605|FG000|STARTED|Overall Study||25
10450241|NCT00976664|11597606|FG001|STARTED|Overall Study||25
10450242|NCT00976664|11597605|FG000|COMPLETED|Overall Study||22
10450243|NCT00976664|11597606|FG001|COMPLETED|Overall Study||24
10450244|NCT00976664|11597605|FG000|NOT COMPLETED|Overall Study||3
10450245|NCT00976664|11597606|FG001|NOT COMPLETED|Overall Study||1
10450246|NCT00976677|11597614|FG000|STARTED|Overall Study||5
10450247|NCT00976677|11597615|FG001|STARTED|Overall Study||5
10450248|NCT00976677|11597614|FG000|COMPLETED|Overall Study||0
10450249|NCT00976677|11597615|FG001|COMPLETED|Overall Study||0
10450250|NCT00976677|11597614|FG000|NOT COMPLETED|Overall Study||5
10450251|NCT00976677|11597615|FG001|NOT COMPLETED|Overall Study||5
10450252|NCT00976703|11597623|FG000|STARTED|Overall Study||99
10450253|NCT00976703|11597624|FG001|STARTED|Overall Study||98
10450254|NCT00976703|11597623|FG000|COMPLETED|Overall Study||96
10450255|NCT00976703|11597624|FG001|COMPLETED|Overall Study||95
10450256|NCT00976703|11597623|FG000|NOT COMPLETED|Overall Study||3
10450257|NCT00976703|11597624|FG001|NOT COMPLETED|Overall Study||3
10450258|NCT00976716|11597630|FG000|STARTED|Overall Study||80
10450259|NCT00976716|11597630|FG000|COMPLETED|Overall Study||79
10450260|NCT00976716|11597630|FG000|NOT COMPLETED|Overall Study||1
10450261|NCT00976820|11597639|FG000|STARTED|Overall Study||67
10450262|NCT00976820|11597640|FG001|STARTED|Overall Study||128
10450263|NCT00976820|11597641|FG002|STARTED|Overall Study||64
10450264|NCT00976820|11597642|FG003|STARTED|Overall Study||63
10450265|NCT00976820|11597639|FG000|COMPLETED|Overall Study||59
10450266|NCT00976820|11597640|FG001|COMPLETED|Overall Study||108
10450267|NCT00976820|11597641|FG002|COMPLETED|Overall Study||60
10450268|NCT00976820|11597642|FG003|COMPLETED|Overall Study||56
10450269|NCT00976820|11597639|FG000|NOT COMPLETED|Overall Study||8
10450270|NCT00976820|11597640|FG001|NOT COMPLETED|Overall Study||20
10450271|NCT00976820|11597641|FG002|NOT COMPLETED|Overall Study||4
10450272|NCT00976820|11597642|FG003|NOT COMPLETED|Overall Study||7
10450273|NCT00976898|11597693|FG000|STARTED|Overall Study||83
10450274|NCT00976898|11597693|FG000|COMPLETED|Overall Study||78
10450275|NCT00976898|11597693|FG000|NOT COMPLETED|Overall Study||5
10450276|NCT00976937|11597699|FG000|STARTED|Overall Study|Randomized|158
10450277|NCT00976937|11597700|FG001|STARTED|Overall Study||161
10450278|NCT00976937|11597699|FG000|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|158
10450279|NCT00976937|11597700|FG001|Treated/Safety Population|Overall Study||161
10450280|NCT00976937|11597699|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All randomized patients who received at least 1 dose of study drug.|158
10450281|NCT00976937|11597700|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||161
10450282|NCT00976937|11597699|FG000|COMPLETED|Overall Study||142
10450283|NCT00976937|11597700|FG001|COMPLETED|Overall Study||150
10450284|NCT00976937|11597699|FG000|NOT COMPLETED|Overall Study||16
10450285|NCT00976937|11597700|FG001|NOT COMPLETED|Overall Study||11
10450286|NCT00976950|11597706|FG000|STARTED|Overall Study||42
10450287|NCT00976950|11597706|FG000|COMPLETED|Overall Study||36
10450288|NCT00976950|11597706|FG000|NOT COMPLETED|Overall Study||6
10450289|NCT00976989|11597713|FG000|STARTED|Overall Study||73
10551295|NCT01536405|11705514|FG001|Received Vaccination 2|Visit 3 (Vaccination 2) to Visit 4||632
10551296|NCT01536405|11705513|FG000|COMPLETED|Visit 3 (Vaccination 2) to Visit 4||615
10551297|NCT01536405|11705514|FG001|COMPLETED|Visit 3 (Vaccination 2) to Visit 4||618
10450290|NCT00976989|11597714|FG001|STARTED|Overall Study||75
10450291|NCT00976989|11597715|FG002|STARTED|Overall Study||77
10450292|NCT00976989|11597713|FG000|COMPLETED|Overall Study||60
10450293|NCT00976989|11597714|FG001|COMPLETED|Overall Study||63
10450294|NCT00976989|11597715|FG002|COMPLETED|Overall Study||60
10450295|NCT00976989|11597713|FG000|NOT COMPLETED|Overall Study||13
10450296|NCT00976989|11597714|FG001|NOT COMPLETED|Overall Study||12
10450297|NCT00976989|11597715|FG002|NOT COMPLETED|Overall Study||17
10450298|NCT00977080|11597727|FG000|STARTED|Overall Study||62
10450299|NCT00977080|11597728|FG001|STARTED|Overall Study||64
10450300|NCT00977080|11597729|FG002|STARTED|Overall Study||72
10450301|NCT00977080|11597730|FG003|STARTED|Overall Study||70
10450302|NCT00977080|11597727|FG000|COMPLETED|Overall Study||50
10450303|NCT00977080|11597728|FG001|COMPLETED|Overall Study||44
10450304|NCT00977080|11597729|FG002|COMPLETED|Overall Study||56
10450305|NCT00977080|11597730|FG003|COMPLETED|Overall Study||53
10450306|NCT00977080|11597727|FG000|NOT COMPLETED|Overall Study||12
10450307|NCT00977080|11597728|FG001|NOT COMPLETED|Overall Study||20
10450308|NCT00977080|11597729|FG002|NOT COMPLETED|Overall Study||16
10450309|NCT00977080|11597730|FG003|NOT COMPLETED|Overall Study||17
10450310|NCT00977106|11597742|FG000|STARTED|Overall Study||47
10450311|NCT00977106|11597743|FG001|STARTED|Overall Study|Includes 3 participants who were randomized to placebo, but received tocilizumab.|56
10450312|NCT00977106|11597742|FG000|COMPLETED|Overall Study||37
10450313|NCT00977106|11597743|FG001|COMPLETED|Overall Study||45
10450314|NCT00977106|11597742|FG000|NOT COMPLETED|Overall Study||10
10450315|NCT00977106|11597743|FG001|NOT COMPLETED|Overall Study||11
10450316|NCT00977171|11597751|FG000|STARTED|Overall Study||3
10450317|NCT00977171|11597751|FG000|COMPLETED|Overall Study||3
10450318|NCT00977171|11597751|FG000|NOT COMPLETED|Overall Study||0
10450319|NCT00977184|11597757|FG000|STARTED|Overall Study||13
10450320|NCT00977184|11597758|FG001|STARTED|Overall Study||13
10450321|NCT00977184|11597757|FG000|COMPLETED|Overall Study||13
10450322|NCT00977184|11597758|FG001|COMPLETED|Overall Study||13
10450323|NCT00977184|11597757|FG000|NOT COMPLETED|Overall Study||0
10450324|NCT00977184|11597758|FG001|NOT COMPLETED|Overall Study||0
10450325|NCT00977197|11597773|FG000|STARTED|Overall Study||41
10450326|NCT00977197|11597774|FG001|STARTED|Overall Study||44
10450327|NCT00977197|11597773|FG000|COMPLETED|Overall Study||32
10450328|NCT00977197|11597774|FG001|COMPLETED|Overall Study||35
10450329|NCT00977197|11597773|FG000|NOT COMPLETED|Overall Study||9
10450330|NCT00977197|11597774|FG001|NOT COMPLETED|Overall Study||9
10450331|NCT00977314|11597782|FG000|STARTED|Overall Study||30
10450332|NCT00977314|11597783|FG001|STARTED|Overall Study|First 5 subjects enrolled were pilot subjects and not included in analysis.|5
10450333|NCT00977314|11597782|FG000|COMPLETED|Overall Study||28
10450334|NCT00977314|11597783|FG001|COMPLETED|Overall Study|First 5 subjects enrolled were pilot subjects and not included in analysis.|5
10450335|NCT00977314|11597782|FG000|NOT COMPLETED|Overall Study||2
10450336|NCT00977314|11597783|FG001|NOT COMPLETED|Overall Study||0
10450337|NCT00977379|11597791|FG000|STARTED|Overall Study|Randomized|12
10450338|NCT00977379|11597792|FG001|STARTED|Overall Study|Randomized|12
10450339|NCT00977379|11597791|FG000|Treated|Overall Study||12
10450340|NCT00977379|11597792|FG001|Treated|Overall Study||11
10450341|NCT00977379|11597791|FG000|COMPLETED|Overall Study||0
10450342|NCT00977379|11597792|FG001|COMPLETED|Overall Study||0
10450343|NCT00977379|11597791|FG000|NOT COMPLETED|Overall Study||12
10450344|NCT00977379|11597792|FG001|NOT COMPLETED|Overall Study||12
10450345|NCT00977431|11597803|FG000|STARTED|Overall Study||7
10450346|NCT00977431|11597804|FG001|STARTED|Overall Study||6
10450347|NCT00977431|11597805|FG002|STARTED|Overall Study||7
10450348|NCT00977431|11597806|FG003|STARTED|Overall Study||3
10450349|NCT00977431|11597807|FG004|STARTED|Overall Study||13
10450350|NCT00977431|11597803|FG000|Discontinued Afatinib Before/on Day 42|Overall Study||1
10450351|NCT00977431|11597804|FG001|Discontinued Afatinib Before/on Day 42|Overall Study||0
10450352|NCT00977431|11597805|FG002|Discontinued Afatinib Before/on Day 42|Overall Study||4
10450353|NCT00977431|11597806|FG003|Discontinued Afatinib Before/on Day 42|Overall Study||0
10450354|NCT00977431|11597807|FG004|Discontinued Afatinib Before/on Day 42|Overall Study||3
10450355|NCT00977431|11597803|FG000|COMPLETED|Overall Study||0
10450356|NCT00977431|11597804|FG001|COMPLETED|Overall Study||0
10450357|NCT00977431|11597805|FG002|COMPLETED|Overall Study||0
10450358|NCT00977431|11597806|FG003|COMPLETED|Overall Study||0
10450359|NCT00977431|11597807|FG004|COMPLETED|Overall Study||0
10450360|NCT00977431|11597803|FG000|NOT COMPLETED|Overall Study||7
10450361|NCT00977431|11597804|FG001|NOT COMPLETED|Overall Study||6
10450362|NCT00977431|11597805|FG002|NOT COMPLETED|Overall Study||7
10450363|NCT00977431|11597806|FG003|NOT COMPLETED|Overall Study||3
10450364|NCT00977431|11597807|FG004|NOT COMPLETED|Overall Study||13
10450365|NCT00977470|11597825|FG000|STARTED|Overall Study||38
10450366|NCT00977470|11597826|FG001|STARTED|Overall Study||38
10450367|NCT00977470|11597825|FG000|COMPLETED|Overall Study||0
10450368|NCT00977470|11597826|FG001|COMPLETED|Overall Study||0
10450369|NCT00977470|11597825|FG000|NOT COMPLETED|Overall Study||38
10450370|NCT00977470|11597826|FG001|NOT COMPLETED|Overall Study||38
10450371|NCT00977548|11597832|FG000|STARTED|Overall Study||39
10450372|NCT00977548|11597832|FG000|COMPLETED|Overall Study||26
10450373|NCT00977548|11597832|FG000|NOT COMPLETED|Overall Study||13
10450374|NCT00977561|11597838|FG000|STARTED|Overall Study||5
10450375|NCT00977561|11597839|FG001|STARTED|Overall Study||4
10450376|NCT00977561|11597838|FG000|COMPLETED|Overall Study||0
10450377|NCT00977561|11597839|FG001|COMPLETED|Overall Study||0
10450378|NCT00977561|11597838|FG000|NOT COMPLETED|Overall Study||5
10450379|NCT00977561|11597839|FG001|NOT COMPLETED|Overall Study||4
10450380|NCT00977613|11597847|FG000|STARTED|Overall Study||50
10450381|NCT00977613|11597847|FG000|COMPLETED|Overall Study||34
10450382|NCT00977613|11597847|FG000|NOT COMPLETED|Overall Study||16
10450383|NCT00977665|11597853|FG000|STARTED|Overall Study||84
10450384|NCT00977665|11597854|FG001|STARTED|Overall Study||90
10450385|NCT00977665|11597853|FG000|COMPLETED|Overall Study||63
10450386|NCT00977665|11597854|FG001|COMPLETED|Overall Study||75
10450387|NCT00977665|11597853|FG000|NOT COMPLETED|Overall Study||21
10450388|NCT00977665|11597854|FG001|NOT COMPLETED|Overall Study||15
10450389|NCT00977704|11597860|FG000|STARTED|Overall Study||20
10450390|NCT00977704|11597860|FG000|COMPLETED|Overall Study||20
10450391|NCT00977704|11597860|FG000|NOT COMPLETED|Overall Study||0
10450392|NCT00977769|11597867|FG000|STARTED|Overall Study||25
10450393|NCT00977769|11597868|FG001|STARTED|Overall Study||26
10450394|NCT00977769|11597869|FG002|STARTED|Overall Study||25
10450395|NCT00977769|11597867|FG000|COMPLETED|Overall Study||25
10450396|NCT00977769|11597868|FG001|COMPLETED|Overall Study||26
10450397|NCT00977769|11597869|FG002|COMPLETED|Overall Study||25
10450398|NCT00977769|11597867|FG000|NOT COMPLETED|Overall Study||0
10450399|NCT00977769|11597868|FG001|NOT COMPLETED|Overall Study||0
10450400|NCT00977769|11597869|FG002|NOT COMPLETED|Overall Study||0
10450401|NCT00977808|11597877|FG000|STARTED|Overall Study||12
10450402|NCT00977808|11597877|FG000|Completion of Open-Loop Admission|Overall Study||12
10450403|NCT00977808|11597877|FG000|Completion of Closed-Loop Admission|Overall Study||11
10450404|NCT00977808|11597877|FG000|COMPLETED|Overall Study||11
10450405|NCT00977808|11597877|FG000|NOT COMPLETED|Overall Study||1
10450406|NCT00977938|11597886|FG000|STARTED|Treatment (12-30 mo. Post Procedure)||5020
10450407|NCT00977938|11597887|FG001|STARTED|Treatment (12-30 mo. Post Procedure)||4941
10450408|NCT00977938|11597888|FG002|STARTED|Treatment (12-30 mo. Post Procedure)||842
10450409|NCT00977938|11597889|FG003|STARTED|Treatment (12-30 mo. Post Procedure)||845
10450410|NCT00977938|11597886|FG000|COMPLETED|Treatment (12-30 mo. Post Procedure)||4783
10450411|NCT00977938|11597887|FG001|COMPLETED|Treatment (12-30 mo. Post Procedure)||4716
10450412|NCT00977938|11597888|FG002|COMPLETED|Treatment (12-30 mo. Post Procedure)||796
10450413|NCT00977938|11597889|FG003|COMPLETED|Treatment (12-30 mo. Post Procedure)||784
10450414|NCT00977938|11597886|FG000|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||237
10450415|NCT00977938|11597887|FG001|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||225
10450416|NCT00977938|11597888|FG002|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||46
10450417|NCT00977938|11597889|FG003|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||61
10450418|NCT00977938|11597886|FG000|STARTED|Observation (30-33 mo. Post Procedure)||4783
10450419|NCT00977938|11597887|FG001|STARTED|Observation (30-33 mo. Post Procedure)||4716
10450420|NCT00977938|11597888|FG002|STARTED|Observation (30-33 mo. Post Procedure)||796
10450421|NCT00977938|11597889|FG003|STARTED|Observation (30-33 mo. Post Procedure)||784
10450422|NCT00977938|11597886|FG000|COMPLETED|Observation (30-33 mo. Post Procedure)||4732
10450423|NCT00977938|11597887|FG001|COMPLETED|Observation (30-33 mo. Post Procedure)||4658
10450424|NCT00977938|11597888|FG002|COMPLETED|Observation (30-33 mo. Post Procedure)||784
10450425|NCT00977938|11597889|FG003|COMPLETED|Observation (30-33 mo. Post Procedure)||781
10450426|NCT00977938|11597886|FG000|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||51
10450427|NCT00977938|11597887|FG001|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||58
10450428|NCT00977938|11597888|FG002|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||12
10450429|NCT00977938|11597889|FG003|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||3
10450430|NCT00978029|11597904|FG000|STARTED|Overall Study||65
10450431|NCT00978029|11597905|FG001|STARTED|Overall Study||66
10450432|NCT00978029|11597906|FG002|STARTED|Overall Study||65
10450433|NCT00978029|11597904|FG000|COMPLETED|Overall Study||64
10450434|NCT00978029|11597905|FG001|COMPLETED|Overall Study||63
10450435|NCT00978029|11597906|FG002|COMPLETED|Overall Study||59
10450436|NCT00978029|11597904|FG000|NOT COMPLETED|Overall Study||1
10450437|NCT00978029|11597905|FG001|NOT COMPLETED|Overall Study||3
10450438|NCT00978029|11597906|FG002|NOT COMPLETED|Overall Study||6
10450439|NCT00978042|11597916|FG000|STARTED|Initial Treatment Period||235
10450440|NCT00978042|11597917|FG001|STARTED|Initial Treatment Period||47
10450441|NCT00978042|11597916|FG000|MITT_treated With VOLUMA XC|Initial Treatment Period||235
10450442|NCT00978042|11597917|FG001|MITT_treated With VOLUMA XC|Initial Treatment Period||35
10450443|NCT00978042|11597916|FG000|COMPLETED|Initial Treatment Period|Completed 24-month Follow-Up|174
10450444|NCT00978042|11597917|FG001|COMPLETED|Initial Treatment Period||32
10450445|NCT00978042|11597916|FG000|NOT COMPLETED|Initial Treatment Period||61
10450446|NCT00978042|11597917|FG001|NOT COMPLETED|Initial Treatment Period||15
10450447|NCT00978042|11597916|FG000|STARTED|Received Repeat Treatment|Participants who were deemed eligible for re-treatment.|141
10450448|NCT00978042|11597917|FG001|STARTED|Received Repeat Treatment|Participants who were deemed eligible for re-treatment.|26
10450449|NCT00978042|11597916|FG000|COMPLETED|Received Repeat Treatment|Completed=Completed Repeat Treatment Follow-up|98
10450450|NCT00978042|11597917|FG001|COMPLETED|Received Repeat Treatment||23
10450451|NCT00978042|11597916|FG000|NOT COMPLETED|Received Repeat Treatment||43
10450452|NCT00978042|11597917|FG001|NOT COMPLETED|Received Repeat Treatment||3
10450453|NCT00978068|11597925|FG000|STARTED|Overall Study||87
10450454|NCT00978068|11597926|FG001|STARTED|Overall Study||89
10450455|NCT00978068|11597925|FG000|Initiated Study Drugs|Overall Study||84
10450456|NCT00978068|11597926|FG001|Initiated Study Drugs|Overall Study||86
10450457|NCT00978068|11597925|FG000|COMPLETED|Overall Study||83
10450458|NCT00978068|11597926|FG001|COMPLETED|Overall Study||80
10450459|NCT00978068|11597925|FG000|NOT COMPLETED|Overall Study||4
10450460|NCT00978068|11597926|FG001|NOT COMPLETED|Overall Study||9
10450461|NCT00978120|11597940|FG000|STARTED|Overall Study||110
10450462|NCT00978120|11597941|FG001|STARTED|Overall Study||107
10450463|NCT00978120|11597942|FG002|STARTED|Overall Study||87
10450464|NCT00978120|11597943|FG003|STARTED|Overall Study||86
10450465|NCT00978120|11597940|FG000|COMPLETED|Overall Study||108
10450466|NCT00978120|11597941|FG001|COMPLETED|Overall Study||107
10450467|NCT00978120|11597942|FG002|COMPLETED|Overall Study||84
10450468|NCT00978120|11597943|FG003|COMPLETED|Overall Study||84
10450469|NCT00978120|11597940|FG000|NOT COMPLETED|Overall Study||2
10450470|NCT00978120|11597941|FG001|NOT COMPLETED|Overall Study||0
10450471|NCT00978120|11597942|FG002|NOT COMPLETED|Overall Study||3
10450472|NCT00978120|11597943|FG003|NOT COMPLETED|Overall Study||2
10450473|NCT00978250|11597961|FG000|STARTED|Overall Study||25
10450474|NCT00978250|11597962|FG001|STARTED|Overall Study||30
10450475|NCT00978250|11597963|FG002|STARTED|Overall Study||18
10450476|NCT00978250|11597964|FG003|STARTED|Overall Study||22
10450477|NCT00978250|11597961|FG000|COMPLETED|Overall Study||25
10450478|NCT00978250|11597962|FG001|COMPLETED|Overall Study||29
10450479|NCT00978250|11597963|FG002|COMPLETED|Overall Study||18
10450480|NCT00978250|11597964|FG003|COMPLETED|Overall Study||21
10450481|NCT00978250|11597961|FG000|NOT COMPLETED|Overall Study||0
10450482|NCT00978250|11597962|FG001|NOT COMPLETED|Overall Study||1
10450483|NCT00978250|11597963|FG002|NOT COMPLETED|Overall Study||0
10450484|NCT00978250|11597964|FG003|NOT COMPLETED|Overall Study||1
10450485|NCT00978341|11597976|FG000|STARTED|First Intervention||8
10450486|NCT00978341|11597977|FG001|STARTED|First Intervention||7
10450487|NCT00978341|11597976|FG000|COMPLETED|First Intervention||8
10450488|NCT00978341|11597977|FG001|COMPLETED|First Intervention||7
10450489|NCT00978341|11597976|FG000|NOT COMPLETED|First Intervention||0
10450490|NCT00978341|11597977|FG001|NOT COMPLETED|First Intervention||0
10450491|NCT00978341|11597976|FG000|STARTED|Washout Period of 2 Weeks||8
10450492|NCT00978341|11597977|FG001|STARTED|Washout Period of 2 Weeks||7
10450493|NCT00978341|11597976|FG000|COMPLETED|Washout Period of 2 Weeks||7
10450494|NCT00978341|11597977|FG001|COMPLETED|Washout Period of 2 Weeks||7
10450495|NCT00978341|11597976|FG000|NOT COMPLETED|Washout Period of 2 Weeks||1
10450496|NCT00978341|11597977|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
10450497|NCT00978341|11597976|FG000|STARTED|Second Intervention||7
10450498|NCT00978341|11597977|FG001|STARTED|Second Intervention||7
10450499|NCT00978341|11597976|FG000|COMPLETED|Second Intervention||7
10450500|NCT00978341|11597977|FG001|COMPLETED|Second Intervention||7
10450501|NCT00978341|11597976|FG000|NOT COMPLETED|Second Intervention||0
10450502|NCT00978341|11597977|FG001|NOT COMPLETED|Second Intervention||0
10450503|NCT00978380|11597984|FG000|STARTED|Overall Study||63
10450504|NCT00978380|11597984|FG000|COMPLETED|Overall Study||44
10450505|NCT00978380|11597984|FG000|NOT COMPLETED|Overall Study||19
10450506|NCT00978432|11597992|FG000|STARTED|Overall Study||10
10450507|NCT00978432|11597993|FG001|STARTED|Overall Study||5
10450508|NCT00978432|11597994|FG002|STARTED|Overall Study||18
10450509|NCT00978432|11597992|FG000|COMPLETED|Overall Study||7
10450510|NCT00978432|11597993|FG001|COMPLETED|Overall Study||4
10450511|NCT00978432|11597994|FG002|COMPLETED|Overall Study||13
10450512|NCT00978432|11597992|FG000|NOT COMPLETED|Overall Study||3
10450513|NCT00978432|11597993|FG001|NOT COMPLETED|Overall Study||1
10450514|NCT00978432|11597994|FG002|NOT COMPLETED|Overall Study||5
10450515|NCT00978445|11598002|FG000|STARTED|Overall Study||12
10450516|NCT00978445|11598003|FG001|STARTED|Overall Study||13
10450517|NCT00978445|11598002|FG000|COMPLETED|Overall Study||10
10450518|NCT00978445|11598003|FG001|COMPLETED|Overall Study||12
10450519|NCT00978445|11598002|FG000|NOT COMPLETED|Overall Study||2
10450520|NCT00978445|11598003|FG001|NOT COMPLETED|Overall Study||1
10450524|NCT00978627|11598017|FG000|STARTED|Main: Week 0 to 26 (NN5401-3594)||366
10450525|NCT00978627|11598018|FG001|STARTED|Main: Week 0 to 26 (NN5401-3594)||182
10450526|NCT00978627|11598017|FG000|Exposed|Main: Week 0 to 26 (NN5401-3594)|Four subjects withdrew prior to exposure to trial products|362
10450527|NCT00978627|11598018|FG001|Exposed|Main: Week 0 to 26 (NN5401-3594)|Two subjects withdrew prior to exposure to trial products|180
10450528|NCT00978627|11598017|FG000|COMPLETED|Main: Week 0 to 26 (NN5401-3594)||320
10450529|NCT00978627|11598018|FG001|COMPLETED|Main: Week 0 to 26 (NN5401-3594)||156
10450530|NCT00978627|11598017|FG000|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3594)||46
10450531|NCT00978627|11598018|FG001|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3594)||26
10450532|NCT00978627|11598017|FG000|STARTED|Extension: Week 27 to 52 (NN5401-3645)|Sixty six subjects from main trial did not continue into extension trial|254
10450533|NCT00978627|11598018|FG001|STARTED|Extension: Week 27 to 52 (NN5401-3645)|Thirty four subjects from main trial did not continue into extension trial|122
10450534|NCT00978627|11598017|FG000|COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||233
10450535|NCT00978627|11598018|FG001|COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||113
10450536|NCT00978627|11598017|FG000|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||21
10450537|NCT00978627|11598018|FG001|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||9
10450538|NCT00978731|11598028|FG000|STARTED|Overall Study||22
10450539|NCT00978731|11598029|FG001|STARTED|Overall Study||15
10450540|NCT00978731|11598030|FG002|STARTED|Overall Study||5
10450541|NCT00978731|11598031|FG003|STARTED|Overall Study||4
10450542|NCT00978731|11598028|FG000|COMPLETED|Overall Study||0
10450543|NCT00978731|11598029|FG001|COMPLETED|Overall Study||0
10450544|NCT00978731|11598030|FG002|COMPLETED|Overall Study||0
10450545|NCT00978731|11598031|FG003|COMPLETED|Overall Study||0
10450546|NCT00978731|11598028|FG000|NOT COMPLETED|Overall Study||22
10450547|NCT00978731|11598029|FG001|NOT COMPLETED|Overall Study||15
10450548|NCT00978731|11598030|FG002|NOT COMPLETED|Overall Study||5
10450549|NCT00978731|11598031|FG003|NOT COMPLETED|Overall Study||4
10450550|NCT00978757|11598047|FG000|STARTED|Overall Study|June 2001|22
10450551|NCT00978757|11598048|FG001|STARTED|Overall Study|June 2001|20
10450552|NCT00978757|11598047|FG000|COMPLETED|Overall Study|June 2008|21
10450553|NCT00978757|11598048|FG001|COMPLETED|Overall Study|June 2008|17
10450554|NCT00978757|11598047|FG000|NOT COMPLETED|Overall Study||1
10450555|NCT00978757|11598048|FG001|NOT COMPLETED|Overall Study||3
10450556|NCT00979017|11598054|FG000|STARTED|Overall Study||41
10450557|NCT00979017|11598054|FG000|COMPLETED|Overall Study||41
10450558|NCT00979017|11598054|FG000|NOT COMPLETED|Overall Study||0
10450559|NCT00979069|11598060|FG000|STARTED|Overall Study||10
10450560|NCT00979069|11598061|FG001|STARTED|Overall Study||10
10450561|NCT00979069|11598060|FG000|COMPLETED|Overall Study||10
10450562|NCT00979069|11598061|FG001|COMPLETED|Overall Study||8
10450563|NCT00979069|11598060|FG000|NOT COMPLETED|Overall Study||0
10450564|NCT00979069|11598061|FG001|NOT COMPLETED|Overall Study||2
10450565|NCT00979121|11598069|FG000|STARTED|Overall Study||379
10450566|NCT00979121|11598070|FG001|STARTED|Overall Study||366
10450567|NCT00979121|11598069|FG000|COMPLETED|Overall Study||379
10450568|NCT00979121|11598070|FG001|COMPLETED|Overall Study||366
10450569|NCT00979121|11598069|FG000|NOT COMPLETED|Overall Study||0
10450570|NCT00979121|11598070|FG001|NOT COMPLETED|Overall Study||0
10450571|NCT00979134|11598085|FG000|STARTED|Overall Study||43
10450572|NCT00979134|11598086|FG001|STARTED|Overall Study||6
10450573|NCT00979134|11598087|FG002|STARTED|Overall Study||45
10450574|NCT00979134|11598085|FG000|COMPLETED|Overall Study|At DCO|10
10450575|NCT00979134|11598086|FG001|COMPLETED|Overall Study|At DCO|0
10450576|NCT00979134|11598087|FG002|COMPLETED|Overall Study|At DCO|5
10450577|NCT00979134|11598085|FG000|NOT COMPLETED|Overall Study||33
10450578|NCT00979134|11598086|FG001|NOT COMPLETED|Overall Study||6
10450579|NCT00979134|11598087|FG002|NOT COMPLETED|Overall Study||40
10450580|NCT00979199|11598100|FG000|STARTED|Overall Study||697
10450581|NCT00979199|11598100|FG000|COMPLETED|Overall Study||475
10450582|NCT00979199|11598100|FG000|NOT COMPLETED|Overall Study||222
10450583|NCT00979303|11598106|FG000|STARTED|Overall Study||37
10450584|NCT00979303|11598107|FG001|STARTED|Overall Study||37
10450585|NCT00979303|11598106|FG000|COMPLETED|Overall Study||37
10450586|NCT00979303|11598107|FG001|COMPLETED|Overall Study||37
10450587|NCT00979303|11598106|FG000|NOT COMPLETED|Overall Study||0
10450588|NCT00979303|11598107|FG001|NOT COMPLETED|Overall Study||0
10450589|NCT00979407|11598115|FG000|STARTED|Overall Study||167
10450590|NCT00979407|11598116|FG001|STARTED|Overall Study||167
10450591|NCT00979407|11598115|FG000|COMPLETED|Overall Study||161
10450592|NCT00979407|11598116|FG001|COMPLETED|Overall Study||160
10450593|NCT00979407|11598115|FG000|NOT COMPLETED|Overall Study||6
10450594|NCT00979407|11598116|FG001|NOT COMPLETED|Overall Study||7
10450595|NCT00979420|11598128|FG000|STARTED|Overall Study||178
10450596|NCT00979420|11598129|FG001|STARTED|Overall Study||57
10450597|NCT00979420|11598130|FG002|STARTED|Overall Study||60
10450598|NCT00979420|11598131|FG003|STARTED|Overall Study||61
10450599|NCT00979420|11598128|FG000|COMPLETED|Overall Study||171
10450600|NCT00979420|11598129|FG001|COMPLETED|Overall Study||57
10450601|NCT00979420|11598130|FG002|COMPLETED|Overall Study||59
10450602|NCT00979420|11598131|FG003|COMPLETED|Overall Study||59
10450603|NCT00979420|11598128|FG000|NOT COMPLETED|Overall Study||7
10450604|NCT00979420|11598129|FG001|NOT COMPLETED|Overall Study||0
10450605|NCT00979420|11598130|FG002|NOT COMPLETED|Overall Study||1
10450606|NCT00979420|11598131|FG003|NOT COMPLETED|Overall Study||2
10450607|NCT00979459|11598139|FG000|STARTED|First Intervention||6
10450608|NCT00979459|11598140|FG001|STARTED|First Intervention||6
10450609|NCT00979459|11598139|FG000|COMPLETED|First Intervention||6
10450610|NCT00979459|11598140|FG001|COMPLETED|First Intervention||6
10450611|NCT00979459|11598139|FG000|NOT COMPLETED|First Intervention||0
10450612|NCT00979459|11598140|FG001|NOT COMPLETED|First Intervention||0
10450613|NCT00979459|11598139|FG000|STARTED|7-day Washout Period||6
10450614|NCT00979459|11598140|FG001|STARTED|7-day Washout Period||6
10450615|NCT00979459|11598139|FG000|COMPLETED|7-day Washout Period||6
10450616|NCT00979459|11598140|FG001|COMPLETED|7-day Washout Period||6
10450617|NCT00979459|11598139|FG000|NOT COMPLETED|7-day Washout Period||0
10450618|NCT00979459|11598140|FG001|NOT COMPLETED|7-day Washout Period||0
10450619|NCT00979459|11598139|FG000|STARTED|Second Intervention||6
10450620|NCT00979459|11598140|FG001|STARTED|Second Intervention||6
10450621|NCT00979459|11598139|FG000|COMPLETED|Second Intervention||6
10450622|NCT00979459|11598140|FG001|COMPLETED|Second Intervention||6
10450623|NCT00979459|11598139|FG000|NOT COMPLETED|Second Intervention||0
10450624|NCT00979459|11598140|FG001|NOT COMPLETED|Second Intervention||0
10450625|NCT00979576|11598151|FG000|STARTED|Combination Treatment Phase||3
10450626|NCT00979576|11598152|FG001|STARTED|Combination Treatment Phase||6
10450627|NCT00979576|11598153|FG002|STARTED|Combination Treatment Phase||9
10450628|NCT00979576|11598151|FG000|COMPLETED|Combination Treatment Phase||0
10450629|NCT00979576|11598152|FG001|COMPLETED|Combination Treatment Phase||0
10789889|NCT03527966|11950306|FG000|STARTED|Overall Study||3
10789890|NCT03527966|11950307|FG001|STARTED|Overall Study||0
10789891|NCT03527966|11950306|FG000|COMPLETED|Overall Study||0
10450630|NCT00979576|11598153|FG002|COMPLETED|Combination Treatment Phase||0
10450631|NCT00979576|11598151|FG000|NOT COMPLETED|Combination Treatment Phase||3
10450632|NCT00979576|11598152|FG001|NOT COMPLETED|Combination Treatment Phase||6
10450633|NCT00979576|11598153|FG002|NOT COMPLETED|Combination Treatment Phase||9
10450634|NCT00979576|11598151|FG000|STARTED|Combination Followed by Monotherapy||0
10450635|NCT00979576|11598152|FG001|STARTED|Combination Followed by Monotherapy||2
10450636|NCT00979576|11598153|FG002|STARTED|Combination Followed by Monotherapy||1
10450637|NCT00979576|11598151|FG000|COMPLETED|Combination Followed by Monotherapy||0
10551298|NCT01536405|11705513|FG000|NOT COMPLETED|Visit 3 (Vaccination 2) to Visit 4||20
10551299|NCT01536405|11705514|FG001|NOT COMPLETED|Visit 3 (Vaccination 2) to Visit 4||16
10551300|NCT01536405|11705513|FG000|STARTED|Visit 4 to Extended Study Follow-up||615
10551301|NCT01536405|11705514|FG001|STARTED|Visit 4 to Extended Study Follow-up||618
10551302|NCT01536405|11705513|FG000|COMPLETED|Visit 4 to Extended Study Follow-up||595
10551303|NCT01536405|11705514|FG001|COMPLETED|Visit 4 to Extended Study Follow-up||595
10551304|NCT01536405|11705513|FG000|NOT COMPLETED|Visit 4 to Extended Study Follow-up||20
10551305|NCT01536405|11705514|FG001|NOT COMPLETED|Visit 4 to Extended Study Follow-up||23
10551306|NCT01536418|11705522|FG000|STARTED|Overall Study||127
10551307|NCT01536418|11705523|FG001|STARTED|Overall Study||126
10551308|NCT01536418|11705522|FG000|COMPLETED|Overall Study||58
10551309|NCT01536418|11705523|FG001|COMPLETED|Overall Study||60
10551310|NCT01536418|11705522|FG000|NOT COMPLETED|Overall Study||69
10551311|NCT01536418|11705523|FG001|NOT COMPLETED|Overall Study||66
10551312|NCT01536496|11705532|FG000|STARTED|Overall Study||57
10551313|NCT01536496|11705533|FG001|STARTED|Overall Study||57
10551314|NCT01536496|11705532|FG000|COMPLETED|Overall Study||55
10551315|NCT01536496|11705533|FG001|COMPLETED|Overall Study||56
10551316|NCT01536496|11705532|FG000|NOT COMPLETED|Overall Study||2
10551317|NCT01536496|11705533|FG001|NOT COMPLETED|Overall Study||1
10551318|NCT01536535|11705543|FG000|STARTED|Overall Study||178
10551319|NCT01536535|11705544|FG001|STARTED|Overall Study||250
10551320|NCT01536535|11705543|FG000|COMPLETED|Overall Study|Patients either completed week 52 visit or had early colectomy or had additional therapy.|163
10551321|NCT01536535|11705544|FG001|COMPLETED|Overall Study|Patients either completed week 52 visit or had early colectomy or had additional therapy.|237
10551322|NCT01536535|11705543|FG000|NOT COMPLETED|Overall Study||15
10551323|NCT01536535|11705544|FG001|NOT COMPLETED|Overall Study||13
10450638|NCT00979576|11598152|FG001|COMPLETED|Combination Followed by Monotherapy||0
10450639|NCT00979576|11598153|FG002|COMPLETED|Combination Followed by Monotherapy||0
10450640|NCT00979576|11598151|FG000|NOT COMPLETED|Combination Followed by Monotherapy||0
10450641|NCT00979576|11598152|FG001|NOT COMPLETED|Combination Followed by Monotherapy||2
10450642|NCT00979576|11598153|FG002|NOT COMPLETED|Combination Followed by Monotherapy||1
10450643|NCT00979602|11598164|FG000|STARTED|Overall Study||2025
10450644|NCT00979602|11598165|FG001|STARTED|Overall Study||2023
10450645|NCT00979602|11598164|FG000|COMPLETED|Overall Study||1880
10450646|NCT00979602|11598165|FG001|COMPLETED|Overall Study||1890
10450647|NCT00979602|11598164|FG000|NOT COMPLETED|Overall Study||145
10450648|NCT00979602|11598165|FG001|NOT COMPLETED|Overall Study||133
10450649|NCT00979615|11598185|FG000|STARTED|Overall Study||63
10450650|NCT00979615|11598186|FG001|STARTED|Overall Study||66
10450651|NCT00979615|11598185|FG000|COMPLETED|Overall Study||57
10450652|NCT00979615|11598186|FG001|COMPLETED|Overall Study||58
10450653|NCT00979615|11598185|FG000|NOT COMPLETED|Overall Study||6
10450654|NCT00979615|11598186|FG001|NOT COMPLETED|Overall Study||8
10525711|NCT01377636|11677668|FG000|COMPLETED|Overall Study||20
10525712|NCT01377636|11677668|FG000|NOT COMPLETED|Overall Study||0
10525713|NCT01377844|11677676|FG000|STARTED|Overall Study||145
10525714|NCT01377844|11677677|FG001|STARTED|Overall Study||143
10525715|NCT01377844|11677676|FG000|Safety Population|Overall Study||145
10525716|NCT01377844|11677677|FG001|Safety Population|Overall Study||141
10525717|NCT01377844|11677676|FG000|COMPLETED|Overall Study||109
10525718|NCT01377844|11677677|FG001|COMPLETED|Overall Study||108
10525719|NCT01377844|11677676|FG000|NOT COMPLETED|Overall Study||36
10525720|NCT01377844|11677677|FG001|NOT COMPLETED|Overall Study||35
10525721|NCT01377922|11677686|FG000|STARTED|Overall Study||22
10525722|NCT01377922|11677687|FG001|STARTED|Overall Study||16
10525723|NCT01377922|11677686|FG000|COMPLETED|Overall Study||21
10525724|NCT01377922|11677687|FG001|COMPLETED|Overall Study||16
10525725|NCT01377922|11677686|FG000|NOT COMPLETED|Overall Study||1
10525726|NCT01377922|11677687|FG001|NOT COMPLETED|Overall Study||0
10525727|NCT01377987|11677693|FG000|STARTED|First Intervention (7 Days)||14
10525728|NCT01377987|11677694|FG001|STARTED|First Intervention (7 Days)||15
10525729|NCT01377987|11677693|FG000|COMPLETED|First Intervention (7 Days)||14
10551324|NCT01536561|11705551|FG000|STARTED|Dosimetric and Therapeutic Treatment||59
10551325|NCT01536561|11705551|FG000|COMPLETED|Dosimetric and Therapeutic Treatment||0
10551326|NCT01536561|11705551|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||59
10789892|NCT03527966|11950307|FG001|COMPLETED|Overall Study||0
10789893|NCT03527966|11950306|FG000|NOT COMPLETED|Overall Study||3
10789894|NCT03527966|11950307|FG001|NOT COMPLETED|Overall Study||0
10450655|NCT00979628|11598195|FG000|STARTED|Overall Study||153
10450656|NCT00979628|11598196|FG001|STARTED|Overall Study||142
10450657|NCT00979628|11598197|FG002|STARTED|Overall Study||80
10450658|NCT00979628|11598195|FG000|COMPLETED|Overall Study||144
10450659|NCT00979628|11598196|FG001|COMPLETED|Overall Study||133
10450660|NCT00979628|11598197|FG002|COMPLETED|Overall Study||74
10450661|NCT00979628|11598195|FG000|NOT COMPLETED|Overall Study||9
10450662|NCT00979628|11598196|FG001|NOT COMPLETED|Overall Study||9
10450663|NCT00979628|11598197|FG002|NOT COMPLETED|Overall Study||6
10450664|NCT00979654|11598208|FG000|STARTED|Overall Study||103
10450665|NCT00979654|11598208|FG000|COMPLETED|Overall Study||67
10450666|NCT00979654|11598208|FG000|NOT COMPLETED|Overall Study||36
10450667|NCT00979732|11598214|FG000|STARTED|Overall Study||15
10450668|NCT00979732|11598215|FG001|STARTED|Overall Study||18
10450669|NCT00979732|11598214|FG000|COMPLETED|Overall Study||12
10450670|NCT00979732|11598215|FG001|COMPLETED|Overall Study||17
10450671|NCT00979732|11598214|FG000|NOT COMPLETED|Overall Study||3
10450672|NCT00979732|11598215|FG001|NOT COMPLETED|Overall Study||1
10450673|NCT00979745|11598223|FG000|STARTED|Overall Study||38
10450674|NCT00979745|11598224|FG001|STARTED|Overall Study||36
10450675|NCT00979745|11598223|FG000|COMPLETED|Overall Study||34
10450676|NCT00979745|11598224|FG001|COMPLETED|Overall Study||34
10450677|NCT00979745|11598223|FG000|NOT COMPLETED|Overall Study||4
10450678|NCT00979745|11598224|FG001|NOT COMPLETED|Overall Study||2
10450679|NCT00979875|11598230|FG000|STARTED|Intervention 1||2
10450680|NCT00979875|11598231|FG001|STARTED|Intervention 1||2
10450681|NCT00979875|11598232|FG002|STARTED|Intervention 1||3
10450682|NCT00979875|11598233|FG003|STARTED|Intervention 1||2
10450683|NCT00979875|11598234|FG004|STARTED|Intervention 1||3
10450684|NCT00979875|11598235|FG005|STARTED|Intervention 1||2
10450685|NCT00979875|11598230|FG000|Received at Least 1 Dose of Study Drug|Intervention 1||2
10450686|NCT00979875|11598231|FG001|Received at Least 1 Dose of Study Drug|Intervention 1||2
10450687|NCT00979875|11598232|FG002|Received at Least 1 Dose of Study Drug|Intervention 1||3
10450688|NCT00979875|11598233|FG003|Received at Least 1 Dose of Study Drug|Intervention 1||2
10450689|NCT00979875|11598234|FG004|Received at Least 1 Dose of Study Drug|Intervention 1||3
10450690|NCT00979875|11598235|FG005|Received at Least 1 Dose of Study Drug|Intervention 1||2
10450691|NCT00979875|11598230|FG000|COMPLETED|Intervention 1||2
10450692|NCT00979875|11598231|FG001|COMPLETED|Intervention 1||2
10450693|NCT00979875|11598232|FG002|COMPLETED|Intervention 1||3
10450694|NCT00979875|11598233|FG003|COMPLETED|Intervention 1||2
10450695|NCT00979875|11598234|FG004|COMPLETED|Intervention 1||3
10450696|NCT00979875|11598235|FG005|COMPLETED|Intervention 1||2
10450697|NCT00979875|11598230|FG000|NOT COMPLETED|Intervention 1||0
10450698|NCT00979875|11598231|FG001|NOT COMPLETED|Intervention 1||0
10450699|NCT00979875|11598232|FG002|NOT COMPLETED|Intervention 1||0
10450700|NCT00979875|11598233|FG003|NOT COMPLETED|Intervention 1||0
10450701|NCT00979875|11598234|FG004|NOT COMPLETED|Intervention 1||0
10450702|NCT00979875|11598235|FG005|NOT COMPLETED|Intervention 1||0
10450703|NCT00979875|11598230|FG000|STARTED|Washout 1 (3 to 14 Days)||2
10450704|NCT00979875|11598231|FG001|STARTED|Washout 1 (3 to 14 Days)||2
10450705|NCT00979875|11598232|FG002|STARTED|Washout 1 (3 to 14 Days)||3
10450706|NCT00979875|11598233|FG003|STARTED|Washout 1 (3 to 14 Days)||2
10450707|NCT00979875|11598234|FG004|STARTED|Washout 1 (3 to 14 Days)||3
10450708|NCT00979875|11598235|FG005|STARTED|Washout 1 (3 to 14 Days)||2
10450709|NCT00979875|11598230|FG000|COMPLETED|Washout 1 (3 to 14 Days)||2
10450710|NCT00979875|11598231|FG001|COMPLETED|Washout 1 (3 to 14 Days)||2
10450711|NCT00979875|11598232|FG002|COMPLETED|Washout 1 (3 to 14 Days)||3
10450712|NCT00979875|11598233|FG003|COMPLETED|Washout 1 (3 to 14 Days)||2
10450713|NCT00979875|11598234|FG004|COMPLETED|Washout 1 (3 to 14 Days)||3
10450714|NCT00979875|11598235|FG005|COMPLETED|Washout 1 (3 to 14 Days)||2
10450715|NCT00979875|11598230|FG000|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
10450716|NCT00979875|11598231|FG001|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
10450717|NCT00979875|11598232|FG002|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
10450718|NCT00979875|11598233|FG003|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
10450719|NCT00979875|11598234|FG004|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
10450720|NCT00979875|11598235|FG005|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
10450721|NCT00979875|11598230|FG000|STARTED|Intervention 2||2
10450722|NCT00979875|11598231|FG001|STARTED|Intervention 2||2
10450723|NCT00979875|11598232|FG002|STARTED|Intervention 2||3
10450724|NCT00979875|11598233|FG003|STARTED|Intervention 2||2
10450725|NCT00979875|11598234|FG004|STARTED|Intervention 2||3
10450726|NCT00979875|11598235|FG005|STARTED|Intervention 2||2
10450727|NCT00979875|11598230|FG000|COMPLETED|Intervention 2||2
10450728|NCT00979875|11598231|FG001|COMPLETED|Intervention 2||2
10450729|NCT00979875|11598232|FG002|COMPLETED|Intervention 2||3
10450730|NCT00979875|11598233|FG003|COMPLETED|Intervention 2||2
10450731|NCT00979875|11598234|FG004|COMPLETED|Intervention 2||3
10450732|NCT00979875|11598235|FG005|COMPLETED|Intervention 2||2
10450733|NCT00979875|11598230|FG000|NOT COMPLETED|Intervention 2||0
10450734|NCT00979875|11598231|FG001|NOT COMPLETED|Intervention 2||0
10450735|NCT00979875|11598232|FG002|NOT COMPLETED|Intervention 2||0
10450736|NCT00979875|11598233|FG003|NOT COMPLETED|Intervention 2||0
10450737|NCT00979875|11598234|FG004|NOT COMPLETED|Intervention 2||0
10450738|NCT00979875|11598235|FG005|NOT COMPLETED|Intervention 2||0
10450739|NCT00979875|11598230|FG000|STARTED|Washout 2 (3 to 14 Days)||2
10450740|NCT00979875|11598231|FG001|STARTED|Washout 2 (3 to 14 Days)||2
10450741|NCT00979875|11598232|FG002|STARTED|Washout 2 (3 to 14 Days)||3
10450742|NCT00979875|11598233|FG003|STARTED|Washout 2 (3 to 14 Days)||2
10450743|NCT00979875|11598234|FG004|STARTED|Washout 2 (3 to 14 Days)||3
10450744|NCT00979875|11598235|FG005|STARTED|Washout 2 (3 to 14 Days)||2
10450745|NCT00979875|11598230|FG000|COMPLETED|Washout 2 (3 to 14 Days)||2
10450746|NCT00979875|11598231|FG001|COMPLETED|Washout 2 (3 to 14 Days)||2
10450747|NCT00979875|11598232|FG002|COMPLETED|Washout 2 (3 to 14 Days)||3
10450748|NCT00979875|11598233|FG003|COMPLETED|Washout 2 (3 to 14 Days)||2
10450749|NCT00979875|11598234|FG004|COMPLETED|Washout 2 (3 to 14 Days)||3
10450750|NCT00979875|11598235|FG005|COMPLETED|Washout 2 (3 to 14 Days)||2
10450751|NCT00979875|11598230|FG000|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
10450752|NCT00979875|11598231|FG001|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
10450753|NCT00979875|11598232|FG002|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
10450754|NCT00979875|11598233|FG003|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
10450755|NCT00979875|11598234|FG004|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
10450756|NCT00979875|11598235|FG005|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
10450757|NCT00979875|11598230|FG000|STARTED|Intervention 3||2
10450758|NCT00979875|11598231|FG001|STARTED|Intervention 3||2
10450759|NCT00979875|11598232|FG002|STARTED|Intervention 3||3
10450760|NCT00979875|11598233|FG003|STARTED|Intervention 3||2
10450761|NCT00979875|11598234|FG004|STARTED|Intervention 3||3
10450762|NCT00979875|11598235|FG005|STARTED|Intervention 3||2
10450763|NCT00979875|11598230|FG000|COMPLETED|Intervention 3||2
10450764|NCT00979875|11598231|FG001|COMPLETED|Intervention 3||2
10450765|NCT00979875|11598232|FG002|COMPLETED|Intervention 3||3
10450766|NCT00979875|11598233|FG003|COMPLETED|Intervention 3||2
10450767|NCT00979875|11598234|FG004|COMPLETED|Intervention 3||3
10450768|NCT00979875|11598235|FG005|COMPLETED|Intervention 3||2
10450769|NCT00979875|11598230|FG000|NOT COMPLETED|Intervention 3||0
10450770|NCT00979875|11598231|FG001|NOT COMPLETED|Intervention 3||0
10450771|NCT00979875|11598232|FG002|NOT COMPLETED|Intervention 3||0
10450772|NCT00979875|11598233|FG003|NOT COMPLETED|Intervention 3||0
10450773|NCT00979875|11598234|FG004|NOT COMPLETED|Intervention 3||0
10450774|NCT00979875|11598235|FG005|NOT COMPLETED|Intervention 3||0
10450775|NCT00979940|11598251|FG000|STARTED|Overall Study||32
10450776|NCT00979940|11598252|FG001|STARTED|Overall Study||28
10450777|NCT00979940|11598251|FG000|COMPLETED|Overall Study||32
10789895|NCT03528174|11950313|FG000|STARTED|Overall Study||10
10789896|NCT03528174|11950313|FG000|COMPLETED|Overall Study||8
10789897|NCT03528174|11950313|FG000|NOT COMPLETED|Overall Study||2
10789898|NCT03528369|11950320|FG000|STARTED|Overall Study||40
10789899|NCT03528369|11950321|FG001|STARTED|Overall Study||42
10789900|NCT03528369|11950322|FG002|STARTED|Overall Study||40
10450778|NCT00979940|11598252|FG001|COMPLETED|Overall Study||28
10450779|NCT00979940|11598251|FG000|NOT COMPLETED|Overall Study||0
10450780|NCT00979940|11598252|FG001|NOT COMPLETED|Overall Study||0
10450781|NCT00979953|11598262|FG000|STARTED|Overall Study||101
10450782|NCT00979953|11598263|FG001|STARTED|Overall Study||99
10450783|NCT00979953|11598264|FG002|STARTED|Overall Study||104
10450784|NCT00979953|11598265|FG003|STARTED|Overall Study||104
10450785|NCT00979953|11598262|FG000|Received at Least 1 Dose of Study Drug|Overall Study||101
10450786|NCT00979953|11598263|FG001|Received at Least 1 Dose of Study Drug|Overall Study||99
10450787|NCT00979953|11598264|FG002|Received at Least 1 Dose of Study Drug|Overall Study||104
10450788|NCT00979953|11598265|FG003|Received at Least 1 Dose of Study Drug|Overall Study||104
10450789|NCT00979953|11598262|FG000|COMPLETED|Overall Study||93
10450790|NCT00979953|11598263|FG001|COMPLETED|Overall Study||94
10450791|NCT00979953|11598264|FG002|COMPLETED|Overall Study||82
10450792|NCT00979953|11598265|FG003|COMPLETED|Overall Study||97
10789901|NCT03528369|11950320|FG000|COMPLETED|Overall Study||37
10789902|NCT03528369|11950321|FG001|COMPLETED|Overall Study||41
10450793|NCT00979953|11598262|FG000|NOT COMPLETED|Overall Study||8
10450794|NCT00979953|11598263|FG001|NOT COMPLETED|Overall Study||5
10450795|NCT00979953|11598264|FG002|NOT COMPLETED|Overall Study||22
10450796|NCT00979953|11598265|FG003|NOT COMPLETED|Overall Study||7
10450797|NCT00979992|11598275|FG000|STARTED|Overall Study||35
10450798|NCT00979992|11598275|FG000|COMPLETED|Overall Study||30
10450799|NCT00979992|11598275|FG000|NOT COMPLETED|Overall Study||5
10450800|NCT00980005|11598281|FG000|STARTED|Overall Study||1055
10450801|NCT00980005|11598282|FG001|STARTED|Overall Study||1061
10450802|NCT00980005|11598281|FG000|COMPLETED|Overall Study||1008
10450803|NCT00980005|11598282|FG001|COMPLETED|Overall Study||998
10450804|NCT00980005|11598281|FG000|NOT COMPLETED|Overall Study||47
10450805|NCT00980005|11598282|FG001|NOT COMPLETED|Overall Study||63
10450806|NCT00980018|11598292|FG000|STARTED|Overall Study||52
10450807|NCT00980018|11598292|FG000|COMPLETED|Overall Study||40
10450808|NCT00980018|11598292|FG000|NOT COMPLETED|Overall Study||12
10450809|NCT00980044|11598299|FG000|STARTED|Overall Study||17
10450810|NCT00980044|11598300|FG001|STARTED|Overall Study||19
10450811|NCT00980044|11598301|FG002|STARTED|Overall Study||17
10450812|NCT00980044|11598299|FG000|COMPLETED|Overall Study||12
10450813|NCT00980044|11598300|FG001|COMPLETED|Overall Study||12
10450814|NCT00980044|11598301|FG002|COMPLETED|Overall Study||12
10450815|NCT00980044|11598299|FG000|NOT COMPLETED|Overall Study||5
10789903|NCT03528369|11950322|FG002|COMPLETED|Overall Study||40
10450816|NCT00980044|11598300|FG001|NOT COMPLETED|Overall Study||7
10789904|NCT03528369|11950320|FG000|NOT COMPLETED|Overall Study||3
10450817|NCT00980044|11598301|FG002|NOT COMPLETED|Overall Study||5
10450818|NCT00980057|11598314|FG000|STARTED|Overall Study||318
10450819|NCT00980057|11598315|FG001|STARTED|Overall Study||160
10450820|NCT00980057|11598314|FG000|COMPLETED|Overall Study||299
10450821|NCT00980057|11598315|FG001|COMPLETED|Overall Study||155
10450822|NCT00980057|11598314|FG000|NOT COMPLETED|Overall Study||19
10450823|NCT00980057|11598315|FG001|NOT COMPLETED|Overall Study||5
10450824|NCT00980148|11598324|FG000|STARTED|Overall Study||284
10450825|NCT00980148|11598325|FG001|STARTED|Overall Study||283
10450826|NCT00980148|11598324|FG000|COMPLETED|Overall Study|Completed primary evaluation at study visit # 2 (day 28 after therapy started)|155
10450827|NCT00980148|11598325|FG001|COMPLETED|Overall Study|Completed primary evaluation at study visit # 2 (day 28 after therapy started)|155
10450828|NCT00980148|11598324|FG000|NOT COMPLETED|Overall Study||129
10450829|NCT00980148|11598325|FG001|NOT COMPLETED|Overall Study||128
10450830|NCT00980174|11598333|FG000|STARTED|Overall Study||121
10450831|NCT00980174|11598334|FG001|STARTED|Overall Study||121
10450832|NCT00980174|11598333|FG000|COMPLETED|Overall Study||117
10450833|NCT00980174|11598334|FG001|COMPLETED|Overall Study||111
10450834|NCT00980174|11598333|FG000|NOT COMPLETED|Overall Study||4
10450835|NCT00980174|11598334|FG001|NOT COMPLETED|Overall Study||10
10450836|NCT00980200|11598340|FG000|STARTED|7-day Treatment Period 1||15
10450837|NCT00980200|11598341|FG001|STARTED|7-day Treatment Period 1||14
10450838|NCT00980200|11598342|FG002|STARTED|7-day Treatment Period 1||15
10450839|NCT00980200|11598343|FG003|STARTED|7-day Treatment Period 1||16
10450840|NCT00980200|11598344|FG004|STARTED|7-day Treatment Period 1||15
10450841|NCT00980200|11598340|FG000|COMPLETED|7-day Treatment Period 1||15
10450842|NCT00980200|11598341|FG001|COMPLETED|7-day Treatment Period 1||13
10450843|NCT00980200|11598342|FG002|COMPLETED|7-day Treatment Period 1||15
10450844|NCT00980200|11598343|FG003|COMPLETED|7-day Treatment Period 1||16
10450845|NCT00980200|11598344|FG004|COMPLETED|7-day Treatment Period 1||15
10450846|NCT00980200|11598340|FG000|NOT COMPLETED|7-day Treatment Period 1||0
10450847|NCT00980200|11598341|FG001|NOT COMPLETED|7-day Treatment Period 1||1
10450848|NCT00980200|11598342|FG002|NOT COMPLETED|7-day Treatment Period 1||0
10450849|NCT00980200|11598343|FG003|NOT COMPLETED|7-day Treatment Period 1||0
10450850|NCT00980200|11598344|FG004|NOT COMPLETED|7-day Treatment Period 1||0
10450851|NCT00980200|11598340|FG000|STARTED|7-day Washout Period 1||15
10450852|NCT00980200|11598341|FG001|STARTED|7-day Washout Period 1||13
10450853|NCT00980200|11598342|FG002|STARTED|7-day Washout Period 1||15
10450854|NCT00980200|11598343|FG003|STARTED|7-day Washout Period 1||16
10450855|NCT00980200|11598344|FG004|STARTED|7-day Washout Period 1||15
10450856|NCT00980200|11598340|FG000|COMPLETED|7-day Washout Period 1||15
10450857|NCT00980200|11598341|FG001|COMPLETED|7-day Washout Period 1||13
10450858|NCT00980200|11598342|FG002|COMPLETED|7-day Washout Period 1||15
10450859|NCT00980200|11598343|FG003|COMPLETED|7-day Washout Period 1||16
10450860|NCT00980200|11598344|FG004|COMPLETED|7-day Washout Period 1||15
10450861|NCT00980200|11598340|FG000|NOT COMPLETED|7-day Washout Period 1||0
10450862|NCT00980200|11598341|FG001|NOT COMPLETED|7-day Washout Period 1||0
10450863|NCT00980200|11598342|FG002|NOT COMPLETED|7-day Washout Period 1||0
10450864|NCT00980200|11598343|FG003|NOT COMPLETED|7-day Washout Period 1||0
10450865|NCT00980200|11598344|FG004|NOT COMPLETED|7-day Washout Period 1||0
10450866|NCT00980200|11598340|FG000|STARTED|7-day Treatment Period 2||15
10450867|NCT00980200|11598341|FG001|STARTED|7-day Treatment Period 2||13
10450868|NCT00980200|11598342|FG002|STARTED|7-day Treatment Period 2||15
10450869|NCT00980200|11598343|FG003|STARTED|7-day Treatment Period 2||16
10450870|NCT00980200|11598344|FG004|STARTED|7-day Treatment Period 2||15
10450871|NCT00980200|11598340|FG000|COMPLETED|7-day Treatment Period 2||15
10450872|NCT00980200|11598341|FG001|COMPLETED|7-day Treatment Period 2||13
10450873|NCT00980200|11598342|FG002|COMPLETED|7-day Treatment Period 2||15
10450874|NCT00980200|11598343|FG003|COMPLETED|7-day Treatment Period 2||16
10450875|NCT00980200|11598344|FG004|COMPLETED|7-day Treatment Period 2||15
10450876|NCT00980200|11598340|FG000|NOT COMPLETED|7-day Treatment Period 2||0
10450877|NCT00980200|11598341|FG001|NOT COMPLETED|7-day Treatment Period 2||0
10450878|NCT00980200|11598342|FG002|NOT COMPLETED|7-day Treatment Period 2||0
10450879|NCT00980200|11598343|FG003|NOT COMPLETED|7-day Treatment Period 2||0
10450880|NCT00980200|11598344|FG004|NOT COMPLETED|7-day Treatment Period 2||0
10450881|NCT00980200|11598340|FG000|STARTED|7-day Washout Period 2||15
10450882|NCT00980200|11598341|FG001|STARTED|7-day Washout Period 2||13
10450883|NCT00980200|11598342|FG002|STARTED|7-day Washout Period 2||15
10450884|NCT00980200|11598343|FG003|STARTED|7-day Washout Period 2||16
10450885|NCT00980200|11598344|FG004|STARTED|7-day Washout Period 2||15
10450886|NCT00980200|11598340|FG000|COMPLETED|7-day Washout Period 2||15
10450887|NCT00980200|11598341|FG001|COMPLETED|7-day Washout Period 2||13
10450888|NCT00980200|11598342|FG002|COMPLETED|7-day Washout Period 2||15
10450889|NCT00980200|11598343|FG003|COMPLETED|7-day Washout Period 2||16
10450890|NCT00980200|11598344|FG004|COMPLETED|7-day Washout Period 2||15
10450891|NCT00980200|11598340|FG000|NOT COMPLETED|7-day Washout Period 2||0
10450892|NCT00980200|11598341|FG001|NOT COMPLETED|7-day Washout Period 2||0
10450893|NCT00980200|11598342|FG002|NOT COMPLETED|7-day Washout Period 2||0
10450894|NCT00980200|11598343|FG003|NOT COMPLETED|7-day Washout Period 2||0
10450895|NCT00980200|11598344|FG004|NOT COMPLETED|7-day Washout Period 2||0
10450896|NCT00980200|11598340|FG000|STARTED|7-day Treatment Period 3||15
10450897|NCT00980200|11598341|FG001|STARTED|7-day Treatment Period 3||13
10450898|NCT00980200|11598342|FG002|STARTED|7-day Treatment Period 3||15
10450899|NCT00980200|11598343|FG003|STARTED|7-day Treatment Period 3||16
10450900|NCT00980200|11598344|FG004|STARTED|7-day Treatment Period 3||15
10450901|NCT00980200|11598340|FG000|COMPLETED|7-day Treatment Period 3||15
10450902|NCT00980200|11598341|FG001|COMPLETED|7-day Treatment Period 3||12
10450903|NCT00980200|11598342|FG002|COMPLETED|7-day Treatment Period 3||15
10450904|NCT00980200|11598343|FG003|COMPLETED|7-day Treatment Period 3||16
10450905|NCT00980200|11598344|FG004|COMPLETED|7-day Treatment Period 3||14
10450906|NCT00980200|11598340|FG000|NOT COMPLETED|7-day Treatment Period 3||0
10450907|NCT00980200|11598341|FG001|NOT COMPLETED|7-day Treatment Period 3||1
10450908|NCT00980200|11598342|FG002|NOT COMPLETED|7-day Treatment Period 3||0
10450909|NCT00980200|11598343|FG003|NOT COMPLETED|7-day Treatment Period 3||0
10450910|NCT00980200|11598344|FG004|NOT COMPLETED|7-day Treatment Period 3||1
10450911|NCT00980200|11598340|FG000|STARTED|7-day Washout Period 3||15
10450912|NCT00980200|11598341|FG001|STARTED|7-day Washout Period 3||12
10450913|NCT00980200|11598342|FG002|STARTED|7-day Washout Period 3||15
10450914|NCT00980200|11598343|FG003|STARTED|7-day Washout Period 3||16
10450915|NCT00980200|11598344|FG004|STARTED|7-day Washout Period 3||14
10450916|NCT00980200|11598340|FG000|COMPLETED|7-day Washout Period 3||15
10450917|NCT00980200|11598341|FG001|COMPLETED|7-day Washout Period 3||12
10450918|NCT00980200|11598342|FG002|COMPLETED|7-day Washout Period 3||15
10450919|NCT00980200|11598343|FG003|COMPLETED|7-day Washout Period 3||16
10450920|NCT00980200|11598344|FG004|COMPLETED|7-day Washout Period 3||14
10450921|NCT00980200|11598340|FG000|NOT COMPLETED|7-day Washout Period 3||0
10450922|NCT00980200|11598341|FG001|NOT COMPLETED|7-day Washout Period 3||0
10450923|NCT00980200|11598342|FG002|NOT COMPLETED|7-day Washout Period 3||0
10450924|NCT00980200|11598343|FG003|NOT COMPLETED|7-day Washout Period 3||0
10450925|NCT00980200|11598344|FG004|NOT COMPLETED|7-day Washout Period 3||0
10450926|NCT00980200|11598340|FG000|STARTED|7-day Treatment Period 4||15
10450927|NCT00980200|11598341|FG001|STARTED|7-day Treatment Period 4||12
10450928|NCT00980200|11598342|FG002|STARTED|7-day Treatment Period 4||15
10450929|NCT00980200|11598343|FG003|STARTED|7-day Treatment Period 4||16
10450930|NCT00980200|11598344|FG004|STARTED|7-day Treatment Period 4||14
10450931|NCT00980200|11598340|FG000|COMPLETED|7-day Treatment Period 4||15
10450932|NCT00980200|11598341|FG001|COMPLETED|7-day Treatment Period 4||12
10450933|NCT00980200|11598342|FG002|COMPLETED|7-day Treatment Period 4||15
10450934|NCT00980200|11598343|FG003|COMPLETED|7-day Treatment Period 4||16
10450935|NCT00980200|11598344|FG004|COMPLETED|7-day Treatment Period 4||14
10450936|NCT00980200|11598340|FG000|NOT COMPLETED|7-day Treatment Period 4||0
10450937|NCT00980200|11598341|FG001|NOT COMPLETED|7-day Treatment Period 4||0
10450938|NCT00980200|11598342|FG002|NOT COMPLETED|7-day Treatment Period 4||0
10450939|NCT00980200|11598343|FG003|NOT COMPLETED|7-day Treatment Period 4||0
10450940|NCT00980200|11598344|FG004|NOT COMPLETED|7-day Treatment Period 4||0
10450941|NCT00980200|11598340|FG000|STARTED|7-day Washout Period 4||15
10450942|NCT00980200|11598341|FG001|STARTED|7-day Washout Period 4||12
10450943|NCT00980200|11598342|FG002|STARTED|7-day Washout Period 4||15
10450944|NCT00980200|11598343|FG003|STARTED|7-day Washout Period 4||16
10450945|NCT00980200|11598344|FG004|STARTED|7-day Washout Period 4||14
10450946|NCT00980200|11598340|FG000|COMPLETED|7-day Washout Period 4||15
10450947|NCT00980200|11598341|FG001|COMPLETED|7-day Washout Period 4||12
10450948|NCT00980200|11598342|FG002|COMPLETED|7-day Washout Period 4||15
10450949|NCT00980200|11598343|FG003|COMPLETED|7-day Washout Period 4||16
10450950|NCT00980200|11598344|FG004|COMPLETED|7-day Washout Period 4||14
10450951|NCT00980200|11598340|FG000|NOT COMPLETED|7-day Washout Period 4||0
10450952|NCT00980200|11598341|FG001|NOT COMPLETED|7-day Washout Period 4||0
10450953|NCT00980200|11598342|FG002|NOT COMPLETED|7-day Washout Period 4||0
10450954|NCT00980200|11598343|FG003|NOT COMPLETED|7-day Washout Period 4||0
10450955|NCT00980200|11598344|FG004|NOT COMPLETED|7-day Washout Period 4||0
10450956|NCT00980200|11598340|FG000|STARTED|7-day Treatment Period 5||15
10450957|NCT00980200|11598341|FG001|STARTED|7-day Treatment Period 5||12
10450958|NCT00980200|11598342|FG002|STARTED|7-day Treatment Period 5||15
10450959|NCT00980200|11598343|FG003|STARTED|7-day Treatment Period 5||16
10450960|NCT00980200|11598344|FG004|STARTED|7-day Treatment Period 5||14
10450961|NCT00980200|11598340|FG000|COMPLETED|7-day Treatment Period 5||15
10450962|NCT00980200|11598341|FG001|COMPLETED|7-day Treatment Period 5||12
10450963|NCT00980200|11598342|FG002|COMPLETED|7-day Treatment Period 5||15
10450964|NCT00980200|11598343|FG003|COMPLETED|7-day Treatment Period 5||16
10450965|NCT00980200|11598344|FG004|COMPLETED|7-day Treatment Period 5||14
10450966|NCT00980200|11598340|FG000|NOT COMPLETED|7-day Treatment Period 5||0
10450967|NCT00980200|11598341|FG001|NOT COMPLETED|7-day Treatment Period 5||0
10450968|NCT00980200|11598342|FG002|NOT COMPLETED|7-day Treatment Period 5||0
10450969|NCT00980200|11598343|FG003|NOT COMPLETED|7-day Treatment Period 5||0
10450970|NCT00980200|11598344|FG004|NOT COMPLETED|7-day Treatment Period 5||0
10450971|NCT00980278|11598358|FG000|STARTED|Overall Study||13
10450972|NCT00980278|11598359|FG001|STARTED|Overall Study||13
10450973|NCT00980278|11598358|FG000|COMPLETED|Overall Study||11
10450974|NCT00980278|11598359|FG001|COMPLETED|Overall Study||13
10450975|NCT00980278|11598358|FG000|NOT COMPLETED|Overall Study||2
10450976|NCT00980278|11598359|FG001|NOT COMPLETED|Overall Study||0
10450977|NCT00980330|11598372|FG000|STARTED|Overall Study||66
10450978|NCT00980330|11598373|FG001|STARTED|Overall Study||65
10450979|NCT00980330|11598374|FG002|STARTED|Overall Study||66
10450980|NCT00980330|11598375|FG003|STARTED|Overall Study||66
10450981|NCT00980330|11598376|FG004|STARTED|Overall Study||68
10450982|NCT00980330|11598377|FG005|STARTED|Overall Study||65
10450983|NCT00980330|11598378|FG006|STARTED|Overall Study||66
10450984|NCT00980330|11598372|FG000|COMPLETED|Overall Study||61
10450985|NCT00980330|11598373|FG001|COMPLETED|Overall Study||60
10450986|NCT00980330|11598374|FG002|COMPLETED|Overall Study||58
10450987|NCT00980330|11598375|FG003|COMPLETED|Overall Study||61
10450988|NCT00980330|11598376|FG004|COMPLETED|Overall Study||63
10450989|NCT00980330|11598377|FG005|COMPLETED|Overall Study||61
10450990|NCT00980330|11598378|FG006|COMPLETED|Overall Study||59
10450991|NCT00980330|11598372|FG000|NOT COMPLETED|Overall Study||5
10450992|NCT00980330|11598373|FG001|NOT COMPLETED|Overall Study||5
10450993|NCT00980330|11598374|FG002|NOT COMPLETED|Overall Study||8
10450994|NCT00980330|11598375|FG003|NOT COMPLETED|Overall Study||5
10450995|NCT00980330|11598376|FG004|NOT COMPLETED|Overall Study||5
10450996|NCT00980330|11598377|FG005|NOT COMPLETED|Overall Study||4
10450997|NCT00980330|11598378|FG006|NOT COMPLETED|Overall Study||7
10450998|NCT00980343|11598397|FG000|STARTED|Overall Study||21
10450999|NCT00980343|11598398|FG001|STARTED|Overall Study||23
10451000|NCT00980343|11598397|FG000|COMPLETED|Overall Study||20
10451001|NCT00980343|11598398|FG001|COMPLETED|Overall Study||20
10451002|NCT00980343|11598397|FG000|NOT COMPLETED|Overall Study||1
10451003|NCT00980343|11598398|FG001|NOT COMPLETED|Overall Study||3
10451004|NCT00980395|11598405|FG000|STARTED|Overall Study||24
10451005|NCT00980395|11598405|FG000|COMPLETED|Overall Study||24
10451006|NCT00980395|11598405|FG000|NOT COMPLETED|Overall Study||0
10451007|NCT00980590|11598411|FG000|STARTED|Overall Study||50
10451008|NCT00980590|11598412|FG001|STARTED|Overall Study||50
10451009|NCT00980590|11598411|FG000|COMPLETED|Overall Study||50
10451010|NCT00980590|11598412|FG001|COMPLETED|Overall Study||50
10451011|NCT00980590|11598411|FG000|NOT COMPLETED|Overall Study||0
10451012|NCT00980590|11598412|FG001|NOT COMPLETED|Overall Study||0
10451013|NCT00980642|11598420|FG000|STARTED|Overall Study||36
10451014|NCT00980642|11598421|FG001|STARTED|Overall Study||20
10451015|NCT00980642|11598420|FG000|COMPLETED|Overall Study||36
10451016|NCT00980642|11598421|FG001|COMPLETED|Overall Study||20
10451017|NCT00980642|11598420|FG000|NOT COMPLETED|Overall Study||0
10451018|NCT00980642|11598421|FG001|NOT COMPLETED|Overall Study||0
10451019|NCT00980655|11598430|FG000|STARTED|Overall Study||61
10451020|NCT00980655|11598431|FG001|STARTED|Overall Study||190
10451021|NCT00980655|11598430|FG000|Vaccinated 13vPnC Dose 1|Overall Study||59
10451022|NCT00980655|11598431|FG001|Vaccinated 13vPnC Dose 1|Overall Study||188
10451023|NCT00980655|11598430|FG000|Vaccinated 13vPnC Dose 2|Overall Study||55
10451024|NCT00980655|11598431|FG001|Vaccinated 13vPnC Dose 2|Overall Study||176
10451025|NCT00980655|11598430|FG000|Vaccinated 13vPnC Dose 3|Overall Study||54
10451026|NCT00980655|11598431|FG001|Vaccinated 13vPnC Dose 3|Overall Study||167
10451027|NCT00980655|11598430|FG000|Vaccinated 13vPnC Dose 4|Overall Study||46
10451028|NCT00980655|11598431|FG001|Vaccinated 13vPnC Dose 4|Overall Study||146
10451029|NCT00980655|11598430|FG000|Vaccinated 23vPS Dose|Overall Study||45
10451030|NCT00980655|11598431|FG001|Vaccinated 23vPS Dose|Overall Study||140
10451031|NCT00980655|11598430|FG000|COMPLETED|Overall Study||45
10451032|NCT00980655|11598431|FG001|COMPLETED|Overall Study||139
10451033|NCT00980655|11598430|FG000|NOT COMPLETED|Overall Study||16
10451034|NCT00980655|11598431|FG001|NOT COMPLETED|Overall Study||51
10451035|NCT00980681|11598442|FG000|STARTED|TOF MRA|Out of the 13 enrolled patients, three did not receive treatment|10
10451036|NCT00980681|11598442|FG000|COMPLETED|TOF MRA||10
10451037|NCT00980681|11598442|FG000|NOT COMPLETED|TOF MRA||0
10451038|NCT00980681|11598442|FG000|STARTED|Dotarem MRA|Out of the 13 enrolled patients, three did not receive treatment|10
10451039|NCT00980681|11598442|FG000|COMPLETED|Dotarem MRA||10
10451040|NCT00980681|11598442|FG000|NOT COMPLETED|Dotarem MRA||0
10451041|NCT00980746|11598454|FG000|STARTED|Overall Study||85
10451042|NCT00980746|11598455|FG001|STARTED|Overall Study||89
10451043|NCT00980746|11598456|FG002|STARTED|Overall Study||95
10451044|NCT00980746|11598457|FG003|STARTED|Overall Study||100
10451045|NCT00980746|11598458|FG004|STARTED|Overall Study||92
10451046|NCT00980746|11598459|FG005|STARTED|Overall Study||96
10451047|NCT00980746|11598454|FG000|Randomized|Overall Study||85
10451048|NCT00980746|11598455|FG001|Randomized|Overall Study||89
10451049|NCT00980746|11598456|FG002|Randomized|Overall Study||95
10451050|NCT00980746|11598457|FG003|Randomized|Overall Study||100
10451051|NCT00980746|11598458|FG004|Randomized|Overall Study||92
10451052|NCT00980746|11598459|FG005|Randomized|Overall Study||96
10451053|NCT00980746|11598454|FG000|Safety Population|Overall Study||85
10451054|NCT00980746|11598455|FG001|Safety Population|Overall Study||89
10451055|NCT00980746|11598456|FG002|Safety Population|Overall Study||95
10451056|NCT00980746|11598457|FG003|Safety Population|Overall Study||100
10451057|NCT00980746|11598458|FG004|Safety Population|Overall Study||92
10451058|NCT00980746|11598459|FG005|Safety Population|Overall Study||96
10451059|NCT00980746|11598454|FG000|Per-protocol|Overall Study||55
10451060|NCT00980746|11598455|FG001|Per-protocol|Overall Study||66
10451061|NCT00980746|11598456|FG002|Per-protocol|Overall Study||73
10451062|NCT00980746|11598457|FG003|Per-protocol|Overall Study||62
10451063|NCT00980746|11598458|FG004|Per-protocol|Overall Study||73
10451064|NCT00980746|11598459|FG005|Per-protocol|Overall Study||74
10451065|NCT00980746|11598454|FG000|COMPLETED|Overall Study||58
10451066|NCT00980746|11598455|FG001|COMPLETED|Overall Study||67
10451067|NCT00980746|11598456|FG002|COMPLETED|Overall Study||75
10451068|NCT00980746|11598457|FG003|COMPLETED|Overall Study||64
10451069|NCT00980746|11598458|FG004|COMPLETED|Overall Study||75
10451070|NCT00980746|11598459|FG005|COMPLETED|Overall Study||78
10451071|NCT00980746|11598454|FG000|NOT COMPLETED|Overall Study||27
10451072|NCT00980746|11598455|FG001|NOT COMPLETED|Overall Study||22
10451073|NCT00980746|11598456|FG002|NOT COMPLETED|Overall Study||20
10451074|NCT00980746|11598457|FG003|NOT COMPLETED|Overall Study||36
10451075|NCT00980746|11598458|FG004|NOT COMPLETED|Overall Study||17
10451076|NCT00980746|11598459|FG005|NOT COMPLETED|Overall Study||18
10451077|NCT00980785|11598475|FG000|STARTED|Overall Study||6
10451078|NCT00980785|11598476|FG001|STARTED|Overall Study||8
10451079|NCT00980785|11598475|FG000|COMPLETED|Overall Study||6
10451080|NCT00980785|11598476|FG001|COMPLETED|Overall Study||8
10451081|NCT00980785|11598475|FG000|NOT COMPLETED|Overall Study||0
10451082|NCT00980785|11598476|FG001|NOT COMPLETED|Overall Study||0
10451083|NCT00980798|11598484|FG000|STARTED|Overall Study||149
10451084|NCT00980798|11598485|FG001|STARTED|Overall Study||139
10451085|NCT00980798|11598484|FG000|COMPLETED|Overall Study||116
10451086|NCT00980798|11598485|FG001|COMPLETED|Overall Study||84
10451087|NCT00980798|11598484|FG000|NOT COMPLETED|Overall Study||33
10451088|NCT00980798|11598485|FG001|NOT COMPLETED|Overall Study||55
10525730|NCT01377987|11677694|FG001|COMPLETED|First Intervention (7 Days)||15
10551327|NCT01536561|11705551|FG000|STARTED|Long-Term Follow-Up||13
10551328|NCT01536561|11705551|FG000|COMPLETED|Long-Term Follow-Up||13
10551329|NCT01536561|11705551|FG000|NOT COMPLETED|Long-Term Follow-Up||0
10525731|NCT01377987|11677693|FG000|NOT COMPLETED|First Intervention (7 Days)||0
10525732|NCT01377987|11677694|FG001|NOT COMPLETED|First Intervention (7 Days)||0
10525733|NCT01377987|11677693|FG000|STARTED|Washout (7 Days)||14
10525734|NCT01377987|11677694|FG001|STARTED|Washout (7 Days)||15
10525735|NCT01377987|11677693|FG000|COMPLETED|Washout (7 Days)||13
10525736|NCT01377987|11677694|FG001|COMPLETED|Washout (7 Days)||14
10525737|NCT01377987|11677693|FG000|NOT COMPLETED|Washout (7 Days)||1
10525738|NCT01377987|11677694|FG001|NOT COMPLETED|Washout (7 Days)||1
10525739|NCT01377987|11677693|FG000|STARTED|Second Intervention (7 Days)||13
10525740|NCT01377987|11677694|FG001|STARTED|Second Intervention (7 Days)||14
10525741|NCT01377987|11677693|FG000|COMPLETED|Second Intervention (7 Days)||13
10525742|NCT01377987|11677694|FG001|COMPLETED|Second Intervention (7 Days)||14
10525743|NCT01377987|11677693|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
10525744|NCT01377987|11677694|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
10525745|NCT01378065|11677700|FG000|STARTED|Overall Study|31 subjects were enrolled/consented. However, 1 subject was not implanted with a study device.|30
10525746|NCT01378065|11677700|FG000|6 Week|Overall Study||30
10525747|NCT01378065|11677700|FG000|3 Months|Overall Study||30
10525748|NCT01378065|11677700|FG000|6 Months|Overall Study||30
10525749|NCT01378065|11677700|FG000|12 Months|Overall Study||30
10525750|NCT01378065|11677700|FG000|COMPLETED|Overall Study||30
10525751|NCT01378065|11677700|FG000|NOT COMPLETED|Overall Study||0
10525752|NCT01378104|11677706|FG000|STARTED|Overall Study||92
10525753|NCT01378104|11677707|FG001|STARTED|Overall Study||86
10525754|NCT01378104|11677706|FG000|COMPLETED|Overall Study||65
10525755|NCT01378104|11677707|FG001|COMPLETED|Overall Study||60
10525756|NCT01378104|11677706|FG000|NOT COMPLETED|Overall Study||27
10525757|NCT01378104|11677707|FG001|NOT COMPLETED|Overall Study||26
10525758|NCT01378117|11677718|FG000|STARTED|Overall Study||31
10525759|NCT01378117|11677719|FG001|STARTED|Overall Study||30
10525760|NCT01378117|11677720|FG002|STARTED|Overall Study||29
10525761|NCT01378117|11677718|FG000|COMPLETED|Overall Study||27
10525762|NCT01378117|11677719|FG001|COMPLETED|Overall Study||29
10525763|NCT01378117|11677720|FG002|COMPLETED|Overall Study||26
10525764|NCT01378117|11677718|FG000|NOT COMPLETED|Overall Study||4
10525765|NCT01378117|11677719|FG001|NOT COMPLETED|Overall Study||1
10525766|NCT01378117|11677720|FG002|NOT COMPLETED|Overall Study||3
10525767|NCT01378195|11677735|FG000|STARTED|Overall Study||75
10525768|NCT01378195|11677736|FG001|STARTED|Overall Study||75
10525769|NCT01378195|11677735|FG000|COMPLETED|Overall Study||46
10525770|NCT01378195|11677736|FG001|COMPLETED|Overall Study||57
10525771|NCT01378195|11677735|FG000|NOT COMPLETED|Overall Study||29
10525772|NCT01378195|11677736|FG001|NOT COMPLETED|Overall Study||18
10525773|NCT01378221|11677744|FG000|STARTED|Overall Study||36
10525774|NCT01378221|11677745|FG001|STARTED|Overall Study||39
10525775|NCT01378221|11677744|FG000|COMPLETED|Overall Study||29
10525776|NCT01378221|11677745|FG001|COMPLETED|Overall Study||30
10525777|NCT01378221|11677744|FG000|NOT COMPLETED|Overall Study||7
10525778|NCT01378221|11677745|FG001|NOT COMPLETED|Overall Study||9
10525779|NCT01378273|11677753|FG000|STARTED|Overall Study||464
10525780|NCT01378273|11677754|FG001|STARTED|Overall Study||477
10525781|NCT01378273|11677753|FG000|COMPLETED|Overall Study||460
10525782|NCT01378273|11677754|FG001|COMPLETED|Overall Study||476
10525783|NCT01378273|11677753|FG000|NOT COMPLETED|Overall Study||4
10525784|NCT01378273|11677754|FG001|NOT COMPLETED|Overall Study||1
10525785|NCT01378299|11677764|FG000|STARTED|Overall Study||105
10525786|NCT01378299|11677764|FG000|BMI group1|Overall Study||38
10525787|NCT01378299|11677764|FG000|BMI Group 2|Overall Study||40
10525788|NCT01378299|11677764|FG000|BMI Group 3|Overall Study||27
10525789|NCT01378299|11677764|FG000|COMPLETED|Overall Study||74
10525790|NCT01378299|11677764|FG000|NOT COMPLETED|Overall Study||31
10525791|NCT01378325|11677796|FG000|STARTED|Overall Study||40
10525792|NCT01378325|11677797|FG001|STARTED|Overall Study||40
10525793|NCT01378325|11677796|FG000|COMPLETED|Overall Study||40
10525794|NCT01378325|11677797|FG001|COMPLETED|Overall Study||39
10525795|NCT01378325|11677796|FG000|NOT COMPLETED|Overall Study||0
10525796|NCT01378325|11677797|FG001|NOT COMPLETED|Overall Study||1
10525797|NCT01378377|11677806|FG000|STARTED|Overall Study||4
10525798|NCT01378377|11677807|FG001|STARTED|Overall Study||23
10525799|NCT01378377|11677808|FG002|STARTED|Overall Study||6
10525800|NCT01378377|11677806|FG000|COMPLETED|Overall Study||4
10525801|NCT01378377|11677807|FG001|COMPLETED|Overall Study||23
10525802|NCT01378377|11677808|FG002|COMPLETED|Overall Study||6
10525803|NCT01378377|11677806|FG000|NOT COMPLETED|Overall Study||0
10525804|NCT01378377|11677807|FG001|NOT COMPLETED|Overall Study||0
10525805|NCT01378377|11677808|FG002|NOT COMPLETED|Overall Study||0
10525806|NCT01378416|11677821|FG000|STARTED|Overall Study||16
10525807|NCT01378416|11677821|FG000|COMPLETED|Overall Study||16
10551330|NCT01536574|11705560|FG000|STARTED|Overall Study||162
10451089|NCT00980980|11598494|FG000|STARTED|Overall Study||16
10451090|NCT00980980|11598495|FG001|STARTED|Overall Study||14
10551331|NCT01536574|11705561|FG001|STARTED|Overall Study||133
10551332|NCT01536574|11705560|FG000|COMPLETED|Overall Study||156
10551333|NCT01536574|11705561|FG001|COMPLETED|Overall Study||126
10551334|NCT01536574|11705560|FG000|NOT COMPLETED|Overall Study||6
10551335|NCT01536574|11705561|FG001|NOT COMPLETED|Overall Study||7
10551336|NCT01536587|11705567|FG000|STARTED|Overall Study||32
10551337|NCT01536587|11705567|FG000|COMPLETED|Overall Study||30
10551338|NCT01536587|11705567|FG000|NOT COMPLETED|Overall Study||2
10551339|NCT01536704|11705571|FG000|STARTED|Period 1||12
10551340|NCT01536704|11705572|FG001|STARTED|Period 1||12
10551341|NCT01536704|11705573|FG002|STARTED|Period 1||13
10551342|NCT01536704|11705574|FG003|STARTED|Period 1||13
10551343|NCT01536704|11705571|FG000|COMPLETED|Period 1||12
10551344|NCT01536704|11705572|FG001|COMPLETED|Period 1||12
10551345|NCT01536704|11705573|FG002|COMPLETED|Period 1||13
10551346|NCT01536704|11705574|FG003|COMPLETED|Period 1||13
10551347|NCT01536704|11705571|FG000|NOT COMPLETED|Period 1||0
10551348|NCT01536704|11705572|FG001|NOT COMPLETED|Period 1||0
10551349|NCT01536704|11705573|FG002|NOT COMPLETED|Period 1||0
10551350|NCT01536704|11705574|FG003|NOT COMPLETED|Period 1||0
10551351|NCT01536704|11705571|FG000|STARTED|Washout Period 1||12
10551352|NCT01536704|11705572|FG001|STARTED|Washout Period 1||12
10551353|NCT01536704|11705573|FG002|STARTED|Washout Period 1||13
10551354|NCT01536704|11705574|FG003|STARTED|Washout Period 1||13
10551355|NCT01536704|11705571|FG000|COMPLETED|Washout Period 1||11
10551356|NCT01536704|11705572|FG001|COMPLETED|Washout Period 1||10
10551357|NCT01536704|11705573|FG002|COMPLETED|Washout Period 1||13
10551358|NCT01536704|11705574|FG003|COMPLETED|Washout Period 1||13
10551359|NCT01536704|11705571|FG000|NOT COMPLETED|Washout Period 1||1
10551360|NCT01536704|11705572|FG001|NOT COMPLETED|Washout Period 1||2
10551361|NCT01536704|11705573|FG002|NOT COMPLETED|Washout Period 1||0
10551362|NCT01536704|11705574|FG003|NOT COMPLETED|Washout Period 1||0
10551363|NCT01536704|11705571|FG000|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
10551364|NCT01536704|11705572|FG001|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|11
10551365|NCT01536704|11705573|FG002|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|10
10551366|NCT01536704|11705574|FG003|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
10551367|NCT01536704|11705571|FG000|COMPLETED|Period 2||13
10551368|NCT01536704|11705572|FG001|COMPLETED|Period 2||11
10551369|NCT01536704|11705573|FG002|COMPLETED|Period 2||10
10551370|NCT01536704|11705574|FG003|COMPLETED|Period 2||13
10551371|NCT01536704|11705571|FG000|NOT COMPLETED|Period 2||0
10551372|NCT01536704|11705572|FG001|NOT COMPLETED|Period 2||0
10551373|NCT01536704|11705573|FG002|NOT COMPLETED|Period 2||0
10551374|NCT01536704|11705574|FG003|NOT COMPLETED|Period 2||0
10551375|NCT01536704|11705571|FG000|STARTED|Washout Period 2||13
10551376|NCT01536704|11705572|FG001|STARTED|Washout Period 2||11
10551377|NCT01536704|11705573|FG002|STARTED|Washout Period 2||10
10551378|NCT01536704|11705574|FG003|STARTED|Washout Period 2||13
10789905|NCT03528369|11950321|FG001|NOT COMPLETED|Overall Study||1
10789906|NCT03528369|11950322|FG002|NOT COMPLETED|Overall Study||0
10789907|NCT03528512|11950332|FG000|STARTED|Overall Study||3
10789908|NCT03528512|11950333|FG001|STARTED|Overall Study||2
10789909|NCT03528512|11950332|FG000|COMPLETED|Overall Study||3
10451091|NCT00980980|11598496|FG002|STARTED|Overall Study||13
10551379|NCT01536704|11705571|FG000|COMPLETED|Washout Period 2||12
10551380|NCT01536704|11705572|FG001|COMPLETED|Washout Period 2||11
10551381|NCT01536704|11705573|FG002|COMPLETED|Washout Period 2||10
10551382|NCT01536704|11705574|FG003|COMPLETED|Washout Period 2||12
10551383|NCT01536704|11705571|FG000|NOT COMPLETED|Washout Period 2||1
10551384|NCT01536704|11705572|FG001|NOT COMPLETED|Washout Period 2||0
10551385|NCT01536704|11705573|FG002|NOT COMPLETED|Washout Period 2||0
10551386|NCT01536704|11705574|FG003|NOT COMPLETED|Washout Period 2||1
10551387|NCT01536704|11705571|FG000|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|10
10551388|NCT01536704|11705572|FG001|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
10551389|NCT01536704|11705573|FG002|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
10551390|NCT01536704|11705574|FG003|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|11
10551391|NCT01536704|11705571|FG000|COMPLETED|Period 3||10
10789910|NCT03528512|11950333|FG001|COMPLETED|Overall Study||2
10789911|NCT03528512|11950332|FG000|NOT COMPLETED|Overall Study||0
10789912|NCT03528512|11950333|FG001|NOT COMPLETED|Overall Study||0
10789913|NCT03528551|11950342|FG000|STARTED|Overall Study||25
10451092|NCT00980980|11598494|FG000|COMPLETED|Overall Study||16
10451093|NCT00980980|11598495|FG001|COMPLETED|Overall Study||13
10451094|NCT00980980|11598496|FG002|COMPLETED|Overall Study||13
10451095|NCT00980980|11598494|FG000|NOT COMPLETED|Overall Study||0
10451096|NCT00980980|11598495|FG001|NOT COMPLETED|Overall Study||1
10451097|NCT00980980|11598496|FG002|NOT COMPLETED|Overall Study||0
10451098|NCT00981019|11598507|FG000|STARTED|Overall Study||778
10451099|NCT00981019|11598507|FG000|COMPLETED|Overall Study||301
10451100|NCT00981019|11598507|FG000|NOT COMPLETED|Overall Study||477
10451101|NCT00981045|11598513|FG000|STARTED|Overall Study||1290
10451102|NCT00981045|11598514|FG001|STARTED|Overall Study||1294
10451103|NCT00981045|11598513|FG000|COMPLETED|Overall Study||1276
10451104|NCT00981045|11598514|FG001|COMPLETED|Overall Study||1285
10451105|NCT00981045|11598513|FG000|NOT COMPLETED|Overall Study||14
10451106|NCT00981045|11598514|FG001|NOT COMPLETED|Overall Study||9
10451107|NCT00981084|11598522|FG000|STARTED|First Intervention (One Day)||16
10451108|NCT00981084|11598523|FG001|STARTED|First Intervention (One Day)||17
10451109|NCT00981084|11598522|FG000|COMPLETED|First Intervention (One Day)||16
10451110|NCT00981084|11598523|FG001|COMPLETED|First Intervention (One Day)||17
10451111|NCT00981084|11598522|FG000|NOT COMPLETED|First Intervention (One Day)||0
10451112|NCT00981084|11598523|FG001|NOT COMPLETED|First Intervention (One Day)||0
10451113|NCT00981084|11598522|FG000|STARTED|Washout Period (7 Days)||16
10451114|NCT00981084|11598523|FG001|STARTED|Washout Period (7 Days)||17
10451115|NCT00981084|11598522|FG000|COMPLETED|Washout Period (7 Days)||16
10451116|NCT00981084|11598523|FG001|COMPLETED|Washout Period (7 Days)||17
10451117|NCT00981084|11598522|FG000|NOT COMPLETED|Washout Period (7 Days)||0
10451118|NCT00981084|11598523|FG001|NOT COMPLETED|Washout Period (7 Days)||0
10451119|NCT00981084|11598522|FG000|STARTED|Second Intervention (One Day)||16
10451120|NCT00981084|11598523|FG001|STARTED|Second Intervention (One Day)||17
10451121|NCT00981084|11598522|FG000|COMPLETED|Second Intervention (One Day)||16
10451122|NCT00981084|11598523|FG001|COMPLETED|Second Intervention (One Day)||17
10451123|NCT00981084|11598522|FG000|NOT COMPLETED|Second Intervention (One Day)||0
10789914|NCT03528551|11950343|FG001|STARTED|Overall Study||133
10789915|NCT03528551|11950344|FG002|STARTED|Overall Study||2
10789916|NCT03528551|11950342|FG000|COMPLETED|Overall Study||23
10789917|NCT03528551|11950343|FG001|COMPLETED|Overall Study||114
10789918|NCT03528551|11950344|FG002|COMPLETED|Overall Study||2
10789919|NCT03528551|11950342|FG000|NOT COMPLETED|Overall Study||2
10789920|NCT03528551|11950343|FG001|NOT COMPLETED|Overall Study||19
10789921|NCT03528551|11950344|FG002|NOT COMPLETED|Overall Study||0
10789922|NCT03528577|11950353|FG000|STARTED|Sequence 1||128
10789923|NCT03528577|11950353|FG000|COMPLETED|Sequence 1|Per report, 119 completed the trial, and all 119 received Treatment A, B, C and D.|126
10789924|NCT03528577|11950353|FG000|NOT COMPLETED|Sequence 1||2
10451124|NCT00981084|11598523|FG001|NOT COMPLETED|Second Intervention (One Day)||0
10451125|NCT00981084|11598522|FG000|STARTED|Post Intervention (Data Analysis)||16
10451126|NCT00981084|11598523|FG001|STARTED|Post Intervention (Data Analysis)||17
10451127|NCT00981084|11598522|FG000|COMPLETED|Post Intervention (Data Analysis)||14
10451128|NCT00981084|11598523|FG001|COMPLETED|Post Intervention (Data Analysis)||16
10451129|NCT00981084|11598522|FG000|NOT COMPLETED|Post Intervention (Data Analysis)||2
10451130|NCT00981084|11598523|FG001|NOT COMPLETED|Post Intervention (Data Analysis)||1
10451131|NCT00981149|11598533|FG000|STARTED|Overall Study||12
10451132|NCT00981149|11598534|FG001|STARTED|Overall Study||12
10451133|NCT00981149|11598533|FG000|COMPLETED|Overall Study||10
10451134|NCT00981149|11598534|FG001|COMPLETED|Overall Study||9
10451135|NCT00981149|11598533|FG000|NOT COMPLETED|Overall Study||2
10451136|NCT00981149|11598534|FG001|NOT COMPLETED|Overall Study||3
10451137|NCT00981175|11598543|FG000|STARTED|Primary Dose Vaccination||101
10451138|NCT00981175|11598544|FG001|STARTED|Primary Dose Vaccination||101
10451139|NCT00981175|11598543|FG000|COMPLETED|Primary Dose Vaccination||98
10451140|NCT00981175|11598544|FG001|COMPLETED|Primary Dose Vaccination||99
10451141|NCT00981175|11598543|FG000|NOT COMPLETED|Primary Dose Vaccination||3
10451142|NCT00981175|11598544|FG001|NOT COMPLETED|Primary Dose Vaccination||2
10451143|NCT00981175|11598543|FG000|STARTED|Booster Dose Vaccination|A sub-set of participants in the group received the booster ChimeriVax™-JE vaccine.|55
10451144|NCT00981175|11598544|FG001|STARTED|Booster Dose Vaccination|A sub-set of participants in the group received the booster ChimeriVax™-JE vaccine.|43
10451145|NCT00981175|11598543|FG000|COMPLETED|Booster Dose Vaccination||53
10451146|NCT00981175|11598544|FG001|COMPLETED|Booster Dose Vaccination||40
10451147|NCT00981175|11598543|FG000|NOT COMPLETED|Booster Dose Vaccination||2
10451148|NCT00981175|11598544|FG001|NOT COMPLETED|Booster Dose Vaccination||3
10451149|NCT00981214|11598557|FG000|STARTED|Overall Study||19
10451150|NCT00981214|11598557|FG000|COMPLETED|Overall Study||19
10451151|NCT00981214|11598557|FG000|NOT COMPLETED|Overall Study||0
10451152|NCT00981227|11598567|FG000|STARTED|Overall Study||102
10451153|NCT00981227|11598568|FG001|STARTED|Overall Study||94
10451154|NCT00981227|11598569|FG002|STARTED|Overall Study||94
10451155|NCT00981227|11598570|FG003|STARTED|Overall Study||94
10451156|NCT00981227|11598571|FG004|STARTED|Overall Study||90
10451157|NCT00981227|11598572|FG005|STARTED|Overall Study||93
10451158|NCT00981227|11598567|FG000|Randomized|Overall Study||102
10451159|NCT00981227|11598568|FG001|Randomized|Overall Study||94
10451160|NCT00981227|11598569|FG002|Randomized|Overall Study||94
10451161|NCT00981227|11598570|FG003|Randomized|Overall Study||94
10451162|NCT00981227|11598571|FG004|Randomized|Overall Study||90
10451163|NCT00981227|11598572|FG005|Randomized|Overall Study||93
10451164|NCT00981227|11598567|FG000|Safety Population|Overall Study||102
10451165|NCT00981227|11598568|FG001|Safety Population|Overall Study||94
10451166|NCT00981227|11598569|FG002|Safety Population|Overall Study||94
10451167|NCT00981227|11598570|FG003|Safety Population|Overall Study||94
10451168|NCT00981227|11598571|FG004|Safety Population|Overall Study||90
10451169|NCT00981227|11598572|FG005|Safety Population|Overall Study||93
10451170|NCT00981227|11598567|FG000|Per-Protocol|Overall Study||69
10451171|NCT00981227|11598568|FG001|Per-Protocol|Overall Study||72
10451172|NCT00981227|11598569|FG002|Per-Protocol|Overall Study||67
10451173|NCT00981227|11598570|FG003|Per-Protocol|Overall Study||68
10789925|NCT03528577|11950353|FG000|STARTED|Sequence 2||128
10789926|NCT03528577|11950353|FG000|COMPLETED|Sequence 2||125
10451174|NCT00981227|11598571|FG004|Per-Protocol|Overall Study||50
10451175|NCT00981227|11598572|FG005|Per-Protocol|Overall Study||70
10451176|NCT00981227|11598567|FG000|COMPLETED|Overall Study||80
10451177|NCT00981227|11598568|FG001|COMPLETED|Overall Study||75
10451178|NCT00981227|11598569|FG002|COMPLETED|Overall Study||73
10451179|NCT00981227|11598570|FG003|COMPLETED|Overall Study||73
10451180|NCT00981227|11598571|FG004|COMPLETED|Overall Study||60
10451181|NCT00981227|11598572|FG005|COMPLETED|Overall Study||75
10451182|NCT00981227|11598567|FG000|NOT COMPLETED|Overall Study||22
10451183|NCT00981227|11598568|FG001|NOT COMPLETED|Overall Study||19
10451184|NCT00981227|11598569|FG002|NOT COMPLETED|Overall Study||21
10551392|NCT01536704|11705572|FG001|COMPLETED|Period 3||12
10551393|NCT01536704|11705573|FG002|COMPLETED|Period 3||12
10551394|NCT01536704|11705574|FG003|COMPLETED|Period 3||10
10551395|NCT01536704|11705571|FG000|NOT COMPLETED|Period 3||0
10551396|NCT01536704|11705572|FG001|NOT COMPLETED|Period 3||0
10551397|NCT01536704|11705573|FG002|NOT COMPLETED|Period 3||0
10551398|NCT01536704|11705574|FG003|NOT COMPLETED|Period 3||1
10789927|NCT03528577|11950353|FG000|NOT COMPLETED|Sequence 2||3
10789928|NCT03528577|11950353|FG000|STARTED|Sequence 3||128
10789929|NCT03528577|11950353|FG000|COMPLETED|Sequence 3||127
10451185|NCT00981227|11598570|FG003|NOT COMPLETED|Overall Study||21
10451186|NCT00981227|11598571|FG004|NOT COMPLETED|Overall Study||30
10451187|NCT00981227|11598572|FG005|NOT COMPLETED|Overall Study||18
10451188|NCT00981253|11598592|FG000|STARTED|Overall Study||76
10451189|NCT00981253|11598593|FG001|STARTED|Overall Study||75
10451190|NCT00981253|11598592|FG000|COMPLETED|Overall Study||73
10451191|NCT00981253|11598593|FG001|COMPLETED|Overall Study||72
10451192|NCT00981253|11598592|FG000|NOT COMPLETED|Overall Study||3
10451193|NCT00981253|11598593|FG001|NOT COMPLETED|Overall Study||3
10451194|NCT00981292|11598606|FG000|STARTED|Day 1||7
10451195|NCT00981292|11598607|FG001|STARTED|Day 1||4
10451196|NCT00981292|11598608|FG002|STARTED|Day 1||6
10451197|NCT00981292|11598609|FG003|STARTED|Day 1||4
10451198|NCT00981292|11598610|FG004|STARTED|Day 1||4
10451199|NCT00981292|11598611|FG005|STARTED|Day 1||7
10451200|NCT00981292|11598606|FG000|COMPLETED|Day 1||6
10451201|NCT00981292|11598607|FG001|COMPLETED|Day 1||4
10451202|NCT00981292|11598608|FG002|COMPLETED|Day 1||6
10451203|NCT00981292|11598609|FG003|COMPLETED|Day 1||4
10451204|NCT00981292|11598610|FG004|COMPLETED|Day 1||4
10451205|NCT00981292|11598611|FG005|COMPLETED|Day 1||5
10451206|NCT00981292|11598606|FG000|NOT COMPLETED|Day 1||1
10451207|NCT00981292|11598607|FG001|NOT COMPLETED|Day 1||0
10451208|NCT00981292|11598608|FG002|NOT COMPLETED|Day 1||0
10451209|NCT00981292|11598609|FG003|NOT COMPLETED|Day 1||0
10551399|NCT01536704|11705571|FG000|STARTED|Washout Period 3||10
10451210|NCT00981292|11598610|FG004|NOT COMPLETED|Day 1||0
10551400|NCT01536704|11705572|FG001|STARTED|Washout Period 3||12
10551401|NCT01536704|11705573|FG002|STARTED|Washout Period 3||12
10551402|NCT01536704|11705574|FG003|STARTED|Washout Period 3||10
10551403|NCT01536704|11705571|FG000|COMPLETED|Washout Period 3||10
10551404|NCT01536704|11705572|FG001|COMPLETED|Washout Period 3||12
10551405|NCT01536704|11705573|FG002|COMPLETED|Washout Period 3||11
10551406|NCT01536704|11705574|FG003|COMPLETED|Washout Period 3||10
10551407|NCT01536704|11705571|FG000|NOT COMPLETED|Washout Period 3||0
10551408|NCT01536704|11705572|FG001|NOT COMPLETED|Washout Period 3||0
10551409|NCT01536704|11705573|FG002|NOT COMPLETED|Washout Period 3||1
10551410|NCT01536704|11705574|FG003|NOT COMPLETED|Washout Period 3||0
10551411|NCT01536704|11705571|FG000|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|12
10551412|NCT01536704|11705572|FG001|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
10551413|NCT01536704|11705573|FG002|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
10551414|NCT01536704|11705574|FG003|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
10551415|NCT01536704|11705571|FG000|COMPLETED|Period 4||12
10551416|NCT01536704|11705572|FG001|COMPLETED|Period 4||11
10551417|NCT01536704|11705573|FG002|COMPLETED|Period 4||10
10551418|NCT01536704|11705574|FG003|COMPLETED|Period 4||10
10551419|NCT01536704|11705571|FG000|NOT COMPLETED|Period 4||0
10551420|NCT01536704|11705572|FG001|NOT COMPLETED|Period 4||0
10551421|NCT01536704|11705573|FG002|NOT COMPLETED|Period 4||0
10551422|NCT01536704|11705574|FG003|NOT COMPLETED|Period 4||0
10551423|NCT01536795|11705590|FG000|STARTED|Overall Study||24
10551424|NCT01536795|11705591|FG001|STARTED|Overall Study||24
10551425|NCT01536795|11705590|FG000|COMPLETED|Overall Study||23
10551426|NCT01536795|11705591|FG001|COMPLETED|Overall Study||22
10551427|NCT01536795|11705590|FG000|NOT COMPLETED|Overall Study||1
10551428|NCT01536795|11705591|FG001|NOT COMPLETED|Overall Study||2
10551429|NCT01536860|11705597|FG000|STARTED|First Intervention (1 Day)||4
10551430|NCT01536860|11705598|FG001|STARTED|First Intervention (1 Day)||4
10551431|NCT01536860|11705599|FG002|STARTED|First Intervention (1 Day)||4
10551432|NCT01536860|11705597|FG000|COMPLETED|First Intervention (1 Day)||4
10551433|NCT01536860|11705598|FG001|COMPLETED|First Intervention (1 Day)||4
10551434|NCT01536860|11705599|FG002|COMPLETED|First Intervention (1 Day)||4
10551435|NCT01536860|11705597|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10551436|NCT01536860|11705598|FG001|NOT COMPLETED|First Intervention (1 Day)||0
10451211|NCT00981292|11598611|FG005|NOT COMPLETED|Day 1||2
10451212|NCT00981292|11598606|FG000|STARTED|Day 2||6
10451213|NCT00981292|11598607|FG001|STARTED|Day 2||4
10451214|NCT00981292|11598608|FG002|STARTED|Day 2||6
10451215|NCT00981292|11598609|FG003|STARTED|Day 2||4
10451216|NCT00981292|11598610|FG004|STARTED|Day 2||4
10551437|NCT01536860|11705599|FG002|NOT COMPLETED|First Intervention (1 Day)||0
10551438|NCT01536860|11705597|FG000|STARTED|Washout Period (3 Days)||4
10551439|NCT01536860|11705598|FG001|STARTED|Washout Period (3 Days)||4
10551440|NCT01536860|11705599|FG002|STARTED|Washout Period (3 Days)||4
10451217|NCT00981292|11598611|FG005|STARTED|Day 2||5
10451218|NCT00981292|11598606|FG000|COMPLETED|Day 2||4
10451219|NCT00981292|11598607|FG001|COMPLETED|Day 2||4
10451220|NCT00981292|11598608|FG002|COMPLETED|Day 2||6
10451221|NCT00981292|11598609|FG003|COMPLETED|Day 2||4
10451222|NCT00981292|11598610|FG004|COMPLETED|Day 2||4
10451223|NCT00981292|11598611|FG005|COMPLETED|Day 2||5
10451224|NCT00981292|11598606|FG000|NOT COMPLETED|Day 2||2
10451225|NCT00981292|11598607|FG001|NOT COMPLETED|Day 2||0
10451226|NCT00981292|11598608|FG002|NOT COMPLETED|Day 2||0
10451227|NCT00981292|11598609|FG003|NOT COMPLETED|Day 2||0
10451228|NCT00981292|11598610|FG004|NOT COMPLETED|Day 2||0
10451229|NCT00981292|11598611|FG005|NOT COMPLETED|Day 2||0
10451230|NCT00981292|11598606|FG000|STARTED|Day 3||4
10451231|NCT00981292|11598607|FG001|STARTED|Day 3||4
10451232|NCT00981292|11598608|FG002|STARTED|Day 3||6
10451233|NCT00981292|11598609|FG003|STARTED|Day 3||4
10451234|NCT00981292|11598610|FG004|STARTED|Day 3||4
10451235|NCT00981292|11598611|FG005|STARTED|Day 3||5
10451236|NCT00981292|11598606|FG000|COMPLETED|Day 3||4
10451237|NCT00981292|11598607|FG001|COMPLETED|Day 3||4
10451238|NCT00981292|11598608|FG002|COMPLETED|Day 3||6
10451239|NCT00981292|11598609|FG003|COMPLETED|Day 3||4
10451240|NCT00981292|11598610|FG004|COMPLETED|Day 3||4
10451241|NCT00981292|11598611|FG005|COMPLETED|Day 3||4
10451242|NCT00981292|11598606|FG000|NOT COMPLETED|Day 3||0
10451243|NCT00981292|11598607|FG001|NOT COMPLETED|Day 3||0
10451244|NCT00981292|11598608|FG002|NOT COMPLETED|Day 3||0
10451245|NCT00981292|11598609|FG003|NOT COMPLETED|Day 3||0
10451246|NCT00981292|11598610|FG004|NOT COMPLETED|Day 3||0
10451247|NCT00981292|11598611|FG005|NOT COMPLETED|Day 3||1
10451248|NCT00981305|11598625|FG000|STARTED|Overall Study||69
10451249|NCT00981305|11598626|FG001|STARTED|Overall Study||67
10451250|NCT00981305|11598625|FG000|COMPLETED|Overall Study||50
10451251|NCT00981305|11598626|FG001|COMPLETED|Overall Study||57
10451252|NCT00981305|11598625|FG000|NOT COMPLETED|Overall Study||19
10451253|NCT00981305|11598626|FG001|NOT COMPLETED|Overall Study||10
10451254|NCT00981409|11598634|FG000|STARTED|Overall Study||30
10451255|NCT00981409|11598635|FG001|STARTED|Overall Study||11
10451256|NCT00981409|11598634|FG000|COMPLETED|Overall Study||24
10451257|NCT00981409|11598635|FG001|COMPLETED|Overall Study||10
10451258|NCT00981409|11598634|FG000|NOT COMPLETED|Overall Study||6
10451259|NCT00981409|11598635|FG001|NOT COMPLETED|Overall Study||1
10451260|NCT00981435|11598644|FG000|STARTED|Overall Study||31
10451261|NCT00981435|11598645|FG001|STARTED|Overall Study||29
10451262|NCT00981435|11598646|FG002|STARTED|Overall Study||37
10451263|NCT00981435|11598644|FG000|COMPLETED|Overall Study||31
10451264|NCT00981435|11598645|FG001|COMPLETED|Overall Study||29
10451265|NCT00981435|11598646|FG002|COMPLETED|Overall Study||37
10451266|NCT00981435|11598644|FG000|NOT COMPLETED|Overall Study||0
10451267|NCT00981435|11598645|FG001|NOT COMPLETED|Overall Study||0
10451268|NCT00981435|11598646|FG002|NOT COMPLETED|Overall Study||0
10451269|NCT00981461|11598656|FG000|STARTED|Overall Study||48
10451270|NCT00981461|11598657|FG001|STARTED|Overall Study||24
10451271|NCT00981461|11598656|FG000|COMPLETED|Overall Study||43
10551441|NCT01536860|11705597|FG000|COMPLETED|Washout Period (3 Days)||4
10551442|NCT01536860|11705598|FG001|COMPLETED|Washout Period (3 Days)||4
10551443|NCT01536860|11705599|FG002|COMPLETED|Washout Period (3 Days)||4
10551444|NCT01536860|11705597|FG000|NOT COMPLETED|Washout Period (3 Days)||0
10451272|NCT00981461|11598657|FG001|COMPLETED|Overall Study||22
10451273|NCT00981461|11598656|FG000|NOT COMPLETED|Overall Study||5
10451274|NCT00981461|11598657|FG001|NOT COMPLETED|Overall Study||2
10451275|NCT00981474|11598665|FG000|STARTED|Overall Study||228
10451276|NCT00981474|11598666|FG001|STARTED|Overall Study||232
10451277|NCT00981474|11598665|FG000|COMPLETED|Overall Study||228
10451278|NCT00981474|11598666|FG001|COMPLETED|Overall Study||232
10451279|NCT00981474|11598665|FG000|NOT COMPLETED|Overall Study||0
10451280|NCT00981474|11598666|FG001|NOT COMPLETED|Overall Study||0
10451281|NCT00981526|11598676|FG000|STARTED|Overall Study||26
10451282|NCT00981526|11598677|FG001|STARTED|Overall Study||28
10451283|NCT00981526|11598676|FG000|COMPLETED|Overall Study||22
10451284|NCT00981526|11598677|FG001|COMPLETED|Overall Study||22
10451285|NCT00981526|11598676|FG000|NOT COMPLETED|Overall Study||4
10451286|NCT00981526|11598677|FG001|NOT COMPLETED|Overall Study||6
10451287|NCT00981578|11598685|FG000|STARTED|Overall Study||17
10451288|NCT00981578|11598685|FG000|COMPLETED|Overall Study||14
10451289|NCT00981578|11598685|FG000|NOT COMPLETED|Overall Study||3
10451290|NCT00981630|11598693|FG000|STARTED|Overall Study||32
10451291|NCT00981630|11598694|FG001|STARTED|Overall Study||32
10451292|NCT00981630|11598695|FG002|STARTED|Overall Study||32
10551445|NCT01536860|11705598|FG001|NOT COMPLETED|Washout Period (3 Days)||0
10551446|NCT01536860|11705599|FG002|NOT COMPLETED|Washout Period (3 Days)||0
10551447|NCT01536860|11705597|FG000|STARTED|Second Intervention (1 Day)||4
10451293|NCT00981630|11598696|FG003|STARTED|Overall Study||32
10451294|NCT00981630|11598693|FG000|COMPLETED|Overall Study||32
10451295|NCT00981630|11598694|FG001|COMPLETED|Overall Study||32
10451296|NCT00981630|11598695|FG002|COMPLETED|Overall Study||32
10451297|NCT00981630|11598696|FG003|COMPLETED|Overall Study||32
10451298|NCT00981630|11598693|FG000|NOT COMPLETED|Overall Study||0
10451299|NCT00981630|11598694|FG001|NOT COMPLETED|Overall Study||0
10451300|NCT00981630|11598695|FG002|NOT COMPLETED|Overall Study||0
10451301|NCT00981630|11598696|FG003|NOT COMPLETED|Overall Study||0
10451302|NCT00981669|11598708|FG000|STARTED|Overall Study||40
10451303|NCT00981669|11598709|FG001|STARTED|Overall Study||40
10451304|NCT00981669|11598708|FG000|COMPLETED|Overall Study||39
10451305|NCT00981669|11598709|FG001|COMPLETED|Overall Study||40
10451306|NCT00981669|11598708|FG000|NOT COMPLETED|Overall Study||1
10451307|NCT00981669|11598709|FG001|NOT COMPLETED|Overall Study||0
10451308|NCT00981682|11598715|FG000|STARTED|Overall Study||376
10451309|NCT00981682|11598715|FG000|COMPLETED|Overall Study||234
10451310|NCT00981682|11598715|FG000|NOT COMPLETED|Overall Study||142
10451311|NCT00981747|11598719|FG000|STARTED|Losartan||12
10451312|NCT00981747|11598719|FG000|Started Losartan|Losartan||12
10451313|NCT00981747|11598719|FG000|Completed Losartan|Losartan|Only 9 were analyzed because only 9 completed all four interventions.|10
10451314|NCT00981747|11598719|FG000|COMPLETED|Losartan|Only 9 were analyzed because only 9 completed all four interventions.|10
10451315|NCT00981747|11598719|FG000|NOT COMPLETED|Losartan||2
10451316|NCT00981747|11598719|FG000|STARTED|Placebo Oral Tablet||10
10451317|NCT00981747|11598719|FG000|Started Placebo Oral Tablet|Placebo Oral Tablet||10
10451318|NCT00981747|11598719|FG000|Completed Placebo Oral Tablet|Placebo Oral Tablet||9
10451319|NCT00981747|11598719|FG000|COMPLETED|Placebo Oral Tablet||9
10451320|NCT00981747|11598719|FG000|NOT COMPLETED|Placebo Oral Tablet||1
10451321|NCT00981747|11598719|FG000|STARTED|Sildenafil||9
10451322|NCT00981747|11598719|FG000|Started Sildenafil|Sildenafil||9
10451323|NCT00981747|11598719|FG000|Completed Sildenafil|Sildenafil||9
10451324|NCT00981747|11598719|FG000|COMPLETED|Sildenafil||9
10451325|NCT00981747|11598719|FG000|NOT COMPLETED|Sildenafil||0
10451326|NCT00981747|11598719|FG000|STARTED|Sildenafil and Losartan||9
10451327|NCT00981747|11598719|FG000|Started Sildenafil and Losartan|Sildenafil and Losartan||9
10451328|NCT00981747|11598719|FG000|Completed Sildenafil and Losartan|Sildenafil and Losartan||9
10451329|NCT00981747|11598719|FG000|COMPLETED|Sildenafil and Losartan||9
10451330|NCT00981747|11598719|FG000|NOT COMPLETED|Sildenafil and Losartan||0
10451331|NCT00981799|11598733|FG000|STARTED|Overall Study||6
10451332|NCT00981799|11598734|FG001|STARTED|Overall Study||7
10451333|NCT00981799|11598735|FG002|STARTED|Overall Study||10
10451334|NCT00981799|11598736|FG003|STARTED|Overall Study||0
10451335|NCT00981799|11598733|FG000|COMPLETED|Overall Study||5
10451336|NCT00981799|11598734|FG001|COMPLETED|Overall Study||6
10451337|NCT00981799|11598735|FG002|COMPLETED|Overall Study||10
10451338|NCT00981799|11598736|FG003|COMPLETED|Overall Study||0
10451339|NCT00981799|11598733|FG000|NOT COMPLETED|Overall Study||1
10451340|NCT00981799|11598734|FG001|NOT COMPLETED|Overall Study||1
10451341|NCT00981799|11598735|FG002|NOT COMPLETED|Overall Study||0
10451342|NCT00981799|11598736|FG003|NOT COMPLETED|Overall Study||0
10451343|NCT00981812|11598747|FG000|STARTED|Overall Study||20
10451344|NCT00981812|11598747|FG000|COMPLETED|Overall Study||20
10451345|NCT00981812|11598747|FG000|NOT COMPLETED|Overall Study||0
10451346|NCT00981825|11598753|FG000|STARTED|First Intervention||11
10451347|NCT00981825|11598754|FG001|STARTED|First Intervention||11
10451348|NCT00981825|11598753|FG000|COMPLETED|First Intervention||11
10451349|NCT00981825|11598754|FG001|COMPLETED|First Intervention||11
10451350|NCT00981825|11598753|FG000|NOT COMPLETED|First Intervention||0
10451351|NCT00981825|11598754|FG001|NOT COMPLETED|First Intervention||0
10451352|NCT00981825|11598753|FG000|STARTED|Washout After 1st Intervention||11
10451353|NCT00981825|11598754|FG001|STARTED|Washout After 1st Intervention||11
10451354|NCT00981825|11598753|FG000|COMPLETED|Washout After 1st Intervention||11
10451355|NCT00981825|11598754|FG001|COMPLETED|Washout After 1st Intervention||11
10451356|NCT00981825|11598753|FG000|NOT COMPLETED|Washout After 1st Intervention||0
10451357|NCT00981825|11598754|FG001|NOT COMPLETED|Washout After 1st Intervention||0
10451358|NCT00981825|11598753|FG000|STARTED|Second Intervention||11
10451359|NCT00981825|11598754|FG001|STARTED|Second Intervention||11
10451360|NCT00981825|11598753|FG000|COMPLETED|Second Intervention||11
10451361|NCT00981825|11598754|FG001|COMPLETED|Second Intervention||11
10451362|NCT00981825|11598753|FG000|NOT COMPLETED|Second Intervention||0
10451363|NCT00981825|11598754|FG001|NOT COMPLETED|Second Intervention||0
10451364|NCT00982007|11598764|FG000|STARTED|Overall Study||250
10451365|NCT00982007|11598765|FG001|STARTED|Overall Study||257
10451366|NCT00982007|11598766|FG002|STARTED|Overall Study||253
10451367|NCT00982007|11598767|FG003|STARTED|Overall Study||251
10451368|NCT00982007|11598764|FG000|COMPLETED|Overall Study||246
10451369|NCT00982007|11598765|FG001|COMPLETED|Overall Study||253
10451370|NCT00982007|11598766|FG002|COMPLETED|Overall Study||253
10451371|NCT00982007|11598767|FG003|COMPLETED|Overall Study||245
10451372|NCT00982007|11598764|FG000|NOT COMPLETED|Overall Study||4
10451373|NCT00982007|11598765|FG001|NOT COMPLETED|Overall Study||4
10451374|NCT00982007|11598766|FG002|NOT COMPLETED|Overall Study||0
10451375|NCT00982007|11598767|FG003|NOT COMPLETED|Overall Study||6
10451376|NCT00982020|11598779|FG000|STARTED|Overall Study||102
10451377|NCT00982020|11598780|FG001|STARTED|Overall Study||101
10451378|NCT00982020|11598779|FG000|Received at Least 1 Dose of Study Drug|Overall Study||102
10451379|NCT00982020|11598780|FG001|Received at Least 1 Dose of Study Drug|Overall Study||101
10451380|NCT00982020|11598779|FG000|COMPLETED|Overall Study||45
10451381|NCT00982020|11598780|FG001|COMPLETED|Overall Study||37
10451382|NCT00982020|11598779|FG000|NOT COMPLETED|Overall Study||57
10451383|NCT00982020|11598780|FG001|NOT COMPLETED|Overall Study||64
10451384|NCT00982033|11598793|FG000|STARTED|Overall Study||25
10451385|NCT00982033|11598794|FG001|STARTED|Overall Study||27
10451386|NCT00982033|11598793|FG000|COMPLETED|Overall Study||25
10451387|NCT00982033|11598794|FG001|COMPLETED|Overall Study||27
10451388|NCT00982033|11598793|FG000|NOT COMPLETED|Overall Study||0
10451389|NCT00982033|11598794|FG001|NOT COMPLETED|Overall Study||0
10451390|NCT00982072|11598802|FG000|STARTED|Overall Study||25
10451391|NCT00982072|11598803|FG001|STARTED|Overall Study||27
10451392|NCT00982072|11598802|FG000|COMPLETED|Overall Study||25
10451393|NCT00982072|11598803|FG001|COMPLETED|Overall Study||25
10451394|NCT00982072|11598802|FG000|NOT COMPLETED|Overall Study||0
10451395|NCT00982072|11598803|FG001|NOT COMPLETED|Overall Study||2
10451396|NCT00982137|11598813|FG000|STARTED|Overall Study||36
10451397|NCT00982137|11598814|FG001|STARTED|Overall Study||36
10451398|NCT00982137|11598815|FG002|STARTED|Overall Study||18
10451399|NCT00982137|11598816|FG003|STARTED|Overall Study||18
10451400|NCT00982137|11598813|FG000|COMPLETED|Overall Study||36
10451401|NCT00982137|11598814|FG001|COMPLETED|Overall Study||35
10451402|NCT00982137|11598815|FG002|COMPLETED|Overall Study||18
10451403|NCT00982137|11598816|FG003|COMPLETED|Overall Study||17
10451404|NCT00982137|11598813|FG000|NOT COMPLETED|Overall Study||0
10451405|NCT00982137|11598814|FG001|NOT COMPLETED|Overall Study||1
10451406|NCT00982137|11598815|FG002|NOT COMPLETED|Overall Study||0
10451407|NCT00982137|11598816|FG003|NOT COMPLETED|Overall Study||1
10451408|NCT00982189|11598837|FG000|STARTED|Overall Study||10
10451409|NCT00982189|11598838|FG001|STARTED|Overall Study||9
10451410|NCT00982189|11598839|FG002|STARTED|Overall Study||9
10451411|NCT00982189|11598840|FG003|STARTED|Overall Study||9
10451412|NCT00982189|11598837|FG000|COMPLETED|Overall Study||10
10451413|NCT00982189|11598838|FG001|COMPLETED|Overall Study||9
10451414|NCT00982189|11598839|FG002|COMPLETED|Overall Study||9
10451415|NCT00982189|11598840|FG003|COMPLETED|Overall Study||9
10451416|NCT00982189|11598837|FG000|NOT COMPLETED|Overall Study||0
10451417|NCT00982189|11598838|FG001|NOT COMPLETED|Overall Study||0
10451418|NCT00982189|11598839|FG002|NOT COMPLETED|Overall Study||0
10451419|NCT00982189|11598840|FG003|NOT COMPLETED|Overall Study||0
10451420|NCT00982228|11598854|FG000|STARTED|Main: Week 0 to 52 (NN1250-3583)||472
10789930|NCT03528577|11950353|FG000|NOT COMPLETED|Sequence 3||1
10789931|NCT03528577|11950353|FG000|STARTED|Sequence 4||128
10789932|NCT03528577|11950353|FG000|COMPLETED|Sequence 4||125
10789933|NCT03528577|11950353|FG000|NOT COMPLETED|Sequence 4||3
10451421|NCT00982228|11598855|FG001|STARTED|Main: Week 0 to 52 (NN1250-3583)||157
10451422|NCT00982228|11598854|FG000|Full Analysis Set|Main: Week 0 to 52 (NN1250-3583)||472
10451423|NCT00982228|11598855|FG001|Full Analysis Set|Main: Week 0 to 52 (NN1250-3583)||157
10451424|NCT00982228|11598854|FG000|Exposed|Main: Week 0 to 52 (NN1250-3583)||472
10451425|NCT00982228|11598855|FG001|Exposed|Main: Week 0 to 52 (NN1250-3583)|Three subjects withdrew prior to exposure to trial drug|154
10451426|NCT00982228|11598854|FG000|COMPLETED|Main: Week 0 to 52 (NN1250-3583)||404
10451427|NCT00982228|11598855|FG001|COMPLETED|Main: Week 0 to 52 (NN1250-3583)||137
10451428|NCT00982228|11598854|FG000|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3583)||68
10451429|NCT00982228|11598855|FG001|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3583)||20
10451430|NCT00982228|11598854|FG000|STARTED|Extension: Week 53 to 104 (NN1250-3644)|Fifty-three subjects from the main trial did not continue into the extension|351
10451431|NCT00982228|11598855|FG001|STARTED|Extension: Week 53 to 104 (NN1250-3644)|Nineteen subjects from the main trial did not continue into the extension|118
10451432|NCT00982228|11598854|FG000|COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||330
10451433|NCT00982228|11598855|FG001|COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||113
10451434|NCT00982228|11598854|FG000|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||21
10451435|NCT00982228|11598855|FG001|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||5
10451436|NCT00982280|11598861|FG000|STARTED|Observation Period||82
10451437|NCT00982280|11598861|FG000|COMPLETED|Observation Period||63
10451438|NCT00982280|11598861|FG000|NOT COMPLETED|Observation Period||19
10451439|NCT00982280|11598861|FG000|STARTED|Titration and Optimal Dose Period||63
10451440|NCT00982280|11598861|FG000|COMPLETED|Titration and Optimal Dose Period||55
10451441|NCT00982280|11598861|FG000|NOT COMPLETED|Titration and Optimal Dose Period||8
10451442|NCT00982280|11598861|FG000|STARTED|Maintenance Period||55
10451443|NCT00982280|11598861|FG000|COMPLETED|Maintenance Period||54
10451444|NCT00982280|11598861|FG000|NOT COMPLETED|Maintenance Period||1
10451445|NCT00982319|11598868|FG000|STARTED|Overall Study||17
10451446|NCT00982319|11598869|FG001|STARTED|Overall Study||17
10451447|NCT00982319|11598868|FG000|COMPLETED|Overall Study||15
10451448|NCT00982319|11598869|FG001|COMPLETED|Overall Study||15
10451449|NCT00982319|11598868|FG000|NOT COMPLETED|Overall Study||2
10451450|NCT00982319|11598869|FG001|NOT COMPLETED|Overall Study||2
10451451|NCT00982345|11598875|FG000|STARTED|Overall Study||20
10451452|NCT00982345|11598875|FG000|COMPLETED|Overall Study||18
10451453|NCT00982345|11598875|FG000|NOT COMPLETED|Overall Study||2
10451454|NCT00982397|11598881|FG000|STARTED|Phase I||236
10451455|NCT00982397|11598882|FG001|STARTED|Phase I||0
10451456|NCT00982397|11598881|FG000|COMPLETED|Phase I||236
10451457|NCT00982397|11598882|FG001|COMPLETED|Phase I||0
10451458|NCT00982397|11598881|FG000|NOT COMPLETED|Phase I||0
10451459|NCT00982397|11598882|FG001|NOT COMPLETED|Phase I||0
10789934|NCT03529162|11950362|FG000|STARTED|Overall Study||2
10789935|NCT03529162|11950363|FG001|STARTED|Overall Study||2
10451460|NCT00982397|11598881|FG000|STARTED|Phase II/Overall Study||2019
10451461|NCT00982397|11598882|FG001|STARTED|Phase II/Overall Study||751
10451663|NCT00983476|11599128|FG000|COMPLETED|Overall Study||78
10451462|NCT00982397|11598881|FG000|Secondary Prevention Randomized 18/24NID|Phase II/Overall Study||231
10789936|NCT03529162|11950362|FG000|COMPLETED|Overall Study||0
10451463|NCT00982397|11598882|FG001|Secondary Prevention Randomized 18/24NID|Phase II/Overall Study||122
10451464|NCT00982397|11598881|FG000|Secondary Prevention Randomized 30/40NID|Phase II/Overall Study||221
10451465|NCT00982397|11598882|FG001|Secondary Prevention Randomized 30/40NID|Phase II/Overall Study||131
10451466|NCT00982397|11598881|FG000|COMPLETED|Phase II/Overall Study||2019
10451467|NCT00982397|11598882|FG001|COMPLETED|Phase II/Overall Study||751
10451468|NCT00982397|11598881|FG000|NOT COMPLETED|Phase II/Overall Study||0
10451469|NCT00982397|11598882|FG001|NOT COMPLETED|Phase II/Overall Study||0
10451470|NCT00982410|11598893|FG000|STARTED|3-month Follow-up Assessment||65
10451471|NCT00982410|11598894|FG001|STARTED|3-month Follow-up Assessment||66
10451472|NCT00982410|11598893|FG000|COMPLETED|3-month Follow-up Assessment||56
10451473|NCT00982410|11598894|FG001|COMPLETED|3-month Follow-up Assessment||53
10451474|NCT00982410|11598893|FG000|NOT COMPLETED|3-month Follow-up Assessment||9
10451475|NCT00982410|11598894|FG001|NOT COMPLETED|3-month Follow-up Assessment||13
10451476|NCT00982410|11598893|FG000|STARTED|6-month Follow-up Assessment|n=65 : intent to treat. Some persons missed follow-up assessment without withdrawing from study.|65
10451477|NCT00982410|11598894|FG001|STARTED|6-month Follow-up Assessment|n=2 persons withdrew before 3-mo. f/u, reducing pool of participants to N=64 with intent to treat.|64
10451478|NCT00982410|11598893|FG000|COMPLETED|6-month Follow-up Assessment||59
10451479|NCT00982410|11598894|FG001|COMPLETED|6-month Follow-up Assessment||53
10451480|NCT00982410|11598893|FG000|NOT COMPLETED|6-month Follow-up Assessment||6
10451481|NCT00982410|11598894|FG001|NOT COMPLETED|6-month Follow-up Assessment||11
10451482|NCT00982410|11598893|FG000|STARTED|12-month Follow-up Assessment|n=65 : intent to treat. Some persons missed follow-up assessment without withdrawing from study.|65
10451483|NCT00982410|11598894|FG001|STARTED|12-month Follow-up Assessment|n=2 persons withdrew before 3-mo. f/u, reducing pool of participants to N=64 with intent to treat.|64
10451484|NCT00982410|11598893|FG000|COMPLETED|12-month Follow-up Assessment||56
10451485|NCT00982410|11598894|FG001|COMPLETED|12-month Follow-up Assessment||55
10451486|NCT00982410|11598893|FG000|NOT COMPLETED|12-month Follow-up Assessment||9
10451487|NCT00982410|11598894|FG001|NOT COMPLETED|12-month Follow-up Assessment||9
10451488|NCT00982423|11598903|FG000|STARTED|Overall Study||13
10451489|NCT00982423|11598904|FG001|STARTED|Overall Study||19
10451490|NCT00982423|11598903|FG000|COMPLETED|Overall Study||13
10451491|NCT00982423|11598904|FG001|COMPLETED|Overall Study||19
10451492|NCT00982423|11598903|FG000|NOT COMPLETED|Overall Study||0
10451493|NCT00982423|11598904|FG001|NOT COMPLETED|Overall Study||0
10451494|NCT00982488|11598916|FG000|STARTED|Overall Study|Received treatment|185
10451495|NCT00982488|11598917|FG001|STARTED|Overall Study|Received treatment|14
10451496|NCT00982488|11598918|FG002|STARTED|Overall Study|Received treatment|34
10451497|NCT00982488|11598919|FG003|STARTED|Overall Study|Received treatment|3
10451498|NCT00982488|11598920|FG004|STARTED|Overall Study|Received treatment|1
10451499|NCT00982488|11598916|FG000|COMPLETED|Overall Study|Still receiving treatment|0
10451500|NCT00982488|11598917|FG001|COMPLETED|Overall Study|Still receiving treatment|0
10451501|NCT00982488|11598918|FG002|COMPLETED|Overall Study|Still receiving treatment|0
10451502|NCT00982488|11598919|FG003|COMPLETED|Overall Study|Still receiving treatment|0
10451503|NCT00982488|11598920|FG004|COMPLETED|Overall Study|Still receiving treatment|0
10451504|NCT00982488|11598916|FG000|NOT COMPLETED|Overall Study||185
10451505|NCT00982488|11598917|FG001|NOT COMPLETED|Overall Study||14
10451506|NCT00982488|11598918|FG002|NOT COMPLETED|Overall Study||34
10451507|NCT00982488|11598919|FG003|NOT COMPLETED|Overall Study||3
10451508|NCT00982488|11598920|FG004|NOT COMPLETED|Overall Study||1
10451509|NCT00982553|11598932|FG000|STARTED|Phase1||14
10451510|NCT00982553|11598932|FG000|COMPLETED|Phase1||14
10451511|NCT00982553|11598932|FG000|NOT COMPLETED|Phase1||0
10451512|NCT00982553|11598932|FG000|STARTED|Phase2||14
10451513|NCT00982553|11598932|FG000|COMPLETED|Phase2||14
10451514|NCT00982553|11598932|FG000|NOT COMPLETED|Phase2||0
10451515|NCT00982553|11598932|FG000|STARTED|Phase3||14
10451516|NCT00982553|11598932|FG000|COMPLETED|Phase3||14
10451517|NCT00982553|11598932|FG000|NOT COMPLETED|Phase3||0
10451518|NCT00982592|11598943|FG000|STARTED|Overall Study||64
10451519|NCT00982592|11598944|FG001|STARTED|Overall Study||60
10451520|NCT00982592|11598943|FG000|Treatment Received|Overall Study||63
10451521|NCT00982592|11598944|FG001|Treatment Received|Overall Study||52
10451522|NCT00982592|11598943|FG000|COMPLETED|Overall Study|patients who were off treatment due to disease progression|33
10451523|NCT00982592|11598944|FG001|COMPLETED|Overall Study|patients who were off treatment due to disease progression|27
10451524|NCT00982592|11598943|FG000|NOT COMPLETED|Overall Study||31
10451525|NCT00982592|11598944|FG001|NOT COMPLETED|Overall Study||33
10451526|NCT00982644|11598952|FG000|STARTED|Main: Week 0 to 52 (NN1250-3579)||773
10451527|NCT00982644|11598953|FG001|STARTED|Main: Week 0 to 52 (NN1250-3579)||257
10451528|NCT00982644|11598952|FG000|Full Analysis Set|Main: Week 0 to 52 (NN1250-3579)||773
10451529|NCT00982644|11598953|FG001|Full Analysis Set|Main: Week 0 to 52 (NN1250-3579)||257
10451530|NCT00982644|11598952|FG000|Exposed|Main: Week 0 to 52 (NN1250-3579)|7 subjects were withdrawn prior to exposure to trial products|766
10451531|NCT00982644|11598953|FG001|Exposed|Main: Week 0 to 52 (NN1250-3579)||257
10451532|NCT00982644|11598952|FG000|COMPLETED|Main: Week 0 to 52 (NN1250-3579)||607
10451533|NCT00982644|11598953|FG001|COMPLETED|Main: Week 0 to 52 (NN1250-3579)||197
10451534|NCT00982644|11598952|FG000|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3579)||166
10451535|NCT00982644|11598953|FG001|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3579)||60
10451536|NCT00982644|11598952|FG000|STARTED|Extension: Week 53 to 104 (NN1250-3643)|Fifty-six subjects did not continue into extension trial|551
10451664|NCT00983476|11599129|FG001|COMPLETED|Overall Study||71
10451537|NCT00982644|11598953|FG001|STARTED|Extension: Week 53 to 104 (NN1250-3643)|Twenty-three subjects did not continue into extension trial|174
10451538|NCT00982644|11598952|FG000|COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||505
10451539|NCT00982644|11598953|FG001|COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||154
10789937|NCT03529162|11950363|FG001|COMPLETED|Overall Study||0
10789938|NCT03529162|11950362|FG000|NOT COMPLETED|Overall Study||2
10789939|NCT03529162|11950363|FG001|NOT COMPLETED|Overall Study||2
10451540|NCT00982644|11598952|FG000|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||46
10451541|NCT00982644|11598953|FG001|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||20
10451542|NCT00982657|11598963|FG000|STARTED|Overall Study||12
10451543|NCT00982657|11598964|FG001|STARTED|Overall Study||3
10451544|NCT00982657|11598965|FG002|STARTED|Overall Study||3
10451545|NCT00982657|11598966|FG003|STARTED|Overall Study||16
10451546|NCT00982657|11598963|FG000|COMPLETED|Overall Study||11
10451547|NCT00982657|11598964|FG001|COMPLETED|Overall Study||3
10451548|NCT00982657|11598965|FG002|COMPLETED|Overall Study||1
10451549|NCT00982657|11598966|FG003|COMPLETED|Overall Study||7
10451550|NCT00982657|11598963|FG000|NOT COMPLETED|Overall Study||1
10451551|NCT00982657|11598964|FG001|NOT COMPLETED|Overall Study||0
10451552|NCT00982657|11598965|FG002|NOT COMPLETED|Overall Study||2
10451553|NCT00982657|11598966|FG003|NOT COMPLETED|Overall Study||9
10451554|NCT00982735|11598986|FG000|STARTED|Overall Study||987
10451555|NCT00982735|11598986|FG000|COMPLETED|Overall Study||757
10451556|NCT00982735|11598986|FG000|NOT COMPLETED|Overall Study||230
10451557|NCT00982865|11598994|FG000|STARTED|Overall Study||49
10451558|NCT00982865|11598995|FG001|STARTED|Overall Study||82
10451559|NCT00982865|11598996|FG002|STARTED|Overall Study||15
10451560|NCT00982865|11598997|FG003|STARTED|Overall Study||34
10451561|NCT00982865|11598994|FG000|COMPLETED|Overall Study||49
10451562|NCT00982865|11598995|FG001|COMPLETED|Overall Study||82
10789940|NCT03529461|11950373|FG000|STARTED|Overall Study||28
10789941|NCT03529461|11950374|FG001|STARTED|Overall Study||28
10789942|NCT03529461|11950373|FG000|COMPLETED|Overall Study||28
10789943|NCT03529461|11950374|FG001|COMPLETED|Overall Study||28
10789944|NCT03529461|11950373|FG000|NOT COMPLETED|Overall Study||0
10789945|NCT03529461|11950374|FG001|NOT COMPLETED|Overall Study||0
10451563|NCT00982865|11598996|FG002|COMPLETED|Overall Study||15
10451564|NCT00982865|11598997|FG003|COMPLETED|Overall Study||34
10451565|NCT00982865|11598994|FG000|NOT COMPLETED|Overall Study||0
10451566|NCT00982865|11598995|FG001|NOT COMPLETED|Overall Study||0
10451567|NCT00982865|11598996|FG002|NOT COMPLETED|Overall Study||0
10451568|NCT00982865|11598997|FG003|NOT COMPLETED|Overall Study||0
10789946|NCT03530098|11950383|FG000|STARTED|Overall Study||939
10789947|NCT03530098|11950384|FG001|STARTED|Overall Study||964
10789948|NCT03530098|11950383|FG000|Ground-truth Labeled|Overall Study||741
10789949|NCT03530098|11950384|FG001|Ground-truth Labeled|Overall Study||794
10789950|NCT03530098|11950383|FG000|Primary Analysis Set|Overall Study||739
10789951|NCT03530098|11950384|FG001|Primary Analysis Set|Overall Study||792
10451569|NCT00982878|11599044|FG000|STARTED|Overall Study||13
10451570|NCT00982878|11599044|FG000|COMPLETED|Overall Study||12
10451571|NCT00982878|11599044|FG000|NOT COMPLETED|Overall Study||1
10451572|NCT00982930|11599048|FG000|STARTED|Overall Study||55
10451573|NCT00982930|11599048|FG000|COMPLETED|Overall Study||51
10451574|NCT00982930|11599048|FG000|NOT COMPLETED|Overall Study||4
10451575|NCT00983073|11599052|FG000|STARTED|Observation Period||224
10451576|NCT00983073|11599052|FG000|COMPLETED|Observation Period|24 participants not eligible to be dosed.|200
10451577|NCT00983073|11599052|FG000|NOT COMPLETED|Observation Period||24
10451578|NCT00983073|11599052|FG000|STARTED|Titration and Optimal Dose Period||200
10451579|NCT00983073|11599052|FG000|COMPLETED|Titration and Optimal Dose Period||160
10451580|NCT00983073|11599052|FG000|NOT COMPLETED|Titration and Optimal Dose Period||40
10451581|NCT00983073|11599052|FG000|STARTED|Maintenance Period||160
10451582|NCT00983073|11599052|FG000|COMPLETED|Maintenance Period||144
10451583|NCT00983073|11599052|FG000|NOT COMPLETED|Maintenance Period||16
10451584|NCT00983216|11599057|FG000|STARTED|Colchicine Alone||24
10451585|NCT00983216|11599057|FG000|COMPLETED|Colchicine Alone||24
10451586|NCT00983216|11599057|FG000|NOT COMPLETED|Colchicine Alone||0
10451587|NCT00983216|11599057|FG000|STARTED|14 Day Washout Period||24
10451588|NCT00983216|11599057|FG000|COMPLETED|14 Day Washout Period||24
10451589|NCT00983216|11599057|FG000|NOT COMPLETED|14 Day Washout Period||0
10451590|NCT00983216|11599057|FG000|STARTED|Ketoconazole Alone||24
10451591|NCT00983216|11599057|FG000|COMPLETED|Ketoconazole Alone||24
10451592|NCT00983216|11599057|FG000|NOT COMPLETED|Ketoconazole Alone||0
10451593|NCT00983216|11599057|FG000|STARTED|Colchicine With Ketoconazole||24
10451594|NCT00983216|11599057|FG000|COMPLETED|Colchicine With Ketoconazole||24
10451595|NCT00983216|11599057|FG000|NOT COMPLETED|Colchicine With Ketoconazole||0
10451596|NCT00983242|11599064|FG000|STARTED|Colchicine Alone||24
10789952|NCT03530098|11950383|FG000|COMPLETED|Overall Study||939
10789953|NCT03530098|11950384|FG001|COMPLETED|Overall Study||964
10789954|NCT03530098|11950383|FG000|NOT COMPLETED|Overall Study||0
10789955|NCT03530098|11950384|FG001|NOT COMPLETED|Overall Study||0
10789956|NCT03530345|11950393|FG000|STARTED|Treatment Period A/Follow-up Period 1||28
10451597|NCT00983242|11599064|FG000|COMPLETED|Colchicine Alone||24
10451598|NCT00983242|11599064|FG000|NOT COMPLETED|Colchicine Alone||0
10789957|NCT03530345|11950394|FG001|STARTED|Treatment Period A/Follow-up Period 1||29
10451599|NCT00983242|11599064|FG000|STARTED|14 Day Washout Period||24
10451600|NCT00983242|11599064|FG000|COMPLETED|14 Day Washout Period||24
10451601|NCT00983242|11599064|FG000|NOT COMPLETED|14 Day Washout Period||0
10451602|NCT00983242|11599064|FG000|STARTED|Verapamil HCl ER Alone||24
10789958|NCT03530345|11950393|FG000|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||26
10789959|NCT03530345|11950394|FG001|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||27
10789960|NCT03530345|11950393|FG000|COMPLETED|Treatment Period A/Follow-up Period 1||7
10789961|NCT03530345|11950394|FG001|COMPLETED|Treatment Period A/Follow-up Period 1||7
10789962|NCT03530345|11950393|FG000|NOT COMPLETED|Treatment Period A/Follow-up Period 1||21
10789963|NCT03530345|11950394|FG001|NOT COMPLETED|Treatment Period A/Follow-up Period 1||22
10789964|NCT03530345|11950393|FG000|STARTED|Treatment Period B/Follow-up Period 2|2 participants completed Treatment Period A/Follow-up Period 1 but were not allocated in Period B.|5
10789965|NCT03530345|11950394|FG001|STARTED|Treatment Period B/Follow-up Period 2||7
10789966|NCT03530345|11950393|FG000|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||4
10789967|NCT03530345|11950394|FG001|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||6
10789968|NCT03530345|11950393|FG000|COMPLETED|Treatment Period B/Follow-up Period 2||0
10789969|NCT03530345|11950394|FG001|COMPLETED|Treatment Period B/Follow-up Period 2||0
10789970|NCT03530345|11950393|FG000|NOT COMPLETED|Treatment Period B/Follow-up Period 2||5
10789971|NCT03530345|11950394|FG001|NOT COMPLETED|Treatment Period B/Follow-up Period 2||7
10789972|NCT03530631|11950406|FG000|STARTED|Adderall/Truth||4
10789973|NCT03530631|11950406|FG000|COMPLETED|Adderall/Truth||4
10789974|NCT03530631|11950406|FG000|NOT COMPLETED|Adderall/Truth||0
10789975|NCT03530631|11950406|FG000|STARTED|Placebo/Truth||4
10789976|NCT03530631|11950406|FG000|COMPLETED|Placebo/Truth||4
10451603|NCT00983242|11599064|FG000|COMPLETED|Verapamil HCl ER Alone||24
10451604|NCT00983242|11599064|FG000|NOT COMPLETED|Verapamil HCl ER Alone||0
10451605|NCT00983242|11599064|FG000|STARTED|Colchicine With Verapamil HCl ER||24
10451606|NCT00983242|11599064|FG000|COMPLETED|Colchicine With Verapamil HCl ER||24
10451607|NCT00983242|11599064|FG000|NOT COMPLETED|Colchicine With Verapamil HCl ER||0
10451608|NCT00983281|11599073|FG000|STARTED|Overall Study||805
10451609|NCT00983281|11599074|FG001|STARTED|Overall Study||909
10451610|NCT00983281|11599073|FG000|COMPLETED|Overall Study||805
10451611|NCT00983281|11599074|FG001|COMPLETED|Overall Study||909
10451612|NCT00983281|11599073|FG000|NOT COMPLETED|Overall Study||0
10451613|NCT00983281|11599074|FG001|NOT COMPLETED|Overall Study||0
10451614|NCT00983294|11599080|FG000|STARTED|Colchicine Alone||24
10451615|NCT00983294|11599080|FG000|COMPLETED|Colchicine Alone||24
10451616|NCT00983294|11599080|FG000|NOT COMPLETED|Colchicine Alone||0
10451617|NCT00983294|11599080|FG000|STARTED|14 Day Washout Period||24
10451618|NCT00983294|11599080|FG000|COMPLETED|14 Day Washout Period|two subjects withdrew consent due to personal reasons|22
10451619|NCT00983294|11599080|FG000|NOT COMPLETED|14 Day Washout Period||2
10451620|NCT00983294|11599080|FG000|STARTED|Azithromycin Alone||22
10451621|NCT00983294|11599080|FG000|COMPLETED|Azithromycin Alone||22
10451622|NCT00983294|11599080|FG000|NOT COMPLETED|Azithromycin Alone||0
10451623|NCT00983294|11599080|FG000|STARTED|Colchicine With Azithromycin||22
10451624|NCT00983294|11599080|FG000|COMPLETED|Colchicine With Azithromycin|withdrawn by sponsor on Day 21 due to vomiting on Day 15, prior to azithromycin dosing(1)|21
10451625|NCT00983294|11599080|FG000|NOT COMPLETED|Colchicine With Azithromycin||1
10451626|NCT00983307|11599087|FG000|STARTED|Overall Study||17
10451627|NCT00983307|11599087|FG000|COMPLETED|Overall Study||17
10451628|NCT00983307|11599087|FG000|NOT COMPLETED|Overall Study||0
10451629|NCT00983346|11599091|FG000|STARTED|Overall Study||17
10451630|NCT00983346|11599091|FG000|COMPLETED|Overall Study||17
10451631|NCT00983346|11599091|FG000|NOT COMPLETED|Overall Study||0
10451632|NCT00983359|11599095|FG000|STARTED|Overall Study||40
10451633|NCT00983359|11599095|FG000|Not Eligible for Analysis|Overall Study||1
10451634|NCT00983359|11599095|FG000|COMPLETED|Overall Study||39
10451635|NCT00983359|11599095|FG000|NOT COMPLETED|Overall Study||1
10451636|NCT00983372|11599099|FG000|STARTED|Colchicine Alone||24
10451637|NCT00983372|11599099|FG000|COMPLETED|Colchicine Alone||24
10451638|NCT00983372|11599099|FG000|NOT COMPLETED|Colchicine Alone||0
10451639|NCT00983372|11599099|FG000|STARTED|14 Day Washout Period||24
10451640|NCT00983372|11599099|FG000|COMPLETED|14 Day Washout Period|subject withdrew consent due to schedule conflict - during washout period or diltiazem alone|23
10451641|NCT00983372|11599099|FG000|NOT COMPLETED|14 Day Washout Period||1
10451642|NCT00983372|11599099|FG000|STARTED|Diltiazem ER Alone||23
10451643|NCT00983372|11599099|FG000|COMPLETED|Diltiazem ER Alone|two subjects dropped due to missed diltiazem ER dose; one subject dropped due to vomitting|20
10451644|NCT00983372|11599099|FG000|NOT COMPLETED|Diltiazem ER Alone||3
10451645|NCT00983372|11599099|FG000|STARTED|Colchicine With Diltiazem ER||20
10451646|NCT00983372|11599099|FG000|COMPLETED|Colchicine With Diltiazem ER||20
10451647|NCT00983372|11599099|FG000|NOT COMPLETED|Colchicine With Diltiazem ER||0
10451648|NCT00983385|11599106|FG000|STARTED|Observation Period||208
10451649|NCT00983385|11599106|FG000|COMPLETED|Observation Period||176
10451650|NCT00983385|11599106|FG000|NOT COMPLETED|Observation Period||32
10451651|NCT00983385|11599106|FG000|STARTED|Titration and Optimal Dose Period||176
10451652|NCT00983385|11599106|FG000|COMPLETED|Titration and Optimal Dose Period||140
10451653|NCT00983385|11599106|FG000|NOT COMPLETED|Titration and Optimal Dose Period||36
10451654|NCT00983385|11599106|FG000|STARTED|Maintenance Period||140
10451655|NCT00983385|11599106|FG000|COMPLETED|Maintenance Period||117
10451656|NCT00983385|11599106|FG000|NOT COMPLETED|Maintenance Period||23
10451657|NCT00983476|11599128|FG000|STARTED|Overall Study||95
10451658|NCT00983476|11599129|FG001|STARTED|Overall Study||93
10451659|NCT00983476|11599130|FG002|STARTED|Overall Study||88
10451660|NCT00983476|11599128|FG000|6 Month Follow up Assessment|Overall Study||71
10451661|NCT00983476|11599129|FG001|6 Month Follow up Assessment|Overall Study||62
10451662|NCT00983476|11599130|FG002|6 Month Follow up Assessment|Overall Study||74
10451665|NCT00983476|11599130|FG002|COMPLETED|Overall Study||88
10451666|NCT00983476|11599128|FG000|NOT COMPLETED|Overall Study||17
10451667|NCT00983476|11599129|FG001|NOT COMPLETED|Overall Study||22
10451668|NCT00983476|11599130|FG002|NOT COMPLETED|Overall Study||0
10451669|NCT00983489|11599147|FG000|STARTED|Overall Study||511
10451670|NCT00983489|11599148|FG001|STARTED|Overall Study||453
10451671|NCT00983489|11599149|FG002|STARTED|Overall Study||447
10451672|NCT00983489|11599147|FG000|COMPLETED|Overall Study||326
10451673|NCT00983489|11599148|FG001|COMPLETED|Overall Study||168
10451674|NCT00983489|11599149|FG002|COMPLETED|Overall Study||135
10451675|NCT00983489|11599147|FG000|NOT COMPLETED|Overall Study||185
10451676|NCT00983489|11599148|FG001|NOT COMPLETED|Overall Study||285
10451677|NCT00983489|11599149|FG002|NOT COMPLETED|Overall Study||312
10451678|NCT00983515|11599157|FG000|STARTED|Colchicine Alone||24
10451679|NCT00983515|11599157|FG000|COMPLETED|Colchicine Alone||24
10451680|NCT00983515|11599157|FG000|NOT COMPLETED|Colchicine Alone||0
10451681|NCT00983515|11599157|FG000|STARTED|14 Day Washout Period||24
10451682|NCT00983515|11599157|FG000|COMPLETED|14 Day Washout Period||24
10451683|NCT00983515|11599157|FG000|NOT COMPLETED|14 Day Washout Period||0
10451684|NCT00983515|11599157|FG000|STARTED|Ritonavir Alone||24
10451685|NCT00983515|11599157|FG000|COMPLETED|Ritonavir Alone||18
10451686|NCT00983515|11599157|FG000|NOT COMPLETED|Ritonavir Alone||6
10451687|NCT00983515|11599157|FG000|STARTED|Colchicine With Ritonavir||18
10451688|NCT00983515|11599157|FG000|COMPLETED|Colchicine With Ritonavir|pharmacokinetic data included since parameters could be estimated for both dosing conditions|17
10451689|NCT00983515|11599157|FG000|NOT COMPLETED|Colchicine With Ritonavir||1
10451690|NCT00983528|11599164|FG000|STARTED|Overall Study||6
10451691|NCT00983528|11599164|FG000|COMPLETED|Overall Study||0
10451692|NCT00983528|11599164|FG000|NOT COMPLETED|Overall Study||6
10451693|NCT00983541|11599168|FG000|STARTED|Overall Study||1
10451694|NCT00983541|11599168|FG000|COMPLETED|Overall Study||1
10451695|NCT00983541|11599168|FG000|NOT COMPLETED|Overall Study||0
10451696|NCT00983580|11599174|FG000|STARTED|Overall Study||54
10451697|NCT00983580|11599175|FG001|STARTED|Overall Study||53
10451698|NCT00983580|11599174|FG000|COMPLETED|Overall Study||49
10451699|NCT00983580|11599175|FG001|COMPLETED|Overall Study||49
10451700|NCT00983580|11599174|FG000|NOT COMPLETED|Overall Study||5
10318683|NCT00216060|11452924|FG001|COMPLETED|Overall Study||31
10318684|NCT00216060|11452923|FG000|NOT COMPLETED|Overall Study||0
10451701|NCT00983580|11599175|FG001|NOT COMPLETED|Overall Study||4
10451702|NCT00983619|11599194|FG000|STARTED|Overall Study||3
10451703|NCT00983619|11599195|FG001|STARTED|Overall Study||4
10451704|NCT00983619|11599196|FG002|STARTED|Overall Study||3
10451705|NCT00983619|11599197|FG003|STARTED|Overall Study||6
10451706|NCT00983619|11599198|FG004|STARTED|Overall Study||3
10451707|NCT00983619|11599199|FG005|STARTED|Overall Study||76
10451708|NCT00983619|11599200|FG006|STARTED|Overall Study||3
10451709|NCT00983619|11599201|FG007|STARTED|Overall Study||3
10451710|NCT00983619|11599202|FG008|STARTED|Overall Study||1
10551448|NCT01536860|11705598|FG001|STARTED|Second Intervention (1 Day)||4
10551449|NCT01536860|11705599|FG002|STARTED|Second Intervention (1 Day)||4
10551450|NCT01536860|11705597|FG000|COMPLETED|Second Intervention (1 Day)||4
10551451|NCT01536860|11705598|FG001|COMPLETED|Second Intervention (1 Day)||4
10551452|NCT01536860|11705599|FG002|COMPLETED|Second Intervention (1 Day)||4
10551453|NCT01536860|11705597|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10451711|NCT00983619|11599203|FG009|STARTED|Overall Study||3
10451712|NCT00983619|11599204|FG010|STARTED|Overall Study||17
10451713|NCT00983619|11599205|FG011|STARTED|Overall Study||14
10451714|NCT00983619|11599194|FG000|COMPLETED|Overall Study||0
10451715|NCT00983619|11599195|FG001|COMPLETED|Overall Study||0
10451716|NCT00983619|11599196|FG002|COMPLETED|Overall Study||0
10451717|NCT00983619|11599197|FG003|COMPLETED|Overall Study||1
10451718|NCT00983619|11599198|FG004|COMPLETED|Overall Study||0
10451719|NCT00983619|11599199|FG005|COMPLETED|Overall Study||9
10451720|NCT00983619|11599200|FG006|COMPLETED|Overall Study||0
10451721|NCT00983619|11599201|FG007|COMPLETED|Overall Study||1
10451722|NCT00983619|11599202|FG008|COMPLETED|Overall Study||0
10451723|NCT00983619|11599203|FG009|COMPLETED|Overall Study||0
10451724|NCT00983619|11599204|FG010|COMPLETED|Overall Study||6
10451725|NCT00983619|11599205|FG011|COMPLETED|Overall Study||3
10451726|NCT00983619|11599194|FG000|NOT COMPLETED|Overall Study||3
10451727|NCT00983619|11599195|FG001|NOT COMPLETED|Overall Study||4
10451728|NCT00983619|11599196|FG002|NOT COMPLETED|Overall Study||3
10451729|NCT00983619|11599197|FG003|NOT COMPLETED|Overall Study||5
10451730|NCT00983619|11599198|FG004|NOT COMPLETED|Overall Study||3
10451731|NCT00983619|11599199|FG005|NOT COMPLETED|Overall Study||67
10451732|NCT00983619|11599200|FG006|NOT COMPLETED|Overall Study||3
10451733|NCT00983619|11599201|FG007|NOT COMPLETED|Overall Study||2
10451734|NCT00983619|11599202|FG008|NOT COMPLETED|Overall Study||1
10451735|NCT00983619|11599203|FG009|NOT COMPLETED|Overall Study||3
10451736|NCT00983619|11599204|FG010|NOT COMPLETED|Overall Study||11
10451737|NCT00983619|11599205|FG011|NOT COMPLETED|Overall Study||11
10451738|NCT00983749|11599253|FG000|STARTED|Acute Phase (Enrollment to Hospital DC)||13
10451739|NCT00983749|11599254|FG001|STARTED|Acute Phase (Enrollment to Hospital DC)||10
10451740|NCT00983749|11599253|FG000|COMPLETED|Acute Phase (Enrollment to Hospital DC)||13
10451741|NCT00983749|11599254|FG001|COMPLETED|Acute Phase (Enrollment to Hospital DC)||10
10451742|NCT00983749|11599253|FG000|NOT COMPLETED|Acute Phase (Enrollment to Hospital DC)||0
10451743|NCT00983749|11599254|FG001|NOT COMPLETED|Acute Phase (Enrollment to Hospital DC)||0
10451744|NCT00983749|11599253|FG000|STARTED|Follow-up Phase (Hospital DC to 30 Days)||13
10451745|NCT00983749|11599254|FG001|STARTED|Follow-up Phase (Hospital DC to 30 Days)||10
10451746|NCT00983749|11599253|FG000|COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||12
10451747|NCT00983749|11599254|FG001|COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||7
10451748|NCT00983749|11599253|FG000|NOT COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||1
10451749|NCT00983749|11599254|FG001|NOT COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||3
10451750|NCT00983801|11599260|FG000|STARTED|Overall Study|Participants who received treatment.|52
10451751|NCT00983801|11599260|FG000|COMPLETED|Overall Study|Participants who were taken off treatment.|52
10451752|NCT00983801|11599260|FG000|NOT COMPLETED|Overall Study||0
10451753|NCT00983827|11599264|FG000|STARTED|Overall Study||8
10451754|NCT00983827|11599264|FG000|COMPLETED|Overall Study||7
10451755|NCT00983827|11599264|FG000|NOT COMPLETED|Overall Study||1
10451756|NCT00983853|11599274|FG000|STARTED|Overall Study||7
10451757|NCT00983853|11599275|FG001|STARTED|Overall Study|1 subject was randomized but not dosed|7
10451758|NCT00983853|11599276|FG002|STARTED|Overall Study|1 subject was randomized but not dosed|17
10451759|NCT00983853|11599277|FG003|STARTED|Overall Study||8
10451760|NCT00983853|11599278|FG004|STARTED|Overall Study||15
10451761|NCT00983853|11599279|FG005|STARTED|Overall Study||8
10451762|NCT00983853|11599274|FG000|COMPLETED|Overall Study||6
10451763|NCT00983853|11599275|FG001|COMPLETED|Overall Study||5
10451764|NCT00983853|11599276|FG002|COMPLETED|Overall Study||14
10451765|NCT00983853|11599277|FG003|COMPLETED|Overall Study||6
10451766|NCT00983853|11599278|FG004|COMPLETED|Overall Study||12
10451767|NCT00983853|11599279|FG005|COMPLETED|Overall Study||7
10451768|NCT00983853|11599274|FG000|NOT COMPLETED|Overall Study||1
10451769|NCT00983853|11599275|FG001|NOT COMPLETED|Overall Study||2
10451770|NCT00983853|11599276|FG002|NOT COMPLETED|Overall Study||3
10451771|NCT00983853|11599277|FG003|NOT COMPLETED|Overall Study||2
10451772|NCT00983853|11599278|FG004|NOT COMPLETED|Overall Study||3
10451773|NCT00983853|11599279|FG005|NOT COMPLETED|Overall Study||1
10451774|NCT00983892|11599297|FG000|STARTED|Overall Study||66
10451775|NCT00983892|11599298|FG001|STARTED|Overall Study||68
10451776|NCT00983892|11599297|FG000|COMPLETED|Overall Study||56
10451777|NCT00983892|11599298|FG001|COMPLETED|Overall Study||56
10451778|NCT00983892|11599297|FG000|NOT COMPLETED|Overall Study||10
10451779|NCT00983892|11599298|FG001|NOT COMPLETED|Overall Study||12
10451780|NCT00983905|11599304|FG000|STARTED|Theophylline Alone||30
10451781|NCT00983905|11599304|FG000|COMPLETED|Theophylline Alone|withdrawn by sponsor due to vomiting(1)|29
10451782|NCT00983905|11599304|FG000|NOT COMPLETED|Theophylline Alone||1
10451783|NCT00983905|11599304|FG000|STARTED|4 Day Washout Period||29
10451784|NCT00983905|11599304|FG000|COMPLETED|4 Day Washout Period||29
10451785|NCT00983905|11599304|FG000|NOT COMPLETED|4 Day Washout Period||0
10451786|NCT00983905|11599304|FG000|STARTED|Colchicine Alone||29
10451787|NCT00983905|11599304|FG000|COMPLETED|Colchicine Alone|withdrawn by sponsor due to: diarrhea(1); vomiting and diarrhea(1)|27
10451788|NCT00983905|11599304|FG000|NOT COMPLETED|Colchicine Alone||2
10451789|NCT00983905|11599304|FG000|STARTED|Theophylline With Colchicine||27
10451790|NCT00983905|11599304|FG000|COMPLETED|Theophylline With Colchicine||27
10451791|NCT00983905|11599304|FG000|NOT COMPLETED|Theophylline With Colchicine||0
10451792|NCT00983918|11599315|FG000|STARTED|Overall Study||20
10789977|NCT03530631|11950406|FG000|NOT COMPLETED|Placebo/Truth||0
10789978|NCT03530631|11950406|FG000|STARTED|Adderall/Deception||4
10789979|NCT03530631|11950406|FG000|COMPLETED|Adderall/Deception||4
10789980|NCT03530631|11950406|FG000|NOT COMPLETED|Adderall/Deception||0
10789981|NCT03530631|11950406|FG000|STARTED|Placebo/Deception||4
10789982|NCT03530631|11950406|FG000|COMPLETED|Placebo/Deception||4
10789983|NCT03530631|11950406|FG000|NOT COMPLETED|Placebo/Deception||0
10789984|NCT03530917|11950424|FG000|STARTED|Overall Study||8
10789985|NCT03530917|11950425|FG001|STARTED|Overall Study||8
10789986|NCT03530917|11950426|FG002|STARTED|Overall Study||8
10789987|NCT03530917|11950427|FG003|STARTED|Overall Study||8
10789988|NCT03530917|11950428|FG004|STARTED|Overall Study||8
10789989|NCT03530917|11950429|FG005|STARTED|Overall Study||6
10789990|NCT03530917|11950430|FG006|STARTED|Overall Study||8
10789991|NCT03530917|11950431|FG007|STARTED|Overall Study||16
10789992|NCT03530917|11950424|FG000|COMPLETED|Overall Study||8
10789993|NCT03530917|11950425|FG001|COMPLETED|Overall Study||8
10789994|NCT03530917|11950426|FG002|COMPLETED|Overall Study||8
10789995|NCT03530917|11950427|FG003|COMPLETED|Overall Study||8
10789996|NCT03530917|11950428|FG004|COMPLETED|Overall Study||8
10789997|NCT03530917|11950429|FG005|COMPLETED|Overall Study||6
10789998|NCT03530917|11950430|FG006|COMPLETED|Overall Study||8
10789999|NCT03530917|11950431|FG007|COMPLETED|Overall Study||16
10790000|NCT03530917|11950424|FG000|NOT COMPLETED|Overall Study||0
10790001|NCT03530917|11950425|FG001|NOT COMPLETED|Overall Study||0
10790002|NCT03530917|11950426|FG002|NOT COMPLETED|Overall Study||0
10451793|NCT00983918|11599316|FG001|STARTED|Overall Study||20
10451794|NCT00983918|11599317|FG002|STARTED|Overall Study||20
10451795|NCT00983918|11599318|FG003|STARTED|Overall Study||20
10451796|NCT00983918|11599315|FG000|COMPLETED|Overall Study||20
10451797|NCT00983918|11599316|FG001|COMPLETED|Overall Study||18
10451798|NCT00983918|11599317|FG002|COMPLETED|Overall Study||18
10451799|NCT00983918|11599318|FG003|COMPLETED|Overall Study||18
10451800|NCT00983918|11599315|FG000|NOT COMPLETED|Overall Study||0
10451801|NCT00983918|11599316|FG001|NOT COMPLETED|Overall Study||2
10451802|NCT00983918|11599317|FG002|NOT COMPLETED|Overall Study||2
10451803|NCT00983918|11599318|FG003|NOT COMPLETED|Overall Study||2
10451804|NCT00983931|11599328|FG000|STARTED|Colchicine Alone||24
10790003|NCT03530917|11950427|FG003|NOT COMPLETED|Overall Study||0
10790004|NCT03530917|11950428|FG004|NOT COMPLETED|Overall Study||0
10790005|NCT03530917|11950429|FG005|NOT COMPLETED|Overall Study||0
10790006|NCT03530917|11950430|FG006|NOT COMPLETED|Overall Study||0
10790007|NCT03530917|11950431|FG007|NOT COMPLETED|Overall Study||0
10790008|NCT03531710|11950461|FG000|STARTED|Overall Study||10
10790009|NCT03531710|11950462|FG001|STARTED|Overall Study||2
10790010|NCT03531710|11950463|FG002|STARTED|Overall Study||7
10451805|NCT00983931|11599328|FG000|COMPLETED|Colchicine Alone||24
10451806|NCT00983931|11599328|FG000|NOT COMPLETED|Colchicine Alone||0
10451807|NCT00983931|11599328|FG000|STARTED|14 Day Washout Period||24
10451808|NCT00983931|11599328|FG000|COMPLETED|14 Day Washout Period|one subject withdrawn due to creatine kinase out of range|23
10451809|NCT00983931|11599328|FG000|NOT COMPLETED|14 Day Washout Period||1
10451810|NCT00983931|11599328|FG000|STARTED|Colchicine With Cyclosporine||23
10451811|NCT00983931|11599328|FG000|COMPLETED|Colchicine With Cyclosporine||23
10451812|NCT00983931|11599328|FG000|NOT COMPLETED|Colchicine With Cyclosporine||0
10451813|NCT00983957|11599334|FG000|STARTED|Overall Study||20
10451814|NCT00983957|11599334|FG000|Treatment A|Overall Study||20
10451815|NCT00983957|11599334|FG000|Treatment B|Overall Study||20
10451816|NCT00983957|11599334|FG000|Treatment C|Overall Study||18
10451817|NCT00983957|11599334|FG000|COMPLETED|Overall Study||18
10451818|NCT00983957|11599334|FG000|NOT COMPLETED|Overall Study||2
10451819|NCT00983983|11599347|FG000|STARTED|Overall Study||8
10451820|NCT00983983|11599348|FG001|STARTED|Overall Study||9
10451821|NCT00983983|11599349|FG002|STARTED|Overall Study||7
10451822|NCT00983983|11599347|FG000|COMPLETED|Overall Study||6
10451823|NCT00983983|11599348|FG001|COMPLETED|Overall Study||8
10451824|NCT00983983|11599349|FG002|COMPLETED|Overall Study||6
10451825|NCT00983983|11599347|FG000|NOT COMPLETED|Overall Study||2
10451826|NCT00983983|11599348|FG001|NOT COMPLETED|Overall Study||1
10451827|NCT00983983|11599349|FG002|NOT COMPLETED|Overall Study||1
10451828|NCT00984009|11599358|FG000|STARTED|Colchicine Alone||22
10451829|NCT00984009|11599358|FG000|COMPLETED|Colchicine Alone||22
10451830|NCT00984009|11599358|FG000|NOT COMPLETED|Colchicine Alone||0
10451831|NCT00984009|11599358|FG000|STARTED|14 Day Washout Period||22
10451832|NCT00984009|11599358|FG000|COMPLETED|14 Day Washout Period||22
10451833|NCT00984009|11599358|FG000|NOT COMPLETED|14 Day Washout Period||0
10451834|NCT00984009|11599358|FG000|STARTED|Grapefruit Juice Alone||22
10451835|NCT00984009|11599358|FG000|COMPLETED|Grapefruit Juice Alone|one subject dropped due to missed a.m. serving of grapefruit juice on Day 16|21
10451836|NCT00984009|11599358|FG000|NOT COMPLETED|Grapefruit Juice Alone||1
10451837|NCT00984009|11599358|FG000|STARTED|Colchicine With Grapefruit Juice||21
10451838|NCT00984009|11599358|FG000|COMPLETED|Colchicine With Grapefruit Juice||21
10451839|NCT00984009|11599358|FG000|NOT COMPLETED|Colchicine With Grapefruit Juice||0
10525808|NCT01378416|11677821|FG000|NOT COMPLETED|Overall Study||0
10525809|NCT01378429|11677827|FG000|STARTED|Overall Study||42
10525810|NCT01378429|11677828|FG001|STARTED|Overall Study||47
10525811|NCT01378429|11677827|FG000|COMPLETED|Overall Study||41
10525812|NCT01378429|11677828|FG001|COMPLETED|Overall Study||47
10525813|NCT01378429|11677827|FG000|NOT COMPLETED|Overall Study||1
10525814|NCT01378429|11677828|FG001|NOT COMPLETED|Overall Study||0
10525815|NCT01378520|11677837|FG000|STARTED|First Intervention (Day 2-3)||10
10525816|NCT01378520|11677838|FG001|STARTED|First Intervention (Day 2-3)||10
10525817|NCT01378520|11677837|FG000|COMPLETED|First Intervention (Day 2-3)||10
10525818|NCT01378520|11677838|FG001|COMPLETED|First Intervention (Day 2-3)||10
10525819|NCT01378520|11677837|FG000|NOT COMPLETED|First Intervention (Day 2-3)||0
10525820|NCT01378520|11677838|FG001|NOT COMPLETED|First Intervention (Day 2-3)||0
10525821|NCT01378520|11677837|FG000|STARTED|Second Intervention (Day 4-6)||10
10525822|NCT01378520|11677838|FG001|STARTED|Second Intervention (Day 4-6)||10
10525823|NCT01378520|11677837|FG000|COMPLETED|Second Intervention (Day 4-6)||10
10525824|NCT01378520|11677838|FG001|COMPLETED|Second Intervention (Day 4-6)||10
10525825|NCT01378520|11677837|FG000|NOT COMPLETED|Second Intervention (Day 4-6)||0
10525826|NCT01378520|11677838|FG001|NOT COMPLETED|Second Intervention (Day 4-6)||0
10525827|NCT01378858|11677846|FG000|STARTED|Overall Study||50
10525828|NCT01378858|11677847|FG001|STARTED|Overall Study||50
10525829|NCT01378858|11677846|FG000|COMPLETED|Overall Study||46
10525830|NCT01378858|11677847|FG001|COMPLETED|Overall Study||46
10525831|NCT01378858|11677846|FG000|NOT COMPLETED|Overall Study||4
10525832|NCT01378858|11677847|FG001|NOT COMPLETED|Overall Study||4
10525833|NCT01378962|11677853|FG000|STARTED|Overall Study||50
10525834|NCT01378962|11677853|FG000|COMPLETED|Overall Study||33
10525835|NCT01378962|11677853|FG000|NOT COMPLETED|Overall Study||17
10525836|NCT01378975|11677859|FG000|STARTED|Overall Study||90
10525837|NCT01378975|11677860|FG001|STARTED|Overall Study||56
10525838|NCT01378975|11677859|FG000|COMPLETED|Overall Study||4
10525839|NCT01378975|11677860|FG001|COMPLETED|Overall Study||6
10790011|NCT03531710|11950464|FG003|STARTED|Overall Study||5
10790012|NCT03531710|11950465|FG004|STARTED|Overall Study||8
10790013|NCT03531710|11950466|FG005|STARTED|Overall Study||2
10790014|NCT03531710|11950461|FG000|COMPLETED|Overall Study||8
10790015|NCT03531710|11950462|FG001|COMPLETED|Overall Study||2
10790016|NCT03531710|11950463|FG002|COMPLETED|Overall Study||7
10790017|NCT03531710|11950464|FG003|COMPLETED|Overall Study||5
10790018|NCT03531710|11950465|FG004|COMPLETED|Overall Study||8
10790019|NCT03531710|11950466|FG005|COMPLETED|Overall Study||2
10790020|NCT03531710|11950461|FG000|NOT COMPLETED|Overall Study||2
10790021|NCT03531710|11950462|FG001|NOT COMPLETED|Overall Study||0
10525840|NCT01378975|11677859|FG000|NOT COMPLETED|Overall Study||86
10525841|NCT01378975|11677860|FG001|NOT COMPLETED|Overall Study||50
10451840|NCT00984022|11599367|FG000|STARTED|Overall Study||43
10451841|NCT00984022|11599368|FG001|STARTED|Overall Study||49
10451842|NCT00984022|11599367|FG000|COMPLETED|Overall Study||33
10451843|NCT00984022|11599368|FG001|COMPLETED|Overall Study||35
10451844|NCT00984022|11599367|FG000|NOT COMPLETED|Overall Study||10
10451845|NCT00984022|11599368|FG001|NOT COMPLETED|Overall Study||14
10451846|NCT00984061|11599374|FG000|STARTED|Colchicine Alone||24
10451847|NCT00984061|11599374|FG000|COMPLETED|Colchicine Alone||24
10451848|NCT00984061|11599374|FG000|NOT COMPLETED|Colchicine Alone||0
10451849|NCT00984061|11599374|FG000|STARTED|21 Day Washout Period||24
10451850|NCT00984061|11599374|FG000|COMPLETED|21 Day Washout Period||24
10451851|NCT00984061|11599374|FG000|NOT COMPLETED|21 Day Washout Period||0
10451852|NCT00984061|11599374|FG000|STARTED|Clarithromycin Alone||24
10451853|NCT00984061|11599374|FG000|COMPLETED|Clarithromycin Alone|One subject was dropped due to noncompliance with outpatient clarithromycin regimen.|23
10451854|NCT00984061|11599374|FG000|NOT COMPLETED|Clarithromycin Alone||1
10451855|NCT00984061|11599374|FG000|STARTED|Colchicine With Clarithromycin||23
10451856|NCT00984061|11599374|FG000|COMPLETED|Colchicine With Clarithromycin||23
10451857|NCT00984061|11599374|FG000|NOT COMPLETED|Colchicine With Clarithromycin||0
10451858|NCT00984126|11599385|FG000|STARTED|Overall Study||27
10451859|NCT00984126|11599386|FG001|STARTED|Overall Study||28
10451860|NCT00984126|11599387|FG002|STARTED|Overall Study||23
10451861|NCT00984126|11599388|FG003|STARTED|Overall Study||135
10451862|NCT00984126|11599385|FG000|COMPLETED|Overall Study||20
10451863|NCT00984126|11599386|FG001|COMPLETED|Overall Study||20
10451864|NCT00984126|11599387|FG002|COMPLETED|Overall Study||16
10451865|NCT00984126|11599388|FG003|COMPLETED|Overall Study||76
10451866|NCT00984126|11599385|FG000|NOT COMPLETED|Overall Study||7
10451867|NCT00984126|11599386|FG001|NOT COMPLETED|Overall Study||8
10451868|NCT00984126|11599387|FG002|NOT COMPLETED|Overall Study||7
10451869|NCT00984126|11599388|FG003|NOT COMPLETED|Overall Study||59
10451870|NCT00984139|11599407|FG000|STARTED|Overall Study||306
10451871|NCT00984139|11599407|FG000|COMPLETED|Overall Study||306
10451872|NCT00984139|11599407|FG000|NOT COMPLETED|Overall Study||0
10451873|NCT00984165|11599415|FG000|STARTED|Overall Study||9
10451874|NCT00984165|11599416|FG001|STARTED|Overall Study||1
10451875|NCT00984165|11599417|FG002|STARTED|Overall Study||4
10451876|NCT00984165|11599418|FG003|STARTED|Overall Study||4
10451877|NCT00984165|11599415|FG000|COMPLETED|Overall Study||2
10451878|NCT00984165|11599416|FG001|COMPLETED|Overall Study||0
10451879|NCT00984165|11599417|FG002|COMPLETED|Overall Study||4
10451880|NCT00984165|11599418|FG003|COMPLETED|Overall Study||0
10451881|NCT00984165|11599415|FG000|NOT COMPLETED|Overall Study||7
10451882|NCT00984165|11599416|FG001|NOT COMPLETED|Overall Study||1
10451883|NCT00984165|11599417|FG002|NOT COMPLETED|Overall Study||0
10451884|NCT00984165|11599418|FG003|NOT COMPLETED|Overall Study||4
10451885|NCT00984204|11599429|FG000|STARTED|Overall Study||188
10451886|NCT00984204|11599429|FG000|COMPLETED|Overall Study|"Seven subjects of the ten Lack of efficacy were acute failures that had no block after 30 min"|173
10451887|NCT00984204|11599429|FG000|NOT COMPLETED|Overall Study||15
10451888|NCT00984256|11599435|FG000|STARTED|Overall Study||6
10451889|NCT00984256|11599436|FG001|STARTED|Overall Study||30
10451890|NCT00984256|11599435|FG000|COMPLETED|Overall Study||6
10451891|NCT00984256|11599436|FG001|COMPLETED|Overall Study||29
10451892|NCT00984256|11599435|FG000|NOT COMPLETED|Overall Study||0
10451893|NCT00984256|11599436|FG001|NOT COMPLETED|Overall Study||1
10451894|NCT00984282|11599453|FG000|STARTED|Double Blind Treatment||207
10451895|NCT00984282|11599454|FG001|STARTED|Double Blind Treatment||210
10451896|NCT00984282|11599453|FG000|Received Treatment|Double Blind Treatment|Subjects at Risk/Safety Population - in RG1 (RG= Reporting Group for Safety Data)|207
10451897|NCT00984282|11599454|FG001|Received Treatment|Double Blind Treatment|Subjects at Risk/Safety Population - in RG2 (RG= Reporting Group for Safety Data)|209
10451898|NCT00984282|11599453|FG000|COMPLETED|Double Blind Treatment||103
10451899|NCT00984282|11599454|FG001|COMPLETED|Double Blind Treatment||172
10451900|NCT00984282|11599453|FG000|NOT COMPLETED|Double Blind Treatment||104
10451901|NCT00984282|11599454|FG001|NOT COMPLETED|Double Blind Treatment||38
10451902|NCT00984282|11599453|FG000|STARTED|Open-label Treatment||86
10451903|NCT00984282|11599454|FG001|STARTED|Open-label Treatment||161
10451904|NCT00984282|11599453|FG000|Received Treatment|Open-label Treatment|Subjects at Risk/Safety Population - in RG3 (RG= Reporting Group for Safety Data)|86
10451905|NCT00984282|11599454|FG001|Received Treatment|Open-label Treatment|Subjects at Risk/Safety Population - in RG4 (RG= Reporting Group for Safety Data)|161
10451906|NCT00984282|11599453|FG000|COMPLETED|Open-label Treatment||0
10451907|NCT00984282|11599454|FG001|COMPLETED|Open-label Treatment||0
10451908|NCT00984282|11599453|FG000|NOT COMPLETED|Open-label Treatment||86
10451909|NCT00984282|11599454|FG001|NOT COMPLETED|Open-label Treatment||161
10451910|NCT00984282|11599453|FG000|STARTED|Long Term Follow-up|Participants entered long-term follow-up if terminated double-blind or open-label periods|72
10451911|NCT00984282|11599454|FG001|STARTED|Long Term Follow-up|Participants entered long-term follow-up if terminated double-blind or open-label periods|124
10451912|NCT00984282|11599453|FG000|COMPLETED|Long Term Follow-up||3
10451913|NCT00984282|11599454|FG001|COMPLETED|Long Term Follow-up||4
10451914|NCT00984282|11599453|FG000|NOT COMPLETED|Long Term Follow-up||69
10451915|NCT00984282|11599454|FG001|NOT COMPLETED|Long Term Follow-up||120
10451916|NCT00984295|11599465|FG000|STARTED|Overall Study|2 patients were incorrectly vaccinated and are excluded from this table.|949
10451917|NCT00984295|11599466|FG001|STARTED|Overall Study||485
10451918|NCT00984295|11599467|FG002|STARTED|Overall Study||479
10451919|NCT00984295|11599465|FG000|Visit 1|Overall Study||949
10451920|NCT00984295|11599466|FG001|Visit 1|Overall Study||485
10451921|NCT00984295|11599467|FG002|Visit 1|Overall Study||479
10451922|NCT00984295|11599465|FG000|Visit 2|Overall Study||909
10451923|NCT00984295|11599466|FG001|Visit 2|Overall Study||468
10451924|NCT00984295|11599467|FG002|Visit 2|Overall Study||453
10451925|NCT00984295|11599465|FG000|COMPLETED|Overall Study||884
10451926|NCT00984295|11599466|FG001|COMPLETED|Overall Study||453
10451927|NCT00984295|11599467|FG002|COMPLETED|Overall Study||442
10451928|NCT00984295|11599465|FG000|NOT COMPLETED|Overall Study||65
10451929|NCT00984295|11599466|FG001|NOT COMPLETED|Overall Study||32
10451930|NCT00984295|11599467|FG002|NOT COMPLETED|Overall Study||37
10451931|NCT00984308|11599477|FG000|STARTED|Overall Study||110
10551454|NCT01536860|11705598|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10551455|NCT01536860|11705599|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
10551456|NCT01536860|11705597|FG000|STARTED|Washout Period (3 Days)||4
10551457|NCT01536860|11705598|FG001|STARTED|Washout Period (3 Days)||4
10551458|NCT01536860|11705599|FG002|STARTED|Washout Period (3 Days)||4
10551459|NCT01536860|11705597|FG000|COMPLETED|Washout Period (3 Days)||3
10551460|NCT01536860|11705598|FG001|COMPLETED|Washout Period (3 Days)||4
10551461|NCT01536860|11705599|FG002|COMPLETED|Washout Period (3 Days)||4
10551462|NCT01536860|11705597|FG000|NOT COMPLETED|Washout Period (3 Days)||1
10551463|NCT01536860|11705598|FG001|NOT COMPLETED|Washout Period (3 Days)||0
10551464|NCT01536860|11705599|FG002|NOT COMPLETED|Washout Period (3 Days)||0
10551465|NCT01536860|11705597|FG000|STARTED|Third Intervention (1 Day)||3
10551466|NCT01536860|11705598|FG001|STARTED|Third Intervention (1 Day)||4
10551467|NCT01536860|11705599|FG002|STARTED|Third Intervention (1 Day)||4
10551468|NCT01536860|11705597|FG000|COMPLETED|Third Intervention (1 Day)||3
10551469|NCT01536860|11705598|FG001|COMPLETED|Third Intervention (1 Day)||4
10551470|NCT01536860|11705599|FG002|COMPLETED|Third Intervention (1 Day)||4
10551471|NCT01536860|11705597|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
10551472|NCT01536860|11705598|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
10551473|NCT01536860|11705599|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
10551474|NCT01536886|11705611|FG000|STARTED|Overall Study||141
10551475|NCT01536886|11705612|FG001|STARTED|Overall Study||135
10551476|NCT01536886|11705613|FG002|STARTED|Overall Study||49
10551477|NCT01536886|11705614|FG003|STARTED|Overall Study||51
10551478|NCT01536886|11705611|FG000|COMPLETED|Overall Study||136
10551479|NCT01536886|11705612|FG001|COMPLETED|Overall Study||127
10551480|NCT01536886|11705613|FG002|COMPLETED|Overall Study||47
10551481|NCT01536886|11705614|FG003|COMPLETED|Overall Study||48
10551482|NCT01536886|11705611|FG000|NOT COMPLETED|Overall Study||5
10551483|NCT01536886|11705612|FG001|NOT COMPLETED|Overall Study||8
10551484|NCT01536886|11705613|FG002|NOT COMPLETED|Overall Study||2
10551485|NCT01536886|11705614|FG003|NOT COMPLETED|Overall Study||3
10551486|NCT01536938|11705627|FG000|STARTED|Overall Study||100
10551487|NCT01536938|11705628|FG001|STARTED|Overall Study||101
10551488|NCT01536938|11705629|FG002|STARTED|Overall Study||101
10551489|NCT01536938|11705627|FG000|COMPLETED|Overall Study||94
10551490|NCT01536938|11705628|FG001|COMPLETED|Overall Study||94
10551491|NCT01536938|11705629|FG002|COMPLETED|Overall Study||93
10551492|NCT01536938|11705627|FG000|NOT COMPLETED|Overall Study||6
10551493|NCT01536938|11705628|FG001|NOT COMPLETED|Overall Study||7
10551494|NCT01536938|11705629|FG002|NOT COMPLETED|Overall Study||8
10551495|NCT01536951|11705639|FG000|STARTED|First Intervention and Washout Period 1||3
10551496|NCT01536951|11705640|FG001|STARTED|First Intervention and Washout Period 1||3
10551497|NCT01536951|11705641|FG002|STARTED|First Intervention and Washout Period 1||3
10551498|NCT01536951|11705642|FG003|STARTED|First Intervention and Washout Period 1||8
10551499|NCT01536951|11705643|FG004|STARTED|First Intervention and Washout Period 1||9
10551500|NCT01536951|11705644|FG005|STARTED|First Intervention and Washout Period 1||9
10551501|NCT01536951|11705645|FG006|STARTED|First Intervention and Washout Period 1||9
10551502|NCT01536951|11705646|FG007|STARTED|First Intervention and Washout Period 1||9
10551503|NCT01536951|11705647|FG008|STARTED|First Intervention and Washout Period 1||9
10551504|NCT01536951|11705639|FG000|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1|Across all reporting groups, study drug is LY3009104, moxifloxacin, or placebo.|3
10551505|NCT01536951|11705640|FG001|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||3
10551506|NCT01536951|11705641|FG002|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||3
10551507|NCT01536951|11705642|FG003|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||8
10551508|NCT01536951|11705643|FG004|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
10551509|NCT01536951|11705644|FG005|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
10551510|NCT01536951|11705645|FG006|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
10551511|NCT01536951|11705646|FG007|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
10551512|NCT01536951|11705647|FG008|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
10551513|NCT01536951|11705639|FG000|COMPLETED|First Intervention and Washout Period 1||3
10551514|NCT01536951|11705640|FG001|COMPLETED|First Intervention and Washout Period 1||3
10551515|NCT01536951|11705641|FG002|COMPLETED|First Intervention and Washout Period 1||2
10551516|NCT01536951|11705642|FG003|COMPLETED|First Intervention and Washout Period 1||8
10551517|NCT01536951|11705643|FG004|COMPLETED|First Intervention and Washout Period 1||9
10551518|NCT01536951|11705644|FG005|COMPLETED|First Intervention and Washout Period 1||9
10551519|NCT01536951|11705645|FG006|COMPLETED|First Intervention and Washout Period 1||9
10551520|NCT01536951|11705646|FG007|COMPLETED|First Intervention and Washout Period 1||9
10451932|NCT00984308|11599478|FG001|STARTED|Overall Study||115
10451933|NCT00984308|11599477|FG000|COMPLETED|Overall Study||92
10451934|NCT00984308|11599478|FG001|COMPLETED|Overall Study||109
10451935|NCT00984308|11599477|FG000|NOT COMPLETED|Overall Study||18
10451936|NCT00984308|11599478|FG001|NOT COMPLETED|Overall Study||6
10451937|NCT00984334|11599489|FG000|STARTED|Overall Study||8
10451938|NCT00984334|11599490|FG001|STARTED|Overall Study||8
10451939|NCT00984334|11599491|FG002|STARTED|Overall Study||8
10451940|NCT00984334|11599492|FG003|STARTED|Overall Study||8
10451941|NCT00984334|11599493|FG004|STARTED|Overall Study||8
10451942|NCT00984334|11599489|FG000|COMPLETED|Overall Study||7
10451943|NCT00984334|11599490|FG001|COMPLETED|Overall Study||7
10451944|NCT00984334|11599491|FG002|COMPLETED|Overall Study||8
10451945|NCT00984334|11599492|FG003|COMPLETED|Overall Study||7
10451946|NCT00984334|11599493|FG004|COMPLETED|Overall Study||7
10451947|NCT00984334|11599489|FG000|NOT COMPLETED|Overall Study||1
10451948|NCT00984334|11599490|FG001|NOT COMPLETED|Overall Study||1
10451949|NCT00984334|11599491|FG002|NOT COMPLETED|Overall Study||0
10451950|NCT00984334|11599492|FG003|NOT COMPLETED|Overall Study||1
10451951|NCT00984334|11599493|FG004|NOT COMPLETED|Overall Study||1
10451952|NCT00984542|11599505|FG000|STARTED|Overall Study||50
10451953|NCT00984542|11599505|FG000|COMPLETED|Overall Study||9
10451954|NCT00984542|11599505|FG000|NOT COMPLETED|Overall Study||41
10451955|NCT00984568|11599512|FG000|STARTED|Overall Study||15
10451956|NCT00984568|11599513|FG001|STARTED|Overall Study||13
10551521|NCT01536951|11705647|FG008|COMPLETED|First Intervention and Washout Period 1||9
10551522|NCT01536951|11705639|FG000|NOT COMPLETED|First Intervention and Washout Period 1||0
10551523|NCT01536951|11705640|FG001|NOT COMPLETED|First Intervention and Washout Period 1||0
10451957|NCT00984568|11599512|FG000|COMPLETED|Overall Study||7
10451958|NCT00984568|11599513|FG001|COMPLETED|Overall Study||7
10451959|NCT00984568|11599512|FG000|NOT COMPLETED|Overall Study||8
10451960|NCT00984568|11599513|FG001|NOT COMPLETED|Overall Study||6
10451961|NCT00984594|11599521|FG000|STARTED|Overall Study||2
10451962|NCT00984594|11599522|FG001|STARTED|Overall Study|One patient withdrew consent and left the study before treatment.|2
10451963|NCT00984594|11599521|FG000|COMPLETED|Overall Study||1
10451964|NCT00984594|11599522|FG001|COMPLETED|Overall Study||1
10451965|NCT00984594|11599521|FG000|NOT COMPLETED|Overall Study||1
10451966|NCT00984594|11599522|FG001|NOT COMPLETED|Overall Study||1
10451967|NCT00984620|11599532|FG000|STARTED|Overall Study||81
10451968|NCT00984620|11599533|FG001|STARTED|Overall Study||79
10451969|NCT00984620|11599532|FG000|COMPLETED|Overall Study||75
10451970|NCT00984620|11599533|FG001|COMPLETED|Overall Study||67
10451971|NCT00984620|11599532|FG000|NOT COMPLETED|Overall Study||6
10451972|NCT00984620|11599533|FG001|NOT COMPLETED|Overall Study||12
10451973|NCT00984659|11599545|FG000|STARTED|2-week Run-in Period||418
10451974|NCT00984659|11599546|FG001|STARTED|2-week Run-in Period||0
10451975|NCT00984659|11599547|FG002|STARTED|2-week Run-in Period||0
10451976|NCT00984659|11599548|FG003|STARTED|2-week Run-in Period||0
10451977|NCT00984659|11599545|FG000|COMPLETED|2-week Run-in Period||366
10451978|NCT00984659|11599546|FG001|COMPLETED|2-week Run-in Period||0
10451979|NCT00984659|11599547|FG002|COMPLETED|2-week Run-in Period||0
10451980|NCT00984659|11599548|FG003|COMPLETED|2-week Run-in Period||0
10451981|NCT00984659|11599545|FG000|NOT COMPLETED|2-week Run-in Period||52
10451982|NCT00984659|11599546|FG001|NOT COMPLETED|2-week Run-in Period||0
10451983|NCT00984659|11599547|FG002|NOT COMPLETED|2-week Run-in Period||0
10451984|NCT00984659|11599548|FG003|NOT COMPLETED|2-week Run-in Period||0
10551524|NCT01536951|11705641|FG002|NOT COMPLETED|First Intervention and Washout Period 1||1
10551525|NCT01536951|11705642|FG003|NOT COMPLETED|First Intervention and Washout Period 1||0
10551526|NCT01536951|11705643|FG004|NOT COMPLETED|First Intervention and Washout Period 1||0
10551527|NCT01536951|11705644|FG005|NOT COMPLETED|First Intervention and Washout Period 1||0
10551528|NCT01536951|11705645|FG006|NOT COMPLETED|First Intervention and Washout Period 1||0
10551529|NCT01536951|11705646|FG007|NOT COMPLETED|First Intervention and Washout Period 1||0
10551530|NCT01536951|11705647|FG008|NOT COMPLETED|First Intervention and Washout Period 1||0
10551531|NCT01536951|11705639|FG000|STARTED|Second Intervention and Washout Period 2||3
10551532|NCT01536951|11705640|FG001|STARTED|Second Intervention and Washout Period 2||3
10551533|NCT01536951|11705641|FG002|STARTED|Second Intervention and Washout Period 2||2
10551534|NCT01536951|11705642|FG003|STARTED|Second Intervention and Washout Period 2||8
10551535|NCT01536951|11705643|FG004|STARTED|Second Intervention and Washout Period 2||9
10551536|NCT01536951|11705644|FG005|STARTED|Second Intervention and Washout Period 2||9
10551537|NCT01536951|11705645|FG006|STARTED|Second Intervention and Washout Period 2||9
10551538|NCT01536951|11705646|FG007|STARTED|Second Intervention and Washout Period 2||9
10551539|NCT01536951|11705647|FG008|STARTED|Second Intervention and Washout Period 2||9
10551540|NCT01536951|11705639|FG000|COMPLETED|Second Intervention and Washout Period 2||3
10551541|NCT01536951|11705640|FG001|COMPLETED|Second Intervention and Washout Period 2||3
10551542|NCT01536951|11705641|FG002|COMPLETED|Second Intervention and Washout Period 2||2
10551543|NCT01536951|11705642|FG003|COMPLETED|Second Intervention and Washout Period 2||8
10551544|NCT01536951|11705643|FG004|COMPLETED|Second Intervention and Washout Period 2||9
10551545|NCT01536951|11705644|FG005|COMPLETED|Second Intervention and Washout Period 2||9
10551546|NCT01536951|11705645|FG006|COMPLETED|Second Intervention and Washout Period 2||9
10551547|NCT01536951|11705646|FG007|COMPLETED|Second Intervention and Washout Period 2||8
10451985|NCT00984659|11599545|FG000|STARTED|6-week Double-blind Treatment Period||0
10451986|NCT00984659|11599546|FG001|STARTED|6-week Double-blind Treatment Period||75
10451987|NCT00984659|11599547|FG002|STARTED|6-week Double-blind Treatment Period||152
10451988|NCT00984659|11599548|FG003|STARTED|6-week Double-blind Treatment Period||139
10451989|NCT00984659|11599545|FG000|COMPLETED|6-week Double-blind Treatment Period||0
10451990|NCT00984659|11599546|FG001|COMPLETED|6-week Double-blind Treatment Period||69
10451991|NCT00984659|11599547|FG002|COMPLETED|6-week Double-blind Treatment Period||141
10451992|NCT00984659|11599548|FG003|COMPLETED|6-week Double-blind Treatment Period||126
10452079|NCT00985166|11599665|FG001|NOT COMPLETED|Overall Study||4
10451993|NCT00984659|11599545|FG000|NOT COMPLETED|6-week Double-blind Treatment Period||0
10451994|NCT00984659|11599546|FG001|NOT COMPLETED|6-week Double-blind Treatment Period||6
10451995|NCT00984659|11599547|FG002|NOT COMPLETED|6-week Double-blind Treatment Period||11
10451996|NCT00984659|11599548|FG003|NOT COMPLETED|6-week Double-blind Treatment Period||13
10451997|NCT00984698|11599557|FG000|STARTED|Overall Study||21
10451998|NCT00984698|11599558|FG001|STARTED|Overall Study||22
10451999|NCT00984698|11599557|FG000|COMPLETED|Overall Study||18
10452000|NCT00984698|11599558|FG001|COMPLETED|Overall Study||14
10452001|NCT00984698|11599557|FG000|NOT COMPLETED|Overall Study||3
10452002|NCT00984698|11599558|FG001|NOT COMPLETED|Overall Study||8
10452003|NCT00984815|11599564|FG000|STARTED|Overall Study||86
10452004|NCT00984815|11599564|FG000|COMPLETED|Overall Study||56
10452005|NCT00984815|11599564|FG000|NOT COMPLETED|Overall Study||30
10452006|NCT00984867|11599570|FG000|STARTED|Overall Study|Of the 226 randomized and treated participants only 224 were included in the full analysis set.|226
10452007|NCT00984867|11599571|FG001|STARTED|Overall Study|Of the 225 randomized and treated participants only 223 were included in the full analysis set.|225
10452008|NCT00984867|11599570|FG000|COMPLETED|Overall Study||203
10452009|NCT00984867|11599571|FG001|COMPLETED|Overall Study||208
10452010|NCT00984867|11599570|FG000|NOT COMPLETED|Overall Study||23
10452011|NCT00984867|11599571|FG001|NOT COMPLETED|Overall Study||17
10452012|NCT00985010|11599581|FG000|STARTED|Overall Study||4
10452013|NCT00985010|11599582|FG001|STARTED|Overall Study||5
10452014|NCT00985010|11599581|FG000|COMPLETED|Overall Study||4
10452015|NCT00985010|11599582|FG001|COMPLETED|Overall Study||5
10452016|NCT00985010|11599581|FG000|NOT COMPLETED|Overall Study||0
10452017|NCT00985010|11599582|FG001|NOT COMPLETED|Overall Study||0
10452018|NCT00985088|11599596|FG000|STARTED|Overall Study||222
10452019|NCT00985088|11599597|FG001|STARTED|Overall Study||114
10452020|NCT00985088|11599598|FG002|STARTED|Overall Study||112
10452021|NCT00985088|11599599|FG003|STARTED|Overall Study||221
10452022|NCT00985088|11599600|FG004|STARTED|Overall Study||223
10452023|NCT00985088|11599601|FG005|STARTED|Overall Study||115
10452024|NCT00985088|11599602|FG006|STARTED|Overall Study||111
10452025|NCT00985088|11599603|FG007|STARTED|Overall Study||222
10452026|NCT00985088|11599596|FG000|COMPLETED|Overall Study||211
10452027|NCT00985088|11599597|FG001|COMPLETED|Overall Study||112
10452028|NCT00985088|11599598|FG002|COMPLETED|Overall Study||108
10452029|NCT00985088|11599599|FG003|COMPLETED|Overall Study||214
10452030|NCT00985088|11599600|FG004|COMPLETED|Overall Study||214
10452031|NCT00985088|11599601|FG005|COMPLETED|Overall Study||108
10452032|NCT00985088|11599602|FG006|COMPLETED|Overall Study||107
10452033|NCT00985088|11599603|FG007|COMPLETED|Overall Study||216
10452034|NCT00985088|11599596|FG000|NOT COMPLETED|Overall Study||11
10452035|NCT00985088|11599597|FG001|NOT COMPLETED|Overall Study||2
10452036|NCT00985088|11599598|FG002|NOT COMPLETED|Overall Study||4
10452037|NCT00985088|11599599|FG003|NOT COMPLETED|Overall Study||7
10452038|NCT00985088|11599600|FG004|NOT COMPLETED|Overall Study||9
10452039|NCT00985088|11599601|FG005|NOT COMPLETED|Overall Study||7
10452040|NCT00985088|11599602|FG006|NOT COMPLETED|Overall Study||4
10452041|NCT00985088|11599603|FG007|NOT COMPLETED|Overall Study||6
10452042|NCT00985114|11599633|FG000|STARTED|Overall Study|38 randomized, 34 received the device|34
10452043|NCT00985114|11599634|FG001|STARTED|Overall Study||39
10452044|NCT00985114|11599633|FG000|Diet + Lifestyle Counseling Cross-over|Overall Study||0
10452045|NCT00985114|11599634|FG001|Diet + Lifestyle Counseling Cross-over|Overall Study|Received device for intended period of 12 months with 6 months follow up|28
10452046|NCT00985114|11599633|FG000|COMPLETED|Overall Study||33
10452047|NCT00985114|11599634|FG001|COMPLETED|Overall Study||37
10452048|NCT00985114|11599633|FG000|NOT COMPLETED|Overall Study||1
10452049|NCT00985114|11599634|FG001|NOT COMPLETED|Overall Study||2
10452050|NCT00985140|11599640|FG000|STARTED|Overall Study||15
10452051|NCT00985140|11599640|FG000|COMPLETED|Overall Study||15
10452052|NCT00985140|11599640|FG000|NOT COMPLETED|Overall Study||0
10452053|NCT00985153|11599648|FG000|STARTED|Overall Study||985
10452054|NCT00985153|11599649|FG001|STARTED|Overall Study||968
10452055|NCT00985153|11599650|FG002|STARTED|Overall Study||962
10452056|NCT00985153|11599651|FG003|STARTED|Overall Study||1012
10452057|NCT00985153|11599648|FG000|Vaccinated at Visit 1|Overall Study||985
10452058|NCT00985153|11599649|FG001|Vaccinated at Visit 1|Overall Study||968
10452059|NCT00985153|11599650|FG002|Vaccinated at Visit 1|Overall Study||962
10452060|NCT00985153|11599651|FG003|Vaccinated at Visit 1|Overall Study||1012
10452061|NCT00985153|11599648|FG000|COMPLETED|Overall Study||950
10452062|NCT00985153|11599649|FG001|COMPLETED|Overall Study||924
10452063|NCT00985153|11599650|FG002|COMPLETED|Overall Study||918
10452064|NCT00985153|11599651|FG003|COMPLETED|Overall Study||965
10452065|NCT00985153|11599648|FG000|NOT COMPLETED|Overall Study||35
10452066|NCT00985153|11599649|FG001|NOT COMPLETED|Overall Study||44
10452067|NCT00985153|11599650|FG002|NOT COMPLETED|Overall Study||44
10452068|NCT00985153|11599651|FG003|NOT COMPLETED|Overall Study||47
10452069|NCT00985166|11599664|FG000|STARTED|Overall Study|Two randomized subjects withdrew consent before vaccination: no demographic information available.|401
10452070|NCT00985166|11599665|FG001|STARTED|Overall Study||205
10452071|NCT00985166|11599666|FG002|STARTED|Overall Study||195
10452072|NCT00985166|11599664|FG000|Vaccinated at Visit 1|Overall Study||399
10452073|NCT00985166|11599665|FG001|Vaccinated at Visit 1|Overall Study||205
10452074|NCT00985166|11599666|FG002|Vaccinated at Visit 1|Overall Study||195
10452075|NCT00985166|11599664|FG000|COMPLETED|Overall Study||392
10452076|NCT00985166|11599665|FG001|COMPLETED|Overall Study||201
10452077|NCT00985166|11599666|FG002|COMPLETED|Overall Study||188
10452078|NCT00985166|11599664|FG000|NOT COMPLETED|Overall Study||9
10452080|NCT00985166|11599666|FG002|NOT COMPLETED|Overall Study||7
10452081|NCT00985192|11599676|FG000|STARTED|Overall Study||49
10452082|NCT00985192|11599676|FG000|COMPLETED|Overall Study||45
10452083|NCT00985192|11599676|FG000|NOT COMPLETED|Overall Study||4
10452084|NCT00985231|11599682|FG000|STARTED|Overall Study||133
10452085|NCT00985231|11599683|FG001|STARTED|Overall Study||132
10452086|NCT00985231|11599682|FG000|COMPLETED|Overall Study||130
10452087|NCT00985231|11599683|FG001|COMPLETED|Overall Study||129
10452088|NCT00985231|11599682|FG000|NOT COMPLETED|Overall Study||3
10452089|NCT00985231|11599683|FG001|NOT COMPLETED|Overall Study||3
10452090|NCT00985257|11599689|FG000|STARTED|Overall Study||123
10452091|NCT00985257|11599689|FG000|COMPLETED|Overall Study||123
10452092|NCT00985257|11599689|FG000|NOT COMPLETED|Overall Study||0
10452093|NCT00985426|11599695|FG000|STARTED|Overall Study||258
10452094|NCT00985426|11599696|FG001|STARTED|Overall Study||263
10452095|NCT00985426|11599695|FG000|COMPLETED|Overall Study||215
10452096|NCT00985426|11599696|FG001|COMPLETED|Overall Study||219
10452097|NCT00985426|11599695|FG000|NOT COMPLETED|Overall Study||43
10452098|NCT00985426|11599696|FG001|NOT COMPLETED|Overall Study||44
10452099|NCT00985439|11599706|FG000|STARTED|Overall Study||49
10452100|NCT00985439|11599707|FG001|STARTED|Overall Study||51
10452101|NCT00985439|11599708|FG002|STARTED|Overall Study||51
10452102|NCT00985439|11599709|FG003|STARTED|Overall Study||51
10452103|NCT00985439|11599706|FG000|COMPLETED|Overall Study||49
10452104|NCT00985439|11599707|FG001|COMPLETED|Overall Study||51
10452105|NCT00985439|11599708|FG002|COMPLETED|Overall Study||50
10452106|NCT00985439|11599709|FG003|COMPLETED|Overall Study||51
10452107|NCT00985439|11599706|FG000|NOT COMPLETED|Overall Study||0
10452108|NCT00985439|11599707|FG001|NOT COMPLETED|Overall Study||0
10452109|NCT00985439|11599708|FG002|NOT COMPLETED|Overall Study||1
10452110|NCT00985439|11599709|FG003|NOT COMPLETED|Overall Study||0
10452111|NCT00985465|11599721|FG000|STARTED|Overall Study||141
10452112|NCT00985465|11599722|FG001|STARTED|Overall Study||69
10452113|NCT00985465|11599721|FG000|COMPLETED|Overall Study||140
10452114|NCT00985465|11599722|FG001|COMPLETED|Overall Study||66
10452115|NCT00985465|11599721|FG000|NOT COMPLETED|Overall Study||1
10452116|NCT00985465|11599722|FG001|NOT COMPLETED|Overall Study||3
10452117|NCT00985491|11599729|FG000|STARTED|Overall Study|46 subjects underwent an attempted implantation procedure|46
10452118|NCT00985491|11599729|FG000|Received Device|Overall Study||43
10452119|NCT00985491|11599729|FG000|COMPLETED|Overall Study|43 subjects received a device, 27 subjects completed 12 month implant period|27
10452120|NCT00985491|11599729|FG000|NOT COMPLETED|Overall Study||19
10452121|NCT00985504|11599736|FG000|STARTED|Acute Treatment Period||244
10452122|NCT00985504|11599737|FG001|STARTED|Acute Treatment Period||239
10452123|NCT00985504|11599736|FG000|COMPLETED|Acute Treatment Period||229
10452124|NCT00985504|11599737|FG001|COMPLETED|Acute Treatment Period||227
10452125|NCT00985504|11599736|FG000|NOT COMPLETED|Acute Treatment Period||15
10452126|NCT00985504|11599737|FG001|NOT COMPLETED|Acute Treatment Period||12
10452127|NCT00985504|11599736|FG000|STARTED|Optimization Period||229
10452128|NCT00985504|11599737|FG001|STARTED|Optimization Period||227
10452129|NCT00985504|11599736|FG000|COMPLETED|Optimization Period||203
10452130|NCT00985504|11599737|FG001|COMPLETED|Optimization Period||204
10452131|NCT00985504|11599736|FG000|NOT COMPLETED|Optimization Period||26
10452132|NCT00985504|11599737|FG001|NOT COMPLETED|Optimization Period||23
10452133|NCT00985517|11599747|FG000|STARTED|Overall Study||3
10452134|NCT00985517|11599748|FG001|STARTED|Overall Study||3
10452135|NCT00985517|11599749|FG002|STARTED|Overall Study||24
10452136|NCT00985517|11599750|FG003|STARTED|Overall Study||27
10452137|NCT00985517|11599747|FG000|COMPLETED|Overall Study||3
10452138|NCT00985517|11599748|FG001|COMPLETED|Overall Study||3
10452139|NCT00985517|11599749|FG002|COMPLETED|Overall Study||23
10452140|NCT00985517|11599750|FG003|COMPLETED|Overall Study||24
10452141|NCT00985517|11599747|FG000|NOT COMPLETED|Overall Study||0
10452142|NCT00985517|11599748|FG001|NOT COMPLETED|Overall Study||0
10452143|NCT00985517|11599749|FG002|NOT COMPLETED|Overall Study||1
10452144|NCT00985517|11599750|FG003|NOT COMPLETED|Overall Study||3
10452145|NCT00985543|11599761|FG000|STARTED|Overall Study||22
10452146|NCT00985543|11599761|FG000|COMPLETED|Overall Study||22
10452147|NCT00985543|11599761|FG000|NOT COMPLETED|Overall Study||0
10452148|NCT00985621|11599771|FG000|STARTED|Overall Study||142
10452149|NCT00985621|11599772|FG001|STARTED|Overall Study||161
10452150|NCT00985621|11599773|FG002|STARTED|Overall Study||152
10452151|NCT00985621|11599774|FG003|STARTED|Overall Study||159
10452152|NCT00985621|11599771|FG000|Treated|Overall Study||141
10452153|NCT00985621|11599772|FG001|Treated|Overall Study||161
10452154|NCT00985621|11599773|FG002|Treated|Overall Study||150
10452155|NCT00985621|11599774|FG003|Treated|Overall Study||158
10452156|NCT00985621|11599771|FG000|COMPLETED|Overall Study||28
10452157|NCT00985621|11599772|FG001|COMPLETED|Overall Study||30
10452158|NCT00985621|11599773|FG002|COMPLETED|Overall Study||29
10452159|NCT00985621|11599774|FG003|COMPLETED|Overall Study||22
10452160|NCT00985621|11599771|FG000|NOT COMPLETED|Overall Study||114
10452161|NCT00985621|11599772|FG001|NOT COMPLETED|Overall Study||131
10452162|NCT00985621|11599773|FG002|NOT COMPLETED|Overall Study||123
10452163|NCT00985621|11599774|FG003|NOT COMPLETED|Overall Study||137
10452164|NCT00985673|11599792|FG000|STARTED|Overall Study||102
10452165|NCT00985673|11599793|FG001|STARTED|Overall Study||104
10452166|NCT00985673|11599794|FG002|STARTED|Overall Study||102
10452167|NCT00985673|11599795|FG003|STARTED|Overall Study||100
10452168|NCT00985673|11599796|FG004|STARTED|Overall Study||101
10452169|NCT00985673|11599797|FG005|STARTED|Overall Study||102
10452170|NCT00985673|11599792|FG000|COMPLETED|Overall Study||95
10452171|NCT00985673|11599793|FG001|COMPLETED|Overall Study||93
10452172|NCT00985673|11599794|FG002|COMPLETED|Overall Study||90
10452173|NCT00985673|11599795|FG003|COMPLETED|Overall Study||88
10452174|NCT00985673|11599796|FG004|COMPLETED|Overall Study||93
10452175|NCT00985673|11599797|FG005|COMPLETED|Overall Study||96
10452176|NCT00985673|11599792|FG000|NOT COMPLETED|Overall Study||7
10452177|NCT00985673|11599793|FG001|NOT COMPLETED|Overall Study||11
10452178|NCT00985673|11599794|FG002|NOT COMPLETED|Overall Study||12
10452179|NCT00985673|11599795|FG003|NOT COMPLETED|Overall Study||12
10452180|NCT00985673|11599796|FG004|NOT COMPLETED|Overall Study||8
10452181|NCT00985673|11599797|FG005|NOT COMPLETED|Overall Study||6
10452182|NCT00985686|11599816|FG000|STARTED|Overall Study||18
10452183|NCT00985686|11599817|FG001|STARTED|Overall Study||16
10452184|NCT00985686|11599818|FG002|STARTED|Overall Study||13
10452185|NCT00985686|11599819|FG003|STARTED|Overall Study||16
10452186|NCT00985686|11599816|FG000|Visit 1: Baseline Data Collection|Overall Study||18
10452187|NCT00985686|11599817|FG001|Visit 1: Baseline Data Collection|Overall Study||15
10452188|NCT00985686|11599818|FG002|Visit 1: Baseline Data Collection|Overall Study||13
10452189|NCT00985686|11599819|FG003|Visit 1: Baseline Data Collection|Overall Study||16
10452190|NCT00985686|11599816|FG000|Visit 2: Data Collection at 8 Weeks|Overall Study||18
10452191|NCT00985686|11599817|FG001|Visit 2: Data Collection at 8 Weeks|Overall Study||15
10452192|NCT00985686|11599818|FG002|Visit 2: Data Collection at 8 Weeks|Overall Study||13
10452193|NCT00985686|11599819|FG003|Visit 2: Data Collection at 8 Weeks|Overall Study||16
10452194|NCT00985686|11599816|FG000|Visit 3: Data Collection at 16 Weeks|Overall Study||17
10452195|NCT00985686|11599817|FG001|Visit 3: Data Collection at 16 Weeks|Overall Study||15
10452196|NCT00985686|11599818|FG002|Visit 3: Data Collection at 16 Weeks|Overall Study||13
10452197|NCT00985686|11599819|FG003|Visit 3: Data Collection at 16 Weeks|Overall Study||16
10452198|NCT00985686|11599816|FG000|Visit 4: Data Collection at 24 Weeks|Overall Study||17
10452199|NCT00985686|11599817|FG001|Visit 4: Data Collection at 24 Weeks|Overall Study||15
10452200|NCT00985686|11599818|FG002|Visit 4: Data Collection at 24 Weeks|Overall Study||13
10452201|NCT00985686|11599819|FG003|Visit 4: Data Collection at 24 Weeks|Overall Study||14
10452202|NCT00985686|11599816|FG000|COMPLETED|Overall Study||17
10452203|NCT00985686|11599817|FG001|COMPLETED|Overall Study||15
10452204|NCT00985686|11599818|FG002|COMPLETED|Overall Study||13
10452205|NCT00985686|11599819|FG003|COMPLETED|Overall Study||14
10452206|NCT00985686|11599816|FG000|NOT COMPLETED|Overall Study||1
10452207|NCT00985686|11599817|FG001|NOT COMPLETED|Overall Study||1
10452208|NCT00985686|11599818|FG002|NOT COMPLETED|Overall Study||0
10452209|NCT00985686|11599819|FG003|NOT COMPLETED|Overall Study||2
10452210|NCT00985712|11599829|FG000|STARTED|Overall Study||133
10452211|NCT00985712|11599830|FG001|STARTED|Overall Study||130
10452212|NCT00985712|11599829|FG000|Received at Least One Dose of Study Drug|Overall Study||131
10452213|NCT00985712|11599830|FG001|Received at Least One Dose of Study Drug|Overall Study||130
10452214|NCT00985712|11599829|FG000|Full Analysis Set (FAS)|Overall Study|Participants completed baseline and had at least 1 post-baseline measurement for efficacy analysis.|128
10452215|NCT00985712|11599830|FG001|Full Analysis Set (FAS)|Overall Study|Participants completed baseline and had at least 1 post-baseline measurement for efficacy analysis.|129
10452216|NCT00985712|11599829|FG000|COMPLETED|Overall Study||127
10452217|NCT00985712|11599830|FG001|COMPLETED|Overall Study||123
10452218|NCT00985712|11599829|FG000|NOT COMPLETED|Overall Study||6
10452219|NCT00985712|11599830|FG001|NOT COMPLETED|Overall Study||7
10452220|NCT00985725|11599838|FG000|STARTED|Overall Study||71
10452221|NCT00985725|11599839|FG001|STARTED|Overall Study||72
10452222|NCT00985725|11599838|FG000|COMPLETED|Overall Study||60
10452223|NCT00985725|11599839|FG001|COMPLETED|Overall Study||59
10452224|NCT00985725|11599838|FG000|NOT COMPLETED|Overall Study||11
10452225|NCT00985725|11599839|FG001|NOT COMPLETED|Overall Study||13
10452226|NCT00985751|11599850|FG000|STARTED|Overall Study||51
10452227|NCT00985751|11599851|FG001|STARTED|Overall Study||52
10452228|NCT00985751|11599852|FG002|STARTED|Overall Study||52
10452229|NCT00985751|11599853|FG003|STARTED|Overall Study||51
10452230|NCT00985751|11599854|FG004|STARTED|Overall Study||51
10452231|NCT00985751|11599850|FG000|COMPLETED|Overall Study||51
10452232|NCT00985751|11599851|FG001|COMPLETED|Overall Study||52
10452233|NCT00985751|11599852|FG002|COMPLETED|Overall Study||52
10452234|NCT00985751|11599853|FG003|COMPLETED|Overall Study||51
10452235|NCT00985751|11599854|FG004|COMPLETED|Overall Study||50
10452236|NCT00985751|11599850|FG000|NOT COMPLETED|Overall Study||0
10452237|NCT00985751|11599851|FG001|NOT COMPLETED|Overall Study||0
10452238|NCT00985751|11599852|FG002|NOT COMPLETED|Overall Study||0
10452239|NCT00985751|11599853|FG003|NOT COMPLETED|Overall Study||0
10452240|NCT00985751|11599854|FG004|NOT COMPLETED|Overall Study||1
10452241|NCT00985790|11599871|FG000|STARTED|Overall Study|95 were primed and 203 were unprimed subjects.|298
10452242|NCT00985790|11599872|FG001|STARTED|Overall Study|97 were primed and 204 were unprimed subjects.|301
10452243|NCT00985790|11599871|FG000|COMPLETED|Overall Study||291
10452244|NCT00985790|11599872|FG001|COMPLETED|Overall Study||293
10452245|NCT00985790|11599871|FG000|NOT COMPLETED|Overall Study||7
10452246|NCT00985790|11599872|FG001|NOT COMPLETED|Overall Study||8
10452247|NCT00985829|11599883|FG000|STARTED|Overall Study||28
10452248|NCT00985829|11599883|FG000|COMPLETED|Overall Study||28
10452249|NCT00985829|11599883|FG000|NOT COMPLETED|Overall Study||0
10452250|NCT00985907|11599888|FG000|STARTED|Overall Study||13
10452251|NCT00985907|11599888|FG000|COMPLETED|Overall Study||0
10452252|NCT00985907|11599888|FG000|NOT COMPLETED|Overall Study||13
10452253|NCT00985946|11599892|FG000|STARTED|Overall Study|Eighty-seven percent (n=13) were evaluable for response.|15
10452254|NCT00985946|11599892|FG000|COMPLETED|Overall Study||8
10452255|NCT00985946|11599892|FG000|NOT COMPLETED|Overall Study||7
10452256|NCT00985959|11599899|FG000|STARTED|Overall Study|Number of participants treated|6
10452257|NCT00985959|11599900|FG001|STARTED|Overall Study|Number of participants treated|6
10452258|NCT00985959|11599901|FG002|STARTED|Overall Study|Number of participants treated|87
10452259|NCT00985959|11599899|FG000|COMPLETED|Overall Study|Completed all 9 cycles|3
10452260|NCT00985959|11599900|FG001|COMPLETED|Overall Study|Completed all 9 cycles|3
10452261|NCT00985959|11599901|FG002|COMPLETED|Overall Study||28
10452262|NCT00985959|11599899|FG000|NOT COMPLETED|Overall Study||3
10452263|NCT00985959|11599900|FG001|NOT COMPLETED|Overall Study||3
10452264|NCT00985959|11599901|FG002|NOT COMPLETED|Overall Study||59
10452265|NCT00985985|11599919|FG000|STARTED|Overall Study||241
10452266|NCT00985985|11599920|FG001|STARTED|Overall Study||242
10452267|NCT00985985|11599921|FG002|STARTED|Overall Study||120
10452268|NCT00985985|11599922|FG003|STARTED|Overall Study||120
10452269|NCT00985985|11599919|FG000|Safety Population|Overall Study||241
10452270|NCT00985985|11599920|FG001|Safety Population|Overall Study||242
10452271|NCT00985985|11599921|FG002|Safety Population|Overall Study||119
10452272|NCT00985985|11599922|FG003|Safety Population|Overall Study||118
10452273|NCT00985985|11599919|FG000|Full Analysis Set (FAS) Population|Overall Study||241
10452274|NCT00985985|11599920|FG001|Full Analysis Set (FAS) Population|Overall Study||242
10452275|NCT00985985|11599921|FG002|Full Analysis Set (FAS) Population|Overall Study||120
10452276|NCT00985985|11599922|FG003|Full Analysis Set (FAS) Population|Overall Study|One participant withdrew consent and was not included as the FAS population.|119
10452277|NCT00985985|11599919|FG000|COMPLETED|Overall Study||217
10452278|NCT00985985|11599920|FG001|COMPLETED|Overall Study||218
10452279|NCT00985985|11599921|FG002|COMPLETED|Overall Study||109
10452280|NCT00985985|11599922|FG003|COMPLETED|Overall Study||107
10452281|NCT00985985|11599919|FG000|NOT COMPLETED|Overall Study||24
10452282|NCT00985985|11599920|FG001|NOT COMPLETED|Overall Study||24
10452283|NCT00985985|11599921|FG002|NOT COMPLETED|Overall Study||11
10452284|NCT00985985|11599922|FG003|NOT COMPLETED|Overall Study||13
10452285|NCT00986102|11599941|FG000|STARTED|Overall Study|Number of participants who received study medication|53
10452286|NCT00986102|11599942|FG001|STARTED|Overall Study|Number of participants who received study medication|77
10452287|NCT00986102|11599943|FG002|STARTED|Overall Study|Number of participants who received study medication|19
10452288|NCT00986102|11599944|FG003|STARTED|Overall Study|Number of participants who received study medication|67
10452289|NCT00986102|11599941|FG000|COMPLETED|Overall Study||52
10452290|NCT00986102|11599942|FG001|COMPLETED|Overall Study||75
10452291|NCT00986102|11599943|FG002|COMPLETED|Overall Study||19
10452292|NCT00986102|11599944|FG003|COMPLETED|Overall Study||66
10452293|NCT00986102|11599941|FG000|NOT COMPLETED|Overall Study||1
10452294|NCT00986102|11599942|FG001|NOT COMPLETED|Overall Study||2
10452295|NCT00986102|11599943|FG002|NOT COMPLETED|Overall Study||0
10452296|NCT00986102|11599944|FG003|NOT COMPLETED|Overall Study||1
10452297|NCT00986154|11599956|FG000|STARTED|Overall Study||4143
10452298|NCT00986154|11599957|FG001|STARTED|Overall Study||4149
10452299|NCT00986154|11599956|FG000|Safety Analysis Set (Received Drug)|Overall Study||4118
10452300|NCT00986154|11599957|FG001|Safety Analysis Set (Received Drug)|Overall Study||4122
10452301|NCT00986154|11599956|FG000|COMPLETED|Overall Study||3937
10452302|NCT00986154|11599957|FG001|COMPLETED|Overall Study||3955
10452303|NCT00986154|11599956|FG000|NOT COMPLETED|Overall Study||206
10452304|NCT00986154|11599957|FG001|NOT COMPLETED|Overall Study||194
10452305|NCT00986180|11599965|FG000|STARTED|Overall Study||321
10452306|NCT00986180|11599966|FG001|STARTED|Overall Study||324
10452307|NCT00986180|11599965|FG000|COMPLETED|Overall Study||277
10452308|NCT00986180|11599966|FG001|COMPLETED|Overall Study||268
10452309|NCT00986180|11599965|FG000|NOT COMPLETED|Overall Study||44
10452310|NCT00986180|11599966|FG001|NOT COMPLETED|Overall Study||56
10452311|NCT00986232|11599976|FG000|STARTED|Overall Study||387
10452312|NCT00986232|11599977|FG001|STARTED|Overall Study|Excludes 1 patient who was randomized to receive ProQuad (Middle Dose), but was not vaccinated.|393
10452313|NCT00986232|11599978|FG002|STARTED|Overall Study||381
10452314|NCT00986232|11599979|FG003|STARTED|Overall Study|Excludes 1 patient who was randomized to receive M-M-R™ II + PUVV, but was not vaccinated.|390
10452315|NCT00986232|11599976|FG000|Vaccination Visit 1|Overall Study||387
10452316|NCT00986232|11599977|FG001|Vaccination Visit 1|Overall Study||393
10452317|NCT00986232|11599978|FG002|Vaccination Visit 1|Overall Study||381
10452318|NCT00986232|11599979|FG003|Vaccination Visit 1|Overall Study||390
10452319|NCT00986232|11599976|FG000|Vaccination Visit 2|Overall Study||360
10452320|NCT00986232|11599977|FG001|Vaccination Visit 2|Overall Study||365
10452321|NCT00986232|11599978|FG002|Vaccination Visit 2|Overall Study||360
10452322|NCT00986232|11599979|FG003|Vaccination Visit 2|Overall Study||0
10452323|NCT00986232|11599976|FG000|COMPLETED|Overall Study||336
10452324|NCT00986232|11599977|FG001|COMPLETED|Overall Study||343
10452325|NCT00986232|11599978|FG002|COMPLETED|Overall Study||346
10452326|NCT00986232|11599979|FG003|COMPLETED|Overall Study||370
10452327|NCT00986232|11599976|FG000|NOT COMPLETED|Overall Study||51
10452328|NCT00986232|11599977|FG001|NOT COMPLETED|Overall Study||50
10452329|NCT00986232|11599978|FG002|NOT COMPLETED|Overall Study||35
10452330|NCT00986232|11599979|FG003|NOT COMPLETED|Overall Study||20
10452331|NCT00986245|11599995|FG000|STARTED|First Intervention||41
10452332|NCT00986245|11599996|FG001|STARTED|First Intervention||41
10452333|NCT00986245|11599995|FG000|COMPLETED|First Intervention||31
10452334|NCT00986245|11599996|FG001|COMPLETED|First Intervention||33
10452335|NCT00986245|11599995|FG000|NOT COMPLETED|First Intervention||10
10452336|NCT00986245|11599996|FG001|NOT COMPLETED|First Intervention||8
10452337|NCT00986245|11599995|FG000|STARTED|Second Intervention||31
10452338|NCT00986245|11599996|FG001|STARTED|Second Intervention||33
10452339|NCT00986245|11599995|FG000|COMPLETED|Second Intervention||29
10452340|NCT00986245|11599996|FG001|COMPLETED|Second Intervention||32
10452341|NCT00986245|11599995|FG000|NOT COMPLETED|Second Intervention||2
10452342|NCT00986245|11599996|FG001|NOT COMPLETED|Second Intervention||1
10452343|NCT00986258|11600007|FG000|STARTED|Observation Period||136
10452344|NCT00986258|11600007|FG000|COMPLETED|Observation Period||125
10452345|NCT00986258|11600007|FG000|NOT COMPLETED|Observation Period||11
10452346|NCT00986258|11600007|FG000|STARTED|Titration and Optimal Dose Period||125
10452347|NCT00986258|11600007|FG000|COMPLETED|Titration and Optimal Dose Period||102
10452348|NCT00986258|11600007|FG000|NOT COMPLETED|Titration and Optimal Dose Period||23
10452349|NCT00986258|11600007|FG000|STARTED|Maintenance Period||102
10452350|NCT00986258|11600007|FG000|COMPLETED|Maintenance Period||93
10452351|NCT00986258|11600007|FG000|NOT COMPLETED|Maintenance Period||9
10452352|NCT00986349|11600021|FG000|STARTED|Overall Study|attempted implant procedures|23
10452353|NCT00986349|11600021|FG000|Successful Implant Procedure|Overall Study|successful device implant procedure|20
10452354|NCT00986349|11600021|FG000|Early Explant|Overall Study||4
10452355|NCT00986349|11600021|FG000|COMPLETED|Overall Study||16
10452356|NCT00986349|11600021|FG000|NOT COMPLETED|Overall Study||7
10452357|NCT00986362|11600036|FG000|STARTED|Overall Study|16 eyes randomized and treated (in 15 subjects).|16
10452358|NCT00986362|11600037|FG001|STARTED|Overall Study|8 eyes randomized and treated (in 8 subjects).|8
10452359|NCT00986362|11600036|FG000|COMPLETED|Overall Study|14 eyes completed the study (in 14 subjects).|14
10452360|NCT00986362|11600037|FG001|COMPLETED|Overall Study|7 eyes completed the study (in 7 subjects).|7
10452361|NCT00986362|11600036|FG000|NOT COMPLETED|Overall Study||2
10452362|NCT00986362|11600037|FG001|NOT COMPLETED|Overall Study||1
10452363|NCT00986401|11600045|FG000|STARTED|Period 1||22
10452364|NCT00986401|11600046|FG001|STARTED|Period 1||22
10452365|NCT00986401|11600045|FG000|COMPLETED|Period 1||22
10452366|NCT00986401|11600046|FG001|COMPLETED|Period 1||21
10452367|NCT00986401|11600045|FG000|NOT COMPLETED|Period 1||0
10452368|NCT00986401|11600046|FG001|NOT COMPLETED|Period 1||1
10452369|NCT00986401|11600045|FG000|STARTED|Period 2||22
10452370|NCT00986401|11600046|FG001|STARTED|Period 2||21
10452371|NCT00986401|11600045|FG000|COMPLETED|Period 2||22
10452372|NCT00986401|11600046|FG001|COMPLETED|Period 2||21
10452373|NCT00986401|11600045|FG000|NOT COMPLETED|Period 2||0
10452374|NCT00986401|11600046|FG001|NOT COMPLETED|Period 2||0
10452375|NCT00986427|11600057|FG000|STARTED|Overall Study||12
10452376|NCT00986427|11600058|FG001|STARTED|Overall Study||12
10452377|NCT00986427|11600057|FG000|COMPLETED|Overall Study||8
10452378|NCT00986427|11600058|FG001|COMPLETED|Overall Study||12
10452379|NCT00986427|11600057|FG000|NOT COMPLETED|Overall Study||4
10452380|NCT00986427|11600058|FG001|NOT COMPLETED|Overall Study||0
10452381|NCT00986440|11600070|FG000|STARTED|Overall Study||41
10452382|NCT00986440|11600071|FG001|STARTED|Overall Study||43
10452383|NCT00986440|11600070|FG000|Randomized, But Not Dosed|Overall Study||0
10452384|NCT00986440|11600071|FG001|Randomized, But Not Dosed|Overall Study||1
10452385|NCT00986440|11600070|FG000|COMPLETED|Overall Study||0
10452386|NCT00986440|11600071|FG001|COMPLETED|Overall Study||0
10452387|NCT00986440|11600070|FG000|NOT COMPLETED|Overall Study||41
10452388|NCT00986440|11600071|FG001|NOT COMPLETED|Overall Study||43
10452389|NCT00986453|11600077|FG000|STARTED|Overall Study||45
10452390|NCT00986453|11600077|FG000|COMPLETED|Overall Study||43
10452391|NCT00986453|11600077|FG000|NOT COMPLETED|Overall Study||2
10452392|NCT00986479|11600085|FG000|STARTED|Period 1||12
10452393|NCT00986479|11600086|FG001|STARTED|Period 1||10
10452394|NCT00986479|11600085|FG000|COMPLETED|Period 1||10
10452395|NCT00986479|11600086|FG001|COMPLETED|Period 1||10
10452396|NCT00986479|11600085|FG000|NOT COMPLETED|Period 1||2
10452397|NCT00986479|11600086|FG001|NOT COMPLETED|Period 1||0
10452398|NCT00986479|11600085|FG000|STARTED|Period 2||10
10452399|NCT00986479|11600086|FG001|STARTED|Period 2||10
10452400|NCT00986479|11600085|FG000|COMPLETED|Period 2||10
10452401|NCT00986479|11600086|FG001|COMPLETED|Period 2||10
10452402|NCT00986479|11600085|FG000|NOT COMPLETED|Period 2||0
10452403|NCT00986479|11600086|FG001|NOT COMPLETED|Period 2||0
10452404|NCT00986544|11600094|FG000|STARTED|Overall Study||53
10452405|NCT00986544|11600095|FG001|STARTED|Overall Study||53
10452406|NCT00986544|11600094|FG000|COMPLETED|Overall Study||53
10452407|NCT00986544|11600095|FG001|COMPLETED|Overall Study||53
10452408|NCT00986544|11600094|FG000|NOT COMPLETED|Overall Study||0
10452409|NCT00986544|11600095|FG001|NOT COMPLETED|Overall Study||0
10452410|NCT00986570|11600102|FG000|STARTED|Overall Study||121
10452411|NCT00986570|11600102|FG000|COMPLETED|Overall Study||114
10452412|NCT00986570|11600102|FG000|NOT COMPLETED|Overall Study||7
10452413|NCT00986583|11600108|FG000|STARTED|Overall Study||38
10452414|NCT00986583|11600109|FG001|STARTED|Overall Study||32
10452415|NCT00986583|11600108|FG000|COMPLETED|Overall Study||38
10452416|NCT00986583|11600109|FG001|COMPLETED|Overall Study||32
10452417|NCT00986583|11600108|FG000|NOT COMPLETED|Overall Study||0
10452418|NCT00986583|11600109|FG001|NOT COMPLETED|Overall Study||0
10452419|NCT00986674|11600119|FG000|STARTED|Overall Study||47
10452420|NCT00986674|11600120|FG001|STARTED|Overall Study||45
10452421|NCT00986674|11600121|FG002|STARTED|Overall Study||48
10452422|NCT00986674|11600119|FG000|Treated|Overall Study||43
10452423|NCT00986674|11600120|FG001|Treated|Overall Study||42
10452424|NCT00986674|11600121|FG002|Treated|Overall Study||47
10452425|NCT00986674|11600119|FG000|Eligible and Treated|Overall Study||39
10452426|NCT00986674|11600120|FG001|Eligible and Treated|Overall Study||41
10452427|NCT00986674|11600121|FG002|Eligible and Treated|Overall Study||47
10452428|NCT00986674|11600119|FG000|COMPLETED|Overall Study||0
10452429|NCT00986674|11600120|FG001|COMPLETED|Overall Study||0
10452430|NCT00986674|11600121|FG002|COMPLETED|Overall Study||0
10452431|NCT00986674|11600119|FG000|NOT COMPLETED|Overall Study||47
10452432|NCT00986674|11600120|FG001|NOT COMPLETED|Overall Study||45
10452433|NCT00986674|11600121|FG002|NOT COMPLETED|Overall Study||48
10452434|NCT00986830|11600129|FG000|STARTED|Overall Study||74
10452435|NCT00986830|11600129|FG000|Treated|Overall Study||69
10452436|NCT00986830|11600129|FG000|COMPLETED|Overall Study||66
10452437|NCT00986830|11600129|FG000|NOT COMPLETED|Overall Study||8
10551548|NCT01536951|11705647|FG008|COMPLETED|Second Intervention and Washout Period 2||9
10551549|NCT01536951|11705639|FG000|NOT COMPLETED|Second Intervention and Washout Period 2||0
10551550|NCT01536951|11705640|FG001|NOT COMPLETED|Second Intervention and Washout Period 2||0
10551551|NCT01536951|11705641|FG002|NOT COMPLETED|Second Intervention and Washout Period 2||0
10551552|NCT01536951|11705642|FG003|NOT COMPLETED|Second Intervention and Washout Period 2||0
10551553|NCT01536951|11705643|FG004|NOT COMPLETED|Second Intervention and Washout Period 2||0
10452438|NCT00986856|11600135|FG000|STARTED|Overall Study||42
10452439|NCT00986856|11600136|FG001|STARTED|Overall Study||16
10452440|NCT00986856|11600135|FG000|COMPLETED|Overall Study||42
10452441|NCT00986856|11600136|FG001|COMPLETED|Overall Study||16
10452442|NCT00986856|11600135|FG000|NOT COMPLETED|Overall Study||0
10452443|NCT00986856|11600136|FG001|NOT COMPLETED|Overall Study||0
10452444|NCT00986921|11600144|FG000|STARTED|Overall Study||25
10452445|NCT00986921|11600145|FG001|STARTED|Overall Study||25
10452446|NCT00986921|11600144|FG000|COMPLETED|Overall Study||24
10452447|NCT00986921|11600145|FG001|COMPLETED|Overall Study||25
10452448|NCT00986921|11600144|FG000|NOT COMPLETED|Overall Study||1
10452449|NCT00986921|11600145|FG001|NOT COMPLETED|Overall Study||0
10452450|NCT00986973|11600154|FG000|STARTED|Overall Study||6
10452451|NCT00986973|11600154|FG000|COMPLETED|Overall Study|One subject was withdrawn from the study due to poor compliance with KUVAN therapy.|5
10452452|NCT00986973|11600154|FG000|NOT COMPLETED|Overall Study||1
10452453|NCT00986986|11600161|FG000|STARTED|Overall Study||10
10452454|NCT00986986|11600162|FG001|STARTED|Overall Study||10
10452455|NCT00986986|11600161|FG000|COMPLETED|Overall Study||10
10452456|NCT00986986|11600162|FG001|COMPLETED|Overall Study||9
10452457|NCT00986986|11600161|FG000|NOT COMPLETED|Overall Study||0
10452458|NCT00986986|11600162|FG001|NOT COMPLETED|Overall Study||1
10452459|NCT00987337|11600172|FG000|STARTED|Overall Study||96
10452460|NCT00987337|11600173|FG001|STARTED|Overall Study||96
10452461|NCT00987337|11600174|FG002|STARTED|Overall Study||96
10452462|NCT00987337|11600172|FG000|COMPLETED|Overall Study||39
10452463|NCT00987337|11600173|FG001|COMPLETED|Overall Study||41
10452464|NCT00987337|11600174|FG002|COMPLETED|Overall Study||45
10452465|NCT00987337|11600172|FG000|NOT COMPLETED|Overall Study||57
10452466|NCT00987337|11600173|FG001|NOT COMPLETED|Overall Study||55
10452467|NCT00987337|11600174|FG002|NOT COMPLETED|Overall Study||51
10452468|NCT00987389|11600186|FG000|STARTED|Overall Study||176
10452469|NCT00987389|11600187|FG001|STARTED|Overall Study||176
10452470|NCT00987389|11600188|FG002|STARTED|Overall Study||175
10452471|NCT00987389|11600189|FG003|STARTED|Overall Study||177
10452472|NCT00987389|11600186|FG000|COMPLETED|Overall Study||167
10452473|NCT00987389|11600187|FG001|COMPLETED|Overall Study||168
10452474|NCT00987389|11600188|FG002|COMPLETED|Overall Study||167
10452475|NCT00987389|11600189|FG003|COMPLETED|Overall Study||174
10452476|NCT00987389|11600186|FG000|NOT COMPLETED|Overall Study||9
10452477|NCT00987389|11600187|FG001|NOT COMPLETED|Overall Study||8
10452478|NCT00987389|11600188|FG002|NOT COMPLETED|Overall Study||8
10452479|NCT00987389|11600189|FG003|NOT COMPLETED|Overall Study||3
10452480|NCT00987402|11600199|FG000|STARTED|Overall Study|January 2007, with crossover every 2 months|1682
10452481|NCT00987402|11600200|FG001|STARTED|Overall Study|January 2007 with crossover every 2 months|1635
10452482|NCT00987402|11600199|FG000|COMPLETED|Overall Study|86 patients did not have some data, and could not be evaluated|1596
10452483|NCT00987402|11600200|FG001|COMPLETED|Overall Study|98 patients did not have sufficient data|1537
10452484|NCT00987402|11600199|FG000|NOT COMPLETED|Overall Study||86
10452485|NCT00987402|11600200|FG001|NOT COMPLETED|Overall Study||98
10452486|NCT00987415|11600208|FG000|STARTED|Overall Study||128
10452487|NCT00987415|11600209|FG001|STARTED|Overall Study||125
10452488|NCT00987415|11600208|FG000|COMPLETED|Overall Study||119
10452489|NCT00987415|11600209|FG001|COMPLETED|Overall Study||116
10452490|NCT00987415|11600208|FG000|NOT COMPLETED|Overall Study||9
10452491|NCT00987415|11600209|FG001|NOT COMPLETED|Overall Study||9
10452492|NCT00987467|11600215|FG000|STARTED|Overall Study||12
10452493|NCT00987467|11600215|FG000|COMPLETED|Overall Study||10
10452494|NCT00987467|11600215|FG000|NOT COMPLETED|Overall Study||2
10452495|NCT00987480|11600220|FG000|STARTED|Overall Study||45
10452496|NCT00987480|11600220|FG000|COMPLETED|Overall Study||45
10452497|NCT00987480|11600220|FG000|NOT COMPLETED|Overall Study||0
10452498|NCT00987558|11600224|FG000|STARTED|Overall Study||13
10452499|NCT00987558|11600225|FG001|STARTED|Overall Study||17
10452500|NCT00987558|11600224|FG000|Simvastatin|Overall Study||13
10452501|NCT00987558|11600225|FG001|Simvastatin|Overall Study||12
10551554|NCT01536951|11705644|FG005|NOT COMPLETED|Second Intervention and Washout Period 2||0
10452502|NCT00987558|11600224|FG000|Washout|Overall Study||13
10452503|NCT00987558|11600225|FG001|Washout|Overall Study||12
10452504|NCT00987558|11600224|FG000|Eslicarbazepine Acetate + Simvastatin|Overall Study||13
10452505|NCT00987558|11600225|FG001|Eslicarbazepine Acetate + Simvastatin|Overall Study||17
10452506|NCT00987558|11600224|FG000|COMPLETED|Overall Study||12
10452507|NCT00987558|11600225|FG001|COMPLETED|Overall Study||12
10452508|NCT00987558|11600224|FG000|NOT COMPLETED|Overall Study||1
10452509|NCT00987558|11600225|FG001|NOT COMPLETED|Overall Study||5
10452510|NCT00987623|11600234|FG000|STARTED|Overall Study||145
10452511|NCT00987623|11600235|FG001|STARTED|Overall Study||154
10452512|NCT00987623|11600234|FG000|COMPLETED|Overall Study||140
10452513|NCT00987623|11600235|FG001|COMPLETED|Overall Study||151
10452514|NCT00987623|11600234|FG000|NOT COMPLETED|Overall Study||5
10452515|NCT00987623|11600235|FG001|NOT COMPLETED|Overall Study||3
10452516|NCT00987727|11600243|FG000|STARTED|Overall Study||41
10452517|NCT00987727|11600244|FG001|STARTED|Overall Study||41
10452518|NCT00987727|11600243|FG000|COMPLETED|Overall Study||36
10452519|NCT00987727|11600244|FG001|COMPLETED|Overall Study||34
10452520|NCT00987727|11600243|FG000|NOT COMPLETED|Overall Study||5
10452521|NCT00987727|11600244|FG001|NOT COMPLETED|Overall Study||7
10452522|NCT00987831|11600253|FG000|STARTED|Overall Study|41 patients improved after depomedrol, if not improved, treated and moved to Group B|41
10452523|NCT00987831|11600254|FG001|STARTED|Overall Study|52 healthy controls donated biomarkers on two occasions in order to verify biomarkers ranges|55
10452524|NCT00987831|11600255|FG002|STARTED|Overall Study|Anyone who entered this arm completed it the same day|62
10452525|NCT00987831|11600253|FG000|COMPLETED|Overall Study|40 patients completed in 6 months. 1 patient did not meet completion definition in 12 months.|40
10452526|NCT00987831|11600254|FG001|COMPLETED|Overall Study|all controls returned for two visits|52
10452527|NCT00987831|11600255|FG002|COMPLETED|Overall Study|Anyone who entered this arm completed it the same day|62
10452528|NCT00987831|11600253|FG000|NOT COMPLETED|Overall Study||1
10452529|NCT00987831|11600254|FG001|NOT COMPLETED|Overall Study||3
10452530|NCT00987831|11600255|FG002|NOT COMPLETED|Overall Study||0
10452531|NCT00987935|11600273|FG000|STARTED|Overall Study||4
10452532|NCT00987935|11600274|FG001|STARTED|Overall Study||3
10452533|NCT00987935|11600275|FG002|STARTED|Overall Study||3
10452534|NCT00987935|11600276|FG003|STARTED|Overall Study||3
10452535|NCT00987935|11600277|FG004|STARTED|Overall Study||7
10452536|NCT00987935|11600278|FG005|STARTED|Overall Study||3
10452537|NCT00987935|11600279|FG006|STARTED|Overall Study||16
10452538|NCT00987935|11600280|FG007|STARTED|Overall Study||63
10452539|NCT00987935|11600281|FG008|STARTED|Overall Study||32
10452540|NCT00987935|11600273|FG000|COMPLETED|Overall Study||0
10452541|NCT00987935|11600274|FG001|COMPLETED|Overall Study||0
10452542|NCT00987935|11600275|FG002|COMPLETED|Overall Study||0
10452543|NCT00987935|11600276|FG003|COMPLETED|Overall Study||0
10452544|NCT00987935|11600277|FG004|COMPLETED|Overall Study||0
10452545|NCT00987935|11600278|FG005|COMPLETED|Overall Study||0
10452546|NCT00987935|11600279|FG006|COMPLETED|Overall Study|On-treatment at analysis cut-off date (16 July 2014).|1
10452547|NCT00987935|11600280|FG007|COMPLETED|Overall Study|On-treatment at analysis cut-off date (16 July 2014).|1
10452548|NCT00987935|11600281|FG008|COMPLETED|Overall Study||0
10452549|NCT00987935|11600273|FG000|NOT COMPLETED|Overall Study||4
10452550|NCT00987935|11600274|FG001|NOT COMPLETED|Overall Study||3
10452551|NCT00987935|11600275|FG002|NOT COMPLETED|Overall Study||3
10452552|NCT00987935|11600276|FG003|NOT COMPLETED|Overall Study||3
10452553|NCT00987935|11600277|FG004|NOT COMPLETED|Overall Study||7
10452554|NCT00987935|11600278|FG005|NOT COMPLETED|Overall Study||3
10452555|NCT00987935|11600279|FG006|NOT COMPLETED|Overall Study||15
10452556|NCT00987935|11600280|FG007|NOT COMPLETED|Overall Study||62
10452557|NCT00987935|11600281|FG008|NOT COMPLETED|Overall Study||32
10452558|NCT00987948|11600307|FG000|STARTED|Overall Study||15
10452559|NCT00987948|11600307|FG000|COMPLETED|Overall Study||12
10452560|NCT00987948|11600307|FG000|NOT COMPLETED|Overall Study||3
10452561|NCT00988000|11600314|FG000|STARTED|Overall Study||49
10452562|NCT00988000|11600315|FG001|STARTED|Overall Study||51
10452563|NCT00988000|11600316|FG002|STARTED|Overall Study||57
10452564|NCT00988000|11600314|FG000|COMPLETED|Overall Study||49
10452565|NCT00988000|11600315|FG001|COMPLETED|Overall Study||51
10452566|NCT00988000|11600316|FG002|COMPLETED|Overall Study||57
10452567|NCT00988000|11600314|FG000|NOT COMPLETED|Overall Study||0
10452568|NCT00988000|11600315|FG001|NOT COMPLETED|Overall Study||0
10452569|NCT00988000|11600316|FG002|NOT COMPLETED|Overall Study||0
10452570|NCT00988013|11600330|FG000|STARTED|Overall Study||3
10452571|NCT00988013|11600331|FG001|STARTED|Overall Study||3
10452572|NCT00988013|11600332|FG002|STARTED|Overall Study||6
10452573|NCT00988013|11600333|FG003|STARTED|Overall Study||2
10452574|NCT00988013|11600330|FG000|COMPLETED|Overall Study||3
10452575|NCT00988013|11600331|FG001|COMPLETED|Overall Study||3
10452576|NCT00988013|11600332|FG002|COMPLETED|Overall Study||6
10452577|NCT00988013|11600333|FG003|COMPLETED|Overall Study||2
10452578|NCT00988013|11600330|FG000|NOT COMPLETED|Overall Study||0
10452579|NCT00988013|11600331|FG001|NOT COMPLETED|Overall Study||0
10452580|NCT00988013|11600332|FG002|NOT COMPLETED|Overall Study||0
10452581|NCT00988013|11600333|FG003|NOT COMPLETED|Overall Study||0
10452582|NCT00988065|11600348|FG000|STARTED|Overall Study|Randomized to double-blind treatment|148
10452583|NCT00988065|11600349|FG001|STARTED|Overall Study|Randomized to double-blind treatment|150
10452584|NCT00988065|11600350|FG002|STARTED|Overall Study|Randomized to double-blind treatment|150
10452585|NCT00988065|11600348|FG000|Received First Randomized Dose|Overall Study||148
10452586|NCT00988065|11600349|FG001|Received First Randomized Dose|Overall Study||150
10452587|NCT00988065|11600350|FG002|Received First Randomized Dose|Overall Study||150
10452588|NCT00988065|11600348|FG000|Received Second Randomized Dose|Overall Study||139
10452589|NCT00988065|11600349|FG001|Received Second Randomized Dose|Overall Study||135
10452590|NCT00988065|11600350|FG002|Received Second Randomized Dose|Overall Study||145
10452591|NCT00988065|11600348|FG000|Received Third Randomized Dose|Overall Study||135
10452592|NCT00988065|11600349|FG001|Received Third Randomized Dose|Overall Study||127
10452593|NCT00988065|11600350|FG002|Received Third Randomized Dose|Overall Study||135
10452594|NCT00988065|11600348|FG000|COMPLETED|Overall Study||135
10452595|NCT00988065|11600349|FG001|COMPLETED|Overall Study||127
10452596|NCT00988065|11600350|FG002|COMPLETED|Overall Study||135
10452597|NCT00988065|11600348|FG000|NOT COMPLETED|Overall Study||13
10452598|NCT00988065|11600349|FG001|NOT COMPLETED|Overall Study||23
10452599|NCT00988065|11600350|FG002|NOT COMPLETED|Overall Study||15
10452600|NCT00988091|11600360|FG000|STARTED|Double-blind Period||298
10452601|NCT00988091|11600361|FG001|STARTED|Double-blind Period||298
10452602|NCT00988091|11600360|FG000|Intent to Treat Population|Double-blind Period|ITT population excludes participants from one site which was closed for non-compliance.|294
10452603|NCT00988091|11600361|FG001|Intent to Treat Population|Double-blind Period|ITT population excludes participants from one site which was closed for non-compliance.|295
10452604|NCT00988091|11600360|FG000|COMPLETED|Double-blind Period||255
10452605|NCT00988091|11600361|FG001|COMPLETED|Double-blind Period||251
10452606|NCT00988091|11600360|FG000|NOT COMPLETED|Double-blind Period||43
10452607|NCT00988091|11600361|FG001|NOT COMPLETED|Double-blind Period||47
10452608|NCT00988091|11600360|FG000|STARTED|Open-label Period|Participation in the Open-label period was optional.|229
10452609|NCT00988091|11600361|FG001|STARTED|Open-label Period|Participation in the Open-label period was optional.|225
10452610|NCT00988091|11600360|FG000|COMPLETED|Open-label Period||208
10452611|NCT00988091|11600361|FG001|COMPLETED|Open-label Period||192
10452612|NCT00988091|11600360|FG000|NOT COMPLETED|Open-label Period||21
10452613|NCT00988091|11600361|FG001|NOT COMPLETED|Open-label Period||33
10452614|NCT00988117|11600368|FG000|STARTED|4.6 mg/24 Hours From Baseline to Week 4||15
10452615|NCT00988117|11600368|FG000|COMPLETED|4.6 mg/24 Hours From Baseline to Week 4||14
10452616|NCT00988117|11600368|FG000|NOT COMPLETED|4.6 mg/24 Hours From Baseline to Week 4||1
10452617|NCT00988117|11600368|FG000|STARTED|9.5 mg/24 Hours From Week 4 to 12||14
10452618|NCT00988117|11600368|FG000|COMPLETED|9.5 mg/24 Hours From Week 4 to 12||12
10452619|NCT00988117|11600368|FG000|NOT COMPLETED|9.5 mg/24 Hours From Week 4 to 12||2
10452620|NCT00988143|11600376|FG000|STARTED|Overall Study||220
10452621|NCT00988143|11600377|FG001|STARTED|Overall Study||190
10452622|NCT00988143|11600378|FG002|STARTED|Overall Study||190
10452623|NCT00988143|11600376|FG000|COMPLETED|Overall Study||220
10452624|NCT00988143|11600377|FG001|COMPLETED|Overall Study||190
10452625|NCT00988143|11600378|FG002|COMPLETED|Overall Study||190
10452626|NCT00988143|11600376|FG000|NOT COMPLETED|Overall Study||0
10452627|NCT00988143|11600377|FG001|NOT COMPLETED|Overall Study||0
10452628|NCT00988143|11600378|FG002|NOT COMPLETED|Overall Study||0
10452629|NCT00988156|11600388|FG000|STARTED|Overall Study||149
10452630|NCT00988156|11600389|FG001|STARTED|Overall Study||155
10452631|NCT00988156|11600388|FG000|Intention-to-Treat Set (ITT)|Overall Study||129
10452632|NCT00988156|11600389|FG001|Intention-to-Treat Set (ITT)|Overall Study||134
10452633|NCT00988156|11600388|FG000|Per Protocol Set (PP)|Overall Study||101
10452634|NCT00988156|11600389|FG001|Per Protocol Set (PP)|Overall Study||97
10452635|NCT00988156|11600388|FG000|Safety Set|Overall Study||129
10452636|NCT00988156|11600389|FG001|Safety Set|Overall Study||134
10452637|NCT00988156|11600388|FG000|COMPLETED|Overall Study||132
10452638|NCT00988156|11600389|FG001|COMPLETED|Overall Study||135
10452639|NCT00988156|11600388|FG000|NOT COMPLETED|Overall Study||17
10452640|NCT00988156|11600389|FG001|NOT COMPLETED|Overall Study||20
10452641|NCT00988169|11600395|FG000|STARTED|Overall Study||6
10452642|NCT00988169|11600395|FG000|COMPLETED|Overall Study||5
10452643|NCT00988169|11600395|FG000|NOT COMPLETED|Overall Study||1
10452644|NCT00988208|11600401|FG000|STARTED|Overall Study||526
10452645|NCT00988208|11600402|FG001|STARTED|Overall Study||533
10452646|NCT00988208|11600401|FG000|Treated|Overall Study||521
10452647|NCT00988208|11600402|FG001|Treated|Overall Study||525
10452648|NCT00988208|11600401|FG000|COMPLETED|Overall Study|DP Completed = kept on treatment with docetaxel/prednisone; Placebo was discontinued in DP arm|95
10452649|NCT00988208|11600402|FG001|COMPLETED|Overall Study|DPL Completed = kept on treatment with docetaxel/prednisone; Lenalidomide discontinued in DPL arm|95
10452650|NCT00988208|11600401|FG000|NOT COMPLETED|Overall Study||431
10452651|NCT00988208|11600402|FG001|NOT COMPLETED|Overall Study||438
10452652|NCT00988221|11600411|FG000|STARTED|Part I||35
10452653|NCT00988221|11600412|FG001|STARTED|Part I||34
10452654|NCT00988221|11600413|FG002|STARTED|Part I||119
10452655|NCT00988221|11600414|FG003|STARTED|Part I|No patients received placebo in Part I of this study.|0
10452656|NCT00988221|11600411|FG000|COMPLETED|Part I||31
10452657|NCT00988221|11600412|FG001|COMPLETED|Part I||24
10452658|NCT00988221|11600413|FG002|COMPLETED|Part I||111
10452659|NCT00988221|11600414|FG003|COMPLETED|Part I||0
10452660|NCT00988221|11600411|FG000|NOT COMPLETED|Part I||4
10452661|NCT00988221|11600412|FG001|NOT COMPLETED|Part I||10
10452662|NCT00988221|11600413|FG002|NOT COMPLETED|Part I||8
10452663|NCT00988221|11600414|FG003|NOT COMPLETED|Part I||0
10318685|NCT00216060|11452924|FG001|NOT COMPLETED|Overall Study||0
10318686|NCT00216086|11452932|FG000|STARTED|Overall Study||22
10318687|NCT00216086|11452932|FG000|COMPLETED|Overall Study||18
10318688|NCT00216086|11452932|FG000|NOT COMPLETED|Overall Study||4
10318689|NCT00216099|11452936|FG000|STARTED|Overall Study||49
10318690|NCT00216099|11452936|FG000|Toxicity Analysis|Overall Study||49
10318691|NCT00216099|11452936|FG000|Response Analysis|Overall Study||48
10318692|NCT00216099|11452936|FG000|COMPLETED|Overall Study||48
10318693|NCT00216099|11452936|FG000|NOT COMPLETED|Overall Study||1
10318694|NCT00216125|11452940|FG000|STARTED|Pre-Randomization Phase||243
10452664|NCT00988221|11600411|FG000|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|16
10452665|NCT00988221|11600412|FG001|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|11
10452666|NCT00988221|11600413|FG002|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|55
10452667|NCT00988221|11600414|FG003|STARTED|Part II||84
10452668|NCT00988221|11600411|FG000|COMPLETED|Part II||15
10452669|NCT00988221|11600412|FG001|COMPLETED|Part II||11
10452670|NCT00988221|11600413|FG002|COMPLETED|Part II|One participant who did not complete Part II was available to continue in the study and did.|52
10452671|NCT00988221|11600414|FG003|COMPLETED|Part II||81
10452672|NCT00988221|11600411|FG000|NOT COMPLETED|Part II||1
10452673|NCT00988221|11600412|FG001|NOT COMPLETED|Part II||0
10452674|NCT00988221|11600413|FG002|NOT COMPLETED|Part II||3
10452675|NCT00988221|11600414|FG003|NOT COMPLETED|Part II||3
10452676|NCT00988221|11600411|FG000|STARTED|Part III||30
10452677|NCT00988221|11600412|FG001|STARTED|Part III||24
10452678|NCT00988221|11600413|FG002|STARTED|Part III||106
10452679|NCT00988221|11600414|FG003|STARTED|Part III|No patients received placebo in Part III of this study.|0
10452680|NCT00988221|11600411|FG000|COMPLETED|Part III||29
10452681|NCT00988221|11600412|FG001|COMPLETED|Part III||23
10452682|NCT00988221|11600413|FG002|COMPLETED|Part III||103
10452683|NCT00988221|11600414|FG003|COMPLETED|Part III||0
10452684|NCT00988221|11600411|FG000|NOT COMPLETED|Part III||1
10452685|NCT00988221|11600412|FG001|NOT COMPLETED|Part III||1
10452686|NCT00988221|11600413|FG002|NOT COMPLETED|Part III||3
10452687|NCT00988221|11600414|FG003|NOT COMPLETED|Part III||0
10452688|NCT00988325|11600436|FG000|STARTED|Overall Study||40
10452689|NCT00988325|11600437|FG001|STARTED|Overall Study||20
10452690|NCT00988325|11600438|FG002|STARTED|Overall Study||5
10452691|NCT00988325|11600436|FG000|COMPLETED|Overall Study||40
10452692|NCT00988325|11600437|FG001|COMPLETED|Overall Study||20
10452693|NCT00988325|11600438|FG002|COMPLETED|Overall Study||5
10452694|NCT00988325|11600436|FG000|NOT COMPLETED|Overall Study||0
10452695|NCT00988325|11600437|FG001|NOT COMPLETED|Overall Study||0
10452696|NCT00988325|11600438|FG002|NOT COMPLETED|Overall Study||0
10452697|NCT00988351|11600452|FG000|STARTED|Overall Study||78
10452698|NCT00988351|11600453|FG001|STARTED|Overall Study||78
10452699|NCT00988351|11600452|FG000|CPAP Titration|Overall Study|8 declined CPAP treatment|78
10452700|NCT00988351|11600453|FG001|CPAP Titration|Overall Study|no titration needed|78
10452701|NCT00988351|11600452|FG000|PAP Setup|Overall Study|CPAP treatment started|70
10452702|NCT00988351|11600453|FG001|PAP Setup|Overall Study|APAP treatment started|78
10452703|NCT00988351|11600452|FG000|Clinic Visit|Overall Study|6 lost to follow-up or no show for clinic|64
10452704|NCT00988351|11600453|FG001|Clinic Visit|Overall Study|9 lost to follow-up or no show for clinic|69
10452705|NCT00988351|11600452|FG000|Using CPAP or APAP|Overall Study|5 not using CPAP (use < 1/2 hour per night)|59
10452706|NCT00988351|11600453|FG001|Using CPAP or APAP|Overall Study|3 not using APAP (less than 1/2 hour per night)|66
10452707|NCT00988351|11600452|FG000|COMPLETED|Overall Study||59
10452708|NCT00988351|11600453|FG001|COMPLETED|Overall Study||66
10452709|NCT00988351|11600452|FG000|NOT COMPLETED|Overall Study||19
10452710|NCT00988351|11600453|FG001|NOT COMPLETED|Overall Study||12
10452711|NCT00988429|11600462|FG000|STARTED|Overall Study||226
10452712|NCT00988429|11600463|FG001|STARTED|Overall Study||216
10452713|NCT00988429|11600464|FG002|STARTED|Overall Study||211
10452714|NCT00988429|11600462|FG000|Safety Population|Overall Study||224
10452715|NCT00988429|11600463|FG001|Safety Population|Overall Study||216
10452716|NCT00988429|11600464|FG002|Safety Population|Overall Study||210
10452717|NCT00988429|11600462|FG000|Intention-to-treat (ITT) Population|Overall Study||220
10452718|NCT00988429|11600463|FG001|Intention-to-treat (ITT) Population|Overall Study||215
10452719|NCT00988429|11600464|FG002|Intention-to-treat (ITT) Population|Overall Study||205
10452720|NCT00988429|11600462|FG000|COMPLETED|Overall Study||189
10452721|NCT00988429|11600463|FG001|COMPLETED|Overall Study||173
10452722|NCT00988429|11600464|FG002|COMPLETED|Overall Study||142
10452723|NCT00988429|11600462|FG000|NOT COMPLETED|Overall Study||37
10452724|NCT00988429|11600463|FG001|NOT COMPLETED|Overall Study||43
10452725|NCT00988429|11600464|FG002|NOT COMPLETED|Overall Study||69
10452726|NCT00988442|11600475|FG000|STARTED|Overall Study||30
10452727|NCT00988442|11600476|FG001|STARTED|Overall Study||29
10452728|NCT00988442|11600475|FG000|COMPLETED|Overall Study||0
10452729|NCT00988442|11600476|FG001|COMPLETED|Overall Study||1
10452730|NCT00988442|11600475|FG000|NOT COMPLETED|Overall Study||30
10452731|NCT00988442|11600476|FG001|NOT COMPLETED|Overall Study||28
10452732|NCT00988533|11600485|FG000|STARTED|Overall Study||30
10452733|NCT00988533|11600485|FG000|COMPLETED|Overall Study||27
10452734|NCT00988533|11600485|FG000|NOT COMPLETED|Overall Study||3
10452735|NCT00988559|11600493|FG000|STARTED|Overall Study||10
10452736|NCT00988559|11600494|FG001|STARTED|Overall Study||11
10318695|NCT00216125|11452941|FG001|STARTED|Pre-Randomization Phase||0
10452737|NCT00988559|11600495|FG002|STARTED|Overall Study||11
10452738|NCT00988559|11600496|FG003|STARTED|Overall Study||7
10452739|NCT00988559|11600493|FG000|COMPLETED|Overall Study||9
10452740|NCT00988559|11600494|FG001|COMPLETED|Overall Study||9
10452741|NCT00988559|11600495|FG002|COMPLETED|Overall Study||9
10452742|NCT00988559|11600496|FG003|COMPLETED|Overall Study||6
10452743|NCT00988559|11600493|FG000|NOT COMPLETED|Overall Study||1
10452744|NCT00988559|11600494|FG001|NOT COMPLETED|Overall Study||2
10452745|NCT00988559|11600495|FG002|NOT COMPLETED|Overall Study||2
10452746|NCT00988559|11600496|FG003|NOT COMPLETED|Overall Study||1
10452747|NCT00988598|11600508|FG000|STARTED|Overall Study||10
10452748|NCT00988598|11600509|FG001|STARTED|Overall Study||5
10452749|NCT00988598|11600508|FG000|COMPLETED|Overall Study||8
10452750|NCT00988598|11600509|FG001|COMPLETED|Overall Study||5
10452751|NCT00988598|11600508|FG000|NOT COMPLETED|Overall Study||2
10452752|NCT00988598|11600509|FG001|NOT COMPLETED|Overall Study||0
10452759|NCT00988832|11600524|FG000|STARTED|Overall Study||380
10452760|NCT00988832|11600524|FG000|COMPLETED|Overall Study||380
10452761|NCT00988832|11600524|FG000|NOT COMPLETED|Overall Study||0
10525842|NCT01378988|11677869|FG000|STARTED|Overall Study||2
10525843|NCT01378988|11677870|FG001|STARTED|Overall Study||3
10525844|NCT01378988|11677869|FG000|COMPLETED|Overall Study||2
10525845|NCT01378988|11677870|FG001|COMPLETED|Overall Study||3
10525846|NCT01378988|11677869|FG000|NOT COMPLETED|Overall Study||0
10525847|NCT01378988|11677870|FG001|NOT COMPLETED|Overall Study||0
10525848|NCT01379183|11677878|FG000|STARTED|Overall Study||19
10525849|NCT01379183|11677879|FG001|STARTED|Overall Study||21
10525850|NCT01379183|11677878|FG000|COMPLETED|Overall Study||19
10525851|NCT01379183|11677879|FG001|COMPLETED|Overall Study||21
10525852|NCT01379183|11677878|FG000|NOT COMPLETED|Overall Study||0
10525853|NCT01379183|11677879|FG001|NOT COMPLETED|Overall Study||0
10525854|NCT01379222|11677887|FG000|STARTED|Overall Study||178
10525855|NCT01379222|11677887|FG000|COMPLETED|Overall Study||105
10525856|NCT01379222|11677887|FG000|NOT COMPLETED|Overall Study||73
10525857|NCT01379508|11677895|FG000|STARTED|Treatment to Week 104||99
10525858|NCT01379508|11677896|FG001|STARTED|Treatment to Week 104||22
10525859|NCT01379508|11677897|FG002|STARTED|Treatment to Week 104||109
10525860|NCT01379508|11677898|FG003|STARTED|Treatment to Week 104||11
10525861|NCT01379508|11677895|FG000|Completed Wk 24|Treatment to Week 104||93
10525862|NCT01379508|11677896|FG001|Completed Wk 24|Treatment to Week 104||22
10525863|NCT01379508|11677897|FG002|Completed Wk 24|Treatment to Week 104||107
10525864|NCT01379508|11677898|FG003|Completed Wk 24|Treatment to Week 104||11
10525865|NCT01379508|11677895|FG000|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||91
10525866|NCT01379508|11677896|FG001|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||21
10525867|NCT01379508|11677897|FG002|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||105
10525868|NCT01379508|11677898|FG003|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||11
10525869|NCT01379508|11677895|FG000|COMPLETED|Treatment to Week 104||80
10525870|NCT01379508|11677896|FG001|COMPLETED|Treatment to Week 104||19
10525871|NCT01379508|11677897|FG002|COMPLETED|Treatment to Week 104||96
10525872|NCT01379508|11677898|FG003|COMPLETED|Treatment to Week 104||11
10525873|NCT01379508|11677895|FG000|NOT COMPLETED|Treatment to Week 104||19
10525874|NCT01379508|11677896|FG001|NOT COMPLETED|Treatment to Week 104||3
10525875|NCT01379508|11677897|FG002|NOT COMPLETED|Treatment to Week 104||13
10525876|NCT01379508|11677898|FG003|NOT COMPLETED|Treatment to Week 104||0
10525877|NCT01379508|11677895|FG000|STARTED|Extension Period Weeks 109-156||64
10525878|NCT01379508|11677896|FG001|STARTED|Extension Period Weeks 109-156||17
10525879|NCT01379508|11677897|FG002|STARTED|Extension Period Weeks 109-156||79
10525880|NCT01379508|11677898|FG003|STARTED|Extension Period Weeks 109-156||10
10525881|NCT01379508|11677895|FG000|COMPLETED|Extension Period Weeks 109-156||45
10525882|NCT01379508|11677896|FG001|COMPLETED|Extension Period Weeks 109-156||14
10525883|NCT01379508|11677897|FG002|COMPLETED|Extension Period Weeks 109-156||65
10525884|NCT01379508|11677898|FG003|COMPLETED|Extension Period Weeks 109-156||10
10525885|NCT01379508|11677895|FG000|NOT COMPLETED|Extension Period Weeks 109-156||19
10525886|NCT01379508|11677896|FG001|NOT COMPLETED|Extension Period Weeks 109-156||3
10525887|NCT01379508|11677897|FG002|NOT COMPLETED|Extension Period Weeks 109-156||14
10525888|NCT01379508|11677898|FG003|NOT COMPLETED|Extension Period Weeks 109-156||0
10525889|NCT01379521|11677914|FG000|STARTED|Overall Study -Treatment Period||33
10525890|NCT01379521|11677915|FG001|STARTED|Overall Study -Treatment Period||26
10525891|NCT01379521|11677914|FG000|COMPLETED|Overall Study -Treatment Period||0
10525892|NCT01379521|11677915|FG001|COMPLETED|Overall Study -Treatment Period||0
10525893|NCT01379521|11677914|FG000|NOT COMPLETED|Overall Study -Treatment Period||33
10525894|NCT01379521|11677915|FG001|NOT COMPLETED|Overall Study -Treatment Period||26
10525895|NCT01379521|11677914|FG000|STARTED|Post-Treatment Evaluations||25
10525896|NCT01379521|11677915|FG001|STARTED|Post-Treatment Evaluations||21
10525897|NCT01379521|11677914|FG000|COMPLETED|Post-Treatment Evaluations||0
10525898|NCT01379521|11677915|FG001|COMPLETED|Post-Treatment Evaluations||0
10525899|NCT01379521|11677914|FG000|NOT COMPLETED|Post-Treatment Evaluations||25
10525900|NCT01379521|11677915|FG001|NOT COMPLETED|Post-Treatment Evaluations||21
10525901|NCT01379534|11677923|FG000|STARTED|Treatment Phase||22
10525902|NCT01379534|11677924|FG001|STARTED|Treatment Phase||31
10525903|NCT01379534|11677923|FG000|COMPLETED|Treatment Phase||0
10525904|NCT01379534|11677924|FG001|COMPLETED|Treatment Phase||0
10525905|NCT01379534|11677923|FG000|NOT COMPLETED|Treatment Phase||22
10525906|NCT01379534|11677924|FG001|NOT COMPLETED|Treatment Phase||31
10525907|NCT01379534|11677923|FG000|STARTED|Tumor Assessment Follow-up (f/u) Phase|All participants discontinued the Treatment Phase. Of these, only 6 qualified for f/u tumor assess..|4
10525908|NCT01379534|11677924|FG001|STARTED|Tumor Assessment Follow-up (f/u) Phase||2
10452762|NCT00988858|11600531|FG000|STARTED|Overall Study||55
10452763|NCT00988858|11600531|FG000|COMPLETED|Overall Study||45
10452764|NCT00988858|11600531|FG000|NOT COMPLETED|Overall Study||10
10452765|NCT00988884|11600537|FG000|STARTED|Overall Study||621
10452766|NCT00988884|11600538|FG001|STARTED|Overall Study||620
10452767|NCT00988884|11600537|FG000|COMPLETED|Overall Study||586
10452768|NCT00988884|11600538|FG001|COMPLETED|Overall Study||584
10452769|NCT00988884|11600537|FG000|NOT COMPLETED|Overall Study||35
10452770|NCT00988884|11600538|FG001|NOT COMPLETED|Overall Study||36
10452771|NCT00989014|11600548|FG000|STARTED|Overall Study||31
10452772|NCT00989014|11600549|FG001|STARTED|Overall Study||31
10452773|NCT00989014|11600550|FG002|STARTED|Overall Study||28
10452774|NCT00989014|11600551|FG003|STARTED|Overall Study||32
10452775|NCT00989014|11600548|FG000|COMPLETED|Overall Study||31
10452776|NCT00989014|11600549|FG001|COMPLETED|Overall Study||31
10452777|NCT00989014|11600550|FG002|COMPLETED|Overall Study||28
10452778|NCT00989014|11600551|FG003|COMPLETED|Overall Study||32
10452779|NCT00989014|11600548|FG000|NOT COMPLETED|Overall Study||0
10452780|NCT00989014|11600549|FG001|NOT COMPLETED|Overall Study||0
10452781|NCT00989014|11600550|FG002|NOT COMPLETED|Overall Study||0
10452782|NCT00989014|11600551|FG003|NOT COMPLETED|Overall Study||0
10452783|NCT00989092|11600563|FG000|STARTED|Overall Study||228
10452784|NCT00989092|11600564|FG001|STARTED|Overall Study||59
10452785|NCT00989092|11600563|FG000|Treated With Darbepoetin Alfa|Overall Study||226
10452786|NCT00989092|11600564|FG001|Treated With Darbepoetin Alfa|Overall Study||33
10452787|NCT00989092|11600563|FG000|COMPLETED|Overall Study||138
10452788|NCT00989092|11600564|FG001|COMPLETED|Overall Study||31
10452789|NCT00989092|11600563|FG000|NOT COMPLETED|Overall Study||90
10452790|NCT00989092|11600564|FG001|NOT COMPLETED|Overall Study||28
10452791|NCT00989157|11600573|FG000|STARTED|Overall Study||10
10452792|NCT00989157|11600574|FG001|STARTED|Overall Study||10
10452793|NCT00989157|11600573|FG000|COMPLETED|Overall Study||10
10452794|NCT00989157|11600574|FG001|COMPLETED|Overall Study||10
10452795|NCT00989157|11600573|FG000|NOT COMPLETED|Overall Study||0
10452796|NCT00989157|11600574|FG001|NOT COMPLETED|Overall Study||0
10452797|NCT00989196|11600582|FG000|STARTED|PK Crossover Period||10
10452798|NCT00989196|11600583|FG001|STARTED|PK Crossover Period||12
10452799|NCT00989196|11600582|FG000|COMPLETED|PK Crossover Period||10
10452800|NCT00989196|11600583|FG001|COMPLETED|PK Crossover Period||12
10452801|NCT00989196|11600582|FG000|NOT COMPLETED|PK Crossover Period||0
10452802|NCT00989196|11600583|FG001|NOT COMPLETED|PK Crossover Period||0
10452803|NCT00989196|11600582|FG000|STARTED|Treatment Period||10
10452804|NCT00989196|11600583|FG001|STARTED|Treatment Period||12
10452805|NCT00989196|11600582|FG000|COMPLETED|Treatment Period||9
10452806|NCT00989196|11600583|FG001|COMPLETED|Treatment Period||12
10452807|NCT00989196|11600582|FG000|NOT COMPLETED|Treatment Period||1
10452808|NCT00989196|11600583|FG001|NOT COMPLETED|Treatment Period||0
10452809|NCT00989235|11600591|FG000|STARTED|Overall Study||58
10452810|NCT00989235|11600592|FG001|STARTED|Overall Study||50
10452811|NCT00989235|11600591|FG000|Number Rescued to Open-Label Treatment|Overall Study||4
10452812|NCT00989235|11600592|FG001|Number Rescued to Open-Label Treatment|Overall Study|Of these, 1 was discontinued from open-label treatment (lost to follow-up).|4
10452813|NCT00989235|11600591|FG000|Number Completing Double-Blind Treatment|Overall Study||51
10452814|NCT00989235|11600592|FG001|Number Completing Double-Blind Treatment|Overall Study||41
10452815|NCT00989235|11600591|FG000|COMPLETED|Overall Study||55
10452816|NCT00989235|11600592|FG001|COMPLETED|Overall Study||44
10452817|NCT00989235|11600591|FG000|NOT COMPLETED|Overall Study||3
10452818|NCT00989235|11600592|FG001|NOT COMPLETED|Overall Study||6
10452819|NCT00989261|11600603|FG000|STARTED|Overall Study||157
10452820|NCT00989261|11600604|FG001|STARTED|Overall Study||176
10452821|NCT00989261|11600603|FG000|COMPLETED|Overall Study||142
10452822|NCT00989261|11600604|FG001|COMPLETED|Overall Study||154
10452823|NCT00989261|11600603|FG000|NOT COMPLETED|Overall Study||15
10452824|NCT00989261|11600604|FG001|NOT COMPLETED|Overall Study||22
10452825|NCT00989287|11600612|FG000|STARTED|Overall Study||65
10452826|NCT00989287|11600613|FG001|STARTED|Overall Study||66
10452827|NCT00989287|11600612|FG000|COMPLETED|Overall Study||64
10452828|NCT00989287|11600613|FG001|COMPLETED|Overall Study||65
10452829|NCT00989287|11600612|FG000|NOT COMPLETED|Overall Study||1
10452830|NCT00989287|11600613|FG001|NOT COMPLETED|Overall Study||1
10452831|NCT00989573|11600635|FG000|STARTED|Overall Study||65
10452832|NCT00989573|11600636|FG001|STARTED|Overall Study||63
10452833|NCT00989573|11600637|FG002|STARTED|Overall Study||63
10452834|NCT00989573|11600635|FG000|COMPLETED|Overall Study||52
10452835|NCT00989573|11600636|FG001|COMPLETED|Overall Study||41
10452836|NCT00989573|11600637|FG002|COMPLETED|Overall Study||55
10452837|NCT00989573|11600635|FG000|NOT COMPLETED|Overall Study||13
10452838|NCT00989573|11600636|FG001|NOT COMPLETED|Overall Study||22
10452839|NCT00989573|11600637|FG002|NOT COMPLETED|Overall Study||8
10452840|NCT00989586|11600647|FG000|STARTED|Overall Study||18
10452841|NCT00989586|11600648|FG001|STARTED|Overall Study||17
10452842|NCT00989586|11600647|FG000|COMPLETED|Overall Study||18
10452843|NCT00989586|11600648|FG001|COMPLETED|Overall Study||17
10452844|NCT00989586|11600647|FG000|NOT COMPLETED|Overall Study||0
10452845|NCT00989586|11600648|FG001|NOT COMPLETED|Overall Study||0
10452846|NCT00989612|11600655|FG000|STARTED|Overall Study||100
10452847|NCT00989612|11600655|FG000|COMPLETED|Overall Study||100
10452848|NCT00989612|11600655|FG000|NOT COMPLETED|Overall Study||0
10452849|NCT00989664|11600661|FG000|STARTED|Dosimetric and Therapeutic Treatment||61
10452850|NCT00989664|11600661|FG000|COMPLETED|Dosimetric and Therapeutic Treatment||0
10452851|NCT00989664|11600661|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||61
10452852|NCT00989664|11600661|FG000|STARTED|Long-Term Follow-Up|14 of the 61 participants withdrawing from Study BEX104504 enrolled in the LTFU study.|14
10452853|NCT00989664|11600661|FG000|COMPLETED|Long-Term Follow-Up||11
10452854|NCT00989664|11600661|FG000|NOT COMPLETED|Long-Term Follow-Up||3
10452855|NCT00989768|11600667|FG000|STARTED|Overall Study|All patients received both treatments. They are their own controls|29
10452856|NCT00989768|11600667|FG000|COMPLETED|Overall Study||28
10452857|NCT00989768|11600667|FG000|NOT COMPLETED|Overall Study||1
10452858|NCT00989781|11600677|FG000|STARTED|Ovarian Response to hCG||21
10452859|NCT00989781|11600678|FG001|STARTED|Ovarian Response to hCG||20
10452860|NCT00989781|11600677|FG000|COMPLETED|Ovarian Response to hCG||18
10452861|NCT00989781|11600678|FG001|COMPLETED|Ovarian Response to hCG||18
10452862|NCT00989781|11600677|FG000|NOT COMPLETED|Ovarian Response to hCG||3
10452863|NCT00989781|11600678|FG001|NOT COMPLETED|Ovarian Response to hCG||2
10452864|NCT00989781|11600677|FG000|STARTED|Adrenal Response ot ACTH|15 subjects that completed part 1 elected to participate in Part 2|18
10452865|NCT00989781|11600678|FG001|STARTED|Adrenal Response ot ACTH|15 subjects that completed part 1 elected to participate in Part 2|18
10452866|NCT00989781|11600677|FG000|COMPLETED|Adrenal Response ot ACTH|Of 18 eligible, 15 consented. 2 dropped out and 13 completed study|13
10452867|NCT00989781|11600678|FG001|COMPLETED|Adrenal Response ot ACTH|Of 18 eligible, 15 consented and completed study|15
10452868|NCT00989781|11600677|FG000|NOT COMPLETED|Adrenal Response ot ACTH||5
10452869|NCT00989781|11600678|FG001|NOT COMPLETED|Adrenal Response ot ACTH||3
10452870|NCT00989833|11600688|FG000|STARTED|Overall Study||21
10452871|NCT00989833|11600689|FG001|STARTED|Overall Study||22
10452872|NCT00989833|11600690|FG002|STARTED|Overall Study||23
10452873|NCT00989833|11600688|FG000|COMPLETED|Overall Study||19
10452874|NCT00989833|11600689|FG001|COMPLETED|Overall Study||19
10452875|NCT00989833|11600690|FG002|COMPLETED|Overall Study||21
10452876|NCT00989833|11600688|FG000|NOT COMPLETED|Overall Study||2
10452877|NCT00989833|11600689|FG001|NOT COMPLETED|Overall Study||3
10452878|NCT00989833|11600690|FG002|NOT COMPLETED|Overall Study||2
10452879|NCT00989911|11600698|FG000|STARTED|Overall Study||10
10452880|NCT00989911|11600698|FG000|COMPLETED|Overall Study||7
10452881|NCT00989911|11600698|FG000|NOT COMPLETED|Overall Study||3
10452882|NCT00989950|11600706|FG000|STARTED|Open Label Dose Optimization||6
10452883|NCT00989950|11600707|FG001|STARTED|Open Label Dose Optimization||9
10452884|NCT00989950|11600708|FG002|STARTED|Open Label Dose Optimization||4
10452885|NCT00989950|11600709|FG003|STARTED|Open Label Dose Optimization||7
10452886|NCT00989950|11600706|FG000|COMPLETED|Open Label Dose Optimization||6
10452887|NCT00989950|11600707|FG001|COMPLETED|Open Label Dose Optimization||9
10452888|NCT00989950|11600708|FG002|COMPLETED|Open Label Dose Optimization||4
10452889|NCT00989950|11600709|FG003|COMPLETED|Open Label Dose Optimization||7
10452890|NCT00989950|11600706|FG000|NOT COMPLETED|Open Label Dose Optimization||0
10452891|NCT00989950|11600707|FG001|NOT COMPLETED|Open Label Dose Optimization||0
10452892|NCT00989950|11600708|FG002|NOT COMPLETED|Open Label Dose Optimization||0
10452893|NCT00989950|11600709|FG003|NOT COMPLETED|Open Label Dose Optimization||0
10452894|NCT00989950|11600706|FG000|STARTED|Randomized Phase||6
10452895|NCT00989950|11600707|FG001|STARTED|Randomized Phase||9
10452896|NCT00989950|11600708|FG002|STARTED|Randomized Phase||4
10452897|NCT00989950|11600709|FG003|STARTED|Randomized Phase||7
10452898|NCT00989950|11600706|FG000|COMPLETED|Randomized Phase||5
10452899|NCT00989950|11600707|FG001|COMPLETED|Randomized Phase||8
10452900|NCT00989950|11600708|FG002|COMPLETED|Randomized Phase||4
10452901|NCT00989950|11600709|FG003|COMPLETED|Randomized Phase||7
10452902|NCT00989950|11600706|FG000|NOT COMPLETED|Randomized Phase||1
10452903|NCT00989950|11600707|FG001|NOT COMPLETED|Randomized Phase||1
10452904|NCT00989950|11600708|FG002|NOT COMPLETED|Randomized Phase||0
10452905|NCT00989950|11600709|FG003|NOT COMPLETED|Randomized Phase||0
10452906|NCT00989963|11600722|FG000|STARTED|Overall Study||12
10452907|NCT00989963|11600723|FG001|STARTED|Overall Study||12
10452908|NCT00989963|11600724|FG002|STARTED|Overall Study||12
10452909|NCT00989963|11600722|FG000|Safety Population|Overall Study|1 participant randomized to MTD received FD 60 ug; was included in FD 60 ug arm for this population|13
10452910|NCT00989963|11600723|FG001|Safety Population|Overall Study||12
10452911|NCT00989963|11600724|FG002|Safety Population|Overall Study|1 participant randomized to MTD received FD 60 ug; was included in FD 60 ug arm for this population|11
10452912|NCT00989963|11600722|FG000|Per-Protocol Population|Overall Study|1 participant randomized to MTD received FD 60 ug; was included in FD 60 ug arm for this population|12
10452913|NCT00989963|11600723|FG001|Per-Protocol Population|Overall Study||11
10452914|NCT00989963|11600724|FG002|Per-Protocol Population|Overall Study|1 participant randomized to MTD received FD 60 ug; was included in FD 60 ug arm for this population|10
10452915|NCT00989963|11600722|FG000|COMPLETED|Overall Study||11
10452916|NCT00989963|11600723|FG001|COMPLETED|Overall Study||11
10452917|NCT00989963|11600724|FG002|COMPLETED|Overall Study||11
10452918|NCT00989963|11600722|FG000|NOT COMPLETED|Overall Study||1
10452919|NCT00989963|11600723|FG001|NOT COMPLETED|Overall Study||1
10452920|NCT00989963|11600724|FG002|NOT COMPLETED|Overall Study||1
10452921|NCT00989989|11600735|FG000|STARTED|Overall Study||132
10452922|NCT00989989|11600736|FG001|STARTED|Overall Study||133
10452923|NCT00989989|11600737|FG002|STARTED|Overall Study||131
10452924|NCT00989989|11600735|FG000|COMPLETED|Overall Study||114
10452925|NCT00989989|11600736|FG001|COMPLETED|Overall Study||123
10452926|NCT00989989|11600737|FG002|COMPLETED|Overall Study||108
10452927|NCT00989989|11600735|FG000|NOT COMPLETED|Overall Study||18
10452928|NCT00989989|11600736|FG001|NOT COMPLETED|Overall Study||10
10452929|NCT00989989|11600737|FG002|NOT COMPLETED|Overall Study||23
10452930|NCT00990093|11600745|FG000|STARTED|Test Period 1 (1-14 Days)||19
10452931|NCT00990093|11600746|FG001|STARTED|Test Period 1 (1-14 Days)||17
10452932|NCT00990093|11600745|FG000|COMPLETED|Test Period 1 (1-14 Days)||15
10452933|NCT00990093|11600746|FG001|COMPLETED|Test Period 1 (1-14 Days)||15
10452934|NCT00990093|11600745|FG000|NOT COMPLETED|Test Period 1 (1-14 Days)||4
10452935|NCT00990093|11600746|FG001|NOT COMPLETED|Test Period 1 (1-14 Days)||2
10452936|NCT00990093|11600745|FG000|STARTED|Test Period 2 (15-28 Days)||15
10452937|NCT00990093|11600746|FG001|STARTED|Test Period 2 (15-28 Days)||15
10452938|NCT00990093|11600745|FG000|COMPLETED|Test Period 2 (15-28 Days)||13
10452939|NCT00990093|11600746|FG001|COMPLETED|Test Period 2 (15-28 Days)||14
10452940|NCT00990093|11600745|FG000|NOT COMPLETED|Test Period 2 (15-28 Days)||2
10452941|NCT00990093|11600746|FG001|NOT COMPLETED|Test Period 2 (15-28 Days)||1
10452942|NCT00990106|11600754|FG000|STARTED|Overall Study||32
10452943|NCT00990106|11600755|FG001|STARTED|Overall Study||35
10452944|NCT00990106|11600754|FG000|COMPLETED|Overall Study||23
10452945|NCT00990106|11600755|FG001|COMPLETED|Overall Study||23
10452946|NCT00990106|11600754|FG000|NOT COMPLETED|Overall Study||9
10452947|NCT00990106|11600755|FG001|NOT COMPLETED|Overall Study||12
10452948|NCT00990184|11600761|FG000|STARTED|Overall Study||21
10452949|NCT00990184|11600761|FG000|COMPLETED|Overall Study||20
10452950|NCT00990184|11600761|FG000|NOT COMPLETED|Overall Study||1
10452951|NCT00990236|11600769|FG000|STARTED|Overall Study||89
10452952|NCT00990236|11600770|FG001|STARTED|Overall Study||96
10452953|NCT00990236|11600769|FG000|COMPLETED|Overall Study||89
10452954|NCT00990236|11600770|FG001|COMPLETED|Overall Study||96
10452955|NCT00990236|11600769|FG000|NOT COMPLETED|Overall Study||0
10452956|NCT00990236|11600770|FG001|NOT COMPLETED|Overall Study||0
10452957|NCT00990249|11600776|FG000|STARTED|Overall Study||120
10452958|NCT00990249|11600776|FG000|COMPLETED|Overall Study||107
10452959|NCT00990249|11600776|FG000|NOT COMPLETED|Overall Study||13
10452960|NCT00990288|11600782|FG000|STARTED|Overall Study||97
10452961|NCT00990288|11600783|FG001|STARTED|Overall Study||99
10452962|NCT00990288|11600782|FG000|COMPLETED|Overall Study||97
10452963|NCT00990288|11600783|FG001|COMPLETED|Overall Study||99
10551555|NCT01536951|11705645|FG006|NOT COMPLETED|Second Intervention and Washout Period 2||0
10551556|NCT01536951|11705646|FG007|NOT COMPLETED|Second Intervention and Washout Period 2||1
10551557|NCT01536951|11705647|FG008|NOT COMPLETED|Second Intervention and Washout Period 2||0
10551558|NCT01536951|11705639|FG000|STARTED|Third Intervention||3
10551559|NCT01536951|11705640|FG001|STARTED|Third Intervention||3
10551560|NCT01536951|11705641|FG002|STARTED|Third Intervention||2
10551561|NCT01536951|11705642|FG003|STARTED|Third Intervention||8
10551562|NCT01536951|11705643|FG004|STARTED|Third Intervention||9
10551563|NCT01536951|11705644|FG005|STARTED|Third Intervention||9
10551564|NCT01536951|11705645|FG006|STARTED|Third Intervention||9
10551565|NCT01536951|11705646|FG007|STARTED|Third Intervention||8
10551566|NCT01536951|11705647|FG008|STARTED|Third Intervention||9
10551567|NCT01536951|11705639|FG000|COMPLETED|Third Intervention||3
10551568|NCT01536951|11705640|FG001|COMPLETED|Third Intervention||3
10551569|NCT01536951|11705641|FG002|COMPLETED|Third Intervention||2
10551570|NCT01536951|11705642|FG003|COMPLETED|Third Intervention||8
10551571|NCT01536951|11705643|FG004|COMPLETED|Third Intervention||9
10551572|NCT01536951|11705644|FG005|COMPLETED|Third Intervention||9
10551573|NCT01536951|11705645|FG006|COMPLETED|Third Intervention||9
10551574|NCT01536951|11705646|FG007|COMPLETED|Third Intervention||8
10551575|NCT01536951|11705647|FG008|COMPLETED|Third Intervention||9
10551576|NCT01536951|11705639|FG000|NOT COMPLETED|Third Intervention||0
10551577|NCT01536951|11705640|FG001|NOT COMPLETED|Third Intervention||0
10551578|NCT01536951|11705641|FG002|NOT COMPLETED|Third Intervention||0
10551579|NCT01536951|11705642|FG003|NOT COMPLETED|Third Intervention||0
10551580|NCT01536951|11705643|FG004|NOT COMPLETED|Third Intervention||0
10551581|NCT01536951|11705644|FG005|NOT COMPLETED|Third Intervention||0
10551582|NCT01536951|11705645|FG006|NOT COMPLETED|Third Intervention||0
10551583|NCT01536951|11705646|FG007|NOT COMPLETED|Third Intervention||0
10551584|NCT01536951|11705647|FG008|NOT COMPLETED|Third Intervention||0
10551585|NCT01537029|11705670|FG000|STARTED|Overall Study||15
10551586|NCT01537029|11705670|FG000|COMPLETED|Overall Study||15
10551587|NCT01537029|11705670|FG000|NOT COMPLETED|Overall Study||0
10551588|NCT01537042|11705676|FG000|STARTED|Overall Study||10
10551589|NCT01537042|11705677|FG001|STARTED|Overall Study||20
10551590|NCT01537042|11705676|FG000|COMPLETED|Overall Study||10
10551591|NCT01537042|11705677|FG001|COMPLETED|Overall Study||15
10551592|NCT01537042|11705676|FG000|NOT COMPLETED|Overall Study||0
10551593|NCT01537042|11705677|FG001|NOT COMPLETED|Overall Study||5
10551594|NCT01537068|11705689|FG000|STARTED|Overall Study||30
10551595|NCT01537068|11705690|FG001|STARTED|Overall Study||29
10551596|NCT01537068|11705689|FG000|COMPLETED|Overall Study||26
10551597|NCT01537068|11705690|FG001|COMPLETED|Overall Study||26
10452964|NCT00990288|11600782|FG000|NOT COMPLETED|Overall Study||0
10452965|NCT00990288|11600783|FG001|NOT COMPLETED|Overall Study||0
10452966|NCT00990314|11600789|FG000|STARTED|Overall Study||31
10452967|NCT00990314|11600789|FG000|COMPLETED|Overall Study||19
10452968|NCT00990314|11600789|FG000|NOT COMPLETED|Overall Study||12
10452969|NCT00990340|11600795|FG000|STARTED|First 14-day Treatment||27
10452970|NCT00990340|11600796|FG001|STARTED|First 14-day Treatment||25
10551598|NCT01537068|11705689|FG000|NOT COMPLETED|Overall Study||4
10551599|NCT01537068|11705690|FG001|NOT COMPLETED|Overall Study||3
10551600|NCT01537081|11705699|FG000|STARTED|Overall Study||1123
10551601|NCT01537081|11705700|FG001|STARTED|Overall Study||1124
10452971|NCT00990340|11600795|FG000|COMPLETED|First 14-day Treatment||21
10452972|NCT00990340|11600796|FG001|COMPLETED|First 14-day Treatment||21
10452973|NCT00990340|11600795|FG000|NOT COMPLETED|First 14-day Treatment||6
10452974|NCT00990340|11600796|FG001|NOT COMPLETED|First 14-day Treatment||4
10452975|NCT00990340|11600795|FG000|STARTED|Second 14-day Treatment||21
10452976|NCT00990340|11600796|FG001|STARTED|Second 14-day Treatment||21
10452977|NCT00990340|11600795|FG000|COMPLETED|Second 14-day Treatment||21
10452978|NCT00990340|11600796|FG001|COMPLETED|Second 14-day Treatment||21
10452979|NCT00990340|11600795|FG000|NOT COMPLETED|Second 14-day Treatment||0
10452980|NCT00990340|11600796|FG001|NOT COMPLETED|Second 14-day Treatment||0
10452981|NCT00990509|11600806|FG000|STARTED|Overall Study||5
10452982|NCT00990509|11600807|FG001|STARTED|Overall Study||9
10452983|NCT00990509|11600806|FG000|COMPLETED|Overall Study||5
10452984|NCT00990509|11600807|FG001|COMPLETED|Overall Study||8
10452985|NCT00990509|11600806|FG000|NOT COMPLETED|Overall Study||0
10452986|NCT00990509|11600807|FG001|NOT COMPLETED|Overall Study||1
10452987|NCT00990561|11600815|FG000|STARTED|Period 1||20
10452988|NCT00990561|11600816|FG001|STARTED|Period 1||20
10452989|NCT00990561|11600817|FG002|STARTED|Period 1||0
10452990|NCT00990561|11600818|FG003|STARTED|Period 1||0
10452991|NCT00990561|11600815|FG000|COMPLETED|Period 1||20
10452992|NCT00990561|11600816|FG001|COMPLETED|Period 1||19
10452993|NCT00990561|11600817|FG002|COMPLETED|Period 1||0
10452994|NCT00990561|11600818|FG003|COMPLETED|Period 1||0
10452995|NCT00990561|11600815|FG000|NOT COMPLETED|Period 1||0
10452996|NCT00990561|11600816|FG001|NOT COMPLETED|Period 1||1
10452997|NCT00990561|11600817|FG002|NOT COMPLETED|Period 1||0
10452998|NCT00990561|11600818|FG003|NOT COMPLETED|Period 1||0
10452999|NCT00990561|11600815|FG000|STARTED|Period 2||0
10453000|NCT00990561|11600816|FG001|STARTED|Period 2||0
10453001|NCT00990561|11600817|FG002|STARTED|Period 2||20
10453002|NCT00990561|11600818|FG003|STARTED|Period 2||19
10453003|NCT00990561|11600815|FG000|COMPLETED|Period 2||0
10453004|NCT00990561|11600816|FG001|COMPLETED|Period 2||0
10453005|NCT00990561|11600817|FG002|COMPLETED|Period 2||20
10453006|NCT00990561|11600818|FG003|COMPLETED|Period 2||17
10453007|NCT00990561|11600815|FG000|NOT COMPLETED|Period 2||0
10453008|NCT00990561|11600816|FG001|NOT COMPLETED|Period 2||0
10453009|NCT00990561|11600817|FG002|NOT COMPLETED|Period 2||0
10453010|NCT00990561|11600818|FG003|NOT COMPLETED|Period 2||2
10453011|NCT00990652|11600824|FG000|STARTED|Pre-surgical Bortezomib||10
10453012|NCT00990652|11600824|FG000|COMPLETED|Pre-surgical Bortezomib||9
10453013|NCT00990652|11600824|FG000|NOT COMPLETED|Pre-surgical Bortezomib||1
10453014|NCT00990652|11600824|FG000|STARTED|Surgical Resection||9
10453015|NCT00990652|11600824|FG000|COMPLETED|Surgical Resection||9
10453016|NCT00990652|11600824|FG000|NOT COMPLETED|Surgical Resection||0
10453017|NCT00990652|11600824|FG000|STARTED|Post-sugery Bortezomib + Temozolomide||9
10453018|NCT00990652|11600824|FG000|COMPLETED|Post-sugery Bortezomib + Temozolomide||8
10453019|NCT00990652|11600824|FG000|NOT COMPLETED|Post-sugery Bortezomib + Temozolomide||1
10453020|NCT00990665|11600829|FG000|STARTED|Overall Study||178
10453021|NCT00990665|11600829|FG000|COMPLETED|Overall Study||130
10453022|NCT00990665|11600829|FG000|NOT COMPLETED|Overall Study||48
10453023|NCT00990704|11600837|FG000|STARTED|Overall Study||14
10453024|NCT00990704|11600838|FG001|STARTED|Overall Study||33
10453025|NCT00990704|11600837|FG000|COMPLETED|Overall Study||13
10453026|NCT00990704|11600838|FG001|COMPLETED|Overall Study||31
10453027|NCT00990704|11600837|FG000|NOT COMPLETED|Overall Study||1
10453028|NCT00990704|11600838|FG001|NOT COMPLETED|Overall Study||2
10453029|NCT00990769|11600846|FG000|STARTED|Overall Study|Signed consent and assigned to High-normal BIS|22
10453030|NCT00990769|11600847|FG001|STARTED|Overall Study|Signed consent and assigned to Low-normal BIS|18
10453031|NCT00990769|11600846|FG000|COMPLETED|Overall Study||22
10453032|NCT00990769|11600847|FG001|COMPLETED|Overall Study||18
10453033|NCT00990769|11600846|FG000|NOT COMPLETED|Overall Study||0
10453034|NCT00990769|11600847|FG001|NOT COMPLETED|Overall Study||0
10453035|NCT00990782|11600853|FG000|STARTED|Overall Study||93
10453036|NCT00990782|11600853|FG000|COMPLETED|Overall Study||88
10453037|NCT00990782|11600853|FG000|NOT COMPLETED|Overall Study||5
10453038|NCT00990821|11600871|FG000|STARTED|Overall Study||14
10453039|NCT00990821|11600872|FG001|STARTED|Overall Study||16
10453040|NCT00990821|11600873|FG002|STARTED|Overall Study||14
10453041|NCT00990821|11600874|FG003|STARTED|Overall Study||8
10453042|NCT00990821|11600875|FG004|STARTED|Overall Study||17
10453043|NCT00990821|11600876|FG005|STARTED|Overall Study||17
10453044|NCT00990821|11600877|FG006|STARTED|Overall Study||12
10453045|NCT00990821|11600878|FG007|STARTED|Overall Study||14
10453046|NCT00990821|11600879|FG008|STARTED|Overall Study||12
10551602|NCT01537081|11705701|FG002|STARTED|Overall Study||563
10551603|NCT01537081|11705699|FG000|Safety Population|Overall Study||1122
10453047|NCT00990821|11600880|FG009|STARTED|Overall Study||14
10453048|NCT00990821|11600881|FG010|STARTED|Overall Study||12
10453049|NCT00990821|11600882|FG011|STARTED|Overall Study||14
10453050|NCT00990821|11600883|FG012|STARTED|Overall Study||12
10453051|NCT00990821|11600884|FG013|STARTED|Overall Study||12
10453052|NCT00990821|11600871|FG000|COMPLETED|Overall Study||14
10453053|NCT00990821|11600872|FG001|COMPLETED|Overall Study||14
10453054|NCT00990821|11600873|FG002|COMPLETED|Overall Study||14
10453055|NCT00990821|11600874|FG003|COMPLETED|Overall Study||8
10453056|NCT00990821|11600875|FG004|COMPLETED|Overall Study||14
10453057|NCT00990821|11600876|FG005|COMPLETED|Overall Study||14
10453058|NCT00990821|11600877|FG006|COMPLETED|Overall Study||11
10453059|NCT00990821|11600878|FG007|COMPLETED|Overall Study||14
10453060|NCT00990821|11600879|FG008|COMPLETED|Overall Study||12
10453061|NCT00990821|11600880|FG009|COMPLETED|Overall Study||13
10453062|NCT00990821|11600881|FG010|COMPLETED|Overall Study||9
10453063|NCT00990821|11600882|FG011|COMPLETED|Overall Study||9
10453064|NCT00990821|11600883|FG012|COMPLETED|Overall Study||10
10453065|NCT00990821|11600884|FG013|COMPLETED|Overall Study||11
10453066|NCT00990821|11600871|FG000|NOT COMPLETED|Overall Study||0
10453067|NCT00990821|11600872|FG001|NOT COMPLETED|Overall Study||2
10453068|NCT00990821|11600873|FG002|NOT COMPLETED|Overall Study||0
10453069|NCT00990821|11600874|FG003|NOT COMPLETED|Overall Study||0
10453070|NCT00990821|11600875|FG004|NOT COMPLETED|Overall Study||3
10453071|NCT00990821|11600876|FG005|NOT COMPLETED|Overall Study||3
10453072|NCT00990821|11600877|FG006|NOT COMPLETED|Overall Study||1
10453073|NCT00990821|11600878|FG007|NOT COMPLETED|Overall Study||0
10453074|NCT00990821|11600879|FG008|NOT COMPLETED|Overall Study||0
10453075|NCT00990821|11600880|FG009|NOT COMPLETED|Overall Study||1
10453076|NCT00990821|11600881|FG010|NOT COMPLETED|Overall Study||3
10453077|NCT00990821|11600882|FG011|NOT COMPLETED|Overall Study||5
10453078|NCT00990821|11600883|FG012|NOT COMPLETED|Overall Study||2
10453079|NCT00990821|11600884|FG013|NOT COMPLETED|Overall Study||1
10453080|NCT00990938|11600907|FG000|STARTED|Overall Study||3
10453081|NCT00990938|11600908|FG001|STARTED|Overall Study||12
10453082|NCT00990938|11600909|FG002|STARTED|Overall Study||12
10453083|NCT00990938|11600910|FG003|STARTED|Overall Study||12
10453084|NCT00990938|11600911|FG004|STARTED|Overall Study||12
10453085|NCT00990938|11600912|FG005|STARTED|Overall Study||12
10453086|NCT00990938|11600907|FG000|COMPLETED|Overall Study||3
10453087|NCT00990938|11600908|FG001|COMPLETED|Overall Study||12
10453088|NCT00990938|11600909|FG002|COMPLETED|Overall Study||12
10453089|NCT00990938|11600910|FG003|COMPLETED|Overall Study||12
10453090|NCT00990938|11600911|FG004|COMPLETED|Overall Study||12
10453091|NCT00990938|11600912|FG005|COMPLETED|Overall Study||12
10453092|NCT00990938|11600907|FG000|NOT COMPLETED|Overall Study||0
10453093|NCT00990938|11600908|FG001|NOT COMPLETED|Overall Study||0
10453094|NCT00990938|11600909|FG002|NOT COMPLETED|Overall Study||0
10453095|NCT00990938|11600910|FG003|NOT COMPLETED|Overall Study||0
10453096|NCT00990938|11600911|FG004|NOT COMPLETED|Overall Study||0
10453097|NCT00990938|11600912|FG005|NOT COMPLETED|Overall Study||0
10453098|NCT00990964|11600926|FG000|STARTED|Overall Study|Total number of subjects enrolled|2014
10525909|NCT01379534|11677923|FG000|COMPLETED|Tumor Assessment Follow-up (f/u) Phase||0
10525910|NCT01379534|11677924|FG001|COMPLETED|Tumor Assessment Follow-up (f/u) Phase||0
10525911|NCT01379534|11677923|FG000|NOT COMPLETED|Tumor Assessment Follow-up (f/u) Phase||4
10525912|NCT01379534|11677924|FG001|NOT COMPLETED|Tumor Assessment Follow-up (f/u) Phase||2
10525913|NCT01379573|11677930|FG000|STARTED|Overall Study||74
10525914|NCT01379573|11677930|FG000|COMPLETED|Overall Study||63
10525915|NCT01379573|11677930|FG000|NOT COMPLETED|Overall Study||11
10525916|NCT01379625|11677936|FG000|STARTED|Overall Study||16
10525917|NCT01379625|11677937|FG001|STARTED|Overall Study||16
10525918|NCT01379625|11677936|FG000|COMPLETED|Overall Study||16
10525919|NCT01379625|11677937|FG001|COMPLETED|Overall Study||16
10525920|NCT01379625|11677936|FG000|NOT COMPLETED|Overall Study||0
10525921|NCT01379625|11677937|FG001|NOT COMPLETED|Overall Study||0
10525922|NCT01379651|11677945|FG000|STARTED|Overall Study||10
10525923|NCT01379651|11677946|FG001|STARTED|Overall Study||10
10525924|NCT01379651|11677945|FG000|COMPLETED|Overall Study||10
10525925|NCT01379651|11677946|FG001|COMPLETED|Overall Study||10
10525926|NCT01379651|11677945|FG000|NOT COMPLETED|Overall Study||0
10525927|NCT01379651|11677946|FG001|NOT COMPLETED|Overall Study||0
10525928|NCT01379664|11677954|FG000|STARTED|Overall Study||714
10525929|NCT01379664|11677955|FG001|STARTED|Overall Study||870
10525930|NCT01379664|11677954|FG000|COMPLETED|Overall Study||714
10525931|NCT01379664|11677955|FG001|COMPLETED|Overall Study||870
10525932|NCT01379664|11677954|FG000|NOT COMPLETED|Overall Study||0
10525933|NCT01379664|11677955|FG001|NOT COMPLETED|Overall Study||0
10525934|NCT01379703|11677961|FG000|STARTED|Study Start Through 9 Months|Participants taking lopinavir/ritonavir tablets/capsules or oral solution during the study (66/2288)|66
10525935|NCT01379703|11677962|FG001|STARTED|Study Start Through 9 Months|Participants taking the lopinavir/ritonavir capsule formulation (only) during study (1206/2288)|1206
10525936|NCT01379703|11677963|FG002|STARTED|Study Start Through 9 Months|Participants taking the lopinavir/ritonavir tablet formulation (only) during study (1016/2288)|1016
10525937|NCT01379703|11677961|FG000|COMPLETED|Study Start Through 9 Months||62
10525938|NCT01379703|11677962|FG001|COMPLETED|Study Start Through 9 Months|Participants taking the capsule formulation were followed for an additional 9 months (up to 18 mos).|1084
10525939|NCT01379703|11677963|FG002|COMPLETED|Study Start Through 9 Months||873
10525940|NCT01379703|11677961|FG000|NOT COMPLETED|Study Start Through 9 Months||4
10525941|NCT01379703|11677962|FG001|NOT COMPLETED|Study Start Through 9 Months||122
10525942|NCT01379703|11677963|FG002|NOT COMPLETED|Study Start Through 9 Months||143
10525943|NCT01379703|11677961|FG000|STARTED|9 Months Through 18 Months|Participants in this subgroup were followed for 9 months.|0
10525944|NCT01379703|11677962|FG001|STARTED|9 Months Through 18 Months|Participants taking the capsule formulation were followed for an additional 9 months (up to 18 mos).|1084
10525945|NCT01379703|11677963|FG002|STARTED|9 Months Through 18 Months|Participants in this subgroup were followed for 9 months.|0
10525946|NCT01379703|11677961|FG000|COMPLETED|9 Months Through 18 Months||0
10525947|NCT01379703|11677962|FG001|COMPLETED|9 Months Through 18 Months||854
10525948|NCT01379703|11677963|FG002|COMPLETED|9 Months Through 18 Months||0
10525949|NCT01379703|11677961|FG000|NOT COMPLETED|9 Months Through 18 Months||0
10453099|NCT00990964|11600926|FG000|Attain Family Study System Attempt|Overall Study|Total number of subjects with an Attain Family lead attempt after an Attain Family catheter attempt|1917
10453100|NCT00990964|11600926|FG000|COMPLETED|Overall Study|Total number of subjects with successful Attain Family lead using Attain Family catheter|1802
10453101|NCT00990964|11600926|FG000|NOT COMPLETED|Overall Study||212
10453102|NCT00991029|11600933|FG000|STARTED|Overall Study||2432
10453103|NCT00991029|11600934|FG001|STARTED|Overall Study||2449
10453104|NCT00991029|11600933|FG000|COMPLETED|Overall Study||2276
10453105|NCT00991029|11600934|FG001|COMPLETED|Overall Study||2281
10453106|NCT00991029|11600933|FG000|NOT COMPLETED|Overall Study||156
10453107|NCT00991029|11600934|FG001|NOT COMPLETED|Overall Study||168
10453108|NCT00991081|11600942|FG000|STARTED|Phase I, Formative Research||20
10453109|NCT00991081|11600943|FG001|STARTED|Phase I, Formative Research||0
10453110|NCT00991081|11600944|FG002|STARTED|Phase I, Formative Research||0
10453111|NCT00991081|11600942|FG000|COMPLETED|Phase I, Formative Research|The 10 smokers interviewed were not enrolled in the Phase II RCT.|20
10453112|NCT00991081|11600943|FG001|COMPLETED|Phase I, Formative Research||0
10453113|NCT00991081|11600944|FG002|COMPLETED|Phase I, Formative Research||0
10453114|NCT00991081|11600942|FG000|NOT COMPLETED|Phase I, Formative Research||0
10453115|NCT00991081|11600943|FG001|NOT COMPLETED|Phase I, Formative Research||0
10453116|NCT00991081|11600944|FG002|NOT COMPLETED|Phase I, Formative Research||0
10453117|NCT00991081|11600942|FG000|STARTED|Phase II, Randomized Control Trial||0
10453118|NCT00991081|11600943|FG001|STARTED|Phase II, Randomized Control Trial|Phase I interview participants were not enrolled in the Phase II RCT.|17
10453119|NCT00991081|11600944|FG002|STARTED|Phase II, Randomized Control Trial|Phase I interview participants were not enrolled in the Phase II RCT.|19
10453120|NCT00991081|11600942|FG000|Received First Clinical Call|Phase II, Randomized Control Trial||0
10453121|NCT00991081|11600943|FG001|Received First Clinical Call|Phase II, Randomized Control Trial||16
10453122|NCT00991081|11600944|FG002|Received First Clinical Call|Phase II, Randomized Control Trial||17
10453123|NCT00991081|11600942|FG000|COMPLETED|Phase II, Randomized Control Trial||0
10453124|NCT00991081|11600943|FG001|COMPLETED|Phase II, Randomized Control Trial||15
10453125|NCT00991081|11600944|FG002|COMPLETED|Phase II, Randomized Control Trial||15
10453126|NCT00991081|11600942|FG000|NOT COMPLETED|Phase II, Randomized Control Trial||0
10453127|NCT00991081|11600943|FG001|NOT COMPLETED|Phase II, Randomized Control Trial||2
10453128|NCT00991081|11600944|FG002|NOT COMPLETED|Phase II, Randomized Control Trial||4
10453129|NCT00991185|11600950|FG000|STARTED|Overall Study||8
10453130|NCT00991185|11600950|FG000|COMPLETED|Overall Study||8
10453131|NCT00991185|11600950|FG000|NOT COMPLETED|Overall Study||0
10453132|NCT00991276|11600960|FG000|STARTED|First Intervention Period||15
10453133|NCT00991276|11600961|FG001|STARTED|First Intervention Period||13
10453134|NCT00991276|11600962|FG002|STARTED|First Intervention Period||14
10453135|NCT00991276|11600963|FG003|STARTED|First Intervention Period||15
10453136|NCT00991276|11600964|FG004|STARTED|First Intervention Period||15
10453137|NCT00991276|11600965|FG005|STARTED|First Intervention Period||13
10453138|NCT00991276|11600960|FG000|COMPLETED|First Intervention Period||15
10453139|NCT00991276|11600961|FG001|COMPLETED|First Intervention Period||10
10453140|NCT00991276|11600962|FG002|COMPLETED|First Intervention Period||14
10453141|NCT00991276|11600963|FG003|COMPLETED|First Intervention Period||11
10453142|NCT00991276|11600964|FG004|COMPLETED|First Intervention Period||11
10453143|NCT00991276|11600965|FG005|COMPLETED|First Intervention Period||12
10453144|NCT00991276|11600960|FG000|NOT COMPLETED|First Intervention Period||0
10453145|NCT00991276|11600961|FG001|NOT COMPLETED|First Intervention Period||3
10453146|NCT00991276|11600962|FG002|NOT COMPLETED|First Intervention Period||0
10453147|NCT00991276|11600963|FG003|NOT COMPLETED|First Intervention Period||4
10453148|NCT00991276|11600964|FG004|NOT COMPLETED|First Intervention Period||4
10453149|NCT00991276|11600965|FG005|NOT COMPLETED|First Intervention Period||1
10453150|NCT00991276|11600960|FG000|STARTED|Placebo Wash-out Period (7 Days)||15
10453151|NCT00991276|11600961|FG001|STARTED|Placebo Wash-out Period (7 Days)||10
10453152|NCT00991276|11600962|FG002|STARTED|Placebo Wash-out Period (7 Days)||14
10453153|NCT00991276|11600963|FG003|STARTED|Placebo Wash-out Period (7 Days)||11
10453154|NCT00991276|11600964|FG004|STARTED|Placebo Wash-out Period (7 Days)||11
10453155|NCT00991276|11600965|FG005|STARTED|Placebo Wash-out Period (7 Days)||12
10453156|NCT00991276|11600960|FG000|COMPLETED|Placebo Wash-out Period (7 Days)||15
10453157|NCT00991276|11600961|FG001|COMPLETED|Placebo Wash-out Period (7 Days)||10
10453158|NCT00991276|11600962|FG002|COMPLETED|Placebo Wash-out Period (7 Days)||14
10453159|NCT00991276|11600963|FG003|COMPLETED|Placebo Wash-out Period (7 Days)||11
10453160|NCT00991276|11600964|FG004|COMPLETED|Placebo Wash-out Period (7 Days)||11
10453161|NCT00991276|11600965|FG005|COMPLETED|Placebo Wash-out Period (7 Days)||12
10453162|NCT00991276|11600960|FG000|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
10453163|NCT00991276|11600961|FG001|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
10453164|NCT00991276|11600962|FG002|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
10453165|NCT00991276|11600963|FG003|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
10453166|NCT00991276|11600964|FG004|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
10453167|NCT00991276|11600965|FG005|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
10453168|NCT00991276|11600960|FG000|STARTED|Second Intervention Period||15
10453169|NCT00991276|11600961|FG001|STARTED|Second Intervention Period||10
10453170|NCT00991276|11600962|FG002|STARTED|Second Intervention Period||14
10453171|NCT00991276|11600963|FG003|STARTED|Second Intervention Period||11
10453172|NCT00991276|11600964|FG004|STARTED|Second Intervention Period||11
10453173|NCT00991276|11600965|FG005|STARTED|Second Intervention Period||12
10453174|NCT00991276|11600960|FG000|COMPLETED|Second Intervention Period||14
10453175|NCT00991276|11600961|FG001|COMPLETED|Second Intervention Period||8
10453176|NCT00991276|11600962|FG002|COMPLETED|Second Intervention Period||14
10453177|NCT00991276|11600963|FG003|COMPLETED|Second Intervention Period||9
10453178|NCT00991276|11600964|FG004|COMPLETED|Second Intervention Period||10
10453179|NCT00991276|11600965|FG005|COMPLETED|Second Intervention Period||11
10453180|NCT00991276|11600960|FG000|NOT COMPLETED|Second Intervention Period||1
10453181|NCT00991276|11600961|FG001|NOT COMPLETED|Second Intervention Period||2
10453182|NCT00991276|11600962|FG002|NOT COMPLETED|Second Intervention Period||0
10453183|NCT00991276|11600963|FG003|NOT COMPLETED|Second Intervention Period||2
10453184|NCT00991276|11600964|FG004|NOT COMPLETED|Second Intervention Period||1
10453185|NCT00991276|11600965|FG005|NOT COMPLETED|Second Intervention Period||1
10453186|NCT00991276|11600960|FG000|STARTED|Placebo Wash-out Period (7 Days)||14
10453187|NCT00991276|11600961|FG001|STARTED|Placebo Wash-out Period (7 Days)||8
10453188|NCT00991276|11600962|FG002|STARTED|Placebo Wash-out Period (7 Days)||14
10453189|NCT00991276|11600963|FG003|STARTED|Placebo Wash-out Period (7 Days)||9
10453190|NCT00991276|11600964|FG004|STARTED|Placebo Wash-out Period (7 Days)||10
10453191|NCT00991276|11600965|FG005|STARTED|Placebo Wash-out Period (7 Days)||11
10453192|NCT00991276|11600960|FG000|COMPLETED|Placebo Wash-out Period (7 Days)||14
10453193|NCT00991276|11600961|FG001|COMPLETED|Placebo Wash-out Period (7 Days)||8
10453194|NCT00991276|11600962|FG002|COMPLETED|Placebo Wash-out Period (7 Days)||14
10453195|NCT00991276|11600963|FG003|COMPLETED|Placebo Wash-out Period (7 Days)||9
10453196|NCT00991276|11600964|FG004|COMPLETED|Placebo Wash-out Period (7 Days)||10
10453197|NCT00991276|11600965|FG005|COMPLETED|Placebo Wash-out Period (7 Days)||11
10453198|NCT00991276|11600960|FG000|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
10453199|NCT00991276|11600961|FG001|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
10453200|NCT00991276|11600962|FG002|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
10453201|NCT00991276|11600963|FG003|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
10453202|NCT00991276|11600964|FG004|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
10453203|NCT00991276|11600965|FG005|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
10453204|NCT00991276|11600960|FG000|STARTED|Third Intervention Period||14
10453205|NCT00991276|11600961|FG001|STARTED|Third Intervention Period||8
10453206|NCT00991276|11600962|FG002|STARTED|Third Intervention Period||14
10453207|NCT00991276|11600963|FG003|STARTED|Third Intervention Period||9
10453208|NCT00991276|11600964|FG004|STARTED|Third Intervention Period||10
10453209|NCT00991276|11600965|FG005|STARTED|Third Intervention Period||11
10453210|NCT00991276|11600960|FG000|COMPLETED|Third Intervention Period||13
10453211|NCT00991276|11600961|FG001|COMPLETED|Third Intervention Period||8
10453212|NCT00991276|11600962|FG002|COMPLETED|Third Intervention Period||13
10453213|NCT00991276|11600963|FG003|COMPLETED|Third Intervention Period||8
10453214|NCT00991276|11600964|FG004|COMPLETED|Third Intervention Period||10
10453215|NCT00991276|11600965|FG005|COMPLETED|Third Intervention Period||10
10453216|NCT00991276|11600960|FG000|NOT COMPLETED|Third Intervention Period||1
10453217|NCT00991276|11600961|FG001|NOT COMPLETED|Third Intervention Period||0
10453218|NCT00991276|11600962|FG002|NOT COMPLETED|Third Intervention Period||1
10453219|NCT00991276|11600963|FG003|NOT COMPLETED|Third Intervention Period||1
10453220|NCT00991276|11600964|FG004|NOT COMPLETED|Third Intervention Period||0
10453221|NCT00991276|11600965|FG005|NOT COMPLETED|Third Intervention Period||1
10453222|NCT00991289|11600974|FG000|STARTED|Overall Study|68 participants enrolled, one was found to have been ineligible and was excluded.|67
10453223|NCT00991289|11600974|FG000|COMPLETED Week 16|Overall Study|Completed 16 weeks of the study (the primary endpoint time point). The study continued to Week 76.|61
10453224|NCT00991289|11600974|FG000|COMPLETED|Overall Study|Completed study.|55
10453225|NCT00991289|11600974|FG000|NOT COMPLETED|Overall Study||12
10453226|NCT00991302|11600980|FG000|STARTED|Overall Study||86
10453227|NCT00991302|11600981|FG001|STARTED|Overall Study||86
10453228|NCT00991302|11600980|FG000|COMPLETED|Overall Study||72
10453229|NCT00991302|11600981|FG001|COMPLETED|Overall Study||73
10453230|NCT00991302|11600980|FG000|NOT COMPLETED|Overall Study||14
10453231|NCT00991302|11600981|FG001|NOT COMPLETED|Overall Study||13
10453232|NCT00991341|11600989|FG000|STARTED|Overall Study||742
10453233|NCT00991341|11600990|FG001|STARTED|Overall Study||739
10453234|NCT00991341|11600989|FG000|COMPLETED|Overall Study||538
10453235|NCT00991341|11600990|FG001|COMPLETED|Overall Study||560
10453236|NCT00991341|11600989|FG000|NOT COMPLETED|Overall Study||204
10453237|NCT00991341|11600990|FG001|NOT COMPLETED|Overall Study||179
10453238|NCT00991406|11600996|FG000|STARTED|Overall Study||9
10453239|NCT00991406|11600996|FG000|COMPLETED|Overall Study|One participant did not respond to FES due to tone.|8
10453240|NCT00991406|11600996|FG000|NOT COMPLETED|Overall Study||1
10453241|NCT00991458|11601003|FG000|STARTED|Overall Study||207
10453242|NCT00991458|11601004|FG001|STARTED|Overall Study||209
10453243|NCT00991458|11601005|FG002|STARTED|Overall Study||205
10453244|NCT00991458|11601003|FG000|COMPLETED|Overall Study||187
10453245|NCT00991458|11601004|FG001|COMPLETED|Overall Study||181
10453246|NCT00991458|11601005|FG002|COMPLETED|Overall Study||180
10453247|NCT00991458|11601003|FG000|NOT COMPLETED|Overall Study||20
10453248|NCT00991458|11601004|FG001|NOT COMPLETED|Overall Study||28
10453249|NCT00991458|11601005|FG002|NOT COMPLETED|Overall Study||25
10453250|NCT00991510|11601015|FG000|STARTED|Period I (Days 1-14)||22
10453251|NCT00991510|11601016|FG001|STARTED|Period I (Days 1-14)||21
10453252|NCT00991510|11601015|FG000|COMPLETED|Period I (Days 1-14)||21
10453253|NCT00991510|11601016|FG001|COMPLETED|Period I (Days 1-14)||21
10453254|NCT00991510|11601015|FG000|NOT COMPLETED|Period I (Days 1-14)||1
10453255|NCT00991510|11601016|FG001|NOT COMPLETED|Period I (Days 1-14)||0
10453256|NCT00991510|11601015|FG000|STARTED|Period II (Days 15-28)||21
10453257|NCT00991510|11601016|FG001|STARTED|Period II (Days 15-28)||21
10453258|NCT00991510|11601015|FG000|COMPLETED|Period II (Days 15-28)||21
10453259|NCT00991510|11601016|FG001|COMPLETED|Period II (Days 15-28)||21
10453260|NCT00991510|11601015|FG000|NOT COMPLETED|Period II (Days 15-28)||0
10453261|NCT00991510|11601016|FG001|NOT COMPLETED|Period II (Days 15-28)||0
10453262|NCT00991510|11601015|FG000|STARTED|Period III (Days 29-112)||21
10453263|NCT00991510|11601016|FG001|STARTED|Period III (Days 29-112)||21
10453264|NCT00991510|11601015|FG000|COMPLETED|Period III (Days 29-112)||20
10453265|NCT00991510|11601016|FG001|COMPLETED|Period III (Days 29-112)||20
10453266|NCT00991510|11601015|FG000|NOT COMPLETED|Period III (Days 29-112)||1
10453267|NCT00991510|11601016|FG001|NOT COMPLETED|Period III (Days 29-112)||1
10453268|NCT00991809|11601028|FG000|STARTED|Overall Study||12
10453269|NCT00991809|11601029|FG001|STARTED|Overall Study||10
10453270|NCT00991809|11601028|FG000|COMPLETED|Overall Study||8
10453271|NCT00991809|11601029|FG001|COMPLETED|Overall Study||4
10453272|NCT00991809|11601028|FG000|NOT COMPLETED|Overall Study||4
10453273|NCT00991809|11601029|FG001|NOT COMPLETED|Overall Study||6
10453274|NCT00991939|11601039|FG000|STARTED|Overall Study||5
10453275|NCT00991939|11601040|FG001|STARTED|Overall Study||3
10453276|NCT00991939|11601039|FG000|COMPLETED|Overall Study||0
10453277|NCT00991939|11601040|FG001|COMPLETED|Overall Study||1
10453278|NCT00991939|11601039|FG000|NOT COMPLETED|Overall Study||5
10453279|NCT00991939|11601040|FG001|NOT COMPLETED|Overall Study||2
10453280|NCT00991952|11601050|FG000|STARTED|Overall Study||13
10453281|NCT00991952|11601051|FG001|STARTED|Overall Study||6
10453282|NCT00991952|11601050|FG000|COMPLETED|Overall Study||13
10453283|NCT00991952|11601051|FG001|COMPLETED|Overall Study||5
10453284|NCT00991952|11601050|FG000|NOT COMPLETED|Overall Study||0
10453285|NCT00991952|11601051|FG001|NOT COMPLETED|Overall Study||1
10453286|NCT00992017|11601057|FG000|STARTED|Overall Study|Two additional women were enrolled but left the clinic before vaccine was administered.|128
10453287|NCT00992017|11601057|FG000|Received Both Study Vaccinations|Overall Study||124
10453288|NCT00992017|11601057|FG000|Received Only One Study Vaccination|Overall Study|Reasons: delivered and LFU; moved; no transportation; ineligible - blood transfusion at delivery|4
10453289|NCT00992017|11601057|FG000|COMPLETED|Overall Study||118
10453290|NCT00992017|11601057|FG000|NOT COMPLETED|Overall Study||10
10453291|NCT00992056|11601068|FG000|STARTED|Treatment Period 1 (6 Weeks)||12
10453292|NCT00992056|11601069|FG001|STARTED|Treatment Period 1 (6 Weeks)||12
10453293|NCT00992056|11601068|FG000|COMPLETED|Treatment Period 1 (6 Weeks)|February 2012|11
10453294|NCT00992056|11601069|FG001|COMPLETED|Treatment Period 1 (6 Weeks)||10
10453295|NCT00992056|11601068|FG000|NOT COMPLETED|Treatment Period 1 (6 Weeks)||1
10453296|NCT00992056|11601069|FG001|NOT COMPLETED|Treatment Period 1 (6 Weeks)||2
10453297|NCT00992056|11601068|FG000|STARTED|Washout Period (2 Weeks)||11
10453298|NCT00992056|11601069|FG001|STARTED|Washout Period (2 Weeks)||10
10453299|NCT00992056|11601068|FG000|COMPLETED|Washout Period (2 Weeks)||10
10453300|NCT00992056|11601069|FG001|COMPLETED|Washout Period (2 Weeks)||10
10453301|NCT00992056|11601068|FG000|NOT COMPLETED|Washout Period (2 Weeks)||1
10453302|NCT00992056|11601069|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0
10453303|NCT00992056|11601068|FG000|STARTED|Treatment Period 2 (6 Weeks)||10
10453304|NCT00992056|11601069|FG001|STARTED|Treatment Period 2 (6 Weeks)||10
10453305|NCT00992056|11601068|FG000|COMPLETED|Treatment Period 2 (6 Weeks)||10
10453306|NCT00992056|11601069|FG001|COMPLETED|Treatment Period 2 (6 Weeks)||10
10453307|NCT00992056|11601068|FG000|NOT COMPLETED|Treatment Period 2 (6 Weeks)||0
10453308|NCT00992056|11601069|FG001|NOT COMPLETED|Treatment Period 2 (6 Weeks)||0
10453309|NCT00992108|11601077|FG000|STARTED|Overall Study||7
10453310|NCT00992108|11601078|FG001|STARTED|Overall Study||10
10453311|NCT00992108|11601077|FG000|COMPLETED|Overall Study||7
10453312|NCT00992108|11601078|FG001|COMPLETED|Overall Study||9
10453313|NCT00992108|11601077|FG000|NOT COMPLETED|Overall Study||0
10453314|NCT00992108|11601078|FG001|NOT COMPLETED|Overall Study||1
10453315|NCT00992186|11601084|FG000|STARTED|Overall Study||46
10453316|NCT00992186|11601084|FG000|COMPLETED|Overall Study||0
10453317|NCT00992186|11601084|FG000|NOT COMPLETED|Overall Study||46
10453318|NCT00992225|11601089|FG000|STARTED|Overall Study||43
10453319|NCT00992225|11601089|FG000|Received at Least One Dose of Study Drug|Overall Study||33
10453320|NCT00992225|11601089|FG000|COMPLETED|Overall Study||33
10453321|NCT00992225|11601089|FG000|NOT COMPLETED|Overall Study||10
10453322|NCT00992264|11601109|FG000|STARTED|Overall Study||116
10453323|NCT00992264|11601110|FG001|STARTED|Overall Study||116
10453324|NCT00992264|11601111|FG002|STARTED|Overall Study||117
10453325|NCT00992264|11601112|FG003|STARTED|Overall Study||117
10453326|NCT00992264|11601113|FG004|STARTED|Overall Study||117
10453327|NCT00992264|11601114|FG005|STARTED|Overall Study||117
10453328|NCT00992264|11601115|FG006|STARTED|Overall Study||116
10453329|NCT00992264|11601116|FG007|STARTED|Overall Study||117
10453330|NCT00992264|11601117|FG008|STARTED|Overall Study||116
10453331|NCT00992264|11601118|FG009|STARTED|Overall Study||116
10453332|NCT00992264|11601119|FG010|STARTED|Overall Study||117
10453333|NCT00992264|11601120|FG011|STARTED|Overall Study||117
10453334|NCT00992264|11601121|FG012|STARTED|Overall Study||116
10453335|NCT00992264|11601122|FG013|STARTED|Overall Study||117
10453336|NCT00992264|11601123|FG014|STARTED|Overall Study||117
10453337|NCT00992264|11601124|FG015|STARTED|Overall Study||116
10453338|NCT00992264|11601109|FG000|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
10453339|NCT00992264|11601110|FG001|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
10453340|NCT00992264|11601111|FG002|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
10453341|NCT00992264|11601112|FG003|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
10453342|NCT00992264|11601113|FG004|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
10453343|NCT00992264|11601114|FG005|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
10453344|NCT00992264|11601115|FG006|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
10453345|NCT00992264|11601116|FG007|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
10453346|NCT00992264|11601117|FG008|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
10453347|NCT00992264|11601118|FG009|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
10453348|NCT00992264|11601119|FG010|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
10453432|NCT00992589|11601196|FG001|COMPLETED|Double-Blind Phase||76
10453349|NCT00992264|11601120|FG011|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
10453350|NCT00992264|11601121|FG012|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
10453351|NCT00992264|11601122|FG013|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
10453352|NCT00992264|11601123|FG014|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
10453353|NCT00992264|11601124|FG015|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
10453354|NCT00992264|11601109|FG000|NOT COMPLETED|Overall Study||0
10453355|NCT00992264|11601110|FG001|NOT COMPLETED|Overall Study||0
10453356|NCT00992264|11601111|FG002|NOT COMPLETED|Overall Study||0
10453357|NCT00992264|11601112|FG003|NOT COMPLETED|Overall Study||0
10453358|NCT00992264|11601113|FG004|NOT COMPLETED|Overall Study||0
10453359|NCT00992264|11601114|FG005|NOT COMPLETED|Overall Study||0
10453360|NCT00992264|11601115|FG006|NOT COMPLETED|Overall Study||0
10453361|NCT00992264|11601116|FG007|NOT COMPLETED|Overall Study||0
10453362|NCT00992264|11601117|FG008|NOT COMPLETED|Overall Study||0
10453363|NCT00992264|11601118|FG009|NOT COMPLETED|Overall Study||0
10453364|NCT00992264|11601119|FG010|NOT COMPLETED|Overall Study||0
10453365|NCT00992264|11601120|FG011|NOT COMPLETED|Overall Study||0
10453366|NCT00992264|11601121|FG012|NOT COMPLETED|Overall Study||0
10453367|NCT00992264|11601122|FG013|NOT COMPLETED|Overall Study||0
10453368|NCT00992264|11601123|FG014|NOT COMPLETED|Overall Study||0
10453369|NCT00992264|11601124|FG015|NOT COMPLETED|Overall Study||0
10453370|NCT00992394|11601137|FG000|STARTED|Overall Study||88
10453371|NCT00992394|11601138|FG001|STARTED|Overall Study||86
10453372|NCT00992394|11601137|FG000|Safety Population|Overall Study||87
10453373|NCT00992394|11601138|FG001|Safety Population|Overall Study||84
10453374|NCT00992394|11601137|FG000|mITT Population|Overall Study||86
10453375|NCT00992394|11601138|FG001|mITT Population|Overall Study||84
10453376|NCT00992394|11601137|FG000|COMPLETED|Overall Study||64
10453377|NCT00992394|11601138|FG001|COMPLETED|Overall Study||72
10453378|NCT00992394|11601137|FG000|NOT COMPLETED|Overall Study||24
10453379|NCT00992394|11601138|FG001|NOT COMPLETED|Overall Study||14
10453380|NCT00992407|11601146|FG000|STARTED|Overall Study||37
10453381|NCT00992407|11601147|FG001|STARTED|Overall Study||38
10453382|NCT00992407|11601146|FG000|Treated|Overall Study||20
10453383|NCT00992407|11601147|FG001|Treated|Overall Study||25
10453384|NCT00992407|11601146|FG000|COMPLETED|Overall Study||6
10453385|NCT00992407|11601147|FG001|COMPLETED|Overall Study||14
10453386|NCT00992407|11601146|FG000|NOT COMPLETED|Overall Study||31
10453387|NCT00992407|11601147|FG001|NOT COMPLETED|Overall Study||24
10453388|NCT00992433|11601158|FG000|STARTED|Overall Study||95
10453389|NCT00992433|11601159|FG001|STARTED|Overall Study||97
10453390|NCT00992433|11601158|FG000|COMPLETED|Overall Study||91
10453391|NCT00992433|11601159|FG001|COMPLETED|Overall Study||90
10453392|NCT00992433|11601158|FG000|NOT COMPLETED|Overall Study||4
10453393|NCT00992433|11601159|FG001|NOT COMPLETED|Overall Study||7
10453394|NCT00992446|11601165|FG000|STARTED|Overall Study||27
10453395|NCT00992446|11601165|FG000|COMPLETED|Overall Study||19
10453396|NCT00992446|11601165|FG000|NOT COMPLETED|Overall Study||8
10453397|NCT00992459|11601171|FG000|STARTED|Overall Study|All patients received HPN 100 placebo in Arm A (+ concomitant active NaPBA)|22
10453398|NCT00992459|11601172|FG001|STARTED|Overall Study|All patients received NaPBA placebo in Arm B (+ concomitant active HPN 100)|24
10453399|NCT00992459|11601171|FG000|COMPLETED|Overall Study|Totals enrolled and completed in Arm A NaPBA treatment + HPN 100 Placebo are not mutually exclusive.|21
10453400|NCT00992459|11601172|FG001|COMPLETED|Overall Study|Totals enrolled and completed in Arm B HPN 100 treatment + NaPBA Placebo are not mutually exclusive.|23
10453401|NCT00992459|11601171|FG000|NOT COMPLETED|Overall Study||1
10453402|NCT00992459|11601172|FG001|NOT COMPLETED|Overall Study||1
10453403|NCT00992511|11601182|FG000|STARTED|Overall Study||76
10453404|NCT00992511|11601183|FG001|STARTED|Overall Study||73
10453405|NCT00992511|11601184|FG002|STARTED|Overall Study||76
10453406|NCT00992511|11601185|FG003|STARTED|Overall Study||75
10453407|NCT00992511|11601182|FG000|COMPLETED|Overall Study||74
10453408|NCT00992511|11601183|FG001|COMPLETED|Overall Study||73
10453409|NCT00992511|11601184|FG002|COMPLETED|Overall Study||74
10453410|NCT00992511|11601185|FG003|COMPLETED|Overall Study||70
10453411|NCT00992511|11601182|FG000|NOT COMPLETED|Overall Study||2
10453412|NCT00992511|11601183|FG001|NOT COMPLETED|Overall Study||0
10453413|NCT00992511|11601184|FG002|NOT COMPLETED|Overall Study||2
10453414|NCT00992511|11601185|FG003|NOT COMPLETED|Overall Study||5
10453415|NCT00992589|11601195|FG000|STARTED|Open-Label Phase||344
10453416|NCT00992589|11601196|FG001|STARTED|Open-Label Phase||0
10453417|NCT00992589|11601197|FG002|STARTED|Open-Label Phase||0
10453418|NCT00992589|11601198|FG003|STARTED|Open-Label Phase||0
10453419|NCT00992589|11601195|FG000|COMPLETED|Open-Label Phase||267
10453420|NCT00992589|11601196|FG001|COMPLETED|Open-Label Phase||0
10453421|NCT00992589|11601197|FG002|COMPLETED|Open-Label Phase||0
10453422|NCT00992589|11601198|FG003|COMPLETED|Open-Label Phase||0
10453423|NCT00992589|11601195|FG000|NOT COMPLETED|Open-Label Phase||77
10453424|NCT00992589|11601196|FG001|NOT COMPLETED|Open-Label Phase||0
10453425|NCT00992589|11601197|FG002|NOT COMPLETED|Open-Label Phase||0
10453426|NCT00992589|11601198|FG003|NOT COMPLETED|Open-Label Phase||0
10453427|NCT00992589|11601195|FG000|STARTED|Double-Blind Phase||0
10453428|NCT00992589|11601196|FG001|STARTED|Double-Blind Phase||89
10453429|NCT00992589|11601197|FG002|STARTED|Double-Blind Phase||90
10453430|NCT00992589|11601198|FG003|STARTED|Double-Blind Phase||88
10453431|NCT00992589|11601195|FG000|COMPLETED|Double-Blind Phase||0
10453433|NCT00992589|11601197|FG002|COMPLETED|Double-Blind Phase||77
10453434|NCT00992589|11601198|FG003|COMPLETED|Double-Blind Phase||78
10453435|NCT00992589|11601195|FG000|NOT COMPLETED|Double-Blind Phase||0
10453436|NCT00992589|11601196|FG001|NOT COMPLETED|Double-Blind Phase||13
10453437|NCT00992589|11601197|FG002|NOT COMPLETED|Double-Blind Phase||13
10453438|NCT00992589|11601198|FG003|NOT COMPLETED|Double-Blind Phase||10
10453439|NCT00992602|11601216|FG000|STARTED|Overall Study||3
10453440|NCT00992602|11601216|FG000|COMPLETED|Overall Study||0
10453441|NCT00992602|11601216|FG000|NOT COMPLETED|Overall Study||3
10453442|NCT00992719|11601223|FG000|STARTED|Overall Study||28
10453443|NCT00992719|11601224|FG001|STARTED|Overall Study||28
10453444|NCT00992719|11601225|FG002|STARTED|Overall Study||28
10453445|NCT00992719|11601223|FG000|COMPLETED|Overall Study||27
10453446|NCT00992719|11601224|FG001|COMPLETED|Overall Study||27
10453447|NCT00992719|11601225|FG002|COMPLETED|Overall Study||28
10453448|NCT00992719|11601223|FG000|NOT COMPLETED|Overall Study||1
10453449|NCT00992719|11601224|FG001|NOT COMPLETED|Overall Study||1
10453450|NCT00992719|11601225|FG002|NOT COMPLETED|Overall Study||0
10453451|NCT00992784|11601236|FG000|STARTED|Overall Study||180
10453452|NCT00992784|11601237|FG001|STARTED|Overall Study||104
10453453|NCT00992784|11601238|FG002|STARTED|Overall Study||86
10453454|NCT00992784|11601236|FG000|COMPLETED|Overall Study||177
10453455|NCT00992784|11601237|FG001|COMPLETED|Overall Study||102
10453456|NCT00992784|11601238|FG002|COMPLETED|Overall Study||85
10453457|NCT00992784|11601236|FG000|NOT COMPLETED|Overall Study||3
10453458|NCT00992784|11601237|FG001|NOT COMPLETED|Overall Study||2
10453459|NCT00992784|11601238|FG002|NOT COMPLETED|Overall Study||1
10453460|NCT00992836|11601246|FG000|STARTED|Overall Study||155
10453461|NCT00992836|11601246|FG000|Received Both Study Vaccinations|Overall Study||150
10453462|NCT00992836|11601246|FG000|COMPLETED|Overall Study||150
10453463|NCT00992836|11601246|FG000|NOT COMPLETED|Overall Study||5
10453464|NCT00992927|11601258|FG000|STARTED|Overall Study||32
10453465|NCT00992927|11601259|FG001|STARTED|Overall Study||22
10453466|NCT00992927|11601258|FG000|COMPLETED|Overall Study||32
10453467|NCT00992927|11601259|FG001|COMPLETED|Overall Study||22
10453468|NCT00992927|11601258|FG000|NOT COMPLETED|Overall Study||0
10453469|NCT00992927|11601259|FG001|NOT COMPLETED|Overall Study||0
10453470|NCT00992992|11601265|FG000|STARTED|Overall Study||25
10453471|NCT00992992|11601265|FG000|COMPLETED|Overall Study||0
10453472|NCT00992992|11601265|FG000|NOT COMPLETED|Overall Study||25
10453473|NCT00993031|11601271|FG000|STARTED|Overall Study||195
10453474|NCT00993031|11601272|FG001|STARTED|Overall Study||194
10453475|NCT00993031|11601271|FG000|Delivered|Overall Study||187
10453476|NCT00993031|11601272|FG001|Delivered|Overall Study||190
10453477|NCT00993031|11601271|FG000|COMPLETED|Overall Study||173
10453478|NCT00993031|11601272|FG001|COMPLETED|Overall Study||175
10453479|NCT00993031|11601271|FG000|NOT COMPLETED|Overall Study||22
10453480|NCT00993031|11601272|FG001|NOT COMPLETED|Overall Study||19
10453481|NCT00993044|11601282|FG000|STARTED|Irinotecan 30 mg||6
10453482|NCT00993044|11601282|FG000|COMPLETED|Irinotecan 30 mg||6
10453483|NCT00993044|11601282|FG000|NOT COMPLETED|Irinotecan 30 mg||0
10453484|NCT00993044|11601282|FG000|STARTED|Irinotecan 50 mg||7
10453485|NCT00993044|11601282|FG000|COMPLETED|Irinotecan 50 mg||6
10453486|NCT00993044|11601282|FG000|NOT COMPLETED|Irinotecan 50 mg||1
10453487|NCT00993148|11601287|FG000|STARTED|Overall Study||25
10453488|NCT00993148|11601287|FG000|COMPLETED|Overall Study||22
10453489|NCT00993148|11601287|FG000|NOT COMPLETED|Overall Study||3
10453490|NCT00993187|11601293|FG000|STARTED|Overall Study||147
10453491|NCT00993187|11601294|FG001|STARTED|Overall Study||145
10453492|NCT00993187|11601293|FG000|Received at Least 1 Dose of Study Drug|Overall Study||146
10453493|NCT00993187|11601294|FG001|Received at Least 1 Dose of Study Drug|Overall Study||144
10453494|NCT00993187|11601293|FG000|COMPLETED|Overall Study||121
10453495|NCT00993187|11601294|FG001|COMPLETED|Overall Study||108
10453496|NCT00993187|11601293|FG000|NOT COMPLETED|Overall Study||26
10453497|NCT00993187|11601294|FG001|NOT COMPLETED|Overall Study||37
10453498|NCT00993200|11601302|FG000|STARTED|Overall Study||13
10453499|NCT00993200|11601303|FG001|STARTED|Overall Study||13
10453500|NCT00993200|11601302|FG000|COMPLETED|Overall Study||13
10453501|NCT00993200|11601303|FG001|COMPLETED|Overall Study||13
10453502|NCT00993200|11601302|FG000|NOT COMPLETED|Overall Study||0
10453503|NCT00993200|11601303|FG001|NOT COMPLETED|Overall Study||0
10453504|NCT00993226|11601314|FG000|STARTED|Overall Study||61
10453505|NCT00993226|11601315|FG001|STARTED|Overall Study||27
10453506|NCT00993226|11601316|FG002|STARTED|Overall Study||27
10453507|NCT00993226|11601314|FG000|COMPLETED|Overall Study||60
10453508|NCT00993226|11601315|FG001|COMPLETED|Overall Study||26
10453509|NCT00993226|11601316|FG002|COMPLETED|Overall Study||27
10453510|NCT00993226|11601314|FG000|NOT COMPLETED|Overall Study||1
10453511|NCT00993226|11601315|FG001|NOT COMPLETED|Overall Study||1
10453512|NCT00993226|11601316|FG002|NOT COMPLETED|Overall Study||0
10453513|NCT00993265|11601326|FG000|STARTED|Overall Study||20
10453514|NCT00993265|11601327|FG001|STARTED|Overall Study||19
10453515|NCT00993265|11601326|FG000|COMPLETED|Overall Study||16
10453516|NCT00993265|11601327|FG001|COMPLETED|Overall Study||19
10453517|NCT00993265|11601326|FG000|NOT COMPLETED|Overall Study||4
10453518|NCT00993265|11601327|FG001|NOT COMPLETED|Overall Study||0
10453519|NCT00993291|11601333|FG000|STARTED|Overall Study||20
10453520|NCT00993291|11601333|FG000|COMPLETED|Overall Study||19
10453521|NCT00993291|11601333|FG000|NOT COMPLETED|Overall Study||1
10453522|NCT00993317|11601339|FG000|STARTED|Overall Study||42
10453523|NCT00993317|11601340|FG001|STARTED|Overall Study||85
10453524|NCT00993317|11601339|FG000|COMPLETED|Overall Study||21
10453525|NCT00993317|11601340|FG001|COMPLETED|Overall Study||60
10453526|NCT00993317|11601339|FG000|NOT COMPLETED|Overall Study||21
10453527|NCT00993317|11601340|FG001|NOT COMPLETED|Overall Study||25
10453528|NCT00993421|11601353|FG000|STARTED|Overall Study||49
10453529|NCT00993421|11601354|FG001|STARTED|Overall Study||49
10453530|NCT00993421|11601355|FG002|STARTED|Overall Study||48
10453531|NCT00993421|11601356|FG003|STARTED|Overall Study||49
10453532|NCT00993421|11601357|FG004|STARTED|Overall Study||52
10453533|NCT00993421|11601358|FG005|STARTED|Overall Study||50
10453534|NCT00993421|11601359|FG006|STARTED|Overall Study||46
10453535|NCT00993421|11601353|FG000|COMPLETED|Overall Study||5
10453536|NCT00993421|11601354|FG001|COMPLETED|Overall Study||4
10453537|NCT00993421|11601355|FG002|COMPLETED|Overall Study||5
10453538|NCT00993421|11601356|FG003|COMPLETED|Overall Study||4
10453539|NCT00993421|11601357|FG004|COMPLETED|Overall Study||6
10453540|NCT00993421|11601358|FG005|COMPLETED|Overall Study||4
10453541|NCT00993421|11601359|FG006|COMPLETED|Overall Study||4
10453542|NCT00993421|11601353|FG000|NOT COMPLETED|Overall Study||44
10453543|NCT00993421|11601354|FG001|NOT COMPLETED|Overall Study||45
10453544|NCT00993421|11601355|FG002|NOT COMPLETED|Overall Study||43
10453545|NCT00993421|11601356|FG003|NOT COMPLETED|Overall Study||45
10453546|NCT00993421|11601357|FG004|NOT COMPLETED|Overall Study||46
10453547|NCT00993421|11601358|FG005|NOT COMPLETED|Overall Study||46
10453548|NCT00993421|11601359|FG006|NOT COMPLETED|Overall Study||42
10453549|NCT00993473|11601377|FG000|STARTED|Overall Study|61 patients randomized to Lantus but 62 patients treated with Lantus due to a dispensation's error|61
10453550|NCT00993473|11601378|FG001|STARTED|Overall Study|64 patients randomized to NPH but only 63 patients treated with NPH due to a dispensation's error|64
10453551|NCT00993473|11601377|FG000|COMPLETED|Overall Study||57
10453552|NCT00993473|11601378|FG001|COMPLETED|Overall Study||54
10453553|NCT00993473|11601377|FG000|NOT COMPLETED|Overall Study||4
10453554|NCT00993473|11601378|FG001|NOT COMPLETED|Overall Study||10
10453555|NCT00993499|11601390|FG000|STARTED|Run-in Period (8 Days)||13
10453556|NCT00993499|11601391|FG001|STARTED|Run-in Period (8 Days)||12
10453557|NCT00993499|11601392|FG002|STARTED|Run-in Period (8 Days)||10
10453558|NCT00993499|11601393|FG003|STARTED|Run-in Period (8 Days)||3
10453559|NCT00993499|11601394|FG004|STARTED|Run-in Period (8 Days)||3
10453560|NCT00993499|11601395|FG005|STARTED|Run-in Period (8 Days)||3
10453561|NCT00993499|11601390|FG000|COMPLETED|Run-in Period (8 Days)||12
10453562|NCT00993499|11601391|FG001|COMPLETED|Run-in Period (8 Days)||9
10453563|NCT00993499|11601392|FG002|COMPLETED|Run-in Period (8 Days)||9
10453564|NCT00993499|11601393|FG003|COMPLETED|Run-in Period (8 Days)||3
10453565|NCT00993499|11601394|FG004|COMPLETED|Run-in Period (8 Days)||3
10453566|NCT00993499|11601395|FG005|COMPLETED|Run-in Period (8 Days)||3
10453567|NCT00993499|11601390|FG000|NOT COMPLETED|Run-in Period (8 Days)||1
10453568|NCT00993499|11601391|FG001|NOT COMPLETED|Run-in Period (8 Days)||3
10453569|NCT00993499|11601392|FG002|NOT COMPLETED|Run-in Period (8 Days)||1
10453570|NCT00993499|11601393|FG003|NOT COMPLETED|Run-in Period (8 Days)||0
10453571|NCT00993499|11601394|FG004|NOT COMPLETED|Run-in Period (8 Days)||0
10453572|NCT00993499|11601395|FG005|NOT COMPLETED|Run-in Period (8 Days)||0
10453573|NCT00993499|11601390|FG000|STARTED|Discontinued Before Starting Course 3||12
10453574|NCT00993499|11601391|FG001|STARTED|Discontinued Before Starting Course 3||9
10453575|NCT00993499|11601392|FG002|STARTED|Discontinued Before Starting Course 3||9
10453576|NCT00993499|11601393|FG003|STARTED|Discontinued Before Starting Course 3||3
10453577|NCT00993499|11601394|FG004|STARTED|Discontinued Before Starting Course 3||3
10453578|NCT00993499|11601395|FG005|STARTED|Discontinued Before Starting Course 3||3
10453579|NCT00993499|11601390|FG000|COMPLETED|Discontinued Before Starting Course 3||8
10453580|NCT00993499|11601391|FG001|COMPLETED|Discontinued Before Starting Course 3||5
10453581|NCT00993499|11601392|FG002|COMPLETED|Discontinued Before Starting Course 3||6
10453582|NCT00993499|11601393|FG003|COMPLETED|Discontinued Before Starting Course 3||2
10453583|NCT00993499|11601394|FG004|COMPLETED|Discontinued Before Starting Course 3||3
10453584|NCT00993499|11601395|FG005|COMPLETED|Discontinued Before Starting Course 3||3
10453585|NCT00993499|11601390|FG000|NOT COMPLETED|Discontinued Before Starting Course 3||4
10453586|NCT00993499|11601391|FG001|NOT COMPLETED|Discontinued Before Starting Course 3||4
10453587|NCT00993499|11601392|FG002|NOT COMPLETED|Discontinued Before Starting Course 3||3
10453588|NCT00993499|11601393|FG003|NOT COMPLETED|Discontinued Before Starting Course 3||1
10453589|NCT00993499|11601394|FG004|NOT COMPLETED|Discontinued Before Starting Course 3||0
10453590|NCT00993499|11601395|FG005|NOT COMPLETED|Discontinued Before Starting Course 3||0
10453591|NCT00993499|11601390|FG000|STARTED|Discontinued After Starting Course 3||12
10453592|NCT00993499|11601391|FG001|STARTED|Discontinued After Starting Course 3||9
10453593|NCT00993499|11601392|FG002|STARTED|Discontinued After Starting Course 3||9
10453594|NCT00993499|11601393|FG003|STARTED|Discontinued After Starting Course 3||3
10453595|NCT00993499|11601394|FG004|STARTED|Discontinued After Starting Course 3||3
10453596|NCT00993499|11601395|FG005|STARTED|Discontinued After Starting Course 3||3
10453597|NCT00993499|11601390|FG000|COMPLETED|Discontinued After Starting Course 3||4
10453598|NCT00993499|11601391|FG001|COMPLETED|Discontinued After Starting Course 3||4
10453599|NCT00993499|11601392|FG002|COMPLETED|Discontinued After Starting Course 3||3
10453600|NCT00993499|11601393|FG003|COMPLETED|Discontinued After Starting Course 3||1
10453601|NCT00993499|11601394|FG004|COMPLETED|Discontinued After Starting Course 3||0
10453602|NCT00993499|11601395|FG005|COMPLETED|Discontinued After Starting Course 3||0
10453603|NCT00993499|11601390|FG000|NOT COMPLETED|Discontinued After Starting Course 3||8
10453604|NCT00993499|11601391|FG001|NOT COMPLETED|Discontinued After Starting Course 3||5
10453605|NCT00993499|11601392|FG002|NOT COMPLETED|Discontinued After Starting Course 3||6
10453606|NCT00993499|11601393|FG003|NOT COMPLETED|Discontinued After Starting Course 3||2
10453607|NCT00993499|11601394|FG004|NOT COMPLETED|Discontinued After Starting Course 3||3
10453608|NCT00993499|11601395|FG005|NOT COMPLETED|Discontinued After Starting Course 3||3
10453609|NCT00993616|11601409|FG000|STARTED|Overall Study||29
10453610|NCT00993616|11601409|FG000|COMPLETED|Overall Study|Number of eligible and evaluable participants|27
10453611|NCT00993616|11601409|FG000|NOT COMPLETED|Overall Study||2
10453612|NCT00993655|11601422|FG000|STARTED|Overall Study||101
10453613|NCT00993655|11601423|FG001|STARTED|Overall Study||72
10453614|NCT00993655|11601424|FG002|STARTED|Overall Study||102
10453615|NCT00993655|11601422|FG000|COMPLETED|Overall Study||101
10453616|NCT00993655|11601423|FG001|COMPLETED|Overall Study||72
10453617|NCT00993655|11601424|FG002|COMPLETED|Overall Study||102
10453618|NCT00993655|11601422|FG000|NOT COMPLETED|Overall Study||0
10453619|NCT00993655|11601423|FG001|NOT COMPLETED|Overall Study||0
10453620|NCT00993655|11601424|FG002|NOT COMPLETED|Overall Study||0
10453621|NCT00993668|11601437|FG000|STARTED|Single-Blind Period||114
10453622|NCT00993668|11601438|FG001|STARTED|Single-Blind Period||110
10453623|NCT00993668|11601437|FG000|COMPLETED|Single-Blind Period||110
10453624|NCT00993668|11601438|FG001|COMPLETED|Single-Blind Period||107
10453625|NCT00993668|11601437|FG000|NOT COMPLETED|Single-Blind Period||4
10453626|NCT00993668|11601438|FG001|NOT COMPLETED|Single-Blind Period||3
10453627|NCT00993668|11601437|FG000|STARTED|Open-Label Period|1 subject chose not to enter the optional open-label period|109
10453628|NCT00993668|11601438|FG001|STARTED|Open-Label Period|1 subject chose not to enter the optional open-label period|106
10453629|NCT00993668|11601437|FG000|COMPLETED|Open-Label Period||86
10453630|NCT00993668|11601438|FG001|COMPLETED|Open-Label Period||91
10453631|NCT00993668|11601437|FG000|NOT COMPLETED|Open-Label Period||23
10453632|NCT00993668|11601438|FG001|NOT COMPLETED|Open-Label Period||15
10453633|NCT00993798|11601448|FG000|STARTED|Overall Study||53
10453634|NCT00993798|11601449|FG001|STARTED|Overall Study||25
10453635|NCT00993798|11601450|FG002|STARTED|Overall Study||29
10453636|NCT00993798|11601451|FG003|STARTED|Overall Study||0
10453637|NCT00993798|11601452|FG004|STARTED|Overall Study||0
10453638|NCT00993798|11601448|FG000|COMPLETED|Overall Study||53
10453639|NCT00993798|11601449|FG001|COMPLETED|Overall Study||25
10453640|NCT00993798|11601450|FG002|COMPLETED|Overall Study||29
10453641|NCT00993798|11601451|FG003|COMPLETED|Overall Study||0
10453642|NCT00993798|11601452|FG004|COMPLETED|Overall Study||0
10453643|NCT00993798|11601448|FG000|NOT COMPLETED|Overall Study||0
10453644|NCT00993798|11601449|FG001|NOT COMPLETED|Overall Study||0
10453645|NCT00993798|11601450|FG002|NOT COMPLETED|Overall Study||0
10453646|NCT00993798|11601451|FG003|NOT COMPLETED|Overall Study||0
10453647|NCT00993798|11601452|FG004|NOT COMPLETED|Overall Study||0
10453648|NCT00993824|11601462|FG000|STARTED|Overall Study||11
10453649|NCT00993824|11601463|FG001|STARTED|Overall Study||10
10453650|NCT00993824|11601462|FG000|COMPLETED|Overall Study||11
10453651|NCT00993824|11601463|FG001|COMPLETED|Overall Study||10
10453652|NCT00993824|11601462|FG000|NOT COMPLETED|Overall Study||0
10453653|NCT00993824|11601463|FG001|NOT COMPLETED|Overall Study||0
10453654|NCT00993915|11601471|FG000|STARTED|Overall Study||687
10453655|NCT00993915|11601471|FG000|COMPLETED|Overall Study||678
10453656|NCT00993915|11601471|FG000|NOT COMPLETED|Overall Study||9
10453657|NCT00993928|11601477|FG000|STARTED|Overall Study||48
10453658|NCT00993928|11601478|FG001|STARTED|Overall Study||45
10453659|NCT00993928|11601477|FG000|COMPLETED|Overall Study||43
10453660|NCT00993928|11601478|FG001|COMPLETED|Overall Study||38
10453661|NCT00993928|11601477|FG000|NOT COMPLETED|Overall Study||5
10453662|NCT00993928|11601478|FG001|NOT COMPLETED|Overall Study||7
10453663|NCT00993954|11601490|FG000|STARTED|Overall Study||145
10453664|NCT00993954|11601491|FG001|STARTED|Overall Study||123
10453665|NCT00993954|11601490|FG000|COMPLETED|Overall Study||124
10453666|NCT00993954|11601491|FG001|COMPLETED|Overall Study||121
10453667|NCT00993954|11601490|FG000|NOT COMPLETED|Overall Study||21
10453668|NCT00993954|11601491|FG001|NOT COMPLETED|Overall Study||2
10453669|NCT00993967|11601497|FG000|STARTED|Overall Study||200
10453670|NCT00993967|11601497|FG000|COMPLETED|Overall Study||139
10453671|NCT00993967|11601497|FG000|NOT COMPLETED|Overall Study||61
10453672|NCT00994110|11601503|FG000|STARTED|Overall Study||217
10453673|NCT00994110|11601504|FG001|STARTED|Overall Study||222
10453674|NCT00994110|11601503|FG000|COMPLETED|Overall Study||152
10453675|NCT00994110|11601504|FG001|COMPLETED|Overall Study||148
10453676|NCT00994110|11601503|FG000|NOT COMPLETED|Overall Study||65
10453677|NCT00994110|11601504|FG001|NOT COMPLETED|Overall Study||74
10453678|NCT00994123|11601513|FG000|STARTED|Overall Study||33
10453679|NCT00994123|11601514|FG001|STARTED|Overall Study||85
10453680|NCT00994123|11601515|FG002|STARTED|Overall Study||44
10453681|NCT00994123|11601513|FG000|COMPLETED|Overall Study||33
10453682|NCT00994123|11601514|FG001|COMPLETED|Overall Study||85
10453683|NCT00994123|11601515|FG002|COMPLETED|Overall Study||44
10453684|NCT00994123|11601513|FG000|NOT COMPLETED|Overall Study||0
10453685|NCT00994123|11601514|FG001|NOT COMPLETED|Overall Study||0
10453686|NCT00994123|11601515|FG002|NOT COMPLETED|Overall Study||0
10453687|NCT00994175|11601534|FG000|STARTED|First Intervention||6
10453688|NCT00994175|11601535|FG001|STARTED|First Intervention||9
10453689|NCT00994175|11601534|FG000|COMPLETED|First Intervention||4
10453690|NCT00994175|11601535|FG001|COMPLETED|First Intervention||8
10453691|NCT00994175|11601534|FG000|NOT COMPLETED|First Intervention||2
10453692|NCT00994175|11601535|FG001|NOT COMPLETED|First Intervention||1
10453693|NCT00994175|11601534|FG000|STARTED|Second Intervention||4
10453694|NCT00994175|11601535|FG001|STARTED|Second Intervention||8
10453695|NCT00994175|11601534|FG000|COMPLETED|Second Intervention||4
10453696|NCT00994175|11601535|FG001|COMPLETED|Second Intervention||8
10453697|NCT00994175|11601534|FG000|NOT COMPLETED|Second Intervention||0
10453698|NCT00994175|11601535|FG001|NOT COMPLETED|Second Intervention||0
10453699|NCT00994214|11601545|FG000|STARTED|ITT (Intention-to-Treat) - Part A||19
10453700|NCT00994214|11601546|FG001|STARTED|ITT (Intention-to-Treat) - Part A||19
10453701|NCT00994214|11601547|FG002|STARTED|ITT (Intention-to-Treat) - Part A||18
10453702|NCT00994214|11601548|FG003|STARTED|ITT (Intention-to-Treat) - Part A||20
10453703|NCT00994214|11601545|FG000|COMPLETED|ITT (Intention-to-Treat) - Part A||5
10453704|NCT00994214|11601546|FG001|COMPLETED|ITT (Intention-to-Treat) - Part A||6
10453705|NCT00994214|11601547|FG002|COMPLETED|ITT (Intention-to-Treat) - Part A||5
10453706|NCT00994214|11601548|FG003|COMPLETED|ITT (Intention-to-Treat) - Part A||5
10453707|NCT00994214|11601545|FG000|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||14
10453708|NCT00994214|11601546|FG001|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||13
10453709|NCT00994214|11601547|FG002|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||13
10453710|NCT00994214|11601548|FG003|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||15
10453711|NCT00994214|11601545|FG000|STARTED|ITT (Intention-to-Treat) - Part B|1 subject did not enter Part B Arm A|4
10453712|NCT00994214|11601546|FG001|STARTED|ITT (Intention-to-Treat) - Part B|3 subjects did not enter Part B Arm B|3
10453713|NCT00994214|11601547|FG002|STARTED|ITT (Intention-to-Treat) - Part B|3 subjects did not enter Part B Arm C|2
10453714|NCT00994214|11601548|FG003|STARTED|ITT (Intention-to-Treat) - Part B|2 subjects did not enter Part B Arm D|3
10453715|NCT00994214|11601545|FG000|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
10453716|NCT00994214|11601546|FG001|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
10453717|NCT00994214|11601547|FG002|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
10453718|NCT00994214|11601548|FG003|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
10453719|NCT00994214|11601545|FG000|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||3
10453720|NCT00994214|11601546|FG001|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
10453721|NCT00994214|11601547|FG002|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
10453722|NCT00994214|11601548|FG003|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
10453723|NCT00994214|11601545|FG000|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||1
10453724|NCT00994214|11601546|FG001|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||3
10453725|NCT00994214|11601547|FG002|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||0
10453726|NCT00994214|11601548|FG003|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||0
10453727|NCT00994214|11601545|FG000|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||0
10453728|NCT00994214|11601546|FG001|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||0
10453729|NCT00994214|11601547|FG002|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||2
10453730|NCT00994214|11601548|FG003|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||3
10453731|NCT00994214|11601545|FG000|COMPLETED|ITT (Intention-to-Treat) - Part B||0
10453732|NCT00994214|11601546|FG001|COMPLETED|ITT (Intention-to-Treat) - Part B||0
10453733|NCT00994214|11601547|FG002|COMPLETED|ITT (Intention-to-Treat) - Part B||0
10453734|NCT00994214|11601548|FG003|COMPLETED|ITT (Intention-to-Treat) - Part B||0
10453735|NCT00994214|11601545|FG000|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||4
10453736|NCT00994214|11601546|FG001|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||3
10453737|NCT00994214|11601547|FG002|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||2
10453738|NCT00994214|11601548|FG003|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||3
10453739|NCT00994240|11601578|FG000|STARTED|Overall Study||41
10453740|NCT00994240|11601579|FG001|STARTED|Overall Study||44
10453741|NCT00994240|11601578|FG000|COMPLETED|Overall Study||35
10453742|NCT00994240|11601579|FG001|COMPLETED|Overall Study||39
10453743|NCT00994240|11601578|FG000|NOT COMPLETED|Overall Study||6
10453744|NCT00994240|11601579|FG001|NOT COMPLETED|Overall Study||5
10453745|NCT00994279|11601587|FG000|STARTED|Overall Study||22
10453746|NCT00994279|11601588|FG001|STARTED|Overall Study||18
10453747|NCT00994279|11601587|FG000|COMPLETED|Overall Study||18
10453748|NCT00994279|11601588|FG001|COMPLETED|Overall Study||13
10453749|NCT00994279|11601587|FG000|NOT COMPLETED|Overall Study||4
10453750|NCT00994279|11601588|FG001|NOT COMPLETED|Overall Study||5
10453751|NCT00994318|11601597|FG000|STARTED|Overall Study||155
10453752|NCT00994318|11601598|FG001|STARTED|Overall Study||154
10453753|NCT00994318|11601599|FG002|STARTED|Overall Study||317
10453754|NCT00994318|11601597|FG000|COMPLETED|Overall Study||133
10453755|NCT00994318|11601598|FG001|COMPLETED|Overall Study||136
10453756|NCT00994318|11601599|FG002|COMPLETED|Overall Study||250
10453757|NCT00994318|11601597|FG000|NOT COMPLETED|Overall Study||22
10453758|NCT00994318|11601598|FG001|NOT COMPLETED|Overall Study||18
10453759|NCT00994318|11601599|FG002|NOT COMPLETED|Overall Study||67
10453760|NCT00994422|11601609|FG000|STARTED|Overall Study||192
10453761|NCT00994422|11601610|FG001|STARTED|Overall Study||55
10453762|NCT00994422|11601609|FG000|COMPLETED|Overall Study||185
10453763|NCT00994422|11601610|FG001|COMPLETED|Overall Study||54
10453764|NCT00994422|11601609|FG000|NOT COMPLETED|Overall Study||7
10453765|NCT00994422|11601610|FG001|NOT COMPLETED|Overall Study||1
10453766|NCT00994448|11601620|FG000|STARTED|Overall Study||12
10453767|NCT00994448|11601621|FG001|STARTED|Overall Study||7
10453768|NCT00994448|11601620|FG000|COMPLETED|Overall Study||4
10453769|NCT00994448|11601621|FG001|COMPLETED|Overall Study||5
10453770|NCT00994448|11601620|FG000|NOT COMPLETED|Overall Study||8
10453771|NCT00994448|11601621|FG001|NOT COMPLETED|Overall Study||2
10525950|NCT01379703|11677962|FG001|NOT COMPLETED|9 Months Through 18 Months||230
10525951|NCT01379703|11677963|FG002|NOT COMPLETED|9 Months Through 18 Months||0
10525952|NCT01379768|11677975|FG000|STARTED|Overall Study||23
10525953|NCT01379768|11677976|FG001|STARTED|Overall Study||22
10525954|NCT01379768|11677977|FG002|STARTED|Overall Study||20
10525955|NCT01379768|11677975|FG000|COMPLETED|Overall Study||20
10525956|NCT01379768|11677976|FG001|COMPLETED|Overall Study||21
10525957|NCT01379768|11677977|FG002|COMPLETED|Overall Study||20
10525958|NCT01379768|11677975|FG000|NOT COMPLETED|Overall Study||3
10525959|NCT01379768|11677976|FG001|NOT COMPLETED|Overall Study||1
10525960|NCT01379768|11677977|FG002|NOT COMPLETED|Overall Study||0
10525961|NCT01379924|11677987|FG000|STARTED|Baseline||72
10525962|NCT01379924|11677988|FG001|STARTED|Baseline||68
10525963|NCT01379924|11677987|FG000|COMPLETED|Baseline||72
10525964|NCT01379924|11677988|FG001|COMPLETED|Baseline||68
10525965|NCT01379924|11677987|FG000|NOT COMPLETED|Baseline||0
10525966|NCT01379924|11677988|FG001|NOT COMPLETED|Baseline||0
10525967|NCT01379924|11677987|FG000|STARTED|12-month Assessment||72
10525968|NCT01379924|11677988|FG001|STARTED|12-month Assessment||68
10525969|NCT01379924|11677987|FG000|COMPLETED|12-month Assessment||62
10525970|NCT01379924|11677988|FG001|COMPLETED|12-month Assessment||55
10525971|NCT01379924|11677987|FG000|NOT COMPLETED|12-month Assessment||10
10525972|NCT01379924|11677988|FG001|NOT COMPLETED|12-month Assessment||13
10525973|NCT01379924|11677987|FG000|STARTED|24-month Assessment||62
10525974|NCT01379924|11677988|FG001|STARTED|24-month Assessment||55
10525975|NCT01379924|11677987|FG000|COMPLETED|24-month Assessment||55
10525976|NCT01379924|11677988|FG001|COMPLETED|24-month Assessment||52
10525977|NCT01379924|11677987|FG000|NOT COMPLETED|24-month Assessment||7
10525978|NCT01379924|11677988|FG001|NOT COMPLETED|24-month Assessment||3
10525979|NCT01379924|11677987|FG000|STARTED|36-month Assessment||55
10525980|NCT01379924|11677988|FG001|STARTED|36-month Assessment||52
10525981|NCT01379924|11677987|FG000|COMPLETED|36-month Assessment||52
10525982|NCT01379924|11677988|FG001|COMPLETED|36-month Assessment||48
10525983|NCT01379924|11677987|FG000|NOT COMPLETED|36-month Assessment||3
10525984|NCT01379924|11677988|FG001|NOT COMPLETED|36-month Assessment||4
10525985|NCT01379937|11678001|FG000|STARTED|Overall Study||156
10525986|NCT01379937|11678002|FG001|STARTED|Overall Study||156
10525987|NCT01379937|11678003|FG002|STARTED|Overall Study||104
10525988|NCT01379937|11678004|FG003|STARTED|Overall Study||104
10525989|NCT01379937|11678001|FG000|COMPLETED|Overall Study||155
10525990|NCT01379937|11678002|FG001|COMPLETED|Overall Study||153
10525991|NCT01379937|11678003|FG002|COMPLETED|Overall Study||102
10525992|NCT01379937|11678004|FG003|COMPLETED|Overall Study||103
10525993|NCT01379937|11678001|FG000|NOT COMPLETED|Overall Study||1
10525994|NCT01379937|11678002|FG001|NOT COMPLETED|Overall Study||3
10525995|NCT01379937|11678003|FG002|NOT COMPLETED|Overall Study||2
10551604|NCT01537081|11705700|FG001|Safety Population|Overall Study||1122
10551605|NCT01537081|11705701|FG002|Safety Population|Overall Study||561
10551606|NCT01537081|11705699|FG000|Modified Intent to Treat Population|Overall Study||1106
10551607|NCT01537081|11705700|FG001|Modified Intent to Treat Population|Overall Study||1109
10551608|NCT01537081|11705701|FG002|Modified Intent to Treat Population|Overall Study||556
10551609|NCT01537081|11705699|FG000|COMPLETED|Overall Study||1084
10525996|NCT01379937|11678004|FG003|NOT COMPLETED|Overall Study||1
10525997|NCT01379963|11678019|FG000|STARTED|Overall Study||780
10525998|NCT01379963|11678019|FG000|COMPLETED|Overall Study||780
10525999|NCT01379963|11678019|FG000|NOT COMPLETED|Overall Study||0
10526000|NCT01380080|11678025|FG000|STARTED|Overall Study||424
10526001|NCT01380080|11678026|FG001|STARTED|Overall Study||426
10526002|NCT01380080|11678025|FG000|COMPLETED|Overall Study||339
10526003|NCT01380080|11678026|FG001|COMPLETED|Overall Study||343
10526004|NCT01380080|11678025|FG000|NOT COMPLETED|Overall Study||85
10526005|NCT01380080|11678026|FG001|NOT COMPLETED|Overall Study||83
10526006|NCT01380093|11678032|FG000|STARTED|Naloxone Challenge Phase||80
10526007|NCT01380093|11678033|FG001|STARTED|Naloxone Challenge Phase||0
10526008|NCT01380093|11678034|FG002|STARTED|Naloxone Challenge Phase||0
10526009|NCT01380093|11678035|FG003|STARTED|Naloxone Challenge Phase||0
10526010|NCT01380093|11678036|FG004|STARTED|Naloxone Challenge Phase||0
10526011|NCT01380093|11678037|FG005|STARTED|Naloxone Challenge Phase||0
10453772|NCT00994461|11601630|FG000|STARTED|Overall Study||76
10453773|NCT00994461|11601631|FG001|STARTED|Overall Study||76
10453774|NCT00994461|11601632|FG002|STARTED|Overall Study|One subject was randomized but did not receive study drug.|37
10453775|NCT00994461|11601630|FG000|COMPLETED|Overall Study||74
10453776|NCT00994461|11601631|FG001|COMPLETED|Overall Study||75
10453777|NCT00994461|11601632|FG002|COMPLETED|Overall Study||37
10453778|NCT00994461|11601630|FG000|NOT COMPLETED|Overall Study||2
10453779|NCT00994461|11601631|FG001|NOT COMPLETED|Overall Study||1
10453780|NCT00994461|11601632|FG002|NOT COMPLETED|Overall Study||0
10453781|NCT00994604|11601640|FG000|STARTED|Overall Study||51
10453782|NCT00994604|11601640|FG000|COMPLETED|Overall Study||45
10453783|NCT00994604|11601640|FG000|NOT COMPLETED|Overall Study||6
10453784|NCT00994643|11601647|FG000|STARTED|Overall Study||11
10453785|NCT00994643|11601647|FG000|COMPLETED|Overall Study||10
10551610|NCT01537081|11705700|FG001|COMPLETED|Overall Study||1086
10551611|NCT01537081|11705701|FG002|COMPLETED|Overall Study||547
10551612|NCT01537081|11705699|FG000|NOT COMPLETED|Overall Study||39
10551613|NCT01537081|11705700|FG001|NOT COMPLETED|Overall Study||38
10551614|NCT01537081|11705701|FG002|NOT COMPLETED|Overall Study||16
10551615|NCT01537120|11705710|FG000|STARTED|Enrolled||25
10551616|NCT01537120|11705710|FG000|COMPLETED|Enrolled||25
10551617|NCT01537120|11705710|FG000|NOT COMPLETED|Enrolled||0
10551618|NCT01537120|11705710|FG000|STARTED|8 Weeks Washout||25
10551619|NCT01537120|11705710|FG000|COMPLETED|8 Weeks Washout||24
10453786|NCT00994643|11601647|FG000|NOT COMPLETED|Overall Study||1
10453787|NCT00994682|11601653|FG000|STARTED|Double Bilnd||51
10453788|NCT00994682|11601654|FG001|STARTED|Double Bilnd||50
10453789|NCT00994682|11601653|FG000|COMPLETED|Double Bilnd||42
10453790|NCT00994682|11601654|FG001|COMPLETED|Double Bilnd||41
10453791|NCT00994682|11601653|FG000|NOT COMPLETED|Double Bilnd||9
10453792|NCT00994682|11601654|FG001|NOT COMPLETED|Double Bilnd||9
10453793|NCT00994682|11601653|FG000|STARTED|Pioglitazone Open Label||42
10453794|NCT00994682|11601654|FG001|STARTED|Pioglitazone Open Label||41
10453795|NCT00994682|11601653|FG000|COMPLETED|Pioglitazone Open Label||29
10453796|NCT00994682|11601654|FG001|COMPLETED|Pioglitazone Open Label||34
10453797|NCT00994682|11601653|FG000|NOT COMPLETED|Pioglitazone Open Label||13
10453798|NCT00994682|11601654|FG001|NOT COMPLETED|Pioglitazone Open Label||7
10453799|NCT00994760|11601664|FG000|STARTED|Overall Study||131
10453800|NCT00994760|11601664|FG000|COMPLETED|Overall Study||107
10453801|NCT00994760|11601664|FG000|NOT COMPLETED|Overall Study||24
10453802|NCT00994890|11601685|FG000|STARTED|Overall Study||231
10453803|NCT00994890|11601686|FG001|STARTED|Overall Study||222
10453804|NCT00994890|11601687|FG002|STARTED|Overall Study||226
10453805|NCT00994890|11601685|FG000|Treated|Overall Study||230
10453806|NCT00994890|11601686|FG001|Treated|Overall Study||222
10453807|NCT00994890|11601687|FG002|Treated|Overall Study||226
10453808|NCT00994890|11601685|FG000|COMPLETED|Overall Study||0
10453809|NCT00994890|11601686|FG001|COMPLETED|Overall Study||0
10453810|NCT00994890|11601687|FG002|COMPLETED|Overall Study||0
10453811|NCT00994890|11601685|FG000|NOT COMPLETED|Overall Study||231
10453812|NCT00994890|11601686|FG001|NOT COMPLETED|Overall Study||222
10453813|NCT00994890|11601687|FG002|NOT COMPLETED|Overall Study||226
10453814|NCT00994929|11601695|FG000|STARTED|Overall Study||9
10453815|NCT00994929|11601695|FG000|COMPLETED|Overall Study||9
10453816|NCT00994929|11601695|FG000|NOT COMPLETED|Overall Study||0
10453817|NCT00995007|11601702|FG000|STARTED|Overall Study||56
10453818|NCT00995007|11601703|FG001|STARTED|Overall Study||56
10453819|NCT00995007|11601702|FG000|Crossover to Vandetanib|Overall Study||42
10453820|NCT00995007|11601703|FG001|Crossover to Vandetanib|Overall Study||0
10453821|NCT00995007|11601702|FG000|COMPLETED|Overall Study||39
10453822|NCT00995007|11601703|FG001|COMPLETED|Overall Study||54
10453823|NCT00995007|11601702|FG000|NOT COMPLETED|Overall Study||17
10453824|NCT00995007|11601703|FG001|NOT COMPLETED|Overall Study||2
10453825|NCT00995020|11601720|FG000|STARTED|Overall Study||51
10453826|NCT00995020|11601721|FG001|STARTED|Overall Study||52
10453827|NCT00995020|11601720|FG000|COMPLETED|Overall Study|"Reasons for not completed:~margin analysis not performed specimen fragmentation thermal damage"|48
10453828|NCT00995020|11601721|FG001|COMPLETED|Overall Study|"Reasons for not completed:~margin analysis not performed specimen fragmentation thermal damage"|45
10453829|NCT00995020|11601720|FG000|NOT COMPLETED|Overall Study||3
10453830|NCT00995020|11601721|FG001|NOT COMPLETED|Overall Study||7
10453831|NCT00995072|11601731|FG000|STARTED|Overall Study||10
10453832|NCT00995072|11601732|FG001|STARTED|Overall Study||15
10453833|NCT00995072|11601731|FG000|COMPLETED|Overall Study||9
10453834|NCT00995072|11601732|FG001|COMPLETED|Overall Study||12
10453835|NCT00995072|11601731|FG000|NOT COMPLETED|Overall Study||1
10453836|NCT00995072|11601732|FG001|NOT COMPLETED|Overall Study||3
10453837|NCT00995085|11601738|FG000|STARTED|Overall Study||43
10453838|NCT00995085|11601738|FG000|COMPLETED|Overall Study||38
10453839|NCT00995085|11601738|FG000|NOT COMPLETED|Overall Study||5
10453840|NCT00995215|11601742|FG000|STARTED|Overall Study||6
10453841|NCT00995215|11601742|FG000|COMPLETED|Overall Study||6
10453842|NCT00995215|11601742|FG000|NOT COMPLETED|Overall Study||0
10453843|NCT00995345|11601752|FG000|STARTED|Overall Study||81
10453844|NCT00995345|11601753|FG001|STARTED|Overall Study||81
10453845|NCT00995345|11601754|FG002|STARTED|Overall Study||80
10453846|NCT00995345|11601755|FG003|STARTED|Overall Study||81
10453847|NCT00995345|11601756|FG004|STARTED|Overall Study||80
10453848|NCT00995345|11601752|FG000|COMPLETED|Overall Study||70
10453849|NCT00995345|11601753|FG001|COMPLETED|Overall Study||74
10453850|NCT00995345|11601754|FG002|COMPLETED|Overall Study||73
10453851|NCT00995345|11601755|FG003|COMPLETED|Overall Study||76
10453852|NCT00995345|11601756|FG004|COMPLETED|Overall Study||75
10453853|NCT00995345|11601752|FG000|NOT COMPLETED|Overall Study||11
10453854|NCT00995345|11601753|FG001|NOT COMPLETED|Overall Study||7
10453855|NCT00995345|11601754|FG002|NOT COMPLETED|Overall Study||7
10453856|NCT00995345|11601755|FG003|NOT COMPLETED|Overall Study||5
10453857|NCT00995345|11601756|FG004|NOT COMPLETED|Overall Study||5
10453858|NCT00995371|11601770|FG000|STARTED|Prior to ESI Cross-over, 6 Weeks||21
10453859|NCT00995371|11601771|FG001|STARTED|Prior to ESI Cross-over, 6 Weeks||17
10453860|NCT00995371|11601770|FG000|COMPLETED|Prior to ESI Cross-over, 6 Weeks||21
10453861|NCT00995371|11601771|FG001|COMPLETED|Prior to ESI Cross-over, 6 Weeks||17
10453862|NCT00995371|11601770|FG000|NOT COMPLETED|Prior to ESI Cross-over, 6 Weeks||0
10453863|NCT00995371|11601771|FG001|NOT COMPLETED|Prior to ESI Cross-over, 6 Weeks||0
10453864|NCT00995371|11601770|FG000|STARTED|After ESI Cross-over to Mild, 26 Weeks||21
10551620|NCT01537120|11705710|FG000|NOT COMPLETED|8 Weeks Washout||1
10551621|NCT01537120|11705710|FG000|STARTED|3 Weeks Placebo||24
10551622|NCT01537120|11705710|FG000|COMPLETED|3 Weeks Placebo||23
10453865|NCT00995371|11601771|FG001|STARTED|After ESI Cross-over to Mild, 26 Weeks||17
10453866|NCT00995371|11601770|FG000|COMPLETED|After ESI Cross-over to Mild, 26 Weeks|All 21 completed Wk 6 Intent to Treat analysis. Sixteen reported Week 26 outcomes.|16
10453867|NCT00995371|11601771|FG001|COMPLETED|After ESI Cross-over to Mild, 26 Weeks|All 17 completed Wk 6 Intent to Treat analysis prior to x-over. After x-over 12 reported Wk 26|12
10453868|NCT00995371|11601770|FG000|NOT COMPLETED|After ESI Cross-over to Mild, 26 Weeks||5
10453869|NCT00995371|11601771|FG001|NOT COMPLETED|After ESI Cross-over to Mild, 26 Weeks||5
10453870|NCT00995410|11601779|FG000|STARTED|Overall Study||380
10453871|NCT00995410|11601779|FG000|Treated|Overall Study||379
10453872|NCT00995410|11601779|FG000|COMPLETED|Overall Study||292
10453873|NCT00995410|11601779|FG000|NOT COMPLETED|Overall Study||88
10453874|NCT00995436|11601786|FG000|STARTED|Overall Study|25|25
10453875|NCT00995436|11601787|FG001|STARTED|Overall Study||27
10453876|NCT00995436|11601788|FG002|STARTED|Overall Study||26
10453877|NCT00995436|11601786|FG000|COMPLETED|Overall Study||23
10453878|NCT00995436|11601787|FG001|COMPLETED|Overall Study||22
10453879|NCT00995436|11601788|FG002|COMPLETED|Overall Study||26
10453880|NCT00995436|11601786|FG000|NOT COMPLETED|Overall Study||2
10453881|NCT00995436|11601787|FG001|NOT COMPLETED|Overall Study||5
10453882|NCT00995436|11601788|FG002|NOT COMPLETED|Overall Study||0
10453883|NCT00995449|11601800|FG000|STARTED|Overall Study||0
10453884|NCT00995449|11601801|FG001|STARTED|Overall Study||0
10453885|NCT00995449|11601802|FG002|STARTED|Overall Study||7
10453886|NCT00995449|11601803|FG003|STARTED|Overall Study||2
10453887|NCT00995449|11601800|FG000|COMPLETED|Overall Study||0
10453888|NCT00995449|11601801|FG001|COMPLETED|Overall Study||0
10453889|NCT00995449|11601802|FG002|COMPLETED|Overall Study||5
10453890|NCT00995449|11601803|FG003|COMPLETED|Overall Study||2
10453891|NCT00995449|11601800|FG000|NOT COMPLETED|Overall Study||0
10453892|NCT00995449|11601801|FG001|NOT COMPLETED|Overall Study||0
10453893|NCT00995449|11601802|FG002|NOT COMPLETED|Overall Study||2
10453894|NCT00995449|11601803|FG003|NOT COMPLETED|Overall Study||0
10453895|NCT00995475|11601811|FG000|STARTED|First Intervention||9
10453896|NCT00995475|11601812|FG001|STARTED|First Intervention||9
10453897|NCT00995475|11601811|FG000|COMPLETED|First Intervention||9
10453898|NCT00995475|11601812|FG001|COMPLETED|First Intervention||9
10453899|NCT00995475|11601811|FG000|NOT COMPLETED|First Intervention||0
10453900|NCT00995475|11601812|FG001|NOT COMPLETED|First Intervention||0
10453901|NCT00995475|11601811|FG000|STARTED|Wash-out Two Week||9
10453902|NCT00995475|11601812|FG001|STARTED|Wash-out Two Week||9
10453903|NCT00995475|11601811|FG000|COMPLETED|Wash-out Two Week||9
10453904|NCT00995475|11601812|FG001|COMPLETED|Wash-out Two Week||9
10453905|NCT00995475|11601811|FG000|NOT COMPLETED|Wash-out Two Week||0
10453906|NCT00995475|11601812|FG001|NOT COMPLETED|Wash-out Two Week||0
10453907|NCT00995475|11601811|FG000|STARTED|Second Intervention||9
10453908|NCT00995475|11601812|FG001|STARTED|Second Intervention||9
10453909|NCT00995475|11601811|FG000|COMPLETED|Second Intervention||9
10453910|NCT00995475|11601812|FG001|COMPLETED|Second Intervention||9
10453911|NCT00995475|11601811|FG000|NOT COMPLETED|Second Intervention||0
10453912|NCT00995475|11601812|FG001|NOT COMPLETED|Second Intervention||0
10453913|NCT00995488|11601818|FG000|STARTED|Overall Study||16
10453914|NCT00995488|11601818|FG000|COMPLETED|Overall Study||15
10453915|NCT00995488|11601818|FG000|NOT COMPLETED|Overall Study||1
10453916|NCT00995501|11601830|FG000|STARTED|Overall Study||52
10551623|NCT01537120|11705710|FG000|NOT COMPLETED|3 Weeks Placebo||1
10453917|NCT00995501|11601831|FG001|STARTED|Overall Study||51
10453918|NCT00995501|11601832|FG002|STARTED|Overall Study||47
10453919|NCT00995501|11601833|FG003|STARTED|Overall Study||46
10453920|NCT00995501|11601834|FG004|STARTED|Overall Study||46
10453921|NCT00995501|11601835|FG005|STARTED|Overall Study||44
10453922|NCT00995501|11601836|FG006|STARTED|Overall Study||49
10453923|NCT00995501|11601837|FG007|STARTED|Overall Study||46
10453924|NCT00995501|11601830|FG000|COMPLETED|Overall Study||52
10453925|NCT00995501|11601831|FG001|COMPLETED|Overall Study||51
10453926|NCT00995501|11601832|FG002|COMPLETED|Overall Study||47
10453927|NCT00995501|11601833|FG003|COMPLETED|Overall Study||46
10453928|NCT00995501|11601834|FG004|COMPLETED|Overall Study||46
10453929|NCT00995501|11601835|FG005|COMPLETED|Overall Study||44
10453930|NCT00995501|11601836|FG006|COMPLETED|Overall Study||49
10453931|NCT00995501|11601837|FG007|COMPLETED|Overall Study||46
10453932|NCT00995501|11601830|FG000|NOT COMPLETED|Overall Study||0
10453933|NCT00995501|11601831|FG001|NOT COMPLETED|Overall Study||0
10453934|NCT00995501|11601832|FG002|NOT COMPLETED|Overall Study||0
10453935|NCT00995501|11601833|FG003|NOT COMPLETED|Overall Study||0
10453936|NCT00995501|11601834|FG004|NOT COMPLETED|Overall Study||0
10453937|NCT00995501|11601835|FG005|NOT COMPLETED|Overall Study||0
10453938|NCT00995501|11601836|FG006|NOT COMPLETED|Overall Study||0
10453939|NCT00995501|11601837|FG007|NOT COMPLETED|Overall Study||0
10453940|NCT00995553|11601857|FG000|STARTED|Overall Study||40
10453941|NCT00995553|11601858|FG001|STARTED|Overall Study||41
10453942|NCT00995553|11601857|FG000|COMPLETED|Overall Study||38
10453943|NCT00995553|11601858|FG001|COMPLETED|Overall Study||35
10453944|NCT00995553|11601857|FG000|NOT COMPLETED|Overall Study||2
10453945|NCT00995553|11601858|FG001|NOT COMPLETED|Overall Study||6
10453946|NCT00995566|11601864|FG000|STARTED|Overall Study||54
10453947|NCT00995566|11601864|FG000|COMPLETED|Overall Study||0
10453948|NCT00995566|11601864|FG000|NOT COMPLETED|Overall Study||54
10453949|NCT00995670|11601871|FG000|STARTED|Overall Study||26
10453950|NCT00995670|11601872|FG001|STARTED|Overall Study||16
10453951|NCT00995670|11601873|FG002|STARTED|Overall Study||17
10453952|NCT00995670|11601871|FG000|COMPLETED|Overall Study|These 26 subjects underwent a total of 58 studies to determine the effect of dose of glucose on I/R.|25
10453953|NCT00995670|11601872|FG001|COMPLETED|Overall Study|These 16 subjects underwent a total of 25 studies on the effect of Vitamin C.|16
10453954|NCT00995670|11601873|FG002|COMPLETED|Overall Study|These 17 volunteers underwent 33 studies on the effect of statins, glucose, and glucose & statins.|14
10453955|NCT00995670|11601871|FG000|NOT COMPLETED|Overall Study||1
10453956|NCT00995670|11601872|FG001|NOT COMPLETED|Overall Study||0
10453957|NCT00995670|11601873|FG002|NOT COMPLETED|Overall Study||3
10453958|NCT00995709|11601884|FG000|STARTED|Overall Study||39
10453959|NCT00995709|11601885|FG001|STARTED|Overall Study||40
10453960|NCT00995709|11601886|FG002|STARTED|Overall Study||39
10453961|NCT00995709|11601884|FG000|COMPLETED|Overall Study||32
10453962|NCT00995709|11601885|FG001|COMPLETED|Overall Study|patient in the 300 mg monthly group was randomized,was not eligible,never received study medication|31
10453963|NCT00995709|11601886|FG002|COMPLETED|Overall Study||34
10453964|NCT00995709|11601884|FG000|NOT COMPLETED|Overall Study||7
10453965|NCT00995709|11601885|FG001|NOT COMPLETED|Overall Study||9
10453966|NCT00995709|11601886|FG002|NOT COMPLETED|Overall Study||5
10453967|NCT00995722|11601896|FG000|STARTED|Double Blinded: 16 Weeks||6
10453968|NCT00995722|11601897|FG001|STARTED|Double Blinded: 16 Weeks||5
10453969|NCT00995722|11601896|FG000|COMPLETED|Double Blinded: 16 Weeks||5
10453970|NCT00995722|11601897|FG001|COMPLETED|Double Blinded: 16 Weeks||4
10453971|NCT00995722|11601896|FG000|NOT COMPLETED|Double Blinded: 16 Weeks||1
10453972|NCT00995722|11601897|FG001|NOT COMPLETED|Double Blinded: 16 Weeks||1
10453973|NCT00995722|11601896|FG000|STARTED|Overall Study: 36 Weeks||5
10453974|NCT00995722|11601897|FG001|STARTED|Overall Study: 36 Weeks||4
10453975|NCT00995722|11601896|FG000|COMPLETED|Overall Study: 36 Weeks||3
10453976|NCT00995722|11601897|FG001|COMPLETED|Overall Study: 36 Weeks||2
10453977|NCT00995722|11601896|FG000|NOT COMPLETED|Overall Study: 36 Weeks||2
10453978|NCT00995722|11601897|FG001|NOT COMPLETED|Overall Study: 36 Weeks||2
10453979|NCT00995761|11601903|FG000|STARTED|Overall Study||48
10453980|NCT00995761|11601903|FG000|COMPLETED|Overall Study||48
10453981|NCT00995761|11601903|FG000|NOT COMPLETED|Overall Study||0
10453982|NCT00995774|11601909|FG000|STARTED|Training Period 1||7
10453983|NCT00995774|11601910|FG001|STARTED|Training Period 1||5
10453984|NCT00995774|11601909|FG000|COMPLETED|Training Period 1||7
10453985|NCT00995774|11601910|FG001|COMPLETED|Training Period 1||5
10453986|NCT00995774|11601909|FG000|NOT COMPLETED|Training Period 1||0
10453987|NCT00995774|11601910|FG001|NOT COMPLETED|Training Period 1||0
10453988|NCT00995774|11601909|FG000|STARTED|Washout Period||7
10453989|NCT00995774|11601910|FG001|STARTED|Washout Period||5
10453990|NCT00995774|11601909|FG000|COMPLETED|Washout Period||7
10453991|NCT00995774|11601910|FG001|COMPLETED|Washout Period||5
10453992|NCT00995774|11601909|FG000|NOT COMPLETED|Washout Period||0
10453993|NCT00995774|11601910|FG001|NOT COMPLETED|Washout Period||0
10453994|NCT00995774|11601909|FG000|STARTED|Training Period 2||7
10453995|NCT00995774|11601910|FG001|STARTED|Training Period 2||5
10453996|NCT00995774|11601909|FG000|COMPLETED|Training Period 2||5
10453997|NCT00995774|11601910|FG001|COMPLETED|Training Period 2||5
10453998|NCT00995774|11601909|FG000|NOT COMPLETED|Training Period 2||2
10453999|NCT00995774|11601910|FG001|NOT COMPLETED|Training Period 2||0
10454000|NCT00995865|11601919|FG000|STARTED|Overall Study||24
10454001|NCT00995865|11601920|FG001|STARTED|Overall Study||24
10454002|NCT00995865|11601921|FG002|STARTED|Overall Study||12
10454003|NCT00995865|11601919|FG000|COMPLETED|Overall Study||22
10454004|NCT00995865|11601920|FG001|COMPLETED|Overall Study||24
10454005|NCT00995865|11601921|FG002|COMPLETED|Overall Study||11
10454006|NCT00995865|11601919|FG000|NOT COMPLETED|Overall Study||2
10454007|NCT00995865|11601920|FG001|NOT COMPLETED|Overall Study||0
10454008|NCT00995865|11601921|FG002|NOT COMPLETED|Overall Study||1
10454009|NCT00995904|11601934|FG000|STARTED|Visit 2 (Randomization)||4
10454010|NCT00995904|11601935|FG001|STARTED|Visit 2 (Randomization)||3
10454011|NCT00995904|11601936|FG002|STARTED|Visit 2 (Randomization)||4
10454012|NCT00995904|11601937|FG003|STARTED|Visit 2 (Randomization)||5
10454013|NCT00995904|11601938|FG004|STARTED|Visit 2 (Randomization)||5
10454014|NCT00995904|11601939|FG005|STARTED|Visit 2 (Randomization)||4
10454015|NCT00995904|11601934|FG000|COMPLETED|Visit 2 (Randomization)||4
10454016|NCT00995904|11601935|FG001|COMPLETED|Visit 2 (Randomization)||3
10454017|NCT00995904|11601936|FG002|COMPLETED|Visit 2 (Randomization)||4
10454018|NCT00995904|11601937|FG003|COMPLETED|Visit 2 (Randomization)||5
10454019|NCT00995904|11601938|FG004|COMPLETED|Visit 2 (Randomization)||5
10454020|NCT00995904|11601939|FG005|COMPLETED|Visit 2 (Randomization)||4
10454021|NCT00995904|11601934|FG000|NOT COMPLETED|Visit 2 (Randomization)||0
10454022|NCT00995904|11601935|FG001|NOT COMPLETED|Visit 2 (Randomization)||0
10454023|NCT00995904|11601936|FG002|NOT COMPLETED|Visit 2 (Randomization)||0
10454024|NCT00995904|11601937|FG003|NOT COMPLETED|Visit 2 (Randomization)||0
10454025|NCT00995904|11601938|FG004|NOT COMPLETED|Visit 2 (Randomization)||0
10454026|NCT00995904|11601939|FG005|NOT COMPLETED|Visit 2 (Randomization)||0
10454027|NCT00995904|11601934|FG000|STARTED|Visit 3||4
10454028|NCT00995904|11601935|FG001|STARTED|Visit 3||3
10454029|NCT00995904|11601936|FG002|STARTED|Visit 3||4
10454030|NCT00995904|11601937|FG003|STARTED|Visit 3||5
10454031|NCT00995904|11601938|FG004|STARTED|Visit 3||5
10454032|NCT00995904|11601939|FG005|STARTED|Visit 3|One subject was withdrawn from the study after completion of Visit 2 but prior to Visit 3.|3
10454033|NCT00995904|11601934|FG000|COMPLETED|Visit 3||4
10454034|NCT00995904|11601935|FG001|COMPLETED|Visit 3||3
10454035|NCT00995904|11601936|FG002|COMPLETED|Visit 3||4
10454036|NCT00995904|11601937|FG003|COMPLETED|Visit 3||5
10454037|NCT00995904|11601938|FG004|COMPLETED|Visit 3||5
10454038|NCT00995904|11601939|FG005|COMPLETED|Visit 3||3
10454039|NCT00995904|11601934|FG000|NOT COMPLETED|Visit 3||0
10454040|NCT00995904|11601935|FG001|NOT COMPLETED|Visit 3||0
10454041|NCT00995904|11601936|FG002|NOT COMPLETED|Visit 3||0
10454042|NCT00995904|11601937|FG003|NOT COMPLETED|Visit 3||0
10454043|NCT00995904|11601938|FG004|NOT COMPLETED|Visit 3||0
10454044|NCT00995904|11601939|FG005|NOT COMPLETED|Visit 3||0
10454045|NCT00995904|11601934|FG000|STARTED|Visit 4||4
10454046|NCT00995904|11601935|FG001|STARTED|Visit 4||3
10454047|NCT00995904|11601936|FG002|STARTED|Visit 4||4
10454048|NCT00995904|11601937|FG003|STARTED|Visit 4||5
10454049|NCT00995904|11601938|FG004|STARTED|Visit 4||5
10454050|NCT00995904|11601939|FG005|STARTED|Visit 4||3
10454051|NCT00995904|11601934|FG000|COMPLETED|Visit 4||4
10454052|NCT00995904|11601935|FG001|COMPLETED|Visit 4||3
10454053|NCT00995904|11601936|FG002|COMPLETED|Visit 4||4
10454054|NCT00995904|11601937|FG003|COMPLETED|Visit 4||5
10454055|NCT00995904|11601938|FG004|COMPLETED|Visit 4||5
10454056|NCT00995904|11601939|FG005|COMPLETED|Visit 4||3
10454057|NCT00995904|11601934|FG000|NOT COMPLETED|Visit 4||0
10454058|NCT00995904|11601935|FG001|NOT COMPLETED|Visit 4||0
10454059|NCT00995904|11601936|FG002|NOT COMPLETED|Visit 4||0
10454060|NCT00995904|11601937|FG003|NOT COMPLETED|Visit 4||0
10454061|NCT00995904|11601938|FG004|NOT COMPLETED|Visit 4||0
10454062|NCT00995904|11601939|FG005|NOT COMPLETED|Visit 4||0
10454063|NCT00995904|11601934|FG000|STARTED|Follow-up Visit (Final Visit)||4
10454064|NCT00995904|11601935|FG001|STARTED|Follow-up Visit (Final Visit)||3
10454065|NCT00995904|11601936|FG002|STARTED|Follow-up Visit (Final Visit)||4
10454066|NCT00995904|11601937|FG003|STARTED|Follow-up Visit (Final Visit)||5
10454067|NCT00995904|11601938|FG004|STARTED|Follow-up Visit (Final Visit)||5
10454068|NCT00995904|11601939|FG005|STARTED|Follow-up Visit (Final Visit)||3
10454069|NCT00995904|11601934|FG000|COMPLETED|Follow-up Visit (Final Visit)||4
10454070|NCT00995904|11601935|FG001|COMPLETED|Follow-up Visit (Final Visit)||3
10454071|NCT00995904|11601936|FG002|COMPLETED|Follow-up Visit (Final Visit)||4
10454072|NCT00995904|11601937|FG003|COMPLETED|Follow-up Visit (Final Visit)||5
10454073|NCT00995904|11601938|FG004|COMPLETED|Follow-up Visit (Final Visit)||5
10454074|NCT00995904|11601939|FG005|COMPLETED|Follow-up Visit (Final Visit)||3
10454075|NCT00995904|11601934|FG000|NOT COMPLETED|Follow-up Visit (Final Visit)||0
10454076|NCT00995904|11601935|FG001|NOT COMPLETED|Follow-up Visit (Final Visit)||0
10454077|NCT00995904|11601936|FG002|NOT COMPLETED|Follow-up Visit (Final Visit)||0
10454078|NCT00995904|11601937|FG003|NOT COMPLETED|Follow-up Visit (Final Visit)||0
10454079|NCT00995904|11601938|FG004|NOT COMPLETED|Follow-up Visit (Final Visit)||0
10454080|NCT00995904|11601939|FG005|NOT COMPLETED|Follow-up Visit (Final Visit)||0
10454081|NCT00995930|11601952|FG000|STARTED|Overall Study||94
10454082|NCT00995930|11601953|FG001|STARTED|Overall Study||95
10454083|NCT00995930|11601952|FG000|Safety Analysis Set|Overall Study||94
10454084|NCT00995930|11601953|FG001|Safety Analysis Set|Overall Study||95
10454085|NCT00995930|11601952|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||0
10454086|NCT00995930|11601953|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||95
10454087|NCT00995930|11601952|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||92
10454088|NCT00995930|11601953|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||92
10454089|NCT00995930|11601952|FG000|Imaging Analysis Set|Overall Study||92
10454090|NCT00995930|11601953|FG001|Imaging Analysis Set|Overall Study||92
10454091|NCT00995930|11601952|FG000|COMPLETED|Overall Study||73
10454092|NCT00995930|11601953|FG001|COMPLETED|Overall Study||67
10454093|NCT00995930|11601952|FG000|NOT COMPLETED|Overall Study||21
10454094|NCT00995930|11601953|FG001|NOT COMPLETED|Overall Study||28
10454095|NCT00996034|11601960|FG000|STARTED|Overall Study||14
10454096|NCT00996034|11601960|FG000|COMPLETED|Overall Study||11
10454097|NCT00996034|11601960|FG000|NOT COMPLETED|Overall Study||3
10454098|NCT00996125|11601966|FG000|STARTED|Overall Study||374
10454099|NCT00996125|11601967|FG001|STARTED|Overall Study||376
10454100|NCT00996125|11601966|FG000|COMPLETED|Overall Study||369
10454101|NCT00996125|11601967|FG001|COMPLETED|Overall Study||365
10454102|NCT00996125|11601966|FG000|NOT COMPLETED|Overall Study||5
10454103|NCT00996125|11601967|FG001|NOT COMPLETED|Overall Study||11
10454104|NCT00996164|11601975|FG000|STARTED|Overall Study||543
10454105|NCT00996164|11601976|FG001|STARTED|Overall Study||547
10454106|NCT00996164|11601975|FG000|COMPLETED|Overall Study||408
10454107|NCT00996164|11601976|FG001|COMPLETED|Overall Study||446
10454108|NCT00996164|11601975|FG000|NOT COMPLETED|Overall Study||135
10454109|NCT00996164|11601976|FG001|NOT COMPLETED|Overall Study||101
10454110|NCT00996203|11601982|FG000|STARTED|Overall Study||201
10454111|NCT00996203|11601982|FG000|COMPLETED|Overall Study||194
10454112|NCT00996203|11601982|FG000|NOT COMPLETED|Overall Study||7
10454113|NCT00996216|11601987|FG000|STARTED|Part 1 (Pre-Antiviral Treatment Phase)||27
10454114|NCT00996216|11601987|FG000|COMPLETED|Part 1 (Pre-Antiviral Treatment Phase)||26
10454115|NCT00996216|11601987|FG000|NOT COMPLETED|Part 1 (Pre-Antiviral Treatment Phase)||1
10454116|NCT00996216|11601987|FG000|STARTED|Part 2 (Antiviral Treatment Phase)|One participant who completed Part 1 didn't qualify to begin antiviral treatment in Part 2.|25
10454117|NCT00996216|11601987|FG000|COMPLETED|Part 2 (Antiviral Treatment Phase)||21
10454118|NCT00996216|11601987|FG000|NOT COMPLETED|Part 2 (Antiviral Treatment Phase)||4
10454119|NCT00996281|11601994|FG000|STARTED|Overall Study||418
10454120|NCT00996281|11601995|FG001|STARTED|Overall Study||419
10454121|NCT00996281|11601994|FG000|COMPLETED|Overall Study||287
10454122|NCT00996281|11601995|FG001|COMPLETED|Overall Study||330
10454123|NCT00996281|11601994|FG000|NOT COMPLETED|Overall Study||131
10454124|NCT00996281|11601995|FG001|NOT COMPLETED|Overall Study||89
10454125|NCT00996307|11602005|FG000|STARTED|Overall Study||164
10790022|NCT03531710|11950463|FG002|NOT COMPLETED|Overall Study||0
10790023|NCT03531710|11950464|FG003|NOT COMPLETED|Overall Study||0
10790024|NCT03531710|11950465|FG004|NOT COMPLETED|Overall Study||0
10790025|NCT03531710|11950466|FG005|NOT COMPLETED|Overall Study||0
10790026|NCT03531840|11950484|FG000|STARTED|Overall Study||5
10790027|NCT03531840|11950485|FG001|STARTED|Overall Study||6
10790028|NCT03531840|11950486|FG002|STARTED|Overall Study||8
10790029|NCT03531840|11950487|FG003|STARTED|Overall Study||4
10790030|NCT03531840|11950484|FG000|COMPLETED|Overall Study||0
10790031|NCT03531840|11950485|FG001|COMPLETED|Overall Study||1
10790032|NCT03531840|11950486|FG002|COMPLETED|Overall Study||3
10790033|NCT03531840|11950487|FG003|COMPLETED|Overall Study||1
10790034|NCT03531840|11950484|FG000|NOT COMPLETED|Overall Study||5
10790035|NCT03531840|11950485|FG001|NOT COMPLETED|Overall Study||5
10454126|NCT00996307|11602006|FG001|STARTED|Overall Study||165
10454127|NCT00996307|11602007|FG002|STARTED|Overall Study||160
10454128|NCT00996307|11602008|FG003|STARTED|Overall Study||165
10454129|NCT00996307|11602005|FG000|COMPLETED|Overall Study||144
10454130|NCT00996307|11602006|FG001|COMPLETED|Overall Study||148
10454131|NCT00996307|11602007|FG002|COMPLETED|Overall Study||146
10454132|NCT00996307|11602008|FG003|COMPLETED|Overall Study||144
10454133|NCT00996307|11602005|FG000|NOT COMPLETED|Overall Study||20
10454134|NCT00996307|11602006|FG001|NOT COMPLETED|Overall Study||17
10454135|NCT00996307|11602007|FG002|NOT COMPLETED|Overall Study||14
10454136|NCT00996307|11602008|FG003|NOT COMPLETED|Overall Study||21
10454137|NCT00996346|11602039|FG000|STARTED|Overall Study||6
10454138|NCT00996346|11602040|FG001|STARTED|Overall Study||8
10454139|NCT00996346|11602041|FG002|STARTED|Overall Study||3
10454140|NCT00996346|11602039|FG000|COMPLETED|Overall Study||6
10454141|NCT00996346|11602040|FG001|COMPLETED|Overall Study||8
10790036|NCT03531840|11950486|FG002|NOT COMPLETED|Overall Study||5
10790037|NCT03531840|11950487|FG003|NOT COMPLETED|Overall Study||3
10790038|NCT03531905|11950505|FG000|STARTED|Overall Study||81
10790039|NCT03531905|11950506|FG001|STARTED|Overall Study||81
10790040|NCT03531905|11950507|FG002|STARTED|Overall Study||80
10790041|NCT03531905|11950505|FG000|COMPLETED|Overall Study||74
10454142|NCT00996346|11602041|FG002|COMPLETED|Overall Study||3
10454143|NCT00996346|11602039|FG000|NOT COMPLETED|Overall Study||0
10454144|NCT00996346|11602040|FG001|NOT COMPLETED|Overall Study||0
10454145|NCT00996346|11602041|FG002|NOT COMPLETED|Overall Study||0
10454146|NCT00996372|11602049|FG000|STARTED|Overall Study||468
10454147|NCT00996372|11602050|FG001|STARTED|Overall Study||481
10454148|NCT00996372|11602049|FG000|COMPLETED|Overall Study||365
10454149|NCT00996372|11602050|FG001|COMPLETED|Overall Study||397
10454150|NCT00996372|11602049|FG000|NOT COMPLETED|Overall Study||103
10454151|NCT00996372|11602050|FG001|NOT COMPLETED|Overall Study||84
10790042|NCT03531905|11950506|FG001|COMPLETED|Overall Study||76
10790043|NCT03531905|11950507|FG002|COMPLETED|Overall Study||77
10790044|NCT03531905|11950505|FG000|NOT COMPLETED|Overall Study||7
10454152|NCT00996437|11602060|FG000|STARTED|Overall Study||125
10454153|NCT00996437|11602061|FG001|STARTED|Overall Study||136
10454154|NCT00996437|11602060|FG000|COMPLETED|Overall Study||120
10454155|NCT00996437|11602061|FG001|COMPLETED|Overall Study||129
10454156|NCT00996437|11602060|FG000|NOT COMPLETED|Overall Study||5
10454157|NCT00996437|11602061|FG001|NOT COMPLETED|Overall Study||7
10454158|NCT00996476|11602072|FG000|STARTED|Overall Study||27
10454159|NCT00996476|11602073|FG001|STARTED|Overall Study||26
10790045|NCT03531905|11950506|FG001|NOT COMPLETED|Overall Study||5
10790046|NCT03531905|11950507|FG002|NOT COMPLETED|Overall Study||3
10790047|NCT03532009|11950519|FG000|STARTED|Overall Study||92
10790048|NCT03532009|11950520|FG001|STARTED|Overall Study||90
10454160|NCT00996476|11602074|FG002|STARTED|Overall Study||13
10454161|NCT00996476|11602075|FG003|STARTED|Overall Study||13
10454162|NCT00996476|11602076|FG004|STARTED|Overall Study||13
10454163|NCT00996476|11602072|FG000|COMPLETED|Overall Study||26
10454164|NCT00996476|11602073|FG001|COMPLETED|Overall Study||23
10454165|NCT00996476|11602074|FG002|COMPLETED|Overall Study||12
10454166|NCT00996476|11602075|FG003|COMPLETED|Overall Study||13
10454167|NCT00996476|11602076|FG004|COMPLETED|Overall Study||11
10454168|NCT00996476|11602072|FG000|NOT COMPLETED|Overall Study||1
10454169|NCT00996476|11602073|FG001|NOT COMPLETED|Overall Study||3
10454170|NCT00996476|11602074|FG002|NOT COMPLETED|Overall Study||1
10454171|NCT00996476|11602075|FG003|NOT COMPLETED|Overall Study||0
10454172|NCT00996476|11602076|FG004|NOT COMPLETED|Overall Study||2
10454173|NCT00996489|11602093|FG000|STARTED|Overall Study||459
10454174|NCT00996489|11602093|FG000|COMPLETED|Overall Study||298
10454175|NCT00996489|11602093|FG000|NOT COMPLETED|Overall Study||161
10454176|NCT00996580|11602097|FG000|STARTED|Overall Study||3597
10454177|NCT00996580|11602097|FG000|Pregnancy Intent-to-Treat Population|Overall Study||3019
10454178|NCT00996580|11602097|FG000|COMPLETED|Overall Study||2144
10454179|NCT00996580|11602097|FG000|NOT COMPLETED|Overall Study||1453
10454180|NCT00996593|11602104|FG000|STARTED|Dosimetric and Therapeutic Treatment||43
10454181|NCT00996593|11602104|FG000|COMPLETED|Dosimetric and Therapeutic Treatment||0
10454182|NCT00996593|11602104|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||43
10454183|NCT00996593|11602104|FG000|STARTED|Long-Term Follow-Up|9 of the 40 participants withdrawing from Study BEX104507 enrolled in long-term follow-up study.|9
10454184|NCT00996593|11602104|FG000|COMPLETED|Long-Term Follow-Up||6
10454185|NCT00996593|11602104|FG000|NOT COMPLETED|Long-Term Follow-Up||3
10454186|NCT00996606|11602108|FG000|STARTED|Overall Study||58
10454187|NCT00996606|11602108|FG000|COMPLETED|Overall Study||50
10454188|NCT00996606|11602108|FG000|NOT COMPLETED|Overall Study||8
10454189|NCT00996632|11602114|FG000|STARTED|Overall Study||38
10454190|NCT00996632|11602115|FG001|STARTED|Overall Study||56
10454191|NCT00996632|11602114|FG000|COMPLETED|Overall Study||38
10454192|NCT00996632|11602115|FG001|COMPLETED|Overall Study||56
10454193|NCT00996632|11602114|FG000|NOT COMPLETED|Overall Study||0
10454194|NCT00996632|11602115|FG001|NOT COMPLETED|Overall Study||0
10454195|NCT00996658|11602123|FG000|STARTED|Overall Study||92
10454196|NCT00996658|11602124|FG001|STARTED|Overall Study||186
10454197|NCT00996658|11602123|FG000|COMPLETED|Overall Study||76
10454198|NCT00996658|11602124|FG001|COMPLETED|Overall Study||165
10454199|NCT00996658|11602123|FG000|NOT COMPLETED|Overall Study||16
10454200|NCT00996658|11602124|FG001|NOT COMPLETED|Overall Study||21
10454201|NCT00996736|11602132|FG000|STARTED|Overall Study||162
10454202|NCT00996736|11602133|FG001|STARTED|Overall Study||161
10454203|NCT00996736|11602132|FG000|3-week Visit|Overall Study|149 visited within pre-specified 3-week window (2.5-5 weeks); 6 had a second visit not within window|155
10454204|NCT00996736|11602133|FG001|3-week Visit|Overall Study|144 visited within pre-specified 3-week window (2.5-5 weeks); 7 had a second visit not within window|151
10454205|NCT00996736|11602132|FG000|3-month Visit|Overall Study||146
10454206|NCT00996736|11602133|FG001|3-month Visit|Overall Study||146
10454207|NCT00996736|11602132|FG000|COMPLETED|Overall Study||141
10454208|NCT00996736|11602133|FG001|COMPLETED|Overall Study||143
10454209|NCT00996736|11602132|FG000|NOT COMPLETED|Overall Study||21
10454210|NCT00996736|11602133|FG001|NOT COMPLETED|Overall Study||18
10454211|NCT00996775|11602141|FG000|STARTED|Overall Study||78
10454212|NCT00996775|11602142|FG001|STARTED|Overall Study||89
10454213|NCT00996775|11602141|FG000|COMPLETED|Overall Study||67
10454214|NCT00996775|11602142|FG001|COMPLETED|Overall Study||75
10454215|NCT00996775|11602141|FG000|NOT COMPLETED|Overall Study||11
10454216|NCT00996775|11602142|FG001|NOT COMPLETED|Overall Study||14
10454217|NCT00996801|11602154|FG000|STARTED|Overall Study||88
10454218|NCT00996801|11602155|FG001|STARTED|Overall Study||88
10454219|NCT00996801|11602156|FG002|STARTED|Overall Study||88
10454220|NCT00996801|11602157|FG003|STARTED|Overall Study||87
10454221|NCT00996801|11602158|FG004|STARTED|Overall Study|15-mg arm was discontinued as a result of Protocol Amendment 1.|88
10454222|NCT00996801|11602159|FG005|STARTED|Overall Study||87
10454223|NCT00996801|11602154|FG000|COMPLETED|Overall Study||68
10454224|NCT00996801|11602155|FG001|COMPLETED|Overall Study||72
10454225|NCT00996801|11602156|FG002|COMPLETED|Overall Study||65
10454226|NCT00996801|11602157|FG003|COMPLETED|Overall Study||56
10454227|NCT00996801|11602158|FG004|COMPLETED|Overall Study||0
10454228|NCT00996801|11602159|FG005|COMPLETED|Overall Study||68
10454229|NCT00996801|11602154|FG000|NOT COMPLETED|Overall Study||20
10454230|NCT00996801|11602155|FG001|NOT COMPLETED|Overall Study||16
10454231|NCT00996801|11602156|FG002|NOT COMPLETED|Overall Study||23
10454232|NCT00996801|11602157|FG003|NOT COMPLETED|Overall Study||31
10454233|NCT00996801|11602158|FG004|NOT COMPLETED|Overall Study||88
10454234|NCT00996801|11602159|FG005|NOT COMPLETED|Overall Study||19
10454235|NCT00996840|11602180|FG000|STARTED|Overall Study||20
10454236|NCT00996840|11602181|FG001|STARTED|Overall Study||9
10454237|NCT00996840|11602182|FG002|STARTED|Overall Study||12
10454238|NCT00996840|11602183|FG003|STARTED|Overall Study||18
10454239|NCT00996840|11602184|FG004|STARTED|Overall Study||18
10454240|NCT00996840|11602180|FG000|COMPLETED|Overall Study||19
10454241|NCT00996840|11602181|FG001|COMPLETED|Overall Study||7
10454242|NCT00996840|11602182|FG002|COMPLETED|Overall Study||11
10454243|NCT00996840|11602183|FG003|COMPLETED|Overall Study||17
10454244|NCT00996840|11602184|FG004|COMPLETED|Overall Study||16
10454245|NCT00996840|11602180|FG000|NOT COMPLETED|Overall Study||1
10454246|NCT00996840|11602181|FG001|NOT COMPLETED|Overall Study||2
10454247|NCT00996840|11602182|FG002|NOT COMPLETED|Overall Study||1
10454248|NCT00996840|11602183|FG003|NOT COMPLETED|Overall Study||1
10454249|NCT00996840|11602184|FG004|NOT COMPLETED|Overall Study||2
10454250|NCT00996892|11602200|FG000|STARTED|Dose-Escalation Stage 1||4
10454251|NCT00996892|11602201|FG001|STARTED|Dose-Escalation Stage 1||3
10454252|NCT00996892|11602202|FG002|STARTED|Dose-Escalation Stage 1||3
10454253|NCT00996892|11602203|FG003|STARTED|Dose-Escalation Stage 1||9
10454254|NCT00996892|11602204|FG004|STARTED|Dose-Escalation Stage 1||11
10454255|NCT00996892|11602205|FG005|STARTED|Dose-Escalation Stage 1||10
10454256|NCT00996892|11602206|FG006|STARTED|Dose-Escalation Stage 1||4
10454257|NCT00996892|11602207|FG007|STARTED|Dose-Escalation Stage 1||0
10454258|NCT00996892|11602208|FG008|STARTED|Dose-Escalation Stage 1||0
10454259|NCT00996892|11602209|FG009|STARTED|Dose-Escalation Stage 1||0
10454260|NCT00996892|11602210|FG010|STARTED|Dose-Escalation Stage 1||0
10551624|NCT01537120|11705710|FG000|STARTED|12 Weeks Vildagliptin||23
10551625|NCT01537120|11705710|FG000|COMPLETED|12 Weeks Vildagliptin||23
10551626|NCT01537120|11705710|FG000|NOT COMPLETED|12 Weeks Vildagliptin||0
10551627|NCT01537133|11705720|FG000|STARTED|Overall Study||28
10551628|NCT01537133|11705721|FG001|STARTED|Overall Study||14
10551629|NCT01537133|11705722|FG002|STARTED|Overall Study||21
10551630|NCT01537133|11705723|FG003|STARTED|Overall Study||21
10551631|NCT01537133|11705720|FG000|COMPLETED|Overall Study||25
10551632|NCT01537133|11705721|FG001|COMPLETED|Overall Study||14
10551633|NCT01537133|11705722|FG002|COMPLETED|Overall Study||21
10551634|NCT01537133|11705723|FG003|COMPLETED|Overall Study||21
10551635|NCT01537133|11705720|FG000|NOT COMPLETED|Overall Study||3
10551636|NCT01537133|11705721|FG001|NOT COMPLETED|Overall Study||0
10551637|NCT01537133|11705722|FG002|NOT COMPLETED|Overall Study||0
10551638|NCT01537133|11705723|FG003|NOT COMPLETED|Overall Study||0
10551639|NCT01537185|11705735|FG000|STARTED|Overall Study||10
10551640|NCT01537185|11705736|FG001|STARTED|Overall Study||12
10551641|NCT01537185|11705737|FG002|STARTED|Overall Study||10
10551642|NCT01537185|11705738|FG003|STARTED|Overall Study||10
10551643|NCT01537185|11705735|FG000|COMPLETED|Overall Study||7
10551644|NCT01537185|11705736|FG001|COMPLETED|Overall Study||6
10551645|NCT01537185|11705737|FG002|COMPLETED|Overall Study||4
10551646|NCT01537185|11705738|FG003|COMPLETED|Overall Study||8
10551647|NCT01537185|11705735|FG000|NOT COMPLETED|Overall Study||3
10551648|NCT01537185|11705736|FG001|NOT COMPLETED|Overall Study||6
10551649|NCT01537185|11705737|FG002|NOT COMPLETED|Overall Study||6
10551650|NCT01537185|11705738|FG003|NOT COMPLETED|Overall Study||2
10551651|NCT01537198|11705750|FG000|STARTED|Overall Study||617
10551652|NCT01537198|11705750|FG000|COMPLETED|Overall Study||463
10551653|NCT01537198|11705750|FG000|NOT COMPLETED|Overall Study||154
10551654|NCT01537211|11705756|FG000|STARTED|Overall Study||4
10551655|NCT01537211|11705757|FG001|STARTED|Overall Study||6
10551656|NCT01537211|11705756|FG000|COMPLETED|Overall Study||4
10551657|NCT01537211|11705757|FG001|COMPLETED|Overall Study||5
10551658|NCT01537211|11705756|FG000|NOT COMPLETED|Overall Study||0
10551659|NCT01537211|11705757|FG001|NOT COMPLETED|Overall Study||1
10551660|NCT01537302|11705767|FG000|STARTED|Overall Study||100
10551661|NCT01537302|11705767|FG000|COMPLETED|Overall Study||100
10551662|NCT01537302|11705767|FG000|NOT COMPLETED|Overall Study||0
10551663|NCT01537315|11705773|FG000|STARTED|Overall Study||1
10551664|NCT01537315|11705774|FG001|STARTED|Overall Study||7
10551665|NCT01537315|11705773|FG000|COMPLETED|Overall Study||1
10551666|NCT01537315|11705774|FG001|COMPLETED|Overall Study||7
10551667|NCT01537315|11705773|FG000|NOT COMPLETED|Overall Study||0
10551668|NCT01537315|11705774|FG001|NOT COMPLETED|Overall Study||0
10551669|NCT01537367|11705783|FG000|STARTED|Overall Study||615
10551670|NCT01537367|11705784|FG001|STARTED|Overall Study||610
10551671|NCT01537367|11705785|FG002|STARTED|Overall Study||613
10551672|NCT01537367|11705783|FG000|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|615
10551673|NCT01537367|11705784|FG001|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|610
10551674|NCT01537367|11705785|FG002|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|613
10551675|NCT01537367|11705783|FG000|NOT COMPLETED|Overall Study||0
10551676|NCT01537367|11705784|FG001|NOT COMPLETED|Overall Study||0
10551677|NCT01537367|11705785|FG002|NOT COMPLETED|Overall Study||0
10650489|NCT02169479|11810755|FG003|100 mg BIA 9-1067|Overall Study||4
10650490|NCT02169479|11810752|FG000|Placebo|Overall Study||3
10650491|NCT02169479|11810753|FG001|Placebo|Overall Study||3
10454261|NCT00996892|11602211|FG011|STARTED|Dose-Escalation Stage 1||0
10454262|NCT00996892|11602212|FG012|STARTED|Dose-Escalation Stage 1||0
10454263|NCT00996892|11602213|FG013|STARTED|Dose-Escalation Stage 1||0
10454264|NCT00996892|11602214|FG014|STARTED|Dose-Escalation Stage 1||0
10454265|NCT00996892|11602215|FG015|STARTED|Dose-Escalation Stage 1||0
10454266|NCT00996892|11602216|FG016|STARTED|Dose-Escalation Stage 1||0
10454267|NCT00996892|11602217|FG017|STARTED|Dose-Escalation Stage 1||0
10454268|NCT00996892|11602218|FG018|STARTED|Dose-Escalation Stage 1||0
10454269|NCT00996892|11602219|FG019|STARTED|Dose-Escalation Stage 1||0
10454270|NCT00996892|11602200|FG000|COMPLETED|Dose-Escalation Stage 1||0
10454271|NCT00996892|11602201|FG001|COMPLETED|Dose-Escalation Stage 1||0
10650492|NCT02169479|11810754|FG002|Placebo|Overall Study||4
10650493|NCT02169479|11810755|FG003|Placebo|Overall Study||4
10650494|NCT02169479|11810752|FG000|COMPLETED|Overall Study||3
10650495|NCT02169479|11810753|FG001|COMPLETED|Overall Study||3
10650496|NCT02169479|11810754|FG002|COMPLETED|Overall Study||4
10650497|NCT02169479|11810755|FG003|COMPLETED|Overall Study||4
10650498|NCT02169479|11810752|FG000|NOT COMPLETED|Overall Study||1
10650499|NCT02169479|11810753|FG001|NOT COMPLETED|Overall Study||1
10650500|NCT02169479|11810754|FG002|NOT COMPLETED|Overall Study||0
10650501|NCT02169479|11810755|FG003|NOT COMPLETED|Overall Study||0
10650502|NCT02169505|11810765|FG000|STARTED|Overall Study||2
10650503|NCT02169505|11810765|FG000|COMPLETED|Overall Study||1
10650504|NCT02169505|11810765|FG000|NOT COMPLETED|Overall Study||1
10650505|NCT02169674|11810771|FG000|STARTED|Overall Study||137
10650506|NCT02169674|11810772|FG001|STARTED|Overall Study||213
10454272|NCT00996892|11602202|FG002|COMPLETED|Dose-Escalation Stage 1||0
10454273|NCT00996892|11602203|FG003|COMPLETED|Dose-Escalation Stage 1||0
10454274|NCT00996892|11602204|FG004|COMPLETED|Dose-Escalation Stage 1||0
10454275|NCT00996892|11602205|FG005|COMPLETED|Dose-Escalation Stage 1||0
10454276|NCT00996892|11602206|FG006|COMPLETED|Dose-Escalation Stage 1||0
10454277|NCT00996892|11602207|FG007|COMPLETED|Dose-Escalation Stage 1||0
10454278|NCT00996892|11602208|FG008|COMPLETED|Dose-Escalation Stage 1||0
10454279|NCT00996892|11602209|FG009|COMPLETED|Dose-Escalation Stage 1||0
10454280|NCT00996892|11602210|FG010|COMPLETED|Dose-Escalation Stage 1||0
10454281|NCT00996892|11602211|FG011|COMPLETED|Dose-Escalation Stage 1||0
10454282|NCT00996892|11602212|FG012|COMPLETED|Dose-Escalation Stage 1||0
10454283|NCT00996892|11602213|FG013|COMPLETED|Dose-Escalation Stage 1||0
10454284|NCT00996892|11602214|FG014|COMPLETED|Dose-Escalation Stage 1||0
10454285|NCT00996892|11602215|FG015|COMPLETED|Dose-Escalation Stage 1||0
10454286|NCT00996892|11602216|FG016|COMPLETED|Dose-Escalation Stage 1||0
10454287|NCT00996892|11602217|FG017|COMPLETED|Dose-Escalation Stage 1||0
10454288|NCT00996892|11602218|FG018|COMPLETED|Dose-Escalation Stage 1||0
10454289|NCT00996892|11602219|FG019|COMPLETED|Dose-Escalation Stage 1||0
10454290|NCT00996892|11602200|FG000|NOT COMPLETED|Dose-Escalation Stage 1||4
10454291|NCT00996892|11602201|FG001|NOT COMPLETED|Dose-Escalation Stage 1||3
10454292|NCT00996892|11602202|FG002|NOT COMPLETED|Dose-Escalation Stage 1||3
10454293|NCT00996892|11602203|FG003|NOT COMPLETED|Dose-Escalation Stage 1||9
10454294|NCT00996892|11602204|FG004|NOT COMPLETED|Dose-Escalation Stage 1||11
10454295|NCT00996892|11602205|FG005|NOT COMPLETED|Dose-Escalation Stage 1||10
10454296|NCT00996892|11602206|FG006|NOT COMPLETED|Dose-Escalation Stage 1||4
10454297|NCT00996892|11602207|FG007|NOT COMPLETED|Dose-Escalation Stage 1||0
10454298|NCT00996892|11602208|FG008|NOT COMPLETED|Dose-Escalation Stage 1||0
10454299|NCT00996892|11602209|FG009|NOT COMPLETED|Dose-Escalation Stage 1||0
10454300|NCT00996892|11602210|FG010|NOT COMPLETED|Dose-Escalation Stage 1||0
10454301|NCT00996892|11602211|FG011|NOT COMPLETED|Dose-Escalation Stage 1||0
10454302|NCT00996892|11602212|FG012|NOT COMPLETED|Dose-Escalation Stage 1||0
10454303|NCT00996892|11602213|FG013|NOT COMPLETED|Dose-Escalation Stage 1||0
10454304|NCT00996892|11602214|FG014|NOT COMPLETED|Dose-Escalation Stage 1||0
10454305|NCT00996892|11602215|FG015|NOT COMPLETED|Dose-Escalation Stage 1||0
10454306|NCT00996892|11602216|FG016|NOT COMPLETED|Dose-Escalation Stage 1||0
10454307|NCT00996892|11602217|FG017|NOT COMPLETED|Dose-Escalation Stage 1||0
10454308|NCT00996892|11602218|FG018|NOT COMPLETED|Dose-Escalation Stage 1||0
10454309|NCT00996892|11602219|FG019|NOT COMPLETED|Dose-Escalation Stage 1||0
10454310|NCT00996892|11602200|FG000|STARTED|Dose-Escalation Stage 1A||0
10454311|NCT00996892|11602201|FG001|STARTED|Dose-Escalation Stage 1A||0
10454312|NCT00996892|11602202|FG002|STARTED|Dose-Escalation Stage 1A||0
10454313|NCT00996892|11602203|FG003|STARTED|Dose-Escalation Stage 1A||0
10454314|NCT00996892|11602204|FG004|STARTED|Dose-Escalation Stage 1A||0
10454315|NCT00996892|11602205|FG005|STARTED|Dose-Escalation Stage 1A||0
10454316|NCT00996892|11602206|FG006|STARTED|Dose-Escalation Stage 1A||0
10454317|NCT00996892|11602207|FG007|STARTED|Dose-Escalation Stage 1A||3
10454318|NCT00996892|11602208|FG008|STARTED|Dose-Escalation Stage 1A||3
10454319|NCT00996892|11602209|FG009|STARTED|Dose-Escalation Stage 1A||4
10454320|NCT00996892|11602210|FG010|STARTED|Dose-Escalation Stage 1A||7
10454321|NCT00996892|11602211|FG011|STARTED|Dose-Escalation Stage 1A||9
10454322|NCT00996892|11602212|FG012|STARTED|Dose-Escalation Stage 1A||8
10454323|NCT00996892|11602213|FG013|STARTED|Dose-Escalation Stage 1A||5
10454324|NCT00996892|11602214|FG014|STARTED|Dose-Escalation Stage 1A||0
10454325|NCT00996892|11602215|FG015|STARTED|Dose-Escalation Stage 1A||0
10454326|NCT00996892|11602216|FG016|STARTED|Dose-Escalation Stage 1A||0
10454327|NCT00996892|11602217|FG017|STARTED|Dose-Escalation Stage 1A||0
10454328|NCT00996892|11602218|FG018|STARTED|Dose-Escalation Stage 1A||0
10454329|NCT00996892|11602219|FG019|STARTED|Dose-Escalation Stage 1A||0
10454330|NCT00996892|11602200|FG000|COMPLETED|Dose-Escalation Stage 1A||0
10454331|NCT00996892|11602201|FG001|COMPLETED|Dose-Escalation Stage 1A||0
10454332|NCT00996892|11602202|FG002|COMPLETED|Dose-Escalation Stage 1A||0
10454333|NCT00996892|11602203|FG003|COMPLETED|Dose-Escalation Stage 1A||0
10454334|NCT00996892|11602204|FG004|COMPLETED|Dose-Escalation Stage 1A||0
10454335|NCT00996892|11602205|FG005|COMPLETED|Dose-Escalation Stage 1A||0
10454336|NCT00996892|11602206|FG006|COMPLETED|Dose-Escalation Stage 1A||0
10454337|NCT00996892|11602207|FG007|COMPLETED|Dose-Escalation Stage 1A||0
10454338|NCT00996892|11602208|FG008|COMPLETED|Dose-Escalation Stage 1A||0
10454339|NCT00996892|11602209|FG009|COMPLETED|Dose-Escalation Stage 1A||0
10318696|NCT00216125|11452942|FG002|STARTED|Pre-Randomization Phase||0
10318697|NCT00216125|11452940|FG000|DSMB Cohort for Futility|Pre-Randomization Phase||203
10454340|NCT00996892|11602210|FG010|COMPLETED|Dose-Escalation Stage 1A||0
10454341|NCT00996892|11602211|FG011|COMPLETED|Dose-Escalation Stage 1A||0
10454342|NCT00996892|11602212|FG012|COMPLETED|Dose-Escalation Stage 1A||0
10454343|NCT00996892|11602213|FG013|COMPLETED|Dose-Escalation Stage 1A||0
10454344|NCT00996892|11602214|FG014|COMPLETED|Dose-Escalation Stage 1A||0
10454345|NCT00996892|11602215|FG015|COMPLETED|Dose-Escalation Stage 1A||0
10454346|NCT00996892|11602216|FG016|COMPLETED|Dose-Escalation Stage 1A||0
10454347|NCT00996892|11602217|FG017|COMPLETED|Dose-Escalation Stage 1A||0
10454348|NCT00996892|11602218|FG018|COMPLETED|Dose-Escalation Stage 1A||0
10454349|NCT00996892|11602219|FG019|COMPLETED|Dose-Escalation Stage 1A||0
10454350|NCT00996892|11602200|FG000|NOT COMPLETED|Dose-Escalation Stage 1A||0
10454351|NCT00996892|11602201|FG001|NOT COMPLETED|Dose-Escalation Stage 1A||0
10454352|NCT00996892|11602202|FG002|NOT COMPLETED|Dose-Escalation Stage 1A||0
10454353|NCT00996892|11602203|FG003|NOT COMPLETED|Dose-Escalation Stage 1A||0
10454354|NCT00996892|11602204|FG004|NOT COMPLETED|Dose-Escalation Stage 1A||0
10454355|NCT00996892|11602205|FG005|NOT COMPLETED|Dose-Escalation Stage 1A||0
10454356|NCT00996892|11602206|FG006|NOT COMPLETED|Dose-Escalation Stage 1A||0
10454357|NCT00996892|11602207|FG007|NOT COMPLETED|Dose-Escalation Stage 1A||3
10454358|NCT00996892|11602208|FG008|NOT COMPLETED|Dose-Escalation Stage 1A||3
10454359|NCT00996892|11602209|FG009|NOT COMPLETED|Dose-Escalation Stage 1A||4
10454360|NCT00996892|11602210|FG010|NOT COMPLETED|Dose-Escalation Stage 1A||7
10454361|NCT00996892|11602211|FG011|NOT COMPLETED|Dose-Escalation Stage 1A||9
10454362|NCT00996892|11602212|FG012|NOT COMPLETED|Dose-Escalation Stage 1A||8
10454363|NCT00996892|11602213|FG013|NOT COMPLETED|Dose-Escalation Stage 1A||5
10454364|NCT00996892|11602214|FG014|NOT COMPLETED|Dose-Escalation Stage 1A||0
10454365|NCT00996892|11602215|FG015|NOT COMPLETED|Dose-Escalation Stage 1A||0
10454366|NCT00996892|11602216|FG016|NOT COMPLETED|Dose-Escalation Stage 1A||0
10454367|NCT00996892|11602217|FG017|NOT COMPLETED|Dose-Escalation Stage 1A||0
10454368|NCT00996892|11602218|FG018|NOT COMPLETED|Dose-Escalation Stage 1A||0
10454369|NCT00996892|11602219|FG019|NOT COMPLETED|Dose-Escalation Stage 1A||0
10454370|NCT00996892|11602200|FG000|STARTED|Dose-Escalation Stage 1B||0
10454371|NCT00996892|11602201|FG001|STARTED|Dose-Escalation Stage 1B||0
10454372|NCT00996892|11602202|FG002|STARTED|Dose-Escalation Stage 1B||0
10454373|NCT00996892|11602203|FG003|STARTED|Dose-Escalation Stage 1B||0
10454374|NCT00996892|11602204|FG004|STARTED|Dose-Escalation Stage 1B||0
10454375|NCT00996892|11602205|FG005|STARTED|Dose-Escalation Stage 1B||0
10454376|NCT00996892|11602206|FG006|STARTED|Dose-Escalation Stage 1B||0
10454377|NCT00996892|11602207|FG007|STARTED|Dose-Escalation Stage 1B||0
10454378|NCT00996892|11602208|FG008|STARTED|Dose-Escalation Stage 1B||0
10454379|NCT00996892|11602209|FG009|STARTED|Dose-Escalation Stage 1B||0
10454380|NCT00996892|11602210|FG010|STARTED|Dose-Escalation Stage 1B||0
10454381|NCT00996892|11602211|FG011|STARTED|Dose-Escalation Stage 1B||0
10454382|NCT00996892|11602212|FG012|STARTED|Dose-Escalation Stage 1B||0
10454383|NCT00996892|11602213|FG013|STARTED|Dose-Escalation Stage 1B||0
10454384|NCT00996892|11602214|FG014|STARTED|Dose-Escalation Stage 1B||4
10454385|NCT00996892|11602215|FG015|STARTED|Dose-Escalation Stage 1B||3
10454386|NCT00996892|11602216|FG016|STARTED|Dose-Escalation Stage 1B||3
10454387|NCT00996892|11602217|FG017|STARTED|Dose-Escalation Stage 1B||5
10454388|NCT00996892|11602218|FG018|STARTED|Dose-Escalation Stage 1B||0
10454389|NCT00996892|11602219|FG019|STARTED|Dose-Escalation Stage 1B||0
10454390|NCT00996892|11602200|FG000|COMPLETED|Dose-Escalation Stage 1B||0
10454391|NCT00996892|11602201|FG001|COMPLETED|Dose-Escalation Stage 1B||0
10454392|NCT00996892|11602202|FG002|COMPLETED|Dose-Escalation Stage 1B||0
10454393|NCT00996892|11602203|FG003|COMPLETED|Dose-Escalation Stage 1B||0
10454394|NCT00996892|11602204|FG004|COMPLETED|Dose-Escalation Stage 1B||0
10454395|NCT00996892|11602205|FG005|COMPLETED|Dose-Escalation Stage 1B||0
10454396|NCT00996892|11602206|FG006|COMPLETED|Dose-Escalation Stage 1B||0
10454397|NCT00996892|11602207|FG007|COMPLETED|Dose-Escalation Stage 1B||0
10454398|NCT00996892|11602208|FG008|COMPLETED|Dose-Escalation Stage 1B||0
10454399|NCT00996892|11602209|FG009|COMPLETED|Dose-Escalation Stage 1B||0
10454400|NCT00996892|11602210|FG010|COMPLETED|Dose-Escalation Stage 1B||0
10454401|NCT00996892|11602211|FG011|COMPLETED|Dose-Escalation Stage 1B||0
10454402|NCT00996892|11602212|FG012|COMPLETED|Dose-Escalation Stage 1B||0
10454403|NCT00996892|11602213|FG013|COMPLETED|Dose-Escalation Stage 1B||0
10454404|NCT00996892|11602214|FG014|COMPLETED|Dose-Escalation Stage 1B||0
10454405|NCT00996892|11602215|FG015|COMPLETED|Dose-Escalation Stage 1B||0
10454406|NCT00996892|11602216|FG016|COMPLETED|Dose-Escalation Stage 1B||0
10454407|NCT00996892|11602217|FG017|COMPLETED|Dose-Escalation Stage 1B||0
10454408|NCT00996892|11602218|FG018|COMPLETED|Dose-Escalation Stage 1B||0
10454409|NCT00996892|11602219|FG019|COMPLETED|Dose-Escalation Stage 1B||0
10454410|NCT00996892|11602200|FG000|NOT COMPLETED|Dose-Escalation Stage 1B||0
10454411|NCT00996892|11602201|FG001|NOT COMPLETED|Dose-Escalation Stage 1B||0
10454412|NCT00996892|11602202|FG002|NOT COMPLETED|Dose-Escalation Stage 1B||0
10454413|NCT00996892|11602203|FG003|NOT COMPLETED|Dose-Escalation Stage 1B||0
10454414|NCT00996892|11602204|FG004|NOT COMPLETED|Dose-Escalation Stage 1B||0
10454415|NCT00996892|11602205|FG005|NOT COMPLETED|Dose-Escalation Stage 1B||0
10454416|NCT00996892|11602206|FG006|NOT COMPLETED|Dose-Escalation Stage 1B||0
10454417|NCT00996892|11602207|FG007|NOT COMPLETED|Dose-Escalation Stage 1B||0
10454418|NCT00996892|11602208|FG008|NOT COMPLETED|Dose-Escalation Stage 1B||0
10454419|NCT00996892|11602209|FG009|NOT COMPLETED|Dose-Escalation Stage 1B||0
10454420|NCT00996892|11602210|FG010|NOT COMPLETED|Dose-Escalation Stage 1B||0
10454421|NCT00996892|11602211|FG011|NOT COMPLETED|Dose-Escalation Stage 1B||0
10454422|NCT00996892|11602212|FG012|NOT COMPLETED|Dose-Escalation Stage 1B||0
10454423|NCT00996892|11602213|FG013|NOT COMPLETED|Dose-Escalation Stage 1B||0
10454424|NCT00996892|11602214|FG014|NOT COMPLETED|Dose-Escalation Stage 1B||4
10454425|NCT00996892|11602215|FG015|NOT COMPLETED|Dose-Escalation Stage 1B||3
10454426|NCT00996892|11602216|FG016|NOT COMPLETED|Dose-Escalation Stage 1B||3
10454427|NCT00996892|11602217|FG017|NOT COMPLETED|Dose-Escalation Stage 1B||5
10454428|NCT00996892|11602218|FG018|NOT COMPLETED|Dose-Escalation Stage 1B||0
10454429|NCT00996892|11602219|FG019|NOT COMPLETED|Dose-Escalation Stage 1B||0
10454430|NCT00996892|11602200|FG000|STARTED|Expansion Stage 2||0
10454431|NCT00996892|11602201|FG001|STARTED|Expansion Stage 2||0
10454432|NCT00996892|11602202|FG002|STARTED|Expansion Stage 2||0
10454433|NCT00996892|11602203|FG003|STARTED|Expansion Stage 2||0
10454434|NCT00996892|11602204|FG004|STARTED|Expansion Stage 2||0
10454435|NCT00996892|11602205|FG005|STARTED|Expansion Stage 2||0
10454436|NCT00996892|11602206|FG006|STARTED|Expansion Stage 2||0
10454437|NCT00996892|11602207|FG007|STARTED|Expansion Stage 2||0
10454438|NCT00996892|11602208|FG008|STARTED|Expansion Stage 2||0
10454439|NCT00996892|11602209|FG009|STARTED|Expansion Stage 2||0
10454440|NCT00996892|11602210|FG010|STARTED|Expansion Stage 2||0
10454441|NCT00996892|11602211|FG011|STARTED|Expansion Stage 2||0
10454442|NCT00996892|11602212|FG012|STARTED|Expansion Stage 2||0
10454443|NCT00996892|11602213|FG013|STARTED|Expansion Stage 2||0
10454444|NCT00996892|11602214|FG014|STARTED|Expansion Stage 2||0
10454445|NCT00996892|11602215|FG015|STARTED|Expansion Stage 2||0
10454446|NCT00996892|11602216|FG016|STARTED|Expansion Stage 2||0
10454447|NCT00996892|11602217|FG017|STARTED|Expansion Stage 2||0
10454448|NCT00996892|11602218|FG018|STARTED|Expansion Stage 2||35
10454449|NCT00996892|11602219|FG019|STARTED|Expansion Stage 2||0
10454450|NCT00996892|11602200|FG000|COMPLETED|Expansion Stage 2||0
10454451|NCT00996892|11602201|FG001|COMPLETED|Expansion Stage 2||0
10454452|NCT00996892|11602202|FG002|COMPLETED|Expansion Stage 2||0
10454453|NCT00996892|11602203|FG003|COMPLETED|Expansion Stage 2||0
10454454|NCT00996892|11602204|FG004|COMPLETED|Expansion Stage 2||0
10454455|NCT00996892|11602205|FG005|COMPLETED|Expansion Stage 2||0
10454456|NCT00996892|11602206|FG006|COMPLETED|Expansion Stage 2||0
10454457|NCT00996892|11602207|FG007|COMPLETED|Expansion Stage 2||0
10454458|NCT00996892|11602208|FG008|COMPLETED|Expansion Stage 2||0
10454459|NCT00996892|11602209|FG009|COMPLETED|Expansion Stage 2||0
10454460|NCT00996892|11602210|FG010|COMPLETED|Expansion Stage 2||0
10454461|NCT00996892|11602211|FG011|COMPLETED|Expansion Stage 2||0
10454462|NCT00996892|11602212|FG012|COMPLETED|Expansion Stage 2||0
10454463|NCT00996892|11602213|FG013|COMPLETED|Expansion Stage 2||0
10454464|NCT00996892|11602214|FG014|COMPLETED|Expansion Stage 2||0
10454465|NCT00996892|11602215|FG015|COMPLETED|Expansion Stage 2||0
10454466|NCT00996892|11602216|FG016|COMPLETED|Expansion Stage 2||0
10454467|NCT00996892|11602217|FG017|COMPLETED|Expansion Stage 2||0
10454468|NCT00996892|11602218|FG018|COMPLETED|Expansion Stage 2||0
10454469|NCT00996892|11602219|FG019|COMPLETED|Expansion Stage 2||0
10454470|NCT00996892|11602200|FG000|NOT COMPLETED|Expansion Stage 2||0
10454471|NCT00996892|11602201|FG001|NOT COMPLETED|Expansion Stage 2||0
10454472|NCT00996892|11602202|FG002|NOT COMPLETED|Expansion Stage 2||0
10454473|NCT00996892|11602203|FG003|NOT COMPLETED|Expansion Stage 2||0
10454474|NCT00996892|11602204|FG004|NOT COMPLETED|Expansion Stage 2||0
10454475|NCT00996892|11602205|FG005|NOT COMPLETED|Expansion Stage 2||0
10454476|NCT00996892|11602206|FG006|NOT COMPLETED|Expansion Stage 2||0
10454477|NCT00996892|11602207|FG007|NOT COMPLETED|Expansion Stage 2||0
10454478|NCT00996892|11602208|FG008|NOT COMPLETED|Expansion Stage 2||0
10454479|NCT00996892|11602209|FG009|NOT COMPLETED|Expansion Stage 2||0
10454480|NCT00996892|11602210|FG010|NOT COMPLETED|Expansion Stage 2||0
10454481|NCT00996892|11602211|FG011|NOT COMPLETED|Expansion Stage 2||0
10454482|NCT00996892|11602212|FG012|NOT COMPLETED|Expansion Stage 2||0
10454483|NCT00996892|11602213|FG013|NOT COMPLETED|Expansion Stage 2||0
10454484|NCT00996892|11602214|FG014|NOT COMPLETED|Expansion Stage 2||0
10454485|NCT00996892|11602215|FG015|NOT COMPLETED|Expansion Stage 2||0
10454486|NCT00996892|11602216|FG016|NOT COMPLETED|Expansion Stage 2||0
10454487|NCT00996892|11602217|FG017|NOT COMPLETED|Expansion Stage 2||0
10454488|NCT00996892|11602218|FG018|NOT COMPLETED|Expansion Stage 2||35
10454489|NCT00996892|11602219|FG019|NOT COMPLETED|Expansion Stage 2||0
10454490|NCT00996892|11602200|FG000|STARTED|Expansion Stage 2A||0
10454491|NCT00996892|11602201|FG001|STARTED|Expansion Stage 2A||0
10454492|NCT00996892|11602202|FG002|STARTED|Expansion Stage 2A||0
10454493|NCT00996892|11602203|FG003|STARTED|Expansion Stage 2A||0
10454494|NCT00996892|11602204|FG004|STARTED|Expansion Stage 2A||0
10454495|NCT00996892|11602205|FG005|STARTED|Expansion Stage 2A||0
10454496|NCT00996892|11602206|FG006|STARTED|Expansion Stage 2A||0
10454497|NCT00996892|11602207|FG007|STARTED|Expansion Stage 2A||0
10454498|NCT00996892|11602208|FG008|STARTED|Expansion Stage 2A||0
10454499|NCT00996892|11602209|FG009|STARTED|Expansion Stage 2A||0
10454500|NCT00996892|11602210|FG010|STARTED|Expansion Stage 2A||0
10454501|NCT00996892|11602211|FG011|STARTED|Expansion Stage 2A||0
10454502|NCT00996892|11602212|FG012|STARTED|Expansion Stage 2A||0
10454503|NCT00996892|11602213|FG013|STARTED|Expansion Stage 2A||0
10454504|NCT00996892|11602214|FG014|STARTED|Expansion Stage 2A||0
10454505|NCT00996892|11602215|FG015|STARTED|Expansion Stage 2A||0
10454506|NCT00996892|11602216|FG016|STARTED|Expansion Stage 2A||0
10454507|NCT00996892|11602217|FG017|STARTED|Expansion Stage 2A||0
10454508|NCT00996892|11602218|FG018|STARTED|Expansion Stage 2A||0
10454509|NCT00996892|11602219|FG019|STARTED|Expansion Stage 2A||45
10454510|NCT00996892|11602200|FG000|COMPLETED|Expansion Stage 2A||0
10454511|NCT00996892|11602201|FG001|COMPLETED|Expansion Stage 2A||0
10454512|NCT00996892|11602202|FG002|COMPLETED|Expansion Stage 2A||0
10454513|NCT00996892|11602203|FG003|COMPLETED|Expansion Stage 2A||0
10454514|NCT00996892|11602204|FG004|COMPLETED|Expansion Stage 2A||0
10454515|NCT00996892|11602205|FG005|COMPLETED|Expansion Stage 2A||0
10454516|NCT00996892|11602206|FG006|COMPLETED|Expansion Stage 2A||0
10454517|NCT00996892|11602207|FG007|COMPLETED|Expansion Stage 2A||0
10454518|NCT00996892|11602208|FG008|COMPLETED|Expansion Stage 2A||0
10454519|NCT00996892|11602209|FG009|COMPLETED|Expansion Stage 2A||0
10454520|NCT00996892|11602210|FG010|COMPLETED|Expansion Stage 2A||0
10454521|NCT00996892|11602211|FG011|COMPLETED|Expansion Stage 2A||0
10454522|NCT00996892|11602212|FG012|COMPLETED|Expansion Stage 2A||0
10454523|NCT00996892|11602213|FG013|COMPLETED|Expansion Stage 2A||0
10454524|NCT00996892|11602214|FG014|COMPLETED|Expansion Stage 2A||0
10454525|NCT00996892|11602215|FG015|COMPLETED|Expansion Stage 2A||0
10454526|NCT00996892|11602216|FG016|COMPLETED|Expansion Stage 2A||0
10454527|NCT00996892|11602217|FG017|COMPLETED|Expansion Stage 2A||0
10454528|NCT00996892|11602218|FG018|COMPLETED|Expansion Stage 2A||0
10454529|NCT00996892|11602219|FG019|COMPLETED|Expansion Stage 2A||0
10454530|NCT00996892|11602200|FG000|NOT COMPLETED|Expansion Stage 2A||0
10454531|NCT00996892|11602201|FG001|NOT COMPLETED|Expansion Stage 2A||0
10454532|NCT00996892|11602202|FG002|NOT COMPLETED|Expansion Stage 2A||0
10454533|NCT00996892|11602203|FG003|NOT COMPLETED|Expansion Stage 2A||0
10454534|NCT00996892|11602204|FG004|NOT COMPLETED|Expansion Stage 2A||0
10454535|NCT00996892|11602205|FG005|NOT COMPLETED|Expansion Stage 2A||0
10454536|NCT00996892|11602206|FG006|NOT COMPLETED|Expansion Stage 2A||0
10454537|NCT00996892|11602207|FG007|NOT COMPLETED|Expansion Stage 2A||0
10454538|NCT00996892|11602208|FG008|NOT COMPLETED|Expansion Stage 2A||0
10454539|NCT00996892|11602209|FG009|NOT COMPLETED|Expansion Stage 2A||0
10454540|NCT00996892|11602210|FG010|NOT COMPLETED|Expansion Stage 2A||0
10454541|NCT00996892|11602211|FG011|NOT COMPLETED|Expansion Stage 2A||0
10454542|NCT00996892|11602212|FG012|NOT COMPLETED|Expansion Stage 2A||0
10454543|NCT00996892|11602213|FG013|NOT COMPLETED|Expansion Stage 2A||0
10454544|NCT00996892|11602214|FG014|NOT COMPLETED|Expansion Stage 2A||0
10454545|NCT00996892|11602215|FG015|NOT COMPLETED|Expansion Stage 2A||0
10454546|NCT00996892|11602216|FG016|NOT COMPLETED|Expansion Stage 2A||0
10454547|NCT00996892|11602217|FG017|NOT COMPLETED|Expansion Stage 2A||0
10454548|NCT00996892|11602218|FG018|NOT COMPLETED|Expansion Stage 2A||0
10454549|NCT00996892|11602219|FG019|NOT COMPLETED|Expansion Stage 2A||45
10454550|NCT00996918|11602285|FG000|STARTED|Overall Study||39
10454551|NCT00996918|11602286|FG001|STARTED|Overall Study||66
10454552|NCT00996918|11602287|FG002|STARTED|Overall Study||37
10454553|NCT00996918|11602288|FG003|STARTED|Overall Study||56
10454554|NCT00996918|11602289|FG004|STARTED|Overall Study||4
10454555|NCT00996918|11602285|FG000|Treated|Overall Study||39
10454556|NCT00996918|11602286|FG001|Treated|Overall Study||66
10454557|NCT00996918|11602287|FG002|Treated|Overall Study||37
10454558|NCT00996918|11602288|FG003|Treated|Overall Study||56
10454559|NCT00996918|11602289|FG004|Treated|Overall Study||4
10454560|NCT00996918|11602285|FG000|COMPLETED|Overall Study||0
10454561|NCT00996918|11602286|FG001|COMPLETED|Overall Study||0
10454562|NCT00996918|11602287|FG002|COMPLETED|Overall Study||0
10454563|NCT00996918|11602288|FG003|COMPLETED|Overall Study||0
10454564|NCT00996918|11602289|FG004|COMPLETED|Overall Study||0
10454565|NCT00996918|11602285|FG000|NOT COMPLETED|Overall Study||39
10454566|NCT00996918|11602286|FG001|NOT COMPLETED|Overall Study||66
10454567|NCT00996918|11602287|FG002|NOT COMPLETED|Overall Study||37
10454568|NCT00996918|11602288|FG003|NOT COMPLETED|Overall Study||56
10454569|NCT00996918|11602289|FG004|NOT COMPLETED|Overall Study||4
10454570|NCT00996931|11602301|FG000|STARTED|Overall Study||6
10454571|NCT00996931|11602301|FG000|COMPLETED|Overall Study||6
10454572|NCT00996931|11602301|FG000|NOT COMPLETED|Overall Study||0
10454573|NCT00996944|11602308|FG000|STARTED|Double-blind Treatment Period||22
10454574|NCT00996944|11602309|FG001|STARTED|Double-blind Treatment Period||12
10454575|NCT00996944|11602308|FG000|COMPLETED|Double-blind Treatment Period||12
10454576|NCT00996944|11602309|FG001|COMPLETED|Double-blind Treatment Period||5
10454577|NCT00996944|11602308|FG000|NOT COMPLETED|Double-blind Treatment Period||10
10454578|NCT00996944|11602309|FG001|NOT COMPLETED|Double-blind Treatment Period||7
10454579|NCT00996944|11602308|FG000|STARTED|Long-term Treatment Period||12
10454580|NCT00996944|11602309|FG001|STARTED|Long-term Treatment Period||5
10454581|NCT00996944|11602308|FG000|COMPLETED|Long-term Treatment Period||0
10454582|NCT00996944|11602309|FG001|COMPLETED|Long-term Treatment Period||0
10454583|NCT00996944|11602308|FG000|NOT COMPLETED|Long-term Treatment Period||12
10454584|NCT00996944|11602309|FG001|NOT COMPLETED|Long-term Treatment Period||5
10454585|NCT00996996|11602317|FG000|STARTED|Overall Study||77
10454586|NCT00996996|11602317|FG000|COMPLETED|Overall Study|These participants completed 12 years of follow-up.|44
10454587|NCT00996996|11602317|FG000|NOT COMPLETED|Overall Study||33
10454588|NCT00997035|11602323|FG000|STARTED|3-week Followup Visit||121
10454589|NCT00997035|11602324|FG001|STARTED|3-week Followup Visit||119
10454590|NCT00997035|11602323|FG000|COMPLETED|3-week Followup Visit||112
10454591|NCT00997035|11602324|FG001|COMPLETED|3-week Followup Visit||113
10454592|NCT00997035|11602323|FG000|NOT COMPLETED|3-week Followup Visit||9
10454593|NCT00997035|11602324|FG001|NOT COMPLETED|3-week Followup Visit||6
10454594|NCT00997035|11602323|FG000|STARTED|3-month Follow-up Visit||112
10454595|NCT00997035|11602324|FG001|STARTED|3-month Follow-up Visit||113
10454596|NCT00997035|11602323|FG000|COMPLETED|3-month Follow-up Visit||100
10454597|NCT00997035|11602324|FG001|COMPLETED|3-month Follow-up Visit||107
10454598|NCT00997035|11602323|FG000|NOT COMPLETED|3-month Follow-up Visit||12
10454599|NCT00997035|11602324|FG001|NOT COMPLETED|3-month Follow-up Visit||6
10454600|NCT00997113|11602342|FG000|STARTED|Overall Study||10
10454601|NCT00997113|11602343|FG001|STARTED|Overall Study||10
10454602|NCT00997113|11602342|FG000|COMPLETED|Overall Study||10
10454603|NCT00997113|11602343|FG001|COMPLETED|Overall Study||10
10454604|NCT00997113|11602342|FG000|NOT COMPLETED|Overall Study||0
10454605|NCT00997113|11602343|FG001|NOT COMPLETED|Overall Study||0
10454606|NCT00997126|11602351|FG000|STARTED|Overall Study||63
10454607|NCT00997126|11602352|FG001|STARTED|Overall Study||63
10454608|NCT00997126|11602351|FG000|COMPLETED|Overall Study||56
10454609|NCT00997126|11602352|FG001|COMPLETED|Overall Study||52
10454610|NCT00997126|11602351|FG000|NOT COMPLETED|Overall Study||7
10454611|NCT00997126|11602352|FG001|NOT COMPLETED|Overall Study||11
10454612|NCT00997139|11602358|FG000|STARTED|Overall Study||216
10454613|NCT00997139|11602358|FG000|Treated for Positive Baseline Culture|Overall Study||30
10454614|NCT00997139|11602358|FG000|COMPLETED|Overall Study||30
10454615|NCT00997139|11602358|FG000|NOT COMPLETED|Overall Study||186
10454616|NCT00997204|11602366|FG000|STARTED|Naive Treatment Phase||25
10454617|NCT00997204|11602367|FG001|STARTED|Naive Treatment Phase|Non-naive patients participated in the study but they were not treated in the naive treatment phase|79
10454618|NCT00997204|11602366|FG000|COMPLETED|Naive Treatment Phase||19
10454619|NCT00997204|11602367|FG001|COMPLETED|Naive Treatment Phase||0
10454620|NCT00997204|11602366|FG000|NOT COMPLETED|Naive Treatment Phase||6
10454621|NCT00997204|11602367|FG001|NOT COMPLETED|Naive Treatment Phase||79
10454622|NCT00997204|11602366|FG000|STARTED|Self-administration Phase||19
10454623|NCT00997204|11602367|FG001|STARTED|Self-administration Phase|1 subject did not self-administered icatibant but had a HCP to perform. the data were not included.|78
10454624|NCT00997204|11602366|FG000|COMPLETED|Self-administration Phase||19
10454625|NCT00997204|11602367|FG001|COMPLETED|Self-administration Phase||77
10454626|NCT00997204|11602366|FG000|NOT COMPLETED|Self-administration Phase||0
10454627|NCT00997204|11602367|FG001|NOT COMPLETED|Self-administration Phase||1
10454628|NCT00997243|11602377|FG000|STARTED|Overall Study||7
10454629|NCT00997243|11602377|FG000|COMPLETED|Overall Study||0
10454630|NCT00997243|11602377|FG000|NOT COMPLETED|Overall Study||7
10454631|NCT00997321|11602383|FG000|STARTED|Overall Study||50
10454632|NCT00997321|11602384|FG001|STARTED|Overall Study||50
10454633|NCT00997321|11602383|FG000|COMPLETED|Overall Study||50
10454634|NCT00997321|11602384|FG001|COMPLETED|Overall Study||47
10454635|NCT00997321|11602383|FG000|NOT COMPLETED|Overall Study||0
10454636|NCT00997321|11602384|FG001|NOT COMPLETED|Overall Study||3
10454637|NCT00997334|11602396|FG000|STARTED|Overall Study||60
10454638|NCT00997334|11602396|FG000|Eligible for Repeat Biopsy|Overall Study|Patients who experience disease progression on treatment were eligible for repeat biopsy|44
10454639|NCT00997334|11602396|FG000|Evaluable|Overall Study|Patients with tissue available for re-biopsy at time of progression|35
10454640|NCT00997334|11602396|FG000|COMPLETED|Overall Study||35
10454641|NCT00997334|11602396|FG000|NOT COMPLETED|Overall Study||25
10454642|NCT00997373|11602402|FG000|STARTED|Overall Study||28
10454643|NCT00997373|11602403|FG001|STARTED|Overall Study||15
10454644|NCT00997373|11602402|FG000|Received Letrozole|Overall Study||23
10454645|NCT00997373|11602403|FG001|Received Letrozole|Overall Study||0
10454646|NCT00997373|11602402|FG000|Completed Hysterectomy|Overall Study||17
10454647|NCT00997373|11602403|FG001|Completed Hysterectomy|Overall Study||15
10454648|NCT00997373|11602402|FG000|COMPLETED|Overall Study||13
10454649|NCT00997373|11602403|FG001|COMPLETED|Overall Study||15
10454650|NCT00997373|11602402|FG000|NOT COMPLETED|Overall Study||15
10454651|NCT00997373|11602403|FG001|NOT COMPLETED|Overall Study||0
10454652|NCT00997425|11602409|FG000|STARTED|Overall Study||19
10454653|NCT00997425|11602409|FG000|COMPLETED|Overall Study||19
10454654|NCT00997425|11602409|FG000|NOT COMPLETED|Overall Study||0
10454655|NCT00997438|11602417|FG000|STARTED|Overall Study||21
10454656|NCT00997438|11602418|FG001|STARTED|Overall Study||24
10454657|NCT00997438|11602419|FG002|STARTED|Overall Study||24
10454658|NCT00997438|11602417|FG000|COMPLETED|Overall Study||16
10454659|NCT00997438|11602418|FG001|COMPLETED|Overall Study||21
10454660|NCT00997438|11602419|FG002|COMPLETED|Overall Study||20
10454661|NCT00997438|11602417|FG000|NOT COMPLETED|Overall Study||5
10454662|NCT00997438|11602418|FG001|NOT COMPLETED|Overall Study||3
10454663|NCT00997438|11602419|FG002|NOT COMPLETED|Overall Study||4
10454664|NCT00997503|11602428|FG000|STARTED|Overall Study||4199
10454665|NCT00997503|11602428|FG000|12 Months|Overall Study|4059 subjects evaluable at 12-months (cardiac death/MI within 365 days or completed follow-up)|4059
10454666|NCT00997503|11602428|FG000|COMPLETED|Overall Study||3926
10454667|NCT00997503|11602428|FG000|NOT COMPLETED|Overall Study||273
10454668|NCT00997516|11602437|FG000|STARTED|Short-term Follow-up (Post Operative)||37
10454669|NCT00997516|11602438|FG001|STARTED|Short-term Follow-up (Post Operative)||38
10454670|NCT00997516|11602437|FG000|COMPLETED|Short-term Follow-up (Post Operative)||37
10454671|NCT00997516|11602438|FG001|COMPLETED|Short-term Follow-up (Post Operative)||38
10454672|NCT00997516|11602437|FG000|NOT COMPLETED|Short-term Follow-up (Post Operative)||0
10454673|NCT00997516|11602438|FG001|NOT COMPLETED|Short-term Follow-up (Post Operative)||0
10454674|NCT00997516|11602437|FG000|STARTED|Long-term Follow-up (After 6 Months)||37
10454675|NCT00997516|11602438|FG001|STARTED|Long-term Follow-up (After 6 Months)||38
10454676|NCT00997516|11602437|FG000|COMPLETED|Long-term Follow-up (After 6 Months)||31
10454677|NCT00997516|11602438|FG001|COMPLETED|Long-term Follow-up (After 6 Months)||36
10454678|NCT00997516|11602437|FG000|NOT COMPLETED|Long-term Follow-up (After 6 Months)||6
10454679|NCT00997516|11602438|FG001|NOT COMPLETED|Long-term Follow-up (After 6 Months)||2
10454680|NCT00997555|11602446|FG000|STARTED|Overall Study||13
10454681|NCT00997555|11602447|FG001|STARTED|Overall Study||15
10454682|NCT00997555|11602446|FG000|COMPLETED|Overall Study||13
10454683|NCT00997555|11602447|FG001|COMPLETED|Overall Study||15
10454684|NCT00997555|11602446|FG000|NOT COMPLETED|Overall Study||0
10454685|NCT00997555|11602447|FG001|NOT COMPLETED|Overall Study||0
10454686|NCT00997594|11602455|FG000|STARTED|Overall Study||9
10790049|NCT03532009|11950519|FG000|Received Treatment|Overall Study||91
10790050|NCT03532009|11950520|FG001|Received Treatment|Overall Study||90
10790051|NCT03532009|11950519|FG000|COMPLETED|Overall Study||90
10790052|NCT03532009|11950520|FG001|COMPLETED|Overall Study||86
10454687|NCT00997594|11602456|FG001|STARTED|Overall Study||9
10454688|NCT00997594|11602455|FG000|Completion of Ablation Procedure|Overall Study||9
10454689|NCT00997594|11602456|FG001|Completion of Ablation Procedure|Overall Study||9
10454690|NCT00997594|11602455|FG000|COMPLETED|Overall Study||9
10454691|NCT00997594|11602456|FG001|COMPLETED|Overall Study||9
10454692|NCT00997594|11602455|FG000|NOT COMPLETED|Overall Study||0
10790053|NCT03532009|11950519|FG000|NOT COMPLETED|Overall Study||2
10790054|NCT03532009|11950520|FG001|NOT COMPLETED|Overall Study||4
10790055|NCT03532048|11950528|FG000|STARTED|Overall Study|68 individuals (19 fathers, 31 children & 18 mothers)|68
10790056|NCT03532048|11950529|FG001|STARTED|Overall Study|67 individuals (17 fathers, 33 children & 17 mothers)|67
10790057|NCT03532048|11950528|FG000|COMPLETED|Overall Study|49 individuals (14 fathers, 22 children, 13 mothers). 1 father only took part in interview|49
10790058|NCT03532048|11950529|FG001|COMPLETED|Overall Study|50 individuals (13 fathers, 24 children & 13 mothers)|50
10454693|NCT00997594|11602456|FG001|NOT COMPLETED|Overall Study||0
10454694|NCT00997620|11602464|FG000|STARTED|Overall Study||19
10454695|NCT00997620|11602465|FG001|STARTED|Overall Study||21
10454696|NCT00997620|11602464|FG000|COMPLETED|Overall Study||19
10454697|NCT00997620|11602465|FG001|COMPLETED|Overall Study||21
10454698|NCT00997620|11602464|FG000|NOT COMPLETED|Overall Study||0
10454699|NCT00997620|11602465|FG001|NOT COMPLETED|Overall Study||0
10454700|NCT00997672|11602476|FG000|STARTED|Overall Study||4
10454701|NCT00997672|11602477|FG001|STARTED|Overall Study||5
10454702|NCT00997672|11602476|FG000|COMPLETED|Overall Study||0
10454703|NCT00997672|11602477|FG001|COMPLETED|Overall Study||1
10454704|NCT00997672|11602476|FG000|NOT COMPLETED|Overall Study||4
10454705|NCT00997672|11602477|FG001|NOT COMPLETED|Overall Study||4
10454706|NCT00997893|11602486|FG000|STARTED|Overall Study||14
10454707|NCT00997893|11602487|FG001|STARTED|Overall Study||13
10454708|NCT00997893|11602488|FG002|STARTED|Overall Study||13
10454709|NCT00997893|11602486|FG000|COMPLETED|Overall Study||12
10454710|NCT00997893|11602487|FG001|COMPLETED|Overall Study||12
10454711|NCT00997893|11602488|FG002|COMPLETED|Overall Study||13
10454712|NCT00997893|11602486|FG000|NOT COMPLETED|Overall Study||2
10454713|NCT00997893|11602487|FG001|NOT COMPLETED|Overall Study||1
10454714|NCT00997893|11602488|FG002|NOT COMPLETED|Overall Study||0
10454715|NCT00997932|11602496|FG000|STARTED|Overall Study||29
10454716|NCT00997932|11602496|FG000|COMPLETED|Overall Study||27
10454717|NCT00997932|11602496|FG000|NOT COMPLETED|Overall Study||2
10454718|NCT00997984|11602504|FG000|STARTED|Overall Study||113
10454719|NCT00997984|11602505|FG001|STARTED|Overall Study||113
10454720|NCT00997984|11602506|FG002|STARTED|Overall Study||114
10454721|NCT00997984|11602504|FG000|COMPLETED|Overall Study||76
10454722|NCT00997984|11602505|FG001|COMPLETED|Overall Study||79
10454723|NCT00997984|11602506|FG002|COMPLETED|Overall Study||88
10454724|NCT00997984|11602504|FG000|NOT COMPLETED|Overall Study||37
10454725|NCT00997984|11602505|FG001|NOT COMPLETED|Overall Study||34
10454726|NCT00997984|11602506|FG002|NOT COMPLETED|Overall Study||26
10454727|NCT00998010|11602516|FG000|STARTED|Overall Study||24
10454728|NCT00998010|11602516|FG000|COMPLETED|Overall Study||24
10454729|NCT00998010|11602516|FG000|NOT COMPLETED|Overall Study||0
10454730|NCT00998023|11602522|FG000|STARTED|Overall Study||32
10454731|NCT00998023|11602523|FG001|STARTED|Overall Study||32
10454732|NCT00998023|11602522|FG000|COMPLETED|Overall Study||32
10454733|NCT00998023|11602523|FG001|COMPLETED|Overall Study||32
10454734|NCT00998023|11602522|FG000|NOT COMPLETED|Overall Study||0
10454735|NCT00998023|11602523|FG001|NOT COMPLETED|Overall Study||0
10454736|NCT00998049|11602529|FG000|STARTED|Overall Study||39
10454737|NCT00998049|11602529|FG000|COMPLETED|Overall Study||39
10454738|NCT00998049|11602529|FG000|NOT COMPLETED|Overall Study||0
10454739|NCT00998205|11602533|FG000|STARTED|Overall Study||16
10454740|NCT00998205|11602533|FG000|COMPLETED|Overall Study||16
10454741|NCT00998205|11602533|FG000|NOT COMPLETED|Overall Study||0
10454742|NCT00998296|11602549|FG000|STARTED|Overall Study||6
10454743|NCT00998296|11602550|FG001|STARTED|Overall Study||3
10454744|NCT00998296|11602551|FG002|STARTED|Overall Study||3
10454745|NCT00998296|11602552|FG003|STARTED|Overall Study||3
10454746|NCT00998296|11602553|FG004|STARTED|Overall Study||8
10454747|NCT00998296|11602554|FG005|STARTED|Overall Study||3
10454748|NCT00998296|11602555|FG006|STARTED|Overall Study||7
10454749|NCT00998296|11602556|FG007|STARTED|Overall Study||6
10454750|NCT00998296|11602557|FG008|STARTED|Overall Study||6
10454751|NCT00998296|11602558|FG009|STARTED|Overall Study||18
10454752|NCT00998296|11602559|FG010|STARTED|Overall Study||7
10454753|NCT00998296|11602549|FG000|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
10454754|NCT00998296|11602550|FG001|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|2
10454755|NCT00998296|11602551|FG002|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
10454756|NCT00998296|11602552|FG003|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
10454757|NCT00998296|11602553|FG004|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
10454758|NCT00998296|11602554|FG005|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
10454759|NCT00998296|11602555|FG006|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
10454760|NCT00998296|11602556|FG007|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|4
10454761|NCT00998296|11602557|FG008|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|4
10454762|NCT00998296|11602558|FG009|COMPLETED|Overall Study||0
10454763|NCT00998296|11602559|FG010|COMPLETED|Overall Study||0
10454764|NCT00998296|11602549|FG000|NOT COMPLETED|Overall Study||0
10454765|NCT00998296|11602550|FG001|NOT COMPLETED|Overall Study||1
10454766|NCT00998296|11602551|FG002|NOT COMPLETED|Overall Study||0
10790059|NCT03532048|11950528|FG000|NOT COMPLETED|Overall Study||19
10454767|NCT00998296|11602552|FG003|NOT COMPLETED|Overall Study||0
10454768|NCT00998296|11602553|FG004|NOT COMPLETED|Overall Study||2
10454769|NCT00998296|11602554|FG005|NOT COMPLETED|Overall Study||0
10454770|NCT00998296|11602555|FG006|NOT COMPLETED|Overall Study||1
10454771|NCT00998296|11602556|FG007|NOT COMPLETED|Overall Study||2
10454772|NCT00998296|11602557|FG008|NOT COMPLETED|Overall Study||2
10454773|NCT00998296|11602558|FG009|NOT COMPLETED|Overall Study||18
10454774|NCT00998296|11602559|FG010|NOT COMPLETED|Overall Study||7
10454775|NCT00998309|11602588|FG000|STARTED|Overall Study||502
10454776|NCT00998309|11602588|FG000|COMPLETED|Overall Study||498
10454777|NCT00998309|11602588|FG000|NOT COMPLETED|Overall Study||4
10454778|NCT00998335|11602642|FG000|STARTED|Initial Treatment (Months 0 - 3)||30
10454779|NCT00998335|11602643|FG001|STARTED|Initial Treatment (Months 0 - 3)||0
10454780|NCT00998335|11602642|FG000|COMPLETED|Initial Treatment (Months 0 - 3)||30
10454781|NCT00998335|11602643|FG001|COMPLETED|Initial Treatment (Months 0 - 3)||0
10454782|NCT00998335|11602642|FG000|NOT COMPLETED|Initial Treatment (Months 0 - 3)||0
10454783|NCT00998335|11602643|FG001|NOT COMPLETED|Initial Treatment (Months 0 - 3)||0
10454784|NCT00998335|11602642|FG000|STARTED|Randomized Period (Months 3 to 6)|"All participants started in the Insulin detemir only arm. At month 3 subjects were randomized 2:1."|8
10454785|NCT00998335|11602643|FG001|STARTED|Randomized Period (Months 3 to 6)|"All participants started in the Insulin detemir only arm. At month 3 subjects were randomized 2:1."|22
10454786|NCT00998335|11602642|FG000|COMPLETED|Randomized Period (Months 3 to 6)||8
10454787|NCT00998335|11602643|FG001|COMPLETED|Randomized Period (Months 3 to 6)||20
10454788|NCT00998335|11602642|FG000|NOT COMPLETED|Randomized Period (Months 3 to 6)||0
10454789|NCT00998335|11602643|FG001|NOT COMPLETED|Randomized Period (Months 3 to 6)||2
10454790|NCT00998374|11602657|FG000|STARTED|Overall Study||39
10454791|NCT00998374|11602658|FG001|STARTED|Overall Study||23
10454792|NCT00998374|11602657|FG000|COMPLETED|Overall Study||27
10454793|NCT00998374|11602658|FG001|COMPLETED|Overall Study||12
10454794|NCT00998374|11602657|FG000|NOT COMPLETED|Overall Study||12
10454795|NCT00998374|11602658|FG001|NOT COMPLETED|Overall Study||11
10454796|NCT00998400|11602668|FG000|STARTED|Overall Study||50
10454797|NCT00998400|11602669|FG001|STARTED|Overall Study||50
10454798|NCT00998400|11602668|FG000|COMPLETED|Overall Study||48
10454799|NCT00998400|11602669|FG001|COMPLETED|Overall Study||48
10454800|NCT00998400|11602668|FG000|NOT COMPLETED|Overall Study||2
10454801|NCT00998400|11602669|FG001|NOT COMPLETED|Overall Study||2
10454802|NCT00998426|11602676|FG000|STARTED|Overall Study||5
10454803|NCT00998426|11602676|FG000|Blood Glucose Monitoring|Overall Study||5
10454804|NCT00998426|11602676|FG000|COMPLETED|Overall Study||5
10454805|NCT00998426|11602676|FG000|NOT COMPLETED|Overall Study||0
10454806|NCT00998517|11602684|FG000|STARTED|Overall Study||888
10454807|NCT00998517|11602685|FG001|STARTED|Overall Study||906
10454808|NCT00998517|11602686|FG002|STARTED|Overall Study||918
10454809|NCT00998517|11602684|FG000|COMPLETED|Overall Study||888
10454810|NCT00998517|11602685|FG001|COMPLETED|Overall Study||906
10454811|NCT00998517|11602686|FG002|COMPLETED|Overall Study||918
10454812|NCT00998517|11602684|FG000|NOT COMPLETED|Overall Study||0
10454813|NCT00998517|11602685|FG001|NOT COMPLETED|Overall Study||0
10454814|NCT00998517|11602686|FG002|NOT COMPLETED|Overall Study||0
10454815|NCT00998582|11602696|FG000|STARTED|Overall Study||13
10454816|NCT00998582|11602697|FG001|STARTED|Overall Study||14
10454817|NCT00998582|11602696|FG000|COMPLETED|Overall Study||13
10454818|NCT00998582|11602697|FG001|COMPLETED|Overall Study||14
10454819|NCT00998582|11602696|FG000|NOT COMPLETED|Overall Study||0
10454820|NCT00998582|11602697|FG001|NOT COMPLETED|Overall Study||0
10454821|NCT00998660|11602706|FG000|STARTED|Overall Study||100
10454822|NCT00998660|11602706|FG000|Implanted|Overall Study||93
10454823|NCT00998660|11602706|FG000|Month 3 Visit|Overall Study||87
10454824|NCT00998660|11602706|FG000|COMPLETED|Overall Study|87 subjects reached the final study visit at Month 6.|87
10454825|NCT00998660|11602706|FG000|NOT COMPLETED|Overall Study||13
10454826|NCT00998764|11602712|FG000|STARTED|Overall Study||216
10454827|NCT00998764|11602713|FG001|STARTED|Overall Study||276
10454828|NCT00998764|11602712|FG000|Treated|Overall Study||215
10454829|NCT00998764|11602713|FG001|Treated|Overall Study||275
10454830|NCT00998764|11602712|FG000|COMPLETED|Overall Study||0
10454831|NCT00998764|11602713|FG001|COMPLETED|Overall Study||2
10454832|NCT00998764|11602712|FG000|NOT COMPLETED|Overall Study||216
10454833|NCT00998764|11602713|FG001|NOT COMPLETED|Overall Study||274
10454834|NCT00998790|11602721|FG000|STARTED|Overall Study||114
10454835|NCT00998790|11602721|FG000|Participants Who Were Treated|Overall Study||113
10454836|NCT00998790|11602721|FG000|COMPLETED|Overall Study||93
10454837|NCT00998790|11602721|FG000|NOT COMPLETED|Overall Study||21
10454838|NCT00998868|11602725|FG000|STARTED|Overall Study|>=10 for each muscle strength per MRC scale, after excluding the cases following exclusion criteria|51
10454839|NCT00998868|11602725|FG000|COMPLETED|Overall Study||51
10454840|NCT00998868|11602725|FG000|NOT COMPLETED|Overall Study||0
10454841|NCT00998881|11602731|FG000|STARTED|Overall Study||104
10454842|NCT00998881|11602732|FG001|STARTED|Overall Study||99
10454843|NCT00998881|11602731|FG000|COMPLETED|Overall Study||96
10454844|NCT00998881|11602732|FG001|COMPLETED|Overall Study||97
10454845|NCT00998881|11602731|FG000|NOT COMPLETED|Overall Study||8
10454846|NCT00998881|11602732|FG001|NOT COMPLETED|Overall Study||2
10454847|NCT00998946|11602738|FG000|STARTED|Overall Study||29
10454848|NCT00998946|11602738|FG000|Safety Population|Overall Study|Safety population included all participants who received at least 1 dose of the study drug.|27
10454849|NCT00998946|11602738|FG000|COMPLETED|Overall Study||20
10454850|NCT00998946|11602738|FG000|NOT COMPLETED|Overall Study||9
10454851|NCT00998985|11602756|FG000|STARTED|Overall Study||5
10454852|NCT00998985|11602757|FG001|STARTED|Overall Study||5
10454853|NCT00998985|11602758|FG002|STARTED|Overall Study||15
10454854|NCT00998985|11602759|FG003|STARTED|Overall Study||5
10454855|NCT00998985|11602760|FG004|STARTED|Overall Study||5
10454856|NCT00998985|11602761|FG005|STARTED|Overall Study||5
10454857|NCT00998985|11602762|FG006|STARTED|Overall Study||5
10454858|NCT00998985|11602763|FG007|STARTED|Overall Study||5
10454859|NCT00998985|11602764|FG008|STARTED|Overall Study||6
10454860|NCT00998985|11602765|FG009|STARTED|Overall Study||5
10454861|NCT00998985|11602766|FG010|STARTED|Overall Study||5
10454862|NCT00998985|11602767|FG011|STARTED|Overall Study||5
10454863|NCT00998985|11602768|FG012|STARTED|Overall Study||5
10454864|NCT00998985|11602769|FG013|STARTED|Overall Study||15
10454865|NCT00998985|11602756|FG000|COMPLETED|Overall Study||5
10454866|NCT00998985|11602757|FG001|COMPLETED|Overall Study||5
10454867|NCT00998985|11602758|FG002|COMPLETED|Overall Study||15
10454868|NCT00998985|11602759|FG003|COMPLETED|Overall Study||5
10454869|NCT00998985|11602760|FG004|COMPLETED|Overall Study||5
10454870|NCT00998985|11602761|FG005|COMPLETED|Overall Study||4
10454871|NCT00998985|11602762|FG006|COMPLETED|Overall Study||5
10454872|NCT00998985|11602763|FG007|COMPLETED|Overall Study||5
10454873|NCT00998985|11602764|FG008|COMPLETED|Overall Study||5
10454874|NCT00998985|11602765|FG009|COMPLETED|Overall Study||5
10454875|NCT00998985|11602766|FG010|COMPLETED|Overall Study||5
10454876|NCT00998985|11602767|FG011|COMPLETED|Overall Study||5
10454877|NCT00998985|11602768|FG012|COMPLETED|Overall Study||5
10454878|NCT00998985|11602769|FG013|COMPLETED|Overall Study||15
10454879|NCT00998985|11602756|FG000|NOT COMPLETED|Overall Study||0
10454880|NCT00998985|11602757|FG001|NOT COMPLETED|Overall Study||0
10454881|NCT00998985|11602758|FG002|NOT COMPLETED|Overall Study||0
10454882|NCT00998985|11602759|FG003|NOT COMPLETED|Overall Study||0
10454883|NCT00998985|11602760|FG004|NOT COMPLETED|Overall Study||0
10454884|NCT00998985|11602761|FG005|NOT COMPLETED|Overall Study||1
10454885|NCT00998985|11602762|FG006|NOT COMPLETED|Overall Study||0
10454886|NCT00998985|11602763|FG007|NOT COMPLETED|Overall Study||0
10454887|NCT00998985|11602764|FG008|NOT COMPLETED|Overall Study||1
10454888|NCT00998985|11602765|FG009|NOT COMPLETED|Overall Study||0
10454889|NCT00998985|11602766|FG010|NOT COMPLETED|Overall Study||0
10454890|NCT00998985|11602767|FG011|NOT COMPLETED|Overall Study||0
10454891|NCT00998985|11602768|FG012|NOT COMPLETED|Overall Study||0
10454892|NCT00998985|11602769|FG013|NOT COMPLETED|Overall Study||0
10454893|NCT00999037|11602816|FG000|STARTED|Overall Study||9
10454894|NCT00999037|11602817|FG001|STARTED|Overall Study|20|9
10454895|NCT00999037|11602816|FG000|COMPLETED|Overall Study||9
10454896|NCT00999037|11602817|FG001|COMPLETED|Overall Study||9
10454897|NCT00999037|11602816|FG000|NOT COMPLETED|Overall Study||0
10454898|NCT00999037|11602817|FG001|NOT COMPLETED|Overall Study||0
10454899|NCT00999102|11602825|FG000|STARTED|4 Weeks at Lower Dose of First Drug||16
10454900|NCT00999102|11602826|FG001|STARTED|4 Weeks at Lower Dose of First Drug||17
10454901|NCT00999102|11602825|FG000|COMPLETED|4 Weeks at Lower Dose of First Drug||15
10454902|NCT00999102|11602826|FG001|COMPLETED|4 Weeks at Lower Dose of First Drug||16
10454903|NCT00999102|11602825|FG000|NOT COMPLETED|4 Weeks at Lower Dose of First Drug||1
10454904|NCT00999102|11602826|FG001|NOT COMPLETED|4 Weeks at Lower Dose of First Drug||1
10454905|NCT00999102|11602825|FG000|STARTED|4 Weeks at Higher Dose of First Drug||15
10454906|NCT00999102|11602826|FG001|STARTED|4 Weeks at Higher Dose of First Drug||16
10454907|NCT00999102|11602825|FG000|COMPLETED|4 Weeks at Higher Dose of First Drug||15
10454908|NCT00999102|11602826|FG001|COMPLETED|4 Weeks at Higher Dose of First Drug||16
10454909|NCT00999102|11602825|FG000|NOT COMPLETED|4 Weeks at Higher Dose of First Drug||0
10454910|NCT00999102|11602826|FG001|NOT COMPLETED|4 Weeks at Higher Dose of First Drug||0
10454911|NCT00999102|11602825|FG000|STARTED|4 Weeks at Lower Dose of Second Drug||15
10454912|NCT00999102|11602826|FG001|STARTED|4 Weeks at Lower Dose of Second Drug||16
10454913|NCT00999102|11602825|FG000|COMPLETED|4 Weeks at Lower Dose of Second Drug||15
10454914|NCT00999102|11602826|FG001|COMPLETED|4 Weeks at Lower Dose of Second Drug||16
10454915|NCT00999102|11602825|FG000|NOT COMPLETED|4 Weeks at Lower Dose of Second Drug||0
10454916|NCT00999102|11602826|FG001|NOT COMPLETED|4 Weeks at Lower Dose of Second Drug||0
10454917|NCT00999102|11602825|FG000|STARTED|4 Weeks at Higher Dose of Second Drug||15
10454918|NCT00999102|11602826|FG001|STARTED|4 Weeks at Higher Dose of Second Drug||16
10454919|NCT00999102|11602825|FG000|COMPLETED|4 Weeks at Higher Dose of Second Drug||15
10454920|NCT00999102|11602826|FG001|COMPLETED|4 Weeks at Higher Dose of Second Drug||16
10454921|NCT00999102|11602825|FG000|NOT COMPLETED|4 Weeks at Higher Dose of Second Drug||0
10454922|NCT00999102|11602826|FG001|NOT COMPLETED|4 Weeks at Higher Dose of Second Drug||0
10454923|NCT00999141|11602836|FG000|STARTED|Overall Study|Randomized and treated|75
10454924|NCT00999141|11602836|FG000|COMPLETED|Overall Study||75
10454925|NCT00999141|11602836|FG000|NOT COMPLETED|Overall Study||0
10454926|NCT00999167|11602894|FG000|STARTED|Part A: Open Label Safety run-in||15
10454927|NCT00999167|11602895|FG001|STARTED|Part A: Open Label Safety run-in||0
10454928|NCT00999167|11602896|FG002|STARTED|Part A: Open Label Safety run-in||0
10454929|NCT00999167|11602894|FG000|Received 9 mL BID|Part A: Open Label Safety run-in||15
10454930|NCT00999167|11602895|FG001|Received 9 mL BID|Part A: Open Label Safety run-in||0
10454931|NCT00999167|11602896|FG002|Received 9 mL BID|Part A: Open Label Safety run-in||0
10454932|NCT00999167|11602894|FG000|COMPLETED|Part A: Open Label Safety run-in||8
10454933|NCT00999167|11602895|FG001|COMPLETED|Part A: Open Label Safety run-in||0
10454934|NCT00999167|11602896|FG002|COMPLETED|Part A: Open Label Safety run-in||0
10454935|NCT00999167|11602894|FG000|NOT COMPLETED|Part A: Open Label Safety run-in||7
10454936|NCT00999167|11602895|FG001|NOT COMPLETED|Part A: Open Label Safety run-in||0
10454937|NCT00999167|11602896|FG002|NOT COMPLETED|Part A: Open Label Safety run-in||0
10454938|NCT00999167|11602894|FG000|STARTED|Part B: Randomized, Placebo Controlled||0
10454939|NCT00999167|11602895|FG001|STARTED|Part B: Randomized, Placebo Controlled|4 subjects who participated in Part A enrolled in Part B and remainder were newly enrolled|90
10454940|NCT00999167|11602896|FG002|STARTED|Part B: Randomized, Placebo Controlled||88
10454941|NCT00999167|11602894|FG000|COMPLETED|Part B: Randomized, Placebo Controlled||0
10454942|NCT00999167|11602895|FG001|COMPLETED|Part B: Randomized, Placebo Controlled||55
10454943|NCT00999167|11602896|FG002|COMPLETED|Part B: Randomized, Placebo Controlled||67
10454944|NCT00999167|11602894|FG000|NOT COMPLETED|Part B: Randomized, Placebo Controlled||0
10454945|NCT00999167|11602895|FG001|NOT COMPLETED|Part B: Randomized, Placebo Controlled||35
10454946|NCT00999167|11602896|FG002|NOT COMPLETED|Part B: Randomized, Placebo Controlled||21
10454947|NCT00999466|11602909|FG000|STARTED|Pilot Part||6
10454948|NCT00999466|11602910|FG001|STARTED|Pilot Part|AZD8848 nasal spray 60 μg group was not participated in the Pilot part|0
10454949|NCT00999466|11602911|FG002|STARTED|Pilot Part||3
10454950|NCT00999466|11602909|FG000|COMPLETED|Pilot Part||6
10454951|NCT00999466|11602910|FG001|COMPLETED|Pilot Part||0
10454952|NCT00999466|11602911|FG002|COMPLETED|Pilot Part||3
10454953|NCT00999466|11602909|FG000|NOT COMPLETED|Pilot Part||0
10454954|NCT00999466|11602910|FG001|NOT COMPLETED|Pilot Part||0
10454955|NCT00999466|11602911|FG002|NOT COMPLETED|Pilot Part||0
10454956|NCT00999466|11602909|FG000|STARTED|Main Part|AZD8848 nasal spray 30 μg group was not participated in the Main part|0
10454957|NCT00999466|11602910|FG001|STARTED|Main Part||26
10454958|NCT00999466|11602911|FG002|STARTED|Main Part||25
10454959|NCT00999466|11602909|FG000|COMPLETED|Main Part||0
10454960|NCT00999466|11602910|FG001|COMPLETED|Main Part||22
10454961|NCT00999466|11602911|FG002|COMPLETED|Main Part||21
10454962|NCT00999466|11602909|FG000|NOT COMPLETED|Main Part||0
10454963|NCT00999466|11602910|FG001|NOT COMPLETED|Main Part||4
10454964|NCT00999466|11602911|FG002|NOT COMPLETED|Main Part||4
10526012|NCT01380093|11678038|FG006|STARTED|Naloxone Challenge Phase||0
10526013|NCT01380093|11678039|FG007|STARTED|Naloxone Challenge Phase||0
10526014|NCT01380093|11678040|FG008|STARTED|Naloxone Challenge Phase||0
10526015|NCT01380093|11678032|FG000|TREATED|Naloxone Challenge Phase||59
10526016|NCT01380093|11678033|FG001|TREATED|Naloxone Challenge Phase||0
10526017|NCT01380093|11678034|FG002|TREATED|Naloxone Challenge Phase||0
10526018|NCT01380093|11678035|FG003|TREATED|Naloxone Challenge Phase||0
10526019|NCT01380093|11678036|FG004|TREATED|Naloxone Challenge Phase||0
10526020|NCT01380093|11678037|FG005|TREATED|Naloxone Challenge Phase||0
10526021|NCT01380093|11678038|FG006|TREATED|Naloxone Challenge Phase||0
10526022|NCT01380093|11678039|FG007|TREATED|Naloxone Challenge Phase||0
10526023|NCT01380093|11678040|FG008|TREATED|Naloxone Challenge Phase||0
10526024|NCT01380093|11678032|FG000|COMPLETED|Naloxone Challenge Phase||59
10526025|NCT01380093|11678033|FG001|COMPLETED|Naloxone Challenge Phase||0
10526026|NCT01380093|11678034|FG002|COMPLETED|Naloxone Challenge Phase||0
10526027|NCT01380093|11678035|FG003|COMPLETED|Naloxone Challenge Phase||0
10526028|NCT01380093|11678036|FG004|COMPLETED|Naloxone Challenge Phase||0
10526029|NCT01380093|11678037|FG005|COMPLETED|Naloxone Challenge Phase||0
10526030|NCT01380093|11678038|FG006|COMPLETED|Naloxone Challenge Phase||0
10526031|NCT01380093|11678039|FG007|COMPLETED|Naloxone Challenge Phase||0
10526032|NCT01380093|11678040|FG008|COMPLETED|Naloxone Challenge Phase||0
10526033|NCT01380093|11678032|FG000|NOT COMPLETED|Naloxone Challenge Phase||21
10526034|NCT01380093|11678033|FG001|NOT COMPLETED|Naloxone Challenge Phase||0
10526035|NCT01380093|11678034|FG002|NOT COMPLETED|Naloxone Challenge Phase||0
10526036|NCT01380093|11678035|FG003|NOT COMPLETED|Naloxone Challenge Phase||0
10526037|NCT01380093|11678036|FG004|NOT COMPLETED|Naloxone Challenge Phase||0
10526038|NCT01380093|11678037|FG005|NOT COMPLETED|Naloxone Challenge Phase||0
10526039|NCT01380093|11678038|FG006|NOT COMPLETED|Naloxone Challenge Phase||0
10526040|NCT01380093|11678039|FG007|NOT COMPLETED|Naloxone Challenge Phase||0
10526041|NCT01380093|11678040|FG008|NOT COMPLETED|Naloxone Challenge Phase||0
10526042|NCT01380093|11678032|FG000|STARTED|Drug Discrimination Phase: Day 1||0
10526043|NCT01380093|11678033|FG001|STARTED|Drug Discrimination Phase: Day 1||30
10526044|NCT01380093|11678034|FG002|STARTED|Drug Discrimination Phase: Day 1||29
10526045|NCT01380093|11678035|FG003|STARTED|Drug Discrimination Phase: Day 1||0
10526046|NCT01380093|11678036|FG004|STARTED|Drug Discrimination Phase: Day 1||0
10526047|NCT01380093|11678037|FG005|STARTED|Drug Discrimination Phase: Day 1||0
10526048|NCT01380093|11678038|FG006|STARTED|Drug Discrimination Phase: Day 1||0
10526049|NCT01380093|11678039|FG007|STARTED|Drug Discrimination Phase: Day 1||0
10526050|NCT01380093|11678040|FG008|STARTED|Drug Discrimination Phase: Day 1||0
10526051|NCT01380093|11678032|FG000|COMPLETED|Drug Discrimination Phase: Day 1||0
10526052|NCT01380093|11678033|FG001|COMPLETED|Drug Discrimination Phase: Day 1||29
10526053|NCT01380093|11678034|FG002|COMPLETED|Drug Discrimination Phase: Day 1||29
10526054|NCT01380093|11678035|FG003|COMPLETED|Drug Discrimination Phase: Day 1||0
10526055|NCT01380093|11678036|FG004|COMPLETED|Drug Discrimination Phase: Day 1||0
10526056|NCT01380093|11678037|FG005|COMPLETED|Drug Discrimination Phase: Day 1||0
10526057|NCT01380093|11678038|FG006|COMPLETED|Drug Discrimination Phase: Day 1||0
10526058|NCT01380093|11678039|FG007|COMPLETED|Drug Discrimination Phase: Day 1||0
10526059|NCT01380093|11678040|FG008|COMPLETED|Drug Discrimination Phase: Day 1||0
10526060|NCT01380093|11678032|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
10526061|NCT01380093|11678033|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 1||1
10526062|NCT01380093|11678034|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
10526063|NCT01380093|11678035|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
10526064|NCT01380093|11678036|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
10526065|NCT01380093|11678037|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
10454965|NCT00999518|11602924|FG000|STARTED|Overall Study||43
10454966|NCT00999518|11602925|FG001|STARTED|Overall Study||42
10454967|NCT00999518|11602926|FG002|STARTED|Overall Study||39
10454968|NCT00999518|11602927|FG003|STARTED|Overall Study||40
10454969|NCT00999518|11602928|FG004|STARTED|Overall Study||41
10454970|NCT00999518|11602924|FG000|Treated|Overall Study||42
10454971|NCT00999518|11602925|FG001|Treated|Overall Study||41
10454972|NCT00999518|11602926|FG002|Treated|Overall Study||37
10454973|NCT00999518|11602927|FG003|Treated|Overall Study||40
10454974|NCT00999518|11602928|FG004|Treated|Overall Study||40
10454975|NCT00999518|11602924|FG000|COMPLETED|Overall Study||19
10454976|NCT00999518|11602925|FG001|COMPLETED|Overall Study||17
10454977|NCT00999518|11602926|FG002|COMPLETED|Overall Study||17
10454978|NCT00999518|11602927|FG003|COMPLETED|Overall Study||18
10454979|NCT00999518|11602928|FG004|COMPLETED|Overall Study||17
10454980|NCT00999518|11602924|FG000|NOT COMPLETED|Overall Study||24
10454981|NCT00999518|11602925|FG001|NOT COMPLETED|Overall Study||25
10454982|NCT00999518|11602926|FG002|NOT COMPLETED|Overall Study||22
10454983|NCT00999518|11602927|FG003|NOT COMPLETED|Overall Study||22
10454984|NCT00999518|11602928|FG004|NOT COMPLETED|Overall Study||24
10454985|NCT00999544|11602944|FG000|STARTED|Overall Study||9
10551678|NCT01537393|11705795|FG000|STARTED|Overall Study||707
10551679|NCT01537393|11705796|FG001|STARTED|Overall Study||698
10551680|NCT01537393|11705795|FG000|COMPLETED|Overall Study||553
10551681|NCT01537393|11705796|FG001|COMPLETED|Overall Study||507
10551682|NCT01537393|11705795|FG000|NOT COMPLETED|Overall Study||154
10551683|NCT01537393|11705796|FG001|NOT COMPLETED|Overall Study||191
10551684|NCT01537419|11705804|FG000|STARTED|Overall Study||63
10551685|NCT01537419|11705805|FG001|STARTED|Overall Study||66
10551686|NCT01537419|11705804|FG000|COMPLETED|Overall Study||52
10551687|NCT01537419|11705805|FG001|COMPLETED|Overall Study||54
10551688|NCT01537419|11705804|FG000|NOT COMPLETED|Overall Study||11
10551689|NCT01537419|11705805|FG001|NOT COMPLETED|Overall Study||12
10551690|NCT01537432|11705813|FG000|STARTED|Overall Study||24
10551691|NCT01537432|11705814|FG001|STARTED|Overall Study||12
10551692|NCT01537432|11705813|FG000|COMPLETED|Overall Study||18
10551693|NCT01537432|11705814|FG001|COMPLETED|Overall Study||10
10551694|NCT01537432|11705813|FG000|NOT COMPLETED|Overall Study||6
10551695|NCT01537432|11705814|FG001|NOT COMPLETED|Overall Study||2
10551696|NCT01537549|11705820|FG000|STARTED|Overall Study||11
10551697|NCT01537549|11705820|FG000|COMPLETED|Overall Study||8
10551698|NCT01537549|11705820|FG000|NOT COMPLETED|Overall Study||3
10455027|NCT00999908|11603012|FG002|COMPLETED|Treatment Period 2||19
10551699|NCT01537666|11705830|FG000|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
10551700|NCT01537666|11705831|FG001|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
10551701|NCT01537666|11705832|FG002|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
10551702|NCT01537666|11705833|FG003|STARTED|Overall Study|5 of 7 patients received a 32 mg dose of AeroVanc followed by a dose of 80 mg at least 1 week later.|7
10551703|NCT01537666|11705830|FG000|COMPLETED|Overall Study||6
10551704|NCT01537666|11705831|FG001|COMPLETED|Overall Study||6
10551705|NCT01537666|11705832|FG002|COMPLETED|Overall Study||6
10551706|NCT01537666|11705833|FG003|COMPLETED|Overall Study|1 patient withdrew after a 32 mg dose and was replaced by a patient who only received an 80 mg dose.|7
10551707|NCT01537666|11705830|FG000|NOT COMPLETED|Overall Study||0
10551708|NCT01537666|11705831|FG001|NOT COMPLETED|Overall Study||0
10454986|NCT00999544|11602944|FG000|COMPLETED|Overall Study||8
10454987|NCT00999544|11602944|FG000|NOT COMPLETED|Overall Study||1
10454988|NCT00999596|11602977|FG000|STARTED|Overall Study||107
10526066|NCT01380093|11678038|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
10526067|NCT01380093|11678039|FG007|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
10526068|NCT01380093|11678040|FG008|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
10526069|NCT01380093|11678032|FG000|STARTED|Drug Discrimination Phase: Day 2||0
10526070|NCT01380093|11678033|FG001|STARTED|Drug Discrimination Phase: Day 2||29
10526071|NCT01380093|11678034|FG002|STARTED|Drug Discrimination Phase: Day 2||29
10526072|NCT01380093|11678035|FG003|STARTED|Drug Discrimination Phase: Day 2||0
10526073|NCT01380093|11678036|FG004|STARTED|Drug Discrimination Phase: Day 2||0
10526074|NCT01380093|11678037|FG005|STARTED|Drug Discrimination Phase: Day 2||0
10526075|NCT01380093|11678038|FG006|STARTED|Drug Discrimination Phase: Day 2||0
10526076|NCT01380093|11678039|FG007|STARTED|Drug Discrimination Phase: Day 2||0
10526077|NCT01380093|11678040|FG008|STARTED|Drug Discrimination Phase: Day 2||0
10526078|NCT01380093|11678032|FG000|COMPLETED|Drug Discrimination Phase: Day 2||0
10526079|NCT01380093|11678033|FG001|COMPLETED|Drug Discrimination Phase: Day 2||20
10526080|NCT01380093|11678034|FG002|COMPLETED|Drug Discrimination Phase: Day 2||16
10526081|NCT01380093|11678035|FG003|COMPLETED|Drug Discrimination Phase: Day 2||0
10526082|NCT01380093|11678036|FG004|COMPLETED|Drug Discrimination Phase: Day 2||0
10526083|NCT01380093|11678037|FG005|COMPLETED|Drug Discrimination Phase: Day 2||0
10526084|NCT01380093|11678038|FG006|COMPLETED|Drug Discrimination Phase: Day 2||0
10526085|NCT01380093|11678039|FG007|COMPLETED|Drug Discrimination Phase: Day 2||0
10526086|NCT01380093|11678040|FG008|COMPLETED|Drug Discrimination Phase: Day 2||0
10526087|NCT01380093|11678032|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
10526088|NCT01380093|11678033|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 2||9
10526089|NCT01380093|11678034|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 2||13
10526090|NCT01380093|11678035|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
10526091|NCT01380093|11678036|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
10454989|NCT00999596|11602977|FG000|New FDA Guideline Released|Overall Study|FDA Guidance: Class II Special Controls Guidance Document: Full-Field Digital Mammography System|6
10454990|NCT00999596|11602977|FG000|COMPLETED|Overall Study|Not all patient images were used for the reader evaluation based on new FDA Guidelines|6
10454991|NCT00999596|11602977|FG000|NOT COMPLETED|Overall Study||101
10454992|NCT00999661|11602982|FG000|STARTED|Overall Study||231
10454993|NCT00999661|11602982|FG000|COMPLETED|Overall Study||161
10454994|NCT00999661|11602982|FG000|NOT COMPLETED|Overall Study||70
10454995|NCT00999687|11602986|FG000|STARTED|First Intervention|16 used the INOE on the right hand,15 used the INOE on the left hand.|31
10454996|NCT00999687|11602986|FG000|COMPLETED|First Intervention||30
10454997|NCT00999687|11602986|FG000|NOT COMPLETED|First Intervention||1
10454998|NCT00999687|11602986|FG000|STARTED|Second Intervention|From week 13 to 24, all participants applied INOE to both hands twice daily.|30
10454999|NCT00999687|11602986|FG000|COMPLETED|Second Intervention||27
10455000|NCT00999687|11602986|FG000|NOT COMPLETED|Second Intervention||3
10455001|NCT00999713|11602994|FG000|STARTED|Overall Study||26
10455002|NCT00999713|11602995|FG001|STARTED|Overall Study||17
10455003|NCT00999713|11602994|FG000|COMPLETED|Overall Study||24
10455004|NCT00999713|11602995|FG001|COMPLETED|Overall Study||17
10455005|NCT00999713|11602994|FG000|NOT COMPLETED|Overall Study||2
10455006|NCT00999713|11602995|FG001|NOT COMPLETED|Overall Study||0
10455007|NCT00999830|11603003|FG000|STARTED|Overall Study||14
10455008|NCT00999830|11603004|FG001|STARTED|Overall Study||13
10455009|NCT00999830|11603003|FG000|COMPLETED|Overall Study||14
10455010|NCT00999830|11603004|FG001|COMPLETED|Overall Study||13
10455011|NCT00999830|11603003|FG000|NOT COMPLETED|Overall Study||0
10455012|NCT00999830|11603004|FG001|NOT COMPLETED|Overall Study||0
10455013|NCT00999908|11603010|FG000|STARTED|Treatment Period 1||19
10455014|NCT00999908|11603011|FG001|STARTED|Treatment Period 1||16
10455015|NCT00999908|11603012|FG002|STARTED|Treatment Period 1||19
10455016|NCT00999908|11603010|FG000|COMPLETED|Treatment Period 1||17
10455017|NCT00999908|11603011|FG001|COMPLETED|Treatment Period 1||16
10455018|NCT00999908|11603012|FG002|COMPLETED|Treatment Period 1||19
10455019|NCT00999908|11603010|FG000|NOT COMPLETED|Treatment Period 1||2
10455020|NCT00999908|11603011|FG001|NOT COMPLETED|Treatment Period 1||0
10455021|NCT00999908|11603012|FG002|NOT COMPLETED|Treatment Period 1||0
10455022|NCT00999908|11603010|FG000|STARTED|Treatment Period 2||17
10455023|NCT00999908|11603011|FG001|STARTED|Treatment Period 2||16
10455024|NCT00999908|11603012|FG002|STARTED|Treatment Period 2||19
10455025|NCT00999908|11603010|FG000|COMPLETED|Treatment Period 2||16
10455026|NCT00999908|11603011|FG001|COMPLETED|Treatment Period 2||16
10455028|NCT00999908|11603010|FG000|NOT COMPLETED|Treatment Period 2||1
10455029|NCT00999908|11603011|FG001|NOT COMPLETED|Treatment Period 2||0
10455030|NCT00999908|11603012|FG002|NOT COMPLETED|Treatment Period 2||0
10455031|NCT00999908|11603010|FG000|STARTED|Treatment Period 3||16
10455032|NCT00999908|11603011|FG001|STARTED|Treatment Period 3||16
10455033|NCT00999908|11603012|FG002|STARTED|Treatment Period 3||19
10455034|NCT00999908|11603010|FG000|COMPLETED|Treatment Period 3||16
10455035|NCT00999908|11603011|FG001|COMPLETED|Treatment Period 3||16
10455036|NCT00999908|11603012|FG002|COMPLETED|Treatment Period 3||19
10455037|NCT00999908|11603010|FG000|NOT COMPLETED|Treatment Period 3||0
10455038|NCT00999908|11603011|FG001|NOT COMPLETED|Treatment Period 3||0
10455039|NCT00999908|11603012|FG002|NOT COMPLETED|Treatment Period 3||0
10455040|NCT00999921|11603022|FG000|STARTED|Overall Study||127
10455041|NCT00999921|11603023|FG001|STARTED|Overall Study||129
10455042|NCT00999921|11603022|FG000|COMPLETED|Overall Study||117
10455043|NCT00999921|11603023|FG001|COMPLETED|Overall Study||110
10455044|NCT00999921|11603022|FG000|NOT COMPLETED|Overall Study||10
10455045|NCT00999921|11603023|FG001|NOT COMPLETED|Overall Study||19
10455046|NCT01000025|11603034|FG000|STARTED|Overall Study||480
10455047|NCT01000025|11603035|FG001|STARTED|Overall Study||240
10455048|NCT01000025|11603034|FG000|COMPLETED|Overall Study||12
10455049|NCT01000025|11603035|FG001|COMPLETED|Overall Study||2
10455050|NCT01000025|11603034|FG000|NOT COMPLETED|Overall Study||468
10455051|NCT01000025|11603035|FG001|NOT COMPLETED|Overall Study||238
10455052|NCT01000051|11603043|FG000|STARTED|Overall Study||42
10455053|NCT01000051|11603044|FG001|STARTED|Overall Study||18
10455054|NCT01000051|11603043|FG000|COMPLETED|Overall Study||39
10455055|NCT01000051|11603044|FG001|COMPLETED|Overall Study||17
10455056|NCT01000051|11603043|FG000|NOT COMPLETED|Overall Study||3
10455057|NCT01000051|11603044|FG001|NOT COMPLETED|Overall Study||1
10455058|NCT01000064|11603050|FG000|STARTED|Overall Study||7
10455059|NCT01000064|11603051|FG001|STARTED|Overall Study||6
10455060|NCT01000064|11603050|FG000|COMPLETED|Overall Study||6
10455061|NCT01000064|11603051|FG001|COMPLETED|Overall Study||5
10455062|NCT01000064|11603050|FG000|NOT COMPLETED|Overall Study||1
10455063|NCT01000064|11603051|FG001|NOT COMPLETED|Overall Study||1
10455064|NCT01000155|11603060|FG000|STARTED|Overall Study||5
10455065|NCT01000155|11603060|FG000|COMPLETED|Overall Study||3
10455066|NCT01000155|11603060|FG000|NOT COMPLETED|Overall Study||2
10455067|NCT01000285|11603066|FG000|STARTED|Overall Study||18
10455068|NCT01000285|11603066|FG000|COMPLETED|Overall Study||18
10455069|NCT01000285|11603066|FG000|NOT COMPLETED|Overall Study||0
10455070|NCT01000311|11603082|FG000|STARTED|Overall Study||258
10455071|NCT01000311|11603083|FG001|STARTED|Overall Study||271
10455072|NCT01000311|11603082|FG000|COMPLETED|Overall Study||213
10455073|NCT01000311|11603083|FG001|COMPLETED|Overall Study||201
10455074|NCT01000311|11603082|FG000|NOT COMPLETED|Overall Study||45
10455075|NCT01000311|11603083|FG001|NOT COMPLETED|Overall Study||70
10551709|NCT01537666|11705832|FG002|NOT COMPLETED|Overall Study||0
10551710|NCT01537666|11705833|FG003|NOT COMPLETED|Overall Study||0
10551711|NCT01537783|11705855|FG000|STARTED|Overall Study||25
10551712|NCT01537783|11705856|FG001|STARTED|Overall Study||25
10551713|NCT01537783|11705855|FG000|COMPLETED|Overall Study||14
10551714|NCT01537783|11705856|FG001|COMPLETED|Overall Study||23
10551715|NCT01537783|11705855|FG000|NOT COMPLETED|Overall Study||11
10551716|NCT01537783|11705856|FG001|NOT COMPLETED|Overall Study||2
10551717|NCT01537835|11705865|FG000|STARTED|Overall Study||37
10551718|NCT01537835|11705866|FG001|STARTED|Overall Study||37
10551719|NCT01537835|11705867|FG002|STARTED|Overall Study||35
10551720|NCT01537835|11705865|FG000|COMPLETED|Overall Study||37
10551721|NCT01537835|11705866|FG001|COMPLETED|Overall Study||37
10551722|NCT01537835|11705867|FG002|COMPLETED|Overall Study||35
10551723|NCT01537835|11705865|FG000|NOT COMPLETED|Overall Study||0
10551724|NCT01537835|11705866|FG001|NOT COMPLETED|Overall Study||0
10551725|NCT01537835|11705867|FG002|NOT COMPLETED|Overall Study||0
10551726|NCT01537887|11705875|FG000|STARTED|Period 1||12
10551727|NCT01537887|11705876|FG001|STARTED|Period 1||12
10551728|NCT01537887|11705877|FG002|STARTED|Period 1||12
10551729|NCT01537887|11705878|FG003|STARTED|Period 1||12
10551730|NCT01537887|11705879|FG004|STARTED|Period 1||12
10551731|NCT01537887|11705880|FG005|STARTED|Period 1||12
10551732|NCT01537887|11705875|FG000|Received at Least 1 Dose of Study Drug|Period 1||12
10551733|NCT01537887|11705876|FG001|Received at Least 1 Dose of Study Drug|Period 1||12
10551734|NCT01537887|11705877|FG002|Received at Least 1 Dose of Study Drug|Period 1||11
10551735|NCT01537887|11705878|FG003|Received at Least 1 Dose of Study Drug|Period 1||12
10551736|NCT01537887|11705879|FG004|Received at Least 1 Dose of Study Drug|Period 1||12
10551737|NCT01537887|11705880|FG005|Received at Least 1 Dose of Study Drug|Period 1||12
10551738|NCT01537887|11705875|FG000|COMPLETED|Period 1||12
10551739|NCT01537887|11705876|FG001|COMPLETED|Period 1||12
10551740|NCT01537887|11705877|FG002|COMPLETED|Period 1||11
10551741|NCT01537887|11705878|FG003|COMPLETED|Period 1||12
10551742|NCT01537887|11705879|FG004|COMPLETED|Period 1||11
10551743|NCT01537887|11705880|FG005|COMPLETED|Period 1||11
10551744|NCT01537887|11705875|FG000|NOT COMPLETED|Period 1||0
10551745|NCT01537887|11705876|FG001|NOT COMPLETED|Period 1||0
10551746|NCT01537887|11705877|FG002|NOT COMPLETED|Period 1||1
10551747|NCT01537887|11705878|FG003|NOT COMPLETED|Period 1||0
10551748|NCT01537887|11705879|FG004|NOT COMPLETED|Period 1||1
10551749|NCT01537887|11705880|FG005|NOT COMPLETED|Period 1||1
10551750|NCT01537887|11705875|FG000|STARTED|Period 2||12
10551751|NCT01537887|11705876|FG001|STARTED|Period 2||12
10551752|NCT01537887|11705877|FG002|STARTED|Period 2||11
10551753|NCT01537887|11705878|FG003|STARTED|Period 2||12
10551754|NCT01537887|11705879|FG004|STARTED|Period 2||11
10551755|NCT01537887|11705880|FG005|STARTED|Period 2||11
10551756|NCT01537887|11705875|FG000|COMPLETED|Period 2||12
10551757|NCT01537887|11705876|FG001|COMPLETED|Period 2||11
10551758|NCT01537887|11705877|FG002|COMPLETED|Period 2||11
10551759|NCT01537887|11705878|FG003|COMPLETED|Period 2||12
10551760|NCT01537887|11705879|FG004|COMPLETED|Period 2||11
10551761|NCT01537887|11705880|FG005|COMPLETED|Period 2||11
10551762|NCT01537887|11705875|FG000|NOT COMPLETED|Period 2||0
10551763|NCT01537887|11705876|FG001|NOT COMPLETED|Period 2||1
10551764|NCT01537887|11705877|FG002|NOT COMPLETED|Period 2||0
10551765|NCT01537887|11705878|FG003|NOT COMPLETED|Period 2||0
10551766|NCT01537887|11705879|FG004|NOT COMPLETED|Period 2||0
10551767|NCT01537887|11705880|FG005|NOT COMPLETED|Period 2||0
10551768|NCT01537887|11705875|FG000|STARTED|Period 3||12
10551769|NCT01537887|11705876|FG001|STARTED|Period 3||11
10551770|NCT01537887|11705877|FG002|STARTED|Period 3||11
10551771|NCT01537887|11705878|FG003|STARTED|Period 3||12
10551772|NCT01537887|11705879|FG004|STARTED|Period 3||11
10551773|NCT01537887|11705880|FG005|STARTED|Period 3||11
10551774|NCT01537887|11705875|FG000|COMPLETED|Period 3||12
10551775|NCT01537887|11705876|FG001|COMPLETED|Period 3||10
10551776|NCT01537887|11705877|FG002|COMPLETED|Period 3||10
10551777|NCT01537887|11705878|FG003|COMPLETED|Period 3||12
10551778|NCT01537887|11705879|FG004|COMPLETED|Period 3||11
10551779|NCT01537887|11705880|FG005|COMPLETED|Period 3||11
10551780|NCT01537887|11705875|FG000|NOT COMPLETED|Period 3||0
10551781|NCT01537887|11705876|FG001|NOT COMPLETED|Period 3||1
10551782|NCT01537887|11705877|FG002|NOT COMPLETED|Period 3||1
10551783|NCT01537887|11705878|FG003|NOT COMPLETED|Period 3||0
10551784|NCT01537887|11705879|FG004|NOT COMPLETED|Period 3||0
10551785|NCT01537887|11705880|FG005|NOT COMPLETED|Period 3||0
10551786|NCT01537900|11705888|FG000|STARTED|Overall Study||4
10551787|NCT01537900|11705888|FG000|COMPLETED|Overall Study||4
10551788|NCT01537900|11705888|FG000|NOT COMPLETED|Overall Study||0
10551789|NCT01537926|11705894|FG000|STARTED|Overall Study||29
10551790|NCT01537926|11705895|FG001|STARTED|Overall Study||13
10551791|NCT01537926|11705894|FG000|COMPLETED|Overall Study||24
10551792|NCT01537926|11705895|FG001|COMPLETED|Overall Study||11
10551793|NCT01537926|11705894|FG000|NOT COMPLETED|Overall Study||5
10551794|NCT01537926|11705895|FG001|NOT COMPLETED|Overall Study||2
10551795|NCT01538199|11705908|FG000|STARTED|Overall Study||10
10551796|NCT01538199|11705909|FG001|STARTED|Overall Study||11
10551797|NCT01538199|11705910|FG002|STARTED|Overall Study||4
10551798|NCT01538199|11705911|FG003|STARTED|Overall Study||3
10551799|NCT01538199|11705908|FG000|COMPLETED|Overall Study|"1 completed study but was excluded as a completer from analyses because started a new treatment"|8
10551800|NCT01538199|11705909|FG001|COMPLETED|Overall Study|"1 completed study but was excluded as a completer from analyses because started a new treatment"|8
10650507|NCT02169674|11810771|FG000|COMPLETED|Overall Study||105
10551801|NCT01538199|11705910|FG002|COMPLETED|Overall Study|1 non-completer included in analyses because only missed follow up, completed all treatment visits.|3
10551802|NCT01538199|11705911|FG003|COMPLETED|Overall Study|Completer excluded from analyses because determined to be not eligible at end of study.|1
10551803|NCT01538199|11705908|FG000|NOT COMPLETED|Overall Study||2
10551804|NCT01538199|11705909|FG001|NOT COMPLETED|Overall Study||3
10551805|NCT01538199|11705910|FG002|NOT COMPLETED|Overall Study||1
10551806|NCT01538199|11705911|FG003|NOT COMPLETED|Overall Study||2
10551807|NCT01538472|11705928|FG000|STARTED|Overall Study||40
10551808|NCT01538472|11705928|FG000|COMPLETED|Overall Study||36
10551809|NCT01538472|11705928|FG000|NOT COMPLETED|Overall Study||4
10551810|NCT01538615|11705934|FG000|STARTED|Overall Study||162
10551811|NCT01538615|11705935|FG001|STARTED|Overall Study||158
10551812|NCT01538615|11705934|FG000|COMPLETED|Overall Study||140
10551813|NCT01538615|11705935|FG001|COMPLETED|Overall Study||146
10551814|NCT01538615|11705934|FG000|NOT COMPLETED|Overall Study||22
10551815|NCT01538615|11705935|FG001|NOT COMPLETED|Overall Study||12
10551816|NCT01538628|11705943|FG000|STARTED|Overall Study||149
10551817|NCT01538628|11705944|FG001|STARTED|Overall Study||73
10551818|NCT01538628|11705943|FG000|COMPLETED|Overall Study||148
10551819|NCT01538628|11705944|FG001|COMPLETED|Overall Study||71
10551820|NCT01538628|11705943|FG000|NOT COMPLETED|Overall Study||1
10551821|NCT01538628|11705944|FG001|NOT COMPLETED|Overall Study||2
10551822|NCT01538719|11705953|FG000|STARTED|Overall Study||7
10551823|NCT01538719|11705954|FG001|STARTED|Overall Study||12
10551824|NCT01538719|11705953|FG000|COMPLETED|Overall Study||5
10551825|NCT01538719|11705954|FG001|COMPLETED|Overall Study||12
10551826|NCT01538719|11705953|FG000|NOT COMPLETED|Overall Study||2
10551827|NCT01538719|11705954|FG001|NOT COMPLETED|Overall Study||0
10551828|NCT01538745|11705962|FG000|STARTED|Overall Study||24
10551829|NCT01538745|11705963|FG001|STARTED|Overall Study||21
10551830|NCT01538745|11705962|FG000|COMPLETED|Overall Study||24
10551831|NCT01538745|11705963|FG001|COMPLETED|Overall Study||21
10551832|NCT01538745|11705962|FG000|NOT COMPLETED|Overall Study||0
10551833|NCT01538745|11705963|FG001|NOT COMPLETED|Overall Study||0
10551834|NCT01538862|11705969|FG000|STARTED|Overall Study||7
10551835|NCT01538862|11705969|FG000|COMPLETED|Overall Study||7
10551836|NCT01538862|11705969|FG000|NOT COMPLETED|Overall Study||0
10551837|NCT01539070|11705976|FG000|STARTED|Overall Study||168
10551838|NCT01539070|11705977|FG001|STARTED|Overall Study||138
10551839|NCT01539070|11705976|FG000|COMPLETED|Overall Study||109
10551840|NCT01539070|11705977|FG001|COMPLETED|Overall Study||99
10551841|NCT01539070|11705976|FG000|NOT COMPLETED|Overall Study||59
10551842|NCT01539070|11705977|FG001|NOT COMPLETED|Overall Study||39
10551843|NCT01539083|11705983|FG000|STARTED|Before Randomization (VCD Induction)||256
10551844|NCT01539083|11705984|FG001|STARTED|Before Randomization (VCD Induction)||0
10551845|NCT01539083|11705985|FG002|STARTED|Before Randomization (VCD Induction)||0
10551846|NCT01539083|11705983|FG000|Treated|Before Randomization (VCD Induction)||254
10551847|NCT01539083|11705984|FG001|Treated|Before Randomization (VCD Induction)||0
10551848|NCT01539083|11705985|FG002|Treated|Before Randomization (VCD Induction)||0
10551849|NCT01539083|11705983|FG000|COMPLETED|Before Randomization (VCD Induction)||203
10551850|NCT01539083|11705984|FG001|COMPLETED|Before Randomization (VCD Induction)||0
10551851|NCT01539083|11705985|FG002|COMPLETED|Before Randomization (VCD Induction)||0
10551852|NCT01539083|11705983|FG000|NOT COMPLETED|Before Randomization (VCD Induction)||53
10551853|NCT01539083|11705984|FG001|NOT COMPLETED|Before Randomization (VCD Induction)||0
10551854|NCT01539083|11705985|FG002|NOT COMPLETED|Before Randomization (VCD Induction)||0
10551855|NCT01539083|11705983|FG000|STARTED|After Randomization (TP and VTP)||0
10551856|NCT01539083|11705984|FG001|STARTED|After Randomization (TP and VTP)|Participants who completed induction phase were randomized for the consolidated treatment.|100
10551857|NCT01539083|11705985|FG002|STARTED|After Randomization (TP and VTP)|Participants who completed induction phase were randomized for the consolidation treatment phase.|103
10551858|NCT01539083|11705983|FG000|Safety Population|After Randomization (TP and VTP)||0
10551859|NCT01539083|11705984|FG001|Safety Population|After Randomization (TP and VTP)|One participant was randomized but not treated. Hence, was not included in safety population.|99
10551860|NCT01539083|11705985|FG002|Safety Population|After Randomization (TP and VTP)||103
10551861|NCT01539083|11705983|FG000|COMPLETED|After Randomization (TP and VTP)||0
10551862|NCT01539083|11705984|FG001|COMPLETED|After Randomization (TP and VTP)||79
10551863|NCT01539083|11705985|FG002|COMPLETED|After Randomization (TP and VTP)||80
10551864|NCT01539083|11705983|FG000|NOT COMPLETED|After Randomization (TP and VTP)||0
10551865|NCT01539083|11705984|FG001|NOT COMPLETED|After Randomization (TP and VTP)||21
10551866|NCT01539083|11705985|FG002|NOT COMPLETED|After Randomization (TP and VTP)||23
10551867|NCT01539135|11705994|FG000|STARTED|Overall Study||43
10551868|NCT01539135|11705995|FG001|STARTED|Overall Study||37
10551869|NCT01539135|11705994|FG000|COMPLETED|Overall Study||43
10790060|NCT03532048|11950529|FG001|NOT COMPLETED|Overall Study||17
10551870|NCT01539135|11705995|FG001|COMPLETED|Overall Study||37
10551871|NCT01539135|11705994|FG000|NOT COMPLETED|Overall Study||0
10551872|NCT01539135|11705995|FG001|NOT COMPLETED|Overall Study||0
10551873|NCT01539239|11706003|FG000|STARTED|Overall Study||369
10551874|NCT01539239|11706004|FG001|STARTED|Overall Study||187
10551875|NCT01539239|11706003|FG000|COMPLETED|Overall Study||357
10551876|NCT01539239|11706004|FG001|COMPLETED|Overall Study||170
10551877|NCT01539239|11706003|FG000|NOT COMPLETED|Overall Study||12
10551878|NCT01539239|11706004|FG001|NOT COMPLETED|Overall Study||17
10551879|NCT01539291|11706013|FG000|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|106
10790061|NCT03532308|11950537|FG000|STARTED|Overall Study||10
10790062|NCT03532308|11950538|FG001|STARTED|Overall Study||9
10790063|NCT03532308|11950537|FG000|Completed Assessments|Overall Study||9
10551880|NCT01539291|11706014|FG001|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|4
10551881|NCT01539291|11706015|FG002|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|42
10551882|NCT01539291|11706016|FG003|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|44
10551883|NCT01539291|11706013|FG000|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|81
10551884|NCT01539291|11706014|FG001|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|4
10551885|NCT01539291|11706015|FG002|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|42
10551886|NCT01539291|11706016|FG003|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|44
10551887|NCT01539291|11706013|FG000|NOT COMPLETED|Study GS-US-312-0116||25
10551888|NCT01539291|11706014|FG001|NOT COMPLETED|Study GS-US-312-0116||0
10551889|NCT01539291|11706015|FG002|NOT COMPLETED|Study GS-US-312-0116||0
10551890|NCT01539291|11706016|FG003|NOT COMPLETED|Study GS-US-312-0116||0
10551891|NCT01539291|11706013|FG000|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|71
10551892|NCT01539291|11706014|FG001|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|4
10551893|NCT01539291|11706015|FG002|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|42
10551894|NCT01539291|11706016|FG003|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|44
10551895|NCT01539291|11706013|FG000|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|30
10551896|NCT01539291|11706014|FG001|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|2
10551897|NCT01539291|11706015|FG002|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|20
10551898|NCT01539291|11706016|FG003|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|18
10551899|NCT01539291|11706013|FG000|NOT COMPLETED|Study GS-US-312-0117||41
10551900|NCT01539291|11706014|FG001|NOT COMPLETED|Study GS-US-312-0117||2
10551901|NCT01539291|11706015|FG002|NOT COMPLETED|Study GS-US-312-0117||22
10551902|NCT01539291|11706016|FG003|NOT COMPLETED|Study GS-US-312-0117||26
10551903|NCT01539317|11706035|FG000|STARTED|Overall Study||25
10551904|NCT01539317|11706036|FG001|STARTED|Overall Study||25
10551905|NCT01539317|11706035|FG000|COMPLETED|Overall Study||24
10551906|NCT01539317|11706036|FG001|COMPLETED|Overall Study||25
10551907|NCT01539317|11706035|FG000|NOT COMPLETED|Overall Study||1
10551908|NCT01539317|11706036|FG001|NOT COMPLETED|Overall Study||0
10551909|NCT01539512|11706047|FG000|STARTED|Overall Study||110
10551910|NCT01539512|11706048|FG001|STARTED|Overall Study||110
10551911|NCT01539512|11706047|FG000|COMPLETED|Overall Study|Completed=reached primary efficacy endpoint (progressive disease or death) or finished study period.|87
10551912|NCT01539512|11706048|FG001|COMPLETED|Overall Study|Completed=reached primary efficacy endpoint (progressive disease or death) or finished study period.|97
10551913|NCT01539512|11706047|FG000|NOT COMPLETED|Overall Study||23
10551914|NCT01539512|11706048|FG001|NOT COMPLETED|Overall Study||13
10551915|NCT01539525|11706057|FG000|STARTED|Overall Study||145
10551916|NCT01539525|11706058|FG001|STARTED|Overall Study||143
10551917|NCT01539525|11706059|FG002|STARTED|Overall Study||151
10551918|NCT01539525|11706057|FG000|COMPLETED|Overall Study||125
10551919|NCT01539525|11706058|FG001|COMPLETED|Overall Study||127
10551920|NCT01539525|11706059|FG002|COMPLETED|Overall Study||134
10551921|NCT01539525|11706057|FG000|NOT COMPLETED|Overall Study||20
10551922|NCT01539525|11706058|FG001|NOT COMPLETED|Overall Study||16
10551923|NCT01539525|11706059|FG002|NOT COMPLETED|Overall Study||17
10551924|NCT01539538|11706072|FG000|STARTED|Overall Study||177
10551925|NCT01539538|11706073|FG001|STARTED|Overall Study||180
10551926|NCT01539538|11706072|FG000|COMPLETED|Overall Study||146
10551927|NCT01539538|11706073|FG001|COMPLETED|Overall Study||136
10551928|NCT01539538|11706072|FG000|NOT COMPLETED|Overall Study||31
10551929|NCT01539538|11706073|FG001|NOT COMPLETED|Overall Study||44
10551930|NCT01539642|11706081|FG000|STARTED|Overall Study||114
10551931|NCT01539642|11706082|FG001|STARTED|Overall Study||58
10551932|NCT01539642|11706081|FG000|COMPLETED|Overall Study||78
10551933|NCT01539642|11706082|FG001|COMPLETED|Overall Study||27
10551934|NCT01539642|11706081|FG000|NOT COMPLETED|Overall Study||36
10551935|NCT01539642|11706082|FG001|NOT COMPLETED|Overall Study||31
10551936|NCT01539694|11706088|FG000|STARTED|Overall Study||63
10551937|NCT01539694|11706089|FG001|STARTED|Overall Study||63
10551938|NCT01539694|11706088|FG000|COMPLETED|Overall Study||62
10551939|NCT01539694|11706089|FG001|COMPLETED|Overall Study||62
10551940|NCT01539694|11706088|FG000|NOT COMPLETED|Overall Study||1
10551941|NCT01539694|11706089|FG001|NOT COMPLETED|Overall Study||1
10551942|NCT01539759|11706097|FG000|STARTED|Overall Study||56
10551943|NCT01539759|11706098|FG001|STARTED|Overall Study||56
10551944|NCT01539759|11706097|FG000|Had Successful IUD Placement|Overall Study||34
10551945|NCT01539759|11706098|FG001|Had Successful IUD Placement|Overall Study||53
10551946|NCT01539759|11706097|FG000|IUD Expulsion|Overall Study||1
10551947|NCT01539759|11706098|FG001|IUD Expulsion|Overall Study||4
10551948|NCT01539759|11706097|FG000|IUD Removal|Overall Study||2
10551949|NCT01539759|11706098|FG001|IUD Removal|Overall Study||7
10790064|NCT03532308|11950538|FG001|Completed Assessments|Overall Study||7
10790065|NCT03532308|11950537|FG000|COMPLETED|Overall Study||10
10551950|NCT01539759|11706097|FG000|IUD in Place at 6 Months Posptartum|Overall Study||32
10551951|NCT01539759|11706098|FG001|IUD in Place at 6 Months Posptartum|Overall Study||40
10551952|NCT01539759|11706097|FG000|COMPLETED|Overall Study||50
10551953|NCT01539759|11706098|FG001|COMPLETED|Overall Study||48
10551954|NCT01539759|11706097|FG000|NOT COMPLETED|Overall Study||6
10551955|NCT01539759|11706098|FG001|NOT COMPLETED|Overall Study||8
10551956|NCT01539837|11706107|FG000|STARTED|Overall Study||8
10551957|NCT01539837|11706108|FG001|STARTED|Overall Study||7
10551958|NCT01539837|11706109|FG002|STARTED|Overall Study||7
10551959|NCT01539837|11706107|FG000|COMPLETED|Overall Study||8
10551960|NCT01539837|11706108|FG001|COMPLETED|Overall Study||6
10551961|NCT01539837|11706109|FG002|COMPLETED|Overall Study||5
10551962|NCT01539837|11706107|FG000|NOT COMPLETED|Overall Study||0
10551963|NCT01539837|11706108|FG001|NOT COMPLETED|Overall Study||1
10551964|NCT01539837|11706109|FG002|NOT COMPLETED|Overall Study||2
10551965|NCT01539980|11706117|FG000|STARTED|Overall Study||30
10551966|NCT01539980|11706117|FG000|COMPLETED|Overall Study||30
10551967|NCT01539980|11706117|FG000|NOT COMPLETED|Overall Study||0
10551968|NCT01540045|11706121|FG000|STARTED|Overall Study||40
10551969|NCT01540045|11706121|FG000|COMPLETED|Overall Study||40
10551970|NCT01540045|11706121|FG000|NOT COMPLETED|Overall Study||0
10551971|NCT01540071|11706146|FG000|STARTED|Overall Study||38
10551972|NCT01540071|11706146|FG000|COMPLETED|Overall Study||38
10551973|NCT01540071|11706146|FG000|NOT COMPLETED|Overall Study||0
10551974|NCT01540162|11706153|FG000|STARTED|Overall Study||30
10551975|NCT01540162|11706154|FG001|STARTED|Overall Study||32
10551976|NCT01540162|11706153|FG000|COMPLETED|Overall Study||30
10551977|NCT01540162|11706154|FG001|COMPLETED|Overall Study||32
10551978|NCT01540162|11706153|FG000|NOT COMPLETED|Overall Study||0
10551979|NCT01540162|11706154|FG001|NOT COMPLETED|Overall Study||0
10551980|NCT01540266|11706166|FG000|STARTED|Overall Study||63
10551981|NCT01540266|11706167|FG001|STARTED|Overall Study||42
10551982|NCT01540266|11706168|FG002|STARTED|Overall Study||60
10551983|NCT01540266|11706169|FG003|STARTED|Overall Study||38
10551984|NCT01540266|11706170|FG004|STARTED|Overall Study||20
10551985|NCT01540266|11706171|FG005|STARTED|Overall Study||19
10551986|NCT01540266|11706166|FG000|COMPLETED|Overall Study||57
10551987|NCT01540266|11706167|FG001|COMPLETED|Overall Study||41
10551988|NCT01540266|11706168|FG002|COMPLETED|Overall Study||59
10551989|NCT01540266|11706169|FG003|COMPLETED|Overall Study||38
10551990|NCT01540266|11706170|FG004|COMPLETED|Overall Study||20
10551991|NCT01540266|11706171|FG005|COMPLETED|Overall Study||19
10551992|NCT01540266|11706166|FG000|NOT COMPLETED|Overall Study||6
10551993|NCT01540266|11706167|FG001|NOT COMPLETED|Overall Study||1
10551994|NCT01540266|11706168|FG002|NOT COMPLETED|Overall Study||1
10551995|NCT01540266|11706169|FG003|NOT COMPLETED|Overall Study||0
10551996|NCT01540266|11706170|FG004|NOT COMPLETED|Overall Study||0
10551997|NCT01540266|11706171|FG005|NOT COMPLETED|Overall Study||0
10551998|NCT01540370|11706185|FG000|STARTED|Overall Study||102
10551999|NCT01540370|11706185|FG000|COMPLETED|Overall Study||100
10552000|NCT01540370|11706185|FG000|NOT COMPLETED|Overall Study||2
10552001|NCT01540409|11706191|FG000|STARTED|Overall Study||6
10552002|NCT01540409|11706192|FG001|STARTED|Overall Study||6
10552003|NCT01540409|11706191|FG000|COMPLETED|Overall Study||6
10552004|NCT01540409|11706192|FG001|COMPLETED|Overall Study||6
10552005|NCT01540409|11706191|FG000|NOT COMPLETED|Overall Study||0
10552006|NCT01540409|11706192|FG001|NOT COMPLETED|Overall Study||0
10552007|NCT01540474|11706205|FG000|STARTED|Vaccination Period||10
10552008|NCT01540474|11706206|FG001|STARTED|Vaccination Period||10
10552009|NCT01540474|11706207|FG002|STARTED|Vaccination Period||10
10552010|NCT01540474|11706208|FG003|STARTED|Vaccination Period||0
10552011|NCT01540474|11706205|FG000|COMPLETED|Vaccination Period||10
10552012|NCT01540474|11706206|FG001|COMPLETED|Vaccination Period||9
10552013|NCT01540474|11706207|FG002|COMPLETED|Vaccination Period||10
10552014|NCT01540474|11706208|FG003|COMPLETED|Vaccination Period||0
10552015|NCT01540474|11706205|FG000|NOT COMPLETED|Vaccination Period||0
10552016|NCT01540474|11706206|FG001|NOT COMPLETED|Vaccination Period||1
10552017|NCT01540474|11706207|FG002|NOT COMPLETED|Vaccination Period||0
10552018|NCT01540474|11706208|FG003|NOT COMPLETED|Vaccination Period||0
10552019|NCT01540474|11706205|FG000|STARTED|Malaria Challenge||10
10552020|NCT01540474|11706206|FG001|STARTED|Malaria Challenge||9
10552021|NCT01540474|11706207|FG002|STARTED|Malaria Challenge||10
10552022|NCT01540474|11706208|FG003|STARTED|Malaria Challenge||6
10552023|NCT01540474|11706205|FG000|COMPLETED|Malaria Challenge||10
10552024|NCT01540474|11706206|FG001|COMPLETED|Malaria Challenge||9
10552025|NCT01540474|11706207|FG002|COMPLETED|Malaria Challenge||10
10552026|NCT01540474|11706208|FG003|COMPLETED|Malaria Challenge||5
10552027|NCT01540474|11706205|FG000|NOT COMPLETED|Malaria Challenge||0
10552028|NCT01540474|11706206|FG001|NOT COMPLETED|Malaria Challenge||0
10552029|NCT01540474|11706207|FG002|NOT COMPLETED|Malaria Challenge||0
10552030|NCT01540474|11706208|FG003|NOT COMPLETED|Malaria Challenge||1
10552031|NCT01540487|11706221|FG000|STARTED|Overall Study||24
10552032|NCT01540487|11706222|FG001|STARTED|Overall Study||24
10552033|NCT01540487|11706221|FG000|COMPLETED|Overall Study||23
10552034|NCT01540487|11706222|FG001|COMPLETED|Overall Study||24
10552035|NCT01540487|11706221|FG000|NOT COMPLETED|Overall Study||1
10552036|NCT01540487|11706222|FG001|NOT COMPLETED|Overall Study||0
10552037|NCT01540513|11706232|FG000|STARTED|Overall Study||12
10552038|NCT01540513|11706232|FG000|COMPLETED|Overall Study||12
10552039|NCT01540513|11706232|FG000|NOT COMPLETED|Overall Study||0
10552040|NCT01540565|11706236|FG000|STARTED|Overall Study||52
10552041|NCT01540565|11706236|FG000|COMPLETED|Overall Study||50
10552042|NCT01540565|11706236|FG000|NOT COMPLETED|Overall Study||2
10552043|NCT01540773|11706240|FG000|STARTED|First Intervention||8
10552044|NCT01540773|11706241|FG001|STARTED|First Intervention||8
10552045|NCT01540773|11706240|FG000|COMPLETED|First Intervention||8
10552046|NCT01540773|11706241|FG001|COMPLETED|First Intervention||8
10552047|NCT01540773|11706240|FG000|NOT COMPLETED|First Intervention||0
10552048|NCT01540773|11706241|FG001|NOT COMPLETED|First Intervention||0
10552049|NCT01540773|11706240|FG000|STARTED|Wash Out Period of 1 Week||8
10552050|NCT01540773|11706241|FG001|STARTED|Wash Out Period of 1 Week||8
10552051|NCT01540773|11706240|FG000|COMPLETED|Wash Out Period of 1 Week||8
10552052|NCT01540773|11706241|FG001|COMPLETED|Wash Out Period of 1 Week||8
10552053|NCT01540773|11706240|FG000|NOT COMPLETED|Wash Out Period of 1 Week||0
10552054|NCT01540773|11706241|FG001|NOT COMPLETED|Wash Out Period of 1 Week||0
10552055|NCT01540773|11706240|FG000|STARTED|Second Intervention||8
10552056|NCT01540773|11706241|FG001|STARTED|Second Intervention||8
10552057|NCT01540773|11706240|FG000|COMPLETED|Second Intervention||8
10552058|NCT01540773|11706241|FG001|COMPLETED|Second Intervention||8
10552059|NCT01540773|11706240|FG000|NOT COMPLETED|Second Intervention||0
10552060|NCT01540773|11706241|FG001|NOT COMPLETED|Second Intervention||0
10552061|NCT01540825|11706260|FG000|STARTED|Overall Study||20
10552062|NCT01540825|11706261|FG001|STARTED|Overall Study||6
10552063|NCT01540825|11706262|FG002|STARTED|Overall Study||6
10552064|NCT01540825|11706263|FG003|STARTED|Overall Study||6
10552065|NCT01540825|11706264|FG004|STARTED|Overall Study||6
10552066|NCT01540825|11706265|FG005|STARTED|Overall Study||6
10552067|NCT01540825|11706266|FG006|STARTED|Overall Study||6
10552068|NCT01540825|11706267|FG007|STARTED|Overall Study||6
10552069|NCT01540825|11706268|FG008|STARTED|Overall Study||6
10552070|NCT01540825|11706269|FG009|STARTED|Overall Study||6
10552071|NCT01540825|11706270|FG010|STARTED|Overall Study||6
10552072|NCT01540825|11706260|FG000|COMPLETED|Overall Study||20
10552073|NCT01540825|11706261|FG001|COMPLETED|Overall Study||6
10552074|NCT01540825|11706262|FG002|COMPLETED|Overall Study||6
10552075|NCT01540825|11706263|FG003|COMPLETED|Overall Study||6
10552076|NCT01540825|11706264|FG004|COMPLETED|Overall Study||6
10552077|NCT01540825|11706265|FG005|COMPLETED|Overall Study||6
10552078|NCT01540825|11706266|FG006|COMPLETED|Overall Study||6
10552079|NCT01540825|11706267|FG007|COMPLETED|Overall Study||6
10552080|NCT01540825|11706268|FG008|COMPLETED|Overall Study||6
10552081|NCT01540825|11706269|FG009|COMPLETED|Overall Study||6
10552082|NCT01540825|11706270|FG010|COMPLETED|Overall Study||6
10552083|NCT01540825|11706260|FG000|NOT COMPLETED|Overall Study||0
10552084|NCT01540825|11706261|FG001|NOT COMPLETED|Overall Study||0
10552085|NCT01540825|11706262|FG002|NOT COMPLETED|Overall Study||0
10552086|NCT01540825|11706263|FG003|NOT COMPLETED|Overall Study||0
10552087|NCT01540825|11706264|FG004|NOT COMPLETED|Overall Study||0
10552088|NCT01540825|11706265|FG005|NOT COMPLETED|Overall Study||0
10552089|NCT01540825|11706266|FG006|NOT COMPLETED|Overall Study||0
10552090|NCT01540825|11706267|FG007|NOT COMPLETED|Overall Study||0
10552091|NCT01540825|11706268|FG008|NOT COMPLETED|Overall Study||0
10552092|NCT01540825|11706269|FG009|NOT COMPLETED|Overall Study||0
10552093|NCT01540825|11706270|FG010|NOT COMPLETED|Overall Study||0
10552094|NCT01540838|11706306|FG000|STARTED|Overall Study||188
10552095|NCT01540838|11706307|FG001|STARTED|Overall Study||187
10552096|NCT01540838|11706306|FG000|COMPLETED|Overall Study||166
10552097|NCT01540838|11706307|FG001|COMPLETED|Overall Study||164
10552098|NCT01540838|11706306|FG000|NOT COMPLETED|Overall Study||22
10552099|NCT01540838|11706307|FG001|NOT COMPLETED|Overall Study||23
10552100|NCT01540851|11706315|FG000|STARTED|Overall Study||154
10552101|NCT01540851|11706316|FG001|STARTED|Overall Study||154
10552102|NCT01540851|11706315|FG000|COMPLETED|Overall Study||133
10552103|NCT01540851|11706316|FG001|COMPLETED|Overall Study||136
10552104|NCT01540851|11706315|FG000|NOT COMPLETED|Overall Study||21
10552105|NCT01540851|11706316|FG001|NOT COMPLETED|Overall Study||18
10552106|NCT01540981|11706326|FG000|STARTED|Overall Study||6
10552107|NCT01540981|11706327|FG001|STARTED|Overall Study||6
10552108|NCT01540981|11706326|FG000|COMPLETED|Overall Study||5
10552109|NCT01540981|11706327|FG001|COMPLETED|Overall Study||6
10552110|NCT01540981|11706326|FG000|NOT COMPLETED|Overall Study||1
10552111|NCT01540981|11706327|FG001|NOT COMPLETED|Overall Study||0
10552112|NCT01541215|11706335|FG000|STARTED|Treatment Period (52 Weeks)||66
10552113|NCT01541215|11706336|FG001|STARTED|Treatment Period (52 Weeks)||69
10552114|NCT01541215|11706335|FG000|Exposed|Treatment Period (52 Weeks)||66
10552115|NCT01541215|11706336|FG001|Exposed|Treatment Period (52 Weeks)||68
10552116|NCT01541215|11706335|FG000|COMPLETED|Treatment Period (52 Weeks)||56
10552117|NCT01541215|11706336|FG001|COMPLETED|Treatment Period (52 Weeks)||53
10552118|NCT01541215|11706335|FG000|NOT COMPLETED|Treatment Period (52 Weeks)||10
10552119|NCT01541215|11706336|FG001|NOT COMPLETED|Treatment Period (52 Weeks)||16
10552120|NCT01541215|11706335|FG000|STARTED|Follow up 1 (Weeks 53-104)|Subjects who attended safety follow up visit at week 104 were included.|52
10552121|NCT01541215|11706336|FG001|STARTED|Follow up 1 (Weeks 53-104)|Follow up was not planned for the subjects who received placebo.|0
10552122|NCT01541215|11706335|FG000|COMPLETED|Follow up 1 (Weeks 53-104)||50
10552123|NCT01541215|11706336|FG001|COMPLETED|Follow up 1 (Weeks 53-104)||0
10552124|NCT01541215|11706335|FG000|NOT COMPLETED|Follow up 1 (Weeks 53-104)||2
10552125|NCT01541215|11706336|FG001|NOT COMPLETED|Follow up 1 (Weeks 53-104)||0
10552126|NCT01541215|11706335|FG000|STARTED|Follow up 2 (Weeks 105-156)|Subjects who attended safety follow up visit at week 156 were included.|48
10552127|NCT01541215|11706336|FG001|STARTED|Follow up 2 (Weeks 105-156)||0
10552128|NCT01541215|11706335|FG000|COMPLETED|Follow up 2 (Weeks 105-156)||48
10552129|NCT01541215|11706336|FG001|COMPLETED|Follow up 2 (Weeks 105-156)||0
10552130|NCT01541215|11706335|FG000|NOT COMPLETED|Follow up 2 (Weeks 105-156)||0
10552131|NCT01541215|11706336|FG001|NOT COMPLETED|Follow up 2 (Weeks 105-156)||0
10552132|NCT01541254|11706346|FG000|STARTED|Overall Study||36
10552133|NCT01541254|11706346|FG000|COMPLETED|Overall Study||30
10552134|NCT01541254|11706346|FG000|NOT COMPLETED|Overall Study||6
10552135|NCT01541358|11706350|FG000|STARTED|Overall Study||2
10552136|NCT01541358|11706350|FG000|COMPLETED|Overall Study||2
10552137|NCT01541358|11706350|FG000|NOT COMPLETED|Overall Study||0
10552138|NCT01541371|11706355|FG000|STARTED|Overall Study||403
10552139|NCT01541371|11706355|FG000|Full Analysis Set|Overall Study||394
10552140|NCT01541371|11706355|FG000|COMPLETED|Overall Study||326
10552141|NCT01541371|11706355|FG000|NOT COMPLETED|Overall Study||77
10552142|NCT01541384|11706366|FG000|STARTED|Overall Study||40
10552143|NCT01541384|11706367|FG001|STARTED|Overall Study||40
10552144|NCT01541384|11706368|FG002|STARTED|Overall Study||40
10552145|NCT01541384|11706366|FG000|COMPLETED|Overall Study||40
10552146|NCT01541384|11706367|FG001|COMPLETED|Overall Study||39
10552147|NCT01541384|11706368|FG002|COMPLETED|Overall Study||38
10552148|NCT01541384|11706366|FG000|NOT COMPLETED|Overall Study||0
10552149|NCT01541384|11706367|FG001|NOT COMPLETED|Overall Study||1
10552150|NCT01541384|11706368|FG002|NOT COMPLETED|Overall Study||2
10552151|NCT01541553|11706378|FG000|STARTED|Overall Study||167
10552152|NCT01541553|11706379|FG001|STARTED|Overall Study||162
10552153|NCT01541553|11706378|FG000|COMPLETED|Overall Study||155
10552154|NCT01541553|11706379|FG001|COMPLETED|Overall Study||148
10552155|NCT01541553|11706378|FG000|NOT COMPLETED|Overall Study||12
10552156|NCT01541553|11706379|FG001|NOT COMPLETED|Overall Study||14
10552157|NCT01541644|11706385|FG000|STARTED|Overall Study||27
10552158|NCT01541644|11706385|FG000|COMPLETED|Overall Study||24
10552159|NCT01541644|11706385|FG000|NOT COMPLETED|Overall Study||3
10552160|NCT01541735|11706391|FG000|STARTED|Overall Study||7
10552161|NCT01541735|11706392|FG001|STARTED|Overall Study||7
10552162|NCT01541735|11706391|FG000|COMPLETED|Overall Study||7
10552163|NCT01541735|11706392|FG001|COMPLETED|Overall Study||7
10552164|NCT01541735|11706391|FG000|NOT COMPLETED|Overall Study||0
10552165|NCT01541735|11706392|FG001|NOT COMPLETED|Overall Study||0
10552166|NCT01541748|11706398|FG000|STARTED|Overall Study|74 subjects were consented; however, 5 were screen failures and 1 did not receive the study device.|74
10552167|NCT01541748|11706398|FG000|COMPLETED|Overall Study||43
10552168|NCT01541748|11706398|FG000|NOT COMPLETED|Overall Study||31
10552169|NCT01541826|11706414|FG000|STARTED|Overall Study||28
10552170|NCT01541826|11706415|FG001|STARTED|Overall Study||28
10552171|NCT01541826|11706416|FG002|STARTED|Overall Study||6
10552172|NCT01541826|11706414|FG000|COMPLETED|Overall Study||24
10552173|NCT01541826|11706415|FG001|COMPLETED|Overall Study||25
10552174|NCT01541826|11706416|FG002|COMPLETED|Overall Study||6
10552175|NCT01541826|11706414|FG000|NOT COMPLETED|Overall Study||4
10552176|NCT01541826|11706415|FG001|NOT COMPLETED|Overall Study||3
10552177|NCT01541826|11706416|FG002|NOT COMPLETED|Overall Study||0
10552178|NCT01541865|11706424|FG000|STARTED|Overall Study||146
10552179|NCT01541865|11706424|FG000|COMPLETED|Overall Study||124
10552180|NCT01541865|11706424|FG000|NOT COMPLETED|Overall Study||22
10552181|NCT01541891|11706430|FG000|STARTED|Overall Study||15
10552182|NCT01541891|11706431|FG001|STARTED|Overall Study||15
10552183|NCT01541891|11706430|FG000|COMPLETED|Overall Study||14
10552184|NCT01541891|11706431|FG001|COMPLETED|Overall Study||14
10552185|NCT01541891|11706430|FG000|NOT COMPLETED|Overall Study||1
10552186|NCT01541891|11706431|FG001|NOT COMPLETED|Overall Study||1
10552187|NCT01541917|11706442|FG000|STARTED|Overall Study||144
10552188|NCT01541917|11706443|FG001|STARTED|Overall Study||145
10552189|NCT01541917|11706442|FG000|COMPLETED|Overall Study||129
10552190|NCT01541917|11706443|FG001|COMPLETED|Overall Study||136
10552191|NCT01541917|11706442|FG000|NOT COMPLETED|Overall Study||15
10552192|NCT01541917|11706443|FG001|NOT COMPLETED|Overall Study||9
10552193|NCT01541930|11706452|FG000|STARTED|Overall Study||21
10552194|NCT01541930|11706452|FG000|COMPLETED|Overall Study||20
10552195|NCT01541930|11706452|FG000|NOT COMPLETED|Overall Study||1
10552196|NCT01541969|11706469|FG000|STARTED|Double-blind (0-12 Weeks)||50
10552197|NCT01541969|11706470|FG001|STARTED|Double-blind (0-12 Weeks)||50
10552198|NCT01541969|11706469|FG000|COMPLETED|Double-blind (0-12 Weeks)||44
10552199|NCT01541969|11706470|FG001|COMPLETED|Double-blind (0-12 Weeks)||48
10552200|NCT01541969|11706469|FG000|NOT COMPLETED|Double-blind (0-12 Weeks)||6
10552201|NCT01541969|11706470|FG001|NOT COMPLETED|Double-blind (0-12 Weeks)||2
10552202|NCT01541969|11706469|FG000|STARTED|Open Label Extension (12-36 Weeks)||44
10552203|NCT01541969|11706470|FG001|STARTED|Open Label Extension (12-36 Weeks)||48
10552204|NCT01541969|11706469|FG000|COMPLETED|Open Label Extension (12-36 Weeks)||33
10552205|NCT01541969|11706470|FG001|COMPLETED|Open Label Extension (12-36 Weeks)||35
10552206|NCT01541969|11706469|FG000|NOT COMPLETED|Open Label Extension (12-36 Weeks)||11
10552207|NCT01541969|11706470|FG001|NOT COMPLETED|Open Label Extension (12-36 Weeks)||13
10552208|NCT01542034|11706481|FG000|STARTED|Overall Study||256
10552209|NCT01542034|11706482|FG001|STARTED|Overall Study||250
10552210|NCT01542034|11706481|FG000|Received Treatment|Overall Study||256
10552211|NCT01542034|11706482|FG001|Received Treatment|Overall Study||249
10552212|NCT01542034|11706481|FG000|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|226
10552213|NCT01542034|11706482|FG001|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|227
10552214|NCT01542034|11706481|FG000|NOT COMPLETED|Overall Study||30
10552215|NCT01542034|11706482|FG001|NOT COMPLETED|Overall Study||23
10552216|NCT01542125|11706490|FG000|STARTED|Overall Study||140
10552217|NCT01542125|11706491|FG001|STARTED|Overall Study||141
10552218|NCT01542125|11706490|FG000|COMPLETED|Overall Study||140
10552219|NCT01542125|11706491|FG001|COMPLETED|Overall Study||141
10552220|NCT01542125|11706490|FG000|NOT COMPLETED|Overall Study||0
10552221|NCT01542125|11706491|FG001|NOT COMPLETED|Overall Study||0
10552222|NCT01542229|11706499|FG000|STARTED|Overall Study||68
10552223|NCT01542229|11706500|FG001|STARTED|Overall Study||66
10552224|NCT01542229|11706499|FG000|COMPLETED|Overall Study||45
10552225|NCT01542229|11706500|FG001|COMPLETED|Overall Study||30
10552226|NCT01542229|11706499|FG000|NOT COMPLETED|Overall Study||23
10552227|NCT01542229|11706500|FG001|NOT COMPLETED|Overall Study||36
10552228|NCT01542255|11706507|FG000|STARTED|Overall Study||7
10552229|NCT01542255|11706507|FG000|Analyzed for Time to Progression|Overall Study||7
10552230|NCT01542255|11706507|FG000|COMPLETED|Overall Study||7
10552231|NCT01542255|11706507|FG000|NOT COMPLETED|Overall Study||0
10552232|NCT01542307|11706512|FG000|STARTED|Overall Study|Each subject inhaled Oxygen for 30 minutes in blinded fashion for 2 of the 4 migraine attacks|22
10552233|NCT01542307|11706513|FG001|STARTED|Overall Study|Each subject inhaled Medical Air for 30 minutes in blinded fashion for 2 of the 4 migraine attacks|22
10552234|NCT01542307|11706512|FG000|COMPLETED|Overall Study||22
10552235|NCT01542307|11706513|FG001|COMPLETED|Overall Study||22
10552236|NCT01542307|11706512|FG000|NOT COMPLETED|Overall Study||0
10552237|NCT01542307|11706513|FG001|NOT COMPLETED|Overall Study||0
10552238|NCT01542372|11706519|FG000|STARTED|Overall Study||11
10552239|NCT01542372|11706520|FG001|STARTED|Overall Study||11
10552240|NCT01542372|11706519|FG000|COMPLETED|Overall Study||11
10552241|NCT01542372|11706520|FG001|COMPLETED|Overall Study||11
10552242|NCT01542372|11706519|FG000|NOT COMPLETED|Overall Study||0
10552243|NCT01542372|11706520|FG001|NOT COMPLETED|Overall Study||0
10552244|NCT01542398|11706527|FG000|STARTED|Overall Study||79
10552245|NCT01542398|11706528|FG001|STARTED|Overall Study||80
10552246|NCT01542398|11706527|FG000|Post-Intervention Assessment|Overall Study||78
10650508|NCT02169674|11810772|FG001|COMPLETED|Overall Study||135
10552247|NCT01542398|11706528|FG001|Post-Intervention Assessment|Overall Study||80
10552248|NCT01542398|11706527|FG000|COMPLETED|Overall Study||71
10552249|NCT01542398|11706528|FG001|COMPLETED|Overall Study||67
10552250|NCT01542398|11706527|FG000|NOT COMPLETED|Overall Study||8
10552251|NCT01542398|11706528|FG001|NOT COMPLETED|Overall Study||13
10552252|NCT01542502|11706536|FG000|STARTED|Overall Study||6
10552253|NCT01542502|11706537|FG001|STARTED|Overall Study||6
10552254|NCT01542502|11706536|FG000|COMPLETED|Overall Study||6
10552255|NCT01542502|11706537|FG001|COMPLETED|Overall Study||6
10552256|NCT01542502|11706536|FG000|NOT COMPLETED|Overall Study||0
10552257|NCT01542502|11706537|FG001|NOT COMPLETED|Overall Study||0
10552258|NCT01542528|11706546|FG000|STARTED|Overall Study||61
10552259|NCT01542528|11706547|FG001|STARTED|Overall Study||56
10552260|NCT01542528|11706546|FG000|COMPLETED|Overall Study||49
10552261|NCT01542528|11706547|FG001|COMPLETED|Overall Study||49
10552262|NCT01542528|11706546|FG000|NOT COMPLETED|Overall Study||12
10552263|NCT01542528|11706547|FG001|NOT COMPLETED|Overall Study||7
10552264|NCT01542541|11706555|FG000|STARTED|Overall Study||38
10552265|NCT01542541|11706556|FG001|STARTED|Overall Study||30
10552266|NCT01542541|11706555|FG000|COMPLETED|Overall Study||30
10552267|NCT01542541|11706556|FG001|COMPLETED|Overall Study||30
10552268|NCT01542541|11706555|FG000|NOT COMPLETED|Overall Study||8
10552269|NCT01542541|11706556|FG001|NOT COMPLETED|Overall Study||0
10552270|NCT01542632|11706568|FG000|STARTED|Overall Study||25
10552271|NCT01542632|11706569|FG001|STARTED|Overall Study||25
10552272|NCT01542632|11706570|FG002|STARTED|Overall Study||24
10552273|NCT01542632|11706571|FG003|STARTED|Overall Study||21
10552274|NCT01542632|11706572|FG004|STARTED|Overall Study||21
10552275|NCT01542632|11706573|FG005|STARTED|Overall Study||24
10552276|NCT01542632|11706568|FG000|COMPLETED|Overall Study||25
10552277|NCT01542632|11706569|FG001|COMPLETED|Overall Study||24
10552278|NCT01542632|11706570|FG002|COMPLETED|Overall Study||23
10552279|NCT01542632|11706571|FG003|COMPLETED|Overall Study||19
10552280|NCT01542632|11706572|FG004|COMPLETED|Overall Study||17
10552281|NCT01542632|11706573|FG005|COMPLETED|Overall Study||24
10552282|NCT01542632|11706568|FG000|NOT COMPLETED|Overall Study||0
10552283|NCT01542632|11706569|FG001|NOT COMPLETED|Overall Study||1
10552284|NCT01542632|11706570|FG002|NOT COMPLETED|Overall Study||1
10552285|NCT01542632|11706571|FG003|NOT COMPLETED|Overall Study||2
10552286|NCT01542632|11706572|FG004|NOT COMPLETED|Overall Study||4
10552287|NCT01542632|11706573|FG005|NOT COMPLETED|Overall Study||0
10552288|NCT01542645|11706594|FG000|STARTED|Overall Study||82
10552289|NCT01542645|11706595|FG001|STARTED|Overall Study||82
10552290|NCT01542645|11706594|FG000|COMPLETED|Overall Study||77
10552291|NCT01542645|11706595|FG001|COMPLETED|Overall Study||79
10552292|NCT01542645|11706594|FG000|NOT COMPLETED|Overall Study||5
10552293|NCT01542645|11706595|FG001|NOT COMPLETED|Overall Study||3
10552294|NCT01542684|11706605|FG000|STARTED|Overall Study||8
10552295|NCT01542684|11706605|FG000|COMPLETED|Overall Study||8
10552296|NCT01542684|11706605|FG000|NOT COMPLETED|Overall Study||0
10552297|NCT01542788|11706611|FG000|STARTED|Overall Study||209
10552298|NCT01542788|11706612|FG001|STARTED|Overall Study||71
10552299|NCT01542788|11706611|FG000|Randomized and Treated|Overall Study||207
10552300|NCT01542788|11706612|FG001|Randomized and Treated|Overall Study||71
10552301|NCT01542788|11706611|FG000|COMPLETED|Overall Study||154
10552302|NCT01542788|11706612|FG001|COMPLETED|Overall Study||0
10552303|NCT01542788|11706611|FG000|NOT COMPLETED|Overall Study||55
10552304|NCT01542788|11706612|FG001|NOT COMPLETED|Overall Study||71
10552305|NCT01542957|11706620|FG000|STARTED|End of Therapy||65
10552306|NCT01542957|11706621|FG001|STARTED|End of Therapy||63
10552307|NCT01542957|11706620|FG000|COMPLETED|End of Therapy||53
10552308|NCT01542957|11706621|FG001|COMPLETED|End of Therapy||53
10552309|NCT01542957|11706620|FG000|NOT COMPLETED|End of Therapy||12
10552310|NCT01542957|11706621|FG001|NOT COMPLETED|End of Therapy||10
10552311|NCT01542957|11706620|FG000|STARTED|3-month Follow-up||53
10552312|NCT01542957|11706621|FG001|STARTED|3-month Follow-up||53
10552313|NCT01542957|11706620|FG000|COMPLETED|3-month Follow-up||50
10552314|NCT01542957|11706621|FG001|COMPLETED|3-month Follow-up||45
10552315|NCT01542957|11706620|FG000|NOT COMPLETED|3-month Follow-up||3
10552316|NCT01542957|11706621|FG001|NOT COMPLETED|3-month Follow-up||8
10552317|NCT01542957|11706620|FG000|STARTED|12-month Follow-up||53
10552318|NCT01542957|11706621|FG001|STARTED|12-month Follow-up||53
10552319|NCT01542957|11706620|FG000|COMPLETED|12-month Follow-up||37
10552320|NCT01542957|11706621|FG001|COMPLETED|12-month Follow-up||40
10552321|NCT01542957|11706620|FG000|NOT COMPLETED|12-month Follow-up||16
10552322|NCT01542957|11706621|FG001|NOT COMPLETED|12-month Follow-up||13
10552323|NCT01543074|11706631|FG000|STARTED|Overall Study||5
10552324|NCT01543074|11706632|FG001|STARTED|Overall Study||7
10552325|NCT01543074|11706633|FG002|STARTED|Overall Study||5
10552326|NCT01543074|11706634|FG003|STARTED|Overall Study||6
10552327|NCT01543074|11706631|FG000|COMPLETED|Overall Study||5
10552328|NCT01543074|11706632|FG001|COMPLETED|Overall Study||7
10552329|NCT01543074|11706633|FG002|COMPLETED|Overall Study||5
10552330|NCT01543074|11706634|FG003|COMPLETED|Overall Study||6
10552331|NCT01543074|11706631|FG000|NOT COMPLETED|Overall Study||0
10552332|NCT01543074|11706632|FG001|NOT COMPLETED|Overall Study||0
10552333|NCT01543074|11706633|FG002|NOT COMPLETED|Overall Study||0
10552334|NCT01543074|11706634|FG003|NOT COMPLETED|Overall Study||0
10552335|NCT01543087|11706654|FG000|STARTED|Stage 1 (48 Months)||70
10552336|NCT01543087|11706655|FG001|STARTED|Stage 1 (48 Months)||103
10552337|NCT01543087|11706656|FG002|STARTED|Stage 1 (48 Months)||277
10552338|NCT01543087|11706657|FG003|STARTED|Stage 1 (48 Months)||116
10552339|NCT01543087|11706658|FG004|STARTED|Stage 1 (48 Months)||86
10552340|NCT01543087|11706659|FG005|STARTED|Stage 1 (48 Months)||46
10552341|NCT01543087|11706654|FG000|Safety Population|Stage 1 (48 Months)||70
10552342|NCT01543087|11706655|FG001|Safety Population|Stage 1 (48 Months)||101
10552343|NCT01543087|11706656|FG002|Safety Population|Stage 1 (48 Months)||277
10552344|NCT01543087|11706657|FG003|Safety Population|Stage 1 (48 Months)||116
10552345|NCT01543087|11706658|FG004|Safety Population|Stage 1 (48 Months)||86
10552346|NCT01543087|11706659|FG005|Safety Population|Stage 1 (48 Months)||46
10552347|NCT01543087|11706654|FG000|COMPLETED|Stage 1 (48 Months)||56
10552348|NCT01543087|11706655|FG001|COMPLETED|Stage 1 (48 Months)||93
10552349|NCT01543087|11706656|FG002|COMPLETED|Stage 1 (48 Months)||237
10552350|NCT01543087|11706657|FG003|COMPLETED|Stage 1 (48 Months)||108
10552351|NCT01543087|11706658|FG004|COMPLETED|Stage 1 (48 Months)||83
10552352|NCT01543087|11706659|FG005|COMPLETED|Stage 1 (48 Months)||46
10552353|NCT01543087|11706654|FG000|NOT COMPLETED|Stage 1 (48 Months)||14
10552354|NCT01543087|11706655|FG001|NOT COMPLETED|Stage 1 (48 Months)||10
10552355|NCT01543087|11706656|FG002|NOT COMPLETED|Stage 1 (48 Months)||40
10552356|NCT01543087|11706657|FG003|NOT COMPLETED|Stage 1 (48 Months)||8
10552357|NCT01543087|11706658|FG004|NOT COMPLETED|Stage 1 (48 Months)||3
10552358|NCT01543087|11706659|FG005|NOT COMPLETED|Stage 1 (48 Months)||0
10552359|NCT01543087|11706654|FG000|STARTED|Booster Stage (26 Months)|Group1 participants (primary study B1971015)were not invited to participate in Booster stage (BS).|0
10552360|NCT01543087|11706655|FG001|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|60
10552361|NCT01543087|11706656|FG002|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|92
10552362|NCT01543087|11706657|FG003|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|64
10552363|NCT01543087|11706658|FG004|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|56
10552364|NCT01543087|11706659|FG005|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|32
10552365|NCT01543087|11706654|FG000|Vaccinated|Booster Stage (26 Months)||0
10552366|NCT01543087|11706655|FG001|Vaccinated|Booster Stage (26 Months)||59
10552367|NCT01543087|11706656|FG002|Vaccinated|Booster Stage (26 Months)||92
10552368|NCT01543087|11706657|FG003|Vaccinated|Booster Stage (26 Months)||64
10552369|NCT01543087|11706658|FG004|Vaccinated|Booster Stage (26 Months)||54
10552370|NCT01543087|11706659|FG005|Vaccinated|Booster Stage (26 Months)||32
10552371|NCT01543087|11706654|FG000|COMPLETED|Booster Stage (26 Months)||0
10552372|NCT01543087|11706655|FG001|COMPLETED|Booster Stage (26 Months)||59
10552373|NCT01543087|11706656|FG002|COMPLETED|Booster Stage (26 Months)||91
10552374|NCT01543087|11706657|FG003|COMPLETED|Booster Stage (26 Months)||64
10552375|NCT01543087|11706658|FG004|COMPLETED|Booster Stage (26 Months)||54
10552376|NCT01543087|11706659|FG005|COMPLETED|Booster Stage (26 Months)||32
10552377|NCT01543087|11706654|FG000|NOT COMPLETED|Booster Stage (26 Months)||0
10552378|NCT01543087|11706655|FG001|NOT COMPLETED|Booster Stage (26 Months)||1
10552379|NCT01543087|11706656|FG002|NOT COMPLETED|Booster Stage (26 Months)||1
10552380|NCT01543087|11706657|FG003|NOT COMPLETED|Booster Stage (26 Months)||0
10552381|NCT01543087|11706658|FG004|NOT COMPLETED|Booster Stage (26 Months)||2
10552382|NCT01543087|11706659|FG005|NOT COMPLETED|Booster Stage (26 Months)||0
10552383|NCT01543152|11706700|FG000|STARTED|Overall Study||3
10552384|NCT01543152|11706701|FG001|STARTED|Overall Study||6
10552385|NCT01543152|11706702|FG002|STARTED|Overall Study||11
10552386|NCT01543152|11706703|FG003|STARTED|Overall Study||3
10552387|NCT01543152|11706704|FG004|STARTED|Overall Study||3
10552388|NCT01543152|11706700|FG000|COMPLETED|Overall Study||3
10552389|NCT01543152|11706701|FG001|COMPLETED|Overall Study||4
10552390|NCT01543152|11706702|FG002|COMPLETED|Overall Study||11
10552391|NCT01543152|11706703|FG003|COMPLETED|Overall Study||3
10552392|NCT01543152|11706704|FG004|COMPLETED|Overall Study||3
10552393|NCT01543152|11706700|FG000|NOT COMPLETED|Overall Study||0
10552394|NCT01543152|11706701|FG001|NOT COMPLETED|Overall Study||2
10552395|NCT01543152|11706702|FG002|NOT COMPLETED|Overall Study||0
10552396|NCT01543152|11706703|FG003|NOT COMPLETED|Overall Study||0
10552397|NCT01543152|11706704|FG004|NOT COMPLETED|Overall Study||0
10552398|NCT01543178|11706719|FG000|STARTED|Open-label Period|2583 subjects entered the open-label period, but 4 received no rifaximin; 2579 received rifaximin.|2583
10552399|NCT01543178|11706720|FG001|STARTED|Open-label Period|The double-blind rifaximin arm/group is not applicable to the open-label period.|0
10552400|NCT01543178|11706721|FG002|STARTED|Open-label Period|The double-blind placebo arm/group is not applicable to the open-label period.|0
10552401|NCT01543178|11706719|FG000|COMPLETED|Open-label Period||636
10552402|NCT01543178|11706720|FG001|COMPLETED|Open-label Period||0
10552403|NCT01543178|11706721|FG002|COMPLETED|Open-label Period||0
10552404|NCT01543178|11706719|FG000|NOT COMPLETED|Open-label Period||1947
10552405|NCT01543178|11706720|FG001|NOT COMPLETED|Open-label Period||0
10552406|NCT01543178|11706721|FG002|NOT COMPLETED|Open-label Period||0
10552407|NCT01543178|11706719|FG000|STARTED|Double-blind Period|The open-label rifaximin arm/group is not applicable to the double-blind period.|0
10552408|NCT01543178|11706720|FG001|STARTED|Double-blind Period|636 subjects had recurrence in open-label period; 328 randomized to rifaximin.|328
10552409|NCT01543178|11706721|FG002|STARTED|Double-blind Period|636 subjects had recurrence in open-label period; 308 randomized to placebo.|308
10790066|NCT03532308|11950538|FG001|COMPLETED|Overall Study||8
10790067|NCT03532308|11950537|FG000|NOT COMPLETED|Overall Study||0
10552410|NCT01543178|11706719|FG000|COMPLETED|Double-blind Period||0
10552411|NCT01543178|11706720|FG001|COMPLETED|Double-blind Period|295 completed 1st double-blind retreatment and 284 completed 2nd double-blind retreatment.|284
10552412|NCT01543178|11706721|FG002|COMPLETED|Double-blind Period|283 completed 1st double-blind retreatment and 271 completed 2nd double-blind retreatment.|271
10552413|NCT01543178|11706719|FG000|NOT COMPLETED|Double-blind Period||0
10552414|NCT01543178|11706720|FG001|NOT COMPLETED|Double-blind Period||44
10552415|NCT01543178|11706721|FG002|NOT COMPLETED|Double-blind Period||37
10552416|NCT01543204|11706728|FG000|STARTED|Overall Study||64
10552417|NCT01543204|11706728|FG000|COMPLETED|Overall Study||56
10552418|NCT01543204|11706728|FG000|NOT COMPLETED|Overall Study||8
10552419|NCT01543490|11706738|FG000|STARTED|Overall Study||368
10552420|NCT01543490|11706739|FG001|STARTED|Overall Study||190
10552421|NCT01543490|11706738|FG000|COMPLETED|Overall Study||352
10552422|NCT01543490|11706739|FG001|COMPLETED|Overall Study||185
10552423|NCT01543490|11706738|FG000|NOT COMPLETED|Overall Study||16
10552424|NCT01543490|11706739|FG001|NOT COMPLETED|Overall Study||5
10552425|NCT01543503|11706747|FG000|STARTED|Overall Study||426
10552426|NCT01543503|11706748|FG001|STARTED|Overall Study||798
10790068|NCT03532308|11950538|FG001|NOT COMPLETED|Overall Study||1
10790069|NCT03532776|11950547|FG000|STARTED|Overall Study||201
10790070|NCT03532776|11950548|FG001|STARTED|Overall Study||198
10790071|NCT03532776|11950549|FG002|STARTED|Overall Study||67
10790072|NCT03532776|11950547|FG000|COMPLETED|Overall Study||196
10790073|NCT03532776|11950548|FG001|COMPLETED|Overall Study||194
10552427|NCT01543503|11706747|FG000|COMPLETED|Overall Study||350
10552428|NCT01543503|11706748|FG001|COMPLETED|Overall Study||711
10552429|NCT01543503|11706747|FG000|NOT COMPLETED|Overall Study||76
10552430|NCT01543503|11706748|FG001|NOT COMPLETED|Overall Study||87
10552431|NCT01543568|11706754|FG000|STARTED|Overall Study||46
10552432|NCT01543568|11706754|FG000|COMPLETED|Overall Study||45
10552433|NCT01543568|11706754|FG000|NOT COMPLETED|Overall Study||1
10552434|NCT01543581|11706758|FG000|STARTED|Overall Study||1
10552435|NCT01543581|11706759|FG001|STARTED|Overall Study||0
10552436|NCT01543581|11706758|FG000|COMPLETED|Overall Study||1
10552437|NCT01543581|11706759|FG001|COMPLETED|Overall Study||0
10552438|NCT01543581|11706758|FG000|NOT COMPLETED|Overall Study||0
10552439|NCT01543581|11706759|FG001|NOT COMPLETED|Overall Study||0
10552440|NCT01543607|11706765|FG000|STARTED|Overall Study||1
10552441|NCT01543607|11706765|FG000|COMPLETED|Overall Study||1
10552442|NCT01543607|11706765|FG000|NOT COMPLETED|Overall Study||0
10552443|NCT01543685|11706774|FG000|STARTED|Overall Study||93
10552444|NCT01543685|11706775|FG001|STARTED|Overall Study||91
10552445|NCT01543685|11706776|FG002|STARTED|Overall Study||91
10552446|NCT01543685|11706777|FG003|STARTED|Overall Study||93
10552447|NCT01543685|11706778|FG004|STARTED|Overall Study||94
10552448|NCT01543685|11706774|FG000|COMPLETED|Overall Study||90
10552449|NCT01543685|11706775|FG001|COMPLETED|Overall Study||88
10552450|NCT01543685|11706776|FG002|COMPLETED|Overall Study||89
10552451|NCT01543685|11706777|FG003|COMPLETED|Overall Study||93
10552452|NCT01543685|11706778|FG004|COMPLETED|Overall Study||90
10552453|NCT01543685|11706774|FG000|NOT COMPLETED|Overall Study||3
10552454|NCT01543685|11706775|FG001|NOT COMPLETED|Overall Study||3
10552455|NCT01543685|11706776|FG002|NOT COMPLETED|Overall Study||2
10552456|NCT01543685|11706777|FG003|NOT COMPLETED|Overall Study||0
10552457|NCT01543685|11706778|FG004|NOT COMPLETED|Overall Study||4
10552458|NCT01543776|11706792|FG000|STARTED|Overall Study||36
10552459|NCT01543776|11706793|FG001|STARTED|Overall Study||36
10552460|NCT01543776|11706792|FG000|COMPLETED|Overall Study||34
10552461|NCT01543776|11706793|FG001|COMPLETED|Overall Study||34
10552462|NCT01543776|11706792|FG000|NOT COMPLETED|Overall Study||2
10552463|NCT01543776|11706793|FG001|NOT COMPLETED|Overall Study||2
10552464|NCT01543828|11706801|FG000|STARTED|Treatment 1||20
10552465|NCT01543828|11706802|FG001|STARTED|Treatment 1||20
10552466|NCT01543828|11706801|FG000|COMPLETED|Treatment 1||20
10552467|NCT01543828|11706802|FG001|COMPLETED|Treatment 1||20
10552468|NCT01543828|11706801|FG000|NOT COMPLETED|Treatment 1||0
10552469|NCT01543828|11706802|FG001|NOT COMPLETED|Treatment 1||0
10552470|NCT01543828|11706801|FG000|STARTED|Treatment 2||20
10552471|NCT01543828|11706802|FG001|STARTED|Treatment 2|1 participant completed treatment 1, had an adverse event, and did not receive treatment 2.|19
10790074|NCT03532776|11950549|FG002|COMPLETED|Overall Study||63
10790075|NCT03532776|11950547|FG000|NOT COMPLETED|Overall Study||5
10552472|NCT01543828|11706801|FG000|COMPLETED|Treatment 2||19
10552473|NCT01543828|11706802|FG001|COMPLETED|Treatment 2||19
10552474|NCT01543828|11706801|FG000|NOT COMPLETED|Treatment 2||1
10552475|NCT01543828|11706802|FG001|NOT COMPLETED|Treatment 2||0
10552476|NCT01543958|11706810|FG000|STARTED|Overall Study||40
10552477|NCT01543958|11706810|FG000|COMPLETED|Overall Study||36
10552478|NCT01543958|11706810|FG000|NOT COMPLETED|Overall Study||4
10552479|NCT01544023|11706814|FG000|STARTED|Overall Study|retrospective|207
10552480|NCT01544023|11706814|FG000|COMPLETED|Overall Study||207
10552481|NCT01544023|11706814|FG000|NOT COMPLETED|Overall Study||0
10552482|NCT01544062|11706820|FG000|STARTED|Overall Study||33
10552483|NCT01544062|11706821|FG001|STARTED|Overall Study||35
10790076|NCT03532776|11950548|FG001|NOT COMPLETED|Overall Study||4
10790077|NCT03532776|11950549|FG002|NOT COMPLETED|Overall Study||4
10552484|NCT01544062|11706820|FG000|COMPLETED|Overall Study||33
10552485|NCT01544062|11706821|FG001|COMPLETED|Overall Study||35
10552486|NCT01544062|11706820|FG000|NOT COMPLETED|Overall Study||0
10552487|NCT01544062|11706821|FG001|NOT COMPLETED|Overall Study||0
10552488|NCT01544088|11706830|FG000|STARTED|Overall Study||98
10552489|NCT01544088|11706831|FG001|STARTED|Overall Study||100
10552490|NCT01544088|11706830|FG000|COMPLETED|Overall Study||61
10552491|NCT01544088|11706831|FG001|COMPLETED|Overall Study||79
10552492|NCT01544088|11706830|FG000|NOT COMPLETED|Overall Study||37
10552493|NCT01544088|11706831|FG001|NOT COMPLETED|Overall Study||21
10552494|NCT01544114|11706840|FG000|STARTED|Overall Study||4
10552495|NCT01544114|11706841|FG001|STARTED|Overall Study||20
10552496|NCT01544114|11706842|FG002|STARTED|Overall Study||22
10552497|NCT01544114|11706840|FG000|COMPLETED|Overall Study|completed study and received 6 months of study drug|3
10552498|NCT01544114|11706841|FG001|COMPLETED|Overall Study|completed study and received 6 months of study drug|16
10552499|NCT01544114|11706842|FG002|COMPLETED|Overall Study|completed study and received 6 months of study drug|17
10552500|NCT01544114|11706840|FG000|NOT COMPLETED|Overall Study||1
10552501|NCT01544114|11706841|FG001|NOT COMPLETED|Overall Study||4
10552502|NCT01544114|11706842|FG002|NOT COMPLETED|Overall Study||5
10552503|NCT01544153|11706856|FG000|STARTED|Overall Study||1337
10552504|NCT01544153|11706857|FG001|STARTED|Overall Study||1324
10552505|NCT01544153|11706858|FG002|STARTED|Overall Study||1314
10552506|NCT01544153|11706859|FG003|STARTED|Overall Study||1317
10552507|NCT01544153|11706856|FG000|COMPLETED|Overall Study||1337
10552508|NCT01544153|11706857|FG001|COMPLETED|Overall Study||1323
10552509|NCT01544153|11706858|FG002|COMPLETED|Overall Study||1313
10552510|NCT01544153|11706859|FG003|COMPLETED|Overall Study||1317
10552511|NCT01544153|11706856|FG000|NOT COMPLETED|Overall Study||0
10552512|NCT01544153|11706857|FG001|NOT COMPLETED|Overall Study||1
10552513|NCT01544153|11706858|FG002|NOT COMPLETED|Overall Study||1
10552514|NCT01544153|11706859|FG003|NOT COMPLETED|Overall Study||0
10552515|NCT01544166|11706869|FG000|STARTED|Overall Study||44
10552516|NCT01544166|11706869|FG000|COMPLETED|Overall Study||44
10552517|NCT01544166|11706869|FG000|NOT COMPLETED|Overall Study||0
10552518|NCT01544179|11706878|FG000|STARTED|Overall Study||133
10552519|NCT01544179|11706879|FG001|STARTED|Overall Study||132
10552520|NCT01544179|11706878|FG000|Received Treatment|Overall Study||132
10552521|NCT01544179|11706879|FG001|Received Treatment|Overall Study||132
10552522|NCT01544179|11706878|FG000|Did Not Receive Treatment|Overall Study||1
10552523|NCT01544179|11706879|FG001|Did Not Receive Treatment|Overall Study||0
10552524|NCT01544179|11706878|FG000|COMPLETED|Overall Study|Patients are ongoing in the study|70
10552525|NCT01544179|11706879|FG001|COMPLETED|Overall Study|Patients are ongoing in the study|86
10552526|NCT01544179|11706878|FG000|NOT COMPLETED|Overall Study||63
10552527|NCT01544179|11706879|FG001|NOT COMPLETED|Overall Study||46
10552528|NCT01544309|11706887|FG000|STARTED|Overall Study||524
10552529|NCT01544309|11706888|FG001|STARTED|Overall Study||525
10552530|NCT01544309|11706887|FG000|COMPLETED|Overall Study||504
10552531|NCT01544309|11706888|FG001|COMPLETED|Overall Study||514
10455076|NCT01000324|11603089|FG000|STARTED|Year 16||40
10455077|NCT01000324|11603089|FG000|COMPLETED|Year 16||40
10455078|NCT01000324|11603089|FG000|NOT COMPLETED|Year 16||0
10552532|NCT01544309|11706887|FG000|NOT COMPLETED|Overall Study||20
10552533|NCT01544309|11706888|FG001|NOT COMPLETED|Overall Study||11
10552534|NCT01544348|11706904|FG000|STARTED|Overall Study||17
10552535|NCT01544348|11706905|FG001|STARTED|Overall Study||6
10552536|NCT01544348|11706906|FG002|STARTED|Overall Study||3
10552537|NCT01544348|11706907|FG003|STARTED|Overall Study||3
10552538|NCT01544348|11706908|FG004|STARTED|Overall Study||16
10552539|NCT01544348|11706909|FG005|STARTED|Overall Study||19
10552540|NCT01544348|11706910|FG006|STARTED|Overall Study||14
10552541|NCT01544348|11706911|FG007|STARTED|Overall Study||8
10552542|NCT01544348|11706904|FG000|Treated|Overall Study||17
10552543|NCT01544348|11706905|FG001|Treated|Overall Study||6
10552544|NCT01544348|11706906|FG002|Treated|Overall Study||3
10552545|NCT01544348|11706907|FG003|Treated|Overall Study||3
10552546|NCT01544348|11706908|FG004|Treated|Overall Study||15
10552547|NCT01544348|11706909|FG005|Treated|Overall Study||18
10552548|NCT01544348|11706910|FG006|Treated|Overall Study||14
10552549|NCT01544348|11706911|FG007|Treated|Overall Study||8
10552550|NCT01544348|11706904|FG000|COMPLETED|Overall Study||15
10552551|NCT01544348|11706905|FG001|COMPLETED|Overall Study||6
10552552|NCT01544348|11706906|FG002|COMPLETED|Overall Study||3
10552553|NCT01544348|11706907|FG003|COMPLETED|Overall Study||3
10552554|NCT01544348|11706908|FG004|COMPLETED|Overall Study||15
10552555|NCT01544348|11706909|FG005|COMPLETED|Overall Study||16
10552556|NCT01544348|11706910|FG006|COMPLETED|Overall Study||12
10552557|NCT01544348|11706911|FG007|COMPLETED|Overall Study||8
10552558|NCT01544348|11706904|FG000|NOT COMPLETED|Overall Study||2
10552559|NCT01544348|11706905|FG001|NOT COMPLETED|Overall Study||0
10552560|NCT01544348|11706906|FG002|NOT COMPLETED|Overall Study||0
10455079|NCT01000324|11603089|FG000|STARTED|Year 17||32
10455080|NCT01000324|11603089|FG000|COMPLETED|Year 17||32
10455081|NCT01000324|11603089|FG000|NOT COMPLETED|Year 17||0
10455082|NCT01000324|11603089|FG000|STARTED|Year 18||29
10455083|NCT01000324|11603089|FG000|COMPLETED|Year 18||29
10455084|NCT01000324|11603089|FG000|NOT COMPLETED|Year 18||0
10455085|NCT01000324|11603089|FG000|STARTED|Year 19||28
10455086|NCT01000324|11603089|FG000|COMPLETED|Year 19||28
10455087|NCT01000324|11603089|FG000|NOT COMPLETED|Year 19||0
10455088|NCT01000324|11603089|FG000|STARTED|Year 20||28
10455089|NCT01000324|11603089|FG000|COMPLETED|Year 20||28
10455090|NCT01000324|11603089|FG000|NOT COMPLETED|Year 20||0
10552561|NCT01544348|11706907|FG003|NOT COMPLETED|Overall Study||0
10552562|NCT01544348|11706908|FG004|NOT COMPLETED|Overall Study||1
10552563|NCT01544348|11706909|FG005|NOT COMPLETED|Overall Study||3
10552564|NCT01544348|11706910|FG006|NOT COMPLETED|Overall Study||2
10455091|NCT01000337|11603096|FG000|STARTED|Overall Study||34
10455092|NCT01000337|11603097|FG001|STARTED|Overall Study||33
10552565|NCT01544348|11706911|FG007|NOT COMPLETED|Overall Study||0
10552566|NCT01544361|11706941|FG000|STARTED|Overall Study||8
10552567|NCT01544361|11706942|FG001|STARTED|Overall Study||6
10552568|NCT01544361|11706943|FG002|STARTED|Overall Study||6
10552569|NCT01544361|11706944|FG003|STARTED|Overall Study||6
10552570|NCT01544361|11706945|FG004|STARTED|Overall Study||6
10552571|NCT01544361|11706941|FG000|COMPLETED|Overall Study||8
10552572|NCT01544361|11706942|FG001|COMPLETED|Overall Study||6
10552573|NCT01544361|11706943|FG002|COMPLETED|Overall Study||6
10552574|NCT01544361|11706944|FG003|COMPLETED|Overall Study||6
10552575|NCT01544361|11706945|FG004|COMPLETED|Overall Study||6
10552576|NCT01544361|11706941|FG000|NOT COMPLETED|Overall Study||0
10552577|NCT01544361|11706942|FG001|NOT COMPLETED|Overall Study||0
10552578|NCT01544361|11706943|FG002|NOT COMPLETED|Overall Study||0
10552579|NCT01544361|11706944|FG003|NOT COMPLETED|Overall Study||0
10552580|NCT01544361|11706945|FG004|NOT COMPLETED|Overall Study||0
10650509|NCT02169674|11810771|FG000|NOT COMPLETED|Overall Study||32
10650510|NCT02169674|11810772|FG001|NOT COMPLETED|Overall Study||78
10650511|NCT02169739|11810780|FG000|STARTED|Overall Study||2
10650512|NCT02169739|11810781|FG001|STARTED|Overall Study||4
10650513|NCT02169739|11810780|FG000|COMPLETED|Overall Study||2
10650514|NCT02169739|11810781|FG001|COMPLETED|Overall Study||0
10650515|NCT02169739|11810780|FG000|NOT COMPLETED|Overall Study||0
10650516|NCT02169739|11810781|FG001|NOT COMPLETED|Overall Study||4
10650517|NCT02169791|11810788|FG000|STARTED|Overall Study||25
10650518|NCT02169791|11810788|FG000|COMPLETED|Overall Study||18
10650519|NCT02169791|11810788|FG000|NOT COMPLETED|Overall Study||7
10650520|NCT02169869|11810794|FG000|STARTED|Overall Study||17
10650521|NCT02169869|11810795|FG001|STARTED|Overall Study||16
10650522|NCT02169869|11810794|FG000|COMPLETED|Overall Study||17
10650523|NCT02169869|11810795|FG001|COMPLETED|Overall Study||16
10650524|NCT02169869|11810794|FG000|NOT COMPLETED|Overall Study||0
10650525|NCT02169869|11810795|FG001|NOT COMPLETED|Overall Study||0
10650526|NCT02169895|11810805|FG000|STARTED|Overall Study||4
10650527|NCT02169895|11810806|FG001|STARTED|Overall Study||4
10650528|NCT02169895|11810807|FG002|STARTED|Overall Study||4
10650529|NCT02169895|11810808|FG003|STARTED|Overall Study||4
10650530|NCT02169895|11810805|FG000|25 mg BIA 9-1067|Overall Study||4
10650531|NCT02169895|11810806|FG001|25 mg BIA 9-1067|Overall Study||4
10650532|NCT02169895|11810807|FG002|25 mg BIA 9-1067|Overall Study||4
10650533|NCT02169895|11810808|FG003|25 mg BIA 9-1067|Overall Study||4
10650534|NCT02169895|11810805|FG000|50 mg BIA 9-1067|Overall Study||4
10650535|NCT02169895|11810806|FG001|50 mg BIA 9-1067|Overall Study||4
10650536|NCT02169895|11810807|FG002|50 mg BIA 9-1067|Overall Study||4
10650537|NCT02169895|11810808|FG003|50 mg BIA 9-1067|Overall Study||4
10650538|NCT02169895|11810805|FG000|100 mg BIA 9-1067|Overall Study||4
10650539|NCT02169895|11810806|FG001|100 mg BIA 9-1067|Overall Study||4
10650540|NCT02169895|11810807|FG002|100 mg BIA 9-1067|Overall Study||4
10650541|NCT02169895|11810808|FG003|100 mg BIA 9-1067|Overall Study||2
10650542|NCT02169895|11810805|FG000|Placebo|Overall Study||4
10650543|NCT02169895|11810806|FG001|Placebo|Overall Study||4
10650544|NCT02169895|11810807|FG002|Placebo|Overall Study||4
10650545|NCT02169895|11810808|FG003|Placebo|Overall Study||4
10650546|NCT02169895|11810805|FG000|COMPLETED|Overall Study||4
10650547|NCT02169895|11810806|FG001|COMPLETED|Overall Study||4
10650548|NCT02169895|11810807|FG002|COMPLETED|Overall Study||4
10650549|NCT02169895|11810808|FG003|COMPLETED|Overall Study||2
10650550|NCT02169895|11810805|FG000|NOT COMPLETED|Overall Study||0
10650551|NCT02169895|11810806|FG001|NOT COMPLETED|Overall Study||0
10650552|NCT02169895|11810807|FG002|NOT COMPLETED|Overall Study||0
10650553|NCT02169895|11810808|FG003|NOT COMPLETED|Overall Study||2
10650554|NCT02170025|11810820|FG000|STARTED|Overall Study||14
10650555|NCT02170025|11810821|FG001|STARTED|Overall Study||7
10650556|NCT02170025|11810820|FG000|COMPLETED|Overall Study||12
10650557|NCT02170025|11810821|FG001|COMPLETED|Overall Study||7
10650558|NCT02170025|11810820|FG000|NOT COMPLETED|Overall Study||2
10650559|NCT02170025|11810821|FG001|NOT COMPLETED|Overall Study||0
10650560|NCT02170051|11810829|FG000|STARTED|Overall Study||26
10650561|NCT02170051|11810830|FG001|STARTED|Overall Study||29
10650562|NCT02170051|11810829|FG000|Tested at Mid-point|Overall Study||13
10650563|NCT02170051|11810830|FG001|Tested at Mid-point|Overall Study||18
10650564|NCT02170051|11810829|FG000|Tested at Post-treatment|Overall Study||15
10650565|NCT02170051|11810830|FG001|Tested at Post-treatment|Overall Study||16
10650566|NCT02170051|11810829|FG000|COMPLETED|Overall Study||15
10650567|NCT02170051|11810830|FG001|COMPLETED|Overall Study||16
10650568|NCT02170051|11810829|FG000|NOT COMPLETED|Overall Study||11
10650569|NCT02170051|11810830|FG001|NOT COMPLETED|Overall Study||13
10650570|NCT02170064|11810839|FG000|STARTED|Overall Study||15
10650571|NCT02170064|11810840|FG001|STARTED|Overall Study||9
10650572|NCT02170064|11810841|FG002|STARTED|Overall Study||11
10650573|NCT02170064|11810839|FG000|Safety Population (SP)|Overall Study||12
10650574|NCT02170064|11810840|FG001|Safety Population (SP)|Overall Study||8
10650575|NCT02170064|11810841|FG002|Safety Population (SP)|Overall Study||11
10650576|NCT02170064|11810839|FG000|Pharmacokinetic Population (PKP)|Overall Study||11
10650577|NCT02170064|11810840|FG001|Pharmacokinetic Population (PKP)|Overall Study||8
10650578|NCT02170064|11810841|FG002|Pharmacokinetic Population (PKP)|Overall Study||10
10650579|NCT02170064|11810839|FG000|Efficacy Population (EP)|Overall Study||11
10650580|NCT02170064|11810840|FG001|Efficacy Population (EP)|Overall Study||8
10650581|NCT02170064|11810841|FG002|Efficacy Population (EP)|Overall Study||10
10650582|NCT02170064|11810839|FG000|COMPLETED|Overall Study||9
10650583|NCT02170064|11810840|FG001|COMPLETED|Overall Study||7
10650584|NCT02170064|11810841|FG002|COMPLETED|Overall Study||10
10552581|NCT01544478|11706957|FG000|STARTED|Overall Study||1030
10552582|NCT01544478|11706957|FG000|Vaccination 1|Overall Study||1030
10552583|NCT01544478|11706957|FG000|Vaccination 2|Overall Study||1026
10552584|NCT01544478|11706957|FG000|Vaccination 3|Overall Study||1019
10552585|NCT01544478|11706957|FG000|COMPLETED|Overall Study||912
10552586|NCT01544478|11706957|FG000|NOT COMPLETED|Overall Study||118
10552587|NCT01544491|11706963|FG000|STARTED|Overall Study||52
10790078|NCT03533036|11950560|FG000|STARTED|Overall Study||15
10790079|NCT03533036|11950561|FG001|STARTED|Overall Study||15
10790080|NCT03533036|11950560|FG000|COMPLETED|Overall Study||15
10790081|NCT03533036|11950561|FG001|COMPLETED|Overall Study||15
10552588|NCT01544491|11706964|FG001|STARTED|Overall Study||54
10552589|NCT01544491|11706963|FG000|COMPLETED|Overall Study||47
10552590|NCT01544491|11706964|FG001|COMPLETED|Overall Study||51
10552591|NCT01544491|11706963|FG000|NOT COMPLETED|Overall Study||5
10552592|NCT01544491|11706964|FG001|NOT COMPLETED|Overall Study||3
10552593|NCT01544582|11706973|FG000|STARTED|Screening/Eligibility||713
10552594|NCT01544582|11706974|FG001|STARTED|Screening/Eligibility||0
10552595|NCT01544582|11706975|FG002|STARTED|Screening/Eligibility||0
10552596|NCT01544582|11706976|FG003|STARTED|Screening/Eligibility||0
10552597|NCT01544582|11706973|FG000|Analysis Population|Screening/Eligibility||679
10552598|NCT01544582|11706974|FG001|Analysis Population|Screening/Eligibility||0
10552599|NCT01544582|11706975|FG002|Analysis Population|Screening/Eligibility||0
10552600|NCT01544582|11706976|FG003|Analysis Population|Screening/Eligibility||0
10552601|NCT01544582|11706973|FG000|COMPLETED|Screening/Eligibility|Completed means met criteria for Analysis Population|679
10552602|NCT01544582|11706974|FG001|COMPLETED|Screening/Eligibility||0
10552603|NCT01544582|11706975|FG002|COMPLETED|Screening/Eligibility||0
10552604|NCT01544582|11706976|FG003|COMPLETED|Screening/Eligibility||0
10552605|NCT01544582|11706973|FG000|NOT COMPLETED|Screening/Eligibility||34
10552606|NCT01544582|11706974|FG001|NOT COMPLETED|Screening/Eligibility||0
10552607|NCT01544582|11706975|FG002|NOT COMPLETED|Screening/Eligibility||0
10552608|NCT01544582|11706976|FG003|NOT COMPLETED|Screening/Eligibility||0
10552609|NCT01544582|11706973|FG000|STARTED|Analysis Population|Analysis Population was grouped into Boceprevir+PR, Telaprevir+PR, or PR Alone|0
10552610|NCT01544582|11706974|FG001|STARTED|Analysis Population||298
10552611|NCT01544582|11706975|FG002|STARTED|Analysis Population||307
10552612|NCT01544582|11706976|FG003|STARTED|Analysis Population||74
10552613|NCT01544582|11706973|FG000|COMPLETED|Analysis Population||0
10552614|NCT01544582|11706974|FG001|COMPLETED|Analysis Population||180
10552615|NCT01544582|11706975|FG002|COMPLETED|Analysis Population||205
10552616|NCT01544582|11706976|FG003|COMPLETED|Analysis Population||35
10552617|NCT01544582|11706973|FG000|NOT COMPLETED|Analysis Population||0
10552618|NCT01544582|11706974|FG001|NOT COMPLETED|Analysis Population||118
10552619|NCT01544582|11706975|FG002|NOT COMPLETED|Analysis Population||102
10552620|NCT01544582|11706976|FG003|NOT COMPLETED|Analysis Population||39
10552621|NCT01544595|11706995|FG000|STARTED|Status at Week 68||301
10552622|NCT01544595|11706996|FG001|STARTED|Status at Week 68||363
10552623|NCT01544595|11706997|FG002|STARTED|Status at Week 68||150
10552624|NCT01544595|11706998|FG003|STARTED|Status at Week 68||181
10552625|NCT01544595|11706999|FG004|STARTED|Status at Week 68|These patients were not in the study arms at this time point.|0
10552626|NCT01544595|11707000|FG005|STARTED|Status at Week 68|These patients were not in the study arms at this time point.|0
10552627|NCT01544595|11706995|FG000|COMPLETED|Status at Week 68||262
10552628|NCT01544595|11706996|FG001|COMPLETED|Status at Week 68||346
10552629|NCT01544595|11706997|FG002|COMPLETED|Status at Week 68||87
10552630|NCT01544595|11706998|FG003|COMPLETED|Status at Week 68||130
10552631|NCT01544595|11706999|FG004|COMPLETED|Status at Week 68|These patients were not in the study arms at this time point.|0
10552632|NCT01544595|11707000|FG005|COMPLETED|Status at Week 68|These patients were not in the study arms at this time point.|0
10552633|NCT01544595|11706995|FG000|NOT COMPLETED|Status at Week 68||39
10552634|NCT01544595|11706996|FG001|NOT COMPLETED|Status at Week 68||17
10552635|NCT01544595|11706997|FG002|NOT COMPLETED|Status at Week 68||63
10552636|NCT01544595|11706998|FG003|NOT COMPLETED|Status at Week 68||51
10552637|NCT01544595|11706999|FG004|NOT COMPLETED|Status at Week 68||0
10552638|NCT01544595|11707000|FG005|NOT COMPLETED|Status at Week 68||0
10552639|NCT01544595|11706995|FG000|STARTED|Status at Week 156||301
10552640|NCT01544595|11706996|FG001|STARTED|Status at Week 156||363
10552641|NCT01544595|11706997|FG002|STARTED|Status at Week 156||150
10552642|NCT01544595|11706998|FG003|STARTED|Status at Week 156||181
10552643|NCT01544595|11706999|FG004|STARTED|Status at Week 156||98
10552644|NCT01544595|11707000|FG005|STARTED|Status at Week 156||53
10552645|NCT01544595|11706995|FG000|COMPLETED|Status at Week 156||184
10552646|NCT01544595|11706996|FG001|COMPLETED|Status at Week 156||285
10552647|NCT01544595|11706997|FG002|COMPLETED|Status at Week 156||10
10552648|NCT01544595|11706998|FG003|COMPLETED|Status at Week 156||15
10552649|NCT01544595|11706999|FG004|COMPLETED|Status at Week 156||60
10552650|NCT01544595|11707000|FG005|COMPLETED|Status at Week 156||38
10552651|NCT01544595|11706995|FG000|NOT COMPLETED|Status at Week 156||117
10552652|NCT01544595|11706996|FG001|NOT COMPLETED|Status at Week 156||78
10552653|NCT01544595|11706997|FG002|NOT COMPLETED|Status at Week 156||140
10552654|NCT01544595|11706998|FG003|NOT COMPLETED|Status at Week 156||166
10552655|NCT01544595|11706999|FG004|NOT COMPLETED|Status at Week 156||38
10552656|NCT01544595|11707000|FG005|NOT COMPLETED|Status at Week 156||15
10552657|NCT01544920|11707020|FG000|STARTED|Overall Study||368
10552658|NCT01544920|11707021|FG001|STARTED|Overall Study||369
10552659|NCT01544920|11707020|FG000|COMPLETED|Overall Study||349
10552660|NCT01544920|11707021|FG001|COMPLETED|Overall Study||346
10790082|NCT03533036|11950560|FG000|NOT COMPLETED|Overall Study||0
10552661|NCT01544920|11707020|FG000|NOT COMPLETED|Overall Study||19
10552662|NCT01544920|11707021|FG001|NOT COMPLETED|Overall Study||23
10552663|NCT01544998|11707029|FG000|STARTED|First Intervention (3 Hours)||26
10552664|NCT01544998|11707030|FG001|STARTED|First Intervention (3 Hours)||15
10552665|NCT01544998|11707029|FG000|COMPLETED|First Intervention (3 Hours)||26
10552666|NCT01544998|11707030|FG001|COMPLETED|First Intervention (3 Hours)||15
10552667|NCT01544998|11707029|FG000|NOT COMPLETED|First Intervention (3 Hours)||0
10552668|NCT01544998|11707030|FG001|NOT COMPLETED|First Intervention (3 Hours)||0
10552669|NCT01544998|11707029|FG000|STARTED|Washout (1 Week)||26
10552670|NCT01544998|11707030|FG001|STARTED|Washout (1 Week)||15
10552671|NCT01544998|11707029|FG000|COMPLETED|Washout (1 Week)||26
10552672|NCT01544998|11707030|FG001|COMPLETED|Washout (1 Week)||15
10552673|NCT01544998|11707029|FG000|NOT COMPLETED|Washout (1 Week)||0
10552674|NCT01544998|11707030|FG001|NOT COMPLETED|Washout (1 Week)||0
10552675|NCT01544998|11707029|FG000|STARTED|Second Intervention (3 Hours)||26
10552676|NCT01544998|11707030|FG001|STARTED|Second Intervention (3 Hours)||15
10552677|NCT01544998|11707029|FG000|COMPLETED|Second Intervention (3 Hours)||26
10552678|NCT01544998|11707030|FG001|COMPLETED|Second Intervention (3 Hours)||15
10552679|NCT01544998|11707029|FG000|NOT COMPLETED|Second Intervention (3 Hours)||0
10552680|NCT01544998|11707030|FG001|NOT COMPLETED|Second Intervention (3 Hours)||0
10552681|NCT01545076|11707038|FG000|STARTED|IgPro10 Restabilization Period||208
10552682|NCT01545076|11707039|FG001|STARTED|IgPro10 Restabilization Period||0
10552683|NCT01545076|11707040|FG002|STARTED|IgPro10 Restabilization Period||0
10552684|NCT01545076|11707041|FG003|STARTED|IgPro10 Restabilization Period||0
10552685|NCT01545076|11707042|FG004|STARTED|IgPro10 Restabilization Period||0
10552686|NCT01545076|11707038|FG000|COMPLETED|IgPro10 Restabilization Period||172
10552687|NCT01545076|11707039|FG001|COMPLETED|IgPro10 Restabilization Period||0
10552688|NCT01545076|11707040|FG002|COMPLETED|IgPro10 Restabilization Period||0
10552689|NCT01545076|11707041|FG003|COMPLETED|IgPro10 Restabilization Period||0
10552690|NCT01545076|11707042|FG004|COMPLETED|IgPro10 Restabilization Period||0
10552691|NCT01545076|11707038|FG000|NOT COMPLETED|IgPro10 Restabilization Period||36
10552692|NCT01545076|11707039|FG001|NOT COMPLETED|IgPro10 Restabilization Period||0
10552693|NCT01545076|11707040|FG002|NOT COMPLETED|IgPro10 Restabilization Period||0
10552694|NCT01545076|11707041|FG003|NOT COMPLETED|IgPro10 Restabilization Period||0
10552695|NCT01545076|11707042|FG004|NOT COMPLETED|IgPro10 Restabilization Period||0
10552696|NCT01545076|11707038|FG000|STARTED|IgPro20 Subcutaneous Treatment Period||0
10552697|NCT01545076|11707039|FG001|STARTED|IgPro20 Subcutaneous Treatment Period||58
10552698|NCT01545076|11707040|FG002|STARTED|IgPro20 Subcutaneous Treatment Period||57
10552699|NCT01545076|11707041|FG003|STARTED|IgPro20 Subcutaneous Treatment Period||57
10552700|NCT01545076|11707042|FG004|STARTED|IgPro20 Subcutaneous Treatment Period||0
10552701|NCT01545076|11707038|FG000|COMPLETED|IgPro20 Subcutaneous Treatment Period||0
10552702|NCT01545076|11707039|FG001|COMPLETED|IgPro20 Subcutaneous Treatment Period||39
10552703|NCT01545076|11707040|FG002|COMPLETED|IgPro20 Subcutaneous Treatment Period||36
10552704|NCT01545076|11707041|FG003|COMPLETED|IgPro20 Subcutaneous Treatment Period||21
10552705|NCT01545076|11707042|FG004|COMPLETED|IgPro20 Subcutaneous Treatment Period||0
10552706|NCT01545076|11707038|FG000|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||0
10552707|NCT01545076|11707039|FG001|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||19
10552708|NCT01545076|11707040|FG002|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||21
10552709|NCT01545076|11707041|FG003|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||36
10552710|NCT01545076|11707042|FG004|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||0
10552711|NCT01545076|11707038|FG000|STARTED|IgPro10 Rescue Period||0
10552712|NCT01545076|11707039|FG001|STARTED|IgPro10 Rescue Period||0
10552713|NCT01545076|11707040|FG002|STARTED|IgPro10 Rescue Period||0
10552714|NCT01545076|11707041|FG003|STARTED|IgPro10 Rescue Period||0
10552715|NCT01545076|11707042|FG004|STARTED|IgPro10 Rescue Period||60
10552716|NCT01545076|11707038|FG000|COMPLETED|IgPro10 Rescue Period||0
10552717|NCT01545076|11707039|FG001|COMPLETED|IgPro10 Rescue Period||0
10552718|NCT01545076|11707040|FG002|COMPLETED|IgPro10 Rescue Period||0
10552719|NCT01545076|11707041|FG003|COMPLETED|IgPro10 Rescue Period||0
10552720|NCT01545076|11707042|FG004|COMPLETED|IgPro10 Rescue Period||60
10552721|NCT01545076|11707038|FG000|NOT COMPLETED|IgPro10 Rescue Period||0
10552722|NCT01545076|11707039|FG001|NOT COMPLETED|IgPro10 Rescue Period||0
10552723|NCT01545076|11707040|FG002|NOT COMPLETED|IgPro10 Rescue Period||0
10552724|NCT01545076|11707041|FG003|NOT COMPLETED|IgPro10 Rescue Period||0
10552725|NCT01545076|11707042|FG004|NOT COMPLETED|IgPro10 Rescue Period||0
10552726|NCT01545141|11707059|FG000|STARTED|Overall Study||2
10552727|NCT01545141|11707060|FG001|STARTED|Overall Study||3
10552728|NCT01545141|11707061|FG002|STARTED|Overall Study||3
10552729|NCT01545141|11707062|FG003|STARTED|Overall Study||7
10552730|NCT01545141|11707059|FG000|COMPLETED|Overall Study||2
10552731|NCT01545141|11707060|FG001|COMPLETED|Overall Study||3
10552732|NCT01545141|11707061|FG002|COMPLETED|Overall Study||3
10552733|NCT01545141|11707062|FG003|COMPLETED|Overall Study||7
10552734|NCT01545141|11707059|FG000|NOT COMPLETED|Overall Study||0
10552735|NCT01545141|11707060|FG001|NOT COMPLETED|Overall Study||0
10552736|NCT01545141|11707061|FG002|NOT COMPLETED|Overall Study||0
10552737|NCT01545141|11707062|FG003|NOT COMPLETED|Overall Study||0
10552738|NCT01545193|11707073|FG000|STARTED|Overall Study||150
10552739|NCT01545193|11707074|FG001|STARTED|Overall Study||150
10552740|NCT01545193|11707073|FG000|COMPLETED|Overall Study||150
10552741|NCT01545193|11707074|FG001|COMPLETED|Overall Study||149
10552742|NCT01545193|11707073|FG000|NOT COMPLETED|Overall Study||0
10552743|NCT01545193|11707074|FG001|NOT COMPLETED|Overall Study||1
10552744|NCT01545232|11707082|FG000|STARTED|Overall Study||338
10552745|NCT01545232|11707083|FG001|STARTED|Overall Study||342
10552746|NCT01545232|11707082|FG000|COMPLETED|Overall Study||338
10552747|NCT01545232|11707083|FG001|COMPLETED|Overall Study||342
10552748|NCT01545232|11707082|FG000|NOT COMPLETED|Overall Study||0
10552749|NCT01545232|11707083|FG001|NOT COMPLETED|Overall Study||0
10552750|NCT01545336|11707093|FG000|STARTED|Overall Study||12
10552751|NCT01545336|11707094|FG001|STARTED|Overall Study||6
10552752|NCT01545336|11707093|FG000|COMPLETED|Overall Study||12
10552753|NCT01545336|11707094|FG001|COMPLETED|Overall Study||6
10552754|NCT01545336|11707093|FG000|NOT COMPLETED|Overall Study||0
10552755|NCT01545336|11707094|FG001|NOT COMPLETED|Overall Study||0
10552756|NCT01545375|11707104|FG000|STARTED|Overall Study||900
10552757|NCT01545375|11707105|FG001|STARTED|Overall Study||903
10552758|NCT01545375|11707104|FG000|COMPLETED|Overall Study||803
10552759|NCT01545375|11707105|FG001|COMPLETED|Overall Study||813
10552760|NCT01545375|11707104|FG000|NOT COMPLETED|Overall Study||97
10552761|NCT01545375|11707105|FG001|NOT COMPLETED|Overall Study||90
10552762|NCT01545388|11707114|FG000|STARTED|Overall Study||138
10552763|NCT01545388|11707115|FG001|STARTED|Overall Study||133
10552764|NCT01545388|11707116|FG002|STARTED|Overall Study||66
10552765|NCT01545388|11707114|FG000|COMPLETED|Overall Study||130
10552766|NCT01545388|11707115|FG001|COMPLETED|Overall Study||122
10552767|NCT01545388|11707116|FG002|COMPLETED|Overall Study||58
10552768|NCT01545388|11707114|FG000|NOT COMPLETED|Overall Study||8
10552769|NCT01545388|11707115|FG001|NOT COMPLETED|Overall Study||11
10552770|NCT01545388|11707116|FG002|NOT COMPLETED|Overall Study||8
10552771|NCT01545583|11707133|FG000|STARTED|Overall Study||12
10552772|NCT01545583|11707134|FG001|STARTED|Overall Study||2
10790083|NCT03533036|11950561|FG001|NOT COMPLETED|Overall Study||0
10790084|NCT03533114|11950569|FG000|STARTED|Overall||88
10790085|NCT03533114|11950570|FG001|STARTED|Overall||66
10790086|NCT03533114|11950569|FG000|COMPLETED|Overall||57
10790087|NCT03533114|11950570|FG001|COMPLETED|Overall||38
10790088|NCT03533114|11950569|FG000|NOT COMPLETED|Overall||31
10552773|NCT01545583|11707135|FG002|STARTED|Overall Study||6
10552774|NCT01545583|11707136|FG003|STARTED|Overall Study||6
10552775|NCT01545583|11707137|FG004|STARTED|Overall Study||6
10552776|NCT01545583|11707138|FG005|STARTED|Overall Study||6
10552777|NCT01545583|11707139|FG006|STARTED|Overall Study||6
10552778|NCT01545583|11707140|FG007|STARTED|Overall Study||6
10552779|NCT01545583|11707141|FG008|STARTED|Overall Study||6
10552780|NCT01545583|11707133|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12
10552781|NCT01545583|11707134|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2
10552782|NCT01545583|11707135|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
10552783|NCT01545583|11707136|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
10552784|NCT01545583|11707137|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
10552785|NCT01545583|11707138|FG005|Received at Least 1 Dose of Study Drug|Overall Study||6
10552786|NCT01545583|11707139|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
10552787|NCT01545583|11707140|FG007|Received at Least 1 Dose of Study Drug|Overall Study||6
10552788|NCT01545583|11707141|FG008|Received at Least 1 Dose of Study Drug|Overall Study||6
10552789|NCT01545583|11707133|FG000|COMPLETED|Overall Study||12
10552790|NCT01545583|11707134|FG001|COMPLETED|Overall Study||2
10552791|NCT01545583|11707135|FG002|COMPLETED|Overall Study||6
10790089|NCT03533114|11950570|FG001|NOT COMPLETED|Overall||28
10790090|NCT03533114|11950569|FG000|STARTED|Open Label Titration and Optimization||88
10790091|NCT03533114|11950570|FG001|STARTED|Open Label Titration and Optimization||66
10552792|NCT01545583|11707136|FG003|COMPLETED|Overall Study||6
10552793|NCT01545583|11707137|FG004|COMPLETED|Overall Study||6
10552794|NCT01545583|11707138|FG005|COMPLETED|Overall Study||6
10552795|NCT01545583|11707139|FG006|COMPLETED|Overall Study||6
10552796|NCT01545583|11707140|FG007|COMPLETED|Overall Study||6
10552797|NCT01545583|11707141|FG008|COMPLETED|Overall Study||6
10552798|NCT01545583|11707133|FG000|NOT COMPLETED|Overall Study||0
10552799|NCT01545583|11707134|FG001|NOT COMPLETED|Overall Study||0
10552800|NCT01545583|11707135|FG002|NOT COMPLETED|Overall Study||0
10552801|NCT01545583|11707136|FG003|NOT COMPLETED|Overall Study||0
10552802|NCT01545583|11707137|FG004|NOT COMPLETED|Overall Study||0
10552803|NCT01545583|11707138|FG005|NOT COMPLETED|Overall Study||0
10552804|NCT01545583|11707139|FG006|NOT COMPLETED|Overall Study||0
10552805|NCT01545583|11707140|FG007|NOT COMPLETED|Overall Study||0
10552806|NCT01545583|11707141|FG008|NOT COMPLETED|Overall Study||0
10552807|NCT01545700|11707174|FG000|STARTED|Overall Study||34
10552808|NCT01545700|11707175|FG001|STARTED|Overall Study||33
10552809|NCT01545700|11707176|FG002|STARTED|Overall Study||33
10552810|NCT01545700|11707177|FG003|STARTED|Overall Study||34
10552811|NCT01545700|11707178|FG004|STARTED|Overall Study||33
10552812|NCT01545700|11707179|FG005|STARTED|Overall Study||33
10552813|NCT01545700|11707174|FG000|COMPLETED|Overall Study||33
10552814|NCT01545700|11707175|FG001|COMPLETED|Overall Study||32
10552815|NCT01545700|11707176|FG002|COMPLETED|Overall Study||31
10552816|NCT01545700|11707177|FG003|COMPLETED|Overall Study||34
10552817|NCT01545700|11707178|FG004|COMPLETED|Overall Study||32
10552818|NCT01545700|11707179|FG005|COMPLETED|Overall Study||33
10552819|NCT01545700|11707174|FG000|NOT COMPLETED|Overall Study||1
10552820|NCT01545700|11707175|FG001|NOT COMPLETED|Overall Study||1
10790092|NCT03533114|11950569|FG000|COMPLETED|Open Label Titration and Optimization||72
10790093|NCT03533114|11950570|FG001|COMPLETED|Open Label Titration and Optimization||53
10790094|NCT03533114|11950569|FG000|NOT COMPLETED|Open Label Titration and Optimization||16
10552821|NCT01545700|11707176|FG002|NOT COMPLETED|Overall Study||2
10552822|NCT01545700|11707177|FG003|NOT COMPLETED|Overall Study||0
10552823|NCT01545700|11707178|FG004|NOT COMPLETED|Overall Study||1
10552824|NCT01545700|11707179|FG005|NOT COMPLETED|Overall Study||0
10552825|NCT01545765|11707213|FG000|STARTED|Overall Study||31
10552826|NCT01545765|11707213|FG000|COMPLETED|Overall Study||31
10552827|NCT01545765|11707213|FG000|NOT COMPLETED|Overall Study||0
10552828|NCT01545817|11707220|FG000|STARTED|Pazopanib||74
10552829|NCT01545817|11707221|FG001|STARTED|Pazopanib||0
10552830|NCT01545817|11707220|FG000|COMPLETED|Pazopanib||0
10552831|NCT01545817|11707221|FG001|COMPLETED|Pazopanib||0
10552832|NCT01545817|11707220|FG000|NOT COMPLETED|Pazopanib||74
10552833|NCT01545817|11707221|FG001|NOT COMPLETED|Pazopanib||0
10552834|NCT01545817|11707220|FG000|STARTED|Everolimus||0
10552835|NCT01545817|11707221|FG001|STARTED|Everolimus||38
10552836|NCT01545817|11707220|FG000|COMPLETED|Everolimus||0
10552837|NCT01545817|11707221|FG001|COMPLETED|Everolimus||0
10552838|NCT01545817|11707220|FG000|NOT COMPLETED|Everolimus||0
10552839|NCT01545817|11707221|FG001|NOT COMPLETED|Everolimus||38
10552840|NCT01545843|11707232|FG000|STARTED|Overall Study||19
10552841|NCT01545843|11707233|FG001|STARTED|Overall Study||24
10552842|NCT01545843|11707234|FG002|STARTED|Overall Study||25
10552843|NCT01545843|11707232|FG000|COMPLETED|Overall Study||16
10552844|NCT01545843|11707233|FG001|COMPLETED|Overall Study||17
10552845|NCT01545843|11707234|FG002|COMPLETED|Overall Study||21
10552846|NCT01545843|11707232|FG000|NOT COMPLETED|Overall Study||3
10552847|NCT01545843|11707233|FG001|NOT COMPLETED|Overall Study||7
10552848|NCT01545843|11707234|FG002|NOT COMPLETED|Overall Study||4
10552849|NCT01545934|11707247|FG000|STARTED|Overall Study||132
10552850|NCT01545934|11707248|FG001|STARTED|Overall Study||132
10552851|NCT01545934|11707247|FG000|COMPLETED|Overall Study||127
10552852|NCT01545934|11707248|FG001|COMPLETED|Overall Study||129
10552853|NCT01545934|11707247|FG000|NOT COMPLETED|Overall Study||5
10552854|NCT01545934|11707248|FG001|NOT COMPLETED|Overall Study||3
10552855|NCT01546038|11707261|FG000|STARTED|Overall Study||17
10552856|NCT01546038|11707262|FG001|STARTED|Overall Study||6
10552857|NCT01546038|11707263|FG002|STARTED|Overall Study||4
10552858|NCT01546038|11707264|FG003|STARTED|Overall Study||3
10552859|NCT01546038|11707265|FG004|STARTED|Overall Study||16
10552860|NCT01546038|11707266|FG005|STARTED|Overall Study||6
10552861|NCT01546038|11707267|FG006|STARTED|Overall Study||71
10552862|NCT01546038|11707268|FG007|STARTED|Overall Study||88
10552863|NCT01546038|11707269|FG008|STARTED|Overall Study||44
10552864|NCT01546038|11707261|FG000|Received Treatment|Overall Study||17
10552865|NCT01546038|11707262|FG001|Received Treatment|Overall Study||6
10552866|NCT01546038|11707263|FG002|Received Treatment|Overall Study||4
10552867|NCT01546038|11707264|FG003|Received Treatment|Overall Study||3
10552868|NCT01546038|11707265|FG004|Received Treatment|Overall Study||16
10552869|NCT01546038|11707266|FG005|Received Treatment|Overall Study||6
10552870|NCT01546038|11707267|FG006|Received Treatment|Overall Study||69
10552871|NCT01546038|11707268|FG007|Received Treatment|Overall Study||84
10552872|NCT01546038|11707269|FG008|Received Treatment|Overall Study||41
10552873|NCT01546038|11707261|FG000|COMPLETED|Overall Study||1
10552874|NCT01546038|11707262|FG001|COMPLETED|Overall Study||0
10552875|NCT01546038|11707263|FG002|COMPLETED|Overall Study||0
10552876|NCT01546038|11707264|FG003|COMPLETED|Overall Study||0
10552877|NCT01546038|11707265|FG004|COMPLETED|Overall Study||6
10552878|NCT01546038|11707266|FG005|COMPLETED|Overall Study||2
10552879|NCT01546038|11707267|FG006|COMPLETED|Overall Study||18
10552880|NCT01546038|11707268|FG007|COMPLETED|Overall Study||4
10552881|NCT01546038|11707269|FG008|COMPLETED|Overall Study||1
10552882|NCT01546038|11707261|FG000|NOT COMPLETED|Overall Study||16
10552883|NCT01546038|11707262|FG001|NOT COMPLETED|Overall Study||6
10552884|NCT01546038|11707263|FG002|NOT COMPLETED|Overall Study||4
10552885|NCT01546038|11707264|FG003|NOT COMPLETED|Overall Study||3
10552886|NCT01546038|11707265|FG004|NOT COMPLETED|Overall Study||10
10552887|NCT01546038|11707266|FG005|NOT COMPLETED|Overall Study||4
10552888|NCT01546038|11707267|FG006|NOT COMPLETED|Overall Study||53
10552889|NCT01546038|11707268|FG007|NOT COMPLETED|Overall Study||84
10552890|NCT01546038|11707269|FG008|NOT COMPLETED|Overall Study||43
10552891|NCT01546142|11707321|FG000|STARTED|Overall Study||258
10552892|NCT01546142|11707322|FG001|STARTED|Overall Study||258
10552893|NCT01546142|11707321|FG000|Received Treatment|Overall Study||257
10552894|NCT01546142|11707322|FG001|Received Treatment|Overall Study||257
10552895|NCT01546142|11707321|FG000|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|214
10552896|NCT01546142|11707322|FG001|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|224
10552897|NCT01546142|11707321|FG000|NOT COMPLETED|Overall Study||44
10552898|NCT01546142|11707322|FG001|NOT COMPLETED|Overall Study||34
10552899|NCT01546155|11707328|FG000|STARTED|Overall Study||11
10552900|NCT01546155|11707328|FG000|COMPLETED|Overall Study||8
10552901|NCT01546155|11707328|FG000|NOT COMPLETED|Overall Study||3
10552902|NCT01546168|11707334|FG000|STARTED|Overall Study||55
10552903|NCT01546168|11707335|FG001|STARTED|Overall Study||33
10552904|NCT01546168|11707334|FG000|COMPLETED|Overall Study||51
10552905|NCT01546168|11707335|FG001|COMPLETED|Overall Study||33
10552906|NCT01546168|11707334|FG000|NOT COMPLETED|Overall Study||4
10552907|NCT01546168|11707335|FG001|NOT COMPLETED|Overall Study||0
10552908|NCT01546194|11707343|FG000|STARTED|Overall Study||100
10552909|NCT01546194|11707344|FG001|STARTED|Overall Study||100
10552910|NCT01546194|11707343|FG000|COMPLETED|Overall Study||64
10552911|NCT01546194|11707344|FG001|COMPLETED|Overall Study||65
10552912|NCT01546194|11707343|FG000|NOT COMPLETED|Overall Study||36
10552913|NCT01546194|11707344|FG001|NOT COMPLETED|Overall Study||35
10552914|NCT01546285|11707350|FG000|STARTED|Overall Study||66
10552915|NCT01546285|11707350|FG000|COMPLETED|Overall Study||66
10552916|NCT01546285|11707350|FG000|NOT COMPLETED|Overall Study||0
10552917|NCT01546402|11707358|FG000|STARTED|Overall Study||10
10552918|NCT01546402|11707359|FG001|STARTED|Overall Study||10
10552919|NCT01546402|11707358|FG000|COMPLETED|Overall Study||10
10552920|NCT01546402|11707359|FG001|COMPLETED|Overall Study||10
10552921|NCT01546402|11707358|FG000|NOT COMPLETED|Overall Study||0
10552922|NCT01546402|11707359|FG001|NOT COMPLETED|Overall Study||0
10552923|NCT01546454|11707365|FG000|STARTED|Natural Menstrual Cycle||4
10552924|NCT01546454|11707365|FG000|COMPLETED|Natural Menstrual Cycle||4
10552925|NCT01546454|11707365|FG000|NOT COMPLETED|Natural Menstrual Cycle||0
10552926|NCT01546454|11707365|FG000|STARTED|Oral Contraceptive Cycle||4
10552927|NCT01546454|11707365|FG000|COMPLETED|Oral Contraceptive Cycle||4
10552928|NCT01546454|11707365|FG000|NOT COMPLETED|Oral Contraceptive Cycle||0
10552929|NCT01546454|11707365|FG000|STARTED|Eligard Treatment||4
10552930|NCT01546454|11707365|FG000|COMPLETED|Eligard Treatment||4
10552931|NCT01546454|11707365|FG000|NOT COMPLETED|Eligard Treatment||0
10552932|NCT01546454|11707365|FG000|STARTED|Estrogen/Progesterone Replacement Cycle||4
10552933|NCT01546454|11707365|FG000|COMPLETED|Estrogen/Progesterone Replacement Cycle||4
10552934|NCT01546454|11707365|FG000|NOT COMPLETED|Estrogen/Progesterone Replacement Cycle||0
10552935|NCT01546519|11707375|FG000|STARTED|Overall Study||9
10552936|NCT01546519|11707376|FG001|STARTED|Overall Study||8
10552937|NCT01546519|11707377|FG002|STARTED|Overall Study||8
10552938|NCT01546519|11707378|FG003|STARTED|Overall Study||6
10552939|NCT01546519|11707375|FG000|Safety-Evaluable Participants|Overall Study||9
10552940|NCT01546519|11707376|FG001|Safety-Evaluable Participants|Overall Study||8
10552941|NCT01546519|11707377|FG002|Safety-Evaluable Participants|Overall Study||8
10552942|NCT01546519|11707378|FG003|Safety-Evaluable Participants|Overall Study||6
10552943|NCT01546519|11707375|FG000|COMPLETED|Overall Study||0
10552944|NCT01546519|11707376|FG001|COMPLETED|Overall Study||0
10552945|NCT01546519|11707377|FG002|COMPLETED|Overall Study||0
10552946|NCT01546519|11707378|FG003|COMPLETED|Overall Study||0
10552947|NCT01546519|11707375|FG000|NOT COMPLETED|Overall Study||9
10552948|NCT01546519|11707376|FG001|NOT COMPLETED|Overall Study||8
10552949|NCT01546519|11707377|FG002|NOT COMPLETED|Overall Study||8
10552950|NCT01546519|11707378|FG003|NOT COMPLETED|Overall Study||6
10552951|NCT01546623|11707394|FG000|STARTED|Overall Study||82
10552952|NCT01546623|11707395|FG001|STARTED|Overall Study||80
10552953|NCT01546623|11707394|FG000|Received Study Drug|Overall Study||81
10552954|NCT01546623|11707395|FG001|Received Study Drug|Overall Study||79
10552955|NCT01546623|11707394|FG000|COMPLETED|Overall Study||76
10552956|NCT01546623|11707395|FG001|COMPLETED|Overall Study||74
10552957|NCT01546623|11707394|FG000|NOT COMPLETED|Overall Study||6
10552958|NCT01546623|11707395|FG001|NOT COMPLETED|Overall Study||6
10552959|NCT01546636|11707403|FG000|STARTED|Overall Study||36
10552960|NCT01546636|11707404|FG001|STARTED|Overall Study||34
10552961|NCT01546636|11707403|FG000|COMPLETED|Overall Study||36
10552962|NCT01546636|11707404|FG001|COMPLETED|Overall Study||34
10552963|NCT01546636|11707403|FG000|NOT COMPLETED|Overall Study||0
10552964|NCT01546636|11707404|FG001|NOT COMPLETED|Overall Study||0
10552965|NCT01546649|11707412|FG000|STARTED|Overall Study||83
10552966|NCT01546649|11707413|FG001|STARTED|Overall Study||84
10552967|NCT01546649|11707412|FG000|COMPLETED|Overall Study||75
10552968|NCT01546649|11707413|FG001|COMPLETED|Overall Study||75
10552969|NCT01546649|11707412|FG000|NOT COMPLETED|Overall Study||8
10552970|NCT01546649|11707413|FG001|NOT COMPLETED|Overall Study||9
10552971|NCT01546675|11707421|FG000|STARTED|Overall Study||1
10552972|NCT01546675|11707422|FG001|STARTED|Overall Study||1
10552973|NCT01546675|11707421|FG000|COMPLETED|Overall Study||1
10552974|NCT01546675|11707422|FG001|COMPLETED|Overall Study||1
10552975|NCT01546675|11707421|FG000|NOT COMPLETED|Overall Study||0
10552976|NCT01546675|11707422|FG001|NOT COMPLETED|Overall Study||0
10552977|NCT01546688|11707430|FG000|STARTED|Overall Study||18
10552978|NCT01546688|11707431|FG001|STARTED|Overall Study||33
10552979|NCT01546688|11707430|FG000|COMPLETED|Overall Study||15
10552980|NCT01546688|11707431|FG001|COMPLETED|Overall Study||28
10552981|NCT01546688|11707430|FG000|NOT COMPLETED|Overall Study||3
10552982|NCT01546688|11707431|FG001|NOT COMPLETED|Overall Study||5
10552983|NCT01546857|11707439|FG000|STARTED|Overall Study||14
10552984|NCT01546857|11707440|FG001|STARTED|Overall Study||20
10552985|NCT01546857|11707439|FG000|COMPLETED|Overall Study||12
10552986|NCT01546857|11707440|FG001|COMPLETED|Overall Study||17
10552987|NCT01546857|11707439|FG000|NOT COMPLETED|Overall Study||2
10552988|NCT01546857|11707440|FG001|NOT COMPLETED|Overall Study||3
10552989|NCT01546922|11707447|FG000|STARTED|First Period of 10 Weeks||30
10552990|NCT01546922|11707448|FG001|STARTED|First Period of 10 Weeks||30
10552991|NCT01546922|11707447|FG000|COMPLETED|First Period of 10 Weeks||25
10552992|NCT01546922|11707448|FG001|COMPLETED|First Period of 10 Weeks||28
10552993|NCT01546922|11707447|FG000|NOT COMPLETED|First Period of 10 Weeks||5
10552994|NCT01546922|11707448|FG001|NOT COMPLETED|First Period of 10 Weeks||2
10552995|NCT01546922|11707447|FG000|STARTED|Second Period of 10 Weeks||25
10552996|NCT01546922|11707448|FG001|STARTED|Second Period of 10 Weeks||28
10552997|NCT01546922|11707447|FG000|COMPLETED|Second Period of 10 Weeks||22
10552998|NCT01546922|11707448|FG001|COMPLETED|Second Period of 10 Weeks||25
10552999|NCT01546922|11707447|FG000|NOT COMPLETED|Second Period of 10 Weeks||3
10553000|NCT01546922|11707448|FG001|NOT COMPLETED|Second Period of 10 Weeks||3
10553001|NCT01547000|11707456|FG000|STARTED|Overall Study||18
10553002|NCT01547000|11707457|FG001|STARTED|Overall Study||16
10553003|NCT01547000|11707456|FG000|COMPLETED|Overall Study||18
10553004|NCT01547000|11707457|FG001|COMPLETED|Overall Study||16
10553005|NCT01547000|11707456|FG000|NOT COMPLETED|Overall Study||0
10553006|NCT01547000|11707457|FG001|NOT COMPLETED|Overall Study||0
10553007|NCT01547130|11707465|FG000|STARTED|Overall Study||74
10553008|NCT01547130|11707466|FG001|STARTED|Overall Study||73
10553009|NCT01547130|11707465|FG000|COMPLETED|Overall Study||65
10553010|NCT01547130|11707466|FG001|COMPLETED|Overall Study||68
10553011|NCT01547130|11707465|FG000|NOT COMPLETED|Overall Study||9
10553012|NCT01547130|11707466|FG001|NOT COMPLETED|Overall Study||5
10553013|NCT01547247|11707482|FG000|STARTED|Overall Study||104
10553014|NCT01547247|11707483|FG001|STARTED|Overall Study||104
10553015|NCT01547247|11707482|FG000|COMPLETED|Overall Study||98
10553016|NCT01547247|11707483|FG001|COMPLETED|Overall Study||98
10553017|NCT01547247|11707482|FG000|NOT COMPLETED|Overall Study||6
10553018|NCT01547247|11707483|FG001|NOT COMPLETED|Overall Study||6
10553019|NCT01547286|11707489|FG000|STARTED|Overall Study||7
10553020|NCT01547286|11707489|FG000|COMPLETED|Overall Study||5
10553021|NCT01547286|11707489|FG000|NOT COMPLETED|Overall Study||2
10553022|NCT01547299|11707496|FG000|STARTED|Overall Study||25
10553023|NCT01547299|11707497|FG001|STARTED|Overall Study||27
10553024|NCT01547299|11707496|FG000|COMPLETED|Overall Study||23
10553025|NCT01547299|11707497|FG001|COMPLETED|Overall Study||25
10553026|NCT01547299|11707496|FG000|NOT COMPLETED|Overall Study||2
10553027|NCT01547299|11707497|FG001|NOT COMPLETED|Overall Study||2
10553028|NCT01547390|11707505|FG000|STARTED|Overall Study||27
10553029|NCT01547390|11707506|FG001|STARTED|Overall Study||26
10553030|NCT01547390|11707505|FG000|COMPLETED|Overall Study||14
10553031|NCT01547390|11707506|FG001|COMPLETED|Overall Study||16
10553032|NCT01547390|11707505|FG000|NOT COMPLETED|Overall Study||13
10553033|NCT01547390|11707506|FG001|NOT COMPLETED|Overall Study||10
10553034|NCT01547598|11707514|FG000|STARTED|Overall Study||67
10553035|NCT01547598|11707515|FG001|STARTED|Overall Study||68
10553036|NCT01547598|11707514|FG000|COMPLETED|Overall Study||61
10553037|NCT01547598|11707515|FG001|COMPLETED|Overall Study||63
10553038|NCT01547598|11707514|FG000|NOT COMPLETED|Overall Study||6
10553039|NCT01547598|11707515|FG001|NOT COMPLETED|Overall Study||5
10553040|NCT01547715|11707525|FG000|STARTED|Overall Study||60
10553041|NCT01547715|11707526|FG001|STARTED|Overall Study||60
10553042|NCT01547715|11707527|FG002|STARTED|Overall Study||60
10553043|NCT01547715|11707525|FG000|COMPLETED|Overall Study||60
10553044|NCT01547715|11707526|FG001|COMPLETED|Overall Study||60
10553045|NCT01547715|11707527|FG002|COMPLETED|Overall Study||60
10553046|NCT01547715|11707525|FG000|NOT COMPLETED|Overall Study||0
10553047|NCT01547715|11707526|FG001|NOT COMPLETED|Overall Study||0
10553048|NCT01547715|11707527|FG002|NOT COMPLETED|Overall Study||0
10553049|NCT01547780|11707540|FG000|STARTED|Baseline PET Scan||12
10553050|NCT01547780|11707541|FG001|STARTED|Baseline PET Scan||0
10553051|NCT01547780|11707542|FG002|STARTED|Baseline PET Scan||19
10553052|NCT01547780|11707543|FG003|STARTED|Baseline PET Scan||19
10553053|NCT01547780|11707540|FG000|COMPLETED|Baseline PET Scan||9
10553054|NCT01547780|11707541|FG001|COMPLETED|Baseline PET Scan||0
10553055|NCT01547780|11707542|FG002|COMPLETED|Baseline PET Scan||17
10553056|NCT01547780|11707543|FG003|COMPLETED|Baseline PET Scan||19
10553057|NCT01547780|11707540|FG000|NOT COMPLETED|Baseline PET Scan||3
10553058|NCT01547780|11707541|FG001|NOT COMPLETED|Baseline PET Scan||0
10553059|NCT01547780|11707542|FG002|NOT COMPLETED|Baseline PET Scan||2
10553060|NCT01547780|11707543|FG003|NOT COMPLETED|Baseline PET Scan||0
10553061|NCT01547780|11707540|FG000|STARTED|Repeat PET Scan||0
10553062|NCT01547780|11707541|FG001|STARTED|Repeat PET Scan||4
10553063|NCT01547780|11707542|FG002|STARTED|Repeat PET Scan||0
10553064|NCT01547780|11707543|FG003|STARTED|Repeat PET Scan||0
10553065|NCT01547780|11707540|FG000|COMPLETED|Repeat PET Scan||0
10553066|NCT01547780|11707541|FG001|COMPLETED|Repeat PET Scan||4
10553067|NCT01547780|11707542|FG002|COMPLETED|Repeat PET Scan||0
10553068|NCT01547780|11707543|FG003|COMPLETED|Repeat PET Scan||0
10553069|NCT01547780|11707540|FG000|NOT COMPLETED|Repeat PET Scan||0
10553070|NCT01547780|11707541|FG001|NOT COMPLETED|Repeat PET Scan||0
10553071|NCT01547780|11707542|FG002|NOT COMPLETED|Repeat PET Scan||0
10553072|NCT01547780|11707543|FG003|NOT COMPLETED|Repeat PET Scan||0
10553073|NCT01547806|11707553|FG000|STARTED|Overall Study||49
10553074|NCT01547806|11707553|FG000|COMPLETED|Overall Study||49
10553075|NCT01547806|11707553|FG000|NOT COMPLETED|Overall Study||0
10553076|NCT01548040|11707560|FG000|STARTED|Overall Study||56
10553077|NCT01548040|11707561|FG001|STARTED|Overall Study||55
10553078|NCT01548040|11707560|FG000|COMPLETED|Overall Study||43
10553079|NCT01548040|11707561|FG001|COMPLETED|Overall Study||45
10553080|NCT01548040|11707560|FG000|NOT COMPLETED|Overall Study||13
10553081|NCT01548040|11707561|FG001|NOT COMPLETED|Overall Study||10
10553082|NCT01548287|11707571|FG000|STARTED|Screening||19
10553083|NCT01548287|11707572|FG001|STARTED|Screening||22
10553084|NCT01548287|11707573|FG002|STARTED|Screening||20
10553085|NCT01548287|11707574|FG003|STARTED|Screening||20
10553086|NCT01548287|11707575|FG004|STARTED|Screening||83
10553087|NCT01548287|11707571|FG000|COMPLETED|Screening||19
10553088|NCT01548287|11707572|FG001|COMPLETED|Screening||22
10553089|NCT01548287|11707573|FG002|COMPLETED|Screening||20
10553090|NCT01548287|11707574|FG003|COMPLETED|Screening||20
10553091|NCT01548287|11707575|FG004|COMPLETED|Screening||0
10553092|NCT01548287|11707571|FG000|NOT COMPLETED|Screening||0
10553093|NCT01548287|11707572|FG001|NOT COMPLETED|Screening||0
10553094|NCT01548287|11707573|FG002|NOT COMPLETED|Screening||0
10553095|NCT01548287|11707574|FG003|NOT COMPLETED|Screening||0
10553096|NCT01548287|11707575|FG004|NOT COMPLETED|Screening||83
10553097|NCT01548287|11707571|FG000|STARTED|Randomized Period||19
10553098|NCT01548287|11707572|FG001|STARTED|Randomized Period||22
10553099|NCT01548287|11707573|FG002|STARTED|Randomized Period||20
10553100|NCT01548287|11707574|FG003|STARTED|Randomized Period||20
10553101|NCT01548287|11707575|FG004|STARTED|Randomized Period||0
10553102|NCT01548287|11707571|FG000|COMPLETED|Randomized Period||19
10553103|NCT01548287|11707572|FG001|COMPLETED|Randomized Period||20
10553104|NCT01548287|11707573|FG002|COMPLETED|Randomized Period||13
10553105|NCT01548287|11707574|FG003|COMPLETED|Randomized Period||20
10553106|NCT01548287|11707575|FG004|COMPLETED|Randomized Period||0
10553107|NCT01548287|11707571|FG000|NOT COMPLETED|Randomized Period||0
10553108|NCT01548287|11707572|FG001|NOT COMPLETED|Randomized Period||2
10553109|NCT01548287|11707573|FG002|NOT COMPLETED|Randomized Period||7
10553110|NCT01548287|11707574|FG003|NOT COMPLETED|Randomized Period||0
10553111|NCT01548287|11707575|FG004|NOT COMPLETED|Randomized Period||0
10553112|NCT01548339|11707587|FG000|STARTED|Overall Study||44
10553113|NCT01548339|11707588|FG001|STARTED|Overall Study||42
10553114|NCT01548339|11707587|FG000|COMPLETED|Overall Study||38
10553115|NCT01548339|11707588|FG001|COMPLETED|Overall Study||41
10553116|NCT01548339|11707587|FG000|NOT COMPLETED|Overall Study||6
10553117|NCT01548339|11707588|FG001|NOT COMPLETED|Overall Study||1
10553118|NCT01548404|11707596|FG000|STARTED|Overall Study||54
10553119|NCT01548404|11707597|FG001|STARTED|Overall Study||55
10553120|NCT01548404|11707596|FG000|COMPLETED|Overall Study||24
10553121|NCT01548404|11707597|FG001|COMPLETED|Overall Study||41
10553122|NCT01548404|11707596|FG000|NOT COMPLETED|Overall Study||30
10553123|NCT01548404|11707597|FG001|NOT COMPLETED|Overall Study||14
10553124|NCT01548417|11707606|FG000|STARTED|Overall Study||28
10553125|NCT01548417|11707607|FG001|STARTED|Overall Study||28
10553126|NCT01548417|11707606|FG000|COMPLETED|Overall Study||28
10553127|NCT01548417|11707607|FG001|COMPLETED|Overall Study||26
10553128|NCT01548417|11707606|FG000|NOT COMPLETED|Overall Study||0
10553129|NCT01548417|11707607|FG001|NOT COMPLETED|Overall Study||2
10553130|NCT01548573|11707613|FG000|STARTED|Overall Study||19
10553131|NCT01548573|11707613|FG000|COMPLETED|Overall Study||14
10553132|NCT01548573|11707613|FG000|NOT COMPLETED|Overall Study||5
10553133|NCT01548599|11707620|FG000|STARTED|Overall Study||72
10553134|NCT01548599|11707621|FG001|STARTED|Overall Study||68
10553135|NCT01548599|11707620|FG000|COMPLETED|Overall Study||66
10553136|NCT01548599|11707621|FG001|COMPLETED|Overall Study||66
10553137|NCT01548599|11707620|FG000|NOT COMPLETED|Overall Study||6
10553138|NCT01548599|11707621|FG001|NOT COMPLETED|Overall Study||2
10553139|NCT01548638|11707630|FG000|STARTED|Overall Study||13
10553140|NCT01548638|11707630|FG000|COMPLETED|Overall Study||9
10553141|NCT01548638|11707630|FG000|NOT COMPLETED|Overall Study||4
10553142|NCT01548690|11707639|FG000|STARTED|Overall Study||9
10553143|NCT01548690|11707640|FG001|STARTED|Overall Study||10
10553144|NCT01548690|11707641|FG002|STARTED|Overall Study||13
10553145|NCT01548690|11707642|FG003|STARTED|Overall Study||15
10553146|NCT01548690|11707639|FG000|Evaluable (72 Hours on Infusion)|Overall Study||6
10553147|NCT01548690|11707640|FG001|Evaluable (72 Hours on Infusion)|Overall Study||6
10553148|NCT01548690|11707641|FG002|Evaluable (72 Hours on Infusion)|Overall Study||12
10553149|NCT01548690|11707642|FG003|Evaluable (72 Hours on Infusion)|Overall Study||12
10553150|NCT01548690|11707639|FG000|COMPLETED|Overall Study||9
10553151|NCT01548690|11707640|FG001|COMPLETED|Overall Study||7
10553152|NCT01548690|11707641|FG002|COMPLETED|Overall Study||8
10553153|NCT01548690|11707642|FG003|COMPLETED|Overall Study||10
10553154|NCT01548690|11707639|FG000|NOT COMPLETED|Overall Study||0
10553155|NCT01548690|11707640|FG001|NOT COMPLETED|Overall Study||3
10553156|NCT01548690|11707641|FG002|NOT COMPLETED|Overall Study||5
10553157|NCT01548690|11707642|FG003|NOT COMPLETED|Overall Study||5
10553158|NCT01548742|11707657|FG000|STARTED|Overall Study||58
10553159|NCT01548742|11707658|FG001|STARTED|Overall Study||58
10553160|NCT01548742|11707657|FG000|COMPLETED|Overall Study||45
10553161|NCT01548742|11707658|FG001|COMPLETED|Overall Study||54
10553162|NCT01548742|11707657|FG000|NOT COMPLETED|Overall Study||13
10553163|NCT01548742|11707658|FG001|NOT COMPLETED|Overall Study||4
10553164|NCT01548768|11707670|FG000|STARTED|Overall Study||8
10553165|NCT01548768|11707671|FG001|STARTED|Overall Study||4
10553166|NCT01548768|11707672|FG002|STARTED|Overall Study||16
10553167|NCT01548768|11707673|FG003|STARTED|Overall Study||121
10553168|NCT01548768|11707670|FG000|COMPLETED|Overall Study||7
10553169|NCT01548768|11707671|FG001|COMPLETED|Overall Study||2
10553170|NCT01548768|11707672|FG002|COMPLETED|Overall Study||15
10553171|NCT01548768|11707673|FG003|COMPLETED|Overall Study||117
10553172|NCT01548768|11707670|FG000|NOT COMPLETED|Overall Study||1
10553173|NCT01548768|11707671|FG001|NOT COMPLETED|Overall Study||2
10553174|NCT01548768|11707672|FG002|NOT COMPLETED|Overall Study||1
10553175|NCT01548768|11707673|FG003|NOT COMPLETED|Overall Study||4
10553176|NCT01548833|11707685|FG000|STARTED|Overall Study||39
10553177|NCT01548833|11707685|FG000|COMPLETED|Overall Study||39
10553178|NCT01548833|11707685|FG000|NOT COMPLETED|Overall Study||0
10553179|NCT01548885|11707693|FG000|STARTED|Overall Study||146
10553180|NCT01548885|11707693|FG000|COMPLETED|Overall Study||146
10553181|NCT01548885|11707693|FG000|NOT COMPLETED|Overall Study||0
10553182|NCT01549002|11707699|FG000|STARTED|Overall Study||10
10553183|NCT01549002|11707700|FG001|STARTED|Overall Study||10
10553184|NCT01549002|11707699|FG000|COMPLETED|Overall Study||10
10553185|NCT01549002|11707700|FG001|COMPLETED|Overall Study||6
10553186|NCT01549002|11707699|FG000|NOT COMPLETED|Overall Study||0
10553187|NCT01549002|11707700|FG001|NOT COMPLETED|Overall Study||4
10553188|NCT01549041|11707708|FG000|STARTED|Overall Study||12
10553189|NCT01549041|11707709|FG001|STARTED|Overall Study||18
10455093|NCT01000337|11603096|FG000|COMPLETED|Overall Study||30
10455094|NCT01000337|11603097|FG001|COMPLETED|Overall Study||30
10455095|NCT01000337|11603096|FG000|NOT COMPLETED|Overall Study||4
10455096|NCT01000337|11603097|FG001|NOT COMPLETED|Overall Study||3
10455097|NCT01000376|11603105|FG000|STARTED|Cycle 1 Day 1||6
10455098|NCT01000376|11603106|FG001|STARTED|Cycle 1 Day 1||6
10455099|NCT01000376|11603105|FG000|COMPLETED|Cycle 1 Day 1||4
10455100|NCT01000376|11603106|FG001|COMPLETED|Cycle 1 Day 1||6
10455101|NCT01000376|11603105|FG000|NOT COMPLETED|Cycle 1 Day 1||2
10553190|NCT01549041|11707708|FG000|COMPLETED|Overall Study||10
10553191|NCT01549041|11707709|FG001|COMPLETED|Overall Study||10
10553192|NCT01549041|11707708|FG000|NOT COMPLETED|Overall Study||2
10553193|NCT01549041|11707709|FG001|NOT COMPLETED|Overall Study||8
10553194|NCT01549223|11707717|FG000|STARTED|Overall Study||30
10553195|NCT01549223|11707718|FG001|STARTED|Overall Study||30
10553196|NCT01549223|11707717|FG000|COMPLETED|Overall Study||30
10553197|NCT01549223|11707718|FG001|COMPLETED|Overall Study||30
10553198|NCT01549223|11707717|FG000|NOT COMPLETED|Overall Study||0
10553199|NCT01549223|11707718|FG001|NOT COMPLETED|Overall Study||0
10553200|NCT01549275|11707726|FG000|STARTED|Overall Study||76
10553201|NCT01549275|11707727|FG001|STARTED|Overall Study||29
10553202|NCT01549275|11707726|FG000|COMPLETED|Overall Study||75
10553203|NCT01549275|11707727|FG001|COMPLETED|Overall Study||29
10553204|NCT01549275|11707726|FG000|NOT COMPLETED|Overall Study||1
10553205|NCT01549275|11707727|FG001|NOT COMPLETED|Overall Study||0
10553206|NCT01549314|11707740|FG000|STARTED|Overall Study|1 subject signed the consent form but dropped out prior to any study procedures or data collection.|27
10553207|NCT01549314|11707741|FG001|STARTED|Overall Study||26
10553208|NCT01549314|11707742|FG002|STARTED|Overall Study||26
10553209|NCT01549314|11707740|FG000|COMPLETED|Overall Study||23
10553210|NCT01549314|11707741|FG001|COMPLETED|Overall Study||21
10553211|NCT01549314|11707742|FG002|COMPLETED|Overall Study||24
10553212|NCT01549314|11707740|FG000|NOT COMPLETED|Overall Study||4
10553213|NCT01549314|11707741|FG001|NOT COMPLETED|Overall Study||5
10553214|NCT01549314|11707742|FG002|NOT COMPLETED|Overall Study||2
10553215|NCT01549340|11707750|FG000|STARTED|Overall Study|Advised to receive AIT|8790
10553216|NCT01549340|11707750|FG000|Started AIT|Overall Study||3182
10553217|NCT01549340|11707750|FG000|COMPLETED|Overall Study|Completed 5 years of AIT|385
10553218|NCT01549340|11707750|FG000|NOT COMPLETED|Overall Study||8405
10553219|NCT01549392|11707761|FG000|STARTED|Overall Study||3
10553220|NCT01549392|11707762|FG001|STARTED|Overall Study||0
10553221|NCT01549392|11707761|FG000|COMPLETED|Overall Study||2
10553222|NCT01549392|11707762|FG001|COMPLETED|Overall Study||0
10553223|NCT01549392|11707761|FG000|NOT COMPLETED|Overall Study||1
10553224|NCT01549392|11707762|FG001|NOT COMPLETED|Overall Study||0
10553225|NCT01549405|11707770|FG000|STARTED|Overall Study||20
10553226|NCT01549405|11707771|FG001|STARTED|Overall Study||20
10553227|NCT01549405|11707770|FG000|COMPLETED|Overall Study||20
10553228|NCT01549405|11707771|FG001|COMPLETED|Overall Study||20
10553229|NCT01549405|11707770|FG000|NOT COMPLETED|Overall Study||0
10553230|NCT01549405|11707771|FG001|NOT COMPLETED|Overall Study||0
10553231|NCT01549587|11707781|FG000|STARTED|Overall Study||373
10553232|NCT01549587|11707782|FG001|STARTED|Overall Study||373
10553233|NCT01549587|11707781|FG000|COMPLETED|Overall Study||334
10553234|NCT01549587|11707782|FG001|COMPLETED|Overall Study||336
10553235|NCT01549587|11707781|FG000|NOT COMPLETED|Overall Study||39
10553236|NCT01549587|11707782|FG001|NOT COMPLETED|Overall Study||37
10553237|NCT01549613|11707790|FG000|STARTED|Overall Study||50
10553238|NCT01549613|11707791|FG001|STARTED|Overall Study||50
10553239|NCT01549613|11707790|FG000|COMPLETED|Overall Study||39
10553240|NCT01549613|11707791|FG001|COMPLETED|Overall Study||39
10553241|NCT01549613|11707790|FG000|NOT COMPLETED|Overall Study||11
10553242|NCT01549613|11707791|FG001|NOT COMPLETED|Overall Study||11
10553243|NCT01549652|11707800|FG000|STARTED|Overall Study||27
10553244|NCT01549652|11707801|FG001|STARTED|Overall Study||30
10553245|NCT01549652|11707802|FG002|STARTED|Overall Study||40
10553246|NCT01549652|11707803|FG003|STARTED|Overall Study||36
10553247|NCT01549652|11707800|FG000|COMPLETED|Overall Study||15
10553248|NCT01549652|11707801|FG001|COMPLETED|Overall Study||18
10553249|NCT01549652|11707802|FG002|COMPLETED|Overall Study||23
10553250|NCT01549652|11707803|FG003|COMPLETED|Overall Study||25
10553251|NCT01549652|11707800|FG000|NOT COMPLETED|Overall Study||12
10553252|NCT01549652|11707801|FG001|NOT COMPLETED|Overall Study||12
10553253|NCT01549652|11707802|FG002|NOT COMPLETED|Overall Study||17
10553254|NCT01549652|11707803|FG003|NOT COMPLETED|Overall Study||11
10553255|NCT01549860|11707811|FG000|STARTED|Overall Study||40
10553256|NCT01549860|11707812|FG001|STARTED|Overall Study||41
10553257|NCT01549860|11707811|FG000|COMPLETED|Overall Study||38
10553258|NCT01549860|11707812|FG001|COMPLETED|Overall Study||40
10455102|NCT01000376|11603106|FG001|NOT COMPLETED|Cycle 1 Day 1||0
10455103|NCT01000376|11603105|FG000|STARTED|Cycle 1 Day 15||4
10553259|NCT01549860|11707811|FG000|NOT COMPLETED|Overall Study||2
10553260|NCT01549860|11707812|FG001|NOT COMPLETED|Overall Study||1
10553261|NCT01549873|11707820|FG000|STARTED|Overall Study||15
10553262|NCT01549873|11707821|FG001|STARTED|Overall Study||15
10553263|NCT01549873|11707820|FG000|COMPLETED|Overall Study||15
10553264|NCT01549873|11707821|FG001|COMPLETED|Overall Study||14
10553265|NCT01549873|11707820|FG000|NOT COMPLETED|Overall Study||0
10553266|NCT01549873|11707821|FG001|NOT COMPLETED|Overall Study||1
10553267|NCT01549886|11707829|FG000|STARTED|Overall Study||2
10553268|NCT01549886|11707830|FG001|STARTED|Overall Study||3
10553269|NCT01549886|11707829|FG000|COMPLETED|Overall Study||0
10553270|NCT01549886|11707830|FG001|COMPLETED|Overall Study||0
10553271|NCT01549886|11707829|FG000|NOT COMPLETED|Overall Study||2
10553272|NCT01549886|11707830|FG001|NOT COMPLETED|Overall Study||3
10553273|NCT01549925|11707840|FG000|STARTED|Overall Study||25
10553274|NCT01549925|11707841|FG001|STARTED|Overall Study||25
10553275|NCT01549925|11707840|FG000|COMPLETED|Overall Study||25
10553276|NCT01549925|11707841|FG001|COMPLETED|Overall Study||25
10553277|NCT01549925|11707840|FG000|NOT COMPLETED|Overall Study||0
10553278|NCT01549925|11707841|FG001|NOT COMPLETED|Overall Study||0
10553279|NCT01549951|11707847|FG000|STARTED|Overall Study||50
10553280|NCT01549951|11707847|FG000|Primary Reason Off Study Treatment|Overall Study||50
10553281|NCT01549951|11707847|FG000|COMPLETED|Overall Study||0
10553282|NCT01549951|11707847|FG000|NOT COMPLETED|Overall Study||50
10553283|NCT01549964|11707855|FG000|STARTED|24-Week Treatment Period||132
10553284|NCT01549964|11707856|FG001|STARTED|24-Week Treatment Period||260
10553285|NCT01549964|11707857|FG002|STARTED|24-Week Treatment Period||263
10553286|NCT01549964|11707858|FG003|STARTED|24-Week Treatment Period||261
10553287|NCT01549964|11707855|FG000|Safety Analysis Set=Received Treatment|24-Week Treatment Period||132
10553288|NCT01549964|11707856|FG001|Safety Analysis Set=Received Treatment|24-Week Treatment Period||260
10553289|NCT01549964|11707857|FG002|Safety Analysis Set=Received Treatment|24-Week Treatment Period||263
10553290|NCT01549964|11707858|FG003|Safety Analysis Set=Received Treatment|24-Week Treatment Period||260
10553291|NCT01549964|11707855|FG000|COMPLETED|24-Week Treatment Period||71
10553292|NCT01549964|11707856|FG001|COMPLETED|24-Week Treatment Period||149
10553293|NCT01549964|11707857|FG002|COMPLETED|24-Week Treatment Period||147
10553294|NCT01549964|11707858|FG003|COMPLETED|24-Week Treatment Period||140
10553295|NCT01549964|11707855|FG000|NOT COMPLETED|24-Week Treatment Period||61
10553296|NCT01549964|11707856|FG001|NOT COMPLETED|24-Week Treatment Period||111
10553297|NCT01549964|11707857|FG002|NOT COMPLETED|24-Week Treatment Period||116
10553298|NCT01549964|11707858|FG003|NOT COMPLETED|24-Week Treatment Period||121
10553299|NCT01549964|11707855|FG000|STARTED|80-Week Extension Period||66
10553300|NCT01549964|11707856|FG001|STARTED|80-Week Extension Period||138
10553301|NCT01549964|11707857|FG002|STARTED|80-Week Extension Period||140
10553302|NCT01549964|11707858|FG003|STARTED|80-Week Extension Period||137
10553303|NCT01549964|11707855|FG000|COMPLETED|80-Week Extension Period||0
10553304|NCT01549964|11707856|FG001|COMPLETED|80-Week Extension Period||0
10553305|NCT01549964|11707857|FG002|COMPLETED|80-Week Extension Period||0
10553306|NCT01549964|11707858|FG003|COMPLETED|80-Week Extension Period||0
10553307|NCT01549964|11707855|FG000|NOT COMPLETED|80-Week Extension Period||66
10553308|NCT01549964|11707856|FG001|NOT COMPLETED|80-Week Extension Period||138
10553309|NCT01549964|11707857|FG002|NOT COMPLETED|80-Week Extension Period||140
10553310|NCT01549964|11707858|FG003|NOT COMPLETED|80-Week Extension Period||137
10553311|NCT01550224|11707870|FG000|STARTED|Overall Study||3
10553312|NCT01550224|11707871|FG001|STARTED|Overall Study||20
10553313|NCT01550224|11707870|FG000|COMPLETED|Overall Study||3
10553314|NCT01550224|11707871|FG001|COMPLETED|Overall Study||20
10553315|NCT01550224|11707870|FG000|NOT COMPLETED|Overall Study||0
10553316|NCT01550224|11707871|FG001|NOT COMPLETED|Overall Study||0
10553317|NCT01550341|11707879|FG000|STARTED|Overall Study||32
10553318|NCT01550341|11707880|FG001|STARTED|Overall Study||18
10553319|NCT01550341|11707879|FG000|COMPLETED|Overall Study||32
10553320|NCT01550341|11707880|FG001|COMPLETED|Overall Study||18
10553321|NCT01550341|11707879|FG000|NOT COMPLETED|Overall Study||0
10553322|NCT01550341|11707880|FG001|NOT COMPLETED|Overall Study||0
10553323|NCT01550367|11707886|FG000|STARTED|Overall Study||30
10553324|NCT01550367|11707886|FG000|1200 mg/d HCQ|Overall Study||13
10553325|NCT01550367|11707886|FG000|600 mg/d HCQ|Overall Study||17
10553326|NCT01550367|11707886|FG000|COMPLETED|Overall Study||30
10553327|NCT01550367|11707886|FG000|NOT COMPLETED|Overall Study||0
10553328|NCT01550471|11707895|FG000|STARTED|Run-In Period (3 Weeks)||3
10553329|NCT01550471|11707896|FG001|STARTED|Run-In Period (3 Weeks)||4
10553330|NCT01550471|11707897|FG002|STARTED|Run-In Period (3 Weeks)||3
10553331|NCT01550471|11707898|FG003|STARTED|Run-In Period (3 Weeks)||4
10553332|NCT01550471|11707899|FG004|STARTED|Run-In Period (3 Weeks)||4
10553333|NCT01550471|11707900|FG005|STARTED|Run-In Period (3 Weeks)||4
10553334|NCT01550471|11707895|FG000|COMPLETED|Run-In Period (3 Weeks)||3
10553335|NCT01550471|11707896|FG001|COMPLETED|Run-In Period (3 Weeks)||4
10553336|NCT01550471|11707897|FG002|COMPLETED|Run-In Period (3 Weeks)||3
10553337|NCT01550471|11707898|FG003|COMPLETED|Run-In Period (3 Weeks)||4
10553338|NCT01550471|11707899|FG004|COMPLETED|Run-In Period (3 Weeks)||4
10553339|NCT01550471|11707900|FG005|COMPLETED|Run-In Period (3 Weeks)||4
10553340|NCT01550471|11707895|FG000|NOT COMPLETED|Run-In Period (3 Weeks)||0
10553341|NCT01550471|11707896|FG001|NOT COMPLETED|Run-In Period (3 Weeks)||0
10553342|NCT01550471|11707897|FG002|NOT COMPLETED|Run-In Period (3 Weeks)||0
10553343|NCT01550471|11707898|FG003|NOT COMPLETED|Run-In Period (3 Weeks)||0
10553344|NCT01550471|11707899|FG004|NOT COMPLETED|Run-In Period (3 Weeks)||0
10553345|NCT01550471|11707900|FG005|NOT COMPLETED|Run-In Period (3 Weeks)||0
10553346|NCT01550471|11707895|FG000|STARTED|First Treatment Period (3 Weeks)||3
10553347|NCT01550471|11707896|FG001|STARTED|First Treatment Period (3 Weeks)||4
10553348|NCT01550471|11707897|FG002|STARTED|First Treatment Period (3 Weeks)||3
10553349|NCT01550471|11707898|FG003|STARTED|First Treatment Period (3 Weeks)||4
10553350|NCT01550471|11707899|FG004|STARTED|First Treatment Period (3 Weeks)||4
10553351|NCT01550471|11707900|FG005|STARTED|First Treatment Period (3 Weeks)||4
10553352|NCT01550471|11707895|FG000|COMPLETED|First Treatment Period (3 Weeks)||3
10553353|NCT01550471|11707896|FG001|COMPLETED|First Treatment Period (3 Weeks)||4
10553354|NCT01550471|11707897|FG002|COMPLETED|First Treatment Period (3 Weeks)||3
10553355|NCT01550471|11707898|FG003|COMPLETED|First Treatment Period (3 Weeks)||4
10553356|NCT01550471|11707899|FG004|COMPLETED|First Treatment Period (3 Weeks)||4
10553357|NCT01550471|11707900|FG005|COMPLETED|First Treatment Period (3 Weeks)||4
10553358|NCT01550471|11707895|FG000|NOT COMPLETED|First Treatment Period (3 Weeks)||0
10553359|NCT01550471|11707896|FG001|NOT COMPLETED|First Treatment Period (3 Weeks)||0
10553360|NCT01550471|11707897|FG002|NOT COMPLETED|First Treatment Period (3 Weeks)||0
10553361|NCT01550471|11707898|FG003|NOT COMPLETED|First Treatment Period (3 Weeks)||0
10553362|NCT01550471|11707899|FG004|NOT COMPLETED|First Treatment Period (3 Weeks)||0
10553363|NCT01550471|11707900|FG005|NOT COMPLETED|First Treatment Period (3 Weeks)||0
10553364|NCT01550471|11707895|FG000|STARTED|First Wash Out Period (3 Weeks)||3
10553365|NCT01550471|11707896|FG001|STARTED|First Wash Out Period (3 Weeks)||4
10553366|NCT01550471|11707897|FG002|STARTED|First Wash Out Period (3 Weeks)||3
10553367|NCT01550471|11707898|FG003|STARTED|First Wash Out Period (3 Weeks)||4
10553368|NCT01550471|11707899|FG004|STARTED|First Wash Out Period (3 Weeks)||4
10553369|NCT01550471|11707900|FG005|STARTED|First Wash Out Period (3 Weeks)||4
10553370|NCT01550471|11707895|FG000|COMPLETED|First Wash Out Period (3 Weeks)||3
10553371|NCT01550471|11707896|FG001|COMPLETED|First Wash Out Period (3 Weeks)||4
10553372|NCT01550471|11707897|FG002|COMPLETED|First Wash Out Period (3 Weeks)||3
10553373|NCT01550471|11707898|FG003|COMPLETED|First Wash Out Period (3 Weeks)||4
10553374|NCT01550471|11707899|FG004|COMPLETED|First Wash Out Period (3 Weeks)||4
10553375|NCT01550471|11707900|FG005|COMPLETED|First Wash Out Period (3 Weeks)||4
10553376|NCT01550471|11707895|FG000|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
10553377|NCT01550471|11707896|FG001|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
10553378|NCT01550471|11707897|FG002|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
10553379|NCT01550471|11707898|FG003|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
10553380|NCT01550471|11707899|FG004|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
10553381|NCT01550471|11707900|FG005|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
10553382|NCT01550471|11707895|FG000|STARTED|Second Treatment Period (3 Weeks)||3
10553383|NCT01550471|11707896|FG001|STARTED|Second Treatment Period (3 Weeks)||4
10553384|NCT01550471|11707897|FG002|STARTED|Second Treatment Period (3 Weeks)||3
10553385|NCT01550471|11707898|FG003|STARTED|Second Treatment Period (3 Weeks)||4
10553386|NCT01550471|11707899|FG004|STARTED|Second Treatment Period (3 Weeks)||4
10553387|NCT01550471|11707900|FG005|STARTED|Second Treatment Period (3 Weeks)||4
10553388|NCT01550471|11707895|FG000|COMPLETED|Second Treatment Period (3 Weeks)||3
10553389|NCT01550471|11707896|FG001|COMPLETED|Second Treatment Period (3 Weeks)||4
10553390|NCT01550471|11707897|FG002|COMPLETED|Second Treatment Period (3 Weeks)||3
10553391|NCT01550471|11707898|FG003|COMPLETED|Second Treatment Period (3 Weeks)||4
10553392|NCT01550471|11707899|FG004|COMPLETED|Second Treatment Period (3 Weeks)||4
10553393|NCT01550471|11707900|FG005|COMPLETED|Second Treatment Period (3 Weeks)||4
10553394|NCT01550471|11707895|FG000|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
10553395|NCT01550471|11707896|FG001|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
10553396|NCT01550471|11707897|FG002|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
10553397|NCT01550471|11707898|FG003|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
10553398|NCT01550471|11707899|FG004|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
10553399|NCT01550471|11707900|FG005|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
10553400|NCT01550471|11707895|FG000|STARTED|Second Wash Out Period (3 Weeks)||3
10553401|NCT01550471|11707896|FG001|STARTED|Second Wash Out Period (3 Weeks)||4
10553402|NCT01550471|11707897|FG002|STARTED|Second Wash Out Period (3 Weeks)||3
10553403|NCT01550471|11707898|FG003|STARTED|Second Wash Out Period (3 Weeks)||4
10553404|NCT01550471|11707899|FG004|STARTED|Second Wash Out Period (3 Weeks)||4
10553405|NCT01550471|11707900|FG005|STARTED|Second Wash Out Period (3 Weeks)||4
10553406|NCT01550471|11707895|FG000|COMPLETED|Second Wash Out Period (3 Weeks)||3
10553407|NCT01550471|11707896|FG001|COMPLETED|Second Wash Out Period (3 Weeks)||4
10553408|NCT01550471|11707897|FG002|COMPLETED|Second Wash Out Period (3 Weeks)||3
10553409|NCT01550471|11707898|FG003|COMPLETED|Second Wash Out Period (3 Weeks)||4
10553410|NCT01550471|11707899|FG004|COMPLETED|Second Wash Out Period (3 Weeks)||4
10553411|NCT01550471|11707900|FG005|COMPLETED|Second Wash Out Period (3 Weeks)||3
10553412|NCT01550471|11707895|FG000|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
10553413|NCT01550471|11707896|FG001|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
10553414|NCT01550471|11707897|FG002|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
10553415|NCT01550471|11707898|FG003|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
10553416|NCT01550471|11707899|FG004|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
10553417|NCT01550471|11707900|FG005|NOT COMPLETED|Second Wash Out Period (3 Weeks)||1
10553418|NCT01550471|11707895|FG000|STARTED|Third Treatment Period (3 Weeks)||3
10553419|NCT01550471|11707896|FG001|STARTED|Third Treatment Period (3 Weeks)||4
10553420|NCT01550471|11707897|FG002|STARTED|Third Treatment Period (3 Weeks)||3
10553421|NCT01550471|11707898|FG003|STARTED|Third Treatment Period (3 Weeks)||4
10553422|NCT01550471|11707899|FG004|STARTED|Third Treatment Period (3 Weeks)||4
10553423|NCT01550471|11707900|FG005|STARTED|Third Treatment Period (3 Weeks)||3
10553424|NCT01550471|11707895|FG000|COMPLETED|Third Treatment Period (3 Weeks)||3
10553425|NCT01550471|11707896|FG001|COMPLETED|Third Treatment Period (3 Weeks)||4
10553426|NCT01550471|11707897|FG002|COMPLETED|Third Treatment Period (3 Weeks)||3
10553427|NCT01550471|11707898|FG003|COMPLETED|Third Treatment Period (3 Weeks)||4
10553428|NCT01550471|11707899|FG004|COMPLETED|Third Treatment Period (3 Weeks)||4
10553429|NCT01550471|11707900|FG005|COMPLETED|Third Treatment Period (3 Weeks)||3
10553430|NCT01550471|11707895|FG000|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
10553431|NCT01550471|11707896|FG001|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
10553432|NCT01550471|11707897|FG002|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
10553433|NCT01550471|11707898|FG003|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
10553434|NCT01550471|11707899|FG004|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
10553435|NCT01550471|11707900|FG005|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
10553436|NCT01550471|11707895|FG000|STARTED|Third Wash Out Period (3 Weeks)||3
10553437|NCT01550471|11707896|FG001|STARTED|Third Wash Out Period (3 Weeks)||4
10553438|NCT01550471|11707897|FG002|STARTED|Third Wash Out Period (3 Weeks)||3
10553439|NCT01550471|11707898|FG003|STARTED|Third Wash Out Period (3 Weeks)||4
10553440|NCT01550471|11707899|FG004|STARTED|Third Wash Out Period (3 Weeks)||4
10553441|NCT01550471|11707900|FG005|STARTED|Third Wash Out Period (3 Weeks)||3
10553442|NCT01550471|11707895|FG000|COMPLETED|Third Wash Out Period (3 Weeks)||3
10553443|NCT01550471|11707896|FG001|COMPLETED|Third Wash Out Period (3 Weeks)||4
10790095|NCT03533114|11950570|FG001|NOT COMPLETED|Open Label Titration and Optimization||13
10790096|NCT03533114|11950569|FG000|STARTED|Stable Dose||71
10790097|NCT03533114|11950570|FG001|STARTED|Stable Dose||52
10790098|NCT03533114|11950569|FG000|COMPLETED|Stable Dose||69
10790099|NCT03533114|11950570|FG001|COMPLETED|Stable Dose||50
10790100|NCT03533114|11950569|FG000|NOT COMPLETED|Stable Dose||2
10790101|NCT03533114|11950570|FG001|NOT COMPLETED|Stable Dose||2
10790102|NCT03533114|11950569|FG000|STARTED|Double Blind Randomized-Withdrawal||69
10790103|NCT03533114|11950570|FG001|STARTED|Double Blind Randomized-Withdrawal||47
10790104|NCT03533114|11950569|FG000|JZP-258|Double Blind Randomized-Withdrawal||57
10790105|NCT03533114|11950570|FG001|JZP-258|Double Blind Randomized-Withdrawal||0
10790106|NCT03533114|11950569|FG000|Placebo|Double Blind Randomized-Withdrawal||0
10790107|NCT03533114|11950570|FG001|Placebo|Double Blind Randomized-Withdrawal||59
10790108|NCT03533114|11950569|FG000|COMPLETED|Double Blind Randomized-Withdrawal||67
10790109|NCT03533114|11950570|FG001|COMPLETED|Double Blind Randomized-Withdrawal||46
10790110|NCT03533114|11950569|FG000|NOT COMPLETED|Double Blind Randomized-Withdrawal||2
10790111|NCT03533114|11950570|FG001|NOT COMPLETED|Double Blind Randomized-Withdrawal||1
10790112|NCT03533114|11950569|FG000|STARTED|Open-Label Safety Extension||65
10790113|NCT03533114|11950570|FG001|STARTED|Open-Label Safety Extension||41
10790114|NCT03533114|11950569|FG000|COMPLETED|Open-Label Safety Extension||57
10790115|NCT03533114|11950570|FG001|COMPLETED|Open-Label Safety Extension||38
10790116|NCT03533114|11950569|FG000|NOT COMPLETED|Open-Label Safety Extension||8
10790117|NCT03533114|11950570|FG001|NOT COMPLETED|Open-Label Safety Extension||3
10790118|NCT03533244|11950581|FG000|STARTED|Overall Study||20
10790119|NCT03533244|11950582|FG001|STARTED|Overall Study||22
10790120|NCT03533244|11950583|FG002|STARTED|Overall Study||22
10790121|NCT03533244|11950581|FG000|COMPLETED|Overall Study||18
10790122|NCT03533244|11950582|FG001|COMPLETED|Overall Study||21
10790123|NCT03533244|11950583|FG002|COMPLETED|Overall Study||22
10790124|NCT03533244|11950581|FG000|NOT COMPLETED|Overall Study||2
10790125|NCT03533244|11950582|FG001|NOT COMPLETED|Overall Study||1
10790126|NCT03533244|11950583|FG002|NOT COMPLETED|Overall Study||0
10790127|NCT03533374|11950593|FG000|STARTED|Overall Study||54
10790128|NCT03533374|11950594|FG001|STARTED|Overall Study||46
10790129|NCT03533374|11950593|FG000|COMPLETED|Overall Study||54
10790130|NCT03533374|11950594|FG001|COMPLETED|Overall Study||46
10790131|NCT03533374|11950593|FG000|NOT COMPLETED|Overall Study||0
10790132|NCT03533374|11950594|FG001|NOT COMPLETED|Overall Study||0
10790133|NCT03533608|11950600|FG000|STARTED|Overall Study||39
10790134|NCT03533608|11950600|FG000|COMPLETED|Overall Study||34
10790135|NCT03533608|11950600|FG000|NOT COMPLETED|Overall Study||5
10790136|NCT03533829|11950608|FG000|STARTED|Overall Study||10
10790137|NCT03533829|11950609|FG001|STARTED|Overall Study||10
10790138|NCT03533829|11950610|FG002|STARTED|Overall Study||10
10790139|NCT03533829|11950608|FG000|COMPLETED|Overall Study||10
10790140|NCT03533829|11950609|FG001|COMPLETED|Overall Study||10
10790141|NCT03533829|11950610|FG002|COMPLETED|Overall Study||10
10790142|NCT03533829|11950608|FG000|NOT COMPLETED|Overall Study||0
10790143|NCT03533829|11950609|FG001|NOT COMPLETED|Overall Study||0
10790144|NCT03533829|11950610|FG002|NOT COMPLETED|Overall Study||0
10790145|NCT03534427|11950620|FG000|STARTED|Overall Study||20
10790146|NCT03534427|11950621|FG001|STARTED|Overall Study||20
10790147|NCT03534427|11950620|FG000|COMPLETED|Overall Study||20
10790148|NCT03534427|11950621|FG001|COMPLETED|Overall Study||20
10790149|NCT03534427|11950620|FG000|NOT COMPLETED|Overall Study||0
10790150|NCT03534427|11950621|FG001|NOT COMPLETED|Overall Study||0
10790151|NCT03534986|11950630|FG000|STARTED|Overall Study||10
10790152|NCT03534986|11950631|FG001|STARTED|Overall Study||10
10790153|NCT03534986|11950632|FG002|STARTED|Overall Study||12
10790154|NCT03534986|11950630|FG000|COMPLETED|Overall Study||10
10790155|NCT03534986|11950631|FG001|COMPLETED|Overall Study||10
10790156|NCT03534986|11950632|FG002|COMPLETED|Overall Study||10
10790157|NCT03534986|11950630|FG000|NOT COMPLETED|Overall Study||0
10790158|NCT03534986|11950631|FG001|NOT COMPLETED|Overall Study||0
10790159|NCT03534986|11950632|FG002|NOT COMPLETED|Overall Study||2
10790160|NCT03535194|11950645|FG000|STARTED|Induction Period||454
10790161|NCT03535194|11950646|FG001|STARTED|Induction Period||451
10790162|NCT03535194|11950647|FG002|STARTED|Induction Period||112
10790163|NCT03535194|11950648|FG003|STARTED|Induction Period||448
10790164|NCT03535194|11950649|FG004|STARTED|Induction Period|A plaque psoriasis participant was misrandomized by the site.|19
10790165|NCT03535194|11950645|FG000|Received at Least One Dose of Study Drug|Induction Period||454
10790166|NCT03535194|11950646|FG001|Received at Least One Dose of Study Drug|Induction Period||450
10553444|NCT01550471|11707897|FG002|COMPLETED|Third Wash Out Period (3 Weeks)||3
10553445|NCT01550471|11707898|FG003|COMPLETED|Third Wash Out Period (3 Weeks)||4
10553446|NCT01550471|11707899|FG004|COMPLETED|Third Wash Out Period (3 Weeks)||4
10553447|NCT01550471|11707900|FG005|COMPLETED|Third Wash Out Period (3 Weeks)||3
10553448|NCT01550471|11707895|FG000|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
10553449|NCT01550471|11707896|FG001|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
10553450|NCT01550471|11707897|FG002|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
10553451|NCT01550471|11707898|FG003|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
10553452|NCT01550471|11707899|FG004|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
10553453|NCT01550471|11707900|FG005|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
10553454|NCT01550549|11707909|FG000|STARTED|Overall Study||151
10553455|NCT01550549|11707909|FG000|COMPLETED|Overall Study||151
10553456|NCT01550549|11707909|FG000|NOT COMPLETED|Overall Study||0
10553457|NCT01550705|11707919|FG000|STARTED|Overall Study||11
10553458|NCT01550705|11707919|FG000|COMPLETED|Overall Study||10
10553459|NCT01550705|11707919|FG000|NOT COMPLETED|Overall Study||1
10553460|NCT01550731|11707925|FG000|STARTED|Overall Study||205
10553461|NCT01550731|11707926|FG001|STARTED|Overall Study||209
10553462|NCT01550731|11707925|FG000|COMPLETED|Overall Study||205
10553463|NCT01550731|11707926|FG001|COMPLETED|Overall Study||209
10553464|NCT01550731|11707925|FG000|NOT COMPLETED|Overall Study||0
10553465|NCT01550731|11707926|FG001|NOT COMPLETED|Overall Study||0
10553466|NCT01550744|11707932|FG000|STARTED|Open-Label||478
10553467|NCT01550744|11707933|FG001|STARTED|Open-Label||0
10553468|NCT01550744|11707934|FG002|STARTED|Open-Label||0
10553469|NCT01550744|11707932|FG000|COMPLETED|Open-Label||378
10553470|NCT01550744|11707933|FG001|COMPLETED|Open-Label||0
10553471|NCT01550744|11707934|FG002|COMPLETED|Open-Label||0
10553472|NCT01550744|11707932|FG000|NOT COMPLETED|Open-Label||100
10553473|NCT01550744|11707933|FG001|NOT COMPLETED|Open-Label||0
10553474|NCT01550744|11707934|FG002|NOT COMPLETED|Open-Label||0
10553475|NCT01550744|11707932|FG000|STARTED|Double-Blind||0
10553476|NCT01550744|11707933|FG001|STARTED|Double-Blind||76
10553477|NCT01550744|11707934|FG002|STARTED|Double-Blind||302
10553478|NCT01550744|11707932|FG000|COMPLETED|Double-Blind||0
10553479|NCT01550744|11707933|FG001|COMPLETED|Double-Blind||59
10553480|NCT01550744|11707934|FG002|COMPLETED|Double-Blind||235
10553481|NCT01550744|11707932|FG000|NOT COMPLETED|Double-Blind||0
10553482|NCT01550744|11707933|FG001|NOT COMPLETED|Double-Blind||17
10553483|NCT01550744|11707934|FG002|NOT COMPLETED|Double-Blind||67
10553484|NCT01550757|11707945|FG000|STARTED|Overall Study||56
10553485|NCT01550757|11707946|FG001|STARTED|Overall Study||52
10553486|NCT01550757|11707947|FG002|STARTED|Overall Study||130
10553487|NCT01550757|11707948|FG003|STARTED|Overall Study||144
10553488|NCT01550757|11707945|FG000|COMPLETED|Overall Study||33
10553489|NCT01550757|11707946|FG001|COMPLETED|Overall Study||38
10553490|NCT01550757|11707947|FG002|COMPLETED|Overall Study||85
10790167|NCT03535194|11950647|FG002|Received at Least One Dose of Study Drug|Induction Period||112
10790168|NCT03535194|11950648|FG003|Received at Least One Dose of Study Drug|Induction Period||448
10790169|NCT03535194|11950649|FG004|Received at Least One Dose of Study Drug|Induction Period||19
10790170|NCT03535194|11950645|FG000|COMPLETED|Induction Period||443
10790171|NCT03535194|11950646|FG001|COMPLETED|Induction Period||434
10790172|NCT03535194|11950647|FG002|COMPLETED|Induction Period||104
10790173|NCT03535194|11950648|FG003|COMPLETED|Induction Period||437
10790174|NCT03535194|11950649|FG004|COMPLETED|Induction Period||19
10790175|NCT03535194|11950645|FG000|NOT COMPLETED|Induction Period||11
10790176|NCT03535194|11950646|FG001|NOT COMPLETED|Induction Period||17
10790177|NCT03535194|11950647|FG002|NOT COMPLETED|Induction Period||8
10790178|NCT03535194|11950648|FG003|NOT COMPLETED|Induction Period||11
10790179|NCT03535194|11950649|FG004|NOT COMPLETED|Induction Period||0
10790180|NCT03535194|11950645|FG000|STARTED|Maintenance Period||443
10790181|NCT03535194|11950646|FG001|STARTED|Maintenance Period||434
10790182|NCT03535194|11950647|FG002|STARTED|Maintenance Period||104
10790183|NCT03535194|11950648|FG003|STARTED|Maintenance Period||437
10790184|NCT03535194|11950649|FG004|STARTED|Maintenance Period||19
10790185|NCT03535194|11950645|FG000|COMPLETED|Maintenance Period||421
10790186|NCT03535194|11950646|FG001|COMPLETED|Maintenance Period||418
10790187|NCT03535194|11950647|FG002|COMPLETED|Maintenance Period||96
10790188|NCT03535194|11950648|FG003|COMPLETED|Maintenance Period||400
10790189|NCT03535194|11950649|FG004|COMPLETED|Maintenance Period||13
10790190|NCT03535194|11950645|FG000|NOT COMPLETED|Maintenance Period||22
10790191|NCT03535194|11950646|FG001|NOT COMPLETED|Maintenance Period||16
10790192|NCT03535194|11950647|FG002|NOT COMPLETED|Maintenance Period||8
10790193|NCT03535194|11950648|FG003|NOT COMPLETED|Maintenance Period||37
10790194|NCT03535194|11950649|FG004|NOT COMPLETED|Maintenance Period||6
10790195|NCT03535194|11950645|FG000|STARTED|Post-Treatment Followup Period|Participants who discontinued/completed Induction/Maintenance had option to enter post-treatment|38
10553491|NCT01550757|11707948|FG003|COMPLETED|Overall Study||90
10553492|NCT01550757|11707945|FG000|NOT COMPLETED|Overall Study||23
10553493|NCT01550757|11707946|FG001|NOT COMPLETED|Overall Study||14
10553494|NCT01550757|11707947|FG002|NOT COMPLETED|Overall Study||45
10810709|NCT03792672|11972456|FG000|COMPLETED|Treatment Period 2 (1 Day)||4
10553495|NCT01550757|11707948|FG003|NOT COMPLETED|Overall Study||54
10553496|NCT01550809|11707960|FG000|STARTED|Overall Study|Six patients started with the tBolus, the others with the iBolus, according to a crossover design.|6
10553497|NCT01550809|11707961|FG001|STARTED|Overall Study|Six patients started with the iBolus, the others with the tBolus, according to a crossover design.|6
10553498|NCT01550809|11707960|FG000|COMPLETED|Overall Study||6
10790196|NCT03535194|11950646|FG001|STARTED|Post-Treatment Followup Period|Participants who discontinued/completed Induction/Maintenance had option to enter post-treatment|35
10790197|NCT03535194|11950647|FG002|STARTED|Post-Treatment Followup Period|Participants who discontinued/completed Induction/Maintenance had option to enter post-treatment|18
10790198|NCT03535194|11950648|FG003|STARTED|Post-Treatment Followup Period|Participants who discontinued/completed Induction/Maintenance had option to enter post-treatment|47
10790199|NCT03535194|11950649|FG004|STARTED|Post-Treatment Followup Period|Participants who discontinued/completed Induction/Maintenance had option to enter post-treatment|8
10790200|NCT03535194|11950645|FG000|COMPLETED|Post-Treatment Followup Period||27
10790201|NCT03535194|11950646|FG001|COMPLETED|Post-Treatment Followup Period||21
10790202|NCT03535194|11950647|FG002|COMPLETED|Post-Treatment Followup Period||7
10790203|NCT03535194|11950648|FG003|COMPLETED|Post-Treatment Followup Period||23
10790204|NCT03535194|11950649|FG004|COMPLETED|Post-Treatment Followup Period||8
10790205|NCT03535194|11950645|FG000|NOT COMPLETED|Post-Treatment Followup Period||11
10790206|NCT03535194|11950646|FG001|NOT COMPLETED|Post-Treatment Followup Period||14
10790207|NCT03535194|11950647|FG002|NOT COMPLETED|Post-Treatment Followup Period||11
10790208|NCT03535194|11950648|FG003|NOT COMPLETED|Post-Treatment Followup Period||24
10790209|NCT03535194|11950649|FG004|NOT COMPLETED|Post-Treatment Followup Period||0
10790210|NCT03535571|11950673|FG000|STARTED|Overall Study||20
10790211|NCT03535571|11950673|FG000|COMPLETED|Overall Study||19
10790212|NCT03535571|11950673|FG000|NOT COMPLETED|Overall Study||1
10790213|NCT03535649|11950679|FG000|STARTED|Overall Study||105
10790214|NCT03535649|11950679|FG000|COMPLETED|Overall Study||105
10790215|NCT03535649|11950679|FG000|NOT COMPLETED|Overall Study||0
10790216|NCT03535844|11950685|FG000|STARTED|Overall Study||22
10790217|NCT03535844|11950686|FG001|STARTED|Overall Study||19
10790218|NCT03535844|11950685|FG000|COMPLETED|Overall Study||22
10790219|NCT03535844|11950686|FG001|COMPLETED|Overall Study||18
10790220|NCT03535844|11950685|FG000|NOT COMPLETED|Overall Study||0
10790221|NCT03535844|11950686|FG001|NOT COMPLETED|Overall Study||1
10790222|NCT03535974|11950695|FG000|STARTED|First Intervention Weeks 0-6 (V1-V2)||14
10790223|NCT03535974|11950696|FG001|STARTED|First Intervention Weeks 0-6 (V1-V2)||19
10790224|NCT03535974|11950697|FG002|STARTED|First Intervention Weeks 0-6 (V1-V2)||5
10790225|NCT03535974|11950695|FG000|COMPLETED|First Intervention Weeks 0-6 (V1-V2)||12
10790226|NCT03535974|11950696|FG001|COMPLETED|First Intervention Weeks 0-6 (V1-V2)||17
10790227|NCT03535974|11950697|FG002|COMPLETED|First Intervention Weeks 0-6 (V1-V2)||5
10790228|NCT03535974|11950695|FG000|NOT COMPLETED|First Intervention Weeks 0-6 (V1-V2)||2
10790229|NCT03535974|11950696|FG001|NOT COMPLETED|First Intervention Weeks 0-6 (V1-V2)||2
10790230|NCT03535974|11950697|FG002|NOT COMPLETED|First Intervention Weeks 0-6 (V1-V2)||0
10790231|NCT03535974|11950695|FG000|STARTED|Second Intervention Weeks 6-12 (V2-V3)||12
10790232|NCT03535974|11950696|FG001|STARTED|Second Intervention Weeks 6-12 (V2-V3)||17
10790233|NCT03535974|11950697|FG002|STARTED|Second Intervention Weeks 6-12 (V2-V3)||5
10790234|NCT03535974|11950695|FG000|COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||12
10790235|NCT03535974|11950696|FG001|COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||17
10790236|NCT03535974|11950697|FG002|COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||5
10790237|NCT03535974|11950695|FG000|NOT COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||0
10790238|NCT03535974|11950696|FG001|NOT COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||0
10790239|NCT03535974|11950697|FG002|NOT COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||0
10790240|NCT03536663|11950705|FG000|STARTED|Optiflux||23
10790241|NCT03536663|11950705|FG000|COMPLETED|Optiflux||19
10790242|NCT03536663|11950705|FG000|NOT COMPLETED|Optiflux||4
10790243|NCT03536663|11950705|FG000|STARTED|Endexo|One subject completed the Optiflux period but missed Visit 13 and was withdrawn per protocol.|18
10790244|NCT03536663|11950705|FG000|COMPLETED|Endexo||17
10790245|NCT03536663|11950705|FG000|NOT COMPLETED|Endexo||1
10790246|NCT03536702|11950716|FG000|STARTED|Overall Study||40
10790247|NCT03536702|11950717|FG001|STARTED|Overall Study||20
10790248|NCT03536702|11950716|FG000|COMPLETED|Overall Study||26
10790249|NCT03536702|11950717|FG001|COMPLETED|Overall Study||8
10790250|NCT03536702|11950716|FG000|NOT COMPLETED|Overall Study||14
10790251|NCT03536702|11950717|FG001|NOT COMPLETED|Overall Study||12
10790252|NCT03536819|11950723|FG000|STARTED|Overall Study||20
10790253|NCT03536819|11950723|FG000|COMPLETED|Overall Study||15
10790254|NCT03536819|11950723|FG000|NOT COMPLETED|Overall Study||5
10790255|NCT03536923|11950727|FG000|STARTED|Overall Study||23
10790256|NCT03536923|11950727|FG000|COMPLETED|Overall Study||23
10790257|NCT03536923|11950727|FG000|NOT COMPLETED|Overall Study||0
10790258|NCT03536949|11950733|FG000|STARTED|Overall Study||157
10790259|NCT03536949|11950734|FG001|STARTED|Overall Study||77
10790260|NCT03536949|11950733|FG000|COMPLETED|Overall Study||143
10790261|NCT03536949|11950734|FG001|COMPLETED|Overall Study||75
10790262|NCT03536949|11950733|FG000|NOT COMPLETED|Overall Study||14
10790263|NCT03536949|11950734|FG001|NOT COMPLETED|Overall Study||2
10790264|NCT03537092|11950740|FG000|STARTED|Overall Study||64
10790265|NCT03537092|11950740|FG000|COMPLETED|Overall Study||64
10790266|NCT03537092|11950740|FG000|NOT COMPLETED|Overall Study||0
10790267|NCT03537261|11950746|FG000|STARTED|Overall Study||41
10790268|NCT03537261|11950747|FG001|STARTED|Overall Study||39
10790269|NCT03537261|11950746|FG000|Completed Baseline Assessment|Overall Study|One participant did not attend the CPI-Parent training but remained in the study.|35
10790270|NCT03537261|11950747|FG001|Completed Baseline Assessment|Overall Study||28
10790271|NCT03537261|11950746|FG000|COMPLETED|Overall Study|One participant did not attend the CPI-Parent training but remained in the study.|33
10790272|NCT03537261|11950747|FG001|COMPLETED|Overall Study||27
10790273|NCT03537261|11950746|FG000|NOT COMPLETED|Overall Study||8
10790274|NCT03537261|11950747|FG001|NOT COMPLETED|Overall Study||12
10790275|NCT03537274|11950757|FG000|STARTED|Overall Study||315
10553499|NCT01550809|11707961|FG001|COMPLETED|Overall Study||6
10553500|NCT01550809|11707960|FG000|NOT COMPLETED|Overall Study||0
10553501|NCT01550809|11707961|FG001|NOT COMPLETED|Overall Study||0
10553502|NCT01550952|11707967|FG000|STARTED|Overall Study||10
10553503|NCT01550952|11707967|FG000|COMPLETED|Overall Study||10
10553504|NCT01550952|11707967|FG000|NOT COMPLETED|Overall Study||0
10790276|NCT03537274|11950758|FG001|STARTED|Overall Study||298
10790277|NCT03537274|11950759|FG002|STARTED|Overall Study||304
10790278|NCT03537274|11950760|FG003|STARTED|Overall Study||307
10790279|NCT03537274|11950757|FG000|Treated|Overall Study||315
10790280|NCT03537274|11950758|FG001|Treated|Overall Study||297
10790281|NCT03537274|11950759|FG002|Treated|Overall Study||304
10790282|NCT03537274|11950760|FG003|Treated|Overall Study||303
10790283|NCT03537274|11950757|FG000|COMPLETED|Overall Study||255
10790284|NCT03537274|11950758|FG001|COMPLETED|Overall Study||229
10790285|NCT03537274|11950759|FG002|COMPLETED|Overall Study||228
10790286|NCT03537274|11950760|FG003|COMPLETED|Overall Study||231
10790287|NCT03537274|11950757|FG000|NOT COMPLETED|Overall Study||60
10790288|NCT03537274|11950758|FG001|NOT COMPLETED|Overall Study||69
10790289|NCT03537274|11950759|FG002|NOT COMPLETED|Overall Study||76
10790290|NCT03537274|11950760|FG003|NOT COMPLETED|Overall Study||76
10790291|NCT03537404|11950773|FG000|STARTED|First Intervention (A or B or C)||18
10790292|NCT03537404|11950774|FG001|STARTED|First Intervention (A or B or C)||18
10790293|NCT03537404|11950773|FG000|COMPLETED|First Intervention (A or B or C)||18
10790294|NCT03537404|11950774|FG001|COMPLETED|First Intervention (A or B or C)||18
10790295|NCT03537404|11950773|FG000|NOT COMPLETED|First Intervention (A or B or C)||0
10790296|NCT03537404|11950774|FG001|NOT COMPLETED|First Intervention (A or B or C)||0
10790297|NCT03537404|11950773|FG000|STARTED|First Washout Period (8 Days)||18
10790298|NCT03537404|11950774|FG001|STARTED|First Washout Period (8 Days)||18
10790299|NCT03537404|11950773|FG000|COMPLETED|First Washout Period (8 Days)||18
10790300|NCT03537404|11950774|FG001|COMPLETED|First Washout Period (8 Days)||18
10790301|NCT03537404|11950773|FG000|NOT COMPLETED|First Washout Period (8 Days)||0
10790302|NCT03537404|11950774|FG001|NOT COMPLETED|First Washout Period (8 Days)||0
10790303|NCT03537404|11950773|FG000|STARTED|Second Intervention (A or B or C)||18
10790304|NCT03537404|11950774|FG001|STARTED|Second Intervention (A or B or C)||18
10790305|NCT03537404|11950773|FG000|COMPLETED|Second Intervention (A or B or C)||18
10790306|NCT03537404|11950774|FG001|COMPLETED|Second Intervention (A or B or C)||18
10790307|NCT03537404|11950773|FG000|NOT COMPLETED|Second Intervention (A or B or C)||0
10790308|NCT03537404|11950774|FG001|NOT COMPLETED|Second Intervention (A or B or C)||0
10790309|NCT03537404|11950773|FG000|STARTED|Second Washout Period (8 Days)||18
10790310|NCT03537404|11950774|FG001|STARTED|Second Washout Period (8 Days)||18
10790311|NCT03537404|11950773|FG000|COMPLETED|Second Washout Period (8 Days)||18
10790312|NCT03537404|11950774|FG001|COMPLETED|Second Washout Period (8 Days)||18
10790313|NCT03537404|11950773|FG000|NOT COMPLETED|Second Washout Period (8 Days)||0
10790314|NCT03537404|11950774|FG001|NOT COMPLETED|Second Washout Period (8 Days)||0
10790315|NCT03537404|11950773|FG000|STARTED|Third Intervention (A or B or C)||18
10790316|NCT03537404|11950774|FG001|STARTED|Third Intervention (A or B or C)||18
10790317|NCT03537404|11950773|FG000|COMPLETED|Third Intervention (A or B or C)||18
10790318|NCT03537404|11950774|FG001|COMPLETED|Third Intervention (A or B or C)||18
10790319|NCT03537404|11950773|FG000|NOT COMPLETED|Third Intervention (A or B or C)||0
10790320|NCT03537404|11950774|FG001|NOT COMPLETED|Third Intervention (A or B or C)||0
10790321|NCT03537651|11950798|FG000|STARTED|Overall Study||130
10790322|NCT03537651|11950798|FG000|113B/116 FAS|Overall Study||64
10790323|NCT03537651|11950798|FG000|113B/116 LCI FAS|Overall Study||30
10790324|NCT03537651|11950798|FG000|115/116 FAS|Overall Study||66
10790325|NCT03537651|11950798|FG000|115/116 FAS (TEZ/IVA Group)|Overall Study||53
10790326|NCT03537651|11950798|FG000|COMPLETED|Overall Study||69
10790327|NCT03537651|11950798|FG000|NOT COMPLETED|Overall Study||61
10790328|NCT03537664|11950805|FG000|STARTED|Overall Study||20
10790329|NCT03537664|11950806|FG001|STARTED|Overall Study||25
10790330|NCT03537664|11950805|FG000|Metabolic Activity of Bacteria|Overall Study|5 patients were excluded from metabolic activity analysis (lost of RNA)|15
10790331|NCT03537664|11950806|FG001|Metabolic Activity of Bacteria|Overall Study||25
10790332|NCT03537664|11950805|FG000|Bacterial Levels|Overall Study||20
10790333|NCT03537664|11950806|FG001|Bacterial Levels|Overall Study||25
10790334|NCT03537664|11950805|FG000|Bacterial Community Diversity|Overall Study||10
10790335|NCT03537664|11950806|FG001|Bacterial Community Diversity|Overall Study||0
10790336|NCT03537664|11950805|FG000|Endodontic Success|Overall Study||20
10790337|NCT03537664|11950806|FG001|Endodontic Success|Overall Study||10
10790338|NCT03537664|11950805|FG000|COMPLETED|Overall Study||20
10790339|NCT03537664|11950806|FG001|COMPLETED|Overall Study||25
10790340|NCT03537664|11950805|FG000|NOT COMPLETED|Overall Study||0
10790341|NCT03537664|11950806|FG001|NOT COMPLETED|Overall Study||0
10553505|NCT01550965|11707971|FG000|STARTED|Overall Study||463
10553506|NCT01550965|11707971|FG000|COMPLETED|Overall Study||353
10790342|NCT03538431|11950817|FG000|STARTED|Overall Study||13
10790343|NCT03538431|11950818|FG001|STARTED|Overall Study||13
10790344|NCT03538431|11950817|FG000|COMPLETED|Overall Study||12
10790345|NCT03538431|11950818|FG001|COMPLETED|Overall Study||12
10790346|NCT03538431|11950817|FG000|NOT COMPLETED|Overall Study||1
10790347|NCT03538431|11950818|FG001|NOT COMPLETED|Overall Study||1
10790348|NCT03538678|11950828|FG000|STARTED|Overall Study||20
10790349|NCT03538678|11950829|FG001|STARTED|Overall Study||20
10790350|NCT03538678|11950828|FG000|COMPLETED|Overall Study||5
10790351|NCT03538678|11950829|FG001|COMPLETED|Overall Study||9
10790352|NCT03538678|11950828|FG000|NOT COMPLETED|Overall Study||15
10790353|NCT03538678|11950829|FG001|NOT COMPLETED|Overall Study||11
10790354|NCT03538743|11950844|FG000|STARTED|Overall Study||25
10790355|NCT03538743|11950845|FG001|STARTED|Overall Study||9
10790356|NCT03538743|11950846|FG002|STARTED|Overall Study||9
10790357|NCT03538743|11950847|FG003|STARTED|Overall Study||10
10790358|NCT03538743|11950848|FG004|STARTED|Overall Study||9
10790359|NCT03538743|11950849|FG005|STARTED|Overall Study||9
10790360|NCT03538743|11950850|FG006|STARTED|Overall Study||9
10790361|NCT03538743|11950851|FG007|STARTED|Overall Study||8
10790362|NCT03538743|11950852|FG008|STARTED|Overall Study||10
10790363|NCT03538743|11950844|FG000|Received Treatment|Overall Study||25
10790364|NCT03538743|11950845|FG001|Received Treatment|Overall Study||9
10790365|NCT03538743|11950846|FG002|Received Treatment|Overall Study||9
10790366|NCT03538743|11950847|FG003|Received Treatment|Overall Study||10
10790367|NCT03538743|11950848|FG004|Received Treatment|Overall Study||9
10790368|NCT03538743|11950849|FG005|Received Treatment|Overall Study||9
10790369|NCT03538743|11950850|FG006|Received Treatment|Overall Study||9
10790370|NCT03538743|11950851|FG007|Received Treatment|Overall Study||8
10790371|NCT03538743|11950852|FG008|Received Treatment|Overall Study||10
10790372|NCT03538743|11950844|FG000|COMPLETED|Overall Study||25
10790373|NCT03538743|11950845|FG001|COMPLETED|Overall Study||9
10790374|NCT03538743|11950846|FG002|COMPLETED|Overall Study||8
10790375|NCT03538743|11950847|FG003|COMPLETED|Overall Study||8
10790376|NCT03538743|11950848|FG004|COMPLETED|Overall Study||9
10790377|NCT03538743|11950849|FG005|COMPLETED|Overall Study||9
10790378|NCT03538743|11950850|FG006|COMPLETED|Overall Study||9
10790379|NCT03538743|11950851|FG007|COMPLETED|Overall Study||8
10790380|NCT03538743|11950852|FG008|COMPLETED|Overall Study||7
10790381|NCT03538743|11950844|FG000|NOT COMPLETED|Overall Study||0
10790382|NCT03538743|11950845|FG001|NOT COMPLETED|Overall Study||0
10790383|NCT03538743|11950846|FG002|NOT COMPLETED|Overall Study||1
10790384|NCT03538743|11950847|FG003|NOT COMPLETED|Overall Study||2
10790385|NCT03538743|11950848|FG004|NOT COMPLETED|Overall Study||0
10790386|NCT03538743|11950849|FG005|NOT COMPLETED|Overall Study||0
10790387|NCT03538743|11950850|FG006|NOT COMPLETED|Overall Study||0
10790388|NCT03538743|11950851|FG007|NOT COMPLETED|Overall Study||0
10790389|NCT03538743|11950852|FG008|NOT COMPLETED|Overall Study||3
10790390|NCT03538795|11950880|FG000|STARTED|Overall Study||3
10790391|NCT03538795|11950880|FG000|COMPLETED|Overall Study||3
10790392|NCT03538795|11950880|FG000|NOT COMPLETED|Overall Study||0
10790393|NCT03538808|11950888|FG000|STARTED|Overall Study||20
10790394|NCT03538808|11950889|FG001|STARTED|Overall Study||20
10790395|NCT03538808|11950890|FG002|STARTED|Overall Study||20
10790396|NCT03538808|11950891|FG003|STARTED|Overall Study||20
10790397|NCT03538808|11950888|FG000|COMPLETED|Overall Study||18
10790398|NCT03538808|11950889|FG001|COMPLETED|Overall Study||20
10790399|NCT03538808|11950890|FG002|COMPLETED|Overall Study||16
10790400|NCT03538808|11950891|FG003|COMPLETED|Overall Study||18
10790401|NCT03538808|11950888|FG000|NOT COMPLETED|Overall Study||2
10790402|NCT03538808|11950889|FG001|NOT COMPLETED|Overall Study||0
10790403|NCT03538808|11950890|FG002|NOT COMPLETED|Overall Study||4
10790404|NCT03538808|11950891|FG003|NOT COMPLETED|Overall Study||2
10790405|NCT03539211|11950903|FG000|STARTED|Overall Study||16
10790406|NCT03539211|11950904|FG001|STARTED|Overall Study||15
10790407|NCT03539211|11950903|FG000|COMPLETED|Overall Study||16
10790408|NCT03539211|11950904|FG001|COMPLETED|Overall Study||15
10790409|NCT03539211|11950903|FG000|NOT COMPLETED|Overall Study||0
10790410|NCT03539211|11950904|FG001|NOT COMPLETED|Overall Study||0
10790411|NCT03539432|11950912|FG000|STARTED|Overall Study||2
10790412|NCT03539432|11950913|FG001|STARTED|Overall Study||1
10790413|NCT03539432|11950912|FG000|COMPLETED|Overall Study||2
10790414|NCT03539432|11950913|FG001|COMPLETED|Overall Study||0
10790415|NCT03539432|11950912|FG000|NOT COMPLETED|Overall Study||0
10790416|NCT03539432|11950913|FG001|NOT COMPLETED|Overall Study||1
10790417|NCT03539484|11950926|FG000|STARTED|Overall Study||1
10790418|NCT03539484|11950927|FG001|STARTED|Overall Study||1
10790419|NCT03539484|11950928|FG002|STARTED|Overall Study||1
10790420|NCT03539484|11950929|FG003|STARTED|Overall Study||3
10790421|NCT03539484|11950930|FG004|STARTED|Overall Study||13
10790422|NCT03539484|11950931|FG005|STARTED|Overall Study||5
10790423|NCT03539484|11950932|FG006|STARTED|Overall Study||2
10790424|NCT03539484|11950926|FG000|COMPLETED|Overall Study||0
10790425|NCT03539484|11950927|FG001|COMPLETED|Overall Study||0
10790426|NCT03539484|11950928|FG002|COMPLETED|Overall Study||0
10790427|NCT03539484|11950929|FG003|COMPLETED|Overall Study||0
10790428|NCT03539484|11950930|FG004|COMPLETED|Overall Study||0
10790429|NCT03539484|11950931|FG005|COMPLETED|Overall Study||0
10790430|NCT03539484|11950932|FG006|COMPLETED|Overall Study||0
10790431|NCT03539484|11950926|FG000|NOT COMPLETED|Overall Study||1
10790432|NCT03539484|11950927|FG001|NOT COMPLETED|Overall Study||1
10790433|NCT03539484|11950928|FG002|NOT COMPLETED|Overall Study||1
10790434|NCT03539484|11950929|FG003|NOT COMPLETED|Overall Study||3
10790435|NCT03539484|11950930|FG004|NOT COMPLETED|Overall Study||13
10790436|NCT03539484|11950931|FG005|NOT COMPLETED|Overall Study||5
10790437|NCT03539484|11950932|FG006|NOT COMPLETED|Overall Study||2
10790438|NCT03539549|11950953|FG000|STARTED|Overall Study||123
10790439|NCT03539549|11950953|FG000|COMPLETED|Overall Study||106
10790440|NCT03539549|11950953|FG000|NOT COMPLETED|Overall Study||17
10790441|NCT03540030|11950959|FG000|STARTED|Overall Study||48
10790442|NCT03540030|11950960|FG001|STARTED|Overall Study||38
10790443|NCT03540030|11950959|FG000|COMPLETED|Overall Study||30
10790444|NCT03540030|11950960|FG001|COMPLETED|Overall Study||35
10790445|NCT03540030|11950959|FG000|NOT COMPLETED|Overall Study||18
10790446|NCT03540030|11950960|FG001|NOT COMPLETED|Overall Study||3
10790447|NCT03540134|11950966|FG000|STARTED|Overall Study||4
10553507|NCT01550965|11707971|FG000|NOT COMPLETED|Overall Study||110
10553508|NCT01551030|11707976|FG000|STARTED|Overall Study||19
10553509|NCT01551030|11707976|FG000|COMPLETED|Overall Study||19
10553510|NCT01551030|11707976|FG000|NOT COMPLETED|Overall Study||0
10553511|NCT01551056|11707982|FG000|STARTED|Overall Study||46
10553512|NCT01551056|11707983|FG001|STARTED|Overall Study||45
10553513|NCT01551056|11707982|FG000|COMPLETED|Overall Study||44
10553514|NCT01551056|11707983|FG001|COMPLETED|Overall Study||45
10553515|NCT01551056|11707982|FG000|NOT COMPLETED|Overall Study||2
10553516|NCT01551056|11707983|FG001|NOT COMPLETED|Overall Study||0
10553517|NCT01551095|11707989|FG000|STARTED|Overall Study||7
10553518|NCT01551095|11707989|FG000|COMPLETED|Overall Study||7
10553519|NCT01551095|11707989|FG000|NOT COMPLETED|Overall Study||0
10553520|NCT01551173|11707995|FG000|STARTED|Overall Study|"Started indicates randomized"|218
10553521|NCT01551173|11707996|FG001|STARTED|Overall Study||218
10553522|NCT01551173|11707995|FG000|Full Analysis Set (FAS)|Overall Study|Patients took at least 1 dose of study drug & had at least 1 post-randomization efficacy parameter|210
10553523|NCT01551173|11707996|FG001|Full Analysis Set (FAS)|Overall Study||214
10553524|NCT01551173|11707995|FG000|COMPLETED|Overall Study||190
10553525|NCT01551173|11707996|FG001|COMPLETED|Overall Study||186
10553526|NCT01551173|11707995|FG000|NOT COMPLETED|Overall Study||28
10553527|NCT01551173|11707996|FG001|NOT COMPLETED|Overall Study||32
10553528|NCT01551186|11708005|FG000|STARTED|Overall Study||50
10553529|NCT01551186|11708006|FG001|STARTED|Overall Study||53
10553530|NCT01551186|11708005|FG000|COMPLETED|Overall Study||30
10553531|NCT01551186|11708006|FG001|COMPLETED|Overall Study||40
10553532|NCT01551186|11708005|FG000|NOT COMPLETED|Overall Study||20
10553533|NCT01551186|11708006|FG001|NOT COMPLETED|Overall Study||13
10553534|NCT01551199|11708012|FG000|STARTED|Overall Study||7
10553535|NCT01551199|11708012|FG000|COMPLETED|Overall Study||2
10553536|NCT01551199|11708012|FG000|NOT COMPLETED|Overall Study||5
10553537|NCT01551212|11708018|FG000|STARTED|Overall Study||171
10553538|NCT01551212|11708019|FG001|STARTED|Overall Study||168
10553539|NCT01551212|11708018|FG000|Full Anylsis Set (FAS)|Overall Study||169
10553540|NCT01551212|11708019|FG001|Full Anylsis Set (FAS)|Overall Study||164
10553541|NCT01551212|11708018|FG000|Safety Set|Overall Study||169
10553542|NCT01551212|11708019|FG001|Safety Set|Overall Study||164
10553543|NCT01551212|11708018|FG000|Per Protocol Set (PP)|Overall Study||110
10553544|NCT01551212|11708019|FG001|Per Protocol Set (PP)|Overall Study||101
10553545|NCT01551212|11708018|FG000|COMPLETED|Overall Study||166
10553546|NCT01551212|11708019|FG001|COMPLETED|Overall Study||148
10553547|NCT01551212|11708018|FG000|NOT COMPLETED|Overall Study||5
10553548|NCT01551212|11708019|FG001|NOT COMPLETED|Overall Study||20
10553549|NCT01551264|11708027|FG000|STARTED|Overall Study||70
10553550|NCT01551264|11708028|FG001|STARTED|Overall Study||69
10553551|NCT01551264|11708027|FG000|Started Bracing|Overall Study||69
10553552|NCT01551264|11708028|FG001|Started Bracing|Overall Study||67
10553553|NCT01551264|11708027|FG000|Data for at Least One Follow-up After Brace Discontinuation Ascertained|Overall Study|Attended at least one visit within one year after discontinuing bracing|44
10553554|NCT01551264|11708028|FG001|Data for at Least One Follow-up After Brace Discontinuation Ascertained|Overall Study|Attended at least one visit within one year after discontinuing bracing|55
10553555|NCT01551264|11708027|FG000|COMPLETED|Overall Study|Attended 60 month follow-up visit|38
10553556|NCT01551264|11708028|FG001|COMPLETED|Overall Study|Attended 36 month follow-up visit|41
10553557|NCT01551264|11708027|FG000|NOT COMPLETED|Overall Study||32
10553558|NCT01551264|11708028|FG001|NOT COMPLETED|Overall Study||28
10553559|NCT01551303|11708036|FG000|STARTED|Overall Study||25
10553560|NCT01551303|11708037|FG001|STARTED|Overall Study||22
10553561|NCT01551303|11708036|FG000|COMPLETED|Overall Study||21
10553562|NCT01551303|11708037|FG001|COMPLETED|Overall Study||15
10553563|NCT01551303|11708036|FG000|NOT COMPLETED|Overall Study||4
10553564|NCT01551303|11708037|FG001|NOT COMPLETED|Overall Study||7
10553565|NCT01551355|11708049|FG000|STARTED|Overall Study||622
10553566|NCT01551355|11708050|FG001|STARTED|Overall Study||594
10553567|NCT01551355|11708051|FG002|STARTED|Overall Study||493
10553568|NCT01551355|11708052|FG003|STARTED|Overall Study||435
10553569|NCT01551355|11708053|FG004|STARTED|Overall Study||64
10553570|NCT01551355|11708054|FG005|STARTED|Overall Study||71
10553571|NCT01551355|11708049|FG000|COMPLETED|Overall Study||571
10553572|NCT01551355|11708050|FG001|COMPLETED|Overall Study||545
10553573|NCT01551355|11708051|FG002|COMPLETED|Overall Study||459
10553574|NCT01551355|11708052|FG003|COMPLETED|Overall Study||411
10553575|NCT01551355|11708053|FG004|COMPLETED|Overall Study||55
10553576|NCT01551355|11708054|FG005|COMPLETED|Overall Study||65
10553577|NCT01551355|11708049|FG000|NOT COMPLETED|Overall Study||51
10553578|NCT01551355|11708050|FG001|NOT COMPLETED|Overall Study||49
10553579|NCT01551355|11708051|FG002|NOT COMPLETED|Overall Study||34
10553580|NCT01551355|11708052|FG003|NOT COMPLETED|Overall Study||24
10553581|NCT01551355|11708053|FG004|NOT COMPLETED|Overall Study||9
10553582|NCT01551355|11708054|FG005|NOT COMPLETED|Overall Study||6
10553583|NCT01551420|11708064|FG000|STARTED|In-laboratory (Part A)||39
10553584|NCT01551420|11708065|FG001|STARTED|In-laboratory (Part A)||13
10553585|NCT01551420|11708064|FG000|COMPLETED|In-laboratory (Part A)||33
10553586|NCT01551420|11708065|FG001|COMPLETED|In-laboratory (Part A)||11
10553587|NCT01551420|11708064|FG000|NOT COMPLETED|In-laboratory (Part A)||6
10790448|NCT03540134|11950966|FG000|COMPLETED|Overall Study||4
10790449|NCT03540134|11950966|FG000|NOT COMPLETED|Overall Study||0
10553588|NCT01551420|11708065|FG001|NOT COMPLETED|In-laboratory (Part A)||2
10553589|NCT01551420|11708064|FG000|STARTED|Screened for Part B Eligibility||33
10553590|NCT01551420|11708065|FG001|STARTED|Screened for Part B Eligibility||11
10553591|NCT01551420|11708064|FG000|COMPLETED|Screened for Part B Eligibility||24
10553592|NCT01551420|11708065|FG001|COMPLETED|Screened for Part B Eligibility||8
10553593|NCT01551420|11708064|FG000|NOT COMPLETED|Screened for Part B Eligibility||9
10553594|NCT01551420|11708065|FG001|NOT COMPLETED|Screened for Part B Eligibility||3
10553595|NCT01551420|11708064|FG000|STARTED|Home Use (Part B)||24
10553596|NCT01551420|11708065|FG001|STARTED|Home Use (Part B)||8
10553597|NCT01551420|11708064|FG000|COMPLETED|Home Use (Part B)||18
10553598|NCT01551420|11708065|FG001|COMPLETED|Home Use (Part B)||7
10553599|NCT01551420|11708064|FG000|NOT COMPLETED|Home Use (Part B)||6
10553600|NCT01551420|11708065|FG001|NOT COMPLETED|Home Use (Part B)||1
10553601|NCT01551693|11708073|FG000|STARTED|Overall Study||1
10553602|NCT01551693|11708074|FG001|STARTED|Overall Study||2
10553603|NCT01551693|11708073|FG000|COMPLETED|Overall Study||0
10553604|NCT01551693|11708074|FG001|COMPLETED|Overall Study||0
10553605|NCT01551693|11708073|FG000|NOT COMPLETED|Overall Study||1
10553606|NCT01551693|11708074|FG001|NOT COMPLETED|Overall Study||2
10553607|NCT01551745|11708080|FG000|STARTED|Overall Study||5
10553608|NCT01551745|11708080|FG000|COMPLETED|Overall Study|"Completed means subject had been given all manufactured doses"|2
10553609|NCT01551745|11708080|FG000|NOT COMPLETED|Overall Study||3
10650585|NCT02170064|11810839|FG000|NOT COMPLETED|Overall Study||6
10650586|NCT02170064|11810840|FG001|NOT COMPLETED|Overall Study||2
10650587|NCT02170064|11810841|FG002|NOT COMPLETED|Overall Study||1
10650588|NCT02170077|11810852|FG000|STARTED|Overall Study||50
10650589|NCT02170077|11810853|FG001|STARTED|Overall Study||47
10650590|NCT02170077|11810854|FG002|STARTED|Overall Study||47
10650591|NCT02170077|11810852|FG000|Intent to Treat (ITT) Population|Overall Study||50
10650592|NCT02170077|11810853|FG001|Intent to Treat (ITT) Population|Overall Study||46
10650593|NCT02170077|11810854|FG002|Intent to Treat (ITT) Population|Overall Study||47
10650594|NCT02170077|11810852|FG000|COMPLETED|Overall Study||41
10650595|NCT02170077|11810853|FG001|COMPLETED|Overall Study||34
10650596|NCT02170077|11810854|FG002|COMPLETED|Overall Study||35
10650597|NCT02170077|11810852|FG000|NOT COMPLETED|Overall Study||9
10650598|NCT02170077|11810853|FG001|NOT COMPLETED|Overall Study||13
10650599|NCT02170077|11810854|FG002|NOT COMPLETED|Overall Study||12
10650600|NCT02170207|11810862|FG000|STARTED|Overall Study||63
10650601|NCT02170207|11810862|FG000|COMPLETED|Overall Study||58
10650602|NCT02170207|11810862|FG000|NOT COMPLETED|Overall Study||5
10650603|NCT02170220|11810868|FG000|STARTED|Overall Study||6
10650604|NCT02170220|11810869|FG001|STARTED|Overall Study||6
10650605|NCT02170220|11810868|FG000|COMPLETED|Overall Study||6
10650606|NCT02170220|11810869|FG001|COMPLETED|Overall Study||6
10650607|NCT02170220|11810868|FG000|NOT COMPLETED|Overall Study||0
10650608|NCT02170220|11810869|FG001|NOT COMPLETED|Overall Study||0
10650609|NCT02170376|11810880|FG000|STARTED|Overall Study||16
10650610|NCT02170376|11810881|FG001|STARTED|Overall Study||16
10650611|NCT02170376|11810882|FG002|STARTED|Overall Study||16
10650612|NCT02170376|11810883|FG003|STARTED|Overall Study||16
10650613|NCT02170376|11810884|FG004|STARTED|Overall Study||16
10650614|NCT02170376|11810880|FG000|Pharmacokinetic Population|Overall Study||16
10650615|NCT02170376|11810881|FG001|Pharmacokinetic Population|Overall Study||15
10650616|NCT02170376|11810882|FG002|Pharmacokinetic Population|Overall Study||16
10650617|NCT02170376|11810883|FG003|Pharmacokinetic Population|Overall Study||16
10650618|NCT02170376|11810884|FG004|Pharmacokinetic Population|Overall Study||16
10650619|NCT02170376|11810880|FG000|COMPLETED|Overall Study||16
10650620|NCT02170376|11810881|FG001|COMPLETED|Overall Study||15
10650621|NCT02170376|11810882|FG002|COMPLETED|Overall Study||16
10650622|NCT02170376|11810883|FG003|COMPLETED|Overall Study||16
10650623|NCT02170376|11810884|FG004|COMPLETED|Overall Study||16
10650624|NCT02170376|11810880|FG000|NOT COMPLETED|Overall Study||0
10650625|NCT02170376|11810881|FG001|NOT COMPLETED|Overall Study||1
10650626|NCT02170376|11810882|FG002|NOT COMPLETED|Overall Study||0
10650627|NCT02170376|11810883|FG003|NOT COMPLETED|Overall Study||0
10650628|NCT02170376|11810884|FG004|NOT COMPLETED|Overall Study||0
10650629|NCT02170389|11810896|FG000|STARTED|Overall Study||5
10650630|NCT02170389|11810896|FG000|COMPLETED|Overall Study||4
10650631|NCT02170389|11810896|FG000|NOT COMPLETED|Overall Study||1
10650632|NCT02170519|11810902|FG000|STARTED|Overall Study||22
10650633|NCT02170519|11810903|FG001|STARTED|Overall Study||5
10650634|NCT02170519|11810902|FG000|COMPLETED|Overall Study||22
10650635|NCT02170519|11810903|FG001|COMPLETED|Overall Study||5
10650636|NCT02170519|11810902|FG000|NOT COMPLETED|Overall Study||0
10650637|NCT02170519|11810903|FG001|NOT COMPLETED|Overall Study||0
10650638|NCT02170532|11810910|FG000|STARTED|Overall Study||10
10650639|NCT02170532|11810910|FG000|COMPLETED|Overall Study||10
10650640|NCT02170532|11810910|FG000|NOT COMPLETED|Overall Study||0
10650641|NCT02170649|11810921|FG000|STARTED|Fasting Period||12
10650642|NCT02170649|11810921|FG000|COMPLETED|Fasting Period||12
10650643|NCT02170649|11810921|FG000|NOT COMPLETED|Fasting Period||0
10650644|NCT02170649|11810921|FG000|STARTED|Fed Period||12
10650645|NCT02170649|11810921|FG000|COMPLETED|Fed Period||12
10650646|NCT02170649|11810921|FG000|NOT COMPLETED|Fed Period||0
10650647|NCT02170662|11810927|FG000|STARTED|Overall Study||3
10650648|NCT02170662|11810928|FG001|STARTED|Overall Study||6
10650649|NCT02170662|11810927|FG000|COMPLETED|Overall Study||3
10650650|NCT02170662|11810928|FG001|COMPLETED|Overall Study||6
10650651|NCT02170662|11810927|FG000|NOT COMPLETED|Overall Study||0
10650652|NCT02170662|11810928|FG001|NOT COMPLETED|Overall Study||0
10553610|NCT01551758|11708086|FG000|STARTED|Overall Study||1403
10553611|NCT01551758|11708087|FG001|STARTED|Overall Study||1396
10553612|NCT01551758|11708086|FG000|COMPLETED|Overall Study||1309
10553613|NCT01551758|11708087|FG001|COMPLETED|Overall Study||1291
10553614|NCT01551758|11708086|FG000|NOT COMPLETED|Overall Study||94
10553615|NCT01551758|11708087|FG001|NOT COMPLETED|Overall Study||105
10553616|NCT01551888|11708097|FG000|STARTED|Period 1||12
10553617|NCT01551888|11708098|FG001|STARTED|Period 1||12
10553618|NCT01551888|11708097|FG000|COMPLETED|Period 1||12
10553619|NCT01551888|11708098|FG001|COMPLETED|Period 1||12
10553620|NCT01551888|11708097|FG000|NOT COMPLETED|Period 1||0
10553621|NCT01551888|11708098|FG001|NOT COMPLETED|Period 1||0
10553622|NCT01551888|11708097|FG000|STARTED|Period 2||12
10553623|NCT01551888|11708098|FG001|STARTED|Period 2||12
10553624|NCT01551888|11708097|FG000|COMPLETED|Period 2||12
10553625|NCT01551888|11708098|FG001|COMPLETED|Period 2||12
10553626|NCT01551888|11708097|FG000|NOT COMPLETED|Period 2||0
10553627|NCT01551888|11708098|FG001|NOT COMPLETED|Period 2||0
10553628|NCT01551979|11708106|FG000|STARTED|Overall Study||10
10553629|NCT01551979|11708107|FG001|STARTED|Overall Study||7
10553630|NCT01551979|11708106|FG000|Last Day of Treatment (After 5 Days)|Overall Study||10
10553631|NCT01551979|11708107|FG001|Last Day of Treatment (After 5 Days)|Overall Study||7
10553632|NCT01551979|11708106|FG000|1 Week Post Treatment|Overall Study||10
10553633|NCT01551979|11708107|FG001|1 Week Post Treatment|Overall Study||6
10553634|NCT01551979|11708106|FG000|COMPLETED|Overall Study||8
10553635|NCT01551979|11708107|FG001|COMPLETED|Overall Study||5
10553636|NCT01551979|11708106|FG000|NOT COMPLETED|Overall Study||2
10553637|NCT01551979|11708107|FG001|NOT COMPLETED|Overall Study||2
10553638|NCT01552057|11708115|FG000|STARTED|Overall Study||196
10553639|NCT01552057|11708116|FG001|STARTED|Overall Study||197
10553640|NCT01552057|11708115|FG000|Received at Least 1 Dose of Study Drug|Overall Study||194
10553641|NCT01552057|11708116|FG001|Received at Least 1 Dose of Study Drug|Overall Study||196
10553642|NCT01552057|11708115|FG000|COMPLETED|Overall Study||166
10553643|NCT01552057|11708116|FG001|COMPLETED|Overall Study||149
10553644|NCT01552057|11708115|FG000|NOT COMPLETED|Overall Study||30
10553645|NCT01552057|11708116|FG001|NOT COMPLETED|Overall Study||48
10553646|NCT01552213|11708124|FG000|STARTED|Overall Study||50
10553647|NCT01552213|11708125|FG001|STARTED|Overall Study||45
10553648|NCT01552213|11708124|FG000|Analyzed|Overall Study||42
10553649|NCT01552213|11708125|FG001|Analyzed|Overall Study||41
10553650|NCT01552213|11708124|FG000|COMPLETED|Overall Study||37
10553651|NCT01552213|11708125|FG001|COMPLETED|Overall Study||37
10553652|NCT01552213|11708124|FG000|NOT COMPLETED|Overall Study||13
10553653|NCT01552213|11708125|FG001|NOT COMPLETED|Overall Study||8
10553654|NCT01552343|11708133|FG000|STARTED|Overall Study||29
10553655|NCT01552343|11708134|FG001|STARTED|Overall Study||27
10553656|NCT01552343|11708133|FG000|COMPLETED|Overall Study||29
10553657|NCT01552343|11708134|FG001|COMPLETED|Overall Study||27
10553658|NCT01552343|11708133|FG000|NOT COMPLETED|Overall Study||0
10553659|NCT01552343|11708134|FG001|NOT COMPLETED|Overall Study||0
10553660|NCT01552369|11708151|FG000|STARTED|Overall Study||100
10553661|NCT01552369|11708152|FG001|STARTED|Overall Study||105
10553662|NCT01552369|11708151|FG000|One Year|Overall Study||100
10553663|NCT01552369|11708152|FG001|One Year|Overall Study||105
10553664|NCT01552369|11708151|FG000|Final Follow up|Overall Study||92
10553665|NCT01552369|11708152|FG001|Final Follow up|Overall Study||96
10553666|NCT01552369|11708151|FG000|COMPLETED|Overall Study||92
10553667|NCT01552369|11708152|FG001|COMPLETED|Overall Study||96
10553668|NCT01552369|11708151|FG000|NOT COMPLETED|Overall Study||8
10553669|NCT01552369|11708152|FG001|NOT COMPLETED|Overall Study||9
10553670|NCT01552408|11708162|FG000|STARTED|Overall Study||20
10553671|NCT01552408|11708163|FG001|STARTED|Overall Study||20
10553672|NCT01552408|11708162|FG000|COMPLETED|Overall Study||16
10553673|NCT01552408|11708163|FG001|COMPLETED|Overall Study||18
10553674|NCT01552408|11708162|FG000|NOT COMPLETED|Overall Study||4
10553675|NCT01552408|11708163|FG001|NOT COMPLETED|Overall Study||2
10553676|NCT01552603|11708170|FG000|STARTED|Overall Study||14
10553677|NCT01552603|11708170|FG000|COMPLETED|Overall Study||13
10553678|NCT01552603|11708170|FG000|NOT COMPLETED|Overall Study||1
10553679|NCT01552681|11708176|FG000|STARTED|Overall Study||33
10553680|NCT01552681|11708177|FG001|STARTED|Overall Study||19
10553681|NCT01552681|11708176|FG000|COMPLETED|Overall Study||28
10553682|NCT01552681|11708177|FG001|COMPLETED|Overall Study||18
10553683|NCT01552681|11708176|FG000|NOT COMPLETED|Overall Study||5
10553684|NCT01552681|11708177|FG001|NOT COMPLETED|Overall Study||1
10553685|NCT01552694|11708185|FG000|STARTED|Overall Study||18
10553686|NCT01552694|11708186|FG001|STARTED|Overall Study||20
10553687|NCT01552694|11708185|FG000|COMPLETED|Overall Study||18
10553688|NCT01552694|11708186|FG001|COMPLETED|Overall Study||18
10553689|NCT01552694|11708185|FG000|NOT COMPLETED|Overall Study||0
10553690|NCT01552694|11708186|FG001|NOT COMPLETED|Overall Study||2
10553691|NCT01552772|11708192|FG000|STARTED|Overall Study||60
10553692|NCT01552772|11708192|FG000|COMPLETED|Overall Study|Participants who completed the Day 28 visit were defined as completers for the trial.|56
10553693|NCT01552772|11708192|FG000|NOT COMPLETED|Overall Study||4
10553694|NCT01552876|11708197|FG000|STARTED|Overall Study||20
10553695|NCT01552876|11708198|FG001|STARTED|Overall Study||20
10553696|NCT01552876|11708197|FG000|COMPLETED|Overall Study||20
10553697|NCT01552876|11708198|FG001|COMPLETED|Overall Study||20
10553698|NCT01552876|11708197|FG000|NOT COMPLETED|Overall Study||0
10553699|NCT01552876|11708198|FG001|NOT COMPLETED|Overall Study||0
10553700|NCT01552889|11708212|FG000|STARTED|Overall Study||101
10553701|NCT01552889|11708213|FG001|STARTED|Overall Study||100
10553702|NCT01552889|11708212|FG000|COMPLETED|Overall Study||90
10553703|NCT01552889|11708213|FG001|COMPLETED|Overall Study||95
10553704|NCT01552889|11708212|FG000|NOT COMPLETED|Overall Study||11
10553705|NCT01552889|11708213|FG001|NOT COMPLETED|Overall Study||5
10553706|NCT01552902|11708224|FG000|STARTED|Overall Study||110
10553707|NCT01552902|11708225|FG001|STARTED|Overall Study||218
10553708|NCT01552902|11708226|FG002|STARTED|Overall Study||219
10553709|NCT01552902|11708224|FG000|COMPLETED|Overall Study||97
10553710|NCT01552902|11708225|FG001|COMPLETED|Overall Study||181
10553711|NCT01552902|11708226|FG002|COMPLETED|Overall Study||186
10553712|NCT01552902|11708224|FG000|NOT COMPLETED|Overall Study||13
10553713|NCT01552902|11708225|FG001|NOT COMPLETED|Overall Study||37
10553714|NCT01552902|11708226|FG002|NOT COMPLETED|Overall Study||33
10553715|NCT01552915|11708237|FG000|STARTED|Overall Study|This population is from the Safety Set. Two randomized subjects were not dosed and were excluded.|91
10553716|NCT01552915|11708238|FG001|STARTED|Overall Study|This population is from the Safety Set. Two randomized subjects were not dosed and were excluded.|184
10553717|NCT01552915|11708239|FG002|STARTED|Overall Study|This population is from the Safety Set. One randomized subject was not dosed and was excluded.|184
10553718|NCT01552915|11708237|FG000|COMPLETED|Overall Study||68
10553719|NCT01552915|11708238|FG001|COMPLETED|Overall Study||155
10553720|NCT01552915|11708239|FG002|COMPLETED|Overall Study||157
10553721|NCT01552915|11708237|FG000|NOT COMPLETED|Overall Study||23
10553722|NCT01552915|11708238|FG001|NOT COMPLETED|Overall Study||29
10553723|NCT01552915|11708239|FG002|NOT COMPLETED|Overall Study||27
10553724|NCT01552928|11708251|FG000|STARTED|Period 1||14
10553725|NCT01552928|11708252|FG001|STARTED|Period 1||15
10553726|NCT01552928|11708253|FG002|STARTED|Period 1||15
10553727|NCT01552928|11708254|FG003|STARTED|Period 1||16
10553728|NCT01552928|11708251|FG000|COMPLETED|Period 1||14
10553729|NCT01552928|11708252|FG001|COMPLETED|Period 1||15
10553730|NCT01552928|11708253|FG002|COMPLETED|Period 1||15
10553731|NCT01552928|11708254|FG003|COMPLETED|Period 1||16
10553732|NCT01552928|11708251|FG000|NOT COMPLETED|Period 1||0
10553733|NCT01552928|11708252|FG001|NOT COMPLETED|Period 1||0
10553734|NCT01552928|11708253|FG002|NOT COMPLETED|Period 1||0
10553735|NCT01552928|11708254|FG003|NOT COMPLETED|Period 1||0
10553736|NCT01552928|11708251|FG000|STARTED|Period 2||14
10553737|NCT01552928|11708252|FG001|STARTED|Period 2||15
10553738|NCT01552928|11708253|FG002|STARTED|Period 2||15
10553739|NCT01552928|11708254|FG003|STARTED|Period 2||16
10553740|NCT01552928|11708251|FG000|COMPLETED|Period 2||14
10553741|NCT01552928|11708252|FG001|COMPLETED|Period 2||15
10553742|NCT01552928|11708253|FG002|COMPLETED|Period 2||15
10553743|NCT01552928|11708254|FG003|COMPLETED|Period 2||16
10553744|NCT01552928|11708251|FG000|NOT COMPLETED|Period 2||0
10553745|NCT01552928|11708252|FG001|NOT COMPLETED|Period 2||0
10553746|NCT01552928|11708253|FG002|NOT COMPLETED|Period 2||0
10553747|NCT01552928|11708254|FG003|NOT COMPLETED|Period 2||0
10553748|NCT01552928|11708251|FG000|STARTED|Period 3||14
10553749|NCT01552928|11708252|FG001|STARTED|Period 3||15
10553750|NCT01552928|11708253|FG002|STARTED|Period 3||15
10553751|NCT01552928|11708254|FG003|STARTED|Period 3||16
10553752|NCT01552928|11708251|FG000|COMPLETED|Period 3||14
10553753|NCT01552928|11708252|FG001|COMPLETED|Period 3||15
10553754|NCT01552928|11708253|FG002|COMPLETED|Period 3||14
10553755|NCT01552928|11708254|FG003|COMPLETED|Period 3||16
10553756|NCT01552928|11708251|FG000|NOT COMPLETED|Period 3||0
10553757|NCT01552928|11708252|FG001|NOT COMPLETED|Period 3||0
10553758|NCT01552928|11708253|FG002|NOT COMPLETED|Period 3||1
10553759|NCT01552928|11708254|FG003|NOT COMPLETED|Period 3||0
10553760|NCT01552928|11708251|FG000|STARTED|Period 4||14
10553761|NCT01552928|11708252|FG001|STARTED|Period 4||15
10553762|NCT01552928|11708253|FG002|STARTED|Period 4||14
10553763|NCT01552928|11708254|FG003|STARTED|Period 4||16
10553764|NCT01552928|11708251|FG000|COMPLETED|Period 4||14
10553765|NCT01552928|11708252|FG001|COMPLETED|Period 4||15
10553766|NCT01552928|11708253|FG002|COMPLETED|Period 4||14
10553767|NCT01552928|11708254|FG003|COMPLETED|Period 4||16
10553768|NCT01552928|11708251|FG000|NOT COMPLETED|Period 4||0
10553769|NCT01552928|11708252|FG001|NOT COMPLETED|Period 4||0
10553770|NCT01552928|11708253|FG002|NOT COMPLETED|Period 4||0
10553771|NCT01552928|11708254|FG003|NOT COMPLETED|Period 4||0
10553772|NCT01552954|11708273|FG000|STARTED|Overall Study|A total of 13 patients were withdrawn from 269 patients. The remained 256 patients were randomized.|131
10553773|NCT01552954|11708274|FG001|STARTED|Overall Study||125
10553774|NCT01552954|11708273|FG000|COMPLETED|Overall Study||126
10553775|NCT01552954|11708274|FG001|COMPLETED|Overall Study||119
10553776|NCT01552954|11708273|FG000|NOT COMPLETED|Overall Study||5
10553777|NCT01552954|11708274|FG001|NOT COMPLETED|Overall Study||6
10553778|NCT01553058|11708283|FG000|STARTED|Overall Study||33
10553779|NCT01553058|11708284|FG001|STARTED|Overall Study||31
10553780|NCT01553058|11708285|FG002|STARTED|Overall Study||33
10553781|NCT01553058|11708283|FG000|COMPLETED|Overall Study||32
10553782|NCT01553058|11708284|FG001|COMPLETED|Overall Study||30
10553783|NCT01553058|11708285|FG002|COMPLETED|Overall Study||30
10553784|NCT01553058|11708283|FG000|NOT COMPLETED|Overall Study||1
10553785|NCT01553058|11708284|FG001|NOT COMPLETED|Overall Study||1
10553786|NCT01553058|11708285|FG002|NOT COMPLETED|Overall Study||3
10553787|NCT01553084|11708300|FG000|STARTED|Overall Study||241
10553788|NCT01553084|11708301|FG001|STARTED|Overall Study||421
10553789|NCT01553084|11708302|FG002|STARTED|Overall Study||424
10553790|NCT01553084|11708300|FG000|COMPLETED|Overall Study||226
10553791|NCT01553084|11708301|FG001|COMPLETED|Overall Study||408
10553792|NCT01553084|11708302|FG002|COMPLETED|Overall Study||389
10553793|NCT01553084|11708300|FG000|NOT COMPLETED|Overall Study||15
10553794|NCT01553084|11708301|FG001|NOT COMPLETED|Overall Study||13
10553795|NCT01553084|11708302|FG002|NOT COMPLETED|Overall Study||35
10553796|NCT01553136|11708314|FG000|STARTED|Overall Study||64
10553797|NCT01553136|11708315|FG001|STARTED|Overall Study||67
10553798|NCT01553136|11708314|FG000|Completed Treatment|Overall Study||55
10553799|NCT01553136|11708315|FG001|Completed Treatment|Overall Study||52
10553800|NCT01553136|11708314|FG000|COMPLETED|Overall Study||48
10553801|NCT01553136|11708315|FG001|COMPLETED|Overall Study||45
10553802|NCT01553136|11708314|FG000|NOT COMPLETED|Overall Study||16
10553803|NCT01553136|11708315|FG001|NOT COMPLETED|Overall Study||22
10553804|NCT01553188|11708325|FG000|STARTED|Overall Study||3
10553805|NCT01553188|11708326|FG001|STARTED|Overall Study||6
10553806|NCT01553188|11708327|FG002|STARTED|Overall Study||16
10553807|NCT01553188|11708328|FG003|STARTED|Overall Study||11
10553808|NCT01553188|11708325|FG000|COMPLETED|Overall Study||2
10553809|NCT01553188|11708326|FG001|COMPLETED|Overall Study||5
10553810|NCT01553188|11708327|FG002|COMPLETED|Overall Study||14
10553811|NCT01553188|11708328|FG003|COMPLETED|Overall Study||11
10553812|NCT01553188|11708325|FG000|NOT COMPLETED|Overall Study||1
10553813|NCT01553188|11708326|FG001|NOT COMPLETED|Overall Study||1
10553814|NCT01553188|11708327|FG002|NOT COMPLETED|Overall Study||2
10553815|NCT01553188|11708328|FG003|NOT COMPLETED|Overall Study||0
10553816|NCT01553201|11708343|FG000|STARTED|Overall Study||15
10553817|NCT01553201|11708344|FG001|STARTED|Overall Study||15
10553818|NCT01553201|11708343|FG000|COMPLETED|Overall Study||15
10553819|NCT01553201|11708344|FG001|COMPLETED|Overall Study||15
10553820|NCT01553201|11708343|FG000|NOT COMPLETED|Overall Study||0
10553821|NCT01553201|11708344|FG001|NOT COMPLETED|Overall Study||0
10553822|NCT01553279|11708352|FG000|STARTED|Part 1 (Infant Vaccinations)||142
10553823|NCT01553279|11708353|FG001|STARTED|Part 1 (Infant Vaccinations)||142
10553824|NCT01553279|11708352|FG000|COMPLETED|Part 1 (Infant Vaccinations)||140
10553825|NCT01553279|11708353|FG001|COMPLETED|Part 1 (Infant Vaccinations)||141
10553826|NCT01553279|11708352|FG000|NOT COMPLETED|Part 1 (Infant Vaccinations)||2
10553827|NCT01553279|11708353|FG001|NOT COMPLETED|Part 1 (Infant Vaccinations)||1
10553828|NCT01553279|11708352|FG000|STARTED|Interim Period||140
10553829|NCT01553279|11708353|FG001|STARTED|Interim Period||141
10553830|NCT01553279|11708352|FG000|COMPLETED|Interim Period||137
10553831|NCT01553279|11708353|FG001|COMPLETED|Interim Period||139
10553832|NCT01553279|11708352|FG000|NOT COMPLETED|Interim Period||3
10553833|NCT01553279|11708353|FG001|NOT COMPLETED|Interim Period||2
10553834|NCT01553279|11708352|FG000|STARTED|Period 2: Toddler Vaccinations||137
10553835|NCT01553279|11708353|FG001|STARTED|Period 2: Toddler Vaccinations||139
10553836|NCT01553279|11708352|FG000|COMPLETED|Period 2: Toddler Vaccinations||134
10553837|NCT01553279|11708353|FG001|COMPLETED|Period 2: Toddler Vaccinations||132
10553838|NCT01553279|11708352|FG000|NOT COMPLETED|Period 2: Toddler Vaccinations||3
10553839|NCT01553279|11708353|FG001|NOT COMPLETED|Period 2: Toddler Vaccinations||7
10553840|NCT01553292|11708360|FG000|STARTED|Overall Study||21
10553841|NCT01553292|11708360|FG000|COMPLETED|Overall Study||21
10553842|NCT01553292|11708360|FG000|NOT COMPLETED|Overall Study||0
10553843|NCT01553318|11708368|FG000|STARTED|Overall Study||24
10553844|NCT01553318|11708369|FG001|STARTED|Overall Study||27
10553845|NCT01553318|11708368|FG000|COMPLETED|Overall Study||21
10553846|NCT01553318|11708369|FG001|COMPLETED|Overall Study||25
10553847|NCT01553318|11708368|FG000|NOT COMPLETED|Overall Study||3
10553848|NCT01553318|11708369|FG001|NOT COMPLETED|Overall Study||2
10553849|NCT01553539|11708377|FG000|STARTED|Overall Study||20
10553850|NCT01553539|11708377|FG000|COMPLETED|Overall Study||20
10553851|NCT01553539|11708377|FG000|NOT COMPLETED|Overall Study||0
10553852|NCT01553591|11708384|FG000|STARTED|Overall Study||429
10553853|NCT01553591|11708385|FG001|STARTED|Overall Study||426
10553854|NCT01553591|11708386|FG002|STARTED|Overall Study||427
10553855|NCT01553591|11708384|FG000|Attended Week 12 Visit|Overall Study||341
10553856|NCT01553591|11708385|FG001|Attended Week 12 Visit|Overall Study||330
10553857|NCT01553591|11708386|FG002|Attended Week 12 Visit|Overall Study||342
10553858|NCT01553591|11708384|FG000|Attended Week 26 Visit|Overall Study||289
10553859|NCT01553591|11708385|FG001|Attended Week 26 Visit|Overall Study||291
10553860|NCT01553591|11708386|FG002|Attended Week 26 Visit|Overall Study||290
10553861|NCT01553591|11708384|FG000|COMPLETED|Overall Study||257
10553862|NCT01553591|11708385|FG001|COMPLETED|Overall Study||257
10553863|NCT01553591|11708386|FG002|COMPLETED|Overall Study||269
10553864|NCT01553591|11708384|FG000|NOT COMPLETED|Overall Study||172
10553865|NCT01553591|11708385|FG001|NOT COMPLETED|Overall Study||169
10553866|NCT01553591|11708386|FG002|NOT COMPLETED|Overall Study||158
10553867|NCT01553708|11708396|FG000|STARTED|Overall Study||17
10553868|NCT01553708|11708397|FG001|STARTED|Overall Study||17
10553869|NCT01553708|11708396|FG000|COMPLETED|Overall Study||17
10553870|NCT01553708|11708397|FG001|COMPLETED|Overall Study||17
10553871|NCT01553708|11708396|FG000|NOT COMPLETED|Overall Study||0
10553872|NCT01553708|11708397|FG001|NOT COMPLETED|Overall Study||0
10553873|NCT01553747|11708406|FG000|STARTED|Overall Study||381
10553874|NCT01553747|11708407|FG001|STARTED|Overall Study||383
10553875|NCT01553747|11708408|FG002|STARTED|Overall Study||382
10553876|NCT01553747|11708406|FG000|Attended Week 12 Visit|Overall Study||296
10553877|NCT01553747|11708407|FG001|Attended Week 12 Visit|Overall Study||301
10553878|NCT01553747|11708408|FG002|Attended Week 12 Visit|Overall Study||312
10553879|NCT01553747|11708406|FG000|Attended Week 26 Visit|Overall Study||259
10553880|NCT01553747|11708407|FG001|Attended Week 26 Visit|Overall Study||271
10553881|NCT01553747|11708408|FG002|Attended Week 26 Visit|Overall Study||278
10553882|NCT01553747|11708406|FG000|Participated in Blinded-Placebo Period|Overall Study||246
10553883|NCT01553747|11708407|FG001|Participated in Blinded-Placebo Period|Overall Study||253
10553884|NCT01553747|11708408|FG002|Participated in Blinded-Placebo Period|Overall Study||272
10553885|NCT01553747|11708406|FG000|COMPLETED|Overall Study||250
10553886|NCT01553747|11708407|FG001|COMPLETED|Overall Study||264
10553887|NCT01553747|11708408|FG002|COMPLETED|Overall Study||273
10553888|NCT01553747|11708406|FG000|NOT COMPLETED|Overall Study||131
10553889|NCT01553747|11708407|FG001|NOT COMPLETED|Overall Study||119
10553890|NCT01553747|11708408|FG002|NOT COMPLETED|Overall Study||109
10553891|NCT01553851|11708419|FG000|STARTED|Overall Study||20
10553892|NCT01553851|11708419|FG000|COMPLETED|Overall Study||17
10553893|NCT01553851|11708419|FG000|NOT COMPLETED|Overall Study||3
10553894|NCT01553916|11708423|FG000|STARTED|Overall Study||19
10553895|NCT01553916|11708423|FG000|COMPLETED|Overall Study||16
10553896|NCT01553916|11708423|FG000|NOT COMPLETED|Overall Study||3
10553897|NCT01554176|11708429|FG000|STARTED|Treatment Phase||65
10553898|NCT01554176|11708430|FG001|STARTED|Treatment Phase||64
10553899|NCT01554176|11708431|FG002|STARTED|Treatment Phase||0
10553900|NCT01554176|11708432|FG003|STARTED|Treatment Phase||0
10553901|NCT01554176|11708433|FG004|STARTED|Treatment Phase||0
10553902|NCT01554176|11708429|FG000|Treated|Treatment Phase||64
10553903|NCT01554176|11708430|FG001|Treated|Treatment Phase||64
10553904|NCT01554176|11708431|FG002|Treated|Treatment Phase||0
10553905|NCT01554176|11708432|FG003|Treated|Treatment Phase||0
10553906|NCT01554176|11708433|FG004|Treated|Treatment Phase||0
10553907|NCT01554176|11708429|FG000|COMPLETED|Treatment Phase||57
10553908|NCT01554176|11708430|FG001|COMPLETED|Treatment Phase||59
10553909|NCT01554176|11708431|FG002|COMPLETED|Treatment Phase||0
10553910|NCT01554176|11708432|FG003|COMPLETED|Treatment Phase||0
10553911|NCT01554176|11708433|FG004|COMPLETED|Treatment Phase||0
10553912|NCT01554176|11708429|FG000|NOT COMPLETED|Treatment Phase||8
10553913|NCT01554176|11708430|FG001|NOT COMPLETED|Treatment Phase||5
10553914|NCT01554176|11708431|FG002|NOT COMPLETED|Treatment Phase||0
10553915|NCT01554176|11708432|FG003|NOT COMPLETED|Treatment Phase||0
10553916|NCT01554176|11708433|FG004|NOT COMPLETED|Treatment Phase||0
10553917|NCT01554176|11708429|FG000|STARTED|Run-out Phase||0
10553918|NCT01554176|11708430|FG001|STARTED|Run-out Phase||0
10553919|NCT01554176|11708431|FG002|STARTED|Run-out Phase||29
10553920|NCT01554176|11708432|FG003|STARTED|Run-out Phase||28
10553921|NCT01554176|11708433|FG004|STARTED|Run-out Phase||59
10553922|NCT01554176|11708429|FG000|Treated|Run-out Phase||0
10553923|NCT01554176|11708430|FG001|Treated|Run-out Phase||0
10553924|NCT01554176|11708431|FG002|Treated|Run-out Phase||29
10553925|NCT01554176|11708432|FG003|Treated|Run-out Phase||28
10553926|NCT01554176|11708433|FG004|Treated|Run-out Phase||59
10553927|NCT01554176|11708429|FG000|COMPLETED|Run-out Phase||0
10553928|NCT01554176|11708430|FG001|COMPLETED|Run-out Phase||0
10553929|NCT01554176|11708431|FG002|COMPLETED|Run-out Phase||29
10553930|NCT01554176|11708432|FG003|COMPLETED|Run-out Phase||27
10553931|NCT01554176|11708433|FG004|COMPLETED|Run-out Phase||59
10553932|NCT01554176|11708429|FG000|NOT COMPLETED|Run-out Phase||0
10553933|NCT01554176|11708430|FG001|NOT COMPLETED|Run-out Phase||0
10553934|NCT01554176|11708431|FG002|NOT COMPLETED|Run-out Phase||0
10553935|NCT01554176|11708432|FG003|NOT COMPLETED|Run-out Phase||1
10553936|NCT01554176|11708433|FG004|NOT COMPLETED|Run-out Phase||0
10553937|NCT01554241|11708449|FG000|STARTED|Overall Study||23
10553938|NCT01554241|11708450|FG001|STARTED|Overall Study||20
10553939|NCT01554241|11708451|FG002|STARTED|Overall Study||24
10553940|NCT01554241|11708452|FG003|STARTED|Overall Study||14
10553941|NCT01554241|11708449|FG000|COMPLETED|Overall Study||20
10553942|NCT01554241|11708450|FG001|COMPLETED|Overall Study||19
10553943|NCT01554241|11708451|FG002|COMPLETED|Overall Study||20
10553944|NCT01554241|11708452|FG003|COMPLETED|Overall Study||13
10553945|NCT01554241|11708449|FG000|NOT COMPLETED|Overall Study||3
10553946|NCT01554241|11708450|FG001|NOT COMPLETED|Overall Study||1
10553947|NCT01554241|11708451|FG002|NOT COMPLETED|Overall Study||4
10553948|NCT01554241|11708452|FG003|NOT COMPLETED|Overall Study||1
10553949|NCT01554371|11708465|FG000|STARTED|Overall Study||3
10553950|NCT01554371|11708466|FG001|STARTED|Overall Study||3
10553951|NCT01554371|11708467|FG002|STARTED|Overall Study||38
10553952|NCT01554371|11708465|FG000|COMPLETED|Overall Study||3
10553953|NCT01554371|11708466|FG001|COMPLETED|Overall Study||3
10553954|NCT01554371|11708467|FG002|COMPLETED|Overall Study||38
10553955|NCT01554371|11708465|FG000|NOT COMPLETED|Overall Study||0
10553956|NCT01554371|11708466|FG001|NOT COMPLETED|Overall Study||0
10553957|NCT01554371|11708467|FG002|NOT COMPLETED|Overall Study||0
10553958|NCT01554488|11708480|FG000|STARTED|Overall Study||13
10553959|NCT01554488|11708481|FG001|STARTED|Overall Study||12
10553960|NCT01554488|11708480|FG000|COMPLETED|Overall Study||12
10553961|NCT01554488|11708481|FG001|COMPLETED|Overall Study||9
10553962|NCT01554488|11708480|FG000|NOT COMPLETED|Overall Study||1
10553963|NCT01554488|11708481|FG001|NOT COMPLETED|Overall Study||3
10553964|NCT01554514|11708487|FG000|STARTED|Overall Study||19
10553965|NCT01554514|11708487|FG000|COMPLETED|Overall Study||17
10553966|NCT01554514|11708487|FG000|NOT COMPLETED|Overall Study||2
10553967|NCT01554527|11708494|FG000|STARTED|Overall Study||34
10553968|NCT01554527|11708495|FG001|STARTED|Overall Study||38
10553969|NCT01554527|11708496|FG002|STARTED|Overall Study||33
10553970|NCT01554527|11708494|FG000|Crossed Over to Control|Overall Study||0
10553971|NCT01554527|11708495|FG001|Crossed Over to Control|Overall Study||0
10553972|NCT01554527|11708496|FG002|Crossed Over to Control|Overall Study||2
10553973|NCT01554527|11708494|FG000|Had CPAP Titration|Overall Study|No control group members received CPAP (definitionally)|0
10553974|NCT01554527|11708495|FG001|Had CPAP Titration|Overall Study||38
10553975|NCT01554527|11708496|FG002|Had CPAP Titration|Overall Study||30
10553976|NCT01554527|11708494|FG000|Initiated CPAP Treatment at Home|Overall Study||0
10553977|NCT01554527|11708495|FG001|Initiated CPAP Treatment at Home|Overall Study||38
10553978|NCT01554527|11708496|FG002|Initiated CPAP Treatment at Home|Overall Study||28
10553979|NCT01554527|11708494|FG000|Completed as a Control|Overall Study||33
10553980|NCT01554527|11708495|FG001|Completed as a Control|Overall Study||0
10553981|NCT01554527|11708496|FG002|Completed as a Control|Overall Study||1
10553982|NCT01554527|11708494|FG000|COMPLETED|Overall Study||33
10553983|NCT01554527|11708495|FG001|COMPLETED|Overall Study||38
10553984|NCT01554527|11708496|FG002|COMPLETED|Overall Study||25
10553985|NCT01554527|11708494|FG000|NOT COMPLETED|Overall Study||1
10553986|NCT01554527|11708495|FG001|NOT COMPLETED|Overall Study||0
10553987|NCT01554527|11708496|FG002|NOT COMPLETED|Overall Study||8
10553988|NCT01554579|11708507|FG000|STARTED|Overall Study||86
10553989|NCT01554579|11708508|FG001|STARTED|Overall Study||85
10553990|NCT01554579|11708507|FG000|COMPLETED|Overall Study||76
10553991|NCT01554579|11708508|FG001|COMPLETED|Overall Study||58
10553992|NCT01554579|11708507|FG000|NOT COMPLETED|Overall Study||10
10553993|NCT01554579|11708508|FG001|NOT COMPLETED|Overall Study||27
10553994|NCT01554618|11708517|FG000|STARTED|Randomized Through Start of Treatment||59
10553995|NCT01554618|11708518|FG001|STARTED|Randomized Through Start of Treatment||24
10553996|NCT01554618|11708517|FG000|COMPLETED|Randomized Through Start of Treatment||58
10553997|NCT01554618|11708518|FG001|COMPLETED|Randomized Through Start of Treatment||24
10553998|NCT01554618|11708517|FG000|NOT COMPLETED|Randomized Through Start of Treatment||1
10553999|NCT01554618|11708518|FG001|NOT COMPLETED|Randomized Through Start of Treatment||0
10554000|NCT01554618|11708517|FG000|STARTED|Controlled Assessment Period||58
10554001|NCT01554618|11708518|FG001|STARTED|Controlled Assessment Period||24
10554002|NCT01554618|11708517|FG000|COMPLETED|Controlled Assessment Period||50
10554003|NCT01554618|11708518|FG001|COMPLETED|Controlled Assessment Period||23
10554004|NCT01554618|11708517|FG000|NOT COMPLETED|Controlled Assessment Period||8
10554005|NCT01554618|11708518|FG001|NOT COMPLETED|Controlled Assessment Period||1
10554006|NCT01554618|11708517|FG000|STARTED|Open-Label Extension Period|1 patient who was noncompliant with study medication did not enter the open-label extension period|49
10554007|NCT01554618|11708518|FG001|STARTED|Open-Label Extension Period||23
10554008|NCT01554618|11708517|FG000|COMPLETED|Open-Label Extension Period||46
10554009|NCT01554618|11708518|FG001|COMPLETED|Open-Label Extension Period||18
10554010|NCT01554618|11708517|FG000|NOT COMPLETED|Open-Label Extension Period||3
10554011|NCT01554618|11708518|FG001|NOT COMPLETED|Open-Label Extension Period||5
10554012|NCT01554683|11708528|FG000|STARTED|Overall Study||2
10554013|NCT01554683|11708529|FG001|STARTED|Overall Study||1
10554014|NCT01554683|11708530|FG002|STARTED|Overall Study||3
10554015|NCT01554683|11708531|FG003|STARTED|Overall Study||2
10554016|NCT01554683|11708532|FG004|STARTED|Overall Study||1
10554017|NCT01554683|11708533|FG005|STARTED|Overall Study||0
10554018|NCT01554683|11708528|FG000|COMPLETED|Overall Study||2
10554019|NCT01554683|11708529|FG001|COMPLETED|Overall Study||1
10554020|NCT01554683|11708530|FG002|COMPLETED|Overall Study||3
10554021|NCT01554683|11708531|FG003|COMPLETED|Overall Study||2
10554022|NCT01554683|11708532|FG004|COMPLETED|Overall Study||1
10554023|NCT01554683|11708533|FG005|COMPLETED|Overall Study||0
10554024|NCT01554683|11708528|FG000|NOT COMPLETED|Overall Study||0
10554025|NCT01554683|11708529|FG001|NOT COMPLETED|Overall Study||0
10554026|NCT01554683|11708530|FG002|NOT COMPLETED|Overall Study||0
10554027|NCT01554683|11708531|FG003|NOT COMPLETED|Overall Study||0
10554028|NCT01554683|11708532|FG004|NOT COMPLETED|Overall Study||0
10554029|NCT01554683|11708533|FG005|NOT COMPLETED|Overall Study||0
10554030|NCT01554891|11708544|FG000|STARTED|Overall Study||105
10554031|NCT01554891|11708545|FG001|STARTED|Overall Study||120
10554032|NCT01554891|11708546|FG002|STARTED|Overall Study||57
10554033|NCT01554891|11708544|FG000|COMPLETED|Overall Study||98
10554034|NCT01554891|11708545|FG001|COMPLETED|Overall Study||115
10554035|NCT01554891|11708546|FG002|COMPLETED|Overall Study||55
10554036|NCT01554891|11708544|FG000|NOT COMPLETED|Overall Study||7
10554037|NCT01554891|11708545|FG001|NOT COMPLETED|Overall Study||5
10554038|NCT01554891|11708546|FG002|NOT COMPLETED|Overall Study||2
10554039|NCT01554904|11708554|FG000|STARTED|Overall Study||18
10554040|NCT01554904|11708554|FG000|Home Sleep Study 1|Overall Study|After informed consent signed.|18
10554041|NCT01554904|11708554|FG000|Start 6 Weeks of Facial Training|Overall Study|1 participant was found to have obstructive sleep apnea on the home sleep study #1|17
10554042|NCT01554904|11708554|FG000|Complete 6 Weeks of Facial Training|Overall Study|3 subjects withdrew during training|14
10554043|NCT01554904|11708554|FG000|Home Sleep Study 2|Overall Study||14
10554044|NCT01554904|11708554|FG000|COMPLETED|Overall Study||14
10554045|NCT01554904|11708554|FG000|NOT COMPLETED|Overall Study||4
10554046|NCT01554982|11708558|FG000|STARTED|Overall Study||168
10554047|NCT01554982|11708558|FG000|Received Drug|Overall Study||166
10554048|NCT01554982|11708558|FG000|COMPLETED|Overall Study||125
10554049|NCT01554982|11708558|FG000|NOT COMPLETED|Overall Study||43
10554050|NCT01555125|11708565|FG000|STARTED|Induction Period||59
10554051|NCT01555125|11708566|FG001|STARTED|Induction Period||59
10554052|NCT01555125|11708567|FG002|STARTED|Induction Period||0
10554053|NCT01555125|11708568|FG003|STARTED|Induction Period||0
10554054|NCT01555125|11708569|FG004|STARTED|Induction Period||59
10554055|NCT01555125|11708565|FG000|COMPLETED|Induction Period||58
10554056|NCT01555125|11708566|FG001|COMPLETED|Induction Period||56
10554057|NCT01555125|11708567|FG002|COMPLETED|Induction Period||0
10554058|NCT01555125|11708568|FG003|COMPLETED|Induction Period||0
10554059|NCT01555125|11708569|FG004|COMPLETED|Induction Period||56
10554060|NCT01555125|11708565|FG000|NOT COMPLETED|Induction Period||1
10554061|NCT01555125|11708566|FG001|NOT COMPLETED|Induction Period||3
10554062|NCT01555125|11708567|FG002|NOT COMPLETED|Induction Period||0
10554063|NCT01555125|11708568|FG003|NOT COMPLETED|Induction Period||0
10554064|NCT01555125|11708569|FG004|NOT COMPLETED|Induction Period||3
10554065|NCT01555125|11708565|FG000|STARTED|Maintenance Period||58
10554066|NCT01555125|11708566|FG001|STARTED|Maintenance Period||56
10554067|NCT01555125|11708567|FG002|STARTED|Maintenance Period||29
10554068|NCT01555125|11708568|FG003|STARTED|Maintenance Period||27
10554069|NCT01555125|11708569|FG004|STARTED|Maintenance Period||0
10554070|NCT01555125|11708565|FG000|COMPLETED|Maintenance Period||48
10554071|NCT01555125|11708566|FG001|COMPLETED|Maintenance Period||52
10554072|NCT01555125|11708567|FG002|COMPLETED|Maintenance Period||25
10554073|NCT01555125|11708568|FG003|COMPLETED|Maintenance Period||25
10554074|NCT01555125|11708569|FG004|COMPLETED|Maintenance Period||0
10554075|NCT01555125|11708565|FG000|NOT COMPLETED|Maintenance Period||10
10554076|NCT01555125|11708566|FG001|NOT COMPLETED|Maintenance Period||4
10554077|NCT01555125|11708567|FG002|NOT COMPLETED|Maintenance Period||4
10554078|NCT01555125|11708568|FG003|NOT COMPLETED|Maintenance Period||2
10554079|NCT01555125|11708569|FG004|NOT COMPLETED|Maintenance Period||0
10554080|NCT01555125|11708565|FG000|STARTED|Extension||46
10554081|NCT01555125|11708566|FG001|STARTED|Extension||51
10554082|NCT01555125|11708567|FG002|STARTED|Extension||23
10554083|NCT01555125|11708568|FG003|STARTED|Extension||23
10554084|NCT01555125|11708569|FG004|STARTED|Extension||0
10554085|NCT01555125|11708565|FG000|COMPLETED|Extension||1
10554086|NCT01555125|11708566|FG001|COMPLETED|Extension||0
10554087|NCT01555125|11708567|FG002|COMPLETED|Extension||0
10554088|NCT01555125|11708568|FG003|COMPLETED|Extension||1
10554089|NCT01555125|11708569|FG004|COMPLETED|Extension||0
10554090|NCT01555125|11708565|FG000|NOT COMPLETED|Extension||45
10554091|NCT01555125|11708566|FG001|NOT COMPLETED|Extension||51
10554092|NCT01555125|11708567|FG002|NOT COMPLETED|Extension||23
10554093|NCT01555125|11708568|FG003|NOT COMPLETED|Extension||22
10554094|NCT01555125|11708569|FG004|NOT COMPLETED|Extension||0
10554095|NCT01555125|11708565|FG000|STARTED|Follow-Up Period||36
10554096|NCT01555125|11708566|FG001|STARTED|Follow-Up Period||31
10554097|NCT01555125|11708567|FG002|STARTED|Follow-Up Period||19
10554098|NCT01555125|11708568|FG003|STARTED|Follow-Up Period||18
10554099|NCT01555125|11708569|FG004|STARTED|Follow-Up Period||0
10554100|NCT01555125|11708565|FG000|COMPLETED|Follow-Up Period||32
10554101|NCT01555125|11708566|FG001|COMPLETED|Follow-Up Period||30
10554102|NCT01555125|11708567|FG002|COMPLETED|Follow-Up Period||18
10554103|NCT01555125|11708568|FG003|COMPLETED|Follow-Up Period||17
10554104|NCT01555125|11708569|FG004|COMPLETED|Follow-Up Period||0
10554105|NCT01555125|11708565|FG000|NOT COMPLETED|Follow-Up Period||4
10554106|NCT01555125|11708566|FG001|NOT COMPLETED|Follow-Up Period||1
10554107|NCT01555125|11708567|FG002|NOT COMPLETED|Follow-Up Period||1
10554108|NCT01555125|11708568|FG003|NOT COMPLETED|Follow-Up Period||1
10554109|NCT01555125|11708569|FG004|NOT COMPLETED|Follow-Up Period||0
10554110|NCT01555138|11708586|FG000|STARTED|Overall Study||293
10554111|NCT01555138|11708587|FG001|STARTED|Overall Study||288
10554112|NCT01555138|11708586|FG000|COMPLETED|Overall Study||246
10554113|NCT01555138|11708587|FG001|COMPLETED|Overall Study||250
10554114|NCT01555138|11708586|FG000|NOT COMPLETED|Overall Study||47
10554115|NCT01555138|11708587|FG001|NOT COMPLETED|Overall Study||38
10554116|NCT01555151|11708597|FG000|STARTED|Overall Study||188
10554117|NCT01555151|11708598|FG001|STARTED|Overall Study||181
10554118|NCT01555151|11708599|FG002|STARTED|Overall Study||184
10554119|NCT01555151|11708600|FG003|STARTED|Overall Study||186
10554120|NCT01555151|11708597|FG000|Safety Set (SAF)|Overall Study||186
10554121|NCT01555151|11708598|FG001|Safety Set (SAF)|Overall Study||180
10554122|NCT01555151|11708599|FG002|Safety Set (SAF)|Overall Study||183
10554123|NCT01555151|11708600|FG003|Safety Set (SAF)|Overall Study||186
10554124|NCT01555151|11708597|FG000|COMPLETED|Overall Study||175
10554125|NCT01555151|11708598|FG001|COMPLETED|Overall Study||173
10554126|NCT01555151|11708599|FG002|COMPLETED|Overall Study||178
10554127|NCT01555151|11708600|FG003|COMPLETED|Overall Study||176
10554128|NCT01555151|11708597|FG000|NOT COMPLETED|Overall Study||13
10554129|NCT01555151|11708598|FG001|NOT COMPLETED|Overall Study||8
10554130|NCT01555151|11708599|FG002|NOT COMPLETED|Overall Study||6
10554131|NCT01555151|11708600|FG003|NOT COMPLETED|Overall Study||10
10554132|NCT01555164|11708613|FG000|STARTED|Overall Study||222
10554133|NCT01555164|11708614|FG001|STARTED|Overall Study||220
10554134|NCT01555164|11708613|FG000|COMPLETED|Overall Study||182
10554135|NCT01555164|11708614|FG001|COMPLETED|Overall Study||185
10554136|NCT01555164|11708613|FG000|NOT COMPLETED|Overall Study||40
10554137|NCT01555164|11708614|FG001|NOT COMPLETED|Overall Study||35
10554138|NCT01555463|11708622|FG000|STARTED|Treatment||483
10554139|NCT01555463|11708623|FG001|STARTED|Treatment||478
10554140|NCT01555463|11708622|FG000|COMPLETED|Treatment||419
10554141|NCT01555463|11708623|FG001|COMPLETED|Treatment||399
10554142|NCT01555463|11708622|FG000|NOT COMPLETED|Treatment||64
10554143|NCT01555463|11708623|FG001|NOT COMPLETED|Treatment||79
10554144|NCT01555463|11708622|FG000|STARTED|Follow up|Treatment completers and non-completers were asked to participate in the follow-up phase.|447
10554145|NCT01555463|11708623|FG001|STARTED|Follow up|Treatment completers and non-completers were asked to participate in the follow-up phase.|439
10554146|NCT01555463|11708622|FG000|COMPLETED|Follow up||409
10554147|NCT01555463|11708623|FG001|COMPLETED|Follow up||394
10554148|NCT01555463|11708622|FG000|NOT COMPLETED|Follow up||38
10554149|NCT01555463|11708623|FG001|NOT COMPLETED|Follow up||45
10554150|NCT01555567|11708633|FG000|STARTED|12 Week||12
10554151|NCT01555567|11708634|FG001|STARTED|12 Week||13
10554152|NCT01555567|11708635|FG002|STARTED|12 Week||9
10554153|NCT01555567|11708636|FG003|STARTED|12 Week||9
10554154|NCT01555567|11708633|FG000|COMPLETED|12 Week||11
10554155|NCT01555567|11708634|FG001|COMPLETED|12 Week||12
10554156|NCT01555567|11708635|FG002|COMPLETED|12 Week||8
10554157|NCT01555567|11708636|FG003|COMPLETED|12 Week||9
10554158|NCT01555567|11708633|FG000|NOT COMPLETED|12 Week||1
10554159|NCT01555567|11708634|FG001|NOT COMPLETED|12 Week||1
10554160|NCT01555567|11708635|FG002|NOT COMPLETED|12 Week||1
10554161|NCT01555567|11708636|FG003|NOT COMPLETED|12 Week||0
10554162|NCT01555567|11708633|FG000|STARTED|Return to Activity||11
10554163|NCT01555567|11708634|FG001|STARTED|Return to Activity||12
10554164|NCT01555567|11708635|FG002|STARTED|Return to Activity||8
10554165|NCT01555567|11708636|FG003|STARTED|Return to Activity||9
10554166|NCT01555567|11708633|FG000|COMPLETED|Return to Activity||10
10554167|NCT01555567|11708634|FG001|COMPLETED|Return to Activity||10
10554168|NCT01555567|11708635|FG002|COMPLETED|Return to Activity||8
10554169|NCT01555567|11708636|FG003|COMPLETED|Return to Activity||8
10554170|NCT01555567|11708633|FG000|NOT COMPLETED|Return to Activity||1
10554171|NCT01555567|11708634|FG001|NOT COMPLETED|Return to Activity||2
10554172|NCT01555567|11708635|FG002|NOT COMPLETED|Return to Activity||0
10554173|NCT01555567|11708636|FG003|NOT COMPLETED|Return to Activity||1
10554174|NCT01555671|11708648|FG000|STARTED|Overall Study||125
10554175|NCT01555671|11708649|FG001|STARTED|Overall Study||125
10554176|NCT01555671|11708648|FG000|COMPLETED|Overall Study||105
10554177|NCT01555671|11708649|FG001|COMPLETED|Overall Study||100
10554178|NCT01555671|11708648|FG000|NOT COMPLETED|Overall Study||20
10554179|NCT01555671|11708649|FG001|NOT COMPLETED|Overall Study||25
10554228|NCT01555762|11708684|FG000|STARTED|Overall Study||402
10554229|NCT01555762|11708684|FG000|Safety Population|Overall Study||383
10554230|NCT01555762|11708684|FG000|Efficacy Population|Overall Study||358
10554231|NCT01555762|11708684|FG000|COMPLETED|Overall Study||128
10554232|NCT01555762|11708684|FG000|NOT COMPLETED|Overall Study||274
10554233|NCT01555931|11708690|FG000|STARTED|Overall Study||17
10554234|NCT01555931|11708691|FG001|STARTED|Overall Study||18
10554235|NCT01555931|11708690|FG000|COMPLETED|Overall Study||15
10554236|NCT01555931|11708691|FG001|COMPLETED|Overall Study||13
10554237|NCT01555931|11708690|FG000|NOT COMPLETED|Overall Study||2
10554238|NCT01555931|11708691|FG001|NOT COMPLETED|Overall Study||5
10554239|NCT01555957|11708699|FG000|STARTED|Overall Study||20
10554240|NCT01555957|11708700|FG001|STARTED|Overall Study||20
10554241|NCT01555957|11708699|FG000|COMPLETED|Overall Study||20
10554242|NCT01555957|11708700|FG001|COMPLETED|Overall Study||20
10554243|NCT01555957|11708699|FG000|NOT COMPLETED|Overall Study||0
10554244|NCT01555957|11708700|FG001|NOT COMPLETED|Overall Study||0
10554245|NCT01555983|11708706|FG000|STARTED|Overall Study||9
10554246|NCT01555983|11708707|FG001|STARTED|Overall Study||7
10554247|NCT01555983|11708708|FG002|STARTED|Overall Study||7
10554248|NCT01555983|11708709|FG003|STARTED|Overall Study||7
10554249|NCT01555983|11708710|FG004|STARTED|Overall Study||5
10554250|NCT01555983|11708711|FG005|STARTED|Overall Study||7
10554251|NCT01555983|11708706|FG000|COMPLETED|Overall Study|One subject only finished the placebo session, then dropped out of study|8
10554252|NCT01555983|11708707|FG001|COMPLETED|Overall Study||7
10554253|NCT01555983|11708708|FG002|COMPLETED|Overall Study||7
10554254|NCT01555983|11708709|FG003|COMPLETED|Overall Study||7
10554255|NCT01555983|11708710|FG004|COMPLETED|Overall Study|One subject complete 6.7%THC and placebo sessions, then dropped out|4
10554256|NCT01555983|11708711|FG005|COMPLETED|Overall Study|One subject completed the 6.7%THC session, then dropped out.|6
10554257|NCT01555983|11708706|FG000|NOT COMPLETED|Overall Study||1
10554258|NCT01555983|11708707|FG001|NOT COMPLETED|Overall Study||0
10554259|NCT01555983|11708708|FG002|NOT COMPLETED|Overall Study||0
10554260|NCT01555983|11708709|FG003|NOT COMPLETED|Overall Study||0
10554261|NCT01555983|11708710|FG004|NOT COMPLETED|Overall Study||1
10554262|NCT01555983|11708711|FG005|NOT COMPLETED|Overall Study||1
10554263|NCT01556061|11708721|FG000|STARTED|Overall Study||25
10554264|NCT01556061|11708722|FG001|STARTED|Overall Study||25
10554265|NCT01556061|11708721|FG000|COMPLETED|Overall Study||25
10554266|NCT01556061|11708722|FG001|COMPLETED|Overall Study||25
10554267|NCT01556061|11708721|FG000|NOT COMPLETED|Overall Study||0
10554268|NCT01556061|11708722|FG001|NOT COMPLETED|Overall Study||0
10554269|NCT01556100|11708730|FG000|STARTED|Overall Study||40
10554270|NCT01556100|11708730|FG000|COMPLETED|Overall Study||34
10554271|NCT01556100|11708730|FG000|NOT COMPLETED|Overall Study||6
10554272|NCT01556165|11708736|FG000|STARTED|Overall Study||65
10554273|NCT01556165|11708737|FG001|STARTED|Overall Study||65
10554274|NCT01556165|11708736|FG000|COMPLETED|Overall Study||53
10554275|NCT01556165|11708737|FG001|COMPLETED|Overall Study||58
10554276|NCT01556165|11708736|FG000|NOT COMPLETED|Overall Study||12
10554277|NCT01556165|11708737|FG001|NOT COMPLETED|Overall Study||7
10554278|NCT01556204|11708745|FG000|STARTED|Overall Study||35
10554279|NCT01556204|11708746|FG001|STARTED|Overall Study||38
10554280|NCT01556204|11708745|FG000|COMPLETED|Overall Study||35
10554281|NCT01556204|11708746|FG001|COMPLETED|Overall Study||38
10554282|NCT01556204|11708745|FG000|NOT COMPLETED|Overall Study||0
10554283|NCT01556204|11708746|FG001|NOT COMPLETED|Overall Study||0
10554284|NCT01556347|11708752|FG000|STARTED|Induction Immunotherapy||2
10554285|NCT01556347|11708752|FG000|COMPLETED|Induction Immunotherapy||2
10554286|NCT01556347|11708752|FG000|NOT COMPLETED|Induction Immunotherapy||0
10554287|NCT01556347|11708752|FG000|STARTED|Bortezomib Treatment Phase||2
10554288|NCT01556347|11708752|FG000|COMPLETED|Bortezomib Treatment Phase||2
10554289|NCT01556347|11708752|FG000|NOT COMPLETED|Bortezomib Treatment Phase||0
10554290|NCT01556347|11708752|FG000|STARTED|Recovery Phase||2
10554291|NCT01556347|11708752|FG000|COMPLETED|Recovery Phase||2
10554292|NCT01556347|11708752|FG000|NOT COMPLETED|Recovery Phase||0
10554293|NCT01556425|11708784|FG000|STARTED|Overall Study||25
10554294|NCT01556425|11708785|FG001|STARTED|Overall Study||23
10554295|NCT01556425|11708786|FG002|STARTED|Overall Study||18
10554296|NCT01556425|11708787|FG003|STARTED|Overall Study||18
10554297|NCT01556425|11708784|FG000|COMPLETED|Overall Study||25
10554298|NCT01556425|11708785|FG001|COMPLETED|Overall Study||23
10554299|NCT01556425|11708786|FG002|COMPLETED|Overall Study||18
10554300|NCT01556425|11708787|FG003|COMPLETED|Overall Study||18
10554301|NCT01556425|11708784|FG000|NOT COMPLETED|Overall Study||0
10554302|NCT01556425|11708785|FG001|NOT COMPLETED|Overall Study||0
10554303|NCT01556425|11708786|FG002|NOT COMPLETED|Overall Study||0
10554304|NCT01556425|11708787|FG003|NOT COMPLETED|Overall Study||0
10554305|NCT01556438|11708799|FG000|STARTED|Overall Study||4
10554306|NCT01556438|11708800|FG001|STARTED|Overall Study||12
10554307|NCT01556438|11708799|FG000|Received at Least 1 Dose of Study Drug|Overall Study|100 mg tabalumab IV|4
10554308|NCT01556438|11708800|FG001|Received at Least 1 Dose of Study Drug|Overall Study|300 mg tabalumab IV|12
10554309|NCT01556438|11708799|FG000|Received BTZ IV|Overall Study||4
10554310|NCT01556438|11708800|FG001|Received BTZ IV|Overall Study||4
10554311|NCT01556438|11708799|FG000|Received BTZ SC|Overall Study||0
10554312|NCT01556438|11708800|FG001|Received BTZ SC|Overall Study||8
10554313|NCT01556438|11708799|FG000|COMPLETED|Overall Study||0
10554314|NCT01556438|11708800|FG001|COMPLETED|Overall Study||1
10554315|NCT01556438|11708799|FG000|NOT COMPLETED|Overall Study||4
10554316|NCT01556438|11708800|FG001|NOT COMPLETED|Overall Study||11
10554317|NCT01556451|11708814|FG000|STARTED|Overall Study||180
10554318|NCT01556451|11708814|FG000|COMPLETED|Overall Study||180
10554319|NCT01556451|11708814|FG000|NOT COMPLETED|Overall Study||0
10554320|NCT01556581|11708820|FG000|STARTED|Overall Study||61
10554321|NCT01556581|11708821|FG001|STARTED|Overall Study||58
10554322|NCT01556581|11708820|FG000|COMPLETED|Overall Study||61
10554323|NCT01556581|11708821|FG001|COMPLETED|Overall Study||58
10554324|NCT01556581|11708820|FG000|NOT COMPLETED|Overall Study||0
10554325|NCT01556581|11708821|FG001|NOT COMPLETED|Overall Study||0
10554326|NCT01556594|11708830|FG000|STARTED|Overall Study||10
10554327|NCT01556594|11708831|FG001|STARTED|Overall Study||2
10554328|NCT01556594|11708832|FG002|STARTED|Overall Study||6
10554329|NCT01556594|11708830|FG000|COMPLETED|Overall Study||10
10554330|NCT01556594|11708831|FG001|COMPLETED|Overall Study||2
10554331|NCT01556594|11708832|FG002|COMPLETED|Overall Study||6
10554332|NCT01556594|11708830|FG000|NOT COMPLETED|Overall Study||0
10554333|NCT01556594|11708831|FG001|NOT COMPLETED|Overall Study||0
10554334|NCT01556594|11708832|FG002|NOT COMPLETED|Overall Study||0
10554335|NCT01556633|11708844|FG000|STARTED|Overall Study||10
10554336|NCT01556633|11708845|FG001|STARTED|Overall Study||6
10554337|NCT01556633|11708844|FG000|COMPLETED|Overall Study||10
10554338|NCT01556633|11708845|FG001|COMPLETED|Overall Study||6
10554339|NCT01556633|11708844|FG000|NOT COMPLETED|Overall Study||0
10554340|NCT01556633|11708845|FG001|NOT COMPLETED|Overall Study||0
10554341|NCT01556724|11708856|FG000|STARTED|Overall Study||16
10554342|NCT01556724|11708857|FG001|STARTED|Overall Study||14
10554343|NCT01556724|11708856|FG000|COMPLETED|Overall Study||16
10554344|NCT01556724|11708857|FG001|COMPLETED|Overall Study||14
10554345|NCT01556724|11708856|FG000|NOT COMPLETED|Overall Study||0
10554346|NCT01556724|11708857|FG001|NOT COMPLETED|Overall Study||0
10554347|NCT01556763|11708869|FG000|STARTED|Overall Study||4
10554348|NCT01556763|11708870|FG001|STARTED|Overall Study||9
10554349|NCT01556763|11708871|FG002|STARTED|Overall Study||8
10554350|NCT01556763|11708869|FG000|COMPLETED|Overall Study||4
10554351|NCT01556763|11708870|FG001|COMPLETED|Overall Study||8
10554352|NCT01556763|11708871|FG002|COMPLETED|Overall Study||8
10554353|NCT01556763|11708869|FG000|NOT COMPLETED|Overall Study||0
10554354|NCT01556763|11708870|FG001|NOT COMPLETED|Overall Study||1
10554355|NCT01556763|11708871|FG002|NOT COMPLETED|Overall Study||0
10554356|NCT01556906|11708881|FG000|STARTED|Overall Study||6
10554357|NCT01556906|11708881|FG000|COMPLETED|Overall Study||6
10554358|NCT01556906|11708881|FG000|NOT COMPLETED|Overall Study||0
10554359|NCT01556932|11708885|FG000|STARTED|Baseline First Treatment||13
10554360|NCT01556932|11708886|FG001|STARTED|Baseline First Treatment||9
10554361|NCT01556932|11708885|FG000|Recieved|Baseline First Treatment||13
10554362|NCT01556932|11708886|FG001|Recieved|Baseline First Treatment||9
10554363|NCT01556932|11708885|FG000|COMPLETED|Baseline First Treatment||13
10554364|NCT01556932|11708886|FG001|COMPLETED|Baseline First Treatment||9
10554365|NCT01556932|11708885|FG000|NOT COMPLETED|Baseline First Treatment||0
10554366|NCT01556932|11708886|FG001|NOT COMPLETED|Baseline First Treatment||0
10554367|NCT01556932|11708885|FG000|STARTED|Time Point 60 Minutes|1 subject withdrew and never started second treatment.|13
10554368|NCT01556932|11708886|FG001|STARTED|Time Point 60 Minutes|1 subject withdrew and never started second treatment.|9
10554369|NCT01556932|11708885|FG000|Recieved|Time Point 60 Minutes||12
10554370|NCT01556932|11708886|FG001|Recieved|Time Point 60 Minutes||8
10554371|NCT01556932|11708885|FG000|COMPLETED|Time Point 60 Minutes||12
10554372|NCT01556932|11708886|FG001|COMPLETED|Time Point 60 Minutes||8
10554373|NCT01556932|11708885|FG000|NOT COMPLETED|Time Point 60 Minutes||1
10554374|NCT01556932|11708886|FG001|NOT COMPLETED|Time Point 60 Minutes||1
10554375|NCT01556932|11708885|FG000|STARTED|Second Treament||12
10554376|NCT01556932|11708886|FG001|STARTED|Second Treament||8
10554377|NCT01556932|11708885|FG000|Recieved|Second Treament||12
10554378|NCT01556932|11708886|FG001|Recieved|Second Treament||8
10554379|NCT01556932|11708885|FG000|COMPLETED|Second Treament||12
10554380|NCT01556932|11708886|FG001|COMPLETED|Second Treament||8
10554381|NCT01556932|11708885|FG000|NOT COMPLETED|Second Treament||0
10554382|NCT01556932|11708886|FG001|NOT COMPLETED|Second Treament||0
10554383|NCT01556997|11708894|FG000|STARTED|Overall Study||279
10554384|NCT01556997|11708895|FG001|STARTED|Overall Study||280
10790450|NCT03540147|11950970|FG000|STARTED|Overall Study||20
10790451|NCT03540147|11950970|FG000|COMPLETED|Overall Study||20
10790452|NCT03540147|11950970|FG000|NOT COMPLETED|Overall Study||0
10790453|NCT03540160|11950982|FG000|STARTED|Overall Study||558
10554385|NCT01556997|11708896|FG002|STARTED|Overall Study||278
10554386|NCT01556997|11708894|FG000|COMPLETED|Overall Study||253
10554387|NCT01556997|11708895|FG001|COMPLETED|Overall Study||252
10554388|NCT01556997|11708896|FG002|COMPLETED|Overall Study||246
10554389|NCT01556997|11708894|FG000|NOT COMPLETED|Overall Study||26
10554390|NCT01556997|11708895|FG001|NOT COMPLETED|Overall Study||28
10554391|NCT01556997|11708896|FG002|NOT COMPLETED|Overall Study||32
10554392|NCT01557166|11708906|FG000|STARTED|Overall Study||180
10554393|NCT01557166|11708907|FG001|STARTED|Overall Study||179
10554394|NCT01557166|11708906|FG000|Exposed|Overall Study||176
10554395|NCT01557166|11708907|FG001|Exposed|Overall Study||179
10554396|NCT01557166|11708906|FG000|COMPLETED|Overall Study||134
10554397|NCT01557166|11708907|FG001|COMPLETED|Overall Study||142
10554398|NCT01557166|11708906|FG000|NOT COMPLETED|Overall Study||46
10554399|NCT01557166|11708907|FG001|NOT COMPLETED|Overall Study||37
10554400|NCT01557244|11708918|FG000|STARTED|Active Comparator/Efficacy Phase:12Weeks||42
10554401|NCT01557244|11708919|FG001|STARTED|Active Comparator/Efficacy Phase:12Weeks||42
10554402|NCT01557244|11708920|FG002|STARTED|Active Comparator/Efficacy Phase:12Weeks||40
10554403|NCT01557244|11708921|FG003|STARTED|Active Comparator/Efficacy Phase:12Weeks||0
10554404|NCT01557244|11708922|FG004|STARTED|Active Comparator/Efficacy Phase:12Weeks||0
10554405|NCT01557244|11708923|FG005|STARTED|Active Comparator/Efficacy Phase:12Weeks||28
10554406|NCT01557244|11708924|FG006|STARTED|Active Comparator/Efficacy Phase:12Weeks||29
10554407|NCT01557244|11708918|FG000|Treated|Active Comparator/Efficacy Phase:12Weeks||42
10554408|NCT01557244|11708919|FG001|Treated|Active Comparator/Efficacy Phase:12Weeks||42
10554409|NCT01557244|11708920|FG002|Treated|Active Comparator/Efficacy Phase:12Weeks||40
10554410|NCT01557244|11708921|FG003|Treated|Active Comparator/Efficacy Phase:12Weeks||0
10554411|NCT01557244|11708922|FG004|Treated|Active Comparator/Efficacy Phase:12Weeks||0
10554412|NCT01557244|11708923|FG005|Treated|Active Comparator/Efficacy Phase:12Weeks||28
10554413|NCT01557244|11708924|FG006|Treated|Active Comparator/Efficacy Phase:12Weeks||29
10554414|NCT01557244|11708918|FG000|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||33
10554415|NCT01557244|11708919|FG001|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||40
10554416|NCT01557244|11708920|FG002|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||36
10554417|NCT01557244|11708921|FG003|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||0
10554418|NCT01557244|11708922|FG004|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||0
10554419|NCT01557244|11708923|FG005|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||21
10554420|NCT01557244|11708924|FG006|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||28
10554421|NCT01557244|11708918|FG000|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||9
10554422|NCT01557244|11708919|FG001|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||2
10554423|NCT01557244|11708920|FG002|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||4
10554424|NCT01557244|11708921|FG003|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||0
10554425|NCT01557244|11708922|FG004|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||0
10554426|NCT01557244|11708923|FG005|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||7
10554427|NCT01557244|11708924|FG006|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||1
10554428|NCT01557244|11708918|FG000|STARTED|Safety Extension Phase: 12 Weeks||33
10554429|NCT01557244|11708919|FG001|STARTED|Safety Extension Phase: 12 Weeks||40
10554430|NCT01557244|11708920|FG002|STARTED|Safety Extension Phase: 12 Weeks|Did not receive oxybutynin in safety extension phase.|0
10554431|NCT01557244|11708921|FG003|STARTED|Safety Extension Phase: 12 Weeks|Allocated from oxybutynin arm to this arm by investigator in safety extension phase.|16
10554432|NCT01557244|11708922|FG004|STARTED|Safety Extension Phase: 12 Weeks|Allocated from oxybutynin arm to this arm by investigator in safety extension phase.|20
10554433|NCT01557244|11708923|FG005|STARTED|Safety Extension Phase: 12 Weeks||21
10554434|NCT01557244|11708924|FG006|STARTED|Safety Extension Phase: 12 Weeks||28
10554435|NCT01557244|11708918|FG000|Treated|Safety Extension Phase: 12 Weeks||30
10554436|NCT01557244|11708919|FG001|Treated|Safety Extension Phase: 12 Weeks||37
10554437|NCT01557244|11708920|FG002|Treated|Safety Extension Phase: 12 Weeks||0
10554438|NCT01557244|11708921|FG003|Treated|Safety Extension Phase: 12 Weeks||16
10554439|NCT01557244|11708922|FG004|Treated|Safety Extension Phase: 12 Weeks||20
10554440|NCT01557244|11708923|FG005|Treated|Safety Extension Phase: 12 Weeks||20
10554441|NCT01557244|11708924|FG006|Treated|Safety Extension Phase: 12 Weeks||28
10554442|NCT01557244|11708918|FG000|COMPLETED|Safety Extension Phase: 12 Weeks||30
10554443|NCT01557244|11708919|FG001|COMPLETED|Safety Extension Phase: 12 Weeks||36
10554444|NCT01557244|11708920|FG002|COMPLETED|Safety Extension Phase: 12 Weeks||0
10554445|NCT01557244|11708921|FG003|COMPLETED|Safety Extension Phase: 12 Weeks||15
10554446|NCT01557244|11708922|FG004|COMPLETED|Safety Extension Phase: 12 Weeks||20
10554447|NCT01557244|11708923|FG005|COMPLETED|Safety Extension Phase: 12 Weeks||20
10554448|NCT01557244|11708924|FG006|COMPLETED|Safety Extension Phase: 12 Weeks||28
10554449|NCT01557244|11708918|FG000|NOT COMPLETED|Safety Extension Phase: 12 Weeks||3
10554450|NCT01557244|11708919|FG001|NOT COMPLETED|Safety Extension Phase: 12 Weeks||4
10554451|NCT01557244|11708920|FG002|NOT COMPLETED|Safety Extension Phase: 12 Weeks||0
10554452|NCT01557244|11708921|FG003|NOT COMPLETED|Safety Extension Phase: 12 Weeks||1
10554453|NCT01557244|11708922|FG004|NOT COMPLETED|Safety Extension Phase: 12 Weeks||0
10554454|NCT01557244|11708923|FG005|NOT COMPLETED|Safety Extension Phase: 12 Weeks||1
10554455|NCT01557244|11708924|FG006|NOT COMPLETED|Safety Extension Phase: 12 Weeks||0
10554456|NCT01557283|11708952|FG000|STARTED|Overall Study||140
10554457|NCT01557283|11708952|FG000|COMPLETED|Overall Study||96
10554458|NCT01557283|11708952|FG000|NOT COMPLETED|Overall Study||44
10554459|NCT01557322|11708958|FG000|STARTED|Overall Study||211
10554460|NCT01557322|11708959|FG001|STARTED|Overall Study||1543
10554461|NCT01557322|11708958|FG000|COMPLETED|Overall Study||211
10554462|NCT01557322|11708959|FG001|COMPLETED|Overall Study||1543
10554463|NCT01557322|11708958|FG000|NOT COMPLETED|Overall Study||0
10554464|NCT01557322|11708959|FG001|NOT COMPLETED|Overall Study||0
10554465|NCT01557348|11708967|FG000|STARTED|Overall Study||604
10554466|NCT01557348|11708968|FG001|STARTED|Overall Study||507
10554467|NCT01557348|11708967|FG000|Safety Population|Overall Study||604
10554468|NCT01557348|11708968|FG001|Safety Population|Overall Study||507
10554469|NCT01557348|11708967|FG000|COMPLETED|Overall Study||524
10554470|NCT01557348|11708968|FG001|COMPLETED|Overall Study||417
10554471|NCT01557348|11708967|FG000|NOT COMPLETED|Overall Study||80
10554472|NCT01557348|11708968|FG001|NOT COMPLETED|Overall Study||90
10554473|NCT01557400|11708975|FG000|STARTED|Overall Study||94
10554474|NCT01557400|11708975|FG000|Received at Least 1 Dose of Study Drug|Overall Study||94
10554475|NCT01557400|11708975|FG000|COMPLETED|Overall Study||37
10554476|NCT01557400|11708975|FG000|NOT COMPLETED|Overall Study||57
10554477|NCT01557452|11708979|FG000|STARTED|Overall Study||1
10554478|NCT01557452|11708979|FG000|COMPLETED|Overall Study||1
10554479|NCT01557452|11708979|FG000|NOT COMPLETED|Overall Study||0
10554480|NCT01557504|11708986|FG000|STARTED|Overall Study||13
10554481|NCT01557504|11708987|FG001|STARTED|Overall Study||12
10554482|NCT01557504|11708986|FG000|COMPLETED|Overall Study||12
10554483|NCT01557504|11708987|FG001|COMPLETED|Overall Study||12
10554484|NCT01557504|11708986|FG000|NOT COMPLETED|Overall Study||1
10554485|NCT01557504|11708987|FG001|NOT COMPLETED|Overall Study||0
10554486|NCT01557517|11709001|FG000|STARTED|Overall Study||19
10554487|NCT01557517|11709002|FG001|STARTED|Overall Study||21
10554488|NCT01557517|11709001|FG000|COMPLETED|Overall Study||17
10554489|NCT01557517|11709002|FG001|COMPLETED|Overall Study||17
10554490|NCT01557517|11709001|FG000|NOT COMPLETED|Overall Study||2
10554491|NCT01557517|11709002|FG001|NOT COMPLETED|Overall Study||4
10554492|NCT01557569|11709017|FG000|STARTED|Overall Study|Those who received at least one dose of medication|6
10554493|NCT01557569|11709018|FG001|STARTED|Overall Study|Those who received at least one dose of medication|7
10554494|NCT01557569|11709017|FG000|Completed 2-wk Residential Stay|Overall Study||3
10554495|NCT01557569|11709018|FG001|Completed 2-wk Residential Stay|Overall Study||1
10554496|NCT01557569|11709017|FG000|COMPLETED|Overall Study||1
10554497|NCT01557569|11709018|FG001|COMPLETED|Overall Study||0
10554498|NCT01557569|11709017|FG000|NOT COMPLETED|Overall Study||5
10554499|NCT01557569|11709018|FG001|NOT COMPLETED|Overall Study||7
10554500|NCT01557582|11709024|FG000|STARTED|Overall Study||103
10554501|NCT01557582|11709024|FG000|COMPLETED|Overall Study||97
10554502|NCT01557582|11709024|FG000|NOT COMPLETED|Overall Study||6
10554503|NCT01557595|11709028|FG000|STARTED|Overall Study||22
10554504|NCT01557595|11709028|FG000|COMPLETED|Overall Study||14
10554505|NCT01557595|11709028|FG000|NOT COMPLETED|Overall Study||8
10554506|NCT01557699|11709035|FG000|STARTED|Overall Study||20
10554507|NCT01557699|11709036|FG001|STARTED|Overall Study||20
10554508|NCT01557699|11709037|FG002|STARTED|Overall Study||20
10554509|NCT01557699|11709035|FG000|COMPLETED|Overall Study||20
10554510|NCT01557699|11709036|FG001|COMPLETED|Overall Study||20
10554511|NCT01557699|11709037|FG002|COMPLETED|Overall Study||20
10554512|NCT01557699|11709035|FG000|NOT COMPLETED|Overall Study||0
10554513|NCT01557699|11709036|FG001|NOT COMPLETED|Overall Study||0
10554514|NCT01557699|11709037|FG002|NOT COMPLETED|Overall Study||0
10554515|NCT01557790|11709048|FG000|STARTED|Overall Study||5
10554516|NCT01557790|11709048|FG000|COMPLETED|Overall Study||4
10554517|NCT01557790|11709048|FG000|NOT COMPLETED|Overall Study||1
10554518|NCT01557842|11709054|FG000|STARTED|Overall Study||9
10554519|NCT01557842|11709055|FG001|STARTED|Overall Study||6
10554520|NCT01557842|11709054|FG000|COMPLETED|Overall Study||0
10554521|NCT01557842|11709055|FG001|COMPLETED|Overall Study||0
10554522|NCT01557842|11709054|FG000|NOT COMPLETED|Overall Study||9
10554523|NCT01557842|11709055|FG001|NOT COMPLETED|Overall Study||6
10554524|NCT01557868|11709063|FG000|STARTED|Overall Study||103
10554525|NCT01557868|11709064|FG001|STARTED|Overall Study||95
10554526|NCT01557868|11709063|FG000|COMPLETED|Overall Study||76
10554527|NCT01557868|11709064|FG001|COMPLETED|Overall Study||65
10554528|NCT01557868|11709063|FG000|NOT COMPLETED|Overall Study||27
10554529|NCT01557868|11709064|FG001|NOT COMPLETED|Overall Study||30
10554530|NCT01557894|11709072|FG000|STARTED|Overall Study||38
10554531|NCT01557894|11709073|FG001|STARTED|Overall Study||38
10554532|NCT01557894|11709072|FG000|COMPLETED|Overall Study||35
10554533|NCT01557894|11709073|FG001|COMPLETED|Overall Study||33
10554534|NCT01557894|11709072|FG000|NOT COMPLETED|Overall Study||3
10554535|NCT01557894|11709073|FG001|NOT COMPLETED|Overall Study||5
10554536|NCT01557920|11709080|FG000|STARTED|Overall Study||9
10554537|NCT01557920|11709081|FG001|STARTED|Overall Study||9
10554538|NCT01557920|11709080|FG000|COMPLETED|Overall Study||6
10554539|NCT01557920|11709081|FG001|COMPLETED|Overall Study||6
10554540|NCT01557920|11709080|FG000|NOT COMPLETED|Overall Study||3
10554541|NCT01557920|11709081|FG001|NOT COMPLETED|Overall Study||3
10554542|NCT01557946|11709116|FG000|STARTED|Overall Study||20
10554543|NCT01557946|11709117|FG001|STARTED|Overall Study||12
10554544|NCT01557946|11709116|FG000|COMPLETED|Overall Study|20 consented and scanned - 1 subject's data not used due to ongoing neurological condition.|17
10554545|NCT01557946|11709117|FG001|COMPLETED|Overall Study|2 subjects with unusable imaging data.|12
10554546|NCT01557946|11709116|FG000|NOT COMPLETED|Overall Study||3
10554547|NCT01557946|11709117|FG001|NOT COMPLETED|Overall Study||0
10554548|NCT01557959|11709122|FG000|STARTED|Overall Study||45
10554549|NCT01557959|11709122|FG000|COMPLETED|Overall Study||45
10554550|NCT01557959|11709122|FG000|NOT COMPLETED|Overall Study||0
10554551|NCT01558063|11709134|FG000|STARTED|Overall Study||5
10554552|NCT01558063|11709135|FG001|STARTED|Overall Study||6
10554553|NCT01558063|11709136|FG002|STARTED|Overall Study||8
10554554|NCT01558063|11709137|FG003|STARTED|Overall Study||5
10554555|NCT01558063|11709138|FG004|STARTED|Overall Study||9
10554556|NCT01558063|11709139|FG005|STARTED|Overall Study||5
10554557|NCT01558063|11709134|FG000|COMPLETED|Overall Study||5
10554558|NCT01558063|11709135|FG001|COMPLETED|Overall Study||6
10554559|NCT01558063|11709136|FG002|COMPLETED|Overall Study||8
10554560|NCT01558063|11709137|FG003|COMPLETED|Overall Study||5
10554561|NCT01558063|11709138|FG004|COMPLETED|Overall Study||9
10554562|NCT01558063|11709139|FG005|COMPLETED|Overall Study||5
10554563|NCT01558063|11709134|FG000|NOT COMPLETED|Overall Study||0
10554564|NCT01558063|11709135|FG001|NOT COMPLETED|Overall Study||0
10554565|NCT01558063|11709136|FG002|NOT COMPLETED|Overall Study||0
10554566|NCT01558063|11709137|FG003|NOT COMPLETED|Overall Study||0
10554567|NCT01558063|11709138|FG004|NOT COMPLETED|Overall Study||0
10554568|NCT01558063|11709139|FG005|NOT COMPLETED|Overall Study||0
10554569|NCT01558089|11709148|FG000|STARTED|Overall Study||76
10554570|NCT01558089|11709148|FG000|COMPLETED|Overall Study||63
10554571|NCT01558089|11709148|FG000|NOT COMPLETED|Overall Study||13
10554572|NCT01558128|11709152|FG000|STARTED|Overall Study||1
10554573|NCT01558128|11709152|FG000|COMPLETED|Overall Study||1
10554574|NCT01558128|11709152|FG000|NOT COMPLETED|Overall Study||0
10554575|NCT01558271|11709159|FG000|STARTED|Overall Study||281
10554576|NCT01558271|11709160|FG001|STARTED|Overall Study||70
10554577|NCT01558271|11709161|FG002|STARTED|Overall Study||141
10554578|NCT01558271|11709159|FG000|Received at Least 1 Dose of Study Drug|Overall Study||280
10554579|NCT01558271|11709160|FG001|Received at Least 1 Dose of Study Drug|Overall Study||70
10554580|NCT01558271|11709161|FG002|Received at Least 1 Dose of Study Drug|Overall Study||137
10554581|NCT01558271|11709159|FG000|Completed 26 Weeks|Overall Study||271
10554582|NCT01558271|11709160|FG001|Completed 26 Weeks|Overall Study||63
10554583|NCT01558271|11709161|FG002|Completed 26 Weeks|Overall Study||128
10554584|NCT01558271|11709159|FG000|COMPLETED|Overall Study||263
10554585|NCT01558271|11709160|FG001|COMPLETED|Overall Study||59
10554586|NCT01558271|11709161|FG002|COMPLETED|Overall Study||124
10554587|NCT01558271|11709159|FG000|NOT COMPLETED|Overall Study||18
10554588|NCT01558271|11709160|FG001|NOT COMPLETED|Overall Study||11
10554589|NCT01558271|11709161|FG002|NOT COMPLETED|Overall Study||17
10554590|NCT01558297|11709176|FG000|STARTED|Overall Study||30
10554591|NCT01558297|11709177|FG001|STARTED|Overall Study||29
10554592|NCT01558297|11709178|FG002|STARTED|Overall Study||30
10554593|NCT01558297|11709176|FG000|COMPLETED|Overall Study||28
10554594|NCT01558297|11709177|FG001|COMPLETED|Overall Study||27
10554595|NCT01558297|11709178|FG002|COMPLETED|Overall Study||29
10554596|NCT01558297|11709176|FG000|NOT COMPLETED|Overall Study||2
10554597|NCT01558297|11709177|FG001|NOT COMPLETED|Overall Study||2
10554598|NCT01558297|11709178|FG002|NOT COMPLETED|Overall Study||1
10554599|NCT01558596|11709188|FG000|STARTED|Overall Study||104
10554600|NCT01558596|11709189|FG001|STARTED|Overall Study||101
10554601|NCT01558596|11709188|FG000|COMPLETED|Overall Study||101
10554602|NCT01558596|11709189|FG001|COMPLETED|Overall Study||100
10554603|NCT01558596|11709188|FG000|NOT COMPLETED|Overall Study||3
10554604|NCT01558596|11709189|FG001|NOT COMPLETED|Overall Study||1
10554605|NCT01558635|11709195|FG000|STARTED|Overall Study||17
10554606|NCT01558635|11709195|FG000|Treated|Overall Study||17
10554607|NCT01558635|11709195|FG000|Discharge /1 Month Post-procedure|Overall Study||15
10554608|NCT01558635|11709195|FG000|3 Months Post-procedure|Overall Study||14
10554609|NCT01558635|11709195|FG000|6 Months Post-procedure|Overall Study||14
10554610|NCT01558635|11709195|FG000|COMPLETED|Overall Study||11
10554611|NCT01558635|11709195|FG000|NOT COMPLETED|Overall Study||6
10554612|NCT01558661|11709206|FG000|STARTED|Overall Study||33
10554613|NCT01558661|11709206|FG000|First Stage|Overall Study||18
10554614|NCT01558661|11709206|FG000|Second Stage|Overall Study||15
10554615|NCT01558661|11709206|FG000|COMPLETED|Overall Study||33
10554616|NCT01558661|11709206|FG000|NOT COMPLETED|Overall Study||0
10650653|NCT02170688|11810939|FG000|STARTED|Overall Study||29
10650654|NCT02170688|11810940|FG001|STARTED|Overall Study||29
10650655|NCT02170688|11810941|FG002|STARTED|Overall Study||29
10650656|NCT02170688|11810942|FG003|STARTED|Overall Study||27
10650657|NCT02170688|11810943|FG004|STARTED|Overall Study||25
10650658|NCT02170688|11810939|FG000|COMPLETED|Overall Study||25
10650659|NCT02170688|11810940|FG001|COMPLETED|Overall Study||26
10650660|NCT02170688|11810941|FG002|COMPLETED|Overall Study||25
10650661|NCT02170688|11810942|FG003|COMPLETED|Overall Study||25
10650662|NCT02170688|11810943|FG004|COMPLETED|Overall Study||25
10650663|NCT02170688|11810939|FG000|NOT COMPLETED|Overall Study||4
10650664|NCT02170688|11810940|FG001|NOT COMPLETED|Overall Study||3
10650665|NCT02170688|11810941|FG002|NOT COMPLETED|Overall Study||4
10650666|NCT02170688|11810942|FG003|NOT COMPLETED|Overall Study||2
10650667|NCT02170688|11810943|FG004|NOT COMPLETED|Overall Study||0
10650668|NCT02170727|11810957|FG000|STARTED|Overall Study||138
10650669|NCT02170727|11810958|FG001|STARTED|Overall Study||31
10650670|NCT02170727|11810957|FG000|COMPLETED|Overall Study||135
10650671|NCT02170727|11810958|FG001|COMPLETED|Overall Study||31
10650672|NCT02170727|11810957|FG000|NOT COMPLETED|Overall Study||3
10650673|NCT02170727|11810958|FG001|NOT COMPLETED|Overall Study||0
10650674|NCT02170779|11810969|FG000|STARTED|Overall Study||20
10650675|NCT02170779|11810970|FG001|STARTED|Overall Study||20
10650676|NCT02170779|11810969|FG000|COMPLETED|Overall Study||19
10650677|NCT02170779|11810970|FG001|COMPLETED|Overall Study||19
10650678|NCT02170779|11810969|FG000|NOT COMPLETED|Overall Study||1
10650679|NCT02170779|11810970|FG001|NOT COMPLETED|Overall Study||1
10650680|NCT02170870|11810982|FG000|STARTED|Overall Study||13
10650681|NCT02170870|11810983|FG001|STARTED|Overall Study||11
10650682|NCT02170870|11810984|FG002|STARTED|Overall Study||20
10650683|NCT02170870|11810985|FG003|STARTED|Overall Study||20
10650684|NCT02170870|11810986|FG004|STARTED|Overall Study||20
10650685|NCT02170870|11810987|FG005|STARTED|Overall Study||20
10650686|NCT02170870|11810982|FG000|COMPLETED|Overall Study||13
10650687|NCT02170870|11810983|FG001|COMPLETED|Overall Study||11
10650688|NCT02170870|11810984|FG002|COMPLETED|Overall Study||20
10650689|NCT02170870|11810985|FG003|COMPLETED|Overall Study||20
10650690|NCT02170870|11810986|FG004|COMPLETED|Overall Study||20
10650691|NCT02170870|11810987|FG005|COMPLETED|Overall Study||20
10650692|NCT02170870|11810982|FG000|NOT COMPLETED|Overall Study||0
10650693|NCT02170870|11810983|FG001|NOT COMPLETED|Overall Study||0
10650694|NCT02170870|11810984|FG002|NOT COMPLETED|Overall Study||0
10554617|NCT01558674|11709212|FG000|STARTED|Part 1||11
10554618|NCT01558674|11709213|FG001|STARTED|Part 1||0
10554619|NCT01558674|11709212|FG000|COMPLETED|Part 1||0
10554620|NCT01558674|11709213|FG001|COMPLETED|Part 1||0
10554621|NCT01558674|11709212|FG000|NOT COMPLETED|Part 1||11
10554622|NCT01558674|11709213|FG001|NOT COMPLETED|Part 1||0
10554623|NCT01558674|11709212|FG000|STARTED|Part 2||0
10554624|NCT01558674|11709213|FG001|STARTED|Part 2||0
10554625|NCT01558674|11709212|FG000|COMPLETED|Part 2||0
10554626|NCT01558674|11709213|FG001|COMPLETED|Part 2||0
10554627|NCT01558674|11709212|FG000|NOT COMPLETED|Part 2||0
10554628|NCT01558674|11709213|FG001|NOT COMPLETED|Part 2||0
10554629|NCT01558700|11709234|FG000|STARTED|Overall Study||19
10554630|NCT01558700|11709235|FG001|STARTED|Overall Study||21
10554631|NCT01558700|11709234|FG000|COMPLETED|Overall Study||19
10554632|NCT01558700|11709235|FG001|COMPLETED|Overall Study||21
10554633|NCT01558700|11709234|FG000|NOT COMPLETED|Overall Study||0
10554634|NCT01558700|11709235|FG001|NOT COMPLETED|Overall Study||0
10554635|NCT01558739|11709241|FG000|STARTED|Overall Study||48
10554636|NCT01558739|11709241|FG000|COMPLETED|Overall Study||31
10554637|NCT01558739|11709241|FG000|NOT COMPLETED|Overall Study||17
10554638|NCT01558752|11709247|FG000|STARTED|Overall Study||42
10554639|NCT01558752|11709248|FG001|STARTED|Overall Study||46
10554640|NCT01558752|11709247|FG000|COMPLETED|Overall Study||40
10554641|NCT01558752|11709248|FG001|COMPLETED|Overall Study||46
10554642|NCT01558752|11709247|FG000|NOT COMPLETED|Overall Study||2
10554643|NCT01558752|11709248|FG001|NOT COMPLETED|Overall Study||0
10554644|NCT01558791|11709256|FG000|STARTED|Overall Study||607
10554645|NCT01558791|11709257|FG001|STARTED|Overall Study||629
10554646|NCT01558791|11709256|FG000|COMPLETED|Overall Study||607
10554647|NCT01558791|11709257|FG001|COMPLETED|Overall Study||629
10554648|NCT01558791|11709256|FG000|NOT COMPLETED|Overall Study||0
10554649|NCT01558791|11709257|FG001|NOT COMPLETED|Overall Study||0
10554650|NCT01559012|11709267|FG000|STARTED|Overall Study||6
10554651|NCT01559012|11709268|FG001|STARTED|Overall Study|1 more patient added to randomization list to reach the pre-assignment number of treated patients|7
10554652|NCT01559012|11709267|FG000|COMPLETED|Overall Study||6
10554653|NCT01559012|11709268|FG001|COMPLETED|Overall Study|Patient N. 2 withdrew from study for alleged side effects at day 1 of placebo cycle.|6
10554654|NCT01559012|11709267|FG000|NOT COMPLETED|Overall Study||0
10554655|NCT01559012|11709268|FG001|NOT COMPLETED|Overall Study||1
10554656|NCT01559064|11709292|FG000|STARTED|Overall Study||16
10790454|NCT03540160|11950982|FG000|COMPLETED|Overall Study||179
10790455|NCT03540160|11950982|FG000|NOT COMPLETED|Overall Study||379
10790456|NCT03541044|11950986|FG000|STARTED|Study Period 1: Up to Day 1||23
10790457|NCT03541044|11950987|FG001|STARTED|Study Period 1: Up to Day 1||23
10554657|NCT01559064|11709293|FG001|STARTED|Overall Study||40
10554658|NCT01559064|11709294|FG002|STARTED|Overall Study||59
10554659|NCT01559064|11709292|FG000|COMPLETED|Overall Study||15
10554660|NCT01559064|11709293|FG001|COMPLETED|Overall Study||39
10554661|NCT01559064|11709294|FG002|COMPLETED|Overall Study||57
10554662|NCT01559064|11709292|FG000|NOT COMPLETED|Overall Study||1
10554663|NCT01559064|11709293|FG001|NOT COMPLETED|Overall Study||1
10554664|NCT01559064|11709294|FG002|NOT COMPLETED|Overall Study||2
10554665|NCT01559090|11709305|FG000|STARTED|Stage I||6
10554666|NCT01559090|11709306|FG001|STARTED|Stage I||5
10554667|NCT01559090|11709307|FG002|STARTED|Stage I||6
10554668|NCT01559090|11709305|FG000|COMPLETED|Stage I||4
10554669|NCT01559090|11709306|FG001|COMPLETED|Stage I||3
10554670|NCT01559090|11709307|FG002|COMPLETED|Stage I||3
10554671|NCT01559090|11709305|FG000|NOT COMPLETED|Stage I||2
10554672|NCT01559090|11709306|FG001|NOT COMPLETED|Stage I||2
10554673|NCT01559090|11709307|FG002|NOT COMPLETED|Stage I||3
10554674|NCT01559090|11709305|FG000|STARTED|Stage II||4
10554675|NCT01559090|11709306|FG001|STARTED|Stage II||3
10554676|NCT01559090|11709307|FG002|STARTED|Stage II|One subject who completed Stage I did not agree to participate in Stage II|2
10554677|NCT01559090|11709305|FG000|COMPLETED|Stage II||3
10554678|NCT01559090|11709306|FG001|COMPLETED|Stage II||3
10554679|NCT01559090|11709307|FG002|COMPLETED|Stage II||2
10554680|NCT01559090|11709305|FG000|NOT COMPLETED|Stage II||1
10554681|NCT01559090|11709306|FG001|NOT COMPLETED|Stage II||0
10554682|NCT01559090|11709307|FG002|NOT COMPLETED|Stage II||0
10554683|NCT01559116|11709315|FG000|STARTED|Overall Study|Randomised|219
10554684|NCT01559116|11709315|FG000|COMPLETED|Overall Study|Completed all 4 treatment periods|193
10554685|NCT01559116|11709315|FG000|NOT COMPLETED|Overall Study||26
10554686|NCT01559129|11709334|FG000|STARTED|Treatment Phase||12
10554687|NCT01559129|11709335|FG001|STARTED|Treatment Phase||11
10554688|NCT01559129|11709334|FG000|Received Treatment|Treatment Phase||12
10554689|NCT01559129|11709335|FG001|Received Treatment|Treatment Phase||10
10554690|NCT01559129|11709334|FG000|COMPLETED|Treatment Phase||7
10554691|NCT01559129|11709335|FG001|COMPLETED|Treatment Phase||4
10554692|NCT01559129|11709334|FG000|NOT COMPLETED|Treatment Phase||5
10554693|NCT01559129|11709335|FG001|NOT COMPLETED|Treatment Phase||7
10554694|NCT01559129|11709334|FG000|STARTED|Open-label Extension Period|One participant elected not to enter the Extension Phase.|6
10554695|NCT01559129|11709335|FG001|STARTED|Open-label Extension Period|Two participants elected not to enter the Extension Phase.|2
10554696|NCT01559129|11709334|FG000|COMPLETED|Open-label Extension Period||0
10554697|NCT01559129|11709335|FG001|COMPLETED|Open-label Extension Period||0
10554698|NCT01559129|11709334|FG000|NOT COMPLETED|Open-label Extension Period||6
10554699|NCT01559129|11709335|FG001|NOT COMPLETED|Open-label Extension Period||2
10554700|NCT01559259|11709352|FG000|STARTED|Overall Study||30
10554701|NCT01559259|11709353|FG001|STARTED|Overall Study||90
10554702|NCT01559259|11709354|FG002|STARTED|Overall Study||93
10554703|NCT01559259|11709355|FG003|STARTED|Overall Study||89
10554704|NCT01559259|11709356|FG004|STARTED|Overall Study||92
10554705|NCT01559259|11709352|FG000|COMPLETED|Overall Study||30
10554706|NCT01559259|11709353|FG001|COMPLETED|Overall Study||89
10554707|NCT01559259|11709354|FG002|COMPLETED|Overall Study||92
10554708|NCT01559259|11709355|FG003|COMPLETED|Overall Study||88
10554709|NCT01559259|11709356|FG004|COMPLETED|Overall Study||92
10554710|NCT01559259|11709352|FG000|NOT COMPLETED|Overall Study||0
10554711|NCT01559259|11709353|FG001|NOT COMPLETED|Overall Study||1
10554712|NCT01559259|11709354|FG002|NOT COMPLETED|Overall Study||1
10554713|NCT01559259|11709355|FG003|NOT COMPLETED|Overall Study||1
10554714|NCT01559259|11709356|FG004|NOT COMPLETED|Overall Study||0
10554715|NCT01559311|11709371|FG000|STARTED|Overall Study|Enrollment & Baseline|30
10554716|NCT01559311|11709372|FG001|STARTED|Overall Study|Enrollment & Baseline|34
10554717|NCT01559311|11709373|FG002|STARTED|Overall Study|Enrollment & Baseline|34
10554718|NCT01559311|11709371|FG000|Implant|Overall Study||28
10554719|NCT01559311|11709372|FG001|Implant|Overall Study||34
10554720|NCT01559311|11709373|FG002|Implant|Overall Study||32
10554721|NCT01559311|11709371|FG000|1-Month|Overall Study||27
10554722|NCT01559311|11709372|FG001|1-Month|Overall Study||34
10554723|NCT01559311|11709373|FG002|1-Month|Overall Study||29
10554724|NCT01559311|11709371|FG000|3-Month|Overall Study||27
10554725|NCT01559311|11709372|FG001|3-Month|Overall Study||34
10554726|NCT01559311|11709373|FG002|3-Month|Overall Study||29
10554727|NCT01559311|11709371|FG000|6-Month|Overall Study||27
10554728|NCT01559311|11709372|FG001|6-Month|Overall Study||33
10554729|NCT01559311|11709373|FG002|6-Month|Overall Study||28
10554730|NCT01559311|11709371|FG000|COMPLETED|Overall Study|12-Month|27
10554731|NCT01559311|11709372|FG001|COMPLETED|Overall Study|12-Month|28
10554732|NCT01559311|11709373|FG002|COMPLETED|Overall Study|12-Month|26
10554733|NCT01559311|11709371|FG000|NOT COMPLETED|Overall Study||3
10554734|NCT01559311|11709372|FG001|NOT COMPLETED|Overall Study||6
10554735|NCT01559311|11709373|FG002|NOT COMPLETED|Overall Study||8
10554736|NCT01559389|11709383|FG000|STARTED|Overall Study||69
10554737|NCT01559389|11709384|FG001|STARTED|Overall Study||69
10554738|NCT01559389|11709383|FG000|COMPLETED|Overall Study||49
10554739|NCT01559389|11709384|FG001|COMPLETED|Overall Study||49
10554740|NCT01559389|11709383|FG000|NOT COMPLETED|Overall Study||20
10554741|NCT01559389|11709384|FG001|NOT COMPLETED|Overall Study||20
10554742|NCT01559454|11709396|FG000|STARTED|Overall Study||9
10554743|NCT01559454|11709397|FG001|STARTED|Overall Study||10
10554744|NCT01559454|11709396|FG000|COMPLETED|Overall Study||6
10554745|NCT01559454|11709397|FG001|COMPLETED|Overall Study||4
10554746|NCT01559454|11709396|FG000|NOT COMPLETED|Overall Study||3
10554747|NCT01559454|11709397|FG001|NOT COMPLETED|Overall Study||6
10554748|NCT01559506|11709405|FG000|STARTED|Overall Study||20
10554749|NCT01559506|11709406|FG001|STARTED|Overall Study||21
10554750|NCT01559506|11709405|FG000|COMPLETED|Overall Study||20
10554751|NCT01559506|11709406|FG001|COMPLETED|Overall Study||18
10554752|NCT01559506|11709405|FG000|NOT COMPLETED|Overall Study||0
10554753|NCT01559506|11709406|FG001|NOT COMPLETED|Overall Study||3
10554754|NCT01559649|11709414|FG000|STARTED|Overall Study||269
10554755|NCT01559649|11709415|FG001|STARTED|Overall Study|Started with 10 nurses. As an RN dropped out due to scheduling, etc, RN replaced with another RN|15
10554756|NCT01559649|11709414|FG000|COMPLETED|Overall Study|Screening not completed in 11, VFSS not completed in 2, 6 excluded from analysis. N=250 analyzed|250
10554757|NCT01559649|11709415|FG001|COMPLETED|Overall Study||9
10554758|NCT01559649|11709414|FG000|NOT COMPLETED|Overall Study||19
10554759|NCT01559649|11709415|FG001|NOT COMPLETED|Overall Study||6
10554760|NCT01559675|11709424|FG000|STARTED|Overall Study||58
10554761|NCT01559675|11709425|FG001|STARTED|Overall Study||63
10554762|NCT01559675|11709424|FG000|COMPLETED|Overall Study||43
10554763|NCT01559675|11709425|FG001|COMPLETED|Overall Study||49
10554764|NCT01559675|11709424|FG000|NOT COMPLETED|Overall Study||15
10554765|NCT01559675|11709425|FG001|NOT COMPLETED|Overall Study||14
10554766|NCT01559844|11709431|FG000|STARTED|Overall Study||61
10554767|NCT01559844|11709431|FG000|COMPLETED|Overall Study||36
10554768|NCT01559844|11709431|FG000|NOT COMPLETED|Overall Study||25
10554769|NCT01559857|11709437|FG000|STARTED|Overall Study||19
10554770|NCT01559857|11709438|FG001|STARTED|Overall Study||18
10554771|NCT01559857|11709437|FG000|COMPLETED|Overall Study||19
10554772|NCT01559857|11709438|FG001|COMPLETED|Overall Study||18
10554773|NCT01559857|11709437|FG000|NOT COMPLETED|Overall Study||0
10554774|NCT01559857|11709438|FG001|NOT COMPLETED|Overall Study||0
10554775|NCT01559922|11709448|FG000|STARTED|Overall Study||50
10554776|NCT01559922|11709449|FG001|STARTED|Overall Study||97
10554777|NCT01559922|11709448|FG000|COMPLETED|Overall Study||46
10554778|NCT01559922|11709449|FG001|COMPLETED|Overall Study||87
10554779|NCT01559922|11709448|FG000|NOT COMPLETED|Overall Study||4
10554780|NCT01559922|11709449|FG001|NOT COMPLETED|Overall Study||10
10554781|NCT01559948|11709457|FG000|STARTED|Overall Study||15
10554782|NCT01559948|11709458|FG001|STARTED|Overall Study||15
10554783|NCT01559948|11709457|FG000|COMPLETED|Overall Study||15
10554784|NCT01559948|11709458|FG001|COMPLETED|Overall Study||15
10554785|NCT01559948|11709457|FG000|NOT COMPLETED|Overall Study||0
10554786|NCT01559948|11709458|FG001|NOT COMPLETED|Overall Study||0
10554787|NCT01560143|11709468|FG000|STARTED|Overall Study||12
10554788|NCT01560143|11709468|FG000|COMPLETED|Overall Study||12
10554789|NCT01560143|11709468|FG000|NOT COMPLETED|Overall Study||0
10554790|NCT01560234|11709480|FG000|STARTED|Overall Study||16
10554791|NCT01560234|11709481|FG001|STARTED|Overall Study||4
10554792|NCT01560234|11709482|FG002|STARTED|Overall Study||4
10554793|NCT01560234|11709483|FG003|STARTED|Overall Study||3
10554794|NCT01560234|11709484|FG004|STARTED|Overall Study||4
10554795|NCT01560234|11709485|FG005|STARTED|Overall Study||4
10554796|NCT01560234|11709486|FG006|STARTED|Overall Study||4
10554797|NCT01560234|11709487|FG007|STARTED|Overall Study||8
10554798|NCT01560234|11709480|FG000|COMPLETED|Overall Study||13
10554799|NCT01560234|11709481|FG001|COMPLETED|Overall Study||4
10554800|NCT01560234|11709482|FG002|COMPLETED|Overall Study||3
10554801|NCT01560234|11709483|FG003|COMPLETED|Overall Study||3
10554802|NCT01560234|11709484|FG004|COMPLETED|Overall Study||4
10554803|NCT01560234|11709485|FG005|COMPLETED|Overall Study||2
10554804|NCT01560234|11709486|FG006|COMPLETED|Overall Study||4
10554805|NCT01560234|11709487|FG007|COMPLETED|Overall Study||6
10554806|NCT01560234|11709480|FG000|NOT COMPLETED|Overall Study||3
10554807|NCT01560234|11709481|FG001|NOT COMPLETED|Overall Study||0
10554808|NCT01560234|11709482|FG002|NOT COMPLETED|Overall Study||1
10554809|NCT01560234|11709483|FG003|NOT COMPLETED|Overall Study||0
10554810|NCT01560234|11709484|FG004|NOT COMPLETED|Overall Study||0
10554811|NCT01560234|11709485|FG005|NOT COMPLETED|Overall Study||2
10554812|NCT01560234|11709486|FG006|NOT COMPLETED|Overall Study||0
10554813|NCT01560234|11709487|FG007|NOT COMPLETED|Overall Study||2
10554814|NCT01560260|11709505|FG000|STARTED|Overall Study||20
10554815|NCT01560260|11709505|FG000|COMPLETED|Overall Study||20
10554816|NCT01560260|11709505|FG000|NOT COMPLETED|Overall Study||0
10554817|NCT01560286|11709511|FG000|STARTED|Overall Study||24
10554818|NCT01560286|11709511|FG000|COMPLETED|Overall Study||24
10554819|NCT01560286|11709511|FG000|NOT COMPLETED|Overall Study||0
10554820|NCT01560377|11709515|FG000|STARTED|Overall Study||147
10554821|NCT01560377|11709515|FG000|Eligible for Analysis|Overall Study||139
10554822|NCT01560377|11709515|FG000|COMPLETED|Overall Study||147
10554823|NCT01560377|11709515|FG000|NOT COMPLETED|Overall Study||0
10554824|NCT01560403|11709521|FG000|STARTED|Overall Study||5
10554825|NCT01560403|11709522|FG001|STARTED|Overall Study||9
10554826|NCT01560403|11709521|FG000|COMPLETED|Overall Study||5
10554827|NCT01560403|11709522|FG001|COMPLETED|Overall Study||8
10554828|NCT01560403|11709521|FG000|NOT COMPLETED|Overall Study||0
10554829|NCT01560403|11709522|FG001|NOT COMPLETED|Overall Study||1
10554830|NCT01560416|11709530|FG000|STARTED|Randomized Phase||15
10554831|NCT01560416|11709531|FG001|STARTED|Randomized Phase||35
10554832|NCT01560416|11709530|FG000|COMPLETED|Randomized Phase||8
10554833|NCT01560416|11709531|FG001|COMPLETED|Randomized Phase||35
10554834|NCT01560416|11709530|FG000|NOT COMPLETED|Randomized Phase||7
10554835|NCT01560416|11709531|FG001|NOT COMPLETED|Randomized Phase||0
10554836|NCT01560416|11709530|FG000|STARTED|Crossover Phase||7
10554837|NCT01560416|11709531|FG001|STARTED|Crossover Phase||0
10554838|NCT01560416|11709530|FG000|COMPLETED|Crossover Phase||7
10554839|NCT01560416|11709531|FG001|COMPLETED|Crossover Phase||0
10554840|NCT01560416|11709530|FG000|NOT COMPLETED|Crossover Phase||0
10554841|NCT01560416|11709531|FG001|NOT COMPLETED|Crossover Phase||0
10554842|NCT01560429|11709541|FG000|STARTED|Overall Study||26
10554843|NCT01560429|11709542|FG001|STARTED|Overall Study||26
10554844|NCT01560429|11709541|FG000|COMPLETED|Overall Study||23
10554845|NCT01560429|11709542|FG001|COMPLETED|Overall Study||20
10554846|NCT01560429|11709541|FG000|NOT COMPLETED|Overall Study||3
10554847|NCT01560429|11709542|FG001|NOT COMPLETED|Overall Study||6
10554848|NCT01560624|11709552|FG000|STARTED|Overall Study||346
10554849|NCT01560624|11709553|FG001|STARTED|Overall Study||344
10554850|NCT01560624|11709552|FG000|Clinical Worsening Event|Overall Study||91
10554851|NCT01560624|11709553|FG001|Clinical Worsening Event|Overall Study||133
10554852|NCT01560624|11709552|FG000|Early Discontinuation From Treatment|Overall Study||107
10554853|NCT01560624|11709553|FG001|Early Discontinuation From Treatment|Overall Study||56
10554854|NCT01560624|11709552|FG000|COMPLETED|Overall Study||148
10554855|NCT01560624|11709553|FG001|COMPLETED|Overall Study||155
10554856|NCT01560624|11709552|FG000|NOT COMPLETED|Overall Study||198
10554857|NCT01560624|11709553|FG001|NOT COMPLETED|Overall Study||189
10554858|NCT01560780|11709561|FG000|STARTED|Overall Study||42
10554859|NCT01560780|11709562|FG001|STARTED|Overall Study||42
10554860|NCT01560780|11709561|FG000|Clinical Follow-Up at 12 Months|Overall Study||42
10554861|NCT01560780|11709562|FG001|Clinical Follow-Up at 12 Months|Overall Study||42
10554862|NCT01560780|11709561|FG000|Completed Study Drug for 12 Months|Overall Study||27
10554863|NCT01560780|11709562|FG001|Completed Study Drug for 12 Months|Overall Study||27
10554864|NCT01560780|11709561|FG000|COMPLETED|Overall Study||29
10554865|NCT01560780|11709562|FG001|COMPLETED|Overall Study||30
10554866|NCT01560780|11709561|FG000|NOT COMPLETED|Overall Study||13
10554867|NCT01560780|11709562|FG001|NOT COMPLETED|Overall Study||12
10554868|NCT01560819|11709570|FG000|STARTED|Overall Study||10
10554869|NCT01560819|11709571|FG001|STARTED|Overall Study||10
10554870|NCT01560819|11709570|FG000|COMPLETED|Overall Study||9
10554871|NCT01560819|11709571|FG001|COMPLETED|Overall Study||10
10554872|NCT01560819|11709570|FG000|NOT COMPLETED|Overall Study||1
10554873|NCT01560819|11709571|FG001|NOT COMPLETED|Overall Study||0
10554874|NCT01560871|11709577|FG000|STARTED|Overall Study||9
10554875|NCT01560871|11709578|FG001|STARTED|Overall Study||7
10554876|NCT01560871|11709577|FG000|COMPLETED|Overall Study||3
10554877|NCT01560871|11709578|FG001|COMPLETED|Overall Study||5
10554878|NCT01560871|11709577|FG000|NOT COMPLETED|Overall Study||6
10554879|NCT01560871|11709578|FG001|NOT COMPLETED|Overall Study||2
10554880|NCT01560923|11709587|FG000|STARTED|Overall Study||24
10554881|NCT01560923|11709588|FG001|STARTED|Overall Study||22
10554882|NCT01560923|11709587|FG000|COMPLETED|Overall Study||24
10554883|NCT01560923|11709588|FG001|COMPLETED|Overall Study||22
10554884|NCT01560923|11709587|FG000|NOT COMPLETED|Overall Study||0
10554885|NCT01560923|11709588|FG001|NOT COMPLETED|Overall Study||0
10554886|NCT01560949|11709594|FG000|STARTED|Systemic Phase: mFOLFIRINOX||33
10554887|NCT01560949|11709594|FG000|COMPLETED|Systemic Phase: mFOLFIRINOX||27
10554888|NCT01560949|11709594|FG000|NOT COMPLETED|Systemic Phase: mFOLFIRINOX||6
10554889|NCT01560949|11709594|FG000|STARTED|Chemoradiation Phase: With Gemcitabine||23
10554890|NCT01560949|11709594|FG000|COMPLETED|Chemoradiation Phase: With Gemcitabine||23
10554891|NCT01560949|11709594|FG000|NOT COMPLETED|Chemoradiation Phase: With Gemcitabine||0
10554892|NCT01560949|11709594|FG000|STARTED|Surgery Phase||18
10554893|NCT01560949|11709594|FG000|COMPLETED|Surgery Phase||15
10554894|NCT01560949|11709594|FG000|NOT COMPLETED|Surgery Phase||3
10554895|NCT01560975|11709602|FG000|STARTED|Overall Study||10
10554896|NCT01560975|11709602|FG000|COMPLETED|Overall Study||10
10554897|NCT01560975|11709602|FG000|NOT COMPLETED|Overall Study||0
10554898|NCT01560988|11709610|FG000|STARTED|First Intervention (Six Weeks)||32
10554899|NCT01560988|11709611|FG001|STARTED|First Intervention (Six Weeks)||30
10554900|NCT01560988|11709610|FG000|COMPLETED|First Intervention (Six Weeks)||22
10554901|NCT01560988|11709611|FG001|COMPLETED|First Intervention (Six Weeks)||26
10554902|NCT01560988|11709610|FG000|NOT COMPLETED|First Intervention (Six Weeks)||10
10554903|NCT01560988|11709611|FG001|NOT COMPLETED|First Intervention (Six Weeks)||4
10554904|NCT01560988|11709610|FG000|STARTED|Washout (Six Weeks)||22
10554905|NCT01560988|11709611|FG001|STARTED|Washout (Six Weeks)||26
10554906|NCT01560988|11709610|FG000|COMPLETED|Washout (Six Weeks)||20
10554907|NCT01560988|11709611|FG001|COMPLETED|Washout (Six Weeks)||24
10554908|NCT01560988|11709610|FG000|NOT COMPLETED|Washout (Six Weeks)||2
10554909|NCT01560988|11709611|FG001|NOT COMPLETED|Washout (Six Weeks)||2
10554910|NCT01560988|11709610|FG000|STARTED|Second Intervention (Six Weeks)||20
10554911|NCT01560988|11709611|FG001|STARTED|Second Intervention (Six Weeks)||24
10554912|NCT01560988|11709610|FG000|COMPLETED|Second Intervention (Six Weeks)||18
10554913|NCT01560988|11709611|FG001|COMPLETED|Second Intervention (Six Weeks)||22
10554914|NCT01560988|11709610|FG000|NOT COMPLETED|Second Intervention (Six Weeks)||2
10554915|NCT01560988|11709611|FG001|NOT COMPLETED|Second Intervention (Six Weeks)||2
10554916|NCT01561053|11709626|FG000|STARTED|Overall Study||86
10554917|NCT01561053|11709627|FG001|STARTED|Overall Study||92
10554918|NCT01561053|11709628|FG002|STARTED|Overall Study||82
10554919|NCT01561053|11709629|FG003|STARTED|Overall Study||87
10554920|NCT01561053|11709626|FG000|Patients With Baseline MMSE:18-21|Overall Study||47
10554921|NCT01561053|11709627|FG001|Patients With Baseline MMSE:18-21|Overall Study||40
10554922|NCT01561053|11709628|FG002|Patients With Baseline MMSE:18-21|Overall Study||47
10554923|NCT01561053|11709629|FG003|Patients With Baseline MMSE:18-21|Overall Study||42
10554924|NCT01561053|11709626|FG000|Patients With Baseline MMSE:22-26|Overall Study||39
10554925|NCT01561053|11709627|FG001|Patients With Baseline MMSE:22-26|Overall Study||52
10554926|NCT01561053|11709628|FG002|Patients With Baseline MMSE:22-26|Overall Study||35
10554927|NCT01561053|11709629|FG003|Patients With Baseline MMSE:22-26|Overall Study||45
10554928|NCT01561053|11709626|FG000|Randomized Not Treated|Overall Study||8
10554929|NCT01561053|11709627|FG001|Randomized Not Treated|Overall Study||6
10554930|NCT01561053|11709628|FG002|Randomized Not Treated|Overall Study||4
10554931|NCT01561053|11709629|FG003|Randomized Not Treated|Overall Study||7
10554932|NCT01561053|11709626|FG000|Evaluable Subjects|Overall Study||78
10554933|NCT01561053|11709627|FG001|Evaluable Subjects|Overall Study||86
10554934|NCT01561053|11709628|FG002|Evaluable Subjects|Overall Study||78
10554935|NCT01561053|11709629|FG003|Evaluable Subjects|Overall Study||80
10554936|NCT01561053|11709626|FG000|COMPLETED|Overall Study||51
10554937|NCT01561053|11709627|FG001|COMPLETED|Overall Study||56
10554938|NCT01561053|11709628|FG002|COMPLETED|Overall Study||61
10554939|NCT01561053|11709629|FG003|COMPLETED|Overall Study||64
10554940|NCT01561053|11709626|FG000|NOT COMPLETED|Overall Study||35
10554941|NCT01561053|11709627|FG001|NOT COMPLETED|Overall Study||36
10554942|NCT01561053|11709628|FG002|NOT COMPLETED|Overall Study||21
10554943|NCT01561053|11709629|FG003|NOT COMPLETED|Overall Study||23
10554944|NCT01561079|11709640|FG000|STARTED|Overall Study||127
10554945|NCT01561079|11709640|FG000|COMPLETED|Overall Study||49
10554946|NCT01561079|11709640|FG000|NOT COMPLETED|Overall Study||78
10554947|NCT01561300|11709683|FG000|STARTED|Run in on Placebo||15
10554948|NCT01561300|11709684|FG001|STARTED|Run in on Placebo||15
10554949|NCT01561300|11709683|FG000|COMPLETED|Run in on Placebo||14
10554950|NCT01561300|11709684|FG001|COMPLETED|Run in on Placebo||15
10554951|NCT01561300|11709683|FG000|NOT COMPLETED|Run in on Placebo||1
10554952|NCT01561300|11709684|FG001|NOT COMPLETED|Run in on Placebo||0
10554953|NCT01561300|11709683|FG000|STARTED|First Intervention||14
10554954|NCT01561300|11709684|FG001|STARTED|First Intervention||15
10554955|NCT01561300|11709683|FG000|COMPLETED|First Intervention||14
10554956|NCT01561300|11709684|FG001|COMPLETED|First Intervention||15
10554957|NCT01561300|11709683|FG000|NOT COMPLETED|First Intervention||0
10554958|NCT01561300|11709684|FG001|NOT COMPLETED|First Intervention||0
10554959|NCT01561300|11709683|FG000|STARTED|Washout on Placebo||14
10554960|NCT01561300|11709684|FG001|STARTED|Washout on Placebo||15
10554961|NCT01561300|11709683|FG000|COMPLETED|Washout on Placebo||14
10554962|NCT01561300|11709684|FG001|COMPLETED|Washout on Placebo||15
10554963|NCT01561300|11709683|FG000|NOT COMPLETED|Washout on Placebo||0
10554964|NCT01561300|11709684|FG001|NOT COMPLETED|Washout on Placebo||0
10554965|NCT01561300|11709683|FG000|STARTED|Second Intervention||14
10554966|NCT01561300|11709684|FG001|STARTED|Second Intervention||15
10554967|NCT01561300|11709683|FG000|COMPLETED|Second Intervention||14
10554968|NCT01561300|11709684|FG001|COMPLETED|Second Intervention||15
10554969|NCT01561300|11709683|FG000|NOT COMPLETED|Second Intervention||0
10554970|NCT01561300|11709684|FG001|NOT COMPLETED|Second Intervention||0
10554971|NCT01561313|11709693|FG000|STARTED|Overall Study||33
10554972|NCT01561313|11709694|FG001|STARTED|Overall Study||31
10554973|NCT01561313|11709693|FG000|COMPLETED|Overall Study||31
10554974|NCT01561313|11709694|FG001|COMPLETED|Overall Study||31
10554975|NCT01561313|11709693|FG000|NOT COMPLETED|Overall Study||2
10554976|NCT01561313|11709694|FG001|NOT COMPLETED|Overall Study||0
10554977|NCT01561469|11709702|FG000|STARTED|Overall Study||101
10554978|NCT01561469|11709703|FG001|STARTED|Overall Study||87
10554979|NCT01561469|11709702|FG000|COMPLETED|Overall Study||101
10554980|NCT01561469|11709703|FG001|COMPLETED|Overall Study||87
10554981|NCT01561469|11709702|FG000|NOT COMPLETED|Overall Study||0
10554982|NCT01561469|11709703|FG001|NOT COMPLETED|Overall Study||0
10554983|NCT01561560|11709709|FG000|STARTED|First Two Weeks of Wear||60
10554984|NCT01561560|11709710|FG001|STARTED|First Two Weeks of Wear||61
10554985|NCT01561560|11709709|FG000|COMPLETED|First Two Weeks of Wear||60
10554986|NCT01561560|11709710|FG001|COMPLETED|First Two Weeks of Wear||59
10554987|NCT01561560|11709709|FG000|NOT COMPLETED|First Two Weeks of Wear||0
10554988|NCT01561560|11709710|FG001|NOT COMPLETED|First Two Weeks of Wear||2
10554989|NCT01561560|11709709|FG000|STARTED|Second Two Weeks of Wear||60
10554990|NCT01561560|11709710|FG001|STARTED|Second Two Weeks of Wear||59
10554991|NCT01561560|11709709|FG000|COMPLETED|Second Two Weeks of Wear||60
10554992|NCT01561560|11709710|FG001|COMPLETED|Second Two Weeks of Wear||58
10554993|NCT01561560|11709709|FG000|NOT COMPLETED|Second Two Weeks of Wear||0
10554994|NCT01561560|11709710|FG001|NOT COMPLETED|Second Two Weeks of Wear||1
10554995|NCT01561703|11709718|FG000|STARTED|Overall Study||28
10554996|NCT01561703|11709719|FG001|STARTED|Overall Study||30
10554997|NCT01561703|11709718|FG000|COMPLETED|Overall Study||20
10554998|NCT01561703|11709719|FG001|COMPLETED|Overall Study||24
10554999|NCT01561703|11709718|FG000|NOT COMPLETED|Overall Study||8
10555000|NCT01561703|11709719|FG001|NOT COMPLETED|Overall Study||6
10555001|NCT01561716|11709731|FG000|STARTED|Overall Study||5
10555002|NCT01561716|11709732|FG001|STARTED|Overall Study||5
10555003|NCT01561716|11709733|FG002|STARTED|Overall Study||5
10555004|NCT01561716|11709734|FG003|STARTED|Overall Study||5
10555005|NCT01561716|11709735|FG004|STARTED|Overall Study||5
10555006|NCT01561716|11709736|FG005|STARTED|Overall Study||5
10555007|NCT01561716|11709731|FG000|COMPLETED|Overall Study||5
10555008|NCT01561716|11709732|FG001|COMPLETED|Overall Study||5
10555009|NCT01561716|11709733|FG002|COMPLETED|Overall Study||5
10555010|NCT01561716|11709734|FG003|COMPLETED|Overall Study||5
10555011|NCT01561716|11709735|FG004|COMPLETED|Overall Study||5
10555012|NCT01561716|11709736|FG005|COMPLETED|Overall Study||5
10555013|NCT01561716|11709731|FG000|NOT COMPLETED|Overall Study||0
10555014|NCT01561716|11709732|FG001|NOT COMPLETED|Overall Study||0
10555015|NCT01561716|11709733|FG002|NOT COMPLETED|Overall Study||0
10555016|NCT01561716|11709734|FG003|NOT COMPLETED|Overall Study||0
10555017|NCT01561716|11709735|FG004|NOT COMPLETED|Overall Study||0
10555018|NCT01561716|11709736|FG005|NOT COMPLETED|Overall Study||0
10555019|NCT01561755|11709752|FG000|STARTED|Overall Study||6
10555020|NCT01561755|11709753|FG001|STARTED|Overall Study||6
10555021|NCT01561755|11709752|FG000|COMPLETED|Overall Study||6
10555022|NCT01561755|11709753|FG001|COMPLETED|Overall Study||5
10555023|NCT01561755|11709752|FG000|NOT COMPLETED|Overall Study||0
10555024|NCT01561755|11709753|FG001|NOT COMPLETED|Overall Study||1
10555025|NCT01561833|11709759|FG000|STARTED|Overall Study||12
10555026|NCT01561833|11709759|FG000|COMPLETED|Overall Study||12
10555027|NCT01561833|11709759|FG000|NOT COMPLETED|Overall Study||0
10555028|NCT01561898|11709767|FG000|STARTED|Overall Study||7
10555029|NCT01561898|11709768|FG001|STARTED|Overall Study||92
10555030|NCT01561898|11709769|FG002|STARTED|Overall Study||97
10555031|NCT01561898|11709770|FG003|STARTED|Overall Study||32
10555032|NCT01561898|11709767|FG000|COMPLETED|Overall Study||5
10555033|NCT01561898|11709768|FG001|COMPLETED|Overall Study||51
10555034|NCT01561898|11709769|FG002|COMPLETED|Overall Study||53
10555035|NCT01561898|11709770|FG003|COMPLETED|Overall Study||12
10555036|NCT01561898|11709767|FG000|NOT COMPLETED|Overall Study||2
10555037|NCT01561898|11709768|FG001|NOT COMPLETED|Overall Study||41
10555038|NCT01561898|11709769|FG002|NOT COMPLETED|Overall Study||44
10555039|NCT01561898|11709770|FG003|NOT COMPLETED|Overall Study||20
10555040|NCT01561963|11709778|FG000|STARTED|Overall Study||21
10555041|NCT01561963|11709778|FG000|Received Period 1 Treatment|Overall Study||21
10555042|NCT01561963|11709778|FG000|Received Period 2 Treatment|Overall Study||20
10555043|NCT01561963|11709778|FG000|Received Period 3 Treatment|Overall Study||20
10555044|NCT01561963|11709778|FG000|COMPLETED|Overall Study||20
10555045|NCT01561963|11709778|FG000|NOT COMPLETED|Overall Study||1
10555046|NCT01561976|11709793|FG000|STARTED|Period 1||5
10555047|NCT01561976|11709794|FG001|STARTED|Period 1||5
10555048|NCT01561976|11709795|FG002|STARTED|Period 1||5
10555049|NCT01561976|11709796|FG003|STARTED|Period 1||5
10555050|NCT01561976|11709797|FG004|STARTED|Period 1||5
10555051|NCT01561976|11709798|FG005|STARTED|Period 1||5
10555052|NCT01561976|11709793|FG000|COMPLETED|Period 1||5
10555053|NCT01561976|11709794|FG001|COMPLETED|Period 1||5
10555054|NCT01561976|11709795|FG002|COMPLETED|Period 1||4
10555055|NCT01561976|11709796|FG003|COMPLETED|Period 1||5
10555056|NCT01561976|11709797|FG004|COMPLETED|Period 1||5
10555057|NCT01561976|11709798|FG005|COMPLETED|Period 1||5
10555058|NCT01561976|11709793|FG000|NOT COMPLETED|Period 1||0
10555059|NCT01561976|11709794|FG001|NOT COMPLETED|Period 1||0
10555060|NCT01561976|11709795|FG002|NOT COMPLETED|Period 1||1
10555061|NCT01561976|11709796|FG003|NOT COMPLETED|Period 1||0
10555062|NCT01561976|11709797|FG004|NOT COMPLETED|Period 1||0
10555063|NCT01561976|11709798|FG005|NOT COMPLETED|Period 1||0
10555064|NCT01561976|11709793|FG000|STARTED|Washout Period 1 (7 Days)||5
10555065|NCT01561976|11709794|FG001|STARTED|Washout Period 1 (7 Days)||5
10555066|NCT01561976|11709795|FG002|STARTED|Washout Period 1 (7 Days)||4
10555067|NCT01561976|11709796|FG003|STARTED|Washout Period 1 (7 Days)||5
10555068|NCT01561976|11709797|FG004|STARTED|Washout Period 1 (7 Days)||5
10555069|NCT01561976|11709798|FG005|STARTED|Washout Period 1 (7 Days)||5
10555070|NCT01561976|11709793|FG000|COMPLETED|Washout Period 1 (7 Days)||5
10555071|NCT01561976|11709794|FG001|COMPLETED|Washout Period 1 (7 Days)||5
10555072|NCT01561976|11709795|FG002|COMPLETED|Washout Period 1 (7 Days)||4
10555073|NCT01561976|11709796|FG003|COMPLETED|Washout Period 1 (7 Days)||4
10555074|NCT01561976|11709797|FG004|COMPLETED|Washout Period 1 (7 Days)||5
10555075|NCT01561976|11709798|FG005|COMPLETED|Washout Period 1 (7 Days)||4
10555076|NCT01561976|11709793|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
10555077|NCT01561976|11709794|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
10555078|NCT01561976|11709795|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
10555079|NCT01561976|11709796|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||1
10555080|NCT01561976|11709797|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
10555081|NCT01561976|11709798|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||1
10555082|NCT01561976|11709793|FG000|STARTED|Period 2||5
10555083|NCT01561976|11709794|FG001|STARTED|Period 2||5
10555084|NCT01561976|11709795|FG002|STARTED|Period 2||4
10555085|NCT01561976|11709796|FG003|STARTED|Period 2||4
10555086|NCT01561976|11709797|FG004|STARTED|Period 2||5
10555087|NCT01561976|11709798|FG005|STARTED|Period 2||4
10555088|NCT01561976|11709793|FG000|COMPLETED|Period 2||5
10555089|NCT01561976|11709794|FG001|COMPLETED|Period 2||5
10555090|NCT01561976|11709795|FG002|COMPLETED|Period 2||4
10555091|NCT01561976|11709796|FG003|COMPLETED|Period 2||4
10555092|NCT01561976|11709797|FG004|COMPLETED|Period 2||5
10555093|NCT01561976|11709798|FG005|COMPLETED|Period 2||4
10555094|NCT01561976|11709793|FG000|NOT COMPLETED|Period 2||0
10555095|NCT01561976|11709794|FG001|NOT COMPLETED|Period 2||0
10555096|NCT01561976|11709795|FG002|NOT COMPLETED|Period 2||0
10555097|NCT01561976|11709796|FG003|NOT COMPLETED|Period 2||0
10555098|NCT01561976|11709797|FG004|NOT COMPLETED|Period 2||0
10555099|NCT01561976|11709798|FG005|NOT COMPLETED|Period 2||0
10555100|NCT01561976|11709793|FG000|STARTED|Washout Period 2 (7 Days)||5
10555101|NCT01561976|11709794|FG001|STARTED|Washout Period 2 (7 Days)||5
10555102|NCT01561976|11709795|FG002|STARTED|Washout Period 2 (7 Days)||4
10555103|NCT01561976|11709796|FG003|STARTED|Washout Period 2 (7 Days)||4
10555104|NCT01561976|11709797|FG004|STARTED|Washout Period 2 (7 Days)||5
10555105|NCT01561976|11709798|FG005|STARTED|Washout Period 2 (7 Days)||4
10555106|NCT01561976|11709793|FG000|COMPLETED|Washout Period 2 (7 Days)||4
10555107|NCT01561976|11709794|FG001|COMPLETED|Washout Period 2 (7 Days)||5
10555108|NCT01561976|11709795|FG002|COMPLETED|Washout Period 2 (7 Days)||3
10555109|NCT01561976|11709796|FG003|COMPLETED|Washout Period 2 (7 Days)||4
10555110|NCT01561976|11709797|FG004|COMPLETED|Washout Period 2 (7 Days)||5
10555111|NCT01561976|11709798|FG005|COMPLETED|Washout Period 2 (7 Days)||4
10555112|NCT01561976|11709793|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||1
10555113|NCT01561976|11709794|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
10555114|NCT01561976|11709795|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||1
10555115|NCT01561976|11709796|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
10555116|NCT01561976|11709797|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
10555117|NCT01561976|11709798|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
10555118|NCT01561976|11709793|FG000|STARTED|Period 3||4
10555119|NCT01561976|11709794|FG001|STARTED|Period 3||5
10555120|NCT01561976|11709795|FG002|STARTED|Period 3||3
10555121|NCT01561976|11709796|FG003|STARTED|Period 3||4
10555122|NCT01561976|11709797|FG004|STARTED|Period 3||5
10555123|NCT01561976|11709798|FG005|STARTED|Period 3||4
10555124|NCT01561976|11709793|FG000|COMPLETED|Period 3||4
10555125|NCT01561976|11709794|FG001|COMPLETED|Period 3||5
10555126|NCT01561976|11709795|FG002|COMPLETED|Period 3||3
10555127|NCT01561976|11709796|FG003|COMPLETED|Period 3||4
10555128|NCT01561976|11709797|FG004|COMPLETED|Period 3||5
10555129|NCT01561976|11709798|FG005|COMPLETED|Period 3||4
10555130|NCT01561976|11709793|FG000|NOT COMPLETED|Period 3||0
10555131|NCT01561976|11709794|FG001|NOT COMPLETED|Period 3||0
10555132|NCT01561976|11709795|FG002|NOT COMPLETED|Period 3||0
10555133|NCT01561976|11709796|FG003|NOT COMPLETED|Period 3||0
10555134|NCT01561976|11709797|FG004|NOT COMPLETED|Period 3||0
10555135|NCT01561976|11709798|FG005|NOT COMPLETED|Period 3||0
10555142|NCT01562041|11709815|FG000|STARTED|Overall Study||14
10555143|NCT01562041|11709815|FG000|COMPLETED|Overall Study||14
10555144|NCT01562041|11709815|FG000|NOT COMPLETED|Overall Study||0
10555145|NCT01562132|11709821|FG000|STARTED|Overall Study||3
10555146|NCT01562132|11709822|FG001|STARTED|Overall Study||3
10555147|NCT01562132|11709821|FG000|COMPLETED|Overall Study||3
10555148|NCT01562132|11709822|FG001|COMPLETED|Overall Study||3
10555149|NCT01562132|11709821|FG000|NOT COMPLETED|Overall Study||0
10555150|NCT01562132|11709822|FG001|NOT COMPLETED|Overall Study||0
10555151|NCT01562275|11709841|FG000|STARTED|Stage 1||3
10555152|NCT01562275|11709842|FG001|STARTED|Stage 1||7
10555153|NCT01562275|11709843|FG002|STARTED|Stage 1||3
10555154|NCT01562275|11709844|FG003|STARTED|Stage 1||4
10555155|NCT01562275|11709845|FG004|STARTED|Stage 1||4
10555156|NCT01562275|11709846|FG005|STARTED|Stage 1||4
10555157|NCT01562275|11709847|FG006|STARTED|Stage 1||3
10555158|NCT01562275|11709848|FG007|STARTED|Stage 1||7
10555159|NCT01562275|11709849|FG008|STARTED|Stage 1||3
10555160|NCT01562275|11709850|FG009|STARTED|Stage 1||7
10555161|NCT01562275|11709851|FG010|STARTED|Stage 1||3
10555162|NCT01562275|11709852|FG011|STARTED|Stage 1||0
10555163|NCT01562275|11709853|FG012|STARTED|Stage 1||0
10555164|NCT01562275|11709841|FG000|COMPLETED|Stage 1||0
10555165|NCT01562275|11709842|FG001|COMPLETED|Stage 1||0
10555166|NCT01562275|11709843|FG002|COMPLETED|Stage 1||0
10555167|NCT01562275|11709844|FG003|COMPLETED|Stage 1||0
10555168|NCT01562275|11709845|FG004|COMPLETED|Stage 1||0
10555169|NCT01562275|11709846|FG005|COMPLETED|Stage 1||0
10555170|NCT01562275|11709847|FG006|COMPLETED|Stage 1||0
10555171|NCT01562275|11709848|FG007|COMPLETED|Stage 1||0
10555172|NCT01562275|11709849|FG008|COMPLETED|Stage 1||0
10555173|NCT01562275|11709850|FG009|COMPLETED|Stage 1||0
10555174|NCT01562275|11709851|FG010|COMPLETED|Stage 1||0
10555175|NCT01562275|11709852|FG011|COMPLETED|Stage 1||0
10555176|NCT01562275|11709853|FG012|COMPLETED|Stage 1||0
10555177|NCT01562275|11709841|FG000|NOT COMPLETED|Stage 1||3
10555178|NCT01562275|11709842|FG001|NOT COMPLETED|Stage 1||7
10555179|NCT01562275|11709843|FG002|NOT COMPLETED|Stage 1||3
10555180|NCT01562275|11709844|FG003|NOT COMPLETED|Stage 1||4
10790458|NCT03541044|11950986|FG000|COMPLETED|Study Period 1: Up to Day 1||23
10790459|NCT03541044|11950987|FG001|COMPLETED|Study Period 1: Up to Day 1||23
10790460|NCT03541044|11950986|FG000|NOT COMPLETED|Study Period 1: Up to Day 1||0
10555181|NCT01562275|11709845|FG004|NOT COMPLETED|Stage 1||4
10555182|NCT01562275|11709846|FG005|NOT COMPLETED|Stage 1||4
10555183|NCT01562275|11709847|FG006|NOT COMPLETED|Stage 1||3
10555184|NCT01562275|11709848|FG007|NOT COMPLETED|Stage 1||7
10555185|NCT01562275|11709849|FG008|NOT COMPLETED|Stage 1||3
10555186|NCT01562275|11709850|FG009|NOT COMPLETED|Stage 1||7
10555187|NCT01562275|11709851|FG010|NOT COMPLETED|Stage 1||3
10555188|NCT01562275|11709852|FG011|NOT COMPLETED|Stage 1||0
10555189|NCT01562275|11709853|FG012|NOT COMPLETED|Stage 1||0
10555190|NCT01562275|11709841|FG000|STARTED|Stage 2||0
10555191|NCT01562275|11709842|FG001|STARTED|Stage 2||0
10555192|NCT01562275|11709843|FG002|STARTED|Stage 2||0
10555193|NCT01562275|11709844|FG003|STARTED|Stage 2||0
10555194|NCT01562275|11709845|FG004|STARTED|Stage 2||0
10555195|NCT01562275|11709846|FG005|STARTED|Stage 2||0
10555196|NCT01562275|11709847|FG006|STARTED|Stage 2||0
10555197|NCT01562275|11709848|FG007|STARTED|Stage 2||0
10555198|NCT01562275|11709849|FG008|STARTED|Stage 2||0
10555199|NCT01562275|11709850|FG009|STARTED|Stage 2||0
10555200|NCT01562275|11709851|FG010|STARTED|Stage 2||0
10555201|NCT01562275|11709852|FG011|STARTED|Stage 2||14
10555202|NCT01562275|11709853|FG012|STARTED|Stage 2||5
10555203|NCT01562275|11709841|FG000|COMPLETED|Stage 2||0
10555204|NCT01562275|11709842|FG001|COMPLETED|Stage 2||0
10555205|NCT01562275|11709843|FG002|COMPLETED|Stage 2||0
10555206|NCT01562275|11709844|FG003|COMPLETED|Stage 2||0
10555207|NCT01562275|11709845|FG004|COMPLETED|Stage 2||0
10555208|NCT01562275|11709846|FG005|COMPLETED|Stage 2||0
10555209|NCT01562275|11709847|FG006|COMPLETED|Stage 2||0
10555210|NCT01562275|11709848|FG007|COMPLETED|Stage 2||0
10555211|NCT01562275|11709849|FG008|COMPLETED|Stage 2||0
10555212|NCT01562275|11709850|FG009|COMPLETED|Stage 2||0
10555213|NCT01562275|11709851|FG010|COMPLETED|Stage 2||0
10555214|NCT01562275|11709852|FG011|COMPLETED|Stage 2||0
10555215|NCT01562275|11709853|FG012|COMPLETED|Stage 2||0
10555216|NCT01562275|11709841|FG000|NOT COMPLETED|Stage 2||0
10555217|NCT01562275|11709842|FG001|NOT COMPLETED|Stage 2||0
10555218|NCT01562275|11709843|FG002|NOT COMPLETED|Stage 2||0
10555219|NCT01562275|11709844|FG003|NOT COMPLETED|Stage 2||0
10555220|NCT01562275|11709845|FG004|NOT COMPLETED|Stage 2||0
10555221|NCT01562275|11709846|FG005|NOT COMPLETED|Stage 2||0
10555222|NCT01562275|11709847|FG006|NOT COMPLETED|Stage 2||0
10555223|NCT01562275|11709848|FG007|NOT COMPLETED|Stage 2||0
10555224|NCT01562275|11709849|FG008|NOT COMPLETED|Stage 2||0
10555225|NCT01562275|11709850|FG009|NOT COMPLETED|Stage 2||0
10555226|NCT01562275|11709851|FG010|NOT COMPLETED|Stage 2||0
10555227|NCT01562275|11709852|FG011|NOT COMPLETED|Stage 2||14
10555228|NCT01562275|11709853|FG012|NOT COMPLETED|Stage 2||5
10555229|NCT01562314|11709885|FG000|STARTED|Overall Study||29
10555230|NCT01562314|11709886|FG001|STARTED|Overall Study||31
10555231|NCT01562314|11709885|FG000|Received at Least 1 Dose of Study Drug|Overall Study||29
10555232|NCT01562314|11709886|FG001|Received at Least 1 Dose of Study Drug|Overall Study||31
10555233|NCT01562314|11709885|FG000|Intent-to-Treat (ITT) Analysis Set|Overall Study||29
10555234|NCT01562314|11709886|FG001|Intent-to-Treat (ITT) Analysis Set|Overall Study||31
10555235|NCT01562314|11709885|FG000|Per Protocol (PP) Analysis Set|Overall Study||17
10555236|NCT01562314|11709886|FG001|Per Protocol (PP) Analysis Set|Overall Study||27
10555237|NCT01562314|11709885|FG000|COMPLETED|Overall Study||16
10555238|NCT01562314|11709886|FG001|COMPLETED|Overall Study||23
10555239|NCT01562314|11709885|FG000|NOT COMPLETED|Overall Study||13
10555240|NCT01562314|11709886|FG001|NOT COMPLETED|Overall Study||8
10555241|NCT01562327|11709892|FG000|STARTED|Overall Study||50
10555242|NCT01562327|11709892|FG000|COMPLETED|Overall Study||42
10555243|NCT01562327|11709892|FG000|NOT COMPLETED|Overall Study||8
10555244|NCT01562379|11709902|FG000|STARTED|Overall Study||1438
10555245|NCT01562379|11709903|FG001|STARTED|Overall Study||1492
10555246|NCT01562379|11709904|FG002|STARTED|Overall Study||851
10555247|NCT01562379|11709905|FG003|STARTED|Overall Study||843
10555248|NCT01562379|11709906|FG004|STARTED|Overall Study||825
10555249|NCT01562379|11709902|FG000|COMPLETED|Overall Study||1312
10555250|NCT01562379|11709903|FG001|COMPLETED|Overall Study||1395
10555251|NCT01562379|11709904|FG002|COMPLETED|Overall Study||789
10555252|NCT01562379|11709905|FG003|COMPLETED|Overall Study||786
10555253|NCT01562379|11709906|FG004|COMPLETED|Overall Study||785
10555254|NCT01562379|11709902|FG000|NOT COMPLETED|Overall Study||126
10555255|NCT01562379|11709903|FG001|NOT COMPLETED|Overall Study||97
10555256|NCT01562379|11709904|FG002|NOT COMPLETED|Overall Study||62
10555257|NCT01562379|11709905|FG003|NOT COMPLETED|Overall Study||57
10555258|NCT01562379|11709906|FG004|NOT COMPLETED|Overall Study||40
10555259|NCT01562444|11709921|FG000|STARTED|Overall Study||48
10555260|NCT01562444|11709922|FG001|STARTED|Overall Study||51
10555261|NCT01562444|11709923|FG002|STARTED|Overall Study||106
10555262|NCT01562444|11709921|FG000|COMPLETED|Overall Study||43
10555263|NCT01562444|11709922|FG001|COMPLETED|Overall Study||49
10555264|NCT01562444|11709923|FG002|COMPLETED|Overall Study||99
10555265|NCT01562444|11709921|FG000|NOT COMPLETED|Overall Study||5
10555266|NCT01562444|11709922|FG001|NOT COMPLETED|Overall Study||2
10555267|NCT01562444|11709923|FG002|NOT COMPLETED|Overall Study||7
10555268|NCT01562548|11709935|FG000|STARTED|Overall Study||25
10555269|NCT01562548|11709936|FG001|STARTED|Overall Study||15
10555270|NCT01562548|11709937|FG002|STARTED|Overall Study||25
10555271|NCT01562548|11709938|FG003|STARTED|Overall Study||14
10555272|NCT01562548|11709935|FG000|COMPLETED|Overall Study||25
10555273|NCT01562548|11709936|FG001|COMPLETED|Overall Study||15
10555274|NCT01562548|11709937|FG002|COMPLETED|Overall Study||24
10555275|NCT01562548|11709938|FG003|COMPLETED|Overall Study||14
10555276|NCT01562548|11709935|FG000|NOT COMPLETED|Overall Study||0
10555277|NCT01562548|11709936|FG001|NOT COMPLETED|Overall Study||0
10555278|NCT01562548|11709937|FG002|NOT COMPLETED|Overall Study||1
10555279|NCT01562548|11709938|FG003|NOT COMPLETED|Overall Study||0
10555280|NCT01562613|11709950|FG000|STARTED|Overall Study||533
10555281|NCT01562613|11709950|FG000|COMPLETED|Overall Study||529
10555282|NCT01562613|11709950|FG000|NOT COMPLETED|Overall Study||4
10555283|NCT01562678|11709956|FG000|STARTED|Overall Study||14
10555284|NCT01562678|11709957|FG001|STARTED|Overall Study||14
10555285|NCT01562678|11709956|FG000|COMPLETED|Overall Study||8
10555286|NCT01562678|11709957|FG001|COMPLETED|Overall Study||12
10555287|NCT01562678|11709956|FG000|NOT COMPLETED|Overall Study||6
10555288|NCT01562678|11709957|FG001|NOT COMPLETED|Overall Study||2
10555289|NCT01562743|11709963|FG000|STARTED|Overall Study||185
10555290|NCT01562743|11709963|FG000|COMPLETED|Overall Study||133
10555291|NCT01562743|11709963|FG000|NOT COMPLETED|Overall Study||52
10555292|NCT01562756|11709967|FG000|STARTED|Overall Study||6
10555293|NCT01562756|11709967|FG000|COMPLETED|Overall Study||6
10555294|NCT01562756|11709967|FG000|NOT COMPLETED|Overall Study||0
10555295|NCT01562782|11709973|FG000|STARTED|Overall Study||19
10555296|NCT01562782|11709974|FG001|STARTED|Overall Study||20
10555297|NCT01562782|11709973|FG000|COMPLETED|Overall Study||15
10555298|NCT01562782|11709974|FG001|COMPLETED|Overall Study||15
10555299|NCT01562782|11709973|FG000|NOT COMPLETED|Overall Study||4
10555300|NCT01562782|11709974|FG001|NOT COMPLETED|Overall Study||5
10555301|NCT01562873|11709980|FG000|STARTED|Overall Study||21
10555302|NCT01562873|11709981|FG001|STARTED|Overall Study|The observed number of objective responses in Cohort A was not sufficient for Cohort B to open.|0
10555303|NCT01562873|11709980|FG000|COMPLETED|Overall Study||0
10555304|NCT01562873|11709981|FG001|COMPLETED|Overall Study||0
10555305|NCT01562873|11709980|FG000|NOT COMPLETED|Overall Study||21
10555306|NCT01562873|11709981|FG001|NOT COMPLETED|Overall Study||0
10555307|NCT01562886|11709985|FG000|STARTED|Overall Study||14
10555308|NCT01562886|11709985|FG000|COMPLETED|Overall Study||13
10555309|NCT01562886|11709985|FG000|NOT COMPLETED|Overall Study||1
10555310|NCT01563003|11709991|FG000|STARTED|Overall Study||16
10555311|NCT01563003|11709992|FG001|STARTED|Overall Study||15
10555312|NCT01563003|11709991|FG000|COMPLETED|Overall Study||16
10555313|NCT01563003|11709992|FG001|COMPLETED|Overall Study||15
10555314|NCT01563003|11709991|FG000|NOT COMPLETED|Overall Study||0
10555315|NCT01563003|11709992|FG001|NOT COMPLETED|Overall Study||0
10555316|NCT01563029|11710003|FG000|STARTED|Overall Study||119
10555317|NCT01563029|11710004|FG001|STARTED|Overall Study||118
10555318|NCT01563029|11710005|FG002|STARTED|Overall Study||120
10555319|NCT01563029|11710006|FG003|STARTED|Overall Study||118
10555320|NCT01563029|11710007|FG004|STARTED|Overall Study||118
10555321|NCT01563029|11710003|FG000|COMPLETED|Overall Study||66
10555322|NCT01563029|11710004|FG001|COMPLETED|Overall Study||94
10555323|NCT01563029|11710005|FG002|COMPLETED|Overall Study||87
10555324|NCT01563029|11710006|FG003|COMPLETED|Overall Study||85
10555325|NCT01563029|11710007|FG004|COMPLETED|Overall Study||89
10555326|NCT01563029|11710003|FG000|NOT COMPLETED|Overall Study||53
10555327|NCT01563029|11710004|FG001|NOT COMPLETED|Overall Study||24
10555328|NCT01563029|11710005|FG002|NOT COMPLETED|Overall Study||33
10555329|NCT01563029|11710006|FG003|NOT COMPLETED|Overall Study||33
10555330|NCT01563029|11710007|FG004|NOT COMPLETED|Overall Study||29
10555331|NCT01563055|11710020|FG000|STARTED|Overall Study||10
10555332|NCT01563055|11710020|FG000|COMPLETED|Overall Study||10
10555333|NCT01563055|11710020|FG000|NOT COMPLETED|Overall Study||0
10555334|NCT01563081|11710029|FG000|STARTED|Overall Study||30
10555335|NCT01563081|11710030|FG001|STARTED|Overall Study||30
10555336|NCT01563081|11710029|FG000|COMPLETED|Overall Study||30
10555337|NCT01563081|11710030|FG001|COMPLETED|Overall Study||30
10555338|NCT01563081|11710029|FG000|NOT COMPLETED|Overall Study||0
10555339|NCT01563081|11710030|FG001|NOT COMPLETED|Overall Study||0
10555340|NCT01563172|11710040|FG000|STARTED|Overall Study||65
10555341|NCT01563172|11710040|FG000|Experimental Dentifrice 0.5g/2 Min|Overall Study||59
10555342|NCT01563172|11710040|FG000|Experimental Dentifrice 0.5g/45 Sec|Overall Study||59
10555343|NCT01563172|11710040|FG000|Experimental Dentifrice 1.5g/ 2min|Overall Study||58
10555344|NCT01563172|11710040|FG000|Experimental Dentifrice 1.5g/ 45 Sec|Overall Study||58
10555345|NCT01563172|11710040|FG000|Control Dentifrice|Overall Study||60
10555346|NCT01563172|11710040|FG000|COMPLETED|Overall Study||52
10555347|NCT01563172|11710040|FG000|NOT COMPLETED|Overall Study||13
10555348|NCT01563185|11710055|FG000|STARTED|Overall Study||12
10555349|NCT01563185|11710055|FG000|COMPLETED|Overall Study||10
10555350|NCT01563185|11710055|FG000|NOT COMPLETED|Overall Study||2
10555351|NCT01563198|11710059|FG000|STARTED|Baseline||49733
10555352|NCT01563198|11710059|FG000|COMPLETED|Baseline||49733
10555353|NCT01563198|11710059|FG000|NOT COMPLETED|Baseline||0
10555354|NCT01563198|11710059|FG000|STARTED|After Training||47979
10555355|NCT01563198|11710059|FG000|COMPLETED|After Training||47979
10555356|NCT01563198|11710059|FG000|NOT COMPLETED|After Training||0
10555357|NCT01563237|11710063|FG000|STARTED|Overall Study||64
10555358|NCT01563237|11710064|FG001|STARTED|Overall Study||5
10555359|NCT01563237|11710063|FG000|COMPLETED|Overall Study||54
10555360|NCT01563237|11710064|FG001|COMPLETED|Overall Study||5
10555361|NCT01563237|11710063|FG000|NOT COMPLETED|Overall Study||10
10555362|NCT01563237|11710064|FG001|NOT COMPLETED|Overall Study||0
10555363|NCT01563354|11710072|FG000|STARTED|Core Phase||41
10555364|NCT01563354|11710073|FG001|STARTED|Core Phase||42
10555365|NCT01563354|11710074|FG002|STARTED|Core Phase||41
10555366|NCT01563354|11710072|FG000|Entered Extension Phase|Core Phase||12
10555367|NCT01563354|11710073|FG001|Entered Extension Phase|Core Phase||14
10555368|NCT01563354|11710074|FG002|Entered Extension Phase|Core Phase||15
10555369|NCT01563354|11710072|FG000|COMPLETED|Core Phase||12
10555370|NCT01563354|11710073|FG001|COMPLETED|Core Phase||14
10555371|NCT01563354|11710074|FG002|COMPLETED|Core Phase||15
10555372|NCT01563354|11710072|FG000|NOT COMPLETED|Core Phase||29
10555373|NCT01563354|11710073|FG001|NOT COMPLETED|Core Phase||28
10555374|NCT01563354|11710074|FG002|NOT COMPLETED|Core Phase||26
10555375|NCT01563354|11710072|FG000|STARTED|Extension Phase|Criteria to enter Extension: continued clinical benefit and no unacceptable toxicity|12
10555376|NCT01563354|11710073|FG001|STARTED|Extension Phase|Criteria to enter Extension: continued clinical benefit and no unacceptable toxicity|14
10555377|NCT01563354|11710074|FG002|STARTED|Extension Phase||15
10555378|NCT01563354|11710072|FG000|COMPLETED|Extension Phase||0
10555379|NCT01563354|11710073|FG001|COMPLETED|Extension Phase||0
10555380|NCT01563354|11710074|FG002|COMPLETED|Extension Phase||0
10555381|NCT01563354|11710072|FG000|NOT COMPLETED|Extension Phase||12
10555382|NCT01563354|11710073|FG001|NOT COMPLETED|Extension Phase||14
10555383|NCT01563354|11710074|FG002|NOT COMPLETED|Extension Phase||15
10555384|NCT01563406|11710086|FG000|STARTED|Overall Study|194 hubs|60
10555385|NCT01563406|11710087|FG001|STARTED|Overall Study|102 hubs|30
10555386|NCT01563406|11710088|FG002|STARTED|Overall Study|101 hubs|30
10555387|NCT01563406|11710089|FG003|STARTED|Overall Study|112 hubs|29
10555388|NCT01563406|11710086|FG000|COMPLETED|Overall Study|194 hubs|60
10555389|NCT01563406|11710087|FG001|COMPLETED|Overall Study|102 hubs|30
10555390|NCT01563406|11710088|FG002|COMPLETED|Overall Study|101 hubs|30
10555391|NCT01563406|11710089|FG003|COMPLETED|Overall Study|112 hubs|29
10555392|NCT01563406|11710086|FG000|NOT COMPLETED|Overall Study||0
10555393|NCT01563406|11710087|FG001|NOT COMPLETED|Overall Study||0
10555394|NCT01563406|11710088|FG002|NOT COMPLETED|Overall Study||0
10555395|NCT01563406|11710089|FG003|NOT COMPLETED|Overall Study||0
10555396|NCT01563536|11710105|FG000|STARTED|Overall Study||6
10555397|NCT01563536|11710106|FG001|STARTED|Overall Study||6
10555398|NCT01563536|11710105|FG000|COMPLETED|Overall Study||5
10555399|NCT01563536|11710106|FG001|COMPLETED|Overall Study||4
10555400|NCT01563536|11710105|FG000|NOT COMPLETED|Overall Study||1
10555401|NCT01563536|11710106|FG001|NOT COMPLETED|Overall Study||2
10555402|NCT01563913|11710114|FG000|STARTED|Overall Study||15
10555403|NCT01563913|11710115|FG001|STARTED|Overall Study||15
10555404|NCT01563913|11710114|FG000|COMPLETED|Overall Study||13
10555405|NCT01563913|11710115|FG001|COMPLETED|Overall Study||15
10555406|NCT01563913|11710114|FG000|NOT COMPLETED|Overall Study||2
10555407|NCT01563913|11710115|FG001|NOT COMPLETED|Overall Study||0
10555408|NCT01563978|11710123|FG000|STARTED|Overall Study|Patients who received treatment.|68
10555409|NCT01563978|11710124|FG001|STARTED|Overall Study|Patients who received treatment.|67
10555410|NCT01563978|11710123|FG000|Randomised But Did Not Receive Treatment|Overall Study||0
10555411|NCT01563978|11710124|FG001|Randomised But Did Not Receive Treatment|Overall Study||0
10555412|NCT01563978|11710123|FG000|COMPLETED|Overall Study||64
10555413|NCT01563978|11710124|FG001|COMPLETED|Overall Study||65
10555414|NCT01563978|11710123|FG000|NOT COMPLETED|Overall Study||4
10555415|NCT01563978|11710124|FG001|NOT COMPLETED|Overall Study||2
10555416|NCT01564277|11710132|FG000|STARTED|Overall Study||12
10555417|NCT01564277|11710133|FG001|STARTED|Overall Study||12
10555418|NCT01564277|11710132|FG000|COMPLETED|Overall Study||11
10555419|NCT01564277|11710133|FG001|COMPLETED|Overall Study||11
10555420|NCT01564277|11710132|FG000|NOT COMPLETED|Overall Study||1
10555421|NCT01564277|11710133|FG001|NOT COMPLETED|Overall Study||1
10555422|NCT01564394|11710141|FG000|STARTED|Overall Study|Prostate cancer survivors n=20, family n=10. Only survivors were randomized.|30
10555423|NCT01564394|11710142|FG001|STARTED|Overall Study|Prostate cancer survivors n=20, family n=10. Only survivors were randomized.|30
10555424|NCT01564394|11710141|FG000|COMPLETED|Overall Study|Prostate cancer survivors n=16, family n=8.|24
10555425|NCT01564394|11710142|FG001|COMPLETED|Overall Study|Prostate cancer survivors n=13, family n=7.|20
10790461|NCT03541044|11950987|FG001|NOT COMPLETED|Study Period 1: Up to Day 1||0
10790462|NCT03541044|11950986|FG000|STARTED|Washout Period: 5 to 7 Days||23
10790463|NCT03541044|11950987|FG001|STARTED|Washout Period: 5 to 7 Days||23
10790464|NCT03541044|11950986|FG000|COMPLETED|Washout Period: 5 to 7 Days||23
10790465|NCT03541044|11950987|FG001|COMPLETED|Washout Period: 5 to 7 Days||23
10790466|NCT03541044|11950986|FG000|NOT COMPLETED|Washout Period: 5 to 7 Days||0
10790467|NCT03541044|11950987|FG001|NOT COMPLETED|Washout Period: 5 to 7 Days||0
10790468|NCT03541044|11950986|FG000|STARTED|Study Period 2: Up to Day 8||23
10790469|NCT03541044|11950987|FG001|STARTED|Study Period 2: Up to Day 8||23
10455104|NCT01000376|11603106|FG001|STARTED|Cycle 1 Day 15||6
10455105|NCT01000376|11603105|FG000|COMPLETED|Cycle 1 Day 15||4
10455106|NCT01000376|11603106|FG001|COMPLETED|Cycle 1 Day 15||6
10455107|NCT01000376|11603105|FG000|NOT COMPLETED|Cycle 1 Day 15||0
10455108|NCT01000376|11603106|FG001|NOT COMPLETED|Cycle 1 Day 15||0
10455109|NCT01000480|11603112|FG000|STARTED|Induction Phase||90
10455110|NCT01000480|11603112|FG000|Received at Least 1 Dose of Either Drug|Induction Phase||90
10455111|NCT01000480|11603112|FG000|Death (Any Cause) or Disease Progression|Induction Phase|Participants who died (any cause) or had disease progression considered to have completed phase.|8
10455112|NCT01000480|11603112|FG000|COMPLETED|Induction Phase||83
10455113|NCT01000480|11603112|FG000|NOT COMPLETED|Induction Phase||7
10455114|NCT01000480|11603112|FG000|STARTED|Concurrent Therapy Phase|Eight participants (pts) who completed Induction Phase, not eligible for Concurrent Therapy Phase.|75
10455115|NCT01000480|11603112|FG000|Death (Any Cause) or Disease Progression|Concurrent Therapy Phase|Pts who died (any cause) or had disease progression considered to have completed the phase.|1
10455116|NCT01000480|11603112|FG000|COMPLETED|Concurrent Therapy Phase||65
10455117|NCT01000480|11603112|FG000|NOT COMPLETED|Concurrent Therapy Phase||10
10455118|NCT01000480|11603112|FG000|STARTED|Follow-Up Period|One pt lost to follow-up during induction, 1 pt died in concurrent therapy, both not enter follow-up|88
10455119|NCT01000480|11603112|FG000|COMPLETED|Follow-Up Period||88
10455120|NCT01000480|11603112|FG000|NOT COMPLETED|Follow-Up Period||0
10455121|NCT01000493|11603118|FG000|STARTED|Overall Study||60
10455122|NCT01000493|11603119|FG001|STARTED|Overall Study||69
10455123|NCT01000493|11603118|FG000|COMPLETED|Overall Study||21
10455124|NCT01000493|11603119|FG001|COMPLETED|Overall Study||14
10455125|NCT01000493|11603118|FG000|NOT COMPLETED|Overall Study||39
10455126|NCT01000493|11603119|FG001|NOT COMPLETED|Overall Study||55
10455127|NCT01000506|11603129|FG000|STARTED|Overall Study||155
10455128|NCT01000506|11603130|FG001|STARTED|Overall Study||153
10455129|NCT01000506|11603131|FG002|STARTED|Overall Study||152
10455130|NCT01000506|11603132|FG003|STARTED|Overall Study||156
10455131|NCT01000506|11603129|FG000|COMPLETED|Overall Study||127
10455132|NCT01000506|11603130|FG001|COMPLETED|Overall Study||129
10455133|NCT01000506|11603131|FG002|COMPLETED|Overall Study||131
10455134|NCT01000506|11603132|FG003|COMPLETED|Overall Study||133
10455135|NCT01000506|11603129|FG000|NOT COMPLETED|Overall Study||28
10455136|NCT01000506|11603130|FG001|NOT COMPLETED|Overall Study||24
10455137|NCT01000506|11603131|FG002|NOT COMPLETED|Overall Study||21
10455138|NCT01000506|11603132|FG003|NOT COMPLETED|Overall Study||23
10455139|NCT01000610|11603142|FG000|STARTED|Overall Study||18
10455140|NCT01000610|11603142|FG000|COMPLETED|Overall Study||12
10455141|NCT01000610|11603142|FG000|NOT COMPLETED|Overall Study||6
10455142|NCT01000636|11603146|FG000|STARTED|Overall Study||9
10455143|NCT01000636|11603146|FG000|COMPLETED|Overall Study||7
10455144|NCT01000636|11603146|FG000|NOT COMPLETED|Overall Study||2
10455145|NCT01000649|11603154|FG000|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|10
10455146|NCT01000649|11603155|FG001|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|19
10455147|NCT01000649|11603156|FG002|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|2
10455148|NCT01000649|11603157|FG003|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|21
10455149|NCT01000649|11603154|FG000|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|10
10455150|NCT01000649|11603155|FG001|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|20
10455151|NCT01000649|11603156|FG002|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|2
10455152|NCT01000649|11603157|FG003|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|21
10455153|NCT01000649|11603154|FG000|COMPLETED|Overall Study||5
10455154|NCT01000649|11603155|FG001|COMPLETED|Overall Study||16
10455155|NCT01000649|11603156|FG002|COMPLETED|Overall Study||0
10455156|NCT01000649|11603157|FG003|COMPLETED|Overall Study||15
10455157|NCT01000649|11603154|FG000|NOT COMPLETED|Overall Study||5
10455158|NCT01000649|11603155|FG001|NOT COMPLETED|Overall Study||3
10455159|NCT01000649|11603156|FG002|NOT COMPLETED|Overall Study||2
10455160|NCT01000649|11603157|FG003|NOT COMPLETED|Overall Study||6
10455161|NCT01000662|11603168|FG000|STARTED|Overall Study||206
10455162|NCT01000662|11603169|FG001|STARTED|Overall Study||206
10455163|NCT01000662|11603168|FG000|COMPLETED|Overall Study||202
10455164|NCT01000662|11603169|FG001|COMPLETED|Overall Study||198
10455165|NCT01000662|11603168|FG000|NOT COMPLETED|Overall Study||4
10455166|NCT01000662|11603169|FG001|NOT COMPLETED|Overall Study||8
10455167|NCT01000727|11603179|FG000|STARTED|Overall Study||6522
10455168|NCT01000727|11603180|FG001|STARTED|Overall Study||6504
10455169|NCT01000727|11603179|FG000|COMPLETED|Overall Study||6347
10555426|NCT01564394|11710141|FG000|NOT COMPLETED|Overall Study||6
10555427|NCT01564394|11710142|FG001|NOT COMPLETED|Overall Study||10
10555428|NCT01564407|11710153|FG000|STARTED|Overall Study||4
10555429|NCT01564407|11710154|FG001|STARTED|Overall Study||5
10555430|NCT01564407|11710155|FG002|STARTED|Overall Study||4
10555431|NCT01564407|11710156|FG003|STARTED|Overall Study||2
10555432|NCT01564407|11710157|FG004|STARTED|Overall Study||0
10555433|NCT01564407|11710153|FG000|COMPLETED|Overall Study||4
10555434|NCT01564407|11710154|FG001|COMPLETED|Overall Study||3
10555435|NCT01564407|11710155|FG002|COMPLETED|Overall Study||4
10555436|NCT01564407|11710156|FG003|COMPLETED|Overall Study||1
10555437|NCT01564407|11710157|FG004|COMPLETED|Overall Study||0
10555438|NCT01564407|11710153|FG000|NOT COMPLETED|Overall Study||0
10555439|NCT01564407|11710154|FG001|NOT COMPLETED|Overall Study||2
10555440|NCT01564407|11710155|FG002|NOT COMPLETED|Overall Study||0
10555441|NCT01564407|11710156|FG003|NOT COMPLETED|Overall Study||1
10555442|NCT01564407|11710157|FG004|NOT COMPLETED|Overall Study||0
10555443|NCT01564459|11710181|FG000|STARTED|Run-In||12
10555444|NCT01564459|11710182|FG001|STARTED|Run-In|1 participant randomized to placebo arm received MK-6096 10 mg|87
10555445|NCT01564459|11710183|FG002|STARTED|Run-In|1 participant randomized to placebo arm received MK-6096 10 mg|83
10555446|NCT01564459|11710181|FG000|COMPLETED|Run-In||0
10555447|NCT01564459|11710182|FG001|COMPLETED|Run-In||87
10555448|NCT01564459|11710183|FG002|COMPLETED|Run-In||83
10555449|NCT01564459|11710181|FG000|NOT COMPLETED|Run-In||12
10555450|NCT01564459|11710182|FG001|NOT COMPLETED|Run-In||0
10555451|NCT01564459|11710183|FG002|NOT COMPLETED|Run-In||0
10555452|NCT01564459|11710181|FG000|STARTED|Double-blind Treatment||0
10555453|NCT01564459|11710182|FG001|STARTED|Double-blind Treatment|1 participant randomized to placebo arm received MK-6096 10 mg|87
10555454|NCT01564459|11710183|FG002|STARTED|Double-blind Treatment|1 participant randomized to placebo arm received MK-6096 10 mg|83
10555455|NCT01564459|11710181|FG000|COMPLETED|Double-blind Treatment||0
10555456|NCT01564459|11710182|FG001|COMPLETED|Double-blind Treatment||87
10555457|NCT01564459|11710183|FG002|COMPLETED|Double-blind Treatment||82
10555458|NCT01564459|11710181|FG000|NOT COMPLETED|Double-blind Treatment||0
10555459|NCT01564459|11710182|FG001|NOT COMPLETED|Double-blind Treatment||0
10555460|NCT01564459|11710183|FG002|NOT COMPLETED|Double-blind Treatment||1
10555461|NCT01564485|11710196|FG000|STARTED|Overall Study||92
10555462|NCT01564485|11710197|FG001|STARTED|Overall Study||101
10555463|NCT01564485|11710196|FG000|COMPLETED|Overall Study||84
10555464|NCT01564485|11710197|FG001|COMPLETED|Overall Study||78
10555465|NCT01564485|11710196|FG000|NOT COMPLETED|Overall Study||8
10555466|NCT01564485|11710197|FG001|NOT COMPLETED|Overall Study||23
10555467|NCT01564628|11710203|FG000|STARTED|Overall Study||185
10555468|NCT01564628|11710204|FG001|STARTED|Overall Study||58
10555469|NCT01564628|11710205|FG002|STARTED|Overall Study||63
10555470|NCT01564628|11710203|FG000|COMPLETED|Overall Study||181
10555471|NCT01564628|11710204|FG001|COMPLETED|Overall Study||56
10555472|NCT01564628|11710205|FG002|COMPLETED|Overall Study||61
10555473|NCT01564628|11710203|FG000|NOT COMPLETED|Overall Study||4
10555474|NCT01564628|11710204|FG001|NOT COMPLETED|Overall Study||2
10555475|NCT01564628|11710205|FG002|NOT COMPLETED|Overall Study||2
10555476|NCT01564654|11710209|FG000|STARTED|Overall Study|106 knees (bilateral)|89
10555477|NCT01564654|11710209|FG000|COMPLETED|Overall Study|106 knees (bilateral)|89
10555478|NCT01564654|11710209|FG000|NOT COMPLETED|Overall Study||0
10555479|NCT01564693|11710216|FG000|STARTED|Overall Study|Originally we planned to study 4 patients. We expanded to 9 to improve consistency of the results.|9
10555480|NCT01564693|11710217|FG001|STARTED|Overall Study||4
10555481|NCT01564693|11710218|FG002|STARTED|Overall Study|Only 2 patients were found necessary to give statistical relevance to the patients' results.|2
10555482|NCT01564693|11710216|FG000|COMPLETED|Overall Study||9
10555483|NCT01564693|11710217|FG001|COMPLETED|Overall Study||4
10555484|NCT01564693|11710218|FG002|COMPLETED|Overall Study||2
10555485|NCT01564693|11710216|FG000|NOT COMPLETED|Overall Study||0
10555486|NCT01564693|11710217|FG001|NOT COMPLETED|Overall Study||0
10555487|NCT01564693|11710218|FG002|NOT COMPLETED|Overall Study||0
10555488|NCT01564706|11710226|FG000|STARTED|Overall Study||9
10555489|NCT01564706|11710226|FG000|COMPLETED|Overall Study||9
10555490|NCT01564706|11710226|FG000|NOT COMPLETED|Overall Study||0
10555491|NCT01564758|11710230|FG000|STARTED|Overall Study||99
10555492|NCT01564758|11710230|FG000|COMPLETED|Overall Study||85
10555493|NCT01564758|11710230|FG000|NOT COMPLETED|Overall Study||14
10555494|NCT01564784|11710236|FG000|STARTED|Overall Study|Treated (164 randomized)|164
10555495|NCT01564784|11710237|FG001|STARTED|Overall Study|Treated (162 randomized)|143
10555496|NCT01564784|11710236|FG000|COMPLETED|Overall Study||30
10555497|NCT01564784|11710237|FG001|COMPLETED|Overall Study||10
10555498|NCT01564784|11710236|FG000|NOT COMPLETED|Overall Study||134
10555499|NCT01564784|11710237|FG001|NOT COMPLETED|Overall Study||133
10555500|NCT01564862|11710246|FG000|STARTED|Overall Study||198
10555501|NCT01564862|11710247|FG001|STARTED|Overall Study||210
10555502|NCT01564862|11710248|FG002|STARTED|Overall Study||194
10555503|NCT01564862|11710246|FG000|Received Treatment|Overall Study||196
10555504|NCT01564862|11710247|FG001|Received Treatment|Overall Study||207
10555505|NCT01564862|11710248|FG002|Received Treatment|Overall Study||191
10555506|NCT01564862|11710246|FG000|COMPLETED|Overall Study||168
10555507|NCT01564862|11710247|FG001|COMPLETED|Overall Study||176
10555508|NCT01564862|11710248|FG002|COMPLETED|Overall Study||164
10555509|NCT01564862|11710246|FG000|NOT COMPLETED|Overall Study||30
10555510|NCT01564862|11710247|FG001|NOT COMPLETED|Overall Study||34
10555511|NCT01564862|11710248|FG002|NOT COMPLETED|Overall Study||30
10555512|NCT01564914|11710258|FG000|STARTED|Overall Study||16
10555513|NCT01564914|11710259|FG001|STARTED|Overall Study||6
10555514|NCT01564914|11710258|FG000|COMPLETED|Overall Study||16
10555515|NCT01564914|11710259|FG001|COMPLETED|Overall Study||6
10555516|NCT01564914|11710258|FG000|NOT COMPLETED|Overall Study||0
10555517|NCT01564914|11710259|FG001|NOT COMPLETED|Overall Study||0
10555518|NCT01564953|11710268|FG000|STARTED|Overall Study||143
10555519|NCT01564953|11710268|FG000|COMPLETED|Overall Study||143
10555520|NCT01564953|11710268|FG000|NOT COMPLETED|Overall Study||0
10555521|NCT01565083|11710278|FG000|STARTED|Overall Study||106
10555522|NCT01565083|11710279|FG001|STARTED|Overall Study||107
10555523|NCT01565083|11710278|FG000|COMPLETED|Overall Study||73
10555524|NCT01565083|11710279|FG001|COMPLETED|Overall Study||68
10555525|NCT01565083|11710278|FG000|NOT COMPLETED|Overall Study||33
10555526|NCT01565083|11710279|FG001|NOT COMPLETED|Overall Study||39
10555527|NCT01565148|11710289|FG000|STARTED|Overall Study||47
10555528|NCT01565148|11710290|FG001|STARTED|Overall Study||46
10555529|NCT01565148|11710291|FG002|STARTED|Overall Study||47
10555530|NCT01565148|11710292|FG003|STARTED|Overall Study||45
10555531|NCT01565148|11710289|FG000|COMPLETED|Overall Study||32
10555532|NCT01565148|11710290|FG001|COMPLETED|Overall Study||31
10555533|NCT01565148|11710291|FG002|COMPLETED|Overall Study||40
10555534|NCT01565148|11710292|FG003|COMPLETED|Overall Study||32
10555535|NCT01565148|11710289|FG000|NOT COMPLETED|Overall Study||15
10555536|NCT01565148|11710290|FG001|NOT COMPLETED|Overall Study||15
10555537|NCT01565148|11710291|FG002|NOT COMPLETED|Overall Study||7
10555538|NCT01565148|11710292|FG003|NOT COMPLETED|Overall Study||13
10555539|NCT01565291|11710308|FG000|STARTED|Overall Study||16
10555540|NCT01565291|11710309|FG001|STARTED|Overall Study||16
10555541|NCT01565291|11710308|FG000|COMPLETED|Overall Study||15
10555542|NCT01565291|11710309|FG001|COMPLETED|Overall Study||16
10555543|NCT01565291|11710308|FG000|NOT COMPLETED|Overall Study||1
10555544|NCT01565291|11710309|FG001|NOT COMPLETED|Overall Study||0
10555545|NCT01565330|11710319|FG000|STARTED|Overall Study||5
10555546|NCT01565330|11710320|FG001|STARTED|Overall Study||4
10555547|NCT01565330|11710321|FG002|STARTED|Overall Study||4
10555548|NCT01565330|11710322|FG003|STARTED|Overall Study||7
10555549|NCT01565330|11710319|FG000|COMPLETED|Overall Study||5
10555550|NCT01565330|11710320|FG001|COMPLETED|Overall Study||4
10555551|NCT01565330|11710321|FG002|COMPLETED|Overall Study||4
10555552|NCT01565330|11710322|FG003|COMPLETED|Overall Study||7
10555553|NCT01565330|11710319|FG000|NOT COMPLETED|Overall Study||0
10555554|NCT01565330|11710320|FG001|NOT COMPLETED|Overall Study||0
10555555|NCT01565330|11710321|FG002|NOT COMPLETED|Overall Study||0
10555556|NCT01565330|11710322|FG003|NOT COMPLETED|Overall Study||0
10555557|NCT01565343|11710336|FG000|STARTED|Overall Study||11
10555558|NCT01565343|11710337|FG001|STARTED|Overall Study||4
10555559|NCT01565343|11710338|FG002|STARTED|Overall Study||10
10555560|NCT01565343|11710336|FG000|COMPLETED|Overall Study||10
10555561|NCT01565343|11710337|FG001|COMPLETED|Overall Study||4
10555562|NCT01565343|11710338|FG002|COMPLETED|Overall Study||10
10555563|NCT01565343|11710336|FG000|NOT COMPLETED|Overall Study||1
10555564|NCT01565343|11710337|FG001|NOT COMPLETED|Overall Study||0
10555565|NCT01565343|11710338|FG002|NOT COMPLETED|Overall Study||0
10555566|NCT01565356|11710345|FG000|STARTED|Overall Study||41
10555567|NCT01565356|11710345|FG000|COMPLETED|Overall Study||41
10555568|NCT01565356|11710345|FG000|NOT COMPLETED|Overall Study||0
10555569|NCT01565369|11710349|FG000|STARTED|Overall Study||35
10555570|NCT01565369|11710349|FG000|COMPLETED|Overall Study||35
10555571|NCT01565369|11710349|FG000|NOT COMPLETED|Overall Study||0
10650695|NCT02170870|11810985|FG003|NOT COMPLETED|Overall Study||0
10650696|NCT02170870|11810986|FG004|NOT COMPLETED|Overall Study||0
10650697|NCT02170870|11810987|FG005|NOT COMPLETED|Overall Study||0
10650698|NCT02171065|11811007|FG000|STARTED|Overall Study||89
10650699|NCT02171065|11811008|FG001|STARTED|Overall Study||93
10650700|NCT02171065|11811009|FG002|STARTED|Overall Study||716
10650701|NCT02171065|11811007|FG000|COMPLETED|Overall Study||88
10650702|NCT02171065|11811008|FG001|COMPLETED|Overall Study||93
10650703|NCT02171065|11811009|FG002|COMPLETED|Overall Study||715
10650704|NCT02171065|11811007|FG000|NOT COMPLETED|Overall Study||1
10650705|NCT02171065|11811008|FG001|NOT COMPLETED|Overall Study||0
10650706|NCT02171065|11811009|FG002|NOT COMPLETED|Overall Study||1
10650707|NCT02171130|11811019|FG000|STARTED|Overall Study||129
10650708|NCT02171130|11811019|FG000|Received at Least One Dose of Study Drug|Overall Study||87
10650709|NCT02171130|11811019|FG000|Experienced Hypoglycemic Event|Overall Study|Experienced at least one hypoglycemic event and received at least one dose of study drug.|87
10650710|NCT02171130|11811019|FG000|COMPLETED|Overall Study|Including participants who completed the 6-month study but did not experience any hypoglycemia event|101
10650711|NCT02171130|11811019|FG000|NOT COMPLETED|Overall Study||28
10650712|NCT02171195|11811032|FG000|STARTED|Overall Study||16
10650713|NCT02171195|11811033|FG001|STARTED|Overall Study||6
10650714|NCT02171195|11811034|FG002|STARTED|Overall Study||6
10650715|NCT02171195|11811035|FG003|STARTED|Overall Study||6
10650716|NCT02171195|11811036|FG004|STARTED|Overall Study||6
10650717|NCT02171195|11811037|FG005|STARTED|Overall Study||6
10650718|NCT02171195|11811038|FG006|STARTED|Overall Study||6
10650719|NCT02171195|11811039|FG007|STARTED|Overall Study||6
10650720|NCT02171195|11811040|FG008|STARTED|Overall Study||6
10650721|NCT02171195|11811032|FG000|COMPLETED|Overall Study||16
10650722|NCT02171195|11811033|FG001|COMPLETED|Overall Study||6
10650723|NCT02171195|11811034|FG002|COMPLETED|Overall Study||6
10650724|NCT02171195|11811035|FG003|COMPLETED|Overall Study||6
10650725|NCT02171195|11811036|FG004|COMPLETED|Overall Study||6
10650726|NCT02171195|11811037|FG005|COMPLETED|Overall Study||6
10555578|NCT01565499|11710360|FG000|STARTED|Overall Study||83
10555579|NCT01565499|11710360|FG000|COMPLETED|Overall Study||75
10555580|NCT01565499|11710360|FG000|NOT COMPLETED|Overall Study||8
10555581|NCT01565538|11710366|FG000|STARTED|Overall Study||61
10555582|NCT01565538|11710367|FG001|STARTED|Overall Study||62
10555583|NCT01565538|11710366|FG000|COMPLETED|Overall Study||61
10555584|NCT01565538|11710367|FG001|COMPLETED|Overall Study||62
10555585|NCT01565538|11710366|FG000|NOT COMPLETED|Overall Study||0
10555586|NCT01565538|11710367|FG001|NOT COMPLETED|Overall Study||0
10555587|NCT01565551|11710375|FG000|STARTED|Overall Study||586
10555588|NCT01565551|11710376|FG001|STARTED|Overall Study||51
10555589|NCT01565551|11710375|FG000|Clinical/Demographics|Overall Study||586
10555590|NCT01565551|11710376|FG001|Clinical/Demographics|Overall Study||51
10555591|NCT01565551|11710375|FG000|Biospecimens/Biomarkers|Overall Study||479
10555592|NCT01565551|11710376|FG001|Biospecimens/Biomarkers|Overall Study||22
10555593|NCT01565551|11710375|FG000|Neuroimaging|Overall Study||233
10555594|NCT01565551|11710376|FG001|Neuroimaging|Overall Study||25
10555595|NCT01565551|11710375|FG000|6-Month Outcomes|Overall Study||412
10555596|NCT01565551|11710376|FG001|6-Month Outcomes|Overall Study||30
10555597|NCT01565551|11710375|FG000|COMPLETED|Overall Study||586
10555598|NCT01565551|11710376|FG001|COMPLETED|Overall Study||51
10555599|NCT01565551|11710375|FG000|NOT COMPLETED|Overall Study||0
10555600|NCT01565551|11710376|FG001|NOT COMPLETED|Overall Study||0
10555601|NCT01565564|11710384|FG000|STARTED|Overall Study||344
10555602|NCT01565564|11710385|FG001|STARTED|Overall Study||362
10555603|NCT01565564|11710384|FG000|COMPLETED|Overall Study||339
10555604|NCT01565564|11710385|FG001|COMPLETED|Overall Study||361
10555605|NCT01565564|11710384|FG000|NOT COMPLETED|Overall Study||5
10555606|NCT01565564|11710385|FG001|NOT COMPLETED|Overall Study||1
10555607|NCT01565616|11710391|FG000|STARTED|Overall Study||22
10555608|NCT01565616|11710391|FG000|First Component: 5 Related Donors|Overall Study||5
10555609|NCT01565616|11710391|FG000|Second Component: Related or Unrelated|Overall Study||17
10555610|NCT01565616|11710391|FG000|COMPLETED|Overall Study||22
10555611|NCT01565616|11710391|FG000|NOT COMPLETED|Overall Study||0
10555612|NCT01565642|11710397|FG000|STARTED|Overall Study||151
10555613|NCT01565642|11710398|FG001|STARTED|Overall Study||151
10555614|NCT01565642|11710397|FG000|COMPLETED|Overall Study||149
10555615|NCT01565642|11710398|FG001|COMPLETED|Overall Study||150
10555616|NCT01565642|11710397|FG000|NOT COMPLETED|Overall Study||2
10555617|NCT01565642|11710398|FG001|NOT COMPLETED|Overall Study||1
10555618|NCT01565668|11710406|FG000|STARTED|Overall Study||38
10555619|NCT01565668|11710407|FG001|STARTED|Overall Study||38
10555709|NCT01565902|11710483|FG003|NOT COMPLETED|Overall Study||0
10555620|NCT01565668|11710406|FG000|Completed Treatment Per Protocol|Overall Study||0
10555621|NCT01565668|11710407|FG001|Completed Treatment Per Protocol|Overall Study||0
10555622|NCT01565668|11710406|FG000|Started 30-day Follow-up|Overall Study||37
10555623|NCT01565668|11710407|FG001|Started 30-day Follow-up|Overall Study||37
10555624|NCT01565668|11710406|FG000|Completed 30-day Follow-up|Overall Study||11
10555625|NCT01565668|11710407|FG001|Completed 30-day Follow-up|Overall Study||5
10555626|NCT01565668|11710406|FG000|Started Long-term Follow-up|Overall Study||36
10555627|NCT01565668|11710407|FG001|Started Long-term Follow-up|Overall Study||33
10555628|NCT01565668|11710406|FG000|Completed Long-term Follow-up|Overall Study||0
10555629|NCT01565668|11710407|FG001|Completed Long-term Follow-up|Overall Study||0
10555630|NCT01565668|11710406|FG000|COMPLETED|Overall Study||0
10555631|NCT01565668|11710407|FG001|COMPLETED|Overall Study||0
10555632|NCT01565668|11710406|FG000|NOT COMPLETED|Overall Study||38
10555633|NCT01565668|11710407|FG001|NOT COMPLETED|Overall Study||38
10555634|NCT01565694|11710413|FG000|STARTED|Dose-Titration Period||76
10555635|NCT01565694|11710413|FG000|COMPLETED|Dose-Titration Period||62
10555636|NCT01565694|11710413|FG000|NOT COMPLETED|Dose-Titration Period||14
10555637|NCT01565694|11710413|FG000|STARTED|Fixed-Dose Assessment Period||62
10555638|NCT01565694|11710413|FG000|COMPLETED|Fixed-Dose Assessment Period||58
10555639|NCT01565694|11710413|FG000|NOT COMPLETED|Fixed-Dose Assessment Period||4
10555640|NCT01565707|11710421|FG000|STARTED|Overall Study||75
10555641|NCT01565707|11710422|FG001|STARTED|Overall Study||73
10555642|NCT01565707|11710423|FG002|STARTED|Overall Study||19
10555643|NCT01565707|11710424|FG003|STARTED|Overall Study||22
10555644|NCT01565707|11710421|FG000|Treated|Overall Study||73
10555645|NCT01565707|11710422|FG001|Treated|Overall Study||73
10555646|NCT01565707|11710423|FG002|Treated|Overall Study||19
10555647|NCT01565707|11710424|FG003|Treated|Overall Study||22
10555648|NCT01565707|11710421|FG000|COMPLETED|Overall Study||66
10555649|NCT01565707|11710422|FG001|COMPLETED|Overall Study||65
10555650|NCT01565707|11710423|FG002|COMPLETED|Overall Study||16
10555651|NCT01565707|11710424|FG003|COMPLETED|Overall Study||17
10555652|NCT01565707|11710421|FG000|NOT COMPLETED|Overall Study||9
10555653|NCT01565707|11710422|FG001|NOT COMPLETED|Overall Study||8
10555654|NCT01565707|11710423|FG002|NOT COMPLETED|Overall Study||3
10555655|NCT01565707|11710424|FG003|NOT COMPLETED|Overall Study||5
10555656|NCT01565850|11710443|FG000|STARTED|Overall Study||103
10555657|NCT01565850|11710444|FG001|STARTED|Overall Study||50
10555658|NCT01565850|11710443|FG000|COMPLETED|Overall Study||83
10555659|NCT01565850|11710444|FG001|COMPLETED|Overall Study||42
10555660|NCT01565850|11710443|FG000|NOT COMPLETED|Overall Study||20
10555661|NCT01565850|11710444|FG001|NOT COMPLETED|Overall Study||8
10555662|NCT01565889|11710456|FG000|STARTED|Part A||12
10555663|NCT01565889|11710457|FG001|STARTED|Part A||4
10555664|NCT01565889|11710458|FG002|STARTED|Part A||8
10555665|NCT01565889|11710459|FG003|STARTED|Part A||7
10555666|NCT01565889|11710460|FG004|STARTED|Part A||7
10555667|NCT01565889|11710461|FG005|STARTED|Part A||0
10555668|NCT01565889|11710456|FG000|COMPLETED|Part A|3 participants from this group continued in the Part B: SOF+PEG+RBV group.|11
10555669|NCT01565889|11710457|FG001|COMPLETED|Part A|No participants from this group continued in the Part B: SOF+PEG+RBV group.|4
10555670|NCT01565889|11710458|FG002|COMPLETED|Part A|3 participants from this group continued in the Part B: SOF+PEG+RBV group.|8
10555671|NCT01565889|11710459|FG003|COMPLETED|Part A|2 participants from this group continued in the Part B: SOF+PEG+RBV group.|7
10555672|NCT01565889|11710460|FG004|COMPLETED|Part A|1 participant from this group continued in the Part B: SOF+PEG+RBV group.|7
10555673|NCT01565889|11710461|FG005|COMPLETED|Part A||0
10555674|NCT01565889|11710456|FG000|NOT COMPLETED|Part A||1
10555675|NCT01565889|11710457|FG001|NOT COMPLETED|Part A||0
10555676|NCT01565889|11710458|FG002|NOT COMPLETED|Part A||0
10555677|NCT01565889|11710459|FG003|NOT COMPLETED|Part A||0
10555678|NCT01565889|11710460|FG004|NOT COMPLETED|Part A||0
10555679|NCT01565889|11710461|FG005|NOT COMPLETED|Part A||0
10555680|NCT01565889|11710456|FG000|STARTED|Part B||0
10555681|NCT01565889|11710457|FG001|STARTED|Part B||0
10555682|NCT01565889|11710458|FG002|STARTED|Part B||0
10555683|NCT01565889|11710459|FG003|STARTED|Part B||0
10555684|NCT01565889|11710460|FG004|STARTED|Part B||0
10555685|NCT01565889|11710461|FG005|STARTED|Part B|9 participants in this group transferred from a Part A cohort, and 14 participants joined the study.|23
10555686|NCT01565889|11710456|FG000|COMPLETED|Part B||0
10555687|NCT01565889|11710457|FG001|COMPLETED|Part B||0
10555688|NCT01565889|11710458|FG002|COMPLETED|Part B||0
10555689|NCT01565889|11710459|FG003|COMPLETED|Part B||0
10555690|NCT01565889|11710460|FG004|COMPLETED|Part B||0
10555691|NCT01565889|11710461|FG005|COMPLETED|Part B||19
10555692|NCT01565889|11710456|FG000|NOT COMPLETED|Part B||0
10555693|NCT01565889|11710457|FG001|NOT COMPLETED|Part B||0
10555694|NCT01565889|11710458|FG002|NOT COMPLETED|Part B||0
10555695|NCT01565889|11710459|FG003|NOT COMPLETED|Part B||0
10555696|NCT01565889|11710460|FG004|NOT COMPLETED|Part B||0
10555697|NCT01565889|11710461|FG005|NOT COMPLETED|Part B||4
10555698|NCT01565902|11710480|FG000|STARTED|Overall Study||8
10555699|NCT01565902|11710481|FG001|STARTED|Overall Study||8
10555700|NCT01565902|11710482|FG002|STARTED|Overall Study||8
10555701|NCT01565902|11710483|FG003|STARTED|Overall Study||16
10555702|NCT01565902|11710480|FG000|COMPLETED|Overall Study||8
10555703|NCT01565902|11710481|FG001|COMPLETED|Overall Study||8
10555704|NCT01565902|11710482|FG002|COMPLETED|Overall Study||8
10555705|NCT01565902|11710483|FG003|COMPLETED|Overall Study||16
10555706|NCT01565902|11710480|FG000|NOT COMPLETED|Overall Study||0
10555707|NCT01565902|11710481|FG001|NOT COMPLETED|Overall Study||0
10555708|NCT01565902|11710482|FG002|NOT COMPLETED|Overall Study||0
10555710|NCT01565928|11710496|FG000|STARTED|Overall Study||22
10555711|NCT01565928|11710496|FG000|COMPLETED|Overall Study||0
10555712|NCT01565928|11710496|FG000|NOT COMPLETED|Overall Study||22
10555719|NCT01565980|11710516|FG000|STARTED|Overall Study||20
10555720|NCT01565980|11710517|FG001|STARTED|Overall Study|Three patients had started the intervention protocol at the time of study withdrawal.|20
10555721|NCT01565980|11710516|FG000|COMPLETED|Overall Study||16
10555722|NCT01565980|11710517|FG001|COMPLETED|Overall Study||16
10555723|NCT01565980|11710516|FG000|NOT COMPLETED|Overall Study||4
10555724|NCT01565980|11710517|FG001|NOT COMPLETED|Overall Study||4
10555725|NCT01565993|11710529|FG000|STARTED|Overall Study||66
10555726|NCT01565993|11710530|FG001|STARTED|Overall Study|3 patients were excluded for failing to meet the inclusion criteria|42
10555727|NCT01565993|11710529|FG000|COMPLETED|Overall Study|A total of 105 polypectomies were performed on 98 patients|66
10555728|NCT01565993|11710530|FG001|COMPLETED|Overall Study||39
10555729|NCT01565993|11710529|FG000|NOT COMPLETED|Overall Study||0
10555730|NCT01565993|11710530|FG001|NOT COMPLETED|Overall Study||3
10555731|NCT01566084|11710538|FG000|STARTED|Overall Study||7
10555732|NCT01566084|11710539|FG001|STARTED|Overall Study||10
10555733|NCT01566084|11710538|FG000|COMPLETED|Overall Study||7
10555734|NCT01566084|11710539|FG001|COMPLETED|Overall Study||10
10555735|NCT01566084|11710538|FG000|NOT COMPLETED|Overall Study||0
10555736|NCT01566084|11710539|FG001|NOT COMPLETED|Overall Study||0
10555737|NCT01566162|11710553|FG000|STARTED|Overall Study||191
10555738|NCT01566162|11710553|FG000|COMPLETED|Overall Study||155
10555739|NCT01566162|11710553|FG000|NOT COMPLETED|Overall Study||36
10555740|NCT01566214|11710559|FG000|STARTED|Overall Study||6
10555741|NCT01566214|11710560|FG001|STARTED|Overall Study||6
10555742|NCT01566214|11710559|FG000|COMPLETED|Overall Study||3
10555743|NCT01566214|11710560|FG001|COMPLETED|Overall Study||6
10555744|NCT01566214|11710559|FG000|NOT COMPLETED|Overall Study||3
10555745|NCT01566214|11710560|FG001|NOT COMPLETED|Overall Study||0
10555746|NCT01566331|11710568|FG000|STARTED|Overall Study||40
10555747|NCT01566331|11710569|FG001|STARTED|Overall Study||40
10555748|NCT01566331|11710568|FG000|COMPLETED|Overall Study||40
10555749|NCT01566331|11710569|FG001|COMPLETED|Overall Study||40
10555750|NCT01566331|11710568|FG000|NOT COMPLETED|Overall Study||0
10555751|NCT01566331|11710569|FG001|NOT COMPLETED|Overall Study||0
10555752|NCT01566409|11710577|FG000|STARTED|Overall Study||49
10555753|NCT01566409|11710578|FG001|STARTED|Overall Study||53
10555754|NCT01566409|11710577|FG000|COMPLETED|Overall Study||47
10555755|NCT01566409|11710578|FG001|COMPLETED|Overall Study||48
10555756|NCT01566409|11710577|FG000|NOT COMPLETED|Overall Study||2
10555757|NCT01566409|11710578|FG001|NOT COMPLETED|Overall Study||5
10555758|NCT01566435|11710584|FG000|STARTED|ACF Induction Therapy||30
10555759|NCT01566435|11710584|FG000|COMPLETED|ACF Induction Therapy||30
10555760|NCT01566435|11710584|FG000|NOT COMPLETED|ACF Induction Therapy||0
10555761|NCT01566435|11710584|FG000|STARTED|ACF Definitive Chemoradiation-cisplatin||28
10555762|NCT01566435|11710584|FG000|COMPLETED|ACF Definitive Chemoradiation-cisplatin||27
10555763|NCT01566435|11710584|FG000|NOT COMPLETED|ACF Definitive Chemoradiation-cisplatin||1
10555764|NCT01566435|11710584|FG000|STARTED|ACF Definitive Chemoradiation-cetuximab||2
10555765|NCT01566435|11710584|FG000|COMPLETED|ACF Definitive Chemoradiation-cetuximab||2
10555766|NCT01566435|11710584|FG000|NOT COMPLETED|ACF Definitive Chemoradiation-cetuximab||0
10555767|NCT01566448|11710592|FG000|STARTED|Overall Study||30
10555768|NCT01566448|11710592|FG000|COMPLETED|Overall Study||30
10555769|NCT01566448|11710592|FG000|NOT COMPLETED|Overall Study||0
10555770|NCT01566461|11710598|FG000|STARTED|IN.PACT SFA I Phase||99
10555771|NCT01566461|11710599|FG001|STARTED|IN.PACT SFA I Phase||51
10555772|NCT01566461|11710598|FG000|COMPLETED|IN.PACT SFA I Phase||88
10555773|NCT01566461|11710599|FG001|COMPLETED|IN.PACT SFA I Phase||49
10555774|NCT01566461|11710598|FG000|NOT COMPLETED|IN.PACT SFA I Phase||11
10555775|NCT01566461|11710599|FG001|NOT COMPLETED|IN.PACT SFA I Phase||2
10555776|NCT01566461|11710598|FG000|STARTED|IN.PACT SFA II Phase||121
10555777|NCT01566461|11710599|FG001|STARTED|IN.PACT SFA II Phase||60
10555778|NCT01566461|11710598|FG000|COMPLETED|IN.PACT SFA II Phase||109
10555779|NCT01566461|11710599|FG001|COMPLETED|IN.PACT SFA II Phase||55
10555780|NCT01566461|11710598|FG000|NOT COMPLETED|IN.PACT SFA II Phase||12
10555781|NCT01566461|11710599|FG001|NOT COMPLETED|IN.PACT SFA II Phase||5
10555782|NCT01566500|11710605|FG000|STARTED|Overall Study||140
10555783|NCT01566500|11710605|FG000|COMPLETED|Overall Study||140
10555784|NCT01566500|11710605|FG000|NOT COMPLETED|Overall Study||0
10555785|NCT01566526|11710609|FG000|STARTED|Overall Study||26
10555786|NCT01566526|11710609|FG000|COMPLETED|Overall Study||26
10555787|NCT01566526|11710609|FG000|NOT COMPLETED|Overall Study||0
10555788|NCT01566539|11710621|FG000|STARTED|Main Study Period||101
10555789|NCT01566539|11710622|FG001|STARTED|Main Study Period||100
10555790|NCT01566539|11710623|FG002|STARTED|Main Study Period||104
10555791|NCT01566539|11710624|FG003|STARTED|Main Study Period||0
10555792|NCT01566539|11710625|FG004|STARTED|Main Study Period||40
10555793|NCT01566539|11710626|FG005|STARTED|Main Study Period||43
10555794|NCT01566539|11710627|FG006|STARTED|Main Study Period||30
10555795|NCT01566539|11710628|FG007|STARTED|Main Study Period||30
10555796|NCT01566539|11710629|FG008|STARTED|Main Study Period||1
10555797|NCT01566539|11710621|FG000|COMPLETED|Main Study Period||100
10555798|NCT01566539|11710622|FG001|COMPLETED|Main Study Period||100
10555799|NCT01566539|11710623|FG002|COMPLETED|Main Study Period||104
10555800|NCT01566539|11710624|FG003|COMPLETED|Main Study Period||0
10555801|NCT01566539|11710625|FG004|COMPLETED|Main Study Period||40
10555802|NCT01566539|11710626|FG005|COMPLETED|Main Study Period||40
10555803|NCT01566539|11710627|FG006|COMPLETED|Main Study Period||30
10555804|NCT01566539|11710628|FG007|COMPLETED|Main Study Period||30
10555805|NCT01566539|11710629|FG008|COMPLETED|Main Study Period||1
10555806|NCT01566539|11710621|FG000|NOT COMPLETED|Main Study Period||1
10555807|NCT01566539|11710622|FG001|NOT COMPLETED|Main Study Period||0
10555808|NCT01566539|11710623|FG002|NOT COMPLETED|Main Study Period||0
10555809|NCT01566539|11710624|FG003|NOT COMPLETED|Main Study Period||0
10555810|NCT01566539|11710625|FG004|NOT COMPLETED|Main Study Period||0
10555811|NCT01566539|11710626|FG005|NOT COMPLETED|Main Study Period||3
10555812|NCT01566539|11710627|FG006|NOT COMPLETED|Main Study Period||0
10555813|NCT01566539|11710628|FG007|NOT COMPLETED|Main Study Period||0
10555814|NCT01566539|11710629|FG008|NOT COMPLETED|Main Study Period||0
10555815|NCT01566539|11710621|FG000|STARTED|Within Subject Group||0
10555816|NCT01566539|11710622|FG001|STARTED|Within Subject Group||0
10555817|NCT01566539|11710623|FG002|STARTED|Within Subject Group||0
10555818|NCT01566539|11710624|FG003|STARTED|Within Subject Group|Participants can move from Healthy Volunteers-AVP, OT and Placebo groups to the within subject group|156
10555819|NCT01566539|11710625|FG004|STARTED|Within Subject Group||0
10555820|NCT01566539|11710626|FG005|STARTED|Within Subject Group||0
10555821|NCT01566539|11710627|FG006|STARTED|Within Subject Group||0
10555822|NCT01566539|11710628|FG007|STARTED|Within Subject Group||0
10555823|NCT01566539|11710629|FG008|STARTED|Within Subject Group||0
10555824|NCT01566539|11710621|FG000|COMPLETED|Within Subject Group||0
10555825|NCT01566539|11710622|FG001|COMPLETED|Within Subject Group||0
10555826|NCT01566539|11710623|FG002|COMPLETED|Within Subject Group||0
10555827|NCT01566539|11710624|FG003|COMPLETED|Within Subject Group|Participants can move from Healthy Volunteers-AVP, OT and Placebo groups to the within subject group|153
10555828|NCT01566539|11710625|FG004|COMPLETED|Within Subject Group||0
10555829|NCT01566539|11710626|FG005|COMPLETED|Within Subject Group||0
10555830|NCT01566539|11710627|FG006|COMPLETED|Within Subject Group||0
10555831|NCT01566539|11710628|FG007|COMPLETED|Within Subject Group||0
10555832|NCT01566539|11710629|FG008|COMPLETED|Within Subject Group||0
10555833|NCT01566539|11710621|FG000|NOT COMPLETED|Within Subject Group||0
10555834|NCT01566539|11710622|FG001|NOT COMPLETED|Within Subject Group||0
10555835|NCT01566539|11710623|FG002|NOT COMPLETED|Within Subject Group||0
10555836|NCT01566539|11710624|FG003|NOT COMPLETED|Within Subject Group||3
10555837|NCT01566539|11710625|FG004|NOT COMPLETED|Within Subject Group||0
10555838|NCT01566539|11710626|FG005|NOT COMPLETED|Within Subject Group||0
10555839|NCT01566539|11710627|FG006|NOT COMPLETED|Within Subject Group||0
10555840|NCT01566539|11710628|FG007|NOT COMPLETED|Within Subject Group||0
10555841|NCT01566539|11710629|FG008|NOT COMPLETED|Within Subject Group||0
10555842|NCT01566604|11710653|FG000|STARTED|Overall Study||306
10555843|NCT01566604|11710654|FG001|STARTED|Overall Study||154
10555844|NCT01566604|11710653|FG000|Safety Set|Overall Study||305
10555845|NCT01566604|11710654|FG001|Safety Set|Overall Study||154
10555846|NCT01566604|11710653|FG000|Full Analysis Set (FAS)|Overall Study||305
10555847|NCT01566604|11710654|FG001|Full Analysis Set (FAS)|Overall Study||154
10555848|NCT01566604|11710653|FG000|FAS, Serial Spirometry Subgroup|Overall Study||134
10555849|NCT01566604|11710654|FG001|FAS, Serial Spirometry Subgroup|Overall Study||58
10555850|NCT01566604|11710653|FG000|COMPLETED|Overall Study||282
10555851|NCT01566604|11710654|FG001|COMPLETED|Overall Study||143
10555852|NCT01566604|11710653|FG000|NOT COMPLETED|Overall Study||24
10555853|NCT01566604|11710654|FG001|NOT COMPLETED|Overall Study||11
10555854|NCT01566630|11710662|FG000|STARTED|Overall Study||2
10555855|NCT01566630|11710663|FG001|STARTED|Overall Study||1
10555856|NCT01566630|11710662|FG000|COMPLETED|Overall Study||2
10555857|NCT01566630|11710663|FG001|COMPLETED|Overall Study||1
10555858|NCT01566630|11710662|FG000|NOT COMPLETED|Overall Study||0
10555859|NCT01566630|11710663|FG001|NOT COMPLETED|Overall Study||0
10555860|NCT01566682|11710675|FG000|STARTED|Overall Study||420
10555861|NCT01566682|11710675|FG000|COMPLETED|Overall Study||374
10555862|NCT01566682|11710675|FG000|NOT COMPLETED|Overall Study||46
10555863|NCT01566721|11710681|FG000|STARTED|Treatment Period||1867
10555864|NCT01566721|11710682|FG001|STARTED|Treatment Period||710
10555865|NCT01566721|11710681|FG000|COMPLETED|Treatment Period||1670
10555866|NCT01566721|11710682|FG001|COMPLETED|Treatment Period||652
10555867|NCT01566721|11710681|FG000|NOT COMPLETED|Treatment Period||197
10555868|NCT01566721|11710682|FG001|NOT COMPLETED|Treatment Period||58
10555869|NCT01566721|11710681|FG000|STARTED|Safety Follow-up|Participants who discontinued treatment were allowed to join the SFU Period.|1865
10555870|NCT01566721|11710682|FG001|STARTED|Safety Follow-up|Participants who discontinued treatment were allowed to join the SFU Period.|708
10555871|NCT01566721|11710681|FG000|COMPLETED|Safety Follow-up||1318
10555872|NCT01566721|11710682|FG001|COMPLETED|Safety Follow-up||501
10555873|NCT01566721|11710681|FG000|NOT COMPLETED|Safety Follow-up||547
10555874|NCT01566721|11710682|FG001|NOT COMPLETED|Safety Follow-up||207
10555875|NCT01566773|11710695|FG000|STARTED|Overall Study||140
10555876|NCT01566773|11710695|FG000|GP MDI 18 µg BID|Overall Study||64
10555877|NCT01566773|11710695|FG000|GP MDI 9 µg BID|Overall Study||64
10555878|NCT01566773|11710695|FG000|GP MDI 4.6 µg BID|Overall Study||62
10555879|NCT01566773|11710695|FG000|GP MDI 2.4 µg BID|Overall Study||64
10555880|NCT01566773|11710695|FG000|GP MDI 1.2 µg BID|Overall Study||57
10555881|NCT01566773|11710695|FG000|GP MDI 0.6 µg BID|Overall Study||59
10555882|NCT01566773|11710695|FG000|Placebo MDI|Overall Study||62
10555883|NCT01566773|11710695|FG000|Spiriva® Handihaler®|Overall Study||62
10555884|NCT01566773|11710695|FG000|COMPLETED|Overall Study||110
10555885|NCT01566773|11710695|FG000|NOT COMPLETED|Overall Study||30
10555886|NCT01566838|11710717|FG000|STARTED|Overall Study||41
10555887|NCT01566838|11710718|FG001|STARTED|Overall Study||42
10555888|NCT01566838|11710717|FG000|COMPLETED|Overall Study||38
10555889|NCT01566838|11710718|FG001|COMPLETED|Overall Study||42
10555890|NCT01566838|11710717|FG000|NOT COMPLETED|Overall Study||3
10555891|NCT01566838|11710718|FG001|NOT COMPLETED|Overall Study||0
10555892|NCT01566981|11710726|FG000|STARTED|Overall Study||58
10555893|NCT01566981|11710727|FG001|STARTED|Overall Study||62
10555894|NCT01566981|11710726|FG000|COMPLETED|Overall Study||53
10555895|NCT01566981|11710727|FG001|COMPLETED|Overall Study||54
10555896|NCT01566981|11710726|FG000|NOT COMPLETED|Overall Study||5
10555897|NCT01566981|11710727|FG001|NOT COMPLETED|Overall Study||8
10555898|NCT01567020|11710739|FG000|STARTED|Overall Study||28
10555899|NCT01567020|11710740|FG001|STARTED|Overall Study||46
10555900|NCT01567020|11710741|FG002|STARTED|Overall Study||20
10555901|NCT01567020|11710742|FG003|STARTED|Overall Study||11
10555902|NCT01567020|11710739|FG000|COMPLETED|Overall Study||21
10555903|NCT01567020|11710740|FG001|COMPLETED|Overall Study||41
10555904|NCT01567020|11710741|FG002|COMPLETED|Overall Study||18
10555905|NCT01567020|11710742|FG003|COMPLETED|Overall Study||10
10555906|NCT01567020|11710739|FG000|NOT COMPLETED|Overall Study||7
10555907|NCT01567020|11710740|FG001|NOT COMPLETED|Overall Study||5
10555908|NCT01567020|11710741|FG002|NOT COMPLETED|Overall Study||2
10555909|NCT01567020|11710742|FG003|NOT COMPLETED|Overall Study||1
10555910|NCT01567085|11710752|FG000|STARTED|Overall Study||80
10555911|NCT01567085|11710752|FG000|Received at Least 1 Dose of Study Drug|Overall Study||80
10555912|NCT01567085|11710752|FG000|COMPLETED|Overall Study||60
10555913|NCT01567085|11710752|FG000|NOT COMPLETED|Overall Study||20
10555914|NCT01567150|11710758|FG000|STARTED|Overall Study||21
10555915|NCT01567150|11710759|FG001|STARTED|Overall Study||18
10555916|NCT01567150|11710758|FG000|COMPLETED|Overall Study||19
10555917|NCT01567150|11710759|FG001|COMPLETED|Overall Study||16
10555918|NCT01567150|11710758|FG000|NOT COMPLETED|Overall Study||2
10555919|NCT01567150|11710759|FG001|NOT COMPLETED|Overall Study||2
10555920|NCT01567163|11710765|FG000|STARTED|Overall Study||22
10555921|NCT01567163|11710765|FG000|Received at Least 1 Dose of Study Drug|Overall Study||22
10650727|NCT02171195|11811038|FG006|COMPLETED|Overall Study||6
10555922|NCT01567163|11710765|FG000|Drug-Drug Interaction Population|Overall Study|Completed Cycle 1, Day 1 and Cycle 2, Day 1 treatment with required assessments.|18
10555923|NCT01567163|11710765|FG000|COMPLETED|Overall Study||18
10555924|NCT01567163|11710765|FG000|NOT COMPLETED|Overall Study||4
10555925|NCT01567306|11710780|FG000|STARTED|Overall Study||27
10555926|NCT01567306|11710781|FG001|STARTED|Overall Study||25
10555927|NCT01567306|11710782|FG002|STARTED|Overall Study||24
10555928|NCT01567306|11710783|FG003|STARTED|Overall Study||24
10555929|NCT01567306|11710784|FG004|STARTED|Overall Study||25
10555930|NCT01567306|11710785|FG005|STARTED|Overall Study||26
10555931|NCT01567306|11710780|FG000|COMPLETED|Overall Study||24
10555932|NCT01567306|11710781|FG001|COMPLETED|Overall Study||23
10555933|NCT01567306|11710782|FG002|COMPLETED|Overall Study||24
10555934|NCT01567306|11710783|FG003|COMPLETED|Overall Study||19
10555935|NCT01567306|11710784|FG004|COMPLETED|Overall Study||18
10555936|NCT01567306|11710785|FG005|COMPLETED|Overall Study||23
10555937|NCT01567306|11710780|FG000|NOT COMPLETED|Overall Study||3
10555938|NCT01567306|11710781|FG001|NOT COMPLETED|Overall Study||2
10555939|NCT01567306|11710782|FG002|NOT COMPLETED|Overall Study||0
10555940|NCT01567306|11710783|FG003|NOT COMPLETED|Overall Study||5
10555941|NCT01567306|11710784|FG004|NOT COMPLETED|Overall Study||7
10555942|NCT01567306|11710785|FG005|NOT COMPLETED|Overall Study||3
10555943|NCT01567371|11710799|FG000|STARTED|Overall Study||30
10555944|NCT01567371|11710799|FG000|COMPLETED|Overall Study||30
10555945|NCT01567371|11710799|FG000|NOT COMPLETED|Overall Study||0
10555946|NCT01567462|11710805|FG000|STARTED|Overall Study||45
10555947|NCT01567462|11710806|FG001|STARTED|Overall Study||45
10555948|NCT01567462|11710805|FG000|COMPLETED|Overall Study||41
10555949|NCT01567462|11710806|FG001|COMPLETED|Overall Study||38
10555950|NCT01567462|11710805|FG000|NOT COMPLETED|Overall Study||4
10555951|NCT01567462|11710806|FG001|NOT COMPLETED|Overall Study||7
10555952|NCT01567527|11710814|FG000|STARTED|Conversion Phase.||466
10555953|NCT01567527|11710815|FG001|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
10555954|NCT01567527|11710816|FG002|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
10555955|NCT01567527|11710817|FG003|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
10555956|NCT01567527|11710818|FG004|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
10555957|NCT01567527|11710814|FG000|COMPLETED|Conversion Phase.||367
10555958|NCT01567527|11710815|FG001|COMPLETED|Conversion Phase.||0
10555959|NCT01567527|11710816|FG002|COMPLETED|Conversion Phase.||0
10555960|NCT01567527|11710817|FG003|COMPLETED|Conversion Phase.||0
10555961|NCT01567527|11710818|FG004|COMPLETED|Conversion Phase.||0
10555962|NCT01567527|11710814|FG000|NOT COMPLETED|Conversion Phase.||99
10555963|NCT01567527|11710815|FG001|NOT COMPLETED|Conversion Phase.||0
10555964|NCT01567527|11710816|FG002|NOT COMPLETED|Conversion Phase.||0
10555965|NCT01567527|11710817|FG003|NOT COMPLETED|Conversion Phase.||0
10555966|NCT01567527|11710818|FG004|NOT COMPLETED|Conversion Phase.||0
10555967|NCT01567527|11710814|FG000|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
10556041|NCT01567865|11710861|FG002|STARTED|Evaluated for Immunogenicity||211
10555968|NCT01567527|11710815|FG001|STARTED|Oral Aripiprazole Stabilization Phase.|265 of the 632 subjects who started this phase entered the Oral Stabilization Phase directly.|632
10555969|NCT01567527|11710816|FG002|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
10555970|NCT01567527|11710817|FG003|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
10555971|NCT01567527|11710818|FG004|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
10555972|NCT01567527|11710814|FG000|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
10555973|NCT01567527|11710815|FG001|COMPLETED|Oral Aripiprazole Stabilization Phase.||425
10555974|NCT01567527|11710816|FG002|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
10555975|NCT01567527|11710817|FG003|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
10555976|NCT01567527|11710818|FG004|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
10555977|NCT01567527|11710814|FG000|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
10555978|NCT01567527|11710815|FG001|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||207
10555979|NCT01567527|11710816|FG002|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
10555980|NCT01567527|11710817|FG003|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
10555981|NCT01567527|11710818|FG004|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
10555982|NCT01567527|11710814|FG000|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
10555983|NCT01567527|11710815|FG001|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
10555984|NCT01567527|11710816|FG002|STARTED|IM Depot Stabilization.||425
10555985|NCT01567527|11710817|FG003|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
10555986|NCT01567527|11710818|FG004|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
10555987|NCT01567527|11710814|FG000|COMPLETED|IM Depot Stabilization.||0
10555988|NCT01567527|11710815|FG001|COMPLETED|IM Depot Stabilization.||0
10555989|NCT01567527|11710816|FG002|COMPLETED|IM Depot Stabilization.||266
10555990|NCT01567527|11710817|FG003|COMPLETED|IM Depot Stabilization.||0
10555991|NCT01567527|11710818|FG004|COMPLETED|IM Depot Stabilization.||0
10555992|NCT01567527|11710814|FG000|NOT COMPLETED|IM Depot Stabilization.||0
10555993|NCT01567527|11710815|FG001|NOT COMPLETED|IM Depot Stabilization.||0
10555994|NCT01567527|11710816|FG002|NOT COMPLETED|IM Depot Stabilization.||159
10555995|NCT01567527|11710817|FG003|NOT COMPLETED|IM Depot Stabilization.||0
10555996|NCT01567527|11710818|FG004|NOT COMPLETED|IM Depot Stabilization.||0
10555997|NCT01567527|11710814|FG000|STARTED|Double-blind, Placebo-controlled Phase||0
10555998|NCT01567527|11710815|FG001|STARTED|Double-blind, Placebo-controlled Phase||0
10555999|NCT01567527|11710816|FG002|STARTED|Double-blind, Placebo-controlled Phase|Subjects were randomized to Aripiprazole IM Depot and placebo groups in this phase of the study|0
10556000|NCT01567527|11710817|FG003|STARTED|Double-blind, Placebo-controlled Phase||133
10556001|NCT01567527|11710818|FG004|STARTED|Double-blind, Placebo-controlled Phase||133
10556002|NCT01567527|11710814|FG000|COMPLETED|Double-blind, Placebo-controlled Phase||0
10556003|NCT01567527|11710815|FG001|COMPLETED|Double-blind, Placebo-controlled Phase||0
10556004|NCT01567527|11710816|FG002|COMPLETED|Double-blind, Placebo-controlled Phase||0
10556005|NCT01567527|11710817|FG003|COMPLETED|Double-blind, Placebo-controlled Phase||64
10556006|NCT01567527|11710818|FG004|COMPLETED|Double-blind, Placebo-controlled Phase||38
10556007|NCT01567527|11710814|FG000|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
10556008|NCT01567527|11710815|FG001|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
10556009|NCT01567527|11710816|FG002|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
10556010|NCT01567527|11710817|FG003|NOT COMPLETED|Double-blind, Placebo-controlled Phase||69
10556011|NCT01567527|11710818|FG004|NOT COMPLETED|Double-blind, Placebo-controlled Phase||95
10556012|NCT01567826|11710829|FG000|STARTED|Overall Study||43
10556013|NCT01567826|11710830|FG001|STARTED|Overall Study||44
10556014|NCT01567826|11710829|FG000|COMPLETED|Overall Study||40
10556015|NCT01567826|11710830|FG001|COMPLETED|Overall Study||42
10556016|NCT01567826|11710829|FG000|NOT COMPLETED|Overall Study||3
10556017|NCT01567826|11710830|FG001|NOT COMPLETED|Overall Study||2
10556018|NCT01567839|11710838|FG000|STARTED|Overall Study||60
10556019|NCT01567839|11710838|FG000|COMPLETED|Overall Study||60
10556020|NCT01567839|11710838|FG000|NOT COMPLETED|Overall Study||0
10556021|NCT01567852|11710848|FG000|STARTED|Overall Study||8
10556022|NCT01567852|11710849|FG001|STARTED|Overall Study||12
10556023|NCT01567852|11710848|FG000|COMPLETED|Overall Study||4
10556024|NCT01567852|11710849|FG001|COMPLETED|Overall Study||5
10556025|NCT01567852|11710848|FG000|NOT COMPLETED|Overall Study||4
10556026|NCT01567852|11710849|FG001|NOT COMPLETED|Overall Study||7
10556027|NCT01567865|11710859|FG000|STARTED|Enrolled and Vaccinated (Day 0)||163
10556028|NCT01567865|11710860|FG001|STARTED|Enrolled and Vaccinated (Day 0)||220
10556029|NCT01567865|11710861|FG002|STARTED|Enrolled and Vaccinated (Day 0)||211
10556030|NCT01567865|11710862|FG003|STARTED|Enrolled and Vaccinated (Day 0)||224
10556031|NCT01567865|11710859|FG000|COMPLETED|Enrolled and Vaccinated (Day 0)||163
10556032|NCT01567865|11710860|FG001|COMPLETED|Enrolled and Vaccinated (Day 0)||220
10556033|NCT01567865|11710861|FG002|COMPLETED|Enrolled and Vaccinated (Day 0)||211
10556034|NCT01567865|11710862|FG003|COMPLETED|Enrolled and Vaccinated (Day 0)||224
10556035|NCT01567865|11710859|FG000|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
10556036|NCT01567865|11710860|FG001|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
10556037|NCT01567865|11710861|FG002|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
10556038|NCT01567865|11710862|FG003|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
10556039|NCT01567865|11710859|FG000|STARTED|Evaluated for Immunogenicity||163
10556040|NCT01567865|11710860|FG001|STARTED|Evaluated for Immunogenicity||220
10556042|NCT01567865|11710862|FG003|STARTED|Evaluated for Immunogenicity||224
10556043|NCT01567865|11710859|FG000|COMPLETED|Evaluated for Immunogenicity||146
10556044|NCT01567865|11710860|FG001|COMPLETED|Evaluated for Immunogenicity||195
10556045|NCT01567865|11710861|FG002|COMPLETED|Evaluated for Immunogenicity||192
10556046|NCT01567865|11710862|FG003|COMPLETED|Evaluated for Immunogenicity||194
10556047|NCT01567865|11710859|FG000|NOT COMPLETED|Evaluated for Immunogenicity||17
10556048|NCT01567865|11710860|FG001|NOT COMPLETED|Evaluated for Immunogenicity||25
10556049|NCT01567865|11710861|FG002|NOT COMPLETED|Evaluated for Immunogenicity||19
10556050|NCT01567865|11710862|FG003|NOT COMPLETED|Evaluated for Immunogenicity||30
10556051|NCT01567891|11710873|FG000|STARTED|Overall Study||9
10556052|NCT01567891|11710873|FG000|Received T-cell|Overall Study||6
10556053|NCT01567891|11710873|FG000|COMPLETED|Overall Study||6
10556054|NCT01567891|11710873|FG000|NOT COMPLETED|Overall Study||3
10556055|NCT01567943|11710888|FG000|STARTED|Overall Study||40
10556056|NCT01567943|11710889|FG001|STARTED|Overall Study||39
10556057|NCT01567943|11710890|FG002|STARTED|Overall Study||44
10556058|NCT01567943|11710888|FG000|COMPLETED|Overall Study||26
10556059|NCT01567943|11710889|FG001|COMPLETED|Overall Study||29
10556060|NCT01567943|11710890|FG002|COMPLETED|Overall Study||44
10556061|NCT01567943|11710888|FG000|NOT COMPLETED|Overall Study||14
10556062|NCT01567943|11710889|FG001|NOT COMPLETED|Overall Study||10
10556063|NCT01567943|11710890|FG002|NOT COMPLETED|Overall Study||0
10556064|NCT01568008|11710896|FG000|STARTED|Overall Study||933
10556065|NCT01568008|11710896|FG000|COMPLETED|Overall Study||699
10556066|NCT01568008|11710896|FG000|NOT COMPLETED|Overall Study||234
10556067|NCT01568021|11710900|FG000|STARTED|Overall Study||99
10556068|NCT01568021|11710900|FG000|COMPLETED|Overall Study||83
10556069|NCT01568021|11710900|FG000|NOT COMPLETED|Overall Study||16
10556070|NCT01568034|11710904|FG000|STARTED|Overall Study||2
10556071|NCT01568034|11710905|FG001|STARTED|Overall Study||2
10556072|NCT01568034|11710906|FG002|STARTED|Overall Study||3
10556073|NCT01568034|11710907|FG003|STARTED|Overall Study||3
10556074|NCT01568034|11710904|FG000|25 mg BIA 9-1067|Overall Study||2
10556075|NCT01568034|11710905|FG001|25 mg BIA 9-1067|Overall Study||2
10556076|NCT01568034|11710906|FG002|25 mg BIA 9-1067|Overall Study||3
10556077|NCT01568034|11710907|FG003|25 mg BIA 9-1067|Overall Study||3
10556078|NCT01568034|11710904|FG000|50 mg BIA 9-1067|Overall Study||2
10556079|NCT01568034|11710905|FG001|50 mg BIA 9-1067|Overall Study||2
10556080|NCT01568034|11710906|FG002|50 mg BIA 9-1067|Overall Study||3
10556081|NCT01568034|11710907|FG003|50 mg BIA 9-1067|Overall Study||3
10556082|NCT01568034|11710904|FG000|100 mg BIA 9-1067|Overall Study||2
10556083|NCT01568034|11710905|FG001|100 mg BIA 9-1067|Overall Study||2
10556084|NCT01568034|11710906|FG002|100 mg BIA 9-1067|Overall Study||3
10556085|NCT01568034|11710907|FG003|100 mg BIA 9-1067|Overall Study||3
10556086|NCT01568034|11710904|FG000|Placebo|Overall Study||1
10556087|NCT01568034|11710905|FG001|Placebo|Overall Study||2
10556088|NCT01568034|11710906|FG002|Placebo|Overall Study||3
10556089|NCT01568034|11710907|FG003|Placebo|Overall Study||3
10556090|NCT01568034|11710904|FG000|COMPLETED|Overall Study||1
10556091|NCT01568034|11710905|FG001|COMPLETED|Overall Study||2
10556092|NCT01568034|11710906|FG002|COMPLETED|Overall Study||3
10556093|NCT01568034|11710907|FG003|COMPLETED|Overall Study||3
10556094|NCT01568034|11710904|FG000|NOT COMPLETED|Overall Study||1
10556095|NCT01568034|11710905|FG001|NOT COMPLETED|Overall Study||0
10556096|NCT01568034|11710906|FG002|NOT COMPLETED|Overall Study||0
10556097|NCT01568034|11710907|FG003|NOT COMPLETED|Overall Study||0
10556098|NCT01568047|11710921|FG000|STARTED|Overall Study||10
10556099|NCT01568047|11710922|FG001|STARTED|Overall Study||10
10556100|NCT01568047|11710923|FG002|STARTED|Overall Study||10
10556101|NCT01568047|11710924|FG003|STARTED|Overall Study||10
10556102|NCT01568047|11710921|FG000|COMPLETED|Overall Study||9
10556103|NCT01568047|11710922|FG001|COMPLETED|Overall Study||9
10556104|NCT01568047|11710923|FG002|COMPLETED|Overall Study||9
10556105|NCT01568047|11710924|FG003|COMPLETED|Overall Study||9
10556106|NCT01568047|11710921|FG000|NOT COMPLETED|Overall Study||1
10556107|NCT01568047|11710922|FG001|NOT COMPLETED|Overall Study||1
10556108|NCT01568047|11710923|FG002|NOT COMPLETED|Overall Study||1
10556109|NCT01568047|11710924|FG003|NOT COMPLETED|Overall Study||1
10556110|NCT01568073|11710939|FG000|STARTED|Overall Study||121
10556111|NCT01568073|11710940|FG001|STARTED|Overall Study||122
10556112|NCT01568073|11710941|FG002|STARTED|Overall Study||122
10556113|NCT01568073|11710942|FG003|STARTED|Overall Study||119
10556114|NCT01568073|11710943|FG004|STARTED|Overall Study||116
10556115|NCT01568073|11710939|FG000|COMPLETED|Overall Study||110
10556116|NCT01568073|11710940|FG001|COMPLETED|Overall Study||107
10556117|NCT01568073|11710941|FG002|COMPLETED|Overall Study||110
10556118|NCT01568073|11710942|FG003|COMPLETED|Overall Study||108
10556119|NCT01568073|11710943|FG004|COMPLETED|Overall Study||107
10556120|NCT01568073|11710939|FG000|NOT COMPLETED|Overall Study||11
10556121|NCT01568073|11710940|FG001|NOT COMPLETED|Overall Study||15
10556122|NCT01568073|11710941|FG002|NOT COMPLETED|Overall Study||12
10556123|NCT01568073|11710942|FG003|NOT COMPLETED|Overall Study||11
10556124|NCT01568073|11710943|FG004|NOT COMPLETED|Overall Study||9
10556125|NCT01568112|11710959|FG000|STARTED|Overall Study||44
10556126|NCT01568112|11710960|FG001|STARTED|Overall Study||44
10556127|NCT01568112|11710961|FG002|STARTED|Overall Study||43
10556128|NCT01568112|11710962|FG003|STARTED|Overall Study||42
10556129|NCT01568112|11710959|FG000|COMPLETED|Overall Study||39
10556130|NCT01568112|11710960|FG001|COMPLETED|Overall Study||36
10556131|NCT01568112|11710961|FG002|COMPLETED|Overall Study||36
10556132|NCT01568112|11710962|FG003|COMPLETED|Overall Study||30
10556133|NCT01568112|11710959|FG000|NOT COMPLETED|Overall Study||5
10556134|NCT01568112|11710960|FG001|NOT COMPLETED|Overall Study||8
10556135|NCT01568112|11710961|FG002|NOT COMPLETED|Overall Study||7
10556136|NCT01568112|11710962|FG003|NOT COMPLETED|Overall Study||12
10556137|NCT01568255|11710975|FG000|STARTED|Overall Study||5
10556138|NCT01568255|11710976|FG001|STARTED|Overall Study||6
10556139|NCT01568255|11710975|FG000|COMPLETED|Overall Study||5
10556140|NCT01568255|11710976|FG001|COMPLETED|Overall Study||6
10556141|NCT01568255|11710975|FG000|NOT COMPLETED|Overall Study||0
10556142|NCT01568255|11710976|FG001|NOT COMPLETED|Overall Study||0
10556143|NCT01568320|11710982|FG000|STARTED|Overall Study||73
10556144|NCT01568320|11710982|FG000|5-Year|Overall Study|Patients eligible for Follow-up at 5 year|36
10556145|NCT01568320|11710982|FG000|COMPLETED|Overall Study||32
10556146|NCT01568320|11710982|FG000|NOT COMPLETED|Overall Study||41
10556147|NCT01568528|11710989|FG000|STARTED|Overall Study||19
10556148|NCT01568528|11710990|FG001|STARTED|Overall Study||11
10556149|NCT01568528|11710991|FG002|STARTED|Overall Study||9
10556150|NCT01568528|11710989|FG000|COMPLETED|Overall Study||19
10556151|NCT01568528|11710990|FG001|COMPLETED|Overall Study||11
10556152|NCT01568528|11710991|FG002|COMPLETED|Overall Study||9
10556153|NCT01568528|11710989|FG000|NOT COMPLETED|Overall Study||0
10556154|NCT01568528|11710990|FG001|NOT COMPLETED|Overall Study||0
10556155|NCT01568528|11710991|FG002|NOT COMPLETED|Overall Study||0
10556156|NCT01568593|11711001|FG000|STARTED|Overall Study||48
10556157|NCT01568593|11711002|FG001|STARTED|Overall Study||45
10556158|NCT01568593|11711001|FG000|COMPLETED|Overall Study||41
10556159|NCT01568593|11711002|FG001|COMPLETED|Overall Study||42
10556160|NCT01568593|11711001|FG000|NOT COMPLETED|Overall Study||7
10556161|NCT01568593|11711002|FG001|NOT COMPLETED|Overall Study||3
10556162|NCT01568606|11711008|FG000|STARTED|Overall Study||20
10556163|NCT01568606|11711008|FG000|COMPLETED|Overall Study||20
10556164|NCT01568606|11711008|FG000|NOT COMPLETED|Overall Study||0
10556165|NCT01568827|11711014|FG000|STARTED|First Intervention (6 Days)||5
10556166|NCT01568827|11711015|FG001|STARTED|First Intervention (6 Days)||5
10556167|NCT01568827|11711014|FG000|COMPLETED|First Intervention (6 Days)||5
10556168|NCT01568827|11711015|FG001|COMPLETED|First Intervention (6 Days)||5
10556169|NCT01568827|11711014|FG000|NOT COMPLETED|First Intervention (6 Days)||0
10556170|NCT01568827|11711015|FG001|NOT COMPLETED|First Intervention (6 Days)||0
10556171|NCT01568827|11711014|FG000|STARTED|Washout (2 Days)||5
10556172|NCT01568827|11711015|FG001|STARTED|Washout (2 Days)||5
10556173|NCT01568827|11711014|FG000|COMPLETED|Washout (2 Days)||5
10556174|NCT01568827|11711015|FG001|COMPLETED|Washout (2 Days)||5
10556175|NCT01568827|11711014|FG000|NOT COMPLETED|Washout (2 Days)||0
10556176|NCT01568827|11711015|FG001|NOT COMPLETED|Washout (2 Days)||0
10556177|NCT01568827|11711014|FG000|STARTED|Intervention 2 (5 Days)||5
10556178|NCT01568827|11711015|FG001|STARTED|Intervention 2 (5 Days)||5
10556179|NCT01568827|11711014|FG000|COMPLETED|Intervention 2 (5 Days)||5
10556180|NCT01568827|11711015|FG001|COMPLETED|Intervention 2 (5 Days)||5
10556181|NCT01568827|11711014|FG000|NOT COMPLETED|Intervention 2 (5 Days)||0
10556182|NCT01568827|11711015|FG001|NOT COMPLETED|Intervention 2 (5 Days)||0
10556191|NCT01568892|11711032|FG000|STARTED|Double-blind Phase||14
10556192|NCT01568892|11711033|FG001|STARTED|Double-blind Phase||16
10556193|NCT01568892|11711032|FG000|COMPLETED|Double-blind Phase||14
10556194|NCT01568892|11711033|FG001|COMPLETED|Double-blind Phase||16
10556195|NCT01568892|11711032|FG000|NOT COMPLETED|Double-blind Phase||0
10556196|NCT01568892|11711033|FG001|NOT COMPLETED|Double-blind Phase||0
10556197|NCT01568892|11711032|FG000|STARTED|Open-label Phase|One participant completing the DB Phase withdrew on Day 8 and did not enter the Open-label Phase.|13
10556198|NCT01568892|11711033|FG001|STARTED|Open-label Phase||16
10556199|NCT01568892|11711032|FG000|COMPLETED|Open-label Phase||7
10556200|NCT01568892|11711033|FG001|COMPLETED|Open-label Phase||13
10556201|NCT01568892|11711032|FG000|NOT COMPLETED|Open-label Phase||6
10556202|NCT01568892|11711033|FG001|NOT COMPLETED|Open-label Phase||3
10556203|NCT01568905|11711043|FG000|STARTED|Overall Study||13
10556204|NCT01568905|11711044|FG001|STARTED|Overall Study||11
10556205|NCT01568905|11711045|FG002|STARTED|Overall Study||12
10556206|NCT01568905|11711043|FG000|COMPLETED|Overall Study||12
10556207|NCT01568905|11711044|FG001|COMPLETED|Overall Study||11
10556208|NCT01568905|11711045|FG002|COMPLETED|Overall Study||12
10556209|NCT01568905|11711043|FG000|NOT COMPLETED|Overall Study||1
10556210|NCT01568905|11711044|FG001|NOT COMPLETED|Overall Study||0
10556211|NCT01568905|11711045|FG002|NOT COMPLETED|Overall Study||0
10556212|NCT01568944|11711055|FG000|STARTED|Overall Study||8
10790470|NCT03541044|11950986|FG000|COMPLETED|Study Period 2: Up to Day 8||21
10790471|NCT03541044|11950987|FG001|COMPLETED|Study Period 2: Up to Day 8||23
10790472|NCT03541044|11950986|FG000|NOT COMPLETED|Study Period 2: Up to Day 8||2
10790473|NCT03541044|11950987|FG001|NOT COMPLETED|Study Period 2: Up to Day 8||0
10790474|NCT03541356|11951000|FG000|STARTED|Overall Study||8
10790475|NCT03541356|11951001|FG001|STARTED|Overall Study||6
10790476|NCT03541356|11951002|FG002|STARTED|Overall Study||6
10790477|NCT03541356|11951003|FG003|STARTED|Overall Study||6
10790478|NCT03541356|11951004|FG004|STARTED|Overall Study||6
10790479|NCT03541356|11951000|FG000|COMPLETED|Overall Study||8
10790480|NCT03541356|11951001|FG001|COMPLETED|Overall Study||6
10790481|NCT03541356|11951002|FG002|COMPLETED|Overall Study||6
10790482|NCT03541356|11951003|FG003|COMPLETED|Overall Study||6
10790483|NCT03541356|11951004|FG004|COMPLETED|Overall Study||6
10790484|NCT03541356|11951000|FG000|NOT COMPLETED|Overall Study||0
10790485|NCT03541356|11951001|FG001|NOT COMPLETED|Overall Study||0
10790486|NCT03541356|11951002|FG002|NOT COMPLETED|Overall Study||0
10790487|NCT03541356|11951003|FG003|NOT COMPLETED|Overall Study||0
10790488|NCT03541356|11951004|FG004|NOT COMPLETED|Overall Study||0
10790489|NCT03541941|11951024|FG000|STARTED|Overall Study||57
10790490|NCT03541941|11951025|FG001|STARTED|Overall Study||55
10790491|NCT03541941|11951026|FG002|STARTED|Overall Study||52
10790492|NCT03541941|11951024|FG000|COMPLETED|Overall Study||57
10790493|NCT03541941|11951025|FG001|COMPLETED|Overall Study||55
10556213|NCT01568944|11711056|FG001|STARTED|Overall Study||10
10556214|NCT01568944|11711055|FG000|COMPLETED|Overall Study||8
10556215|NCT01568944|11711056|FG001|COMPLETED|Overall Study||10
10556216|NCT01568944|11711055|FG000|NOT COMPLETED|Overall Study||0
10556217|NCT01568944|11711056|FG001|NOT COMPLETED|Overall Study||0
10556218|NCT01569022|11711062|FG000|STARTED|First Intervention||21
10556219|NCT01569022|11711063|FG001|STARTED|First Intervention||21
10556220|NCT01569022|11711062|FG000|COMPLETED|First Intervention||19
10556221|NCT01569022|11711063|FG001|COMPLETED|First Intervention||20
10556222|NCT01569022|11711062|FG000|NOT COMPLETED|First Intervention||2
10556223|NCT01569022|11711063|FG001|NOT COMPLETED|First Intervention||1
10556224|NCT01569022|11711062|FG000|STARTED|Second Intervention||19
10556225|NCT01569022|11711063|FG001|STARTED|Second Intervention||20
10556226|NCT01569022|11711062|FG000|COMPLETED|Second Intervention||17
10556227|NCT01569022|11711063|FG001|COMPLETED|Second Intervention||18
10556228|NCT01569022|11711062|FG000|NOT COMPLETED|Second Intervention||2
10556229|NCT01569022|11711063|FG001|NOT COMPLETED|Second Intervention||2
10790494|NCT03541941|11951026|FG002|COMPLETED|Overall Study||52
10790495|NCT03541941|11951024|FG000|NOT COMPLETED|Overall Study||0
10790496|NCT03541941|11951025|FG001|NOT COMPLETED|Overall Study||0
10790497|NCT03541941|11951026|FG002|NOT COMPLETED|Overall Study||0
10790498|NCT03541980|11951036|FG000|STARTED|Overall Study||35
10556230|NCT01569074|11711076|FG000|STARTED|Overall Study|Patients who received treatment|31
10556231|NCT01569074|11711077|FG001|STARTED|Overall Study|Patients who received treatment|33
10556232|NCT01569074|11711078|FG002|STARTED|Overall Study|Patients who received treatment|33
10556233|NCT01569074|11711079|FG003|STARTED|Overall Study|Patients who received treatment|33
10556234|NCT01569074|11711080|FG004|STARTED|Overall Study|Patients who received treatment|33
10556235|NCT01569074|11711076|FG000|Randomised But Did Not Receive Treatment|Overall Study||0
10556236|NCT01569074|11711077|FG001|Randomised But Did Not Receive Treatment|Overall Study||0
10556237|NCT01569074|11711078|FG002|Randomised But Did Not Receive Treatment|Overall Study||0
10556238|NCT01569074|11711079|FG003|Randomised But Did Not Receive Treatment|Overall Study||0
10556239|NCT01569074|11711080|FG004|Randomised But Did Not Receive Treatment|Overall Study||0
10556240|NCT01569074|11711076|FG000|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|24
10556241|NCT01569074|11711077|FG001|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|24
10556242|NCT01569074|11711078|FG002|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|21
10556243|NCT01569074|11711079|FG003|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|25
10556244|NCT01569074|11711080|FG004|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|25
10556245|NCT01569074|11711076|FG000|NOT COMPLETED|Overall Study||7
10556246|NCT01569074|11711077|FG001|NOT COMPLETED|Overall Study||9
10556247|NCT01569074|11711078|FG002|NOT COMPLETED|Overall Study||12
10556248|NCT01569074|11711079|FG003|NOT COMPLETED|Overall Study||8
10556249|NCT01569074|11711080|FG004|NOT COMPLETED|Overall Study||8
10556250|NCT01569087|11711099|FG000|STARTED|Overall Study||21
10556251|NCT01569087|11711100|FG001|STARTED|Overall Study||20
10556252|NCT01569087|11711101|FG002|STARTED|Overall Study||19
10556253|NCT01569087|11711099|FG000|COMPLETED|Overall Study||20
10556254|NCT01569087|11711100|FG001|COMPLETED|Overall Study||20
10556255|NCT01569087|11711101|FG002|COMPLETED|Overall Study||18
10556256|NCT01569087|11711099|FG000|NOT COMPLETED|Overall Study||1
10556257|NCT01569087|11711100|FG001|NOT COMPLETED|Overall Study||0
10556258|NCT01569087|11711101|FG002|NOT COMPLETED|Overall Study||1
10556259|NCT01569126|11711115|FG000|STARTED|Overall Study||8
10556260|NCT01569126|11711116|FG001|STARTED|Overall Study||8
10556261|NCT01569126|11711117|FG002|STARTED|Overall Study||8
10556262|NCT01569126|11711118|FG003|STARTED|Overall Study||8
10556263|NCT01569126|11711119|FG004|STARTED|Overall Study||12
10556264|NCT01569126|11711120|FG005|STARTED|Overall Study||12
10556265|NCT01569126|11711115|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
10556266|NCT01569126|11711116|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
10556267|NCT01569126|11711117|FG002|Received at Least 1 Dose of Study Drug|Overall Study||8
10556268|NCT01569126|11711118|FG003|Received at Least 1 Dose of Study Drug|Overall Study||8
10556269|NCT01569126|11711119|FG004|Received at Least 1 Dose of Study Drug|Overall Study||12
10556270|NCT01569126|11711120|FG005|Received at Least 1 Dose of Study Drug|Overall Study||12
10556271|NCT01569126|11711115|FG000|COMPLETED|Overall Study||8
10556272|NCT01569126|11711116|FG001|COMPLETED|Overall Study||8
10556273|NCT01569126|11711117|FG002|COMPLETED|Overall Study||8
10556274|NCT01569126|11711118|FG003|COMPLETED|Overall Study||8
10556275|NCT01569126|11711119|FG004|COMPLETED|Overall Study||12
10556276|NCT01569126|11711120|FG005|COMPLETED|Overall Study||12
10556277|NCT01569126|11711115|FG000|NOT COMPLETED|Overall Study||0
10556278|NCT01569126|11711116|FG001|NOT COMPLETED|Overall Study||0
10556279|NCT01569126|11711117|FG002|NOT COMPLETED|Overall Study||0
10556280|NCT01569126|11711118|FG003|NOT COMPLETED|Overall Study||0
10556281|NCT01569126|11711119|FG004|NOT COMPLETED|Overall Study||0
10556282|NCT01569126|11711120|FG005|NOT COMPLETED|Overall Study||0
10556283|NCT01569152|11711141|FG000|STARTED|Phase IIa, Period 1||41
10556284|NCT01569152|11711142|FG001|STARTED|Phase IIa, Period 1||41
10556285|NCT01569152|11711143|FG002|STARTED|Phase IIa, Period 1||0
10556286|NCT01569152|11711141|FG000|COMPLETED|Phase IIa, Period 1||20
10556287|NCT01569152|11711142|FG001|COMPLETED|Phase IIa, Period 1||9
10556288|NCT01569152|11711143|FG002|COMPLETED|Phase IIa, Period 1||0
10556289|NCT01569152|11711141|FG000|NOT COMPLETED|Phase IIa, Period 1||21
10556290|NCT01569152|11711142|FG001|NOT COMPLETED|Phase IIa, Period 1||32
10556291|NCT01569152|11711143|FG002|NOT COMPLETED|Phase IIa, Period 1||0
10556292|NCT01569152|11711141|FG000|STARTED|Safety Extension, Period 3||0
10556293|NCT01569152|11711142|FG001|STARTED|Safety Extension, Period 3||0
10556294|NCT01569152|11711143|FG002|STARTED|Safety Extension, Period 3|Includes 29 completers and 26 early escapees from Base Study Phase IIa|55
10556295|NCT01569152|11711141|FG000|COMPLETED|Safety Extension, Period 3||0
10556296|NCT01569152|11711142|FG001|COMPLETED|Safety Extension, Period 3||0
10556297|NCT01569152|11711143|FG002|COMPLETED|Safety Extension, Period 3||0
10556298|NCT01569152|11711141|FG000|NOT COMPLETED|Safety Extension, Period 3||0
10556299|NCT01569152|11711142|FG001|NOT COMPLETED|Safety Extension, Period 3||0
10556300|NCT01569152|11711143|FG002|NOT COMPLETED|Safety Extension, Period 3||55
10556301|NCT01569191|11711152|FG000|STARTED|Overall Study||11
10556302|NCT01569191|11711153|FG001|STARTED|Overall Study||7
10556303|NCT01569191|11711152|FG000|COMPLETED|Overall Study||11
10556304|NCT01569191|11711153|FG001|COMPLETED|Overall Study||7
10556305|NCT01569191|11711152|FG000|NOT COMPLETED|Overall Study||0
10556306|NCT01569191|11711153|FG001|NOT COMPLETED|Overall Study||0
10556307|NCT01569295|11711165|FG000|STARTED|Overall Study||207
10556308|NCT01569295|11711166|FG001|STARTED|Overall Study||209
10556309|NCT01569295|11711165|FG000|Long-Term Follow-up|Overall Study||109
10556310|NCT01569295|11711166|FG001|Long-Term Follow-up|Overall Study||161
10556311|NCT01569295|11711165|FG000|COMPLETED|Overall Study||0
10556312|NCT01569295|11711166|FG001|COMPLETED|Overall Study||0
10556313|NCT01569295|11711165|FG000|NOT COMPLETED|Overall Study||207
10556314|NCT01569295|11711166|FG001|NOT COMPLETED|Overall Study||209
10556315|NCT01569438|11711175|FG000|STARTED|Overall Study||52
10556316|NCT01569438|11711176|FG001|STARTED|Overall Study||55
10556317|NCT01569438|11711175|FG000|Treated|Overall Study||51
10556318|NCT01569438|11711176|FG001|Treated|Overall Study||54
10556319|NCT01569438|11711175|FG000|Titration Set|Overall Study||38
10556320|NCT01569438|11711176|FG001|Titration Set|Overall Study||36
10556321|NCT01569438|11711175|FG000|COMPLETED|Overall Study||45
10556322|NCT01569438|11711176|FG001|COMPLETED|Overall Study||33
10556323|NCT01569438|11711175|FG000|NOT COMPLETED|Overall Study||7
10556324|NCT01569438|11711176|FG001|NOT COMPLETED|Overall Study||22
10556325|NCT01569451|11711184|FG000|STARTED|Overall Study||26
10556326|NCT01569451|11711185|FG001|STARTED|Overall Study||27
10556327|NCT01569451|11711184|FG000|COMPLETED|Overall Study||12
10556328|NCT01569451|11711185|FG001|COMPLETED|Overall Study||14
10556329|NCT01569451|11711184|FG000|NOT COMPLETED|Overall Study||14
10556330|NCT01569451|11711185|FG001|NOT COMPLETED|Overall Study||13
10556331|NCT01569464|11711195|FG000|STARTED|Overall Study||101
10556332|NCT01569464|11711196|FG001|STARTED|Overall Study||49
10556333|NCT01569464|11711195|FG000|COMPLETED|Overall Study||91
10556334|NCT01569464|11711196|FG001|COMPLETED|Overall Study||44
10556335|NCT01569464|11711195|FG000|NOT COMPLETED|Overall Study||10
10556336|NCT01569464|11711196|FG001|NOT COMPLETED|Overall Study||5
10556337|NCT01569529|11711206|FG000|STARTED|Overall Study||2676
10556338|NCT01569529|11711207|FG001|STARTED|Overall Study||394
10556339|NCT01569529|11711206|FG000|COMPLETED|Overall Study||2676
10556340|NCT01569529|11711207|FG001|COMPLETED|Overall Study||394
10556341|NCT01569529|11711206|FG000|NOT COMPLETED|Overall Study||0
10556342|NCT01569529|11711207|FG001|NOT COMPLETED|Overall Study||0
10556343|NCT01569568|11711215|FG000|STARTED|Overall Study||20
10556344|NCT01569568|11711216|FG001|STARTED|Overall Study||29
10556345|NCT01569568|11711215|FG000|COMPLETED|Overall Study||20
10556346|NCT01569568|11711216|FG001|COMPLETED|Overall Study||27
10556347|NCT01569568|11711215|FG000|NOT COMPLETED|Overall Study||0
10556348|NCT01569568|11711216|FG001|NOT COMPLETED|Overall Study||2
10556349|NCT01569594|11711222|FG000|STARTED|Overall Study||230
10556350|NCT01569594|11711222|FG000|COMPLETED|Overall Study||163
10556351|NCT01569594|11711222|FG000|NOT COMPLETED|Overall Study||67
10556352|NCT01569607|11711228|FG000|STARTED|Overall Study||11
10556353|NCT01569607|11711229|FG001|STARTED|Overall Study||11
10556354|NCT01569607|11711228|FG000|COMPLETED|Overall Study||10
10556355|NCT01569607|11711229|FG001|COMPLETED|Overall Study||10
10556356|NCT01569607|11711228|FG000|NOT COMPLETED|Overall Study||1
10556357|NCT01569607|11711229|FG001|NOT COMPLETED|Overall Study||1
10556358|NCT01569737|11711235|FG000|STARTED|Overall Study||98
10556359|NCT01569737|11711235|FG000|COMPLETED|Overall Study||95
10556360|NCT01569737|11711235|FG000|NOT COMPLETED|Overall Study||3
10556361|NCT01569763|11711241|FG000|STARTED|Overall Study||102
10556362|NCT01569763|11711242|FG001|STARTED|Overall Study||51
10556363|NCT01569763|11711241|FG000|Treated|Overall Study||102
10556364|NCT01569763|11711242|FG001|Treated|Overall Study||51
10556365|NCT01569763|11711241|FG000|COMPLETED|Overall Study|Completed 12 Months of Follow-up|99
10556366|NCT01569763|11711242|FG001|COMPLETED|Overall Study|Completed 12 Months of Follow-up|44
10556367|NCT01569763|11711241|FG000|NOT COMPLETED|Overall Study||3
10556368|NCT01569763|11711242|FG001|NOT COMPLETED|Overall Study||7
10556369|NCT01569815|11711252|FG000|STARTED|Overall Study||8
10556370|NCT01569815|11711253|FG001|STARTED|Overall Study||8
10556371|NCT01569815|11711254|FG002|STARTED|Overall Study||8
10556372|NCT01569815|11711255|FG003|STARTED|Overall Study||8
10556373|NCT01569815|11711252|FG000|COMPLETED|Overall Study||8
10556374|NCT01569815|11711253|FG001|COMPLETED|Overall Study||8
10556375|NCT01569815|11711254|FG002|COMPLETED|Overall Study||8
10556376|NCT01569815|11711255|FG003|COMPLETED|Overall Study||8
10556377|NCT01569815|11711252|FG000|NOT COMPLETED|Overall Study||0
10556378|NCT01569815|11711253|FG001|NOT COMPLETED|Overall Study||0
10556379|NCT01569815|11711254|FG002|NOT COMPLETED|Overall Study||0
10556380|NCT01569815|11711255|FG003|NOT COMPLETED|Overall Study||0
10556381|NCT01569828|11711268|FG000|STARTED|Overall Study||6
10556382|NCT01569828|11711269|FG001|STARTED|Overall Study||6
10556383|NCT01569828|11711268|FG000|COMPLETED|Overall Study||6
10556384|NCT01569828|11711269|FG001|COMPLETED|Overall Study||6
10556385|NCT01569828|11711268|FG000|NOT COMPLETED|Overall Study||0
10556386|NCT01569828|11711269|FG001|NOT COMPLETED|Overall Study||0
10556387|NCT01569841|11711276|FG000|STARTED|Period A (6 Weeks)||12
10556388|NCT01569841|11711277|FG001|STARTED|Period A (6 Weeks)||12
10556389|NCT01569841|11711276|FG000|Exposed|Period A (6 Weeks)||12
10556390|NCT01569841|11711277|FG001|Exposed|Period A (6 Weeks)||12
10556391|NCT01569841|11711276|FG000|COMPLETED|Period A (6 Weeks)||12
10556392|NCT01569841|11711277|FG001|COMPLETED|Period A (6 Weeks)||11
10556393|NCT01569841|11711276|FG000|NOT COMPLETED|Period A (6 Weeks)||0
10556394|NCT01569841|11711277|FG001|NOT COMPLETED|Period A (6 Weeks)||1
10556395|NCT01569841|11711276|FG000|STARTED|Period B (6 Weeks)||12
10556396|NCT01569841|11711277|FG001|STARTED|Period B (6 Weeks)||11
10556397|NCT01569841|11711276|FG000|Exposed|Period B (6 Weeks)||12
10556398|NCT01569841|11711277|FG001|Exposed|Period B (6 Weeks)||11
10556399|NCT01569841|11711276|FG000|COMPLETED|Period B (6 Weeks)||12
10556400|NCT01569841|11711277|FG001|COMPLETED|Period B (6 Weeks)||11
10556401|NCT01569841|11711276|FG000|NOT COMPLETED|Period B (6 Weeks)||0
10556402|NCT01569841|11711277|FG001|NOT COMPLETED|Period B (6 Weeks)||0
10556403|NCT01570036|11711287|FG000|STARTED|Overall Study||136
10556404|NCT01570036|11711288|FG001|STARTED|Overall Study||139
10556405|NCT01570036|11711287|FG000|Primary Vaccine Series Completed|Overall Study||121
10556406|NCT01570036|11711288|FG001|Primary Vaccine Series Completed|Overall Study||132
10556407|NCT01570036|11711287|FG000|Booster Series Completed|Overall Study||40
10556408|NCT01570036|11711288|FG001|Booster Series Completed|Overall Study||30
10556409|NCT01570036|11711287|FG000|COMPLETED|Overall Study||18
10556410|NCT01570036|11711288|FG001|COMPLETED|Overall Study||17
10556411|NCT01570036|11711287|FG000|NOT COMPLETED|Overall Study||118
10556412|NCT01570036|11711288|FG001|NOT COMPLETED|Overall Study||122
10556413|NCT01570192|11711296|FG000|STARTED|Overall Study||13
10556414|NCT01570192|11711297|FG001|STARTED|Overall Study||30
10556415|NCT01570192|11711296|FG000|COMPLETED|Overall Study||6
10556416|NCT01570192|11711297|FG001|COMPLETED|Overall Study||17
10556417|NCT01570192|11711296|FG000|NOT COMPLETED|Overall Study||7
10556418|NCT01570192|11711297|FG001|NOT COMPLETED|Overall Study||13
10556419|NCT01570244|11711308|FG000|STARTED|Microgynon||16
10556420|NCT01570244|11711308|FG000|COMPLETED|Microgynon||16
10556421|NCT01570244|11711308|FG000|NOT COMPLETED|Microgynon||0
10556422|NCT01570244|11711308|FG000|STARTED|Microgynon+Faldaprevir||16
10556423|NCT01570244|11711308|FG000|COMPLETED|Microgynon+Faldaprevir||15
10556424|NCT01570244|11711308|FG000|NOT COMPLETED|Microgynon+Faldaprevir||1
10556425|NCT01570283|11711317|FG000|STARTED|Cohort 1: Dose Level 1||1
10556426|NCT01570283|11711318|FG001|STARTED|Cohort 1: Dose Level 1||3
10556427|NCT01570283|11711319|FG002|STARTED|Cohort 1: Dose Level 1||0
10556428|NCT01570283|11711320|FG003|STARTED|Cohort 1: Dose Level 1||0
10556429|NCT01570283|11711321|FG004|STARTED|Cohort 1: Dose Level 1||0
10556430|NCT01570283|11711322|FG005|STARTED|Cohort 1: Dose Level 1||0
10556431|NCT01570283|11711317|FG000|COMPLETED|Cohort 1: Dose Level 1||1
10556432|NCT01570283|11711318|FG001|COMPLETED|Cohort 1: Dose Level 1||1
10556433|NCT01570283|11711319|FG002|COMPLETED|Cohort 1: Dose Level 1||0
10556434|NCT01570283|11711320|FG003|COMPLETED|Cohort 1: Dose Level 1||0
10790499|NCT03541980|11951037|FG001|STARTED|Overall Study||36
10790500|NCT03541980|11951036|FG000|COMPLETED|Overall Study||35
10790501|NCT03541980|11951037|FG001|COMPLETED|Overall Study||36
10556435|NCT01570283|11711321|FG004|COMPLETED|Cohort 1: Dose Level 1||0
10556436|NCT01570283|11711322|FG005|COMPLETED|Cohort 1: Dose Level 1||0
10556437|NCT01570283|11711317|FG000|NOT COMPLETED|Cohort 1: Dose Level 1||0
10556438|NCT01570283|11711318|FG001|NOT COMPLETED|Cohort 1: Dose Level 1||2
10556439|NCT01570283|11711319|FG002|NOT COMPLETED|Cohort 1: Dose Level 1||0
10556440|NCT01570283|11711320|FG003|NOT COMPLETED|Cohort 1: Dose Level 1||0
10556441|NCT01570283|11711321|FG004|NOT COMPLETED|Cohort 1: Dose Level 1||0
10556442|NCT01570283|11711322|FG005|NOT COMPLETED|Cohort 1: Dose Level 1||0
10556443|NCT01570283|11711317|FG000|STARTED|Cohort 2: Dose Level 2||0
10556444|NCT01570283|11711318|FG001|STARTED|Cohort 2: Dose Level 2||0
10556445|NCT01570283|11711319|FG002|STARTED|Cohort 2: Dose Level 2||2
10556446|NCT01570283|11711320|FG003|STARTED|Cohort 2: Dose Level 2||2
10556447|NCT01570283|11711321|FG004|STARTED|Cohort 2: Dose Level 2||0
10556448|NCT01570283|11711322|FG005|STARTED|Cohort 2: Dose Level 2||0
10556449|NCT01570283|11711317|FG000|COMPLETED|Cohort 2: Dose Level 2||0
10556450|NCT01570283|11711318|FG001|COMPLETED|Cohort 2: Dose Level 2||0
10556451|NCT01570283|11711319|FG002|COMPLETED|Cohort 2: Dose Level 2||1
10556452|NCT01570283|11711320|FG003|COMPLETED|Cohort 2: Dose Level 2||1
10556453|NCT01570283|11711321|FG004|COMPLETED|Cohort 2: Dose Level 2||0
10556454|NCT01570283|11711322|FG005|COMPLETED|Cohort 2: Dose Level 2||0
10556455|NCT01570283|11711317|FG000|NOT COMPLETED|Cohort 2: Dose Level 2||0
10556456|NCT01570283|11711318|FG001|NOT COMPLETED|Cohort 2: Dose Level 2||0
10556457|NCT01570283|11711319|FG002|NOT COMPLETED|Cohort 2: Dose Level 2||1
10556458|NCT01570283|11711320|FG003|NOT COMPLETED|Cohort 2: Dose Level 2||1
10556459|NCT01570283|11711321|FG004|NOT COMPLETED|Cohort 2: Dose Level 2||0
10556460|NCT01570283|11711322|FG005|NOT COMPLETED|Cohort 2: Dose Level 2||0
10556461|NCT01570283|11711317|FG000|STARTED|Cohort 3: Dose Level 3||0
10556462|NCT01570283|11711318|FG001|STARTED|Cohort 3: Dose Level 3||0
10556463|NCT01570283|11711319|FG002|STARTED|Cohort 3: Dose Level 3||0
10556464|NCT01570283|11711320|FG003|STARTED|Cohort 3: Dose Level 3||0
10556465|NCT01570283|11711321|FG004|STARTED|Cohort 3: Dose Level 3||1
10556466|NCT01570283|11711322|FG005|STARTED|Cohort 3: Dose Level 3||12
10556467|NCT01570283|11711317|FG000|COMPLETED|Cohort 3: Dose Level 3||0
10556468|NCT01570283|11711318|FG001|COMPLETED|Cohort 3: Dose Level 3||0
10556469|NCT01570283|11711319|FG002|COMPLETED|Cohort 3: Dose Level 3||0
10556470|NCT01570283|11711320|FG003|COMPLETED|Cohort 3: Dose Level 3||0
10556471|NCT01570283|11711321|FG004|COMPLETED|Cohort 3: Dose Level 3||1
10556472|NCT01570283|11711322|FG005|COMPLETED|Cohort 3: Dose Level 3||10
10556473|NCT01570283|11711317|FG000|NOT COMPLETED|Cohort 3: Dose Level 3||0
10556474|NCT01570283|11711318|FG001|NOT COMPLETED|Cohort 3: Dose Level 3||0
10556475|NCT01570283|11711319|FG002|NOT COMPLETED|Cohort 3: Dose Level 3||0
10556476|NCT01570283|11711320|FG003|NOT COMPLETED|Cohort 3: Dose Level 3||0
10790502|NCT03541980|11951036|FG000|NOT COMPLETED|Overall Study||0
10556477|NCT01570283|11711321|FG004|NOT COMPLETED|Cohort 3: Dose Level 3||0
10556478|NCT01570283|11711322|FG005|NOT COMPLETED|Cohort 3: Dose Level 3||2
10556479|NCT01570309|11711338|FG000|STARTED|Overall Study||48
10556480|NCT01570309|11711339|FG001|STARTED|Overall Study||48
10556481|NCT01570309|11711338|FG000|COMPLETED|Overall Study||45
10556482|NCT01570309|11711339|FG001|COMPLETED|Overall Study||45
10556483|NCT01570309|11711338|FG000|NOT COMPLETED|Overall Study||3
10556484|NCT01570309|11711339|FG001|NOT COMPLETED|Overall Study||3
10556485|NCT01570348|11711349|FG000|STARTED|Overall Study||2
10556486|NCT01570348|11711349|FG000|COMPLETED|Overall Study||2
10790503|NCT03541980|11951037|FG001|NOT COMPLETED|Overall Study||0
10790504|NCT03542019|11951052|FG000|STARTED|Overall Study||20
10790505|NCT03542019|11951053|FG001|STARTED|Overall Study||20
10790506|NCT03542019|11951054|FG002|STARTED|Overall Study||20
10790507|NCT03542019|11951052|FG000|COMPLETED|Overall Study||19
10556487|NCT01570348|11711349|FG000|NOT COMPLETED|Overall Study||0
10556488|NCT01570361|11711355|FG000|STARTED|Overall Study||128
10556489|NCT01570361|11711356|FG001|STARTED|Overall Study||127
10556490|NCT01570361|11711355|FG000|Received Study Treatment|Overall Study||102
10556491|NCT01570361|11711356|FG001|Received Study Treatment|Overall Study||123
10556492|NCT01570361|11711355|FG000|Cross-over (AAD Therapy to RF Ablation)|Overall Study||0
10556493|NCT01570361|11711356|FG001|Cross-over (AAD Therapy to RF Ablation)|Overall Study||15
10556494|NCT01570361|11711355|FG000|AAD Therapy Only|Overall Study||0
10556495|NCT01570361|11711356|FG001|AAD Therapy Only|Overall Study||108
10556496|NCT01570361|11711355|FG000|COMPLETED|Overall Study||46
10556497|NCT01570361|11711356|FG001|COMPLETED|Overall Study||52
10556498|NCT01570361|11711355|FG000|NOT COMPLETED|Overall Study||82
10556499|NCT01570361|11711356|FG001|NOT COMPLETED|Overall Study||75
10556500|NCT01570387|11711369|FG000|STARTED|Overall Study||6
10556501|NCT01570387|11711370|FG001|STARTED|Overall Study||3
10556502|NCT01570387|11711371|FG002|STARTED|Overall Study||6
10556503|NCT01570387|11711372|FG003|STARTED|Overall Study||12
10556504|NCT01570387|11711369|FG000|Dose Limiting Toxicity|Overall Study||0
10556505|NCT01570387|11711370|FG001|Dose Limiting Toxicity|Overall Study||0
10556506|NCT01570387|11711371|FG002|Dose Limiting Toxicity|Overall Study||6
10556507|NCT01570387|11711372|FG003|Dose Limiting Toxicity|Overall Study||12
10556508|NCT01570387|11711369|FG000|Response to Maximal Tolerated Dose|Overall Study||0
10556509|NCT01570387|11711370|FG001|Response to Maximal Tolerated Dose|Overall Study||0
10556510|NCT01570387|11711371|FG002|Response to Maximal Tolerated Dose|Overall Study||3
10556511|NCT01570387|11711372|FG003|Response to Maximal Tolerated Dose|Overall Study||6
10556512|NCT01570387|11711369|FG000|COMPLETED|Overall Study||5
10556513|NCT01570387|11711370|FG001|COMPLETED|Overall Study||3
10556514|NCT01570387|11711371|FG002|COMPLETED|Overall Study||6
10556515|NCT01570387|11711372|FG003|COMPLETED|Overall Study||10
10556516|NCT01570387|11711369|FG000|NOT COMPLETED|Overall Study||1
10556517|NCT01570387|11711370|FG001|NOT COMPLETED|Overall Study||0
10556518|NCT01570387|11711371|FG002|NOT COMPLETED|Overall Study||0
10556519|NCT01570387|11711372|FG003|NOT COMPLETED|Overall Study||2
10556520|NCT01570491|11711381|FG000|STARTED|Overall Study||19
10556521|NCT01570491|11711382|FG001|STARTED|Overall Study||19
10556522|NCT01570491|11711381|FG000|COMPLETED|Overall Study||14
10556523|NCT01570491|11711382|FG001|COMPLETED|Overall Study||18
10556524|NCT01570491|11711381|FG000|NOT COMPLETED|Overall Study||5
10556525|NCT01570491|11711382|FG001|NOT COMPLETED|Overall Study||1
10556526|NCT01570686|11711390|FG000|STARTED|Overall Study||296
10556527|NCT01570686|11711391|FG001|STARTED|Overall Study||294
10556528|NCT01570686|11711390|FG000|Safety and Full Analysis Set (FAS)|Overall Study|One patient was mis-randomized and never received study drug. Hence not included in Safety or FAS.|295
10556529|NCT01570686|11711391|FG001|Safety and Full Analysis Set (FAS)|Overall Study||294
10556530|NCT01570686|11711390|FG000|COMPLETED|Overall Study||274
10556531|NCT01570686|11711391|FG001|COMPLETED|Overall Study||278
10556532|NCT01570686|11711390|FG000|NOT COMPLETED|Overall Study||22
10556533|NCT01570686|11711391|FG001|NOT COMPLETED|Overall Study||16
10556534|NCT01570751|11711399|FG000|STARTED|Period A (16 Weeks)||73
10556535|NCT01570751|11711400|FG001|STARTED|Period A (16 Weeks)||72
10556536|NCT01570751|11711399|FG000|Exposed|Period A (16 Weeks)||73
10556537|NCT01570751|11711400|FG001|Exposed|Period A (16 Weeks)||72
10556538|NCT01570751|11711399|FG000|COMPLETED|Period A (16 Weeks)||70
10556539|NCT01570751|11711400|FG001|COMPLETED|Period A (16 Weeks)||67
10556540|NCT01570751|11711399|FG000|NOT COMPLETED|Period A (16 Weeks)||3
10556541|NCT01570751|11711400|FG001|NOT COMPLETED|Period A (16 Weeks)||5
10556542|NCT01570751|11711399|FG000|STARTED|Period B (16 Weeks)||70
10556543|NCT01570751|11711400|FG001|STARTED|Period B (16 Weeks)||67
10556544|NCT01570751|11711399|FG000|Exposed|Period B (16 Weeks)||70
10556545|NCT01570751|11711400|FG001|Exposed|Period B (16 Weeks)||67
10556546|NCT01570751|11711399|FG000|COMPLETED|Period B (16 Weeks)||69
10556547|NCT01570751|11711400|FG001|COMPLETED|Period B (16 Weeks)||66
10556548|NCT01570751|11711399|FG000|NOT COMPLETED|Period B (16 Weeks)||1
10556549|NCT01570751|11711400|FG001|NOT COMPLETED|Period B (16 Weeks)||1
10556550|NCT01570829|11711410|FG000|STARTED|Overall Study||164
10556551|NCT01570829|11711411|FG001|STARTED|Overall Study||167
10556552|NCT01570829|11711410|FG000|COMPLETED|Overall Study||164
10556553|NCT01570829|11711411|FG001|COMPLETED|Overall Study||167
10556554|NCT01570829|11711410|FG000|NOT COMPLETED|Overall Study||0
10556555|NCT01570829|11711411|FG001|NOT COMPLETED|Overall Study||0
10556556|NCT01570868|11711419|FG000|STARTED|Overall Study||43
10556557|NCT01570868|11711420|FG001|STARTED|Overall Study||8
10556558|NCT01570868|11711419|FG000|COMPLETED|Overall Study||0
10556559|NCT01570868|11711420|FG001|COMPLETED|Overall Study||0
10556560|NCT01570868|11711419|FG000|NOT COMPLETED|Overall Study||43
10556561|NCT01570868|11711420|FG001|NOT COMPLETED|Overall Study||8
10556562|NCT01571232|11711432|FG000|STARTED|Overall Study||10
10556563|NCT01571232|11711433|FG001|STARTED|Overall Study||10
10556564|NCT01571232|11711432|FG000|COMPLETED|Overall Study||9
10556565|NCT01571232|11711433|FG001|COMPLETED|Overall Study||9
10556566|NCT01571232|11711432|FG000|NOT COMPLETED|Overall Study||1
10556567|NCT01571232|11711433|FG001|NOT COMPLETED|Overall Study||1
10556568|NCT01571284|11711440|FG000|STARTED|Overall Study||781
10556569|NCT01571284|11711440|FG000|Safety Population|Overall Study||779
10556570|NCT01571284|11711440|FG000|COMPLETED|Overall Study|403 participants with DP and 209 with adverse events were considered as completed.|612
10556571|NCT01571284|11711440|FG000|NOT COMPLETED|Overall Study||169
10556572|NCT01571362|11711444|FG000|STARTED|Open-Label Conversion + Titration Period||410
10556573|NCT01571362|11711445|FG001|STARTED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
10556574|NCT01571362|11711446|FG002|STARTED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
10556575|NCT01571362|11711444|FG000|COMPLETED|Open-Label Conversion + Titration Period||281
10556576|NCT01571362|11711445|FG001|COMPLETED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
10556577|NCT01571362|11711446|FG002|COMPLETED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
10556578|NCT01571362|11711444|FG000|NOT COMPLETED|Open-Label Conversion + Titration Period||129
10556579|NCT01571362|11711445|FG001|NOT COMPLETED|Open-Label Conversion + Titration Period||0
10556580|NCT01571362|11711446|FG002|NOT COMPLETED|Open-Label Conversion + Titration Period||0
10556581|NCT01571362|11711444|FG000|STARTED|Double-Blind Treatment Period|This phase preceded the Double-Blind Treatment Period.|0
10556582|NCT01571362|11711445|FG001|STARTED|Double-Blind Treatment Period||134
10556583|NCT01571362|11711446|FG002|STARTED|Double-Blind Treatment Period||146
10556584|NCT01571362|11711444|FG000|COMPLETED|Double-Blind Treatment Period|This phase preceded the Double-Blind Treatment Period.|0
10556585|NCT01571362|11711445|FG001|COMPLETED|Double-Blind Treatment Period||81
10556586|NCT01571362|11711446|FG002|COMPLETED|Double-Blind Treatment Period||107
10556587|NCT01571362|11711444|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
10556588|NCT01571362|11711445|FG001|NOT COMPLETED|Double-Blind Treatment Period||53
10556589|NCT01571362|11711446|FG002|NOT COMPLETED|Double-Blind Treatment Period||39
10650728|NCT02171195|11811039|FG007|COMPLETED|Overall Study||6
10650729|NCT02171195|11811040|FG008|COMPLETED|Overall Study||6
10650730|NCT02171195|11811032|FG000|NOT COMPLETED|Overall Study||0
10650731|NCT02171195|11811033|FG001|NOT COMPLETED|Overall Study||0
10650732|NCT02171195|11811034|FG002|NOT COMPLETED|Overall Study||0
10650733|NCT02171195|11811035|FG003|NOT COMPLETED|Overall Study||0
10650734|NCT02171195|11811036|FG004|NOT COMPLETED|Overall Study||0
10650735|NCT02171195|11811037|FG005|NOT COMPLETED|Overall Study||0
10650736|NCT02171195|11811038|FG006|NOT COMPLETED|Overall Study||0
10650737|NCT02171195|11811039|FG007|NOT COMPLETED|Overall Study||0
10650738|NCT02171195|11811040|FG008|NOT COMPLETED|Overall Study||0
10650739|NCT02171234|11811065|FG000|STARTED|Overall Study||8
10650740|NCT02171234|11811066|FG001|STARTED|Overall Study||6
10650741|NCT02171234|11811067|FG002|STARTED|Overall Study||6
10650742|NCT02171234|11811068|FG003|STARTED|Overall Study||6
10650743|NCT02171234|11811069|FG004|STARTED|Overall Study||6
10650744|NCT02171234|11811065|FG000|COMPLETED|Overall Study||8
10650745|NCT02171234|11811066|FG001|COMPLETED|Overall Study||6
10650746|NCT02171234|11811067|FG002|COMPLETED|Overall Study||6
10650747|NCT02171234|11811068|FG003|COMPLETED|Overall Study||6
10650748|NCT02171234|11811069|FG004|COMPLETED|Overall Study||6
10650749|NCT02171234|11811065|FG000|NOT COMPLETED|Overall Study||0
10650750|NCT02171234|11811066|FG001|NOT COMPLETED|Overall Study||0
10650751|NCT02171234|11811067|FG002|NOT COMPLETED|Overall Study||0
10650752|NCT02171234|11811068|FG003|NOT COMPLETED|Overall Study||0
10650753|NCT02171234|11811069|FG004|NOT COMPLETED|Overall Study||0
10650754|NCT02171247|11811083|FG000|STARTED|Overall Study||16
10650755|NCT02171247|11811084|FG001|STARTED|Overall Study||17
10650756|NCT02171247|11811083|FG000|COMPLETED|Overall Study||16
10650757|NCT02171247|11811084|FG001|COMPLETED|Overall Study||17
10650758|NCT02171247|11811083|FG000|NOT COMPLETED|Overall Study||0
10650759|NCT02171247|11811084|FG001|NOT COMPLETED|Overall Study||0
10650760|NCT02171260|11811094|FG000|STARTED|Overall Study||6
10650761|NCT02171260|11811095|FG001|STARTED|Overall Study||6
10650762|NCT02171260|11811096|FG002|STARTED|Overall Study||5
10650763|NCT02171260|11811097|FG003|STARTED|Overall Study||5
10650764|NCT02171260|11811094|FG000|COMPLETED|Overall Study||0
10650765|NCT02171260|11811095|FG001|COMPLETED|Overall Study||0
10650766|NCT02171260|11811096|FG002|COMPLETED|Overall Study||0
10650767|NCT02171260|11811097|FG003|COMPLETED|Overall Study||0
10650768|NCT02171260|11811094|FG000|NOT COMPLETED|Overall Study||6
10650769|NCT02171260|11811095|FG001|NOT COMPLETED|Overall Study||6
10650770|NCT02171260|11811096|FG002|NOT COMPLETED|Overall Study||5
10650771|NCT02171260|11811097|FG003|NOT COMPLETED|Overall Study||5
10650772|NCT02171429|11811116|FG000|STARTED|Overall Study||72
10650773|NCT02171429|11811117|FG001|STARTED|Overall Study||143
10650774|NCT02171429|11811118|FG002|STARTED|Overall Study||143
10650775|NCT02171429|11811116|FG000|Completed Week 10 Visit|Overall Study||70
10650776|NCT02171429|11811117|FG001|Completed Week 10 Visit|Overall Study||141
10650777|NCT02171429|11811118|FG002|Completed Week 10 Visit|Overall Study||141
10650778|NCT02171429|11811116|FG000|COMPLETED|Overall Study||71
10650779|NCT02171429|11811117|FG001|COMPLETED|Overall Study||140
10650780|NCT02171429|11811118|FG002|COMPLETED|Overall Study||138
10650781|NCT02171429|11811116|FG000|NOT COMPLETED|Overall Study||1
10650782|NCT02171429|11811117|FG001|NOT COMPLETED|Overall Study||3
10650783|NCT02171429|11811118|FG002|NOT COMPLETED|Overall Study||5
10650784|NCT02171611|11811129|FG000|STARTED|Overall Study||5
10650785|NCT02171611|11811130|FG001|STARTED|Overall Study||5
10650786|NCT02171611|11811131|FG002|STARTED|Overall Study||5
10650787|NCT02171611|11811132|FG003|STARTED|Overall Study||5
10556590|NCT01571427|11711456|FG000|STARTED|Overall Study||41
10556591|NCT01571427|11711457|FG001|STARTED|Overall Study||42
10556592|NCT01571427|11711456|FG000|COMPLETED|Overall Study||41
10556593|NCT01571427|11711457|FG001|COMPLETED|Overall Study||42
10556594|NCT01571427|11711456|FG000|NOT COMPLETED|Overall Study||0
10556595|NCT01571427|11711457|FG001|NOT COMPLETED|Overall Study||0
10556596|NCT01571453|11711465|FG000|STARTED|Overall Study||211
10556597|NCT01571453|11711466|FG001|STARTED|Overall Study||226
10556598|NCT01571453|11711465|FG000|COMPLETED|Overall Study||173
10556599|NCT01571453|11711466|FG001|COMPLETED|Overall Study||164
10556600|NCT01571453|11711465|FG000|NOT COMPLETED|Overall Study||38
10556601|NCT01571453|11711466|FG001|NOT COMPLETED|Overall Study||62
10556602|NCT01571557|11711472|FG000|STARTED|Overall Study||573
10556603|NCT01571557|11711472|FG000|COMPLETED|Overall Study||573
10556604|NCT01571557|11711472|FG000|NOT COMPLETED|Overall Study||0
10556605|NCT01571596|11711479|FG000|STARTED|Overall Study||21
10556606|NCT01571596|11711480|FG001|STARTED|Overall Study||1
10556607|NCT01571596|11711481|FG002|STARTED|Overall Study||1
10556608|NCT01571596|11711479|FG000|COMPLETED|Overall Study||19
10556609|NCT01571596|11711480|FG001|COMPLETED|Overall Study||0
10556610|NCT01571596|11711481|FG002|COMPLETED|Overall Study||0
10556611|NCT01571596|11711479|FG000|NOT COMPLETED|Overall Study||2
10556612|NCT01571596|11711480|FG001|NOT COMPLETED|Overall Study||1
10556613|NCT01571596|11711481|FG002|NOT COMPLETED|Overall Study||1
10556614|NCT01572038|11711491|FG000|STARTED|Overall Study|All participants who were enrolled in the study.|1436
10556615|NCT01572038|11711491|FG000|Received at Least One Dose of Study Drug|Overall Study||1436
10556616|NCT01572038|11711491|FG000|COMPLETED|Overall Study||445
10556617|NCT01572038|11711491|FG000|NOT COMPLETED|Overall Study||991
10556618|NCT01572298|11711519|FG000|STARTED|Overall Study||14
10556619|NCT01572298|11711520|FG001|STARTED|Overall Study||13
10556620|NCT01572298|11711519|FG000|COMPLETED|Overall Study||12
10556621|NCT01572298|11711520|FG001|COMPLETED|Overall Study||12
10556622|NCT01572298|11711519|FG000|NOT COMPLETED|Overall Study||2
10556623|NCT01572298|11711520|FG001|NOT COMPLETED|Overall Study||1
10556624|NCT01572389|11711530|FG000|STARTED|Overall Study||136
10556625|NCT01572389|11711531|FG001|STARTED|Overall Study||89
10556626|NCT01572389|11711530|FG000|COMPLETED|Overall Study||90
10556627|NCT01572389|11711531|FG001|COMPLETED|Overall Study||68
10556628|NCT01572389|11711530|FG000|NOT COMPLETED|Overall Study||46
10556629|NCT01572389|11711531|FG001|NOT COMPLETED|Overall Study||21
10556630|NCT01572428|11711539|FG000|STARTED|Overall Study||402
10556631|NCT01572428|11711540|FG001|STARTED|Overall Study||402
10556632|NCT01572428|11711539|FG000|COMPLETED|Overall Study||399
10556633|NCT01572428|11711540|FG001|COMPLETED|Overall Study||401
10556634|NCT01572428|11711539|FG000|NOT COMPLETED|Overall Study||3
10556635|NCT01572428|11711540|FG001|NOT COMPLETED|Overall Study||1
10556636|NCT01572727|11711548|FG000|STARTED|Overall Study||207
10556637|NCT01572727|11711549|FG001|STARTED|Overall Study||209
10556638|NCT01572727|11711548|FG000|Pts With Treatment + Safety Assessment|Overall Study|patients who received study treatment and had at least one post-baseline safety assessment|202
10556639|NCT01572727|11711549|FG001|Pts With Treatment + Safety Assessment|Overall Study|patients who received study treatment and had at least one post-baseline safety assessment|201
10556640|NCT01572727|11711548|FG000|COMPLETED|Overall Study||0
10556641|NCT01572727|11711549|FG001|COMPLETED|Overall Study||0
10556642|NCT01572727|11711548|FG000|NOT COMPLETED|Overall Study||207
10556643|NCT01572727|11711549|FG001|NOT COMPLETED|Overall Study||209
10556644|NCT01572740|11711557|FG000|STARTED|Overall Study||127
10556645|NCT01572740|11711558|FG001|STARTED|Overall Study||130
10556646|NCT01572740|11711557|FG000|COMPLETED|Overall Study||121
10556647|NCT01572740|11711558|FG001|COMPLETED|Overall Study||125
10556648|NCT01572740|11711557|FG000|NOT COMPLETED|Overall Study||6
10556649|NCT01572740|11711558|FG001|NOT COMPLETED|Overall Study||5
10556650|NCT01572792|11711569|FG000|STARTED|Lead-in Study||337
10556651|NCT01572792|11711570|FG001|STARTED|Lead-in Study||338
10556652|NCT01572792|11711571|FG002|STARTED|Lead-in Study||338
10556653|NCT01572792|11711572|FG003|STARTED|Lead-in Study||340
10556654|NCT01572792|11711573|FG004|STARTED|Lead-in Study||339
10556655|NCT01572792|11711569|FG000|COMPLETED|Lead-in Study||236
10556656|NCT01572792|11711570|FG001|COMPLETED|Lead-in Study||272
10556657|NCT01572792|11711571|FG002|COMPLETED|Lead-in Study||276
10556658|NCT01572792|11711572|FG003|COMPLETED|Lead-in Study||268
10556659|NCT01572792|11711573|FG004|COMPLETED|Lead-in Study||270
10556660|NCT01572792|11711569|FG000|NOT COMPLETED|Lead-in Study||101
10556661|NCT01572792|11711570|FG001|NOT COMPLETED|Lead-in Study||66
10556662|NCT01572792|11711571|FG002|NOT COMPLETED|Lead-in Study||62
10556663|NCT01572792|11711572|FG003|NOT COMPLETED|Lead-in Study||72
10556664|NCT01572792|11711573|FG004|NOT COMPLETED|Lead-in Study||69
10556665|NCT01572792|11711569|FG000|STARTED|Extension Study||146
10556666|NCT01572792|11711570|FG001|STARTED|Extension Study||184
10556667|NCT01572792|11711571|FG002|STARTED|Extension Study||205
10556668|NCT01572792|11711572|FG003|STARTED|Extension Study||194
10556669|NCT01572792|11711573|FG004|STARTED|Extension Study||192
10556670|NCT01572792|11711569|FG000|COMPLETED|Extension Study||121
10556671|NCT01572792|11711570|FG001|COMPLETED|Extension Study||155
10556672|NCT01572792|11711571|FG002|COMPLETED|Extension Study||179
10556673|NCT01572792|11711572|FG003|COMPLETED|Extension Study||165
10556674|NCT01572792|11711573|FG004|COMPLETED|Extension Study||160
10556675|NCT01572792|11711569|FG000|NOT COMPLETED|Extension Study||25
10556676|NCT01572792|11711570|FG001|NOT COMPLETED|Extension Study||29
10556677|NCT01572792|11711571|FG002|NOT COMPLETED|Extension Study||26
10556678|NCT01572792|11711572|FG003|NOT COMPLETED|Extension Study||29
10556679|NCT01572792|11711573|FG004|NOT COMPLETED|Extension Study||32
10556680|NCT01572844|11711586|FG000|STARTED|Overall Study||3
10556681|NCT01572844|11711587|FG001|STARTED|Overall Study||3
10556682|NCT01572844|11711586|FG000|COMPLETED|Overall Study||2
10556683|NCT01572844|11711587|FG001|COMPLETED|Overall Study||2
10556684|NCT01572844|11711586|FG000|NOT COMPLETED|Overall Study||1
10556685|NCT01572844|11711587|FG001|NOT COMPLETED|Overall Study||1
10556686|NCT01572909|11711598|FG000|STARTED|Overall Study||152
10556687|NCT01572909|11711599|FG001|STARTED|Overall Study||148
10556688|NCT01572909|11711598|FG000|COMPLETED|Overall Study||120
10556689|NCT01572909|11711599|FG001|COMPLETED|Overall Study||123
10556690|NCT01572909|11711598|FG000|NOT COMPLETED|Overall Study||32
10556691|NCT01572909|11711599|FG001|NOT COMPLETED|Overall Study||25
10556692|NCT01572922|11711607|FG000|STARTED|Overall Study||142
10556693|NCT01572922|11711607|FG000|COMPLETED|Overall Study||139
10556694|NCT01572922|11711607|FG000|NOT COMPLETED|Overall Study||3
10556695|NCT01572948|11711618|FG000|STARTED|Overall Study||11
10556696|NCT01572948|11711619|FG001|STARTED|Overall Study||16
10556697|NCT01572948|11711618|FG000|COMPLETED|Overall Study||10
10556698|NCT01572948|11711619|FG001|COMPLETED|Overall Study||15
10556699|NCT01572948|11711618|FG000|NOT COMPLETED|Overall Study||1
10556700|NCT01572948|11711619|FG001|NOT COMPLETED|Overall Study||1
10556701|NCT01573000|11711631|FG000|STARTED|Dosimetric and Therapeutic Treatment||42
10556702|NCT01573000|11711632|FG001|STARTED|Dosimetric and Therapeutic Treatment||36
10556703|NCT01573000|11711631|FG000|COMPLETED|Dosimetric and Therapeutic Treatment|These participants completed 2 years of follow up and enrolled in BEX104526.|7
10556704|NCT01573000|11711632|FG001|COMPLETED|Dosimetric and Therapeutic Treatment|These participants completed 2 years of follow up and enrolled in BEX104526.|1
10556705|NCT01573000|11711631|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||35
10556706|NCT01573000|11711632|FG001|NOT COMPLETED|Dosimetric and Therapeutic Treatment||35
10556707|NCT01573000|11711631|FG000|STARTED|Crossover Phase||0
10556708|NCT01573000|11711632|FG001|STARTED|Crossover Phase|19 of 36 par. randomized to receive Unlabeled TST crossed over to receive TST and Iodine I 131 TST.|19
10556709|NCT01573000|11711631|FG000|COMPLETED|Crossover Phase||0
10556710|NCT01573000|11711632|FG001|COMPLETED|Crossover Phase|This participant completed 2 years of follow up and enrolled in BEX104526.|1
10556711|NCT01573000|11711631|FG000|NOT COMPLETED|Crossover Phase||0
10556712|NCT01573000|11711632|FG001|NOT COMPLETED|Crossover Phase||18
10556713|NCT01573000|11711631|FG000|STARTED|Long-Term Follow-Up|14 of the 35 participants withdrawing from Study BEX104515 enrolled in long-term follow-up study.|14
10556714|NCT01573000|11711632|FG001|STARTED|Long-Term Follow-Up|5 of the 35 participants withdrawing from Study BEX104515 enrolled in long-term follow-up study.|5
10556715|NCT01573000|11711631|FG000|COMPLETED|Long-Term Follow-Up||11
10556716|NCT01573000|11711632|FG001|COMPLETED|Long-Term Follow-Up|One participant who received crossover treatment was lost to follow up.|4
10556717|NCT01573000|11711631|FG000|NOT COMPLETED|Long-Term Follow-Up||3
10556718|NCT01573000|11711632|FG001|NOT COMPLETED|Long-Term Follow-Up||1
10556719|NCT01573052|11711644|FG000|STARTED|Overall Study||9
10556720|NCT01573052|11711645|FG001|STARTED|Overall Study||17
10556721|NCT01573052|11711644|FG000|COMPLETED|Overall Study||6
10556722|NCT01573052|11711645|FG001|COMPLETED|Overall Study||11
10556723|NCT01573052|11711644|FG000|NOT COMPLETED|Overall Study||3
10556724|NCT01573052|11711645|FG001|NOT COMPLETED|Overall Study||6
10556725|NCT01573169|11711654|FG000|STARTED|Overall Study||38
10556726|NCT01573169|11711655|FG001|STARTED|Overall Study||35
10556727|NCT01573169|11711654|FG000|COMPLETED|Overall Study||38
10556728|NCT01573169|11711655|FG001|COMPLETED|Overall Study||35
10556729|NCT01573169|11711654|FG000|NOT COMPLETED|Overall Study||0
10556730|NCT01573169|11711655|FG001|NOT COMPLETED|Overall Study||0
10556731|NCT01573260|11711663|FG000|STARTED|Overall Study||18
10556732|NCT01573260|11711664|FG001|STARTED|Overall Study||15
10556733|NCT01573260|11711663|FG000|COMPLETED|Overall Study||18
10556734|NCT01573260|11711664|FG001|COMPLETED|Overall Study||15
10556735|NCT01573260|11711663|FG000|NOT COMPLETED|Overall Study||0
10556736|NCT01573260|11711664|FG001|NOT COMPLETED|Overall Study||0
10556737|NCT01573273|11711676|FG000|STARTED|TSST : Trier Social Stress Task||24
10556738|NCT01573273|11711677|FG001|STARTED|TSST : Trier Social Stress Task||25
10556739|NCT01573273|11711678|FG002|STARTED|TSST : Trier Social Stress Task||0
10556740|NCT01573273|11711679|FG003|STARTED|TSST : Trier Social Stress Task||0
10556741|NCT01573273|11711680|FG004|STARTED|TSST : Trier Social Stress Task||0
10556742|NCT01573273|11711681|FG005|STARTED|TSST : Trier Social Stress Task||0
10556743|NCT01573273|11711682|FG006|STARTED|TSST : Trier Social Stress Task||32
10556744|NCT01573273|11711683|FG007|STARTED|TSST : Trier Social Stress Task||31
10556745|NCT01573273|11711684|FG008|STARTED|TSST : Trier Social Stress Task||0
10556746|NCT01573273|11711685|FG009|STARTED|TSST : Trier Social Stress Task||0
10556747|NCT01573273|11711686|FG010|STARTED|TSST : Trier Social Stress Task||0
10556748|NCT01573273|11711687|FG011|STARTED|TSST : Trier Social Stress Task||0
10556749|NCT01573273|11711676|FG000|COMPLETED|TSST : Trier Social Stress Task||24
10556750|NCT01573273|11711677|FG001|COMPLETED|TSST : Trier Social Stress Task||25
10556751|NCT01573273|11711678|FG002|COMPLETED|TSST : Trier Social Stress Task||0
10556752|NCT01573273|11711679|FG003|COMPLETED|TSST : Trier Social Stress Task||0
10556753|NCT01573273|11711680|FG004|COMPLETED|TSST : Trier Social Stress Task||0
10556754|NCT01573273|11711681|FG005|COMPLETED|TSST : Trier Social Stress Task||0
10556755|NCT01573273|11711682|FG006|COMPLETED|TSST : Trier Social Stress Task||32
10556756|NCT01573273|11711683|FG007|COMPLETED|TSST : Trier Social Stress Task||31
10556757|NCT01573273|11711684|FG008|COMPLETED|TSST : Trier Social Stress Task||0
10556758|NCT01573273|11711685|FG009|COMPLETED|TSST : Trier Social Stress Task||0
10556759|NCT01573273|11711686|FG010|COMPLETED|TSST : Trier Social Stress Task||0
10556760|NCT01573273|11711687|FG011|COMPLETED|TSST : Trier Social Stress Task||0
10556761|NCT01573273|11711676|FG000|NOT COMPLETED|TSST : Trier Social Stress Task||0
10556762|NCT01573273|11711677|FG001|NOT COMPLETED|TSST : Trier Social Stress Task||0
10556763|NCT01573273|11711678|FG002|NOT COMPLETED|TSST : Trier Social Stress Task||0
10556764|NCT01573273|11711679|FG003|NOT COMPLETED|TSST : Trier Social Stress Task||0
10556765|NCT01573273|11711680|FG004|NOT COMPLETED|TSST : Trier Social Stress Task||0
10556766|NCT01573273|11711681|FG005|NOT COMPLETED|TSST : Trier Social Stress Task||0
10556767|NCT01573273|11711682|FG006|NOT COMPLETED|TSST : Trier Social Stress Task||0
10556768|NCT01573273|11711683|FG007|NOT COMPLETED|TSST : Trier Social Stress Task||0
10556769|NCT01573273|11711684|FG008|NOT COMPLETED|TSST : Trier Social Stress Task||0
10556770|NCT01573273|11711685|FG009|NOT COMPLETED|TSST : Trier Social Stress Task||0
10556771|NCT01573273|11711686|FG010|NOT COMPLETED|TSST : Trier Social Stress Task||0
10556772|NCT01573273|11711687|FG011|NOT COMPLETED|TSST : Trier Social Stress Task||0
10556773|NCT01573273|11711676|FG000|STARTED|MRI 1||0
10556774|NCT01573273|11711677|FG001|STARTED|MRI 1||0
10556775|NCT01573273|11711678|FG002|STARTED|MRI 1||19
10556776|NCT01573273|11711679|FG003|STARTED|MRI 1||23
10556777|NCT01573273|11711680|FG004|STARTED|MRI 1||0
10556778|NCT01573273|11711681|FG005|STARTED|MRI 1||0
10556779|NCT01573273|11711682|FG006|STARTED|MRI 1||0
10556780|NCT01573273|11711683|FG007|STARTED|MRI 1||0
10556781|NCT01573273|11711684|FG008|STARTED|MRI 1||28
10556782|NCT01573273|11711685|FG009|STARTED|MRI 1||29
10556783|NCT01573273|11711686|FG010|STARTED|MRI 1||0
10556784|NCT01573273|11711687|FG011|STARTED|MRI 1||0
10556785|NCT01573273|11711676|FG000|COMPLETED|MRI 1||0
10556786|NCT01573273|11711677|FG001|COMPLETED|MRI 1||0
10556787|NCT01573273|11711678|FG002|COMPLETED|MRI 1||19
10556788|NCT01573273|11711679|FG003|COMPLETED|MRI 1||23
10556789|NCT01573273|11711680|FG004|COMPLETED|MRI 1||0
10556790|NCT01573273|11711681|FG005|COMPLETED|MRI 1||0
10556791|NCT01573273|11711682|FG006|COMPLETED|MRI 1||0
10556792|NCT01573273|11711683|FG007|COMPLETED|MRI 1||0
10556793|NCT01573273|11711684|FG008|COMPLETED|MRI 1||28
10556794|NCT01573273|11711685|FG009|COMPLETED|MRI 1||29
10556795|NCT01573273|11711686|FG010|COMPLETED|MRI 1||0
10556796|NCT01573273|11711687|FG011|COMPLETED|MRI 1||0
10556797|NCT01573273|11711676|FG000|NOT COMPLETED|MRI 1||0
10556798|NCT01573273|11711677|FG001|NOT COMPLETED|MRI 1||0
10556799|NCT01573273|11711678|FG002|NOT COMPLETED|MRI 1||0
10556800|NCT01573273|11711679|FG003|NOT COMPLETED|MRI 1||0
10556801|NCT01573273|11711680|FG004|NOT COMPLETED|MRI 1||0
10556802|NCT01573273|11711681|FG005|NOT COMPLETED|MRI 1||0
10556803|NCT01573273|11711682|FG006|NOT COMPLETED|MRI 1||0
10556804|NCT01573273|11711683|FG007|NOT COMPLETED|MRI 1||0
10556805|NCT01573273|11711684|FG008|NOT COMPLETED|MRI 1||0
10556806|NCT01573273|11711685|FG009|NOT COMPLETED|MRI 1||0
10556807|NCT01573273|11711686|FG010|NOT COMPLETED|MRI 1||0
10556808|NCT01573273|11711687|FG011|NOT COMPLETED|MRI 1||0
10556809|NCT01573273|11711676|FG000|STARTED|MRI 2||0
10556810|NCT01573273|11711677|FG001|STARTED|MRI 2||0
10556811|NCT01573273|11711678|FG002|STARTED|MRI 2||0
10556812|NCT01573273|11711679|FG003|STARTED|MRI 2||0
10556813|NCT01573273|11711680|FG004|STARTED|MRI 2||23
10556814|NCT01573273|11711681|FG005|STARTED|MRI 2||18
10556815|NCT01573273|11711682|FG006|STARTED|MRI 2||0
10556816|NCT01573273|11711683|FG007|STARTED|MRI 2||0
10556817|NCT01573273|11711684|FG008|STARTED|MRI 2||0
10556818|NCT01573273|11711685|FG009|STARTED|MRI 2||0
10556819|NCT01573273|11711686|FG010|STARTED|MRI 2||27
10556820|NCT01573273|11711687|FG011|STARTED|MRI 2||28
10556821|NCT01573273|11711676|FG000|COMPLETED|MRI 2||0
10556822|NCT01573273|11711677|FG001|COMPLETED|MRI 2||0
10556823|NCT01573273|11711678|FG002|COMPLETED|MRI 2||0
10556824|NCT01573273|11711679|FG003|COMPLETED|MRI 2||0
10556825|NCT01573273|11711680|FG004|COMPLETED|MRI 2||23
10556826|NCT01573273|11711681|FG005|COMPLETED|MRI 2||18
10556827|NCT01573273|11711682|FG006|COMPLETED|MRI 2||0
10556828|NCT01573273|11711683|FG007|COMPLETED|MRI 2||0
10556829|NCT01573273|11711684|FG008|COMPLETED|MRI 2||0
10556830|NCT01573273|11711685|FG009|COMPLETED|MRI 2||0
10556831|NCT01573273|11711686|FG010|COMPLETED|MRI 2||27
10556832|NCT01573273|11711687|FG011|COMPLETED|MRI 2||28
10556833|NCT01573273|11711676|FG000|NOT COMPLETED|MRI 2||0
10556834|NCT01573273|11711677|FG001|NOT COMPLETED|MRI 2||0
10556835|NCT01573273|11711678|FG002|NOT COMPLETED|MRI 2||0
10556836|NCT01573273|11711679|FG003|NOT COMPLETED|MRI 2||0
10556837|NCT01573273|11711680|FG004|NOT COMPLETED|MRI 2||0
10556838|NCT01573273|11711681|FG005|NOT COMPLETED|MRI 2||0
10556839|NCT01573273|11711682|FG006|NOT COMPLETED|MRI 2||0
10556840|NCT01573273|11711683|FG007|NOT COMPLETED|MRI 2||0
10556841|NCT01573273|11711684|FG008|NOT COMPLETED|MRI 2||0
10556842|NCT01573273|11711685|FG009|NOT COMPLETED|MRI 2||0
10556843|NCT01573273|11711686|FG010|NOT COMPLETED|MRI 2||0
10556844|NCT01573273|11711687|FG011|NOT COMPLETED|MRI 2||0
10556845|NCT01573325|11711713|FG000|STARTED|Overall Study||50
10556846|NCT01573325|11711713|FG000|COMPLETED|Overall Study||50
10556847|NCT01573325|11711713|FG000|NOT COMPLETED|Overall Study||0
10556848|NCT01573442|11711720|FG000|STARTED|Overall Study||113
10556849|NCT01573442|11711721|FG001|STARTED|Overall Study||114
10556850|NCT01573442|11711720|FG000|COMPLETED|Overall Study||104
10556851|NCT01573442|11711721|FG001|COMPLETED|Overall Study||104
10556852|NCT01573442|11711720|FG000|NOT COMPLETED|Overall Study||9
10556853|NCT01573442|11711721|FG001|NOT COMPLETED|Overall Study||10
10556854|NCT01573533|11711727|FG000|STARTED|Overall Study||9
10556855|NCT01573533|11711727|FG000|COMPLETED|Overall Study||9
10556856|NCT01573533|11711727|FG000|NOT COMPLETED|Overall Study||0
10556857|NCT01573572|11711731|FG000|STARTED|Overall Study||131
10556858|NCT01573572|11711731|FG000|COMPLETED|Overall Study||103
10556859|NCT01573572|11711731|FG000|NOT COMPLETED|Overall Study||28
10556860|NCT01573624|11711735|FG000|STARTED|Period 1 : Treatment Period 1 (14 Days)||64
10556861|NCT01573624|11711736|FG001|STARTED|Period 1 : Treatment Period 1 (14 Days)||62
10556862|NCT01573624|11711737|FG002|STARTED|Period 1 : Treatment Period 1 (14 Days)||60
10556863|NCT01573624|11711738|FG003|STARTED|Period 1 : Treatment Period 1 (14 Days)||63
10556864|NCT01573624|11711739|FG004|STARTED|Period 1 : Treatment Period 1 (14 Days)||58
10556865|NCT01573624|11711740|FG005|STARTED|Period 1 : Treatment Period 1 (14 Days)||55
10556866|NCT01573624|11711741|FG006|STARTED|Period 1 : Treatment Period 1 (14 Days)||59
10556867|NCT01573624|11711735|FG000|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||58
10556868|NCT01573624|11711736|FG001|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||59
10556869|NCT01573624|11711737|FG002|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||51
10556870|NCT01573624|11711738|FG003|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||61
10556871|NCT01573624|11711739|FG004|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||56
10556872|NCT01573624|11711740|FG005|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||51
10556873|NCT01573624|11711741|FG006|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||57
10556874|NCT01573624|11711735|FG000|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||6
10556875|NCT01573624|11711736|FG001|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||3
10556876|NCT01573624|11711737|FG002|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||9
10556877|NCT01573624|11711738|FG003|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
10556878|NCT01573624|11711739|FG004|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
10556879|NCT01573624|11711740|FG005|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||4
10556880|NCT01573624|11711741|FG006|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
10556881|NCT01573624|11711735|FG000|STARTED|Period 2 : Washout Period 1 (12-14 Days)||58
10556882|NCT01573624|11711736|FG001|STARTED|Period 2 : Washout Period 1 (12-14 Days)||59
10556883|NCT01573624|11711737|FG002|STARTED|Period 2 : Washout Period 1 (12-14 Days)||51
10556884|NCT01573624|11711738|FG003|STARTED|Period 2 : Washout Period 1 (12-14 Days)||61
10556885|NCT01573624|11711739|FG004|STARTED|Period 2 : Washout Period 1 (12-14 Days)||56
10556886|NCT01573624|11711740|FG005|STARTED|Period 2 : Washout Period 1 (12-14 Days)||51
10556887|NCT01573624|11711741|FG006|STARTED|Period 2 : Washout Period 1 (12-14 Days)||57
10556888|NCT01573624|11711735|FG000|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||57
10556889|NCT01573624|11711736|FG001|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||58
10556890|NCT01573624|11711737|FG002|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||48
10556891|NCT01573624|11711738|FG003|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||56
10556892|NCT01573624|11711739|FG004|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||56
10556893|NCT01573624|11711740|FG005|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||48
10556894|NCT01573624|11711741|FG006|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||55
10556895|NCT01573624|11711735|FG000|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||1
10556896|NCT01573624|11711736|FG001|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||1
10556897|NCT01573624|11711737|FG002|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||3
10556898|NCT01573624|11711738|FG003|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||5
10556899|NCT01573624|11711739|FG004|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||0
10556900|NCT01573624|11711740|FG005|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||3
10556901|NCT01573624|11711741|FG006|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||2
10556902|NCT01573624|11711735|FG000|STARTED|Period 3 : Treatment Period 2 (14 Days)||57
10556903|NCT01573624|11711736|FG001|STARTED|Period 3 : Treatment Period 2 (14 Days)||58
10556904|NCT01573624|11711737|FG002|STARTED|Period 3 : Treatment Period 2 (14 Days)||48
10556905|NCT01573624|11711738|FG003|STARTED|Period 3 : Treatment Period 2 (14 Days)||56
10556906|NCT01573624|11711739|FG004|STARTED|Period 3 : Treatment Period 2 (14 Days)||56
10790508|NCT03542019|11951053|FG001|COMPLETED|Overall Study||17
10790509|NCT03542019|11951054|FG002|COMPLETED|Overall Study||19
10790510|NCT03542019|11951052|FG000|NOT COMPLETED|Overall Study||1
10790511|NCT03542019|11951053|FG001|NOT COMPLETED|Overall Study||3
10790512|NCT03542019|11951054|FG002|NOT COMPLETED|Overall Study||1
10790513|NCT03542305|11951066|FG000|STARTED|Overall Study||8
10790514|NCT03542305|11951067|FG001|STARTED|Overall Study||8
10790515|NCT03542305|11951068|FG002|STARTED|Overall Study||8
10790516|NCT03542305|11951069|FG003|STARTED|Overall Study||5
10790517|NCT03542305|11951066|FG000|COMPLETED|Overall Study||8
10790518|NCT03542305|11951067|FG001|COMPLETED|Overall Study||8
10790519|NCT03542305|11951068|FG002|COMPLETED|Overall Study||8
10790520|NCT03542305|11951069|FG003|COMPLETED|Overall Study||5
10790521|NCT03542305|11951066|FG000|NOT COMPLETED|Overall Study||0
10790522|NCT03542305|11951067|FG001|NOT COMPLETED|Overall Study||0
10790523|NCT03542305|11951068|FG002|NOT COMPLETED|Overall Study||0
10790524|NCT03542305|11951069|FG003|NOT COMPLETED|Overall Study||0
10790525|NCT03542474|11951079|FG000|STARTED|Overall Study||8
10790526|NCT03542474|11951079|FG000|COMPLETED|Overall Study||8
10556907|NCT01573624|11711740|FG005|STARTED|Period 3 : Treatment Period 2 (14 Days)||48
10556908|NCT01573624|11711741|FG006|STARTED|Period 3 : Treatment Period 2 (14 Days)||55
10556909|NCT01573624|11711735|FG000|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||50
10790527|NCT03542474|11951079|FG000|NOT COMPLETED|Overall Study||0
10790528|NCT03543085|11951083|FG000|STARTED|Overall Study||10
10556910|NCT01573624|11711736|FG001|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||52
10556911|NCT01573624|11711737|FG002|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||45
10556912|NCT01573624|11711738|FG003|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||55
10556913|NCT01573624|11711739|FG004|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||53
10556914|NCT01573624|11711740|FG005|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||43
10556915|NCT01573624|11711741|FG006|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||55
10556916|NCT01573624|11711735|FG000|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||7
10556917|NCT01573624|11711736|FG001|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||6
10556918|NCT01573624|11711737|FG002|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||3
10556919|NCT01573624|11711738|FG003|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||1
10556920|NCT01573624|11711739|FG004|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||3
10556921|NCT01573624|11711740|FG005|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||5
10556922|NCT01573624|11711741|FG006|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||0
10556923|NCT01573624|11711735|FG000|STARTED|Period 4 : Washout Period 2 (12-14 Days)||50
10556924|NCT01573624|11711736|FG001|STARTED|Period 4 : Washout Period 2 (12-14 Days)||52
10556925|NCT01573624|11711737|FG002|STARTED|Period 4 : Washout Period 2 (12-14 Days)||45
10556926|NCT01573624|11711738|FG003|STARTED|Period 4 : Washout Period 2 (12-14 Days)||55
10556927|NCT01573624|11711739|FG004|STARTED|Period 4 : Washout Period 2 (12-14 Days)||53
10556928|NCT01573624|11711740|FG005|STARTED|Period 4 : Washout Period 2 (12-14 Days)||43
10556929|NCT01573624|11711741|FG006|STARTED|Period 4 : Washout Period 2 (12-14 Days)||55
10556930|NCT01573624|11711735|FG000|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||49
10556931|NCT01573624|11711736|FG001|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||48
10556932|NCT01573624|11711737|FG002|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||43
10556933|NCT01573624|11711738|FG003|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||53
10556934|NCT01573624|11711739|FG004|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||52
10556935|NCT01573624|11711740|FG005|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||41
10556936|NCT01573624|11711741|FG006|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||52
10556937|NCT01573624|11711735|FG000|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||1
10556938|NCT01573624|11711736|FG001|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||4
10556939|NCT01573624|11711737|FG002|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
10556940|NCT01573624|11711738|FG003|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
10556941|NCT01573624|11711739|FG004|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||1
10556942|NCT01573624|11711740|FG005|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
10556943|NCT01573624|11711741|FG006|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||3
10556944|NCT01573624|11711735|FG000|STARTED|Period 5 : Treatment Period 3 (14 Days)||49
10556945|NCT01573624|11711736|FG001|STARTED|Period 5 : Treatment Period 3 (14 Days)||48
10556946|NCT01573624|11711737|FG002|STARTED|Period 5 : Treatment Period 3 (14 Days)||43
10556947|NCT01573624|11711738|FG003|STARTED|Period 5 : Treatment Period 3 (14 Days)||53
10556948|NCT01573624|11711739|FG004|STARTED|Period 5 : Treatment Period 3 (14 Days)||52
10556949|NCT01573624|11711740|FG005|STARTED|Period 5 : Treatment Period 3 (14 Days)||41
10556950|NCT01573624|11711741|FG006|STARTED|Period 5 : Treatment Period 3 (14 Days)||52
10556951|NCT01573624|11711735|FG000|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||46
10556952|NCT01573624|11711736|FG001|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||47
10556953|NCT01573624|11711737|FG002|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||43
10556954|NCT01573624|11711738|FG003|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||53
10556955|NCT01573624|11711739|FG004|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||51
10556956|NCT01573624|11711740|FG005|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||39
10556957|NCT01573624|11711741|FG006|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||48
10556958|NCT01573624|11711735|FG000|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||3
10556959|NCT01573624|11711736|FG001|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||1
10556960|NCT01573624|11711737|FG002|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||0
10557048|NCT01574326|11711860|FG000|STARTED|Overall Study||51
10556961|NCT01573624|11711738|FG003|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||0
10556962|NCT01573624|11711739|FG004|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||1
10556963|NCT01573624|11711740|FG005|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||2
10556964|NCT01573624|11711741|FG006|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||4
10556965|NCT01573624|11711735|FG000|STARTED|Period 6 : Follow-up Period (7 Days)||46
10556966|NCT01573624|11711736|FG001|STARTED|Period 6 : Follow-up Period (7 Days)||47
10556967|NCT01573624|11711737|FG002|STARTED|Period 6 : Follow-up Period (7 Days)||43
10556968|NCT01573624|11711738|FG003|STARTED|Period 6 : Follow-up Period (7 Days)||53
10556969|NCT01573624|11711739|FG004|STARTED|Period 6 : Follow-up Period (7 Days)||51
10556970|NCT01573624|11711740|FG005|STARTED|Period 6 : Follow-up Period (7 Days)||39
10556971|NCT01573624|11711741|FG006|STARTED|Period 6 : Follow-up Period (7 Days)||48
10556972|NCT01573624|11711735|FG000|COMPLETED|Period 6 : Follow-up Period (7 Days)||45
10556973|NCT01573624|11711736|FG001|COMPLETED|Period 6 : Follow-up Period (7 Days)||47
10556974|NCT01573624|11711737|FG002|COMPLETED|Period 6 : Follow-up Period (7 Days)||43
10556975|NCT01573624|11711738|FG003|COMPLETED|Period 6 : Follow-up Period (7 Days)||53
10556976|NCT01573624|11711739|FG004|COMPLETED|Period 6 : Follow-up Period (7 Days)||49
10556977|NCT01573624|11711740|FG005|COMPLETED|Period 6 : Follow-up Period (7 Days)||38
10556978|NCT01573624|11711741|FG006|COMPLETED|Period 6 : Follow-up Period (7 Days)||48
10556979|NCT01573624|11711735|FG000|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||1
10556980|NCT01573624|11711736|FG001|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
10556981|NCT01573624|11711737|FG002|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
10556982|NCT01573624|11711738|FG003|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
10556983|NCT01573624|11711739|FG004|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||2
10556984|NCT01573624|11711740|FG005|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||1
10556985|NCT01573624|11711741|FG006|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
10556986|NCT01573702|11711763|FG000|STARTED|Overall Study||25
10556987|NCT01573702|11711763|FG000|COMPLETED|Overall Study||25
10556988|NCT01573702|11711763|FG000|NOT COMPLETED|Overall Study||0
10556989|NCT01573767|11711772|FG000|STARTED|Overall Study||115
10556990|NCT01573767|11711773|FG001|STARTED|Overall Study||114
10556991|NCT01573767|11711774|FG002|STARTED|Overall Study||113
10556992|NCT01573767|11711775|FG003|STARTED|Overall Study||114
10556993|NCT01573767|11711772|FG000|COMPLETED|Overall Study||93
10556994|NCT01573767|11711773|FG001|COMPLETED|Overall Study||93
10556995|NCT01573767|11711774|FG002|COMPLETED|Overall Study||99
10556996|NCT01573767|11711775|FG003|COMPLETED|Overall Study||90
10556997|NCT01573767|11711772|FG000|NOT COMPLETED|Overall Study||22
10556998|NCT01573767|11711773|FG001|NOT COMPLETED|Overall Study||21
10556999|NCT01573767|11711774|FG002|NOT COMPLETED|Overall Study||14
10557000|NCT01573767|11711775|FG003|NOT COMPLETED|Overall Study||24
10557001|NCT01573910|11711787|FG000|STARTED|Overall Study||489
10557002|NCT01573910|11711788|FG001|STARTED|Overall Study||493
10557003|NCT01573910|11711787|FG000|COMPLETED|Overall Study||469
10557004|NCT01573910|11711788|FG001|COMPLETED|Overall Study||476
10557005|NCT01573910|11711787|FG000|NOT COMPLETED|Overall Study||20
10557006|NCT01573910|11711788|FG001|NOT COMPLETED|Overall Study||17
10557007|NCT01573949|11711794|FG000|STARTED|Overall Study||7
10557008|NCT01573949|11711794|FG000|COMPLETED|Overall Study||7
10557009|NCT01573949|11711794|FG000|NOT COMPLETED|Overall Study||0
10557010|NCT01574079|11711800|FG000|STARTED|Overall Study||18
10557011|NCT01574079|11711801|FG001|STARTED|Overall Study||15
10557012|NCT01574079|11711800|FG000|COMPLETED|Overall Study||17
10557013|NCT01574079|11711801|FG001|COMPLETED|Overall Study||13
10557014|NCT01574079|11711800|FG000|NOT COMPLETED|Overall Study||1
10557015|NCT01574079|11711801|FG001|NOT COMPLETED|Overall Study||2
10557016|NCT01574105|11711809|FG000|STARTED|Overall Study||29
10557017|NCT01574105|11711810|FG001|STARTED|Overall Study||37
10557018|NCT01574105|11711809|FG000|COMPLETED|Overall Study||29
10557019|NCT01574105|11711810|FG001|COMPLETED|Overall Study||37
10557020|NCT01574105|11711809|FG000|NOT COMPLETED|Overall Study||0
10557021|NCT01574105|11711810|FG001|NOT COMPLETED|Overall Study||0
10557022|NCT01574144|11711816|FG000|STARTED|Overall Study||70
10557023|NCT01574144|11711816|FG000|COMPLETED|Overall Study||70
10557024|NCT01574144|11711816|FG000|NOT COMPLETED|Overall Study||0
10557025|NCT01574157|11711823|FG000|STARTED|Overall Study||35
10557026|NCT01574157|11711824|FG001|STARTED|Overall Study||39
10557027|NCT01574157|11711823|FG000|Month 3|Overall Study||31
10557028|NCT01574157|11711824|FG001|Month 3|Overall Study||33
10557029|NCT01574157|11711823|FG000|COMPLETED|Overall Study||31
10557030|NCT01574157|11711824|FG001|COMPLETED|Overall Study||31
10557031|NCT01574157|11711823|FG000|NOT COMPLETED|Overall Study||4
10557032|NCT01574157|11711824|FG001|NOT COMPLETED|Overall Study||8
10557033|NCT01574183|11711836|FG000|STARTED|Overall Study||41
10557034|NCT01574183|11711837|FG001|STARTED|Overall Study||35
10557035|NCT01574183|11711836|FG000|COMPLETED|Overall Study||14
10557036|NCT01574183|11711837|FG001|COMPLETED|Overall Study||17
10557037|NCT01574183|11711836|FG000|NOT COMPLETED|Overall Study||27
10557038|NCT01574183|11711837|FG001|NOT COMPLETED|Overall Study||18
10557039|NCT01574248|11711847|FG000|STARTED|Overall Study||15
10557040|NCT01574248|11711848|FG001|STARTED|Overall Study||18
10557041|NCT01574248|11711847|FG000|COMPLETED|Overall Study||12
10557042|NCT01574248|11711848|FG001|COMPLETED|Overall Study||18
10557043|NCT01574248|11711847|FG000|NOT COMPLETED|Overall Study||3
10557044|NCT01574248|11711848|FG001|NOT COMPLETED|Overall Study||0
10557045|NCT01574287|11711854|FG000|STARTED|Overall Study||4
10557046|NCT01574287|11711854|FG000|COMPLETED|Overall Study||4
10557047|NCT01574287|11711854|FG000|NOT COMPLETED|Overall Study||0
10557049|NCT01574326|11711861|FG001|STARTED|Overall Study||50
10557050|NCT01574326|11711860|FG000|Treated|Overall Study||51
10557051|NCT01574326|11711861|FG001|Treated|Overall Study||49
10557052|NCT01574326|11711860|FG000|COMPLETED|Overall Study||35
10557053|NCT01574326|11711861|FG001|COMPLETED|Overall Study||31
10557054|NCT01574326|11711860|FG000|NOT COMPLETED|Overall Study||16
10557055|NCT01574326|11711861|FG001|NOT COMPLETED|Overall Study||19
10557056|NCT01574352|11711874|FG000|STARTED|Overall Study|59 participants where randomized, but 4 dropped out prior to baseline measurements.|55
10557057|NCT01574352|11711875|FG001|STARTED|Overall Study|56 participants where randomized, but 5 dropped out prior to baseline measurements.|51
10557058|NCT01574352|11711874|FG000|COMPLETED|Overall Study|Participated in the last follow up measurement.|48
10557059|NCT01574352|11711875|FG001|COMPLETED|Overall Study|Participated in the last follow up measurement.|38
10557060|NCT01574352|11711874|FG000|NOT COMPLETED|Overall Study||7
10557061|NCT01574352|11711875|FG001|NOT COMPLETED|Overall Study||13
10557062|NCT01574612|11711881|FG000|STARTED|Overall Study|patients who were identified as having the appropriate medical history of herpes labialis|54
10557063|NCT01574612|11711881|FG000|COMPLETED|Overall Study||46
10557064|NCT01574612|11711881|FG000|NOT COMPLETED|Overall Study||8
10557065|NCT01574651|11711887|FG000|STARTED|Overall Study||476
10557066|NCT01574651|11711888|FG001|STARTED|Overall Study||458
10557067|NCT01574651|11711887|FG000|Full Analysis Set (FAS)|Overall Study||476
10557068|NCT01574651|11711888|FG001|Full Analysis Set (FAS)|Overall Study||458
10557069|NCT01574651|11711887|FG000|Per Protocol Set (PPS)|Overall Study||373
10557070|NCT01574651|11711888|FG001|Per Protocol Set (PPS)|Overall Study||374
10557071|NCT01574651|11711887|FG000|COMPLETED|Overall Study||415
10557072|NCT01574651|11711888|FG001|COMPLETED|Overall Study||406
10557073|NCT01574651|11711887|FG000|NOT COMPLETED|Overall Study||61
10557074|NCT01574651|11711888|FG001|NOT COMPLETED|Overall Study||52
10557075|NCT01574703|11711898|FG000|STARTED|Overall Study||1192
10557076|NCT01574703|11711899|FG001|STARTED|Overall Study||1166
10557077|NCT01574703|11711900|FG002|STARTED|Overall Study||1116
10557078|NCT01574703|11711901|FG003|STARTED|Overall Study||1121
10557079|NCT01574703|11711898|FG000|COMPLETED|Overall Study||1067
10557080|NCT01574703|11711899|FG001|COMPLETED|Overall Study||1054
10557081|NCT01574703|11711900|FG002|COMPLETED|Overall Study||1011
10557082|NCT01574703|11711901|FG003|COMPLETED|Overall Study||1007
10557083|NCT01574703|11711898|FG000|NOT COMPLETED|Overall Study||125
10557084|NCT01574703|11711899|FG001|NOT COMPLETED|Overall Study||112
10557085|NCT01574703|11711900|FG002|NOT COMPLETED|Overall Study||105
10557086|NCT01574703|11711901|FG003|NOT COMPLETED|Overall Study||114
10557087|NCT01574716|11711916|FG000|STARTED|Part 1||3
10557088|NCT01574716|11711917|FG001|STARTED|Part 1||4
10557089|NCT01574716|11711918|FG002|STARTED|Part 1||9
10557090|NCT01574716|11711919|FG003|STARTED|Part 1||0
10557091|NCT01574716|11711920|FG004|STARTED|Part 1||0
10557092|NCT01574716|11711916|FG000|COMPLETED|Part 1||0
10557093|NCT01574716|11711917|FG001|COMPLETED|Part 1||0
10557094|NCT01574716|11711918|FG002|COMPLETED|Part 1||0
10557095|NCT01574716|11711919|FG003|COMPLETED|Part 1||0
10557096|NCT01574716|11711920|FG004|COMPLETED|Part 1||0
10557097|NCT01574716|11711916|FG000|NOT COMPLETED|Part 1||3
10557098|NCT01574716|11711917|FG001|NOT COMPLETED|Part 1||4
10557099|NCT01574716|11711918|FG002|NOT COMPLETED|Part 1||9
10557100|NCT01574716|11711919|FG003|NOT COMPLETED|Part 1||0
10557101|NCT01574716|11711920|FG004|NOT COMPLETED|Part 1||0
10557102|NCT01574716|11711916|FG000|STARTED|Part 2||0
10557103|NCT01574716|11711917|FG001|STARTED|Part 2||0
10557104|NCT01574716|11711918|FG002|STARTED|Part 2||0
10790529|NCT03543085|11951083|FG000|COMPLETED|Overall Study||10
10790530|NCT03543085|11951083|FG000|NOT COMPLETED|Overall Study||0
10790531|NCT03543137|11951087|FG000|STARTED|Study Period 1: Up to Day 1||18
10790532|NCT03543137|11951088|FG001|STARTED|Study Period 1: Up to Day 1||19
10790533|NCT03543137|11951087|FG000|COMPLETED|Study Period 1: Up to Day 1||18
10790534|NCT03543137|11951088|FG001|COMPLETED|Study Period 1: Up to Day 1||19
10790535|NCT03543137|11951087|FG000|NOT COMPLETED|Study Period 1: Up to Day 1||0
10790536|NCT03543137|11951088|FG001|NOT COMPLETED|Study Period 1: Up to Day 1||0
10790537|NCT03543137|11951087|FG000|STARTED|Washout Period: 5 to 7 Days||18
10790538|NCT03543137|11951088|FG001|STARTED|Washout Period: 5 to 7 Days||19
10790539|NCT03543137|11951087|FG000|COMPLETED|Washout Period: 5 to 7 Days||18
10790540|NCT03543137|11951088|FG001|COMPLETED|Washout Period: 5 to 7 Days||19
10790541|NCT03543137|11951087|FG000|NOT COMPLETED|Washout Period: 5 to 7 Days||0
10790542|NCT03543137|11951088|FG001|NOT COMPLETED|Washout Period: 5 to 7 Days||0
10790543|NCT03543137|11951087|FG000|STARTED|Study Period 2: Up to Day 8||18
10790544|NCT03543137|11951088|FG001|STARTED|Study Period 2: Up to Day 8||19
10790545|NCT03543137|11951087|FG000|Treated|Study Period 2: Up to Day 8||16
10790546|NCT03543137|11951088|FG001|Treated|Study Period 2: Up to Day 8||18
10790547|NCT03543137|11951087|FG000|COMPLETED|Study Period 2: Up to Day 8||16
10790548|NCT03543137|11951088|FG001|COMPLETED|Study Period 2: Up to Day 8||18
10790549|NCT03543137|11951087|FG000|NOT COMPLETED|Study Period 2: Up to Day 8||2
10790550|NCT03543137|11951088|FG001|NOT COMPLETED|Study Period 2: Up to Day 8||1
10790551|NCT03543176|11951098|FG000|STARTED|Overall Study||392
10790552|NCT03543176|11951099|FG001|STARTED|Overall Study||397
10790553|NCT03543176|11951098|FG000|COMPLETED|Overall Study||392
10790554|NCT03543176|11951099|FG001|COMPLETED|Overall Study||397
10790555|NCT03543176|11951098|FG000|NOT COMPLETED|Overall Study||0
10790556|NCT03543176|11951099|FG001|NOT COMPLETED|Overall Study||0
10790557|NCT03543878|11951107|FG000|STARTED|Overall Study||5
10790558|NCT03543878|11951108|FG001|STARTED|Overall Study||5
10790559|NCT03543878|11951107|FG000|COMPLETED|Overall Study||5
10790560|NCT03543878|11951108|FG001|COMPLETED|Overall Study||5
10790561|NCT03543878|11951107|FG000|NOT COMPLETED|Overall Study||0
10790562|NCT03543878|11951108|FG001|NOT COMPLETED|Overall Study||0
10790563|NCT03544216|11951117|FG000|STARTED|Overall Study||42
10790564|NCT03544216|11951118|FG001|STARTED|Overall Study||42
10557105|NCT01574716|11711919|FG003|STARTED|Part 2||139
10557106|NCT01574716|11711920|FG004|STARTED|Part 2||70
10557107|NCT01574716|11711916|FG000|Treated Participants|Part 2||0
10557108|NCT01574716|11711917|FG001|Treated Participants|Part 2||0
10557109|NCT01574716|11711918|FG002|Treated Participants|Part 2||0
10557110|NCT01574716|11711919|FG003|Treated Participants|Part 2||140
10557111|NCT01574716|11711920|FG004|Treated Participants|Part 2||67
10557112|NCT01574716|11711916|FG000|COMPLETED|Part 2||0
10790565|NCT03544216|11951117|FG000|COMPLETED|Overall Study||42
10790566|NCT03544216|11951118|FG001|COMPLETED|Overall Study||42
10790567|NCT03544216|11951117|FG000|NOT COMPLETED|Overall Study||0
10557113|NCT01574716|11711917|FG001|COMPLETED|Part 2||0
10557114|NCT01574716|11711918|FG002|COMPLETED|Part 2||0
10557115|NCT01574716|11711919|FG003|COMPLETED|Part 2||2
10557116|NCT01574716|11711920|FG004|COMPLETED|Part 2||0
10557117|NCT01574716|11711916|FG000|NOT COMPLETED|Part 2||0
10557118|NCT01574716|11711917|FG001|NOT COMPLETED|Part 2||0
10557119|NCT01574716|11711918|FG002|NOT COMPLETED|Part 2||0
10557120|NCT01574716|11711919|FG003|NOT COMPLETED|Part 2||137
10557121|NCT01574716|11711920|FG004|NOT COMPLETED|Part 2||70
10557122|NCT01574807|11711929|FG000|STARTED|First Appointment||50
10557123|NCT01574807|11711930|FG001|STARTED|First Appointment||50
10557124|NCT01574807|11711929|FG000|COMPLETED|First Appointment||50
10557125|NCT01574807|11711930|FG001|COMPLETED|First Appointment||50
10557126|NCT01574807|11711929|FG000|NOT COMPLETED|First Appointment||0
10557127|NCT01574807|11711930|FG001|NOT COMPLETED|First Appointment||0
10557128|NCT01574807|11711929|FG000|STARTED|Wash Out Period 2 Weeks||50
10557129|NCT01574807|11711930|FG001|STARTED|Wash Out Period 2 Weeks||50
10557130|NCT01574807|11711929|FG000|COMPLETED|Wash Out Period 2 Weeks||50
10557131|NCT01574807|11711930|FG001|COMPLETED|Wash Out Period 2 Weeks||50
10557132|NCT01574807|11711929|FG000|NOT COMPLETED|Wash Out Period 2 Weeks||0
10557133|NCT01574807|11711930|FG001|NOT COMPLETED|Wash Out Period 2 Weeks||0
10557134|NCT01574807|11711929|FG000|STARTED|Second Appointment||50
10557135|NCT01574807|11711930|FG001|STARTED|Second Appointment||50
10557136|NCT01574807|11711929|FG000|COMPLETED|Second Appointment||50
10557137|NCT01574807|11711930|FG001|COMPLETED|Second Appointment||50
10557138|NCT01574807|11711929|FG000|NOT COMPLETED|Second Appointment||0
10557139|NCT01574807|11711930|FG001|NOT COMPLETED|Second Appointment||0
10557140|NCT01575054|11711937|FG000|STARTED|Overall Study||233
10557141|NCT01575054|11711938|FG001|STARTED|Overall Study||235
10557142|NCT01575054|11711937|FG000|COMPLETED|Overall Study||204
10557143|NCT01575054|11711938|FG001|COMPLETED|Overall Study||209
10557144|NCT01575054|11711937|FG000|NOT COMPLETED|Overall Study||29
10557145|NCT01575054|11711938|FG001|NOT COMPLETED|Overall Study||26
10557146|NCT01575080|11711944|FG000|STARTED|Overall Study||102
10557147|NCT01575080|11711944|FG000|COMPLETED|Overall Study||102
10557148|NCT01575080|11711944|FG000|NOT COMPLETED|Overall Study||0
10557149|NCT01575106|11711948|FG000|STARTED|Overall Study||38
10557150|NCT01575106|11711948|FG000|COMPLETED|Overall Study||24
10557151|NCT01575106|11711948|FG000|NOT COMPLETED|Overall Study||14
10557152|NCT01575197|11711956|FG000|STARTED|Overall Study||152
10557153|NCT01575197|11711957|FG001|STARTED|Overall Study||152
10557154|NCT01575197|11711958|FG002|STARTED|Overall Study||152
10557155|NCT01575197|11711956|FG000|COMPLETED|Overall Study||149
10557156|NCT01575197|11711957|FG001|COMPLETED|Overall Study||143
10557157|NCT01575197|11711958|FG002|COMPLETED|Overall Study||146
10557158|NCT01575197|11711956|FG000|NOT COMPLETED|Overall Study||3
10557159|NCT01575197|11711957|FG001|NOT COMPLETED|Overall Study||9
10557160|NCT01575197|11711958|FG002|NOT COMPLETED|Overall Study||6
10557161|NCT01575275|11711966|FG000|STARTED|Overall Study||8
10557162|NCT01575275|11711966|FG000|COMPLETED|Overall Study||8
10557163|NCT01575275|11711966|FG000|NOT COMPLETED|Overall Study||0
10557164|NCT01575522|11711970|FG000|STARTED|Overall Study||22
10557165|NCT01575522|11711970|FG000|COMPLETED|Overall Study||22
10557166|NCT01575522|11711970|FG000|NOT COMPLETED|Overall Study||0
10557167|NCT01575561|11711977|FG000|STARTED|Overall Study||377
10557168|NCT01575561|11711977|FG000|COMPLETED|Overall Study||338
10557169|NCT01575561|11711977|FG000|NOT COMPLETED|Overall Study||39
10557170|NCT01575756|11711981|FG000|STARTED|Treatment Period 1||11
10557171|NCT01575756|11711982|FG001|STARTED|Treatment Period 1||11
10557172|NCT01575756|11711981|FG000|COMPLETED|Treatment Period 1||11
10557173|NCT01575756|11711982|FG001|COMPLETED|Treatment Period 1||11
10557174|NCT01575756|11711981|FG000|NOT COMPLETED|Treatment Period 1||0
10557175|NCT01575756|11711982|FG001|NOT COMPLETED|Treatment Period 1||0
10557176|NCT01575756|11711981|FG000|STARTED|Treatment Period 2||11
10557177|NCT01575756|11711982|FG001|STARTED|Treatment Period 2||11
10557178|NCT01575756|11711981|FG000|COMPLETED|Treatment Period 2||11
10557179|NCT01575756|11711982|FG001|COMPLETED|Treatment Period 2||11
10557180|NCT01575756|11711981|FG000|NOT COMPLETED|Treatment Period 2||0
10557181|NCT01575756|11711982|FG001|NOT COMPLETED|Treatment Period 2||0
10557182|NCT01575769|11711989|FG000|STARTED|Overall Study||41
10557183|NCT01575769|11711989|FG000|COMPLETED|Overall Study||0
10557184|NCT01575769|11711989|FG000|NOT COMPLETED|Overall Study||41
10557185|NCT01575808|11711997|FG000|STARTED|Overall Study||103
10557186|NCT01575808|11711998|FG001|STARTED|Overall Study||68
10557187|NCT01575808|11711997|FG000|COMPLETED|Overall Study|Study ongoing. All 103 assessed for primary invasiveness endpoints,100 for primary efficacy endpoint|100
10557188|NCT01575808|11711998|FG001|COMPLETED|Overall Study||68
10557189|NCT01575808|11711997|FG000|NOT COMPLETED|Overall Study||3
10557190|NCT01575808|11711998|FG001|NOT COMPLETED|Overall Study||0
10557203|NCT01575873|11712023|FG000|STARTED|Overall Study||145
10557204|NCT01575873|11712024|FG001|STARTED|Overall Study||145
10557205|NCT01575873|11712025|FG002|STARTED|Overall Study||252
10557206|NCT01575873|11712026|FG003|STARTED|Overall Study||253
10557207|NCT01575873|11712023|FG000|Received Study Drug|Overall Study|Participants who received oral risedronate|140
10557208|NCT01575873|11712024|FG001|Received Study Drug|Overall Study|Participants who received subcutaneous denosumab|142
10650788|NCT02171611|11811133|FG004|STARTED|Overall Study||5
10557209|NCT01575873|11712025|FG002|Received Study Drug|Overall Study|Participants who received oral risedronate|246
10557210|NCT01575873|11712026|FG003|Received Study Drug|Overall Study|Participants who received subcutaneous denosumab|251
10557211|NCT01575873|11712023|FG000|COMPLETED|Overall Study||117
10557212|NCT01575873|11712024|FG001|COMPLETED|Overall Study||109
10557213|NCT01575873|11712025|FG002|COMPLETED|Overall Study||178
10557214|NCT01575873|11712026|FG003|COMPLETED|Overall Study||186
10557215|NCT01575873|11712023|FG000|NOT COMPLETED|Overall Study||28
10557216|NCT01575873|11712024|FG001|NOT COMPLETED|Overall Study||36
10557217|NCT01575873|11712025|FG002|NOT COMPLETED|Overall Study||74
10557218|NCT01575873|11712026|FG003|NOT COMPLETED|Overall Study||67
10557219|NCT01575899|11712037|FG000|STARTED|Overall Study||73
10557220|NCT01575899|11712038|FG001|STARTED|Overall Study||73
10557221|NCT01575899|11712039|FG002|STARTED|Overall Study|Included patients still with Hp infection after previous therapy without levofloxacin and Augmentin.|62
10557222|NCT01575899|11712037|FG000|COMPLETED|Overall Study||68
10557223|NCT01575899|11712038|FG001|COMPLETED|Overall Study||68
10557224|NCT01575899|11712039|FG002|COMPLETED|Overall Study||60
10557225|NCT01575899|11712037|FG000|NOT COMPLETED|Overall Study||5
10557226|NCT01575899|11712038|FG001|NOT COMPLETED|Overall Study||5
10557227|NCT01575899|11712039|FG002|NOT COMPLETED|Overall Study||2
10557228|NCT01575912|11712052|FG000|STARTED|Overall Study||30
10557229|NCT01575912|11712053|FG001|STARTED|Overall Study||32
10557230|NCT01575912|11712054|FG002|STARTED|Overall Study||30
10557231|NCT01575912|11712052|FG000|COMPLETED|Overall Study||30
10557232|NCT01575912|11712053|FG001|COMPLETED|Overall Study||32
10557233|NCT01575912|11712054|FG002|COMPLETED|Overall Study||30
10557234|NCT01575912|11712052|FG000|NOT COMPLETED|Overall Study||0
10557235|NCT01575912|11712053|FG001|NOT COMPLETED|Overall Study||0
10557236|NCT01575912|11712054|FG002|NOT COMPLETED|Overall Study||0
10557237|NCT01576003|11712065|FG000|STARTED|Overall Study||2
10557238|NCT01576003|11712066|FG001|STARTED|Overall Study||3
10557239|NCT01576003|11712067|FG002|STARTED|Overall Study||4
10557240|NCT01576003|11712065|FG000|COMPLETED|Overall Study||1
10557241|NCT01576003|11712066|FG001|COMPLETED|Overall Study||1
10557242|NCT01576003|11712067|FG002|COMPLETED|Overall Study||4
10557243|NCT01576003|11712065|FG000|NOT COMPLETED|Overall Study||1
10557244|NCT01576003|11712066|FG001|NOT COMPLETED|Overall Study||2
10557245|NCT01576003|11712067|FG002|NOT COMPLETED|Overall Study||0
10557246|NCT01576016|11712077|FG000|STARTED|Lead Safety||920
10557247|NCT01576016|11712078|FG001|STARTED|Lead Safety||0
10557248|NCT01576016|11712077|FG000|COMPLETED|Lead Safety||647
10557249|NCT01576016|11712078|FG001|COMPLETED|Lead Safety||0
10557250|NCT01576016|11712077|FG000|NOT COMPLETED|Lead Safety||273
10557251|NCT01576016|11712078|FG001|NOT COMPLETED|Lead Safety||0
10557252|NCT01576016|11712077|FG000|STARTED|MRI Safety||0
10557253|NCT01576016|11712078|FG001|STARTED|MRI Safety|255 enrollments includes 30 supplemental scans performed in Australia using the same scan protocol.|255
10557254|NCT01576016|11712077|FG000|COMPLETED|MRI Safety||0
10557255|NCT01576016|11712078|FG001|COMPLETED|MRI Safety||181
10557256|NCT01576016|11712077|FG000|NOT COMPLETED|MRI Safety||0
10557257|NCT01576016|11712078|FG001|NOT COMPLETED|MRI Safety||74
10557258|NCT01576042|11712088|FG000|STARTED|Overall Study||13
10557259|NCT01576042|11712089|FG001|STARTED|Overall Study||14
10557260|NCT01576042|11712088|FG000|Switched to the Other Arm|Overall Study||5
10557261|NCT01576042|11712089|FG001|Switched to the Other Arm|Overall Study||1
10557262|NCT01576042|11712088|FG000|COMPLETED|Overall Study||11
10557263|NCT01576042|11712089|FG001|COMPLETED|Overall Study||14
10557264|NCT01576042|11712088|FG000|NOT COMPLETED|Overall Study||2
10557265|NCT01576042|11712089|FG001|NOT COMPLETED|Overall Study||0
10557266|NCT01576055|11712097|FG000|STARTED|Overall Study||197
10557267|NCT01576055|11712098|FG001|STARTED|Overall Study||70
10557268|NCT01576055|11712097|FG000|COMPLETED|Overall Study||178
10557269|NCT01576055|11712098|FG001|COMPLETED|Overall Study||64
10557270|NCT01576055|11712097|FG000|NOT COMPLETED|Overall Study||19
10557271|NCT01576055|11712098|FG001|NOT COMPLETED|Overall Study||6
10557272|NCT01576120|11712106|FG000|STARTED|Overall Study||21
10557273|NCT01576120|11712107|FG001|STARTED|Overall Study||19
10557274|NCT01576120|11712106|FG000|COMPLETED|Overall Study||21
10557275|NCT01576120|11712107|FG001|COMPLETED|Overall Study||19
10557276|NCT01576120|11712106|FG000|NOT COMPLETED|Overall Study||0
10557277|NCT01576120|11712107|FG001|NOT COMPLETED|Overall Study||0
10557278|NCT01576146|11712113|FG000|STARTED|Extension Period 1||30
10557279|NCT01576146|11712113|FG000|COMPLETED|Extension Period 1||20
10557280|NCT01576146|11712113|FG000|NOT COMPLETED|Extension Period 1||10
10557281|NCT01576146|11712113|FG000|STARTED|Extension Period 2|Three participants who completed Extension Period 1 did not enroll in Period 2|17
10557282|NCT01576146|11712113|FG000|COMPLETED|Extension Period 2||0
10557283|NCT01576146|11712113|FG000|NOT COMPLETED|Extension Period 2||17
10557284|NCT01576159|11712121|FG000|STARTED|Overall Study||12
10557285|NCT01576159|11712122|FG001|STARTED|Overall Study||12
10557286|NCT01576159|11712123|FG002|STARTED|Overall Study||12
10557287|NCT01576159|11712124|FG003|STARTED|Overall Study||12
10557288|NCT01576159|11712121|FG000|COMPLETED|Overall Study||11
10557289|NCT01576159|11712122|FG001|COMPLETED|Overall Study||11
10557290|NCT01576159|11712123|FG002|COMPLETED|Overall Study||11
10557291|NCT01576159|11712124|FG003|COMPLETED|Overall Study||11
10557292|NCT01576159|11712121|FG000|NOT COMPLETED|Overall Study||1
10557293|NCT01576159|11712122|FG001|NOT COMPLETED|Overall Study||1
10557294|NCT01576159|11712123|FG002|NOT COMPLETED|Overall Study||1
10557295|NCT01576159|11712124|FG003|NOT COMPLETED|Overall Study||1
10557296|NCT01576172|11712143|FG000|STARTED|Overall Study||79
10557297|NCT01576172|11712144|FG001|STARTED|Overall Study||80
10557298|NCT01576172|11712143|FG000|COMPLETED|Overall Study||74
10557299|NCT01576172|11712144|FG001|COMPLETED|Overall Study||79
10557300|NCT01576172|11712143|FG000|NOT COMPLETED|Overall Study||5
10557301|NCT01576172|11712144|FG001|NOT COMPLETED|Overall Study||1
10557302|NCT01576276|11712154|FG000|STARTED|Overall Study||22
10557303|NCT01576276|11712155|FG001|STARTED|Overall Study||29
10557304|NCT01576276|11712154|FG000|COMPLETED|Overall Study||14
10557305|NCT01576276|11712155|FG001|COMPLETED|Overall Study||18
10557306|NCT01576276|11712154|FG000|NOT COMPLETED|Overall Study||8
10557307|NCT01576276|11712155|FG001|NOT COMPLETED|Overall Study||11
10557308|NCT01576341|11712162|FG000|STARTED|Overall Study||417
10557309|NCT01576341|11712162|FG000|COMPLETED|Overall Study||324
10557310|NCT01576341|11712162|FG000|NOT COMPLETED|Overall Study||93
10557311|NCT01576367|11712169|FG000|STARTED|Overall Study||17
10557312|NCT01576367|11712169|FG000|COMPLETED|Overall Study||14
10557313|NCT01576367|11712169|FG000|NOT COMPLETED|Overall Study||3
10557314|NCT01576406|11712179|FG000|STARTED|Overall Study||11
10557315|NCT01576406|11712180|FG001|STARTED|Overall Study||15
10557316|NCT01576406|11712181|FG002|STARTED|Overall Study||20
10557317|NCT01576406|11712182|FG003|STARTED|Overall Study||10
10557318|NCT01576406|11712183|FG004|STARTED|Overall Study||16
10557319|NCT01576406|11712184|FG005|STARTED|Overall Study||16
10557320|NCT01576406|11712179|FG000|COMPLETED|Overall Study||5
10557321|NCT01576406|11712180|FG001|COMPLETED|Overall Study||7
10557322|NCT01576406|11712181|FG002|COMPLETED|Overall Study||4
10557323|NCT01576406|11712182|FG003|COMPLETED|Overall Study||1
10557324|NCT01576406|11712183|FG004|COMPLETED|Overall Study||8
10557325|NCT01576406|11712184|FG005|COMPLETED|Overall Study||4
10557326|NCT01576406|11712179|FG000|NOT COMPLETED|Overall Study||6
10557327|NCT01576406|11712180|FG001|NOT COMPLETED|Overall Study||8
10557328|NCT01576406|11712181|FG002|NOT COMPLETED|Overall Study||16
10557329|NCT01576406|11712182|FG003|NOT COMPLETED|Overall Study||9
10557330|NCT01576406|11712183|FG004|NOT COMPLETED|Overall Study||8
10557331|NCT01576406|11712184|FG005|NOT COMPLETED|Overall Study||12
10557332|NCT01576471|11712200|FG000|STARTED|Overall Study||125
10557333|NCT01576471|11712201|FG001|STARTED|Overall Study||125
10557334|NCT01576471|11712200|FG000|COMPLETED|Overall Study||117
10557335|NCT01576471|11712201|FG001|COMPLETED|Overall Study||116
10557336|NCT01576471|11712200|FG000|NOT COMPLETED|Overall Study||8
10557337|NCT01576471|11712201|FG001|NOT COMPLETED|Overall Study||9
10557338|NCT01576484|11712209|FG000|STARTED|Overall Study||12
10557339|NCT01576484|11712210|FG001|STARTED|Overall Study||46
10557340|NCT01576484|11712209|FG000|COMPLETED|Overall Study||7
10557341|NCT01576484|11712210|FG001|COMPLETED|Overall Study||27
10557342|NCT01576484|11712209|FG000|NOT COMPLETED|Overall Study||5
10557343|NCT01576484|11712210|FG001|NOT COMPLETED|Overall Study||19
10557344|NCT01576523|11712224|FG000|STARTED|Dosing Period 1||3
10557345|NCT01576523|11712225|FG001|STARTED|Dosing Period 1||3
10557346|NCT01576523|11712226|FG002|STARTED|Dosing Period 1||3
10557347|NCT01576523|11712227|FG003|STARTED|Dosing Period 1||3
10557348|NCT01576523|11712228|FG004|STARTED|Dosing Period 1||3
10557349|NCT01576523|11712229|FG005|STARTED|Dosing Period 1||3
10557350|NCT01576523|11712224|FG000|COMPLETED|Dosing Period 1||3
10557351|NCT01576523|11712225|FG001|COMPLETED|Dosing Period 1||3
10557352|NCT01576523|11712226|FG002|COMPLETED|Dosing Period 1||3
10557353|NCT01576523|11712227|FG003|COMPLETED|Dosing Period 1||3
10557354|NCT01576523|11712228|FG004|COMPLETED|Dosing Period 1||3
10557355|NCT01576523|11712229|FG005|COMPLETED|Dosing Period 1||3
10557356|NCT01576523|11712224|FG000|NOT COMPLETED|Dosing Period 1||0
10557357|NCT01576523|11712225|FG001|NOT COMPLETED|Dosing Period 1||0
10557358|NCT01576523|11712226|FG002|NOT COMPLETED|Dosing Period 1||0
10557359|NCT01576523|11712227|FG003|NOT COMPLETED|Dosing Period 1||0
10557360|NCT01576523|11712228|FG004|NOT COMPLETED|Dosing Period 1||0
10557361|NCT01576523|11712229|FG005|NOT COMPLETED|Dosing Period 1||0
10557362|NCT01576523|11712224|FG000|STARTED|Dosing Period 2||3
10557363|NCT01576523|11712225|FG001|STARTED|Dosing Period 2||3
10557364|NCT01576523|11712226|FG002|STARTED|Dosing Period 2||3
10557365|NCT01576523|11712227|FG003|STARTED|Dosing Period 2||3
10557366|NCT01576523|11712228|FG004|STARTED|Dosing Period 2||3
10557367|NCT01576523|11712229|FG005|STARTED|Dosing Period 2||3
10557368|NCT01576523|11712224|FG000|COMPLETED|Dosing Period 2||3
10557369|NCT01576523|11712225|FG001|COMPLETED|Dosing Period 2||3
10557370|NCT01576523|11712226|FG002|COMPLETED|Dosing Period 2||3
10557371|NCT01576523|11712227|FG003|COMPLETED|Dosing Period 2||3
10557372|NCT01576523|11712228|FG004|COMPLETED|Dosing Period 2||3
10557373|NCT01576523|11712229|FG005|COMPLETED|Dosing Period 2||3
10557374|NCT01576523|11712224|FG000|NOT COMPLETED|Dosing Period 2||0
10557375|NCT01576523|11712225|FG001|NOT COMPLETED|Dosing Period 2||0
10557376|NCT01576523|11712226|FG002|NOT COMPLETED|Dosing Period 2||0
10557377|NCT01576523|11712227|FG003|NOT COMPLETED|Dosing Period 2||0
10557378|NCT01576523|11712228|FG004|NOT COMPLETED|Dosing Period 2||0
10557379|NCT01576523|11712229|FG005|NOT COMPLETED|Dosing Period 2||0
10557380|NCT01576536|11712238|FG000|STARTED|Overall Study||117
10557381|NCT01576536|11712238|FG000|COMPLETED|Overall Study||117
10557382|NCT01576536|11712238|FG000|NOT COMPLETED|Overall Study||0
10557383|NCT01576588|11712242|FG000|STARTED|Overall Study||25
10557384|NCT01576588|11712242|FG000|COMPLETED|Overall Study||23
10557385|NCT01576588|11712242|FG000|NOT COMPLETED|Overall Study||2
10557386|NCT01576705|11712251|FG000|STARTED|Overall Study||43
10557387|NCT01576705|11712252|FG001|STARTED|Overall Study||45
10557388|NCT01576705|11712253|FG002|STARTED|Overall Study||43
10557389|NCT01576705|11712254|FG003|STARTED|Overall Study||44
10557390|NCT01576705|11712251|FG000|COMPLETED|Overall Study||40
10557391|NCT01576705|11712252|FG001|COMPLETED|Overall Study||37
10557392|NCT01576705|11712253|FG002|COMPLETED|Overall Study||38
10557393|NCT01576705|11712254|FG003|COMPLETED|Overall Study||41
10557394|NCT01576705|11712251|FG000|NOT COMPLETED|Overall Study||3
10557395|NCT01576705|11712252|FG001|NOT COMPLETED|Overall Study||8
10557396|NCT01576705|11712253|FG002|NOT COMPLETED|Overall Study||5
10557397|NCT01576705|11712254|FG003|NOT COMPLETED|Overall Study||3
10557398|NCT01576718|11712270|FG000|STARTED|Pre-Assignment Period (Run-In Placebo)||889
10557399|NCT01576718|11712271|FG001|STARTED|Pre-Assignment Period (Run-In Placebo)||0
10557400|NCT01576718|11712272|FG002|STARTED|Pre-Assignment Period (Run-In Placebo)||0
10557401|NCT01576718|11712273|FG003|STARTED|Pre-Assignment Period (Run-In Placebo)||0
10557402|NCT01576718|11712274|FG004|STARTED|Pre-Assignment Period (Run-In Placebo)||0
10557403|NCT01576718|11712275|FG005|STARTED|Pre-Assignment Period (Run-In Placebo)||0
10557404|NCT01576718|11712276|FG006|STARTED|Pre-Assignment Period (Run-In Placebo)||0
10557405|NCT01576718|11712270|FG000|COMPLETED|Pre-Assignment Period (Run-In Placebo)|Participants randomized into the Treatment Period|640
10557406|NCT01576718|11712271|FG001|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
10557407|NCT01576718|11712272|FG002|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
10557408|NCT01576718|11712273|FG003|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
10557409|NCT01576718|11712274|FG004|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
10557410|NCT01576718|11712275|FG005|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
10557411|NCT01576718|11712276|FG006|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
10557412|NCT01576718|11712270|FG000|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||249
10557413|NCT01576718|11712271|FG001|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
10557414|NCT01576718|11712272|FG002|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
10557415|NCT01576718|11712273|FG003|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
10557416|NCT01576718|11712274|FG004|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
10557417|NCT01576718|11712275|FG005|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
10557418|NCT01576718|11712276|FG006|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
10557419|NCT01576718|11712270|FG000|STARTED|Treatment Period||0
10557420|NCT01576718|11712271|FG001|STARTED|Treatment Period||107
10557421|NCT01576718|11712272|FG002|STARTED|Treatment Period||107
10557422|NCT01576718|11712273|FG003|STARTED|Treatment Period||106
10557423|NCT01576718|11712274|FG004|STARTED|Treatment Period||107
10557424|NCT01576718|11712275|FG005|STARTED|Treatment Period||106
10557425|NCT01576718|11712276|FG006|STARTED|Treatment Period||107
10557426|NCT01576718|11712270|FG000|Safety Population|Treatment Period||0
10557427|NCT01576718|11712271|FG001|Safety Population|Treatment Period||107
10557428|NCT01576718|11712272|FG002|Safety Population|Treatment Period||107
10557429|NCT01576718|11712273|FG003|Safety Population|Treatment Period||106
10557430|NCT01576718|11712274|FG004|Safety Population|Treatment Period||107
10557431|NCT01576718|11712275|FG005|Safety Population|Treatment Period||106
10557432|NCT01576718|11712276|FG006|Safety Population|Treatment Period||106
10557433|NCT01576718|11712270|FG000|Efficacy Population (Full Analysis Set)|Treatment Period||0
10557434|NCT01576718|11712271|FG001|Efficacy Population (Full Analysis Set)|Treatment Period||107
10557435|NCT01576718|11712272|FG002|Efficacy Population (Full Analysis Set)|Treatment Period||106
10557436|NCT01576718|11712273|FG003|Efficacy Population (Full Analysis Set)|Treatment Period||102
10557437|NCT01576718|11712274|FG004|Efficacy Population (Full Analysis Set)|Treatment Period||107
10557438|NCT01576718|11712275|FG005|Efficacy Population (Full Analysis Set)|Treatment Period||105
10557439|NCT01576718|11712276|FG006|Efficacy Population (Full Analysis Set)|Treatment Period||103
10557440|NCT01576718|11712270|FG000|COMPLETED|Treatment Period||0
10557441|NCT01576718|11712271|FG001|COMPLETED|Treatment Period||82
10557442|NCT01576718|11712272|FG002|COMPLETED|Treatment Period||87
10557443|NCT01576718|11712273|FG003|COMPLETED|Treatment Period||75
10557444|NCT01576718|11712274|FG004|COMPLETED|Treatment Period||80
10557445|NCT01576718|11712275|FG005|COMPLETED|Treatment Period||58
10557446|NCT01576718|11712276|FG006|COMPLETED|Treatment Period||77
10557447|NCT01576718|11712270|FG000|NOT COMPLETED|Treatment Period||0
10557448|NCT01576718|11712271|FG001|NOT COMPLETED|Treatment Period||25
10557449|NCT01576718|11712272|FG002|NOT COMPLETED|Treatment Period||20
10790568|NCT03544216|11951118|FG001|NOT COMPLETED|Overall Study||0
10810710|NCT03792672|11972457|FG001|COMPLETED|Treatment Period 2 (1 Day)||4
10810711|NCT03792672|11972458|FG002|COMPLETED|Treatment Period 2 (1 Day)||4
10810712|NCT03792672|11972459|FG003|COMPLETED|Treatment Period 2 (1 Day)||4
10810713|NCT03792672|11972460|FG004|COMPLETED|Treatment Period 2 (1 Day)||4
10810714|NCT03792672|11972461|FG005|COMPLETED|Treatment Period 2 (1 Day)||4
10810715|NCT03792672|11972456|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0
10810716|NCT03792672|11972457|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0
10810717|NCT03792672|11972458|FG002|NOT COMPLETED|Treatment Period 2 (1 Day)||0
10810718|NCT03792672|11972459|FG003|NOT COMPLETED|Treatment Period 2 (1 Day)||0
10810719|NCT03792672|11972460|FG004|NOT COMPLETED|Treatment Period 2 (1 Day)||0
10810720|NCT03792672|11972461|FG005|NOT COMPLETED|Treatment Period 2 (1 Day)||0
10810721|NCT03792672|11972456|FG000|STARTED|Washout Period 2 (10 Days)||4
10810722|NCT03792672|11972457|FG001|STARTED|Washout Period 2 (10 Days)||4
10810723|NCT03792672|11972458|FG002|STARTED|Washout Period 2 (10 Days)||4
10810724|NCT03792672|11972459|FG003|STARTED|Washout Period 2 (10 Days)||4
10810725|NCT03792672|11972460|FG004|STARTED|Washout Period 2 (10 Days)||4
10557450|NCT01576718|11712273|FG003|NOT COMPLETED|Treatment Period||31
10557451|NCT01576718|11712274|FG004|NOT COMPLETED|Treatment Period||27
10557452|NCT01576718|11712275|FG005|NOT COMPLETED|Treatment Period||48
10557453|NCT01576718|11712276|FG006|NOT COMPLETED|Treatment Period||30
10557454|NCT01576783|11712292|FG000|STARTED|Overall Study||189
10557455|NCT01576783|11712293|FG001|STARTED|Overall Study||188
10557456|NCT01576783|11712292|FG000|COMPLETED|Overall Study||169
10557457|NCT01576783|11712293|FG001|COMPLETED|Overall Study||171
10557458|NCT01576783|11712292|FG000|NOT COMPLETED|Overall Study||20
10557459|NCT01576783|11712293|FG001|NOT COMPLETED|Overall Study||17
10557460|NCT01576809|11712299|FG000|STARTED|Overall Study||51
10557461|NCT01576809|11712299|FG000|COMPLETED|Overall Study||51
10557462|NCT01576809|11712299|FG000|NOT COMPLETED|Overall Study||0
10557463|NCT01576874|11712305|FG000|STARTED|Overall Study||72
10557464|NCT01576874|11712306|FG001|STARTED|Overall Study||72
10557465|NCT01576874|11712305|FG000|COMPLETED|Overall Study||72
10557466|NCT01576874|11712306|FG001|COMPLETED|Overall Study||72
10557467|NCT01576874|11712305|FG000|NOT COMPLETED|Overall Study||0
10557468|NCT01576874|11712306|FG001|NOT COMPLETED|Overall Study||0
10557469|NCT01576939|11712312|FG000|STARTED|Overall Study||30
10557470|NCT01576939|11712312|FG000|COMPLETED|Overall Study||30
10557471|NCT01576939|11712312|FG000|NOT COMPLETED|Overall Study||0
10557472|NCT01576952|11712318|FG000|STARTED|Overall Study||180
10557473|NCT01576952|11712319|FG001|STARTED|Overall Study||88
10557474|NCT01576952|11712318|FG000|Safety Population|Overall Study||169
10557475|NCT01576952|11712319|FG001|Safety Population|Overall Study||85
10557476|NCT01576952|11712318|FG000|mITT Population|Overall Study||168
10557477|NCT01576952|11712319|FG001|mITT Population|Overall Study||85
10557478|NCT01576952|11712318|FG000|COMPLETED|Overall Study||139
10557479|NCT01576952|11712319|FG001|COMPLETED|Overall Study||33
10557480|NCT01576952|11712318|FG000|NOT COMPLETED|Overall Study||41
10557481|NCT01576952|11712319|FG001|NOT COMPLETED|Overall Study||55
10557482|NCT01577108|11712327|FG000|STARTED|Overall Study||54
10557483|NCT01577108|11712328|FG001|STARTED|Overall Study||56
10557484|NCT01577108|11712327|FG000|COMPLETED|Overall Study||49
10557485|NCT01577108|11712328|FG001|COMPLETED|Overall Study||50
10790569|NCT03544307|11951127|FG000|STARTED|Overall Study||10
10790570|NCT03544307|11951128|FG001|STARTED|Overall Study||10
10790571|NCT03544307|11951127|FG000|COMPLETED|Overall Study||10
10790572|NCT03544307|11951128|FG001|COMPLETED|Overall Study||10
10790573|NCT03544307|11951127|FG000|NOT COMPLETED|Overall Study||0
10790574|NCT03544307|11951128|FG001|NOT COMPLETED|Overall Study||0
10790575|NCT03544333|11951136|FG000|STARTED|Overall Study||3
10790576|NCT03544333|11951137|FG001|STARTED|Overall Study||2
10790577|NCT03544333|11951136|FG000|COMPLETED|Overall Study||2
10790578|NCT03544333|11951137|FG001|COMPLETED|Overall Study||2
10790579|NCT03544333|11951136|FG000|NOT COMPLETED|Overall Study||1
10790580|NCT03544333|11951137|FG001|NOT COMPLETED|Overall Study||0
10790581|NCT03544879|11951145|FG000|STARTED|Overall Study||22
10790582|NCT03544879|11951146|FG001|STARTED|Overall Study||24
10790583|NCT03544879|11951145|FG000|Completed Follow-up Physical Assessment|Overall Study||20
10790584|NCT03544879|11951146|FG001|Completed Follow-up Physical Assessment|Overall Study||21
10790585|NCT03544879|11951145|FG000|COMPLETED|Overall Study||22
10790586|NCT03544879|11951146|FG001|COMPLETED|Overall Study||23
10790587|NCT03544879|11951145|FG000|NOT COMPLETED|Overall Study||0
10790588|NCT03544879|11951146|FG001|NOT COMPLETED|Overall Study||1
10790589|NCT03545165|11951154|FG000|STARTED|Overall Study||6
10790590|NCT03545165|11951154|FG000|COMPLETED|Overall Study||6
10790591|NCT03545165|11951154|FG000|NOT COMPLETED|Overall Study||0
10790592|NCT03545412|11951158|FG000|STARTED|Overall Study||25
10790593|NCT03545412|11951158|FG000|COMPLETED|Overall Study||25
10790594|NCT03545412|11951158|FG000|NOT COMPLETED|Overall Study||0
10790595|NCT03545503|11951164|FG000|STARTED|Overall Study||208
10790596|NCT03545503|11951165|FG001|STARTED|Overall Study||220
10790597|NCT03545503|11951164|FG000|COMPLETED|Overall Study||194
10790598|NCT03545503|11951165|FG001|COMPLETED|Overall Study||204
10790599|NCT03545503|11951164|FG000|NOT COMPLETED|Overall Study||14
10790600|NCT03545503|11951165|FG001|NOT COMPLETED|Overall Study||16
10790601|NCT03545893|11951173|FG000|STARTED|Overall Study||35
10790602|NCT03545893|11951174|FG001|STARTED|Overall Study||35
10790603|NCT03545893|11951173|FG000|COMPLETED|Overall Study||35
10790604|NCT03545893|11951174|FG001|COMPLETED|Overall Study||35
10790605|NCT03545893|11951173|FG000|NOT COMPLETED|Overall Study||0
10790606|NCT03545893|11951174|FG001|NOT COMPLETED|Overall Study||0
10790607|NCT03545984|11951182|FG000|STARTED|Overall Study||24
10790608|NCT03545984|11951183|FG001|STARTED|Overall Study||24
10790609|NCT03545984|11951182|FG000|COMPLETED|Overall Study||13
10557486|NCT01577108|11712327|FG000|NOT COMPLETED|Overall Study||5
10557487|NCT01577108|11712328|FG001|NOT COMPLETED|Overall Study||6
10557488|NCT01577160|11712334|FG000|STARTED|Overall Study||353
10557489|NCT01577160|11712334|FG000|COMPLETED|Overall Study||255
10557490|NCT01577160|11712334|FG000|NOT COMPLETED|Overall Study||98
10557491|NCT01577186|11712338|FG000|STARTED|Overall Study||480
10557492|NCT01577186|11712338|FG000|COMPLETED|Overall Study||350
10557493|NCT01577186|11712338|FG000|NOT COMPLETED|Overall Study||130
10557494|NCT01577238|11712344|FG000|STARTED|Overall Study||127
10557495|NCT01577238|11712345|FG001|STARTED|Overall Study||123
10557496|NCT01577238|11712344|FG000|COMPLETED|Overall Study||117
10790610|NCT03545984|11951183|FG001|COMPLETED|Overall Study||15
10790611|NCT03545984|11951182|FG000|NOT COMPLETED|Overall Study||11
10790612|NCT03545984|11951183|FG001|NOT COMPLETED|Overall Study||9
10557497|NCT01577238|11712345|FG001|COMPLETED|Overall Study||111
10557498|NCT01577238|11712344|FG000|NOT COMPLETED|Overall Study||10
10557499|NCT01577238|11712345|FG001|NOT COMPLETED|Overall Study||12
10790613|NCT03546270|11951191|FG000|STARTED|Overall Study||52
10790614|NCT03546270|11951192|FG001|STARTED|Overall Study||48
10790615|NCT03546270|11951191|FG000|COMPLETED|Overall Study||52
10557500|NCT01577329|11712353|FG000|STARTED|Overall Study||19
10557501|NCT01577329|11712354|FG001|STARTED|Overall Study||22
10557502|NCT01577329|11712353|FG000|COMPLETED|Overall Study||16
10557503|NCT01577329|11712354|FG001|COMPLETED|Overall Study||22
10557504|NCT01577329|11712353|FG000|NOT COMPLETED|Overall Study||3
10557505|NCT01577329|11712354|FG001|NOT COMPLETED|Overall Study||0
10557506|NCT01577381|11712364|FG000|STARTED|Overall Study||2
10557507|NCT01577381|11712365|FG001|STARTED|Overall Study||3
10557508|NCT01577381|11712366|FG002|STARTED|Overall Study||3
10557509|NCT01577381|11712367|FG003|STARTED|Overall Study||2
10557510|NCT01577381|11712364|FG000|COMPLETED|Overall Study||0
10557511|NCT01577381|11712365|FG001|COMPLETED|Overall Study||0
10557512|NCT01577381|11712366|FG002|COMPLETED|Overall Study||0
10557513|NCT01577381|11712367|FG003|COMPLETED|Overall Study||0
10557514|NCT01577381|11712364|FG000|NOT COMPLETED|Overall Study||2
10557515|NCT01577381|11712365|FG001|NOT COMPLETED|Overall Study||3
10557516|NCT01577381|11712366|FG002|NOT COMPLETED|Overall Study||3
10557517|NCT01577381|11712367|FG003|NOT COMPLETED|Overall Study||2
10557518|NCT01577537|11712379|FG000|STARTED|Overall Study||128
10557519|NCT01577537|11712380|FG001|STARTED|Overall Study||123
10557520|NCT01577537|11712379|FG000|COMPLETED|Overall Study||120
10557521|NCT01577537|11712380|FG001|COMPLETED|Overall Study||116
10557522|NCT01577537|11712379|FG000|NOT COMPLETED|Overall Study||8
10557523|NCT01577537|11712380|FG001|NOT COMPLETED|Overall Study||7
10557524|NCT01577706|11712386|FG000|STARTED|First Intervention (1 Day)||3
10557525|NCT01577706|11712387|FG001|STARTED|First Intervention (1 Day)||1
10557526|NCT01577706|11712388|FG002|STARTED|First Intervention (1 Day)||3
10557527|NCT01577706|11712386|FG000|COMPLETED|First Intervention (1 Day)||3
10557528|NCT01577706|11712387|FG001|COMPLETED|First Intervention (1 Day)||1
10557529|NCT01577706|11712388|FG002|COMPLETED|First Intervention (1 Day)||3
10557530|NCT01577706|11712386|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10557531|NCT01577706|11712387|FG001|NOT COMPLETED|First Intervention (1 Day)||0
10557532|NCT01577706|11712388|FG002|NOT COMPLETED|First Intervention (1 Day)||0
10557533|NCT01577706|11712386|FG000|STARTED|Washout (at Least 1 Week)||3
10557534|NCT01577706|11712387|FG001|STARTED|Washout (at Least 1 Week)||1
10557535|NCT01577706|11712388|FG002|STARTED|Washout (at Least 1 Week)||3
10557536|NCT01577706|11712386|FG000|COMPLETED|Washout (at Least 1 Week)||3
10557537|NCT01577706|11712387|FG001|COMPLETED|Washout (at Least 1 Week)||1
10557538|NCT01577706|11712388|FG002|COMPLETED|Washout (at Least 1 Week)||3
10557539|NCT01577706|11712386|FG000|NOT COMPLETED|Washout (at Least 1 Week)||0
10557540|NCT01577706|11712387|FG001|NOT COMPLETED|Washout (at Least 1 Week)||0
10557541|NCT01577706|11712388|FG002|NOT COMPLETED|Washout (at Least 1 Week)||0
10557542|NCT01577706|11712386|FG000|STARTED|Second Intervention (1 Day)||3
10557543|NCT01577706|11712387|FG001|STARTED|Second Intervention (1 Day)||1
10557544|NCT01577706|11712388|FG002|STARTED|Second Intervention (1 Day)||3
10557545|NCT01577706|11712386|FG000|COMPLETED|Second Intervention (1 Day)||3
10557546|NCT01577706|11712387|FG001|COMPLETED|Second Intervention (1 Day)||1
10557547|NCT01577706|11712388|FG002|COMPLETED|Second Intervention (1 Day)||3
10557548|NCT01577706|11712386|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10557549|NCT01577706|11712387|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10557550|NCT01577706|11712388|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
10557551|NCT01577706|11712386|FG000|STARTED|Washout (at Least 1 Week)||3
10557552|NCT01577706|11712387|FG001|STARTED|Washout (at Least 1 Week)||1
10557553|NCT01577706|11712388|FG002|STARTED|Washout (at Least 1 Week)||3
10557554|NCT01577706|11712386|FG000|COMPLETED|Washout (at Least 1 Week)||3
10557555|NCT01577706|11712387|FG001|COMPLETED|Washout (at Least 1 Week)||1
10557556|NCT01577706|11712388|FG002|COMPLETED|Washout (at Least 1 Week)||3
10557557|NCT01577706|11712386|FG000|NOT COMPLETED|Washout (at Least 1 Week)||0
10557558|NCT01577706|11712387|FG001|NOT COMPLETED|Washout (at Least 1 Week)||0
10557559|NCT01577706|11712388|FG002|NOT COMPLETED|Washout (at Least 1 Week)||0
10557560|NCT01577706|11712386|FG000|STARTED|Third Intervention (1 Day)||3
10557561|NCT01577706|11712387|FG001|STARTED|Third Intervention (1 Day)||1
10557562|NCT01577706|11712388|FG002|STARTED|Third Intervention (1 Day)||3
10557563|NCT01577706|11712386|FG000|COMPLETED|Third Intervention (1 Day)||3
10557564|NCT01577706|11712387|FG001|COMPLETED|Third Intervention (1 Day)||1
10557565|NCT01577706|11712388|FG002|COMPLETED|Third Intervention (1 Day)||3
10557566|NCT01577706|11712386|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
10557567|NCT01577706|11712387|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
10557568|NCT01577706|11712388|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
10557569|NCT01577732|11712396|FG000|STARTED|Overall Study||300
10557570|NCT01577732|11712396|FG000|COMPLETED|Overall Study||300
10557571|NCT01577732|11712396|FG000|NOT COMPLETED|Overall Study||0
10557572|NCT01577745|11712406|FG000|STARTED|Overall Study||3
10557573|NCT01577745|11712407|FG001|STARTED|Overall Study||3
10557574|NCT01577745|11712408|FG002|STARTED|Overall Study||3
10557575|NCT01577745|11712409|FG003|STARTED|Overall Study||6
10557576|NCT01577745|11712410|FG004|STARTED|Overall Study||5
10557577|NCT01577745|11712411|FG005|STARTED|Overall Study||5
10557578|NCT01577745|11712406|FG000|COMPLETED|Overall Study||0
10557579|NCT01577745|11712407|FG001|COMPLETED|Overall Study||0
10557580|NCT01577745|11712408|FG002|COMPLETED|Overall Study||1
10557581|NCT01577745|11712409|FG003|COMPLETED|Overall Study||0
10557582|NCT01577745|11712410|FG004|COMPLETED|Overall Study||0
10557583|NCT01577745|11712411|FG005|COMPLETED|Overall Study||1
10557584|NCT01577745|11712406|FG000|NOT COMPLETED|Overall Study||3
10557585|NCT01577745|11712407|FG001|NOT COMPLETED|Overall Study||3
10557586|NCT01577745|11712408|FG002|NOT COMPLETED|Overall Study||2
10557587|NCT01577745|11712409|FG003|NOT COMPLETED|Overall Study||6
10557588|NCT01577745|11712410|FG004|NOT COMPLETED|Overall Study||5
10557589|NCT01577745|11712411|FG005|NOT COMPLETED|Overall Study||4
10557590|NCT01577758|11712430|FG000|STARTED|Dose Escalation Phase||2
10557591|NCT01577758|11712431|FG001|STARTED|Dose Escalation Phase||2
10557592|NCT01577758|11712432|FG002|STARTED|Dose Escalation Phase||2
10557593|NCT01577758|11712433|FG003|STARTED|Dose Escalation Phase||2
10557594|NCT01577758|11712434|FG004|STARTED|Dose Escalation Phase||6
10557595|NCT01577758|11712435|FG005|STARTED|Dose Escalation Phase||4
10557596|NCT01577758|11712436|FG006|STARTED|Dose Escalation Phase||1
10557597|NCT01577758|11712437|FG007|STARTED|Dose Escalation Phase||0
10557598|NCT01577758|11712430|FG000|COMPLETED|Dose Escalation Phase||0
10557599|NCT01577758|11712431|FG001|COMPLETED|Dose Escalation Phase||0
10557600|NCT01577758|11712432|FG002|COMPLETED|Dose Escalation Phase||0
10557601|NCT01577758|11712433|FG003|COMPLETED|Dose Escalation Phase||0
10557602|NCT01577758|11712434|FG004|COMPLETED|Dose Escalation Phase||0
10557603|NCT01577758|11712435|FG005|COMPLETED|Dose Escalation Phase||0
10557604|NCT01577758|11712436|FG006|COMPLETED|Dose Escalation Phase||0
10557605|NCT01577758|11712437|FG007|COMPLETED|Dose Escalation Phase||0
10557606|NCT01577758|11712430|FG000|NOT COMPLETED|Dose Escalation Phase||2
10557607|NCT01577758|11712431|FG001|NOT COMPLETED|Dose Escalation Phase||2
10557608|NCT01577758|11712432|FG002|NOT COMPLETED|Dose Escalation Phase||2
10557609|NCT01577758|11712433|FG003|NOT COMPLETED|Dose Escalation Phase||2
10557610|NCT01577758|11712434|FG004|NOT COMPLETED|Dose Escalation Phase||6
10557611|NCT01577758|11712435|FG005|NOT COMPLETED|Dose Escalation Phase||4
10557612|NCT01577758|11712436|FG006|NOT COMPLETED|Dose Escalation Phase||1
10557613|NCT01577758|11712437|FG007|NOT COMPLETED|Dose Escalation Phase||0
10557614|NCT01577758|11712430|FG000|STARTED|mCRC Expansion Phase||0
10557615|NCT01577758|11712431|FG001|STARTED|mCRC Expansion Phase||0
10557616|NCT01577758|11712432|FG002|STARTED|mCRC Expansion Phase||0
10557617|NCT01577758|11712433|FG003|STARTED|mCRC Expansion Phase||0
10557618|NCT01577758|11712434|FG004|STARTED|mCRC Expansion Phase||0
10557619|NCT01577758|11712435|FG005|STARTED|mCRC Expansion Phase||0
10557620|NCT01577758|11712436|FG006|STARTED|mCRC Expansion Phase||0
10557621|NCT01577758|11712437|FG007|STARTED|mCRC Expansion Phase||25
10557622|NCT01577758|11712430|FG000|COMPLETED|mCRC Expansion Phase||0
10557623|NCT01577758|11712431|FG001|COMPLETED|mCRC Expansion Phase||0
10557624|NCT01577758|11712432|FG002|COMPLETED|mCRC Expansion Phase||0
10557625|NCT01577758|11712433|FG003|COMPLETED|mCRC Expansion Phase||0
10557626|NCT01577758|11712434|FG004|COMPLETED|mCRC Expansion Phase||0
10557627|NCT01577758|11712435|FG005|COMPLETED|mCRC Expansion Phase||0
10557628|NCT01577758|11712436|FG006|COMPLETED|mCRC Expansion Phase||0
10557629|NCT01577758|11712437|FG007|COMPLETED|mCRC Expansion Phase||0
10557630|NCT01577758|11712430|FG000|NOT COMPLETED|mCRC Expansion Phase||0
10557631|NCT01577758|11712431|FG001|NOT COMPLETED|mCRC Expansion Phase||0
10557632|NCT01577758|11712432|FG002|NOT COMPLETED|mCRC Expansion Phase||0
10557633|NCT01577758|11712433|FG003|NOT COMPLETED|mCRC Expansion Phase||0
10557634|NCT01577758|11712434|FG004|NOT COMPLETED|mCRC Expansion Phase||0
10557635|NCT01577758|11712435|FG005|NOT COMPLETED|mCRC Expansion Phase||0
10557636|NCT01577758|11712436|FG006|NOT COMPLETED|mCRC Expansion Phase||0
10557637|NCT01577758|11712437|FG007|NOT COMPLETED|mCRC Expansion Phase||25
10557638|NCT01577966|11712457|FG000|STARTED|Overall Study||9
10557639|NCT01577966|11712457|FG000|COMPLETED|Overall Study||9
10557640|NCT01577966|11712457|FG000|NOT COMPLETED|Overall Study||0
10557641|NCT01578031|11712465|FG000|STARTED|Overall Study||129
10557642|NCT01578031|11712466|FG001|STARTED|Overall Study||69
10557643|NCT01578031|11712467|FG002|STARTED|Overall Study||12
10557644|NCT01578031|11712468|FG003|STARTED|Overall Study||30
10557645|NCT01578031|11712465|FG000|COMPLETED|Overall Study|Follow-up obtained only in subjects with average PAP use at least 4 hr/day|67
10557646|NCT01578031|11712466|FG001|COMPLETED|Overall Study|Follow-up obtained only in subjects with average PAP use at least 4 hr/day|35
10557647|NCT01578031|11712467|FG002|COMPLETED|Overall Study|Only baseline data collected|12
10557648|NCT01578031|11712468|FG003|COMPLETED|Overall Study|Only baseline data collected|30
10557649|NCT01578031|11712465|FG000|NOT COMPLETED|Overall Study||62
10557650|NCT01578031|11712466|FG001|NOT COMPLETED|Overall Study||34
10557651|NCT01578031|11712467|FG002|NOT COMPLETED|Overall Study||0
10557652|NCT01578031|11712468|FG003|NOT COMPLETED|Overall Study||0
10557653|NCT01578044|11712478|FG000|STARTED|Overall Study||6
10557654|NCT01578044|11712479|FG001|STARTED|Overall Study||6
10557655|NCT01578044|11712478|FG000|COMPLETED|Overall Study||6
10557656|NCT01578044|11712479|FG001|COMPLETED|Overall Study||6
10557657|NCT01578044|11712478|FG000|NOT COMPLETED|Overall Study||0
10557658|NCT01578044|11712479|FG001|NOT COMPLETED|Overall Study||0
10557659|NCT01578187|11712485|FG000|STARTED|Label Comprehension Phase||63
10557660|NCT01578187|11712485|FG000|COMPLETED|Label Comprehension Phase||63
10557661|NCT01578187|11712485|FG000|NOT COMPLETED|Label Comprehension Phase||0
10557662|NCT01578187|11712485|FG000|STARTED|Usability Phase||48
10557663|NCT01578187|11712485|FG000|COMPLETED|Usability Phase||47
10557664|NCT01578187|11712485|FG000|NOT COMPLETED|Usability Phase||1
10557665|NCT01578278|11712495|FG000|STARTED|Overall Study||152
10557666|NCT01578278|11712496|FG001|STARTED|Overall Study||152
10557667|NCT01578278|11712497|FG002|STARTED|Overall Study||154
10557668|NCT01578278|11712498|FG003|STARTED|Overall Study||148
10557669|NCT01578278|11712495|FG000|COMPLETED|Overall Study||148
10557670|NCT01578278|11712496|FG001|COMPLETED|Overall Study||150
10557671|NCT01578278|11712497|FG002|COMPLETED|Overall Study||150
10557672|NCT01578278|11712498|FG003|COMPLETED|Overall Study||139
10557673|NCT01578278|11712495|FG000|NOT COMPLETED|Overall Study||4
10557674|NCT01578278|11712496|FG001|NOT COMPLETED|Overall Study||2
10557675|NCT01578278|11712497|FG002|NOT COMPLETED|Overall Study||4
10557676|NCT01578278|11712498|FG003|NOT COMPLETED|Overall Study||9
10557677|NCT01578317|11712510|FG000|STARTED|Overall Study||22
10557678|NCT01578317|11712511|FG001|STARTED|Overall Study||21
10557679|NCT01578317|11712510|FG000|Analysis Population|Overall Study||22
10557680|NCT01578317|11712511|FG001|Analysis Population|Overall Study||20
10557681|NCT01578317|11712510|FG000|COMPLETED|Overall Study||22
10557682|NCT01578317|11712511|FG001|COMPLETED|Overall Study||20
10557683|NCT01578317|11712510|FG000|NOT COMPLETED|Overall Study||0
10557684|NCT01578317|11712511|FG001|NOT COMPLETED|Overall Study||1
10557685|NCT01578330|11712517|FG000|STARTED|Overall Study||42
10557686|NCT01578330|11712517|FG000|Per Protocol Population|Overall Study||35
10557687|NCT01578330|11712517|FG000|COMPLETED|Overall Study||35
10557688|NCT01578330|11712517|FG000|NOT COMPLETED|Overall Study||7
10557689|NCT01578486|11712521|FG000|STARTED|Overall Study||13
10557690|NCT01578486|11712521|FG000|COMPLETED|Overall Study||8
10557691|NCT01578486|11712521|FG000|NOT COMPLETED|Overall Study||5
10650789|NCT02171611|11811134|FG005|STARTED|Overall Study||5
10650790|NCT02171611|11811129|FG000|COMPLETED|Overall Study||5
10650791|NCT02171611|11811130|FG001|COMPLETED|Overall Study||5
10650792|NCT02171611|11811131|FG002|COMPLETED|Overall Study||5
10650793|NCT02171611|11811132|FG003|COMPLETED|Overall Study||5
10650794|NCT02171611|11811133|FG004|COMPLETED|Overall Study||5
10650795|NCT02171611|11811134|FG005|COMPLETED|Overall Study||5
10650796|NCT02171611|11811129|FG000|NOT COMPLETED|Overall Study||0
10650797|NCT02171611|11811130|FG001|NOT COMPLETED|Overall Study||0
10650798|NCT02171611|11811131|FG002|NOT COMPLETED|Overall Study||0
10650799|NCT02171611|11811132|FG003|NOT COMPLETED|Overall Study||0
10650800|NCT02171611|11811133|FG004|NOT COMPLETED|Overall Study||0
10650801|NCT02171611|11811134|FG005|NOT COMPLETED|Overall Study||0
10650802|NCT02171819|11811145|FG000|STARTED|Overall Study||31
10650803|NCT02171819|11811146|FG001|STARTED|Overall Study||32
10650804|NCT02171819|11811147|FG002|STARTED|Overall Study||12
10650805|NCT02171819|11811145|FG000|COMPLETED|Overall Study||31
10650806|NCT02171819|11811146|FG001|COMPLETED|Overall Study||32
10650807|NCT02171819|11811147|FG002|COMPLETED|Overall Study||12
10650808|NCT02171819|11811145|FG000|NOT COMPLETED|Overall Study||0
10650809|NCT02171819|11811146|FG001|NOT COMPLETED|Overall Study||0
10650810|NCT02171819|11811147|FG002|NOT COMPLETED|Overall Study||0
10650811|NCT02172040|11811163|FG000|STARTED|Overall Study||49
10650812|NCT02172040|11811164|FG001|STARTED|Overall Study||45
10650813|NCT02172040|11811165|FG002|STARTED|Overall Study||31
10650814|NCT02172040|11811166|FG003|STARTED|Overall Study||27
10650815|NCT02172040|11811163|FG000|COMPLETED|Overall Study||49
10650816|NCT02172040|11811164|FG001|COMPLETED|Overall Study||42
10650817|NCT02172040|11811165|FG002|COMPLETED|Overall Study||29
10650818|NCT02172040|11811166|FG003|COMPLETED|Overall Study||26
10650819|NCT02172040|11811163|FG000|NOT COMPLETED|Overall Study||0
10650820|NCT02172040|11811164|FG001|NOT COMPLETED|Overall Study||3
10650821|NCT02172040|11811165|FG002|NOT COMPLETED|Overall Study||2
10650822|NCT02172040|11811166|FG003|NOT COMPLETED|Overall Study||1
10650823|NCT02172625|11811179|FG000|STARTED|Overall Study||19
10650824|NCT02172625|11811180|FG001|STARTED|Overall Study||19
10650825|NCT02172625|11811179|FG000|COMPLETED|Overall Study||19
10650826|NCT02172625|11811180|FG001|COMPLETED|Overall Study||16
10650827|NCT02172625|11811179|FG000|NOT COMPLETED|Overall Study||0
10650828|NCT02172625|11811180|FG001|NOT COMPLETED|Overall Study||3
10650829|NCT02172664|11811190|FG000|STARTED|Overall Study||33
10650830|NCT02172664|11811191|FG001|STARTED|Overall Study||33
10650831|NCT02172664|11811190|FG000|COMPLETED|Overall Study||27
10650832|NCT02172664|11811191|FG001|COMPLETED|Overall Study||27
10650833|NCT02172664|11811190|FG000|NOT COMPLETED|Overall Study||6
10650834|NCT02172664|11811191|FG001|NOT COMPLETED|Overall Study||6
10650835|NCT02172742|11811198|FG000|STARTED|Overall Study||7
10650836|NCT02172742|11811199|FG001|STARTED|Overall Study||6
10650837|NCT02172742|11811198|FG000|COMPLETED|Overall Study||6
10650838|NCT02172742|11811199|FG001|COMPLETED|Overall Study||6
10650839|NCT02172742|11811198|FG000|NOT COMPLETED|Overall Study||1
10650840|NCT02172742|11811199|FG001|NOT COMPLETED|Overall Study||0
10650841|NCT02172755|11811206|FG000|STARTED|Overall Study||14
10650842|NCT02172755|11811207|FG001|STARTED|Overall Study||16
10650843|NCT02172755|11811206|FG000|COMPLETED|Overall Study||12
10650844|NCT02172755|11811207|FG001|COMPLETED|Overall Study||12
10650845|NCT02172755|11811206|FG000|NOT COMPLETED|Overall Study||2
10650846|NCT02172755|11811207|FG001|NOT COMPLETED|Overall Study||4
10650847|NCT02172820|11811215|FG000|STARTED|Overall Study||65
10650848|NCT02172820|11811216|FG001|STARTED|Overall Study||65
10650849|NCT02172820|11811215|FG000|COMPLETED|Overall Study||65
10650850|NCT02172820|11811216|FG001|COMPLETED|Overall Study||65
10650851|NCT02172820|11811215|FG000|NOT COMPLETED|Overall Study||0
10650852|NCT02172820|11811216|FG001|NOT COMPLETED|Overall Study||0
10650853|NCT02172911|11811224|FG000|STARTED|Overall Study||7
10650854|NCT02172911|11811225|FG001|STARTED|Overall Study||3
10650855|NCT02172911|11811224|FG000|COMPLETED|Overall Study||6
10650856|NCT02172911|11811225|FG001|COMPLETED|Overall Study||1
10650857|NCT02172911|11811224|FG000|NOT COMPLETED|Overall Study||1
10650858|NCT02172911|11811225|FG001|NOT COMPLETED|Overall Study||2
10650859|NCT02172950|11811233|FG000|STARTED|Overall Study||222
10650860|NCT02172950|11811234|FG001|STARTED|Overall Study||24
10650861|NCT02172950|11811233|FG000|COMPLETED|Overall Study||197
10650862|NCT02172950|11811234|FG001|COMPLETED|Overall Study||19
10557692|NCT01578499|11712527|FG000|STARTED|Overall Study||66
10557693|NCT01578499|11712528|FG001|STARTED|Overall Study||65
10557694|NCT01578499|11712527|FG000|Safety Population: Treated|Overall Study||66
10557695|NCT01578499|11712528|FG001|Safety Population: Treated|Overall Study||62
10557696|NCT01578499|11712527|FG000|Intent to Treat Population: CD30+|Overall Study||64
10557697|NCT01578499|11712528|FG001|Intent to Treat Population: CD30+|Overall Study||64
10557698|NCT01578499|11712527|FG000|COMPLETED|Overall Study||32
10557699|NCT01578499|11712528|FG001|COMPLETED|Overall Study||22
10557700|NCT01578499|11712527|FG000|NOT COMPLETED|Overall Study||34
10557701|NCT01578499|11712528|FG001|NOT COMPLETED|Overall Study||43
10557702|NCT01578551|11712540|FG000|STARTED|Overall Study||19
10557703|NCT01578551|11712541|FG001|STARTED|Overall Study||6
10557704|NCT01578551|11712540|FG000|COMPLETED|Overall Study||18
10557705|NCT01578551|11712541|FG001|COMPLETED|Overall Study||6
10557706|NCT01578551|11712540|FG000|NOT COMPLETED|Overall Study||1
10557707|NCT01578551|11712541|FG001|NOT COMPLETED|Overall Study||0
10557708|NCT01578577|11712551|FG000|STARTED|Overall Study||305
10557709|NCT01578577|11712552|FG001|STARTED|Overall Study||302
10557710|NCT01578577|11712553|FG002|STARTED|Overall Study||313
10557711|NCT01578577|11712551|FG000|COMPLETED|Overall Study||254
10557712|NCT01578577|11712552|FG001|COMPLETED|Overall Study||262
10557713|NCT01578577|11712553|FG002|COMPLETED|Overall Study||278
10557714|NCT01578577|11712551|FG000|NOT COMPLETED|Overall Study||51
10557715|NCT01578577|11712552|FG001|NOT COMPLETED|Overall Study||40
10557716|NCT01578577|11712553|FG002|NOT COMPLETED|Overall Study||35
10557717|NCT01578707|11712573|FG000|STARTED|Overall Study||196
10557718|NCT01578707|11712574|FG001|STARTED|Overall Study||195
10557719|NCT01578707|11712573|FG000|COMPLETED|Overall Study||196
10557720|NCT01578707|11712574|FG001|COMPLETED|Overall Study||195
10557721|NCT01578707|11712573|FG000|NOT COMPLETED|Overall Study||0
10557722|NCT01578707|11712574|FG001|NOT COMPLETED|Overall Study||0
10557723|NCT01578772|11712580|FG000|STARTED|Overall Study||17
10557724|NCT01578772|11712580|FG000|COMPLETED|Overall Study||17
10557725|NCT01578772|11712580|FG000|NOT COMPLETED|Overall Study||0
10557726|NCT01578850|11712587|FG000|STARTED|Period 1|491 participants were enrolled in open-label treatment but 2 did not receive study medication.|489
10557727|NCT01578850|11712588|FG001|STARTED|Period 1||0
10557728|NCT01578850|11712589|FG002|STARTED|Period 1||0
10557729|NCT01578850|11712587|FG000|COMPLETED|Period 1||452
10557730|NCT01578850|11712588|FG001|COMPLETED|Period 1||0
10557731|NCT01578850|11712589|FG002|COMPLETED|Period 1||0
10557732|NCT01578850|11712587|FG000|NOT COMPLETED|Period 1||37
10557733|NCT01578850|11712588|FG001|NOT COMPLETED|Period 1||0
10557734|NCT01578850|11712589|FG002|NOT COMPLETED|Period 1||0
10557735|NCT01578850|11712587|FG000|STARTED|Period 2||0
10557736|NCT01578850|11712588|FG001|STARTED|Period 2|Two participants in ETN did not receive treatment.|167
10557737|NCT01578850|11712589|FG002|STARTED|Period 2|One participants in PBO did not receive treatment.|176
10557738|NCT01578850|11712587|FG000|COMPLETED|Period 2||0
10557739|NCT01578850|11712588|FG001|COMPLETED|Period 2||154
10557740|NCT01578850|11712589|FG002|COMPLETED|Period 2||162
10557741|NCT01578850|11712587|FG000|NOT COMPLETED|Period 2||0
10557742|NCT01578850|11712588|FG001|NOT COMPLETED|Period 2||13
10557743|NCT01578850|11712589|FG002|NOT COMPLETED|Period 2||14
10557744|NCT01578902|11712597|FG000|STARTED|Overall Study||84
10557745|NCT01578902|11712597|FG000|COMPLETED|Overall Study||84
10557746|NCT01578902|11712597|FG000|NOT COMPLETED|Overall Study||0
10557747|NCT01578980|11712604|FG000|STARTED|Overall Study||20
10557748|NCT01578980|11712604|FG000|COMPLETED|Overall Study||20
10557749|NCT01578980|11712604|FG000|NOT COMPLETED|Overall Study||0
10557750|NCT01578993|11712608|FG000|STARTED|Overall Study||101
10557751|NCT01578993|11712608|FG000|COMPLETED|Overall Study||101
10557752|NCT01578993|11712608|FG000|NOT COMPLETED|Overall Study||0
10557753|NCT01579006|11712612|FG000|STARTED|Overall Study||184
10557754|NCT01579006|11712612|FG000|COMPLETED|Overall Study||151
10557755|NCT01579006|11712612|FG000|NOT COMPLETED|Overall Study||33
10557756|NCT01579045|11712616|FG000|STARTED|Overall Study||24
10790616|NCT03546270|11951192|FG001|COMPLETED|Overall Study||48
10790617|NCT03546270|11951191|FG000|NOT COMPLETED|Overall Study||0
10790618|NCT03546270|11951192|FG001|NOT COMPLETED|Overall Study||0
10790619|NCT03546491|11951198|FG000|STARTED|Overall Study||32
10790620|NCT03546491|11951198|FG000|Recieved Test Product 1|Overall Study||32
10790621|NCT03546491|11951198|FG000|Received Test Product 2|Overall Study||32
10790622|NCT03546491|11951198|FG000|COMPLETED|Overall Study||30
10790623|NCT03546491|11951198|FG000|NOT COMPLETED|Overall Study||2
10557757|NCT01579045|11712616|FG000|COMPLETED|Overall Study||24
10557758|NCT01579045|11712616|FG000|NOT COMPLETED|Overall Study||0
10557759|NCT01579084|11712638|FG000|STARTED|Overall Study||8
10557760|NCT01579084|11712639|FG001|STARTED|Overall Study||8
10790624|NCT03546621|11951212|FG000|STARTED|Overall Study||28
10790625|NCT03546621|11951213|FG001|STARTED|Overall Study||32
10790626|NCT03546621|11951214|FG002|STARTED|Overall Study||30
10557761|NCT01579084|11712640|FG002|STARTED|Overall Study||8
10557762|NCT01579084|11712641|FG003|STARTED|Overall Study||8
10557763|NCT01579084|11712642|FG004|STARTED|Overall Study||8
10557764|NCT01579084|11712643|FG005|STARTED|Overall Study||8
10557765|NCT01579084|11712644|FG006|STARTED|Overall Study||4
10557766|NCT01579084|11712645|FG007|STARTED|Overall Study||4
10557767|NCT01579084|11712646|FG008|STARTED|Overall Study||4
10557768|NCT01579084|11712647|FG009|STARTED|Overall Study||4
10557769|NCT01579084|11712638|FG000|COMPLETED|Overall Study||8
10557770|NCT01579084|11712639|FG001|COMPLETED|Overall Study||8
10557771|NCT01579084|11712640|FG002|COMPLETED|Overall Study||8
10557772|NCT01579084|11712641|FG003|COMPLETED|Overall Study||8
10557773|NCT01579084|11712642|FG004|COMPLETED|Overall Study||8
10557774|NCT01579084|11712643|FG005|COMPLETED|Overall Study||8
10557775|NCT01579084|11712644|FG006|COMPLETED|Overall Study||4
10557776|NCT01579084|11712645|FG007|COMPLETED|Overall Study||4
10557777|NCT01579084|11712646|FG008|COMPLETED|Overall Study||4
10557778|NCT01579084|11712647|FG009|COMPLETED|Overall Study||4
10557779|NCT01579084|11712638|FG000|NOT COMPLETED|Overall Study||0
10557780|NCT01579084|11712639|FG001|NOT COMPLETED|Overall Study||0
10557781|NCT01579084|11712640|FG002|NOT COMPLETED|Overall Study||0
10557782|NCT01579084|11712641|FG003|NOT COMPLETED|Overall Study||0
10557783|NCT01579084|11712642|FG004|NOT COMPLETED|Overall Study||0
10557784|NCT01579084|11712643|FG005|NOT COMPLETED|Overall Study||0
10557785|NCT01579084|11712644|FG006|NOT COMPLETED|Overall Study||0
10557786|NCT01579084|11712645|FG007|NOT COMPLETED|Overall Study||0
10557787|NCT01579084|11712646|FG008|NOT COMPLETED|Overall Study||0
10557788|NCT01579084|11712647|FG009|NOT COMPLETED|Overall Study||0
10557789|NCT01579162|11712668|FG000|STARTED|Overall Study||16
10557790|NCT01579162|11712669|FG001|STARTED|Overall Study||8
10557791|NCT01579162|11712670|FG002|STARTED|Overall Study||8
10557792|NCT01579162|11712671|FG003|STARTED|Overall Study||8
10557793|NCT01579162|11712672|FG004|STARTED|Overall Study||8
10557794|NCT01579162|11712668|FG000|COMPLETED|Overall Study||16
10557795|NCT01579162|11712669|FG001|COMPLETED|Overall Study||8
10557796|NCT01579162|11712670|FG002|COMPLETED|Overall Study||8
10557797|NCT01579162|11712671|FG003|COMPLETED|Overall Study||8
10557798|NCT01579162|11712672|FG004|COMPLETED|Overall Study||8
10557799|NCT01579162|11712668|FG000|NOT COMPLETED|Overall Study||0
10557800|NCT01579162|11712669|FG001|NOT COMPLETED|Overall Study||0
10557801|NCT01579162|11712670|FG002|NOT COMPLETED|Overall Study||0
10557802|NCT01579162|11712671|FG003|NOT COMPLETED|Overall Study||0
10557803|NCT01579162|11712672|FG004|NOT COMPLETED|Overall Study||0
10557804|NCT01579214|11712687|FG000|STARTED|Overall Study||45
10557805|NCT01579214|11712688|FG001|STARTED|Overall Study||138
10557806|NCT01579214|11712687|FG000|COMPLETED|Overall Study||45
10557807|NCT01579214|11712688|FG001|COMPLETED|Overall Study||138
10557808|NCT01579214|11712687|FG000|NOT COMPLETED|Overall Study||0
10557809|NCT01579214|11712688|FG001|NOT COMPLETED|Overall Study||0
10557810|NCT01579305|11712696|FG000|STARTED|Overall Study|Subjects that signed Informed Consent, passed screening criteria, and were randomized.|139
10557811|NCT01579305|11712697|FG001|STARTED|Overall Study|Subjects that signed Informed Consent, passed screening criteria, and were randomized.|142
10557812|NCT01579305|11712696|FG000|Discontinued Before Treatment|Overall Study||0
10557813|NCT01579305|11712697|FG001|Discontinued Before Treatment|Overall Study||1
10557814|NCT01579305|11712696|FG000|Continued After Treatment|Overall Study||139
10557815|NCT01579305|11712697|FG001|Continued After Treatment|Overall Study||141
10557816|NCT01579305|11712696|FG000|COMPLETED|Overall Study||118
10557817|NCT01579305|11712697|FG001|COMPLETED|Overall Study||115
10557818|NCT01579305|11712696|FG000|NOT COMPLETED|Overall Study||21
10557819|NCT01579305|11712697|FG001|NOT COMPLETED|Overall Study||27
10557820|NCT01579318|11712703|FG000|STARTED|Overall Study||2
10557821|NCT01579318|11712703|FG000|COMPLETED|Overall Study||1
10557822|NCT01579318|11712703|FG000|NOT COMPLETED|Overall Study||1
10557823|NCT01579474|11712713|FG000|STARTED|Overall Study||44
10557824|NCT01579474|11712714|FG001|STARTED|Overall Study||43
10557825|NCT01579474|11712715|FG002|STARTED|Overall Study||29
10557826|NCT01579474|11712716|FG003|STARTED|Overall Study||3
10557827|NCT01579474|11712717|FG004|STARTED|Overall Study||10
10557828|NCT01579474|11712718|FG005|STARTED|Overall Study||2
10557829|NCT01579474|11712713|FG000|COMPLETED|Overall Study||41
10557830|NCT01579474|11712714|FG001|COMPLETED|Overall Study||30
10557831|NCT01579474|11712715|FG002|COMPLETED|Overall Study||27
10557832|NCT01579474|11712716|FG003|COMPLETED|Overall Study||3
10557833|NCT01579474|11712717|FG004|COMPLETED|Overall Study||9
10557834|NCT01579474|11712718|FG005|COMPLETED|Overall Study||1
10557835|NCT01579474|11712713|FG000|NOT COMPLETED|Overall Study||3
10557836|NCT01579474|11712714|FG001|NOT COMPLETED|Overall Study||13
10557837|NCT01579474|11712715|FG002|NOT COMPLETED|Overall Study||2
10557838|NCT01579474|11712716|FG003|NOT COMPLETED|Overall Study||0
10557839|NCT01579474|11712717|FG004|NOT COMPLETED|Overall Study||1
10557840|NCT01579474|11712718|FG005|NOT COMPLETED|Overall Study||1
10557841|NCT01579513|11712733|FG000|STARTED|Primary Hospitalization||91
10557842|NCT01579513|11712734|FG001|STARTED|Primary Hospitalization||99
10557843|NCT01579513|11712733|FG000|COMPLETED|Primary Hospitalization||81
10557844|NCT01579513|11712734|FG001|COMPLETED|Primary Hospitalization||95
10557845|NCT01579513|11712733|FG000|NOT COMPLETED|Primary Hospitalization||10
10557846|NCT01579513|11712734|FG001|NOT COMPLETED|Primary Hospitalization||4
10557847|NCT01579513|11712733|FG000|STARTED|1 Year Neurodevelopmental Follow up||81
10557848|NCT01579513|11712734|FG001|STARTED|1 Year Neurodevelopmental Follow up||95
10557849|NCT01579513|11712733|FG000|COMPLETED|1 Year Neurodevelopmental Follow up||61
10557850|NCT01579513|11712734|FG001|COMPLETED|1 Year Neurodevelopmental Follow up||68
10557851|NCT01579513|11712733|FG000|NOT COMPLETED|1 Year Neurodevelopmental Follow up||20
10557852|NCT01579513|11712734|FG001|NOT COMPLETED|1 Year Neurodevelopmental Follow up||27
10557853|NCT01579565|11712742|FG000|STARTED|Randomized||207
10557854|NCT01579565|11712743|FG001|STARTED|Randomized||209
10557855|NCT01579565|11712742|FG000|COMPLETED|Randomized||202
10557856|NCT01579565|11712743|FG001|COMPLETED|Randomized||204
10557857|NCT01579565|11712742|FG000|NOT COMPLETED|Randomized||5
10557858|NCT01579565|11712743|FG001|NOT COMPLETED|Randomized||5
10557859|NCT01579565|11712742|FG000|STARTED|Treated||202
10557860|NCT01579565|11712743|FG001|STARTED|Treated||204
10557861|NCT01579565|11712742|FG000|COMPLETED|Treated||200
10557862|NCT01579565|11712743|FG001|COMPLETED|Treated||201
10557863|NCT01579565|11712742|FG000|NOT COMPLETED|Treated||2
10557864|NCT01579565|11712743|FG001|NOT COMPLETED|Treated||3
10557865|NCT01579578|11712753|FG000|STARTED|Overall Study||13
10557866|NCT01579578|11712754|FG001|STARTED|Overall Study||12
10557867|NCT01579578|11712753|FG000|Ongoing|Overall Study||3
10557868|NCT01579578|11712754|FG001|Ongoing|Overall Study||0
10557869|NCT01579578|11712753|FG000|COMPLETED|Overall Study||0
10557870|NCT01579578|11712754|FG001|COMPLETED|Overall Study||0
10557871|NCT01579578|11712753|FG000|NOT COMPLETED|Overall Study||13
10557872|NCT01579578|11712754|FG001|NOT COMPLETED|Overall Study||12
10557873|NCT01579669|11712762|FG000|STARTED|Overall Study||170
10557874|NCT01579669|11712763|FG001|STARTED|Overall Study||41
10557875|NCT01579669|11712762|FG000|COMPLETED|Overall Study||134
10557876|NCT01579669|11712763|FG001|COMPLETED|Overall Study||41
10557877|NCT01579669|11712762|FG000|NOT COMPLETED|Overall Study||36
10557878|NCT01579669|11712763|FG001|NOT COMPLETED|Overall Study||0
10557879|NCT01579747|11712771|FG000|STARTED|Overall Study||12
10557880|NCT01579747|11712772|FG001|STARTED|Overall Study||12
10557881|NCT01579747|11712771|FG000|COMPLETED|Overall Study||12
10557882|NCT01579747|11712772|FG001|COMPLETED|Overall Study||12
10557883|NCT01579747|11712771|FG000|NOT COMPLETED|Overall Study||0
10557884|NCT01579747|11712772|FG001|NOT COMPLETED|Overall Study||0
10557885|NCT01579812|11712778|FG000|STARTED|Overall Study||90
10557886|NCT01579812|11712778|FG000|COMPLETED|Overall Study||38
10557887|NCT01579812|11712778|FG000|NOT COMPLETED|Overall Study||52
10557888|NCT01579916|11712787|FG000|STARTED|Overall Study||242
10557889|NCT01579916|11712788|FG001|STARTED|Overall Study||61
10557890|NCT01579916|11712787|FG000|COMPLETED|Overall Study||234
10557891|NCT01579916|11712788|FG001|COMPLETED|Overall Study||59
10557892|NCT01579916|11712787|FG000|NOT COMPLETED|Overall Study||8
10557893|NCT01579916|11712788|FG001|NOT COMPLETED|Overall Study||2
10557894|NCT01580020|11712796|FG000|STARTED|Overall Study||52
10557895|NCT01580020|11712797|FG001|STARTED|Overall Study||40
10557896|NCT01580020|11712798|FG002|STARTED|Overall Study||61
10557897|NCT01580020|11712799|FG003|STARTED|Overall Study||22
10790627|NCT03546621|11951215|FG003|STARTED|Overall Study|2 patients from Tenofovir only group withdrew from the study before treatment.|28
10790628|NCT03546621|11951212|FG000|COMPLETED|Overall Study||28
10557898|NCT01580020|11712796|FG000|COMPLETED|Overall Study||51
10557899|NCT01580020|11712797|FG001|COMPLETED|Overall Study||33
10557900|NCT01580020|11712798|FG002|COMPLETED|Overall Study||57
10557901|NCT01580020|11712799|FG003|COMPLETED|Overall Study||20
10557902|NCT01580020|11712796|FG000|NOT COMPLETED|Overall Study||1
10557903|NCT01580020|11712797|FG001|NOT COMPLETED|Overall Study||7
10557904|NCT01580020|11712798|FG002|NOT COMPLETED|Overall Study||4
10557905|NCT01580020|11712799|FG003|NOT COMPLETED|Overall Study||2
10557906|NCT01580072|11712812|FG000|STARTED|Overall Study||28
10557907|NCT01580072|11712813|FG001|STARTED|Overall Study||37
10557908|NCT01580072|11712814|FG002|STARTED|Overall Study||0
10557909|NCT01580072|11712812|FG000|COMPLETED|Overall Study||16
10557910|NCT01580072|11712813|FG001|COMPLETED|Overall Study||28
10557911|NCT01580072|11712814|FG002|COMPLETED|Overall Study||0
10557912|NCT01580072|11712812|FG000|NOT COMPLETED|Overall Study||12
10557913|NCT01580072|11712813|FG001|NOT COMPLETED|Overall Study||9
10557914|NCT01580072|11712814|FG002|NOT COMPLETED|Overall Study||0
10557915|NCT01580098|11712824|FG000|STARTED|Overall Study||76
10557916|NCT01580098|11712825|FG001|STARTED|Overall Study||114
10557917|NCT01580098|11712826|FG002|STARTED|Overall Study||3
10557918|NCT01580098|11712824|FG000|COMPLETED|Overall Study||61
10557919|NCT01580098|11712825|FG001|COMPLETED|Overall Study||101
10557920|NCT01580098|11712826|FG002|COMPLETED|Overall Study|Due to high age and bad health conditions no patients finished (nursing)|0
10557921|NCT01580098|11712824|FG000|NOT COMPLETED|Overall Study||15
10557922|NCT01580098|11712825|FG001|NOT COMPLETED|Overall Study||13
10557923|NCT01580098|11712826|FG002|NOT COMPLETED|Overall Study||3
10557924|NCT01580293|11712840|FG000|STARTED|Part A_Main Trial||20
10557925|NCT01580293|11712841|FG001|STARTED|Part A_Main Trial||114
10557926|NCT01580293|11712842|FG002|STARTED|Part A_Main Trial|Participants in Part B were not counted for Part A|0
10557927|NCT01580293|11712840|FG000|COMPLETED|Part A_Main Trial||18
10557928|NCT01580293|11712841|FG001|COMPLETED|Part A_Main Trial||108
10557929|NCT01580293|11712842|FG002|COMPLETED|Part A_Main Trial||0
10557930|NCT01580293|11712840|FG000|NOT COMPLETED|Part A_Main Trial||2
10557931|NCT01580293|11712841|FG001|NOT COMPLETED|Part A_Main Trial||6
10557932|NCT01580293|11712842|FG002|NOT COMPLETED|Part A_Main Trial||0
10557933|NCT01580293|11712840|FG000|STARTED|Part A_Extension|Not all participants from main trial entered extension or remained in the same arm.|14
10557934|NCT01580293|11712841|FG001|STARTED|Part A_Extension|Not all participants from main trial entered extension or remained in the same arm.|107
10557935|NCT01580293|11712842|FG002|STARTED|Part A_Extension|Participants in Part B were not counted for part A|0
10557936|NCT01580293|11712840|FG000|COMPLETED|Part A_Extension||14
10557937|NCT01580293|11712841|FG001|COMPLETED|Part A_Extension||95
10557938|NCT01580293|11712842|FG002|COMPLETED|Part A_Extension||0
10557939|NCT01580293|11712840|FG000|NOT COMPLETED|Part A_Extension||0
10557940|NCT01580293|11712841|FG001|NOT COMPLETED|Part A_Extension||12
10557941|NCT01580293|11712842|FG002|NOT COMPLETED|Part A_Extension||0
10557942|NCT01580293|11712840|FG000|STARTED|Part B|Time in Part A for 8 participants coming from Part A was not counted in part B.|0
10557943|NCT01580293|11712841|FG001|STARTED|Part B|Time in Part A for 8 participants coming from Part A was not counted in part B.|0
10557944|NCT01580293|11712842|FG002|STARTED|Part B|11 participants were enrolled in Part B only, 8 participants switched from Part A to Part B.|19
10557945|NCT01580293|11712840|FG000|COMPLETED|Part B||0
10557946|NCT01580293|11712841|FG001|COMPLETED|Part B||0
10557947|NCT01580293|11712842|FG002|COMPLETED|Part B||17
10557948|NCT01580293|11712840|FG000|NOT COMPLETED|Part B||0
10557949|NCT01580293|11712841|FG001|NOT COMPLETED|Part B||0
10557950|NCT01580293|11712842|FG002|NOT COMPLETED|Part B||2
10557951|NCT01580306|11712873|FG000|STARTED|Overall Study||8
10557952|NCT01580306|11712874|FG001|STARTED|Overall Study||8
10557953|NCT01580306|11712875|FG002|STARTED|Overall Study||8
10557954|NCT01580306|11712876|FG003|STARTED|Overall Study||8
10557955|NCT01580306|11712873|FG000|COMPLETED|Overall Study||8
10557956|NCT01580306|11712874|FG001|COMPLETED|Overall Study||8
10557957|NCT01580306|11712875|FG002|COMPLETED|Overall Study||8
10557958|NCT01580306|11712876|FG003|COMPLETED|Overall Study||8
10557959|NCT01580306|11712873|FG000|NOT COMPLETED|Overall Study||0
10557960|NCT01580306|11712874|FG001|NOT COMPLETED|Overall Study||0
10557961|NCT01580306|11712875|FG002|NOT COMPLETED|Overall Study||0
10557962|NCT01580306|11712876|FG003|NOT COMPLETED|Overall Study||0
10557963|NCT01580410|11712888|FG000|STARTED|Overall Study||68
10557964|NCT01580410|11712889|FG001|STARTED|Overall Study||68
10557965|NCT01580410|11712888|FG000|COMPLETED|Overall Study||57
10557966|NCT01580410|11712889|FG001|COMPLETED|Overall Study||60
10557967|NCT01580410|11712888|FG000|NOT COMPLETED|Overall Study||11
10557968|NCT01580410|11712889|FG001|NOT COMPLETED|Overall Study||8
10557969|NCT01580423|11712895|FG000|STARTED|First Intervention||8
10557970|NCT01580423|11712896|FG001|STARTED|First Intervention||8
10557971|NCT01580423|11712895|FG000|COMPLETED|First Intervention||8
10557972|NCT01580423|11712896|FG001|COMPLETED|First Intervention||8
10557973|NCT01580423|11712895|FG000|NOT COMPLETED|First Intervention||0
10557974|NCT01580423|11712896|FG001|NOT COMPLETED|First Intervention||0
10557975|NCT01580423|11712895|FG000|STARTED|Second Intervention||8
10557976|NCT01580423|11712896|FG001|STARTED|Second Intervention||8
10557977|NCT01580423|11712895|FG000|COMPLETED|Second Intervention||8
10557978|NCT01580423|11712896|FG001|COMPLETED|Second Intervention||8
10557979|NCT01580423|11712895|FG000|NOT COMPLETED|Second Intervention||0
10557980|NCT01580423|11712896|FG001|NOT COMPLETED|Second Intervention||0
10557981|NCT01580488|11712903|FG000|STARTED|Overall Study||24
10557982|NCT01580488|11712903|FG000|COMPLETED|Overall Study||23
10557983|NCT01580488|11712903|FG000|NOT COMPLETED|Overall Study||1
10557984|NCT01580592|11712920|FG000|STARTED|Overall Study||10
10557985|NCT01580592|11712921|FG001|STARTED|Overall Study||9
10557986|NCT01580592|11712922|FG002|STARTED|Overall Study||12
10557987|NCT01580592|11712920|FG000|COMPLETED|Overall Study||10
10557988|NCT01580592|11712921|FG001|COMPLETED|Overall Study||9
10557989|NCT01580592|11712922|FG002|COMPLETED|Overall Study||12
10557990|NCT01580592|11712920|FG000|NOT COMPLETED|Overall Study||0
10557991|NCT01580592|11712921|FG001|NOT COMPLETED|Overall Study||0
10557992|NCT01580592|11712922|FG002|NOT COMPLETED|Overall Study||0
10557993|NCT01580618|11712932|FG000|STARTED|Overall Study||8
10557994|NCT01580618|11712933|FG001|STARTED|Overall Study||12
10557995|NCT01580618|11712932|FG000|COMPLETED|Overall Study|One patient was switched from the normal saline to TNKase arm at attending physician request.|7
10557996|NCT01580618|11712933|FG001|COMPLETED|Overall Study||12
10557997|NCT01580618|11712932|FG000|NOT COMPLETED|Overall Study||1
10557998|NCT01580618|11712933|FG001|NOT COMPLETED|Overall Study||0
10557999|NCT01580670|11712939|FG000|STARTED|Induction Period (Week 0 to 14)||14
10558000|NCT01580670|11712939|FG000|COMPLETED|Induction Period (Week 0 to 14)||14
10558001|NCT01580670|11712939|FG000|NOT COMPLETED|Induction Period (Week 0 to 14)||0
10558002|NCT01580670|11712939|FG000|STARTED|Maintenance Period (Week 14 to 54)||14
10558003|NCT01580670|11712939|FG000|COMPLETED|Maintenance Period (Week 14 to 54)||12
10558004|NCT01580670|11712939|FG000|NOT COMPLETED|Maintenance Period (Week 14 to 54)||2
10558005|NCT01580904|11712945|FG000|STARTED|Overall Study||51
10558006|NCT01580904|11712946|FG001|STARTED|Overall Study||49
10558007|NCT01580904|11712945|FG000|COMPLETED|Overall Study||47
10558008|NCT01580904|11712946|FG001|COMPLETED|Overall Study||42
10558009|NCT01580904|11712945|FG000|NOT COMPLETED|Overall Study||4
10558010|NCT01580904|11712946|FG001|NOT COMPLETED|Overall Study||7
10558011|NCT01580969|11712956|FG000|STARTED|Overall Study||6
10558012|NCT01580969|11712957|FG001|STARTED|Overall Study||3
10558013|NCT01580969|11712958|FG002|STARTED|Overall Study||13
10558014|NCT01580969|11712956|FG000|COMPLETED|Overall Study||3
10558015|NCT01580969|11712957|FG001|COMPLETED|Overall Study||3
10558016|NCT01580969|11712958|FG002|COMPLETED|Overall Study||13
10558017|NCT01580969|11712956|FG000|NOT COMPLETED|Overall Study||3
10558018|NCT01580969|11712957|FG001|NOT COMPLETED|Overall Study||0
10558019|NCT01580969|11712958|FG002|NOT COMPLETED|Overall Study||0
10558020|NCT01580995|11712968|FG000|STARTED|Overall Study||10
10558021|NCT01580995|11712969|FG001|STARTED|Overall Study||9
10558022|NCT01580995|11712968|FG000|COMPLETED|Overall Study||8
10558023|NCT01580995|11712969|FG001|COMPLETED|Overall Study||7
10558024|NCT01580995|11712968|FG000|NOT COMPLETED|Overall Study||2
10558025|NCT01580995|11712969|FG001|NOT COMPLETED|Overall Study||2
10558026|NCT01581008|11712977|FG000|STARTED|Overall Study||17
10558027|NCT01581008|11712978|FG001|STARTED|Overall Study||13
10558028|NCT01581008|11712977|FG000|COMPLETED|Overall Study||16
10558029|NCT01581008|11712978|FG001|COMPLETED|Overall Study||7
10558030|NCT01581008|11712977|FG000|NOT COMPLETED|Overall Study||1
10558031|NCT01581008|11712978|FG001|NOT COMPLETED|Overall Study||6
10558032|NCT01581021|11712987|FG000|STARTED|Overall Study||29
10558033|NCT01581021|11712988|FG001|STARTED|Overall Study||29
10558034|NCT01581021|11712987|FG000|COMPLETED|Overall Study||19
10558035|NCT01581021|11712988|FG001|COMPLETED|Overall Study||18
10558036|NCT01581021|11712987|FG000|NOT COMPLETED|Overall Study||10
10558037|NCT01581021|11712988|FG001|NOT COMPLETED|Overall Study||11
10558038|NCT01581281|11712997|FG000|STARTED|Overall Study||145
10558039|NCT01581281|11712998|FG001|STARTED|Overall Study||72
10558040|NCT01581281|11712999|FG002|STARTED|Overall Study||144
10558041|NCT01581281|11712997|FG000|COMPLETED|Overall Study||130
10558042|NCT01581281|11712998|FG001|COMPLETED|Overall Study||66
10558043|NCT01581281|11712999|FG002|COMPLETED|Overall Study||132
10558044|NCT01581281|11712997|FG000|NOT COMPLETED|Overall Study||15
10558045|NCT01581281|11712998|FG001|NOT COMPLETED|Overall Study||6
10558046|NCT01581281|11712999|FG002|NOT COMPLETED|Overall Study||12
10558047|NCT01581307|11713008|FG000|STARTED|Overall Study||9
10558048|NCT01581307|11713008|FG000|COMPLETED|Overall Study||8
10558049|NCT01581307|11713008|FG000|NOT COMPLETED|Overall Study||1
10558050|NCT01581437|11713012|FG000|STARTED|Overall Study||78
10558051|NCT01581437|11713012|FG000|COMPLETED|Overall Study||78
10558052|NCT01581437|11713012|FG000|NOT COMPLETED|Overall Study||0
10558053|NCT01581541|11713020|FG000|STARTED|Overall Study||1
10558054|NCT01581541|11713021|FG001|STARTED|Overall Study||1
10558055|NCT01581541|11713022|FG002|STARTED|Overall Study||1
10790629|NCT03546621|11951213|FG001|COMPLETED|Overall Study||29
10790630|NCT03546621|11951214|FG002|COMPLETED|Overall Study||28
10790631|NCT03546621|11951215|FG003|COMPLETED|Overall Study||25
10790632|NCT03546621|11951212|FG000|NOT COMPLETED|Overall Study||0
10790633|NCT03546621|11951213|FG001|NOT COMPLETED|Overall Study||3
10790634|NCT03546621|11951214|FG002|NOT COMPLETED|Overall Study||2
10790635|NCT03546621|11951215|FG003|NOT COMPLETED|Overall Study||3
10790636|NCT03546647|11951225|FG000|STARTED|Overall Study||18
10790637|NCT03546647|11951226|FG001|STARTED|Overall Study|34|17
10790638|NCT03546647|11951225|FG000|COMPLETED|Overall Study||17
10790639|NCT03546647|11951226|FG001|COMPLETED|Overall Study||17
10790640|NCT03546647|11951225|FG000|NOT COMPLETED|Overall Study||1
10790641|NCT03546647|11951226|FG001|NOT COMPLETED|Overall Study||0
10790642|NCT03546816|11951234|FG000|STARTED|Overall Study||142
10790643|NCT03546816|11951235|FG001|STARTED|Overall Study||143
10790644|NCT03546816|11951234|FG000|COMPLETED|Overall Study||121
10790645|NCT03546816|11951235|FG001|COMPLETED|Overall Study||124
10790646|NCT03546816|11951234|FG000|NOT COMPLETED|Overall Study||21
10790647|NCT03546816|11951235|FG001|NOT COMPLETED|Overall Study||19
10790648|NCT03546842|11951243|FG000|STARTED|Overall Study||201
10790649|NCT03546842|11951243|FG000|Vaccination 1|Overall Study||200
10790650|NCT03546842|11951243|FG000|Vaccination 2|Overall Study||200
10790651|NCT03546842|11951243|FG000|Vaccination 3|Overall Study||198
10790652|NCT03546842|11951243|FG000|COMPLETED|Overall Study||198
10790653|NCT03546842|11951243|FG000|NOT COMPLETED|Overall Study||3
10790654|NCT03547154|11951249|FG000|STARTED|Overall Study||173
10790655|NCT03547154|11951250|FG001|STARTED|Overall Study||171
10790656|NCT03547154|11951249|FG000|COMPLETED|Overall Study||50
10790657|NCT03547154|11951250|FG001|COMPLETED|Overall Study||55
10790658|NCT03547154|11951249|FG000|NOT COMPLETED|Overall Study||123
10790659|NCT03547154|11951250|FG001|NOT COMPLETED|Overall Study||116
10790660|NCT03547167|11951258|FG000|STARTED|Overall Study||1135
10790661|NCT03547167|11951259|FG001|STARTED|Overall Study||380
10790662|NCT03547167|11951258|FG000|Vaccination 1 - (V114 or Prevnar 13™, Day 1)|Overall Study||1133
10790663|NCT03547167|11951259|FG001|Vaccination 1 - (V114 or Prevnar 13™, Day 1)|Overall Study||379
10790664|NCT03547167|11951258|FG000|Vaccination 2 - (PNEUMOVAX™23, Month 6)|Overall Study||1035
10790665|NCT03547167|11951259|FG001|Vaccination 2 - (PNEUMOVAX™23, Month 6)|Overall Study||346
10790666|NCT03547167|11951258|FG000|COMPLETED|Overall Study||1038
10790667|NCT03547167|11951259|FG001|COMPLETED|Overall Study||350
10790668|NCT03547167|11951258|FG000|NOT COMPLETED|Overall Study||97
10790669|NCT03547167|11951259|FG001|NOT COMPLETED|Overall Study||30
10790670|NCT03547531|11951271|FG000|STARTED|Overall Study||62
10790671|NCT03547531|11951272|FG001|STARTED|Overall Study||62
10790672|NCT03547531|11951271|FG000|COMPLETED|Overall Study||60
10790673|NCT03547531|11951272|FG001|COMPLETED|Overall Study||58
10790674|NCT03547531|11951271|FG000|NOT COMPLETED|Overall Study||2
10790675|NCT03547531|11951272|FG001|NOT COMPLETED|Overall Study||4
10790676|NCT03547583|11951281|FG000|STARTED|Overall Study||263
10790677|NCT03547583|11951282|FG001|STARTED|Overall Study||264
10790678|NCT03547583|11951283|FG002|STARTED|Overall Study||262
10790679|NCT03547583|11951281|FG000|Treated|Overall Study||262
10790680|NCT03547583|11951282|FG001|Treated|Overall Study||264
10790681|NCT03547583|11951283|FG002|Treated|Overall Study||262
10790682|NCT03547583|11951281|FG000|COMPLETED|Overall Study||218
10790683|NCT03547583|11951282|FG001|COMPLETED|Overall Study||224
10790684|NCT03547583|11951283|FG002|COMPLETED|Overall Study||230
10790685|NCT03547583|11951281|FG000|NOT COMPLETED|Overall Study||45
10790686|NCT03547583|11951282|FG001|NOT COMPLETED|Overall Study||40
10790687|NCT03547583|11951283|FG002|NOT COMPLETED|Overall Study||32
10790688|NCT03547635|11951297|FG000|STARTED|Overall Study||41
10790689|NCT03547635|11951298|FG001|STARTED|Overall Study||38
10790690|NCT03547635|11951299|FG002|STARTED|Overall Study||37
10790691|NCT03547635|11951297|FG000|COMPLETED|Overall Study||33
10790692|NCT03547635|11951298|FG001|COMPLETED|Overall Study||31
10790693|NCT03547635|11951299|FG002|COMPLETED|Overall Study||29
10790694|NCT03547635|11951297|FG000|NOT COMPLETED|Overall Study||8
10558056|NCT01581541|11713023|FG003|STARTED|Overall Study||1
10558057|NCT01581541|11713024|FG004|STARTED|Overall Study||2
10558058|NCT01581541|11713025|FG005|STARTED|Overall Study||3
10558059|NCT01581541|11713026|FG006|STARTED|Overall Study||1
10558060|NCT01581541|11713027|FG007|STARTED|Overall Study||2
10790695|NCT03547635|11951298|FG001|NOT COMPLETED|Overall Study||7
10558061|NCT01581541|11713028|FG008|STARTED|Overall Study||1
10558062|NCT01581541|11713029|FG009|STARTED|Overall Study||3
10558063|NCT01581541|11713030|FG010|STARTED|Overall Study||1
10558064|NCT01581541|11713020|FG000|COMPLETED|Overall Study||1
10558065|NCT01581541|11713021|FG001|COMPLETED|Overall Study||1
10558066|NCT01581541|11713022|FG002|COMPLETED|Overall Study||1
10558067|NCT01581541|11713023|FG003|COMPLETED|Overall Study||1
10558068|NCT01581541|11713024|FG004|COMPLETED|Overall Study||2
10558069|NCT01581541|11713025|FG005|COMPLETED|Overall Study||3
10558070|NCT01581541|11713026|FG006|COMPLETED|Overall Study||1
10558071|NCT01581541|11713027|FG007|COMPLETED|Overall Study||2
10558072|NCT01581541|11713028|FG008|COMPLETED|Overall Study||1
10558073|NCT01581541|11713029|FG009|COMPLETED|Overall Study||3
10558074|NCT01581541|11713030|FG010|COMPLETED|Overall Study||1
10558075|NCT01581541|11713020|FG000|NOT COMPLETED|Overall Study||0
10558076|NCT01581541|11713021|FG001|NOT COMPLETED|Overall Study||0
10558077|NCT01581541|11713022|FG002|NOT COMPLETED|Overall Study||0
10558078|NCT01581541|11713023|FG003|NOT COMPLETED|Overall Study||0
10558079|NCT01581541|11713024|FG004|NOT COMPLETED|Overall Study||0
10558080|NCT01581541|11713025|FG005|NOT COMPLETED|Overall Study||0
10558081|NCT01581541|11713026|FG006|NOT COMPLETED|Overall Study||0
10558082|NCT01581541|11713027|FG007|NOT COMPLETED|Overall Study||0
10558083|NCT01581541|11713028|FG008|NOT COMPLETED|Overall Study||0
10558084|NCT01581541|11713029|FG009|NOT COMPLETED|Overall Study||0
10558085|NCT01581541|11713030|FG010|NOT COMPLETED|Overall Study||0
10558086|NCT01581593|11713055|FG000|STARTED|Overall Study||45
10558087|NCT01581593|11713055|FG000|COMPLETED|Overall Study||44
10558088|NCT01581593|11713055|FG000|NOT COMPLETED|Overall Study||1
10558089|NCT01581619|11713063|FG000|STARTED|Overall Study||54
10558090|NCT01581619|11713063|FG000|COMPLETED|Overall Study||52
10558091|NCT01581619|11713063|FG000|NOT COMPLETED|Overall Study||2
10558092|NCT01581658|11713073|FG000|STARTED|Overall Study||8
10558093|NCT01581658|11713074|FG001|STARTED|Overall Study||8
10790696|NCT03547635|11951299|FG002|NOT COMPLETED|Overall Study||8
10790697|NCT03547687|11951307|FG000|STARTED|Overall Study||9
10790698|NCT03547687|11951307|FG000|COMPLETED|Overall Study||7
10790699|NCT03547687|11951307|FG000|NOT COMPLETED|Overall Study||2
10790700|NCT03548337|11951313|FG000|STARTED|Infant Series||151
10790701|NCT03548337|11951314|FG001|STARTED|Infant Series||150
10558094|NCT01581658|11713075|FG002|STARTED|Overall Study||8
10558095|NCT01581658|11713076|FG003|STARTED|Overall Study||8
10558096|NCT01581658|11713073|FG000|COMPLETED|Overall Study||8
10558097|NCT01581658|11713074|FG001|COMPLETED|Overall Study||8
10558098|NCT01581658|11713075|FG002|COMPLETED|Overall Study||8
10558099|NCT01581658|11713076|FG003|COMPLETED|Overall Study||8
10558100|NCT01581658|11713073|FG000|NOT COMPLETED|Overall Study||0
10558101|NCT01581658|11713074|FG001|NOT COMPLETED|Overall Study||0
10558102|NCT01581658|11713075|FG002|NOT COMPLETED|Overall Study||0
10558103|NCT01581658|11713076|FG003|NOT COMPLETED|Overall Study||0
10558104|NCT01581684|11713096|FG000|STARTED|Overall Study||14
10558105|NCT01581684|11713097|FG001|STARTED|Overall Study||6
10558106|NCT01581684|11713098|FG002|STARTED|Overall Study||6
10558107|NCT01581684|11713099|FG003|STARTED|Overall Study||6
10558108|NCT01581684|11713100|FG004|STARTED|Overall Study||6
10558109|NCT01581684|11713101|FG005|STARTED|Overall Study||6
10558110|NCT01581684|11713102|FG006|STARTED|Overall Study||6
10558111|NCT01581684|11713103|FG007|STARTED|Overall Study||6
10558112|NCT01581684|11713104|FG008|STARTED|Overall Study||1
10558113|NCT01581684|11713105|FG009|STARTED|Overall Study||5
10558114|NCT01581684|11713096|FG000|COMPLETED|Overall Study||14
10558115|NCT01581684|11713097|FG001|COMPLETED|Overall Study||6
10558116|NCT01581684|11713098|FG002|COMPLETED|Overall Study||6
10558117|NCT01581684|11713099|FG003|COMPLETED|Overall Study||6
10558118|NCT01581684|11713100|FG004|COMPLETED|Overall Study||6
10558119|NCT01581684|11713101|FG005|COMPLETED|Overall Study||6
10558120|NCT01581684|11713102|FG006|COMPLETED|Overall Study||6
10558121|NCT01581684|11713103|FG007|COMPLETED|Overall Study||6
10558122|NCT01581684|11713104|FG008|COMPLETED|Overall Study||0
10558123|NCT01581684|11713105|FG009|COMPLETED|Overall Study||5
10558124|NCT01581684|11713096|FG000|NOT COMPLETED|Overall Study||0
10558125|NCT01581684|11713097|FG001|NOT COMPLETED|Overall Study||0
10558126|NCT01581684|11713098|FG002|NOT COMPLETED|Overall Study||0
10790702|NCT03548337|11951313|FG000|Vaccination 1|Infant Series||150
10558127|NCT01581684|11713099|FG003|NOT COMPLETED|Overall Study||0
10558128|NCT01581684|11713100|FG004|NOT COMPLETED|Overall Study||0
10558129|NCT01581684|11713101|FG005|NOT COMPLETED|Overall Study||0
10558130|NCT01581684|11713102|FG006|NOT COMPLETED|Overall Study||0
10558131|NCT01581684|11713103|FG007|NOT COMPLETED|Overall Study||0
10558132|NCT01581684|11713104|FG008|NOT COMPLETED|Overall Study||1
10558133|NCT01581684|11713105|FG009|NOT COMPLETED|Overall Study||0
10558134|NCT01581710|11713138|FG000|STARTED|First Intervention (14days)||18
10558135|NCT01581710|11713139|FG001|STARTED|First Intervention (14days)||14
10558136|NCT01581710|11713138|FG000|COMPLETED|First Intervention (14days)||18
10558137|NCT01581710|11713139|FG001|COMPLETED|First Intervention (14days)||14
10558138|NCT01581710|11713138|FG000|NOT COMPLETED|First Intervention (14days)||0
10558139|NCT01581710|11713139|FG001|NOT COMPLETED|First Intervention (14days)||0
10558140|NCT01581710|11713138|FG000|STARTED|Washout Period (14days)||18
10558141|NCT01581710|11713139|FG001|STARTED|Washout Period (14days)||14
10558142|NCT01581710|11713138|FG000|COMPLETED|Washout Period (14days)||18
10558143|NCT01581710|11713139|FG001|COMPLETED|Washout Period (14days)||14
10558144|NCT01581710|11713138|FG000|NOT COMPLETED|Washout Period (14days)||0
10558145|NCT01581710|11713139|FG001|NOT COMPLETED|Washout Period (14days)||0
10558146|NCT01581710|11713138|FG000|STARTED|Second Intervention (14days)||18
10558147|NCT01581710|11713139|FG001|STARTED|Second Intervention (14days)||14
10558148|NCT01581710|11713138|FG000|COMPLETED|Second Intervention (14days)||18
10558149|NCT01581710|11713139|FG001|COMPLETED|Second Intervention (14days)||12
10558150|NCT01581710|11713138|FG000|NOT COMPLETED|Second Intervention (14days)||0
10558151|NCT01581710|11713139|FG001|NOT COMPLETED|Second Intervention (14days)||2
10558152|NCT01581931|11713149|FG000|STARTED|First Period||16
10558153|NCT01581931|11713150|FG001|STARTED|First Period||16
10558154|NCT01581931|11713149|FG000|COMPLETED|First Period||16
10558155|NCT01581931|11713150|FG001|COMPLETED|First Period||16
10558156|NCT01581931|11713149|FG000|NOT COMPLETED|First Period||0
10558157|NCT01581931|11713150|FG001|NOT COMPLETED|First Period||0
10558158|NCT01581931|11713149|FG000|STARTED|Washout||16
10558159|NCT01581931|11713150|FG001|STARTED|Washout||16
10558160|NCT01581931|11713149|FG000|COMPLETED|Washout||16
10558161|NCT01581931|11713150|FG001|COMPLETED|Washout||15
10558162|NCT01581931|11713149|FG000|NOT COMPLETED|Washout||0
10558163|NCT01581931|11713150|FG001|NOT COMPLETED|Washout||1
10558164|NCT01581931|11713149|FG000|STARTED|Second Period||16
10558165|NCT01581931|11713150|FG001|STARTED|Second Period||15
10558166|NCT01581931|11713149|FG000|COMPLETED|Second Period||16
10558167|NCT01581931|11713150|FG001|COMPLETED|Second Period||15
10558168|NCT01581931|11713149|FG000|NOT COMPLETED|Second Period||0
10558169|NCT01581931|11713150|FG001|NOT COMPLETED|Second Period||0
10558170|NCT01581970|11713156|FG000|STARTED|Overall Study||7
10558171|NCT01581970|11713156|FG000|COMPLETED|Overall Study||7
10558172|NCT01581970|11713156|FG000|NOT COMPLETED|Overall Study||0
10558176|NCT01582061|11713166|FG000|STARTED|Overall Study||49
10558177|NCT01582061|11713167|FG001|STARTED|Overall Study||55
10558178|NCT01582061|11713166|FG000|COMPLETED|Overall Study||21
10558179|NCT01582061|11713167|FG001|COMPLETED|Overall Study||19
10558180|NCT01582061|11713166|FG000|NOT COMPLETED|Overall Study||28
10558181|NCT01582061|11713167|FG001|NOT COMPLETED|Overall Study||36
10558182|NCT01582139|11713185|FG000|STARTED|Overall Study||6
10558183|NCT01582139|11713186|FG001|STARTED|Overall Study||6
10558184|NCT01582139|11713185|FG000|COMPLETED|Overall Study||6
10558185|NCT01582139|11713186|FG001|COMPLETED|Overall Study||6
10558186|NCT01582139|11713185|FG000|NOT COMPLETED|Overall Study||0
10558187|NCT01582139|11713186|FG001|NOT COMPLETED|Overall Study||0
10558188|NCT01582152|11713194|FG000|STARTED|Overall Study||6
10558189|NCT01582152|11713195|FG001|STARTED|Overall Study||6
10558190|NCT01582152|11713194|FG000|COMPLETED|Overall Study||0
10558191|NCT01582152|11713195|FG001|COMPLETED|Overall Study||0
10558192|NCT01582152|11713194|FG000|NOT COMPLETED|Overall Study||6
10558193|NCT01582152|11713195|FG001|NOT COMPLETED|Overall Study||6
10558194|NCT01582178|11713203|FG000|STARTED|Overall Study||106
10558195|NCT01582178|11713204|FG001|STARTED|Overall Study||106
10558196|NCT01582178|11713203|FG000|COMPLETED|Overall Study||100
10558197|NCT01582178|11713204|FG001|COMPLETED|Overall Study||101
10558198|NCT01582178|11713203|FG000|NOT COMPLETED|Overall Study||6
10558199|NCT01582178|11713204|FG001|NOT COMPLETED|Overall Study||5
10558200|NCT01582243|11713210|FG000|STARTED|Overall Study||40
10558201|NCT01582243|11713210|FG000|COMPLETED|Overall Study||37
10558202|NCT01582243|11713210|FG000|NOT COMPLETED|Overall Study||3
10790703|NCT03548337|11951314|FG001|Vaccination 1|Infant Series||150
10790704|NCT03548337|11951313|FG000|Vaccination 2|Infant Series||144
10790705|NCT03548337|11951314|FG001|Vaccination 2|Infant Series||144
10790706|NCT03548337|11951313|FG000|Vaccination 3|Infant Series||144
10790707|NCT03548337|11951314|FG001|Vaccination 3|Infant Series||141
10790708|NCT03548337|11951313|FG000|COMPLETED|Infant Series||139
10790709|NCT03548337|11951314|FG001|COMPLETED|Infant Series||139
10790710|NCT03548337|11951313|FG000|NOT COMPLETED|Infant Series||12
10790711|NCT03548337|11951314|FG001|NOT COMPLETED|Infant Series||11
10790712|NCT03548337|11951313|FG000|STARTED|Toddler Dose||139
10790713|NCT03548337|11951314|FG001|STARTED|Toddler Dose||139
10790714|NCT03548337|11951313|FG000|Vaccination 4|Toddler Dose||139
10790715|NCT03548337|11951314|FG001|Vaccination 4|Toddler Dose||139
10790716|NCT03548337|11951313|FG000|COMPLETED|Toddler Dose||138
10790717|NCT03548337|11951314|FG001|COMPLETED|Toddler Dose||138
10790718|NCT03548337|11951313|FG000|NOT COMPLETED|Toddler Dose||1
10558203|NCT01582282|11713217|FG000|STARTED|Overall Study||15
10558204|NCT01582282|11713218|FG001|STARTED|Overall Study||14
10558205|NCT01582282|11713219|FG002|STARTED|Overall Study||8
10558206|NCT01582282|11713217|FG000|COMPLETED|Overall Study||13
10558207|NCT01582282|11713218|FG001|COMPLETED|Overall Study||12
10558208|NCT01582282|11713219|FG002|COMPLETED|Overall Study||8
10558209|NCT01582282|11713217|FG000|NOT COMPLETED|Overall Study||2
10558210|NCT01582282|11713218|FG001|NOT COMPLETED|Overall Study||2
10558211|NCT01582282|11713219|FG002|NOT COMPLETED|Overall Study||0
10558212|NCT01582308|11713227|FG000|STARTED|Period 1||2
10558213|NCT01582308|11713228|FG001|STARTED|Period 1||2
10558214|NCT01582308|11713229|FG002|STARTED|Period 1||2
10558215|NCT01582308|11713230|FG003|STARTED|Period 1||2
10558216|NCT01582308|11713231|FG004|STARTED|Period 1|Includes replacement for a participant who discontinued after period 1|3
10558217|NCT01582308|11713232|FG005|STARTED|Period 1||2
10558218|NCT01582308|11713233|FG006|STARTED|Period 1|Includes replacement for a participant who discontinued during period 1|3
10790719|NCT03548337|11951314|FG001|NOT COMPLETED|Toddler Dose||1
10790720|NCT03548935|11951328|FG000|STARTED|Overall Study||1306
10790721|NCT03548935|11951329|FG001|STARTED|Overall Study||655
10558219|NCT01582308|11713234|FG007|STARTED|Period 1||2
10558220|NCT01582308|11713235|FG008|STARTED|Period 1||2
10558221|NCT01582308|11713236|FG009|STARTED|Period 1||2
10558222|NCT01582308|11713227|FG000|COMPLETED|Period 1||2
10558223|NCT01582308|11713228|FG001|COMPLETED|Period 1||2
10558224|NCT01582308|11713229|FG002|COMPLETED|Period 1||2
10558225|NCT01582308|11713230|FG003|COMPLETED|Period 1||2
10558226|NCT01582308|11713231|FG004|COMPLETED|Period 1||3
10558227|NCT01582308|11713232|FG005|COMPLETED|Period 1||2
10558228|NCT01582308|11713233|FG006|COMPLETED|Period 1||2
10558229|NCT01582308|11713234|FG007|COMPLETED|Period 1||2
10558230|NCT01582308|11713235|FG008|COMPLETED|Period 1||2
10558231|NCT01582308|11713236|FG009|COMPLETED|Period 1||2
10558232|NCT01582308|11713227|FG000|NOT COMPLETED|Period 1||0
10558233|NCT01582308|11713228|FG001|NOT COMPLETED|Period 1||0
10558234|NCT01582308|11713229|FG002|NOT COMPLETED|Period 1||0
10558235|NCT01582308|11713230|FG003|NOT COMPLETED|Period 1||0
10558236|NCT01582308|11713231|FG004|NOT COMPLETED|Period 1||0
10558237|NCT01582308|11713232|FG005|NOT COMPLETED|Period 1||0
10558238|NCT01582308|11713233|FG006|NOT COMPLETED|Period 1||1
10558239|NCT01582308|11713234|FG007|NOT COMPLETED|Period 1||0
10558240|NCT01582308|11713235|FG008|NOT COMPLETED|Period 1||0
10558241|NCT01582308|11713236|FG009|NOT COMPLETED|Period 1||0
10558242|NCT01582308|11713227|FG000|STARTED|10-day Washout Following Period 1||2
10558243|NCT01582308|11713228|FG001|STARTED|10-day Washout Following Period 1||2
10558244|NCT01582308|11713229|FG002|STARTED|10-day Washout Following Period 1||2
10558245|NCT01582308|11713230|FG003|STARTED|10-day Washout Following Period 1||2
10558246|NCT01582308|11713231|FG004|STARTED|10-day Washout Following Period 1||3
10558247|NCT01582308|11713232|FG005|STARTED|10-day Washout Following Period 1||2
10558248|NCT01582308|11713233|FG006|STARTED|10-day Washout Following Period 1||2
10558249|NCT01582308|11713234|FG007|STARTED|10-day Washout Following Period 1||2
10558250|NCT01582308|11713235|FG008|STARTED|10-day Washout Following Period 1||2
10558251|NCT01582308|11713236|FG009|STARTED|10-day Washout Following Period 1||2
10558252|NCT01582308|11713227|FG000|COMPLETED|10-day Washout Following Period 1||2
10558253|NCT01582308|11713228|FG001|COMPLETED|10-day Washout Following Period 1||2
10558254|NCT01582308|11713229|FG002|COMPLETED|10-day Washout Following Period 1||2
10558255|NCT01582308|11713230|FG003|COMPLETED|10-day Washout Following Period 1||2
10558256|NCT01582308|11713231|FG004|COMPLETED|10-day Washout Following Period 1||2
10558257|NCT01582308|11713232|FG005|COMPLETED|10-day Washout Following Period 1||2
10558258|NCT01582308|11713233|FG006|COMPLETED|10-day Washout Following Period 1||2
10790722|NCT03548935|11951328|FG000|Full Analysis Set (FAS)|Overall Study||1306
10790723|NCT03548935|11951329|FG001|Full Analysis Set (FAS)|Overall Study||655
10790724|NCT03548935|11951328|FG000|Safety Analysis Set (SAS)|Overall Study||1306
10558259|NCT01582308|11713234|FG007|COMPLETED|10-day Washout Following Period 1||2
10558260|NCT01582308|11713235|FG008|COMPLETED|10-day Washout Following Period 1||2
10558261|NCT01582308|11713236|FG009|COMPLETED|10-day Washout Following Period 1||2
10558262|NCT01582308|11713227|FG000|NOT COMPLETED|10-day Washout Following Period 1||0
10558263|NCT01582308|11713228|FG001|NOT COMPLETED|10-day Washout Following Period 1||0
10558264|NCT01582308|11713229|FG002|NOT COMPLETED|10-day Washout Following Period 1||0
10558265|NCT01582308|11713230|FG003|NOT COMPLETED|10-day Washout Following Period 1||0
10558266|NCT01582308|11713231|FG004|NOT COMPLETED|10-day Washout Following Period 1||1
10558267|NCT01582308|11713232|FG005|NOT COMPLETED|10-day Washout Following Period 1||0
10558268|NCT01582308|11713233|FG006|NOT COMPLETED|10-day Washout Following Period 1||0
10558269|NCT01582308|11713234|FG007|NOT COMPLETED|10-day Washout Following Period 1||0
10558270|NCT01582308|11713235|FG008|NOT COMPLETED|10-day Washout Following Period 1||0
10558271|NCT01582308|11713236|FG009|NOT COMPLETED|10-day Washout Following Period 1||0
10558272|NCT01582308|11713227|FG000|STARTED|Period 2||2
10558273|NCT01582308|11713228|FG001|STARTED|Period 2||2
10558274|NCT01582308|11713229|FG002|STARTED|Period 2||2
10558275|NCT01582308|11713230|FG003|STARTED|Period 2||2
10558276|NCT01582308|11713231|FG004|STARTED|Period 2||2
10558277|NCT01582308|11713232|FG005|STARTED|Period 2||2
10558278|NCT01582308|11713233|FG006|STARTED|Period 2||2
10558279|NCT01582308|11713234|FG007|STARTED|Period 2||2
10558280|NCT01582308|11713235|FG008|STARTED|Period 2||2
10558281|NCT01582308|11713236|FG009|STARTED|Period 2||2
10558282|NCT01582308|11713227|FG000|COMPLETED|Period 2||2
10558283|NCT01582308|11713228|FG001|COMPLETED|Period 2||2
10558284|NCT01582308|11713229|FG002|COMPLETED|Period 2||2
10558285|NCT01582308|11713230|FG003|COMPLETED|Period 2||2
10558286|NCT01582308|11713231|FG004|COMPLETED|Period 2||2
10558287|NCT01582308|11713232|FG005|COMPLETED|Period 2||2
10558288|NCT01582308|11713233|FG006|COMPLETED|Period 2||2
10558289|NCT01582308|11713234|FG007|COMPLETED|Period 2||2
10558290|NCT01582308|11713235|FG008|COMPLETED|Period 2||2
10558291|NCT01582308|11713236|FG009|COMPLETED|Period 2||2
10558292|NCT01582308|11713227|FG000|NOT COMPLETED|Period 2||0
10558293|NCT01582308|11713228|FG001|NOT COMPLETED|Period 2||0
10558294|NCT01582308|11713229|FG002|NOT COMPLETED|Period 2||0
10558295|NCT01582308|11713230|FG003|NOT COMPLETED|Period 2||0
10558296|NCT01582308|11713231|FG004|NOT COMPLETED|Period 2||0
10558297|NCT01582308|11713232|FG005|NOT COMPLETED|Period 2||0
10558298|NCT01582308|11713233|FG006|NOT COMPLETED|Period 2||0
10558299|NCT01582308|11713234|FG007|NOT COMPLETED|Period 2||0
10558300|NCT01582308|11713235|FG008|NOT COMPLETED|Period 2||0
10558301|NCT01582308|11713236|FG009|NOT COMPLETED|Period 2||0
10558302|NCT01582308|11713227|FG000|STARTED|10-day Washout Following Period 2||2
10558303|NCT01582308|11713228|FG001|STARTED|10-day Washout Following Period 2||2
10558304|NCT01582308|11713229|FG002|STARTED|10-day Washout Following Period 2||2
10558305|NCT01582308|11713230|FG003|STARTED|10-day Washout Following Period 2||2
10558306|NCT01582308|11713231|FG004|STARTED|10-day Washout Following Period 2||2
10558307|NCT01582308|11713232|FG005|STARTED|10-day Washout Following Period 2||2
10558308|NCT01582308|11713233|FG006|STARTED|10-day Washout Following Period 2||2
10558309|NCT01582308|11713234|FG007|STARTED|10-day Washout Following Period 2||2
10558310|NCT01582308|11713235|FG008|STARTED|10-day Washout Following Period 2||2
10558311|NCT01582308|11713236|FG009|STARTED|10-day Washout Following Period 2||2
10558312|NCT01582308|11713227|FG000|COMPLETED|10-day Washout Following Period 2||2
10558313|NCT01582308|11713228|FG001|COMPLETED|10-day Washout Following Period 2||2
10558314|NCT01582308|11713229|FG002|COMPLETED|10-day Washout Following Period 2||2
10558315|NCT01582308|11713230|FG003|COMPLETED|10-day Washout Following Period 2||2
10558316|NCT01582308|11713231|FG004|COMPLETED|10-day Washout Following Period 2||2
10558317|NCT01582308|11713232|FG005|COMPLETED|10-day Washout Following Period 2||2
10558318|NCT01582308|11713233|FG006|COMPLETED|10-day Washout Following Period 2||2
10558319|NCT01582308|11713234|FG007|COMPLETED|10-day Washout Following Period 2||2
10558320|NCT01582308|11713235|FG008|COMPLETED|10-day Washout Following Period 2||2
10558321|NCT01582308|11713236|FG009|COMPLETED|10-day Washout Following Period 2||2
10558322|NCT01582308|11713227|FG000|NOT COMPLETED|10-day Washout Following Period 2||0
10558323|NCT01582308|11713228|FG001|NOT COMPLETED|10-day Washout Following Period 2||0
10558324|NCT01582308|11713229|FG002|NOT COMPLETED|10-day Washout Following Period 2||0
10558325|NCT01582308|11713230|FG003|NOT COMPLETED|10-day Washout Following Period 2||0
10558326|NCT01582308|11713231|FG004|NOT COMPLETED|10-day Washout Following Period 2||0
10558327|NCT01582308|11713232|FG005|NOT COMPLETED|10-day Washout Following Period 2||0
10558328|NCT01582308|11713233|FG006|NOT COMPLETED|10-day Washout Following Period 2||0
10558329|NCT01582308|11713234|FG007|NOT COMPLETED|10-day Washout Following Period 2||0
10558330|NCT01582308|11713235|FG008|NOT COMPLETED|10-day Washout Following Period 2||0
10558331|NCT01582308|11713236|FG009|NOT COMPLETED|10-day Washout Following Period 2||0
10558332|NCT01582308|11713227|FG000|STARTED|Period 3||2
10558333|NCT01582308|11713228|FG001|STARTED|Period 3||2
10558334|NCT01582308|11713229|FG002|STARTED|Period 3||2
10558335|NCT01582308|11713230|FG003|STARTED|Period 3||2
10558336|NCT01582308|11713231|FG004|STARTED|Period 3||2
10558337|NCT01582308|11713232|FG005|STARTED|Period 3||2
10558338|NCT01582308|11713233|FG006|STARTED|Period 3||2
10558339|NCT01582308|11713234|FG007|STARTED|Period 3||2
10558340|NCT01582308|11713235|FG008|STARTED|Period 3||2
10558341|NCT01582308|11713236|FG009|STARTED|Period 3||2
10558342|NCT01582308|11713227|FG000|COMPLETED|Period 3||2
10558343|NCT01582308|11713228|FG001|COMPLETED|Period 3||2
10558344|NCT01582308|11713229|FG002|COMPLETED|Period 3||2
10558345|NCT01582308|11713230|FG003|COMPLETED|Period 3||2
10558346|NCT01582308|11713231|FG004|COMPLETED|Period 3||2
10558347|NCT01582308|11713232|FG005|COMPLETED|Period 3||2
10558348|NCT01582308|11713233|FG006|COMPLETED|Period 3||2
10558349|NCT01582308|11713234|FG007|COMPLETED|Period 3||2
10558350|NCT01582308|11713235|FG008|COMPLETED|Period 3||2
10558351|NCT01582308|11713236|FG009|COMPLETED|Period 3||2
10558352|NCT01582308|11713227|FG000|NOT COMPLETED|Period 3||0
10558353|NCT01582308|11713228|FG001|NOT COMPLETED|Period 3||0
10558354|NCT01582308|11713229|FG002|NOT COMPLETED|Period 3||0
10558355|NCT01582308|11713230|FG003|NOT COMPLETED|Period 3||0
10558356|NCT01582308|11713231|FG004|NOT COMPLETED|Period 3||0
10558357|NCT01582308|11713232|FG005|NOT COMPLETED|Period 3||0
10558358|NCT01582308|11713233|FG006|NOT COMPLETED|Period 3||0
10558359|NCT01582308|11713234|FG007|NOT COMPLETED|Period 3||0
10558360|NCT01582308|11713235|FG008|NOT COMPLETED|Period 3||0
10558361|NCT01582308|11713236|FG009|NOT COMPLETED|Period 3||0
10558362|NCT01582308|11713227|FG000|STARTED|10-day Washout Following Period 3||2
10558363|NCT01582308|11713228|FG001|STARTED|10-day Washout Following Period 3||2
10558364|NCT01582308|11713229|FG002|STARTED|10-day Washout Following Period 3||2
10558365|NCT01582308|11713230|FG003|STARTED|10-day Washout Following Period 3||2
10558366|NCT01582308|11713231|FG004|STARTED|10-day Washout Following Period 3||2
10558367|NCT01582308|11713232|FG005|STARTED|10-day Washout Following Period 3||2
10558368|NCT01582308|11713233|FG006|STARTED|10-day Washout Following Period 3||2
10558369|NCT01582308|11713234|FG007|STARTED|10-day Washout Following Period 3||2
10558370|NCT01582308|11713235|FG008|STARTED|10-day Washout Following Period 3||2
10558371|NCT01582308|11713236|FG009|STARTED|10-day Washout Following Period 3||2
10558372|NCT01582308|11713227|FG000|COMPLETED|10-day Washout Following Period 3||2
10558373|NCT01582308|11713228|FG001|COMPLETED|10-day Washout Following Period 3||2
10558374|NCT01582308|11713229|FG002|COMPLETED|10-day Washout Following Period 3||2
10558375|NCT01582308|11713230|FG003|COMPLETED|10-day Washout Following Period 3||2
10558376|NCT01582308|11713231|FG004|COMPLETED|10-day Washout Following Period 3||2
10558377|NCT01582308|11713232|FG005|COMPLETED|10-day Washout Following Period 3||2
10558378|NCT01582308|11713233|FG006|COMPLETED|10-day Washout Following Period 3||2
10558379|NCT01582308|11713234|FG007|COMPLETED|10-day Washout Following Period 3||2
10558380|NCT01582308|11713235|FG008|COMPLETED|10-day Washout Following Period 3||2
10558381|NCT01582308|11713236|FG009|COMPLETED|10-day Washout Following Period 3||2
10558382|NCT01582308|11713227|FG000|NOT COMPLETED|10-day Washout Following Period 3||0
10558383|NCT01582308|11713228|FG001|NOT COMPLETED|10-day Washout Following Period 3||0
10558384|NCT01582308|11713229|FG002|NOT COMPLETED|10-day Washout Following Period 3||0
10558385|NCT01582308|11713230|FG003|NOT COMPLETED|10-day Washout Following Period 3||0
10558386|NCT01582308|11713231|FG004|NOT COMPLETED|10-day Washout Following Period 3||0
10558387|NCT01582308|11713232|FG005|NOT COMPLETED|10-day Washout Following Period 3||0
10558388|NCT01582308|11713233|FG006|NOT COMPLETED|10-day Washout Following Period 3||0
10558389|NCT01582308|11713234|FG007|NOT COMPLETED|10-day Washout Following Period 3||0
10558390|NCT01582308|11713235|FG008|NOT COMPLETED|10-day Washout Following Period 3||0
10558391|NCT01582308|11713236|FG009|NOT COMPLETED|10-day Washout Following Period 3||0
10558392|NCT01582308|11713227|FG000|STARTED|Period 4||2
10558393|NCT01582308|11713228|FG001|STARTED|Period 4||2
10558394|NCT01582308|11713229|FG002|STARTED|Period 4||2
10558395|NCT01582308|11713230|FG003|STARTED|Period 4||2
10558396|NCT01582308|11713231|FG004|STARTED|Period 4||2
10558397|NCT01582308|11713232|FG005|STARTED|Period 4||2
10558398|NCT01582308|11713233|FG006|STARTED|Period 4||2
10558399|NCT01582308|11713234|FG007|STARTED|Period 4||2
10558400|NCT01582308|11713235|FG008|STARTED|Period 4||2
10558401|NCT01582308|11713236|FG009|STARTED|Period 4||2
10558402|NCT01582308|11713227|FG000|COMPLETED|Period 4||1
10558403|NCT01582308|11713228|FG001|COMPLETED|Period 4||2
10558404|NCT01582308|11713229|FG002|COMPLETED|Period 4||2
10558405|NCT01582308|11713230|FG003|COMPLETED|Period 4||2
10558406|NCT01582308|11713231|FG004|COMPLETED|Period 4||2
10558407|NCT01582308|11713232|FG005|COMPLETED|Period 4||1
10558408|NCT01582308|11713233|FG006|COMPLETED|Period 4||2
10558409|NCT01582308|11713234|FG007|COMPLETED|Period 4||2
10558410|NCT01582308|11713235|FG008|COMPLETED|Period 4||2
10558411|NCT01582308|11713236|FG009|COMPLETED|Period 4||1
10558412|NCT01582308|11713227|FG000|NOT COMPLETED|Period 4||1
10558413|NCT01582308|11713228|FG001|NOT COMPLETED|Period 4||0
10558414|NCT01582308|11713229|FG002|NOT COMPLETED|Period 4||0
10558415|NCT01582308|11713230|FG003|NOT COMPLETED|Period 4||0
10558416|NCT01582308|11713231|FG004|NOT COMPLETED|Period 4||0
10558417|NCT01582308|11713232|FG005|NOT COMPLETED|Period 4||1
10558418|NCT01582308|11713233|FG006|NOT COMPLETED|Period 4||0
10558419|NCT01582308|11713234|FG007|NOT COMPLETED|Period 4||0
10558420|NCT01582308|11713235|FG008|NOT COMPLETED|Period 4||0
10558421|NCT01582308|11713236|FG009|NOT COMPLETED|Period 4||1
10558422|NCT01582308|11713227|FG000|STARTED|10-day Washout Following Period 4||1
10558423|NCT01582308|11713228|FG001|STARTED|10-day Washout Following Period 4||2
10558424|NCT01582308|11713229|FG002|STARTED|10-day Washout Following Period 4||2
10558425|NCT01582308|11713230|FG003|STARTED|10-day Washout Following Period 4||2
10558426|NCT01582308|11713231|FG004|STARTED|10-day Washout Following Period 4||2
10558427|NCT01582308|11713232|FG005|STARTED|10-day Washout Following Period 4||1
10558428|NCT01582308|11713233|FG006|STARTED|10-day Washout Following Period 4||2
10558429|NCT01582308|11713234|FG007|STARTED|10-day Washout Following Period 4||2
10558430|NCT01582308|11713235|FG008|STARTED|10-day Washout Following Period 4||2
10790725|NCT03548935|11951329|FG001|Safety Analysis Set (SAS)|Overall Study||655
10790726|NCT03548935|11951328|FG000|COMPLETED|Overall Study||1240
10790727|NCT03548935|11951329|FG001|COMPLETED|Overall Study||609
10790728|NCT03548935|11951328|FG000|NOT COMPLETED|Overall Study||66
10790729|NCT03548935|11951329|FG001|NOT COMPLETED|Overall Study||46
10790730|NCT03549117|11951337|FG000|STARTED|Overall Study||70
10790731|NCT03549117|11951338|FG001|STARTED|Overall Study||70
10790732|NCT03549117|11951337|FG000|COMPLETED|Overall Study||69
10790733|NCT03549117|11951338|FG001|COMPLETED|Overall Study||70
10790734|NCT03549117|11951337|FG000|NOT COMPLETED|Overall Study||1
10790735|NCT03549117|11951338|FG001|NOT COMPLETED|Overall Study||0
10790736|NCT03549130|11951346|FG000|STARTED|Overall Study||64
10790737|NCT03549130|11951347|FG001|STARTED|Overall Study||66
10790738|NCT03549130|11951346|FG000|COMPLETED|Overall Study||64
10790739|NCT03549130|11951347|FG001|COMPLETED|Overall Study||64
10790740|NCT03549130|11951346|FG000|NOT COMPLETED|Overall Study||0
10790741|NCT03549130|11951347|FG001|NOT COMPLETED|Overall Study||2
10790742|NCT03549234|11951357|FG000|STARTED|Overall Study||50
10790743|NCT03549234|11951358|FG001|STARTED|Overall Study||50
10790744|NCT03549234|11951357|FG000|COMPLETED|Overall Study||50
10790745|NCT03549234|11951358|FG001|COMPLETED|Overall Study||50
10790746|NCT03549234|11951357|FG000|NOT COMPLETED|Overall Study||0
10790747|NCT03549234|11951358|FG001|NOT COMPLETED|Overall Study||0
10558431|NCT01582308|11713236|FG009|STARTED|10-day Washout Following Period 4||1
10558432|NCT01582308|11713227|FG000|COMPLETED|10-day Washout Following Period 4||1
10558433|NCT01582308|11713228|FG001|COMPLETED|10-day Washout Following Period 4||2
10558434|NCT01582308|11713229|FG002|COMPLETED|10-day Washout Following Period 4||2
10558435|NCT01582308|11713230|FG003|COMPLETED|10-day Washout Following Period 4||2
10558436|NCT01582308|11713231|FG004|COMPLETED|10-day Washout Following Period 4||2
10558437|NCT01582308|11713232|FG005|COMPLETED|10-day Washout Following Period 4||1
10558438|NCT01582308|11713233|FG006|COMPLETED|10-day Washout Following Period 4||2
10558439|NCT01582308|11713234|FG007|COMPLETED|10-day Washout Following Period 4||2
10558440|NCT01582308|11713235|FG008|COMPLETED|10-day Washout Following Period 4||2
10558441|NCT01582308|11713236|FG009|COMPLETED|10-day Washout Following Period 4||1
10558442|NCT01582308|11713227|FG000|NOT COMPLETED|10-day Washout Following Period 4||0
10558443|NCT01582308|11713228|FG001|NOT COMPLETED|10-day Washout Following Period 4||0
10558444|NCT01582308|11713229|FG002|NOT COMPLETED|10-day Washout Following Period 4||0
10558445|NCT01582308|11713230|FG003|NOT COMPLETED|10-day Washout Following Period 4||0
10558446|NCT01582308|11713231|FG004|NOT COMPLETED|10-day Washout Following Period 4||0
10558447|NCT01582308|11713232|FG005|NOT COMPLETED|10-day Washout Following Period 4||0
10558448|NCT01582308|11713233|FG006|NOT COMPLETED|10-day Washout Following Period 4||0
10558449|NCT01582308|11713234|FG007|NOT COMPLETED|10-day Washout Following Period 4||0
10558450|NCT01582308|11713235|FG008|NOT COMPLETED|10-day Washout Following Period 4||0
10790748|NCT03549338|11951367|FG000|STARTED|Overall Study||1
10790749|NCT03549338|11951368|FG001|STARTED|Overall Study||1
10558451|NCT01582308|11713236|FG009|NOT COMPLETED|10-day Washout Following Period 4||0
10318698|NCT00216125|11452941|FG001|DSMB Cohort for Futility|Pre-Randomization Phase||0
10318699|NCT00216125|11452942|FG002|DSMB Cohort for Futility|Pre-Randomization Phase||0
10318700|NCT00216125|11452940|FG000|COMPLETED|Pre-Randomization Phase||166
10318701|NCT00216125|11452941|FG001|COMPLETED|Pre-Randomization Phase||0
10318702|NCT00216125|11452942|FG002|COMPLETED|Pre-Randomization Phase||0
10318703|NCT00216125|11452940|FG000|NOT COMPLETED|Pre-Randomization Phase||77
10318704|NCT00216125|11452941|FG001|NOT COMPLETED|Pre-Randomization Phase||0
10318705|NCT00216125|11452942|FG002|NOT COMPLETED|Pre-Randomization Phase||0
10318706|NCT00216125|11452940|FG000|STARTED|Randomization Phase||0
10318707|NCT00216125|11452941|FG001|STARTED|Randomization Phase||84
10318708|NCT00216125|11452942|FG002|STARTED|Randomization Phase||82
10318709|NCT00216125|11452940|FG000|DSMB Cohort for Futility|Randomization Phase||0
10318710|NCT00216125|11452941|FG001|DSMB Cohort for Futility|Randomization Phase||73
10318711|NCT00216125|11452942|FG002|DSMB Cohort for Futility|Randomization Phase||74
10318712|NCT00216125|11452940|FG000|COMPLETED|Randomization Phase||0
10318713|NCT00216125|11452941|FG001|COMPLETED|Randomization Phase||73
10318714|NCT00216125|11452942|FG002|COMPLETED|Randomization Phase||74
10318715|NCT00216125|11452940|FG000|NOT COMPLETED|Randomization Phase||0
10558452|NCT01582308|11713227|FG000|STARTED|Period 5||1
10558453|NCT01582308|11713228|FG001|STARTED|Period 5||2
10558454|NCT01582308|11713229|FG002|STARTED|Period 5||2
10558455|NCT01582308|11713230|FG003|STARTED|Period 5||2
10558456|NCT01582308|11713231|FG004|STARTED|Period 5||2
10558457|NCT01582308|11713232|FG005|STARTED|Period 5||1
10558458|NCT01582308|11713233|FG006|STARTED|Period 5||2
10558459|NCT01582308|11713234|FG007|STARTED|Period 5||2
10558460|NCT01582308|11713235|FG008|STARTED|Period 5||2
10558461|NCT01582308|11713236|FG009|STARTED|Period 5||1
10558462|NCT01582308|11713227|FG000|COMPLETED|Period 5||1
10558463|NCT01582308|11713228|FG001|COMPLETED|Period 5||2
10558464|NCT01582308|11713229|FG002|COMPLETED|Period 5||2
10558465|NCT01582308|11713230|FG003|COMPLETED|Period 5||2
10558466|NCT01582308|11713231|FG004|COMPLETED|Period 5||2
10558467|NCT01582308|11713232|FG005|COMPLETED|Period 5||1
10558468|NCT01582308|11713233|FG006|COMPLETED|Period 5||2
10558469|NCT01582308|11713234|FG007|COMPLETED|Period 5||2
10558470|NCT01582308|11713235|FG008|COMPLETED|Period 5||2
10558471|NCT01582308|11713236|FG009|COMPLETED|Period 5||1
10558472|NCT01582308|11713227|FG000|NOT COMPLETED|Period 5||0
10558473|NCT01582308|11713228|FG001|NOT COMPLETED|Period 5||0
10558474|NCT01582308|11713229|FG002|NOT COMPLETED|Period 5||0
10558475|NCT01582308|11713230|FG003|NOT COMPLETED|Period 5||0
10558476|NCT01582308|11713231|FG004|NOT COMPLETED|Period 5||0
10558477|NCT01582308|11713232|FG005|NOT COMPLETED|Period 5||0
10558478|NCT01582308|11713233|FG006|NOT COMPLETED|Period 5||0
10558479|NCT01582308|11713234|FG007|NOT COMPLETED|Period 5||0
10558480|NCT01582308|11713235|FG008|NOT COMPLETED|Period 5||0
10558481|NCT01582308|11713236|FG009|NOT COMPLETED|Period 5||0
10558482|NCT01582451|11713251|FG000|STARTED|Overall Study||307
10558483|NCT01582451|11713252|FG001|STARTED|Overall Study||159
10558484|NCT01582451|11713251|FG000|Received at Least 1 Dose of Study Drug|Overall Study||305
10558485|NCT01582451|11713252|FG001|Received at Least 1 Dose of Study Drug|Overall Study||159
10558486|NCT01582451|11713251|FG000|COMPLETED|Overall Study||275
10558487|NCT01582451|11713252|FG001|COMPLETED|Overall Study||139
10558488|NCT01582451|11713251|FG000|NOT COMPLETED|Overall Study||32
10558489|NCT01582451|11713252|FG001|NOT COMPLETED|Overall Study||20
10558490|NCT01582477|11713260|FG000|STARTED|Overall Study||12
10558491|NCT01582477|11713261|FG001|STARTED|Overall Study||12
10558492|NCT01582477|11713260|FG000|COMPLETED|Overall Study||12
10558493|NCT01582477|11713261|FG001|COMPLETED|Overall Study||12
10558494|NCT01582477|11713260|FG000|NOT COMPLETED|Overall Study||0
10558495|NCT01582477|11713261|FG001|NOT COMPLETED|Overall Study||0
10558496|NCT01582490|11713269|FG000|STARTED|Overall Study||9
10558497|NCT01582490|11713270|FG001|STARTED|Overall Study||10
10558498|NCT01582490|11713269|FG000|COMPLETED|Overall Study||8
10558499|NCT01582490|11713270|FG001|COMPLETED|Overall Study||9
10558500|NCT01582490|11713269|FG000|NOT COMPLETED|Overall Study||1
10558501|NCT01582490|11713270|FG001|NOT COMPLETED|Overall Study||1
10558502|NCT01582789|11713278|FG000|STARTED|First Intervention (14 Days)||34
10558503|NCT01582789|11713279|FG001|STARTED|First Intervention (14 Days)||27
10558504|NCT01582789|11713278|FG000|COMPLETED|First Intervention (14 Days)||34
10558505|NCT01582789|11713279|FG001|COMPLETED|First Intervention (14 Days)||27
10558506|NCT01582789|11713278|FG000|NOT COMPLETED|First Intervention (14 Days)||0
10318716|NCT00216125|11452941|FG001|NOT COMPLETED|Randomization Phase||11
10558507|NCT01582789|11713279|FG001|NOT COMPLETED|First Intervention (14 Days)||0
10558508|NCT01582789|11713278|FG000|STARTED|Second Intervention (14 Days)||34
10558509|NCT01582789|11713279|FG001|STARTED|Second Intervention (14 Days)||27
10558510|NCT01582789|11713278|FG000|COMPLETED|Second Intervention (14 Days)||33
10558511|NCT01582789|11713279|FG001|COMPLETED|Second Intervention (14 Days)||27
10558512|NCT01582789|11713278|FG000|NOT COMPLETED|Second Intervention (14 Days)||1
10558513|NCT01582789|11713279|FG001|NOT COMPLETED|Second Intervention (14 Days)||0
10558514|NCT01582854|11713289|FG000|STARTED|Overall Study||248
10558515|NCT01582854|11713290|FG001|STARTED|Overall Study||255
10558516|NCT01582854|11713289|FG000|COMPLETED|Overall Study||212
10558517|NCT01582854|11713290|FG001|COMPLETED|Overall Study||221
10558518|NCT01582854|11713289|FG000|NOT COMPLETED|Overall Study||36
10558519|NCT01582854|11713290|FG001|NOT COMPLETED|Overall Study||34
10318717|NCT00216125|11452942|FG002|NOT COMPLETED|Randomization Phase||8
10318718|NCT00216203|11452949|FG000|STARTED|Overall Study||36
10558520|NCT01582880|11713296|FG000|STARTED|Overall Study||1
10558521|NCT01582880|11713296|FG000|COMPLETED|Overall Study||1
10558522|NCT01582880|11713296|FG000|NOT COMPLETED|Overall Study||0
10558523|NCT01582945|11713300|FG000|STARTED|Overall Study||14
10558524|NCT01582945|11713300|FG000|COMPLETED|Overall Study||12
10558525|NCT01582945|11713300|FG000|NOT COMPLETED|Overall Study||2
10558526|NCT01582971|11713306|FG000|STARTED|Overall Study||128
10558527|NCT01582971|11713307|FG001|STARTED|Overall Study||128
10558528|NCT01582971|11713306|FG000|COMPLETED|Overall Study||89
10558529|NCT01582971|11713307|FG001|COMPLETED|Overall Study||91
10558530|NCT01582971|11713306|FG000|NOT COMPLETED|Overall Study||39
10558531|NCT01582971|11713307|FG001|NOT COMPLETED|Overall Study||37
10558532|NCT01583101|11713321|FG000|STARTED|Overall Study||1076
10558533|NCT01583101|11713322|FG001|STARTED|Overall Study||1161
10558534|NCT01583101|11713321|FG000|COMPLETED|Overall Study||1076
10558535|NCT01583101|11713322|FG001|COMPLETED|Overall Study||1161
10558536|NCT01583101|11713321|FG000|NOT COMPLETED|Overall Study||0
10558537|NCT01583101|11713322|FG001|NOT COMPLETED|Overall Study||0
10558538|NCT01583166|11713330|FG000|STARTED|Overall Study||45
10558539|NCT01583166|11713331|FG001|STARTED|Overall Study||45
10558540|NCT01583166|11713330|FG000|COMPLETED|Overall Study||41
10558541|NCT01583166|11713331|FG001|COMPLETED|Overall Study||39
10558542|NCT01583166|11713330|FG000|NOT COMPLETED|Overall Study||4
10558543|NCT01583166|11713331|FG001|NOT COMPLETED|Overall Study||6
10558544|NCT01583179|11713339|FG000|STARTED|Overall Study||14
10558545|NCT01583179|11713340|FG001|STARTED|Overall Study||12
10558546|NCT01583179|11713339|FG000|COMPLETED|Overall Study||13
10558547|NCT01583179|11713340|FG001|COMPLETED|Overall Study||10
10558548|NCT01583179|11713339|FG000|NOT COMPLETED|Overall Study||1
10558549|NCT01583179|11713340|FG001|NOT COMPLETED|Overall Study||2
10558550|NCT01583218|11713348|FG000|STARTED|Overall Study||3759
10558551|NCT01583218|11713349|FG001|STARTED|Overall Study||3754
10558552|NCT01583218|11713348|FG000|COMPLETED|Overall Study||3470
10558553|NCT01583218|11713349|FG001|COMPLETED|Overall Study||3471
10558554|NCT01583218|11713348|FG000|NOT COMPLETED|Overall Study||289
10558555|NCT01583218|11713349|FG001|NOT COMPLETED|Overall Study||283
10558556|NCT01583296|11713357|FG000|STARTED|Overall Study||27
10558557|NCT01583296|11713358|FG001|STARTED|Overall Study||26
10558558|NCT01583296|11713357|FG000|COMPLETED|Overall Study||16
10558559|NCT01583296|11713358|FG001|COMPLETED|Overall Study||16
10558560|NCT01583296|11713357|FG000|NOT COMPLETED|Overall Study||11
10558561|NCT01583296|11713358|FG001|NOT COMPLETED|Overall Study||10
10558562|NCT01583374|11713367|FG000|STARTED|Placebo-controlled Phase (Week 0-24)||164
10558563|NCT01583374|11713368|FG001|STARTED|Placebo-controlled Phase (Week 0-24)||163
10558564|NCT01583374|11713369|FG002|STARTED|Placebo-controlled Phase (Week 0-24)||163
10558565|NCT01583374|11713370|FG003|STARTED|Placebo-controlled Phase (Week 0-24)||0
10558566|NCT01583374|11713371|FG004|STARTED|Placebo-controlled Phase (Week 0-24)||0
10558567|NCT01583374|11713372|FG005|STARTED|Placebo-controlled Phase (Week 0-24)||0
10558568|NCT01583374|11713373|FG006|STARTED|Placebo-controlled Phase (Week 0-24)||0
10558569|NCT01583374|11713374|FG007|STARTED|Placebo-controlled Phase (Week 0-24)||0
10558570|NCT01583374|11713375|FG008|STARTED|Placebo-controlled Phase (Week 0-24)||0
10558571|NCT01583374|11713367|FG000|Received Treatment|Placebo-controlled Phase (Week 0-24)||164
10558572|NCT01583374|11713368|FG001|Received Treatment|Placebo-controlled Phase (Week 0-24)||163
10558573|NCT01583374|11713369|FG002|Received Treatment|Placebo-controlled Phase (Week 0-24)||163
10558574|NCT01583374|11713370|FG003|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
10558575|NCT01583374|11713371|FG004|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
10558576|NCT01583374|11713372|FG005|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
10558577|NCT01583374|11713373|FG006|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
10558578|NCT01583374|11713374|FG007|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
10558579|NCT01583374|11713375|FG008|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
10558580|NCT01583374|11713367|FG000|Completed Week 16|Placebo-controlled Phase (Week 0-24)||150
10558581|NCT01583374|11713368|FG001|Completed Week 16|Placebo-controlled Phase (Week 0-24)||151
10558582|NCT01583374|11713369|FG002|Completed Week 16|Placebo-controlled Phase (Week 0-24)||144
10558583|NCT01583374|11713370|FG003|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
10558584|NCT01583374|11713371|FG004|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
10558738|NCT01584232|11713498|FG000|NOT COMPLETED|Overall Study||8
10558585|NCT01583374|11713372|FG005|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
10558586|NCT01583374|11713373|FG006|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
10558587|NCT01583374|11713374|FG007|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
10558588|NCT01583374|11713375|FG008|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
10558589|NCT01583374|11713367|FG000|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|One participant who escaped early did not complete Week 24|51
10558590|NCT01583374|11713368|FG001|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||49
10558591|NCT01583374|11713369|FG002|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|One participant who escaped early did not complete Week 24|49
10558592|NCT01583374|11713370|FG003|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
10558593|NCT01583374|11713371|FG004|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
10558594|NCT01583374|11713372|FG005|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
10558595|NCT01583374|11713373|FG006|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
10558596|NCT01583374|11713374|FG007|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
10558597|NCT01583374|11713375|FG008|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
10650863|NCT02172950|11811233|FG000|NOT COMPLETED|Overall Study||25
10558598|NCT01583374|11713367|FG000|COMPLETED|Placebo-controlled Phase (Week 0-24)|Completed = participants who completed the Placebo-controlled Phase|145
10558599|NCT01583374|11713368|FG001|COMPLETED|Placebo-controlled Phase (Week 0-24)|Completed = participants who completed the Placebo-controlled Phase|147
10558600|NCT01583374|11713369|FG002|COMPLETED|Placebo-controlled Phase (Week 0-24)|Completed = participants who completed the Placebo-controlled Phase|138
10558601|NCT01583374|11713370|FG003|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
10558602|NCT01583374|11713371|FG004|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
10558603|NCT01583374|11713372|FG005|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
10558604|NCT01583374|11713373|FG006|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
10558605|NCT01583374|11713374|FG007|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
10558606|NCT01583374|11713375|FG008|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
10558607|NCT01583374|11713367|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||19
10558608|NCT01583374|11713368|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||16
10558609|NCT01583374|11713369|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||25
10558610|NCT01583374|11713370|FG003|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
10558611|NCT01583374|11713371|FG004|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
10558612|NCT01583374|11713372|FG005|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
10558613|NCT01583374|11713373|FG006|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
10558614|NCT01583374|11713374|FG007|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
10558615|NCT01583374|11713375|FG008|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
10558616|NCT01583374|11713367|FG000|STARTED|Extension Phase (Weeks 24 to 52)||0
10558617|NCT01583374|11713368|FG001|STARTED|Extension Phase (Weeks 24 to 52)||74
10558618|NCT01583374|11713369|FG002|STARTED|Extension Phase (Weeks 24 to 52)||65
10558619|NCT01583374|11713370|FG003|STARTED|Extension Phase (Weeks 24 to 52)||47
10558620|NCT01583374|11713371|FG004|STARTED|Extension Phase (Weeks 24 to 52)||91
10558621|NCT01583374|11713372|FG005|STARTED|Extension Phase (Weeks 24 to 52)||48
10558622|NCT01583374|11713373|FG006|STARTED|Extension Phase (Weeks 24 to 52)||48
10558623|NCT01583374|11713374|FG007|STARTED|Extension Phase (Weeks 24 to 52)||25
10558624|NCT01583374|11713375|FG008|STARTED|Extension Phase (Weeks 24 to 52)||23
10558625|NCT01583374|11713367|FG000|COMPLETED|Extension Phase (Weeks 24 to 52)||0
10558626|NCT01583374|11713368|FG001|COMPLETED|Extension Phase (Weeks 24 to 52)||69
10558627|NCT01583374|11713369|FG002|COMPLETED|Extension Phase (Weeks 24 to 52)||61
10558628|NCT01583374|11713370|FG003|COMPLETED|Extension Phase (Weeks 24 to 52)||41
10558629|NCT01583374|11713371|FG004|COMPLETED|Extension Phase (Weeks 24 to 52)||85
10558630|NCT01583374|11713372|FG005|COMPLETED|Extension Phase (Weeks 24 to 52)||43
10558631|NCT01583374|11713373|FG006|COMPLETED|Extension Phase (Weeks 24 to 52)||43
10558632|NCT01583374|11713374|FG007|COMPLETED|Extension Phase (Weeks 24 to 52)||22
10558633|NCT01583374|11713375|FG008|COMPLETED|Extension Phase (Weeks 24 to 52)||21
10558634|NCT01583374|11713367|FG000|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||0
10558635|NCT01583374|11713368|FG001|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
10558636|NCT01583374|11713369|FG002|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||4
10558637|NCT01583374|11713370|FG003|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||6
10558638|NCT01583374|11713371|FG004|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||6
10558639|NCT01583374|11713372|FG005|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
10558640|NCT01583374|11713373|FG006|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
10558641|NCT01583374|11713374|FG007|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||3
10558642|NCT01583374|11713375|FG008|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||2
10558643|NCT01583374|11713367|FG000|STARTED|Long-Term Extension Phase Weeks 52-260||0
10558644|NCT01583374|11713368|FG001|STARTED|Long-Term Extension Phase Weeks 52-260||66
10558645|NCT01583374|11713369|FG002|STARTED|Long-Term Extension Phase Weeks 52-260||61
10558646|NCT01583374|11713370|FG003|STARTED|Long-Term Extension Phase Weeks 52-260||35
10558647|NCT01583374|11713371|FG004|STARTED|Long-Term Extension Phase Weeks 52-260||81
10558648|NCT01583374|11713372|FG005|STARTED|Long-Term Extension Phase Weeks 52-260||39
10558649|NCT01583374|11713373|FG006|STARTED|Long-Term Extension Phase Weeks 52-260||38
10558650|NCT01583374|11713374|FG007|STARTED|Long-Term Extension Phase Weeks 52-260||21
10558651|NCT01583374|11713375|FG008|STARTED|Long-Term Extension Phase Weeks 52-260||20
10558652|NCT01583374|11713367|FG000|COMPLETED|Long-Term Extension Phase Weeks 52-260||0
10558653|NCT01583374|11713368|FG001|COMPLETED|Long-Term Extension Phase Weeks 52-260||40
10558654|NCT01583374|11713369|FG002|COMPLETED|Long-Term Extension Phase Weeks 52-260||41
10558655|NCT01583374|11713370|FG003|COMPLETED|Long-Term Extension Phase Weeks 52-260||22
10558656|NCT01583374|11713371|FG004|COMPLETED|Long-Term Extension Phase Weeks 52-260||50
10558657|NCT01583374|11713372|FG005|COMPLETED|Long-Term Extension Phase Weeks 52-260||22
10558658|NCT01583374|11713373|FG006|COMPLETED|Long-Term Extension Phase Weeks 52-260||20
10558659|NCT01583374|11713374|FG007|COMPLETED|Long-Term Extension Phase Weeks 52-260||12
10558660|NCT01583374|11713375|FG008|COMPLETED|Long-Term Extension Phase Weeks 52-260||10
10558661|NCT01583374|11713367|FG000|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||0
10558662|NCT01583374|11713368|FG001|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||26
10558663|NCT01583374|11713369|FG002|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||20
10558664|NCT01583374|11713370|FG003|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||13
10558665|NCT01583374|11713371|FG004|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||31
10790750|NCT03549338|11951369|FG002|STARTED|Overall Study||0
10790751|NCT03549338|11951367|FG000|COMPLETED|Overall Study||0
10790752|NCT03549338|11951368|FG001|COMPLETED|Overall Study|Patient crossed-over to Sym004 at the EOC1 per Sponsor decision following trial termination.|0
10790753|NCT03549338|11951369|FG002|COMPLETED|Overall Study||0
10558666|NCT01583374|11713372|FG005|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||17
10558667|NCT01583374|11713373|FG006|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||18
10558668|NCT01583374|11713374|FG007|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||9
10558669|NCT01583374|11713375|FG008|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||10
10558670|NCT01583452|11713396|FG000|STARTED|Overall Study||21
10558671|NCT01583452|11713397|FG001|STARTED|Overall Study||20
10558672|NCT01583452|11713396|FG000|COMPLETED|Overall Study||21
10558673|NCT01583452|11713397|FG001|COMPLETED|Overall Study||20
10558674|NCT01583452|11713396|FG000|NOT COMPLETED|Overall Study||0
10558675|NCT01583452|11713397|FG001|NOT COMPLETED|Overall Study||0
10558676|NCT01583530|11713412|FG000|STARTED|Overall Study||19
10558677|NCT01583530|11713413|FG001|STARTED|Overall Study||20
10558678|NCT01583530|11713414|FG002|STARTED|Overall Study||20
10558679|NCT01583530|11713415|FG003|STARTED|Overall Study||19
10558680|NCT01583530|11713416|FG004|STARTED|Overall Study||20
10558681|NCT01583530|11713417|FG005|STARTED|Overall Study||20
10558682|NCT01583530|11713412|FG000|COMPLETED|Overall Study||19
10558683|NCT01583530|11713413|FG001|COMPLETED|Overall Study||17
10558684|NCT01583530|11713414|FG002|COMPLETED|Overall Study||20
10558685|NCT01583530|11713415|FG003|COMPLETED|Overall Study||18
10558686|NCT01583530|11713416|FG004|COMPLETED|Overall Study||15
10558687|NCT01583530|11713417|FG005|COMPLETED|Overall Study||17
10558688|NCT01583530|11713412|FG000|NOT COMPLETED|Overall Study||0
10558689|NCT01583530|11713413|FG001|NOT COMPLETED|Overall Study||3
10558690|NCT01583530|11713414|FG002|NOT COMPLETED|Overall Study||0
10558691|NCT01583530|11713415|FG003|NOT COMPLETED|Overall Study||1
10558692|NCT01583530|11713416|FG004|NOT COMPLETED|Overall Study||5
10558693|NCT01583530|11713417|FG005|NOT COMPLETED|Overall Study||3
10558694|NCT01583543|11713434|FG000|STARTED|Overall Study||12
10558695|NCT01583543|11713434|FG000|COMPLETED|Overall Study||12
10558696|NCT01583543|11713434|FG000|NOT COMPLETED|Overall Study||0
10558697|NCT01583686|11713446|FG000|STARTED|Overall Study||3
10558698|NCT01583686|11713447|FG001|STARTED|Overall Study||3
10558699|NCT01583686|11713448|FG002|STARTED|Overall Study||3
10558700|NCT01583686|11713449|FG003|STARTED|Overall Study||3
10558701|NCT01583686|11713450|FG004|STARTED|Overall Study||3
10558702|NCT01583686|11713446|FG000|COMPLETED|Overall Study||3
10558703|NCT01583686|11713447|FG001|COMPLETED|Overall Study||3
10558704|NCT01583686|11713448|FG002|COMPLETED|Overall Study||3
10558705|NCT01583686|11713449|FG003|COMPLETED|Overall Study||3
10558706|NCT01583686|11713450|FG004|COMPLETED|Overall Study||3
10558707|NCT01583686|11713446|FG000|NOT COMPLETED|Overall Study||0
10558708|NCT01583686|11713447|FG001|NOT COMPLETED|Overall Study||0
10558709|NCT01583686|11713448|FG002|NOT COMPLETED|Overall Study||0
10558710|NCT01583686|11713449|FG003|NOT COMPLETED|Overall Study||0
10558711|NCT01583686|11713450|FG004|NOT COMPLETED|Overall Study||0
10558712|NCT01583868|11713467|FG000|STARTED|Overall Study||108
10558713|NCT01583868|11713468|FG001|STARTED|Overall Study||108
10558714|NCT01583868|11713467|FG000|COMPLETED|Overall Study||104
10558715|NCT01583868|11713468|FG001|COMPLETED|Overall Study||104
10558716|NCT01583868|11713467|FG000|NOT COMPLETED|Overall Study||4
10558717|NCT01583868|11713468|FG001|NOT COMPLETED|Overall Study||4
10558718|NCT01583894|11713478|FG000|STARTED|Overall Study||828
10558719|NCT01583894|11713478|FG000|COMPLETED|Overall Study||813
10558720|NCT01583894|11713478|FG000|NOT COMPLETED|Overall Study||15
10558721|NCT01583985|11713484|FG000|STARTED|Overall Study||120
10558722|NCT01583985|11713485|FG001|STARTED|Overall Study||120
10558723|NCT01583985|11713484|FG000|Included in Primary Analysis|Overall Study||119
10558724|NCT01583985|11713485|FG001|Included in Primary Analysis|Overall Study||119
10558725|NCT01583985|11713484|FG000|COMPLETED|Overall Study||117
10558726|NCT01583985|11713485|FG001|COMPLETED|Overall Study||117
10558727|NCT01583985|11713484|FG000|NOT COMPLETED|Overall Study||3
10558728|NCT01583985|11713485|FG001|NOT COMPLETED|Overall Study||3
10558729|NCT01584024|11713491|FG000|STARTED|Overall Study||42
10558730|NCT01584024|11713491|FG000|COMPLETED|Overall Study||29
10558731|NCT01584024|11713491|FG000|NOT COMPLETED|Overall Study||13
10558732|NCT01584232|11713498|FG000|STARTED|Overall Study||181
10558733|NCT01584232|11713499|FG001|STARTED|Overall Study||180
10558734|NCT01584232|11713498|FG000|Received at Least 1 Dose of Study Drug|Overall Study||181
10558735|NCT01584232|11713499|FG001|Received at Least 1 Dose of Study Drug|Overall Study||180
10558736|NCT01584232|11713498|FG000|COMPLETED|Overall Study||173
10558737|NCT01584232|11713499|FG001|COMPLETED|Overall Study||177
10558739|NCT01584232|11713499|FG001|NOT COMPLETED|Overall Study||3
10558740|NCT01584388|11713505|FG000|STARTED|Overall Study||30
10558741|NCT01584388|11713505|FG000|COMPLETED|Overall Study||30
10558742|NCT01584388|11713505|FG000|NOT COMPLETED|Overall Study||0
10558743|NCT01584440|11713525|FG000|STARTED|Stage 1 (5 Weeks)||93
10558744|NCT01584440|11713526|FG001|STARTED|Stage 1 (5 Weeks)||127
10558745|NCT01584440|11713527|FG002|STARTED|Stage 1 (5 Weeks)||0
10558746|NCT01584440|11713528|FG003|STARTED|Stage 1 (5 Weeks)||0
10558747|NCT01584440|11713529|FG004|STARTED|Stage 1 (5 Weeks)||0
10558748|NCT01584440|11713525|FG000|COMPLETED|Stage 1 (5 Weeks)||83
10558749|NCT01584440|11713526|FG001|COMPLETED|Stage 1 (5 Weeks)||119
10558750|NCT01584440|11713527|FG002|COMPLETED|Stage 1 (5 Weeks)||0
10558751|NCT01584440|11713528|FG003|COMPLETED|Stage 1 (5 Weeks)||0
10558752|NCT01584440|11713529|FG004|COMPLETED|Stage 1 (5 Weeks)||0
10558753|NCT01584440|11713525|FG000|NOT COMPLETED|Stage 1 (5 Weeks)||10
10558754|NCT01584440|11713526|FG001|NOT COMPLETED|Stage 1 (5 Weeks)||8
10558755|NCT01584440|11713527|FG002|NOT COMPLETED|Stage 1 (5 Weeks)||0
10558756|NCT01584440|11713528|FG003|NOT COMPLETED|Stage 1 (5 Weeks)||0
10558757|NCT01584440|11713529|FG004|NOT COMPLETED|Stage 1 (5 Weeks)||0
10558758|NCT01584440|11713525|FG000|STARTED|Stage 2 (5 Weeks)||0
10558759|NCT01584440|11713526|FG001|STARTED|Stage 2 (5 Weeks)||0
10558760|NCT01584440|11713527|FG002|STARTED|Stage 2 (5 Weeks)||83
10558761|NCT01584440|11713528|FG003|STARTED|Stage 2 (5 Weeks)||59
10558762|NCT01584440|11713529|FG004|STARTED|Stage 2 (5 Weeks)||60
10558763|NCT01584440|11713525|FG000|COMPLETED|Stage 2 (5 Weeks)||0
10558764|NCT01584440|11713526|FG001|COMPLETED|Stage 2 (5 Weeks)||0
10558765|NCT01584440|11713527|FG002|COMPLETED|Stage 2 (5 Weeks)||80
10558766|NCT01584440|11713528|FG003|COMPLETED|Stage 2 (5 Weeks)||55
10558767|NCT01584440|11713529|FG004|COMPLETED|Stage 2 (5 Weeks)||59
10558768|NCT01584440|11713525|FG000|NOT COMPLETED|Stage 2 (5 Weeks)||0
10558769|NCT01584440|11713526|FG001|NOT COMPLETED|Stage 2 (5 Weeks)||0
10558770|NCT01584440|11713527|FG002|NOT COMPLETED|Stage 2 (5 Weeks)||3
10558771|NCT01584440|11713528|FG003|NOT COMPLETED|Stage 2 (5 Weeks)||4
10558772|NCT01584440|11713529|FG004|NOT COMPLETED|Stage 2 (5 Weeks)||1
10558773|NCT01584479|11713546|FG000|STARTED|Overall Study||732
10558774|NCT01584479|11713547|FG001|STARTED|Overall Study||1686
10558775|NCT01584479|11713548|FG002|STARTED|Overall Study||852
10558776|NCT01584479|11713549|FG003|STARTED|Overall Study||1847
10558777|NCT01584479|11713546|FG000|COMPLETED|Overall Study||732
10558778|NCT01584479|11713547|FG001|COMPLETED|Overall Study||1686
10558779|NCT01584479|11713548|FG002|COMPLETED|Overall Study||852
10558780|NCT01584479|11713549|FG003|COMPLETED|Overall Study||1847
10558781|NCT01584479|11713546|FG000|NOT COMPLETED|Overall Study||0
10558782|NCT01584479|11713547|FG001|NOT COMPLETED|Overall Study||0
10558783|NCT01584479|11713548|FG002|NOT COMPLETED|Overall Study||0
10558784|NCT01584479|11713549|FG003|NOT COMPLETED|Overall Study||0
10558785|NCT01584518|11713561|FG000|STARTED|Overall Study||25
10558786|NCT01584518|11713562|FG001|STARTED|Overall Study||25
10558787|NCT01584518|11713561|FG000|COMPLETED|Overall Study||25
10558788|NCT01584518|11713562|FG001|COMPLETED|Overall Study||25
10558789|NCT01584518|11713561|FG000|NOT COMPLETED|Overall Study||0
10558790|NCT01584518|11713562|FG001|NOT COMPLETED|Overall Study||0
10558791|NCT01584544|11713573|FG000|STARTED|Overall Study||3
10558792|NCT01584544|11713574|FG001|STARTED|Overall Study||6
10558793|NCT01584544|11713575|FG002|STARTED|Overall Study||6
10558794|NCT01584544|11713576|FG003|STARTED|Overall Study||3
10558795|NCT01584544|11713577|FG004|STARTED|Overall Study||6
10558796|NCT01584544|11713573|FG000|COMPLETED|Overall Study||3
10558797|NCT01584544|11713574|FG001|COMPLETED|Overall Study||6
10558798|NCT01584544|11713575|FG002|COMPLETED|Overall Study||6
10558799|NCT01584544|11713576|FG003|COMPLETED|Overall Study||3
10558800|NCT01584544|11713577|FG004|COMPLETED|Overall Study||6
10558801|NCT01584544|11713573|FG000|NOT COMPLETED|Overall Study||0
10558802|NCT01584544|11713574|FG001|NOT COMPLETED|Overall Study||0
10558803|NCT01584544|11713575|FG002|NOT COMPLETED|Overall Study||0
10558804|NCT01584544|11713576|FG003|NOT COMPLETED|Overall Study||0
10558805|NCT01584544|11713577|FG004|NOT COMPLETED|Overall Study||0
10558806|NCT01584609|11713591|FG000|STARTED|Overall Study||98
10558807|NCT01584609|11713592|FG001|STARTED|Overall Study||100
10558808|NCT01584609|11713591|FG000|COMPLETED|Overall Study||86
10558809|NCT01584609|11713592|FG001|COMPLETED|Overall Study||96
10558810|NCT01584609|11713591|FG000|NOT COMPLETED|Overall Study||12
10558811|NCT01584609|11713592|FG001|NOT COMPLETED|Overall Study||4
10558812|NCT01584648|11713600|FG000|STARTED|Overall Study||211
10558813|NCT01584648|11713601|FG001|STARTED|Overall Study||212
10558814|NCT01584648|11713600|FG000|Safety Set|Overall Study||209
10558815|NCT01584648|11713601|FG001|Safety Set|Overall Study||211
10558816|NCT01584648|11713600|FG000|Crossover Population|Overall Study||0
10558817|NCT01584648|11713601|FG001|Crossover Population|Overall Study||28
10558818|NCT01584648|11713600|FG000|COMPLETED|Overall Study||0
10558819|NCT01584648|11713601|FG001|COMPLETED|Overall Study||0
10558820|NCT01584648|11713600|FG000|NOT COMPLETED|Overall Study||211
10790754|NCT03549338|11951367|FG000|NOT COMPLETED|Overall Study||1
10790755|NCT03549338|11951368|FG001|NOT COMPLETED|Overall Study||1
10790756|NCT03549338|11951369|FG002|NOT COMPLETED|Overall Study||0
10790757|NCT03549429|11951377|FG000|STARTED|Overall Study||81
10790758|NCT03549429|11951378|FG001|STARTED|Overall Study||78
10790759|NCT03549429|11951377|FG000|COMPLETED|Overall Study||76
10790760|NCT03549429|11951378|FG001|COMPLETED|Overall Study||75
10790761|NCT03549429|11951377|FG000|NOT COMPLETED|Overall Study||5
10790762|NCT03549429|11951378|FG001|NOT COMPLETED|Overall Study||3
10790763|NCT03549598|11951386|FG000|STARTED|Overall Study||15
10790764|NCT03549598|11951386|FG000|COMPLETED|Overall Study||15
10558821|NCT01584648|11713601|FG001|NOT COMPLETED|Overall Study||212
10558822|NCT01584843|11713614|FG000|STARTED|First Treatment Period||3
10558823|NCT01584843|11713615|FG001|STARTED|First Treatment Period||4
10558824|NCT01584843|11713616|FG002|STARTED|First Treatment Period||3
10558825|NCT01584843|11713617|FG003|STARTED|First Treatment Period||10
10558826|NCT01584843|11713618|FG004|STARTED|First Treatment Period||10
10558827|NCT01584843|11713619|FG005|STARTED|First Treatment Period||11
10558828|NCT01584843|11713614|FG000|COMPLETED|First Treatment Period||3
10558829|NCT01584843|11713615|FG001|COMPLETED|First Treatment Period||4
10558830|NCT01584843|11713616|FG002|COMPLETED|First Treatment Period||2
10558831|NCT01584843|11713617|FG003|COMPLETED|First Treatment Period||10
10558832|NCT01584843|11713618|FG004|COMPLETED|First Treatment Period||10
10558833|NCT01584843|11713619|FG005|COMPLETED|First Treatment Period||9
10558834|NCT01584843|11713614|FG000|NOT COMPLETED|First Treatment Period||0
10558835|NCT01584843|11713615|FG001|NOT COMPLETED|First Treatment Period||0
10790765|NCT03549598|11951386|FG000|NOT COMPLETED|Overall Study||0
10790766|NCT03550066|11951394|FG000|STARTED|Overall Study||49
10558836|NCT01584843|11713616|FG002|NOT COMPLETED|First Treatment Period||1
10558837|NCT01584843|11713617|FG003|NOT COMPLETED|First Treatment Period||0
10558838|NCT01584843|11713618|FG004|NOT COMPLETED|First Treatment Period||0
10558839|NCT01584843|11713619|FG005|NOT COMPLETED|First Treatment Period||2
10558840|NCT01584843|11713614|FG000|STARTED|Second Treatment Period||2
10558841|NCT01584843|11713615|FG001|STARTED|Second Treatment Period||1
10558842|NCT01584843|11713616|FG002|STARTED|Second Treatment Period||2
10558843|NCT01584843|11713617|FG003|STARTED|Second Treatment Period||6
10558844|NCT01584843|11713618|FG004|STARTED|Second Treatment Period||3
10558845|NCT01584843|11713619|FG005|STARTED|Second Treatment Period||1
10558846|NCT01584843|11713614|FG000|COMPLETED|Second Treatment Period||2
10558847|NCT01584843|11713615|FG001|COMPLETED|Second Treatment Period||1
10558848|NCT01584843|11713616|FG002|COMPLETED|Second Treatment Period||2
10558849|NCT01584843|11713617|FG003|COMPLETED|Second Treatment Period||6
10558850|NCT01584843|11713618|FG004|COMPLETED|Second Treatment Period||3
10558851|NCT01584843|11713619|FG005|COMPLETED|Second Treatment Period||0
10558852|NCT01584843|11713614|FG000|NOT COMPLETED|Second Treatment Period||0
10558853|NCT01584843|11713615|FG001|NOT COMPLETED|Second Treatment Period||0
10558854|NCT01584843|11713616|FG002|NOT COMPLETED|Second Treatment Period||0
10558855|NCT01584843|11713617|FG003|NOT COMPLETED|Second Treatment Period||0
10558856|NCT01584843|11713618|FG004|NOT COMPLETED|Second Treatment Period||0
10558857|NCT01584843|11713619|FG005|NOT COMPLETED|Second Treatment Period||1
10558858|NCT01585025|11713638|FG000|STARTED|Overall Study||10
10558859|NCT01585025|11713639|FG001|STARTED|Overall Study||13
10558860|NCT01585025|11713640|FG002|STARTED|Overall Study||12
10558861|NCT01585025|11713638|FG000|COMPLETED|Overall Study||10
10558862|NCT01585025|11713639|FG001|COMPLETED|Overall Study||10
10558863|NCT01585025|11713640|FG002|COMPLETED|Overall Study||8
10558864|NCT01585025|11713638|FG000|NOT COMPLETED|Overall Study||0
10558865|NCT01585025|11713639|FG001|NOT COMPLETED|Overall Study||3
10558866|NCT01585025|11713640|FG002|NOT COMPLETED|Overall Study||4
10558867|NCT01585038|11713650|FG000|STARTED|Overall Study||20
10558868|NCT01585038|11713651|FG001|STARTED|Overall Study||20
10558869|NCT01585038|11713650|FG000|COMPLETED|Overall Study||18
10558870|NCT01585038|11713651|FG001|COMPLETED|Overall Study||18
10558871|NCT01585038|11713650|FG000|NOT COMPLETED|Overall Study||2
10558872|NCT01585038|11713651|FG001|NOT COMPLETED|Overall Study||2
10558873|NCT01585129|11713659|FG000|STARTED|Overall Study||41
10558874|NCT01585129|11713660|FG001|STARTED|Overall Study||39
10558875|NCT01585129|11713659|FG000|COMPLETED|Overall Study||41
10558876|NCT01585129|11713660|FG001|COMPLETED|Overall Study||39
10558877|NCT01585129|11713659|FG000|NOT COMPLETED|Overall Study||0
10558878|NCT01585129|11713660|FG001|NOT COMPLETED|Overall Study||0
10558879|NCT01585155|11713666|FG000|STARTED|Overall Study||21
10558880|NCT01585155|11713666|FG000|COMPLETED|Overall Study||16
10558881|NCT01585155|11713666|FG000|NOT COMPLETED|Overall Study||5
10558882|NCT01585168|11713672|FG000|STARTED|Overall Study||18
10558883|NCT01585168|11713673|FG001|STARTED|Overall Study||18
10558884|NCT01585168|11713674|FG002|STARTED|Overall Study||16
10558885|NCT01585168|11713675|FG003|STARTED|Overall Study||19
10558886|NCT01585168|11713672|FG000|COMPLETED|Overall Study||15
10318719|NCT00216203|11452949|FG000|COMPLETED|Overall Study||34
10318720|NCT00216203|11452949|FG000|NOT COMPLETED|Overall Study||2
10318721|NCT00216320|11452957|FG000|STARTED|Phase 1 (Weeks 0 - 6)||43
10318722|NCT00216320|11452958|FG001|STARTED|Phase 1 (Weeks 0 - 6)||39
10318723|NCT00216320|11452959|FG002|STARTED|Phase 1 (Weeks 0 - 6)||30
10318724|NCT00216320|11452957|FG000|COMPLETED|Phase 1 (Weeks 0 - 6)||43
10558887|NCT01585168|11713673|FG001|COMPLETED|Overall Study||17
10558888|NCT01585168|11713674|FG002|COMPLETED|Overall Study||15
10558889|NCT01585168|11713675|FG003|COMPLETED|Overall Study||18
10558890|NCT01585168|11713672|FG000|NOT COMPLETED|Overall Study||3
10558891|NCT01585168|11713673|FG001|NOT COMPLETED|Overall Study||1
10558892|NCT01585168|11713674|FG002|NOT COMPLETED|Overall Study||1
10558893|NCT01585168|11713675|FG003|NOT COMPLETED|Overall Study||1
10558894|NCT01585194|11713683|FG000|STARTED|Overall Study||39
10558895|NCT01585194|11713683|FG000|COMPLETED|Overall Study||35
10558896|NCT01585194|11713683|FG000|NOT COMPLETED|Overall Study||4
10558897|NCT01585207|11713687|FG000|STARTED|Overall Study||4
10558898|NCT01585207|11713687|FG000|COMPLETED|Overall Study||4
10558899|NCT01585207|11713687|FG000|NOT COMPLETED|Overall Study||0
10558900|NCT01585246|11713696|FG000|STARTED|Overall Study||3
10558901|NCT01585246|11713697|FG001|STARTED|Overall Study||4
10558902|NCT01585246|11713698|FG002|STARTED|Overall Study||20
10558903|NCT01585246|11713699|FG003|STARTED|Overall Study||10
10558904|NCT01585246|11713700|FG004|STARTED|Overall Study||11
10558905|NCT01585246|11713696|FG000|COMPLETED|Overall Study||3
10558906|NCT01585246|11713697|FG001|COMPLETED|Overall Study||3
10558907|NCT01585246|11713698|FG002|COMPLETED|Overall Study||16
10558908|NCT01585246|11713699|FG003|COMPLETED|Overall Study||6
10558909|NCT01585246|11713700|FG004|COMPLETED|Overall Study||9
10558910|NCT01585246|11713696|FG000|NOT COMPLETED|Overall Study||0
10558911|NCT01585246|11713697|FG001|NOT COMPLETED|Overall Study||1
10558912|NCT01585246|11713698|FG002|NOT COMPLETED|Overall Study||4
10558913|NCT01585246|11713699|FG003|NOT COMPLETED|Overall Study||4
10558914|NCT01585246|11713700|FG004|NOT COMPLETED|Overall Study||2
10558915|NCT01585272|11713715|FG000|STARTED|Overall Study||121
10558916|NCT01585272|11713715|FG000|Safety Set|Overall Study|Subjects received 3 mg bid Exelon caps for more than 4 weeks & used at least 1 dose of Exelon patch.|102
10558917|NCT01585272|11713715|FG000|Exelon Patch 5 cm2|Overall Study||114
10558918|NCT01585272|11713715|FG000|Exelon Patch 10 cm2|Overall Study||96
10318725|NCT00216320|11452958|FG001|COMPLETED|Phase 1 (Weeks 0 - 6)||35
10558919|NCT01585272|11713715|FG000|COMPLETED|Overall Study||82
10558920|NCT01585272|11713715|FG000|NOT COMPLETED|Overall Study||39
10558921|NCT01585298|11713719|FG000|STARTED|Overall Study||6998
10558922|NCT01585298|11713719|FG000|COMPLETED|Overall Study||6961
10558923|NCT01585298|11713719|FG000|NOT COMPLETED|Overall Study||37
10650864|NCT02172950|11811234|FG001|NOT COMPLETED|Overall Study||5
10650865|NCT02173054|11811244|FG000|STARTED|Overall Study||40
10650866|NCT02173054|11811245|FG001|STARTED|Overall Study||40
10650867|NCT02173054|11811246|FG002|STARTED|Overall Study||40
10650868|NCT02173054|11811244|FG000|COMPLETED|Overall Study||39
10650869|NCT02173054|11811245|FG001|COMPLETED|Overall Study||40
10650870|NCT02173054|11811246|FG002|COMPLETED|Overall Study||39
10650871|NCT02173054|11811244|FG000|NOT COMPLETED|Overall Study||1
10650872|NCT02173054|11811245|FG001|NOT COMPLETED|Overall Study||0
10650873|NCT02173054|11811246|FG002|NOT COMPLETED|Overall Study||1
10650874|NCT02173158|11811254|FG000|STARTED|Efficacy Phase||9
10650875|NCT02173158|11811254|FG000|COMPLETED|Efficacy Phase||8
10650876|NCT02173158|11811254|FG000|NOT COMPLETED|Efficacy Phase||1
10650877|NCT02173158|11811254|FG000|STARTED|Safety Phase||8
10650878|NCT02173158|11811254|FG000|COMPLETED|Safety Phase||8
10650879|NCT02173158|11811254|FG000|NOT COMPLETED|Safety Phase||0
10650880|NCT02173392|11811261|FG000|STARTED|Overall Study||73
10650881|NCT02173392|11811262|FG001|STARTED|Overall Study||72
10650882|NCT02173392|11811261|FG000|COMPLETED|Overall Study||59
10650883|NCT02173392|11811262|FG001|COMPLETED|Overall Study||68
10650884|NCT02173392|11811261|FG000|NOT COMPLETED|Overall Study||14
10650885|NCT02173392|11811262|FG001|NOT COMPLETED|Overall Study||4
10654460|NCT02202980|11815245|FG004|COMPLETED|Overall Study||7
10654461|NCT02202980|11815246|FG005|COMPLETED|Overall Study||14
10654462|NCT02202980|11815247|FG006|COMPLETED|Overall Study||4
10654463|NCT02202980|11815248|FG007|COMPLETED|Overall Study||12
10654464|NCT02202980|11815249|FG008|COMPLETED|Overall Study||14
10654465|NCT02202980|11815250|FG009|COMPLETED|Overall Study||17
10654466|NCT02202980|11815251|FG010|COMPLETED|Overall Study||19
10654467|NCT02202980|11815252|FG011|COMPLETED|Overall Study||25
10654468|NCT02202980|11815253|FG012|COMPLETED|Overall Study||19
10654469|NCT02202980|11815254|FG013|COMPLETED|Overall Study||4
10654470|NCT02202980|11815241|FG000|NOT COMPLETED|Overall Study||1
10654471|NCT02202980|11815242|FG001|NOT COMPLETED|Overall Study||2
10654472|NCT02202980|11815243|FG002|NOT COMPLETED|Overall Study||10
10654473|NCT02202980|11815244|FG003|NOT COMPLETED|Overall Study||4
10654474|NCT02202980|11815245|FG004|NOT COMPLETED|Overall Study||6
10654475|NCT02202980|11815246|FG005|NOT COMPLETED|Overall Study||1
10654476|NCT02202980|11815247|FG006|NOT COMPLETED|Overall Study||11
10654477|NCT02202980|11815248|FG007|NOT COMPLETED|Overall Study||3
10790767|NCT03550066|11951395|FG001|STARTED|Overall Study||41
10790768|NCT03550066|11951394|FG000|COMPLETED|Overall Study||49
10654478|NCT02202980|11815249|FG008|NOT COMPLETED|Overall Study||4
10654479|NCT02202980|11815250|FG009|NOT COMPLETED|Overall Study||0
10654480|NCT02202980|11815251|FG010|NOT COMPLETED|Overall Study||0
10654481|NCT02202980|11815252|FG011|NOT COMPLETED|Overall Study||3
10654482|NCT02202980|11815253|FG012|NOT COMPLETED|Overall Study||11
10654483|NCT02202980|11815254|FG013|NOT COMPLETED|Overall Study||0
10654484|NCT02203019|11815286|FG000|STARTED|Overall Study||19
10654485|NCT02203019|11815287|FG001|STARTED|Overall Study||17
10654486|NCT02203019|11815286|FG000|COMPLETED|Overall Study||19
10654487|NCT02203019|11815287|FG001|COMPLETED|Overall Study||17
10654488|NCT02203019|11815286|FG000|NOT COMPLETED|Overall Study||0
10654489|NCT02203019|11815287|FG001|NOT COMPLETED|Overall Study||0
10654490|NCT02203032|11815293|FG000|STARTED|Open Label Run-in (Week 0 to Week 16)||872
10654491|NCT02203032|11815294|FG001|STARTED|Open Label Run-in (Week 0 to Week 16)||0
10654492|NCT02203032|11815295|FG002|STARTED|Open Label Run-in (Week 0 to Week 16)||0
10654493|NCT02203032|11815296|FG003|STARTED|Open Label Run-in (Week 0 to Week 16)||0
10654494|NCT02203032|11815293|FG000|Treated|Open Label Run-in (Week 0 to Week 16)||871
10654495|NCT02203032|11815294|FG001|Treated|Open Label Run-in (Week 0 to Week 16)||0
10654496|NCT02203032|11815295|FG002|Treated|Open Label Run-in (Week 0 to Week 16)||0
10654497|NCT02203032|11815296|FG003|Treated|Open Label Run-in (Week 0 to Week 16)||0
10654498|NCT02203032|11815293|FG000|COMPLETED|Open Label Run-in (Week 0 to Week 16)||853
10654499|NCT02203032|11815294|FG001|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
10654500|NCT02203032|11815295|FG002|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
10654501|NCT02203032|11815296|FG003|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
10654502|NCT02203032|11815293|FG000|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||19
10654503|NCT02203032|11815294|FG001|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
10654504|NCT02203032|11815295|FG002|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
10654505|NCT02203032|11815296|FG003|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
10654506|NCT02203032|11815293|FG000|STARTED|Blinded Phase (Week 16 to Week 44)||0
10654507|NCT02203032|11815294|FG001|STARTED|Blinded Phase (Week 16 to Week 44)||135
10654508|NCT02203032|11815295|FG002|STARTED|Blinded Phase (Week 16 to Week 44)||133
10790769|NCT03550066|11951395|FG001|COMPLETED|Overall Study||41
10654509|NCT02203032|11815296|FG003|STARTED|Blinded Phase (Week 16 to Week 44)||585
10654510|NCT02203032|11815293|FG000|COMPLETED|Blinded Phase (Week 16 to Week 44)||0
10654511|NCT02203032|11815294|FG001|COMPLETED|Blinded Phase (Week 16 to Week 44)||120
10654512|NCT02203032|11815295|FG002|COMPLETED|Blinded Phase (Week 16 to Week 44)||107
10654513|NCT02203032|11815296|FG003|COMPLETED|Blinded Phase (Week 16 to Week 44)||539
10654514|NCT02203032|11815293|FG000|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||0
10654515|NCT02203032|11815294|FG001|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||15
10558924|NCT01585324|11713723|FG000|STARTED|Overall Study||30
10558925|NCT01585324|11713723|FG000|COMPLETED|Overall Study||30
10558926|NCT01585324|11713723|FG000|NOT COMPLETED|Overall Study||0
10558927|NCT01585428|11713731|FG000|STARTED|Overall Study||18
10558928|NCT01585428|11713732|FG001|STARTED|Overall Study||11
10558929|NCT01585428|11713731|FG000|COMPLETED|Overall Study||17
10558930|NCT01585428|11713732|FG001|COMPLETED|Overall Study||11
10558931|NCT01585428|11713731|FG000|NOT COMPLETED|Overall Study||1
10558932|NCT01585428|11713732|FG001|NOT COMPLETED|Overall Study||0
10558933|NCT01585441|11713741|FG000|STARTED|Overall Study||3
10558934|NCT01585441|11713742|FG001|STARTED|Overall Study||3
10558935|NCT01585441|11713741|FG000|Month 3|Overall Study|One participant was not evaluated at Month 3 but at the final visit due to study terminating early.|2
10558936|NCT01585441|11713742|FG001|Month 3|Overall Study||3
10790770|NCT03550066|11951394|FG000|NOT COMPLETED|Overall Study||0
10790771|NCT03550066|11951395|FG001|NOT COMPLETED|Overall Study||0
10790772|NCT03550209|11951405|FG000|STARTED|Overall Study||12
10790773|NCT03550209|11951406|FG001|STARTED|Overall Study||12
10790774|NCT03550209|11951407|FG002|STARTED|Overall Study||13
10790775|NCT03550209|11951408|FG003|STARTED|Overall Study||35
10790776|NCT03550209|11951405|FG000|COMPLETED|Overall Study||11
10790777|NCT03550209|11951406|FG001|COMPLETED|Overall Study||9
10790778|NCT03550209|11951407|FG002|COMPLETED|Overall Study||11
10790779|NCT03550209|11951408|FG003|COMPLETED|Overall Study||31
10790780|NCT03550209|11951405|FG000|NOT COMPLETED|Overall Study||1
10790781|NCT03550209|11951406|FG001|NOT COMPLETED|Overall Study||3
10790782|NCT03550209|11951407|FG002|NOT COMPLETED|Overall Study||2
10790783|NCT03550209|11951408|FG003|NOT COMPLETED|Overall Study||4
10790784|NCT03550313|11951421|FG000|STARTED|Overall Study||192
10790785|NCT03550313|11951422|FG001|STARTED|Overall Study||187
10790786|NCT03550313|11951423|FG002|STARTED|Overall Study||186
10790787|NCT03550313|11951421|FG000|Vaccinated for Dose 1|Overall Study||171
10790788|NCT03550313|11951422|FG001|Vaccinated for Dose 1|Overall Study||147
10790789|NCT03550313|11951423|FG002|Vaccinated for Dose 1|Overall Study||166
10790790|NCT03550313|11951421|FG000|Vaccinated for Dose 2|Overall Study||159
10790791|NCT03550313|11951422|FG001|Vaccinated for Dose 2|Overall Study||135
10790792|NCT03550313|11951423|FG002|Vaccinated for Dose 2|Overall Study||153
10790793|NCT03550313|11951421|FG000|Vaccinated for Dose 3|Overall Study||151
10790794|NCT03550313|11951422|FG001|Vaccinated for Dose 3|Overall Study||127
10790795|NCT03550313|11951423|FG002|Vaccinated for Dose 3|Overall Study||146
10790796|NCT03550313|11951421|FG000|COMPLETED|Overall Study||95
10790797|NCT03550313|11951422|FG001|COMPLETED|Overall Study||77
10790798|NCT03550313|11951423|FG002|COMPLETED|Overall Study||72
10790799|NCT03550313|11951421|FG000|NOT COMPLETED|Overall Study||97
10790800|NCT03550313|11951422|FG001|NOT COMPLETED|Overall Study||110
10790801|NCT03550313|11951423|FG002|NOT COMPLETED|Overall Study||114
10790802|NCT03550378|11951434|FG000|STARTED|Overall Study||20
10790803|NCT03550378|11951435|FG001|STARTED|Overall Study||21
10790804|NCT03550378|11951434|FG000|COMPLETED|Overall Study||20
10790805|NCT03550378|11951435|FG001|COMPLETED|Overall Study||20
10790806|NCT03550378|11951434|FG000|NOT COMPLETED|Overall Study||0
10790807|NCT03550378|11951435|FG001|NOT COMPLETED|Overall Study||1
10790808|NCT03550989|11951446|FG000|STARTED|Overall Study||190
10790809|NCT03550989|11951447|FG001|STARTED|Overall Study||74
10790810|NCT03550989|11951448|FG002|STARTED|Overall Study||77
10790811|NCT03550989|11951449|FG003|STARTED|Overall Study||60
10790812|NCT03550989|11951446|FG000|COMPLETED|Overall Study||188
10790813|NCT03550989|11951447|FG001|COMPLETED|Overall Study||73
10790814|NCT03550989|11951448|FG002|COMPLETED|Overall Study||76
10790815|NCT03550989|11951449|FG003|COMPLETED|Overall Study||60
10790816|NCT03550989|11951446|FG000|NOT COMPLETED|Overall Study||2
10790817|NCT03550989|11951447|FG001|NOT COMPLETED|Overall Study||1
10790818|NCT03550989|11951448|FG002|NOT COMPLETED|Overall Study||1
10790819|NCT03550989|11951449|FG003|NOT COMPLETED|Overall Study||0
10790820|NCT03551730|11951467|FG000|STARTED|Overall Study||9
10790821|NCT03551730|11951468|FG001|STARTED|Overall Study||6
10790822|NCT03551730|11951469|FG002|STARTED|Overall Study||6
10790823|NCT03551730|11951470|FG003|STARTED|Overall Study||6
10790824|NCT03551730|11951467|FG000|COMPLETED|Overall Study||8
10790825|NCT03551730|11951468|FG001|COMPLETED|Overall Study||6
10790826|NCT03551730|11951469|FG002|COMPLETED|Overall Study||6
10790827|NCT03551730|11951470|FG003|COMPLETED|Overall Study||6
10790828|NCT03551730|11951467|FG000|NOT COMPLETED|Overall Study||1
10790868|NCT03552289|11951521|FG001|NOT COMPLETED|Overall Study||3
10558937|NCT01585441|11713741|FG000|Received Finasteride at Month 3|Overall Study||2
10558938|NCT01585441|11713742|FG001|Received Finasteride at Month 3|Overall Study||2
10790829|NCT03551730|11951468|FG001|NOT COMPLETED|Overall Study||0
10790830|NCT03551730|11951469|FG002|NOT COMPLETED|Overall Study||0
10790831|NCT03551730|11951470|FG003|NOT COMPLETED|Overall Study||0
10790832|NCT03551743|11951484|FG000|STARTED|Overall Study||10
10790833|NCT03551743|11951485|FG001|STARTED|Overall Study||6
10790834|NCT03551743|11951486|FG002|STARTED|Overall Study||6
10790835|NCT03551743|11951487|FG003|STARTED|Overall Study||6
10558939|NCT01585441|11713741|FG000|Final Study Safety Visit|Overall Study||3
10790836|NCT03551743|11951484|FG000|COMPLETED|Overall Study||8
10790837|NCT03551743|11951485|FG001|COMPLETED|Overall Study||6
10790838|NCT03551743|11951486|FG002|COMPLETED|Overall Study||6
10790839|NCT03551743|11951487|FG003|COMPLETED|Overall Study||6
10790840|NCT03551743|11951484|FG000|NOT COMPLETED|Overall Study||2
10790841|NCT03551743|11951485|FG001|NOT COMPLETED|Overall Study||0
10790842|NCT03551743|11951486|FG002|NOT COMPLETED|Overall Study||0
10790843|NCT03551743|11951487|FG003|NOT COMPLETED|Overall Study||0
10790844|NCT03551821|11951497|FG000|STARTED|Overall Study||1
10558940|NCT01585441|11713742|FG001|Final Study Safety Visit|Overall Study|A final study visit was not required for the placebo participant who completed the study at Month 3.|2
10558941|NCT01585441|11713741|FG000|COMPLETED|Overall Study|Defined as completing the Month 3 masked phase of the study and/or the final safety visit|3
10558942|NCT01585441|11713742|FG001|COMPLETED|Overall Study|Defined as completing the Month 3 masked phase of the study and/or the final safety visit|3
10558943|NCT01585441|11713741|FG000|NOT COMPLETED|Overall Study||0
10558944|NCT01585441|11713742|FG001|NOT COMPLETED|Overall Study||0
10558945|NCT01585558|11713751|FG000|STARTED|Overall Study||62
10558946|NCT01585558|11713752|FG001|STARTED|Overall Study||69
10558947|NCT01585558|11713753|FG002|STARTED|Overall Study||49
10558948|NCT01585558|11713751|FG000|COMPLETED|Overall Study||49
10558949|NCT01585558|11713752|FG001|COMPLETED|Overall Study||57
10558950|NCT01585558|11713753|FG002|COMPLETED|Overall Study||34
10558951|NCT01585558|11713751|FG000|NOT COMPLETED|Overall Study||13
10558952|NCT01585558|11713752|FG001|NOT COMPLETED|Overall Study||12
10558953|NCT01585558|11713753|FG002|NOT COMPLETED|Overall Study||15
10558954|NCT01585584|11713761|FG000|STARTED|Overall Study||10
10558955|NCT01585584|11713761|FG000|COMPLETED|Overall Study||6
10558956|NCT01585584|11713761|FG000|NOT COMPLETED|Overall Study||4
10558957|NCT01585597|11713765|FG000|STARTED|Overall Study||20
10558958|NCT01585597|11713765|FG000|COMPLETED|Overall Study||20
10558959|NCT01585597|11713765|FG000|NOT COMPLETED|Overall Study||0
10558960|NCT01585766|11713775|FG000|STARTED|Overall Study||7
10558961|NCT01585766|11713776|FG001|STARTED|Overall Study||5
10558962|NCT01585766|11713777|FG002|STARTED|Overall Study||3
10558963|NCT01585766|11713778|FG003|STARTED|Overall Study||4
10558964|NCT01585766|11713779|FG004|STARTED|Overall Study||3
10558965|NCT01585766|11713780|FG005|STARTED|Overall Study||6
10558966|NCT01585766|11713775|FG000|COMPLETED|Overall Study||7
10558967|NCT01585766|11713776|FG001|COMPLETED|Overall Study||3
10558968|NCT01585766|11713777|FG002|COMPLETED|Overall Study||1
10558969|NCT01585766|11713778|FG003|COMPLETED|Overall Study||4
10558970|NCT01585766|11713779|FG004|COMPLETED|Overall Study||3
10558971|NCT01585766|11713780|FG005|COMPLETED|Overall Study||6
10558972|NCT01585766|11713775|FG000|NOT COMPLETED|Overall Study||0
10558973|NCT01585766|11713776|FG001|NOT COMPLETED|Overall Study||2
10558974|NCT01585766|11713777|FG002|NOT COMPLETED|Overall Study||2
10558975|NCT01585766|11713778|FG003|NOT COMPLETED|Overall Study||0
10558976|NCT01585766|11713779|FG004|NOT COMPLETED|Overall Study||0
10558977|NCT01585766|11713780|FG005|NOT COMPLETED|Overall Study||0
10558978|NCT01585779|11713803|FG000|STARTED|Overall Study||36
10558979|NCT01585779|11713804|FG001|STARTED|Overall Study||28
10558980|NCT01585779|11713803|FG000|COMPLETED|Overall Study||26
10558981|NCT01585779|11713804|FG001|COMPLETED|Overall Study||21
10558982|NCT01585779|11713803|FG000|NOT COMPLETED|Overall Study||10
10558983|NCT01585779|11713804|FG001|NOT COMPLETED|Overall Study||7
10558984|NCT01585831|11713813|FG000|STARTED|Overall Study||28
10558985|NCT01585831|11713814|FG001|STARTED|Overall Study||20
10790845|NCT03551821|11951497|FG000|COMPLETED|Overall Study||1
10790846|NCT03551821|11951497|FG000|NOT COMPLETED|Overall Study||0
10790847|NCT03552198|11951505|FG000|STARTED|Overall Study||83
10790848|NCT03552198|11951506|FG001|STARTED|Overall Study||84
10790849|NCT03552198|11951507|FG002|STARTED|Overall Study||24
10790850|NCT03552198|11951508|FG003|STARTED|Overall Study||34
10790851|NCT03552198|11951505|FG000|Final Questionnaire 4 Weeks Follow-up|Overall Study||34
10790852|NCT03552198|11951506|FG001|Final Questionnaire 4 Weeks Follow-up|Overall Study||29
10790853|NCT03552198|11951507|FG002|Final Questionnaire 4 Weeks Follow-up|Overall Study||7
10790854|NCT03552198|11951508|FG003|Final Questionnaire 4 Weeks Follow-up|Overall Study||12
10790855|NCT03552198|11951505|FG000|COMPLETED|Overall Study||34
10790856|NCT03552198|11951506|FG001|COMPLETED|Overall Study||29
10790857|NCT03552198|11951507|FG002|COMPLETED|Overall Study||7
10790858|NCT03552198|11951508|FG003|COMPLETED|Overall Study||12
10790859|NCT03552198|11951505|FG000|NOT COMPLETED|Overall Study||49
10790860|NCT03552198|11951506|FG001|NOT COMPLETED|Overall Study||55
10790861|NCT03552198|11951507|FG002|NOT COMPLETED|Overall Study||17
10790862|NCT03552198|11951508|FG003|NOT COMPLETED|Overall Study||22
10790863|NCT03552289|11951520|FG000|STARTED|Overall Study||102
10790864|NCT03552289|11951521|FG001|STARTED|Overall Study||109
10790865|NCT03552289|11951520|FG000|COMPLETED|Overall Study||101
10790866|NCT03552289|11951521|FG001|COMPLETED|Overall Study||106
10790867|NCT03552289|11951520|FG000|NOT COMPLETED|Overall Study||1
10790869|NCT03552523|11951527|FG000|STARTED|Overall Study||5
10790870|NCT03552523|11951528|FG001|STARTED|Overall Study||2
10790871|NCT03552523|11951527|FG000|COMPLETED|Overall Study||4
10790872|NCT03552523|11951528|FG001|COMPLETED|Overall Study||1
10790873|NCT03552523|11951527|FG000|NOT COMPLETED|Overall Study||1
10790874|NCT03552523|11951528|FG001|NOT COMPLETED|Overall Study||1
10790875|NCT03552536|11951537|FG000|STARTED|Overall Study||5
10790876|NCT03552536|11951538|FG001|STARTED|Overall Study||0
10558986|NCT01585831|11713813|FG000|COMPLETED|Overall Study||26
10558987|NCT01585831|11713814|FG001|COMPLETED|Overall Study||18
10558988|NCT01585831|11713813|FG000|NOT COMPLETED|Overall Study||2
10558989|NCT01585831|11713814|FG001|NOT COMPLETED|Overall Study||2
10790877|NCT03552536|11951539|FG002|STARTED|Overall Study||0
10790878|NCT03552536|11951537|FG000|COMPLETED|Overall Study||5
10790879|NCT03552536|11951538|FG001|COMPLETED|Overall Study||0
10790880|NCT03552536|11951539|FG002|COMPLETED|Overall Study||0
10558990|NCT01585961|11713820|FG000|STARTED|Overall Study||511
10558991|NCT01585961|11713820|FG000|Safety|Overall Study|Patients ablated with study catheter|508
10558992|NCT01585961|11713820|FG000|COMPLETED|Overall Study||478
10558993|NCT01585961|11713820|FG000|NOT COMPLETED|Overall Study||33
10558994|NCT01585987|11713826|FG000|STARTED|Randomized||57
10558995|NCT01585987|11713827|FG001|STARTED|Randomized||57
10558996|NCT01585987|11713826|FG000|COMPLETED|Randomized||57
10558997|NCT01585987|11713827|FG001|COMPLETED|Randomized||51
10558998|NCT01585987|11713826|FG000|NOT COMPLETED|Randomized||0
10558999|NCT01585987|11713827|FG001|NOT COMPLETED|Randomized||6
10559000|NCT01585987|11713826|FG000|STARTED|Treated||57
10559001|NCT01585987|11713827|FG001|STARTED|Treated||51
10559002|NCT01585987|11713826|FG000|COMPLETED|Treated||3
10559003|NCT01585987|11713827|FG001|COMPLETED|Treated||2
10559004|NCT01585987|11713826|FG000|NOT COMPLETED|Treated||54
10559005|NCT01585987|11713827|FG001|NOT COMPLETED|Treated||49
10559006|NCT01586026|11713834|FG000|STARTED|Overall Study||350
10559007|NCT01586026|11713835|FG001|STARTED|Overall Study||414
10559008|NCT01586026|11713836|FG002|STARTED|Overall Study||271
10559009|NCT01586026|11713834|FG000|COMPLETED|Overall Study||350
10559010|NCT01586026|11713835|FG001|COMPLETED|Overall Study||414
10790881|NCT03552536|11951537|FG000|NOT COMPLETED|Overall Study||0
10790882|NCT03552536|11951538|FG001|NOT COMPLETED|Overall Study||0
10790883|NCT03552536|11951539|FG002|NOT COMPLETED|Overall Study||0
10790884|NCT03552549|11951547|FG000|STARTED|Overall Study||63
10790885|NCT03552549|11951548|FG001|STARTED|Overall Study||63
10790886|NCT03552549|11951547|FG000|Treated|Overall Study||62
10790887|NCT03552549|11951548|FG001|Treated|Overall Study||62
10790888|NCT03552549|11951547|FG000|COMPLETED|Overall Study||10
10790889|NCT03552549|11951548|FG001|COMPLETED|Overall Study||11
10790890|NCT03552549|11951547|FG000|NOT COMPLETED|Overall Study||53
10790891|NCT03552549|11951548|FG001|NOT COMPLETED|Overall Study||52
10790892|NCT03552757|11951557|FG000|STARTED|Overall Study||403
10790893|NCT03552757|11951558|FG001|STARTED|Overall Study||404
10790894|NCT03552757|11951559|FG002|STARTED|Overall Study||403
10790895|NCT03552757|11951557|FG000|Exposed|Overall Study||402
10790896|NCT03552757|11951558|FG001|Exposed|Overall Study||403
10790897|NCT03552757|11951559|FG002|Exposed|Overall Study||402
10790898|NCT03552757|11951557|FG000|Full Analysis Set (FAS)|Overall Study||403
10790899|NCT03552757|11951558|FG001|Full Analysis Set (FAS)|Overall Study||404
10790900|NCT03552757|11951559|FG002|Full Analysis Set (FAS)|Overall Study||403
10790901|NCT03552757|11951557|FG000|Safety Analysis Set (SAS)|Overall Study||402
10790902|NCT03552757|11951558|FG001|Safety Analysis Set (SAS)|Overall Study||403
10790903|NCT03552757|11951559|FG002|Safety Analysis Set (SAS)|Overall Study||402
10790904|NCT03552757|11951557|FG000|COMPLETED|Overall Study||390
10790905|NCT03552757|11951558|FG001|COMPLETED|Overall Study||391
10790906|NCT03552757|11951559|FG002|COMPLETED|Overall Study||383
10790907|NCT03552757|11951557|FG000|NOT COMPLETED|Overall Study||13
10790908|NCT03552757|11951558|FG001|NOT COMPLETED|Overall Study||13
10790909|NCT03552757|11951559|FG002|NOT COMPLETED|Overall Study||20
10790910|NCT03553758|11951570|FG000|STARTED|Overall Study||16
10790911|NCT03553758|11951570|FG000|Completed Screening Visit|Overall Study||16
10790912|NCT03553758|11951570|FG000|COMPLETED|Overall Study||15
10790913|NCT03553758|11951570|FG000|NOT COMPLETED|Overall Study||1
10790914|NCT03553823|11951578|FG000|STARTED|Overall Study||20
10790915|NCT03553823|11951579|FG001|STARTED|Overall Study||20
10790916|NCT03553823|11951578|FG000|COMPLETED|Overall Study||20
10790917|NCT03553823|11951579|FG001|COMPLETED|Overall Study||19
10790918|NCT03553823|11951578|FG000|NOT COMPLETED|Overall Study||0
10790919|NCT03553823|11951579|FG001|NOT COMPLETED|Overall Study||1
10790920|NCT03553940|11951587|FG000|STARTED|Overall Study||22
10790921|NCT03553940|11951588|FG001|STARTED|Overall Study||21
10790922|NCT03553940|11951587|FG000|COMPLETED|Overall Study||22
10790923|NCT03553940|11951588|FG001|COMPLETED|Overall Study||21
10790924|NCT03553940|11951587|FG000|NOT COMPLETED|Overall Study||0
10790925|NCT03553940|11951588|FG001|NOT COMPLETED|Overall Study||0
10790926|NCT03554005|11951600|FG000|STARTED|Overall Study||1
10790927|NCT03554005|11951601|FG001|STARTED|Overall Study||2
10790928|NCT03554005|11951602|FG002|STARTED|Overall Study||2
10790929|NCT03554005|11951603|FG003|STARTED|Overall Study||2
10790930|NCT03554005|11951604|FG004|STARTED|Overall Study||11
10790931|NCT03554005|11951605|FG005|STARTED|Overall Study||11
10790932|NCT03554005|11951600|FG000|COMPLETED|Overall Study||0
10559011|NCT01586026|11713836|FG002|COMPLETED|Overall Study||271
10559012|NCT01586026|11713834|FG000|NOT COMPLETED|Overall Study||0
10559013|NCT01586026|11713835|FG001|NOT COMPLETED|Overall Study||0
10559014|NCT01586026|11713836|FG002|NOT COMPLETED|Overall Study||0
10559015|NCT01586039|11713848|FG000|STARTED|Overall Study||8
10559016|NCT01586039|11713849|FG001|STARTED|Overall Study||9
10559017|NCT01586039|11713850|FG002|STARTED|Overall Study||8
10559018|NCT01586039|11713851|FG003|STARTED|Overall Study||8
10559019|NCT01586039|11713848|FG000|COMPLETED|Overall Study||8
10559020|NCT01586039|11713849|FG001|COMPLETED|Overall Study||8
10559021|NCT01586039|11713850|FG002|COMPLETED|Overall Study||8
10559022|NCT01586039|11713851|FG003|COMPLETED|Overall Study||8
10559023|NCT01586039|11713848|FG000|NOT COMPLETED|Overall Study||0
10559024|NCT01586039|11713849|FG001|NOT COMPLETED|Overall Study||1
10559025|NCT01586039|11713850|FG002|NOT COMPLETED|Overall Study||0
10559026|NCT01586039|11713851|FG003|NOT COMPLETED|Overall Study||0
10559027|NCT01586091|11713864|FG000|STARTED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
10790933|NCT03554005|11951601|FG001|COMPLETED|Overall Study||1
10790934|NCT03554005|11951602|FG002|COMPLETED|Overall Study||1
10790935|NCT03554005|11951603|FG003|COMPLETED|Overall Study||1
10790936|NCT03554005|11951604|FG004|COMPLETED|Overall Study||5
10790937|NCT03554005|11951605|FG005|COMPLETED|Overall Study||0
10559028|NCT01586091|11713865|FG001|STARTED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
10559029|NCT01586091|11713866|FG002|STARTED|Overall Study||6
10559030|NCT01586091|11713864|FG000|COMPLETED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
10559031|NCT01586091|11713865|FG001|COMPLETED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
10559032|NCT01586091|11713866|FG002|COMPLETED|Overall Study||6
10559033|NCT01586091|11713864|FG000|NOT COMPLETED|Overall Study||0
10559034|NCT01586091|11713865|FG001|NOT COMPLETED|Overall Study||0
10559035|NCT01586091|11713866|FG002|NOT COMPLETED|Overall Study||0
10559036|NCT01586156|11713880|FG000|STARTED|Overall Study||10
10559037|NCT01586156|11713881|FG001|STARTED|Overall Study||10
10559038|NCT01586156|11713882|FG002|STARTED|Overall Study||10
10559039|NCT01586156|11713880|FG000|COMPLETED|Overall Study||10
10559040|NCT01586156|11713881|FG001|COMPLETED|Overall Study||9
10559041|NCT01586156|11713882|FG002|COMPLETED|Overall Study||10
10559042|NCT01586156|11713880|FG000|NOT COMPLETED|Overall Study||0
10559043|NCT01586156|11713881|FG001|NOT COMPLETED|Overall Study||1
10559044|NCT01586156|11713882|FG002|NOT COMPLETED|Overall Study||0
10559045|NCT01586195|11713890|FG000|STARTED|Overall Study||31
10559046|NCT01586195|11713890|FG000|COMPLETED|Overall Study||5
10559047|NCT01586195|11713890|FG000|NOT COMPLETED|Overall Study||26
10559048|NCT01586312|11713896|FG000|STARTED|Overall Study||15
10559049|NCT01586312|11713897|FG001|STARTED|Overall Study||15
10559050|NCT01586312|11713896|FG000|COMPLETED|Overall Study||15
10559051|NCT01586312|11713897|FG001|COMPLETED|Overall Study||15
10559052|NCT01586312|11713896|FG000|NOT COMPLETED|Overall Study||0
10559053|NCT01586312|11713897|FG001|NOT COMPLETED|Overall Study||0
10559054|NCT01586338|11713903|FG000|STARTED|Overall Study||237
10559055|NCT01586338|11713903|FG000|COMPLETED|Overall Study||229
10559056|NCT01586338|11713903|FG000|NOT COMPLETED|Overall Study||8
10559057|NCT01586364|11713907|FG000|STARTED|Overall Study||301
10559058|NCT01586364|11713907|FG000|COMPLETED|Overall Study||184
10559059|NCT01586364|11713907|FG000|NOT COMPLETED|Overall Study||117
10559060|NCT01586624|11713919|FG000|STARTED|Overall Study||6
10559061|NCT01586624|11713920|FG001|STARTED|Overall Study||6
10559062|NCT01586624|11713921|FG002|STARTED|Overall Study||6
10559063|NCT01586624|11713922|FG003|STARTED|Overall Study||7
10559064|NCT01586624|11713923|FG004|STARTED|Overall Study||9
10559065|NCT01586624|11713924|FG005|STARTED|Overall Study||8
10559066|NCT01586624|11713925|FG006|STARTED|Overall Study||8
10559067|NCT01586624|11713926|FG007|STARTED|Overall Study||11
10559068|NCT01586624|11713919|FG000|COMPLETED|Overall Study||2
10559069|NCT01586624|11713920|FG001|COMPLETED|Overall Study||2
10559070|NCT01586624|11713921|FG002|COMPLETED|Overall Study||1
10559071|NCT01586624|11713922|FG003|COMPLETED|Overall Study||0
10559072|NCT01586624|11713923|FG004|COMPLETED|Overall Study||1
10559073|NCT01586624|11713924|FG005|COMPLETED|Overall Study||0
10559074|NCT01586624|11713925|FG006|COMPLETED|Overall Study||0
10559075|NCT01586624|11713926|FG007|COMPLETED|Overall Study||1
10559076|NCT01586624|11713919|FG000|NOT COMPLETED|Overall Study||4
10559077|NCT01586624|11713920|FG001|NOT COMPLETED|Overall Study||4
10559078|NCT01586624|11713921|FG002|NOT COMPLETED|Overall Study||5
10559079|NCT01586624|11713922|FG003|NOT COMPLETED|Overall Study||7
10559080|NCT01586624|11713923|FG004|NOT COMPLETED|Overall Study||8
10559081|NCT01586624|11713924|FG005|NOT COMPLETED|Overall Study||8
10559082|NCT01586624|11713925|FG006|NOT COMPLETED|Overall Study||8
10559083|NCT01586624|11713926|FG007|NOT COMPLETED|Overall Study||10
10559084|NCT01586741|11713948|FG000|STARTED|Overall Study||28
10559085|NCT01586741|11713949|FG001|STARTED|Overall Study||29
10559086|NCT01586741|11713950|FG002|STARTED|Overall Study||32
10559087|NCT01586741|11713948|FG000|COMPLETED|Overall Study||27
10559088|NCT01586741|11713949|FG001|COMPLETED|Overall Study||29
10559089|NCT01586741|11713950|FG002|COMPLETED|Overall Study||30
10559090|NCT01586741|11713948|FG000|NOT COMPLETED|Overall Study||1
10559091|NCT01586741|11713949|FG001|NOT COMPLETED|Overall Study||0
10559092|NCT01586741|11713950|FG002|NOT COMPLETED|Overall Study||2
10559093|NCT01586806|11713961|FG000|STARTED|Overall Study||65
10559094|NCT01586806|11713962|FG001|STARTED|Overall Study||65
10559095|NCT01586806|11713963|FG002|STARTED|Overall Study||65
10559096|NCT01586806|11713961|FG000|COMPLETED|Overall Study||62
10559097|NCT01586806|11713962|FG001|COMPLETED|Overall Study||61
10559098|NCT01586806|11713963|FG002|COMPLETED|Overall Study||63
10559099|NCT01586806|11713961|FG000|NOT COMPLETED|Overall Study||3
10559100|NCT01586806|11713962|FG001|NOT COMPLETED|Overall Study||4
10559101|NCT01586806|11713963|FG002|NOT COMPLETED|Overall Study||2
10559102|NCT01586819|11713973|FG000|STARTED|Overall Study||12
10559103|NCT01586819|11713974|FG001|STARTED|Overall Study||14
10559104|NCT01586819|11713973|FG000|COMPLETED|Overall Study||11
10559105|NCT01586819|11713974|FG001|COMPLETED|Overall Study||14
10559106|NCT01586819|11713973|FG000|NOT COMPLETED|Overall Study||1
10559107|NCT01586819|11713974|FG001|NOT COMPLETED|Overall Study||0
10559108|NCT01586871|11713983|FG000|STARTED|Overall Study||560
10559109|NCT01586871|11713984|FG001|STARTED|Overall Study||554
10559110|NCT01586871|11713985|FG002|STARTED|Overall Study||33
10559111|NCT01586871|11713983|FG000|COMPLETED|Overall Study||560
10559112|NCT01586871|11713984|FG001|COMPLETED|Overall Study||554
10559113|NCT01586871|11713985|FG002|COMPLETED|Overall Study||33
10559114|NCT01586871|11713983|FG000|NOT COMPLETED|Overall Study||0
10559115|NCT01586871|11713984|FG001|NOT COMPLETED|Overall Study||0
10559116|NCT01586871|11713985|FG002|NOT COMPLETED|Overall Study||0
10559117|NCT01586897|11713995|FG000|STARTED|Overall Study||26
10559118|NCT01586897|11713996|FG001|STARTED|Overall Study||26
10559119|NCT01586897|11713995|FG000|COMPLETED|Overall Study||26
10559120|NCT01586897|11713996|FG001|COMPLETED|Overall Study||26
10559121|NCT01586897|11713995|FG000|NOT COMPLETED|Overall Study||0
10559122|NCT01586897|11713996|FG001|NOT COMPLETED|Overall Study||0
10559123|NCT01586962|11714004|FG000|STARTED|Overall Study||56
10559124|NCT01586962|11714004|FG000|COMPLETED|Overall Study||56
10559125|NCT01586962|11714004|FG000|NOT COMPLETED|Overall Study||0
10559126|NCT01586975|11714011|FG000|STARTED|Overall Study||15
10559127|NCT01586975|11714012|FG001|STARTED|Overall Study||32
10559128|NCT01586975|11714013|FG002|STARTED|Overall Study||46
10559129|NCT01586975|11714011|FG000|COMPLETED|Overall Study||15
10559130|NCT01586975|11714012|FG001|COMPLETED|Overall Study||32
10559131|NCT01586975|11714013|FG002|COMPLETED|Overall Study||46
10559132|NCT01586975|11714011|FG000|NOT COMPLETED|Overall Study||0
10559133|NCT01586975|11714012|FG001|NOT COMPLETED|Overall Study||0
10559134|NCT01586975|11714013|FG002|NOT COMPLETED|Overall Study||0
10559135|NCT01587001|11714023|FG000|STARTED|Overall Study||14
10559136|NCT01587001|11714024|FG001|STARTED|Overall Study||3
10559137|NCT01587001|11714023|FG000|COMPLETED|Overall Study||8
10559138|NCT01587001|11714024|FG001|COMPLETED|Overall Study||2
10559139|NCT01587001|11714023|FG000|NOT COMPLETED|Overall Study||6
10559140|NCT01587001|11714024|FG001|NOT COMPLETED|Overall Study||1
10559141|NCT01587014|11714031|FG000|STARTED|Overall Study||26
10559142|NCT01587014|11714031|FG000|COMPLETED|Overall Study||24
10559143|NCT01587014|11714031|FG000|NOT COMPLETED|Overall Study||2
10559144|NCT01587027|11714037|FG000|STARTED|First Intervention (1 Day)||8
10790938|NCT03554005|11951600|FG000|NOT COMPLETED|Overall Study||1
10790939|NCT03554005|11951601|FG001|NOT COMPLETED|Overall Study||1
10790940|NCT03554005|11951602|FG002|NOT COMPLETED|Overall Study||1
10790941|NCT03554005|11951603|FG003|NOT COMPLETED|Overall Study||1
10790942|NCT03554005|11951604|FG004|NOT COMPLETED|Overall Study||6
10790943|NCT03554005|11951605|FG005|NOT COMPLETED|Overall Study||11
10790944|NCT03554018|11951621|FG000|STARTED|Overall Study||60
10790945|NCT03554018|11951622|FG001|STARTED|Overall Study||60
10790946|NCT03554018|11951621|FG000|COMPLETED|Overall Study||57
10790947|NCT03554018|11951622|FG001|COMPLETED|Overall Study||53
10790948|NCT03554018|11951621|FG000|NOT COMPLETED|Overall Study||3
10790949|NCT03554018|11951622|FG001|NOT COMPLETED|Overall Study||7
10790950|NCT03554486|11951630|FG000|STARTED|Run-in Period (2 Weeks)||24
10790951|NCT03554486|11951631|FG001|STARTED|Run-in Period (2 Weeks)||0
10790952|NCT03554486|11951632|FG002|STARTED|Run-in Period (2 Weeks)||0
10790953|NCT03554486|11951630|FG000|COMPLETED|Run-in Period (2 Weeks)||21
10790954|NCT03554486|11951631|FG001|COMPLETED|Run-in Period (2 Weeks)||0
10790955|NCT03554486|11951632|FG002|COMPLETED|Run-in Period (2 Weeks)||0
10790956|NCT03554486|11951630|FG000|NOT COMPLETED|Run-in Period (2 Weeks)||3
10790957|NCT03554486|11951631|FG001|NOT COMPLETED|Run-in Period (2 Weeks)||0
10790958|NCT03554486|11951632|FG002|NOT COMPLETED|Run-in Period (2 Weeks)||0
10790959|NCT03554486|11951630|FG000|STARTED|Treatment Period 1 (2 Weeks)||0
10790960|NCT03554486|11951631|FG001|STARTED|Treatment Period 1 (2 Weeks)||11
10790961|NCT03554486|11951632|FG002|STARTED|Treatment Period 1 (2 Weeks)||10
10790962|NCT03554486|11951630|FG000|COMPLETED|Treatment Period 1 (2 Weeks)||0
10790963|NCT03554486|11951631|FG001|COMPLETED|Treatment Period 1 (2 Weeks)||10
10790964|NCT03554486|11951632|FG002|COMPLETED|Treatment Period 1 (2 Weeks)||9
10790965|NCT03554486|11951630|FG000|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
10790966|NCT03554486|11951631|FG001|NOT COMPLETED|Treatment Period 1 (2 Weeks)||1
10790967|NCT03554486|11951632|FG002|NOT COMPLETED|Treatment Period 1 (2 Weeks)||1
10790968|NCT03554486|11951630|FG000|STARTED|Treatment Period 2 (2 Weeks)||0
10790969|NCT03554486|11951631|FG001|STARTED|Treatment Period 2 (2 Weeks)||10
10790970|NCT03554486|11951632|FG002|STARTED|Treatment Period 2 (2 Weeks)||9
10790971|NCT03554486|11951630|FG000|COMPLETED|Treatment Period 2 (2 Weeks)||0
10790972|NCT03554486|11951631|FG001|COMPLETED|Treatment Period 2 (2 Weeks)||10
10790973|NCT03554486|11951632|FG002|COMPLETED|Treatment Period 2 (2 Weeks)||9
10790974|NCT03554486|11951630|FG000|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
10790975|NCT03554486|11951631|FG001|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
10790976|NCT03554486|11951632|FG002|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
10790977|NCT03554629|11951639|FG000|STARTED|Overall Study|8 filterlines per participant for four scripted activities with supplemental oxygen|29
10790978|NCT03554629|11951639|FG000|COMPLETED|Overall Study|8 filterlines (CCSF) per participate for four scripted activities with supplemental oxygen.|23
10790979|NCT03554629|11951639|FG000|NOT COMPLETED|Overall Study||6
10790980|NCT03554746|11951669|FG000|STARTED|Overall Study||24
10790981|NCT03554746|11951670|FG001|STARTED|Overall Study||24
10790982|NCT03554746|11951669|FG000|COMPLETED|Overall Study||24
10790983|NCT03554746|11951670|FG001|COMPLETED|Overall Study||24
10790984|NCT03554746|11951669|FG000|NOT COMPLETED|Overall Study||0
10559145|NCT01587027|11714038|FG001|STARTED|First Intervention (1 Day)||8
10559146|NCT01587027|11714037|FG000|COMPLETED|First Intervention (1 Day)||8
10559147|NCT01587027|11714038|FG001|COMPLETED|First Intervention (1 Day)||8
10790985|NCT03554746|11951670|FG001|NOT COMPLETED|Overall Study||0
10790986|NCT03554772|11951680|FG000|STARTED|Overall Study||30
10790987|NCT03554772|11951681|FG001|STARTED|Overall Study||30
10790988|NCT03554772|11951682|FG002|STARTED|Overall Study||29
10790989|NCT03554772|11951683|FG003|STARTED|Overall Study||31
10790990|NCT03554772|11951680|FG000|Completed Treatment Period (8 Hours Post Dose)|Overall Study||30
10790991|NCT03554772|11951681|FG001|Completed Treatment Period (8 Hours Post Dose)|Overall Study||30
10790992|NCT03554772|11951682|FG002|Completed Treatment Period (8 Hours Post Dose)|Overall Study||29
10559148|NCT01587027|11714037|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10559149|NCT01587027|11714038|FG001|NOT COMPLETED|First Intervention (1 Day)||0
10559150|NCT01587027|11714037|FG000|STARTED|Washout (1 Day)||8
10559151|NCT01587027|11714038|FG001|STARTED|Washout (1 Day)||8
10559152|NCT01587027|11714037|FG000|COMPLETED|Washout (1 Day)||8
10559153|NCT01587027|11714038|FG001|COMPLETED|Washout (1 Day)||8
10559154|NCT01587027|11714037|FG000|NOT COMPLETED|Washout (1 Day)||0
10559155|NCT01587027|11714038|FG001|NOT COMPLETED|Washout (1 Day)||0
10559156|NCT01587027|11714037|FG000|STARTED|Second Intervention (1 Day)||8
10559157|NCT01587027|11714038|FG001|STARTED|Second Intervention (1 Day)||8
10559158|NCT01587027|11714037|FG000|COMPLETED|Second Intervention (1 Day)||8
10559159|NCT01587027|11714038|FG001|COMPLETED|Second Intervention (1 Day)||8
10559160|NCT01587027|11714037|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10559161|NCT01587027|11714038|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10559162|NCT01587027|11714037|FG000|STARTED|Washout (1 Day)||8
10790993|NCT03554772|11951683|FG003|Completed Treatment Period (8 Hours Post Dose)|Overall Study||31
10790994|NCT03554772|11951680|FG000|COMPLETED|Overall Study||30
10790995|NCT03554772|11951681|FG001|COMPLETED|Overall Study||30
10790996|NCT03554772|11951682|FG002|COMPLETED|Overall Study||29
10790997|NCT03554772|11951683|FG003|COMPLETED|Overall Study||29
10559163|NCT01587027|11714038|FG001|STARTED|Washout (1 Day)||8
10559164|NCT01587027|11714037|FG000|COMPLETED|Washout (1 Day)||8
10559165|NCT01587027|11714038|FG001|COMPLETED|Washout (1 Day)||8
10559166|NCT01587027|11714037|FG000|NOT COMPLETED|Washout (1 Day)||0
10559167|NCT01587027|11714038|FG001|NOT COMPLETED|Washout (1 Day)||0
10559168|NCT01587027|11714037|FG000|STARTED|Third Intervention (1 Day)||8
10559169|NCT01587027|11714038|FG001|STARTED|Third Intervention (1 Day)||8
10559170|NCT01587027|11714037|FG000|COMPLETED|Third Intervention (1 Day)||8
10559171|NCT01587027|11714038|FG001|COMPLETED|Third Intervention (1 Day)||8
10559172|NCT01587027|11714037|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
10559173|NCT01587027|11714038|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
10559174|NCT01587027|11714037|FG000|STARTED|Discharge (1 Day)||8
10559175|NCT01587027|11714038|FG001|STARTED|Discharge (1 Day)||8
10559176|NCT01587027|11714037|FG000|COMPLETED|Discharge (1 Day)||8
10559177|NCT01587027|11714038|FG001|COMPLETED|Discharge (1 Day)||8
10559178|NCT01587027|11714037|FG000|NOT COMPLETED|Discharge (1 Day)||0
10559179|NCT01587027|11714038|FG001|NOT COMPLETED|Discharge (1 Day)||0
10559180|NCT01587079|11714044|FG000|STARTED|Overall Study||159
10559181|NCT01587079|11714044|FG000|COMPLETED|Overall Study||120
10559182|NCT01587079|11714044|FG000|NOT COMPLETED|Overall Study||39
10559183|NCT01587105|11714080|FG000|STARTED|Overall Study||150
10559184|NCT01587105|11714081|FG001|STARTED|Overall Study||181
10559185|NCT01587105|11714080|FG000|COMPLETED|Overall Study||144
10559186|NCT01587105|11714081|FG001|COMPLETED|Overall Study||138
10559187|NCT01587105|11714080|FG000|NOT COMPLETED|Overall Study||6
10559188|NCT01587105|11714081|FG001|NOT COMPLETED|Overall Study||43
10790998|NCT03554772|11951680|FG000|NOT COMPLETED|Overall Study||0
10790999|NCT03554772|11951681|FG001|NOT COMPLETED|Overall Study||0
10791000|NCT03554772|11951682|FG002|NOT COMPLETED|Overall Study||0
10791001|NCT03554772|11951683|FG003|NOT COMPLETED|Overall Study||2
10791002|NCT03554954|11951693|FG000|STARTED|Overall Study||108
10791003|NCT03554954|11951693|FG000|COMPLETED|Overall Study||108
10791004|NCT03554954|11951693|FG000|NOT COMPLETED|Overall Study||0
10791005|NCT03555266|11951703|FG000|STARTED|Overall Study||32
10791006|NCT03555266|11951704|FG001|STARTED|Overall Study||31
10791007|NCT03555266|11951703|FG000|COMPLETED|Overall Study||26
10791008|NCT03555266|11951704|FG001|COMPLETED|Overall Study||27
10791009|NCT03555266|11951703|FG000|NOT COMPLETED|Overall Study||6
10791010|NCT03555266|11951704|FG001|NOT COMPLETED|Overall Study||4
10791011|NCT03555305|11951710|FG000|STARTED|Period 1||29
10791012|NCT03555305|11951711|FG001|STARTED|Period 1||29
10791013|NCT03555305|11951710|FG000|Received at Least 1 Dose of Study Drug|Period 1||29
10791014|NCT03555305|11951711|FG001|Received at Least 1 Dose of Study Drug|Period 1||29
10791015|NCT03555305|11951710|FG000|COMPLETED|Period 1||29
10791016|NCT03555305|11951711|FG001|COMPLETED|Period 1||27
10791017|NCT03555305|11951710|FG000|NOT COMPLETED|Period 1||0
10791018|NCT03555305|11951711|FG001|NOT COMPLETED|Period 1||2
10791019|NCT03555305|11951710|FG000|STARTED|Period 2||29
10791020|NCT03555305|11951711|FG001|STARTED|Period 2||27
10791021|NCT03555305|11951710|FG000|COMPLETED|Period 2||29
10791022|NCT03555305|11951711|FG001|COMPLETED|Period 2||27
10791023|NCT03555305|11951710|FG000|NOT COMPLETED|Period 2||0
10791024|NCT03555305|11951711|FG001|NOT COMPLETED|Period 2||0
10791025|NCT03555435|11951720|FG000|STARTED|Overall Study||28
10791026|NCT03555435|11951721|FG001|STARTED|Overall Study||27
10791027|NCT03555435|11951722|FG002|STARTED|Overall Study||26
10559189|NCT01587118|11714087|FG000|STARTED|Overall Study|31 signed consent and 18 were deemed eligible and initiated treatment with adjunctive asenapine.|18
10559190|NCT01587118|11714087|FG000|COMPLETED|Overall Study||11
10559191|NCT01587118|11714087|FG000|NOT COMPLETED|Overall Study||7
10559192|NCT01587274|11714094|FG000|STARTED|Overall Study||108
10559193|NCT01587274|11714095|FG001|STARTED|Overall Study||108
10559194|NCT01587274|11714096|FG002|STARTED|Overall Study||107
10559195|NCT01587274|11714094|FG000|COMPLETED|Overall Study||104
10791028|NCT03555435|11951720|FG000|COMPLETED|Overall Study||11
10791029|NCT03555435|11951721|FG001|COMPLETED|Overall Study||8
10791030|NCT03555435|11951722|FG002|COMPLETED|Overall Study||18
10791031|NCT03555435|11951720|FG000|NOT COMPLETED|Overall Study||17
10791032|NCT03555435|11951721|FG001|NOT COMPLETED|Overall Study||19
10791033|NCT03555435|11951722|FG002|NOT COMPLETED|Overall Study||8
10791034|NCT03555565|11951730|FG000|STARTED|Overall Study||1026
10559196|NCT01587274|11714095|FG001|COMPLETED|Overall Study||103
10559197|NCT01587274|11714096|FG002|COMPLETED|Overall Study||104
10559198|NCT01587274|11714094|FG000|NOT COMPLETED|Overall Study||4
10559199|NCT01587274|11714095|FG001|NOT COMPLETED|Overall Study||5
10559200|NCT01587274|11714096|FG002|NOT COMPLETED|Overall Study||3
10559201|NCT01587651|11714107|FG000|STARTED|Overall Study||34
10559202|NCT01587651|11714108|FG001|STARTED|Overall Study||41
10559203|NCT01587651|11714109|FG002|STARTED|Overall Study||35
10559204|NCT01587651|11714107|FG000|COMPLETED|Overall Study||34
10559205|NCT01587651|11714108|FG001|COMPLETED|Overall Study||38
10559206|NCT01587651|11714109|FG002|COMPLETED|Overall Study||34
10559207|NCT01587651|11714107|FG000|NOT COMPLETED|Overall Study||0
10559208|NCT01587651|11714108|FG001|NOT COMPLETED|Overall Study||3
10559209|NCT01587651|11714109|FG002|NOT COMPLETED|Overall Study||1
10559210|NCT01587703|11714136|FG000|STARTED|Part1 QD(Median Exposure of 1.38months)||3
10559211|NCT01587703|11714137|FG001|STARTED|Part1 QD(Median Exposure of 1.38months)||4
10559212|NCT01587703|11714138|FG002|STARTED|Part1 QD(Median Exposure of 1.38months)||1
10559213|NCT01587703|11714139|FG003|STARTED|Part1 QD(Median Exposure of 1.38months)||3
10559214|NCT01587703|11714140|FG004|STARTED|Part1 QD(Median Exposure of 1.38months)||4
10559215|NCT01587703|11714141|FG005|STARTED|Part1 QD(Median Exposure of 1.38months)||9
10559216|NCT01587703|11714142|FG006|STARTED|Part1 QD(Median Exposure of 1.38months)||32
10559217|NCT01587703|11714143|FG007|STARTED|Part1 QD(Median Exposure of 1.38months)||9
10559218|NCT01587703|11714144|FG008|STARTED|Part1 QD(Median Exposure of 1.38months)||0
10559219|NCT01587703|11714145|FG009|STARTED|Part1 QD(Median Exposure of 1.38months)||0
10559220|NCT01587703|11714146|FG010|STARTED|Part1 QD(Median Exposure of 1.38months)||0
10559221|NCT01587703|11714147|FG011|STARTED|Part1 QD(Median Exposure of 1.38months)||0
10559222|NCT01587703|11714148|FG012|STARTED|Part1 QD(Median Exposure of 1.38months)||0
10559223|NCT01587703|11714149|FG013|STARTED|Part1 QD(Median Exposure of 1.38months)||0
10559224|NCT01587703|11714150|FG014|STARTED|Part1 QD(Median Exposure of 1.38months)||0
10559225|NCT01587703|11714151|FG015|STARTED|Part1 QD(Median Exposure of 1.38months)||0
10559226|NCT01587703|11714152|FG016|STARTED|Part1 QD(Median Exposure of 1.38months)||0
10559227|NCT01587703|11714153|FG017|STARTED|Part1 QD(Median Exposure of 1.38months)||0
10559228|NCT01587703|11714154|FG018|STARTED|Part1 QD(Median Exposure of 1.38months)||0
10559229|NCT01587703|11714136|FG000|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
10559230|NCT01587703|11714137|FG001|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
10559231|NCT01587703|11714138|FG002|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
10559232|NCT01587703|11714139|FG003|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
10559233|NCT01587703|11714140|FG004|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
10559234|NCT01587703|11714141|FG005|COMPLETED|Part1 QD(Median Exposure of 1.38months)||1
10559235|NCT01587703|11714142|FG006|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
10559236|NCT01587703|11714143|FG007|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
10559237|NCT01587703|11714144|FG008|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
10559238|NCT01587703|11714145|FG009|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
10559239|NCT01587703|11714146|FG010|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
10559240|NCT01587703|11714147|FG011|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
10559241|NCT01587703|11714148|FG012|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
10559242|NCT01587703|11714149|FG013|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
10559243|NCT01587703|11714150|FG014|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
10559244|NCT01587703|11714151|FG015|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
10559245|NCT01587703|11714152|FG016|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
10559246|NCT01587703|11714153|FG017|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
10559247|NCT01587703|11714154|FG018|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
10559248|NCT01587703|11714136|FG000|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||3
10559249|NCT01587703|11714137|FG001|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||4
10559250|NCT01587703|11714138|FG002|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||1
10559251|NCT01587703|11714139|FG003|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||3
10559252|NCT01587703|11714140|FG004|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||4
10559253|NCT01587703|11714141|FG005|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||8
10559254|NCT01587703|11714142|FG006|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||32
10559255|NCT01587703|11714143|FG007|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||9
10559256|NCT01587703|11714144|FG008|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
10559257|NCT01587703|11714145|FG009|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
10559258|NCT01587703|11714146|FG010|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
10559259|NCT01587703|11714147|FG011|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
10559260|NCT01587703|11714148|FG012|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
10559261|NCT01587703|11714149|FG013|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
10559262|NCT01587703|11714150|FG014|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
10559263|NCT01587703|11714151|FG015|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
10559264|NCT01587703|11714152|FG016|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
10559265|NCT01587703|11714153|FG017|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
10559266|NCT01587703|11714154|FG018|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
10559267|NCT01587703|11714136|FG000|STARTED|Part1 BID(Median Exposure of 1.41months)||0
10559268|NCT01587703|11714137|FG001|STARTED|Part1 BID(Median Exposure of 1.41months)||0
10559269|NCT01587703|11714138|FG002|STARTED|Part1 BID(Median Exposure of 1.41months)||0
10559270|NCT01587703|11714139|FG003|STARTED|Part1 BID(Median Exposure of 1.41months)||0
10559271|NCT01587703|11714140|FG004|STARTED|Part1 BID(Median Exposure of 1.41months)||0
10559272|NCT01587703|11714141|FG005|STARTED|Part1 BID(Median Exposure of 1.41months)||0
10559273|NCT01587703|11714142|FG006|STARTED|Part1 BID(Median Exposure of 1.41months)||0
10559274|NCT01587703|11714143|FG007|STARTED|Part1 BID(Median Exposure of 1.41months)||0
10559275|NCT01587703|11714144|FG008|STARTED|Part1 BID(Median Exposure of 1.41months)||4
10559276|NCT01587703|11714145|FG009|STARTED|Part1 BID(Median Exposure of 1.41months)||10
10559277|NCT01587703|11714146|FG010|STARTED|Part1 BID(Median Exposure of 1.41months)||5
10559278|NCT01587703|11714147|FG011|STARTED|Part1 BID(Median Exposure of 1.41months)||0
10559279|NCT01587703|11714148|FG012|STARTED|Part1 BID(Median Exposure of 1.41months)||0
10559280|NCT01587703|11714149|FG013|STARTED|Part1 BID(Median Exposure of 1.41months)||0
10559281|NCT01587703|11714150|FG014|STARTED|Part1 BID(Median Exposure of 1.41months)||0
10559282|NCT01587703|11714151|FG015|STARTED|Part1 BID(Median Exposure of 1.41months)||0
10559283|NCT01587703|11714152|FG016|STARTED|Part1 BID(Median Exposure of 1.41months)||0
10559284|NCT01587703|11714153|FG017|STARTED|Part1 BID(Median Exposure of 1.41months)||0
10559285|NCT01587703|11714154|FG018|STARTED|Part1 BID(Median Exposure of 1.41months)||0
10559286|NCT01587703|11714136|FG000|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
10559287|NCT01587703|11714137|FG001|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
10559288|NCT01587703|11714138|FG002|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
10559289|NCT01587703|11714139|FG003|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
10559290|NCT01587703|11714140|FG004|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
10559291|NCT01587703|11714141|FG005|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
10559292|NCT01587703|11714142|FG006|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
10559293|NCT01587703|11714143|FG007|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
10559294|NCT01587703|11714144|FG008|COMPLETED|Part1 BID(Median Exposure of 1.41months)||1
10559295|NCT01587703|11714145|FG009|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
10559296|NCT01587703|11714146|FG010|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
10559297|NCT01587703|11714147|FG011|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
10559298|NCT01587703|11714148|FG012|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
10559299|NCT01587703|11714149|FG013|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
10559300|NCT01587703|11714150|FG014|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
10559301|NCT01587703|11714151|FG015|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
10559302|NCT01587703|11714152|FG016|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
10559303|NCT01587703|11714153|FG017|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
10791035|NCT03555565|11951730|FG000|COMPLETED|Overall Study||1011
10791036|NCT03555565|11951730|FG000|NOT COMPLETED|Overall Study||15
10791037|NCT03555890|11951738|FG000|STARTED|Part 1:Treatment Period 1 (3 Days)||12
10791038|NCT03555890|11951739|FG001|STARTED|Part 1:Treatment Period 1 (3 Days)||12
10791039|NCT03555890|11951740|FG002|STARTED|Part 1:Treatment Period 1 (3 Days)||0
10791040|NCT03555890|11951741|FG003|STARTED|Part 1:Treatment Period 1 (3 Days)||0
10791041|NCT03555890|11951738|FG000|COMPLETED|Part 1:Treatment Period 1 (3 Days)||12
10791042|NCT03555890|11951739|FG001|COMPLETED|Part 1:Treatment Period 1 (3 Days)||12
10791043|NCT03555890|11951740|FG002|COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
10791044|NCT03555890|11951741|FG003|COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
10791045|NCT03555890|11951738|FG000|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
10791046|NCT03555890|11951739|FG001|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
10791047|NCT03555890|11951740|FG002|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
10791048|NCT03555890|11951741|FG003|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
10791049|NCT03555890|11951738|FG000|STARTED|Part 1:Washout Period (at Least 5 Days)||12
10791050|NCT03555890|11951739|FG001|STARTED|Part 1:Washout Period (at Least 5 Days)||12
10791051|NCT03555890|11951740|FG002|STARTED|Part 1:Washout Period (at Least 5 Days)||0
10791052|NCT03555890|11951741|FG003|STARTED|Part 1:Washout Period (at Least 5 Days)||0
10791053|NCT03555890|11951738|FG000|COMPLETED|Part 1:Washout Period (at Least 5 Days)||12
10791054|NCT03555890|11951739|FG001|COMPLETED|Part 1:Washout Period (at Least 5 Days)||12
10791055|NCT03555890|11951740|FG002|COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
10791056|NCT03555890|11951741|FG003|COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
10791057|NCT03555890|11951738|FG000|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
10791058|NCT03555890|11951739|FG001|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
10791059|NCT03555890|11951740|FG002|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
10791060|NCT03555890|11951741|FG003|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
10791061|NCT03555890|11951738|FG000|STARTED|Part 1:Treatment Period 2 (10 Days)||12
10791062|NCT03555890|11951739|FG001|STARTED|Part 1:Treatment Period 2 (10 Days)||12
10791063|NCT03555890|11951740|FG002|STARTED|Part 1:Treatment Period 2 (10 Days)||0
10791064|NCT03555890|11951741|FG003|STARTED|Part 1:Treatment Period 2 (10 Days)||0
10791065|NCT03555890|11951738|FG000|COMPLETED|Part 1:Treatment Period 2 (10 Days)||12
10791066|NCT03555890|11951739|FG001|COMPLETED|Part 1:Treatment Period 2 (10 Days)||12
10791067|NCT03555890|11951740|FG002|COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
10791068|NCT03555890|11951741|FG003|COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
10791069|NCT03555890|11951738|FG000|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
10791070|NCT03555890|11951739|FG001|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
10791071|NCT03555890|11951740|FG002|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
10791072|NCT03555890|11951741|FG003|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
10791073|NCT03555890|11951738|FG000|STARTED|Part 2:Treatment Period 1 (3 Days)||0
10559304|NCT01587703|11714154|FG018|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
10559305|NCT01587703|11714136|FG000|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
10559306|NCT01587703|11714137|FG001|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
10559307|NCT01587703|11714138|FG002|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
10559308|NCT01587703|11714139|FG003|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
10559309|NCT01587703|11714140|FG004|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
10559310|NCT01587703|11714141|FG005|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
10559311|NCT01587703|11714142|FG006|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
10559312|NCT01587703|11714143|FG007|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
10559313|NCT01587703|11714144|FG008|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||3
10559314|NCT01587703|11714145|FG009|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||10
10559315|NCT01587703|11714146|FG010|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||5
10559316|NCT01587703|11714147|FG011|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
10559317|NCT01587703|11714148|FG012|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
10559318|NCT01587703|11714149|FG013|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
10559319|NCT01587703|11714150|FG014|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
10559320|NCT01587703|11714151|FG015|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
10559321|NCT01587703|11714152|FG016|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
10559322|NCT01587703|11714153|FG017|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
10559323|NCT01587703|11714154|FG018|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
10559324|NCT01587703|11714136|FG000|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559325|NCT01587703|11714137|FG001|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559326|NCT01587703|11714138|FG002|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559327|NCT01587703|11714139|FG003|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559328|NCT01587703|11714140|FG004|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559329|NCT01587703|11714141|FG005|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559330|NCT01587703|11714142|FG006|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559331|NCT01587703|11714143|FG007|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559332|NCT01587703|11714144|FG008|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559333|NCT01587703|11714145|FG009|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559334|NCT01587703|11714146|FG010|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559335|NCT01587703|11714147|FG011|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559336|NCT01587703|11714148|FG012|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559337|NCT01587703|11714149|FG013|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559338|NCT01587703|11714150|FG014|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559339|NCT01587703|11714151|FG015|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559340|NCT01587703|11714152|FG016|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559341|NCT01587703|11714153|FG017|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||5
10559342|NCT01587703|11714154|FG018|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||5
10559343|NCT01587703|11714136|FG000|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559344|NCT01587703|11714137|FG001|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559345|NCT01587703|11714138|FG002|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559346|NCT01587703|11714139|FG003|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559347|NCT01587703|11714140|FG004|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559348|NCT01587703|11714141|FG005|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559349|NCT01587703|11714142|FG006|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559350|NCT01587703|11714143|FG007|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559351|NCT01587703|11714144|FG008|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559352|NCT01587703|11714145|FG009|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559353|NCT01587703|11714146|FG010|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559354|NCT01587703|11714147|FG011|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559355|NCT01587703|11714148|FG012|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559356|NCT01587703|11714149|FG013|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559357|NCT01587703|11714150|FG014|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559358|NCT01587703|11714151|FG015|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559359|NCT01587703|11714152|FG016|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559360|NCT01587703|11714153|FG017|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||5
10559361|NCT01587703|11714154|FG018|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||5
10559362|NCT01587703|11714136|FG000|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559363|NCT01587703|11714137|FG001|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559364|NCT01587703|11714138|FG002|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559365|NCT01587703|11714139|FG003|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559366|NCT01587703|11714140|FG004|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559367|NCT01587703|11714141|FG005|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559368|NCT01587703|11714142|FG006|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559369|NCT01587703|11714143|FG007|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559370|NCT01587703|11714144|FG008|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559371|NCT01587703|11714145|FG009|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559372|NCT01587703|11714146|FG010|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559373|NCT01587703|11714147|FG011|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559374|NCT01587703|11714148|FG012|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559375|NCT01587703|11714149|FG013|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559376|NCT01587703|11714150|FG014|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559377|NCT01587703|11714151|FG015|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559378|NCT01587703|11714152|FG016|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559379|NCT01587703|11714153|FG017|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559380|NCT01587703|11714154|FG018|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
10559381|NCT01587703|11714136|FG000|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
10559382|NCT01587703|11714137|FG001|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
10559383|NCT01587703|11714138|FG002|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
10559384|NCT01587703|11714139|FG003|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
10559385|NCT01587703|11714140|FG004|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
10559386|NCT01587703|11714141|FG005|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
10559387|NCT01587703|11714142|FG006|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
10559388|NCT01587703|11714143|FG007|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
10559389|NCT01587703|11714144|FG008|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
10559390|NCT01587703|11714145|FG009|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
10791074|NCT03555890|11951739|FG001|STARTED|Part 2:Treatment Period 1 (3 Days)||0
10791075|NCT03555890|11951740|FG002|STARTED|Part 2:Treatment Period 1 (3 Days)||24
10791076|NCT03555890|11951741|FG003|STARTED|Part 2:Treatment Period 1 (3 Days)||24
10791077|NCT03555890|11951738|FG000|COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
10791078|NCT03555890|11951739|FG001|COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
10791079|NCT03555890|11951740|FG002|COMPLETED|Part 2:Treatment Period 1 (3 Days)||24
10791080|NCT03555890|11951741|FG003|COMPLETED|Part 2:Treatment Period 1 (3 Days)||24
10791081|NCT03555890|11951738|FG000|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
10791082|NCT03555890|11951739|FG001|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
10791083|NCT03555890|11951740|FG002|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
10791084|NCT03555890|11951741|FG003|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
10791085|NCT03555890|11951738|FG000|STARTED|Part 2:Washout Period (at Least 5 Days)||0
10791086|NCT03555890|11951739|FG001|STARTED|Part 2:Washout Period (at Least 5 Days)||0
10791087|NCT03555890|11951740|FG002|STARTED|Part 2:Washout Period (at Least 5 Days)||24
10791088|NCT03555890|11951741|FG003|STARTED|Part 2:Washout Period (at Least 5 Days)||24
10791089|NCT03555890|11951738|FG000|COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
10791090|NCT03555890|11951739|FG001|COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
10791091|NCT03555890|11951740|FG002|COMPLETED|Part 2:Washout Period (at Least 5 Days)||24
10791092|NCT03555890|11951741|FG003|COMPLETED|Part 2:Washout Period (at Least 5 Days)||23
10791093|NCT03555890|11951738|FG000|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
10791094|NCT03555890|11951739|FG001|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
10791095|NCT03555890|11951740|FG002|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
10791096|NCT03555890|11951741|FG003|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||1
10791097|NCT03555890|11951738|FG000|STARTED|Part 2:Treatment Period 2 (10 Days)||0
10791098|NCT03555890|11951739|FG001|STARTED|Part 2:Treatment Period 2 (10 Days)||0
10791099|NCT03555890|11951740|FG002|STARTED|Part 2:Treatment Period 2 (10 Days)||24
10791100|NCT03555890|11951741|FG003|STARTED|Part 2:Treatment Period 2 (10 Days)||23
10791101|NCT03555890|11951738|FG000|COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
10791102|NCT03555890|11951739|FG001|COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
10791103|NCT03555890|11951740|FG002|COMPLETED|Part 2:Treatment Period 2 (10 Days)||24
10791104|NCT03555890|11951741|FG003|COMPLETED|Part 2:Treatment Period 2 (10 Days)||23
10791105|NCT03555890|11951738|FG000|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
10791106|NCT03555890|11951739|FG001|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
10791107|NCT03555890|11951740|FG002|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
10791108|NCT03555890|11951741|FG003|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
10791109|NCT03556579|11951751|FG000|STARTED|Visit 1||16
10791110|NCT03556579|11951752|FG001|STARTED|Visit 1||14
10791111|NCT03556579|11951753|FG002|STARTED|Visit 1||14
10791112|NCT03556579|11951754|FG003|STARTED|Visit 1||16
10791113|NCT03556579|11951751|FG000|COMPLETED|Visit 1||16
10791114|NCT03556579|11951752|FG001|COMPLETED|Visit 1||14
10791115|NCT03556579|11951753|FG002|COMPLETED|Visit 1||14
10791116|NCT03556579|11951754|FG003|COMPLETED|Visit 1||16
10791117|NCT03556579|11951751|FG000|NOT COMPLETED|Visit 1||0
10791118|NCT03556579|11951752|FG001|NOT COMPLETED|Visit 1||0
10791119|NCT03556579|11951753|FG002|NOT COMPLETED|Visit 1||0
10791120|NCT03556579|11951754|FG003|NOT COMPLETED|Visit 1||0
10791121|NCT03556579|11951751|FG000|STARTED|Visit 2||16
10791122|NCT03556579|11951752|FG001|STARTED|Visit 2||14
10791123|NCT03556579|11951753|FG002|STARTED|Visit 2||14
10791124|NCT03556579|11951754|FG003|STARTED|Visit 2||16
10791125|NCT03556579|11951751|FG000|COMPLETED|Visit 2||16
10791126|NCT03556579|11951752|FG001|COMPLETED|Visit 2||14
10791127|NCT03556579|11951753|FG002|COMPLETED|Visit 2||14
10791128|NCT03556579|11951754|FG003|COMPLETED|Visit 2||16
10791129|NCT03556579|11951751|FG000|NOT COMPLETED|Visit 2||0
10791130|NCT03556579|11951752|FG001|NOT COMPLETED|Visit 2||0
10791131|NCT03556579|11951753|FG002|NOT COMPLETED|Visit 2||0
10791132|NCT03556579|11951754|FG003|NOT COMPLETED|Visit 2||0
10791133|NCT03556761|11951766|FG000|STARTED|Overall Study||192
10791134|NCT03556761|11951767|FG001|STARTED|Overall Study||192
10791135|NCT03556761|11951766|FG000|COMPLETED|Overall Study||168
10791136|NCT03556761|11951767|FG001|COMPLETED|Overall Study||163
10791137|NCT03556761|11951766|FG000|NOT COMPLETED|Overall Study||24
10559391|NCT01587703|11714146|FG010|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
10559392|NCT01587703|11714147|FG011|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
10559393|NCT01587703|11714148|FG012|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
10559394|NCT01587703|11714149|FG013|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
10559395|NCT01587703|11714150|FG014|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
10559396|NCT01587703|11714151|FG015|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
10559397|NCT01587703|11714152|FG016|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
10559398|NCT01587703|11714153|FG017|STARTED|Substudy-P2, Week1Day3 to Week2Day1||5
10559399|NCT01587703|11714154|FG018|STARTED|Substudy-P2, Week1Day3 to Week2Day1||5
10559400|NCT01587703|11714136|FG000|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
10559401|NCT01587703|11714137|FG001|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
10559402|NCT01587703|11714138|FG002|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
10559403|NCT01587703|11714139|FG003|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
10559404|NCT01587703|11714140|FG004|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
10559405|NCT01587703|11714141|FG005|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
10559406|NCT01587703|11714142|FG006|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
10559407|NCT01587703|11714143|FG007|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
10559408|NCT01587703|11714144|FG008|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
10559409|NCT01587703|11714145|FG009|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
10559410|NCT01587703|11714146|FG010|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
10559411|NCT01587703|11714147|FG011|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
10559412|NCT01587703|11714148|FG012|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
10559413|NCT01587703|11714149|FG013|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
10559414|NCT01587703|11714150|FG014|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
10559415|NCT01587703|11714151|FG015|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
10559416|NCT01587703|11714152|FG016|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
10559417|NCT01587703|11714153|FG017|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||5
10559418|NCT01587703|11714154|FG018|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||5
10559419|NCT01587703|11714136|FG000|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
10559420|NCT01587703|11714137|FG001|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
10559421|NCT01587703|11714138|FG002|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
10559422|NCT01587703|11714139|FG003|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
10559423|NCT01587703|11714140|FG004|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
10559424|NCT01587703|11714141|FG005|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
10559425|NCT01587703|11714142|FG006|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
10559426|NCT01587703|11714143|FG007|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
10559427|NCT01587703|11714144|FG008|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
10559428|NCT01587703|11714145|FG009|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
10559429|NCT01587703|11714146|FG010|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
10559430|NCT01587703|11714147|FG011|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
10559431|NCT01587703|11714148|FG012|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
10559432|NCT01587703|11714149|FG013|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
10559433|NCT01587703|11714150|FG014|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
10559434|NCT01587703|11714151|FG015|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
10559435|NCT01587703|11714152|FG016|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
10559436|NCT01587703|11714153|FG017|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
10559437|NCT01587703|11714154|FG018|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
10559438|NCT01587703|11714136|FG000|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
10559439|NCT01587703|11714137|FG001|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
10559440|NCT01587703|11714138|FG002|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
10559441|NCT01587703|11714139|FG003|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
10559442|NCT01587703|11714140|FG004|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
10559443|NCT01587703|11714141|FG005|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
10559444|NCT01587703|11714142|FG006|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
10559445|NCT01587703|11714143|FG007|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
10559446|NCT01587703|11714144|FG008|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
10559447|NCT01587703|11714145|FG009|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
10559448|NCT01587703|11714146|FG010|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
10559449|NCT01587703|11714147|FG011|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
10559450|NCT01587703|11714148|FG012|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
10559451|NCT01587703|11714149|FG013|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
10559452|NCT01587703|11714150|FG014|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
10559453|NCT01587703|11714151|FG015|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
10559454|NCT01587703|11714152|FG016|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
10559455|NCT01587703|11714153|FG017|STARTED|Substudy-P3, Week2Day1 to Week2Day3||5
10559456|NCT01587703|11714154|FG018|STARTED|Substudy-P3, Week2Day1 to Week2Day3||5
10559457|NCT01587703|11714136|FG000|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
10559458|NCT01587703|11714137|FG001|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
10559459|NCT01587703|11714138|FG002|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
10559460|NCT01587703|11714139|FG003|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
10559461|NCT01587703|11714140|FG004|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
10559462|NCT01587703|11714141|FG005|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
10559463|NCT01587703|11714142|FG006|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
10559464|NCT01587703|11714143|FG007|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
10559465|NCT01587703|11714144|FG008|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
10559466|NCT01587703|11714145|FG009|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
10559467|NCT01587703|11714146|FG010|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
10559468|NCT01587703|11714147|FG011|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
10559469|NCT01587703|11714148|FG012|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
10559470|NCT01587703|11714149|FG013|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
10559471|NCT01587703|11714150|FG014|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
10559472|NCT01587703|11714151|FG015|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
10559473|NCT01587703|11714152|FG016|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
10559474|NCT01587703|11714153|FG017|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||5
10559475|NCT01587703|11714154|FG018|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||5
10559476|NCT01587703|11714136|FG000|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
10559477|NCT01587703|11714137|FG001|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
10559478|NCT01587703|11714138|FG002|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
10559479|NCT01587703|11714139|FG003|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
10559480|NCT01587703|11714140|FG004|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
10559481|NCT01587703|11714141|FG005|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
10559482|NCT01587703|11714142|FG006|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
10559483|NCT01587703|11714143|FG007|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
10559484|NCT01587703|11714144|FG008|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
10559485|NCT01587703|11714145|FG009|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
10559486|NCT01587703|11714146|FG010|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
10559487|NCT01587703|11714147|FG011|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
10791138|NCT03556761|11951767|FG001|NOT COMPLETED|Overall Study||29
10791139|NCT03556891|11951773|FG000|STARTED|Overall Study||133
10791140|NCT03556891|11951773|FG000|COMPLETED|Overall Study||120
10791141|NCT03556891|11951773|FG000|NOT COMPLETED|Overall Study||13
10791142|NCT03557034|11951779|FG000|STARTED|Overall Study||49
10791143|NCT03557034|11951780|FG001|STARTED|Overall Study||51
10791144|NCT03557034|11951779|FG000|Randomization|Overall Study||49
10791145|NCT03557034|11951780|FG001|Randomization|Overall Study||51
10791146|NCT03557034|11951779|FG000|COMPLETED|Overall Study||48
10791147|NCT03557034|11951780|FG001|COMPLETED|Overall Study||51
10791148|NCT03557034|11951779|FG000|NOT COMPLETED|Overall Study||1
10791149|NCT03557034|11951780|FG001|NOT COMPLETED|Overall Study||0
10791150|NCT03557086|11951788|FG000|STARTED|Overall Study||26
10559488|NCT01587703|11714148|FG012|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
10559489|NCT01587703|11714149|FG013|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
10791151|NCT03557086|11951789|FG001|STARTED|Overall Study||24
10791152|NCT03557086|11951788|FG000|COMPLETED|Overall Study||26
10791153|NCT03557086|11951789|FG001|COMPLETED|Overall Study||24
10791154|NCT03557086|11951788|FG000|NOT COMPLETED|Overall Study||0
10791155|NCT03557086|11951789|FG001|NOT COMPLETED|Overall Study||0
10791156|NCT03557125|11951799|FG000|STARTED|Overall Study||22
10791157|NCT03557125|11951800|FG001|STARTED|Overall Study||24
10791158|NCT03557125|11951799|FG000|COMPLETED|Overall Study||22
10559490|NCT01587703|11714150|FG014|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
10559491|NCT01587703|11714151|FG015|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
10559492|NCT01587703|11714152|FG016|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
10559493|NCT01587703|11714153|FG017|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
10559494|NCT01587703|11714154|FG018|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
10559495|NCT01587703|11714136|FG000|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
10559496|NCT01587703|11714137|FG001|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
10559497|NCT01587703|11714138|FG002|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
10559498|NCT01587703|11714139|FG003|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
10559499|NCT01587703|11714140|FG004|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
10559500|NCT01587703|11714141|FG005|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
10559501|NCT01587703|11714142|FG006|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
10559502|NCT01587703|11714143|FG007|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
10559503|NCT01587703|11714144|FG008|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
10559504|NCT01587703|11714145|FG009|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
10559505|NCT01587703|11714146|FG010|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
10559506|NCT01587703|11714147|FG011|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
10559507|NCT01587703|11714148|FG012|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
10559508|NCT01587703|11714149|FG013|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
10559509|NCT01587703|11714150|FG014|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
10559510|NCT01587703|11714151|FG015|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
10559511|NCT01587703|11714152|FG016|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
10559512|NCT01587703|11714153|FG017|STARTED|Substudy-P4,Maximum Exposure of 5.5month||5
10559513|NCT01587703|11714154|FG018|STARTED|Substudy-P4,Maximum Exposure of 5.5month||5
10559514|NCT01587703|11714136|FG000|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
10559515|NCT01587703|11714137|FG001|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
10559516|NCT01587703|11714138|FG002|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
10559517|NCT01587703|11714139|FG003|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
10559518|NCT01587703|11714140|FG004|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
10559519|NCT01587703|11714141|FG005|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
10559520|NCT01587703|11714142|FG006|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
10559521|NCT01587703|11714143|FG007|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
10559522|NCT01587703|11714144|FG008|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
10559523|NCT01587703|11714145|FG009|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
10791159|NCT03557125|11951800|FG001|COMPLETED|Overall Study||24
10791160|NCT03557125|11951799|FG000|NOT COMPLETED|Overall Study||0
10791161|NCT03557125|11951800|FG001|NOT COMPLETED|Overall Study||0
10791162|NCT03557333|11951806|FG000|STARTED|Overall Study||354
10791163|NCT03557333|11951806|FG000|COMPLETED|Overall Study||262
10791164|NCT03557333|11951806|FG000|NOT COMPLETED|Overall Study||92
10791165|NCT03557372|11951812|FG000|STARTED|Overall Study||14
10791166|NCT03557372|11951812|FG000|COMPLETED|Overall Study||14
10791167|NCT03557372|11951812|FG000|NOT COMPLETED|Overall Study||0
10791168|NCT03557476|11951818|FG000|STARTED|Overall Study||13
10791169|NCT03557476|11951819|FG001|STARTED|Overall Study||13
10791170|NCT03557476|11951818|FG000|COMPLETED|Overall Study||13
10791171|NCT03557476|11951819|FG001|COMPLETED|Overall Study||13
10791172|NCT03557476|11951818|FG000|NOT COMPLETED|Overall Study||0
10791173|NCT03557476|11951819|FG001|NOT COMPLETED|Overall Study||0
10791174|NCT03557658|11951827|FG000|STARTED|Overall Study||8
10791175|NCT03557658|11951828|FG001|STARTED|Overall Study||8
10791176|NCT03557658|11951827|FG000|COMPLETED|Overall Study||8
10791177|NCT03557658|11951828|FG001|COMPLETED|Overall Study||8
10791178|NCT03557658|11951827|FG000|NOT COMPLETED|Overall Study||0
10791179|NCT03557658|11951828|FG001|NOT COMPLETED|Overall Study||0
10791180|NCT03557775|11951837|FG000|STARTED|Overall Study||5
10791181|NCT03557775|11951838|FG001|STARTED|Overall Study||7
10791182|NCT03557775|11951839|FG002|STARTED|Overall Study||8
10791183|NCT03557775|11951837|FG000|COMPLETED|Overall Study||4
10791184|NCT03557775|11951838|FG001|COMPLETED|Overall Study||4
10791185|NCT03557775|11951839|FG002|COMPLETED|Overall Study||4
10791186|NCT03557775|11951837|FG000|NOT COMPLETED|Overall Study||1
10791187|NCT03557775|11951838|FG001|NOT COMPLETED|Overall Study||3
10791188|NCT03557775|11951839|FG002|NOT COMPLETED|Overall Study||4
10791189|NCT03557801|11951850|FG000|STARTED|Overall Study||34
10791190|NCT03557801|11951851|FG001|STARTED|Overall Study||33
10791191|NCT03557801|11951852|FG002|STARTED|Overall Study||33
10791192|NCT03557801|11951850|FG000|COMPLETED|Overall Study||32
10559524|NCT01587703|11714146|FG010|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
10791193|NCT03557801|11951851|FG001|COMPLETED|Overall Study||32
10791194|NCT03557801|11951852|FG002|COMPLETED|Overall Study||30
10791195|NCT03557801|11951850|FG000|NOT COMPLETED|Overall Study||2
10791196|NCT03557801|11951851|FG001|NOT COMPLETED|Overall Study||1
10791197|NCT03557801|11951852|FG002|NOT COMPLETED|Overall Study||3
10791198|NCT03558061|11951860|FG000|STARTED|Overall Study||30
10791199|NCT03558061|11951860|FG000|COMPLETED|Overall Study||29
10791200|NCT03558061|11951860|FG000|NOT COMPLETED|Overall Study||1
10791201|NCT03558074|11951864|FG000|STARTED|Overall Study||26
10791202|NCT03558074|11951864|FG000|COMPLETED|Overall Study||24
10791203|NCT03558074|11951864|FG000|NOT COMPLETED|Overall Study||2
10791204|NCT03558230|11951871|FG000|STARTED|Overall Study||7
10791205|NCT03558230|11951872|FG001|STARTED|Overall Study||6
10791206|NCT03558230|11951871|FG000|COMPLETED|Overall Study||7
10559525|NCT01587703|11714147|FG011|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
10559526|NCT01587703|11714148|FG012|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
10559527|NCT01587703|11714149|FG013|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
10559528|NCT01587703|11714150|FG014|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
10559529|NCT01587703|11714151|FG015|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
10559530|NCT01587703|11714152|FG016|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
10559531|NCT01587703|11714153|FG017|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
10559532|NCT01587703|11714154|FG018|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
10559533|NCT01587703|11714136|FG000|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
10559534|NCT01587703|11714137|FG001|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
10559535|NCT01587703|11714138|FG002|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
10559536|NCT01587703|11714139|FG003|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
10559537|NCT01587703|11714140|FG004|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
10559538|NCT01587703|11714141|FG005|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
10559539|NCT01587703|11714142|FG006|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
10650886|NCT02173522|11811272|FG000|STARTED|Overall Study||4
10791207|NCT03558230|11951872|FG001|COMPLETED|Overall Study||6
10791208|NCT03558230|11951871|FG000|NOT COMPLETED|Overall Study||0
10791209|NCT03558230|11951872|FG001|NOT COMPLETED|Overall Study||0
10791210|NCT03558516|11951880|FG000|STARTED|Overall Study||40
10791211|NCT03558516|11951881|FG001|STARTED|Overall Study||40
10791212|NCT03558516|11951880|FG000|COMPLETED|Overall Study||38
10791213|NCT03558516|11951881|FG001|COMPLETED|Overall Study||38
10791214|NCT03558516|11951880|FG000|NOT COMPLETED|Overall Study||2
10791215|NCT03558516|11951881|FG001|NOT COMPLETED|Overall Study||2
10791216|NCT03558555|11951889|FG000|STARTED|Overall Study||58
10791217|NCT03558555|11951890|FG001|STARTED|Overall Study||45
10791218|NCT03558555|11951889|FG000|COMPLETED|Overall Study||56
10791219|NCT03558555|11951890|FG001|COMPLETED|Overall Study||44
10791220|NCT03558555|11951889|FG000|NOT COMPLETED|Overall Study||2
10791221|NCT03558555|11951890|FG001|NOT COMPLETED|Overall Study||1
10791222|NCT03558672|11951896|FG000|STARTED|Overall Study||18
10791223|NCT03558672|11951896|FG000|COMPLETED|Overall Study||8
10791224|NCT03558672|11951896|FG000|NOT COMPLETED|Overall Study||10
10791225|NCT03558997|11951904|FG000|STARTED|Overall Study||25
10791226|NCT03558997|11951905|FG001|STARTED|Overall Study||26
10791227|NCT03558997|11951906|FG002|STARTED|Overall Study||26
10791228|NCT03558997|11951907|FG003|STARTED|Overall Study||26
10791229|NCT03558997|11951904|FG000|COMPLETED|Overall Study||24
10791230|NCT03558997|11951905|FG001|COMPLETED|Overall Study||24
10791231|NCT03558997|11951906|FG002|COMPLETED|Overall Study||18
10791232|NCT03558997|11951907|FG003|COMPLETED|Overall Study||24
10791233|NCT03558997|11951904|FG000|NOT COMPLETED|Overall Study||1
10791234|NCT03558997|11951905|FG001|NOT COMPLETED|Overall Study||2
10791235|NCT03558997|11951906|FG002|NOT COMPLETED|Overall Study||8
10791236|NCT03558997|11951907|FG003|NOT COMPLETED|Overall Study||2
10791237|NCT03559062|11951923|FG000|STARTED|Overall Study||10
10791238|NCT03559062|11951924|FG001|STARTED|Overall Study||54
10791239|NCT03559062|11951925|FG002|STARTED|Overall Study||3
10791240|NCT03559062|11951923|FG000|COMPLETED|Overall Study||10
10791241|NCT03559062|11951924|FG001|COMPLETED|Overall Study||53
10791242|NCT03559062|11951925|FG002|COMPLETED|Overall Study||3
10791243|NCT03559062|11951923|FG000|NOT COMPLETED|Overall Study||0
10791244|NCT03559062|11951924|FG001|NOT COMPLETED|Overall Study||1
10791245|NCT03559062|11951925|FG002|NOT COMPLETED|Overall Study||0
10791246|NCT03559179|11951937|FG000|STARTED|Overall Study||8
10791247|NCT03559179|11951938|FG001|STARTED|Overall Study||24
10791248|NCT03559179|11951939|FG002|STARTED|Overall Study||23
10791249|NCT03559179|11951937|FG000|COMPLETED|Overall Study||8
10791250|NCT03559179|11951938|FG001|COMPLETED|Overall Study||23
10791251|NCT03559179|11951939|FG002|COMPLETED|Overall Study||23
10791252|NCT03559179|11951937|FG000|NOT COMPLETED|Overall Study||0
10791253|NCT03559179|11951938|FG001|NOT COMPLETED|Overall Study||1
10791254|NCT03559179|11951939|FG002|NOT COMPLETED|Overall Study||0
10791255|NCT03559205|11951958|FG000|STARTED|Overall Study||177
10791256|NCT03559205|11951959|FG001|STARTED|Overall Study||144
10791257|NCT03559205|11951958|FG000|Baseline Data|Overall Study||141
10791258|NCT03559205|11951959|FG001|Baseline Data|Overall Study||132
10791259|NCT03559205|11951958|FG000|COMPLETED|Overall Study||65
10791260|NCT03559205|11951959|FG001|COMPLETED|Overall Study||57
10791261|NCT03559205|11951958|FG000|NOT COMPLETED|Overall Study||112
10791262|NCT03559205|11951959|FG001|NOT COMPLETED|Overall Study||87
10791263|NCT03559218|11951967|FG000|STARTED|Overall Study||12
10791264|NCT03559218|11951968|FG001|STARTED|Overall Study||13
10791265|NCT03559218|11951967|FG000|COMPLETED|Overall Study||11
10791266|NCT03559218|11951968|FG001|COMPLETED|Overall Study||13
10791267|NCT03559218|11951967|FG000|NOT COMPLETED|Overall Study||1
10791268|NCT03559218|11951968|FG001|NOT COMPLETED|Overall Study||0
10791269|NCT03559257|11951976|FG000|STARTED|Double Blind Treatment Period||230
10791270|NCT03559257|11951977|FG001|STARTED|Double Blind Treatment Period||233
10791271|NCT03559257|11951976|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment Period||230
10791272|NCT03559257|11951977|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment Period||232
10791273|NCT03559257|11951976|FG000|COMPLETED|Double Blind Treatment Period||226
10791274|NCT03559257|11951977|FG001|COMPLETED|Double Blind Treatment Period||225
10791275|NCT03559257|11951976|FG000|NOT COMPLETED|Double Blind Treatment Period||4
10791276|NCT03559257|11951977|FG001|NOT COMPLETED|Double Blind Treatment Period||8
10559540|NCT01587703|11714143|FG007|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
10559541|NCT01587703|11714144|FG008|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
10559542|NCT01587703|11714145|FG009|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
10559543|NCT01587703|11714146|FG010|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
10559544|NCT01587703|11714147|FG011|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
10559545|NCT01587703|11714148|FG012|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
10559546|NCT01587703|11714149|FG013|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
10559547|NCT01587703|11714150|FG014|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
10559548|NCT01587703|11714151|FG015|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
10559549|NCT01587703|11714152|FG016|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
10559550|NCT01587703|11714153|FG017|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||5
10559551|NCT01587703|11714154|FG018|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||5
10559552|NCT01587703|11714136|FG000|STARTED|Part2(Median Exposure of 1.41 Months)||0
10559553|NCT01587703|11714137|FG001|STARTED|Part2(Median Exposure of 1.41 Months)||0
10559554|NCT01587703|11714138|FG002|STARTED|Part2(Median Exposure of 1.41 Months)||0
10559555|NCT01587703|11714139|FG003|STARTED|Part2(Median Exposure of 1.41 Months)||0
10559556|NCT01587703|11714140|FG004|STARTED|Part2(Median Exposure of 1.41 Months)||0
10559557|NCT01587703|11714141|FG005|STARTED|Part2(Median Exposure of 1.41 Months)||0
10559558|NCT01587703|11714142|FG006|STARTED|Part2(Median Exposure of 1.41 Months)||0
10559559|NCT01587703|11714143|FG007|STARTED|Part2(Median Exposure of 1.41 Months)||0
10559560|NCT01587703|11714144|FG008|STARTED|Part2(Median Exposure of 1.41 Months)||0
10559561|NCT01587703|11714145|FG009|STARTED|Part2(Median Exposure of 1.41 Months)||0
10559562|NCT01587703|11714146|FG010|STARTED|Part2(Median Exposure of 1.41 Months)||0
10791277|NCT03559257|11951976|FG000|STARTED|Open-label Treatment Period|One participant who completed double blind period has withdrawn from the study.|225
10791278|NCT03559257|11951977|FG001|STARTED|Open-label Treatment Period|One participant who completed double blind period had discontinued due to adverse event.|224
10791279|NCT03559257|11951976|FG000|COMPLETED|Open-label Treatment Period||215
10791280|NCT03559257|11951977|FG001|COMPLETED|Open-label Treatment Period||217
10791281|NCT03559257|11951976|FG000|NOT COMPLETED|Open-label Treatment Period||10
10791282|NCT03559257|11951977|FG001|NOT COMPLETED|Open-label Treatment Period||7
10791283|NCT03559517|11951989|FG000|STARTED|Overall Study||8
10791284|NCT03559517|11951990|FG001|STARTED|Overall Study||9
10791285|NCT03559517|11951991|FG002|STARTED|Overall Study||12
10791286|NCT03559517|11951989|FG000|COMPLETED|Overall Study||7
10791287|NCT03559517|11951990|FG001|COMPLETED|Overall Study||9
10791288|NCT03559517|11951991|FG002|COMPLETED|Overall Study||12
10791289|NCT03559517|11951989|FG000|NOT COMPLETED|Overall Study||1
10791290|NCT03559517|11951990|FG001|NOT COMPLETED|Overall Study||0
10791291|NCT03559517|11951991|FG002|NOT COMPLETED|Overall Study||0
10791292|NCT03559530|11951999|FG000|STARTED|Overall Study||197
10791293|NCT03559530|11952000|FG001|STARTED|Overall Study||65
10791294|NCT03559530|11951999|FG000|COMPLETED|Overall Study||106
10791295|NCT03559530|11952000|FG001|COMPLETED|Overall Study||65
10791296|NCT03559530|11951999|FG000|NOT COMPLETED|Overall Study||91
10791297|NCT03559530|11952000|FG001|NOT COMPLETED|Overall Study||0
10791298|NCT03559829|11952005|FG000|STARTED|Overall Study||20
10791299|NCT03559829|11952005|FG000|COMPLETED|Overall Study||20
10791300|NCT03559829|11952005|FG000|NOT COMPLETED|Overall Study||0
10791301|NCT03559933|11952009|FG000|STARTED|Overall Study||12
10791302|NCT03559933|11952009|FG000|COMPLETED|Overall Study||12
10791303|NCT03559933|11952009|FG000|NOT COMPLETED|Overall Study||0
10791304|NCT03560102|11952014|FG000|STARTED|Overall Study||1
10791305|NCT03560102|11952014|FG000|COMPLETED|Overall Study||1
10791306|NCT03560102|11952014|FG000|NOT COMPLETED|Overall Study||0
10791307|NCT03560128|11952020|FG000|STARTED|Overall Study||306
10791308|NCT03560128|11952021|FG001|STARTED|Overall Study||306
10791309|NCT03560128|11952020|FG000|COMPLETED|Overall Study||294
10791310|NCT03560128|11952021|FG001|COMPLETED|Overall Study||298
10791311|NCT03560128|11952020|FG000|NOT COMPLETED|Overall Study||12
10791312|NCT03560128|11952021|FG001|NOT COMPLETED|Overall Study||8
10791313|NCT03560141|11952029|FG000|STARTED|Overall Study||6
10559563|NCT01587703|11714147|FG011|STARTED|Part2(Median Exposure of 1.41 Months)||12
10559564|NCT01587703|11714148|FG012|STARTED|Part2(Median Exposure of 1.41 Months)||14
10559565|NCT01587703|11714149|FG013|STARTED|Part2(Median Exposure of 1.41 Months)||23
10791314|NCT03560141|11952030|FG001|STARTED|Overall Study||5
10791315|NCT03560141|11952029|FG000|COMPLETED|Overall Study||6
10791316|NCT03560141|11952030|FG001|COMPLETED|Overall Study||5
10791317|NCT03560141|11952029|FG000|NOT COMPLETED|Overall Study||0
10791318|NCT03560141|11952030|FG001|NOT COMPLETED|Overall Study||0
10791319|NCT03560245|11952040|FG000|STARTED|Overall Study||53
10791320|NCT03560245|11952041|FG001|STARTED|Overall Study||55
10791321|NCT03560245|11952040|FG000|COMPLETED|Overall Study||48
10791322|NCT03560245|11952041|FG001|COMPLETED|Overall Study||48
10791323|NCT03560245|11952040|FG000|NOT COMPLETED|Overall Study||5
10791324|NCT03560245|11952041|FG001|NOT COMPLETED|Overall Study||7
10791325|NCT03560518|11952052|FG000|STARTED|Double Blind Treatment Period||147
10791326|NCT03560518|11952053|FG001|STARTED|Double Blind Treatment Period||145
10791327|NCT03560518|11952054|FG002|STARTED|Double Blind Treatment Period||147
10791328|NCT03560518|11952052|FG000|COMPLETED|Double Blind Treatment Period||122
10791329|NCT03560518|11952053|FG001|COMPLETED|Double Blind Treatment Period||116
10791330|NCT03560518|11952054|FG002|COMPLETED|Double Blind Treatment Period||124
10791331|NCT03560518|11952052|FG000|NOT COMPLETED|Double Blind Treatment Period||25
10559566|NCT01587703|11714150|FG014|STARTED|Part2(Median Exposure of 1.41 Months)||19
10559567|NCT01587703|11714151|FG015|STARTED|Part2(Median Exposure of 1.41 Months)||21
10559568|NCT01587703|11714152|FG016|STARTED|Part2(Median Exposure of 1.41 Months)||13
10559569|NCT01587703|11714153|FG017|STARTED|Part2(Median Exposure of 1.41 Months)||0
10559570|NCT01587703|11714154|FG018|STARTED|Part2(Median Exposure of 1.41 Months)||0
10559571|NCT01587703|11714136|FG000|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
10559572|NCT01587703|11714137|FG001|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
10559573|NCT01587703|11714138|FG002|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
10559574|NCT01587703|11714139|FG003|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
10559575|NCT01587703|11714140|FG004|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
10559576|NCT01587703|11714141|FG005|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
10559577|NCT01587703|11714142|FG006|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
10559578|NCT01587703|11714143|FG007|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
10559579|NCT01587703|11714144|FG008|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
10559580|NCT01587703|11714145|FG009|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
10559581|NCT01587703|11714146|FG010|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
10559582|NCT01587703|11714147|FG011|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
10559583|NCT01587703|11714148|FG012|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
10559584|NCT01587703|11714149|FG013|COMPLETED|Part2(Median Exposure of 1.41 Months)||1
10559585|NCT01587703|11714150|FG014|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
10559586|NCT01587703|11714151|FG015|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
10559587|NCT01587703|11714152|FG016|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
10559588|NCT01587703|11714153|FG017|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
10559589|NCT01587703|11714154|FG018|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
10559590|NCT01587703|11714136|FG000|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
10559591|NCT01587703|11714137|FG001|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
10559592|NCT01587703|11714138|FG002|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
10559593|NCT01587703|11714139|FG003|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
10559594|NCT01587703|11714140|FG004|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
10559595|NCT01587703|11714141|FG005|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
10559596|NCT01587703|11714142|FG006|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
10559597|NCT01587703|11714143|FG007|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
10559598|NCT01587703|11714144|FG008|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
10559599|NCT01587703|11714145|FG009|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
10559600|NCT01587703|11714146|FG010|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
10559601|NCT01587703|11714147|FG011|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||12
10559602|NCT01587703|11714148|FG012|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||14
10559603|NCT01587703|11714149|FG013|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||22
10559604|NCT01587703|11714150|FG014|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||19
10559605|NCT01587703|11714151|FG015|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||21
10559606|NCT01587703|11714152|FG016|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||13
10559607|NCT01587703|11714153|FG017|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
10559608|NCT01587703|11714154|FG018|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
10559609|NCT01587885|11714213|FG000|STARTED|Treatment Period 1||26
10559610|NCT01587885|11714214|FG001|STARTED|Treatment Period 1||22
10559611|NCT01587885|11714213|FG000|COMPLETED|Treatment Period 1||26
10559612|NCT01587885|11714214|FG001|COMPLETED|Treatment Period 1||19
10559613|NCT01587885|11714213|FG000|NOT COMPLETED|Treatment Period 1||0
10559614|NCT01587885|11714214|FG001|NOT COMPLETED|Treatment Period 1||3
10559615|NCT01587885|11714213|FG000|STARTED|Treatment Period 2||26
10559616|NCT01587885|11714214|FG001|STARTED|Treatment Period 2||19
10559617|NCT01587885|11714213|FG000|COMPLETED|Treatment Period 2||26
10559618|NCT01587885|11714214|FG001|COMPLETED|Treatment Period 2||19
10559619|NCT01587885|11714213|FG000|NOT COMPLETED|Treatment Period 2||0
10559620|NCT01587885|11714214|FG001|NOT COMPLETED|Treatment Period 2||0
10559621|NCT01587898|11714225|FG000|STARTED|Overall Study||18
10559622|NCT01587898|11714226|FG001|STARTED|Overall Study||17
10559623|NCT01587898|11714227|FG002|STARTED|Overall Study||18
10559624|NCT01587898|11714228|FG003|STARTED|Overall Study||19
10559625|NCT01587898|11714225|FG000|COMPLETED|Overall Study||14
10559626|NCT01587898|11714226|FG001|COMPLETED|Overall Study||12
10559627|NCT01587898|11714227|FG002|COMPLETED|Overall Study||16
10559628|NCT01587898|11714228|FG003|COMPLETED|Overall Study||17
10559629|NCT01587898|11714225|FG000|NOT COMPLETED|Overall Study||4
10559630|NCT01587898|11714226|FG001|NOT COMPLETED|Overall Study||5
10559631|NCT01587898|11714227|FG002|NOT COMPLETED|Overall Study||2
10559632|NCT01587898|11714228|FG003|NOT COMPLETED|Overall Study||2
10559633|NCT01587924|11714245|FG000|STARTED|Overall Study||21
10559634|NCT01587924|11714246|FG001|STARTED|Overall Study||21
10559635|NCT01587924|11714247|FG002|STARTED|Overall Study||21
10559636|NCT01587924|11714248|FG003|STARTED|Overall Study||20
10559637|NCT01587924|11714245|FG000|COMPLETED|Overall Study||17
10559638|NCT01587924|11714246|FG001|COMPLETED|Overall Study||17
10559639|NCT01587924|11714247|FG002|COMPLETED|Overall Study||17
10559640|NCT01587924|11714248|FG003|COMPLETED|Overall Study||19
10559641|NCT01587924|11714245|FG000|NOT COMPLETED|Overall Study||4
10559642|NCT01587924|11714246|FG001|NOT COMPLETED|Overall Study||4
10559643|NCT01587924|11714247|FG002|NOT COMPLETED|Overall Study||4
10559644|NCT01587924|11714248|FG003|NOT COMPLETED|Overall Study||1
10559645|NCT01587950|11714258|FG000|STARTED|Period 1||12
10559646|NCT01587950|11714258|FG000|Received 5% KNO3 Solution (5 Minutes)|Period 1||5
10559647|NCT01587950|11714258|FG000|Received 5% KNO3 Solution (2 Minutes)|Period 1||3
10559648|NCT01587950|11714258|FG000|Received Sterile Water (2 Minutes)|Period 1||2
10559649|NCT01587950|11714258|FG000|Received 5% KNO3 Solution (10 Minutes)|Period 1||4
10559650|NCT01587950|11714258|FG000|Received 2.5% KNO3 Solution (2 Minutes)|Period 1||4
10559651|NCT01587950|11714258|FG000|Received 2.5% KNO3 Solution (10 Minutes)|Period 1||3
10559652|NCT01587950|11714258|FG000|Received Sterile Water (10 Minutes)|Period 1||5
10559653|NCT01587950|11714258|FG000|Received 2.5% KNO3 Solution (5 Minutes)|Period 1||5
10559654|NCT01587950|11714258|FG000|Received Sterile Water (5 Minutes)|Period 1||5
10559655|NCT01587950|11714258|FG000|COMPLETED|Period 1||12
10559656|NCT01587950|11714258|FG000|NOT COMPLETED|Period 1||0
10559657|NCT01587950|11714258|FG000|STARTED|Washout 1||12
10559658|NCT01587950|11714258|FG000|COMPLETED|Washout 1||12
10559659|NCT01587950|11714258|FG000|NOT COMPLETED|Washout 1||0
10559660|NCT01587950|11714258|FG000|STARTED|Period 2||12
10559661|NCT01587950|11714258|FG000|Received Sterile Water (2 Minutes)|Period 2||8
10559662|NCT01587950|11714258|FG000|Received 5% KNO3 Solution (10 Minutes)|Period 2||4
10559663|NCT01587950|11714258|FG000|Received 2.5% KNO3 Solution (5 Minutes)|Period 2||2
10559664|NCT01587950|11714258|FG000|Received 2.5% KNO3 Solution (10 Minutes)|Period 2||6
10559665|NCT01587950|11714258|FG000|Received 5% KNO3 Solution (2 Minutes)|Period 2||6
10559666|NCT01587950|11714258|FG000|Received Sterile Water (5 Minutes)|Period 2||2
10559667|NCT01587950|11714258|FG000|Received 2.5% KNO3 Solution (2 Minutes)|Period 2||4
10559668|NCT01587950|11714258|FG000|Received Sterile Water (10 Minutes)|Period 2||2
10559669|NCT01587950|11714258|FG000|Received 5% KNO3 Solution (5 Minutes)|Period 2||2
10559670|NCT01587950|11714258|FG000|COMPLETED|Period 2||12
10559671|NCT01587950|11714258|FG000|NOT COMPLETED|Period 2||0
10559672|NCT01587950|11714258|FG000|STARTED|Washout 2||12
10559673|NCT01587950|11714258|FG000|COMPLETED|Washout 2||12
10559674|NCT01587950|11714258|FG000|NOT COMPLETED|Washout 2||0
10559675|NCT01587950|11714258|FG000|STARTED|Period 3||12
10559676|NCT01587950|11714258|FG000|Received 2.5% KNO3 Solution (2 Minutes)|Period 3||4
10559677|NCT01587950|11714258|FG000|Received Sterile Water (10 Minutes)|Period 3||5
10559678|NCT01587950|11714258|FG000|Received Sterile Water (2 Minutes)|Period 3||2
10559679|NCT01587950|11714258|FG000|Received 5% KNO3 Solution (10 Minutes)|Period 3||4
10559680|NCT01587950|11714258|FG000|Received Sterile Water (5 Minutes)|Period 3||5
10559681|NCT01587950|11714258|FG000|Received 5% KNO3 Solution (5 Minutes)|Period 3||5
10559682|NCT01587950|11714258|FG000|Received 5% KNO3 Solution (2 Minutes)|Period 3||3
10559683|NCT01587950|11714258|FG000|Received 2.5% KNO3 Solution (10 Minutes)|Period 3||3
10559684|NCT01587950|11714258|FG000|Received 2.5% KNO3 Solution (5 Minutes)|Period 3||5
10559685|NCT01587950|11714258|FG000|COMPLETED|Period 3||12
10559686|NCT01587950|11714258|FG000|NOT COMPLETED|Period 3||0
10559687|NCT01587989|11714273|FG000|STARTED|12-Week Open-Label Run-In Period||77
10559688|NCT01587989|11714274|FG001|STARTED|12-Week Open-Label Run-In Period||0
10559689|NCT01587989|11714275|FG002|STARTED|12-Week Open-Label Run-In Period||0
10559690|NCT01587989|11714273|FG000|COMPLETED|12-Week Open-Label Run-In Period||65
10559691|NCT01587989|11714274|FG001|COMPLETED|12-Week Open-Label Run-In Period||0
10559692|NCT01587989|11714275|FG002|COMPLETED|12-Week Open-Label Run-In Period||0
10559693|NCT01587989|11714273|FG000|NOT COMPLETED|12-Week Open-Label Run-In Period||12
10559694|NCT01587989|11714274|FG001|NOT COMPLETED|12-Week Open-Label Run-In Period||0
10559695|NCT01587989|11714275|FG002|NOT COMPLETED|12-Week Open-Label Run-In Period||0
10559696|NCT01587989|11714273|FG000|STARTED|Randomized Study Treatment||0
10559697|NCT01587989|11714274|FG001|STARTED|Randomized Study Treatment||32
10559698|NCT01587989|11714275|FG002|STARTED|Randomized Study Treatment||33
10559699|NCT01587989|11714273|FG000|COMPLETED|Randomized Study Treatment||0
10559700|NCT01587989|11714274|FG001|COMPLETED|Randomized Study Treatment||30
10559701|NCT01587989|11714275|FG002|COMPLETED|Randomized Study Treatment||32
10559702|NCT01587989|11714273|FG000|NOT COMPLETED|Randomized Study Treatment||0
10559703|NCT01587989|11714274|FG001|NOT COMPLETED|Randomized Study Treatment||2
10559704|NCT01587989|11714275|FG002|NOT COMPLETED|Randomized Study Treatment||1
10559705|NCT01588106|11714283|FG000|STARTED|Overall Study||78
10559706|NCT01588106|11714284|FG001|STARTED|Overall Study||76
10559707|NCT01588106|11714283|FG000|COMPLETED|Overall Study||73
10559708|NCT01588106|11714284|FG001|COMPLETED|Overall Study||72
10559709|NCT01588106|11714283|FG000|NOT COMPLETED|Overall Study||5
10559710|NCT01588106|11714284|FG001|NOT COMPLETED|Overall Study||4
10559711|NCT01588158|11714292|FG000|STARTED|Overall Study||4
10559712|NCT01588158|11714293|FG001|STARTED|Overall Study||3
10559713|NCT01588158|11714292|FG000|COMPLETED|Overall Study||4
10559714|NCT01588158|11714293|FG001|COMPLETED|Overall Study||3
10559715|NCT01588158|11714292|FG000|NOT COMPLETED|Overall Study||0
10559716|NCT01588158|11714293|FG001|NOT COMPLETED|Overall Study||0
10559717|NCT01588184|11714305|FG000|STARTED|Overall Study||11
10559718|NCT01588184|11714306|FG001|STARTED|Overall Study||41
10559719|NCT01588184|11714307|FG002|STARTED|Overall Study||7
10559720|NCT01588184|11714308|FG003|STARTED|Overall Study||6
10559721|NCT01588184|11714309|FG004|STARTED|Overall Study||16
10559722|NCT01588184|11714310|FG005|STARTED|Overall Study||14
10559723|NCT01588184|11714305|FG000|COMPLETED|Overall Study||8
10559724|NCT01588184|11714306|FG001|COMPLETED|Overall Study||28
10559725|NCT01588184|11714307|FG002|COMPLETED|Overall Study||5
10559726|NCT01588184|11714308|FG003|COMPLETED|Overall Study||3
10559727|NCT01588184|11714309|FG004|COMPLETED|Overall Study||14
10559728|NCT01588184|11714310|FG005|COMPLETED|Overall Study||10
10559729|NCT01588184|11714305|FG000|NOT COMPLETED|Overall Study||3
10559730|NCT01588184|11714306|FG001|NOT COMPLETED|Overall Study||13
10559731|NCT01588184|11714307|FG002|NOT COMPLETED|Overall Study||2
10559732|NCT01588184|11714308|FG003|NOT COMPLETED|Overall Study||3
10559733|NCT01588184|11714309|FG004|NOT COMPLETED|Overall Study||2
10559734|NCT01588184|11714310|FG005|NOT COMPLETED|Overall Study||4
10559735|NCT01588197|11714326|FG000|STARTED|Overall Study||10
10559736|NCT01588197|11714327|FG001|STARTED|Overall Study||10
10559737|NCT01588197|11714326|FG000|COMPLETED|Overall Study||9
10559738|NCT01588197|11714327|FG001|COMPLETED|Overall Study||9
10559739|NCT01588197|11714326|FG000|NOT COMPLETED|Overall Study||1
10559740|NCT01588197|11714327|FG001|NOT COMPLETED|Overall Study||1
10559741|NCT01588236|11714336|FG000|STARTED|Overall Study||92
10559742|NCT01588236|11714337|FG001|STARTED|Overall Study||94
10559743|NCT01588236|11714338|FG002|STARTED|Overall Study||94
10559744|NCT01588236|11714336|FG000|COMPLETED|Overall Study||76
10559745|NCT01588236|11714337|FG001|COMPLETED|Overall Study||66
10559746|NCT01588236|11714338|FG002|COMPLETED|Overall Study||69
10559747|NCT01588236|11714336|FG000|NOT COMPLETED|Overall Study||16
10559748|NCT01588236|11714337|FG001|NOT COMPLETED|Overall Study||28
10559749|NCT01588236|11714338|FG002|NOT COMPLETED|Overall Study||25
10559750|NCT01588353|11714349|FG000|STARTED|Step1||6
10559751|NCT01588353|11714350|FG001|STARTED|Step1||0
10559752|NCT01588353|11714351|FG002|STARTED|Step1||0
10559753|NCT01588353|11714349|FG000|COMPLETED|Step1||6
10559754|NCT01588353|11714350|FG001|COMPLETED|Step1||0
10559755|NCT01588353|11714351|FG002|COMPLETED|Step1||0
10559756|NCT01588353|11714349|FG000|NOT COMPLETED|Step1||0
10559757|NCT01588353|11714350|FG001|NOT COMPLETED|Step1||0
10559758|NCT01588353|11714351|FG002|NOT COMPLETED|Step1||0
10559759|NCT01588353|11714349|FG000|STARTED|Step2||0
10559760|NCT01588353|11714350|FG001|STARTED|Step2||71
10559761|NCT01588353|11714351|FG002|STARTED|Step2||0
10559762|NCT01588353|11714349|FG000|COMPLETED|Step2||0
10559763|NCT01588353|11714350|FG001|COMPLETED|Step2||70
10559764|NCT01588353|11714351|FG002|COMPLETED|Step2||0
10559765|NCT01588353|11714349|FG000|NOT COMPLETED|Step2||0
10559766|NCT01588353|11714350|FG001|NOT COMPLETED|Step2||1
10559767|NCT01588353|11714351|FG002|NOT COMPLETED|Step2||0
10559768|NCT01588353|11714349|FG000|STARTED|Step3||0
10559769|NCT01588353|11714350|FG001|STARTED|Step3||0
10559770|NCT01588353|11714351|FG002|STARTED|Step3||25
10559771|NCT01588353|11714349|FG000|COMPLETED|Step3||0
10559772|NCT01588353|11714350|FG001|COMPLETED|Step3||0
10559773|NCT01588353|11714351|FG002|COMPLETED|Step3||23
10559774|NCT01588353|11714349|FG000|NOT COMPLETED|Step3||0
10559775|NCT01588353|11714350|FG001|NOT COMPLETED|Step3||0
10559776|NCT01588353|11714351|FG002|NOT COMPLETED|Step3||2
10559777|NCT01588366|11714363|FG000|STARTED|Overall Study||2
10559778|NCT01588366|11714364|FG001|STARTED|Overall Study||7
10559779|NCT01588366|11714365|FG002|STARTED|Overall Study||2
10559780|NCT01588366|11714366|FG003|STARTED|Overall Study||7
10559781|NCT01588366|11714367|FG004|STARTED|Overall Study||3
10559782|NCT01588366|11714368|FG005|STARTED|Overall Study||9
10559783|NCT01588366|11714363|FG000|Received at Least One Dose of Study Drug|Overall Study||2
10559784|NCT01588366|11714364|FG001|Received at Least One Dose of Study Drug|Overall Study||7
10559785|NCT01588366|11714365|FG002|Received at Least One Dose of Study Drug|Overall Study||2
10559786|NCT01588366|11714366|FG003|Received at Least One Dose of Study Drug|Overall Study||7
10559787|NCT01588366|11714367|FG004|Received at Least One Dose of Study Drug|Overall Study||3
10559788|NCT01588366|11714368|FG005|Received at Least One Dose of Study Drug|Overall Study||9
10559789|NCT01588366|11714363|FG000|COMPLETED|Overall Study||2
10559790|NCT01588366|11714364|FG001|COMPLETED|Overall Study||6
10559791|NCT01588366|11714365|FG002|COMPLETED|Overall Study||2
10559792|NCT01588366|11714366|FG003|COMPLETED|Overall Study||6
10559793|NCT01588366|11714367|FG004|COMPLETED|Overall Study||3
10559794|NCT01588366|11714368|FG005|COMPLETED|Overall Study||7
10559795|NCT01588366|11714363|FG000|NOT COMPLETED|Overall Study||0
10559796|NCT01588366|11714364|FG001|NOT COMPLETED|Overall Study||1
10559797|NCT01588366|11714365|FG002|NOT COMPLETED|Overall Study||0
10559798|NCT01588366|11714366|FG003|NOT COMPLETED|Overall Study||1
10559799|NCT01588366|11714367|FG004|NOT COMPLETED|Overall Study||0
10559800|NCT01588366|11714368|FG005|NOT COMPLETED|Overall Study||2
10559801|NCT01588405|11714384|FG000|STARTED|Overall Study||33
10559802|NCT01588405|11714384|FG000|COMPLETED|Overall Study||31
10559803|NCT01588405|11714384|FG000|NOT COMPLETED|Overall Study||2
10559804|NCT01588418|11714391|FG000|STARTED|Overall Study||11
10559805|NCT01588418|11714392|FG001|STARTED|Overall Study||4
10559806|NCT01588418|11714391|FG000|COMPLETED|Overall Study||11
10559807|NCT01588418|11714392|FG001|COMPLETED|Overall Study||4
10559808|NCT01588418|11714391|FG000|NOT COMPLETED|Overall Study||0
10559809|NCT01588418|11714392|FG001|NOT COMPLETED|Overall Study||0
10559810|NCT01588444|11714400|FG000|STARTED|Overall Study||20
10559811|NCT01588444|11714401|FG001|STARTED|Overall Study||20
10559812|NCT01588444|11714400|FG000|COMPLETED|Overall Study||20
10559813|NCT01588444|11714401|FG001|COMPLETED|Overall Study||20
10559814|NCT01588444|11714400|FG000|NOT COMPLETED|Overall Study||0
10559815|NCT01588444|11714401|FG001|NOT COMPLETED|Overall Study||0
10559816|NCT01588457|11714409|FG000|STARTED|Randomization 1||53
10559817|NCT01588457|11714410|FG001|STARTED|Randomization 1||59
10559818|NCT01588457|11714411|FG002|STARTED|Randomization 1|No subject assigned during first randomization to monotherapy|0
10559819|NCT01588457|11714412|FG003|STARTED|Randomization 1|No subject assigned during first randomization to monotherapy|0
10559820|NCT01588457|11714409|FG000|COMPLETED|Randomization 1||30
10559821|NCT01588457|11714410|FG001|COMPLETED|Randomization 1||43
10559822|NCT01588457|11714411|FG002|COMPLETED|Randomization 1||0
10559823|NCT01588457|11714412|FG003|COMPLETED|Randomization 1||0
10559824|NCT01588457|11714409|FG000|NOT COMPLETED|Randomization 1||23
10559825|NCT01588457|11714410|FG001|NOT COMPLETED|Randomization 1||16
10559826|NCT01588457|11714411|FG002|NOT COMPLETED|Randomization 1||0
10559827|NCT01588457|11714412|FG003|NOT COMPLETED|Randomization 1||0
10559828|NCT01588457|11714409|FG000|STARTED|Randomization 2|Some subjects who completed the first randomization had QTP or LTG added to regimen|21
10559829|NCT01588457|11714410|FG001|STARTED|Randomization 2|Some subjects who completed the first randomization had QTP or LTG added to regimen|31
10559830|NCT01588457|11714411|FG002|STARTED|Randomization 2|Assignment of Quetiapine plus monotherapy for symptoms of depression|17
10559831|NCT01588457|11714412|FG003|STARTED|Randomization 2|Assignment of Lamotrigine plus monotherapy for symptoms of depression|18
10559832|NCT01588457|11714409|FG000|COMPLETED|Randomization 2||1
10559833|NCT01588457|11714410|FG001|COMPLETED|Randomization 2||3
10559834|NCT01588457|11714411|FG002|COMPLETED|Randomization 2||12
10559835|NCT01588457|11714412|FG003|COMPLETED|Randomization 2||13
10559836|NCT01588457|11714409|FG000|NOT COMPLETED|Randomization 2||20
10559837|NCT01588457|11714410|FG001|NOT COMPLETED|Randomization 2||28
10559838|NCT01588457|11714411|FG002|NOT COMPLETED|Randomization 2||5
10559839|NCT01588457|11714412|FG003|NOT COMPLETED|Randomization 2||5
10559840|NCT01588470|11714432|FG000|STARTED|Overall Study|First enrolled April 2007|130
10559841|NCT01588470|11714432|FG000|COMPLETED|Overall Study|Completed Dec. 2011|50
10559842|NCT01588470|11714432|FG000|NOT COMPLETED|Overall Study||80
10559843|NCT01588496|11714444|FG000|STARTED|Overall Study||8
10559844|NCT01588496|11714445|FG001|STARTED|Overall Study||17
10559845|NCT01588496|11714446|FG002|STARTED|Overall Study||33
10559846|NCT01588496|11714444|FG000|Received Treatment|Overall Study||8
10559847|NCT01588496|11714445|FG001|Received Treatment|Overall Study||16
10559848|NCT01588496|11714446|FG002|Received Treatment|Overall Study||33
10559849|NCT01588496|11714444|FG000|COMPLETED|Overall Study||8
10559850|NCT01588496|11714445|FG001|COMPLETED|Overall Study||16
10559851|NCT01588496|11714446|FG002|COMPLETED|Overall Study||33
10559852|NCT01588496|11714444|FG000|NOT COMPLETED|Overall Study||0
10559853|NCT01588496|11714445|FG001|NOT COMPLETED|Overall Study||1
10559854|NCT01588496|11714446|FG002|NOT COMPLETED|Overall Study||0
10559855|NCT01588509|11714456|FG000|STARTED|Overall Study||30
10559856|NCT01588509|11714457|FG001|STARTED|Overall Study||30
10559857|NCT01588509|11714456|FG000|Received Treatment|Overall Study||30
10559858|NCT01588509|11714457|FG001|Received Treatment|Overall Study||30
10559859|NCT01588509|11714456|FG000|COMPLETED|Overall Study||29
10559860|NCT01588509|11714457|FG001|COMPLETED|Overall Study||30
10559861|NCT01588509|11714456|FG000|NOT COMPLETED|Overall Study||1
10791332|NCT03560518|11952053|FG001|NOT COMPLETED|Double Blind Treatment Period||29
10791333|NCT03560518|11952054|FG002|NOT COMPLETED|Double Blind Treatment Period||23
10791334|NCT03560518|11952052|FG000|STARTED|Safety Follow-Up Period||10
10791335|NCT03560518|11952053|FG001|STARTED|Safety Follow-Up Period||17
10791336|NCT03560518|11952054|FG002|STARTED|Safety Follow-Up Period||22
10791337|NCT03560518|11952052|FG000|COMPLETED|Safety Follow-Up Period||10
10791338|NCT03560518|11952053|FG001|COMPLETED|Safety Follow-Up Period||17
10791339|NCT03560518|11952054|FG002|COMPLETED|Safety Follow-Up Period||22
10791340|NCT03560518|11952052|FG000|NOT COMPLETED|Safety Follow-Up Period||0
10791341|NCT03560518|11952053|FG001|NOT COMPLETED|Safety Follow-Up Period||0
10791342|NCT03560518|11952054|FG002|NOT COMPLETED|Safety Follow-Up Period||0
10791343|NCT03560739|11952066|FG000|STARTED|Overall Study||128
10791344|NCT03560739|11952067|FG001|STARTED|Overall Study||130
10791345|NCT03560739|11952068|FG002|STARTED|Overall Study||13
10791346|NCT03560739|11952069|FG003|STARTED|Overall Study||13
10791347|NCT03560739|11952066|FG000|COMPLETED|Overall Study||128
10791348|NCT03560739|11952067|FG001|COMPLETED|Overall Study||129
10791349|NCT03560739|11952068|FG002|COMPLETED|Overall Study||13
10791350|NCT03560739|11952069|FG003|COMPLETED|Overall Study||13
10791351|NCT03560739|11952066|FG000|NOT COMPLETED|Overall Study||0
10791352|NCT03560739|11952067|FG001|NOT COMPLETED|Overall Study||1
10791353|NCT03560739|11952068|FG002|NOT COMPLETED|Overall Study||0
10791354|NCT03560739|11952069|FG003|NOT COMPLETED|Overall Study||0
10791355|NCT03560869|11952079|FG000|STARTED|Overall Study||14
10559862|NCT01588509|11714457|FG001|NOT COMPLETED|Overall Study||0
10559863|NCT01588548|11714469|FG000|STARTED|Overall Study||3
10559864|NCT01588548|11714470|FG001|STARTED|Overall Study||7
10559865|NCT01588548|11714471|FG002|STARTED|Overall Study||6
10559866|NCT01588548|11714472|FG003|STARTED|Overall Study||7
10559867|NCT01588548|11714473|FG004|STARTED|Overall Study||6
10559868|NCT01588548|11714474|FG005|STARTED|Overall Study||6
10559869|NCT01588548|11714469|FG000|Cycle 1 Day 21|Overall Study||3
10559870|NCT01588548|11714470|FG001|Cycle 1 Day 21|Overall Study||5
10559871|NCT01588548|11714471|FG002|Cycle 1 Day 21|Overall Study||2
10559872|NCT01588548|11714472|FG003|Cycle 1 Day 21|Overall Study||5
10559873|NCT01588548|11714473|FG004|Cycle 1 Day 21|Overall Study||3
10559874|NCT01588548|11714474|FG005|Cycle 1 Day 21|Overall Study||3
10791356|NCT03560869|11952080|FG001|STARTED|Overall Study||21
10791357|NCT03560869|11952079|FG000|COMPLETED|Overall Study||7
10791358|NCT03560869|11952080|FG001|COMPLETED|Overall Study||12
10791359|NCT03560869|11952079|FG000|NOT COMPLETED|Overall Study||7
10791360|NCT03560869|11952080|FG001|NOT COMPLETED|Overall Study||9
10791361|NCT03560986|11952088|FG000|STARTED|Treatment Period A/Follow-up Period 1||48
10791362|NCT03560986|11952089|FG001|STARTED|Treatment Period A/Follow-up Period 1|One additional participant was allocated to placebo but not treated.|51
10791363|NCT03560986|11952088|FG000|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||45
10791364|NCT03560986|11952089|FG001|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||45
10559875|NCT01588548|11714469|FG000|COMPLETED|Overall Study||0
10559876|NCT01588548|11714470|FG001|COMPLETED|Overall Study||0
10559877|NCT01588548|11714471|FG002|COMPLETED|Overall Study||0
10559878|NCT01588548|11714472|FG003|COMPLETED|Overall Study||0
10559879|NCT01588548|11714473|FG004|COMPLETED|Overall Study||0
10559880|NCT01588548|11714474|FG005|COMPLETED|Overall Study||0
10559881|NCT01588548|11714469|FG000|NOT COMPLETED|Overall Study||3
10559882|NCT01588548|11714470|FG001|NOT COMPLETED|Overall Study||7
10559883|NCT01588548|11714471|FG002|NOT COMPLETED|Overall Study||6
10559884|NCT01588548|11714472|FG003|NOT COMPLETED|Overall Study||7
10559885|NCT01588548|11714473|FG004|NOT COMPLETED|Overall Study||6
10559886|NCT01588548|11714474|FG005|NOT COMPLETED|Overall Study||6
10559887|NCT01588561|11714488|FG000|STARTED|Overall Study||14
10559888|NCT01588561|11714489|FG001|STARTED|Overall Study||1
10559889|NCT01588561|11714488|FG000|First Injection (Visit 1)|Overall Study||14
10559890|NCT01588561|11714489|FG001|First Injection (Visit 1)|Overall Study||1
10559891|NCT01588561|11714488|FG000|Rest Period|Overall Study||14
10559892|NCT01588561|11714489|FG001|Rest Period|Overall Study||1
10559893|NCT01588561|11714488|FG000|Second Injection (Visit 2)|Overall Study||14
10559894|NCT01588561|11714489|FG001|Second Injection (Visit 2)|Overall Study||1
10559895|NCT01588561|11714488|FG000|COMPLETED|Overall Study||14
10559896|NCT01588561|11714489|FG001|COMPLETED|Overall Study||1
10559897|NCT01588561|11714488|FG000|NOT COMPLETED|Overall Study||0
10559898|NCT01588561|11714489|FG001|NOT COMPLETED|Overall Study||0
10559899|NCT01588821|11714495|FG000|STARTED|Overall Study||37
10559900|NCT01588821|11714495|FG000|COMPLETED|Overall Study||37
10559901|NCT01588821|11714495|FG000|NOT COMPLETED|Overall Study||0
10559902|NCT01588951|11714503|FG000|STARTED|Overall Study||2
10559903|NCT01588951|11714504|FG001|STARTED|Overall Study||2
10559904|NCT01588951|11714505|FG002|STARTED|Overall Study||6
10559905|NCT01588951|11714503|FG000|COMPLETED|Overall Study||2
10559906|NCT01588951|11714504|FG001|COMPLETED|Overall Study||2
10559907|NCT01588951|11714505|FG002|COMPLETED|Overall Study||5
10559908|NCT01588951|11714503|FG000|NOT COMPLETED|Overall Study||0
10559909|NCT01588951|11714504|FG001|NOT COMPLETED|Overall Study||0
10559910|NCT01588951|11714505|FG002|NOT COMPLETED|Overall Study||1
10559911|NCT01588990|11714513|FG000|STARTED|Phase A||128
10559912|NCT01588990|11714513|FG000|COMPLETED|Phase A|A total of 58 participants had disease progression in Phase A and ended Phase A.|58
10559913|NCT01588990|11714513|FG000|NOT COMPLETED|Phase A||70
10559914|NCT01588990|11714513|FG000|STARTED|Phase B|Of 58 participants who had documented disease progression in Phase A, 53 entered in Phase B.|53
10559915|NCT01588990|11714513|FG000|COMPLETED|Phase B|A total of 37 participants had disease progression in Phase B and ended Phase B.|37
10559916|NCT01588990|11714513|FG000|NOT COMPLETED|Phase B||16
10559917|NCT01589094|11714521|FG000|STARTED|Overall Study||51
10559918|NCT01589094|11714521|FG000|COMPLETED|Overall Study||49
10559919|NCT01589094|11714521|FG000|NOT COMPLETED|Overall Study||2
10559920|NCT01589185|11714530|FG000|STARTED|Overall Study||6
10559921|NCT01589185|11714531|FG001|STARTED|Overall Study||8
10559922|NCT01589185|11714532|FG002|STARTED|Overall Study||10
10559923|NCT01589185|11714533|FG003|STARTED|Overall Study||8
10559924|NCT01589185|11714534|FG004|STARTED|Overall Study||16
10559925|NCT01589185|11714530|FG000|COMPLETED|Overall Study||4
10559926|NCT01589185|11714531|FG001|COMPLETED|Overall Study||6
10559927|NCT01589185|11714532|FG002|COMPLETED|Overall Study||6
10559928|NCT01589185|11714533|FG003|COMPLETED|Overall Study||5
10559929|NCT01589185|11714534|FG004|COMPLETED|Overall Study||15
10559930|NCT01589185|11714530|FG000|NOT COMPLETED|Overall Study||2
10559931|NCT01589185|11714531|FG001|NOT COMPLETED|Overall Study||2
10559932|NCT01589185|11714532|FG002|NOT COMPLETED|Overall Study||4
10559933|NCT01589185|11714533|FG003|NOT COMPLETED|Overall Study||3
10559934|NCT01589185|11714534|FG004|NOT COMPLETED|Overall Study||1
10559935|NCT01589237|11714551|FG000|STARTED|Part A (52 Weeks)|"Started = Full analysis set/safety set"|11
10559936|NCT01589237|11714552|FG001|STARTED|Part A (52 Weeks)||12
10559937|NCT01589237|11714553|FG002|STARTED|Part A (52 Weeks)||10
10559938|NCT01589237|11714554|FG003|STARTED|Part A (52 Weeks)||5
10559939|NCT01589237|11714551|FG000|COMPLETED|Part A (52 Weeks)||9
10559940|NCT01589237|11714552|FG001|COMPLETED|Part A (52 Weeks)||9
10559941|NCT01589237|11714553|FG002|COMPLETED|Part A (52 Weeks)||8
10559942|NCT01589237|11714554|FG003|COMPLETED|Part A (52 Weeks)||5
10559943|NCT01589237|11714551|FG000|NOT COMPLETED|Part A (52 Weeks)||2
10559944|NCT01589237|11714552|FG001|NOT COMPLETED|Part A (52 Weeks)||3
10559945|NCT01589237|11714553|FG002|NOT COMPLETED|Part A (52 Weeks)||2
10559946|NCT01589237|11714554|FG003|NOT COMPLETED|Part A (52 Weeks)||0
10559947|NCT01589237|11714551|FG000|STARTED|Part B (Planned for 78 Week-terminated)||5
10559948|NCT01589237|11714552|FG001|STARTED|Part B (Planned for 78 Week-terminated)||6
10559949|NCT01589237|11714553|FG002|STARTED|Part B (Planned for 78 Week-terminated)||4
10559950|NCT01589237|11714554|FG003|STARTED|Part B (Planned for 78 Week-terminated)||4
10559951|NCT01589237|11714551|FG000|COMPLETED|Part B (Planned for 78 Week-terminated)||0
10559952|NCT01589237|11714552|FG001|COMPLETED|Part B (Planned for 78 Week-terminated)||0
10559953|NCT01589237|11714553|FG002|COMPLETED|Part B (Planned for 78 Week-terminated)||0
10559954|NCT01589237|11714554|FG003|COMPLETED|Part B (Planned for 78 Week-terminated)||0
10559955|NCT01589237|11714551|FG000|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||5
10559956|NCT01589237|11714552|FG001|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||6
10559957|NCT01589237|11714553|FG002|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||4
10559958|NCT01589237|11714554|FG003|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||4
10559959|NCT01589263|11714570|FG000|STARTED|Overall Study||9
10559960|NCT01589263|11714571|FG001|STARTED|Overall Study||12
10559961|NCT01589263|11714570|FG000|COMPLETED|Overall Study||9
10559962|NCT01589263|11714571|FG001|COMPLETED|Overall Study||12
10559963|NCT01589263|11714570|FG000|NOT COMPLETED|Overall Study||0
10559964|NCT01589263|11714571|FG001|NOT COMPLETED|Overall Study||0
10559970|NCT01589315|11714582|FG000|STARTED|Overall Study||17
10559971|NCT01589315|11714582|FG000|COMPLETED|Overall Study||16
10559972|NCT01589315|11714582|FG000|NOT COMPLETED|Overall Study||1
10559973|NCT01589445|11714586|FG000|STARTED|001 (Pioglitazone) -3 Months||77
10559974|NCT01589445|11714586|FG000|COMPLETED|001 (Pioglitazone) -3 Months|dropped out 7 patients|70
10559975|NCT01589445|11714586|FG000|NOT COMPLETED|001 (Pioglitazone) -3 Months||7
10559976|NCT01589445|11714586|FG000|STARTED|002 (Metformin)-3 Months|70 patients participated for trial of drug 002.|70
10559977|NCT01589445|11714586|FG000|COMPLETED|002 (Metformin)-3 Months|61 patients completed the drug 002.9 patients dropped out.|61
10559978|NCT01589445|11714586|FG000|NOT COMPLETED|002 (Metformin)-3 Months||9
10559979|NCT01589484|11714594|FG000|STARTED|Overall Study||104
10559980|NCT01589484|11714594|FG000|COMPLETED|Overall Study||100
10559981|NCT01589484|11714594|FG000|NOT COMPLETED|Overall Study||4
10559982|NCT01589497|11714603|FG000|STARTED|Overall Study||18
10559983|NCT01589497|11714604|FG001|STARTED|Overall Study||17
10559984|NCT01589497|11714605|FG002|STARTED|Overall Study||16
10559985|NCT01589497|11714606|FG003|STARTED|Overall Study||18
10559986|NCT01589497|11714603|FG000|COMPLETED|Overall Study|1 participant who completed study but had insufficient sputum volume was excluded from the analyses|17
10559987|NCT01589497|11714604|FG001|COMPLETED|Overall Study|1 participant who completed study but had insufficient sputum volume was excluded from the analyses|16
10559988|NCT01589497|11714605|FG002|COMPLETED|Overall Study||15
10559989|NCT01589497|11714606|FG003|COMPLETED|Overall Study||17
10559990|NCT01589497|11714603|FG000|NOT COMPLETED|Overall Study||1
10559991|NCT01589497|11714604|FG001|NOT COMPLETED|Overall Study||1
10559992|NCT01589497|11714605|FG002|NOT COMPLETED|Overall Study||1
10559993|NCT01589497|11714606|FG003|NOT COMPLETED|Overall Study||1
10559994|NCT01589510|11714621|FG000|STARTED|Overall Study||419
10559995|NCT01589510|11714621|FG000|COMPLETED|Overall Study||386
10559996|NCT01589510|11714621|FG000|NOT COMPLETED|Overall Study||33
10559997|NCT01589601|11714627|FG000|STARTED|Overall Study||75
10559998|NCT01589601|11714628|FG001|STARTED|Overall Study||75
10559999|NCT01589601|11714627|FG000|COMPLETED|Overall Study||28
10560000|NCT01589601|11714628|FG001|COMPLETED|Overall Study||26
10560001|NCT01589601|11714627|FG000|NOT COMPLETED|Overall Study||47
10560002|NCT01589601|11714628|FG001|NOT COMPLETED|Overall Study||49
10560003|NCT01589653|11714636|FG000|STARTED|Overall Study||76
10560004|NCT01589653|11714637|FG001|STARTED|Overall Study||79
10560005|NCT01589653|11714636|FG000|Exposed|Overall Study||76
10560006|NCT01589653|11714637|FG001|Exposed|Overall Study||78
10560007|NCT01589653|11714636|FG000|COMPLETED|Overall Study||69
10560008|NCT01589653|11714637|FG001|COMPLETED|Overall Study||68
10560009|NCT01589653|11714636|FG000|NOT COMPLETED|Overall Study||7
10560010|NCT01589653|11714637|FG001|NOT COMPLETED|Overall Study||11
10560011|NCT01589770|11714645|FG000|STARTED|Overall Study||67
10560012|NCT01589770|11714646|FG001|STARTED|Overall Study||61
10560013|NCT01589770|11714645|FG000|COMPLETED|Overall Study||59
10560014|NCT01589770|11714646|FG001|COMPLETED|Overall Study||56
10560015|NCT01589770|11714645|FG000|NOT COMPLETED|Overall Study||8
10560016|NCT01589770|11714646|FG001|NOT COMPLETED|Overall Study||5
10560017|NCT01589822|11714655|FG000|STARTED|Overall Study||84
10560018|NCT01589822|11714656|FG001|STARTED|Overall Study||89
10560019|NCT01589822|11714657|FG002|STARTED|Overall Study||41
10560020|NCT01589822|11714655|FG000|COMPLETED|Overall Study||80
10560021|NCT01589822|11714656|FG001|COMPLETED|Overall Study||86
10560022|NCT01589822|11714657|FG002|COMPLETED|Overall Study||40
10560023|NCT01589822|11714655|FG000|NOT COMPLETED|Overall Study||4
10560024|NCT01589822|11714656|FG001|NOT COMPLETED|Overall Study||3
10560025|NCT01589822|11714657|FG002|NOT COMPLETED|Overall Study||1
10560026|NCT01589978|11714667|FG000|STARTED|Overall Study||2681
10560027|NCT01589978|11714667|FG000|COMPLETED|Overall Study||2681
10560028|NCT01589978|11714667|FG000|NOT COMPLETED|Overall Study||0
10560032|NCT01590082|11714678|FG000|STARTED|Overall Study||11
10560033|NCT01590082|11714679|FG001|STARTED|Overall Study||1
10560034|NCT01590082|11714678|FG000|COMPLETED|Overall Study||9
10560035|NCT01590082|11714679|FG001|COMPLETED|Overall Study||1
10560036|NCT01590082|11714678|FG000|NOT COMPLETED|Overall Study||2
10560037|NCT01590082|11714679|FG001|NOT COMPLETED|Overall Study||0
10560038|NCT01590212|11714688|FG000|STARTED|Overall Study||12
10560039|NCT01590212|11714689|FG001|STARTED|Overall Study||9
10560040|NCT01590212|11714690|FG002|STARTED|Overall Study||14
10560041|NCT01590212|11714688|FG000|Baseline (Pre-intervention)|Overall Study|withdrew=2|10
10560042|NCT01590212|11714689|FG001|Baseline (Pre-intervention)|Overall Study||9
10560043|NCT01590212|11714690|FG002|Baseline (Pre-intervention)|Overall Study|failed contact=2|12
10560044|NCT01590212|11714688|FG000|Post-intervention|Overall Study|failed contact=3|7
10560045|NCT01590212|11714689|FG001|Post-intervention|Overall Study|failed contact=2; withdrew=1|6
10560046|NCT01590212|11714690|FG002|Post-intervention|Overall Study|failed contact=1|10
10650887|NCT02173522|11811273|FG001|STARTED|Overall Study||0
10560047|NCT01590212|11714688|FG000|COMPLETED|Overall Study|Includes 2 contacted who failed contact at post-intervention data collection point|9
10560048|NCT01590212|11714689|FG001|COMPLETED|Overall Study||5
10560049|NCT01590212|11714690|FG002|COMPLETED|Overall Study||9
10560050|NCT01590212|11714688|FG000|NOT COMPLETED|Overall Study||3
10560051|NCT01590212|11714689|FG001|NOT COMPLETED|Overall Study||4
10560052|NCT01590212|11714690|FG002|NOT COMPLETED|Overall Study||5
10560053|NCT01590238|11714699|FG000|STARTED|Overall Study||15
10560054|NCT01590238|11714699|FG000|COMPLETED|Overall Study||13
10560055|NCT01590238|11714699|FG000|NOT COMPLETED|Overall Study||2
10560056|NCT01590264|11714703|FG000|STARTED|Overall Study||5
10560057|NCT01590264|11714703|FG000|COMPLETED|Overall Study||5
10560058|NCT01590264|11714703|FG000|NOT COMPLETED|Overall Study||0
10560059|NCT01590433|11714709|FG000|STARTED|Overall Study||127
10560060|NCT01590433|11714710|FG001|STARTED|Overall Study||55
10560061|NCT01590433|11714709|FG000|COMPLETED|Overall Study||75
10560062|NCT01590433|11714710|FG001|COMPLETED|Overall Study||33
10560063|NCT01590433|11714709|FG000|NOT COMPLETED|Overall Study||52
10560064|NCT01590433|11714710|FG001|NOT COMPLETED|Overall Study||22
10560065|NCT01590550|11714716|FG000|STARTED|Overall Study||18
10560066|NCT01590550|11714716|FG000|COMPLETED|Overall Study||18
10560067|NCT01590550|11714716|FG000|NOT COMPLETED|Overall Study||0
10560068|NCT01590563|11714721|FG000|STARTED|Overall Study||15
10560069|NCT01590563|11714721|FG000|COMPLETED|Overall Study||14
10560070|NCT01590563|11714721|FG000|NOT COMPLETED|Overall Study||1
10560071|NCT01590758|11714728|FG000|STARTED|Overall Study||85
10560072|NCT01590758|11714729|FG001|STARTED|Overall Study||104
10560073|NCT01590758|11714728|FG000|COMPLETED|Overall Study||80
10560074|NCT01590758|11714729|FG001|COMPLETED|Overall Study||97
10560075|NCT01590758|11714728|FG000|NOT COMPLETED|Overall Study||5
10560076|NCT01590758|11714729|FG001|NOT COMPLETED|Overall Study||7
10560077|NCT01590771|11714737|FG000|STARTED|Overall Study||249
10560078|NCT01590771|11714738|FG001|STARTED|Overall Study||249
10560079|NCT01590771|11714737|FG000|COMPLETED|Overall Study||230
10560080|NCT01590771|11714738|FG001|COMPLETED|Overall Study||210
10560081|NCT01590771|11714737|FG000|NOT COMPLETED|Overall Study||19
10560082|NCT01590771|11714738|FG001|NOT COMPLETED|Overall Study||39
10560083|NCT01590797|11714746|FG000|STARTED|Overall Study||234
10560084|NCT01590797|11714747|FG001|STARTED|Overall Study||233
10560085|NCT01590797|11714746|FG000|COMPLETED|Overall Study||217
10560086|NCT01590797|11714747|FG001|COMPLETED|Overall Study||217
10560087|NCT01590797|11714746|FG000|NOT COMPLETED|Overall Study||17
10560088|NCT01590797|11714747|FG001|NOT COMPLETED|Overall Study||16
10560089|NCT01590810|11714758|FG000|STARTED|Overall Study||8
10560090|NCT01590810|11714759|FG001|STARTED|Overall Study||8
10560091|NCT01590810|11714760|FG002|STARTED|Overall Study||8
10560092|NCT01590810|11714761|FG003|STARTED|Overall Study||8
10560093|NCT01590810|11714762|FG004|STARTED|Overall Study||2
10560094|NCT01590810|11714758|FG000|COMPLETED|Overall Study||8
10560095|NCT01590810|11714759|FG001|COMPLETED|Overall Study||7
10560096|NCT01590810|11714760|FG002|COMPLETED|Overall Study||7
10560097|NCT01590810|11714761|FG003|COMPLETED|Overall Study||8
10560098|NCT01590810|11714762|FG004|COMPLETED|Overall Study||2
10560099|NCT01590810|11714758|FG000|NOT COMPLETED|Overall Study||0
10560100|NCT01590810|11714759|FG001|NOT COMPLETED|Overall Study||1
10560101|NCT01590810|11714760|FG002|NOT COMPLETED|Overall Study||1
10560102|NCT01590810|11714761|FG003|NOT COMPLETED|Overall Study||0
10560103|NCT01590810|11714762|FG004|NOT COMPLETED|Overall Study||0
10560104|NCT01590875|11714797|FG000|STARTED|Overall Study||10
10560105|NCT01590875|11714798|FG001|STARTED|Overall Study||10
10560106|NCT01590875|11714797|FG000|COMPLETED|Overall Study||10
10560107|NCT01590875|11714798|FG001|COMPLETED|Overall Study||10
10560108|NCT01590875|11714797|FG000|NOT COMPLETED|Overall Study||0
10560109|NCT01590875|11714798|FG001|NOT COMPLETED|Overall Study||0
10560110|NCT01590888|11714809|FG000|STARTED|Overall Study||36
10560111|NCT01590888|11714810|FG001|STARTED|Overall Study||38
10560112|NCT01590888|11714811|FG002|STARTED|Overall Study||35
10560113|NCT01590888|11714809|FG000|COMPLETED|Overall Study||32
10560114|NCT01590888|11714810|FG001|COMPLETED|Overall Study||38
10560115|NCT01590888|11714811|FG002|COMPLETED|Overall Study||34
10560116|NCT01590888|11714809|FG000|NOT COMPLETED|Overall Study||4
10560117|NCT01590888|11714810|FG001|NOT COMPLETED|Overall Study||0
10560118|NCT01590888|11714811|FG002|NOT COMPLETED|Overall Study||1
10560119|NCT01590979|11714821|FG000|STARTED|Overall Study||27
10560120|NCT01590979|11714822|FG001|STARTED|Overall Study||27
10560121|NCT01590979|11714821|FG000|COMPLETED|Overall Study||27
10560122|NCT01590979|11714822|FG001|COMPLETED|Overall Study||27
10560123|NCT01590979|11714821|FG000|NOT COMPLETED|Overall Study||0
10560124|NCT01590979|11714822|FG001|NOT COMPLETED|Overall Study||0
10560125|NCT01591005|11714832|FG000|STARTED|Overall Study||53
10560126|NCT01591005|11714833|FG001|STARTED|Overall Study||53
10560127|NCT01591005|11714834|FG002|STARTED|Overall Study||68
10560128|NCT01591005|11714835|FG003|STARTED|Overall Study||68
10560129|NCT01591005|11714832|FG000|COMPLETED|Overall Study||53
10560130|NCT01591005|11714833|FG001|COMPLETED|Overall Study||53
10560131|NCT01591005|11714834|FG002|COMPLETED|Overall Study||68
10560132|NCT01591005|11714835|FG003|COMPLETED|Overall Study||68
10560133|NCT01591005|11714832|FG000|NOT COMPLETED|Overall Study||0
10560134|NCT01591005|11714833|FG001|NOT COMPLETED|Overall Study||0
10560135|NCT01591005|11714834|FG002|NOT COMPLETED|Overall Study||0
10560136|NCT01591005|11714835|FG003|NOT COMPLETED|Overall Study||0
10560137|NCT01591018|11714847|FG000|STARTED|Overall Study||60
10560138|NCT01591018|11714848|FG001|STARTED|Overall Study||60
10560139|NCT01591018|11714847|FG000|COMPLETED|Overall Study||60
10560140|NCT01591018|11714848|FG001|COMPLETED|Overall Study||60
10560141|NCT01591018|11714847|FG000|NOT COMPLETED|Overall Study||0
10560142|NCT01591018|11714848|FG001|NOT COMPLETED|Overall Study||0
10560143|NCT01591044|11714857|FG000|STARTED|Overall Study||101
10560144|NCT01591044|11714858|FG001|STARTED|Overall Study||100
10560145|NCT01591044|11714859|FG002|STARTED|Overall Study||100
10560146|NCT01591044|11714857|FG000|COMPLETED|Overall Study||94
10560147|NCT01591044|11714858|FG001|COMPLETED|Overall Study||91
10560148|NCT01591044|11714859|FG002|COMPLETED|Overall Study||96
10560149|NCT01591044|11714857|FG000|NOT COMPLETED|Overall Study||7
10560150|NCT01591044|11714858|FG001|NOT COMPLETED|Overall Study||9
10560151|NCT01591044|11714859|FG002|NOT COMPLETED|Overall Study||4
10560152|NCT01591161|11714869|FG000|STARTED|Overall Study||245
10560153|NCT01591161|11714870|FG001|STARTED|Overall Study||124
10560154|NCT01591161|11714869|FG000|COMPLETED|Overall Study||174
10560155|NCT01591161|11714870|FG001|COMPLETED|Overall Study||68
10560156|NCT01591161|11714869|FG000|NOT COMPLETED|Overall Study||71
10560157|NCT01591161|11714870|FG001|NOT COMPLETED|Overall Study||56
10560158|NCT01591317|11714879|FG000|STARTED|Overall Study||10
10560159|NCT01591317|11714880|FG001|STARTED|Overall Study||10
10560160|NCT01591317|11714881|FG002|STARTED|Overall Study||10
10560161|NCT01591317|11714879|FG000|COMPLETED|Overall Study||10
10560162|NCT01591317|11714880|FG001|COMPLETED|Overall Study||10
10560163|NCT01591317|11714881|FG002|COMPLETED|Overall Study||10
10560164|NCT01591317|11714879|FG000|NOT COMPLETED|Overall Study||0
10560165|NCT01591317|11714880|FG001|NOT COMPLETED|Overall Study||0
10560166|NCT01591317|11714881|FG002|NOT COMPLETED|Overall Study||0
10560167|NCT01591330|11714894|FG000|STARTED|Period 1||8
10560168|NCT01591330|11714895|FG001|STARTED|Period 1||9
10560169|NCT01591330|11714896|FG002|STARTED|Period 1||9
10560170|NCT01591330|11714897|FG003|STARTED|Period 1||9
10560171|NCT01591330|11714894|FG000|Received at Least 1 Dose of Study Drug|Period 1||8
10560172|NCT01591330|11714895|FG001|Received at Least 1 Dose of Study Drug|Period 1||9
10560173|NCT01591330|11714896|FG002|Received at Least 1 Dose of Study Drug|Period 1||9
10560174|NCT01591330|11714897|FG003|Received at Least 1 Dose of Study Drug|Period 1||9
10560175|NCT01591330|11714894|FG000|COMPLETED|Period 1||7
10560176|NCT01591330|11714895|FG001|COMPLETED|Period 1||9
10560177|NCT01591330|11714896|FG002|COMPLETED|Period 1||9
10560178|NCT01591330|11714897|FG003|COMPLETED|Period 1||9
10560179|NCT01591330|11714894|FG000|NOT COMPLETED|Period 1||1
10560180|NCT01591330|11714895|FG001|NOT COMPLETED|Period 1||0
10560181|NCT01591330|11714896|FG002|NOT COMPLETED|Period 1||0
10560182|NCT01591330|11714897|FG003|NOT COMPLETED|Period 1||0
10560183|NCT01591330|11714894|FG000|STARTED|Washout of at Least 3 Days||7
10560184|NCT01591330|11714895|FG001|STARTED|Washout of at Least 3 Days||9
10560185|NCT01591330|11714896|FG002|STARTED|Washout of at Least 3 Days||9
10560186|NCT01591330|11714897|FG003|STARTED|Washout of at Least 3 Days||9
10560187|NCT01591330|11714894|FG000|COMPLETED|Washout of at Least 3 Days||6
10560188|NCT01591330|11714895|FG001|COMPLETED|Washout of at Least 3 Days||9
10560189|NCT01591330|11714896|FG002|COMPLETED|Washout of at Least 3 Days||9
10560190|NCT01591330|11714897|FG003|COMPLETED|Washout of at Least 3 Days||9
10560191|NCT01591330|11714894|FG000|NOT COMPLETED|Washout of at Least 3 Days||1
10560192|NCT01591330|11714895|FG001|NOT COMPLETED|Washout of at Least 3 Days||0
10560193|NCT01591330|11714896|FG002|NOT COMPLETED|Washout of at Least 3 Days||0
10560194|NCT01591330|11714897|FG003|NOT COMPLETED|Washout of at Least 3 Days||0
10560195|NCT01591330|11714894|FG000|STARTED|Period 2||6
10560196|NCT01591330|11714895|FG001|STARTED|Period 2||9
10560197|NCT01591330|11714896|FG002|STARTED|Period 2||9
10560198|NCT01591330|11714897|FG003|STARTED|Period 2||9
10560199|NCT01591330|11714894|FG000|COMPLETED|Period 2||5
10560200|NCT01591330|11714895|FG001|COMPLETED|Period 2||9
10560201|NCT01591330|11714896|FG002|COMPLETED|Period 2||9
10560202|NCT01591330|11714897|FG003|COMPLETED|Period 2||9
10791365|NCT03560986|11952088|FG000|COMPLETED|Treatment Period A/Follow-up Period 1||12
10791366|NCT03560986|11952089|FG001|COMPLETED|Treatment Period A/Follow-up Period 1||13
10791367|NCT03560986|11952088|FG000|NOT COMPLETED|Treatment Period A/Follow-up Period 1||36
10791368|NCT03560986|11952089|FG001|NOT COMPLETED|Treatment Period A/Follow-up Period 1||38
10560203|NCT01591330|11714894|FG000|NOT COMPLETED|Period 2||1
10560204|NCT01591330|11714895|FG001|NOT COMPLETED|Period 2||0
10560205|NCT01591330|11714896|FG002|NOT COMPLETED|Period 2||0
10560206|NCT01591330|11714897|FG003|NOT COMPLETED|Period 2||0
10560207|NCT01591330|11714894|FG000|STARTED|Washout of at Least 3 Days||5
10560208|NCT01591330|11714895|FG001|STARTED|Washout of at Least 3 Days||9
10560209|NCT01591330|11714896|FG002|STARTED|Washout of at Least 3 Days||9
10560210|NCT01591330|11714897|FG003|STARTED|Washout of at Least 3 Days||9
10560211|NCT01591330|11714894|FG000|COMPLETED|Washout of at Least 3 Days||5
10560212|NCT01591330|11714895|FG001|COMPLETED|Washout of at Least 3 Days||9
10560213|NCT01591330|11714896|FG002|COMPLETED|Washout of at Least 3 Days||9
10560214|NCT01591330|11714897|FG003|COMPLETED|Washout of at Least 3 Days||9
10560215|NCT01591330|11714894|FG000|NOT COMPLETED|Washout of at Least 3 Days||0
10810726|NCT03792672|11972461|FG005|STARTED|Washout Period 2 (10 Days)||4
10560216|NCT01591330|11714895|FG001|NOT COMPLETED|Washout of at Least 3 Days||0
10560217|NCT01591330|11714896|FG002|NOT COMPLETED|Washout of at Least 3 Days||0
10560218|NCT01591330|11714897|FG003|NOT COMPLETED|Washout of at Least 3 Days||0
10560219|NCT01591330|11714894|FG000|STARTED|Period 3||5
10560220|NCT01591330|11714895|FG001|STARTED|Period 3||9
10560221|NCT01591330|11714896|FG002|STARTED|Period 3||9
10560222|NCT01591330|11714897|FG003|STARTED|Period 3||9
10560223|NCT01591330|11714894|FG000|COMPLETED|Period 3||5
10791369|NCT03560986|11952088|FG000|STARTED|Treatment Period B/Follow-up Period 2|3 Participants completed Treatment Period A/Follow-up Period 1 but were not allocated in Period B.|9
10791370|NCT03560986|11952089|FG001|STARTED|Treatment Period B/Follow-up Period 2|5 Part. completed Placebo Treatment Period A/Follow-up Period 1 but were not allocated in Period B.|8
10791371|NCT03560986|11952088|FG000|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||8
10791372|NCT03560986|11952089|FG001|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||8
10791373|NCT03560986|11952088|FG000|COMPLETED|Treatment Period B/Follow-up Period 2||1
10791374|NCT03560986|11952089|FG001|COMPLETED|Treatment Period B/Follow-up Period 2||0
10791375|NCT03560986|11952088|FG000|NOT COMPLETED|Treatment Period B/Follow-up Period 2||8
10791376|NCT03560986|11952089|FG001|NOT COMPLETED|Treatment Period B/Follow-up Period 2||8
10791377|NCT03561090|11952103|FG000|STARTED|Overall Study||247
10791378|NCT03561090|11952104|FG001|STARTED|Overall Study||248
10560224|NCT01591330|11714895|FG001|COMPLETED|Period 3||9
10560225|NCT01591330|11714896|FG002|COMPLETED|Period 3||9
10560226|NCT01591330|11714897|FG003|COMPLETED|Period 3||9
10560227|NCT01591330|11714894|FG000|NOT COMPLETED|Period 3||0
10560228|NCT01591330|11714895|FG001|NOT COMPLETED|Period 3||0
10560229|NCT01591330|11714896|FG002|NOT COMPLETED|Period 3||0
10560230|NCT01591330|11714897|FG003|NOT COMPLETED|Period 3||0
10560231|NCT01591330|11714894|FG000|STARTED|Washout of at Least 3 Days||5
10560232|NCT01591330|11714895|FG001|STARTED|Washout of at Least 3 Days||9
10560233|NCT01591330|11714896|FG002|STARTED|Washout of at Least 3 Days||9
10560234|NCT01591330|11714897|FG003|STARTED|Washout of at Least 3 Days||9
10560235|NCT01591330|11714894|FG000|COMPLETED|Washout of at Least 3 Days||5
10560236|NCT01591330|11714895|FG001|COMPLETED|Washout of at Least 3 Days||9
10560237|NCT01591330|11714896|FG002|COMPLETED|Washout of at Least 3 Days||9
10560238|NCT01591330|11714897|FG003|COMPLETED|Washout of at Least 3 Days||9
10560239|NCT01591330|11714894|FG000|NOT COMPLETED|Washout of at Least 3 Days||0
10560240|NCT01591330|11714895|FG001|NOT COMPLETED|Washout of at Least 3 Days||0
10560241|NCT01591330|11714896|FG002|NOT COMPLETED|Washout of at Least 3 Days||0
10560242|NCT01591330|11714897|FG003|NOT COMPLETED|Washout of at Least 3 Days||0
10560243|NCT01591330|11714894|FG000|STARTED|Period 4||5
10791379|NCT03561090|11952103|FG000|Randomized and Treated|Overall Study||246
10791380|NCT03561090|11952104|FG001|Randomized and Treated|Overall Study||247
10791381|NCT03561090|11952103|FG000|COMPLETED|Overall Study||207
10791382|NCT03561090|11952104|FG001|COMPLETED|Overall Study||212
10791383|NCT03561090|11952103|FG000|NOT COMPLETED|Overall Study||40
10791384|NCT03561090|11952104|FG001|NOT COMPLETED|Overall Study||36
10791385|NCT03561883|11952114|FG000|STARTED|Overall Study||305
10791386|NCT03561883|11952115|FG001|STARTED|Overall Study||304
10791387|NCT03561883|11952114|FG000|COMPLETED|Overall Study||259
10791388|NCT03561883|11952115|FG001|COMPLETED|Overall Study||261
10791389|NCT03561883|11952114|FG000|NOT COMPLETED|Overall Study||46
10791390|NCT03561883|11952115|FG001|NOT COMPLETED|Overall Study||43
10791391|NCT03562117|11952124|FG000|STARTED|Part 1, Up to 3 Days||8
10791392|NCT03562117|11952125|FG001|STARTED|Part 1, Up to 3 Days||8
10791393|NCT03562117|11952126|FG002|STARTED|Part 1, Up to 3 Days||0
10791394|NCT03562117|11952124|FG000|COMPLETED|Part 1, Up to 3 Days||7
10791395|NCT03562117|11952125|FG001|COMPLETED|Part 1, Up to 3 Days||8
10791396|NCT03562117|11952126|FG002|COMPLETED|Part 1, Up to 3 Days||0
10791397|NCT03562117|11952124|FG000|NOT COMPLETED|Part 1, Up to 3 Days||1
10791398|NCT03562117|11952125|FG001|NOT COMPLETED|Part 1, Up to 3 Days||0
10791399|NCT03562117|11952126|FG002|NOT COMPLETED|Part 1, Up to 3 Days||0
10791400|NCT03562117|11952124|FG000|STARTED|Part 2, Up to 3 Days|Only 1 additional participant with normal hepatic function enrolled in Part 2 received dosing|8
10791401|NCT03562117|11952125|FG001|STARTED|Part 2, Up to 3 Days||0
10791402|NCT03562117|11952126|FG002|STARTED|Part 2, Up to 3 Days||8
10791403|NCT03562117|11952124|FG000|COMPLETED|Part 2, Up to 3 Days||8
10791404|NCT03562117|11952125|FG001|COMPLETED|Part 2, Up to 3 Days||0
10791405|NCT03562117|11952126|FG002|COMPLETED|Part 2, Up to 3 Days||8
10791406|NCT03562117|11952124|FG000|NOT COMPLETED|Part 2, Up to 3 Days||0
10791407|NCT03562117|11952125|FG001|NOT COMPLETED|Part 2, Up to 3 Days||0
10791408|NCT03562117|11952126|FG002|NOT COMPLETED|Part 2, Up to 3 Days||0
10791409|NCT03562377|11952136|FG000|STARTED|Treatment Period|Number of participants assigned to treatment|107
10791410|NCT03562377|11952137|FG001|STARTED|Treatment Period|Number of participants assigned to treatment|108
10791411|NCT03562377|11952136|FG000|Safety Analysis Set|Treatment Period||107
10560244|NCT01591330|11714895|FG001|STARTED|Period 4||9
10791412|NCT03562377|11952137|FG001|Safety Analysis Set|Treatment Period||107
10791413|NCT03562377|11952136|FG000|Per Protocol Anaysis Set|Treatment Period||88
10791414|NCT03562377|11952137|FG001|Per Protocol Anaysis Set|Treatment Period||78
10791415|NCT03562377|11952136|FG000|Full Analysis Set|Treatment Period||106
10791416|NCT03562377|11952137|FG001|Full Analysis Set|Treatment Period||108
10791417|NCT03562377|11952136|FG000|COMPLETED|Treatment Period|Number of participants attending the Week 16 visit (end of treatment visit)|100
10560245|NCT01591330|11714896|FG002|STARTED|Period 4||9
10560246|NCT01591330|11714897|FG003|STARTED|Period 4||9
10560247|NCT01591330|11714894|FG000|COMPLETED|Period 4||5
10560248|NCT01591330|11714895|FG001|COMPLETED|Period 4||9
10560249|NCT01591330|11714896|FG002|COMPLETED|Period 4||9
10560250|NCT01591330|11714897|FG003|COMPLETED|Period 4||9
10560251|NCT01591330|11714894|FG000|NOT COMPLETED|Period 4||0
10791418|NCT03562377|11952137|FG001|COMPLETED|Treatment Period|Number of participants attending the Week 16 visit (end of treatment visit)|89
10791419|NCT03562377|11952136|FG000|NOT COMPLETED|Treatment Period||7
10560252|NCT01591330|11714895|FG001|NOT COMPLETED|Period 4||0
10560253|NCT01591330|11714896|FG002|NOT COMPLETED|Period 4||0
10560254|NCT01591330|11714897|FG003|NOT COMPLETED|Period 4||0
10560255|NCT01591382|11714909|FG000|STARTED|Overall Study||32
10560256|NCT01591382|11714910|FG001|STARTED|Overall Study||32
10560257|NCT01591382|11714909|FG000|COMPLETED|Overall Study||29
10560258|NCT01591382|11714910|FG001|COMPLETED|Overall Study||30
10560259|NCT01591382|11714909|FG000|NOT COMPLETED|Overall Study||3
10560260|NCT01591382|11714910|FG001|NOT COMPLETED|Overall Study||2
10560261|NCT01591408|11714918|FG000|STARTED|Overall Study||36
10560262|NCT01591408|11714919|FG001|STARTED|Overall Study||32
10560263|NCT01591408|11714918|FG000|COMPLETED|Overall Study||24
10560264|NCT01591408|11714919|FG001|COMPLETED|Overall Study||24
10560265|NCT01591408|11714918|FG000|NOT COMPLETED|Overall Study||12
10560266|NCT01591408|11714919|FG001|NOT COMPLETED|Overall Study||8
10560267|NCT01591460|11714925|FG000|STARTED|Overall Study|Those with elevated (Week 12) or detectable (Week 24) virus discontinued due to the Futility Rule.|165
10791420|NCT03562377|11952137|FG001|NOT COMPLETED|Treatment Period||19
10791421|NCT03562377|11952136|FG000|STARTED|Safety Follow-up Period|Last contact after exposure end. Main reason for not entering follow-up: transfer to extension trial|75
10791422|NCT03562377|11952137|FG001|STARTED|Safety Follow-up Period|Last contact after exposure end. Main reason for not entering follow-up: transfer to extension trial|75
10791423|NCT03562377|11952136|FG000|COMPLETED|Safety Follow-up Period|Attended Week 30 visit. Main reason for not attending was transfer to long-term extension trial.|16
10791424|NCT03562377|11952137|FG001|COMPLETED|Safety Follow-up Period|Attended Week 30 visit. Main reason for not attending was transfer to long-term extension trial.|18
10791425|NCT03562377|11952136|FG000|NOT COMPLETED|Safety Follow-up Period||59
10791426|NCT03562377|11952137|FG001|NOT COMPLETED|Safety Follow-up Period||57
10791427|NCT03562481|11952145|FG000|STARTED|First Intervention||12
10791428|NCT03562481|11952146|FG001|STARTED|First Intervention||14
10791429|NCT03562481|11952145|FG000|COMPLETED|First Intervention||11
10791430|NCT03562481|11952146|FG001|COMPLETED|First Intervention||14
10791431|NCT03562481|11952145|FG000|NOT COMPLETED|First Intervention||1
10791432|NCT03562481|11952146|FG001|NOT COMPLETED|First Intervention||0
10791433|NCT03562481|11952145|FG000|STARTED|Washout||11
10791434|NCT03562481|11952146|FG001|STARTED|Washout||14
10791435|NCT03562481|11952145|FG000|COMPLETED|Washout||11
10791436|NCT03562481|11952146|FG001|COMPLETED|Washout||14
10791437|NCT03562481|11952145|FG000|NOT COMPLETED|Washout||0
10791438|NCT03562481|11952146|FG001|NOT COMPLETED|Washout||0
10791439|NCT03562481|11952145|FG000|STARTED|Second Intervention||11
10791440|NCT03562481|11952146|FG001|STARTED|Second Intervention||14
10791441|NCT03562481|11952145|FG000|COMPLETED|Second Intervention||11
10791442|NCT03562481|11952146|FG001|COMPLETED|Second Intervention||14
10791443|NCT03562481|11952145|FG000|NOT COMPLETED|Second Intervention||0
10791444|NCT03562481|11952146|FG001|NOT COMPLETED|Second Intervention||0
10791445|NCT03562559|11952156|FG000|STARTED|Overall Study||40
10791446|NCT03562559|11952156|FG000|COMPLETED|Overall Study||40
10791447|NCT03562559|11952156|FG000|NOT COMPLETED|Overall Study||0
10791448|NCT03562663|11952162|FG000|STARTED|Overall Study||41
10791449|NCT03562663|11952163|FG001|STARTED|Overall Study||41
10791450|NCT03562663|11952162|FG000|COMPLETED|Overall Study||34
10791451|NCT03562663|11952163|FG001|COMPLETED|Overall Study||35
10791452|NCT03562663|11952162|FG000|NOT COMPLETED|Overall Study||7
10791453|NCT03562663|11952163|FG001|NOT COMPLETED|Overall Study||6
10810727|NCT03792672|11972456|FG000|COMPLETED|Washout Period 2 (10 Days)||4
10810728|NCT03792672|11972457|FG001|COMPLETED|Washout Period 2 (10 Days)||4
10810729|NCT03792672|11972458|FG002|COMPLETED|Washout Period 2 (10 Days)||4
10810730|NCT03792672|11972459|FG003|COMPLETED|Washout Period 2 (10 Days)||4
10810731|NCT03792672|11972460|FG004|COMPLETED|Washout Period 2 (10 Days)||4
10810732|NCT03792672|11972461|FG005|COMPLETED|Washout Period 2 (10 Days)||4
10810733|NCT03792672|11972456|FG000|NOT COMPLETED|Washout Period 2 (10 Days)||0
10810734|NCT03792672|11972457|FG001|NOT COMPLETED|Washout Period 2 (10 Days)||0
10810735|NCT03792672|11972458|FG002|NOT COMPLETED|Washout Period 2 (10 Days)||0
10810736|NCT03792672|11972459|FG003|NOT COMPLETED|Washout Period 2 (10 Days)||0
10810737|NCT03792672|11972460|FG004|NOT COMPLETED|Washout Period 2 (10 Days)||0
10810738|NCT03792672|11972461|FG005|NOT COMPLETED|Washout Period 2 (10 Days)||0
10810739|NCT03792672|11972456|FG000|STARTED|Treatment Period 3 (1 Day)||4
10810740|NCT03792672|11972457|FG001|STARTED|Treatment Period 3 (1 Day)||4
10560268|NCT01591460|11714925|FG000|COMPLETED|Overall Study|The number who completed PEG-IFN, as scheduled according to response-guided treatment, is presented.|139
10560269|NCT01591460|11714925|FG000|NOT COMPLETED|Overall Study||26
10560270|NCT01591499|11714937|FG000|STARTED|Baseline Visit||33
10560271|NCT01591499|11714938|FG001|STARTED|Baseline Visit||39
10560272|NCT01591499|11714939|FG002|STARTED|Baseline Visit||31
10810741|NCT03792672|11972458|FG002|STARTED|Treatment Period 3 (1 Day)||4
10810742|NCT03792672|11972459|FG003|STARTED|Treatment Period 3 (1 Day)||4
10810743|NCT03792672|11972460|FG004|STARTED|Treatment Period 3 (1 Day)||4
10560273|NCT01591499|11714940|FG003|STARTED|Baseline Visit||39
10560274|NCT01591499|11714937|FG000|COMPLETED|Baseline Visit||33
10560275|NCT01591499|11714938|FG001|COMPLETED|Baseline Visit||37
10560276|NCT01591499|11714939|FG002|COMPLETED|Baseline Visit||31
10810744|NCT03792672|11972461|FG005|STARTED|Treatment Period 3 (1 Day)||4
10810745|NCT03792672|11972456|FG000|COMPLETED|Treatment Period 3 (1 Day)||4
10810746|NCT03792672|11972457|FG001|COMPLETED|Treatment Period 3 (1 Day)||4
10810747|NCT03792672|11972458|FG002|COMPLETED|Treatment Period 3 (1 Day)||4
10810748|NCT03792672|11972459|FG003|COMPLETED|Treatment Period 3 (1 Day)||4
10810749|NCT03792672|11972460|FG004|COMPLETED|Treatment Period 3 (1 Day)||4
10560277|NCT01591499|11714940|FG003|COMPLETED|Baseline Visit||37
10560278|NCT01591499|11714937|FG000|NOT COMPLETED|Baseline Visit||0
10560279|NCT01591499|11714938|FG001|NOT COMPLETED|Baseline Visit||2
10560280|NCT01591499|11714939|FG002|NOT COMPLETED|Baseline Visit||0
10560281|NCT01591499|11714940|FG003|NOT COMPLETED|Baseline Visit||2
10560282|NCT01591499|11714937|FG000|STARTED|First Intervention (up to 24 Days)||33
10560283|NCT01591499|11714938|FG001|STARTED|First Intervention (up to 24 Days)||37
10560284|NCT01591499|11714939|FG002|STARTED|First Intervention (up to 24 Days)||31
10560285|NCT01591499|11714940|FG003|STARTED|First Intervention (up to 24 Days)||37
10560286|NCT01591499|11714937|FG000|COMPLETED|First Intervention (up to 24 Days)||33
10560287|NCT01591499|11714938|FG001|COMPLETED|First Intervention (up to 24 Days)||37
10560288|NCT01591499|11714939|FG002|COMPLETED|First Intervention (up to 24 Days)||31
10560289|NCT01591499|11714940|FG003|COMPLETED|First Intervention (up to 24 Days)||37
10560290|NCT01591499|11714937|FG000|NOT COMPLETED|First Intervention (up to 24 Days)||0
10560291|NCT01591499|11714938|FG001|NOT COMPLETED|First Intervention (up to 24 Days)||0
10560292|NCT01591499|11714939|FG002|NOT COMPLETED|First Intervention (up to 24 Days)||0
10560293|NCT01591499|11714940|FG003|NOT COMPLETED|First Intervention (up to 24 Days)||0
10560294|NCT01591499|11714937|FG000|STARTED|Second Intervention (up to 24 Days)||33
10560295|NCT01591499|11714938|FG001|STARTED|Second Intervention (up to 24 Days)||37
10560296|NCT01591499|11714939|FG002|STARTED|Second Intervention (up to 24 Days)||31
10560297|NCT01591499|11714940|FG003|STARTED|Second Intervention (up to 24 Days)||37
10560298|NCT01591499|11714937|FG000|COMPLETED|Second Intervention (up to 24 Days)||27
10560299|NCT01591499|11714938|FG001|COMPLETED|Second Intervention (up to 24 Days)||34
10560300|NCT01591499|11714939|FG002|COMPLETED|Second Intervention (up to 24 Days)||28
10560301|NCT01591499|11714940|FG003|COMPLETED|Second Intervention (up to 24 Days)||34
10560302|NCT01591499|11714937|FG000|NOT COMPLETED|Second Intervention (up to 24 Days)||6
10560303|NCT01591499|11714938|FG001|NOT COMPLETED|Second Intervention (up to 24 Days)||3
10560304|NCT01591499|11714939|FG002|NOT COMPLETED|Second Intervention (up to 24 Days)||3
10560305|NCT01591499|11714940|FG003|NOT COMPLETED|Second Intervention (up to 24 Days)||3
10650888|NCT02173522|11811272|FG000|COMPLETED|Overall Study||4
10650889|NCT02173522|11811273|FG001|COMPLETED|Overall Study||0
10650890|NCT02173522|11811272|FG000|NOT COMPLETED|Overall Study||0
10650891|NCT02173522|11811273|FG001|NOT COMPLETED|Overall Study||0
10650892|NCT02173535|11811297|FG000|STARTED|Period 1||12
10650893|NCT02173535|11811298|FG001|STARTED|Period 1||12
10650894|NCT02173535|11811299|FG002|STARTED|Period 1||12
10650895|NCT02173535|11811300|FG003|STARTED|Period 1||12
10650896|NCT02173535|11811301|FG004|STARTED|Period 1||12
10650897|NCT02173535|11811302|FG005|STARTED|Period 1||12
10650898|NCT02173535|11811303|FG006|STARTED|Period 1||12
10650899|NCT02173535|11811304|FG007|STARTED|Period 1||12
10650900|NCT02173535|11811305|FG008|STARTED|Period 1||12
10650901|NCT02173535|11811306|FG009|STARTED|Period 1||12
10650902|NCT02173535|11811307|FG010|STARTED|Period 1||12
10650903|NCT02173535|11811308|FG011|STARTED|Period 1||12
10791454|NCT03562988|11952169|FG000|STARTED|Overall Study||17
10791455|NCT03562988|11952170|FG001|STARTED|Overall Study||18
10791456|NCT03562988|11952169|FG000|COMPLETED|Overall Study||15
10791457|NCT03562988|11952170|FG001|COMPLETED|Overall Study||15
10791458|NCT03562988|11952169|FG000|NOT COMPLETED|Overall Study||2
10791459|NCT03562988|11952170|FG001|NOT COMPLETED|Overall Study||3
10791460|NCT03563027|11952183|FG000|STARTED|Overall Study||60
10791461|NCT03563027|11952184|FG001|STARTED|Overall Study||60
10791462|NCT03563027|11952185|FG002|STARTED|Overall Study||60
10791463|NCT03563027|11952183|FG000|COMPLETED|Overall Study||60
10791464|NCT03563027|11952184|FG001|COMPLETED|Overall Study||60
10791465|NCT03563027|11952185|FG002|COMPLETED|Overall Study||58
10791466|NCT03563027|11952183|FG000|NOT COMPLETED|Overall Study||0
10791467|NCT03563027|11952184|FG001|NOT COMPLETED|Overall Study||0
10791468|NCT03563027|11952185|FG002|NOT COMPLETED|Overall Study||2
10791469|NCT03563183|11952193|FG000|STARTED|Overall Study||26976
10791470|NCT03563183|11952193|FG000|COMPLETED|Overall Study||26976
10791471|NCT03563183|11952193|FG000|NOT COMPLETED|Overall Study||0
10791472|NCT03563209|11952212|FG000|STARTED|Overall Study||60
10791473|NCT03563209|11952212|FG000|COMPLETED|Overall Study||60
10791474|NCT03563209|11952212|FG000|NOT COMPLETED|Overall Study||0
10791475|NCT03563313|11952220|FG000|STARTED|Overall Study||112
10791476|NCT03563313|11952221|FG001|STARTED|Overall Study||56
10791477|NCT03563313|11952220|FG000|COMPLETED|Overall Study||112
10791478|NCT03563313|11952221|FG001|COMPLETED|Overall Study||56
10791479|NCT03563313|11952220|FG000|NOT COMPLETED|Overall Study||0
10650904|NCT02173535|11811309|FG012|STARTED|Period 1||12
10650905|NCT02173535|11811310|FG013|STARTED|Period 1||12
10650906|NCT02173535|11811311|FG014|STARTED|Period 1||12
10650907|NCT02173535|11811312|FG015|STARTED|Period 1||12
10650908|NCT02173535|11811313|FG016|STARTED|Period 1||12
10650909|NCT02173535|11811314|FG017|STARTED|Period 1||12
10650910|NCT02173535|11811315|FG018|STARTED|Period 1||12
10650911|NCT02173535|11811316|FG019|STARTED|Period 1||12
10650912|NCT02173535|11811297|FG000|COMPLETED|Period 1||12
10650913|NCT02173535|11811298|FG001|COMPLETED|Period 1||12
10650914|NCT02173535|11811299|FG002|COMPLETED|Period 1||12
10650915|NCT02173535|11811300|FG003|COMPLETED|Period 1||12
10650916|NCT02173535|11811301|FG004|COMPLETED|Period 1||12
10791480|NCT03563313|11952221|FG001|NOT COMPLETED|Overall Study||0
10650917|NCT02173535|11811302|FG005|COMPLETED|Period 1||12
10650918|NCT02173535|11811303|FG006|COMPLETED|Period 1||12
10791481|NCT03564444|11952235|FG000|STARTED|Overall Study||60
10791482|NCT03564444|11952236|FG001|STARTED|Overall Study||240
10650919|NCT02173535|11811304|FG007|COMPLETED|Period 1||12
10560306|NCT01591616|11714964|FG000|STARTED|Overall Study||16
10560307|NCT01591616|11714964|FG000|COMPLETED|Overall Study||15
10560308|NCT01591616|11714964|FG000|NOT COMPLETED|Overall Study||1
10791483|NCT03564444|11952235|FG000|COMPLETED|Overall Study||60
10791484|NCT03564444|11952236|FG001|COMPLETED|Overall Study||240
10791485|NCT03564444|11952235|FG000|NOT COMPLETED|Overall Study||0
10791486|NCT03564444|11952236|FG001|NOT COMPLETED|Overall Study||0
10791487|NCT03564886|11952244|FG000|STARTED|Overall Study||24
10791488|NCT03564886|11952245|FG001|STARTED|Overall Study||24
10791489|NCT03564886|11952244|FG000|COMPLETED|Overall Study||23
10791490|NCT03564886|11952245|FG001|COMPLETED|Overall Study||23
10791491|NCT03564886|11952244|FG000|NOT COMPLETED|Overall Study||1
10791492|NCT03564886|11952245|FG001|NOT COMPLETED|Overall Study||1
10791493|NCT03565068|11952260|FG000|STARTED|Overall Study||12
10791494|NCT03565068|11952261|FG001|STARTED|Overall Study||4
10791495|NCT03565068|11952262|FG002|STARTED|Overall Study||12
10791496|NCT03565068|11952263|FG003|STARTED|Overall Study||4
10791497|NCT03565068|11952264|FG004|STARTED|Overall Study||12
10791498|NCT03565068|11952265|FG005|STARTED|Overall Study||1
10791499|NCT03565068|11952266|FG006|STARTED|Overall Study||4
10791500|NCT03565068|11952267|FG007|STARTED|Overall Study||17
10791501|NCT03565068|11952268|FG008|STARTED|Overall Study||9
10791502|NCT03565068|11952260|FG000|COMPLETED|Overall Study||12
10791503|NCT03565068|11952261|FG001|COMPLETED|Overall Study||4
10791504|NCT03565068|11952262|FG002|COMPLETED|Overall Study||11
10791505|NCT03565068|11952263|FG003|COMPLETED|Overall Study||4
10791506|NCT03565068|11952264|FG004|COMPLETED|Overall Study||8
10791507|NCT03565068|11952265|FG005|COMPLETED|Overall Study||0
10791508|NCT03565068|11952266|FG006|COMPLETED|Overall Study||3
10791509|NCT03565068|11952267|FG007|COMPLETED|Overall Study||9
10791510|NCT03565068|11952268|FG008|COMPLETED|Overall Study||8
10791511|NCT03565068|11952260|FG000|NOT COMPLETED|Overall Study||0
10791512|NCT03565068|11952261|FG001|NOT COMPLETED|Overall Study||0
10791513|NCT03565068|11952262|FG002|NOT COMPLETED|Overall Study||1
10791514|NCT03565068|11952263|FG003|NOT COMPLETED|Overall Study||0
10791515|NCT03565068|11952264|FG004|NOT COMPLETED|Overall Study||4
10791516|NCT03565068|11952265|FG005|NOT COMPLETED|Overall Study||1
10791517|NCT03565068|11952266|FG006|NOT COMPLETED|Overall Study||1
10791518|NCT03565068|11952267|FG007|NOT COMPLETED|Overall Study||8
10791519|NCT03565068|11952268|FG008|NOT COMPLETED|Overall Study||1
10791520|NCT03565211|11952325|FG000|STARTED|Overall Study||254
10791521|NCT03565211|11952325|FG000|Modified Intention-to-treat (mITT)|Overall Study|Had successful oocyte retrieval, received >=1 dose of IMP, and completed fresh embryo transfer|243
10791522|NCT03565211|11952325|FG000|COMPLETED|Overall Study||206
10791523|NCT03565211|11952325|FG000|NOT COMPLETED|Overall Study||48
10791524|NCT03565315|11952333|FG000|STARTED|Overall Study||3
10791525|NCT03565315|11952334|FG001|STARTED|Overall Study||3
10791526|NCT03565315|11952335|FG002|STARTED|Overall Study||1
10791527|NCT03565315|11952336|FG003|STARTED|Overall Study||2
10791528|NCT03565315|11952333|FG000|Product Administration Completed|Overall Study||3
10791529|NCT03565315|11952334|FG001|Product Administration Completed|Overall Study||0
10791530|NCT03565315|11952335|FG002|Product Administration Completed|Overall Study||1
10791531|NCT03565315|11952336|FG003|Product Administration Completed|Overall Study||0
10791532|NCT03565315|11952333|FG000|Discontinued Product Administrations|Overall Study||0
10791533|NCT03565315|11952334|FG001|Discontinued Product Administrations|Overall Study||3
10791534|NCT03565315|11952335|FG002|Discontinued Product Administrations|Overall Study||0
10791535|NCT03565315|11952336|FG003|Discontinued Product Administrations|Overall Study|One Group 4 participant enrolled but did not receive product due to IND/PI voluntary study pause.|2
10791536|NCT03565315|11952333|FG000|COMPLETED|Overall Study||3
10791537|NCT03565315|11952334|FG001|COMPLETED|Overall Study||3
10791538|NCT03565315|11952335|FG002|COMPLETED|Overall Study||1
10791539|NCT03565315|11952336|FG003|COMPLETED|Overall Study||1
10791540|NCT03565315|11952333|FG000|NOT COMPLETED|Overall Study||0
10791541|NCT03565315|11952334|FG001|NOT COMPLETED|Overall Study||0
10791542|NCT03565315|11952335|FG002|NOT COMPLETED|Overall Study||0
10791543|NCT03565315|11952336|FG003|NOT COMPLETED|Overall Study||1
10791544|NCT03565666|11952359|FG000|STARTED|Overall Study||12
10791545|NCT03565666|11952360|FG001|STARTED|Overall Study||12
10791546|NCT03565666|11952361|FG002|STARTED|Overall Study||12
10791547|NCT03565666|11952359|FG000|COMPLETED|Overall Study||12
10791548|NCT03565666|11952360|FG001|COMPLETED|Overall Study||12
10791549|NCT03565666|11952361|FG002|COMPLETED|Overall Study||11
10791550|NCT03565666|11952359|FG000|NOT COMPLETED|Overall Study||0
10791551|NCT03565666|11952360|FG001|NOT COMPLETED|Overall Study||0
10791552|NCT03565666|11952361|FG002|NOT COMPLETED|Overall Study||1
10791553|NCT03565679|11952372|FG000|STARTED|Overall Study||10
10791554|NCT03565679|11952372|FG000|COMPLETED|Overall Study||10
10791555|NCT03565679|11952372|FG000|NOT COMPLETED|Overall Study||0
10791556|NCT03565874|11952379|FG000|STARTED|Overall Study||6
10791557|NCT03565874|11952379|FG000|COMPLETED|Overall Study||4
10791558|NCT03565874|11952379|FG000|NOT COMPLETED|Overall Study||2
10791559|NCT03565887|11952385|FG000|STARTED|Overall Study||109
10791560|NCT03565887|11952386|FG001|STARTED|Overall Study||55
10791561|NCT03565887|11952385|FG000|COMPLETED|Overall Study||108
10791562|NCT03565887|11952386|FG001|COMPLETED|Overall Study||53
10791563|NCT03565887|11952385|FG000|NOT COMPLETED|Overall Study||1
10791564|NCT03565887|11952386|FG001|NOT COMPLETED|Overall Study||2
10791565|NCT03566238|11952395|FG000|STARTED|Overall Study||23
10791566|NCT03566238|11952396|FG001|STARTED|Overall Study||19
10560309|NCT01591655|11715105|FG000|STARTED|Overall Study||240
10560310|NCT01591655|11715106|FG001|STARTED|Overall Study||120
10560311|NCT01591655|11715105|FG000|COMPLETED|Overall Study||168
10560312|NCT01591655|11715106|FG001|COMPLETED|Overall Study||57
10560313|NCT01591655|11715105|FG000|NOT COMPLETED|Overall Study||72
10560314|NCT01591655|11715106|FG001|NOT COMPLETED|Overall Study||63
10560315|NCT01591681|11715112|FG000|STARTED|Overall Study||49
10560316|NCT01591681|11715112|FG000|COMPLETED|Overall Study||45
10560317|NCT01591681|11715112|FG000|NOT COMPLETED|Overall Study||4
10560318|NCT01591733|11715118|FG000|STARTED|Overall Study||48
10560319|NCT01591733|11715118|FG000|COMPLETED|Overall Study||48
10560320|NCT01591733|11715118|FG000|NOT COMPLETED|Overall Study||0
10560321|NCT01591746|11715126|FG000|STARTED|Overall Study||68
10560322|NCT01591746|11715127|FG001|STARTED|Overall Study||63
10560323|NCT01591746|11715126|FG000|COMPLETED|Overall Study||68
10560324|NCT01591746|11715127|FG001|COMPLETED|Overall Study||63
10560325|NCT01591746|11715126|FG000|NOT COMPLETED|Overall Study||0
10560326|NCT01591746|11715127|FG001|NOT COMPLETED|Overall Study||0
10560327|NCT01591785|11715135|FG000|STARTED|Overall Study||30
10560328|NCT01591785|11715136|FG001|STARTED|Overall Study||30
10560329|NCT01591785|11715135|FG000|COMPLETED|Overall Study||26
10560330|NCT01591785|11715136|FG001|COMPLETED|Overall Study||28
10560331|NCT01591785|11715135|FG000|NOT COMPLETED|Overall Study||4
10560332|NCT01591785|11715136|FG001|NOT COMPLETED|Overall Study||2
10560333|NCT01591837|11715144|FG000|STARTED|Overall Study||60
10560334|NCT01591837|11715145|FG001|STARTED|Overall Study||60
10560335|NCT01591837|11715144|FG000|COMPLETED|Overall Study||60
10560336|NCT01591837|11715145|FG001|COMPLETED|Overall Study||60
10560337|NCT01591837|11715144|FG000|NOT COMPLETED|Overall Study||0
10560338|NCT01591837|11715145|FG001|NOT COMPLETED|Overall Study||0
10560339|NCT01591863|11715151|FG000|STARTED|Overall Study||38
10560340|NCT01591863|11715151|FG000|COMPLETED|Overall Study||24
10560341|NCT01591863|11715151|FG000|NOT COMPLETED|Overall Study||14
10560342|NCT01592006|11715155|FG000|STARTED|Overall Study||3
10560343|NCT01592006|11715155|FG000|COMPLETED|Overall Study||3
10560344|NCT01592006|11715155|FG000|NOT COMPLETED|Overall Study||0
10560345|NCT01592045|11715161|FG000|STARTED|Overall Study||14
10560346|NCT01592045|11715162|FG001|STARTED|Overall Study||14
10560347|NCT01592045|11715161|FG000|Completed Course 1|Overall Study||13
10560348|NCT01592045|11715162|FG001|Completed Course 1|Overall Study||14
10560349|NCT01592045|11715161|FG000|Completed Course 2|Overall Study||13
10560350|NCT01592045|11715162|FG001|Completed Course 2|Overall Study||13
10560351|NCT01592045|11715161|FG000|Completed Course 3|Overall Study||11
10560352|NCT01592045|11715162|FG001|Completed Course 3|Overall Study||13
10560353|NCT01592045|11715161|FG000|Completed Course 4|Overall Study||11
10560354|NCT01592045|11715162|FG001|Completed Course 4|Overall Study||12
10560355|NCT01592045|11715161|FG000|Completed Course 5|Overall Study||9
10560356|NCT01592045|11715162|FG001|Completed Course 5|Overall Study||12
10560357|NCT01592045|11715161|FG000|COMPLETED|Overall Study||9
10560358|NCT01592045|11715162|FG001|COMPLETED|Overall Study||12
10791567|NCT03566238|11952397|FG002|STARTED|Overall Study||20
10791568|NCT03566238|11952395|FG000|Received Treatment|Overall Study||23
10791569|NCT03566238|11952396|FG001|Received Treatment|Overall Study||19
10791570|NCT03566238|11952397|FG002|Received Treatment|Overall Study||20
10791571|NCT03566238|11952395|FG000|COMPLETED|Overall Study||18
10791572|NCT03566238|11952396|FG001|COMPLETED|Overall Study||16
10791573|NCT03566238|11952397|FG002|COMPLETED|Overall Study||15
10791574|NCT03566238|11952395|FG000|NOT COMPLETED|Overall Study||5
10791575|NCT03566238|11952396|FG001|NOT COMPLETED|Overall Study||3
10791576|NCT03566238|11952397|FG002|NOT COMPLETED|Overall Study||5
10791577|NCT03566485|11952407|FG000|STARTED|Overall Study||5
10791578|NCT03566485|11952408|FG001|STARTED|Overall Study|Dose level 1 (Idasanutlin 100mg PO)|7
10791579|NCT03566485|11952407|FG000|COMPLETED|Overall Study||0
10791580|NCT03566485|11952408|FG001|COMPLETED|Overall Study||0
10791581|NCT03566485|11952407|FG000|NOT COMPLETED|Overall Study||5
10791582|NCT03566485|11952408|FG001|NOT COMPLETED|Overall Study||7
10791583|NCT03566550|11952416|FG000|STARTED|Overall Study||12
10791584|NCT03566550|11952417|FG001|STARTED|Overall Study||13
10791585|NCT03566550|11952416|FG000|COMPLETED|Overall Study||12
10791586|NCT03566550|11952417|FG001|COMPLETED|Overall Study||12
10791587|NCT03566550|11952416|FG000|NOT COMPLETED|Overall Study||0
10560359|NCT01592045|11715161|FG000|NOT COMPLETED|Overall Study||5
10791588|NCT03566550|11952417|FG001|NOT COMPLETED|Overall Study||1
10791589|NCT03566680|11952423|FG000|STARTED|Overall Study||46
10560360|NCT01592045|11715162|FG001|NOT COMPLETED|Overall Study||2
10560361|NCT01592071|11715168|FG000|STARTED|Overall Study||120
10560362|NCT01592071|11715168|FG000|COMPLETED|Overall Study||120
10560363|NCT01592071|11715168|FG000|NOT COMPLETED|Overall Study||0
10560364|NCT01592240|11715179|FG000|STARTED|Overall Study||50
10560365|NCT01592240|11715180|FG001|STARTED|Overall Study||50
10560366|NCT01592240|11715181|FG002|STARTED|Overall Study||52
10560367|NCT01592240|11715182|FG003|STARTED|Overall Study||50
10560368|NCT01592240|11715183|FG004|STARTED|Overall Study||51
10560369|NCT01592240|11715184|FG005|STARTED|Overall Study||50
10560370|NCT01592240|11715185|FG006|STARTED|Overall Study||51
10560371|NCT01592240|11715179|FG000|COMPLETED|Overall Study||47
10560372|NCT01592240|11715180|FG001|COMPLETED|Overall Study||39
10791590|NCT03566680|11952423|FG000|COMPLETED|Overall Study||29
10791591|NCT03566680|11952423|FG000|NOT COMPLETED|Overall Study||17
10791592|NCT03566810|11952431|FG000|STARTED|Treatment Period 1 (Day 1-Day 3)||19
10560373|NCT01592240|11715181|FG002|COMPLETED|Overall Study||45
10560374|NCT01592240|11715182|FG003|COMPLETED|Overall Study||47
10560375|NCT01592240|11715183|FG004|COMPLETED|Overall Study||44
10560376|NCT01592240|11715184|FG005|COMPLETED|Overall Study||47
10791593|NCT03566810|11952432|FG001|STARTED|Treatment Period 1 (Day 1-Day 3)||19
10560377|NCT01592240|11715185|FG006|COMPLETED|Overall Study||48
10560378|NCT01592240|11715179|FG000|NOT COMPLETED|Overall Study||3
10560379|NCT01592240|11715180|FG001|NOT COMPLETED|Overall Study||11
10560380|NCT01592240|11715181|FG002|NOT COMPLETED|Overall Study||7
10560381|NCT01592240|11715182|FG003|NOT COMPLETED|Overall Study||3
10560382|NCT01592240|11715183|FG004|NOT COMPLETED|Overall Study||7
10560383|NCT01592240|11715184|FG005|NOT COMPLETED|Overall Study||3
10560384|NCT01592240|11715185|FG006|NOT COMPLETED|Overall Study||3
10560385|NCT01592292|11715208|FG000|STARTED|Overall Study||46
10560386|NCT01592292|11715209|FG001|STARTED|Overall Study||20
10560387|NCT01592292|11715210|FG002|STARTED|Overall Study||13
10560388|NCT01592292|11715211|FG003|STARTED|Overall Study||11
10560389|NCT01592292|11715208|FG000|Intention to Treat (ITT) Set|Overall Study|Excluding primary effect evaluation omission.|34
10560390|NCT01592292|11715209|FG001|Intention to Treat (ITT) Set|Overall Study||13
10560391|NCT01592292|11715210|FG002|Intention to Treat (ITT) Set|Overall Study||10
10560392|NCT01592292|11715211|FG003|Intention to Treat (ITT) Set|Overall Study||8
10560393|NCT01592292|11715208|FG000|Standard Population Set (SPS)|Overall Study|Excluding participants with change of administration drug or suspension of drug administration.|31
10560394|NCT01592292|11715209|FG001|Standard Population Set (SPS)|Overall Study||10
10560395|NCT01592292|11715210|FG002|Standard Population Set (SPS)|Overall Study||7
10560396|NCT01592292|11715211|FG003|Standard Population Set (SPS)|Overall Study||7
10560397|NCT01592292|11715208|FG000|COMPLETED|Overall Study|Participants who completed 12 months visit.|40
10560398|NCT01592292|11715209|FG001|COMPLETED|Overall Study||15
10560399|NCT01592292|11715210|FG002|COMPLETED|Overall Study||10
10560400|NCT01592292|11715211|FG003|COMPLETED|Overall Study||10
10791594|NCT03566810|11952433|FG002|STARTED|Treatment Period 1 (Day 1-Day 3)||8
10791595|NCT03566810|11952434|FG003|STARTED|Treatment Period 1 (Day 1-Day 3)||8
10791596|NCT03566810|11952431|FG000|Treated|Treatment Period 1 (Day 1-Day 3)||19
10791597|NCT03566810|11952432|FG001|Treated|Treatment Period 1 (Day 1-Day 3)||18
10791598|NCT03566810|11952433|FG002|Treated|Treatment Period 1 (Day 1-Day 3)||8
10791599|NCT03566810|11952434|FG003|Treated|Treatment Period 1 (Day 1-Day 3)||8
10791600|NCT03566810|11952431|FG000|COMPLETED|Treatment Period 1 (Day 1-Day 3)||19
10791601|NCT03566810|11952432|FG001|COMPLETED|Treatment Period 1 (Day 1-Day 3)||18
10791602|NCT03566810|11952433|FG002|COMPLETED|Treatment Period 1 (Day 1-Day 3)||8
10791603|NCT03566810|11952434|FG003|COMPLETED|Treatment Period 1 (Day 1-Day 3)||8
10791604|NCT03566810|11952431|FG000|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
10791605|NCT03566810|11952432|FG001|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||1
10791606|NCT03566810|11952433|FG002|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
10791607|NCT03566810|11952434|FG003|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
10791608|NCT03566810|11952431|FG000|STARTED|Treatment Period 2 (Day 8- Day 10)||19
10791609|NCT03566810|11952432|FG001|STARTED|Treatment Period 2 (Day 8- Day 10)||18
10791610|NCT03566810|11952433|FG002|STARTED|Treatment Period 2 (Day 8- Day 10)||8
10791611|NCT03566810|11952434|FG003|STARTED|Treatment Period 2 (Day 8- Day 10)||8
10791612|NCT03566810|11952431|FG000|COMPLETED|Treatment Period 2 (Day 8- Day 10)||19
10791613|NCT03566810|11952432|FG001|COMPLETED|Treatment Period 2 (Day 8- Day 10)||18
10791614|NCT03566810|11952433|FG002|COMPLETED|Treatment Period 2 (Day 8- Day 10)||8
10791615|NCT03566810|11952434|FG003|COMPLETED|Treatment Period 2 (Day 8- Day 10)||8
10791616|NCT03566810|11952431|FG000|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
10791617|NCT03566810|11952432|FG001|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
10791618|NCT03566810|11952433|FG002|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
10791619|NCT03566810|11952434|FG003|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
10791620|NCT03566823|11952447|FG000|STARTED|Overall Study||6
10791621|NCT03566823|11952448|FG001|STARTED|Overall Study||15
10791622|NCT03566823|11952449|FG002|STARTED|Overall Study||13
10791623|NCT03566823|11952447|FG000|COMPLETED|Overall Study||4
10791624|NCT03566823|11952448|FG001|COMPLETED|Overall Study||12
10791625|NCT03566823|11952449|FG002|COMPLETED|Overall Study||11
10791626|NCT03566823|11952447|FG000|NOT COMPLETED|Overall Study||2
10791627|NCT03566823|11952448|FG001|NOT COMPLETED|Overall Study||3
10791628|NCT03566823|11952449|FG002|NOT COMPLETED|Overall Study||2
10791629|NCT03566979|11952461|FG000|STARTED|Overall Study||58
10791630|NCT03566979|11952462|FG001|STARTED|Overall Study||152
10791631|NCT03566979|11952463|FG002|STARTED|Overall Study||142
10791632|NCT03566979|11952464|FG003|STARTED|Overall Study||149
10791633|NCT03566979|11952461|FG000|COMPLETED|Overall Study||53
10791634|NCT03566979|11952462|FG001|COMPLETED|Overall Study||145
10791635|NCT03566979|11952463|FG002|COMPLETED|Overall Study||132
10791636|NCT03566979|11952464|FG003|COMPLETED|Overall Study||143
10791637|NCT03566979|11952461|FG000|NOT COMPLETED|Overall Study||5
10791638|NCT03566979|11952462|FG001|NOT COMPLETED|Overall Study||7
10791639|NCT03566979|11952463|FG002|NOT COMPLETED|Overall Study||10
10791640|NCT03566979|11952464|FG003|NOT COMPLETED|Overall Study||6
10791641|NCT03567005|11952474|FG000|STARTED|Period 1, First 7 Days of Wear||29
10791642|NCT03567005|11952475|FG001|STARTED|Period 1, First 7 Days of Wear||31
10791643|NCT03567005|11952474|FG000|COMPLETED|Period 1, First 7 Days of Wear||29
10791644|NCT03567005|11952475|FG001|COMPLETED|Period 1, First 7 Days of Wear||31
10791645|NCT03567005|11952474|FG000|NOT COMPLETED|Period 1, First 7 Days of Wear||0
10791646|NCT03567005|11952475|FG001|NOT COMPLETED|Period 1, First 7 Days of Wear||0
10560401|NCT01592292|11715208|FG000|NOT COMPLETED|Overall Study||6
10791647|NCT03567005|11952474|FG000|STARTED|Period 2, Second 7 Days of Wear||29
10791648|NCT03567005|11952475|FG001|STARTED|Period 2, Second 7 Days of Wear||31
10791649|NCT03567005|11952474|FG000|COMPLETED|Period 2, Second 7 Days of Wear||29
10560402|NCT01592292|11715209|FG001|NOT COMPLETED|Overall Study||5
10560403|NCT01592292|11715210|FG002|NOT COMPLETED|Overall Study||3
10560404|NCT01592292|11715211|FG003|NOT COMPLETED|Overall Study||1
10560405|NCT01592344|11715219|FG000|STARTED|Overall Study||45
10560406|NCT01592344|11715220|FG001|STARTED|Overall Study||49
10791650|NCT03567005|11952475|FG001|COMPLETED|Period 2, Second 7 Days of Wear||31
10791651|NCT03567005|11952474|FG000|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
10791652|NCT03567005|11952475|FG001|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
10791653|NCT03567252|11952483|FG000|STARTED|Overall Study||48
10791654|NCT03567252|11952484|FG001|STARTED|Overall Study||19
10791655|NCT03567252|11952483|FG000|COMPLETED|Overall Study||48
10791656|NCT03567252|11952484|FG001|COMPLETED|Overall Study||19
10791657|NCT03567252|11952483|FG000|NOT COMPLETED|Overall Study||0
10791658|NCT03567252|11952484|FG001|NOT COMPLETED|Overall Study||0
10791659|NCT03567291|11952490|FG000|STARTED|Period I||228
10791660|NCT03567291|11952491|FG001|STARTED|Period I||0
10791661|NCT03567291|11952492|FG002|STARTED|Period I||0
10791662|NCT03567291|11952493|FG003|STARTED|Period I||0
10791663|NCT03567291|11952490|FG000|Safety Set|Period I||227
10791664|NCT03567291|11952491|FG001|Safety Set|Period I||0
10791665|NCT03567291|11952492|FG002|Safety Set|Period I||0
10791666|NCT03567291|11952493|FG003|Safety Set|Period I||0
10791667|NCT03567291|11952490|FG000|Intent to Treat Set|Period I||228
10791668|NCT03567291|11952491|FG001|Intent to Treat Set|Period I||0
10791669|NCT03567291|11952492|FG002|Intent to Treat Set|Period I||0
10791670|NCT03567291|11952493|FG003|Intent to Treat Set|Period I||0
10791671|NCT03567291|11952490|FG000|COMPLETED|Period I||137
10791672|NCT03567291|11952491|FG001|COMPLETED|Period I||0
10791673|NCT03567291|11952492|FG002|COMPLETED|Period I||0
10791674|NCT03567291|11952493|FG003|COMPLETED|Period I||0
10791675|NCT03567291|11952490|FG000|NOT COMPLETED|Period I||91
10791676|NCT03567291|11952491|FG001|NOT COMPLETED|Period I||0
10791677|NCT03567291|11952492|FG002|NOT COMPLETED|Period I||0
10791678|NCT03567291|11952493|FG003|NOT COMPLETED|Period I||0
10791679|NCT03567291|11952490|FG000|STARTED|Period II||0
10791680|NCT03567291|11952491|FG001|STARTED|Period II||91
10791681|NCT03567291|11952492|FG002|STARTED|Period II||46
10791682|NCT03567291|11952493|FG003|STARTED|Period II||0
10791683|NCT03567291|11952490|FG000|COMPLETED|Period II||0
10791684|NCT03567291|11952491|FG001|COMPLETED|Period II||88
10791685|NCT03567291|11952492|FG002|COMPLETED|Period II||45
10791686|NCT03567291|11952493|FG003|COMPLETED|Period II||0
10791687|NCT03567291|11952490|FG000|NOT COMPLETED|Period II||0
10791688|NCT03567291|11952491|FG001|NOT COMPLETED|Period II||3
10791689|NCT03567291|11952492|FG002|NOT COMPLETED|Period II||1
10791690|NCT03567291|11952493|FG003|NOT COMPLETED|Period II||0
10791691|NCT03567291|11952490|FG000|STARTED|Period III||0
10791692|NCT03567291|11952491|FG001|STARTED|Period III||0
10791693|NCT03567291|11952492|FG002|STARTED|Period III||0
10791694|NCT03567291|11952493|FG003|STARTED|Period III||133
10791695|NCT03567291|11952490|FG000|COMPLETED|Period III||0
10791696|NCT03567291|11952491|FG001|COMPLETED|Period III||0
10791697|NCT03567291|11952492|FG002|COMPLETED|Period III||0
10791698|NCT03567291|11952493|FG003|COMPLETED|Period III||48
10791699|NCT03567291|11952490|FG000|NOT COMPLETED|Period III||0
10791700|NCT03567291|11952491|FG001|NOT COMPLETED|Period III||0
10791701|NCT03567291|11952492|FG002|NOT COMPLETED|Period III||0
10791702|NCT03567291|11952493|FG003|NOT COMPLETED|Period III||85
10791703|NCT03567382|11952501|FG000|STARTED|Overall Study||10
10791704|NCT03567382|11952502|FG001|STARTED|Overall Study||81
10791705|NCT03567382|11952503|FG002|STARTED|Overall Study||9
10791706|NCT03567382|11952504|FG003|STARTED|Overall Study||79
10791707|NCT03567382|11952501|FG000|Received Tenofovir|Overall Study||9
10791708|NCT03567382|11952502|FG001|Received Tenofovir|Overall Study||0
10791709|NCT03567382|11952503|FG002|Received Tenofovir|Overall Study||0
10791710|NCT03567382|11952504|FG003|Received Tenofovir|Overall Study||0
10791711|NCT03567382|11952501|FG000|COMPLETED|Overall Study||7
10791712|NCT03567382|11952502|FG001|COMPLETED|Overall Study||46
10791713|NCT03567382|11952503|FG002|COMPLETED|Overall Study||7
10791714|NCT03567382|11952504|FG003|COMPLETED|Overall Study||46
10791715|NCT03567382|11952501|FG000|NOT COMPLETED|Overall Study||3
10791716|NCT03567382|11952502|FG001|NOT COMPLETED|Overall Study||35
10791717|NCT03567382|11952503|FG002|NOT COMPLETED|Overall Study||2
10791718|NCT03567382|11952504|FG003|NOT COMPLETED|Overall Study||33
10791719|NCT03567616|11952517|FG000|STARTED|Overall Study||8
10791720|NCT03567616|11952517|FG000|COMPLETED|Overall Study||0
10791721|NCT03567616|11952517|FG000|NOT COMPLETED|Overall Study||8
10791722|NCT03567980|11952524|FG000|STARTED|Overall Study||30
10560407|NCT01592344|11715219|FG000|COMPLETED|Overall Study||41
10791723|NCT03567980|11952524|FG000|COMPLETED|Overall Study||29
10791724|NCT03567980|11952524|FG000|NOT COMPLETED|Overall Study||1
10791725|NCT03568500|11952531|FG000|STARTED|Overall Study||18
10791726|NCT03568500|11952532|FG001|STARTED|Overall Study||20
10791727|NCT03568500|11952533|FG002|STARTED|Overall Study||6
10791728|NCT03568500|11952531|FG000|Received At Least 1 Dose of Study Drug|Overall Study||18
10791729|NCT03568500|11952532|FG001|Received At Least 1 Dose of Study Drug|Overall Study||19
10791730|NCT03568500|11952533|FG002|Received At Least 1 Dose of Study Drug|Overall Study||6
10791731|NCT03568500|11952531|FG000|COMPLETED|Overall Study||8
10791732|NCT03568500|11952532|FG001|COMPLETED|Overall Study||14
10791733|NCT03568500|11952533|FG002|COMPLETED|Overall Study||2
10560408|NCT01592344|11715220|FG001|COMPLETED|Overall Study||44
10791734|NCT03568500|11952531|FG000|NOT COMPLETED|Overall Study||10
10791735|NCT03568500|11952532|FG001|NOT COMPLETED|Overall Study||6
10791736|NCT03568500|11952533|FG002|NOT COMPLETED|Overall Study||4
10560409|NCT01592344|11715219|FG000|NOT COMPLETED|Overall Study||4
10560410|NCT01592344|11715220|FG001|NOT COMPLETED|Overall Study||5
10560411|NCT01592396|11715228|FG000|STARTED|Overall Study||10
10560412|NCT01592396|11715229|FG001|STARTED|Overall Study||10
10560413|NCT01592396|11715228|FG000|COMPLETED|Overall Study||10
10560414|NCT01592396|11715229|FG001|COMPLETED|Overall Study||10
10560415|NCT01592396|11715228|FG000|NOT COMPLETED|Overall Study||0
10560416|NCT01592396|11715229|FG001|NOT COMPLETED|Overall Study||0
10560417|NCT01592409|11715238|FG000|STARTED|Overall Study||67
10560418|NCT01592409|11715239|FG001|STARTED|Overall Study||32
10560419|NCT01592409|11715238|FG000|COMPLETED|Overall Study||67
10560420|NCT01592409|11715239|FG001|COMPLETED|Overall Study||31
10560421|NCT01592409|11715238|FG000|NOT COMPLETED|Overall Study||0
10560422|NCT01592409|11715239|FG001|NOT COMPLETED|Overall Study||1
10560423|NCT01592435|11715245|FG000|STARTED|Overall Study||76
10560424|NCT01592435|11715245|FG000|COMPLETED|Overall Study||76
10560425|NCT01592435|11715245|FG000|NOT COMPLETED|Overall Study||0
10560426|NCT01592500|11715255|FG000|STARTED|Overall Study|Randomized Participants|14
10560427|NCT01592500|11715256|FG001|STARTED|Overall Study||15
10560428|NCT01592500|11715257|FG002|STARTED|Overall Study||14
10560429|NCT01592500|11715258|FG003|STARTED|Overall Study|Randomized Participants|13
10560430|NCT01592500|11715255|FG000|COMPLETED|Overall Study||13
10560431|NCT01592500|11715256|FG001|COMPLETED|Overall Study||15
10560432|NCT01592500|11715257|FG002|COMPLETED|Overall Study||14
10560433|NCT01592500|11715258|FG003|COMPLETED|Overall Study||11
10560434|NCT01592500|11715255|FG000|NOT COMPLETED|Overall Study||1
10560435|NCT01592500|11715256|FG001|NOT COMPLETED|Overall Study||0
10560436|NCT01592500|11715257|FG002|NOT COMPLETED|Overall Study||0
10560437|NCT01592500|11715258|FG003|NOT COMPLETED|Overall Study||2
10560438|NCT01592695|11715270|FG000|STARTED|Overall Study||31
10560439|NCT01592695|11715271|FG001|STARTED|Overall Study||32
10560440|NCT01592695|11715270|FG000|COMPLETED|Overall Study||23
10560441|NCT01592695|11715271|FG001|COMPLETED|Overall Study||28
10560442|NCT01592695|11715270|FG000|NOT COMPLETED|Overall Study||8
10560443|NCT01592695|11715271|FG001|NOT COMPLETED|Overall Study||4
10560444|NCT01592708|11715279|FG000|STARTED|Overall Study||96
10560445|NCT01592708|11715280|FG001|STARTED|Overall Study||137
10560446|NCT01592708|11715279|FG000|COMPLETED|Overall Study||93
10560447|NCT01592708|11715280|FG001|COMPLETED|Overall Study||137
10560448|NCT01592708|11715279|FG000|NOT COMPLETED|Overall Study||3
10560449|NCT01592708|11715280|FG001|NOT COMPLETED|Overall Study||0
10560450|NCT01592747|11715292|FG000|STARTED|Overall Study|Based on Randomized Population|160
10560451|NCT01592747|11715293|FG001|STARTED|Overall Study|Based on Randomized Population|161
10560452|NCT01592747|11715294|FG002|STARTED|Overall Study|Based on Randomized Population|158
10560453|NCT01592747|11715292|FG000|COMPLETED|Overall Study||44
10560454|NCT01592747|11715293|FG001|COMPLETED|Overall Study||50
10560455|NCT01592747|11715294|FG002|COMPLETED|Overall Study||50
10560456|NCT01592747|11715292|FG000|NOT COMPLETED|Overall Study||116
10560457|NCT01592747|11715293|FG001|NOT COMPLETED|Overall Study||111
10560458|NCT01592747|11715294|FG002|NOT COMPLETED|Overall Study||108
10560459|NCT01592760|11715306|FG000|STARTED|Perioperative to Discharge||90
10560460|NCT01592760|11715307|FG001|STARTED|Perioperative to Discharge||90
10560461|NCT01592760|11715308|FG002|STARTED|Perioperative to Discharge||45
10560462|NCT01592760|11715306|FG000|COMPLETED|Perioperative to Discharge||90
10560463|NCT01592760|11715307|FG001|COMPLETED|Perioperative to Discharge||90
10560464|NCT01592760|11715308|FG002|COMPLETED|Perioperative to Discharge||45
10560465|NCT01592760|11715306|FG000|NOT COMPLETED|Perioperative to Discharge||0
10560466|NCT01592760|11715307|FG001|NOT COMPLETED|Perioperative to Discharge||0
10560467|NCT01592760|11715308|FG002|NOT COMPLETED|Perioperative to Discharge||0
10560468|NCT01592760|11715306|FG000|STARTED|24-hour Follow-Up||90
10560469|NCT01592760|11715307|FG001|STARTED|24-hour Follow-Up||90
10560470|NCT01592760|11715308|FG002|STARTED|24-hour Follow-Up||45
10560471|NCT01592760|11715306|FG000|COMPLETED|24-hour Follow-Up||86
10560472|NCT01592760|11715307|FG001|COMPLETED|24-hour Follow-Up||87
10560473|NCT01592760|11715308|FG002|COMPLETED|24-hour Follow-Up||43
10560474|NCT01592760|11715306|FG000|NOT COMPLETED|24-hour Follow-Up||4
10560475|NCT01592760|11715307|FG001|NOT COMPLETED|24-hour Follow-Up||3
10560476|NCT01592760|11715308|FG002|NOT COMPLETED|24-hour Follow-Up||2
10560477|NCT01592773|11715319|FG000|STARTED|Overall Study|All enrolled patients received at least 1 dose of investigational product (Safety Population).|747
10560478|NCT01592773|11715319|FG000|COMPLETED|Overall Study||81
10560479|NCT01592773|11715319|FG000|NOT COMPLETED|Overall Study||666
10560480|NCT01592786|11715323|FG000|STARTED|Overall Study|Participants in the Safety Population are being presented.|903
10560481|NCT01592786|11715323|FG000|COMPLETED|Overall Study||765
10560482|NCT01592786|11715323|FG000|NOT COMPLETED|Overall Study||138
10560483|NCT01592799|11715327|FG000|STARTED|Overall Study||501
10560484|NCT01592799|11715327|FG000|COMPLETED|Overall Study||501
10560485|NCT01592799|11715327|FG000|NOT COMPLETED|Overall Study||0
10560486|NCT01592851|11715335|FG000|STARTED|Overall Study||56
10560487|NCT01592851|11715336|FG001|STARTED|Overall Study||57
10560488|NCT01592851|11715335|FG000|COMPLETED|Overall Study||56
10560489|NCT01592851|11715336|FG001|COMPLETED|Overall Study||57
10560490|NCT01592851|11715335|FG000|NOT COMPLETED|Overall Study||0
10560491|NCT01592851|11715336|FG001|NOT COMPLETED|Overall Study||0
10560492|NCT01592864|11715344|FG000|STARTED|Overall Study||60
10560493|NCT01592864|11715345|FG001|STARTED|Overall Study||58
10560494|NCT01592864|11715344|FG000|COMPLETED|Overall Study||60
10560495|NCT01592864|11715345|FG001|COMPLETED|Overall Study||57
10560496|NCT01592864|11715344|FG000|NOT COMPLETED|Overall Study||0
10560497|NCT01592864|11715345|FG001|NOT COMPLETED|Overall Study||1
10560498|NCT01593020|11715353|FG000|STARTED|Overall Study||28
10560499|NCT01593020|11715354|FG001|STARTED|Overall Study||23
10560500|NCT01593020|11715353|FG000|COMPLETED|Overall Study||26
10560501|NCT01593020|11715354|FG001|COMPLETED|Overall Study||21
10560502|NCT01593020|11715353|FG000|NOT COMPLETED|Overall Study||2
10560503|NCT01593020|11715354|FG001|NOT COMPLETED|Overall Study||2
10560504|NCT01593215|11715362|FG000|STARTED|Overall Study||25
10560505|NCT01593215|11715363|FG001|STARTED|Overall Study||25
10560506|NCT01593215|11715362|FG000|COMPLETED|Overall Study||24
10560507|NCT01593215|11715363|FG001|COMPLETED|Overall Study||25
10560508|NCT01593215|11715362|FG000|NOT COMPLETED|Overall Study||1
10560509|NCT01593215|11715363|FG001|NOT COMPLETED|Overall Study||0
10560510|NCT01593592|11715371|FG000|STARTED|Overall Study||35
10560511|NCT01593592|11715372|FG001|STARTED|Overall Study||35
10560512|NCT01593592|11715371|FG000|COMPLETED|Overall Study||35
10560513|NCT01593592|11715372|FG001|COMPLETED|Overall Study||35
10560514|NCT01593592|11715371|FG000|NOT COMPLETED|Overall Study||0
10560515|NCT01593592|11715372|FG001|NOT COMPLETED|Overall Study||0
10560516|NCT01593670|11715378|FG000|STARTED|Overall Study||9
10560517|NCT01593670|11715378|FG000|COMPLETED|Overall Study||9
10560518|NCT01593670|11715378|FG000|NOT COMPLETED|Overall Study||0
10560519|NCT01593696|11715386|FG000|STARTED|Dose Escalation||16
10560520|NCT01593696|11715387|FG001|STARTED|Dose Escalation||5
10560521|NCT01593696|11715388|FG002|STARTED|Dose Escalation||0
10560522|NCT01593696|11715389|FG003|STARTED|Dose Escalation||0
10560523|NCT01593696|11715386|FG000|Prior Transplant|Dose Escalation||7
10560524|NCT01593696|11715387|FG001|Prior Transplant|Dose Escalation||1
10560525|NCT01593696|11715388|FG002|Prior Transplant|Dose Escalation||0
10560526|NCT01593696|11715389|FG003|Prior Transplant|Dose Escalation||0
10560527|NCT01593696|11715386|FG000|No Prior Transplant|Dose Escalation||9
10560528|NCT01593696|11715387|FG001|No Prior Transplant|Dose Escalation||4
10560529|NCT01593696|11715388|FG002|No Prior Transplant|Dose Escalation||0
10560530|NCT01593696|11715389|FG003|No Prior Transplant|Dose Escalation||0
10560531|NCT01593696|11715386|FG000|COMPLETED|Dose Escalation||14
10560532|NCT01593696|11715387|FG001|COMPLETED|Dose Escalation||5
10560533|NCT01593696|11715388|FG002|COMPLETED|Dose Escalation||0
10560534|NCT01593696|11715389|FG003|COMPLETED|Dose Escalation||0
10560535|NCT01593696|11715386|FG000|NOT COMPLETED|Dose Escalation||2
10560536|NCT01593696|11715387|FG001|NOT COMPLETED|Dose Escalation||0
10560537|NCT01593696|11715388|FG002|NOT COMPLETED|Dose Escalation||0
10560538|NCT01593696|11715389|FG003|NOT COMPLETED|Dose Escalation||0
10560539|NCT01593696|11715386|FG000|STARTED|Dose Expansion||0
10560540|NCT01593696|11715387|FG001|STARTED|Dose Expansion||0
10560541|NCT01593696|11715388|FG002|STARTED|Dose Expansion||16
10560542|NCT01593696|11715389|FG003|STARTED|Dose Expansion||16
10560543|NCT01593696|11715386|FG000|COMPLETED|Dose Expansion||0
10560544|NCT01593696|11715387|FG001|COMPLETED|Dose Expansion||0
10560545|NCT01593696|11715388|FG002|COMPLETED|Dose Expansion||15
10560546|NCT01593696|11715389|FG003|COMPLETED|Dose Expansion||16
10560547|NCT01593696|11715386|FG000|NOT COMPLETED|Dose Expansion||0
10560548|NCT01593696|11715387|FG001|NOT COMPLETED|Dose Expansion||0
10560549|NCT01593696|11715388|FG002|NOT COMPLETED|Dose Expansion||1
10560550|NCT01593696|11715389|FG003|NOT COMPLETED|Dose Expansion||0
10560551|NCT01593722|11715401|FG000|STARTED|Overall Study||6
10560552|NCT01593722|11715402|FG001|STARTED|Overall Study||6
10560553|NCT01593722|11715401|FG000|COMPLETED|Overall Study||6
10560554|NCT01593722|11715402|FG001|COMPLETED|Overall Study||6
10560555|NCT01593722|11715401|FG000|NOT COMPLETED|Overall Study||0
10560556|NCT01593722|11715402|FG001|NOT COMPLETED|Overall Study||0
10560557|NCT01593748|11715412|FG000|STARTED|Overall Study||45
10560558|NCT01593748|11715413|FG001|STARTED|Overall Study||45
10560559|NCT01593748|11715412|FG000|COMPLETED|Overall Study||45
10560560|NCT01593748|11715413|FG001|COMPLETED|Overall Study||45
10560561|NCT01593748|11715412|FG000|NOT COMPLETED|Overall Study||0
10560562|NCT01593748|11715413|FG001|NOT COMPLETED|Overall Study||0
10560563|NCT01593787|11715422|FG000|STARTED|Overall Study||6
10560564|NCT01593787|11715423|FG001|STARTED|Overall Study||8
10560565|NCT01593787|11715424|FG002|STARTED|Overall Study||18
10560566|NCT01593787|11715422|FG000|COMPLETED|Overall Study||5
10560567|NCT01593787|11715423|FG001|COMPLETED|Overall Study||8
10560568|NCT01593787|11715424|FG002|COMPLETED|Overall Study||18
10560569|NCT01593787|11715422|FG000|NOT COMPLETED|Overall Study||1
10560570|NCT01593787|11715423|FG001|NOT COMPLETED|Overall Study||0
10560571|NCT01593787|11715424|FG002|NOT COMPLETED|Overall Study||0
10560572|NCT01593917|11715434|FG000|STARTED|Overall Study||329
10560573|NCT01593917|11715434|FG000|COMPLETED|Overall Study||159
10560574|NCT01593917|11715434|FG000|NOT COMPLETED|Overall Study||170
10560575|NCT01594125|11715443|FG000|STARTED|Overall Study||4
10560576|NCT01594125|11715444|FG001|STARTED|Overall Study||12
10560577|NCT01594125|11715445|FG002|STARTED|Overall Study||3
10560578|NCT01594125|11715446|FG003|STARTED|Overall Study||4
10560579|NCT01594125|11715447|FG004|STARTED|Overall Study||7
10560580|NCT01594125|11715443|FG000|COMPLETED|Overall Study||0
10560581|NCT01594125|11715444|FG001|COMPLETED|Overall Study||0
10560582|NCT01594125|11715445|FG002|COMPLETED|Overall Study||0
10560583|NCT01594125|11715446|FG003|COMPLETED|Overall Study||0
10560584|NCT01594125|11715447|FG004|COMPLETED|Overall Study||0
10560585|NCT01594125|11715443|FG000|NOT COMPLETED|Overall Study||4
10560586|NCT01594125|11715444|FG001|NOT COMPLETED|Overall Study||12
10560587|NCT01594125|11715445|FG002|NOT COMPLETED|Overall Study||3
10560588|NCT01594125|11715446|FG003|NOT COMPLETED|Overall Study||4
10560589|NCT01594125|11715447|FG004|NOT COMPLETED|Overall Study||7
10560590|NCT01594281|11715462|FG000|STARTED|Interventional Core Phase||36
10560591|NCT01594281|11715463|FG001|STARTED|Interventional Core Phase||36
10560592|NCT01594281|11715464|FG002|STARTED|Interventional Core Phase||36
10560593|NCT01594281|11715462|FG000|Full Analysis Set (FAS)|Interventional Core Phase||35
10560594|NCT01594281|11715463|FG001|Full Analysis Set (FAS)|Interventional Core Phase||35
10560595|NCT01594281|11715464|FG002|Full Analysis Set (FAS)|Interventional Core Phase||36
10560596|NCT01594281|11715462|FG000|COMPLETED|Interventional Core Phase||29
10560597|NCT01594281|11715463|FG001|COMPLETED|Interventional Core Phase||26
10560598|NCT01594281|11715464|FG002|COMPLETED|Interventional Core Phase||28
10560599|NCT01594281|11715462|FG000|NOT COMPLETED|Interventional Core Phase||7
10560600|NCT01594281|11715463|FG001|NOT COMPLETED|Interventional Core Phase||10
10560601|NCT01594281|11715464|FG002|NOT COMPLETED|Interventional Core Phase||8
10560602|NCT01594281|11715462|FG000|STARTED|Non-Interventional Follow Up Phase|1 patient exited after completing Core Phase and did not start the Follow-Up Phase|28
10560603|NCT01594281|11715463|FG001|STARTED|Non-Interventional Follow Up Phase|5 patients exited after completing Core Phase and did not start the Follow-Up Phase|21
10560604|NCT01594281|11715464|FG002|STARTED|Non-Interventional Follow Up Phase|3 patients exited after completing Core Phase and did not start the Follow-Up Phase|25
10560605|NCT01594281|11715462|FG000|Follow Up Set (FUS)|Non-Interventional Follow Up Phase||28
10560606|NCT01594281|11715463|FG001|Follow Up Set (FUS)|Non-Interventional Follow Up Phase||20
10560607|NCT01594281|11715464|FG002|Follow Up Set (FUS)|Non-Interventional Follow Up Phase||25
10560608|NCT01594281|11715462|FG000|COMPLETED|Non-Interventional Follow Up Phase||25
10560609|NCT01594281|11715463|FG001|COMPLETED|Non-Interventional Follow Up Phase||19
10560610|NCT01594281|11715464|FG002|COMPLETED|Non-Interventional Follow Up Phase||23
10560611|NCT01594281|11715462|FG000|NOT COMPLETED|Non-Interventional Follow Up Phase||3
10560612|NCT01594281|11715463|FG001|NOT COMPLETED|Non-Interventional Follow Up Phase||2
10560613|NCT01594281|11715464|FG002|NOT COMPLETED|Non-Interventional Follow Up Phase||2
10560614|NCT01594294|11715477|FG000|STARTED|Overall Study||39
10560615|NCT01594294|11715478|FG001|STARTED|Overall Study||40
10560616|NCT01594294|11715477|FG000|COMPLETED|Overall Study||36
10560617|NCT01594294|11715478|FG001|COMPLETED|Overall Study||36
10560618|NCT01594294|11715477|FG000|NOT COMPLETED|Overall Study||3
10560619|NCT01594294|11715478|FG001|NOT COMPLETED|Overall Study||4
10560620|NCT01594333|11715486|FG000|STARTED|Overall Study||2391
10560621|NCT01594333|11715487|FG001|STARTED|Overall Study||2395
10560622|NCT01594333|11715486|FG000|COMPLETED|Overall Study||2230
10560623|NCT01594333|11715487|FG001|COMPLETED|Overall Study||2244
10560624|NCT01594333|11715486|FG000|NOT COMPLETED|Overall Study||161
10560625|NCT01594333|11715487|FG001|NOT COMPLETED|Overall Study||151
10560626|NCT01594385|11715495|FG000|STARTED|Overall Study||17
10560627|NCT01594385|11715496|FG001|STARTED|Overall Study||13
10560628|NCT01594385|11715495|FG000|COMPLETED|Overall Study||17
10560629|NCT01594385|11715496|FG001|COMPLETED|Overall Study||13
10560630|NCT01594385|11715495|FG000|NOT COMPLETED|Overall Study||0
10560631|NCT01594385|11715496|FG001|NOT COMPLETED|Overall Study||0
10560632|NCT01594411|11715506|FG000|STARTED|Overall Study||251
10560633|NCT01594411|11715506|FG000|COMPLETED|Overall Study||249
10560634|NCT01594411|11715506|FG000|NOT COMPLETED|Overall Study||2
10560635|NCT01594424|11715513|FG000|STARTED|Overall Study||10
10560636|NCT01594424|11715513|FG000|COMPLETED|Overall Study||8
10560637|NCT01594424|11715513|FG000|NOT COMPLETED|Overall Study||2
10560638|NCT01594476|11715519|FG000|STARTED|Overall Study||101
10560639|NCT01594476|11715520|FG001|STARTED|Overall Study||100
10560640|NCT01594476|11715519|FG000|Received Intervention|Overall Study||66
10560641|NCT01594476|11715520|FG001|Received Intervention|Overall Study||73
10560642|NCT01594476|11715519|FG000|Excluded After Allocation|Overall Study||1
10560643|NCT01594476|11715520|FG001|Excluded After Allocation|Overall Study||3
10560644|NCT01594476|11715519|FG000|IUD Removal|Overall Study||3
10560645|NCT01594476|11715520|FG001|IUD Removal|Overall Study||5
10560646|NCT01594476|11715519|FG000|IUD Expulsion|Overall Study||2
10560647|NCT01594476|11715520|FG001|IUD Expulsion|Overall Study||0
10560648|NCT01594476|11715519|FG000|Pregnant|Overall Study||2
10560649|NCT01594476|11715520|FG001|Pregnant|Overall Study||5
10560650|NCT01594476|11715519|FG000|COMPLETED|Overall Study||100
10560651|NCT01594476|11715520|FG001|COMPLETED|Overall Study||97
10560652|NCT01594476|11715519|FG000|NOT COMPLETED|Overall Study||1
10560653|NCT01594476|11715520|FG001|NOT COMPLETED|Overall Study||3
10560654|NCT01594515|11715540|FG000|STARTED|Overall Study||6
10560655|NCT01594515|11715541|FG001|STARTED|Overall Study||6
10560656|NCT01594515|11715542|FG002|STARTED|Overall Study||6
10560657|NCT01594515|11715543|FG003|STARTED|Overall Study||6
10560658|NCT01594515|11715544|FG004|STARTED|Overall Study||6
10560659|NCT01594515|11715545|FG005|STARTED|Overall Study||6
10560660|NCT01594515|11715546|FG006|STARTED|Overall Study||6
10560661|NCT01594515|11715547|FG007|STARTED|Overall Study||6
10560662|NCT01594515|11715548|FG008|STARTED|Overall Study||6
10560663|NCT01594515|11715549|FG009|STARTED|Overall Study||16
10560664|NCT01594515|11715540|FG000|COMPLETED|Overall Study||6
10560665|NCT01594515|11715541|FG001|COMPLETED|Overall Study||6
10560666|NCT01594515|11715542|FG002|COMPLETED|Overall Study||6
10560667|NCT01594515|11715543|FG003|COMPLETED|Overall Study||6
10560668|NCT01594515|11715544|FG004|COMPLETED|Overall Study||6
10560669|NCT01594515|11715545|FG005|COMPLETED|Overall Study||6
10560670|NCT01594515|11715546|FG006|COMPLETED|Overall Study||6
10560671|NCT01594515|11715547|FG007|COMPLETED|Overall Study||6
10560672|NCT01594515|11715548|FG008|COMPLETED|Overall Study||6
10560673|NCT01594515|11715549|FG009|COMPLETED|Overall Study||16
10560674|NCT01594515|11715540|FG000|NOT COMPLETED|Overall Study||0
10560675|NCT01594515|11715541|FG001|NOT COMPLETED|Overall Study||0
10560676|NCT01594515|11715542|FG002|NOT COMPLETED|Overall Study||0
10560677|NCT01594515|11715543|FG003|NOT COMPLETED|Overall Study||0
10560678|NCT01594515|11715544|FG004|NOT COMPLETED|Overall Study||0
10560679|NCT01594515|11715545|FG005|NOT COMPLETED|Overall Study||0
10560680|NCT01594515|11715546|FG006|NOT COMPLETED|Overall Study||0
10560681|NCT01594515|11715547|FG007|NOT COMPLETED|Overall Study||0
10560682|NCT01594515|11715548|FG008|NOT COMPLETED|Overall Study||0
10560683|NCT01594515|11715549|FG009|NOT COMPLETED|Overall Study||0
10560684|NCT01594528|11715574|FG000|STARTED|Overall Study||16
10560685|NCT01594528|11715575|FG001|STARTED|Overall Study||17
10560686|NCT01594528|11715576|FG002|STARTED|Overall Study||16
10560687|NCT01594528|11715574|FG000|COMPLETED|Overall Study||16
10560688|NCT01594528|11715575|FG001|COMPLETED|Overall Study||17
10560689|NCT01594528|11715576|FG002|COMPLETED|Overall Study||16
10560690|NCT01594528|11715574|FG000|NOT COMPLETED|Overall Study||0
10560691|NCT01594528|11715575|FG001|NOT COMPLETED|Overall Study||0
10560692|NCT01594528|11715576|FG002|NOT COMPLETED|Overall Study||0
10560693|NCT01594749|11715584|FG000|STARTED|Overall Study||507
10560694|NCT01594749|11715585|FG001|STARTED|Overall Study||508
10560695|NCT01594749|11715584|FG000|Treated|Overall Study||503
10318726|NCT00216320|11452959|FG002|COMPLETED|Phase 1 (Weeks 0 - 6)||25
10318727|NCT00216320|11452957|FG000|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||0
10318728|NCT00216320|11452958|FG001|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||4
10560696|NCT01594749|11715585|FG001|Treated|Overall Study||498
10560697|NCT01594749|11715584|FG000|COMPLETED|Overall Study||485
10560698|NCT01594749|11715585|FG001|COMPLETED|Overall Study||490
10560699|NCT01594749|11715584|FG000|NOT COMPLETED|Overall Study||22
10560700|NCT01594749|11715585|FG001|NOT COMPLETED|Overall Study||18
10560701|NCT01594762|11715593|FG000|STARTED|Overall Study||97
10560702|NCT01594762|11715594|FG001|STARTED|Overall Study||103
10560703|NCT01594762|11715593|FG000|COMPLETED|Overall Study||86
10560704|NCT01594762|11715594|FG001|COMPLETED|Overall Study||93
10560705|NCT01594762|11715593|FG000|NOT COMPLETED|Overall Study||11
10560706|NCT01594762|11715594|FG001|NOT COMPLETED|Overall Study||10
10560707|NCT01594827|11715602|FG000|STARTED|Overall Study||14
10560708|NCT01594827|11715603|FG001|STARTED|Overall Study||15
10560709|NCT01594827|11715602|FG000|COMPLETED|Overall Study||10
10560710|NCT01594827|11715603|FG001|COMPLETED|Overall Study||15
10560711|NCT01594827|11715602|FG000|NOT COMPLETED|Overall Study||4
10560712|NCT01594827|11715603|FG001|NOT COMPLETED|Overall Study||0
10560713|NCT01594853|11715613|FG000|STARTED|Overall Study||16
10560714|NCT01594853|11715614|FG001|STARTED|Overall Study||15
10560715|NCT01594853|11715613|FG000|COMPLETED|Overall Study||14
10560716|NCT01594853|11715614|FG001|COMPLETED|Overall Study||12
10560717|NCT01594853|11715613|FG000|NOT COMPLETED|Overall Study||2
10560718|NCT01594853|11715614|FG001|NOT COMPLETED|Overall Study||3
10560719|NCT01594931|11715623|FG000|STARTED|Overall Study||160
10560720|NCT01594931|11715624|FG001|STARTED|Overall Study||157
10560721|NCT01594931|11715625|FG002|STARTED|Overall Study|One randomized subject was not treated.|160
10560722|NCT01594931|11715623|FG000|COMPLETED|Overall Study||131
10560723|NCT01594931|11715624|FG001|COMPLETED|Overall Study||145
10560724|NCT01594931|11715625|FG002|COMPLETED|Overall Study||146
10560725|NCT01594931|11715623|FG000|NOT COMPLETED|Overall Study||29
10560726|NCT01594931|11715624|FG001|NOT COMPLETED|Overall Study||12
10560727|NCT01594931|11715625|FG002|NOT COMPLETED|Overall Study||14
10560728|NCT01594970|11715636|FG000|STARTED|Overall Study||295
10560729|NCT01594970|11715637|FG001|STARTED|Overall Study||248
10560730|NCT01594970|11715638|FG002|STARTED|Overall Study||257
10560731|NCT01594970|11715636|FG000|COMPLETED|Overall Study||220
10560732|NCT01594970|11715637|FG001|COMPLETED|Overall Study||166
10560733|NCT01594970|11715638|FG002|COMPLETED|Overall Study||191
10560734|NCT01594970|11715636|FG000|NOT COMPLETED|Overall Study||75
10560735|NCT01594970|11715637|FG001|NOT COMPLETED|Overall Study||82
10560736|NCT01594970|11715638|FG002|NOT COMPLETED|Overall Study||66
10560737|NCT01595282|11715648|FG000|STARTED|Overall Study||47
10560738|NCT01595282|11715649|FG001|STARTED|Overall Study||47
10560739|NCT01595282|11715648|FG000|COMPLETED|Overall Study||47
10560740|NCT01595282|11715649|FG001|COMPLETED|Overall Study||47
10560741|NCT01595282|11715648|FG000|NOT COMPLETED|Overall Study||0
10560742|NCT01595282|11715649|FG001|NOT COMPLETED|Overall Study||0
10560743|NCT01595386|11715657|FG000|STARTED|Overall Study||21
10560744|NCT01595386|11715658|FG001|STARTED|Overall Study||19
10560745|NCT01595386|11715657|FG000|COMPLETED|Overall Study||21
10560746|NCT01595386|11715658|FG001|COMPLETED|Overall Study||19
10560747|NCT01595386|11715657|FG000|NOT COMPLETED|Overall Study||0
10560748|NCT01595386|11715658|FG001|NOT COMPLETED|Overall Study||0
10560749|NCT01595438|11715666|FG000|STARTED|Overall Study||516
10560750|NCT01595438|11715667|FG001|STARTED|Overall Study||517
10560751|NCT01595438|11715666|FG000|COMPLETED|Overall Study||473
10560752|NCT01595438|11715667|FG001|COMPLETED|Overall Study||476
10560753|NCT01595438|11715666|FG000|NOT COMPLETED|Overall Study||43
10560754|NCT01595438|11715667|FG001|NOT COMPLETED|Overall Study||41
10560755|NCT01595516|11715676|FG000|STARTED|Overall Study||16
10560756|NCT01595516|11715677|FG001|STARTED|Overall Study||16
10560757|NCT01595516|11715678|FG002|STARTED|Overall Study||12
10560758|NCT01595516|11715676|FG000|COMPLETED|Overall Study||16
10560759|NCT01595516|11715677|FG001|COMPLETED|Overall Study||16
10560760|NCT01595516|11715678|FG002|COMPLETED|Overall Study||12
10560761|NCT01595516|11715676|FG000|NOT COMPLETED|Overall Study||0
10560762|NCT01595516|11715677|FG001|NOT COMPLETED|Overall Study||0
10560763|NCT01595516|11715678|FG002|NOT COMPLETED|Overall Study||0
10560764|NCT01595529|11715702|FG000|STARTED|Overall Study||348
10560765|NCT01595529|11715703|FG001|STARTED|Overall Study||345
10791737|NCT03568539|11952548|FG000|STARTED|Overall Study||3
10791738|NCT03568539|11952549|FG001|STARTED|Overall Study||36
10791739|NCT03568539|11952548|FG000|COMPLETED|Overall Study||3
10791740|NCT03568539|11952549|FG001|COMPLETED|Overall Study||36
10791741|NCT03568539|11952548|FG000|NOT COMPLETED|Overall Study||0
10791742|NCT03568539|11952549|FG001|NOT COMPLETED|Overall Study||0
10560766|NCT01595529|11715702|FG000|Treated|Overall Study||337
10560767|NCT01595529|11715703|FG001|Treated|Overall Study||340
10560768|NCT01595529|11715702|FG000|Evaluated for Primary Endpoint, ITT|Overall Study||328
10560769|NCT01595529|11715703|FG001|Evaluated for Primary Endpoint, ITT|Overall Study||336
10560770|NCT01595529|11715702|FG000|ITT Without Treatment Failure|Overall Study||326
10560771|NCT01595529|11715703|FG001|ITT Without Treatment Failure|Overall Study||322
10560772|NCT01595529|11715702|FG000|ITT With Stool Sample at TOC|Overall Study||298
10560773|NCT01595529|11715703|FG001|ITT With Stool Sample at TOC|Overall Study||310
10560774|NCT01595529|11715702|FG000|Per-protocol, Completed 80% of Dose|Overall Study||308
10560775|NCT01595529|11715703|FG001|Per-protocol, Completed 80% of Dose|Overall Study||314
10560776|NCT01595529|11715702|FG000|Per-protocol Without Treatment Failure|Overall Study||306
10560777|NCT01595529|11715703|FG001|Per-protocol Without Treatment Failure|Overall Study||305
10560778|NCT01595529|11715702|FG000|Per-protocol With Stool Sample at TOC|Overall Study||280
10560779|NCT01595529|11715703|FG001|Per-protocol With Stool Sample at TOC|Overall Study||289
10560780|NCT01595529|11715702|FG000|Completed All Milestones|Overall Study||318
10560781|NCT01595529|11715703|FG001|Completed All Milestones|Overall Study||318
10560782|NCT01595529|11715702|FG000|COMPLETED|Overall Study||324
10560783|NCT01595529|11715703|FG001|COMPLETED|Overall Study||325
10560784|NCT01595529|11715702|FG000|NOT COMPLETED|Overall Study||24
10560785|NCT01595529|11715703|FG001|NOT COMPLETED|Overall Study||20
10560786|NCT01595646|11715712|FG000|STARTED|Overall Study||13
10560787|NCT01595646|11715713|FG001|STARTED|Overall Study||12
10560788|NCT01595646|11715714|FG002|STARTED|Overall Study||12
10560789|NCT01595646|11715712|FG000|COMPLETED|Overall Study||12
10560790|NCT01595646|11715713|FG001|COMPLETED|Overall Study||12
10560791|NCT01595646|11715714|FG002|COMPLETED|Overall Study||12
10560792|NCT01595646|11715712|FG000|NOT COMPLETED|Overall Study||1
10560793|NCT01595646|11715713|FG001|NOT COMPLETED|Overall Study||0
10560794|NCT01595646|11715714|FG002|NOT COMPLETED|Overall Study||0
10560795|NCT01595854|11715730|FG000|STARTED|Overall Study||8
10560796|NCT01595854|11715731|FG001|STARTED|Overall Study||4
10560797|NCT01595854|11715732|FG002|STARTED|Overall Study||8
10560798|NCT01595854|11715733|FG003|STARTED|Overall Study||4
10560799|NCT01595854|11715734|FG004|STARTED|Overall Study||12
10560800|NCT01595854|11715730|FG000|COMPLETED|Overall Study||8
10560801|NCT01595854|11715731|FG001|COMPLETED|Overall Study||4
10560802|NCT01595854|11715732|FG002|COMPLETED|Overall Study||8
10560803|NCT01595854|11715733|FG003|COMPLETED|Overall Study||4
10560804|NCT01595854|11715734|FG004|COMPLETED|Overall Study||12
10560805|NCT01595854|11715730|FG000|NOT COMPLETED|Overall Study||0
10560806|NCT01595854|11715731|FG001|NOT COMPLETED|Overall Study||0
10560807|NCT01595854|11715732|FG002|NOT COMPLETED|Overall Study||0
10560808|NCT01595854|11715733|FG003|NOT COMPLETED|Overall Study||0
10560809|NCT01595854|11715734|FG004|NOT COMPLETED|Overall Study||0
10560810|NCT01596062|11715755|FG000|STARTED|Overall Study||3
10560811|NCT01596062|11715756|FG001|STARTED|Overall Study||6
10560812|NCT01596062|11715757|FG002|STARTED|Overall Study||7
10560813|NCT01596062|11715755|FG000|COMPLETED|Overall Study||2
10560814|NCT01596062|11715756|FG001|COMPLETED|Overall Study||6
10560815|NCT01596062|11715757|FG002|COMPLETED|Overall Study||4
10560816|NCT01596062|11715755|FG000|NOT COMPLETED|Overall Study||1
10560817|NCT01596062|11715756|FG001|NOT COMPLETED|Overall Study||0
10560818|NCT01596062|11715757|FG002|NOT COMPLETED|Overall Study||3
10791743|NCT03568942|11952556|FG000|STARTED|Overall Study||22
10560819|NCT01596088|11715765|FG000|STARTED|Overall Study||2
10560820|NCT01596088|11715765|FG000|COMPLETED|Overall Study||2
10560821|NCT01596088|11715765|FG000|NOT COMPLETED|Overall Study||0
10560822|NCT01596127|11715769|FG000|STARTED|Overall Study||4
10560823|NCT01596127|11715769|FG000|COMPLETED|Overall Study||3
10560824|NCT01596127|11715769|FG000|NOT COMPLETED|Overall Study||1
10560825|NCT01596231|11715775|FG000|STARTED|Overall Study||10
10560826|NCT01596231|11715776|FG001|STARTED|Overall Study||10
10560827|NCT01596231|11715775|FG000|COMPLETED|Overall Study||10
10791744|NCT03568942|11952556|FG000|COMPLETED|Overall Study||20
10791745|NCT03568942|11952556|FG000|NOT COMPLETED|Overall Study||2
10791746|NCT03569020|11952562|FG000|STARTED|Period 1||22
10560828|NCT01596231|11715776|FG001|COMPLETED|Overall Study||10
10560829|NCT01596231|11715775|FG000|NOT COMPLETED|Overall Study||0
10560830|NCT01596231|11715776|FG001|NOT COMPLETED|Overall Study||0
10560831|NCT01596283|11715784|FG000|STARTED|Overall Study||69
10560832|NCT01596283|11715785|FG001|STARTED|Overall Study||66
10560833|NCT01596283|11715784|FG000|COMPLETED|Overall Study||69
10560834|NCT01596283|11715785|FG001|COMPLETED|Overall Study||66
10560835|NCT01596283|11715784|FG000|NOT COMPLETED|Overall Study||0
10560836|NCT01596283|11715785|FG001|NOT COMPLETED|Overall Study||0
10560837|NCT01596335|11715795|FG000|STARTED|Overall Study||16
10560838|NCT01596335|11715796|FG001|STARTED|Overall Study||15
10560839|NCT01596335|11715795|FG000|COMPLETED|Overall Study||11
10560840|NCT01596335|11715796|FG001|COMPLETED|Overall Study||6
10560841|NCT01596335|11715795|FG000|NOT COMPLETED|Overall Study||5
10560842|NCT01596335|11715796|FG001|NOT COMPLETED|Overall Study||9
10791747|NCT03569020|11952563|FG001|STARTED|Period 1||21
10560843|NCT01596504|11715805|FG000|STARTED|Overall Study||48
10560844|NCT01596504|11715806|FG001|STARTED|Overall Study||47
10560845|NCT01596504|11715807|FG002|STARTED|Overall Study||47
10560846|NCT01596504|11715805|FG000|COMPLETED|Overall Study||46
10560847|NCT01596504|11715806|FG001|COMPLETED|Overall Study||44
10560848|NCT01596504|11715807|FG002|COMPLETED|Overall Study||46
10560849|NCT01596504|11715805|FG000|NOT COMPLETED|Overall Study||2
10560850|NCT01596504|11715806|FG001|NOT COMPLETED|Overall Study||3
10560851|NCT01596504|11715807|FG002|NOT COMPLETED|Overall Study||1
10560852|NCT01596582|11715818|FG000|STARTED|Overall Study||172
10560853|NCT01596582|11715819|FG001|STARTED|Overall Study||180
10560854|NCT01596582|11715818|FG000|COMPLETED|Overall Study||168
10560855|NCT01596582|11715819|FG001|COMPLETED|Overall Study||173
10560856|NCT01596582|11715818|FG000|NOT COMPLETED|Overall Study||4
10560857|NCT01596582|11715819|FG001|NOT COMPLETED|Overall Study||7
10560858|NCT01596595|11715832|FG000|STARTED|Overall Study||1779
10560859|NCT01596595|11715832|FG000|COMPLETED|Overall Study||814
10560860|NCT01596595|11715832|FG000|NOT COMPLETED|Overall Study||965
10560861|NCT01596699|11715838|FG000|STARTED|Overall Study||10
10560862|NCT01596699|11715839|FG001|STARTED|Overall Study||6
10560863|NCT01596699|11715838|FG000|COMPLETED|Overall Study||10
10560864|NCT01596699|11715839|FG001|COMPLETED|Overall Study||6
10560865|NCT01596699|11715838|FG000|NOT COMPLETED|Overall Study||0
10560866|NCT01596699|11715839|FG001|NOT COMPLETED|Overall Study||0
10560867|NCT01596751|11715854|FG000|STARTED|Overall Study||5
10560868|NCT01596751|11715855|FG001|STARTED|Overall Study||4
10560869|NCT01596751|11715856|FG002|STARTED|Overall Study||3
10560870|NCT01596751|11715857|FG003|STARTED|Overall Study||6
10560871|NCT01596751|11715858|FG004|STARTED|Overall Study||4
10560872|NCT01596751|11715859|FG005|STARTED|Overall Study||6
10560873|NCT01596751|11715860|FG006|STARTED|Overall Study||17
10560874|NCT01596751|11715861|FG007|STARTED|Overall Study||22
10560875|NCT01596751|11715854|FG000|COMPLETED|Overall Study||5
10560876|NCT01596751|11715855|FG001|COMPLETED|Overall Study||4
10560877|NCT01596751|11715856|FG002|COMPLETED|Overall Study||3
10560878|NCT01596751|11715857|FG003|COMPLETED|Overall Study||6
10560879|NCT01596751|11715858|FG004|COMPLETED|Overall Study||4
10560880|NCT01596751|11715859|FG005|COMPLETED|Overall Study||6
10560881|NCT01596751|11715860|FG006|COMPLETED|Overall Study||17
10560882|NCT01596751|11715861|FG007|COMPLETED|Overall Study||22
10560883|NCT01596751|11715854|FG000|NOT COMPLETED|Overall Study||0
10560884|NCT01596751|11715855|FG001|NOT COMPLETED|Overall Study||0
10560885|NCT01596751|11715856|FG002|NOT COMPLETED|Overall Study||0
10560886|NCT01596751|11715857|FG003|NOT COMPLETED|Overall Study||0
10560887|NCT01596751|11715858|FG004|NOT COMPLETED|Overall Study||0
10560888|NCT01596751|11715859|FG005|NOT COMPLETED|Overall Study||0
10560889|NCT01596751|11715860|FG006|NOT COMPLETED|Overall Study||0
10560890|NCT01596751|11715861|FG007|NOT COMPLETED|Overall Study||0
10560891|NCT01596842|11715881|FG000|STARTED|Overall Study||10
10560892|NCT01596842|11715882|FG001|STARTED|Overall Study||7
10560893|NCT01596842|11715881|FG000|COMPLETED|Overall Study||8
10560894|NCT01596842|11715882|FG001|COMPLETED|Overall Study||7
10560895|NCT01596842|11715881|FG000|NOT COMPLETED|Overall Study||2
10560896|NCT01596842|11715882|FG001|NOT COMPLETED|Overall Study||0
10560897|NCT01596972|11715890|FG000|STARTED|Overall Study||25
10560898|NCT01596972|11715891|FG001|STARTED|Overall Study||26
10560899|NCT01596972|11715890|FG000|COMPLETED|Overall Study||24
10560900|NCT01596972|11715891|FG001|COMPLETED|Overall Study||12
10560901|NCT01596972|11715890|FG000|NOT COMPLETED|Overall Study||1
10560902|NCT01596972|11715891|FG001|NOT COMPLETED|Overall Study||14
10560903|NCT01597050|11715899|FG000|STARTED|Overall Study||36
10560904|NCT01597050|11715900|FG001|STARTED|Overall Study||18
10560905|NCT01597050|11715899|FG000|COMPLETED|Overall Study||35
10560906|NCT01597050|11715900|FG001|COMPLETED|Overall Study||18
10560907|NCT01597050|11715899|FG000|NOT COMPLETED|Overall Study||1
10560908|NCT01597050|11715900|FG001|NOT COMPLETED|Overall Study||0
10560909|NCT01597128|11715908|FG000|STARTED|Overall Study||18
10560910|NCT01597128|11715909|FG001|STARTED|Overall Study||17
10560911|NCT01597128|11715908|FG000|COMPLETED|Overall Study||18
10560912|NCT01597128|11715909|FG001|COMPLETED|Overall Study||17
10560913|NCT01597128|11715908|FG000|NOT COMPLETED|Overall Study||0
10560914|NCT01597128|11715909|FG001|NOT COMPLETED|Overall Study||0
10560915|NCT01597141|11715917|FG000|STARTED|Overall Study||50
10560916|NCT01597141|11715918|FG001|STARTED|Overall Study||50
10560917|NCT01597141|11715917|FG000|COMPLETED|Overall Study||50
10560918|NCT01597141|11715918|FG001|COMPLETED|Overall Study||50
10560919|NCT01597141|11715917|FG000|NOT COMPLETED|Overall Study||0
10560920|NCT01597141|11715918|FG001|NOT COMPLETED|Overall Study||0
10560921|NCT01597193|11715933|FG000|STARTED|Stage 1: Dose Escalation (141 Days)||7
10560922|NCT01597193|11715934|FG001|STARTED|Stage 1: Dose Escalation (141 Days)||8
10560923|NCT01597193|11715935|FG002|STARTED|Stage 1: Dose Escalation (141 Days)||0
10560924|NCT01597193|11715936|FG003|STARTED|Stage 1: Dose Escalation (141 Days)||0
10560925|NCT01597193|11715937|FG004|STARTED|Stage 1: Dose Escalation (141 Days)||0
10560926|NCT01597193|11715938|FG005|STARTED|Stage 1: Dose Escalation (141 Days)||0
10560927|NCT01597193|11715939|FG006|STARTED|Stage 1: Dose Escalation (141 Days)||0
10560928|NCT01597193|11715933|FG000|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
10560929|NCT01597193|11715934|FG001|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
10560930|NCT01597193|11715935|FG002|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
10560931|NCT01597193|11715936|FG003|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
10560932|NCT01597193|11715937|FG004|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
10560933|NCT01597193|11715938|FG005|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
10560934|NCT01597193|11715939|FG006|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
10560935|NCT01597193|11715933|FG000|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||7
10560936|NCT01597193|11715934|FG001|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||8
10560937|NCT01597193|11715935|FG002|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
10560938|NCT01597193|11715936|FG003|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
10560939|NCT01597193|11715937|FG004|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
10560940|NCT01597193|11715938|FG005|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
10560941|NCT01597193|11715939|FG006|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
10560942|NCT01597193|11715933|FG000|STARTED|Stage 2: Dose Expansion (1067 Days)||0
10560943|NCT01597193|11715934|FG001|STARTED|Stage 2: Dose Expansion (1067 Days)||0
10560944|NCT01597193|11715935|FG002|STARTED|Stage 2: Dose Expansion (1067 Days)||14
10560945|NCT01597193|11715936|FG003|STARTED|Stage 2: Dose Expansion (1067 Days)||20
10560946|NCT01597193|11715937|FG004|STARTED|Stage 2: Dose Expansion (1067 Days)||16
10560947|NCT01597193|11715938|FG005|STARTED|Stage 2: Dose Expansion (1067 Days)||23
10560948|NCT01597193|11715939|FG006|STARTED|Stage 2: Dose Expansion (1067 Days)||11
10560949|NCT01597193|11715933|FG000|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
10560950|NCT01597193|11715934|FG001|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
10560951|NCT01597193|11715935|FG002|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
10560952|NCT01597193|11715936|FG003|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
10560953|NCT01597193|11715937|FG004|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
10560954|NCT01597193|11715938|FG005|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
10560955|NCT01597193|11715939|FG006|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
10560956|NCT01597193|11715933|FG000|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
10560957|NCT01597193|11715934|FG001|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
10791748|NCT03569020|11952562|FG000|COMPLETED|Period 1||22
10791749|NCT03569020|11952563|FG001|COMPLETED|Period 1||21
10560958|NCT01597193|11715935|FG002|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||14
10560959|NCT01597193|11715936|FG003|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||20
10560960|NCT01597193|11715937|FG004|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||16
10560961|NCT01597193|11715938|FG005|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||23
10560962|NCT01597193|11715939|FG006|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||11
10560963|NCT01597245|11715964|FG000|STARTED|Induction Period (Week 0 - Week 12)||168
10560964|NCT01597245|11715965|FG001|STARTED|Induction Period (Week 0 - Week 12)||358
10560965|NCT01597245|11715966|FG002|STARTED|Induction Period (Week 0 - Week 12)||347
10560966|NCT01597245|11715967|FG003|STARTED|Induction Period (Week 0 - Week 12)||351
10560967|NCT01597245|11715968|FG004|STARTED|Induction Period (Week 0 - Week 12)||0
10560968|NCT01597245|11715969|FG005|STARTED|Induction Period (Week 0 - Week 12)||0
10560969|NCT01597245|11715970|FG006|STARTED|Induction Period (Week 0 - Week 12)||0
10560970|NCT01597245|11715971|FG007|STARTED|Induction Period (Week 0 - Week 12)||0
10560971|NCT01597245|11715972|FG008|STARTED|Induction Period (Week 0 - Week 12)||0
10560972|NCT01597245|11715973|FG009|STARTED|Induction Period (Week 0 - Week 12)||0
10560973|NCT01597245|11715974|FG010|STARTED|Induction Period (Week 0 - Week 12)||0
10560974|NCT01597245|11715975|FG011|STARTED|Induction Period (Week 0 - Week 12)||0
10560975|NCT01597245|11715976|FG012|STARTED|Induction Period (Week 0 - Week 12)||0
10560976|NCT01597245|11715977|FG013|STARTED|Induction Period (Week 0 - Week 12)||0
10560977|NCT01597245|11715978|FG014|STARTED|Induction Period (Week 0 - Week 12)||0
10560978|NCT01597245|11715979|FG015|STARTED|Induction Period (Week 0 - Week 12)||0
10560979|NCT01597245|11715980|FG016|STARTED|Induction Period (Week 0 - Week 12)||0
10560980|NCT01597245|11715981|FG017|STARTED|Induction Period (Week 0 - Week 12)||0
10560981|NCT01597245|11715982|FG018|STARTED|Induction Period (Week 0 - Week 12)||0
10560982|NCT01597245|11715983|FG019|STARTED|Induction Period (Week 0 - Week 12)||0
10560983|NCT01597245|11715984|FG020|STARTED|Induction Period (Week 0 - Week 12)||0
10560984|NCT01597245|11715964|FG000|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||167
10560985|NCT01597245|11715965|FG001|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||357
10560986|NCT01597245|11715966|FG002|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||347
10560987|NCT01597245|11715967|FG003|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||350
10560988|NCT01597245|11715968|FG004|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
10560989|NCT01597245|11715969|FG005|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
10560990|NCT01597245|11715970|FG006|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
10560991|NCT01597245|11715971|FG007|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
10560992|NCT01597245|11715972|FG008|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
10560993|NCT01597245|11715973|FG009|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
10560994|NCT01597245|11715974|FG010|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
10560995|NCT01597245|11715975|FG011|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
10560996|NCT01597245|11715976|FG012|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
10560997|NCT01597245|11715977|FG013|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
10791750|NCT03569020|11952562|FG000|NOT COMPLETED|Period 1||0
10560998|NCT01597245|11715978|FG014|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
10560999|NCT01597245|11715979|FG015|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
10561000|NCT01597245|11715980|FG016|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
10561001|NCT01597245|11715981|FG017|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
10561002|NCT01597245|11715982|FG018|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
10561003|NCT01597245|11715983|FG019|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
10561004|NCT01597245|11715984|FG020|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
10561005|NCT01597245|11715964|FG000|COMPLETED|Induction Period (Week 0 - Week 12)||158
10561006|NCT01597245|11715965|FG001|COMPLETED|Induction Period (Week 0 - Week 12)|1 participant randomized to maintenance period but did not receive a dose in the maintenance period.|333
10561007|NCT01597245|11715966|FG002|COMPLETED|Induction Period (Week 0 - Week 12)||328
10561008|NCT01597245|11715967|FG003|COMPLETED|Induction Period (Week 0 - Week 12)|2 participants discontinued after IND completion and prior to randomizing into maintenance period.|342
10561009|NCT01597245|11715968|FG004|COMPLETED|Induction Period (Week 0 - Week 12)||0
10561010|NCT01597245|11715969|FG005|COMPLETED|Induction Period (Week 0 - Week 12)||0
10561011|NCT01597245|11715970|FG006|COMPLETED|Induction Period (Week 0 - Week 12)||0
10561012|NCT01597245|11715971|FG007|COMPLETED|Induction Period (Week 0 - Week 12)||0
10561013|NCT01597245|11715972|FG008|COMPLETED|Induction Period (Week 0 - Week 12)||0
10561014|NCT01597245|11715973|FG009|COMPLETED|Induction Period (Week 0 - Week 12)||0
10561015|NCT01597245|11715974|FG010|COMPLETED|Induction Period (Week 0 - Week 12)||0
10561016|NCT01597245|11715975|FG011|COMPLETED|Induction Period (Week 0 - Week 12)||0
10561017|NCT01597245|11715976|FG012|COMPLETED|Induction Period (Week 0 - Week 12)||0
10561018|NCT01597245|11715977|FG013|COMPLETED|Induction Period (Week 0 - Week 12)||0
10561019|NCT01597245|11715978|FG014|COMPLETED|Induction Period (Week 0 - Week 12)||0
10561020|NCT01597245|11715979|FG015|COMPLETED|Induction Period (Week 0 - Week 12)||0
10561021|NCT01597245|11715980|FG016|COMPLETED|Induction Period (Week 0 - Week 12)||0
10561022|NCT01597245|11715981|FG017|COMPLETED|Induction Period (Week 0 - Week 12)||0
10561023|NCT01597245|11715982|FG018|COMPLETED|Induction Period (Week 0 - Week 12)||0
10561024|NCT01597245|11715983|FG019|COMPLETED|Induction Period (Week 0 - Week 12)||0
10561025|NCT01597245|11715984|FG020|COMPLETED|Induction Period (Week 0 - Week 12)||0
10561026|NCT01597245|11715964|FG000|NOT COMPLETED|Induction Period (Week 0 - Week 12)||10
10561027|NCT01597245|11715965|FG001|NOT COMPLETED|Induction Period (Week 0 - Week 12)||25
10561028|NCT01597245|11715966|FG002|NOT COMPLETED|Induction Period (Week 0 - Week 12)||19
10561029|NCT01597245|11715967|FG003|NOT COMPLETED|Induction Period (Week 0 - Week 12)||9
10561030|NCT01597245|11715968|FG004|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
10561031|NCT01597245|11715969|FG005|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
10561032|NCT01597245|11715970|FG006|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
10561033|NCT01597245|11715971|FG007|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
10561034|NCT01597245|11715972|FG008|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
10561035|NCT01597245|11715973|FG009|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
10561036|NCT01597245|11715974|FG010|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
10561037|NCT01597245|11715975|FG011|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
10561038|NCT01597245|11715976|FG012|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
10561039|NCT01597245|11715977|FG013|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
10561040|NCT01597245|11715978|FG014|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
10561041|NCT01597245|11715979|FG015|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
10561042|NCT01597245|11715980|FG016|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
10561043|NCT01597245|11715981|FG017|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
10561044|NCT01597245|11715982|FG018|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
10561045|NCT01597245|11715983|FG019|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
10561046|NCT01597245|11715984|FG020|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
10561047|NCT01597245|11715964|FG000|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0
10561048|NCT01597245|11715965|FG001|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0
10561049|NCT01597245|11715966|FG002|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0
10561050|NCT01597245|11715967|FG003|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0
10561051|NCT01597245|11715968|FG004|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|176
10561052|NCT01597245|11715969|FG005|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|187
10561053|NCT01597245|11715970|FG006|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|181
10561054|NCT01597245|11715971|FG007|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|3
10561055|NCT01597245|11715972|FG008|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|155
10561056|NCT01597245|11715973|FG009|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|132
10561057|NCT01597245|11715974|FG010|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|200
10561058|NCT01597245|11715975|FG011|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|75
10650920|NCT02173535|11811305|FG008|COMPLETED|Period 1||12
10561059|NCT01597245|11715976|FG012|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|49
10561060|NCT01597245|11715977|FG013|STARTED|Maintenance Period (Week 12 to Week 60)||0
10561061|NCT01597245|11715978|FG014|STARTED|Maintenance Period (Week 12 to Week 60)||0
10561062|NCT01597245|11715979|FG015|STARTED|Maintenance Period (Week 12 to Week 60)||0
10561063|NCT01597245|11715980|FG016|STARTED|Maintenance Period (Week 12 to Week 60)||0
10561064|NCT01597245|11715981|FG017|STARTED|Maintenance Period (Week 12 to Week 60)||0
10561065|NCT01597245|11715982|FG018|STARTED|Maintenance Period (Week 12 to Week 60)||0
10561066|NCT01597245|11715983|FG019|STARTED|Maintenance Period (Week 12 to Week 60)||0
10561067|NCT01597245|11715984|FG020|STARTED|Maintenance Period (Week 12 to Week 60)||0
10561068|NCT01597245|11715964|FG000|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
10561069|NCT01597245|11715965|FG001|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
10561070|NCT01597245|11715966|FG002|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
10561071|NCT01597245|11715967|FG003|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
10561072|NCT01597245|11715968|FG004|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||176
10561073|NCT01597245|11715969|FG005|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||187
10561074|NCT01597245|11715970|FG006|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||181
10561075|NCT01597245|11715971|FG007|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||3
10561076|NCT01597245|11715972|FG008|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||155
10561077|NCT01597245|11715973|FG009|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||132
10561078|NCT01597245|11715974|FG010|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||200
10561079|NCT01597245|11715975|FG011|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||75
10561080|NCT01597245|11715976|FG012|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||49
10561081|NCT01597245|11715977|FG013|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
10561082|NCT01597245|11715978|FG014|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
10561083|NCT01597245|11715979|FG015|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
10561084|NCT01597245|11715980|FG016|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
10561085|NCT01597245|11715981|FG017|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
10561086|NCT01597245|11715982|FG018|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
10561087|NCT01597245|11715983|FG019|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
10791751|NCT03569020|11952563|FG001|NOT COMPLETED|Period 1||0
10791752|NCT03569020|11952562|FG000|STARTED|Period 2||22
10791753|NCT03569020|11952563|FG001|STARTED|Period 2||21
10791754|NCT03569020|11952562|FG000|COMPLETED|Period 2||22
10791755|NCT03569020|11952563|FG001|COMPLETED|Period 2||21
10791756|NCT03569020|11952562|FG000|NOT COMPLETED|Period 2||0
10791757|NCT03569020|11952563|FG001|NOT COMPLETED|Period 2||0
10791758|NCT03569033|11952575|FG000|STARTED|Overall Study||23
10791759|NCT03569033|11952576|FG001|STARTED|Overall Study||23
10791760|NCT03569033|11952575|FG000|COMPLETED|Overall Study||23
10791761|NCT03569033|11952576|FG001|COMPLETED|Overall Study||23
10791762|NCT03569033|11952575|FG000|NOT COMPLETED|Overall Study||0
10791763|NCT03569033|11952576|FG001|NOT COMPLETED|Overall Study||0
10791764|NCT03569098|11952585|FG000|STARTED|Double-Blind Treatment Cycle 1||63
10791765|NCT03569098|11952586|FG001|STARTED|Double-Blind Treatment Cycle 1||63
10791766|NCT03569098|11952587|FG002|STARTED|Double-Blind Treatment Cycle 1||60
10561088|NCT01597245|11715984|FG020|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
10561089|NCT01597245|11715964|FG000|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
10561090|NCT01597245|11715965|FG001|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
10561091|NCT01597245|11715966|FG002|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
10561092|NCT01597245|11715967|FG003|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
10561093|NCT01597245|11715968|FG004|COMPLETED|Maintenance Period (Week 12 to Week 60)||15
10561094|NCT01597245|11715969|FG005|COMPLETED|Maintenance Period (Week 12 to Week 60)||149
10561095|NCT01597245|11715970|FG006|COMPLETED|Maintenance Period (Week 12 to Week 60)||92
10561096|NCT01597245|11715971|FG007|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
10561097|NCT01597245|11715972|FG008|COMPLETED|Maintenance Period (Week 12 to Week 60)||135
10561098|NCT01597245|11715973|FG009|COMPLETED|Maintenance Period (Week 12 to Week 60)||11
10561099|NCT01597245|11715974|FG010|COMPLETED|Maintenance Period (Week 12 to Week 60)||178
10561100|NCT01597245|11715975|FG011|COMPLETED|Maintenance Period (Week 12 to Week 60)||56
10561101|NCT01597245|11715976|FG012|COMPLETED|Maintenance Period (Week 12 to Week 60)||37
10561102|NCT01597245|11715977|FG013|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
10561103|NCT01597245|11715978|FG014|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
10791767|NCT03569098|11952585|FG000|Received Study Medication|Double-Blind Treatment Cycle 1||61
10791768|NCT03569098|11952586|FG001|Received Study Medication|Double-Blind Treatment Cycle 1||63
10791769|NCT03569098|11952587|FG002|Received Study Medication|Double-Blind Treatment Cycle 1||56
10791770|NCT03569098|11952585|FG000|COMPLETED|Double-Blind Treatment Cycle 1||55
10791771|NCT03569098|11952586|FG001|COMPLETED|Double-Blind Treatment Cycle 1||53
10791772|NCT03569098|11952587|FG002|COMPLETED|Double-Blind Treatment Cycle 1||49
10791773|NCT03569098|11952585|FG000|NOT COMPLETED|Double-Blind Treatment Cycle 1||8
10791774|NCT03569098|11952586|FG001|NOT COMPLETED|Double-Blind Treatment Cycle 1||10
10791775|NCT03569098|11952587|FG002|NOT COMPLETED|Double-Blind Treatment Cycle 1||11
10791776|NCT03569098|11952585|FG000|STARTED|Open-Label Treatment Cycle 2|No participants were treated with placebo during the open-label treatment cycle 2.|0
10561104|NCT01597245|11715979|FG015|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
10561105|NCT01597245|11715980|FG016|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
10561106|NCT01597245|11715981|FG017|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
10561107|NCT01597245|11715982|FG018|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
10561108|NCT01597245|11715983|FG019|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
10561109|NCT01597245|11715984|FG020|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
10561110|NCT01597245|11715964|FG000|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
10561111|NCT01597245|11715965|FG001|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
10561112|NCT01597245|11715966|FG002|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
10561113|NCT01597245|11715967|FG003|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
10561114|NCT01597245|11715968|FG004|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||161
10561115|NCT01597245|11715969|FG005|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||38
10561116|NCT01597245|11715970|FG006|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||89
10561117|NCT01597245|11715971|FG007|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||3
10561118|NCT01597245|11715972|FG008|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||20
10561119|NCT01597245|11715973|FG009|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||121
10561120|NCT01597245|11715974|FG010|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||22
10561121|NCT01597245|11715975|FG011|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||19
10561122|NCT01597245|11715976|FG012|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||12
10561123|NCT01597245|11715977|FG013|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
10561124|NCT01597245|11715978|FG014|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
10561125|NCT01597245|11715979|FG015|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
10561126|NCT01597245|11715980|FG016|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
10561127|NCT01597245|11715981|FG017|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
10561128|NCT01597245|11715982|FG018|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
10561129|NCT01597245|11715983|FG019|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
10561130|NCT01597245|11715984|FG020|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
10561131|NCT01597245|11715964|FG000|STARTED|Long Term Extension (Week 60 - Week 264)||0
10561132|NCT01597245|11715965|FG001|STARTED|Long Term Extension (Week 60 - Week 264)||0
10561133|NCT01597245|11715966|FG002|STARTED|Long Term Extension (Week 60 - Week 264)||0
10561134|NCT01597245|11715967|FG003|STARTED|Long Term Extension (Week 60 - Week 264)||0
10561135|NCT01597245|11715968|FG004|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
10561136|NCT01597245|11715969|FG005|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
10561137|NCT01597245|11715970|FG006|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
10561138|NCT01597245|11715971|FG007|STARTED|Long Term Extension (Week 60 - Week 264)||0
10561139|NCT01597245|11715972|FG008|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
10561140|NCT01597245|11715973|FG009|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
10561141|NCT01597245|11715974|FG010|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
10561142|NCT01597245|11715975|FG011|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
10561143|NCT01597245|11715976|FG012|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
10561144|NCT01597245|11715977|FG013|STARTED|Long Term Extension (Week 60 - Week 264)|Participants who received placebo at the start of the long-term extension period.|26
10561145|NCT01597245|11715978|FG014|STARTED|Long Term Extension (Week 60 - Week 264)|Participants received ixe at the start of the long-term extension.|979
10561146|NCT01597245|11715979|FG015|STARTED|Long Term Extension (Week 60 - Week 264)|Participants received ixe in all dosing regimens, including participants who switched PBO to ixe.|1002
10561147|NCT01597245|11715980|FG016|STARTED|Long Term Extension (Week 60 - Week 264)||0
10561148|NCT01597245|11715981|FG017|STARTED|Long Term Extension (Week 60 - Week 264)||0
10561149|NCT01597245|11715982|FG018|STARTED|Long Term Extension (Week 60 - Week 264)||0
10561150|NCT01597245|11715983|FG019|STARTED|Long Term Extension (Week 60 - Week 264)||0
10561151|NCT01597245|11715984|FG020|STARTED|Long Term Extension (Week 60 - Week 264)||0
10561152|NCT01597245|11715964|FG000|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
10561153|NCT01597245|11715965|FG001|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
10561154|NCT01597245|11715966|FG002|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
10561155|NCT01597245|11715967|FG003|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
10561156|NCT01597245|11715968|FG004|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
10561157|NCT01597245|11715969|FG005|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
10561158|NCT01597245|11715970|FG006|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
10561159|NCT01597245|11715971|FG007|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
10561160|NCT01597245|11715972|FG008|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
10561161|NCT01597245|11715973|FG009|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
10561162|NCT01597245|11715974|FG010|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
10561163|NCT01597245|11715975|FG011|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
10650921|NCT02173535|11811306|FG009|COMPLETED|Period 1||12
10791777|NCT03569098|11952586|FG001|STARTED|Open-Label Treatment Cycle 2|All participants who met retreatment criteria were treated with Dysport 300 U during the open-label treatment cycle 2.|146
10810750|NCT03792672|11972461|FG005|COMPLETED|Treatment Period 3 (1 Day)||4
10561164|NCT01597245|11715976|FG012|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
10561165|NCT01597245|11715977|FG013|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
10561166|NCT01597245|11715978|FG014|COMPLETED|Long Term Extension (Week 60 - Week 264)||754
10561167|NCT01597245|11715979|FG015|COMPLETED|Long Term Extension (Week 60 - Week 264)||774
10561168|NCT01597245|11715980|FG016|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
10561169|NCT01597245|11715981|FG017|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
10561170|NCT01597245|11715982|FG018|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
10561171|NCT01597245|11715983|FG019|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
10561172|NCT01597245|11715984|FG020|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
10561173|NCT01597245|11715964|FG000|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
10561174|NCT01597245|11715965|FG001|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
10561175|NCT01597245|11715966|FG002|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
10561176|NCT01597245|11715967|FG003|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
10561177|NCT01597245|11715968|FG004|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
10561178|NCT01597245|11715969|FG005|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
10561179|NCT01597245|11715970|FG006|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
10561180|NCT01597245|11715971|FG007|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
10561181|NCT01597245|11715972|FG008|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
10561182|NCT01597245|11715973|FG009|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
10561183|NCT01597245|11715974|FG010|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
10561184|NCT01597245|11715975|FG011|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
10561185|NCT01597245|11715976|FG012|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
10561186|NCT01597245|11715977|FG013|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||26
10791778|NCT03569098|11952587|FG002|STARTED|Open-Label Treatment Cycle 2|No participants were treated with Dysport 500 U during the open-label treatment cycle 2.|0
10791779|NCT03569098|11952585|FG000|COMPLETED|Open-Label Treatment Cycle 2||0
10791780|NCT03569098|11952586|FG001|COMPLETED|Open-Label Treatment Cycle 2||111
10791781|NCT03569098|11952587|FG002|COMPLETED|Open-Label Treatment Cycle 2||0
10791782|NCT03569098|11952585|FG000|NOT COMPLETED|Open-Label Treatment Cycle 2||0
10791783|NCT03569098|11952586|FG001|NOT COMPLETED|Open-Label Treatment Cycle 2||35
10791784|NCT03569098|11952587|FG002|NOT COMPLETED|Open-Label Treatment Cycle 2||0
10791785|NCT03569098|11952585|FG000|STARTED|Open-Label Treatment Cycle 3||0
10810751|NCT03792672|11972456|FG000|NOT COMPLETED|Treatment Period 3 (1 Day)||0
10561187|NCT01597245|11715978|FG014|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||225
10561188|NCT01597245|11715979|FG015|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||228
10561189|NCT01597245|11715980|FG016|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
10561190|NCT01597245|11715981|FG017|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
10561191|NCT01597245|11715982|FG018|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
10561192|NCT01597245|11715983|FG019|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
10561193|NCT01597245|11715984|FG020|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
10561194|NCT01597245|11715964|FG000|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
10561195|NCT01597245|11715965|FG001|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
10561196|NCT01597245|11715966|FG002|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
10561197|NCT01597245|11715967|FG003|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
10561198|NCT01597245|11715968|FG004|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
10561199|NCT01597245|11715969|FG005|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
10561200|NCT01597245|11715970|FG006|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
10561201|NCT01597245|11715971|FG007|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
10561202|NCT01597245|11715972|FG008|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
10561203|NCT01597245|11715973|FG009|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
10561204|NCT01597245|11715974|FG010|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
10561205|NCT01597245|11715975|FG011|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
10561206|NCT01597245|11715976|FG012|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
10561207|NCT01597245|11715977|FG013|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
10561208|NCT01597245|11715978|FG014|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
10561209|NCT01597245|11715979|FG015|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
10561210|NCT01597245|11715980|FG016|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|16
10561211|NCT01597245|11715981|FG017|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|6
10561212|NCT01597245|11715982|FG018|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|24
10561213|NCT01597245|11715983|FG019|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|656
10561214|NCT01597245|11715984|FG020|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|248
10561215|NCT01597245|11715964|FG000|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
10561216|NCT01597245|11715965|FG001|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
10561217|NCT01597245|11715966|FG002|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
10561218|NCT01597245|11715967|FG003|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
10561219|NCT01597245|11715968|FG004|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
10561220|NCT01597245|11715969|FG005|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
10561221|NCT01597245|11715970|FG006|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
10561222|NCT01597245|11715971|FG007|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
10561223|NCT01597245|11715972|FG008|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
10561224|NCT01597245|11715973|FG009|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
10561225|NCT01597245|11715974|FG010|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
10561226|NCT01597245|11715975|FG011|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
10561227|NCT01597245|11715976|FG012|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
10561228|NCT01597245|11715977|FG013|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
10561229|NCT01597245|11715978|FG014|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
10561230|NCT01597245|11715979|FG015|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
10561231|NCT01597245|11715980|FG016|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
10561232|NCT01597245|11715981|FG017|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
10561233|NCT01597245|11715982|FG018|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||14
10561234|NCT01597245|11715983|FG019|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||489
10561235|NCT01597245|11715984|FG020|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||212
10561236|NCT01597245|11715964|FG000|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
10561237|NCT01597245|11715965|FG001|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
10561238|NCT01597245|11715966|FG002|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
10561239|NCT01597245|11715967|FG003|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
10561240|NCT01597245|11715968|FG004|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
10561241|NCT01597245|11715969|FG005|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
10561242|NCT01597245|11715970|FG006|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
10561243|NCT01597245|11715971|FG007|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
10561244|NCT01597245|11715972|FG008|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
10561245|NCT01597245|11715973|FG009|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
10561246|NCT01597245|11715974|FG010|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
10561247|NCT01597245|11715975|FG011|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
10561248|NCT01597245|11715976|FG012|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
10561249|NCT01597245|11715977|FG013|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
10561250|NCT01597245|11715978|FG014|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
10561251|NCT01597245|11715979|FG015|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
10561252|NCT01597245|11715980|FG016|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||16
10561253|NCT01597245|11715981|FG017|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||6
10561254|NCT01597245|11715982|FG018|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||10
10561255|NCT01597245|11715983|FG019|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||167
10561256|NCT01597245|11715984|FG020|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||36
10791786|NCT03569098|11952586|FG001|STARTED|Open-Label Treatment Cycle 3|Participants were treated with Dysport 300 U during open-label treatment cycle 3 based on investigator judgment following clinical evaluation of the participant at the time of retreatment.|8
10791787|NCT03569098|11952587|FG002|STARTED|Open-Label Treatment Cycle 3|Participants were treated with Dysport 500 U during open-label treatment cycle 3 based on investigator judgment following clinical evaluation of the participant at the time of retreatment.|56
10561257|NCT01597258|11716017|FG000|STARTED|Overall Study||2029
10561258|NCT01597258|11716017|FG000|COMPLETED|Overall Study||2028
10561259|NCT01597258|11716017|FG000|NOT COMPLETED|Overall Study||1
10561260|NCT01597375|11716021|FG000|STARTED|First Intervention (4 Weeks)||23
10561261|NCT01597375|11716022|FG001|STARTED|First Intervention (4 Weeks)||23
10561262|NCT01597375|11716021|FG000|COMPLETED|First Intervention (4 Weeks)||21
10561263|NCT01597375|11716022|FG001|COMPLETED|First Intervention (4 Weeks)||22
10561264|NCT01597375|11716021|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2
10561265|NCT01597375|11716022|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1
10561266|NCT01597375|11716021|FG000|STARTED|Washout (2 Weeks)||21
10561267|NCT01597375|11716022|FG001|STARTED|Washout (2 Weeks)||22
10561268|NCT01597375|11716021|FG000|COMPLETED|Washout (2 Weeks)||20
10561269|NCT01597375|11716022|FG001|COMPLETED|Washout (2 Weeks)||22
10561270|NCT01597375|11716021|FG000|NOT COMPLETED|Washout (2 Weeks)||1
10561271|NCT01597375|11716022|FG001|NOT COMPLETED|Washout (2 Weeks)||0
10561272|NCT01597375|11716021|FG000|STARTED|Second Intervention||20
10561273|NCT01597375|11716022|FG001|STARTED|Second Intervention||22
10561274|NCT01597375|11716021|FG000|COMPLETED|Second Intervention||19
10561275|NCT01597375|11716022|FG001|COMPLETED|Second Intervention||21
10561276|NCT01597375|11716021|FG000|NOT COMPLETED|Second Intervention||1
10561277|NCT01597375|11716022|FG001|NOT COMPLETED|Second Intervention||1
10561278|NCT01597440|11716031|FG000|STARTED|Overall Study||1
10561279|NCT01597440|11716032|FG001|STARTED|Overall Study||0
10561280|NCT01597440|11716031|FG000|COMPLETED|Overall Study||1
10561281|NCT01597440|11716032|FG001|COMPLETED|Overall Study||0
10561282|NCT01597440|11716031|FG000|NOT COMPLETED|Overall Study||0
10561283|NCT01597440|11716032|FG001|NOT COMPLETED|Overall Study||0
10561284|NCT01597479|11716042|FG000|STARTED|Overall Study||26
10561285|NCT01597479|11716043|FG001|STARTED|Overall Study||26
10561286|NCT01597479|11716042|FG000|COMPLETED|Overall Study||24
10561287|NCT01597479|11716043|FG001|COMPLETED|Overall Study||26
10561288|NCT01597479|11716042|FG000|NOT COMPLETED|Overall Study||2
10561289|NCT01597479|11716043|FG001|NOT COMPLETED|Overall Study||0
10561290|NCT01597492|11716052|FG000|STARTED|Overall Study||34
10791788|NCT03569098|11952585|FG000|COMPLETED|Open-Label Treatment Cycle 3||0
10455170|NCT01000727|11603180|FG001|COMPLETED|Overall Study||6328
10455171|NCT01000727|11603179|FG000|NOT COMPLETED|Overall Study||175
10455172|NCT01000727|11603180|FG001|NOT COMPLETED|Overall Study||176
10455173|NCT01000805|11603190|FG000|STARTED|Overall Study||262
10455174|NCT01000805|11603191|FG001|STARTED|Overall Study||266
10455175|NCT01000805|11603190|FG000|COMPLETED|Overall Study||192
10561291|NCT01597492|11716053|FG001|STARTED|Overall Study||45
10561292|NCT01597492|11716052|FG000|COMPLETED|Overall Study||28
10561293|NCT01597492|11716053|FG001|COMPLETED|Overall Study||41
10561294|NCT01597492|11716052|FG000|NOT COMPLETED|Overall Study||6
10561295|NCT01597492|11716053|FG001|NOT COMPLETED|Overall Study||4
10561296|NCT01597505|11716061|FG000|STARTED|Overall Study|Randomized participants|308
10561297|NCT01597505|11716062|FG001|STARTED|Overall Study|Randomized participants|298
10561298|NCT01597505|11716061|FG000|Treated|Overall Study|One participant was instead randomized to vancomycin|305
10561299|NCT01597505|11716062|FG001|Treated|Overall Study||286
10561300|NCT01597505|11716061|FG000|COMPLETED|Overall Study||264
10561301|NCT01597505|11716062|FG001|COMPLETED|Overall Study||265
10561302|NCT01597505|11716061|FG000|NOT COMPLETED|Overall Study||44
10561303|NCT01597505|11716062|FG001|NOT COMPLETED|Overall Study||33
10561304|NCT01597557|11716071|FG000|STARTED|Overall Study||132
10561305|NCT01597557|11716072|FG001|STARTED|Overall Study||129
10561306|NCT01597557|11716071|FG000|COMPLETED|Overall Study||128
10561307|NCT01597557|11716072|FG001|COMPLETED|Overall Study||126
10561308|NCT01597557|11716071|FG000|NOT COMPLETED|Overall Study||4
10561309|NCT01597557|11716072|FG001|NOT COMPLETED|Overall Study||3
10561310|NCT01597596|11716080|FG000|STARTED|Overall Study||1
10561311|NCT01597596|11716081|FG001|STARTED|Overall Study||3
10561312|NCT01597596|11716080|FG000|COMPLETED|Overall Study||0
10561313|NCT01597596|11716081|FG001|COMPLETED|Overall Study||2
10561314|NCT01597596|11716080|FG000|NOT COMPLETED|Overall Study||1
10561315|NCT01597596|11716081|FG001|NOT COMPLETED|Overall Study||1
10561316|NCT01597622|11716087|FG000|STARTED|Overall Study||142
10561317|NCT01597622|11716087|FG000|COMPLETED|Overall Study||104
10561318|NCT01597622|11716087|FG000|NOT COMPLETED|Overall Study||38
10561319|NCT01597635|11716094|FG000|STARTED|Part A||5
10561320|NCT01597635|11716095|FG001|STARTED|Part A||0
10561321|NCT01597635|11716096|FG002|STARTED|Part A||0
10561322|NCT01597635|11716094|FG000|COMPLETED|Part A||2
10561323|NCT01597635|11716095|FG001|COMPLETED|Part A||0
10561324|NCT01597635|11716096|FG002|COMPLETED|Part A||0
10561325|NCT01597635|11716094|FG000|NOT COMPLETED|Part A||3
10561326|NCT01597635|11716095|FG001|NOT COMPLETED|Part A||0
10561327|NCT01597635|11716096|FG002|NOT COMPLETED|Part A||0
10561328|NCT01597635|11716094|FG000|STARTED|Part B||0
10561329|NCT01597635|11716095|FG001|STARTED|Part B||20
10561330|NCT01597635|11716096|FG002|STARTED|Part B||19
10561331|NCT01597635|11716094|FG000|COMPLETED|Part B||0
10561332|NCT01597635|11716095|FG001|COMPLETED|Part B||14
10561333|NCT01597635|11716096|FG002|COMPLETED|Part B||15
10561334|NCT01597635|11716094|FG000|NOT COMPLETED|Part B||0
10561335|NCT01597635|11716095|FG001|NOT COMPLETED|Part B||6
10561336|NCT01597635|11716096|FG002|NOT COMPLETED|Part B||4
10561337|NCT01597687|11716108|FG000|STARTED|Overall Study||76
10561338|NCT01597687|11716109|FG001|STARTED|Overall Study||89
10561339|NCT01597687|11716110|FG002|STARTED|Overall Study||147
10561340|NCT01597687|11716108|FG000|COMPLETED|Overall Study||76
10561341|NCT01597687|11716109|FG001|COMPLETED|Overall Study||89
10561342|NCT01597687|11716110|FG002|COMPLETED|Overall Study||147
10561343|NCT01597687|11716108|FG000|NOT COMPLETED|Overall Study||0
10561344|NCT01597687|11716109|FG001|NOT COMPLETED|Overall Study||0
10561345|NCT01597687|11716110|FG002|NOT COMPLETED|Overall Study||0
10561346|NCT01597791|11716136|FG000|STARTED|Overall Study||28
10561347|NCT01597791|11716137|FG001|STARTED|Overall Study||28
10561348|NCT01597791|11716136|FG000|COMPLETED|Overall Study||20
10561349|NCT01597791|11716137|FG001|COMPLETED|Overall Study||18
10791789|NCT03569098|11952586|FG001|COMPLETED|Open-Label Treatment Cycle 3||7
10455176|NCT01000805|11603191|FG001|COMPLETED|Overall Study||204
10455177|NCT01000805|11603190|FG000|NOT COMPLETED|Overall Study||70
10455178|NCT01000805|11603191|FG001|NOT COMPLETED|Overall Study||62
10455179|NCT01000818|11603198|FG000|STARTED|Raltegravir||18
10455180|NCT01000818|11603198|FG000|COMPLETED|Raltegravir||18
10455181|NCT01000818|11603198|FG000|NOT COMPLETED|Raltegravir||0
10455182|NCT01000818|11603198|FG000|STARTED|Famotidine + Raltegravir||18
10455183|NCT01000818|11603198|FG000|COMPLETED|Famotidine + Raltegravir||18
10455184|NCT01000818|11603198|FG000|NOT COMPLETED|Famotidine + Raltegravir||0
10455185|NCT01000818|11603198|FG000|STARTED|Omeprazole + Raltegravir||18
10455186|NCT01000818|11603198|FG000|COMPLETED|Omeprazole + Raltegravir||18
10455187|NCT01000818|11603198|FG000|NOT COMPLETED|Omeprazole + Raltegravir||0
10455188|NCT01000961|11603207|FG000|STARTED|Run-in Period of 2-3 Weeks on Cystagon|Part of the Safety analysis set|21
10455189|NCT01000961|11603208|FG001|STARTED|Run-in Period of 2-3 Weeks on Cystagon|Part of the Safety analysis set|22
10561350|NCT01597791|11716136|FG000|NOT COMPLETED|Overall Study||8
10561351|NCT01597791|11716137|FG001|NOT COMPLETED|Overall Study||10
10561352|NCT01597843|11716146|FG000|STARTED|Overall Study||79
10561353|NCT01597843|11716147|FG001|STARTED|Overall Study||122
10561354|NCT01597843|11716148|FG002|STARTED|Overall Study||81
10561355|NCT01597843|11716146|FG000|Survey 1 Responses|Overall Study||45
10561356|NCT01597843|11716147|FG001|Survey 1 Responses|Overall Study||71
10561357|NCT01597843|11716148|FG002|Survey 1 Responses|Overall Study||59
10561358|NCT01597843|11716146|FG000|Survey 2 Responses|Overall Study||52
10561359|NCT01597843|11716147|FG001|Survey 2 Responses|Overall Study||42
10561360|NCT01597843|11716148|FG002|Survey 2 Responses|Overall Study||58
10561361|NCT01597843|11716146|FG000|Survey 3 Responses|Overall Study||65
10561362|NCT01597843|11716147|FG001|Survey 3 Responses|Overall Study||56
10561363|NCT01597843|11716148|FG002|Survey 3 Responses|Overall Study||76
10561364|NCT01597843|11716146|FG000|COMPLETED|Overall Study||79
10791790|NCT03569098|11952587|FG002|COMPLETED|Open-Label Treatment Cycle 3||50
10561365|NCT01597843|11716147|FG001|COMPLETED|Overall Study||122
10561366|NCT01597843|11716148|FG002|COMPLETED|Overall Study||81
10561367|NCT01597843|11716146|FG000|NOT COMPLETED|Overall Study||0
10561368|NCT01597843|11716147|FG001|NOT COMPLETED|Overall Study||0
10561369|NCT01597843|11716148|FG002|NOT COMPLETED|Overall Study||0
10561370|NCT01597856|11716159|FG000|STARTED|Overall Study||85
10561371|NCT01597856|11716160|FG001|STARTED|Overall Study||87
10561372|NCT01597856|11716161|FG002|STARTED|Overall Study||174
10561373|NCT01597856|11716159|FG000|Week 4 Follow-up|Overall Study||62
10561374|NCT01597856|11716160|FG001|Week 4 Follow-up|Overall Study||67
10561375|NCT01597856|11716161|FG002|Week 4 Follow-up|Overall Study||129
10561376|NCT01597856|11716159|FG000|COMPLETED|Overall Study||63
10561377|NCT01597856|11716160|FG001|COMPLETED|Overall Study||61
10561378|NCT01597856|11716161|FG002|COMPLETED|Overall Study||120
10561379|NCT01597856|11716159|FG000|NOT COMPLETED|Overall Study||22
10791791|NCT03569098|11952585|FG000|NOT COMPLETED|Open-Label Treatment Cycle 3||0
10791792|NCT03569098|11952586|FG001|NOT COMPLETED|Open-Label Treatment Cycle 3||1
10791793|NCT03569098|11952587|FG002|NOT COMPLETED|Open-Label Treatment Cycle 3||6
10791794|NCT03569202|11952600|FG000|STARTED|Part 1|Emulsion Eye Drops were used on one eye only.|3
10791795|NCT03569202|11952601|FG001|STARTED|Part 1|Control Eye Drops were not used for Part 1.|0
10791796|NCT03569202|11952600|FG000|COMPLETED|Part 1|No participant completing Part 1 was allowed to continue to Parts 2 or 3.|3
10791797|NCT03569202|11952601|FG001|COMPLETED|Part 1||0
10791798|NCT03569202|11952600|FG000|NOT COMPLETED|Part 1||0
10791799|NCT03569202|11952601|FG001|NOT COMPLETED|Part 1||0
10791800|NCT03569202|11952600|FG000|STARTED|Part 2|Emulsion Eye Drops were used on one randomized eye. Participants were different from Part 1.|9
10791801|NCT03569202|11952601|FG001|STARTED|Part 2|Control Eye Drops were used on contralateral eye. Participants were different from Part 1.|9
10791802|NCT03569202|11952600|FG000|COMPLETED|Part 2|No participant completing Part 2 was allowed to continue to Part 3.|9
10791803|NCT03569202|11952601|FG001|COMPLETED|Part 2|No participant completing Part 2 was allowed to continue to Part 3.|9
10791804|NCT03569202|11952600|FG000|NOT COMPLETED|Part 2||0
10791805|NCT03569202|11952601|FG001|NOT COMPLETED|Part 2||0
10791806|NCT03569202|11952600|FG000|STARTED|Part 3|Emulsion Eye Drops were used on both eyes. Participants were different from Parts 1 and 2.|26
10810752|NCT03792672|11972457|FG001|NOT COMPLETED|Treatment Period 3 (1 Day)||0
10561380|NCT01597856|11716160|FG001|NOT COMPLETED|Overall Study||26
10561381|NCT01597856|11716161|FG002|NOT COMPLETED|Overall Study||54
10561382|NCT01597908|11716172|FG000|STARTED|Randomized Phase||352
10561383|NCT01597908|11716173|FG001|STARTED|Randomized Phase||352
10561384|NCT01597908|11716174|FG002|STARTED|Randomized Phase||0
10561385|NCT01597908|11716172|FG000|Safety Set|Randomized Phase||350
10561386|NCT01597908|11716173|FG001|Safety Set|Randomized Phase||349
10561387|NCT01597908|11716174|FG002|Safety Set|Randomized Phase||0
10561388|NCT01597908|11716172|FG000|COMPLETED|Randomized Phase||1
10561389|NCT01597908|11716173|FG001|COMPLETED|Randomized Phase||0
10561390|NCT01597908|11716174|FG002|COMPLETED|Randomized Phase||0
10561391|NCT01597908|11716172|FG000|NOT COMPLETED|Randomized Phase||351
10561392|NCT01597908|11716173|FG001|NOT COMPLETED|Randomized Phase||352
10561393|NCT01597908|11716174|FG002|NOT COMPLETED|Randomized Phase||0
10561394|NCT01597908|11716172|FG000|STARTED|Crossover Phase||0
10561395|NCT01597908|11716173|FG001|STARTED|Crossover Phase||0
10561396|NCT01597908|11716174|FG002|STARTED|Crossover Phase||34
10561397|NCT01597908|11716172|FG000|COMPLETED|Crossover Phase||0
10561398|NCT01597908|11716173|FG001|COMPLETED|Crossover Phase||0
10561399|NCT01597908|11716174|FG002|COMPLETED|Crossover Phase||0
10561400|NCT01597908|11716172|FG000|NOT COMPLETED|Crossover Phase||0
10561401|NCT01597908|11716173|FG001|NOT COMPLETED|Crossover Phase||0
10561402|NCT01597908|11716174|FG002|NOT COMPLETED|Crossover Phase||34
10561403|NCT01597973|11716185|FG000|STARTED|Overall Study||234
10561404|NCT01597973|11716186|FG001|STARTED|Overall Study||230
10561405|NCT01597973|11716185|FG000|Began First Dose|Overall Study||230
10561406|NCT01597973|11716186|FG001|Began First Dose|Overall Study||228
10561407|NCT01597973|11716185|FG000|COMPLETED|Overall Study||214
10561408|NCT01597973|11716186|FG001|COMPLETED|Overall Study||211
10561409|NCT01597973|11716185|FG000|NOT COMPLETED|Overall Study||20
10561410|NCT01597973|11716186|FG001|NOT COMPLETED|Overall Study||19
10561411|NCT01598064|11716196|FG000|STARTED|Overall Study||25
10561412|NCT01598064|11716197|FG001|STARTED|Overall Study||24
10561413|NCT01598064|11716196|FG000|COMPLETED|Overall Study||25
10561414|NCT01598064|11716197|FG001|COMPLETED|Overall Study||24
10561415|NCT01598064|11716196|FG000|NOT COMPLETED|Overall Study||0
10561416|NCT01598064|11716197|FG001|NOT COMPLETED|Overall Study||0
10561417|NCT01598090|11716208|FG000|STARTED|Treatment Period||27
10561418|NCT01598090|11716209|FG001|STARTED|Treatment Period||411
10561419|NCT01598090|11716210|FG002|STARTED|Treatment Period||206
10561420|NCT01598090|11716208|FG000|COMPLETED|Treatment Period||16
10561421|NCT01598090|11716209|FG001|COMPLETED|Treatment Period||339
10561422|NCT01598090|11716210|FG002|COMPLETED|Treatment Period||171
10561423|NCT01598090|11716208|FG000|NOT COMPLETED|Treatment Period||11
10561424|NCT01598090|11716209|FG001|NOT COMPLETED|Treatment Period||72
10561425|NCT01598090|11716210|FG002|NOT COMPLETED|Treatment Period||35
10650922|NCT02173535|11811307|FG010|COMPLETED|Period 1||12
10791807|NCT03569202|11952601|FG001|STARTED|Part 3|Control Eye Drops were used on both eyes. Participants were different from Parts 1 and 2.|26
10561426|NCT01598090|11716208|FG000|STARTED|Follow-up Period|Includes 10 participants who re-joined from treatment period to follow-up period.|26
10561427|NCT01598090|11716209|FG001|STARTED|Follow-up Period|Includes 60 participants who re-joined from treatment period to follow-up period.|399
10561428|NCT01598090|11716210|FG002|STARTED|Follow-up Period|Includes 28 participants who re-joined from treatment period to follow-up period.|199
10561429|NCT01598090|11716208|FG000|COMPLETED|Follow-up Period||21
10561430|NCT01598090|11716209|FG001|COMPLETED|Follow-up Period||364
10561431|NCT01598090|11716210|FG002|COMPLETED|Follow-up Period||171
10561432|NCT01598090|11716208|FG000|NOT COMPLETED|Follow-up Period||5
10561433|NCT01598090|11716209|FG001|NOT COMPLETED|Follow-up Period||35
10561434|NCT01598090|11716210|FG002|NOT COMPLETED|Follow-up Period||28
10561435|NCT01598129|11716221|FG000|STARTED|Overall Study||12
10561436|NCT01598129|11716221|FG000|COMPLETED|Overall Study||3
10561437|NCT01598129|11716221|FG000|NOT COMPLETED|Overall Study||9
10561438|NCT01598194|11716228|FG000|STARTED|Overall Study||30
10561439|NCT01598194|11716229|FG001|STARTED|Overall Study||30
10561440|NCT01598194|11716228|FG000|2 Passes With 25G for Cytology|Overall Study||30
10561441|NCT01598194|11716229|FG001|2 Passes With 25G for Cytology|Overall Study||30
10561442|NCT01598194|11716228|FG000|1 Pass With 22Gpc for Cytology|Overall Study|1 participant's pass could not be performed|29
10561443|NCT01598194|11716229|FG001|1 Pass With 22Gpc for Cytology|Overall Study||30
10561444|NCT01598194|11716228|FG000|1 Pass With 22Gpc for Histology|Overall Study|3 participants passes could not be performed|27
10561445|NCT01598194|11716229|FG001|1 Pass With 22Gpc for Histology|Overall Study|1 participant's pass could not be performed|29
10561446|NCT01598194|11716228|FG000|COMPLETED|Overall Study||30
10561447|NCT01598194|11716229|FG001|COMPLETED|Overall Study||30
10561448|NCT01598194|11716228|FG000|NOT COMPLETED|Overall Study||0
10561449|NCT01598194|11716229|FG001|NOT COMPLETED|Overall Study||0
10561450|NCT01598207|11716241|FG000|STARTED|Overall Study||7
10561451|NCT01598207|11716242|FG001|STARTED|Overall Study||6
10561452|NCT01598207|11716241|FG000|COMPLETED|Overall Study||6
10561453|NCT01598207|11716242|FG001|COMPLETED|Overall Study||6
10561454|NCT01598207|11716241|FG000|NOT COMPLETED|Overall Study||1
10561455|NCT01598207|11716242|FG001|NOT COMPLETED|Overall Study||0
10561456|NCT01598298|11716250|FG000|STARTED|Overall Study||150
10561457|NCT01598298|11716251|FG001|STARTED|Overall Study||149
10561458|NCT01598298|11716250|FG000|Patients Evaluable for Primary Endpoint|Overall Study||127
10561459|NCT01598298|11716251|FG001|Patients Evaluable for Primary Endpoint|Overall Study||128
10561460|NCT01598298|11716250|FG000|Patients Evaluable for Adverse Events|Overall Study||138
10561461|NCT01598298|11716251|FG001|Patients Evaluable for Adverse Events|Overall Study||141
10561462|NCT01598298|11716250|FG000|COMPLETED|Overall Study||110
10561463|NCT01598298|11716251|FG001|COMPLETED|Overall Study||108
10561464|NCT01598298|11716250|FG000|NOT COMPLETED|Overall Study||40
10561465|NCT01598298|11716251|FG001|NOT COMPLETED|Overall Study||41
10650923|NCT02173535|11811308|FG011|COMPLETED|Period 1||12
10650924|NCT02173535|11811309|FG012|COMPLETED|Period 1||12
10650925|NCT02173535|11811310|FG013|COMPLETED|Period 1||12
10650926|NCT02173535|11811311|FG014|COMPLETED|Period 1||12
10650927|NCT02173535|11811312|FG015|COMPLETED|Period 1||12
10650928|NCT02173535|11811313|FG016|COMPLETED|Period 1||12
10650929|NCT02173535|11811314|FG017|COMPLETED|Period 1||12
10650930|NCT02173535|11811315|FG018|COMPLETED|Period 1||12
10650931|NCT02173535|11811316|FG019|COMPLETED|Period 1||12
10650932|NCT02173535|11811297|FG000|NOT COMPLETED|Period 1||0
10650933|NCT02173535|11811298|FG001|NOT COMPLETED|Period 1||0
10650934|NCT02173535|11811299|FG002|NOT COMPLETED|Period 1||0
10650935|NCT02173535|11811300|FG003|NOT COMPLETED|Period 1||0
10650936|NCT02173535|11811301|FG004|NOT COMPLETED|Period 1||0
10650937|NCT02173535|11811302|FG005|NOT COMPLETED|Period 1||0
10650938|NCT02173535|11811303|FG006|NOT COMPLETED|Period 1||0
10650939|NCT02173535|11811304|FG007|NOT COMPLETED|Period 1||0
10650940|NCT02173535|11811305|FG008|NOT COMPLETED|Period 1||0
10650941|NCT02173535|11811306|FG009|NOT COMPLETED|Period 1||0
10650942|NCT02173535|11811307|FG010|NOT COMPLETED|Period 1||0
10650943|NCT02173535|11811308|FG011|NOT COMPLETED|Period 1||0
10650944|NCT02173535|11811309|FG012|NOT COMPLETED|Period 1||0
10650945|NCT02173535|11811310|FG013|NOT COMPLETED|Period 1||0
10650946|NCT02173535|11811311|FG014|NOT COMPLETED|Period 1||0
10650947|NCT02173535|11811312|FG015|NOT COMPLETED|Period 1||0
10650948|NCT02173535|11811313|FG016|NOT COMPLETED|Period 1||0
10650949|NCT02173535|11811314|FG017|NOT COMPLETED|Period 1||0
10650950|NCT02173535|11811315|FG018|NOT COMPLETED|Period 1||0
10650951|NCT02173535|11811316|FG019|NOT COMPLETED|Period 1||0
10650952|NCT02173535|11811297|FG000|STARTED|Period 2||12
10650953|NCT02173535|11811298|FG001|STARTED|Period 2||12
10650954|NCT02173535|11811299|FG002|STARTED|Period 2||12
10650955|NCT02173535|11811300|FG003|STARTED|Period 2||12
10650956|NCT02173535|11811301|FG004|STARTED|Period 2||12
10650957|NCT02173535|11811302|FG005|STARTED|Period 2||12
10561476|NCT01598350|11716266|FG000|STARTED|Overall Study||6
10561477|NCT01598350|11716266|FG000|COMPLETED|Overall Study||6
10561478|NCT01598350|11716266|FG000|NOT COMPLETED|Overall Study||0
10561479|NCT01598428|11716270|FG000|STARTED|Overall Study||20
10561480|NCT01598428|11716270|FG000|COMPLETED|Overall Study||20
10561481|NCT01598428|11716270|FG000|NOT COMPLETED|Overall Study||0
10561482|NCT01598506|11716275|FG000|STARTED|Overall Study||22
10561483|NCT01598506|11716275|FG000|COMPLETED|Overall Study||20
10561484|NCT01598506|11716275|FG000|NOT COMPLETED|Overall Study||2
10561485|NCT01598532|11716280|FG000|STARTED|Overall Study||22
10561486|NCT01598532|11716280|FG000|COMPLETED|Overall Study||11
10561487|NCT01598532|11716280|FG000|NOT COMPLETED|Overall Study||11
10561488|NCT01598545|11716287|FG000|STARTED|Overall Study||20
10561489|NCT01598545|11716287|FG000|COMPLETED|Overall Study||20
10561490|NCT01598545|11716287|FG000|NOT COMPLETED|Overall Study||0
10561491|NCT01598610|11716291|FG000|STARTED|Overall Study||220
10561492|NCT01598610|11716291|FG000|COMPLETED|Overall Study||219
10561493|NCT01598610|11716291|FG000|NOT COMPLETED|Overall Study||1
10561494|NCT01598662|11716297|FG000|STARTED|Overall Study||11
10561495|NCT01598662|11716298|FG001|STARTED|Overall Study||21
10561496|NCT01598662|11716297|FG000|Patients Who Received IUD|Overall Study|Subjects did not return at 6 weeks for IUD insertion.|0
10561497|NCT01598662|11716298|FG001|Patients Who Received IUD|Overall Study||18
10561498|NCT01598662|11716297|FG000|Patients Returned for 6 wk Postpartum|Overall Study||0
10561499|NCT01598662|11716298|FG001|Patients Returned for 6 wk Postpartum|Overall Study||2
10561500|NCT01598662|11716297|FG000|COMPLETED|Overall Study||0
10561501|NCT01598662|11716298|FG001|COMPLETED|Overall Study||0
10561502|NCT01598662|11716297|FG000|NOT COMPLETED|Overall Study||11
10561503|NCT01598662|11716298|FG001|NOT COMPLETED|Overall Study||21
10561504|NCT01598701|11716306|FG000|STARTED|Overall Study||50
10561505|NCT01598701|11716307|FG001|STARTED|Overall Study||50
10561506|NCT01598701|11716306|FG000|COMPLETED|Overall Study||45
10561507|NCT01598701|11716307|FG001|COMPLETED|Overall Study||41
10561508|NCT01598701|11716306|FG000|NOT COMPLETED|Overall Study||5
10561509|NCT01598701|11716307|FG001|NOT COMPLETED|Overall Study||9
10561510|NCT01598740|11716315|FG000|STARTED|Period 1||9
10561511|NCT01598740|11716316|FG001|STARTED|Period 1||9
10561512|NCT01598740|11716315|FG000|COMPLETED|Period 1||9
10561513|NCT01598740|11716316|FG001|COMPLETED|Period 1||9
10561514|NCT01598740|11716315|FG000|NOT COMPLETED|Period 1||0
10561515|NCT01598740|11716316|FG001|NOT COMPLETED|Period 1||0
10561516|NCT01598740|11716315|FG000|STARTED|Period 2|1 subject discontinued during the washout period prior to starting treatment period 2.|8
10561517|NCT01598740|11716316|FG001|STARTED|Period 2||9
10561518|NCT01598740|11716315|FG000|COMPLETED|Period 2||7
10561519|NCT01598740|11716316|FG001|COMPLETED|Period 2||9
10561520|NCT01598740|11716315|FG000|NOT COMPLETED|Period 2||1
10561521|NCT01598740|11716316|FG001|NOT COMPLETED|Period 2||0
10561522|NCT01598753|11716327|FG000|STARTED|Overall Study||37
10561523|NCT01598753|11716328|FG001|STARTED|Overall Study||31
10561524|NCT01598753|11716329|FG002|STARTED|Overall Study||32
10561525|NCT01598753|11716330|FG003|STARTED|Overall Study||34
10561526|NCT01598753|11716327|FG000|COMPLETED|Overall Study||25
10561527|NCT01598753|11716328|FG001|COMPLETED|Overall Study||16
10561528|NCT01598753|11716329|FG002|COMPLETED|Overall Study||24
10561529|NCT01598753|11716330|FG003|COMPLETED|Overall Study||19
10561530|NCT01598753|11716327|FG000|NOT COMPLETED|Overall Study||12
10561531|NCT01598753|11716328|FG001|NOT COMPLETED|Overall Study||15
10561532|NCT01598753|11716329|FG002|NOT COMPLETED|Overall Study||8
10561533|NCT01598753|11716330|FG003|NOT COMPLETED|Overall Study||15
10561534|NCT01598779|11716340|FG000|STARTED|Overall Study||150
10561535|NCT01598779|11716340|FG000|COMPLETED|Overall Study||150
10561536|NCT01598779|11716340|FG000|NOT COMPLETED|Overall Study||0
10561537|NCT01598831|11716346|FG000|STARTED|Overall Study||402
10561538|NCT01598831|11716347|FG001|STARTED|Overall Study||414
10561539|NCT01598831|11716346|FG000|Received at Least 1 Dose Study Treatment|Overall Study||395
10561540|NCT01598831|11716347|FG001|Received at Least 1 Dose Study Treatment|Overall Study||405
10561541|NCT01598831|11716346|FG000|COMPLETED|Overall Study||283
10561542|NCT01598831|11716347|FG001|COMPLETED|Overall Study||278
10561543|NCT01598831|11716346|FG000|NOT COMPLETED|Overall Study||119
10561544|NCT01598831|11716347|FG001|NOT COMPLETED|Overall Study||136
10561545|NCT01598896|11716355|FG000|STARTED|Overall Study||3
10561546|NCT01598896|11716356|FG001|STARTED|Overall Study||4
10561547|NCT01598896|11716355|FG000|COMPLETED|Overall Study||3
10561548|NCT01598896|11716356|FG001|COMPLETED|Overall Study||2
10561549|NCT01598896|11716355|FG000|NOT COMPLETED|Overall Study||0
10561550|NCT01598896|11716356|FG001|NOT COMPLETED|Overall Study||2
10561551|NCT01598922|11716364|FG000|STARTED|Overall Study||37
10561552|NCT01598922|11716365|FG001|STARTED|Overall Study||40
10561553|NCT01598922|11716364|FG000|COMPLETED|Overall Study||34
10561554|NCT01598922|11716365|FG001|COMPLETED|Overall Study||30
10561555|NCT01598922|11716364|FG000|NOT COMPLETED|Overall Study||3
10561556|NCT01598922|11716365|FG001|NOT COMPLETED|Overall Study||10
10561557|NCT01598987|11716371|FG000|STARTED|Baseline to Month 12||56
10561558|NCT01598987|11716371|FG000|COMPLETED|Baseline to Month 12||50
10561559|NCT01598987|11716371|FG000|NOT COMPLETED|Baseline to Month 12||6
10561560|NCT01598987|11716371|FG000|STARTED|Baseline to 24 Month||56
10561561|NCT01598987|11716371|FG000|COMPLETED|Baseline to 24 Month||48
10561562|NCT01598987|11716371|FG000|NOT COMPLETED|Baseline to 24 Month||8
10561563|NCT01599104|11716385|FG000|STARTED|Overall Study||387
10561564|NCT01599104|11716386|FG001|STARTED|Overall Study||385
10561565|NCT01599104|11716387|FG002|STARTED|Overall Study||389
10561566|NCT01599104|11716385|FG000|COMPLETED|Overall Study||371
10561567|NCT01599104|11716386|FG001|COMPLETED|Overall Study||371
10561568|NCT01599104|11716387|FG002|COMPLETED|Overall Study||363
10561569|NCT01599104|11716385|FG000|NOT COMPLETED|Overall Study||16
10561570|NCT01599104|11716386|FG001|NOT COMPLETED|Overall Study||14
10561571|NCT01599104|11716387|FG002|NOT COMPLETED|Overall Study||26
10561572|NCT01599234|11716397|FG000|STARTED|Overall Study||167
10561573|NCT01599234|11716398|FG001|STARTED|Overall Study||170
10561574|NCT01599234|11716397|FG000|COMPLETED|Overall Study||150
10561575|NCT01599234|11716398|FG001|COMPLETED|Overall Study||155
10561576|NCT01599234|11716397|FG000|NOT COMPLETED|Overall Study||17
10561577|NCT01599234|11716398|FG001|NOT COMPLETED|Overall Study||15
10561578|NCT01599286|11716406|FG000|STARTED|Overall Study||24
10561579|NCT01599286|11716407|FG001|STARTED|Overall Study||23
10561580|NCT01599286|11716406|FG000|COMPLETED|Overall Study||24
10561581|NCT01599286|11716407|FG001|COMPLETED|Overall Study||23
10561582|NCT01599286|11716406|FG000|NOT COMPLETED|Overall Study||0
10561583|NCT01599286|11716407|FG001|NOT COMPLETED|Overall Study||0
10561584|NCT01599325|11716413|FG000|STARTED|Primary Parent Phase||72
10561585|NCT01599325|11716413|FG000|Intent to Treat (ITT) Population|Primary Parent Phase|Includes all participants who were enrolled into the study|72
10561586|NCT01599325|11716413|FG000|Pharmacokinetic (PK) Population|Primary Parent Phase|Includes all participants with evaluable azacitidine plasma PK profiles.|12
10561587|NCT01599325|11716413|FG000|COMPLETED|Primary Parent Phase|Participants still on study treatment at time of study closure|15
10561588|NCT01599325|11716413|FG000|NOT COMPLETED|Primary Parent Phase||57
10561589|NCT01599325|11716413|FG000|STARTED|Extension Phase||15
10561590|NCT01599325|11716413|FG000|COMPLETED|Extension Phase||0
10561591|NCT01599325|11716413|FG000|NOT COMPLETED|Extension Phase||15
10561592|NCT01599585|11716420|FG000|STARTED|Overall Study||62
10561593|NCT01599585|11716421|FG001|STARTED|Overall Study||59
10561594|NCT01599585|11716420|FG000|COMPLETED|Overall Study||40
10561595|NCT01599585|11716421|FG001|COMPLETED|Overall Study||42
10561596|NCT01599585|11716420|FG000|NOT COMPLETED|Overall Study||22
10561597|NCT01599585|11716421|FG001|NOT COMPLETED|Overall Study||17
10561598|NCT01599637|11716430|FG000|STARTED|Overall Study|" started indicates randomized safety, pharmacodynamics and pharmocokinetics set"|20
10561599|NCT01599637|11716431|FG001|STARTED|Overall Study||10
10561600|NCT01599637|11716432|FG002|STARTED|Overall Study||10
10561601|NCT01599637|11716430|FG000|COMPLETED|Overall Study||19
10561602|NCT01599637|11716431|FG001|COMPLETED|Overall Study||8
10561603|NCT01599637|11716432|FG002|COMPLETED|Overall Study||10
10561604|NCT01599637|11716430|FG000|NOT COMPLETED|Overall Study||1
10561605|NCT01599637|11716431|FG001|NOT COMPLETED|Overall Study||2
10561606|NCT01599637|11716432|FG002|NOT COMPLETED|Overall Study||0
10561607|NCT01599650|11716445|FG000|STARTED|Overall Study||183
10561608|NCT01599650|11716446|FG001|STARTED|Overall Study||180
10561609|NCT01599650|11716447|FG002|STARTED|Overall Study||92
10561610|NCT01599650|11716445|FG000|Completed 6 Mos|Overall Study||174
10561611|NCT01599650|11716446|FG001|Completed 6 Mos|Overall Study||170
10561612|NCT01599650|11716447|FG002|Completed 6 Mos|Overall Study||80
10561613|NCT01599650|11716445|FG000|COMPLETED|Overall Study||161
10561614|NCT01599650|11716446|FG001|COMPLETED|Overall Study||154
10561615|NCT01599650|11716447|FG002|COMPLETED|Overall Study||65
10561616|NCT01599650|11716445|FG000|NOT COMPLETED|Overall Study||22
10561617|NCT01599650|11716446|FG001|NOT COMPLETED|Overall Study||26
10561618|NCT01599650|11716447|FG002|NOT COMPLETED|Overall Study||27
10561619|NCT01599754|11716459|FG000|STARTED|Overall Study||363
10561620|NCT01599754|11716460|FG001|STARTED|Overall Study||361
10561621|NCT01599754|11716459|FG000|Treated|Overall Study||360
10561622|NCT01599754|11716460|FG001|Treated|Overall Study||360
10561623|NCT01599754|11716459|FG000|COMPLETED|Overall Study||0
10561624|NCT01599754|11716460|FG001|COMPLETED|Overall Study||1
10561625|NCT01599754|11716459|FG000|NOT COMPLETED|Overall Study||363
10561626|NCT01599754|11716460|FG001|NOT COMPLETED|Overall Study||360
10561627|NCT01599793|11716466|FG000|STARTED|Overall Study||19
10561628|NCT01599793|11716466|FG000|COMPLETED|Overall Study||17
10561629|NCT01599793|11716466|FG000|NOT COMPLETED|Overall Study||2
10561630|NCT01599806|11716472|FG000|STARTED|Overall Study||516
10561631|NCT01599806|11716473|FG001|STARTED|Overall Study||517
10561632|NCT01599806|11716472|FG000|COMPLETED|Overall Study||473
10561633|NCT01599806|11716473|FG001|COMPLETED|Overall Study||476
10561634|NCT01599806|11716472|FG000|NOT COMPLETED|Overall Study||43
10561635|NCT01599806|11716473|FG001|NOT COMPLETED|Overall Study||41
10561636|NCT01599832|11716479|FG000|STARTED|Overall Study||20
10561637|NCT01599832|11716479|FG000|COMPLETED|Overall Study||20
10561638|NCT01599832|11716479|FG000|NOT COMPLETED|Overall Study||0
10561639|NCT01600014|11716483|FG000|STARTED|1. Cycle & Observation Period D1 to W52|Subjects completing W52 without having been administered a 2nd cycle are counted as completers.|450
10561640|NCT01600014|11716484|FG001|STARTED|1. Cycle & Observation Period D1 to W52||0
10561641|NCT01600014|11716483|FG000|COMPLETED|1. Cycle & Observation Period D1 to W52||162
10561642|NCT01600014|11716484|FG001|COMPLETED|1. Cycle & Observation Period D1 to W52||0
10561643|NCT01600014|11716483|FG000|NOT COMPLETED|1. Cycle & Observation Period D1 to W52||288
10561644|NCT01600014|11716484|FG001|NOT COMPLETED|1. Cycle & Observation Period D1 to W52||0
10561645|NCT01600014|11716483|FG000|STARTED|2. Cycle Recalcitrant Subgroup W8 to W52||92
10561646|NCT01600014|11716484|FG001|STARTED|2. Cycle Recalcitrant Subgroup W8 to W52||49
10561647|NCT01600014|11716483|FG000|COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||80
10561648|NCT01600014|11716484|FG001|COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||39
10561649|NCT01600014|11716483|FG000|NOT COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||12
10561650|NCT01600014|11716484|FG001|NOT COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||10
10561651|NCT01600014|11716483|FG000|STARTED|2. Cycl Recurrent Subgroup W26/44 to W52||42
10561652|NCT01600014|11716484|FG001|STARTED|2. Cycl Recurrent Subgroup W26/44 to W52||20
10561653|NCT01600014|11716483|FG000|COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||39
10561654|NCT01600014|11716484|FG001|COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||20
10561655|NCT01600014|11716483|FG000|NOT COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||3
10561656|NCT01600014|11716484|FG001|NOT COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||0
10561657|NCT01600053|11716502|FG000|STARTED|Overall Study||11
10561658|NCT01600053|11716502|FG000|COMPLETED|Overall Study||0
10561659|NCT01600053|11716502|FG000|NOT COMPLETED|Overall Study||11
10561660|NCT01600092|11716508|FG000|STARTED|Overall Study||513
10561661|NCT01600092|11716509|FG001|STARTED|Overall Study||507
10561662|NCT01600092|11716508|FG000|Received at Least 1 Vaccination|Overall Study|1 participant received RotaTeq™ existing formulation as their first vaccination|510
10561663|NCT01600092|11716509|FG001|Received at Least 1 Vaccination|Overall Study||504
10561664|NCT01600092|11716508|FG000|Received All 3 Vaccinations|Overall Study||500
10561665|NCT01600092|11716509|FG001|Received All 3 Vaccinations|Overall Study||494
10561666|NCT01600092|11716508|FG000|COMPLETED|Overall Study||495
10561667|NCT01600092|11716509|FG001|COMPLETED|Overall Study||491
10561668|NCT01600092|11716508|FG000|NOT COMPLETED|Overall Study||18
10561669|NCT01600092|11716509|FG001|NOT COMPLETED|Overall Study||16
10561670|NCT01600105|11716517|FG000|STARTED|Total Participants||255
10561671|NCT01600105|11716518|FG001|STARTED|Total Participants||21
10561672|NCT01600105|11716517|FG000|COMPLETED|Total Participants||214
10561673|NCT01600105|11716518|FG001|COMPLETED|Total Participants||11
10561674|NCT01600105|11716517|FG000|NOT COMPLETED|Total Participants||41
10561675|NCT01600105|11716518|FG001|NOT COMPLETED|Total Participants||10
10561676|NCT01600105|11716517|FG000|STARTED|Sub Study I||19
10561677|NCT01600105|11716518|FG001|STARTED|Sub Study I||21
10561678|NCT01600105|11716517|FG000|COMPLETED|Sub Study I||19
10561679|NCT01600105|11716518|FG001|COMPLETED|Sub Study I||11
10561680|NCT01600105|11716517|FG000|NOT COMPLETED|Sub Study I||0
10561681|NCT01600105|11716518|FG001|NOT COMPLETED|Sub Study I||10
10561682|NCT01600105|11716517|FG000|STARTED|Sub Study II||65
10561683|NCT01600105|11716518|FG001|STARTED|Sub Study II||0
10561684|NCT01600105|11716517|FG000|COMPLETED|Sub Study II||60
10561685|NCT01600105|11716518|FG001|COMPLETED|Sub Study II||0
10561686|NCT01600105|11716517|FG000|NOT COMPLETED|Sub Study II||5
10561687|NCT01600105|11716518|FG001|NOT COMPLETED|Sub Study II||0
10561688|NCT01600105|11716517|FG000|STARTED|Sub Study III||39
10561689|NCT01600105|11716518|FG001|STARTED|Sub Study III||0
10561690|NCT01600105|11716517|FG000|COMPLETED|Sub Study III||34
10561691|NCT01600105|11716518|FG001|COMPLETED|Sub Study III||0
10561692|NCT01600105|11716517|FG000|NOT COMPLETED|Sub Study III||5
10561693|NCT01600105|11716518|FG001|NOT COMPLETED|Sub Study III||0
10561694|NCT01600105|11716517|FG000|STARTED|Sub Study IV||41
10561695|NCT01600105|11716518|FG001|STARTED|Sub Study IV||8
10561696|NCT01600105|11716517|FG000|COMPLETED|Sub Study IV||41
10561697|NCT01600105|11716518|FG001|COMPLETED|Sub Study IV||8
10561698|NCT01600105|11716517|FG000|NOT COMPLETED|Sub Study IV||0
10561699|NCT01600105|11716518|FG001|NOT COMPLETED|Sub Study IV||0
10561700|NCT01600105|11716517|FG000|STARTED|Sub Study V||52
10561701|NCT01600105|11716518|FG001|STARTED|Sub Study V||0
10561702|NCT01600105|11716517|FG000|COMPLETED|Sub Study V||50
10561703|NCT01600105|11716518|FG001|COMPLETED|Sub Study V||0
10561704|NCT01600105|11716517|FG000|NOT COMPLETED|Sub Study V||2
10561705|NCT01600105|11716518|FG001|NOT COMPLETED|Sub Study V||0
10561706|NCT01600170|11716530|FG000|STARTED|Period 1|Participants were assigned atorvastatin for 12 wks followed by a washout and then placebo.|6
10561707|NCT01600170|11716531|FG001|STARTED|Period 1|Participants were assigned placebo for 12 wks followed by a washout and then atorvastatin.|5
10561708|NCT01600170|11716530|FG000|COMPLETED|Period 1||6
10561709|NCT01600170|11716531|FG001|COMPLETED|Period 1||5
10561710|NCT01600170|11716530|FG000|NOT COMPLETED|Period 1||0
10561711|NCT01600170|11716531|FG001|NOT COMPLETED|Period 1||0
10561712|NCT01600170|11716530|FG000|STARTED|Period 2|These 6 were on atorvastatin in period 1 and on placebo in Period 2.|6
10561713|NCT01600170|11716531|FG001|STARTED|Period 2|These 5 were on placebo in Period 1 and on Atorvastatin in Period 2.|5
10561714|NCT01600170|11716530|FG000|COMPLETED|Period 2|One subject moved away from the area due to job responsibilities and dropped out of study.|5
10561715|NCT01600170|11716531|FG001|COMPLETED|Period 2||5
10561716|NCT01600170|11716530|FG000|NOT COMPLETED|Period 2||1
10561717|NCT01600170|11716531|FG001|NOT COMPLETED|Period 2||0
10561718|NCT01600222|11716539|FG000|STARTED|Overall Study||37
10561719|NCT01600222|11716539|FG000|COMPLETED|Overall Study||35
10561720|NCT01600222|11716539|FG000|NOT COMPLETED|Overall Study||2
10561721|NCT01600287|11716546|FG000|STARTED|Overall Study||20
10561722|NCT01600287|11716547|FG001|STARTED|Overall Study||20
10561723|NCT01600287|11716546|FG000|COMPLETED|Overall Study||20
10561724|NCT01600287|11716547|FG001|COMPLETED|Overall Study||20
10561725|NCT01600287|11716546|FG000|NOT COMPLETED|Overall Study||0
10561726|NCT01600287|11716547|FG001|NOT COMPLETED|Overall Study||0
10561727|NCT01600326|11716555|FG000|STARTED|Overall Study||15
10561728|NCT01600326|11716556|FG001|STARTED|Overall Study||15
10561729|NCT01600326|11716555|FG000|Primary Outcome Measure Data Collection|Overall Study||15
10561730|NCT01600326|11716556|FG001|Primary Outcome Measure Data Collection|Overall Study||15
10561731|NCT01600326|11716555|FG000|COMPLETED|Overall Study||14
10561732|NCT01600326|11716556|FG001|COMPLETED|Overall Study||14
10561733|NCT01600326|11716555|FG000|NOT COMPLETED|Overall Study||1
10561734|NCT01600326|11716556|FG001|NOT COMPLETED|Overall Study||1
10561735|NCT01600482|11716564|FG000|STARTED|Overall Study||148
10561736|NCT01600482|11716565|FG001|STARTED|Overall Study|Last 26 patients allocated to CELT ACD|59
10561737|NCT01600482|11716564|FG000|COMPLETED|Overall Study|Last 26 patients allocated to CELT ACD|148
10561738|NCT01600482|11716565|FG001|COMPLETED|Overall Study||59
10561739|NCT01600482|11716564|FG000|NOT COMPLETED|Overall Study||0
10561740|NCT01600482|11716565|FG001|NOT COMPLETED|Overall Study||0
10561741|NCT01600495|11716573|FG000|STARTED|Overall Study|We start with the prediction of collecting 20 patients in the treated group|23
10561742|NCT01600495|11716574|FG001|STARTED|Overall Study|We start with the prediction of collecting 20 control patients|23
10561743|NCT01600495|11716573|FG000|COMPLETED|Overall Study|We finished the job with 23 patients for each group (treated and control)|23
10561744|NCT01600495|11716574|FG001|COMPLETED|Overall Study|We finished the job with 23 patients for each group (treated and control)|23
10561745|NCT01600495|11716573|FG000|NOT COMPLETED|Overall Study||0
10561746|NCT01600495|11716574|FG001|NOT COMPLETED|Overall Study||0
10561747|NCT01600586|11716583|FG000|STARTED|Overall Study||49
10561748|NCT01600586|11716584|FG001|STARTED|Overall Study||51
10561749|NCT01600586|11716583|FG000|COMPLETED|Overall Study||46
10561750|NCT01600586|11716584|FG001|COMPLETED|Overall Study||48
10561751|NCT01600586|11716583|FG000|NOT COMPLETED|Overall Study||3
10561752|NCT01600586|11716584|FG001|NOT COMPLETED|Overall Study||3
10561753|NCT01600638|11716597|FG000|STARTED|Overall Study||25
10561754|NCT01600638|11716597|FG000|COMPLETED|Overall Study||25
10561755|NCT01600638|11716597|FG000|NOT COMPLETED|Overall Study||0
10561756|NCT01600677|11716603|FG000|STARTED|Overall Study||7
10561757|NCT01600677|11716604|FG001|STARTED|Overall Study||4
10561758|NCT01600677|11716603|FG000|COMPLETED|Overall Study||7
10561759|NCT01600677|11716604|FG001|COMPLETED|Overall Study||4
10561760|NCT01600677|11716603|FG000|NOT COMPLETED|Overall Study||0
10561761|NCT01600677|11716604|FG001|NOT COMPLETED|Overall Study||0
10561762|NCT01600703|11716610|FG000|STARTED|First Intervention||7
10561763|NCT01600703|11716611|FG001|STARTED|First Intervention||8
10561764|NCT01600703|11716610|FG000|COMPLETED|First Intervention||7
10561765|NCT01600703|11716611|FG001|COMPLETED|First Intervention||8
10561766|NCT01600703|11716610|FG000|NOT COMPLETED|First Intervention||0
10561767|NCT01600703|11716611|FG001|NOT COMPLETED|First Intervention||0
10561768|NCT01600703|11716610|FG000|STARTED|Second Intervention||7
10561769|NCT01600703|11716611|FG001|STARTED|Second Intervention||8
10561770|NCT01600703|11716610|FG000|COMPLETED|Second Intervention||7
10561771|NCT01600703|11716611|FG001|COMPLETED|Second Intervention||8
10561772|NCT01600703|11716610|FG000|NOT COMPLETED|Second Intervention||0
10561773|NCT01600703|11716611|FG001|NOT COMPLETED|Second Intervention||0
10561774|NCT01600716|11716619|FG000|STARTED|Overall Study||66
10561775|NCT01600716|11716620|FG001|STARTED|Overall Study||78
10561776|NCT01600716|11716619|FG000|COMPLETED|Overall Study||59
10561777|NCT01600716|11716620|FG001|COMPLETED|Overall Study||71
10561778|NCT01600716|11716619|FG000|NOT COMPLETED|Overall Study||7
10561779|NCT01600716|11716620|FG001|NOT COMPLETED|Overall Study||7
10561780|NCT01600729|11716628|FG000|STARTED|Overall Study||66
10561781|NCT01600729|11716628|FG000|COMPLETED|Overall Study||65
10561782|NCT01600729|11716628|FG000|NOT COMPLETED|Overall Study||1
10561783|NCT01600885|11716632|FG000|STARTED|First Period||10
10561784|NCT01600885|11716633|FG001|STARTED|First Period||9
10561785|NCT01600885|11716632|FG000|COMPLETED|First Period||8
10561786|NCT01600885|11716633|FG001|COMPLETED|First Period||8
10561787|NCT01600885|11716632|FG000|NOT COMPLETED|First Period||2
10561788|NCT01600885|11716633|FG001|NOT COMPLETED|First Period||1
10561789|NCT01600885|11716632|FG000|STARTED|Wash Out Period||8
10561790|NCT01600885|11716633|FG001|STARTED|Wash Out Period||8
10561791|NCT01600885|11716632|FG000|COMPLETED|Wash Out Period||8
10561792|NCT01600885|11716633|FG001|COMPLETED|Wash Out Period||8
10561793|NCT01600885|11716632|FG000|NOT COMPLETED|Wash Out Period||0
10561794|NCT01600885|11716633|FG001|NOT COMPLETED|Wash Out Period||0
10561795|NCT01600885|11716632|FG000|STARTED|Second Period||8
10561796|NCT01600885|11716633|FG001|STARTED|Second Period||8
10561797|NCT01600885|11716632|FG000|COMPLETED|Second Period||8
10561798|NCT01600885|11716633|FG001|COMPLETED|Second Period||8
10561799|NCT01600885|11716632|FG000|NOT COMPLETED|Second Period||0
10561800|NCT01600885|11716633|FG001|NOT COMPLETED|Second Period||0
10561801|NCT01600950|11716639|FG000|STARTED|Period 1||10
10561802|NCT01600950|11716640|FG001|STARTED|Period 1||10
10561803|NCT01600950|11716639|FG000|COMPLETED|Period 1||10
10561804|NCT01600950|11716640|FG001|COMPLETED|Period 1||10
10561805|NCT01600950|11716639|FG000|NOT COMPLETED|Period 1||0
10561806|NCT01600950|11716640|FG001|NOT COMPLETED|Period 1||0
10561807|NCT01600950|11716639|FG000|STARTED|Period 2||10
10561808|NCT01600950|11716640|FG001|STARTED|Period 2||10
10561809|NCT01600950|11716639|FG000|COMPLETED|Period 2||10
10561810|NCT01600950|11716640|FG001|COMPLETED|Period 2||10
10561811|NCT01600950|11716639|FG000|NOT COMPLETED|Period 2||0
10561812|NCT01600950|11716640|FG001|NOT COMPLETED|Period 2||0
10561813|NCT01601067|11716648|FG000|STARTED|Overall Study||63
10561814|NCT01601067|11716649|FG001|STARTED|Overall Study||56
10561815|NCT01601067|11716648|FG000|COMPLETED|Overall Study||30
10561816|NCT01601067|11716649|FG001|COMPLETED|Overall Study||34
10561817|NCT01601067|11716648|FG000|NOT COMPLETED|Overall Study||33
10561818|NCT01601067|11716649|FG001|NOT COMPLETED|Overall Study||22
10561819|NCT01601132|11716655|FG000|STARTED|Overall Study||30
10561820|NCT01601132|11716655|FG000|COMPLETED|Overall Study||28
10561821|NCT01601132|11716655|FG000|NOT COMPLETED|Overall Study||2
10561822|NCT01601236|11716668|FG000|STARTED|Overall Study||7
10561823|NCT01601236|11716669|FG001|STARTED|Overall Study||3
10561824|NCT01601236|11716670|FG002|STARTED|Overall Study||14
10561825|NCT01601236|11716671|FG003|STARTED|Overall Study||6
10561826|NCT01601236|11716672|FG004|STARTED|Overall Study||3
10561827|NCT01601236|11716673|FG005|STARTED|Overall Study||1
10561828|NCT01601236|11716668|FG000|COMPLETED|Overall Study||2
10561829|NCT01601236|11716669|FG001|COMPLETED|Overall Study||2
10561830|NCT01601236|11716670|FG002|COMPLETED|Overall Study||8
10561831|NCT01601236|11716671|FG003|COMPLETED|Overall Study||4
10561832|NCT01601236|11716672|FG004|COMPLETED|Overall Study||0
10561833|NCT01601236|11716673|FG005|COMPLETED|Overall Study||0
10561834|NCT01601236|11716668|FG000|NOT COMPLETED|Overall Study||5
10561835|NCT01601236|11716669|FG001|NOT COMPLETED|Overall Study||1
10561836|NCT01601236|11716670|FG002|NOT COMPLETED|Overall Study||6
10561837|NCT01601236|11716671|FG003|NOT COMPLETED|Overall Study||2
10561838|NCT01601236|11716672|FG004|NOT COMPLETED|Overall Study||3
10561839|NCT01601236|11716673|FG005|NOT COMPLETED|Overall Study||1
10561840|NCT01601431|11716684|FG000|STARTED|Overall Study||223
10561841|NCT01601431|11716685|FG001|STARTED|Overall Study||217
10791808|NCT03569202|11952600|FG000|COMPLETED|Part 3|Per-protocol (PP) dataset. 'Not Completed' participants are included in safety and ITT datasets.|24
10791809|NCT03569202|11952601|FG001|COMPLETED|Part 3|Per-protocol (PP) dataset. 'Not Completed' participants are included in safety and ITT datasets.|25
10791810|NCT03569202|11952600|FG000|NOT COMPLETED|Part 3||2
10791811|NCT03569202|11952601|FG001|NOT COMPLETED|Part 3||1
10791815|NCT03569397|11952613|FG000|STARTED|Overall Study||29
10791816|NCT03569397|11952614|FG001|STARTED|Overall Study||28
10791817|NCT03569397|11952613|FG000|COMPLETED|Overall Study||29
10791818|NCT03569397|11952614|FG001|COMPLETED|Overall Study||28
10791819|NCT03569397|11952613|FG000|NOT COMPLETED|Overall Study||0
10791820|NCT03569397|11952614|FG001|NOT COMPLETED|Overall Study||0
10791821|NCT03569618|11952621|FG000|STARTED|Overall Study||23
10791822|NCT03569618|11952622|FG001|STARTED|Overall Study||21
10791823|NCT03569618|11952621|FG000|COMPLETED|Overall Study||20
10791824|NCT03569618|11952622|FG001|COMPLETED|Overall Study||20
10791825|NCT03569618|11952621|FG000|NOT COMPLETED|Overall Study||3
10791826|NCT03569618|11952622|FG001|NOT COMPLETED|Overall Study||1
10791827|NCT03569748|11952631|FG000|STARTED|Overall Study||110
10791828|NCT03569748|11952632|FG001|STARTED|Overall Study||110
10791829|NCT03569748|11952631|FG000|COMPLETED|Overall Study||110
10791830|NCT03569748|11952632|FG001|COMPLETED|Overall Study||101
10791831|NCT03569748|11952631|FG000|NOT COMPLETED|Overall Study||0
10791832|NCT03569748|11952632|FG001|NOT COMPLETED|Overall Study||9
10791833|NCT03570047|11952649|FG000|STARTED|Overall Study||15902
10791834|NCT03570047|11952650|FG001|STARTED|Overall Study||22336
10791835|NCT03570047|11952651|FG002|STARTED|Overall Study||6925
10791836|NCT03570047|11952652|FG003|STARTED|Overall Study||16564
10791837|NCT03570047|11952653|FG004|STARTED|Overall Study||12262
10791838|NCT03570047|11952649|FG000|COMPLETED|Overall Study||15902
10791839|NCT03570047|11952650|FG001|COMPLETED|Overall Study||22336
10791840|NCT03570047|11952651|FG002|COMPLETED|Overall Study||6925
10791841|NCT03570047|11952652|FG003|COMPLETED|Overall Study||16564
10791842|NCT03570047|11952653|FG004|COMPLETED|Overall Study||12262
10791843|NCT03570047|11952649|FG000|NOT COMPLETED|Overall Study||0
10791844|NCT03570047|11952650|FG001|NOT COMPLETED|Overall Study||0
10791845|NCT03570047|11952651|FG002|NOT COMPLETED|Overall Study||0
10791846|NCT03570047|11952652|FG003|NOT COMPLETED|Overall Study||0
10791847|NCT03570047|11952653|FG004|NOT COMPLETED|Overall Study||0
10791848|NCT03570255|11952665|FG000|STARTED|Overall Study||28
10791849|NCT03570255|11952665|FG000|COMPLETED|Overall Study||28
10791850|NCT03570255|11952665|FG000|NOT COMPLETED|Overall Study||0
10791851|NCT03570476|11952669|FG000|STARTED|Overall Study||2
10791852|NCT03570476|11952669|FG000|COMPLETED|Overall Study||2
10791853|NCT03570476|11952669|FG000|NOT COMPLETED|Overall Study||0
10791854|NCT03570554|11952678|FG000|STARTED|Overall Study||10
10791855|NCT03570554|11952679|FG001|STARTED|Overall Study||10
10791856|NCT03570554|11952680|FG002|STARTED|Overall Study||11
10791857|NCT03570554|11952681|FG003|STARTED|Overall Study||10
10791858|NCT03570554|11952678|FG000|COMPLETED|Overall Study||10
10791859|NCT03570554|11952679|FG001|COMPLETED|Overall Study||10
10791860|NCT03570554|11952680|FG002|COMPLETED|Overall Study||10
10561842|NCT01601431|11716684|FG000|COMPLETED|Overall Study||211
10561843|NCT01601431|11716685|FG001|COMPLETED|Overall Study||214
10561844|NCT01601431|11716684|FG000|NOT COMPLETED|Overall Study||12
10561845|NCT01601431|11716685|FG001|NOT COMPLETED|Overall Study||3
10561846|NCT01601470|11716691|FG000|STARTED|Period 1 - Sildenafil||28
10791861|NCT03570554|11952681|FG003|COMPLETED|Overall Study||9
10791862|NCT03570554|11952678|FG000|NOT COMPLETED|Overall Study||0
10791863|NCT03570554|11952679|FG001|NOT COMPLETED|Overall Study||0
10791864|NCT03570554|11952680|FG002|NOT COMPLETED|Overall Study||1
10791865|NCT03570554|11952681|FG003|NOT COMPLETED|Overall Study||1
10791866|NCT03570658|11952695|FG000|STARTED|Single Ascending Dose (SAD)||6
10791867|NCT03570658|11952696|FG001|STARTED|Single Ascending Dose (SAD)||2
10791868|NCT03570658|11952697|FG002|STARTED|Single Ascending Dose (SAD)||10
10791869|NCT03570658|11952698|FG003|STARTED|Single Ascending Dose (SAD)||10
10791870|NCT03570658|11952695|FG000|COMPLETED|Single Ascending Dose (SAD)||6
10791871|NCT03570658|11952696|FG001|COMPLETED|Single Ascending Dose (SAD)||2
10791872|NCT03570658|11952697|FG002|COMPLETED|Single Ascending Dose (SAD)||10
10791873|NCT03570658|11952698|FG003|COMPLETED|Single Ascending Dose (SAD)||10
10561847|NCT01601470|11716691|FG000|PK Analysis Set|Period 1 - Sildenafil||28
10561848|NCT01601470|11716691|FG000|Safety Set|Period 1 - Sildenafil||28
10561849|NCT01601470|11716691|FG000|COMPLETED|Period 1 - Sildenafil||28
10561850|NCT01601470|11716691|FG000|NOT COMPLETED|Period 1 - Sildenafil||0
10561851|NCT01601470|11716691|FG000|STARTED|Period 2 - LCZ696||28
10561852|NCT01601470|11716691|FG000|PK Analysis Set|Period 2 - LCZ696||27
10561853|NCT01601470|11716691|FG000|Safety Set|Period 2 - LCZ696||27
10561854|NCT01601470|11716691|FG000|COMPLETED|Period 2 - LCZ696||27
10561855|NCT01601470|11716691|FG000|NOT COMPLETED|Period 2 - LCZ696||1
10791874|NCT03570658|11952695|FG000|NOT COMPLETED|Single Ascending Dose (SAD)||0
10791875|NCT03570658|11952696|FG001|NOT COMPLETED|Single Ascending Dose (SAD)||0
10561856|NCT01601470|11716691|FG000|STARTED|Period 3 - LCZ696+Sildenafil||27
10561857|NCT01601470|11716691|FG000|PK Analysis Set|Period 3 - LCZ696+Sildenafil||27
10561858|NCT01601470|11716691|FG000|Safety Set|Period 3 - LCZ696+Sildenafil||27
10561859|NCT01601470|11716691|FG000|COMPLETED|Period 3 - LCZ696+Sildenafil||27
10561860|NCT01601470|11716691|FG000|NOT COMPLETED|Period 3 - LCZ696+Sildenafil||0
10561861|NCT01601496|11716697|FG000|STARTED|Overall Study|Enrolled|117
10561862|NCT01601496|11716697|FG000|COMPLETED|Overall Study|Completed 12-M F/up|102
10561863|NCT01601496|11716697|FG000|NOT COMPLETED|Overall Study||15
10561864|NCT01601535|11716707|FG000|STARTED|Phase 1||6
10561865|NCT01601535|11716708|FG001|STARTED|Phase 1||6
10561866|NCT01601535|11716709|FG002|STARTED|Phase 1||6
10561867|NCT01601535|11716710|FG003|STARTED|Phase 1||4
10561868|NCT01601535|11716711|FG004|STARTED|Phase 1||0
10561869|NCT01601535|11716712|FG005|STARTED|Phase 1||0
10561870|NCT01601535|11716707|FG000|COMPLETED|Phase 1||0
10561871|NCT01601535|11716708|FG001|COMPLETED|Phase 1||0
10561872|NCT01601535|11716709|FG002|COMPLETED|Phase 1||1
10561873|NCT01601535|11716710|FG003|COMPLETED|Phase 1||0
10561874|NCT01601535|11716711|FG004|COMPLETED|Phase 1||0
10561875|NCT01601535|11716712|FG005|COMPLETED|Phase 1||0
10561876|NCT01601535|11716707|FG000|NOT COMPLETED|Phase 1||6
10561877|NCT01601535|11716708|FG001|NOT COMPLETED|Phase 1||6
10561878|NCT01601535|11716709|FG002|NOT COMPLETED|Phase 1||5
10561879|NCT01601535|11716710|FG003|NOT COMPLETED|Phase 1||4
10561880|NCT01601535|11716711|FG004|NOT COMPLETED|Phase 1||0
10561881|NCT01601535|11716712|FG005|NOT COMPLETED|Phase 1||0
10561882|NCT01601535|11716707|FG000|STARTED|Phase 2||0
10561883|NCT01601535|11716708|FG001|STARTED|Phase 2||0
10561884|NCT01601535|11716709|FG002|STARTED|Phase 2||0
10561885|NCT01601535|11716710|FG003|STARTED|Phase 2||0
10561886|NCT01601535|11716711|FG004|STARTED|Phase 2||20
10561887|NCT01601535|11716712|FG005|STARTED|Phase 2||12
10561888|NCT01601535|11716707|FG000|COMPLETED|Phase 2||0
10561889|NCT01601535|11716708|FG001|COMPLETED|Phase 2||0
10561890|NCT01601535|11716709|FG002|COMPLETED|Phase 2||0
10561891|NCT01601535|11716710|FG003|COMPLETED|Phase 2||0
10561892|NCT01601535|11716711|FG004|COMPLETED|Phase 2||1
10561893|NCT01601535|11716712|FG005|COMPLETED|Phase 2||0
10561894|NCT01601535|11716707|FG000|NOT COMPLETED|Phase 2||0
10561895|NCT01601535|11716708|FG001|NOT COMPLETED|Phase 2||0
10561896|NCT01601535|11716709|FG002|NOT COMPLETED|Phase 2||0
10561897|NCT01601535|11716710|FG003|NOT COMPLETED|Phase 2||0
10561898|NCT01601535|11716711|FG004|NOT COMPLETED|Phase 2||19
10561899|NCT01601535|11716712|FG005|NOT COMPLETED|Phase 2||12
10561900|NCT01601626|11716738|FG000|STARTED|Overall Study||24
10561901|NCT01601626|11716739|FG001|STARTED|Overall Study||24
10561902|NCT01601626|11716740|FG002|STARTED|Overall Study||23
10561903|NCT01601626|11716738|FG000|COMPLETED|Overall Study||21
10561904|NCT01601626|11716739|FG001|COMPLETED|Overall Study||19
10561905|NCT01601626|11716740|FG002|COMPLETED|Overall Study||21
10561906|NCT01601626|11716738|FG000|NOT COMPLETED|Overall Study||3
10561907|NCT01601626|11716739|FG001|NOT COMPLETED|Overall Study||5
10561908|NCT01601626|11716740|FG002|NOT COMPLETED|Overall Study||2
10561909|NCT01601652|11716748|FG000|STARTED|Overall Study||12
10561910|NCT01601652|11716748|FG000|COMPLETED|Overall Study||11
10561911|NCT01601652|11716748|FG000|NOT COMPLETED|Overall Study||1
10561912|NCT01601691|11716752|FG000|STARTED|Overall Study||10
10561913|NCT01601691|11716752|FG000|COMPLETED|Overall Study||10
10561914|NCT01601691|11716752|FG000|NOT COMPLETED|Overall Study||0
10561915|NCT01601704|11716758|FG000|STARTED|Overall Study||4456
10561916|NCT01601704|11716759|FG001|STARTED|Overall Study||4454
10561917|NCT01601704|11716758|FG000|Treated|Overall Study||4455
10561918|NCT01601704|11716759|FG001|Treated|Overall Study||4450
10561919|NCT01601704|11716758|FG000|COMPLETED|Overall Study||4455
10561920|NCT01601704|11716759|FG001|COMPLETED|Overall Study||4450
10561921|NCT01601704|11716758|FG000|NOT COMPLETED|Overall Study||1
10561922|NCT01601704|11716759|FG001|NOT COMPLETED|Overall Study||4
10561923|NCT01601782|11716765|FG000|STARTED|Overall Study||16
10561924|NCT01601782|11716765|FG000|COMPLETED|Overall Study||16
10561925|NCT01601782|11716765|FG000|NOT COMPLETED|Overall Study||0
10561926|NCT01601821|11716771|FG000|STARTED|Overall Study||125
10561927|NCT01601821|11716772|FG001|STARTED|Overall Study||120
10561928|NCT01601821|11716771|FG000|COMPLETED|Overall Study||96
10561929|NCT01601821|11716772|FG001|COMPLETED|Overall Study||91
10561930|NCT01601821|11716771|FG000|NOT COMPLETED|Overall Study||29
10561931|NCT01601821|11716772|FG001|NOT COMPLETED|Overall Study||29
10561932|NCT01601847|11716780|FG000|STARTED|Overall Study||153
10561933|NCT01601847|11716781|FG001|STARTED|Overall Study||147
10561934|NCT01601847|11716780|FG000|COMPLETED|Overall Study||140
10561935|NCT01601847|11716781|FG001|COMPLETED|Overall Study||137
10561936|NCT01601847|11716780|FG000|NOT COMPLETED|Overall Study||13
10561937|NCT01601847|11716781|FG001|NOT COMPLETED|Overall Study||10
10561938|NCT01601860|11716789|FG000|STARTED|Overall Study||40
10791876|NCT03570658|11952697|FG002|NOT COMPLETED|Single Ascending Dose (SAD)||0
10791877|NCT03570658|11952698|FG003|NOT COMPLETED|Single Ascending Dose (SAD)||0
10791878|NCT03570658|11952695|FG000|STARTED|Multiple Ascending Dose (MAD)||4
10791879|NCT03570658|11952696|FG001|STARTED|Multiple Ascending Dose (MAD)||0
10561939|NCT01601860|11716790|FG001|STARTED|Overall Study||40
10561940|NCT01601860|11716789|FG000|COMPLETED|Overall Study||19
10561941|NCT01601860|11716790|FG001|COMPLETED|Overall Study||31
10561942|NCT01601860|11716789|FG000|NOT COMPLETED|Overall Study||21
10561943|NCT01601860|11716790|FG001|NOT COMPLETED|Overall Study||9
10561944|NCT01601873|11716799|FG000|STARTED|Overall Study||50
10561945|NCT01601873|11716800|FG001|STARTED|Overall Study||47
10561946|NCT01601873|11716799|FG000|COMPLETED|Overall Study||48
10561947|NCT01601873|11716800|FG001|COMPLETED|Overall Study||44
10561948|NCT01601873|11716799|FG000|NOT COMPLETED|Overall Study||2
10561949|NCT01601873|11716800|FG001|NOT COMPLETED|Overall Study||3
10561950|NCT01601977|11716806|FG000|STARTED|Overall Study|5 patients consented for study participation but did not attend for study assessments.|10
10561951|NCT01601977|11716806|FG000|COMPLETED|Overall Study||10
10561952|NCT01601977|11716806|FG000|NOT COMPLETED|Overall Study||0
10561953|NCT01602068|11716814|FG000|STARTED|Overall Study|Day before surgery|23
10561954|NCT01602068|11716815|FG001|STARTED|Overall Study|Day before surgery|22
10561955|NCT01602068|11716814|FG000|COMPLETED|Overall Study||23
10561956|NCT01602068|11716815|FG001|COMPLETED|Overall Study||22
10561957|NCT01602068|11716814|FG000|NOT COMPLETED|Overall Study||0
10561958|NCT01602068|11716815|FG001|NOT COMPLETED|Overall Study||0
10561959|NCT01602120|11716825|FG000|STARTED|Overall Study||29
10561960|NCT01602120|11716826|FG001|STARTED|Overall Study||60
10561961|NCT01602120|11716827|FG002|STARTED|Overall Study||17
10561962|NCT01602120|11716828|FG003|STARTED|Overall Study||53
10561963|NCT01602120|11716825|FG000|COMPLETED|Overall Study||0
10561964|NCT01602120|11716826|FG001|COMPLETED|Overall Study||0
10561965|NCT01602120|11716827|FG002|COMPLETED|Overall Study||0
10561966|NCT01602120|11716828|FG003|COMPLETED|Overall Study||0
10561967|NCT01602120|11716825|FG000|NOT COMPLETED|Overall Study||29
10561968|NCT01602120|11716826|FG001|NOT COMPLETED|Overall Study||60
10561969|NCT01602120|11716827|FG002|NOT COMPLETED|Overall Study||17
10561970|NCT01602120|11716828|FG003|NOT COMPLETED|Overall Study||53
10561971|NCT01602172|11716843|FG000|STARTED|Overall Study||37
10561972|NCT01602172|11716844|FG001|STARTED|Overall Study||23
10561973|NCT01602172|11716845|FG002|STARTED|Overall Study||22
10561974|NCT01602172|11716843|FG000|COMPLETED|Overall Study||32
10561975|NCT01602172|11716844|FG001|COMPLETED|Overall Study||17
10561976|NCT01602172|11716845|FG002|COMPLETED|Overall Study||22
10561977|NCT01602172|11716843|FG000|NOT COMPLETED|Overall Study||5
10561978|NCT01602172|11716844|FG001|NOT COMPLETED|Overall Study||6
10561979|NCT01602172|11716845|FG002|NOT COMPLETED|Overall Study||0
10561980|NCT01602224|11716862|FG000|STARTED|Overall Study||74
10561981|NCT01602224|11716863|FG001|STARTED|Overall Study||74
10561982|NCT01602224|11716864|FG002|STARTED|Overall Study||72
10791880|NCT03570658|11952697|FG002|STARTED|Multiple Ascending Dose (MAD)||10
10791881|NCT03570658|11952698|FG003|STARTED|Multiple Ascending Dose (MAD)||10
10791882|NCT03570658|11952695|FG000|COMPLETED|Multiple Ascending Dose (MAD)||4
10791883|NCT03570658|11952696|FG001|COMPLETED|Multiple Ascending Dose (MAD)||0
10791884|NCT03570658|11952697|FG002|COMPLETED|Multiple Ascending Dose (MAD)||10
10791885|NCT03570658|11952698|FG003|COMPLETED|Multiple Ascending Dose (MAD)||10
10791886|NCT03570658|11952695|FG000|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
10791887|NCT03570658|11952696|FG001|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
10791888|NCT03570658|11952697|FG002|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
10791889|NCT03570658|11952698|FG003|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
10791890|NCT03571256|11952725|FG000|STARTED|Overall Study||52
10791891|NCT03571256|11952726|FG001|STARTED|Overall Study||54
10791892|NCT03571256|11952727|FG002|STARTED|Overall Study||52
10791893|NCT03571256|11952725|FG000|Safety Analysis Set|Overall Study||52
10791894|NCT03571256|11952726|FG001|Safety Analysis Set|Overall Study||54
10791895|NCT03571256|11952727|FG002|Safety Analysis Set|Overall Study||51
10791896|NCT03571256|11952725|FG000|Modified ITT (mITT) Analysis Set|Overall Study||49
10791897|NCT03571256|11952726|FG001|Modified ITT (mITT) Analysis Set|Overall Study||53
10791898|NCT03571256|11952727|FG002|Modified ITT (mITT) Analysis Set|Overall Study||51
10791899|NCT03571256|11952725|FG000|COMPLETED|Overall Study||46
10791900|NCT03571256|11952726|FG001|COMPLETED|Overall Study||51
10561983|NCT01602224|11716862|FG000|Received at Least 1 Dose of Study Drug|Overall Study||73
10561984|NCT01602224|11716863|FG001|Received at Least 1 Dose of Study Drug|Overall Study||74
10561985|NCT01602224|11716864|FG002|Received at Least 1 Dose of Study Drug|Overall Study||72
10561986|NCT01602224|11716862|FG000|COMPLETED|Overall Study||66
10561987|NCT01602224|11716863|FG001|COMPLETED|Overall Study||66
10561988|NCT01602224|11716864|FG002|COMPLETED|Overall Study||66
10561989|NCT01602224|11716862|FG000|NOT COMPLETED|Overall Study||8
10561990|NCT01602224|11716863|FG001|NOT COMPLETED|Overall Study||8
10561991|NCT01602224|11716864|FG002|NOT COMPLETED|Overall Study||6
10561992|NCT01602315|11716881|FG000|STARTED|Overall Study||16
10561993|NCT01602315|11716882|FG001|STARTED|Overall Study||5
10561994|NCT01602315|11716883|FG002|STARTED|Overall Study||18
10561995|NCT01602315|11716884|FG003|STARTED|Overall Study||6
10791901|NCT03571256|11952727|FG002|COMPLETED|Overall Study||48
10791902|NCT03571256|11952725|FG000|NOT COMPLETED|Overall Study||6
10791903|NCT03571256|11952726|FG001|NOT COMPLETED|Overall Study||3
10791904|NCT03571256|11952727|FG002|NOT COMPLETED|Overall Study||4
10791905|NCT03571516|11952739|FG000|STARTED|Overall Study||5
10791906|NCT03571516|11952740|FG001|STARTED|Overall Study||5
10791907|NCT03571516|11952739|FG000|COMPLETED|Overall Study||4
10561996|NCT01602315|11716885|FG004|STARTED|Overall Study||71
10561997|NCT01602315|11716886|FG005|STARTED|Overall Study||35
10561998|NCT01602315|11716887|FG006|STARTED|Overall Study||29
10561999|NCT01602315|11716881|FG000|COMPLETED|Overall Study||0
10562000|NCT01602315|11716882|FG001|COMPLETED|Overall Study||0
10562001|NCT01602315|11716883|FG002|COMPLETED|Overall Study||0
10562002|NCT01602315|11716884|FG003|COMPLETED|Overall Study||0
10562003|NCT01602315|11716885|FG004|COMPLETED|Overall Study||0
10562004|NCT01602315|11716886|FG005|COMPLETED|Overall Study||0
10562005|NCT01602315|11716887|FG006|COMPLETED|Overall Study||0
10562006|NCT01602315|11716881|FG000|NOT COMPLETED|Overall Study||16
10562007|NCT01602315|11716882|FG001|NOT COMPLETED|Overall Study||5
10562008|NCT01602315|11716883|FG002|NOT COMPLETED|Overall Study||18
10562009|NCT01602315|11716884|FG003|NOT COMPLETED|Overall Study||6
10562010|NCT01602315|11716885|FG004|NOT COMPLETED|Overall Study||71
10562011|NCT01602315|11716886|FG005|NOT COMPLETED|Overall Study||35
10562012|NCT01602315|11716887|FG006|NOT COMPLETED|Overall Study||29
10562013|NCT01602341|11716925|FG000|STARTED|Overall Study||44
10562014|NCT01602341|11716926|FG001|STARTED|Overall Study||42
10562015|NCT01602341|11716925|FG000|COMPLETED|Overall Study||44
10562016|NCT01602341|11716926|FG001|COMPLETED|Overall Study||41
10562017|NCT01602341|11716925|FG000|NOT COMPLETED|Overall Study||0
10562018|NCT01602341|11716926|FG001|NOT COMPLETED|Overall Study||1
10562019|NCT01602419|11716936|FG000|STARTED|Overall Study||120
10562020|NCT01602419|11716936|FG000|SAF Population|Overall Study||111
10562021|NCT01602419|11716936|FG000|ITT Population|Overall Study||102
10562022|NCT01602419|11716936|FG000|EFF Population|Overall Study||91
10562023|NCT01602419|11716936|FG000|COMPLETED|Overall Study||91
10562024|NCT01602419|11716936|FG000|NOT COMPLETED|Overall Study||29
10562025|NCT01602484|11716983|FG000|STARTED|Overall Study||25
10562026|NCT01602484|11716984|FG001|STARTED|Overall Study||25
10562027|NCT01602484|11716983|FG000|COMPLETED|Overall Study||25
10562028|NCT01602484|11716984|FG001|COMPLETED|Overall Study||24
10562029|NCT01602484|11716983|FG000|NOT COMPLETED|Overall Study||0
10562030|NCT01602484|11716984|FG001|NOT COMPLETED|Overall Study||1
10562031|NCT01602510|11716990|FG000|STARTED|Open Label Phase||420
10562032|NCT01602510|11716991|FG001|STARTED|Open Label Phase||0
10562033|NCT01602510|11716992|FG002|STARTED|Open Label Phase||0
10562034|NCT01602510|11716990|FG000|COMPLETED|Open Label Phase||117
10562035|NCT01602510|11716991|FG001|COMPLETED|Open Label Phase||0
10562036|NCT01602510|11716992|FG002|COMPLETED|Open Label Phase||0
10562037|NCT01602510|11716990|FG000|NOT COMPLETED|Open Label Phase||303
10562038|NCT01602510|11716991|FG001|NOT COMPLETED|Open Label Phase||0
10562039|NCT01602510|11716992|FG002|NOT COMPLETED|Open Label Phase||0
10562040|NCT01602510|11716990|FG000|STARTED|Randomized Phase||0
10562041|NCT01602510|11716991|FG001|STARTED|Randomized Phase||133
10562042|NCT01602510|11716992|FG002|STARTED|Randomized Phase||131
10562043|NCT01602510|11716990|FG000|COMPLETED|Randomized Phase||0
10562044|NCT01602510|11716991|FG001|COMPLETED|Randomized Phase||59
10562045|NCT01602510|11716992|FG002|COMPLETED|Randomized Phase||58
10562046|NCT01602510|11716990|FG000|NOT COMPLETED|Randomized Phase||0
10562047|NCT01602510|11716991|FG001|NOT COMPLETED|Randomized Phase||74
10562048|NCT01602510|11716992|FG002|NOT COMPLETED|Randomized Phase||73
10562049|NCT01602549|11717000|FG000|STARTED|Overall Study||19
10562050|NCT01602549|11717001|FG001|STARTED|Overall Study||38
10562051|NCT01602549|11717000|FG000|COMPLETED|Overall Study||18
10562052|NCT01602549|11717001|FG001|COMPLETED|Overall Study||37
10562053|NCT01602549|11717000|FG000|NOT COMPLETED|Overall Study||1
10562054|NCT01602549|11717001|FG001|NOT COMPLETED|Overall Study||1
10562055|NCT01602562|11717011|FG000|STARTED|Overall Study||21
10791908|NCT03571516|11952740|FG001|COMPLETED|Overall Study||4
10791909|NCT03571516|11952739|FG000|NOT COMPLETED|Overall Study||1
10791910|NCT03571516|11952740|FG001|NOT COMPLETED|Overall Study||1
10791911|NCT03571555|11952748|FG000|STARTED|Overall Study||252
10791912|NCT03571555|11952749|FG001|STARTED|Overall Study||263
10791913|NCT03571555|11952748|FG000|COMPLETED|Overall Study||177
10791914|NCT03571555|11952749|FG001|COMPLETED|Overall Study||195
10791915|NCT03571555|11952748|FG000|NOT COMPLETED|Overall Study||75
10562056|NCT01602562|11717012|FG001|STARTED|Overall Study||19
10562057|NCT01602562|11717011|FG000|COMPLETED|Overall Study||16
10562058|NCT01602562|11717012|FG001|COMPLETED|Overall Study||16
10562059|NCT01602562|11717011|FG000|NOT COMPLETED|Overall Study||5
10562060|NCT01602562|11717012|FG001|NOT COMPLETED|Overall Study||3
10562061|NCT01602614|11717023|FG000|STARTED|Overall Study||0
10562062|NCT01602614|11717024|FG001|STARTED|Overall Study||10
10562063|NCT01602614|11717025|FG002|STARTED|Overall Study||8
10562064|NCT01602614|11717026|FG003|STARTED|Overall Study||0
10562065|NCT01602614|11717023|FG000|COMPLETED|Overall Study||0
10562066|NCT01602614|11717024|FG001|COMPLETED|Overall Study||10
10791916|NCT03571555|11952749|FG001|NOT COMPLETED|Overall Study||68
10562067|NCT01602614|11717025|FG002|COMPLETED|Overall Study||8
10562068|NCT01602614|11717026|FG003|COMPLETED|Overall Study||0
10562069|NCT01602614|11717023|FG000|NOT COMPLETED|Overall Study||0
10562070|NCT01602614|11717024|FG001|NOT COMPLETED|Overall Study||0
10562071|NCT01602614|11717025|FG002|NOT COMPLETED|Overall Study||0
10562072|NCT01602614|11717026|FG003|NOT COMPLETED|Overall Study||0
10562073|NCT01602679|11717042|FG000|STARTED|Overall Study||4
10562074|NCT01602679|11717043|FG001|STARTED|Overall Study||3
10562075|NCT01602679|11717042|FG000|COMPLETED|Overall Study||4
10562076|NCT01602679|11717043|FG001|COMPLETED|Overall Study||3
10791917|NCT03571607|11952757|FG000|STARTED|Overall Study||53
10791918|NCT03571607|11952758|FG001|STARTED|Overall Study||153
10791919|NCT03571607|11952757|FG000|Vaccinated|Overall Study||53
10562077|NCT01602679|11717042|FG000|NOT COMPLETED|Overall Study||0
10562078|NCT01602679|11717043|FG001|NOT COMPLETED|Overall Study||0
10562079|NCT01602692|11717051|FG000|STARTED|Overall Study||20
10562080|NCT01602692|11717052|FG001|STARTED|Overall Study||20
10562081|NCT01602692|11717051|FG000|COMPLETED|Overall Study||20
10562082|NCT01602692|11717052|FG001|COMPLETED|Overall Study||20
10562083|NCT01602692|11717051|FG000|NOT COMPLETED|Overall Study||0
10562084|NCT01602692|11717052|FG001|NOT COMPLETED|Overall Study||0
10562085|NCT01602731|11717062|FG000|STARTED|Overall Study||45
10562086|NCT01602731|11717062|FG000|Cognitive Impairment|Overall Study|After repeat cognitive testing, additional 1 patient had no cognitive impairment and did not proceed|44
10562087|NCT01602731|11717062|FG000|Poor Medication Adherence|Overall Study|24 out of 35 patients who completed 1-month pill counts had medication adherence <88%.|24
10562088|NCT01602731|11717062|FG000|COMPLETED|Overall Study||15
10562089|NCT01602731|11717062|FG000|NOT COMPLETED|Overall Study||30
10562090|NCT01602744|11717070|FG000|STARTED|Overall Study||176
10562091|NCT01602744|11717071|FG001|STARTED|Overall Study||183
10562092|NCT01602744|11717070|FG000|COMPLETED|Overall Study||146
10562093|NCT01602744|11717071|FG001|COMPLETED|Overall Study||160
10562094|NCT01602744|11717070|FG000|NOT COMPLETED|Overall Study||30
10562095|NCT01602744|11717071|FG001|NOT COMPLETED|Overall Study||23
10562096|NCT01602965|11717079|FG000|STARTED|Overall Study||20
10562097|NCT01602965|11717080|FG001|STARTED|Overall Study||20
10562098|NCT01602965|11717079|FG000|COMPLETED|Overall Study||16
10562099|NCT01602965|11717080|FG001|COMPLETED|Overall Study||18
10562100|NCT01602965|11717079|FG000|NOT COMPLETED|Overall Study||4
10562101|NCT01602965|11717080|FG001|NOT COMPLETED|Overall Study||2
10562102|NCT01603056|11717088|FG000|STARTED|Overall Study||413
10562103|NCT01603056|11717089|FG001|STARTED|Overall Study||204
10562104|NCT01603056|11717088|FG000|COMPLETED|Overall Study||379
10562105|NCT01603056|11717089|FG001|COMPLETED|Overall Study||190
10562106|NCT01603056|11717088|FG000|NOT COMPLETED|Overall Study||34
10562107|NCT01603056|11717089|FG001|NOT COMPLETED|Overall Study||14
10562108|NCT01603082|11717097|FG000|STARTED|Overall Study|Randomized|51
10562109|NCT01603082|11717098|FG001|STARTED|Overall Study|Randomized|49
10562110|NCT01603082|11717097|FG000|COMPLETED|Overall Study|Completed the study.|49
10562111|NCT01603082|11717098|FG001|COMPLETED|Overall Study|Completed the study|48
10562112|NCT01603082|11717097|FG000|NOT COMPLETED|Overall Study||2
10562113|NCT01603082|11717098|FG001|NOT COMPLETED|Overall Study||1
10562114|NCT01603277|11717106|FG000|STARTED|Overall Study||78
10562115|NCT01603277|11717107|FG001|STARTED|Overall Study||82
10562116|NCT01603277|11717106|FG000|COMPLETED|Overall Study||64
10562117|NCT01603277|11717107|FG001|COMPLETED|Overall Study||64
10562118|NCT01603277|11717106|FG000|NOT COMPLETED|Overall Study||14
10562119|NCT01603277|11717107|FG001|NOT COMPLETED|Overall Study||18
10562120|NCT01603355|11717113|FG000|STARTED|Overall Study||3
10562121|NCT01603355|11717113|FG000|COMPLETED|Overall Study||1
10562122|NCT01603355|11717113|FG000|NOT COMPLETED|Overall Study||2
10562123|NCT01603368|11717119|FG000|STARTED|Overall Study||68
10562124|NCT01603368|11717120|FG001|STARTED|Overall Study||66
10562125|NCT01603368|11717119|FG000|COMPLETED|Overall Study||68
10562126|NCT01603368|11717120|FG001|COMPLETED|Overall Study||66
10562127|NCT01603368|11717119|FG000|NOT COMPLETED|Overall Study||0
10562128|NCT01603368|11717120|FG001|NOT COMPLETED|Overall Study||0
10562129|NCT01603420|11717128|FG000|STARTED|Overall Study||1
10562130|NCT01603420|11717129|FG001|STARTED|Overall Study||1
10562131|NCT01603420|11717128|FG000|COMPLETED|Overall Study||1
10562132|NCT01603420|11717129|FG001|COMPLETED|Overall Study||1
10562133|NCT01603420|11717128|FG000|NOT COMPLETED|Overall Study||0
10562134|NCT01603420|11717129|FG001|NOT COMPLETED|Overall Study||0
10562135|NCT01603459|11717138|FG000|STARTED|Overall Study||155
10562136|NCT01603459|11717138|FG000|COMPLETED|Overall Study||137
10562137|NCT01603459|11717138|FG000|NOT COMPLETED|Overall Study||18
10562138|NCT01603602|11717163|FG000|STARTED|Overall Study||77
10562139|NCT01603602|11717164|FG001|STARTED|Overall Study||78
10562140|NCT01603602|11717165|FG002|STARTED|Overall Study||80
10562141|NCT01603602|11717163|FG000|COMPLETED|Overall Study||75
10562142|NCT01603602|11717164|FG001|COMPLETED|Overall Study||78
10562143|NCT01603602|11717165|FG002|COMPLETED|Overall Study||79
10562144|NCT01603602|11717163|FG000|NOT COMPLETED|Overall Study||2
10562145|NCT01603602|11717164|FG001|NOT COMPLETED|Overall Study||0
10562146|NCT01603602|11717165|FG002|NOT COMPLETED|Overall Study||1
10562147|NCT01603615|11717173|FG000|STARTED|Overall Study||220
10562148|NCT01603615|11717173|FG000|Safety Population (Treated)|Overall Study||213
10562149|NCT01603615|11717173|FG000|COMPLETED|Overall Study||186
10562150|NCT01603615|11717173|FG000|NOT COMPLETED|Overall Study||34
10562151|NCT01603628|11717180|FG000|STARTED|Overall Study||128
10562152|NCT01603628|11717181|FG001|STARTED|Overall Study||126
10562153|NCT01603628|11717182|FG002|STARTED|Overall Study||130
10562154|NCT01603628|11717180|FG000|Safety Population: Received Treatment|Overall Study||128
10562155|NCT01603628|11717181|FG001|Safety Population: Received Treatment|Overall Study||126
10562156|NCT01603628|11717182|FG002|Safety Population: Received Treatment|Overall Study||128
10562157|NCT01603628|11717180|FG000|COMPLETED|Overall Study||125
10562158|NCT01603628|11717181|FG001|COMPLETED|Overall Study||123
10562159|NCT01603628|11717182|FG002|COMPLETED|Overall Study||128
10562160|NCT01603628|11717180|FG000|NOT COMPLETED|Overall Study||3
10562161|NCT01603628|11717181|FG001|NOT COMPLETED|Overall Study||3
10562162|NCT01603628|11717182|FG002|NOT COMPLETED|Overall Study||2
10562163|NCT01603641|11717190|FG000|STARTED|Overall Study||370
10562164|NCT01603641|11717190|FG000|Safety Population (Treated)|Overall Study||367
10562165|NCT01603641|11717190|FG000|Modified Intent-to-treat Population|Overall Study||366
10562166|NCT01603641|11717190|FG000|COMPLETED|Overall Study||335
10562167|NCT01603641|11717190|FG000|NOT COMPLETED|Overall Study||35
10562168|NCT01603875|11717197|FG000|STARTED|Overall Study||35
10562169|NCT01603875|11717198|FG001|STARTED|Overall Study||35
10562170|NCT01603875|11717199|FG002|STARTED|Overall Study||35
10562171|NCT01603875|11717197|FG000|COMPLETED|Overall Study||28
10562172|NCT01603875|11717198|FG001|COMPLETED|Overall Study||27
10562173|NCT01603875|11717199|FG002|COMPLETED|Overall Study||26
10562174|NCT01603875|11717197|FG000|NOT COMPLETED|Overall Study||7
10562175|NCT01603875|11717198|FG001|NOT COMPLETED|Overall Study||8
10562176|NCT01603875|11717199|FG002|NOT COMPLETED|Overall Study||9
10562177|NCT01603940|11717209|FG000|STARTED|Overall Study||16
10562178|NCT01603940|11717210|FG001|STARTED|Overall Study||14
10562179|NCT01603940|11717209|FG000|COMPLETED|Overall Study||16
10562180|NCT01603940|11717210|FG001|COMPLETED|Overall Study||14
10562181|NCT01603940|11717209|FG000|NOT COMPLETED|Overall Study||0
10562182|NCT01603940|11717210|FG001|NOT COMPLETED|Overall Study||0
10562183|NCT01604109|11717218|FG000|STARTED|Overall Study||150
10562184|NCT01604109|11717219|FG001|STARTED|Overall Study||146
10562185|NCT01604109|11717218|FG000|COMPLETED|Overall Study||117
10562186|NCT01604109|11717219|FG001|COMPLETED|Overall Study||112
10562187|NCT01604109|11717218|FG000|NOT COMPLETED|Overall Study||33
10562188|NCT01604109|11717219|FG001|NOT COMPLETED|Overall Study||34
10562189|NCT01604122|11717227|FG000|STARTED|Overall Study||60
10562190|NCT01604122|11717228|FG001|STARTED|Overall Study||32
10562191|NCT01604122|11717227|FG000|COMPLETED|Overall Study||60
10562192|NCT01604122|11717228|FG001|COMPLETED|Overall Study||32
10562193|NCT01604122|11717227|FG000|NOT COMPLETED|Overall Study||0
10562194|NCT01604122|11717228|FG001|NOT COMPLETED|Overall Study||0
10562195|NCT01604265|11717237|FG000|STARTED|Overall Study||34
10562196|NCT01604265|11717238|FG001|STARTED|Overall Study||32
10562197|NCT01604265|11717237|FG000|COMPLETED|Overall Study||32
10562198|NCT01604265|11717238|FG001|COMPLETED|Overall Study||32
10562199|NCT01604265|11717237|FG000|NOT COMPLETED|Overall Study||2
10562200|NCT01604265|11717238|FG001|NOT COMPLETED|Overall Study||0
10562201|NCT01604278|11717246|FG000|STARTED|Overall Study||226
10562202|NCT01604278|11717247|FG001|STARTED|Overall Study||223
10562203|NCT01604278|11717246|FG000|Safety Set|Overall Study||226
10562204|NCT01604278|11717247|FG001|Safety Set|Overall Study|Two randomized participants who did not receive study drug were excluded from this set.|221
10562205|NCT01604278|11717246|FG000|Full Analysis Set|Overall Study||226
10562206|NCT01604278|11717247|FG001|Full Analysis Set|Overall Study|Three randomized participants excluded: 2 who did not receive study drug; 1 with a major deviation.|220
10562207|NCT01604278|11717246|FG000|COMPLETED|Overall Study||212
10562208|NCT01604278|11717247|FG001|COMPLETED|Overall Study||210
10562209|NCT01604278|11717246|FG000|NOT COMPLETED|Overall Study||14
10562210|NCT01604278|11717247|FG001|NOT COMPLETED|Overall Study||13
10562211|NCT01604291|11717257|FG000|STARTED|Overall Study||311
10562212|NCT01604291|11717258|FG001|STARTED|Overall Study||443
10562213|NCT01604291|11717259|FG002|STARTED|Overall Study||193
10562214|NCT01604291|11717260|FG003|STARTED|Overall Study||44
10562215|NCT01604291|11717257|FG000|COMPLETED|Overall Study||311
10791920|NCT03571607|11952758|FG001|Vaccinated|Overall Study||153
10791921|NCT03571607|11952757|FG000|COMPLETED|Overall Study||53
10791922|NCT03571607|11952758|FG001|COMPLETED|Overall Study||153
10791923|NCT03571607|11952757|FG000|NOT COMPLETED|Overall Study||0
10791924|NCT03571607|11952758|FG001|NOT COMPLETED|Overall Study||0
10791925|NCT03571672|11952766|FG000|STARTED|Overall Study||153
10791926|NCT03571672|11952766|FG000|COMPLETED|Overall Study||148
10791927|NCT03571672|11952766|FG000|NOT COMPLETED|Overall Study||5
10791928|NCT03571724|11952776|FG000|STARTED|Week -1 (Prior to Switching)||0
10791929|NCT03571724|11952777|FG001|STARTED|Week -1 (Prior to Switching)||0
10791930|NCT03571724|11952778|FG002|STARTED|Week -1 (Prior to Switching)||72
10791931|NCT03571724|11952779|FG003|STARTED|Week -1 (Prior to Switching)||70
10791932|NCT03571724|11952776|FG000|Topography|Week -1 (Prior to Switching)||0
10791933|NCT03571724|11952777|FG001|Topography|Week -1 (Prior to Switching)||0
10791934|NCT03571724|11952778|FG002|Topography|Week -1 (Prior to Switching)|These subjects switched into VLN arms.|18
10791935|NCT03571724|11952779|FG003|Topography|Week -1 (Prior to Switching)|These subjects switched into VLN arms.|18
10791936|NCT03571724|11952776|FG000|PK Nicotine|Week -1 (Prior to Switching)||0
10791937|NCT03571724|11952777|FG001|PK Nicotine|Week -1 (Prior to Switching)||0
10791938|NCT03571724|11952778|FG002|PK Nicotine|Week -1 (Prior to Switching)|These subjects switched into VLN arms.|12
10791939|NCT03571724|11952779|FG003|PK Nicotine|Week -1 (Prior to Switching)|These subjects switched into VLN arms.|12
10562216|NCT01604291|11717258|FG001|COMPLETED|Overall Study||443
10562217|NCT01604291|11717259|FG002|COMPLETED|Overall Study||193
10562218|NCT01604291|11717260|FG003|COMPLETED|Overall Study||44
10562219|NCT01604291|11717257|FG000|NOT COMPLETED|Overall Study||0
10562220|NCT01604291|11717258|FG001|NOT COMPLETED|Overall Study||0
10562221|NCT01604291|11717259|FG002|NOT COMPLETED|Overall Study||0
10562222|NCT01604291|11717260|FG003|NOT COMPLETED|Overall Study||0
10562223|NCT01604343|11717281|FG000|STARTED|Prior to W52 Administration(Through W52)||556
10562224|NCT01604343|11717282|FG001|STARTED|Prior to W52 Administration(Through W52)||0
10562225|NCT01604343|11717283|FG002|STARTED|Prior to W52 Administration(Through W52)||557
10562226|NCT01604343|11717284|FG003|STARTED|Prior to W52 Administration(Through W52)||0
10562227|NCT01604343|11717285|FG004|STARTED|Prior to W52 Administration(Through W52)||557
10562228|NCT01604343|11717281|FG000|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)|Out of 187, 95 were re-randomized to sirukumab 50 mg and 92 were re-randomized to 100 mg group.|187
10791940|NCT03571724|11952776|FG000|COMPLETED|Week -1 (Prior to Switching)||0
10791941|NCT03571724|11952777|FG001|COMPLETED|Week -1 (Prior to Switching)||0
10791942|NCT03571724|11952778|FG002|COMPLETED|Week -1 (Prior to Switching)||72
10791943|NCT03571724|11952779|FG003|COMPLETED|Week -1 (Prior to Switching)||70
10791944|NCT03571724|11952776|FG000|NOT COMPLETED|Week -1 (Prior to Switching)||0
10791945|NCT03571724|11952777|FG001|NOT COMPLETED|Week -1 (Prior to Switching)||0
10562229|NCT01604343|11717282|FG001|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
10562230|NCT01604343|11717283|FG002|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
10562231|NCT01604343|11717284|FG003|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
10562232|NCT01604343|11717285|FG004|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
10562233|NCT01604343|11717281|FG000|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)|Out of 24, 12 were re-randomized to sirukumab 50 mg and 12 were re-randomized to 100 mg group.|24
10562234|NCT01604343|11717282|FG001|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
10562235|NCT01604343|11717283|FG002|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
10562236|NCT01604343|11717284|FG003|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
10562237|NCT01604343|11717285|FG004|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
10562238|NCT01604343|11717281|FG000|COMPLETED|Prior to W52 Administration(Through W52)||458
10562239|NCT01604343|11717282|FG001|COMPLETED|Prior to W52 Administration(Through W52)||0
10562240|NCT01604343|11717283|FG002|COMPLETED|Prior to W52 Administration(Through W52)||481
10562241|NCT01604343|11717284|FG003|COMPLETED|Prior to W52 Administration(Through W52)||0
10562242|NCT01604343|11717285|FG004|COMPLETED|Prior to W52 Administration(Through W52)||470
10562243|NCT01604343|11717281|FG000|NOT COMPLETED|Prior to W52 Administration(Through W52)||98
10562244|NCT01604343|11717282|FG001|NOT COMPLETED|Prior to W52 Administration(Through W52)||0
10562245|NCT01604343|11717283|FG002|NOT COMPLETED|Prior to W52 Administration(Through W52)||76
10562246|NCT01604343|11717284|FG003|NOT COMPLETED|Prior to W52 Administration(Through W52)||0
10562247|NCT01604343|11717285|FG004|NOT COMPLETED|Prior to W52 Administration(Through W52)||87
10562248|NCT01604343|11717281|FG000|STARTED|Week 52 to Week 104||0
10562249|NCT01604343|11717282|FG001|STARTED|Week 52 to Week 104|Participants re-randomized at Week 18 (95), 40 (12) and 52 were included|243
10562250|NCT01604343|11717283|FG002|STARTED|Week 52 to Week 104||481
10562251|NCT01604343|11717284|FG003|STARTED|Week 52 to Week 104|Participants re-randomized at Week 18 (92), 40 (12) and 52 were included|241
10562252|NCT01604343|11717285|FG004|STARTED|Week 52 to Week 104||470
10562253|NCT01604343|11717281|FG000|Treated|Week 52 to Week 104||0
10562254|NCT01604343|11717282|FG001|Treated|Week 52 to Week 104||242
10562255|NCT01604343|11717283|FG002|Treated|Week 52 to Week 104||481
10562256|NCT01604343|11717284|FG003|Treated|Week 52 to Week 104||241
10562257|NCT01604343|11717285|FG004|Treated|Week 52 to Week 104||470
10562258|NCT01604343|11717281|FG000|COMPLETED|Week 52 to Week 104||0
10562259|NCT01604343|11717282|FG001|COMPLETED|Week 52 to Week 104||200
10562260|NCT01604343|11717283|FG002|COMPLETED|Week 52 to Week 104||414
10562261|NCT01604343|11717284|FG003|COMPLETED|Week 52 to Week 104||195
10562262|NCT01604343|11717285|FG004|COMPLETED|Week 52 to Week 104||429
10562263|NCT01604343|11717281|FG000|NOT COMPLETED|Week 52 to Week 104||0
10562264|NCT01604343|11717282|FG001|NOT COMPLETED|Week 52 to Week 104||43
10562265|NCT01604343|11717283|FG002|NOT COMPLETED|Week 52 to Week 104||67
10562266|NCT01604343|11717284|FG003|NOT COMPLETED|Week 52 to Week 104||46
10562267|NCT01604343|11717285|FG004|NOT COMPLETED|Week 52 to Week 104||41
10562268|NCT01604343|11717281|FG000|STARTED|Safety Follow-up Period (Week 104-120)||109
10562269|NCT01604343|11717282|FG001|STARTED|Safety Follow-up Period (Week 104-120)||27
10562270|NCT01604343|11717283|FG002|STARTED|Safety Follow-up Period (Week 104-120)||105
10562271|NCT01604343|11717284|FG003|STARTED|Safety Follow-up Period (Week 104-120)||36
10562272|NCT01604343|11717285|FG004|STARTED|Safety Follow-up Period (Week 104-120)||114
10562273|NCT01604343|11717281|FG000|Safety Population|Safety Follow-up Period (Week 104-120)||109
10562274|NCT01604343|11717282|FG001|Safety Population|Safety Follow-up Period (Week 104-120)||26
10562275|NCT01604343|11717283|FG002|Safety Population|Safety Follow-up Period (Week 104-120)||105
10562276|NCT01604343|11717284|FG003|Safety Population|Safety Follow-up Period (Week 104-120)||36
10562277|NCT01604343|11717285|FG004|Safety Population|Safety Follow-up Period (Week 104-120)||114
10562278|NCT01604343|11717281|FG000|COMPLETED|Safety Follow-up Period (Week 104-120)||79
10562279|NCT01604343|11717282|FG001|COMPLETED|Safety Follow-up Period (Week 104-120)||20
10562280|NCT01604343|11717283|FG002|COMPLETED|Safety Follow-up Period (Week 104-120)||72
10562281|NCT01604343|11717284|FG003|COMPLETED|Safety Follow-up Period (Week 104-120)||26
10562282|NCT01604343|11717285|FG004|COMPLETED|Safety Follow-up Period (Week 104-120)||85
10562283|NCT01604343|11717281|FG000|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||30
10562284|NCT01604343|11717282|FG001|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||7
10562285|NCT01604343|11717283|FG002|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||33
10562286|NCT01604343|11717284|FG003|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||10
10562287|NCT01604343|11717285|FG004|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||29
10562288|NCT01604408|11717297|FG000|STARTED|Treatment Period 1||102
10562289|NCT01604408|11717298|FG001|STARTED|Treatment Period 1||99
10562290|NCT01604408|11717297|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||102
10562291|NCT01604408|11717298|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1||99
10562292|NCT01604408|11717297|FG000|COMPLETED|Treatment Period 1||102
10562293|NCT01604408|11717298|FG001|COMPLETED|Treatment Period 1||98
10791946|NCT03571724|11952778|FG002|NOT COMPLETED|Week -1 (Prior to Switching)||0
10562294|NCT01604408|11717297|FG000|NOT COMPLETED|Treatment Period 1||0
10562295|NCT01604408|11717298|FG001|NOT COMPLETED|Treatment Period 1||1
10562296|NCT01604408|11717297|FG000|STARTED|Treatment Period 2||102
10562297|NCT01604408|11717298|FG001|STARTED|Treatment Period 2||98
10562298|NCT01604408|11717297|FG000|COMPLETED|Treatment Period 2||100
10562299|NCT01604408|11717298|FG001|COMPLETED|Treatment Period 2||96
10562300|NCT01604408|11717297|FG000|NOT COMPLETED|Treatment Period 2||2
10562301|NCT01604408|11717298|FG001|NOT COMPLETED|Treatment Period 2||2
10562302|NCT01604408|11717297|FG000|STARTED|Treatment Period 3||100
10562303|NCT01604408|11717298|FG001|STARTED|Treatment Period 3||96
10562304|NCT01604408|11717297|FG000|COMPLETED|Treatment Period 3||95
10562305|NCT01604408|11717298|FG001|COMPLETED|Treatment Period 3||91
10562306|NCT01604408|11717297|FG000|NOT COMPLETED|Treatment Period 3||5
10562307|NCT01604408|11717298|FG001|NOT COMPLETED|Treatment Period 3||5
10562308|NCT01604408|11717297|FG000|STARTED|Treatment Period 4||95
10562309|NCT01604408|11717298|FG001|STARTED|Treatment Period 4||91
10562310|NCT01604408|11717297|FG000|COMPLETED|Treatment Period 4||92
10562311|NCT01604408|11717298|FG001|COMPLETED|Treatment Period 4||89
10562312|NCT01604408|11717297|FG000|NOT COMPLETED|Treatment Period 4||3
10562313|NCT01604408|11717298|FG001|NOT COMPLETED|Treatment Period 4||2
10562314|NCT01604408|11717297|FG000|STARTED|Treatment Period 5||92
10562315|NCT01604408|11717298|FG001|STARTED|Treatment Period 5||89
10562316|NCT01604408|11717297|FG000|COMPLETED|Treatment Period 5||88
10562317|NCT01604408|11717298|FG001|COMPLETED|Treatment Period 5||89
10562318|NCT01604408|11717297|FG000|NOT COMPLETED|Treatment Period 5||4
10562319|NCT01604408|11717298|FG001|NOT COMPLETED|Treatment Period 5||0
10562320|NCT01604408|11717297|FG000|STARTED|Treatment Period 6||88
10562321|NCT01604408|11717298|FG001|STARTED|Treatment Period 6||89
10562322|NCT01604408|11717297|FG000|COMPLETED|Treatment Period 6||86
10562323|NCT01604408|11717298|FG001|COMPLETED|Treatment Period 6||87
10562324|NCT01604408|11717297|FG000|NOT COMPLETED|Treatment Period 6||2
10562325|NCT01604408|11717298|FG001|NOT COMPLETED|Treatment Period 6||2
10562326|NCT01604408|11717297|FG000|STARTED|Observation Period||86
10562327|NCT01604408|11717298|FG001|STARTED|Observation Period||87
10562328|NCT01604408|11717297|FG000|COMPLETED|Observation Period||85
10562329|NCT01604408|11717298|FG001|COMPLETED|Observation Period||84
10562330|NCT01604408|11717297|FG000|NOT COMPLETED|Observation Period||1
10562331|NCT01604408|11717298|FG001|NOT COMPLETED|Observation Period||3
10562332|NCT01604772|11717304|FG000|STARTED|Overall Study||16
10562333|NCT01604772|11717304|FG000|COMPLETED|Overall Study||16
10562334|NCT01604772|11717304|FG000|NOT COMPLETED|Overall Study||0
10562335|NCT01604785|11717311|FG000|STARTED|Overall Study||37
10562336|NCT01604785|11717312|FG001|STARTED|Overall Study||37
10562337|NCT01604785|11717311|FG000|COMPLETED|Overall Study||30
10562338|NCT01604785|11717312|FG001|COMPLETED|Overall Study||36
10562339|NCT01604785|11717311|FG000|NOT COMPLETED|Overall Study||7
10562340|NCT01604785|11717312|FG001|NOT COMPLETED|Overall Study||1
10650958|NCT02173535|11811303|FG006|STARTED|Period 2||12
10650959|NCT02173535|11811304|FG007|STARTED|Period 2||12
10650960|NCT02173535|11811305|FG008|STARTED|Period 2||12
10650961|NCT02173535|11811306|FG009|STARTED|Period 2||12
10650962|NCT02173535|11811307|FG010|STARTED|Period 2||12
10650963|NCT02173535|11811308|FG011|STARTED|Period 2||12
10650964|NCT02173535|11811309|FG012|STARTED|Period 2||12
10318729|NCT00216320|11452959|FG002|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||5
10318730|NCT00216320|11452957|FG000|STARTED|Phase 2 (Weeks 6 -12)||43
10318731|NCT00216320|11452958|FG001|STARTED|Phase 2 (Weeks 6 -12)||35
10318732|NCT00216320|11452959|FG002|STARTED|Phase 2 (Weeks 6 -12)||25
10318733|NCT00216320|11452957|FG000|COMPLETED|Phase 2 (Weeks 6 -12)||38
10318734|NCT00216320|11452958|FG001|COMPLETED|Phase 2 (Weeks 6 -12)||31
10650965|NCT02173535|11811310|FG013|STARTED|Period 2||12
10650966|NCT02173535|11811311|FG014|STARTED|Period 2||12
10791947|NCT03571724|11952779|FG003|NOT COMPLETED|Week -1 (Prior to Switching)||0
10791948|NCT03571724|11952776|FG000|STARTED|Week 1-6|Non-menthol VLN subjects were assigned to this arm after randomization at week 1|50
10791949|NCT03571724|11952777|FG001|STARTED|Week 1-6|Menthol VLN subjects were assigned to this arm after randomization at week 1|50
10650967|NCT02173535|11811312|FG015|STARTED|Period 2||12
10650968|NCT02173535|11811313|FG016|STARTED|Period 2||12
10650969|NCT02173535|11811314|FG017|STARTED|Period 2||12
10650970|NCT02173535|11811315|FG018|STARTED|Period 2||12
10650971|NCT02173535|11811316|FG019|STARTED|Period 2||12
10650972|NCT02173535|11811297|FG000|COMPLETED|Period 2||12
10650973|NCT02173535|11811298|FG001|COMPLETED|Period 2||12
10650974|NCT02173535|11811299|FG002|COMPLETED|Period 2||12
10650975|NCT02173535|11811300|FG003|COMPLETED|Period 2||12
10650976|NCT02173535|11811301|FG004|COMPLETED|Period 2||12
10650977|NCT02173535|11811302|FG005|COMPLETED|Period 2||12
10650978|NCT02173535|11811303|FG006|COMPLETED|Period 2||12
10650979|NCT02173535|11811304|FG007|COMPLETED|Period 2||12
10650980|NCT02173535|11811305|FG008|COMPLETED|Period 2||12
10650981|NCT02173535|11811306|FG009|COMPLETED|Period 2||12
10650982|NCT02173535|11811307|FG010|COMPLETED|Period 2||12
10650983|NCT02173535|11811308|FG011|COMPLETED|Period 2||12
10650984|NCT02173535|11811309|FG012|COMPLETED|Period 2||12
10650985|NCT02173535|11811310|FG013|COMPLETED|Period 2||12
10318735|NCT00216320|11452959|FG002|COMPLETED|Phase 2 (Weeks 6 -12)||24
10650986|NCT02173535|11811311|FG014|COMPLETED|Period 2||12
10650987|NCT02173535|11811312|FG015|COMPLETED|Period 2||12
10650988|NCT02173535|11811313|FG016|COMPLETED|Period 2||12
10650989|NCT02173535|11811314|FG017|COMPLETED|Period 2||12
10650990|NCT02173535|11811315|FG018|COMPLETED|Period 2||12
10650991|NCT02173535|11811316|FG019|COMPLETED|Period 2||12
10562341|NCT01604824|11717322|FG000|STARTED|Double-blind (DB) Period||6
10562342|NCT01604824|11717323|FG001|STARTED|Double-blind (DB) Period||7
10562343|NCT01604824|11717324|FG002|STARTED|Double-blind (DB) Period||5
10562344|NCT01604824|11717325|FG003|STARTED|Double-blind (DB) Period||5
10562345|NCT01604824|11717326|FG004|STARTED|Double-blind (DB) Period||0
10562346|NCT01604824|11717327|FG005|STARTED|Double-blind (DB) Period||0
10562347|NCT01604824|11717322|FG000|Completed DB Period (Day 99)|Double-blind (DB) Period||6
10562348|NCT01604824|11717323|FG001|Completed DB Period (Day 99)|Double-blind (DB) Period||7
10562349|NCT01604824|11717324|FG002|Completed DB Period (Day 99)|Double-blind (DB) Period||5
10562350|NCT01604824|11717325|FG003|Completed DB Period (Day 99)|Double-blind (DB) Period||5
10562351|NCT01604824|11717326|FG004|Completed DB Period (Day 99)|Double-blind (DB) Period||0
10562352|NCT01604824|11717327|FG005|Completed DB Period (Day 99)|Double-blind (DB) Period||0
10562353|NCT01604824|11717322|FG000|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||6
10562354|NCT01604824|11717323|FG001|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||7
10562355|NCT01604824|11717324|FG002|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||5
10562356|NCT01604824|11717325|FG003|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||5
10562357|NCT01604824|11717326|FG004|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||0
10562358|NCT01604824|11717327|FG005|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||0
10562359|NCT01604824|11717322|FG000|COMPLETED|Double-blind (DB) Period||6
10562360|NCT01604824|11717323|FG001|COMPLETED|Double-blind (DB) Period||7
10562361|NCT01604824|11717324|FG002|COMPLETED|Double-blind (DB) Period||5
10562362|NCT01604824|11717325|FG003|COMPLETED|Double-blind (DB) Period||5
10562363|NCT01604824|11717326|FG004|COMPLETED|Double-blind (DB) Period||0
10562364|NCT01604824|11717327|FG005|COMPLETED|Double-blind (DB) Period||0
10562365|NCT01604824|11717322|FG000|NOT COMPLETED|Double-blind (DB) Period||0
10562366|NCT01604824|11717323|FG001|NOT COMPLETED|Double-blind (DB) Period||0
10562367|NCT01604824|11717324|FG002|NOT COMPLETED|Double-blind (DB) Period||0
10562368|NCT01604824|11717325|FG003|NOT COMPLETED|Double-blind (DB) Period||0
10562369|NCT01604824|11717326|FG004|NOT COMPLETED|Double-blind (DB) Period||0
10562370|NCT01604824|11717327|FG005|NOT COMPLETED|Double-blind (DB) Period||0
10562371|NCT01604824|11717322|FG000|STARTED|Open-label Extension (OLE) Period||0
10562372|NCT01604824|11717323|FG001|STARTED|Open-label Extension (OLE) Period||0
10562373|NCT01604824|11717324|FG002|STARTED|Open-label Extension (OLE) Period||0
10562374|NCT01604824|11717325|FG003|STARTED|Open-label Extension (OLE) Period||0
10562375|NCT01604824|11717326|FG004|STARTED|Open-label Extension (OLE) Period|Completed DB Period (Day 99)|13
10562376|NCT01604824|11717327|FG005|STARTED|Open-label Extension (OLE) Period|Completed DB follow-up (Day 155)|10
10562377|NCT01604824|11717322|FG000|Started Open-label Extension Period|Open-label Extension (OLE) Period||0
10562378|NCT01604824|11717323|FG001|Started Open-label Extension Period|Open-label Extension (OLE) Period||0
10562379|NCT01604824|11717324|FG002|Started Open-label Extension Period|Open-label Extension (OLE) Period||0
10562380|NCT01604824|11717325|FG003|Started Open-label Extension Period|Open-label Extension (OLE) Period||0
10562381|NCT01604824|11717326|FG004|Started Open-label Extension Period|Open-label Extension (OLE) Period|Two subjects chose not to enter OLE period|11
10562382|NCT01604824|11717327|FG005|Started Open-label Extension Period|Open-label Extension (OLE) Period||10
10562383|NCT01604824|11717322|FG000|Completed Study|Open-label Extension (OLE) Period||0
10562384|NCT01604824|11717323|FG001|Completed Study|Open-label Extension (OLE) Period||0
10562385|NCT01604824|11717324|FG002|Completed Study|Open-label Extension (OLE) Period||0
10562386|NCT01604824|11717325|FG003|Completed Study|Open-label Extension (OLE) Period||0
10562387|NCT01604824|11717326|FG004|Completed Study|Open-label Extension (OLE) Period||10
10562388|NCT01604824|11717327|FG005|Completed Study|Open-label Extension (OLE) Period||10
10562389|NCT01604824|11717322|FG000|COMPLETED|Open-label Extension (OLE) Period||0
10562390|NCT01604824|11717323|FG001|COMPLETED|Open-label Extension (OLE) Period||0
10562391|NCT01604824|11717324|FG002|COMPLETED|Open-label Extension (OLE) Period||0
10562392|NCT01604824|11717325|FG003|COMPLETED|Open-label Extension (OLE) Period||0
10562393|NCT01604824|11717326|FG004|COMPLETED|Open-label Extension (OLE) Period||10
10562394|NCT01604824|11717327|FG005|COMPLETED|Open-label Extension (OLE) Period||10
10562395|NCT01604824|11717322|FG000|NOT COMPLETED|Open-label Extension (OLE) Period||0
10562396|NCT01604824|11717323|FG001|NOT COMPLETED|Open-label Extension (OLE) Period||0
10562397|NCT01604824|11717324|FG002|NOT COMPLETED|Open-label Extension (OLE) Period||0
10562398|NCT01604824|11717325|FG003|NOT COMPLETED|Open-label Extension (OLE) Period||0
10562399|NCT01604824|11717326|FG004|NOT COMPLETED|Open-label Extension (OLE) Period||3
10562400|NCT01604824|11717327|FG005|NOT COMPLETED|Open-label Extension (OLE) Period||0
10562401|NCT01604850|11717341|FG000|STARTED|Overall Study||103
10562402|NCT01604850|11717342|FG001|STARTED|Overall Study||99
10562403|NCT01604850|11717341|FG000|Enrolled and Treated|Overall Study||103
10562404|NCT01604850|11717342|FG001|Enrolled and Treated|Overall Study||98
10562405|NCT01604850|11717341|FG000|COMPLETED|Overall Study||51
10562406|NCT01604850|11717342|FG001|COMPLETED|Overall Study||69
10562407|NCT01604850|11717341|FG000|NOT COMPLETED|Overall Study||52
10562408|NCT01604850|11717342|FG001|NOT COMPLETED|Overall Study||30
10562409|NCT01604941|11717350|FG000|STARTED|Overall Study||11
10562410|NCT01604941|11717351|FG001|STARTED|Overall Study||4
10562411|NCT01604941|11717352|FG002|STARTED|Overall Study||3
10562412|NCT01604941|11717353|FG003|STARTED|Overall Study||3
10562413|NCT01604941|11717354|FG004|STARTED|Overall Study||4
10562414|NCT01604941|11717355|FG005|STARTED|Overall Study||7
10562415|NCT01604941|11717350|FG000|COMPLETED|Overall Study||0
10562416|NCT01604941|11717351|FG001|COMPLETED|Overall Study||0
10562417|NCT01604941|11717352|FG002|COMPLETED|Overall Study||0
10562418|NCT01604941|11717353|FG003|COMPLETED|Overall Study||0
10562419|NCT01604941|11717354|FG004|COMPLETED|Overall Study||3
10562420|NCT01604941|11717355|FG005|COMPLETED|Overall Study||0
10562421|NCT01604941|11717350|FG000|NOT COMPLETED|Overall Study||11
10562422|NCT01604941|11717351|FG001|NOT COMPLETED|Overall Study||4
10562423|NCT01604941|11717352|FG002|NOT COMPLETED|Overall Study||3
10562424|NCT01604941|11717353|FG003|NOT COMPLETED|Overall Study||3
10562425|NCT01604941|11717354|FG004|NOT COMPLETED|Overall Study||1
10562426|NCT01604941|11717355|FG005|NOT COMPLETED|Overall Study||7
10562427|NCT01605032|11717361|FG000|STARTED|Overall Study||19
10562428|NCT01605032|11717361|FG000|COMPLETED|Overall Study||18
10562429|NCT01605032|11717361|FG000|NOT COMPLETED|Overall Study||1
10562430|NCT01605071|11717367|FG000|STARTED|Overall Study||27
10562431|NCT01605071|11717368|FG001|STARTED|Overall Study||26
10562432|NCT01605071|11717367|FG000|COMPLETED|Overall Study||24
10562433|NCT01605071|11717368|FG001|COMPLETED|Overall Study||24
10562434|NCT01605071|11717367|FG000|NOT COMPLETED|Overall Study||3
10562435|NCT01605071|11717368|FG001|NOT COMPLETED|Overall Study||2
10562436|NCT01605097|11717376|FG000|STARTED|Overall Study|One patient consented but was ineligible due to lack of lesion visible on mpMRI|26
10562437|NCT01605097|11717376|FG000|COMPLETED|Overall Study||25
10562438|NCT01605097|11717376|FG000|NOT COMPLETED|Overall Study||1
10562439|NCT01605136|11717383|FG000|STARTED|Study Period||48
10562440|NCT01605136|11717384|FG001|STARTED|Study Period||45
10562441|NCT01605136|11717383|FG000|COMPLETED|Study Period||45
10562442|NCT01605136|11717384|FG001|COMPLETED|Study Period||42
10562443|NCT01605136|11717383|FG000|NOT COMPLETED|Study Period||3
10562444|NCT01605136|11717384|FG001|NOT COMPLETED|Study Period||3
10562445|NCT01605136|11717383|FG000|STARTED|Safety Follow-Up Period||45
10562446|NCT01605136|11717384|FG001|STARTED|Safety Follow-Up Period||42
10562447|NCT01605136|11717383|FG000|COMPLETED|Safety Follow-Up Period||44
10562448|NCT01605136|11717384|FG001|COMPLETED|Safety Follow-Up Period||40
10562449|NCT01605136|11717383|FG000|NOT COMPLETED|Safety Follow-Up Period||1
10562450|NCT01605136|11717384|FG001|NOT COMPLETED|Safety Follow-Up Period||2
10562451|NCT01605227|11717392|FG000|STARTED|Overall Study||682
10562452|NCT01605227|11717393|FG001|STARTED|Overall Study||346
10562453|NCT01605227|11717392|FG000|COMPLETED|Overall Study||61
10562454|NCT01605227|11717393|FG001|COMPLETED|Overall Study||17
10562455|NCT01605227|11717392|FG000|NOT COMPLETED|Overall Study||621
10562456|NCT01605227|11717393|FG001|NOT COMPLETED|Overall Study||329
10562457|NCT01605292|11717401|FG000|STARTED|Overall Study||351
10562458|NCT01605292|11717402|FG001|STARTED|Overall Study||347
10791950|NCT03571724|11952778|FG002|STARTED|Week 1-6||22
10791951|NCT03571724|11952779|FG003|STARTED|Week 1-6||20
10791952|NCT03571724|11952776|FG000|COMPLETED|Week 1-6||43
10791953|NCT03571724|11952777|FG001|COMPLETED|Week 1-6||42
10791954|NCT03571724|11952778|FG002|COMPLETED|Week 1-6||19
10791955|NCT03571724|11952779|FG003|COMPLETED|Week 1-6||20
10791956|NCT03571724|11952776|FG000|NOT COMPLETED|Week 1-6||7
10791957|NCT03571724|11952777|FG001|NOT COMPLETED|Week 1-6||8
10791958|NCT03571724|11952778|FG002|NOT COMPLETED|Week 1-6||3
10791959|NCT03571724|11952779|FG003|NOT COMPLETED|Week 1-6||0
10791960|NCT03572062|11952810|FG000|STARTED|Overall Study||32
10791961|NCT03572062|11952811|FG001|STARTED|Overall Study||32
10791962|NCT03572062|11952812|FG002|STARTED|Overall Study||32
10791963|NCT03572062|11952813|FG003|STARTED|Overall Study||31
10791964|NCT03572062|11952814|FG004|STARTED|Overall Study||32
10791965|NCT03572062|11952815|FG005|STARTED|Overall Study||32
10791966|NCT03572062|11952816|FG006|STARTED|Overall Study||32
10791967|NCT03572062|11952817|FG007|STARTED|Overall Study||31
10791968|NCT03572062|11952818|FG008|STARTED|Overall Study||32
10791969|NCT03572062|11952819|FG009|STARTED|Overall Study||31
10791970|NCT03572062|11952810|FG000|Treated|Overall Study||32
10791971|NCT03572062|11952811|FG001|Treated|Overall Study||32
10791972|NCT03572062|11952812|FG002|Treated|Overall Study||32
10791973|NCT03572062|11952813|FG003|Treated|Overall Study||31
10791974|NCT03572062|11952814|FG004|Treated|Overall Study||31
10791975|NCT03572062|11952815|FG005|Treated|Overall Study||30
10791976|NCT03572062|11952816|FG006|Treated|Overall Study||32
10791977|NCT03572062|11952817|FG007|Treated|Overall Study||30
10791978|NCT03572062|11952818|FG008|Treated|Overall Study||32
10562459|NCT01605292|11717401|FG000|COMPLETED|Overall Study||351
10562460|NCT01605292|11717402|FG001|COMPLETED|Overall Study||347
10562461|NCT01605292|11717401|FG000|NOT COMPLETED|Overall Study||0
10562462|NCT01605292|11717402|FG001|NOT COMPLETED|Overall Study||0
10562463|NCT01605396|11717410|FG000|STARTED|Overall Study||40
10562464|NCT01605396|11717411|FG001|STARTED|Overall Study||40
10562465|NCT01605396|11717410|FG000|Treated|Overall Study||39
10562466|NCT01605396|11717411|FG001|Treated|Overall Study||40
10562467|NCT01605396|11717410|FG000|COMPLETED|Overall Study||0
10562468|NCT01605396|11717411|FG001|COMPLETED|Overall Study||0
10562469|NCT01605396|11717410|FG000|NOT COMPLETED|Overall Study||40
10791979|NCT03572062|11952819|FG009|Treated|Overall Study||31
10791980|NCT03572062|11952810|FG000|COMPLETED|Overall Study||32
10791981|NCT03572062|11952811|FG001|COMPLETED|Overall Study||32
10791982|NCT03572062|11952812|FG002|COMPLETED|Overall Study||32
10791983|NCT03572062|11952813|FG003|COMPLETED|Overall Study||31
10791984|NCT03572062|11952814|FG004|COMPLETED|Overall Study||31
10791985|NCT03572062|11952815|FG005|COMPLETED|Overall Study||28
10791986|NCT03572062|11952816|FG006|COMPLETED|Overall Study||31
10791987|NCT03572062|11952817|FG007|COMPLETED|Overall Study||30
10791988|NCT03572062|11952818|FG008|COMPLETED|Overall Study||0
10791989|NCT03572062|11952819|FG009|COMPLETED|Overall Study||0
10562470|NCT01605396|11717411|FG001|NOT COMPLETED|Overall Study||40
10562471|NCT01605435|11717417|FG000|STARTED|Overall Study||2
10562472|NCT01605435|11717418|FG001|STARTED|Overall Study||3
10562473|NCT01605435|11717417|FG000|COMPLETED|Overall Study||2
10562474|NCT01605435|11717418|FG001|COMPLETED|Overall Study||3
10562475|NCT01605435|11717417|FG000|NOT COMPLETED|Overall Study||0
10562476|NCT01605435|11717418|FG001|NOT COMPLETED|Overall Study||0
10562477|NCT01605461|11717435|FG000|STARTED|Overall Study||12
10562478|NCT01605461|11717435|FG000|COMPLETED|Overall Study||8
10562479|NCT01605461|11717435|FG000|NOT COMPLETED|Overall Study||4
10562480|NCT01605539|11717441|FG000|STARTED|Overall Study||3
10562481|NCT01605539|11717442|FG001|STARTED|Overall Study||3
10562482|NCT01605539|11717443|FG002|STARTED|Overall Study||4
10562483|NCT01605539|11717441|FG000|COMPLETED|Overall Study||3
10562484|NCT01605539|11717442|FG001|COMPLETED|Overall Study||2
10562485|NCT01605539|11717443|FG002|COMPLETED|Overall Study||4
10562486|NCT01605539|11717441|FG000|NOT COMPLETED|Overall Study||0
10562487|NCT01605539|11717442|FG001|NOT COMPLETED|Overall Study||1
10562488|NCT01605539|11717443|FG002|NOT COMPLETED|Overall Study||0
10562489|NCT01605552|11717454|FG000|STARTED|Overall Study||13
10562490|NCT01605552|11717455|FG001|STARTED|Overall Study||16
10562491|NCT01605552|11717454|FG000|COMPLETED|Overall Study|4 dropped out before the first BtB visit; it is unlikely that the treatment was the cause of dropout|7
10562492|NCT01605552|11717455|FG001|COMPLETED|Overall Study||14
10562493|NCT01605552|11717454|FG000|NOT COMPLETED|Overall Study||6
10562494|NCT01605552|11717455|FG001|NOT COMPLETED|Overall Study||2
10562495|NCT01605669|11717461|FG000|STARTED|Overall Study||50
10562496|NCT01605669|11717461|FG000|COMPLETED|Overall Study||50
10562497|NCT01605669|11717461|FG000|NOT COMPLETED|Overall Study||0
10562498|NCT01605799|11717468|FG000|STARTED|Overall Study||17
10562499|NCT01605799|11717469|FG001|STARTED|Overall Study||16
10562500|NCT01605799|11717468|FG000|COMPLETED|Overall Study||15
10562501|NCT01605799|11717469|FG001|COMPLETED|Overall Study||15
10562502|NCT01605799|11717468|FG000|NOT COMPLETED|Overall Study||2
10562503|NCT01605799|11717469|FG001|NOT COMPLETED|Overall Study||1
10791990|NCT03572062|11952810|FG000|NOT COMPLETED|Overall Study||0
10791991|NCT03572062|11952811|FG001|NOT COMPLETED|Overall Study||0
10791992|NCT03572062|11952812|FG002|NOT COMPLETED|Overall Study||0
10791993|NCT03572062|11952813|FG003|NOT COMPLETED|Overall Study||0
10791994|NCT03572062|11952814|FG004|NOT COMPLETED|Overall Study||1
10791995|NCT03572062|11952815|FG005|NOT COMPLETED|Overall Study||4
10791996|NCT03572062|11952816|FG006|NOT COMPLETED|Overall Study||1
10791997|NCT03572062|11952817|FG007|NOT COMPLETED|Overall Study||1
10791998|NCT03572062|11952818|FG008|NOT COMPLETED|Overall Study||32
10791999|NCT03572062|11952819|FG009|NOT COMPLETED|Overall Study||31
10792000|NCT03572218|11952841|FG000|STARTED|Overall Study||36
10792001|NCT03572218|11952842|FG001|STARTED|Overall Study||36
10792002|NCT03572218|11952841|FG000|Week 12|Overall Study||30
10792003|NCT03572218|11952842|FG001|Week 12|Overall Study||31
10792004|NCT03572218|11952841|FG000|Week 26|Overall Study||30
10792005|NCT03572218|11952842|FG001|Week 26|Overall Study||31
10792006|NCT03572218|11952841|FG000|COMPLETED|Overall Study||30
10792007|NCT03572218|11952842|FG001|COMPLETED|Overall Study||31
10792008|NCT03572218|11952841|FG000|NOT COMPLETED|Overall Study||6
10792009|NCT03572218|11952842|FG001|NOT COMPLETED|Overall Study||5
10792010|NCT03572478|11952848|FG000|STARTED|Overall Study||12
10792011|NCT03572478|11952848|FG000|COMPLETED|Overall Study||12
10792012|NCT03572478|11952848|FG000|NOT COMPLETED|Overall Study||0
10792013|NCT03572972|11952857|FG000|STARTED|Overall Study||10548
10792014|NCT03572972|11952858|FG001|STARTED|Overall Study||11414
10792015|NCT03572972|11952859|FG002|STARTED|Overall Study||17779
10792016|NCT03572972|11952860|FG003|STARTED|Overall Study||8648
10792017|NCT03572972|11952861|FG004|STARTED|Overall Study||16295
10792018|NCT03572972|11952857|FG000|COMPLETED|Overall Study||10548
10792019|NCT03572972|11952858|FG001|COMPLETED|Overall Study||11414
10792020|NCT03572972|11952859|FG002|COMPLETED|Overall Study||17779
10792021|NCT03572972|11952860|FG003|COMPLETED|Overall Study||8648
10792022|NCT03572972|11952861|FG004|COMPLETED|Overall Study||16295
10562504|NCT01605825|11717477|FG000|STARTED|Overall Study||55
10562505|NCT01605825|11717478|FG001|STARTED|Overall Study||28
10562506|NCT01605825|11717477|FG000|COMPLETED|Overall Study||45
10562507|NCT01605825|11717478|FG001|COMPLETED|Overall Study||25
10562508|NCT01605825|11717477|FG000|NOT COMPLETED|Overall Study||10
10562509|NCT01605825|11717478|FG001|NOT COMPLETED|Overall Study||3
10562510|NCT01605877|11717484|FG000|STARTED|Overall Study||64
10562511|NCT01605877|11717484|FG000|COMPLETED|Overall Study||63
10562512|NCT01605877|11717484|FG000|NOT COMPLETED|Overall Study||1
10562513|NCT01605890|11717506|FG000|STARTED|Overall Study||30
10562514|NCT01605890|11717506|FG000|COMPLETED|Overall Study||28
10562515|NCT01605890|11717506|FG000|NOT COMPLETED|Overall Study||2
10562516|NCT01605903|11717512|FG000|STARTED|Overall Study||345
10792023|NCT03572972|11952857|FG000|NOT COMPLETED|Overall Study||0
10792024|NCT03572972|11952858|FG001|NOT COMPLETED|Overall Study||0
10792025|NCT03572972|11952859|FG002|NOT COMPLETED|Overall Study||0
10792026|NCT03572972|11952860|FG003|NOT COMPLETED|Overall Study||0
10792027|NCT03572972|11952861|FG004|NOT COMPLETED|Overall Study||0
10792028|NCT03573206|11952881|FG000|STARTED|Overall Study||168
10792029|NCT03573206|11952881|FG000|COMPLETED|Overall Study||168
10792030|NCT03573206|11952881|FG000|NOT COMPLETED|Overall Study||0
10792031|NCT03573323|11952887|FG000|STARTED|Blinded Treatment Period (Weeks 0-24)||520
10792032|NCT03573323|11952888|FG001|STARTED|Blinded Treatment Period (Weeks 0-24)||507
10562517|NCT01605903|11717513|FG001|STARTED|Overall Study||343
10562518|NCT01605903|11717512|FG000|COMPLETED|Overall Study||345
10562519|NCT01605903|11717513|FG001|COMPLETED|Overall Study||343
10562520|NCT01605903|11717512|FG000|NOT COMPLETED|Overall Study||0
10562521|NCT01605903|11717513|FG001|NOT COMPLETED|Overall Study||0
10562522|NCT01605916|11717524|FG000|STARTED|Overall Study||4
10562523|NCT01605916|11717525|FG001|STARTED|Overall Study||4
10562524|NCT01605916|11717526|FG002|STARTED|Overall Study||4
10562525|NCT01605916|11717527|FG003|STARTED|Overall Study||6
10562526|NCT01605916|11717528|FG004|STARTED|Overall Study||7
10562527|NCT01605916|11717524|FG000|COMPLETED|Overall Study||0
10562528|NCT01605916|11717525|FG001|COMPLETED|Overall Study||0
10562529|NCT01605916|11717526|FG002|COMPLETED|Overall Study|Subject ongoing the study at data cut off|1
10562530|NCT01605916|11717527|FG003|COMPLETED|Overall Study||0
10562531|NCT01605916|11717528|FG004|COMPLETED|Overall Study|Subject ongoing the study at data cut off|1
10562532|NCT01605916|11717524|FG000|NOT COMPLETED|Overall Study||4
10562533|NCT01605916|11717525|FG001|NOT COMPLETED|Overall Study||4
10562534|NCT01605916|11717526|FG002|NOT COMPLETED|Overall Study||3
10562535|NCT01605916|11717527|FG003|NOT COMPLETED|Overall Study||6
10562536|NCT01605916|11717528|FG004|NOT COMPLETED|Overall Study||6
10562537|NCT01605942|11717543|FG000|STARTED|Overall Study||6
10562538|NCT01605942|11717544|FG001|STARTED|Overall Study||2
10562539|NCT01605942|11717543|FG000|COMPLETED|Overall Study||6
10562540|NCT01605942|11717544|FG001|COMPLETED|Overall Study||2
10562541|NCT01605942|11717543|FG000|NOT COMPLETED|Overall Study||0
10562542|NCT01605942|11717544|FG001|NOT COMPLETED|Overall Study||0
10562543|NCT01606007|11717553|FG000|STARTED|Overall Study||176
10562544|NCT01606007|11717554|FG001|STARTED|Overall Study||179
10562545|NCT01606007|11717555|FG002|STARTED|Overall Study||179
10562546|NCT01606007|11717553|FG000|COMPLETED|Overall Study||161
10562547|NCT01606007|11717554|FG001|COMPLETED|Overall Study||160
10562548|NCT01606007|11717555|FG002|COMPLETED|Overall Study||169
10562549|NCT01606007|11717553|FG000|NOT COMPLETED|Overall Study||15
10562550|NCT01606007|11717554|FG001|NOT COMPLETED|Overall Study||19
10562551|NCT01606007|11717555|FG002|NOT COMPLETED|Overall Study||10
10562552|NCT01606124|11717565|FG000|STARTED|Overall Study||19
10562553|NCT01606124|11717566|FG001|STARTED|Overall Study||20
10562554|NCT01606124|11717565|FG000|COMPLETED|Overall Study||19
10562555|NCT01606124|11717566|FG001|COMPLETED|Overall Study||20
10562556|NCT01606124|11717565|FG000|NOT COMPLETED|Overall Study||0
10562557|NCT01606124|11717566|FG001|NOT COMPLETED|Overall Study||0
10562558|NCT01606137|11717572|FG000|STARTED|Overall Study||507
10562559|NCT01606137|11717572|FG000|COMPLETED|Overall Study||245
10562560|NCT01606137|11717572|FG000|NOT COMPLETED|Overall Study||262
10562561|NCT01606176|11717578|FG000|STARTED|Overall Study||36
10562562|NCT01606176|11717579|FG001|STARTED|Overall Study||34
10562563|NCT01606176|11717578|FG000|COMPLETED|Overall Study||32
10562564|NCT01606176|11717579|FG001|COMPLETED|Overall Study||31
10562565|NCT01606176|11717578|FG000|NOT COMPLETED|Overall Study||4
10562566|NCT01606176|11717579|FG001|NOT COMPLETED|Overall Study||3
10562567|NCT01606189|11717585|FG000|STARTED|First Intenvention (14-20 Days)||8
10792033|NCT03573323|11952887|FG000|Received at Least One Dose of Study Drug|Blinded Treatment Period (Weeks 0-24)||519
10792034|NCT03573323|11952888|FG001|Received at Least One Dose of Study Drug|Blinded Treatment Period (Weeks 0-24)||506
10792035|NCT03573323|11952887|FG000|COMPLETED|Blinded Treatment Period (Weeks 0-24)||465
10792036|NCT03573323|11952888|FG001|COMPLETED|Blinded Treatment Period (Weeks 0-24)||459
10792037|NCT03573323|11952887|FG000|NOT COMPLETED|Blinded Treatment Period (Weeks 0-24)||55
10792038|NCT03573323|11952888|FG001|NOT COMPLETED|Blinded Treatment Period (Weeks 0-24)||48
10792039|NCT03573323|11952887|FG000|STARTED|Post-Treatment Follow Up (Weeks 25-36)||465
10562568|NCT01606189|11717586|FG001|STARTED|First Intenvention (14-20 Days)||8
10562569|NCT01606189|11717587|FG002|STARTED|First Intenvention (14-20 Days)||8
10562570|NCT01606189|11717588|FG003|STARTED|First Intenvention (14-20 Days)||8
10562571|NCT01606189|11717589|FG004|STARTED|First Intenvention (14-20 Days)||8
10562572|NCT01606189|11717590|FG005|STARTED|First Intenvention (14-20 Days)||8
10562573|NCT01606189|11717585|FG000|COMPLETED|First Intenvention (14-20 Days)||8
10562574|NCT01606189|11717586|FG001|COMPLETED|First Intenvention (14-20 Days)||8
10562575|NCT01606189|11717587|FG002|COMPLETED|First Intenvention (14-20 Days)||8
10562576|NCT01606189|11717588|FG003|COMPLETED|First Intenvention (14-20 Days)||8
10562577|NCT01606189|11717589|FG004|COMPLETED|First Intenvention (14-20 Days)||8
10562578|NCT01606189|11717590|FG005|COMPLETED|First Intenvention (14-20 Days)||8
10562579|NCT01606189|11717585|FG000|NOT COMPLETED|First Intenvention (14-20 Days)||0
10562580|NCT01606189|11717586|FG001|NOT COMPLETED|First Intenvention (14-20 Days)||0
10562581|NCT01606189|11717587|FG002|NOT COMPLETED|First Intenvention (14-20 Days)||0
10562582|NCT01606189|11717588|FG003|NOT COMPLETED|First Intenvention (14-20 Days)||0
10562583|NCT01606189|11717589|FG004|NOT COMPLETED|First Intenvention (14-20 Days)||0
10562584|NCT01606189|11717590|FG005|NOT COMPLETED|First Intenvention (14-20 Days)||0
10562585|NCT01606189|11717585|FG000|STARTED|Second Intenvention (14-20 Days)||8
10562586|NCT01606189|11717586|FG001|STARTED|Second Intenvention (14-20 Days)||8
10562587|NCT01606189|11717587|FG002|STARTED|Second Intenvention (14-20 Days)||8
10562588|NCT01606189|11717588|FG003|STARTED|Second Intenvention (14-20 Days)||8
10562589|NCT01606189|11717589|FG004|STARTED|Second Intenvention (14-20 Days)||8
10562590|NCT01606189|11717590|FG005|STARTED|Second Intenvention (14-20 Days)||8
10562591|NCT01606189|11717585|FG000|COMPLETED|Second Intenvention (14-20 Days)||8
10562592|NCT01606189|11717586|FG001|COMPLETED|Second Intenvention (14-20 Days)||8
10792040|NCT03573323|11952888|FG001|STARTED|Post-Treatment Follow Up (Weeks 25-36)|Excludes participants who completed treatment and did not enter the PTFU.|456
10562593|NCT01606189|11717587|FG002|COMPLETED|Second Intenvention (14-20 Days)||8
10562594|NCT01606189|11717588|FG003|COMPLETED|Second Intenvention (14-20 Days)||8
10562595|NCT01606189|11717589|FG004|COMPLETED|Second Intenvention (14-20 Days)||8
10562596|NCT01606189|11717590|FG005|COMPLETED|Second Intenvention (14-20 Days)||7
10562597|NCT01606189|11717585|FG000|NOT COMPLETED|Second Intenvention (14-20 Days)||0
10562598|NCT01606189|11717586|FG001|NOT COMPLETED|Second Intenvention (14-20 Days)||0
10562599|NCT01606189|11717587|FG002|NOT COMPLETED|Second Intenvention (14-20 Days)||0
10562600|NCT01606189|11717588|FG003|NOT COMPLETED|Second Intenvention (14-20 Days)||0
10562601|NCT01606189|11717589|FG004|NOT COMPLETED|Second Intenvention (14-20 Days)||0
10562602|NCT01606189|11717590|FG005|NOT COMPLETED|Second Intenvention (14-20 Days)||1
10562603|NCT01606189|11717585|FG000|STARTED|Third Intenvention (14-20 Days)||8
10562604|NCT01606189|11717586|FG001|STARTED|Third Intenvention (14-20 Days)||8
10562605|NCT01606189|11717587|FG002|STARTED|Third Intenvention (14-20 Days)||8
10562606|NCT01606189|11717588|FG003|STARTED|Third Intenvention (14-20 Days)||8
10562607|NCT01606189|11717589|FG004|STARTED|Third Intenvention (14-20 Days)||8
10562608|NCT01606189|11717590|FG005|STARTED|Third Intenvention (14-20 Days)||7
10562609|NCT01606189|11717585|FG000|COMPLETED|Third Intenvention (14-20 Days)||8
10562610|NCT01606189|11717586|FG001|COMPLETED|Third Intenvention (14-20 Days)||8
10562611|NCT01606189|11717587|FG002|COMPLETED|Third Intenvention (14-20 Days)||8
10562612|NCT01606189|11717588|FG003|COMPLETED|Third Intenvention (14-20 Days)||8
10562613|NCT01606189|11717589|FG004|COMPLETED|Third Intenvention (14-20 Days)||8
10562614|NCT01606189|11717590|FG005|COMPLETED|Third Intenvention (14-20 Days)||6
10562615|NCT01606189|11717585|FG000|NOT COMPLETED|Third Intenvention (14-20 Days)||0
10562616|NCT01606189|11717586|FG001|NOT COMPLETED|Third Intenvention (14-20 Days)||0
10562617|NCT01606189|11717587|FG002|NOT COMPLETED|Third Intenvention (14-20 Days)||0
10562618|NCT01606189|11717588|FG003|NOT COMPLETED|Third Intenvention (14-20 Days)||0
10562619|NCT01606189|11717589|FG004|NOT COMPLETED|Third Intenvention (14-20 Days)||0
10562620|NCT01606189|11717590|FG005|NOT COMPLETED|Third Intenvention (14-20 Days)||1
10562621|NCT01606202|11717600|FG000|STARTED|Overall Study||56
10562622|NCT01606202|11717601|FG001|STARTED|Overall Study||60
10562623|NCT01606202|11717600|FG000|COMPLETED|Overall Study||49
10562624|NCT01606202|11717601|FG001|COMPLETED|Overall Study||57
10562625|NCT01606202|11717600|FG000|NOT COMPLETED|Overall Study||7
10562626|NCT01606202|11717601|FG001|NOT COMPLETED|Overall Study||3
10562627|NCT01606228|11717607|FG000|STARTED|Overall Study||188
10562628|NCT01606228|11717607|FG000|COMPLETED|Overall Study||159
10562629|NCT01606228|11717607|FG000|NOT COMPLETED|Overall Study||29
10562630|NCT01606254|11717615|FG000|STARTED|Overall Study||14
10562631|NCT01606254|11717616|FG001|STARTED|Overall Study||14
10562632|NCT01606254|11717617|FG002|STARTED|Overall Study||14
10562633|NCT01606254|11717618|FG003|STARTED|Overall Study||14
10562634|NCT01606254|11717615|FG000|COMPLETED|Overall Study||12
10562635|NCT01606254|11717616|FG001|COMPLETED|Overall Study||10
10562636|NCT01606254|11717617|FG002|COMPLETED|Overall Study||14
10562637|NCT01606254|11717618|FG003|COMPLETED|Overall Study||11
10562638|NCT01606254|11717615|FG000|NOT COMPLETED|Overall Study||2
10562639|NCT01606254|11717616|FG001|NOT COMPLETED|Overall Study||4
10562640|NCT01606254|11717617|FG002|NOT COMPLETED|Overall Study||0
10562641|NCT01606254|11717618|FG003|NOT COMPLETED|Overall Study||3
10562642|NCT01606306|11717634|FG000|STARTED|Overall Study||50
10562643|NCT01606306|11717635|FG001|STARTED|Overall Study||49
10562644|NCT01606306|11717636|FG002|STARTED|Overall Study||51
10562645|NCT01606306|11717637|FG003|STARTED|Overall Study||51
10562646|NCT01606306|11717638|FG004|STARTED|Overall Study||52
10562647|NCT01606306|11717639|FG005|STARTED|Overall Study||47
10562648|NCT01606306|11717634|FG000|Completed First Treatment Period|Overall Study||43
10562649|NCT01606306|11717635|FG001|Completed First Treatment Period|Overall Study||47
10562650|NCT01606306|11717636|FG002|Completed First Treatment Period|Overall Study||47
10562651|NCT01606306|11717637|FG003|Completed First Treatment Period|Overall Study||45
10562652|NCT01606306|11717638|FG004|Completed First Treatment Period|Overall Study||47
10562653|NCT01606306|11717639|FG005|Completed First Treatment Period|Overall Study||44
10562654|NCT01606306|11717634|FG000|Completed Second Treatment Period|Overall Study||41
10562655|NCT01606306|11717635|FG001|Completed Second Treatment Period|Overall Study||38
10562656|NCT01606306|11717636|FG002|Completed Second Treatment Period|Overall Study||43
10562657|NCT01606306|11717637|FG003|Completed Second Treatment Period|Overall Study||44
10562658|NCT01606306|11717638|FG004|Completed Second Treatment Period|Overall Study||46
10562659|NCT01606306|11717639|FG005|Completed Second Treatment Period|Overall Study||41
10562660|NCT01606306|11717634|FG000|Completed Third Treatment Period|Overall Study||35
10562661|NCT01606306|11717635|FG001|Completed Third Treatment Period|Overall Study||39
10562662|NCT01606306|11717636|FG002|Completed Third Treatment Period|Overall Study||37
10562663|NCT01606306|11717637|FG003|Completed Third Treatment Period|Overall Study||38
10562664|NCT01606306|11717638|FG004|Completed Third Treatment Period|Overall Study||41
10562665|NCT01606306|11717639|FG005|Completed Third Treatment Period|Overall Study||36
10562666|NCT01606306|11717634|FG000|COMPLETED|Overall Study||35
10562667|NCT01606306|11717635|FG001|COMPLETED|Overall Study||39
10562668|NCT01606306|11717636|FG002|COMPLETED|Overall Study||37
10562669|NCT01606306|11717637|FG003|COMPLETED|Overall Study||38
10562670|NCT01606306|11717638|FG004|COMPLETED|Overall Study||41
10562671|NCT01606306|11717639|FG005|COMPLETED|Overall Study||36
10562672|NCT01606306|11717634|FG000|NOT COMPLETED|Overall Study||15
10562673|NCT01606306|11717635|FG001|NOT COMPLETED|Overall Study||10
10562674|NCT01606306|11717636|FG002|NOT COMPLETED|Overall Study||14
10562675|NCT01606306|11717637|FG003|NOT COMPLETED|Overall Study||13
10562676|NCT01606306|11717638|FG004|NOT COMPLETED|Overall Study||11
10562677|NCT01606306|11717639|FG005|NOT COMPLETED|Overall Study||11
10562678|NCT01606319|11717647|FG000|STARTED|Overall Study||150
10562679|NCT01606319|11717648|FG001|STARTED|Overall Study||150
10562680|NCT01606319|11717647|FG000|COMPLETED|Overall Study||116
10562681|NCT01606319|11717648|FG001|COMPLETED|Overall Study||110
10562682|NCT01606319|11717647|FG000|NOT COMPLETED|Overall Study||34
10562683|NCT01606319|11717648|FG001|NOT COMPLETED|Overall Study||40
10562684|NCT01606670|11717654|FG000|STARTED|Overall Study||93
10562685|NCT01606670|11717654|FG000|Safety Set|Overall Study||93
10562686|NCT01606670|11717654|FG000|Full Analysis Set|Overall Study||70
10562687|NCT01606670|11717654|FG000|COMPLETED|Overall Study||77
10562688|NCT01606670|11717654|FG000|NOT COMPLETED|Overall Study||16
10562689|NCT01606735|11717661|FG000|STARTED|Overall Study||58
10562690|NCT01606735|11717662|FG001|STARTED|Overall Study||56
10562691|NCT01606735|11717663|FG002|STARTED|Overall Study||58
10562692|NCT01606735|11717661|FG000|COMPLETED|Overall Study||58
10562693|NCT01606735|11717662|FG001|COMPLETED|Overall Study||56
10562694|NCT01606735|11717663|FG002|COMPLETED|Overall Study||58
10562695|NCT01606735|11717661|FG000|NOT COMPLETED|Overall Study||0
10562696|NCT01606735|11717662|FG001|NOT COMPLETED|Overall Study||0
10792041|NCT03573323|11952887|FG000|COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||406
10792042|NCT03573323|11952888|FG001|COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||399
10792043|NCT03573323|11952887|FG000|NOT COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||59
10792044|NCT03573323|11952888|FG001|NOT COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||57
10792045|NCT03573505|11952900|FG000|STARTED|Overall Study||52
10792046|NCT03573505|11952901|FG001|STARTED|Overall Study||54
10792047|NCT03573505|11952900|FG000|COMPLETED|Overall Study||0
10562697|NCT01606735|11717663|FG002|NOT COMPLETED|Overall Study||0
10562698|NCT01606748|11717673|FG000|STARTED|Overall Study||18
10562699|NCT01606748|11717674|FG001|STARTED|Overall Study||17
10562700|NCT01606748|11717673|FG000|Received at Least 1 Dose of Study Drug|Overall Study||18
10562701|NCT01606748|11717674|FG001|Received at Least 1 Dose of Study Drug|Overall Study||17
10562702|NCT01606748|11717673|FG000|COMPLETED|Overall Study||15
10562703|NCT01606748|11717674|FG001|COMPLETED|Overall Study||17
10562704|NCT01606748|11717673|FG000|NOT COMPLETED|Overall Study||3
10562705|NCT01606748|11717674|FG001|NOT COMPLETED|Overall Study||0
10562706|NCT01606761|11717695|FG000|STARTED|Prior to Week 24||294
10562707|NCT01606761|11717696|FG001|STARTED|Prior to Week 24||292
10562708|NCT01606761|11717697|FG002|STARTED|Prior to Week 24||292
10562709|NCT01606761|11717698|FG003|STARTED|Prior to Week 24||0
10562710|NCT01606761|11717699|FG004|STARTED|Prior to Week 24||0
10562711|NCT01606761|11717695|FG000|Participants Re-randomized at Week 18|Prior to Week 24|Out of 94, 46 were re-randomized to sirukumab 50 mg and 48 were re-randomized to 100 mg group.|94
10562712|NCT01606761|11717696|FG001|Participants Re-randomized at Week 18|Prior to Week 24||0
10562713|NCT01606761|11717697|FG002|Participants Re-randomized at Week 18|Prior to Week 24||0
10562714|NCT01606761|11717698|FG003|Participants Re-randomized at Week 18|Prior to Week 24||0
10562715|NCT01606761|11717699|FG004|Participants Re-randomized at Week 18|Prior to Week 24||0
10562716|NCT01606761|11717695|FG000|COMPLETED|Prior to Week 24||252
10562717|NCT01606761|11717696|FG001|COMPLETED|Prior to Week 24||237
10562718|NCT01606761|11717697|FG002|COMPLETED|Prior to Week 24||245
10562719|NCT01606761|11717698|FG003|COMPLETED|Prior to Week 24||0
10562720|NCT01606761|11717699|FG004|COMPLETED|Prior to Week 24||0
10562721|NCT01606761|11717695|FG000|NOT COMPLETED|Prior to Week 24||42
10562722|NCT01606761|11717696|FG001|NOT COMPLETED|Prior to Week 24||55
10562723|NCT01606761|11717697|FG002|NOT COMPLETED|Prior to Week 24||47
10562724|NCT01606761|11717698|FG003|NOT COMPLETED|Prior to Week 24||0
10562725|NCT01606761|11717699|FG004|NOT COMPLETED|Prior to Week 24||0
10562726|NCT01606761|11717695|FG000|STARTED|Week 24 to Week 52||0
10562727|NCT01606761|11717696|FG001|STARTED|Week 24 to Week 52||237
10562728|NCT01606761|11717697|FG002|STARTED|Week 24 to Week 52||245
10562729|NCT01606761|11717698|FG003|STARTED|Week 24 to Week 52|Participants re-randomized at Week 18 (46) and Week 24 (80) were included.|126
10562730|NCT01606761|11717699|FG004|STARTED|Week 24 to Week 52|Participants re-randomized at Week 18 (48) and Week 24 (78) were included.|126
10562731|NCT01606761|11717695|FG000|Treated|Week 24 to Week 52||0
10562732|NCT01606761|11717696|FG001|Treated|Week 24 to Week 52||237
10562733|NCT01606761|11717697|FG002|Treated|Week 24 to Week 52||245
10562734|NCT01606761|11717698|FG003|Treated|Week 24 to Week 52||124
10562735|NCT01606761|11717699|FG004|Treated|Week 24 to Week 52||126
10562736|NCT01606761|11717695|FG000|COMPLETED|Week 24 to Week 52||0
10562737|NCT01606761|11717696|FG001|COMPLETED|Week 24 to Week 52||204
10562738|NCT01606761|11717697|FG002|COMPLETED|Week 24 to Week 52||212
10562739|NCT01606761|11717698|FG003|COMPLETED|Week 24 to Week 52||109
10562740|NCT01606761|11717699|FG004|COMPLETED|Week 24 to Week 52||106
10562741|NCT01606761|11717695|FG000|NOT COMPLETED|Week 24 to Week 52||0
10562742|NCT01606761|11717696|FG001|NOT COMPLETED|Week 24 to Week 52||33
10562743|NCT01606761|11717697|FG002|NOT COMPLETED|Week 24 to Week 52||33
10562744|NCT01606761|11717698|FG003|NOT COMPLETED|Week 24 to Week 52||17
10562745|NCT01606761|11717699|FG004|NOT COMPLETED|Week 24 to Week 52||20
10562746|NCT01606761|11717695|FG000|STARTED|Safety Follow-up Period (Week 52-68)||28
10562747|NCT01606761|11717696|FG001|STARTED|Safety Follow-up Period (Week 52-68)||65
10562748|NCT01606761|11717697|FG002|STARTED|Safety Follow-up Period (Week 52-68)||62
10562749|NCT01606761|11717698|FG003|STARTED|Safety Follow-up Period (Week 52-68)||9
10562750|NCT01606761|11717699|FG004|STARTED|Safety Follow-up Period (Week 52-68)||19
10792048|NCT03573505|11952901|FG001|COMPLETED|Overall Study||0
10792049|NCT03573505|11952900|FG000|NOT COMPLETED|Overall Study||52
10562751|NCT01606761|11717695|FG000|Safety Population|Safety Follow-up Period (Week 52-68)||28
10562752|NCT01606761|11717696|FG001|Safety Population|Safety Follow-up Period (Week 52-68)||65
10562753|NCT01606761|11717697|FG002|Safety Population|Safety Follow-up Period (Week 52-68)||62
10562754|NCT01606761|11717698|FG003|Safety Population|Safety Follow-up Period (Week 52-68)||7
10562755|NCT01606761|11717699|FG004|Safety Population|Safety Follow-up Period (Week 52-68)||19
10562756|NCT01606761|11717695|FG000|COMPLETED|Safety Follow-up Period (Week 52-68)||24
10562757|NCT01606761|11717696|FG001|COMPLETED|Safety Follow-up Period (Week 52-68)||55
10562758|NCT01606761|11717697|FG002|COMPLETED|Safety Follow-up Period (Week 52-68)||45
10562759|NCT01606761|11717698|FG003|COMPLETED|Safety Follow-up Period (Week 52-68)||7
10562760|NCT01606761|11717699|FG004|COMPLETED|Safety Follow-up Period (Week 52-68)||11
10562761|NCT01606761|11717695|FG000|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||4
10562762|NCT01606761|11717696|FG001|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||10
10562763|NCT01606761|11717697|FG002|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||17
10562764|NCT01606761|11717698|FG003|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||2
10562765|NCT01606761|11717699|FG004|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||8
10562766|NCT01606787|11717716|FG000|STARTED|Overall Study||105
10562767|NCT01606787|11717717|FG001|STARTED|Overall Study||105
10562768|NCT01606787|11717716|FG000|COMPLETED|Overall Study||101
10562769|NCT01606787|11717717|FG001|COMPLETED|Overall Study||98
10562770|NCT01606787|11717716|FG000|NOT COMPLETED|Overall Study||4
10562771|NCT01606787|11717717|FG001|NOT COMPLETED|Overall Study||7
10562772|NCT01606800|11717725|FG000|STARTED|Overall Study||22
10562773|NCT01606800|11717726|FG001|STARTED|Overall Study||23
10562774|NCT01606800|11717725|FG000|Treated|Overall Study||22
10562775|NCT01606800|11717726|FG001|Treated|Overall Study||23
10562776|NCT01606800|11717725|FG000|COMPLETED|Overall Study||17
10562777|NCT01606800|11717726|FG001|COMPLETED|Overall Study||21
10562778|NCT01606800|11717725|FG000|NOT COMPLETED|Overall Study||5
10562779|NCT01606800|11717726|FG001|NOT COMPLETED|Overall Study||2
10562780|NCT01606852|11717734|FG000|STARTED|Overall Study||7
10562781|NCT01606852|11717735|FG001|STARTED|Overall Study||8
10562782|NCT01606852|11717734|FG000|COMPLETED|Overall Study||7
10562783|NCT01606852|11717735|FG001|COMPLETED|Overall Study||8
10562784|NCT01606852|11717734|FG000|NOT COMPLETED|Overall Study||0
10562785|NCT01606852|11717735|FG001|NOT COMPLETED|Overall Study||0
10562786|NCT01607073|11717741|FG000|STARTED|Overall Study||2
10562787|NCT01607073|11717741|FG000|COMPLETED|Overall Study||1
10562788|NCT01607073|11717741|FG000|NOT COMPLETED|Overall Study||1
10562789|NCT01607112|11717750|FG000|STARTED|Overall Study||60
10562790|NCT01607112|11717751|FG001|STARTED|Overall Study||59
10562791|NCT01607112|11717750|FG000|COMPLETED|Overall Study||60
10562792|NCT01607112|11717751|FG001|COMPLETED|Overall Study||59
10562793|NCT01607112|11717750|FG000|NOT COMPLETED|Overall Study||0
10562794|NCT01607112|11717751|FG001|NOT COMPLETED|Overall Study||0
10562795|NCT01607203|11717763|FG000|STARTED|Overall Study||59
10562796|NCT01607203|11717764|FG001|STARTED|Overall Study||61
10562797|NCT01607203|11717763|FG000|COMPLETED|Overall Study||59
10562798|NCT01607203|11717764|FG001|COMPLETED|Overall Study||61
10562799|NCT01607203|11717763|FG000|NOT COMPLETED|Overall Study||0
10562800|NCT01607203|11717764|FG001|NOT COMPLETED|Overall Study||0
10562801|NCT01607255|11717774|FG000|STARTED|Overall Study||161
10562802|NCT01607255|11717775|FG001|STARTED|Overall Study||160
10562803|NCT01607255|11717776|FG002|STARTED|Overall Study||159
10562804|NCT01607255|11717774|FG000|COMPLETED|Overall Study||161
10562805|NCT01607255|11717775|FG001|COMPLETED|Overall Study||160
10562806|NCT01607255|11717776|FG002|COMPLETED|Overall Study||159
10562807|NCT01607255|11717774|FG000|NOT COMPLETED|Overall Study||0
10562808|NCT01607255|11717775|FG001|NOT COMPLETED|Overall Study||0
10562809|NCT01607255|11717776|FG002|NOT COMPLETED|Overall Study||0
10562810|NCT01607346|11717784|FG000|STARTED|Overall Study||10
10562811|NCT01607346|11717784|FG000|COMPLETED|Overall Study||7
10562812|NCT01607346|11717784|FG000|NOT COMPLETED|Overall Study||3
10562813|NCT01607398|11717790|FG000|STARTED|Overall Study||28
10562814|NCT01607398|11717791|FG001|STARTED|Overall Study||28
10562815|NCT01607398|11717790|FG000|COMPLETED|Overall Study||26
10562816|NCT01607398|11717791|FG001|COMPLETED|Overall Study||26
10562817|NCT01607398|11717790|FG000|NOT COMPLETED|Overall Study||2
10562818|NCT01607398|11717791|FG001|NOT COMPLETED|Overall Study||2
10562819|NCT01607411|11717797|FG000|STARTED|Period I||14
10562820|NCT01607411|11717798|FG001|STARTED|Period I||13
10562821|NCT01607411|11717799|FG002|STARTED|Period I||14
10562822|NCT01607411|11717800|FG003|STARTED|Period I||14
10562823|NCT01607411|11717797|FG000|COMPLETED|Period I||14
10562824|NCT01607411|11717798|FG001|COMPLETED|Period I||13
10562825|NCT01607411|11717799|FG002|COMPLETED|Period I||14
10562826|NCT01607411|11717800|FG003|COMPLETED|Period I||14
10562827|NCT01607411|11717797|FG000|NOT COMPLETED|Period I||0
10562828|NCT01607411|11717798|FG001|NOT COMPLETED|Period I||0
10562829|NCT01607411|11717799|FG002|NOT COMPLETED|Period I||0
10562830|NCT01607411|11717800|FG003|NOT COMPLETED|Period I||0
10562831|NCT01607411|11717797|FG000|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
10562832|NCT01607411|11717798|FG001|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
10562833|NCT01607411|11717799|FG002|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|13
10562834|NCT01607411|11717800|FG003|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
10562835|NCT01607411|11717797|FG000|COMPLETED|Period II||14
10562836|NCT01607411|11717798|FG001|COMPLETED|Period II||14
10562837|NCT01607411|11717799|FG002|COMPLETED|Period II||13
10562838|NCT01607411|11717800|FG003|COMPLETED|Period II||14
10562839|NCT01607411|11717797|FG000|NOT COMPLETED|Period II||0
10562840|NCT01607411|11717798|FG001|NOT COMPLETED|Period II||0
10562841|NCT01607411|11717799|FG002|NOT COMPLETED|Period II||0
10562842|NCT01607411|11717800|FG003|NOT COMPLETED|Period II||0
10562843|NCT01607411|11717797|FG000|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
10562844|NCT01607411|11717798|FG001|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
10562845|NCT01607411|11717799|FG002|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
10562846|NCT01607411|11717800|FG003|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|13
10562847|NCT01607411|11717797|FG000|COMPLETED|Period III||14
10562848|NCT01607411|11717798|FG001|COMPLETED|Period III||14
10562849|NCT01607411|11717799|FG002|COMPLETED|Period III||14
10562850|NCT01607411|11717800|FG003|COMPLETED|Period III||13
10562851|NCT01607411|11717797|FG000|NOT COMPLETED|Period III||0
10562852|NCT01607411|11717798|FG001|NOT COMPLETED|Period III||0
10562853|NCT01607411|11717799|FG002|NOT COMPLETED|Period III||0
10562854|NCT01607411|11717800|FG003|NOT COMPLETED|Period III||0
10562855|NCT01607411|11717797|FG000|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|13
10562856|NCT01607411|11717798|FG001|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
10562857|NCT01607411|11717799|FG002|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
10562858|NCT01607411|11717800|FG003|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
10562859|NCT01607411|11717797|FG000|COMPLETED|Period IV||13
10562860|NCT01607411|11717798|FG001|COMPLETED|Period IV||14
10562861|NCT01607411|11717799|FG002|COMPLETED|Period IV||14
10562862|NCT01607411|11717800|FG003|COMPLETED|Period IV||14
10562863|NCT01607411|11717797|FG000|NOT COMPLETED|Period IV||0
10562864|NCT01607411|11717798|FG001|NOT COMPLETED|Period IV||0
10562865|NCT01607411|11717799|FG002|NOT COMPLETED|Period IV||0
10792050|NCT03573505|11952901|FG001|NOT COMPLETED|Overall Study||54
10792051|NCT03573804|11952908|FG000|STARTED|Overall Study||72
10792052|NCT03573804|11952908|FG000|COMPLETED|Overall Study||62
10792053|NCT03573804|11952908|FG000|NOT COMPLETED|Overall Study||10
10792054|NCT03573830|11952920|FG000|STARTED|Overall Study||364
10792055|NCT03573830|11952921|FG001|STARTED|Overall Study||367
10792056|NCT03573830|11952920|FG000|Reviewed Assigned Material|Overall Study|All participants assigned to this arm reviewed their assigned material.|364
10792057|NCT03573830|11952921|FG001|Reviewed Assigned Material|Overall Study|360 reviewed their assigned material:Transport Canada information plus the enhanced material.|360
10792058|NCT03573830|11952920|FG000|COMPLETED|Overall Study||360
10792059|NCT03573830|11952921|FG001|COMPLETED|Overall Study||360
10792060|NCT03573830|11952920|FG000|NOT COMPLETED|Overall Study||4
10792061|NCT03573830|11952921|FG001|NOT COMPLETED|Overall Study||7
10792062|NCT03573908|11952928|FG000|STARTED|Treatment Period||308
10792063|NCT03573908|11952929|FG001|STARTED|Treatment Period||306
10792064|NCT03573908|11952930|FG002|STARTED|Treatment Period||0
10792065|NCT03573908|11952931|FG003|STARTED|Treatment Period||0
10792066|NCT03573908|11952932|FG004|STARTED|Treatment Period||0
10792067|NCT03573908|11952928|FG000|COMPLETED|Treatment Period||284
10792068|NCT03573908|11952929|FG001|COMPLETED|Treatment Period||280
10792069|NCT03573908|11952930|FG002|COMPLETED|Treatment Period||0
10792070|NCT03573908|11952931|FG003|COMPLETED|Treatment Period||0
10792071|NCT03573908|11952932|FG004|COMPLETED|Treatment Period||0
10792072|NCT03573908|11952928|FG000|NOT COMPLETED|Treatment Period||24
10792073|NCT03573908|11952929|FG001|NOT COMPLETED|Treatment Period||26
10792074|NCT03573908|11952930|FG002|NOT COMPLETED|Treatment Period||0
10792075|NCT03573908|11952931|FG003|NOT COMPLETED|Treatment Period||0
10792076|NCT03573908|11952932|FG004|NOT COMPLETED|Treatment Period||0
10792077|NCT03573908|11952928|FG000|STARTED|Randomized Withdrawal Period||0
10792078|NCT03573908|11952929|FG001|STARTED|Randomized Withdrawal Period||0
10792079|NCT03573908|11952930|FG002|STARTED|Randomized Withdrawal Period||280
10792080|NCT03573908|11952931|FG003|STARTED|Randomized Withdrawal Period||138
10792081|NCT03573908|11952932|FG004|STARTED|Randomized Withdrawal Period||139
10792082|NCT03573908|11952928|FG000|COMPLETED|Randomized Withdrawal Period||0
10792083|NCT03573908|11952929|FG001|COMPLETED|Randomized Withdrawal Period||0
10792084|NCT03573908|11952930|FG002|COMPLETED|Randomized Withdrawal Period||272
10792085|NCT03573908|11952931|FG003|COMPLETED|Randomized Withdrawal Period||136
10792086|NCT03573908|11952932|FG004|COMPLETED|Randomized Withdrawal Period||137
10792087|NCT03573908|11952928|FG000|NOT COMPLETED|Randomized Withdrawal Period||0
10792088|NCT03573908|11952929|FG001|NOT COMPLETED|Randomized Withdrawal Period||0
10792089|NCT03573908|11952930|FG002|NOT COMPLETED|Randomized Withdrawal Period||8
10792090|NCT03573908|11952931|FG003|NOT COMPLETED|Randomized Withdrawal Period||2
10792091|NCT03573908|11952932|FG004|NOT COMPLETED|Randomized Withdrawal Period||2
10562866|NCT01607411|11717800|FG003|NOT COMPLETED|Period IV||0
10562867|NCT01607450|11717817|FG000|STARTED|Overall Study||6
10562868|NCT01607450|11717818|FG001|STARTED|Overall Study||8
10562869|NCT01607450|11717819|FG002|STARTED|Overall Study||7
10562870|NCT01607450|11717820|FG003|STARTED|Overall Study||11
10792092|NCT03574181|11952941|FG000|STARTED|Overall Study||9
10792093|NCT03574181|11952941|FG000|COMPLETED|Overall Study||0
10792094|NCT03574181|11952941|FG000|NOT COMPLETED|Overall Study||9
10792095|NCT03574441|11952948|FG000|STARTED|Overall Study||31
10792096|NCT03574441|11952949|FG001|STARTED|Overall Study||30
10792097|NCT03574441|11952950|FG002|STARTED|Overall Study||30
10792098|NCT03574441|11952948|FG000|COMPLETED|Overall Study||31
10562871|NCT01607450|11717821|FG004|STARTED|Overall Study||1
10562872|NCT01607450|11717822|FG005|STARTED|Overall Study||0
10562873|NCT01607450|11717823|FG006|STARTED|Overall Study||0
10562874|NCT01607450|11717817|FG000|COMPLETED|Overall Study||6
10562875|NCT01607450|11717818|FG001|COMPLETED|Overall Study||8
10562876|NCT01607450|11717819|FG002|COMPLETED|Overall Study||7
10562877|NCT01607450|11717820|FG003|COMPLETED|Overall Study||11
10562878|NCT01607450|11717821|FG004|COMPLETED|Overall Study||1
10562879|NCT01607450|11717822|FG005|COMPLETED|Overall Study||0
10562880|NCT01607450|11717823|FG006|COMPLETED|Overall Study||0
10562881|NCT01607450|11717817|FG000|NOT COMPLETED|Overall Study||0
10562882|NCT01607450|11717818|FG001|NOT COMPLETED|Overall Study||0
10562883|NCT01607450|11717819|FG002|NOT COMPLETED|Overall Study||0
10562884|NCT01607450|11717820|FG003|NOT COMPLETED|Overall Study||0
10562885|NCT01607450|11717821|FG004|NOT COMPLETED|Overall Study||0
10562886|NCT01607450|11717822|FG005|NOT COMPLETED|Overall Study||0
10562887|NCT01607450|11717823|FG006|NOT COMPLETED|Overall Study||0
10562888|NCT01607476|11717847|FG000|STARTED|Overall Study||25
10562889|NCT01607476|11717848|FG001|STARTED|Overall Study||30
10562890|NCT01607476|11717849|FG002|STARTED|Overall Study||33
10562891|NCT01607476|11717847|FG000|COMPLETED|Overall Study||24
10562892|NCT01607476|11717848|FG001|COMPLETED|Overall Study||30
10562893|NCT01607476|11717849|FG002|COMPLETED|Overall Study||30
10562894|NCT01607476|11717847|FG000|NOT COMPLETED|Overall Study||1
10562895|NCT01607476|11717848|FG001|NOT COMPLETED|Overall Study||0
10562896|NCT01607476|11717849|FG002|NOT COMPLETED|Overall Study||3
10562897|NCT01607554|11717857|FG000|STARTED|Overall Study||2
10562898|NCT01607554|11717857|FG000|COMPLETED|Overall Study||0
10562899|NCT01607554|11717857|FG000|NOT COMPLETED|Overall Study||2
10562900|NCT01607593|11717861|FG000|STARTED|Overall Study||122
10562901|NCT01607593|11717861|FG000|COMPLETED|Overall Study||29
10562902|NCT01607593|11717861|FG000|NOT COMPLETED|Overall Study||93
10562903|NCT01607645|11717867|FG000|STARTED|Overall Study||4
10562904|NCT01607645|11717868|FG001|STARTED|Overall Study||3
10562905|NCT01607645|11717867|FG000|COMPLETED|Overall Study||4
10562906|NCT01607645|11717868|FG001|COMPLETED|Overall Study||3
10562907|NCT01607645|11717867|FG000|NOT COMPLETED|Overall Study||0
10562908|NCT01607645|11717868|FG001|NOT COMPLETED|Overall Study||0
10562909|NCT01607658|11717878|FG000|STARTED|Overall Study||65
10562910|NCT01607658|11717879|FG001|STARTED|Overall Study||67
10562911|NCT01607658|11717880|FG002|STARTED|Overall Study||58
10562912|NCT01607658|11717881|FG003|STARTED|Overall Study||63
10562913|NCT01607658|11717878|FG000|COMPLETED|Overall Study||56
10562914|NCT01607658|11717879|FG001|COMPLETED|Overall Study||56
10562915|NCT01607658|11717880|FG002|COMPLETED|Overall Study||47
10562916|NCT01607658|11717881|FG003|COMPLETED|Overall Study||52
10562917|NCT01607658|11717878|FG000|NOT COMPLETED|Overall Study||9
10562918|NCT01607658|11717879|FG001|NOT COMPLETED|Overall Study||11
10562919|NCT01607658|11717880|FG002|NOT COMPLETED|Overall Study||11
10562920|NCT01607658|11717881|FG003|NOT COMPLETED|Overall Study||11
10562921|NCT01607853|11717891|FG000|STARTED|Overall Study||24
10562922|NCT01607853|11717891|FG000|COMPLETED|Overall Study||24
10562923|NCT01607853|11717891|FG000|NOT COMPLETED|Overall Study||0
10562924|NCT01607892|11717903|FG000|STARTED|Overall Study||58
10562925|NCT01607892|11717904|FG001|STARTED|Overall Study||27
10562926|NCT01607892|11717905|FG002|STARTED|Overall Study||81
10562927|NCT01607892|11717906|FG003|STARTED|Overall Study||95
10562928|NCT01607892|11717907|FG004|STARTED|Overall Study||24
10562929|NCT01607892|11717903|FG000|COMPLETED|Overall Study||0
10562930|NCT01607892|11717904|FG001|COMPLETED|Overall Study||0
10562931|NCT01607892|11717905|FG002|COMPLETED|Overall Study||0
10562932|NCT01607892|11717906|FG003|COMPLETED|Overall Study||0
10562933|NCT01607892|11717907|FG004|COMPLETED|Overall Study||0
10562934|NCT01607892|11717903|FG000|NOT COMPLETED|Overall Study||58
10562935|NCT01607892|11717904|FG001|NOT COMPLETED|Overall Study||27
10562936|NCT01607892|11717905|FG002|NOT COMPLETED|Overall Study||81
10562937|NCT01607892|11717906|FG003|NOT COMPLETED|Overall Study||95
10562938|NCT01607892|11717907|FG004|NOT COMPLETED|Overall Study||24
10562939|NCT01607905|11717940|FG000|STARTED|Overall Study||60
10562940|NCT01607905|11717941|FG001|STARTED|Overall Study||20
10562941|NCT01607905|11717942|FG002|STARTED|Overall Study||21
10562942|NCT01607905|11717943|FG003|STARTED|Overall Study||21
10562943|NCT01607905|11717944|FG004|STARTED|Overall Study||7
10562944|NCT01607905|11717945|FG005|STARTED|Overall Study||15
10562945|NCT01607905|11717946|FG006|STARTED|Overall Study||47
10562946|NCT01607905|11717940|FG000|Received Study Drug|Overall Study||59
10562947|NCT01607905|11717941|FG001|Received Study Drug|Overall Study||20
10562948|NCT01607905|11717942|FG002|Received Study Drug|Overall Study||21
10562949|NCT01607905|11717943|FG003|Received Study Drug|Overall Study||21
10562950|NCT01607905|11717944|FG004|Received Study Drug|Overall Study||6
10562951|NCT01607905|11717945|FG005|Received Study Drug|Overall Study||15
10562952|NCT01607905|11717946|FG006|Received Study Drug|Overall Study||47
10562953|NCT01607905|11717940|FG000|Low Dose (<30 mg/m^2)|Overall Study||16
10562954|NCT01607905|11717941|FG001|Low Dose (<30 mg/m^2)|Overall Study||5
10562955|NCT01607905|11717942|FG002|Low Dose (<30 mg/m^2)|Overall Study||3
10562956|NCT01607905|11717943|FG003|Low Dose (<30 mg/m^2)|Overall Study||0
10562957|NCT01607905|11717944|FG004|Low Dose (<30 mg/m^2)|Overall Study||0
10562958|NCT01607905|11717945|FG005|Low Dose (<30 mg/m^2)|Overall Study||2
10562959|NCT01607905|11717946|FG006|Low Dose (<30 mg/m^2)|Overall Study||8
10562960|NCT01607905|11717940|FG000|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||27
10562961|NCT01607905|11717941|FG001|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||11
10562962|NCT01607905|11717942|FG002|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||15
10562963|NCT01607905|11717943|FG003|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||8
10562964|NCT01607905|11717944|FG004|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||6
10562965|NCT01607905|11717945|FG005|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||3
10562966|NCT01607905|11717946|FG006|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||21
10562967|NCT01607905|11717940|FG000|High Dose (>= 55 mg/m^2)|Overall Study||16
10562968|NCT01607905|11717941|FG001|High Dose (>= 55 mg/m^2)|Overall Study||4
10562969|NCT01607905|11717942|FG002|High Dose (>= 55 mg/m^2)|Overall Study||3
10562970|NCT01607905|11717943|FG003|High Dose (>= 55 mg/m^2)|Overall Study||13
10562971|NCT01607905|11717944|FG004|High Dose (>= 55 mg/m^2)|Overall Study||0
10562972|NCT01607905|11717945|FG005|High Dose (>= 55 mg/m^2)|Overall Study||10
10562973|NCT01607905|11717946|FG006|High Dose (>= 55 mg/m^2)|Overall Study||18
10562974|NCT01607905|11717940|FG000|COMPLETED|Overall Study||0
10562975|NCT01607905|11717941|FG001|COMPLETED|Overall Study||0
10562976|NCT01607905|11717942|FG002|COMPLETED|Overall Study||0
10562977|NCT01607905|11717943|FG003|COMPLETED|Overall Study||0
10562978|NCT01607905|11717944|FG004|COMPLETED|Overall Study||0
10562979|NCT01607905|11717945|FG005|COMPLETED|Overall Study||0
10562980|NCT01607905|11717946|FG006|COMPLETED|Overall Study||0
10562981|NCT01607905|11717940|FG000|NOT COMPLETED|Overall Study||60
10562982|NCT01607905|11717941|FG001|NOT COMPLETED|Overall Study||20
10562983|NCT01607905|11717942|FG002|NOT COMPLETED|Overall Study||21
10562984|NCT01607905|11717943|FG003|NOT COMPLETED|Overall Study||21
10562985|NCT01607905|11717944|FG004|NOT COMPLETED|Overall Study||7
10562986|NCT01607905|11717945|FG005|NOT COMPLETED|Overall Study||15
10562987|NCT01607905|11717946|FG006|NOT COMPLETED|Overall Study||47
10562988|NCT01607957|11718006|FG000|STARTED|Overall Study||534
10562989|NCT01607957|11718007|FG001|STARTED|Overall Study||266
10562990|NCT01607957|11718006|FG000|Treated|Overall Study||533
10562991|NCT01607957|11718007|FG001|Treated|Overall Study||265
10562992|NCT01607957|11718006|FG000|COMPLETED|Overall Study||162
10562993|NCT01607957|11718007|FG001|COMPLETED|Overall Study||51
10562994|NCT01607957|11718006|FG000|NOT COMPLETED|Overall Study||372
10562995|NCT01607957|11718007|FG001|NOT COMPLETED|Overall Study||215
10562996|NCT01608061|11718015|FG000|STARTED|Blinded Period||21
10562997|NCT01608061|11718016|FG001|STARTED|Blinded Period||21
10562998|NCT01608061|11718015|FG000|COMPLETED|Blinded Period||21
10562999|NCT01608061|11718016|FG001|COMPLETED|Blinded Period||21
10563000|NCT01608061|11718015|FG000|NOT COMPLETED|Blinded Period||0
10563001|NCT01608061|11718016|FG001|NOT COMPLETED|Blinded Period||0
10563002|NCT01608061|11718015|FG000|STARTED|Long Term Follow-Up||21
10563003|NCT01608061|11718016|FG001|STARTED|Long Term Follow-Up||21
10563004|NCT01608061|11718015|FG000|COMPLETED|Long Term Follow-Up||14
10563005|NCT01608061|11718016|FG001|COMPLETED|Long Term Follow-Up||16
10563006|NCT01608061|11718015|FG000|NOT COMPLETED|Long Term Follow-Up||7
10563007|NCT01608061|11718016|FG001|NOT COMPLETED|Long Term Follow-Up||5
10563008|NCT01608061|11718015|FG000|STARTED|Extension Period||14
10563009|NCT01608061|11718016|FG001|STARTED|Extension Period||16
10563010|NCT01608061|11718015|FG000|COMPLETED|Extension Period||14
10563011|NCT01608061|11718016|FG001|COMPLETED|Extension Period||14
10563012|NCT01608061|11718015|FG000|NOT COMPLETED|Extension Period||0
10563013|NCT01608061|11718016|FG001|NOT COMPLETED|Extension Period||2
10563014|NCT01608087|11718026|FG000|STARTED|Overall Study||30
10563015|NCT01608087|11718027|FG001|STARTED|Overall Study||30
10563016|NCT01608087|11718028|FG002|STARTED|Overall Study||31
10563017|NCT01608087|11718026|FG000|COMPLETED|Overall Study||30
10563018|NCT01608087|11718027|FG001|COMPLETED|Overall Study||28
10563019|NCT01608087|11718028|FG002|COMPLETED|Overall Study||31
10563020|NCT01608087|11718026|FG000|NOT COMPLETED|Overall Study||0
10563021|NCT01608087|11718027|FG001|NOT COMPLETED|Overall Study||2
10563022|NCT01608087|11718028|FG002|NOT COMPLETED|Overall Study||0
10563023|NCT01608100|11718036|FG000|STARTED|Overall Study||1101
10563024|NCT01608100|11718036|FG000|COMPLETED|Overall Study||1101
10563025|NCT01608100|11718036|FG000|NOT COMPLETED|Overall Study||0
10563026|NCT01608295|11718062|FG000|STARTED|Overall Study||26
10563027|NCT01608295|11718063|FG001|STARTED|Overall Study||30
10563028|NCT01608295|11718062|FG000|COMPLETED|Overall Study||20
10563029|NCT01608295|11718063|FG001|COMPLETED|Overall Study||25
10563030|NCT01608295|11718062|FG000|NOT COMPLETED|Overall Study||6
10563031|NCT01608295|11718063|FG001|NOT COMPLETED|Overall Study||5
10563032|NCT01608308|11718074|FG000|STARTED|Overall Study||31
10563033|NCT01608308|11718075|FG001|STARTED|Overall Study||31
10563034|NCT01608308|11718074|FG000|COMPLETED|Overall Study||31
10563035|NCT01608308|11718075|FG001|COMPLETED|Overall Study||29
10563036|NCT01608308|11718074|FG000|NOT COMPLETED|Overall Study||0
10563037|NCT01608308|11718075|FG001|NOT COMPLETED|Overall Study||2
10563038|NCT01608321|11718083|FG000|STARTED|Overall Study||13
10563039|NCT01608321|11718084|FG001|STARTED|Overall Study||4
10563040|NCT01608321|11718083|FG000|COMPLETED|Overall Study||12
10563041|NCT01608321|11718084|FG001|COMPLETED|Overall Study||4
10563042|NCT01608321|11718083|FG000|NOT COMPLETED|Overall Study||1
10563043|NCT01608321|11718084|FG001|NOT COMPLETED|Overall Study||0
10563044|NCT01608490|11718092|FG000|STARTED|Overall Study||158
10563045|NCT01608490|11718093|FG001|STARTED|Overall Study||157
10563046|NCT01608490|11718092|FG000|COMPLETED|Overall Study||141
10563047|NCT01608490|11718093|FG001|COMPLETED|Overall Study||142
10563048|NCT01608490|11718092|FG000|NOT COMPLETED|Overall Study||17
10563049|NCT01608490|11718093|FG001|NOT COMPLETED|Overall Study||15
10563050|NCT01608659|11718099|FG000|STARTED|Overall Study||110
10563051|NCT01608659|11718099|FG000|COMPLETED|Overall Study||94
10563052|NCT01608659|11718099|FG000|NOT COMPLETED|Overall Study||16
10563053|NCT01608672|11718103|FG000|STARTED|Overall Study||207
10563054|NCT01608672|11718103|FG000|COMPLETED|Overall Study||207
10563055|NCT01608672|11718103|FG000|NOT COMPLETED|Overall Study||0
10563056|NCT01608724|11718107|FG000|STARTED|Overall Study|One patient was excluded because the Informed Consent Form was destroyed by site staff by mistake.|1423
10563057|NCT01608724|11718107|FG000|Treated|Overall Study||1361
10563058|NCT01608724|11718107|FG000|COMPLETED|Overall Study||1180
10563059|NCT01608724|11718107|FG000|NOT COMPLETED|Overall Study||243
10563060|NCT01608815|11718114|FG000|STARTED|Overall Study||188
10563061|NCT01608815|11718115|FG001|STARTED|Overall Study||7
10563062|NCT01608815|11718116|FG002|STARTED|Overall Study||5
10563063|NCT01608815|11718114|FG000|COMPLETED|Overall Study||188
10563064|NCT01608815|11718115|FG001|COMPLETED|Overall Study||7
10563065|NCT01608815|11718116|FG002|COMPLETED|Overall Study||5
10563066|NCT01608815|11718114|FG000|NOT COMPLETED|Overall Study||0
10563067|NCT01608815|11718115|FG001|NOT COMPLETED|Overall Study||0
10563068|NCT01608815|11718116|FG002|NOT COMPLETED|Overall Study||0
10563069|NCT01608971|11718127|FG000|STARTED|Overall Study||15
10563070|NCT01608971|11718128|FG001|STARTED|Overall Study||15
10563071|NCT01608971|11718127|FG000|COMPLETED|Overall Study||15
10563072|NCT01608971|11718128|FG001|COMPLETED|Overall Study||15
10563073|NCT01608971|11718127|FG000|NOT COMPLETED|Overall Study||0
10563074|NCT01608971|11718128|FG001|NOT COMPLETED|Overall Study||0
10563075|NCT01609010|11718138|FG000|STARTED|Overall Study||156
10563076|NCT01609010|11718139|FG001|STARTED|Overall Study||157
10563077|NCT01609010|11718138|FG000|Entering Cycle 2|Overall Study||120
10563078|NCT01609010|11718139|FG001|Entering Cycle 2|Overall Study||124
10563079|NCT01609010|11718138|FG000|COMPLETED|Overall Study||113
10563080|NCT01609010|11718139|FG001|COMPLETED|Overall Study||120
10563081|NCT01609010|11718138|FG000|NOT COMPLETED|Overall Study||43
10563082|NCT01609010|11718139|FG001|NOT COMPLETED|Overall Study||37
10792099|NCT03574441|11952949|FG001|COMPLETED|Overall Study||30
10792100|NCT03574441|11952950|FG002|COMPLETED|Overall Study||30
10792101|NCT03574441|11952948|FG000|NOT COMPLETED|Overall Study||0
10792102|NCT03574441|11952949|FG001|NOT COMPLETED|Overall Study||0
10792103|NCT03574441|11952950|FG002|NOT COMPLETED|Overall Study||0
10792104|NCT03574753|11952958|FG000|STARTED|Overall Study||23
10792105|NCT03574753|11952958|FG000|COMPLETED|Overall Study||0
10792106|NCT03574753|11952958|FG000|NOT COMPLETED|Overall Study||23
10792107|NCT03574818|11952963|FG000|STARTED|Overall Study||1
10792108|NCT03574818|11952963|FG000|COMPLETED|Overall Study||1
10792109|NCT03574818|11952963|FG000|NOT COMPLETED|Overall Study||0
10792110|NCT03575702|11952969|FG000|STARTED|Overall Study||149
10792111|NCT03575702|11952970|FG001|STARTED|Overall Study||150
10792112|NCT03575702|11952969|FG000|COMPLETED|Overall Study||143
10792113|NCT03575702|11952970|FG001|COMPLETED|Overall Study||146
10792114|NCT03575702|11952969|FG000|NOT COMPLETED|Overall Study||6
10792115|NCT03575702|11952970|FG001|NOT COMPLETED|Overall Study||4
10792116|NCT03575754|11952978|FG000|STARTED|Overall Study||25
10792117|NCT03575754|11952979|FG001|STARTED|Overall Study||25
10792118|NCT03575754|11952978|FG000|COMPLETED|Overall Study||25
10792119|NCT03575754|11952979|FG001|COMPLETED|Overall Study||25
10792120|NCT03575754|11952978|FG000|NOT COMPLETED|Overall Study||0
10792121|NCT03575754|11952979|FG001|NOT COMPLETED|Overall Study||0
10792122|NCT03575806|11952987|FG000|STARTED|Overall Study||25
10792123|NCT03575806|11952988|FG001|STARTED|Overall Study||27
10792124|NCT03575806|11952987|FG000|COMPLETED|Overall Study||25
10792125|NCT03575806|11952988|FG001|COMPLETED|Overall Study||23
10792126|NCT03575806|11952987|FG000|NOT COMPLETED|Overall Study||0
10792127|NCT03575806|11952988|FG001|NOT COMPLETED|Overall Study||4
10792128|NCT03575871|11952997|FG000|STARTED|Overall Study||158
10792129|NCT03575871|11952998|FG001|STARTED|Overall Study||155
10792130|NCT03575871|11952999|FG002|STARTED|Overall Study||78
10792131|NCT03575871|11952997|FG000|COMPLETED|Overall Study||137
10792132|NCT03575871|11952998|FG001|COMPLETED|Overall Study||141
10792133|NCT03575871|11952999|FG002|COMPLETED|Overall Study||52
10792134|NCT03575871|11952997|FG000|NOT COMPLETED|Overall Study||21
10792135|NCT03575871|11952998|FG001|NOT COMPLETED|Overall Study||14
10792136|NCT03575871|11952999|FG002|NOT COMPLETED|Overall Study||26
10792137|NCT03575962|11953007|FG000|STARTED|Treatment Period 1 (4 Days)||7
10792138|NCT03575962|11953008|FG001|STARTED|Treatment Period 1 (4 Days)||7
10792139|NCT03575962|11953007|FG000|COMPLETED|Treatment Period 1 (4 Days)||7
10792140|NCT03575962|11953008|FG001|COMPLETED|Treatment Period 1 (4 Days)||7
10563083|NCT01609023|11718145|FG000|STARTED|Overall Study||67
10563084|NCT01609023|11718145|FG000|COMPLETED|Overall Study||34
10563085|NCT01609023|11718145|FG000|NOT COMPLETED|Overall Study||33
10563086|NCT01609062|11718151|FG000|STARTED|Primary Phase||15
10563087|NCT01609062|11718152|FG001|STARTED|Primary Phase||10
10563088|NCT01609062|11718151|FG000|COMPLETED|Primary Phase||15
10563089|NCT01609062|11718152|FG001|COMPLETED|Primary Phase||10
10563090|NCT01609062|11718151|FG000|NOT COMPLETED|Primary Phase||0
10792141|NCT03575962|11953007|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||0
10792142|NCT03575962|11953008|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||0
10792143|NCT03575962|11953007|FG000|STARTED|Washout Period (7 Days)||7
10792144|NCT03575962|11953008|FG001|STARTED|Washout Period (7 Days)||7
10792145|NCT03575962|11953007|FG000|COMPLETED|Washout Period (7 Days)||7
10792146|NCT03575962|11953008|FG001|COMPLETED|Washout Period (7 Days)||7
10792147|NCT03575962|11953007|FG000|NOT COMPLETED|Washout Period (7 Days)||0
10792148|NCT03575962|11953008|FG001|NOT COMPLETED|Washout Period (7 Days)||0
10792149|NCT03575962|11953007|FG000|STARTED|Treatment Period 2 (4 Days)||7
10563091|NCT01609062|11718152|FG001|NOT COMPLETED|Primary Phase||0
10563092|NCT01609062|11718151|FG000|STARTED|Extension Phase||15
10563093|NCT01609062|11718152|FG001|STARTED|Extension Phase||10
10563094|NCT01609062|11718151|FG000|COMPLETED|Extension Phase||0
10563095|NCT01609062|11718152|FG001|COMPLETED|Extension Phase|EAP = Expanded Access Program|0
10563096|NCT01609062|11718151|FG000|NOT COMPLETED|Extension Phase||15
10563097|NCT01609062|11718152|FG001|NOT COMPLETED|Extension Phase||10
10563098|NCT01609218|11718159|FG000|STARTED|Period 1||13
10563099|NCT01609218|11718160|FG001|STARTED|Period 1||14
10563100|NCT01609218|11718159|FG000|Received LY2140023|Period 1||13
10563101|NCT01609218|11718160|FG001|Received LY2140023|Period 1||14
10563102|NCT01609218|11718159|FG000|Received Activated Charcoal|Period 1|Participants in this treatment sequence did not receive activated charcoal during Period 1.|0
10563103|NCT01609218|11718160|FG001|Received Activated Charcoal|Period 1|Two participants discontinued after receiving LY2140023 but prior to receiving activated charcoal.|12
10563104|NCT01609218|11718159|FG000|COMPLETED|Period 1||10
10563105|NCT01609218|11718160|FG001|COMPLETED|Period 1||8
10563106|NCT01609218|11718159|FG000|NOT COMPLETED|Period 1||3
10563107|NCT01609218|11718160|FG001|NOT COMPLETED|Period 1||6
10563108|NCT01609218|11718159|FG000|STARTED|Period 2||10
10563109|NCT01609218|11718160|FG001|STARTED|Period 2|One participant did not complete Period 1 but did continue onto Period 2.|9
10563110|NCT01609218|11718159|FG000|Received LY2140023|Period 2||10
10563111|NCT01609218|11718160|FG001|Received LY2140023|Period 2||9
10563112|NCT01609218|11718159|FG000|Received Activated Charcoal|Period 2||9
10563113|NCT01609218|11718160|FG001|Received Activated Charcoal|Period 2|Participants in this treatment sequence did not receive activated charcoal during Period 2.|0
10563114|NCT01609218|11718159|FG000|COMPLETED|Period 2||9
10563115|NCT01609218|11718160|FG001|COMPLETED|Period 2||9
10563116|NCT01609218|11718159|FG000|NOT COMPLETED|Period 2||1
10563117|NCT01609218|11718160|FG001|NOT COMPLETED|Period 2||0
10563118|NCT01609257|11718168|FG000|STARTED|Overall Study||67
10563119|NCT01609257|11718169|FG001|STARTED|Overall Study||65
10563120|NCT01609257|11718168|FG000|Received 2 Doses|Overall Study||63
10563121|NCT01609257|11718169|FG001|Received 2 Doses|Overall Study||64
10563122|NCT01609257|11718168|FG000|Received Challenge Product|Overall Study||56
10563123|NCT01609257|11718169|FG001|Received Challenge Product|Overall Study||53
10563124|NCT01609257|11718168|FG000|COMPLETED|Overall Study||61
10563125|NCT01609257|11718169|FG001|COMPLETED|Overall Study||57
10563126|NCT01609257|11718168|FG000|NOT COMPLETED|Overall Study||6
10563127|NCT01609257|11718169|FG001|NOT COMPLETED|Overall Study||8
10563128|NCT01609296|11718178|FG000|STARTED|Overall Study||1406
10563129|NCT01609296|11718178|FG000|COMPLETED|Overall Study||918
10563130|NCT01609296|11718178|FG000|NOT COMPLETED|Overall Study||488
10563131|NCT01609348|11718188|FG000|STARTED|Overall Study||3
10563132|NCT01609348|11718189|FG001|STARTED|Overall Study||2
10563133|NCT01609348|11718188|FG000|COMPLETED|Overall Study||3
10563134|NCT01609348|11718189|FG001|COMPLETED|Overall Study||2
10563135|NCT01609348|11718188|FG000|NOT COMPLETED|Overall Study||0
10563136|NCT01609348|11718189|FG001|NOT COMPLETED|Overall Study||0
10563137|NCT01609478|11718198|FG000|STARTED|Overall Study||111
10563138|NCT01609478|11718199|FG001|STARTED|Overall Study||108
10563139|NCT01609478|11718200|FG002|STARTED|Overall Study||116
10563140|NCT01609478|11718198|FG000|Full Analysis Set (FAS)|Overall Study||110
10563141|NCT01609478|11718199|FG001|Full Analysis Set (FAS)|Overall Study||108
10563142|NCT01609478|11718200|FG002|Full Analysis Set (FAS)|Overall Study||115
10563143|NCT01609478|11718198|FG000|COMPLETED|Overall Study||104
10563144|NCT01609478|11718199|FG001|COMPLETED|Overall Study||106
10563145|NCT01609478|11718200|FG002|COMPLETED|Overall Study||107
10563146|NCT01609478|11718198|FG000|NOT COMPLETED|Overall Study||7
10563147|NCT01609478|11718199|FG001|NOT COMPLETED|Overall Study||2
10563148|NCT01609478|11718200|FG002|NOT COMPLETED|Overall Study||9
10563149|NCT01609543|11718208|FG000|STARTED|Overall Study||62
10563150|NCT01609543|11718208|FG000|COMPLETED|Overall Study||20
10563151|NCT01609543|11718208|FG000|NOT COMPLETED|Overall Study||42
10563152|NCT01609556|11718229|FG000|STARTED|Dose Escalation: Maximum 101.3 Weeks||2
10563153|NCT01609556|11718230|FG001|STARTED|Dose Escalation: Maximum 101.3 Weeks||1
10792150|NCT03575962|11953008|FG001|STARTED|Treatment Period 2 (4 Days)||7
10792151|NCT03575962|11953007|FG000|COMPLETED|Treatment Period 2 (4 Days)||7
10792152|NCT03575962|11953008|FG001|COMPLETED|Treatment Period 2 (4 Days)||7
10792153|NCT03575962|11953007|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0
10792154|NCT03575962|11953008|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0
10792155|NCT03575975|11953017|FG000|STARTED|Overall Study||4
10792156|NCT03575975|11953018|FG001|STARTED|Overall Study||5
10563154|NCT01609556|11718231|FG002|STARTED|Dose Escalation: Maximum 101.3 Weeks||1
10563155|NCT01609556|11718232|FG003|STARTED|Dose Escalation: Maximum 101.3 Weeks||1
10563156|NCT01609556|11718233|FG004|STARTED|Dose Escalation: Maximum 101.3 Weeks||9
10563157|NCT01609556|11718234|FG005|STARTED|Dose Escalation: Maximum 101.3 Weeks||18
10563158|NCT01609556|11718235|FG006|STARTED|Dose Escalation: Maximum 101.3 Weeks||7
10563159|NCT01609556|11718236|FG007|STARTED|Dose Escalation: Maximum 101.3 Weeks||5
10563160|NCT01609556|11718237|FG008|STARTED|Dose Escalation: Maximum 101.3 Weeks||5
10563161|NCT01609556|11718238|FG009|STARTED|Dose Escalation: Maximum 101.3 Weeks||4
10563162|NCT01609556|11718239|FG010|STARTED|Dose Escalation: Maximum 101.3 Weeks||9
10563163|NCT01609556|11718240|FG011|STARTED|Dose Escalation: Maximum 101.3 Weeks||7
10563164|NCT01609556|11718241|FG012|STARTED|Dose Escalation: Maximum 101.3 Weeks||0
10563165|NCT01609556|11718242|FG013|STARTED|Dose Escalation: Maximum 101.3 Weeks||0
10563166|NCT01609556|11718243|FG014|STARTED|Dose Escalation: Maximum 101.3 Weeks||0
10792157|NCT03575975|11953019|FG002|STARTED|Overall Study||0
10563167|NCT01609556|11718244|FG015|STARTED|Dose Escalation: Maximum 101.3 Weeks||0
10563168|NCT01609556|11718229|FG000|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||2
10563169|NCT01609556|11718230|FG001|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||1
10563170|NCT01609556|11718231|FG002|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||1
10563171|NCT01609556|11718232|FG003|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||1
10563172|NCT01609556|11718233|FG004|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||9
10563173|NCT01609556|11718234|FG005|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||18
10563174|NCT01609556|11718235|FG006|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||7
10563175|NCT01609556|11718236|FG007|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||5
10563176|NCT01609556|11718237|FG008|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||5
10563177|NCT01609556|11718238|FG009|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||4
10563178|NCT01609556|11718239|FG010|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||9
10563179|NCT01609556|11718240|FG011|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||7
10563180|NCT01609556|11718241|FG012|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||0
10563181|NCT01609556|11718242|FG013|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||0
10563182|NCT01609556|11718243|FG014|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||0
10563183|NCT01609556|11718244|FG015|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||0
10563184|NCT01609556|11718229|FG000|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
10563185|NCT01609556|11718230|FG001|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
10563186|NCT01609556|11718231|FG002|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
10563187|NCT01609556|11718232|FG003|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
10563188|NCT01609556|11718233|FG004|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
10563189|NCT01609556|11718234|FG005|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
10563190|NCT01609556|11718235|FG006|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
10563191|NCT01609556|11718236|FG007|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
10563192|NCT01609556|11718237|FG008|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
10563193|NCT01609556|11718238|FG009|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
10563194|NCT01609556|11718239|FG010|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
10563195|NCT01609556|11718240|FG011|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
10563196|NCT01609556|11718241|FG012|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
10563197|NCT01609556|11718242|FG013|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
10563198|NCT01609556|11718243|FG014|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
10563199|NCT01609556|11718244|FG015|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
10563200|NCT01609556|11718229|FG000|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||2
10563201|NCT01609556|11718230|FG001|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||1
10563202|NCT01609556|11718231|FG002|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||1
10792158|NCT03575975|11953017|FG000|COMPLETED|Overall Study||3
10792159|NCT03575975|11953018|FG001|COMPLETED|Overall Study||5
10792160|NCT03575975|11953019|FG002|COMPLETED|Overall Study||0
10792161|NCT03575975|11953017|FG000|NOT COMPLETED|Overall Study||1
10792162|NCT03575975|11953018|FG001|NOT COMPLETED|Overall Study||0
10792163|NCT03575975|11953019|FG002|NOT COMPLETED|Overall Study||0
10792164|NCT03576066|11953027|FG000|STARTED|Overall Study||45
10792165|NCT03576066|11953028|FG001|STARTED|Overall Study||28
10792166|NCT03576066|11953027|FG000|COMPLETED|Overall Study||45
10792167|NCT03576066|11953028|FG001|COMPLETED|Overall Study||27
10792168|NCT03576066|11953027|FG000|NOT COMPLETED|Overall Study||0
10792169|NCT03576066|11953028|FG001|NOT COMPLETED|Overall Study||1
10792170|NCT03576118|11953040|FG000|STARTED|Overall Study||37
10792171|NCT03576118|11953041|FG001|STARTED|Overall Study||37
10792172|NCT03576118|11953040|FG000|COMPLETED|Overall Study||34
10792173|NCT03576118|11953041|FG001|COMPLETED|Overall Study||33
10792174|NCT03576118|11953040|FG000|NOT COMPLETED|Overall Study||3
10792175|NCT03576118|11953041|FG001|NOT COMPLETED|Overall Study||4
10792176|NCT03576183|11953049|FG000|STARTED|Overall Study||17
10792177|NCT03576183|11953050|FG001|STARTED|Overall Study||17
10792178|NCT03576183|11953049|FG000|COMPLETED|Overall Study||15
10792179|NCT03576183|11953050|FG001|COMPLETED|Overall Study||16
10792180|NCT03576183|11953049|FG000|NOT COMPLETED|Overall Study||2
10792181|NCT03576183|11953050|FG001|NOT COMPLETED|Overall Study||1
10792182|NCT03576768|11953060|FG000|STARTED|Overall Study||13
10792183|NCT03576768|11953061|FG001|STARTED|Overall Study||12
10792235|NCT03578549|11953130|FG000|NOT COMPLETED|Overall Study||1
10792184|NCT03576768|11953062|FG002|STARTED|Overall Study|The study was ended before recruitment into this arm started.|0
10792185|NCT03576768|11953063|FG003|STARTED|Overall Study|The study was ended before recruitment into this arm started.|0
10792186|NCT03576768|11953060|FG000|COMPLETED|Overall Study||10
10792187|NCT03576768|11953061|FG001|COMPLETED|Overall Study||9
10792188|NCT03576768|11953062|FG002|COMPLETED|Overall Study||0
10792189|NCT03576768|11953063|FG003|COMPLETED|Overall Study||0
10792190|NCT03576768|11953060|FG000|NOT COMPLETED|Overall Study||3
10792191|NCT03576768|11953061|FG001|NOT COMPLETED|Overall Study||3
10792192|NCT03576768|11953062|FG002|NOT COMPLETED|Overall Study||0
10792193|NCT03576768|11953063|FG003|NOT COMPLETED|Overall Study||0
10792194|NCT03577171|11953075|FG000|STARTED|Overall Study||13
10792195|NCT03577171|11953076|FG001|STARTED|Overall Study||12
10792196|NCT03577171|11953075|FG000|COMPLETED|Overall Study||13
10792197|NCT03577171|11953076|FG001|COMPLETED|Overall Study||12
10563203|NCT01609556|11718232|FG003|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||1
10563204|NCT01609556|11718233|FG004|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||9
10563205|NCT01609556|11718234|FG005|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||18
10563206|NCT01609556|11718235|FG006|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||7
10563207|NCT01609556|11718236|FG007|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||5
10563208|NCT01609556|11718237|FG008|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||5
10563209|NCT01609556|11718238|FG009|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||4
10563210|NCT01609556|11718239|FG010|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||9
10563211|NCT01609556|11718240|FG011|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||7
10563212|NCT01609556|11718241|FG012|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
10563213|NCT01609556|11718242|FG013|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
10563214|NCT01609556|11718243|FG014|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
10563215|NCT01609556|11718244|FG015|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
10563216|NCT01609556|11718229|FG000|STARTED|Dose Expansion: Maximum 124 Weeks||0
10563217|NCT01609556|11718230|FG001|STARTED|Dose Expansion: Maximum 124 Weeks||0
10563218|NCT01609556|11718231|FG002|STARTED|Dose Expansion: Maximum 124 Weeks||0
10563219|NCT01609556|11718232|FG003|STARTED|Dose Expansion: Maximum 124 Weeks||0
10563220|NCT01609556|11718233|FG004|STARTED|Dose Expansion: Maximum 124 Weeks||0
10563221|NCT01609556|11718234|FG005|STARTED|Dose Expansion: Maximum 124 Weeks||0
10563222|NCT01609556|11718235|FG006|STARTED|Dose Expansion: Maximum 124 Weeks||0
10563223|NCT01609556|11718236|FG007|STARTED|Dose Expansion: Maximum 124 Weeks||0
10563224|NCT01609556|11718237|FG008|STARTED|Dose Expansion: Maximum 124 Weeks||0
10563225|NCT01609556|11718238|FG009|STARTED|Dose Expansion: Maximum 124 Weeks||0
10563226|NCT01609556|11718239|FG010|STARTED|Dose Expansion: Maximum 124 Weeks||0
10563227|NCT01609556|11718240|FG011|STARTED|Dose Expansion: Maximum 124 Weeks||0
10563228|NCT01609556|11718241|FG012|STARTED|Dose Expansion: Maximum 124 Weeks||46
10563229|NCT01609556|11718242|FG013|STARTED|Dose Expansion: Maximum 124 Weeks||24
10563230|NCT01609556|11718243|FG014|STARTED|Dose Expansion: Maximum 124 Weeks||27
10563231|NCT01609556|11718244|FG015|STARTED|Dose Expansion: Maximum 124 Weeks||40
10563232|NCT01609556|11718229|FG000|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
10563233|NCT01609556|11718230|FG001|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
10563234|NCT01609556|11718231|FG002|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
10563235|NCT01609556|11718232|FG003|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
10792198|NCT03577171|11953075|FG000|NOT COMPLETED|Overall Study||0
10792199|NCT03577171|11953076|FG001|NOT COMPLETED|Overall Study||0
10792200|NCT03577275|11953082|FG000|STARTED|Overall Study|All participants received all of the 4 interventions|32
10792201|NCT03577275|11953082|FG000|Placebo|Overall Study||32
10792202|NCT03577275|11953082|FG000|Moxifloxacin 400mg|Overall Study||32
10792203|NCT03577275|11953082|FG000|NST-4016 600mg|Overall Study||32
10792204|NCT03577275|11953082|FG000|NST-4016 2000mg|Overall Study||32
10792205|NCT03577275|11953082|FG000|COMPLETED|Overall Study||32
10792206|NCT03577275|11953082|FG000|NOT COMPLETED|Overall Study||0
10792207|NCT03577730|11953098|FG000|STARTED|Overall Study||34
10792208|NCT03577730|11953099|FG001|STARTED|Overall Study||31
10792209|NCT03577730|11953098|FG000|Received Treatment|Overall Study||33
10792210|NCT03577730|11953099|FG001|Received Treatment|Overall Study||31
10792211|NCT03577730|11953098|FG000|COMPLETED|Overall Study||30
10792212|NCT03577730|11953099|FG001|COMPLETED|Overall Study||30
10792213|NCT03577730|11953098|FG000|NOT COMPLETED|Overall Study||4
10792214|NCT03577730|11953099|FG001|NOT COMPLETED|Overall Study||1
10792215|NCT03578146|11953111|FG000|STARTED|Overall Study||16
10792216|NCT03578146|11953112|FG001|STARTED|Overall Study||6
10792217|NCT03578146|11953113|FG002|STARTED|Overall Study||6
10792218|NCT03578146|11953114|FG003|STARTED|Overall Study||6
10792219|NCT03578146|11953115|FG004|STARTED|Overall Study||6
10792220|NCT03578146|11953116|FG005|STARTED|Overall Study||8
10792221|NCT03578146|11953111|FG000|COMPLETED|Overall Study||15
10792222|NCT03578146|11953112|FG001|COMPLETED|Overall Study||5
10792223|NCT03578146|11953113|FG002|COMPLETED|Overall Study||5
10792224|NCT03578146|11953114|FG003|COMPLETED|Overall Study||6
10792225|NCT03578146|11953115|FG004|COMPLETED|Overall Study||6
10792226|NCT03578146|11953116|FG005|COMPLETED|Overall Study||5
10792227|NCT03578146|11953111|FG000|NOT COMPLETED|Overall Study||1
10792228|NCT03578146|11953112|FG001|NOT COMPLETED|Overall Study||1
10792229|NCT03578146|11953113|FG002|NOT COMPLETED|Overall Study||1
10792230|NCT03578146|11953114|FG003|NOT COMPLETED|Overall Study||0
10792231|NCT03578146|11953115|FG004|NOT COMPLETED|Overall Study||0
10792232|NCT03578146|11953116|FG005|NOT COMPLETED|Overall Study||3
10792233|NCT03578549|11953130|FG000|STARTED|Overall Study||30
10792234|NCT03578549|11953130|FG000|COMPLETED|Overall Study||29
10792236|NCT03578926|11953134|FG000|STARTED|First Intervention||21
10792237|NCT03578926|11953135|FG001|STARTED|First Intervention||23
10792238|NCT03578926|11953134|FG000|COMPLETED|First Intervention||21
10792239|NCT03578926|11953135|FG001|COMPLETED|First Intervention||23
10792240|NCT03578926|11953134|FG000|NOT COMPLETED|First Intervention||0
10792241|NCT03578926|11953135|FG001|NOT COMPLETED|First Intervention||0
10792242|NCT03578926|11953134|FG000|STARTED|Second Intervention||23
10792243|NCT03578926|11953135|FG001|STARTED|Second Intervention||21
10792244|NCT03578926|11953134|FG000|COMPLETED|Second Intervention||23
10792245|NCT03578926|11953135|FG001|COMPLETED|Second Intervention||21
10792246|NCT03578926|11953134|FG000|NOT COMPLETED|Second Intervention||0
10792247|NCT03578926|11953135|FG001|NOT COMPLETED|Second Intervention||0
10792248|NCT03579290|11953143|FG000|STARTED|Overall Study||40
10563236|NCT01609556|11718233|FG004|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
10563237|NCT01609556|11718234|FG005|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
10563238|NCT01609556|11718235|FG006|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
10563239|NCT01609556|11718236|FG007|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
10563240|NCT01609556|11718237|FG008|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
10563241|NCT01609556|11718238|FG009|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
10563242|NCT01609556|11718239|FG010|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
10563243|NCT01609556|11718240|FG011|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
10563244|NCT01609556|11718241|FG012|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
10563245|NCT01609556|11718242|FG013|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
10563246|NCT01609556|11718243|FG014|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
10563247|NCT01609556|11718244|FG015|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
10563248|NCT01609556|11718229|FG000|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
10563249|NCT01609556|11718230|FG001|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
10563250|NCT01609556|11718231|FG002|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
10563251|NCT01609556|11718232|FG003|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
10563252|NCT01609556|11718233|FG004|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
10563253|NCT01609556|11718234|FG005|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
10563254|NCT01609556|11718235|FG006|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
10563255|NCT01609556|11718236|FG007|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
10563256|NCT01609556|11718237|FG008|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
10563257|NCT01609556|11718238|FG009|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
10563258|NCT01609556|11718239|FG010|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
10563259|NCT01609556|11718240|FG011|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
10563260|NCT01609556|11718241|FG012|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||46
10563261|NCT01609556|11718242|FG013|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||24
10563262|NCT01609556|11718243|FG014|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||27
10563263|NCT01609556|11718244|FG015|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||40
10563264|NCT01609582|11718287|FG000|STARTED|Overall Study||1603
10563265|NCT01609582|11718288|FG001|STARTED|Overall Study||1604
10563266|NCT01609582|11718287|FG000|Treated|Overall Study||1603
10563267|NCT01609582|11718288|FG001|Treated|Overall Study||1601
10563268|NCT01609582|11718287|FG000|COMPLETED|Overall Study||0
10563269|NCT01609582|11718288|FG001|COMPLETED|Overall Study||0
10563270|NCT01609582|11718287|FG000|NOT COMPLETED|Overall Study||1603
10563271|NCT01609582|11718288|FG001|NOT COMPLETED|Overall Study||1604
10563272|NCT01609933|11718294|FG000|STARTED|Overall Study||32
10563273|NCT01609933|11718294|FG000|COMPLETED|Overall Study||28
10563274|NCT01609933|11718294|FG000|NOT COMPLETED|Overall Study||4
10563275|NCT01610011|11718302|FG000|STARTED|Overall Study||19
10563276|NCT01610011|11718303|FG001|STARTED|Overall Study||2
10563277|NCT01610011|11718302|FG000|COMPLETED|Overall Study||9
10563278|NCT01610011|11718303|FG001|COMPLETED|Overall Study||2
10563279|NCT01610011|11718302|FG000|NOT COMPLETED|Overall Study||10
10563280|NCT01610011|11718303|FG001|NOT COMPLETED|Overall Study||0
10563281|NCT01610037|11718312|FG000|STARTED|All Patients||407
10563282|NCT01610037|11718313|FG001|STARTED|All Patients||405
10563283|NCT01610037|11718314|FG002|STARTED|All Patients||404
10563284|NCT01610037|11718312|FG000|Randomized Set (RAN)|All Patients||407
10563285|NCT01610037|11718313|FG001|Randomized Set (RAN)|All Patients||405
10563286|NCT01610037|11718314|FG002|Randomized Set (RAN)|All Patients||404
10563287|NCT01610037|11718312|FG000|Full Analysis Set (FAS)|All Patients||407
10563288|NCT01610037|11718313|FG001|Full Analysis Set (FAS)|All Patients||405
10563289|NCT01610037|11718314|FG002|Full Analysis Set (FAS)|All Patients||403
10563290|NCT01610037|11718312|FG000|COMPLETED|All Patients||348
10563291|NCT01610037|11718313|FG001|COMPLETED|All Patients||354
10563292|NCT01610037|11718314|FG002|COMPLETED|All Patients||320
10563293|NCT01610037|11718312|FG000|NOT COMPLETED|All Patients||59
10563294|NCT01610037|11718313|FG001|NOT COMPLETED|All Patients||51
10563295|NCT01610037|11718314|FG002|NOT COMPLETED|All Patients||84
10563296|NCT01610037|11718312|FG000|STARTED|Treatment and Follow up Period||407
10563297|NCT01610037|11718313|FG001|STARTED|Treatment and Follow up Period||405
10563298|NCT01610037|11718314|FG002|STARTED|Treatment and Follow up Period||404
10563299|NCT01610037|11718312|FG000|COMPLETED|Treatment and Follow up Period||382
10563300|NCT01610037|11718313|FG001|COMPLETED|Treatment and Follow up Period||377
10563301|NCT01610037|11718314|FG002|COMPLETED|Treatment and Follow up Period||378
10792249|NCT03579290|11953143|FG000|COMPLETED|Overall Study||31
10792250|NCT03579290|11953143|FG000|NOT COMPLETED|Overall Study||9
10563302|NCT01610037|11718312|FG000|NOT COMPLETED|Treatment and Follow up Period||25
10563303|NCT01610037|11718313|FG001|NOT COMPLETED|Treatment and Follow up Period||28
10563304|NCT01610037|11718314|FG002|NOT COMPLETED|Treatment and Follow up Period||26
10563305|NCT01610063|11718324|FG000|STARTED|Overall Study||114
10563306|NCT01610063|11718325|FG001|STARTED|Overall Study||113
10563307|NCT01610063|11718324|FG000|Baseline|Overall Study||114
10563308|NCT01610063|11718325|FG001|Baseline|Overall Study||113
10563309|NCT01610063|11718324|FG000|Completed 2-week|Overall Study||97
10563310|NCT01610063|11718325|FG001|Completed 2-week|Overall Study||105
10563311|NCT01610063|11718324|FG000|Completed 4-week|Overall Study||86
10563312|NCT01610063|11718325|FG001|Completed 4-week|Overall Study||98
10563313|NCT01610063|11718324|FG000|Completed 8-week|Overall Study||72
10563314|NCT01610063|11718325|FG001|Completed 8-week|Overall Study||93
10563315|NCT01610063|11718324|FG000|COMPLETED|Overall Study||72
10563316|NCT01610063|11718325|FG001|COMPLETED|Overall Study||93
10792251|NCT03579433|11953147|FG000|STARTED|Overall Study||104
10563317|NCT01610063|11718324|FG000|NOT COMPLETED|Overall Study||42
10563318|NCT01610063|11718325|FG001|NOT COMPLETED|Overall Study||20
10563319|NCT01610076|11718333|FG000|STARTED|Overall Study||103
10563320|NCT01610076|11718334|FG001|STARTED|Overall Study||105
10563321|NCT01610076|11718333|FG000|COMPLETED|Overall Study||100
10563322|NCT01610076|11718334|FG001|COMPLETED|Overall Study||100
10563323|NCT01610076|11718333|FG000|NOT COMPLETED|Overall Study||3
10563324|NCT01610076|11718334|FG001|NOT COMPLETED|Overall Study||5
10563325|NCT01610154|11718341|FG000|STARTED|Overall Study||85
10563326|NCT01610154|11718341|FG000|COMPLETED|Overall Study||84
10563327|NCT01610154|11718341|FG000|NOT COMPLETED|Overall Study||1
10563328|NCT01610167|11718350|FG000|STARTED|Overall Study||52
10563329|NCT01610167|11718351|FG001|STARTED|Overall Study||49
10563330|NCT01610167|11718352|FG002|STARTED|Overall Study||50
10563331|NCT01610167|11718350|FG000|COMPLETED|Overall Study||52
10563332|NCT01610167|11718351|FG001|COMPLETED|Overall Study||49
10563333|NCT01610167|11718352|FG002|COMPLETED|Overall Study||48
10563334|NCT01610167|11718350|FG000|NOT COMPLETED|Overall Study||0
10563335|NCT01610167|11718351|FG001|NOT COMPLETED|Overall Study||0
10563336|NCT01610167|11718352|FG002|NOT COMPLETED|Overall Study||2
10563337|NCT01610206|11718362|FG000|STARTED|Overall Study||73
10563338|NCT01610206|11718363|FG001|STARTED|Overall Study||75
10563339|NCT01610206|11718362|FG000|COMPLETED|Overall Study||63
10563340|NCT01610206|11718363|FG001|COMPLETED|Overall Study||45
10563341|NCT01610206|11718362|FG000|NOT COMPLETED|Overall Study||10
10563342|NCT01610206|11718363|FG001|NOT COMPLETED|Overall Study||30
10563343|NCT01610271|11718371|FG000|STARTED|Overall Study||150
10563344|NCT01610271|11718372|FG001|STARTED|Overall Study||150
10563345|NCT01610271|11718371|FG000|COMPLETED|Overall Study||148
10563346|NCT01610271|11718372|FG001|COMPLETED|Overall Study||146
10563347|NCT01610271|11718371|FG000|NOT COMPLETED|Overall Study||2
10563348|NCT01610271|11718372|FG001|NOT COMPLETED|Overall Study||4
10563349|NCT01610284|11718382|FG000|STARTED|Randomization Phase||576
10563350|NCT01610284|11718383|FG001|STARTED|Randomization Phase||571
10563351|NCT01610284|11718382|FG000|Safety Set (SS)|Randomization Phase||573
10563352|NCT01610284|11718383|FG001|Safety Set (SS)|Randomization Phase||570
10563353|NCT01610284|11718382|FG000|COMPLETED|Randomization Phase||574
10563354|NCT01610284|11718383|FG001|COMPLETED|Randomization Phase||569
10563355|NCT01610284|11718382|FG000|NOT COMPLETED|Randomization Phase||2
10563356|NCT01610284|11718383|FG001|NOT COMPLETED|Randomization Phase||2
10563357|NCT01610284|11718382|FG000|STARTED|Treatment Phase||574
10563358|NCT01610284|11718383|FG001|STARTED|Treatment Phase||569
10563359|NCT01610284|11718382|FG000|BKM120 Pharmacokinetic Analysis Set|Treatment Phase||93
10563360|NCT01610284|11718383|FG001|BKM120 Pharmacokinetic Analysis Set|Treatment Phase||0
10563361|NCT01610284|11718382|FG000|Full Pharmacokinetic Analysis Set (FPAS)|Treatment Phase||35
10563362|NCT01610284|11718383|FG001|Full Pharmacokinetic Analysis Set (FPAS)|Treatment Phase||0
10563363|NCT01610284|11718382|FG000|COMPLETED|Treatment Phase||0
10563364|NCT01610284|11718383|FG001|COMPLETED|Treatment Phase||0
10563365|NCT01610284|11718382|FG000|NOT COMPLETED|Treatment Phase||574
10563366|NCT01610284|11718383|FG001|NOT COMPLETED|Treatment Phase||569
10563367|NCT01610284|11718382|FG000|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|89
10563368|NCT01610284|11718383|FG001|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|29
10563369|NCT01610284|11718382|FG000|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
10563370|NCT01610284|11718383|FG001|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
10563371|NCT01610284|11718382|FG000|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||89
10563372|NCT01610284|11718383|FG001|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||29
10563373|NCT01610297|11718389|FG000|STARTED|Overall Study||27
10563374|NCT01610297|11718389|FG000|COMPLETED|Overall Study||26
10563375|NCT01610297|11718389|FG000|NOT COMPLETED|Overall Study||1
10563376|NCT01610336|11718404|FG000|STARTED|Overall Study||5
10563377|NCT01610336|11718405|FG001|STARTED|Overall Study||7
10563378|NCT01610336|11718406|FG002|STARTED|Overall Study||6
10563379|NCT01610336|11718407|FG003|STARTED|Overall Study||7
10563380|NCT01610336|11718408|FG004|STARTED|Overall Study||4
10563381|NCT01610336|11718409|FG005|STARTED|Overall Study||12
10563382|NCT01610336|11718410|FG006|STARTED|Overall Study||5
10563383|NCT01610336|11718411|FG007|STARTED|Overall Study||7
10563384|NCT01610336|11718412|FG008|STARTED|Overall Study||8
10563385|NCT01610336|11718413|FG009|STARTED|Overall Study||53
10563386|NCT01610336|11718414|FG010|STARTED|Overall Study||47
10563387|NCT01610336|11718404|FG000|COMPLETED|Overall Study||0
10563388|NCT01610336|11718405|FG001|COMPLETED|Overall Study||0
10563389|NCT01610336|11718406|FG002|COMPLETED|Overall Study||0
10563390|NCT01610336|11718407|FG003|COMPLETED|Overall Study||0
10563391|NCT01610336|11718408|FG004|COMPLETED|Overall Study||0
10563392|NCT01610336|11718409|FG005|COMPLETED|Overall Study||0
10563393|NCT01610336|11718410|FG006|COMPLETED|Overall Study||0
10563394|NCT01610336|11718411|FG007|COMPLETED|Overall Study||0
10563395|NCT01610336|11718412|FG008|COMPLETED|Overall Study||0
10563396|NCT01610336|11718413|FG009|COMPLETED|Overall Study||0
10563397|NCT01610336|11718414|FG010|COMPLETED|Overall Study||0
10563398|NCT01610336|11718404|FG000|NOT COMPLETED|Overall Study||5
10563399|NCT01610336|11718405|FG001|NOT COMPLETED|Overall Study||7
10563400|NCT01610336|11718406|FG002|NOT COMPLETED|Overall Study||6
10563401|NCT01610336|11718407|FG003|NOT COMPLETED|Overall Study||7
10563402|NCT01610336|11718408|FG004|NOT COMPLETED|Overall Study||4
10563403|NCT01610336|11718409|FG005|NOT COMPLETED|Overall Study||12
10563404|NCT01610336|11718410|FG006|NOT COMPLETED|Overall Study||5
10563405|NCT01610336|11718411|FG007|NOT COMPLETED|Overall Study||7
10563406|NCT01610336|11718412|FG008|NOT COMPLETED|Overall Study||8
10563407|NCT01610336|11718413|FG009|NOT COMPLETED|Overall Study||53
10563408|NCT01610336|11718414|FG010|NOT COMPLETED|Overall Study||47
10563409|NCT01610414|11718444|FG000|STARTED|Study Start - Month 13||922
10563410|NCT01610414|11718445|FG001|STARTED|Study Start - Month 13||924
10563411|NCT01610414|11718444|FG000|COMPLETED|Study Start - Month 13||807
10563412|NCT01610414|11718445|FG001|COMPLETED|Study Start - Month 13||795
10563413|NCT01610414|11718444|FG000|NOT COMPLETED|Study Start - Month 13||115
10563414|NCT01610414|11718445|FG001|NOT COMPLETED|Study Start - Month 13||129
10563415|NCT01610414|11718444|FG000|STARTED|Month 13 - Month 25||922
10563416|NCT01610414|11718445|FG001|STARTED|Month 13 - Month 25||924
10563417|NCT01610414|11718444|FG000|COMPLETED|Month 13 - Month 25||857
10563418|NCT01610414|11718445|FG001|COMPLETED|Month 13 - Month 25||854
10563419|NCT01610414|11718444|FG000|NOT COMPLETED|Month 13 - Month 25||65
10563420|NCT01610414|11718445|FG001|NOT COMPLETED|Month 13 - Month 25||70
10563421|NCT01610414|11718444|FG000|STARTED|After Month 25||922
10563422|NCT01610414|11718445|FG001|STARTED|After Month 25||924
10563423|NCT01610414|11718444|FG000|COMPLETED|After Month 25||874
10563424|NCT01610414|11718445|FG001|COMPLETED|After Month 25||871
10563425|NCT01610414|11718444|FG000|NOT COMPLETED|After Month 25||48
10563426|NCT01610414|11718445|FG001|NOT COMPLETED|After Month 25||53
10563427|NCT01610427|11718452|FG000|STARTED|Overall Study||22
10563428|NCT01610427|11718452|FG000|COMPLETED|Overall Study||22
10563429|NCT01610427|11718452|FG000|NOT COMPLETED|Overall Study||0
10563430|NCT01610453|11718456|FG000|STARTED|Overall Study||150
10563431|NCT01610453|11718456|FG000|COMPLETED|Overall Study||150
10563432|NCT01610453|11718456|FG000|NOT COMPLETED|Overall Study||0
10563433|NCT01610492|11718461|FG000|STARTED|Overall Study||14
10563434|NCT01610492|11718461|FG000|COMPLETED|Overall Study||8
10563435|NCT01610492|11718461|FG000|NOT COMPLETED|Overall Study||6
10563436|NCT01610557|11718469|FG000|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 1: 14 unilateral and 2 bilateral (left eye assigned to Grp 3)|16
10563437|NCT01610557|11718470|FG001|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 2: 12 unilateral and 1 bilateral (left eye assigned to Grp 4)|13
10563438|NCT01610557|11718471|FG002|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 3: 13 unilateral and 1 bilateral (left eye assigned to Grp 1)|14
10563439|NCT01610557|11718472|FG003|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 4: 11 unilateral and 2 bilateral (left eye assigned to Grp 2)|13
10563440|NCT01610557|11718473|FG004|STARTED|36-Week Randomized Crossover Phase|Not applicable for 36-week double-masked randomized crossover phase|0
10563441|NCT01610557|11718469|FG000|COMPLETED|36-Week Randomized Crossover Phase||16
10563442|NCT01610557|11718470|FG001|COMPLETED|36-Week Randomized Crossover Phase|Unilateral participant unable to return for visits after Wk 4 due to recovery from an adverse event|12
10563443|NCT01610557|11718471|FG002|COMPLETED|36-Week Randomized Crossover Phase||14
10563444|NCT01610557|11718472|FG003|COMPLETED|36-Week Randomized Crossover Phase||13
10563445|NCT01610557|11718473|FG004|COMPLETED|36-Week Randomized Crossover Phase|Not applicable for 36-week double-masked randomized crossover phase|0
10563446|NCT01610557|11718469|FG000|NOT COMPLETED|36-Week Randomized Crossover Phase||0
10563447|NCT01610557|11718470|FG001|NOT COMPLETED|36-Week Randomized Crossover Phase||1
10563448|NCT01610557|11718471|FG002|NOT COMPLETED|36-Week Randomized Crossover Phase||0
10563449|NCT01610557|11718472|FG003|NOT COMPLETED|36-Week Randomized Crossover Phase||0
10563450|NCT01610557|11718473|FG004|NOT COMPLETED|36-Week Randomized Crossover Phase||0
10563451|NCT01610557|11718469|FG000|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
10563452|NCT01610557|11718470|FG001|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
10563453|NCT01610557|11718471|FG002|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
10563454|NCT01610557|11718472|FG003|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
10563455|NCT01610557|11718473|FG004|STARTED|Post-36-Week Extension Phase||55
10563456|NCT01610557|11718469|FG000|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
10563457|NCT01610557|11718470|FG001|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
10563458|NCT01610557|11718471|FG002|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
10563459|NCT01610557|11718472|FG003|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
10563460|NCT01610557|11718473|FG004|COMPLETED|Post-36-Week Extension Phase|2 bilateral participants withdrew before their first post-36-week extension visit|52
10563461|NCT01610557|11718469|FG000|NOT COMPLETED|Post-36-Week Extension Phase||0
10563462|NCT01610557|11718470|FG001|NOT COMPLETED|Post-36-Week Extension Phase||0
10563463|NCT01610557|11718471|FG002|NOT COMPLETED|Post-36-Week Extension Phase||0
10563464|NCT01610557|11718472|FG003|NOT COMPLETED|Post-36-Week Extension Phase||0
10563465|NCT01610557|11718473|FG004|NOT COMPLETED|Post-36-Week Extension Phase||3
10792252|NCT03579433|11953147|FG000|ORA With VerifEye+|Overall Study||96
10792253|NCT03579433|11953147|FG000|Barrett Calculator|Overall Study||102
10792254|NCT03579433|11953147|FG000|COMPLETED|Overall Study||98
10792255|NCT03579433|11953147|FG000|NOT COMPLETED|Overall Study||6
10792256|NCT03579719|11953155|FG000|STARTED|Overall Study||15
10792257|NCT03579719|11953155|FG000|COMPLETED|Overall Study||14
10792258|NCT03579719|11953155|FG000|NOT COMPLETED|Overall Study||1
10792259|NCT03579940|11953170|FG000|STARTED|Period 1||3
10792260|NCT03579940|11953171|FG001|STARTED|Period 1||2
10792261|NCT03579940|11953172|FG002|STARTED|Period 1||2
10792262|NCT03579940|11953173|FG003|STARTED|Period 1||2
10792263|NCT03579940|11953174|FG004|STARTED|Period 1||2
10563466|NCT01610570|11718488|FG000|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
10563467|NCT01610570|11718489|FG001|STARTED|Ph I >/= 12 mo. Children & Adolescents||2
10563468|NCT01610570|11718490|FG002|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
10563469|NCT01610570|11718491|FG003|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
10563470|NCT01610570|11718488|FG000|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
10563471|NCT01610570|11718489|FG001|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||2
10563472|NCT01610570|11718490|FG002|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
10563473|NCT01610570|11718491|FG003|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
10563474|NCT01610570|11718488|FG000|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
10563475|NCT01610570|11718489|FG001|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
10563476|NCT01610570|11718490|FG002|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
10563477|NCT01610570|11718491|FG003|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
10563478|NCT01610570|11718488|FG000|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
10563479|NCT01610570|11718489|FG001|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
10563480|NCT01610570|11718490|FG002|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
10563481|NCT01610570|11718491|FG003|STARTED|Ph II >/= 18yrs of Age at Enrollment||6
10563482|NCT01610570|11718488|FG000|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
10563483|NCT01610570|11718489|FG001|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
10563484|NCT01610570|11718490|FG002|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
10563485|NCT01610570|11718491|FG003|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||6
10563486|NCT01610570|11718488|FG000|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
10563487|NCT01610570|11718489|FG001|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
10563488|NCT01610570|11718490|FG002|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
10563489|NCT01610570|11718491|FG003|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
10563490|NCT01610570|11718488|FG000|STARTED|Ph II >/= 12 mo. & </=17yrs||0
10563491|NCT01610570|11718489|FG001|STARTED|Ph II >/= 12 mo. & </=17yrs||0
10563492|NCT01610570|11718490|FG002|STARTED|Ph II >/= 12 mo. & </=17yrs||0
10563493|NCT01610570|11718491|FG003|STARTED|Ph II >/= 12 mo. & </=17yrs||0
10563494|NCT01610570|11718488|FG000|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
10563495|NCT01610570|11718489|FG001|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
10563496|NCT01610570|11718490|FG002|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
10563497|NCT01610570|11718491|FG003|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
10563498|NCT01610570|11718488|FG000|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
10563499|NCT01610570|11718489|FG001|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
10792264|NCT03579940|11953175|FG005|STARTED|Period 1||2
10792265|NCT03579940|11953176|FG006|STARTED|Period 1||3
10792266|NCT03579940|11953177|FG007|STARTED|Period 1||3
10792267|NCT03579940|11953178|FG008|STARTED|Period 1||3
10792268|NCT03579940|11953179|FG009|STARTED|Period 1||2
10792269|NCT03579940|11953180|FG010|STARTED|Period 1||3
10792270|NCT03579940|11953170|FG000|Received at Least 1 Dose of Study Drug|Period 1||3
10792271|NCT03579940|11953171|FG001|Received at Least 1 Dose of Study Drug|Period 1||2
10792272|NCT03579940|11953172|FG002|Received at Least 1 Dose of Study Drug|Period 1||2
10792273|NCT03579940|11953173|FG003|Received at Least 1 Dose of Study Drug|Period 1||2
10792274|NCT03579940|11953174|FG004|Received at Least 1 Dose of Study Drug|Period 1||2
10792275|NCT03579940|11953175|FG005|Received at Least 1 Dose of Study Drug|Period 1||2
10792276|NCT03579940|11953176|FG006|Received at Least 1 Dose of Study Drug|Period 1||3
10792277|NCT03579940|11953177|FG007|Received at Least 1 Dose of Study Drug|Period 1||3
10792278|NCT03579940|11953178|FG008|Received at Least 1 Dose of Study Drug|Period 1||3
10792279|NCT03579940|11953179|FG009|Received at Least 1 Dose of Study Drug|Period 1||2
10792280|NCT03579940|11953180|FG010|Received at Least 1 Dose of Study Drug|Period 1||3
10792281|NCT03579940|11953170|FG000|COMPLETED|Period 1||3
10792282|NCT03579940|11953171|FG001|COMPLETED|Period 1||2
10792283|NCT03579940|11953172|FG002|COMPLETED|Period 1||2
10792284|NCT03579940|11953173|FG003|COMPLETED|Period 1||2
10792285|NCT03579940|11953174|FG004|COMPLETED|Period 1||2
10792286|NCT03579940|11953175|FG005|COMPLETED|Period 1||2
10792287|NCT03579940|11953176|FG006|COMPLETED|Period 1||3
10792288|NCT03579940|11953177|FG007|COMPLETED|Period 1||3
10792289|NCT03579940|11953178|FG008|COMPLETED|Period 1||3
10792290|NCT03579940|11953179|FG009|COMPLETED|Period 1||2
10792291|NCT03579940|11953180|FG010|COMPLETED|Period 1||3
10792292|NCT03579940|11953170|FG000|NOT COMPLETED|Period 1||0
10792293|NCT03579940|11953171|FG001|NOT COMPLETED|Period 1||0
10792294|NCT03579940|11953172|FG002|NOT COMPLETED|Period 1||0
10792295|NCT03579940|11953173|FG003|NOT COMPLETED|Period 1||0
10792296|NCT03579940|11953174|FG004|NOT COMPLETED|Period 1||0
10792297|NCT03579940|11953175|FG005|NOT COMPLETED|Period 1||0
10792298|NCT03579940|11953176|FG006|NOT COMPLETED|Period 1||0
10792299|NCT03579940|11953177|FG007|NOT COMPLETED|Period 1||0
10792300|NCT03579940|11953178|FG008|NOT COMPLETED|Period 1||0
10792301|NCT03579940|11953179|FG009|NOT COMPLETED|Period 1||0
10792302|NCT03579940|11953180|FG010|NOT COMPLETED|Period 1||0
10792303|NCT03579940|11953170|FG000|STARTED|Period 2||3
10792304|NCT03579940|11953171|FG001|STARTED|Period 2||2
10792305|NCT03579940|11953172|FG002|STARTED|Period 2||2
10792306|NCT03579940|11953173|FG003|STARTED|Period 2||2
10792307|NCT03579940|11953174|FG004|STARTED|Period 2||2
10792308|NCT03579940|11953175|FG005|STARTED|Period 2||2
10792309|NCT03579940|11953176|FG006|STARTED|Period 2||3
10792310|NCT03579940|11953177|FG007|STARTED|Period 2||3
10792311|NCT03579940|11953178|FG008|STARTED|Period 2||3
10792312|NCT03579940|11953179|FG009|STARTED|Period 2||2
10792313|NCT03579940|11953180|FG010|STARTED|Period 2||3
10792314|NCT03579940|11953170|FG000|COMPLETED|Period 2||3
10563500|NCT01610570|11718490|FG002|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
10563501|NCT01610570|11718491|FG003|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
10563502|NCT01610596|11718509|FG000|STARTED|Overall Study||36
10563503|NCT01610596|11718510|FG001|STARTED|Overall Study||36
10563504|NCT01610596|11718509|FG000|COMPLETED|Overall Study||36
10563505|NCT01610596|11718510|FG001|COMPLETED|Overall Study||35
10563506|NCT01610596|11718509|FG000|NOT COMPLETED|Overall Study||0
10563507|NCT01610596|11718510|FG001|NOT COMPLETED|Overall Study||1
10563508|NCT01610687|11718516|FG000|STARTED|Overall Study||137
10563509|NCT01610687|11718516|FG000|COMPLETED|Overall Study||70
10563510|NCT01610687|11718516|FG000|NOT COMPLETED|Overall Study||67
10563511|NCT01610700|11718522|FG000|STARTED|Overall Study||80
10563512|NCT01610700|11718523|FG001|STARTED|Overall Study||80
10563513|NCT01610700|11718522|FG000|COMPLETED|Overall Study||77
10563514|NCT01610700|11718523|FG001|COMPLETED|Overall Study||77
10563515|NCT01610700|11718522|FG000|NOT COMPLETED|Overall Study||3
10792315|NCT03579940|11953171|FG001|COMPLETED|Period 2||2
10792316|NCT03579940|11953172|FG002|COMPLETED|Period 2||1
10792317|NCT03579940|11953173|FG003|COMPLETED|Period 2||2
10792318|NCT03579940|11953174|FG004|COMPLETED|Period 2||2
10792319|NCT03579940|11953175|FG005|COMPLETED|Period 2||2
10792320|NCT03579940|11953176|FG006|COMPLETED|Period 2||3
10792321|NCT03579940|11953177|FG007|COMPLETED|Period 2||3
10792322|NCT03579940|11953178|FG008|COMPLETED|Period 2||3
10792323|NCT03579940|11953179|FG009|COMPLETED|Period 2||2
10792324|NCT03579940|11953180|FG010|COMPLETED|Period 2||3
10792325|NCT03579940|11953170|FG000|NOT COMPLETED|Period 2||0
10792326|NCT03579940|11953171|FG001|NOT COMPLETED|Period 2||0
10792327|NCT03579940|11953172|FG002|NOT COMPLETED|Period 2||1
10792328|NCT03579940|11953173|FG003|NOT COMPLETED|Period 2||0
10792329|NCT03579940|11953174|FG004|NOT COMPLETED|Period 2||0
10792330|NCT03579940|11953175|FG005|NOT COMPLETED|Period 2||0
10792331|NCT03579940|11953176|FG006|NOT COMPLETED|Period 2||0
10792332|NCT03579940|11953177|FG007|NOT COMPLETED|Period 2||0
10792333|NCT03579940|11953178|FG008|NOT COMPLETED|Period 2||0
10792334|NCT03579940|11953179|FG009|NOT COMPLETED|Period 2||0
10792335|NCT03579940|11953180|FG010|NOT COMPLETED|Period 2||0
10792336|NCT03579940|11953170|FG000|STARTED|Period 3||3
10792337|NCT03579940|11953171|FG001|STARTED|Period 3||2
10792338|NCT03579940|11953172|FG002|STARTED|Period 3||1
10792339|NCT03579940|11953173|FG003|STARTED|Period 3||2
10792340|NCT03579940|11953174|FG004|STARTED|Period 3||2
10792341|NCT03579940|11953175|FG005|STARTED|Period 3||2
10792342|NCT03579940|11953176|FG006|STARTED|Period 3||3
10792343|NCT03579940|11953177|FG007|STARTED|Period 3||3
10792344|NCT03579940|11953178|FG008|STARTED|Period 3||3
10792345|NCT03579940|11953179|FG009|STARTED|Period 3||2
10792346|NCT03579940|11953180|FG010|STARTED|Period 3||3
10792347|NCT03579940|11953170|FG000|COMPLETED|Period 3||3
10792348|NCT03579940|11953171|FG001|COMPLETED|Period 3||2
10792349|NCT03579940|11953172|FG002|COMPLETED|Period 3||1
10792350|NCT03579940|11953173|FG003|COMPLETED|Period 3||2
10792351|NCT03579940|11953174|FG004|COMPLETED|Period 3||2
10792352|NCT03579940|11953175|FG005|COMPLETED|Period 3||2
10792353|NCT03579940|11953176|FG006|COMPLETED|Period 3||3
10792354|NCT03579940|11953177|FG007|COMPLETED|Period 3||3
10792355|NCT03579940|11953178|FG008|COMPLETED|Period 3||3
10792356|NCT03579940|11953179|FG009|COMPLETED|Period 3||2
10792357|NCT03579940|11953180|FG010|COMPLETED|Period 3||3
10792358|NCT03579940|11953170|FG000|NOT COMPLETED|Period 3||0
10792359|NCT03579940|11953171|FG001|NOT COMPLETED|Period 3||0
10792360|NCT03579940|11953172|FG002|NOT COMPLETED|Period 3||0
10792361|NCT03579940|11953173|FG003|NOT COMPLETED|Period 3||0
10792362|NCT03579940|11953174|FG004|NOT COMPLETED|Period 3||0
10792363|NCT03579940|11953175|FG005|NOT COMPLETED|Period 3||0
10792364|NCT03579940|11953176|FG006|NOT COMPLETED|Period 3||0
10792365|NCT03579940|11953177|FG007|NOT COMPLETED|Period 3||0
10792366|NCT03579940|11953178|FG008|NOT COMPLETED|Period 3||0
10792367|NCT03579940|11953179|FG009|NOT COMPLETED|Period 3||0
10792368|NCT03579940|11953180|FG010|NOT COMPLETED|Period 3||0
10792369|NCT03580343|11953212|FG000|STARTED|Overall Study||5
10792370|NCT03580343|11953212|FG000|COMPLETED|Overall Study||4
10792371|NCT03580343|11953212|FG000|NOT COMPLETED|Overall Study||1
10792372|NCT03581084|11953216|FG000|STARTED|Overall Study||1
10792373|NCT03581084|11953216|FG000|COMPLETED|Overall Study||1
10792374|NCT03581084|11953216|FG000|NOT COMPLETED|Overall Study||0
10792375|NCT03581097|11953222|FG000|STARTED|Overall Study||46
10563516|NCT01610700|11718523|FG001|NOT COMPLETED|Overall Study||3
10650992|NCT02173535|11811297|FG000|NOT COMPLETED|Period 2||0
10650993|NCT02173535|11811298|FG001|NOT COMPLETED|Period 2||0
10650994|NCT02173535|11811299|FG002|NOT COMPLETED|Period 2||0
10792376|NCT03581097|11953223|FG001|STARTED|Overall Study||47
10650995|NCT02173535|11811300|FG003|NOT COMPLETED|Period 2||0
10792377|NCT03581097|11953222|FG000|COMPLETED|Overall Study||46
10792378|NCT03581097|11953223|FG001|COMPLETED|Overall Study||47
10792379|NCT03581097|11953222|FG000|NOT COMPLETED|Overall Study||0
10792380|NCT03581097|11953223|FG001|NOT COMPLETED|Overall Study||0
10792381|NCT03581474|11953231|FG000|STARTED|Overall Study||12
10792382|NCT03581474|11953231|FG000|COMPLETED|Overall Study||12
10792383|NCT03581474|11953231|FG000|NOT COMPLETED|Overall Study||0
10792384|NCT03581825|11953235|FG000|STARTED|Period 1||31
10792385|NCT03581825|11953236|FG001|STARTED|Period 1||31
10792386|NCT03581825|11953235|FG000|COMPLETED|Period 1||30
10792387|NCT03581825|11953236|FG001|COMPLETED|Period 1||31
10792388|NCT03581825|11953235|FG000|NOT COMPLETED|Period 1||1
10792389|NCT03581825|11953236|FG001|NOT COMPLETED|Period 1||0
10792390|NCT03581825|11953235|FG000|STARTED|Period 2||30
10563517|NCT01610713|11718532|FG000|STARTED|Overall Study||77
10563518|NCT01610713|11718533|FG001|STARTED|Overall Study||77
10563519|NCT01610713|11718532|FG000|COMPLETED|Overall Study||71
10563520|NCT01610713|11718533|FG001|COMPLETED|Overall Study||76
10563521|NCT01610713|11718532|FG000|NOT COMPLETED|Overall Study||6
10563522|NCT01610713|11718533|FG001|NOT COMPLETED|Overall Study||1
10563523|NCT01610752|11718542|FG000|STARTED|Overall Study||18
10563524|NCT01610752|11718543|FG001|STARTED|Overall Study||19
10563525|NCT01610752|11718544|FG002|STARTED|Overall Study||17
10563526|NCT01610752|11718542|FG000|COMPLETED|Overall Study||18
10563527|NCT01610752|11718543|FG001|COMPLETED|Overall Study||19
10563528|NCT01610752|11718544|FG002|COMPLETED|Overall Study||13
10563529|NCT01610752|11718542|FG000|NOT COMPLETED|Overall Study||0
10563530|NCT01610752|11718543|FG001|NOT COMPLETED|Overall Study||0
10563531|NCT01610752|11718544|FG002|NOT COMPLETED|Overall Study||4
10563532|NCT01610791|11718552|FG000|STARTED|Overall Study||121
10563533|NCT01610791|11718552|FG000|COMPLETED|Overall Study||100
10563534|NCT01610791|11718552|FG000|NOT COMPLETED|Overall Study||21
10563535|NCT01611090|11718558|FG000|STARTED|Randomized Period||289
10563536|NCT01611090|11718559|FG001|STARTED|Randomized Period||289
10563537|NCT01611090|11718560|FG002|STARTED|Randomized Period||0
10563538|NCT01611090|11718558|FG000|Treated|Randomized Period||287
10563539|NCT01611090|11718559|FG001|Treated|Randomized Period||287
10563540|NCT01611090|11718560|FG002|Treated|Randomized Period||0
10563541|NCT01611090|11718558|FG000|COMPLETED|Randomized Period||259
10792391|NCT03581825|11953236|FG001|STARTED|Period 2||31
10792392|NCT03581825|11953235|FG000|COMPLETED|Period 2||30
10792393|NCT03581825|11953236|FG001|COMPLETED|Period 2||30
10792394|NCT03581825|11953235|FG000|NOT COMPLETED|Period 2||0
10792395|NCT03581825|11953236|FG001|NOT COMPLETED|Period 2||1
10792396|NCT03582215|11953250|FG000|STARTED|Overall Study||6
10792397|NCT03582215|11953251|FG001|STARTED|Overall Study||6
10792398|NCT03582215|11953252|FG002|STARTED|Overall Study||6
10792399|NCT03582215|11953253|FG003|STARTED|Overall Study||6
10792400|NCT03582215|11953254|FG004|STARTED|Overall Study||12
10792401|NCT03582215|11953255|FG005|STARTED|Overall Study||12
10792402|NCT03582215|11953256|FG006|STARTED|Overall Study||12
10792403|NCT03582215|11953257|FG007|STARTED|Overall Study||12
10792404|NCT03582215|11953250|FG000|COMPLETED|Overall Study||5
10792405|NCT03582215|11953251|FG001|COMPLETED|Overall Study||6
10792406|NCT03582215|11953252|FG002|COMPLETED|Overall Study||6
10792407|NCT03582215|11953253|FG003|COMPLETED|Overall Study||6
10792408|NCT03582215|11953254|FG004|COMPLETED|Overall Study||12
10792409|NCT03582215|11953255|FG005|COMPLETED|Overall Study||12
10792410|NCT03582215|11953256|FG006|COMPLETED|Overall Study||10
10792411|NCT03582215|11953257|FG007|COMPLETED|Overall Study||10
10792412|NCT03582215|11953250|FG000|NOT COMPLETED|Overall Study||1
10792413|NCT03582215|11953251|FG001|NOT COMPLETED|Overall Study||0
10792414|NCT03582215|11953252|FG002|NOT COMPLETED|Overall Study||0
10792415|NCT03582215|11953253|FG003|NOT COMPLETED|Overall Study||0
10792416|NCT03582215|11953254|FG004|NOT COMPLETED|Overall Study||0
10792417|NCT03582215|11953255|FG005|NOT COMPLETED|Overall Study||0
10792418|NCT03582215|11953256|FG006|NOT COMPLETED|Overall Study||2
10792419|NCT03582215|11953257|FG007|NOT COMPLETED|Overall Study||2
10792420|NCT03582553|11953292|FG000|STARTED|Intervention 1/Visit 1||3
10792421|NCT03582553|11953293|FG001|STARTED|Intervention 1/Visit 1||3
10792422|NCT03582553|11953294|FG002|STARTED|Intervention 1/Visit 1||3
10792423|NCT03582553|11953295|FG003|STARTED|Intervention 1/Visit 1||3
10792424|NCT03582553|11953296|FG004|STARTED|Intervention 1/Visit 1||3
10792425|NCT03582553|11953297|FG005|STARTED|Intervention 1/Visit 1||3
10792426|NCT03582553|11953292|FG000|COMPLETED|Intervention 1/Visit 1||3
10792427|NCT03582553|11953293|FG001|COMPLETED|Intervention 1/Visit 1||3
10792428|NCT03582553|11953294|FG002|COMPLETED|Intervention 1/Visit 1||3
10792429|NCT03582553|11953295|FG003|COMPLETED|Intervention 1/Visit 1||3
10792430|NCT03582553|11953296|FG004|COMPLETED|Intervention 1/Visit 1||3
10792431|NCT03582553|11953297|FG005|COMPLETED|Intervention 1/Visit 1||3
10792432|NCT03582553|11953292|FG000|NOT COMPLETED|Intervention 1/Visit 1||0
10792433|NCT03582553|11953293|FG001|NOT COMPLETED|Intervention 1/Visit 1||0
10792434|NCT03582553|11953294|FG002|NOT COMPLETED|Intervention 1/Visit 1||0
10792435|NCT03582553|11953295|FG003|NOT COMPLETED|Intervention 1/Visit 1||0
10792436|NCT03582553|11953296|FG004|NOT COMPLETED|Intervention 1/Visit 1||0
10792437|NCT03582553|11953297|FG005|NOT COMPLETED|Intervention 1/Visit 1||0
10792438|NCT03582553|11953292|FG000|STARTED|Washout Period ( At Least 1 Week)||3
10792439|NCT03582553|11953293|FG001|STARTED|Washout Period ( At Least 1 Week)||3
10792440|NCT03582553|11953294|FG002|STARTED|Washout Period ( At Least 1 Week)||3
10792441|NCT03582553|11953295|FG003|STARTED|Washout Period ( At Least 1 Week)||3
10792442|NCT03582553|11953296|FG004|STARTED|Washout Period ( At Least 1 Week)||3
10792443|NCT03582553|11953297|FG005|STARTED|Washout Period ( At Least 1 Week)||3
10792444|NCT03582553|11953292|FG000|COMPLETED|Washout Period ( At Least 1 Week)||3
10792445|NCT03582553|11953293|FG001|COMPLETED|Washout Period ( At Least 1 Week)||3
10563542|NCT01611090|11718559|FG001|COMPLETED|Randomized Period||260
10563543|NCT01611090|11718560|FG002|COMPLETED|Randomized Period||0
10563544|NCT01611090|11718558|FG000|NOT COMPLETED|Randomized Period||30
10792446|NCT03582553|11953294|FG002|COMPLETED|Washout Period ( At Least 1 Week)||3
10563545|NCT01611090|11718559|FG001|NOT COMPLETED|Randomized Period||29
10563546|NCT01611090|11718560|FG002|NOT COMPLETED|Randomized Period||0
10563547|NCT01611090|11718558|FG000|STARTED|Cross Over (Placebo to Ibrutinib)||0
10792447|NCT03582553|11953295|FG003|COMPLETED|Washout Period ( At Least 1 Week)||3
10792448|NCT03582553|11953296|FG004|COMPLETED|Washout Period ( At Least 1 Week)||3
10810753|NCT03792672|11972458|FG002|NOT COMPLETED|Treatment Period 3 (1 Day)||0
10563548|NCT01611090|11718559|FG001|STARTED|Cross Over (Placebo to Ibrutinib)||0
10563549|NCT01611090|11718560|FG002|STARTED|Cross Over (Placebo to Ibrutinib)||183
10563550|NCT01611090|11718558|FG000|Treated|Cross Over (Placebo to Ibrutinib)||0
10563551|NCT01611090|11718559|FG001|Treated|Cross Over (Placebo to Ibrutinib)||0
10563552|NCT01611090|11718560|FG002|Treated|Cross Over (Placebo to Ibrutinib)||183
10563553|NCT01611090|11718558|FG000|COMPLETED|Cross Over (Placebo to Ibrutinib)||0
10563554|NCT01611090|11718559|FG001|COMPLETED|Cross Over (Placebo to Ibrutinib)||0
10563555|NCT01611090|11718560|FG002|COMPLETED|Cross Over (Placebo to Ibrutinib)||178
10563556|NCT01611090|11718558|FG000|NOT COMPLETED|Cross Over (Placebo to Ibrutinib)||0
10563557|NCT01611090|11718559|FG001|NOT COMPLETED|Cross Over (Placebo to Ibrutinib)||0
10563558|NCT01611090|11718560|FG002|NOT COMPLETED|Cross Over (Placebo to Ibrutinib)||5
10563559|NCT01611155|11718569|FG000|STARTED|Overall Study||25
10563560|NCT01611155|11718570|FG001|STARTED|Overall Study||25
10563561|NCT01611155|11718569|FG000|Received Treatment|Overall Study||25
10563562|NCT01611155|11718570|FG001|Received Treatment|Overall Study||25
10563563|NCT01611155|11718569|FG000|COMPLETED|Overall Study||16
10563564|NCT01611155|11718570|FG001|COMPLETED|Overall Study||18
10563565|NCT01611155|11718569|FG000|NOT COMPLETED|Overall Study||9
10563566|NCT01611155|11718570|FG001|NOT COMPLETED|Overall Study||7
10563567|NCT01611194|11718578|FG000|STARTED|Overall Study||36
10792449|NCT03582553|11953297|FG005|COMPLETED|Washout Period ( At Least 1 Week)||3
10792450|NCT03582553|11953292|FG000|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
10792451|NCT03582553|11953293|FG001|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
10792452|NCT03582553|11953294|FG002|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
10792453|NCT03582553|11953295|FG003|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
10792454|NCT03582553|11953296|FG004|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
10792455|NCT03582553|11953297|FG005|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
10792456|NCT03582553|11953292|FG000|STARTED|Intervention 2/Visit 2||3
10792457|NCT03582553|11953293|FG001|STARTED|Intervention 2/Visit 2||3
10792458|NCT03582553|11953294|FG002|STARTED|Intervention 2/Visit 2||3
10792459|NCT03582553|11953295|FG003|STARTED|Intervention 2/Visit 2||3
10792460|NCT03582553|11953296|FG004|STARTED|Intervention 2/Visit 2||3
10792461|NCT03582553|11953297|FG005|STARTED|Intervention 2/Visit 2||3
10792462|NCT03582553|11953292|FG000|COMPLETED|Intervention 2/Visit 2||3
10792463|NCT03582553|11953293|FG001|COMPLETED|Intervention 2/Visit 2||3
10792464|NCT03582553|11953294|FG002|COMPLETED|Intervention 2/Visit 2||3
10792465|NCT03582553|11953295|FG003|COMPLETED|Intervention 2/Visit 2||3
10792466|NCT03582553|11953296|FG004|COMPLETED|Intervention 2/Visit 2||3
10792467|NCT03582553|11953297|FG005|COMPLETED|Intervention 2/Visit 2||3
10792468|NCT03582553|11953292|FG000|NOT COMPLETED|Intervention 2/Visit 2||0
10792469|NCT03582553|11953293|FG001|NOT COMPLETED|Intervention 2/Visit 2||0
10792470|NCT03582553|11953294|FG002|NOT COMPLETED|Intervention 2/Visit 2||0
10792471|NCT03582553|11953295|FG003|NOT COMPLETED|Intervention 2/Visit 2||0
10792472|NCT03582553|11953296|FG004|NOT COMPLETED|Intervention 2/Visit 2||0
10792473|NCT03582553|11953297|FG005|NOT COMPLETED|Intervention 2/Visit 2||0
10792474|NCT03582553|11953292|FG000|STARTED|Washout Period (At Least 1 Week)||3
10792475|NCT03582553|11953293|FG001|STARTED|Washout Period (At Least 1 Week)||3
10792476|NCT03582553|11953294|FG002|STARTED|Washout Period (At Least 1 Week)||3
10792477|NCT03582553|11953295|FG003|STARTED|Washout Period (At Least 1 Week)||3
10792478|NCT03582553|11953296|FG004|STARTED|Washout Period (At Least 1 Week)||3
10792479|NCT03582553|11953297|FG005|STARTED|Washout Period (At Least 1 Week)||3
10792480|NCT03582553|11953292|FG000|COMPLETED|Washout Period (At Least 1 Week)||3
10792481|NCT03582553|11953293|FG001|COMPLETED|Washout Period (At Least 1 Week)||3
10792482|NCT03582553|11953294|FG002|COMPLETED|Washout Period (At Least 1 Week)||3
10792483|NCT03582553|11953295|FG003|COMPLETED|Washout Period (At Least 1 Week)||3
10792484|NCT03582553|11953296|FG004|COMPLETED|Washout Period (At Least 1 Week)||3
10792485|NCT03582553|11953297|FG005|COMPLETED|Washout Period (At Least 1 Week)||3
10792486|NCT03582553|11953292|FG000|NOT COMPLETED|Washout Period (At Least 1 Week)||0
10792487|NCT03582553|11953293|FG001|NOT COMPLETED|Washout Period (At Least 1 Week)||0
10792488|NCT03582553|11953294|FG002|NOT COMPLETED|Washout Period (At Least 1 Week)||0
10792489|NCT03582553|11953295|FG003|NOT COMPLETED|Washout Period (At Least 1 Week)||0
10792490|NCT03582553|11953296|FG004|NOT COMPLETED|Washout Period (At Least 1 Week)||0
10792491|NCT03582553|11953297|FG005|NOT COMPLETED|Washout Period (At Least 1 Week)||0
10792492|NCT03582553|11953292|FG000|STARTED|Intervention 3/Visit 3||3
10563568|NCT01611194|11718579|FG001|STARTED|Overall Study||35
10563569|NCT01611194|11718578|FG000|COMPLETED|Overall Study||36
10563570|NCT01611194|11718579|FG001|COMPLETED|Overall Study||32
10563571|NCT01611194|11718578|FG000|NOT COMPLETED|Overall Study||0
10563572|NCT01611194|11718579|FG001|NOT COMPLETED|Overall Study||3
10563573|NCT01611259|11718585|FG000|STARTED|Overall Study||48
10792493|NCT03582553|11953293|FG001|STARTED|Intervention 3/Visit 3||3
10792494|NCT03582553|11953294|FG002|STARTED|Intervention 3/Visit 3||3
10792495|NCT03582553|11953295|FG003|STARTED|Intervention 3/Visit 3||3
10792496|NCT03582553|11953296|FG004|STARTED|Intervention 3/Visit 3||3
10792497|NCT03582553|11953297|FG005|STARTED|Intervention 3/Visit 3||3
10563574|NCT01611259|11718585|FG000|COMPLETED|Overall Study||34
10563575|NCT01611259|11718585|FG000|NOT COMPLETED|Overall Study||14
10792498|NCT03582553|11953292|FG000|COMPLETED|Intervention 3/Visit 3||3
10792499|NCT03582553|11953293|FG001|COMPLETED|Intervention 3/Visit 3||3
10792500|NCT03582553|11953294|FG002|COMPLETED|Intervention 3/Visit 3||3
10792501|NCT03582553|11953295|FG003|COMPLETED|Intervention 3/Visit 3||3
10792502|NCT03582553|11953296|FG004|COMPLETED|Intervention 3/Visit 3||3
10792503|NCT03582553|11953297|FG005|COMPLETED|Intervention 3/Visit 3||3
10563576|NCT01611298|11718589|FG000|STARTED|Overall Study||7
10563577|NCT01611298|11718589|FG000|COMPLETED|Overall Study||5
10563578|NCT01611298|11718589|FG000|NOT COMPLETED|Overall Study||2
10563579|NCT01611454|11718595|FG000|STARTED|Overall Study||58
10563580|NCT01611454|11718596|FG001|STARTED|Overall Study||48
10563581|NCT01611454|11718595|FG000|COMPLETED|Overall Study||40
10563582|NCT01611454|11718596|FG001|COMPLETED|Overall Study||38
10563583|NCT01611454|11718595|FG000|NOT COMPLETED|Overall Study||18
10563584|NCT01611454|11718596|FG001|NOT COMPLETED|Overall Study||10
10563585|NCT01611558|11718606|FG000|STARTED|Induction Phase||40
10563586|NCT01611558|11718606|FG000|COMPLETED|Induction Phase||2
10563587|NCT01611558|11718606|FG000|NOT COMPLETED|Induction Phase||38
10563588|NCT01611558|11718606|FG000|STARTED|Maintenance Phase||2
10563589|NCT01611558|11718606|FG000|COMPLETED|Maintenance Phase||0
10563590|NCT01611558|11718606|FG000|NOT COMPLETED|Maintenance Phase||2
10563591|NCT01611571|11718614|FG000|STARTED|Overall Study||11
10563592|NCT01611571|11718615|FG001|STARTED|Overall Study||10
10563593|NCT01611571|11718616|FG002|STARTED|Overall Study||10
10563594|NCT01611571|11718614|FG000|COMPLETED|Overall Study||10
10563595|NCT01611571|11718615|FG001|COMPLETED|Overall Study||10
10563596|NCT01611571|11718616|FG002|COMPLETED|Overall Study||9
10563597|NCT01611571|11718614|FG000|NOT COMPLETED|Overall Study||1
10563598|NCT01611571|11718615|FG001|NOT COMPLETED|Overall Study||0
10563599|NCT01611571|11718616|FG002|NOT COMPLETED|Overall Study||1
10563600|NCT01611662|11718624|FG000|STARTED|Overall Study||32
10563601|NCT01611662|11718624|FG000|COMPLETED|Overall Study||31
10563602|NCT01611662|11718624|FG000|NOT COMPLETED|Overall Study||1
10563603|NCT01611779|11718628|FG000|STARTED|Overall Study||5
10563604|NCT01611779|11718628|FG000|COMPLETED|Overall Study||5
10563605|NCT01611779|11718628|FG000|NOT COMPLETED|Overall Study||0
10563606|NCT01611792|11718634|FG000|STARTED|Initial Period: Time 0||29
10563607|NCT01611792|11718635|FG001|STARTED|Initial Period: Time 0||29
10563608|NCT01611792|11718634|FG000|COMPLETED|Initial Period: Time 0||17
10563609|NCT01611792|11718635|FG001|COMPLETED|Initial Period: Time 0||20
10563610|NCT01611792|11718634|FG000|NOT COMPLETED|Initial Period: Time 0||12
10563611|NCT01611792|11718635|FG001|NOT COMPLETED|Initial Period: Time 0||9
10563612|NCT01611792|11718634|FG000|STARTED|Follow-up: at 11 Weeks||17
10563613|NCT01611792|11718635|FG001|STARTED|Follow-up: at 11 Weeks||20
10563614|NCT01611792|11718634|FG000|COMPLETED|Follow-up: at 11 Weeks||17
10563615|NCT01611792|11718635|FG001|COMPLETED|Follow-up: at 11 Weeks||20
10563616|NCT01611792|11718634|FG000|NOT COMPLETED|Follow-up: at 11 Weeks||0
10563617|NCT01611792|11718635|FG001|NOT COMPLETED|Follow-up: at 11 Weeks||0
10563618|NCT01611792|11718634|FG000|STARTED|Followup: at 6 Months||17
10563619|NCT01611792|11718635|FG001|STARTED|Followup: at 6 Months||20
10563620|NCT01611792|11718634|FG000|COMPLETED|Followup: at 6 Months||11
10563621|NCT01611792|11718635|FG001|COMPLETED|Followup: at 6 Months||7
10563622|NCT01611792|11718634|FG000|NOT COMPLETED|Followup: at 6 Months||6
10563623|NCT01611792|11718635|FG001|NOT COMPLETED|Followup: at 6 Months||13
10563624|NCT01611857|11718644|FG000|STARTED|Overall Study|Three dose levels of tivantinib (120 mg, 240 mg, and 360 mg) were evaluated to determine the MTD.|15
10563625|NCT01611857|11718645|FG001|STARTED|Overall Study||34
10563626|NCT01611857|11718644|FG000|Tivantinib 120 mg|Overall Study||5
10563627|NCT01611857|11718645|FG001|Tivantinib 120 mg|Overall Study||0
10563628|NCT01611857|11718644|FG000|Tivantinib 240 mg|Overall Study||3
10563629|NCT01611857|11718645|FG001|Tivantinib 240 mg|Overall Study||0
10563630|NCT01611857|11718644|FG000|Tivantinib 360 mg|Overall Study||7
10563631|NCT01611857|11718645|FG001|Tivantinib 360 mg|Overall Study|Two participants withdrew prior to receiving drug.|32
10563632|NCT01611857|11718644|FG000|COMPLETED|Overall Study||15
10563633|NCT01611857|11718645|FG001|COMPLETED|Overall Study||32
10563634|NCT01611857|11718644|FG000|NOT COMPLETED|Overall Study||0
10563635|NCT01611857|11718645|FG001|NOT COMPLETED|Overall Study||2
10563636|NCT01611935|11718655|FG000|STARTED|Overall Study||50
10563637|NCT01611935|11718656|FG001|STARTED|Overall Study||51
10563638|NCT01611935|11718655|FG000|COMPLETED|Overall Study||49
10563639|NCT01611935|11718656|FG001|COMPLETED|Overall Study||51
10563640|NCT01611935|11718655|FG000|NOT COMPLETED|Overall Study||1
10563641|NCT01611935|11718656|FG001|NOT COMPLETED|Overall Study||0
10563642|NCT01611948|11718664|FG000|STARTED|Overall Study||32
10563643|NCT01611948|11718665|FG001|STARTED|Overall Study||38
10563644|NCT01611948|11718664|FG000|COMPLETED|Overall Study||18
10563645|NCT01611948|11718665|FG001|COMPLETED|Overall Study||26
10563646|NCT01611948|11718664|FG000|NOT COMPLETED|Overall Study||14
10563647|NCT01611948|11718665|FG001|NOT COMPLETED|Overall Study||12
10563648|NCT01611974|11718674|FG000|STARTED|Overall Study||40
10563649|NCT01611974|11718675|FG001|STARTED|Overall Study||40
10563650|NCT01611974|11718676|FG002|STARTED|Overall Study||40
10563651|NCT01611974|11718674|FG000|COMPLETED|Overall Study||25
10563652|NCT01611974|11718675|FG001|COMPLETED|Overall Study||25
10563653|NCT01611974|11718676|FG002|COMPLETED|Overall Study||24
10563654|NCT01611974|11718674|FG000|NOT COMPLETED|Overall Study||15
10563655|NCT01611974|11718675|FG001|NOT COMPLETED|Overall Study||15
10563656|NCT01611974|11718676|FG002|NOT COMPLETED|Overall Study||16
10563657|NCT01612000|11718688|FG000|STARTED|Overall Study||84
10563658|NCT01612000|11718689|FG001|STARTED|Overall Study||86
10563659|NCT01612000|11718690|FG002|STARTED|Overall Study||85
10563660|NCT01612000|11718691|FG003|STARTED|Overall Study||86
10563661|NCT01612000|11718688|FG000|COMPLETED|Overall Study||75
10563662|NCT01612000|11718689|FG001|COMPLETED|Overall Study||81
10563663|NCT01612000|11718690|FG002|COMPLETED|Overall Study||78
10563664|NCT01612000|11718691|FG003|COMPLETED|Overall Study||76
10563665|NCT01612000|11718688|FG000|NOT COMPLETED|Overall Study||9
10563666|NCT01612000|11718689|FG001|NOT COMPLETED|Overall Study||5
10563667|NCT01612000|11718690|FG002|NOT COMPLETED|Overall Study||7
10563668|NCT01612000|11718691|FG003|NOT COMPLETED|Overall Study||10
10563669|NCT01612156|11718703|FG000|STARTED|Overall Study||42
10563670|NCT01612156|11718704|FG001|STARTED|Overall Study||48
10563671|NCT01612156|11718703|FG000|COMPLETED|Overall Study|Contraindication to urodynamics (urinary tract infection) diagnosed after randomization|40
10563672|NCT01612156|11718704|FG001|COMPLETED|Overall Study||48
10563673|NCT01612156|11718703|FG000|NOT COMPLETED|Overall Study||2
10563674|NCT01612156|11718704|FG001|NOT COMPLETED|Overall Study||0
10563675|NCT01612221|11718712|FG000|STARTED|Overall Study||50
10563676|NCT01612221|11718713|FG001|STARTED|Overall Study||50
10563677|NCT01612221|11718712|FG000|COMPLETED|Overall Study||50
10563678|NCT01612221|11718713|FG001|COMPLETED|Overall Study||50
10563679|NCT01612221|11718712|FG000|NOT COMPLETED|Overall Study||0
10563680|NCT01612221|11718713|FG001|NOT COMPLETED|Overall Study||0
10563681|NCT01612494|11718721|FG000|STARTED|Overall Study||21
10792504|NCT03582553|11953292|FG000|NOT COMPLETED|Intervention 3/Visit 3||0
10792505|NCT03582553|11953293|FG001|NOT COMPLETED|Intervention 3/Visit 3||0
10792506|NCT03582553|11953294|FG002|NOT COMPLETED|Intervention 3/Visit 3||0
10792507|NCT03582553|11953295|FG003|NOT COMPLETED|Intervention 3/Visit 3||0
10792508|NCT03582553|11953296|FG004|NOT COMPLETED|Intervention 3/Visit 3||0
10792509|NCT03582553|11953297|FG005|NOT COMPLETED|Intervention 3/Visit 3||0
10792510|NCT03582813|11953317|FG000|STARTED|Overall Study||114
10563682|NCT01612494|11718722|FG001|STARTED|Overall Study||23
10563683|NCT01612494|11718721|FG000|COMPLETED|Overall Study||21
10563684|NCT01612494|11718722|FG001|COMPLETED|Overall Study||23
10563685|NCT01612494|11718721|FG000|NOT COMPLETED|Overall Study||0
10563686|NCT01612494|11718722|FG001|NOT COMPLETED|Overall Study||0
10563687|NCT01612546|11718728|FG000|STARTED|Overall Study||10
10563688|NCT01612546|11718728|FG000|COMPLETED|Overall Study||10
10563689|NCT01612546|11718728|FG000|NOT COMPLETED|Overall Study||0
10563690|NCT01612676|11718736|FG000|STARTED|Overall Study||6
10792511|NCT03582813|11953318|FG001|STARTED|Overall Study||102
10563691|NCT01612676|11718737|FG001|STARTED|Overall Study||7
10563692|NCT01612676|11718738|FG002|STARTED|Overall Study||5
10563693|NCT01612676|11718739|FG003|STARTED|Overall Study||13
10563694|NCT01612676|11718736|FG000|Dosed|Overall Study||5
10563695|NCT01612676|11718737|FG001|Dosed|Overall Study||7
10563696|NCT01612676|11718738|FG002|Dosed|Overall Study||5
10563697|NCT01612676|11718739|FG003|Dosed|Overall Study||13
10563698|NCT01612676|11718736|FG000|COMPLETED|Overall Study||4
10563699|NCT01612676|11718737|FG001|COMPLETED|Overall Study||3
10563700|NCT01612676|11718738|FG002|COMPLETED|Overall Study||4
10563701|NCT01612676|11718739|FG003|COMPLETED|Overall Study||10
10563702|NCT01612676|11718736|FG000|NOT COMPLETED|Overall Study||2
10563703|NCT01612676|11718737|FG001|NOT COMPLETED|Overall Study||4
10563704|NCT01612676|11718738|FG002|NOT COMPLETED|Overall Study||1
10563705|NCT01612676|11718739|FG003|NOT COMPLETED|Overall Study||3
10563706|NCT01612702|11718753|FG000|STARTED|Overall Study||146
10792512|NCT03582813|11953317|FG000|COMPLETED|Overall Study||95
10792513|NCT03582813|11953318|FG001|COMPLETED|Overall Study||81
10792514|NCT03582813|11953317|FG000|NOT COMPLETED|Overall Study||19
10792515|NCT03582813|11953318|FG001|NOT COMPLETED|Overall Study||21
10792516|NCT03582826|11953326|FG000|STARTED|Overall Study||119
10563707|NCT01612702|11718754|FG001|STARTED|Overall Study||145
10563708|NCT01612702|11718753|FG000|COMPLETED|Overall Study||135
10563709|NCT01612702|11718754|FG001|COMPLETED|Overall Study||134
10563710|NCT01612702|11718753|FG000|NOT COMPLETED|Overall Study||11
10563711|NCT01612702|11718754|FG001|NOT COMPLETED|Overall Study||11
10563712|NCT01612767|11718760|FG000|STARTED|Overall Study||329
10563713|NCT01612767|11718760|FG000|COMPLETED|Overall Study||287
10563714|NCT01612767|11718760|FG000|NOT COMPLETED|Overall Study||42
10563715|NCT01612780|11718785|FG000|STARTED|Overall Study||82
10563716|NCT01612780|11718785|FG000|COMPLETED|Overall Study||76
10563717|NCT01612780|11718785|FG000|NOT COMPLETED|Overall Study||6
10563718|NCT01612793|11718791|FG000|STARTED|Overall Study||2
10563719|NCT01612793|11718792|FG001|STARTED|Overall Study||2
10563720|NCT01612793|11718791|FG000|COMPLETED|Overall Study||2
10563721|NCT01612793|11718792|FG001|COMPLETED|Overall Study||2
10563722|NCT01612793|11718791|FG000|NOT COMPLETED|Overall Study||0
10563723|NCT01612793|11718792|FG001|NOT COMPLETED|Overall Study||0
10563724|NCT01612858|11718800|FG000|STARTED|Overall Study||16
10563725|NCT01612858|11718801|FG001|STARTED|Overall Study||4
10563726|NCT01612858|11718800|FG000|COMPLETED|Overall Study||11
10563727|NCT01612858|11718801|FG001|COMPLETED|Overall Study||3
10563728|NCT01612858|11718800|FG000|NOT COMPLETED|Overall Study||5
10563729|NCT01612858|11718801|FG001|NOT COMPLETED|Overall Study||1
10563730|NCT01612884|11718809|FG000|STARTED|Overall Study||19
10563731|NCT01612884|11718810|FG001|STARTED|Overall Study||18
10563732|NCT01612884|11718809|FG000|COMPLETED|Overall Study||19
10563733|NCT01612884|11718810|FG001|COMPLETED|Overall Study||18
10563734|NCT01612884|11718809|FG000|NOT COMPLETED|Overall Study||0
10563735|NCT01612884|11718810|FG001|NOT COMPLETED|Overall Study||0
10563736|NCT01613014|11718818|FG000|STARTED|Overall Study||75
10563737|NCT01613014|11718819|FG001|STARTED|Overall Study||75
10563738|NCT01613014|11718818|FG000|COMPLETED|Overall Study||57
10563739|NCT01613014|11718819|FG001|COMPLETED|Overall Study||63
10563740|NCT01613014|11718818|FG000|NOT COMPLETED|Overall Study||18
10563741|NCT01613014|11718819|FG001|NOT COMPLETED|Overall Study||12
10563742|NCT01613027|11718825|FG000|STARTED|Overall Study||135
10563743|NCT01613027|11718825|FG000|COMPLETED|Overall Study||127
10563744|NCT01613027|11718825|FG000|NOT COMPLETED|Overall Study||8
10563745|NCT01613131|11718831|FG000|STARTED|Overall Study||20
10563746|NCT01613131|11718832|FG001|STARTED|Overall Study||18
10563747|NCT01613131|11718831|FG000|COMPLETED|Overall Study||17
10563748|NCT01613131|11718832|FG001|COMPLETED|Overall Study||13
10563749|NCT01613131|11718831|FG000|NOT COMPLETED|Overall Study||3
10563750|NCT01613131|11718832|FG001|NOT COMPLETED|Overall Study||5
10563751|NCT01613222|11718838|FG000|STARTED|Overall Study||63
10563752|NCT01613222|11718838|FG000|COMPLETED|Overall Study||51
10563753|NCT01613222|11718838|FG000|NOT COMPLETED|Overall Study||12
10563754|NCT01613248|11718857|FG000|STARTED|Overall Study||139
10563755|NCT01613248|11718858|FG001|STARTED|Overall Study||138
10563756|NCT01613248|11718859|FG002|STARTED|Overall Study||139
10563757|NCT01613248|11718860|FG003|STARTED|Overall Study||139
10563758|NCT01613248|11718861|FG004|STARTED|Overall Study||139
10563759|NCT01613248|11718862|FG005|STARTED|Overall Study||140
10563760|NCT01613248|11718857|FG000|COMPLETED|Overall Study||110
10563761|NCT01613248|11718858|FG001|COMPLETED|Overall Study||104
10563762|NCT01613248|11718859|FG002|COMPLETED|Overall Study||106
10563763|NCT01613248|11718860|FG003|COMPLETED|Overall Study||101
10563764|NCT01613248|11718861|FG004|COMPLETED|Overall Study||104
10563765|NCT01613248|11718862|FG005|COMPLETED|Overall Study||102
10563766|NCT01613248|11718857|FG000|NOT COMPLETED|Overall Study||29
10563767|NCT01613248|11718858|FG001|NOT COMPLETED|Overall Study||34
10563768|NCT01613248|11718859|FG002|NOT COMPLETED|Overall Study||33
10563769|NCT01613248|11718860|FG003|NOT COMPLETED|Overall Study||38
10563770|NCT01613248|11718861|FG004|NOT COMPLETED|Overall Study||35
10563771|NCT01613248|11718862|FG005|NOT COMPLETED|Overall Study||38
10563772|NCT01613313|11718880|FG000|STARTED|Overall Study||2
10792517|NCT03582826|11953327|FG001|STARTED|Overall Study||6
10792518|NCT03582826|11953326|FG000|COMPLETED|Overall Study||78
10792519|NCT03582826|11953327|FG001|COMPLETED|Overall Study||6
10792520|NCT03582826|11953326|FG000|NOT COMPLETED|Overall Study||41
10563773|NCT01613313|11718881|FG001|STARTED|Overall Study||4
10563774|NCT01613313|11718882|FG002|STARTED|Overall Study||4
10563775|NCT01613313|11718883|FG003|STARTED|Overall Study||4
10563776|NCT01613313|11718880|FG000|COMPLETED|Overall Study||2
10563777|NCT01613313|11718881|FG001|COMPLETED|Overall Study||4
10563778|NCT01613313|11718882|FG002|COMPLETED|Overall Study||4
10563779|NCT01613313|11718883|FG003|COMPLETED|Overall Study||4
10563780|NCT01613313|11718880|FG000|NOT COMPLETED|Overall Study||0
10563781|NCT01613313|11718881|FG001|NOT COMPLETED|Overall Study||0
10563782|NCT01613313|11718882|FG002|NOT COMPLETED|Overall Study||0
10563783|NCT01613313|11718883|FG003|NOT COMPLETED|Overall Study||0
10563784|NCT01613326|11718895|FG000|STARTED|Overall Study||327
10563785|NCT01613326|11718896|FG001|STARTED|Overall Study||330
10563786|NCT01613326|11718895|FG000|COMPLETED|Overall Study||314
10563787|NCT01613326|11718896|FG001|COMPLETED|Overall Study||316
10563788|NCT01613326|11718895|FG000|NOT COMPLETED|Overall Study||13
10563789|NCT01613326|11718896|FG001|NOT COMPLETED|Overall Study||14
10563790|NCT01613339|11718904|FG000|STARTED|Overall Study||24
10563791|NCT01613339|11718905|FG001|STARTED|Overall Study||22
10563792|NCT01613339|11718904|FG000|COMPLETED|Overall Study||21
10563793|NCT01613339|11718905|FG001|COMPLETED|Overall Study||21
10563794|NCT01613339|11718904|FG000|NOT COMPLETED|Overall Study||3
10563795|NCT01613339|11718905|FG001|NOT COMPLETED|Overall Study||1
10563796|NCT01613378|11718910|FG000|STARTED|Overall Study||200
10563797|NCT01613378|11718910|FG000|COMPLETED|Overall Study||161
10563798|NCT01613378|11718910|FG000|NOT COMPLETED|Overall Study||39
10563799|NCT01613417|11718916|FG000|STARTED|First Injection||113
10563800|NCT01613417|11718917|FG001|STARTED|First Injection||116
10563801|NCT01613417|11718916|FG000|COMPLETED|First Injection||113
10563802|NCT01613417|11718917|FG001|COMPLETED|First Injection||116
10563803|NCT01613417|11718916|FG000|NOT COMPLETED|First Injection||0
10563804|NCT01613417|11718917|FG001|NOT COMPLETED|First Injection||0
10563805|NCT01613417|11718916|FG000|STARTED|Washout (no Second Injection/MRI)||113
10563806|NCT01613417|11718917|FG001|STARTED|Washout (no Second Injection/MRI)||116
10563807|NCT01613417|11718916|FG000|COMPLETED|Washout (no Second Injection/MRI)||100
10792521|NCT03582826|11953327|FG001|NOT COMPLETED|Overall Study||0
10792522|NCT03582943|11953344|FG000|STARTED|Allocated to Groups||42
10792523|NCT03582943|11953345|FG001|STARTED|Allocated to Groups||40
10792524|NCT03582943|11953344|FG000|COMPLETED|Allocated to Groups||41
10792525|NCT03582943|11953345|FG001|COMPLETED|Allocated to Groups||39
10792526|NCT03582943|11953344|FG000|NOT COMPLETED|Allocated to Groups||1
10792527|NCT03582943|11953345|FG001|NOT COMPLETED|Allocated to Groups||1
10792528|NCT03582943|11953344|FG000|STARTED|Intervention and Follow up||41
10792529|NCT03582943|11953345|FG001|STARTED|Intervention and Follow up||39
10792530|NCT03582943|11953344|FG000|COMPLETED|Intervention and Follow up||37
10792531|NCT03582943|11953345|FG001|COMPLETED|Intervention and Follow up||37
10792532|NCT03582943|11953344|FG000|NOT COMPLETED|Intervention and Follow up||4
10792533|NCT03582943|11953345|FG001|NOT COMPLETED|Intervention and Follow up||2
10792534|NCT03582943|11953344|FG000|STARTED|Analyzed||37
10792535|NCT03582943|11953345|FG001|STARTED|Analyzed||37
10792536|NCT03582943|11953344|FG000|COMPLETED|Analyzed||33
10792537|NCT03582943|11953345|FG001|COMPLETED|Analyzed||36
10792538|NCT03582943|11953344|FG000|NOT COMPLETED|Analyzed||4
10792539|NCT03582943|11953345|FG001|NOT COMPLETED|Analyzed||1
10792540|NCT03583372|11953355|FG000|STARTED|Overall Study||92
10792541|NCT03583372|11953356|FG001|STARTED|Overall Study||182
10792542|NCT03583372|11953357|FG002|STARTED|Overall Study||91
10792543|NCT03583372|11953358|FG003|STARTED|Overall Study||141
10792544|NCT03583372|11953355|FG000|COMPLETED|Overall Study||79
10792545|NCT03583372|11953356|FG001|COMPLETED|Overall Study||156
10792546|NCT03583372|11953357|FG002|COMPLETED|Overall Study||72
10792547|NCT03583372|11953358|FG003|COMPLETED|Overall Study||123
10792548|NCT03583372|11953355|FG000|NOT COMPLETED|Overall Study||13
10792549|NCT03583372|11953356|FG001|NOT COMPLETED|Overall Study||26
10792550|NCT03583372|11953357|FG002|NOT COMPLETED|Overall Study||19
10792551|NCT03583372|11953358|FG003|NOT COMPLETED|Overall Study||18
10792552|NCT03583385|11953368|FG000|STARTED|Treatment Period 1||24
10792553|NCT03583385|11953369|FG001|STARTED|Treatment Period 1||24
10792554|NCT03583385|11953368|FG000|COMPLETED|Treatment Period 1||23
10792555|NCT03583385|11953369|FG001|COMPLETED|Treatment Period 1||23
10792556|NCT03583385|11953368|FG000|NOT COMPLETED|Treatment Period 1||1
10792557|NCT03583385|11953369|FG001|NOT COMPLETED|Treatment Period 1||1
10792558|NCT03583385|11953368|FG000|STARTED|Treatment Period 2|Of 46 participants who completed period 1, 45 entered period2 & 1 participant didn't attend period2.|22
10792559|NCT03583385|11953369|FG001|STARTED|Treatment Period 2||23
10792560|NCT03583385|11953368|FG000|COMPLETED|Treatment Period 2||21
10792561|NCT03583385|11953369|FG001|COMPLETED|Treatment Period 2||23
10792562|NCT03583385|11953368|FG000|NOT COMPLETED|Treatment Period 2||1
10792563|NCT03583385|11953369|FG001|NOT COMPLETED|Treatment Period 2||0
10792564|NCT03583450|11953377|FG000|STARTED|Overall Study||34
10792565|NCT03583450|11953378|FG001|STARTED|Overall Study||37
10792566|NCT03583450|11953377|FG000|COMPLETED|Overall Study||33
10792567|NCT03583450|11953378|FG001|COMPLETED|Overall Study||37
10792568|NCT03583450|11953377|FG000|NOT COMPLETED|Overall Study||1
10792569|NCT03583450|11953378|FG001|NOT COMPLETED|Overall Study||0
10792570|NCT03583606|11953389|FG000|STARTED|Overall Study||22
10792571|NCT03583606|11953390|FG001|STARTED|Overall Study||20
10792572|NCT03583606|11953391|FG002|STARTED|Overall Study||19
10563808|NCT01613417|11718917|FG001|COMPLETED|Washout (no Second Injection/MRI)||109
10563809|NCT01613417|11718916|FG000|NOT COMPLETED|Washout (no Second Injection/MRI)||13
10563810|NCT01613417|11718917|FG001|NOT COMPLETED|Washout (no Second Injection/MRI)||7
10563811|NCT01613417|11718916|FG000|STARTED|Second Injection||100
10563812|NCT01613417|11718917|FG001|STARTED|Second Injection||109
10792573|NCT03583606|11953389|FG000|COMPLETED|Overall Study||21
10792574|NCT03583606|11953390|FG001|COMPLETED|Overall Study||19
10792575|NCT03583606|11953391|FG002|COMPLETED|Overall Study||19
10563813|NCT01613417|11718916|FG000|COMPLETED|Second Injection||100
10563814|NCT01613417|11718917|FG001|COMPLETED|Second Injection||109
10563815|NCT01613417|11718916|FG000|NOT COMPLETED|Second Injection||0
10563816|NCT01613417|11718917|FG001|NOT COMPLETED|Second Injection||0
10563817|NCT01613599|11718933|FG000|STARTED|Overall Study||97
10563818|NCT01613599|11718933|FG000|COMPLETED|Overall Study||72
10563819|NCT01613599|11718933|FG000|NOT COMPLETED|Overall Study||25
10563820|NCT01613716|11718937|FG000|STARTED|Overall Study||30
10792576|NCT03583606|11953389|FG000|NOT COMPLETED|Overall Study||1
10792577|NCT03583606|11953390|FG001|NOT COMPLETED|Overall Study||1
10792578|NCT03583606|11953391|FG002|NOT COMPLETED|Overall Study||0
10792579|NCT03584100|11953400|FG000|STARTED|Overall Study||12
10792580|NCT03584100|11953400|FG000|COMPLETED|Overall Study||12
10792581|NCT03584100|11953400|FG000|NOT COMPLETED|Overall Study||0
10792582|NCT03585244|11953407|FG000|STARTED|Overall Study||180
10792583|NCT03585244|11953407|FG000|COMPLETED|Overall Study||165
10792584|NCT03585244|11953407|FG000|NOT COMPLETED|Overall Study||15
10792585|NCT03585296|11953411|FG000|STARTED|Overall Study||22
10792586|NCT03585296|11953411|FG000|COMPLETED|Overall Study||17
10792587|NCT03585296|11953411|FG000|NOT COMPLETED|Overall Study||5
10810754|NCT03792672|11972459|FG003|NOT COMPLETED|Treatment Period 3 (1 Day)||0
10810755|NCT03792672|11972460|FG004|NOT COMPLETED|Treatment Period 3 (1 Day)||0
10810756|NCT03792672|11972461|FG005|NOT COMPLETED|Treatment Period 3 (1 Day)||0
10810757|NCT03792672|11972456|FG000|STARTED|Washout Period 3 (10 Days)||4
10810758|NCT03792672|11972457|FG001|STARTED|Washout Period 3 (10 Days)||4
10810759|NCT03792672|11972458|FG002|STARTED|Washout Period 3 (10 Days)||4
10810760|NCT03792672|11972459|FG003|STARTED|Washout Period 3 (10 Days)||4
10810761|NCT03792672|11972460|FG004|STARTED|Washout Period 3 (10 Days)||4
10810762|NCT03792672|11972461|FG005|STARTED|Washout Period 3 (10 Days)||4
10810763|NCT03792672|11972456|FG000|COMPLETED|Washout Period 3 (10 Days)||3
10810764|NCT03792672|11972457|FG001|COMPLETED|Washout Period 3 (10 Days)||4
10810765|NCT03792672|11972458|FG002|COMPLETED|Washout Period 3 (10 Days)||3
10810766|NCT03792672|11972459|FG003|COMPLETED|Washout Period 3 (10 Days)||2
10810767|NCT03792672|11972460|FG004|COMPLETED|Washout Period 3 (10 Days)||4
10810768|NCT03792672|11972461|FG005|COMPLETED|Washout Period 3 (10 Days)||4
10810769|NCT03792672|11972456|FG000|NOT COMPLETED|Washout Period 3 (10 Days)||1
10810770|NCT03792672|11972457|FG001|NOT COMPLETED|Washout Period 3 (10 Days)||0
10810771|NCT03792672|11972458|FG002|NOT COMPLETED|Washout Period 3 (10 Days)||1
10810772|NCT03792672|11972459|FG003|NOT COMPLETED|Washout Period 3 (10 Days)||2
10810773|NCT03792672|11972460|FG004|NOT COMPLETED|Washout Period 3 (10 Days)||0
10810774|NCT03792672|11972461|FG005|NOT COMPLETED|Washout Period 3 (10 Days)||0
10810775|NCT03792672|11972456|FG000|STARTED|Treatment Period 4 (2 Days)||3
10810776|NCT03792672|11972457|FG001|STARTED|Treatment Period 4 (2 Days)||4
10810777|NCT03792672|11972458|FG002|STARTED|Treatment Period 4 (2 Days)||3
10810778|NCT03792672|11972459|FG003|STARTED|Treatment Period 4 (2 Days)||2
10810779|NCT03792672|11972460|FG004|STARTED|Treatment Period 4 (2 Days)||4
10810780|NCT03792672|11972461|FG005|STARTED|Treatment Period 4 (2 Days)||4
10810781|NCT03792672|11972456|FG000|COMPLETED|Treatment Period 4 (2 Days)||2
10810782|NCT03792672|11972457|FG001|COMPLETED|Treatment Period 4 (2 Days)||4
10810783|NCT03792672|11972458|FG002|COMPLETED|Treatment Period 4 (2 Days)||3
10810784|NCT03792672|11972459|FG003|COMPLETED|Treatment Period 4 (2 Days)||2
10810785|NCT03792672|11972460|FG004|COMPLETED|Treatment Period 4 (2 Days)||4
10810786|NCT03792672|11972461|FG005|COMPLETED|Treatment Period 4 (2 Days)||4
10810787|NCT03792672|11972456|FG000|NOT COMPLETED|Treatment Period 4 (2 Days)||1
10810788|NCT03792672|11972457|FG001|NOT COMPLETED|Treatment Period 4 (2 Days)||0
10810789|NCT03792672|11972458|FG002|NOT COMPLETED|Treatment Period 4 (2 Days)||0
10810790|NCT03792672|11972459|FG003|NOT COMPLETED|Treatment Period 4 (2 Days)||0
10810791|NCT03792672|11972460|FG004|NOT COMPLETED|Treatment Period 4 (2 Days)||0
10810792|NCT03792672|11972461|FG005|NOT COMPLETED|Treatment Period 4 (2 Days)||0
10810793|NCT03786744|11972473|FG000|STARTED|Overall Study||10
10810794|NCT03786744|11972474|FG001|STARTED|Overall Study||10
10810795|NCT03786744|11972473|FG000|COMPLETED|Overall Study||10
10810796|NCT03786744|11972474|FG001|COMPLETED|Overall Study||10
10810797|NCT03786744|11972473|FG000|NOT COMPLETED|Overall Study||0
10810798|NCT03786744|11972474|FG001|NOT COMPLETED|Overall Study||0
10810799|NCT03782181|11972483|FG000|STARTED|Overall Study||20
10810800|NCT03782181|11972484|FG001|STARTED|Overall Study||20
10810801|NCT03782181|11972483|FG000|COMPLETED|Overall Study||20
10810802|NCT03782181|11972484|FG001|COMPLETED|Overall Study||20
10810803|NCT03782181|11972483|FG000|NOT COMPLETED|Overall Study||0
10810804|NCT03782181|11972484|FG001|NOT COMPLETED|Overall Study||0
10810805|NCT03792191|11972493|FG000|STARTED|Overall Study||140
10810806|NCT03792191|11972494|FG001|STARTED|Overall Study||140
10810807|NCT03792191|11972493|FG000|COMPLETED|Overall Study||140
10810808|NCT03792191|11972494|FG001|COMPLETED|Overall Study||140
10810809|NCT03792191|11972493|FG000|NOT COMPLETED|Overall Study||0
10810810|NCT03792191|11972494|FG001|NOT COMPLETED|Overall Study||0
10810811|NCT03791489|11972500|FG000|STARTED|30 Days||30
10563821|NCT01613716|11718937|FG000|COMPLETED|Overall Study||23
10810812|NCT03791489|11972500|FG000|COMPLETED|30 Days||30
10563822|NCT01613716|11718937|FG000|NOT COMPLETED|Overall Study||7
10810813|NCT03791489|11972500|FG000|NOT COMPLETED|30 Days||0
10810814|NCT03791489|11972500|FG000|STARTED|90 Days (Primary Endpoint)||30
10563823|NCT01613768|11718941|FG000|STARTED|Overall Study||29
10563824|NCT01613768|11718941|FG000|COMPLETED|Overall Study||29
10810815|NCT03791489|11972500|FG000|COMPLETED|90 Days (Primary Endpoint)||30
10563825|NCT01613768|11718941|FG000|NOT COMPLETED|Overall Study||0
10563826|NCT01614093|11718946|FG000|STARTED|Overall Study||17
10563827|NCT01614093|11718946|FG000|COMPLETED|Overall Study||16
10563828|NCT01614093|11718946|FG000|NOT COMPLETED|Overall Study||1
10563829|NCT01614210|11718951|FG000|STARTED|Overall Study||52
10563830|NCT01614210|11718951|FG000|COMPLETED|Overall Study||52
10563831|NCT01614210|11718951|FG000|NOT COMPLETED|Overall Study||0
10563832|NCT01614249|11718957|FG000|STARTED|Overall Study|Participants received every two-weeks supply and monitored regularly on cell-phone and face-to-face.|107
10563833|NCT01614249|11718958|FG001|STARTED|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|109
10563834|NCT01614249|11718957|FG000|At Week-4|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|98
10563835|NCT01614249|11718958|FG001|At Week-4|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|92
10563836|NCT01614249|11718957|FG000|At Week-8 (End of Study Period)|Overall Study|End of study data collected for all participants who completed the 8-week trial period.|96
10563837|NCT01614249|11718958|FG001|At Week-8 (End of Study Period)|Overall Study|End of study data collected for all participants who completed the 8-week trial period.|86
10563838|NCT01614249|11718957|FG000|COMPLETED|Overall Study|End of study data analyzed for only participants who completed the 8-week trial period.|96
10563839|NCT01614249|11718958|FG001|COMPLETED|Overall Study|End of study data analyzed for only participants who completed the 8-week trial period.|86
10563840|NCT01614249|11718957|FG000|NOT COMPLETED|Overall Study||11
10563841|NCT01614249|11718958|FG001|NOT COMPLETED|Overall Study||23
10563842|NCT01614392|11718966|FG000|STARTED|Overall Study||25
10563843|NCT01614392|11718967|FG001|STARTED|Overall Study||27
10563844|NCT01614392|11718966|FG000|COMPLETED|Overall Study||24
10563845|NCT01614392|11718967|FG001|COMPLETED|Overall Study||24
10563846|NCT01614392|11718966|FG000|NOT COMPLETED|Overall Study||1
10563847|NCT01614392|11718967|FG001|NOT COMPLETED|Overall Study||3
10563848|NCT01614457|11718975|FG000|STARTED|Overall Study||34
10563849|NCT01614457|11718976|FG001|STARTED|Overall Study||35
10563850|NCT01614457|11718975|FG000|COMPLETED|Overall Study||32
10563851|NCT01614457|11718976|FG001|COMPLETED|Overall Study||35
10563852|NCT01614457|11718975|FG000|NOT COMPLETED|Overall Study||2
10563853|NCT01614457|11718976|FG001|NOT COMPLETED|Overall Study||0
10563854|NCT01614470|11718984|FG000|STARTED|Part 1: Treatment Period 1 (8 Weeks)||20
10563855|NCT01614470|11718985|FG001|STARTED|Part 1: Treatment Period 1 (8 Weeks)||19
10563856|NCT01614470|11718986|FG002|STARTED|Part 1: Treatment Period 1 (8 Weeks)||0
10563857|NCT01614470|11718984|FG000|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||18
10563858|NCT01614470|11718985|FG001|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||18
10563859|NCT01614470|11718986|FG002|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||0
10563860|NCT01614470|11718984|FG000|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||2
10563861|NCT01614470|11718985|FG001|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||1
10563862|NCT01614470|11718986|FG002|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||0
10563863|NCT01614470|11718984|FG000|STARTED|Part 1: Washout Period (4 to 8 Weeks)||18
10792588|NCT03585504|11953417|FG000|STARTED|Overall Study||41
10792589|NCT03585504|11953418|FG001|STARTED|Overall Study||40
10792590|NCT03585504|11953417|FG000|COMPLETED|Overall Study||15
10792591|NCT03585504|11953418|FG001|COMPLETED|Overall Study||11
10792592|NCT03585504|11953417|FG000|NOT COMPLETED|Overall Study||26
10792593|NCT03585504|11953418|FG001|NOT COMPLETED|Overall Study||29
10792594|NCT03585543|11953424|FG000|STARTED|Overall Study||30
10792595|NCT03585543|11953424|FG000|Mid-intervention Assessment (6-weeks)|Overall Study||25
10792596|NCT03585543|11953424|FG000|End-of-intervention Assessment (12 Weeks|Overall Study||22
10792597|NCT03585543|11953424|FG000|3-month Post-intervention Follow-up (6 m|Overall Study||15
10792598|NCT03585543|11953424|FG000|COMPLETED|Overall Study||15
10792599|NCT03585543|11953424|FG000|NOT COMPLETED|Overall Study||15
10792600|NCT03585712|11953429|FG000|STARTED|Treatment Period 1||52
10792601|NCT03585712|11953430|FG001|STARTED|Treatment Period 1|Randomization in Treatment Period 2|0
10792602|NCT03585712|11953431|FG002|STARTED|Treatment Period 1|Randomization in Treatment Period 2|0
10792603|NCT03585712|11953429|FG000|COMPLETED|Treatment Period 1||51
10792604|NCT03585712|11953430|FG001|COMPLETED|Treatment Period 1||0
10792605|NCT03585712|11953431|FG002|COMPLETED|Treatment Period 1||0
10792606|NCT03585712|11953429|FG000|NOT COMPLETED|Treatment Period 1||1
10792607|NCT03585712|11953430|FG001|NOT COMPLETED|Treatment Period 1||0
10792608|NCT03585712|11953431|FG002|NOT COMPLETED|Treatment Period 1||0
10792609|NCT03585712|11953429|FG000|STARTED|Treatment Periods 2 and 3|Subjects having completed Treatment Period 1 randomized in Arm A or Arm B|0
10792610|NCT03585712|11953430|FG001|STARTED|Treatment Periods 2 and 3||26
10792611|NCT03585712|11953431|FG002|STARTED|Treatment Periods 2 and 3||25
10792612|NCT03585712|11953429|FG000|COMPLETED|Treatment Periods 2 and 3||0
10792613|NCT03585712|11953430|FG001|COMPLETED|Treatment Periods 2 and 3||23
10792614|NCT03585712|11953431|FG002|COMPLETED|Treatment Periods 2 and 3||22
10792615|NCT03585712|11953429|FG000|NOT COMPLETED|Treatment Periods 2 and 3||0
10792616|NCT03585712|11953430|FG001|NOT COMPLETED|Treatment Periods 2 and 3||3
10792617|NCT03585712|11953431|FG002|NOT COMPLETED|Treatment Periods 2 and 3||3
10792618|NCT03585790|11953450|FG000|STARTED|First Intervention (1 Week)||23
10792619|NCT03585790|11953451|FG001|STARTED|First Intervention (1 Week)||22
10792620|NCT03585790|11953450|FG000|COMPLETED|First Intervention (1 Week)||23
10792621|NCT03585790|11953451|FG001|COMPLETED|First Intervention (1 Week)||22
10792622|NCT03585790|11953450|FG000|NOT COMPLETED|First Intervention (1 Week)||0
10792623|NCT03585790|11953451|FG001|NOT COMPLETED|First Intervention (1 Week)||0
10792624|NCT03585790|11953450|FG000|STARTED|Second Intervention (1 Week)||23
10563864|NCT01614470|11718985|FG001|STARTED|Part 1: Washout Period (4 to 8 Weeks)||18
10563865|NCT01614470|11718986|FG002|STARTED|Part 1: Washout Period (4 to 8 Weeks)||0
10563866|NCT01614470|11718984|FG000|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||18
10563867|NCT01614470|11718985|FG001|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||18
10563868|NCT01614470|11718986|FG002|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
10563869|NCT01614470|11718984|FG000|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
10563870|NCT01614470|11718985|FG001|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
10563871|NCT01614470|11718986|FG002|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
10563872|NCT01614470|11718984|FG000|STARTED|Part 1: Treatment Period 2 (8 Weeks)||18
10563873|NCT01614470|11718985|FG001|STARTED|Part 1: Treatment Period 2 (8 Weeks)||18
10563874|NCT01614470|11718986|FG002|STARTED|Part 1: Treatment Period 2 (8 Weeks)||0
10563875|NCT01614470|11718984|FG000|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||18
10563876|NCT01614470|11718985|FG001|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||18
10563877|NCT01614470|11718986|FG002|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
10563878|NCT01614470|11718984|FG000|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
10563879|NCT01614470|11718985|FG001|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
10563880|NCT01614470|11718986|FG002|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
10563881|NCT01614470|11718984|FG000|STARTED|Part 2: Open-label Period (16 Weeks)||0
10563882|NCT01614470|11718985|FG001|STARTED|Part 2: Open-label Period (16 Weeks)||0
10563883|NCT01614470|11718986|FG002|STARTED|Part 2: Open-label Period (16 Weeks)||36
10563884|NCT01614470|11718984|FG000|COMPLETED|Part 2: Open-label Period (16 Weeks)||0
10563885|NCT01614470|11718985|FG001|COMPLETED|Part 2: Open-label Period (16 Weeks)||0
10563886|NCT01614470|11718986|FG002|COMPLETED|Part 2: Open-label Period (16 Weeks)||36
10563887|NCT01614470|11718984|FG000|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
10563888|NCT01614470|11718985|FG001|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
10563889|NCT01614470|11718986|FG002|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
10563890|NCT01614509|11718997|FG000|STARTED|Overall Study||24
10563891|NCT01614509|11718998|FG001|STARTED|Overall Study||21
10563892|NCT01614509|11718997|FG000|COMPLETED|Overall Study||23
10563893|NCT01614509|11718998|FG001|COMPLETED|Overall Study||18
10563894|NCT01614509|11718997|FG000|NOT COMPLETED|Overall Study||1
10563895|NCT01614509|11718998|FG001|NOT COMPLETED|Overall Study||3
10563896|NCT01614574|11719004|FG000|STARTED|Overall Study||6
10563897|NCT01614574|11719004|FG000|COMPLETED|Overall Study||6
10563898|NCT01614574|11719004|FG000|NOT COMPLETED|Overall Study||0
10563899|NCT01614600|11719008|FG000|STARTED|Overall Study||88
10563900|NCT01614600|11719008|FG000|COMPLETED|Overall Study||84
10792625|NCT03585790|11953451|FG001|STARTED|Second Intervention (1 Week)||22
10792626|NCT03585790|11953450|FG000|COMPLETED|Second Intervention (1 Week)||23
10792627|NCT03585790|11953451|FG001|COMPLETED|Second Intervention (1 Week)||22
10792628|NCT03585790|11953450|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
10792629|NCT03585790|11953451|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
10792630|NCT03585959|11953458|FG000|STARTED|Overall Study||50
10792631|NCT03585959|11953458|FG000|COMPLETED|Overall Study||47
10792632|NCT03585959|11953458|FG000|NOT COMPLETED|Overall Study||3
10792633|NCT03586167|11953466|FG000|STARTED|Overall Study||58
10792634|NCT03586167|11953467|FG001|STARTED|Overall Study||28
10792635|NCT03586167|11953466|FG000|COMPLETED|Overall Study||57
10792636|NCT03586167|11953467|FG001|COMPLETED|Overall Study||28
10792637|NCT03586167|11953466|FG000|NOT COMPLETED|Overall Study||1
10792638|NCT03586167|11953467|FG001|NOT COMPLETED|Overall Study||0
10792639|NCT03586544|11953475|FG000|STARTED|First Intervention||6
10792640|NCT03586544|11953476|FG001|STARTED|First Intervention||12
10792641|NCT03586544|11953475|FG000|COMPLETED|First Intervention||6
10792642|NCT03586544|11953476|FG001|COMPLETED|First Intervention||11
10792643|NCT03586544|11953475|FG000|NOT COMPLETED|First Intervention||0
10792644|NCT03586544|11953476|FG001|NOT COMPLETED|First Intervention||1
10792645|NCT03586544|11953475|FG000|STARTED|Second Intervention||6
10792646|NCT03586544|11953476|FG001|STARTED|Second Intervention||11
10792647|NCT03586544|11953475|FG000|COMPLETED|Second Intervention||6
10792648|NCT03586544|11953476|FG001|COMPLETED|Second Intervention||10
10792649|NCT03586544|11953475|FG000|NOT COMPLETED|Second Intervention||0
10792650|NCT03586544|11953476|FG001|NOT COMPLETED|Second Intervention||1
10792651|NCT03586583|11953482|FG000|STARTED|Overall Study||600
10792652|NCT03586583|11953482|FG000|COMPLETED|Overall Study||600
10792653|NCT03586583|11953482|FG000|NOT COMPLETED|Overall Study||0
10792654|NCT03586648|11953487|FG000|STARTED|Period 1||36
10792655|NCT03586648|11953488|FG001|STARTED|Period 1||34
10792656|NCT03586648|11953487|FG000|COMPLETED|Period 1||32
10792657|NCT03586648|11953488|FG001|COMPLETED|Period 1||30
10792658|NCT03586648|11953487|FG000|NOT COMPLETED|Period 1||4
10563901|NCT01614600|11719008|FG000|NOT COMPLETED|Overall Study||4
10563902|NCT01614613|11719012|FG000|STARTED|Overall Study||146
10563903|NCT01614613|11719012|FG000|COMPLETED|Overall Study||146
10563904|NCT01614613|11719012|FG000|NOT COMPLETED|Overall Study||0
10792659|NCT03586648|11953488|FG001|NOT COMPLETED|Period 1||4
10792660|NCT03586648|11953487|FG000|STARTED|Period 2||32
10792661|NCT03586648|11953488|FG001|STARTED|Period 2||30
10792662|NCT03586648|11953487|FG000|COMPLETED|Period 2||31
10792663|NCT03586648|11953488|FG001|COMPLETED|Period 2||30
10792664|NCT03586648|11953487|FG000|NOT COMPLETED|Period 2||1
10792665|NCT03586648|11953488|FG001|NOT COMPLETED|Period 2||0
10792666|NCT03586726|11953494|FG000|STARTED|Overall Study||16
10792667|NCT03586726|11953494|FG000|COMPLETED|Overall Study||15
10792668|NCT03586726|11953494|FG000|NOT COMPLETED|Overall Study||1
10563905|NCT01614743|11719019|FG000|STARTED|Overall Study||4
10563906|NCT01614743|11719020|FG001|STARTED|Overall Study||5
10563907|NCT01614743|11719019|FG000|COMPLETED|Overall Study||3
10563908|NCT01614743|11719020|FG001|COMPLETED|Overall Study|Subject in the placebo group (5) also received the treatment (IncobotulinumtoxinA) at Visit 5.|5
10563909|NCT01614743|11719019|FG000|NOT COMPLETED|Overall Study||1
10563910|NCT01614743|11719020|FG001|NOT COMPLETED|Overall Study||0
10563911|NCT01614769|11719026|FG000|STARTED|Period 1||2
10563912|NCT01614769|11719027|FG001|STARTED|Period 1||1
10563913|NCT01614769|11719028|FG002|STARTED|Period 1||2
10563914|NCT01614769|11719029|FG003|STARTED|Period 1||2
10563915|NCT01614769|11719030|FG004|STARTED|Period 1||1
10563916|NCT01614769|11719031|FG005|STARTED|Period 1||2
10563917|NCT01614769|11719026|FG000|COMPLETED|Period 1||1
10563918|NCT01614769|11719027|FG001|COMPLETED|Period 1||1
10563919|NCT01614769|11719028|FG002|COMPLETED|Period 1||2
10563920|NCT01614769|11719029|FG003|COMPLETED|Period 1||0
10563921|NCT01614769|11719030|FG004|COMPLETED|Period 1||1
10563922|NCT01614769|11719031|FG005|COMPLETED|Period 1||1
10792669|NCT03586830|11953502|FG000|STARTED|Overall Study||50
10792670|NCT03586830|11953503|FG001|STARTED|Overall Study||48
10792671|NCT03586830|11953504|FG002|STARTED|Overall Study||49
10792672|NCT03586830|11953505|FG003|STARTED|Overall Study||49
10792673|NCT03586830|11953502|FG000|Treated|Overall Study||49
10792674|NCT03586830|11953503|FG001|Treated|Overall Study||48
10792675|NCT03586830|11953504|FG002|Treated|Overall Study||49
10792676|NCT03586830|11953505|FG003|Treated|Overall Study||49
10792677|NCT03586830|11953502|FG000|COMPLETED|Overall Study||48
10792678|NCT03586830|11953503|FG001|COMPLETED|Overall Study||42
10792679|NCT03586830|11953504|FG002|COMPLETED|Overall Study||41
10792680|NCT03586830|11953505|FG003|COMPLETED|Overall Study||44
10792681|NCT03586830|11953502|FG000|NOT COMPLETED|Overall Study||2
10792682|NCT03586830|11953503|FG001|NOT COMPLETED|Overall Study||6
10792683|NCT03586830|11953504|FG002|NOT COMPLETED|Overall Study||8
10792684|NCT03586830|11953505|FG003|NOT COMPLETED|Overall Study||5
10792685|NCT03587207|11953520|FG000|STARTED|Overall Study||100
10792686|NCT03587207|11953521|FG001|STARTED|Overall Study||104
10792687|NCT03587207|11953522|FG002|STARTED|Overall Study||100
10792688|NCT03587207|11953523|FG003|STARTED|Overall Study||94
10792689|NCT03587207|11953524|FG004|STARTED|Overall Study||102
10792690|NCT03587207|11953520|FG000|COMPLETED|Overall Study||100
10792691|NCT03587207|11953521|FG001|COMPLETED|Overall Study||104
10792692|NCT03587207|11953522|FG002|COMPLETED|Overall Study||100
10792693|NCT03587207|11953523|FG003|COMPLETED|Overall Study||94
10792694|NCT03587207|11953524|FG004|COMPLETED|Overall Study||102
10792695|NCT03587207|11953520|FG000|NOT COMPLETED|Overall Study||0
10792696|NCT03587207|11953521|FG001|NOT COMPLETED|Overall Study||0
10792697|NCT03587207|11953522|FG002|NOT COMPLETED|Overall Study||0
10792698|NCT03587207|11953523|FG003|NOT COMPLETED|Overall Study||0
10792699|NCT03587207|11953524|FG004|NOT COMPLETED|Overall Study||0
10792700|NCT03587428|11953536|FG000|STARTED|Period 1||3
10792701|NCT03587428|11953537|FG001|STARTED|Period 1||2
10792702|NCT03587428|11953538|FG002|STARTED|Period 1||3
10792703|NCT03587428|11953539|FG003|STARTED|Period 1||3
10792704|NCT03587428|11953540|FG004|STARTED|Period 1||2
10792705|NCT03587428|11953541|FG005|STARTED|Period 1||2
10792706|NCT03587428|11953536|FG000|COMPLETED|Period 1||3
10792707|NCT03587428|11953537|FG001|COMPLETED|Period 1||2
10792708|NCT03587428|11953538|FG002|COMPLETED|Period 1||3
10792709|NCT03587428|11953539|FG003|COMPLETED|Period 1||3
10792710|NCT03587428|11953540|FG004|COMPLETED|Period 1||2
10792711|NCT03587428|11953541|FG005|COMPLETED|Period 1||2
10792712|NCT03587428|11953536|FG000|NOT COMPLETED|Period 1||0
10792713|NCT03587428|11953537|FG001|NOT COMPLETED|Period 1||0
10792714|NCT03587428|11953538|FG002|NOT COMPLETED|Period 1||0
10792715|NCT03587428|11953539|FG003|NOT COMPLETED|Period 1||0
10792716|NCT03587428|11953540|FG004|NOT COMPLETED|Period 1||0
10792717|NCT03587428|11953541|FG005|NOT COMPLETED|Period 1||0
10792718|NCT03587428|11953536|FG000|STARTED|Period 2||3
10792719|NCT03587428|11953537|FG001|STARTED|Period 2||2
10792720|NCT03587428|11953538|FG002|STARTED|Period 2||3
10792721|NCT03587428|11953539|FG003|STARTED|Period 2||3
10792722|NCT03587428|11953540|FG004|STARTED|Period 2||2
10792723|NCT03587428|11953541|FG005|STARTED|Period 2||2
10792724|NCT03587428|11953536|FG000|COMPLETED|Period 2||3
10792725|NCT03587428|11953537|FG001|COMPLETED|Period 2||2
10792726|NCT03587428|11953538|FG002|COMPLETED|Period 2||3
10792727|NCT03587428|11953539|FG003|COMPLETED|Period 2||3
10792728|NCT03587428|11953540|FG004|COMPLETED|Period 2||2
10563923|NCT01614769|11719026|FG000|NOT COMPLETED|Period 1||1
10563924|NCT01614769|11719027|FG001|NOT COMPLETED|Period 1||0
10563925|NCT01614769|11719028|FG002|NOT COMPLETED|Period 1||0
10563926|NCT01614769|11719029|FG003|NOT COMPLETED|Period 1||2
10563927|NCT01614769|11719030|FG004|NOT COMPLETED|Period 1||0
10563928|NCT01614769|11719031|FG005|NOT COMPLETED|Period 1||1
10563929|NCT01614769|11719026|FG000|STARTED|7-Day Washout||1
10792729|NCT03587428|11953541|FG005|COMPLETED|Period 2||2
10792730|NCT03587428|11953536|FG000|NOT COMPLETED|Period 2||0
10792731|NCT03587428|11953537|FG001|NOT COMPLETED|Period 2||0
10792732|NCT03587428|11953538|FG002|NOT COMPLETED|Period 2||0
10563930|NCT01614769|11719027|FG001|STARTED|7-Day Washout||1
10563931|NCT01614769|11719028|FG002|STARTED|7-Day Washout||2
10792733|NCT03587428|11953539|FG003|NOT COMPLETED|Period 2||0
10792734|NCT03587428|11953540|FG004|NOT COMPLETED|Period 2||0
10792735|NCT03587428|11953541|FG005|NOT COMPLETED|Period 2||0
10792736|NCT03587428|11953536|FG000|STARTED|Period 3||3
10792737|NCT03587428|11953537|FG001|STARTED|Period 3||2
10792738|NCT03587428|11953538|FG002|STARTED|Period 3||3
10563932|NCT01614769|11719029|FG003|STARTED|7-Day Washout||0
10563933|NCT01614769|11719030|FG004|STARTED|7-Day Washout||1
10563934|NCT01614769|11719031|FG005|STARTED|7-Day Washout||1
10563935|NCT01614769|11719026|FG000|COMPLETED|7-Day Washout||1
10563936|NCT01614769|11719027|FG001|COMPLETED|7-Day Washout||1
10563937|NCT01614769|11719028|FG002|COMPLETED|7-Day Washout||2
10563938|NCT01614769|11719029|FG003|COMPLETED|7-Day Washout||0
10563939|NCT01614769|11719030|FG004|COMPLETED|7-Day Washout||1
10563940|NCT01614769|11719031|FG005|COMPLETED|7-Day Washout||1
10563941|NCT01614769|11719026|FG000|NOT COMPLETED|7-Day Washout||0
10563942|NCT01614769|11719027|FG001|NOT COMPLETED|7-Day Washout||0
10563943|NCT01614769|11719028|FG002|NOT COMPLETED|7-Day Washout||0
10563944|NCT01614769|11719029|FG003|NOT COMPLETED|7-Day Washout||0
10563945|NCT01614769|11719030|FG004|NOT COMPLETED|7-Day Washout||0
10563946|NCT01614769|11719031|FG005|NOT COMPLETED|7-Day Washout||0
10563947|NCT01614769|11719026|FG000|STARTED|Period 2||1
10563948|NCT01614769|11719027|FG001|STARTED|Period 2||1
10563949|NCT01614769|11719028|FG002|STARTED|Period 2||2
10563950|NCT01614769|11719029|FG003|STARTED|Period 2||0
10563951|NCT01614769|11719030|FG004|STARTED|Period 2||1
10563952|NCT01614769|11719031|FG005|STARTED|Period 2||1
10563953|NCT01614769|11719026|FG000|COMPLETED|Period 2||1
10563954|NCT01614769|11719027|FG001|COMPLETED|Period 2||1
10563955|NCT01614769|11719028|FG002|COMPLETED|Period 2||2
10563956|NCT01614769|11719029|FG003|COMPLETED|Period 2||0
10563957|NCT01614769|11719030|FG004|COMPLETED|Period 2||1
10563958|NCT01614769|11719031|FG005|COMPLETED|Period 2||1
10563959|NCT01614769|11719026|FG000|NOT COMPLETED|Period 2||0
10792739|NCT03587428|11953539|FG003|STARTED|Period 3||3
10792740|NCT03587428|11953540|FG004|STARTED|Period 3||2
10792741|NCT03587428|11953541|FG005|STARTED|Period 3||2
10792742|NCT03587428|11953536|FG000|COMPLETED|Period 3||3
10792743|NCT03587428|11953537|FG001|COMPLETED|Period 3||2
10792744|NCT03587428|11953538|FG002|COMPLETED|Period 3||3
10792745|NCT03587428|11953539|FG003|COMPLETED|Period 3||3
10792746|NCT03587428|11953540|FG004|COMPLETED|Period 3||2
10792747|NCT03587428|11953541|FG005|COMPLETED|Period 3||2
10792748|NCT03587428|11953536|FG000|NOT COMPLETED|Period 3||0
10792749|NCT03587428|11953537|FG001|NOT COMPLETED|Period 3||0
10792750|NCT03587428|11953538|FG002|NOT COMPLETED|Period 3||0
10792751|NCT03587428|11953539|FG003|NOT COMPLETED|Period 3||0
10792752|NCT03587428|11953540|FG004|NOT COMPLETED|Period 3||0
10792753|NCT03587428|11953541|FG005|NOT COMPLETED|Period 3||0
10792754|NCT03587974|11953551|FG000|STARTED|Overall Study||30
10792755|NCT03587974|11953552|FG001|STARTED|Overall Study||30
10792756|NCT03587974|11953551|FG000|COMPLETED|Overall Study||25
10792757|NCT03587974|11953552|FG001|COMPLETED|Overall Study||26
10792758|NCT03587974|11953551|FG000|NOT COMPLETED|Overall Study||5
10792759|NCT03587974|11953552|FG001|NOT COMPLETED|Overall Study||4
10792760|NCT03588572|11953560|FG000|STARTED|Visitation 1||22
10792761|NCT03588572|11953561|FG001|STARTED|Visitation 1||21
10792762|NCT03588572|11953560|FG000|COMPLETED|Visitation 1||21
10792763|NCT03588572|11953561|FG001|COMPLETED|Visitation 1||20
10792764|NCT03588572|11953560|FG000|NOT COMPLETED|Visitation 1||1
10792765|NCT03588572|11953561|FG001|NOT COMPLETED|Visitation 1||1
10792766|NCT03588572|11953560|FG000|STARTED|Visitation 2||21
10792767|NCT03588572|11953561|FG001|STARTED|Visitation 2||20
10792768|NCT03588572|11953560|FG000|COMPLETED|Visitation 2||19
10792769|NCT03588572|11953561|FG001|COMPLETED|Visitation 2||18
10792770|NCT03588572|11953560|FG000|NOT COMPLETED|Visitation 2||2
10792771|NCT03588572|11953561|FG001|NOT COMPLETED|Visitation 2||2
10792772|NCT03588572|11953560|FG000|STARTED|Visitation 3||19
10792773|NCT03588572|11953561|FG001|STARTED|Visitation 3||18
10792774|NCT03588572|11953560|FG000|COMPLETED|Visitation 3||16
10792775|NCT03588572|11953561|FG001|COMPLETED|Visitation 3||16
10792776|NCT03588572|11953560|FG000|NOT COMPLETED|Visitation 3||3
10792777|NCT03588572|11953561|FG001|NOT COMPLETED|Visitation 3||2
10792778|NCT03588741|11953567|FG000|STARTED|Overall Study||1
10792779|NCT03588741|11953567|FG000|COMPLETED|Overall Study||0
10792780|NCT03588741|11953567|FG000|NOT COMPLETED|Overall Study||1
10792781|NCT03588806|11953571|FG000|STARTED|Overall Study||11
10792782|NCT03588806|11953571|FG000|COMPLETED|Overall Study||11
10563960|NCT01614769|11719027|FG001|NOT COMPLETED|Period 2||0
10563961|NCT01614769|11719028|FG002|NOT COMPLETED|Period 2||0
10563962|NCT01614769|11719029|FG003|NOT COMPLETED|Period 2||0
10563963|NCT01614769|11719030|FG004|NOT COMPLETED|Period 2||0
10563964|NCT01614769|11719031|FG005|NOT COMPLETED|Period 2||0
10563965|NCT01614769|11719026|FG000|STARTED|7-Day Washout||1
10563966|NCT01614769|11719027|FG001|STARTED|7-Day Washout||1
10563967|NCT01614769|11719028|FG002|STARTED|7-Day Washout||2
10563968|NCT01614769|11719029|FG003|STARTED|7-Day Washout||0
10792783|NCT03588806|11953571|FG000|NOT COMPLETED|Overall Study||0
10792784|NCT03588910|11953577|FG000|STARTED|Overall Study||60
10792785|NCT03588910|11953578|FG001|STARTED|Overall Study||60
10792786|NCT03588910|11953577|FG000|Post Op Day 1 Survey|Overall Study||52
10792787|NCT03588910|11953578|FG001|Post Op Day 1 Survey|Overall Study||47
10792788|NCT03588910|11953577|FG000|COMPLETED|Overall Study||47
10792789|NCT03588910|11953578|FG001|COMPLETED|Overall Study||45
10792790|NCT03588910|11953577|FG000|NOT COMPLETED|Overall Study||13
10792791|NCT03588910|11953578|FG001|NOT COMPLETED|Overall Study||15
10792792|NCT03589807|11953590|FG000|STARTED|Overall Study||27
10792793|NCT03589807|11953591|FG001|STARTED|Overall Study||30
10792794|NCT03589807|11953592|FG002|STARTED|Overall Study||33
10792795|NCT03589807|11953593|FG003|STARTED|Overall Study||32
10792796|NCT03589807|11953594|FG004|STARTED|Overall Study||28
10563969|NCT01614769|11719030|FG004|STARTED|7-Day Washout||1
10563970|NCT01614769|11719031|FG005|STARTED|7-Day Washout||1
10563971|NCT01614769|11719026|FG000|COMPLETED|7-Day Washout||1
10563972|NCT01614769|11719027|FG001|COMPLETED|7-Day Washout||1
10563973|NCT01614769|11719028|FG002|COMPLETED|7-Day Washout||2
10563974|NCT01614769|11719029|FG003|COMPLETED|7-Day Washout||0
10563975|NCT01614769|11719030|FG004|COMPLETED|7-Day Washout||1
10563976|NCT01614769|11719031|FG005|COMPLETED|7-Day Washout||1
10563977|NCT01614769|11719026|FG000|NOT COMPLETED|7-Day Washout||0
10563978|NCT01614769|11719027|FG001|NOT COMPLETED|7-Day Washout||0
10563979|NCT01614769|11719028|FG002|NOT COMPLETED|7-Day Washout||0
10563980|NCT01614769|11719029|FG003|NOT COMPLETED|7-Day Washout||0
10563981|NCT01614769|11719030|FG004|NOT COMPLETED|7-Day Washout||0
10563982|NCT01614769|11719031|FG005|NOT COMPLETED|7-Day Washout||0
10563983|NCT01614769|11719026|FG000|STARTED|Period 3||1
10563984|NCT01614769|11719027|FG001|STARTED|Period 3||1
10563985|NCT01614769|11719028|FG002|STARTED|Period 3||2
10563986|NCT01614769|11719029|FG003|STARTED|Period 3||0
10563987|NCT01614769|11719030|FG004|STARTED|Period 3||1
10563988|NCT01614769|11719031|FG005|STARTED|Period 3||1
10563989|NCT01614769|11719026|FG000|COMPLETED|Period 3||1
10563990|NCT01614769|11719027|FG001|COMPLETED|Period 3||1
10563991|NCT01614769|11719028|FG002|COMPLETED|Period 3||1
10563992|NCT01614769|11719029|FG003|COMPLETED|Period 3||0
10563993|NCT01614769|11719030|FG004|COMPLETED|Period 3||1
10563994|NCT01614769|11719031|FG005|COMPLETED|Period 3||1
10563995|NCT01614769|11719026|FG000|NOT COMPLETED|Period 3||0
10563996|NCT01614769|11719027|FG001|NOT COMPLETED|Period 3||0
10563997|NCT01614769|11719028|FG002|NOT COMPLETED|Period 3||1
10563998|NCT01614769|11719029|FG003|NOT COMPLETED|Period 3||0
10563999|NCT01614769|11719030|FG004|NOT COMPLETED|Period 3||0
10564000|NCT01614769|11719031|FG005|NOT COMPLETED|Period 3||0
10564001|NCT01614795|11719043|FG000|STARTED|Overall Study||11
10564002|NCT01614795|11719044|FG001|STARTED|Overall Study||12
10564003|NCT01614795|11719045|FG002|STARTED|Overall Study||11
10564004|NCT01614795|11719046|FG003|STARTED|Overall Study||12
10564005|NCT01614795|11719043|FG000|COMPLETED|Overall Study||0
10564006|NCT01614795|11719044|FG001|COMPLETED|Overall Study||0
10564007|NCT01614795|11719045|FG002|COMPLETED|Overall Study||0
10564008|NCT01614795|11719046|FG003|COMPLETED|Overall Study||0
10564009|NCT01614795|11719043|FG000|NOT COMPLETED|Overall Study||11
10564010|NCT01614795|11719044|FG001|NOT COMPLETED|Overall Study||12
10564011|NCT01614795|11719045|FG002|NOT COMPLETED|Overall Study||11
10792797|NCT03589807|11953595|FG005|STARTED|Overall Study||30
10792798|NCT03589807|11953590|FG000|COMPLETED|Overall Study||27
10792799|NCT03589807|11953591|FG001|COMPLETED|Overall Study||23
10792800|NCT03589807|11953592|FG002|COMPLETED|Overall Study||31
10792801|NCT03589807|11953593|FG003|COMPLETED|Overall Study||28
10792802|NCT03589807|11953594|FG004|COMPLETED|Overall Study||26
10792803|NCT03589807|11953595|FG005|COMPLETED|Overall Study||29
10792804|NCT03589807|11953590|FG000|NOT COMPLETED|Overall Study||0
10792805|NCT03589807|11953591|FG001|NOT COMPLETED|Overall Study||7
10792806|NCT03589807|11953592|FG002|NOT COMPLETED|Overall Study||2
10792807|NCT03589807|11953593|FG003|NOT COMPLETED|Overall Study||4
10792808|NCT03589807|11953594|FG004|NOT COMPLETED|Overall Study||2
10792809|NCT03589807|11953595|FG005|NOT COMPLETED|Overall Study||1
10792810|NCT03589885|11953615|FG000|STARTED|Treatment Period 1-Randomized Set||41
10792811|NCT03589885|11953616|FG001|STARTED|Treatment Period 1-Randomized Set||41
10792812|NCT03589885|11953617|FG002|STARTED|Treatment Period 1-Randomized Set||40
10792813|NCT03589885|11953618|FG003|STARTED|Treatment Period 1-Randomized Set||0
10792814|NCT03589885|11953619|FG004|STARTED|Treatment Period 1-Randomized Set||0
10792815|NCT03589885|11953615|FG000|COMPLETED|Treatment Period 1-Randomized Set||41
10792816|NCT03589885|11953616|FG001|COMPLETED|Treatment Period 1-Randomized Set||39
10792817|NCT03589885|11953617|FG002|COMPLETED|Treatment Period 1-Randomized Set||37
10792818|NCT03589885|11953618|FG003|COMPLETED|Treatment Period 1-Randomized Set||0
10792819|NCT03589885|11953619|FG004|COMPLETED|Treatment Period 1-Randomized Set||0
10792820|NCT03589885|11953615|FG000|NOT COMPLETED|Treatment Period 1-Randomized Set||0
10792821|NCT03589885|11953616|FG001|NOT COMPLETED|Treatment Period 1-Randomized Set||2
10792822|NCT03589885|11953617|FG002|NOT COMPLETED|Treatment Period 1-Randomized Set||3
10792823|NCT03589885|11953618|FG003|NOT COMPLETED|Treatment Period 1-Randomized Set||0
10792824|NCT03589885|11953619|FG004|NOT COMPLETED|Treatment Period 1-Randomized Set||0
10792825|NCT03589885|11953615|FG000|STARTED|Treatment Period 2-Randomized Set||41
10792826|NCT03589885|11953616|FG001|STARTED|Treatment Period 2-Randomized Set||39
10792827|NCT03589885|11953617|FG002|STARTED|Treatment Period 2-Randomized Set||4
10792828|NCT03589885|11953618|FG003|STARTED|Treatment Period 2-Randomized Set||16
10564012|NCT01614795|11719046|FG003|NOT COMPLETED|Overall Study||12
10792829|NCT03589885|11953619|FG004|STARTED|Treatment Period 2-Randomized Set||17
10792830|NCT03589885|11953615|FG000|COMPLETED|Treatment Period 2-Randomized Set||40
10792831|NCT03589885|11953616|FG001|COMPLETED|Treatment Period 2-Randomized Set||34
10564013|NCT01614821|11719057|FG000|STARTED|Overall Study||63
10564014|NCT01614821|11719057|FG000|COMPLETED|Overall Study||63
10564015|NCT01614821|11719057|FG000|NOT COMPLETED|Overall Study||0
10564016|NCT01614847|11719063|FG000|STARTED|Day 1|Four subjects chosen at random received Drop A (hyaluronate) during Day 1.|4
10564017|NCT01614847|11719064|FG001|STARTED|Day 1|The other 4 subjects, not to Group 1, received Drop B (saline) on Day 1.|4
10564018|NCT01614847|11719063|FG000|COMPLETED|Day 1||4
10564019|NCT01614847|11719064|FG001|COMPLETED|Day 1|See Arm 1 comments.|4
10564020|NCT01614847|11719063|FG000|NOT COMPLETED|Day 1||0
10564021|NCT01614847|11719064|FG001|NOT COMPLETED|Day 1||0
10650996|NCT02173535|11811301|FG004|NOT COMPLETED|Period 2||0
10564022|NCT01614847|11719063|FG000|STARTED|Day 2 (24 Hours Later)|On Day 2, these subject will received Drop B (normal saline).|4
10564023|NCT01614847|11719064|FG001|STARTED|Day 2 (24 Hours Later)|On Day 2, these subjects received Drop A (hyaluronate).|4
10564024|NCT01614847|11719063|FG000|COMPLETED|Day 2 (24 Hours Later)||4
10564025|NCT01614847|11719064|FG001|COMPLETED|Day 2 (24 Hours Later)||4
10564026|NCT01614847|11719063|FG000|NOT COMPLETED|Day 2 (24 Hours Later)||0
10564027|NCT01614847|11719064|FG001|NOT COMPLETED|Day 2 (24 Hours Later)||0
10564028|NCT01614886|11719077|FG000|STARTED|Overall Study||107
10564029|NCT01614886|11719078|FG001|STARTED|Overall Study||109
10564030|NCT01614886|11719077|FG000|Safety Population (SAF)|Overall Study||107
10564031|NCT01614886|11719078|FG001|Safety Population (SAF)|Overall Study||108
10564032|NCT01614886|11719077|FG000|Full Analysis Set (FAS)|Overall Study||104
10792832|NCT03589885|11953617|FG002|COMPLETED|Treatment Period 2-Randomized Set||3
10792833|NCT03589885|11953618|FG003|COMPLETED|Treatment Period 2-Randomized Set||16
10792834|NCT03589885|11953619|FG004|COMPLETED|Treatment Period 2-Randomized Set||16
10792835|NCT03589885|11953615|FG000|NOT COMPLETED|Treatment Period 2-Randomized Set||1
10792836|NCT03589885|11953616|FG001|NOT COMPLETED|Treatment Period 2-Randomized Set||5
10792837|NCT03589885|11953617|FG002|NOT COMPLETED|Treatment Period 2-Randomized Set||1
10792838|NCT03589885|11953618|FG003|NOT COMPLETED|Treatment Period 2-Randomized Set||0
10792839|NCT03589885|11953619|FG004|NOT COMPLETED|Treatment Period 2-Randomized Set||1
10792840|NCT03590613|11953637|FG000|STARTED|Period 1, 4 Days||3
10792841|NCT03590613|11953638|FG001|STARTED|Period 1, 4 Days||3
10792842|NCT03590613|11953639|FG002|STARTED|Period 1, 4 Days||3
10792843|NCT03590613|11953640|FG003|STARTED|Period 1, 4 Days||3
10792844|NCT03590613|11953637|FG000|COMPLETED|Period 1, 4 Days||3
10792845|NCT03590613|11953638|FG001|COMPLETED|Period 1, 4 Days||3
10792846|NCT03590613|11953639|FG002|COMPLETED|Period 1, 4 Days||3
10792847|NCT03590613|11953640|FG003|COMPLETED|Period 1, 4 Days||3
10792848|NCT03590613|11953637|FG000|NOT COMPLETED|Period 1, 4 Days||0
10792849|NCT03590613|11953638|FG001|NOT COMPLETED|Period 1, 4 Days||0
10792850|NCT03590613|11953639|FG002|NOT COMPLETED|Period 1, 4 Days||0
10792851|NCT03590613|11953640|FG003|NOT COMPLETED|Period 1, 4 Days||0
10792852|NCT03590613|11953637|FG000|STARTED|Period 1, Wash-out, at Least 3 Days||3
10792853|NCT03590613|11953638|FG001|STARTED|Period 1, Wash-out, at Least 3 Days||3
10792854|NCT03590613|11953639|FG002|STARTED|Period 1, Wash-out, at Least 3 Days||3
10792855|NCT03590613|11953640|FG003|STARTED|Period 1, Wash-out, at Least 3 Days||3
10792856|NCT03590613|11953637|FG000|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
10792857|NCT03590613|11953638|FG001|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
10792858|NCT03590613|11953639|FG002|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
10792859|NCT03590613|11953640|FG003|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
10792860|NCT03590613|11953637|FG000|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
10792861|NCT03590613|11953638|FG001|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
10792862|NCT03590613|11953639|FG002|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
10792863|NCT03590613|11953640|FG003|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
10792864|NCT03590613|11953637|FG000|STARTED|Period 2, 4 Days||3
10792865|NCT03590613|11953638|FG001|STARTED|Period 2, 4 Days||3
10792866|NCT03590613|11953639|FG002|STARTED|Period 2, 4 Days||3
10792867|NCT03590613|11953640|FG003|STARTED|Period 2, 4 Days|One additional participant was enrolled in Period 2.|4
10792868|NCT03590613|11953637|FG000|COMPLETED|Period 2, 4 Days||3
10792869|NCT03590613|11953638|FG001|COMPLETED|Period 2, 4 Days||3
10792870|NCT03590613|11953639|FG002|COMPLETED|Period 2, 4 Days||3
10792871|NCT03590613|11953640|FG003|COMPLETED|Period 2, 4 Days||3
10792872|NCT03590613|11953637|FG000|NOT COMPLETED|Period 2, 4 Days||0
10792873|NCT03590613|11953638|FG001|NOT COMPLETED|Period 2, 4 Days||0
10792874|NCT03590613|11953639|FG002|NOT COMPLETED|Period 2, 4 Days||0
10792875|NCT03590613|11953640|FG003|NOT COMPLETED|Period 2, 4 Days||1
10792876|NCT03590613|11953637|FG000|STARTED|Period 2, Wash-out, at Least 3 Days||3
10792877|NCT03590613|11953638|FG001|STARTED|Period 2, Wash-out, at Least 3 Days||3
10792878|NCT03590613|11953639|FG002|STARTED|Period 2, Wash-out, at Least 3 Days||3
10792879|NCT03590613|11953640|FG003|STARTED|Period 2, Wash-out, at Least 3 Days||3
10792880|NCT03590613|11953637|FG000|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
10792881|NCT03590613|11953638|FG001|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
10792882|NCT03590613|11953639|FG002|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
10792883|NCT03590613|11953640|FG003|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
10792884|NCT03590613|11953637|FG000|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
10792885|NCT03590613|11953638|FG001|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
10792886|NCT03590613|11953639|FG002|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
10792887|NCT03590613|11953640|FG003|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
10792888|NCT03590613|11953637|FG000|STARTED|Period 3, 4 Days||3
10792889|NCT03590613|11953638|FG001|STARTED|Period 3, 4 Days||3
10792890|NCT03590613|11953639|FG002|STARTED|Period 3, 4 Days||3
10792891|NCT03590613|11953640|FG003|STARTED|Period 3, 4 Days||3
10792892|NCT03590613|11953637|FG000|COMPLETED|Period 3, 4 Days||3
10792893|NCT03590613|11953638|FG001|COMPLETED|Period 3, 4 Days||3
10792894|NCT03590613|11953639|FG002|COMPLETED|Period 3, 4 Days||3
10792895|NCT03590613|11953640|FG003|COMPLETED|Period 3, 4 Days||3
10792896|NCT03590613|11953637|FG000|NOT COMPLETED|Period 3, 4 Days||0
10792897|NCT03590613|11953638|FG001|NOT COMPLETED|Period 3, 4 Days||0
10792898|NCT03590613|11953639|FG002|NOT COMPLETED|Period 3, 4 Days||0
10792899|NCT03590613|11953640|FG003|NOT COMPLETED|Period 3, 4 Days||0
10792900|NCT03590613|11953637|FG000|STARTED|Period 3,Wash-out, at Least 3 Days||3
10792901|NCT03590613|11953638|FG001|STARTED|Period 3,Wash-out, at Least 3 Days||3
10564033|NCT01614886|11719078|FG001|Full Analysis Set (FAS)|Overall Study||105
10564034|NCT01614886|11719077|FG000|COMPLETED|Overall Study||87
10564035|NCT01614886|11719078|FG001|COMPLETED|Overall Study||83
10564036|NCT01614886|11719077|FG000|NOT COMPLETED|Overall Study||20
10564037|NCT01614886|11719078|FG001|NOT COMPLETED|Overall Study||26
10564038|NCT01614925|11719086|FG000|STARTED|Overall Study||18
10792902|NCT03590613|11953639|FG002|STARTED|Period 3,Wash-out, at Least 3 Days||3
10792903|NCT03590613|11953640|FG003|STARTED|Period 3,Wash-out, at Least 3 Days||3
10792904|NCT03590613|11953637|FG000|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
10792905|NCT03590613|11953638|FG001|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
10792906|NCT03590613|11953639|FG002|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
10792907|NCT03590613|11953640|FG003|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
10792908|NCT03590613|11953637|FG000|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
10792909|NCT03590613|11953638|FG001|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
10792910|NCT03590613|11953639|FG002|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
10792911|NCT03590613|11953640|FG003|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
10792912|NCT03590613|11953637|FG000|STARTED|Period 4, 4 Days||3
10792913|NCT03590613|11953638|FG001|STARTED|Period 4, 4 Days||3
10792914|NCT03590613|11953639|FG002|STARTED|Period 4, 4 Days||3
10792915|NCT03590613|11953640|FG003|STARTED|Period 4, 4 Days||3
10792916|NCT03590613|11953637|FG000|COMPLETED|Period 4, 4 Days||3
10792917|NCT03590613|11953638|FG001|COMPLETED|Period 4, 4 Days||3
10792918|NCT03590613|11953639|FG002|COMPLETED|Period 4, 4 Days||3
10792919|NCT03590613|11953640|FG003|COMPLETED|Period 4, 4 Days||3
10792920|NCT03590613|11953637|FG000|NOT COMPLETED|Period 4, 4 Days||0
10792921|NCT03590613|11953638|FG001|NOT COMPLETED|Period 4, 4 Days||0
10792922|NCT03590613|11953639|FG002|NOT COMPLETED|Period 4, 4 Days||0
10792923|NCT03590613|11953640|FG003|NOT COMPLETED|Period 4, 4 Days||0
10792924|NCT03591068|11953653|FG000|STARTED|Overall Study||11
10792925|NCT03591068|11953653|FG000|COMPLETED|Overall Study||9
10792926|NCT03591068|11953653|FG000|NOT COMPLETED|Overall Study||2
10792927|NCT03591146|11953664|FG000|STARTED|TLC590 190mg and Naropin 150mg||12
10792928|NCT03591146|11953665|FG001|STARTED|TLC590 190mg and Naropin 150mg||0
10792929|NCT03591146|11953666|FG002|STARTED|TLC590 190mg and Naropin 150mg||0
10792930|NCT03591146|11953667|FG003|STARTED|TLC590 190mg and Naropin 150mg||0
10792931|NCT03591146|11953668|FG004|STARTED|TLC590 190mg and Naropin 150mg||4
10792932|NCT03591146|11953664|FG000|COMPLETED|TLC590 190mg and Naropin 150mg||12
10792933|NCT03591146|11953665|FG001|COMPLETED|TLC590 190mg and Naropin 150mg||0
10792934|NCT03591146|11953666|FG002|COMPLETED|TLC590 190mg and Naropin 150mg||0
10792935|NCT03591146|11953667|FG003|COMPLETED|TLC590 190mg and Naropin 150mg||0
10792936|NCT03591146|11953668|FG004|COMPLETED|TLC590 190mg and Naropin 150mg||3
10792937|NCT03591146|11953664|FG000|NOT COMPLETED|TLC590 190mg and Naropin 150mg||0
10792938|NCT03591146|11953665|FG001|NOT COMPLETED|TLC590 190mg and Naropin 150mg||0
10792939|NCT03591146|11953666|FG002|NOT COMPLETED|TLC590 190mg and Naropin 150mg||0
10792940|NCT03591146|11953667|FG003|NOT COMPLETED|TLC590 190mg and Naropin 150mg||0
10792941|NCT03591146|11953668|FG004|NOT COMPLETED|TLC590 190mg and Naropin 150mg||1
10792942|NCT03591146|11953664|FG000|STARTED|TLC590 380mg and Naropin 150mg||0
10792943|NCT03591146|11953665|FG001|STARTED|TLC590 380mg and Naropin 150mg||12
10792944|NCT03591146|11953666|FG002|STARTED|TLC590 380mg and Naropin 150mg||0
10792945|NCT03591146|11953667|FG003|STARTED|TLC590 380mg and Naropin 150mg||0
10792946|NCT03591146|11953668|FG004|STARTED|TLC590 380mg and Naropin 150mg||5
10792947|NCT03591146|11953664|FG000|COMPLETED|TLC590 380mg and Naropin 150mg||0
10792948|NCT03591146|11953665|FG001|COMPLETED|TLC590 380mg and Naropin 150mg||11
10792949|NCT03591146|11953666|FG002|COMPLETED|TLC590 380mg and Naropin 150mg||0
10792950|NCT03591146|11953667|FG003|COMPLETED|TLC590 380mg and Naropin 150mg||0
10792951|NCT03591146|11953668|FG004|COMPLETED|TLC590 380mg and Naropin 150mg||4
10792952|NCT03591146|11953664|FG000|NOT COMPLETED|TLC590 380mg and Naropin 150mg||0
10792953|NCT03591146|11953665|FG001|NOT COMPLETED|TLC590 380mg and Naropin 150mg||1
10792954|NCT03591146|11953666|FG002|NOT COMPLETED|TLC590 380mg and Naropin 150mg||0
10792955|NCT03591146|11953667|FG003|NOT COMPLETED|TLC590 380mg and Naropin 150mg||0
10564039|NCT01614925|11719087|FG001|STARTED|Overall Study||17
10564040|NCT01614925|11719086|FG000|COMPLETED|Overall Study||14
10564041|NCT01614925|11719087|FG001|COMPLETED|Overall Study||15
10792956|NCT03591146|11953668|FG004|NOT COMPLETED|TLC590 380mg and Naropin 150mg||1
10792957|NCT03591146|11953664|FG000|STARTED|TLC590 570mg and Naropin 150mg||0
10792958|NCT03591146|11953665|FG001|STARTED|TLC590 570mg and Naropin 150mg||0
10792959|NCT03591146|11953666|FG002|STARTED|TLC590 570mg and Naropin 150mg||12
10792960|NCT03591146|11953667|FG003|STARTED|TLC590 570mg and Naropin 150mg||0
10792961|NCT03591146|11953668|FG004|STARTED|TLC590 570mg and Naropin 150mg||4
10792962|NCT03591146|11953664|FG000|COMPLETED|TLC590 570mg and Naropin 150mg||0
10792963|NCT03591146|11953665|FG001|COMPLETED|TLC590 570mg and Naropin 150mg||0
10792964|NCT03591146|11953666|FG002|COMPLETED|TLC590 570mg and Naropin 150mg||11
10792965|NCT03591146|11953667|FG003|COMPLETED|TLC590 570mg and Naropin 150mg||0
10792966|NCT03591146|11953668|FG004|COMPLETED|TLC590 570mg and Naropin 150mg||3
10792967|NCT03591146|11953664|FG000|NOT COMPLETED|TLC590 570mg and Naropin 150mg||0
10792968|NCT03591146|11953665|FG001|NOT COMPLETED|TLC590 570mg and Naropin 150mg||0
10792969|NCT03591146|11953666|FG002|NOT COMPLETED|TLC590 570mg and Naropin 150mg||1
10792970|NCT03591146|11953667|FG003|NOT COMPLETED|TLC590 570mg and Naropin 150mg||0
10792971|NCT03591146|11953668|FG004|NOT COMPLETED|TLC590 570mg and Naropin 150mg||1
10564042|NCT01614925|11719086|FG000|NOT COMPLETED|Overall Study||4
10564043|NCT01614925|11719087|FG001|NOT COMPLETED|Overall Study||2
10564044|NCT01615120|11719095|FG000|STARTED|Overall Study||38
10564045|NCT01615120|11719096|FG001|STARTED|Overall Study||39
10564046|NCT01615120|11719095|FG000|COMPLETED|Overall Study||23
10564047|NCT01615120|11719096|FG001|COMPLETED|Overall Study||19
10564048|NCT01615120|11719095|FG000|NOT COMPLETED|Overall Study||15
10564049|NCT01615120|11719096|FG001|NOT COMPLETED|Overall Study||20
10792972|NCT03591146|11953664|FG000|STARTED|TLC590 475mg and Naropin 150mg||0
10792973|NCT03591146|11953665|FG001|STARTED|TLC590 475mg and Naropin 150mg||0
10792974|NCT03591146|11953666|FG002|STARTED|TLC590 475mg and Naropin 150mg||0
10792975|NCT03591146|11953667|FG003|STARTED|TLC590 475mg and Naropin 150mg||12
10792976|NCT03591146|11953668|FG004|STARTED|TLC590 475mg and Naropin 150mg||4
10792977|NCT03591146|11953664|FG000|COMPLETED|TLC590 475mg and Naropin 150mg||0
10792978|NCT03591146|11953665|FG001|COMPLETED|TLC590 475mg and Naropin 150mg||0
10792979|NCT03591146|11953666|FG002|COMPLETED|TLC590 475mg and Naropin 150mg||0
10792980|NCT03591146|11953667|FG003|COMPLETED|TLC590 475mg and Naropin 150mg||12
10792981|NCT03591146|11953668|FG004|COMPLETED|TLC590 475mg and Naropin 150mg||4
10792982|NCT03591146|11953664|FG000|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0
10792983|NCT03591146|11953665|FG001|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0
10792984|NCT03591146|11953666|FG002|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0
10792985|NCT03591146|11953667|FG003|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0
10792986|NCT03591146|11953668|FG004|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0
10792987|NCT03591406|11953682|FG000|STARTED|Overall Study||188
10792988|NCT03591406|11953683|FG001|STARTED|Overall Study||183
10792989|NCT03591406|11953682|FG000|COMPLETED|Overall Study||181
10792990|NCT03591406|11953683|FG001|COMPLETED|Overall Study||174
10792991|NCT03591406|11953682|FG000|NOT COMPLETED|Overall Study||7
10792992|NCT03591406|11953683|FG001|NOT COMPLETED|Overall Study||9
10792993|NCT03592121|11953691|FG000|STARTED|Overall Study||3
10792994|NCT03592121|11953692|FG001|STARTED|Overall Study||0
10792995|NCT03592121|11953691|FG000|COMPLETED|Overall Study||3
10792996|NCT03592121|11953692|FG001|COMPLETED|Overall Study||0
10792997|NCT03592121|11953691|FG000|NOT COMPLETED|Overall Study||0
10792998|NCT03592121|11953692|FG001|NOT COMPLETED|Overall Study||0
10792999|NCT03592745|11953700|FG000|STARTED|Overall Study||18
10793000|NCT03592745|11953701|FG001|STARTED|Overall Study||18
10793001|NCT03592745|11953700|FG000|COMPLETED|Overall Study||15
10793002|NCT03592745|11953701|FG001|COMPLETED|Overall Study||15
10793003|NCT03592745|11953700|FG000|NOT COMPLETED|Overall Study||3
10793004|NCT03592745|11953701|FG001|NOT COMPLETED|Overall Study||3
10793005|NCT03593200|11953707|FG000|STARTED|Overall Study||4
10793006|NCT03593200|11953707|FG000|COMPLETED|Overall Study||4
10793007|NCT03593200|11953707|FG000|NOT COMPLETED|Overall Study||0
10793008|NCT03593538|11953714|FG000|STARTED|Overall Study||26
10793009|NCT03593538|11953715|FG001|STARTED|Overall Study||21
10793010|NCT03593538|11953716|FG002|STARTED|Overall Study||22
10793011|NCT03593538|11953714|FG000|COMPLETED|Overall Study||15
10793012|NCT03593538|11953715|FG001|COMPLETED|Overall Study||15
10793013|NCT03593538|11953716|FG002|COMPLETED|Overall Study||11
10793014|NCT03593538|11953714|FG000|NOT COMPLETED|Overall Study||11
10793015|NCT03593538|11953715|FG001|NOT COMPLETED|Overall Study||6
10793016|NCT03593538|11953716|FG002|NOT COMPLETED|Overall Study||11
10793017|NCT03593681|11953724|FG000|STARTED|Overall Study||150
10793018|NCT03593681|11953724|FG000|COMPLETED|Overall Study||115
10793019|NCT03593681|11953724|FG000|NOT COMPLETED|Overall Study||35
10793020|NCT03593876|11953745|FG000|STARTED|Overall Study||16
10793021|NCT03593876|11953745|FG000|COMPLETED|Overall Study||13
10793022|NCT03593876|11953745|FG000|NOT COMPLETED|Overall Study||3
10793023|NCT03593902|11953749|FG000|STARTED|Overall Study||9
10564050|NCT01615198|11719104|FG000|STARTED|Overall Study||296
10564051|NCT01615198|11719105|FG001|STARTED|Overall Study||292
10564052|NCT01615198|11719104|FG000|Full Analysis Set|Overall Study||296
10564053|NCT01615198|11719105|FG001|Full Analysis Set|Overall Study||292
10564054|NCT01615198|11719104|FG000|Ambulatory BP Monitoring (ABPM) Subset|Overall Study||154
10564055|NCT01615198|11719105|FG001|Ambulatory BP Monitoring (ABPM) Subset|Overall Study||157
10564056|NCT01615198|11719104|FG000|Safety Set|Overall Study||296
10564057|NCT01615198|11719105|FG001|Safety Set|Overall Study||292
10564058|NCT01615198|11719104|FG000|ABPM Dipper Status Subset|Overall Study||82
10564059|NCT01615198|11719105|FG001|ABPM Dipper Status Subset|Overall Study||84
10564060|NCT01615198|11719104|FG000|COMPLETED|Overall Study||272
10564061|NCT01615198|11719105|FG001|COMPLETED|Overall Study||273
10564062|NCT01615198|11719104|FG000|NOT COMPLETED|Overall Study||24
10564063|NCT01615198|11719105|FG001|NOT COMPLETED|Overall Study||19
10564064|NCT01615263|11719113|FG000|STARTED|Overall Study||20
10564065|NCT01615263|11719114|FG001|STARTED|Overall Study||20
10564066|NCT01615263|11719113|FG000|COMPLETED|Overall Study||20
10793024|NCT03593902|11953749|FG000|COMPLETED|Overall Study||9
10793025|NCT03593902|11953749|FG000|NOT COMPLETED|Overall Study||0
10793026|NCT03594045|11953755|FG000|STARTED|Overall Study||0
10793027|NCT03594045|11953756|FG001|STARTED|Overall Study||5
10564067|NCT01615263|11719114|FG001|COMPLETED|Overall Study||18
10564068|NCT01615263|11719113|FG000|NOT COMPLETED|Overall Study||0
10564069|NCT01615263|11719114|FG001|NOT COMPLETED|Overall Study||2
10793028|NCT03594045|11953755|FG000|COMPLETED|Overall Study||0
10793029|NCT03594045|11953756|FG001|COMPLETED|Overall Study||5
10793030|NCT03594045|11953755|FG000|NOT COMPLETED|Overall Study||0
10793031|NCT03594045|11953756|FG001|NOT COMPLETED|Overall Study||0
10793032|NCT03594071|11953762|FG000|STARTED|Overall Study||294
10793033|NCT03594071|11953762|FG000|COMPLETED|Overall Study||289
10793034|NCT03594071|11953762|FG000|NOT COMPLETED|Overall Study||5
10564070|NCT01615328|11719122|FG000|STARTED|Overall Study||42
10564071|NCT01615328|11719123|FG001|STARTED|Overall Study||43
10564072|NCT01615328|11719122|FG000|COMPLETED|Overall Study||39
10793035|NCT03594227|11953770|FG000|STARTED|Overall Study||23
10793036|NCT03594227|11953771|FG001|STARTED|Overall Study||23
10793037|NCT03594227|11953772|FG002|STARTED|Overall Study||22
10793038|NCT03594227|11953773|FG003|STARTED|Overall Study||19
10793039|NCT03594227|11953770|FG000|COMPLETED|Overall Study||18
10793040|NCT03594227|11953771|FG001|COMPLETED|Overall Study||19
10793041|NCT03594227|11953772|FG002|COMPLETED|Overall Study||19
10793042|NCT03594227|11953773|FG003|COMPLETED|Overall Study||14
10793043|NCT03594227|11953770|FG000|NOT COMPLETED|Overall Study||5
10793044|NCT03594227|11953771|FG001|NOT COMPLETED|Overall Study||4
10793045|NCT03594227|11953772|FG002|NOT COMPLETED|Overall Study||3
10793046|NCT03594227|11953773|FG003|NOT COMPLETED|Overall Study||5
10793047|NCT03594500|11953796|FG000|STARTED|Overall Study||66
10793048|NCT03594500|11953797|FG001|STARTED|Overall Study||67
10793049|NCT03594500|11953796|FG000|COMPLETED|Overall Study||60
10793050|NCT03594500|11953797|FG001|COMPLETED|Overall Study||63
10793051|NCT03594500|11953796|FG000|NOT COMPLETED|Overall Study||6
10793052|NCT03594500|11953797|FG001|NOT COMPLETED|Overall Study||4
10793053|NCT03595215|11953806|FG000|STARTED|Overall Study||18
10793054|NCT03595215|11953806|FG000|COMPLETED|Overall Study||10
10793055|NCT03595215|11953806|FG000|NOT COMPLETED|Overall Study||8
10793056|NCT03595280|11953813|FG000|STARTED|Overall Study||119
10793057|NCT03595280|11953814|FG001|STARTED|Overall Study||117
10793058|NCT03595280|11953815|FG002|STARTED|Overall Study||113
10793059|NCT03595280|11953813|FG000|COMPLETED|Overall Study||113
10793060|NCT03595280|11953814|FG001|COMPLETED|Overall Study||108
10793061|NCT03595280|11953815|FG002|COMPLETED|Overall Study||98
10793062|NCT03595280|11953813|FG000|NOT COMPLETED|Overall Study||6
10793063|NCT03595280|11953814|FG001|NOT COMPLETED|Overall Study||9
10793064|NCT03595280|11953815|FG002|NOT COMPLETED|Overall Study||15
10793065|NCT03595449|11953825|FG000|STARTED|Overall Study||118
10793066|NCT03595449|11953826|FG001|STARTED|Overall Study||115
10793067|NCT03595449|11953825|FG000|COMPLETED|Overall Study||118
10793068|NCT03595449|11953826|FG001|COMPLETED|Overall Study||115
10793069|NCT03595449|11953825|FG000|NOT COMPLETED|Overall Study||0
10793070|NCT03595449|11953826|FG001|NOT COMPLETED|Overall Study||0
10793071|NCT03595579|11953834|FG000|STARTED|Overall Study||48
10793072|NCT03595579|11953835|FG001|STARTED|Overall Study||49
10793073|NCT03595579|11953834|FG000|mITT Population|Overall Study||43
10793074|NCT03595579|11953835|FG001|mITT Population|Overall Study||37
10793075|NCT03595579|11953834|FG000|Safety Population|Overall Study||48
10793076|NCT03595579|11953835|FG001|Safety Population|Overall Study||48
10793077|NCT03595579|11953834|FG000|COMPLETED|Overall Study||38
10793078|NCT03595579|11953835|FG001|COMPLETED|Overall Study||35
10793079|NCT03595579|11953834|FG000|NOT COMPLETED|Overall Study||10
10793080|NCT03595579|11953835|FG001|NOT COMPLETED|Overall Study||14
10793081|NCT03595618|11953845|FG000|STARTED|Overall Study||234
10793082|NCT03595618|11953846|FG001|STARTED|Overall Study||231
10793083|NCT03595618|11953847|FG002|STARTED|Overall Study||233
10793084|NCT03595618|11953848|FG003|STARTED|Overall Study||234
10793085|NCT03595618|11953845|FG000|Treated|Overall Study||234
10793086|NCT03595618|11953846|FG001|Treated|Overall Study||231
10793087|NCT03595618|11953847|FG002|Treated|Overall Study||232
10793088|NCT03595618|11953848|FG003|Treated|Overall Study||234
10793089|NCT03595618|11953845|FG000|COMPLETED|Overall Study||191
10793090|NCT03595618|11953846|FG001|COMPLETED|Overall Study||191
10793091|NCT03595618|11953847|FG002|COMPLETED|Overall Study||177
10793092|NCT03595618|11953848|FG003|COMPLETED|Overall Study||200
10793093|NCT03595618|11953845|FG000|NOT COMPLETED|Overall Study||43
10793094|NCT03595618|11953846|FG001|NOT COMPLETED|Overall Study||40
10793095|NCT03595618|11953847|FG002|NOT COMPLETED|Overall Study||56
10793096|NCT03595618|11953848|FG003|NOT COMPLETED|Overall Study||34
10793097|NCT03595904|11953860|FG000|STARTED|Overall Study||39
10793098|NCT03595904|11953861|FG001|STARTED|Overall Study||39
10793099|NCT03595904|11953860|FG000|COMPLETED|Overall Study||29
10564073|NCT01615328|11719123|FG001|COMPLETED|Overall Study||38
10564074|NCT01615328|11719122|FG000|NOT COMPLETED|Overall Study||3
10793100|NCT03595904|11953861|FG001|COMPLETED|Overall Study||34
10793101|NCT03595904|11953860|FG000|NOT COMPLETED|Overall Study||10
10793102|NCT03595904|11953861|FG001|NOT COMPLETED|Overall Study||5
10793103|NCT03596151|11953867|FG000|STARTED|Overall Study||295
10793104|NCT03596151|11953867|FG000|COMPLETED|Overall Study||294
10793105|NCT03596151|11953867|FG000|NOT COMPLETED|Overall Study||1
10793106|NCT03596177|11953873|FG000|STARTED|Single Blind Period||9
10564075|NCT01615328|11719123|FG001|NOT COMPLETED|Overall Study||5
10564076|NCT01615367|11719135|FG000|STARTED|Overall Study||19
10793107|NCT03596177|11953874|FG001|STARTED|Single Blind Period||19
10793108|NCT03596177|11953873|FG000|COMPLETED|Single Blind Period||7
10793109|NCT03596177|11953874|FG001|COMPLETED|Single Blind Period||18
10793110|NCT03596177|11953873|FG000|NOT COMPLETED|Single Blind Period||2
10793111|NCT03596177|11953874|FG001|NOT COMPLETED|Single Blind Period||1
10793112|NCT03596177|11953873|FG000|STARTED|Double Blind Period||7
10793113|NCT03596177|11953874|FG001|STARTED|Double Blind Period||18
10793114|NCT03596177|11953873|FG000|COMPLETED|Double Blind Period||7
10793115|NCT03596177|11953874|FG001|COMPLETED|Double Blind Period||12
10793116|NCT03596177|11953873|FG000|NOT COMPLETED|Double Blind Period||0
10793117|NCT03596177|11953874|FG001|NOT COMPLETED|Double Blind Period||6
10793118|NCT03596723|11953882|FG000|STARTED|Overall Study||1
10793119|NCT03596723|11953883|FG001|STARTED|Overall Study||1
10793120|NCT03596723|11953882|FG000|COMPLETED|Overall Study||1
10564077|NCT01615367|11719136|FG001|STARTED|Overall Study||19
10564078|NCT01615367|11719135|FG000|COMPLETED|Overall Study||14
10564079|NCT01615367|11719136|FG001|COMPLETED|Overall Study|11 TAU participants chose to participate in NEW Tx after the completion of the waitlist period.|13
10564080|NCT01615367|11719135|FG000|NOT COMPLETED|Overall Study||5
10793121|NCT03596723|11953883|FG001|COMPLETED|Overall Study||1
10793122|NCT03596723|11953882|FG000|NOT COMPLETED|Overall Study||0
10793123|NCT03596723|11953883|FG001|NOT COMPLETED|Overall Study||0
10793124|NCT03597009|11953889|FG000|STARTED|Overall Study||1
10793125|NCT03597009|11953889|FG000|COMPLETED|Overall Study||1
10793126|NCT03597009|11953889|FG000|NOT COMPLETED|Overall Study||0
10793127|NCT03597022|11953896|FG000|STARTED|Overall Study||8
10793128|NCT03597022|11953897|FG001|STARTED|Overall Study||8
10793129|NCT03597022|11953898|FG002|STARTED|Overall Study||8
10793130|NCT03597022|11953896|FG000|COMPLETED|Overall Study||0
10793131|NCT03597022|11953897|FG001|COMPLETED|Overall Study||0
10793132|NCT03597022|11953898|FG002|COMPLETED|Overall Study||0
10793133|NCT03597022|11953896|FG000|NOT COMPLETED|Overall Study||8
10793134|NCT03597022|11953897|FG001|NOT COMPLETED|Overall Study||8
10793135|NCT03597022|11953898|FG002|NOT COMPLETED|Overall Study||8
10793136|NCT03597061|11953908|FG000|STARTED|Overall Study||17
10793137|NCT03597061|11953909|FG001|STARTED|Overall Study||17
10793138|NCT03597061|11953908|FG000|COMPLETED|Overall Study||16
10793139|NCT03597061|11953909|FG001|COMPLETED|Overall Study||16
10793140|NCT03597061|11953908|FG000|NOT COMPLETED|Overall Study||1
10793141|NCT03597061|11953909|FG001|NOT COMPLETED|Overall Study||1
10793142|NCT03597139|11953917|FG000|STARTED|Overall Study||51
10793143|NCT03597139|11953918|FG001|STARTED|Overall Study||49
10793144|NCT03597139|11953917|FG000|COMPLETED|Overall Study||47
10793145|NCT03597139|11953918|FG001|COMPLETED|Overall Study||49
10793146|NCT03597139|11953917|FG000|NOT COMPLETED|Overall Study||4
10793147|NCT03597139|11953918|FG001|NOT COMPLETED|Overall Study||0
10793148|NCT03597178|11953924|FG000|STARTED|Overall Study||14
10793149|NCT03597178|11953924|FG000|COMPLETED|Overall Study||14
10793150|NCT03597178|11953924|FG000|NOT COMPLETED|Overall Study||0
10793151|NCT03597347|11953931|FG000|STARTED|Overall Study||7
10793152|NCT03597347|11953932|FG001|STARTED|Overall Study||3
10793153|NCT03597347|11953933|FG002|STARTED|Overall Study||4
10793154|NCT03597347|11953931|FG000|COMPLETED|Overall Study||0
10793155|NCT03597347|11953932|FG001|COMPLETED|Overall Study||0
10793156|NCT03597347|11953933|FG002|COMPLETED|Overall Study||0
10793157|NCT03597347|11953931|FG000|NOT COMPLETED|Overall Study||7
10793158|NCT03597347|11953932|FG001|NOT COMPLETED|Overall Study||3
10793159|NCT03597347|11953933|FG002|NOT COMPLETED|Overall Study||4
10793160|NCT03597529|11953943|FG000|STARTED|Overall Study||42
10793161|NCT03597529|11953944|FG001|STARTED|Overall Study||42
10793162|NCT03597529|11953943|FG000|Follow-up|Overall Study||22
10793163|NCT03597529|11953944|FG001|Follow-up|Overall Study||24
10793164|NCT03597529|11953943|FG000|COMPLETED|Overall Study||22
10793165|NCT03597529|11953944|FG001|COMPLETED|Overall Study||24
10793166|NCT03597529|11953943|FG000|NOT COMPLETED|Overall Study||20
10793167|NCT03597529|11953944|FG001|NOT COMPLETED|Overall Study||18
10793168|NCT03597789|11953950|FG000|STARTED|Overall Study||45
10793169|NCT03597789|11953950|FG000|COMPLETED|Overall Study||10
10793170|NCT03597789|11953950|FG000|NOT COMPLETED|Overall Study||35
10793171|NCT03598647|11953956|FG000|STARTED|Exercisers vs. Non-exercisers||30
10793172|NCT03598647|11953957|FG001|STARTED|Exercisers vs. Non-exercisers||30
10793173|NCT03598647|11953958|FG002|STARTED|Exercisers vs. Non-exercisers||0
10793174|NCT03598647|11953959|FG003|STARTED|Exercisers vs. Non-exercisers||0
10793175|NCT03598647|11953956|FG000|COMPLETED|Exercisers vs. Non-exercisers||29
10793176|NCT03598647|11953957|FG001|COMPLETED|Exercisers vs. Non-exercisers||30
10793177|NCT03598647|11953958|FG002|COMPLETED|Exercisers vs. Non-exercisers||0
10793178|NCT03598647|11953959|FG003|COMPLETED|Exercisers vs. Non-exercisers||0
10793179|NCT03598647|11953956|FG000|NOT COMPLETED|Exercisers vs. Non-exercisers||1
10793180|NCT03598647|11953957|FG001|NOT COMPLETED|Exercisers vs. Non-exercisers||0
10793181|NCT03598647|11953958|FG002|NOT COMPLETED|Exercisers vs. Non-exercisers||0
10793182|NCT03598647|11953959|FG003|NOT COMPLETED|Exercisers vs. Non-exercisers||0
10793183|NCT03598647|11953956|FG000|STARTED|Interventions for Non-exercisers||0
10793184|NCT03598647|11953957|FG001|STARTED|Interventions for Non-exercisers||0
10793185|NCT03598647|11953958|FG002|STARTED|Interventions for Non-exercisers||14
10793186|NCT03598647|11953959|FG003|STARTED|Interventions for Non-exercisers||16
10793187|NCT03598647|11953956|FG000|COMPLETED|Interventions for Non-exercisers||0
10793188|NCT03598647|11953957|FG001|COMPLETED|Interventions for Non-exercisers||0
10793189|NCT03598647|11953958|FG002|COMPLETED|Interventions for Non-exercisers||14
10793190|NCT03598647|11953959|FG003|COMPLETED|Interventions for Non-exercisers||16
10793191|NCT03598647|11953956|FG000|NOT COMPLETED|Interventions for Non-exercisers||0
10564081|NCT01615367|11719136|FG001|NOT COMPLETED|Overall Study||6
10564082|NCT01615484|11719144|FG000|STARTED|Overall Study||0
10564083|NCT01615484|11719145|FG001|STARTED|Overall Study||24
10564084|NCT01615484|11719144|FG000|COMPLETED|Overall Study||0
10793192|NCT03598647|11953957|FG001|NOT COMPLETED|Interventions for Non-exercisers||0
10793193|NCT03598647|11953958|FG002|NOT COMPLETED|Interventions for Non-exercisers||0
10793194|NCT03598647|11953959|FG003|NOT COMPLETED|Interventions for Non-exercisers||0
10793195|NCT03599089|11953973|FG000|STARTED|Overall Study||36
10793196|NCT03599089|11953974|FG001|STARTED|Overall Study||36
10793197|NCT03599089|11953975|FG002|STARTED|Overall Study||38
10793198|NCT03599089|11953976|FG003|STARTED|Overall Study||37
10793199|NCT03599089|11953973|FG000|COMPLETED|Overall Study||33
10793200|NCT03599089|11953974|FG001|COMPLETED|Overall Study||35
10564085|NCT01615484|11719145|FG001|COMPLETED|Overall Study||24
10564086|NCT01615484|11719144|FG000|NOT COMPLETED|Overall Study||0
10564087|NCT01615484|11719145|FG001|NOT COMPLETED|Overall Study||0
10564088|NCT01615731|11719153|FG000|STARTED|Overall Study||24
10564089|NCT01615731|11719154|FG001|STARTED|Overall Study||26
10564090|NCT01615731|11719153|FG000|COMPLETED|Overall Study||21
10564091|NCT01615731|11719154|FG001|COMPLETED|Overall Study||24
10564092|NCT01615731|11719153|FG000|NOT COMPLETED|Overall Study||3
10564093|NCT01615731|11719154|FG001|NOT COMPLETED|Overall Study||2
10564094|NCT01615809|11719160|FG000|STARTED|Overall Study|basal visit|32
10564095|NCT01615809|11719160|FG000|COMPLETED|Overall Study||22
10564096|NCT01615809|11719160|FG000|NOT COMPLETED|Overall Study||10
10564097|NCT01615822|11719167|FG000|STARTED|Period 1||8
10564098|NCT01615822|11719168|FG001|STARTED|Period 1||11
10564099|NCT01615822|11719169|FG002|STARTED|Period 1||6
10564100|NCT01615822|11719167|FG000|COMPLETED|Period 1||7
10564101|NCT01615822|11719168|FG001|COMPLETED|Period 1||9
10564102|NCT01615822|11719169|FG002|COMPLETED|Period 1||6
10564103|NCT01615822|11719167|FG000|NOT COMPLETED|Period 1||1
10564104|NCT01615822|11719168|FG001|NOT COMPLETED|Period 1||2
10564105|NCT01615822|11719169|FG002|NOT COMPLETED|Period 1||0
10564106|NCT01615822|11719167|FG000|STARTED|Period 2||7
10564107|NCT01615822|11719168|FG001|STARTED|Period 2||9
10564108|NCT01615822|11719169|FG002|STARTED|Period 2||6
10564109|NCT01615822|11719167|FG000|COMPLETED|Period 2||7
10564110|NCT01615822|11719168|FG001|COMPLETED|Period 2||8
10564111|NCT01615822|11719169|FG002|COMPLETED|Period 2||4
10564112|NCT01615822|11719167|FG000|NOT COMPLETED|Period 2||0
10564113|NCT01615822|11719168|FG001|NOT COMPLETED|Period 2||1
10564114|NCT01615822|11719169|FG002|NOT COMPLETED|Period 2||2
10564115|NCT01615939|11719182|FG000|STARTED|Overall Study||13
10564116|NCT01615939|11719183|FG001|STARTED|Overall Study||4
10564117|NCT01615939|11719182|FG000|COMPLETED|Overall Study||8
10564118|NCT01615939|11719183|FG001|COMPLETED|Overall Study||4
10564119|NCT01615939|11719182|FG000|NOT COMPLETED|Overall Study||5
10564120|NCT01615939|11719183|FG001|NOT COMPLETED|Overall Study||0
10564121|NCT01616056|11719189|FG000|STARTED|Overall Study||20
10564122|NCT01616056|11719189|FG000|COMPLETED|Overall Study||19
10564123|NCT01616056|11719189|FG000|NOT COMPLETED|Overall Study||1
10564124|NCT01616082|11719195|FG000|STARTED|Overall Study||19
10564125|NCT01616082|11719196|FG001|STARTED|Overall Study||20
10564126|NCT01616082|11719195|FG000|COMPLETED|Overall Study||19
10564127|NCT01616082|11719196|FG001|COMPLETED|Overall Study||18
10564128|NCT01616082|11719195|FG000|NOT COMPLETED|Overall Study||0
10564129|NCT01616082|11719196|FG001|NOT COMPLETED|Overall Study||2
10564130|NCT01616160|11719203|FG000|STARTED|Overall Study||11
10564131|NCT01616160|11719203|FG000|COMPLETED|Overall Study||9
10564132|NCT01616160|11719203|FG000|NOT COMPLETED|Overall Study||2
10564133|NCT01616173|11719210|FG000|STARTED|Overall Study||27
10564134|NCT01616173|11719211|FG001|STARTED|Overall Study||26
10564135|NCT01616173|11719212|FG002|STARTED|Overall Study||27
10564136|NCT01616173|11719210|FG000|COMPLETED|Overall Study||27
10564137|NCT01616173|11719211|FG001|COMPLETED|Overall Study||24
10564138|NCT01616173|11719212|FG002|COMPLETED|Overall Study||27
10564139|NCT01616173|11719210|FG000|NOT COMPLETED|Overall Study||0
10564140|NCT01616173|11719211|FG001|NOT COMPLETED|Overall Study||2
10564141|NCT01616173|11719212|FG002|NOT COMPLETED|Overall Study||0
10564142|NCT01616459|11719224|FG000|STARTED|Overall Study||240
10564143|NCT01616459|11719225|FG001|STARTED|Overall Study||240
10564144|NCT01616459|11719226|FG002|STARTED|Overall Study||230
10564145|NCT01616459|11719227|FG003|STARTED|Overall Study||241
10564146|NCT01616459|11719224|FG000|COMPLETED|Overall Study||236
10564147|NCT01616459|11719225|FG001|COMPLETED|Overall Study||223
10564148|NCT01616459|11719226|FG002|COMPLETED|Overall Study||220
10564149|NCT01616459|11719227|FG003|COMPLETED|Overall Study||233
10564150|NCT01616459|11719224|FG000|NOT COMPLETED|Overall Study||4
10564151|NCT01616459|11719225|FG001|NOT COMPLETED|Overall Study||17
10564152|NCT01616459|11719226|FG002|NOT COMPLETED|Overall Study||10
10564153|NCT01616459|11719227|FG003|NOT COMPLETED|Overall Study||8
10564154|NCT01616563|11719242|FG000|STARTED|Overall Study||293
10564155|NCT01616563|11719242|FG000|COMPLETED|Overall Study||253
10564156|NCT01616563|11719242|FG000|NOT COMPLETED|Overall Study||40
10564157|NCT01616576|11719249|FG000|STARTED|Overall Study||18
10564158|NCT01616576|11719250|FG001|STARTED|Overall Study||18
10564159|NCT01616576|11719249|FG000|COMPLETED|Overall Study||18
10564160|NCT01616576|11719250|FG001|COMPLETED|Overall Study||18
10564161|NCT01616576|11719249|FG000|NOT COMPLETED|Overall Study||0
10564162|NCT01616576|11719250|FG001|NOT COMPLETED|Overall Study||0
10564163|NCT01616654|11719264|FG000|STARTED|Overall Study||61
10564164|NCT01616654|11719265|FG001|STARTED|Overall Study||61
10564165|NCT01616654|11719266|FG002|STARTED|Overall Study||60
10564166|NCT01616654|11719267|FG003|STARTED|Overall Study||61
10564167|NCT01616654|11719268|FG004|STARTED|Overall Study||61
10564168|NCT01616654|11719264|FG000|COMPLETED|Overall Study||56
10564169|NCT01616654|11719265|FG001|COMPLETED|Overall Study||53
10564170|NCT01616654|11719266|FG002|COMPLETED|Overall Study||50
10564171|NCT01616654|11719267|FG003|COMPLETED|Overall Study||53
10564172|NCT01616654|11719268|FG004|COMPLETED|Overall Study||49
10564173|NCT01616654|11719264|FG000|NOT COMPLETED|Overall Study||5
10564174|NCT01616654|11719265|FG001|NOT COMPLETED|Overall Study||8
10564175|NCT01616654|11719266|FG002|NOT COMPLETED|Overall Study||10
10564176|NCT01616654|11719267|FG003|NOT COMPLETED|Overall Study||8
10564177|NCT01616654|11719268|FG004|NOT COMPLETED|Overall Study||12
10564178|NCT01616693|11719285|FG000|STARTED|Evaluated for Safety||155
10564179|NCT01616693|11719286|FG001|STARTED|Evaluated for Safety||155
10564180|NCT01616693|11719287|FG002|STARTED|Evaluated for Safety||155
10564181|NCT01616693|11719288|FG003|STARTED|Evaluated for Safety||155
10564182|NCT01616693|11719285|FG000|COMPLETED|Evaluated for Safety||154
10564183|NCT01616693|11719286|FG001|COMPLETED|Evaluated for Safety||155
10564184|NCT01616693|11719287|FG002|COMPLETED|Evaluated for Safety||154
10564185|NCT01616693|11719288|FG003|COMPLETED|Evaluated for Safety||155
10564186|NCT01616693|11719285|FG000|NOT COMPLETED|Evaluated for Safety||1
10564187|NCT01616693|11719286|FG001|NOT COMPLETED|Evaluated for Safety||0
10564188|NCT01616693|11719287|FG002|NOT COMPLETED|Evaluated for Safety||1
10564189|NCT01616693|11719288|FG003|NOT COMPLETED|Evaluated for Safety||0
10564190|NCT01616693|11719285|FG000|STARTED|Received Both Vaccines||154
10564191|NCT01616693|11719286|FG001|STARTED|Received Both Vaccines||155
10564192|NCT01616693|11719287|FG002|STARTED|Received Both Vaccines||154
10564193|NCT01616693|11719288|FG003|STARTED|Received Both Vaccines||155
10564194|NCT01616693|11719285|FG000|COMPLETED|Received Both Vaccines||141
10564195|NCT01616693|11719286|FG001|COMPLETED|Received Both Vaccines||145
10564196|NCT01616693|11719287|FG002|COMPLETED|Received Both Vaccines||142
10564197|NCT01616693|11719288|FG003|COMPLETED|Received Both Vaccines||136
10564198|NCT01616693|11719285|FG000|NOT COMPLETED|Received Both Vaccines||13
10564199|NCT01616693|11719286|FG001|NOT COMPLETED|Received Both Vaccines||10
10564200|NCT01616693|11719287|FG002|NOT COMPLETED|Received Both Vaccines||12
10564201|NCT01616693|11719288|FG003|NOT COMPLETED|Received Both Vaccines||19
10564202|NCT01616693|11719285|FG000|STARTED|Blood Analyzed for Immunogenicity||141
10564203|NCT01616693|11719286|FG001|STARTED|Blood Analyzed for Immunogenicity||145
10564204|NCT01616693|11719287|FG002|STARTED|Blood Analyzed for Immunogenicity||142
10564205|NCT01616693|11719288|FG003|STARTED|Blood Analyzed for Immunogenicity||136
10564206|NCT01616693|11719285|FG000|COMPLETED|Blood Analyzed for Immunogenicity||137
10564207|NCT01616693|11719286|FG001|COMPLETED|Blood Analyzed for Immunogenicity||143
10564208|NCT01616693|11719287|FG002|COMPLETED|Blood Analyzed for Immunogenicity||136
10564209|NCT01616693|11719288|FG003|COMPLETED|Blood Analyzed for Immunogenicity||135
10564210|NCT01616693|11719285|FG000|NOT COMPLETED|Blood Analyzed for Immunogenicity||4
10564211|NCT01616693|11719286|FG001|NOT COMPLETED|Blood Analyzed for Immunogenicity||2
10564212|NCT01616693|11719287|FG002|NOT COMPLETED|Blood Analyzed for Immunogenicity||6
10564213|NCT01616693|11719288|FG003|NOT COMPLETED|Blood Analyzed for Immunogenicity||1
10564214|NCT01616771|11719302|FG000|STARTED|Macintosh Laryngoscopy for 5 Sec||23
10564215|NCT01616771|11719302|FG000|COMPLETED|Macintosh Laryngoscopy for 5 Sec||23
10564216|NCT01616771|11719302|FG000|NOT COMPLETED|Macintosh Laryngoscopy for 5 Sec||0
10564217|NCT01616771|11719302|FG000|STARTED|GVL Selected by Weight for 5 Sec||23
10564218|NCT01616771|11719302|FG000|COMPLETED|GVL Selected by Weight for 5 Sec||23
10564219|NCT01616771|11719302|FG000|NOT COMPLETED|GVL Selected by Weight for 5 Sec||0
10564220|NCT01616771|11719302|FG000|STARTED|Smaller Sized GVL for 5 Sec|Four of 23 patients could not be evaluated by smaller sized GVL, because there was no smaller one.|23
10564221|NCT01616771|11719302|FG000|COMPLETED|Smaller Sized GVL for 5 Sec||19
10564222|NCT01616771|11719302|FG000|NOT COMPLETED|Smaller Sized GVL for 5 Sec||4
10564223|NCT01616953|11719313|FG000|STARTED|Overall Study||10
10564224|NCT01616953|11719314|FG001|STARTED|Overall Study||8
10564225|NCT01616953|11719313|FG000|Implant Placement Surgery|Overall Study||9
10564226|NCT01616953|11719314|FG001|Implant Placement Surgery|Overall Study||8
10564227|NCT01616953|11719313|FG000|Implant Uncovery|Overall Study||8
10564228|NCT01616953|11719314|FG001|Implant Uncovery|Overall Study||8
10564229|NCT01616953|11719313|FG000|6 Months Post-loading|Overall Study||8
10564230|NCT01616953|11719314|FG001|6 Months Post-loading|Overall Study||8
10564231|NCT01616953|11719313|FG000|COMPLETED|Overall Study||8
10564232|NCT01616953|11719314|FG001|COMPLETED|Overall Study||8
10564233|NCT01616953|11719313|FG000|NOT COMPLETED|Overall Study||2
10564234|NCT01616953|11719314|FG001|NOT COMPLETED|Overall Study||0
10564235|NCT01617005|11719320|FG000|STARTED|Overall Study||50
10564236|NCT01617005|11719320|FG000|COMPLETED|Overall Study||48
10564237|NCT01617005|11719320|FG000|NOT COMPLETED|Overall Study||2
10564238|NCT01617070|11719324|FG000|STARTED|LNAA (4 Weeks)||10
10564239|NCT01617070|11719324|FG000|COMPLETED|LNAA (4 Weeks)||10
10564240|NCT01617070|11719324|FG000|NOT COMPLETED|LNAA (4 Weeks)||0
10564241|NCT01617070|11719324|FG000|STARTED|Washout (4 Weeks)||10
10564242|NCT01617070|11719324|FG000|COMPLETED|Washout (4 Weeks)||10
10564243|NCT01617070|11719324|FG000|NOT COMPLETED|Washout (4 Weeks)||0
10564244|NCT01617070|11719324|FG000|STARTED|BH4 Therapy (4 Weeks)||10
10564245|NCT01617070|11719324|FG000|COMPLETED|BH4 Therapy (4 Weeks)||10
10564246|NCT01617070|11719324|FG000|NOT COMPLETED|BH4 Therapy (4 Weeks)||0
10564247|NCT01617070|11719324|FG000|STARTED|BH4 and LNAA (4 Weeks)||10
10564248|NCT01617070|11719324|FG000|COMPLETED|BH4 and LNAA (4 Weeks)||9
10564249|NCT01617070|11719324|FG000|NOT COMPLETED|BH4 and LNAA (4 Weeks)||1
10564250|NCT01617083|11719337|FG000|STARTED|Overall Study||18
10564251|NCT01617083|11719338|FG001|STARTED|Overall Study||14
10564252|NCT01617083|11719339|FG002|STARTED|Overall Study||15
10564253|NCT01617083|11719337|FG000|COMPLETED|Overall Study||18
10564254|NCT01617083|11719338|FG001|COMPLETED|Overall Study||14
10564255|NCT01617083|11719339|FG002|COMPLETED|Overall Study||15
10564256|NCT01617083|11719337|FG000|NOT COMPLETED|Overall Study||0
10564257|NCT01617083|11719338|FG001|NOT COMPLETED|Overall Study||0
10564258|NCT01617083|11719339|FG002|NOT COMPLETED|Overall Study||0
10564259|NCT01617148|11719346|FG000|STARTED|Overall Study||26
10564260|NCT01617148|11719346|FG000|COMPLETED|Overall Study||26
10564261|NCT01617148|11719346|FG000|NOT COMPLETED|Overall Study||0
10564262|NCT01617369|11719351|FG000|STARTED|Overall Study||12
10564263|NCT01617369|11719351|FG000|COMPLETED|Overall Study||12
10564264|NCT01617369|11719351|FG000|NOT COMPLETED|Overall Study||0
10564265|NCT01617421|11719357|FG000|STARTED|Overall Study||18
10564266|NCT01617421|11719357|FG000|COMPLETED|Overall Study||12
10564267|NCT01617421|11719357|FG000|NOT COMPLETED|Overall Study||6
10564268|NCT01617434|11719363|FG000|STARTED|Overall Study||226
10564269|NCT01617434|11719364|FG001|STARTED|Overall Study||225
10564270|NCT01617434|11719363|FG000|Exposed|Overall Study||225
10564271|NCT01617434|11719364|FG001|Exposed|Overall Study||225
10564272|NCT01617434|11719363|FG000|COMPLETED|Overall Study||191
10564273|NCT01617434|11719364|FG001|COMPLETED|Overall Study||174
10564274|NCT01617434|11719363|FG000|NOT COMPLETED|Overall Study||35
10564275|NCT01617434|11719364|FG001|NOT COMPLETED|Overall Study||51
10564276|NCT01617447|11719372|FG000|STARTED|Overall Study||47
10564277|NCT01617447|11719373|FG001|STARTED|Overall Study||45
10564278|NCT01617447|11719372|FG000|COMPLETED|Overall Study||47
10564279|NCT01617447|11719373|FG001|COMPLETED|Overall Study||42
10564280|NCT01617447|11719372|FG000|NOT COMPLETED|Overall Study||0
10564281|NCT01617447|11719373|FG001|NOT COMPLETED|Overall Study||3
10564282|NCT01617460|11719379|FG000|STARTED|Overall Study||86
10564283|NCT01617460|11719379|FG000|COMPLETED|Overall Study||46
10564284|NCT01617460|11719379|FG000|NOT COMPLETED|Overall Study||40
10564285|NCT01617577|11719385|FG000|STARTED|Overall Study||5
10564286|NCT01617577|11719386|FG001|STARTED|Overall Study||3
10564287|NCT01617577|11719385|FG000|COMPLETED|Overall Study||5
10564288|NCT01617577|11719386|FG001|COMPLETED|Overall Study||3
10564289|NCT01617577|11719385|FG000|NOT COMPLETED|Overall Study||0
10564290|NCT01617577|11719386|FG001|NOT COMPLETED|Overall Study||0
10564291|NCT01617603|11719396|FG000|STARTED|Overall Study||20
10564292|NCT01617603|11719397|FG001|STARTED|Overall Study||21
10564293|NCT01617603|11719398|FG002|STARTED|Overall Study||21
10564294|NCT01617603|11719396|FG000|COMPLETED|Overall Study||17
10564295|NCT01617603|11719397|FG001|COMPLETED|Overall Study||19
10564296|NCT01617603|11719398|FG002|COMPLETED|Overall Study||20
10564297|NCT01617603|11719396|FG000|NOT COMPLETED|Overall Study||3
10564298|NCT01617603|11719397|FG001|NOT COMPLETED|Overall Study||2
10564299|NCT01617603|11719398|FG002|NOT COMPLETED|Overall Study||1
10564300|NCT01617629|11719406|FG000|STARTED|Overall Study||9
10564301|NCT01617629|11719406|FG000|COMPLETED|Overall Study||3
10564302|NCT01617629|11719406|FG000|NOT COMPLETED|Overall Study||6
10564303|NCT01617655|11719412|FG000|STARTED|Overall Study|Randomized|35
10564304|NCT01617655|11719413|FG001|STARTED|Overall Study|Randomized|72
10564305|NCT01617655|11719412|FG000|Treated|Overall Study||35
10564306|NCT01617655|11719413|FG001|Treated|Overall Study||72
10564307|NCT01617655|11719412|FG000|COMPLETED|Overall Study||26
10564308|NCT01617655|11719413|FG001|COMPLETED|Overall Study||43
10564309|NCT01617655|11719412|FG000|NOT COMPLETED|Overall Study||9
10564310|NCT01617655|11719413|FG001|NOT COMPLETED|Overall Study||29
10564311|NCT01617668|11719423|FG000|STARTED|Overall Study||51
10564401|NCT01618214|11719504|FG001|NOT COMPLETED|Overall Study||13
10564312|NCT01617668|11719424|FG001|STARTED|Overall Study|54 patients were randomized and only 50 received study treatment.|50
10564313|NCT01617668|11719425|FG002|STARTED|Overall Study||55
10564314|NCT01617668|11719426|FG003|STARTED|Overall Study|55 patients were randomized and only 53 received study treatment.|53
10564315|NCT01617668|11719423|FG000|Randomized Patients|Overall Study||51
10564316|NCT01617668|11719424|FG001|Randomized Patients|Overall Study||54
10564317|NCT01617668|11719425|FG002|Randomized Patients|Overall Study||55
10564318|NCT01617668|11719426|FG003|Randomized Patients|Overall Study||55
10564319|NCT01617668|11719423|FG000|COMPLETED|Overall Study||38
10564320|NCT01617668|11719424|FG001|COMPLETED|Overall Study||41
10564321|NCT01617668|11719425|FG002|COMPLETED|Overall Study||32
10564322|NCT01617668|11719426|FG003|COMPLETED|Overall Study||38
10564323|NCT01617668|11719423|FG000|NOT COMPLETED|Overall Study||13
10564324|NCT01617668|11719424|FG001|NOT COMPLETED|Overall Study||9
10564325|NCT01617668|11719425|FG002|NOT COMPLETED|Overall Study||23
10564326|NCT01617668|11719426|FG003|NOT COMPLETED|Overall Study||15
10564327|NCT01617681|11719444|FG000|STARTED|Period 1 Double Blind||32
10564328|NCT01617681|11719445|FG001|STARTED|Period 1 Double Blind||31
10564329|NCT01617681|11719446|FG002|STARTED|Period 1 Double Blind||33
10564330|NCT01617681|11719447|FG003|STARTED|Period 1 Double Blind||31
10564331|NCT01617681|11719448|FG004|STARTED|Period 1 Double Blind||0
10564332|NCT01617681|11719444|FG000|Full Analysis Set (FAS)|Period 1 Double Blind||31
10564333|NCT01617681|11719445|FG001|Full Analysis Set (FAS)|Period 1 Double Blind||31
10564334|NCT01617681|11719446|FG002|Full Analysis Set (FAS)|Period 1 Double Blind||33
10564335|NCT01617681|11719447|FG003|Full Analysis Set (FAS)|Period 1 Double Blind||31
10564336|NCT01617681|11719448|FG004|Full Analysis Set (FAS)|Period 1 Double Blind||0
10564337|NCT01617681|11719444|FG000|COMPLETED|Period 1 Double Blind||29
10564338|NCT01617681|11719445|FG001|COMPLETED|Period 1 Double Blind||30
10564339|NCT01617681|11719446|FG002|COMPLETED|Period 1 Double Blind||32
10564340|NCT01617681|11719447|FG003|COMPLETED|Period 1 Double Blind||29
10564341|NCT01617681|11719448|FG004|COMPLETED|Period 1 Double Blind||0
10564342|NCT01617681|11719444|FG000|NOT COMPLETED|Period 1 Double Blind||3
10564343|NCT01617681|11719445|FG001|NOT COMPLETED|Period 1 Double Blind||1
10564344|NCT01617681|11719446|FG002|NOT COMPLETED|Period 1 Double Blind||1
10564345|NCT01617681|11719447|FG003|NOT COMPLETED|Period 1 Double Blind||2
10564346|NCT01617681|11719448|FG004|NOT COMPLETED|Period 1 Double Blind||0
10564347|NCT01617681|11719444|FG000|STARTED|Period 2 Open Label||0
10564348|NCT01617681|11719445|FG001|STARTED|Period 2 Open Label||0
10564349|NCT01617681|11719446|FG002|STARTED|Period 2 Open Label||0
10564350|NCT01617681|11719447|FG003|STARTED|Period 2 Open Label||0
10564351|NCT01617681|11719448|FG004|STARTED|Period 2 Open Label||120
10564352|NCT01617681|11719444|FG000|COMPLETED|Period 2 Open Label||0
10564353|NCT01617681|11719445|FG001|COMPLETED|Period 2 Open Label||0
10564354|NCT01617681|11719446|FG002|COMPLETED|Period 2 Open Label||0
10564355|NCT01617681|11719447|FG003|COMPLETED|Period 2 Open Label||0
10564356|NCT01617681|11719448|FG004|COMPLETED|Period 2 Open Label||114
10564357|NCT01617681|11719444|FG000|NOT COMPLETED|Period 2 Open Label||0
10564358|NCT01617681|11719445|FG001|NOT COMPLETED|Period 2 Open Label||0
10564359|NCT01617681|11719446|FG002|NOT COMPLETED|Period 2 Open Label||0
10564360|NCT01617681|11719447|FG003|NOT COMPLETED|Period 2 Open Label||0
10564361|NCT01617681|11719448|FG004|NOT COMPLETED|Period 2 Open Label||6
10564362|NCT01617967|11719463|FG000|STARTED|Overall Study||4
10564363|NCT01617967|11719464|FG001|STARTED|Overall Study||3
10564364|NCT01617967|11719465|FG002|STARTED|Overall Study||3
10564365|NCT01617967|11719466|FG003|STARTED|Overall Study||7
10564366|NCT01617967|11719467|FG004|STARTED|Overall Study||3
10564367|NCT01617967|11719468|FG005|STARTED|Overall Study||9
10564368|NCT01617967|11719463|FG000|COMPLETED|Overall Study||3
10564369|NCT01617967|11719464|FG001|COMPLETED|Overall Study||3
10564370|NCT01617967|11719465|FG002|COMPLETED|Overall Study||3
10564371|NCT01617967|11719466|FG003|COMPLETED|Overall Study||6
10564372|NCT01617967|11719467|FG004|COMPLETED|Overall Study||3
10564373|NCT01617967|11719468|FG005|COMPLETED|Overall Study||8
10564374|NCT01617967|11719463|FG000|NOT COMPLETED|Overall Study||1
10564375|NCT01617967|11719464|FG001|NOT COMPLETED|Overall Study||0
10564376|NCT01617967|11719465|FG002|NOT COMPLETED|Overall Study||0
10564377|NCT01617967|11719466|FG003|NOT COMPLETED|Overall Study||1
10564378|NCT01617967|11719467|FG004|NOT COMPLETED|Overall Study||0
10564379|NCT01617967|11719468|FG005|NOT COMPLETED|Overall Study||1
10564380|NCT01618019|11719485|FG000|STARTED|Overall Study||55
10564381|NCT01618019|11719486|FG001|STARTED|Overall Study||54
10564382|NCT01618019|11719485|FG000|COMPLETED|Overall Study||41
10564383|NCT01618019|11719486|FG001|COMPLETED|Overall Study||40
10564384|NCT01618019|11719485|FG000|NOT COMPLETED|Overall Study||14
10564385|NCT01618019|11719486|FG001|NOT COMPLETED|Overall Study||14
10564386|NCT01618162|11719494|FG000|STARTED|Overall Study||289
10564387|NCT01618162|11719495|FG001|STARTED|Overall Study||146
10564388|NCT01618162|11719494|FG000|Exposed|Overall Study||288
10564389|NCT01618162|11719495|FG001|Exposed|Overall Study||146
10564390|NCT01618162|11719494|FG000|COMPLETED|Overall Study||251
10564391|NCT01618162|11719495|FG001|COMPLETED|Overall Study||111
10564392|NCT01618162|11719494|FG000|NOT COMPLETED|Overall Study||38
10564393|NCT01618162|11719495|FG001|NOT COMPLETED|Overall Study||35
10564394|NCT01618214|11719503|FG000|STARTED|Overall Study||172
10564395|NCT01618214|11719504|FG001|STARTED|Overall Study||172
10564396|NCT01618214|11719503|FG000|Exposed|Overall Study||172
10564397|NCT01618214|11719504|FG001|Exposed|Overall Study||172
10564398|NCT01618214|11719503|FG000|COMPLETED|Overall Study||162
10564399|NCT01618214|11719504|FG001|COMPLETED|Overall Study||159
10564400|NCT01618214|11719503|FG000|NOT COMPLETED|Overall Study||10
10650997|NCT02173535|11811302|FG005|NOT COMPLETED|Period 2||0
10650998|NCT02173535|11811303|FG006|NOT COMPLETED|Period 2||0
10650999|NCT02173535|11811304|FG007|NOT COMPLETED|Period 2||0
10651000|NCT02173535|11811305|FG008|NOT COMPLETED|Period 2||0
10651001|NCT02173535|11811306|FG009|NOT COMPLETED|Period 2||0
10651002|NCT02173535|11811307|FG010|NOT COMPLETED|Period 2||0
10651003|NCT02173535|11811308|FG011|NOT COMPLETED|Period 2||0
10651004|NCT02173535|11811309|FG012|NOT COMPLETED|Period 2||0
10651005|NCT02173535|11811310|FG013|NOT COMPLETED|Period 2||0
10651006|NCT02173535|11811311|FG014|NOT COMPLETED|Period 2||0
10651007|NCT02173535|11811312|FG015|NOT COMPLETED|Period 2||0
10651008|NCT02173535|11811313|FG016|NOT COMPLETED|Period 2||0
10651009|NCT02173535|11811314|FG017|NOT COMPLETED|Period 2||0
10651010|NCT02173535|11811315|FG018|NOT COMPLETED|Period 2||0
10651011|NCT02173535|11811316|FG019|NOT COMPLETED|Period 2||0
10651012|NCT02173535|11811297|FG000|STARTED|Period 3||12
10651013|NCT02173535|11811298|FG001|STARTED|Period 3||12
10651014|NCT02173535|11811299|FG002|STARTED|Period 3||12
10651015|NCT02173535|11811300|FG003|STARTED|Period 3||12
10651016|NCT02173535|11811301|FG004|STARTED|Period 3||12
10651017|NCT02173535|11811302|FG005|STARTED|Period 3||12
10651018|NCT02173535|11811303|FG006|STARTED|Period 3||12
10651019|NCT02173535|11811304|FG007|STARTED|Period 3||12
10651020|NCT02173535|11811305|FG008|STARTED|Period 3||12
10651021|NCT02173535|11811306|FG009|STARTED|Period 3||12
10651022|NCT02173535|11811307|FG010|STARTED|Period 3||12
10651023|NCT02173535|11811308|FG011|STARTED|Period 3||12
10651024|NCT02173535|11811309|FG012|STARTED|Period 3||12
10651025|NCT02173535|11811310|FG013|STARTED|Period 3||12
10651026|NCT02173535|11811311|FG014|STARTED|Period 3||12
10651027|NCT02173535|11811312|FG015|STARTED|Period 3||12
10651028|NCT02173535|11811313|FG016|STARTED|Period 3||12
10651029|NCT02173535|11811314|FG017|STARTED|Period 3||12
10651030|NCT02173535|11811315|FG018|STARTED|Period 3||12
10651031|NCT02173535|11811316|FG019|STARTED|Period 3||12
10651032|NCT02173535|11811297|FG000|COMPLETED|Period 3||12
10651033|NCT02173535|11811298|FG001|COMPLETED|Period 3||12
10651034|NCT02173535|11811299|FG002|COMPLETED|Period 3||12
10651035|NCT02173535|11811300|FG003|COMPLETED|Period 3||12
10651036|NCT02173535|11811301|FG004|COMPLETED|Period 3||12
10651037|NCT02173535|11811302|FG005|COMPLETED|Period 3||12
10651038|NCT02173535|11811303|FG006|COMPLETED|Period 3||12
10651039|NCT02173535|11811304|FG007|COMPLETED|Period 3||12
10651040|NCT02173535|11811305|FG008|COMPLETED|Period 3||12
10651041|NCT02173535|11811306|FG009|COMPLETED|Period 3||12
10651042|NCT02173535|11811307|FG010|COMPLETED|Period 3||12
10651043|NCT02173535|11811308|FG011|COMPLETED|Period 3||12
10564402|NCT01618227|11719512|FG000|STARTED|Overall Study||2
10564403|NCT01618227|11719513|FG001|STARTED|Overall Study||2
10564404|NCT01618227|11719512|FG000|COMPLETED|Overall Study||2
10564405|NCT01618227|11719513|FG001|COMPLETED|Overall Study||0
10564406|NCT01618227|11719512|FG000|NOT COMPLETED|Overall Study||0
10564407|NCT01618227|11719513|FG001|NOT COMPLETED|Overall Study||2
10564408|NCT01618240|11719519|FG000|STARTED|Overall Study||30
10564409|NCT01618240|11719519|FG000|COMPLETED|Overall Study||30
10564410|NCT01618240|11719519|FG000|NOT COMPLETED|Overall Study||0
10564411|NCT01618266|11719523|FG000|STARTED|Overall Study||375
10564412|NCT01618266|11719523|FG000|COMPLETED|Overall Study||279
10564413|NCT01618266|11719523|FG000|NOT COMPLETED|Overall Study||96
10564414|NCT01618305|11719529|FG000|STARTED|Overall Study||202
10564415|NCT01618305|11719530|FG001|STARTED|Overall Study||206
10564416|NCT01618305|11719529|FG000|COMPLETED|Overall Study||187
10564417|NCT01618305|11719530|FG001|COMPLETED|Overall Study||196
10564418|NCT01618305|11719529|FG000|NOT COMPLETED|Overall Study||15
10564419|NCT01618305|11719530|FG001|NOT COMPLETED|Overall Study||10
10564420|NCT01618344|11719540|FG000|STARTED|Overall Study||32
10564421|NCT01618344|11719540|FG000|COMPLETED|Overall Study||23
10564422|NCT01618344|11719540|FG000|NOT COMPLETED|Overall Study||9
10564423|NCT01618422|11719546|FG000|STARTED|Overall Study||114
10564424|NCT01618422|11719547|FG001|STARTED|Overall Study||111
10564425|NCT01618422|11719546|FG000|COMPLETED|Overall Study||114
10564426|NCT01618422|11719547|FG001|COMPLETED|Overall Study||111
10564427|NCT01618422|11719546|FG000|NOT COMPLETED|Overall Study||0
10564428|NCT01618422|11719547|FG001|NOT COMPLETED|Overall Study||0
10564429|NCT01618669|11719555|FG000|STARTED|Overall Study||578
10564430|NCT01618669|11719556|FG001|STARTED|Overall Study||569
10564431|NCT01618669|11719555|FG000|Received Treatment|Overall Study||575
10564432|NCT01618669|11719556|FG001|Received Treatment|Overall Study||567
10564433|NCT01618669|11719555|FG000|COMPLETED|Overall Study||544
10564434|NCT01618669|11719556|FG001|COMPLETED|Overall Study||546
10564435|NCT01618669|11719555|FG000|NOT COMPLETED|Overall Study||34
10564436|NCT01618669|11719556|FG001|NOT COMPLETED|Overall Study||23
10564437|NCT01618695|11719578|FG000|STARTED|Core Phase||177
10564438|NCT01618695|11719579|FG001|STARTED|Core Phase||176
10564439|NCT01618695|11719580|FG002|STARTED|Core Phase||177
10564440|NCT01618695|11719581|FG003|STARTED|Core Phase||180
10564441|NCT01618695|11719578|FG000|Treated (Safety Analysis Set)|Core Phase||176
10564442|NCT01618695|11719579|FG001|Treated (Safety Analysis Set)|Core Phase||176
10564443|NCT01618695|11719580|FG002|Treated (Safety Analysis Set)|Core Phase||175
10564444|NCT01618695|11719581|FG003|Treated (Safety Analysis Set)|Core Phase||180
10564445|NCT01618695|11719578|FG000|COMPLETED|Core Phase||152
10793201|NCT03599089|11953975|FG002|COMPLETED|Overall Study||37
10793202|NCT03599089|11953976|FG003|COMPLETED|Overall Study||35
10793203|NCT03599089|11953973|FG000|NOT COMPLETED|Overall Study||3
10793204|NCT03599089|11953974|FG001|NOT COMPLETED|Overall Study||1
10564446|NCT01618695|11719579|FG001|COMPLETED|Core Phase||156
10564447|NCT01618695|11719580|FG002|COMPLETED|Core Phase||147
10564448|NCT01618695|11719581|FG003|COMPLETED|Core Phase||144
10564449|NCT01618695|11719578|FG000|NOT COMPLETED|Core Phase||25
10564450|NCT01618695|11719579|FG001|NOT COMPLETED|Core Phase||20
10564451|NCT01618695|11719580|FG002|NOT COMPLETED|Core Phase||30
10564452|NCT01618695|11719581|FG003|NOT COMPLETED|Core Phase||36
10564453|NCT01618695|11719578|FG000|STARTED|Extension Phase|Participants who completed Core Phase and gave consent, entered the Extension Phase.|151
10564454|NCT01618695|11719579|FG001|STARTED|Extension Phase||156
10564455|NCT01618695|11719580|FG002|STARTED|Extension Phase|Participants who completed Core Phase and gave consent, entered the Extension Phase.|146
10564456|NCT01618695|11719581|FG003|STARTED|Extension Phase|Participants who completed Core Phase and gave consent, entered the Extension Phase.|143
10564457|NCT01618695|11719578|FG000|COMPLETED|Extension Phase||56
10564458|NCT01618695|11719579|FG001|COMPLETED|Extension Phase||40
10564459|NCT01618695|11719580|FG002|COMPLETED|Extension Phase||54
10564460|NCT01618695|11719581|FG003|COMPLETED|Extension Phase||46
10564461|NCT01618695|11719578|FG000|NOT COMPLETED|Extension Phase||95
10564462|NCT01618695|11719579|FG001|NOT COMPLETED|Extension Phase||116
10564463|NCT01618695|11719580|FG002|NOT COMPLETED|Extension Phase||92
10564464|NCT01618695|11719581|FG003|NOT COMPLETED|Extension Phase||97
10564465|NCT01618708|11719594|FG000|STARTED|Overall Study||175
10564466|NCT01618708|11719595|FG001|STARTED|Overall Study||182
10564467|NCT01618708|11719594|FG000|Treated|Overall Study||172
10564468|NCT01618708|11719595|FG001|Treated|Overall Study||180
10564469|NCT01618708|11719594|FG000|COMPLETED|Overall Study||131
10564470|NCT01618708|11719595|FG001|COMPLETED|Overall Study||136
10564471|NCT01618708|11719594|FG000|NOT COMPLETED|Overall Study||44
10564472|NCT01618708|11719595|FG001|NOT COMPLETED|Overall Study||46
10564473|NCT01618838|11719602|FG000|STARTED|Overall Study||4
10564474|NCT01618838|11719602|FG000|COMPLETED|Overall Study||0
10564475|NCT01618838|11719602|FG000|NOT COMPLETED|Overall Study||4
10564476|NCT01618864|11719607|FG000|STARTED|Overall Study||23
10564477|NCT01618864|11719607|FG000|Completed 2 Weeks|Overall Study||19
10564478|NCT01618864|11719607|FG000|COMPLETED|Overall Study|Completed 4 weeks and 8 weeks of treatment|19
10564479|NCT01618864|11719607|FG000|NOT COMPLETED|Overall Study||4
10564480|NCT01618916|11719622|FG000|STARTED|Overall Study||12
10564481|NCT01618916|11719623|FG001|STARTED|Overall Study||10
10564482|NCT01618916|11719624|FG002|STARTED|Overall Study||11
10564483|NCT01618916|11719625|FG003|STARTED|Overall Study||9
10564484|NCT01618916|11719626|FG004|STARTED|Overall Study||5
10564485|NCT01618916|11719627|FG005|STARTED|Overall Study||4
10793205|NCT03599089|11953975|FG002|NOT COMPLETED|Overall Study||1
10793206|NCT03599089|11953976|FG003|NOT COMPLETED|Overall Study||2
10564486|NCT01618916|11719622|FG000|Received At Least 1 Dose of Study Drug|Overall Study||12
10564487|NCT01618916|11719623|FG001|Received At Least 1 Dose of Study Drug|Overall Study||10
10564488|NCT01618916|11719624|FG002|Received At Least 1 Dose of Study Drug|Overall Study||11
10564489|NCT01618916|11719625|FG003|Received At Least 1 Dose of Study Drug|Overall Study||9
10564490|NCT01618916|11719626|FG004|Received At Least 1 Dose of Study Drug|Overall Study||5
10564491|NCT01618916|11719627|FG005|Received At Least 1 Dose of Study Drug|Overall Study||4
10564492|NCT01618916|11719622|FG000|COMPLETED|Overall Study||10
10564493|NCT01618916|11719623|FG001|COMPLETED|Overall Study||9
10564494|NCT01618916|11719624|FG002|COMPLETED|Overall Study||10
10564495|NCT01618916|11719625|FG003|COMPLETED|Overall Study||7
10564496|NCT01618916|11719626|FG004|COMPLETED|Overall Study||4
10564497|NCT01618916|11719627|FG005|COMPLETED|Overall Study||4
10564498|NCT01618916|11719622|FG000|NOT COMPLETED|Overall Study||2
10564499|NCT01618916|11719623|FG001|NOT COMPLETED|Overall Study||1
10564500|NCT01618916|11719624|FG002|NOT COMPLETED|Overall Study||1
10564501|NCT01618916|11719625|FG003|NOT COMPLETED|Overall Study||2
10564502|NCT01618916|11719626|FG004|NOT COMPLETED|Overall Study||1
10564503|NCT01618916|11719627|FG005|NOT COMPLETED|Overall Study||0
10564504|NCT01618942|11719642|FG000|STARTED|Overall Study||50
10564505|NCT01618942|11719643|FG001|STARTED|Overall Study||50
10564506|NCT01618942|11719642|FG000|COMPLETED|Overall Study||50
10564507|NCT01618942|11719643|FG001|COMPLETED|Overall Study||50
10564508|NCT01618942|11719642|FG000|NOT COMPLETED|Overall Study||0
10564509|NCT01618942|11719643|FG001|NOT COMPLETED|Overall Study||0
10564510|NCT01618955|11719653|FG000|STARTED|Overall Study||20
10564511|NCT01618955|11719654|FG001|STARTED|Overall Study||30
10564512|NCT01618955|11719655|FG002|STARTED|Overall Study||31
10564513|NCT01618955|11719656|FG003|STARTED|Overall Study||20
10564514|NCT01618955|11719653|FG000|COMPLETED|Overall Study||20
10564515|NCT01618955|11719654|FG001|COMPLETED|Overall Study||30
10564516|NCT01618955|11719655|FG002|COMPLETED|Overall Study||31
10564517|NCT01618955|11719656|FG003|COMPLETED|Overall Study||20
10564518|NCT01618955|11719653|FG000|NOT COMPLETED|Overall Study||0
10564519|NCT01618955|11719654|FG001|NOT COMPLETED|Overall Study||0
10564520|NCT01618955|11719655|FG002|NOT COMPLETED|Overall Study||0
10564521|NCT01618955|11719656|FG003|NOT COMPLETED|Overall Study||0
10564522|NCT01618968|11719670|FG000|STARTED|Overall Study||13
10564523|NCT01618968|11719671|FG001|STARTED|Overall Study||12
10564524|NCT01618968|11719672|FG002|STARTED|Overall Study||12
10564525|NCT01618968|11719673|FG003|STARTED|Overall Study||12
10564526|NCT01618968|11719670|FG000|Received Treatment A|Overall Study||12
10564527|NCT01618968|11719671|FG001|Received Treatment A|Overall Study||12
10564528|NCT01618968|11719672|FG002|Received Treatment A|Overall Study||12
10564529|NCT01618968|11719673|FG003|Received Treatment A|Overall Study||11
10564530|NCT01618968|11719670|FG000|Received Treatment B|Overall Study||13
10564531|NCT01618968|11719671|FG001|Received Treatment B|Overall Study||12
10564532|NCT01618968|11719672|FG002|Received Treatment B|Overall Study||12
10564533|NCT01618968|11719673|FG003|Received Treatment B|Overall Study||12
10564534|NCT01618968|11719670|FG000|Received Treatment C|Overall Study||12
10564535|NCT01618968|11719671|FG001|Received Treatment C|Overall Study||12
10564536|NCT01618968|11719672|FG002|Received Treatment C|Overall Study||12
10564537|NCT01618968|11719673|FG003|Received Treatment C|Overall Study||11
10564538|NCT01618968|11719670|FG000|COMPLETED|Overall Study||12
10564539|NCT01618968|11719671|FG001|COMPLETED|Overall Study||12
10564540|NCT01618968|11719672|FG002|COMPLETED|Overall Study||12
10564541|NCT01618968|11719673|FG003|COMPLETED|Overall Study||11
10564542|NCT01618968|11719670|FG000|NOT COMPLETED|Overall Study||1
10564543|NCT01618968|11719671|FG001|NOT COMPLETED|Overall Study||0
10564544|NCT01618968|11719672|FG002|NOT COMPLETED|Overall Study||0
10564545|NCT01618968|11719673|FG003|NOT COMPLETED|Overall Study||1
10564546|NCT01619059|11719684|FG000|STARTED|Short-Term (ST) Treatment Period||162
10564547|NCT01619059|11719685|FG001|STARTED|Short-Term (ST) Treatment Period||153
10564548|NCT01619059|11719684|FG000|COMPLETED|Short-Term (ST) Treatment Period||156
10564549|NCT01619059|11719685|FG001|COMPLETED|Short-Term (ST) Treatment Period||142
10564550|NCT01619059|11719684|FG000|NOT COMPLETED|Short-Term (ST) Treatment Period||6
10564551|NCT01619059|11719685|FG001|NOT COMPLETED|Short-Term (ST) Treatment Period||11
10564552|NCT01619059|11719684|FG000|STARTED|Long-Term (LT) Treatment Period||155
10564553|NCT01619059|11719685|FG001|STARTED|Long-Term (LT) Treatment Period||142
10564554|NCT01619059|11719684|FG000|COMPLETED|Long-Term (LT) Treatment Period||147
10564555|NCT01619059|11719685|FG001|COMPLETED|Long-Term (LT) Treatment Period||133
10564556|NCT01619059|11719684|FG000|NOT COMPLETED|Long-Term (LT) Treatment Period||8
10564557|NCT01619059|11719685|FG001|NOT COMPLETED|Long-Term (LT) Treatment Period||9
10564558|NCT01619410|11719693|FG000|STARTED|Overall Study||14
10564559|NCT01619410|11719694|FG001|STARTED|Overall Study||11
10564560|NCT01619410|11719693|FG000|COMPLETED|Overall Study||7
10564561|NCT01619410|11719694|FG001|COMPLETED|Overall Study||7
10564562|NCT01619410|11719693|FG000|NOT COMPLETED|Overall Study||7
10564563|NCT01619410|11719694|FG001|NOT COMPLETED|Overall Study||4
10564564|NCT01619423|11719704|FG000|STARTED|Part 1 (Dose Escalation)||0
10564565|NCT01619423|11719705|FG001|STARTED|Part 1 (Dose Escalation)||5
10564566|NCT01619423|11719706|FG002|STARTED|Part 1 (Dose Escalation)||3
10564567|NCT01619423|11719707|FG003|STARTED|Part 1 (Dose Escalation)||5
10564568|NCT01619423|11719704|FG000|COMPLETED|Part 1 (Dose Escalation)||0
10564569|NCT01619423|11719705|FG001|COMPLETED|Part 1 (Dose Escalation)||3
10564570|NCT01619423|11719706|FG002|COMPLETED|Part 1 (Dose Escalation)||3
10564571|NCT01619423|11719707|FG003|COMPLETED|Part 1 (Dose Escalation)||5
10564572|NCT01619423|11719704|FG000|NOT COMPLETED|Part 1 (Dose Escalation)||0
10564573|NCT01619423|11719705|FG001|NOT COMPLETED|Part 1 (Dose Escalation)||2
10564574|NCT01619423|11719706|FG002|NOT COMPLETED|Part 1 (Dose Escalation)||0
10564575|NCT01619423|11719707|FG003|NOT COMPLETED|Part 1 (Dose Escalation)||0
10564576|NCT01619423|11719704|FG000|STARTED|Part 2a||15
10564577|NCT01619423|11719705|FG001|STARTED|Part 2a||13
10564578|NCT01619423|11719706|FG002|STARTED|Part 2a||0
10564579|NCT01619423|11719707|FG003|STARTED|Part 2a||11
10564580|NCT01619423|11719704|FG000|COMPLETED|Part 2a||15
10564581|NCT01619423|11719705|FG001|COMPLETED|Part 2a||13
10564582|NCT01619423|11719706|FG002|COMPLETED|Part 2a||0
10564583|NCT01619423|11719707|FG003|COMPLETED|Part 2a||11
10564584|NCT01619423|11719704|FG000|NOT COMPLETED|Part 2a||0
10564585|NCT01619423|11719705|FG001|NOT COMPLETED|Part 2a||0
10564586|NCT01619423|11719706|FG002|NOT COMPLETED|Part 2a||0
10564587|NCT01619423|11719707|FG003|NOT COMPLETED|Part 2a||0
10564588|NCT01619423|11719704|FG000|STARTED|Part 2b||45
10564589|NCT01619423|11719705|FG001|STARTED|Part 2b||44
10564590|NCT01619423|11719706|FG002|STARTED|Part 2b||45
10564591|NCT01619423|11719707|FG003|STARTED|Part 2b||0
10564592|NCT01619423|11719704|FG000|COMPLETED|Part 2b||45
10564593|NCT01619423|11719705|FG001|COMPLETED|Part 2b||44
10564594|NCT01619423|11719706|FG002|COMPLETED|Part 2b||45
10564595|NCT01619423|11719707|FG003|COMPLETED|Part 2b||0
10564596|NCT01619423|11719704|FG000|NOT COMPLETED|Part 2b||0
10564597|NCT01619423|11719705|FG001|NOT COMPLETED|Part 2b||0
10564598|NCT01619423|11719706|FG002|NOT COMPLETED|Part 2b||0
10564599|NCT01619423|11719707|FG003|NOT COMPLETED|Part 2b||0
10564600|NCT01619579|11719720|FG000|STARTED|Overall Study||5
10564601|NCT01619579|11719721|FG001|STARTED|Overall Study||17
10564602|NCT01619579|11719720|FG000|COMPLETED|Overall Study||5
10564603|NCT01619579|11719721|FG001|COMPLETED|Overall Study||14
10564604|NCT01619579|11719720|FG000|NOT COMPLETED|Overall Study||0
10564605|NCT01619579|11719721|FG001|NOT COMPLETED|Overall Study||3
10564606|NCT01619774|11719727|FG000|STARTED|Overall Study||23
10564607|NCT01619774|11719727|FG000|COMPLETED|Overall Study||23
10564608|NCT01619774|11719727|FG000|NOT COMPLETED|Overall Study||0
10564609|NCT01619787|11719733|FG000|STARTED|Overall Study||217
10564610|NCT01619787|11719733|FG000|COMPLETED|Overall Study||212
10564611|NCT01619787|11719733|FG000|NOT COMPLETED|Overall Study||5
10564612|NCT01619839|11719744|FG000|STARTED|Overall Study||48
10564613|NCT01619839|11719745|FG001|STARTED|Overall Study||31
10564614|NCT01619839|11719746|FG002|STARTED|Overall Study||18
10564615|NCT01619839|11719747|FG003|STARTED|Overall Study||10
10564616|NCT01619839|11719748|FG004|STARTED|Overall Study||106
10564617|NCT01619839|11719744|FG000|COMPLETED|Overall Study||43
10564618|NCT01619839|11719745|FG001|COMPLETED|Overall Study||27
10564619|NCT01619839|11719746|FG002|COMPLETED|Overall Study||17
10564620|NCT01619839|11719747|FG003|COMPLETED|Overall Study||9
10564621|NCT01619839|11719748|FG004|COMPLETED|Overall Study||97
10564622|NCT01619839|11719744|FG000|NOT COMPLETED|Overall Study||5
10564623|NCT01619839|11719745|FG001|NOT COMPLETED|Overall Study||4
10564624|NCT01619839|11719746|FG002|NOT COMPLETED|Overall Study||1
10564625|NCT01619839|11719747|FG003|NOT COMPLETED|Overall Study||1
10564626|NCT01619839|11719748|FG004|NOT COMPLETED|Overall Study||9
10564627|NCT01619852|11719759|FG000|STARTED|24 Hour Assessment||75
10564628|NCT01619852|11719760|FG001|STARTED|24 Hour Assessment||75
10564629|NCT01619852|11719759|FG000|COMPLETED|24 Hour Assessment||74
10564630|NCT01619852|11719760|FG001|COMPLETED|24 Hour Assessment||74
10564631|NCT01619852|11719759|FG000|NOT COMPLETED|24 Hour Assessment||1
10564632|NCT01619852|11719760|FG001|NOT COMPLETED|24 Hour Assessment||1
10564633|NCT01619852|11719759|FG000|STARTED|3 Month Follow up||74
10564634|NCT01619852|11719760|FG001|STARTED|3 Month Follow up||74
10564635|NCT01619852|11719759|FG000|COMPLETED|3 Month Follow up||43
10564636|NCT01619852|11719760|FG001|COMPLETED|3 Month Follow up||40
10564637|NCT01619852|11719759|FG000|NOT COMPLETED|3 Month Follow up||31
10564638|NCT01619852|11719760|FG001|NOT COMPLETED|3 Month Follow up||34
10564639|NCT01619865|11719767|FG000|STARTED|Overall Study||223
10564640|NCT01619865|11719767|FG000|COMPLETED|Overall Study||219
10564641|NCT01619865|11719767|FG000|NOT COMPLETED|Overall Study||4
10564642|NCT01619878|11719772|FG000|STARTED|6 Week Follow-up Phase||20
10564643|NCT01619878|11719772|FG000|COMPLETED|6 Week Follow-up Phase||19
10564644|NCT01619878|11719772|FG000|NOT COMPLETED|6 Week Follow-up Phase||1
10564645|NCT01619878|11719772|FG000|STARTED|Follow-up at 12 Months of Age||20
10564646|NCT01619878|11719772|FG000|COMPLETED|Follow-up at 12 Months of Age||17
10564647|NCT01619878|11719772|FG000|NOT COMPLETED|Follow-up at 12 Months of Age||3
10564648|NCT01619982|11719778|FG000|STARTED|Overall Study||20
10564649|NCT01619982|11719779|FG001|STARTED|Overall Study||12
10564650|NCT01619982|11719778|FG000|COMPLETED|Overall Study||20
10564651|NCT01619982|11719779|FG001|COMPLETED|Overall Study||12
10564652|NCT01619982|11719778|FG000|NOT COMPLETED|Overall Study||0
10564653|NCT01619982|11719779|FG001|NOT COMPLETED|Overall Study||0
10564654|NCT01620047|11719792|FG000|STARTED|Overall Study||20
10564655|NCT01620047|11719793|FG001|STARTED|Overall Study||20
10564656|NCT01620047|11719794|FG002|STARTED|Overall Study||20
10564657|NCT01620047|11719792|FG000|COMPLETED|Overall Study||20
10564658|NCT01620047|11719793|FG001|COMPLETED|Overall Study||20
10564659|NCT01620047|11719794|FG002|COMPLETED|Overall Study||20
10564660|NCT01620047|11719792|FG000|NOT COMPLETED|Overall Study||0
10564661|NCT01620047|11719793|FG001|NOT COMPLETED|Overall Study||0
10564662|NCT01620047|11719794|FG002|NOT COMPLETED|Overall Study||0
10564663|NCT01620060|11719802|FG000|STARTED|Overall Study||105
10564664|NCT01620060|11719802|FG000|COMPLETED|Overall Study||90
10564665|NCT01620060|11719802|FG000|NOT COMPLETED|Overall Study||15
10564666|NCT01620086|11719808|FG000|STARTED|Overall Study||13
10564667|NCT01620086|11719809|FG001|STARTED|Overall Study||11
10564668|NCT01620086|11719810|FG002|STARTED|Overall Study||2
10564669|NCT01620086|11719808|FG000|COMPLETED|Overall Study||8
10564670|NCT01620086|11719809|FG001|COMPLETED|Overall Study||4
10564671|NCT01620086|11719810|FG002|COMPLETED|Overall Study||2
10564672|NCT01620086|11719808|FG000|NOT COMPLETED|Overall Study||5
10564673|NCT01620086|11719809|FG001|NOT COMPLETED|Overall Study||7
10564674|NCT01620086|11719810|FG002|NOT COMPLETED|Overall Study||0
10564675|NCT01620138|11719821|FG000|STARTED|Overall Study||12
10564676|NCT01620138|11719822|FG001|STARTED|Overall Study||9
10564677|NCT01620138|11719821|FG000|COMPLETED|Overall Study||6
10564678|NCT01620138|11719822|FG001|COMPLETED|Overall Study||9
10564679|NCT01620138|11719821|FG000|NOT COMPLETED|Overall Study||6
10564680|NCT01620138|11719822|FG001|NOT COMPLETED|Overall Study||0
10564681|NCT01620177|11719828|FG000|STARTED|Overall Study||98
10564682|NCT01620177|11719828|FG000|COMPLETED|Overall Study||19
10564683|NCT01620177|11719828|FG000|NOT COMPLETED|Overall Study||79
10564684|NCT01620190|11719845|FG000|STARTED|Overall Study||26
10564685|NCT01620190|11719845|FG000|COMPLETED|Overall Study||26
10564686|NCT01620190|11719845|FG000|NOT COMPLETED|Overall Study||0
10564687|NCT01620216|11719856|FG000|STARTED|Overall Study||4
10564688|NCT01620216|11719857|FG001|STARTED|Overall Study||2
10564689|NCT01620216|11719858|FG002|STARTED|Overall Study||6
10564690|NCT01620216|11719859|FG003|STARTED|Overall Study||0
10564691|NCT01620216|11719860|FG004|STARTED|Overall Study||0
10564692|NCT01620216|11719861|FG005|STARTED|Overall Study||0
10564693|NCT01620216|11719862|FG006|STARTED|Overall Study||0
10564694|NCT01620216|11719856|FG000|COMPLETED|Overall Study||4
10564695|NCT01620216|11719857|FG001|COMPLETED|Overall Study||2
10564696|NCT01620216|11719858|FG002|COMPLETED|Overall Study||6
10564697|NCT01620216|11719859|FG003|COMPLETED|Overall Study||0
10564698|NCT01620216|11719860|FG004|COMPLETED|Overall Study||0
10564699|NCT01620216|11719861|FG005|COMPLETED|Overall Study||0
10564700|NCT01620216|11719862|FG006|COMPLETED|Overall Study||0
10564701|NCT01620216|11719856|FG000|NOT COMPLETED|Overall Study||0
10564702|NCT01620216|11719857|FG001|NOT COMPLETED|Overall Study||0
10564703|NCT01620216|11719858|FG002|NOT COMPLETED|Overall Study||0
10564704|NCT01620216|11719859|FG003|NOT COMPLETED|Overall Study||0
10564705|NCT01620216|11719860|FG004|NOT COMPLETED|Overall Study||0
10564706|NCT01620216|11719861|FG005|NOT COMPLETED|Overall Study||0
10564707|NCT01620216|11719862|FG006|NOT COMPLETED|Overall Study||0
10564708|NCT01620255|11719883|FG000|STARTED|Overall Study||73
10564709|NCT01620255|11719884|FG001|STARTED|Overall Study||71
10564710|NCT01620255|11719885|FG002|STARTED|Overall Study||70
10564711|NCT01620255|11719886|FG003|STARTED|Overall Study||73
10564712|NCT01620255|11719887|FG004|STARTED|Overall Study||70
10564713|NCT01620255|11719883|FG000|Treated|Overall Study||73
10564714|NCT01620255|11719884|FG001|Treated|Overall Study||71
10564715|NCT01620255|11719885|FG002|Treated|Overall Study||70
10564716|NCT01620255|11719886|FG003|Treated|Overall Study||73
10564717|NCT01620255|11719887|FG004|Treated|Overall Study||70
10564718|NCT01620255|11719883|FG000|COMPLETED|Overall Study||69
10564719|NCT01620255|11719884|FG001|COMPLETED|Overall Study||65
10564720|NCT01620255|11719885|FG002|COMPLETED|Overall Study||68
10564721|NCT01620255|11719886|FG003|COMPLETED|Overall Study||70
10564722|NCT01620255|11719887|FG004|COMPLETED|Overall Study||64
10564723|NCT01620255|11719883|FG000|NOT COMPLETED|Overall Study||4
10564724|NCT01620255|11719884|FG001|NOT COMPLETED|Overall Study||6
10564725|NCT01620255|11719885|FG002|NOT COMPLETED|Overall Study||2
10564726|NCT01620255|11719886|FG003|NOT COMPLETED|Overall Study||3
10564727|NCT01620255|11719887|FG004|NOT COMPLETED|Overall Study||6
10564728|NCT01620489|11719901|FG000|STARTED|Overall Study||140
10564729|NCT01620489|11719902|FG001|STARTED|Overall Study||139
10564730|NCT01620489|11719901|FG000|Exposed|Overall Study||140
10564731|NCT01620489|11719902|FG001|Exposed|Overall Study|2 subjects did not take trial product|137
10564732|NCT01620489|11719901|FG000|COMPLETED|Overall Study||105
10564733|NCT01620489|11719902|FG001|COMPLETED|Overall Study|2 subjects did not take trial product|105
10564734|NCT01620489|11719901|FG000|NOT COMPLETED|Overall Study||35
10564735|NCT01620489|11719902|FG001|NOT COMPLETED|Overall Study||34
10564736|NCT01620528|11719911|FG000|STARTED|Treatment Period||374
10564737|NCT01620528|11719912|FG001|STARTED|Treatment Period||249
10564738|NCT01620528|11719913|FG002|STARTED|Treatment Period|1 subject did not receive study drug|249
10564739|NCT01620528|11719911|FG000|COMPLETED|Treatment Period||274
10564740|NCT01620528|11719912|FG001|COMPLETED|Treatment Period||196
10564741|NCT01620528|11719913|FG002|COMPLETED|Treatment Period||183
10564742|NCT01620528|11719911|FG000|NOT COMPLETED|Treatment Period||100
10564743|NCT01620528|11719912|FG001|NOT COMPLETED|Treatment Period||53
10564744|NCT01620528|11719913|FG002|NOT COMPLETED|Treatment Period||66
10564745|NCT01620528|11719911|FG000|STARTED|Post-Treatment Follow-Up Period|elected to enter the PTFU Period|68
10564746|NCT01620528|11719912|FG001|STARTED|Post-Treatment Follow-Up Period|elected to enter the PTFU Period|48
10564747|NCT01620528|11719913|FG002|STARTED|Post-Treatment Follow-Up Period|elected to enter the PTFU Period|51
10564748|NCT01620528|11719911|FG000|Completed PTFU Month 6|Post-Treatment Follow-Up Period||46
10564749|NCT01620528|11719912|FG001|Completed PTFU Month 6|Post-Treatment Follow-Up Period|Met criteria (reported a post-treatment menses, met the DXA criteria, and had a PTFU Month 6 visit).|26
10564750|NCT01620528|11719913|FG002|Completed PTFU Month 6|Post-Treatment Follow-Up Period|Met criteria (reported a post-treatment menses, met the DXA criteria, and had a PTFU Month 6 visit).|18
10564751|NCT01620528|11719911|FG000|Completed PTFU Month 12|Post-Treatment Follow-Up Period||2
10564752|NCT01620528|11719912|FG001|Completed PTFU Month 12|Post-Treatment Follow-Up Period||5
10564753|NCT01620528|11719913|FG002|Completed PTFU Month 12|Post-Treatment Follow-Up Period||19
10564754|NCT01620528|11719911|FG000|COMPLETED|Post-Treatment Follow-Up Period||48
10564755|NCT01620528|11719912|FG001|COMPLETED|Post-Treatment Follow-Up Period||31
10564756|NCT01620528|11719913|FG002|COMPLETED|Post-Treatment Follow-Up Period||37
10564757|NCT01620528|11719911|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||20
10564758|NCT01620528|11719912|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||17
10564759|NCT01620528|11719913|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||14
10564760|NCT01620567|11719923|FG000|STARTED|Overall Study||23
10564761|NCT01620567|11719924|FG001|STARTED|Overall Study||25
10564762|NCT01620567|11719923|FG000|COMPLETED|Overall Study||20
10564763|NCT01620567|11719924|FG001|COMPLETED|Overall Study||20
10564764|NCT01620567|11719923|FG000|NOT COMPLETED|Overall Study||3
10564765|NCT01620567|11719924|FG001|NOT COMPLETED|Overall Study||5
10564766|NCT01620593|11719935|FG000|STARTED|Overall Study||21
10564767|NCT01620593|11719936|FG001|STARTED|Overall Study||20
10564768|NCT01620593|11719935|FG000|COMPLETED|Overall Study||17
10564769|NCT01620593|11719936|FG001|COMPLETED|Overall Study||19
10564770|NCT01620593|11719935|FG000|NOT COMPLETED|Overall Study||4
10564771|NCT01620593|11719936|FG001|NOT COMPLETED|Overall Study||1
10564772|NCT01620762|11719945|FG000|STARTED|Overall Study||468
10564773|NCT01620762|11719946|FG001|STARTED|Overall Study||470
10564774|NCT01620762|11719947|FG002|STARTED|Overall Study||470
10564775|NCT01620762|11719945|FG000|COMPLETED|Overall Study||420
10564776|NCT01620762|11719946|FG001|COMPLETED|Overall Study||412
10564777|NCT01620762|11719947|FG002|COMPLETED|Overall Study||417
10564778|NCT01620762|11719945|FG000|NOT COMPLETED|Overall Study||48
10564779|NCT01620762|11719946|FG001|NOT COMPLETED|Overall Study||58
10564780|NCT01620762|11719947|FG002|NOT COMPLETED|Overall Study||53
10564781|NCT01620983|11719958|FG000|STARTED|Overall Study||130
10564782|NCT01620983|11719959|FG001|STARTED|Overall Study||135
10564783|NCT01620983|11719960|FG002|STARTED|Overall Study||137
10564784|NCT01620983|11719958|FG000|COMPLETED|Overall Study||111
10564785|NCT01620983|11719959|FG001|COMPLETED|Overall Study||113
10564786|NCT01620983|11719960|FG002|COMPLETED|Overall Study||122
10564787|NCT01620983|11719958|FG000|NOT COMPLETED|Overall Study||19
10564788|NCT01620983|11719959|FG001|NOT COMPLETED|Overall Study||22
10564789|NCT01620983|11719960|FG002|NOT COMPLETED|Overall Study||15
10564790|NCT01621009|11719972|FG000|STARTED|Overall Study||113
10564791|NCT01621009|11719973|FG001|STARTED|Overall Study||116
10564792|NCT01621009|11719974|FG002|STARTED|Overall Study||121
10564793|NCT01621009|11719975|FG003|STARTED|Overall Study||113
10564794|NCT01621009|11719972|FG000|COMPLETED|Overall Study||70
10564795|NCT01621009|11719973|FG001|COMPLETED|Overall Study||65
10564796|NCT01621009|11719974|FG002|COMPLETED|Overall Study||58
10564797|NCT01621009|11719975|FG003|COMPLETED|Overall Study||60
10564798|NCT01621009|11719972|FG000|NOT COMPLETED|Overall Study||43
10564799|NCT01621009|11719973|FG001|NOT COMPLETED|Overall Study||51
10564800|NCT01621009|11719974|FG002|NOT COMPLETED|Overall Study||63
10564801|NCT01621009|11719975|FG003|NOT COMPLETED|Overall Study||53
10564802|NCT01621126|11719983|FG000|STARTED|Overall Study||40
10564803|NCT01621126|11719983|FG000|COMPLETED|Overall Study||34
10564804|NCT01621126|11719983|FG000|NOT COMPLETED|Overall Study||6
10564805|NCT01621178|11719990|FG000|STARTED|Overall Study||194
10564806|NCT01621178|11719991|FG001|STARTED|Overall Study||190
10564807|NCT01621178|11719992|FG002|STARTED|Overall Study||193
10564808|NCT01621178|11719990|FG000|Received at Least One Dose of Study Drug|Overall Study||194
10564809|NCT01621178|11719991|FG001|Received at Least One Dose of Study Drug|Overall Study||190
10564810|NCT01621178|11719992|FG002|Received at Least One Dose of Study Drug|Overall Study||192
10564811|NCT01621178|11719990|FG000|Modified Intent to Treat Population|Overall Study||186
10564812|NCT01621178|11719991|FG001|Modified Intent to Treat Population|Overall Study||180
10564813|NCT01621178|11719992|FG002|Modified Intent to Treat Population|Overall Study||183
10564814|NCT01621178|11719990|FG000|COMPLETED|Overall Study||163
10564815|NCT01621178|11719991|FG001|COMPLETED|Overall Study||160
10564816|NCT01621178|11719992|FG002|COMPLETED|Overall Study||157
10564817|NCT01621178|11719990|FG000|NOT COMPLETED|Overall Study||31
10564818|NCT01621178|11719991|FG001|NOT COMPLETED|Overall Study||30
10564819|NCT01621178|11719992|FG002|NOT COMPLETED|Overall Study||36
10564820|NCT01621191|11720004|FG000|STARTED|Overall Study||149
10564821|NCT01621191|11720004|FG000|Received at Least 1 Dose of Study Drug|Overall Study||149
10564822|NCT01621191|11720004|FG000|Had at Least 1 Post-Baseline Observation|Overall Study||148
10564823|NCT01621191|11720004|FG000|COMPLETED|Overall Study||124
10564824|NCT01621191|11720004|FG000|NOT COMPLETED|Overall Study||25
10564825|NCT01621230|11720011|FG000|STARTED|Overall Study||154
10564826|NCT01621230|11720012|FG001|STARTED|Overall Study||156
10564827|NCT01621230|11720011|FG000|COMPLETED|Overall Study||154
10564828|NCT01621230|11720012|FG001|COMPLETED|Overall Study||156
10564829|NCT01621230|11720011|FG000|NOT COMPLETED|Overall Study||0
10564830|NCT01621230|11720012|FG001|NOT COMPLETED|Overall Study||0
10564831|NCT01621477|11720021|FG000|STARTED|Overall Study||17
10564832|NCT01621477|11720021|FG000|COMPLETED|Overall Study||17
10564833|NCT01621477|11720021|FG000|NOT COMPLETED|Overall Study||0
10564834|NCT01621490|11720034|FG000|STARTED|Overall Study||41
10564835|NCT01621490|11720035|FG001|STARTED|Overall Study||44
10564836|NCT01621490|11720036|FG002|STARTED|Overall Study||11
10564837|NCT01621490|11720037|FG003|STARTED|Overall Study||10
10564838|NCT01621490|11720038|FG004|STARTED|Overall Study||6
10564839|NCT01621490|11720039|FG005|STARTED|Overall Study||25
10564840|NCT01621490|11720040|FG006|STARTED|Overall Study||11
10564841|NCT01621490|11720041|FG007|STARTED|Overall Study||10
10564842|NCT01621490|11720042|FG008|STARTED|Overall Study||10
10564843|NCT01621490|11720034|FG000|COMPLETED|Overall Study||0
10564844|NCT01621490|11720035|FG001|COMPLETED|Overall Study||0
10564845|NCT01621490|11720036|FG002|COMPLETED|Overall Study||0
10564846|NCT01621490|11720037|FG003|COMPLETED|Overall Study||1
10564847|NCT01621490|11720038|FG004|COMPLETED|Overall Study||0
10564848|NCT01621490|11720039|FG005|COMPLETED|Overall Study||1
10564849|NCT01621490|11720040|FG006|COMPLETED|Overall Study||0
10564850|NCT01621490|11720041|FG007|COMPLETED|Overall Study||0
10564851|NCT01621490|11720042|FG008|COMPLETED|Overall Study||2
10564852|NCT01621490|11720034|FG000|NOT COMPLETED|Overall Study||41
10564853|NCT01621490|11720035|FG001|NOT COMPLETED|Overall Study||44
10564854|NCT01621490|11720036|FG002|NOT COMPLETED|Overall Study||11
10564855|NCT01621490|11720037|FG003|NOT COMPLETED|Overall Study||9
10564856|NCT01621490|11720038|FG004|NOT COMPLETED|Overall Study||6
10564857|NCT01621490|11720039|FG005|NOT COMPLETED|Overall Study||24
10564858|NCT01621490|11720040|FG006|NOT COMPLETED|Overall Study||11
10564859|NCT01621490|11720041|FG007|NOT COMPLETED|Overall Study||10
10564860|NCT01621490|11720042|FG008|NOT COMPLETED|Overall Study||8
10564861|NCT01621542|11720161|FG000|STARTED|Overall Study||5
10564862|NCT01621542|11720162|FG001|STARTED|Overall Study||5
10564863|NCT01621542|11720163|FG002|STARTED|Overall Study||6
10564864|NCT01621542|11720164|FG003|STARTED|Overall Study||28
10564865|NCT01621542|11720165|FG004|STARTED|Overall Study||9
10564866|NCT01621542|11720166|FG005|STARTED|Overall Study||9
10564867|NCT01621542|11720161|FG000|COMPLETED|Overall Study||0
10564868|NCT01621542|11720162|FG001|COMPLETED|Overall Study||0
10564869|NCT01621542|11720163|FG002|COMPLETED|Overall Study||0
10564870|NCT01621542|11720164|FG003|COMPLETED|Overall Study||0
10564871|NCT01621542|11720165|FG004|COMPLETED|Overall Study||0
10564872|NCT01621542|11720166|FG005|COMPLETED|Overall Study||0
10564873|NCT01621542|11720161|FG000|NOT COMPLETED|Overall Study||5
10564874|NCT01621542|11720162|FG001|NOT COMPLETED|Overall Study||5
10564875|NCT01621542|11720163|FG002|NOT COMPLETED|Overall Study||6
10564876|NCT01621542|11720164|FG003|NOT COMPLETED|Overall Study||28
10564877|NCT01621542|11720165|FG004|NOT COMPLETED|Overall Study||9
10564878|NCT01621542|11720166|FG005|NOT COMPLETED|Overall Study||9
10564879|NCT01621633|11720184|FG000|STARTED|Overall Study||8
10564880|NCT01621633|11720185|FG001|STARTED|Overall Study||8
10564881|NCT01621633|11720186|FG002|STARTED|Overall Study||8
10564882|NCT01621633|11720187|FG003|STARTED|Overall Study||8
10564883|NCT01621633|11720184|FG000|COMPLETED|Overall Study||8
10564884|NCT01621633|11720185|FG001|COMPLETED|Overall Study||8
10564885|NCT01621633|11720186|FG002|COMPLETED|Overall Study||8
10564886|NCT01621633|11720187|FG003|COMPLETED|Overall Study||8
10564887|NCT01621633|11720184|FG000|NOT COMPLETED|Overall Study||0
10564888|NCT01621633|11720185|FG001|NOT COMPLETED|Overall Study||0
10564889|NCT01621633|11720186|FG002|NOT COMPLETED|Overall Study||0
10564890|NCT01621633|11720187|FG003|NOT COMPLETED|Overall Study||0
10564891|NCT01621672|11720199|FG000|STARTED|Overall Study||25
10564892|NCT01621672|11720200|FG001|STARTED|Overall Study||17
10564893|NCT01621672|11720199|FG000|COMPLETED|Overall Study||25
10564894|NCT01621672|11720200|FG001|COMPLETED|Overall Study||17
10564895|NCT01621672|11720199|FG000|NOT COMPLETED|Overall Study||0
10564896|NCT01621672|11720200|FG001|NOT COMPLETED|Overall Study||0
10564897|NCT01621776|11720209|FG000|STARTED|Overall Study||41
10564898|NCT01621776|11720210|FG001|STARTED|Overall Study||40
10564899|NCT01621776|11720211|FG002|STARTED|Overall Study||18
10564900|NCT01621776|11720209|FG000|COMPLETED|Overall Study||41
10564901|NCT01621776|11720210|FG001|COMPLETED|Overall Study||40
10564902|NCT01621776|11720211|FG002|COMPLETED|Overall Study||18
10564903|NCT01621776|11720209|FG000|NOT COMPLETED|Overall Study||0
10564904|NCT01621776|11720210|FG001|NOT COMPLETED|Overall Study||0
10564905|NCT01621776|11720211|FG002|NOT COMPLETED|Overall Study||0
10564906|NCT01621802|11720225|FG000|STARTED|Overall Study||802
10564907|NCT01621802|11720226|FG001|STARTED|Overall Study||298
10564908|NCT01621802|11720227|FG002|STARTED|Overall Study||796
10318736|NCT00216320|11452957|FG000|NOT COMPLETED|Phase 2 (Weeks 6 -12)||5
10318737|NCT00216320|11452958|FG001|NOT COMPLETED|Phase 2 (Weeks 6 -12)||4
10318738|NCT00216320|11452959|FG002|NOT COMPLETED|Phase 2 (Weeks 6 -12)||1
10318739|NCT00216476|11452970|FG000|STARTED|Overall Study||329
10318740|NCT00216476|11452971|FG001|STARTED|Overall Study||337
10318741|NCT00216476|11452972|FG002|STARTED|Overall Study||45
10318742|NCT00216476|11452970|FG000|COMPLETED|Overall Study||224
10318743|NCT00216476|11452971|FG001|COMPLETED|Overall Study||230
10564909|NCT01621802|11720228|FG003|STARTED|Overall Study||303
10564910|NCT01621802|11720229|FG004|STARTED|Overall Study||1319
10564911|NCT01621802|11720230|FG005|STARTED|Overall Study||489
10564912|NCT01621802|11720225|FG000|COMPLETED|Overall Study||755
10564913|NCT01621802|11720226|FG001|COMPLETED|Overall Study||275
10564914|NCT01621802|11720227|FG002|COMPLETED|Overall Study||763
10564915|NCT01621802|11720228|FG003|COMPLETED|Overall Study||292
10564916|NCT01621802|11720229|FG004|COMPLETED|Overall Study||1284
10564917|NCT01621802|11720230|FG005|COMPLETED|Overall Study||477
10564918|NCT01621802|11720225|FG000|NOT COMPLETED|Overall Study||47
10564919|NCT01621802|11720226|FG001|NOT COMPLETED|Overall Study||23
10564920|NCT01621802|11720227|FG002|NOT COMPLETED|Overall Study||33
10564921|NCT01621802|11720228|FG003|NOT COMPLETED|Overall Study||11
10564922|NCT01621802|11720229|FG004|NOT COMPLETED|Overall Study||35
10564923|NCT01621802|11720230|FG005|NOT COMPLETED|Overall Study||12
10564924|NCT01621880|11720249|FG000|STARTED|Overall Study||58
10318744|NCT00216476|11452972|FG002|COMPLETED|Overall Study||28
10564925|NCT01621880|11720250|FG001|STARTED|Overall Study||54
10564926|NCT01621880|11720249|FG000|COMPLETED|Overall Study||48
10564927|NCT01621880|11720250|FG001|COMPLETED|Overall Study||49
10564928|NCT01621880|11720249|FG000|NOT COMPLETED|Overall Study||10
10564929|NCT01621880|11720250|FG001|NOT COMPLETED|Overall Study||5
10564930|NCT01622010|11720259|FG000|STARTED|Overall Study||18
10564931|NCT01622010|11720260|FG001|STARTED|Overall Study||12
10564932|NCT01622010|11720259|FG000|COMPLETED|Overall Study||12
10564933|NCT01622010|11720260|FG001|COMPLETED|Overall Study||8
10564934|NCT01622010|11720259|FG000|NOT COMPLETED|Overall Study||6
10564935|NCT01622010|11720260|FG001|NOT COMPLETED|Overall Study||4
10564936|NCT01622231|11720268|FG000|STARTED|Overall Study||61
10564937|NCT01622231|11720268|FG000|COMPLETED|Overall Study||59
10564938|NCT01622231|11720268|FG000|NOT COMPLETED|Overall Study||2
10564939|NCT01622257|11720275|FG000|STARTED|Overall Study||66
10564940|NCT01622257|11720276|FG001|STARTED|Overall Study||66
10564941|NCT01622257|11720277|FG002|STARTED|Overall Study||66
10564942|NCT01622257|11720275|FG000|COMPLETED|Overall Study||66
10564943|NCT01622257|11720276|FG001|COMPLETED|Overall Study||66
10564944|NCT01622257|11720277|FG002|COMPLETED|Overall Study||66
10564945|NCT01622257|11720275|FG000|NOT COMPLETED|Overall Study||0
10564946|NCT01622257|11720276|FG001|NOT COMPLETED|Overall Study||0
10564947|NCT01622257|11720277|FG002|NOT COMPLETED|Overall Study||0
10564948|NCT01622296|11720285|FG000|STARTED|First Intervention||10
10564949|NCT01622296|11720286|FG001|STARTED|First Intervention||10
10564950|NCT01622296|11720285|FG000|COMPLETED|First Intervention||10
10564951|NCT01622296|11720286|FG001|COMPLETED|First Intervention||10
10564952|NCT01622296|11720285|FG000|NOT COMPLETED|First Intervention||0
10564953|NCT01622296|11720286|FG001|NOT COMPLETED|First Intervention||0
10564954|NCT01622296|11720285|FG000|STARTED|Washout Period of at Least 1 Week||10
10564955|NCT01622296|11720286|FG001|STARTED|Washout Period of at Least 1 Week||10
10564956|NCT01622296|11720285|FG000|COMPLETED|Washout Period of at Least 1 Week||10
10564957|NCT01622296|11720286|FG001|COMPLETED|Washout Period of at Least 1 Week||10
10564958|NCT01622296|11720285|FG000|NOT COMPLETED|Washout Period of at Least 1 Week||0
10564959|NCT01622296|11720286|FG001|NOT COMPLETED|Washout Period of at Least 1 Week||0
10564960|NCT01622296|11720285|FG000|STARTED|Second Intervention||10
10564961|NCT01622296|11720286|FG001|STARTED|Second Intervention||10
10564962|NCT01622296|11720285|FG000|COMPLETED|Second Intervention||10
10564963|NCT01622296|11720286|FG001|COMPLETED|Second Intervention||10
10564964|NCT01622296|11720285|FG000|NOT COMPLETED|Second Intervention||0
10564965|NCT01622296|11720286|FG001|NOT COMPLETED|Second Intervention||0
10564966|NCT01622348|11720294|FG000|STARTED|Overall Study||15
10564967|NCT01622348|11720295|FG001|STARTED|Overall Study||14
10564968|NCT01622348|11720296|FG002|STARTED|Overall Study||15
10564969|NCT01622348|11720294|FG000|COMPLETED|Overall Study||14
10564970|NCT01622348|11720295|FG001|COMPLETED|Overall Study||14
10564971|NCT01622348|11720296|FG002|COMPLETED|Overall Study||14
10564972|NCT01622348|11720294|FG000|NOT COMPLETED|Overall Study||1
10564973|NCT01622348|11720295|FG001|NOT COMPLETED|Overall Study||0
10564974|NCT01622348|11720296|FG002|NOT COMPLETED|Overall Study||1
10564975|NCT01622543|11720306|FG000|STARTED|Overall Study||51
10564976|NCT01622543|11720307|FG001|STARTED|Overall Study||52
10564977|NCT01622543|11720306|FG000|COMPLETED|Overall Study||51
10564978|NCT01622543|11720307|FG001|COMPLETED|Overall Study||52
10564979|NCT01622543|11720306|FG000|NOT COMPLETED|Overall Study||0
10564980|NCT01622543|11720307|FG001|NOT COMPLETED|Overall Study||0
10564981|NCT01622569|11720317|FG000|STARTED|Double-Blind Treatment Phase (Wks 1-16)||82
10564982|NCT01622569|11720318|FG001|STARTED|Double-Blind Treatment Phase (Wks 1-16)||81
10564983|NCT01622569|11720319|FG002|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
10564984|NCT01622569|11720320|FG003|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
10564985|NCT01622569|11720317|FG000|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||70
10564986|NCT01622569|11720318|FG001|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||75
10564987|NCT01622569|11720319|FG002|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||71
10564988|NCT01622569|11720320|FG003|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||76
10564989|NCT01622569|11720317|FG000|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||12
10564990|NCT01622569|11720318|FG001|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||6
10564991|NCT01622569|11720319|FG002|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||9
10564992|NCT01622569|11720320|FG003|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||4
10564993|NCT01622569|11720317|FG000|STARTED|Open-Label Extension Phase (Wks 17-24)||68
10564994|NCT01622569|11720318|FG001|STARTED|Open-Label Extension Phase (Wks 17-24)||72
10564995|NCT01622569|11720319|FG002|STARTED|Open-Label Extension Phase (Wks 17-24)||67
10564996|NCT01622569|11720320|FG003|STARTED|Open-Label Extension Phase (Wks 17-24)||75
10564997|NCT01622569|11720317|FG000|COMPLETED|Open-Label Extension Phase (Wks 17-24)||67
10564998|NCT01622569|11720318|FG001|COMPLETED|Open-Label Extension Phase (Wks 17-24)||70
10564999|NCT01622569|11720319|FG002|COMPLETED|Open-Label Extension Phase (Wks 17-24)||64
10565000|NCT01622569|11720320|FG003|COMPLETED|Open-Label Extension Phase (Wks 17-24)||73
10565001|NCT01622569|11720317|FG000|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
10565002|NCT01622569|11720318|FG001|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2
10565003|NCT01622569|11720319|FG002|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||3
10565004|NCT01622569|11720320|FG003|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2
10565005|NCT01622660|11720340|FG000|STARTED|Overall Study||2
10565006|NCT01622660|11720340|FG000|COMPLETED|Overall Study||1
10565007|NCT01622660|11720340|FG000|NOT COMPLETED|Overall Study||1
10565008|NCT01622673|11720350|FG000|STARTED|Treatment Period 1||4
10565009|NCT01622673|11720351|FG001|STARTED|Treatment Period 1||5
10565010|NCT01622673|11720352|FG002|STARTED|Treatment Period 1||4
10565011|NCT01622673|11720353|FG003|STARTED|Treatment Period 1||6
10565012|NCT01622673|11720354|FG004|STARTED|Treatment Period 1||4
10565013|NCT01622673|11720355|FG005|STARTED|Treatment Period 1||4
10565014|NCT01622673|11720350|FG000|COMPLETED|Treatment Period 1||4
10565015|NCT01622673|11720351|FG001|COMPLETED|Treatment Period 1||4
10565016|NCT01622673|11720352|FG002|COMPLETED|Treatment Period 1||4
10565017|NCT01622673|11720353|FG003|COMPLETED|Treatment Period 1||5
10565018|NCT01622673|11720354|FG004|COMPLETED|Treatment Period 1||4
10565019|NCT01622673|11720355|FG005|COMPLETED|Treatment Period 1||4
10565020|NCT01622673|11720350|FG000|NOT COMPLETED|Treatment Period 1||0
10565021|NCT01622673|11720351|FG001|NOT COMPLETED|Treatment Period 1||1
10565022|NCT01622673|11720352|FG002|NOT COMPLETED|Treatment Period 1||0
10565023|NCT01622673|11720353|FG003|NOT COMPLETED|Treatment Period 1||1
10565024|NCT01622673|11720354|FG004|NOT COMPLETED|Treatment Period 1||0
10565025|NCT01622673|11720355|FG005|NOT COMPLETED|Treatment Period 1||0
10565026|NCT01622673|11720350|FG000|STARTED|Treatment Period 2||4
10565027|NCT01622673|11720351|FG001|STARTED|Treatment Period 2||4
10565028|NCT01622673|11720352|FG002|STARTED|Treatment Period 2||4
10565029|NCT01622673|11720353|FG003|STARTED|Treatment Period 2||5
10565030|NCT01622673|11720354|FG004|STARTED|Treatment Period 2||4
10565031|NCT01622673|11720355|FG005|STARTED|Treatment Period 2||4
10565032|NCT01622673|11720350|FG000|COMPLETED|Treatment Period 2||4
10565033|NCT01622673|11720351|FG001|COMPLETED|Treatment Period 2||4
10565034|NCT01622673|11720352|FG002|COMPLETED|Treatment Period 2||4
10565035|NCT01622673|11720353|FG003|COMPLETED|Treatment Period 2||4
10565036|NCT01622673|11720354|FG004|COMPLETED|Treatment Period 2||4
10565037|NCT01622673|11720355|FG005|COMPLETED|Treatment Period 2||4
10565038|NCT01622673|11720350|FG000|NOT COMPLETED|Treatment Period 2||0
10565039|NCT01622673|11720351|FG001|NOT COMPLETED|Treatment Period 2||0
10565040|NCT01622673|11720352|FG002|NOT COMPLETED|Treatment Period 2||0
10565041|NCT01622673|11720353|FG003|NOT COMPLETED|Treatment Period 2||1
10565042|NCT01622673|11720354|FG004|NOT COMPLETED|Treatment Period 2||0
10565043|NCT01622673|11720355|FG005|NOT COMPLETED|Treatment Period 2||0
10565044|NCT01622673|11720350|FG000|STARTED|Treatment Period 3||4
10565045|NCT01622673|11720351|FG001|STARTED|Treatment Period 3||4
10565046|NCT01622673|11720352|FG002|STARTED|Treatment Period 3||4
10565047|NCT01622673|11720353|FG003|STARTED|Treatment Period 3||4
10565048|NCT01622673|11720354|FG004|STARTED|Treatment Period 3||4
10565049|NCT01622673|11720355|FG005|STARTED|Treatment Period 3||4
10565050|NCT01622673|11720350|FG000|COMPLETED|Treatment Period 3||4
10565051|NCT01622673|11720351|FG001|COMPLETED|Treatment Period 3||3
10565052|NCT01622673|11720352|FG002|COMPLETED|Treatment Period 3||4
10793207|NCT03599193|11953988|FG000|STARTED|Overall Study||34
10793208|NCT03599193|11953989|FG001|STARTED|Overall Study||24
10793209|NCT03599193|11953988|FG000|COMPLETED|Overall Study||32
10793210|NCT03599193|11953989|FG001|COMPLETED|Overall Study||21
10565053|NCT01622673|11720353|FG003|COMPLETED|Treatment Period 3||4
10565054|NCT01622673|11720354|FG004|COMPLETED|Treatment Period 3||4
10565055|NCT01622673|11720355|FG005|COMPLETED|Treatment Period 3||4
10565056|NCT01622673|11720350|FG000|NOT COMPLETED|Treatment Period 3||0
10565057|NCT01622673|11720351|FG001|NOT COMPLETED|Treatment Period 3||1
10565058|NCT01622673|11720352|FG002|NOT COMPLETED|Treatment Period 3||0
10565059|NCT01622673|11720353|FG003|NOT COMPLETED|Treatment Period 3||0
10565060|NCT01622673|11720354|FG004|NOT COMPLETED|Treatment Period 3||0
10565061|NCT01622673|11720355|FG005|NOT COMPLETED|Treatment Period 3||0
10565062|NCT01622673|11720350|FG000|STARTED|Treatment Period 4||4
10565063|NCT01622673|11720351|FG001|STARTED|Treatment Period 4||3
10565064|NCT01622673|11720352|FG002|STARTED|Treatment Period 4||4
10565065|NCT01622673|11720353|FG003|STARTED|Treatment Period 4||4
10565066|NCT01622673|11720354|FG004|STARTED|Treatment Period 4||4
10565067|NCT01622673|11720355|FG005|STARTED|Treatment Period 4||4
10565068|NCT01622673|11720350|FG000|COMPLETED|Treatment Period 4||4
10565069|NCT01622673|11720351|FG001|COMPLETED|Treatment Period 4||3
10565070|NCT01622673|11720352|FG002|COMPLETED|Treatment Period 4||4
10565071|NCT01622673|11720353|FG003|COMPLETED|Treatment Period 4||4
10565072|NCT01622673|11720354|FG004|COMPLETED|Treatment Period 4||4
10565073|NCT01622673|11720355|FG005|COMPLETED|Treatment Period 4||4
10565074|NCT01622673|11720350|FG000|NOT COMPLETED|Treatment Period 4||0
10565075|NCT01622673|11720351|FG001|NOT COMPLETED|Treatment Period 4||0
10565076|NCT01622673|11720352|FG002|NOT COMPLETED|Treatment Period 4||0
10793211|NCT03599193|11953988|FG000|NOT COMPLETED|Overall Study||2
10793212|NCT03599193|11953989|FG001|NOT COMPLETED|Overall Study||3
10793213|NCT03599271|11953998|FG000|STARTED|Overall Study||70
10793214|NCT03599271|11953999|FG001|STARTED|Overall Study||5
10793215|NCT03599271|11953998|FG000|Drug-Coated Device|Overall Study||70
10793216|NCT03599271|11953999|FG001|Drug-Coated Device|Overall Study||5
10793217|NCT03599271|11953998|FG000|Control Device|Overall Study||70
10793218|NCT03599271|11953999|FG001|Control Device|Overall Study||0
10793219|NCT03599271|11953998|FG000|COMPLETED|Overall Study||70
10793220|NCT03599271|11953999|FG001|COMPLETED|Overall Study||5
10793221|NCT03599271|11953998|FG000|NOT COMPLETED|Overall Study||0
10565077|NCT01622673|11720353|FG003|NOT COMPLETED|Treatment Period 4||0
10565078|NCT01622673|11720354|FG004|NOT COMPLETED|Treatment Period 4||0
10565079|NCT01622673|11720355|FG005|NOT COMPLETED|Treatment Period 4||0
10565080|NCT01622673|11720350|FG000|STARTED|Treatment Period 5||4
10565081|NCT01622673|11720351|FG001|STARTED|Treatment Period 5||3
10793222|NCT03599271|11953999|FG001|NOT COMPLETED|Overall Study||0
10793223|NCT03599349|11954007|FG000|STARTED|Overall Study||20
10565082|NCT01622673|11720352|FG002|STARTED|Treatment Period 5||4
10565083|NCT01622673|11720353|FG003|STARTED|Treatment Period 5||4
10565084|NCT01622673|11720354|FG004|STARTED|Treatment Period 5||4
10565085|NCT01622673|11720355|FG005|STARTED|Treatment Period 5||4
10565086|NCT01622673|11720350|FG000|COMPLETED|Treatment Period 5||4
10565087|NCT01622673|11720351|FG001|COMPLETED|Treatment Period 5||3
10565088|NCT01622673|11720352|FG002|COMPLETED|Treatment Period 5||4
10565089|NCT01622673|11720353|FG003|COMPLETED|Treatment Period 5||4
10565090|NCT01622673|11720354|FG004|COMPLETED|Treatment Period 5||4
10565091|NCT01622673|11720355|FG005|COMPLETED|Treatment Period 5||4
10565092|NCT01622673|11720350|FG000|NOT COMPLETED|Treatment Period 5||0
10565093|NCT01622673|11720351|FG001|NOT COMPLETED|Treatment Period 5||0
10565094|NCT01622673|11720352|FG002|NOT COMPLETED|Treatment Period 5||0
10565095|NCT01622673|11720353|FG003|NOT COMPLETED|Treatment Period 5||0
10565096|NCT01622673|11720354|FG004|NOT COMPLETED|Treatment Period 5||0
10565097|NCT01622673|11720355|FG005|NOT COMPLETED|Treatment Period 5||0
10565098|NCT01622699|11720376|FG000|STARTED|Overall Study||213
10565099|NCT01622699|11720377|FG001|STARTED|Overall Study||217
10565100|NCT01622699|11720376|FG000|COMPLETED|Overall Study||213
10565101|NCT01622699|11720377|FG001|COMPLETED|Overall Study||217
10565102|NCT01622699|11720376|FG000|NOT COMPLETED|Overall Study||0
10565103|NCT01622699|11720377|FG001|NOT COMPLETED|Overall Study||0
10565104|NCT01623037|11720383|FG000|STARTED|Overall Study||15
10565105|NCT01623037|11720383|FG000|COMPLETED|Overall Study||15
10565106|NCT01623037|11720383|FG000|NOT COMPLETED|Overall Study||0
10565107|NCT01623050|11720389|FG000|STARTED|Overall Study||36
10565108|NCT01623050|11720389|FG000|Treated|Overall Study||34
10565109|NCT01623050|11720389|FG000|COMPLETED|Overall Study||27
10565110|NCT01623050|11720389|FG000|NOT COMPLETED|Overall Study||9
10565111|NCT01623115|11720395|FG000|STARTED|Overall Study|Randomized|163
10565112|NCT01623115|11720396|FG001|STARTED|Overall Study|Randomized|323
10565113|NCT01623115|11720395|FG000|Treated|Overall Study||163
10565114|NCT01623115|11720396|FG001|Treated|Overall Study||322
10565115|NCT01623115|11720395|FG000|COMPLETED|Overall Study||130
10565116|NCT01623115|11720396|FG001|COMPLETED|Overall Study||246
10565117|NCT01623115|11720395|FG000|NOT COMPLETED|Overall Study||33
10565118|NCT01623115|11720396|FG001|NOT COMPLETED|Overall Study||77
10565119|NCT01623154|11720402|FG000|STARTED|Overall Study||99
10565120|NCT01623154|11720402|FG000|Available for Analysis|Overall Study||95
10565121|NCT01623154|11720402|FG000|COMPLETED|Overall Study||95
10565122|NCT01623154|11720402|FG000|NOT COMPLETED|Overall Study||4
10565123|NCT01623271|11720408|FG000|STARTED|Overall Study||5
10565124|NCT01623271|11720408|FG000|COMPLETED|Overall Study||3
10565125|NCT01623271|11720408|FG000|NOT COMPLETED|Overall Study||2
10565126|NCT01623310|11720412|FG000|STARTED|Overall Study||223
10565127|NCT01623310|11720412|FG000|COMPLETED|Overall Study||144
10565128|NCT01623310|11720412|FG000|NOT COMPLETED|Overall Study||79
10565129|NCT01623323|11720416|FG000|STARTED|Overall Study||705
10565130|NCT01623323|11720416|FG000|COMPLETED|Overall Study||601
10565131|NCT01623323|11720416|FG000|NOT COMPLETED|Overall Study||104
10565132|NCT01623466|11720422|FG000|STARTED|Overall Study||18
10565133|NCT01623466|11720423|FG001|STARTED|Overall Study||18
10565134|NCT01623466|11720422|FG000|COMPLETED|Overall Study||17
10565135|NCT01623466|11720423|FG001|COMPLETED|Overall Study||18
10565136|NCT01623466|11720422|FG000|NOT COMPLETED|Overall Study||1
10565137|NCT01623466|11720423|FG001|NOT COMPLETED|Overall Study||0
10565138|NCT01623479|11720429|FG000|STARTED|Overall Study||585
10565139|NCT01623479|11720429|FG000|COMPLETED|Overall Study||585
10565140|NCT01623479|11720429|FG000|NOT COMPLETED|Overall Study||0
10565141|NCT01623531|11720435|FG000|STARTED|Overall Study||31
10565142|NCT01623531|11720436|FG001|STARTED|Overall Study||31
10565143|NCT01623531|11720435|FG000|COMPLETED|Overall Study||27
10565144|NCT01623531|11720436|FG001|COMPLETED|Overall Study||29
10565145|NCT01623531|11720435|FG000|NOT COMPLETED|Overall Study||4
10565146|NCT01623531|11720436|FG001|NOT COMPLETED|Overall Study||2
10565147|NCT01623596|11720447|FG000|STARTED|Overall Study||436
10565148|NCT01623596|11720448|FG001|STARTED|Overall Study||439
10565149|NCT01623596|11720447|FG000|On Randomized Treatment|Overall Study||352
10565150|NCT01623596|11720448|FG001|On Randomized Treatment|Overall Study||125
10565151|NCT01623596|11720447|FG000|On Switched Treatment|Overall Study||22
10565152|NCT01623596|11720448|FG001|On Switched Treatment|Overall Study||214
10565153|NCT01623596|11720447|FG000|COMPLETED|Overall Study||374
10565154|NCT01623596|11720448|FG001|COMPLETED|Overall Study||339
10565155|NCT01623596|11720447|FG000|NOT COMPLETED|Overall Study||62
10565156|NCT01623596|11720448|FG001|NOT COMPLETED|Overall Study||100
10565157|NCT01623739|11720458|FG000|STARTED|Overall Study||19
10565158|NCT01623739|11720459|FG001|STARTED|Overall Study||19
10565159|NCT01623739|11720458|FG000|COMPLETED|Overall Study||17
10565160|NCT01623739|11720459|FG001|COMPLETED|Overall Study||15
10565161|NCT01623739|11720458|FG000|NOT COMPLETED|Overall Study||2
10565162|NCT01623739|11720459|FG001|NOT COMPLETED|Overall Study||4
10565163|NCT01623752|11720469|FG000|STARTED|Phase 1 (78 Weeks)||1378
10565164|NCT01623752|11720470|FG001|STARTED|Phase 1 (78 Weeks)||440
10565165|NCT01623752|11720471|FG002|STARTED|Phase 1 (78 Weeks)||3
10565166|NCT01623752|11720469|FG000|COMPLETED|Phase 1 (78 Weeks)||747
10565167|NCT01623752|11720470|FG001|COMPLETED|Phase 1 (78 Weeks)||233
10565168|NCT01623752|11720471|FG002|COMPLETED|Phase 1 (78 Weeks)||1
10565169|NCT01623752|11720469|FG000|NOT COMPLETED|Phase 1 (78 Weeks)||631
10565170|NCT01623752|11720470|FG001|NOT COMPLETED|Phase 1 (78 Weeks)||207
10565171|NCT01623752|11720471|FG002|NOT COMPLETED|Phase 1 (78 Weeks)||2
10651044|NCT02173535|11811309|FG012|COMPLETED|Period 3||12
10565172|NCT01623752|11720469|FG000|STARTED|Phase 2 (78 Weeks)|Participants only who consented to continue in Period 2.|291
10565173|NCT01623752|11720470|FG001|STARTED|Phase 2 (78 Weeks)|Participants only who consented to continue in Period 2.|116
10565174|NCT01623752|11720471|FG002|STARTED|Phase 2 (78 Weeks)|Participants only who consented to continue in Period 2.|0
10565175|NCT01623752|11720469|FG000|COMPLETED|Phase 2 (78 Weeks)||225
10565176|NCT01623752|11720470|FG001|COMPLETED|Phase 2 (78 Weeks)||98
10565177|NCT01623752|11720471|FG002|COMPLETED|Phase 2 (78 Weeks)||0
10565178|NCT01623752|11720469|FG000|NOT COMPLETED|Phase 2 (78 Weeks)||66
10565179|NCT01623752|11720470|FG001|NOT COMPLETED|Phase 2 (78 Weeks)||18
10565180|NCT01623752|11720471|FG002|NOT COMPLETED|Phase 2 (78 Weeks)||0
10565181|NCT01623830|11720482|FG000|STARTED|Overall Study||45
10565182|NCT01623830|11720483|FG001|STARTED|Overall Study||44
10565183|NCT01623830|11720482|FG000|COMPLETED|Overall Study||38
10565184|NCT01623830|11720483|FG001|COMPLETED|Overall Study||35
10565185|NCT01623830|11720482|FG000|NOT COMPLETED|Overall Study||7
10565186|NCT01623830|11720483|FG001|NOT COMPLETED|Overall Study||9
10565187|NCT01623869|11720489|FG000|STARTED|Overall Study||16
10565188|NCT01623869|11720489|FG000|COMPLETED|Overall Study||16
10565189|NCT01623869|11720489|FG000|NOT COMPLETED|Overall Study||0
10565190|NCT01624090|11720497|FG000|STARTED|Overall Study||2
10565191|NCT01624090|11720498|FG001|STARTED|Overall Study||2
10565192|NCT01624090|11720499|FG002|STARTED|Overall Study||10
10565193|NCT01624090|11720500|FG003|STARTED|Overall Study||2
10565194|NCT01624090|11720497|FG000|COMPLETED|Overall Study||2
10565195|NCT01624090|11720498|FG001|COMPLETED|Overall Study||0
10565196|NCT01624090|11720499|FG002|COMPLETED|Overall Study||3
10565197|NCT01624090|11720500|FG003|COMPLETED|Overall Study||2
10565198|NCT01624090|11720497|FG000|NOT COMPLETED|Overall Study||0
10565199|NCT01624090|11720498|FG001|NOT COMPLETED|Overall Study||2
10565200|NCT01624090|11720499|FG002|NOT COMPLETED|Overall Study||7
10565201|NCT01624090|11720500|FG003|NOT COMPLETED|Overall Study||0
10565202|NCT01624142|11720512|FG000|STARTED|Overall Study||106
10565203|NCT01624142|11720513|FG001|STARTED|Overall Study||194
10565204|NCT01624142|11720512|FG000|COMPLETED|Overall Study||74
10565205|NCT01624142|11720513|FG001|COMPLETED|Overall Study||178
10565206|NCT01624142|11720512|FG000|NOT COMPLETED|Overall Study||32
10565207|NCT01624142|11720513|FG001|NOT COMPLETED|Overall Study||16
10565208|NCT01624168|11720523|FG000|STARTED|Overall Study||19
10565209|NCT01624168|11720524|FG001|STARTED|Overall Study||28
10565210|NCT01624168|11720525|FG002|STARTED|Overall Study||28
10565211|NCT01624168|11720523|FG000|COMPLETED|Overall Study||15
10565212|NCT01624168|11720524|FG001|COMPLETED|Overall Study||16
10565213|NCT01624168|11720525|FG002|COMPLETED|Overall Study||22
10565214|NCT01624168|11720523|FG000|NOT COMPLETED|Overall Study||4
10565215|NCT01624168|11720524|FG001|NOT COMPLETED|Overall Study||12
10565216|NCT01624168|11720525|FG002|NOT COMPLETED|Overall Study||6
10565217|NCT01624194|11720535|FG000|STARTED|Overall Study||16
10565218|NCT01624194|11720536|FG001|STARTED|Overall Study||18
10565219|NCT01624194|11720535|FG000|COMPLETED|Overall Study||14
10565220|NCT01624194|11720536|FG001|COMPLETED|Overall Study||18
10565221|NCT01624194|11720535|FG000|NOT COMPLETED|Overall Study||2
10565222|NCT01624194|11720536|FG001|NOT COMPLETED|Overall Study||0
10565223|NCT01624233|11720543|FG000|STARTED|Period 2 - Induction||91
10565224|NCT01624233|11720543|FG000|Received at Least 1 Dose of Study Drug|Period 2 - Induction||91
10565225|NCT01624233|11720543|FG000|Erythrodermic Psoriasis (Ps)|Period 2 - Induction||8
10565226|NCT01624233|11720543|FG000|Pustular Ps|Period 2 - Induction||5
10565227|NCT01624233|11720543|FG000|Plaque Ps|Period 2 - Induction||78
10565228|NCT01624233|11720543|FG000|COMPLETED|Period 2 - Induction||90
10565229|NCT01624233|11720543|FG000|NOT COMPLETED|Period 2 - Induction||1
10565230|NCT01624233|11720543|FG000|STARTED|Period 3 - Maintenance||90
10565231|NCT01624233|11720543|FG000|Received at Least 1 Dose of Study Drug|Period 3 - Maintenance||90
10565232|NCT01624233|11720543|FG000|COMPLETED|Period 3 - Maintenance||83
10565233|NCT01624233|11720543|FG000|NOT COMPLETED|Period 3 - Maintenance||7
10565234|NCT01624233|11720543|FG000|STARTED|Period 4 - Drug Free Period|Only responders in participants with plaque Ps moved to the Drug Free Period 4.|70
10565235|NCT01624233|11720543|FG000|Adverse Event|Period 4 - Drug Free Period|1 participant who discontinued due to adverse event is included in the participants who relapsed.|1
10565236|NCT01624233|11720543|FG000|Physician Decision|Period 4 - Drug Free Period|1 participant who discontinued due to physician decision is included in the participants relapsed.|1
10565237|NCT01624233|11720543|FG000|COMPLETED|Period 4 - Drug Free Period||9
10565238|NCT01624233|11720543|FG000|NOT COMPLETED|Period 4 - Drug Free Period||61
10565239|NCT01624233|11720543|FG000|STARTED|Period 5 - Retreatment Period|Period 5 included (participants with erythrodermic Ps or pustular Ps) or Period 4 completers.|80
10565240|NCT01624233|11720543|FG000|COMPLETED|Period 5 - Retreatment Period||70
10565241|NCT01624233|11720543|FG000|NOT COMPLETED|Period 5 - Retreatment Period||10
10565242|NCT01624233|11720543|FG000|STARTED|Period 6: Follow-up|Period 6 included participants received a dose of drug and exhibited the required neutrophil count.|88
10565243|NCT01624233|11720543|FG000|COMPLETED|Period 6: Follow-up||79
10565244|NCT01624233|11720543|FG000|NOT COMPLETED|Period 6: Follow-up||9
10565245|NCT01624259|11720553|FG000|STARTED|Overall Study||299
10565246|NCT01624259|11720554|FG001|STARTED|Overall Study||300
10565247|NCT01624259|11720553|FG000|Received at Least One Dose of Study Drug|Overall Study||299
10565248|NCT01624259|11720554|FG001|Received at Least One Dose of Study Drug|Overall Study||300
10565249|NCT01624259|11720553|FG000|COMPLETED|Overall Study|Completed the study on study treatment|269
10565250|NCT01624259|11720554|FG001|COMPLETED|Overall Study|Completed the study on study treatment|269
10565251|NCT01624259|11720553|FG000|NOT COMPLETED|Overall Study||30
10565252|NCT01624259|11720554|FG001|NOT COMPLETED|Overall Study||31
10565253|NCT01624350|11720562|FG000|STARTED|Overall Study||100
10565254|NCT01624350|11720562|FG000|COMPLETED|Overall Study||75
10565255|NCT01624350|11720562|FG000|NOT COMPLETED|Overall Study||25
10565256|NCT01624363|11720582|FG000|STARTED|Overall Study||341
10565257|NCT01624363|11720582|FG000|COMPLETED|Overall Study||341
10565258|NCT01624363|11720582|FG000|NOT COMPLETED|Overall Study||0
10565259|NCT01624467|11720586|FG000|STARTED|Overall Study||75
10565260|NCT01624467|11720586|FG000|Received at Least One Dose of Study Drug|Overall Study||75
10565261|NCT01624467|11720586|FG000|COMPLETED|Overall Study||44
10565262|NCT01624467|11720586|FG000|NOT COMPLETED|Overall Study||31
10565263|NCT01624506|11720594|FG000|STARTED|Overall Study||530
10565264|NCT01624506|11720595|FG001|STARTED|Overall Study||230
10565265|NCT01624506|11720594|FG000|COMPLETED|Overall Study||465
10565266|NCT01624506|11720595|FG001|COMPLETED|Overall Study||213
10565267|NCT01624506|11720594|FG000|NOT COMPLETED|Overall Study||65
10565268|NCT01624506|11720595|FG001|NOT COMPLETED|Overall Study||17
10565269|NCT01624662|11720605|FG000|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
10565270|NCT01624662|11720606|FG001|STARTED|Double-Blind Treatment Phase (Wks 1-16)||81
10565271|NCT01624662|11720607|FG002|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
10565272|NCT01624662|11720608|FG003|STARTED|Double-Blind Treatment Phase (Wks 1-16)||82
10565273|NCT01624662|11720605|FG000|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||70
10565274|NCT01624662|11720606|FG001|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||78
10565275|NCT01624662|11720607|FG002|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||76
10565276|NCT01624662|11720608|FG003|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||82
10565277|NCT01624662|11720605|FG000|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||10
10565278|NCT01624662|11720606|FG001|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||3
10565279|NCT01624662|11720607|FG002|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||4
10565280|NCT01624662|11720608|FG003|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||0
10565281|NCT01624662|11720605|FG000|STARTED|Open-Label Extension Phase (Wks 17-24)||70
10565282|NCT01624662|11720606|FG001|STARTED|Open-Label Extension Phase (Wks 17-24)||78
10565283|NCT01624662|11720607|FG002|STARTED|Open-Label Extension Phase (Wks 17-24)||72
10565284|NCT01624662|11720608|FG003|STARTED|Open-Label Extension Phase (Wks 17-24)||79
10565285|NCT01624662|11720605|FG000|COMPLETED|Open-Label Extension Phase (Wks 17-24)||69
10565286|NCT01624662|11720606|FG001|COMPLETED|Open-Label Extension Phase (Wks 17-24)||76
10565287|NCT01624662|11720607|FG002|COMPLETED|Open-Label Extension Phase (Wks 17-24)||71
10565288|NCT01624662|11720608|FG003|COMPLETED|Open-Label Extension Phase (Wks 17-24)||78
10565289|NCT01624662|11720605|FG000|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
10565290|NCT01624662|11720606|FG001|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2
10565291|NCT01624662|11720607|FG002|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
10793224|NCT03599349|11954007|FG000|Treated|Overall Study||20
10793225|NCT03599349|11954007|FG000|COMPLETED|Overall Study||19
10793226|NCT03599349|11954007|FG000|NOT COMPLETED|Overall Study||1
10793227|NCT03599362|11954011|FG000|STARTED|Overall Study||7
10793228|NCT03599362|11954011|FG000|COMPLETED|Overall Study||4
10793229|NCT03599362|11954011|FG000|NOT COMPLETED|Overall Study||3
10793230|NCT03599687|11954017|FG000|STARTED|Overall Study||82
10793231|NCT03599687|11954018|FG001|STARTED|Overall Study||82
10793232|NCT03599687|11954017|FG000|COMPLETED|Overall Study||82
10565292|NCT01624662|11720608|FG003|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
10565293|NCT01624870|11720629|FG000|STARTED|Overall Study|provided informed consent|200
10565294|NCT01624870|11720629|FG000|COMPLETED|Overall Study|Completed 6 month follow up|173
10565295|NCT01624870|11720629|FG000|NOT COMPLETED|Overall Study||27
10565296|NCT01624740|11720637|FG000|STARTED|First Intervention (3-4 Days)||9
10565297|NCT01624740|11720638|FG001|STARTED|First Intervention (3-4 Days)||9
10565298|NCT01624740|11720637|FG000|COMPLETED|First Intervention (3-4 Days)||9
10565299|NCT01624740|11720638|FG001|COMPLETED|First Intervention (3-4 Days)||9
10565300|NCT01624740|11720637|FG000|NOT COMPLETED|First Intervention (3-4 Days)||0
10565301|NCT01624740|11720638|FG001|NOT COMPLETED|First Intervention (3-4 Days)||0
10565302|NCT01624740|11720637|FG000|STARTED|Washout (1 Hour)||9
10565303|NCT01624740|11720638|FG001|STARTED|Washout (1 Hour)||9
10565304|NCT01624740|11720637|FG000|COMPLETED|Washout (1 Hour)||9
10565305|NCT01624740|11720638|FG001|COMPLETED|Washout (1 Hour)||9
10565306|NCT01624740|11720637|FG000|NOT COMPLETED|Washout (1 Hour)||0
10565307|NCT01624740|11720638|FG001|NOT COMPLETED|Washout (1 Hour)||0
10565308|NCT01624740|11720637|FG000|STARTED|Second Intervention (3-4 Days)||9
10565309|NCT01624740|11720638|FG001|STARTED|Second Intervention (3-4 Days)||9
10565310|NCT01624740|11720637|FG000|COMPLETED|Second Intervention (3-4 Days)||8
10565311|NCT01624740|11720638|FG001|COMPLETED|Second Intervention (3-4 Days)||9
10565312|NCT01624740|11720637|FG000|NOT COMPLETED|Second Intervention (3-4 Days)||1
10565313|NCT01624740|11720638|FG001|NOT COMPLETED|Second Intervention (3-4 Days)||0
10565314|NCT01624948|11720647|FG000|STARTED|Overall Study||20
10793233|NCT03599687|11954018|FG001|COMPLETED|Overall Study||82
10565315|NCT01624948|11720648|FG001|STARTED|Overall Study||20
10565316|NCT01624948|11720647|FG000|COMPLETED|Overall Study||20
10565317|NCT01624948|11720648|FG001|COMPLETED|Overall Study||20
10565318|NCT01624948|11720647|FG000|NOT COMPLETED|Overall Study||0
10565319|NCT01624948|11720648|FG001|NOT COMPLETED|Overall Study||0
10565320|NCT01624974|11720660|FG000|STARTED|Period III of Treatment (4 Weeks)||54
10565321|NCT01624974|11720661|FG001|STARTED|Period III of Treatment (4 Weeks)||53
10793234|NCT03599687|11954017|FG000|NOT COMPLETED|Overall Study||0
10793235|NCT03599687|11954018|FG001|NOT COMPLETED|Overall Study||0
10793236|NCT03599986|11954024|FG000|STARTED|Overall Study||398
10565322|NCT01624974|11720660|FG000|COMPLETED|Period III of Treatment (4 Weeks)||47
10565323|NCT01624974|11720661|FG001|COMPLETED|Period III of Treatment (4 Weeks)||45
10565324|NCT01624974|11720660|FG000|NOT COMPLETED|Period III of Treatment (4 Weeks)||7
10565325|NCT01624974|11720661|FG001|NOT COMPLETED|Period III of Treatment (4 Weeks)||8
10565326|NCT01624974|11720660|FG000|STARTED|Period IV Washout (4 Weeks)||47
10565327|NCT01624974|11720661|FG001|STARTED|Period IV Washout (4 Weeks)||45
10565328|NCT01624974|11720660|FG000|COMPLETED|Period IV Washout (4 Weeks)||44
10565329|NCT01624974|11720661|FG001|COMPLETED|Period IV Washout (4 Weeks)||42
10565330|NCT01624974|11720660|FG000|NOT COMPLETED|Period IV Washout (4 Weeks)||3
10565331|NCT01624974|11720661|FG001|NOT COMPLETED|Period IV Washout (4 Weeks)||3
10565332|NCT01624974|11720660|FG000|STARTED|Period V of Treatment (4 Weeks)||44
10565333|NCT01624974|11720661|FG001|STARTED|Period V of Treatment (4 Weeks)||42
10565334|NCT01624974|11720660|FG000|COMPLETED|Period V of Treatment (4 Weeks)||39
10565335|NCT01624974|11720661|FG001|COMPLETED|Period V of Treatment (4 Weeks)||42
10565336|NCT01624974|11720660|FG000|NOT COMPLETED|Period V of Treatment (4 Weeks)||5
10565337|NCT01624974|11720661|FG001|NOT COMPLETED|Period V of Treatment (4 Weeks)||0
10565338|NCT01625000|11720673|FG000|STARTED|Overall Study||126
10565339|NCT01625000|11720674|FG001|STARTED|Overall Study||133
10565340|NCT01625000|11720675|FG002|STARTED|Overall Study||67
10565341|NCT01625000|11720676|FG003|STARTED|Overall Study||56
10565342|NCT01625000|11720677|FG004|STARTED|Overall Study||126
10565343|NCT01625000|11720673|FG000|COMPLETED|Overall Study||74
10565344|NCT01625000|11720674|FG001|COMPLETED|Overall Study||81
10565345|NCT01625000|11720675|FG002|COMPLETED|Overall Study||34
10565346|NCT01625000|11720676|FG003|COMPLETED|Overall Study||37
10565347|NCT01625000|11720677|FG004|COMPLETED|Overall Study||71
10565348|NCT01625000|11720673|FG000|NOT COMPLETED|Overall Study||52
10565349|NCT01625000|11720674|FG001|NOT COMPLETED|Overall Study||52
10565350|NCT01625000|11720675|FG002|NOT COMPLETED|Overall Study||33
10565351|NCT01625000|11720676|FG003|NOT COMPLETED|Overall Study||19
10565352|NCT01625000|11720677|FG004|NOT COMPLETED|Overall Study||55
10565353|NCT01625013|11720689|FG000|STARTED|Overall Study||51
10565354|NCT01625013|11720689|FG000|COMPLETED|Overall Study||48
10565355|NCT01625013|11720689|FG000|NOT COMPLETED|Overall Study||3
10565356|NCT01625091|11720696|FG000|STARTED|Intervention||96
10565357|NCT01625091|11720697|FG001|STARTED|Intervention||98
10565358|NCT01625091|11720696|FG000|2 Months|Intervention||90
10565359|NCT01625091|11720697|FG001|2 Months|Intervention||93
10565360|NCT01625091|11720696|FG000|4 Months|Intervention||85
10565361|NCT01625091|11720697|FG001|4 Months|Intervention||87
10565362|NCT01625091|11720696|FG000|COMPLETED|Intervention||85
10565363|NCT01625091|11720697|FG001|COMPLETED|Intervention||87
10565364|NCT01625091|11720696|FG000|NOT COMPLETED|Intervention||11
10565365|NCT01625091|11720697|FG001|NOT COMPLETED|Intervention||11
10565366|NCT01625091|11720696|FG000|STARTED|Post-intervention||85
10565367|NCT01625091|11720697|FG001|STARTED|Post-intervention||87
10565368|NCT01625091|11720696|FG000|7 Months|Post-intervention||81
10565369|NCT01625091|11720697|FG001|7 Months|Post-intervention||85
10565370|NCT01625091|11720696|FG000|COMPLETED|Post-intervention||81
10565371|NCT01625091|11720697|FG001|COMPLETED|Post-intervention||85
10565372|NCT01625091|11720696|FG000|NOT COMPLETED|Post-intervention||4
10565373|NCT01625091|11720697|FG001|NOT COMPLETED|Post-intervention||2
10565374|NCT01625104|11720705|FG000|STARTED|Overall Study||448
10565375|NCT01625104|11720706|FG001|STARTED|Overall Study||434
10565376|NCT01625104|11720705|FG000|COMPLETED|Overall Study||448
10565377|NCT01625104|11720706|FG001|COMPLETED|Overall Study||434
10565378|NCT01625104|11720705|FG000|NOT COMPLETED|Overall Study||0
10565379|NCT01625104|11720706|FG001|NOT COMPLETED|Overall Study||0
10565380|NCT01625169|11720712|FG000|STARTED|Overall Study||9
10565381|NCT01625169|11720712|FG000|COMPLETED|Overall Study||9
10565382|NCT01625169|11720712|FG000|NOT COMPLETED|Overall Study||0
10565383|NCT01625182|11720718|FG000|STARTED|Overall Study||54
10565384|NCT01625182|11720719|FG001|STARTED|Overall Study||52
10565385|NCT01625182|11720718|FG000|COMPLETED|Overall Study||34
10565386|NCT01625182|11720719|FG001|COMPLETED|Overall Study||41
10565387|NCT01625182|11720718|FG000|NOT COMPLETED|Overall Study||20
10565388|NCT01625182|11720719|FG001|NOT COMPLETED|Overall Study||11
10565389|NCT01625221|11720726|FG000|STARTED|Overall Study||35
10565390|NCT01625221|11720726|FG000|COMPLETED|Overall Study||28
10565391|NCT01625221|11720726|FG000|NOT COMPLETED|Overall Study||7
10651045|NCT02173535|11811310|FG013|COMPLETED|Period 3||12
10651046|NCT02173535|11811311|FG014|COMPLETED|Period 3||12
10651047|NCT02173535|11811312|FG015|COMPLETED|Period 3||12
10651048|NCT02173535|11811313|FG016|COMPLETED|Period 3||12
10651049|NCT02173535|11811314|FG017|COMPLETED|Period 3||12
10651050|NCT02173535|11811315|FG018|COMPLETED|Period 3||12
10651051|NCT02173535|11811316|FG019|COMPLETED|Period 3||12
10651052|NCT02173535|11811297|FG000|NOT COMPLETED|Period 3||0
10651053|NCT02173535|11811298|FG001|NOT COMPLETED|Period 3||0
10651054|NCT02173535|11811299|FG002|NOT COMPLETED|Period 3||0
10651055|NCT02173535|11811300|FG003|NOT COMPLETED|Period 3||0
10651056|NCT02173535|11811301|FG004|NOT COMPLETED|Period 3||0
10651057|NCT02173535|11811302|FG005|NOT COMPLETED|Period 3||0
10651058|NCT02173535|11811303|FG006|NOT COMPLETED|Period 3||0
10651059|NCT02173535|11811304|FG007|NOT COMPLETED|Period 3||0
10651060|NCT02173535|11811305|FG008|NOT COMPLETED|Period 3||0
10651061|NCT02173535|11811306|FG009|NOT COMPLETED|Period 3||0
10651062|NCT02173535|11811307|FG010|NOT COMPLETED|Period 3||0
10651063|NCT02173535|11811308|FG011|NOT COMPLETED|Period 3||0
10651064|NCT02173535|11811309|FG012|NOT COMPLETED|Period 3||0
10651065|NCT02173535|11811310|FG013|NOT COMPLETED|Period 3||0
10565392|NCT01625338|11720733|FG000|STARTED|Overall Study||114
10565393|NCT01625338|11720734|FG001|STARTED|Overall Study||200
10565394|NCT01625338|11720735|FG002|STARTED|Overall Study||220
10565395|NCT01625338|11720733|FG000|COMPLETED|Overall Study||82
10565396|NCT01625338|11720734|FG001|COMPLETED|Overall Study||156
10565397|NCT01625338|11720735|FG002|COMPLETED|Overall Study||181
10565398|NCT01625338|11720733|FG000|NOT COMPLETED|Overall Study||32
10565399|NCT01625338|11720734|FG001|NOT COMPLETED|Overall Study||44
10565400|NCT01625338|11720735|FG002|NOT COMPLETED|Overall Study||39
10565401|NCT01625377|11720745|FG000|STARTED|Overall Study|"Started indicates randomized patients."|95
10565402|NCT01625377|11720746|FG001|STARTED|Overall Study||93
10565403|NCT01625377|11720745|FG000|Safety Set of Population|Overall Study||94
10565404|NCT01625377|11720746|FG001|Safety Set of Population|Overall Study||90
10565405|NCT01625377|11720745|FG000|Intent to Treat Population|Overall Study||93
10565406|NCT01625377|11720746|FG001|Intent to Treat Population|Overall Study||90
10565407|NCT01625377|11720745|FG000|COMPLETED|Overall Study||88
10565408|NCT01625377|11720746|FG001|COMPLETED|Overall Study||71
10565409|NCT01625377|11720745|FG000|NOT COMPLETED|Overall Study||7
10565410|NCT01625377|11720746|FG001|NOT COMPLETED|Overall Study||22
10565411|NCT01625416|11720754|FG000|STARTED|Overall Study||60
10565412|NCT01625416|11720755|FG001|STARTED|Overall Study||61
10565413|NCT01625416|11720754|FG000|COMPLETED|Overall Study||51
10565414|NCT01625416|11720755|FG001|COMPLETED|Overall Study||54
10565415|NCT01625416|11720754|FG000|NOT COMPLETED|Overall Study||9
10565416|NCT01625416|11720755|FG001|NOT COMPLETED|Overall Study||7
10565417|NCT01625455|11720764|FG000|STARTED|Overall Study||2
10565418|NCT01625455|11720765|FG001|STARTED|Overall Study||3
10565419|NCT01625455|11720764|FG000|COMPLETED|Overall Study||2
10565420|NCT01625455|11720765|FG001|COMPLETED|Overall Study||3
10565421|NCT01625455|11720764|FG000|NOT COMPLETED|Overall Study||0
10565422|NCT01625455|11720765|FG001|NOT COMPLETED|Overall Study||0
10565423|NCT01625507|11720771|FG000|STARTED|Overall Study||73
10565424|NCT01625507|11720771|FG000|COMPLETED|Overall Study||63
10565425|NCT01625507|11720771|FG000|NOT COMPLETED|Overall Study||10
10565426|NCT01625689|11720778|FG000|STARTED|Overall Study||150
10565427|NCT01625689|11720779|FG001|STARTED|Overall Study||150
10565428|NCT01625689|11720778|FG000|COMPLETED|Overall Study||148
10565429|NCT01625689|11720779|FG001|COMPLETED|Overall Study||149
10565430|NCT01625689|11720778|FG000|NOT COMPLETED|Overall Study||2
10565431|NCT01625689|11720779|FG001|NOT COMPLETED|Overall Study||1
10565432|NCT01625845|11720787|FG000|STARTED|Overall Study||10
10565433|NCT01625845|11720788|FG001|STARTED|Overall Study||6
10565434|NCT01625845|11720787|FG000|COMPLETED|Overall Study||5
10565435|NCT01625845|11720788|FG001|COMPLETED|Overall Study||3
10565436|NCT01625845|11720787|FG000|NOT COMPLETED|Overall Study||5
10565437|NCT01625845|11720788|FG001|NOT COMPLETED|Overall Study||3
10565438|NCT01625897|11720796|FG000|STARTED|Overall Study||83
10565439|NCT01625897|11720797|FG001|STARTED|Overall Study||42
10565440|NCT01625897|11720796|FG000|COMPLETED|Overall Study||31
10565441|NCT01625897|11720797|FG001|COMPLETED|Overall Study||28
10565442|NCT01625897|11720796|FG000|NOT COMPLETED|Overall Study||52
10565443|NCT01625897|11720797|FG001|NOT COMPLETED|Overall Study||14
10565444|NCT01625910|11720805|FG000|STARTED|Overall Study||35
10565445|NCT01625910|11720806|FG001|STARTED|Overall Study||37
10565446|NCT01625910|11720805|FG000|COMPLETED|Overall Study||32
10565447|NCT01625910|11720806|FG001|COMPLETED|Overall Study||33
10565448|NCT01625910|11720805|FG000|NOT COMPLETED|Overall Study||3
10565449|NCT01625910|11720806|FG001|NOT COMPLETED|Overall Study||4
10565450|NCT01625923|11720814|FG000|STARTED|Overall Study||3
10565451|NCT01625923|11720814|FG000|COMPLETED|Overall Study||3
10565452|NCT01625923|11720814|FG000|NOT COMPLETED|Overall Study||0
10565453|NCT01625988|11720821|FG000|STARTED|Overall Study|One participant was randomized inappropriately and was discontinued before start of study treatment.|108
10565454|NCT01625988|11720822|FG001|STARTED|Overall Study||110
10565455|NCT01625988|11720821|FG000|Received at Least One Dose of Study Drug|Overall Study||107
10565456|NCT01625988|11720822|FG001|Received at Least One Dose of Study Drug|Overall Study||110
10565457|NCT01625988|11720821|FG000|COMPLETED|Overall Study||94
10565458|NCT01625988|11720822|FG001|COMPLETED|Overall Study||97
10565459|NCT01625988|11720821|FG000|NOT COMPLETED|Overall Study||14
10565460|NCT01625988|11720822|FG001|NOT COMPLETED|Overall Study||13
10565461|NCT01626092|11720831|FG000|STARTED|Overall Study||3
10565462|NCT01626092|11720831|FG000|COMPLETED|Overall Study||3
10565463|NCT01626092|11720831|FG000|NOT COMPLETED|Overall Study||0
10565464|NCT01626118|11720839|FG000|STARTED|Overall Study||94
10565465|NCT01626118|11720840|FG001|STARTED|Overall Study||93
10565466|NCT01626118|11720841|FG002|STARTED|Overall Study||92
10565467|NCT01626118|11720842|FG003|STARTED|Overall Study||94
10565468|NCT01626118|11720839|FG000|COMPLETED|Overall Study||92
10565469|NCT01626118|11720840|FG001|COMPLETED|Overall Study||91
10565470|NCT01626118|11720841|FG002|COMPLETED|Overall Study||90
10565471|NCT01626118|11720842|FG003|COMPLETED|Overall Study||91
10565472|NCT01626118|11720839|FG000|NOT COMPLETED|Overall Study||2
10565473|NCT01626118|11720840|FG001|NOT COMPLETED|Overall Study||2
10565474|NCT01626118|11720841|FG002|NOT COMPLETED|Overall Study||2
10565475|NCT01626118|11720842|FG003|NOT COMPLETED|Overall Study||3
10565476|NCT01626352|11720852|FG000|STARTED|Overall Study||22
10565477|NCT01626352|11720852|FG000|COMPLETED|Overall Study||12
10565478|NCT01626352|11720852|FG000|NOT COMPLETED|Overall Study||10
10565479|NCT01626391|11720861|FG000|STARTED|Overall Study||5
10565480|NCT01626391|11720862|FG001|STARTED|Overall Study||4
10565481|NCT01626391|11720861|FG000|COMPLETED|Overall Study||3
10565482|NCT01626391|11720862|FG001|COMPLETED|Overall Study||4
10565483|NCT01626391|11720861|FG000|NOT COMPLETED|Overall Study||2
10565484|NCT01626391|11720862|FG001|NOT COMPLETED|Overall Study||0
10565485|NCT01626456|11720870|FG000|STARTED|Overall Study||110
10565486|NCT01626456|11720871|FG001|STARTED|Overall Study||368
10565487|NCT01626456|11720870|FG000|COMPLETED|Overall Study||75
10565488|NCT01626456|11720871|FG001|COMPLETED|Overall Study||251
10565489|NCT01626456|11720870|FG000|NOT COMPLETED|Overall Study||35
10565490|NCT01626456|11720871|FG001|NOT COMPLETED|Overall Study||117
10565491|NCT01626495|11720886|FG000|STARTED|Overall Study|Number of enrolled subjects|73
10565492|NCT01626495|11720886|FG000|Intervention|Overall Study||62
10565493|NCT01626495|11720886|FG000|COMPLETED|Overall Study|Follow up phase completed as per protocol|21
10565494|NCT01626495|11720886|FG000|NOT COMPLETED|Overall Study||52
10565495|NCT01626664|11720892|FG000|STARTED|Randomization Period||47
10565496|NCT01626664|11720893|FG001|STARTED|Randomization Period||24
10565497|NCT01626664|11720894|FG002|STARTED|Randomization Period||0
10565498|NCT01626664|11720892|FG000|COMPLETED|Randomization Period||47
10565499|NCT01626664|11720893|FG001|COMPLETED|Randomization Period||24
10565500|NCT01626664|11720894|FG002|COMPLETED|Randomization Period||0
10565501|NCT01626664|11720892|FG000|NOT COMPLETED|Randomization Period||0
10565502|NCT01626664|11720893|FG001|NOT COMPLETED|Randomization Period||0
10565503|NCT01626664|11720894|FG002|NOT COMPLETED|Randomization Period||0
10565504|NCT01626664|11720892|FG000|STARTED|Crossover Period||0
10565505|NCT01626664|11720893|FG001|STARTED|Crossover Period||0
10565506|NCT01626664|11720894|FG002|STARTED|Crossover Period||18
10565507|NCT01626664|11720892|FG000|COMPLETED|Crossover Period||0
10565508|NCT01626664|11720893|FG001|COMPLETED|Crossover Period||0
10565509|NCT01626664|11720894|FG002|COMPLETED|Crossover Period||18
10565510|NCT01626664|11720892|FG000|NOT COMPLETED|Crossover Period||0
10565511|NCT01626664|11720893|FG001|NOT COMPLETED|Crossover Period||0
10565512|NCT01626664|11720894|FG002|NOT COMPLETED|Crossover Period||0
10565513|NCT01626690|11720903|FG000|STARTED|Overall Study||49
10565514|NCT01626690|11720904|FG001|STARTED|Overall Study||51
10565515|NCT01626690|11720903|FG000|COMPLETED|Overall Study||47
10565516|NCT01626690|11720904|FG001|COMPLETED|Overall Study||51
10565517|NCT01626690|11720903|FG000|NOT COMPLETED|Overall Study||2
10565518|NCT01626690|11720904|FG001|NOT COMPLETED|Overall Study||0
10565519|NCT01626820|11720914|FG000|STARTED|Overall Study||56
10565520|NCT01626820|11720915|FG001|STARTED|Overall Study||57
10565521|NCT01626820|11720914|FG000|COMPLETED|Overall Study||56
10565522|NCT01626820|11720915|FG001|COMPLETED|Overall Study||57
10565523|NCT01626820|11720914|FG000|NOT COMPLETED|Overall Study||0
10565524|NCT01626820|11720915|FG001|NOT COMPLETED|Overall Study||0
10565525|NCT01626859|11720925|FG000|STARTED|Overall Study||11
10565526|NCT01626859|11720926|FG001|STARTED|Overall Study||16
10565527|NCT01626859|11720927|FG002|STARTED|Overall Study||11
10565528|NCT01626859|11720925|FG000|COMPLETED|Overall Study||9
10565529|NCT01626859|11720926|FG001|COMPLETED|Overall Study||8
10565530|NCT01626859|11720927|FG002|COMPLETED|Overall Study||7
10565531|NCT01626859|11720925|FG000|NOT COMPLETED|Overall Study||2
10565532|NCT01626859|11720926|FG001|NOT COMPLETED|Overall Study||8
10565533|NCT01626859|11720927|FG002|NOT COMPLETED|Overall Study||4
10565534|NCT01626872|11720938|FG000|STARTED|Overall Study||81
10565535|NCT01626872|11720939|FG001|STARTED|Overall Study||109
10565536|NCT01626872|11720940|FG002|STARTED|Overall Study||58
10565537|NCT01626872|11720938|FG000|COMPLETED|Overall Study||29
10565538|NCT01626872|11720939|FG001|COMPLETED|Overall Study||43
10565539|NCT01626872|11720940|FG002|COMPLETED|Overall Study||34
10565540|NCT01626872|11720938|FG000|NOT COMPLETED|Overall Study||52
10565541|NCT01626872|11720939|FG001|NOT COMPLETED|Overall Study||66
10565542|NCT01626872|11720940|FG002|NOT COMPLETED|Overall Study||24
10565543|NCT01626885|11720948|FG000|STARTED|Overall Study||42
10565544|NCT01626885|11720948|FG000|COMPLETED|Overall Study||30
10565545|NCT01626885|11720948|FG000|NOT COMPLETED|Overall Study||12
10565546|NCT01626989|11720952|FG000|STARTED|Screening Period||44
10565547|NCT01626989|11720953|FG001|STARTED|Screening Period||0
10565548|NCT01626989|11720954|FG002|STARTED|Screening Period||0
10565549|NCT01626989|11720952|FG000|COMPLETED|Screening Period||27
10565550|NCT01626989|11720953|FG001|COMPLETED|Screening Period||0
10565551|NCT01626989|11720954|FG002|COMPLETED|Screening Period||0
10565552|NCT01626989|11720952|FG000|NOT COMPLETED|Screening Period||17
10565553|NCT01626989|11720953|FG001|NOT COMPLETED|Screening Period||0
10565554|NCT01626989|11720954|FG002|NOT COMPLETED|Screening Period||0
10565555|NCT01626989|11720952|FG000|STARTED|Fist Intervention (Night 1)||0
10565556|NCT01626989|11720953|FG001|STARTED|Fist Intervention (Night 1)||15
10565557|NCT01626989|11720954|FG002|STARTED|Fist Intervention (Night 1)||12
10565558|NCT01626989|11720952|FG000|COMPLETED|Fist Intervention (Night 1)||0
10565559|NCT01626989|11720953|FG001|COMPLETED|Fist Intervention (Night 1)||15
10565560|NCT01626989|11720954|FG002|COMPLETED|Fist Intervention (Night 1)||12
10565561|NCT01626989|11720952|FG000|NOT COMPLETED|Fist Intervention (Night 1)||0
10565562|NCT01626989|11720953|FG001|NOT COMPLETED|Fist Intervention (Night 1)||0
10565563|NCT01626989|11720954|FG002|NOT COMPLETED|Fist Intervention (Night 1)||0
10565564|NCT01626989|11720952|FG000|STARTED|Second Intervention (Night 2)||0
10565565|NCT01626989|11720953|FG001|STARTED|Second Intervention (Night 2)||15
10565566|NCT01626989|11720954|FG002|STARTED|Second Intervention (Night 2)||12
10565567|NCT01626989|11720952|FG000|COMPLETED|Second Intervention (Night 2)||0
10565568|NCT01626989|11720953|FG001|COMPLETED|Second Intervention (Night 2)||15
10565569|NCT01626989|11720954|FG002|COMPLETED|Second Intervention (Night 2)||12
10565570|NCT01626989|11720952|FG000|NOT COMPLETED|Second Intervention (Night 2)||0
10565571|NCT01626989|11720953|FG001|NOT COMPLETED|Second Intervention (Night 2)||0
10565572|NCT01626989|11720954|FG002|NOT COMPLETED|Second Intervention (Night 2)||0
10565573|NCT01627002|11720965|FG000|STARTED|Overall Study||4
10565574|NCT01627002|11720966|FG001|STARTED|Overall Study||4
10565575|NCT01627002|11720967|FG002|STARTED|Overall Study||4
10565576|NCT01627002|11720968|FG003|STARTED|Overall Study||4
10565577|NCT01627002|11720969|FG004|STARTED|Overall Study||2
10565578|NCT01627002|11720970|FG005|STARTED|Overall Study||9
10565579|NCT01627002|11720971|FG006|STARTED|Overall Study||10
10565580|NCT01627002|11720972|FG007|STARTED|Overall Study||5
10565581|NCT01627002|11720973|FG008|STARTED|Overall Study||7
10565582|NCT01627002|11720965|FG000|COMPLETED|Overall Study||4
10565583|NCT01627002|11720966|FG001|COMPLETED|Overall Study||4
10565584|NCT01627002|11720967|FG002|COMPLETED|Overall Study||4
10565585|NCT01627002|11720968|FG003|COMPLETED|Overall Study||4
10565586|NCT01627002|11720969|FG004|COMPLETED|Overall Study||2
10565587|NCT01627002|11720970|FG005|COMPLETED|Overall Study||9
10565588|NCT01627002|11720971|FG006|COMPLETED|Overall Study||10
10565589|NCT01627002|11720972|FG007|COMPLETED|Overall Study||5
10565590|NCT01627002|11720973|FG008|COMPLETED|Overall Study||7
10565591|NCT01627002|11720965|FG000|NOT COMPLETED|Overall Study||0
10565592|NCT01627002|11720966|FG001|NOT COMPLETED|Overall Study||0
10565593|NCT01627002|11720967|FG002|NOT COMPLETED|Overall Study||0
10565594|NCT01627002|11720968|FG003|NOT COMPLETED|Overall Study||0
10565595|NCT01627002|11720969|FG004|NOT COMPLETED|Overall Study||0
10565596|NCT01627002|11720970|FG005|NOT COMPLETED|Overall Study||0
10565597|NCT01627002|11720971|FG006|NOT COMPLETED|Overall Study||0
10565598|NCT01627002|11720972|FG007|NOT COMPLETED|Overall Study||0
10565599|NCT01627002|11720973|FG008|NOT COMPLETED|Overall Study||0
10565600|NCT01627067|11721000|FG000|STARTED|Overall Study||23
10565601|NCT01627067|11721000|FG000|COMPLETED|Overall Study||22
10565602|NCT01627067|11721000|FG000|NOT COMPLETED|Overall Study||1
10565603|NCT01627249|11721009|FG000|STARTED|Overall Study||224
10565604|NCT01627249|11721010|FG001|STARTED|Overall Study||218
10565605|NCT01627249|11721011|FG002|STARTED|Overall Study||218
10565606|NCT01627249|11721009|FG000|COMPLETED|Overall Study||208
10565607|NCT01627249|11721010|FG001|COMPLETED|Overall Study||206
10565608|NCT01627249|11721011|FG002|COMPLETED|Overall Study||206
10565609|NCT01627249|11721009|FG000|NOT COMPLETED|Overall Study||16
10565610|NCT01627249|11721010|FG001|NOT COMPLETED|Overall Study||12
10565611|NCT01627249|11721011|FG002|NOT COMPLETED|Overall Study||12
10565612|NCT01627288|11721023|FG000|STARTED|Overall Study||3
10565613|NCT01627288|11721024|FG001|STARTED|Overall Study||3
10565614|NCT01627288|11721025|FG002|STARTED|Overall Study||6
10565615|NCT01627288|11721026|FG003|STARTED|Overall Study||0
10565616|NCT01627288|11721023|FG000|COMPLETED|Overall Study||3
10565617|NCT01627288|11721024|FG001|COMPLETED|Overall Study||3
10565618|NCT01627288|11721025|FG002|COMPLETED|Overall Study||6
10565619|NCT01627288|11721026|FG003|COMPLETED|Overall Study||0
10565620|NCT01627288|11721023|FG000|NOT COMPLETED|Overall Study||0
10565621|NCT01627288|11721024|FG001|NOT COMPLETED|Overall Study||0
10565622|NCT01627288|11721025|FG002|NOT COMPLETED|Overall Study||0
10565623|NCT01627288|11721026|FG003|NOT COMPLETED|Overall Study||0
10565624|NCT01627327|11721040|FG000|STARTED|Overall Study||310
10565625|NCT01627327|11721041|FG001|STARTED|Overall Study||313
10565626|NCT01627327|11721040|FG000|COMPLETED|Overall Study||291
10565627|NCT01627327|11721041|FG001|COMPLETED|Overall Study||274
10565628|NCT01627327|11721040|FG000|NOT COMPLETED|Overall Study||19
10565629|NCT01627327|11721041|FG001|NOT COMPLETED|Overall Study||39
10565630|NCT01627340|11721049|FG000|STARTED|Overall Study||416
10565631|NCT01627340|11721050|FG001|STARTED|Overall Study||258
10565632|NCT01627340|11721049|FG000|COMPLETED|Overall Study||404
10565633|NCT01627340|11721050|FG001|COMPLETED|Overall Study||254
10565634|NCT01627340|11721049|FG000|NOT COMPLETED|Overall Study||12
10565635|NCT01627340|11721050|FG001|NOT COMPLETED|Overall Study||4
10565636|NCT01627691|11721058|FG000|STARTED|Overall Study||250
10565637|NCT01627691|11721058|FG000|Primary Endpoint (30days)|Overall Study||239
10565638|NCT01627691|11721058|FG000|COMPLETED|Overall Study||232
10565639|NCT01627691|11721058|FG000|NOT COMPLETED|Overall Study||18
10565640|NCT01627782|11721066|FG000|STARTED|Overall Study||17
10793237|NCT03599986|11954024|FG000|COMPLETED|Overall Study||366
10793238|NCT03599986|11954024|FG000|NOT COMPLETED|Overall Study||32
10565641|NCT01627782|11721067|FG001|STARTED|Overall Study||18
10565642|NCT01627782|11721068|FG002|STARTED|Overall Study||16
10565643|NCT01627782|11721069|FG003|STARTED|Overall Study||17
10565644|NCT01627782|11721066|FG000|Treated|Overall Study||16
10565645|NCT01627782|11721067|FG001|Treated|Overall Study||18
10793239|NCT03600194|11954029|FG000|STARTED|Screening||38
10565646|NCT01627782|11721068|FG002|Treated|Overall Study||16
10565647|NCT01627782|11721069|FG003|Treated|Overall Study||17
10565648|NCT01627782|11721066|FG000|COMPLETED|Overall Study||1
10565649|NCT01627782|11721067|FG001|COMPLETED|Overall Study||12
10793240|NCT03600194|11954030|FG001|STARTED|Screening||0
10793241|NCT03600194|11954031|FG002|STARTED|Screening||0
10565650|NCT01627782|11721068|FG002|COMPLETED|Overall Study||1
10565651|NCT01627782|11721069|FG003|COMPLETED|Overall Study||11
10565652|NCT01627782|11721066|FG000|NOT COMPLETED|Overall Study||16
10565653|NCT01627782|11721067|FG001|NOT COMPLETED|Overall Study||6
10565654|NCT01627782|11721068|FG002|NOT COMPLETED|Overall Study||15
10565655|NCT01627782|11721069|FG003|NOT COMPLETED|Overall Study||6
10565656|NCT01627860|11721083|FG000|STARTED|Overall Study||35
10565657|NCT01627860|11721084|FG001|STARTED|Overall Study||20
10565658|NCT01627860|11721083|FG000|COMPLETED|Overall Study||23
10793242|NCT03600194|11954029|FG000|COMPLETED|Screening||11
10565659|NCT01627860|11721084|FG001|COMPLETED|Overall Study||14
10565660|NCT01627860|11721083|FG000|NOT COMPLETED|Overall Study||12
10565661|NCT01627860|11721084|FG001|NOT COMPLETED|Overall Study||6
10565662|NCT01628016|11721093|FG000|STARTED|Pretraining to Posttraining||27
10565663|NCT01628016|11721094|FG001|STARTED|Pretraining to Posttraining||27
10565664|NCT01628016|11721095|FG002|STARTED|Pretraining to Posttraining||23
10565665|NCT01628016|11721093|FG000|COMPLETED|Pretraining to Posttraining||27
10565666|NCT01628016|11721094|FG001|COMPLETED|Pretraining to Posttraining||27
10565667|NCT01628016|11721095|FG002|COMPLETED|Pretraining to Posttraining||23
10565668|NCT01628016|11721093|FG000|NOT COMPLETED|Pretraining to Posttraining||0
10565669|NCT01628016|11721094|FG001|NOT COMPLETED|Pretraining to Posttraining||0
10565670|NCT01628016|11721095|FG002|NOT COMPLETED|Pretraining to Posttraining||0
10565671|NCT01628016|11721093|FG000|STARTED|Posttraining to 5 Follow-ups||27
10565672|NCT01628016|11721094|FG001|STARTED|Posttraining to 5 Follow-ups||27
10565673|NCT01628016|11721095|FG002|STARTED|Posttraining to 5 Follow-ups||23
10565674|NCT01628016|11721093|FG000|COMPLETED|Posttraining to 5 Follow-ups||23
10565675|NCT01628016|11721094|FG001|COMPLETED|Posttraining to 5 Follow-ups||20
10565676|NCT01628016|11721095|FG002|COMPLETED|Posttraining to 5 Follow-ups||18
10565677|NCT01628016|11721093|FG000|NOT COMPLETED|Posttraining to 5 Follow-ups||4
10565678|NCT01628016|11721094|FG001|NOT COMPLETED|Posttraining to 5 Follow-ups||7
10565679|NCT01628016|11721095|FG002|NOT COMPLETED|Posttraining to 5 Follow-ups||5
10565680|NCT01628042|11721109|FG000|STARTED|Overall Study||8
10565681|NCT01628042|11721110|FG001|STARTED|Overall Study||8
10565682|NCT01628042|11721111|FG002|STARTED|Overall Study||8
10565683|NCT01628042|11721112|FG003|STARTED|Overall Study||8
10565684|NCT01628042|11721109|FG000|COMPLETED|Overall Study||8
10565685|NCT01628042|11721110|FG001|COMPLETED|Overall Study||8
10565686|NCT01628042|11721111|FG002|COMPLETED|Overall Study||8
10565687|NCT01628042|11721112|FG003|COMPLETED|Overall Study||8
10565688|NCT01628042|11721109|FG000|NOT COMPLETED|Overall Study||0
10565689|NCT01628042|11721110|FG001|NOT COMPLETED|Overall Study||0
10565690|NCT01628042|11721111|FG002|NOT COMPLETED|Overall Study||0
10565691|NCT01628042|11721112|FG003|NOT COMPLETED|Overall Study||0
10565692|NCT01628107|11721122|FG000|STARTED|Overall Study||414
10565693|NCT01628107|11721122|FG000|Treated|Overall Study||406
10565694|NCT01628107|11721122|FG000|COMPLETED|Overall Study||295
10565695|NCT01628107|11721122|FG000|NOT COMPLETED|Overall Study||119
10565696|NCT01628120|11721126|FG000|STARTED|Overall Study||173
10565697|NCT01628120|11721126|FG000|Treated|Overall Study||170
10565698|NCT01628120|11721126|FG000|COMPLETED|Overall Study||129
10565699|NCT01628120|11721126|FG000|NOT COMPLETED|Overall Study||44
10565700|NCT01628159|11721130|FG000|STARTED|Overall Study||657
10565701|NCT01628159|11721130|FG000|COMPLETED|Overall Study||493
10565702|NCT01628159|11721130|FG000|NOT COMPLETED|Overall Study||164
10565703|NCT01628198|11721134|FG000|STARTED|Overall Study||38
10565704|NCT01628198|11721134|FG000|COMPLETED|Overall Study||20
10565705|NCT01628198|11721134|FG000|NOT COMPLETED|Overall Study||18
10565706|NCT01628250|11721140|FG000|STARTED|Overall Study||49
10565707|NCT01628250|11721141|FG001|STARTED|Overall Study||50
10565708|NCT01628250|11721140|FG000|COMPLETED|Overall Study||49
10565709|NCT01628250|11721141|FG001|COMPLETED|Overall Study||50
10565710|NCT01628250|11721140|FG000|NOT COMPLETED|Overall Study||0
10565711|NCT01628250|11721141|FG001|NOT COMPLETED|Overall Study||0
10565712|NCT01628367|11721149|FG000|STARTED|Overall Study||16
10565713|NCT01628367|11721150|FG001|STARTED|Overall Study||16
10565714|NCT01628367|11721149|FG000|COMPLETED|Overall Study||15
10565715|NCT01628367|11721150|FG001|COMPLETED|Overall Study||16
10565716|NCT01628367|11721149|FG000|NOT COMPLETED|Overall Study||1
10565717|NCT01628367|11721150|FG001|NOT COMPLETED|Overall Study||0
10565718|NCT01628393|11721159|FG000|STARTED|Placebo-controlled Treatment Period||88
10565719|NCT01628393|11721160|FG001|STARTED|Placebo-controlled Treatment Period||87
10565720|NCT01628393|11721161|FG002|STARTED|Placebo-controlled Treatment Period||83
10565721|NCT01628393|11721162|FG003|STARTED|Placebo-controlled Treatment Period||0
10565722|NCT01628393|11721163|FG004|STARTED|Placebo-controlled Treatment Period||0
10565723|NCT01628393|11721159|FG000|COMPLETED|Placebo-controlled Treatment Period||85
10565724|NCT01628393|11721160|FG001|COMPLETED|Placebo-controlled Treatment Period||85
10565725|NCT01628393|11721161|FG002|COMPLETED|Placebo-controlled Treatment Period||82
10565726|NCT01628393|11721162|FG003|COMPLETED|Placebo-controlled Treatment Period||0
10565727|NCT01628393|11721163|FG004|COMPLETED|Placebo-controlled Treatment Period||0
10565728|NCT01628393|11721159|FG000|NOT COMPLETED|Placebo-controlled Treatment Period||3
10565729|NCT01628393|11721160|FG001|NOT COMPLETED|Placebo-controlled Treatment Period||2
10565730|NCT01628393|11721161|FG002|NOT COMPLETED|Placebo-controlled Treatment Period||1
10565731|NCT01628393|11721162|FG003|NOT COMPLETED|Placebo-controlled Treatment Period||0
10565732|NCT01628393|11721163|FG004|NOT COMPLETED|Placebo-controlled Treatment Period||0
10565733|NCT01628393|11721159|FG000|STARTED|Blinded Active Extension Period||0
10565734|NCT01628393|11721160|FG001|STARTED|Blinded Active Extension Period||85
10565735|NCT01628393|11721161|FG002|STARTED|Blinded Active Extension Period||81
10793243|NCT03600194|11954030|FG001|COMPLETED|Screening||0
10565736|NCT01628393|11721162|FG003|STARTED|Blinded Active Extension Period||41
10565737|NCT01628393|11721163|FG004|STARTED|Blinded Active Extension Period||42
10565738|NCT01628393|11721159|FG000|COMPLETED|Blinded Active Extension Period||0
10565739|NCT01628393|11721160|FG001|COMPLETED|Blinded Active Extension Period||75
10565740|NCT01628393|11721161|FG002|COMPLETED|Blinded Active Extension Period||75
10565741|NCT01628393|11721162|FG003|COMPLETED|Blinded Active Extension Period||37
10793244|NCT03600194|11954031|FG002|COMPLETED|Screening||0
10793245|NCT03600194|11954029|FG000|NOT COMPLETED|Screening||27
10793246|NCT03600194|11954030|FG001|NOT COMPLETED|Screening||0
10793247|NCT03600194|11954031|FG002|NOT COMPLETED|Screening||0
10565742|NCT01628393|11721163|FG004|COMPLETED|Blinded Active Extension Period||36
10565743|NCT01628393|11721159|FG000|NOT COMPLETED|Blinded Active Extension Period||0
10565744|NCT01628393|11721160|FG001|NOT COMPLETED|Blinded Active Extension Period||10
10565745|NCT01628393|11721161|FG002|NOT COMPLETED|Blinded Active Extension Period||6
10565746|NCT01628393|11721162|FG003|NOT COMPLETED|Blinded Active Extension Period||4
10565747|NCT01628393|11721163|FG004|NOT COMPLETED|Blinded Active Extension Period||6
10565748|NCT01628510|11721179|FG000|STARTED|Overall Study||51
10565749|NCT01628510|11721180|FG001|STARTED|Overall Study||49
10565750|NCT01628510|11721179|FG000|COMPLETED|Overall Study||48
10793248|NCT03600194|11954029|FG000|STARTED|In Lab Phase||0
10793249|NCT03600194|11954030|FG001|STARTED|In Lab Phase||5
10793250|NCT03600194|11954031|FG002|STARTED|In Lab Phase||6
10565751|NCT01628510|11721180|FG001|COMPLETED|Overall Study||44
10565752|NCT01628510|11721179|FG000|NOT COMPLETED|Overall Study||3
10565753|NCT01628510|11721180|FG001|NOT COMPLETED|Overall Study||5
10565754|NCT01628523|11721188|FG000|STARTED|Overall Study||219
10565755|NCT01628523|11721188|FG000|COMPLETED|Overall Study||219
10565756|NCT01628523|11721188|FG000|NOT COMPLETED|Overall Study||0
10565757|NCT01628549|11721197|FG000|STARTED|Overall Study||73
10565758|NCT01628549|11721198|FG001|STARTED|Overall Study||76
10565759|NCT01628549|11721199|FG002|STARTED|Overall Study||70
10565760|NCT01628549|11721200|FG003|STARTED|Overall Study||66
10565761|NCT01628549|11721197|FG000|COMPLETED|Overall Study||64
10565762|NCT01628549|11721198|FG001|COMPLETED|Overall Study||64
10565763|NCT01628549|11721199|FG002|COMPLETED|Overall Study||60
10565764|NCT01628549|11721200|FG003|COMPLETED|Overall Study||57
10565765|NCT01628549|11721197|FG000|NOT COMPLETED|Overall Study||9
10565766|NCT01628549|11721198|FG001|NOT COMPLETED|Overall Study||12
10565767|NCT01628549|11721199|FG002|NOT COMPLETED|Overall Study||10
10565768|NCT01628549|11721200|FG003|NOT COMPLETED|Overall Study||9
10565769|NCT01628588|11721210|FG000|STARTED|Overall Study||854
10565770|NCT01628588|11721210|FG000|COMPLETED|Overall Study||838
10565771|NCT01628588|11721210|FG000|NOT COMPLETED|Overall Study||16
10565772|NCT01628601|11721214|FG000|STARTED|Overall Study||392
10565773|NCT01628601|11721214|FG000|COMPLETED|Overall Study||351
10565774|NCT01628601|11721214|FG000|NOT COMPLETED|Overall Study||41
10565775|NCT01628614|11721218|FG000|STARTED|Overall Study||4812
10565776|NCT01628614|11721218|FG000|COMPLETED|Overall Study||3037
10565777|NCT01628614|11721218|FG000|NOT COMPLETED|Overall Study||1775
10565778|NCT01628692|11721228|FG000|STARTED|Overall Study||53
10565779|NCT01628692|11721229|FG001|STARTED|Overall Study||23
10565780|NCT01628692|11721230|FG002|STARTED|Overall Study||51
10565781|NCT01628692|11721231|FG003|STARTED|Overall Study||20
10565782|NCT01628692|11721232|FG004|STARTED|Overall Study||12
10565783|NCT01628692|11721233|FG005|STARTED|Overall Study||9
10565784|NCT01628692|11721228|FG000|COMPLETED|Overall Study||46
10565785|NCT01628692|11721229|FG001|COMPLETED|Overall Study||17
10565786|NCT01628692|11721230|FG002|COMPLETED|Overall Study||43
10565787|NCT01628692|11721231|FG003|COMPLETED|Overall Study||19
10565788|NCT01628692|11721232|FG004|COMPLETED|Overall Study||8
10565789|NCT01628692|11721233|FG005|COMPLETED|Overall Study||0
10565790|NCT01628692|11721228|FG000|NOT COMPLETED|Overall Study||7
10565791|NCT01628692|11721229|FG001|NOT COMPLETED|Overall Study||6
10565792|NCT01628692|11721230|FG002|NOT COMPLETED|Overall Study||8
10565793|NCT01628692|11721231|FG003|NOT COMPLETED|Overall Study||1
10565794|NCT01628692|11721232|FG004|NOT COMPLETED|Overall Study||4
10565795|NCT01628692|11721233|FG005|NOT COMPLETED|Overall Study||9
10565796|NCT01628718|11721252|FG000|STARTED|Overall Study||60
10565797|NCT01628718|11721253|FG001|STARTED|Overall Study||62
10565798|NCT01628718|11721252|FG000|COMPLETED|Overall Study||33
10565799|NCT01628718|11721253|FG001|COMPLETED|Overall Study||37
10565800|NCT01628718|11721252|FG000|NOT COMPLETED|Overall Study||27
10565801|NCT01628718|11721253|FG001|NOT COMPLETED|Overall Study||25
10793251|NCT03600194|11954029|FG000|COMPLETED|In Lab Phase||0
10793252|NCT03600194|11954030|FG001|COMPLETED|In Lab Phase||5
10793253|NCT03600194|11954031|FG002|COMPLETED|In Lab Phase||6
10565802|NCT01628848|11721261|FG000|STARTED|Overall Study||87
10565803|NCT01628848|11721262|FG001|STARTED|Overall Study||87
10565804|NCT01628848|11721261|FG000|COMPLETED|Overall Study||75
10565805|NCT01628848|11721262|FG001|COMPLETED|Overall Study||73
10565806|NCT01628848|11721261|FG000|NOT COMPLETED|Overall Study||12
10565807|NCT01628848|11721262|FG001|NOT COMPLETED|Overall Study||14
10565808|NCT01628874|11721270|FG000|STARTED|Overall Study||34
10565809|NCT01628874|11721271|FG001|STARTED|Overall Study||32
10565810|NCT01628874|11721270|FG000|COMPLETED|Overall Study||29
10565811|NCT01628874|11721271|FG001|COMPLETED|Overall Study||29
10565812|NCT01628874|11721270|FG000|NOT COMPLETED|Overall Study||5
10565813|NCT01628874|11721271|FG001|NOT COMPLETED|Overall Study||3
10793254|NCT03600194|11954029|FG000|NOT COMPLETED|In Lab Phase||0
10565814|NCT01628913|11721279|FG000|STARTED|Overall Study||31
10565815|NCT01628913|11721280|FG001|STARTED|Overall Study||31
10793255|NCT03600194|11954030|FG001|NOT COMPLETED|In Lab Phase||0
10793256|NCT03600194|11954031|FG002|NOT COMPLETED|In Lab Phase||0
10793257|NCT03600376|11954044|FG000|STARTED|Overall Study||9
10565816|NCT01628913|11721279|FG000|COMPLETED|Overall Study||0
10565817|NCT01628913|11721280|FG001|COMPLETED|Overall Study||0
10565818|NCT01628913|11721279|FG000|NOT COMPLETED|Overall Study||31
10565819|NCT01628913|11721280|FG001|NOT COMPLETED|Overall Study||31
10793258|NCT03600376|11954045|FG001|STARTED|Overall Study||8
10565820|NCT01628926|11721289|FG000|STARTED|Overall Study||168
10565821|NCT01628926|11721290|FG001|STARTED|Overall Study||167
10565822|NCT01628926|11721291|FG002|STARTED|Overall Study||85
10565823|NCT01628926|11721289|FG000|COMPLETED|Overall Study||142
10565824|NCT01628926|11721290|FG001|COMPLETED|Overall Study||144
10565825|NCT01628926|11721291|FG002|COMPLETED|Overall Study||68
10565826|NCT01628926|11721289|FG000|NOT COMPLETED|Overall Study||26
10565827|NCT01628926|11721290|FG001|NOT COMPLETED|Overall Study||23
10565828|NCT01628926|11721291|FG002|NOT COMPLETED|Overall Study||17
10565829|NCT01628965|11721300|FG000|STARTED|Overall Study||143
10565830|NCT01628965|11721300|FG000|COMPLETED|Overall Study||94
10565831|NCT01628965|11721300|FG000|NOT COMPLETED|Overall Study||49
10565832|NCT01629134|11721304|FG000|STARTED|Overall Study||62
10565833|NCT01629134|11721304|FG000|COMPLETED|Overall Study||62
10565834|NCT01629134|11721304|FG000|NOT COMPLETED|Overall Study||0
10565835|NCT01629290|11721308|FG000|STARTED|Overall Study||15
10565836|NCT01629290|11721308|FG000|COMPLETED|Overall Study||15
10565837|NCT01629290|11721308|FG000|NOT COMPLETED|Overall Study||0
10565838|NCT01629381|11721320|FG000|STARTED|Overall Study||122
10565839|NCT01629381|11721321|FG001|STARTED|Overall Study||119
10565840|NCT01629381|11721320|FG000|COMPLETED|Overall Study||120
10565841|NCT01629381|11721321|FG001|COMPLETED|Overall Study||114
10565842|NCT01629381|11721320|FG000|NOT COMPLETED|Overall Study||2
10565843|NCT01629381|11721321|FG001|NOT COMPLETED|Overall Study||5
10565844|NCT01629563|11721333|FG000|STARTED|Overall Study||228
10565845|NCT01629563|11721334|FG001|STARTED|Overall Study|2 subjects randomised to 10mg received 5mg treatment in error (FAS 1: 10mg, Safety Set: 5mg)|223
10565846|NCT01629563|11721333|FG000|Safety Population|Overall Study||230
10565847|NCT01629563|11721334|FG001|Safety Population|Overall Study||221
10565848|NCT01629563|11721333|FG000|Started Treatment Course 2|Overall Study||213
10565849|NCT01629563|11721334|FG001|Started Treatment Course 2|Overall Study||207
10565850|NCT01629563|11721333|FG000|Started Treatment Course 3|Overall Study||191
10565851|NCT01629563|11721334|FG001|Started Treatment Course 3|Overall Study||190
10565852|NCT01629563|11721333|FG000|Started Treatment Course 4|Overall Study||178
10565853|NCT01629563|11721334|FG001|Started Treatment Course 4|Overall Study||176
10565854|NCT01629563|11721333|FG000|COMPLETED|Overall Study||167
10565855|NCT01629563|11721334|FG001|COMPLETED|Overall Study||170
10565856|NCT01629563|11721333|FG000|NOT COMPLETED|Overall Study||61
10565857|NCT01629563|11721334|FG001|NOT COMPLETED|Overall Study||53
10565858|NCT01629589|11721342|FG000|STARTED|Overall Study||212
10565859|NCT01629589|11721343|FG001|STARTED|Overall Study||211
10565860|NCT01629589|11721342|FG000|COMPLETED|Overall Study|A participant received the Boostrix vaccine. Study data reported for the Boostrix vaccine group.|204
10565861|NCT01629589|11721343|FG001|COMPLETED|Overall Study||204
10565862|NCT01629589|11721342|FG000|NOT COMPLETED|Overall Study||8
10565863|NCT01629589|11721343|FG001|NOT COMPLETED|Overall Study||7
10565864|NCT01629615|11721349|FG000|STARTED|Overall Study||50
10565865|NCT01629615|11721349|FG000|COMPLETED|Overall Study||50
10565866|NCT01629615|11721349|FG000|NOT COMPLETED|Overall Study||0
10565867|NCT01629667|11721356|FG000|STARTED|Overall Study||59
10565868|NCT01629667|11721357|FG001|STARTED|Overall Study||58
10565869|NCT01629667|11721358|FG002|STARTED|Overall Study||59
10565870|NCT01629667|11721356|FG000|Randomized and Treated|Overall Study||57
10565871|NCT01629667|11721357|FG001|Randomized and Treated|Overall Study||57
10565872|NCT01629667|11721358|FG002|Randomized and Treated|Overall Study||59
10565873|NCT01629667|11721356|FG000|COMPLETED|Overall Study||12
10565874|NCT01629667|11721357|FG001|COMPLETED|Overall Study||17
10565875|NCT01629667|11721358|FG002|COMPLETED|Overall Study||14
10565876|NCT01629667|11721356|FG000|NOT COMPLETED|Overall Study||47
10565877|NCT01629667|11721357|FG001|NOT COMPLETED|Overall Study||41
10565878|NCT01629667|11721358|FG002|NOT COMPLETED|Overall Study||45
10565879|NCT01629693|11721370|FG000|STARTED|Overall Study||193
10565880|NCT01629693|11721371|FG001|STARTED|Overall Study||188
10565881|NCT01629693|11721370|FG000|COMPLETED|Overall Study||188
10565882|NCT01629693|11721371|FG001|COMPLETED|Overall Study||178
10565883|NCT01629693|11721370|FG000|NOT COMPLETED|Overall Study||5
10565884|NCT01629693|11721371|FG001|NOT COMPLETED|Overall Study||10
10565885|NCT01629706|11721377|FG000|STARTED|Phase 1 PureVision||44
10565886|NCT01629706|11721377|FG000|COMPLETED|Phase 1 PureVision||35
10565887|NCT01629706|11721377|FG000|NOT COMPLETED|Phase 1 PureVision||9
10565888|NCT01629706|11721377|FG000|STARTED|Phase 2 Habitual|Phase 2 enrolled 48 new participants, plus 10 participants from Phase 1|58
10565889|NCT01629706|11721377|FG000|COMPLETED|Phase 2 Habitual||48
10565890|NCT01629706|11721377|FG000|NOT COMPLETED|Phase 2 Habitual||10
10565891|NCT01629771|11721387|FG000|STARTED|Overall Study||36
10565892|NCT01629771|11721388|FG001|STARTED|Overall Study||36
10565893|NCT01629771|11721387|FG000|COMPLETED|Overall Study||36
10565894|NCT01629771|11721388|FG001|COMPLETED|Overall Study||36
10565895|NCT01629771|11721387|FG000|NOT COMPLETED|Overall Study||0
10793259|NCT03600376|11954044|FG000|COMPLETED|Overall Study||7
10793260|NCT03600376|11954045|FG001|COMPLETED|Overall Study||2
10565896|NCT01629771|11721388|FG001|NOT COMPLETED|Overall Study||0
10565897|NCT01629784|11721394|FG000|STARTED|Overall Study||31
10565898|NCT01629784|11721394|FG000|COMPLETED|Overall Study||25
10565899|NCT01629784|11721394|FG000|NOT COMPLETED|Overall Study||6
10793261|NCT03600376|11954044|FG000|NOT COMPLETED|Overall Study||2
10565900|NCT01629797|11721401|FG000|STARTED|Overall Study||100
10565901|NCT01629797|11721401|FG000|COMPLETED|Overall Study||82
10565902|NCT01629797|11721401|FG000|NOT COMPLETED|Overall Study||18
10565903|NCT01629823|11721411|FG000|STARTED|Trial Period||66
10565904|NCT01629823|11721412|FG001|STARTED|Trial Period||69
10793262|NCT03600376|11954045|FG001|NOT COMPLETED|Overall Study||6
10793263|NCT03600428|11954053|FG000|STARTED|Overall Study||79
10793264|NCT03600428|11954054|FG001|STARTED|Overall Study||73
10565905|NCT01629823|11721413|FG002|STARTED|Trial Period||59
10565906|NCT01629823|11721411|FG000|COMPLETED|Trial Period||53
10565907|NCT01629823|11721412|FG001|COMPLETED|Trial Period||56
10565908|NCT01629823|11721413|FG002|COMPLETED|Trial Period||49
10565909|NCT01629823|11721411|FG000|NOT COMPLETED|Trial Period||13
10565910|NCT01629823|11721412|FG001|NOT COMPLETED|Trial Period||13
10565911|NCT01629823|11721413|FG002|NOT COMPLETED|Trial Period||10
10565912|NCT01629823|11721411|FG000|STARTED|Washout Period||54
10565913|NCT01629823|11721412|FG001|STARTED|Washout Period||57
10565914|NCT01629823|11721413|FG002|STARTED|Washout Period||50
10565915|NCT01629823|11721411|FG000|COMPLETED|Washout Period||51
10565916|NCT01629823|11721412|FG001|COMPLETED|Washout Period||51
10565917|NCT01629823|11721413|FG002|COMPLETED|Washout Period||50
10565918|NCT01629823|11721411|FG000|NOT COMPLETED|Washout Period||3
10565919|NCT01629823|11721412|FG001|NOT COMPLETED|Washout Period||6
10565920|NCT01629823|11721413|FG002|NOT COMPLETED|Washout Period||0
10565921|NCT01629862|11721423|FG000|STARTED|Overall Study||28
10565922|NCT01629862|11721424|FG001|STARTED|Overall Study||25
10565923|NCT01629862|11721423|FG000|COMPLETED|Overall Study||26
10565924|NCT01629862|11721424|FG001|COMPLETED|Overall Study||23
10565925|NCT01629862|11721423|FG000|NOT COMPLETED|Overall Study||2
10565926|NCT01629862|11721424|FG001|NOT COMPLETED|Overall Study||2
10565927|NCT01629953|11721432|FG000|STARTED|Overall Study||65
10565928|NCT01629953|11721433|FG001|STARTED|Overall Study||75
10565929|NCT01629953|11721432|FG000|COMPLETED|Overall Study||52
10565930|NCT01629953|11721433|FG001|COMPLETED|Overall Study||60
10565931|NCT01629953|11721432|FG000|NOT COMPLETED|Overall Study||13
10565932|NCT01629953|11721433|FG001|NOT COMPLETED|Overall Study||15
10565933|NCT01629966|11721442|FG000|STARTED|Overall Study||221
10565934|NCT01629966|11721443|FG001|STARTED|Overall Study||227
10565935|NCT01629966|11721444|FG002|STARTED|Overall Study||225
10565936|NCT01629966|11721442|FG000|COMPLETED|Overall Study||180
10565937|NCT01629966|11721443|FG001|COMPLETED|Overall Study||175
10565938|NCT01629966|11721444|FG002|COMPLETED|Overall Study||159
10565939|NCT01629966|11721442|FG000|NOT COMPLETED|Overall Study||41
10565940|NCT01629966|11721443|FG001|NOT COMPLETED|Overall Study||52
10565941|NCT01629966|11721444|FG002|NOT COMPLETED|Overall Study||66
10565942|NCT01630109|11721455|FG000|STARTED|Overall Study||1
10565943|NCT01630109|11721456|FG001|STARTED|Overall Study||1
10565944|NCT01630109|11721457|FG002|STARTED|Overall Study||3
10565945|NCT01630109|11721455|FG000|COMPLETED|Overall Study||1
10565946|NCT01630109|11721456|FG001|COMPLETED|Overall Study||1
10565947|NCT01630109|11721457|FG002|COMPLETED|Overall Study||3
10565948|NCT01630109|11721455|FG000|NOT COMPLETED|Overall Study||0
10565949|NCT01630109|11721456|FG001|NOT COMPLETED|Overall Study||0
10565950|NCT01630109|11721457|FG002|NOT COMPLETED|Overall Study||0
10565951|NCT01630135|11721473|FG000|STARTED|Overall Study||131
10565952|NCT01630135|11721474|FG001|STARTED|Overall Study||130
10565953|NCT01630135|11721473|FG000|COMPLETED|Overall Study||131
10565954|NCT01630135|11721474|FG001|COMPLETED|Overall Study||128
10565955|NCT01630135|11721473|FG000|NOT COMPLETED|Overall Study||0
10565956|NCT01630135|11721474|FG001|NOT COMPLETED|Overall Study||2
10565957|NCT01630200|11721482|FG000|STARTED|Overall Study||40
10565958|NCT01630200|11721483|FG001|STARTED|Overall Study||40
10565959|NCT01630200|11721482|FG000|COMPLETED|Overall Study||33
10565960|NCT01630200|11721483|FG001|COMPLETED|Overall Study||34
10565961|NCT01630200|11721482|FG000|NOT COMPLETED|Overall Study||7
10565962|NCT01630200|11721483|FG001|NOT COMPLETED|Overall Study||6
10565963|NCT01630616|11721495|FG000|STARTED|Overall Study||5
10565964|NCT01630616|11721496|FG001|STARTED|Overall Study||3
10565965|NCT01630616|11721497|FG002|STARTED|Overall Study||3
10565966|NCT01630616|11721498|FG003|STARTED|Overall Study||12
10565967|NCT01630616|11721499|FG004|STARTED|Overall Study||6
10565968|NCT01630616|11721500|FG005|STARTED|Overall Study||2
10565969|NCT01630616|11721495|FG000|COMPLETED|Overall Study||5
10565970|NCT01630616|11721496|FG001|COMPLETED|Overall Study||3
10565971|NCT01630616|11721497|FG002|COMPLETED|Overall Study||3
10565972|NCT01630616|11721498|FG003|COMPLETED|Overall Study||9
10565973|NCT01630616|11721499|FG004|COMPLETED|Overall Study||6
10565974|NCT01630616|11721500|FG005|COMPLETED|Overall Study||2
10565975|NCT01630616|11721495|FG000|NOT COMPLETED|Overall Study||0
10793265|NCT03600428|11954053|FG000|15-day Follow-up|Overall Study||76
10565976|NCT01630616|11721496|FG001|NOT COMPLETED|Overall Study||0
10565977|NCT01630616|11721497|FG002|NOT COMPLETED|Overall Study||0
10565978|NCT01630616|11721498|FG003|NOT COMPLETED|Overall Study||3
10565979|NCT01630616|11721499|FG004|NOT COMPLETED|Overall Study||0
10565980|NCT01630616|11721500|FG005|NOT COMPLETED|Overall Study||0
10565981|NCT01630694|11721519|FG000|STARTED|Overall Study||12
10565982|NCT01630694|11721520|FG001|STARTED|Overall Study||16
10565983|NCT01630694|11721519|FG000|COMPLETED|Overall Study||12
10565984|NCT01630694|11721520|FG001|COMPLETED|Overall Study||16
10565985|NCT01630694|11721519|FG000|NOT COMPLETED|Overall Study||0
10565986|NCT01630694|11721520|FG001|NOT COMPLETED|Overall Study||0
10565987|NCT01630811|11721526|FG000|STARTED|First Intervention (8 Weeks)||7
10565988|NCT01630811|11721527|FG001|STARTED|First Intervention (8 Weeks)||6
10565989|NCT01630811|11721526|FG000|COMPLETED|First Intervention (8 Weeks)||7
10565990|NCT01630811|11721527|FG001|COMPLETED|First Intervention (8 Weeks)||6
10565991|NCT01630811|11721526|FG000|NOT COMPLETED|First Intervention (8 Weeks)||0
10565992|NCT01630811|11721527|FG001|NOT COMPLETED|First Intervention (8 Weeks)||0
10565993|NCT01630811|11721526|FG000|STARTED|Washout (4 Weeks)||7
10793266|NCT03600428|11954054|FG001|15-day Follow-up|Overall Study||70
10565994|NCT01630811|11721527|FG001|STARTED|Washout (4 Weeks)||6
10565995|NCT01630811|11721526|FG000|COMPLETED|Washout (4 Weeks)||7
10565996|NCT01630811|11721527|FG001|COMPLETED|Washout (4 Weeks)||6
10565997|NCT01630811|11721526|FG000|NOT COMPLETED|Washout (4 Weeks)||0
10565998|NCT01630811|11721527|FG001|NOT COMPLETED|Washout (4 Weeks)||0
10565999|NCT01630811|11721526|FG000|STARTED|Second Intervention (8 Weeks)||7
10566000|NCT01630811|11721527|FG001|STARTED|Second Intervention (8 Weeks)||6
10566001|NCT01630811|11721526|FG000|COMPLETED|Second Intervention (8 Weeks)||6
10566002|NCT01630811|11721527|FG001|COMPLETED|Second Intervention (8 Weeks)||6
10566003|NCT01630811|11721526|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||1
10566004|NCT01630811|11721527|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0
10566005|NCT01630811|11721526|FG000|STARTED|Second Washout (4 Weeks)||6
10566006|NCT01630811|11721527|FG001|STARTED|Second Washout (4 Weeks)||6
10566007|NCT01630811|11721526|FG000|COMPLETED|Second Washout (4 Weeks)||6
10566008|NCT01630811|11721527|FG001|COMPLETED|Second Washout (4 Weeks)||6
10566009|NCT01630811|11721526|FG000|NOT COMPLETED|Second Washout (4 Weeks)||0
10566010|NCT01630811|11721527|FG001|NOT COMPLETED|Second Washout (4 Weeks)||0
10566011|NCT01630889|11721535|FG000|STARTED|Overall Study||15
10566012|NCT01630889|11721535|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
10566013|NCT01630889|11721535|FG000|COMPLETED|Overall Study||5
10566014|NCT01630889|11721535|FG000|NOT COMPLETED|Overall Study||10
10566015|NCT01631071|11721541|FG000|STARTED|Overall Study||55
10566016|NCT01631071|11721542|FG001|STARTED|Overall Study||55
10566017|NCT01631071|11721541|FG000|COMPLETED|Overall Study||55
10566018|NCT01631071|11721542|FG001|COMPLETED|Overall Study||55
10566019|NCT01631071|11721541|FG000|NOT COMPLETED|Overall Study||0
10566020|NCT01631071|11721542|FG001|NOT COMPLETED|Overall Study||0
10566021|NCT01631110|11721550|FG000|STARTED|Overall Study||55
10566022|NCT01631110|11721551|FG001|STARTED|Overall Study||55
10566023|NCT01631110|11721550|FG000|COMPLETED|Overall Study||55
10566024|NCT01631110|11721551|FG001|COMPLETED|Overall Study||55
10566025|NCT01631110|11721550|FG000|NOT COMPLETED|Overall Study||0
10566026|NCT01631110|11721551|FG001|NOT COMPLETED|Overall Study||0
10566027|NCT01631149|11721559|FG000|STARTED|Overall Study||12
10566028|NCT01631149|11721560|FG001|STARTED|Overall Study||12
10566029|NCT01631149|11721559|FG000|COMPLETED|Overall Study||12
10566030|NCT01631149|11721560|FG001|COMPLETED|Overall Study||12
10566031|NCT01631149|11721559|FG000|NOT COMPLETED|Overall Study||0
10566032|NCT01631149|11721560|FG001|NOT COMPLETED|Overall Study||0
10566033|NCT01631188|11721566|FG000|STARTED|Overall Study||100
10566034|NCT01631188|11721566|FG000|COMPLETED|Overall Study||25
10566035|NCT01631188|11721566|FG000|NOT COMPLETED|Overall Study||75
10566036|NCT01631214|11721572|FG000|STARTED|Overall Study||2047
10566037|NCT01631214|11721573|FG001|STARTED|Overall Study||2046
10566038|NCT01631214|11721572|FG000|Received Double-blind Treatment|Overall Study||2040
10566039|NCT01631214|11721573|FG001|Received Double-blind Treatment|Overall Study||2038
10566040|NCT01631214|11721572|FG000|Completed Double-blind Period|Overall Study||1823
10566041|NCT01631214|11721573|FG001|Completed Double-blind Period|Overall Study||1831
10566042|NCT01631214|11721572|FG000|Completed Primary Analysis Period|Overall Study||1576
10566043|NCT01631214|11721573|FG001|Completed Primary Analysis Period|Overall Study||1574
10566044|NCT01631214|11721572|FG000|COMPLETED|Overall Study||1503
10566045|NCT01631214|11721573|FG001|COMPLETED|Overall Study||1523
10566046|NCT01631214|11721572|FG000|NOT COMPLETED|Overall Study||544
10566047|NCT01631214|11721573|FG001|NOT COMPLETED|Overall Study||523
10566048|NCT01631227|11721583|FG000|STARTED|Overall Study||333
10566049|NCT01631227|11721584|FG001|STARTED|Overall Study||332
10566050|NCT01631227|11721583|FG000|Safety Subject Sample|Overall Study|1 patient was randomized by mistake and never received study medication.|332
10566051|NCT01631227|11721584|FG001|Safety Subject Sample|Overall Study||332
10566052|NCT01631227|11721583|FG000|Full Analysis Set Population|Overall Study|2 patients not eligible for the Full Analysis Set due to missing post-baseline efficacy measurement|330
10566053|NCT01631227|11721584|FG001|Full Analysis Set Population|Overall Study|1 patient not eligible for the Full Analysis Set due to missing post-baseline efficacy measurement|331
10566054|NCT01631227|11721583|FG000|COMPLETED|Overall Study||303
10566055|NCT01631227|11721584|FG001|COMPLETED|Overall Study||310
10566056|NCT01631227|11721583|FG000|NOT COMPLETED|Overall Study||30
10566057|NCT01631227|11721584|FG001|NOT COMPLETED|Overall Study||22
10566058|NCT01631331|11721590|FG000|STARTED|Overall Study||15
10566059|NCT01631331|11721590|FG000|COMPLETED|Overall Study||11
10566060|NCT01631331|11721590|FG000|NOT COMPLETED|Overall Study||4
10566061|NCT01631435|11721595|FG000|STARTED|Overall Study||75
10566062|NCT01631435|11721595|FG000|COMPLETED|Overall Study||66
10566063|NCT01631435|11721595|FG000|NOT COMPLETED|Overall Study||9
10566064|NCT01631474|11721605|FG000|STARTED|Overall Study||72
10566065|NCT01631474|11721606|FG001|STARTED|Overall Study||76
10566066|NCT01631474|11721607|FG002|STARTED|Overall Study||70
10566067|NCT01631474|11721608|FG003|STARTED|Overall Study||70
10566068|NCT01631474|11721609|FG004|STARTED|Overall Study||75
10566069|NCT01631474|11721605|FG000|COMPLETED|Overall Study||58
10566070|NCT01631474|11721606|FG001|COMPLETED|Overall Study||64
10566071|NCT01631474|11721607|FG002|COMPLETED|Overall Study||61
10566072|NCT01631474|11721608|FG003|COMPLETED|Overall Study||59
10566073|NCT01631474|11721609|FG004|COMPLETED|Overall Study||62
10566074|NCT01631474|11721605|FG000|NOT COMPLETED|Overall Study||14
10566075|NCT01631474|11721606|FG001|NOT COMPLETED|Overall Study||12
10566076|NCT01631474|11721607|FG002|NOT COMPLETED|Overall Study||9
10566077|NCT01631474|11721608|FG003|NOT COMPLETED|Overall Study||11
10566078|NCT01631474|11721609|FG004|NOT COMPLETED|Overall Study||13
10566079|NCT01631552|11721625|FG000|STARTED|Overall Study||83
10566080|NCT01631552|11721626|FG001|STARTED|Overall Study||420
10566081|NCT01631552|11721627|FG002|STARTED|Overall Study||9
10566082|NCT01631552|11721628|FG003|STARTED|Overall Study||3
10566083|NCT01631552|11721625|FG000|Enrolled and Treated|Overall Study||81
10566084|NCT01631552|11721626|FG001|Enrolled and Treated|Overall Study||402
10566085|NCT01631552|11721627|FG002|Enrolled and Treated|Overall Study||9
10566086|NCT01631552|11721628|FG003|Enrolled and Treated|Overall Study||3
10566087|NCT01631552|11721625|FG000|COMPLETED|Overall Study||81
10566088|NCT01631552|11721626|FG001|COMPLETED|Overall Study||400
10566089|NCT01631552|11721627|FG002|COMPLETED|Overall Study||9
10566090|NCT01631552|11721628|FG003|COMPLETED|Overall Study||3
10566091|NCT01631552|11721625|FG000|NOT COMPLETED|Overall Study||2
10566092|NCT01631552|11721626|FG001|NOT COMPLETED|Overall Study||20
10566093|NCT01631552|11721627|FG002|NOT COMPLETED|Overall Study||0
10566094|NCT01631552|11721628|FG003|NOT COMPLETED|Overall Study||0
10566095|NCT01631630|11721642|FG000|STARTED|Overall Study||8
10566096|NCT01631630|11721643|FG001|STARTED|Overall Study||8
10566097|NCT01631630|11721642|FG000|COMPLETED|Overall Study||5
10566098|NCT01631630|11721643|FG001|COMPLETED|Overall Study||8
10566099|NCT01631630|11721642|FG000|NOT COMPLETED|Overall Study||3
10566100|NCT01631630|11721643|FG001|NOT COMPLETED|Overall Study||0
10566101|NCT01631656|11721651|FG000|STARTED|Overall Study||5
10566102|NCT01631656|11721652|FG001|STARTED|Overall Study||5
10566103|NCT01631656|11721651|FG000|COMPLETED|Overall Study||5
10566104|NCT01631656|11721652|FG001|COMPLETED|Overall Study||5
10566105|NCT01631656|11721651|FG000|NOT COMPLETED|Overall Study||0
10566106|NCT01631656|11721652|FG001|NOT COMPLETED|Overall Study||0
10566107|NCT01631682|11721662|FG000|STARTED|Overall Study||55
10566108|NCT01631682|11721663|FG001|STARTED|Overall Study||66
10566109|NCT01631682|11721664|FG002|STARTED|Overall Study||44
10566110|NCT01631682|11721665|FG003|STARTED|Overall Study||7
10566111|NCT01631682|11721662|FG000|COMPLETED|Overall Study||24
10566112|NCT01631682|11721663|FG001|COMPLETED|Overall Study||21
10566113|NCT01631682|11721664|FG002|COMPLETED|Overall Study||13
10566114|NCT01631682|11721665|FG003|COMPLETED|Overall Study||5
10566115|NCT01631682|11721662|FG000|NOT COMPLETED|Overall Study||31
10566116|NCT01631682|11721663|FG001|NOT COMPLETED|Overall Study||45
10566117|NCT01631682|11721664|FG002|NOT COMPLETED|Overall Study||31
10566118|NCT01631682|11721665|FG003|NOT COMPLETED|Overall Study||2
10566119|NCT01631747|11721677|FG000|STARTED|Randomization Through End of Pregnancy||141
10566120|NCT01631747|11721678|FG001|STARTED|Randomization Through End of Pregnancy||140
10566121|NCT01631747|11721677|FG000|COMPLETED|Randomization Through End of Pregnancy||140
10566122|NCT01631747|11721678|FG001|COMPLETED|Randomization Through End of Pregnancy||140
10566123|NCT01631747|11721677|FG000|NOT COMPLETED|Randomization Through End of Pregnancy||1
10566124|NCT01631747|11721678|FG001|NOT COMPLETED|Randomization Through End of Pregnancy||0
10566125|NCT01631747|11721677|FG000|STARTED|Live Birth||140
10566126|NCT01631747|11721678|FG001|STARTED|Live Birth||140
10566127|NCT01631747|11721677|FG000|COMPLETED|Live Birth||136
10566128|NCT01631747|11721678|FG001|COMPLETED|Live Birth||139
10566129|NCT01631747|11721677|FG000|NOT COMPLETED|Live Birth||4
10566130|NCT01631747|11721678|FG001|NOT COMPLETED|Live Birth||1
10566131|NCT01631747|11721677|FG000|STARTED|One Year Infant Outcomes||136
10566132|NCT01631747|11721678|FG001|STARTED|One Year Infant Outcomes||139
10566133|NCT01631747|11721677|FG000|COMPLETED|One Year Infant Outcomes||123
10566134|NCT01631747|11721678|FG001|COMPLETED|One Year Infant Outcomes||130
10566135|NCT01631747|11721677|FG000|NOT COMPLETED|One Year Infant Outcomes||13
10566136|NCT01631747|11721678|FG001|NOT COMPLETED|One Year Infant Outcomes||9
10566137|NCT01631812|11721685|FG000|STARTED|Overall Study||130
10566138|NCT01631812|11721685|FG000|COMPLETED|Overall Study||93
10566139|NCT01631812|11721685|FG000|NOT COMPLETED|Overall Study||37
10566140|NCT01631825|11721689|FG000|STARTED|Overall Study||321
10566141|NCT01631825|11721689|FG000|COMPLETED|Overall Study||256
10566142|NCT01631825|11721689|FG000|NOT COMPLETED|Overall Study||65
10566143|NCT01631864|11721695|FG000|STARTED|Overall Study||50
10566144|NCT01631864|11721696|FG001|STARTED|Overall Study||48
10566145|NCT01631864|11721695|FG000|COMPLETED|Overall Study||48
10566146|NCT01631864|11721696|FG001|COMPLETED|Overall Study||44
10566147|NCT01631864|11721695|FG000|NOT COMPLETED|Overall Study||2
10566148|NCT01631864|11721696|FG001|NOT COMPLETED|Overall Study||4
10566149|NCT01631929|11721704|FG000|STARTED|Overall Study||6
10566150|NCT01631929|11721705|FG001|STARTED|Overall Study||6
10566151|NCT01631929|11721704|FG000|COMPLETED|Overall Study||6
10566152|NCT01631929|11721705|FG001|COMPLETED|Overall Study||6
10566153|NCT01631929|11721704|FG000|NOT COMPLETED|Overall Study||0
10566154|NCT01631929|11721705|FG001|NOT COMPLETED|Overall Study||0
10566155|NCT01632150|11721711|FG000|STARTED|Overall Study||40
10566156|NCT01632150|11721711|FG000|Received Cyclophosphamide|Overall Study||11
10566157|NCT01632150|11721711|FG000|COMPLETED|Overall Study|Completed=still receiving treatment|0
10566158|NCT01632150|11721711|FG000|NOT COMPLETED|Overall Study||40
10566159|NCT01632202|11721720|FG000|STARTED|Overall Study||1
10566160|NCT01632202|11721721|FG001|STARTED|Overall Study||7
10566161|NCT01632202|11721720|FG000|COMPLETED|Overall Study||1
10566162|NCT01632202|11721721|FG001|COMPLETED|Overall Study||7
10566163|NCT01632202|11721720|FG000|NOT COMPLETED|Overall Study||0
10566164|NCT01632202|11721721|FG001|NOT COMPLETED|Overall Study||0
10566165|NCT01632215|11721729|FG000|STARTED|Overall Study||20
10566166|NCT01632215|11721730|FG001|STARTED|Overall Study||20
10566167|NCT01632215|11721729|FG000|COMPLETED|Overall Study||18
10566168|NCT01632215|11721730|FG001|COMPLETED|Overall Study||19
10566169|NCT01632215|11721729|FG000|NOT COMPLETED|Overall Study||2
10566170|NCT01632215|11721730|FG001|NOT COMPLETED|Overall Study||1
10566171|NCT01632241|11721738|FG000|STARTED|Double-blinded (Up to Week 52)||165
10566172|NCT01632241|11721739|FG001|STARTED|Double-blinded (Up to Week 52)||331
10566173|NCT01632241|11721738|FG000|COMPLETED|Double-blinded (Up to Week 52)||121
10566174|NCT01632241|11721739|FG001|COMPLETED|Double-blinded (Up to Week 52)||252
10566175|NCT01632241|11721738|FG000|NOT COMPLETED|Double-blinded (Up to Week 52)||44
10566176|NCT01632241|11721739|FG001|NOT COMPLETED|Double-blinded (Up to Week 52)||79
10566177|NCT01632241|11721738|FG000|STARTED|Open-label (Week 52 to Week 76)|As the OL phase was optional, participants did not choose to enter the OL Phase.|117
10566178|NCT01632241|11721739|FG001|STARTED|Open-label (Week 52 to Week 76)|As the OL phase was optional, participants did not choose to enter the OL Phase.|242
10566179|NCT01632241|11721738|FG000|COMPLETED|Open-label (Week 52 to Week 76)||107
10566180|NCT01632241|11721739|FG001|COMPLETED|Open-label (Week 52 to Week 76)||220
10566181|NCT01632241|11721738|FG000|NOT COMPLETED|Open-label (Week 52 to Week 76)||10
10566182|NCT01632241|11721739|FG001|NOT COMPLETED|Open-label (Week 52 to Week 76)||22
10651066|NCT02173535|11811311|FG014|NOT COMPLETED|Period 3||0
10651067|NCT02173535|11811312|FG015|NOT COMPLETED|Period 3||0
10651068|NCT02173535|11811313|FG016|NOT COMPLETED|Period 3||0
10651069|NCT02173535|11811314|FG017|NOT COMPLETED|Period 3||0
10651070|NCT02173535|11811315|FG018|NOT COMPLETED|Period 3||0
10651071|NCT02173535|11811316|FG019|NOT COMPLETED|Period 3||0
10651072|NCT02173535|11811297|FG000|STARTED|Period 4||12
10651073|NCT02173535|11811298|FG001|STARTED|Period 4||12
10651074|NCT02173535|11811299|FG002|STARTED|Period 4||12
10651075|NCT02173535|11811300|FG003|STARTED|Period 4||12
10651076|NCT02173535|11811301|FG004|STARTED|Period 4||12
10651077|NCT02173535|11811302|FG005|STARTED|Period 4||12
10651078|NCT02173535|11811303|FG006|STARTED|Period 4||12
10651079|NCT02173535|11811304|FG007|STARTED|Period 4||12
10651080|NCT02173535|11811305|FG008|STARTED|Period 4||12
10651081|NCT02173535|11811306|FG009|STARTED|Period 4||12
10651082|NCT02173535|11811307|FG010|STARTED|Period 4||12
10651083|NCT02173535|11811308|FG011|STARTED|Period 4||12
10651084|NCT02173535|11811309|FG012|STARTED|Period 4||12
10651085|NCT02173535|11811310|FG013|STARTED|Period 4||12
10651086|NCT02173535|11811311|FG014|STARTED|Period 4||12
10651087|NCT02173535|11811312|FG015|STARTED|Period 4||12
10651088|NCT02173535|11811313|FG016|STARTED|Period 4||12
10651089|NCT02173535|11811314|FG017|STARTED|Period 4||12
10651090|NCT02173535|11811315|FG018|STARTED|Period 4||12
10651091|NCT02173535|11811316|FG019|STARTED|Period 4||12
10651092|NCT02173535|11811297|FG000|COMPLETED|Period 4||12
10651093|NCT02173535|11811298|FG001|COMPLETED|Period 4||12
10651094|NCT02173535|11811299|FG002|COMPLETED|Period 4||12
10651095|NCT02173535|11811300|FG003|COMPLETED|Period 4||12
10651096|NCT02173535|11811301|FG004|COMPLETED|Period 4||12
10651097|NCT02173535|11811302|FG005|COMPLETED|Period 4||12
10651098|NCT02173535|11811303|FG006|COMPLETED|Period 4||12
10651099|NCT02173535|11811304|FG007|COMPLETED|Period 4||12
10651100|NCT02173535|11811305|FG008|COMPLETED|Period 4||12
10651101|NCT02173535|11811306|FG009|COMPLETED|Period 4||12
10651102|NCT02173535|11811307|FG010|COMPLETED|Period 4||12
10651103|NCT02173535|11811308|FG011|COMPLETED|Period 4||12
10651104|NCT02173535|11811309|FG012|COMPLETED|Period 4||12
10651105|NCT02173535|11811310|FG013|COMPLETED|Period 4||12
10651106|NCT02173535|11811311|FG014|COMPLETED|Period 4||12
10651107|NCT02173535|11811312|FG015|COMPLETED|Period 4||12
10651108|NCT02173535|11811313|FG016|COMPLETED|Period 4||12
10651109|NCT02173535|11811314|FG017|COMPLETED|Period 4||12
10651110|NCT02173535|11811315|FG018|COMPLETED|Period 4||12
10651111|NCT02173535|11811316|FG019|COMPLETED|Period 4||12
10651112|NCT02173535|11811297|FG000|NOT COMPLETED|Period 4||0
10651113|NCT02173535|11811298|FG001|NOT COMPLETED|Period 4||0
10651114|NCT02173535|11811299|FG002|NOT COMPLETED|Period 4||0
10651115|NCT02173535|11811300|FG003|NOT COMPLETED|Period 4||0
10651116|NCT02173535|11811301|FG004|NOT COMPLETED|Period 4||0
10651117|NCT02173535|11811302|FG005|NOT COMPLETED|Period 4||0
10651118|NCT02173535|11811303|FG006|NOT COMPLETED|Period 4||0
10651119|NCT02173535|11811304|FG007|NOT COMPLETED|Period 4||0
10651120|NCT02173535|11811305|FG008|NOT COMPLETED|Period 4||0
10651121|NCT02173535|11811306|FG009|NOT COMPLETED|Period 4||0
10651122|NCT02173535|11811307|FG010|NOT COMPLETED|Period 4||0
10651123|NCT02173535|11811308|FG011|NOT COMPLETED|Period 4||0
10651124|NCT02173535|11811309|FG012|NOT COMPLETED|Period 4||0
10651125|NCT02173535|11811310|FG013|NOT COMPLETED|Period 4||0
10651126|NCT02173535|11811311|FG014|NOT COMPLETED|Period 4||0
10651127|NCT02173535|11811312|FG015|NOT COMPLETED|Period 4||0
10651128|NCT02173535|11811313|FG016|NOT COMPLETED|Period 4||0
10651129|NCT02173535|11811314|FG017|NOT COMPLETED|Period 4||0
10651130|NCT02173535|11811315|FG018|NOT COMPLETED|Period 4||0
10651131|NCT02173535|11811316|FG019|NOT COMPLETED|Period 4||0
10651132|NCT02173535|11811297|FG000|STARTED|Period 5||12
10651133|NCT02173535|11811298|FG001|STARTED|Period 5||12
10651134|NCT02173535|11811299|FG002|STARTED|Period 5||12
10651135|NCT02173535|11811300|FG003|STARTED|Period 5||12
10651136|NCT02173535|11811301|FG004|STARTED|Period 5||12
10651137|NCT02173535|11811302|FG005|STARTED|Period 5||12
10651138|NCT02173535|11811303|FG006|STARTED|Period 5||12
10651139|NCT02173535|11811304|FG007|STARTED|Period 5||12
10651140|NCT02173535|11811305|FG008|STARTED|Period 5||12
10651141|NCT02173535|11811306|FG009|STARTED|Period 5||12
10651142|NCT02173535|11811307|FG010|STARTED|Period 5||12
10651143|NCT02173535|11811308|FG011|STARTED|Period 5||12
10651144|NCT02173535|11811309|FG012|STARTED|Period 5||12
10651145|NCT02173535|11811310|FG013|STARTED|Period 5||12
10651146|NCT02173535|11811311|FG014|STARTED|Period 5||12
10651147|NCT02173535|11811312|FG015|STARTED|Period 5||12
10566183|NCT01632267|11721751|FG000|STARTED|Overall Study||104
10566184|NCT01632267|11721751|FG000|COMPLETED|Overall Study||97
10566185|NCT01632267|11721751|FG000|NOT COMPLETED|Overall Study||7
10566186|NCT01632280|11721757|FG000|STARTED|Overall Study||6
10566187|NCT01632280|11721758|FG001|STARTED|Overall Study||6
10566188|NCT01632280|11721757|FG000|COMPLETED|Overall Study||5
10566189|NCT01632280|11721758|FG001|COMPLETED|Overall Study||6
10566190|NCT01632280|11721757|FG000|NOT COMPLETED|Overall Study||1
10566191|NCT01632280|11721758|FG001|NOT COMPLETED|Overall Study||0
10566192|NCT01632306|11721766|FG000|STARTED|Overall Study||3
10566193|NCT01632306|11721767|FG001|STARTED|Overall Study||10
10566194|NCT01632306|11721768|FG002|STARTED|Overall Study||0
10566195|NCT01632306|11721766|FG000|Received at Least One Dose of Study Drug|Overall Study||3
10566196|NCT01632306|11721767|FG001|Received at Least One Dose of Study Drug|Overall Study||10
10566197|NCT01632306|11721768|FG002|Received at Least One Dose of Study Drug|Overall Study||0
10566198|NCT01632306|11721766|FG000|COMPLETED|Overall Study||2
10566199|NCT01632306|11721767|FG001|COMPLETED|Overall Study||10
10566200|NCT01632306|11721768|FG002|COMPLETED|Overall Study||0
10566201|NCT01632306|11721766|FG000|NOT COMPLETED|Overall Study||1
10566202|NCT01632306|11721767|FG001|NOT COMPLETED|Overall Study||0
10566203|NCT01632306|11721768|FG002|NOT COMPLETED|Overall Study||0
10566204|NCT01632345|11721779|FG000|STARTED|Randomized Participants||41
10566205|NCT01632345|11721780|FG001|STARTED|Randomized Participants||43
10566206|NCT01632345|11721781|FG002|STARTED|Randomized Participants||42
10566207|NCT01632345|11721782|FG003|STARTED|Randomized Participants||41
10566208|NCT01632345|11721783|FG004|STARTED|Randomized Participants||43
10566209|NCT01632345|11721784|FG005|STARTED|Randomized Participants||66
10566210|NCT01632345|11721785|FG006|STARTED|Randomized Participants||66
10566211|NCT01632345|11721779|FG000|COMPLETED|Randomized Participants||41
10566212|NCT01632345|11721780|FG001|COMPLETED|Randomized Participants||43
10566213|NCT01632345|11721781|FG002|COMPLETED|Randomized Participants||42
10566214|NCT01632345|11721782|FG003|COMPLETED|Randomized Participants||41
10566215|NCT01632345|11721783|FG004|COMPLETED|Randomized Participants||43
10566216|NCT01632345|11721784|FG005|COMPLETED|Randomized Participants||66
10566217|NCT01632345|11721785|FG006|COMPLETED|Randomized Participants||66
10566218|NCT01632345|11721779|FG000|NOT COMPLETED|Randomized Participants||0
10566219|NCT01632345|11721780|FG001|NOT COMPLETED|Randomized Participants||0
10566220|NCT01632345|11721781|FG002|NOT COMPLETED|Randomized Participants||0
10566221|NCT01632345|11721782|FG003|NOT COMPLETED|Randomized Participants||0
10566222|NCT01632345|11721783|FG004|NOT COMPLETED|Randomized Participants||0
10566223|NCT01632345|11721784|FG005|NOT COMPLETED|Randomized Participants||0
10566224|NCT01632345|11721785|FG006|NOT COMPLETED|Randomized Participants||0
10566225|NCT01632345|11721779|FG000|STARTED|Treatment: Part I||41
10566226|NCT01632345|11721780|FG001|STARTED|Treatment: Part I||43
10566227|NCT01632345|11721781|FG002|STARTED|Treatment: Part I||42
10566228|NCT01632345|11721782|FG003|STARTED|Treatment: Part I||41
10566229|NCT01632345|11721783|FG004|STARTED|Treatment: Part I||43
10566230|NCT01632345|11721784|FG005|STARTED|Treatment: Part I|Participants in Part II did not participate in Part I.|0
10566231|NCT01632345|11721785|FG006|STARTED|Treatment: Part I|Participants in Part II did not participate in Part I.|0
10566232|NCT01632345|11721779|FG000|Treated|Treatment: Part I||40
10566233|NCT01632345|11721780|FG001|Treated|Treatment: Part I||43
10566234|NCT01632345|11721781|FG002|Treated|Treatment: Part I||42
10566235|NCT01632345|11721782|FG003|Treated|Treatment: Part I||41
10566236|NCT01632345|11721783|FG004|Treated|Treatment: Part I||43
10566237|NCT01632345|11721784|FG005|Treated|Treatment: Part I||0
10566238|NCT01632345|11721785|FG006|Treated|Treatment: Part I||0
10566239|NCT01632345|11721779|FG000|COMPLETED|Treatment: Part I||29
10566240|NCT01632345|11721780|FG001|COMPLETED|Treatment: Part I||28
10566241|NCT01632345|11721781|FG002|COMPLETED|Treatment: Part I||32
10793267|NCT03600428|11954053|FG000|43-day Follow-up|Overall Study||74
10793268|NCT03600428|11954054|FG001|43-day Follow-up|Overall Study||68
10566242|NCT01632345|11721782|FG003|COMPLETED|Treatment: Part I||33
10566243|NCT01632345|11721783|FG004|COMPLETED|Treatment: Part I||30
10566244|NCT01632345|11721784|FG005|COMPLETED|Treatment: Part I||0
10566245|NCT01632345|11721785|FG006|COMPLETED|Treatment: Part I||0
10566246|NCT01632345|11721779|FG000|NOT COMPLETED|Treatment: Part I||12
10566247|NCT01632345|11721780|FG001|NOT COMPLETED|Treatment: Part I||15
10566248|NCT01632345|11721781|FG002|NOT COMPLETED|Treatment: Part I||10
10566249|NCT01632345|11721782|FG003|NOT COMPLETED|Treatment: Part I||8
10566250|NCT01632345|11721783|FG004|NOT COMPLETED|Treatment: Part I||13
10566251|NCT01632345|11721784|FG005|NOT COMPLETED|Treatment: Part I||0
10566252|NCT01632345|11721785|FG006|NOT COMPLETED|Treatment: Part I||0
10566253|NCT01632345|11721779|FG000|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
10566254|NCT01632345|11721780|FG001|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
10566255|NCT01632345|11721781|FG002|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
10566256|NCT01632345|11721782|FG003|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
10566257|NCT01632345|11721783|FG004|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
10566258|NCT01632345|11721784|FG005|STARTED|Treatment: Part II|66 new participants enrolled at 100 mg dose in Part II.|66
10566259|NCT01632345|11721785|FG006|STARTED|Treatment: Part II|66 new participants enrolled at efavirenz treatment in Part II.|66
10566260|NCT01632345|11721779|FG000|Treated|Treatment: Part II||0
10566261|NCT01632345|11721780|FG001|Treated|Treatment: Part II||0
10566262|NCT01632345|11721781|FG002|Treated|Treatment: Part II||0
10793269|NCT03600428|11954053|FG000|COMPLETED|Overall Study||74
10566263|NCT01632345|11721782|FG003|Treated|Treatment: Part II||0
10566264|NCT01632345|11721783|FG004|Treated|Treatment: Part II||0
10566265|NCT01632345|11721784|FG005|Treated|Treatment: Part II||66
10566266|NCT01632345|11721785|FG006|Treated|Treatment: Part II||66
10566267|NCT01632345|11721779|FG000|COMPLETED|Treatment: Part II||0
10566268|NCT01632345|11721780|FG001|COMPLETED|Treatment: Part II||0
10566269|NCT01632345|11721781|FG002|COMPLETED|Treatment: Part II||0
10566270|NCT01632345|11721782|FG003|COMPLETED|Treatment: Part II||0
10566271|NCT01632345|11721783|FG004|COMPLETED|Treatment: Part II||0
10566272|NCT01632345|11721784|FG005|COMPLETED|Treatment: Part II||55
10566273|NCT01632345|11721785|FG006|COMPLETED|Treatment: Part II||55
10566274|NCT01632345|11721779|FG000|NOT COMPLETED|Treatment: Part II||0
10566275|NCT01632345|11721780|FG001|NOT COMPLETED|Treatment: Part II||0
10566276|NCT01632345|11721781|FG002|NOT COMPLETED|Treatment: Part II||0
10566277|NCT01632345|11721782|FG003|NOT COMPLETED|Treatment: Part II||0
10566278|NCT01632345|11721783|FG004|NOT COMPLETED|Treatment: Part II||0
10566279|NCT01632345|11721784|FG005|NOT COMPLETED|Treatment: Part II||11
10566280|NCT01632345|11721785|FG006|NOT COMPLETED|Treatment: Part II||11
10566281|NCT01632423|11721800|FG000|STARTED|Overall Study||10337
10566282|NCT01632423|11721800|FG000|COMPLETED|Overall Study||10091
10566283|NCT01632423|11721800|FG000|NOT COMPLETED|Overall Study||246
10566284|NCT01632566|11721809|FG000|STARTED|Overall Study||8
10566285|NCT01632566|11721810|FG001|STARTED|Overall Study||10
10566286|NCT01632566|11721811|FG002|STARTED|Overall Study||9
10566287|NCT01632566|11721812|FG003|STARTED|Overall Study||6
10566288|NCT01632566|11721813|FG004|STARTED|Overall Study||6
10566289|NCT01632566|11721809|FG000|Received at Least One Dose LY3031207|Overall Study||8
10566290|NCT01632566|11721810|FG001|Received at Least One Dose LY3031207|Overall Study||10
10566291|NCT01632566|11721811|FG002|Received at Least One Dose LY3031207|Overall Study||9
10566292|NCT01632566|11721812|FG003|Received at Least One Dose LY3031207|Overall Study||0
10566293|NCT01632566|11721813|FG004|Received at Least One Dose LY3031207|Overall Study||0
10566294|NCT01632566|11721809|FG000|Received at Least One Dose Simvastatin|Overall Study||0
10566295|NCT01632566|11721810|FG001|Received at Least One Dose Simvastatin|Overall Study||10
10566296|NCT01632566|11721811|FG002|Received at Least One Dose Simvastatin|Overall Study||9
10566297|NCT01632566|11721812|FG003|Received at Least One Dose Simvastatin|Overall Study||4
10566298|NCT01632566|11721813|FG004|Received at Least One Dose Simvastatin|Overall Study||4
10566299|NCT01632566|11721809|FG000|COMPLETED|Overall Study||8
10566300|NCT01632566|11721810|FG001|COMPLETED|Overall Study||7
10566301|NCT01632566|11721811|FG002|COMPLETED|Overall Study||0
10566302|NCT01632566|11721812|FG003|COMPLETED|Overall Study||4
10566303|NCT01632566|11721813|FG004|COMPLETED|Overall Study||4
10566304|NCT01632566|11721809|FG000|NOT COMPLETED|Overall Study||0
10566305|NCT01632566|11721810|FG001|NOT COMPLETED|Overall Study||3
10566306|NCT01632566|11721811|FG002|NOT COMPLETED|Overall Study||9
10566307|NCT01632566|11721812|FG003|NOT COMPLETED|Overall Study||2
10566308|NCT01632566|11721813|FG004|NOT COMPLETED|Overall Study||2
10566309|NCT01632579|11721829|FG000|STARTED|Period 1 (First Intervention)||2
10566310|NCT01632579|11721830|FG001|STARTED|Period 1 (First Intervention)||6
10566311|NCT01632579|11721831|FG002|STARTED|Period 1 (First Intervention)||2
10566312|NCT01632579|11721832|FG003|STARTED|Period 1 (First Intervention)||2
10566313|NCT01632579|11721833|FG004|STARTED|Period 1 (First Intervention)||6
10566314|NCT01632579|11721834|FG005|STARTED|Period 1 (First Intervention)||2
10566315|NCT01632579|11721835|FG006|STARTED|Period 1 (First Intervention)||2
10566316|NCT01632579|11721836|FG007|STARTED|Period 1 (First Intervention)||6
10566317|NCT01632579|11721837|FG008|STARTED|Period 1 (First Intervention)||2
10566318|NCT01632579|11721829|FG000|Received at Least 1 Dose|Period 1 (First Intervention)||2
10566319|NCT01632579|11721830|FG001|Received at Least 1 Dose|Period 1 (First Intervention)||6
10566320|NCT01632579|11721831|FG002|Received at Least 1 Dose|Period 1 (First Intervention)||2
10566321|NCT01632579|11721832|FG003|Received at Least 1 Dose|Period 1 (First Intervention)||2
10566322|NCT01632579|11721833|FG004|Received at Least 1 Dose|Period 1 (First Intervention)||6
10566323|NCT01632579|11721834|FG005|Received at Least 1 Dose|Period 1 (First Intervention)||2
10566324|NCT01632579|11721835|FG006|Received at Least 1 Dose|Period 1 (First Intervention)||2
10566325|NCT01632579|11721836|FG007|Received at Least 1 Dose|Period 1 (First Intervention)||6
10566326|NCT01632579|11721837|FG008|Received at Least 1 Dose|Period 1 (First Intervention)||2
10566327|NCT01632579|11721829|FG000|COMPLETED|Period 1 (First Intervention)||2
10566328|NCT01632579|11721830|FG001|COMPLETED|Period 1 (First Intervention)||6
10566329|NCT01632579|11721831|FG002|COMPLETED|Period 1 (First Intervention)||2
10566330|NCT01632579|11721832|FG003|COMPLETED|Period 1 (First Intervention)||2
10566331|NCT01632579|11721833|FG004|COMPLETED|Period 1 (First Intervention)||6
10566332|NCT01632579|11721834|FG005|COMPLETED|Period 1 (First Intervention)||2
10566333|NCT01632579|11721835|FG006|COMPLETED|Period 1 (First Intervention)||2
10566334|NCT01632579|11721836|FG007|COMPLETED|Period 1 (First Intervention)||6
10566335|NCT01632579|11721837|FG008|COMPLETED|Period 1 (First Intervention)||2
10566336|NCT01632579|11721829|FG000|NOT COMPLETED|Period 1 (First Intervention)||0
10566337|NCT01632579|11721830|FG001|NOT COMPLETED|Period 1 (First Intervention)||0
10566338|NCT01632579|11721831|FG002|NOT COMPLETED|Period 1 (First Intervention)||0
10566339|NCT01632579|11721832|FG003|NOT COMPLETED|Period 1 (First Intervention)||0
10566340|NCT01632579|11721833|FG004|NOT COMPLETED|Period 1 (First Intervention)||0
10566341|NCT01632579|11721834|FG005|NOT COMPLETED|Period 1 (First Intervention)||0
10566342|NCT01632579|11721835|FG006|NOT COMPLETED|Period 1 (First Intervention)||0
10566343|NCT01632579|11721836|FG007|NOT COMPLETED|Period 1 (First Intervention)||0
10566344|NCT01632579|11721837|FG008|NOT COMPLETED|Period 1 (First Intervention)||0
10566345|NCT01632579|11721829|FG000|STARTED|Washout Period||2
10566346|NCT01632579|11721830|FG001|STARTED|Washout Period||6
10566347|NCT01632579|11721831|FG002|STARTED|Washout Period||2
10566348|NCT01632579|11721832|FG003|STARTED|Washout Period||2
10566349|NCT01632579|11721833|FG004|STARTED|Washout Period||6
10566350|NCT01632579|11721834|FG005|STARTED|Washout Period||2
10566351|NCT01632579|11721835|FG006|STARTED|Washout Period||2
10566352|NCT01632579|11721836|FG007|STARTED|Washout Period||6
10566353|NCT01632579|11721837|FG008|STARTED|Washout Period||2
10566354|NCT01632579|11721829|FG000|COMPLETED|Washout Period||1
10566355|NCT01632579|11721830|FG001|COMPLETED|Washout Period||6
10566356|NCT01632579|11721831|FG002|COMPLETED|Washout Period||2
10566357|NCT01632579|11721832|FG003|COMPLETED|Washout Period||2
10566358|NCT01632579|11721833|FG004|COMPLETED|Washout Period||6
10566359|NCT01632579|11721834|FG005|COMPLETED|Washout Period||2
10566360|NCT01632579|11721835|FG006|COMPLETED|Washout Period||2
10566361|NCT01632579|11721836|FG007|COMPLETED|Washout Period||6
10566362|NCT01632579|11721837|FG008|COMPLETED|Washout Period||2
10566363|NCT01632579|11721829|FG000|NOT COMPLETED|Washout Period||1
10566364|NCT01632579|11721830|FG001|NOT COMPLETED|Washout Period||0
10566365|NCT01632579|11721831|FG002|NOT COMPLETED|Washout Period||0
10566366|NCT01632579|11721832|FG003|NOT COMPLETED|Washout Period||0
10566367|NCT01632579|11721833|FG004|NOT COMPLETED|Washout Period||0
10566368|NCT01632579|11721834|FG005|NOT COMPLETED|Washout Period||0
10566369|NCT01632579|11721835|FG006|NOT COMPLETED|Washout Period||0
10566370|NCT01632579|11721836|FG007|NOT COMPLETED|Washout Period||0
10566371|NCT01632579|11721837|FG008|NOT COMPLETED|Washout Period||0
10566372|NCT01632579|11721829|FG000|STARTED|Period 2 (Second Intervention)||1
10566373|NCT01632579|11721830|FG001|STARTED|Period 2 (Second Intervention)||6
10566374|NCT01632579|11721831|FG002|STARTED|Period 2 (Second Intervention)||2
10566375|NCT01632579|11721832|FG003|STARTED|Period 2 (Second Intervention)||2
10566376|NCT01632579|11721833|FG004|STARTED|Period 2 (Second Intervention)||6
10566377|NCT01632579|11721834|FG005|STARTED|Period 2 (Second Intervention)||2
10566378|NCT01632579|11721835|FG006|STARTED|Period 2 (Second Intervention)||2
10566379|NCT01632579|11721836|FG007|STARTED|Period 2 (Second Intervention)||6
10566380|NCT01632579|11721837|FG008|STARTED|Period 2 (Second Intervention)||2
10566381|NCT01632579|11721829|FG000|Received at Least 1 Dose|Period 2 (Second Intervention)||1
10566382|NCT01632579|11721830|FG001|Received at Least 1 Dose|Period 2 (Second Intervention)||6
10566383|NCT01632579|11721831|FG002|Received at Least 1 Dose|Period 2 (Second Intervention)||2
10566384|NCT01632579|11721832|FG003|Received at Least 1 Dose|Period 2 (Second Intervention)||2
10566385|NCT01632579|11721833|FG004|Received at Least 1 Dose|Period 2 (Second Intervention)||6
10566386|NCT01632579|11721834|FG005|Received at Least 1 Dose|Period 2 (Second Intervention)||2
10566387|NCT01632579|11721835|FG006|Received at Least 1 Dose|Period 2 (Second Intervention)||2
10566388|NCT01632579|11721836|FG007|Received at Least 1 Dose|Period 2 (Second Intervention)||6
10566389|NCT01632579|11721837|FG008|Received at Least 1 Dose|Period 2 (Second Intervention)||2
10566390|NCT01632579|11721829|FG000|COMPLETED|Period 2 (Second Intervention)||0
10566391|NCT01632579|11721830|FG001|COMPLETED|Period 2 (Second Intervention)||6
10566392|NCT01632579|11721831|FG002|COMPLETED|Period 2 (Second Intervention)||2
10566393|NCT01632579|11721832|FG003|COMPLETED|Period 2 (Second Intervention)||2
10566394|NCT01632579|11721833|FG004|COMPLETED|Period 2 (Second Intervention)||6
10566395|NCT01632579|11721834|FG005|COMPLETED|Period 2 (Second Intervention)||2
10566396|NCT01632579|11721835|FG006|COMPLETED|Period 2 (Second Intervention)||2
10793270|NCT03600428|11954054|FG001|COMPLETED|Overall Study||68
10793271|NCT03600428|11954053|FG000|NOT COMPLETED|Overall Study||5
10793272|NCT03600428|11954054|FG001|NOT COMPLETED|Overall Study||5
10793273|NCT03601052|11954060|FG000|STARTED|Overall Study||14
10793274|NCT03601052|11954060|FG000|COMPLETED|Overall Study||12
10793275|NCT03601052|11954060|FG000|NOT COMPLETED|Overall Study||2
10793276|NCT03601715|11954072|FG000|STARTED|First Intervention||7
10793277|NCT03601715|11954073|FG001|STARTED|First Intervention||7
10793278|NCT03601715|11954074|FG002|STARTED|First Intervention||6
10793279|NCT03601715|11954072|FG000|COMPLETED|First Intervention||7
10793280|NCT03601715|11954073|FG001|COMPLETED|First Intervention||7
10793281|NCT03601715|11954074|FG002|COMPLETED|First Intervention||6
10793282|NCT03601715|11954072|FG000|NOT COMPLETED|First Intervention||0
10793283|NCT03601715|11954073|FG001|NOT COMPLETED|First Intervention||0
10793284|NCT03601715|11954074|FG002|NOT COMPLETED|First Intervention||0
10793285|NCT03601715|11954072|FG000|STARTED|Washout 1 (at Least 24 Hours)||7
10793286|NCT03601715|11954073|FG001|STARTED|Washout 1 (at Least 24 Hours)||7
10793287|NCT03601715|11954074|FG002|STARTED|Washout 1 (at Least 24 Hours)||6
10793288|NCT03601715|11954072|FG000|COMPLETED|Washout 1 (at Least 24 Hours)||7
10793289|NCT03601715|11954073|FG001|COMPLETED|Washout 1 (at Least 24 Hours)||7
10566397|NCT01632579|11721836|FG007|COMPLETED|Period 2 (Second Intervention)||6
10566398|NCT01632579|11721837|FG008|COMPLETED|Period 2 (Second Intervention)||2
10566399|NCT01632579|11721829|FG000|NOT COMPLETED|Period 2 (Second Intervention)||1
10566400|NCT01632579|11721830|FG001|NOT COMPLETED|Period 2 (Second Intervention)||0
10566401|NCT01632579|11721831|FG002|NOT COMPLETED|Period 2 (Second Intervention)||0
10793290|NCT03601715|11954074|FG002|COMPLETED|Washout 1 (at Least 24 Hours)||6
10793291|NCT03601715|11954072|FG000|NOT COMPLETED|Washout 1 (at Least 24 Hours)||0
10793292|NCT03601715|11954073|FG001|NOT COMPLETED|Washout 1 (at Least 24 Hours)||0
10793293|NCT03601715|11954074|FG002|NOT COMPLETED|Washout 1 (at Least 24 Hours)||0
10793294|NCT03601715|11954072|FG000|STARTED|Second Intervention||7
10793295|NCT03601715|11954073|FG001|STARTED|Second Intervention||7
10566402|NCT01632579|11721832|FG003|NOT COMPLETED|Period 2 (Second Intervention)||0
10566403|NCT01632579|11721833|FG004|NOT COMPLETED|Period 2 (Second Intervention)||0
10566404|NCT01632579|11721834|FG005|NOT COMPLETED|Period 2 (Second Intervention)||0
10566405|NCT01632579|11721835|FG006|NOT COMPLETED|Period 2 (Second Intervention)||0
10566406|NCT01632579|11721836|FG007|NOT COMPLETED|Period 2 (Second Intervention)||0
10566407|NCT01632579|11721837|FG008|NOT COMPLETED|Period 2 (Second Intervention)||0
10566408|NCT01632579|11721829|FG000|STARTED|Washout Period||0
10566409|NCT01632579|11721830|FG001|STARTED|Washout Period||6
10566410|NCT01632579|11721831|FG002|STARTED|Washout Period||2
10566411|NCT01632579|11721832|FG003|STARTED|Washout Period||2
10566412|NCT01632579|11721833|FG004|STARTED|Washout Period||6
10566413|NCT01632579|11721834|FG005|STARTED|Washout Period||2
10566414|NCT01632579|11721835|FG006|STARTED|Washout Period||2
10566415|NCT01632579|11721836|FG007|STARTED|Washout Period||6
10566416|NCT01632579|11721837|FG008|STARTED|Washout Period||2
10566417|NCT01632579|11721829|FG000|COMPLETED|Washout Period||0
10566418|NCT01632579|11721830|FG001|COMPLETED|Washout Period||6
10566419|NCT01632579|11721831|FG002|COMPLETED|Washout Period||2
10566420|NCT01632579|11721832|FG003|COMPLETED|Washout Period||2
10566421|NCT01632579|11721833|FG004|COMPLETED|Washout Period||6
10566422|NCT01632579|11721834|FG005|COMPLETED|Washout Period||2
10566423|NCT01632579|11721835|FG006|COMPLETED|Washout Period||2
10566424|NCT01632579|11721836|FG007|COMPLETED|Washout Period||6
10566425|NCT01632579|11721837|FG008|COMPLETED|Washout Period||2
10566426|NCT01632579|11721829|FG000|NOT COMPLETED|Washout Period||0
10566427|NCT01632579|11721830|FG001|NOT COMPLETED|Washout Period||0
10566428|NCT01632579|11721831|FG002|NOT COMPLETED|Washout Period||0
10566429|NCT01632579|11721832|FG003|NOT COMPLETED|Washout Period||0
10566430|NCT01632579|11721833|FG004|NOT COMPLETED|Washout Period||0
10566431|NCT01632579|11721834|FG005|NOT COMPLETED|Washout Period||0
10566432|NCT01632579|11721835|FG006|NOT COMPLETED|Washout Period||0
10566433|NCT01632579|11721836|FG007|NOT COMPLETED|Washout Period||0
10566434|NCT01632579|11721837|FG008|NOT COMPLETED|Washout Period||0
10566435|NCT01632579|11721829|FG000|STARTED|Period 3 (Third Intervention)||0
10566436|NCT01632579|11721830|FG001|STARTED|Period 3 (Third Intervention)||6
10566437|NCT01632579|11721831|FG002|STARTED|Period 3 (Third Intervention)||2
10566438|NCT01632579|11721832|FG003|STARTED|Period 3 (Third Intervention)||2
10566439|NCT01632579|11721833|FG004|STARTED|Period 3 (Third Intervention)||6
10566440|NCT01632579|11721834|FG005|STARTED|Period 3 (Third Intervention)||2
10566441|NCT01632579|11721835|FG006|STARTED|Period 3 (Third Intervention)||2
10566442|NCT01632579|11721836|FG007|STARTED|Period 3 (Third Intervention)||6
10566443|NCT01632579|11721837|FG008|STARTED|Period 3 (Third Intervention)||2
10566444|NCT01632579|11721829|FG000|Received at Least 1 Dose|Period 3 (Third Intervention)||0
10566445|NCT01632579|11721830|FG001|Received at Least 1 Dose|Period 3 (Third Intervention)||6
10566446|NCT01632579|11721831|FG002|Received at Least 1 Dose|Period 3 (Third Intervention)||2
10566447|NCT01632579|11721832|FG003|Received at Least 1 Dose|Period 3 (Third Intervention)||2
10566448|NCT01632579|11721833|FG004|Received at Least 1 Dose|Period 3 (Third Intervention)||6
10566449|NCT01632579|11721834|FG005|Received at Least 1 Dose|Period 3 (Third Intervention)||2
10566450|NCT01632579|11721835|FG006|Received at Least 1 Dose|Period 3 (Third Intervention)||2
10566451|NCT01632579|11721836|FG007|Received at Least 1 Dose|Period 3 (Third Intervention)||6
10566452|NCT01632579|11721837|FG008|Received at Least 1 Dose|Period 3 (Third Intervention)||2
10566453|NCT01632579|11721829|FG000|COMPLETED|Period 3 (Third Intervention)||0
10566454|NCT01632579|11721830|FG001|COMPLETED|Period 3 (Third Intervention)||6
10566455|NCT01632579|11721831|FG002|COMPLETED|Period 3 (Third Intervention)||2
10566456|NCT01632579|11721832|FG003|COMPLETED|Period 3 (Third Intervention)||2
10566457|NCT01632579|11721833|FG004|COMPLETED|Period 3 (Third Intervention)||6
10566458|NCT01632579|11721834|FG005|COMPLETED|Period 3 (Third Intervention)||2
10566459|NCT01632579|11721835|FG006|COMPLETED|Period 3 (Third Intervention)||2
10566460|NCT01632579|11721836|FG007|COMPLETED|Period 3 (Third Intervention)||6
10566461|NCT01632579|11721837|FG008|COMPLETED|Period 3 (Third Intervention)||2
10566462|NCT01632579|11721829|FG000|NOT COMPLETED|Period 3 (Third Intervention)||0
10566463|NCT01632579|11721830|FG001|NOT COMPLETED|Period 3 (Third Intervention)||0
10566464|NCT01632579|11721831|FG002|NOT COMPLETED|Period 3 (Third Intervention)||0
10566465|NCT01632579|11721832|FG003|NOT COMPLETED|Period 3 (Third Intervention)||0
10566466|NCT01632579|11721833|FG004|NOT COMPLETED|Period 3 (Third Intervention)||0
10566467|NCT01632579|11721834|FG005|NOT COMPLETED|Period 3 (Third Intervention)||0
10566468|NCT01632579|11721835|FG006|NOT COMPLETED|Period 3 (Third Intervention)||0
10566469|NCT01632579|11721836|FG007|NOT COMPLETED|Period 3 (Third Intervention)||0
10566470|NCT01632579|11721837|FG008|NOT COMPLETED|Period 3 (Third Intervention)||0
10566471|NCT01632683|11721863|FG000|STARTED|Overall Study||548
10566472|NCT01632683|11721864|FG001|STARTED|Overall Study||552
10566473|NCT01632683|11721863|FG000|COMPLETED|Overall Study||548
10566474|NCT01632683|11721864|FG001|COMPLETED|Overall Study||552
10566475|NCT01632683|11721863|FG000|NOT COMPLETED|Overall Study||0
10566476|NCT01632683|11721864|FG001|NOT COMPLETED|Overall Study||0
10566477|NCT01632709|11721874|FG000|STARTED|Overall Study||4
10566478|NCT01632709|11721875|FG001|STARTED|Overall Study||3
10566479|NCT01632709|11721876|FG002|STARTED|Overall Study||5
10566480|NCT01632709|11721877|FG003|STARTED|Overall Study||4
10566481|NCT01632709|11721874|FG000|Completed Visit 2 (Received Injection)|Overall Study||4
10566482|NCT01632709|11721875|FG001|Completed Visit 2 (Received Injection)|Overall Study||2
10566483|NCT01632709|11721876|FG002|Completed Visit 2 (Received Injection)|Overall Study||5
10651148|NCT02173535|11811313|FG016|STARTED|Period 5||12
10566484|NCT01632709|11721877|FG003|Completed Visit 2 (Received Injection)|Overall Study||3
10566485|NCT01632709|11721874|FG000|COMPLETED|Overall Study||2
10566486|NCT01632709|11721875|FG001|COMPLETED|Overall Study||2
10566487|NCT01632709|11721876|FG002|COMPLETED|Overall Study||5
10566488|NCT01632709|11721877|FG003|COMPLETED|Overall Study||3
10566489|NCT01632709|11721874|FG000|NOT COMPLETED|Overall Study||2
10566490|NCT01632709|11721875|FG001|NOT COMPLETED|Overall Study||1
10566491|NCT01632709|11721876|FG002|NOT COMPLETED|Overall Study||0
10566492|NCT01632709|11721877|FG003|NOT COMPLETED|Overall Study||1
10566493|NCT01632735|11721887|FG000|STARTED|Overall Study||40
10566494|NCT01632735|11721888|FG001|STARTED|Overall Study||40
10566495|NCT01632735|11721887|FG000|COMPLETED|Overall Study||36
10566496|NCT01632735|11721888|FG001|COMPLETED|Overall Study||37
10566497|NCT01632735|11721887|FG000|NOT COMPLETED|Overall Study||4
10566498|NCT01632735|11721888|FG001|NOT COMPLETED|Overall Study||3
10566499|NCT01632800|11721894|FG000|STARTED|Overall Study||26
10566500|NCT01632800|11721894|FG000|COMPLETED|Overall Study||25
10566501|NCT01632800|11721894|FG000|NOT COMPLETED|Overall Study||1
10566502|NCT01632891|11721900|FG000|STARTED|Overall Study||26
10566503|NCT01632891|11721901|FG001|STARTED|Overall Study||26
10566504|NCT01632891|11721900|FG000|COMPLETED|Overall Study||25
10566505|NCT01632891|11721901|FG001|COMPLETED|Overall Study||25
10793296|NCT03601715|11954074|FG002|STARTED|Second Intervention||6
10566506|NCT01632891|11721900|FG000|NOT COMPLETED|Overall Study||1
10566507|NCT01632891|11721901|FG001|NOT COMPLETED|Overall Study||1
10566508|NCT01632904|11721913|FG000|STARTED|Overall Study||54
10566509|NCT01632904|11721914|FG001|STARTED|Overall Study||56
10566510|NCT01632904|11721913|FG000|COMPLETED|Overall Study|Patients still in the study as of data cutoff, 27MAR2014.|47
10566511|NCT01632904|11721914|FG001|COMPLETED|Overall Study|Patients still in the study as of 27MAR2014, including those who crossed over to ruxolitinib|50
10566512|NCT01632904|11721913|FG000|NOT COMPLETED|Overall Study||7
10566513|NCT01632904|11721914|FG001|NOT COMPLETED|Overall Study||6
10566514|NCT01632995|11721920|FG000|STARTED|Pre-screening to Enrollment Period||1069
10566515|NCT01632995|11721920|FG000|COMPLETED|Pre-screening to Enrollment Period||557
10566516|NCT01632995|11721920|FG000|NOT COMPLETED|Pre-screening to Enrollment Period||512
10566517|NCT01632995|11721920|FG000|STARTED|Main Study Follow-up Period||557
10566518|NCT01632995|11721920|FG000|COMPLETED|Main Study Follow-up Period||437
10566519|NCT01632995|11721920|FG000|NOT COMPLETED|Main Study Follow-up Period||120
10566520|NCT01633060|11721928|FG000|STARTED|Randomization Phase|All randomized patients|289
10566521|NCT01633060|11721929|FG001|STARTED|Randomization Phase|All randomized patients|143
10566522|NCT01633060|11721928|FG000|COMPLETED|Randomization Phase||288
10566523|NCT01633060|11721929|FG001|COMPLETED|Randomization Phase||140
10566524|NCT01633060|11721928|FG000|NOT COMPLETED|Randomization Phase||1
10566525|NCT01633060|11721929|FG001|NOT COMPLETED|Randomization Phase||3
10566526|NCT01633060|11721928|FG000|STARTED|Treatment Phase||288
10566527|NCT01633060|11721929|FG001|STARTED|Treatment Phase||140
10566528|NCT01633060|11721928|FG000|FAS - ctDNA PIK3CA Mutant|Treatment Phase||100
10566529|NCT01633060|11721929|FG001|FAS - ctDNA PIK3CA Mutant|Treatment Phase||35
10566530|NCT01633060|11721928|FG000|FAS - ctDNA PIK3CA Non-mutant|Treatment Phase||132
10566531|NCT01633060|11721929|FG001|FAS - ctDNA PIK3CA Non-mutant|Treatment Phase||81
10566532|NCT01633060|11721928|FG000|Safety Set (SS)|Treatment Phase||288
10566533|NCT01633060|11721929|FG001|Safety Set (SS)|Treatment Phase||140
10566534|NCT01633060|11721928|FG000|Pharmacokinetic Analysis Set (PAS)|Treatment Phase||63
10566535|NCT01633060|11721929|FG001|Pharmacokinetic Analysis Set (PAS)|Treatment Phase||0
10566536|NCT01633060|11721928|FG000|COMPLETED|Treatment Phase||0
10566537|NCT01633060|11721929|FG001|COMPLETED|Treatment Phase||0
10566538|NCT01633060|11721928|FG000|NOT COMPLETED|Treatment Phase||288
10566539|NCT01633060|11721929|FG001|NOT COMPLETED|Treatment Phase||140
10566540|NCT01633060|11721928|FG000|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|16
10566541|NCT01633060|11721929|FG001|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|2
10566542|NCT01633060|11721928|FG000|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
10566543|NCT01633060|11721929|FG001|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
10566544|NCT01633060|11721928|FG000|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||16
10566545|NCT01633060|11721929|FG001|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||2
10566546|NCT01633112|11721939|FG000|STARTED|Overall Study||352
10566547|NCT01633112|11721940|FG001|STARTED|Overall Study||370
10566548|NCT01633112|11721941|FG002|STARTED|Overall Study||342
10566549|NCT01633112|11721939|FG000|COMPLETED|Overall Study||299
10566550|NCT01633112|11721940|FG001|COMPLETED|Overall Study||310
10566551|NCT01633112|11721941|FG002|COMPLETED|Overall Study||250
10566552|NCT01633112|11721939|FG000|NOT COMPLETED|Overall Study||53
10566553|NCT01633112|11721940|FG001|NOT COMPLETED|Overall Study||60
10566554|NCT01633112|11721941|FG002|NOT COMPLETED|Overall Study||92
10566555|NCT01633320|11721952|FG000|STARTED|Overall Study||132
10566556|NCT01633320|11721953|FG001|STARTED|Overall Study||68
10566557|NCT01633320|11721952|FG000|COMPLETED|Overall Study||132
10566558|NCT01633320|11721953|FG001|COMPLETED|Overall Study||68
10566559|NCT01633320|11721952|FG000|NOT COMPLETED|Overall Study||0
10566560|NCT01633320|11721953|FG001|NOT COMPLETED|Overall Study||0
10566561|NCT01633398|11721961|FG000|STARTED|Overall Study||4779
10566562|NCT01633398|11721962|FG001|STARTED|Overall Study||1550
10566563|NCT01633398|11721961|FG000|COMPLETED|Overall Study||4779
10793297|NCT03601715|11954072|FG000|COMPLETED|Second Intervention||6
10566564|NCT01633398|11721962|FG001|COMPLETED|Overall Study||1550
10566565|NCT01633398|11721961|FG000|NOT COMPLETED|Overall Study||0
10566566|NCT01633398|11721962|FG001|NOT COMPLETED|Overall Study||0
10566567|NCT01633788|11721972|FG000|STARTED|Overall Study||57
10566568|NCT01633788|11721973|FG001|STARTED|Overall Study||58
10566569|NCT01633788|11721974|FG002|STARTED|Overall Study||59
10566570|NCT01633788|11721975|FG003|STARTED|Overall Study||58
10566571|NCT01633788|11721972|FG000|COMPLETED|Overall Study||50
10566572|NCT01633788|11721973|FG001|COMPLETED|Overall Study||50
10566573|NCT01633788|11721974|FG002|COMPLETED|Overall Study||49
10566574|NCT01633788|11721975|FG003|COMPLETED|Overall Study||45
10566575|NCT01633788|11721972|FG000|NOT COMPLETED|Overall Study||7
10566576|NCT01633788|11721973|FG001|NOT COMPLETED|Overall Study||8
10566577|NCT01633788|11721974|FG002|NOT COMPLETED|Overall Study||10
10566578|NCT01633788|11721975|FG003|NOT COMPLETED|Overall Study||13
10566579|NCT01633827|11721985|FG000|STARTED|First Intervention||11
10566580|NCT01633827|11721986|FG001|STARTED|First Intervention||11
10566581|NCT01633827|11721985|FG000|COMPLETED|First Intervention||11
10566582|NCT01633827|11721986|FG001|COMPLETED|First Intervention||11
10566583|NCT01633827|11721985|FG000|NOT COMPLETED|First Intervention||0
10566584|NCT01633827|11721986|FG001|NOT COMPLETED|First Intervention||0
10566585|NCT01633827|11721985|FG000|STARTED|Washout Period||11
10566586|NCT01633827|11721986|FG001|STARTED|Washout Period||11
10566587|NCT01633827|11721985|FG000|COMPLETED|Washout Period||11
10566588|NCT01633827|11721986|FG001|COMPLETED|Washout Period||11
10566589|NCT01633827|11721985|FG000|NOT COMPLETED|Washout Period||0
10566590|NCT01633827|11721986|FG001|NOT COMPLETED|Washout Period||0
10566591|NCT01633827|11721985|FG000|STARTED|Second Intervention||11
10566592|NCT01633827|11721986|FG001|STARTED|Second Intervention||11
10566593|NCT01633827|11721985|FG000|COMPLETED|Second Intervention||11
10566594|NCT01633827|11721986|FG001|COMPLETED|Second Intervention||11
10566595|NCT01633827|11721985|FG000|NOT COMPLETED|Second Intervention||0
10566596|NCT01633827|11721986|FG001|NOT COMPLETED|Second Intervention||0
10566597|NCT01633853|11722001|FG000|STARTED|Overall Study||104
10566598|NCT01633853|11722002|FG001|STARTED|Overall Study||100
10566599|NCT01633853|11722001|FG000|COMPLETED|Overall Study||104
10566600|NCT01633853|11722002|FG001|COMPLETED|Overall Study||100
10566601|NCT01633853|11722001|FG000|NOT COMPLETED|Overall Study||0
10566602|NCT01633853|11722002|FG001|NOT COMPLETED|Overall Study||0
10566603|NCT01633892|11722009|FG000|STARTED|Overall Study||5
10566604|NCT01633892|11722009|FG000|COMPLETED|Overall Study||5
10566605|NCT01633892|11722009|FG000|NOT COMPLETED|Overall Study||0
10566606|NCT01633944|11722015|FG000|STARTED|Open-label Titration Phase||752
10566607|NCT01633944|11722016|FG001|STARTED|Open-label Titration Phase||0
10566608|NCT01633944|11722017|FG002|STARTED|Open-label Titration Phase||0
10566609|NCT01633944|11722015|FG000|COMPLETED|Open-label Titration Phase||462
10566610|NCT01633944|11722016|FG001|COMPLETED|Open-label Titration Phase||0
10566611|NCT01633944|11722017|FG002|COMPLETED|Open-label Titration Phase||0
10566612|NCT01633944|11722015|FG000|NOT COMPLETED|Open-label Titration Phase||290
10566613|NCT01633944|11722016|FG001|NOT COMPLETED|Open-label Titration Phase||0
10566614|NCT01633944|11722017|FG002|NOT COMPLETED|Open-label Titration Phase||0
10566615|NCT01633944|11722015|FG000|STARTED|Double-blind Treatment Phase|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
10566616|NCT01633944|11722016|FG001|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|230
10793299|NCT03601715|11954074|FG002|COMPLETED|Second Intervention||6
10566617|NCT01633944|11722017|FG002|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|232
10566618|NCT01633944|11722015|FG000|COMPLETED|Double-blind Treatment Phase||0
10566619|NCT01633944|11722016|FG001|COMPLETED|Double-blind Treatment Phase||176
10566620|NCT01633944|11722017|FG002|COMPLETED|Double-blind Treatment Phase||174
10566621|NCT01633944|11722015|FG000|NOT COMPLETED|Double-blind Treatment Phase||0
10566622|NCT01633944|11722016|FG001|NOT COMPLETED|Double-blind Treatment Phase||54
10566623|NCT01633944|11722017|FG002|NOT COMPLETED|Double-blind Treatment Phase||58
10566624|NCT01634100|11722025|FG000|STARTED|Overall Study||3
10566625|NCT01634100|11722026|FG001|STARTED|Overall Study||3
10566626|NCT01634100|11722027|FG002|STARTED|Overall Study||3
10566627|NCT01634100|11722028|FG003|STARTED|Overall Study||3
10566628|NCT01634100|11722029|FG004|STARTED|Overall Study||3
10566629|NCT01634100|11722030|FG005|STARTED|Overall Study||3
10566630|NCT01634100|11722025|FG000|Received Empa Alone|Overall Study||3
10566631|NCT01634100|11722026|FG001|Received Empa Alone|Overall Study||3
10566632|NCT01634100|11722027|FG002|Received Empa Alone|Overall Study||3
10566633|NCT01634100|11722028|FG003|Received Empa Alone|Overall Study||3
10566634|NCT01634100|11722029|FG004|Received Empa Alone|Overall Study||3
10566635|NCT01634100|11722030|FG005|Received Empa Alone|Overall Study||3
10566636|NCT01634100|11722025|FG000|Received Empa + Rifampicin|Overall Study||3
10566637|NCT01634100|11722026|FG001|Received Empa + Rifampicin|Overall Study||3
10566638|NCT01634100|11722027|FG002|Received Empa + Rifampicin|Overall Study||3
10566639|NCT01634100|11722028|FG003|Received Empa + Rifampicin|Overall Study||3
10566640|NCT01634100|11722029|FG004|Received Empa + Rifampicin|Overall Study||3
10566641|NCT01634100|11722030|FG005|Received Empa + Rifampicin|Overall Study||3
10566642|NCT01634100|11722025|FG000|Received Empa + Probenecid|Overall Study||2
10566643|NCT01634100|11722026|FG001|Received Empa + Probenecid|Overall Study||3
10566644|NCT01634100|11722027|FG002|Received Empa + Probenecid|Overall Study||2
10566645|NCT01634100|11722028|FG003|Received Empa + Probenecid|Overall Study||3
10566646|NCT01634100|11722029|FG004|Received Empa + Probenecid|Overall Study||3
10566647|NCT01634100|11722030|FG005|Received Empa + Probenecid|Overall Study||3
10566648|NCT01634100|11722025|FG000|COMPLETED|Overall Study||2
10566649|NCT01634100|11722026|FG001|COMPLETED|Overall Study||3
10566650|NCT01634100|11722027|FG002|COMPLETED|Overall Study||2
10566651|NCT01634100|11722028|FG003|COMPLETED|Overall Study||3
10566652|NCT01634100|11722029|FG004|COMPLETED|Overall Study||3
10566653|NCT01634100|11722030|FG005|COMPLETED|Overall Study||3
10566654|NCT01634100|11722025|FG000|NOT COMPLETED|Overall Study||1
10566655|NCT01634100|11722026|FG001|NOT COMPLETED|Overall Study||0
10566656|NCT01634100|11722027|FG002|NOT COMPLETED|Overall Study||1
10566657|NCT01634100|11722028|FG003|NOT COMPLETED|Overall Study||0
10566658|NCT01634100|11722029|FG004|NOT COMPLETED|Overall Study||0
10566659|NCT01634100|11722030|FG005|NOT COMPLETED|Overall Study||0
10566660|NCT01634113|11722041|FG000|STARTED|Overall Study||34
10566661|NCT01634113|11722042|FG001|STARTED|Overall Study||36
10566662|NCT01634113|11722043|FG002|STARTED|Overall Study||32
10566663|NCT01634113|11722041|FG000|COMPLETED|Overall Study||34
10566664|NCT01634113|11722042|FG001|COMPLETED|Overall Study||36
10566665|NCT01634113|11722043|FG002|COMPLETED|Overall Study||31
10566666|NCT01634113|11722041|FG000|NOT COMPLETED|Overall Study||0
10566667|NCT01634113|11722042|FG001|NOT COMPLETED|Overall Study||0
10566668|NCT01634113|11722043|FG002|NOT COMPLETED|Overall Study||1
10566669|NCT01634139|11722054|FG000|STARTED|Overall Study||132
10566670|NCT01634139|11722055|FG001|STARTED|Overall Study||136
10566671|NCT01634139|11722056|FG002|STARTED|Overall Study||135
10566672|NCT01634139|11722054|FG000|COMPLETED|Overall Study||122
10566673|NCT01634139|11722055|FG001|COMPLETED|Overall Study||130
10566674|NCT01634139|11722056|FG002|COMPLETED|Overall Study||130
10566675|NCT01634139|11722054|FG000|NOT COMPLETED|Overall Study||10
10566676|NCT01634139|11722055|FG001|NOT COMPLETED|Overall Study||6
10566677|NCT01634139|11722056|FG002|NOT COMPLETED|Overall Study||5
10566678|NCT01634152|11722067|FG000|STARTED|Overall Study||134
10566679|NCT01634152|11722068|FG001|STARTED|Overall Study||137
10566680|NCT01634152|11722069|FG002|STARTED|Overall Study||130
10566681|NCT01634152|11722067|FG000|COMPLETED|Overall Study||130
10566682|NCT01634152|11722068|FG001|COMPLETED|Overall Study||136
10566683|NCT01634152|11722069|FG002|COMPLETED|Overall Study||126
10566684|NCT01634152|11722067|FG000|NOT COMPLETED|Overall Study||4
10566685|NCT01634152|11722068|FG001|NOT COMPLETED|Overall Study||1
10566686|NCT01634152|11722069|FG002|NOT COMPLETED|Overall Study||4
10566687|NCT01634165|11722077|FG000|STARTED|Period 1||6
10566688|NCT01634165|11722078|FG001|STARTED|Period 1||6
10566689|NCT01634165|11722079|FG002|STARTED|Period 1||6
10566690|NCT01634165|11722080|FG003|STARTED|Period 1||6
10566691|NCT01634165|11722077|FG000|Received at Least 1 Dose of Study Drug|Period 1||6
10566692|NCT01634165|11722078|FG001|Received at Least 1 Dose of Study Drug|Period 1||6
10566693|NCT01634165|11722079|FG002|Received at Least 1 Dose of Study Drug|Period 1||6
10566694|NCT01634165|11722080|FG003|Received at Least 1 Dose of Study Drug|Period 1||6
10566695|NCT01634165|11722077|FG000|COMPLETED|Period 1||6
10566696|NCT01634165|11722078|FG001|COMPLETED|Period 1||6
10566697|NCT01634165|11722079|FG002|COMPLETED|Period 1||6
10566698|NCT01634165|11722080|FG003|COMPLETED|Period 1||6
10566699|NCT01634165|11722077|FG000|NOT COMPLETED|Period 1||0
10566700|NCT01634165|11722078|FG001|NOT COMPLETED|Period 1||0
10566701|NCT01634165|11722079|FG002|NOT COMPLETED|Period 1||0
10566702|NCT01634165|11722080|FG003|NOT COMPLETED|Period 1||0
10566703|NCT01634165|11722077|FG000|STARTED|Period 2||6
10566704|NCT01634165|11722078|FG001|STARTED|Period 2||6
10793298|NCT03601715|11954073|FG001|COMPLETED|Second Intervention||6
10793300|NCT03601715|11954072|FG000|NOT COMPLETED|Second Intervention||1
10793301|NCT03601715|11954073|FG001|NOT COMPLETED|Second Intervention||1
10793302|NCT03601715|11954074|FG002|NOT COMPLETED|Second Intervention||0
10793303|NCT03601715|11954072|FG000|STARTED|Wash Out 2 (at Least 24 Hours)||6
10793304|NCT03601715|11954073|FG001|STARTED|Wash Out 2 (at Least 24 Hours)||6
10793305|NCT03601715|11954074|FG002|STARTED|Wash Out 2 (at Least 24 Hours)||6
10793306|NCT03601715|11954072|FG000|COMPLETED|Wash Out 2 (at Least 24 Hours)||6
10793307|NCT03601715|11954073|FG001|COMPLETED|Wash Out 2 (at Least 24 Hours)||6
10793308|NCT03601715|11954074|FG002|COMPLETED|Wash Out 2 (at Least 24 Hours)||6
10793309|NCT03601715|11954072|FG000|NOT COMPLETED|Wash Out 2 (at Least 24 Hours)||0
10793310|NCT03601715|11954073|FG001|NOT COMPLETED|Wash Out 2 (at Least 24 Hours)||0
10793311|NCT03601715|11954074|FG002|NOT COMPLETED|Wash Out 2 (at Least 24 Hours)||0
10793312|NCT03601715|11954072|FG000|STARTED|Third Intervention||6
10793313|NCT03601715|11954073|FG001|STARTED|Third Intervention||6
10793314|NCT03601715|11954074|FG002|STARTED|Third Intervention||6
10793315|NCT03601715|11954072|FG000|COMPLETED|Third Intervention||6
10793316|NCT03601715|11954073|FG001|COMPLETED|Third Intervention||6
10793317|NCT03601715|11954074|FG002|COMPLETED|Third Intervention||6
10793318|NCT03601715|11954072|FG000|NOT COMPLETED|Third Intervention||0
10793319|NCT03601715|11954073|FG001|NOT COMPLETED|Third Intervention||0
10793320|NCT03601715|11954074|FG002|NOT COMPLETED|Third Intervention||0
10793321|NCT03602053|11954085|FG000|STARTED|Overall Study||150
10793322|NCT03602053|11954086|FG001|STARTED|Overall Study||150
10793323|NCT03602053|11954087|FG002|STARTED|Overall Study||150
10566705|NCT01634165|11722079|FG002|STARTED|Period 2||6
10566706|NCT01634165|11722080|FG003|STARTED|Period 2||6
10566707|NCT01634165|11722077|FG000|COMPLETED|Period 2||6
10566708|NCT01634165|11722078|FG001|COMPLETED|Period 2||5
10566709|NCT01634165|11722079|FG002|COMPLETED|Period 2||6
10566710|NCT01634165|11722080|FG003|COMPLETED|Period 2||6
10566711|NCT01634165|11722077|FG000|NOT COMPLETED|Period 2||0
10566712|NCT01634165|11722078|FG001|NOT COMPLETED|Period 2||1
10566713|NCT01634165|11722079|FG002|NOT COMPLETED|Period 2||0
10566714|NCT01634165|11722080|FG003|NOT COMPLETED|Period 2||0
10566715|NCT01634165|11722077|FG000|STARTED|Period 3||6
10566716|NCT01634165|11722078|FG001|STARTED|Period 3||5
10566717|NCT01634165|11722079|FG002|STARTED|Period 3||6
10566718|NCT01634165|11722080|FG003|STARTED|Period 3||6
10566719|NCT01634165|11722077|FG000|COMPLETED|Period 3||6
10566720|NCT01634165|11722078|FG001|COMPLETED|Period 3||5
10566721|NCT01634165|11722079|FG002|COMPLETED|Period 3||6
10566722|NCT01634165|11722080|FG003|COMPLETED|Period 3||6
10566723|NCT01634165|11722077|FG000|NOT COMPLETED|Period 3||0
10566724|NCT01634165|11722078|FG001|NOT COMPLETED|Period 3||0
10566725|NCT01634165|11722079|FG002|NOT COMPLETED|Period 3||0
10566726|NCT01634165|11722080|FG003|NOT COMPLETED|Period 3||0
10566727|NCT01634165|11722077|FG000|STARTED|Period 4||6
10566728|NCT01634165|11722078|FG001|STARTED|Period 4||5
10566729|NCT01634165|11722079|FG002|STARTED|Period 4||6
10566730|NCT01634165|11722080|FG003|STARTED|Period 4||6
10566731|NCT01634165|11722077|FG000|COMPLETED|Period 4||6
10566732|NCT01634165|11722078|FG001|COMPLETED|Period 4||5
10566733|NCT01634165|11722079|FG002|COMPLETED|Period 4||6
10566734|NCT01634165|11722080|FG003|COMPLETED|Period 4||6
10566735|NCT01634165|11722077|FG000|NOT COMPLETED|Period 4||0
10566736|NCT01634165|11722078|FG001|NOT COMPLETED|Period 4||0
10566737|NCT01634165|11722079|FG002|NOT COMPLETED|Period 4||0
10566738|NCT01634165|11722080|FG003|NOT COMPLETED|Period 4||0
10566739|NCT01634178|11722090|FG000|STARTED|Treatment Period 1||23
10566740|NCT01634178|11722091|FG001|STARTED|Treatment Period 1||23
10566741|NCT01634178|11722090|FG000|COMPLETED|Treatment Period 1||23
10566742|NCT01634178|11722091|FG001|COMPLETED|Treatment Period 1||22
10566743|NCT01634178|11722090|FG000|NOT COMPLETED|Treatment Period 1||0
10566744|NCT01634178|11722091|FG001|NOT COMPLETED|Treatment Period 1||1
10566745|NCT01634178|11722090|FG000|STARTED|Treatment Period 2||23
10566746|NCT01634178|11722091|FG001|STARTED|Treatment Period 2||22
10566747|NCT01634178|11722090|FG000|COMPLETED|Treatment Period 2||22
10566748|NCT01634178|11722091|FG001|COMPLETED|Treatment Period 2||22
10566749|NCT01634178|11722090|FG000|NOT COMPLETED|Treatment Period 2||1
10566750|NCT01634178|11722091|FG001|NOT COMPLETED|Treatment Period 2||0
10566751|NCT01634191|11722102|FG000|STARTED|Overall Study||18
10566752|NCT01634191|11722103|FG001|STARTED|Overall Study||18
10566753|NCT01634191|11722102|FG000|COMPLETED|Overall Study||18
10566754|NCT01634191|11722103|FG001|COMPLETED|Overall Study||18
10566755|NCT01634191|11722102|FG000|NOT COMPLETED|Overall Study||0
10566756|NCT01634191|11722103|FG001|NOT COMPLETED|Overall Study||0
10566757|NCT01634243|11722122|FG000|STARTED|Overall Study||21
10566758|NCT01634243|11722123|FG001|STARTED|Overall Study||43
10566759|NCT01634243|11722122|FG000|COMPLETED|Overall Study||15
10566760|NCT01634243|11722123|FG001|COMPLETED|Overall Study||38
10566761|NCT01634243|11722122|FG000|NOT COMPLETED|Overall Study||6
10566762|NCT01634243|11722123|FG001|NOT COMPLETED|Overall Study||5
10566763|NCT01634256|11722131|FG000|STARTED|Overall Study||30
10566764|NCT01634256|11722132|FG001|STARTED|Overall Study||30
10566765|NCT01634256|11722131|FG000|COMPLETED|Overall Study||26
10566766|NCT01634256|11722132|FG001|COMPLETED|Overall Study||22
10566767|NCT01634256|11722131|FG000|NOT COMPLETED|Overall Study||4
10566768|NCT01634256|11722132|FG001|NOT COMPLETED|Overall Study||8
10566769|NCT01634269|11722138|FG000|STARTED|Overall Study||20
10566770|NCT01634269|11722138|FG000|30 Days|Overall Study||20
10566771|NCT01634269|11722138|FG000|6 Month|Overall Study||20
10566772|NCT01634269|11722138|FG000|12 Month|Overall Study||20
10566773|NCT01634269|11722138|FG000|24 Month|Overall Study||18
10566774|NCT01634269|11722138|FG000|COMPLETED|Overall Study||18
10566775|NCT01634269|11722138|FG000|NOT COMPLETED|Overall Study||2
10566776|NCT01634360|11722150|FG000|STARTED|Overall Study||49
10566777|NCT01634360|11722151|FG001|STARTED|Overall Study||136
10566778|NCT01634360|11722150|FG000|COMPLETED|Overall Study||0
10566779|NCT01634360|11722151|FG001|COMPLETED|Overall Study||0
10566780|NCT01634360|11722150|FG000|NOT COMPLETED|Overall Study||49
10566781|NCT01634360|11722151|FG001|NOT COMPLETED|Overall Study||136
10566782|NCT01634555|11722157|FG000|STARTED|Overall Study||29
10566783|NCT01634555|11722157|FG000|Received at Least 1 Dose of Study Drug|Overall Study||29
10566784|NCT01634555|11722157|FG000|Drug-Drug Interaction (DDI) Population|Overall Study|Completed the required treatment in Cycle 1, Day 1 and Cycle 2, Day 1.|25
10566785|NCT01634555|11722157|FG000|COMPLETED|Overall Study|Completed the required treatment and assessment.|25
10566786|NCT01634555|11722157|FG000|NOT COMPLETED|Overall Study||4
10566787|NCT01634620|11722162|FG000|STARTED|Overall Study||200
10566788|NCT01634620|11722162|FG000|COMPLETED|Overall Study||200
10566789|NCT01634620|11722162|FG000|NOT COMPLETED|Overall Study||0
10566790|NCT01634659|11722173|FG000|STARTED|Period 1 - First 8 Days of Wear||155
10566791|NCT01634659|11722174|FG001|STARTED|Period 1 - First 8 Days of Wear||158
10566792|NCT01634659|11722173|FG000|COMPLETED|Period 1 - First 8 Days of Wear||155
10566793|NCT01634659|11722174|FG001|COMPLETED|Period 1 - First 8 Days of Wear||158
10566794|NCT01634659|11722173|FG000|NOT COMPLETED|Period 1 - First 8 Days of Wear||0
10566795|NCT01634659|11722174|FG001|NOT COMPLETED|Period 1 - First 8 Days of Wear||0
10566796|NCT01634659|11722173|FG000|STARTED|Period 2 - Second 8 Days of Wear||155
10566797|NCT01634659|11722174|FG001|STARTED|Period 2 - Second 8 Days of Wear||158
10566798|NCT01634659|11722173|FG000|COMPLETED|Period 2 - Second 8 Days of Wear||152
10566799|NCT01634659|11722174|FG001|COMPLETED|Period 2 - Second 8 Days of Wear||158
10566800|NCT01634659|11722173|FG000|NOT COMPLETED|Period 2 - Second 8 Days of Wear||3
10566801|NCT01634659|11722174|FG001|NOT COMPLETED|Period 2 - Second 8 Days of Wear||0
10566802|NCT01634854|11722182|FG000|STARTED|Overall Study||64
10566803|NCT01634854|11722183|FG001|STARTED|Overall Study||66
10566804|NCT01634854|11722182|FG000|COMPLETED|Overall Study||62
10566805|NCT01634854|11722183|FG001|COMPLETED|Overall Study||59
10566806|NCT01634854|11722182|FG000|NOT COMPLETED|Overall Study||2
10566807|NCT01634854|11722183|FG001|NOT COMPLETED|Overall Study||7
10566808|NCT01635062|11722191|FG000|STARTED|Overall Study||9
10566809|NCT01635062|11722192|FG001|STARTED|Overall Study||9
10566810|NCT01635062|11722191|FG000|Sodium Restriction Baseline Visit|Overall Study||9
10566811|NCT01635062|11722192|FG001|Sodium Restriction Baseline Visit|Overall Study||9
10566812|NCT01635062|11722191|FG000|Sodium Loading Baseline Visit|Overall Study||9
10566813|NCT01635062|11722192|FG001|Sodium Loading Baseline Visit|Overall Study||9
10566814|NCT01635062|11722191|FG000|Post-randomization Sodium Restriction|Overall Study||9
10566815|NCT01635062|11722192|FG001|Post-randomization Sodium Restriction|Overall Study||9
10566816|NCT01635062|11722191|FG000|Post-Randomization Sodium Loaded|Overall Study||9
10566817|NCT01635062|11722192|FG001|Post-Randomization Sodium Loaded|Overall Study||9
10566818|NCT01635062|11722191|FG000|COMPLETED|Overall Study||9
10566819|NCT01635062|11722192|FG001|COMPLETED|Overall Study||9
10566820|NCT01635062|11722191|FG000|NOT COMPLETED|Overall Study||0
10566821|NCT01635062|11722192|FG001|NOT COMPLETED|Overall Study||0
10566822|NCT01635101|11722205|FG000|STARTED|Overall Study||61
10566823|NCT01635101|11722206|FG001|STARTED|Overall Study||67
10566824|NCT01635101|11722207|FG002|STARTED|Overall Study||69
10566825|NCT01635101|11722205|FG000|Safety Population|Overall Study||61
10566826|NCT01635101|11722206|FG001|Safety Population|Overall Study||67
10566827|NCT01635101|11722207|FG002|Safety Population|Overall Study||69
10566828|NCT01635101|11722205|FG000|Modified Intent to Treat (mITT)|Overall Study||61
10566829|NCT01635101|11722206|FG001|Modified Intent to Treat (mITT)|Overall Study||67
10566830|NCT01635101|11722207|FG002|Modified Intent to Treat (mITT)|Overall Study||69
10566831|NCT01635101|11722205|FG000|Pharmacokinetics Evaluable Population|Overall Study||50
10566832|NCT01635101|11722206|FG001|Pharmacokinetics Evaluable Population|Overall Study||59
10566833|NCT01635101|11722207|FG002|Pharmacokinetics Evaluable Population|Overall Study||58
10566834|NCT01635101|11722205|FG000|COMPLETED|Overall Study||52
10566835|NCT01635101|11722206|FG001|COMPLETED|Overall Study||55
10566836|NCT01635101|11722207|FG002|COMPLETED|Overall Study||52
10566837|NCT01635101|11722205|FG000|NOT COMPLETED|Overall Study||9
10566838|NCT01635101|11722206|FG001|NOT COMPLETED|Overall Study||12
10566839|NCT01635101|11722207|FG002|NOT COMPLETED|Overall Study||17
10566840|NCT01635153|11722220|FG000|STARTED|Overall Study||72
10566841|NCT01635153|11722221|FG001|STARTED|Overall Study||79
10566842|NCT01635153|11722220|FG000|COMPLETED|Overall Study||32
10566843|NCT01635153|11722221|FG001|COMPLETED|Overall Study||36
10566844|NCT01635153|11722220|FG000|NOT COMPLETED|Overall Study||40
10566845|NCT01635153|11722221|FG001|NOT COMPLETED|Overall Study||43
10566846|NCT01635218|11722230|FG000|STARTED|Overall Study||44
10566847|NCT01635218|11722231|FG001|STARTED|Overall Study||46
10566848|NCT01635218|11722232|FG002|STARTED|Overall Study||43
10566849|NCT01635218|11722230|FG000|COMPLETED|Overall Study||41
10566850|NCT01635218|11722231|FG001|COMPLETED|Overall Study||39
10566851|NCT01635218|11722232|FG002|COMPLETED|Overall Study||37
10566852|NCT01635218|11722230|FG000|NOT COMPLETED|Overall Study||3
10566853|NCT01635218|11722231|FG001|NOT COMPLETED|Overall Study||7
10566854|NCT01635218|11722232|FG002|NOT COMPLETED|Overall Study||6
10793324|NCT03602053|11954085|FG000|COMPLETED|Overall Study||131
10793325|NCT03602053|11954086|FG001|COMPLETED|Overall Study||132
10793326|NCT03602053|11954087|FG002|COMPLETED|Overall Study||139
10793327|NCT03602053|11954085|FG000|NOT COMPLETED|Overall Study||19
10793328|NCT03602053|11954086|FG001|NOT COMPLETED|Overall Study||18
10793329|NCT03602053|11954087|FG002|NOT COMPLETED|Overall Study||11
10793330|NCT03602339|11954099|FG000|STARTED|Overall Study||157
10793331|NCT03602339|11954099|FG000|Completed Period 1 (Gadoterate)|Overall Study||155
10566855|NCT01635244|11722243|FG000|STARTED|Overall Study||18
10566856|NCT01635244|11722244|FG001|STARTED|Overall Study||22
10566857|NCT01635244|11722245|FG002|STARTED|Overall Study||20
10566858|NCT01635244|11722243|FG000|COMPLETED|Overall Study||17
10566859|NCT01635244|11722244|FG001|COMPLETED|Overall Study||21
10566860|NCT01635244|11722245|FG002|COMPLETED|Overall Study||18
10566861|NCT01635244|11722243|FG000|NOT COMPLETED|Overall Study||1
10566862|NCT01635244|11722244|FG001|NOT COMPLETED|Overall Study||1
10566863|NCT01635244|11722245|FG002|NOT COMPLETED|Overall Study||2
10566864|NCT01635283|11722253|FG000|STARTED|Overall Study||5
10793332|NCT03602339|11954099|FG000|Started Period 2 (Gadobutrol)|Overall Study||142
10793333|NCT03602339|11954099|FG000|COMPLETED|Overall Study||142
10793334|NCT03602339|11954099|FG000|NOT COMPLETED|Overall Study||15
10793335|NCT03602482|11954108|FG000|STARTED|Overall Study||50
10793336|NCT03602482|11954109|FG001|STARTED|Overall Study||50
10793337|NCT03602482|11954110|FG002|STARTED|Overall Study||20
10793338|NCT03602482|11954111|FG003|STARTED|Overall Study||19
10793339|NCT03602482|11954108|FG000|COMPLETED|Overall Study||44
10793340|NCT03602482|11954109|FG001|COMPLETED|Overall Study||43
10793341|NCT03602482|11954110|FG002|COMPLETED|Overall Study||20
10793342|NCT03602482|11954111|FG003|COMPLETED|Overall Study||19
10793343|NCT03602482|11954108|FG000|NOT COMPLETED|Overall Study||6
10793344|NCT03602482|11954109|FG001|NOT COMPLETED|Overall Study||7
10793345|NCT03602482|11954110|FG002|NOT COMPLETED|Overall Study||0
10566865|NCT01635283|11722253|FG000|COMPLETED|Overall Study||1
10566866|NCT01635283|11722253|FG000|NOT COMPLETED|Overall Study||4
10566867|NCT01635439|11722262|FG000|STARTED|Overall Study||100
10566868|NCT01635439|11722263|FG001|STARTED|Overall Study||100
10566869|NCT01635439|11722262|FG000|COMPLETED|Overall Study||100
10566870|NCT01635439|11722263|FG001|COMPLETED|Overall Study||100
10566871|NCT01635439|11722262|FG000|NOT COMPLETED|Overall Study||0
10566872|NCT01635439|11722263|FG001|NOT COMPLETED|Overall Study||0
10566873|NCT01635504|11722269|FG000|STARTED|Overall Study||5
10566874|NCT01635504|11722269|FG000|COMPLETED|Overall Study||5
10318745|NCT00216476|11452970|FG000|NOT COMPLETED|Overall Study||105
10318746|NCT00216476|11452971|FG001|NOT COMPLETED|Overall Study||107
10318747|NCT00216476|11452972|FG002|NOT COMPLETED|Overall Study||17
10566875|NCT01635504|11722269|FG000|NOT COMPLETED|Overall Study||0
10566876|NCT01635764|11722278|FG000|STARTED|Overall Study||508
10566877|NCT01635764|11722278|FG000|COMPLETED|Overall Study||235
10566878|NCT01635764|11722278|FG000|NOT COMPLETED|Overall Study||273
10566879|NCT01635855|11722289|FG000|STARTED|Overall Study||117
10566880|NCT01635855|11722289|FG000|COMPLETED|Overall Study||113
10566881|NCT01635855|11722289|FG000|NOT COMPLETED|Overall Study||4
10566882|NCT01635881|11722293|FG000|STARTED|Overall Study||60
10566883|NCT01635881|11722293|FG000|COMPLETED|Overall Study||60
10566884|NCT01635881|11722293|FG000|NOT COMPLETED|Overall Study||0
10566885|NCT01635920|11722299|FG000|STARTED|Overall Study||125
10566886|NCT01635920|11722300|FG001|STARTED|Overall Study||126
10566887|NCT01635920|11722299|FG000|COMPLETED|Overall Study||122
10566888|NCT01635920|11722300|FG001|COMPLETED|Overall Study||125
10566889|NCT01635920|11722299|FG000|NOT COMPLETED|Overall Study||3
10566890|NCT01635920|11722300|FG001|NOT COMPLETED|Overall Study||1
10566891|NCT01635933|11722309|FG000|STARTED|Overall Study||178
10566892|NCT01635933|11722310|FG001|STARTED|Overall Study||185
10566893|NCT01635933|11722309|FG000|COMPLETED|Overall Study||176
10566894|NCT01635933|11722310|FG001|COMPLETED|Overall Study||177
10566895|NCT01635933|11722309|FG000|NOT COMPLETED|Overall Study||2
10566896|NCT01635933|11722310|FG001|NOT COMPLETED|Overall Study||8
10566897|NCT01635998|11722318|FG000|STARTED|Overall Study||28
10566898|NCT01635998|11722319|FG001|STARTED|Overall Study||22
10566899|NCT01635998|11722318|FG000|COMPLETED|Overall Study||24
10566900|NCT01635998|11722319|FG001|COMPLETED|Overall Study||15
10566901|NCT01635998|11722318|FG000|NOT COMPLETED|Overall Study||4
10566902|NCT01635998|11722319|FG001|NOT COMPLETED|Overall Study||7
10566903|NCT01636063|11722327|FG000|STARTED|Overall Study||21
10566904|NCT01636063|11722328|FG001|STARTED|Overall Study||21
10566905|NCT01636063|11722327|FG000|COMPLETED|Overall Study||21
10566906|NCT01636063|11722328|FG001|COMPLETED|Overall Study||21
10566907|NCT01636063|11722327|FG000|NOT COMPLETED|Overall Study||0
10566908|NCT01636063|11722328|FG001|NOT COMPLETED|Overall Study||0
10566909|NCT01636076|11722336|FG000|STARTED|Overall Study||316
10566910|NCT01636076|11722337|FG001|STARTED|Overall Study||313
10566911|NCT01636076|11722336|FG000|COMPLETED|Overall Study||299
10566912|NCT01636076|11722337|FG001|COMPLETED|Overall Study||288
10566913|NCT01636076|11722336|FG000|NOT COMPLETED|Overall Study||17
10566914|NCT01636076|11722337|FG001|NOT COMPLETED|Overall Study||25
10566915|NCT01636102|11722352|FG000|STARTED|Overall Study||63
10566916|NCT01636102|11722353|FG001|STARTED|Overall Study||63
10566917|NCT01636102|11722352|FG000|COMPLETED|Overall Study||63
10566918|NCT01636102|11722353|FG001|COMPLETED|Overall Study||63
10566919|NCT01636102|11722352|FG000|NOT COMPLETED|Overall Study||0
10566920|NCT01636102|11722353|FG001|NOT COMPLETED|Overall Study||0
10566921|NCT01636206|11722362|FG000|STARTED|Overall Study||111
10566922|NCT01636206|11722363|FG001|STARTED|Overall Study||221
10566923|NCT01636206|11722362|FG000|COMPLETED|Overall Study||92
10566924|NCT01636206|11722363|FG001|COMPLETED|Overall Study||170
10566925|NCT01636206|11722362|FG000|NOT COMPLETED|Overall Study||19
10566926|NCT01636206|11722363|FG001|NOT COMPLETED|Overall Study||51
10566927|NCT01636284|11722369|FG000|STARTED|Overall Study||16
10566928|NCT01636284|11722369|FG000|COMPLETED|Overall Study||16
10566929|NCT01636284|11722369|FG000|NOT COMPLETED|Overall Study||0
10566930|NCT01636297|11722376|FG000|STARTED|Overall Study||40
10566931|NCT01636297|11722377|FG001|STARTED|Overall Study||40
10566932|NCT01636297|11722378|FG002|STARTED|Overall Study||20
10566933|NCT01636297|11722376|FG000|COMPLETED|Overall Study||36
10566934|NCT01636297|11722377|FG001|COMPLETED|Overall Study||36
10566935|NCT01636297|11722378|FG002|COMPLETED|Overall Study||19
10566936|NCT01636297|11722376|FG000|NOT COMPLETED|Overall Study||4
10566937|NCT01636297|11722377|FG001|NOT COMPLETED|Overall Study||4
10566938|NCT01636297|11722378|FG002|NOT COMPLETED|Overall Study||1
10566939|NCT01636362|11722388|FG000|STARTED|Overall Study||45
10566940|NCT01636362|11722388|FG000|COMPLETED|Overall Study||37
10566941|NCT01636362|11722388|FG000|NOT COMPLETED|Overall Study||8
10566942|NCT01636414|11722395|FG000|STARTED|Overall Study||64
10566943|NCT01636414|11722396|FG001|STARTED|Overall Study||66
10566944|NCT01636414|11722397|FG002|STARTED|Overall Study||74
10566945|NCT01636414|11722395|FG000|COMPLETED|Overall Study||61
10566946|NCT01636414|11722396|FG001|COMPLETED|Overall Study||60
10566947|NCT01636414|11722397|FG002|COMPLETED|Overall Study||65
10318748|NCT00216671|11452985|FG000|STARTED|Overall Study||110
10566948|NCT01636414|11722395|FG000|NOT COMPLETED|Overall Study||3
10566949|NCT01636414|11722396|FG001|NOT COMPLETED|Overall Study||6
10566950|NCT01636414|11722397|FG002|NOT COMPLETED|Overall Study||9
10566951|NCT01636453|11722405|FG000|STARTED|Overall Study||120
10566952|NCT01636453|11722405|FG000|COMPLETED|Overall Study||112
10566953|NCT01636453|11722405|FG000|NOT COMPLETED|Overall Study||8
10566954|NCT01636661|11722411|FG000|STARTED|Overall Study||5
10566955|NCT01636661|11722412|FG001|STARTED|Overall Study||6
10566956|NCT01636661|11722411|FG000|COMPLETED|Overall Study||5
10566957|NCT01636661|11722412|FG001|COMPLETED|Overall Study||6
10566958|NCT01636661|11722411|FG000|NOT COMPLETED|Overall Study||0
10566959|NCT01636661|11722412|FG001|NOT COMPLETED|Overall Study||0
10566960|NCT01636687|11722421|FG000|STARTED|Induction Period||61
10566961|NCT01636687|11722422|FG001|STARTED|Induction Period||60
10566962|NCT01636687|11722423|FG002|STARTED|Induction Period||0
10566963|NCT01636687|11722424|FG003|STARTED|Induction Period||0
10566964|NCT01636687|11722425|FG004|STARTED|Induction Period||61
10566965|NCT01636687|11722421|FG000|COMPLETED|Induction Period||58
10566966|NCT01636687|11722422|FG001|COMPLETED|Induction Period||60
10566967|NCT01636687|11722423|FG002|COMPLETED|Induction Period||0
10566968|NCT01636687|11722424|FG003|COMPLETED|Induction Period||0
10566969|NCT01636687|11722425|FG004|COMPLETED|Induction Period||59
10566970|NCT01636687|11722421|FG000|NOT COMPLETED|Induction Period||3
10566971|NCT01636687|11722422|FG001|NOT COMPLETED|Induction Period||0
10566972|NCT01636687|11722423|FG002|NOT COMPLETED|Induction Period||0
10566973|NCT01636687|11722424|FG003|NOT COMPLETED|Induction Period||0
10566974|NCT01636687|11722425|FG004|NOT COMPLETED|Induction Period||2
10566975|NCT01636687|11722421|FG000|STARTED|Maintenance Period||58
10566976|NCT01636687|11722422|FG001|STARTED|Maintenance Period||60
10566977|NCT01636687|11722423|FG002|STARTED|Maintenance Period||28
10566978|NCT01636687|11722424|FG003|STARTED|Maintenance Period||28
10566979|NCT01636687|11722425|FG004|STARTED|Maintenance Period||3
10566980|NCT01636687|11722421|FG000|COMPLETED|Maintenance Period||50
10566981|NCT01636687|11722422|FG001|COMPLETED|Maintenance Period||58
10566982|NCT01636687|11722423|FG002|COMPLETED|Maintenance Period||26
10566983|NCT01636687|11722424|FG003|COMPLETED|Maintenance Period||28
10566984|NCT01636687|11722425|FG004|COMPLETED|Maintenance Period||1
10566985|NCT01636687|11722421|FG000|NOT COMPLETED|Maintenance Period||8
10566986|NCT01636687|11722422|FG001|NOT COMPLETED|Maintenance Period||2
10566987|NCT01636687|11722423|FG002|NOT COMPLETED|Maintenance Period||2
10566988|NCT01636687|11722424|FG003|NOT COMPLETED|Maintenance Period||0
10566989|NCT01636687|11722425|FG004|NOT COMPLETED|Maintenance Period||2
10566990|NCT01636687|11722421|FG000|STARTED|Extension Period||47
10566991|NCT01636687|11722422|FG001|STARTED|Extension Period||54
10566992|NCT01636687|11722423|FG002|STARTED|Extension Period||25
10566993|NCT01636687|11722424|FG003|STARTED|Extension Period||28
10566994|NCT01636687|11722425|FG004|STARTED|Extension Period||0
10566995|NCT01636687|11722421|FG000|COMPLETED|Extension Period||0
10566996|NCT01636687|11722422|FG001|COMPLETED|Extension Period||0
10566997|NCT01636687|11722423|FG002|COMPLETED|Extension Period||0
10566998|NCT01636687|11722424|FG003|COMPLETED|Extension Period||0
10566999|NCT01636687|11722425|FG004|COMPLETED|Extension Period||0
10567000|NCT01636687|11722421|FG000|NOT COMPLETED|Extension Period||47
10567001|NCT01636687|11722422|FG001|NOT COMPLETED|Extension Period||54
10567002|NCT01636687|11722423|FG002|NOT COMPLETED|Extension Period||25
10567003|NCT01636687|11722424|FG003|NOT COMPLETED|Extension Period||28
10567004|NCT01636687|11722425|FG004|NOT COMPLETED|Extension Period||0
10567005|NCT01636687|11722421|FG000|STARTED|Follow-up Period||38
10567006|NCT01636687|11722422|FG001|STARTED|Follow-up Period||45
10567007|NCT01636687|11722423|FG002|STARTED|Follow-up Period||21
10567008|NCT01636687|11722424|FG003|STARTED|Follow-up Period||20
10567009|NCT01636687|11722425|FG004|STARTED|Follow-up Period||2
10567010|NCT01636687|11722421|FG000|COMPLETED|Follow-up Period||37
10567011|NCT01636687|11722422|FG001|COMPLETED|Follow-up Period||45
10567012|NCT01636687|11722423|FG002|COMPLETED|Follow-up Period||21
10567013|NCT01636687|11722424|FG003|COMPLETED|Follow-up Period||20
10567014|NCT01636687|11722425|FG004|COMPLETED|Follow-up Period||1
10567015|NCT01636687|11722421|FG000|NOT COMPLETED|Follow-up Period||1
10567016|NCT01636687|11722422|FG001|NOT COMPLETED|Follow-up Period||0
10567017|NCT01636687|11722423|FG002|NOT COMPLETED|Follow-up Period||0
10567018|NCT01636687|11722424|FG003|NOT COMPLETED|Follow-up Period||0
10567019|NCT01636687|11722425|FG004|NOT COMPLETED|Follow-up Period||1
10567020|NCT01636713|11722446|FG000|STARTED|Overall Study||193
10567021|NCT01636713|11722447|FG001|STARTED|Overall Study||194
10567022|NCT01636713|11722448|FG002|STARTED|Overall Study||193
10567023|NCT01636713|11722446|FG000|COMPLETED|Overall Study||161
10567024|NCT01636713|11722447|FG001|COMPLETED|Overall Study||166
10567025|NCT01636713|11722448|FG002|COMPLETED|Overall Study||170
10567026|NCT01636713|11722446|FG000|NOT COMPLETED|Overall Study||32
10567027|NCT01636713|11722447|FG001|NOT COMPLETED|Overall Study||28
10567028|NCT01636713|11722448|FG002|NOT COMPLETED|Overall Study||23
10567029|NCT01636765|11722456|FG000|STARTED|Overall Study||104
10567030|NCT01636765|11722456|FG000|COMPLETED|Overall Study||104
10567031|NCT01636765|11722456|FG000|NOT COMPLETED|Overall Study||0
10567032|NCT01636778|11722460|FG000|STARTED|Pre-Antiviral Treatment Period (Part 1)||45
10567033|NCT01636778|11722461|FG001|STARTED|Pre-Antiviral Treatment Period (Part 1)||0
10567034|NCT01636778|11722462|FG002|STARTED|Pre-Antiviral Treatment Period (Part 1)||0
10567035|NCT01636778|11722460|FG000|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||41
10567036|NCT01636778|11722461|FG001|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
10567037|NCT01636778|11722462|FG002|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
10567038|NCT01636778|11722460|FG000|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||4
10567039|NCT01636778|11722461|FG001|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
10567040|NCT01636778|11722462|FG002|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
10567041|NCT01636778|11722460|FG000|STARTED|Antiviral Treatment Period (Part 2)||0
10567042|NCT01636778|11722461|FG001|STARTED|Antiviral Treatment Period (Part 2)||41
10567043|NCT01636778|11722462|FG002|STARTED|Antiviral Treatment Period (Part 2)||0
10567044|NCT01636778|11722460|FG000|COMPLETED|Antiviral Treatment Period (Part 2)||0
10567045|NCT01636778|11722461|FG001|COMPLETED|Antiviral Treatment Period (Part 2)||31
10567046|NCT01636778|11722462|FG002|COMPLETED|Antiviral Treatment Period (Part 2)||0
10567047|NCT01636778|11722460|FG000|NOT COMPLETED|Antiviral Treatment Period (Part 2)||0
10567048|NCT01636778|11722461|FG001|NOT COMPLETED|Antiviral Treatment Period (Part 2)||10
10567049|NCT01636778|11722462|FG002|NOT COMPLETED|Antiviral Treatment Period (Part 2)||0
10567050|NCT01636778|11722460|FG000|STARTED|Follow-up Period After Part 2||0
10567051|NCT01636778|11722461|FG001|STARTED|Follow-up Period After Part 2||0
10567052|NCT01636778|11722462|FG002|STARTED|Follow-up Period After Part 2||41
10567053|NCT01636778|11722460|FG000|COMPLETED|Follow-up Period After Part 2||0
10567054|NCT01636778|11722461|FG001|COMPLETED|Follow-up Period After Part 2||0
10567055|NCT01636778|11722462|FG002|COMPLETED|Follow-up Period After Part 2||37
10567056|NCT01636778|11722460|FG000|NOT COMPLETED|Follow-up Period After Part 2||0
10567057|NCT01636778|11722461|FG001|NOT COMPLETED|Follow-up Period After Part 2||0
10567058|NCT01636778|11722462|FG002|NOT COMPLETED|Follow-up Period After Part 2||4
10567059|NCT01636882|11722470|FG000|STARTED|Overall Study||16
10567060|NCT01636882|11722470|FG000|COMPLETED|Overall Study||16
10567061|NCT01636882|11722470|FG000|NOT COMPLETED|Overall Study||0
10567062|NCT01636934|11722476|FG000|STARTED|Overall Study||25
10567063|NCT01636934|11722477|FG001|STARTED|Overall Study||24
10567064|NCT01636934|11722476|FG000|COMPLETED|Overall Study||19
10567065|NCT01636934|11722477|FG001|COMPLETED|Overall Study||21
10567066|NCT01636934|11722476|FG000|NOT COMPLETED|Overall Study||6
10567067|NCT01636934|11722477|FG001|NOT COMPLETED|Overall Study||3
10567068|NCT01636947|11722485|FG000|STARTED|Overall Study||244
10567069|NCT01636947|11722486|FG001|STARTED|Overall Study||250
10567070|NCT01636947|11722485|FG000|Treated|Overall Study||242
10567071|NCT01636947|11722486|FG001|Treated|Overall Study||248
10567072|NCT01636947|11722485|FG000|COMPLETED|Overall Study||232
10567073|NCT01636947|11722486|FG001|COMPLETED|Overall Study||239
10567074|NCT01636947|11722485|FG000|NOT COMPLETED|Overall Study||12
10567075|NCT01636947|11722486|FG001|NOT COMPLETED|Overall Study||11
10567076|NCT01636960|11722492|FG000|STARTED|Induction Phase||9
10567077|NCT01636960|11722492|FG000|COMPLETED|Induction Phase|Participants continuing into Maintenance Phase|7
10567078|NCT01636960|11722492|FG000|NOT COMPLETED|Induction Phase||2
10567079|NCT01636960|11722492|FG000|STARTED|Maintenance Phase||7
10567080|NCT01636960|11722492|FG000|COMPLETED|Maintenance Phase||0
10567081|NCT01636960|11722492|FG000|NOT COMPLETED|Maintenance Phase||7
10567082|NCT01636986|11722498|FG000|STARTED|Overall Study||30
10567083|NCT01636986|11722499|FG001|STARTED|Overall Study||32
10567084|NCT01636986|11722498|FG000|COMPLETED|Overall Study||30
10567085|NCT01636986|11722499|FG001|COMPLETED|Overall Study||30
10567086|NCT01636986|11722498|FG000|NOT COMPLETED|Overall Study||0
10567087|NCT01636986|11722499|FG001|NOT COMPLETED|Overall Study||2
10567088|NCT01637077|11722507|FG000|STARTED|Overall Study||23
10567089|NCT01637077|11722508|FG001|STARTED|Overall Study||23
10567090|NCT01637077|11722507|FG000|COMPLETED|Overall Study||19
10567091|NCT01637077|11722508|FG001|COMPLETED|Overall Study||22
10567092|NCT01637077|11722507|FG000|NOT COMPLETED|Overall Study||4
10567093|NCT01637077|11722508|FG001|NOT COMPLETED|Overall Study||1
10567094|NCT01637090|11722514|FG000|STARTED|Overall Study||3
10567095|NCT01637090|11722514|FG000|COMPLETED|Overall Study||0
10567096|NCT01637090|11722514|FG000|NOT COMPLETED|Overall Study||3
10567097|NCT01637142|11722518|FG000|STARTED|Treatment Period 1||18
10567098|NCT01637142|11722518|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||18
10567099|NCT01637142|11722518|FG000|COMPLETED|Treatment Period 1||18
10567100|NCT01637142|11722518|FG000|NOT COMPLETED|Treatment Period 1||0
10567101|NCT01637142|11722518|FG000|STARTED|Washout Period (at Least 3 Days)||18
10567102|NCT01637142|11722518|FG000|COMPLETED|Washout Period (at Least 3 Days)||17
10567103|NCT01637142|11722518|FG000|NOT COMPLETED|Washout Period (at Least 3 Days)||1
10567104|NCT01637142|11722518|FG000|STARTED|Treatment Period 2||17
10567105|NCT01637142|11722518|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 2||17
10567106|NCT01637142|11722518|FG000|COMPLETED|Treatment Period 2||17
10567107|NCT01637142|11722518|FG000|NOT COMPLETED|Treatment Period 2||0
10567108|NCT01637246|11722524|FG000|STARTED|Overall Study||4385
10567109|NCT01637246|11722524|FG000|COMPLETED|Overall Study||2246
10567110|NCT01637246|11722524|FG000|NOT COMPLETED|Overall Study||2139
10567111|NCT01637272|11722528|FG000|STARTED|Overall Study||43
10567112|NCT01637272|11722528|FG000|Completed sc Phase|Overall Study||33
10567113|NCT01637272|11722528|FG000|Completed Core Phase (sc + LAR)|Overall Study||31
10567114|NCT01637272|11722528|FG000|Entered Extension Phase|Overall Study||27
10567115|NCT01637272|11722528|FG000|Completed Core But Did no Enter Ext..|Overall Study||4
10567116|NCT01637272|11722528|FG000|COMPLETED|Overall Study||23
10567117|NCT01637272|11722528|FG000|NOT COMPLETED|Overall Study||20
10567118|NCT01637402|11722547|FG000|STARTED|Standard Dose Regimen||41
10567119|NCT01637402|11722548|FG001|STARTED|Standard Dose Regimen|Escalated dose not introduced as treatment option until after Week 12 evaluation|0
10567120|NCT01637402|11722547|FG000|COMPLETED|Standard Dose Regimen||38
10567121|NCT01637402|11722548|FG001|COMPLETED|Standard Dose Regimen||0
10567122|NCT01637402|11722547|FG000|NOT COMPLETED|Standard Dose Regimen||3
10567123|NCT01637402|11722548|FG001|NOT COMPLETED|Standard Dose Regimen||0
10567124|NCT01637402|11722547|FG000|STARTED|Week 12 Evaluation||38
10567125|NCT01637402|11722548|FG001|STARTED|Week 12 Evaluation|Escalated dose not introduced as treatment option until after Week 12 evaluation|0
10567126|NCT01637402|11722547|FG000|COMPLETED|Week 12 Evaluation||32
10567127|NCT01637402|11722548|FG001|COMPLETED|Week 12 Evaluation||0
10567128|NCT01637402|11722547|FG000|NOT COMPLETED|Week 12 Evaluation||6
10567129|NCT01637402|11722548|FG001|NOT COMPLETED|Week 12 Evaluation||0
10567130|NCT01637402|11722547|FG000|STARTED|Treatment Regiments Post Week 12|Patients continuing on standard dose|14
10567131|NCT01637402|11722548|FG001|STARTED|Treatment Regiments Post Week 12|Patients who progressed after decline on standard dose|18
10567132|NCT01637402|11722547|FG000|COMPLETED|Treatment Regiments Post Week 12||5
10567133|NCT01637402|11722548|FG001|COMPLETED|Treatment Regiments Post Week 12||14
10567134|NCT01637402|11722547|FG000|NOT COMPLETED|Treatment Regiments Post Week 12||9
10567135|NCT01637402|11722548|FG001|NOT COMPLETED|Treatment Regiments Post Week 12||4
10567136|NCT01637584|11722575|FG000|STARTED|Overall Study||20
10567137|NCT01637584|11722576|FG001|STARTED|Overall Study||20
10567138|NCT01637584|11722575|FG000|COMPLETED|Overall Study||19
10567139|NCT01637584|11722576|FG001|COMPLETED|Overall Study||17
10567140|NCT01637584|11722575|FG000|NOT COMPLETED|Overall Study||1
10567141|NCT01637584|11722576|FG001|NOT COMPLETED|Overall Study||3
10567142|NCT01637623|11722586|FG000|STARTED|Overall Study||29
10567143|NCT01637623|11722587|FG001|STARTED|Overall Study||30
10567144|NCT01637623|11722588|FG002|STARTED|Overall Study||28
10567145|NCT01637623|11722586|FG000|Received Intervention|Overall Study||28
10567146|NCT01637623|11722587|FG001|Received Intervention|Overall Study||30
10567147|NCT01637623|11722588|FG002|Received Intervention|Overall Study||27
10567148|NCT01637623|11722586|FG000|Did Not Receive Intervention|Overall Study||1
10567149|NCT01637623|11722587|FG001|Did Not Receive Intervention|Overall Study||0
10567150|NCT01637623|11722588|FG002|Did Not Receive Intervention|Overall Study||1
10567151|NCT01637623|11722586|FG000|Analyzed|Overall Study||28
10567152|NCT01637623|11722587|FG001|Analyzed|Overall Study||30
10567153|NCT01637623|11722588|FG002|Analyzed|Overall Study||28
10567154|NCT01637623|11722586|FG000|COMPLETED|Overall Study||28
10567155|NCT01637623|11722587|FG001|COMPLETED|Overall Study||30
10567156|NCT01637623|11722588|FG002|COMPLETED|Overall Study||25
10567157|NCT01637623|11722586|FG000|NOT COMPLETED|Overall Study||1
10567158|NCT01637623|11722587|FG001|NOT COMPLETED|Overall Study||0
10567159|NCT01637623|11722588|FG002|NOT COMPLETED|Overall Study||3
10567160|NCT01637870|11722596|FG000|STARTED|Overall Study||110
10567161|NCT01637870|11722596|FG000|COMPLETED|Overall Study||110
10567162|NCT01637870|11722596|FG000|NOT COMPLETED|Overall Study||0
10567163|NCT01637922|11722602|FG000|STARTED|Overall Study||15
10567164|NCT01637922|11722603|FG001|STARTED|Overall Study||19
10567165|NCT01637922|11722602|FG000|COMPLETED|Overall Study||13
10567166|NCT01637922|11722603|FG001|COMPLETED|Overall Study||14
10567167|NCT01637922|11722602|FG000|NOT COMPLETED|Overall Study||2
10567168|NCT01637922|11722603|FG001|NOT COMPLETED|Overall Study||5
10567169|NCT01637935|11722612|FG000|STARTED|Overall Study||34181
10567170|NCT01637935|11722613|FG001|STARTED|Overall Study||158918
10567171|NCT01637935|11722612|FG000|COMPLETED|Overall Study||34181
10567172|NCT01637935|11722613|FG001|COMPLETED|Overall Study||158918
10567173|NCT01637935|11722612|FG000|NOT COMPLETED|Overall Study||0
10567174|NCT01637935|11722613|FG001|NOT COMPLETED|Overall Study||0
10567175|NCT01637961|11722619|FG000|STARTED|Overall Study||23
10567176|NCT01637961|11722619|FG000|COMPLETED|Overall Study|Eligible and treated patients.|21
10567177|NCT01637961|11722619|FG000|NOT COMPLETED|Overall Study||2
10567178|NCT01638000|11722631|FG000|STARTED|Overall Study||943
10567179|NCT01638000|11722632|FG001|STARTED|Overall Study||944
10567180|NCT01638000|11722631|FG000|Received at Least 1 Double-Blind Dose|Overall Study||936
10567181|NCT01638000|11722632|FG001|Received at Least 1 Double-Blind Dose|Overall Study||934
10567182|NCT01638000|11722631|FG000|COMPLETED|Overall Study||883
10567183|NCT01638000|11722632|FG001|COMPLETED|Overall Study||873
10567184|NCT01638000|11722631|FG000|NOT COMPLETED|Overall Study||60
10567185|NCT01638000|11722632|FG001|NOT COMPLETED|Overall Study||71
10567186|NCT01638013|11722641|FG000|STARTED|Overall Study||201
10567187|NCT01638013|11722642|FG001|STARTED|Overall Study||225
10567188|NCT01638013|11722643|FG002|STARTED|Overall Study||417
10567189|NCT01638013|11722641|FG000|COMPLETED|Overall Study||70
10567190|NCT01638013|11722642|FG001|COMPLETED|Overall Study||147
10567191|NCT01638013|11722643|FG002|COMPLETED|Overall Study||296
10567192|NCT01638013|11722641|FG000|NOT COMPLETED|Overall Study||131
10567193|NCT01638013|11722642|FG001|NOT COMPLETED|Overall Study||78
10567194|NCT01638013|11722643|FG002|NOT COMPLETED|Overall Study||121
10567195|NCT01638052|11722657|FG000|STARTED|Overall Study||28
10567196|NCT01638052|11722658|FG001|STARTED|Overall Study||28
10567197|NCT01638052|11722657|FG000|COMPLETED|Overall Study||28
10567198|NCT01638052|11722658|FG001|COMPLETED|Overall Study||28
10567199|NCT01638052|11722657|FG000|NOT COMPLETED|Overall Study||0
10793346|NCT03602482|11954111|FG003|NOT COMPLETED|Overall Study||0
10793347|NCT03603028|11954124|FG000|STARTED|Overall Study||13
10793348|NCT03603028|11954124|FG000|COMPLETED|Overall Study||12
10793349|NCT03603028|11954124|FG000|NOT COMPLETED|Overall Study||1
10793350|NCT03603106|11954139|FG000|STARTED|Overall Study||6
10793351|NCT03603106|11954140|FG001|STARTED|Overall Study||6
10567200|NCT01638052|11722658|FG001|NOT COMPLETED|Overall Study||0
10567201|NCT01638312|11722666|FG000|STARTED|Overall Study||20
10567202|NCT01638312|11722667|FG001|STARTED|Overall Study||30
10567203|NCT01638312|11722666|FG000|COMPLETED|Overall Study||20
10567204|NCT01638312|11722667|FG001|COMPLETED|Overall Study||30
10567205|NCT01638312|11722666|FG000|NOT COMPLETED|Overall Study||0
10567206|NCT01638312|11722667|FG001|NOT COMPLETED|Overall Study||0
10567207|NCT01638390|11722673|FG000|STARTED|Overall Study|enrolled|357
10567208|NCT01638390|11722673|FG000|COMPLETED|Overall Study|treated eyes|336
10567209|NCT01638390|11722673|FG000|NOT COMPLETED|Overall Study||21
10567210|NCT01638416|11722686|FG000|STARTED|Overall Study||2490
10567211|NCT01638416|11722687|FG001|STARTED|Overall Study||2504
10793352|NCT03603106|11954141|FG002|STARTED|Overall Study||6
10793353|NCT03603106|11954142|FG003|STARTED|Overall Study||6
10793354|NCT03603106|11954143|FG004|STARTED|Overall Study||6
10793355|NCT03603106|11954144|FG005|STARTED|Overall Study||6
10567212|NCT01638416|11722686|FG000|COMPLETED|Overall Study||2457
10567213|NCT01638416|11722687|FG001|COMPLETED|Overall Study||2462
10567214|NCT01638416|11722686|FG000|NOT COMPLETED|Overall Study||33
10567215|NCT01638416|11722687|FG001|NOT COMPLETED|Overall Study||42
10567216|NCT01638429|11722694|FG000|STARTED|Overall Study||12
10567217|NCT01638429|11722694|FG000|Pre-treatment Testing|Overall Study||11
10567218|NCT01638429|11722694|FG000|Antibiotic Treatment|Overall Study||11
10567219|NCT01638429|11722694|FG000|Post-treatment Testing|Overall Study||11
10567220|NCT01638429|11722694|FG000|COMPLETED|Overall Study||11
10567221|NCT01638429|11722694|FG000|NOT COMPLETED|Overall Study||1
10567222|NCT01638468|11722702|FG000|STARTED|Overall Study||7
10567223|NCT01638468|11722702|FG000|COMPLETED|Overall Study||7
10567224|NCT01638468|11722702|FG000|NOT COMPLETED|Overall Study||0
10567225|NCT01638507|11722706|FG000|STARTED|Overall Study||230
10567226|NCT01638507|11722706|FG000|COMPLETED|Overall Study||224
10567227|NCT01638507|11722706|FG000|NOT COMPLETED|Overall Study||6
10567228|NCT01638546|11722714|FG000|STARTED|Overall Study||52
10567229|NCT01638546|11722715|FG001|STARTED|Overall Study||45
10567230|NCT01638546|11722714|FG000|COMPLETED|Overall Study||51
10567231|NCT01638546|11722715|FG001|COMPLETED|Overall Study||42
10567232|NCT01638546|11722714|FG000|NOT COMPLETED|Overall Study||1
10567233|NCT01638546|11722715|FG001|NOT COMPLETED|Overall Study||3
10567234|NCT01638559|11722723|FG000|STARTED|Overall Study||88
10567235|NCT01638559|11722723|FG000|COMPLETED|Overall Study|Completion through the time of the primary endpoint (outcome).|85
10567236|NCT01638559|11722723|FG000|NOT COMPLETED|Overall Study||3
10567237|NCT01638819|11722740|FG000|STARTED|Overall Study||15
10567238|NCT01638819|11722741|FG001|STARTED|Overall Study||15
10567239|NCT01638819|11722740|FG000|First Intervention (8 Weeks)|Overall Study||15
10567240|NCT01638819|11722741|FG001|First Intervention (8 Weeks)|Overall Study||15
10567241|NCT01638819|11722740|FG000|Second Intervention (24 Weeks)|Overall Study||14
10567242|NCT01638819|11722741|FG001|Second Intervention (24 Weeks)|Overall Study||15
10567243|NCT01638819|11722740|FG000|COMPLETED|Overall Study||14
10567244|NCT01638819|11722741|FG001|COMPLETED|Overall Study||15
10567245|NCT01638819|11722740|FG000|NOT COMPLETED|Overall Study||1
10567246|NCT01638819|11722741|FG001|NOT COMPLETED|Overall Study||0
10567247|NCT01639001|11722748|FG000|STARTED|Overall Study||104
10567248|NCT01639001|11722749|FG001|STARTED|Overall Study||103
10567249|NCT01639001|11722748|FG000|Treated|Overall Study||104
10567250|NCT01639001|11722749|FG001|Treated|Overall Study||101
10567251|NCT01639001|11722748|FG000|COMPLETED|Overall Study||29
10567252|NCT01639001|11722749|FG001|COMPLETED|Overall Study||26
10567253|NCT01639001|11722748|FG000|NOT COMPLETED|Overall Study||75
10567254|NCT01639001|11722749|FG001|NOT COMPLETED|Overall Study||77
10567255|NCT01639040|11722759|FG000|STARTED|Overall Study||10
10567256|NCT01639040|11722760|FG001|STARTED|Overall Study||21
10567257|NCT01639040|11722759|FG000|COMPLETED|Overall Study||9
10567258|NCT01639040|11722760|FG001|COMPLETED|Overall Study||21
10567259|NCT01639040|11722759|FG000|NOT COMPLETED|Overall Study||1
10567260|NCT01639040|11722760|FG001|NOT COMPLETED|Overall Study||0
10567261|NCT01639144|11722771|FG000|STARTED|Overall Study||260
10793356|NCT03603106|11954145|FG006|STARTED|Overall Study||18
10793357|NCT03603106|11954146|FG007|STARTED|Overall Study||3
10793358|NCT03603106|11954147|FG008|STARTED|Overall Study||3
10793359|NCT03603106|11954148|FG009|STARTED|Overall Study||3
10793360|NCT03603106|11954149|FG010|STARTED|Overall Study||3
10793361|NCT03603106|11954139|FG000|COMPLETED|Overall Study||6
10793362|NCT03603106|11954140|FG001|COMPLETED|Overall Study||6
10793363|NCT03603106|11954141|FG002|COMPLETED|Overall Study||6
10793364|NCT03603106|11954142|FG003|COMPLETED|Overall Study||6
10567262|NCT01639144|11722772|FG001|STARTED|Overall Study||255
10567263|NCT01639144|11722771|FG000|COMPLETED|Overall Study||250
10567264|NCT01639144|11722772|FG001|COMPLETED|Overall Study||250
10567265|NCT01639144|11722771|FG000|NOT COMPLETED|Overall Study||10
10567266|NCT01639144|11722772|FG001|NOT COMPLETED|Overall Study||5
10567267|NCT01639157|11722778|FG000|STARTED|Overall Study||4
10567268|NCT01639157|11722779|FG001|STARTED|Overall Study||5
10567269|NCT01639157|11722778|FG000|COMPLETED|Overall Study||4
10567270|NCT01639157|11722779|FG001|COMPLETED|Overall Study||5
10567271|NCT01639157|11722778|FG000|NOT COMPLETED|Overall Study||0
10567272|NCT01639157|11722779|FG001|NOT COMPLETED|Overall Study||0
10567273|NCT01639222|11722785|FG000|STARTED|Overall Study||55
10567274|NCT01639222|11722785|FG000|COMPLETED|Overall Study||55
10567275|NCT01639222|11722785|FG000|NOT COMPLETED|Overall Study||0
10651149|NCT02173535|11811314|FG017|STARTED|Period 5||12
10651150|NCT02173535|11811315|FG018|STARTED|Period 5||12
10651151|NCT02173535|11811316|FG019|STARTED|Period 5||12
10651152|NCT02173535|11811297|FG000|COMPLETED|Period 5||12
10651153|NCT02173535|11811298|FG001|COMPLETED|Period 5||12
10651154|NCT02173535|11811299|FG002|COMPLETED|Period 5||12
10651155|NCT02173535|11811300|FG003|COMPLETED|Period 5||12
10651156|NCT02173535|11811301|FG004|COMPLETED|Period 5||12
10651157|NCT02173535|11811302|FG005|COMPLETED|Period 5||12
10651158|NCT02173535|11811303|FG006|COMPLETED|Period 5||12
10793365|NCT03603106|11954143|FG004|COMPLETED|Overall Study||6
10793366|NCT03603106|11954144|FG005|COMPLETED|Overall Study||6
10793367|NCT03603106|11954145|FG006|COMPLETED|Overall Study||18
10651159|NCT02173535|11811304|FG007|COMPLETED|Period 5||12
10651160|NCT02173535|11811305|FG008|COMPLETED|Period 5||12
10651161|NCT02173535|11811306|FG009|COMPLETED|Period 5||12
10651162|NCT02173535|11811307|FG010|COMPLETED|Period 5||12
10793368|NCT03603106|11954146|FG007|COMPLETED|Overall Study||3
10793369|NCT03603106|11954147|FG008|COMPLETED|Overall Study||3
10567276|NCT01639339|11722793|FG000|STARTED|Double-blind Period (Up to Week 104)||224
10567277|NCT01639339|11722794|FG001|STARTED|Double-blind Period (Up to Week 104)||224
10567278|NCT01639339|11722793|FG000|COMPLETED|Double-blind Period (Up to Week 104)||170
10567279|NCT01639339|11722794|FG001|COMPLETED|Double-blind Period (Up to Week 104)||186
10567280|NCT01639339|11722793|FG000|NOT COMPLETED|Double-blind Period (Up to Week 104)||54
10567281|NCT01639339|11722794|FG001|NOT COMPLETED|Double-blind Period (Up to Week 104)||38
10567282|NCT01639339|11722793|FG000|STARTED|Open-label Period (Up to Week 28)|Of the 356 participants who completed the double-blind period, 279 were eligible for open-label treatment. As enrolling into the open-label period was optional, only 257 participants enrolled, of whom 255 started open-label treatment.|123
10567283|NCT01639339|11722794|FG001|STARTED|Open-label Period (Up to Week 28)||132
10567284|NCT01639339|11722793|FG000|COMPLETED|Open-label Period (Up to Week 28)||122
10567285|NCT01639339|11722794|FG001|COMPLETED|Open-label Period (Up to Week 28)||124
10567286|NCT01639339|11722793|FG000|NOT COMPLETED|Open-label Period (Up to Week 28)||1
10567287|NCT01639339|11722794|FG001|NOT COMPLETED|Open-label Period (Up to Week 28)||8
10567288|NCT01639352|11722804|FG000|STARTED|Overall Study||20
10567289|NCT01639352|11722804|FG000|COMPLETED|Overall Study||20
10567290|NCT01639352|11722804|FG000|NOT COMPLETED|Overall Study||0
10567291|NCT01639443|11722810|FG000|STARTED|Overall Study|These individuals opted into Fast-tracked group and were consented.|180
10567292|NCT01639443|11722811|FG001|STARTED|Overall Study|These individuals opted to not participate in Fast-tracked group, and were not consented.|4855
10567293|NCT01639443|11722810|FG000|COMPLETED|Overall Study|Intervention is limited to appointment booking, and all completed.|180
10567294|NCT01639443|11722811|FG001|COMPLETED|Overall Study|These individuals all booked appointments using typical booking.|4855
10567295|NCT01639443|11722810|FG000|NOT COMPLETED|Overall Study||0
10567296|NCT01639443|11722811|FG001|NOT COMPLETED|Overall Study||0
10567297|NCT01639469|11722819|FG000|STARTED|Overall Study||89
10567298|NCT01639469|11722820|FG001|STARTED|Overall Study||80
10793370|NCT03603106|11954148|FG009|COMPLETED|Overall Study||3
10793371|NCT03603106|11954149|FG010|COMPLETED|Overall Study||3
10567299|NCT01639469|11722819|FG000|COMPLETED|Overall Study||84
10567300|NCT01639469|11722820|FG001|COMPLETED|Overall Study||77
10567301|NCT01639469|11722819|FG000|NOT COMPLETED|Overall Study||5
10567302|NCT01639469|11722820|FG001|NOT COMPLETED|Overall Study||3
10567303|NCT01639495|11722826|FG000|STARTED|Overall Study|Patients who signed the informed consent.|148
10567304|NCT01639495|11722826|FG000|Safety Cohort|Overall Study||144
10567305|NCT01639495|11722826|FG000|Primary Effectiveness Cohort|Overall Study||138
10567306|NCT01639495|11722826|FG000|COMPLETED|Overall Study||132
10567307|NCT01639495|11722826|FG000|NOT COMPLETED|Overall Study||16
10567308|NCT01639560|11722832|FG000|STARTED|Overall Study||45
10567309|NCT01639560|11722833|FG001|STARTED|Overall Study||48
10567310|NCT01639560|11722832|FG000|End of Treatment|Overall Study||28
10567311|NCT01639560|11722833|FG001|End of Treatment|Overall Study||20
10567312|NCT01639560|11722832|FG000|COMPLETED|Overall Study||26
10567313|NCT01639560|11722833|FG001|COMPLETED|Overall Study||19
10567314|NCT01639560|11722832|FG000|NOT COMPLETED|Overall Study||19
10567315|NCT01639560|11722833|FG001|NOT COMPLETED|Overall Study||29
10567316|NCT01639599|11722842|FG000|STARTED|Overall Study||50
10567317|NCT01639599|11722843|FG001|STARTED|Overall Study||50
10567318|NCT01639599|11722844|FG002|STARTED|Overall Study||50
10567319|NCT01639599|11722842|FG000|COMPLETED|Overall Study||50
10567320|NCT01639599|11722843|FG001|COMPLETED|Overall Study||49
10567321|NCT01639599|11722844|FG002|COMPLETED|Overall Study||50
10567322|NCT01639599|11722842|FG000|NOT COMPLETED|Overall Study||0
10567323|NCT01639599|11722843|FG001|NOT COMPLETED|Overall Study||1
10567324|NCT01639599|11722844|FG002|NOT COMPLETED|Overall Study||0
10567325|NCT01639664|11722854|FG000|STARTED|Overall Study||63
10567326|NCT01639664|11722855|FG001|STARTED|Overall Study||52
10567327|NCT01639664|11722854|FG000|COMPLETED|Overall Study||63
10567328|NCT01639664|11722855|FG001|COMPLETED|Overall Study||52
10567329|NCT01639664|11722854|FG000|NOT COMPLETED|Overall Study||0
10567330|NCT01639664|11722855|FG001|NOT COMPLETED|Overall Study||0
10567331|NCT01639703|11722862|FG000|STARTED|Overall Study||96
10567332|NCT01639703|11722862|FG000|COMPLETED|Overall Study||84
10567333|NCT01639703|11722862|FG000|NOT COMPLETED|Overall Study||12
10567334|NCT01639729|11722878|FG000|STARTED|Overall Study||4
10567335|NCT01639729|11722879|FG001|STARTED|Overall Study||4
10567336|NCT01639729|11722880|FG002|STARTED|Overall Study||4
10567337|NCT01639729|11722881|FG003|STARTED|Overall Study||5
10567338|NCT01639729|11722882|FG004|STARTED|Overall Study||4
10567339|NCT01639729|11722883|FG005|STARTED|Overall Study||4
10567340|NCT01639729|11722878|FG000|COMPLETED|Overall Study||3
10567341|NCT01639729|11722879|FG001|COMPLETED|Overall Study||4
10567342|NCT01639729|11722880|FG002|COMPLETED|Overall Study||3
10567343|NCT01639729|11722881|FG003|COMPLETED|Overall Study||4
10567344|NCT01639729|11722882|FG004|COMPLETED|Overall Study||4
10567345|NCT01639729|11722883|FG005|COMPLETED|Overall Study||4
10567346|NCT01639729|11722878|FG000|NOT COMPLETED|Overall Study||1
10567347|NCT01639729|11722879|FG001|NOT COMPLETED|Overall Study||0
10567348|NCT01639729|11722880|FG002|NOT COMPLETED|Overall Study||1
10567349|NCT01639729|11722881|FG003|NOT COMPLETED|Overall Study||1
10567350|NCT01639729|11722882|FG004|NOT COMPLETED|Overall Study||0
10567351|NCT01639729|11722883|FG005|NOT COMPLETED|Overall Study||0
10567352|NCT01639742|11722893|FG000|STARTED|Overall Study||18
10567353|NCT01639742|11722893|FG000|COMPLETED|Overall Study||0
10567354|NCT01639742|11722893|FG000|NOT COMPLETED|Overall Study||18
10567355|NCT01639755|11722897|FG000|STARTED|Overall Study||19
10793372|NCT03603106|11954139|FG000|NOT COMPLETED|Overall Study||0
10567356|NCT01639755|11722897|FG000|COMPLETED|Overall Study||0
10567357|NCT01639755|11722897|FG000|NOT COMPLETED|Overall Study||19
10567358|NCT01639833|11722903|FG000|STARTED|Overall Study||45
10567359|NCT01639833|11722904|FG001|STARTED|Overall Study||45
10567360|NCT01639833|11722903|FG000|COMPLETED|Overall Study||39
10567361|NCT01639833|11722904|FG001|COMPLETED|Overall Study||41
10567362|NCT01639833|11722903|FG000|NOT COMPLETED|Overall Study||6
10567363|NCT01639833|11722904|FG001|NOT COMPLETED|Overall Study||4
10567364|NCT01639872|11722912|FG000|STARTED|Overall Study||24
10567365|NCT01639872|11722913|FG001|STARTED|Overall Study||25
10567366|NCT01639872|11722912|FG000|COMPLETED|Overall Study||14
10567367|NCT01639872|11722913|FG001|COMPLETED|Overall Study||20
10567368|NCT01639872|11722912|FG000|NOT COMPLETED|Overall Study||10
10567369|NCT01639872|11722913|FG001|NOT COMPLETED|Overall Study||5
10567370|NCT01640054|11722919|FG000|STARTED|Overall Study|Patients who received treatment|115
10567371|NCT01640054|11722919|FG000|Did Not Receive Treatment|Overall Study||0
10567372|NCT01640054|11722919|FG000|COMPLETED|Overall Study|Number of patients on treatment when the study was stopped.|109
10567373|NCT01640054|11722919|FG000|NOT COMPLETED|Overall Study||6
10567374|NCT01640171|11722923|FG000|STARTED|Overall Study||57
10567375|NCT01640171|11722923|FG000|COMPLETED|Overall Study||57
10567376|NCT01640171|11722923|FG000|NOT COMPLETED|Overall Study||0
10567377|NCT01640184|11722931|FG000|STARTED|Overall Study||34
10567378|NCT01640184|11722932|FG001|STARTED|Overall Study||23
10567379|NCT01640184|11722933|FG002|STARTED|Overall Study||22
10567380|NCT01640184|11722931|FG000|COMPLETED|Overall Study||26
10567381|NCT01640184|11722932|FG001|COMPLETED|Overall Study||21
10567382|NCT01640184|11722933|FG002|COMPLETED|Overall Study||20
10567383|NCT01640184|11722931|FG000|NOT COMPLETED|Overall Study||8
10567384|NCT01640184|11722932|FG001|NOT COMPLETED|Overall Study||2
10567385|NCT01640184|11722933|FG002|NOT COMPLETED|Overall Study||2
10567386|NCT01640197|11722946|FG000|STARTED|Overall Study||30
10567387|NCT01640197|11722947|FG001|STARTED|Overall Study||30
10567388|NCT01640197|11722946|FG000|COMPLETED|Overall Study||30
10567389|NCT01640197|11722947|FG001|COMPLETED|Overall Study||30
10567390|NCT01640197|11722946|FG000|NOT COMPLETED|Overall Study||0
10567391|NCT01640197|11722947|FG001|NOT COMPLETED|Overall Study||0
10567392|NCT01640249|11722960|FG000|STARTED|Period 1||3
10567393|NCT01640249|11722961|FG001|STARTED|Period 1||2
10567394|NCT01640249|11722962|FG002|STARTED|Period 1||2
10567395|NCT01640249|11722963|FG003|STARTED|Period 1||2
10567396|NCT01640249|11722964|FG004|STARTED|Period 1||2
10567397|NCT01640249|11722965|FG005|STARTED|Period 1||5
10567398|NCT01640249|11722966|FG006|STARTED|Period 1||2
10567399|NCT01640249|11722960|FG000|Received at Least 1 Dose of Study Drug|Period 1||3
10567400|NCT01640249|11722961|FG001|Received at Least 1 Dose of Study Drug|Period 1||2
10567401|NCT01640249|11722962|FG002|Received at Least 1 Dose of Study Drug|Period 1||2
10567402|NCT01640249|11722963|FG003|Received at Least 1 Dose of Study Drug|Period 1||2
10567403|NCT01640249|11722964|FG004|Received at Least 1 Dose of Study Drug|Period 1||2
10567404|NCT01640249|11722965|FG005|Received at Least 1 Dose of Study Drug|Period 1||5
10567405|NCT01640249|11722966|FG006|Received at Least 1 Dose of Study Drug|Period 1||2
10567406|NCT01640249|11722960|FG000|COMPLETED|Period 1||2
10567407|NCT01640249|11722961|FG001|COMPLETED|Period 1||2
10567408|NCT01640249|11722962|FG002|COMPLETED|Period 1||2
10567409|NCT01640249|11722963|FG003|COMPLETED|Period 1||2
10567410|NCT01640249|11722964|FG004|COMPLETED|Period 1||2
10567411|NCT01640249|11722965|FG005|COMPLETED|Period 1||4
10567412|NCT01640249|11722966|FG006|COMPLETED|Period 1||2
10567413|NCT01640249|11722960|FG000|NOT COMPLETED|Period 1||1
10567414|NCT01640249|11722961|FG001|NOT COMPLETED|Period 1||0
10567415|NCT01640249|11722962|FG002|NOT COMPLETED|Period 1||0
10567416|NCT01640249|11722963|FG003|NOT COMPLETED|Period 1||0
10567417|NCT01640249|11722964|FG004|NOT COMPLETED|Period 1||0
10567418|NCT01640249|11722965|FG005|NOT COMPLETED|Period 1||1
10567419|NCT01640249|11722966|FG006|NOT COMPLETED|Period 1||0
10567420|NCT01640249|11722960|FG000|STARTED|Period 2||2
10567421|NCT01640249|11722961|FG001|STARTED|Period 2||2
10567422|NCT01640249|11722962|FG002|STARTED|Period 2||2
10567423|NCT01640249|11722963|FG003|STARTED|Period 2||2
10567424|NCT01640249|11722964|FG004|STARTED|Period 2||2
10567425|NCT01640249|11722965|FG005|STARTED|Period 2||4
10567426|NCT01640249|11722966|FG006|STARTED|Period 2||2
10567427|NCT01640249|11722960|FG000|COMPLETED|Period 2||2
10567428|NCT01640249|11722961|FG001|COMPLETED|Period 2||2
10567429|NCT01640249|11722962|FG002|COMPLETED|Period 2||2
10567430|NCT01640249|11722963|FG003|COMPLETED|Period 2||2
10567431|NCT01640249|11722964|FG004|COMPLETED|Period 2||2
10567432|NCT01640249|11722965|FG005|COMPLETED|Period 2||4
10567433|NCT01640249|11722966|FG006|COMPLETED|Period 2||2
10567434|NCT01640249|11722960|FG000|NOT COMPLETED|Period 2||0
10567435|NCT01640249|11722961|FG001|NOT COMPLETED|Period 2||0
10567436|NCT01640249|11722962|FG002|NOT COMPLETED|Period 2||0
10567437|NCT01640249|11722963|FG003|NOT COMPLETED|Period 2||0
10567438|NCT01640249|11722964|FG004|NOT COMPLETED|Period 2||0
10567439|NCT01640249|11722965|FG005|NOT COMPLETED|Period 2||0
10567440|NCT01640249|11722966|FG006|NOT COMPLETED|Period 2||0
10567441|NCT01640249|11722960|FG000|STARTED|Period 3||2
10567442|NCT01640249|11722961|FG001|STARTED|Period 3||2
10567443|NCT01640249|11722962|FG002|STARTED|Period 3||2
10567444|NCT01640249|11722963|FG003|STARTED|Period 3||2
10567445|NCT01640249|11722964|FG004|STARTED|Period 3|Cohort 2 was planned for only 2 dosing periods.|0
10567446|NCT01640249|11722965|FG005|STARTED|Period 3|Cohort 2 was planned for only 2 dosing periods.|0
10567447|NCT01640249|11722966|FG006|STARTED|Period 3|Cohort 2 was planned for only 2 dosing periods.|0
10793373|NCT03603106|11954140|FG001|NOT COMPLETED|Overall Study||0
10793374|NCT03603106|11954141|FG002|NOT COMPLETED|Overall Study||0
10793375|NCT03603106|11954142|FG003|NOT COMPLETED|Overall Study||0
10793376|NCT03603106|11954143|FG004|NOT COMPLETED|Overall Study||0
10793377|NCT03603106|11954144|FG005|NOT COMPLETED|Overall Study||0
10793378|NCT03603106|11954145|FG006|NOT COMPLETED|Overall Study||0
10793379|NCT03603106|11954146|FG007|NOT COMPLETED|Overall Study||0
10793380|NCT03603106|11954147|FG008|NOT COMPLETED|Overall Study||0
10793381|NCT03603106|11954148|FG009|NOT COMPLETED|Overall Study||0
10567448|NCT01640249|11722960|FG000|COMPLETED|Period 3||2
10567449|NCT01640249|11722961|FG001|COMPLETED|Period 3||2
10567450|NCT01640249|11722962|FG002|COMPLETED|Period 3||2
10567451|NCT01640249|11722963|FG003|COMPLETED|Period 3||1
10567452|NCT01640249|11722964|FG004|COMPLETED|Period 3||0
10567453|NCT01640249|11722965|FG005|COMPLETED|Period 3||0
10567454|NCT01640249|11722966|FG006|COMPLETED|Period 3||0
10567455|NCT01640249|11722960|FG000|NOT COMPLETED|Period 3||0
10567456|NCT01640249|11722961|FG001|NOT COMPLETED|Period 3||0
10567457|NCT01640249|11722962|FG002|NOT COMPLETED|Period 3||0
10567458|NCT01640249|11722963|FG003|NOT COMPLETED|Period 3||1
10567459|NCT01640249|11722964|FG004|NOT COMPLETED|Period 3||0
10567460|NCT01640249|11722965|FG005|NOT COMPLETED|Period 3||0
10567461|NCT01640249|11722966|FG006|NOT COMPLETED|Period 3||0
10567462|NCT01640288|11722987|FG000|STARTED|Overall Study||100
10567463|NCT01640288|11722988|FG001|STARTED|Overall Study||71
10567464|NCT01640288|11722987|FG000|Received Allocated Intervention|Overall Study|74 rec'd the gas (inc. 4 images were not obtained due to equipment failure = 70)|70
10567465|NCT01640288|11722988|FG001|Received Allocated Intervention|Overall Study|53 rec'd the gas (exc. 1 images not obtained due to equipment failure, 4 poor images = 48 )|48
10567466|NCT01640288|11722987|FG000|Did Not Receive Allocated Intervention|Overall Study||26
10567467|NCT01640288|11722988|FG001|Did Not Receive Allocated Intervention|Overall Study||18
10567468|NCT01640288|11722987|FG000|COMPLETED|Overall Study|One subject was lost to followup but rec'd the gas and images were obtained|70
10567469|NCT01640288|11722988|FG001|COMPLETED|Overall Study||48
10567470|NCT01640288|11722987|FG000|NOT COMPLETED|Overall Study||30
10567471|NCT01640288|11722988|FG001|NOT COMPLETED|Overall Study||23
10567472|NCT01640314|11722997|FG000|STARTED|Overall Study||63
10567473|NCT01640314|11722998|FG001|STARTED|Overall Study||63
10567474|NCT01640314|11722997|FG000|COMPLETED|Overall Study||63
10567475|NCT01640314|11722998|FG001|COMPLETED|Overall Study||62
10567476|NCT01640314|11722997|FG000|NOT COMPLETED|Overall Study||0
10567477|NCT01640314|11722998|FG001|NOT COMPLETED|Overall Study||1
10567478|NCT01640327|11723006|FG000|STARTED|Overall Study||63
10567479|NCT01640327|11723007|FG001|STARTED|Overall Study||63
10567480|NCT01640327|11723006|FG000|COMPLETED|Overall Study||63
10567481|NCT01640327|11723007|FG001|COMPLETED|Overall Study||63
10567482|NCT01640327|11723006|FG000|NOT COMPLETED|Overall Study||0
10567483|NCT01640327|11723007|FG001|NOT COMPLETED|Overall Study||0
10567484|NCT01640340|11723015|FG000|STARTED|Overall Study||20
10567485|NCT01640340|11723016|FG001|STARTED|Overall Study||20
10567486|NCT01640340|11723015|FG000|Overall Complete Response Rate|Overall Study||20
10567487|NCT01640340|11723016|FG001|Overall Complete Response Rate|Overall Study||20
10567488|NCT01640340|11723015|FG000|COMPLETED|Overall Study||20
10567489|NCT01640340|11723016|FG001|COMPLETED|Overall Study||20
10567490|NCT01640340|11723015|FG000|NOT COMPLETED|Overall Study||0
10567491|NCT01640340|11723016|FG001|NOT COMPLETED|Overall Study||0
10567492|NCT01640353|11723022|FG000|STARTED|Overall Study||194
10567493|NCT01640353|11723022|FG000|Treated|Overall Study||172
10567494|NCT01640353|11723022|FG000|Month 1|Overall Study||171
10567495|NCT01640353|11723022|FG000|Month 3|Overall Study||169
10567496|NCT01640353|11723022|FG000|Month 6|Overall Study||168
10567497|NCT01640353|11723022|FG000|Month 12|Overall Study||160
10567498|NCT01640353|11723022|FG000|Month 18|Overall Study||150
10567499|NCT01640353|11723022|FG000|COMPLETED|Overall Study||149
10567500|NCT01640353|11723022|FG000|NOT COMPLETED|Overall Study||45
10567501|NCT01640366|11723026|FG000|STARTED|Overall Study||200
10567502|NCT01640366|11723026|FG000|Day 21 Follow-up|Overall Study||185
10567503|NCT01640366|11723026|FG000|Day 42 Follow-up|Overall Study||177
10567504|NCT01640366|11723026|FG000|Day 90 Follow-up|Overall Study||178
10567505|NCT01640366|11723026|FG000|COMPLETED|Overall Study||178
10567506|NCT01640366|11723026|FG000|NOT COMPLETED|Overall Study||22
10567507|NCT01640379|11723034|FG000|STARTED|Overall Study||149
10567508|NCT01640379|11723035|FG001|STARTED|Overall Study||137
10567509|NCT01640379|11723034|FG000|COMPLETED|Overall Study||135
10567510|NCT01640379|11723035|FG001|COMPLETED|Overall Study||125
10567511|NCT01640379|11723034|FG000|NOT COMPLETED|Overall Study||14
10567512|NCT01640379|11723035|FG001|NOT COMPLETED|Overall Study||12
10567513|NCT01640548|11723042|FG000|STARTED|Overall Study||309
10567514|NCT01640548|11723042|FG000|COMPLETED|Overall Study||309
10793382|NCT03603106|11954149|FG010|NOT COMPLETED|Overall Study||0
10793383|NCT03603652|11954182|FG000|STARTED|Overall Study||10
10793384|NCT03603652|11954182|FG000|COMPLETED|Overall Study||8
10793385|NCT03603652|11954182|FG000|NOT COMPLETED|Overall Study||2
10567515|NCT01640548|11723042|FG000|NOT COMPLETED|Overall Study||0
10567516|NCT01640808|11723048|FG000|STARTED|Overall Study||309
10567517|NCT01640808|11723049|FG001|STARTED|Overall Study||307
10567518|NCT01640808|11723048|FG000|Subjects Received Treatment|Overall Study||305
10567519|NCT01640808|11723049|FG001|Subjects Received Treatment|Overall Study||305
10567520|NCT01640808|11723048|FG000|COMPLETED|Overall Study||251
10567521|NCT01640808|11723049|FG001|COMPLETED|Overall Study||291
10567522|NCT01640808|11723048|FG000|NOT COMPLETED|Overall Study||58
10567523|NCT01640808|11723049|FG001|NOT COMPLETED|Overall Study||16
10567524|NCT01640834|11723058|FG000|STARTED|Overall Study||8
10567525|NCT01640834|11723059|FG001|STARTED|Overall Study||8
10567526|NCT01640834|11723060|FG002|STARTED|Overall Study||4
10567527|NCT01640834|11723058|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
10567528|NCT01640834|11723059|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
10567529|NCT01640834|11723060|FG002|Received at Least 1 Dose of Study Drug|Overall Study||4
10567530|NCT01640834|11723058|FG000|COMPLETED|Overall Study||8
10567531|NCT01640834|11723059|FG001|COMPLETED|Overall Study||8
10567532|NCT01640834|11723060|FG002|COMPLETED|Overall Study||4
10567533|NCT01640834|11723058|FG000|NOT COMPLETED|Overall Study||0
10567534|NCT01640834|11723059|FG001|NOT COMPLETED|Overall Study||0
10567535|NCT01640834|11723060|FG002|NOT COMPLETED|Overall Study||0
10567536|NCT01640873|11723072|FG000|STARTED|Overall Study||22
10567537|NCT01640873|11723073|FG001|STARTED|Overall Study||11
10567538|NCT01640873|11723072|FG000|COMPLETED|Overall Study||20
10567539|NCT01640873|11723073|FG001|COMPLETED|Overall Study||10
10567540|NCT01640873|11723072|FG000|NOT COMPLETED|Overall Study||2
10567541|NCT01640873|11723073|FG001|NOT COMPLETED|Overall Study||1
10567542|NCT01640925|11723081|FG000|STARTED|Overall Study||175
10567543|NCT01640925|11723082|FG001|STARTED|Overall Study||175
10567544|NCT01640925|11723081|FG000|COMPLETED|Overall Study||161
10567545|NCT01640925|11723082|FG001|COMPLETED|Overall Study||164
10567546|NCT01640925|11723081|FG000|NOT COMPLETED|Overall Study||14
10567547|NCT01640925|11723082|FG001|NOT COMPLETED|Overall Study||11
10567548|NCT01640951|11723096|FG000|STARTED|Overall Study||77
10567549|NCT01640951|11723097|FG001|STARTED|Overall Study||75
10567550|NCT01640951|11723098|FG002|STARTED|Overall Study||168
10567551|NCT01640951|11723099|FG003|STARTED|Overall Study||55
10567552|NCT01640951|11723100|FG004|STARTED|Overall Study||95
10567553|NCT01640951|11723101|FG005|STARTED|Overall Study||60
10567554|NCT01640951|11723102|FG006|STARTED|Overall Study||112
10567555|NCT01640951|11723103|FG007|STARTED|Overall Study||33
10567556|NCT01640951|11723096|FG000|COMPLETED|Overall Study||31
10567557|NCT01640951|11723097|FG001|COMPLETED|Overall Study||60
10567558|NCT01640951|11723098|FG002|COMPLETED|Overall Study||126
10567559|NCT01640951|11723099|FG003|COMPLETED|Overall Study||10
10567560|NCT01640951|11723100|FG004|COMPLETED|Overall Study||82
10567561|NCT01640951|11723101|FG005|COMPLETED|Overall Study||13
10567562|NCT01640951|11723102|FG006|COMPLETED|Overall Study||94
10567563|NCT01640951|11723103|FG007|COMPLETED|Overall Study||17
10567564|NCT01640951|11723096|FG000|NOT COMPLETED|Overall Study||46
10567565|NCT01640951|11723097|FG001|NOT COMPLETED|Overall Study||15
10567566|NCT01640951|11723098|FG002|NOT COMPLETED|Overall Study||42
10567567|NCT01640951|11723099|FG003|NOT COMPLETED|Overall Study||45
10567568|NCT01640951|11723100|FG004|NOT COMPLETED|Overall Study||13
10567569|NCT01640951|11723101|FG005|NOT COMPLETED|Overall Study||47
10567570|NCT01640951|11723102|FG006|NOT COMPLETED|Overall Study||18
10567571|NCT01640951|11723103|FG007|NOT COMPLETED|Overall Study||16
10567572|NCT01640964|11723126|FG000|STARTED|Overall Study||20
10567573|NCT01640964|11723127|FG001|STARTED|Overall Study||20
10567574|NCT01640964|11723128|FG002|STARTED|Overall Study||6
10567575|NCT01640964|11723126|FG000|COMPLETED|Overall Study||19
10567576|NCT01640964|11723127|FG001|COMPLETED|Overall Study||19
10567577|NCT01640964|11723128|FG002|COMPLETED|Overall Study||3
10567578|NCT01640964|11723126|FG000|NOT COMPLETED|Overall Study||1
10567579|NCT01640964|11723127|FG001|NOT COMPLETED|Overall Study||1
10567580|NCT01640964|11723128|FG002|NOT COMPLETED|Overall Study||3
10567581|NCT01641042|11723139|FG000|STARTED|Overall Study||43
10567582|NCT01641042|11723140|FG001|STARTED|Overall Study||43
10567583|NCT01641042|11723139|FG000|COMPLETED|Overall Study||43
10567584|NCT01641042|11723140|FG001|COMPLETED|Overall Study||43
10567585|NCT01641042|11723139|FG000|NOT COMPLETED|Overall Study||0
10567586|NCT01641042|11723140|FG001|NOT COMPLETED|Overall Study||0
10567587|NCT01641081|11723146|FG000|STARTED|Period 1||18
10567588|NCT01641081|11723147|FG001|STARTED|Period 1||18
10567589|NCT01641081|11723148|FG002|STARTED|Period 1||15
10567590|NCT01641081|11723149|FG003|STARTED|Period 1||22
10567591|NCT01641081|11723150|FG004|STARTED|Period 1||17
10567592|NCT01641081|11723151|FG005|STARTED|Period 1||19
10567593|NCT01641081|11723152|FG006|STARTED|Period 1||19
10567594|NCT01641081|11723153|FG007|STARTED|Period 1||17
10567595|NCT01641081|11723154|FG008|STARTED|Period 1||15
10567596|NCT01641081|11723155|FG009|STARTED|Period 1||14
10567597|NCT01641081|11723146|FG000|COMPLETED|Period 1||17
10567598|NCT01641081|11723147|FG001|COMPLETED|Period 1||18
10567599|NCT01641081|11723148|FG002|COMPLETED|Period 1||15
10567600|NCT01641081|11723149|FG003|COMPLETED|Period 1||22
10567601|NCT01641081|11723150|FG004|COMPLETED|Period 1||16
10567602|NCT01641081|11723151|FG005|COMPLETED|Period 1||19
10567603|NCT01641081|11723152|FG006|COMPLETED|Period 1||18
10567604|NCT01641081|11723153|FG007|COMPLETED|Period 1||14
10567605|NCT01641081|11723154|FG008|COMPLETED|Period 1||15
10567606|NCT01641081|11723155|FG009|COMPLETED|Period 1||14
10567607|NCT01641081|11723146|FG000|NOT COMPLETED|Period 1||1
10567608|NCT01641081|11723147|FG001|NOT COMPLETED|Period 1||0
10567609|NCT01641081|11723148|FG002|NOT COMPLETED|Period 1||0
10567610|NCT01641081|11723149|FG003|NOT COMPLETED|Period 1||0
10567611|NCT01641081|11723150|FG004|NOT COMPLETED|Period 1||1
10567612|NCT01641081|11723151|FG005|NOT COMPLETED|Period 1||0
10567613|NCT01641081|11723152|FG006|NOT COMPLETED|Period 1||1
10567614|NCT01641081|11723153|FG007|NOT COMPLETED|Period 1||3
10567615|NCT01641081|11723154|FG008|NOT COMPLETED|Period 1||0
10567616|NCT01641081|11723155|FG009|NOT COMPLETED|Period 1||0
10567617|NCT01641081|11723146|FG000|STARTED|Period 2||17
10567618|NCT01641081|11723147|FG001|STARTED|Period 2||18
10567619|NCT01641081|11723148|FG002|STARTED|Period 2||15
10567620|NCT01641081|11723149|FG003|STARTED|Period 2||22
10567621|NCT01641081|11723150|FG004|STARTED|Period 2||16
10567622|NCT01641081|11723151|FG005|STARTED|Period 2||19
10567623|NCT01641081|11723152|FG006|STARTED|Period 2||18
10567624|NCT01641081|11723153|FG007|STARTED|Period 2||14
10567625|NCT01641081|11723154|FG008|STARTED|Period 2||15
10567626|NCT01641081|11723155|FG009|STARTED|Period 2||14
10567627|NCT01641081|11723146|FG000|COMPLETED|Period 2||16
10567628|NCT01641081|11723147|FG001|COMPLETED|Period 2||18
10567629|NCT01641081|11723148|FG002|COMPLETED|Period 2||15
10567630|NCT01641081|11723149|FG003|COMPLETED|Period 2||21
10567631|NCT01641081|11723150|FG004|COMPLETED|Period 2||16
10567632|NCT01641081|11723151|FG005|COMPLETED|Period 2||18
10567633|NCT01641081|11723152|FG006|COMPLETED|Period 2||16
10567634|NCT01641081|11723153|FG007|COMPLETED|Period 2||14
10567635|NCT01641081|11723154|FG008|COMPLETED|Period 2||15
10567636|NCT01641081|11723155|FG009|COMPLETED|Period 2||14
10567637|NCT01641081|11723146|FG000|NOT COMPLETED|Period 2||1
10567638|NCT01641081|11723147|FG001|NOT COMPLETED|Period 2||0
10567639|NCT01641081|11723148|FG002|NOT COMPLETED|Period 2||0
10567640|NCT01641081|11723149|FG003|NOT COMPLETED|Period 2||1
10567641|NCT01641081|11723150|FG004|NOT COMPLETED|Period 2||0
10567642|NCT01641081|11723151|FG005|NOT COMPLETED|Period 2||1
10567643|NCT01641081|11723152|FG006|NOT COMPLETED|Period 2||2
10567644|NCT01641081|11723153|FG007|NOT COMPLETED|Period 2||0
10567645|NCT01641081|11723154|FG008|NOT COMPLETED|Period 2||0
10567646|NCT01641081|11723155|FG009|NOT COMPLETED|Period 2||0
10567647|NCT01641081|11723146|FG000|STARTED|Period 3||16
10567648|NCT01641081|11723147|FG001|STARTED|Period 3||18
10567649|NCT01641081|11723148|FG002|STARTED|Period 3||15
10567650|NCT01641081|11723149|FG003|STARTED|Period 3||21
10567651|NCT01641081|11723150|FG004|STARTED|Period 3||16
10567652|NCT01641081|11723151|FG005|STARTED|Period 3||18
10567653|NCT01641081|11723152|FG006|STARTED|Period 3||16
10567654|NCT01641081|11723153|FG007|STARTED|Period 3||14
10567655|NCT01641081|11723154|FG008|STARTED|Period 3||15
10567656|NCT01641081|11723155|FG009|STARTED|Period 3||14
10567657|NCT01641081|11723146|FG000|COMPLETED|Period 3||16
10567658|NCT01641081|11723147|FG001|COMPLETED|Period 3||18
10567659|NCT01641081|11723148|FG002|COMPLETED|Period 3||14
10567660|NCT01641081|11723149|FG003|COMPLETED|Period 3||21
10567661|NCT01641081|11723150|FG004|COMPLETED|Period 3||16
10567662|NCT01641081|11723151|FG005|COMPLETED|Period 3||18
10567663|NCT01641081|11723152|FG006|COMPLETED|Period 3||16
10567664|NCT01641081|11723153|FG007|COMPLETED|Period 3||14
10567665|NCT01641081|11723154|FG008|COMPLETED|Period 3||14
10567666|NCT01641081|11723155|FG009|COMPLETED|Period 3||14
10567667|NCT01641081|11723146|FG000|NOT COMPLETED|Period 3||0
10567668|NCT01641081|11723147|FG001|NOT COMPLETED|Period 3||0
10567669|NCT01641081|11723148|FG002|NOT COMPLETED|Period 3||1
10567670|NCT01641081|11723149|FG003|NOT COMPLETED|Period 3||0
10567671|NCT01641081|11723150|FG004|NOT COMPLETED|Period 3||0
10567672|NCT01641081|11723151|FG005|NOT COMPLETED|Period 3||0
10567673|NCT01641081|11723152|FG006|NOT COMPLETED|Period 3||0
10567674|NCT01641081|11723153|FG007|NOT COMPLETED|Period 3||0
10567675|NCT01641081|11723154|FG008|NOT COMPLETED|Period 3||1
10567676|NCT01641081|11723155|FG009|NOT COMPLETED|Period 3||0
10567677|NCT01641081|11723146|FG000|STARTED|Period 4||16
10567678|NCT01641081|11723147|FG001|STARTED|Period 4||18
10567679|NCT01641081|11723148|FG002|STARTED|Period 4||14
10567680|NCT01641081|11723149|FG003|STARTED|Period 4||21
10567681|NCT01641081|11723150|FG004|STARTED|Period 4||16
10567682|NCT01641081|11723151|FG005|STARTED|Period 4||18
10567683|NCT01641081|11723152|FG006|STARTED|Period 4||16
10567684|NCT01641081|11723153|FG007|STARTED|Period 4||14
10567685|NCT01641081|11723154|FG008|STARTED|Period 4||14
10567686|NCT01641081|11723155|FG009|STARTED|Period 4||14
10567687|NCT01641081|11723146|FG000|COMPLETED|Period 4||16
10567688|NCT01641081|11723147|FG001|COMPLETED|Period 4||17
10567689|NCT01641081|11723148|FG002|COMPLETED|Period 4||14
10567690|NCT01641081|11723149|FG003|COMPLETED|Period 4||20
10567691|NCT01641081|11723150|FG004|COMPLETED|Period 4||16
10567692|NCT01641081|11723151|FG005|COMPLETED|Period 4||18
10567693|NCT01641081|11723152|FG006|COMPLETED|Period 4||16
10567694|NCT01641081|11723153|FG007|COMPLETED|Period 4||14
10567695|NCT01641081|11723154|FG008|COMPLETED|Period 4||14
10567696|NCT01641081|11723155|FG009|COMPLETED|Period 4||14
10567697|NCT01641081|11723146|FG000|NOT COMPLETED|Period 4||0
10567698|NCT01641081|11723147|FG001|NOT COMPLETED|Period 4||1
10567699|NCT01641081|11723148|FG002|NOT COMPLETED|Period 4||0
10567700|NCT01641081|11723149|FG003|NOT COMPLETED|Period 4||1
10567701|NCT01641081|11723150|FG004|NOT COMPLETED|Period 4||0
10567702|NCT01641081|11723151|FG005|NOT COMPLETED|Period 4||0
10567703|NCT01641081|11723152|FG006|NOT COMPLETED|Period 4||0
10567704|NCT01641081|11723153|FG007|NOT COMPLETED|Period 4||0
10567705|NCT01641081|11723154|FG008|NOT COMPLETED|Period 4||0
10567706|NCT01641081|11723155|FG009|NOT COMPLETED|Period 4||0
10567707|NCT01641081|11723146|FG000|STARTED|Period 5||16
10567708|NCT01641081|11723147|FG001|STARTED|Period 5||17
10567709|NCT01641081|11723148|FG002|STARTED|Period 5||14
10567710|NCT01641081|11723149|FG003|STARTED|Period 5||20
10567711|NCT01641081|11723150|FG004|STARTED|Period 5||16
10567712|NCT01641081|11723151|FG005|STARTED|Period 5||18
10567713|NCT01641081|11723152|FG006|STARTED|Period 5||16
10567714|NCT01641081|11723153|FG007|STARTED|Period 5||14
10567715|NCT01641081|11723154|FG008|STARTED|Period 5||14
10567716|NCT01641081|11723155|FG009|STARTED|Period 5||14
10567717|NCT01641081|11723146|FG000|COMPLETED|Period 5||16
10567718|NCT01641081|11723147|FG001|COMPLETED|Period 5||17
10567719|NCT01641081|11723148|FG002|COMPLETED|Period 5||12
10567720|NCT01641081|11723149|FG003|COMPLETED|Period 5||20
10567721|NCT01641081|11723150|FG004|COMPLETED|Period 5||16
10567722|NCT01641081|11723151|FG005|COMPLETED|Period 5||18
10567723|NCT01641081|11723152|FG006|COMPLETED|Period 5||16
10567724|NCT01641081|11723153|FG007|COMPLETED|Period 5||14
10567725|NCT01641081|11723154|FG008|COMPLETED|Period 5||14
10567726|NCT01641081|11723155|FG009|COMPLETED|Period 5||14
10567727|NCT01641081|11723146|FG000|NOT COMPLETED|Period 5||0
10567728|NCT01641081|11723147|FG001|NOT COMPLETED|Period 5||0
10567729|NCT01641081|11723148|FG002|NOT COMPLETED|Period 5||2
10567730|NCT01641081|11723149|FG003|NOT COMPLETED|Period 5||0
10567731|NCT01641081|11723150|FG004|NOT COMPLETED|Period 5||0
10567732|NCT01641081|11723151|FG005|NOT COMPLETED|Period 5||0
10567733|NCT01641081|11723152|FG006|NOT COMPLETED|Period 5||0
10567734|NCT01641081|11723153|FG007|NOT COMPLETED|Period 5||0
10567735|NCT01641081|11723154|FG008|NOT COMPLETED|Period 5||0
10567736|NCT01641081|11723155|FG009|NOT COMPLETED|Period 5||0
10567737|NCT01641120|11723167|FG000|STARTED|25 Gauge Needle Weeks 1, 4, 5||20
10567738|NCT01641120|11723167|FG000|COMPLETED|25 Gauge Needle Weeks 1, 4, 5||20
10567739|NCT01641120|11723167|FG000|NOT COMPLETED|25 Gauge Needle Weeks 1, 4, 5||0
10567740|NCT01641120|11723167|FG000|STARTED|30 Gauge Needle Weeks 2 and 3||20
10567741|NCT01641120|11723167|FG000|COMPLETED|30 Gauge Needle Weeks 2 and 3||20
10567742|NCT01641120|11723167|FG000|NOT COMPLETED|30 Gauge Needle Weeks 2 and 3||0
10567743|NCT01641133|11723177|FG000|STARTED|Overall Study||97
10567744|NCT01641133|11723178|FG001|STARTED|Overall Study||99
10567745|NCT01641133|11723179|FG002|STARTED|Overall Study||98
10567746|NCT01641133|11723177|FG000|COMPLETED|Overall Study||87
10567747|NCT01641133|11723178|FG001|COMPLETED|Overall Study||90
10567748|NCT01641133|11723179|FG002|COMPLETED|Overall Study||90
10567749|NCT01641133|11723177|FG000|NOT COMPLETED|Overall Study||10
10567750|NCT01641133|11723178|FG001|NOT COMPLETED|Overall Study||9
10567751|NCT01641133|11723179|FG002|NOT COMPLETED|Overall Study||8
10567752|NCT01641159|11723189|FG000|STARTED|Overall Study||35
10567753|NCT01641159|11723190|FG001|STARTED|Overall Study||27
10567754|NCT01641159|11723189|FG000|COMPLETED|Overall Study||33
10567755|NCT01641159|11723190|FG001|COMPLETED|Overall Study||25
10567756|NCT01641159|11723189|FG000|NOT COMPLETED|Overall Study||2
10567757|NCT01641159|11723190|FG001|NOT COMPLETED|Overall Study||2
10567758|NCT01641198|11723199|FG000|STARTED|After 12 Months of Function||20
10567759|NCT01641198|11723200|FG001|STARTED|After 12 Months of Function||19
10567760|NCT01641198|11723201|FG002|STARTED|After 12 Months of Function||19
10567761|NCT01641198|11723199|FG000|COMPLETED|After 12 Months of Function|Participants: 3 interval violation, 1 protocol violation. Implants: 13 bone loss not measurable|16
10567762|NCT01641198|11723200|FG001|COMPLETED|After 12 Months of Function|Participants: 2 interval violation, 1 adverse event. Implants: 3 bone loss not measurable|16
10567763|NCT01641198|11723201|FG002|COMPLETED|After 12 Months of Function|Participants: 2 interval violation. Implants: 3 bone loss not measurable|17
10567764|NCT01641198|11723199|FG000|NOT COMPLETED|After 12 Months of Function||4
10567765|NCT01641198|11723200|FG001|NOT COMPLETED|After 12 Months of Function||3
10567766|NCT01641198|11723201|FG002|NOT COMPLETED|After 12 Months of Function||2
10567767|NCT01641198|11723199|FG000|STARTED|After 24 Months of Function||16
10567768|NCT01641198|11723200|FG001|STARTED|After 24 Months of Function||16
10567769|NCT01641198|11723201|FG002|STARTED|After 24 Months of Function||17
10567770|NCT01641198|11723199|FG000|COMPLETED|After 24 Months of Function|Participants: 4 interval violation. Implants: 3 bone loss not measurable|12
10567771|NCT01641198|11723200|FG001|COMPLETED|After 24 Months of Function|Participants: 9 interval violation|7
10567772|NCT01641198|11723201|FG002|COMPLETED|After 24 Months of Function|Participants: 6 interval violation. Implants: 2 bone loss not measurable|11
10567773|NCT01641198|11723199|FG000|NOT COMPLETED|After 24 Months of Function||4
10567774|NCT01641198|11723200|FG001|NOT COMPLETED|After 24 Months of Function||9
10567775|NCT01641198|11723201|FG002|NOT COMPLETED|After 24 Months of Function||6
10567776|NCT01641198|11723199|FG000|STARTED|At 15-20 Years of Function||12
10567777|NCT01641198|11723200|FG001|STARTED|At 15-20 Years of Function||7
10567778|NCT01641198|11723201|FG002|STARTED|At 15-20 Years of Function||11
10567779|NCT01641198|11723199|FG000|COMPLETED|At 15-20 Years of Function|Participants: 5 interval violation, 1 death|6
10567780|NCT01641198|11723200|FG001|COMPLETED|At 15-20 Years of Function|Participants: 1 interval violation|6
10567781|NCT01641198|11723201|FG002|COMPLETED|At 15-20 Years of Function|Participants: 1 interval violation, 1 death|9
10567782|NCT01641198|11723199|FG000|NOT COMPLETED|At 15-20 Years of Function||6
10567783|NCT01641198|11723200|FG001|NOT COMPLETED|At 15-20 Years of Function||1
10567784|NCT01641198|11723201|FG002|NOT COMPLETED|At 15-20 Years of Function||2
10567785|NCT01641237|11723210|FG000|STARTED|Period I||16
10567786|NCT01641237|11723211|FG001|STARTED|Period I||16
10567787|NCT01641237|11723212|FG002|STARTED|Period I||15
10567788|NCT01641237|11723213|FG003|STARTED|Period I||15
10567789|NCT01641237|11723210|FG000|COMPLETED|Period I||16
10567790|NCT01641237|11723211|FG001|COMPLETED|Period I||16
10567791|NCT01641237|11723212|FG002|COMPLETED|Period I||15
10567792|NCT01641237|11723213|FG003|COMPLETED|Period I||15
10567793|NCT01641237|11723210|FG000|NOT COMPLETED|Period I||0
10567794|NCT01641237|11723211|FG001|NOT COMPLETED|Period I||0
10567795|NCT01641237|11723212|FG002|NOT COMPLETED|Period I||0
10567796|NCT01641237|11723213|FG003|NOT COMPLETED|Period I||0
10567797|NCT01641237|11723210|FG000|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|15
10567798|NCT01641237|11723211|FG001|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|16
10567799|NCT01641237|11723212|FG002|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|16
10567800|NCT01641237|11723213|FG003|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|15
10567801|NCT01641237|11723210|FG000|COMPLETED|Period II||14
10567802|NCT01641237|11723211|FG001|COMPLETED|Period II||16
10567803|NCT01641237|11723212|FG002|COMPLETED|Period II||16
10567804|NCT01641237|11723213|FG003|COMPLETED|Period II||15
10567805|NCT01641237|11723210|FG000|NOT COMPLETED|Period II||1
10567806|NCT01641237|11723211|FG001|NOT COMPLETED|Period II||0
10567807|NCT01641237|11723212|FG002|NOT COMPLETED|Period II||0
10567808|NCT01641237|11723213|FG003|NOT COMPLETED|Period II||0
10567809|NCT01641237|11723210|FG000|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|16
10567810|NCT01641237|11723211|FG001|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
10567811|NCT01641237|11723212|FG002|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|15
10567812|NCT01641237|11723213|FG003|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|16
10567813|NCT01641237|11723210|FG000|COMPLETED|Period III||15
10567814|NCT01641237|11723211|FG001|COMPLETED|Period III||14
10567815|NCT01641237|11723212|FG002|COMPLETED|Period III||15
10567816|NCT01641237|11723213|FG003|COMPLETED|Period III||16
10567817|NCT01641237|11723210|FG000|NOT COMPLETED|Period III||1
10567818|NCT01641237|11723211|FG001|NOT COMPLETED|Period III||0
10567819|NCT01641237|11723212|FG002|NOT COMPLETED|Period III||0
10567820|NCT01641237|11723213|FG003|NOT COMPLETED|Period III||0
10567821|NCT01641237|11723210|FG000|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
10567822|NCT01641237|11723211|FG001|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
10793386|NCT03604263|11954186|FG000|STARTED|Overall Study||17
10793387|NCT03604263|11954186|FG000|COMPLETED|Overall Study||15
10793388|NCT03604263|11954186|FG000|NOT COMPLETED|Overall Study||2
10793389|NCT03604341|11954192|FG000|STARTED|Overall Study||35
10793390|NCT03604341|11954193|FG001|STARTED|Overall Study||35
10793391|NCT03604341|11954192|FG000|COMPLETED|Overall Study||33
10567823|NCT01641237|11723212|FG002|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
10567824|NCT01641237|11723213|FG003|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
10567825|NCT01641237|11723210|FG000|COMPLETED|Period IV||15
10567826|NCT01641237|11723211|FG001|COMPLETED|Period IV||15
10567827|NCT01641237|11723212|FG002|COMPLETED|Period IV||15
10567828|NCT01641237|11723213|FG003|COMPLETED|Period IV||15
10567829|NCT01641237|11723210|FG000|NOT COMPLETED|Period IV||0
10567830|NCT01641237|11723211|FG001|NOT COMPLETED|Period IV||0
10567831|NCT01641237|11723212|FG002|NOT COMPLETED|Period IV||0
10567832|NCT01641237|11723213|FG003|NOT COMPLETED|Period IV||0
10567833|NCT01641367|11723229|FG000|STARTED|Cohorts||287
10567834|NCT01641367|11723230|FG001|STARTED|Cohorts||74
10567835|NCT01641367|11723231|FG002|STARTED|Cohorts||72
10567836|NCT01641367|11723232|FG003|STARTED|Cohorts||8
10793392|NCT03604341|11954193|FG001|COMPLETED|Overall Study||33
10793393|NCT03604341|11954192|FG000|NOT COMPLETED|Overall Study||2
10793394|NCT03604341|11954193|FG001|NOT COMPLETED|Overall Study||2
10567837|NCT01641367|11723233|FG004|STARTED|Cohorts||70
10567838|NCT01641367|11723234|FG005|STARTED|Cohorts||34
10567839|NCT01641367|11723235|FG006|STARTED|Cohorts||0
10567840|NCT01641367|11723236|FG007|STARTED|Cohorts||0
10567841|NCT01641367|11723229|FG000|Followed 72 Weeks on Step 1/2|Cohorts||211
10567842|NCT01641367|11723230|FG001|Followed 72 Weeks on Step 1/2|Cohorts||60
10567843|NCT01641367|11723231|FG002|Followed 72 Weeks on Step 1/2|Cohorts||60
10567844|NCT01641367|11723232|FG003|Followed 72 Weeks on Step 1/2|Cohorts||6
10567845|NCT01641367|11723233|FG004|Followed 72 Weeks on Step 1/2|Cohorts||52
10567846|NCT01641367|11723234|FG005|Followed 72 Weeks on Step 1/2|Cohorts||30
10567847|NCT01641367|11723235|FG006|Followed 72 Weeks on Step 1/2|Cohorts||0
10567848|NCT01641367|11723236|FG007|Followed 72 Weeks on Step 1/2|Cohorts||0
10567849|NCT01641367|11723229|FG000|COMPLETED|Cohorts||253
10567850|NCT01641367|11723230|FG001|COMPLETED|Cohorts||73
10567851|NCT01641367|11723231|FG002|COMPLETED|Cohorts||68
10567852|NCT01641367|11723232|FG003|COMPLETED|Cohorts||8
10567853|NCT01641367|11723233|FG004|COMPLETED|Cohorts||67
10567854|NCT01641367|11723234|FG005|COMPLETED|Cohorts||33
10567855|NCT01641367|11723235|FG006|COMPLETED|Cohorts||0
10567856|NCT01641367|11723236|FG007|COMPLETED|Cohorts||0
10567857|NCT01641367|11723229|FG000|NOT COMPLETED|Cohorts||34
10567858|NCT01641367|11723230|FG001|NOT COMPLETED|Cohorts||1
10567859|NCT01641367|11723231|FG002|NOT COMPLETED|Cohorts||4
10567860|NCT01641367|11723232|FG003|NOT COMPLETED|Cohorts||0
10567861|NCT01641367|11723233|FG004|NOT COMPLETED|Cohorts||3
10567862|NCT01641367|11723234|FG005|NOT COMPLETED|Cohorts||1
10567863|NCT01641367|11723235|FG006|NOT COMPLETED|Cohorts||0
10567864|NCT01641367|11723236|FG007|NOT COMPLETED|Cohorts||0
10567865|NCT01641367|11723229|FG000|STARTED|Randomized Adherence Intervention||0
10567866|NCT01641367|11723230|FG001|STARTED|Randomized Adherence Intervention||0
10793395|NCT03604497|11954199|FG000|STARTED|Overall Study||437
10793396|NCT03604497|11954199|FG000|COMPLETED|Overall Study||385
10793397|NCT03604497|11954199|FG000|NOT COMPLETED|Overall Study||52
10793398|NCT03604523|11954209|FG000|STARTED|Overall Study||5
10793399|NCT03604523|11954210|FG001|STARTED|Overall Study||5
10567867|NCT01641367|11723231|FG002|STARTED|Randomized Adherence Intervention||0
10567868|NCT01641367|11723232|FG003|STARTED|Randomized Adherence Intervention||0
10567869|NCT01641367|11723233|FG004|STARTED|Randomized Adherence Intervention||0
10567870|NCT01641367|11723234|FG005|STARTED|Randomized Adherence Intervention||0
10793400|NCT03604523|11954209|FG000|COMPLETED|Overall Study||4
10793401|NCT03604523|11954210|FG001|COMPLETED|Overall Study||5
10793402|NCT03604523|11954209|FG000|NOT COMPLETED|Overall Study||1
10793403|NCT03604523|11954210|FG001|NOT COMPLETED|Overall Study||0
10793404|NCT03604705|11954216|FG000|STARTED|Overall Study||21
10793405|NCT03604705|11954216|FG000|COMPLETED|Overall Study||20
10793406|NCT03604705|11954216|FG000|NOT COMPLETED|Overall Study||1
10793407|NCT03605212|11954233|FG000|STARTED|Baseline Period||3
10793408|NCT03605212|11954234|FG001|STARTED|Baseline Period||0
10793409|NCT03605212|11954235|FG002|STARTED|Baseline Period||3
10793410|NCT03605212|11954236|FG003|STARTED|Baseline Period||0
10793411|NCT03605212|11954237|FG004|STARTED|Baseline Period||24
10793412|NCT03605212|11954233|FG000|COMPLETED|Baseline Period||3
10793413|NCT03605212|11954234|FG001|COMPLETED|Baseline Period||0
10793414|NCT03605212|11954235|FG002|COMPLETED|Baseline Period||3
10793415|NCT03605212|11954236|FG003|COMPLETED|Baseline Period||0
10793416|NCT03605212|11954237|FG004|COMPLETED|Baseline Period||24
10793417|NCT03605212|11954233|FG000|NOT COMPLETED|Baseline Period||0
10793418|NCT03605212|11954234|FG001|NOT COMPLETED|Baseline Period||0
10793419|NCT03605212|11954235|FG002|NOT COMPLETED|Baseline Period||0
10793420|NCT03605212|11954236|FG003|NOT COMPLETED|Baseline Period||0
10793421|NCT03605212|11954237|FG004|NOT COMPLETED|Baseline Period||0
10793422|NCT03605212|11954233|FG000|STARTED|Treatment Period||3
10793423|NCT03605212|11954234|FG001|STARTED|Treatment Period||0
10793424|NCT03605212|11954235|FG002|STARTED|Treatment Period||3
10793425|NCT03605212|11954236|FG003|STARTED|Treatment Period||0
10793426|NCT03605212|11954237|FG004|STARTED|Treatment Period||24
10793427|NCT03605212|11954233|FG000|COMPLETED|Treatment Period||2
10793428|NCT03605212|11954234|FG001|COMPLETED|Treatment Period||0
10793429|NCT03605212|11954235|FG002|COMPLETED|Treatment Period||3
10793430|NCT03605212|11954236|FG003|COMPLETED|Treatment Period||0
10793431|NCT03605212|11954237|FG004|COMPLETED|Treatment Period||23
10793432|NCT03605212|11954233|FG000|NOT COMPLETED|Treatment Period||1
10793433|NCT03605212|11954234|FG001|NOT COMPLETED|Treatment Period||0
10793434|NCT03605212|11954235|FG002|NOT COMPLETED|Treatment Period||0
10793435|NCT03605212|11954236|FG003|NOT COMPLETED|Treatment Period||0
10793436|NCT03605212|11954237|FG004|NOT COMPLETED|Treatment Period||1
10793437|NCT03605693|11954252|FG000|STARTED|Overall Study||5
10793438|NCT03605693|11954253|FG001|STARTED|Overall Study||5
10567871|NCT01641367|11723235|FG006|STARTED|Randomized Adherence Intervention||257
10567872|NCT01641367|11723236|FG007|STARTED|Randomized Adherence Intervention||264
10567873|NCT01641367|11723229|FG000|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
10567874|NCT01641367|11723230|FG001|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
10567875|NCT01641367|11723231|FG002|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
10567876|NCT01641367|11723232|FG003|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
10567877|NCT01641367|11723233|FG004|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
10567878|NCT01641367|11723234|FG005|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
10567879|NCT01641367|11723235|FG006|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||196
10567880|NCT01641367|11723236|FG007|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||202
10567881|NCT01641367|11723229|FG000|COMPLETED|Randomized Adherence Intervention||0
10567882|NCT01641367|11723230|FG001|COMPLETED|Randomized Adherence Intervention||0
10567883|NCT01641367|11723231|FG002|COMPLETED|Randomized Adherence Intervention||0
10567884|NCT01641367|11723232|FG003|COMPLETED|Randomized Adherence Intervention||0
10567885|NCT01641367|11723233|FG004|COMPLETED|Randomized Adherence Intervention||0
10567886|NCT01641367|11723234|FG005|COMPLETED|Randomized Adherence Intervention||0
10567887|NCT01641367|11723235|FG006|COMPLETED|Randomized Adherence Intervention||238
10567888|NCT01641367|11723236|FG007|COMPLETED|Randomized Adherence Intervention||240
10567889|NCT01641367|11723229|FG000|NOT COMPLETED|Randomized Adherence Intervention||0
10567890|NCT01641367|11723230|FG001|NOT COMPLETED|Randomized Adherence Intervention||0
10567891|NCT01641367|11723231|FG002|NOT COMPLETED|Randomized Adherence Intervention||0
10567892|NCT01641367|11723232|FG003|NOT COMPLETED|Randomized Adherence Intervention||0
10567893|NCT01641367|11723233|FG004|NOT COMPLETED|Randomized Adherence Intervention||0
10567894|NCT01641367|11723234|FG005|NOT COMPLETED|Randomized Adherence Intervention||0
10567895|NCT01641367|11723235|FG006|NOT COMPLETED|Randomized Adherence Intervention||19
10567896|NCT01641367|11723236|FG007|NOT COMPLETED|Randomized Adherence Intervention||24
10567897|NCT01641380|11723261|FG000|STARTED|First Injection Cycle||50
10793439|NCT03605693|11954252|FG000|COMPLETED|Overall Study||0
10793440|NCT03605693|11954253|FG001|COMPLETED|Overall Study||5
10793441|NCT03605693|11954252|FG000|NOT COMPLETED|Overall Study||5
10793442|NCT03605693|11954253|FG001|NOT COMPLETED|Overall Study||0
10793443|NCT03605745|11954259|FG000|STARTED|Overall Study||47
10793444|NCT03605745|11954259|FG000|2 Weeks|Overall Study||47
10793445|NCT03605745|11954259|FG000|6 Weeks|Overall Study||47
10793446|NCT03605745|11954259|FG000|3 Months|Overall Study||47
10793447|NCT03605745|11954259|FG000|6 Months|Overall Study||47
10793448|NCT03605745|11954259|FG000|12 Months|Overall Study||40
10793449|NCT03605745|11954259|FG000|24 Months|Overall Study||1
10793450|NCT03605745|11954259|FG000|COMPLETED|Overall Study||0
10567898|NCT01641380|11723262|FG001|STARTED|First Injection Cycle||50
10567899|NCT01641380|11723261|FG000|COMPLETED|First Injection Cycle||43
10793451|NCT03605745|11954259|FG000|NOT COMPLETED|Overall Study||47
10793452|NCT03605836|11954267|FG000|STARTED|OL Placebo Run-in Period [1 Week]||590
10793453|NCT03605836|11954268|FG001|STARTED|OL Placebo Run-in Period [1 Week]||0
10793454|NCT03605836|11954269|FG002|STARTED|OL Placebo Run-in Period [1 Week]||0
10793455|NCT03605836|11954270|FG003|STARTED|OL Placebo Run-in Period [1 Week]||0
10567900|NCT01641380|11723262|FG001|COMPLETED|First Injection Cycle||44
10567901|NCT01641380|11723261|FG000|NOT COMPLETED|First Injection Cycle||7
10567902|NCT01641380|11723262|FG001|NOT COMPLETED|First Injection Cycle||6
10567903|NCT01641380|11723261|FG000|STARTED|Second Injection Cycle||43
10567904|NCT01641380|11723262|FG001|STARTED|Second Injection Cycle||44
10567905|NCT01641380|11723261|FG000|COMPLETED|Second Injection Cycle||39
10567906|NCT01641380|11723262|FG001|COMPLETED|Second Injection Cycle||38
10567907|NCT01641380|11723261|FG000|NOT COMPLETED|Second Injection Cycle||4
10567908|NCT01641380|11723262|FG001|NOT COMPLETED|Second Injection Cycle||6
10567909|NCT01641380|11723261|FG000|STARTED|Third Injection Cycle||39
10567910|NCT01641380|11723262|FG001|STARTED|Third Injection Cycle||38
10567911|NCT01641380|11723261|FG000|COMPLETED|Third Injection Cycle||36
10567912|NCT01641380|11723262|FG001|COMPLETED|Third Injection Cycle||33
10567913|NCT01641380|11723261|FG000|NOT COMPLETED|Third Injection Cycle||3
10567914|NCT01641380|11723262|FG001|NOT COMPLETED|Third Injection Cycle||5
10567915|NCT01641445|11723271|FG000|STARTED|Overall Study||41
10567916|NCT01641445|11723272|FG001|STARTED|Overall Study||41
10567917|NCT01641445|11723271|FG000|COMPLETED|Overall Study||31
10567918|NCT01641445|11723272|FG001|COMPLETED|Overall Study||36
10567919|NCT01641445|11723271|FG000|NOT COMPLETED|Overall Study||10
10567920|NCT01641445|11723272|FG001|NOT COMPLETED|Overall Study||5
10567921|NCT01641471|11723280|FG000|STARTED|Overall Study||58
10567922|NCT01641471|11723281|FG001|STARTED|Overall Study||58
10567923|NCT01641471|11723280|FG000|COMPLETED|Overall Study||35
10567924|NCT01641471|11723281|FG001|COMPLETED|Overall Study||31
10567925|NCT01641471|11723280|FG000|NOT COMPLETED|Overall Study||23
10567926|NCT01641471|11723281|FG001|NOT COMPLETED|Overall Study||27
10567927|NCT01641640|11723287|FG000|STARTED|Overall Study||328
10567928|NCT01641640|11723287|FG000|Enrolled and Treated|Overall Study||327
10567929|NCT01641640|11723287|FG000|COMPLETED|Overall Study||292
10567930|NCT01641640|11723287|FG000|NOT COMPLETED|Overall Study||36
10567931|NCT01641653|11723293|FG000|STARTED|Overall Study||30
10567932|NCT01641653|11723294|FG001|STARTED|Overall Study||30
10567933|NCT01641653|11723293|FG000|COMPLETED|Overall Study||30
10567934|NCT01641653|11723294|FG001|COMPLETED|Overall Study||30
10567935|NCT01641653|11723293|FG000|NOT COMPLETED|Overall Study||0
10567936|NCT01641653|11723294|FG001|NOT COMPLETED|Overall Study||0
10567937|NCT01641692|11723303|FG000|STARTED|Treatment Period 1||42
10567938|NCT01641692|11723304|FG001|STARTED|Treatment Period 1||45
10567939|NCT01641692|11723305|FG002|STARTED|Treatment Period 1||51
10567940|NCT01641692|11723306|FG003|STARTED|Treatment Period 1||41
10567941|NCT01641692|11723307|FG004|STARTED|Treatment Period 1||43
10567942|NCT01641692|11723308|FG005|STARTED|Treatment Period 1||39
10567943|NCT01641692|11723309|FG006|STARTED|Treatment Period 1||38
10567944|NCT01641692|11723310|FG007|STARTED|Treatment Period 1||51
10567945|NCT01641692|11723303|FG000|COMPLETED|Treatment Period 1||40
10567946|NCT01641692|11723304|FG001|COMPLETED|Treatment Period 1||45
10567947|NCT01641692|11723305|FG002|COMPLETED|Treatment Period 1||50
10567948|NCT01641692|11723306|FG003|COMPLETED|Treatment Period 1||41
10567949|NCT01641692|11723307|FG004|COMPLETED|Treatment Period 1||39
10567950|NCT01641692|11723308|FG005|COMPLETED|Treatment Period 1||37
10567951|NCT01641692|11723309|FG006|COMPLETED|Treatment Period 1||38
10567952|NCT01641692|11723310|FG007|COMPLETED|Treatment Period 1||48
10567953|NCT01641692|11723303|FG000|NOT COMPLETED|Treatment Period 1||2
10567954|NCT01641692|11723304|FG001|NOT COMPLETED|Treatment Period 1||0
10567955|NCT01641692|11723305|FG002|NOT COMPLETED|Treatment Period 1||1
10567956|NCT01641692|11723306|FG003|NOT COMPLETED|Treatment Period 1||0
10567957|NCT01641692|11723307|FG004|NOT COMPLETED|Treatment Period 1||4
10567958|NCT01641692|11723308|FG005|NOT COMPLETED|Treatment Period 1||2
10567959|NCT01641692|11723309|FG006|NOT COMPLETED|Treatment Period 1||0
10567960|NCT01641692|11723310|FG007|NOT COMPLETED|Treatment Period 1||3
10567961|NCT01641692|11723303|FG000|STARTED|Washout Period 1 (12-14 Days)||40
10567962|NCT01641692|11723304|FG001|STARTED|Washout Period 1 (12-14 Days)||45
10455190|NCT01000961|11603207|FG000|COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||21
10455191|NCT01000961|11603208|FG001|COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||22
10455192|NCT01000961|11603207|FG000|NOT COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||0
10455193|NCT01000961|11603208|FG001|NOT COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||0
10455194|NCT01000961|11603207|FG000|STARTED|First Intervention (3 Weeks)||21
10455195|NCT01000961|11603208|FG001|STARTED|First Intervention (3 Weeks)||22
10455196|NCT01000961|11603207|FG000|COMPLETED|First Intervention (3 Weeks)||21
10455197|NCT01000961|11603208|FG001|COMPLETED|First Intervention (3 Weeks)||20
10455198|NCT01000961|11603207|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0
10455199|NCT01000961|11603208|FG001|NOT COMPLETED|First Intervention (3 Weeks)||2
10455200|NCT01000961|11603207|FG000|STARTED|Second Intervention (3 Weeks)||21
10455201|NCT01000961|11603208|FG001|STARTED|Second Intervention (3 Weeks)||20
10455202|NCT01000961|11603207|FG000|COMPLETED|Second Intervention (3 Weeks)|Part of Efficacy analysis set|21
10455203|NCT01000961|11603208|FG001|COMPLETED|Second Intervention (3 Weeks)|Part of Efficacy analysis set|20
10455204|NCT01000961|11603207|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
10455205|NCT01000961|11603208|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
10455206|NCT01000974|11603219|FG000|STARTED|Primary Vaccination Phase||2963
10455207|NCT01000974|11603220|FG001|STARTED|Primary Vaccination Phase||520
10455208|NCT01000974|11603221|FG002|STARTED|Primary Vaccination Phase||520
10567963|NCT01641692|11723305|FG002|STARTED|Washout Period 1 (12-14 Days)||50
10567964|NCT01641692|11723306|FG003|STARTED|Washout Period 1 (12-14 Days)||41
10567965|NCT01641692|11723307|FG004|STARTED|Washout Period 1 (12-14 Days)||39
10455209|NCT01000974|11603219|FG000|COMPLETED|Primary Vaccination Phase||2625
10567966|NCT01641692|11723308|FG005|STARTED|Washout Period 1 (12-14 Days)||37
10567967|NCT01641692|11723309|FG006|STARTED|Washout Period 1 (12-14 Days)||38
10567968|NCT01641692|11723310|FG007|STARTED|Washout Period 1 (12-14 Days)||48
10567969|NCT01641692|11723303|FG000|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|36
10567970|NCT01641692|11723304|FG001|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|44
10567971|NCT01641692|11723305|FG002|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|47
10567972|NCT01641692|11723306|FG003|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|39
10567973|NCT01641692|11723307|FG004|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|35
10567974|NCT01641692|11723308|FG005|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|37
10567975|NCT01641692|11723309|FG006|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|36
10567976|NCT01641692|11723310|FG007|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|47
10567977|NCT01641692|11723303|FG000|NOT COMPLETED|Washout Period 1 (12-14 Days)||4
10567978|NCT01641692|11723304|FG001|NOT COMPLETED|Washout Period 1 (12-14 Days)||1
10567979|NCT01641692|11723305|FG002|NOT COMPLETED|Washout Period 1 (12-14 Days)||3
10567980|NCT01641692|11723306|FG003|NOT COMPLETED|Washout Period 1 (12-14 Days)||2
10567981|NCT01641692|11723307|FG004|NOT COMPLETED|Washout Period 1 (12-14 Days)||4
10567982|NCT01641692|11723308|FG005|NOT COMPLETED|Washout Period 1 (12-14 Days)||0
10567983|NCT01641692|11723309|FG006|NOT COMPLETED|Washout Period 1 (12-14 Days)||2
10567984|NCT01641692|11723310|FG007|NOT COMPLETED|Washout Period 1 (12-14 Days)||1
10567985|NCT01641692|11723303|FG000|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|33
10567986|NCT01641692|11723304|FG001|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|46
10567987|NCT01641692|11723305|FG002|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|40
10567988|NCT01641692|11723306|FG003|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|41
10567989|NCT01641692|11723307|FG004|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|37
10567990|NCT01641692|11723308|FG005|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|45
10567991|NCT01641692|11723309|FG006|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|43
10567992|NCT01641692|11723310|FG007|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|36
10567993|NCT01641692|11723303|FG000|COMPLETED|Treatment Period 2||30
10567994|NCT01641692|11723304|FG001|COMPLETED|Treatment Period 2||46
10567995|NCT01641692|11723305|FG002|COMPLETED|Treatment Period 2||40
10567996|NCT01641692|11723306|FG003|COMPLETED|Treatment Period 2||41
10567997|NCT01641692|11723307|FG004|COMPLETED|Treatment Period 2||37
10567998|NCT01641692|11723308|FG005|COMPLETED|Treatment Period 2||43
10567999|NCT01641692|11723309|FG006|COMPLETED|Treatment Period 2||43
10568000|NCT01641692|11723310|FG007|COMPLETED|Treatment Period 2||35
10568001|NCT01641692|11723303|FG000|NOT COMPLETED|Treatment Period 2||3
10568002|NCT01641692|11723304|FG001|NOT COMPLETED|Treatment Period 2||0
10568003|NCT01641692|11723305|FG002|NOT COMPLETED|Treatment Period 2||0
10568004|NCT01641692|11723306|FG003|NOT COMPLETED|Treatment Period 2||0
10568005|NCT01641692|11723307|FG004|NOT COMPLETED|Treatment Period 2||0
10568006|NCT01641692|11723308|FG005|NOT COMPLETED|Treatment Period 2||2
10568007|NCT01641692|11723309|FG006|NOT COMPLETED|Treatment Period 2||0
10568008|NCT01641692|11723310|FG007|NOT COMPLETED|Treatment Period 2||1
10568009|NCT01641692|11723303|FG000|STARTED|Washout Period 2 (12-14 Days)||30
10568010|NCT01641692|11723304|FG001|STARTED|Washout Period 2 (12-14 Days)||46
10568011|NCT01641692|11723305|FG002|STARTED|Washout Period 2 (12-14 Days)||40
10568012|NCT01641692|11723306|FG003|STARTED|Washout Period 2 (12-14 Days)||41
10455210|NCT01000974|11603220|FG001|COMPLETED|Primary Vaccination Phase||470
10455211|NCT01000974|11603221|FG002|COMPLETED|Primary Vaccination Phase||457
10455212|NCT01000974|11603219|FG000|NOT COMPLETED|Primary Vaccination Phase||338
10455213|NCT01000974|11603220|FG001|NOT COMPLETED|Primary Vaccination Phase||50
10455214|NCT01000974|11603221|FG002|NOT COMPLETED|Primary Vaccination Phase||63
10455215|NCT01000974|11603219|FG000|STARTED|Booster Vaccination Phase||2337
10455216|NCT01000974|11603220|FG001|STARTED|Booster Vaccination Phase||435
10455217|NCT01000974|11603221|FG002|STARTED|Booster Vaccination Phase||400
10455218|NCT01000974|11603219|FG000|COMPLETED|Booster Vaccination Phase||2270
10455219|NCT01000974|11603220|FG001|COMPLETED|Booster Vaccination Phase||423
10455220|NCT01000974|11603221|FG002|COMPLETED|Booster Vaccination Phase||386
10455221|NCT01000974|11603219|FG000|NOT COMPLETED|Booster Vaccination Phase||67
10455222|NCT01000974|11603220|FG001|NOT COMPLETED|Booster Vaccination Phase||12
10455223|NCT01000974|11603221|FG002|NOT COMPLETED|Booster Vaccination Phase||14
10455224|NCT01000987|11603235|FG000|STARTED|Overall Study||12
10455225|NCT01000987|11603236|FG001|STARTED|Overall Study||15
10455226|NCT01000987|11603237|FG002|STARTED|Overall Study||17
10455227|NCT01000987|11603235|FG000|COMPLETED|Overall Study||12
10455228|NCT01000987|11603236|FG001|COMPLETED|Overall Study||15
10455229|NCT01000987|11603237|FG002|COMPLETED|Overall Study||17
10568013|NCT01641692|11723307|FG004|STARTED|Washout Period 2 (12-14 Days)||37
10568014|NCT01641692|11723308|FG005|STARTED|Washout Period 2 (12-14 Days)||43
10568015|NCT01641692|11723309|FG006|STARTED|Washout Period 2 (12-14 Days)||43
10568016|NCT01641692|11723310|FG007|STARTED|Washout Period 2 (12-14 Days)||35
10568017|NCT01641692|11723303|FG000|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|30
10568018|NCT01641692|11723304|FG001|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|46
10568019|NCT01641692|11723305|FG002|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|39
10568020|NCT01641692|11723306|FG003|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|41
10568021|NCT01641692|11723307|FG004|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|34
10568022|NCT01641692|11723308|FG005|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|42
10568023|NCT01641692|11723309|FG006|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|42
10568024|NCT01641692|11723310|FG007|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|34
10568025|NCT01641692|11723303|FG000|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
10568026|NCT01641692|11723304|FG001|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
10568027|NCT01641692|11723305|FG002|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
10568028|NCT01641692|11723306|FG003|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
10568029|NCT01641692|11723307|FG004|NOT COMPLETED|Washout Period 2 (12-14 Days)||3
10568030|NCT01641692|11723308|FG005|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
10568031|NCT01641692|11723309|FG006|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
10568032|NCT01641692|11723310|FG007|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
10568033|NCT01641692|11723303|FG000|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|43
10568034|NCT01641692|11723304|FG001|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|33
10568035|NCT01641692|11723305|FG002|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|38
10568036|NCT01641692|11723306|FG003|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|42
10568037|NCT01641692|11723307|FG004|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|40
10568038|NCT01641692|11723308|FG005|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|39
10568039|NCT01641692|11723309|FG006|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|35
10568040|NCT01641692|11723310|FG007|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|38
10568041|NCT01641692|11723303|FG000|COMPLETED|Treatment Period 3||43
10568042|NCT01641692|11723304|FG001|COMPLETED|Treatment Period 3||32
10568043|NCT01641692|11723305|FG002|COMPLETED|Treatment Period 3||37
10568044|NCT01641692|11723306|FG003|COMPLETED|Treatment Period 3||42
10568045|NCT01641692|11723307|FG004|COMPLETED|Treatment Period 3||40
10568046|NCT01641692|11723308|FG005|COMPLETED|Treatment Period 3||39
10568047|NCT01641692|11723309|FG006|COMPLETED|Treatment Period 3||33
10568048|NCT01641692|11723310|FG007|COMPLETED|Treatment Period 3||38
10568049|NCT01641692|11723303|FG000|NOT COMPLETED|Treatment Period 3||0
10568050|NCT01641692|11723304|FG001|NOT COMPLETED|Treatment Period 3||1
10568051|NCT01641692|11723305|FG002|NOT COMPLETED|Treatment Period 3||1
10568052|NCT01641692|11723306|FG003|NOT COMPLETED|Treatment Period 3||0
10568053|NCT01641692|11723307|FG004|NOT COMPLETED|Treatment Period 3||0
10568054|NCT01641692|11723308|FG005|NOT COMPLETED|Treatment Period 3||0
10568055|NCT01641692|11723309|FG006|NOT COMPLETED|Treatment Period 3||2
10568056|NCT01641692|11723310|FG007|NOT COMPLETED|Treatment Period 3||0
10568057|NCT01641692|11723303|FG000|STARTED|Washout Period 3 or Follow-up||43
10568058|NCT01641692|11723304|FG001|STARTED|Washout Period 3 or Follow-up||32
10568059|NCT01641692|11723305|FG002|STARTED|Washout Period 3 or Follow-up||37
10568060|NCT01641692|11723306|FG003|STARTED|Washout Period 3 or Follow-up||42
10568061|NCT01641692|11723307|FG004|STARTED|Washout Period 3 or Follow-up||40
10568062|NCT01641692|11723308|FG005|STARTED|Washout Period 3 or Follow-up||39
10568063|NCT01641692|11723309|FG006|STARTED|Washout Period 3 or Follow-up||33
10568064|NCT01641692|11723310|FG007|STARTED|Washout Period 3 or Follow-up||38
10568065|NCT01641692|11723303|FG000|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|42
10568066|NCT01641692|11723304|FG001|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|32
10568067|NCT01641692|11723305|FG002|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|36
10568068|NCT01641692|11723306|FG003|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|41
10568069|NCT01641692|11723307|FG004|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|40
10568070|NCT01641692|11723308|FG005|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|37
10568071|NCT01641692|11723309|FG006|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|32
10568072|NCT01641692|11723310|FG007|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|38
10568073|NCT01641692|11723303|FG000|NOT COMPLETED|Washout Period 3 or Follow-up||1
10568074|NCT01641692|11723304|FG001|NOT COMPLETED|Washout Period 3 or Follow-up||0
10568075|NCT01641692|11723305|FG002|NOT COMPLETED|Washout Period 3 or Follow-up||1
10568076|NCT01641692|11723306|FG003|NOT COMPLETED|Washout Period 3 or Follow-up||1
10568077|NCT01641692|11723307|FG004|NOT COMPLETED|Washout Period 3 or Follow-up||0
10568078|NCT01641692|11723308|FG005|NOT COMPLETED|Washout Period 3 or Follow-up||2
10568079|NCT01641692|11723309|FG006|NOT COMPLETED|Washout Period 3 or Follow-up||1
10568080|NCT01641692|11723310|FG007|NOT COMPLETED|Washout Period 3 or Follow-up||0
10568081|NCT01641809|11723333|FG000|STARTED|Induction Phase (Day 1 to Week 24)||60
10568082|NCT01641809|11723334|FG001|STARTED|Induction Phase (Day 1 to Week 24)||60
10568083|NCT01641809|11723335|FG002|STARTED|Induction Phase (Day 1 to Week 24)||61
10568084|NCT01641809|11723336|FG003|STARTED|Induction Phase (Day 1 to Week 24)||62
10568085|NCT01641809|11723333|FG000|COMPLETED|Induction Phase (Day 1 to Week 24)||52
10568086|NCT01641809|11723334|FG001|COMPLETED|Induction Phase (Day 1 to Week 24)||53
10568087|NCT01641809|11723335|FG002|COMPLETED|Induction Phase (Day 1 to Week 24)||55
10568088|NCT01641809|11723336|FG003|COMPLETED|Induction Phase (Day 1 to Week 24)||47
10568089|NCT01641809|11723333|FG000|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||8
10568090|NCT01641809|11723334|FG001|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||7
10568091|NCT01641809|11723335|FG002|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||6
10568092|NCT01641809|11723336|FG003|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||15
10568093|NCT01641809|11723333|FG000|STARTED|Maintenance Phase (Week 24 to Week 96)||52
10568094|NCT01641809|11723334|FG001|STARTED|Maintenance Phase (Week 24 to Week 96)||53
10568095|NCT01641809|11723335|FG002|STARTED|Maintenance Phase (Week 24 to Week 96)||55
10568096|NCT01641809|11723336|FG003|STARTED|Maintenance Phase (Week 24 to Week 96)||47
10568097|NCT01641809|11723333|FG000|COMPLETED|Maintenance Phase (Week 24 to Week 96)||46
10568098|NCT01641809|11723334|FG001|COMPLETED|Maintenance Phase (Week 24 to Week 96)||48
10568099|NCT01641809|11723335|FG002|COMPLETED|Maintenance Phase (Week 24 to Week 96)||52
10568100|NCT01641809|11723336|FG003|COMPLETED|Maintenance Phase (Week 24 to Week 96)||41
10568101|NCT01641809|11723333|FG000|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||6
10568102|NCT01641809|11723334|FG001|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||5
10568103|NCT01641809|11723335|FG002|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||3
10568104|NCT01641809|11723336|FG003|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||6
10568105|NCT01641809|11723333|FG000|STARTED|Open-label (Week 96 to Week 324)||46
10568106|NCT01641809|11723334|FG001|STARTED|Open-label (Week 96 to Week 324)|1 participant completed study as per protocol at Week 96 and opted to not enter open-label phase|47
10568107|NCT01641809|11723335|FG002|STARTED|Open-label (Week 96 to Week 324)|1 participant completed study as per protocol at Week 96 and opted to not enter open-label phase|51
10568108|NCT01641809|11723336|FG003|STARTED|Open-label (Week 96 to Week 324)|Participants completed study at Week 96 and did not enter open-label phase|0
10568109|NCT01641809|11723333|FG000|COMPLETED|Open-label (Week 96 to Week 324)||30
10568110|NCT01641809|11723334|FG001|COMPLETED|Open-label (Week 96 to Week 324)||35
10568111|NCT01641809|11723335|FG002|COMPLETED|Open-label (Week 96 to Week 324)||43
10568112|NCT01641809|11723336|FG003|COMPLETED|Open-label (Week 96 to Week 324)||0
10568113|NCT01641809|11723333|FG000|NOT COMPLETED|Open-label (Week 96 to Week 324)||16
10568114|NCT01641809|11723334|FG001|NOT COMPLETED|Open-label (Week 96 to Week 324)||12
10568115|NCT01641809|11723335|FG002|NOT COMPLETED|Open-label (Week 96 to Week 324)||8
10568116|NCT01641809|11723336|FG003|NOT COMPLETED|Open-label (Week 96 to Week 324)||0
10568117|NCT01641822|11723356|FG000|STARTED|Run-in Phase||107
10568118|NCT01641822|11723357|FG001|STARTED|Run-in Phase||0
10568119|NCT01641822|11723358|FG002|STARTED|Run-in Phase||0
10568120|NCT01641822|11723356|FG000|COMPLETED|Run-in Phase|3 participants who completed the TIS Run-In Phase did not continue to the Comparative Phase.|93
10568121|NCT01641822|11723357|FG001|COMPLETED|Run-in Phase||0
10568122|NCT01641822|11723358|FG002|COMPLETED|Run-in Phase||0
10568123|NCT01641822|11723356|FG000|NOT COMPLETED|Run-in Phase||14
10568124|NCT01641822|11723357|FG001|NOT COMPLETED|Run-in Phase||0
10568125|NCT01641822|11723358|FG002|NOT COMPLETED|Run-in Phase||0
10568195|NCT01641991|11723437|FG000|STARTED|Overall Study||82
10568126|NCT01641822|11723356|FG000|STARTED|Comparative Phase|Participants continuing into the Comparative Phase were randomized to the AZLI or Placebo group.|0
10568127|NCT01641822|11723357|FG001|STARTED|Comparative Phase||43
10568128|NCT01641822|11723358|FG002|STARTED|Comparative Phase||47
10568129|NCT01641822|11723356|FG000|Received Randomized Study Drug Treatment|Comparative Phase||0
10568130|NCT01641822|11723357|FG001|Received Randomized Study Drug Treatment|Comparative Phase||42
10568131|NCT01641822|11723358|FG002|Received Randomized Study Drug Treatment|Comparative Phase||46
10568132|NCT01641822|11723356|FG000|COMPLETED|Comparative Phase||0
10568133|NCT01641822|11723357|FG001|COMPLETED|Comparative Phase||37
10568134|NCT01641822|11723358|FG002|COMPLETED|Comparative Phase||37
10568135|NCT01641822|11723356|FG000|NOT COMPLETED|Comparative Phase||0
10568136|NCT01641822|11723357|FG001|NOT COMPLETED|Comparative Phase||6
10568137|NCT01641822|11723358|FG002|NOT COMPLETED|Comparative Phase||10
10568138|NCT01641835|11723365|FG000|STARTED|Overall Study||303
10568139|NCT01641835|11723365|FG000|COMPLETED|Overall Study||303
10793456|NCT03605836|11954267|FG000|Treated|OL Placebo Run-in Period [1 Week]||579
10793457|NCT03605836|11954268|FG001|Treated|OL Placebo Run-in Period [1 Week]||0
10793458|NCT03605836|11954269|FG002|Treated|OL Placebo Run-in Period [1 Week]||0
10793459|NCT03605836|11954270|FG003|Treated|OL Placebo Run-in Period [1 Week]||0
10793460|NCT03605836|11954267|FG000|COMPLETED|OL Placebo Run-in Period [1 Week]||440
10793461|NCT03605836|11954268|FG001|COMPLETED|OL Placebo Run-in Period [1 Week]||0
10793462|NCT03605836|11954269|FG002|COMPLETED|OL Placebo Run-in Period [1 Week]||0
10793463|NCT03605836|11954270|FG003|COMPLETED|OL Placebo Run-in Period [1 Week]||0
10793464|NCT03605836|11954267|FG000|NOT COMPLETED|OL Placebo Run-in Period [1 Week]||150
10568140|NCT01641835|11723365|FG000|NOT COMPLETED|Overall Study||0
10568141|NCT01641861|11723371|FG000|STARTED|Overall Study||246
10568142|NCT01641861|11723372|FG001|STARTED|Overall Study||242
10568143|NCT01641861|11723371|FG000|COMPLETED|Overall Study||211
10568144|NCT01641861|11723372|FG001|COMPLETED|Overall Study||217
10568145|NCT01641861|11723371|FG000|NOT COMPLETED|Overall Study||35
10568146|NCT01641861|11723372|FG001|NOT COMPLETED|Overall Study||25
10568147|NCT01641900|11723380|FG000|STARTED|Overall Study||28
10568148|NCT01641900|11723381|FG001|STARTED|Overall Study||31
10568149|NCT01641900|11723380|FG000|Completed Placebo Intervention|Overall Study|n=1,assigned to placebo intervention first, completed the session and dropped out of the study.|27
10568150|NCT01641900|11723381|FG001|Completed Placebo Intervention|Overall Study|n=2,both assigned to placebo intervention first, completed the session and dropped out of the study.|29
10568151|NCT01641900|11723380|FG000|Completed Drug Intervention|Overall Study|n=1,assigned to drug intervention first, completed the session and dropped out of the study.|26
10568152|NCT01641900|11723381|FG001|Completed Drug Intervention|Overall Study||29
10568153|NCT01641900|11723380|FG000|COMPLETED|Overall Study||26
10568154|NCT01641900|11723381|FG001|COMPLETED|Overall Study||29
10568155|NCT01641900|11723380|FG000|NOT COMPLETED|Overall Study||2
10568156|NCT01641900|11723381|FG001|NOT COMPLETED|Overall Study||2
10568157|NCT01641926|11723393|FG000|STARTED|Overall Study||143
10568158|NCT01641926|11723394|FG001|STARTED|Overall Study||145
10568159|NCT01641926|11723395|FG002|STARTED|Overall Study||57
10568160|NCT01641926|11723396|FG003|STARTED|Overall Study||57
10568161|NCT01641926|11723393|FG000|Treated (All Participants as Treated)|Overall Study||142
10568162|NCT01641926|11723394|FG001|Treated (All Participants as Treated)|Overall Study||144
10568163|NCT01641926|11723395|FG002|Treated (All Participants as Treated)|Overall Study||56
10793465|NCT03605836|11954268|FG001|NOT COMPLETED|OL Placebo Run-in Period [1 Week]||0
10793466|NCT03605836|11954269|FG002|NOT COMPLETED|OL Placebo Run-in Period [1 Week]||0
10793467|NCT03605836|11954270|FG003|NOT COMPLETED|OL Placebo Run-in Period [1 Week]||0
10793468|NCT03605836|11954267|FG000|STARTED|Double-blind Treatment Period [6 Weeks]||0
10793469|NCT03605836|11954268|FG001|STARTED|Double-blind Treatment Period [6 Weeks]||147
10568164|NCT01641926|11723396|FG003|Treated (All Participants as Treated)|Overall Study||57
10568165|NCT01641926|11723393|FG000|COMPLETED|Overall Study||115
10568166|NCT01641926|11723394|FG001|COMPLETED|Overall Study||130
10568167|NCT01641926|11723395|FG002|COMPLETED|Overall Study||46
10568168|NCT01641926|11723396|FG003|COMPLETED|Overall Study||53
10568169|NCT01641926|11723393|FG000|NOT COMPLETED|Overall Study||28
10568170|NCT01641926|11723394|FG001|NOT COMPLETED|Overall Study||15
10568171|NCT01641926|11723395|FG002|NOT COMPLETED|Overall Study||11
10568172|NCT01641926|11723396|FG003|NOT COMPLETED|Overall Study||4
10568173|NCT01641939|11723409|FG000|STARTED|Overall Study||117
10568174|NCT01641939|11723410|FG001|STARTED|Overall Study||228
10568175|NCT01641939|11723411|FG002|STARTED|Overall Study||70
10568176|NCT01641939|11723409|FG000|Stage 1|Overall Study||37
10568177|NCT01641939|11723410|FG001|Stage 1|Overall Study||75
10568178|NCT01641939|11723411|FG002|Stage 1|Overall Study||70
10568179|NCT01641939|11723409|FG000|Stage 2|Overall Study||80
10568180|NCT01641939|11723410|FG001|Stage 2|Overall Study||153
10568181|NCT01641939|11723411|FG002|Stage 2|Overall Study||0
10568182|NCT01641939|11723409|FG000|COMPLETED|Overall Study||0
10568183|NCT01641939|11723410|FG001|COMPLETED|Overall Study||0
10568184|NCT01641939|11723411|FG002|COMPLETED|Overall Study||0
10568185|NCT01641939|11723409|FG000|NOT COMPLETED|Overall Study||117
10568186|NCT01641939|11723410|FG001|NOT COMPLETED|Overall Study||228
10568187|NCT01641939|11723411|FG002|NOT COMPLETED|Overall Study||70
10568188|NCT01641952|11723421|FG000|STARTED|Overall Study||505
10568189|NCT01641952|11723421|FG000|Treated|Overall Study||504
10568190|NCT01641952|11723421|FG000|COMPLETED|Overall Study||471
10568191|NCT01641952|11723421|FG000|NOT COMPLETED|Overall Study||34
10568192|NCT01641978|11723425|FG000|STARTED|Overall Study||125
10568193|NCT01641978|11723425|FG000|COMPLETED|Overall Study||125
10568194|NCT01641978|11723425|FG000|NOT COMPLETED|Overall Study||0
10568196|NCT01641991|11723438|FG001|STARTED|Overall Study||82
10568197|NCT01641991|11723439|FG002|STARTED|Overall Study||82
10568198|NCT01641991|11723440|FG003|STARTED|Overall Study||82
10568199|NCT01641991|11723437|FG000|COMPLETED|Overall Study||73
10568200|NCT01641991|11723438|FG001|COMPLETED|Overall Study||74
10568201|NCT01641991|11723439|FG002|COMPLETED|Overall Study||65
10568202|NCT01641991|11723440|FG003|COMPLETED|Overall Study||66
10568203|NCT01641991|11723437|FG000|NOT COMPLETED|Overall Study||9
10568204|NCT01641991|11723438|FG001|NOT COMPLETED|Overall Study||8
10568205|NCT01641991|11723439|FG002|NOT COMPLETED|Overall Study||17
10568206|NCT01641991|11723440|FG003|NOT COMPLETED|Overall Study||16
10568207|NCT01642056|11723455|FG000|STARTED|First Intervention||10
10568208|NCT01642056|11723456|FG001|STARTED|First Intervention||10
10568209|NCT01642056|11723455|FG000|COMPLETED|First Intervention||9
10568210|NCT01642056|11723456|FG001|COMPLETED|First Intervention||10
10568211|NCT01642056|11723455|FG000|NOT COMPLETED|First Intervention||1
10568212|NCT01642056|11723456|FG001|NOT COMPLETED|First Intervention||0
10568213|NCT01642056|11723455|FG000|STARTED|Second Intervention||9
10568214|NCT01642056|11723456|FG001|STARTED|Second Intervention||10
10793470|NCT03605836|11954269|FG002|STARTED|Double-blind Treatment Period [6 Weeks]||147
10793471|NCT03605836|11954270|FG003|STARTED|Double-blind Treatment Period [6 Weeks]||146
10568215|NCT01642056|11723455|FG000|COMPLETED|Second Intervention||8
10568216|NCT01642056|11723456|FG001|COMPLETED|Second Intervention||8
10568217|NCT01642056|11723455|FG000|NOT COMPLETED|Second Intervention||1
10568218|NCT01642056|11723456|FG001|NOT COMPLETED|Second Intervention||2
10568219|NCT01642082|11723462|FG000|STARTED|Overall Study||28
10568220|NCT01642082|11723462|FG000|COMPLETED|Overall Study||28
10568221|NCT01642082|11723462|FG000|NOT COMPLETED|Overall Study||0
10568222|NCT01642147|11723475|FG000|STARTED|Overall Study||30
10568223|NCT01642147|11723476|FG001|STARTED|Overall Study||30
10568224|NCT01642147|11723475|FG000|COMPLETED|Overall Study||30
10568225|NCT01642147|11723476|FG001|COMPLETED|Overall Study||30
10568226|NCT01642147|11723475|FG000|NOT COMPLETED|Overall Study||0
10568227|NCT01642147|11723476|FG001|NOT COMPLETED|Overall Study||0
10568228|NCT01642212|11723484|FG000|STARTED|Single-blind Baseline||119
10568229|NCT01642212|11723485|FG001|STARTED|Single-blind Baseline||0
10568230|NCT01642212|11723486|FG002|STARTED|Single-blind Baseline||0
10568231|NCT01642212|11723487|FG003|STARTED|Single-blind Baseline||0
10793472|NCT03605836|11954267|FG000|Treated|Double-blind Treatment Period [6 Weeks]||0
10793473|NCT03605836|11954268|FG001|Treated|Double-blind Treatment Period [6 Weeks]||145
10793474|NCT03605836|11954269|FG002|Treated|Double-blind Treatment Period [6 Weeks]||143
10793475|NCT03605836|11954270|FG003|Treated|Double-blind Treatment Period [6 Weeks]||142
10793476|NCT03605836|11954267|FG000|COMPLETED|Double-blind Treatment Period [6 Weeks]||0
10793477|NCT03605836|11954268|FG001|COMPLETED|Double-blind Treatment Period [6 Weeks]||111
10568232|NCT01642212|11723488|FG004|STARTED|Single-blind Baseline||0
10568233|NCT01642212|11723484|FG000|COMPLETED|Single-blind Baseline||93
10568234|NCT01642212|11723485|FG001|COMPLETED|Single-blind Baseline||0
10568235|NCT01642212|11723486|FG002|COMPLETED|Single-blind Baseline||0
10568236|NCT01642212|11723487|FG003|COMPLETED|Single-blind Baseline||0
10568237|NCT01642212|11723488|FG004|COMPLETED|Single-blind Baseline||0
10568238|NCT01642212|11723484|FG000|NOT COMPLETED|Single-blind Baseline||26
10568239|NCT01642212|11723485|FG001|NOT COMPLETED|Single-blind Baseline||0
10568240|NCT01642212|11723486|FG002|NOT COMPLETED|Single-blind Baseline||0
10793478|NCT03605836|11954269|FG002|COMPLETED|Double-blind Treatment Period [6 Weeks]||102
10793479|NCT03605836|11954270|FG003|COMPLETED|Double-blind Treatment Period [6 Weeks]||123
10793480|NCT03605836|11954267|FG000|NOT COMPLETED|Double-blind Treatment Period [6 Weeks]||0
10793481|NCT03605836|11954268|FG001|NOT COMPLETED|Double-blind Treatment Period [6 Weeks]||36
10793482|NCT03605836|11954269|FG002|NOT COMPLETED|Double-blind Treatment Period [6 Weeks]||45
10793483|NCT03605836|11954270|FG003|NOT COMPLETED|Double-blind Treatment Period [6 Weeks]||23
10793484|NCT03605914|11954281|FG000|STARTED|Overall Study||57
10793485|NCT03605914|11954282|FG001|STARTED|Overall Study||43
10793486|NCT03605914|11954281|FG000|Completed Day 1 Assessment|Overall Study||31
10793487|NCT03605914|11954282|FG001|Completed Day 1 Assessment|Overall Study||26
10793488|NCT03605914|11954281|FG000|Completed Day 2 Assessment|Overall Study||32
10793489|NCT03605914|11954282|FG001|Completed Day 2 Assessment|Overall Study||27
10793490|NCT03605914|11954281|FG000|Completed Day 3 Assessment|Overall Study||31
10793491|NCT03605914|11954282|FG001|Completed Day 3 Assessment|Overall Study||28
10793492|NCT03605914|11954281|FG000|Completed Day 5 Assessment|Overall Study||30
10793493|NCT03605914|11954282|FG001|Completed Day 5 Assessment|Overall Study||24
10793494|NCT03605914|11954281|FG000|COMPLETED|Overall Study||30
10793495|NCT03605914|11954282|FG001|COMPLETED|Overall Study||24
10793496|NCT03605914|11954281|FG000|NOT COMPLETED|Overall Study||27
10793497|NCT03605914|11954282|FG001|NOT COMPLETED|Overall Study||19
10793498|NCT03606187|11954290|FG000|STARTED|Overall Study||67
10793499|NCT03606187|11954291|FG001|STARTED|Overall Study||61
10793500|NCT03606187|11954290|FG000|COMPLETED|Overall Study||67
10793501|NCT03606187|11954291|FG001|COMPLETED|Overall Study||61
10793502|NCT03606187|11954290|FG000|NOT COMPLETED|Overall Study||0
10793503|NCT03606187|11954291|FG001|NOT COMPLETED|Overall Study||0
10793504|NCT03606343|11954297|FG000|STARTED|Overall Study||21
10793505|NCT03606343|11954297|FG000|COMPLETED|Overall Study||21
10793506|NCT03606343|11954297|FG000|NOT COMPLETED|Overall Study||0
10793507|NCT03606460|11954303|FG000|STARTED|Overall Study||95
10793508|NCT03606460|11954304|FG001|STARTED|Overall Study||46
10793509|NCT03606460|11954303|FG000|COMPLETED|Overall Study||94
10793510|NCT03606460|11954304|FG001|COMPLETED|Overall Study||38
10793511|NCT03606460|11954303|FG000|NOT COMPLETED|Overall Study||1
10793512|NCT03606460|11954304|FG001|NOT COMPLETED|Overall Study||8
10793513|NCT03607539|11954313|FG000|STARTED|Overall Study||266
10793514|NCT03607539|11954314|FG001|STARTED|Overall Study||131
10793515|NCT03607539|11954313|FG000|COMPLETED|Overall Study||0
10793516|NCT03607539|11954314|FG001|COMPLETED|Overall Study||0
10793517|NCT03607539|11954313|FG000|NOT COMPLETED|Overall Study||266
10793518|NCT03607539|11954314|FG001|NOT COMPLETED|Overall Study||131
10793519|NCT03607682|11954320|FG000|STARTED|Overall Study||2
10793520|NCT03607682|11954320|FG000|COMPLETED|Overall Study||0
10793521|NCT03607682|11954320|FG000|NOT COMPLETED|Overall Study||2
10793522|NCT03607695|11954324|FG000|STARTED|2 Week||19
10793523|NCT03607695|11954324|FG000|COMPLETED|2 Week||19
10793524|NCT03607695|11954324|FG000|NOT COMPLETED|2 Week||0
10793525|NCT03607695|11954324|FG000|STARTED|10 Week||19
10793526|NCT03607695|11954324|FG000|COMPLETED|10 Week||18
10793527|NCT03607695|11954324|FG000|NOT COMPLETED|10 Week||1
10793528|NCT03607695|11954324|FG000|STARTED|16 Week||18
10793529|NCT03607695|11954324|FG000|COMPLETED|16 Week||16
10793530|NCT03607695|11954324|FG000|NOT COMPLETED|16 Week||2
10568241|NCT01642212|11723487|FG003|NOT COMPLETED|Single-blind Baseline||0
10568242|NCT01642212|11723488|FG004|NOT COMPLETED|Single-blind Baseline||0
10793531|NCT03608488|11954332|FG000|STARTED|Overall Study||22
10568243|NCT01642212|11723484|FG000|STARTED|Double-blind Treatment||0
10568244|NCT01642212|11723485|FG001|STARTED|Double-blind Treatment||42
10568245|NCT01642212|11723486|FG002|STARTED|Double-blind Treatment||51
10568246|NCT01642212|11723487|FG003|STARTED|Double-blind Treatment||0
10568247|NCT01642212|11723488|FG004|STARTED|Double-blind Treatment||0
10568248|NCT01642212|11723484|FG000|COMPLETED|Double-blind Treatment||0
10568249|NCT01642212|11723485|FG001|COMPLETED|Double-blind Treatment||39
10568250|NCT01642212|11723486|FG002|COMPLETED|Double-blind Treatment||49
10568251|NCT01642212|11723487|FG003|COMPLETED|Double-blind Treatment||0
10568252|NCT01642212|11723488|FG004|COMPLETED|Double-blind Treatment||0
10568253|NCT01642212|11723484|FG000|NOT COMPLETED|Double-blind Treatment||0
10568254|NCT01642212|11723485|FG001|NOT COMPLETED|Double-blind Treatment||3
10568255|NCT01642212|11723486|FG002|NOT COMPLETED|Double-blind Treatment||2
10568256|NCT01642212|11723487|FG003|NOT COMPLETED|Double-blind Treatment||0
10568257|NCT01642212|11723488|FG004|NOT COMPLETED|Double-blind Treatment||0
10568258|NCT01642212|11723484|FG000|STARTED|Open-label Extension||0
10568259|NCT01642212|11723485|FG001|STARTED|Open-label Extension||0
10568260|NCT01642212|11723486|FG002|STARTED|Open-label Extension||0
10568261|NCT01642212|11723487|FG003|STARTED|Open-label Extension|Two participants completed double-blind treatment but did not enter the open-label extension.|37
10568262|NCT01642212|11723488|FG004|STARTED|Open-label Extension|Four participants completed double-blind treatment but did not enter the open-label extension.|45
10568263|NCT01642212|11723484|FG000|COMPLETED|Open-label Extension||0
10568264|NCT01642212|11723485|FG001|COMPLETED|Open-label Extension||0
10568265|NCT01642212|11723486|FG002|COMPLETED|Open-label Extension||0
10568266|NCT01642212|11723487|FG003|COMPLETED|Open-label Extension||27
10793532|NCT03608488|11954333|FG001|STARTED|Overall Study||21
10793533|NCT03608488|11954334|FG002|STARTED|Overall Study||22
10793534|NCT03608488|11954335|FG003|STARTED|Overall Study||45
10793535|NCT03608488|11954332|FG000|COMPLETED|Overall Study||21
10793536|NCT03608488|11954333|FG001|COMPLETED|Overall Study||18
10793537|NCT03608488|11954334|FG002|COMPLETED|Overall Study||20
10793538|NCT03608488|11954335|FG003|COMPLETED|Overall Study||40
10793539|NCT03608488|11954332|FG000|NOT COMPLETED|Overall Study||1
10793540|NCT03608488|11954333|FG001|NOT COMPLETED|Overall Study||3
10793541|NCT03608488|11954334|FG002|NOT COMPLETED|Overall Study||2
10793542|NCT03608488|11954335|FG003|NOT COMPLETED|Overall Study||5
10793543|NCT03608774|11954347|FG000|STARTED|Overall Study||89
10568267|NCT01642212|11723488|FG004|COMPLETED|Open-label Extension||37
10568268|NCT01642212|11723484|FG000|NOT COMPLETED|Open-label Extension||0
10568269|NCT01642212|11723485|FG001|NOT COMPLETED|Open-label Extension||0
10568270|NCT01642212|11723486|FG002|NOT COMPLETED|Open-label Extension||0
10568271|NCT01642212|11723487|FG003|NOT COMPLETED|Open-label Extension||10
10568272|NCT01642212|11723488|FG004|NOT COMPLETED|Open-label Extension||8
10568273|NCT01642238|11723496|FG000|STARTED|First Intervention (1 Day)||7
10568274|NCT01642238|11723497|FG001|STARTED|First Intervention (1 Day)||8
10568275|NCT01642238|11723496|FG000|COMPLETED|First Intervention (1 Day)||7
10568276|NCT01642238|11723497|FG001|COMPLETED|First Intervention (1 Day)||8
10568277|NCT01642238|11723496|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10568278|NCT01642238|11723497|FG001|NOT COMPLETED|First Intervention (1 Day)||0
10568279|NCT01642238|11723496|FG000|STARTED|Washout (1-2 Weeks)||7
10568280|NCT01642238|11723497|FG001|STARTED|Washout (1-2 Weeks)||8
10568281|NCT01642238|11723496|FG000|COMPLETED|Washout (1-2 Weeks)||7
10568282|NCT01642238|11723497|FG001|COMPLETED|Washout (1-2 Weeks)||8
10568283|NCT01642238|11723496|FG000|NOT COMPLETED|Washout (1-2 Weeks)||0
10568284|NCT01642238|11723497|FG001|NOT COMPLETED|Washout (1-2 Weeks)||0
10568285|NCT01642238|11723496|FG000|STARTED|Second Intervention (1 Day)||7
10568286|NCT01642238|11723497|FG001|STARTED|Second Intervention (1 Day)||8
10568287|NCT01642238|11723496|FG000|COMPLETED|Second Intervention (1 Day)||7
10568288|NCT01642238|11723497|FG001|COMPLETED|Second Intervention (1 Day)||8
10568289|NCT01642238|11723496|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10568290|NCT01642238|11723497|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10568291|NCT01642251|11723506|FG000|STARTED|Overall Study||3
10568292|NCT01642251|11723507|FG001|STARTED|Overall Study||6
10568293|NCT01642251|11723508|FG002|STARTED|Overall Study||75
10568294|NCT01642251|11723509|FG003|STARTED|Overall Study||72
10568295|NCT01642251|11723506|FG000|Started Protocol Therapy|Overall Study||3
10568296|NCT01642251|11723507|FG001|Started Protocol Therapy|Overall Study||6
10568297|NCT01642251|11723508|FG002|Started Protocol Therapy|Overall Study||66
10568298|NCT01642251|11723509|FG003|Started Protocol Therapy|Overall Study||66
10568299|NCT01642251|11723506|FG000|Eligible|Overall Study||3
10568300|NCT01642251|11723507|FG001|Eligible|Overall Study||6
10568301|NCT01642251|11723508|FG002|Eligible|Overall Study||72
10568302|NCT01642251|11723509|FG003|Eligible|Overall Study||69
10568303|NCT01642251|11723506|FG000|Eligible and Treated|Overall Study||3
10568304|NCT01642251|11723507|FG001|Eligible and Treated|Overall Study||6
10793544|NCT03608774|11954348|FG001|STARTED|Overall Study||88
10568305|NCT01642251|11723508|FG002|Eligible and Treated|Overall Study||64
10568306|NCT01642251|11723509|FG003|Eligible and Treated|Overall Study||64
10568307|NCT01642251|11723506|FG000|COMPLETED|Overall Study||3
10568308|NCT01642251|11723507|FG001|COMPLETED|Overall Study||6
10568309|NCT01642251|11723508|FG002|COMPLETED|Overall Study||53
10568310|NCT01642251|11723509|FG003|COMPLETED|Overall Study||49
10793545|NCT03608774|11954347|FG000|COMPLETED|Overall Study||82
10793546|NCT03608774|11954348|FG001|COMPLETED|Overall Study||81
10793547|NCT03608774|11954347|FG000|NOT COMPLETED|Overall Study||7
10793548|NCT03608774|11954348|FG001|NOT COMPLETED|Overall Study||7
10568311|NCT01642251|11723506|FG000|NOT COMPLETED|Overall Study||0
10568312|NCT01642251|11723507|FG001|NOT COMPLETED|Overall Study||0
10568313|NCT01642251|11723508|FG002|NOT COMPLETED|Overall Study||22
10568314|NCT01642251|11723509|FG003|NOT COMPLETED|Overall Study||23
10568315|NCT01642277|11723520|FG000|STARTED|Overall Study||74
10793549|NCT03608839|11954357|FG000|STARTED|Overall Study||9
10793550|NCT03608839|11954358|FG001|STARTED|Overall Study||9
10793551|NCT03608839|11954359|FG002|STARTED|Overall Study||9
10793552|NCT03608839|11954357|FG000|COMPLETED|Overall Study||9
10793553|NCT03608839|11954358|FG001|COMPLETED|Overall Study||9
10793554|NCT03608839|11954359|FG002|COMPLETED|Overall Study||9
10793555|NCT03608839|11954357|FG000|NOT COMPLETED|Overall Study||0
10793556|NCT03608839|11954358|FG001|NOT COMPLETED|Overall Study||0
10793557|NCT03608839|11954359|FG002|NOT COMPLETED|Overall Study||0
10793558|NCT03609619|11954369|FG000|STARTED|Overall Study||54
10793559|NCT03609619|11954370|FG001|STARTED|Overall Study||55
10793560|NCT03609619|11954369|FG000|COMPLETED|Overall Study||44
10568316|NCT01642277|11723521|FG001|STARTED|Overall Study||60
10568317|NCT01642277|11723520|FG000|COMPLETED|Overall Study||50
10568318|NCT01642277|11723521|FG001|COMPLETED|Overall Study||60
10568319|NCT01642277|11723520|FG000|NOT COMPLETED|Overall Study||24
10568320|NCT01642277|11723521|FG001|NOT COMPLETED|Overall Study||0
10568321|NCT01642407|11723528|FG000|STARTED|Part 1 (Screening Till Week 16)||6
10568322|NCT01642407|11723528|FG000|COMPLETED|Part 1 (Screening Till Week 16)||3
10568323|NCT01642407|11723528|FG000|NOT COMPLETED|Part 1 (Screening Till Week 16)||3
10568324|NCT01642407|11723528|FG000|STARTED|Part 2(Week17 to Maximum of 119.6 Weeks)||3
10568325|NCT01642407|11723528|FG000|COMPLETED|Part 2(Week17 to Maximum of 119.6 Weeks)||1
10568326|NCT01642407|11723528|FG000|NOT COMPLETED|Part 2(Week17 to Maximum of 119.6 Weeks)||2
10568327|NCT01642485|11723532|FG000|STARTED|Period 1, Day 1|crossover so all subjects had this treatment|4
10568328|NCT01642485|11723533|FG001|STARTED|Period 1, Day 1||4
10568329|NCT01642485|11723534|FG002|STARTED|Period 1, Day 1||4
10568330|NCT01642485|11723535|FG003|STARTED|Period 1, Day 1||4
10568331|NCT01642485|11723536|FG004|STARTED|Period 1, Day 1||4
10568332|NCT01642485|11723537|FG005|STARTED|Period 1, Day 1||4
10568333|NCT01642485|11723538|FG006|STARTED|Period 1, Day 1||4
10568334|NCT01642485|11723539|FG007|STARTED|Period 1, Day 1||4
10568335|NCT01642485|11723532|FG000|COMPLETED|Period 1, Day 1||4
10568336|NCT01642485|11723533|FG001|COMPLETED|Period 1, Day 1||4
10568337|NCT01642485|11723534|FG002|COMPLETED|Period 1, Day 1||4
10568338|NCT01642485|11723535|FG003|COMPLETED|Period 1, Day 1||4
10568339|NCT01642485|11723536|FG004|COMPLETED|Period 1, Day 1||4
10568340|NCT01642485|11723537|FG005|COMPLETED|Period 1, Day 1||4
10568341|NCT01642485|11723538|FG006|COMPLETED|Period 1, Day 1||4
10568342|NCT01642485|11723539|FG007|COMPLETED|Period 1, Day 1||4
10568343|NCT01642485|11723532|FG000|NOT COMPLETED|Period 1, Day 1||0
10568344|NCT01642485|11723533|FG001|NOT COMPLETED|Period 1, Day 1||0
10568345|NCT01642485|11723534|FG002|NOT COMPLETED|Period 1, Day 1||0
10568346|NCT01642485|11723535|FG003|NOT COMPLETED|Period 1, Day 1||0
10568347|NCT01642485|11723536|FG004|NOT COMPLETED|Period 1, Day 1||0
10568348|NCT01642485|11723537|FG005|NOT COMPLETED|Period 1, Day 1||0
10568349|NCT01642485|11723538|FG006|NOT COMPLETED|Period 1, Day 1||0
10568350|NCT01642485|11723539|FG007|NOT COMPLETED|Period 1, Day 1||0
10568351|NCT01642485|11723532|FG000|STARTED|Period 1, Day 2||4
10568352|NCT01642485|11723533|FG001|STARTED|Period 1, Day 2||4
10568353|NCT01642485|11723534|FG002|STARTED|Period 1, Day 2||4
10568354|NCT01642485|11723535|FG003|STARTED|Period 1, Day 2||4
10568355|NCT01642485|11723536|FG004|STARTED|Period 1, Day 2||4
10568356|NCT01642485|11723537|FG005|STARTED|Period 1, Day 2||4
10568357|NCT01642485|11723538|FG006|STARTED|Period 1, Day 2||4
10568358|NCT01642485|11723539|FG007|STARTED|Period 1, Day 2||4
10568359|NCT01642485|11723532|FG000|COMPLETED|Period 1, Day 2||4
10568360|NCT01642485|11723533|FG001|COMPLETED|Period 1, Day 2||4
10568361|NCT01642485|11723534|FG002|COMPLETED|Period 1, Day 2||4
10568362|NCT01642485|11723535|FG003|COMPLETED|Period 1, Day 2||4
10568363|NCT01642485|11723536|FG004|COMPLETED|Period 1, Day 2||4
10568364|NCT01642485|11723537|FG005|COMPLETED|Period 1, Day 2||4
10568365|NCT01642485|11723538|FG006|COMPLETED|Period 1, Day 2||4
10568366|NCT01642485|11723539|FG007|COMPLETED|Period 1, Day 2||4
10568367|NCT01642485|11723532|FG000|NOT COMPLETED|Period 1, Day 2||0
10568368|NCT01642485|11723533|FG001|NOT COMPLETED|Period 1, Day 2||0
10568369|NCT01642485|11723534|FG002|NOT COMPLETED|Period 1, Day 2||0
10568370|NCT01642485|11723535|FG003|NOT COMPLETED|Period 1, Day 2||0
10568371|NCT01642485|11723536|FG004|NOT COMPLETED|Period 1, Day 2||0
10568372|NCT01642485|11723537|FG005|NOT COMPLETED|Period 1, Day 2||0
10568373|NCT01642485|11723538|FG006|NOT COMPLETED|Period 1, Day 2||0
10568374|NCT01642485|11723539|FG007|NOT COMPLETED|Period 1, Day 2||0
10568375|NCT01642485|11723532|FG000|STARTED|Period 1, Day 3||4
10568376|NCT01642485|11723533|FG001|STARTED|Period 1, Day 3||4
10568377|NCT01642485|11723534|FG002|STARTED|Period 1, Day 3||4
10568378|NCT01642485|11723535|FG003|STARTED|Period 1, Day 3||4
10568379|NCT01642485|11723536|FG004|STARTED|Period 1, Day 3||4
10568380|NCT01642485|11723537|FG005|STARTED|Period 1, Day 3||4
10568381|NCT01642485|11723538|FG006|STARTED|Period 1, Day 3||4
10568382|NCT01642485|11723539|FG007|STARTED|Period 1, Day 3||4
10568383|NCT01642485|11723532|FG000|COMPLETED|Period 1, Day 3||4
10793561|NCT03609619|11954370|FG001|COMPLETED|Overall Study||49
10568384|NCT01642485|11723533|FG001|COMPLETED|Period 1, Day 3||4
10568385|NCT01642485|11723534|FG002|COMPLETED|Period 1, Day 3||4
10568386|NCT01642485|11723535|FG003|COMPLETED|Period 1, Day 3||4
10568387|NCT01642485|11723536|FG004|COMPLETED|Period 1, Day 3||4
10568388|NCT01642485|11723537|FG005|COMPLETED|Period 1, Day 3||4
10793562|NCT03609619|11954369|FG000|NOT COMPLETED|Overall Study||10
10568389|NCT01642485|11723538|FG006|COMPLETED|Period 1, Day 3||4
10568390|NCT01642485|11723539|FG007|COMPLETED|Period 1, Day 3||4
10568391|NCT01642485|11723532|FG000|NOT COMPLETED|Period 1, Day 3||0
10568392|NCT01642485|11723533|FG001|NOT COMPLETED|Period 1, Day 3||0
10568393|NCT01642485|11723534|FG002|NOT COMPLETED|Period 1, Day 3||0
10568394|NCT01642485|11723535|FG003|NOT COMPLETED|Period 1, Day 3||0
10568395|NCT01642485|11723536|FG004|NOT COMPLETED|Period 1, Day 3||0
10568396|NCT01642485|11723537|FG005|NOT COMPLETED|Period 1, Day 3||0
10568397|NCT01642485|11723538|FG006|NOT COMPLETED|Period 1, Day 3||0
10568398|NCT01642485|11723539|FG007|NOT COMPLETED|Period 1, Day 3||0
10568399|NCT01642485|11723532|FG000|STARTED|Period 2, Day 1||4
10568400|NCT01642485|11723533|FG001|STARTED|Period 2, Day 1||4
10568401|NCT01642485|11723534|FG002|STARTED|Period 2, Day 1||4
10568402|NCT01642485|11723535|FG003|STARTED|Period 2, Day 1||4
10568403|NCT01642485|11723536|FG004|STARTED|Period 2, Day 1||4
10568404|NCT01642485|11723537|FG005|STARTED|Period 2, Day 1||4
10568405|NCT01642485|11723538|FG006|STARTED|Period 2, Day 1||4
10568406|NCT01642485|11723539|FG007|STARTED|Period 2, Day 1||4
10568407|NCT01642485|11723532|FG000|COMPLETED|Period 2, Day 1||4
10568408|NCT01642485|11723533|FG001|COMPLETED|Period 2, Day 1||4
10568409|NCT01642485|11723534|FG002|COMPLETED|Period 2, Day 1||4
10568410|NCT01642485|11723535|FG003|COMPLETED|Period 2, Day 1||4
10568411|NCT01642485|11723536|FG004|COMPLETED|Period 2, Day 1||4
10568412|NCT01642485|11723537|FG005|COMPLETED|Period 2, Day 1||4
10568413|NCT01642485|11723538|FG006|COMPLETED|Period 2, Day 1||4
10568414|NCT01642485|11723539|FG007|COMPLETED|Period 2, Day 1||4
10568415|NCT01642485|11723532|FG000|NOT COMPLETED|Period 2, Day 1||0
10568416|NCT01642485|11723533|FG001|NOT COMPLETED|Period 2, Day 1||0
10568417|NCT01642485|11723534|FG002|NOT COMPLETED|Period 2, Day 1||0
10568418|NCT01642485|11723535|FG003|NOT COMPLETED|Period 2, Day 1||0
10568419|NCT01642485|11723536|FG004|NOT COMPLETED|Period 2, Day 1||0
10568420|NCT01642485|11723537|FG005|NOT COMPLETED|Period 2, Day 1||0
10568421|NCT01642485|11723538|FG006|NOT COMPLETED|Period 2, Day 1||0
10568422|NCT01642485|11723539|FG007|NOT COMPLETED|Period 2, Day 1||0
10568423|NCT01642485|11723532|FG000|STARTED|Period 2, Day 2||4
10568424|NCT01642485|11723533|FG001|STARTED|Period 2, Day 2||4
10568425|NCT01642485|11723534|FG002|STARTED|Period 2, Day 2||4
10793563|NCT03609619|11954370|FG001|NOT COMPLETED|Overall Study||6
10793564|NCT03609658|11954378|FG000|STARTED|Overall Study||379
10793565|NCT03609658|11954379|FG001|STARTED|Overall Study||380
10793566|NCT03609658|11954378|FG000|COMPLETED|Overall Study||379
10793567|NCT03609658|11954379|FG001|COMPLETED|Overall Study||380
10793568|NCT03609658|11954378|FG000|NOT COMPLETED|Overall Study||0
10568426|NCT01642485|11723535|FG003|STARTED|Period 2, Day 2||4
10568427|NCT01642485|11723536|FG004|STARTED|Period 2, Day 2||4
10568428|NCT01642485|11723537|FG005|STARTED|Period 2, Day 2||4
10568429|NCT01642485|11723538|FG006|STARTED|Period 2, Day 2||4
10568430|NCT01642485|11723539|FG007|STARTED|Period 2, Day 2||4
10568431|NCT01642485|11723532|FG000|COMPLETED|Period 2, Day 2||4
10568432|NCT01642485|11723533|FG001|COMPLETED|Period 2, Day 2||4
10793569|NCT03609658|11954379|FG001|NOT COMPLETED|Overall Study||0
10793570|NCT03610048|11954385|FG000|STARTED|Overall Study||175
10793571|NCT03610048|11954385|FG000|Completed Treatment|Overall Study||15
10793572|NCT03610048|11954385|FG000|COMPLETED|Overall Study||14
10793573|NCT03610048|11954385|FG000|NOT COMPLETED|Overall Study||161
10793574|NCT03610165|11954391|FG000|STARTED|Overall Study||108
10793575|NCT03610165|11954392|FG001|STARTED|Overall Study||106
10793576|NCT03610165|11954391|FG000|COMPLETED|Overall Study||108
10793577|NCT03610165|11954392|FG001|COMPLETED|Overall Study||105
10793578|NCT03610165|11954391|FG000|NOT COMPLETED|Overall Study||0
10793579|NCT03610165|11954392|FG001|NOT COMPLETED|Overall Study||1
10793580|NCT03610269|11954398|FG000|STARTED|Overall Study||143
10793581|NCT03610269|11954398|FG000|COMPLETED|Overall Study||127
10793582|NCT03610269|11954398|FG000|NOT COMPLETED|Overall Study||16
10793583|NCT03610399|11954405|FG000|STARTED|Overall Study||63
10793584|NCT03610399|11954406|FG001|STARTED|Overall Study||96
10793585|NCT03610399|11954407|FG002|STARTED|Overall Study||95
10793586|NCT03610399|11954405|FG000|COMPLETED|Overall Study||53
10568433|NCT01642485|11723534|FG002|COMPLETED|Period 2, Day 2||4
10793587|NCT03610399|11954406|FG001|COMPLETED|Overall Study||78
10793588|NCT03610399|11954407|FG002|COMPLETED|Overall Study||79
10793589|NCT03610399|11954405|FG000|NOT COMPLETED|Overall Study||10
10793590|NCT03610399|11954406|FG001|NOT COMPLETED|Overall Study||18
10793591|NCT03610399|11954407|FG002|NOT COMPLETED|Overall Study||16
10793592|NCT03610464|11954415|FG000|STARTED|Overall Study||5
10793593|NCT03610464|11954415|FG000|COMPLETED|Overall Study||5
10793594|NCT03610464|11954415|FG000|NOT COMPLETED|Overall Study||0
10793595|NCT03610581|11954422|FG000|STARTED|Overall Study||5
10568434|NCT01642485|11723535|FG003|COMPLETED|Period 2, Day 2||4
10568435|NCT01642485|11723536|FG004|COMPLETED|Period 2, Day 2||4
10568436|NCT01642485|11723537|FG005|COMPLETED|Period 2, Day 2||4
10568437|NCT01642485|11723538|FG006|COMPLETED|Period 2, Day 2||4
10568438|NCT01642485|11723539|FG007|COMPLETED|Period 2, Day 2||4
10568439|NCT01642485|11723532|FG000|NOT COMPLETED|Period 2, Day 2||0
10568440|NCT01642485|11723533|FG001|NOT COMPLETED|Period 2, Day 2||0
10568441|NCT01642485|11723534|FG002|NOT COMPLETED|Period 2, Day 2||0
10568442|NCT01642485|11723535|FG003|NOT COMPLETED|Period 2, Day 2||0
10568443|NCT01642485|11723536|FG004|NOT COMPLETED|Period 2, Day 2||0
10568444|NCT01642485|11723537|FG005|NOT COMPLETED|Period 2, Day 2||0
10568445|NCT01642485|11723538|FG006|NOT COMPLETED|Period 2, Day 2||0
10568446|NCT01642485|11723539|FG007|NOT COMPLETED|Period 2, Day 2||0
10793596|NCT03610581|11954423|FG001|STARTED|Overall Study||4
10793597|NCT03610581|11954422|FG000|Vaccinated|Overall Study||4
10568447|NCT01642485|11723532|FG000|STARTED|Period 2, Day 3||4
10568448|NCT01642485|11723533|FG001|STARTED|Period 2, Day 3||4
10568449|NCT01642485|11723534|FG002|STARTED|Period 2, Day 3||4
10568450|NCT01642485|11723535|FG003|STARTED|Period 2, Day 3||4
10568451|NCT01642485|11723536|FG004|STARTED|Period 2, Day 3||4
10568452|NCT01642485|11723537|FG005|STARTED|Period 2, Day 3||4
10568453|NCT01642485|11723538|FG006|STARTED|Period 2, Day 3||4
10568454|NCT01642485|11723539|FG007|STARTED|Period 2, Day 3||4
10568455|NCT01642485|11723532|FG000|COMPLETED|Period 2, Day 3||4
10568456|NCT01642485|11723533|FG001|COMPLETED|Period 2, Day 3||4
10568457|NCT01642485|11723534|FG002|COMPLETED|Period 2, Day 3||4
10568458|NCT01642485|11723535|FG003|COMPLETED|Period 2, Day 3||4
10568459|NCT01642485|11723536|FG004|COMPLETED|Period 2, Day 3||4
10568460|NCT01642485|11723537|FG005|COMPLETED|Period 2, Day 3||4
10568461|NCT01642485|11723538|FG006|COMPLETED|Period 2, Day 3||4
10568462|NCT01642485|11723539|FG007|COMPLETED|Period 2, Day 3||4
10568463|NCT01642485|11723532|FG000|NOT COMPLETED|Period 2, Day 3||0
10568464|NCT01642485|11723533|FG001|NOT COMPLETED|Period 2, Day 3||0
10568465|NCT01642485|11723534|FG002|NOT COMPLETED|Period 2, Day 3||0
10568466|NCT01642485|11723535|FG003|NOT COMPLETED|Period 2, Day 3||0
10568467|NCT01642485|11723536|FG004|NOT COMPLETED|Period 2, Day 3||0
10568468|NCT01642485|11723537|FG005|NOT COMPLETED|Period 2, Day 3||0
10568469|NCT01642485|11723538|FG006|NOT COMPLETED|Period 2, Day 3||0
10568470|NCT01642485|11723539|FG007|NOT COMPLETED|Period 2, Day 3||0
10568471|NCT01642589|11723559|FG000|STARTED|Overall Study||200
10568472|NCT01642589|11723560|FG001|STARTED|Overall Study||100
10568473|NCT01642589|11723559|FG000|COMPLETED|Overall Study||199
10568474|NCT01642589|11723560|FG001|COMPLETED|Overall Study||99
10568475|NCT01642589|11723559|FG000|NOT COMPLETED|Overall Study||1
10568476|NCT01642589|11723560|FG001|NOT COMPLETED|Overall Study||1
10568477|NCT01642602|11723566|FG000|STARTED|Overall Study||104
10568478|NCT01642602|11723566|FG000|COMPLETED|Overall Study||102
10568479|NCT01642602|11723566|FG000|NOT COMPLETED|Overall Study||2
10568480|NCT01642615|11723570|FG000|STARTED|Open Label Maintenance Phase||63
10568481|NCT01642615|11723571|FG001|STARTED|Open Label Maintenance Phase||0
10568482|NCT01642615|11723572|FG002|STARTED|Open Label Maintenance Phase||0
10568483|NCT01642615|11723570|FG000|Safety Analysis Set|Open Label Maintenance Phase||62
10568484|NCT01642615|11723571|FG001|Safety Analysis Set|Open Label Maintenance Phase||0
10568485|NCT01642615|11723572|FG002|Safety Analysis Set|Open Label Maintenance Phase||0
10568486|NCT01642615|11723570|FG000|COMPLETED|Open Label Maintenance Phase||58
10568487|NCT01642615|11723571|FG001|COMPLETED|Open Label Maintenance Phase||0
10568488|NCT01642615|11723572|FG002|COMPLETED|Open Label Maintenance Phase||0
10568489|NCT01642615|11723570|FG000|NOT COMPLETED|Open Label Maintenance Phase||5
10568490|NCT01642615|11723571|FG001|NOT COMPLETED|Open Label Maintenance Phase||0
10568491|NCT01642615|11723572|FG002|NOT COMPLETED|Open Label Maintenance Phase||0
10568492|NCT01642615|11723570|FG000|STARTED|Double Blind Maintenance Phase||0
10568493|NCT01642615|11723571|FG001|STARTED|Double Blind Maintenance Phase||25
10568494|NCT01642615|11723572|FG002|STARTED|Double Blind Maintenance Phase||26
10568495|NCT01642615|11723570|FG000|COMPLETED|Double Blind Maintenance Phase||0
10568496|NCT01642615|11723571|FG001|COMPLETED|Double Blind Maintenance Phase||18
10568497|NCT01642615|11723572|FG002|COMPLETED|Double Blind Maintenance Phase||20
10568498|NCT01642615|11723570|FG000|NOT COMPLETED|Double Blind Maintenance Phase||0
10568499|NCT01642615|11723571|FG001|NOT COMPLETED|Double Blind Maintenance Phase||7
10568500|NCT01642615|11723572|FG002|NOT COMPLETED|Double Blind Maintenance Phase||6
10568501|NCT01642914|11723583|FG000|STARTED|Overall Study||173
10568502|NCT01642914|11723584|FG001|STARTED|Overall Study||154
10568503|NCT01642914|11723585|FG002|STARTED|Overall Study||160
10568504|NCT01642914|11723583|FG000|COMPLETED|Overall Study||127
10568505|NCT01642914|11723584|FG001|COMPLETED|Overall Study||122
10568506|NCT01642914|11723585|FG002|COMPLETED|Overall Study||120
10568507|NCT01642914|11723583|FG000|NOT COMPLETED|Overall Study||46
10568508|NCT01642914|11723584|FG001|NOT COMPLETED|Overall Study||32
10568509|NCT01642914|11723585|FG002|NOT COMPLETED|Overall Study||40
10568510|NCT01643044|11723597|FG000|STARTED|Overall Study||24
10568511|NCT01643044|11723598|FG001|STARTED|Overall Study||24
10568512|NCT01643044|11723597|FG000|COMPLETED|Overall Study||20
10568513|NCT01643044|11723598|FG001|COMPLETED|Overall Study||19
10568514|NCT01643044|11723597|FG000|NOT COMPLETED|Overall Study||4
10568515|NCT01643044|11723598|FG001|NOT COMPLETED|Overall Study||5
10568516|NCT01643213|11723606|FG000|STARTED|Overall Study||13
10568517|NCT01643213|11723607|FG001|STARTED|Overall Study||14
10568518|NCT01643213|11723606|FG000|COMPLETED|Overall Study||12
10568519|NCT01643213|11723607|FG001|COMPLETED|Overall Study||14
10568520|NCT01643213|11723606|FG000|NOT COMPLETED|Overall Study||1
10568521|NCT01643213|11723607|FG001|NOT COMPLETED|Overall Study||0
10568522|NCT01643382|11723615|FG000|STARTED|Overall Study||30
10568523|NCT01643382|11723616|FG001|STARTED|Overall Study||30
10568524|NCT01643382|11723615|FG000|COMPLETED|Overall Study||30
10568525|NCT01643382|11723616|FG001|COMPLETED|Overall Study||30
10568526|NCT01643382|11723615|FG000|NOT COMPLETED|Overall Study||0
10568527|NCT01643382|11723616|FG001|NOT COMPLETED|Overall Study||0
10568528|NCT01643408|11723622|FG000|STARTED|Overall Study||30
10568529|NCT01643408|11723622|FG000|COMPLETED|Overall Study||16
10568530|NCT01643408|11723622|FG000|NOT COMPLETED|Overall Study||14
10568531|NCT01643473|11723628|FG000|STARTED|Overall Study||21
10568532|NCT01643473|11723629|FG001|STARTED|Overall Study||21
10568533|NCT01643473|11723628|FG000|COMPLETED|Overall Study||20
10568534|NCT01643473|11723629|FG001|COMPLETED|Overall Study||21
10568535|NCT01643473|11723628|FG000|NOT COMPLETED|Overall Study||1
10568536|NCT01643473|11723629|FG001|NOT COMPLETED|Overall Study||0
10568537|NCT01643616|11723637|FG000|STARTED|Overall Study||125
10568538|NCT01643616|11723638|FG001|STARTED|Overall Study||125
10568539|NCT01643616|11723637|FG000|COMPLETED|Overall Study||125
10568540|NCT01643616|11723638|FG001|COMPLETED|Overall Study||125
10568541|NCT01643616|11723637|FG000|NOT COMPLETED|Overall Study||0
10568542|NCT01643616|11723638|FG001|NOT COMPLETED|Overall Study||0
10568543|NCT01643668|11723644|FG000|STARTED|Overall Study||34
10568544|NCT01643668|11723644|FG000|COMPLETED|Overall Study||33
10568545|NCT01643668|11723644|FG000|NOT COMPLETED|Overall Study||1
10568546|NCT01643707|11723650|FG000|STARTED|Overall Study||858
10568547|NCT01643707|11723651|FG001|STARTED|Overall Study||484
10568548|NCT01643707|11723650|FG000|COMPLETED|Overall Study||823
10568549|NCT01643707|11723651|FG001|COMPLETED|Overall Study||470
10568550|NCT01643707|11723650|FG000|NOT COMPLETED|Overall Study||35
10568551|NCT01643707|11723651|FG001|NOT COMPLETED|Overall Study||14
10568552|NCT01643772|11723664|FG000|STARTED|Overall Study||15
10568553|NCT01643772|11723665|FG001|STARTED|Overall Study||15
10568554|NCT01643772|11723666|FG002|STARTED|Overall Study||15
10568555|NCT01643772|11723667|FG003|STARTED|Overall Study||16
10568556|NCT01643772|11723664|FG000|COMPLETED|Overall Study||15
10568557|NCT01643772|11723665|FG001|COMPLETED|Overall Study||15
10568558|NCT01643772|11723666|FG002|COMPLETED|Overall Study||15
10568559|NCT01643772|11723667|FG003|COMPLETED|Overall Study||14
10568560|NCT01643772|11723664|FG000|NOT COMPLETED|Overall Study||0
10568561|NCT01643772|11723665|FG001|NOT COMPLETED|Overall Study||0
10568562|NCT01643772|11723666|FG002|NOT COMPLETED|Overall Study||0
10568563|NCT01643772|11723667|FG003|NOT COMPLETED|Overall Study||2
10568564|NCT01643798|11723679|FG000|STARTED|Pretreatment 1 and Stimulation||7
10568565|NCT01643798|11723680|FG001|STARTED|Pretreatment 1 and Stimulation||8
10568566|NCT01643798|11723679|FG000|COMPLETED|Pretreatment 1 and Stimulation||6
10568567|NCT01643798|11723680|FG001|COMPLETED|Pretreatment 1 and Stimulation||8
10568568|NCT01643798|11723679|FG000|NOT COMPLETED|Pretreatment 1 and Stimulation||1
10568569|NCT01643798|11723680|FG001|NOT COMPLETED|Pretreatment 1 and Stimulation||0
10568570|NCT01643798|11723679|FG000|STARTED|Pretreatment 2 and Stimulation||6
10568571|NCT01643798|11723680|FG001|STARTED|Pretreatment 2 and Stimulation||8
10568572|NCT01643798|11723679|FG000|COMPLETED|Pretreatment 2 and Stimulation||6
10568573|NCT01643798|11723680|FG001|COMPLETED|Pretreatment 2 and Stimulation||8
10568574|NCT01643798|11723679|FG000|NOT COMPLETED|Pretreatment 2 and Stimulation||0
10568575|NCT01643798|11723680|FG001|NOT COMPLETED|Pretreatment 2 and Stimulation||0
10568576|NCT01643850|11723700|FG000|STARTED|Overall Study||5
10568577|NCT01643850|11723701|FG001|STARTED|Overall Study||2
10568578|NCT01643850|11723702|FG002|STARTED|Overall Study||8
10568579|NCT01643850|11723703|FG003|STARTED|Overall Study||3
10793598|NCT03610581|11954423|FG001|Vaccinated|Overall Study||4
10793599|NCT03610581|11954422|FG000|COMPLETED|Overall Study||2
10793600|NCT03610581|11954423|FG001|COMPLETED|Overall Study||3
10793601|NCT03610581|11954422|FG000|NOT COMPLETED|Overall Study||3
10455230|NCT01000987|11603235|FG000|NOT COMPLETED|Overall Study||0
10455231|NCT01000987|11603236|FG001|NOT COMPLETED|Overall Study||0
10455232|NCT01000987|11603237|FG002|NOT COMPLETED|Overall Study||0
10455233|NCT01001052|11603245|FG000|STARTED|Overall Study||20
10455234|NCT01001052|11603246|FG001|STARTED|Overall Study||18
10455235|NCT01001052|11603245|FG000|COMPLETED|Overall Study||20
10455236|NCT01001052|11603246|FG001|COMPLETED|Overall Study||18
10455237|NCT01001052|11603245|FG000|NOT COMPLETED|Overall Study||0
10455238|NCT01001052|11603246|FG001|NOT COMPLETED|Overall Study||0
10455239|NCT01001078|11603254|FG000|STARTED|Overall Study||50
10455240|NCT01001078|11603255|FG001|STARTED|Overall Study||50
10455241|NCT01001078|11603254|FG000|Received Allocated Intervention|Overall Study||46
10455242|NCT01001078|11603255|FG001|Received Allocated Intervention|Overall Study||46
10455243|NCT01001078|11603254|FG000|Received Crossover|Overall Study||2
10455244|NCT01001078|11603255|FG001|Received Crossover|Overall Study||3
10455245|NCT01001078|11603254|FG000|Intubated|Overall Study||2
10455246|NCT01001078|11603255|FG001|Intubated|Overall Study||1
10455247|NCT01001078|11603254|FG000|Lost to Followup Interview|Overall Study|Could not be interviewed.|5
10455248|NCT01001078|11603255|FG001|Lost to Followup Interview|Overall Study|Could not be interviewed.|2
10455249|NCT01001078|11603254|FG000|COMPLETED|Overall Study|Analyzed: 46, excluded from interview analysis: 5|50
10455250|NCT01001078|11603255|FG001|COMPLETED|Overall Study|Analyzed: 46, excluded from interview analysis: 2|50
10455251|NCT01001078|11603254|FG000|NOT COMPLETED|Overall Study||0
10455252|NCT01001078|11603255|FG001|NOT COMPLETED|Overall Study||0
10455253|NCT01001104|11603267|FG000|STARTED|Overall Study||35
10455254|NCT01001104|11603268|FG001|STARTED|Overall Study||37
10455255|NCT01001104|11603269|FG002|STARTED|Overall Study||36
10455256|NCT01001104|11603270|FG003|STARTED|Overall Study||37
10455257|NCT01001104|11603267|FG000|COMPLETED|Overall Study||33
10455258|NCT01001104|11603268|FG001|COMPLETED|Overall Study||36
10455259|NCT01001104|11603269|FG002|COMPLETED|Overall Study||35
10455260|NCT01001104|11603270|FG003|COMPLETED|Overall Study||34
10455261|NCT01001104|11603267|FG000|NOT COMPLETED|Overall Study||2
10455262|NCT01001104|11603268|FG001|NOT COMPLETED|Overall Study||1
10568580|NCT01643850|11723704|FG004|STARTED|Overall Study||3
10568581|NCT01643850|11723705|FG005|STARTED|Overall Study||3
10568582|NCT01643850|11723706|FG006|STARTED|Overall Study||4
10568583|NCT01643850|11723707|FG007|STARTED|Overall Study||4
10568584|NCT01643850|11723708|FG008|STARTED|Overall Study||4
10568585|NCT01643850|11723700|FG000|COMPLETED|Overall Study||5
10793602|NCT03610581|11954423|FG001|NOT COMPLETED|Overall Study||1
10568586|NCT01643850|11723701|FG001|COMPLETED|Overall Study||2
10568587|NCT01643850|11723702|FG002|COMPLETED|Overall Study||7
10568588|NCT01643850|11723703|FG003|COMPLETED|Overall Study||3
10568589|NCT01643850|11723704|FG004|COMPLETED|Overall Study||0
10568590|NCT01643850|11723705|FG005|COMPLETED|Overall Study||3
10568591|NCT01643850|11723706|FG006|COMPLETED|Overall Study||3
10568592|NCT01643850|11723707|FG007|COMPLETED|Overall Study||4
10568593|NCT01643850|11723708|FG008|COMPLETED|Overall Study||3
10568594|NCT01643850|11723700|FG000|NOT COMPLETED|Overall Study||0
10568595|NCT01643850|11723701|FG001|NOT COMPLETED|Overall Study||0
10568596|NCT01643850|11723702|FG002|NOT COMPLETED|Overall Study||1
10568597|NCT01643850|11723703|FG003|NOT COMPLETED|Overall Study||0
10568598|NCT01643850|11723704|FG004|NOT COMPLETED|Overall Study||3
10568599|NCT01643850|11723705|FG005|NOT COMPLETED|Overall Study||0
10568600|NCT01643850|11723706|FG006|NOT COMPLETED|Overall Study||1
10568601|NCT01643850|11723707|FG007|NOT COMPLETED|Overall Study||0
10568602|NCT01643850|11723708|FG008|NOT COMPLETED|Overall Study||1
10568603|NCT01643876|11723774|FG000|STARTED|Overall Study||48
10568604|NCT01643876|11723774|FG000|COMPLETED|Overall Study||48
10568605|NCT01643876|11723774|FG000|NOT COMPLETED|Overall Study||0
10568606|NCT01643902|11723778|FG000|STARTED|Overall Study||20
10568607|NCT01643902|11723778|FG000|COMPLETED|Overall Study||20
10568608|NCT01643902|11723778|FG000|NOT COMPLETED|Overall Study||0
10568609|NCT01643928|11723788|FG000|STARTED|Overall Study||58
10568610|NCT01643928|11723789|FG001|STARTED|Overall Study||32
10568611|NCT01643928|11723790|FG002|STARTED|Overall Study||33
10568612|NCT01643928|11723791|FG003|STARTED|Overall Study||30
10568613|NCT01643928|11723792|FG004|STARTED|Overall Study||30
10568614|NCT01643928|11723788|FG000|COMPLETED|Overall Study||48
10568615|NCT01643928|11723789|FG001|COMPLETED|Overall Study||30
10568616|NCT01643928|11723790|FG002|COMPLETED|Overall Study||30
10568617|NCT01643928|11723791|FG003|COMPLETED|Overall Study||27
10568618|NCT01643928|11723792|FG004|COMPLETED|Overall Study||28
10568619|NCT01643928|11723788|FG000|NOT COMPLETED|Overall Study||10
10568620|NCT01643928|11723789|FG001|NOT COMPLETED|Overall Study||2
10568621|NCT01643928|11723790|FG002|NOT COMPLETED|Overall Study||3
10568622|NCT01643928|11723791|FG003|NOT COMPLETED|Overall Study||3
10568623|NCT01643928|11723792|FG004|NOT COMPLETED|Overall Study||2
10568624|NCT01644058|11723833|FG000|STARTED|Overall Study||18
10568625|NCT01644058|11723833|FG000|COMPLETED|Overall Study||18
10568626|NCT01644058|11723833|FG000|NOT COMPLETED|Overall Study||0
10568627|NCT01644149|11723840|FG000|STARTED|Overall Study||43
10568628|NCT01644149|11723841|FG001|STARTED|Overall Study||40
10568629|NCT01644149|11723840|FG000|COMPLETED|Overall Study|One subject discontinued prior to vaccination. 28 day serum samples not obtained from 3 subjects.|39
10568630|NCT01644149|11723841|FG001|COMPLETED|Overall Study|28 day serum samples were not obtained from one NS subject.|39
10568631|NCT01644149|11723840|FG000|NOT COMPLETED|Overall Study||4
10568632|NCT01644149|11723841|FG001|NOT COMPLETED|Overall Study||1
10568633|NCT01644175|11723850|FG000|STARTED|Overall Study|Randomized|107
10568634|NCT01644175|11723851|FG001|STARTED|Overall Study|Randomized|209
10568635|NCT01644175|11723850|FG000|Treated|Overall Study||107
10568636|NCT01644175|11723851|FG001|Treated|Overall Study||207
10568637|NCT01644175|11723850|FG000|COMPLETED|Overall Study||75
10568638|NCT01644175|11723851|FG001|COMPLETED|Overall Study||156
10568639|NCT01644175|11723850|FG000|NOT COMPLETED|Overall Study||32
10568640|NCT01644175|11723851|FG001|NOT COMPLETED|Overall Study||53
10793603|NCT03610633|11954431|FG000|STARTED|Overall Study||5
10793604|NCT03610633|11954432|FG001|STARTED|Overall Study||6
10793605|NCT03610633|11954431|FG000|COMPLETED|Overall Study||5
10793606|NCT03610633|11954432|FG001|COMPLETED|Overall Study||5
10793607|NCT03610633|11954431|FG000|NOT COMPLETED|Overall Study||0
10793608|NCT03610633|11954432|FG001|NOT COMPLETED|Overall Study||1
10793609|NCT03611062|11954440|FG000|STARTED|Overall Study||14
10793610|NCT03611062|11954441|FG001|STARTED|Overall Study||13
10793611|NCT03611062|11954440|FG000|COMPLETED|Overall Study||13
10793612|NCT03611062|11954441|FG001|COMPLETED|Overall Study||12
10793613|NCT03611062|11954440|FG000|NOT COMPLETED|Overall Study||1
10793614|NCT03611062|11954441|FG001|NOT COMPLETED|Overall Study||1
10810816|NCT03791489|11972500|FG000|NOT COMPLETED|90 Days (Primary Endpoint)||0
10810817|NCT03790865|11972507|FG000|STARTED|Overall Study||52
10810818|NCT03790865|11972508|FG001|STARTED|Overall Study||52
10810819|NCT03790865|11972509|FG002|STARTED|Overall Study||54
10810820|NCT03790865|11972507|FG000|COMPLETED|Overall Study||52
10810821|NCT03790865|11972508|FG001|COMPLETED|Overall Study||50
10810822|NCT03790865|11972509|FG002|COMPLETED|Overall Study||54
10810823|NCT03790865|11972507|FG000|NOT COMPLETED|Overall Study||0
10810824|NCT03790865|11972508|FG001|NOT COMPLETED|Overall Study||2
10810825|NCT03790865|11972509|FG002|NOT COMPLETED|Overall Study||0
10810826|NCT03784300|11972523|FG000|STARTED|Overall Study||6
10810827|NCT03784300|11972524|FG001|STARTED|Overall Study||2
10810828|NCT03784300|11972525|FG002|STARTED|Overall Study||6
10810829|NCT03784300|11972526|FG003|STARTED|Overall Study||2
10568641|NCT01644188|11723859|FG000|STARTED|Overall Study|Randomized|479
10568642|NCT01644188|11723860|FG001|STARTED|Overall Study|Randomized|241
10568643|NCT01644188|11723859|FG000|Treated|Overall Study||479
10568644|NCT01644188|11723860|FG001|Treated|Overall Study||241
10568645|NCT01644188|11723859|FG000|COMPLETED|Overall Study||357
10568646|NCT01644188|11723860|FG001|COMPLETED|Overall Study||166
10568647|NCT01644188|11723859|FG000|NOT COMPLETED|Overall Study||122
10568648|NCT01644188|11723860|FG001|NOT COMPLETED|Overall Study||75
10568649|NCT01644240|11723869|FG000|STARTED|Overall Study||6
10568650|NCT01644240|11723870|FG001|STARTED|Overall Study||4
10568651|NCT01644240|11723871|FG002|STARTED|Overall Study||6
10568652|NCT01644240|11723869|FG000|COMPLETED|Overall Study||6
10568653|NCT01644240|11723870|FG001|COMPLETED|Overall Study||4
10568654|NCT01644240|11723871|FG002|COMPLETED|Overall Study||6
10568655|NCT01644240|11723869|FG000|NOT COMPLETED|Overall Study||0
10568656|NCT01644240|11723870|FG001|NOT COMPLETED|Overall Study||0
10568657|NCT01644240|11723871|FG002|NOT COMPLETED|Overall Study||0
10568658|NCT01644292|11723879|FG000|STARTED|Overall Study||2
10568659|NCT01644292|11723879|FG000|COMPLETED|Overall Study||2
10568660|NCT01644292|11723879|FG000|NOT COMPLETED|Overall Study||0
10568661|NCT01644331|11723885|FG000|STARTED|Overall Study||129
10568662|NCT01644331|11723886|FG001|STARTED|Overall Study||128
10568663|NCT01644331|11723885|FG000|COMPLETED|Overall Study||118
10568664|NCT01644331|11723886|FG001|COMPLETED|Overall Study||118
10568665|NCT01644331|11723885|FG000|NOT COMPLETED|Overall Study||11
10568666|NCT01644331|11723886|FG001|NOT COMPLETED|Overall Study||10
10568667|NCT01644396|11723892|FG000|STARTED|Overall Study||50
10568668|NCT01644396|11723892|FG000|COMPLETED|Overall Study||50
10568669|NCT01644396|11723892|FG000|NOT COMPLETED|Overall Study||0
10568670|NCT01644474|11723899|FG000|STARTED|Overall Study|Randomized|51
10568671|NCT01644474|11723900|FG001|STARTED|Overall Study|Randomized|52
10568672|NCT01644474|11723899|FG000|Treated|Overall Study||51
10568673|NCT01644474|11723900|FG001|Treated|Overall Study||52
10568674|NCT01644474|11723899|FG000|COMPLETED|Overall Study||44
10568675|NCT01644474|11723900|FG001|COMPLETED|Overall Study||44
10568676|NCT01644474|11723899|FG000|NOT COMPLETED|Overall Study||7
10568677|NCT01644474|11723900|FG001|NOT COMPLETED|Overall Study||8
10568678|NCT01644500|11723909|FG000|STARTED|Overall Study||244
10568679|NCT01644500|11723910|FG001|STARTED|Overall Study||248
10568680|NCT01644500|11723911|FG002|STARTED|Overall Study||245
10568681|NCT01644500|11723909|FG000|Received at Least One Dose of Study Drug|Overall Study||244
10568682|NCT01644500|11723910|FG001|Received at Least One Dose of Study Drug|Overall Study||248
10568683|NCT01644500|11723911|FG002|Received at Least One Dose of Study Drug|Overall Study||243
10568684|NCT01644500|11723909|FG000|Modified Intent-to-treat Population|Overall Study||239
10568685|NCT01644500|11723910|FG001|Modified Intent-to-treat Population|Overall Study||239
10568686|NCT01644500|11723911|FG002|Modified Intent-to-treat Population|Overall Study||242
10568687|NCT01644500|11723909|FG000|COMPLETED|Overall Study||222
10568688|NCT01644500|11723910|FG001|COMPLETED|Overall Study||224
10568689|NCT01644500|11723911|FG002|COMPLETED|Overall Study||230
10568690|NCT01644500|11723909|FG000|NOT COMPLETED|Overall Study||22
10568691|NCT01644500|11723910|FG001|NOT COMPLETED|Overall Study||24
10568692|NCT01644500|11723911|FG002|NOT COMPLETED|Overall Study||15
10568693|NCT01644565|11723919|FG000|STARTED|Overall Study||5
10568694|NCT01644565|11723920|FG001|STARTED|Overall Study||5
10793615|NCT03611582|11954449|FG000|STARTED|Overall Study||407
10793616|NCT03611582|11954450|FG001|STARTED|Overall Study||204
10793617|NCT03611582|11954449|FG000|Full Analysis Set (FAS)|Overall Study||407
10793618|NCT03611582|11954450|FG001|Full Analysis Set (FAS)|Overall Study||204
10793619|NCT03611582|11954449|FG000|Safety Analysis Set (SAS)|Overall Study||407
10793620|NCT03611582|11954450|FG001|Safety Analysis Set (SAS)|Overall Study||204
10793621|NCT03611582|11954449|FG000|COMPLETED|Overall Study||339
10793622|NCT03611582|11954450|FG001|COMPLETED|Overall Study||166
10793623|NCT03611582|11954449|FG000|NOT COMPLETED|Overall Study||68
10793624|NCT03611582|11954450|FG001|NOT COMPLETED|Overall Study||38
10793625|NCT03611777|11954458|FG000|STARTED|Overall Study||432
10793626|NCT03611777|11954459|FG001|STARTED|Overall Study||469
10793627|NCT03611777|11954458|FG000|COMPLETED|Overall Study||432
10793628|NCT03611777|11954459|FG001|COMPLETED|Overall Study||469
10793629|NCT03611777|11954458|FG000|NOT COMPLETED|Overall Study||0
10793630|NCT03611777|11954459|FG001|NOT COMPLETED|Overall Study||0
10793631|NCT03611829|11954470|FG000|STARTED|Overall Study||43
10793632|NCT03611829|11954471|FG001|STARTED|Overall Study||44
10793633|NCT03611829|11954470|FG000|COMPLETED|Overall Study||21
10793634|NCT03611829|11954471|FG001|COMPLETED|Overall Study||19
10793635|NCT03611829|11954470|FG000|NOT COMPLETED|Overall Study||22
10793636|NCT03611829|11954471|FG001|NOT COMPLETED|Overall Study||25
10793637|NCT03613129|11954482|FG000|STARTED|Pre-treatment Assessment||3
10793638|NCT03613129|11954483|FG001|STARTED|Pre-treatment Assessment||3
10793639|NCT03613129|11954484|FG002|STARTED|Pre-treatment Assessment||7
10793640|NCT03613129|11954485|FG003|STARTED|Pre-treatment Assessment||2
10568695|NCT01644565|11723921|FG002|STARTED|Overall Study||5
10568696|NCT01644565|11723922|FG003|STARTED|Overall Study||5
10568697|NCT01644565|11723923|FG004|STARTED|Overall Study||5
10568698|NCT01644565|11723924|FG005|STARTED|Overall Study||7
10568699|NCT01644565|11723925|FG006|STARTED|Overall Study||7
10568700|NCT01644565|11723926|FG007|STARTED|Overall Study||10
10568701|NCT01644565|11723927|FG008|STARTED|Overall Study||8
10568702|NCT01644565|11723919|FG000|COMPLETED|Overall Study||4
10793641|NCT03613129|11954486|FG004|STARTED|Pre-treatment Assessment||2
10793642|NCT03613129|11954482|FG000|COMPLETED|Pre-treatment Assessment||0
10793643|NCT03613129|11954483|FG001|COMPLETED|Pre-treatment Assessment||3
10793644|NCT03613129|11954484|FG002|COMPLETED|Pre-treatment Assessment||7
10793645|NCT03613129|11954485|FG003|COMPLETED|Pre-treatment Assessment||2
10568703|NCT01644565|11723920|FG001|COMPLETED|Overall Study||5
10568704|NCT01644565|11723921|FG002|COMPLETED|Overall Study||5
10568705|NCT01644565|11723922|FG003|COMPLETED|Overall Study||4
10568706|NCT01644565|11723923|FG004|COMPLETED|Overall Study||4
10568707|NCT01644565|11723924|FG005|COMPLETED|Overall Study||7
10568708|NCT01644565|11723925|FG006|COMPLETED|Overall Study||7
10568709|NCT01644565|11723926|FG007|COMPLETED|Overall Study||8
10568710|NCT01644565|11723927|FG008|COMPLETED|Overall Study||7
10568711|NCT01644565|11723919|FG000|NOT COMPLETED|Overall Study||1
10568712|NCT01644565|11723920|FG001|NOT COMPLETED|Overall Study||0
10568713|NCT01644565|11723921|FG002|NOT COMPLETED|Overall Study||0
10568714|NCT01644565|11723922|FG003|NOT COMPLETED|Overall Study||1
10568715|NCT01644565|11723923|FG004|NOT COMPLETED|Overall Study||1
10568716|NCT01644565|11723924|FG005|NOT COMPLETED|Overall Study||0
10568717|NCT01644565|11723925|FG006|NOT COMPLETED|Overall Study||0
10568718|NCT01644565|11723926|FG007|NOT COMPLETED|Overall Study||2
10568719|NCT01644565|11723927|FG008|NOT COMPLETED|Overall Study||1
10568720|NCT01644617|11723950|FG000|STARTED|Overall Study||42
10568721|NCT01644617|11723951|FG001|STARTED|Overall Study||41
10568722|NCT01644617|11723952|FG002|STARTED|Overall Study||41
10568723|NCT01644617|11723950|FG000|COMPLETED|Overall Study||36
10568724|NCT01644617|11723951|FG001|COMPLETED|Overall Study||36
10568725|NCT01644617|11723952|FG002|COMPLETED|Overall Study||34
10568726|NCT01644617|11723950|FG000|NOT COMPLETED|Overall Study||6
10568727|NCT01644617|11723951|FG001|NOT COMPLETED|Overall Study||5
10568728|NCT01644617|11723952|FG002|NOT COMPLETED|Overall Study||7
10568729|NCT01644643|11723964|FG000|STARTED|Overall Study||15
10568730|NCT01644643|11723965|FG001|STARTED|Overall Study||12
10568731|NCT01644643|11723966|FG002|STARTED|Overall Study||153
10568732|NCT01644643|11723967|FG003|STARTED|Overall Study||153
10568733|NCT01644643|11723964|FG000|COMPLETED|Overall Study||13
10568734|NCT01644643|11723965|FG001|COMPLETED|Overall Study||12
10568735|NCT01644643|11723966|FG002|COMPLETED|Overall Study||148
10568736|NCT01644643|11723967|FG003|COMPLETED|Overall Study||143
10568737|NCT01644643|11723964|FG000|NOT COMPLETED|Overall Study||2
10568738|NCT01644643|11723965|FG001|NOT COMPLETED|Overall Study||0
10568739|NCT01644643|11723966|FG002|NOT COMPLETED|Overall Study||5
10568740|NCT01644643|11723967|FG003|NOT COMPLETED|Overall Study||10
10568741|NCT01644695|11723983|FG000|STARTED|Overall Study||85
10568742|NCT01644695|11723983|FG000|COMPLETED|Overall Study||85
10568743|NCT01644695|11723983|FG000|NOT COMPLETED|Overall Study||0
10568744|NCT01644734|11723987|FG000|STARTED|Overall Study|Patients with documentation of treatment.|1282
10568745|NCT01644734|11723987|FG000|COMPLETED|Overall Study||1016
10568746|NCT01644734|11723987|FG000|NOT COMPLETED|Overall Study||266
10568747|NCT01644890|11723993|FG000|STARTED|Overall Study||218
10568748|NCT01644890|11723994|FG001|STARTED|Overall Study||218
10568749|NCT01644890|11723993|FG000|COMPLETED|Overall Study||2
10568750|NCT01644890|11723994|FG001|COMPLETED|Overall Study||3
10568751|NCT01644890|11723993|FG000|NOT COMPLETED|Overall Study||216
10568752|NCT01644890|11723994|FG001|NOT COMPLETED|Overall Study||215
10651163|NCT02173535|11811308|FG011|COMPLETED|Period 5||12
10651164|NCT02173535|11811309|FG012|COMPLETED|Period 5||12
10651165|NCT02173535|11811310|FG013|COMPLETED|Period 5||12
10651166|NCT02173535|11811311|FG014|COMPLETED|Period 5||12
10651167|NCT02173535|11811312|FG015|COMPLETED|Period 5||12
10651168|NCT02173535|11811313|FG016|COMPLETED|Period 5||12
10651169|NCT02173535|11811314|FG017|COMPLETED|Period 5||12
10651170|NCT02173535|11811315|FG018|COMPLETED|Period 5||12
10651171|NCT02173535|11811316|FG019|COMPLETED|Period 5||12
10651172|NCT02173535|11811297|FG000|NOT COMPLETED|Period 5||0
10651173|NCT02173535|11811298|FG001|NOT COMPLETED|Period 5||0
10651174|NCT02173535|11811299|FG002|NOT COMPLETED|Period 5||0
10793646|NCT03613129|11954486|FG004|COMPLETED|Pre-treatment Assessment||2
10793647|NCT03613129|11954482|FG000|NOT COMPLETED|Pre-treatment Assessment||3
10651175|NCT02173535|11811300|FG003|NOT COMPLETED|Period 5||0
10651176|NCT02173535|11811301|FG004|NOT COMPLETED|Period 5||0
10651177|NCT02173535|11811302|FG005|NOT COMPLETED|Period 5||0
10651178|NCT02173535|11811303|FG006|NOT COMPLETED|Period 5||0
10651179|NCT02173535|11811304|FG007|NOT COMPLETED|Period 5||0
10651180|NCT02173535|11811305|FG008|NOT COMPLETED|Period 5||0
10651181|NCT02173535|11811306|FG009|NOT COMPLETED|Period 5||0
10651182|NCT02173535|11811307|FG010|NOT COMPLETED|Period 5||0
10651183|NCT02173535|11811308|FG011|NOT COMPLETED|Period 5||0
10651184|NCT02173535|11811309|FG012|NOT COMPLETED|Period 5||0
10651185|NCT02173535|11811310|FG013|NOT COMPLETED|Period 5||0
10651186|NCT02173535|11811311|FG014|NOT COMPLETED|Period 5||0
10651187|NCT02173535|11811312|FG015|NOT COMPLETED|Period 5||0
10651188|NCT02173535|11811313|FG016|NOT COMPLETED|Period 5||0
10793648|NCT03613129|11954483|FG001|NOT COMPLETED|Pre-treatment Assessment||0
10651189|NCT02173535|11811314|FG017|NOT COMPLETED|Period 5||0
10651190|NCT02173535|11811315|FG018|NOT COMPLETED|Period 5||0
10651191|NCT02173535|11811316|FG019|NOT COMPLETED|Period 5||0
10651192|NCT02173548|11811345|FG000|STARTED|Overall Study||21
10651193|NCT02173548|11811346|FG001|STARTED|Overall Study||10
10651194|NCT02173548|11811345|FG000|COMPLETED|Overall Study||20
10651195|NCT02173548|11811346|FG001|COMPLETED|Overall Study||8
10651196|NCT02173548|11811345|FG000|NOT COMPLETED|Overall Study||1
10651197|NCT02173548|11811346|FG001|NOT COMPLETED|Overall Study||2
10651198|NCT02173704|11811354|FG000|STARTED|Overall Study||150
10651199|NCT02173704|11811355|FG001|STARTED|Overall Study||75
10651200|NCT02173704|11811354|FG000|COMPLETED|Overall Study||137
10651201|NCT02173704|11811355|FG001|COMPLETED|Overall Study||71
10651202|NCT02173704|11811354|FG000|NOT COMPLETED|Overall Study||13
10568753|NCT01645059|11724000|FG000|STARTED|Overall Study||129
10568754|NCT01645059|11724000|FG000|COMPLETED|Overall Study||129
10568755|NCT01645059|11724000|FG000|NOT COMPLETED|Overall Study||0
10568756|NCT01645098|11724011|FG000|STARTED|Overall Study||24
10568757|NCT01645098|11724012|FG001|STARTED|Overall Study||29
10568758|NCT01645098|11724011|FG000|COMPLETED|Overall Study||24
10568759|NCT01645098|11724012|FG001|COMPLETED|Overall Study||29
10568760|NCT01645098|11724011|FG000|NOT COMPLETED|Overall Study||0
10568761|NCT01645098|11724012|FG001|NOT COMPLETED|Overall Study||0
10568762|NCT01645111|11724018|FG000|STARTED|Overall Study||50
10568763|NCT01645111|11724018|FG000|COMPLETED|Overall Study||35
10568764|NCT01645111|11724018|FG000|NOT COMPLETED|Overall Study||15
10568765|NCT01645176|11724022|FG000|STARTED|Overall Study||21
10568766|NCT01645176|11724022|FG000|COMPLETED|Overall Study||16
10568767|NCT01645176|11724022|FG000|NOT COMPLETED|Overall Study||5
10568768|NCT01645280|11724031|FG000|STARTED|Overall Study|16 participants in placebo group early escaped to receive Ustekinmab; included in safety population.|55
10568769|NCT01645280|11724032|FG001|STARTED|Overall Study||54
10568770|NCT01645280|11724033|FG002|STARTED|Overall Study||55
10568771|NCT01645280|11724034|FG003|STARTED|Overall Study||54
10568772|NCT01645280|11724035|FG004|STARTED|Overall Study||55
10568773|NCT01645280|11724031|FG000|COMPLETED|Overall Study||49
10568774|NCT01645280|11724032|FG001|COMPLETED|Overall Study||51
10568775|NCT01645280|11724033|FG002|COMPLETED|Overall Study||49
10568776|NCT01645280|11724034|FG003|COMPLETED|Overall Study||48
10568777|NCT01645280|11724035|FG004|COMPLETED|Overall Study||47
10568778|NCT01645280|11724031|FG000|NOT COMPLETED|Overall Study||6
10568779|NCT01645280|11724032|FG001|NOT COMPLETED|Overall Study||3
10568780|NCT01645280|11724033|FG002|NOT COMPLETED|Overall Study||6
10568781|NCT01645280|11724034|FG003|NOT COMPLETED|Overall Study||6
10568782|NCT01645280|11724035|FG004|NOT COMPLETED|Overall Study||8
10568783|NCT01645306|11724051|FG000|STARTED|Overall Study||51
10568784|NCT01645306|11724052|FG001|STARTED|Overall Study||54
10568785|NCT01645306|11724053|FG002|STARTED|Overall Study||53
10568786|NCT01645306|11724051|FG000|COMPLETED|Overall Study||49
10568787|NCT01645306|11724052|FG001|COMPLETED|Overall Study||50
10568788|NCT01645306|11724053|FG002|COMPLETED|Overall Study||48
10568789|NCT01645306|11724051|FG000|NOT COMPLETED|Overall Study||2
10568790|NCT01645306|11724052|FG001|NOT COMPLETED|Overall Study||4
10568791|NCT01645306|11724053|FG002|NOT COMPLETED|Overall Study||5
10568792|NCT01645735|11724063|FG000|STARTED|Overall Study||32
10568793|NCT01645735|11724064|FG001|STARTED|Overall Study||17
10568794|NCT01645735|11724063|FG000|COMPLETED|Overall Study||28
10568795|NCT01645735|11724064|FG001|COMPLETED|Overall Study||16
10568796|NCT01645735|11724063|FG000|NOT COMPLETED|Overall Study||4
10568797|NCT01645735|11724064|FG001|NOT COMPLETED|Overall Study||1
10568798|NCT01645930|11724071|FG000|STARTED|Overall Study||43
10568799|NCT01645930|11724071|FG000|COMPLETED|Overall Study||0
10568800|NCT01645930|11724071|FG000|NOT COMPLETED|Overall Study||43
10568801|NCT01646021|11724077|FG000|STARTED|Overall Study||139
10568802|NCT01646021|11724078|FG001|STARTED|Overall Study||141
10568803|NCT01646021|11724077|FG000|Treated|Overall Study||139
10568804|NCT01646021|11724078|FG001|Treated|Overall Study||139
10568805|NCT01646021|11724077|FG000|COMPLETED|Overall Study||0
10568806|NCT01646021|11724078|FG001|COMPLETED|Overall Study||0
10568807|NCT01646021|11724077|FG000|NOT COMPLETED|Overall Study||139
10568808|NCT01646021|11724078|FG001|NOT COMPLETED|Overall Study||141
10568809|NCT01646073|11724086|FG000|STARTED|Period A (12 Weeks)||87
10568810|NCT01646073|11724087|FG001|STARTED|Period A (12 Weeks)||338
10568811|NCT01646073|11724086|FG000|COMPLETED|Period A (12 Weeks)||85
10568812|NCT01646073|11724087|FG001|COMPLETED|Period A (12 Weeks)||333
10568813|NCT01646073|11724086|FG000|NOT COMPLETED|Period A (12 Weeks)||2
10568814|NCT01646073|11724087|FG001|NOT COMPLETED|Period A (12 Weeks)||5
10568815|NCT01646073|11724086|FG000|STARTED|Period B (12 Weeks)||85
10568816|NCT01646073|11724087|FG001|STARTED|Period B (12 Weeks)||333
10568817|NCT01646073|11724086|FG000|COMPLETED|Period B (12 Weeks)||84
10568818|NCT01646073|11724087|FG001|COMPLETED|Period B (12 Weeks)||320
10568819|NCT01646073|11724086|FG000|NOT COMPLETED|Period B (12 Weeks)||1
10568820|NCT01646073|11724087|FG001|NOT COMPLETED|Period B (12 Weeks)||13
10568821|NCT01646125|11724098|FG000|STARTED|Overall Study||31
10568822|NCT01646125|11724099|FG001|STARTED|Overall Study||28
10568823|NCT01646125|11724098|FG000|COMPLETED|Overall Study||0
10568824|NCT01646125|11724099|FG001|COMPLETED|Overall Study||0
10568825|NCT01646125|11724098|FG000|NOT COMPLETED|Overall Study||31
10568826|NCT01646125|11724099|FG001|NOT COMPLETED|Overall Study||28
10568827|NCT01646138|11724111|FG000|STARTED|Overall Study||5
10568828|NCT01646138|11724112|FG001|STARTED|Overall Study||4
10568829|NCT01646138|11724113|FG002|STARTED|Overall Study||5
10568830|NCT01646138|11724114|FG003|STARTED|Overall Study||19
10568831|NCT01646138|11724115|FG004|STARTED|Overall Study||15
10568832|NCT01646138|11724111|FG000|COMPLETED|Overall Study||5
10568833|NCT01646138|11724112|FG001|COMPLETED|Overall Study||4
10568834|NCT01646138|11724113|FG002|COMPLETED|Overall Study||5
10568835|NCT01646138|11724114|FG003|COMPLETED|Overall Study||19
10568836|NCT01646138|11724115|FG004|COMPLETED|Overall Study||13
10568837|NCT01646138|11724111|FG000|NOT COMPLETED|Overall Study||0
10568838|NCT01646138|11724112|FG001|NOT COMPLETED|Overall Study||0
10568839|NCT01646138|11724113|FG002|NOT COMPLETED|Overall Study||0
10568840|NCT01646138|11724114|FG003|NOT COMPLETED|Overall Study||0
10568841|NCT01646138|11724115|FG004|NOT COMPLETED|Overall Study||2
10568842|NCT01646151|11724127|FG000|STARTED|Overall Study||2580
10568843|NCT01646151|11724127|FG000|COMPLETED|Overall Study||2410
10793649|NCT03613129|11954484|FG002|NOT COMPLETED|Pre-treatment Assessment||0
10793650|NCT03613129|11954485|FG003|NOT COMPLETED|Pre-treatment Assessment||0
10793651|NCT03613129|11954486|FG004|NOT COMPLETED|Pre-treatment Assessment||0
10793652|NCT03613129|11954482|FG000|STARTED|Treatment||0
10793653|NCT03613129|11954483|FG001|STARTED|Treatment||3
10793654|NCT03613129|11954484|FG002|STARTED|Treatment||7
10793655|NCT03613129|11954485|FG003|STARTED|Treatment||2
10793656|NCT03613129|11954486|FG004|STARTED|Treatment||2
10793657|NCT03613129|11954482|FG000|COMPLETED|Treatment||0
10568844|NCT01646151|11724127|FG000|NOT COMPLETED|Overall Study||170
10568845|NCT01646177|11724135|FG000|STARTED|Blinded Induction Dosing (Week 0-12)||193
10568846|NCT01646177|11724136|FG001|STARTED|Blinded Induction Dosing (Week 0-12)||382
10568847|NCT01646177|11724137|FG002|STARTED|Blinded Induction Dosing (Week 0-12)||386
10568848|NCT01646177|11724138|FG003|STARTED|Blinded Induction Dosing (Week 0-12)||385
10568849|NCT01646177|11724139|FG004|STARTED|Blinded Induction Dosing (Week 0-12)||0
10568850|NCT01646177|11724140|FG005|STARTED|Blinded Induction Dosing (Week 0-12)||0
10568851|NCT01646177|11724141|FG006|STARTED|Blinded Induction Dosing (Week 0-12)||0
10568852|NCT01646177|11724142|FG007|STARTED|Blinded Induction Dosing (Week 0-12)||0
10568853|NCT01646177|11724143|FG008|STARTED|Blinded Induction Dosing (Week 0-12)||0
10568854|NCT01646177|11724144|FG009|STARTED|Blinded Induction Dosing (Week 0-12)||0
10568855|NCT01646177|11724145|FG010|STARTED|Blinded Induction Dosing (Week 0-12)||0
10568856|NCT01646177|11724146|FG011|STARTED|Blinded Induction Dosing (Week 0-12)||0
10568857|NCT01646177|11724135|FG000|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||193
10568858|NCT01646177|11724136|FG001|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||382
10568859|NCT01646177|11724137|FG002|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||382
10568860|NCT01646177|11724138|FG003|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||384
10568861|NCT01646177|11724139|FG004|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
10568862|NCT01646177|11724140|FG005|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
10568863|NCT01646177|11724141|FG006|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
10568864|NCT01646177|11724142|FG007|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
10568865|NCT01646177|11724143|FG008|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
10568866|NCT01646177|11724144|FG009|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
10568867|NCT01646177|11724145|FG010|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
10568868|NCT01646177|11724146|FG011|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
10568869|NCT01646177|11724135|FG000|COMPLETED|Blinded Induction Dosing (Week 0-12)||183
10568870|NCT01646177|11724136|FG001|COMPLETED|Blinded Induction Dosing (Week 0-12)||369
10568871|NCT01646177|11724137|FG002|COMPLETED|Blinded Induction Dosing (Week 0-12)||360
10568872|NCT01646177|11724138|FG003|COMPLETED|Blinded Induction Dosing (Week 0-12)||363
10568873|NCT01646177|11724139|FG004|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
10568874|NCT01646177|11724140|FG005|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
10568875|NCT01646177|11724141|FG006|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
10568876|NCT01646177|11724142|FG007|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
10568877|NCT01646177|11724143|FG008|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
10568878|NCT01646177|11724144|FG009|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
10568879|NCT01646177|11724145|FG010|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
10568880|NCT01646177|11724146|FG011|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
10568881|NCT01646177|11724135|FG000|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||10
10568882|NCT01646177|11724136|FG001|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||13
10568883|NCT01646177|11724137|FG002|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||26
10568884|NCT01646177|11724138|FG003|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||22
10568885|NCT01646177|11724139|FG004|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
10568886|NCT01646177|11724140|FG005|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
10568887|NCT01646177|11724141|FG006|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
10568888|NCT01646177|11724142|FG007|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
10568889|NCT01646177|11724143|FG008|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
10568890|NCT01646177|11724144|FG009|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
10568891|NCT01646177|11724145|FG010|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
10793658|NCT03613129|11954483|FG001|COMPLETED|Treatment|ID35 received only 1 infusion (due to symptom worsening)|3
10793659|NCT03613129|11954484|FG002|COMPLETED|Treatment||7
10793660|NCT03613129|11954485|FG003|COMPLETED|Treatment|ID34 did not receive 3rd infusion (for lack of venous access)|2
10793661|NCT03613129|11954486|FG004|COMPLETED|Treatment||2
10793662|NCT03613129|11954482|FG000|NOT COMPLETED|Treatment||0
10793663|NCT03613129|11954483|FG001|NOT COMPLETED|Treatment||0
10793664|NCT03613129|11954484|FG002|NOT COMPLETED|Treatment||0
10793665|NCT03613129|11954485|FG003|NOT COMPLETED|Treatment||0
10793666|NCT03613129|11954486|FG004|NOT COMPLETED|Treatment||0
10793667|NCT03613129|11954482|FG000|STARTED|Post-treatment Assessment||0
10793668|NCT03613129|11954483|FG001|STARTED|Post-treatment Assessment||3
10793669|NCT03613129|11954484|FG002|STARTED|Post-treatment Assessment||7
10793670|NCT03613129|11954485|FG003|STARTED|Post-treatment Assessment||2
10793671|NCT03613129|11954486|FG004|STARTED|Post-treatment Assessment||2
10793672|NCT03613129|11954482|FG000|COMPLETED|Post-treatment Assessment||0
10793673|NCT03613129|11954483|FG001|COMPLETED|Post-treatment Assessment||3
10793674|NCT03613129|11954484|FG002|COMPLETED|Post-treatment Assessment||7
10568892|NCT01646177|11724146|FG011|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
10568893|NCT01646177|11724135|FG000|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0
10568894|NCT01646177|11724136|FG001|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0
10568895|NCT01646177|11724137|FG002|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0
10568896|NCT01646177|11724138|FG003|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0
10568897|NCT01646177|11724139|FG004|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|183
10568898|NCT01646177|11724140|FG005|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|369
10568899|NCT01646177|11724141|FG006|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|360
10568900|NCT01646177|11724142|FG007|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|362
10568901|NCT01646177|11724143|FG008|STARTED|Long-Term Extension Period (Week 12-264)||0
10793675|NCT03613129|11954485|FG003|COMPLETED|Post-treatment Assessment||2
10793676|NCT03613129|11954486|FG004|COMPLETED|Post-treatment Assessment||2
10793677|NCT03613129|11954482|FG000|NOT COMPLETED|Post-treatment Assessment||0
10793678|NCT03613129|11954483|FG001|NOT COMPLETED|Post-treatment Assessment||0
10793679|NCT03613129|11954484|FG002|NOT COMPLETED|Post-treatment Assessment||0
10793680|NCT03613129|11954485|FG003|NOT COMPLETED|Post-treatment Assessment||0
10793681|NCT03613129|11954486|FG004|NOT COMPLETED|Post-treatment Assessment||0
10793682|NCT03613454|11954500|FG000|STARTED|Overall Study||24
10793683|NCT03613454|11954501|FG001|STARTED|Overall Study||24
10793684|NCT03613454|11954500|FG000|COMPLETED|Overall Study||23
10793685|NCT03613454|11954501|FG001|COMPLETED|Overall Study||23
10793686|NCT03613454|11954500|FG000|NOT COMPLETED|Overall Study||1
10793687|NCT03613454|11954501|FG001|NOT COMPLETED|Overall Study||1
10793688|NCT03613493|11954511|FG000|STARTED|Overall Study||10
10793689|NCT03613493|11954512|FG001|STARTED|Overall Study||75
10793690|NCT03613493|11954513|FG002|STARTED|Overall Study||0
10793691|NCT03613493|11954514|FG003|STARTED|Overall Study||90
10793692|NCT03613493|11954511|FG000|Enrollment Criteria Met|Overall Study||10
10793693|NCT03613493|11954512|FG001|Enrollment Criteria Met|Overall Study||74
10793694|NCT03613493|11954513|FG002|Enrollment Criteria Met|Overall Study||0
10793695|NCT03613493|11954514|FG003|Enrollment Criteria Met|Overall Study||89
10793696|NCT03613493|11954511|FG000|COMPLETED|Overall Study||10
10793697|NCT03613493|11954512|FG001|COMPLETED|Overall Study||73
10793698|NCT03613493|11954513|FG002|COMPLETED|Overall Study||0
10793699|NCT03613493|11954514|FG003|COMPLETED|Overall Study||83
10793700|NCT03613493|11954511|FG000|NOT COMPLETED|Overall Study||0
10793701|NCT03613493|11954512|FG001|NOT COMPLETED|Overall Study||2
10793702|NCT03613493|11954513|FG002|NOT COMPLETED|Overall Study||0
10793703|NCT03613493|11954514|FG003|NOT COMPLETED|Overall Study||7
10793704|NCT03613649|11954535|FG000|STARTED|First Treatment||6
10793705|NCT03613649|11954536|FG001|STARTED|First Treatment||6
10793706|NCT03613649|11954537|FG002|STARTED|First Treatment||6
10793707|NCT03613649|11954538|FG003|STARTED|First Treatment||6
10793708|NCT03613649|11954539|FG004|STARTED|First Treatment||6
10793709|NCT03613649|11954540|FG005|STARTED|First Treatment||6
10793710|NCT03613649|11954541|FG006|STARTED|First Treatment||6
10793711|NCT03613649|11954542|FG007|STARTED|First Treatment||6
10793712|NCT03613649|11954543|FG008|STARTED|First Treatment||6
10793713|NCT03613649|11954544|FG009|STARTED|First Treatment||6
10793714|NCT03613649|11954545|FG010|STARTED|First Treatment||6
10793715|NCT03613649|11954546|FG011|STARTED|First Treatment||6
10793716|NCT03613649|11954535|FG000|Received Treatment|First Treatment||6
10793717|NCT03613649|11954536|FG001|Received Treatment|First Treatment||6
10793718|NCT03613649|11954537|FG002|Received Treatment|First Treatment||6
10793719|NCT03613649|11954538|FG003|Received Treatment|First Treatment||6
10793720|NCT03613649|11954539|FG004|Received Treatment|First Treatment||6
10793721|NCT03613649|11954540|FG005|Received Treatment|First Treatment||6
10793722|NCT03613649|11954541|FG006|Received Treatment|First Treatment||6
10793723|NCT03613649|11954542|FG007|Received Treatment|First Treatment||6
10793724|NCT03613649|11954543|FG008|Received Treatment|First Treatment||6
10793725|NCT03613649|11954544|FG009|Received Treatment|First Treatment||6
10793726|NCT03613649|11954545|FG010|Received Treatment|First Treatment||6
10793727|NCT03613649|11954546|FG011|Received Treatment|First Treatment||6
10793728|NCT03613649|11954535|FG000|COMPLETED|First Treatment||6
10793729|NCT03613649|11954536|FG001|COMPLETED|First Treatment||6
10793730|NCT03613649|11954537|FG002|COMPLETED|First Treatment||6
10793731|NCT03613649|11954538|FG003|COMPLETED|First Treatment||6
10793732|NCT03613649|11954539|FG004|COMPLETED|First Treatment||6
10793733|NCT03613649|11954540|FG005|COMPLETED|First Treatment||6
10793734|NCT03613649|11954541|FG006|COMPLETED|First Treatment||6
10793735|NCT03613649|11954542|FG007|COMPLETED|First Treatment||6
10793736|NCT03613649|11954543|FG008|COMPLETED|First Treatment||6
10793737|NCT03613649|11954544|FG009|COMPLETED|First Treatment||6
10793738|NCT03613649|11954545|FG010|COMPLETED|First Treatment||6
10793739|NCT03613649|11954546|FG011|COMPLETED|First Treatment||6
10793740|NCT03613649|11954535|FG000|NOT COMPLETED|First Treatment||0
10793741|NCT03613649|11954536|FG001|NOT COMPLETED|First Treatment||0
10793742|NCT03613649|11954537|FG002|NOT COMPLETED|First Treatment||0
10793743|NCT03613649|11954538|FG003|NOT COMPLETED|First Treatment||0
10568902|NCT01646177|11724144|FG009|STARTED|Long-Term Extension Period (Week 12-264)||0
10568903|NCT01646177|11724145|FG010|STARTED|Long-Term Extension Period (Week 12-264)||0
10568904|NCT01646177|11724146|FG011|STARTED|Long-Term Extension Period (Week 12-264)||0
10568905|NCT01646177|11724135|FG000|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
10568906|NCT01646177|11724136|FG001|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
10568907|NCT01646177|11724137|FG002|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
10568908|NCT01646177|11724138|FG003|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
10568909|NCT01646177|11724139|FG004|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||183
10568910|NCT01646177|11724140|FG005|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||369
10568911|NCT01646177|11724141|FG006|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||360
10568912|NCT01646177|11724142|FG007|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||362
10568913|NCT01646177|11724143|FG008|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
10568914|NCT01646177|11724144|FG009|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
10568915|NCT01646177|11724145|FG010|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
10568916|NCT01646177|11724146|FG011|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
10568917|NCT01646177|11724135|FG000|COMPLETED|Long-Term Extension Period (Week 12-264)||0
10568918|NCT01646177|11724136|FG001|COMPLETED|Long-Term Extension Period (Week 12-264)||0
10568919|NCT01646177|11724137|FG002|COMPLETED|Long-Term Extension Period (Week 12-264)||0
10568920|NCT01646177|11724138|FG003|COMPLETED|Long-Term Extension Period (Week 12-264)||0
10568921|NCT01646177|11724139|FG004|COMPLETED|Long-Term Extension Period (Week 12-264)||135
10568922|NCT01646177|11724140|FG005|COMPLETED|Long-Term Extension Period (Week 12-264)||256
10568923|NCT01646177|11724141|FG006|COMPLETED|Long-Term Extension Period (Week 12-264)||244
10568924|NCT01646177|11724142|FG007|COMPLETED|Long-Term Extension Period (Week 12-264)||255
10568925|NCT01646177|11724143|FG008|COMPLETED|Long-Term Extension Period (Week 12-264)||0
10568926|NCT01646177|11724144|FG009|COMPLETED|Long-Term Extension Period (Week 12-264)||0
10568927|NCT01646177|11724145|FG010|COMPLETED|Long-Term Extension Period (Week 12-264)||0
10568928|NCT01646177|11724146|FG011|COMPLETED|Long-Term Extension Period (Week 12-264)||0
10568929|NCT01646177|11724135|FG000|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
10568930|NCT01646177|11724136|FG001|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
10568931|NCT01646177|11724137|FG002|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
10568932|NCT01646177|11724138|FG003|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
10568933|NCT01646177|11724139|FG004|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||48
10568934|NCT01646177|11724140|FG005|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||113
10568935|NCT01646177|11724141|FG006|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||116
10568936|NCT01646177|11724142|FG007|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||107
10568937|NCT01646177|11724143|FG008|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
10568938|NCT01646177|11724144|FG009|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
10568939|NCT01646177|11724145|FG010|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
10568940|NCT01646177|11724146|FG011|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
10568941|NCT01646177|11724135|FG000|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0
10568942|NCT01646177|11724136|FG001|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0
10568943|NCT01646177|11724137|FG002|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0
10568944|NCT01646177|11724138|FG003|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0
10568945|NCT01646177|11724139|FG004|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
10568946|NCT01646177|11724140|FG005|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
10568947|NCT01646177|11724141|FG006|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
10568948|NCT01646177|11724142|FG007|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
10568949|NCT01646177|11724143|FG008|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|157
10568950|NCT01646177|11724144|FG009|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|309
10568951|NCT01646177|11724145|FG010|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|305
10568952|NCT01646177|11724146|FG011|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|313
10568953|NCT01646177|11724135|FG000|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
10568954|NCT01646177|11724136|FG001|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
10568955|NCT01646177|11724137|FG002|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
10651203|NCT02173704|11811355|FG001|NOT COMPLETED|Overall Study||4
10793744|NCT03613649|11954539|FG004|NOT COMPLETED|First Treatment||0
10793745|NCT03613649|11954540|FG005|NOT COMPLETED|First Treatment||0
10793746|NCT03613649|11954541|FG006|NOT COMPLETED|First Treatment||0
10793747|NCT03613649|11954542|FG007|NOT COMPLETED|First Treatment||0
10793748|NCT03613649|11954543|FG008|NOT COMPLETED|First Treatment||0
10793749|NCT03613649|11954544|FG009|NOT COMPLETED|First Treatment||0
10793750|NCT03613649|11954545|FG010|NOT COMPLETED|First Treatment||0
10568956|NCT01646177|11724138|FG003|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
10568957|NCT01646177|11724139|FG004|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
10568958|NCT01646177|11724140|FG005|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
10568959|NCT01646177|11724141|FG006|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
10568960|NCT01646177|11724142|FG007|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
10568961|NCT01646177|11724143|FG008|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||157
10568962|NCT01646177|11724144|FG009|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||309
10568963|NCT01646177|11724145|FG010|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||305
10568964|NCT01646177|11724146|FG011|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||313
10568965|NCT01646177|11724135|FG000|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
10568966|NCT01646177|11724136|FG001|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
10568967|NCT01646177|11724137|FG002|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
10568968|NCT01646177|11724138|FG003|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
10568969|NCT01646177|11724139|FG004|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
10568970|NCT01646177|11724140|FG005|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
10568971|NCT01646177|11724141|FG006|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
10568972|NCT01646177|11724142|FG007|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
10568973|NCT01646177|11724143|FG008|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||126
10568974|NCT01646177|11724144|FG009|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||233
10568975|NCT01646177|11724145|FG010|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||225
10568976|NCT01646177|11724146|FG011|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||230
10568977|NCT01646177|11724135|FG000|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
10568978|NCT01646177|11724136|FG001|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
10568979|NCT01646177|11724137|FG002|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
10568980|NCT01646177|11724138|FG003|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
10568981|NCT01646177|11724139|FG004|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
10568982|NCT01646177|11724140|FG005|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
10568983|NCT01646177|11724141|FG006|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
10568984|NCT01646177|11724142|FG007|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
10568985|NCT01646177|11724143|FG008|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||31
10568986|NCT01646177|11724144|FG009|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||76
10568987|NCT01646177|11724145|FG010|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||80
10568988|NCT01646177|11724146|FG011|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||83
10568989|NCT01646203|11724169|FG000|STARTED|Overall Study||2
10568990|NCT01646203|11724170|FG001|STARTED|Overall Study||5
10568991|NCT01646203|11724171|FG002|STARTED|Overall Study||7
10568992|NCT01646203|11724169|FG000|Received at Least One Dose of Study Drug|Overall Study||2
10568993|NCT01646203|11724170|FG001|Received at Least One Dose of Study Drug|Overall Study||5
10568994|NCT01646203|11724171|FG002|Received at Least One Dose of Study Drug|Overall Study||7
10568995|NCT01646203|11724169|FG000|COMPLETED|Overall Study||0
10568996|NCT01646203|11724170|FG001|COMPLETED|Overall Study||3
10568997|NCT01646203|11724171|FG002|COMPLETED|Overall Study||6
10568998|NCT01646203|11724169|FG000|NOT COMPLETED|Overall Study||2
10568999|NCT01646203|11724170|FG001|NOT COMPLETED|Overall Study||2
10793751|NCT03613649|11954546|FG011|NOT COMPLETED|First Treatment||0
10793752|NCT03613649|11954535|FG000|STARTED|Second Treatment||6
10793753|NCT03613649|11954536|FG001|STARTED|Second Treatment||6
10793754|NCT03613649|11954537|FG002|STARTED|Second Treatment||6
10793755|NCT03613649|11954538|FG003|STARTED|Second Treatment||6
10793756|NCT03613649|11954539|FG004|STARTED|Second Treatment||6
10793757|NCT03613649|11954540|FG005|STARTED|Second Treatment||6
10793758|NCT03613649|11954541|FG006|STARTED|Second Treatment||6
10793759|NCT03613649|11954542|FG007|STARTED|Second Treatment||6
10793760|NCT03613649|11954543|FG008|STARTED|Second Treatment||6
10793761|NCT03613649|11954544|FG009|STARTED|Second Treatment||6
10793762|NCT03613649|11954545|FG010|STARTED|Second Treatment||6
10793763|NCT03613649|11954546|FG011|STARTED|Second Treatment||6
10793764|NCT03613649|11954535|FG000|Received Treatment|Second Treatment||6
10793765|NCT03613649|11954536|FG001|Received Treatment|Second Treatment||6
10793766|NCT03613649|11954537|FG002|Received Treatment|Second Treatment||6
10793767|NCT03613649|11954538|FG003|Received Treatment|Second Treatment||6
10793768|NCT03613649|11954539|FG004|Received Treatment|Second Treatment||6
10793769|NCT03613649|11954540|FG005|Received Treatment|Second Treatment||6
10793770|NCT03613649|11954541|FG006|Received Treatment|Second Treatment||6
10793771|NCT03613649|11954542|FG007|Received Treatment|Second Treatment||6
10793772|NCT03613649|11954543|FG008|Received Treatment|Second Treatment||6
10793773|NCT03613649|11954544|FG009|Received Treatment|Second Treatment||6
10793774|NCT03613649|11954545|FG010|Received Treatment|Second Treatment||6
10793775|NCT03613649|11954546|FG011|Received Treatment|Second Treatment||6
10793776|NCT03613649|11954535|FG000|COMPLETED|Second Treatment||6
10793777|NCT03613649|11954536|FG001|COMPLETED|Second Treatment||6
10793778|NCT03613649|11954537|FG002|COMPLETED|Second Treatment||5
10793779|NCT03613649|11954538|FG003|COMPLETED|Second Treatment||6
10793780|NCT03613649|11954539|FG004|COMPLETED|Second Treatment||5
10793781|NCT03613649|11954540|FG005|COMPLETED|Second Treatment||6
10793782|NCT03613649|11954541|FG006|COMPLETED|Second Treatment||6
10793783|NCT03613649|11954542|FG007|COMPLETED|Second Treatment||6
10569000|NCT01646203|11724171|FG002|NOT COMPLETED|Overall Study||1
10569001|NCT01646216|11724186|FG000|STARTED|Overall Study||17
10569002|NCT01646216|11724187|FG001|STARTED|Overall Study||17
10569003|NCT01646216|11724186|FG000|COMPLETED|Overall Study||6
10569004|NCT01646216|11724187|FG001|COMPLETED|Overall Study||4
10569005|NCT01646216|11724186|FG000|NOT COMPLETED|Overall Study||11
10569006|NCT01646216|11724187|FG001|NOT COMPLETED|Overall Study||13
10569007|NCT01646255|11724199|FG000|STARTED|Overall Study||172
10569008|NCT01646255|11724200|FG001|STARTED|Overall Study||174
10569009|NCT01646255|11724199|FG000|COMPLETED|Overall Study||151
10569010|NCT01646255|11724200|FG001|COMPLETED|Overall Study||160
10569011|NCT01646255|11724199|FG000|NOT COMPLETED|Overall Study||21
10569012|NCT01646255|11724200|FG001|NOT COMPLETED|Overall Study||14
10569013|NCT01646268|11724209|FG000|STARTED|Overall Study||124
10569014|NCT01646268|11724210|FG001|STARTED|Overall Study||123
10569015|NCT01646268|11724209|FG000|COMPLETED|Overall Study||113
10569016|NCT01646268|11724210|FG001|COMPLETED|Overall Study||107
10569017|NCT01646268|11724209|FG000|NOT COMPLETED|Overall Study||11
10569018|NCT01646268|11724210|FG001|NOT COMPLETED|Overall Study||16
10569019|NCT01646320|11724218|FG000|STARTED|Short-term Period (Day 1 to Week 24)||160
10569020|NCT01646320|11724219|FG001|STARTED|Short-term Period (Day 1 to Week 24)||160
10569021|NCT01646320|11724218|FG000|COMPLETED|Short-term Period (Day 1 to Week 24)||148
10569022|NCT01646320|11724219|FG001|COMPLETED|Short-term Period (Day 1 to Week 24)||153
10569023|NCT01646320|11724218|FG000|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||12
10569024|NCT01646320|11724219|FG001|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||7
10569025|NCT01646320|11724218|FG000|STARTED|Long-term Period (Weeks 24 to 52)||147
10569026|NCT01646320|11724219|FG001|STARTED|Long-term Period (Weeks 24 to 52)||147
10569027|NCT01646320|11724218|FG000|COMPLETED|Long-term Period (Weeks 24 to 52)||141
10569028|NCT01646320|11724219|FG001|COMPLETED|Long-term Period (Weeks 24 to 52)||140
10569029|NCT01646320|11724218|FG000|NOT COMPLETED|Long-term Period (Weeks 24 to 52)||6
10569030|NCT01646320|11724219|FG001|NOT COMPLETED|Long-term Period (Weeks 24 to 52)||7
10569031|NCT01646346|11724225|FG000|STARTED|Overall Study||46
10569032|NCT01646346|11724225|FG000|COMPLETED|Overall Study||46
10569033|NCT01646346|11724225|FG000|NOT COMPLETED|Overall Study||0
10569034|NCT01646385|11724231|FG000|STARTED|Overall Study||3529
10569035|NCT01646385|11724232|FG001|STARTED|Overall Study||2864
10569036|NCT01646385|11724231|FG000|COMPLETED|Overall Study|Completed refers to participants who continued up to last follow-up.|2691
10569037|NCT01646385|11724232|FG001|COMPLETED|Overall Study|Completed refers to participants who continued up to last follow-up.|1993
10569038|NCT01646385|11724231|FG000|NOT COMPLETED|Overall Study||838
10569039|NCT01646385|11724232|FG001|NOT COMPLETED|Overall Study||871
10569040|NCT01646398|11724240|FG000|STARTED|Overall Study||382
10569041|NCT01646398|11724241|FG001|STARTED|Overall Study||382
10569042|NCT01646398|11724240|FG000|COMPLETED|Overall Study||381
10569043|NCT01646398|11724241|FG001|COMPLETED|Overall Study||382
10569044|NCT01646398|11724240|FG000|NOT COMPLETED|Overall Study||1
10569045|NCT01646398|11724241|FG001|NOT COMPLETED|Overall Study||0
10569046|NCT01646645|11724247|FG000|STARTED|Overall Study||58
10569047|NCT01646645|11724247|FG000|COMPLETED|Overall Study||28
10569048|NCT01646645|11724247|FG000|NOT COMPLETED|Overall Study||30
10569049|NCT01646671|11724254|FG000|STARTED|Overall Study||3
10569050|NCT01646671|11724255|FG001|STARTED|Overall Study||11
10569051|NCT01646671|11724256|FG002|STARTED|Overall Study||21
10569052|NCT01646671|11724254|FG000|COMPLETED|Overall Study||3
10569053|NCT01646671|11724255|FG001|COMPLETED|Overall Study||11
10569054|NCT01646671|11724256|FG002|COMPLETED|Overall Study||21
10569055|NCT01646671|11724254|FG000|NOT COMPLETED|Overall Study||0
10569056|NCT01646671|11724255|FG001|NOT COMPLETED|Overall Study||0
10569057|NCT01646671|11724256|FG002|NOT COMPLETED|Overall Study||0
10569058|NCT01646762|11724266|FG000|STARTED|Overall Study||13
10569059|NCT01646762|11724266|FG000|COMPLETED|Overall Study||13
10569060|NCT01646762|11724266|FG000|NOT COMPLETED|Overall Study||0
10569061|NCT01646827|11724272|FG000|STARTED|Overall Study||18
10569062|NCT01646827|11724273|FG001|STARTED|Overall Study||19
10569063|NCT01646827|11724272|FG000|COMPLETED|Overall Study||16
10569064|NCT01646827|11724273|FG001|COMPLETED|Overall Study||14
10569065|NCT01646827|11724272|FG000|NOT COMPLETED|Overall Study||2
10569066|NCT01646827|11724273|FG001|NOT COMPLETED|Overall Study||5
10569067|NCT01647217|11724281|FG000|STARTED|Overall Study||8
10569068|NCT01647217|11724282|FG001|STARTED|Overall Study||9
10569069|NCT01647217|11724281|FG000|COMPLETED|Overall Study||7
10569070|NCT01647217|11724282|FG001|COMPLETED|Overall Study||8
10569071|NCT01647217|11724281|FG000|NOT COMPLETED|Overall Study||1
10569072|NCT01647217|11724282|FG001|NOT COMPLETED|Overall Study||1
10569073|NCT01647282|11724292|FG000|STARTED|Overall Study||30
10569074|NCT01647282|11724293|FG001|STARTED|Overall Study||30
10569075|NCT01647282|11724292|FG000|COMPLETED|Overall Study||23
10569076|NCT01647282|11724293|FG001|COMPLETED|Overall Study||25
10569077|NCT01647282|11724292|FG000|NOT COMPLETED|Overall Study||7
10569078|NCT01647282|11724293|FG001|NOT COMPLETED|Overall Study||5
10569079|NCT01647438|11724301|FG000|STARTED|Overall Study||32
10569080|NCT01647438|11724302|FG001|STARTED|Overall Study||31
10569081|NCT01647438|11724301|FG000|COMPLETED|Overall Study||32
10569082|NCT01647438|11724302|FG001|COMPLETED|Overall Study||31
10569083|NCT01647438|11724301|FG000|NOT COMPLETED|Overall Study||0
10569084|NCT01647438|11724302|FG001|NOT COMPLETED|Overall Study||0
10569085|NCT01647464|11724308|FG000|STARTED|Overall Study||10
10569086|NCT01647464|11724308|FG000|COMPLETED|Overall Study||10
10569087|NCT01647464|11724308|FG000|NOT COMPLETED|Overall Study||0
10569088|NCT01647516|11724315|FG000|STARTED|Induction Period (IP)||66
10569089|NCT01647516|11724316|FG001|STARTED|Induction Period (IP)||66
10569090|NCT01647516|11724317|FG002|STARTED|Induction Period (IP)||67
10569091|NCT01647516|11724318|FG003|STARTED|Induction Period (IP)||0
10569092|NCT01647516|11724319|FG004|STARTED|Induction Period (IP)||0
10569093|NCT01647516|11724320|FG005|STARTED|Induction Period (IP)||0
10569094|NCT01647516|11724315|FG000|Received Study Drug|Induction Period (IP)||65
10569095|NCT01647516|11724316|FG001|Received Study Drug|Induction Period (IP)||65
10569096|NCT01647516|11724317|FG002|Received Study Drug|Induction Period (IP)||67
10569097|NCT01647516|11724318|FG003|Received Study Drug|Induction Period (IP)||0
10569098|NCT01647516|11724319|FG004|Received Study Drug|Induction Period (IP)||0
10569099|NCT01647516|11724320|FG005|Received Study Drug|Induction Period (IP)||0
10569100|NCT01647516|11724315|FG000|COMPLETED|Induction Period (IP)||60
10569101|NCT01647516|11724316|FG001|COMPLETED|Induction Period (IP)||63
10569102|NCT01647516|11724317|FG002|COMPLETED|Induction Period (IP)||63
10569103|NCT01647516|11724318|FG003|COMPLETED|Induction Period (IP)||0
10569104|NCT01647516|11724319|FG004|COMPLETED|Induction Period (IP)||0
10569105|NCT01647516|11724320|FG005|COMPLETED|Induction Period (IP)||0
10569106|NCT01647516|11724315|FG000|NOT COMPLETED|Induction Period (IP)||6
10569107|NCT01647516|11724316|FG001|NOT COMPLETED|Induction Period (IP)||3
10569108|NCT01647516|11724317|FG002|NOT COMPLETED|Induction Period (IP)||4
10569109|NCT01647516|11724318|FG003|NOT COMPLETED|Induction Period (IP)||0
10318749|NCT00216671|11452986|FG001|STARTED|Overall Study||110
10318750|NCT00216671|11452985|FG000|COMPLETED|Overall Study||75
10318751|NCT00216671|11452986|FG001|COMPLETED|Overall Study||60
10318752|NCT00216671|11452985|FG000|NOT COMPLETED|Overall Study||35
10318753|NCT00216671|11452986|FG001|NOT COMPLETED|Overall Study||50
10318754|NCT00216736|11452994|FG000|STARTED|Overall Study||32
10318755|NCT00216736|11452995|FG001|STARTED|Overall Study||31
10569110|NCT01647516|11724319|FG004|NOT COMPLETED|Induction Period (IP)||0
10569111|NCT01647516|11724320|FG005|NOT COMPLETED|Induction Period (IP)||0
10569112|NCT01647516|11724315|FG000|STARTED|Maintenance Period (MP)|The MP includes participants who were responders at week 8.|25
10569113|NCT01647516|11724316|FG001|STARTED|Maintenance Period (MP)|The MP includes participants who were responders at week 8.|36
10569114|NCT01647516|11724317|FG002|STARTED|Maintenance Period (MP)|The MP includes participants who were responders at week 8.|42
10569115|NCT01647516|11724318|FG003|STARTED|Maintenance Period (MP)||0
10569116|NCT01647516|11724319|FG004|STARTED|Maintenance Period (MP)||0
10569117|NCT01647516|11724320|FG005|STARTED|Maintenance Period (MP)||0
10569118|NCT01647516|11724315|FG000|COMPLETED|Maintenance Period (MP)||21
10569119|NCT01647516|11724316|FG001|COMPLETED|Maintenance Period (MP)||30
10569120|NCT01647516|11724317|FG002|COMPLETED|Maintenance Period (MP)||40
10569121|NCT01647516|11724318|FG003|COMPLETED|Maintenance Period (MP)||0
10569122|NCT01647516|11724319|FG004|COMPLETED|Maintenance Period (MP)||0
10569123|NCT01647516|11724320|FG005|COMPLETED|Maintenance Period (MP)||0
10569124|NCT01647516|11724315|FG000|NOT COMPLETED|Maintenance Period (MP)||4
10569125|NCT01647516|11724316|FG001|NOT COMPLETED|Maintenance Period (MP)||6
10569126|NCT01647516|11724317|FG002|NOT COMPLETED|Maintenance Period (MP)||2
10569127|NCT01647516|11724318|FG003|NOT COMPLETED|Maintenance Period (MP)||0
10569128|NCT01647516|11724319|FG004|NOT COMPLETED|Maintenance Period (MP)||0
10569129|NCT01647516|11724320|FG005|NOT COMPLETED|Maintenance Period (MP)||0
10569130|NCT01647516|11724315|FG000|STARTED|Open-Label Period||0
10569131|NCT01647516|11724316|FG001|STARTED|Open-Label Period||0
10569132|NCT01647516|11724317|FG002|STARTED|Open-Label Period||0
10569133|NCT01647516|11724318|FG003|STARTED|Open-Label Period|"The participants were:~non-responders at Week 8,completed the MP or had disease relapse during MP"|55
10569134|NCT01647516|11724319|FG004|STARTED|Open-Label Period|"The participants were:~non-responders at Week 8,completed the MP or had disease relapse during MP"|56
10569135|NCT01647516|11724320|FG005|STARTED|Open-Label Period|"The participants were:~non-responders at Week 8,completed the MP or had disease relapse during MP"|59
10569136|NCT01647516|11724315|FG000|COMPLETED|Open-Label Period||0
10569137|NCT01647516|11724316|FG001|COMPLETED|Open-Label Period||0
10569138|NCT01647516|11724317|FG002|COMPLETED|Open-Label Period||0
10569139|NCT01647516|11724318|FG003|COMPLETED|Open-Label Period||6
10569140|NCT01647516|11724319|FG004|COMPLETED|Open-Label Period||5
10569141|NCT01647516|11724320|FG005|COMPLETED|Open-Label Period||3
10569142|NCT01647516|11724315|FG000|NOT COMPLETED|Open-Label Period||0
10569143|NCT01647516|11724316|FG001|NOT COMPLETED|Open-Label Period||0
10569144|NCT01647516|11724317|FG002|NOT COMPLETED|Open-Label Period||0
10569145|NCT01647516|11724318|FG003|NOT COMPLETED|Open-Label Period||49
10569146|NCT01647516|11724319|FG004|NOT COMPLETED|Open-Label Period||51
10569147|NCT01647516|11724320|FG005|NOT COMPLETED|Open-Label Period||56
10569148|NCT01647542|11724338|FG000|STARTED|Overall Study||131
10569149|NCT01647542|11724339|FG001|STARTED|Overall Study||131
10569150|NCT01647542|11724340|FG002|STARTED|Overall Study||131
10569151|NCT01647542|11724338|FG000|COMPLETED|Overall Study||55
10569152|NCT01647542|11724339|FG001|COMPLETED|Overall Study||58
10569153|NCT01647542|11724340|FG002|COMPLETED|Overall Study||59
10569154|NCT01647542|11724338|FG000|NOT COMPLETED|Overall Study||76
10569155|NCT01647542|11724339|FG001|NOT COMPLETED|Overall Study||73
10569156|NCT01647542|11724340|FG002|NOT COMPLETED|Overall Study||72
10569157|NCT01647581|11724350|FG000|STARTED|Overall Study||547
10569158|NCT01647581|11724351|FG001|STARTED|Overall Study||551
10569159|NCT01647581|11724350|FG000|COMPLETED|Overall Study||530
10569160|NCT01647581|11724351|FG001|COMPLETED|Overall Study||520
10318756|NCT00216736|11452994|FG000|COMPLETED|Overall Study||31
10569161|NCT01647581|11724350|FG000|NOT COMPLETED|Overall Study||17
10318757|NCT00216736|11452995|FG001|COMPLETED|Overall Study||30
10318758|NCT00216736|11452994|FG000|NOT COMPLETED|Overall Study||1
10569162|NCT01647581|11724351|FG001|NOT COMPLETED|Overall Study||31
10569163|NCT01647711|11724362|FG000|STARTED|Overall Study||6
10569164|NCT01647711|11724363|FG001|STARTED|Overall Study||3
10569165|NCT01647711|11724364|FG002|STARTED|Overall Study||9
10569166|NCT01647711|11724365|FG003|STARTED|Overall Study||11
10569167|NCT01647711|11724366|FG004|STARTED|Overall Study||6
10569168|NCT01647711|11724362|FG000|COMPLETED|Overall Study||0
10793784|NCT03613649|11954543|FG008|COMPLETED|Second Treatment||6
10793785|NCT03613649|11954544|FG009|COMPLETED|Second Treatment||6
10793786|NCT03613649|11954545|FG010|COMPLETED|Second Treatment||6
10569169|NCT01647711|11724363|FG001|COMPLETED|Overall Study||0
10569170|NCT01647711|11724364|FG002|COMPLETED|Overall Study||0
10569171|NCT01647711|11724365|FG003|COMPLETED|Overall Study||0
10569172|NCT01647711|11724366|FG004|COMPLETED|Overall Study||0
10569173|NCT01647711|11724362|FG000|NOT COMPLETED|Overall Study||6
10569174|NCT01647711|11724363|FG001|NOT COMPLETED|Overall Study||3
10569175|NCT01647711|11724364|FG002|NOT COMPLETED|Overall Study||9
10569176|NCT01647711|11724365|FG003|NOT COMPLETED|Overall Study||11
10569177|NCT01647711|11724366|FG004|NOT COMPLETED|Overall Study||6
10569178|NCT01647737|11724382|FG000|STARTED|Overall Study||30
10569179|NCT01647737|11724383|FG001|STARTED|Overall Study||30
10793787|NCT03613649|11954546|FG011|COMPLETED|Second Treatment||6
10793788|NCT03613649|11954535|FG000|NOT COMPLETED|Second Treatment||0
10793789|NCT03613649|11954536|FG001|NOT COMPLETED|Second Treatment||0
10793790|NCT03613649|11954537|FG002|NOT COMPLETED|Second Treatment||1
10793791|NCT03613649|11954538|FG003|NOT COMPLETED|Second Treatment||0
10793792|NCT03613649|11954539|FG004|NOT COMPLETED|Second Treatment||1
10793793|NCT03613649|11954540|FG005|NOT COMPLETED|Second Treatment||0
10793794|NCT03613649|11954541|FG006|NOT COMPLETED|Second Treatment||0
10793795|NCT03613649|11954542|FG007|NOT COMPLETED|Second Treatment||0
10793796|NCT03613649|11954543|FG008|NOT COMPLETED|Second Treatment||0
10793797|NCT03613649|11954544|FG009|NOT COMPLETED|Second Treatment||0
10793798|NCT03613649|11954545|FG010|NOT COMPLETED|Second Treatment||0
10793799|NCT03613649|11954546|FG011|NOT COMPLETED|Second Treatment||0
10793800|NCT03613649|11954535|FG000|STARTED|Third Treatment||6
10793801|NCT03613649|11954536|FG001|STARTED|Third Treatment||6
10793802|NCT03613649|11954537|FG002|STARTED|Third Treatment||5
10793803|NCT03613649|11954538|FG003|STARTED|Third Treatment||6
10793804|NCT03613649|11954539|FG004|STARTED|Third Treatment||5
10793805|NCT03613649|11954540|FG005|STARTED|Third Treatment||6
10793806|NCT03613649|11954541|FG006|STARTED|Third Treatment||6
10793807|NCT03613649|11954542|FG007|STARTED|Third Treatment||6
10793808|NCT03613649|11954543|FG008|STARTED|Third Treatment||6
10793809|NCT03613649|11954544|FG009|STARTED|Third Treatment||6
10793810|NCT03613649|11954545|FG010|STARTED|Third Treatment||6
10793811|NCT03613649|11954546|FG011|STARTED|Third Treatment||6
10793812|NCT03613649|11954535|FG000|Received Treatment|Third Treatment||6
10793813|NCT03613649|11954536|FG001|Received Treatment|Third Treatment||6
10793814|NCT03613649|11954537|FG002|Received Treatment|Third Treatment||5
10793815|NCT03613649|11954538|FG003|Received Treatment|Third Treatment||6
10793816|NCT03613649|11954539|FG004|Received Treatment|Third Treatment||5
10793817|NCT03613649|11954540|FG005|Received Treatment|Third Treatment||6
10793818|NCT03613649|11954541|FG006|Received Treatment|Third Treatment||5
10793819|NCT03613649|11954542|FG007|Received Treatment|Third Treatment||6
10793820|NCT03613649|11954543|FG008|Received Treatment|Third Treatment||6
10793821|NCT03613649|11954544|FG009|Received Treatment|Third Treatment||6
10793822|NCT03613649|11954545|FG010|Received Treatment|Third Treatment||6
10793823|NCT03613649|11954546|FG011|Received Treatment|Third Treatment||6
10793824|NCT03613649|11954535|FG000|COMPLETED|Third Treatment||6
10793825|NCT03613649|11954536|FG001|COMPLETED|Third Treatment||6
10793826|NCT03613649|11954537|FG002|COMPLETED|Third Treatment||5
10793827|NCT03613649|11954538|FG003|COMPLETED|Third Treatment||6
10793828|NCT03613649|11954539|FG004|COMPLETED|Third Treatment||4
10793829|NCT03613649|11954540|FG005|COMPLETED|Third Treatment||6
10793830|NCT03613649|11954541|FG006|COMPLETED|Third Treatment||5
10793831|NCT03613649|11954542|FG007|COMPLETED|Third Treatment||6
10793832|NCT03613649|11954543|FG008|COMPLETED|Third Treatment||6
10569180|NCT01647737|11724382|FG000|COMPLETED|Overall Study||26
10569181|NCT01647737|11724383|FG001|COMPLETED|Overall Study||25
10569182|NCT01647737|11724382|FG000|NOT COMPLETED|Overall Study||4
10569183|NCT01647737|11724383|FG001|NOT COMPLETED|Overall Study||5
10793833|NCT03613649|11954544|FG009|COMPLETED|Third Treatment||6
10793834|NCT03613649|11954545|FG010|COMPLETED|Third Treatment||6
10793835|NCT03613649|11954546|FG011|COMPLETED|Third Treatment||4
10793836|NCT03613649|11954535|FG000|NOT COMPLETED|Third Treatment||0
10793837|NCT03613649|11954536|FG001|NOT COMPLETED|Third Treatment||0
10793838|NCT03613649|11954537|FG002|NOT COMPLETED|Third Treatment||0
10793839|NCT03613649|11954538|FG003|NOT COMPLETED|Third Treatment||0
10793840|NCT03613649|11954539|FG004|NOT COMPLETED|Third Treatment||1
10793841|NCT03613649|11954540|FG005|NOT COMPLETED|Third Treatment||0
10793842|NCT03613649|11954541|FG006|NOT COMPLETED|Third Treatment||1
10793843|NCT03613649|11954542|FG007|NOT COMPLETED|Third Treatment||0
10793844|NCT03613649|11954543|FG008|NOT COMPLETED|Third Treatment||0
10569184|NCT01647945|11724393|FG000|STARTED|Overall Study||6
10569185|NCT01647945|11724394|FG001|STARTED|Overall Study||6
10569186|NCT01647945|11724395|FG002|STARTED|Overall Study||5
10793845|NCT03613649|11954544|FG009|NOT COMPLETED|Third Treatment||0
10793846|NCT03613649|11954545|FG010|NOT COMPLETED|Third Treatment||0
10793847|NCT03613649|11954546|FG011|NOT COMPLETED|Third Treatment||2
10793848|NCT03613649|11954535|FG000|STARTED|Fourth Treatment||6
10793849|NCT03613649|11954536|FG001|STARTED|Fourth Treatment||6
10569187|NCT01647945|11724396|FG003|STARTED|Overall Study||6
10569188|NCT01647945|11724393|FG000|COMPLETED|Overall Study||6
10569189|NCT01647945|11724394|FG001|COMPLETED|Overall Study||6
10569190|NCT01647945|11724395|FG002|COMPLETED|Overall Study||3
10569191|NCT01647945|11724396|FG003|COMPLETED|Overall Study||5
10569192|NCT01647945|11724393|FG000|NOT COMPLETED|Overall Study||0
10569193|NCT01647945|11724394|FG001|NOT COMPLETED|Overall Study||0
10569194|NCT01647945|11724395|FG002|NOT COMPLETED|Overall Study||2
10569195|NCT01647945|11724396|FG003|NOT COMPLETED|Overall Study||1
10569196|NCT01647958|11724408|FG000|STARTED|Initial Study||41
10569197|NCT01647958|11724409|FG001|STARTED|Initial Study||24
10569198|NCT01647958|11724408|FG000|COMPLETED|Initial Study||39
10569199|NCT01647958|11724409|FG001|COMPLETED|Initial Study||21
10569200|NCT01647958|11724408|FG000|NOT COMPLETED|Initial Study||2
10569201|NCT01647958|11724409|FG001|NOT COMPLETED|Initial Study||3
10569202|NCT01647958|11724408|FG000|STARTED|Continuation Phase||39
10569203|NCT01647958|11724409|FG001|STARTED|Continuation Phase||21
10569204|NCT01647958|11724408|FG000|COMPLETED|Continuation Phase|Treatment-arm patients received TIF procedure during Initial Study phase|0
10569205|NCT01647958|11724409|FG001|COMPLETED|Continuation Phase|21 Control patients received TIF crossover procedure following 6-month follow-up visit.|21
10569206|NCT01647958|11724408|FG000|NOT COMPLETED|Continuation Phase||39
10569207|NCT01647958|11724409|FG001|NOT COMPLETED|Continuation Phase||0
10569208|NCT01647958|11724408|FG000|STARTED|Extended Follow-up Phase|Treatment and Control/Crossover patients were combined into 1 cohort for this follow up. 39+21=60|60
10793850|NCT03613649|11954537|FG002|STARTED|Fourth Treatment||5
10793851|NCT03613649|11954538|FG003|STARTED|Fourth Treatment||6
10793852|NCT03613649|11954539|FG004|STARTED|Fourth Treatment||4
10793853|NCT03613649|11954540|FG005|STARTED|Fourth Treatment||6
10793854|NCT03613649|11954541|FG006|STARTED|Fourth Treatment||5
10793855|NCT03613649|11954542|FG007|STARTED|Fourth Treatment||6
10793856|NCT03613649|11954543|FG008|STARTED|Fourth Treatment||6
10793857|NCT03613649|11954544|FG009|STARTED|Fourth Treatment||6
10793858|NCT03613649|11954545|FG010|STARTED|Fourth Treatment||6
10793859|NCT03613649|11954546|FG011|STARTED|Fourth Treatment||4
10793860|NCT03613649|11954535|FG000|Received Treatment|Fourth Treatment||5
10793861|NCT03613649|11954536|FG001|Received Treatment|Fourth Treatment||6
10793862|NCT03613649|11954537|FG002|Received Treatment|Fourth Treatment||5
10793863|NCT03613649|11954538|FG003|Received Treatment|Fourth Treatment||6
10793864|NCT03613649|11954539|FG004|Received Treatment|Fourth Treatment||4
10793865|NCT03613649|11954540|FG005|Received Treatment|Fourth Treatment||6
10793866|NCT03613649|11954541|FG006|Received Treatment|Fourth Treatment||4
10793867|NCT03613649|11954542|FG007|Received Treatment|Fourth Treatment||6
10793868|NCT03613649|11954543|FG008|Received Treatment|Fourth Treatment||6
10793869|NCT03613649|11954544|FG009|Received Treatment|Fourth Treatment||6
10793870|NCT03613649|11954545|FG010|Received Treatment|Fourth Treatment||6
10793871|NCT03613649|11954546|FG011|Received Treatment|Fourth Treatment||4
10793872|NCT03613649|11954535|FG000|COMPLETED|Fourth Treatment||5
10793873|NCT03613649|11954536|FG001|COMPLETED|Fourth Treatment||6
10793874|NCT03613649|11954537|FG002|COMPLETED|Fourth Treatment||5
10793875|NCT03613649|11954538|FG003|COMPLETED|Fourth Treatment||6
10793876|NCT03613649|11954539|FG004|COMPLETED|Fourth Treatment||3
10793877|NCT03613649|11954540|FG005|COMPLETED|Fourth Treatment||6
10793878|NCT03613649|11954541|FG006|COMPLETED|Fourth Treatment||4
10793879|NCT03613649|11954542|FG007|COMPLETED|Fourth Treatment||6
10793880|NCT03613649|11954543|FG008|COMPLETED|Fourth Treatment||6
10793881|NCT03613649|11954544|FG009|COMPLETED|Fourth Treatment||6
10793882|NCT03613649|11954545|FG010|COMPLETED|Fourth Treatment||6
10793883|NCT03613649|11954546|FG011|COMPLETED|Fourth Treatment||4
10793884|NCT03613649|11954535|FG000|NOT COMPLETED|Fourth Treatment||1
10793885|NCT03613649|11954536|FG001|NOT COMPLETED|Fourth Treatment||0
10793886|NCT03613649|11954537|FG002|NOT COMPLETED|Fourth Treatment||0
10793887|NCT03613649|11954538|FG003|NOT COMPLETED|Fourth Treatment||0
10793888|NCT03613649|11954539|FG004|NOT COMPLETED|Fourth Treatment||1
10793889|NCT03613649|11954540|FG005|NOT COMPLETED|Fourth Treatment||0
10569209|NCT01647958|11724409|FG001|STARTED|Extended Follow-up Phase|Treatment and Control/Crossover patients combined into 1 cohort for this period=60, 0 under Control|0
10569210|NCT01647958|11724408|FG000|COMPLETED|Extended Follow-up Phase|The 8 lost to follow up patients are of the combined Treatment and Control cohort of 52 patients|52
10793890|NCT03613649|11954541|FG006|NOT COMPLETED|Fourth Treatment||1
10793891|NCT03613649|11954542|FG007|NOT COMPLETED|Fourth Treatment||0
10793892|NCT03613649|11954543|FG008|NOT COMPLETED|Fourth Treatment||0
10793893|NCT03613649|11954544|FG009|NOT COMPLETED|Fourth Treatment||0
10793894|NCT03613649|11954545|FG010|NOT COMPLETED|Fourth Treatment||0
10793895|NCT03613649|11954546|FG011|NOT COMPLETED|Fourth Treatment||0
10793896|NCT03613818|11954566|FG000|STARTED|Overall Study||174
10793897|NCT03613818|11954567|FG001|STARTED|Overall Study||137
10793898|NCT03613818|11954566|FG000|COMPLETED|Overall Study||137
10793899|NCT03613818|11954567|FG001|COMPLETED|Overall Study||110
10793900|NCT03613818|11954566|FG000|NOT COMPLETED|Overall Study||37
10793901|NCT03613818|11954567|FG001|NOT COMPLETED|Overall Study||27
10793902|NCT03614078|11954576|FG000|STARTED|Overall Study||31
10793903|NCT03614078|11954577|FG001|STARTED|Overall Study||30
10793904|NCT03614078|11954578|FG002|STARTED|Overall Study||31
10793905|NCT03614078|11954576|FG000|COMPLETED|Overall Study||28
10793906|NCT03614078|11954577|FG001|COMPLETED|Overall Study||23
10793907|NCT03614078|11954578|FG002|COMPLETED|Overall Study||26
10793908|NCT03614078|11954576|FG000|NOT COMPLETED|Overall Study||3
10793909|NCT03614078|11954577|FG001|NOT COMPLETED|Overall Study||7
10569211|NCT01647958|11724409|FG001|COMPLETED|Extended Follow-up Phase||0
10569212|NCT01647958|11724408|FG000|NOT COMPLETED|Extended Follow-up Phase||8
10569213|NCT01647958|11724409|FG001|NOT COMPLETED|Extended Follow-up Phase||0
10569214|NCT01648101|11724427|FG000|STARTED|Titration Phase (4 Weeks)||25
10569215|NCT01648101|11724428|FG001|STARTED|Titration Phase (4 Weeks)||26
10569216|NCT01648101|11724429|FG002|STARTED|Titration Phase (4 Weeks)||24
10569217|NCT01648101|11724427|FG000|COMPLETED|Titration Phase (4 Weeks)||23
10569218|NCT01648101|11724428|FG001|COMPLETED|Titration Phase (4 Weeks)||23
10569219|NCT01648101|11724429|FG002|COMPLETED|Titration Phase (4 Weeks)||18
10793910|NCT03614078|11954578|FG002|NOT COMPLETED|Overall Study||5
10793911|NCT03614130|11954588|FG000|STARTED|Overall Study||10
10793912|NCT03614130|11954589|FG001|STARTED|Overall Study||12
10793913|NCT03614130|11954588|FG000|COMPLETED|Overall Study||10
10793914|NCT03614130|11954589|FG001|COMPLETED|Overall Study||12
10793915|NCT03614130|11954588|FG000|NOT COMPLETED|Overall Study||0
10793916|NCT03614130|11954589|FG001|NOT COMPLETED|Overall Study||0
10793917|NCT03614156|11954600|FG000|STARTED|Open-Label Treatment Period||363
10793918|NCT03614156|11954601|FG001|STARTED|Open-Label Treatment Period||0
10793919|NCT03614156|11954602|FG002|STARTED|Open-Label Treatment Period||0
10793920|NCT03614156|11954603|FG003|STARTED|Open-Label Treatment Period||0
10793921|NCT03614156|11954600|FG000|COMPLETED|Open-Label Treatment Period||209
10793922|NCT03614156|11954601|FG001|COMPLETED|Open-Label Treatment Period||0
10793923|NCT03614156|11954602|FG002|COMPLETED|Open-Label Treatment Period||0
10793924|NCT03614156|11954603|FG003|COMPLETED|Open-Label Treatment Period||0
10793925|NCT03614156|11954600|FG000|NOT COMPLETED|Open-Label Treatment Period||154
10793926|NCT03614156|11954601|FG001|NOT COMPLETED|Open-Label Treatment Period||0
10793927|NCT03614156|11954602|FG002|NOT COMPLETED|Open-Label Treatment Period||0
10793928|NCT03614156|11954603|FG003|NOT COMPLETED|Open-Label Treatment Period||0
10793929|NCT03614156|11954600|FG000|STARTED|Double-Blind Treatment Period (DBTP)||0
10793930|NCT03614156|11954601|FG001|STARTED|Double-Blind Treatment Period (DBTP)||40
10793931|NCT03614156|11954602|FG002|STARTED|Double-Blind Treatment Period (DBTP)||42
10793932|NCT03614156|11954603|FG003|STARTED|Double-Blind Treatment Period (DBTP)||55
10793933|NCT03614156|11954600|FG000|COMPLETED|Double-Blind Treatment Period (DBTP)||0
10793934|NCT03614156|11954601|FG001|COMPLETED|Double-Blind Treatment Period (DBTP)||10
10793935|NCT03614156|11954602|FG002|COMPLETED|Double-Blind Treatment Period (DBTP)||11
10793936|NCT03614156|11954603|FG003|COMPLETED|Double-Blind Treatment Period (DBTP)||10
10793937|NCT03614156|11954600|FG000|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||0
10793938|NCT03614156|11954601|FG001|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||30
10793939|NCT03614156|11954602|FG002|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||31
10793940|NCT03614156|11954603|FG003|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||45
10793941|NCT03614156|11954600|FG000|STARTED|Safety Follow-Up Period||165
10793942|NCT03614156|11954601|FG001|STARTED|Safety Follow-Up Period||26
10793943|NCT03614156|11954602|FG002|STARTED|Safety Follow-Up Period||30
10793944|NCT03614156|11954603|FG003|STARTED|Safety Follow-Up Period||35
10793945|NCT03614156|11954600|FG000|COMPLETED|Safety Follow-Up Period||162
10793946|NCT03614156|11954601|FG001|COMPLETED|Safety Follow-Up Period||26
10793947|NCT03614156|11954602|FG002|COMPLETED|Safety Follow-Up Period||29
10793948|NCT03614156|11954603|FG003|COMPLETED|Safety Follow-Up Period||34
10793949|NCT03614156|11954600|FG000|NOT COMPLETED|Safety Follow-Up Period||3
10793950|NCT03614156|11954601|FG001|NOT COMPLETED|Safety Follow-Up Period||0
10793951|NCT03614156|11954602|FG002|NOT COMPLETED|Safety Follow-Up Period||1
10793952|NCT03614156|11954603|FG003|NOT COMPLETED|Safety Follow-Up Period||1
10793953|NCT03614416|11954612|FG000|STARTED|Overall Study||13
10793954|NCT03614416|11954612|FG000|COMPLETED|Overall Study||13
10793955|NCT03614416|11954612|FG000|NOT COMPLETED|Overall Study||0
10793956|NCT03614975|11954620|FG000|STARTED|Overall Study||85
10793957|NCT03614975|11954621|FG001|STARTED|Overall Study||81
10793958|NCT03614975|11954620|FG000|COMPLETED|Overall Study||75
10793959|NCT03614975|11954621|FG001|COMPLETED|Overall Study||73
10793960|NCT03614975|11954620|FG000|NOT COMPLETED|Overall Study||10
10793961|NCT03614975|11954621|FG001|NOT COMPLETED|Overall Study||8
10793962|NCT03615001|11954627|FG000|STARTED|Overall Study||20
10793963|NCT03615001|11954627|FG000|COMPLETED|Overall Study||20
10793964|NCT03615001|11954627|FG000|NOT COMPLETED|Overall Study||0
10793965|NCT03615079|11954631|FG000|STARTED|Overall Study||28
10793966|NCT03615079|11954631|FG000|COMPLETED|Overall Study||11
10793967|NCT03615079|11954631|FG000|NOT COMPLETED|Overall Study||17
10793968|NCT03615183|11954640|FG000|STARTED|Overall Study||6
10569220|NCT01648101|11724427|FG000|NOT COMPLETED|Titration Phase (4 Weeks)||2
10569221|NCT01648101|11724428|FG001|NOT COMPLETED|Titration Phase (4 Weeks)||3
10793969|NCT03615183|11954641|FG001|STARTED|Overall Study||6
10793970|NCT03615183|11954642|FG002|STARTED|Overall Study||5
10793971|NCT03615183|11954643|FG003|STARTED|Overall Study|Panel D was not conducted as the scientific study objectives were met in the conducted panels.|0
10793972|NCT03615183|11954644|FG004|STARTED|Overall Study|Panel E was not conducted as the scientific study objectives were met in the conducted panels.|0
10793973|NCT03615183|11954640|FG000|COMPLETED|Overall Study||6
10793974|NCT03615183|11954641|FG001|COMPLETED|Overall Study||6
10793975|NCT03615183|11954642|FG002|COMPLETED|Overall Study||5
10793976|NCT03615183|11954643|FG003|COMPLETED|Overall Study||0
10793977|NCT03615183|11954644|FG004|COMPLETED|Overall Study||0
10793978|NCT03615183|11954640|FG000|NOT COMPLETED|Overall Study||0
10793979|NCT03615183|11954641|FG001|NOT COMPLETED|Overall Study||0
10793980|NCT03615183|11954642|FG002|NOT COMPLETED|Overall Study||0
10793981|NCT03615183|11954643|FG003|NOT COMPLETED|Overall Study||0
10569222|NCT01648101|11724429|FG002|NOT COMPLETED|Titration Phase (4 Weeks)||6
10569223|NCT01648101|11724427|FG000|STARTED|Maintenance Phase (12 Weeks)||23
10569224|NCT01648101|11724428|FG001|STARTED|Maintenance Phase (12 Weeks)||23
10569225|NCT01648101|11724429|FG002|STARTED|Maintenance Phase (12 Weeks)||18
10569226|NCT01648101|11724427|FG000|COMPLETED|Maintenance Phase (12 Weeks)||20
10569227|NCT01648101|11724428|FG001|COMPLETED|Maintenance Phase (12 Weeks)||20
10569228|NCT01648101|11724429|FG002|COMPLETED|Maintenance Phase (12 Weeks)||12
10569229|NCT01648101|11724427|FG000|NOT COMPLETED|Maintenance Phase (12 Weeks)||3
10569230|NCT01648101|11724428|FG001|NOT COMPLETED|Maintenance Phase (12 Weeks)||3
10569231|NCT01648101|11724429|FG002|NOT COMPLETED|Maintenance Phase (12 Weeks)||6
10569232|NCT01648101|11724427|FG000|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|17
10569233|NCT01648101|11724428|FG001|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|18
10569234|NCT01648101|11724429|FG002|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|9
10569235|NCT01648101|11724427|FG000|COMPLETED|Transition Phase (4 Weeks)||12
10569236|NCT01648101|11724428|FG001|COMPLETED|Transition Phase (4 Weeks)||13
10569237|NCT01648101|11724429|FG002|COMPLETED|Transition Phase (4 Weeks)||5
10569238|NCT01648101|11724427|FG000|NOT COMPLETED|Transition Phase (4 Weeks)||5
10569239|NCT01648101|11724428|FG001|NOT COMPLETED|Transition Phase (4 Weeks)||5
10569240|NCT01648101|11724429|FG002|NOT COMPLETED|Transition Phase (4 Weeks)||4
10569241|NCT01648101|11724427|FG000|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|1
10569242|NCT01648101|11724428|FG001|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|2
10569243|NCT01648101|11724429|FG002|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|3
10569244|NCT01648101|11724427|FG000|COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
10569245|NCT01648101|11724428|FG001|COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
10793982|NCT03615183|11954644|FG004|NOT COMPLETED|Overall Study||0
10793983|NCT03615404|11954652|FG000|STARTED|Overall Study||11
10793984|NCT03615404|11954652|FG000|COMPLETED|Overall Study||9
10793985|NCT03615404|11954652|FG000|NOT COMPLETED|Overall Study||2
10793994|NCT03615534|11954669|FG000|STARTED|Overall Study||14
10793995|NCT03615534|11954670|FG001|STARTED|Overall Study||15
10793996|NCT03615534|11954671|FG002|STARTED|Overall Study||14
10793997|NCT03615534|11954672|FG003|STARTED|Overall Study||14
10793998|NCT03615534|11954669|FG000|COMPLETED|Overall Study||12
10793999|NCT03615534|11954670|FG001|COMPLETED|Overall Study||15
10794000|NCT03615534|11954671|FG002|COMPLETED|Overall Study||14
10794001|NCT03615534|11954672|FG003|COMPLETED|Overall Study||13
10794002|NCT03615534|11954669|FG000|NOT COMPLETED|Overall Study||2
10794003|NCT03615534|11954670|FG001|NOT COMPLETED|Overall Study||0
10794004|NCT03615534|11954671|FG002|NOT COMPLETED|Overall Study||0
10794005|NCT03615534|11954672|FG003|NOT COMPLETED|Overall Study||1
10794006|NCT03615807|11954684|FG000|STARTED|Overall Study||91
10794007|NCT03615807|11954685|FG001|STARTED|Overall Study||91
10794008|NCT03615807|11954684|FG000|COMPLETED|Overall Study||79
10794009|NCT03615807|11954685|FG001|COMPLETED|Overall Study||80
10794010|NCT03615807|11954684|FG000|NOT COMPLETED|Overall Study||12
10794011|NCT03615807|11954685|FG001|NOT COMPLETED|Overall Study||11
10794012|NCT03615911|11954693|FG000|STARTED|Overall Study||14
10794013|NCT03615911|11954694|FG001|STARTED|Overall Study||12
10794014|NCT03615911|11954693|FG000|Received Late Booster Immunization|Overall Study||3
10794015|NCT03615911|11954694|FG001|Received Late Booster Immunization|Overall Study||7
10794016|NCT03615911|11954693|FG000|COMPLETED|Overall Study|A subgroup received an additional booster of 1x10^8 PFU MVA-MERS-S 12 (+/-4) months after prime.|12
10794017|NCT03615911|11954694|FG001|COMPLETED|Overall Study|A subgroup received an additional booster of 1x10^8 PFU MVA-MERS-S 12 (+/-4) months after prime.|11
10794018|NCT03615911|11954693|FG000|NOT COMPLETED|Overall Study||2
10794019|NCT03615911|11954694|FG001|NOT COMPLETED|Overall Study||1
10794020|NCT03615924|11954704|FG000|STARTED|Overall Study||101
10794021|NCT03615924|11954705|FG001|STARTED|Overall Study||92
10794022|NCT03615924|11954704|FG000|Received Treatment|Overall Study||101
10794023|NCT03615924|11954705|FG001|Received Treatment|Overall Study||92
10794024|NCT03615924|11954704|FG000|COMPLETED|Overall Study||0
10794025|NCT03615924|11954705|FG001|COMPLETED|Overall Study||0
10794026|NCT03615924|11954704|FG000|NOT COMPLETED|Overall Study||101
10794027|NCT03615924|11954705|FG001|NOT COMPLETED|Overall Study||92
10794028|NCT03616106|11954713|FG000|STARTED|Overall Study||56
10794029|NCT03616106|11954714|FG001|STARTED|Overall Study||3
10794030|NCT03616106|11954713|FG000|COMPLETED|Overall Study||42
10794031|NCT03616106|11954714|FG001|COMPLETED|Overall Study||2
10794032|NCT03616106|11954713|FG000|NOT COMPLETED|Overall Study||14
10794033|NCT03616106|11954714|FG001|NOT COMPLETED|Overall Study||1
10794034|NCT03616171|11954721|FG000|STARTED|Overall Study||4
10794035|NCT03616171|11954722|FG001|STARTED|Overall Study||2
10794036|NCT03616171|11954721|FG000|COMPLETED|Overall Study||4
10794037|NCT03616171|11954722|FG001|COMPLETED|Overall Study||2
10569246|NCT01648101|11724429|FG002|COMPLETED|Taper/Follow-up Phase (4 Weeks)||3
10569247|NCT01648101|11724427|FG000|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||0
10794038|NCT03616171|11954721|FG000|NOT COMPLETED|Overall Study||0
10794039|NCT03616171|11954722|FG001|NOT COMPLETED|Overall Study||0
10794040|NCT03616600|11954731|FG000|STARTED|Overall Study||16
10794041|NCT03616600|11954732|FG001|STARTED|Overall Study||15
10794042|NCT03616600|11954731|FG000|COMPLETED|Overall Study||15
10794043|NCT03616600|11954732|FG001|COMPLETED|Overall Study||15
10569248|NCT01648101|11724428|FG001|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
10569249|NCT01648101|11724429|FG002|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||0
10569250|NCT01648140|11724445|FG000|STARTED|Overall Study||41
10794044|NCT03616600|11954731|FG000|NOT COMPLETED|Overall Study||1
10794045|NCT03616600|11954732|FG001|NOT COMPLETED|Overall Study||0
10794046|NCT03616899|11954741|FG000|STARTED|Overall Study||447
10569251|NCT01648140|11724446|FG001|STARTED|Overall Study||40
10569252|NCT01648140|11724447|FG002|STARTED|Overall Study||17
10569253|NCT01648140|11724448|FG003|STARTED|Overall Study||13
10569254|NCT01648140|11724445|FG000|COMPLETED|Overall Study||29
10569255|NCT01648140|11724446|FG001|COMPLETED|Overall Study||28
10569256|NCT01648140|11724447|FG002|COMPLETED|Overall Study||9
10794047|NCT03616899|11954742|FG001|STARTED|Overall Study||454
10794048|NCT03616899|11954741|FG000|COMPLETED|Overall Study||437
10794049|NCT03616899|11954742|FG001|COMPLETED|Overall Study||453
10794050|NCT03616899|11954741|FG000|NOT COMPLETED|Overall Study||10
10794051|NCT03616899|11954742|FG001|NOT COMPLETED|Overall Study||1
10794052|NCT03616977|11954748|FG000|STARTED|Period 1||34
10794053|NCT03616977|11954749|FG001|STARTED|Period 1||35
10794054|NCT03616977|11954748|FG000|Received at Least One Dose of Study Drug|Period 1||34
10794055|NCT03616977|11954749|FG001|Received at Least One Dose of Study Drug|Period 1||34
10794056|NCT03616977|11954748|FG000|COMPLETED|Period 1||34
10794057|NCT03616977|11954749|FG001|COMPLETED|Period 1||34
10794058|NCT03616977|11954748|FG000|NOT COMPLETED|Period 1||0
10794059|NCT03616977|11954749|FG001|NOT COMPLETED|Period 1||1
10794060|NCT03616977|11954748|FG000|STARTED|Period 2||34
10794061|NCT03616977|11954749|FG001|STARTED|Period 2||34
10794062|NCT03616977|11954748|FG000|COMPLETED|Period 2||34
10794063|NCT03616977|11954749|FG001|COMPLETED|Period 2||34
10794064|NCT03616977|11954748|FG000|NOT COMPLETED|Period 2||0
10794065|NCT03616977|11954749|FG001|NOT COMPLETED|Period 2||0
10794066|NCT03616977|11954748|FG000|STARTED|Period 3||34
10794067|NCT03616977|11954749|FG001|STARTED|Period 3|Participant completed Period 2 and withdrew from the study.|33
10794068|NCT03616977|11954748|FG000|Received Study Drug|Period 3|Participant not dosed due to adverse event.|33
10794069|NCT03616977|11954749|FG001|Received Study Drug|Period 3|Participant not dosed due to adverse event.|32
10794070|NCT03616977|11954748|FG000|COMPLETED|Period 3||33
10794071|NCT03616977|11954749|FG001|COMPLETED|Period 3||32
10794072|NCT03616977|11954748|FG000|NOT COMPLETED|Period 3||1
10794073|NCT03616977|11954749|FG001|NOT COMPLETED|Period 3||1
10794074|NCT03616977|11954748|FG000|STARTED|Period 4||33
10794075|NCT03616977|11954749|FG001|STARTED|Period 4||32
10794076|NCT03616977|11954748|FG000|COMPLETED|Period 4||33
10794077|NCT03616977|11954749|FG001|COMPLETED|Period 4||32
10794078|NCT03616977|11954748|FG000|NOT COMPLETED|Period 4||0
10794079|NCT03616977|11954749|FG001|NOT COMPLETED|Period 4||0
10569257|NCT01648140|11724448|FG003|COMPLETED|Overall Study||11
10569258|NCT01648140|11724445|FG000|NOT COMPLETED|Overall Study||12
10569259|NCT01648140|11724446|FG001|NOT COMPLETED|Overall Study||12
10794080|NCT03617419|11954756|FG000|STARTED|Part 1||2
10794081|NCT03617419|11954756|FG000|COMPLETED|Part 1||2
10794082|NCT03617419|11954756|FG000|NOT COMPLETED|Part 1||0
10794083|NCT03617419|11954756|FG000|STARTED|Part 2||14
10794084|NCT03617419|11954756|FG000|COMPLETED|Part 2||14
10794085|NCT03617419|11954756|FG000|NOT COMPLETED|Part 2||0
10794086|NCT03617588|11954762|FG000|STARTED|Overall Study||20
10794087|NCT03617588|11954763|FG001|STARTED|Overall Study||29
10794088|NCT03617588|11954762|FG000|COMPLETED|Overall Study||19
10794089|NCT03617588|11954763|FG001|COMPLETED|Overall Study||29
10794090|NCT03617588|11954762|FG000|NOT COMPLETED|Overall Study||1
10794091|NCT03617588|11954763|FG001|NOT COMPLETED|Overall Study||0
10794092|NCT03617770|11954775|FG000|STARTED|Overall Study|9|9
10794093|NCT03617770|11954776|FG001|STARTED|Overall Study|5|5
10569260|NCT01648140|11724447|FG002|NOT COMPLETED|Overall Study||8
10794094|NCT03617770|11954775|FG000|COMPLETED|Overall Study|8|8
10794095|NCT03617770|11954776|FG001|COMPLETED|Overall Study||5
10794096|NCT03617770|11954775|FG000|NOT COMPLETED|Overall Study||1
10794097|NCT03617770|11954776|FG001|NOT COMPLETED|Overall Study||0
10794098|NCT03617861|11954784|FG000|STARTED|First Intervention (1 Day)||5
10794099|NCT03617861|11954785|FG001|STARTED|First Intervention (1 Day)||5
10794100|NCT03617861|11954786|FG002|STARTED|First Intervention (1 Day)||5
10794101|NCT03617861|11954787|FG003|STARTED|First Intervention (1 Day)||5
10794102|NCT03617861|11954784|FG000|COMPLETED|First Intervention (1 Day)||5
10794103|NCT03617861|11954785|FG001|COMPLETED|First Intervention (1 Day)||5
10569261|NCT01648140|11724448|FG003|NOT COMPLETED|Overall Study||2
10569262|NCT01648166|11724469|FG000|STARTED|Overall Study||153
10794104|NCT03617861|11954786|FG002|COMPLETED|First Intervention (1 Day)||5
10794105|NCT03617861|11954787|FG003|COMPLETED|First Intervention (1 Day)||5
10794106|NCT03617861|11954784|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10794107|NCT03617861|11954785|FG001|NOT COMPLETED|First Intervention (1 Day)||0
10794108|NCT03617861|11954786|FG002|NOT COMPLETED|First Intervention (1 Day)||0
10794109|NCT03617861|11954787|FG003|NOT COMPLETED|First Intervention (1 Day)||0
10794110|NCT03617861|11954784|FG000|STARTED|Washout (1 to 4 Weeks)||5
10569263|NCT01648166|11724470|FG001|STARTED|Overall Study||367
10569264|NCT01648166|11724469|FG000|COMPLETED|Overall Study||100
10569265|NCT01648166|11724470|FG001|COMPLETED|Overall Study||267
10569266|NCT01648166|11724469|FG000|NOT COMPLETED|Overall Study||53
10569267|NCT01648166|11724470|FG001|NOT COMPLETED|Overall Study||100
10569268|NCT01648283|11724476|FG000|STARTED|Overall Study||78
10569269|NCT01648283|11724476|FG000|COMPLETED|Overall Study||64
10569270|NCT01648283|11724476|FG000|NOT COMPLETED|Overall Study||14
10569271|NCT01648322|11724486|FG000|STARTED|Overall Study||35
10569272|NCT01648322|11724487|FG001|STARTED|Overall Study||67
10569273|NCT01648322|11724488|FG002|STARTED|Overall Study||65
10569274|NCT01648322|11724489|FG003|STARTED|Overall Study||65
10569275|NCT01648322|11724486|FG000|COMPLETED|Overall Study||33
10569276|NCT01648322|11724487|FG001|COMPLETED|Overall Study||62
10569277|NCT01648322|11724488|FG002|COMPLETED|Overall Study||60
10569278|NCT01648322|11724489|FG003|COMPLETED|Overall Study||61
10569279|NCT01648322|11724486|FG000|NOT COMPLETED|Overall Study||2
10569280|NCT01648322|11724487|FG001|NOT COMPLETED|Overall Study||5
10569281|NCT01648322|11724488|FG002|NOT COMPLETED|Overall Study||5
10569282|NCT01648322|11724489|FG003|NOT COMPLETED|Overall Study||4
10569283|NCT01648348|11724518|FG000|STARTED|Overall Study||5
10569284|NCT01648348|11724519|FG001|STARTED|Overall Study||3
10569285|NCT01648348|11724520|FG002|STARTED|Overall Study||4
10569286|NCT01648348|11724521|FG003|STARTED|Overall Study||3
10569287|NCT01648348|11724522|FG004|STARTED|Overall Study||52
10569288|NCT01648348|11724523|FG005|STARTED|Overall Study||49
10569289|NCT01648348|11724518|FG000|COMPLETED|Overall Study||3
10569290|NCT01648348|11724519|FG001|COMPLETED|Overall Study||3
10569291|NCT01648348|11724520|FG002|COMPLETED|Overall Study||3
10569292|NCT01648348|11724521|FG003|COMPLETED|Overall Study||3
10569293|NCT01648348|11724522|FG004|COMPLETED|Overall Study||49
10569294|NCT01648348|11724523|FG005|COMPLETED|Overall Study||43
10569295|NCT01648348|11724518|FG000|NOT COMPLETED|Overall Study||2
10569296|NCT01648348|11724519|FG001|NOT COMPLETED|Overall Study||0
10569297|NCT01648348|11724520|FG002|NOT COMPLETED|Overall Study||1
10569298|NCT01648348|11724521|FG003|NOT COMPLETED|Overall Study||0
10569299|NCT01648348|11724522|FG004|NOT COMPLETED|Overall Study||3
10569300|NCT01648348|11724523|FG005|NOT COMPLETED|Overall Study||6
10569301|NCT01648452|11724536|FG000|STARTED|Overall Study||5
10569302|NCT01648452|11724536|FG000|COMPLETED|Overall Study|One participant was explanted due to an adverse event. Remainder kept implant at study completion.|5
10569303|NCT01648452|11724536|FG000|NOT COMPLETED|Overall Study||0
10569304|NCT01648491|11724542|FG000|STARTED|Overall Study||1
10569305|NCT01648491|11724542|FG000|COMPLETED|Overall Study||1
10569306|NCT01648491|11724542|FG000|NOT COMPLETED|Overall Study||0
10569307|NCT01648530|11724547|FG000|STARTED|Overall Study||16789
10569308|NCT01648530|11724547|FG000|COMPLETED|Overall Study||5915
10569309|NCT01648530|11724547|FG000|NOT COMPLETED|Overall Study||10874
10569310|NCT01648582|11724556|FG000|STARTED|Overall Study||258
10569311|NCT01648582|11724557|FG001|STARTED|Overall Study||257
10569312|NCT01648582|11724558|FG002|STARTED|Overall Study||259
10569313|NCT01648582|11724556|FG000|Received at Least One Dose of Study Drug|Overall Study||258
10569314|NCT01648582|11724557|FG001|Received at Least One Dose of Study Drug|Overall Study||257
10569315|NCT01648582|11724558|FG002|Received at Least One Dose of Study Drug|Overall Study||259
10569316|NCT01648582|11724556|FG000|Modified Intent-to-Treat Population|Overall Study||253
10569317|NCT01648582|11724557|FG001|Modified Intent-to-Treat Population|Overall Study||252
10569318|NCT01648582|11724558|FG002|Modified Intent-to-Treat Population|Overall Study||250
10569319|NCT01648582|11724556|FG000|COMPLETED|Overall Study||226
10569320|NCT01648582|11724557|FG001|COMPLETED|Overall Study||219
10569321|NCT01648582|11724558|FG002|COMPLETED|Overall Study||227
10569322|NCT01648582|11724556|FG000|NOT COMPLETED|Overall Study||32
10569323|NCT01648582|11724557|FG001|NOT COMPLETED|Overall Study||38
10569324|NCT01648582|11724558|FG002|NOT COMPLETED|Overall Study||32
10569325|NCT01648699|11724569|FG000|STARTED|Overall Study||20
10569326|NCT01648699|11724569|FG000|COMPLETED|Overall Study||15
10569327|NCT01648699|11724569|FG000|NOT COMPLETED|Overall Study||5
10569328|NCT01648764|11724596|FG000|STARTED|Overall Study||3
10569329|NCT01648764|11724597|FG001|STARTED|Overall Study||3
10569330|NCT01648764|11724598|FG002|STARTED|Overall Study||3
10569331|NCT01648764|11724599|FG003|STARTED|Overall Study||3
10569332|NCT01648764|11724600|FG004|STARTED|Overall Study||3
10569333|NCT01648764|11724601|FG005|STARTED|Overall Study||5
10569334|NCT01648764|11724602|FG006|STARTED|Overall Study||9
10569335|NCT01648764|11724603|FG007|STARTED|Overall Study||3
10569336|NCT01648764|11724604|FG008|STARTED|Overall Study||3
10569337|NCT01648764|11724605|FG009|STARTED|Overall Study||7
10569338|NCT01648764|11724606|FG010|STARTED|Overall Study||3
10569339|NCT01648764|11724607|FG011|STARTED|Overall Study||9
10569340|NCT01648764|11724608|FG012|STARTED|Overall Study||7
10569341|NCT01648764|11724609|FG013|STARTED|Overall Study||12
10569342|NCT01648764|11724596|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
10569343|NCT01648764|11724597|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
10569344|NCT01648764|11724598|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
10569345|NCT01648764|11724599|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
10569346|NCT01648764|11724600|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3
10569347|NCT01648764|11724601|FG005|Received at Least 1 Dose of Study Drug|Overall Study||5
10569348|NCT01648764|11724602|FG006|Received at Least 1 Dose of Study Drug|Overall Study||9
10569349|NCT01648764|11724603|FG007|Received at Least 1 Dose of Study Drug|Overall Study||3
10569350|NCT01648764|11724604|FG008|Received at Least 1 Dose of Study Drug|Overall Study||3
10569351|NCT01648764|11724605|FG009|Received at Least 1 Dose of Study Drug|Overall Study||7
10569352|NCT01648764|11724606|FG010|Received at Least 1 Dose of Study Drug|Overall Study||3
10569353|NCT01648764|11724607|FG011|Received at Least 1 Dose of Study Drug|Overall Study||9
10569354|NCT01648764|11724608|FG012|Received at Least 1 Dose of Study Drug|Overall Study||7
10569355|NCT01648764|11724609|FG013|Received at Least 1 Dose of Study Drug|Overall Study||12
10569356|NCT01648764|11724596|FG000|COMPLETED|Overall Study||3
10569357|NCT01648764|11724597|FG001|COMPLETED|Overall Study||2
10569358|NCT01648764|11724598|FG002|COMPLETED|Overall Study||3
10569359|NCT01648764|11724599|FG003|COMPLETED|Overall Study||3
10569360|NCT01648764|11724600|FG004|COMPLETED|Overall Study||3
10569361|NCT01648764|11724601|FG005|COMPLETED|Overall Study||3
10569362|NCT01648764|11724602|FG006|COMPLETED|Overall Study||4
10569363|NCT01648764|11724603|FG007|COMPLETED|Overall Study||3
10569364|NCT01648764|11724604|FG008|COMPLETED|Overall Study||3
10569365|NCT01648764|11724605|FG009|COMPLETED|Overall Study||4
10569366|NCT01648764|11724606|FG010|COMPLETED|Overall Study||3
10569367|NCT01648764|11724607|FG011|COMPLETED|Overall Study||4
10569368|NCT01648764|11724608|FG012|COMPLETED|Overall Study||3
10569369|NCT01648764|11724609|FG013|COMPLETED|Overall Study||9
10569370|NCT01648764|11724596|FG000|NOT COMPLETED|Overall Study||0
10569371|NCT01648764|11724597|FG001|NOT COMPLETED|Overall Study||1
10569372|NCT01648764|11724598|FG002|NOT COMPLETED|Overall Study||0
10569373|NCT01648764|11724599|FG003|NOT COMPLETED|Overall Study||0
10569374|NCT01648764|11724600|FG004|NOT COMPLETED|Overall Study||0
10569375|NCT01648764|11724601|FG005|NOT COMPLETED|Overall Study||2
10569376|NCT01648764|11724602|FG006|NOT COMPLETED|Overall Study||5
10569377|NCT01648764|11724603|FG007|NOT COMPLETED|Overall Study||0
10569378|NCT01648764|11724604|FG008|NOT COMPLETED|Overall Study||0
10569379|NCT01648764|11724605|FG009|NOT COMPLETED|Overall Study||3
10569380|NCT01648764|11724606|FG010|NOT COMPLETED|Overall Study||0
10569381|NCT01648764|11724607|FG011|NOT COMPLETED|Overall Study||5
10569382|NCT01648764|11724608|FG012|NOT COMPLETED|Overall Study||4
10569383|NCT01648764|11724609|FG013|NOT COMPLETED|Overall Study||3
10569384|NCT01648790|11724643|FG000|STARTED|Treatment 1||4
10569385|NCT01648790|11724644|FG001|STARTED|Treatment 1||4
10569386|NCT01648790|11724645|FG002|STARTED|Treatment 1||4
10569387|NCT01648790|11724646|FG003|STARTED|Treatment 1||4
10569388|NCT01648790|11724647|FG004|STARTED|Treatment 1||4
10569389|NCT01648790|11724643|FG000|Received at Least 1 Dose of Study Drug|Treatment 1||4
10569390|NCT01648790|11724644|FG001|Received at Least 1 Dose of Study Drug|Treatment 1||4
10569391|NCT01648790|11724645|FG002|Received at Least 1 Dose of Study Drug|Treatment 1||4
10569392|NCT01648790|11724646|FG003|Received at Least 1 Dose of Study Drug|Treatment 1||4
10569393|NCT01648790|11724647|FG004|Received at Least 1 Dose of Study Drug|Treatment 1||4
10569394|NCT01648790|11724643|FG000|COMPLETED|Treatment 1||4
10569395|NCT01648790|11724644|FG001|COMPLETED|Treatment 1||4
10569396|NCT01648790|11724645|FG002|COMPLETED|Treatment 1||4
10569397|NCT01648790|11724646|FG003|COMPLETED|Treatment 1||4
10569398|NCT01648790|11724647|FG004|COMPLETED|Treatment 1||4
10569399|NCT01648790|11724643|FG000|NOT COMPLETED|Treatment 1||0
10569400|NCT01648790|11724644|FG001|NOT COMPLETED|Treatment 1||0
10569401|NCT01648790|11724645|FG002|NOT COMPLETED|Treatment 1||0
10569402|NCT01648790|11724646|FG003|NOT COMPLETED|Treatment 1||0
10569403|NCT01648790|11724647|FG004|NOT COMPLETED|Treatment 1||0
10569404|NCT01648790|11724643|FG000|STARTED|Treatment 2||4
10569405|NCT01648790|11724644|FG001|STARTED|Treatment 2||4
10569406|NCT01648790|11724645|FG002|STARTED|Treatment 2||4
10569407|NCT01648790|11724646|FG003|STARTED|Treatment 2||4
10569408|NCT01648790|11724647|FG004|STARTED|Treatment 2||4
10569409|NCT01648790|11724643|FG000|COMPLETED|Treatment 2||4
10569410|NCT01648790|11724644|FG001|COMPLETED|Treatment 2||4
10569411|NCT01648790|11724645|FG002|COMPLETED|Treatment 2||4
10569412|NCT01648790|11724646|FG003|COMPLETED|Treatment 2||4
10569413|NCT01648790|11724647|FG004|COMPLETED|Treatment 2||4
10569414|NCT01648790|11724643|FG000|NOT COMPLETED|Treatment 2||0
10569415|NCT01648790|11724644|FG001|NOT COMPLETED|Treatment 2||0
10569416|NCT01648790|11724645|FG002|NOT COMPLETED|Treatment 2||0
10569417|NCT01648790|11724646|FG003|NOT COMPLETED|Treatment 2||0
10569418|NCT01648790|11724647|FG004|NOT COMPLETED|Treatment 2||0
10569419|NCT01648790|11724643|FG000|STARTED|Treatment 3||4
10569420|NCT01648790|11724644|FG001|STARTED|Treatment 3||4
10569421|NCT01648790|11724645|FG002|STARTED|Treatment 3||4
10569422|NCT01648790|11724646|FG003|STARTED|Treatment 3|Withdrew consent prior to dosing on this treatment day.|4
10569423|NCT01648790|11724647|FG004|STARTED|Treatment 3||4
10569424|NCT01648790|11724643|FG000|COMPLETED|Treatment 3||4
10569425|NCT01648790|11724644|FG001|COMPLETED|Treatment 3||4
10569426|NCT01648790|11724645|FG002|COMPLETED|Treatment 3||4
10569427|NCT01648790|11724646|FG003|COMPLETED|Treatment 3||3
10569428|NCT01648790|11724647|FG004|COMPLETED|Treatment 3||4
10569429|NCT01648790|11724643|FG000|NOT COMPLETED|Treatment 3||0
10569430|NCT01648790|11724644|FG001|NOT COMPLETED|Treatment 3||0
10569431|NCT01648790|11724645|FG002|NOT COMPLETED|Treatment 3||0
10569432|NCT01648790|11724646|FG003|NOT COMPLETED|Treatment 3||1
10569433|NCT01648790|11724647|FG004|NOT COMPLETED|Treatment 3||0
10569434|NCT01648790|11724643|FG000|STARTED|Treatment 4||4
10569435|NCT01648790|11724644|FG001|STARTED|Treatment 4||4
10569436|NCT01648790|11724645|FG002|STARTED|Treatment 4||4
10569437|NCT01648790|11724646|FG003|STARTED|Treatment 4||3
10569438|NCT01648790|11724647|FG004|STARTED|Treatment 4||4
10569439|NCT01648790|11724643|FG000|COMPLETED|Treatment 4||4
10569440|NCT01648790|11724644|FG001|COMPLETED|Treatment 4||4
10569441|NCT01648790|11724645|FG002|COMPLETED|Treatment 4||4
10569442|NCT01648790|11724646|FG003|COMPLETED|Treatment 4||3
10569443|NCT01648790|11724647|FG004|COMPLETED|Treatment 4||4
10569444|NCT01648790|11724643|FG000|NOT COMPLETED|Treatment 4||0
10569445|NCT01648790|11724644|FG001|NOT COMPLETED|Treatment 4||0
10569446|NCT01648790|11724645|FG002|NOT COMPLETED|Treatment 4||0
10569447|NCT01648790|11724646|FG003|NOT COMPLETED|Treatment 4||0
10569448|NCT01648790|11724647|FG004|NOT COMPLETED|Treatment 4||0
10569449|NCT01648790|11724643|FG000|STARTED|Treatment 5||4
10569450|NCT01648790|11724644|FG001|STARTED|Treatment 5||4
10569451|NCT01648790|11724645|FG002|STARTED|Treatment 5||4
10569452|NCT01648790|11724646|FG003|STARTED|Treatment 5||3
10569453|NCT01648790|11724647|FG004|STARTED|Treatment 5||4
10569454|NCT01648790|11724643|FG000|COMPLETED|Treatment 5||4
10569455|NCT01648790|11724644|FG001|COMPLETED|Treatment 5||4
10569456|NCT01648790|11724645|FG002|COMPLETED|Treatment 5||4
10569457|NCT01648790|11724646|FG003|COMPLETED|Treatment 5||3
10569458|NCT01648790|11724647|FG004|COMPLETED|Treatment 5||4
10569459|NCT01648790|11724643|FG000|NOT COMPLETED|Treatment 5||0
10569460|NCT01648790|11724644|FG001|NOT COMPLETED|Treatment 5||0
10569461|NCT01648790|11724645|FG002|NOT COMPLETED|Treatment 5||0
10569462|NCT01648790|11724646|FG003|NOT COMPLETED|Treatment 5||0
10569463|NCT01648790|11724647|FG004|NOT COMPLETED|Treatment 5||0
10569464|NCT01648920|11724659|FG000|STARTED|Overall Study||50
10569465|NCT01648920|11724659|FG000|COMPLETED|Overall Study||50
10569466|NCT01648920|11724659|FG000|NOT COMPLETED|Overall Study||0
10569467|NCT01648959|11724663|FG000|STARTED|Overall Study||5
10569468|NCT01648959|11724663|FG000|COMPLETED|Overall Study||5
10569469|NCT01648959|11724663|FG000|NOT COMPLETED|Overall Study||0
10569470|NCT01649180|11724667|FG000|STARTED|Overall Study||3
10569471|NCT01649180|11724667|FG000|COMPLETED|Overall Study||3
10569472|NCT01649180|11724667|FG000|NOT COMPLETED|Overall Study||0
10569473|NCT01649232|11724673|FG000|STARTED|Overall Study||30
10569474|NCT01649232|11724674|FG001|STARTED|Overall Study||30
10569475|NCT01649232|11724673|FG000|COMPLETED|Overall Study|technical problems or excessive artifacts, two data sets were excluded from further analysis.|28
10569476|NCT01649232|11724674|FG001|COMPLETED|Overall Study||30
10569477|NCT01649232|11724673|FG000|NOT COMPLETED|Overall Study||2
10569478|NCT01649232|11724674|FG001|NOT COMPLETED|Overall Study||0
10569479|NCT01649271|11724688|FG000|STARTED|Overall Study||6
10569480|NCT01649271|11724689|FG001|STARTED|Overall Study||7
10569481|NCT01649271|11724688|FG000|COMPLETED|Overall Study||0
10569482|NCT01649271|11724689|FG001|COMPLETED|Overall Study||0
10569483|NCT01649271|11724688|FG000|NOT COMPLETED|Overall Study||6
10569484|NCT01649271|11724689|FG001|NOT COMPLETED|Overall Study||7
10569485|NCT01649297|11724701|FG000|STARTED|Overall Study|randomised|219
10569486|NCT01649297|11724702|FG001|STARTED|Overall Study|randomised|218
10569487|NCT01649297|11724703|FG002|STARTED|Overall Study|randomised|219
10569488|NCT01649297|11724704|FG003|STARTED|Overall Study|randomised|220
10569489|NCT01649297|11724705|FG004|STARTED|Overall Study|randomised|107
10569490|NCT01649297|11724701|FG000|COMPLETED|Overall Study||205
10569491|NCT01649297|11724702|FG001|COMPLETED|Overall Study||205
10569492|NCT01649297|11724703|FG002|COMPLETED|Overall Study||202
10569493|NCT01649297|11724704|FG003|COMPLETED|Overall Study||201
10569494|NCT01649297|11724705|FG004|COMPLETED|Overall Study||103
10569495|NCT01649297|11724701|FG000|NOT COMPLETED|Overall Study||14
10569496|NCT01649297|11724702|FG001|NOT COMPLETED|Overall Study||13
10569497|NCT01649297|11724703|FG002|NOT COMPLETED|Overall Study||17
10569498|NCT01649297|11724704|FG003|NOT COMPLETED|Overall Study||19
10569499|NCT01649297|11724705|FG004|NOT COMPLETED|Overall Study||4
10569500|NCT01649362|11724719|FG000|STARTED|Overall Study||47
10569501|NCT01649362|11724720|FG001|STARTED|Overall Study||54
10569502|NCT01649362|11724719|FG000|COMPLETED|Overall Study||46
10569503|NCT01649362|11724720|FG001|COMPLETED|Overall Study||40
10569504|NCT01649362|11724719|FG000|NOT COMPLETED|Overall Study||1
10569505|NCT01649362|11724720|FG001|NOT COMPLETED|Overall Study||14
10569506|NCT01649375|11724729|FG000|STARTED|Up to Week 16||73
10569507|NCT01649375|11724730|FG001|STARTED|Up to Week 16||72
10569508|NCT01649375|11724731|FG002|STARTED|Up to Week 16||74
10569509|NCT01649375|11724732|FG003|STARTED|Up to Week 16||0
10569510|NCT01649375|11724733|FG004|STARTED|Up to Week 16||0
10569511|NCT01649375|11724729|FG000|COMPLETED|Up to Week 16||68
10569512|NCT01649375|11724730|FG001|COMPLETED|Up to Week 16||66
10569513|NCT01649375|11724731|FG002|COMPLETED|Up to Week 16||66
10569514|NCT01649375|11724732|FG003|COMPLETED|Up to Week 16||0
10569515|NCT01649375|11724733|FG004|COMPLETED|Up to Week 16||0
10569516|NCT01649375|11724729|FG000|NOT COMPLETED|Up to Week 16||5
10569517|NCT01649375|11724730|FG001|NOT COMPLETED|Up to Week 16||6
10569518|NCT01649375|11724731|FG002|NOT COMPLETED|Up to Week 16||8
10569519|NCT01649375|11724732|FG003|NOT COMPLETED|Up to Week 16||0
10569520|NCT01649375|11724733|FG004|NOT COMPLETED|Up to Week 16||0
10569521|NCT01649375|11724729|FG000|STARTED|Week 16 up to Week 260||68
10569522|NCT01649375|11724730|FG001|STARTED|Week 16 up to Week 260||66
10569523|NCT01649375|11724731|FG002|STARTED|Week 16 up to Week 260||0
10569524|NCT01649375|11724732|FG003|STARTED|Week 16 up to Week 260||32
10569525|NCT01649375|11724733|FG004|STARTED|Week 16 up to Week 260||34
10569526|NCT01649375|11724729|FG000|COMPLETED|Week 16 up to Week 260||48
10569527|NCT01649375|11724730|FG001|COMPLETED|Week 16 up to Week 260||53
10569528|NCT01649375|11724731|FG002|COMPLETED|Week 16 up to Week 260||0
10569529|NCT01649375|11724732|FG003|COMPLETED|Week 16 up to Week 260||20
10569530|NCT01649375|11724733|FG004|COMPLETED|Week 16 up to Week 260||29
10569531|NCT01649375|11724729|FG000|NOT COMPLETED|Week 16 up to Week 260||20
10569532|NCT01649375|11724730|FG001|NOT COMPLETED|Week 16 up to Week 260||13
10569533|NCT01649375|11724731|FG002|NOT COMPLETED|Week 16 up to Week 260||0
10569534|NCT01649375|11724732|FG003|NOT COMPLETED|Week 16 up to Week 260||12
10569535|NCT01649375|11724733|FG004|NOT COMPLETED|Week 16 up to Week 260||5
10569536|NCT01649427|11724743|FG000|STARTED|Overall Study||35
10569537|NCT01649427|11724744|FG001|STARTED|Overall Study||38
10569538|NCT01649427|11724743|FG000|COMPLETED|Overall Study||24
10569539|NCT01649427|11724744|FG001|COMPLETED|Overall Study||26
10569540|NCT01649427|11724743|FG000|NOT COMPLETED|Overall Study||11
10569541|NCT01649427|11724744|FG001|NOT COMPLETED|Overall Study||12
10569542|NCT01649557|11724753|FG000|STARTED|Overall Study||179
10569543|NCT01649557|11724754|FG001|STARTED|Overall Study||41
10569544|NCT01649557|11724755|FG002|STARTED|Overall Study||24
10569545|NCT01649557|11724753|FG000|6-week Enrollers|Overall Study||159
10569546|NCT01649557|11724754|FG001|6-week Enrollers|Overall Study||35
10569547|NCT01649557|11724755|FG002|6-week Enrollers|Overall Study||22
10569548|NCT01649557|11724753|FG000|52-week Enrollers|Overall Study||20
10569549|NCT01649557|11724754|FG001|52-week Enrollers|Overall Study||6
10569550|NCT01649557|11724755|FG002|52-week Enrollers|Overall Study||2
10569551|NCT01649557|11724753|FG000|COMPLETED|Overall Study||135
10569552|NCT01649557|11724754|FG001|COMPLETED|Overall Study||27
10569553|NCT01649557|11724755|FG002|COMPLETED|Overall Study||15
10569554|NCT01649557|11724753|FG000|NOT COMPLETED|Overall Study||44
10569555|NCT01649557|11724754|FG001|NOT COMPLETED|Overall Study||14
10569556|NCT01649557|11724755|FG002|NOT COMPLETED|Overall Study||9
10569557|NCT01649596|11724765|FG000|STARTED|Overall Study||46
10569558|NCT01649596|11724766|FG001|STARTED|Overall Study||48
10569559|NCT01649596|11724765|FG000|COMPLETED|Overall Study||46
10569560|NCT01649596|11724766|FG001|COMPLETED|Overall Study||48
10569561|NCT01649596|11724765|FG000|NOT COMPLETED|Overall Study||0
10569562|NCT01649596|11724766|FG001|NOT COMPLETED|Overall Study||0
10794111|NCT03617861|11954785|FG001|STARTED|Washout (1 to 4 Weeks)||5
10794112|NCT03617861|11954786|FG002|STARTED|Washout (1 to 4 Weeks)||5
10794113|NCT03617861|11954787|FG003|STARTED|Washout (1 to 4 Weeks)||5
10794114|NCT03617861|11954784|FG000|COMPLETED|Washout (1 to 4 Weeks)||5
10794115|NCT03617861|11954785|FG001|COMPLETED|Washout (1 to 4 Weeks)||5
10794116|NCT03617861|11954786|FG002|COMPLETED|Washout (1 to 4 Weeks)||5
10794117|NCT03617861|11954787|FG003|COMPLETED|Washout (1 to 4 Weeks)||5
10794118|NCT03617861|11954784|FG000|NOT COMPLETED|Washout (1 to 4 Weeks)||0
10794119|NCT03617861|11954785|FG001|NOT COMPLETED|Washout (1 to 4 Weeks)||0
10794120|NCT03617861|11954786|FG002|NOT COMPLETED|Washout (1 to 4 Weeks)||0
10794121|NCT03617861|11954787|FG003|NOT COMPLETED|Washout (1 to 4 Weeks)||0
10794122|NCT03617861|11954784|FG000|STARTED|Second Intervention (1 Day)||5
10794123|NCT03617861|11954785|FG001|STARTED|Second Intervention (1 Day)||5
10794124|NCT03617861|11954786|FG002|STARTED|Second Intervention (1 Day)||5
10794125|NCT03617861|11954787|FG003|STARTED|Second Intervention (1 Day)||5
10794126|NCT03617861|11954784|FG000|COMPLETED|Second Intervention (1 Day)||5
10794127|NCT03617861|11954785|FG001|COMPLETED|Second Intervention (1 Day)||5
10794128|NCT03617861|11954786|FG002|COMPLETED|Second Intervention (1 Day)||4
10794129|NCT03617861|11954787|FG003|COMPLETED|Second Intervention (1 Day)||5
10794130|NCT03617861|11954784|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10794131|NCT03617861|11954785|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10794132|NCT03617861|11954786|FG002|NOT COMPLETED|Second Intervention (1 Day)||1
10794133|NCT03617861|11954787|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
10794134|NCT03617913|11954797|FG000|STARTED|Overall Study||2
10794135|NCT03617913|11954797|FG000|COMPLETED|Overall Study||2
10794136|NCT03617913|11954797|FG000|NOT COMPLETED|Overall Study||0
10794137|NCT03618017|11954803|FG000|STARTED|Overall Study||33
10794138|NCT03618017|11954804|FG001|STARTED|Overall Study||33
10794139|NCT03618017|11954803|FG000|COMPLETED|Overall Study||26
10794140|NCT03618017|11954804|FG001|COMPLETED|Overall Study||28
10794141|NCT03618017|11954803|FG000|NOT COMPLETED|Overall Study||7
10794142|NCT03618017|11954804|FG001|NOT COMPLETED|Overall Study||5
10794143|NCT03618030|11954814|FG000|STARTED|Overall Study||15
10794144|NCT03618030|11954815|FG001|STARTED|Overall Study||14
10794145|NCT03618030|11954816|FG002|STARTED|Overall Study||21
10794146|NCT03618030|11954817|FG003|STARTED|Overall Study||39
10794147|NCT03618030|11954818|FG004|STARTED|Overall Study||36
10794148|NCT03618030|11954819|FG005|STARTED|Overall Study||27
10794149|NCT03618030|11954820|FG006|STARTED|Overall Study||18
10794150|NCT03618030|11954821|FG007|STARTED|Overall Study||118
10794151|NCT03618030|11954814|FG000|COMPLETED|Overall Study||3
10794152|NCT03618030|11954815|FG001|COMPLETED|Overall Study||3
10569563|NCT01649609|11724774|FG000|STARTED|Overall Study||20
10794153|NCT03618030|11954816|FG002|COMPLETED|Overall Study||13
10794154|NCT03618030|11954817|FG003|COMPLETED|Overall Study||30
10794155|NCT03618030|11954818|FG004|COMPLETED|Overall Study||29
10794156|NCT03618030|11954819|FG005|COMPLETED|Overall Study||21
10794157|NCT03618030|11954820|FG006|COMPLETED|Overall Study||14
10794158|NCT03618030|11954821|FG007|COMPLETED|Overall Study||108
10794159|NCT03618030|11954814|FG000|NOT COMPLETED|Overall Study||12
10794160|NCT03618030|11954815|FG001|NOT COMPLETED|Overall Study||11
10794161|NCT03618030|11954816|FG002|NOT COMPLETED|Overall Study||8
10569564|NCT01649609|11724775|FG001|STARTED|Overall Study||20
10569565|NCT01649609|11724774|FG000|COMPLETED|Overall Study||20
10569566|NCT01649609|11724775|FG001|COMPLETED|Overall Study||20
10569567|NCT01649609|11724774|FG000|NOT COMPLETED|Overall Study||0
10569568|NCT01649609|11724775|FG001|NOT COMPLETED|Overall Study||0
10794162|NCT03618030|11954817|FG003|NOT COMPLETED|Overall Study||9
10794163|NCT03618030|11954818|FG004|NOT COMPLETED|Overall Study||7
10794164|NCT03618030|11954819|FG005|NOT COMPLETED|Overall Study||6
10794165|NCT03618030|11954820|FG006|NOT COMPLETED|Overall Study||4
10569569|NCT01649765|11724783|FG000|STARTED|Overall Study||40
10569570|NCT01649765|11724784|FG001|STARTED|Overall Study||53
10569571|NCT01649765|11724783|FG000|COMPLETED|Overall Study||31
10569572|NCT01649765|11724784|FG001|COMPLETED|Overall Study||45
10569573|NCT01649765|11724783|FG000|NOT COMPLETED|Overall Study||9
10569574|NCT01649765|11724784|FG001|NOT COMPLETED|Overall Study||8
10569575|NCT01649791|11724791|FG000|STARTED|Overall Study||8
10569576|NCT01649791|11724791|FG000|COMPLETED|Overall Study||5
10569577|NCT01649791|11724791|FG000|NOT COMPLETED|Overall Study||3
10569578|NCT01649804|11724795|FG000|STARTED|Overall Study||12
10569579|NCT01649804|11724795|FG000|COMPLETED|Overall Study||4
10569580|NCT01649804|11724795|FG000|NOT COMPLETED|Overall Study||8
10569581|NCT01649856|11724801|FG000|STARTED|Overall Study||369
10569582|NCT01649856|11724802|FG001|STARTED|Overall Study||203
10569583|NCT01649856|11724801|FG000|COMPLETED|Overall Study||230
10569584|NCT01649856|11724802|FG001|COMPLETED|Overall Study||125
10569585|NCT01649856|11724801|FG000|NOT COMPLETED|Overall Study||139
10569586|NCT01649856|11724802|FG001|NOT COMPLETED|Overall Study||78
10569587|NCT01649869|11724810|FG000|STARTED|Overall Study||18
10569588|NCT01649869|11724811|FG001|STARTED|Overall Study||17
10569589|NCT01649869|11724810|FG000|COMPLETED|Overall Study||16
10569590|NCT01649869|11724811|FG001|COMPLETED|Overall Study||16
10569591|NCT01649869|11724810|FG000|NOT COMPLETED|Overall Study||2
10569592|NCT01649869|11724811|FG001|NOT COMPLETED|Overall Study||1
10569593|NCT01649947|11724821|FG000|STARTED|Overall Study||12
10569594|NCT01649947|11724822|FG001|STARTED|Overall Study||20
10569595|NCT01649947|11724821|FG000|COMPLETED|Overall Study||0
10569596|NCT01649947|11724822|FG001|COMPLETED|Overall Study||2
10569597|NCT01649947|11724821|FG000|NOT COMPLETED|Overall Study||12
10569598|NCT01649947|11724822|FG001|NOT COMPLETED|Overall Study||18
10569599|NCT01650194|11724829|FG000|STARTED|Overall Study||60
10569600|NCT01650194|11724829|FG000|Treated|Overall Study||60
10569601|NCT01650194|11724829|FG000|COMPLETED|Overall Study||13
10794166|NCT03618030|11954821|FG007|NOT COMPLETED|Overall Study||10
10794167|NCT03618147|11954834|FG000|STARTED|Overall Study||314
10794168|NCT03618147|11954834|FG000|COMPLETED|Overall Study||314
10794169|NCT03618147|11954834|FG000|NOT COMPLETED|Overall Study||0
10794170|NCT03618628|11954839|FG000|STARTED|Overall Study||3
10794171|NCT03618628|11954839|FG000|COMPLETED|Overall Study||1
10569602|NCT01650194|11724829|FG000|NOT COMPLETED|Overall Study||47
10569603|NCT01650246|11724834|FG000|STARTED|Overall Study||143
10794172|NCT03618628|11954839|FG000|NOT COMPLETED|Overall Study||2
10794173|NCT03618823|11954845|FG000|STARTED|Overall Study||132
10794174|NCT03618823|11954846|FG001|STARTED|Overall Study||136
10794175|NCT03618823|11954845|FG000|COMPLETED|Overall Study||69
10794176|NCT03618823|11954846|FG001|COMPLETED|Overall Study||75
10794177|NCT03618823|11954845|FG000|NOT COMPLETED|Overall Study||63
10794178|NCT03618823|11954846|FG001|NOT COMPLETED|Overall Study||61
10794179|NCT03619135|11954857|FG000|STARTED|Overall Study||50
10794180|NCT03619135|11954858|FG001|STARTED|Overall Study||50
10794181|NCT03619135|11954857|FG000|COMPLETED|Overall Study||50
10794182|NCT03619135|11954858|FG001|COMPLETED|Overall Study||50
10794183|NCT03619135|11954857|FG000|NOT COMPLETED|Overall Study||0
10794184|NCT03619135|11954858|FG001|NOT COMPLETED|Overall Study||0
10794185|NCT03619590|11954864|FG000|STARTED|Overall Study||103
10794186|NCT03619590|11954864|FG000|COMPLETED|Overall Study||103
10794187|NCT03619590|11954864|FG000|NOT COMPLETED|Overall Study||0
10794188|NCT03619811|11954868|FG000|STARTED|Overall Study||43
10794189|NCT03619811|11954868|FG000|COMPLETED|Overall Study||31
10794190|NCT03619811|11954868|FG000|NOT COMPLETED|Overall Study||12
10794191|NCT03619837|11954872|FG000|STARTED|Screening||122
10794192|NCT03619837|11954872|FG000|COMPLETED|Screening||24
10794193|NCT03619837|11954872|FG000|NOT COMPLETED|Screening||98
10794194|NCT03619837|11954872|FG000|STARTED|Main Study||24
10794195|NCT03619837|11954872|FG000|COMPLETED|Main Study||24
10794196|NCT03619837|11954872|FG000|NOT COMPLETED|Main Study||0
10569604|NCT01650246|11724834|FG000|COMPLETED|Overall Study||0
10794197|NCT03619889|11954878|FG000|STARTED|Overall Study||37
10794198|NCT03619889|11954879|FG001|STARTED|Overall Study||37
10794199|NCT03619889|11954878|FG000|COMPLETED|Overall Study||35
10794200|NCT03619889|11954879|FG001|COMPLETED|Overall Study||37
10794201|NCT03619889|11954878|FG000|NOT COMPLETED|Overall Study||2
10794202|NCT03619889|11954879|FG001|NOT COMPLETED|Overall Study||0
10794203|NCT03620162|11954890|FG000|STARTED|Overall Study||179
10794204|NCT03620162|11954891|FG001|STARTED|Overall Study||181
10794205|NCT03620162|11954892|FG002|STARTED|Overall Study||180
10794206|NCT03620162|11954893|FG003|STARTED|Overall Study||180
10794207|NCT03620162|11954894|FG004|STARTED|Overall Study||180
10794208|NCT03620162|11954890|FG000|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||179
10794209|NCT03620162|11954891|FG001|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||181
10794210|NCT03620162|11954892|FG002|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||178
10569605|NCT01650246|11724834|FG000|NOT COMPLETED|Overall Study||143
10569606|NCT01650259|11724840|FG000|STARTED|Overall Study|Started are the registered patients|2513
10569607|NCT01650259|11724841|FG001|STARTED|Overall Study|Started are the registered patients|2363
10569608|NCT01650259|11724840|FG000|COMPLETED|Overall Study||1470
10569609|NCT01650259|11724841|FG001|COMPLETED|Overall Study||2128
10569610|NCT01650259|11724840|FG000|NOT COMPLETED|Overall Study||1043
10569611|NCT01650259|11724841|FG001|NOT COMPLETED|Overall Study||235
10569612|NCT01650298|11724847|FG000|STARTED|Overall Study||16
10569613|NCT01650298|11724848|FG001|STARTED|Overall Study||48
10569614|NCT01650298|11724847|FG000|COMPLETED|Overall Study||11
10569615|NCT01650298|11724848|FG001|COMPLETED|Overall Study||42
10569616|NCT01650298|11724847|FG000|NOT COMPLETED|Overall Study||5
10569617|NCT01650298|11724848|FG001|NOT COMPLETED|Overall Study||6
10569618|NCT01650324|11724859|FG000|STARTED|Overall Study||8
10569619|NCT01650324|11724860|FG001|STARTED|Overall Study||6
10569620|NCT01650324|11724861|FG002|STARTED|Overall Study||6
10569621|NCT01650324|11724862|FG003|STARTED|Overall Study||6
10569622|NCT01650324|11724863|FG004|STARTED|Overall Study||6
10569623|NCT01650324|11724859|FG000|COMPLETED|Overall Study||8
10569624|NCT01650324|11724860|FG001|COMPLETED|Overall Study||6
10569625|NCT01650324|11724861|FG002|COMPLETED|Overall Study||6
10569626|NCT01650324|11724862|FG003|COMPLETED|Overall Study||6
10569627|NCT01650324|11724863|FG004|COMPLETED|Overall Study||6
10569628|NCT01650324|11724859|FG000|NOT COMPLETED|Overall Study||0
10569629|NCT01650324|11724860|FG001|NOT COMPLETED|Overall Study||0
10569630|NCT01650324|11724861|FG002|NOT COMPLETED|Overall Study||0
10569631|NCT01650324|11724862|FG003|NOT COMPLETED|Overall Study||0
10569632|NCT01650324|11724863|FG004|NOT COMPLETED|Overall Study||0
10569633|NCT01650402|11724882|FG000|STARTED|Overall Study||99
10569634|NCT01650402|11724883|FG001|STARTED|Overall Study||100
10569635|NCT01650402|11724882|FG000|COMPLETED|Overall Study||79
10569636|NCT01650402|11724883|FG001|COMPLETED|Overall Study||86
10794211|NCT03620162|11954893|FG003|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||179
10794212|NCT03620162|11954894|FG004|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||179
10794213|NCT03620162|11954890|FG000|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||176
10794214|NCT03620162|11954891|FG001|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||175
10794215|NCT03620162|11954892|FG002|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||166
10794216|NCT03620162|11954893|FG003|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||169
10794217|NCT03620162|11954894|FG004|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||173
10794218|NCT03620162|11954890|FG000|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||175
10794219|NCT03620162|11954891|FG001|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||174
10794220|NCT03620162|11954892|FG002|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||161
10794221|NCT03620162|11954893|FG003|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||167
10794222|NCT03620162|11954894|FG004|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||173
10794223|NCT03620162|11954890|FG000|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||165
10794224|NCT03620162|11954891|FG001|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||168
10794225|NCT03620162|11954892|FG002|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||150
10794226|NCT03620162|11954893|FG003|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||162
10794227|NCT03620162|11954894|FG004|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||168
10794228|NCT03620162|11954890|FG000|COMPLETED|Overall Study||164
10794229|NCT03620162|11954891|FG001|COMPLETED|Overall Study||167
10794230|NCT03620162|11954892|FG002|COMPLETED|Overall Study||147
10794231|NCT03620162|11954893|FG003|COMPLETED|Overall Study||160
10794232|NCT03620162|11954894|FG004|COMPLETED|Overall Study||167
10794233|NCT03620162|11954890|FG000|NOT COMPLETED|Overall Study||15
10794234|NCT03620162|11954891|FG001|NOT COMPLETED|Overall Study||14
10794235|NCT03620162|11954892|FG002|NOT COMPLETED|Overall Study||33
10794236|NCT03620162|11954893|FG003|NOT COMPLETED|Overall Study||20
10794237|NCT03620162|11954894|FG004|NOT COMPLETED|Overall Study||13
10794238|NCT03620383|11954910|FG000|STARTED|Overall Study||30
10794239|NCT03620383|11954911|FG001|STARTED|Overall Study||15
10794240|NCT03620383|11954910|FG000|COMPLETED|Overall Study||30
10794241|NCT03620383|11954911|FG001|COMPLETED|Overall Study||15
10794242|NCT03620383|11954910|FG000|NOT COMPLETED|Overall Study||0
10794243|NCT03620383|11954911|FG001|NOT COMPLETED|Overall Study||0
10794244|NCT03620708|11954920|FG000|STARTED|Overall Study||19
10794245|NCT03620708|11954921|FG001|STARTED|Overall Study||19
10794246|NCT03620708|11954922|FG002|STARTED|Overall Study||20
10794247|NCT03620708|11954920|FG000|COMPLETED|Overall Study||18
10794248|NCT03620708|11954921|FG001|COMPLETED|Overall Study||18
10794249|NCT03620708|11954922|FG002|COMPLETED|Overall Study||17
10794250|NCT03620708|11954920|FG000|NOT COMPLETED|Overall Study||1
10794251|NCT03620708|11954921|FG001|NOT COMPLETED|Overall Study||1
10794252|NCT03620708|11954922|FG002|NOT COMPLETED|Overall Study||3
10794253|NCT03620890|11954932|FG000|STARTED|Overall Study||57
10794254|NCT03620890|11954933|FG001|STARTED|Overall Study||51
10794255|NCT03620890|11954932|FG000|First Trimester Miscarriage|Overall Study||2
10794256|NCT03620890|11954933|FG001|First Trimester Miscarriage|Overall Study||1
10794257|NCT03620890|11954932|FG000|Major Fetal Anomalies (Hypoplastic Left Heart and Sacral Agenesis) With 2nd Trimester Stillbirth|Overall Study||1
10794258|NCT03620890|11954933|FG001|Major Fetal Anomalies (Hypoplastic Left Heart and Sacral Agenesis) With 2nd Trimester Stillbirth|Overall Study||0
10794259|NCT03620890|11954932|FG000|Major Fetal Anomaly (Holoprosencephaly) With 2nd Trimester Pregnancy Termination|Overall Study||1
10794260|NCT03620890|11954933|FG001|Major Fetal Anomaly (Holoprosencephaly) With 2nd Trimester Pregnancy Termination|Overall Study||0
10794261|NCT03620890|11954932|FG000|COMPLETED|Overall Study||53
10794262|NCT03620890|11954933|FG001|COMPLETED|Overall Study||50
10794263|NCT03620890|11954932|FG000|NOT COMPLETED|Overall Study||4
10569637|NCT01650402|11724882|FG000|NOT COMPLETED|Overall Study||20
10569638|NCT01650402|11724883|FG001|NOT COMPLETED|Overall Study||14
10569639|NCT01650519|11724891|FG000|STARTED|Overall Study||20
10569640|NCT01650519|11724892|FG001|STARTED|Overall Study||31
10569641|NCT01650519|11724891|FG000|COMPLETED|Overall Study||19
10569642|NCT01650519|11724892|FG001|COMPLETED|Overall Study||31
10569643|NCT01650519|11724891|FG000|NOT COMPLETED|Overall Study||1
10569644|NCT01650519|11724892|FG001|NOT COMPLETED|Overall Study||0
10569645|NCT01650545|11724900|FG000|STARTED|Overall Study||11
10569646|NCT01650545|11724901|FG001|STARTED|Overall Study||10
10569647|NCT01650545|11724900|FG000|COMPLETED|Overall Study||11
10794264|NCT03620890|11954933|FG001|NOT COMPLETED|Overall Study||1
10794265|NCT03621085|11954939|FG000|STARTED|Enrollment||22
10794266|NCT03621085|11954940|FG001|STARTED|Enrollment||21
10794267|NCT03621085|11954939|FG000|COMPLETED|Enrollment||16
10794268|NCT03621085|11954940|FG001|COMPLETED|Enrollment||14
10794269|NCT03621085|11954939|FG000|NOT COMPLETED|Enrollment||6
10794270|NCT03621085|11954940|FG001|NOT COMPLETED|Enrollment||7
10794271|NCT03621085|11954939|FG000|STARTED|First Visit||16
10794272|NCT03621085|11954940|FG001|STARTED|First Visit||14
10794273|NCT03621085|11954939|FG000|COMPLETED|First Visit||16
10794274|NCT03621085|11954940|FG001|COMPLETED|First Visit||14
10794275|NCT03621085|11954939|FG000|NOT COMPLETED|First Visit||0
10794276|NCT03621085|11954940|FG001|NOT COMPLETED|First Visit||0
10794277|NCT03621085|11954939|FG000|STARTED|Washout (at Least 48 Hours)||16
10794278|NCT03621085|11954940|FG001|STARTED|Washout (at Least 48 Hours)||14
10794279|NCT03621085|11954939|FG000|COMPLETED|Washout (at Least 48 Hours)||16
10794280|NCT03621085|11954940|FG001|COMPLETED|Washout (at Least 48 Hours)||14
10794281|NCT03621085|11954939|FG000|NOT COMPLETED|Washout (at Least 48 Hours)||0
10794282|NCT03621085|11954940|FG001|NOT COMPLETED|Washout (at Least 48 Hours)||0
10794283|NCT03621085|11954939|FG000|STARTED|Second Visit||16
10794284|NCT03621085|11954940|FG001|STARTED|Second Visit||14
10794285|NCT03621085|11954939|FG000|COMPLETED|Second Visit||16
10794286|NCT03621085|11954940|FG001|COMPLETED|Second Visit||14
10794287|NCT03621085|11954939|FG000|NOT COMPLETED|Second Visit||0
10794288|NCT03621085|11954940|FG001|NOT COMPLETED|Second Visit||0
10794289|NCT03621189|11954948|FG000|STARTED|Overall Study||40
10794290|NCT03621189|11954949|FG001|STARTED|Overall Study||40
10794291|NCT03621189|11954948|FG000|COMPLETED|Overall Study||40
10794292|NCT03621189|11954949|FG001|COMPLETED|Overall Study||35
10794293|NCT03621189|11954948|FG000|NOT COMPLETED|Overall Study||0
10794294|NCT03621189|11954949|FG001|NOT COMPLETED|Overall Study||5
10794295|NCT03621202|11954956|FG000|STARTED|Overall Study||66
10794296|NCT03621202|11954956|FG000|COMPLETED|Overall Study||60
10794297|NCT03621202|11954956|FG000|NOT COMPLETED|Overall Study||6
10794298|NCT03621787|11954960|FG000|STARTED|Overall Study||9
10794299|NCT03621787|11954960|FG000|COMPLETED|Overall Study||9
10794300|NCT03621787|11954960|FG000|NOT COMPLETED|Overall Study||0
10794301|NCT03621878|11954967|FG000|STARTED|Overall Study||17
10794302|NCT03621878|11954968|FG001|STARTED|Overall Study||17
10794303|NCT03621878|11954969|FG002|STARTED|Overall Study||17
10794304|NCT03621878|11954967|FG000|COMPLETED|Overall Study||17
10794305|NCT03621878|11954968|FG001|COMPLETED|Overall Study||17
10794306|NCT03621878|11954969|FG002|COMPLETED|Overall Study||17
10794307|NCT03621878|11954967|FG000|NOT COMPLETED|Overall Study||0
10794308|NCT03621878|11954968|FG001|NOT COMPLETED|Overall Study||0
10794309|NCT03621878|11954969|FG002|NOT COMPLETED|Overall Study||0
10794310|NCT03622112|11954984|FG000|STARTED|Overall Study||110
10794311|NCT03622112|11954985|FG001|STARTED|Overall Study||112
10794312|NCT03622112|11954986|FG002|STARTED|Overall Study||111
10794313|NCT03622112|11954987|FG003|STARTED|Overall Study||113
10794314|NCT03622112|11954988|FG004|STARTED|Overall Study||134
10794315|NCT03622112|11954989|FG005|STARTED|Overall Study||113
10794316|NCT03622112|11954990|FG006|STARTED|Overall Study||112
10794317|NCT03622112|11954984|FG000|COMPLETED|Overall Study||85
10794318|NCT03622112|11954985|FG001|COMPLETED|Overall Study||92
10794319|NCT03622112|11954986|FG002|COMPLETED|Overall Study||95
10794320|NCT03622112|11954987|FG003|COMPLETED|Overall Study||91
10794321|NCT03622112|11954988|FG004|COMPLETED|Overall Study||124
10794322|NCT03622112|11954989|FG005|COMPLETED|Overall Study||71
10794323|NCT03622112|11954990|FG006|COMPLETED|Overall Study||103
10794324|NCT03622112|11954984|FG000|NOT COMPLETED|Overall Study||25
10794325|NCT03622112|11954985|FG001|NOT COMPLETED|Overall Study||20
10794326|NCT03622112|11954986|FG002|NOT COMPLETED|Overall Study||16
10794327|NCT03622112|11954987|FG003|NOT COMPLETED|Overall Study||22
10569648|NCT01650545|11724901|FG001|COMPLETED|Overall Study||10
10569649|NCT01650545|11724900|FG000|NOT COMPLETED|Overall Study||0
10569650|NCT01650545|11724901|FG001|NOT COMPLETED|Overall Study||0
10794328|NCT03622112|11954988|FG004|NOT COMPLETED|Overall Study||10
10794329|NCT03622112|11954989|FG005|NOT COMPLETED|Overall Study||42
10794330|NCT03622112|11954990|FG006|NOT COMPLETED|Overall Study||9
10794331|NCT03622619|11955008|FG000|STARTED|Overall Study||23
10794332|NCT03622619|11955009|FG001|STARTED|Overall Study||23
10794333|NCT03622619|11955008|FG000|COMPLETED|Overall Study||21
10794334|NCT03622619|11955009|FG001|COMPLETED|Overall Study||21
10794335|NCT03622619|11955008|FG000|NOT COMPLETED|Overall Study||2
10794336|NCT03622619|11955009|FG001|NOT COMPLETED|Overall Study||2
10794337|NCT03623035|11955015|FG000|STARTED|Overall Study||10
10794338|NCT03623035|11955015|FG000|COMPLETED|Overall Study||10
10794339|NCT03623035|11955015|FG000|NOT COMPLETED|Overall Study||0
10794340|NCT03623334|11955022|FG000|STARTED|Overall Study||15
10794341|NCT03623334|11955023|FG001|STARTED|Overall Study||21
10794342|NCT03623334|11955024|FG002|STARTED|Overall Study||19
10569660|NCT01650584|11724925|FG000|STARTED|Overall Study|Each participant received one of 2 treatments in each eye.|35
10569661|NCT01650584|11724925|FG000|COMPLETED|Overall Study||35
10794343|NCT03623334|11955022|FG000|COMPLETED|Overall Study||15
10794344|NCT03623334|11955023|FG001|COMPLETED|Overall Study||21
10794345|NCT03623334|11955024|FG002|COMPLETED|Overall Study||19
10794346|NCT03623334|11955022|FG000|NOT COMPLETED|Overall Study||0
10794347|NCT03623334|11955023|FG001|NOT COMPLETED|Overall Study||0
10794348|NCT03623334|11955024|FG002|NOT COMPLETED|Overall Study||0
10794349|NCT03623698|11955032|FG000|STARTED|Overall Study||24
10794350|NCT03623698|11955032|FG000|COMPLETED|Overall Study||24
10794351|NCT03623698|11955032|FG000|NOT COMPLETED|Overall Study||0
10794352|NCT03624192|11955043|FG000|STARTED|Overall Study||3
10794353|NCT03624192|11955044|FG001|STARTED|Overall Study||3
10794354|NCT03624192|11955043|FG000|COMPLETED|Overall Study||2
10794355|NCT03624192|11955044|FG001|COMPLETED|Overall Study||2
10794356|NCT03624192|11955043|FG000|NOT COMPLETED|Overall Study||1
10794357|NCT03624192|11955044|FG001|NOT COMPLETED|Overall Study||1
10794358|NCT03624504|11955052|FG000|STARTED|Overall Study||82
10794359|NCT03624504|11955052|FG000|COMPLETED|Overall Study||81
10794360|NCT03624504|11955052|FG000|NOT COMPLETED|Overall Study||1
10794361|NCT03624920|11955062|FG000|STARTED|Overall Study||14
10794362|NCT03624920|11955063|FG001|STARTED|Overall Study||14
10794363|NCT03624920|11955064|FG002|STARTED|Overall Study||13
10794364|NCT03624920|11955065|FG003|STARTED|Overall Study||13
10794365|NCT03624920|11955066|FG004|STARTED|Overall Study||11
10794366|NCT03624920|11955067|FG005|STARTED|Overall Study||12
10794367|NCT03624920|11955062|FG000|COMPLETED|Overall Study||13
10794368|NCT03624920|11955063|FG001|COMPLETED|Overall Study||12
10794369|NCT03624920|11955064|FG002|COMPLETED|Overall Study||12
10794370|NCT03624920|11955065|FG003|COMPLETED|Overall Study||12
10794371|NCT03624920|11955066|FG004|COMPLETED|Overall Study||7
10794372|NCT03624920|11955067|FG005|COMPLETED|Overall Study||11
10794373|NCT03624920|11955062|FG000|NOT COMPLETED|Overall Study||1
10794374|NCT03624920|11955063|FG001|NOT COMPLETED|Overall Study||2
10794375|NCT03624920|11955064|FG002|NOT COMPLETED|Overall Study||1
10794376|NCT03624920|11955065|FG003|NOT COMPLETED|Overall Study||1
10794377|NCT03624920|11955066|FG004|NOT COMPLETED|Overall Study||4
10794378|NCT03624920|11955067|FG005|NOT COMPLETED|Overall Study||1
10794379|NCT03624946|11955077|FG000|STARTED|Overall Study||19
10794380|NCT03624946|11955078|FG001|STARTED|Overall Study||11
10794381|NCT03624946|11955077|FG000|COMPLETED|Overall Study||19
10794382|NCT03624946|11955078|FG001|COMPLETED|Overall Study||10
10794383|NCT03624946|11955077|FG000|NOT COMPLETED|Overall Study||0
10794384|NCT03624946|11955078|FG001|NOT COMPLETED|Overall Study||1
10794385|NCT03624972|11955091|FG000|STARTED|Overall Study||71
10794386|NCT03624972|11955092|FG001|STARTED|Overall Study||73
10794387|NCT03624972|11955093|FG002|STARTED|Overall Study||9
10794388|NCT03624972|11955091|FG000|COMPLETED|Overall Study||69
10794389|NCT03624972|11955092|FG001|COMPLETED|Overall Study||71
10794390|NCT03624972|11955093|FG002|COMPLETED|Overall Study||9
10794391|NCT03624972|11955091|FG000|NOT COMPLETED|Overall Study||2
10794392|NCT03624972|11955092|FG001|NOT COMPLETED|Overall Study||2
10794393|NCT03624972|11955093|FG002|NOT COMPLETED|Overall Study||0
10794394|NCT03626415|11955105|FG000|STARTED|Overall Study||8
10794395|NCT03626415|11955106|FG001|STARTED|Overall Study||8
10794396|NCT03626415|11955107|FG002|STARTED|Overall Study||8
10794397|NCT03626415|11955105|FG000|COMPLETED|Overall Study||8
10794398|NCT03626415|11955106|FG001|COMPLETED|Overall Study||8
10794399|NCT03626415|11955107|FG002|COMPLETED|Overall Study||8
10794400|NCT03626415|11955105|FG000|NOT COMPLETED|Overall Study||0
10794401|NCT03626415|11955106|FG001|NOT COMPLETED|Overall Study||0
10794402|NCT03626415|11955107|FG002|NOT COMPLETED|Overall Study||0
10794403|NCT03626623|11955117|FG000|STARTED|Overall Study||5
10794404|NCT03626623|11955118|FG001|STARTED|Overall Study||10
10794405|NCT03626623|11955117|FG000|COMPLETED|Overall Study||0
10794406|NCT03626623|11955118|FG001|COMPLETED|Overall Study||0
10794407|NCT03626623|11955117|FG000|NOT COMPLETED|Overall Study||5
10794408|NCT03626623|11955118|FG001|NOT COMPLETED|Overall Study||10
10794409|NCT03626714|11955124|FG000|STARTED|Overall Study||8
10794410|NCT03626714|11955124|FG000|COMPLETED|Overall Study||8
10794411|NCT03626714|11955124|FG000|NOT COMPLETED|Overall Study||0
10794412|NCT03627065|11955128|FG000|STARTED|Overall Study||10
10569662|NCT01650584|11724925|FG000|NOT COMPLETED|Overall Study||0
10794413|NCT03627065|11955128|FG000|COMPLETED|Overall Study||7
10794414|NCT03627065|11955128|FG000|NOT COMPLETED|Overall Study||3
10794415|NCT03627195|11955138|FG000|STARTED|Overall Study||6
10794416|NCT03627195|11955139|FG001|STARTED|Overall Study||6
10794417|NCT03627195|11955140|FG002|STARTED|Overall Study||6
10794418|NCT03627195|11955141|FG003|STARTED|Overall Study||6
10794419|NCT03627195|11955142|FG004|STARTED|Overall Study||6
10794420|NCT03627195|11955143|FG005|STARTED|Overall Study||10
10794421|NCT03627195|11955138|FG000|COMPLETED|Overall Study||5
10794422|NCT03627195|11955139|FG001|COMPLETED|Overall Study||6
10794423|NCT03627195|11955140|FG002|COMPLETED|Overall Study||6
10794424|NCT03627195|11955141|FG003|COMPLETED|Overall Study||6
10794425|NCT03627195|11955142|FG004|COMPLETED|Overall Study||6
10794426|NCT03627195|11955143|FG005|COMPLETED|Overall Study||10
10794427|NCT03627195|11955138|FG000|NOT COMPLETED|Overall Study||1
10569663|NCT01650636|11724932|FG000|STARTED|Intervention Phase||150
10569664|NCT01650636|11724933|FG001|STARTED|Intervention Phase||150
10569665|NCT01650636|11724932|FG000|COMPLETED|Intervention Phase||150
10569666|NCT01650636|11724933|FG001|COMPLETED|Intervention Phase||150
10569667|NCT01650636|11724932|FG000|NOT COMPLETED|Intervention Phase||0
10569668|NCT01650636|11724933|FG001|NOT COMPLETED|Intervention Phase||0
10569669|NCT01650636|11724932|FG000|STARTED|Washout up to 5 Months||150
10569670|NCT01650636|11724933|FG001|STARTED|Washout up to 5 Months||150
10794428|NCT03627195|11955139|FG001|NOT COMPLETED|Overall Study||0
10794429|NCT03627195|11955140|FG002|NOT COMPLETED|Overall Study||0
10794430|NCT03627195|11955141|FG003|NOT COMPLETED|Overall Study||0
10794431|NCT03627195|11955142|FG004|NOT COMPLETED|Overall Study||0
10794432|NCT03627195|11955143|FG005|NOT COMPLETED|Overall Study||0
10794433|NCT03627299|11955157|FG000|STARTED|Overall Study||10
10794434|NCT03627299|11955157|FG000|COMPLETED|Overall Study||10
10794435|NCT03627299|11955157|FG000|NOT COMPLETED|Overall Study||0
10794436|NCT03627416|11955163|FG000|STARTED|Overall Study||8
10794437|NCT03627416|11955164|FG001|STARTED|Overall Study||7
10794438|NCT03627416|11955163|FG000|COMPLETED|Overall Study||8
10794439|NCT03627416|11955164|FG001|COMPLETED|Overall Study||6
10794440|NCT03627416|11955163|FG000|NOT COMPLETED|Overall Study||0
10794441|NCT03627416|11955164|FG001|NOT COMPLETED|Overall Study||1
10794442|NCT03627494|11955182|FG000|STARTED|Part A Period 1 (4 Days)||3
10794443|NCT03627494|11955183|FG001|STARTED|Part A Period 1 (4 Days)||3
10794444|NCT03627494|11955184|FG002|STARTED|Part A Period 1 (4 Days)||3
10794445|NCT03627494|11955185|FG003|STARTED|Part A Period 1 (4 Days)||3
10794446|NCT03627494|11955186|FG004|STARTED|Part A Period 1 (4 Days)||3
10794447|NCT03627494|11955187|FG005|STARTED|Part A Period 1 (4 Days)||3
10794448|NCT03627494|11955188|FG006|STARTED|Part A Period 1 (4 Days)||0
10794449|NCT03627494|11955189|FG007|STARTED|Part A Period 1 (4 Days)||0
10569671|NCT01650636|11724932|FG000|COMPLETED|Washout up to 5 Months||141
10569672|NCT01650636|11724933|FG001|COMPLETED|Washout up to 5 Months||132
10569673|NCT01650636|11724932|FG000|NOT COMPLETED|Washout up to 5 Months||9
10569674|NCT01650636|11724933|FG001|NOT COMPLETED|Washout up to 5 Months||18
10569675|NCT01650636|11724932|FG000|STARTED|5 Month Visit||141
10569676|NCT01650636|11724933|FG001|STARTED|5 Month Visit||132
10569677|NCT01650636|11724932|FG000|COMPLETED|5 Month Visit||141
10569678|NCT01650636|11724933|FG001|COMPLETED|5 Month Visit||132
10794450|NCT03627494|11955190|FG008|STARTED|Part A Period 1 (4 Days)||0
10794451|NCT03627494|11955191|FG009|STARTED|Part A Period 1 (4 Days)||0
10794452|NCT03627494|11955192|FG010|STARTED|Part A Period 1 (4 Days)||0
10794453|NCT03627494|11955193|FG011|STARTED|Part A Period 1 (4 Days)||0
10794454|NCT03627494|11955182|FG000|COMPLETED|Part A Period 1 (4 Days)||3
10794455|NCT03627494|11955183|FG001|COMPLETED|Part A Period 1 (4 Days)||3
10569679|NCT01650636|11724932|FG000|NOT COMPLETED|5 Month Visit||0
10569680|NCT01650636|11724933|FG001|NOT COMPLETED|5 Month Visit||0
10569681|NCT01650636|11724932|FG000|STARTED|Washout up to 9 Months||141
10569682|NCT01650636|11724933|FG001|STARTED|Washout up to 9 Months||132
10569683|NCT01650636|11724932|FG000|COMPLETED|Washout up to 9 Months||135
10794456|NCT03627494|11955184|FG002|COMPLETED|Part A Period 1 (4 Days)||3
10794457|NCT03627494|11955185|FG003|COMPLETED|Part A Period 1 (4 Days)||3
10794458|NCT03627494|11955186|FG004|COMPLETED|Part A Period 1 (4 Days)||3
10794459|NCT03627494|11955187|FG005|COMPLETED|Part A Period 1 (4 Days)||3
10794460|NCT03627494|11955188|FG006|COMPLETED|Part A Period 1 (4 Days)||0
10794461|NCT03627494|11955189|FG007|COMPLETED|Part A Period 1 (4 Days)||0
10794462|NCT03627494|11955190|FG008|COMPLETED|Part A Period 1 (4 Days)||0
10794463|NCT03627494|11955191|FG009|COMPLETED|Part A Period 1 (4 Days)||0
10794464|NCT03627494|11955192|FG010|COMPLETED|Part A Period 1 (4 Days)||0
10794465|NCT03627494|11955193|FG011|COMPLETED|Part A Period 1 (4 Days)||0
10794466|NCT03627494|11955182|FG000|NOT COMPLETED|Part A Period 1 (4 Days)||0
10794467|NCT03627494|11955183|FG001|NOT COMPLETED|Part A Period 1 (4 Days)||0
10794468|NCT03627494|11955184|FG002|NOT COMPLETED|Part A Period 1 (4 Days)||0
10794469|NCT03627494|11955185|FG003|NOT COMPLETED|Part A Period 1 (4 Days)||0
10794470|NCT03627494|11955186|FG004|NOT COMPLETED|Part A Period 1 (4 Days)||0
10794471|NCT03627494|11955187|FG005|NOT COMPLETED|Part A Period 1 (4 Days)||0
10794472|NCT03627494|11955188|FG006|NOT COMPLETED|Part A Period 1 (4 Days)||0
10794473|NCT03627494|11955189|FG007|NOT COMPLETED|Part A Period 1 (4 Days)||0
10794474|NCT03627494|11955190|FG008|NOT COMPLETED|Part A Period 1 (4 Days)||0
10794475|NCT03627494|11955191|FG009|NOT COMPLETED|Part A Period 1 (4 Days)||0
10794476|NCT03627494|11955192|FG010|NOT COMPLETED|Part A Period 1 (4 Days)||0
10794477|NCT03627494|11955193|FG011|NOT COMPLETED|Part A Period 1 (4 Days)||0
10794478|NCT03627494|11955182|FG000|STARTED|Part A Washout 1 (7 Days)||3
10794479|NCT03627494|11955183|FG001|STARTED|Part A Washout 1 (7 Days)||3
10794480|NCT03627494|11955184|FG002|STARTED|Part A Washout 1 (7 Days)||3
10794481|NCT03627494|11955185|FG003|STARTED|Part A Washout 1 (7 Days)||3
10794482|NCT03627494|11955186|FG004|STARTED|Part A Washout 1 (7 Days)||3
10794483|NCT03627494|11955187|FG005|STARTED|Part A Washout 1 (7 Days)||3
10794484|NCT03627494|11955188|FG006|STARTED|Part A Washout 1 (7 Days)||0
10794485|NCT03627494|11955189|FG007|STARTED|Part A Washout 1 (7 Days)||0
10794486|NCT03627494|11955190|FG008|STARTED|Part A Washout 1 (7 Days)||0
10794487|NCT03627494|11955191|FG009|STARTED|Part A Washout 1 (7 Days)||0
10794488|NCT03627494|11955192|FG010|STARTED|Part A Washout 1 (7 Days)||0
10794489|NCT03627494|11955193|FG011|STARTED|Part A Washout 1 (7 Days)||0
10794490|NCT03627494|11955182|FG000|COMPLETED|Part A Washout 1 (7 Days)||3
10794491|NCT03627494|11955183|FG001|COMPLETED|Part A Washout 1 (7 Days)||3
10794492|NCT03627494|11955184|FG002|COMPLETED|Part A Washout 1 (7 Days)||3
10794493|NCT03627494|11955185|FG003|COMPLETED|Part A Washout 1 (7 Days)||3
10794494|NCT03627494|11955186|FG004|COMPLETED|Part A Washout 1 (7 Days)||3
10794495|NCT03627494|11955187|FG005|COMPLETED|Part A Washout 1 (7 Days)||3
10794496|NCT03627494|11955188|FG006|COMPLETED|Part A Washout 1 (7 Days)||0
10794497|NCT03627494|11955189|FG007|COMPLETED|Part A Washout 1 (7 Days)||0
10794498|NCT03627494|11955190|FG008|COMPLETED|Part A Washout 1 (7 Days)||0
10794499|NCT03627494|11955191|FG009|COMPLETED|Part A Washout 1 (7 Days)||0
10794500|NCT03627494|11955192|FG010|COMPLETED|Part A Washout 1 (7 Days)||0
10794501|NCT03627494|11955193|FG011|COMPLETED|Part A Washout 1 (7 Days)||0
10794502|NCT03627494|11955182|FG000|NOT COMPLETED|Part A Washout 1 (7 Days)||0
10794503|NCT03627494|11955183|FG001|NOT COMPLETED|Part A Washout 1 (7 Days)||0
10794504|NCT03627494|11955184|FG002|NOT COMPLETED|Part A Washout 1 (7 Days)||0
10794505|NCT03627494|11955185|FG003|NOT COMPLETED|Part A Washout 1 (7 Days)||0
10794506|NCT03627494|11955186|FG004|NOT COMPLETED|Part A Washout 1 (7 Days)||0
10794507|NCT03627494|11955187|FG005|NOT COMPLETED|Part A Washout 1 (7 Days)||0
10794508|NCT03627494|11955188|FG006|NOT COMPLETED|Part A Washout 1 (7 Days)||0
10794509|NCT03627494|11955189|FG007|NOT COMPLETED|Part A Washout 1 (7 Days)||0
10794510|NCT03627494|11955190|FG008|NOT COMPLETED|Part A Washout 1 (7 Days)||0
10794511|NCT03627494|11955191|FG009|NOT COMPLETED|Part A Washout 1 (7 Days)||0
10794512|NCT03627494|11955192|FG010|NOT COMPLETED|Part A Washout 1 (7 Days)||0
10794513|NCT03627494|11955193|FG011|NOT COMPLETED|Part A Washout 1 (7 Days)||0
10794514|NCT03627494|11955182|FG000|STARTED|Part A Period 2 (4 Days)||3
10794515|NCT03627494|11955183|FG001|STARTED|Part A Period 2 (4 Days)||3
10794516|NCT03627494|11955184|FG002|STARTED|Part A Period 2 (4 Days)||3
10794517|NCT03627494|11955185|FG003|STARTED|Part A Period 2 (4 Days)||3
10794518|NCT03627494|11955186|FG004|STARTED|Part A Period 2 (4 Days)||3
10794519|NCT03627494|11955187|FG005|STARTED|Part A Period 2 (4 Days)||3
10794520|NCT03627494|11955188|FG006|STARTED|Part A Period 2 (4 Days)||0
10794521|NCT03627494|11955189|FG007|STARTED|Part A Period 2 (4 Days)||0
10569684|NCT01650636|11724933|FG001|COMPLETED|Washout up to 9 Months||129
10569685|NCT01650636|11724932|FG000|NOT COMPLETED|Washout up to 9 Months||6
10794522|NCT03627494|11955190|FG008|STARTED|Part A Period 2 (4 Days)||0
10794523|NCT03627494|11955191|FG009|STARTED|Part A Period 2 (4 Days)||0
10794524|NCT03627494|11955192|FG010|STARTED|Part A Period 2 (4 Days)||0
10794525|NCT03627494|11955193|FG011|STARTED|Part A Period 2 (4 Days)||0
10794526|NCT03627494|11955182|FG000|COMPLETED|Part A Period 2 (4 Days)||3
10794527|NCT03627494|11955183|FG001|COMPLETED|Part A Period 2 (4 Days)||3
10794528|NCT03627494|11955184|FG002|COMPLETED|Part A Period 2 (4 Days)||3
10794529|NCT03627494|11955185|FG003|COMPLETED|Part A Period 2 (4 Days)||3
10794530|NCT03627494|11955186|FG004|COMPLETED|Part A Period 2 (4 Days)||3
10794531|NCT03627494|11955187|FG005|COMPLETED|Part A Period 2 (4 Days)||3
10569686|NCT01650636|11724933|FG001|NOT COMPLETED|Washout up to 9 Months||3
10569687|NCT01650636|11724932|FG000|STARTED|9 Month Visit||135
10569688|NCT01650636|11724933|FG001|STARTED|9 Month Visit||129
10569689|NCT01650636|11724932|FG000|COMPLETED|9 Month Visit||135
10569690|NCT01650636|11724933|FG001|COMPLETED|9 Month Visit||129
10569691|NCT01650636|11724932|FG000|NOT COMPLETED|9 Month Visit||0
10569692|NCT01650636|11724933|FG001|NOT COMPLETED|9 Month Visit||0
10569693|NCT01650779|11724939|FG000|STARTED|Overall Study||15
10569694|NCT01650779|11724939|FG000|COMPLETED|Overall Study||14
10569695|NCT01650779|11724939|FG000|NOT COMPLETED|Overall Study||1
10569696|NCT01650805|11724945|FG000|STARTED|Overall Study|Started means patient has been randomized.|155
10569697|NCT01650805|11724946|FG001|STARTED|Overall Study||152
10569698|NCT01650805|11724945|FG000|COMPLETED|Overall Study|Completed means patient initiated and discontinued study treatment.|154
10569699|NCT01650805|11724946|FG001|COMPLETED|Overall Study||152
10569700|NCT01650805|11724945|FG000|NOT COMPLETED|Overall Study||1
10569701|NCT01650805|11724946|FG001|NOT COMPLETED|Overall Study||0
10569702|NCT01650831|11724952|FG000|STARTED|Overall Study||113
10569703|NCT01650831|11724952|FG000|COMPLETED|Overall Study||112
10569704|NCT01650831|11724952|FG000|NOT COMPLETED|Overall Study||1
10569705|NCT01650844|11724962|FG000|STARTED|Overall Study||200
10569706|NCT01650844|11724963|FG001|STARTED|Overall Study||200
10569707|NCT01650844|11724962|FG000|COMPLETED|Overall Study||199
10569708|NCT01650844|11724963|FG001|COMPLETED|Overall Study||196
10569709|NCT01650844|11724962|FG000|NOT COMPLETED|Overall Study||1
10569710|NCT01650844|11724963|FG001|NOT COMPLETED|Overall Study||4
10569711|NCT01651000|11724971|FG000|STARTED|Overall Study||72
10569712|NCT01651000|11724972|FG001|STARTED|Overall Study||141
10569713|NCT01651000|11724971|FG000|Entered Extension Study|Overall Study||50
10569714|NCT01651000|11724972|FG001|Entered Extension Study|Overall Study||93
10569715|NCT01651000|11724971|FG000|COMPLETED|Overall Study||62
10569716|NCT01651000|11724972|FG001|COMPLETED|Overall Study||113
10569717|NCT01651000|11724971|FG000|NOT COMPLETED|Overall Study||10
10569718|NCT01651000|11724972|FG001|NOT COMPLETED|Overall Study||28
10569719|NCT01651039|11724978|FG000|STARTED|Overall Study||32
10569720|NCT01651039|11724978|FG000|COMPLETED|Overall Study||2
10569721|NCT01651039|11724978|FG000|NOT COMPLETED|Overall Study||30
10569722|NCT01651052|11724982|FG000|STARTED|Overall Study||133
10569723|NCT01651052|11724982|FG000|Study Valve Group|Overall Study||133
10569724|NCT01651052|11724982|FG000|COMPLETED|Overall Study||107
10569725|NCT01651052|11724982|FG000|NOT COMPLETED|Overall Study||26
10569726|NCT01651078|11724986|FG000|STARTED|Overall Study|Two (2) out of 44 patients were enrolled but did not go on to have the NeuroBlate Procedure.|42
10569727|NCT01651078|11724986|FG000|COMPLETED|Overall Study||16
10569728|NCT01651078|11724986|FG000|NOT COMPLETED|Overall Study||26
10569729|NCT01651104|11724990|FG000|STARTED|Overall Study||63
10569730|NCT01651104|11724990|FG000|COMPLETED|Overall Study||63
10569731|NCT01651104|11724990|FG000|NOT COMPLETED|Overall Study||0
10569732|NCT01651117|11724998|FG000|STARTED|Overall Study||156
10794532|NCT03627494|11955188|FG006|COMPLETED|Part A Period 2 (4 Days)||0
10794533|NCT03627494|11955189|FG007|COMPLETED|Part A Period 2 (4 Days)||0
10794534|NCT03627494|11955190|FG008|COMPLETED|Part A Period 2 (4 Days)||0
10794535|NCT03627494|11955191|FG009|COMPLETED|Part A Period 2 (4 Days)||0
10794536|NCT03627494|11955192|FG010|COMPLETED|Part A Period 2 (4 Days)||0
10794537|NCT03627494|11955193|FG011|COMPLETED|Part A Period 2 (4 Days)||0
10794538|NCT03627494|11955182|FG000|NOT COMPLETED|Part A Period 2 (4 Days)||0
10794539|NCT03627494|11955183|FG001|NOT COMPLETED|Part A Period 2 (4 Days)||0
10794540|NCT03627494|11955184|FG002|NOT COMPLETED|Part A Period 2 (4 Days)||0
10794541|NCT03627494|11955185|FG003|NOT COMPLETED|Part A Period 2 (4 Days)||0
10794542|NCT03627494|11955186|FG004|NOT COMPLETED|Part A Period 2 (4 Days)||0
10794543|NCT03627494|11955187|FG005|NOT COMPLETED|Part A Period 2 (4 Days)||0
10794544|NCT03627494|11955188|FG006|NOT COMPLETED|Part A Period 2 (4 Days)||0
10794545|NCT03627494|11955189|FG007|NOT COMPLETED|Part A Period 2 (4 Days)||0
10794546|NCT03627494|11955190|FG008|NOT COMPLETED|Part A Period 2 (4 Days)||0
10794547|NCT03627494|11955191|FG009|NOT COMPLETED|Part A Period 2 (4 Days)||0
10794548|NCT03627494|11955192|FG010|NOT COMPLETED|Part A Period 2 (4 Days)||0
10569733|NCT01651117|11724999|FG001|STARTED|Overall Study||205
10569734|NCT01651117|11725000|FG002|STARTED|Overall Study||49
10569735|NCT01651117|11725001|FG003|STARTED|Overall Study||70
10569736|NCT01651117|11724998|FG000|COMPLETED|Overall Study||154
10569737|NCT01651117|11724999|FG001|COMPLETED|Overall Study||202
10569738|NCT01651117|11725000|FG002|COMPLETED|Overall Study||47
10569739|NCT01651117|11725001|FG003|COMPLETED|Overall Study||68
10569740|NCT01651117|11724998|FG000|NOT COMPLETED|Overall Study||2
10569741|NCT01651117|11724999|FG001|NOT COMPLETED|Overall Study||3
10569742|NCT01651117|11725000|FG002|NOT COMPLETED|Overall Study||2
10569743|NCT01651117|11725001|FG003|NOT COMPLETED|Overall Study||2
10569744|NCT01651195|11725018|FG000|STARTED|Overall Study||284
10569745|NCT01651195|11725019|FG001|STARTED|Overall Study||284
10569746|NCT01651195|11725020|FG002|STARTED|Overall Study||204
10794549|NCT03627494|11955193|FG011|NOT COMPLETED|Part A Period 2 (4 Days)||0
10794550|NCT03627494|11955182|FG000|STARTED|Part A Washout 2 (7 Days)||3
10794551|NCT03627494|11955183|FG001|STARTED|Part A Washout 2 (7 Days)||3
10569747|NCT01651195|11725021|FG003|STARTED|Overall Study||211
10569748|NCT01651195|11725018|FG000|COMPLETED|Overall Study||63
10569749|NCT01651195|11725019|FG001|COMPLETED|Overall Study||73
10569750|NCT01651195|11725020|FG002|COMPLETED|Overall Study||121
10569751|NCT01651195|11725021|FG003|COMPLETED|Overall Study||103
10569752|NCT01651195|11725018|FG000|NOT COMPLETED|Overall Study||221
10569753|NCT01651195|11725019|FG001|NOT COMPLETED|Overall Study||211
10569754|NCT01651195|11725020|FG002|NOT COMPLETED|Overall Study||83
10569755|NCT01651195|11725021|FG003|NOT COMPLETED|Overall Study||108
10569756|NCT01651208|11725037|FG000|STARTED|Overall Study||227
10569757|NCT01651208|11725038|FG001|STARTED|Overall Study||225
10569758|NCT01651208|11725037|FG000|COMPLETED|Overall Study|14 patients had no pharmacy claims data to analyze primary outcome|213
10569759|NCT01651208|11725038|FG001|COMPLETED|Overall Study|16 subjects had no pharmacy claims data to analyze primary outcome|209
10569760|NCT01651208|11725037|FG000|NOT COMPLETED|Overall Study||14
10569761|NCT01651208|11725038|FG001|NOT COMPLETED|Overall Study||16
10569762|NCT01651260|11725045|FG000|STARTED|Overall Study||65
10569763|NCT01651260|11725045|FG000|COMPLETED|Overall Study||62
10794552|NCT03627494|11955184|FG002|STARTED|Part A Washout 2 (7 Days)||3
10794553|NCT03627494|11955185|FG003|STARTED|Part A Washout 2 (7 Days)||3
10794554|NCT03627494|11955186|FG004|STARTED|Part A Washout 2 (7 Days)||3
10794555|NCT03627494|11955187|FG005|STARTED|Part A Washout 2 (7 Days)||3
10794556|NCT03627494|11955188|FG006|STARTED|Part A Washout 2 (7 Days)||0
10794557|NCT03627494|11955189|FG007|STARTED|Part A Washout 2 (7 Days)||0
10794558|NCT03627494|11955190|FG008|STARTED|Part A Washout 2 (7 Days)||0
10794559|NCT03627494|11955191|FG009|STARTED|Part A Washout 2 (7 Days)||0
10794560|NCT03627494|11955192|FG010|STARTED|Part A Washout 2 (7 Days)||0
10794561|NCT03627494|11955193|FG011|STARTED|Part A Washout 2 (7 Days)||0
10794562|NCT03627494|11955182|FG000|COMPLETED|Part A Washout 2 (7 Days)||2
10794563|NCT03627494|11955183|FG001|COMPLETED|Part A Washout 2 (7 Days)||3
10794564|NCT03627494|11955184|FG002|COMPLETED|Part A Washout 2 (7 Days)||2
10794565|NCT03627494|11955185|FG003|COMPLETED|Part A Washout 2 (7 Days)||3
10794566|NCT03627494|11955186|FG004|COMPLETED|Part A Washout 2 (7 Days)||3
10794567|NCT03627494|11955187|FG005|COMPLETED|Part A Washout 2 (7 Days)||3
10794568|NCT03627494|11955188|FG006|COMPLETED|Part A Washout 2 (7 Days)||0
10794569|NCT03627494|11955189|FG007|COMPLETED|Part A Washout 2 (7 Days)||0
10794570|NCT03627494|11955190|FG008|COMPLETED|Part A Washout 2 (7 Days)||0
10794571|NCT03627494|11955191|FG009|COMPLETED|Part A Washout 2 (7 Days)||0
10794572|NCT03627494|11955192|FG010|COMPLETED|Part A Washout 2 (7 Days)||0
10794573|NCT03627494|11955193|FG011|COMPLETED|Part A Washout 2 (7 Days)||0
10794574|NCT03627494|11955182|FG000|NOT COMPLETED|Part A Washout 2 (7 Days)||1
10794575|NCT03627494|11955183|FG001|NOT COMPLETED|Part A Washout 2 (7 Days)||0
10794576|NCT03627494|11955184|FG002|NOT COMPLETED|Part A Washout 2 (7 Days)||1
10794577|NCT03627494|11955185|FG003|NOT COMPLETED|Part A Washout 2 (7 Days)||0
10794578|NCT03627494|11955186|FG004|NOT COMPLETED|Part A Washout 2 (7 Days)||0
10794579|NCT03627494|11955187|FG005|NOT COMPLETED|Part A Washout 2 (7 Days)||0
10794580|NCT03627494|11955188|FG006|NOT COMPLETED|Part A Washout 2 (7 Days)||0
10794581|NCT03627494|11955189|FG007|NOT COMPLETED|Part A Washout 2 (7 Days)||0
10794582|NCT03627494|11955190|FG008|NOT COMPLETED|Part A Washout 2 (7 Days)||0
10794583|NCT03627494|11955191|FG009|NOT COMPLETED|Part A Washout 2 (7 Days)||0
10794584|NCT03627494|11955192|FG010|NOT COMPLETED|Part A Washout 2 (7 Days)||0
10794585|NCT03627494|11955193|FG011|NOT COMPLETED|Part A Washout 2 (7 Days)||0
10794586|NCT03627494|11955182|FG000|STARTED|Part A Period3(4days)+Follow-up(14days)||2
10794587|NCT03627494|11955183|FG001|STARTED|Part A Period3(4days)+Follow-up(14days)||3
10794588|NCT03627494|11955184|FG002|STARTED|Part A Period3(4days)+Follow-up(14days)||2
10794589|NCT03627494|11955185|FG003|STARTED|Part A Period3(4days)+Follow-up(14days)||3
10794590|NCT03627494|11955186|FG004|STARTED|Part A Period3(4days)+Follow-up(14days)||3
10794591|NCT03627494|11955187|FG005|STARTED|Part A Period3(4days)+Follow-up(14days)||3
10794592|NCT03627494|11955188|FG006|STARTED|Part A Period3(4days)+Follow-up(14days)||0
10794593|NCT03627494|11955189|FG007|STARTED|Part A Period3(4days)+Follow-up(14days)||0
10794594|NCT03627494|11955190|FG008|STARTED|Part A Period3(4days)+Follow-up(14days)||0
10794595|NCT03627494|11955191|FG009|STARTED|Part A Period3(4days)+Follow-up(14days)||0
10794596|NCT03627494|11955192|FG010|STARTED|Part A Period3(4days)+Follow-up(14days)||0
10794597|NCT03627494|11955193|FG011|STARTED|Part A Period3(4days)+Follow-up(14days)||0
10794598|NCT03627494|11955182|FG000|COMPLETED|Part A Period3(4days)+Follow-up(14days)||2
10794599|NCT03627494|11955183|FG001|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3
10794600|NCT03627494|11955184|FG002|COMPLETED|Part A Period3(4days)+Follow-up(14days)||2
10794601|NCT03627494|11955185|FG003|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3
10794602|NCT03627494|11955186|FG004|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3
10794603|NCT03627494|11955187|FG005|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3
10794604|NCT03627494|11955188|FG006|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
10794605|NCT03627494|11955189|FG007|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
10794606|NCT03627494|11955190|FG008|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
10794607|NCT03627494|11955191|FG009|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
10794608|NCT03627494|11955192|FG010|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
10794609|NCT03627494|11955193|FG011|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
10794610|NCT03627494|11955182|FG000|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
10794611|NCT03627494|11955183|FG001|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
10794612|NCT03627494|11955184|FG002|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
10794613|NCT03627494|11955185|FG003|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
10794614|NCT03627494|11955186|FG004|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
10794615|NCT03627494|11955187|FG005|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
10794616|NCT03627494|11955188|FG006|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
10794617|NCT03627494|11955189|FG007|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
10794618|NCT03627494|11955190|FG008|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
10794619|NCT03627494|11955191|FG009|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
10569764|NCT01651260|11725045|FG000|NOT COMPLETED|Overall Study||3
10569765|NCT01651351|11725052|FG000|STARTED|Overall Study||15
10569766|NCT01651351|11725053|FG001|STARTED|Overall Study||15
10569767|NCT01651351|11725052|FG000|COMPLETED|Overall Study||15
10794620|NCT03627494|11955192|FG010|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
10794621|NCT03627494|11955193|FG011|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
10794622|NCT03627494|11955182|FG000|STARTED|Part B (Maximum of 34 Days)||0
10794623|NCT03627494|11955183|FG001|STARTED|Part B (Maximum of 34 Days)||0
10794624|NCT03627494|11955184|FG002|STARTED|Part B (Maximum of 34 Days)||0
10794625|NCT03627494|11955185|FG003|STARTED|Part B (Maximum of 34 Days)||0
10794626|NCT03627494|11955186|FG004|STARTED|Part B (Maximum of 34 Days)||0
10794627|NCT03627494|11955187|FG005|STARTED|Part B (Maximum of 34 Days)||0
10794628|NCT03627494|11955188|FG006|STARTED|Part B (Maximum of 34 Days)||9
10794629|NCT03627494|11955189|FG007|STARTED|Part B (Maximum of 34 Days)||9
10794630|NCT03627494|11955190|FG008|STARTED|Part B (Maximum of 34 Days)||9
10794631|NCT03627494|11955191|FG009|STARTED|Part B (Maximum of 34 Days)||9
10794632|NCT03627494|11955192|FG010|STARTED|Part B (Maximum of 34 Days)||0
10794633|NCT03627494|11955193|FG011|STARTED|Part B (Maximum of 34 Days)||0
10794634|NCT03627494|11955182|FG000|COMPLETED|Part B (Maximum of 34 Days)||0
10794635|NCT03627494|11955183|FG001|COMPLETED|Part B (Maximum of 34 Days)||0
10794636|NCT03627494|11955184|FG002|COMPLETED|Part B (Maximum of 34 Days)||0
10794637|NCT03627494|11955185|FG003|COMPLETED|Part B (Maximum of 34 Days)||0
10794638|NCT03627494|11955186|FG004|COMPLETED|Part B (Maximum of 34 Days)||0
10794639|NCT03627494|11955187|FG005|COMPLETED|Part B (Maximum of 34 Days)||0
10794640|NCT03627494|11955188|FG006|COMPLETED|Part B (Maximum of 34 Days)||9
10794641|NCT03627494|11955189|FG007|COMPLETED|Part B (Maximum of 34 Days)||9
10794642|NCT03627494|11955190|FG008|COMPLETED|Part B (Maximum of 34 Days)||7
10794643|NCT03627494|11955191|FG009|COMPLETED|Part B (Maximum of 34 Days)||9
10794644|NCT03627494|11955192|FG010|COMPLETED|Part B (Maximum of 34 Days)||0
10794645|NCT03627494|11955193|FG011|COMPLETED|Part B (Maximum of 34 Days)||0
10794646|NCT03627494|11955182|FG000|NOT COMPLETED|Part B (Maximum of 34 Days)||0
10794647|NCT03627494|11955183|FG001|NOT COMPLETED|Part B (Maximum of 34 Days)||0
10794648|NCT03627494|11955184|FG002|NOT COMPLETED|Part B (Maximum of 34 Days)||0
10794649|NCT03627494|11955185|FG003|NOT COMPLETED|Part B (Maximum of 34 Days)||0
10794650|NCT03627494|11955186|FG004|NOT COMPLETED|Part B (Maximum of 34 Days)||0
10794651|NCT03627494|11955187|FG005|NOT COMPLETED|Part B (Maximum of 34 Days)||0
10794652|NCT03627494|11955188|FG006|NOT COMPLETED|Part B (Maximum of 34 Days)||0
10794653|NCT03627494|11955189|FG007|NOT COMPLETED|Part B (Maximum of 34 Days)||0
10794654|NCT03627494|11955190|FG008|NOT COMPLETED|Part B (Maximum of 34 Days)||2
10794655|NCT03627494|11955191|FG009|NOT COMPLETED|Part B (Maximum of 34 Days)||0
10794656|NCT03627494|11955192|FG010|NOT COMPLETED|Part B (Maximum of 34 Days)||0
10794657|NCT03627494|11955193|FG011|NOT COMPLETED|Part B (Maximum of 34 Days)||0
10794658|NCT03627494|11955182|FG000|STARTED|Part C Period 1 (4 Days)||0
10794659|NCT03627494|11955183|FG001|STARTED|Part C Period 1 (4 Days)||0
10794660|NCT03627494|11955184|FG002|STARTED|Part C Period 1 (4 Days)||0
10794661|NCT03627494|11955185|FG003|STARTED|Part C Period 1 (4 Days)||0
10794662|NCT03627494|11955186|FG004|STARTED|Part C Period 1 (4 Days)||0
10794663|NCT03627494|11955187|FG005|STARTED|Part C Period 1 (4 Days)||0
10794664|NCT03627494|11955188|FG006|STARTED|Part C Period 1 (4 Days)||0
10794665|NCT03627494|11955189|FG007|STARTED|Part C Period 1 (4 Days)||0
10794666|NCT03627494|11955190|FG008|STARTED|Part C Period 1 (4 Days)||0
10794667|NCT03627494|11955191|FG009|STARTED|Part C Period 1 (4 Days)||0
10794668|NCT03627494|11955192|FG010|STARTED|Part C Period 1 (4 Days)||6
10794669|NCT03627494|11955193|FG011|STARTED|Part C Period 1 (4 Days)||6
10794670|NCT03627494|11955182|FG000|COMPLETED|Part C Period 1 (4 Days)||0
10794671|NCT03627494|11955183|FG001|COMPLETED|Part C Period 1 (4 Days)||0
10794672|NCT03627494|11955184|FG002|COMPLETED|Part C Period 1 (4 Days)||0
10794673|NCT03627494|11955185|FG003|COMPLETED|Part C Period 1 (4 Days)||0
10794674|NCT03627494|11955186|FG004|COMPLETED|Part C Period 1 (4 Days)||0
10794675|NCT03627494|11955187|FG005|COMPLETED|Part C Period 1 (4 Days)||0
10794676|NCT03627494|11955188|FG006|COMPLETED|Part C Period 1 (4 Days)||0
10794677|NCT03627494|11955189|FG007|COMPLETED|Part C Period 1 (4 Days)||0
10794678|NCT03627494|11955190|FG008|COMPLETED|Part C Period 1 (4 Days)||0
10794679|NCT03627494|11955191|FG009|COMPLETED|Part C Period 1 (4 Days)||0
10794680|NCT03627494|11955192|FG010|COMPLETED|Part C Period 1 (4 Days)||6
10794681|NCT03627494|11955193|FG011|COMPLETED|Part C Period 1 (4 Days)||6
10794682|NCT03627494|11955182|FG000|NOT COMPLETED|Part C Period 1 (4 Days)||0
10794683|NCT03627494|11955183|FG001|NOT COMPLETED|Part C Period 1 (4 Days)||0
10794684|NCT03627494|11955184|FG002|NOT COMPLETED|Part C Period 1 (4 Days)||0
10794685|NCT03627494|11955185|FG003|NOT COMPLETED|Part C Period 1 (4 Days)||0
10794686|NCT03627494|11955186|FG004|NOT COMPLETED|Part C Period 1 (4 Days)||0
10794687|NCT03627494|11955187|FG005|NOT COMPLETED|Part C Period 1 (4 Days)||0
10794688|NCT03627494|11955188|FG006|NOT COMPLETED|Part C Period 1 (4 Days)||0
10794689|NCT03627494|11955189|FG007|NOT COMPLETED|Part C Period 1 (4 Days)||0
10794690|NCT03627494|11955190|FG008|NOT COMPLETED|Part C Period 1 (4 Days)||0
10794691|NCT03627494|11955191|FG009|NOT COMPLETED|Part C Period 1 (4 Days)||0
10794692|NCT03627494|11955192|FG010|NOT COMPLETED|Part C Period 1 (4 Days)||0
10794693|NCT03627494|11955193|FG011|NOT COMPLETED|Part C Period 1 (4 Days)||0
10794694|NCT03627494|11955182|FG000|STARTED|Part C Washout 1 (7 Days)||0
10794695|NCT03627494|11955183|FG001|STARTED|Part C Washout 1 (7 Days)||0
10794696|NCT03627494|11955184|FG002|STARTED|Part C Washout 1 (7 Days)||0
10569768|NCT01651351|11725053|FG001|COMPLETED|Overall Study||15
10569769|NCT01651351|11725052|FG000|NOT COMPLETED|Overall Study||0
10569770|NCT01651351|11725053|FG001|NOT COMPLETED|Overall Study||0
10569771|NCT01651442|11725062|FG000|STARTED|Phase I Treatment||104
10569772|NCT01651442|11725063|FG001|STARTED|Phase I Treatment||107
10569773|NCT01651442|11725064|FG002|STARTED|Phase I Treatment||0
10569774|NCT01651442|11725065|FG003|STARTED|Phase I Treatment||0
10569775|NCT01651442|11725066|FG004|STARTED|Phase I Treatment||0
10569776|NCT01651442|11725067|FG005|STARTED|Phase I Treatment||0
10794697|NCT03627494|11955185|FG003|STARTED|Part C Washout 1 (7 Days)||0
10794698|NCT03627494|11955186|FG004|STARTED|Part C Washout 1 (7 Days)||0
10794699|NCT03627494|11955187|FG005|STARTED|Part C Washout 1 (7 Days)||0
10794700|NCT03627494|11955188|FG006|STARTED|Part C Washout 1 (7 Days)||0
10794701|NCT03627494|11955189|FG007|STARTED|Part C Washout 1 (7 Days)||0
10794702|NCT03627494|11955190|FG008|STARTED|Part C Washout 1 (7 Days)||0
10794703|NCT03627494|11955191|FG009|STARTED|Part C Washout 1 (7 Days)||0
10794704|NCT03627494|11955192|FG010|STARTED|Part C Washout 1 (7 Days)||6
10794705|NCT03627494|11955193|FG011|STARTED|Part C Washout 1 (7 Days)||6
10794706|NCT03627494|11955182|FG000|COMPLETED|Part C Washout 1 (7 Days)||0
10794707|NCT03627494|11955183|FG001|COMPLETED|Part C Washout 1 (7 Days)||0
10794708|NCT03627494|11955184|FG002|COMPLETED|Part C Washout 1 (7 Days)||0
10794709|NCT03627494|11955185|FG003|COMPLETED|Part C Washout 1 (7 Days)||0
10794710|NCT03627494|11955186|FG004|COMPLETED|Part C Washout 1 (7 Days)||0
10794711|NCT03627494|11955187|FG005|COMPLETED|Part C Washout 1 (7 Days)||0
10794712|NCT03627494|11955188|FG006|COMPLETED|Part C Washout 1 (7 Days)||0
10794713|NCT03627494|11955189|FG007|COMPLETED|Part C Washout 1 (7 Days)||0
10794714|NCT03627494|11955190|FG008|COMPLETED|Part C Washout 1 (7 Days)||0
10794715|NCT03627494|11955191|FG009|COMPLETED|Part C Washout 1 (7 Days)||0
10794716|NCT03627494|11955192|FG010|COMPLETED|Part C Washout 1 (7 Days)||5
10794717|NCT03627494|11955193|FG011|COMPLETED|Part C Washout 1 (7 Days)||5
10794718|NCT03627494|11955182|FG000|NOT COMPLETED|Part C Washout 1 (7 Days)||0
10794719|NCT03627494|11955183|FG001|NOT COMPLETED|Part C Washout 1 (7 Days)||0
10794720|NCT03627494|11955184|FG002|NOT COMPLETED|Part C Washout 1 (7 Days)||0
10794721|NCT03627494|11955185|FG003|NOT COMPLETED|Part C Washout 1 (7 Days)||0
10794722|NCT03627494|11955186|FG004|NOT COMPLETED|Part C Washout 1 (7 Days)||0
10794723|NCT03627494|11955187|FG005|NOT COMPLETED|Part C Washout 1 (7 Days)||0
10794724|NCT03627494|11955188|FG006|NOT COMPLETED|Part C Washout 1 (7 Days)||0
10794725|NCT03627494|11955189|FG007|NOT COMPLETED|Part C Washout 1 (7 Days)||0
10794726|NCT03627494|11955190|FG008|NOT COMPLETED|Part C Washout 1 (7 Days)||0
10794727|NCT03627494|11955191|FG009|NOT COMPLETED|Part C Washout 1 (7 Days)||0
10794728|NCT03627494|11955192|FG010|NOT COMPLETED|Part C Washout 1 (7 Days)||1
10794729|NCT03627494|11955193|FG011|NOT COMPLETED|Part C Washout 1 (7 Days)||1
10794730|NCT03627494|11955182|FG000|STARTED|Part C Period2(4days)+Follow-up(14days)||0
10794731|NCT03627494|11955183|FG001|STARTED|Part C Period2(4days)+Follow-up(14days)||0
10794732|NCT03627494|11955184|FG002|STARTED|Part C Period2(4days)+Follow-up(14days)||0
10794733|NCT03627494|11955185|FG003|STARTED|Part C Period2(4days)+Follow-up(14days)||0
10794734|NCT03627494|11955186|FG004|STARTED|Part C Period2(4days)+Follow-up(14days)||0
10794735|NCT03627494|11955187|FG005|STARTED|Part C Period2(4days)+Follow-up(14days)||0
10794736|NCT03627494|11955188|FG006|STARTED|Part C Period2(4days)+Follow-up(14days)||0
10794737|NCT03627494|11955189|FG007|STARTED|Part C Period2(4days)+Follow-up(14days)||0
10794738|NCT03627494|11955190|FG008|STARTED|Part C Period2(4days)+Follow-up(14days)||0
10794739|NCT03627494|11955191|FG009|STARTED|Part C Period2(4days)+Follow-up(14days)||0
10794740|NCT03627494|11955192|FG010|STARTED|Part C Period2(4days)+Follow-up(14days)||5
10794741|NCT03627494|11955193|FG011|STARTED|Part C Period2(4days)+Follow-up(14days)||5
10794742|NCT03627494|11955182|FG000|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
10794743|NCT03627494|11955183|FG001|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
10794744|NCT03627494|11955184|FG002|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
10794745|NCT03627494|11955185|FG003|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
10794746|NCT03627494|11955186|FG004|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
10794747|NCT03627494|11955187|FG005|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
10794748|NCT03627494|11955188|FG006|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
10794749|NCT03627494|11955189|FG007|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
10794750|NCT03627494|11955190|FG008|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
10794751|NCT03627494|11955191|FG009|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
10794752|NCT03627494|11955192|FG010|COMPLETED|Part C Period2(4days)+Follow-up(14days)||5
10794753|NCT03627494|11955193|FG011|COMPLETED|Part C Period2(4days)+Follow-up(14days)||5
10794754|NCT03627494|11955182|FG000|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
10569777|NCT01651442|11725062|FG000|COMPLETED|Phase I Treatment||88
10569778|NCT01651442|11725063|FG001|COMPLETED|Phase I Treatment||80
10569779|NCT01651442|11725064|FG002|COMPLETED|Phase I Treatment||0
10569780|NCT01651442|11725065|FG003|COMPLETED|Phase I Treatment||0
10569781|NCT01651442|11725066|FG004|COMPLETED|Phase I Treatment||0
10569782|NCT01651442|11725067|FG005|COMPLETED|Phase I Treatment||0
10569783|NCT01651442|11725062|FG000|NOT COMPLETED|Phase I Treatment||16
10569784|NCT01651442|11725063|FG001|NOT COMPLETED|Phase I Treatment||27
10794755|NCT03627494|11955183|FG001|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
10794756|NCT03627494|11955184|FG002|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
10794757|NCT03627494|11955185|FG003|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
10794758|NCT03627494|11955186|FG004|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
10794759|NCT03627494|11955187|FG005|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
10794760|NCT03627494|11955188|FG006|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
10569785|NCT01651442|11725064|FG002|NOT COMPLETED|Phase I Treatment||0
10569786|NCT01651442|11725065|FG003|NOT COMPLETED|Phase I Treatment||0
10569787|NCT01651442|11725066|FG004|NOT COMPLETED|Phase I Treatment||0
10569788|NCT01651442|11725067|FG005|NOT COMPLETED|Phase I Treatment||0
10569789|NCT01651442|11725062|FG000|STARTED|Phase II Treatment||0
10794761|NCT03627494|11955189|FG007|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
10794762|NCT03627494|11955190|FG008|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
10794763|NCT03627494|11955191|FG009|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
10794764|NCT03627494|11955192|FG010|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
10794765|NCT03627494|11955193|FG011|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
10794766|NCT03627767|11955235|FG000|STARTED|Open-label (OL) Run-in Period (12 Weeks)||1235
10794767|NCT03627767|11955236|FG001|STARTED|Open-label (OL) Run-in Period (12 Weeks)||0
10794768|NCT03627767|11955237|FG002|STARTED|Open-label (OL) Run-in Period (12 Weeks)||0
10794769|NCT03627767|11955238|FG003|STARTED|Open-label (OL) Run-in Period (12 Weeks)||0
10794770|NCT03627767|11955239|FG004|STARTED|Open-label (OL) Run-in Period (12 Weeks)||0
10794771|NCT03627767|11955235|FG000|Treated|Open-label (OL) Run-in Period (12 Weeks)||1233
10794772|NCT03627767|11955236|FG001|Treated|Open-label (OL) Run-in Period (12 Weeks)||0
10794773|NCT03627767|11955237|FG002|Treated|Open-label (OL) Run-in Period (12 Weeks)||0
10794774|NCT03627767|11955238|FG003|Treated|Open-label (OL) Run-in Period (12 Weeks)||0
10794775|NCT03627767|11955239|FG004|Treated|Open-label (OL) Run-in Period (12 Weeks)||0
10794776|NCT03627767|11955235|FG000|COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||798
10794777|NCT03627767|11955236|FG001|COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
10794778|NCT03627767|11955237|FG002|COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
10794779|NCT03627767|11955238|FG003|COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
10794780|NCT03627767|11955239|FG004|COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
10794781|NCT03627767|11955235|FG000|NOT COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||437
10794782|NCT03627767|11955236|FG001|NOT COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
10794783|NCT03627767|11955237|FG002|NOT COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
10794784|NCT03627767|11955238|FG003|NOT COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
10794785|NCT03627767|11955239|FG004|NOT COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
10794786|NCT03627767|11955235|FG000|STARTED|Double-blind Treatment Period (40 Weeks)|Participants did not enter into the DB period.|0
10794787|NCT03627767|11955236|FG001|STARTED|Double-blind Treatment Period (40 Weeks)|Participants who met the pre-defined criteria for DB.|267
10794788|NCT03627767|11955237|FG002|STARTED|Double-blind Treatment Period (40 Weeks)|Participants who met the pre-defined criteria for DB.|265
10794789|NCT03627767|11955238|FG003|STARTED|Double-blind Treatment Period (40 Weeks)|Participants who met the pre-defined criteria for DB.|266
10794790|NCT03627767|11955239|FG004|STARTED|Double-blind Treatment Period (40 Weeks)||0
10794791|NCT03627767|11955235|FG000|Participants Entered Rescue Period|Double-blind Treatment Period (40 Weeks)||0
10794792|NCT03627767|11955236|FG001|Participants Entered Rescue Period|Double-blind Treatment Period (40 Weeks)||208
10794793|NCT03627767|11955237|FG002|Participants Entered Rescue Period|Double-blind Treatment Period (40 Weeks)||109
10794794|NCT03627767|11955238|FG003|Participants Entered Rescue Period|Double-blind Treatment Period (40 Weeks)||44
10794795|NCT03627767|11955239|FG004|Participants Entered Rescue Period|Double-blind Treatment Period (40 Weeks)||0
10794796|NCT03627767|11955235|FG000|Completed After Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||0
10794797|NCT03627767|11955236|FG001|Completed After Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||201
10794798|NCT03627767|11955237|FG002|Completed After Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||99
10794799|NCT03627767|11955238|FG003|Completed After Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||41
10794800|NCT03627767|11955239|FG004|Completed After Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||0
10794801|NCT03627767|11955235|FG000|Completed Without Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||0
10794802|NCT03627767|11955236|FG001|Completed Without Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||43
10794803|NCT03627767|11955237|FG002|Completed Without Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||134
10794804|NCT03627767|11955238|FG003|Completed Without Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||187
10794805|NCT03627767|11955239|FG004|Completed Without Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||0
10794806|NCT03627767|11955235|FG000|COMPLETED|Double-blind Treatment Period (40 Weeks)||0
10794807|NCT03627767|11955236|FG001|COMPLETED|Double-blind Treatment Period (40 Weeks)|208 entered RP+43 completed study in DB period|251
10794808|NCT03627767|11955237|FG002|COMPLETED|Double-blind Treatment Period (40 Weeks)|109 entered RP+134 completed study in DB period|243
10794809|NCT03627767|11955238|FG003|COMPLETED|Double-blind Treatment Period (40 Weeks)|44 entered RP+187 completed study in DB period|231
10794810|NCT03627767|11955239|FG004|COMPLETED|Double-blind Treatment Period (40 Weeks)||0
10794811|NCT03627767|11955235|FG000|NOT COMPLETED|Double-blind Treatment Period (40 Weeks)||0
10794812|NCT03627767|11955236|FG001|NOT COMPLETED|Double-blind Treatment Period (40 Weeks)||16
10794813|NCT03627767|11955237|FG002|NOT COMPLETED|Double-blind Treatment Period (40 Weeks)||22
10794814|NCT03627767|11955238|FG003|NOT COMPLETED|Double-blind Treatment Period (40 Weeks)||35
10794815|NCT03627767|11955239|FG004|NOT COMPLETED|Double-blind Treatment Period (40 Weeks)||0
10794816|NCT03627767|11955235|FG000|STARTED|Open-label Rescue Period (12 Weeks)||0
10794817|NCT03627767|11955236|FG001|STARTED|Open-label Rescue Period (12 Weeks)|Participants did not enter into the OL- Rescue Period.|0
10569790|NCT01651442|11725063|FG001|STARTED|Phase II Treatment||0
10569791|NCT01651442|11725064|FG002|STARTED|Phase II Treatment||27
10569792|NCT01651442|11725065|FG003|STARTED|Phase II Treatment||27
10569793|NCT01651442|11725066|FG004|STARTED|Phase II Treatment||27
10569794|NCT01651442|11725067|FG005|STARTED|Phase II Treatment||27
10569795|NCT01651442|11725062|FG000|COMPLETED|Phase II Treatment||0
10569796|NCT01651442|11725063|FG001|COMPLETED|Phase II Treatment||0
10569797|NCT01651442|11725064|FG002|COMPLETED|Phase II Treatment||25
10569798|NCT01651442|11725065|FG003|COMPLETED|Phase II Treatment||15
10569799|NCT01651442|11725066|FG004|COMPLETED|Phase II Treatment||21
10569800|NCT01651442|11725067|FG005|COMPLETED|Phase II Treatment||17
10569801|NCT01651442|11725062|FG000|NOT COMPLETED|Phase II Treatment||0
10569802|NCT01651442|11725063|FG001|NOT COMPLETED|Phase II Treatment||0
10569803|NCT01651442|11725064|FG002|NOT COMPLETED|Phase II Treatment||2
10569804|NCT01651442|11725065|FG003|NOT COMPLETED|Phase II Treatment||12
10569805|NCT01651442|11725066|FG004|NOT COMPLETED|Phase II Treatment||6
10569806|NCT01651442|11725067|FG005|NOT COMPLETED|Phase II Treatment||10
10569807|NCT01651780|11725081|FG000|STARTED|Overall Study||405
10569808|NCT01651780|11725082|FG001|STARTED|Overall Study||398
10569809|NCT01651780|11725081|FG000|Intent-To-Treat (ITT) Population|Overall Study||404
10569810|NCT01651780|11725082|FG001|Intent-To-Treat (ITT) Population|Overall Study||398
10569811|NCT01651780|11725081|FG000|Received at Least 1 Dose of Study Drug|Overall Study|All but 1 participant in the bivalirudin group (withdrew consent) comprised the ITT population.|393
10569812|NCT01651780|11725082|FG001|Received at Least 1 Dose of Study Drug|Overall Study||394
10569813|NCT01651780|11725081|FG000|BRAVO 2 Feasibility Cohort|Overall Study|1st 2 participants/site made up the bivalirudin feasibility cohort (BRAVO2) and analyzed separately.|65
10569814|NCT01651780|11725082|FG001|BRAVO 2 Feasibility Cohort|Overall Study|1st 2 participants/site made up the bivalirudin feasibility cohort (BRAVO2) and analyzed separately.|0
10569815|NCT01651780|11725081|FG000|COMPLETED|Overall Study||394
10569816|NCT01651780|11725082|FG001|COMPLETED|Overall Study||388
10569817|NCT01651780|11725081|FG000|NOT COMPLETED|Overall Study||11
10569818|NCT01651780|11725082|FG001|NOT COMPLETED|Overall Study||10
10569819|NCT01651793|11725092|FG000|STARTED|Overall Study||6
10569820|NCT01651793|11725093|FG001|STARTED|Overall Study||6
10569821|NCT01651793|11725094|FG002|STARTED|Overall Study||6
10569822|NCT01651793|11725095|FG003|STARTED|Overall Study||6
10569823|NCT01651793|11725092|FG000|COMPLETED|Overall Study||6
10569824|NCT01651793|11725093|FG001|COMPLETED|Overall Study||6
10569825|NCT01651793|11725094|FG002|COMPLETED|Overall Study||6
10569826|NCT01651793|11725095|FG003|COMPLETED|Overall Study||5
10569827|NCT01651793|11725092|FG000|NOT COMPLETED|Overall Study||0
10569828|NCT01651793|11725093|FG001|NOT COMPLETED|Overall Study||0
10569829|NCT01651793|11725094|FG002|NOT COMPLETED|Overall Study||0
10569830|NCT01651793|11725095|FG003|NOT COMPLETED|Overall Study||1
10569831|NCT01651806|11725114|FG000|STARTED|Overall Study||13
10569832|NCT01651806|11725115|FG001|STARTED|Overall Study||12
10569833|NCT01651806|11725116|FG002|STARTED|Overall Study||25
10569834|NCT01651806|11725117|FG003|STARTED|Overall Study||7
10569835|NCT01651806|11725118|FG004|STARTED|Overall Study||8
10569836|NCT01651806|11725114|FG000|COMPLETED|Overall Study||13
10569837|NCT01651806|11725115|FG001|COMPLETED|Overall Study||12
10569838|NCT01651806|11725116|FG002|COMPLETED|Overall Study||25
10569839|NCT01651806|11725117|FG003|COMPLETED|Overall Study||7
10569840|NCT01651806|11725118|FG004|COMPLETED|Overall Study||8
10569841|NCT01651806|11725114|FG000|NOT COMPLETED|Overall Study||0
10569842|NCT01651806|11725115|FG001|NOT COMPLETED|Overall Study||0
10569843|NCT01651806|11725116|FG002|NOT COMPLETED|Overall Study||0
10569844|NCT01651806|11725117|FG003|NOT COMPLETED|Overall Study||0
10569845|NCT01651806|11725118|FG004|NOT COMPLETED|Overall Study||0
10569846|NCT01651936|11725133|FG000|STARTED|Base Study||30
10569847|NCT01651936|11725134|FG001|STARTED|Base Study||26
10569848|NCT01651936|11725135|FG002|STARTED|Base Study||0
10569849|NCT01651936|11725133|FG000|COMPLETED|Base Study||3
10569850|NCT01651936|11725134|FG001|COMPLETED|Base Study||1
10569851|NCT01651936|11725135|FG002|COMPLETED|Base Study||0
10569852|NCT01651936|11725133|FG000|NOT COMPLETED|Base Study||27
10569853|NCT01651936|11725134|FG001|NOT COMPLETED|Base Study||25
10569854|NCT01651936|11725135|FG002|NOT COMPLETED|Base Study||0
10569855|NCT01651936|11725133|FG000|STARTED|Extension Study||0
10569856|NCT01651936|11725134|FG001|STARTED|Extension Study||0
10569857|NCT01651936|11725135|FG002|STARTED|Extension Study|Includes completers and early escapees from the Base Study|14
10569858|NCT01651936|11725133|FG000|COMPLETED|Extension Study||0
10569859|NCT01651936|11725134|FG001|COMPLETED|Extension Study||0
10569860|NCT01651936|11725135|FG002|COMPLETED|Extension Study||0
10569861|NCT01651936|11725133|FG000|NOT COMPLETED|Extension Study||0
10569862|NCT01651936|11725134|FG001|NOT COMPLETED|Extension Study||0
10569863|NCT01651936|11725135|FG002|NOT COMPLETED|Extension Study||14
10569864|NCT01651949|11725145|FG000|STARTED|Overall Study||1106
10569865|NCT01651949|11725146|FG001|STARTED|Overall Study||1101
10569866|NCT01651949|11725147|FG002|STARTED|Overall Study||313
10569867|NCT01651949|11725145|FG000|Vaccination 1|Overall Study||1103
10569868|NCT01651949|11725146|FG001|Vaccination 1|Overall Study||1099
10569869|NCT01651949|11725147|FG002|Vaccination 1|Overall Study||313
10569870|NCT01651949|11725145|FG000|Vaccination 2|Overall Study||1089
10569871|NCT01651949|11725146|FG001|Vaccination 2|Overall Study||1069
10569872|NCT01651949|11725147|FG002|Vaccination 2|Overall Study||298
10569873|NCT01651949|11725145|FG000|Vaccination 3|Overall Study||1067
10569874|NCT01651949|11725146|FG001|Vaccination 3|Overall Study||1037
10569875|NCT01651949|11725147|FG002|Vaccination 3|Overall Study||291
10569876|NCT01651949|11725145|FG000|COMPLETED|Overall Study||1053
10569877|NCT01651949|11725146|FG001|COMPLETED|Overall Study||1015
10569878|NCT01651949|11725147|FG002|COMPLETED|Overall Study||282
10569879|NCT01651949|11725145|FG000|NOT COMPLETED|Overall Study||53
10569880|NCT01651949|11725146|FG001|NOT COMPLETED|Overall Study||86
10569881|NCT01651949|11725147|FG002|NOT COMPLETED|Overall Study||31
10569882|NCT01652001|11725157|FG000|STARTED|Overall Study||100
10569883|NCT01652001|11725158|FG001|STARTED|Overall Study||85
10569884|NCT01652001|11725157|FG000|COMPLETED|Overall Study||91
10569885|NCT01652001|11725158|FG001|COMPLETED|Overall Study||79
10569886|NCT01652001|11725157|FG000|NOT COMPLETED|Overall Study||9
10569887|NCT01652001|11725158|FG001|NOT COMPLETED|Overall Study||6
10651204|NCT02173769|11811361|FG000|STARTED|Overall Study||1858
10651205|NCT02173769|11811361|FG000|COMPLETED|Overall Study||1854
10651206|NCT02173769|11811361|FG000|NOT COMPLETED|Overall Study||4
10651207|NCT02174198|11811368|FG000|STARTED|Overall Study||16
10651208|NCT02174198|11811369|FG001|STARTED|Overall Study||16
10651209|NCT02174198|11811368|FG000|COMPLETED|Overall Study||16
10651210|NCT02174198|11811369|FG001|COMPLETED|Overall Study||16
10651211|NCT02174198|11811368|FG000|NOT COMPLETED|Overall Study||0
10651212|NCT02174198|11811369|FG001|NOT COMPLETED|Overall Study||0
10651213|NCT02174276|11811379|FG000|STARTED|Study Treatment Phase (Weeks 1 to 48)||27
10651214|NCT02174276|11811380|FG001|STARTED|Study Treatment Phase (Weeks 1 to 48)||57
10651215|NCT02174276|11811381|FG002|STARTED|Study Treatment Phase (Weeks 1 to 48)||56
10651216|NCT02174276|11811382|FG003|STARTED|Study Treatment Phase (Weeks 1 to 48)||55
10651217|NCT02174276|11811379|FG000|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||26
10651218|NCT02174276|11811380|FG001|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||56
10651219|NCT02174276|11811381|FG002|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||53
10651220|NCT02174276|11811382|FG003|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||55
10651221|NCT02174276|11811379|FG000|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||1
10651222|NCT02174276|11811380|FG001|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||1
10651223|NCT02174276|11811381|FG002|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||3
10651224|NCT02174276|11811382|FG003|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||0
10651225|NCT02174276|11811379|FG000|STARTED|OTEP (Weeks 48 to 144)||26
10651226|NCT02174276|11811380|FG001|STARTED|OTEP (Weeks 48 to 144)|2 Participants completed the study treatment phase but did not continue in OTEP.|54
10651227|NCT02174276|11811381|FG002|STARTED|OTEP (Weeks 48 to 144)|2 Participants completed the study treatment phase but did not continue in OTEP.|51
10651228|NCT02174276|11811382|FG003|STARTED|OTEP (Weeks 48 to 144)|3 Participants completed the study treatment phase but did not continue in OTEP.|52
10651229|NCT02174276|11811379|FG000|COMPLETED|OTEP (Weeks 48 to 144)||25
10651230|NCT02174276|11811380|FG001|COMPLETED|OTEP (Weeks 48 to 144)||54
10651231|NCT02174276|11811381|FG002|COMPLETED|OTEP (Weeks 48 to 144)||48
10651232|NCT02174276|11811382|FG003|COMPLETED|OTEP (Weeks 48 to 144)||50
10651233|NCT02174276|11811379|FG000|NOT COMPLETED|OTEP (Weeks 48 to 144)||1
10651234|NCT02174276|11811380|FG001|NOT COMPLETED|OTEP (Weeks 48 to 144)||0
10651235|NCT02174276|11811381|FG002|NOT COMPLETED|OTEP (Weeks 48 to 144)||3
10651236|NCT02174276|11811382|FG003|NOT COMPLETED|OTEP (Weeks 48 to 144)||2
10651237|NCT02174419|11811395|FG000|STARTED|Overall Study||22
10651238|NCT02174419|11811396|FG001|STARTED|Overall Study||18
10651239|NCT02174419|11811397|FG002|STARTED|Overall Study||22
10651240|NCT02174419|11811395|FG000|COMPLETED|Overall Study||18
10651241|NCT02174419|11811396|FG001|COMPLETED|Overall Study||12
10651242|NCT02174419|11811397|FG002|COMPLETED|Overall Study||20
10651243|NCT02174419|11811395|FG000|NOT COMPLETED|Overall Study||4
10651244|NCT02174419|11811396|FG001|NOT COMPLETED|Overall Study||6
10651245|NCT02174419|11811397|FG002|NOT COMPLETED|Overall Study||2
10651246|NCT02174432|11811405|FG000|STARTED|Overall Study||36
10651247|NCT02174432|11811405|FG000|COMPLETED|Overall Study||16
10651248|NCT02174432|11811405|FG000|NOT COMPLETED|Overall Study||20
10651249|NCT02174510|11811413|FG000|STARTED|Overall Study||8
10651250|NCT02174510|11811414|FG001|STARTED|Overall Study||8
10651251|NCT02174510|11811415|FG002|STARTED|Overall Study||12
10651252|NCT02174510|11811416|FG003|STARTED|Overall Study||9
10651253|NCT02174510|11811413|FG000|COMPLETED|Overall Study||8
10651254|NCT02174510|11811414|FG001|COMPLETED|Overall Study||8
10651255|NCT02174510|11811415|FG002|COMPLETED|Overall Study||12
10651256|NCT02174510|11811416|FG003|COMPLETED|Overall Study||9
10651257|NCT02174510|11811413|FG000|NOT COMPLETED|Overall Study||0
10651258|NCT02174510|11811414|FG001|NOT COMPLETED|Overall Study||0
10651259|NCT02174510|11811415|FG002|NOT COMPLETED|Overall Study||0
10651260|NCT02174510|11811416|FG003|NOT COMPLETED|Overall Study||0
10651261|NCT02174523|11811427|FG000|STARTED|Overall Study||10
10651262|NCT02174523|11811428|FG001|STARTED|Overall Study||4
10651263|NCT02174523|11811427|FG000|COMPLETED|Overall Study||9
10651264|NCT02174523|11811428|FG001|COMPLETED|Overall Study||4
10651265|NCT02174523|11811427|FG000|NOT COMPLETED|Overall Study||1
10651266|NCT02174523|11811428|FG001|NOT COMPLETED|Overall Study||0
10651267|NCT02174562|11811435|FG000|STARTED|Overall Study||50
10651268|NCT02174562|11811436|FG001|STARTED|Overall Study||51
10651269|NCT02174562|11811435|FG000|COMPLETED|Overall Study||41
10651270|NCT02174562|11811436|FG001|COMPLETED|Overall Study||46
10651271|NCT02174562|11811435|FG000|NOT COMPLETED|Overall Study||9
10651272|NCT02174562|11811436|FG001|NOT COMPLETED|Overall Study||5
10651273|NCT02174627|11811444|FG000|STARTED|Overall Study||1384
10651274|NCT02174627|11811445|FG001|STARTED|Overall Study||1377
10651275|NCT02174627|11811444|FG000|Received Treatment|Overall Study||1384
10651276|NCT02174627|11811445|FG001|Received Treatment|Overall Study||1376
10651277|NCT02174627|11811444|FG000|Discontinued Treatment|Overall Study||499
10651278|NCT02174627|11811445|FG001|Discontinued Treatment|Overall Study||801
10651279|NCT02174627|11811444|FG000|COMPLETED|Overall Study||1300
10651280|NCT02174627|11811445|FG001|COMPLETED|Overall Study||1247
10569888|NCT01652040|11725166|FG000|STARTED|Overall Study||13
10569889|NCT01652040|11725167|FG001|STARTED|Overall Study||13
10569890|NCT01652040|11725166|FG000|COMPLETED|Overall Study||11
10569891|NCT01652040|11725167|FG001|COMPLETED|Overall Study||11
10569892|NCT01652040|11725166|FG000|NOT COMPLETED|Overall Study||2
10569893|NCT01652040|11725167|FG001|NOT COMPLETED|Overall Study||2
10569894|NCT01652287|11725176|FG000|STARTED|Overall Study||31
10569895|NCT01652287|11725177|FG001|STARTED|Overall Study||31
10569896|NCT01652287|11725176|FG000|COMPLETED|Overall Study|• Did not receive allocated intervention (withdrew consent) (n=2)|29
10569897|NCT01652287|11725177|FG001|COMPLETED|Overall Study||31
10569898|NCT01652287|11725176|FG000|NOT COMPLETED|Overall Study||2
10569899|NCT01652287|11725177|FG001|NOT COMPLETED|Overall Study||0
10569906|NCT01652495|11725194|FG000|STARTED|Overall Study||22
10569907|NCT01652495|11725195|FG001|STARTED|Overall Study||22
10569908|NCT01652495|11725194|FG000|COMPLETED|Overall Study||20
10569909|NCT01652495|11725195|FG001|COMPLETED|Overall Study||20
10569910|NCT01652495|11725194|FG000|NOT COMPLETED|Overall Study||2
10569911|NCT01652495|11725195|FG001|NOT COMPLETED|Overall Study||2
10569912|NCT01652573|11725205|FG000|STARTED|Overall Study||10
10569913|NCT01652573|11725206|FG001|STARTED|Overall Study||11
10569914|NCT01652573|11725205|FG000|COMPLETED|Overall Study||10
10569915|NCT01652573|11725206|FG001|COMPLETED|Overall Study||10
10569916|NCT01652573|11725205|FG000|NOT COMPLETED|Overall Study||0
10569917|NCT01652573|11725206|FG001|NOT COMPLETED|Overall Study||1
10569918|NCT01652664|11725214|FG000|STARTED|Overall Study||77
10569919|NCT01652664|11725215|FG001|STARTED|Overall Study||75
10569920|NCT01652664|11725214|FG000|COMPLETED|Overall Study||71
10569921|NCT01652664|11725215|FG001|COMPLETED|Overall Study||74
10569922|NCT01652664|11725214|FG000|NOT COMPLETED|Overall Study||6
10569923|NCT01652664|11725215|FG001|NOT COMPLETED|Overall Study||1
10569924|NCT01652690|11725224|FG000|STARTED|Overall Study||300
10569925|NCT01652690|11725225|FG001|STARTED|Overall Study||300
10569926|NCT01652690|11725224|FG000|COMPLETED|Overall Study||265
10569927|NCT01652690|11725225|FG001|COMPLETED|Overall Study||279
10569928|NCT01652690|11725224|FG000|NOT COMPLETED|Overall Study||35
10569929|NCT01652690|11725225|FG001|NOT COMPLETED|Overall Study||21
10569930|NCT01652703|11725237|FG000|STARTED|Overall Study||52
10569931|NCT01652703|11725238|FG001|STARTED|Overall Study||51
10569932|NCT01652703|11725239|FG002|STARTED|Overall Study||50
10569933|NCT01652703|11725240|FG003|STARTED|Overall Study||52
10569934|NCT01652703|11725241|FG004|STARTED|Overall Study||52
10569935|NCT01652703|11725242|FG005|STARTED|Overall Study||53
10569936|NCT01652703|11725237|FG000|Received Treatment|Overall Study||52
10569937|NCT01652703|11725238|FG001|Received Treatment|Overall Study||50
10569938|NCT01652703|11725239|FG002|Received Treatment|Overall Study||49
10569939|NCT01652703|11725240|FG003|Received Treatment|Overall Study||52
10569940|NCT01652703|11725241|FG004|Received Treatment|Overall Study||51
10569941|NCT01652703|11725242|FG005|Received Treatment|Overall Study||53
10569942|NCT01652703|11725237|FG000|COMPLETED|Overall Study||52
10569943|NCT01652703|11725238|FG001|COMPLETED|Overall Study||50
10569944|NCT01652703|11725239|FG002|COMPLETED|Overall Study||47
10569945|NCT01652703|11725240|FG003|COMPLETED|Overall Study||50
10569946|NCT01652703|11725241|FG004|COMPLETED|Overall Study||51
10569947|NCT01652703|11725242|FG005|COMPLETED|Overall Study||51
10569948|NCT01652703|11725237|FG000|NOT COMPLETED|Overall Study||0
10569949|NCT01652703|11725238|FG001|NOT COMPLETED|Overall Study||1
10569950|NCT01652703|11725239|FG002|NOT COMPLETED|Overall Study||3
10569951|NCT01652703|11725240|FG003|NOT COMPLETED|Overall Study||2
10569952|NCT01652703|11725241|FG004|NOT COMPLETED|Overall Study||1
10569953|NCT01652703|11725242|FG005|NOT COMPLETED|Overall Study||2
10569954|NCT01652716|11725258|FG000|STARTED|Overall Study||229
10569955|NCT01652716|11725259|FG001|STARTED|Overall Study|Two subjects in the exenatide BID group withdrew from the study before receiving study drug.|148
10569956|NCT01652716|11725258|FG000|Completed 28-week|Overall Study||197
10569957|NCT01652716|11725259|FG001|Completed 28-week|Overall Study||118
10569958|NCT01652716|11725258|FG000|COMPLETED|Overall Study|* completed study|173
10569959|NCT01652716|11725259|FG001|COMPLETED|Overall Study|* completed study|102
10569960|NCT01652716|11725258|FG000|NOT COMPLETED|Overall Study||56
10569961|NCT01652716|11725259|FG001|NOT COMPLETED|Overall Study||46
10569962|NCT01652729|11725268|FG000|STARTED|Overall Study|One subject was enrolled twice at different sites. He was randomized to exenatide at both sites.|182
10569963|NCT01652729|11725269|FG001|STARTED|Overall Study||122
10569964|NCT01652729|11725270|FG002|STARTED|Overall Study||61
10569965|NCT01652729|11725268|FG000|Modified Intent-to-Treat|Overall Study|All randomized subjects who received at least one dose of study drug.|181
10569966|NCT01652729|11725269|FG001|Modified Intent-to-Treat|Overall Study||122
10569967|NCT01652729|11725270|FG002|Modified Intent-to-Treat|Overall Study||61
10569968|NCT01652729|11725268|FG000|Treated|Overall Study|All subjects who received at least one dose of study medication even if not randomized.|181
10569969|NCT01652729|11725269|FG001|Treated|Overall Study||122
10569970|NCT01652729|11725270|FG002|Treated|Overall Study||61
10569971|NCT01652729|11725268|FG000|Evaluable|Overall Study|Subjects who completed study procedures to Week 24 or beyond and had adequate study drug exposure|143
10569972|NCT01652729|11725269|FG001|Evaluable|Overall Study||91
10569973|NCT01652729|11725270|FG002|Evaluable|Overall Study||43
10569974|NCT01652729|11725268|FG000|Meal Test Subjects|Overall Study||60
10569975|NCT01652729|11725269|FG001|Meal Test Subjects|Overall Study||41
10569976|NCT01652729|11725270|FG002|Meal Test Subjects|Overall Study||20
10569977|NCT01652729|11725268|FG000|Meal Test Evaluable|Overall Study|ITT subjects who ate >=75% of meal and did not miss 2-hour postprandial glucose measures at V3 and 8|44
10569978|NCT01652729|11725269|FG001|Meal Test Evaluable|Overall Study||31
10569979|NCT01652729|11725270|FG002|Meal Test Evaluable|Overall Study||15
10569980|NCT01652729|11725268|FG000|COMPLETED|Overall Study|The double-enrolled subject's reasons for withdrawal were LTFU and PV. Only PV is shown below.|155
10569981|NCT01652729|11725269|FG001|COMPLETED|Overall Study||109
10569982|NCT01652729|11725270|FG002|COMPLETED|Overall Study||47
10569983|NCT01652729|11725268|FG000|NOT COMPLETED|Overall Study||27
10569984|NCT01652729|11725269|FG001|NOT COMPLETED|Overall Study||13
10569985|NCT01652729|11725270|FG002|NOT COMPLETED|Overall Study||14
10569994|NCT01652885|11725287|FG000|STARTED|Overall Study||23
10569995|NCT01652885|11725287|FG000|COMPLETED|Overall Study||22
10569996|NCT01652885|11725287|FG000|NOT COMPLETED|Overall Study||1
10569997|NCT01652976|11725291|FG000|STARTED|Overall Study||44
10569998|NCT01652976|11725291|FG000|COMPLETED|Overall Study||44
10569999|NCT01652976|11725291|FG000|NOT COMPLETED|Overall Study||0
10570000|NCT01653028|11725300|FG000|STARTED|Overall Study||12
10570001|NCT01653028|11725301|FG001|STARTED|Overall Study||10
10570002|NCT01653028|11725302|FG002|STARTED|Overall Study||11
10570003|NCT01653028|11725303|FG003|STARTED|Overall Study||10
10570004|NCT01653028|11725304|FG004|STARTED|Overall Study||29
10570005|NCT01653028|11725300|FG000|COMPLETED|Overall Study||12
10570006|NCT01653028|11725301|FG001|COMPLETED|Overall Study||10
10570007|NCT01653028|11725302|FG002|COMPLETED|Overall Study||11
10570008|NCT01653028|11725303|FG003|COMPLETED|Overall Study||10
10570009|NCT01653028|11725304|FG004|COMPLETED|Overall Study||29
10570010|NCT01653028|11725300|FG000|NOT COMPLETED|Overall Study||0
10570011|NCT01653028|11725301|FG001|NOT COMPLETED|Overall Study||0
10570012|NCT01653028|11725302|FG002|NOT COMPLETED|Overall Study||0
10570013|NCT01653028|11725303|FG003|NOT COMPLETED|Overall Study||0
10570014|NCT01653028|11725304|FG004|NOT COMPLETED|Overall Study||0
10570015|NCT01653132|11725316|FG000|STARTED|First Intervention||5
10570016|NCT01653132|11725317|FG001|STARTED|First Intervention||5
10570017|NCT01653132|11725316|FG000|COMPLETED|First Intervention|one dropped out: wanted to start anticholinergic drug for tremor that could affect saliva volume|4
10570018|NCT01653132|11725317|FG001|COMPLETED|First Intervention||5
10570019|NCT01653132|11725316|FG000|NOT COMPLETED|First Intervention||1
10570020|NCT01653132|11725317|FG001|NOT COMPLETED|First Intervention||0
10570021|NCT01653132|11725316|FG000|STARTED|Washout 1-2 Months||4
10570022|NCT01653132|11725317|FG001|STARTED|Washout 1-2 Months||5
10570023|NCT01653132|11725316|FG000|COMPLETED|Washout 1-2 Months||4
10570024|NCT01653132|11725317|FG001|COMPLETED|Washout 1-2 Months||5
10570025|NCT01653132|11725316|FG000|NOT COMPLETED|Washout 1-2 Months||0
10570026|NCT01653132|11725317|FG001|NOT COMPLETED|Washout 1-2 Months||0
10570027|NCT01653132|11725316|FG000|STARTED|Second Intervention||4
10570028|NCT01653132|11725317|FG001|STARTED|Second Intervention||5
10570029|NCT01653132|11725316|FG000|COMPLETED|Second Intervention||4
10570030|NCT01653132|11725317|FG001|COMPLETED|Second Intervention||5
10570031|NCT01653132|11725316|FG000|NOT COMPLETED|Second Intervention||0
10570032|NCT01653132|11725317|FG001|NOT COMPLETED|Second Intervention||0
10570033|NCT01653158|11725327|FG000|STARTED|Overall Study||3
10570034|NCT01653158|11725328|FG001|STARTED|Overall Study||3
10570035|NCT01653158|11725329|FG002|STARTED|Overall Study||3
10570036|NCT01653158|11725330|FG003|STARTED|Overall Study||3
10570037|NCT01653158|11725331|FG004|STARTED|Overall Study||3
10570038|NCT01653158|11725332|FG005|STARTED|Overall Study||3
10570039|NCT01653158|11725333|FG006|STARTED|Overall Study||9
10794818|NCT03627767|11955237|FG002|STARTED|Open-label Rescue Period (12 Weeks)|Participants did not enter into the OL- Rescue Period.|0
10794819|NCT03627767|11955238|FG003|STARTED|Open-label Rescue Period (12 Weeks)|Participants did not enter into the OL- Rescue Period.|0
10794820|NCT03627767|11955239|FG004|STARTED|Open-label Rescue Period (12 Weeks)|Participants who met the pre-defined criteria for OL- Rescue Period.|361
10794821|NCT03627767|11955235|FG000|Met Protocol-defined Flare Criteria|Open-label Rescue Period (12 Weeks)||0
10794822|NCT03627767|11955236|FG001|Met Protocol-defined Flare Criteria|Open-label Rescue Period (12 Weeks)||0
10794823|NCT03627767|11955237|FG002|Met Protocol-defined Flare Criteria|Open-label Rescue Period (12 Weeks)||0
10570040|NCT01653158|11725334|FG007|STARTED|Overall Study|Six (6) and 13 participants were enrolled in dose escalation and expansion cohorts, respectively.|19
10794824|NCT03627767|11955238|FG003|Met Protocol-defined Flare Criteria|Open-label Rescue Period (12 Weeks)||0
10570041|NCT01653158|11725327|FG000|COMPLETED|Overall Study||2
10570042|NCT01653158|11725328|FG001|COMPLETED|Overall Study||3
10570043|NCT01653158|11725329|FG002|COMPLETED|Overall Study||3
10570044|NCT01653158|11725330|FG003|COMPLETED|Overall Study||1
10570045|NCT01653158|11725331|FG004|COMPLETED|Overall Study||2
10570046|NCT01653158|11725332|FG005|COMPLETED|Overall Study||2
10570047|NCT01653158|11725333|FG006|COMPLETED|Overall Study||7
10570048|NCT01653158|11725334|FG007|COMPLETED|Overall Study||4
10570049|NCT01653158|11725327|FG000|NOT COMPLETED|Overall Study||1
10570050|NCT01653158|11725328|FG001|NOT COMPLETED|Overall Study||0
10570051|NCT01653158|11725329|FG002|NOT COMPLETED|Overall Study||0
10570052|NCT01653158|11725330|FG003|NOT COMPLETED|Overall Study||2
10570053|NCT01653158|11725331|FG004|NOT COMPLETED|Overall Study||1
10570054|NCT01653158|11725332|FG005|NOT COMPLETED|Overall Study||1
10570055|NCT01653158|11725333|FG006|NOT COMPLETED|Overall Study||2
10570056|NCT01653158|11725334|FG007|NOT COMPLETED|Overall Study||15
10570057|NCT01653210|11725357|FG000|STARTED|Overall Study||15
10570058|NCT01653210|11725357|FG000|COMPLETED|Overall Study||12
10570059|NCT01653210|11725357|FG000|NOT COMPLETED|Overall Study||3
10570060|NCT01653262|11725361|FG000|STARTED|Overall Study||29
10570061|NCT01653262|11725361|FG000|COMPLETED|Overall Study||26
10570062|NCT01653262|11725361|FG000|NOT COMPLETED|Overall Study||3
10570063|NCT01653288|11725367|FG000|STARTED|Overall Study||36
10570064|NCT01653288|11725368|FG001|STARTED|Overall Study||36
10570065|NCT01653288|11725367|FG000|COMPLETED|Overall Study||26
10570066|NCT01653288|11725368|FG001|COMPLETED|Overall Study||35
10570067|NCT01653288|11725367|FG000|NOT COMPLETED|Overall Study||10
10570068|NCT01653288|11725368|FG001|NOT COMPLETED|Overall Study||1
10570069|NCT01653327|11725376|FG000|STARTED|Overall Study||11
10570070|NCT01653327|11725376|FG000|COMPLETED|Overall Study||10
10570071|NCT01653327|11725376|FG000|NOT COMPLETED|Overall Study||1
10794825|NCT03627767|11955239|FG004|Met Protocol-defined Flare Criteria|Open-label Rescue Period (12 Weeks)||351
10794826|NCT03627767|11955235|FG000|COMPLETED|Open-label Rescue Period (12 Weeks)||0
10794827|NCT03627767|11955236|FG001|COMPLETED|Open-label Rescue Period (12 Weeks)||0
10570072|NCT01653405|11725384|FG000|STARTED|Overall Study||11794
10570073|NCT01653405|11725385|FG001|STARTED|Overall Study||1248782
10570074|NCT01653405|11725384|FG000|COMPLETED|Overall Study|These patients had enough data to calculate TTR.|8029
10570075|NCT01653405|11725385|FG001|COMPLETED|Overall Study|These patients had enough data to calculate TTR.|179979
10570076|NCT01653405|11725384|FG000|NOT COMPLETED|Overall Study||3765
10570077|NCT01653405|11725385|FG001|NOT COMPLETED|Overall Study||1068803
10570078|NCT01653418|11725391|FG000|STARTED|Overall Study||10
10570079|NCT01653418|11725391|FG000|COMPLETED|Overall Study||10
10570080|NCT01653418|11725391|FG000|NOT COMPLETED|Overall Study||0
10570081|NCT01653509|11725397|FG000|STARTED|Overall Study||12
10570082|NCT01653509|11725398|FG001|STARTED|Overall Study||13
10570083|NCT01653509|11725397|FG000|COMPLETED|Overall Study||12
10570084|NCT01653509|11725398|FG001|COMPLETED|Overall Study||13
10570085|NCT01653509|11725397|FG000|NOT COMPLETED|Overall Study||0
10570086|NCT01653509|11725398|FG001|NOT COMPLETED|Overall Study||0
10570087|NCT01653587|11725408|FG000|STARTED|Overall Study||120
10570088|NCT01653587|11725409|FG001|STARTED|Overall Study||120
10570089|NCT01653587|11725408|FG000|COMPLETED|Overall Study||120
10570090|NCT01653587|11725409|FG001|COMPLETED|Overall Study||120
10570091|NCT01653587|11725408|FG000|NOT COMPLETED|Overall Study||0
10570092|NCT01653587|11725409|FG001|NOT COMPLETED|Overall Study||0
10570093|NCT01653704|11725417|FG000|STARTED|Overall Study||21
10570094|NCT01653704|11725418|FG001|STARTED|Overall Study||21
10570095|NCT01653704|11725417|FG000|COMPLETED|Overall Study||19
10570096|NCT01653704|11725418|FG001|COMPLETED|Overall Study||20
10570097|NCT01653704|11725417|FG000|NOT COMPLETED|Overall Study||2
10570098|NCT01653704|11725418|FG001|NOT COMPLETED|Overall Study||1
10570099|NCT01653743|11725426|FG000|STARTED|Overall Study||54
10570100|NCT01653743|11725427|FG001|STARTED|Overall Study||27
10570101|NCT01653743|11725426|FG000|COMPLETED|Overall Study||50
10570102|NCT01653743|11725427|FG001|COMPLETED|Overall Study||27
10570103|NCT01653743|11725426|FG000|NOT COMPLETED|Overall Study||4
10570104|NCT01653743|11725427|FG001|NOT COMPLETED|Overall Study||0
10794828|NCT03627767|11955237|FG002|COMPLETED|Open-label Rescue Period (12 Weeks)||0
10794829|NCT03627767|11955238|FG003|COMPLETED|Open-label Rescue Period (12 Weeks)||0
10794830|NCT03627767|11955239|FG004|COMPLETED|Open-label Rescue Period (12 Weeks)||341
10570105|NCT01653782|11725436|FG000|STARTED|Overall Study||52
10570106|NCT01653782|11725437|FG001|STARTED|Overall Study||55
10570107|NCT01653782|11725438|FG002|STARTED|Overall Study||52
10570108|NCT01653782|11725436|FG000|COMPLETED|Overall Study||36
10570109|NCT01653782|11725437|FG001|COMPLETED|Overall Study||37
10570110|NCT01653782|11725438|FG002|COMPLETED|Overall Study||46
10570111|NCT01653782|11725436|FG000|NOT COMPLETED|Overall Study||16
10570112|NCT01653782|11725437|FG001|NOT COMPLETED|Overall Study||18
10570113|NCT01653782|11725438|FG002|NOT COMPLETED|Overall Study||6
10570114|NCT01653847|11725448|FG000|STARTED|Overall Study||20
10570115|NCT01653847|11725449|FG001|STARTED|Overall Study||20
10570116|NCT01653847|11725448|FG000|COMPLETED|Overall Study||19
10570117|NCT01653847|11725449|FG001|COMPLETED|Overall Study||20
10570118|NCT01653847|11725448|FG000|NOT COMPLETED|Overall Study||1
10570119|NCT01653847|11725449|FG001|NOT COMPLETED|Overall Study||0
10570120|NCT01653912|11725457|FG000|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||4
10570121|NCT01653912|11725458|FG001|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
10570122|NCT01653912|11725459|FG002|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
10570123|NCT01653912|11725460|FG003|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
10570124|NCT01653912|11725461|FG004|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
10570125|NCT01653912|11725462|FG005|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
10570126|NCT01653912|11725457|FG000|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||4
10570127|NCT01653912|11725458|FG001|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
10570128|NCT01653912|11725459|FG002|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
10570129|NCT01653912|11725460|FG003|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
10570130|NCT01653912|11725461|FG004|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
10570131|NCT01653912|11725462|FG005|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
10570132|NCT01653912|11725457|FG000|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
10570133|NCT01653912|11725458|FG001|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
10570134|NCT01653912|11725459|FG002|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
10570135|NCT01653912|11725460|FG003|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
10570136|NCT01653912|11725461|FG004|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
10570137|NCT01653912|11725462|FG005|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
10570138|NCT01653912|11725457|FG000|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
10570139|NCT01653912|11725458|FG001|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||4
10570140|NCT01653912|11725459|FG002|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
10570141|NCT01653912|11725460|FG003|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
10570142|NCT01653912|11725461|FG004|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
10570143|NCT01653912|11725462|FG005|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
10570144|NCT01653912|11725457|FG000|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
10570145|NCT01653912|11725458|FG001|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||3
10570146|NCT01653912|11725459|FG002|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
10570147|NCT01653912|11725460|FG003|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
10570148|NCT01653912|11725461|FG004|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
10570149|NCT01653912|11725462|FG005|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
10570150|NCT01653912|11725457|FG000|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
10570151|NCT01653912|11725458|FG001|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||1
10570152|NCT01653912|11725459|FG002|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
10570153|NCT01653912|11725460|FG003|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
10570154|NCT01653912|11725461|FG004|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
10570155|NCT01653912|11725462|FG005|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
10570156|NCT01653912|11725457|FG000|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
10570157|NCT01653912|11725458|FG001|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
10570158|NCT01653912|11725459|FG002|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||6
10570159|NCT01653912|11725460|FG003|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
10570160|NCT01653912|11725461|FG004|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
10570161|NCT01653912|11725462|FG005|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
10570162|NCT01653912|11725457|FG000|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
10570163|NCT01653912|11725458|FG001|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
10570164|NCT01653912|11725459|FG002|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||4
10570165|NCT01653912|11725460|FG003|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
10570166|NCT01653912|11725461|FG004|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
10570167|NCT01653912|11725462|FG005|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
10570168|NCT01653912|11725457|FG000|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
10570169|NCT01653912|11725458|FG001|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
10570170|NCT01653912|11725459|FG002|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||2
10570171|NCT01653912|11725460|FG003|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
10570172|NCT01653912|11725461|FG004|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
10570173|NCT01653912|11725462|FG005|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
10570174|NCT01653912|11725457|FG000|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
10570175|NCT01653912|11725458|FG001|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
10570176|NCT01653912|11725459|FG002|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
10570177|NCT01653912|11725460|FG003|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||12
10570178|NCT01653912|11725461|FG004|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
10570179|NCT01653912|11725462|FG005|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
10570180|NCT01653912|11725457|FG000|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
10570181|NCT01653912|11725458|FG001|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
10570182|NCT01653912|11725459|FG002|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
10570183|NCT01653912|11725460|FG003|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||10
10570184|NCT01653912|11725461|FG004|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
10570185|NCT01653912|11725462|FG005|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
10570186|NCT01653912|11725457|FG000|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
10570187|NCT01653912|11725458|FG001|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
10570188|NCT01653912|11725459|FG002|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
10570189|NCT01653912|11725460|FG003|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||2
10570190|NCT01653912|11725461|FG004|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
10570191|NCT01653912|11725462|FG005|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
10570192|NCT01653912|11725457|FG000|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
10570193|NCT01653912|11725458|FG001|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
10570194|NCT01653912|11725459|FG002|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
10570195|NCT01653912|11725460|FG003|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
10570196|NCT01653912|11725461|FG004|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||3
10570197|NCT01653912|11725462|FG005|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
10570198|NCT01653912|11725457|FG000|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
10570199|NCT01653912|11725458|FG001|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
10570200|NCT01653912|11725459|FG002|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
10570201|NCT01653912|11725460|FG003|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
10570202|NCT01653912|11725461|FG004|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||3
10570203|NCT01653912|11725462|FG005|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
10570204|NCT01653912|11725457|FG000|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
10570205|NCT01653912|11725458|FG001|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
10570206|NCT01653912|11725459|FG002|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
10570207|NCT01653912|11725460|FG003|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
10570208|NCT01653912|11725461|FG004|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
10570209|NCT01653912|11725462|FG005|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
10570210|NCT01653912|11725457|FG000|STARTED|Phase 2: GSK2110183 125 mg||0
10570211|NCT01653912|11725458|FG001|STARTED|Phase 2: GSK2110183 125 mg||0
10570212|NCT01653912|11725459|FG002|STARTED|Phase 2: GSK2110183 125 mg||0
10570213|NCT01653912|11725460|FG003|STARTED|Phase 2: GSK2110183 125 mg||0
10570214|NCT01653912|11725461|FG004|STARTED|Phase 2: GSK2110183 125 mg||0
10570215|NCT01653912|11725462|FG005|STARTED|Phase 2: GSK2110183 125 mg|Per SAP, Cohort B (n=2) data was summarized in phase 2 total column as cohort B had <10 subjects.|30
10570216|NCT01653912|11725457|FG000|COMPLETED|Phase 2: GSK2110183 125 mg||0
10570217|NCT01653912|11725458|FG001|COMPLETED|Phase 2: GSK2110183 125 mg||0
10570218|NCT01653912|11725459|FG002|COMPLETED|Phase 2: GSK2110183 125 mg||0
10570219|NCT01653912|11725460|FG003|COMPLETED|Phase 2: GSK2110183 125 mg||0
10570220|NCT01653912|11725461|FG004|COMPLETED|Phase 2: GSK2110183 125 mg||0
10570221|NCT01653912|11725462|FG005|COMPLETED|Phase 2: GSK2110183 125 mg||22
10570222|NCT01653912|11725457|FG000|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
10570223|NCT01653912|11725458|FG001|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
10570224|NCT01653912|11725459|FG002|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
10570225|NCT01653912|11725460|FG003|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
10570226|NCT01653912|11725461|FG004|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
10570227|NCT01653912|11725462|FG005|NOT COMPLETED|Phase 2: GSK2110183 125 mg||8
10570228|NCT01653964|11725468|FG000|STARTED|Overall Study||82
10570229|NCT01653964|11725468|FG000|COMPLETED|Overall Study||82
10570230|NCT01653964|11725468|FG000|NOT COMPLETED|Overall Study||0
10570231|NCT01654068|11725472|FG000|STARTED|Overall Study||14
10570232|NCT01654068|11725472|FG000|COMPLETED|Overall Study||14
10570233|NCT01654068|11725472|FG000|NOT COMPLETED|Overall Study||0
10570234|NCT01654107|11725478|FG000|STARTED|Overall Study||28
10570235|NCT01654107|11725479|FG001|STARTED|Overall Study||30
10570236|NCT01654107|11725478|FG000|COMPLETED|Overall Study||25
10570237|NCT01654107|11725479|FG001|COMPLETED|Overall Study||22
10570238|NCT01654107|11725478|FG000|NOT COMPLETED|Overall Study||3
10570239|NCT01654107|11725479|FG001|NOT COMPLETED|Overall Study||8
10570240|NCT01654224|11725487|FG000|STARTED|Overall Study||95
10570241|NCT01654224|11725488|FG001|STARTED|Overall Study||110
10570242|NCT01654224|11725487|FG000|COMPLETED|Overall Study||89
10570243|NCT01654224|11725488|FG001|COMPLETED|Overall Study||98
10570244|NCT01654224|11725487|FG000|NOT COMPLETED|Overall Study||6
10570245|NCT01654224|11725488|FG001|NOT COMPLETED|Overall Study||12
10570246|NCT01654250|11725496|FG000|STARTED|Overall Study||44
10570247|NCT01654250|11725497|FG001|STARTED|Overall Study||42
10570248|NCT01654250|11725496|FG000|COMPLETED|Overall Study||43
10570249|NCT01654250|11725497|FG001|COMPLETED|Overall Study||42
10570250|NCT01654250|11725496|FG000|NOT COMPLETED|Overall Study||1
10570251|NCT01654250|11725497|FG001|NOT COMPLETED|Overall Study||0
10570252|NCT01654263|11725510|FG000|STARTED|Overall Study||164
10570253|NCT01654263|11725511|FG001|STARTED|Overall Study||147
10570254|NCT01654263|11725512|FG002|STARTED|Overall Study||139
10570255|NCT01654263|11725513|FG003|STARTED|Overall Study||145
10570256|NCT01654263|11725514|FG004|STARTED|Overall Study||140
10570257|NCT01654263|11725515|FG005|STARTED|Overall Study||149
10570258|NCT01654263|11725510|FG000|COMPLETED|Overall Study||164
10570259|NCT01654263|11725511|FG001|COMPLETED|Overall Study||147
10570260|NCT01654263|11725512|FG002|COMPLETED|Overall Study||137
10570261|NCT01654263|11725513|FG003|COMPLETED|Overall Study||144
10570262|NCT01654263|11725514|FG004|COMPLETED|Overall Study||139
10570263|NCT01654263|11725515|FG005|COMPLETED|Overall Study||148
10570264|NCT01654263|11725510|FG000|NOT COMPLETED|Overall Study||0
10570265|NCT01654263|11725511|FG001|NOT COMPLETED|Overall Study||0
10570266|NCT01654263|11725512|FG002|NOT COMPLETED|Overall Study||2
10570267|NCT01654263|11725513|FG003|NOT COMPLETED|Overall Study||1
10570268|NCT01654263|11725514|FG004|NOT COMPLETED|Overall Study||1
10570269|NCT01654263|11725515|FG005|NOT COMPLETED|Overall Study||1
10570270|NCT01654276|11725526|FG000|STARTED|Overall Study||24
10570271|NCT01654276|11725526|FG000|Visit 2 (2 Months)|Overall Study||19
10570272|NCT01654276|11725526|FG000|Visit 3 (4 Months)|Overall Study||18
10570273|NCT01654276|11725526|FG000|Visit 4 (6months)|Overall Study||18
10570274|NCT01654276|11725526|FG000|COMPLETED|Overall Study||18
10570275|NCT01654276|11725526|FG000|NOT COMPLETED|Overall Study||6
10570276|NCT01654289|11725533|FG000|STARTED|Overall Study||138
10570277|NCT01654289|11725534|FG001|STARTED|Overall Study||137
10570278|NCT01654289|11725535|FG002|STARTED|Overall Study||138
10570279|NCT01654289|11725533|FG000|COMPLETED|Overall Study||111
10570280|NCT01654289|11725534|FG001|COMPLETED|Overall Study||109
10570281|NCT01654289|11725535|FG002|COMPLETED|Overall Study||133
10570282|NCT01654289|11725533|FG000|NOT COMPLETED|Overall Study||27
10570283|NCT01654289|11725534|FG001|NOT COMPLETED|Overall Study||28
10570284|NCT01654289|11725535|FG002|NOT COMPLETED|Overall Study||5
10570285|NCT01654302|11725545|FG000|STARTED|First Intervention (Day 1)||20
10570286|NCT01654302|11725546|FG001|STARTED|First Intervention (Day 1)||20
10570287|NCT01654302|11725545|FG000|COMPLETED|First Intervention (Day 1)||20
10570288|NCT01654302|11725546|FG001|COMPLETED|First Intervention (Day 1)||20
10570289|NCT01654302|11725545|FG000|NOT COMPLETED|First Intervention (Day 1)||0
10570290|NCT01654302|11725546|FG001|NOT COMPLETED|First Intervention (Day 1)||0
10570291|NCT01654302|11725545|FG000|STARTED|Second Intervention (Day 7)||20
10570292|NCT01654302|11725546|FG001|STARTED|Second Intervention (Day 7)||20
10570293|NCT01654302|11725545|FG000|COMPLETED|Second Intervention (Day 7)||19
10570294|NCT01654302|11725546|FG001|COMPLETED|Second Intervention (Day 7)||19
10570295|NCT01654302|11725545|FG000|NOT COMPLETED|Second Intervention (Day 7)||1
10570296|NCT01654302|11725546|FG001|NOT COMPLETED|Second Intervention (Day 7)||1
10570297|NCT01654380|11725554|FG000|STARTED|Part A, Period 1||4
10570298|NCT01654380|11725555|FG001|STARTED|Part A, Period 1||4
10570299|NCT01654380|11725556|FG002|STARTED|Part A, Period 1||0
10570300|NCT01654380|11725557|FG003|STARTED|Part A, Period 1||0
10570301|NCT01654380|11725554|FG000|Received at Least 1 Dose of Study Drug|Part A, Period 1||4
10570302|NCT01654380|11725555|FG001|Received at Least 1 Dose of Study Drug|Part A, Period 1||4
10570303|NCT01654380|11725556|FG002|Received at Least 1 Dose of Study Drug|Part A, Period 1||0
10570304|NCT01654380|11725557|FG003|Received at Least 1 Dose of Study Drug|Part A, Period 1||0
10570305|NCT01654380|11725554|FG000|COMPLETED|Part A, Period 1||4
10570306|NCT01654380|11725555|FG001|COMPLETED|Part A, Period 1||4
10570307|NCT01654380|11725556|FG002|COMPLETED|Part A, Period 1||0
10570308|NCT01654380|11725557|FG003|COMPLETED|Part A, Period 1||0
10570309|NCT01654380|11725554|FG000|NOT COMPLETED|Part A, Period 1||0
10570310|NCT01654380|11725555|FG001|NOT COMPLETED|Part A, Period 1||0
10570311|NCT01654380|11725556|FG002|NOT COMPLETED|Part A, Period 1||0
10570312|NCT01654380|11725557|FG003|NOT COMPLETED|Part A, Period 1||0
10570313|NCT01654380|11725554|FG000|STARTED|Part A, Washout of at Least 6 Days||4
10570314|NCT01654380|11725555|FG001|STARTED|Part A, Washout of at Least 6 Days||4
10570315|NCT01654380|11725556|FG002|STARTED|Part A, Washout of at Least 6 Days||0
10570316|NCT01654380|11725557|FG003|STARTED|Part A, Washout of at Least 6 Days||0
10570317|NCT01654380|11725554|FG000|COMPLETED|Part A, Washout of at Least 6 Days||4
10570318|NCT01654380|11725555|FG001|COMPLETED|Part A, Washout of at Least 6 Days||4
10570319|NCT01654380|11725556|FG002|COMPLETED|Part A, Washout of at Least 6 Days||0
10570320|NCT01654380|11725557|FG003|COMPLETED|Part A, Washout of at Least 6 Days||0
10570321|NCT01654380|11725554|FG000|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
10570322|NCT01654380|11725555|FG001|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
10570323|NCT01654380|11725556|FG002|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
10570324|NCT01654380|11725557|FG003|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
10570325|NCT01654380|11725554|FG000|STARTED|Part A, Period 2||4
10570326|NCT01654380|11725555|FG001|STARTED|Part A, Period 2||4
10570327|NCT01654380|11725556|FG002|STARTED|Part A, Period 2||0
10570328|NCT01654380|11725557|FG003|STARTED|Part A, Period 2||0
10570329|NCT01654380|11725554|FG000|COMPLETED|Part A, Period 2||4
10570330|NCT01654380|11725555|FG001|COMPLETED|Part A, Period 2||4
10570331|NCT01654380|11725556|FG002|COMPLETED|Part A, Period 2||0
10570332|NCT01654380|11725557|FG003|COMPLETED|Part A, Period 2||0
10570333|NCT01654380|11725554|FG000|NOT COMPLETED|Part A, Period 2||0
10570334|NCT01654380|11725555|FG001|NOT COMPLETED|Part A, Period 2||0
10570335|NCT01654380|11725556|FG002|NOT COMPLETED|Part A, Period 2||0
10570336|NCT01654380|11725557|FG003|NOT COMPLETED|Part A, Period 2||0
10570337|NCT01654380|11725554|FG000|STARTED|Part A, Washout of at Least 6 Days||4
10570338|NCT01654380|11725555|FG001|STARTED|Part A, Washout of at Least 6 Days||4
10570339|NCT01654380|11725556|FG002|STARTED|Part A, Washout of at Least 6 Days||0
10570340|NCT01654380|11725557|FG003|STARTED|Part A, Washout of at Least 6 Days||0
10570341|NCT01654380|11725554|FG000|COMPLETED|Part A, Washout of at Least 6 Days||4
10570342|NCT01654380|11725555|FG001|COMPLETED|Part A, Washout of at Least 6 Days||4
10570343|NCT01654380|11725556|FG002|COMPLETED|Part A, Washout of at Least 6 Days||0
10570344|NCT01654380|11725557|FG003|COMPLETED|Part A, Washout of at Least 6 Days||0
10570345|NCT01654380|11725554|FG000|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
10570346|NCT01654380|11725555|FG001|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
10570347|NCT01654380|11725556|FG002|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
10570348|NCT01654380|11725557|FG003|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
10570349|NCT01654380|11725554|FG000|STARTED|Part A, Period 3||4
10570350|NCT01654380|11725555|FG001|STARTED|Part A, Period 3||4
10570351|NCT01654380|11725556|FG002|STARTED|Part A, Period 3||0
10570352|NCT01654380|11725557|FG003|STARTED|Part A, Period 3||0
10570353|NCT01654380|11725554|FG000|COMPLETED|Part A, Period 3||4
10570354|NCT01654380|11725555|FG001|COMPLETED|Part A, Period 3||4
10570355|NCT01654380|11725556|FG002|COMPLETED|Part A, Period 3||0
10570356|NCT01654380|11725557|FG003|COMPLETED|Part A, Period 3||0
10570357|NCT01654380|11725554|FG000|NOT COMPLETED|Part A, Period 3||0
10570358|NCT01654380|11725555|FG001|NOT COMPLETED|Part A, Period 3||0
10570359|NCT01654380|11725556|FG002|NOT COMPLETED|Part A, Period 3||0
10570360|NCT01654380|11725557|FG003|NOT COMPLETED|Part A, Period 3||0
10570361|NCT01654380|11725554|FG000|STARTED|Part A, Washout of at Least 6 Days||4
10570362|NCT01654380|11725555|FG001|STARTED|Part A, Washout of at Least 6 Days||4
10570363|NCT01654380|11725556|FG002|STARTED|Part A, Washout of at Least 6 Days||0
10570364|NCT01654380|11725557|FG003|STARTED|Part A, Washout of at Least 6 Days||0
10570365|NCT01654380|11725554|FG000|COMPLETED|Part A, Washout of at Least 6 Days||4
10570366|NCT01654380|11725555|FG001|COMPLETED|Part A, Washout of at Least 6 Days||4
10570367|NCT01654380|11725556|FG002|COMPLETED|Part A, Washout of at Least 6 Days||0
10570368|NCT01654380|11725557|FG003|COMPLETED|Part A, Washout of at Least 6 Days||0
10570369|NCT01654380|11725554|FG000|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
10570370|NCT01654380|11725555|FG001|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
10570371|NCT01654380|11725556|FG002|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
10570372|NCT01654380|11725557|FG003|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
10570373|NCT01654380|11725554|FG000|STARTED|Part A, Period 4||4
10570374|NCT01654380|11725555|FG001|STARTED|Part A, Period 4||4
10570375|NCT01654380|11725556|FG002|STARTED|Part A, Period 4||0
10570376|NCT01654380|11725557|FG003|STARTED|Part A, Period 4||0
10570377|NCT01654380|11725554|FG000|COMPLETED|Part A, Period 4||4
10570378|NCT01654380|11725555|FG001|COMPLETED|Part A, Period 4||4
10570379|NCT01654380|11725556|FG002|COMPLETED|Part A, Period 4||0
10570380|NCT01654380|11725557|FG003|COMPLETED|Part A, Period 4||0
10570381|NCT01654380|11725554|FG000|NOT COMPLETED|Part A, Period 4||0
10570382|NCT01654380|11725555|FG001|NOT COMPLETED|Part A, Period 4||0
10570383|NCT01654380|11725556|FG002|NOT COMPLETED|Part A, Period 4||0
10570384|NCT01654380|11725557|FG003|NOT COMPLETED|Part A, Period 4||0
10570385|NCT01654380|11725554|FG000|STARTED|Part B, Period 1|Participants in Part A were not included in Part B.|0
10570386|NCT01654380|11725555|FG001|STARTED|Part B, Period 1|Participants in Part A were not included in Part B.|0
10570387|NCT01654380|11725556|FG002|STARTED|Part B, Period 1|Participants in Part B were not included in Part A.|7
10570388|NCT01654380|11725557|FG003|STARTED|Part B, Period 1|Participants in Part B were not included in Part A.|7
10570389|NCT01654380|11725554|FG000|Received at Least 1 Dose of Study Drug|Part B, Period 1||0
10570390|NCT01654380|11725555|FG001|Received at Least 1 Dose of Study Drug|Part B, Period 1||0
10570391|NCT01654380|11725556|FG002|Received at Least 1 Dose of Study Drug|Part B, Period 1||7
10570392|NCT01654380|11725557|FG003|Received at Least 1 Dose of Study Drug|Part B, Period 1||7
10570393|NCT01654380|11725554|FG000|COMPLETED|Part B, Period 1||0
10570394|NCT01654380|11725555|FG001|COMPLETED|Part B, Period 1||0
10570395|NCT01654380|11725556|FG002|COMPLETED|Part B, Period 1|Participant who did not complete received only 1 dose of LY2605541 74.1 mU/min IV for 8 hours|6
10570396|NCT01654380|11725557|FG003|COMPLETED|Part B, Period 1||7
10570397|NCT01654380|11725554|FG000|NOT COMPLETED|Part B, Period 1||0
10570398|NCT01654380|11725555|FG001|NOT COMPLETED|Part B, Period 1||0
10570399|NCT01654380|11725556|FG002|NOT COMPLETED|Part B, Period 1||1
10570400|NCT01654380|11725557|FG003|NOT COMPLETED|Part B, Period 1||0
10570401|NCT01654380|11725554|FG000|STARTED|Part B, Washout of at Least 6 Days||0
10570402|NCT01654380|11725555|FG001|STARTED|Part B, Washout of at Least 6 Days||0
10570403|NCT01654380|11725556|FG002|STARTED|Part B, Washout of at Least 6 Days||6
10570404|NCT01654380|11725557|FG003|STARTED|Part B, Washout of at Least 6 Days||7
10570405|NCT01654380|11725554|FG000|COMPLETED|Part B, Washout of at Least 6 Days||0
10570406|NCT01654380|11725555|FG001|COMPLETED|Part B, Washout of at Least 6 Days||0
10570407|NCT01654380|11725556|FG002|COMPLETED|Part B, Washout of at Least 6 Days||6
10570408|NCT01654380|11725557|FG003|COMPLETED|Part B, Washout of at Least 6 Days||7
10570409|NCT01654380|11725554|FG000|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
10570410|NCT01654380|11725555|FG001|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
10570411|NCT01654380|11725556|FG002|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
10570412|NCT01654380|11725557|FG003|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
10570413|NCT01654380|11725554|FG000|STARTED|Part B, Period 2||0
10570414|NCT01654380|11725555|FG001|STARTED|Part B, Period 2||0
10570415|NCT01654380|11725556|FG002|STARTED|Part B, Period 2||6
10570416|NCT01654380|11725557|FG003|STARTED|Part B, Period 2||7
10570417|NCT01654380|11725554|FG000|COMPLETED|Part B, Period 2||0
10570418|NCT01654380|11725555|FG001|COMPLETED|Part B, Period 2||0
10570419|NCT01654380|11725556|FG002|COMPLETED|Part B, Period 2||6
10570420|NCT01654380|11725557|FG003|COMPLETED|Part B, Period 2||7
10570421|NCT01654380|11725554|FG000|NOT COMPLETED|Part B, Period 2||0
10570422|NCT01654380|11725555|FG001|NOT COMPLETED|Part B, Period 2||0
10570423|NCT01654380|11725556|FG002|NOT COMPLETED|Part B, Period 2||0
10570424|NCT01654380|11725557|FG003|NOT COMPLETED|Part B, Period 2||0
10570425|NCT01654380|11725554|FG000|STARTED|Part B, Washout of at Least 6 Days||0
10570426|NCT01654380|11725555|FG001|STARTED|Part B, Washout of at Least 6 Days||0
10570427|NCT01654380|11725556|FG002|STARTED|Part B, Washout of at Least 6 Days||6
10570428|NCT01654380|11725557|FG003|STARTED|Part B, Washout of at Least 6 Days||7
10570429|NCT01654380|11725554|FG000|COMPLETED|Part B, Washout of at Least 6 Days||0
10570430|NCT01654380|11725555|FG001|COMPLETED|Part B, Washout of at Least 6 Days||0
10570431|NCT01654380|11725556|FG002|COMPLETED|Part B, Washout of at Least 6 Days||6
10570432|NCT01654380|11725557|FG003|COMPLETED|Part B, Washout of at Least 6 Days||7
10570433|NCT01654380|11725554|FG000|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
10570434|NCT01654380|11725555|FG001|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
10570435|NCT01654380|11725556|FG002|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
10570436|NCT01654380|11725557|FG003|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
10570437|NCT01654380|11725554|FG000|STARTED|Part B, Period 3||0
10570438|NCT01654380|11725555|FG001|STARTED|Part B, Period 3||0
10570439|NCT01654380|11725556|FG002|STARTED|Part B, Period 3||6
10570440|NCT01654380|11725557|FG003|STARTED|Part B, Period 3||7
10570441|NCT01654380|11725554|FG000|COMPLETED|Part B, Period 3||0
10570442|NCT01654380|11725555|FG001|COMPLETED|Part B, Period 3||0
10570443|NCT01654380|11725556|FG002|COMPLETED|Part B, Period 3||6
10570444|NCT01654380|11725557|FG003|COMPLETED|Part B, Period 3||7
10570445|NCT01654380|11725554|FG000|NOT COMPLETED|Part B, Period 3||0
10570446|NCT01654380|11725555|FG001|NOT COMPLETED|Part B, Period 3||0
10570447|NCT01654380|11725556|FG002|NOT COMPLETED|Part B, Period 3||0
10570448|NCT01654380|11725557|FG003|NOT COMPLETED|Part B, Period 3||0
10570449|NCT01654380|11725554|FG000|STARTED|Part B, Washout of at Least 6 Days||0
10570450|NCT01654380|11725555|FG001|STARTED|Part B, Washout of at Least 6 Days||0
10570451|NCT01654380|11725556|FG002|STARTED|Part B, Washout of at Least 6 Days||6
10570452|NCT01654380|11725557|FG003|STARTED|Part B, Washout of at Least 6 Days||7
10570453|NCT01654380|11725554|FG000|COMPLETED|Part B, Washout of at Least 6 Days||0
10570454|NCT01654380|11725555|FG001|COMPLETED|Part B, Washout of at Least 6 Days||0
10570455|NCT01654380|11725556|FG002|COMPLETED|Part B, Washout of at Least 6 Days||6
10570456|NCT01654380|11725557|FG003|COMPLETED|Part B, Washout of at Least 6 Days||7
10570457|NCT01654380|11725554|FG000|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
10570458|NCT01654380|11725555|FG001|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
10570459|NCT01654380|11725556|FG002|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
10570460|NCT01654380|11725557|FG003|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
10570461|NCT01654380|11725554|FG000|STARTED|Part B, Period 4||0
10455263|NCT01001104|11603269|FG002|NOT COMPLETED|Overall Study||1
10455264|NCT01001104|11603270|FG003|NOT COMPLETED|Overall Study||3
10455265|NCT01001169|11603285|FG000|STARTED|Overall Study||30
10455266|NCT01001169|11603286|FG001|STARTED|Overall Study||30
10455267|NCT01001169|11603285|FG000|COMPLETED|Overall Study||28
10455268|NCT01001169|11603286|FG001|COMPLETED|Overall Study||29
10570462|NCT01654380|11725555|FG001|STARTED|Part B, Period 4||0
10570463|NCT01654380|11725556|FG002|STARTED|Part B, Period 4||6
10570464|NCT01654380|11725557|FG003|STARTED|Part B, Period 4||7
10570465|NCT01654380|11725554|FG000|COMPLETED|Part B, Period 4||0
10570466|NCT01654380|11725555|FG001|COMPLETED|Part B, Period 4||0
10570467|NCT01654380|11725556|FG002|COMPLETED|Part B, Period 4||6
10570468|NCT01654380|11725557|FG003|COMPLETED|Part B, Period 4||7
10570469|NCT01654380|11725554|FG000|NOT COMPLETED|Part B, Period 4||0
10570470|NCT01654380|11725555|FG001|NOT COMPLETED|Part B, Period 4||0
10570471|NCT01654380|11725556|FG002|NOT COMPLETED|Part B, Period 4||0
10570472|NCT01654380|11725557|FG003|NOT COMPLETED|Part B, Period 4||0
10570473|NCT01654445|11725576|FG000|STARTED|Overall Study||25
10570474|NCT01654445|11725577|FG001|STARTED|Overall Study||25
10570475|NCT01654445|11725576|FG000|COMPLETED|Overall Study||25
10570476|NCT01654445|11725577|FG001|COMPLETED|Overall Study||25
10570477|NCT01654445|11725576|FG000|NOT COMPLETED|Overall Study||0
10570478|NCT01654445|11725577|FG001|NOT COMPLETED|Overall Study||0
10570479|NCT01654523|11725583|FG000|STARTED|Overall Study||20
10570480|NCT01654523|11725583|FG000|COMPLETED|Overall Study||19
10570481|NCT01654523|11725583|FG000|NOT COMPLETED|Overall Study||1
10570482|NCT01654536|11725589|FG000|STARTED|Overall Study||368
10570483|NCT01654536|11725590|FG001|STARTED|Overall Study||369
10570484|NCT01654536|11725589|FG000|COMPLETED|Overall Study||324
10570485|NCT01654536|11725590|FG001|COMPLETED|Overall Study||331
10570486|NCT01654536|11725589|FG000|NOT COMPLETED|Overall Study||44
10570487|NCT01654536|11725590|FG001|NOT COMPLETED|Overall Study||38
10570488|NCT01654549|11725599|FG000|STARTED|Overall Study||20
10570489|NCT01654549|11725600|FG001|STARTED|Overall Study||20
10570490|NCT01654549|11725599|FG000|COMPLETED|Overall Study||20
10570491|NCT01654549|11725600|FG001|COMPLETED|Overall Study||19
10570492|NCT01654549|11725599|FG000|NOT COMPLETED|Overall Study||0
10570493|NCT01654549|11725600|FG001|NOT COMPLETED|Overall Study||1
10570494|NCT01654601|11725612|FG000|STARTED|1st Administration||14
10570495|NCT01654601|11725613|FG001|STARTED|1st Administration||14
10570496|NCT01654601|11725612|FG000|COMPLETED|1st Administration||12
10570497|NCT01654601|11725613|FG001|COMPLETED|1st Administration||12
10570498|NCT01654601|11725612|FG000|NOT COMPLETED|1st Administration||2
10570499|NCT01654601|11725613|FG001|NOT COMPLETED|1st Administration||2
10570500|NCT01654601|11725612|FG000|STARTED|2nd Administration||12
10570501|NCT01654601|11725613|FG001|STARTED|2nd Administration||12
10570502|NCT01654601|11725612|FG000|COMPLETED|2nd Administration||11
10570503|NCT01654601|11725613|FG001|COMPLETED|2nd Administration||11
10570504|NCT01654601|11725612|FG000|NOT COMPLETED|2nd Administration||1
10570505|NCT01654601|11725613|FG001|NOT COMPLETED|2nd Administration||1
10570506|NCT01654666|11725622|FG000|STARTED|Overall Study||63
10570507|NCT01654666|11725623|FG001|STARTED|Overall Study||63
10570508|NCT01654666|11725624|FG002|STARTED|Overall Study||63
10570509|NCT01654666|11725622|FG000|Primary Analysis|Overall Study||52
10570510|NCT01654666|11725623|FG001|Primary Analysis|Overall Study||56
10570511|NCT01654666|11725624|FG002|Primary Analysis|Overall Study||54
10570512|NCT01654666|11725622|FG000|COMPLETED|Overall Study||48
10570513|NCT01654666|11725623|FG001|COMPLETED|Overall Study||50
10570514|NCT01654666|11725624|FG002|COMPLETED|Overall Study||49
10570515|NCT01654666|11725622|FG000|NOT COMPLETED|Overall Study||15
10570516|NCT01654666|11725623|FG001|NOT COMPLETED|Overall Study||13
10570517|NCT01654666|11725624|FG002|NOT COMPLETED|Overall Study||14
10570518|NCT01654796|11725635|FG000|STARTED|Overall Study||26
10570519|NCT01654796|11725636|FG001|STARTED|Overall Study||29
10570520|NCT01654796|11725637|FG002|STARTED|Overall Study||29
10570521|NCT01654796|11725635|FG000|COMPLETED|Overall Study||25
10570522|NCT01654796|11725636|FG001|COMPLETED|Overall Study||26
10570523|NCT01654796|11725637|FG002|COMPLETED|Overall Study||28
10570524|NCT01654796|11725635|FG000|NOT COMPLETED|Overall Study||1
10455269|NCT01001169|11603285|FG000|NOT COMPLETED|Overall Study||2
10455270|NCT01001169|11603286|FG001|NOT COMPLETED|Overall Study||1
10455271|NCT01001195|11603304|FG000|STARTED|Overall Study||39
10455272|NCT01001195|11603305|FG001|STARTED|Overall Study||41
10455273|NCT01001195|11603306|FG002|STARTED|Overall Study||44
10455274|NCT01001195|11603307|FG003|STARTED|Overall Study||41
10455275|NCT01001195|11603304|FG000|COMPLETED|Overall Study||37
10455276|NCT01001195|11603305|FG001|COMPLETED|Overall Study||39
10570525|NCT01654796|11725636|FG001|NOT COMPLETED|Overall Study||3
10570526|NCT01654796|11725637|FG002|NOT COMPLETED|Overall Study||1
10570527|NCT01654861|11725646|FG000|STARTED|Overall Study||3
10570528|NCT01654861|11725646|FG000|COMPLETED|Overall Study||3
10570529|NCT01654861|11725646|FG000|NOT COMPLETED|Overall Study||0
10570530|NCT01654887|11725652|FG000|STARTED|Overall Study||103
10570531|NCT01654887|11725653|FG001|STARTED|Overall Study||88
10570532|NCT01654887|11725652|FG000|COMPLETED|Overall Study||103
10570533|NCT01654887|11725653|FG001|COMPLETED|Overall Study||88
10570534|NCT01654887|11725652|FG000|NOT COMPLETED|Overall Study||0
10570535|NCT01654887|11725653|FG001|NOT COMPLETED|Overall Study||0
10570536|NCT01655043|11725660|FG000|STARTED|Overall Study||20
10570537|NCT01655043|11725660|FG000|COMPLETED|Overall Study||20
10570538|NCT01655043|11725660|FG000|NOT COMPLETED|Overall Study||0
10570539|NCT01655069|11725668|FG000|STARTED|Overall Study||61
10570540|NCT01655069|11725669|FG001|STARTED|Overall Study||58
10570541|NCT01655069|11725670|FG002|STARTED|Overall Study||14
10570542|NCT01655069|11725671|FG003|STARTED|Overall Study||15
10570543|NCT01655069|11725668|FG000|Safety Analysis Set (SAF)|Overall Study||61
10570544|NCT01655069|11725669|FG001|Safety Analysis Set (SAF)|Overall Study||57
10570545|NCT01655069|11725670|FG002|Safety Analysis Set (SAF)|Overall Study||14
10570546|NCT01655069|11725671|FG003|Safety Analysis Set (SAF)|Overall Study||15
10570547|NCT01655069|11725668|FG000|Full Analysis Set (FAS)|Overall Study||60
10570548|NCT01655069|11725669|FG001|Full Analysis Set (FAS)|Overall Study||57
10570549|NCT01655069|11725670|FG002|Full Analysis Set (FAS)|Overall Study||14
10570550|NCT01655069|11725671|FG003|Full Analysis Set (FAS)|Overall Study||15
10570551|NCT01655069|11725668|FG000|COMPLETED|Overall Study||53
10570552|NCT01655069|11725669|FG001|COMPLETED|Overall Study||46
10570553|NCT01655069|11725670|FG002|COMPLETED|Overall Study||12
10570554|NCT01655069|11725671|FG003|COMPLETED|Overall Study||11
10570555|NCT01655069|11725668|FG000|NOT COMPLETED|Overall Study||8
10570556|NCT01655069|11725669|FG001|NOT COMPLETED|Overall Study||12
10570557|NCT01655069|11725670|FG002|NOT COMPLETED|Overall Study||2
10570558|NCT01655069|11725671|FG003|NOT COMPLETED|Overall Study||4
10570559|NCT01655329|11725679|FG000|STARTED|Overall Study|The same 10 radiologists are interpreting images in both arms.|10
10570560|NCT01655329|11725679|FG000|COMPLETED|Overall Study||10
10570561|NCT01655329|11725679|FG000|NOT COMPLETED|Overall Study||0
10570562|NCT01655381|11725693|FG000|STARTED|Overall Study||15
10570563|NCT01655381|11725693|FG000|COMPLETED|Overall Study||12
10570564|NCT01655381|11725693|FG000|NOT COMPLETED|Overall Study||3
10570565|NCT01655498|11725698|FG000|STARTED|Overall Study||61
10570566|NCT01655498|11725698|FG000|COMPLETED|Overall Study||56
10570567|NCT01655498|11725698|FG000|NOT COMPLETED|Overall Study||5
10570568|NCT01655563|11725707|FG000|STARTED|Overall Study||18
10570569|NCT01655563|11725708|FG001|STARTED|Overall Study||35
10570570|NCT01655563|11725707|FG000|COMPLETED|Overall Study||18
10570571|NCT01655563|11725708|FG001|COMPLETED|Overall Study||35
10570572|NCT01655563|11725707|FG000|NOT COMPLETED|Overall Study||0
10570573|NCT01655563|11725708|FG001|NOT COMPLETED|Overall Study||0
10570574|NCT01655693|11725717|FG000|STARTED|Overall Study||130
10570575|NCT01655693|11725718|FG001|STARTED|Overall Study||133
10570576|NCT01655693|11725719|FG002|STARTED|Overall Study||134
10570577|NCT01655693|11725717|FG000|COMPLETED|Overall Study||4
10570578|NCT01655693|11725718|FG001|COMPLETED|Overall Study||7
10570579|NCT01655693|11725719|FG002|COMPLETED|Overall Study||4
10570580|NCT01655693|11725717|FG000|NOT COMPLETED|Overall Study||126
10570581|NCT01655693|11725718|FG001|NOT COMPLETED|Overall Study||126
10570582|NCT01655693|11725719|FG002|NOT COMPLETED|Overall Study||130
10570583|NCT01655719|11725737|FG000|STARTED|Overall Study||1
10570584|NCT01655719|11725737|FG000|COMPLETED|Overall Study||1
10570585|NCT01655719|11725737|FG000|NOT COMPLETED|Overall Study||0
10570586|NCT01655823|11725746|FG000|STARTED|Overall Study||25
10570587|NCT01655823|11725747|FG001|STARTED|Overall Study||25
10570588|NCT01655823|11725748|FG002|STARTED|Overall Study||24
10570589|NCT01655823|11725749|FG003|STARTED|Overall Study||25
10570590|NCT01655823|11725750|FG004|STARTED|Overall Study||26
10570591|NCT01655823|11725746|FG000|COMPLETED|Overall Study||25
10570592|NCT01655823|11725747|FG001|COMPLETED|Overall Study||23
10570593|NCT01655823|11725748|FG002|COMPLETED|Overall Study||24
10570594|NCT01655823|11725749|FG003|COMPLETED|Overall Study||24
10570595|NCT01655823|11725750|FG004|COMPLETED|Overall Study||25
10570596|NCT01655823|11725746|FG000|NOT COMPLETED|Overall Study||0
10570597|NCT01655823|11725747|FG001|NOT COMPLETED|Overall Study||2
10570598|NCT01655823|11725748|FG002|NOT COMPLETED|Overall Study||0
10570599|NCT01655823|11725749|FG003|NOT COMPLETED|Overall Study||1
10570600|NCT01655823|11725750|FG004|NOT COMPLETED|Overall Study||1
10570601|NCT01655901|11725762|FG000|STARTED|First Intervention (Hour 1)||5
10570602|NCT01655901|11725763|FG001|STARTED|First Intervention (Hour 1)||5
10570603|NCT01655901|11725764|FG002|STARTED|First Intervention (Hour 1)||5
10570604|NCT01655901|11725765|FG003|STARTED|First Intervention (Hour 1)||5
10570605|NCT01655901|11725766|FG004|STARTED|First Intervention (Hour 1)||5
10570606|NCT01655901|11725767|FG005|STARTED|First Intervention (Hour 1)||5
10570607|NCT01655901|11725762|FG000|COMPLETED|First Intervention (Hour 1)||5
10570608|NCT01655901|11725763|FG001|COMPLETED|First Intervention (Hour 1)||5
10570609|NCT01655901|11725764|FG002|COMPLETED|First Intervention (Hour 1)||5
10570610|NCT01655901|11725765|FG003|COMPLETED|First Intervention (Hour 1)||5
10570611|NCT01655901|11725766|FG004|COMPLETED|First Intervention (Hour 1)||5
10570612|NCT01655901|11725767|FG005|COMPLETED|First Intervention (Hour 1)||5
10570613|NCT01655901|11725762|FG000|NOT COMPLETED|First Intervention (Hour 1)||0
10570614|NCT01655901|11725763|FG001|NOT COMPLETED|First Intervention (Hour 1)||0
10570615|NCT01655901|11725764|FG002|NOT COMPLETED|First Intervention (Hour 1)||0
10570616|NCT01655901|11725765|FG003|NOT COMPLETED|First Intervention (Hour 1)||0
10570617|NCT01655901|11725766|FG004|NOT COMPLETED|First Intervention (Hour 1)||0
10570618|NCT01655901|11725767|FG005|NOT COMPLETED|First Intervention (Hour 1)||0
10570619|NCT01655901|11725762|FG000|STARTED|Washout (1 Week)||5
10570620|NCT01655901|11725763|FG001|STARTED|Washout (1 Week)||5
10570621|NCT01655901|11725764|FG002|STARTED|Washout (1 Week)||5
10570622|NCT01655901|11725765|FG003|STARTED|Washout (1 Week)||5
10570623|NCT01655901|11725766|FG004|STARTED|Washout (1 Week)||5
10570624|NCT01655901|11725767|FG005|STARTED|Washout (1 Week)||5
10570625|NCT01655901|11725762|FG000|COMPLETED|Washout (1 Week)||5
10570626|NCT01655901|11725763|FG001|COMPLETED|Washout (1 Week)||5
10570627|NCT01655901|11725764|FG002|COMPLETED|Washout (1 Week)||5
10570628|NCT01655901|11725765|FG003|COMPLETED|Washout (1 Week)||5
10570629|NCT01655901|11725766|FG004|COMPLETED|Washout (1 Week)||5
10570630|NCT01655901|11725767|FG005|COMPLETED|Washout (1 Week)||5
10570631|NCT01655901|11725762|FG000|NOT COMPLETED|Washout (1 Week)||0
10570632|NCT01655901|11725763|FG001|NOT COMPLETED|Washout (1 Week)||0
10570633|NCT01655901|11725764|FG002|NOT COMPLETED|Washout (1 Week)||0
10570634|NCT01655901|11725765|FG003|NOT COMPLETED|Washout (1 Week)||0
10570635|NCT01655901|11725766|FG004|NOT COMPLETED|Washout (1 Week)||0
10570636|NCT01655901|11725767|FG005|NOT COMPLETED|Washout (1 Week)||0
10570637|NCT01655901|11725762|FG000|STARTED|Second Intervention (Hour 2)||5
10570638|NCT01655901|11725763|FG001|STARTED|Second Intervention (Hour 2)||5
10570639|NCT01655901|11725764|FG002|STARTED|Second Intervention (Hour 2)||5
10570640|NCT01655901|11725765|FG003|STARTED|Second Intervention (Hour 2)||5
10570641|NCT01655901|11725766|FG004|STARTED|Second Intervention (Hour 2)||5
10570642|NCT01655901|11725767|FG005|STARTED|Second Intervention (Hour 2)||5
10570643|NCT01655901|11725762|FG000|COMPLETED|Second Intervention (Hour 2)||5
10570644|NCT01655901|11725763|FG001|COMPLETED|Second Intervention (Hour 2)||5
10570645|NCT01655901|11725764|FG002|COMPLETED|Second Intervention (Hour 2)||5
10570646|NCT01655901|11725765|FG003|COMPLETED|Second Intervention (Hour 2)||5
10570647|NCT01655901|11725766|FG004|COMPLETED|Second Intervention (Hour 2)||5
10570648|NCT01655901|11725767|FG005|COMPLETED|Second Intervention (Hour 2)||5
10570649|NCT01655901|11725762|FG000|NOT COMPLETED|Second Intervention (Hour 2)||0
10570650|NCT01655901|11725763|FG001|NOT COMPLETED|Second Intervention (Hour 2)||0
10570651|NCT01655901|11725764|FG002|NOT COMPLETED|Second Intervention (Hour 2)||0
10570652|NCT01655901|11725765|FG003|NOT COMPLETED|Second Intervention (Hour 2)||0
10570653|NCT01655901|11725766|FG004|NOT COMPLETED|Second Intervention (Hour 2)||0
10570654|NCT01655901|11725767|FG005|NOT COMPLETED|Second Intervention (Hour 2)||0
10570655|NCT01655901|11725762|FG000|STARTED|Washout (1 Week)||5
10570656|NCT01655901|11725763|FG001|STARTED|Washout (1 Week)||5
10570657|NCT01655901|11725764|FG002|STARTED|Washout (1 Week)||5
10570658|NCT01655901|11725765|FG003|STARTED|Washout (1 Week)||5
10570659|NCT01655901|11725766|FG004|STARTED|Washout (1 Week)||5
10570660|NCT01655901|11725767|FG005|STARTED|Washout (1 Week)||5
10570661|NCT01655901|11725762|FG000|COMPLETED|Washout (1 Week)||5
10570662|NCT01655901|11725763|FG001|COMPLETED|Washout (1 Week)||5
10570663|NCT01655901|11725764|FG002|COMPLETED|Washout (1 Week)||5
10570664|NCT01655901|11725765|FG003|COMPLETED|Washout (1 Week)||5
10570665|NCT01655901|11725766|FG004|COMPLETED|Washout (1 Week)||5
10570666|NCT01655901|11725767|FG005|COMPLETED|Washout (1 Week)||5
10570667|NCT01655901|11725762|FG000|NOT COMPLETED|Washout (1 Week)||0
10570668|NCT01655901|11725763|FG001|NOT COMPLETED|Washout (1 Week)||0
10570669|NCT01655901|11725764|FG002|NOT COMPLETED|Washout (1 Week)||0
10570670|NCT01655901|11725765|FG003|NOT COMPLETED|Washout (1 Week)||0
10570671|NCT01655901|11725766|FG004|NOT COMPLETED|Washout (1 Week)||0
10570672|NCT01655901|11725767|FG005|NOT COMPLETED|Washout (1 Week)||0
10570673|NCT01655901|11725762|FG000|STARTED|Third Intervention (Hour 3)||5
10570674|NCT01655901|11725763|FG001|STARTED|Third Intervention (Hour 3)||5
10570675|NCT01655901|11725764|FG002|STARTED|Third Intervention (Hour 3)||5
10570676|NCT01655901|11725765|FG003|STARTED|Third Intervention (Hour 3)||5
10570677|NCT01655901|11725766|FG004|STARTED|Third Intervention (Hour 3)||5
10570678|NCT01655901|11725767|FG005|STARTED|Third Intervention (Hour 3)||5
10570679|NCT01655901|11725762|FG000|COMPLETED|Third Intervention (Hour 3)||4
10570680|NCT01655901|11725763|FG001|COMPLETED|Third Intervention (Hour 3)||4
10570681|NCT01655901|11725764|FG002|COMPLETED|Third Intervention (Hour 3)||4
10570682|NCT01655901|11725765|FG003|COMPLETED|Third Intervention (Hour 3)||5
10570683|NCT01655901|11725766|FG004|COMPLETED|Third Intervention (Hour 3)||4
10570684|NCT01655901|11725767|FG005|COMPLETED|Third Intervention (Hour 3)||5
10570685|NCT01655901|11725762|FG000|NOT COMPLETED|Third Intervention (Hour 3)||1
10570686|NCT01655901|11725763|FG001|NOT COMPLETED|Third Intervention (Hour 3)||1
10570687|NCT01655901|11725764|FG002|NOT COMPLETED|Third Intervention (Hour 3)||1
10570688|NCT01655901|11725765|FG003|NOT COMPLETED|Third Intervention (Hour 3)||0
10570689|NCT01655901|11725766|FG004|NOT COMPLETED|Third Intervention (Hour 3)||1
10570690|NCT01655901|11725767|FG005|NOT COMPLETED|Third Intervention (Hour 3)||0
10570691|NCT01656031|11725776|FG000|STARTED|Overall Study||39
10570692|NCT01656031|11725776|FG000|COMPLETED|Overall Study||39
10570693|NCT01656031|11725776|FG000|NOT COMPLETED|Overall Study||0
10570694|NCT01656161|11725780|FG000|STARTED|Overall Study|Intention to treat analysis set|120
10570695|NCT01656161|11725780|FG000|Received Triptorelin at Day 1|Overall Study|Safety analysis set|120
10570696|NCT01656161|11725780|FG000|Received Triptorelin at Day 169|Overall Study||115
10570697|NCT01656161|11725780|FG000|COMPLETED|Overall Study|Per protocol analysis set|113
10570698|NCT01656161|11725780|FG000|NOT COMPLETED|Overall Study||7
10570699|NCT01656187|11725789|FG000|STARTED|First Intervention (24 Weeks)||20
10570700|NCT01656187|11725790|FG001|STARTED|First Intervention (24 Weeks)||26
10570701|NCT01656187|11725789|FG000|COMPLETED|First Intervention (24 Weeks)||14
10570702|NCT01656187|11725790|FG001|COMPLETED|First Intervention (24 Weeks)||23
10570703|NCT01656187|11725789|FG000|NOT COMPLETED|First Intervention (24 Weeks)||6
10570704|NCT01656187|11725790|FG001|NOT COMPLETED|First Intervention (24 Weeks)||3
10570705|NCT01656187|11725789|FG000|STARTED|Washout (4 Weeks)||14
10570706|NCT01656187|11725790|FG001|STARTED|Washout (4 Weeks)||23
10570707|NCT01656187|11725789|FG000|COMPLETED|Washout (4 Weeks)||14
10570708|NCT01656187|11725790|FG001|COMPLETED|Washout (4 Weeks)||22
10570709|NCT01656187|11725789|FG000|NOT COMPLETED|Washout (4 Weeks)||0
10570710|NCT01656187|11725790|FG001|NOT COMPLETED|Washout (4 Weeks)||1
10570711|NCT01656187|11725789|FG000|STARTED|Second Intervention (24 Weeks)||14
10570712|NCT01656187|11725790|FG001|STARTED|Second Intervention (24 Weeks)||22
10570713|NCT01656187|11725789|FG000|COMPLETED|Second Intervention (24 Weeks)||13
10570714|NCT01656187|11725790|FG001|COMPLETED|Second Intervention (24 Weeks)||19
10570715|NCT01656187|11725789|FG000|NOT COMPLETED|Second Intervention (24 Weeks)||1
10570716|NCT01656187|11725790|FG001|NOT COMPLETED|Second Intervention (24 Weeks)||3
10570717|NCT01656200|11725796|FG000|STARTED|Overall Study||17
10570718|NCT01656200|11725796|FG000|COMPLETED|Overall Study||16
10570719|NCT01656200|11725796|FG000|NOT COMPLETED|Overall Study||1
10570720|NCT01656252|11725800|FG000|STARTED|Phase I||14
10570721|NCT01656252|11725800|FG000|COMPLETED|Phase I||14
10570722|NCT01656252|11725800|FG000|NOT COMPLETED|Phase I||0
10570723|NCT01656252|11725800|FG000|STARTED|Phase II||0
10570724|NCT01656252|11725800|FG000|COMPLETED|Phase II||0
10570725|NCT01656252|11725800|FG000|NOT COMPLETED|Phase II||0
10570726|NCT01656304|11725806|FG000|STARTED|Overall Study||16
10570727|NCT01656304|11725806|FG000|COMPLETED|Overall Study||15
10570728|NCT01656304|11725806|FG000|NOT COMPLETED|Overall Study||1
10570729|NCT01656395|11725816|FG000|STARTED|Overall Study||60
10570730|NCT01656395|11725817|FG001|STARTED|Overall Study||127
10570731|NCT01656395|11725818|FG002|STARTED|Overall Study||142
10570732|NCT01656395|11725819|FG003|STARTED|Overall Study||53
10570733|NCT01656395|11725820|FG004|STARTED|Overall Study||60
10570734|NCT01656395|11725821|FG005|STARTED|Overall Study||134
10570735|NCT01656395|11725822|FG006|STARTED|Overall Study||0
10570736|NCT01656395|11725823|FG007|STARTED|Overall Study||0
10570737|NCT01656395|11725816|FG000|Treated Participants|Overall Study||58
10570738|NCT01656395|11725817|FG001|Treated Participants|Overall Study||126
10570739|NCT01656395|11725818|FG002|Treated Participants|Overall Study||135
10570740|NCT01656395|11725819|FG003|Treated Participants|Overall Study||52
10570741|NCT01656395|11725820|FG004|Treated Participants|Overall Study||60
10570742|NCT01656395|11725821|FG005|Treated Participants|Overall Study||126
10570743|NCT01656395|11725822|FG006|Treated Participants|Overall Study||0
10570744|NCT01656395|11725823|FG007|Treated Participants|Overall Study||0
10570745|NCT01656395|11725816|FG000|COMPLETED|Overall Study||43
10570746|NCT01656395|11725817|FG001|COMPLETED|Overall Study||93
10570747|NCT01656395|11725818|FG002|COMPLETED|Overall Study||106
10570748|NCT01656395|11725819|FG003|COMPLETED|Overall Study||41
10570749|NCT01656395|11725820|FG004|COMPLETED|Overall Study||46
10570750|NCT01656395|11725821|FG005|COMPLETED|Overall Study||94
10570751|NCT01656395|11725822|FG006|COMPLETED|Overall Study||0
10570752|NCT01656395|11725823|FG007|COMPLETED|Overall Study||0
10570753|NCT01656395|11725816|FG000|NOT COMPLETED|Overall Study||17
10570754|NCT01656395|11725817|FG001|NOT COMPLETED|Overall Study||34
10570755|NCT01656395|11725818|FG002|NOT COMPLETED|Overall Study||36
10570756|NCT01656395|11725819|FG003|NOT COMPLETED|Overall Study||12
10570757|NCT01656395|11725820|FG004|NOT COMPLETED|Overall Study||14
10570758|NCT01656395|11725821|FG005|NOT COMPLETED|Overall Study||40
10570759|NCT01656395|11725822|FG006|NOT COMPLETED|Overall Study||0
10570760|NCT01656395|11725823|FG007|NOT COMPLETED|Overall Study||0
10570761|NCT01656408|11725847|FG000|STARTED|Overall Study||8
10570762|NCT01656408|11725848|FG001|STARTED|Overall Study||8
10570763|NCT01656408|11725849|FG002|STARTED|Overall Study||8
10570764|NCT01656408|11725850|FG003|STARTED|Overall Study||7
10570765|NCT01656408|11725851|FG004|STARTED|Overall Study||9
10570766|NCT01656408|11725852|FG005|STARTED|Overall Study||9
10570767|NCT01656408|11725853|FG006|STARTED|Overall Study||10
10570768|NCT01656408|11725854|FG007|STARTED|Overall Study||8
10570769|NCT01656408|11725855|FG008|STARTED|Overall Study||18
10570770|NCT01656408|11725856|FG009|STARTED|Overall Study||18
10570771|NCT01656408|11725847|FG000|COMPLETED|Overall Study||7
10570772|NCT01656408|11725848|FG001|COMPLETED|Overall Study||8
10570773|NCT01656408|11725849|FG002|COMPLETED|Overall Study||6
10570774|NCT01656408|11725850|FG003|COMPLETED|Overall Study||7
10570775|NCT01656408|11725851|FG004|COMPLETED|Overall Study||8
10570776|NCT01656408|11725852|FG005|COMPLETED|Overall Study||7
10570777|NCT01656408|11725853|FG006|COMPLETED|Overall Study||9
10570778|NCT01656408|11725854|FG007|COMPLETED|Overall Study||7
10570779|NCT01656408|11725855|FG008|COMPLETED|Overall Study||16
10570780|NCT01656408|11725856|FG009|COMPLETED|Overall Study||15
10570781|NCT01656408|11725847|FG000|NOT COMPLETED|Overall Study||1
10570782|NCT01656408|11725848|FG001|NOT COMPLETED|Overall Study||0
10570783|NCT01656408|11725849|FG002|NOT COMPLETED|Overall Study||2
10570784|NCT01656408|11725850|FG003|NOT COMPLETED|Overall Study||0
10570785|NCT01656408|11725851|FG004|NOT COMPLETED|Overall Study||1
10570786|NCT01656408|11725852|FG005|NOT COMPLETED|Overall Study||2
10570787|NCT01656408|11725853|FG006|NOT COMPLETED|Overall Study||1
10570788|NCT01656408|11725854|FG007|NOT COMPLETED|Overall Study||1
10570789|NCT01656408|11725855|FG008|NOT COMPLETED|Overall Study||2
10570790|NCT01656408|11725856|FG009|NOT COMPLETED|Overall Study||3
10570791|NCT01656460|11725902|FG000|STARTED|Overall Study||3
10794831|NCT03627767|11955235|FG000|NOT COMPLETED|Open-label Rescue Period (12 Weeks)||0
10794832|NCT03627767|11955236|FG001|NOT COMPLETED|Open-label Rescue Period (12 Weeks)||0
10794833|NCT03627767|11955237|FG002|NOT COMPLETED|Open-label Rescue Period (12 Weeks)||0
10794834|NCT03627767|11955238|FG003|NOT COMPLETED|Open-label Rescue Period (12 Weeks)||0
10794835|NCT03627767|11955239|FG004|NOT COMPLETED|Open-label Rescue Period (12 Weeks)||20
10794836|NCT03627832|11955252|FG000|STARTED|Overall Study||28
10794837|NCT03627832|11955253|FG001|STARTED|Overall Study||28
10794838|NCT03627832|11955252|FG000|COMPLETED|Overall Study||18
10794839|NCT03627832|11955253|FG001|COMPLETED|Overall Study||27
10794840|NCT03627832|11955252|FG000|NOT COMPLETED|Overall Study||10
10794841|NCT03627832|11955253|FG001|NOT COMPLETED|Overall Study||1
10455277|NCT01001195|11603306|FG002|COMPLETED|Overall Study||44
10455278|NCT01001195|11603307|FG003|COMPLETED|Overall Study||41
10455279|NCT01001195|11603304|FG000|NOT COMPLETED|Overall Study||2
10455280|NCT01001195|11603305|FG001|NOT COMPLETED|Overall Study||2
10455281|NCT01001195|11603306|FG002|NOT COMPLETED|Overall Study||0
10455282|NCT01001195|11603307|FG003|NOT COMPLETED|Overall Study||0
10455283|NCT01001208|11603319|FG000|STARTED|Overall Study||239
10455284|NCT01001208|11603320|FG001|STARTED|Overall Study||239
10455285|NCT01001208|11603319|FG000|COMPLETED|Overall Study||211
10455286|NCT01001208|11603320|FG001|COMPLETED|Overall Study||206
10455287|NCT01001208|11603319|FG000|NOT COMPLETED|Overall Study||28
10455288|NCT01001208|11603320|FG001|NOT COMPLETED|Overall Study||33
10455289|NCT01001221|11603330|FG000|STARTED|Overall Study||5
10455290|NCT01001221|11603331|FG001|STARTED|Overall Study||5
10455291|NCT01001221|11603332|FG002|STARTED|Overall Study||3
10455292|NCT01001221|11603333|FG003|STARTED|Overall Study||6
10528941|NCT01397591|11681321|FG000|NOT COMPLETED|Overall Study||0
10528942|NCT01397617|11681329|FG000|STARTED|Overall Study||64
10528943|NCT01397617|11681330|FG001|STARTED|Overall Study||53
10528944|NCT01397617|11681331|FG002|STARTED|Overall Study||60
10528945|NCT01397617|11681329|FG000|COMPLETED|Overall Study||33
10528946|NCT01397617|11681330|FG001|COMPLETED|Overall Study||30
10528947|NCT01397617|11681331|FG002|COMPLETED|Overall Study||31
10528948|NCT01397617|11681329|FG000|NOT COMPLETED|Overall Study||31
10528949|NCT01397617|11681330|FG001|NOT COMPLETED|Overall Study||23
10528950|NCT01397617|11681331|FG002|NOT COMPLETED|Overall Study||29
10528951|NCT01397656|11681344|FG000|STARTED|Overall Study||33
10528952|NCT01397656|11681345|FG001|STARTED|Overall Study||30
10528953|NCT01397656|11681344|FG000|COMPLETED|Overall Study||33
10528954|NCT01397656|11681345|FG001|COMPLETED|Overall Study||30
10528955|NCT01397656|11681344|FG000|NOT COMPLETED|Overall Study||0
10528956|NCT01397656|11681345|FG001|NOT COMPLETED|Overall Study||0
10528957|NCT01397747|11681353|FG000|STARTED|Overall Study||11016
10528958|NCT01397747|11681353|FG000|COMPLETED|Overall Study||9989
10528959|NCT01397747|11681353|FG000|NOT COMPLETED|Overall Study||1027
10528960|NCT01397786|11681361|FG000|STARTED|Phase A|Subjects in NCT01668797 Phase A at IA-related study termination rolled over to NCT01397786 Phase A.|12
10528961|NCT01397786|11681362|FG001|STARTED|Phase A||0
10528962|NCT01397786|11681363|FG002|STARTED|Phase A||227
10528963|NCT01397786|11681361|FG000|COMPLETED|Phase A||12
10528964|NCT01397786|11681362|FG001|COMPLETED|Phase A||0
10528965|NCT01397786|11681363|FG002|COMPLETED|Phase A||199
10528966|NCT01397786|11681361|FG000|NOT COMPLETED|Phase A||0
10528967|NCT01397786|11681362|FG001|NOT COMPLETED|Phase A||0
10528968|NCT01397786|11681363|FG002|NOT COMPLETED|Phase A||28
10528969|NCT01397786|11681361|FG000|STARTED|Phase B||611
10528970|NCT01397786|11681362|FG001|STARTED|Phase B||204
10528971|NCT01397786|11681363|FG002|STARTED|Phase B||229
10528972|NCT01397786|11681361|FG000|COMPLETED|Phase B||308
10528973|NCT01397786|11681362|FG001|COMPLETED|Phase B||109
10528974|NCT01397786|11681363|FG002|COMPLETED|Phase B||91
10528975|NCT01397786|11681361|FG000|NOT COMPLETED|Phase B||303
10528976|NCT01397786|11681362|FG001|NOT COMPLETED|Phase B||95
10528977|NCT01397786|11681363|FG002|NOT COMPLETED|Phase B||138
10528978|NCT01397825|11681379|FG000|STARTED|Overall Study||13
10528979|NCT01397825|11681380|FG001|STARTED|Overall Study||4
10528980|NCT01397825|11681381|FG002|STARTED|Overall Study||25
10528981|NCT01397825|11681382|FG003|STARTED|Overall Study||3
10528982|NCT01397825|11681383|FG004|STARTED|Overall Study||0
10528983|NCT01397825|11681379|FG000|COMPLETED|Overall Study||0
10528984|NCT01397825|11681380|FG001|COMPLETED|Overall Study||0
10528985|NCT01397825|11681381|FG002|COMPLETED|Overall Study||0
10528986|NCT01397825|11681382|FG003|COMPLETED|Overall Study||0
10528987|NCT01397825|11681383|FG004|COMPLETED|Overall Study||0
10528988|NCT01397825|11681379|FG000|NOT COMPLETED|Overall Study||13
10528989|NCT01397825|11681380|FG001|NOT COMPLETED|Overall Study||4
10528990|NCT01397825|11681381|FG002|NOT COMPLETED|Overall Study||25
10528991|NCT01397825|11681382|FG003|NOT COMPLETED|Overall Study||3
10528992|NCT01397825|11681383|FG004|NOT COMPLETED|Overall Study||0
10528993|NCT01397851|11681399|FG000|STARTED|Overall Study||41634
10528994|NCT01397851|11681400|FG001|STARTED|Overall Study||39963
10528995|NCT01397851|11681399|FG000|COMPLETED|Overall Study||41555
10528996|NCT01397851|11681400|FG001|COMPLETED|Overall Study||39917
10528997|NCT01397851|11681399|FG000|NOT COMPLETED|Overall Study||79
10528998|NCT01397851|11681400|FG001|NOT COMPLETED|Overall Study||46
10528999|NCT01397890|11681408|FG000|STARTED|Overall Study||287
10529000|NCT01397890|11681409|FG001|STARTED|Overall Study||291
10529001|NCT01397890|11681408|FG000|Post-baseline Efficacy Data Collected|Overall Study|'Full Analysis Set' used for efficacy analysis|287
10548396|NCT01519284|11702194|FG002|COMPLETED|Overall Study||16
10570792|NCT01656460|11725903|FG001|STARTED|Overall Study||3
10570793|NCT01656460|11725904|FG002|STARTED|Overall Study||3
10570794|NCT01656460|11725905|FG003|STARTED|Overall Study||3
10570795|NCT01656460|11725902|FG000|COMPLETED|Overall Study||3
10570796|NCT01656460|11725903|FG001|COMPLETED|Overall Study||3
10570797|NCT01656460|11725904|FG002|COMPLETED|Overall Study||3
10570798|NCT01656460|11725905|FG003|COMPLETED|Overall Study||3
10570799|NCT01656460|11725902|FG000|NOT COMPLETED|Overall Study||0
10570800|NCT01656460|11725903|FG001|NOT COMPLETED|Overall Study||0
10570801|NCT01656460|11725904|FG002|NOT COMPLETED|Overall Study||0
10570802|NCT01656460|11725905|FG003|NOT COMPLETED|Overall Study||0
10570803|NCT01656629|11725918|FG000|STARTED|Overall Study||21
10570804|NCT01656629|11725919|FG001|STARTED|Overall Study||18
10570805|NCT01656629|11725920|FG002|STARTED|Overall Study||16
10570806|NCT01656629|11725918|FG000|COMPLETED|Overall Study||16
10570807|NCT01656629|11725919|FG001|COMPLETED|Overall Study||16
10570808|NCT01656629|11725920|FG002|COMPLETED|Overall Study||14
10570809|NCT01656629|11725918|FG000|NOT COMPLETED|Overall Study||5
10570810|NCT01656629|11725919|FG001|NOT COMPLETED|Overall Study||2
10570811|NCT01656629|11725920|FG002|NOT COMPLETED|Overall Study||2
10570812|NCT01656733|11725930|FG000|STARTED|Overall Study|4 discontinued after BL visit (lost to follow up)|67
10570813|NCT01656733|11725931|FG001|STARTED|Overall Study|5 discontinued after BL visit ( lost to follow up)|70
10570814|NCT01656733|11725930|FG000|Visit 1 (1 Week After Quit Date)|Overall Study||45
10570815|NCT01656733|11725931|FG001|Visit 1 (1 Week After Quit Date)|Overall Study||42
10570816|NCT01656733|11725930|FG000|Visit 2 (2 Weeks After Quit Date)|Overall Study||32
10570817|NCT01656733|11725931|FG001|Visit 2 (2 Weeks After Quit Date)|Overall Study||44
10570818|NCT01656733|11725930|FG000|Visit 3 (3 Weeks After Quit Date)|Overall Study||33
10570819|NCT01656733|11725931|FG001|Visit 3 (3 Weeks After Quit Date)|Overall Study||34
10570820|NCT01656733|11725930|FG000|Visit 4 (4 Weeks After Quit Date)|Overall Study||32
10570821|NCT01656733|11725931|FG001|Visit 4 (4 Weeks After Quit Date)|Overall Study||30
10570822|NCT01656733|11725930|FG000|Visit 5 (6 Weeks After Quit Date)|Overall Study||37
10570823|NCT01656733|11725931|FG001|Visit 5 (6 Weeks After Quit Date)|Overall Study||36
10570824|NCT01656733|11725930|FG000|Visit 6 ( 32-36 Weeks Gestation)|Overall Study||39
10570825|NCT01656733|11725931|FG001|Visit 6 ( 32-36 Weeks Gestation)|Overall Study||47
10570826|NCT01656733|11725930|FG000|Participants With Perinatal Outcomes|Overall Study||67
10570827|NCT01656733|11725931|FG001|Participants With Perinatal Outcomes|Overall Study||66
10570828|NCT01656733|11725930|FG000|Visit 7 (1 Month Postpartum) Phone Call|Overall Study||47
10570829|NCT01656733|11725931|FG001|Visit 7 (1 Month Postpartum) Phone Call|Overall Study||50
10570830|NCT01656733|11725930|FG000|Visit 8 (6 Months Postpartum)|Overall Study||30
10570831|NCT01656733|11725931|FG001|Visit 8 (6 Months Postpartum)|Overall Study||28
10570832|NCT01656733|11725930|FG000|COMPLETED|Overall Study||67
10570833|NCT01656733|11725931|FG001|COMPLETED|Overall Study||66
10570834|NCT01656733|11725930|FG000|NOT COMPLETED|Overall Study||0
10570835|NCT01656733|11725931|FG001|NOT COMPLETED|Overall Study||4
10570836|NCT01656759|11725939|FG000|STARTED|Overall Study||27
10570837|NCT01656759|11725940|FG001|STARTED|Overall Study||25
10570838|NCT01656759|11725939|FG000|COMPLETED|Overall Study||25
10570839|NCT01656759|11725940|FG001|COMPLETED|Overall Study||22
10570840|NCT01656759|11725939|FG000|NOT COMPLETED|Overall Study||2
10570841|NCT01656759|11725940|FG001|NOT COMPLETED|Overall Study||3
10570842|NCT01656772|11725948|FG000|STARTED|Overall Study||43
10570843|NCT01656772|11725949|FG001|STARTED|Overall Study||77
10570844|NCT01656772|11725948|FG000|COMPLETED|Overall Study||43
10570845|NCT01656772|11725949|FG001|COMPLETED|Overall Study||77
10570846|NCT01656772|11725948|FG000|NOT COMPLETED|Overall Study||0
10570847|NCT01656772|11725949|FG001|NOT COMPLETED|Overall Study||0
10794842|NCT03628417|11955259|FG000|STARTED|Overall Study||7
10794843|NCT03628417|11955260|FG001|STARTED|Overall Study||7
10794844|NCT03628417|11955259|FG000|Day 0|Overall Study||7
10794845|NCT03628417|11955260|FG001|Day 0|Overall Study||7
10794846|NCT03628417|11955259|FG000|Day 7|Overall Study||7
10794847|NCT03628417|11955260|FG001|Day 7|Overall Study||7
10794848|NCT03628417|11955259|FG000|Day 15|Overall Study||7
10794849|NCT03628417|11955260|FG001|Day 15|Overall Study||7
10794850|NCT03628417|11955259|FG000|Day 30|Overall Study||7
10794851|NCT03628417|11955260|FG001|Day 30|Overall Study||7
10794852|NCT03628417|11955259|FG000|Day 60|Overall Study||7
10794853|NCT03628417|11955260|FG001|Day 60|Overall Study||7
10794854|NCT03628417|11955259|FG000|Day 90|Overall Study||7
10794855|NCT03628417|11955260|FG001|Day 90|Overall Study||7
10794856|NCT03628417|11955259|FG000|Day 180|Overall Study||7
10794857|NCT03628417|11955260|FG001|Day 180|Overall Study||7
10794858|NCT03628417|11955259|FG000|COMPLETED|Overall Study|One patient died and 3 more Ca electroporated lesions were removed before the one-year closing visit|6
10794859|NCT03628417|11955260|FG001|COMPLETED|Overall Study|One patient died before the one-year closing visit,this is why decreased the number of metastases|6
10794860|NCT03628417|11955259|FG000|NOT COMPLETED|Overall Study||1
10794861|NCT03628417|11955260|FG001|NOT COMPLETED|Overall Study||1
10794862|NCT03628456|11955270|FG000|STARTED|Overall Study||10
10794863|NCT03628456|11955270|FG000|COMPLETED|Overall Study||10
10570848|NCT01656850|11725957|FG000|STARTED|First Intervention (3 Months)||20
10570849|NCT01656850|11725958|FG001|STARTED|First Intervention (3 Months)||20
10794864|NCT03628456|11955270|FG000|NOT COMPLETED|Overall Study||0
10794865|NCT03628508|11955278|FG000|STARTED|Overall Study||40
10794866|NCT03628508|11955278|FG000|COMPLETED|Overall Study||39
10794867|NCT03628508|11955278|FG000|NOT COMPLETED|Overall Study||1
10794868|NCT03628599|11955284|FG000|STARTED|Overall Study||18
10570850|NCT01656850|11725957|FG000|COMPLETED|First Intervention (3 Months)||17
10570851|NCT01656850|11725958|FG001|COMPLETED|First Intervention (3 Months)||16
10570852|NCT01656850|11725957|FG000|NOT COMPLETED|First Intervention (3 Months)||3
10570853|NCT01656850|11725958|FG001|NOT COMPLETED|First Intervention (3 Months)||4
10570854|NCT01656850|11725957|FG000|STARTED|Washout (2 Weeks)||17
10570855|NCT01656850|11725958|FG001|STARTED|Washout (2 Weeks)||16
10570856|NCT01656850|11725957|FG000|COMPLETED|Washout (2 Weeks)||17
10570857|NCT01656850|11725958|FG001|COMPLETED|Washout (2 Weeks)||16
10570858|NCT01656850|11725957|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10570859|NCT01656850|11725958|FG001|NOT COMPLETED|Washout (2 Weeks)||0
10570860|NCT01656850|11725957|FG000|STARTED|Second Intervention (3 Months)||17
10570861|NCT01656850|11725958|FG001|STARTED|Second Intervention (3 Months)||16
10570862|NCT01656850|11725957|FG000|COMPLETED|Second Intervention (3 Months)||17
10570863|NCT01656850|11725958|FG001|COMPLETED|Second Intervention (3 Months)||16
10570864|NCT01656850|11725957|FG000|NOT COMPLETED|Second Intervention (3 Months)||0
10570865|NCT01656850|11725958|FG001|NOT COMPLETED|Second Intervention (3 Months)||0
10570866|NCT01656889|11725970|FG000|STARTED|Treatment Period, 12 Weeks|Randomized (Met all I/E criteria at completion of run-in)|222
10570867|NCT01656889|11725971|FG001|STARTED|Treatment Period, 12 Weeks|Randomized (Met all I/E criteria at completion of run-in)|225
10570868|NCT01656889|11725970|FG000|COMPLETED|Treatment Period, 12 Weeks|Completed treatment|210
10570869|NCT01656889|11725971|FG001|COMPLETED|Treatment Period, 12 Weeks|Completed treatment|214
10570870|NCT01656889|11725970|FG000|NOT COMPLETED|Treatment Period, 12 Weeks||12
10570871|NCT01656889|11725971|FG001|NOT COMPLETED|Treatment Period, 12 Weeks||11
10570872|NCT01656889|11725970|FG000|STARTED|Post Treatment Follow-Up, 3 Months||210
10570873|NCT01656889|11725971|FG001|STARTED|Post Treatment Follow-Up, 3 Months||213
10570874|NCT01656889|11725970|FG000|COMPLETED|Post Treatment Follow-Up, 3 Months||206
10570875|NCT01656889|11725971|FG001|COMPLETED|Post Treatment Follow-Up, 3 Months||204
10570876|NCT01656889|11725970|FG000|NOT COMPLETED|Post Treatment Follow-Up, 3 Months||4
10570877|NCT01656889|11725971|FG001|NOT COMPLETED|Post Treatment Follow-Up, 3 Months||9
10570878|NCT01656967|11725979|FG000|STARTED|Overall Study||33
10570879|NCT01656967|11725980|FG001|STARTED|Overall Study||33
10570880|NCT01656967|11725979|FG000|SGA Placement|Overall Study||32
10570881|NCT01656967|11725980|FG001|SGA Placement|Overall Study||33
10570882|NCT01656967|11725979|FG000|ETT Insertion|Overall Study||29
10570883|NCT01656967|11725980|FG001|ETT Insertion|Overall Study||31
10570884|NCT01656967|11725979|FG000|COMPLETED|Overall Study||29
10570885|NCT01656967|11725980|FG001|COMPLETED|Overall Study||31
10570886|NCT01656967|11725979|FG000|NOT COMPLETED|Overall Study||4
10570887|NCT01656967|11725980|FG001|NOT COMPLETED|Overall Study||2
10570888|NCT01657019|11725990|FG000|STARTED|Overall Study||604
10570889|NCT01657019|11725990|FG000|COMPLETED|Overall Study||369
10570890|NCT01657019|11725990|FG000|NOT COMPLETED|Overall Study||235
10570891|NCT01657032|11725996|FG000|STARTED|Overall Study||44
10570892|NCT01657032|11725997|FG001|STARTED|Overall Study||44
10570893|NCT01657032|11725996|FG000|COMPLETED|Overall Study||44
10570894|NCT01657032|11725997|FG001|COMPLETED|Overall Study||37
10570895|NCT01657032|11725996|FG000|NOT COMPLETED|Overall Study||0
10570896|NCT01657032|11725997|FG001|NOT COMPLETED|Overall Study||7
10570897|NCT01657162|11726005|FG000|STARTED|Overall Study||558
10570898|NCT01657162|11726006|FG001|STARTED|Overall Study||581
10570899|NCT01657162|11726005|FG000|Study 003 ITT Population|Overall Study|Participants received 80 mcg abaloparatide SC during Study 003.|824
10570900|NCT01657162|11726006|FG001|Study 003 ITT Population|Overall Study|Participants received abaloparatide-matching placebo during Study 003.|821
10570901|NCT01657162|11726005|FG000|Study 003 Modified ITT (mITT) Population|Overall Study|Participants received 80 mcg abaloparatide SC during Study 003.|690
10570902|NCT01657162|11726006|FG001|Study 003 Modified ITT (mITT) Population|Overall Study|Participants received abaloparatide-matching placebo during Study 003.|711
10570903|NCT01657162|11726005|FG000|Completed Study 003|Overall Study|Participants received 80 mcg abaloparatide SC during Study 003.|606
10570904|NCT01657162|11726006|FG001|Completed Study 003|Overall Study|Participants received abaloparatide-matching placebo during Study 003.|637
10570905|NCT01657162|11726005|FG000|Study 005 ITT Population|Overall Study||558
10570906|NCT01657162|11726006|FG001|Study 005 ITT Population|Overall Study||581
10570907|NCT01657162|11726005|FG000|Study 005 Safety Population|Overall Study||553
10570908|NCT01657162|11726006|FG001|Study 005 Safety Population|Overall Study||580
10570909|NCT01657162|11726005|FG000|Study 005 mITT Population|Overall Study||544
10570910|NCT01657162|11726006|FG001|Study 005 mITT Population|Overall Study||568
10570911|NCT01657162|11726005|FG000|COMPLETED|Overall Study||499
10570912|NCT01657162|11726006|FG001|COMPLETED|Overall Study||506
10570913|NCT01657162|11726005|FG000|NOT COMPLETED|Overall Study||59
10570914|NCT01657162|11726006|FG001|NOT COMPLETED|Overall Study||75
10570915|NCT01657253|11726014|FG000|STARTED|Overall Study||93
10570916|NCT01657253|11726015|FG001|STARTED|Overall Study||90
10570917|NCT01657253|11726014|FG000|COMPLETED|Overall Study||76
10570918|NCT01657253|11726015|FG001|COMPLETED|Overall Study||72
10570919|NCT01657253|11726014|FG000|NOT COMPLETED|Overall Study||17
10570920|NCT01657253|11726015|FG001|NOT COMPLETED|Overall Study||18
10570921|NCT01657266|11726023|FG000|STARTED|Overall Study||73
10570922|NCT01657266|11726024|FG001|STARTED|Overall Study||75
10570923|NCT01657266|11726023|FG000|COMPLETED|Overall Study||69
10570924|NCT01657266|11726024|FG001|COMPLETED|Overall Study||70
10570925|NCT01657266|11726023|FG000|NOT COMPLETED|Overall Study||4
10570926|NCT01657266|11726024|FG001|NOT COMPLETED|Overall Study||5
10570927|NCT01657292|11726030|FG000|STARTED|Overall Study||61
10570928|NCT01657292|11726030|FG000|COMPLETED|Overall Study||51
10570929|NCT01657292|11726030|FG000|NOT COMPLETED|Overall Study||10
10570930|NCT01657305|11726037|FG000|STARTED|Overall Study||107
10570931|NCT01657305|11726037|FG000|COMPLETED|Overall Study||82
10570932|NCT01657305|11726037|FG000|NOT COMPLETED|Overall Study||25
10570933|NCT01657344|11726077|FG000|STARTED|Overall Study||421622
10570934|NCT01657344|11726078|FG001|STARTED|Overall Study||409967
10570935|NCT01657344|11726079|FG002|STARTED|Overall Study||196300
10570936|NCT01657344|11726080|FG003|STARTED|Overall Study||376517
10570937|NCT01657344|11726081|FG004|STARTED|Overall Study||157802
10570938|NCT01657344|11726082|FG005|STARTED|Overall Study||316477
10570939|NCT01657344|11726083|FG006|STARTED|Overall Study||140776
10570940|NCT01657344|11726077|FG000|COMPLETED|Overall Study||421622
10570941|NCT01657344|11726078|FG001|COMPLETED|Overall Study||409967
10570942|NCT01657344|11726079|FG002|COMPLETED|Overall Study||196300
10570943|NCT01657344|11726080|FG003|COMPLETED|Overall Study||376517
10570944|NCT01657344|11726081|FG004|COMPLETED|Overall Study||157802
10570945|NCT01657344|11726082|FG005|COMPLETED|Overall Study||316477
10570946|NCT01657344|11726083|FG006|COMPLETED|Overall Study||140776
10570947|NCT01657344|11726077|FG000|NOT COMPLETED|Overall Study||0
10570948|NCT01657344|11726078|FG001|NOT COMPLETED|Overall Study||0
10570949|NCT01657344|11726079|FG002|NOT COMPLETED|Overall Study||0
10570950|NCT01657344|11726080|FG003|NOT COMPLETED|Overall Study||0
10570951|NCT01657344|11726081|FG004|NOT COMPLETED|Overall Study||0
10570952|NCT01657344|11726082|FG005|NOT COMPLETED|Overall Study||0
10570953|NCT01657344|11726083|FG006|NOT COMPLETED|Overall Study||0
10570954|NCT01657370|11726099|FG000|STARTED|Overall Study||33
10570955|NCT01657370|11726100|FG001|STARTED|Overall Study||32
10570956|NCT01657370|11726101|FG002|STARTED|Overall Study||32
10570957|NCT01657370|11726102|FG003|STARTED|Overall Study||33
10570958|NCT01657370|11726103|FG004|STARTED|Overall Study||34
10570959|NCT01657370|11726104|FG005|STARTED|Overall Study||31
10570960|NCT01657370|11726099|FG000|COMPLETED|Overall Study||27
10570961|NCT01657370|11726100|FG001|COMPLETED|Overall Study||28
10570962|NCT01657370|11726101|FG002|COMPLETED|Overall Study||25
10570963|NCT01657370|11726102|FG003|COMPLETED|Overall Study||28
10570964|NCT01657370|11726103|FG004|COMPLETED|Overall Study||27
10570965|NCT01657370|11726104|FG005|COMPLETED|Overall Study||27
10570966|NCT01657370|11726099|FG000|NOT COMPLETED|Overall Study||6
10570967|NCT01657370|11726100|FG001|NOT COMPLETED|Overall Study||4
10570968|NCT01657370|11726101|FG002|NOT COMPLETED|Overall Study||7
10570969|NCT01657370|11726102|FG003|NOT COMPLETED|Overall Study||5
10570970|NCT01657370|11726103|FG004|NOT COMPLETED|Overall Study||7
10570971|NCT01657370|11726104|FG005|NOT COMPLETED|Overall Study||4
10570972|NCT01657461|11726125|FG000|STARTED|Overall Study||98
10570973|NCT01657461|11726126|FG001|STARTED|Overall Study||98
10570974|NCT01657461|11726125|FG000|COMPLETED|Overall Study||88
10570975|NCT01657461|11726126|FG001|COMPLETED|Overall Study||78
10570976|NCT01657461|11726125|FG000|NOT COMPLETED|Overall Study||10
10570977|NCT01657461|11726126|FG001|NOT COMPLETED|Overall Study||20
10570978|NCT01657617|11726132|FG000|STARTED|Overall Study||35
10570979|NCT01657617|11726132|FG000|COMPLETED|Overall Study||35
10570980|NCT01657617|11726132|FG000|NOT COMPLETED|Overall Study||0
10570981|NCT01657760|11726138|FG000|STARTED|Overall Study||5
10570982|NCT01657760|11726139|FG001|STARTED|Overall Study||7
10570983|NCT01657760|11726140|FG002|STARTED|Overall Study||7
10570984|NCT01657760|11726141|FG003|STARTED|Overall Study||7
10570985|NCT01657760|11726138|FG000|COMPLETED|Overall Study||4
10570986|NCT01657760|11726139|FG001|COMPLETED|Overall Study||6
10570987|NCT01657760|11726140|FG002|COMPLETED|Overall Study||6
10570988|NCT01657760|11726141|FG003|COMPLETED|Overall Study||4
10570989|NCT01657760|11726138|FG000|NOT COMPLETED|Overall Study||1
10570990|NCT01657760|11726139|FG001|NOT COMPLETED|Overall Study||1
10570991|NCT01657760|11726140|FG002|NOT COMPLETED|Overall Study||1
10570992|NCT01657760|11726141|FG003|NOT COMPLETED|Overall Study||3
10570993|NCT01657799|11726156|FG000|STARTED|Overall Study||102
10570994|NCT01657799|11726157|FG001|STARTED|Overall Study||103
10570995|NCT01657799|11726158|FG002|STARTED|Overall Study||102
10570996|NCT01657799|11726156|FG000|Received Treatment|Overall Study||101
10570997|NCT01657799|11726157|FG001|Received Treatment|Overall Study||103
10570998|NCT01657799|11726158|FG002|Received Treatment|Overall Study||102
10570999|NCT01657799|11726156|FG000|COMPLETED|Overall Study||0
10571000|NCT01657799|11726157|FG001|COMPLETED|Overall Study||0
10571001|NCT01657799|11726158|FG002|COMPLETED|Overall Study||0
10571002|NCT01657799|11726156|FG000|NOT COMPLETED|Overall Study||102
10571003|NCT01657799|11726157|FG001|NOT COMPLETED|Overall Study||103
10571004|NCT01657799|11726158|FG002|NOT COMPLETED|Overall Study||102
10571005|NCT01657877|11726166|FG000|STARTED|Overall Study||79
10571006|NCT01657877|11726166|FG000|Received 500ppm Fluoride as SMFP+ 0% CSP|Overall Study|Discontinuations: 1 due to other reason in P2 and 1 protocol violation in P4|70
10571007|NCT01657877|11726166|FG000|Received 1500ppm Fluoride as SMFP+5% CSP|Overall Study|Discontinuations:2 withdrawal of consent in period (P) 1; 1 AE in P2;1 protocol violation in P3 & P4|75
10571008|NCT01657877|11726166|FG000|Received 0ppm Fluoride+ 5% CSP|Overall Study|Discontinuations: 1 protocol violation in P1 and P2 each and 1 withdrawal of consent in P1.|71
10571009|NCT01657877|11726166|FG000|Received 0ppm Fluoride+ 0% CSP|Overall Study|Discontinuation: 1 in P4 due to other reasons|69
10571010|NCT01657877|11726166|FG000|Received 1500ppm Fluoride as SMFP+0% CSP|Overall Study|Discontinuations: 1 protocol violation in P1 and 1 withdrawal of consent and AE in P3|71
10571011|NCT01657877|11726166|FG000|COMPLETED|Overall Study||65
10571012|NCT01657877|11726166|FG000|NOT COMPLETED|Overall Study||14
10571013|NCT01657903|11726183|FG000|STARTED|Overall Study||56
10571014|NCT01657903|11726183|FG000|Received Placebo (No NaF/KNO3)Toothpaste|Overall Study|One participant was lost to follow up in study period 1|56
10651281|NCT02174627|11811444|FG000|NOT COMPLETED|Overall Study||84
10571015|NCT01657903|11726183|FG000|Received NaF/KNO3 Toothpaste 1|Overall Study|One participant withdrew consent in study period 3|55
10571016|NCT01657903|11726183|FG000|Received NaF/KNO3 Toothpaste 3|Overall Study||54
10571017|NCT01657903|11726183|FG000|Received NaF/KNO3 Toothpaste 2|Overall Study||55
10571018|NCT01657903|11726183|FG000|COMPLETED|Overall Study||54
10571019|NCT01657903|11726183|FG000|NOT COMPLETED|Overall Study||2
10571020|NCT01658020|11726196|FG000|STARTED|Overall Study||175
10571021|NCT01658020|11726197|FG001|STARTED|Overall Study||167
10571022|NCT01658020|11726196|FG000|COMPLETED|Overall Study||167
10571023|NCT01658020|11726197|FG001|COMPLETED|Overall Study||158
10571024|NCT01658020|11726196|FG000|NOT COMPLETED|Overall Study||8
10571025|NCT01658020|11726197|FG001|NOT COMPLETED|Overall Study||9
10571026|NCT01658059|11726204|FG000|STARTED|First Intervention- 2 Days||12
10571027|NCT01658059|11726205|FG001|STARTED|First Intervention- 2 Days||10
10571028|NCT01658059|11726204|FG000|COMPLETED|First Intervention- 2 Days||6
10571029|NCT01658059|11726205|FG001|COMPLETED|First Intervention- 2 Days||5
10571030|NCT01658059|11726204|FG000|NOT COMPLETED|First Intervention- 2 Days||6
10571031|NCT01658059|11726205|FG001|NOT COMPLETED|First Intervention- 2 Days||5
10571032|NCT01658059|11726204|FG000|STARTED|Washout Period- 14 Days||6
10571033|NCT01658059|11726205|FG001|STARTED|Washout Period- 14 Days||5
10571034|NCT01658059|11726204|FG000|COMPLETED|Washout Period- 14 Days||6
10571035|NCT01658059|11726205|FG001|COMPLETED|Washout Period- 14 Days||5
10571036|NCT01658059|11726204|FG000|NOT COMPLETED|Washout Period- 14 Days||0
10571037|NCT01658059|11726205|FG001|NOT COMPLETED|Washout Period- 14 Days||0
10571038|NCT01658059|11726204|FG000|STARTED|Second Intervention- 2 Days||6
10571039|NCT01658059|11726205|FG001|STARTED|Second Intervention- 2 Days||5
10571040|NCT01658059|11726204|FG000|COMPLETED|Second Intervention- 2 Days||6
10571041|NCT01658059|11726205|FG001|COMPLETED|Second Intervention- 2 Days||5
10571042|NCT01658059|11726204|FG000|NOT COMPLETED|Second Intervention- 2 Days||0
10571043|NCT01658059|11726205|FG001|NOT COMPLETED|Second Intervention- 2 Days||0
10571044|NCT01658072|11726213|FG000|STARTED|Overall Study||45
10571045|NCT01658072|11726214|FG001|STARTED|Overall Study||45
10571046|NCT01658072|11726213|FG000|COMPLETED|Overall Study||41
10571047|NCT01658072|11726214|FG001|COMPLETED|Overall Study||43
10571048|NCT01658072|11726213|FG000|NOT COMPLETED|Overall Study||4
10571049|NCT01658072|11726214|FG001|NOT COMPLETED|Overall Study||2
10571050|NCT01658150|11726220|FG000|STARTED|Overall Study||11
10571051|NCT01658150|11726220|FG000|COMPLETED|Overall Study||10
10571052|NCT01658150|11726220|FG000|NOT COMPLETED|Overall Study||1
10571053|NCT01658228|11726227|FG000|STARTED|Overall Study||30
10571054|NCT01658228|11726228|FG001|STARTED|Overall Study||31
10571055|NCT01658228|11726227|FG000|COMPLETED|Overall Study||23
10571056|NCT01658228|11726228|FG001|COMPLETED|Overall Study||23
10571057|NCT01658228|11726227|FG000|NOT COMPLETED|Overall Study||7
10571058|NCT01658228|11726228|FG001|NOT COMPLETED|Overall Study||8
10571059|NCT01658436|11726234|FG000|STARTED|Overall Study||20
10571060|NCT01658436|11726235|FG001|STARTED|Overall Study||11
10571061|NCT01658436|11726234|FG000|COMPLETED|Overall Study||0
10571062|NCT01658436|11726235|FG001|COMPLETED|Overall Study||0
10571063|NCT01658436|11726234|FG000|NOT COMPLETED|Overall Study||20
10571064|NCT01658436|11726235|FG001|NOT COMPLETED|Overall Study||11
10571065|NCT01658514|11726244|FG000|STARTED|Overall Study||14
10571066|NCT01658514|11726245|FG001|STARTED|Overall Study||11
10571067|NCT01658514|11726246|FG002|STARTED|Overall Study||14
10571068|NCT01658514|11726244|FG000|Completed Treatment A|Overall Study||14
10571069|NCT01658514|11726245|FG001|Completed Treatment A|Overall Study||11
10571070|NCT01658514|11726246|FG002|Completed Treatment A|Overall Study||12
10571071|NCT01658514|11726244|FG000|Completed Treatment B|Overall Study||13
10571072|NCT01658514|11726245|FG001|Completed Treatment B|Overall Study||11
10571073|NCT01658514|11726246|FG002|Completed Treatment B|Overall Study||14
10571074|NCT01658514|11726244|FG000|Completed Treatment C|Overall Study||13
10571075|NCT01658514|11726245|FG001|Completed Treatment C|Overall Study||11
10571076|NCT01658514|11726246|FG002|Completed Treatment C|Overall Study||12
10571077|NCT01658514|11726244|FG000|Started - Normal RF Cohort Only|Overall Study||3
10571078|NCT01658514|11726245|FG001|Started - Normal RF Cohort Only|Overall Study||2
10571079|NCT01658514|11726246|FG002|Started - Normal RF Cohort Only|Overall Study||3
10571080|NCT01658514|11726244|FG000|Completed - Normal RF Cohort Only|Overall Study||3
10571081|NCT01658514|11726245|FG001|Completed - Normal RF Cohort Only|Overall Study||2
10571082|NCT01658514|11726246|FG002|Completed - Normal RF Cohort Only|Overall Study||3
10571083|NCT01658514|11726244|FG000|Started - Mild RI Cohort Only|Overall Study||4
10571084|NCT01658514|11726245|FG001|Started - Mild RI Cohort Only|Overall Study||3
10571085|NCT01658514|11726246|FG002|Started - Mild RI Cohort Only|Overall Study||4
10571086|NCT01658514|11726244|FG000|Completed - Mild RI Cohort Only|Overall Study||4
10571087|NCT01658514|11726245|FG001|Completed - Mild RI Cohort Only|Overall Study||3
10571088|NCT01658514|11726246|FG002|Completed - Mild RI Cohort Only|Overall Study||4
10571089|NCT01658514|11726244|FG000|Started - Moderate RI Cohort Only|Overall Study||4
10571090|NCT01658514|11726245|FG001|Started - Moderate RI Cohort Only|Overall Study||4
10571091|NCT01658514|11726246|FG002|Started - Moderate RI Cohort Only|Overall Study||4
10571092|NCT01658514|11726244|FG000|Completed - Moderate RI Cohort Only|Overall Study||3
10571093|NCT01658514|11726245|FG001|Completed - Moderate RI Cohort Only|Overall Study||4
10571094|NCT01658514|11726246|FG002|Completed - Moderate RI Cohort Only|Overall Study||2
10571095|NCT01658514|11726244|FG000|Started - Severe RI Cohort Only|Overall Study||3
10571096|NCT01658514|11726245|FG001|Started - Severe RI Cohort Only|Overall Study||2
10571097|NCT01658514|11726246|FG002|Started - Severe RI Cohort Only|Overall Study||3
10571098|NCT01658514|11726244|FG000|Completed - Severe RI Cohort Only|Overall Study||3
10571099|NCT01658514|11726245|FG001|Completed - Severe RI Cohort Only|Overall Study||2
10571100|NCT01658514|11726246|FG002|Completed - Severe RI Cohort Only|Overall Study||3
10571101|NCT01658514|11726244|FG000|COMPLETED|Overall Study||13
10571102|NCT01658514|11726245|FG001|COMPLETED|Overall Study||11
10571103|NCT01658514|11726246|FG002|COMPLETED|Overall Study||12
10571104|NCT01658514|11726244|FG000|NOT COMPLETED|Overall Study||1
10571105|NCT01658514|11726245|FG001|NOT COMPLETED|Overall Study||0
10571106|NCT01658514|11726246|FG002|NOT COMPLETED|Overall Study||2
10571107|NCT01658579|11726257|FG000|STARTED|Treatment Period A||15
10571108|NCT01658579|11726258|FG001|STARTED|Treatment Period A||15
10571109|NCT01658579|11726259|FG002|STARTED|Treatment Period A||15
10571110|NCT01658579|11726260|FG003|STARTED|Treatment Period A||14
10571111|NCT01658579|11726257|FG000|COMPLETED|Treatment Period A||14
10571112|NCT01658579|11726258|FG001|COMPLETED|Treatment Period A||15
10571113|NCT01658579|11726259|FG002|COMPLETED|Treatment Period A||14
10571114|NCT01658579|11726260|FG003|COMPLETED|Treatment Period A||13
10571115|NCT01658579|11726257|FG000|NOT COMPLETED|Treatment Period A||1
10571116|NCT01658579|11726258|FG001|NOT COMPLETED|Treatment Period A||0
10571117|NCT01658579|11726259|FG002|NOT COMPLETED|Treatment Period A||1
10571118|NCT01658579|11726260|FG003|NOT COMPLETED|Treatment Period A||1
10571119|NCT01658579|11726257|FG000|STARTED|Treatment Period B||14
10571120|NCT01658579|11726258|FG001|STARTED|Treatment Period B||15
10571121|NCT01658579|11726259|FG002|STARTED|Treatment Period B||14
10571122|NCT01658579|11726260|FG003|STARTED|Treatment Period B||13
10571123|NCT01658579|11726257|FG000|COMPLETED|Treatment Period B||14
10571124|NCT01658579|11726258|FG001|COMPLETED|Treatment Period B||15
10571125|NCT01658579|11726259|FG002|COMPLETED|Treatment Period B||14
10571126|NCT01658579|11726260|FG003|COMPLETED|Treatment Period B||12
10571127|NCT01658579|11726257|FG000|NOT COMPLETED|Treatment Period B||0
10571128|NCT01658579|11726258|FG001|NOT COMPLETED|Treatment Period B||0
10571129|NCT01658579|11726259|FG002|NOT COMPLETED|Treatment Period B||0
10571130|NCT01658579|11726260|FG003|NOT COMPLETED|Treatment Period B||1
10571131|NCT01658657|11726268|FG000|STARTED|Overall Study||7
10571132|NCT01658657|11726269|FG001|STARTED|Overall Study||10
10571133|NCT01658657|11726268|FG000|COMPLETED|Overall Study||4
10571134|NCT01658657|11726269|FG001|COMPLETED|Overall Study||7
10571135|NCT01658657|11726268|FG000|NOT COMPLETED|Overall Study||3
10571136|NCT01658657|11726269|FG001|NOT COMPLETED|Overall Study||3
10571137|NCT01658735|11726278|FG000|STARTED|Overall Study||39
10571138|NCT01658735|11726279|FG001|STARTED|Overall Study||36
10571139|NCT01658735|11726280|FG002|STARTED|Overall Study||38
10571140|NCT01658735|11726278|FG000|COMPLETED|Overall Study||34
10571141|NCT01658735|11726279|FG001|COMPLETED|Overall Study||29
10571142|NCT01658735|11726280|FG002|COMPLETED|Overall Study||34
10571143|NCT01658735|11726278|FG000|NOT COMPLETED|Overall Study||5
10571144|NCT01658735|11726279|FG001|NOT COMPLETED|Overall Study||7
10571145|NCT01658735|11726280|FG002|NOT COMPLETED|Overall Study||4
10571146|NCT01658839|11726288|FG000|STARTED|Overall Study||25
10571147|NCT01658839|11726288|FG000|COMPLETED|Overall Study||25
10571148|NCT01658839|11726288|FG000|NOT COMPLETED|Overall Study||0
10651282|NCT02174627|11811445|FG001|NOT COMPLETED|Overall Study||130
10651283|NCT02174731|11811453|FG000|STARTED|Overall Study||1051
10651284|NCT02174731|11811454|FG001|STARTED|Overall Study||1055
10651285|NCT02174731|11811453|FG000|Received Treatment|Overall Study||1048
10651286|NCT02174731|11811454|FG001|Received Treatment|Overall Study||1053
10651287|NCT02174731|11811453|FG000|COMPLETED|Overall Study||982
10651288|NCT02174731|11811454|FG001|COMPLETED|Overall Study||990
10651289|NCT02174731|11811453|FG000|NOT COMPLETED|Overall Study||69
10651290|NCT02174731|11811454|FG001|NOT COMPLETED|Overall Study||65
10651291|NCT02174848|11811462|FG000|STARTED|Overall Study||24
10651292|NCT02174848|11811463|FG001|STARTED|Overall Study||44
10651293|NCT02174848|11811462|FG000|Provided Post-baseline Efficacy Data|Overall Study||19
10651294|NCT02174848|11811463|FG001|Provided Post-baseline Efficacy Data|Overall Study||43
10651295|NCT02174848|11811462|FG000|COMPLETED|Overall Study||17
10651296|NCT02174848|11811463|FG001|COMPLETED|Overall Study||38
10651297|NCT02174848|11811462|FG000|NOT COMPLETED|Overall Study||7
10651298|NCT02174848|11811463|FG001|NOT COMPLETED|Overall Study||6
10651299|NCT02174913|11811476|FG000|STARTED|Overall Study||17
10651300|NCT02174913|11811477|FG001|STARTED|Overall Study||17
10651301|NCT02174913|11811476|FG000|COMPLETED|Overall Study||17
10651302|NCT02174913|11811477|FG001|COMPLETED|Overall Study||17
10651303|NCT02174913|11811476|FG000|NOT COMPLETED|Overall Study||0
10651304|NCT02174913|11811477|FG001|NOT COMPLETED|Overall Study||0
10651305|NCT02175121|11811488|FG000|STARTED|Overall Study||34
10651306|NCT02175121|11811489|FG001|STARTED|Overall Study||35
10651307|NCT02175121|11811490|FG002|STARTED|Overall Study||34
10651308|NCT02175121|11811491|FG003|STARTED|Overall Study||35
10651309|NCT02175121|11811492|FG004|STARTED|Overall Study||34
10651310|NCT02175121|11811488|FG000|COMPLETED|Overall Study||33
10651311|NCT02175121|11811489|FG001|COMPLETED|Overall Study||34
10651312|NCT02175121|11811490|FG002|COMPLETED|Overall Study||32
10651313|NCT02175121|11811491|FG003|COMPLETED|Overall Study||34
10651314|NCT02175121|11811492|FG004|COMPLETED|Overall Study||33
10651315|NCT02175121|11811488|FG000|NOT COMPLETED|Overall Study||1
10651316|NCT02175121|11811489|FG001|NOT COMPLETED|Overall Study||1
10651317|NCT02175121|11811490|FG002|NOT COMPLETED|Overall Study||2
10651318|NCT02175121|11811491|FG003|NOT COMPLETED|Overall Study||1
10651319|NCT02175121|11811492|FG004|NOT COMPLETED|Overall Study||1
10651320|NCT02175199|11811510|FG000|STARTED|Overall Study||74
10571149|NCT01658904|11726295|FG000|STARTED|Overall Study||3
10571150|NCT01658904|11726296|FG001|STARTED|Overall Study||0
10571151|NCT01658904|11726297|FG002|STARTED|Overall Study||0
10571152|NCT01658904|11726295|FG000|COMPLETED|Overall Study||1
10571153|NCT01658904|11726296|FG001|COMPLETED|Overall Study||0
10571154|NCT01658904|11726297|FG002|COMPLETED|Overall Study||0
10571155|NCT01658904|11726295|FG000|NOT COMPLETED|Overall Study||2
10571156|NCT01658904|11726296|FG001|NOT COMPLETED|Overall Study||0
10571157|NCT01658904|11726297|FG002|NOT COMPLETED|Overall Study||0
10571158|NCT01658943|11726310|FG000|STARTED|Overall Study||70
10571159|NCT01658943|11726311|FG001|STARTED|Overall Study||67
10571160|NCT01658943|11726310|FG000|Eligible|Overall Study||63
10571161|NCT01658943|11726311|FG001|Eligible|Overall Study||58
10571162|NCT01658943|11726310|FG000|Eligible and Began Protocol Therapy|Overall Study||62
10571163|NCT01658943|11726311|FG001|Eligible and Began Protocol Therapy|Overall Study||58
10571164|NCT01658943|11726310|FG000|COMPLETED|Overall Study||0
10571165|NCT01658943|11726311|FG001|COMPLETED|Overall Study||0
10571166|NCT01658943|11726310|FG000|NOT COMPLETED|Overall Study||70
10571167|NCT01658943|11726311|FG001|NOT COMPLETED|Overall Study||67
10571168|NCT01658995|11726319|FG000|STARTED|Overall Study||42
10571169|NCT01658995|11726320|FG001|STARTED|Overall Study||40
10571170|NCT01658995|11726319|FG000|COMPLETED|Overall Study||42
10571171|NCT01658995|11726320|FG001|COMPLETED|Overall Study||40
10571172|NCT01658995|11726319|FG000|NOT COMPLETED|Overall Study||0
10571173|NCT01658995|11726320|FG001|NOT COMPLETED|Overall Study||0
10571174|NCT01659021|11726328|FG000|STARTED|Main Study||174
10571175|NCT01659021|11726329|FG001|STARTED|Main Study||87
10571176|NCT01659021|11726328|FG000|Randomized and Treated|Main Study||173
10571177|NCT01659021|11726329|FG001|Randomized and Treated|Main Study||86
10571178|NCT01659021|11726328|FG000|COMPLETED|Main Study||100
10571179|NCT01659021|11726329|FG001|COMPLETED|Main Study||50
10571180|NCT01659021|11726328|FG000|NOT COMPLETED|Main Study||74
10571181|NCT01659021|11726329|FG001|NOT COMPLETED|Main Study||37
10571182|NCT01659021|11726328|FG000|STARTED|Long-Term Follow Up|Participants did not have to complete the main study to enter the Long-Term Follow Up period.|138
10571183|NCT01659021|11726329|FG001|STARTED|Long-Term Follow Up|Participants did not have to complete the main study to enter the Long-Term Follow Up period.|69
10571184|NCT01659021|11726328|FG000|COMPLETED|Long-Term Follow Up||133
10571185|NCT01659021|11726329|FG001|COMPLETED|Long-Term Follow Up||65
10571186|NCT01659021|11726328|FG000|NOT COMPLETED|Long-Term Follow Up||5
10571187|NCT01659021|11726329|FG001|NOT COMPLETED|Long-Term Follow Up||4
10571188|NCT01659125|11726339|FG000|STARTED|Overall Study||26
10571189|NCT01659125|11726339|FG000|Initiated Treatment|Overall Study||24
10571190|NCT01659125|11726339|FG000|Completed the Posttreatment Assessment|Overall Study||17
10571191|NCT01659125|11726339|FG000|Completed 3-month Follow-up|Overall Study||16
10571192|NCT01659125|11726339|FG000|Completed 6-month Follow-up|Overall Study||12
10571193|NCT01659125|11726339|FG000|COMPLETED|Overall Study||12
10571194|NCT01659125|11726339|FG000|NOT COMPLETED|Overall Study||14
10571195|NCT01659255|11726360|FG000|STARTED|Overall Study||3
10571196|NCT01659255|11726361|FG001|STARTED|Overall Study||3
10571197|NCT01659255|11726362|FG002|STARTED|Overall Study||4
10571198|NCT01659255|11726363|FG003|STARTED|Overall Study||3
10571199|NCT01659255|11726364|FG004|STARTED|Overall Study||3
10571200|NCT01659255|11726365|FG005|STARTED|Overall Study||3
10571201|NCT01659255|11726366|FG006|STARTED|Overall Study||3
10571202|NCT01659255|11726367|FG007|STARTED|Overall Study||3
10571203|NCT01659255|11726368|FG008|STARTED|Overall Study||3
10571204|NCT01659255|11726369|FG009|STARTED|Overall Study||3
10571205|NCT01659255|11726370|FG010|STARTED|Overall Study||3
10571206|NCT01659255|11726371|FG011|STARTED|Overall Study||5
10571207|NCT01659255|11726372|FG012|STARTED|Overall Study||8
10571208|NCT01659255|11726373|FG013|STARTED|Overall Study||21
10571209|NCT01659255|11726374|FG014|STARTED|Overall Study||10
10571210|NCT01659255|11726375|FG015|STARTED|Overall Study||9
10571211|NCT01659255|11726376|FG016|STARTED|Overall Study||3
10571212|NCT01659255|11726360|FG000|COMPLETED|Overall Study||1
10571213|NCT01659255|11726361|FG001|COMPLETED|Overall Study||2
10571214|NCT01659255|11726362|FG002|COMPLETED|Overall Study||4
10571215|NCT01659255|11726363|FG003|COMPLETED|Overall Study||3
10571216|NCT01659255|11726364|FG004|COMPLETED|Overall Study||3
10571217|NCT01659255|11726365|FG005|COMPLETED|Overall Study||2
10571218|NCT01659255|11726366|FG006|COMPLETED|Overall Study||1
10571219|NCT01659255|11726367|FG007|COMPLETED|Overall Study||1
10571220|NCT01659255|11726368|FG008|COMPLETED|Overall Study||2
10571221|NCT01659255|11726369|FG009|COMPLETED|Overall Study||0
10571222|NCT01659255|11726370|FG010|COMPLETED|Overall Study||0
10571223|NCT01659255|11726371|FG011|COMPLETED|Overall Study||1
10571224|NCT01659255|11726372|FG012|COMPLETED|Overall Study||0
10571225|NCT01659255|11726373|FG013|COMPLETED|Overall Study||3
10571226|NCT01659255|11726374|FG014|COMPLETED|Overall Study||2
10571227|NCT01659255|11726375|FG015|COMPLETED|Overall Study||4
10571228|NCT01659255|11726376|FG016|COMPLETED|Overall Study||0
10571229|NCT01659255|11726360|FG000|NOT COMPLETED|Overall Study||2
10571230|NCT01659255|11726361|FG001|NOT COMPLETED|Overall Study||1
10571231|NCT01659255|11726362|FG002|NOT COMPLETED|Overall Study||0
10571232|NCT01659255|11726363|FG003|NOT COMPLETED|Overall Study||0
10571233|NCT01659255|11726364|FG004|NOT COMPLETED|Overall Study||0
10571234|NCT01659255|11726365|FG005|NOT COMPLETED|Overall Study||1
10571235|NCT01659255|11726366|FG006|NOT COMPLETED|Overall Study||2
10571236|NCT01659255|11726367|FG007|NOT COMPLETED|Overall Study||2
10571237|NCT01659255|11726368|FG008|NOT COMPLETED|Overall Study||1
10571238|NCT01659255|11726369|FG009|NOT COMPLETED|Overall Study||3
10571239|NCT01659255|11726370|FG010|NOT COMPLETED|Overall Study||3
10571240|NCT01659255|11726371|FG011|NOT COMPLETED|Overall Study||4
10571241|NCT01659255|11726372|FG012|NOT COMPLETED|Overall Study||8
10571242|NCT01659255|11726373|FG013|NOT COMPLETED|Overall Study||18
10571243|NCT01659255|11726374|FG014|NOT COMPLETED|Overall Study||8
10571244|NCT01659255|11726375|FG015|NOT COMPLETED|Overall Study||5
10571245|NCT01659255|11726376|FG016|NOT COMPLETED|Overall Study||3
10571246|NCT01659268|11726416|FG000|STARTED|Overall Study||9
10571247|NCT01659268|11726417|FG001|STARTED|Overall Study||8
10571248|NCT01659268|11726416|FG000|COMPLETED|Overall Study||9
10571249|NCT01659268|11726417|FG001|COMPLETED|Overall Study||8
10571250|NCT01659268|11726416|FG000|NOT COMPLETED|Overall Study||0
10571251|NCT01659268|11726417|FG001|NOT COMPLETED|Overall Study||0
10571252|NCT01659320|11726423|FG000|STARTED|Overall Study||16
10571253|NCT01659320|11726423|FG000|COMPLETED|Overall Study||13
10571254|NCT01659320|11726423|FG000|NOT COMPLETED|Overall Study||3
10571255|NCT01659567|11726427|FG000|STARTED|Overall Study||516
10571256|NCT01659567|11726427|FG000|COMPLETED|Overall Study||393
10571257|NCT01659567|11726427|FG000|NOT COMPLETED|Overall Study||123
10571258|NCT01659736|11726433|FG000|STARTED|Treatment Period||14
10571259|NCT01659736|11726434|FG001|STARTED|Treatment Period||12
10571260|NCT01659736|11726433|FG000|COMPLETED|Treatment Period|n = 10, but data from one completer was excluded from all analyses due to protocol violation.|9
10571261|NCT01659736|11726434|FG001|COMPLETED|Treatment Period||10
10571262|NCT01659736|11726433|FG000|NOT COMPLETED|Treatment Period||5
10571263|NCT01659736|11726434|FG001|NOT COMPLETED|Treatment Period||2
10571264|NCT01659736|11726433|FG000|STARTED|3-month Follow-up||9
10571265|NCT01659736|11726434|FG001|STARTED|3-month Follow-up||10
10571266|NCT01659736|11726433|FG000|COMPLETED|3-month Follow-up||9
10571267|NCT01659736|11726434|FG001|COMPLETED|3-month Follow-up||9
10571268|NCT01659736|11726433|FG000|NOT COMPLETED|3-month Follow-up||0
10571269|NCT01659736|11726434|FG001|NOT COMPLETED|3-month Follow-up||1
10571288|NCT01659866|11726453|FG000|STARTED|Overall Study||430
10571289|NCT01659866|11726454|FG001|STARTED|Overall Study||80
10571290|NCT01659866|11726453|FG000|COMPLETED|Overall Study||430
10571291|NCT01659866|11726454|FG001|COMPLETED|Overall Study||80
10571292|NCT01659866|11726453|FG000|NOT COMPLETED|Overall Study||0
10571293|NCT01659866|11726454|FG001|NOT COMPLETED|Overall Study||0
10571294|NCT01659996|11726463|FG000|STARTED|Overall Study||421
10571295|NCT01659996|11726464|FG001|STARTED|Overall Study||395
10571296|NCT01659996|11726465|FG002|STARTED|Overall Study||472
10571297|NCT01659996|11726463|FG000|COMPLETED|Overall Study||413
10571298|NCT01659996|11726464|FG001|COMPLETED|Overall Study||388
10571299|NCT01659996|11726465|FG002|COMPLETED|Overall Study||461
10571300|NCT01659996|11726463|FG000|NOT COMPLETED|Overall Study||8
10571301|NCT01659996|11726464|FG001|NOT COMPLETED|Overall Study||7
10571302|NCT01659996|11726465|FG002|NOT COMPLETED|Overall Study||11
10794869|NCT03628599|11955285|FG001|STARTED|Overall Study||19
10794870|NCT03628599|11955284|FG000|COMPLETED|Overall Study||18
10794871|NCT03628599|11955285|FG001|COMPLETED|Overall Study||18
10794872|NCT03628599|11955284|FG000|NOT COMPLETED|Overall Study||0
10794873|NCT03628599|11955285|FG001|NOT COMPLETED|Overall Study||1
10794874|NCT03628885|11955298|FG000|STARTED|Overall Study||306
10794875|NCT03628885|11955299|FG001|STARTED|Overall Study||299
10571303|NCT01660022|11726481|FG000|STARTED|First Sequence (7 Days)||8
10571304|NCT01660022|11726482|FG001|STARTED|First Sequence (7 Days)||8
10571305|NCT01660022|11726483|FG002|STARTED|First Sequence (7 Days)||8
10571306|NCT01660022|11726484|FG003|STARTED|First Sequence (7 Days)||8
10571307|NCT01660022|11726485|FG004|STARTED|First Sequence (7 Days)||7
10571308|NCT01660022|11726486|FG005|STARTED|First Sequence (7 Days)||20
10571309|NCT01660022|11726481|FG000|COMPLETED|First Sequence (7 Days)||8
10571310|NCT01660022|11726482|FG001|COMPLETED|First Sequence (7 Days)||7
10571311|NCT01660022|11726483|FG002|COMPLETED|First Sequence (7 Days)||8
10571312|NCT01660022|11726484|FG003|COMPLETED|First Sequence (7 Days)||7
10571313|NCT01660022|11726485|FG004|COMPLETED|First Sequence (7 Days)||6
10571314|NCT01660022|11726486|FG005|COMPLETED|First Sequence (7 Days)||16
10571315|NCT01660022|11726481|FG000|NOT COMPLETED|First Sequence (7 Days)||0
10571316|NCT01660022|11726482|FG001|NOT COMPLETED|First Sequence (7 Days)||1
10571317|NCT01660022|11726483|FG002|NOT COMPLETED|First Sequence (7 Days)||0
10571318|NCT01660022|11726484|FG003|NOT COMPLETED|First Sequence (7 Days)||1
10794876|NCT03628885|11955300|FG002|STARTED|Overall Study||303
10794877|NCT03628885|11955298|FG000|COMPLETED|Overall Study||267
10571319|NCT01660022|11726485|FG004|NOT COMPLETED|First Sequence (7 Days)||1
10571320|NCT01660022|11726486|FG005|NOT COMPLETED|First Sequence (7 Days)||4
10571321|NCT01660022|11726481|FG000|STARTED|Second Sequence (42 Days)||8
10571322|NCT01660022|11726482|FG001|STARTED|Second Sequence (42 Days)||7
10571323|NCT01660022|11726483|FG002|STARTED|Second Sequence (42 Days)||8
10571324|NCT01660022|11726484|FG003|STARTED|Second Sequence (42 Days)||7
10571325|NCT01660022|11726485|FG004|STARTED|Second Sequence (42 Days)||6
10571326|NCT01660022|11726486|FG005|STARTED|Second Sequence (42 Days)||16
10571327|NCT01660022|11726481|FG000|COMPLETED|Second Sequence (42 Days)||8
10571328|NCT01660022|11726482|FG001|COMPLETED|Second Sequence (42 Days)||7
10571329|NCT01660022|11726483|FG002|COMPLETED|Second Sequence (42 Days)||8
10571330|NCT01660022|11726484|FG003|COMPLETED|Second Sequence (42 Days)||7
10571331|NCT01660022|11726485|FG004|COMPLETED|Second Sequence (42 Days)||6
10571332|NCT01660022|11726486|FG005|COMPLETED|Second Sequence (42 Days)||16
10571333|NCT01660022|11726481|FG000|NOT COMPLETED|Second Sequence (42 Days)||0
10571334|NCT01660022|11726482|FG001|NOT COMPLETED|Second Sequence (42 Days)||0
10571335|NCT01660022|11726483|FG002|NOT COMPLETED|Second Sequence (42 Days)||0
10571336|NCT01660022|11726484|FG003|NOT COMPLETED|Second Sequence (42 Days)||0
10571337|NCT01660022|11726485|FG004|NOT COMPLETED|Second Sequence (42 Days)||0
10571338|NCT01660022|11726486|FG005|NOT COMPLETED|Second Sequence (42 Days)||0
10571339|NCT01660191|11726515|FG000|STARTED|Enrollment and Washout||45
10571340|NCT01660191|11726516|FG001|STARTED|Enrollment and Washout||45
10571341|NCT01660191|11726517|FG002|STARTED|Enrollment and Washout||44
10571342|NCT01660191|11726515|FG000|COMPLETED|Enrollment and Washout||45
10571343|NCT01660191|11726516|FG001|COMPLETED|Enrollment and Washout||45
10571344|NCT01660191|11726517|FG002|COMPLETED|Enrollment and Washout||44
10571345|NCT01660191|11726515|FG000|NOT COMPLETED|Enrollment and Washout||0
10571346|NCT01660191|11726516|FG001|NOT COMPLETED|Enrollment and Washout||0
10571347|NCT01660191|11726517|FG002|NOT COMPLETED|Enrollment and Washout||0
10571348|NCT01660191|11726515|FG000|STARTED|Randomization||45
10571349|NCT01660191|11726516|FG001|STARTED|Randomization||45
10571350|NCT01660191|11726517|FG002|STARTED|Randomization||44
10571351|NCT01660191|11726515|FG000|COMPLETED|Randomization||45
10571352|NCT01660191|11726516|FG001|COMPLETED|Randomization||45
10571353|NCT01660191|11726517|FG002|COMPLETED|Randomization||44
10571354|NCT01660191|11726515|FG000|NOT COMPLETED|Randomization||0
10571355|NCT01660191|11726516|FG001|NOT COMPLETED|Randomization||0
10571356|NCT01660191|11726517|FG002|NOT COMPLETED|Randomization||0
10571357|NCT01660191|11726515|FG000|STARTED|End of Treatment||45
10571358|NCT01660191|11726516|FG001|STARTED|End of Treatment||45
10571359|NCT01660191|11726517|FG002|STARTED|End of Treatment||44
10571360|NCT01660191|11726515|FG000|COMPLETED|End of Treatment||44
10571361|NCT01660191|11726516|FG001|COMPLETED|End of Treatment||39
10571362|NCT01660191|11726517|FG002|COMPLETED|End of Treatment||43
10571363|NCT01660191|11726515|FG000|NOT COMPLETED|End of Treatment||1
10571364|NCT01660191|11726516|FG001|NOT COMPLETED|End of Treatment||6
10571365|NCT01660191|11726517|FG002|NOT COMPLETED|End of Treatment||1
10571366|NCT01660230|11726537|FG000|STARTED|Overall Study||4
10571367|NCT01660230|11726538|FG001|STARTED|Overall Study||4
10571368|NCT01660230|11726539|FG002|STARTED|Overall Study||4
10571369|NCT01660230|11726540|FG003|STARTED|Overall Study||4
10571370|NCT01660230|11726541|FG004|STARTED|Overall Study||4
10571371|NCT01660230|11726542|FG005|STARTED|Overall Study||2
10571372|NCT01660230|11726543|FG006|STARTED|Overall Study||4
10571373|NCT01660230|11726544|FG007|STARTED|Overall Study||6
10571374|NCT01660230|11726545|FG008|STARTED|Overall Study||6
10571375|NCT01660230|11726546|FG009|STARTED|Overall Study||6
10571376|NCT01660230|11726547|FG010|STARTED|Overall Study||6
10571377|NCT01660230|11726548|FG011|STARTED|Overall Study||14
10571378|NCT01660230|11726537|FG000|COMPLETED|Overall Study||4
10571379|NCT01660230|11726538|FG001|COMPLETED|Overall Study||4
10571380|NCT01660230|11726539|FG002|COMPLETED|Overall Study||4
10571381|NCT01660230|11726540|FG003|COMPLETED|Overall Study||4
10571382|NCT01660230|11726541|FG004|COMPLETED|Overall Study||4
10571383|NCT01660230|11726542|FG005|COMPLETED|Overall Study||2
10571384|NCT01660230|11726543|FG006|COMPLETED|Overall Study||4
10571385|NCT01660230|11726544|FG007|COMPLETED|Overall Study||6
10571386|NCT01660230|11726545|FG008|COMPLETED|Overall Study||6
10571387|NCT01660230|11726546|FG009|COMPLETED|Overall Study||6
10571388|NCT01660230|11726547|FG010|COMPLETED|Overall Study||6
10571389|NCT01660230|11726548|FG011|COMPLETED|Overall Study||14
10571390|NCT01660230|11726537|FG000|NOT COMPLETED|Overall Study||0
10571391|NCT01660230|11726538|FG001|NOT COMPLETED|Overall Study||0
10571392|NCT01660230|11726539|FG002|NOT COMPLETED|Overall Study||0
10571393|NCT01660230|11726540|FG003|NOT COMPLETED|Overall Study||0
10571394|NCT01660230|11726541|FG004|NOT COMPLETED|Overall Study||0
10571395|NCT01660230|11726542|FG005|NOT COMPLETED|Overall Study||0
10571396|NCT01660230|11726543|FG006|NOT COMPLETED|Overall Study||0
10571397|NCT01660230|11726544|FG007|NOT COMPLETED|Overall Study||0
10571398|NCT01660230|11726545|FG008|NOT COMPLETED|Overall Study||0
10571399|NCT01660230|11726546|FG009|NOT COMPLETED|Overall Study||0
10571400|NCT01660230|11726547|FG010|NOT COMPLETED|Overall Study||0
10571401|NCT01660230|11726548|FG011|NOT COMPLETED|Overall Study||0
10571402|NCT01660256|11726578|FG000|STARTED|Overall Study||84
10571403|NCT01660256|11726579|FG001|STARTED|Overall Study||83
10571404|NCT01660256|11726580|FG002|STARTED|Overall Study||42
10571405|NCT01660256|11726578|FG000|COMPLETED|Overall Study||79
10571406|NCT01660256|11726579|FG001|COMPLETED|Overall Study||83
10571407|NCT01660256|11726580|FG002|COMPLETED|Overall Study||38
10571408|NCT01660256|11726578|FG000|NOT COMPLETED|Overall Study||5
10571409|NCT01660256|11726579|FG001|NOT COMPLETED|Overall Study||0
10571410|NCT01660256|11726580|FG002|NOT COMPLETED|Overall Study||4
10571411|NCT01660321|11726588|FG000|STARTED|Overall Study||26
10571412|NCT01660321|11726588|FG000|COMPLETED|Overall Study||26
10571413|NCT01660321|11726588|FG000|NOT COMPLETED|Overall Study||0
10571414|NCT01660334|11726592|FG000|STARTED|Overall Study||13
10571415|NCT01660334|11726592|FG000|COMPLETED|Overall Study||12
10571416|NCT01660334|11726592|FG000|NOT COMPLETED|Overall Study||1
10571417|NCT01660412|11726596|FG000|STARTED|Overall Study||29
10571418|NCT01660412|11726597|FG001|STARTED|Overall Study||31
10571419|NCT01660412|11726596|FG000|Head|Overall Study||1
10571420|NCT01660412|11726597|FG001|Head|Overall Study||4
10571421|NCT01660412|11726596|FG000|Thorax|Overall Study||9
10571422|NCT01660412|11726597|FG001|Thorax|Overall Study||9
10571423|NCT01660412|11726596|FG000|Appendicular Structures|Overall Study||17
10571424|NCT01660412|11726597|FG001|Appendicular Structures|Overall Study||11
10571425|NCT01660412|11726596|FG000|Other|Overall Study||2
10571426|NCT01660412|11726597|FG001|Other|Overall Study||4
10571427|NCT01660412|11726596|FG000|Injection 1|Overall Study||29
10571428|NCT01660412|11726597|FG001|Injection 1|Overall Study||31
10571429|NCT01660412|11726596|FG000|Injection 2|Overall Study||29
10571430|NCT01660412|11726597|FG001|Injection 2|Overall Study||31
10571431|NCT01660412|11726596|FG000|Injection 3|Overall Study||29
10571432|NCT01660412|11726597|FG001|Injection 3|Overall Study||31
10571433|NCT01660412|11726596|FG000|Injection 4|Overall Study||29
10571434|NCT01660412|11726597|FG001|Injection 4|Overall Study||31
10571435|NCT01660412|11726596|FG000|COMPLETED|Overall Study||29
10571436|NCT01660412|11726597|FG001|COMPLETED|Overall Study||28
10571437|NCT01660412|11726596|FG000|NOT COMPLETED|Overall Study||0
10571438|NCT01660412|11726597|FG001|NOT COMPLETED|Overall Study||3
10571439|NCT01660672|11726603|FG000|STARTED|Overall Study||7
10571440|NCT01660672|11726603|FG000|COMPLETED|Overall Study||7
10571441|NCT01660672|11726603|FG000|NOT COMPLETED|Overall Study||0
10571442|NCT01660698|11726610|FG000|STARTED|Overall Study||10
10571443|NCT01660698|11726611|FG001|STARTED|Overall Study||10
10571444|NCT01660698|11726610|FG000|COMPLETED|Overall Study||10
10571445|NCT01660698|11726611|FG001|COMPLETED|Overall Study||10
10571446|NCT01660698|11726610|FG000|NOT COMPLETED|Overall Study||0
10571447|NCT01660698|11726611|FG001|NOT COMPLETED|Overall Study||0
10571448|NCT01660711|11726617|FG000|STARTED|Overall Study||22
10571449|NCT01660711|11726617|FG000|COMPLETED|Overall Study||14
10571450|NCT01660711|11726617|FG000|NOT COMPLETED|Overall Study||8
10571451|NCT01660737|11726621|FG000|STARTED|Overall Study||123
10571452|NCT01660737|11726621|FG000|COMPLETED|Overall Study||123
10571453|NCT01660737|11726621|FG000|NOT COMPLETED|Overall Study||0
10571454|NCT01660763|11726627|FG000|STARTED|Overall Study||315
10571455|NCT01660763|11726628|FG001|STARTED|Overall Study||104
10571456|NCT01660763|11726627|FG000|COMPLETED|Overall Study||215
10571457|NCT01660763|11726628|FG001|COMPLETED|Overall Study||43
10571458|NCT01660763|11726627|FG000|NOT COMPLETED|Overall Study||100
10571459|NCT01660763|11726628|FG001|NOT COMPLETED|Overall Study||61
10571460|NCT01660802|11726636|FG000|STARTED|Overall Study||130
10571461|NCT01660802|11726637|FG001|STARTED|Overall Study||132
10571462|NCT01660802|11726636|FG000|COMPLETED|Overall Study||126
10571463|NCT01660802|11726637|FG001|COMPLETED|Overall Study||121
10571464|NCT01660802|11726636|FG000|NOT COMPLETED|Overall Study||4
10571465|NCT01660802|11726637|FG001|NOT COMPLETED|Overall Study||11
10794878|NCT03628885|11955299|FG001|COMPLETED|Overall Study||252
10794879|NCT03628885|11955300|FG002|COMPLETED|Overall Study||243
10794880|NCT03628885|11955298|FG000|NOT COMPLETED|Overall Study||39
10794881|NCT03628885|11955299|FG001|NOT COMPLETED|Overall Study||47
10571466|NCT01660815|11726643|FG000|STARTED|Overall Study||7
10571467|NCT01660815|11726643|FG000|COMPLETED|Overall Study||7
10571468|NCT01660815|11726643|FG000|NOT COMPLETED|Overall Study||0
10571469|NCT01660893|11726651|FG000|STARTED|Overall Study||10
10571470|NCT01660893|11726652|FG001|STARTED|Overall Study||10
10571471|NCT01660893|11726653|FG002|STARTED|Overall Study||6
10571472|NCT01660893|11726651|FG000|COMPLETED|Overall Study||10
10571473|NCT01660893|11726652|FG001|COMPLETED|Overall Study||10
10571474|NCT01660893|11726653|FG002|COMPLETED|Overall Study||6
10571475|NCT01660893|11726651|FG000|NOT COMPLETED|Overall Study||0
10571476|NCT01660893|11726652|FG001|NOT COMPLETED|Overall Study||0
10571477|NCT01660893|11726653|FG002|NOT COMPLETED|Overall Study||0
10794882|NCT03628885|11955300|FG002|NOT COMPLETED|Overall Study||60
10794883|NCT03628898|11955308|FG000|STARTED|Overall Study||27
10794884|NCT03628898|11955308|FG000|COMPLETED|Overall Study||26
10794885|NCT03628898|11955308|FG000|NOT COMPLETED|Overall Study||1
10571478|NCT01660906|11726661|FG000|STARTED|Overall Study||39
10571479|NCT01660906|11726661|FG000|COMPLETED|Overall Study||36
10571480|NCT01660906|11726661|FG000|NOT COMPLETED|Overall Study||3
10571481|NCT01661062|11726665|FG000|STARTED|Overall Study||23
10571482|NCT01661062|11726665|FG000|COMPLETED|Overall Study||18
10571483|NCT01661062|11726665|FG000|NOT COMPLETED|Overall Study||5
10571484|NCT01661088|11726669|FG000|STARTED|FOLFIRINOX||25
10571485|NCT01661088|11726669|FG000|COMPLETED|FOLFIRINOX||21
10571486|NCT01661088|11726669|FG000|NOT COMPLETED|FOLFIRINOX||4
10571487|NCT01661088|11726669|FG000|STARTED|IMRT With FDR Gemcitabine||21
10571488|NCT01661088|11726669|FG000|COMPLETED|IMRT With FDR Gemcitabine||19
10571489|NCT01661088|11726669|FG000|NOT COMPLETED|IMRT With FDR Gemcitabine||2
10571490|NCT01661114|11726673|FG000|STARTED|Overall Study||39
10571491|NCT01661114|11726673|FG000|COMPLETED|Overall Study||39
10571492|NCT01661114|11726673|FG000|NOT COMPLETED|Overall Study||0
10651321|NCT02175199|11811511|FG001|STARTED|Overall Study||76
10571493|NCT01661140|11726677|FG000|STARTED|Open-Label Period|All participants entered the study in the initial phase for 24 weeks of open label treatment.|427
10571494|NCT01661140|11726678|FG001|STARTED|Open-Label Period||0
10571495|NCT01661140|11726679|FG002|STARTED|Open-Label Period||0
10571496|NCT01661140|11726677|FG000|COMPLETED|Open-Label Period||351
10571497|NCT01661140|11726678|FG001|COMPLETED|Open-Label Period||0
10571498|NCT01661140|11726679|FG002|COMPLETED|Open-Label Period||0
10571499|NCT01661140|11726677|FG000|NOT COMPLETED|Open-Label Period||76
10571500|NCT01661140|11726678|FG001|NOT COMPLETED|Open-Label Period||0
10571501|NCT01661140|11726679|FG002|NOT COMPLETED|Open-Label Period||0
10571502|NCT01661140|11726677|FG000|STARTED|Double-Blind Period|Those with a good/moderate disease response in the initial phase were randomized to the MTX arms.|0
10571503|NCT01661140|11726678|FG001|STARTED|Double-Blind Period|Only those with a good/moderate disease response in the initial phase were randomized.|136
10571504|NCT01661140|11726679|FG002|STARTED|Double-Blind Period|Only those with a good/moderate disease response in the initial phase were randomized.|136
10571505|NCT01661140|11726677|FG000|COMPLETED|Double-Blind Period||0
10571506|NCT01661140|11726678|FG001|COMPLETED|Double-Blind Period||95
10571507|NCT01661140|11726679|FG002|COMPLETED|Double-Blind Period||86
10571508|NCT01661140|11726677|FG000|NOT COMPLETED|Double-Blind Period||0
10571509|NCT01661140|11726678|FG001|NOT COMPLETED|Double-Blind Period||41
10571510|NCT01661140|11726679|FG002|NOT COMPLETED|Double-Blind Period||50
10571511|NCT01661179|11726687|FG000|STARTED|Overall Study||14
10571512|NCT01661179|11726687|FG000|COMPLETED|Overall Study||8
10571513|NCT01661179|11726687|FG000|NOT COMPLETED|Overall Study||6
10571514|NCT01661205|11726691|FG000|STARTED|Overall Study||26
10571515|NCT01661205|11726691|FG000|COMPLETED|Overall Study||24
10571516|NCT01661205|11726691|FG000|NOT COMPLETED|Overall Study||2
10571517|NCT01661270|11726697|FG000|STARTED|Overall Study||109
10571518|NCT01661270|11726698|FG001|STARTED|Overall Study||223
10571519|NCT01661270|11726697|FG000|Adverse Event|Overall Study|Met end of treatment (EOT) criteria.|26
10571520|NCT01661270|11726698|FG001|Adverse Event|Overall Study|Met EOT criteria|47
10571521|NCT01661270|11726697|FG000|Disease Progression|Overall Study|Met EOT criteria|67
10571522|NCT01661270|11726698|FG001|Disease Progression|Overall Study|Met EOT criteria|118
10571523|NCT01661270|11726697|FG000|Physician Decision|Overall Study|Met EOT criteria|1
10571524|NCT01661270|11726698|FG001|Physician Decision|Overall Study|Met EOT criteria|8
10571525|NCT01661270|11726697|FG000|Participant's Request|Overall Study|Met EOT criteria|15
10571526|NCT01661270|11726698|FG001|Participant's Request|Overall Study|Met EOT criteria|48
10571527|NCT01661270|11726697|FG000|Other Reasons|Overall Study||0
10571528|NCT01661270|11726698|FG001|Other Reasons|Overall Study||2
10571529|NCT01661270|11726697|FG000|COMPLETED|Overall Study|Treatment until disease progression/death, toxicity, consent withdrawal or Investigator's decision.|109
10571530|NCT01661270|11726698|FG001|COMPLETED|Overall Study|Treatment until disease progression/death, toxicity, consent withdrawal or Investigator's decision.|223
10571531|NCT01661270|11726697|FG000|NOT COMPLETED|Overall Study||0
10571532|NCT01661270|11726698|FG001|NOT COMPLETED|Overall Study||0
10571533|NCT01661283|11726705|FG000|STARTED|Overall Study|15 patients enrolled in the first stage; 10 patients enrolled in the second stage|25
10571534|NCT01661283|11726705|FG000|COMPLETED|Overall Study||25
10571535|NCT01661283|11726705|FG000|NOT COMPLETED|Overall Study||0
10571536|NCT01661595|11726713|FG000|STARTED|Phase 1: Week 0-4||5
10571537|NCT01661595|11726714|FG001|STARTED|Phase 1: Week 0-4||4
10571538|NCT01661595|11726715|FG002|STARTED|Phase 1: Week 0-4||5
10571539|NCT01661595|11726716|FG003|STARTED|Phase 1: Week 0-4||4
10571540|NCT01661595|11726713|FG000|COMPLETED|Phase 1: Week 0-4||4
10571541|NCT01661595|11726714|FG001|COMPLETED|Phase 1: Week 0-4||4
10571542|NCT01661595|11726715|FG002|COMPLETED|Phase 1: Week 0-4||5
10571543|NCT01661595|11726716|FG003|COMPLETED|Phase 1: Week 0-4||4
10571544|NCT01661595|11726713|FG000|NOT COMPLETED|Phase 1: Week 0-4||1
10571545|NCT01661595|11726714|FG001|NOT COMPLETED|Phase 1: Week 0-4||0
10571546|NCT01661595|11726715|FG002|NOT COMPLETED|Phase 1: Week 0-4||0
10571547|NCT01661595|11726716|FG003|NOT COMPLETED|Phase 1: Week 0-4||0
10571548|NCT01661595|11726713|FG000|STARTED|Phase 2: Week 5-8.||4
10571549|NCT01661595|11726714|FG001|STARTED|Phase 2: Week 5-8.||4
10571550|NCT01661595|11726715|FG002|STARTED|Phase 2: Week 5-8.||5
10571551|NCT01661595|11726716|FG003|STARTED|Phase 2: Week 5-8.||4
10571552|NCT01661595|11726713|FG000|COMPLETED|Phase 2: Week 5-8.||4
10571553|NCT01661595|11726714|FG001|COMPLETED|Phase 2: Week 5-8.||4
10571554|NCT01661595|11726715|FG002|COMPLETED|Phase 2: Week 5-8.||4
10571555|NCT01661595|11726716|FG003|COMPLETED|Phase 2: Week 5-8.||4
10571556|NCT01661595|11726713|FG000|NOT COMPLETED|Phase 2: Week 5-8.||0
10571557|NCT01661595|11726714|FG001|NOT COMPLETED|Phase 2: Week 5-8.||0
10571558|NCT01661595|11726715|FG002|NOT COMPLETED|Phase 2: Week 5-8.||1
10571559|NCT01661595|11726716|FG003|NOT COMPLETED|Phase 2: Week 5-8.||0
10571560|NCT01661621|11726735|FG000|STARTED|Overall Study||116
10571561|NCT01661621|11726736|FG001|STARTED|Overall Study||279
10571562|NCT01661621|11726735|FG000|COMPLETED|Overall Study||116
10571563|NCT01661621|11726736|FG001|COMPLETED|Overall Study||279
10571564|NCT01661621|11726735|FG000|NOT COMPLETED|Overall Study||0
10571565|NCT01661621|11726736|FG001|NOT COMPLETED|Overall Study||0
10571566|NCT01661686|11726744|FG000|STARTED|Overall Study||49
10571567|NCT01661686|11726745|FG001|STARTED|Overall Study||49
10571568|NCT01661686|11726744|FG000|COMPLETED|Overall Study||47
10571569|NCT01661686|11726745|FG001|COMPLETED|Overall Study||47
10571570|NCT01661686|11726744|FG000|NOT COMPLETED|Overall Study||2
10571571|NCT01661686|11726745|FG001|NOT COMPLETED|Overall Study||2
10571572|NCT01661712|11726753|FG000|STARTED|Overall Study|initial sham stimulation night|18
10654625|NCT02203591|11815412|FG007|COMPLETED|Overall Study||61
10571573|NCT01661712|11726754|FG001|STARTED|Overall Study|initial night on transcutaneous electrical stimulation|18
10571574|NCT01661712|11726753|FG000|Washout Period|Overall Study|>Three nights of no stimulation/sham stimulation|18
10571575|NCT01661712|11726754|FG001|Washout Period|Overall Study|>Three nights of no stimulation/sham stimulation|18
10571576|NCT01661712|11726753|FG000|COMPLETED|Overall Study|night on transcutaneous electrical stimulation|18
10571577|NCT01661712|11726754|FG001|COMPLETED|Overall Study|sham stimulation night|18
10571578|NCT01661712|11726753|FG000|NOT COMPLETED|Overall Study||0
10571579|NCT01661712|11726754|FG001|NOT COMPLETED|Overall Study||0
10571580|NCT01661764|11726772|FG000|STARTED|Overall Study||26
10571581|NCT01661764|11726773|FG001|STARTED|Overall Study||25
10571582|NCT01661764|11726774|FG002|STARTED|Overall Study||25
10571583|NCT01661764|11726775|FG003|STARTED|Overall Study||26
10571584|NCT01661764|11726776|FG004|STARTED|Overall Study||19
10571585|NCT01661764|11726777|FG005|STARTED|Overall Study||20
10571586|NCT01661764|11726772|FG000|COMPLETED|Overall Study||24
10571587|NCT01661764|11726773|FG001|COMPLETED|Overall Study||20
10571588|NCT01661764|11726774|FG002|COMPLETED|Overall Study||22
10571589|NCT01661764|11726775|FG003|COMPLETED|Overall Study||24
10571590|NCT01661764|11726776|FG004|COMPLETED|Overall Study||16
10571591|NCT01661764|11726777|FG005|COMPLETED|Overall Study||18
10571592|NCT01661764|11726772|FG000|NOT COMPLETED|Overall Study||2
10571593|NCT01661764|11726773|FG001|NOT COMPLETED|Overall Study||5
10571594|NCT01661764|11726774|FG002|NOT COMPLETED|Overall Study||3
10571595|NCT01661764|11726775|FG003|NOT COMPLETED|Overall Study||2
10571596|NCT01661764|11726776|FG004|NOT COMPLETED|Overall Study||3
10571597|NCT01661764|11726777|FG005|NOT COMPLETED|Overall Study||2
10571598|NCT01661790|11726793|FG000|STARTED|Overall Study||36
10571599|NCT01661790|11726794|FG001|STARTED|Overall Study||36
10571600|NCT01661790|11726793|FG000|COMPLETED|Overall Study||36
10571601|NCT01661790|11726794|FG001|COMPLETED|Overall Study||34
10571602|NCT01661790|11726793|FG000|NOT COMPLETED|Overall Study||0
10571603|NCT01661790|11726794|FG001|NOT COMPLETED|Overall Study||2
10571604|NCT01661933|11726800|FG000|STARTED|Gluten Micro-challenge|All 12 enrolled completed hookworm inoculation and gluten micro-challenge.|12
10571605|NCT01661933|11726800|FG000|COMPLETED|Gluten Micro-challenge|Two gluten intolerant participants did not proceed to the low-dose challenge.|12
10571606|NCT01661933|11726800|FG000|NOT COMPLETED|Gluten Micro-challenge||0
10571607|NCT01661933|11726800|FG000|STARTED|Low-dose Gluten Challenge|One was symptomatically intolerant to gluten >25 mg. One had active CeD pre- & post-micro-challenge|12
10571608|NCT01661933|11726800|FG000|COMPLETED|Low-dose Gluten Challenge|Two had challenge interrupted for 1-2 weeks. All completed challenge.|10
10571609|NCT01661933|11726800|FG000|NOT COMPLETED|Low-dose Gluten Challenge||2
10571610|NCT01661933|11726800|FG000|STARTED|High-dose Gluten Challenge|2 of 10 available after post-GC-1g did not enroll for reasons unrelated to gluten.|10
10571611|NCT01661933|11726800|FG000|COMPLETED|High-dose Gluten Challenge||8
10571612|NCT01661933|11726800|FG000|NOT COMPLETED|High-dose Gluten Challenge||2
10571613|NCT01661946|11726808|FG000|STARTED|Overall Study||5
10571614|NCT01661946|11726809|FG001|STARTED|Overall Study||5
10571615|NCT01661946|11726808|FG000|COMPLETED|Overall Study||5
10794886|NCT03628924|11955315|FG000|STARTED|Placebo Controlled Period (Week 0 - 16)||62
10794887|NCT03628924|11955316|FG001|STARTED|Placebo Controlled Period (Week 0 - 16)||59
10794888|NCT03628924|11955317|FG002|STARTED|Placebo Controlled Period (Week 0 - 16)||60
10794889|NCT03628924|11955318|FG003|STARTED|Placebo Controlled Period (Week 0 - 16)||0
10794890|NCT03628924|11955319|FG004|STARTED|Placebo Controlled Period (Week 0 - 16)||0
10794891|NCT03628924|11955320|FG005|STARTED|Placebo Controlled Period (Week 0 - 16)||0
10794892|NCT03628924|11955321|FG006|STARTED|Placebo Controlled Period (Week 0 - 16)||0
10794893|NCT03628924|11955315|FG000|COMPLETED|Placebo Controlled Period (Week 0 - 16)||56
10794894|NCT03628924|11955316|FG001|COMPLETED|Placebo Controlled Period (Week 0 - 16)||56
10794895|NCT03628924|11955317|FG002|COMPLETED|Placebo Controlled Period (Week 0 - 16)||57
10794896|NCT03628924|11955318|FG003|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
10794897|NCT03628924|11955319|FG004|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
10794898|NCT03628924|11955320|FG005|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
10794899|NCT03628924|11955321|FG006|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
10794900|NCT03628924|11955315|FG000|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||6
10794901|NCT03628924|11955316|FG001|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||3
10794902|NCT03628924|11955317|FG002|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||3
10794903|NCT03628924|11955318|FG003|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
10794904|NCT03628924|11955319|FG004|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
10794905|NCT03628924|11955320|FG005|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
10794906|NCT03628924|11955321|FG006|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
10794907|NCT03628924|11955315|FG000|STARTED|Active Treatment Period (Week 16-48)||0
10794908|NCT03628924|11955316|FG001|STARTED|Active Treatment Period (Week 16-48)||0
10794909|NCT03628924|11955317|FG002|STARTED|Active Treatment Period (Week 16-48)||0
10794910|NCT03628924|11955318|FG003|STARTED|Active Treatment Period (Week 16-48)||28
10794911|NCT03628924|11955319|FG004|STARTED|Active Treatment Period (Week 16-48)||28
10794912|NCT03628924|11955320|FG005|STARTED|Active Treatment Period (Week 16-48)||56
10794913|NCT03628924|11955321|FG006|STARTED|Active Treatment Period (Week 16-48)||57
10794914|NCT03628924|11955315|FG000|COMPLETED|Active Treatment Period (Week 16-48)||0
10794915|NCT03628924|11955316|FG001|COMPLETED|Active Treatment Period (Week 16-48)||0
10794916|NCT03628924|11955317|FG002|COMPLETED|Active Treatment Period (Week 16-48)||0
10571616|NCT01661946|11726809|FG001|COMPLETED|Overall Study||5
10571617|NCT01661946|11726808|FG000|NOT COMPLETED|Overall Study||0
10571618|NCT01661946|11726809|FG001|NOT COMPLETED|Overall Study||0
10571619|NCT01661972|11726817|FG000|STARTED|Overall Study||13
10571620|NCT01661972|11726818|FG001|STARTED|Overall Study||50
10571621|NCT01661972|11726817|FG000|COMPLETED|Overall Study||11
10571622|NCT01661972|11726818|FG001|COMPLETED|Overall Study||46
10571623|NCT01661972|11726817|FG000|NOT COMPLETED|Overall Study||2
10571624|NCT01661972|11726818|FG001|NOT COMPLETED|Overall Study||4
10571625|NCT01662024|11726826|FG000|STARTED|Overall Study||20
10571626|NCT01662024|11726826|FG000|COMPLETED|Overall Study||15
10571627|NCT01662024|11726826|FG000|NOT COMPLETED|Overall Study||5
10571628|NCT01662063|11726835|FG000|STARTED|Overall Study||44
10571629|NCT01662063|11726836|FG001|STARTED|Overall Study||173
10571630|NCT01662063|11726837|FG002|STARTED|Overall Study||1
10571631|NCT01662063|11726835|FG000|COMPLETED|Overall Study||39
10571632|NCT01662063|11726836|FG001|COMPLETED|Overall Study||144
10571633|NCT01662063|11726837|FG002|COMPLETED|Overall Study||0
10571634|NCT01662063|11726835|FG000|NOT COMPLETED|Overall Study||5
10571635|NCT01662063|11726836|FG001|NOT COMPLETED|Overall Study||29
10571636|NCT01662063|11726837|FG002|NOT COMPLETED|Overall Study||1
10571637|NCT01662115|11726848|FG000|STARTED|Overall Study||2
10571638|NCT01662115|11726849|FG001|STARTED|Overall Study||2
10571639|NCT01662115|11726850|FG002|STARTED|Overall Study||0
10571640|NCT01662115|11726848|FG000|COMPLETED|Overall Study||2
10571641|NCT01662115|11726849|FG001|COMPLETED|Overall Study||2
10571642|NCT01662115|11726850|FG002|COMPLETED|Overall Study||0
10571643|NCT01662115|11726848|FG000|NOT COMPLETED|Overall Study||0
10571644|NCT01662115|11726849|FG001|NOT COMPLETED|Overall Study||0
10571645|NCT01662115|11726850|FG002|NOT COMPLETED|Overall Study||0
10571646|NCT01662297|11726860|FG000|STARTED|Overall Study||0
10571647|NCT01662297|11726861|FG001|STARTED|Overall Study||1
10571648|NCT01662297|11726860|FG000|COMPLETED|Overall Study||0
10571649|NCT01662297|11726861|FG001|COMPLETED|Overall Study||1
10571650|NCT01662297|11726860|FG000|NOT COMPLETED|Overall Study||0
10571651|NCT01662297|11726861|FG001|NOT COMPLETED|Overall Study||0
10571652|NCT01662310|11726867|FG000|STARTED|Run-In or Stabilization Phase||201
10571653|NCT01662310|11726868|FG001|STARTED|Run-In or Stabilization Phase||0
10571654|NCT01662310|11726869|FG002|STARTED|Run-In or Stabilization Phase||0
10571655|NCT01662310|11726870|FG003|STARTED|Run-In or Stabilization Phase||0
10571656|NCT01662310|11726871|FG004|STARTED|Run-In or Stabilization Phase||0
10571657|NCT01662310|11726867|FG000|COMPLETED|Run-In or Stabilization Phase||136
10571658|NCT01662310|11726868|FG001|COMPLETED|Run-In or Stabilization Phase||0
10571659|NCT01662310|11726869|FG002|COMPLETED|Run-In or Stabilization Phase||0
10571660|NCT01662310|11726870|FG003|COMPLETED|Run-In or Stabilization Phase||0
10571661|NCT01662310|11726871|FG004|COMPLETED|Run-In or Stabilization Phase||0
10571662|NCT01662310|11726867|FG000|NOT COMPLETED|Run-In or Stabilization Phase||65
10571663|NCT01662310|11726868|FG001|NOT COMPLETED|Run-In or Stabilization Phase||0
10571664|NCT01662310|11726869|FG002|NOT COMPLETED|Run-In or Stabilization Phase||0
10571665|NCT01662310|11726870|FG003|NOT COMPLETED|Run-In or Stabilization Phase||0
10571666|NCT01662310|11726871|FG004|NOT COMPLETED|Run-In or Stabilization Phase||0
10571667|NCT01662310|11726867|FG000|STARTED|Double-Blind Phase||0
10571668|NCT01662310|11726868|FG001|STARTED|Double-Blind Phase||65
10571669|NCT01662310|11726869|FG002|STARTED|Double-Blind Phase||71
10571670|NCT01662310|11726870|FG003|STARTED|Double-Blind Phase||0
10571671|NCT01662310|11726871|FG004|STARTED|Double-Blind Phase||0
10571672|NCT01662310|11726867|FG000|Treated|Double-Blind Phase||0
10571673|NCT01662310|11726868|FG001|Treated|Double-Blind Phase||64
10571674|NCT01662310|11726869|FG002|Treated|Double-Blind Phase||71
10571675|NCT01662310|11726870|FG003|Treated|Double-Blind Phase||0
10571676|NCT01662310|11726871|FG004|Treated|Double-Blind Phase||0
10571677|NCT01662310|11726867|FG000|COMPLETED|Double-Blind Phase||0
10571678|NCT01662310|11726868|FG001|COMPLETED|Double-Blind Phase||50
10571679|NCT01662310|11726869|FG002|COMPLETED|Double-Blind Phase||66
10571680|NCT01662310|11726870|FG003|COMPLETED|Double-Blind Phase||0
10571681|NCT01662310|11726871|FG004|COMPLETED|Double-Blind Phase||0
10571682|NCT01662310|11726867|FG000|NOT COMPLETED|Double-Blind Phase||0
10571683|NCT01662310|11726868|FG001|NOT COMPLETED|Double-Blind Phase||15
10571684|NCT01662310|11726869|FG002|NOT COMPLETED|Double-Blind Phase||5
10571685|NCT01662310|11726870|FG003|NOT COMPLETED|Double-Blind Phase||0
10571686|NCT01662310|11726871|FG004|NOT COMPLETED|Double-Blind Phase||0
10571687|NCT01662310|11726867|FG000|STARTED|Open-Label Extension Phase||0
10571688|NCT01662310|11726868|FG001|STARTED|Open-Label Extension Phase||0
10571689|NCT01662310|11726869|FG002|STARTED|Open-Label Extension Phase||0
10571690|NCT01662310|11726870|FG003|STARTED|Open-Label Extension Phase||47
10571691|NCT01662310|11726871|FG004|STARTED|Open-Label Extension Phase||59
10571692|NCT01662310|11726867|FG000|COMPLETED|Open-Label Extension Phase||0
10571693|NCT01662310|11726868|FG001|COMPLETED|Open-Label Extension Phase||0
10571694|NCT01662310|11726869|FG002|COMPLETED|Open-Label Extension Phase||0
10571695|NCT01662310|11726870|FG003|COMPLETED|Open-Label Extension Phase||36
10571696|NCT01662310|11726871|FG004|COMPLETED|Open-Label Extension Phase||49
10571697|NCT01662310|11726867|FG000|NOT COMPLETED|Open-Label Extension Phase||0
10571698|NCT01662310|11726868|FG001|NOT COMPLETED|Open-Label Extension Phase||0
10571699|NCT01662310|11726869|FG002|NOT COMPLETED|Open-Label Extension Phase||0
10571700|NCT01662310|11726870|FG003|NOT COMPLETED|Open-Label Extension Phase||11
10571701|NCT01662310|11726871|FG004|NOT COMPLETED|Open-Label Extension Phase||10
10571702|NCT01662336|11726883|FG000|STARTED|Overall Study||173
10571703|NCT01662336|11726883|FG000|Completed Month 6 Visit|Overall Study||142
10571704|NCT01662336|11726883|FG000|Completed Month 12 Visit|Overall Study||109
10571705|NCT01662336|11726883|FG000|COMPLETED|Overall Study||107
10571706|NCT01662336|11726883|FG000|NOT COMPLETED|Overall Study||66
10571707|NCT01662362|11726892|FG000|STARTED|Overall Study||63
10571708|NCT01662362|11726892|FG000|COMPLETED|Overall Study||25
10571709|NCT01662362|11726892|FG000|NOT COMPLETED|Overall Study||38
10571710|NCT01662440|11726901|FG000|STARTED|Overall Study||167
10571711|NCT01662440|11726902|FG001|STARTED|Overall Study||217
10571712|NCT01662440|11726903|FG002|STARTED|Overall Study||221
10571713|NCT01662440|11726904|FG003|STARTED|Overall Study||56
10571714|NCT01662440|11726901|FG000|COMPLETED|Overall Study||158
10571715|NCT01662440|11726902|FG001|COMPLETED|Overall Study||211
10571716|NCT01662440|11726903|FG002|COMPLETED|Overall Study||215
10571717|NCT01662440|11726904|FG003|COMPLETED|Overall Study||52
10571718|NCT01662440|11726901|FG000|NOT COMPLETED|Overall Study||9
10571719|NCT01662440|11726902|FG001|NOT COMPLETED|Overall Study||6
10571720|NCT01662440|11726903|FG002|NOT COMPLETED|Overall Study||6
10571721|NCT01662440|11726904|FG003|NOT COMPLETED|Overall Study||4
10571722|NCT01662492|11726927|FG000|STARTED|Overall Study||45
10571723|NCT01662492|11726928|FG001|STARTED|Overall Study||43
10571724|NCT01662492|11726929|FG002|STARTED|Overall Study||37
10571725|NCT01662492|11726927|FG000|COMPLETED|Overall Study||42
10571726|NCT01662492|11726928|FG001|COMPLETED|Overall Study||42
10571727|NCT01662492|11726929|FG002|COMPLETED|Overall Study||31
10571728|NCT01662492|11726927|FG000|NOT COMPLETED|Overall Study||3
10571729|NCT01662492|11726928|FG001|NOT COMPLETED|Overall Study||1
10571730|NCT01662492|11726929|FG002|NOT COMPLETED|Overall Study||6
10571731|NCT01662505|11726940|FG000|STARTED|Overall Study||7
10571732|NCT01662505|11726941|FG001|STARTED|Overall Study||4
10571733|NCT01662505|11726942|FG002|STARTED|Overall Study||8
10571734|NCT01662505|11726940|FG000|COMPLETED|Overall Study||0
10571735|NCT01662505|11726941|FG001|COMPLETED|Overall Study||0
10571736|NCT01662505|11726942|FG002|COMPLETED|Overall Study||0
10571737|NCT01662505|11726940|FG000|NOT COMPLETED|Overall Study||7
10571738|NCT01662505|11726941|FG001|NOT COMPLETED|Overall Study||4
10571739|NCT01662505|11726942|FG002|NOT COMPLETED|Overall Study||8
10571740|NCT01662531|11726953|FG000|STARTED|Overall Study||27
10571741|NCT01662531|11726953|FG000|COMPLETED|Overall Study||27
10571742|NCT01662531|11726953|FG000|NOT COMPLETED|Overall Study||0
10571743|NCT01662583|11726962|FG000|STARTED|Overall Study||216
10571744|NCT01662583|11726963|FG001|STARTED|Overall Study||225
10571745|NCT01662583|11726964|FG002|STARTED|Overall Study||219
10571746|NCT01662583|11726962|FG000|COMPLETED|Overall Study||216
10571747|NCT01662583|11726963|FG001|COMPLETED|Overall Study||225
10571748|NCT01662583|11726964|FG002|COMPLETED|Overall Study||219
10571749|NCT01662583|11726962|FG000|NOT COMPLETED|Overall Study||0
10571750|NCT01662583|11726963|FG001|NOT COMPLETED|Overall Study||0
10571751|NCT01662583|11726964|FG002|NOT COMPLETED|Overall Study||0
10571752|NCT01662635|11726972|FG000|STARTED|Overall Study||230
10571753|NCT01662635|11726972|FG000|COMPLETED|Overall Study||200
10571754|NCT01662635|11726972|FG000|NOT COMPLETED|Overall Study||30
10571755|NCT01662648|11726980|FG000|STARTED|Overall Study||520
10571756|NCT01662648|11726981|FG001|STARTED|Overall Study||597
10571757|NCT01662648|11726980|FG000|COMPLETED|Overall Study||373
10571758|NCT01662648|11726981|FG001|COMPLETED|Overall Study||419
10571759|NCT01662648|11726980|FG000|NOT COMPLETED|Overall Study||147
10571760|NCT01662648|11726981|FG001|NOT COMPLETED|Overall Study||178
10571761|NCT01662752|11726987|FG000|STARTED|Overall Study||30
10571762|NCT01662752|11726987|FG000|COMPLETED|Overall Study||30
10571763|NCT01662752|11726987|FG000|NOT COMPLETED|Overall Study||0
10571764|NCT01662765|11726993|FG000|STARTED|Overall Study||42
10571765|NCT01662765|11726994|FG001|STARTED|Overall Study||42
10571766|NCT01662765|11726993|FG000|COMPLETED|Overall Study||41
10571767|NCT01662765|11726994|FG001|COMPLETED|Overall Study||40
10571768|NCT01662765|11726993|FG000|NOT COMPLETED|Overall Study||1
10571769|NCT01662765|11726994|FG001|NOT COMPLETED|Overall Study||2
10571770|NCT01662778|11727005|FG000|STARTED|Period 1||6
10571771|NCT01662778|11727006|FG001|STARTED|Period 1||5
10571772|NCT01662778|11727007|FG002|STARTED|Period 1||6
10571773|NCT01662778|11727008|FG003|STARTED|Period 1||4
10571774|NCT01662778|11727005|FG000|COMPLETED|Period 1||6
10571775|NCT01662778|11727006|FG001|COMPLETED|Period 1||5
10571776|NCT01662778|11727007|FG002|COMPLETED|Period 1||6
10571777|NCT01662778|11727008|FG003|COMPLETED|Period 1||4
10571778|NCT01662778|11727005|FG000|NOT COMPLETED|Period 1||0
10571779|NCT01662778|11727006|FG001|NOT COMPLETED|Period 1||0
10571780|NCT01662778|11727007|FG002|NOT COMPLETED|Period 1||0
10571781|NCT01662778|11727008|FG003|NOT COMPLETED|Period 1||0
10571782|NCT01662778|11727005|FG000|STARTED|Period 2||6
10571783|NCT01662778|11727006|FG001|STARTED|Period 2||5
10571784|NCT01662778|11727007|FG002|STARTED|Period 2||6
10571785|NCT01662778|11727008|FG003|STARTED|Period 2||4
10571786|NCT01662778|11727005|FG000|COMPLETED|Period 2||6
10571787|NCT01662778|11727006|FG001|COMPLETED|Period 2||5
10571788|NCT01662778|11727007|FG002|COMPLETED|Period 2||6
10571789|NCT01662778|11727008|FG003|COMPLETED|Period 2||4
10571790|NCT01662778|11727005|FG000|NOT COMPLETED|Period 2||0
10571791|NCT01662778|11727006|FG001|NOT COMPLETED|Period 2||0
10571792|NCT01662778|11727007|FG002|NOT COMPLETED|Period 2||0
10571793|NCT01662778|11727008|FG003|NOT COMPLETED|Period 2||0
10571794|NCT01662778|11727005|FG000|STARTED|Period 3||6
10571795|NCT01662778|11727006|FG001|STARTED|Period 3||5
10571796|NCT01662778|11727007|FG002|STARTED|Period 3||6
10571797|NCT01662778|11727008|FG003|STARTED|Period 3||4
10571798|NCT01662778|11727005|FG000|COMPLETED|Period 3||6
10571799|NCT01662778|11727006|FG001|COMPLETED|Period 3||5
10571800|NCT01662778|11727007|FG002|COMPLETED|Period 3||6
10571801|NCT01662778|11727008|FG003|COMPLETED|Period 3||4
10571802|NCT01662778|11727005|FG000|NOT COMPLETED|Period 3||0
10571803|NCT01662778|11727006|FG001|NOT COMPLETED|Period 3||0
10571804|NCT01662778|11727007|FG002|NOT COMPLETED|Period 3||0
10794917|NCT03628924|11955318|FG003|COMPLETED|Active Treatment Period (Week 16-48)||20
10794918|NCT03628924|11955319|FG004|COMPLETED|Active Treatment Period (Week 16-48)||24
10794919|NCT03628924|11955320|FG005|COMPLETED|Active Treatment Period (Week 16-48)||43
10794920|NCT03628924|11955321|FG006|COMPLETED|Active Treatment Period (Week 16-48)||46
10794921|NCT03628924|11955315|FG000|NOT COMPLETED|Active Treatment Period (Week 16-48)||0
10571805|NCT01662778|11727008|FG003|NOT COMPLETED|Period 3||0
10571806|NCT01662778|11727005|FG000|STARTED|Period 4||6
10571807|NCT01662778|11727006|FG001|STARTED|Period 4||5
10571808|NCT01662778|11727007|FG002|STARTED|Period 4||6
10571809|NCT01662778|11727008|FG003|STARTED|Period 4||4
10571810|NCT01662778|11727005|FG000|COMPLETED|Period 4||6
10571811|NCT01662778|11727006|FG001|COMPLETED|Period 4||5
10571812|NCT01662778|11727007|FG002|COMPLETED|Period 4||6
10571813|NCT01662778|11727008|FG003|COMPLETED|Period 4||4
10571814|NCT01662778|11727005|FG000|NOT COMPLETED|Period 4||0
10571815|NCT01662778|11727006|FG001|NOT COMPLETED|Period 4||0
10571816|NCT01662778|11727007|FG002|NOT COMPLETED|Period 4||0
10571817|NCT01662778|11727008|FG003|NOT COMPLETED|Period 4||0
10571818|NCT01662791|11727024|FG000|STARTED|Part 1 - Observational||8
10571819|NCT01662791|11727025|FG001|STARTED|Part 1 - Observational||41
10571820|NCT01662791|11727024|FG000|COMPLETED|Part 1 - Observational||8
10571821|NCT01662791|11727025|FG001|COMPLETED|Part 1 - Observational||41
10571822|NCT01662791|11727024|FG000|NOT COMPLETED|Part 1 - Observational||0
10571823|NCT01662791|11727025|FG001|NOT COMPLETED|Part 1 - Observational||0
10571824|NCT01662791|11727024|FG000|STARTED|Part 2 - Interventional||8
10571825|NCT01662791|11727025|FG001|STARTED|Part 2 - Interventional|The Control Group did not take part in the second part of the study.|0
10571826|NCT01662791|11727024|FG000|COMPLETED|Part 2 - Interventional||8
10571827|NCT01662791|11727025|FG001|COMPLETED|Part 2 - Interventional||0
10571828|NCT01662791|11727024|FG000|NOT COMPLETED|Part 2 - Interventional||0
10571829|NCT01662791|11727025|FG001|NOT COMPLETED|Part 2 - Interventional||0
10571830|NCT01662856|11727033|FG000|STARTED|Part I + Part II (Overall Study)||168
10571831|NCT01662856|11727034|FG001|STARTED|Part I + Part II (Overall Study)||57
10571832|NCT01662856|11727033|FG000|Completed Study up to Week 6|Part I + Part II (Overall Study)||164
10571833|NCT01662856|11727034|FG001|Completed Study up to Week 6|Part I + Part II (Overall Study)||56
10571834|NCT01662856|11727033|FG000|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6|152
10571835|NCT01662856|11727034|FG001|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6|55
10571836|NCT01662856|11727033|FG000|NOT COMPLETED|Part I + Part II (Overall Study)||16
10571837|NCT01662856|11727034|FG001|NOT COMPLETED|Part I + Part II (Overall Study)||2
10571838|NCT01662856|11727033|FG000|STARTED|Primary Part II||109
10571839|NCT01662856|11727034|FG001|STARTED|Primary Part II||57
10571840|NCT01662856|11727033|FG000|Completed Study up to Week 6|Primary Part II||106
10571841|NCT01662856|11727034|FG001|Completed Study up to Week 6|Primary Part II||56
10571842|NCT01662856|11727033|FG000|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6|99
10571843|NCT01662856|11727034|FG001|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6|55
10571844|NCT01662856|11727033|FG000|NOT COMPLETED|Primary Part II||10
10571845|NCT01662856|11727034|FG001|NOT COMPLETED|Primary Part II||2
10571846|NCT01662882|11727043|FG000|STARTED|Overall Study||15
10571847|NCT01662882|11727044|FG001|STARTED|Overall Study||18
10571848|NCT01662882|11727045|FG002|STARTED|Overall Study||15
10571849|NCT01662882|11727043|FG000|COMPLETED|Overall Study||15
10571850|NCT01662882|11727044|FG001|COMPLETED|Overall Study||18
10571851|NCT01662882|11727045|FG002|COMPLETED|Overall Study||15
10571852|NCT01662882|11727043|FG000|NOT COMPLETED|Overall Study||0
10571853|NCT01662882|11727044|FG001|NOT COMPLETED|Overall Study||0
10571854|NCT01662882|11727045|FG002|NOT COMPLETED|Overall Study||0
10571855|NCT01662895|11727055|FG000|STARTED|Overall Study||21
10571856|NCT01662895|11727056|FG001|STARTED|Overall Study||21
10571857|NCT01662895|11727055|FG000|Initiated Study Drug|Overall Study||21
10571858|NCT01662895|11727056|FG001|Initiated Study Drug|Overall Study||21
10571859|NCT01662895|11727055|FG000|COMPLETED|Overall Study||21
10571860|NCT01662895|11727056|FG001|COMPLETED|Overall Study||20
10571861|NCT01662895|11727055|FG000|NOT COMPLETED|Overall Study||0
10571862|NCT01662895|11727056|FG001|NOT COMPLETED|Overall Study||1
10571863|NCT01662908|11727064|FG000|STARTED|Overall Study||56
10571864|NCT01662908|11727065|FG001|STARTED|Overall Study||28
10571865|NCT01662908|11727064|FG000|COMPLETED|Overall Study||50
10571866|NCT01662908|11727065|FG001|COMPLETED|Overall Study||23
10571867|NCT01662908|11727064|FG000|NOT COMPLETED|Overall Study||6
10571868|NCT01662908|11727065|FG001|NOT COMPLETED|Overall Study||5
10571869|NCT01662960|11727075|FG000|STARTED|End of 4 Week Treatment Period||25
10571870|NCT01662960|11727076|FG001|STARTED|End of 4 Week Treatment Period||23
10571871|NCT01662960|11727077|FG002|STARTED|End of 4 Week Treatment Period||9
10571872|NCT01662960|11727078|FG003|STARTED|End of 4 Week Treatment Period||15
10571873|NCT01662960|11727075|FG000|COMPLETED|End of 4 Week Treatment Period||24
10794922|NCT03628924|11955316|FG001|NOT COMPLETED|Active Treatment Period (Week 16-48)||0
10794923|NCT03628924|11955317|FG002|NOT COMPLETED|Active Treatment Period (Week 16-48)||0
10794924|NCT03628924|11955318|FG003|NOT COMPLETED|Active Treatment Period (Week 16-48)||8
10794925|NCT03628924|11955319|FG004|NOT COMPLETED|Active Treatment Period (Week 16-48)||4
10571874|NCT01662960|11727076|FG001|COMPLETED|End of 4 Week Treatment Period||19
10571875|NCT01662960|11727077|FG002|COMPLETED|End of 4 Week Treatment Period||8
10571876|NCT01662960|11727078|FG003|COMPLETED|End of 4 Week Treatment Period||15
10571877|NCT01662960|11727075|FG000|NOT COMPLETED|End of 4 Week Treatment Period||1
10571878|NCT01662960|11727076|FG001|NOT COMPLETED|End of 4 Week Treatment Period||4
10571879|NCT01662960|11727077|FG002|NOT COMPLETED|End of 4 Week Treatment Period||1
10571880|NCT01662960|11727078|FG003|NOT COMPLETED|End of 4 Week Treatment Period||0
10571881|NCT01662960|11727075|FG000|STARTED|3 Month Follow-up||24
10571882|NCT01662960|11727076|FG001|STARTED|3 Month Follow-up||19
10571883|NCT01662960|11727077|FG002|STARTED|3 Month Follow-up||8
10571884|NCT01662960|11727078|FG003|STARTED|3 Month Follow-up||15
10571885|NCT01662960|11727075|FG000|COMPLETED|3 Month Follow-up||21
10571886|NCT01662960|11727076|FG001|COMPLETED|3 Month Follow-up||16
10571887|NCT01662960|11727077|FG002|COMPLETED|3 Month Follow-up||5
10571888|NCT01662960|11727078|FG003|COMPLETED|3 Month Follow-up||13
10571889|NCT01662960|11727075|FG000|NOT COMPLETED|3 Month Follow-up||3
10571890|NCT01662960|11727076|FG001|NOT COMPLETED|3 Month Follow-up||3
10571891|NCT01662960|11727077|FG002|NOT COMPLETED|3 Month Follow-up||3
10571892|NCT01662960|11727078|FG003|NOT COMPLETED|3 Month Follow-up||2
10571893|NCT01662986|11727090|FG000|STARTED|Overall Study||40
10571894|NCT01662986|11727091|FG001|STARTED|Overall Study||39
10571895|NCT01662986|11727090|FG000|COMPLETED|Overall Study||22
10571896|NCT01662986|11727091|FG001|COMPLETED|Overall Study||26
10571897|NCT01662986|11727090|FG000|NOT COMPLETED|Overall Study||18
10571898|NCT01662986|11727091|FG001|NOT COMPLETED|Overall Study||13
10571899|NCT01662999|11727103|FG000|STARTED|Period 1||7
10571900|NCT01662999|11727104|FG001|STARTED|Period 1||7
10571901|NCT01662999|11727105|FG002|STARTED|Period 1||7
10571902|NCT01662999|11727106|FG003|STARTED|Period 1||7
10571903|NCT01662999|11727107|FG004|STARTED|Period 1||7
10571904|NCT01662999|11727108|FG005|STARTED|Period 1||7
10571905|NCT01662999|11727103|FG000|COMPLETED|Period 1||7
10571906|NCT01662999|11727104|FG001|COMPLETED|Period 1||7
10571907|NCT01662999|11727105|FG002|COMPLETED|Period 1||7
10571908|NCT01662999|11727106|FG003|COMPLETED|Period 1||7
10571909|NCT01662999|11727107|FG004|COMPLETED|Period 1||7
10571910|NCT01662999|11727108|FG005|COMPLETED|Period 1||7
10571911|NCT01662999|11727103|FG000|NOT COMPLETED|Period 1||0
10571912|NCT01662999|11727104|FG001|NOT COMPLETED|Period 1||0
10571913|NCT01662999|11727105|FG002|NOT COMPLETED|Period 1||0
10571914|NCT01662999|11727106|FG003|NOT COMPLETED|Period 1||0
10571915|NCT01662999|11727107|FG004|NOT COMPLETED|Period 1||0
10571916|NCT01662999|11727108|FG005|NOT COMPLETED|Period 1||0
10571917|NCT01662999|11727103|FG000|STARTED|Period 2||7
10571918|NCT01662999|11727104|FG001|STARTED|Period 2||7
10571919|NCT01662999|11727105|FG002|STARTED|Period 2||7
10571920|NCT01662999|11727106|FG003|STARTED|Period 2||7
10571921|NCT01662999|11727107|FG004|STARTED|Period 2||7
10571922|NCT01662999|11727108|FG005|STARTED|Period 2||7
10571923|NCT01662999|11727103|FG000|COMPLETED|Period 2||7
10571924|NCT01662999|11727104|FG001|COMPLETED|Period 2||7
10571925|NCT01662999|11727105|FG002|COMPLETED|Period 2||7
10571926|NCT01662999|11727106|FG003|COMPLETED|Period 2||7
10571927|NCT01662999|11727107|FG004|COMPLETED|Period 2||7
10571928|NCT01662999|11727108|FG005|COMPLETED|Period 2||7
10571929|NCT01662999|11727103|FG000|NOT COMPLETED|Period 2||0
10571930|NCT01662999|11727104|FG001|NOT COMPLETED|Period 2||0
10571931|NCT01662999|11727105|FG002|NOT COMPLETED|Period 2||0
10571932|NCT01662999|11727106|FG003|NOT COMPLETED|Period 2||0
10571933|NCT01662999|11727107|FG004|NOT COMPLETED|Period 2||0
10571934|NCT01662999|11727108|FG005|NOT COMPLETED|Period 2||0
10571935|NCT01662999|11727103|FG000|STARTED|Period 3||7
10571936|NCT01662999|11727104|FG001|STARTED|Period 3||7
10571937|NCT01662999|11727105|FG002|STARTED|Period 3||7
10571938|NCT01662999|11727106|FG003|STARTED|Period 3||7
10571939|NCT01662999|11727107|FG004|STARTED|Period 3||7
10571940|NCT01662999|11727108|FG005|STARTED|Period 3||7
10571941|NCT01662999|11727103|FG000|COMPLETED|Period 3||7
10571942|NCT01662999|11727104|FG001|COMPLETED|Period 3|Participant did not provide 36, 48, or 60 hour samples in this period for Treatment B.|6
10571943|NCT01662999|11727105|FG002|COMPLETED|Period 3||7
10571944|NCT01662999|11727106|FG003|COMPLETED|Period 3||7
10571945|NCT01662999|11727107|FG004|COMPLETED|Period 3||7
10571946|NCT01662999|11727108|FG005|COMPLETED|Period 3||7
10571947|NCT01662999|11727103|FG000|NOT COMPLETED|Period 3||0
10571948|NCT01662999|11727104|FG001|NOT COMPLETED|Period 3||1
10571949|NCT01662999|11727105|FG002|NOT COMPLETED|Period 3||0
10571950|NCT01662999|11727106|FG003|NOT COMPLETED|Period 3||0
10571951|NCT01662999|11727107|FG004|NOT COMPLETED|Period 3||0
10571952|NCT01662999|11727108|FG005|NOT COMPLETED|Period 3||0
10571953|NCT01663012|11727138|FG000|STARTED|Overall Study||20
10571954|NCT01663012|11727138|FG000|COMPLETED|Overall Study||20
10571955|NCT01663012|11727138|FG000|NOT COMPLETED|Overall Study||0
10571956|NCT01663103|11727144|FG000|STARTED|Overall Study||21
10571957|NCT01663103|11727145|FG001|STARTED|Overall Study||21
10571958|NCT01663103|11727144|FG000|COMPLETED|Overall Study||18
10571959|NCT01663103|11727145|FG001|COMPLETED|Overall Study||19
10571960|NCT01663103|11727144|FG000|NOT COMPLETED|Overall Study||3
10571961|NCT01663103|11727145|FG001|NOT COMPLETED|Overall Study||2
10571962|NCT01663233|11727157|FG000|STARTED|Overall Study||130
10571963|NCT01663233|11727158|FG001|STARTED|Overall Study||136
10571964|NCT01663233|11727157|FG000|COMPLETED|Overall Study||126
10571965|NCT01663233|11727158|FG001|COMPLETED|Overall Study||129
10571966|NCT01663233|11727157|FG000|NOT COMPLETED|Overall Study||4
10571967|NCT01663233|11727158|FG001|NOT COMPLETED|Overall Study||7
10571968|NCT01663259|11727164|FG000|STARTED|Overall Study||42
10571969|NCT01663259|11727164|FG000|COMPLETED|Overall Study||42
10571970|NCT01663259|11727164|FG000|NOT COMPLETED|Overall Study||0
10571971|NCT01663272|11727168|FG000|STARTED|Overall Study||5
10571972|NCT01663272|11727169|FG001|STARTED|Overall Study||6
10571973|NCT01663272|11727170|FG002|STARTED|Overall Study||1
10571974|NCT01663272|11727168|FG000|COMPLETED|Overall Study||5
10571975|NCT01663272|11727169|FG001|COMPLETED|Overall Study||6
10571976|NCT01663272|11727170|FG002|COMPLETED|Overall Study||1
10571977|NCT01663272|11727168|FG000|NOT COMPLETED|Overall Study||0
10571978|NCT01663272|11727169|FG001|NOT COMPLETED|Overall Study||0
10571979|NCT01663272|11727170|FG002|NOT COMPLETED|Overall Study||0
10571980|NCT01663363|11727174|FG000|STARTED|Overall Study|334 Eyes were treated among 170 participants|170
10571981|NCT01663363|11727174|FG000|COMPLETED|Overall Study|334 Eyes were treated among 170 participants|170
10571982|NCT01663363|11727174|FG000|NOT COMPLETED|Overall Study||0
10571983|NCT01663402|11727180|FG000|STARTED|Overall Study||9462
10571984|NCT01663402|11727181|FG001|STARTED|Overall Study||9462
10571985|NCT01663402|11727180|FG000|Treated|Overall Study||9443
10571986|NCT01663402|11727181|FG001|Treated|Overall Study||9451
10571987|NCT01663402|11727180|FG000|COMPLETED|Overall Study||7947
10571988|NCT01663402|11727181|FG001|COMPLETED|Overall Study||7378
10571989|NCT01663402|11727180|FG000|NOT COMPLETED|Overall Study||1515
10571990|NCT01663402|11727181|FG001|NOT COMPLETED|Overall Study||2084
10571991|NCT01663506|11727187|FG000|STARTED|Overall Study||23
10571992|NCT01663506|11727187|FG000|COMPLETED|Overall Study||15
10571993|NCT01663506|11727187|FG000|NOT COMPLETED|Overall Study||8
10571994|NCT01663532|11727193|FG000|STARTED|Overall Study||168
10571995|NCT01663532|11727194|FG001|STARTED|Overall Study||172
10571996|NCT01663532|11727193|FG000|COMPLETED|Overall Study||94
10571997|NCT01663532|11727194|FG001|COMPLETED|Overall Study||65
10571998|NCT01663532|11727193|FG000|NOT COMPLETED|Overall Study||74
10571999|NCT01663532|11727194|FG001|NOT COMPLETED|Overall Study||107
10572000|NCT01663623|11727202|FG000|STARTED|Overall Study||52
10572001|NCT01663623|11727203|FG001|STARTED|Overall Study||53
10572002|NCT01663623|11727202|FG000|COMPLETED|Overall Study||40
10572003|NCT01663623|11727203|FG001|COMPLETED|Overall Study||33
10572004|NCT01663623|11727202|FG000|NOT COMPLETED|Overall Study||12
10572005|NCT01663623|11727203|FG001|NOT COMPLETED|Overall Study||20
10572006|NCT01663636|11727211|FG000|STARTED|Infant SMS Reminder Feasibility Study||160
10572007|NCT01663636|11727212|FG001|STARTED|Infant SMS Reminder Feasibility Study||161
10572008|NCT01663636|11727211|FG000|COMPLETED|Infant SMS Reminder Feasibility Study||135
10572009|NCT01663636|11727212|FG001|COMPLETED|Infant SMS Reminder Feasibility Study||130
10572010|NCT01663636|11727211|FG000|NOT COMPLETED|Infant SMS Reminder Feasibility Study||25
10572011|NCT01663636|11727212|FG001|NOT COMPLETED|Infant SMS Reminder Feasibility Study||31
10572012|NCT01663636|11727211|FG000|STARTED|Parent SMS Acceptability Assessment||135
10572013|NCT01663636|11727212|FG001|STARTED|Parent SMS Acceptability Assessment||130
10572014|NCT01663636|11727211|FG000|COMPLETED|Parent SMS Acceptability Assessment||135
10572015|NCT01663636|11727212|FG001|COMPLETED|Parent SMS Acceptability Assessment||130
10572016|NCT01663636|11727211|FG000|NOT COMPLETED|Parent SMS Acceptability Assessment||0
10572017|NCT01663636|11727212|FG001|NOT COMPLETED|Parent SMS Acceptability Assessment||0
10572018|NCT01663714|11727218|FG000|STARTED|Dosimetric and Therapeutic Treatment||30
10572019|NCT01663714|11727218|FG000|COMPLETED|Dosimetric and Therapeutic Treatment||0
10572020|NCT01663714|11727218|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||30
10572021|NCT01663714|11727218|FG000|STARTED|Long-Term Follow-Up|22 of the30 participants withdrawing from Study BEX104514 enrolled in the LTFU study.|22
10572022|NCT01663714|11727218|FG000|COMPLETED|Long-Term Follow-Up||16
10572023|NCT01663714|11727218|FG000|NOT COMPLETED|Long-Term Follow-Up||6
10572024|NCT01663727|11727226|FG000|STARTED|Overall Study||242
10572025|NCT01663727|11727227|FG001|STARTED|Overall Study||239
10572026|NCT01663727|11727226|FG000|COMPLETED|Overall Study||0
10572027|NCT01663727|11727227|FG001|COMPLETED|Overall Study||1
10572028|NCT01663727|11727226|FG000|NOT COMPLETED|Overall Study||242
10572029|NCT01663727|11727227|FG001|NOT COMPLETED|Overall Study||238
10572030|NCT01663740|11727235|FG000|STARTED|Overall Study|Safety Population|38
10572031|NCT01663740|11727236|FG001|STARTED|Overall Study|Safety Population|21
10572032|NCT01663740|11727235|FG000|COMPLETED|Overall Study||22
10572033|NCT01663740|11727236|FG001|COMPLETED|Overall Study||13
10572034|NCT01663740|11727235|FG000|NOT COMPLETED|Overall Study||16
10572035|NCT01663740|11727236|FG001|NOT COMPLETED|Overall Study||8
10794926|NCT03628924|11955320|FG005|NOT COMPLETED|Active Treatment Period (Week 16-48)||13
10794927|NCT03628924|11955321|FG006|NOT COMPLETED|Active Treatment Period (Week 16-48)||11
10572036|NCT01663779|11727244|FG000|STARTED|Overall Study||27
10572037|NCT01663779|11727245|FG001|STARTED|Overall Study||23
10572038|NCT01663779|11727244|FG000|COMPLETED|Overall Study||27
10572039|NCT01663779|11727245|FG001|COMPLETED|Overall Study||23
10572040|NCT01663779|11727244|FG000|NOT COMPLETED|Overall Study||0
10572041|NCT01663779|11727245|FG001|NOT COMPLETED|Overall Study||0
10572042|NCT01663857|11727255|FG000|STARTED|Overall Study||6
10572043|NCT01663857|11727256|FG001|STARTED|Overall Study||2
10572044|NCT01663857|11727257|FG002|STARTED|Overall Study||58
10572045|NCT01663857|11727258|FG003|STARTED|Overall Study||52
10572046|NCT01663857|11727255|FG000|Received at Least One Dose of Study Drug|Overall Study||6
10572047|NCT01663857|11727256|FG001|Received at Least One Dose of Study Drug|Overall Study||2
10572048|NCT01663857|11727257|FG002|Received at Least One Dose of Study Drug|Overall Study||58
10572049|NCT01663857|11727258|FG003|Received at Least One Dose of Study Drug|Overall Study||52
10572050|NCT01663857|11727255|FG000|COMPLETED|Overall Study||6
10572051|NCT01663857|11727256|FG001|COMPLETED|Overall Study||1
10572052|NCT01663857|11727257|FG002|COMPLETED|Overall Study||48
10572053|NCT01663857|11727258|FG003|COMPLETED|Overall Study||48
10572054|NCT01663857|11727255|FG000|NOT COMPLETED|Overall Study||0
10572055|NCT01663857|11727256|FG001|NOT COMPLETED|Overall Study||1
10572056|NCT01663857|11727257|FG002|NOT COMPLETED|Overall Study||10
10572057|NCT01663857|11727258|FG003|NOT COMPLETED|Overall Study||4
10572058|NCT01663896|11727274|FG000|STARTED|Overall Study||418
10572059|NCT01663896|11727274|FG000|COMPLETED|Overall Study||375
10572060|NCT01663896|11727274|FG000|NOT COMPLETED|Overall Study||43
10572061|NCT01663922|11727279|FG000|STARTED|First Intervention (14 Days or 5 Days)||8
10572062|NCT01663922|11727280|FG001|STARTED|First Intervention (14 Days or 5 Days)||9
10572063|NCT01663922|11727279|FG000|COMPLETED|First Intervention (14 Days or 5 Days)||8
10572064|NCT01663922|11727280|FG001|COMPLETED|First Intervention (14 Days or 5 Days)||9
10572065|NCT01663922|11727279|FG000|NOT COMPLETED|First Intervention (14 Days or 5 Days)||0
10572066|NCT01663922|11727280|FG001|NOT COMPLETED|First Intervention (14 Days or 5 Days)||0
10572067|NCT01663922|11727279|FG000|STARTED|Washout (7 Days)||8
10572068|NCT01663922|11727280|FG001|STARTED|Washout (7 Days)||9
10572069|NCT01663922|11727279|FG000|COMPLETED|Washout (7 Days)||8
10572070|NCT01663922|11727280|FG001|COMPLETED|Washout (7 Days)||9
10572071|NCT01663922|11727279|FG000|NOT COMPLETED|Washout (7 Days)||0
10572072|NCT01663922|11727280|FG001|NOT COMPLETED|Washout (7 Days)||0
10572073|NCT01663922|11727279|FG000|STARTED|Second Intervention (14 Days)||8
10572074|NCT01663922|11727280|FG001|STARTED|Second Intervention (14 Days)||9
10572075|NCT01663922|11727279|FG000|COMPLETED|Second Intervention (14 Days)||8
10572076|NCT01663922|11727280|FG001|COMPLETED|Second Intervention (14 Days)||9
10572077|NCT01663922|11727279|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
10572078|NCT01663922|11727280|FG001|NOT COMPLETED|Second Intervention (14 Days)||0
10572079|NCT01663922|11727279|FG000|STARTED|Washout (7 Days)||8
10572080|NCT01663922|11727280|FG001|STARTED|Washout (7 Days)||9
10572081|NCT01663922|11727279|FG000|COMPLETED|Washout (7 Days)||8
10572082|NCT01663922|11727280|FG001|COMPLETED|Washout (7 Days)||9
10572083|NCT01663922|11727279|FG000|NOT COMPLETED|Washout (7 Days)||0
10572084|NCT01663922|11727280|FG001|NOT COMPLETED|Washout (7 Days)||0
10572085|NCT01663922|11727279|FG000|STARTED|Third Intervention (14 Days or 5 Days)||8
10572086|NCT01663922|11727280|FG001|STARTED|Third Intervention (14 Days or 5 Days)||9
10572087|NCT01663922|11727279|FG000|COMPLETED|Third Intervention (14 Days or 5 Days)||8
10572088|NCT01663922|11727280|FG001|COMPLETED|Third Intervention (14 Days or 5 Days)||9
10572089|NCT01663922|11727279|FG000|NOT COMPLETED|Third Intervention (14 Days or 5 Days)||0
10572090|NCT01663922|11727280|FG001|NOT COMPLETED|Third Intervention (14 Days or 5 Days)||0
10572091|NCT01663935|11727285|FG000|STARTED|Overall Study||20
10572092|NCT01663935|11727285|FG000|COMPLETED|Overall Study||20
10572093|NCT01663935|11727285|FG000|NOT COMPLETED|Overall Study||0
10572094|NCT01663987|11727291|FG000|STARTED|Overall Study||39
10572095|NCT01663987|11727292|FG001|STARTED|Overall Study||40
10572096|NCT01663987|11727291|FG000|COMPLETED|Overall Study||26
10572097|NCT01663987|11727292|FG001|COMPLETED|Overall Study||34
10572098|NCT01663987|11727291|FG000|NOT COMPLETED|Overall Study||13
10572099|NCT01663987|11727292|FG001|NOT COMPLETED|Overall Study||6
10572100|NCT01664039|11727300|FG000|STARTED|Overall Study||52
10572101|NCT01664039|11727301|FG001|STARTED|Overall Study||52
10572102|NCT01664039|11727300|FG000|COMPLETED|Overall Study||46
10572103|NCT01664039|11727301|FG001|COMPLETED|Overall Study||43
10572104|NCT01664039|11727300|FG000|NOT COMPLETED|Overall Study||6
10572105|NCT01664039|11727301|FG001|NOT COMPLETED|Overall Study||9
10572106|NCT01664052|11727309|FG000|STARTED|Phase 1|Screening and enrollment|31
10572107|NCT01664052|11727310|FG001|STARTED|Phase 1||0
10572108|NCT01664052|11727309|FG000|Insert Placed in at Least One Tube|Phase 1||25
10572109|NCT01664052|11727310|FG001|Insert Placed in at Least One Tube|Phase 1||0
10572110|NCT01664052|11727309|FG000|HSG 1 Hour Post Placement|Phase 1||24
10572111|NCT01664052|11727310|FG001|HSG 1 Hour Post Placement|Phase 1||0
10572112|NCT01664052|11727309|FG000|Repeat HSG and Hysterectomy at 30 Days|Phase 1||9
10572113|NCT01664052|11727310|FG001|Repeat HSG and Hysterectomy at 30 Days|Phase 1||0
10572114|NCT01664052|11727309|FG000|Repeat HSG and Hysterectomy at 60 Days|Phase 1||8
10572115|NCT01664052|11727310|FG001|Repeat HSG and Hysterectomy at 60 Days|Phase 1||0
10572116|NCT01664052|11727309|FG000|Repeat HSG and Hysterectomy at 90 Days|Phase 1||7
10572117|NCT01664052|11727310|FG001|Repeat HSG and Hysterectomy at 90 Days|Phase 1||0
10572118|NCT01664052|11727309|FG000|COMPLETED|Phase 1||24
10572119|NCT01664052|11727310|FG001|COMPLETED|Phase 1||0
10572120|NCT01664052|11727309|FG000|NOT COMPLETED|Phase 1||7
10572121|NCT01664052|11727310|FG001|NOT COMPLETED|Phase 1||0
10572122|NCT01664052|11727309|FG000|STARTED|Phase 2|Screened and enrolled|0
10572123|NCT01664052|11727310|FG001|STARTED|Phase 2||35
10572124|NCT01664052|11727309|FG000|Insert Placed|Phase 2||0
10572125|NCT01664052|11727310|FG001|Insert Placed|Phase 2||31
10572126|NCT01664052|11727309|FG000|HSG 1 Hour Post Placement|Phase 2||0
10572127|NCT01664052|11727310|FG001|HSG 1 Hour Post Placement|Phase 2||31
10572128|NCT01664052|11727309|FG000|Repeat HSG and Hysterectomy at 30 Days|Phase 2||0
10572129|NCT01664052|11727310|FG001|Repeat HSG and Hysterectomy at 30 Days|Phase 2||10
10572130|NCT01664052|11727309|FG000|Repeat HSG and Hysterectomy at 60 Days|Phase 2||0
10572131|NCT01664052|11727310|FG001|Repeat HSG and Hysterectomy at 60 Days|Phase 2||10
10572132|NCT01664052|11727309|FG000|Repeat HSG and Hysterectomy at 90 Days|Phase 2||0
10572133|NCT01664052|11727310|FG001|Repeat HSG and Hysterectomy at 90 Days|Phase 2||10
10572134|NCT01664052|11727309|FG000|COMPLETED|Phase 2||0
10572135|NCT01664052|11727310|FG001|COMPLETED|Phase 2||31
10572136|NCT01664052|11727309|FG000|NOT COMPLETED|Phase 2||0
10572137|NCT01664052|11727310|FG001|NOT COMPLETED|Phase 2||4
10572138|NCT01664078|11727317|FG000|STARTED|Overall Study||190
10572139|NCT01664078|11727317|FG000|COMPLETED|Overall Study||121
10572140|NCT01664078|11727317|FG000|NOT COMPLETED|Overall Study||69
10572141|NCT01664091|11727367|FG000|STARTED|Overall Study||32
10572142|NCT01664091|11727367|FG000|COMPLETED|Overall Study||26
10572143|NCT01664091|11727367|FG000|NOT COMPLETED|Overall Study||6
10572144|NCT01664104|11727372|FG000|STARTED|Overall Study||136
10572145|NCT01664104|11727372|FG000|COMPLETED|Overall Study||120
10572146|NCT01664104|11727372|FG000|NOT COMPLETED|Overall Study||16
10572147|NCT01664117|11727378|FG000|STARTED|Overall Study||209
10572148|NCT01664117|11727378|FG000|COMPLETED|Overall Study||209
10572149|NCT01664117|11727378|FG000|NOT COMPLETED|Overall Study||0
10572150|NCT01664130|11727385|FG000|STARTED|Overall Study||35
10572151|NCT01664130|11727385|FG000|COMPLETED|Overall Study||33
10572152|NCT01664130|11727385|FG000|NOT COMPLETED|Overall Study||2
10572153|NCT01664247|11727394|FG000|STARTED|Overall Study||174
10572154|NCT01664247|11727395|FG001|STARTED|Overall Study||172
10572155|NCT01664247|11727394|FG000|Exposed|Overall Study|1 subject was randomised in error and withdrew before exposure to the drug|173
10572156|NCT01664247|11727395|FG001|Exposed|Overall Study|Two subjects were randomised in error and withdrew prior to exposure to drug|170
10572157|NCT01664247|11727394|FG000|COMPLETED|Overall Study||160
10572158|NCT01664247|11727395|FG001|COMPLETED|Overall Study||131
10572159|NCT01664247|11727394|FG000|NOT COMPLETED|Overall Study||14
10572160|NCT01664247|11727395|FG001|NOT COMPLETED|Overall Study||41
10572161|NCT01664494|11727401|FG000|STARTED|Overall Study||563
10572162|NCT01664494|11727401|FG000|COMPLETED|Overall Study||370
10572163|NCT01664494|11727401|FG000|NOT COMPLETED|Overall Study||193
10651322|NCT02175199|11811510|FG000|Dispensed|Overall Study|Two subjects were randomized but never dispensed study lenses.|72
10651323|NCT02175199|11811511|FG001|Dispensed|Overall Study|Two subjects were randomized but never dispensed study lenses.|74
10651324|NCT02175199|11811510|FG000|COMPLETED|Overall Study||71
10651325|NCT02175199|11811511|FG001|COMPLETED|Overall Study||71
10651326|NCT02175199|11811510|FG000|NOT COMPLETED|Overall Study||3
10651327|NCT02175199|11811511|FG001|NOT COMPLETED|Overall Study||5
10651328|NCT02175212|11811520|FG000|STARTED|Overall Study||177
10651329|NCT02175212|11811521|FG001|STARTED|Overall Study||178
10651330|NCT02175212|11811520|FG000|COMPLETED|Overall Study||14
10651331|NCT02175212|11811521|FG001|COMPLETED|Overall Study||31
10651332|NCT02175212|11811520|FG000|NOT COMPLETED|Overall Study||163
10651333|NCT02175212|11811521|FG001|NOT COMPLETED|Overall Study||147
10651334|NCT02175225|11811529|FG000|STARTED|Overall Study||145
10651335|NCT02175225|11811530|FG001|STARTED|Overall Study||149
10651336|NCT02175225|11811529|FG000|Initiated Study Drug|Overall Study|Subjects in whom study drug was not initiated are not subsequently followed per the protocol.|144
10651337|NCT02175225|11811530|FG001|Initiated Study Drug|Overall Study|Subjects in whom study drug was not initiated are not subsequently followed per the protocol.|147
10651338|NCT02175225|11811529|FG000|90 Day Outcome Obtained|Overall Study||140
10651339|NCT02175225|11811530|FG001|90 Day Outcome Obtained|Overall Study||143
10651340|NCT02175225|11811529|FG000|180 Day Outcome Obtained|Overall Study||135
10651341|NCT02175225|11811530|FG001|180 Day Outcome Obtained|Overall Study||135
10651342|NCT02175225|11811529|FG000|COMPLETED|Overall Study||137
10651343|NCT02175225|11811530|FG001|COMPLETED|Overall Study||138
10651344|NCT02175225|11811529|FG000|NOT COMPLETED|Overall Study||8
10651345|NCT02175225|11811530|FG001|NOT COMPLETED|Overall Study||11
10651346|NCT02175277|11811536|FG000|STARTED|Overall Study||9
10651347|NCT02175277|11811536|FG000|COMPLETED|Overall Study||8
10651348|NCT02175277|11811536|FG000|NOT COMPLETED|Overall Study||1
10651349|NCT02175368|11811540|FG000|STARTED|Overall Study||28
10651350|NCT02175368|11811540|FG000|COMPLETED|Overall Study||27
10651351|NCT02175368|11811540|FG000|NOT COMPLETED|Overall Study||1
10651352|NCT02175472|11811546|FG000|STARTED|Overall Study||45
10651353|NCT02175472|11811547|FG001|STARTED|Overall Study||47
10651354|NCT02175472|11811546|FG000|COMPLETED|Overall Study||38
10651355|NCT02175472|11811547|FG001|COMPLETED|Overall Study||45
10651356|NCT02175472|11811546|FG000|NOT COMPLETED|Overall Study||7
10651357|NCT02175472|11811547|FG001|NOT COMPLETED|Overall Study||2
10651358|NCT02175641|11811555|FG000|STARTED|Overall Study||157
10651359|NCT02175641|11811556|FG001|STARTED|Overall Study||157
10651360|NCT02175641|11811555|FG000|6-month Follow up|Overall Study||144
10651361|NCT02175641|11811556|FG001|6-month Follow up|Overall Study||149
10651362|NCT02175641|11811555|FG000|12-month Follow up|Overall Study||129
10651363|NCT02175641|11811556|FG001|12-month Follow up|Overall Study||136
10651364|NCT02175641|11811555|FG000|18-month Follow up|Overall Study||122
10651365|NCT02175641|11811556|FG001|18-month Follow up|Overall Study||130
10651366|NCT02175641|11811555|FG000|COMPLETED|Overall Study||122
10651367|NCT02175641|11811556|FG001|COMPLETED|Overall Study||130
10651368|NCT02175641|11811555|FG000|NOT COMPLETED|Overall Study||35
10651369|NCT02175641|11811556|FG001|NOT COMPLETED|Overall Study||27
10651370|NCT02175745|11811562|FG000|STARTED|Overall Study||2
10651371|NCT02175745|11811562|FG000|COMPLETED|Overall Study||1
10651372|NCT02175745|11811562|FG000|NOT COMPLETED|Overall Study||1
10651373|NCT02175758|11811572|FG000|STARTED|PK Lead-in Phase||4
10651374|NCT02175758|11811573|FG001|STARTED|PK Lead-in Phase||6
10651375|NCT02175758|11811574|FG002|STARTED|PK Lead-in Phase||2
10651376|NCT02175758|11811575|FG003|STARTED|PK Lead-in Phase||10
10651377|NCT02175758|11811576|FG004|STARTED|PK Lead-in Phase||4
10651378|NCT02175758|11811577|FG005|STARTED|PK Lead-in Phase||8
10651379|NCT02175758|11811572|FG000|COMPLETED|PK Lead-in Phase||4
10651380|NCT02175758|11811573|FG001|COMPLETED|PK Lead-in Phase||6
10651381|NCT02175758|11811574|FG002|COMPLETED|PK Lead-in Phase||2
10572164|NCT01664533|11727405|FG000|STARTED|Overall Study||57
10572165|NCT01664533|11727405|FG000|COMPLETED|Overall Study||0
10572166|NCT01664533|11727405|FG000|NOT COMPLETED|Overall Study||57
10572167|NCT01664559|11727412|FG000|STARTED|Overall Study||34
10572168|NCT01664559|11727413|FG001|STARTED|Overall Study||33
10572169|NCT01664559|11727412|FG000|COMPLETED|Overall Study||34
10572170|NCT01664559|11727413|FG001|COMPLETED|Overall Study||33
10572171|NCT01664559|11727412|FG000|NOT COMPLETED|Overall Study||0
10572172|NCT01664559|11727413|FG001|NOT COMPLETED|Overall Study||0
10572173|NCT01664624|11727423|FG000|STARTED|Overall Study||10
10572174|NCT01664624|11727424|FG001|STARTED|Overall Study||11
10572175|NCT01664624|11727425|FG002|STARTED|Overall Study||10
10572176|NCT01664624|11727426|FG003|STARTED|Overall Study||9
10572177|NCT01664624|11727423|FG000|COMPLETED|Overall Study||10
10572178|NCT01664624|11727424|FG001|COMPLETED|Overall Study||10
10572179|NCT01664624|11727425|FG002|COMPLETED|Overall Study||10
10572180|NCT01664624|11727426|FG003|COMPLETED|Overall Study||9
10572181|NCT01664624|11727423|FG000|NOT COMPLETED|Overall Study||0
10572182|NCT01664624|11727424|FG001|NOT COMPLETED|Overall Study||1
10572183|NCT01664624|11727425|FG002|NOT COMPLETED|Overall Study||0
10572184|NCT01664624|11727426|FG003|NOT COMPLETED|Overall Study||0
10572185|NCT01664741|11727439|FG000|STARTED|Overall Study||6
10572186|NCT01664741|11727440|FG001|STARTED|Overall Study||6
10572187|NCT01664741|11727441|FG002|STARTED|Overall Study||13
10572188|NCT01664741|11727439|FG000|COMPLETED|Overall Study||6
10572189|NCT01664741|11727440|FG001|COMPLETED|Overall Study||6
10572190|NCT01664741|11727441|FG002|COMPLETED|Overall Study||13
10572191|NCT01664741|11727439|FG000|NOT COMPLETED|Overall Study||0
10572192|NCT01664741|11727440|FG001|NOT COMPLETED|Overall Study||0
10572193|NCT01664741|11727441|FG002|NOT COMPLETED|Overall Study||0
10572194|NCT01664793|11727450|FG000|STARTED|Overall Study||49039
10572195|NCT01664793|11727451|FG001|STARTED|Overall Study||38626
10572196|NCT01664793|11727450|FG000|COMPLETED|Overall Study||49039
10572197|NCT01664793|11727451|FG001|COMPLETED|Overall Study||38626
10572198|NCT01664793|11727450|FG000|NOT COMPLETED|Overall Study||0
10572199|NCT01664793|11727451|FG001|NOT COMPLETED|Overall Study||0
10572200|NCT01664806|11727461|FG000|STARTED|Overall Study||20
10572201|NCT01664806|11727462|FG001|STARTED|Overall Study||20
10572202|NCT01664806|11727461|FG000|COMPLETED|Overall Study||20
10572203|NCT01664806|11727462|FG001|COMPLETED|Overall Study||20
10572204|NCT01664806|11727461|FG000|NOT COMPLETED|Overall Study||0
10572205|NCT01664806|11727462|FG001|NOT COMPLETED|Overall Study||0
10572206|NCT01664858|11727471|FG000|STARTED|Overall Study||481
10572207|NCT01664858|11727472|FG001|STARTED|Overall Study||481
10572208|NCT01664858|11727473|FG002|STARTED|Overall Study||240
10572209|NCT01664858|11727471|FG000|COMPLETED|Overall Study||467
10572210|NCT01664858|11727472|FG001|COMPLETED|Overall Study||468
10572211|NCT01664858|11727473|FG002|COMPLETED|Overall Study||234
10572212|NCT01664858|11727471|FG000|NOT COMPLETED|Overall Study||14
10572213|NCT01664858|11727472|FG001|NOT COMPLETED|Overall Study||13
10572214|NCT01664858|11727473|FG002|NOT COMPLETED|Overall Study||6
10572215|NCT01664897|11727484|FG000|STARTED|Overall Study||29
10572216|NCT01664897|11727484|FG000|COMPLETED|Overall Study||29
10572217|NCT01664897|11727484|FG000|NOT COMPLETED|Overall Study||0
10572218|NCT01664923|11727490|FG000|STARTED|Period1:Double Blind Phase-29 Months||198
10572219|NCT01664923|11727491|FG001|STARTED|Period1:Double Blind Phase-29 Months||198
10572220|NCT01664923|11727490|FG000|Received Study Treatment|Period1:Double Blind Phase-29 Months||197
10572221|NCT01664923|11727491|FG001|Received Study Treatment|Period1:Double Blind Phase-29 Months||198
10572222|NCT01664923|11727490|FG000|COMPLETED|Period1:Double Blind Phase-29 Months||93
10572223|NCT01664923|11727491|FG001|COMPLETED|Period1:Double Blind Phase-29 Months||38
10572224|NCT01664923|11727490|FG000|NOT COMPLETED|Period1:Double Blind Phase-29 Months||105
10572225|NCT01664923|11727491|FG001|NOT COMPLETED|Period1:Double Blind Phase-29 Months||160
10572226|NCT01664923|11727490|FG000|STARTED|Period 2: Open-label Phase-36 Months||93
10572227|NCT01664923|11727491|FG001|STARTED|Period 2: Open-label Phase-36 Months||38
10572228|NCT01664923|11727490|FG000|Treated|Period 2: Open-label Phase-36 Months||93
10572229|NCT01664923|11727491|FG001|Treated|Period 2: Open-label Phase-36 Months||37
10572230|NCT01664923|11727490|FG000|COMPLETED|Period 2: Open-label Phase-36 Months||52
10572231|NCT01664923|11727491|FG001|COMPLETED|Period 2: Open-label Phase-36 Months||15
10572232|NCT01664923|11727490|FG000|NOT COMPLETED|Period 2: Open-label Phase-36 Months||41
10572233|NCT01664923|11727491|FG001|NOT COMPLETED|Period 2: Open-label Phase-36 Months||23
10572234|NCT01664949|11727503|FG000|STARTED|Overall Study||224
10572235|NCT01664949|11727504|FG001|STARTED|Overall Study||236
10572236|NCT01664949|11727503|FG000|COMPLETED|Overall Study||200
10572237|NCT01664949|11727504|FG001|COMPLETED|Overall Study||211
10572238|NCT01664949|11727503|FG000|NOT COMPLETED|Overall Study||24
10572239|NCT01664949|11727504|FG001|NOT COMPLETED|Overall Study||25
10572240|NCT01664975|11727512|FG000|STARTED|Overall Study||57
10572241|NCT01664975|11727513|FG001|STARTED|Overall Study||54
10572242|NCT01664975|11727512|FG000|COMPLETED|Overall Study||52
10572243|NCT01664975|11727513|FG001|COMPLETED|Overall Study||51
10572244|NCT01664975|11727512|FG000|NOT COMPLETED|Overall Study||5
10572245|NCT01664975|11727513|FG001|NOT COMPLETED|Overall Study||3
10572246|NCT01665040|11727519|FG000|STARTED|Overall Study||40
10572247|NCT01665040|11727519|FG000|COMPLETED|Overall Study||36
10572248|NCT01665040|11727519|FG000|NOT COMPLETED|Overall Study||4
10572249|NCT01665053|11727525|FG000|STARTED|Overall Study||838
10572250|NCT01665053|11727526|FG001|STARTED|Overall Study||846
10572251|NCT01665053|11727525|FG000|Completed 12-Month Clinical F/U|Overall Study||797
10651382|NCT02175758|11811575|FG003|COMPLETED|PK Lead-in Phase||10
10572252|NCT01665053|11727526|FG001|Completed 12-Month Clinical F/U|Overall Study||822
10572253|NCT01665053|11727525|FG000|No 12-Month F/U|Overall Study||32
10572254|NCT01665053|11727526|FG001|No 12-Month F/U|Overall Study||15
10572255|NCT01665053|11727525|FG000|Death With No 12-month Clinical FU|Overall Study||9
10572256|NCT01665053|11727526|FG001|Death With No 12-month Clinical FU|Overall Study||9
10572257|NCT01665053|11727525|FG000|COMPLETED|Overall Study||806
10572258|NCT01665053|11727526|FG001|COMPLETED|Overall Study||831
10572259|NCT01665053|11727525|FG000|NOT COMPLETED|Overall Study||32
10572260|NCT01665053|11727526|FG001|NOT COMPLETED|Overall Study||15
10572261|NCT01665092|11727536|FG000|STARTED|Overall Study||75
10572262|NCT01665092|11727537|FG001|STARTED|Overall Study||35
10572263|NCT01665092|11727538|FG002|STARTED|Overall Study||34
10572264|NCT01665092|11727539|FG003|STARTED|Overall Study||106
10572265|NCT01665092|11727536|FG000|COMPLETED|Overall Study||75
10572266|NCT01665092|11727537|FG001|COMPLETED|Overall Study||35
10572267|NCT01665092|11727538|FG002|COMPLETED|Overall Study||32
10572268|NCT01665092|11727539|FG003|COMPLETED|Overall Study||105
10572269|NCT01665092|11727536|FG000|NOT COMPLETED|Overall Study||0
10572270|NCT01665092|11727537|FG001|NOT COMPLETED|Overall Study||0
10572271|NCT01665092|11727538|FG002|NOT COMPLETED|Overall Study||2
10572272|NCT01665092|11727539|FG003|NOT COMPLETED|Overall Study||1
10572273|NCT01665157|11727552|FG000|STARTED|Overall Study||60
10572274|NCT01665157|11727553|FG001|STARTED|Overall Study||60
10572275|NCT01665157|11727554|FG002|STARTED|Overall Study||60
10572276|NCT01665157|11727552|FG000|COMPLETED|Overall Study||60
10572277|NCT01665157|11727553|FG001|COMPLETED|Overall Study||60
10572278|NCT01665157|11727554|FG002|COMPLETED|Overall Study||60
10572279|NCT01665157|11727552|FG000|NOT COMPLETED|Overall Study||0
10572280|NCT01665157|11727553|FG001|NOT COMPLETED|Overall Study||0
10572281|NCT01665157|11727554|FG002|NOT COMPLETED|Overall Study||0
10572282|NCT01665170|11727569|FG000|STARTED|Overall Study|First patient in|30
10572283|NCT01665170|11727570|FG001|STARTED|Overall Study||30
10572284|NCT01665170|11727569|FG000|Bevore TSST|Overall Study||30
10572285|NCT01665170|11727570|FG001|Bevore TSST|Overall Study||30
10572286|NCT01665170|11727569|FG000|During TSST|Overall Study||30
10572287|NCT01665170|11727570|FG001|During TSST|Overall Study||30
10572288|NCT01665170|11727569|FG000|After TSST|Overall Study||30
10572289|NCT01665170|11727570|FG001|After TSST|Overall Study||30
10572290|NCT01665170|11727569|FG000|COMPLETED|Overall Study|Last TSST/ last patient out|30
10572291|NCT01665170|11727570|FG001|COMPLETED|Overall Study||30
10572292|NCT01665170|11727569|FG000|NOT COMPLETED|Overall Study||0
10572293|NCT01665170|11727570|FG001|NOT COMPLETED|Overall Study||0
10572294|NCT01665430|11727578|FG000|STARTED|Overall Study||38
10572295|NCT01665430|11727578|FG000|COMPLETED|Overall Study||29
10572296|NCT01665430|11727578|FG000|NOT COMPLETED|Overall Study||9
10572297|NCT01665508|11727582|FG000|STARTED|Overall Study||12
10572298|NCT01665508|11727582|FG000|COMPLETED|Overall Study||7
10572299|NCT01665508|11727582|FG000|NOT COMPLETED|Overall Study||5
10572300|NCT01665599|11727591|FG000|STARTED|Overall Study||180
10572301|NCT01665599|11727591|FG000|COMPLETED|Overall Study||172
10572302|NCT01665599|11727591|FG000|NOT COMPLETED|Overall Study||8
10572303|NCT01665768|11727595|FG000|STARTED|Overall Study||49
10572304|NCT01665768|11727595|FG000|COMPLETED|Overall Study||26
10572305|NCT01665768|11727595|FG000|NOT COMPLETED|Overall Study||23
10572306|NCT01665807|11727602|FG000|STARTED|Overall Study||411
10572307|NCT01665807|11727603|FG001|STARTED|Overall Study||58
10572308|NCT01665807|11727604|FG002|STARTED|Overall Study||402
10572309|NCT01665807|11727602|FG000|COMPLETED|Overall Study||409
10572310|NCT01665807|11727603|FG001|COMPLETED|Overall Study||58
10572311|NCT01665807|11727604|FG002|COMPLETED|Overall Study||401
10572312|NCT01665807|11727602|FG000|NOT COMPLETED|Overall Study||2
10572313|NCT01665807|11727603|FG001|NOT COMPLETED|Overall Study||0
10572314|NCT01665807|11727604|FG002|NOT COMPLETED|Overall Study||1
10572315|NCT01665872|11727614|FG000|STARTED|Screening||172
10572316|NCT01665872|11727615|FG001|STARTED|Screening||172
10572317|NCT01665872|11727614|FG000|COMPLETED|Screening||172
10572318|NCT01665872|11727615|FG001|COMPLETED|Screening||172
10572319|NCT01665872|11727614|FG000|NOT COMPLETED|Screening||0
10572320|NCT01665872|11727615|FG001|NOT COMPLETED|Screening||0
10572321|NCT01665872|11727614|FG000|STARTED|Treatment||87
10572322|NCT01665872|11727615|FG001|STARTED|Treatment||67
10572323|NCT01665872|11727614|FG000|COMPLETED|Treatment||72
10572324|NCT01665872|11727615|FG001|COMPLETED|Treatment||50
10572325|NCT01665872|11727614|FG000|NOT COMPLETED|Treatment||15
10572326|NCT01665872|11727615|FG001|NOT COMPLETED|Treatment||17
10572327|NCT01665872|11727614|FG000|STARTED|6 Month Follow-up||72
10572328|NCT01665872|11727615|FG001|STARTED|6 Month Follow-up||50
10572329|NCT01665872|11727614|FG000|COMPLETED|6 Month Follow-up||66
10572330|NCT01665872|11727615|FG001|COMPLETED|6 Month Follow-up||49
10572331|NCT01665872|11727614|FG000|NOT COMPLETED|6 Month Follow-up||6
10572332|NCT01665872|11727615|FG001|NOT COMPLETED|6 Month Follow-up||1
10572333|NCT01665872|11727614|FG000|STARTED|12 Month Follow-up||72
10572334|NCT01665872|11727615|FG001|STARTED|12 Month Follow-up||50
10572335|NCT01665872|11727614|FG000|COMPLETED|12 Month Follow-up||58
10572336|NCT01665872|11727615|FG001|COMPLETED|12 Month Follow-up||47
10572337|NCT01665872|11727614|FG000|NOT COMPLETED|12 Month Follow-up||14
10572338|NCT01665872|11727615|FG001|NOT COMPLETED|12 Month Follow-up||3
10572339|NCT01665911|11727621|FG000|STARTED|Overall Study||28
10572340|NCT01665911|11727621|FG000|0 mg Fluoride in 200 ml Milk|Overall Study||22
10572341|NCT01665911|11727621|FG000|1.5 mg Sodium Fluoride in 100 ml Milk|Overall Study||23
10572342|NCT01665911|11727621|FG000|1.5 mg Sodium Fluoride in 200 ml Milk|Overall Study||25
10572343|NCT01665911|11727621|FG000|3.0 mg Sodium Fluoride in 100 ml Milk|Overall Study||22
10572344|NCT01665911|11727621|FG000|3.0 mg Sodium Fluoride in 200 ml Milk|Overall Study||22
10572345|NCT01665911|11727621|FG000|COMPLETED|Overall Study||22
10572346|NCT01665911|11727621|FG000|NOT COMPLETED|Overall Study||6
10572347|NCT01665950|11727629|FG000|STARTED|Overall Study||2
10572348|NCT01665950|11727630|FG001|STARTED|Overall Study||0
10572349|NCT01665950|11727631|FG002|STARTED|Overall Study||2
10572350|NCT01665950|11727629|FG000|COMPLETED|Overall Study||1
10572351|NCT01665950|11727630|FG001|COMPLETED|Overall Study||0
10572352|NCT01665950|11727631|FG002|COMPLETED|Overall Study||1
10572353|NCT01665950|11727629|FG000|NOT COMPLETED|Overall Study||1
10572354|NCT01665950|11727630|FG001|NOT COMPLETED|Overall Study||0
10572355|NCT01665950|11727631|FG002|NOT COMPLETED|Overall Study||1
10572356|NCT01666002|11727641|FG000|STARTED|Overall Study||17
10572357|NCT01666002|11727642|FG001|STARTED|Overall Study||10
10572358|NCT01666002|11727641|FG000|COMPLETED|Overall Study||12
10572359|NCT01666002|11727642|FG001|COMPLETED|Overall Study||10
10572360|NCT01666002|11727641|FG000|NOT COMPLETED|Overall Study||5
10572361|NCT01666002|11727642|FG001|NOT COMPLETED|Overall Study||0
10572362|NCT01666119|11727649|FG000|STARTED|Overall Study||249
10572363|NCT01666119|11727649|FG000|COMPLETED|Overall Study||197
10572364|NCT01666119|11727649|FG000|NOT COMPLETED|Overall Study||52
10572365|NCT01666197|11727655|FG000|STARTED|Overall Study||50
10572366|NCT01666197|11727656|FG001|STARTED|Overall Study||50
10572367|NCT01666197|11727655|FG000|COMPLETED|Overall Study||50
10572368|NCT01666197|11727656|FG001|COMPLETED|Overall Study||50
10572369|NCT01666197|11727655|FG000|NOT COMPLETED|Overall Study||0
10572370|NCT01666197|11727656|FG001|NOT COMPLETED|Overall Study||0
10572371|NCT01666210|11727664|FG000|STARTED|Overall Study||30
10572372|NCT01666210|11727665|FG001|STARTED|Overall Study||30
10572373|NCT01666210|11727664|FG000|COMPLETED|Overall Study||28
10572374|NCT01666210|11727665|FG001|COMPLETED|Overall Study||29
10572375|NCT01666210|11727664|FG000|NOT COMPLETED|Overall Study||2
10572376|NCT01666210|11727665|FG001|NOT COMPLETED|Overall Study||1
10572377|NCT01666314|11727679|FG000|STARTED|Overall Study||33
10572378|NCT01666314|11727680|FG001|STARTED|Overall Study||32
10572379|NCT01666314|11727681|FG002|STARTED|Overall Study||36
10572380|NCT01666314|11727682|FG003|STARTED|Overall Study||36
10572381|NCT01666314|11727679|FG000|COMPLETED|Overall Study||0
10572382|NCT01666314|11727680|FG001|COMPLETED|Overall Study||0
10572383|NCT01666314|11727681|FG002|COMPLETED|Overall Study||0
10572384|NCT01666314|11727682|FG003|COMPLETED|Overall Study||0
10572385|NCT01666314|11727679|FG000|NOT COMPLETED|Overall Study||33
10572386|NCT01666314|11727680|FG001|NOT COMPLETED|Overall Study||32
10572387|NCT01666314|11727681|FG002|NOT COMPLETED|Overall Study||36
10572388|NCT01666314|11727682|FG003|NOT COMPLETED|Overall Study||36
10572389|NCT01666444|11727705|FG000|STARTED|Overall Study||149
10572390|NCT01666444|11727706|FG001|STARTED|Overall Study||148
10572391|NCT01666444|11727705|FG000|COMPLETED|Overall Study||147
10572392|NCT01666444|11727706|FG001|COMPLETED|Overall Study||147
10572393|NCT01666444|11727705|FG000|NOT COMPLETED|Overall Study||2
10572394|NCT01666444|11727706|FG001|NOT COMPLETED|Overall Study||1
10572395|NCT01666652|11727717|FG000|STARTED|Overall Study||20
10572396|NCT01666652|11727718|FG001|STARTED|Overall Study||20
10572397|NCT01666652|11727719|FG002|STARTED|Overall Study||20
10572398|NCT01666652|11727720|FG003|STARTED|Overall Study||20
10572399|NCT01666652|11727721|FG004|STARTED|Overall Study||20
10572400|NCT01666652|11727717|FG000|COMPLETED|Overall Study||18
10572401|NCT01666652|11727718|FG001|COMPLETED|Overall Study||19
10572402|NCT01666652|11727719|FG002|COMPLETED|Overall Study||19
10572403|NCT01666652|11727720|FG003|COMPLETED|Overall Study||16
10572404|NCT01666652|11727721|FG004|COMPLETED|Overall Study||19
10572405|NCT01666652|11727717|FG000|NOT COMPLETED|Overall Study||2
10572406|NCT01666652|11727718|FG001|NOT COMPLETED|Overall Study||1
10572407|NCT01666652|11727719|FG002|NOT COMPLETED|Overall Study||1
10572408|NCT01666652|11727720|FG003|NOT COMPLETED|Overall Study||4
10572409|NCT01666652|11727721|FG004|NOT COMPLETED|Overall Study||1
10572410|NCT01666730|11727733|FG000|STARTED|Overall Study||50
10572411|NCT01666730|11727733|FG000|COMPLETED|Overall Study||0
10572412|NCT01666730|11727733|FG000|NOT COMPLETED|Overall Study||50
10572413|NCT01666782|11727739|FG000|STARTED|Overall Study||54
10572414|NCT01666782|11727740|FG001|STARTED|Overall Study||51
10572415|NCT01666782|11727739|FG000|COMPLETED|Overall Study||50
10572416|NCT01666782|11727740|FG001|COMPLETED|Overall Study||50
10572417|NCT01666782|11727739|FG000|NOT COMPLETED|Overall Study||4
10572418|NCT01666782|11727740|FG001|NOT COMPLETED|Overall Study||1
10572419|NCT01666912|11727748|FG000|STARTED|Overall Study||48
10572420|NCT01666912|11727749|FG001|STARTED|Overall Study||48
10572421|NCT01666912|11727748|FG000|COMPLETED|Overall Study||27
10572422|NCT01666912|11727749|FG001|COMPLETED|Overall Study||37
10572423|NCT01666912|11727748|FG000|NOT COMPLETED|Overall Study||21
10572424|NCT01666912|11727749|FG001|NOT COMPLETED|Overall Study||11
10572425|NCT01666951|11727757|FG000|STARTED|Overall Study||18
10572426|NCT01666951|11727758|FG001|STARTED|Overall Study||18
10572427|NCT01666951|11727757|FG000|COMPLETED|Overall Study||17
10572428|NCT01666951|11727758|FG001|COMPLETED|Overall Study||17
10572429|NCT01666951|11727757|FG000|NOT COMPLETED|Overall Study||1
10572430|NCT01666951|11727758|FG001|NOT COMPLETED|Overall Study||1
10572431|NCT01667029|11727764|FG000|STARTED|Overall Study||4
10572432|NCT01667029|11727765|FG001|STARTED|Overall Study||4
10572433|NCT01667029|11727764|FG000|COMPLETED|Overall Study||3
10572434|NCT01667029|11727765|FG001|COMPLETED|Overall Study||3
10572435|NCT01667029|11727764|FG000|NOT COMPLETED|Overall Study||1
10572436|NCT01667029|11727765|FG001|NOT COMPLETED|Overall Study||1
10572437|NCT01667107|11727773|FG000|STARTED|Overall Study||8
10572438|NCT01667107|11727774|FG001|STARTED|Overall Study||18
10572439|NCT01667107|11727773|FG000|COMPLETED|Overall Study||4
10572440|NCT01667107|11727774|FG001|COMPLETED|Overall Study||11
10572441|NCT01667107|11727773|FG000|NOT COMPLETED|Overall Study||4
10572442|NCT01667107|11727774|FG001|NOT COMPLETED|Overall Study||7
10572443|NCT01667224|11727782|FG000|STARTED|Overall Study||40
10572444|NCT01667224|11727783|FG001|STARTED|Overall Study||40
10572445|NCT01667224|11727782|FG000|COMPLETED|Overall Study||36
10572446|NCT01667224|11727783|FG001|COMPLETED|Overall Study||38
10572447|NCT01667224|11727782|FG000|NOT COMPLETED|Overall Study||4
10572448|NCT01667224|11727783|FG001|NOT COMPLETED|Overall Study||2
10572449|NCT01667250|11727793|FG000|STARTED|Run-in (no Treatment)||0
10572450|NCT01667250|11727794|FG001|STARTED|Run-in (no Treatment)||0
10572451|NCT01667250|11727795|FG002|STARTED|Run-in (no Treatment)||73
10572452|NCT01667250|11727793|FG000|COMPLETED|Run-in (no Treatment)||0
10572453|NCT01667250|11727794|FG001|COMPLETED|Run-in (no Treatment)||0
10572454|NCT01667250|11727795|FG002|COMPLETED|Run-in (no Treatment)||59
10572455|NCT01667250|11727793|FG000|NOT COMPLETED|Run-in (no Treatment)||0
10572456|NCT01667250|11727794|FG001|NOT COMPLETED|Run-in (no Treatment)||0
10572457|NCT01667250|11727795|FG002|NOT COMPLETED|Run-in (no Treatment)||14
10572458|NCT01667250|11727793|FG000|STARTED|Randomised Period||30
10572459|NCT01667250|11727794|FG001|STARTED|Randomised Period||29
10572460|NCT01667250|11727795|FG002|STARTED|Randomised Period||0
10572461|NCT01667250|11727793|FG000|COMPLETED|Randomised Period||29
10572462|NCT01667250|11727794|FG001|COMPLETED|Randomised Period||28
10572463|NCT01667250|11727795|FG002|COMPLETED|Randomised Period||0
10572464|NCT01667250|11727793|FG000|NOT COMPLETED|Randomised Period||1
10572465|NCT01667250|11727794|FG001|NOT COMPLETED|Randomised Period||1
10572466|NCT01667250|11727795|FG002|NOT COMPLETED|Randomised Period||0
10572467|NCT01667406|11727812|FG000|STARTED|Overall Study||2
10572468|NCT01667406|11727813|FG001|STARTED|Overall Study||3
10572469|NCT01667406|11727814|FG002|STARTED|Overall Study||24
10572470|NCT01667406|11727815|FG003|STARTED|Overall Study||24
10572471|NCT01667406|11727816|FG004|STARTED|Overall Study||5
10572472|NCT01667406|11727817|FG005|STARTED|Overall Study||20
10572473|NCT01667406|11727818|FG006|STARTED|Overall Study||15
10572474|NCT01667406|11727819|FG007|STARTED|Overall Study||20
10572475|NCT01667406|11727820|FG008|STARTED|Overall Study||31
10572476|NCT01667406|11727821|FG009|STARTED|Overall Study||31
10572477|NCT01667406|11727812|FG000|COMPLETED|Overall Study||2
10794928|NCT03629028|11955335|FG000|STARTED|Overall Study||141
10794929|NCT03629028|11955336|FG001|STARTED|Overall Study||141
10794930|NCT03629028|11955335|FG000|COMPLETED|Overall Study||109
10794931|NCT03629028|11955336|FG001|COMPLETED|Overall Study||116
10794932|NCT03629028|11955335|FG000|NOT COMPLETED|Overall Study||32
10794933|NCT03629028|11955336|FG001|NOT COMPLETED|Overall Study||25
10794934|NCT03629041|11955352|FG000|STARTED|Visit 1||4
10794935|NCT03629041|11955353|FG001|STARTED|Visit 1||4
10794936|NCT03629041|11955354|FG002|STARTED|Visit 1||4
10794937|NCT03629041|11955355|FG003|STARTED|Visit 1||4
10794938|NCT03629041|11955352|FG000|COMPLETED|Visit 1||4
10794939|NCT03629041|11955353|FG001|COMPLETED|Visit 1||4
10794940|NCT03629041|11955354|FG002|COMPLETED|Visit 1||4
10794941|NCT03629041|11955355|FG003|COMPLETED|Visit 1||4
10794942|NCT03629041|11955352|FG000|NOT COMPLETED|Visit 1||0
10794943|NCT03629041|11955353|FG001|NOT COMPLETED|Visit 1||0
10794944|NCT03629041|11955354|FG002|NOT COMPLETED|Visit 1||0
10794945|NCT03629041|11955355|FG003|NOT COMPLETED|Visit 1||0
10794946|NCT03629041|11955352|FG000|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
10794947|NCT03629041|11955353|FG001|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
10794948|NCT03629041|11955354|FG002|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
10794949|NCT03629041|11955355|FG003|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
10794950|NCT03629041|11955352|FG000|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
10794951|NCT03629041|11955353|FG001|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||3
10794952|NCT03629041|11955354|FG002|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
10794953|NCT03629041|11955355|FG003|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
10794954|NCT03629041|11955352|FG000|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||0
10794955|NCT03629041|11955353|FG001|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||1
10794956|NCT03629041|11955354|FG002|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||0
10794957|NCT03629041|11955355|FG003|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||0
10572478|NCT01667406|11727813|FG001|COMPLETED|Overall Study||3
10572479|NCT01667406|11727814|FG002|COMPLETED|Overall Study||24
10572480|NCT01667406|11727815|FG003|COMPLETED|Overall Study||24
10572481|NCT01667406|11727816|FG004|COMPLETED|Overall Study||5
10572482|NCT01667406|11727817|FG005|COMPLETED|Overall Study||20
10572483|NCT01667406|11727818|FG006|COMPLETED|Overall Study||15
10572484|NCT01667406|11727819|FG007|COMPLETED|Overall Study||20
10572485|NCT01667406|11727820|FG008|COMPLETED|Overall Study||31
10572486|NCT01667406|11727821|FG009|COMPLETED|Overall Study||31
10572487|NCT01667406|11727812|FG000|NOT COMPLETED|Overall Study||0
10572488|NCT01667406|11727813|FG001|NOT COMPLETED|Overall Study||0
10572489|NCT01667406|11727814|FG002|NOT COMPLETED|Overall Study||0
10572490|NCT01667406|11727815|FG003|NOT COMPLETED|Overall Study||0
10572491|NCT01667406|11727816|FG004|NOT COMPLETED|Overall Study||0
10572492|NCT01667406|11727817|FG005|NOT COMPLETED|Overall Study||0
10572493|NCT01667406|11727818|FG006|NOT COMPLETED|Overall Study||0
10572494|NCT01667406|11727819|FG007|NOT COMPLETED|Overall Study||0
10572495|NCT01667406|11727820|FG008|NOT COMPLETED|Overall Study||0
10572496|NCT01667406|11727821|FG009|NOT COMPLETED|Overall Study||0
10572497|NCT01667419|11727877|FG000|STARTED|Overall Study||157
10572498|NCT01667419|11727878|FG001|STARTED|Overall Study||157
10572499|NCT01667419|11727879|FG002|STARTED|Overall Study||93
10572500|NCT01667419|11727880|FG003|STARTED|Overall Study||91
10572501|NCT01667419|11727877|FG000|COMPLETED|Overall Study||114
10572502|NCT01667419|11727878|FG001|COMPLETED|Overall Study||110
10572503|NCT01667419|11727879|FG002|COMPLETED|Overall Study||57
10572504|NCT01667419|11727880|FG003|COMPLETED|Overall Study||52
10572505|NCT01667419|11727877|FG000|NOT COMPLETED|Overall Study||43
10572506|NCT01667419|11727878|FG001|NOT COMPLETED|Overall Study||47
10572507|NCT01667419|11727879|FG002|NOT COMPLETED|Overall Study||36
10572508|NCT01667419|11727880|FG003|NOT COMPLETED|Overall Study||39
10572509|NCT01667432|11727891|FG000|STARTED|Overall Study||141
10572510|NCT01667432|11727891|FG000|COMPLETED|Overall Study||84
10572511|NCT01667432|11727891|FG000|NOT COMPLETED|Overall Study||57
10572512|NCT01667471|11727895|FG000|STARTED|Overall Study||7
10572513|NCT01667471|11727895|FG000|COMPLETED|Overall Study||7
10572514|NCT01667471|11727895|FG000|NOT COMPLETED|Overall Study||0
10572515|NCT01667536|11727900|FG000|STARTED|Overall Study||105
10572516|NCT01667536|11727900|FG000|COMPLETED|Overall Study|105 subjects comprised the safety popn, defined as all subjects who received an MIP-1404 injection.|105
10572517|NCT01667536|11727900|FG000|NOT COMPLETED|Overall Study||0
10572518|NCT01667549|11727912|FG000|STARTED|Overall Study|20 dyads=20 infants, 20 mothers|20
10572519|NCT01667549|11727913|FG001|STARTED|Overall Study|20 dyads=20 infants, 20 mothers|20
10572520|NCT01667549|11727914|FG002|STARTED|Overall Study|21 dyads=21 infants, 21 mothers|21
10572521|NCT01667549|11727915|FG003|STARTED|Overall Study|20 dyads= 20 infants, 20 mothers|20
10572522|NCT01667549|11727916|FG004|STARTED|Overall Study|16 dyads=16 infants, 16 mothers|16
10572523|NCT01667549|11727912|FG000|COMPLETED|Overall Study|17 dyads=17 infants, 17 mothers|17
10572524|NCT01667549|11727913|FG001|COMPLETED|Overall Study|15 dyads=15 infants, 15 mothers|15
10572525|NCT01667549|11727914|FG002|COMPLETED|Overall Study|14 dyads=14 infants, 14 mothers|14
10572526|NCT01667549|11727915|FG003|COMPLETED|Overall Study|14 dyads= 14 infants, 14 mothers|14
10572527|NCT01667549|11727916|FG004|COMPLETED|Overall Study|15 dyads=15 infants, 15 mothers|15
10572528|NCT01667549|11727912|FG000|NOT COMPLETED|Overall Study||3
10572529|NCT01667549|11727913|FG001|NOT COMPLETED|Overall Study||5
10572530|NCT01667549|11727914|FG002|NOT COMPLETED|Overall Study||7
10572531|NCT01667549|11727915|FG003|NOT COMPLETED|Overall Study||6
10572532|NCT01667549|11727916|FG004|NOT COMPLETED|Overall Study||1
10572533|NCT01667562|11727933|FG000|STARTED|Diagnostic Phase||375
10572534|NCT01667562|11727934|FG001|STARTED|Diagnostic Phase||0
10572535|NCT01667562|11727933|FG000|COMPLETED|Diagnostic Phase||345
10572536|NCT01667562|11727934|FG001|COMPLETED|Diagnostic Phase||0
10572537|NCT01667562|11727933|FG000|NOT COMPLETED|Diagnostic Phase||30
10572538|NCT01667562|11727934|FG001|NOT COMPLETED|Diagnostic Phase||0
10572539|NCT01667562|11727933|FG000|STARTED|Erlotinib Phase||0
10572540|NCT01667562|11727934|FG001|STARTED|Erlotinib Phase||30
10572541|NCT01667562|11727933|FG000|COMPLETED|Erlotinib Phase||0
10572542|NCT01667562|11727934|FG001|COMPLETED|Erlotinib Phase||27
10572543|NCT01667562|11727933|FG000|NOT COMPLETED|Erlotinib Phase||0
10572544|NCT01667562|11727934|FG001|NOT COMPLETED|Erlotinib Phase||3
10572545|NCT01667679|11727941|FG000|STARTED|Treatment Period 1 (<=12 Weeks)||138
10572546|NCT01667679|11727942|FG001|STARTED|Treatment Period 1 (<=12 Weeks)||137
10572547|NCT01667679|11727941|FG000|COMPLETED|Treatment Period 1 (<=12 Weeks)||122
10572548|NCT01667679|11727942|FG001|COMPLETED|Treatment Period 1 (<=12 Weeks)||107
10572549|NCT01667679|11727941|FG000|NOT COMPLETED|Treatment Period 1 (<=12 Weeks)||16
10572550|NCT01667679|11727942|FG001|NOT COMPLETED|Treatment Period 1 (<=12 Weeks)||30
10572551|NCT01667679|11727941|FG000|STARTED|Treatment Period 2 (<=12 Weeks)||122
10572552|NCT01667679|11727942|FG001|STARTED|Treatment Period 2 (<=12 Weeks)||107
10572553|NCT01667679|11727941|FG000|COMPLETED|Treatment Period 2 (<=12 Weeks)||100
10572554|NCT01667679|11727942|FG001|COMPLETED|Treatment Period 2 (<=12 Weeks)||85
10572555|NCT01667679|11727941|FG000|NOT COMPLETED|Treatment Period 2 (<=12 Weeks)||22
10572556|NCT01667679|11727942|FG001|NOT COMPLETED|Treatment Period 2 (<=12 Weeks)||22
10572557|NCT01667731|11727955|FG000|STARTED|Overall Study||26
10572558|NCT01667731|11727956|FG001|STARTED|Overall Study||42
10572559|NCT01667731|11727957|FG002|STARTED|Overall Study||24
10794958|NCT03629054|11955375|FG000|STARTED|Period 1 (4 Days)|Started this period|15
10794959|NCT03629054|11955376|FG001|STARTED|Period 1 (4 Days)|Started this period|15
10794960|NCT03629054|11955375|FG000|COMPLETED|Period 1 (4 Days)||15
10794961|NCT03629054|11955376|FG001|COMPLETED|Period 1 (4 Days)||15
10794962|NCT03629054|11955375|FG000|NOT COMPLETED|Period 1 (4 Days)||0
10794963|NCT03629054|11955376|FG001|NOT COMPLETED|Period 1 (4 Days)||0
10794964|NCT03629054|11955375|FG000|STARTED|Wasout Period (35 Days)|Started this period|15
10794965|NCT03629054|11955376|FG001|STARTED|Wasout Period (35 Days)|Started this period|15
10794966|NCT03629054|11955375|FG000|COMPLETED|Wasout Period (35 Days)||15
10794967|NCT03629054|11955376|FG001|COMPLETED|Wasout Period (35 Days)||15
10794968|NCT03629054|11955375|FG000|NOT COMPLETED|Wasout Period (35 Days)||0
10794969|NCT03629054|11955376|FG001|NOT COMPLETED|Wasout Period (35 Days)||0
10794970|NCT03629054|11955375|FG000|STARTED|Period 2 (4 Days)|Started this period|15
10572560|NCT01667731|11727958|FG003|STARTED|Overall Study||17
10794971|NCT03629054|11955376|FG001|STARTED|Period 2 (4 Days)|Started this period|15
10794972|NCT03629054|11955375|FG000|Treated|Period 2 (4 Days)||15
10794973|NCT03629054|11955376|FG001|Treated|Period 2 (4 Days)||14
10794974|NCT03629054|11955375|FG000|COMPLETED|Period 2 (4 Days)||15
10794975|NCT03629054|11955376|FG001|COMPLETED|Period 2 (4 Days)||14
10572561|NCT01667731|11727959|FG004|STARTED|Overall Study||115
10572562|NCT01667731|11727955|FG000|COMPLETED|Overall Study||21
10572563|NCT01667731|11727956|FG001|COMPLETED|Overall Study||26
10572564|NCT01667731|11727957|FG002|COMPLETED|Overall Study||22
10572565|NCT01667731|11727958|FG003|COMPLETED|Overall Study||15
10572566|NCT01667731|11727959|FG004|COMPLETED|Overall Study||87
10572567|NCT01667731|11727955|FG000|NOT COMPLETED|Overall Study||5
10572568|NCT01667731|11727956|FG001|NOT COMPLETED|Overall Study||16
10572569|NCT01667731|11727957|FG002|NOT COMPLETED|Overall Study||2
10572570|NCT01667731|11727958|FG003|NOT COMPLETED|Overall Study||2
10572571|NCT01667731|11727959|FG004|NOT COMPLETED|Overall Study||28
10572572|NCT01667796|11727974|FG000|STARTED|Overall Study||27
10572573|NCT01667796|11727975|FG001|STARTED|Overall Study||30
10572574|NCT01667796|11727974|FG000|COMPLETED|Overall Study||24
10572575|NCT01667796|11727975|FG001|COMPLETED|Overall Study||29
10572576|NCT01667796|11727974|FG000|NOT COMPLETED|Overall Study||3
10572577|NCT01667796|11727975|FG001|NOT COMPLETED|Overall Study||1
10572578|NCT01667848|11727987|FG000|STARTED|Overall Study||67
10572579|NCT01667848|11727988|FG001|STARTED|Overall Study||81
10572580|NCT01667848|11727987|FG000|COMPLETED|Overall Study||67
10572581|NCT01667848|11727988|FG001|COMPLETED|Overall Study||81
10572582|NCT01667848|11727987|FG000|NOT COMPLETED|Overall Study||0
10572583|NCT01667848|11727988|FG001|NOT COMPLETED|Overall Study||0
10572584|NCT01667900|11727999|FG000|STARTED|Part A, Period 1||1
10572585|NCT01667900|11728000|FG001|STARTED|Part A, Period 1||1
10572586|NCT01667900|11728001|FG002|STARTED|Part A, Period 1||1
10572587|NCT01667900|11728002|FG003|STARTED|Part A, Period 1||1
10572588|NCT01667900|11728003|FG004|STARTED|Part A, Period 1||1
10572589|NCT01667900|11728004|FG005|STARTED|Part A, Period 1||1
10572590|NCT01667900|11728005|FG006|STARTED|Part A, Period 1||1
10572591|NCT01667900|11728006|FG007|STARTED|Part A, Period 1||1
10572592|NCT01667900|11728007|FG008|STARTED|Part A, Period 1||1
10572593|NCT01667900|11728008|FG009|STARTED|Part A, Period 1||1
10572594|NCT01667900|11728009|FG010|STARTED|Part A, Period 1||1
10572595|NCT01667900|11728010|FG011|STARTED|Part A, Period 1||1
10572596|NCT01667900|11728011|FG012|STARTED|Part A, Period 1||1
10572597|NCT01667900|11728012|FG013|STARTED|Part A, Period 1||1
10572598|NCT01667900|11728013|FG014|STARTED|Part A, Period 1||1
10572599|NCT01667900|11728014|FG015|STARTED|Part A, Period 1||1
10572600|NCT01667900|11728015|FG016|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
10572601|NCT01667900|11728016|FG017|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
10572602|NCT01667900|11728017|FG018|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
10572603|NCT01667900|11728018|FG019|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
10572604|NCT01667900|11727999|FG000|COMPLETED|Part A, Period 1||1
10572605|NCT01667900|11728000|FG001|COMPLETED|Part A, Period 1||1
10572606|NCT01667900|11728001|FG002|COMPLETED|Part A, Period 1||1
10572607|NCT01667900|11728002|FG003|COMPLETED|Part A, Period 1||1
10572608|NCT01667900|11728003|FG004|COMPLETED|Part A, Period 1||1
10572609|NCT01667900|11728004|FG005|COMPLETED|Part A, Period 1||1
10572610|NCT01667900|11728005|FG006|COMPLETED|Part A, Period 1||1
10572611|NCT01667900|11728006|FG007|COMPLETED|Part A, Period 1||1
10572612|NCT01667900|11728007|FG008|COMPLETED|Part A, Period 1||1
10572613|NCT01667900|11728008|FG009|COMPLETED|Part A, Period 1||1
10572614|NCT01667900|11728009|FG010|COMPLETED|Part A, Period 1||1
10572615|NCT01667900|11728010|FG011|COMPLETED|Part A, Period 1||1
10572616|NCT01667900|11728011|FG012|COMPLETED|Part A, Period 1||1
10572617|NCT01667900|11728012|FG013|COMPLETED|Part A, Period 1||1
10572618|NCT01667900|11728013|FG014|COMPLETED|Part A, Period 1||1
10572619|NCT01667900|11728014|FG015|COMPLETED|Part A, Period 1||1
10572620|NCT01667900|11728015|FG016|COMPLETED|Part A, Period 1||0
10572621|NCT01667900|11728016|FG017|COMPLETED|Part A, Period 1||0
10572622|NCT01667900|11728017|FG018|COMPLETED|Part A, Period 1||0
10572623|NCT01667900|11728018|FG019|COMPLETED|Part A, Period 1||0
10572624|NCT01667900|11727999|FG000|NOT COMPLETED|Part A, Period 1||0
10572625|NCT01667900|11728000|FG001|NOT COMPLETED|Part A, Period 1||0
10572626|NCT01667900|11728001|FG002|NOT COMPLETED|Part A, Period 1||0
10572627|NCT01667900|11728002|FG003|NOT COMPLETED|Part A, Period 1||0
10572628|NCT01667900|11728003|FG004|NOT COMPLETED|Part A, Period 1||0
10572629|NCT01667900|11728004|FG005|NOT COMPLETED|Part A, Period 1||0
10572630|NCT01667900|11728005|FG006|NOT COMPLETED|Part A, Period 1||0
10572631|NCT01667900|11728006|FG007|NOT COMPLETED|Part A, Period 1||0
10572632|NCT01667900|11728007|FG008|NOT COMPLETED|Part A, Period 1||0
10572633|NCT01667900|11728008|FG009|NOT COMPLETED|Part A, Period 1||0
10572634|NCT01667900|11728009|FG010|NOT COMPLETED|Part A, Period 1||0
10572635|NCT01667900|11728010|FG011|NOT COMPLETED|Part A, Period 1||0
10572636|NCT01667900|11728011|FG012|NOT COMPLETED|Part A, Period 1||0
10572637|NCT01667900|11728012|FG013|NOT COMPLETED|Part A, Period 1||0
10572638|NCT01667900|11728013|FG014|NOT COMPLETED|Part A, Period 1||0
10572639|NCT01667900|11728014|FG015|NOT COMPLETED|Part A, Period 1||0
10572640|NCT01667900|11728015|FG016|NOT COMPLETED|Part A, Period 1||0
10572641|NCT01667900|11728016|FG017|NOT COMPLETED|Part A, Period 1||0
10572642|NCT01667900|11728017|FG018|NOT COMPLETED|Part A, Period 1||0
10572643|NCT01667900|11728018|FG019|NOT COMPLETED|Part A, Period 1||0
10572644|NCT01667900|11727999|FG000|STARTED|Part A, Washout 1||1
10572645|NCT01667900|11728000|FG001|STARTED|Part A, Washout 1||1
10572646|NCT01667900|11728001|FG002|STARTED|Part A, Washout 1||1
10572647|NCT01667900|11728002|FG003|STARTED|Part A, Washout 1||1
10572648|NCT01667900|11728003|FG004|STARTED|Part A, Washout 1||1
10572649|NCT01667900|11728004|FG005|STARTED|Part A, Washout 1||1
10572650|NCT01667900|11728005|FG006|STARTED|Part A, Washout 1||1
10572651|NCT01667900|11728006|FG007|STARTED|Part A, Washout 1||1
10572652|NCT01667900|11728007|FG008|STARTED|Part A, Washout 1||1
10572653|NCT01667900|11728008|FG009|STARTED|Part A, Washout 1||1
10572654|NCT01667900|11728009|FG010|STARTED|Part A, Washout 1||1
10572655|NCT01667900|11728010|FG011|STARTED|Part A, Washout 1||1
10572656|NCT01667900|11728011|FG012|STARTED|Part A, Washout 1||1
10572657|NCT01667900|11728012|FG013|STARTED|Part A, Washout 1||1
10572658|NCT01667900|11728013|FG014|STARTED|Part A, Washout 1||1
10572659|NCT01667900|11728014|FG015|STARTED|Part A, Washout 1||1
10572660|NCT01667900|11728015|FG016|STARTED|Part A, Washout 1||0
10572661|NCT01667900|11728016|FG017|STARTED|Part A, Washout 1||0
10572662|NCT01667900|11728017|FG018|STARTED|Part A, Washout 1||0
10572663|NCT01667900|11728018|FG019|STARTED|Part A, Washout 1||0
10572664|NCT01667900|11727999|FG000|COMPLETED|Part A, Washout 1||1
10572665|NCT01667900|11728000|FG001|COMPLETED|Part A, Washout 1||1
10572666|NCT01667900|11728001|FG002|COMPLETED|Part A, Washout 1||1
10572667|NCT01667900|11728002|FG003|COMPLETED|Part A, Washout 1||1
10572668|NCT01667900|11728003|FG004|COMPLETED|Part A, Washout 1||1
10572669|NCT01667900|11728004|FG005|COMPLETED|Part A, Washout 1||1
10572670|NCT01667900|11728005|FG006|COMPLETED|Part A, Washout 1||1
10572671|NCT01667900|11728006|FG007|COMPLETED|Part A, Washout 1||1
10572672|NCT01667900|11728007|FG008|COMPLETED|Part A, Washout 1||1
10572673|NCT01667900|11728008|FG009|COMPLETED|Part A, Washout 1||1
10572674|NCT01667900|11728009|FG010|COMPLETED|Part A, Washout 1||1
10572675|NCT01667900|11728010|FG011|COMPLETED|Part A, Washout 1||1
10572676|NCT01667900|11728011|FG012|COMPLETED|Part A, Washout 1||1
10572677|NCT01667900|11728012|FG013|COMPLETED|Part A, Washout 1||1
10572678|NCT01667900|11728013|FG014|COMPLETED|Part A, Washout 1||1
10572679|NCT01667900|11728014|FG015|COMPLETED|Part A, Washout 1||1
10572680|NCT01667900|11728015|FG016|COMPLETED|Part A, Washout 1||0
10572681|NCT01667900|11728016|FG017|COMPLETED|Part A, Washout 1||0
10572682|NCT01667900|11728017|FG018|COMPLETED|Part A, Washout 1||0
10572683|NCT01667900|11728018|FG019|COMPLETED|Part A, Washout 1||0
10572684|NCT01667900|11727999|FG000|NOT COMPLETED|Part A, Washout 1||0
10572685|NCT01667900|11728000|FG001|NOT COMPLETED|Part A, Washout 1||0
10572686|NCT01667900|11728001|FG002|NOT COMPLETED|Part A, Washout 1||0
10572687|NCT01667900|11728002|FG003|NOT COMPLETED|Part A, Washout 1||0
10572688|NCT01667900|11728003|FG004|NOT COMPLETED|Part A, Washout 1||0
10572689|NCT01667900|11728004|FG005|NOT COMPLETED|Part A, Washout 1||0
10572690|NCT01667900|11728005|FG006|NOT COMPLETED|Part A, Washout 1||0
10572691|NCT01667900|11728006|FG007|NOT COMPLETED|Part A, Washout 1||0
10572692|NCT01667900|11728007|FG008|NOT COMPLETED|Part A, Washout 1||0
10572693|NCT01667900|11728008|FG009|NOT COMPLETED|Part A, Washout 1||0
10572694|NCT01667900|11728009|FG010|NOT COMPLETED|Part A, Washout 1||0
10572695|NCT01667900|11728010|FG011|NOT COMPLETED|Part A, Washout 1||0
10572696|NCT01667900|11728011|FG012|NOT COMPLETED|Part A, Washout 1||0
10572697|NCT01667900|11728012|FG013|NOT COMPLETED|Part A, Washout 1||0
10572698|NCT01667900|11728013|FG014|NOT COMPLETED|Part A, Washout 1||0
10572699|NCT01667900|11728014|FG015|NOT COMPLETED|Part A, Washout 1||0
10572700|NCT01667900|11728015|FG016|NOT COMPLETED|Part A, Washout 1||0
10572701|NCT01667900|11728016|FG017|NOT COMPLETED|Part A, Washout 1||0
10572702|NCT01667900|11728017|FG018|NOT COMPLETED|Part A, Washout 1||0
10572703|NCT01667900|11728018|FG019|NOT COMPLETED|Part A, Washout 1||0
10572704|NCT01667900|11727999|FG000|STARTED|Part A, Period 2||1
10572705|NCT01667900|11728000|FG001|STARTED|Part A, Period 2||1
10572706|NCT01667900|11728001|FG002|STARTED|Part A, Period 2||1
10572707|NCT01667900|11728002|FG003|STARTED|Part A, Period 2||1
10572708|NCT01667900|11728003|FG004|STARTED|Part A, Period 2||1
10572709|NCT01667900|11728004|FG005|STARTED|Part A, Period 2||1
10572710|NCT01667900|11728005|FG006|STARTED|Part A, Period 2||1
10572711|NCT01667900|11728006|FG007|STARTED|Part A, Period 2||1
10572712|NCT01667900|11728007|FG008|STARTED|Part A, Period 2||1
10572713|NCT01667900|11728008|FG009|STARTED|Part A, Period 2||1
10572714|NCT01667900|11728009|FG010|STARTED|Part A, Period 2||1
10572715|NCT01667900|11728010|FG011|STARTED|Part A, Period 2||1
10572716|NCT01667900|11728011|FG012|STARTED|Part A, Period 2||1
10572717|NCT01667900|11728012|FG013|STARTED|Part A, Period 2||1
10572718|NCT01667900|11728013|FG014|STARTED|Part A, Period 2||1
10794976|NCT03629054|11955375|FG000|NOT COMPLETED|Period 2 (4 Days)||0
10794977|NCT03629054|11955376|FG001|NOT COMPLETED|Period 2 (4 Days)||1
10572719|NCT01667900|11728014|FG015|STARTED|Part A, Period 2||1
10572720|NCT01667900|11728015|FG016|STARTED|Part A, Period 2||0
10572721|NCT01667900|11728016|FG017|STARTED|Part A, Period 2||0
10572722|NCT01667900|11728017|FG018|STARTED|Part A, Period 2||0
10572723|NCT01667900|11728018|FG019|STARTED|Part A, Period 2||0
10794978|NCT03629184|11955384|FG000|STARTED|Overall Study||115
10794979|NCT03629184|11955385|FG001|STARTED|Overall Study||58
10794980|NCT03629184|11955384|FG000|COMPLETED|Overall Study||112
10794981|NCT03629184|11955385|FG001|COMPLETED|Overall Study||57
10572724|NCT01667900|11727999|FG000|COMPLETED|Part A, Period 2||1
10572725|NCT01667900|11728000|FG001|COMPLETED|Part A, Period 2||1
10572726|NCT01667900|11728001|FG002|COMPLETED|Part A, Period 2||1
10572727|NCT01667900|11728002|FG003|COMPLETED|Part A, Period 2||1
10572728|NCT01667900|11728003|FG004|COMPLETED|Part A, Period 2||1
10572729|NCT01667900|11728004|FG005|COMPLETED|Part A, Period 2||1
10572730|NCT01667900|11728005|FG006|COMPLETED|Part A, Period 2||1
10572731|NCT01667900|11728006|FG007|COMPLETED|Part A, Period 2||1
10572732|NCT01667900|11728007|FG008|COMPLETED|Part A, Period 2||1
10572733|NCT01667900|11728008|FG009|COMPLETED|Part A, Period 2||1
10572734|NCT01667900|11728009|FG010|COMPLETED|Part A, Period 2||1
10572735|NCT01667900|11728010|FG011|COMPLETED|Part A, Period 2||1
10572736|NCT01667900|11728011|FG012|COMPLETED|Part A, Period 2||1
10572737|NCT01667900|11728012|FG013|COMPLETED|Part A, Period 2||1
10572738|NCT01667900|11728013|FG014|COMPLETED|Part A, Period 2||1
10572739|NCT01667900|11728014|FG015|COMPLETED|Part A, Period 2||1
10572740|NCT01667900|11728015|FG016|COMPLETED|Part A, Period 2||0
10572741|NCT01667900|11728016|FG017|COMPLETED|Part A, Period 2||0
10572742|NCT01667900|11728017|FG018|COMPLETED|Part A, Period 2||0
10572743|NCT01667900|11728018|FG019|COMPLETED|Part A, Period 2||0
10572744|NCT01667900|11727999|FG000|NOT COMPLETED|Part A, Period 2||0
10572745|NCT01667900|11728000|FG001|NOT COMPLETED|Part A, Period 2||0
10572746|NCT01667900|11728001|FG002|NOT COMPLETED|Part A, Period 2||0
10572747|NCT01667900|11728002|FG003|NOT COMPLETED|Part A, Period 2||0
10572748|NCT01667900|11728003|FG004|NOT COMPLETED|Part A, Period 2||0
10572749|NCT01667900|11728004|FG005|NOT COMPLETED|Part A, Period 2||0
10572750|NCT01667900|11728005|FG006|NOT COMPLETED|Part A, Period 2||0
10572751|NCT01667900|11728006|FG007|NOT COMPLETED|Part A, Period 2||0
10572752|NCT01667900|11728007|FG008|NOT COMPLETED|Part A, Period 2||0
10572753|NCT01667900|11728008|FG009|NOT COMPLETED|Part A, Period 2||0
10572754|NCT01667900|11728009|FG010|NOT COMPLETED|Part A, Period 2||0
10572755|NCT01667900|11728010|FG011|NOT COMPLETED|Part A, Period 2||0
10572756|NCT01667900|11728011|FG012|NOT COMPLETED|Part A, Period 2||0
10572757|NCT01667900|11728012|FG013|NOT COMPLETED|Part A, Period 2||0
10572758|NCT01667900|11728013|FG014|NOT COMPLETED|Part A, Period 2||0
10572759|NCT01667900|11728014|FG015|NOT COMPLETED|Part A, Period 2||0
10572760|NCT01667900|11728015|FG016|NOT COMPLETED|Part A, Period 2||0
10572761|NCT01667900|11728016|FG017|NOT COMPLETED|Part A, Period 2||0
10572762|NCT01667900|11728017|FG018|NOT COMPLETED|Part A, Period 2||0
10572763|NCT01667900|11728018|FG019|NOT COMPLETED|Part A, Period 2||0
10572764|NCT01667900|11727999|FG000|STARTED|Part A, Washout 2||1
10572765|NCT01667900|11728000|FG001|STARTED|Part A, Washout 2||1
10572766|NCT01667900|11728001|FG002|STARTED|Part A, Washout 2||1
10572767|NCT01667900|11728002|FG003|STARTED|Part A, Washout 2||1
10572768|NCT01667900|11728003|FG004|STARTED|Part A, Washout 2||1
10572769|NCT01667900|11728004|FG005|STARTED|Part A, Washout 2||1
10572770|NCT01667900|11728005|FG006|STARTED|Part A, Washout 2||1
10572771|NCT01667900|11728006|FG007|STARTED|Part A, Washout 2||1
10572772|NCT01667900|11728007|FG008|STARTED|Part A, Washout 2||1
10572773|NCT01667900|11728008|FG009|STARTED|Part A, Washout 2||1
10572774|NCT01667900|11728009|FG010|STARTED|Part A, Washout 2||1
10572775|NCT01667900|11728010|FG011|STARTED|Part A, Washout 2||1
10572776|NCT01667900|11728011|FG012|STARTED|Part A, Washout 2||1
10572777|NCT01667900|11728012|FG013|STARTED|Part A, Washout 2||1
10572778|NCT01667900|11728013|FG014|STARTED|Part A, Washout 2||1
10572779|NCT01667900|11728014|FG015|STARTED|Part A, Washout 2||1
10572780|NCT01667900|11728015|FG016|STARTED|Part A, Washout 2||0
10572781|NCT01667900|11728016|FG017|STARTED|Part A, Washout 2||0
10572782|NCT01667900|11728017|FG018|STARTED|Part A, Washout 2||0
10572783|NCT01667900|11728018|FG019|STARTED|Part A, Washout 2||0
10572784|NCT01667900|11727999|FG000|COMPLETED|Part A, Washout 2||1
10572785|NCT01667900|11728000|FG001|COMPLETED|Part A, Washout 2||1
10572786|NCT01667900|11728001|FG002|COMPLETED|Part A, Washout 2||1
10572787|NCT01667900|11728002|FG003|COMPLETED|Part A, Washout 2||1
10572788|NCT01667900|11728003|FG004|COMPLETED|Part A, Washout 2||1
10572789|NCT01667900|11728004|FG005|COMPLETED|Part A, Washout 2||1
10572790|NCT01667900|11728005|FG006|COMPLETED|Part A, Washout 2||1
10572791|NCT01667900|11728006|FG007|COMPLETED|Part A, Washout 2||1
10572792|NCT01667900|11728007|FG008|COMPLETED|Part A, Washout 2||1
10572793|NCT01667900|11728008|FG009|COMPLETED|Part A, Washout 2||1
10572794|NCT01667900|11728009|FG010|COMPLETED|Part A, Washout 2||1
10572795|NCT01667900|11728010|FG011|COMPLETED|Part A, Washout 2||1
10572796|NCT01667900|11728011|FG012|COMPLETED|Part A, Washout 2||1
10572797|NCT01667900|11728012|FG013|COMPLETED|Part A, Washout 2||1
10572798|NCT01667900|11728013|FG014|COMPLETED|Part A, Washout 2||1
10572799|NCT01667900|11728014|FG015|COMPLETED|Part A, Washout 2||1
10572800|NCT01667900|11728015|FG016|COMPLETED|Part A, Washout 2||0
10572801|NCT01667900|11728016|FG017|COMPLETED|Part A, Washout 2||0
10572802|NCT01667900|11728017|FG018|COMPLETED|Part A, Washout 2||0
10572803|NCT01667900|11728018|FG019|COMPLETED|Part A, Washout 2||0
10572804|NCT01667900|11727999|FG000|NOT COMPLETED|Part A, Washout 2||0
10572805|NCT01667900|11728000|FG001|NOT COMPLETED|Part A, Washout 2||0
10572806|NCT01667900|11728001|FG002|NOT COMPLETED|Part A, Washout 2||0
10572807|NCT01667900|11728002|FG003|NOT COMPLETED|Part A, Washout 2||0
10572808|NCT01667900|11728003|FG004|NOT COMPLETED|Part A, Washout 2||0
10572809|NCT01667900|11728004|FG005|NOT COMPLETED|Part A, Washout 2||0
10572810|NCT01667900|11728005|FG006|NOT COMPLETED|Part A, Washout 2||0
10572811|NCT01667900|11728006|FG007|NOT COMPLETED|Part A, Washout 2||0
10572812|NCT01667900|11728007|FG008|NOT COMPLETED|Part A, Washout 2||0
10572813|NCT01667900|11728008|FG009|NOT COMPLETED|Part A, Washout 2||0
10572814|NCT01667900|11728009|FG010|NOT COMPLETED|Part A, Washout 2||0
10572815|NCT01667900|11728010|FG011|NOT COMPLETED|Part A, Washout 2||0
10572816|NCT01667900|11728011|FG012|NOT COMPLETED|Part A, Washout 2||0
10572817|NCT01667900|11728012|FG013|NOT COMPLETED|Part A, Washout 2||0
10572818|NCT01667900|11728013|FG014|NOT COMPLETED|Part A, Washout 2||0
10572819|NCT01667900|11728014|FG015|NOT COMPLETED|Part A, Washout 2||0
10572820|NCT01667900|11728015|FG016|NOT COMPLETED|Part A, Washout 2||0
10572821|NCT01667900|11728016|FG017|NOT COMPLETED|Part A, Washout 2||0
10572822|NCT01667900|11728017|FG018|NOT COMPLETED|Part A, Washout 2||0
10572823|NCT01667900|11728018|FG019|NOT COMPLETED|Part A, Washout 2||0
10572824|NCT01667900|11727999|FG000|STARTED|Part A, Period 3||1
10572825|NCT01667900|11728000|FG001|STARTED|Part A, Period 3||1
10572826|NCT01667900|11728001|FG002|STARTED|Part A, Period 3||1
10572827|NCT01667900|11728002|FG003|STARTED|Part A, Period 3||1
10572828|NCT01667900|11728003|FG004|STARTED|Part A, Period 3||1
10572829|NCT01667900|11728004|FG005|STARTED|Part A, Period 3||1
10572830|NCT01667900|11728005|FG006|STARTED|Part A, Period 3||1
10572831|NCT01667900|11728006|FG007|STARTED|Part A, Period 3||1
10572832|NCT01667900|11728007|FG008|STARTED|Part A, Period 3||1
10572833|NCT01667900|11728008|FG009|STARTED|Part A, Period 3||1
10572834|NCT01667900|11728009|FG010|STARTED|Part A, Period 3||1
10572835|NCT01667900|11728010|FG011|STARTED|Part A, Period 3||1
10572836|NCT01667900|11728011|FG012|STARTED|Part A, Period 3||1
10572837|NCT01667900|11728012|FG013|STARTED|Part A, Period 3||1
10572838|NCT01667900|11728013|FG014|STARTED|Part A, Period 3||1
10572839|NCT01667900|11728014|FG015|STARTED|Part A, Period 3||1
10572840|NCT01667900|11728015|FG016|STARTED|Part A, Period 3||0
10572841|NCT01667900|11728016|FG017|STARTED|Part A, Period 3||0
10572842|NCT01667900|11728017|FG018|STARTED|Part A, Period 3||0
10572843|NCT01667900|11728018|FG019|STARTED|Part A, Period 3||0
10572844|NCT01667900|11727999|FG000|COMPLETED|Part A, Period 3||1
10572845|NCT01667900|11728000|FG001|COMPLETED|Part A, Period 3||1
10572846|NCT01667900|11728001|FG002|COMPLETED|Part A, Period 3||1
10572847|NCT01667900|11728002|FG003|COMPLETED|Part A, Period 3||1
10572848|NCT01667900|11728003|FG004|COMPLETED|Part A, Period 3||1
10572849|NCT01667900|11728004|FG005|COMPLETED|Part A, Period 3||1
10572850|NCT01667900|11728005|FG006|COMPLETED|Part A, Period 3||1
10572851|NCT01667900|11728006|FG007|COMPLETED|Part A, Period 3||1
10572852|NCT01667900|11728007|FG008|COMPLETED|Part A, Period 3||1
10572853|NCT01667900|11728008|FG009|COMPLETED|Part A, Period 3||1
10572854|NCT01667900|11728009|FG010|COMPLETED|Part A, Period 3||1
10572855|NCT01667900|11728010|FG011|COMPLETED|Part A, Period 3||1
10572856|NCT01667900|11728011|FG012|COMPLETED|Part A, Period 3||1
10572857|NCT01667900|11728012|FG013|COMPLETED|Part A, Period 3||1
10572858|NCT01667900|11728013|FG014|COMPLETED|Part A, Period 3||1
10572859|NCT01667900|11728014|FG015|COMPLETED|Part A, Period 3||1
10572860|NCT01667900|11728015|FG016|COMPLETED|Part A, Period 3||0
10572861|NCT01667900|11728016|FG017|COMPLETED|Part A, Period 3||0
10572862|NCT01667900|11728017|FG018|COMPLETED|Part A, Period 3||0
10572863|NCT01667900|11728018|FG019|COMPLETED|Part A, Period 3||0
10572864|NCT01667900|11727999|FG000|NOT COMPLETED|Part A, Period 3||0
10572865|NCT01667900|11728000|FG001|NOT COMPLETED|Part A, Period 3||0
10572866|NCT01667900|11728001|FG002|NOT COMPLETED|Part A, Period 3||0
10572867|NCT01667900|11728002|FG003|NOT COMPLETED|Part A, Period 3||0
10572868|NCT01667900|11728003|FG004|NOT COMPLETED|Part A, Period 3||0
10572869|NCT01667900|11728004|FG005|NOT COMPLETED|Part A, Period 3||0
10572870|NCT01667900|11728005|FG006|NOT COMPLETED|Part A, Period 3||0
10572871|NCT01667900|11728006|FG007|NOT COMPLETED|Part A, Period 3||0
10572872|NCT01667900|11728007|FG008|NOT COMPLETED|Part A, Period 3||0
10572873|NCT01667900|11728008|FG009|NOT COMPLETED|Part A, Period 3||0
10572874|NCT01667900|11728009|FG010|NOT COMPLETED|Part A, Period 3||0
10572875|NCT01667900|11728010|FG011|NOT COMPLETED|Part A, Period 3||0
10572876|NCT01667900|11728011|FG012|NOT COMPLETED|Part A, Period 3||0
10572877|NCT01667900|11728012|FG013|NOT COMPLETED|Part A, Period 3||0
10572878|NCT01667900|11728013|FG014|NOT COMPLETED|Part A, Period 3||0
10572879|NCT01667900|11728014|FG015|NOT COMPLETED|Part A, Period 3||0
10572880|NCT01667900|11728015|FG016|NOT COMPLETED|Part A, Period 3||0
10572881|NCT01667900|11728016|FG017|NOT COMPLETED|Part A, Period 3||0
10572882|NCT01667900|11728017|FG018|NOT COMPLETED|Part A, Period 3||0
10572883|NCT01667900|11728018|FG019|NOT COMPLETED|Part A, Period 3||0
10572884|NCT01667900|11727999|FG000|STARTED|Part B|Part A participants did not participate in Part B.|0
10572885|NCT01667900|11728000|FG001|STARTED|Part B|Part A participants did not participate in Part B.|0
10572886|NCT01667900|11728001|FG002|STARTED|Part B|Part A participants did not participate in Part B.|0
10572887|NCT01667900|11728002|FG003|STARTED|Part B|Part A participants did not participate in Part B.|0
10572888|NCT01667900|11728003|FG004|STARTED|Part B|Part A participants did not participate in Part B.|0
10572889|NCT01667900|11728004|FG005|STARTED|Part B|Part A participants did not participate in Part B.|0
10572890|NCT01667900|11728005|FG006|STARTED|Part B|Part A participants did not participate in Part B.|0
10572891|NCT01667900|11728006|FG007|STARTED|Part B|Part A participants did not participate in Part B.|0
10572892|NCT01667900|11728007|FG008|STARTED|Part B|Part A participants did not participate in Part B.|0
10572893|NCT01667900|11728008|FG009|STARTED|Part B|Part A participants did not participate in Part B.|0
10572894|NCT01667900|11728009|FG010|STARTED|Part B|Part A participants did not participate in Part B.|0
10572895|NCT01667900|11728010|FG011|STARTED|Part B|Part A participants did not participate in Part B.|0
10572896|NCT01667900|11728011|FG012|STARTED|Part B|Part A participants did not participate in Part B.|0
10572897|NCT01667900|11728012|FG013|STARTED|Part B|Part A participants did not participate in Part B.|0
10572898|NCT01667900|11728013|FG014|STARTED|Part B|Part A participants did not participate in Part B.|0
10572899|NCT01667900|11728014|FG015|STARTED|Part B|Part A participants did not participate in Part B.|0
10572900|NCT01667900|11728015|FG016|STARTED|Part B||11
10572901|NCT01667900|11728016|FG017|STARTED|Part B||11
10572902|NCT01667900|11728017|FG018|STARTED|Part B||10
10572903|NCT01667900|11728018|FG019|STARTED|Part B||10
10572904|NCT01667900|11727999|FG000|COMPLETED|Part B||0
10572905|NCT01667900|11728000|FG001|COMPLETED|Part B||0
10572906|NCT01667900|11728001|FG002|COMPLETED|Part B||0
10572907|NCT01667900|11728002|FG003|COMPLETED|Part B||0
10572908|NCT01667900|11728003|FG004|COMPLETED|Part B||0
10572909|NCT01667900|11728004|FG005|COMPLETED|Part B||0
10572910|NCT01667900|11728005|FG006|COMPLETED|Part B||0
10572911|NCT01667900|11728006|FG007|COMPLETED|Part B||0
10572912|NCT01667900|11728007|FG008|COMPLETED|Part B||0
10572913|NCT01667900|11728008|FG009|COMPLETED|Part B||0
10572914|NCT01667900|11728009|FG010|COMPLETED|Part B||0
10572915|NCT01667900|11728010|FG011|COMPLETED|Part B||0
10572916|NCT01667900|11728011|FG012|COMPLETED|Part B||0
10572917|NCT01667900|11728012|FG013|COMPLETED|Part B||0
10572918|NCT01667900|11728013|FG014|COMPLETED|Part B||0
10572919|NCT01667900|11728014|FG015|COMPLETED|Part B||0
10572920|NCT01667900|11728015|FG016|COMPLETED|Part B||10
10572921|NCT01667900|11728016|FG017|COMPLETED|Part B||11
10572922|NCT01667900|11728017|FG018|COMPLETED|Part B||10
10572923|NCT01667900|11728018|FG019|COMPLETED|Part B||10
10572924|NCT01667900|11727999|FG000|NOT COMPLETED|Part B||0
10572925|NCT01667900|11728000|FG001|NOT COMPLETED|Part B||0
10572926|NCT01667900|11728001|FG002|NOT COMPLETED|Part B||0
10572927|NCT01667900|11728002|FG003|NOT COMPLETED|Part B||0
10572928|NCT01667900|11728003|FG004|NOT COMPLETED|Part B||0
10572929|NCT01667900|11728004|FG005|NOT COMPLETED|Part B||0
10572930|NCT01667900|11728005|FG006|NOT COMPLETED|Part B||0
10572931|NCT01667900|11728006|FG007|NOT COMPLETED|Part B||0
10572932|NCT01667900|11728007|FG008|NOT COMPLETED|Part B||0
10572933|NCT01667900|11728008|FG009|NOT COMPLETED|Part B||0
10572934|NCT01667900|11728009|FG010|NOT COMPLETED|Part B||0
10572935|NCT01667900|11728010|FG011|NOT COMPLETED|Part B||0
10572936|NCT01667900|11728011|FG012|NOT COMPLETED|Part B||0
10572937|NCT01667900|11728012|FG013|NOT COMPLETED|Part B||0
10572938|NCT01667900|11728013|FG014|NOT COMPLETED|Part B||0
10572939|NCT01667900|11728014|FG015|NOT COMPLETED|Part B||0
10572940|NCT01667900|11728015|FG016|NOT COMPLETED|Part B||1
10572941|NCT01667900|11728016|FG017|NOT COMPLETED|Part B||0
10572942|NCT01667900|11728017|FG018|NOT COMPLETED|Part B||0
10572943|NCT01667900|11728018|FG019|NOT COMPLETED|Part B||0
10572944|NCT01667926|11728040|FG000|STARTED|Overall Study||13
10572945|NCT01667926|11728041|FG001|STARTED|Overall Study||13
10572946|NCT01667926|11728042|FG002|STARTED|Overall Study||11
10572947|NCT01667926|11728040|FG000|COMPLETED|Overall Study||8
10318759|NCT00216736|11452995|FG001|NOT COMPLETED|Overall Study||1
10318760|NCT00217022|11453003|FG000|STARTED|Overall Study||12
10318761|NCT00217022|11453004|FG001|STARTED|Overall Study||4
10318762|NCT00217022|11453003|FG000|COMPLETED|Overall Study||11
10318763|NCT00217022|11453004|FG001|COMPLETED|Overall Study||3
10318764|NCT00217022|11453003|FG000|NOT COMPLETED|Overall Study||1
10572948|NCT01667926|11728041|FG001|COMPLETED|Overall Study||9
10572949|NCT01667926|11728042|FG002|COMPLETED|Overall Study|Participants in the screen fail group were not randomized in the study.|0
10572950|NCT01667926|11728040|FG000|NOT COMPLETED|Overall Study||5
10572951|NCT01667926|11728041|FG001|NOT COMPLETED|Overall Study||4
10572952|NCT01667926|11728042|FG002|NOT COMPLETED|Overall Study||11
10572953|NCT01667978|11728050|FG000|STARTED|Overall Study||18
10572954|NCT01667978|11728051|FG001|STARTED|Overall Study||17
10572955|NCT01667978|11728050|FG000|COMPLETED|Overall Study||16
10572956|NCT01667978|11728051|FG001|COMPLETED|Overall Study||17
10572957|NCT01667978|11728050|FG000|NOT COMPLETED|Overall Study||2
10572958|NCT01667978|11728051|FG001|NOT COMPLETED|Overall Study||0
10572959|NCT01668004|11728057|FG000|STARTED|Overall Study||101
10572960|NCT01668004|11728057|FG000|Treated|Overall Study||101
10572961|NCT01668004|11728057|FG000|COMPLETED|Overall Study||76
10572962|NCT01668004|11728057|FG000|NOT COMPLETED|Overall Study||25
10572963|NCT01668017|11728068|FG000|STARTED|Overall Study||4
10572964|NCT01668017|11728069|FG001|STARTED|Overall Study||9
10572965|NCT01668017|11728070|FG002|STARTED|Overall Study||6
10572966|NCT01668017|11728071|FG003|STARTED|Overall Study||5
10572967|NCT01668017|11728072|FG004|STARTED|Overall Study||2
10572968|NCT01668017|11728068|FG000|COMPLETED|Overall Study||4
10572969|NCT01668017|11728069|FG001|COMPLETED|Overall Study||9
10572970|NCT01668017|11728070|FG002|COMPLETED|Overall Study||6
10572971|NCT01668017|11728071|FG003|COMPLETED|Overall Study||5
10572972|NCT01668017|11728072|FG004|COMPLETED|Overall Study||2
10572973|NCT01668017|11728068|FG000|NOT COMPLETED|Overall Study||0
10572974|NCT01668017|11728069|FG001|NOT COMPLETED|Overall Study||0
10572975|NCT01668017|11728070|FG002|NOT COMPLETED|Overall Study||0
10572976|NCT01668017|11728071|FG003|NOT COMPLETED|Overall Study||0
10572977|NCT01668017|11728072|FG004|NOT COMPLETED|Overall Study||0
10572978|NCT01668030|11728099|FG000|STARTED|Overall Study||10
10572979|NCT01668030|11728100|FG001|STARTED|Overall Study||10
10572980|NCT01668030|11728099|FG000|COMPLETED|Overall Study||10
10572981|NCT01668030|11728100|FG001|COMPLETED|Overall Study||10
10572982|NCT01668030|11728099|FG000|NOT COMPLETED|Overall Study||0
10572983|NCT01668030|11728100|FG001|NOT COMPLETED|Overall Study||0
10572984|NCT01668173|11728105|FG000|STARTED|Overall Study||7
10572985|NCT01668173|11728105|FG000|COMPLETED|Overall Study||0
10572986|NCT01668173|11728105|FG000|NOT COMPLETED|Overall Study||7
10572987|NCT01668355|11728111|FG000|STARTED|Overall Study||164
10572988|NCT01668355|11728112|FG001|STARTED|Overall Study||167
10572989|NCT01668355|11728111|FG000|COMPLETED|Overall Study||155
10572990|NCT01668355|11728112|FG001|COMPLETED|Overall Study||165
10572991|NCT01668355|11728111|FG000|NOT COMPLETED|Overall Study||9
10572992|NCT01668355|11728112|FG001|NOT COMPLETED|Overall Study||2
10572993|NCT01668537|11728121|FG000|STARTED|Overall Study||327
10572994|NCT01668537|11728122|FG001|STARTED|Overall Study||324
10572995|NCT01668537|11728121|FG000|COMPLETED|Overall Study||305
10318765|NCT00217022|11453004|FG001|NOT COMPLETED|Overall Study||1
10572996|NCT01668537|11728122|FG001|COMPLETED|Overall Study||314
10572997|NCT01668537|11728121|FG000|NOT COMPLETED|Overall Study||22
10572998|NCT01668537|11728122|FG001|NOT COMPLETED|Overall Study||10
10572999|NCT01668589|11728132|FG000|STARTED|Overall Study||600
10573000|NCT01668589|11728133|FG001|STARTED|Overall Study||300
10573001|NCT01668589|11728134|FG002|STARTED|Overall Study||300
10573002|NCT01668589|11728135|FG003|STARTED|Overall Study||301
10573003|NCT01668589|11728132|FG000|Received Denosumab|Overall Study||599
10573004|NCT01668589|11728133|FG001|Received Denosumab|Overall Study||300
10573005|NCT01668589|11728134|FG002|Received Denosumab|Overall Study||300
10573006|NCT01668589|11728135|FG003|Received Denosumab|Overall Study||301
10573007|NCT01668589|11728132|FG000|COMPLETED|Overall Study||461
10573008|NCT01668589|11728133|FG001|COMPLETED|Overall Study||242
10573009|NCT01668589|11728134|FG002|COMPLETED|Overall Study||265
10573010|NCT01668589|11728135|FG003|COMPLETED|Overall Study||266
10573011|NCT01668589|11728132|FG000|NOT COMPLETED|Overall Study||139
10573012|NCT01668589|11728133|FG001|NOT COMPLETED|Overall Study||58
10573013|NCT01668589|11728134|FG002|NOT COMPLETED|Overall Study||35
10573014|NCT01668589|11728135|FG003|NOT COMPLETED|Overall Study||35
10573015|NCT01668602|11728147|FG000|STARTED|Overall Study||2
10573016|NCT01668602|11728148|FG001|STARTED|Overall Study||22
10573017|NCT01668602|11728147|FG000|Cohort 2 - Began FastFES Sessions|Overall Study|This milestone does not apply to Cohort 1.|0
10573018|NCT01668602|11728148|FG001|Cohort 2 - Began FastFES Sessions|Overall Study||20
10573019|NCT01668602|11728147|FG000|Cohort 2 - Completed 3 Sessions of FastFES|Overall Study|This milestone does not apply to Cohort 1.|0
10573020|NCT01668602|11728148|FG001|Cohort 2 - Completed 3 Sessions of FastFES|Overall Study||19
10573021|NCT01668602|11728147|FG000|Cohort 2 - Began Fast Walking Sessions|Overall Study|This milestone does not apply to Cohort 1.|0
10573022|NCT01668602|11728148|FG001|Cohort 2 - Began Fast Walking Sessions|Overall Study||20
10573023|NCT01668602|11728147|FG000|Cohort 2 - Completed 3 Sessions of Fast Walking|Overall Study|This milestone does not apply to Cohort 1.|0
10573024|NCT01668602|11728148|FG001|Cohort 2 - Completed 3 Sessions of Fast Walking|Overall Study||18
10573025|NCT01668602|11728147|FG000|COMPLETED|Overall Study||2
10573026|NCT01668602|11728148|FG001|COMPLETED|Overall Study||18
10573027|NCT01668602|11728147|FG000|NOT COMPLETED|Overall Study||0
10573028|NCT01668602|11728148|FG001|NOT COMPLETED|Overall Study||4
10573029|NCT01668628|11728159|FG000|STARTED|Overall Study|5 subjects had been excluded due to protocol violation and then data of the rest were anlayzed.|349
10573030|NCT01668628|11728160|FG001|STARTED|Overall Study||359
10573031|NCT01668628|11728161|FG002|STARTED|Overall Study|2 subjects had been excluded due to protocol violation and then data of the rest were anlayzed.|367
10573032|NCT01668628|11728159|FG000|COMPLETED|Overall Study||347
10573033|NCT01668628|11728160|FG001|COMPLETED|Overall Study||359
10573034|NCT01668628|11728161|FG002|COMPLETED|Overall Study||367
10573035|NCT01668628|11728159|FG000|NOT COMPLETED|Overall Study||2
10573036|NCT01668628|11728160|FG001|NOT COMPLETED|Overall Study||0
10573037|NCT01668628|11728161|FG002|NOT COMPLETED|Overall Study||0
10573038|NCT01668654|11728173|FG000|STARTED|Overall Study||4
10573039|NCT01668654|11728173|FG000|COMPLETED|Overall Study||0
10573040|NCT01668654|11728173|FG000|NOT COMPLETED|Overall Study||4
10573041|NCT01668667|11728181|FG000|STARTED|Overall Study||126
10573042|NCT01668667|11728182|FG001|STARTED|Overall Study||125
10573043|NCT01668667|11728183|FG002|STARTED|Overall Study||125
10573044|NCT01668667|11728184|FG003|STARTED|Overall Study||125
10573045|NCT01668667|11728181|FG000|COMPLETED|Overall Study||95
10573046|NCT01668667|11728182|FG001|COMPLETED|Overall Study||99
10573047|NCT01668667|11728183|FG002|COMPLETED|Overall Study||94
10573048|NCT01668667|11728184|FG003|COMPLETED|Overall Study||102
10573049|NCT01668667|11728181|FG000|NOT COMPLETED|Overall Study||31
10573050|NCT01668667|11728182|FG001|NOT COMPLETED|Overall Study||26
10573051|NCT01668667|11728183|FG002|NOT COMPLETED|Overall Study||31
10573052|NCT01668667|11728184|FG003|NOT COMPLETED|Overall Study||23
10573053|NCT01668797|11728196|FG000|STARTED|Phase A (Conversion Phase)||406
10573054|NCT01668797|11728197|FG001|STARTED|Phase A (Conversion Phase)||0
10573055|NCT01668797|11728198|FG002|STARTED|Phase A (Conversion Phase)||0
10573056|NCT01668797|11728199|FG003|STARTED|Phase A (Conversion Phase)||0
10573057|NCT01668797|11728196|FG000|COMPLETED|Phase A (Conversion Phase)||346
10573058|NCT01668797|11728197|FG001|COMPLETED|Phase A (Conversion Phase)||0
10794982|NCT03629184|11955384|FG000|NOT COMPLETED|Overall Study||3
10794983|NCT03629184|11955385|FG001|NOT COMPLETED|Overall Study||1
10794984|NCT03629249|11955394|FG000|STARTED|Overall Study||201
10794985|NCT03629249|11955395|FG001|STARTED|Overall Study||201
10573059|NCT01668797|11728198|FG002|COMPLETED|Phase A (Conversion Phase)||0
10573060|NCT01668797|11728199|FG003|COMPLETED|Phase A (Conversion Phase)||0
10573061|NCT01668797|11728196|FG000|NOT COMPLETED|Phase A (Conversion Phase)||60
10573062|NCT01668797|11728197|FG001|NOT COMPLETED|Phase A (Conversion Phase)||0
10573063|NCT01668797|11728198|FG002|NOT COMPLETED|Phase A (Conversion Phase)||0
10573064|NCT01668797|11728199|FG003|NOT COMPLETED|Phase A (Conversion Phase)||0
10573065|NCT01668797|11728196|FG000|STARTED|Phase B (Stabilization Phase)||0
10573066|NCT01668797|11728197|FG001|STARTED|Phase B (Stabilization Phase)|N= 464; 346 rolled over from Phase A and 118 entered directly into Phase B|464
10794986|NCT03629249|11955396|FG002|STARTED|Overall Study||202
10794987|NCT03629249|11955394|FG000|Full Analysis Set (FAS)|Overall Study||201
10794988|NCT03629249|11955395|FG001|Full Analysis Set (FAS)|Overall Study||200
10573067|NCT01668797|11728198|FG002|STARTED|Phase B (Stabilization Phase)||0
10794989|NCT03629249|11955396|FG002|Full Analysis Set (FAS)|Overall Study||201
10794990|NCT03629249|11955394|FG000|Safety Set (SAF)|Overall Study||201
10794991|NCT03629249|11955395|FG001|Safety Set (SAF)|Overall Study||200
10794992|NCT03629249|11955396|FG002|Safety Set (SAF)|Overall Study||201
10794993|NCT03629249|11955394|FG000|COMPLETED|Overall Study||0
10794994|NCT03629249|11955395|FG001|COMPLETED|Overall Study||0
10573068|NCT01668797|11728199|FG003|STARTED|Phase B (Stabilization Phase)||0
10573069|NCT01668797|11728196|FG000|COMPLETED|Phase B (Stabilization Phase)||0
10573070|NCT01668797|11728197|FG001|COMPLETED|Phase B (Stabilization Phase)||202
10573071|NCT01668797|11728198|FG002|COMPLETED|Phase B (Stabilization Phase)||0
10573072|NCT01668797|11728199|FG003|COMPLETED|Phase B (Stabilization Phase)||0
10573073|NCT01668797|11728196|FG000|NOT COMPLETED|Phase B (Stabilization Phase)||0
10573074|NCT01668797|11728197|FG001|NOT COMPLETED|Phase B (Stabilization Phase)||262
10573075|NCT01668797|11728198|FG002|NOT COMPLETED|Phase B (Stabilization Phase)||0
10573076|NCT01668797|11728199|FG003|NOT COMPLETED|Phase B (Stabilization Phase)||0
10573077|NCT01668797|11728196|FG000|STARTED|Phase C (Double-Blind Maintenance Phase)||0
10573078|NCT01668797|11728197|FG001|STARTED|Phase C (Double-Blind Maintenance Phase)||0
10573079|NCT01668797|11728198|FG002|STARTED|Phase C (Double-Blind Maintenance Phase)|N= 202 rolled over from Phase B|97
10573080|NCT01668797|11728199|FG003|STARTED|Phase C (Double-Blind Maintenance Phase)||105
10573081|NCT01668797|11728196|FG000|COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
10573082|NCT01668797|11728197|FG001|COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
10573083|NCT01668797|11728198|FG002|COMPLETED|Phase C (Double-Blind Maintenance Phase)||14
10573084|NCT01668797|11728199|FG003|COMPLETED|Phase C (Double-Blind Maintenance Phase)||9
10573085|NCT01668797|11728196|FG000|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
10573086|NCT01668797|11728197|FG001|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
10573087|NCT01668797|11728198|FG002|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||83
10573088|NCT01668797|11728199|FG003|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||96
10573089|NCT01668836|11728210|FG000|STARTED|Overall Study||12
10573090|NCT01668836|11728211|FG001|STARTED|Overall Study||12
10573091|NCT01668836|11728212|FG002|STARTED|Overall Study||12
10573092|NCT01668836|11728213|FG003|STARTED|Overall Study||12
10573093|NCT01668836|11728210|FG000|COMPLETED|Overall Study||12
10573094|NCT01668836|11728211|FG001|COMPLETED|Overall Study||12
10573095|NCT01668836|11728212|FG002|COMPLETED|Overall Study||12
10573096|NCT01668836|11728213|FG003|COMPLETED|Overall Study||12
10573097|NCT01668836|11728210|FG000|NOT COMPLETED|Overall Study||0
10573098|NCT01668836|11728211|FG001|NOT COMPLETED|Overall Study||0
10573099|NCT01668836|11728212|FG002|NOT COMPLETED|Overall Study||0
10573100|NCT01668836|11728213|FG003|NOT COMPLETED|Overall Study||0
10573101|NCT01668966|11728229|FG000|STARTED|Overall Study||23
10573102|NCT01668966|11728229|FG000|Treated|Overall Study||21
10573103|NCT01668966|11728229|FG000|COMPLETED|Overall Study||19
10573104|NCT01668966|11728229|FG000|NOT COMPLETED|Overall Study||4
10573105|NCT01669096|11728233|FG000|STARTED|Overall Study||20
10573106|NCT01669096|11728233|FG000|COMPLETED|Overall Study||20
10573107|NCT01669096|11728233|FG000|NOT COMPLETED|Overall Study||0
10573108|NCT01669122|11728237|FG000|STARTED|Period I|Participants who received Lozenge A=10, Lozenge B=10, Lozenge C=10, Reference Lozenge=10|40
10573109|NCT01669122|11728237|FG000|Safety Population|Period I||39
10794995|NCT03629249|11955396|FG002|COMPLETED|Overall Study||0
10794996|NCT03629249|11955394|FG000|NOT COMPLETED|Overall Study||201
10794997|NCT03629249|11955395|FG001|NOT COMPLETED|Overall Study||201
10794998|NCT03629249|11955396|FG002|NOT COMPLETED|Overall Study||202
10794999|NCT03629535|11955404|FG000|STARTED|Overall Study||8
10795000|NCT03629535|11955404|FG000|COMPLETED|Overall Study||8
10573110|NCT01669122|11728237|FG000|COMPLETED|Period I||39
10573111|NCT01669122|11728237|FG000|NOT COMPLETED|Period I||1
10573112|NCT01669122|11728237|FG000|STARTED|Washout Period I||39
10573113|NCT01669122|11728237|FG000|COMPLETED|Washout Period I||39
10573114|NCT01669122|11728237|FG000|NOT COMPLETED|Washout Period I||0
10573115|NCT01669122|11728237|FG000|STARTED|Period II|Participants who received Lozenge A=9, Lozenge B=10, Lozenge C=10, Reference Lozenge=10|39
10573116|NCT01669122|11728237|FG000|COMPLETED|Period II||39
10573117|NCT01669122|11728237|FG000|NOT COMPLETED|Period II||0
10573118|NCT01669122|11728237|FG000|STARTED|Washout Period II||39
10573119|NCT01669122|11728237|FG000|COMPLETED|Washout Period II||37
10573120|NCT01669122|11728237|FG000|NOT COMPLETED|Washout Period II||2
10573121|NCT01669122|11728237|FG000|STARTED|Washout Period III||37
10573122|NCT01669122|11728237|FG000|COMPLETED|Washout Period III||37
10573123|NCT01669122|11728237|FG000|NOT COMPLETED|Washout Period III||0
10573124|NCT01669122|11728237|FG000|STARTED|Period III|Participants who received Lozenge A=10, Lozenge B=8, Lozenge C=10, Reference Lozenge=9|37
10573125|NCT01669122|11728237|FG000|COMPLETED|Period III||37
10795001|NCT03629535|11955404|FG000|NOT COMPLETED|Overall Study||0
10795002|NCT03629886|11955410|FG000|STARTED|Overall Study||1671
10795003|NCT03629886|11955411|FG001|STARTED|Overall Study||1866
10795004|NCT03629886|11955410|FG000|COMPLETED|Overall Study||1671
10795005|NCT03629886|11955411|FG001|COMPLETED|Overall Study||1686
10573126|NCT01669122|11728237|FG000|NOT COMPLETED|Period III||0
10573215|NCT01669785|11728356|FG001|NOT COMPLETED|Overall Study||0
10573127|NCT01669122|11728237|FG000|STARTED|Period IV|Participants who received Lozenge A=9, Lozenge B=10, Lozenge C=9, Reference Lozenge=9|37
10573128|NCT01669122|11728237|FG000|COMPLETED|Period IV||37
10573129|NCT01669122|11728237|FG000|NOT COMPLETED|Period IV||0
10573130|NCT01669174|11728250|FG000|STARTED|Overall Study||33
10573131|NCT01669174|11728251|FG001|STARTED|Overall Study||34
10573132|NCT01669174|11728250|FG000|COMPLETED|Overall Study||27
10573133|NCT01669174|11728251|FG001|COMPLETED|Overall Study||28
10573134|NCT01669174|11728250|FG000|NOT COMPLETED|Overall Study||6
10573135|NCT01669174|11728251|FG001|NOT COMPLETED|Overall Study||6
10573136|NCT01669343|11728257|FG000|STARTED|Part A: All Patients||121
10795006|NCT03629886|11955410|FG000|NOT COMPLETED|Overall Study||0
10573137|NCT01669343|11728257|FG000|COMPLETED|Part A: All Patients||112
10573138|NCT01669343|11728257|FG000|NOT COMPLETED|Part A: All Patients||9
10573139|NCT01669343|11728257|FG000|STARTED|Part B: Patients With BMI>=25||48
10573140|NCT01669343|11728257|FG000|COMPLETED|Part B: Patients With BMI>=25||31
10573141|NCT01669343|11728257|FG000|NOT COMPLETED|Part B: Patients With BMI>=25||17
10573142|NCT01669421|11728264|FG000|STARTED|Phase 1: Standard Dose Therapy||10
10573143|NCT01669421|11728264|FG000|COMPLETED|Phase 1: Standard Dose Therapy||8
10573144|NCT01669421|11728264|FG000|NOT COMPLETED|Phase 1: Standard Dose Therapy||2
10573145|NCT01669421|11728264|FG000|STARTED|Phase 2: Double Dose Therapy||8
10573146|NCT01669421|11728264|FG000|COMPLETED|Phase 2: Double Dose Therapy||8
10573147|NCT01669421|11728264|FG000|NOT COMPLETED|Phase 2: Double Dose Therapy||0
10573148|NCT01669421|11728264|FG000|STARTED|Phase 3: Standard Dose Therapy||8
10573149|NCT01669421|11728264|FG000|COMPLETED|Phase 3: Standard Dose Therapy||8
10573150|NCT01669421|11728264|FG000|NOT COMPLETED|Phase 3: Standard Dose Therapy||0
10573151|NCT01669434|11728280|FG000|STARTED|Overall Study||146
10573152|NCT01669434|11728281|FG001|STARTED|Overall Study||145
10573153|NCT01669434|11728280|FG000|COMPLETED|Overall Study||137
10573154|NCT01669434|11728281|FG001|COMPLETED|Overall Study||138
10573155|NCT01669434|11728280|FG000|NOT COMPLETED|Overall Study||9
10573156|NCT01669434|11728281|FG001|NOT COMPLETED|Overall Study||7
10573157|NCT01669538|11728289|FG000|STARTED|Overall Study||40
10573158|NCT01669538|11728290|FG001|STARTED|Overall Study||42
10573159|NCT01669538|11728289|FG000|COMPLETED|Overall Study||28
10573160|NCT01669538|11728290|FG001|COMPLETED|Overall Study||33
10573161|NCT01669538|11728289|FG000|NOT COMPLETED|Overall Study||12
10573162|NCT01669538|11728290|FG001|NOT COMPLETED|Overall Study||9
10573163|NCT01669577|11728296|FG000|STARTED|Overall Study|calculated ISS<16, no informed consent, not enough data(complete case analysis), were excluded|334
10573164|NCT01669577|11728296|FG000|COMPLETED|Overall Study|complete case analysis (data missing completely at random)|200
10573165|NCT01669577|11728296|FG000|NOT COMPLETED|Overall Study||134
10573166|NCT01669603|11728302|FG000|STARTED|Overall Study||95
10573167|NCT01669603|11728303|FG001|STARTED|Overall Study||95
10573168|NCT01669603|11728302|FG000|COMPLETED|Overall Study||58
10573169|NCT01669603|11728303|FG001|COMPLETED|Overall Study||57
10573170|NCT01669603|11728302|FG000|NOT COMPLETED|Overall Study||37
10573171|NCT01669603|11728303|FG001|NOT COMPLETED|Overall Study||38
10573172|NCT01669629|11728309|FG000|STARTED|Period 1||92
10573173|NCT01669629|11728310|FG001|STARTED|Period 1||91
10573174|NCT01669629|11728309|FG000|COMPLETED|Period 1||91
10573175|NCT01669629|11728310|FG001|COMPLETED|Period 1||89
10573176|NCT01669629|11728309|FG000|NOT COMPLETED|Period 1||1
10573177|NCT01669629|11728310|FG001|NOT COMPLETED|Period 1||2
10573178|NCT01669629|11728309|FG000|STARTED|Period 2||91
10573179|NCT01669629|11728310|FG001|STARTED|Period 2||89
10573180|NCT01669629|11728309|FG000|COMPLETED|Period 2||91
10573181|NCT01669629|11728310|FG001|COMPLETED|Period 2||89
10573182|NCT01669629|11728309|FG000|NOT COMPLETED|Period 2||0
10573183|NCT01669629|11728310|FG001|NOT COMPLETED|Period 2||0
10573184|NCT01669642|11728321|FG000|STARTED|Overall Study||20
10573185|NCT01669642|11728322|FG001|STARTED|Overall Study||20
10573186|NCT01669642|11728323|FG002|STARTED|Overall Study||20
10573187|NCT01669642|11728324|FG003|STARTED|Overall Study||21
10573188|NCT01669642|11728325|FG004|STARTED|Overall Study||20
10573189|NCT01669642|11728326|FG005|STARTED|Overall Study||10
10573190|NCT01669642|11728321|FG000|COMPLETED|Overall Study||20
10573191|NCT01669642|11728322|FG001|COMPLETED|Overall Study||20
10573192|NCT01669642|11728323|FG002|COMPLETED|Overall Study||20
10573193|NCT01669642|11728324|FG003|COMPLETED|Overall Study||20
10573194|NCT01669642|11728325|FG004|COMPLETED|Overall Study||20
10573195|NCT01669642|11728326|FG005|COMPLETED|Overall Study||0
10573196|NCT01669642|11728321|FG000|NOT COMPLETED|Overall Study||0
10573197|NCT01669642|11728322|FG001|NOT COMPLETED|Overall Study||0
10573198|NCT01669642|11728323|FG002|NOT COMPLETED|Overall Study||0
10573199|NCT01669642|11728324|FG003|NOT COMPLETED|Overall Study||1
10573200|NCT01669642|11728325|FG004|NOT COMPLETED|Overall Study||0
10573201|NCT01669642|11728326|FG005|NOT COMPLETED|Overall Study||10
10573202|NCT01669720|11728345|FG000|STARTED|Overall Study||7
10573203|NCT01669720|11728346|FG001|STARTED|Overall Study||3
10573204|NCT01669720|11728345|FG000|COMPLETED|Overall Study||7
10573205|NCT01669720|11728346|FG001|COMPLETED|Overall Study||3
10573206|NCT01669720|11728345|FG000|NOT COMPLETED|Overall Study||0
10573207|NCT01669720|11728346|FG001|NOT COMPLETED|Overall Study||0
10573208|NCT01669785|11728355|FG000|STARTED|Overall Study||45
10573209|NCT01669785|11728356|FG001|STARTED|Overall Study||48
10573210|NCT01669785|11728357|FG002|STARTED|Overall Study||46
10573211|NCT01669785|11728355|FG000|COMPLETED|Overall Study||45
10573212|NCT01669785|11728356|FG001|COMPLETED|Overall Study||48
10573213|NCT01669785|11728357|FG002|COMPLETED|Overall Study||46
10573214|NCT01669785|11728355|FG000|NOT COMPLETED|Overall Study||0
10573216|NCT01669785|11728357|FG002|NOT COMPLETED|Overall Study||0
10573217|NCT01669798|11728366|FG000|STARTED|Overall Study||32
10573218|NCT01669798|11728366|FG000|COMPLETED|Overall Study||27
10573219|NCT01669798|11728366|FG000|NOT COMPLETED|Overall Study||5
10573220|NCT01669811|11728372|FG000|STARTED|Overall Study||145
10573221|NCT01669811|11728373|FG001|STARTED|Overall Study||142
10573222|NCT01669811|11728372|FG000|COMPLETED|Overall Study||142
10573223|NCT01669811|11728373|FG001|COMPLETED|Overall Study||131
10573224|NCT01669811|11728372|FG000|NOT COMPLETED|Overall Study||3
10573225|NCT01669811|11728373|FG001|NOT COMPLETED|Overall Study||11
10573226|NCT01669863|11728379|FG000|STARTED|Overall Study||6
10573227|NCT01669863|11728379|FG000|COMPLETED|Overall Study||6
10573228|NCT01669863|11728379|FG000|NOT COMPLETED|Overall Study||0
10573229|NCT01669902|11728384|FG000|STARTED|Overall Study||107
10573230|NCT01669902|11728384|FG000|COMPLETED|Overall Study||78
10573231|NCT01669902|11728384|FG000|NOT COMPLETED|Overall Study||29
10573232|NCT01669928|11728390|FG000|STARTED|First Intervention||51
10573233|NCT01669928|11728391|FG001|STARTED|First Intervention||52
10573234|NCT01669928|11728390|FG000|COMPLETED|First Intervention||48
10573235|NCT01669928|11728391|FG001|COMPLETED|First Intervention||47
10573236|NCT01669928|11728390|FG000|NOT COMPLETED|First Intervention||3
10573237|NCT01669928|11728391|FG001|NOT COMPLETED|First Intervention||5
10573238|NCT01669928|11728390|FG000|STARTED|Second Intervention||48
10573239|NCT01669928|11728391|FG001|STARTED|Second Intervention||47
10573240|NCT01669928|11728390|FG000|COMPLETED|Second Intervention||48
10573241|NCT01669928|11728391|FG001|COMPLETED|Second Intervention||47
10573242|NCT01669928|11728390|FG000|NOT COMPLETED|Second Intervention||0
10573243|NCT01669928|11728391|FG001|NOT COMPLETED|Second Intervention||0
10573244|NCT01670019|11728401|FG000|STARTED|Overall Study||23
10573245|NCT01670019|11728402|FG001|STARTED|Overall Study||23
10573246|NCT01670019|11728401|FG000|COMPLETED|Overall Study||14
10573247|NCT01670019|11728402|FG001|COMPLETED|Overall Study||23
10573248|NCT01670019|11728401|FG000|NOT COMPLETED|Overall Study||9
10573249|NCT01670019|11728402|FG001|NOT COMPLETED|Overall Study||0
10573250|NCT01670045|11728408|FG000|STARTED|Overall Study||43
10573251|NCT01670045|11728408|FG000|COMPLETED|Overall Study||27
10573252|NCT01670045|11728408|FG000|NOT COMPLETED|Overall Study||16
10573253|NCT01670097|11728414|FG000|STARTED|Overall Study||20
10573254|NCT01670097|11728415|FG001|STARTED|Overall Study||21
10573255|NCT01670097|11728414|FG000|Completed Week 1 Intervention|Overall Study||18
10573256|NCT01670097|11728415|FG001|Completed Week 1 Intervention|Overall Study||17
10573257|NCT01670097|11728414|FG000|Completed Week 2 Intervention|Overall Study||13
10573258|NCT01670097|11728415|FG001|Completed Week 2 Intervention|Overall Study||15
10573259|NCT01670097|11728414|FG000|COMPLETED|Overall Study||18
10573260|NCT01670097|11728415|FG001|COMPLETED|Overall Study||17
10573261|NCT01670097|11728414|FG000|NOT COMPLETED|Overall Study||2
10573262|NCT01670097|11728415|FG001|NOT COMPLETED|Overall Study||4
10573263|NCT01670110|11728423|FG000|STARTED|Overall Study||33
10573264|NCT01670110|11728424|FG001|STARTED|Overall Study||15
10795007|NCT03629886|11955411|FG001|NOT COMPLETED|Overall Study||180
10795008|NCT03629925|11955420|FG000|STARTED|Overall Study||179
10795009|NCT03629925|11955421|FG001|STARTED|Overall Study||178
10795010|NCT03629925|11955420|FG000|COMPLETED|Overall Study||0
10795011|NCT03629925|11955421|FG001|COMPLETED|Overall Study||0
10795012|NCT03629925|11955420|FG000|NOT COMPLETED|Overall Study||179
10795013|NCT03629925|11955421|FG001|NOT COMPLETED|Overall Study||178
10795014|NCT03630016|11955427|FG000|STARTED|Overall Study||11
10795015|NCT03630016|11955427|FG000|COMPLETED|Overall Study||10
10795016|NCT03630016|11955427|FG000|NOT COMPLETED|Overall Study||1
10795017|NCT03630185|11955433|FG000|STARTED|Overall Study||4
10795018|NCT03630185|11955434|FG001|STARTED|Overall Study||4
10795019|NCT03630185|11955433|FG000|30 Day Follow up|Overall Study||1
10795020|NCT03630185|11955434|FG001|30 Day Follow up|Overall Study||1
10795021|NCT03630185|11955433|FG000|90 Day Follow up|Overall Study||0
10795022|NCT03630185|11955434|FG001|90 Day Follow up|Overall Study||1
10795023|NCT03630185|11955433|FG000|6 Month Follow up|Overall Study||0
10795024|NCT03630185|11955434|FG001|6 Month Follow up|Overall Study||0
10795025|NCT03630185|11955433|FG000|COMPLETED|Overall Study||0
10795026|NCT03630185|11955434|FG001|COMPLETED|Overall Study||0
10573265|NCT01670110|11728423|FG000|COMPLETED|Overall Study||29
10573266|NCT01670110|11728424|FG001|COMPLETED|Overall Study||12
10573267|NCT01670110|11728423|FG000|NOT COMPLETED|Overall Study||4
10573268|NCT01670110|11728424|FG001|NOT COMPLETED|Overall Study||3
10573269|NCT01670188|11728432|FG000|STARTED|Overall Study||38
10573270|NCT01670188|11728433|FG001|STARTED|Overall Study||40
10573271|NCT01670188|11728432|FG000|COMPLETED|Overall Study||38
10573272|NCT01670188|11728433|FG001|COMPLETED|Overall Study||39
10795027|NCT03630185|11955433|FG000|NOT COMPLETED|Overall Study||4
10795028|NCT03630185|11955434|FG001|NOT COMPLETED|Overall Study||4
10795029|NCT03630198|11955442|FG000|STARTED|Overall Study||13
10795030|NCT03630198|11955443|FG001|STARTED|Overall Study||18
10573273|NCT01670188|11728432|FG000|NOT COMPLETED|Overall Study||0
10573274|NCT01670188|11728433|FG001|NOT COMPLETED|Overall Study||1
10573275|NCT01670201|11728439|FG000|STARTED|Overall Study||8
10573276|NCT01670201|11728439|FG000|COMPLETED|Overall Study||8
10573277|NCT01670201|11728439|FG000|NOT COMPLETED|Overall Study||0
10573278|NCT01670279|11728446|FG000|STARTED|Overall Study||6
10795031|NCT03630198|11955442|FG000|COMPLETED|Overall Study||13
10795032|NCT03630198|11955443|FG001|COMPLETED|Overall Study||18
10795033|NCT03630198|11955442|FG000|NOT COMPLETED|Overall Study||0
10795034|NCT03630198|11955443|FG001|NOT COMPLETED|Overall Study||0
10795035|NCT03630302|11955449|FG000|STARTED|Surgery||10
10573279|NCT01670279|11728447|FG001|STARTED|Overall Study||7
10573280|NCT01670279|11728448|FG002|STARTED|Overall Study||0
10573281|NCT01670279|11728449|FG003|STARTED|Overall Study||5
10573282|NCT01670279|11728446|FG000|COMPLETED|Overall Study||6
10573283|NCT01670279|11728447|FG001|COMPLETED|Overall Study||5
10573284|NCT01670279|11728448|FG002|COMPLETED|Overall Study||0
10573285|NCT01670279|11728449|FG003|COMPLETED|Overall Study||4
10573286|NCT01670279|11728446|FG000|NOT COMPLETED|Overall Study||0
10573287|NCT01670279|11728447|FG001|NOT COMPLETED|Overall Study||2
10573288|NCT01670279|11728448|FG002|NOT COMPLETED|Overall Study||0
10573289|NCT01670279|11728449|FG003|NOT COMPLETED|Overall Study||1
10573290|NCT01670292|11728457|FG000|STARTED|Overall Study||82
10573291|NCT01670292|11728457|FG000|COMPLETED|Overall Study||68
10573292|NCT01670292|11728457|FG000|NOT COMPLETED|Overall Study||14
10573293|NCT01670487|11728471|FG000|STARTED|Overall Study||150
10573294|NCT01670487|11728472|FG001|STARTED|Overall Study||150
10573295|NCT01670487|11728471|FG000|COMPLETED|Overall Study||150
10573296|NCT01670487|11728472|FG001|COMPLETED|Overall Study||150
10573297|NCT01670487|11728471|FG000|NOT COMPLETED|Overall Study||0
10573298|NCT01670487|11728472|FG001|NOT COMPLETED|Overall Study||0
10573299|NCT01670526|11728480|FG000|STARTED|Overall Study||49
10573300|NCT01670526|11728481|FG001|STARTED|Overall Study||45
10573301|NCT01670526|11728480|FG000|COMPLETED|Overall Study||37
10573302|NCT01670526|11728481|FG001|COMPLETED|Overall Study||39
10573303|NCT01670526|11728480|FG000|NOT COMPLETED|Overall Study||12
10573304|NCT01670526|11728481|FG001|NOT COMPLETED|Overall Study||6
10573305|NCT01670721|11728487|FG000|STARTED|Overall Study||175
10573306|NCT01670721|11728487|FG000|COMPLETED|Overall Study|81 participants with DP and 41 with adverse events were considered as completed.|122
10573307|NCT01670721|11728487|FG000|NOT COMPLETED|Overall Study||53
10573308|NCT01670760|11728491|FG000|STARTED|Overall Study||20
10573309|NCT01670760|11728491|FG000|COMPLETED|Overall Study||20
10573310|NCT01670760|11728491|FG000|NOT COMPLETED|Overall Study||0
10573311|NCT01670825|11728497|FG000|STARTED|Overall Study||42
10573312|NCT01670825|11728498|FG001|STARTED|Overall Study||39
10573313|NCT01670825|11728497|FG000|COMPLETED|Overall Study||42
10573314|NCT01670825|11728498|FG001|COMPLETED|Overall Study||39
10573315|NCT01670825|11728497|FG000|NOT COMPLETED|Overall Study||0
10573316|NCT01670825|11728498|FG001|NOT COMPLETED|Overall Study||0
10573317|NCT01671007|11728515|FG000|STARTED|Overall Study||2089
10573318|NCT01671007|11728516|FG001|STARTED|Overall Study||2834
10573319|NCT01671007|11728517|FG002|STARTED|Overall Study||2033
10573320|NCT01671007|11728518|FG003|STARTED|Overall Study||2214
10573321|NCT01671007|11728519|FG004|STARTED|Overall Study||180
10573322|NCT01671007|11728520|FG005|STARTED|Overall Study||513
10573323|NCT01671007|11728521|FG006|STARTED|Overall Study||80
10573324|NCT01671007|11728522|FG007|STARTED|Overall Study||526
10573325|NCT01671007|11728523|FG008|STARTED|Overall Study||2
10573326|NCT01671007|11728515|FG000|All Eligible|Overall Study||2066
10573327|NCT01671007|11728516|FG001|All Eligible|Overall Study||2758
10573328|NCT01671007|11728517|FG002|All Eligible|Overall Study||2008
10573329|NCT01671007|11728518|FG003|All Eligible|Overall Study||2197
10573330|NCT01671007|11728519|FG004|All Eligible|Overall Study||180
10573331|NCT01671007|11728520|FG005|All Eligible|Overall Study||507
10573332|NCT01671007|11728521|FG006|All Eligible|Overall Study||79
10573333|NCT01671007|11728522|FG007|All Eligible|Overall Study||507
10573334|NCT01671007|11728523|FG008|All Eligible|Overall Study||2
10573335|NCT01671007|11728515|FG000|COMPLETED|Overall Study||1768
10573336|NCT01671007|11728516|FG001|COMPLETED|Overall Study||2183
10573337|NCT01671007|11728517|FG002|COMPLETED|Overall Study||1667
10573338|NCT01671007|11728518|FG003|COMPLETED|Overall Study||1846
10573339|NCT01671007|11728519|FG004|COMPLETED|Overall Study||155
10573340|NCT01671007|11728520|FG005|COMPLETED|Overall Study||401
10573341|NCT01671007|11728521|FG006|COMPLETED|Overall Study||59
10573342|NCT01671007|11728522|FG007|COMPLETED|Overall Study||394
10573343|NCT01671007|11728523|FG008|COMPLETED|Overall Study||2
10573344|NCT01671007|11728515|FG000|NOT COMPLETED|Overall Study||321
10573345|NCT01671007|11728516|FG001|NOT COMPLETED|Overall Study||651
10573346|NCT01671007|11728517|FG002|NOT COMPLETED|Overall Study||366
10573347|NCT01671007|11728518|FG003|NOT COMPLETED|Overall Study||368
10573348|NCT01671007|11728519|FG004|NOT COMPLETED|Overall Study||25
10573349|NCT01671007|11728520|FG005|NOT COMPLETED|Overall Study||112
10573350|NCT01671007|11728521|FG006|NOT COMPLETED|Overall Study||21
10573351|NCT01671007|11728522|FG007|NOT COMPLETED|Overall Study||132
10573352|NCT01671007|11728523|FG008|NOT COMPLETED|Overall Study||0
10573353|NCT01671059|11728534|FG000|STARTED|Overall Study||80
10573354|NCT01671059|11728534|FG000|COMPLETED|Overall Study||75
10573355|NCT01671059|11728534|FG000|NOT COMPLETED|Overall Study||5
10651383|NCT02175758|11811576|FG004|COMPLETED|PK Lead-in Phase||4
10651384|NCT02175758|11811577|FG005|COMPLETED|PK Lead-in Phase||8
10651385|NCT02175758|11811572|FG000|NOT COMPLETED|PK Lead-in Phase||0
10651386|NCT02175758|11811573|FG001|NOT COMPLETED|PK Lead-in Phase||0
10651387|NCT02175758|11811574|FG002|NOT COMPLETED|PK Lead-in Phase||0
10651388|NCT02175758|11811575|FG003|NOT COMPLETED|PK Lead-in Phase||0
10651389|NCT02175758|11811576|FG004|NOT COMPLETED|PK Lead-in Phase||0
10651390|NCT02175758|11811577|FG005|NOT COMPLETED|PK Lead-in Phase||0
10651391|NCT02175758|11811572|FG000|STARTED|Treatment Phase|9 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|13
10651392|NCT02175758|11811573|FG001|STARTED|Treatment Phase|33 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|39
10651393|NCT02175758|11811574|FG002|STARTED|Treatment Phase|11 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|13
10573356|NCT01671085|11728541|FG000|STARTED|Overall Study|1 participant who dropped out was replaced.|11
10573357|NCT01671085|11728542|FG001|STARTED|Overall Study||2
10573358|NCT01671085|11728541|FG000|Received at Least 1 Dose of Study Drug|Overall Study||11
10573359|NCT01671085|11728542|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2
10573360|NCT01671085|11728541|FG000|COMPLETED|Overall Study||10
10573361|NCT01671085|11728542|FG001|COMPLETED|Overall Study||2
10573362|NCT01671085|11728541|FG000|NOT COMPLETED|Overall Study||1
10573363|NCT01671085|11728542|FG001|NOT COMPLETED|Overall Study||0
10573364|NCT01671111|11728549|FG000|STARTED|Overall Study||30
10573365|NCT01671111|11728549|FG000|COMPLETED|Overall Study||0
10573366|NCT01671111|11728549|FG000|NOT COMPLETED|Overall Study||30
10573367|NCT01671176|11728553|FG000|STARTED|Overall Study||30
10573368|NCT01671176|11728553|FG000|COMPLETED|Overall Study||30
10573369|NCT01671176|11728553|FG000|NOT COMPLETED|Overall Study||0
10573370|NCT01671280|11728557|FG000|STARTED|Overall Study|The number is enrollment.|403
10573371|NCT01671280|11728557|FG000|COMPLETED|Overall Study||401
10573372|NCT01671280|11728557|FG000|NOT COMPLETED|Overall Study||2
10573373|NCT01671293|11728563|FG000|STARTED|Overall Study||36
10573374|NCT01671293|11728564|FG001|STARTED|Overall Study||34
10573375|NCT01671293|11728563|FG000|COMPLETED|Overall Study||33
10573376|NCT01671293|11728564|FG001|COMPLETED|Overall Study||32
10573377|NCT01671293|11728563|FG000|NOT COMPLETED|Overall Study||3
10573378|NCT01671293|11728564|FG001|NOT COMPLETED|Overall Study||2
10573379|NCT01671319|11728570|FG000|STARTED|Overall Study||42
10573380|NCT01671319|11728570|FG000|COMPLETED|Overall Study||41
10573381|NCT01671319|11728570|FG000|NOT COMPLETED|Overall Study||1
10573382|NCT01671332|11728576|FG000|STARTED|Overall Study||40
10573383|NCT01671332|11728577|FG001|STARTED|Overall Study||40
10573384|NCT01671332|11728576|FG000|Crossed Over to Docetaxel Plus Suramin|Overall Study||0
10573385|NCT01671332|11728577|FG001|Crossed Over to Docetaxel Plus Suramin|Overall Study|Participants with disease progression on Docetaxel Arm were allowed to crossover to Suramin.|13
10573386|NCT01671332|11728576|FG000|COMPLETED|Overall Study||39
10573387|NCT01671332|11728577|FG001|COMPLETED|Overall Study||39
10573388|NCT01671332|11728576|FG000|NOT COMPLETED|Overall Study||1
10573389|NCT01671332|11728577|FG001|NOT COMPLETED|Overall Study||1
10573390|NCT01671345|11728585|FG000|STARTED|Overall Study||77
10573391|NCT01671345|11728586|FG001|STARTED|Overall Study||92
10573392|NCT01671345|11728585|FG000|COMPLETED|Overall Study||64
10573393|NCT01671345|11728586|FG001|COMPLETED|Overall Study||83
10573394|NCT01671345|11728585|FG000|NOT COMPLETED|Overall Study||13
10573395|NCT01671345|11728586|FG001|NOT COMPLETED|Overall Study||9
10573396|NCT01671423|11728597|FG000|STARTED|Overall Study||20
10573397|NCT01671423|11728598|FG001|STARTED|Overall Study||20
10573398|NCT01671423|11728597|FG000|COMPLETED|Overall Study||14
10795036|NCT03630302|11955449|FG000|COMPLETED|Surgery||9
10795037|NCT03630302|11955449|FG000|NOT COMPLETED|Surgery||1
10795038|NCT03630302|11955449|FG000|STARTED|3 Month Visit||9
10795039|NCT03630302|11955449|FG000|COMPLETED|3 Month Visit||7
10795040|NCT03630302|11955449|FG000|NOT COMPLETED|3 Month Visit||2
10573399|NCT01671423|11728598|FG001|COMPLETED|Overall Study||9
10573400|NCT01671423|11728597|FG000|NOT COMPLETED|Overall Study||6
10573401|NCT01671423|11728598|FG001|NOT COMPLETED|Overall Study||11
10573402|NCT01671488|11728604|FG000|STARTED|Overall Study||11
10573403|NCT01671488|11728604|FG000|COMPLETED|Overall Study||10
10573404|NCT01671488|11728604|FG000|NOT COMPLETED|Overall Study||1
10573405|NCT01671605|11728610|FG000|STARTED|Overall Study||72
10573406|NCT01671605|11728611|FG001|STARTED|Overall Study||31
10573407|NCT01671605|11728610|FG000|COMPLETED|Overall Study||72
10573408|NCT01671605|11728611|FG001|COMPLETED|Overall Study||31
10573409|NCT01671605|11728610|FG000|NOT COMPLETED|Overall Study||0
10573410|NCT01671605|11728611|FG001|NOT COMPLETED|Overall Study||0
10573411|NCT01671748|11728619|FG000|STARTED|4 Week run-in Phase||47
10573412|NCT01671748|11728620|FG001|STARTED|4 Week run-in Phase||0
10573413|NCT01671748|11728619|FG000|COMPLETED|4 Week run-in Phase||36
10573414|NCT01671748|11728620|FG001|COMPLETED|4 Week run-in Phase||0
10573415|NCT01671748|11728619|FG000|NOT COMPLETED|4 Week run-in Phase||11
10573416|NCT01671748|11728620|FG001|NOT COMPLETED|4 Week run-in Phase||0
10573417|NCT01671748|11728619|FG000|STARTED|12 Week Treatment Phase||19
10573418|NCT01671748|11728620|FG001|STARTED|12 Week Treatment Phase||17
10573419|NCT01671748|11728619|FG000|COMPLETED|12 Week Treatment Phase||19
10573420|NCT01671748|11728620|FG001|COMPLETED|12 Week Treatment Phase||17
10573421|NCT01671748|11728619|FG000|NOT COMPLETED|12 Week Treatment Phase||0
10573422|NCT01671748|11728620|FG001|NOT COMPLETED|12 Week Treatment Phase||0
10573423|NCT01671839|11728626|FG000|STARTED|Overall Study||55
10573424|NCT01671839|11728626|FG000|3-year Follow-up|Overall Study||45
10573425|NCT01671839|11728626|FG000|5-year Follow-up|Overall Study||37
10573426|NCT01671839|11728626|FG000|COMPLETED|Overall Study||37
10573427|NCT01671839|11728626|FG000|NOT COMPLETED|Overall Study||18
10573428|NCT01672294|11728637|FG000|STARTED|Overall Study||71
10573429|NCT01672294|11728638|FG001|STARTED|Overall Study||71
10573430|NCT01672294|11728639|FG002|STARTED|Overall Study||72
10573431|NCT01672294|11728640|FG003|STARTED|Overall Study||72
10573432|NCT01672294|11728637|FG000|COMPLETED|Overall Study||65
10573433|NCT01672294|11728638|FG001|COMPLETED|Overall Study||50
10795041|NCT03630302|11955449|FG000|STARTED|Data Post Analyses||7
10573434|NCT01672294|11728639|FG002|COMPLETED|Overall Study||61
10573435|NCT01672294|11728640|FG003|COMPLETED|Overall Study||59
10573436|NCT01672294|11728637|FG000|NOT COMPLETED|Overall Study||6
10573437|NCT01672294|11728638|FG001|NOT COMPLETED|Overall Study||21
10795042|NCT03630302|11955449|FG000|COMPLETED|Data Post Analyses||5
10573438|NCT01672294|11728639|FG002|NOT COMPLETED|Overall Study||11
10573439|NCT01672294|11728640|FG003|NOT COMPLETED|Overall Study||13
10573440|NCT01672658|11728652|FG000|STARTED|Overall Study||16
10573441|NCT01672658|11728653|FG001|STARTED|Overall Study||15
10573442|NCT01672658|11728652|FG000|COMPLETED|Overall Study||16
10573443|NCT01672658|11728653|FG001|COMPLETED|Overall Study||14
10573444|NCT01672658|11728652|FG000|NOT COMPLETED|Overall Study||0
10573445|NCT01672658|11728653|FG001|NOT COMPLETED|Overall Study||1
10573446|NCT01672710|11728661|FG000|STARTED|Controlled Comparison 5 Week Follow-up||22
10573447|NCT01672710|11728662|FG001|STARTED|Controlled Comparison 5 Week Follow-up||10
10573448|NCT01672710|11728661|FG000|COMPLETED|Controlled Comparison 5 Week Follow-up|sauna intervention group repeat all assessments 7 days after complete the regimen|22
10573449|NCT01672710|11728662|FG001|COMPLETED|Controlled Comparison 5 Week Follow-up|waitlist group repeat baseline assessments after 4 week time period then begin sauna|10
10573450|NCT01672710|11728661|FG000|NOT COMPLETED|Controlled Comparison 5 Week Follow-up||0
10573451|NCT01672710|11728662|FG001|NOT COMPLETED|Controlled Comparison 5 Week Follow-up||0
10573452|NCT01672710|11728661|FG000|STARTED|Waitlist Assessed After Sauna Regimen|immediate start group no further assessments until 3 month follow up|22
10573453|NCT01672710|11728662|FG001|STARTED|Waitlist Assessed After Sauna Regimen|waitlisted group receive the 4 week intervention and complete 7 day assessments|10
10573454|NCT01672710|11728661|FG000|COMPLETED|Waitlist Assessed After Sauna Regimen|non applicable, cannot compare the immediate start and waitlist in this period|22
10573455|NCT01672710|11728662|FG001|COMPLETED|Waitlist Assessed After Sauna Regimen||9
10573456|NCT01672710|11728661|FG000|NOT COMPLETED|Waitlist Assessed After Sauna Regimen||0
10573457|NCT01672710|11728662|FG001|NOT COMPLETED|Waitlist Assessed After Sauna Regimen||1
10573458|NCT01672710|11728661|FG000|STARTED|3 Month Follow up||22
10573459|NCT01672710|11728662|FG001|STARTED|3 Month Follow up||9
10573460|NCT01672710|11728661|FG000|COMPLETED|3 Month Follow up||16
10573461|NCT01672710|11728662|FG001|COMPLETED|3 Month Follow up||5
10573462|NCT01672710|11728661|FG000|NOT COMPLETED|3 Month Follow up||6
10573463|NCT01672710|11728662|FG001|NOT COMPLETED|3 Month Follow up||4
10573464|NCT01672723|11728668|FG000|STARTED|First Intervention||19
10573465|NCT01672723|11728669|FG001|STARTED|First Intervention||15
10573466|NCT01672723|11728668|FG000|COMPLETED|First Intervention||16
10573467|NCT01672723|11728669|FG001|COMPLETED|First Intervention||15
10573468|NCT01672723|11728668|FG000|NOT COMPLETED|First Intervention||3
10573469|NCT01672723|11728669|FG001|NOT COMPLETED|First Intervention||0
10573470|NCT01672723|11728668|FG000|STARTED|Washout Period of 10 Days||16
10573471|NCT01672723|11728669|FG001|STARTED|Washout Period of 10 Days||15
10573472|NCT01672723|11728668|FG000|COMPLETED|Washout Period of 10 Days||16
10573473|NCT01672723|11728669|FG001|COMPLETED|Washout Period of 10 Days||15
10573474|NCT01672723|11728668|FG000|NOT COMPLETED|Washout Period of 10 Days||0
10573475|NCT01672723|11728669|FG001|NOT COMPLETED|Washout Period of 10 Days||0
10573476|NCT01672723|11728668|FG000|STARTED|Second Intervention||16
10573477|NCT01672723|11728669|FG001|STARTED|Second Intervention||15
10573478|NCT01672723|11728668|FG000|COMPLETED|Second Intervention||16
10573479|NCT01672723|11728669|FG001|COMPLETED|Second Intervention||15
10573480|NCT01672723|11728668|FG000|NOT COMPLETED|Second Intervention||0
10573481|NCT01672723|11728669|FG001|NOT COMPLETED|Second Intervention||0
10573482|NCT01672736|11728675|FG000|STARTED|Overall Study|Phase I study part stopped early due to manufacturer's decision to stop further drug development.|19
10573483|NCT01672736|11728675|FG000|COMPLETED|Overall Study|3 patients taken off study due to non-availability of further study (Linsitinib) drug supply.|16
10573484|NCT01672736|11728675|FG000|NOT COMPLETED|Overall Study||3
10573485|NCT01672788|11728679|FG000|STARTED|Treatment Period 1 (3 Days)||9
10573486|NCT01672788|11728680|FG001|STARTED|Treatment Period 1 (3 Days)||9
10573487|NCT01672788|11728681|FG002|STARTED|Treatment Period 1 (3 Days)||9
10573488|NCT01672788|11728682|FG003|STARTED|Treatment Period 1 (3 Days)||9
10573489|NCT01672788|11728679|FG000|COMPLETED|Treatment Period 1 (3 Days)||9
10573490|NCT01672788|11728680|FG001|COMPLETED|Treatment Period 1 (3 Days)||9
10573491|NCT01672788|11728681|FG002|COMPLETED|Treatment Period 1 (3 Days)||9
10573492|NCT01672788|11728682|FG003|COMPLETED|Treatment Period 1 (3 Days)||9
10573493|NCT01672788|11728679|FG000|NOT COMPLETED|Treatment Period 1 (3 Days)||0
10573494|NCT01672788|11728680|FG001|NOT COMPLETED|Treatment Period 1 (3 Days)||0
10573495|NCT01672788|11728681|FG002|NOT COMPLETED|Treatment Period 1 (3 Days)||0
10573496|NCT01672788|11728682|FG003|NOT COMPLETED|Treatment Period 1 (3 Days)||0
10573497|NCT01672788|11728679|FG000|STARTED|Washout Period 1 (7 Days)||9
10573498|NCT01672788|11728680|FG001|STARTED|Washout Period 1 (7 Days)||9
10573499|NCT01672788|11728681|FG002|STARTED|Washout Period 1 (7 Days)||9
10573500|NCT01672788|11728682|FG003|STARTED|Washout Period 1 (7 Days)||9
10573501|NCT01672788|11728679|FG000|COMPLETED|Washout Period 1 (7 Days)||9
10573502|NCT01672788|11728680|FG001|COMPLETED|Washout Period 1 (7 Days)||9
10573503|NCT01672788|11728681|FG002|COMPLETED|Washout Period 1 (7 Days)||9
10573504|NCT01672788|11728682|FG003|COMPLETED|Washout Period 1 (7 Days)||9
10573505|NCT01672788|11728679|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
10573506|NCT01672788|11728680|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
10573507|NCT01672788|11728681|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
10573508|NCT01672788|11728682|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
10573509|NCT01672788|11728679|FG000|STARTED|Treatment Period 2 (3 Days)||9
10573510|NCT01672788|11728680|FG001|STARTED|Treatment Period 2 (3 Days)||9
10573511|NCT01672788|11728681|FG002|STARTED|Treatment Period 2 (3 Days)||9
10573512|NCT01672788|11728682|FG003|STARTED|Treatment Period 2 (3 Days)||9
10573513|NCT01672788|11728679|FG000|COMPLETED|Treatment Period 2 (3 Days)||9
10573514|NCT01672788|11728680|FG001|COMPLETED|Treatment Period 2 (3 Days)||9
10573515|NCT01672788|11728681|FG002|COMPLETED|Treatment Period 2 (3 Days)||9
10573516|NCT01672788|11728682|FG003|COMPLETED|Treatment Period 2 (3 Days)||9
10573517|NCT01672788|11728679|FG000|NOT COMPLETED|Treatment Period 2 (3 Days)||0
10573518|NCT01672788|11728680|FG001|NOT COMPLETED|Treatment Period 2 (3 Days)||0
10573519|NCT01672788|11728681|FG002|NOT COMPLETED|Treatment Period 2 (3 Days)||0
10573520|NCT01672788|11728682|FG003|NOT COMPLETED|Treatment Period 2 (3 Days)||0
10573521|NCT01672788|11728679|FG000|STARTED|Washout Period 2 (7 Days)||9
10573522|NCT01672788|11728680|FG001|STARTED|Washout Period 2 (7 Days)||9
10573523|NCT01672788|11728681|FG002|STARTED|Washout Period 2 (7 Days)||9
10573524|NCT01672788|11728682|FG003|STARTED|Washout Period 2 (7 Days)||9
10573525|NCT01672788|11728679|FG000|COMPLETED|Washout Period 2 (7 Days)||9
10573526|NCT01672788|11728680|FG001|COMPLETED|Washout Period 2 (7 Days)||9
10573527|NCT01672788|11728681|FG002|COMPLETED|Washout Period 2 (7 Days)||9
10573528|NCT01672788|11728682|FG003|COMPLETED|Washout Period 2 (7 Days)||8
10573529|NCT01672788|11728679|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
10573530|NCT01672788|11728680|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
10573531|NCT01672788|11728681|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
10573532|NCT01672788|11728682|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||1
10573533|NCT01672788|11728679|FG000|STARTED|Treatment Period 3 (3 Days)||9
10573534|NCT01672788|11728680|FG001|STARTED|Treatment Period 3 (3 Days)||9
10573535|NCT01672788|11728681|FG002|STARTED|Treatment Period 3 (3 Days)||9
10573536|NCT01672788|11728682|FG003|STARTED|Treatment Period 3 (3 Days)||8
10573537|NCT01672788|11728679|FG000|COMPLETED|Treatment Period 3 (3 Days)||9
10573538|NCT01672788|11728680|FG001|COMPLETED|Treatment Period 3 (3 Days)||9
10573539|NCT01672788|11728681|FG002|COMPLETED|Treatment Period 3 (3 Days)||9
10573540|NCT01672788|11728682|FG003|COMPLETED|Treatment Period 3 (3 Days)||8
10573541|NCT01672788|11728679|FG000|NOT COMPLETED|Treatment Period 3 (3 Days)||0
10573542|NCT01672788|11728680|FG001|NOT COMPLETED|Treatment Period 3 (3 Days)||0
10573543|NCT01672788|11728681|FG002|NOT COMPLETED|Treatment Period 3 (3 Days)||0
10573544|NCT01672788|11728682|FG003|NOT COMPLETED|Treatment Period 3 (3 Days)||0
10573545|NCT01672788|11728679|FG000|STARTED|Washout Period 3 (7 Days)||9
10573546|NCT01672788|11728680|FG001|STARTED|Washout Period 3 (7 Days)||9
10573547|NCT01672788|11728681|FG002|STARTED|Washout Period 3 (7 Days)||9
10573548|NCT01672788|11728682|FG003|STARTED|Washout Period 3 (7 Days)||8
10573549|NCT01672788|11728679|FG000|COMPLETED|Washout Period 3 (7 Days)||9
10573550|NCT01672788|11728680|FG001|COMPLETED|Washout Period 3 (7 Days)||9
10573551|NCT01672788|11728681|FG002|COMPLETED|Washout Period 3 (7 Days)||9
10573552|NCT01672788|11728682|FG003|COMPLETED|Washout Period 3 (7 Days)||8
10573553|NCT01672788|11728679|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
10573554|NCT01672788|11728680|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
10573555|NCT01672788|11728681|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
10573556|NCT01672788|11728682|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
10573557|NCT01672788|11728679|FG000|STARTED|Treatment Period 4 (3 Days)||9
10573558|NCT01672788|11728680|FG001|STARTED|Treatment Period 4 (3 Days)||9
10573559|NCT01672788|11728681|FG002|STARTED|Treatment Period 4 (3 Days)||9
10573560|NCT01672788|11728682|FG003|STARTED|Treatment Period 4 (3 Days)||8
10573561|NCT01672788|11728679|FG000|COMPLETED|Treatment Period 4 (3 Days)||9
10573562|NCT01672788|11728680|FG001|COMPLETED|Treatment Period 4 (3 Days)||9
10573563|NCT01672788|11728681|FG002|COMPLETED|Treatment Period 4 (3 Days)||9
10573564|NCT01672788|11728682|FG003|COMPLETED|Treatment Period 4 (3 Days)||8
10573565|NCT01672788|11728679|FG000|NOT COMPLETED|Treatment Period 4 (3 Days)||0
10573566|NCT01672788|11728680|FG001|NOT COMPLETED|Treatment Period 4 (3 Days)||0
10573567|NCT01672788|11728681|FG002|NOT COMPLETED|Treatment Period 4 (3 Days)||0
10573568|NCT01672788|11728682|FG003|NOT COMPLETED|Treatment Period 4 (3 Days)||0
10573569|NCT01672801|11728694|FG000|STARTED|Overall Study||9
10573570|NCT01672801|11728695|FG001|STARTED|Overall Study||9
10573571|NCT01672801|11728694|FG000|COMPLETED|Overall Study||9
10573572|NCT01672801|11728695|FG001|COMPLETED|Overall Study||8
10573573|NCT01672801|11728694|FG000|NOT COMPLETED|Overall Study||0
10573574|NCT01672801|11728695|FG001|NOT COMPLETED|Overall Study||1
10573575|NCT01672827|11728701|FG000|STARTED|Overall Study||276
10573576|NCT01672827|11728701|FG000|COMPLETED|Overall Study||276
10573577|NCT01672827|11728701|FG000|NOT COMPLETED|Overall Study||0
10573578|NCT01672853|11728710|FG000|STARTED|Overall Study||79
10573579|NCT01672853|11728711|FG001|STARTED|Overall Study||77
10795043|NCT03630302|11955449|FG000|NOT COMPLETED|Data Post Analyses||2
10795044|NCT03630679|11955455|FG000|STARTED|Overall Study||20
10795045|NCT03630679|11955456|FG001|STARTED|Overall Study||25
10573580|NCT01672853|11728712|FG002|STARTED|Overall Study||79
10573581|NCT01672853|11728710|FG000|COMPLETED|Overall Study||69
10573582|NCT01672853|11728711|FG001|COMPLETED|Overall Study||60
10573583|NCT01672853|11728712|FG002|COMPLETED|Overall Study||65
10795046|NCT03630679|11955455|FG000|COMPLETED|Overall Study||13
10573584|NCT01672853|11728710|FG000|NOT COMPLETED|Overall Study||10
10573585|NCT01672853|11728711|FG001|NOT COMPLETED|Overall Study||17
10573586|NCT01672853|11728712|FG002|NOT COMPLETED|Overall Study||14
10573587|NCT01672866|11728723|FG000|STARTED|Blinded Phase (up to 240 Weeks)||74
10573588|NCT01672866|11728724|FG001|STARTED|Blinded Phase (up to 240 Weeks)||74
10573589|NCT01672866|11728725|FG002|STARTED|Blinded Phase (up to 240 Weeks)||74
10573590|NCT01672866|11728723|FG000|COMPLETED|Blinded Phase (up to 240 Weeks)||0
10573591|NCT01672866|11728724|FG001|COMPLETED|Blinded Phase (up to 240 Weeks)||0
10573592|NCT01672866|11728725|FG002|COMPLETED|Blinded Phase (up to 240 Weeks)||0
10573593|NCT01672866|11728723|FG000|NOT COMPLETED|Blinded Phase (up to 240 Weeks)||74
10795047|NCT03630679|11955456|FG001|COMPLETED|Overall Study||13
10795048|NCT03630679|11955455|FG000|NOT COMPLETED|Overall Study||7
10573594|NCT01672866|11728724|FG001|NOT COMPLETED|Blinded Phase (up to 240 Weeks)||74
10573595|NCT01672866|11728725|FG002|NOT COMPLETED|Blinded Phase (up to 240 Weeks)||74
10573596|NCT01672866|11728723|FG000|STARTED|Open-Label Phase (up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|11
10573597|NCT01672866|11728724|FG001|STARTED|Open-Label Phase (up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|15
10573598|NCT01672866|11728725|FG002|STARTED|Open-Label Phase (up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|16
10573599|NCT01672866|11728723|FG000|COMPLETED|Open-Label Phase (up to 240 Weeks)||0
10573600|NCT01672866|11728724|FG001|COMPLETED|Open-Label Phase (up to 240 Weeks)||0
10573601|NCT01672866|11728725|FG002|COMPLETED|Open-Label Phase (up to 240 Weeks)||0
10573602|NCT01672866|11728723|FG000|NOT COMPLETED|Open-Label Phase (up to 240 Weeks)||11
10573603|NCT01672866|11728724|FG001|NOT COMPLETED|Open-Label Phase (up to 240 Weeks)||15
10573604|NCT01672866|11728725|FG002|NOT COMPLETED|Open-Label Phase (up to 240 Weeks)||16
10573605|NCT01672879|11728738|FG000|STARTED|Blinded Phase (Up to 240 Weeks)||87
10573606|NCT01672879|11728739|FG001|STARTED|Blinded Phase (Up to 240 Weeks)||86
10573607|NCT01672879|11728740|FG002|STARTED|Blinded Phase (Up to 240 Weeks)||86
10573608|NCT01672879|11728738|FG000|COMPLETED|Blinded Phase (Up to 240 Weeks)||0
10573609|NCT01672879|11728739|FG001|COMPLETED|Blinded Phase (Up to 240 Weeks)||0
10573610|NCT01672879|11728740|FG002|COMPLETED|Blinded Phase (Up to 240 Weeks)||0
10573611|NCT01672879|11728738|FG000|NOT COMPLETED|Blinded Phase (Up to 240 Weeks)||87
10573612|NCT01672879|11728739|FG001|NOT COMPLETED|Blinded Phase (Up to 240 Weeks)||86
10573613|NCT01672879|11728740|FG002|NOT COMPLETED|Blinded Phase (Up to 240 Weeks)||86
10573614|NCT01672879|11728738|FG000|STARTED|Open-Label Phase (Up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|15
10573615|NCT01672879|11728739|FG001|STARTED|Open-Label Phase (Up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|17
10573616|NCT01672879|11728740|FG002|STARTED|Open-Label Phase (Up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|8
10573617|NCT01672879|11728738|FG000|COMPLETED|Open-Label Phase (Up to 240 Weeks)||0
10573618|NCT01672879|11728739|FG001|COMPLETED|Open-Label Phase (Up to 240 Weeks)||0
10573619|NCT01672879|11728740|FG002|COMPLETED|Open-Label Phase (Up to 240 Weeks)||0
10573620|NCT01672879|11728738|FG000|NOT COMPLETED|Open-Label Phase (Up to 240 Weeks)||15
10573621|NCT01672879|11728739|FG001|NOT COMPLETED|Open-Label Phase (Up to 240 Weeks)||17
10573622|NCT01672879|11728740|FG002|NOT COMPLETED|Open-Label Phase (Up to 240 Weeks)||8
10573623|NCT01672957|11728749|FG000|STARTED|Overall Study||128
10573624|NCT01672957|11728749|FG000|Intent-to-treat (ITT) Population|Overall Study|All enrolled participants who had no major protocol violation.|123
10573625|NCT01672957|11728749|FG000|COMPLETED|Overall Study||73
10573626|NCT01672957|11728749|FG000|NOT COMPLETED|Overall Study||55
10573627|NCT01672970|11728753|FG000|STARTED|Overall Study||291
10573628|NCT01672970|11728753|FG000|Treated|Overall Study||290
10573629|NCT01672970|11728753|FG000|COMPLETED|Overall Study||244
10795049|NCT03630679|11955456|FG001|NOT COMPLETED|Overall Study||12
10795050|NCT03631355|11955464|FG000|STARTED|Overall Study||55
10795051|NCT03631355|11955465|FG001|STARTED|Overall Study||55
10795052|NCT03631355|11955464|FG000|COMPLETED|Overall Study||54
10795053|NCT03631355|11955465|FG001|COMPLETED|Overall Study||53
10795054|NCT03631355|11955464|FG000|NOT COMPLETED|Overall Study||1
10795055|NCT03631355|11955465|FG001|NOT COMPLETED|Overall Study||2
10795056|NCT03631433|11955473|FG000|STARTED|Overall Study||49
10795057|NCT03631433|11955474|FG001|STARTED|Overall Study||53
10795058|NCT03631433|11955473|FG000|COMPLETED|Overall Study||49
10795059|NCT03631433|11955474|FG001|COMPLETED|Overall Study||53
10795060|NCT03631433|11955473|FG000|NOT COMPLETED|Overall Study||0
10795061|NCT03631433|11955474|FG001|NOT COMPLETED|Overall Study||0
10795062|NCT03631732|11955482|FG000|STARTED|Randomized Phase Up to Week 24||331
10795063|NCT03631732|11955483|FG001|STARTED|Randomized Phase Up to Week 24||165
10795064|NCT03631732|11955482|FG000|COMPLETED|Randomized Phase Up to Week 24||324
10795065|NCT03631732|11955483|FG001|COMPLETED|Randomized Phase Up to Week 24||163
10795066|NCT03631732|11955482|FG000|NOT COMPLETED|Randomized Phase Up to Week 24||7
10795067|NCT03631732|11955483|FG001|NOT COMPLETED|Randomized Phase Up to Week 24||2
10795068|NCT03631732|11955482|FG000|STARTED|B/F/TAF Treatment Phase (After Week 24)|5 participants completed 24 weeks of the study, but did not receive study treatment after Week 24.|319
10795069|NCT03631732|11955483|FG001|STARTED|B/F/TAF Treatment Phase (After Week 24)||163
10795070|NCT03631732|11955482|FG000|COMPLETED|B/F/TAF Treatment Phase (After Week 24)||303
10795071|NCT03631732|11955483|FG001|COMPLETED|B/F/TAF Treatment Phase (After Week 24)||158
10795072|NCT03631732|11955482|FG000|NOT COMPLETED|B/F/TAF Treatment Phase (After Week 24)||16
10795073|NCT03631732|11955483|FG001|NOT COMPLETED|B/F/TAF Treatment Phase (After Week 24)||5
10795074|NCT03631927|11955493|FG000|STARTED|Overall Study||5094
10573630|NCT01672970|11728753|FG000|NOT COMPLETED|Overall Study||47
10573631|NCT01672983|11728763|FG000|STARTED|Overall Study||18
10573632|NCT01672983|11728764|FG001|STARTED|Overall Study||18
10573633|NCT01672983|11728765|FG002|STARTED|Overall Study||19
10573634|NCT01672983|11728766|FG003|STARTED|Overall Study||18
10573635|NCT01672983|11728767|FG004|STARTED|Overall Study||19
10573636|NCT01672983|11728768|FG005|STARTED|Overall Study||18
10795075|NCT03631927|11955493|FG000|COMPLETED|Overall Study||4669
10795076|NCT03631927|11955493|FG000|NOT COMPLETED|Overall Study||425
10795077|NCT03632083|11955497|FG000|STARTED|First Intervention||5
10795078|NCT03632083|11955498|FG001|STARTED|First Intervention||5
10795079|NCT03632083|11955499|FG002|STARTED|First Intervention||7
10795080|NCT03632083|11955500|FG003|STARTED|First Intervention||7
10573637|NCT01672983|11728763|FG000|Completed Study Drug|Overall Study||18
10573638|NCT01672983|11728764|FG001|Completed Study Drug|Overall Study||17
10573639|NCT01672983|11728765|FG002|Completed Study Drug|Overall Study||18
10573640|NCT01672983|11728766|FG003|Completed Study Drug|Overall Study||18
10573641|NCT01672983|11728767|FG004|Completed Study Drug|Overall Study||12
10573642|NCT01672983|11728768|FG005|Completed Study Drug|Overall Study||17
10573643|NCT01672983|11728763|FG000|COMPLETED|Overall Study||18
10573644|NCT01672983|11728764|FG001|COMPLETED|Overall Study||18
10573645|NCT01672983|11728765|FG002|COMPLETED|Overall Study||19
10573646|NCT01672983|11728766|FG003|COMPLETED|Overall Study||18
10573647|NCT01672983|11728767|FG004|COMPLETED|Overall Study||19
10573648|NCT01672983|11728768|FG005|COMPLETED|Overall Study||18
10573649|NCT01672983|11728763|FG000|NOT COMPLETED|Overall Study||0
10573650|NCT01672983|11728764|FG001|NOT COMPLETED|Overall Study||0
10573651|NCT01672983|11728765|FG002|NOT COMPLETED|Overall Study||0
10573652|NCT01672983|11728766|FG003|NOT COMPLETED|Overall Study||0
10573653|NCT01672983|11728767|FG004|NOT COMPLETED|Overall Study||0
10573654|NCT01672983|11728768|FG005|NOT COMPLETED|Overall Study||0
10573655|NCT01672996|11728797|FG000|STARTED|Overall Study||30
10573656|NCT01672996|11728798|FG001|STARTED|Overall Study||30
10573657|NCT01672996|11728799|FG002|STARTED|Overall Study||6
10573658|NCT01672996|11728797|FG000|COMPLETED|Overall Study||30
10573659|NCT01672996|11728798|FG001|COMPLETED|Overall Study||30
10573660|NCT01672996|11728799|FG002|COMPLETED|Overall Study||6
10573661|NCT01672996|11728797|FG000|NOT COMPLETED|Overall Study||0
10573662|NCT01672996|11728798|FG001|NOT COMPLETED|Overall Study||0
10573663|NCT01672996|11728799|FG002|NOT COMPLETED|Overall Study||0
10573664|NCT01673009|11728815|FG000|STARTED|Overall Study||36
10573665|NCT01673009|11728815|FG000|COMPLETED|Overall Study||23
10573666|NCT01673009|11728815|FG000|NOT COMPLETED|Overall Study||13
10573667|NCT01673022|11728819|FG000|STARTED|Overall Study||430
10573668|NCT01673022|11728819|FG000|COMPLETED|Overall Study||422
10573669|NCT01673022|11728819|FG000|NOT COMPLETED|Overall Study||8
10573670|NCT01673113|11728825|FG000|STARTED|Overall Study||11
10573671|NCT01673113|11728826|FG001|STARTED|Overall Study||11
10573672|NCT01673113|11728825|FG000|COMPLETED|Overall Study||11
10573673|NCT01673113|11728826|FG001|COMPLETED|Overall Study||11
10573674|NCT01673113|11728825|FG000|NOT COMPLETED|Overall Study||0
10573675|NCT01673113|11728826|FG001|NOT COMPLETED|Overall Study||0
10573676|NCT01673126|11728835|FG000|STARTED|Overall Study|First stimulation (20 minutes) Washout (2 days) Second stimulation (20 minutes)|36
10573677|NCT01673126|11728836|FG001|STARTED|Overall Study|First stimulation (20 minutes) Washout (2days) Second stimulation (20 minutes)|26
10573678|NCT01673126|11728835|FG000|COMPLETED|Overall Study||32
10573679|NCT01673126|11728836|FG001|COMPLETED|Overall Study||23
10573680|NCT01673126|11728835|FG000|NOT COMPLETED|Overall Study||4
10573681|NCT01673126|11728836|FG001|NOT COMPLETED|Overall Study||3
10573682|NCT01673178|11728847|FG000|STARTED|Overall Study||22
10573683|NCT01673178|11728848|FG001|STARTED|Overall Study||21
10573684|NCT01673178|11728849|FG002|STARTED|Overall Study||21
10573685|NCT01673178|11728850|FG003|STARTED|Overall Study||22
10573686|NCT01673178|11728851|FG004|STARTED|Overall Study||21
10573687|NCT01673178|11728847|FG000|COMPLETED|Overall Study||19
10573688|NCT01673178|11728848|FG001|COMPLETED|Overall Study||19
10573689|NCT01673178|11728849|FG002|COMPLETED|Overall Study||18
10573690|NCT01673178|11728850|FG003|COMPLETED|Overall Study||14
10573691|NCT01673178|11728851|FG004|COMPLETED|Overall Study||19
10573692|NCT01673178|11728847|FG000|NOT COMPLETED|Overall Study||3
10573693|NCT01673178|11728848|FG001|NOT COMPLETED|Overall Study||2
10573694|NCT01673178|11728849|FG002|NOT COMPLETED|Overall Study||3
10573695|NCT01673178|11728850|FG003|NOT COMPLETED|Overall Study||8
10573696|NCT01673178|11728851|FG004|NOT COMPLETED|Overall Study||2
10573697|NCT01673191|11728869|FG000|STARTED|Overall Study||26
10573698|NCT01673191|11728870|FG001|STARTED|Overall Study||11
10573699|NCT01673191|11728869|FG000|COMPLETED|Overall Study||26
10573700|NCT01673191|11728870|FG001|COMPLETED|Overall Study||11
10573701|NCT01673191|11728869|FG000|NOT COMPLETED|Overall Study||0
10573702|NCT01673191|11728870|FG001|NOT COMPLETED|Overall Study||0
10573703|NCT01673256|11728876|FG000|STARTED|Overall Study||90
10573704|NCT01673256|11728876|FG000|COMPLETED|Overall Study||90
10573705|NCT01673256|11728876|FG000|NOT COMPLETED|Overall Study||0
10573706|NCT01673282|11728882|FG000|STARTED|Overall Study||153
10573707|NCT01673282|11728883|FG001|STARTED|Overall Study||158
10573708|NCT01673282|11728882|FG000|COMPLETED|Overall Study||120
10573709|NCT01673282|11728883|FG001|COMPLETED|Overall Study||132
10573710|NCT01673282|11728882|FG000|NOT COMPLETED|Overall Study||33
10573711|NCT01673282|11728883|FG001|NOT COMPLETED|Overall Study||26
10573712|NCT01673347|11728889|FG000|STARTED|Overall Study||24
10573713|NCT01673347|11728889|FG000|COMPLETED|Overall Study||17
10573714|NCT01673347|11728889|FG000|NOT COMPLETED|Overall Study||7
10573715|NCT01673373|11728893|FG000|STARTED|Overall Study||68
10573716|NCT01673373|11728893|FG000|COMPLETED|Overall Study|Completed primary endpoint follow up.|66
10573717|NCT01673373|11728893|FG000|NOT COMPLETED|Overall Study||2
10573718|NCT01673386|11728897|FG000|STARTED|Overall Study||27
10573719|NCT01673386|11728898|FG001|STARTED|Overall Study||31
10573720|NCT01673386|11728897|FG000|COMPLETED|Overall Study|Of 2 subjects, 1 subject discontinued tivozanib early, completed planned treatment with sunitinib.|2
10573721|NCT01673386|11728898|FG001|COMPLETED|Overall Study|Of 4 subjects, 3 subjects discontinued sunitinib early, completed planned treatment with tivozanib.|4
10573722|NCT01673386|11728897|FG000|NOT COMPLETED|Overall Study||25
10573723|NCT01673386|11728898|FG001|NOT COMPLETED|Overall Study||27
10573724|NCT01673490|11728904|FG000|STARTED|Overall Study||59
10573725|NCT01673490|11728904|FG000|COMPLETED|Overall Study||52
10573726|NCT01673490|11728904|FG000|NOT COMPLETED|Overall Study||7
10573727|NCT01673568|11728910|FG000|STARTED|Overall Study||28
10573728|NCT01673568|11728911|FG001|STARTED|Overall Study||28
10573729|NCT01673568|11728910|FG000|COMPLETED|Overall Study||28
10573730|NCT01673568|11728911|FG001|COMPLETED|Overall Study||28
10573731|NCT01673568|11728910|FG000|NOT COMPLETED|Overall Study||0
10573732|NCT01673568|11728911|FG001|NOT COMPLETED|Overall Study||0
10573733|NCT01673594|11728919|FG000|STARTED|Overall Study||18
10573734|NCT01673594|11728920|FG001|STARTED|Overall Study||19
10573735|NCT01673594|11728919|FG000|COMPLETED|Overall Study||12
10573736|NCT01673594|11728920|FG001|COMPLETED|Overall Study||13
10573737|NCT01673594|11728919|FG000|NOT COMPLETED|Overall Study||6
10573738|NCT01673594|11728920|FG001|NOT COMPLETED|Overall Study||6
10573739|NCT01673646|11728929|FG000|STARTED|Overall Study||11
10573740|NCT01673646|11728930|FG001|STARTED|Overall Study||11
10573741|NCT01673646|11728931|FG002|STARTED|Overall Study||11
10573742|NCT01673646|11728929|FG000|Entered/Treated in Core Phase|Overall Study||11
10573743|NCT01673646|11728930|FG001|Entered/Treated in Core Phase|Overall Study||11
10573744|NCT01673646|11728931|FG002|Entered/Treated in Core Phase|Overall Study||11
10573745|NCT01673646|11728929|FG000|Completed Core Phase|Overall Study||9
10573746|NCT01673646|11728930|FG001|Completed Core Phase|Overall Study||10
10573747|NCT01673646|11728931|FG002|Completed Core Phase|Overall Study||10
10573748|NCT01673646|11728929|FG000|Entered Ext. Phase|Overall Study||7
10573749|NCT01673646|11728930|FG001|Entered Ext. Phase|Overall Study||9
10573750|NCT01673646|11728931|FG002|Entered Ext. Phase|Overall Study||9
10573751|NCT01673646|11728929|FG000|Did Not Enter Ext. Phase|Overall Study||2
10573752|NCT01673646|11728930|FG001|Did Not Enter Ext. Phase|Overall Study||1
10573753|NCT01673646|11728931|FG002|Did Not Enter Ext. Phase|Overall Study||1
10573754|NCT01673646|11728929|FG000|Treated Beyond 24 Months|Overall Study||7
10573755|NCT01673646|11728930|FG001|Treated Beyond 24 Months|Overall Study||8
10573756|NCT01673646|11728931|FG002|Treated Beyond 24 Months|Overall Study||8
10573757|NCT01673646|11728929|FG000|Discontinued Beyond 24 Months|Overall Study||0
10573758|NCT01673646|11728930|FG001|Discontinued Beyond 24 Months|Overall Study||4
10573759|NCT01673646|11728931|FG002|Discontinued Beyond 24 Months|Overall Study||1
10573760|NCT01673646|11728929|FG000|COMPLETED|Overall Study||7
10573761|NCT01673646|11728930|FG001|COMPLETED|Overall Study||4
10573762|NCT01673646|11728931|FG002|COMPLETED|Overall Study||7
10573763|NCT01673646|11728929|FG000|NOT COMPLETED|Overall Study||4
10573764|NCT01673646|11728930|FG001|NOT COMPLETED|Overall Study||7
10573765|NCT01673646|11728931|FG002|NOT COMPLETED|Overall Study||4
10573766|NCT01673698|11728945|FG000|STARTED|Overall Study||187
10573767|NCT01673698|11728946|FG001|STARTED|Overall Study||139
10573768|NCT01673698|11728945|FG000|COMPLETED|Overall Study||136
10573769|NCT01673698|11728946|FG001|COMPLETED|Overall Study||126
10573770|NCT01673698|11728945|FG000|NOT COMPLETED|Overall Study||51
10573771|NCT01673698|11728946|FG001|NOT COMPLETED|Overall Study||13
10573772|NCT01673802|11728953|FG000|STARTED|Gadoxetate Standard Dose 0.025 mmol/kg||8
10573773|NCT01673802|11728953|FG000|COMPLETED|Gadoxetate Standard Dose 0.025 mmol/kg||8
10573774|NCT01673802|11728953|FG000|NOT COMPLETED|Gadoxetate Standard Dose 0.025 mmol/kg||0
10573775|NCT01673802|11728953|FG000|STARTED|Gadoxetate Double Dose 0.050 mmol/kg||10
10573776|NCT01673802|11728953|FG000|COMPLETED|Gadoxetate Double Dose 0.050 mmol/kg||10
10573777|NCT01673802|11728953|FG000|NOT COMPLETED|Gadoxetate Double Dose 0.050 mmol/kg||0
10573778|NCT01673828|11728959|FG000|STARTED|Overall Study||7
10573779|NCT01673828|11728960|FG001|STARTED|Overall Study||6
10573780|NCT01673828|11728959|FG000|COMPLETED|Overall Study||7
10573781|NCT01673828|11728960|FG001|COMPLETED|Overall Study||6
10573782|NCT01673828|11728959|FG000|NOT COMPLETED|Overall Study||0
10573783|NCT01673828|11728960|FG001|NOT COMPLETED|Overall Study||0
10573784|NCT01673854|11728966|FG000|STARTED|Vem 1 Phase (Vemurafenib, 960 mg)||46
10573785|NCT01673854|11728966|FG000|COMPLETED|Vem 1 Phase (Vemurafenib, 960 mg)||46
10573786|NCT01673854|11728966|FG000|NOT COMPLETED|Vem 1 Phase (Vemurafenib, 960 mg)||0
10573787|NCT01673854|11728966|FG000|STARTED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||46
10573788|NCT01673854|11728966|FG000|COMPLETED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||19
10573789|NCT01673854|11728966|FG000|NOT COMPLETED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||27
10573790|NCT01673854|11728966|FG000|STARTED|Vem 2 Phase (Vemurafenib Retreatment)||19
10573791|NCT01673854|11728966|FG000|COMPLETED|Vem 2 Phase (Vemurafenib Retreatment)||0
10573792|NCT01673854|11728966|FG000|NOT COMPLETED|Vem 2 Phase (Vemurafenib Retreatment)||19
10573793|NCT01673893|11728972|FG000|STARTED|Overall Study||59
10573794|NCT01673893|11728972|FG000|COMPLETED|Overall Study||59
10573795|NCT01673893|11728972|FG000|NOT COMPLETED|Overall Study||0
10573796|NCT01673919|11728978|FG000|STARTED|Overall Study||7
10573797|NCT01673919|11728978|FG000|COMPLETED|Overall Study||7
10663104|NCT02271984|11825005|FG008|STARTED|Washout Period 3 (7 Days)||3
10663105|NCT02271984|11825006|FG009|STARTED|Washout Period 3 (7 Days)||3
10663106|NCT02271984|11825007|FG010|STARTED|Washout Period 3 (7 Days)||3
10573798|NCT01673919|11728978|FG000|NOT COMPLETED|Overall Study||0
10573799|NCT01673984|11728984|FG000|STARTED|Overall Study||14
10573800|NCT01673984|11728985|FG001|STARTED|Overall Study||7
10573801|NCT01673984|11728984|FG000|COMPLETED|Overall Study||4
10573802|NCT01673984|11728985|FG001|COMPLETED|Overall Study||1
10573803|NCT01673984|11728984|FG000|NOT COMPLETED|Overall Study||10
10573804|NCT01673984|11728985|FG001|NOT COMPLETED|Overall Study||6
10573805|NCT01674010|11728991|FG000|STARTED|Open Treatment Phase 1||309
10573806|NCT01674010|11728992|FG001|STARTED|Open Treatment Phase 1||0
10573807|NCT01674010|11728993|FG002|STARTED|Open Treatment Phase 1||0
10573808|NCT01674010|11728991|FG000|COMPLETED|Open Treatment Phase 1||129
10573809|NCT01674010|11728992|FG001|COMPLETED|Open Treatment Phase 1||0
10573810|NCT01674010|11728993|FG002|COMPLETED|Open Treatment Phase 1||0
10573811|NCT01674010|11728991|FG000|NOT COMPLETED|Open Treatment Phase 1||180
10573812|NCT01674010|11728992|FG001|NOT COMPLETED|Open Treatment Phase 1||0
10573813|NCT01674010|11728993|FG002|NOT COMPLETED|Open Treatment Phase 1||0
10573814|NCT01674010|11728991|FG000|STARTED|Randomization Phase 2||0
10573815|NCT01674010|11728992|FG001|STARTED|Randomization Phase 2||65
10573816|NCT01674010|11728993|FG002|STARTED|Randomization Phase 2||64
10573817|NCT01674010|11728991|FG000|COMPLETED|Randomization Phase 2||0
10573818|NCT01674010|11728992|FG001|COMPLETED|Randomization Phase 2||3
10573819|NCT01674010|11728993|FG002|COMPLETED|Randomization Phase 2||3
10573820|NCT01674010|11728991|FG000|NOT COMPLETED|Randomization Phase 2||0
10573821|NCT01674010|11728992|FG001|NOT COMPLETED|Randomization Phase 2||62
10573822|NCT01674010|11728993|FG002|NOT COMPLETED|Randomization Phase 2||61
10573823|NCT01674062|11729003|FG000|STARTED|Overall Study||66
10573824|NCT01674062|11729004|FG001|STARTED|Overall Study||29
10573825|NCT01674062|11729003|FG000|COMPLETED|Overall Study||0
10573826|NCT01674062|11729004|FG001|COMPLETED|Overall Study||0
10573827|NCT01674062|11729003|FG000|NOT COMPLETED|Overall Study||66
10573828|NCT01674062|11729004|FG001|NOT COMPLETED|Overall Study||29
10573829|NCT01674478|11729012|FG000|STARTED|Overall Study||9
10573830|NCT01674478|11729013|FG001|STARTED|Overall Study||9
10573831|NCT01674478|11729012|FG000|COMPLETED|Overall Study||9
10573832|NCT01674478|11729013|FG001|COMPLETED|Overall Study||9
10573833|NCT01674478|11729012|FG000|NOT COMPLETED|Overall Study||0
10573834|NCT01674478|11729013|FG001|NOT COMPLETED|Overall Study||0
10573835|NCT01674569|11729019|FG000|STARTED|Overall Study||3
10573836|NCT01674569|11729020|FG001|STARTED|Overall Study||8
10573837|NCT01674569|11729021|FG002|STARTED|Overall Study||4
10573838|NCT01674569|11729022|FG003|STARTED|Overall Study||10
10573839|NCT01674569|11729023|FG004|STARTED|Overall Study||7
10573840|NCT01674569|11729024|FG005|STARTED|Overall Study||3
10573841|NCT01674569|11729019|FG000|COMPLETED|Overall Study||3
10573842|NCT01674569|11729020|FG001|COMPLETED|Overall Study||5
10573843|NCT01674569|11729021|FG002|COMPLETED|Overall Study||2
10573844|NCT01674569|11729022|FG003|COMPLETED|Overall Study||9
10573845|NCT01674569|11729023|FG004|COMPLETED|Overall Study||5
10573846|NCT01674569|11729024|FG005|COMPLETED|Overall Study||1
10573847|NCT01674569|11729019|FG000|NOT COMPLETED|Overall Study||0
10573848|NCT01674569|11729020|FG001|NOT COMPLETED|Overall Study||3
10573849|NCT01674569|11729021|FG002|NOT COMPLETED|Overall Study||2
10573850|NCT01674569|11729022|FG003|NOT COMPLETED|Overall Study||1
10573851|NCT01674569|11729023|FG004|NOT COMPLETED|Overall Study||2
10573852|NCT01674569|11729024|FG005|NOT COMPLETED|Overall Study||2
10573853|NCT01674621|11729033|FG000|STARTED|Overall Study||50
10573854|NCT01674621|11729034|FG001|STARTED|Overall Study||51
10573855|NCT01674621|11729035|FG002|STARTED|Overall Study||48
10573856|NCT01674621|11729036|FG003|STARTED|Overall Study||51
10573857|NCT01674621|11729037|FG004|STARTED|Overall Study||50
10573858|NCT01674621|11729033|FG000|Modified Intent-to-Treat Population|Overall Study||47
10573859|NCT01674621|11729034|FG001|Modified Intent-to-Treat Population|Overall Study||46
10573860|NCT01674621|11729035|FG002|Modified Intent-to-Treat Population|Overall Study||43
10573861|NCT01674621|11729036|FG003|Modified Intent-to-Treat Population|Overall Study||49
10573862|NCT01674621|11729037|FG004|Modified Intent-to-Treat Population|Overall Study||46
10573863|NCT01674621|11729033|FG000|Safety Population|Overall Study||50
10573864|NCT01674621|11729034|FG001|Safety Population|Overall Study||51
10573865|NCT01674621|11729035|FG002|Safety Population|Overall Study||47
10573866|NCT01674621|11729036|FG003|Safety Population|Overall Study||51
10573867|NCT01674621|11729037|FG004|Safety Population|Overall Study||50
10573868|NCT01674621|11729033|FG000|COMPLETED|Overall Study||45
10573869|NCT01674621|11729034|FG001|COMPLETED|Overall Study||43
10573870|NCT01674621|11729035|FG002|COMPLETED|Overall Study||41
10573871|NCT01674621|11729036|FG003|COMPLETED|Overall Study||45
10573872|NCT01674621|11729037|FG004|COMPLETED|Overall Study||44
10573873|NCT01674621|11729033|FG000|NOT COMPLETED|Overall Study||5
10573874|NCT01674621|11729034|FG001|NOT COMPLETED|Overall Study||8
10573875|NCT01674621|11729035|FG002|NOT COMPLETED|Overall Study||7
10573876|NCT01674621|11729036|FG003|NOT COMPLETED|Overall Study||6
10573877|NCT01674621|11729037|FG004|NOT COMPLETED|Overall Study||6
10573878|NCT01674634|11729050|FG000|STARTED|Overall Study||715
10573879|NCT01674634|11729050|FG000|COMPLETED|Overall Study||709
10573880|NCT01674634|11729050|FG000|NOT COMPLETED|Overall Study||6
10573881|NCT01674647|11729060|FG000|STARTED|Treatment Period||1002
10573882|NCT01674647|11729061|FG001|STARTED|Treatment Period||502
10573883|NCT01674647|11729060|FG000|Subjects Received Treatment|Treatment Period||988
10573884|NCT01674647|11729061|FG001|Subjects Received Treatment|Treatment Period||499
10573885|NCT01674647|11729060|FG000|COMPLETED|Treatment Period||846
10573886|NCT01674647|11729061|FG001|COMPLETED|Treatment Period||400
10573887|NCT01674647|11729060|FG000|NOT COMPLETED|Treatment Period||156
10573888|NCT01674647|11729061|FG001|NOT COMPLETED|Treatment Period||102
10573889|NCT01674647|11729060|FG000|STARTED|30-day Safety Follow-up Period||982
10573890|NCT01674647|11729061|FG001|STARTED|30-day Safety Follow-up Period||487
10573891|NCT01674647|11729060|FG000|COMPLETED|30-day Safety Follow-up Period||924
10573892|NCT01674647|11729061|FG001|COMPLETED|30-day Safety Follow-up Period||446
10573893|NCT01674647|11729060|FG000|NOT COMPLETED|30-day Safety Follow-up Period||58
10573894|NCT01674647|11729061|FG001|NOT COMPLETED|30-day Safety Follow-up Period||41
10573895|NCT01674712|11729072|FG000|STARTED|Overall Study||114
10573896|NCT01674712|11729073|FG001|STARTED|Overall Study||117
10573897|NCT01674712|11729074|FG002|STARTED|Overall Study||115
10573898|NCT01674712|11729075|FG003|STARTED|Overall Study||116
10573899|NCT01674712|11729076|FG004|STARTED|Overall Study||113
10573900|NCT01674712|11729072|FG000|Full Analysis Subject Sample|Overall Study||109
10573901|NCT01674712|11729073|FG001|Full Analysis Subject Sample|Overall Study||114
10573902|NCT01674712|11729074|FG002|Full Analysis Subject Sample|Overall Study||110
10573903|NCT01674712|11729075|FG003|Full Analysis Subject Sample|Overall Study||112
10573904|NCT01674712|11729076|FG004|Full Analysis Subject Sample|Overall Study||111
10573905|NCT01674712|11729072|FG000|Safety Subject Sample|Overall Study||111
10573906|NCT01674712|11729073|FG001|Safety Subject Sample|Overall Study||117
10573907|NCT01674712|11729074|FG002|Safety Subject Sample|Overall Study||113
10573908|NCT01674712|11729075|FG003|Safety Subject Sample|Overall Study||115
10573909|NCT01674712|11729076|FG004|Safety Subject Sample|Overall Study||112
10573910|NCT01674712|11729072|FG000|COMPLETED|Overall Study||104
10573911|NCT01674712|11729073|FG001|COMPLETED|Overall Study||108
10573912|NCT01674712|11729074|FG002|COMPLETED|Overall Study||106
10573913|NCT01674712|11729075|FG003|COMPLETED|Overall Study||108
10573914|NCT01674712|11729076|FG004|COMPLETED|Overall Study||102
10573915|NCT01674712|11729072|FG000|NOT COMPLETED|Overall Study||10
10573916|NCT01674712|11729073|FG001|NOT COMPLETED|Overall Study||9
10573917|NCT01674712|11729074|FG002|NOT COMPLETED|Overall Study||9
10573918|NCT01674712|11729075|FG003|NOT COMPLETED|Overall Study||8
10573919|NCT01674712|11729076|FG004|NOT COMPLETED|Overall Study||11
10573920|NCT01674725|11729090|FG000|STARTED|Overall Study||92
10573921|NCT01674725|11729091|FG001|STARTED|Overall Study||95
10573922|NCT01674725|11729090|FG000|COMPLETED|Overall Study||89
10573923|NCT01674725|11729091|FG001|COMPLETED|Overall Study||94
10573924|NCT01674725|11729090|FG000|NOT COMPLETED|Overall Study||3
10573925|NCT01674725|11729091|FG001|NOT COMPLETED|Overall Study||1
10573926|NCT01675050|11729099|FG000|STARTED|Period One Treatment||2
10573927|NCT01675050|11729100|FG001|STARTED|Period One Treatment||2
10795081|NCT03632083|11955501|FG004|STARTED|First Intervention||9
10795082|NCT03632083|11955502|FG005|STARTED|First Intervention||9
10795083|NCT03632083|11955503|FG006|STARTED|First Intervention||7
10795084|NCT03632083|11955504|FG007|STARTED|First Intervention||7
10795085|NCT03632083|11955497|FG000|COMPLETED|First Intervention||5
10795086|NCT03632083|11955498|FG001|COMPLETED|First Intervention||5
10795087|NCT03632083|11955499|FG002|COMPLETED|First Intervention||7
10573928|NCT01675050|11729099|FG000|COMPLETED|Period One Treatment||1
10573929|NCT01675050|11729100|FG001|COMPLETED|Period One Treatment||2
10573930|NCT01675050|11729099|FG000|NOT COMPLETED|Period One Treatment||1
10573931|NCT01675050|11729100|FG001|NOT COMPLETED|Period One Treatment||0
10573932|NCT01675050|11729099|FG000|STARTED|Wash Out Period||1
10573933|NCT01675050|11729100|FG001|STARTED|Wash Out Period||2
10573934|NCT01675050|11729099|FG000|COMPLETED|Wash Out Period||1
10573935|NCT01675050|11729100|FG001|COMPLETED|Wash Out Period||2
10573936|NCT01675050|11729099|FG000|NOT COMPLETED|Wash Out Period||0
10573937|NCT01675050|11729100|FG001|NOT COMPLETED|Wash Out Period||0
10573938|NCT01675050|11729099|FG000|STARTED|Second Period Treatment||1
10573939|NCT01675050|11729100|FG001|STARTED|Second Period Treatment||2
10573940|NCT01675050|11729099|FG000|COMPLETED|Second Period Treatment||1
10573941|NCT01675050|11729100|FG001|COMPLETED|Second Period Treatment||2
10573942|NCT01675050|11729099|FG000|NOT COMPLETED|Second Period Treatment||0
10573943|NCT01675050|11729100|FG001|NOT COMPLETED|Second Period Treatment||0
10573944|NCT01675063|11729106|FG000|STARTED|Overall Study||77
10573945|NCT01675063|11729106|FG000|COMPLETED|Overall Study||77
10573946|NCT01675063|11729106|FG000|NOT COMPLETED|Overall Study||0
10573947|NCT01675128|11729113|FG000|STARTED|Overall Study||4
10573948|NCT01675128|11729114|FG001|STARTED|Overall Study||10
10573949|NCT01675128|11729115|FG002|STARTED|Overall Study||10
10573950|NCT01675128|11729113|FG000|COMPLETED|Overall Study||2
10573951|NCT01675128|11729114|FG001|COMPLETED|Overall Study||8
10573952|NCT01675128|11729115|FG002|COMPLETED|Overall Study||9
10573953|NCT01675128|11729113|FG000|NOT COMPLETED|Overall Study||2
10573954|NCT01675128|11729114|FG001|NOT COMPLETED|Overall Study||2
10573955|NCT01675128|11729115|FG002|NOT COMPLETED|Overall Study||1
10573956|NCT01675141|11729130|FG000|STARTED|Overall Study||11
10573957|NCT01675141|11729130|FG000|COMPLETED|Overall Study||0
10573958|NCT01675141|11729130|FG000|NOT COMPLETED|Overall Study||11
10573959|NCT01675154|11729138|FG000|STARTED|First Intervention Period (4 Weeks)||2
10573960|NCT01675154|11729139|FG001|STARTED|First Intervention Period (4 Weeks)||1
10573961|NCT01675154|11729140|FG002|STARTED|First Intervention Period (4 Weeks)||1
10573962|NCT01675154|11729141|FG003|STARTED|First Intervention Period (4 Weeks)||1
10573963|NCT01675154|11729138|FG000|COMPLETED|First Intervention Period (4 Weeks)||2
10573964|NCT01675154|11729139|FG001|COMPLETED|First Intervention Period (4 Weeks)||1
10573965|NCT01675154|11729140|FG002|COMPLETED|First Intervention Period (4 Weeks)||1
10573966|NCT01675154|11729141|FG003|COMPLETED|First Intervention Period (4 Weeks)||1
10573967|NCT01675154|11729138|FG000|NOT COMPLETED|First Intervention Period (4 Weeks)||0
10573968|NCT01675154|11729139|FG001|NOT COMPLETED|First Intervention Period (4 Weeks)||0
10573969|NCT01675154|11729140|FG002|NOT COMPLETED|First Intervention Period (4 Weeks)||0
10573970|NCT01675154|11729141|FG003|NOT COMPLETED|First Intervention Period (4 Weeks)||0
10795088|NCT03632083|11955500|FG003|COMPLETED|First Intervention||7
10795089|NCT03632083|11955501|FG004|COMPLETED|First Intervention||9
10573971|NCT01675154|11729138|FG000|STARTED|First Washout Period (1 Week)|Subjects were enrolled Regimen 1|2
10573972|NCT01675154|11729139|FG001|STARTED|First Washout Period (1 Week)||1
10573973|NCT01675154|11729140|FG002|STARTED|First Washout Period (1 Week)||1
10573974|NCT01675154|11729141|FG003|STARTED|First Washout Period (1 Week)||1
10573975|NCT01675154|11729138|FG000|COMPLETED|First Washout Period (1 Week)||2
10573976|NCT01675154|11729139|FG001|COMPLETED|First Washout Period (1 Week)||1
10573977|NCT01675154|11729140|FG002|COMPLETED|First Washout Period (1 Week)||1
10573978|NCT01675154|11729141|FG003|COMPLETED|First Washout Period (1 Week)||1
10573979|NCT01675154|11729138|FG000|NOT COMPLETED|First Washout Period (1 Week)||0
10573980|NCT01675154|11729139|FG001|NOT COMPLETED|First Washout Period (1 Week)||0
10573981|NCT01675154|11729140|FG002|NOT COMPLETED|First Washout Period (1 Week)||0
10573982|NCT01675154|11729141|FG003|NOT COMPLETED|First Washout Period (1 Week)||0
10573983|NCT01675154|11729138|FG000|STARTED|Second Intervention Period (4 Weeks)||1
10573984|NCT01675154|11729139|FG001|STARTED|Second Intervention Period (4 Weeks)|Subjects were enrolled in Regimen 2|1
10573985|NCT01675154|11729140|FG002|STARTED|Second Intervention Period (4 Weeks)||1
10573986|NCT01675154|11729141|FG003|STARTED|Second Intervention Period (4 Weeks)||2
10573987|NCT01675154|11729138|FG000|COMPLETED|Second Intervention Period (4 Weeks)||0
10573988|NCT01675154|11729139|FG001|COMPLETED|Second Intervention Period (4 Weeks)||1
10573989|NCT01675154|11729140|FG002|COMPLETED|Second Intervention Period (4 Weeks)||1
10573990|NCT01675154|11729141|FG003|COMPLETED|Second Intervention Period (4 Weeks)||1
10573991|NCT01675154|11729138|FG000|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
10573992|NCT01675154|11729139|FG001|NOT COMPLETED|Second Intervention Period (4 Weeks)||0
10573993|NCT01675154|11729140|FG002|NOT COMPLETED|Second Intervention Period (4 Weeks)||0
10573994|NCT01675154|11729141|FG003|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
10573995|NCT01675154|11729138|FG000|STARTED|Second Washout Period (1 Week)||1
10573996|NCT01675154|11729139|FG001|STARTED|Second Washout Period (1 Week)||1
10573997|NCT01675154|11729140|FG002|STARTED|Second Washout Period (1 Week)||1
10573998|NCT01675154|11729141|FG003|STARTED|Second Washout Period (1 Week)||2
10573999|NCT01675154|11729138|FG000|COMPLETED|Second Washout Period (1 Week)||1
10574000|NCT01675154|11729139|FG001|COMPLETED|Second Washout Period (1 Week)||1
10574001|NCT01675154|11729140|FG002|COMPLETED|Second Washout Period (1 Week)||1
10574002|NCT01675154|11729141|FG003|COMPLETED|Second Washout Period (1 Week)||2
10574003|NCT01675154|11729138|FG000|NOT COMPLETED|Second Washout Period (1 Week)||0
10574004|NCT01675154|11729139|FG001|NOT COMPLETED|Second Washout Period (1 Week)||0
10574005|NCT01675154|11729140|FG002|NOT COMPLETED|Second Washout Period (1 Week)||0
10574006|NCT01675154|11729141|FG003|NOT COMPLETED|Second Washout Period (1 Week)||0
10574007|NCT01675154|11729138|FG000|STARTED|Third Intervention Period (4 Weeks)||1
10574008|NCT01675154|11729139|FG001|STARTED|Third Intervention Period (4 Weeks)||1
10574009|NCT01675154|11729140|FG002|STARTED|Third Intervention Period (4 Weeks)||1
10574010|NCT01675154|11729141|FG003|STARTED|Third Intervention Period (4 Weeks)||0
10574011|NCT01675154|11729138|FG000|COMPLETED|Third Intervention Period (4 Weeks)||1
10574012|NCT01675154|11729139|FG001|COMPLETED|Third Intervention Period (4 Weeks)||0
10574013|NCT01675154|11729140|FG002|COMPLETED|Third Intervention Period (4 Weeks)||1
10574014|NCT01675154|11729141|FG003|COMPLETED|Third Intervention Period (4 Weeks)||0
10574015|NCT01675154|11729138|FG000|NOT COMPLETED|Third Intervention Period (4 Weeks)||0
10574016|NCT01675154|11729139|FG001|NOT COMPLETED|Third Intervention Period (4 Weeks)||1
10574017|NCT01675154|11729140|FG002|NOT COMPLETED|Third Intervention Period (4 Weeks)||0
10574018|NCT01675154|11729141|FG003|NOT COMPLETED|Third Intervention Period (4 Weeks)||0
10574019|NCT01675154|11729138|FG000|STARTED|Third Washout Period (1 Week)||1
10574020|NCT01675154|11729139|FG001|STARTED|Third Washout Period (1 Week)||0
10574021|NCT01675154|11729140|FG002|STARTED|Third Washout Period (1 Week)||1
10574022|NCT01675154|11729141|FG003|STARTED|Third Washout Period (1 Week)||0
10574023|NCT01675154|11729138|FG000|COMPLETED|Third Washout Period (1 Week)||1
10574024|NCT01675154|11729139|FG001|COMPLETED|Third Washout Period (1 Week)||0
10574025|NCT01675154|11729140|FG002|COMPLETED|Third Washout Period (1 Week)||1
10574026|NCT01675154|11729141|FG003|COMPLETED|Third Washout Period (1 Week)||0
10574027|NCT01675154|11729138|FG000|NOT COMPLETED|Third Washout Period (1 Week)||0
10574028|NCT01675154|11729139|FG001|NOT COMPLETED|Third Washout Period (1 Week)||0
10574029|NCT01675154|11729140|FG002|NOT COMPLETED|Third Washout Period (1 Week)||0
10574030|NCT01675154|11729141|FG003|NOT COMPLETED|Third Washout Period (1 Week)||0
10574031|NCT01675154|11729138|FG000|STARTED|Fourth Intervention Period (4 Weeks)||1
10574032|NCT01675154|11729139|FG001|STARTED|Fourth Intervention Period (4 Weeks)||0
10574033|NCT01675154|11729140|FG002|STARTED|Fourth Intervention Period (4 Weeks)||1
10574034|NCT01675154|11729141|FG003|STARTED|Fourth Intervention Period (4 Weeks)||0
10574035|NCT01675154|11729138|FG000|COMPLETED|Fourth Intervention Period (4 Weeks)||1
10574036|NCT01675154|11729139|FG001|COMPLETED|Fourth Intervention Period (4 Weeks)||0
10574037|NCT01675154|11729140|FG002|COMPLETED|Fourth Intervention Period (4 Weeks)||1
10574038|NCT01675154|11729141|FG003|COMPLETED|Fourth Intervention Period (4 Weeks)||0
10574039|NCT01675154|11729138|FG000|NOT COMPLETED|Fourth Intervention Period (4 Weeks)||0
10574040|NCT01675154|11729139|FG001|NOT COMPLETED|Fourth Intervention Period (4 Weeks)||0
10574041|NCT01675154|11729140|FG002|NOT COMPLETED|Fourth Intervention Period (4 Weeks)||0
10574042|NCT01675154|11729141|FG003|NOT COMPLETED|Fourth Intervention Period (4 Weeks)||0
10574043|NCT01675167|11729165|FG000|STARTED|Open-label Titration Phase||815
10574044|NCT01675167|11729166|FG001|STARTED|Open-label Titration Phase||0
10574045|NCT01675167|11729167|FG002|STARTED|Open-label Titration Phase||0
10574046|NCT01675167|11729165|FG000|COMPLETED|Open-label Titration Phase||511
10574047|NCT01675167|11729166|FG001|COMPLETED|Open-label Titration Phase||0
10574048|NCT01675167|11729167|FG002|COMPLETED|Open-label Titration Phase||0
10574049|NCT01675167|11729165|FG000|NOT COMPLETED|Open-label Titration Phase||304
10574050|NCT01675167|11729166|FG001|NOT COMPLETED|Open-label Titration Phase||0
10574051|NCT01675167|11729167|FG002|NOT COMPLETED|Open-label Titration Phase||0
10574052|NCT01675167|11729165|FG000|STARTED|Double-blind Treatment Phase|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
10574053|NCT01675167|11729166|FG001|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|254
10574054|NCT01675167|11729167|FG002|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|257
10574055|NCT01675167|11729165|FG000|COMPLETED|Double-blind Treatment Phase||0
10574056|NCT01675167|11729166|FG001|COMPLETED|Double-blind Treatment Phase||206
10574057|NCT01675167|11729167|FG002|COMPLETED|Double-blind Treatment Phase||147
10574058|NCT01675167|11729165|FG000|NOT COMPLETED|Double-blind Treatment Phase||0
10574059|NCT01675167|11729166|FG001|NOT COMPLETED|Double-blind Treatment Phase||48
10574060|NCT01675167|11729167|FG002|NOT COMPLETED|Double-blind Treatment Phase||110
10574061|NCT01675297|11729177|FG000|STARTED|Overall Study||806
10574062|NCT01675297|11729178|FG001|STARTED|Overall Study||247
10574063|NCT01675297|11729177|FG000|COMPLETED|Overall Study||642
10574064|NCT01675297|11729178|FG001|COMPLETED|Overall Study||199
10574065|NCT01675297|11729177|FG000|NOT COMPLETED|Overall Study||164
10574066|NCT01675297|11729178|FG001|NOT COMPLETED|Overall Study||48
10574067|NCT01675427|11729184|FG000|STARTED|Overall Study||4766
10574068|NCT01675427|11729184|FG000|COMPLETED|Overall Study||4732
10574069|NCT01675427|11729184|FG000|NOT COMPLETED|Overall Study||34
10574070|NCT01675453|11729220|FG000|STARTED|Overall Study||20
10574071|NCT01675453|11729221|FG001|STARTED|Overall Study||20
10574072|NCT01675453|11729220|FG000|COMPLETED|Overall Study||20
10574073|NCT01675453|11729221|FG001|COMPLETED|Overall Study||20
10574074|NCT01675453|11729220|FG000|NOT COMPLETED|Overall Study||0
10574075|NCT01675453|11729221|FG001|NOT COMPLETED|Overall Study||0
10574076|NCT01675492|11729227|FG000|STARTED|Overall Study||84
10574077|NCT01675492|11729227|FG000|COMPLETED|Overall Study||42
10574078|NCT01675492|11729227|FG000|NOT COMPLETED|Overall Study||42
10574079|NCT01675531|11729232|FG000|STARTED|Overall Study||66
10574080|NCT01675531|11729232|FG000|COMPLETED|Overall Study||41
10574081|NCT01675531|11729232|FG000|NOT COMPLETED|Overall Study||25
10574082|NCT01675544|11729237|FG000|STARTED|Overall Study||46
10574083|NCT01675544|11729237|FG000|COMPLETED|Overall Study||44
10574084|NCT01675544|11729237|FG000|NOT COMPLETED|Overall Study||2
10574085|NCT01675596|11729241|FG000|STARTED|Overall Study|One patient did not receive the study device.|199
10574086|NCT01675596|11729241|FG000|COMPLETED|Overall Study||191
10574087|NCT01675596|11729241|FG000|NOT COMPLETED|Overall Study||8
10574088|NCT01675622|11729247|FG000|STARTED|Overall Study||122
10574089|NCT01675622|11729248|FG001|STARTED|Overall Study||120
10574090|NCT01675622|11729247|FG000|COMPLETED|Overall Study||96
10574091|NCT01675622|11729248|FG001|COMPLETED|Overall Study||96
10574092|NCT01675622|11729247|FG000|NOT COMPLETED|Overall Study||26
10574093|NCT01675622|11729248|FG001|NOT COMPLETED|Overall Study||24
10574094|NCT01675635|11729256|FG000|STARTED|Overall Study||117
10574095|NCT01675635|11729257|FG001|STARTED|Overall Study||117
10574096|NCT01675635|11729256|FG000|COMPLETED|Overall Study||117
10574097|NCT01675635|11729257|FG001|COMPLETED|Overall Study||117
10574098|NCT01675635|11729256|FG000|NOT COMPLETED|Overall Study||0
10574099|NCT01675635|11729257|FG001|NOT COMPLETED|Overall Study||0
10574100|NCT01675661|11729270|FG000|STARTED|Overall Study||153
10574101|NCT01675661|11729271|FG001|STARTED|Overall Study||149
10574102|NCT01675661|11729270|FG000|COMPLETED|Overall Study||113
10574103|NCT01675661|11729271|FG001|COMPLETED|Overall Study||103
10795090|NCT03632083|11955502|FG005|COMPLETED|First Intervention||9
10795091|NCT03632083|11955503|FG006|COMPLETED|First Intervention||7
10795092|NCT03632083|11955504|FG007|COMPLETED|First Intervention||7
10795093|NCT03632083|11955497|FG000|NOT COMPLETED|First Intervention||0
10795094|NCT03632083|11955498|FG001|NOT COMPLETED|First Intervention||0
10795095|NCT03632083|11955499|FG002|NOT COMPLETED|First Intervention||0
10795096|NCT03632083|11955500|FG003|NOT COMPLETED|First Intervention||0
10795097|NCT03632083|11955501|FG004|NOT COMPLETED|First Intervention||0
10795098|NCT03632083|11955502|FG005|NOT COMPLETED|First Intervention||0
10795099|NCT03632083|11955503|FG006|NOT COMPLETED|First Intervention||0
10795100|NCT03632083|11955504|FG007|NOT COMPLETED|First Intervention||0
10795101|NCT03632083|11955497|FG000|STARTED|Second Intervention||5
10795102|NCT03632083|11955498|FG001|STARTED|Second Intervention||5
10795103|NCT03632083|11955499|FG002|STARTED|Second Intervention||7
10795104|NCT03632083|11955500|FG003|STARTED|Second Intervention||7
10795105|NCT03632083|11955501|FG004|STARTED|Second Intervention||9
10795106|NCT03632083|11955502|FG005|STARTED|Second Intervention||9
10795107|NCT03632083|11955503|FG006|STARTED|Second Intervention||7
10795108|NCT03632083|11955504|FG007|STARTED|Second Intervention||7
10795109|NCT03632083|11955497|FG000|COMPLETED|Second Intervention||5
10795110|NCT03632083|11955498|FG001|COMPLETED|Second Intervention||5
10795111|NCT03632083|11955499|FG002|COMPLETED|Second Intervention||7
10795112|NCT03632083|11955500|FG003|COMPLETED|Second Intervention||7
10795113|NCT03632083|11955501|FG004|COMPLETED|Second Intervention||9
10795114|NCT03632083|11955502|FG005|COMPLETED|Second Intervention||9
10795115|NCT03632083|11955503|FG006|COMPLETED|Second Intervention||7
10574104|NCT01675661|11729270|FG000|NOT COMPLETED|Overall Study||40
10574105|NCT01675661|11729271|FG001|NOT COMPLETED|Overall Study||46
10574106|NCT01675765|11729279|FG000|STARTED|Overall Study||38
10795116|NCT03632083|11955504|FG007|COMPLETED|Second Intervention||5
10795117|NCT03632083|11955497|FG000|NOT COMPLETED|Second Intervention||0
10795118|NCT03632083|11955498|FG001|NOT COMPLETED|Second Intervention||0
10574107|NCT01675765|11729280|FG001|STARTED|Overall Study||22
10574108|NCT01675765|11729279|FG000|COMPLETED|Overall Study||27
10574109|NCT01675765|11729280|FG001|COMPLETED|Overall Study||14
10574110|NCT01675765|11729279|FG000|NOT COMPLETED|Overall Study||11
10574111|NCT01675765|11729280|FG001|NOT COMPLETED|Overall Study||8
10574112|NCT01675778|11729286|FG000|STARTED|Overall Study||174
10574113|NCT01675778|11729286|FG000|COMPLETED|Overall Study||174
10574114|NCT01675778|11729286|FG000|NOT COMPLETED|Overall Study||0
10574115|NCT01675830|11729291|FG000|STARTED|Overall Study||10
10574116|NCT01675830|11729291|FG000|COMPLETED|Overall Study||10
10574117|NCT01675830|11729291|FG000|NOT COMPLETED|Overall Study||0
10574118|NCT01675882|11729299|FG000|STARTED|Overall Study||53
10574119|NCT01675882|11729300|FG001|STARTED|Overall Study||56
10574120|NCT01675882|11729301|FG002|STARTED|Overall Study||56
10574121|NCT01675882|11729302|FG003|STARTED|Overall Study||56
10574122|NCT01675882|11729299|FG000|COMPLETED|Overall Study||51
10574123|NCT01675882|11729300|FG001|COMPLETED|Overall Study||49
10574124|NCT01675882|11729301|FG002|COMPLETED|Overall Study||53
10574125|NCT01675882|11729302|FG003|COMPLETED|Overall Study||54
10574126|NCT01675882|11729299|FG000|NOT COMPLETED|Overall Study||2
10574127|NCT01675882|11729300|FG001|NOT COMPLETED|Overall Study||7
10574128|NCT01675882|11729301|FG002|NOT COMPLETED|Overall Study||3
10574129|NCT01675882|11729302|FG003|NOT COMPLETED|Overall Study||2
10574130|NCT01676012|11729312|FG000|STARTED|Overall Study||32
10574131|NCT01676012|11729312|FG000|COMPLETED|Overall Study||29
10574132|NCT01676012|11729312|FG000|NOT COMPLETED|Overall Study||3
10574133|NCT01676116|11729318|FG000|STARTED|Overall Study||292
10574134|NCT01676116|11729319|FG001|STARTED|Overall Study||146
10574135|NCT01676116|11729318|FG000|COMPLETED|Overall Study||276
10574136|NCT01676116|11729319|FG001|COMPLETED|Overall Study||117
10574137|NCT01676116|11729318|FG000|NOT COMPLETED|Overall Study||16
10574138|NCT01676116|11729319|FG001|NOT COMPLETED|Overall Study||29
10574139|NCT01676220|11729327|FG000|STARTED|Overall Study||439
10574140|NCT01676220|11729328|FG001|STARTED|Overall Study||439
10574141|NCT01676220|11729327|FG000|Treated|Overall Study||435
10574142|NCT01676220|11729328|FG001|Treated|Overall Study||438
10574143|NCT01676220|11729327|FG000|Modified Intent-To-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|432
10574144|NCT01676220|11729328|FG001|Modified Intent-To-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|430
10574145|NCT01676220|11729327|FG000|COMPLETED|Overall Study||337
10574146|NCT01676220|11729328|FG001|COMPLETED|Overall Study||314
10574147|NCT01676220|11729327|FG000|NOT COMPLETED|Overall Study||102
10574148|NCT01676220|11729328|FG001|NOT COMPLETED|Overall Study||125
10574149|NCT01676298|11729344|FG000|STARTED|Overall Study||1
10574150|NCT01676298|11729345|FG001|STARTED|Overall Study||1
10574151|NCT01676298|11729346|FG002|STARTED|Overall Study||1
10574152|NCT01676298|11729347|FG003|STARTED|Overall Study||1
10574153|NCT01676298|11729348|FG004|STARTED|Overall Study||1
10574154|NCT01676298|11729349|FG005|STARTED|Overall Study||1
10574155|NCT01676298|11729350|FG006|STARTED|Overall Study||1
10574156|NCT01676298|11729351|FG007|STARTED|Overall Study||1
10574157|NCT01676298|11729344|FG000|All Genotypes Confirmed With Reference|Overall Study||1
10574158|NCT01676298|11729345|FG001|All Genotypes Confirmed With Reference|Overall Study||1
10574159|NCT01676298|11729346|FG002|All Genotypes Confirmed With Reference|Overall Study||1
10574160|NCT01676298|11729347|FG003|All Genotypes Confirmed With Reference|Overall Study||1
10574161|NCT01676298|11729348|FG004|All Genotypes Confirmed With Reference|Overall Study||1
10574162|NCT01676298|11729349|FG005|All Genotypes Confirmed With Reference|Overall Study||1
10574163|NCT01676298|11729350|FG006|All Genotypes Confirmed With Reference|Overall Study||1
10574164|NCT01676298|11729351|FG007|All Genotypes Confirmed With Reference|Overall Study||1
10574165|NCT01676298|11729344|FG000|Participated in All Tests|Overall Study||1
10795119|NCT03632083|11955499|FG002|NOT COMPLETED|Second Intervention||0
10795120|NCT03632083|11955500|FG003|NOT COMPLETED|Second Intervention||0
10795121|NCT03632083|11955501|FG004|NOT COMPLETED|Second Intervention||0
10795122|NCT03632083|11955502|FG005|NOT COMPLETED|Second Intervention||0
10795123|NCT03632083|11955503|FG006|NOT COMPLETED|Second Intervention||0
10795124|NCT03632083|11955504|FG007|NOT COMPLETED|Second Intervention||2
10795125|NCT03632109|11955516|FG000|STARTED|Overall Study||13
10795126|NCT03632109|11955516|FG000|COMPLETED|Overall Study||13
10795127|NCT03632109|11955516|FG000|NOT COMPLETED|Overall Study||0
10795128|NCT03632954|11955522|FG000|STARTED|Overall Study||37
10795129|NCT03632954|11955522|FG000|COMPLETED|Overall Study||3
10795130|NCT03632954|11955522|FG000|NOT COMPLETED|Overall Study||34
10795131|NCT03633084|11955529|FG000|STARTED|Overall Study||3
10795132|NCT03633084|11955530|FG001|STARTED|Overall Study||3
10795133|NCT03633084|11955531|FG002|STARTED|Overall Study||3
10574166|NCT01676298|11729345|FG001|Participated in All Tests|Overall Study||1
10574167|NCT01676298|11729346|FG002|Participated in All Tests|Overall Study||1
10574168|NCT01676298|11729347|FG003|Participated in All Tests|Overall Study||1
10574169|NCT01676298|11729348|FG004|Participated in All Tests|Overall Study||1
10574170|NCT01676298|11729349|FG005|Participated in All Tests|Overall Study||1
10574171|NCT01676298|11729350|FG006|Participated in All Tests|Overall Study||1
10574172|NCT01676298|11729351|FG007|Participated in All Tests|Overall Study||1
10574173|NCT01676298|11729344|FG000|COMPLETED|Overall Study||1
10574174|NCT01676298|11729345|FG001|COMPLETED|Overall Study||1
10574175|NCT01676298|11729346|FG002|COMPLETED|Overall Study||1
10574176|NCT01676298|11729347|FG003|COMPLETED|Overall Study||1
10574177|NCT01676298|11729348|FG004|COMPLETED|Overall Study||1
10795134|NCT03633084|11955529|FG000|COMPLETED|Overall Study||3
10574178|NCT01676298|11729349|FG005|COMPLETED|Overall Study||1
10574179|NCT01676298|11729350|FG006|COMPLETED|Overall Study||1
10574180|NCT01676298|11729351|FG007|COMPLETED|Overall Study||1
10574181|NCT01676298|11729344|FG000|NOT COMPLETED|Overall Study||0
10574182|NCT01676298|11729345|FG001|NOT COMPLETED|Overall Study||0
10574183|NCT01676298|11729346|FG002|NOT COMPLETED|Overall Study||0
10574184|NCT01676298|11729347|FG003|NOT COMPLETED|Overall Study||0
10574185|NCT01676298|11729348|FG004|NOT COMPLETED|Overall Study||0
10574186|NCT01676298|11729349|FG005|NOT COMPLETED|Overall Study||0
10574187|NCT01676298|11729350|FG006|NOT COMPLETED|Overall Study||0
10574188|NCT01676298|11729351|FG007|NOT COMPLETED|Overall Study||0
10574189|NCT01676311|11729371|FG000|STARTED|Overall Study||7
10574190|NCT01676311|11729372|FG001|STARTED|Overall Study||7
10574191|NCT01676311|11729371|FG000|COMPLETED|Overall Study||7
10574192|NCT01676311|11729372|FG001|COMPLETED|Overall Study||5
10574193|NCT01676311|11729371|FG000|NOT COMPLETED|Overall Study||0
10574194|NCT01676311|11729372|FG001|NOT COMPLETED|Overall Study||2
10574195|NCT01676415|11729380|FG000|STARTED|Overall Study||4
10574196|NCT01676415|11729381|FG001|STARTED|Overall Study||5
10574197|NCT01676415|11729380|FG000|COMPLETED|Overall Study||4
10574198|NCT01676415|11729381|FG001|COMPLETED|Overall Study||5
10574199|NCT01676415|11729380|FG000|NOT COMPLETED|Overall Study||0
10574200|NCT01676415|11729381|FG001|NOT COMPLETED|Overall Study||0
10574201|NCT01676532|11729387|FG000|STARTED|Overall Study||127
10574202|NCT01676532|11729387|FG000|COMPLETED|Overall Study||127
10574203|NCT01676532|11729387|FG000|NOT COMPLETED|Overall Study||0
10574204|NCT01676714|11729396|FG000|STARTED|Overall Study||10
10574205|NCT01676714|11729396|FG000|COMPLETED|Overall Study||10
10574206|NCT01676714|11729396|FG000|NOT COMPLETED|Overall Study||0
10574207|NCT01676727|11729401|FG000|STARTED|Overall Study||100
10574208|NCT01676727|11729401|FG000|Implanted|Overall Study||92
10574209|NCT01676727|11729401|FG000|COMPLETED|Overall Study||68
10574210|NCT01676727|11729401|FG000|NOT COMPLETED|Overall Study||32
10574211|NCT01676831|11729408|FG000|STARTED|Overall Study||8
10574212|NCT01676831|11729409|FG001|STARTED|Overall Study||5
10574213|NCT01676831|11729408|FG000|COMPLETED|Overall Study||8
10574214|NCT01676831|11729409|FG001|COMPLETED|Overall Study||4
10574215|NCT01676831|11729408|FG000|NOT COMPLETED|Overall Study||0
10574216|NCT01676831|11729409|FG001|NOT COMPLETED|Overall Study||1
10574217|NCT01676896|11729418|FG000|STARTED|Overall Study||96
10574218|NCT01676896|11729419|FG001|STARTED|Overall Study||96
10574219|NCT01676896|11729420|FG002|STARTED|Overall Study||100
10574220|NCT01676896|11729418|FG000|COMPLETED|Overall Study||84
10574221|NCT01676896|11729419|FG001|COMPLETED|Overall Study||89
10574222|NCT01676896|11729420|FG002|COMPLETED|Overall Study||81
10574223|NCT01676896|11729418|FG000|NOT COMPLETED|Overall Study||12
10574224|NCT01676896|11729419|FG001|NOT COMPLETED|Overall Study||7
10574225|NCT01676896|11729420|FG002|NOT COMPLETED|Overall Study||19
10574226|NCT01676909|11729430|FG000|STARTED|Overall Study||124
10574227|NCT01676909|11729431|FG001|STARTED|Overall Study||118
10574228|NCT01676909|11729430|FG000|Post-Treatment Assessment|Overall Study|19 not completed (3 withdrawn, 15 timed out, 1 declined)|105
10574229|NCT01676909|11729431|FG001|Post-Treatment Assessment|Overall Study|11 not completed (5 withdrawn, 6 timed out)|107
10574230|NCT01676909|11729430|FG000|COMPLETED|Overall Study|18 not completed (3 withdrawn, 15 timed out)|106
10574231|NCT01676909|11729431|FG001|COMPLETED|Overall Study|14 not completed (5 withdrawn, 9 timed out|104
10574232|NCT01676909|11729430|FG000|NOT COMPLETED|Overall Study||18
10574233|NCT01676909|11729431|FG001|NOT COMPLETED|Overall Study||14
10574234|NCT01677182|11729442|FG000|STARTED|Overall Study||184
10574235|NCT01677182|11729443|FG001|STARTED|Overall Study||169
10574236|NCT01677182|11729444|FG002|STARTED|Overall Study||182
10574237|NCT01677182|11729442|FG000|COMPLETED|Overall Study||150
10574238|NCT01677182|11729443|FG001|COMPLETED|Overall Study||141
10574239|NCT01677182|11729444|FG002|COMPLETED|Overall Study||143
10574240|NCT01677182|11729442|FG000|NOT COMPLETED|Overall Study||34
10574241|NCT01677182|11729443|FG001|NOT COMPLETED|Overall Study||28
10574242|NCT01677182|11729444|FG002|NOT COMPLETED|Overall Study||39
10574243|NCT01677195|11729455|FG000|STARTED|Overall Study||71
10574244|NCT01677195|11729456|FG001|STARTED|Overall Study||83
10574245|NCT01677195|11729457|FG002|STARTED|Overall Study||80
10574246|NCT01677195|11729455|FG000|COMPLETED|Overall Study||42
10574247|NCT01677195|11729456|FG001|COMPLETED|Overall Study||51
10574248|NCT01677195|11729457|FG002|COMPLETED|Overall Study||50
10574249|NCT01677195|11729455|FG000|NOT COMPLETED|Overall Study||29
10663107|NCT02271984|11825008|FG011|STARTED|Washout Period 3 (7 Days)||3
10455293|NCT01001221|11603334|FG004|STARTED|Overall Study|Inability to determine the MTD during study part 1|0
10455294|NCT01001221|11603330|FG000|Treated|Overall Study||5
10455295|NCT01001221|11603331|FG001|Treated|Overall Study||5
10455296|NCT01001221|11603332|FG002|Treated|Overall Study||2
10574250|NCT01677195|11729456|FG001|NOT COMPLETED|Overall Study||32
10574251|NCT01677195|11729457|FG002|NOT COMPLETED|Overall Study||30
10574252|NCT01677286|11729465|FG000|STARTED|Overall Study||25
10574253|NCT01677286|11729465|FG000|COMPLETED|Overall Study||14
10574254|NCT01677286|11729465|FG000|NOT COMPLETED|Overall Study||11
10574255|NCT01677299|11729475|FG000|STARTED|Overall Study||6
10574256|NCT01677299|11729476|FG001|STARTED|Overall Study||6
10574257|NCT01677299|11729477|FG002|STARTED|Overall Study||6
10574258|NCT01677299|11729478|FG003|STARTED|Overall Study||6
10574259|NCT01677299|11729475|FG000|COMPLETED|Overall Study||6
10574260|NCT01677299|11729476|FG001|COMPLETED|Overall Study||3
10574261|NCT01677299|11729477|FG002|COMPLETED|Overall Study||5
10574262|NCT01677299|11729478|FG003|COMPLETED|Overall Study||5
10574263|NCT01677299|11729475|FG000|NOT COMPLETED|Overall Study||0
10574264|NCT01677299|11729476|FG001|NOT COMPLETED|Overall Study||3
10574265|NCT01677299|11729477|FG002|NOT COMPLETED|Overall Study||1
10574266|NCT01677299|11729478|FG003|NOT COMPLETED|Overall Study||1
10574267|NCT01677312|11729494|FG000|STARTED|Overall Study||36
10574268|NCT01677312|11729495|FG001|STARTED|Overall Study||36
10574269|NCT01677312|11729494|FG000|COMPLETED|Overall Study||36
10574270|NCT01677312|11729495|FG001|COMPLETED|Overall Study||36
10574271|NCT01677312|11729494|FG000|NOT COMPLETED|Overall Study||0
10574272|NCT01677312|11729495|FG001|NOT COMPLETED|Overall Study||0
10574273|NCT01677377|11729504|FG000|STARTED|Overall Study||15
10574274|NCT01677377|11729505|FG001|STARTED|Overall Study||15
10574275|NCT01677377|11729506|FG002|STARTED|Overall Study||15
10574276|NCT01677377|11729504|FG000|COMPLETED|Overall Study||14
10574277|NCT01677377|11729505|FG001|COMPLETED|Overall Study||14
10574278|NCT01677377|11729506|FG002|COMPLETED|Overall Study||9
10574279|NCT01677377|11729504|FG000|NOT COMPLETED|Overall Study||1
10574280|NCT01677377|11729505|FG001|NOT COMPLETED|Overall Study||1
10574281|NCT01677377|11729506|FG002|NOT COMPLETED|Overall Study||6
10574282|NCT01677507|11729514|FG000|STARTED|Initial Assignment||63
10574283|NCT01677507|11729515|FG001|STARTED|Initial Assignment||58
10574284|NCT01677507|11729514|FG000|COMPLETED|Initial Assignment||63
10574285|NCT01677507|11729515|FG001|COMPLETED|Initial Assignment||56
10574286|NCT01677507|11729514|FG000|NOT COMPLETED|Initial Assignment||0
10574287|NCT01677507|11729515|FG001|NOT COMPLETED|Initial Assignment||2
10574288|NCT01677507|11729514|FG000|STARTED|Second Assigment||63
10574289|NCT01677507|11729515|FG001|STARTED|Second Assigment||56
10574290|NCT01677507|11729514|FG000|COMPLETED|Second Assigment||60
10574291|NCT01677507|11729515|FG001|COMPLETED|Second Assigment||51
10574292|NCT01677507|11729514|FG000|NOT COMPLETED|Second Assigment||3
10574293|NCT01677507|11729515|FG001|NOT COMPLETED|Second Assigment||5
10574294|NCT01677624|11729523|FG000|STARTED|Overall Study||28
10574295|NCT01677624|11729523|FG000|COMPLETED|Overall Study||27
10574296|NCT01677624|11729523|FG000|NOT COMPLETED|Overall Study||1
10574297|NCT01677741|11729535|FG000|STARTED|Overall Study||3
10574298|NCT01677741|11729536|FG001|STARTED|Overall Study||10
10574299|NCT01677741|11729537|FG002|STARTED|Overall Study||8
10574300|NCT01677741|11729538|FG003|STARTED|Overall Study||6
10574301|NCT01677741|11729539|FG004|STARTED|Overall Study||17
10574302|NCT01677741|11729540|FG005|STARTED|Overall Study||28
10574303|NCT01677741|11729541|FG006|STARTED|Overall Study||11
10574304|NCT01677741|11729542|FG007|STARTED|Overall Study||2
10574305|NCT01677741|11729535|FG000|DLT Evaluable Population|Overall Study||3
10574306|NCT01677741|11729536|FG001|DLT Evaluable Population|Overall Study||10
10574307|NCT01677741|11729537|FG002|DLT Evaluable Population|Overall Study||8
10574308|NCT01677741|11729538|FG003|DLT Evaluable Population|Overall Study||6
10574309|NCT01677741|11729539|FG004|DLT Evaluable Population|Overall Study||0
10574310|NCT01677741|11729540|FG005|DLT Evaluable Population|Overall Study||0
10574311|NCT01677741|11729541|FG006|DLT Evaluable Population|Overall Study||0
10574312|NCT01677741|11729542|FG007|DLT Evaluable Population|Overall Study||0
10574313|NCT01677741|11729535|FG000|PK Population|Overall Study||3
10574314|NCT01677741|11729536|FG001|PK Population|Overall Study||10
10574315|NCT01677741|11729537|FG002|PK Population|Overall Study||8
10574316|NCT01677741|11729538|FG003|PK Population|Overall Study||6
10574317|NCT01677741|11729539|FG004|PK Population|Overall Study||17
10574318|NCT01677741|11729540|FG005|PK Population|Overall Study||28
10574319|NCT01677741|11729541|FG006|PK Population|Overall Study||11
10574320|NCT01677741|11729542|FG007|PK Population|Overall Study||2
10574321|NCT01677741|11729535|FG000|COMPLETED|Overall Study||0
10574322|NCT01677741|11729536|FG001|COMPLETED|Overall Study||0
10574323|NCT01677741|11729537|FG002|COMPLETED|Overall Study||0
10574324|NCT01677741|11729538|FG003|COMPLETED|Overall Study||0
10574325|NCT01677741|11729539|FG004|COMPLETED|Overall Study||0
10574326|NCT01677741|11729540|FG005|COMPLETED|Overall Study||0
10574327|NCT01677741|11729541|FG006|COMPLETED|Overall Study||0
10574328|NCT01677741|11729542|FG007|COMPLETED|Overall Study||0
10574329|NCT01677741|11729535|FG000|NOT COMPLETED|Overall Study||3
10574330|NCT01677741|11729536|FG001|NOT COMPLETED|Overall Study||10
10574331|NCT01677741|11729537|FG002|NOT COMPLETED|Overall Study||8
10574332|NCT01677741|11729538|FG003|NOT COMPLETED|Overall Study||6
10574333|NCT01677741|11729539|FG004|NOT COMPLETED|Overall Study||17
10574334|NCT01677741|11729540|FG005|NOT COMPLETED|Overall Study||28
10574335|NCT01677741|11729541|FG006|NOT COMPLETED|Overall Study||11
10574336|NCT01677741|11729542|FG007|NOT COMPLETED|Overall Study||2
10651394|NCT02175758|11811575|FG003|STARTED|Treatment Phase|18 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|28
10651395|NCT02175758|11811576|FG004|STARTED|Treatment Phase|1 participant enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|5
10651396|NCT02175758|11811577|FG005|STARTED|Treatment Phase||8
10651397|NCT02175758|11811572|FG000|COMPLETED|Treatment Phase||13
10651398|NCT02175758|11811573|FG001|COMPLETED|Treatment Phase||38
10651399|NCT02175758|11811574|FG002|COMPLETED|Treatment Phase||13
10651400|NCT02175758|11811575|FG003|COMPLETED|Treatment Phase||28
10651401|NCT02175758|11811576|FG004|COMPLETED|Treatment Phase||4
10651402|NCT02175758|11811577|FG005|COMPLETED|Treatment Phase||8
10651403|NCT02175758|11811572|FG000|NOT COMPLETED|Treatment Phase||0
10651404|NCT02175758|11811573|FG001|NOT COMPLETED|Treatment Phase||1
10651405|NCT02175758|11811574|FG002|NOT COMPLETED|Treatment Phase||0
10651406|NCT02175758|11811575|FG003|NOT COMPLETED|Treatment Phase||0
10651407|NCT02175758|11811576|FG004|NOT COMPLETED|Treatment Phase||1
10574337|NCT01677767|11729576|FG000|STARTED|Overall Study||124
10574338|NCT01677767|11729576|FG000|COMPLETED|Overall Study||102
10574339|NCT01677767|11729576|FG000|NOT COMPLETED|Overall Study||22
10574355|NCT01677910|11729611|FG000|STARTED|Double-Blind Treatment Period||45
10574356|NCT01677910|11729612|FG001|STARTED|Double-Blind Treatment Period||45
10574357|NCT01677910|11729613|FG002|STARTED|Double-Blind Treatment Period||45
10574358|NCT01677910|11729614|FG003|STARTED|Double-Blind Treatment Period||0
10574359|NCT01677910|11729611|FG000|COMPLETED|Double-Blind Treatment Period||38
10574360|NCT01677910|11729612|FG001|COMPLETED|Double-Blind Treatment Period||42
10574361|NCT01677910|11729613|FG002|COMPLETED|Double-Blind Treatment Period||38
10574362|NCT01677910|11729614|FG003|COMPLETED|Double-Blind Treatment Period||0
10574363|NCT01677910|11729611|FG000|NOT COMPLETED|Double-Blind Treatment Period||7
10574364|NCT01677910|11729612|FG001|NOT COMPLETED|Double-Blind Treatment Period||3
10574365|NCT01677910|11729613|FG002|NOT COMPLETED|Double-Blind Treatment Period||7
10574366|NCT01677910|11729614|FG003|NOT COMPLETED|Double-Blind Treatment Period||0
10795135|NCT03633084|11955530|FG001|COMPLETED|Overall Study||3
10795136|NCT03633084|11955531|FG002|COMPLETED|Overall Study||3
10795137|NCT03633084|11955529|FG000|NOT COMPLETED|Overall Study||0
10795138|NCT03633084|11955530|FG001|NOT COMPLETED|Overall Study||0
10795139|NCT03633084|11955531|FG002|NOT COMPLETED|Overall Study||0
10795140|NCT03633331|11955540|FG000|STARTED|Overall Study||93
10795141|NCT03633331|11955540|FG000|COMPLETED|Overall Study||92
10795142|NCT03633331|11955540|FG000|NOT COMPLETED|Overall Study||1
10810830|NCT03784300|11972527|FG004|STARTED|Overall Study||6
10810831|NCT03784300|11972528|FG005|STARTED|Overall Study||2
10810832|NCT03784300|11972523|FG000|COMPLETED|Overall Study||6
10810833|NCT03784300|11972524|FG001|COMPLETED|Overall Study||2
10810834|NCT03784300|11972525|FG002|COMPLETED|Overall Study||6
10810835|NCT03784300|11972526|FG003|COMPLETED|Overall Study||2
10810836|NCT03784300|11972527|FG004|COMPLETED|Overall Study||6
10810837|NCT03784300|11972528|FG005|COMPLETED|Overall Study||2
10810838|NCT03784300|11972523|FG000|NOT COMPLETED|Overall Study||0
10810839|NCT03784300|11972524|FG001|NOT COMPLETED|Overall Study||0
10810840|NCT03784300|11972525|FG002|NOT COMPLETED|Overall Study||0
10810841|NCT03784300|11972526|FG003|NOT COMPLETED|Overall Study||0
10810842|NCT03784300|11972527|FG004|NOT COMPLETED|Overall Study||0
10810843|NCT03784300|11972528|FG005|NOT COMPLETED|Overall Study||0
10810844|NCT03790878|11972545|FG000|STARTED|Overall Study||26
10810845|NCT03790878|11972546|FG001|STARTED|Overall Study||27
10810846|NCT03790878|11972547|FG002|STARTED|Overall Study||27
10810847|NCT03790878|11972545|FG000|COMPLETED|Overall Study||26
10810848|NCT03790878|11972546|FG001|COMPLETED|Overall Study||27
10810849|NCT03790878|11972547|FG002|COMPLETED|Overall Study||27
10810850|NCT03790878|11972545|FG000|NOT COMPLETED|Overall Study||0
10810851|NCT03790878|11972546|FG001|NOT COMPLETED|Overall Study||0
10810852|NCT03790878|11972547|FG002|NOT COMPLETED|Overall Study||0
10810853|NCT03789474|11972557|FG000|STARTED|Overall Study||30
10810854|NCT03789474|11972558|FG001|STARTED|Overall Study||30
10810855|NCT03789474|11972557|FG000|COMPLETED|Overall Study||30
10810856|NCT03789474|11972558|FG001|COMPLETED|Overall Study||30
10810857|NCT03789474|11972557|FG000|NOT COMPLETED|Overall Study||0
10810858|NCT03789474|11972558|FG001|NOT COMPLETED|Overall Study||0
10810859|NCT03789175|11972564|FG000|STARTED|Week 0 to Week 12 of NR||1
10810860|NCT03789175|11972564|FG000|COMPLETED|Week 0 to Week 12 of NR||1
10810861|NCT03789175|11972564|FG000|NOT COMPLETED|Week 0 to Week 12 of NR||0
10810862|NCT03789175|11972564|FG000|STARTED|Week 12 to Week 24 of NR||1
10810863|NCT03789175|11972564|FG000|COMPLETED|Week 12 to Week 24 of NR|Participant did not meet primary endpoint and completed study at week 24|1
10810864|NCT03789175|11972564|FG000|NOT COMPLETED|Week 12 to Week 24 of NR||0
10810865|NCT03787615|11972570|FG000|STARTED|Overall Study||31
10810866|NCT03787615|11972570|FG000|COMPLETED|Overall Study||27
10810867|NCT03787615|11972570|FG000|NOT COMPLETED|Overall Study||4
10574367|NCT01677910|11729611|FG000|STARTED|Open-Label Extension Period (OLE)||0
10574368|NCT01677910|11729612|FG001|STARTED|Open-Label Extension Period (OLE)||0
10810868|NCT03786718|11972575|FG000|STARTED|Overall Study||67
10810869|NCT03786718|11972575|FG000|COMPLETED|Overall Study||60
10810870|NCT03786718|11972575|FG000|NOT COMPLETED|Overall Study||7
10810871|NCT03784963|11972584|FG000|STARTED|Overall Study||12
10810872|NCT03784963|11972585|FG001|STARTED|Overall Study||10
10810873|NCT03784963|11972586|FG002|STARTED|Overall Study||1
10810874|NCT03784963|11972587|FG003|STARTED|Overall Study||0
10810875|NCT03784963|11972584|FG000|COMPLETED|Overall Study||0
10810876|NCT03784963|11972585|FG001|COMPLETED|Overall Study||0
10574369|NCT01677910|11729613|FG002|STARTED|Open-Label Extension Period (OLE)||0
10574370|NCT01677910|11729614|FG003|STARTED|Open-Label Extension Period (OLE)||115
10574371|NCT01677910|11729611|FG000|COMPLETED|Open-Label Extension Period (OLE)||0
10574372|NCT01677910|11729612|FG001|COMPLETED|Open-Label Extension Period (OLE)||0
10574373|NCT01677910|11729613|FG002|COMPLETED|Open-Label Extension Period (OLE)||0
10574374|NCT01677910|11729614|FG003|COMPLETED|Open-Label Extension Period (OLE)||79
10574375|NCT01677910|11729611|FG000|NOT COMPLETED|Open-Label Extension Period (OLE)||0
10574376|NCT01677910|11729612|FG001|NOT COMPLETED|Open-Label Extension Period (OLE)||0
10574377|NCT01677910|11729613|FG002|NOT COMPLETED|Open-Label Extension Period (OLE)||0
10574378|NCT01677910|11729614|FG003|NOT COMPLETED|Open-Label Extension Period (OLE)||36
10574379|NCT01677936|11729626|FG000|STARTED|Overall Study|31 randomized to raisins; 4 excluded due to lack of post-baseline evaluation; 27 = full dataset|31
10574380|NCT01677936|11729627|FG001|STARTED|Overall Study|20 randomized to snacks; 1 excluded due to lack of post-baseline evaluation; 19 = full dataset|20
10574381|NCT01677936|11729626|FG000|COMPLETED|Overall Study|Full analysis dataset completers|22
10574382|NCT01677936|11729627|FG001|COMPLETED|Overall Study|Full analysis dataset completers|15
10574383|NCT01677936|11729626|FG000|NOT COMPLETED|Overall Study||9
10574384|NCT01677936|11729627|FG001|NOT COMPLETED|Overall Study||5
10574385|NCT01677988|11729633|FG000|STARTED|Overall Study||3
10574386|NCT01677988|11729633|FG000|COMPLETED|Overall Study||1
10574387|NCT01677988|11729633|FG000|NOT COMPLETED|Overall Study||2
10574397|NCT01678144|11729651|FG000|STARTED|Stage 1: MAR Classic||7
10574398|NCT01678144|11729651|FG000|COMPLETED|Stage 1: MAR Classic||6
10574399|NCT01678144|11729651|FG000|NOT COMPLETED|Stage 1: MAR Classic||1
10574400|NCT01678144|11729651|FG000|STARTED|Stage 2: MAR Regular and MAR Expanded||5
10574401|NCT01678144|11729651|FG000|COMPLETED|Stage 2: MAR Regular and MAR Expanded||5
10574402|NCT01678144|11729651|FG000|NOT COMPLETED|Stage 2: MAR Regular and MAR Expanded||0
10574403|NCT01678196|11729657|FG000|STARTED|Overall Study||34
10574404|NCT01678196|11729658|FG001|STARTED|Overall Study||32
10574405|NCT01678196|11729657|FG000|COMPLETED|Overall Study|Primary outcome data was from the electronic medical record and was available for all participants.|34
10574406|NCT01678196|11729658|FG001|COMPLETED|Overall Study|Primary outcome data was from the electronic medical record and was available for all participants.|32
10574407|NCT01678196|11729657|FG000|NOT COMPLETED|Overall Study||0
10574408|NCT01678196|11729658|FG001|NOT COMPLETED|Overall Study||0
10574409|NCT01678209|11729667|FG000|STARTED|Overall Study||47
10574410|NCT01678209|11729668|FG001|STARTED|Overall Study||40
10574411|NCT01678209|11729669|FG002|STARTED|Overall Study||40
10574412|NCT01678209|11729667|FG000|COMPLETED|Overall Study||30
10574413|NCT01678209|11729668|FG001|COMPLETED|Overall Study||22
10574414|NCT01678209|11729669|FG002|COMPLETED|Overall Study||22
10574415|NCT01678209|11729667|FG000|NOT COMPLETED|Overall Study||17
10574416|NCT01678209|11729668|FG001|NOT COMPLETED|Overall Study||18
10574417|NCT01678209|11729669|FG002|NOT COMPLETED|Overall Study||18
10574418|NCT01678313|11729679|FG000|STARTED|Completed the 3-month Therapy||70
10574419|NCT01678313|11729680|FG001|STARTED|Completed the 3-month Therapy||70
10574420|NCT01678313|11729679|FG000|COMPLETED|Completed the 3-month Therapy||64
10574421|NCT01678313|11729680|FG001|COMPLETED|Completed the 3-month Therapy||58
10574422|NCT01678313|11729679|FG000|NOT COMPLETED|Completed the 3-month Therapy||6
10574423|NCT01678313|11729680|FG001|NOT COMPLETED|Completed the 3-month Therapy||12
10574424|NCT01678313|11729679|FG000|STARTED|PSA >4 ng/dL at 3 Months||64
10574425|NCT01678313|11729680|FG001|STARTED|PSA >4 ng/dL at 3 Months||58
10574426|NCT01678313|11729679|FG000|COMPLETED|PSA >4 ng/dL at 3 Months||56
10574427|NCT01678313|11729680|FG001|COMPLETED|PSA >4 ng/dL at 3 Months||49
10574428|NCT01678313|11729679|FG000|NOT COMPLETED|PSA >4 ng/dL at 3 Months||8
10574429|NCT01678313|11729680|FG001|NOT COMPLETED|PSA >4 ng/dL at 3 Months||9
10574430|NCT01678313|11729679|FG000|STARTED|Prostate Biopsy at 3 Months||56
10574431|NCT01678313|11729680|FG001|STARTED|Prostate Biopsy at 3 Months||49
10574432|NCT01678313|11729679|FG000|COMPLETED|Prostate Biopsy at 3 Months||45
10574433|NCT01678313|11729680|FG001|COMPLETED|Prostate Biopsy at 3 Months||37
10574434|NCT01678313|11729679|FG000|NOT COMPLETED|Prostate Biopsy at 3 Months||11
10574435|NCT01678313|11729680|FG001|NOT COMPLETED|Prostate Biopsy at 3 Months||12
10574436|NCT01678443|11729686|FG000|STARTED|Overall Study||2
10574437|NCT01678443|11729686|FG000|COMPLETED|Overall Study||2
10795143|NCT03633344|11955546|FG000|STARTED|Overall Study||120
10795144|NCT03633344|11955547|FG001|STARTED|Overall Study||24
10795145|NCT03633344|11955546|FG000|COMPLETED|Overall Study||120
10795146|NCT03633344|11955547|FG001|COMPLETED|Overall Study||24
10795147|NCT03633344|11955546|FG000|NOT COMPLETED|Overall Study||0
10795148|NCT03633344|11955547|FG001|NOT COMPLETED|Overall Study||0
10795149|NCT03633448|11955557|FG000|STARTED|Period 1 (1 Day)||12
10795150|NCT03633448|11955558|FG001|STARTED|Period 1 (1 Day)||12
10795151|NCT03633448|11955557|FG000|COMPLETED|Period 1 (1 Day)||12
10795152|NCT03633448|11955558|FG001|COMPLETED|Period 1 (1 Day)||12
10795153|NCT03633448|11955557|FG000|NOT COMPLETED|Period 1 (1 Day)||0
10795154|NCT03633448|11955558|FG001|NOT COMPLETED|Period 1 (1 Day)||0
10574438|NCT01678443|11729686|FG000|NOT COMPLETED|Overall Study||0
10574439|NCT01678560|11729692|FG000|STARTED|Overall Study||26
10574440|NCT01678560|11729693|FG001|STARTED|Overall Study||26
10574441|NCT01678560|11729692|FG000|COMPLETED|Overall Study||22
10574442|NCT01678560|11729693|FG001|COMPLETED|Overall Study||20
10574443|NCT01678560|11729692|FG000|NOT COMPLETED|Overall Study||4
10574444|NCT01678560|11729693|FG001|NOT COMPLETED|Overall Study||6
10574445|NCT01678794|11729705|FG000|STARTED|Overall Study||16
10574446|NCT01678794|11729706|FG001|STARTED|Overall Study||17
10574447|NCT01678794|11729705|FG000|COMPLETED|Overall Study||16
10574448|NCT01678794|11729706|FG001|COMPLETED|Overall Study||17
10574449|NCT01678794|11729705|FG000|NOT COMPLETED|Overall Study||0
10574450|NCT01678794|11729706|FG001|NOT COMPLETED|Overall Study||0
10574451|NCT01678807|11729715|FG000|STARTED|Overall Study||65
10574452|NCT01678807|11729716|FG001|STARTED|Overall Study||65
10574453|NCT01678807|11729717|FG002|STARTED|Overall Study||65
10574454|NCT01678807|11729715|FG000|COMPLETED|Overall Study||61
10574455|NCT01678807|11729716|FG001|COMPLETED|Overall Study||60
10574456|NCT01678807|11729717|FG002|COMPLETED|Overall Study||65
10574457|NCT01678807|11729715|FG000|NOT COMPLETED|Overall Study||4
10574458|NCT01678807|11729716|FG001|NOT COMPLETED|Overall Study||5
10574459|NCT01678807|11729717|FG002|NOT COMPLETED|Overall Study||0
10574460|NCT01678820|11729728|FG000|STARTED|Overall Study||100
10574461|NCT01678820|11729729|FG001|STARTED|Overall Study||99
10574462|NCT01678820|11729730|FG002|STARTED|Overall Study||100
10574463|NCT01678820|11729728|FG000|Treated With Double-blind Study Drug|Overall Study||100
10574464|NCT01678820|11729729|FG001|Treated With Double-blind Study Drug|Overall Study||97
10574465|NCT01678820|11729730|FG002|Treated With Double-blind Study Drug|Overall Study||98
10574466|NCT01678820|11729728|FG000|COMPLETED|Overall Study||38
10574467|NCT01678820|11729729|FG001|COMPLETED|Overall Study||36
10574468|NCT01678820|11729730|FG002|COMPLETED|Overall Study||43
10574469|NCT01678820|11729728|FG000|NOT COMPLETED|Overall Study||62
10574470|NCT01678820|11729729|FG001|NOT COMPLETED|Overall Study||63
10574471|NCT01678820|11729730|FG002|NOT COMPLETED|Overall Study||57
10574472|NCT01678846|11729741|FG000|STARTED|Overall Study|Whole school implementation. Started and completed shows number of students in the end-line survey.|1921
10574473|NCT01678846|11729742|FG001|STARTED|Overall Study||1899
10574474|NCT01678846|11729741|FG000|COMPLETED|Overall Study||1921
10574475|NCT01678846|11729742|FG001|COMPLETED|Overall Study||1899
10574476|NCT01678846|11729741|FG000|NOT COMPLETED|Overall Study||0
10574477|NCT01678846|11729742|FG001|NOT COMPLETED|Overall Study||0
10574478|NCT01678885|11729750|FG000|STARTED|Phase I; 2 Wks Duration, Both Sub-study||22
10574479|NCT01678885|11729751|FG001|STARTED|Phase I; 2 Wks Duration, Both Sub-study||18
10574480|NCT01678885|11729752|FG002|STARTED|Phase I; 2 Wks Duration, Both Sub-study||23
10574481|NCT01678885|11729753|FG003|STARTED|Phase I; 2 Wks Duration, Both Sub-study||24
10574482|NCT01678885|11729754|FG004|STARTED|Phase I; 2 Wks Duration, Both Sub-study||0
10574483|NCT01678885|11729750|FG000|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||22
10574484|NCT01678885|11729751|FG001|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||15
10574485|NCT01678885|11729752|FG002|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||22
10574486|NCT01678885|11729753|FG003|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||21
10574487|NCT01678885|11729754|FG004|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
10574488|NCT01678885|11729750|FG000|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
10574489|NCT01678885|11729751|FG001|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||3
10574490|NCT01678885|11729752|FG002|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||1
10574491|NCT01678885|11729753|FG003|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||3
10574492|NCT01678885|11729754|FG004|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
10574493|NCT01678885|11729750|FG000|STARTED|Phase II; 8 Week Low Calorie Diet||0
10574494|NCT01678885|11729751|FG001|STARTED|Phase II; 8 Week Low Calorie Diet||0
10574495|NCT01678885|11729752|FG002|STARTED|Phase II; 8 Week Low Calorie Diet||0
10574496|NCT01678885|11729753|FG003|STARTED|Phase II; 8 Week Low Calorie Diet||0
10574497|NCT01678885|11729754|FG004|STARTED|Phase II; 8 Week Low Calorie Diet||87
10574498|NCT01678885|11729750|FG000|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
10574499|NCT01678885|11729751|FG001|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
10574500|NCT01678885|11729752|FG002|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
10574501|NCT01678885|11729753|FG003|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
10574502|NCT01678885|11729754|FG004|COMPLETED|Phase II; 8 Week Low Calorie Diet||70
10574503|NCT01678885|11729750|FG000|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
10574504|NCT01678885|11729751|FG001|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
10574505|NCT01678885|11729752|FG002|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
10574506|NCT01678885|11729753|FG003|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
10574507|NCT01678885|11729754|FG004|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||17
10574508|NCT01678898|11729765|FG000|STARTED|PB-102-F01||6
10574509|NCT01678898|11729766|FG001|STARTED|PB-102-F01||8
10574510|NCT01678898|11729767|FG002|STARTED|PB-102-F01||4
10574511|NCT01678898|11729765|FG000|COMPLETED|PB-102-F01||6
10574512|NCT01678898|11729766|FG001|COMPLETED|PB-102-F01||6
10574513|NCT01678898|11729767|FG002|COMPLETED|PB-102-F01||4
10574514|NCT01678898|11729765|FG000|NOT COMPLETED|PB-102-F01||0
10574515|NCT01678898|11729766|FG001|NOT COMPLETED|PB-102-F01||2
10574516|NCT01678898|11729767|FG002|NOT COMPLETED|PB-102-F01||0
10574517|NCT01678898|11729765|FG000|STARTED|PB-102-F02||6
10574518|NCT01678898|11729766|FG001|STARTED|PB-102-F02||6
10574519|NCT01678898|11729767|FG002|STARTED|PB-102-F02||4
10574520|NCT01678898|11729765|FG000|COMPLETED|PB-102-F02||6
10574521|NCT01678898|11729766|FG001|COMPLETED|PB-102-F02||6
10574522|NCT01678898|11729767|FG002|COMPLETED|PB-102-F02||4
10574523|NCT01678898|11729765|FG000|NOT COMPLETED|PB-102-F02||0
10574524|NCT01678898|11729766|FG001|NOT COMPLETED|PB-102-F02||0
10574525|NCT01678898|11729767|FG002|NOT COMPLETED|PB-102-F02||0
10574526|NCT01678911|11729784|FG000|STARTED|First Intervention||4
10574527|NCT01678911|11729785|FG001|STARTED|First Intervention||1
10574528|NCT01678911|11729784|FG000|Cross Over|First Intervention||4
10574529|NCT01678911|11729785|FG001|Cross Over|First Intervention||1
10574530|NCT01678911|11729784|FG000|COMPLETED|First Intervention||4
10574531|NCT01678911|11729785|FG001|COMPLETED|First Intervention||1
10574532|NCT01678911|11729784|FG000|NOT COMPLETED|First Intervention||0
10574533|NCT01678911|11729785|FG001|NOT COMPLETED|First Intervention||0
10574534|NCT01678911|11729784|FG000|STARTED|Second Intervention||4
10574535|NCT01678911|11729785|FG001|STARTED|Second Intervention||1
10574536|NCT01678911|11729784|FG000|COMPLETED|Second Intervention||2
10574537|NCT01678911|11729785|FG001|COMPLETED|Second Intervention||1
10663108|NCT02271984|11824997|FG000|COMPLETED|Washout Period 3 (7 Days)||3
10663109|NCT02271984|11824998|FG001|COMPLETED|Washout Period 3 (7 Days)||3
10663110|NCT02271984|11824999|FG002|COMPLETED|Washout Period 3 (7 Days)||3
10663111|NCT02271984|11825000|FG003|COMPLETED|Washout Period 3 (7 Days)||3
10663112|NCT02271984|11825001|FG004|COMPLETED|Washout Period 3 (7 Days)||3
10663113|NCT02271984|11825002|FG005|COMPLETED|Washout Period 3 (7 Days)||3
10663114|NCT02271984|11825003|FG006|COMPLETED|Washout Period 3 (7 Days)||3
10663115|NCT02271984|11825004|FG007|COMPLETED|Washout Period 3 (7 Days)||3
10663116|NCT02271984|11825005|FG008|COMPLETED|Washout Period 3 (7 Days)||3
10663117|NCT02271984|11825006|FG009|COMPLETED|Washout Period 3 (7 Days)||3
10663118|NCT02271984|11825007|FG010|COMPLETED|Washout Period 3 (7 Days)||3
10663119|NCT02271984|11825008|FG011|COMPLETED|Washout Period 3 (7 Days)||3
10663120|NCT02271984|11824997|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
10663121|NCT02271984|11824998|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
10663122|NCT02271984|11824999|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
10663123|NCT02271984|11825000|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
10663124|NCT02271984|11825001|FG004|NOT COMPLETED|Washout Period 3 (7 Days)||0
10663125|NCT02271984|11825002|FG005|NOT COMPLETED|Washout Period 3 (7 Days)||0
10663126|NCT02271984|11825003|FG006|NOT COMPLETED|Washout Period 3 (7 Days)||0
10663127|NCT02271984|11825004|FG007|NOT COMPLETED|Washout Period 3 (7 Days)||0
10663128|NCT02271984|11825005|FG008|NOT COMPLETED|Washout Period 3 (7 Days)||0
10663129|NCT02271984|11825006|FG009|NOT COMPLETED|Washout Period 3 (7 Days)||0
10663130|NCT02271984|11825007|FG010|NOT COMPLETED|Washout Period 3 (7 Days)||0
10663131|NCT02271984|11825008|FG011|NOT COMPLETED|Washout Period 3 (7 Days)||0
10663132|NCT02271984|11824997|FG000|STARTED|Fourth Intervention Period (Day 1)||3
10663133|NCT02271984|11824998|FG001|STARTED|Fourth Intervention Period (Day 1)||3
10663134|NCT02271984|11824999|FG002|STARTED|Fourth Intervention Period (Day 1)||3
10663135|NCT02271984|11825000|FG003|STARTED|Fourth Intervention Period (Day 1)||3
10663136|NCT02271984|11825001|FG004|STARTED|Fourth Intervention Period (Day 1)||3
10663137|NCT02271984|11825002|FG005|STARTED|Fourth Intervention Period (Day 1)||3
10663138|NCT02271984|11825003|FG006|STARTED|Fourth Intervention Period (Day 1)||3
10663139|NCT02271984|11825004|FG007|STARTED|Fourth Intervention Period (Day 1)||3
10663140|NCT02271984|11825005|FG008|STARTED|Fourth Intervention Period (Day 1)||3
10663141|NCT02271984|11825006|FG009|STARTED|Fourth Intervention Period (Day 1)||3
10663142|NCT02271984|11825007|FG010|STARTED|Fourth Intervention Period (Day 1)||3
10663143|NCT02271984|11825008|FG011|STARTED|Fourth Intervention Period (Day 1)||3
10663144|NCT02271984|11824997|FG000|COMPLETED|Fourth Intervention Period (Day 1)||3
10663145|NCT02271984|11824998|FG001|COMPLETED|Fourth Intervention Period (Day 1)||3
10663146|NCT02271984|11824999|FG002|COMPLETED|Fourth Intervention Period (Day 1)||3
10663147|NCT02271984|11825000|FG003|COMPLETED|Fourth Intervention Period (Day 1)||3
10663148|NCT02271984|11825001|FG004|COMPLETED|Fourth Intervention Period (Day 1)||3
10663149|NCT02271984|11825002|FG005|COMPLETED|Fourth Intervention Period (Day 1)||3
10663150|NCT02271984|11825003|FG006|COMPLETED|Fourth Intervention Period (Day 1)||3
10663151|NCT02271984|11825004|FG007|COMPLETED|Fourth Intervention Period (Day 1)||3
10663152|NCT02271984|11825005|FG008|COMPLETED|Fourth Intervention Period (Day 1)||3
10663153|NCT02271984|11825006|FG009|COMPLETED|Fourth Intervention Period (Day 1)||3
10663154|NCT02271984|11825007|FG010|COMPLETED|Fourth Intervention Period (Day 1)||3
10663155|NCT02271984|11825008|FG011|COMPLETED|Fourth Intervention Period (Day 1)||3
10663156|NCT02271984|11824997|FG000|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
10663157|NCT02271984|11824998|FG001|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
10663158|NCT02271984|11824999|FG002|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
10663159|NCT02271984|11825000|FG003|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
10663160|NCT02271984|11825001|FG004|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
10663161|NCT02271984|11825002|FG005|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
10663162|NCT02271984|11825003|FG006|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
10663163|NCT02271984|11825004|FG007|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
10663164|NCT02271984|11825005|FG008|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
10663165|NCT02271984|11825006|FG009|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
10663166|NCT02271984|11825007|FG010|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
10663167|NCT02271984|11825008|FG011|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
10663168|NCT02271984|11824997|FG000|STARTED|Washout Period 4 (7 Days)||3
10663169|NCT02271984|11824998|FG001|STARTED|Washout Period 4 (7 Days)||3
10663170|NCT02271984|11824999|FG002|STARTED|Washout Period 4 (7 Days)||3
10663171|NCT02271984|11825000|FG003|STARTED|Washout Period 4 (7 Days)||3
10663172|NCT02271984|11825001|FG004|STARTED|Washout Period 4 (7 Days)||3
10663173|NCT02271984|11825002|FG005|STARTED|Washout Period 4 (7 Days)||3
10663174|NCT02271984|11825003|FG006|STARTED|Washout Period 4 (7 Days)||3
10663175|NCT02271984|11825004|FG007|STARTED|Washout Period 4 (7 Days)||3
10663176|NCT02271984|11825005|FG008|STARTED|Washout Period 4 (7 Days)||3
10663177|NCT02271984|11825006|FG009|STARTED|Washout Period 4 (7 Days)||3
10663178|NCT02271984|11825007|FG010|STARTED|Washout Period 4 (7 Days)||3
10663179|NCT02271984|11825008|FG011|STARTED|Washout Period 4 (7 Days)||3
10663180|NCT02271984|11824997|FG000|COMPLETED|Washout Period 4 (7 Days)||3
10663181|NCT02271984|11824998|FG001|COMPLETED|Washout Period 4 (7 Days)||3
10663182|NCT02271984|11824999|FG002|COMPLETED|Washout Period 4 (7 Days)||3
10663183|NCT02271984|11825000|FG003|COMPLETED|Washout Period 4 (7 Days)||3
10663184|NCT02271984|11825001|FG004|COMPLETED|Washout Period 4 (7 Days)||3
10663185|NCT02271984|11825002|FG005|COMPLETED|Washout Period 4 (7 Days)||2
10663186|NCT02271984|11825003|FG006|COMPLETED|Washout Period 4 (7 Days)||3
10663187|NCT02271984|11825004|FG007|COMPLETED|Washout Period 4 (7 Days)||2
10663188|NCT02271984|11825005|FG008|COMPLETED|Washout Period 4 (7 Days)||3
10663189|NCT02271984|11825006|FG009|COMPLETED|Washout Period 4 (7 Days)||3
10663190|NCT02271984|11825007|FG010|COMPLETED|Washout Period 4 (7 Days)||3
10663191|NCT02271984|11825008|FG011|COMPLETED|Washout Period 4 (7 Days)||3
10663192|NCT02271984|11824997|FG000|NOT COMPLETED|Washout Period 4 (7 Days)||0
10663193|NCT02271984|11824998|FG001|NOT COMPLETED|Washout Period 4 (7 Days)||0
10663194|NCT02271984|11824999|FG002|NOT COMPLETED|Washout Period 4 (7 Days)||0
10663195|NCT02271984|11825000|FG003|NOT COMPLETED|Washout Period 4 (7 Days)||0
10663196|NCT02271984|11825001|FG004|NOT COMPLETED|Washout Period 4 (7 Days)||0
10663197|NCT02271984|11825002|FG005|NOT COMPLETED|Washout Period 4 (7 Days)||1
10663198|NCT02271984|11825003|FG006|NOT COMPLETED|Washout Period 4 (7 Days)||0
10663199|NCT02271984|11825004|FG007|NOT COMPLETED|Washout Period 4 (7 Days)||1
10663200|NCT02271984|11825005|FG008|NOT COMPLETED|Washout Period 4 (7 Days)||0
10795155|NCT03633448|11955557|FG000|STARTED|Washout (7 Days)||12
10795156|NCT03633448|11955558|FG001|STARTED|Washout (7 Days)||12
10795157|NCT03633448|11955557|FG000|COMPLETED|Washout (7 Days)||12
10795158|NCT03633448|11955558|FG001|COMPLETED|Washout (7 Days)||12
10795159|NCT03633448|11955557|FG000|NOT COMPLETED|Washout (7 Days)||0
10795160|NCT03633448|11955558|FG001|NOT COMPLETED|Washout (7 Days)||0
10795161|NCT03633448|11955557|FG000|STARTED|Period 2 (1 Day)||12
10795162|NCT03633448|11955558|FG001|STARTED|Period 2 (1 Day)||12
10795163|NCT03633448|11955557|FG000|COMPLETED|Period 2 (1 Day)||12
10795164|NCT03633448|11955558|FG001|COMPLETED|Period 2 (1 Day)||12
10795165|NCT03633448|11955557|FG000|NOT COMPLETED|Period 2 (1 Day)||0
10795166|NCT03633448|11955558|FG001|NOT COMPLETED|Period 2 (1 Day)||0
10795167|NCT03633487|11955568|FG000|STARTED|Overall Study||24
10795168|NCT03633487|11955568|FG000|COMPLETED|Overall Study||24
10795169|NCT03633487|11955568|FG000|NOT COMPLETED|Overall Study||0
10795170|NCT03633526|11955572|FG000|STARTED|Overall Study||16
10795171|NCT03633526|11955572|FG000|COMPLETED|Overall Study||16
10795172|NCT03633526|11955572|FG000|NOT COMPLETED|Overall Study||0
10795173|NCT03633825|11955578|FG000|STARTED|Enrollment||19838
10795174|NCT03633825|11955579|FG001|STARTED|Enrollment||19612
10795175|NCT03633825|11955578|FG000|COMPLETED|Enrollment||805
10795176|NCT03633825|11955579|FG001|COMPLETED|Enrollment||775
10795177|NCT03633825|11955578|FG000|NOT COMPLETED|Enrollment||19033
10795178|NCT03633825|11955579|FG001|NOT COMPLETED|Enrollment||18837
10795179|NCT03633825|11955578|FG000|STARTED|Allocation||805
10795180|NCT03633825|11955579|FG001|STARTED|Allocation||775
10795181|NCT03633825|11955578|FG000|COMPLETED|Allocation||805
10663201|NCT02271984|11825006|FG009|NOT COMPLETED|Washout Period 4 (7 Days)||0
10663202|NCT02271984|11825007|FG010|NOT COMPLETED|Washout Period 4 (7 Days)||0
10663203|NCT02271984|11825008|FG011|NOT COMPLETED|Washout Period 4 (7 Days)||0
10663204|NCT02271984|11824997|FG000|STARTED|Fifth Intervention Period (1 Day)||3
10663205|NCT02271984|11824998|FG001|STARTED|Fifth Intervention Period (1 Day)||3
10663206|NCT02271984|11824999|FG002|STARTED|Fifth Intervention Period (1 Day)||3
10663207|NCT02271984|11825000|FG003|STARTED|Fifth Intervention Period (1 Day)||3
10663208|NCT02271984|11825001|FG004|STARTED|Fifth Intervention Period (1 Day)||3
10663209|NCT02271984|11825002|FG005|STARTED|Fifth Intervention Period (1 Day)||2
10663210|NCT02271984|11825003|FG006|STARTED|Fifth Intervention Period (1 Day)||3
10663211|NCT02271984|11825004|FG007|STARTED|Fifth Intervention Period (1 Day)||2
10663212|NCT02271984|11825005|FG008|STARTED|Fifth Intervention Period (1 Day)||3
10663213|NCT02271984|11825006|FG009|STARTED|Fifth Intervention Period (1 Day)||3
10663214|NCT02271984|11825007|FG010|STARTED|Fifth Intervention Period (1 Day)||3
10663215|NCT02271984|11825008|FG011|STARTED|Fifth Intervention Period (1 Day)||3
10663216|NCT02271984|11824997|FG000|COMPLETED|Fifth Intervention Period (1 Day)||3
10663217|NCT02271984|11824998|FG001|COMPLETED|Fifth Intervention Period (1 Day)||3
10663218|NCT02271984|11824999|FG002|COMPLETED|Fifth Intervention Period (1 Day)||3
10663219|NCT02271984|11825000|FG003|COMPLETED|Fifth Intervention Period (1 Day)||3
10663220|NCT02271984|11825001|FG004|COMPLETED|Fifth Intervention Period (1 Day)||3
10663221|NCT02271984|11825002|FG005|COMPLETED|Fifth Intervention Period (1 Day)||2
10663222|NCT02271984|11825003|FG006|COMPLETED|Fifth Intervention Period (1 Day)||3
10663223|NCT02271984|11825004|FG007|COMPLETED|Fifth Intervention Period (1 Day)||2
10663224|NCT02271984|11825005|FG008|COMPLETED|Fifth Intervention Period (1 Day)||3
10795182|NCT03633825|11955579|FG001|COMPLETED|Allocation||775
10795183|NCT03633825|11955578|FG000|NOT COMPLETED|Allocation||0
10795184|NCT03633825|11955579|FG001|NOT COMPLETED|Allocation||0
10795185|NCT03633825|11955578|FG000|STARTED|Follow up||805
10663225|NCT02271984|11825006|FG009|COMPLETED|Fifth Intervention Period (1 Day)||3
10663226|NCT02271984|11825007|FG010|COMPLETED|Fifth Intervention Period (1 Day)||3
10663227|NCT02271984|11825008|FG011|COMPLETED|Fifth Intervention Period (1 Day)||3
10663228|NCT02271984|11824997|FG000|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
10663229|NCT02271984|11824998|FG001|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
10663230|NCT02271984|11824999|FG002|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
10663231|NCT02271984|11825000|FG003|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
10663232|NCT02271984|11825001|FG004|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
10663233|NCT02271984|11825002|FG005|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
10663234|NCT02271984|11825003|FG006|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
10663235|NCT02271984|11825004|FG007|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
10663236|NCT02271984|11825005|FG008|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
10663237|NCT02271984|11825006|FG009|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
10663238|NCT02271984|11825007|FG010|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
10663239|NCT02271984|11825008|FG011|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
10663240|NCT02272244|11825025|FG000|STARTED|Overall Study||203
10663241|NCT02272244|11825026|FG001|STARTED|Overall Study||197
10663242|NCT02272244|11825025|FG000|COMPLETED|Overall Study||203
10663243|NCT02272244|11825026|FG001|COMPLETED|Overall Study||197
10663244|NCT02272244|11825025|FG000|NOT COMPLETED|Overall Study||0
10663245|NCT02272244|11825026|FG001|NOT COMPLETED|Overall Study||0
10663246|NCT02272413|11825034|FG000|STARTED|Randomized Through Treatment Start|Started for this period|338
10663247|NCT02272413|11825035|FG001|STARTED|Randomized Through Treatment Start|Started for this period|333
10663248|NCT02272413|11825034|FG000|Treated|Randomized Through Treatment Start||335
10663249|NCT02272413|11825035|FG001|Treated|Randomized Through Treatment Start||328
10663250|NCT02272413|11825034|FG000|COMPLETED|Randomized Through Treatment Start||335
10663251|NCT02272413|11825035|FG001|COMPLETED|Randomized Through Treatment Start||328
10663252|NCT02272413|11825034|FG000|NOT COMPLETED|Randomized Through Treatment Start||3
10663253|NCT02272413|11825035|FG001|NOT COMPLETED|Randomized Through Treatment Start||5
10663254|NCT02272413|11825034|FG000|STARTED|Pre-switch Period|Started for this period|335
10663255|NCT02272413|11825035|FG001|STARTED|Pre-switch Period|Started for this period|328
10663256|NCT02272413|11825034|FG000|COMPLETED|Pre-switch Period||42
10663257|NCT02272413|11825035|FG001|COMPLETED|Pre-switch Period||46
10663258|NCT02272413|11825034|FG000|NOT COMPLETED|Pre-switch Period||293
10663259|NCT02272413|11825035|FG001|NOT COMPLETED|Pre-switch Period||282
10663260|NCT02272413|11825034|FG000|STARTED|Post-switch Period|Started for this period|42
10663261|NCT02272413|11825035|FG001|STARTED|Post-switch Period|Started for this period|46
10795186|NCT03633825|11955579|FG001|STARTED|Follow up||775
10795187|NCT03633825|11955578|FG000|COMPLETED|Follow up||327
10795188|NCT03633825|11955579|FG001|COMPLETED|Follow up||325
10795189|NCT03633825|11955578|FG000|NOT COMPLETED|Follow up||478
10795190|NCT03633825|11955579|FG001|NOT COMPLETED|Follow up||450
10795191|NCT03633825|11955578|FG000|STARTED|Analysis||327
10795192|NCT03633825|11955579|FG001|STARTED|Analysis||325
10663262|NCT02272413|11825034|FG000|COMPLETED|Post-switch Period||0
10663263|NCT02272413|11825035|FG001|COMPLETED|Post-switch Period||0
10663264|NCT02272413|11825034|FG000|NOT COMPLETED|Post-switch Period||42
10663265|NCT02272413|11825035|FG001|NOT COMPLETED|Post-switch Period||46
10663266|NCT02272634|11825046|FG000|STARTED|Overall Study||20
10663267|NCT02272634|11825047|FG001|STARTED|Overall Study||21
10663268|NCT02272634|11825048|FG002|STARTED|Overall Study||20
10663269|NCT02272634|11825046|FG000|COMPLETED|Overall Study||19
10663270|NCT02272634|11825047|FG001|COMPLETED|Overall Study||20
10663271|NCT02272634|11825048|FG002|COMPLETED|Overall Study||19
10663272|NCT02272634|11825046|FG000|NOT COMPLETED|Overall Study||1
10663273|NCT02272634|11825047|FG001|NOT COMPLETED|Overall Study||1
10663274|NCT02272634|11825048|FG002|NOT COMPLETED|Overall Study||1
10663275|NCT02272686|11825059|FG000|STARTED|Overall Study||1
10663276|NCT02272686|11825059|FG000|COMPLETED|Overall Study||1
10663277|NCT02272686|11825059|FG000|NOT COMPLETED|Overall Study||0
10663278|NCT02272725|11825065|FG000|STARTED|Overall Study||49
10663279|NCT02272725|11825066|FG001|STARTED|Overall Study||42
10663280|NCT02272725|11825065|FG000|COMPLETED|Overall Study||47
10663281|NCT02272725|11825066|FG001|COMPLETED|Overall Study||42
10663282|NCT02272725|11825065|FG000|NOT COMPLETED|Overall Study||2
10663283|NCT02272725|11825066|FG001|NOT COMPLETED|Overall Study||0
10663284|NCT02272777|11825074|FG000|STARTED|Overall Study||112
10663285|NCT02272777|11825075|FG001|STARTED|Overall Study||113
10663286|NCT02272777|11825074|FG000|COMPLETED|Overall Study||108
10663287|NCT02272777|11825075|FG001|COMPLETED|Overall Study||109
10663288|NCT02272777|11825074|FG000|NOT COMPLETED|Overall Study||4
10663289|NCT02272777|11825075|FG001|NOT COMPLETED|Overall Study||4
10663290|NCT02272816|11825081|FG000|STARTED|Overall Study||48
10663291|NCT02272816|11825081|FG000|COMPLETED|Overall Study||47
10663292|NCT02272816|11825081|FG000|NOT COMPLETED|Overall Study||1
10663293|NCT02272842|11825087|FG000|STARTED|Overall Study||300
10663294|NCT02272842|11825088|FG001|STARTED|Overall Study||300
10663295|NCT02272842|11825087|FG000|COMPLETED|Overall Study||284
10663296|NCT02272842|11825088|FG001|COMPLETED|Overall Study||290
10663297|NCT02272842|11825087|FG000|NOT COMPLETED|Overall Study||16
10663298|NCT02272842|11825088|FG001|NOT COMPLETED|Overall Study||10
10663299|NCT02272985|11825095|FG000|STARTED|Overall Study||15
10663300|NCT02272985|11825095|FG000|COMPLETED|Overall Study||12
10663301|NCT02272985|11825095|FG000|NOT COMPLETED|Overall Study||3
10795193|NCT03633825|11955578|FG000|COMPLETED|Analysis||327
10795194|NCT03633825|11955579|FG001|COMPLETED|Analysis||325
10663302|NCT02273037|11825102|FG000|STARTED|Overall Study||987
10663303|NCT02273037|11825103|FG001|STARTED|Overall Study||1000
10663304|NCT02273037|11825102|FG000|COMPLETED|Overall Study||979
10663305|NCT02273037|11825103|FG001|COMPLETED|Overall Study||992
10663306|NCT02273037|11825102|FG000|NOT COMPLETED|Overall Study||8
10663307|NCT02273037|11825103|FG001|NOT COMPLETED|Overall Study||8
10663308|NCT02273050|11825114|FG000|STARTED|Overall Study||210
10663309|NCT02273050|11825115|FG001|STARTED|Overall Study||216
10663310|NCT02273050|11825116|FG002|STARTED|Overall Study||214
10663311|NCT02273050|11825114|FG000|COMPLETED|Overall Study||186
10663312|NCT02273050|11825115|FG001|COMPLETED|Overall Study||194
10663313|NCT02273050|11825116|FG002|COMPLETED|Overall Study||185
10663314|NCT02273050|11825114|FG000|NOT COMPLETED|Overall Study||24
10663315|NCT02273050|11825115|FG001|NOT COMPLETED|Overall Study||22
10663316|NCT02273050|11825116|FG002|NOT COMPLETED|Overall Study||29
10663317|NCT02273063|11825124|FG000|STARTED|Overall Study||40
10663318|NCT02273063|11825124|FG000|COMPLETED|Overall Study||35
10663319|NCT02273063|11825124|FG000|NOT COMPLETED|Overall Study||5
10663320|NCT02273115|11825133|FG000|STARTED|Overall Study||94
10663321|NCT02273115|11825134|FG001|STARTED|Overall Study||90
10663322|NCT02273115|11825135|FG002|STARTED|Overall Study||67
10663323|NCT02273115|11825136|FG003|STARTED|Overall Study||72
10663324|NCT02273115|11825133|FG000|COMPLETED|Overall Study||94
10663325|NCT02273115|11825134|FG001|COMPLETED|Overall Study||90
10663326|NCT02273115|11825135|FG002|COMPLETED|Overall Study||67
10663327|NCT02273115|11825136|FG003|COMPLETED|Overall Study||71
10663328|NCT02273115|11825133|FG000|NOT COMPLETED|Overall Study||0
10663329|NCT02273115|11825134|FG001|NOT COMPLETED|Overall Study||0
10663330|NCT02273115|11825135|FG002|NOT COMPLETED|Overall Study||0
10663331|NCT02273115|11825136|FG003|NOT COMPLETED|Overall Study||1
10663332|NCT02273141|11825148|FG000|STARTED|Overall Study||257
10663333|NCT02273141|11825149|FG001|STARTED|Overall Study||258
10663334|NCT02273141|11825148|FG000|COMPLETED|Overall Study||240
10663335|NCT02273141|11825149|FG001|COMPLETED|Overall Study||233
10663336|NCT02273141|11825148|FG000|NOT COMPLETED|Overall Study||17
10663337|NCT02273141|11825149|FG001|NOT COMPLETED|Overall Study||25
10663338|NCT02273167|11825158|FG000|STARTED|Overall Study||283
10663339|NCT02273167|11825159|FG001|STARTED|Overall Study||283
10663340|NCT02273167|11825160|FG002|STARTED|Overall Study||283
10663341|NCT02273167|11825158|FG000|COMPLETED|Overall Study||259
10663342|NCT02273167|11825159|FG001|COMPLETED|Overall Study||260
10663343|NCT02273167|11825160|FG002|COMPLETED|Overall Study||262
10663344|NCT02273167|11825158|FG000|NOT COMPLETED|Overall Study||24
10663345|NCT02273167|11825159|FG001|NOT COMPLETED|Overall Study||23
10663346|NCT02273167|11825160|FG002|NOT COMPLETED|Overall Study||21
10663347|NCT02273180|11825171|FG000|STARTED|Overall Study||253
10663348|NCT02273180|11825172|FG001|STARTED|Overall Study||254
10663349|NCT02273180|11825171|FG000|Treated|Overall Study||252
10663350|NCT02273180|11825172|FG001|Treated|Overall Study||254
10663351|NCT02273180|11825171|FG000|COMPLETED|Overall Study||226
10663352|NCT02273180|11825172|FG001|COMPLETED|Overall Study||235
10663353|NCT02273180|11825171|FG000|NOT COMPLETED|Overall Study||27
10795195|NCT03633825|11955578|FG000|NOT COMPLETED|Analysis||0
10795196|NCT03633825|11955579|FG001|NOT COMPLETED|Analysis||0
10795197|NCT03633903|11955587|FG000|STARTED|Overall Study||22
10795198|NCT03633903|11955588|FG001|STARTED|Overall Study||18
10795199|NCT03633903|11955587|FG000|Intent to Treat|Overall Study||0
10795200|NCT03633903|11955588|FG001|Intent to Treat|Overall Study||18
10795201|NCT03633903|11955587|FG000|COMPLETED|Overall Study||16
10795202|NCT03633903|11955588|FG001|COMPLETED|Overall Study||11
10795203|NCT03633903|11955587|FG000|NOT COMPLETED|Overall Study||6
10795204|NCT03633903|11955588|FG001|NOT COMPLETED|Overall Study||7
10795205|NCT03633929|11955594|FG000|STARTED|Overall Study||19
10795206|NCT03633929|11955594|FG000|COMPLETED|Overall Study||15
10795207|NCT03633929|11955594|FG000|NOT COMPLETED|Overall Study||4
10795208|NCT03634085|11955600|FG000|STARTED|Overall Study||8
10795209|NCT03634085|11955601|FG001|STARTED|Overall Study||8
10795210|NCT03634085|11955600|FG000|Period 1|Overall Study|8 subjects started BDM2-50 mg and 8 subjects completed BDM2-50 mg including matching placebo.|8
10795211|NCT03634085|11955601|FG001|Period 1|Overall Study|8 subjects started BDM2 - 150mg and 8 subjects completed BDM2 - 150 mg including matching placebo|8
10795212|NCT03634085|11955600|FG000|Period 2|Overall Study|8 subjects started BDM2 - 450 mg and 7 subjects completed BDM2 - 450 mg (drop out; 1 active)|8
10663354|NCT02273180|11825172|FG001|NOT COMPLETED|Overall Study||19
10663355|NCT02273206|11825180|FG000|STARTED|Overall Study||378
10663356|NCT02273206|11825181|FG001|STARTED|Overall Study||379
10663357|NCT02273206|11825180|FG000|COMPLETED|Overall Study||353
10663358|NCT02273206|11825181|FG001|COMPLETED|Overall Study||337
10663359|NCT02273206|11825180|FG000|NOT COMPLETED|Overall Study||25
10663360|NCT02273206|11825181|FG001|NOT COMPLETED|Overall Study||42
10712127|NCT02667457|11877693|FG000|Full Analysis Set Population (FAS)|Overall Study||25
10712128|NCT02667457|11877694|FG001|Full Analysis Set Population (FAS)|Overall Study||10
10712129|NCT02667457|11877693|FG000|COMPLETED|Overall Study||26
10712130|NCT02667457|11877694|FG001|COMPLETED|Overall Study||10
10795213|NCT03634085|11955601|FG001|Period 2|Overall Study|8 subjects started BDM2 - 900 mg fasted and 8 subjects completed BDM2 - 900 mg fasted|8
10810877|NCT03784963|11972586|FG002|COMPLETED|Overall Study||0
10712131|NCT02667457|11877693|FG000|NOT COMPLETED|Overall Study||1
10712132|NCT02667457|11877694|FG001|NOT COMPLETED|Overall Study||2
10712133|NCT02667626|11877703|FG000|STARTED|Overall Study||86
10712134|NCT02667626|11877704|FG001|STARTED|Overall Study||96
10712135|NCT02667626|11877703|FG000|COMPLETED|Overall Study||86
10712136|NCT02667626|11877704|FG001|COMPLETED|Overall Study||95
10663361|NCT02273310|11825189|FG000|STARTED|Overall Study||42
10663362|NCT02273310|11825190|FG001|STARTED|Overall Study||41
10663363|NCT02273310|11825189|FG000|COMPLETED|Overall Study||24
10663364|NCT02273310|11825190|FG001|COMPLETED|Overall Study||38
10663365|NCT02273310|11825189|FG000|NOT COMPLETED|Overall Study||18
10663366|NCT02273310|11825190|FG001|NOT COMPLETED|Overall Study||3
10663367|NCT02273323|11825197|FG000|STARTED|Overall Study||15
10663368|NCT02273323|11825198|FG001|STARTED|Overall Study||15
10663369|NCT02273323|11825197|FG000|COMPLETED|Overall Study||15
10663370|NCT02273323|11825198|FG001|COMPLETED|Overall Study||15
10663371|NCT02273323|11825197|FG000|NOT COMPLETED|Overall Study||0
10663372|NCT02273323|11825198|FG001|NOT COMPLETED|Overall Study||0
10663373|NCT02273596|11825204|FG000|STARTED|24-Week Treatment Period||29
10663374|NCT02273596|11825204|FG000|Received at Least 1 Dose of Study Drug|24-Week Treatment Period||28
10663375|NCT02273596|11825204|FG000|COMPLETED|24-Week Treatment Period||22
10663376|NCT02273596|11825204|FG000|NOT COMPLETED|24-Week Treatment Period||7
10663377|NCT02273596|11825204|FG000|STARTED|Extension Period||22
10663378|NCT02273596|11825204|FG000|Received at Least 1 Dose of Study Drug|Extension Period||22
10663379|NCT02273596|11825204|FG000|COMPLETED|Extension Period||0
10663380|NCT02273596|11825204|FG000|NOT COMPLETED|Extension Period||22
10663381|NCT02273726|11825216|FG000|STARTED|Overall Study||370
10663382|NCT02273726|11825217|FG001|STARTED|Overall Study||371
10663383|NCT02273726|11825216|FG000|Received at Least 1 Dose of Study Drug|Overall Study||370
10663384|NCT02273726|11825217|FG001|Received at Least 1 Dose of Study Drug|Overall Study||370
10663385|NCT02273726|11825216|FG000|COMPLETED|Overall Study||127
10663386|NCT02273726|11825217|FG001|COMPLETED|Overall Study||183
10663387|NCT02273726|11825216|FG000|NOT COMPLETED|Overall Study||243
10663388|NCT02273726|11825217|FG001|NOT COMPLETED|Overall Study||188
10663389|NCT02273739|11825227|FG000|STARTED|Overall Study||3
10663390|NCT02273739|11825228|FG001|STARTED|Overall Study||4
10663391|NCT02273739|11825229|FG002|STARTED|Overall Study||7
10663392|NCT02273739|11825230|FG003|STARTED|Overall Study||7
10663393|NCT02273739|11825227|FG000|COMPLETED|Overall Study||0
10663394|NCT02273739|11825228|FG001|COMPLETED|Overall Study||0
10663395|NCT02273739|11825229|FG002|COMPLETED|Overall Study||0
10663396|NCT02273739|11825230|FG003|COMPLETED|Overall Study||0
10663397|NCT02273739|11825227|FG000|NOT COMPLETED|Overall Study||3
10663398|NCT02273739|11825228|FG001|NOT COMPLETED|Overall Study||4
10663399|NCT02273739|11825229|FG002|NOT COMPLETED|Overall Study||7
10663400|NCT02273739|11825230|FG003|NOT COMPLETED|Overall Study||7
10663401|NCT02273908|11825247|FG000|STARTED|Overall Study||157
10663402|NCT02273908|11825248|FG001|STARTED|Overall Study||174
10663403|NCT02273908|11825247|FG000|COMPLETED|Overall Study||124
10663404|NCT02273908|11825248|FG001|COMPLETED|Overall Study||169
10663405|NCT02273908|11825247|FG000|NOT COMPLETED|Overall Study||33
10663406|NCT02273908|11825248|FG001|NOT COMPLETED|Overall Study||5
10663407|NCT02273960|11825262|FG000|STARTED|Short Term Period||5
10663408|NCT02273960|11825263|FG001|STARTED|Short Term Period||6
10663409|NCT02273960|11825264|FG002|STARTED|Short Term Period||5
10663410|NCT02273960|11825265|FG003|STARTED|Short Term Period||10
10663411|NCT02273960|11825262|FG000|COMPLETED|Short Term Period||0
10663412|NCT02273960|11825263|FG001|COMPLETED|Short Term Period||0
10663413|NCT02273960|11825264|FG002|COMPLETED|Short Term Period||1
10663414|NCT02273960|11825265|FG003|COMPLETED|Short Term Period||4
10663415|NCT02273960|11825262|FG000|NOT COMPLETED|Short Term Period||5
10663416|NCT02273960|11825263|FG001|NOT COMPLETED|Short Term Period||6
10663417|NCT02273960|11825264|FG002|NOT COMPLETED|Short Term Period||4
10663418|NCT02273960|11825265|FG003|NOT COMPLETED|Short Term Period||6
10663419|NCT02273960|11825262|FG000|STARTED|Long Term Extension||0
10663420|NCT02273960|11825263|FG001|STARTED|Long Term Extension||0
10663421|NCT02273960|11825264|FG002|STARTED|Long Term Extension||1
10663422|NCT02273960|11825265|FG003|STARTED|Long Term Extension||4
10663423|NCT02273960|11825262|FG000|COMPLETED|Long Term Extension||0
10663424|NCT02273960|11825263|FG001|COMPLETED|Long Term Extension||0
10663425|NCT02273960|11825264|FG002|COMPLETED|Long Term Extension||1
10663426|NCT02273960|11825265|FG003|COMPLETED|Long Term Extension||3
10663427|NCT02273960|11825262|FG000|NOT COMPLETED|Long Term Extension||0
10663428|NCT02273960|11825263|FG001|NOT COMPLETED|Long Term Extension||0
10663429|NCT02273960|11825264|FG002|NOT COMPLETED|Long Term Extension||0
10663430|NCT02273960|11825265|FG003|NOT COMPLETED|Long Term Extension||1
10795214|NCT03634085|11955600|FG000|Period 3|Overall Study|8 subjects started BDM2 - 1800 mg and 7 subjects completed BDM2 - 1800 mg (drop out; 1 active)|8
10795215|NCT03634085|11955601|FG001|Period 3|Overall Study|8 subjects started and 6 subjects completed BDM2 - 900 mg fed (dropout; 1 active 1 placebo)|8
10795216|NCT03634085|11955600|FG000|Period 4|Overall Study|8 subjects started BDM2 - 3100 mg and 7 subjects completed BDM2 - 3100 mg (drop out; 1 active)|8
10795217|NCT03634085|11955601|FG001|Period 4|Overall Study|this period is not applicable for Cohort B|0
10795218|NCT03634085|11955600|FG000|COMPLETED|Overall Study|1 subject dropped out due to car accident|7
10795219|NCT03634085|11955601|FG001|COMPLETED|Overall Study|"1 subject dropped out due to personal emergency~1 subject dropped out due to personal circumstances"|6
10795220|NCT03634085|11955600|FG000|NOT COMPLETED|Overall Study||1
10795221|NCT03634085|11955601|FG001|NOT COMPLETED|Overall Study||2
10795222|NCT03634306|11955617|FG000|STARTED|Overall Study||15
10663431|NCT02273973|11825277|FG000|STARTED|Overall Study||166
10663432|NCT02273973|11825278|FG001|STARTED|Overall Study||168
10663433|NCT02273973|11825277|FG000|COMPLETED|Overall Study||157
10663434|NCT02273973|11825278|FG001|COMPLETED|Overall Study||160
10663435|NCT02273973|11825277|FG000|NOT COMPLETED|Overall Study||9
10663436|NCT02273973|11825278|FG001|NOT COMPLETED|Overall Study||8
10663437|NCT02274038|11825284|FG000|STARTED|Overall Study||3
10663438|NCT02274038|11825284|FG000|COMPLETED|Overall Study||2
10663439|NCT02274038|11825284|FG000|NOT COMPLETED|Overall Study||1
10663440|NCT02274311|11825290|FG000|STARTED|Three Months of Clomiphene Treatment||16
10663441|NCT02274311|11825290|FG000|COMPLETED|Three Months of Clomiphene Treatment||16
10663442|NCT02274311|11825290|FG000|NOT COMPLETED|Three Months of Clomiphene Treatment||0
10663443|NCT02274311|11825290|FG000|STARTED|Three Months of Clomiphene Wash-out||16
10663444|NCT02274311|11825290|FG000|COMPLETED|Three Months of Clomiphene Wash-out||15
10663445|NCT02274311|11825290|FG000|NOT COMPLETED|Three Months of Clomiphene Wash-out||1
10663446|NCT02274493|11825296|FG000|STARTED|Overall Study||15
10663447|NCT02274493|11825296|FG000|COMPLETED|Overall Study||14
10663448|NCT02274493|11825296|FG000|NOT COMPLETED|Overall Study||1
10663449|NCT02274558|11825303|FG000|STARTED|Overall Study||78
10663450|NCT02274558|11825304|FG001|STARTED|Overall Study||76
10663451|NCT02274558|11825305|FG002|STARTED|Overall Study||80
10663452|NCT02274558|11825303|FG000|Included in the Safety Analysis Set|Overall Study||76
10663453|NCT02274558|11825304|FG001|Included in the Safety Analysis Set|Overall Study||72
10663454|NCT02274558|11825305|FG002|Included in the Safety Analysis Set|Overall Study||79
10663455|NCT02274558|11825303|FG000|COMPLETED|Overall Study||71
10663456|NCT02274558|11825304|FG001|COMPLETED|Overall Study||63
10663457|NCT02274558|11825305|FG002|COMPLETED|Overall Study||71
10663458|NCT02274558|11825303|FG000|NOT COMPLETED|Overall Study||7
10663459|NCT02274558|11825304|FG001|NOT COMPLETED|Overall Study||13
10663460|NCT02274558|11825305|FG002|NOT COMPLETED|Overall Study||9
10663461|NCT02274649|11825317|FG000|STARTED|Overall Study||101
10663462|NCT02274649|11825318|FG001|STARTED|Overall Study||93
10663463|NCT02274649|11825317|FG000|COMPLETED|Overall Study||77
10663464|NCT02274649|11825318|FG001|COMPLETED|Overall Study||81
10663465|NCT02274649|11825317|FG000|NOT COMPLETED|Overall Study||24
10663466|NCT02274649|11825318|FG001|NOT COMPLETED|Overall Study||12
10663467|NCT02274675|11825324|FG000|STARTED|Overall Study||7
10663468|NCT02274675|11825324|FG000|COMPLETED|Overall Study||7
10663469|NCT02274675|11825324|FG000|NOT COMPLETED|Overall Study||0
10663470|NCT02274688|11825330|FG000|STARTED|Overall Study||86
10663471|NCT02274688|11825331|FG001|STARTED|Overall Study||85
10663472|NCT02274688|11825330|FG000|COMPLETED|Overall Study||72
10663473|NCT02274688|11825331|FG001|COMPLETED|Overall Study||72
10663474|NCT02274688|11825330|FG000|NOT COMPLETED|Overall Study||14
10663475|NCT02274688|11825331|FG001|NOT COMPLETED|Overall Study||13
10663476|NCT02274766|11825340|FG000|STARTED|Overall Study||39
10663477|NCT02274766|11825341|FG001|STARTED|Overall Study||38
10663478|NCT02274766|11825340|FG000|Received Study Drug|Overall Study||38
10663479|NCT02274766|11825341|FG001|Received Study Drug|Overall Study||37
10663480|NCT02274766|11825340|FG000|COMPLETED|Overall Study||35
10663481|NCT02274766|11825341|FG001|COMPLETED|Overall Study||29
10663482|NCT02274766|11825340|FG000|NOT COMPLETED|Overall Study||4
10663483|NCT02274766|11825341|FG001|NOT COMPLETED|Overall Study||9
10663484|NCT02274792|11825347|FG000|STARTED|Overall Study||132
10663485|NCT02274792|11825347|FG000|Received Treatment|Overall Study||131
10663486|NCT02274792|11825347|FG000|COMPLETED|Overall Study||107
10663487|NCT02274792|11825347|FG000|NOT COMPLETED|Overall Study||25
10663488|NCT02274844|11825353|FG000|STARTED|Overall Study||203
10663489|NCT02274844|11825354|FG001|STARTED|Overall Study||270
10663490|NCT02274844|11825353|FG000|COMPLETED|Overall Study||165
10795223|NCT03634306|11955618|FG001|STARTED|Overall Study||15
10795224|NCT03634306|11955619|FG002|STARTED|Overall Study||5
10795225|NCT03634306|11955617|FG000|COMPLETED|Overall Study||15
10663491|NCT02274844|11825354|FG001|COMPLETED|Overall Study||238
10663492|NCT02274844|11825353|FG000|NOT COMPLETED|Overall Study||38
10663493|NCT02274844|11825354|FG001|NOT COMPLETED|Overall Study||32
10663494|NCT02274857|11825362|FG000|STARTED|Overall Study||179
10663495|NCT02274857|11825363|FG001|STARTED|Overall Study||171
10663496|NCT02274857|11825362|FG000|Completed Per Protocol|Overall Study||102
10663497|NCT02274857|11825363|FG001|Completed Per Protocol|Overall Study||114
10663498|NCT02274857|11825362|FG000|COMPLETED|Overall Study||159
10795226|NCT03634306|11955618|FG001|COMPLETED|Overall Study||15
10795227|NCT03634306|11955619|FG002|COMPLETED|Overall Study||5
10795228|NCT03634306|11955617|FG000|NOT COMPLETED|Overall Study||0
10795229|NCT03634306|11955618|FG001|NOT COMPLETED|Overall Study||0
10795230|NCT03634306|11955619|FG002|NOT COMPLETED|Overall Study||0
10795231|NCT03634579|11955627|FG000|STARTED|Overall Study||9
10795232|NCT03634579|11955627|FG000|COMPLETED|Overall Study||0
10795233|NCT03634579|11955627|FG000|NOT COMPLETED|Overall Study||9
10795234|NCT03634800|11955631|FG000|STARTED|Overall Study||6
10795235|NCT03634800|11955631|FG000|COMPLETED|Overall Study||0
10795236|NCT03634800|11955631|FG000|NOT COMPLETED|Overall Study||6
10795237|NCT03634813|11955637|FG000|STARTED|Overall Study||49
10795238|NCT03634813|11955638|FG001|STARTED|Overall Study||51
10795239|NCT03634813|11955637|FG000|COMPLETED|Overall Study||49
10795240|NCT03634813|11955638|FG001|COMPLETED|Overall Study||51
10795241|NCT03634813|11955637|FG000|NOT COMPLETED|Overall Study||0
10795242|NCT03634813|11955638|FG001|NOT COMPLETED|Overall Study||0
10795243|NCT03635086|11955650|FG000|STARTED|Overall Study||12
10795244|NCT03635086|11955651|FG001|STARTED|Overall Study||12
10663499|NCT02274857|11825363|FG001|COMPLETED|Overall Study||165
10663500|NCT02274857|11825362|FG000|NOT COMPLETED|Overall Study||20
10663501|NCT02274857|11825363|FG001|NOT COMPLETED|Overall Study||6
10663502|NCT02274870|11825372|FG000|STARTED|Overall Study||32
10663503|NCT02274870|11825373|FG001|STARTED|Overall Study||33
10663504|NCT02274870|11825372|FG000|COMPLETED|Overall Study||32
10795245|NCT03635086|11955652|FG002|STARTED|Overall Study||12
10663505|NCT02274870|11825373|FG001|COMPLETED|Overall Study||33
10663506|NCT02274870|11825372|FG000|NOT COMPLETED|Overall Study||0
10663507|NCT02274870|11825373|FG001|NOT COMPLETED|Overall Study||0
10663508|NCT02274948|11825384|FG000|STARTED|Overall Study||166
10663509|NCT02274948|11825385|FG001|STARTED|Overall Study||173
10663510|NCT02274948|11825384|FG000|COMPLETED|Overall Study||68
10663511|NCT02274948|11825385|FG001|COMPLETED|Overall Study||82
10663512|NCT02274948|11825384|FG000|NOT COMPLETED|Overall Study||98
10663513|NCT02274948|11825385|FG001|NOT COMPLETED|Overall Study||91
10663514|NCT02275026|11825392|FG000|STARTED|Overall Study||104
10663515|NCT02275026|11825392|FG000|COMPLETED|Overall Study||71
10663516|NCT02275026|11825392|FG000|NOT COMPLETED|Overall Study||33
10663517|NCT02275052|11825399|FG000|STARTED|Period 1: Treatment Period 1 (12 Weeks)||99
10663518|NCT02275052|11825400|FG001|STARTED|Period 1: Treatment Period 1 (12 Weeks)||99
10663519|NCT02275052|11825401|FG002|STARTED|Period 1: Treatment Period 1 (12 Weeks)||0
10663520|NCT02275052|11825402|FG003|STARTED|Period 1: Treatment Period 1 (12 Weeks)||0
10663521|NCT02275052|11825399|FG000|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||90
10663522|NCT02275052|11825400|FG001|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||93
10663523|NCT02275052|11825401|FG002|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
10663524|NCT02275052|11825402|FG003|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
10663525|NCT02275052|11825399|FG000|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||9
10663526|NCT02275052|11825400|FG001|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||6
10663527|NCT02275052|11825401|FG002|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
10663528|NCT02275052|11825402|FG003|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
10663529|NCT02275052|11825399|FG000|STARTED|Washout Period (12-17 Days)||90
10663530|NCT02275052|11825400|FG001|STARTED|Washout Period (12-17 Days)||93
10663531|NCT02275052|11825401|FG002|STARTED|Washout Period (12-17 Days)||0
10663532|NCT02275052|11825402|FG003|STARTED|Washout Period (12-17 Days)||0
10663533|NCT02275052|11825399|FG000|COMPLETED|Washout Period (12-17 Days)||86
10663534|NCT02275052|11825400|FG001|COMPLETED|Washout Period (12-17 Days)||93
10663535|NCT02275052|11825401|FG002|COMPLETED|Washout Period (12-17 Days)||0
10663536|NCT02275052|11825402|FG003|COMPLETED|Washout Period (12-17 Days)||0
10663537|NCT02275052|11825399|FG000|NOT COMPLETED|Washout Period (12-17 Days)||4
10663538|NCT02275052|11825400|FG001|NOT COMPLETED|Washout Period (12-17 Days)||0
10663539|NCT02275052|11825401|FG002|NOT COMPLETED|Washout Period (12-17 Days)||0
10663540|NCT02275052|11825402|FG003|NOT COMPLETED|Washout Period (12-17 Days)||0
10663541|NCT02275052|11825399|FG000|STARTED|Period 2: Treatment Period 2 (12 Weeks)||0
10663542|NCT02275052|11825400|FG001|STARTED|Period 2: Treatment Period 2 (12 Weeks)||0
10663543|NCT02275052|11825401|FG002|STARTED|Period 2: Treatment Period 2 (12 Weeks)||93
10663544|NCT02275052|11825402|FG003|STARTED|Period 2: Treatment Period 2 (12 Weeks)||86
10663545|NCT02275052|11825399|FG000|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
10663546|NCT02275052|11825400|FG001|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
10663547|NCT02275052|11825401|FG002|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||88
10663548|NCT02275052|11825402|FG003|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||72
10663549|NCT02275052|11825399|FG000|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
10663550|NCT02275052|11825400|FG001|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
10663551|NCT02275052|11825401|FG002|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||5
10663552|NCT02275052|11825402|FG003|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||14
10663553|NCT02275065|11825413|FG000|STARTED|Overall Study||5
10663554|NCT02275065|11825414|FG001|STARTED|Overall Study||4
10663555|NCT02275065|11825415|FG002|STARTED|Overall Study||5
10663556|NCT02275065|11825416|FG003|STARTED|Overall Study||5
10663557|NCT02275065|11825417|FG004|STARTED|Overall Study||4
10663558|NCT02275065|11825413|FG000|COMPLETED|Overall Study||4
10663559|NCT02275065|11825414|FG001|COMPLETED|Overall Study||4
10663560|NCT02275065|11825415|FG002|COMPLETED|Overall Study||4
10663561|NCT02275065|11825416|FG003|COMPLETED|Overall Study||4
10663562|NCT02275065|11825417|FG004|COMPLETED|Overall Study||4
10663563|NCT02275065|11825413|FG000|NOT COMPLETED|Overall Study||1
10663564|NCT02275065|11825414|FG001|NOT COMPLETED|Overall Study||0
10663565|NCT02275065|11825415|FG002|NOT COMPLETED|Overall Study||1
10663566|NCT02275065|11825416|FG003|NOT COMPLETED|Overall Study||1
10663567|NCT02275065|11825417|FG004|NOT COMPLETED|Overall Study||0
10663568|NCT02275117|11825434|FG000|STARTED|Overall Study||131
10663569|NCT02275117|11825435|FG001|STARTED|Overall Study||133
10663570|NCT02275117|11825436|FG002|STARTED|Overall Study||134
10663571|NCT02275117|11825437|FG003|STARTED|Overall Study||133
10663572|NCT02275117|11825438|FG004|STARTED|Overall Study||134
10663573|NCT02275117|11825434|FG000|Randomized and Treated|Overall Study||120
10663574|NCT02275117|11825435|FG001|Randomized and Treated|Overall Study||123
10663575|NCT02275117|11825436|FG002|Randomized and Treated|Overall Study||122
10663576|NCT02275117|11825437|FG003|Randomized and Treated|Overall Study||130
10663577|NCT02275117|11825438|FG004|Randomized and Treated|Overall Study||121
10663578|NCT02275117|11825434|FG000|COMPLETED|Overall Study||97
10663579|NCT02275117|11825435|FG001|COMPLETED|Overall Study||96
10663580|NCT02275117|11825436|FG002|COMPLETED|Overall Study||92
10663581|NCT02275117|11825437|FG003|COMPLETED|Overall Study||100
10663582|NCT02275117|11825438|FG004|COMPLETED|Overall Study||98
10663583|NCT02275117|11825434|FG000|NOT COMPLETED|Overall Study||34
10663584|NCT02275117|11825435|FG001|NOT COMPLETED|Overall Study||37
10663585|NCT02275117|11825436|FG002|NOT COMPLETED|Overall Study||42
10663586|NCT02275117|11825437|FG003|NOT COMPLETED|Overall Study||33
10663587|NCT02275117|11825438|FG004|NOT COMPLETED|Overall Study||36
10663588|NCT02275156|11825453|FG000|STARTED|Overall Study||6
10663589|NCT02275156|11825454|FG001|STARTED|Overall Study||6
10663590|NCT02275156|11825455|FG002|STARTED|Overall Study||6
10663591|NCT02275156|11825453|FG000|COMPLETED|Overall Study||6
10663592|NCT02275156|11825454|FG001|COMPLETED|Overall Study||6
10663593|NCT02275156|11825455|FG002|COMPLETED|Overall Study||6
10663594|NCT02275156|11825453|FG000|NOT COMPLETED|Overall Study||0
10663595|NCT02275156|11825454|FG001|NOT COMPLETED|Overall Study||0
10663596|NCT02275156|11825455|FG002|NOT COMPLETED|Overall Study||0
10663597|NCT02275338|11825464|FG000|STARTED|Overall Study||52
10663598|NCT02275338|11825464|FG000|Completed Phase 1|Overall Study||25
10663599|NCT02275338|11825464|FG000|Started Phase 2|Overall Study||21
10663600|NCT02275338|11825464|FG000|COMPLETED|Overall Study||19
10663601|NCT02275338|11825464|FG000|NOT COMPLETED|Overall Study||33
10663602|NCT02275364|11825469|FG000|STARTED|Period 1||14
10663603|NCT02275364|11825470|FG001|STARTED|Period 1||14
10663604|NCT02275364|11825469|FG000|COMPLETED|Period 1||12
10663605|NCT02275364|11825470|FG001|COMPLETED|Period 1||14
10663606|NCT02275364|11825469|FG000|NOT COMPLETED|Period 1||2
10663607|NCT02275364|11825470|FG001|NOT COMPLETED|Period 1||0
10663608|NCT02275364|11825469|FG000|STARTED|Washout Period 1||12
10663609|NCT02275364|11825470|FG001|STARTED|Washout Period 1||14
10663610|NCT02275364|11825469|FG000|COMPLETED|Washout Period 1||12
10663611|NCT02275364|11825470|FG001|COMPLETED|Washout Period 1||14
10663612|NCT02275364|11825469|FG000|NOT COMPLETED|Washout Period 1||0
10663613|NCT02275364|11825470|FG001|NOT COMPLETED|Washout Period 1||0
10663614|NCT02275364|11825469|FG000|STARTED|Period 2||12
10663615|NCT02275364|11825470|FG001|STARTED|Period 2||14
10663616|NCT02275364|11825469|FG000|COMPLETED|Period 2||12
10663617|NCT02275364|11825470|FG001|COMPLETED|Period 2||14
10663618|NCT02275364|11825469|FG000|NOT COMPLETED|Period 2||0
10663619|NCT02275364|11825470|FG001|NOT COMPLETED|Period 2||0
10663620|NCT02275364|11825469|FG000|STARTED|Washout Period 2||12
10663621|NCT02275364|11825470|FG001|STARTED|Washout Period 2||14
10663622|NCT02275364|11825469|FG000|COMPLETED|Washout Period 2||12
10663623|NCT02275364|11825470|FG001|COMPLETED|Washout Period 2||14
10663624|NCT02275364|11825469|FG000|NOT COMPLETED|Washout Period 2||0
10663625|NCT02275364|11825470|FG001|NOT COMPLETED|Washout Period 2||0
10663626|NCT02275364|11825469|FG000|STARTED|Period 3||12
10663627|NCT02275364|11825470|FG001|STARTED|Period 3||14
10663628|NCT02275364|11825469|FG000|COMPLETED|Period 3||12
10663629|NCT02275364|11825470|FG001|COMPLETED|Period 3||14
10663630|NCT02275364|11825469|FG000|NOT COMPLETED|Period 3||0
10663631|NCT02275364|11825470|FG001|NOT COMPLETED|Period 3||0
10663632|NCT02275364|11825469|FG000|STARTED|Period 4||12
10663633|NCT02275364|11825470|FG001|STARTED|Period 4||14
10663634|NCT02275364|11825469|FG000|COMPLETED|Period 4||12
10663635|NCT02275364|11825470|FG001|COMPLETED|Period 4||14
10663636|NCT02275364|11825469|FG000|NOT COMPLETED|Period 4||0
10663637|NCT02275364|11825470|FG001|NOT COMPLETED|Period 4||0
10663638|NCT02275611|11825491|FG000|STARTED|Inpatient Withdrawal||5
10663639|NCT02275611|11825492|FG001|STARTED|Inpatient Withdrawal||4
10663640|NCT02275611|11825493|FG002|STARTED|Inpatient Withdrawal||0
10663641|NCT02275611|11825494|FG003|STARTED|Inpatient Withdrawal||0
10663642|NCT02275611|11825491|FG000|COMPLETED|Inpatient Withdrawal||4
10663643|NCT02275611|11825492|FG001|COMPLETED|Inpatient Withdrawal||4
10663644|NCT02275611|11825493|FG002|COMPLETED|Inpatient Withdrawal||0
10663645|NCT02275611|11825494|FG003|COMPLETED|Inpatient Withdrawal||0
10663646|NCT02275611|11825491|FG000|NOT COMPLETED|Inpatient Withdrawal||1
10663647|NCT02275611|11825492|FG001|NOT COMPLETED|Inpatient Withdrawal||0
10663648|NCT02275611|11825493|FG002|NOT COMPLETED|Inpatient Withdrawal||0
10663649|NCT02275611|11825494|FG003|NOT COMPLETED|Inpatient Withdrawal||0
10663650|NCT02275611|11825491|FG000|STARTED|Outpatient Drinking||0
10663651|NCT02275611|11825492|FG001|STARTED|Outpatient Drinking||0
10663652|NCT02275611|11825493|FG002|STARTED|Outpatient Drinking||6
10663653|NCT02275611|11825494|FG003|STARTED|Outpatient Drinking||3
10663654|NCT02275611|11825491|FG000|COMPLETED|Outpatient Drinking||0
10663655|NCT02275611|11825492|FG001|COMPLETED|Outpatient Drinking||0
10455297|NCT01001221|11603333|FG003|Treated|Overall Study||6
10663656|NCT02275611|11825493|FG002|COMPLETED|Outpatient Drinking||6
10663657|NCT02275611|11825494|FG003|COMPLETED|Outpatient Drinking||3
10663658|NCT02275611|11825491|FG000|NOT COMPLETED|Outpatient Drinking||0
10663659|NCT02275611|11825492|FG001|NOT COMPLETED|Outpatient Drinking||0
10663660|NCT02275611|11825493|FG002|NOT COMPLETED|Outpatient Drinking||0
10663661|NCT02275611|11825494|FG003|NOT COMPLETED|Outpatient Drinking||0
10663662|NCT02275767|11825509|FG000|STARTED|Overall Study||22
10663663|NCT02275767|11825510|FG001|STARTED|Overall Study||22
10663664|NCT02275767|11825511|FG002|STARTED|Overall Study||22
10663665|NCT02275767|11825509|FG000|COMPLETED|Overall Study||20
10663666|NCT02275767|11825510|FG001|COMPLETED|Overall Study||18
10663667|NCT02275767|11825511|FG002|COMPLETED|Overall Study||19
10663668|NCT02275767|11825509|FG000|NOT COMPLETED|Overall Study||2
10663669|NCT02275767|11825510|FG001|NOT COMPLETED|Overall Study||4
10663670|NCT02275767|11825511|FG002|NOT COMPLETED|Overall Study||3
10712137|NCT02667626|11877703|FG000|NOT COMPLETED|Overall Study||0
10663685|NCT02275819|11825530|FG000|STARTED|Overall Study||5
10663686|NCT02275819|11825531|FG001|STARTED|Overall Study||6
10663687|NCT02275819|11825530|FG000|COMPLETED|Overall Study||5
10663688|NCT02275819|11825531|FG001|COMPLETED|Overall Study||5
10663689|NCT02275819|11825530|FG000|NOT COMPLETED|Overall Study||0
10663690|NCT02275819|11825531|FG001|NOT COMPLETED|Overall Study||1
10663691|NCT02275923|11825537|FG000|STARTED|Overall Study||9
10663692|NCT02275923|11825537|FG000|COMPLETED|Overall Study||7
10663693|NCT02275923|11825537|FG000|NOT COMPLETED|Overall Study||2
10663694|NCT02276027|11825545|FG000|STARTED|Overall Study||2
10663695|NCT02276027|11825546|FG001|STARTED|Overall Study||16
10663696|NCT02276027|11825547|FG002|STARTED|Overall Study||26
10663697|NCT02276027|11825548|FG003|STARTED|Overall Study||22
10663698|NCT02276027|11825545|FG000|COMPLETED|Overall Study||0
10663699|NCT02276027|11825546|FG001|COMPLETED|Overall Study||0
10663700|NCT02276027|11825547|FG002|COMPLETED|Overall Study||6
10663701|NCT02276027|11825548|FG003|COMPLETED|Overall Study||0
10663702|NCT02276027|11825545|FG000|NOT COMPLETED|Overall Study||2
10663703|NCT02276027|11825546|FG001|NOT COMPLETED|Overall Study||16
10663704|NCT02276027|11825547|FG002|NOT COMPLETED|Overall Study||20
10663705|NCT02276027|11825548|FG003|NOT COMPLETED|Overall Study||22
10663706|NCT02276040|11825558|FG000|STARTED|Overall Study||26
10663707|NCT02276040|11825558|FG000|COMPLETED|Overall Study||11
10663708|NCT02276040|11825558|FG000|NOT COMPLETED|Overall Study||15
10795246|NCT03635086|11955653|FG003|STARTED|Overall Study||12
10795247|NCT03635086|11955654|FG004|STARTED|Overall Study||12
10795248|NCT03635086|11955650|FG000|COMPLETED|Overall Study||11
10795249|NCT03635086|11955651|FG001|COMPLETED|Overall Study||11
10795250|NCT03635086|11955652|FG002|COMPLETED|Overall Study||11
10795251|NCT03635086|11955653|FG003|COMPLETED|Overall Study||12
10795252|NCT03635086|11955654|FG004|COMPLETED|Overall Study||12
10795253|NCT03635086|11955650|FG000|NOT COMPLETED|Overall Study||1
10795254|NCT03635086|11955651|FG001|NOT COMPLETED|Overall Study||1
10795255|NCT03635086|11955652|FG002|NOT COMPLETED|Overall Study||1
10795256|NCT03635086|11955653|FG003|NOT COMPLETED|Overall Study||0
10795257|NCT03635086|11955654|FG004|NOT COMPLETED|Overall Study||0
10795258|NCT03635320|11955669|FG000|STARTED|Overall Study||94
10795259|NCT03635320|11955670|FG001|STARTED|Overall Study||94
10795260|NCT03635320|11955669|FG000|FAS|Overall Study|1 subject was not implanted the device|93
10795261|NCT03635320|11955670|FG001|FAS|Overall Study|2 subjects were not implant the device|92
10455298|NCT01001221|11603334|FG004|Treated|Overall Study||0
10455299|NCT01001221|11603330|FG000|Completed 1st Treatment Cycle|Overall Study||5
10455300|NCT01001221|11603331|FG001|Completed 1st Treatment Cycle|Overall Study||5
10455301|NCT01001221|11603332|FG002|Completed 1st Treatment Cycle|Overall Study||2
10455302|NCT01001221|11603333|FG003|Completed 1st Treatment Cycle|Overall Study||6
10663709|NCT02276053|11825562|FG000|STARTED|Overall Study||93
10663710|NCT02276053|11825562|FG000|COMPLETED|Overall Study||79
10795262|NCT03635320|11955669|FG000|PPS|Overall Study|11 subjects early discontinued and didn't complete the trial which were excluded from PPS, 1 subject had a risk of unblinding, which was excluded from the PPS.|81
10795263|NCT03635320|11955670|FG001|PPS|Overall Study|6 subjects early discontinued and didn't complete the trial which were excluded from PPS, 1 subject didn't undergo the evaluation or laboratory examination required by the clinical trial, 1 subject violated the inclusion/exclusion criteria and 1 subject used the device beyond the scope of the specifications, which were excluded from the PPS.|83
10795264|NCT03635320|11955669|FG000|COMPLETED|Overall Study||82
10795265|NCT03635320|11955670|FG001|COMPLETED|Overall Study||86
10795266|NCT03635320|11955669|FG000|NOT COMPLETED|Overall Study||12
10795267|NCT03635320|11955670|FG001|NOT COMPLETED|Overall Study||8
10663711|NCT02276053|11825562|FG000|NOT COMPLETED|Overall Study||14
10663712|NCT02276222|11825569|FG000|STARTED|Overall Study||621
10663713|NCT02276222|11825570|FG001|STARTED|Overall Study||466
10663714|NCT02276222|11825569|FG000|COMPLETED|Overall Study|one subject withdrew at randomization due to a pre-treatment event prior to being dosed|436
10663715|NCT02276222|11825570|FG001|COMPLETED|Overall Study||402
10663716|NCT02276222|11825569|FG000|NOT COMPLETED|Overall Study||185
10663717|NCT02276222|11825570|FG001|NOT COMPLETED|Overall Study||64
10663718|NCT02276274|11825578|FG000|STARTED|First Intervention Period||6
10663719|NCT02276274|11825579|FG001|STARTED|First Intervention Period||6
10663720|NCT02276274|11825578|FG000|COMPLETED|First Intervention Period||6
10663721|NCT02276274|11825579|FG001|COMPLETED|First Intervention Period||6
10663722|NCT02276274|11825578|FG000|NOT COMPLETED|First Intervention Period||0
10663723|NCT02276274|11825579|FG001|NOT COMPLETED|First Intervention Period||0
10663724|NCT02276274|11825578|FG000|STARTED|Washout Period (at Least 15 Days)||6
10663725|NCT02276274|11825579|FG001|STARTED|Washout Period (at Least 15 Days)||6
10663726|NCT02276274|11825578|FG000|COMPLETED|Washout Period (at Least 15 Days)||6
10663727|NCT02276274|11825579|FG001|COMPLETED|Washout Period (at Least 15 Days)||6
10663728|NCT02276274|11825578|FG000|NOT COMPLETED|Washout Period (at Least 15 Days)||0
10663729|NCT02276274|11825579|FG001|NOT COMPLETED|Washout Period (at Least 15 Days)||0
10663730|NCT02276274|11825578|FG000|STARTED|Second Intervention Period||6
10663731|NCT02276274|11825579|FG001|STARTED|Second Intervention Period||6
10663732|NCT02276274|11825578|FG000|COMPLETED|Second Intervention Period||6
10663733|NCT02276274|11825579|FG001|COMPLETED|Second Intervention Period||6
10663734|NCT02276274|11825578|FG000|NOT COMPLETED|Second Intervention Period||0
10663735|NCT02276274|11825579|FG001|NOT COMPLETED|Second Intervention Period||0
10663736|NCT02276482|11825587|FG000|STARTED|Overall Study||91
10663737|NCT02276482|11825588|FG001|STARTED|Overall Study||29
10663738|NCT02276482|11825587|FG000|COMPLETED|Overall Study||88
10663739|NCT02276482|11825588|FG001|COMPLETED|Overall Study||28
10663740|NCT02276482|11825587|FG000|NOT COMPLETED|Overall Study||3
10663741|NCT02276482|11825588|FG001|NOT COMPLETED|Overall Study||1
10663742|NCT02276612|11825596|FG000|STARTED|Overall Study||50
10663743|NCT02276612|11825597|FG001|STARTED|Overall Study||10
10663744|NCT02276612|11825596|FG000|COMPLETED|Overall Study||46
10663745|NCT02276612|11825597|FG001|COMPLETED|Overall Study||10
10663746|NCT02276612|11825596|FG000|NOT COMPLETED|Overall Study||4
10663747|NCT02276612|11825597|FG001|NOT COMPLETED|Overall Study||0
10663748|NCT02276638|11825606|FG000|STARTED|Overall Study||28
10663749|NCT02276638|11825607|FG001|STARTED|Overall Study||28
10663750|NCT02276638|11825608|FG002|STARTED|Overall Study||23
10663751|NCT02276638|11825606|FG000|COMPLETED|Overall Study||28
10663752|NCT02276638|11825607|FG001|COMPLETED|Overall Study||28
10663753|NCT02276638|11825608|FG002|COMPLETED|Overall Study||23
10663754|NCT02276638|11825606|FG000|NOT COMPLETED|Overall Study||0
10663755|NCT02276638|11825607|FG001|NOT COMPLETED|Overall Study||0
10663756|NCT02276638|11825608|FG002|NOT COMPLETED|Overall Study||0
10663757|NCT02276807|11825618|FG000|STARTED|Overall Study||68
10663758|NCT02276807|11825619|FG001|STARTED|Overall Study||72
10663759|NCT02276807|11825618|FG000|12-week Assessment|Overall Study||57
10663760|NCT02276807|11825619|FG001|12-week Assessment|Overall Study||63
10663761|NCT02276807|11825618|FG000|COMPLETED|Overall Study||50
10663762|NCT02276807|11825619|FG001|COMPLETED|Overall Study||55
10663763|NCT02276807|11825618|FG000|NOT COMPLETED|Overall Study||18
10663764|NCT02276807|11825619|FG001|NOT COMPLETED|Overall Study||17
10663765|NCT02276872|11825628|FG000|STARTED|Overall Study||10
10663766|NCT02276872|11825629|FG001|STARTED|Overall Study||10
10663767|NCT02276872|11825630|FG002|STARTED|Overall Study||12
10663768|NCT02276872|11825628|FG000|COMPLETED|Overall Study||9
10663769|NCT02276872|11825629|FG001|COMPLETED|Overall Study||10
10663770|NCT02276872|11825630|FG002|COMPLETED|Overall Study||12
10663771|NCT02276872|11825628|FG000|NOT COMPLETED|Overall Study||1
10663772|NCT02276872|11825629|FG001|NOT COMPLETED|Overall Study||0
10663773|NCT02276872|11825630|FG002|NOT COMPLETED|Overall Study||0
10663774|NCT02276963|11825643|FG000|STARTED|Overall Study||6
10663775|NCT02276963|11825643|FG000|COMPLETED|Overall Study||3
10663776|NCT02276963|11825643|FG000|NOT COMPLETED|Overall Study||3
10663777|NCT02277054|11825647|FG000|STARTED|Overall Study||5
10663778|NCT02277054|11825647|FG000|COMPLETED|Overall Study||5
10663779|NCT02277054|11825647|FG000|NOT COMPLETED|Overall Study||0
10663780|NCT02277093|11825652|FG000|STARTED|Overall Study||11
10663781|NCT02277093|11825652|FG000|COMPLETED|Overall Study||11
10663782|NCT02277093|11825652|FG000|NOT COMPLETED|Overall Study||0
10663783|NCT02277249|11825658|FG000|STARTED|Overall Study||30
10663784|NCT02277249|11825659|FG001|STARTED|Overall Study||30
10663785|NCT02277249|11825658|FG000|COMPLETED|Overall Study||30
10663786|NCT02277249|11825659|FG001|COMPLETED|Overall Study||30
10663787|NCT02277249|11825658|FG000|NOT COMPLETED|Overall Study||0
10663788|NCT02277249|11825659|FG001|NOT COMPLETED|Overall Study||0
10663789|NCT02277548|11825667|FG000|STARTED|Overall Study||9
10663790|NCT02277548|11825668|FG001|STARTED|Overall Study||11
10663791|NCT02277548|11825667|FG000|COMPLETED|Overall Study||9
10663792|NCT02277548|11825668|FG001|COMPLETED|Overall Study||9
10663793|NCT02277548|11825667|FG000|NOT COMPLETED|Overall Study||0
10663794|NCT02277548|11825668|FG001|NOT COMPLETED|Overall Study||2
10663795|NCT02277626|11825674|FG000|STARTED|Overall Study||6
10663796|NCT02277626|11825675|FG001|STARTED|Overall Study||9
10663797|NCT02277626|11825674|FG000|COMPLETED|Overall Study||6
10663798|NCT02277626|11825675|FG001|COMPLETED|Overall Study||9
10663799|NCT02277626|11825674|FG000|NOT COMPLETED|Overall Study||0
10663800|NCT02277626|11825675|FG001|NOT COMPLETED|Overall Study||0
10663801|NCT02277639|11825688|FG000|STARTED|Overall Study||0
10663802|NCT02277639|11825689|FG001|STARTED|Overall Study||2
10663803|NCT02277639|11825688|FG000|COMPLETED|Overall Study||0
10663804|NCT02277639|11825689|FG001|COMPLETED|Overall Study||2
10663805|NCT02277639|11825688|FG000|NOT COMPLETED|Overall Study||0
10663806|NCT02277639|11825689|FG001|NOT COMPLETED|Overall Study||0
10663807|NCT02277665|11825697|FG000|STARTED|Overall Study||33
10663808|NCT02277665|11825698|FG001|STARTED|Overall Study||34
10663809|NCT02277665|11825697|FG000|COMPLETED|Overall Study||33
10663810|NCT02277665|11825698|FG001|COMPLETED|Overall Study||34
10663811|NCT02277665|11825697|FG000|NOT COMPLETED|Overall Study||0
10663812|NCT02277665|11825698|FG001|NOT COMPLETED|Overall Study||0
10663813|NCT02277691|11825706|FG000|STARTED|Overall Study||341
10663814|NCT02277691|11825706|FG000|COMPLETED|Overall Study||295
10663815|NCT02277691|11825706|FG000|NOT COMPLETED|Overall Study||46
10663816|NCT02277743|11825713|FG000|STARTED|Overall Study||224
10663817|NCT02277743|11825714|FG001|STARTED|Overall Study||224
10663818|NCT02277743|11825715|FG002|STARTED|Overall Study||223
10663819|NCT02277743|11825713|FG000|Treated|Overall Study||223
10663820|NCT02277743|11825714|FG001|Treated|Overall Study||223
10663821|NCT02277743|11825715|FG002|Treated|Overall Study||223
10663822|NCT02277743|11825713|FG000|Safety Population|Overall Study|1 participant received at least 1 injection of Dupilumab 300mg(analyzed in Dupilumab 300 mg q2w arm)|222
10663823|NCT02277743|11825714|FG001|Safety Population|Overall Study|6 participants (1 [placebo] + 5 [Dupilumab 300 mg qw arm]) analyzed in Dupilumab 300 mg q2w arm|229
10663824|NCT02277743|11825715|FG002|Safety Population|Overall Study|5 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|218
10663825|NCT02277743|11825713|FG000|COMPLETED|Overall Study||184
10663826|NCT02277743|11825714|FG001|COMPLETED|Overall Study||208
10663827|NCT02277743|11825715|FG002|COMPLETED|Overall Study||197
10663828|NCT02277743|11825713|FG000|NOT COMPLETED|Overall Study||40
10663829|NCT02277743|11825714|FG001|NOT COMPLETED|Overall Study||16
10663830|NCT02277743|11825715|FG002|NOT COMPLETED|Overall Study||26
10663831|NCT02277769|11825726|FG000|STARTED|Overall Study||236
10663832|NCT02277769|11825727|FG001|STARTED|Overall Study||233
10663833|NCT02277769|11825728|FG002|STARTED|Overall Study||239
10663834|NCT02277769|11825726|FG000|Treated|Overall Study||235
10663835|NCT02277769|11825727|FG001|Treated|Overall Study||233
10663836|NCT02277769|11825728|FG002|Treated|Overall Study||239
10663880|NCT02278263|11825783|FG002|COMPLETED|Overall Study||51
10663837|NCT02277769|11825726|FG000|Safety Population|Overall Study|1 participant received at least 1 injection of Dupilumab 300mg(analyzed in Dupilumab 300 mg q2w arm)|234
10663838|NCT02277769|11825727|FG001|Safety Population|Overall Study|3 participants (1 [placebo] + 2 [Dupilumab 300 mg qw arm]) analyzed in Dupilumab 300 mg q2w arm|236
10795268|NCT03635775|11955680|FG000|STARTED|Overall Study||5
10795269|NCT03635775|11955681|FG001|STARTED|Overall Study||0
10795270|NCT03635775|11955682|FG002|STARTED|Overall Study||5
10795271|NCT03635775|11955683|FG003|STARTED|Overall Study||10
10795272|NCT03635775|11955680|FG000|COMPLETED|Overall Study||5
10795273|NCT03635775|11955681|FG001|COMPLETED|Overall Study||0
10795274|NCT03635775|11955682|FG002|COMPLETED|Overall Study||5
10795275|NCT03635775|11955683|FG003|COMPLETED|Overall Study||9
10795276|NCT03635775|11955680|FG000|NOT COMPLETED|Overall Study||0
10795277|NCT03635775|11955681|FG001|NOT COMPLETED|Overall Study||0
10795278|NCT03635775|11955682|FG002|NOT COMPLETED|Overall Study||0
10795279|NCT03635775|11955683|FG003|NOT COMPLETED|Overall Study||1
10795280|NCT03635957|11955693|FG000|STARTED|Run-In Period||15
10795281|NCT03635957|11955693|FG000|COMPLETED|Run-In Period||14
10795282|NCT03635957|11955693|FG000|NOT COMPLETED|Run-In Period||1
10795283|NCT03635957|11955693|FG000|STARTED|Pegloticase + IMM Period||14
10795284|NCT03635957|11955693|FG000|Completed Study at 24 Weeks-Amendment 1|Pegloticase + IMM Period||1
10795285|NCT03635957|11955693|FG000|Completed Study at 52 Weeks-Amendment 2|Pegloticase + IMM Period||10
10795286|NCT03635957|11955693|FG000|Discontinued Study Treatment Early|Pegloticase + IMM Period||5
10795287|NCT03635957|11955693|FG000|Had 3-Month Follow-up|Pegloticase + IMM Period||7
10795288|NCT03635957|11955693|FG000|Had 6-Month Follow-up|Pegloticase + IMM Period||6
10795289|NCT03635957|11955693|FG000|COMPLETED|Pegloticase + IMM Period||11
10795290|NCT03635957|11955693|FG000|NOT COMPLETED|Pegloticase + IMM Period||3
10795291|NCT03636061|11955702|FG000|STARTED|Overall Study||47
10795292|NCT03636061|11955703|FG001|STARTED|Overall Study||48
10795293|NCT03636061|11955704|FG002|STARTED|Overall Study||44
10663839|NCT02277769|11825728|FG002|Safety Population|Overall Study|2 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|237
10795294|NCT03636061|11955705|FG003|STARTED|Overall Study||43
10795295|NCT03636061|11955702|FG000|COMPLETED|Overall Study||47
10795296|NCT03636061|11955703|FG001|COMPLETED|Overall Study||46
10795297|NCT03636061|11955704|FG002|COMPLETED|Overall Study||40
10795298|NCT03636061|11955705|FG003|COMPLETED|Overall Study||43
10795299|NCT03636061|11955702|FG000|NOT COMPLETED|Overall Study||0
10795300|NCT03636061|11955703|FG001|NOT COMPLETED|Overall Study||2
10795301|NCT03636061|11955704|FG002|NOT COMPLETED|Overall Study||4
10795302|NCT03636061|11955705|FG003|NOT COMPLETED|Overall Study||0
10795303|NCT03636386|11955720|FG000|STARTED|Overall Study||24
10795304|NCT03636386|11955721|FG001|STARTED|Overall Study||24
10795305|NCT03636386|11955720|FG000|COMPLETED|Overall Study||24
10795306|NCT03636386|11955721|FG001|COMPLETED|Overall Study||24
10795307|NCT03636386|11955720|FG000|NOT COMPLETED|Overall Study||0
10795308|NCT03636386|11955721|FG001|NOT COMPLETED|Overall Study||0
10795309|NCT03636893|11955729|FG000|STARTED|Overall Study||40
10795310|NCT03636893|11955730|FG001|STARTED|Overall Study||34
10795311|NCT03636893|11955729|FG000|COMPLETED|Overall Study||31
10795312|NCT03636893|11955730|FG001|COMPLETED|Overall Study||24
10663840|NCT02277769|11825726|FG000|COMPLETED|Overall Study||190
10663841|NCT02277769|11825727|FG001|COMPLETED|Overall Study||220
10663842|NCT02277769|11825728|FG002|COMPLETED|Overall Study||221
10663843|NCT02277769|11825726|FG000|NOT COMPLETED|Overall Study||46
10663844|NCT02277769|11825727|FG001|NOT COMPLETED|Overall Study||13
10663845|NCT02277769|11825728|FG002|NOT COMPLETED|Overall Study||18
10663846|NCT02277925|11825738|FG000|STARTED|Overall Study||102
10663847|NCT02277925|11825739|FG001|STARTED|Overall Study||102
10663848|NCT02277925|11825738|FG000|Surgery|Overall Study||99
10663849|NCT02277925|11825739|FG001|Surgery|Overall Study||101
10663850|NCT02277925|11825738|FG000|COMPLETED|Overall Study||95
10663851|NCT02277925|11825739|FG001|COMPLETED|Overall Study||87
10663852|NCT02277925|11825738|FG000|NOT COMPLETED|Overall Study||7
10663853|NCT02277925|11825739|FG001|NOT COMPLETED|Overall Study||15
10663854|NCT02277990|11825749|FG000|STARTED|Overall Study||3495
10663855|NCT02277990|11825750|FG001|STARTED|Overall Study||3488
10663856|NCT02277990|11825749|FG000|COMPLETED|Overall Study||3129
10663857|NCT02277990|11825750|FG001|COMPLETED|Overall Study||3112
10663858|NCT02277990|11825749|FG000|NOT COMPLETED|Overall Study||366
10663859|NCT02277990|11825750|FG001|NOT COMPLETED|Overall Study||376
10663860|NCT02278003|11825758|FG000|STARTED|Overall Study||49
10663861|NCT02278003|11825759|FG001|STARTED|Overall Study||20
10663862|NCT02278003|11825758|FG000|COMPLETED|Overall Study||30
10663863|NCT02278003|11825759|FG001|COMPLETED|Overall Study||20
10663864|NCT02278003|11825758|FG000|NOT COMPLETED|Overall Study||19
10663865|NCT02278003|11825759|FG001|NOT COMPLETED|Overall Study||0
10663866|NCT02278146|11825767|FG000|STARTED|Overall Study||6
10663867|NCT02278146|11825768|FG001|STARTED|Overall Study||10
10663868|NCT02278146|11825767|FG000|COMPLETED|Overall Study||6
10663869|NCT02278146|11825768|FG001|COMPLETED|Overall Study||8
10663870|NCT02278146|11825767|FG000|NOT COMPLETED|Overall Study||0
10663871|NCT02278146|11825768|FG001|NOT COMPLETED|Overall Study||2
10663872|NCT02278237|11825774|FG000|STARTED|Overall Study||90
10663873|NCT02278237|11825774|FG000|COMPLETED|Overall Study||83
10663874|NCT02278237|11825774|FG000|NOT COMPLETED|Overall Study||7
10663875|NCT02278263|11825781|FG000|STARTED|Overall Study||30
10663876|NCT02278263|11825782|FG001|STARTED|Overall Study||60
10663877|NCT02278263|11825783|FG002|STARTED|Overall Study||60
10663878|NCT02278263|11825781|FG000|COMPLETED|Overall Study||23
10663879|NCT02278263|11825782|FG001|COMPLETED|Overall Study|Correction|60
10663881|NCT02278263|11825781|FG000|NOT COMPLETED|Overall Study||7
10663882|NCT02278263|11825782|FG001|NOT COMPLETED|Overall Study||0
10663883|NCT02278263|11825783|FG002|NOT COMPLETED|Overall Study||9
10663884|NCT02278289|11825796|FG000|STARTED|Overall Study||30
10663885|NCT02278289|11825797|FG001|STARTED|Overall Study||30
10663886|NCT02278289|11825796|FG000|COMPLETED|Overall Study||24
10663887|NCT02278289|11825797|FG001|COMPLETED|Overall Study||23
10663888|NCT02278289|11825796|FG000|NOT COMPLETED|Overall Study||6
10663889|NCT02278289|11825797|FG001|NOT COMPLETED|Overall Study||7
10663890|NCT02278328|11825803|FG000|STARTED|Neuropsych Screening||10
10663891|NCT02278328|11825804|FG001|STARTED|Neuropsych Screening||7
10663892|NCT02278328|11825805|FG002|STARTED|Neuropsych Screening||8
10663893|NCT02278328|11825803|FG000|COMPLETED|Neuropsych Screening||9
10663894|NCT02278328|11825804|FG001|COMPLETED|Neuropsych Screening||6
10663895|NCT02278328|11825805|FG002|COMPLETED|Neuropsych Screening||6
10663896|NCT02278328|11825803|FG000|NOT COMPLETED|Neuropsych Screening||1
10663897|NCT02278328|11825804|FG001|NOT COMPLETED|Neuropsych Screening||1
10663898|NCT02278328|11825805|FG002|NOT COMPLETED|Neuropsych Screening||2
10663899|NCT02278328|11825803|FG000|STARTED|First Intervention (1 Day)||9
10795313|NCT03636893|11955729|FG000|NOT COMPLETED|Overall Study||9
10795314|NCT03636893|11955730|FG001|NOT COMPLETED|Overall Study||10
10795315|NCT03637296|11955738|FG000|STARTED|Overall Study||10
10795316|NCT03637296|11955739|FG001|STARTED|Overall Study||5
10663900|NCT02278328|11825804|FG001|STARTED|First Intervention (1 Day)||6
10663901|NCT02278328|11825805|FG002|STARTED|First Intervention (1 Day)||6
10663902|NCT02278328|11825803|FG000|COMPLETED|First Intervention (1 Day)||9
10663903|NCT02278328|11825804|FG001|COMPLETED|First Intervention (1 Day)||6
10663904|NCT02278328|11825805|FG002|COMPLETED|First Intervention (1 Day)||6
10663905|NCT02278328|11825803|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10663906|NCT02278328|11825804|FG001|NOT COMPLETED|First Intervention (1 Day)||0
10663907|NCT02278328|11825805|FG002|NOT COMPLETED|First Intervention (1 Day)||0
10663908|NCT02278328|11825803|FG000|STARTED|Washout (1 Week)||9
10663909|NCT02278328|11825804|FG001|STARTED|Washout (1 Week)||6
10663910|NCT02278328|11825805|FG002|STARTED|Washout (1 Week)||6
10663911|NCT02278328|11825803|FG000|COMPLETED|Washout (1 Week)||9
10663912|NCT02278328|11825804|FG001|COMPLETED|Washout (1 Week)||6
10663913|NCT02278328|11825805|FG002|COMPLETED|Washout (1 Week)||6
10663914|NCT02278328|11825803|FG000|NOT COMPLETED|Washout (1 Week)||0
10663915|NCT02278328|11825804|FG001|NOT COMPLETED|Washout (1 Week)||0
10663916|NCT02278328|11825805|FG002|NOT COMPLETED|Washout (1 Week)||0
10663917|NCT02278328|11825803|FG000|STARTED|Second Intervention (1 Day)||9
10663918|NCT02278328|11825804|FG001|STARTED|Second Intervention (1 Day)||6
10663919|NCT02278328|11825805|FG002|STARTED|Second Intervention (1 Day)||6
10663920|NCT02278328|11825803|FG000|COMPLETED|Second Intervention (1 Day)||9
10663921|NCT02278328|11825804|FG001|COMPLETED|Second Intervention (1 Day)||6
10663922|NCT02278328|11825805|FG002|COMPLETED|Second Intervention (1 Day)||6
10663923|NCT02278328|11825803|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10663924|NCT02278328|11825804|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10663925|NCT02278328|11825805|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
10663926|NCT02278328|11825803|FG000|STARTED|Second Washout (1 Week)||9
10663927|NCT02278328|11825804|FG001|STARTED|Second Washout (1 Week)||6
10663928|NCT02278328|11825805|FG002|STARTED|Second Washout (1 Week)||6
10663929|NCT02278328|11825803|FG000|COMPLETED|Second Washout (1 Week)||9
10663930|NCT02278328|11825804|FG001|COMPLETED|Second Washout (1 Week)||6
10663931|NCT02278328|11825805|FG002|COMPLETED|Second Washout (1 Week)||6
10663932|NCT02278328|11825803|FG000|NOT COMPLETED|Second Washout (1 Week)||0
10663933|NCT02278328|11825804|FG001|NOT COMPLETED|Second Washout (1 Week)||0
10663934|NCT02278328|11825805|FG002|NOT COMPLETED|Second Washout (1 Week)||0
10663935|NCT02278328|11825803|FG000|STARTED|Third Intervention (1 Day)||9
10795317|NCT03637296|11955738|FG000|COMPLETED|Overall Study||10
10795318|NCT03637296|11955739|FG001|COMPLETED|Overall Study||5
10795319|NCT03637296|11955738|FG000|NOT COMPLETED|Overall Study||0
10795320|NCT03637296|11955739|FG001|NOT COMPLETED|Overall Study||0
10795321|NCT03637348|11955745|FG000|STARTED|Overall Study||45
10795322|NCT03637348|11955745|FG000|COMPLETED|Overall Study||45
10795323|NCT03637348|11955745|FG000|NOT COMPLETED|Overall Study||0
10795324|NCT03637517|11955753|FG000|STARTED|Overall Study||14
10795325|NCT03637517|11955754|FG001|STARTED|Overall Study||14
10795326|NCT03637517|11955755|FG002|STARTED|Overall Study||14
10795327|NCT03637517|11955753|FG000|COMPLETED|Overall Study||14
10795328|NCT03637517|11955754|FG001|COMPLETED|Overall Study||14
10795329|NCT03637517|11955755|FG002|COMPLETED|Overall Study||14
10795330|NCT03637517|11955753|FG000|NOT COMPLETED|Overall Study||0
10795331|NCT03637517|11955754|FG001|NOT COMPLETED|Overall Study||0
10795332|NCT03637517|11955755|FG002|NOT COMPLETED|Overall Study||0
10795333|NCT03637699|11955765|FG000|STARTED|Overall Study||15
10795334|NCT03637699|11955766|FG001|STARTED|Overall Study||15
10795335|NCT03637699|11955765|FG000|COMPLETED|Overall Study||14
10795336|NCT03637699|11955766|FG001|COMPLETED|Overall Study||14
10795337|NCT03637699|11955765|FG000|NOT COMPLETED|Overall Study||1
10795338|NCT03637699|11955766|FG001|NOT COMPLETED|Overall Study||1
10795339|NCT03637842|11955775|FG000|STARTED|Overall Study||2
10795340|NCT03637842|11955776|FG001|STARTED|Overall Study||2
10795341|NCT03637842|11955775|FG000|COMPLETED|Overall Study||2
10795342|NCT03637842|11955776|FG001|COMPLETED|Overall Study||2
10795343|NCT03637842|11955775|FG000|NOT COMPLETED|Overall Study||0
10795344|NCT03637842|11955776|FG001|NOT COMPLETED|Overall Study||0
10795345|NCT03638323|11955784|FG000|STARTED|Overall Study||38
10795346|NCT03638323|11955784|FG000|COMPLETED|Overall Study||37
10795347|NCT03638323|11955784|FG000|NOT COMPLETED|Overall Study||1
10795348|NCT03638622|11955791|FG000|STARTED|Overall Study||30
10795349|NCT03638622|11955791|FG000|COMPLETED|Overall Study||29
10795350|NCT03638622|11955791|FG000|NOT COMPLETED|Overall Study||1
10795351|NCT03638635|11955797|FG000|STARTED|Initial Hospitalization||39
10795352|NCT03638635|11955798|FG001|STARTED|Initial Hospitalization||24
10795353|NCT03638635|11955797|FG000|COMPLETED|Initial Hospitalization||39
10795354|NCT03638635|11955798|FG001|COMPLETED|Initial Hospitalization||22
10795355|NCT03638635|11955797|FG000|NOT COMPLETED|Initial Hospitalization||0
10795356|NCT03638635|11955798|FG001|NOT COMPLETED|Initial Hospitalization||2
10795357|NCT03638635|11955797|FG000|STARTED|Follow-Up (30 Days After Discharge)||39
10795358|NCT03638635|11955798|FG001|STARTED|Follow-Up (30 Days After Discharge)||22
10795359|NCT03638635|11955797|FG000|COMPLETED|Follow-Up (30 Days After Discharge)||0
10795360|NCT03638635|11955798|FG001|COMPLETED|Follow-Up (30 Days After Discharge)||0
10795361|NCT03638635|11955797|FG000|NOT COMPLETED|Follow-Up (30 Days After Discharge)||39
10795362|NCT03638635|11955798|FG001|NOT COMPLETED|Follow-Up (30 Days After Discharge)||22
10795363|NCT03638908|11955804|FG000|STARTED|Overall Study||8
10795364|NCT03638908|11955804|FG000|COMPLETED|Overall Study||7
10795365|NCT03638908|11955804|FG000|NOT COMPLETED|Overall Study||1
10795366|NCT03639675|11955812|FG000|STARTED|Overall Study||16
10795367|NCT03639675|11955812|FG000|Received Treatment|Overall Study||16
10795368|NCT03639675|11955812|FG000|COMPLETED|Overall Study||15
10795369|NCT03639675|11955812|FG000|NOT COMPLETED|Overall Study||1
10795370|NCT03639766|11955816|FG000|STARTED|Overall Study||3
10795371|NCT03639766|11955816|FG000|COMPLETED|Overall Study||3
10795372|NCT03639766|11955816|FG000|NOT COMPLETED|Overall Study||0
10795373|NCT03639779|11955822|FG000|STARTED|Overall Study||5
10795374|NCT03639779|11955822|FG000|Baseline|Overall Study||5
10795375|NCT03639779|11955822|FG000|Month 1|Overall Study||5
10795376|NCT03639779|11955822|FG000|Month 2|Overall Study||4
10795377|NCT03639779|11955822|FG000|Month 3|Overall Study||4
10795378|NCT03639779|11955822|FG000|COMPLETED|Overall Study||4
10795379|NCT03639779|11955822|FG000|NOT COMPLETED|Overall Study||1
10795380|NCT03639857|11955828|FG000|STARTED|Overall Study||1
10795381|NCT03639857|11955829|FG001|STARTED|Overall Study||3
10795382|NCT03639857|11955830|FG002|STARTED|Overall Study||3
10795383|NCT03639857|11955828|FG000|COMPLETED|Overall Study||1
10795384|NCT03639857|11955829|FG001|COMPLETED|Overall Study||3
10795385|NCT03639857|11955830|FG002|COMPLETED|Overall Study||3
10795386|NCT03639857|11955828|FG000|NOT COMPLETED|Overall Study||0
10663936|NCT02278328|11825804|FG001|STARTED|Third Intervention (1 Day)||6
10663937|NCT02278328|11825805|FG002|STARTED|Third Intervention (1 Day)||6
10795387|NCT03639857|11955829|FG001|NOT COMPLETED|Overall Study||0
10795388|NCT03639857|11955830|FG002|NOT COMPLETED|Overall Study||0
10795389|NCT03639987|11955840|FG000|STARTED|Overall Study||26
10795390|NCT03639987|11955841|FG001|STARTED|Overall Study||26
10795391|NCT03639987|11955840|FG000|COMPLETED|Overall Study||0
10795392|NCT03639987|11955841|FG001|COMPLETED|Overall Study||0
10795393|NCT03639987|11955840|FG000|NOT COMPLETED|Overall Study||26
10663938|NCT02278328|11825803|FG000|COMPLETED|Third Intervention (1 Day)||9
10663939|NCT02278328|11825804|FG001|COMPLETED|Third Intervention (1 Day)||6
10663940|NCT02278328|11825805|FG002|COMPLETED|Third Intervention (1 Day)||6
10663941|NCT02278328|11825803|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
10663942|NCT02278328|11825804|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
10663943|NCT02278328|11825805|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
10663944|NCT02278328|11825803|FG000|STARTED|Third Washout (1 Week)||9
10663945|NCT02278328|11825804|FG001|STARTED|Third Washout (1 Week)||6
10663946|NCT02278328|11825805|FG002|STARTED|Third Washout (1 Week)||6
10663947|NCT02278328|11825803|FG000|COMPLETED|Third Washout (1 Week)||9
10663948|NCT02278328|11825804|FG001|COMPLETED|Third Washout (1 Week)||6
10663949|NCT02278328|11825805|FG002|COMPLETED|Third Washout (1 Week)||6
10663950|NCT02278328|11825803|FG000|NOT COMPLETED|Third Washout (1 Week)||0
10663951|NCT02278328|11825804|FG001|NOT COMPLETED|Third Washout (1 Week)||0
10663952|NCT02278328|11825805|FG002|NOT COMPLETED|Third Washout (1 Week)||0
10663953|NCT02278341|11825813|FG000|STARTED|Overall Study||415
10663954|NCT02278341|11825814|FG001|STARTED|Overall Study||421
10663955|NCT02278341|11825813|FG000|Received Treatment|Overall Study||414
10663956|NCT02278341|11825814|FG001|Received Treatment|Overall Study||420
10663957|NCT02278341|11825813|FG000|COMPLETED|Overall Study||297
10663958|NCT02278341|11825814|FG001|COMPLETED|Overall Study||329
10663959|NCT02278341|11825813|FG000|NOT COMPLETED|Overall Study||118
10663960|NCT02278341|11825814|FG001|NOT COMPLETED|Overall Study||92
10663961|NCT02278354|11825823|FG000|STARTED|Overall Study||12
10795394|NCT03639987|11955841|FG001|NOT COMPLETED|Overall Study||26
10795395|NCT03640052|11955847|FG000|STARTED|Overall Study||2
10795396|NCT03640052|11955848|FG001|STARTED|Overall Study||1
10795397|NCT03640052|11955849|FG002|STARTED|Overall Study||1
10795398|NCT03640052|11955850|FG003|STARTED|Overall Study||1
10795399|NCT03640052|11955851|FG004|STARTED|Overall Study||1
10795400|NCT03640052|11955847|FG000|COMPLETED|Overall Study||2
10795401|NCT03640052|11955848|FG001|COMPLETED|Overall Study|the patient performed 4 out of 5 nights|0
10795402|NCT03640052|11955849|FG002|COMPLETED|Overall Study||1
10795403|NCT03640052|11955850|FG003|COMPLETED|Overall Study||1
10795404|NCT03640052|11955851|FG004|COMPLETED|Overall Study||1
10795405|NCT03640052|11955847|FG000|NOT COMPLETED|Overall Study||0
10795406|NCT03640052|11955848|FG001|NOT COMPLETED|Overall Study||1
10795407|NCT03640052|11955849|FG002|NOT COMPLETED|Overall Study||0
10795408|NCT03640052|11955850|FG003|NOT COMPLETED|Overall Study||0
10795409|NCT03640052|11955851|FG004|NOT COMPLETED|Overall Study||0
10795410|NCT03640507|11955866|FG000|STARTED|Overall Study||10
10795411|NCT03640507|11955867|FG001|STARTED|Overall Study||9
10795412|NCT03640507|11955868|FG002|STARTED|Overall Study||11
10795413|NCT03640507|11955866|FG000|COMPLETED|Overall Study||10
10795414|NCT03640507|11955867|FG001|COMPLETED|Overall Study||9
10795415|NCT03640507|11955868|FG002|COMPLETED|Overall Study||10
10795416|NCT03640507|11955866|FG000|NOT COMPLETED|Overall Study||0
10795417|NCT03640507|11955867|FG001|NOT COMPLETED|Overall Study||0
10795418|NCT03640507|11955868|FG002|NOT COMPLETED|Overall Study||1
10795419|NCT03640559|11955878|FG000|STARTED|Overall Study||25
10795420|NCT03640559|11955879|FG001|STARTED|Overall Study||25
10795421|NCT03640559|11955878|FG000|COMPLETED|Overall Study||23
10795422|NCT03640559|11955879|FG001|COMPLETED|Overall Study||24
10795423|NCT03640559|11955878|FG000|NOT COMPLETED|Overall Study||2
10795424|NCT03640559|11955879|FG001|NOT COMPLETED|Overall Study||1
10795425|NCT03640832|11955887|FG000|STARTED|Overall Study||44
10795426|NCT03640832|11955888|FG001|STARTED|Overall Study||46
10795427|NCT03640832|11955887|FG000|COMPLETED|Overall Study||44
10795428|NCT03640832|11955888|FG001|COMPLETED|Overall Study||46
10795429|NCT03640832|11955887|FG000|NOT COMPLETED|Overall Study||0
10795430|NCT03640832|11955888|FG001|NOT COMPLETED|Overall Study||0
10795431|NCT03641508|11955896|FG000|STARTED|First Injection||37
10795432|NCT03641508|11955897|FG001|STARTED|First Injection||32
10795433|NCT03641508|11955896|FG000|COMPLETED|First Injection||35
10795434|NCT03641508|11955897|FG001|COMPLETED|First Injection||32
10795435|NCT03641508|11955896|FG000|NOT COMPLETED|First Injection||2
10795436|NCT03641508|11955897|FG001|NOT COMPLETED|First Injection||0
10795437|NCT03641508|11955896|FG000|STARTED|Follow-up/Second Injection||2
10318766|NCT00217087|11453012|FG000|STARTED|Overall Study||36
10318767|NCT00217087|11453013|FG001|STARTED|Overall Study||37
10318768|NCT00217087|11453012|FG000|COMPLETED|Overall Study||25
10663962|NCT02278354|11825824|FG001|STARTED|Overall Study||23
10663963|NCT02278354|11825823|FG000|Flortaucipir PET Scan|Overall Study||10
10663964|NCT02278354|11825824|FG001|Flortaucipir PET Scan|Overall Study||20
10663965|NCT02278354|11825823|FG000|COMPLETED|Overall Study||8
10663966|NCT02278354|11825824|FG001|COMPLETED|Overall Study||20
10663967|NCT02278354|11825823|FG000|NOT COMPLETED|Overall Study||4
10663968|NCT02278354|11825824|FG001|NOT COMPLETED|Overall Study||3
10663969|NCT02278367|11825834|FG000|STARTED|Overall Study||69
10663970|NCT02278367|11825835|FG001|STARTED|Overall Study||110
10663971|NCT02278367|11825834|FG000|COMPLETED|Overall Study||59
10663972|NCT02278367|11825835|FG001|COMPLETED|Overall Study||110
10663973|NCT02278367|11825834|FG000|NOT COMPLETED|Overall Study||10
10663974|NCT02278367|11825835|FG001|NOT COMPLETED|Overall Study||0
10663975|NCT02278471|11825843|FG000|STARTED|Overall Study||155
10663976|NCT02278471|11825844|FG001|STARTED|Overall Study||148
10795438|NCT03641508|11955897|FG001|STARTED|Follow-up/Second Injection|Only those who had symptoms at the six-week follow-up received the second injection|10
10795439|NCT03641508|11955896|FG000|COMPLETED|Follow-up/Second Injection|Only those who had symptoms at the six-week follow-up received the second injection|2
10318769|NCT00217087|11453013|FG001|COMPLETED|Overall Study||17
10318770|NCT00217087|11453012|FG000|NOT COMPLETED|Overall Study||11
10318771|NCT00217087|11453013|FG001|NOT COMPLETED|Overall Study||20
10318772|NCT00217399|11453025|FG000|STARTED|Overall Study||35
10318773|NCT00217399|11453025|FG000|COMPLETED|Overall Study||35
10318774|NCT00217399|11453025|FG000|NOT COMPLETED|Overall Study||0
10663977|NCT02278471|11825843|FG000|COMPLETED|Overall Study||147
10663978|NCT02278471|11825844|FG001|COMPLETED|Overall Study||128
10663979|NCT02278471|11825843|FG000|NOT COMPLETED|Overall Study||8
10663980|NCT02278471|11825844|FG001|NOT COMPLETED|Overall Study||20
10663981|NCT02278484|11825851|FG000|STARTED|Overall Study||50
10663982|NCT02278484|11825851|FG000|COMPLETED|Overall Study||50
10663983|NCT02278484|11825851|FG000|NOT COMPLETED|Overall Study||0
10663984|NCT02278562|11825859|FG000|STARTED|Overall Study||9
10663985|NCT02278562|11825860|FG001|STARTED|Overall Study||7
10663986|NCT02278562|11825861|FG002|STARTED|Overall Study||8
10663987|NCT02278562|11825859|FG000|COMPLETED|Overall Study||9
10663988|NCT02278562|11825860|FG001|COMPLETED|Overall Study||7
10663989|NCT02278562|11825861|FG002|COMPLETED|Overall Study||8
10795440|NCT03641508|11955897|FG001|COMPLETED|Follow-up/Second Injection|Only those who had symptoms at the six-week follow-up received the second injection|10
10795441|NCT03641508|11955896|FG000|NOT COMPLETED|Follow-up/Second Injection||0
10795442|NCT03641508|11955897|FG001|NOT COMPLETED|Follow-up/Second Injection||0
10795443|NCT03641716|11955903|FG000|STARTED|Overall Study||20
10795444|NCT03641716|11955903|FG000|COMPLETED|Overall Study||15
10795445|NCT03641716|11955903|FG000|NOT COMPLETED|Overall Study||5
10795446|NCT03642262|11955907|FG000|STARTED|Period 1||12
10795447|NCT03642262|11955908|FG001|STARTED|Period 1||18
10795448|NCT03642262|11955907|FG000|COMPLETED|Period 1||11
10795449|NCT03642262|11955908|FG001|COMPLETED|Period 1||16
10795450|NCT03642262|11955907|FG000|NOT COMPLETED|Period 1||1
10795451|NCT03642262|11955908|FG001|NOT COMPLETED|Period 1||2
10795452|NCT03642262|11955907|FG000|STARTED|Washout: 7 Days||11
10795453|NCT03642262|11955908|FG001|STARTED|Washout: 7 Days||16
10795454|NCT03642262|11955907|FG000|COMPLETED|Washout: 7 Days||11
10795455|NCT03642262|11955908|FG001|COMPLETED|Washout: 7 Days||16
10795456|NCT03642262|11955907|FG000|NOT COMPLETED|Washout: 7 Days||0
10795457|NCT03642262|11955908|FG001|NOT COMPLETED|Washout: 7 Days||0
10795458|NCT03642262|11955907|FG000|STARTED|Period 2||11
10795459|NCT03642262|11955908|FG001|STARTED|Period 2||16
10795460|NCT03642262|11955907|FG000|COMPLETED|Period 2||11
10795461|NCT03642262|11955908|FG001|COMPLETED|Period 2||16
10795462|NCT03642262|11955907|FG000|NOT COMPLETED|Period 2||0
10795463|NCT03642262|11955908|FG001|NOT COMPLETED|Period 2||0
10795464|NCT03642457|11955917|FG000|STARTED|Overall Study||35
10795465|NCT03642457|11955918|FG001|STARTED|Overall Study||30
10795466|NCT03642457|11955917|FG000|COMPLETED|Overall Study||35
10795467|NCT03642457|11955918|FG001|COMPLETED|Overall Study||30
10795468|NCT03642457|11955917|FG000|NOT COMPLETED|Overall Study||0
10795469|NCT03642457|11955918|FG001|NOT COMPLETED|Overall Study||0
10795470|NCT03642717|11955924|FG000|STARTED|Overall Study||658
10795471|NCT03642717|11955924|FG000|COMPLETED|Overall Study||620
10795472|NCT03642717|11955924|FG000|NOT COMPLETED|Overall Study||38
10795473|NCT03642873|11955929|FG000|STARTED|First Intervention (1 Day)||4
10795474|NCT03642873|11955930|FG001|STARTED|First Intervention (1 Day)||4
10795475|NCT03642873|11955931|FG002|STARTED|First Intervention (1 Day)||4
10795476|NCT03642873|11955932|FG003|STARTED|First Intervention (1 Day)||4
10795477|NCT03642873|11955933|FG004|STARTED|First Intervention (1 Day)||4
10795478|NCT03642873|11955934|FG005|STARTED|First Intervention (1 Day)||4
10795479|NCT03642873|11955929|FG000|COMPLETED|First Intervention (1 Day)||4
10795480|NCT03642873|11955930|FG001|COMPLETED|First Intervention (1 Day)||4
10795481|NCT03642873|11955931|FG002|COMPLETED|First Intervention (1 Day)||4
10795482|NCT03642873|11955932|FG003|COMPLETED|First Intervention (1 Day)||4
10795483|NCT03642873|11955933|FG004|COMPLETED|First Intervention (1 Day)||4
10795484|NCT03642873|11955934|FG005|COMPLETED|First Intervention (1 Day)||4
10795485|NCT03642873|11955929|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10795486|NCT03642873|11955930|FG001|NOT COMPLETED|First Intervention (1 Day)||0
10795487|NCT03642873|11955931|FG002|NOT COMPLETED|First Intervention (1 Day)||0
10795488|NCT03642873|11955932|FG003|NOT COMPLETED|First Intervention (1 Day)||0
10795489|NCT03642873|11955933|FG004|NOT COMPLETED|First Intervention (1 Day)||0
10795490|NCT03642873|11955934|FG005|NOT COMPLETED|First Intervention (1 Day)||0
10795491|NCT03642873|11955929|FG000|STARTED|Washout (7 Days)||4
10795492|NCT03642873|11955930|FG001|STARTED|Washout (7 Days)||4
10795493|NCT03642873|11955931|FG002|STARTED|Washout (7 Days)||4
10795494|NCT03642873|11955932|FG003|STARTED|Washout (7 Days)||4
10795495|NCT03642873|11955933|FG004|STARTED|Washout (7 Days)||4
10318775|NCT00217425|11453031|FG000|STARTED|Overall Study||46
10663990|NCT02278562|11825859|FG000|NOT COMPLETED|Overall Study||0
10663991|NCT02278562|11825860|FG001|NOT COMPLETED|Overall Study||0
10663992|NCT02278562|11825861|FG002|NOT COMPLETED|Overall Study||0
10663993|NCT02278614|11825871|FG000|STARTED|Overall Study||127
10663994|NCT02278614|11825872|FG001|STARTED|Overall Study||115
10795496|NCT03642873|11955934|FG005|STARTED|Washout (7 Days)||4
10795497|NCT03642873|11955929|FG000|COMPLETED|Washout (7 Days)||4
10795498|NCT03642873|11955930|FG001|COMPLETED|Washout (7 Days)||4
10795499|NCT03642873|11955931|FG002|COMPLETED|Washout (7 Days)||4
10795500|NCT03642873|11955932|FG003|COMPLETED|Washout (7 Days)||4
10795501|NCT03642873|11955933|FG004|COMPLETED|Washout (7 Days)||4
10795502|NCT03642873|11955934|FG005|COMPLETED|Washout (7 Days)||4
10318776|NCT00217425|11453031|FG000|Treated|Overall Study||44
10318777|NCT00217425|11453031|FG000|Eligible and Treated|Overall Study||39
10663995|NCT02278614|11825871|FG000|COMPLETED|Overall Study||122
10663996|NCT02278614|11825872|FG001|COMPLETED|Overall Study||110
10663997|NCT02278614|11825871|FG000|NOT COMPLETED|Overall Study||5
10663998|NCT02278614|11825872|FG001|NOT COMPLETED|Overall Study||5
10795503|NCT03642873|11955929|FG000|NOT COMPLETED|Washout (7 Days)||0
10795504|NCT03642873|11955930|FG001|NOT COMPLETED|Washout (7 Days)||0
10795505|NCT03642873|11955931|FG002|NOT COMPLETED|Washout (7 Days)||0
10795506|NCT03642873|11955932|FG003|NOT COMPLETED|Washout (7 Days)||0
10795507|NCT03642873|11955933|FG004|NOT COMPLETED|Washout (7 Days)||0
10795508|NCT03642873|11955934|FG005|NOT COMPLETED|Washout (7 Days)||0
10795509|NCT03642873|11955929|FG000|STARTED|Second Intervention (1 Day)||4
10795510|NCT03642873|11955930|FG001|STARTED|Second Intervention (1 Day)||4
10795511|NCT03642873|11955931|FG002|STARTED|Second Intervention (1 Day)||4
10795512|NCT03642873|11955932|FG003|STARTED|Second Intervention (1 Day)||4
10795513|NCT03642873|11955933|FG004|STARTED|Second Intervention (1 Day)||4
10795514|NCT03642873|11955934|FG005|STARTED|Second Intervention (1 Day)||4
10795515|NCT03642873|11955929|FG000|COMPLETED|Second Intervention (1 Day)||4
10795516|NCT03642873|11955930|FG001|COMPLETED|Second Intervention (1 Day)||4
10795517|NCT03642873|11955931|FG002|COMPLETED|Second Intervention (1 Day)||4
10795518|NCT03642873|11955932|FG003|COMPLETED|Second Intervention (1 Day)||4
10795519|NCT03642873|11955933|FG004|COMPLETED|Second Intervention (1 Day)||4
10795520|NCT03642873|11955934|FG005|COMPLETED|Second Intervention (1 Day)||4
10795521|NCT03642873|11955929|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10795522|NCT03642873|11955930|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10795523|NCT03642873|11955931|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
10795524|NCT03642873|11955932|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
10795525|NCT03642873|11955933|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
10795526|NCT03642873|11955934|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
10795527|NCT03642873|11955929|FG000|STARTED|Washout (7 Days)||4
10795528|NCT03642873|11955930|FG001|STARTED|Washout (7 Days)||4
10795529|NCT03642873|11955931|FG002|STARTED|Washout (7 Days)||4
10795530|NCT03642873|11955932|FG003|STARTED|Washout (7 Days)||4
10795531|NCT03642873|11955933|FG004|STARTED|Washout (7 Days)||4
10795532|NCT03642873|11955934|FG005|STARTED|Washout (7 Days)||4
10795533|NCT03642873|11955929|FG000|COMPLETED|Washout (7 Days)||4
10795534|NCT03642873|11955930|FG001|COMPLETED|Washout (7 Days)||4
10795535|NCT03642873|11955931|FG002|COMPLETED|Washout (7 Days)||4
10795536|NCT03642873|11955932|FG003|COMPLETED|Washout (7 Days)||4
10795537|NCT03642873|11955933|FG004|COMPLETED|Washout (7 Days)||4
10795538|NCT03642873|11955934|FG005|COMPLETED|Washout (7 Days)||4
10795539|NCT03642873|11955929|FG000|NOT COMPLETED|Washout (7 Days)||0
10795540|NCT03642873|11955930|FG001|NOT COMPLETED|Washout (7 Days)||0
10795541|NCT03642873|11955931|FG002|NOT COMPLETED|Washout (7 Days)||0
10795542|NCT03642873|11955932|FG003|NOT COMPLETED|Washout (7 Days)||0
10795543|NCT03642873|11955933|FG004|NOT COMPLETED|Washout (7 Days)||0
10795544|NCT03642873|11955934|FG005|NOT COMPLETED|Washout (7 Days)||0
10795545|NCT03642873|11955929|FG000|STARTED|Third Intervention (1 Day)||4
10795546|NCT03642873|11955930|FG001|STARTED|Third Intervention (1 Day)||4
10795547|NCT03642873|11955931|FG002|STARTED|Third Intervention (1 Day)||4
10795548|NCT03642873|11955932|FG003|STARTED|Third Intervention (1 Day)||4
10795549|NCT03642873|11955933|FG004|STARTED|Third Intervention (1 Day)||4
10795550|NCT03642873|11955934|FG005|STARTED|Third Intervention (1 Day)||4
10795551|NCT03642873|11955929|FG000|COMPLETED|Third Intervention (1 Day)||4
10795552|NCT03642873|11955930|FG001|COMPLETED|Third Intervention (1 Day)||4
10795553|NCT03642873|11955931|FG002|COMPLETED|Third Intervention (1 Day)||4
10795554|NCT03642873|11955932|FG003|COMPLETED|Third Intervention (1 Day)||4
10795555|NCT03642873|11955933|FG004|COMPLETED|Third Intervention (1 Day)||3
10795556|NCT03642873|11955934|FG005|COMPLETED|Third Intervention (1 Day)||4
10795557|NCT03642873|11955929|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
10795558|NCT03642873|11955930|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
10795559|NCT03642873|11955931|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
10795560|NCT03642873|11955932|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
10795561|NCT03642873|11955933|FG004|NOT COMPLETED|Third Intervention (1 Day)||1
10795562|NCT03642873|11955934|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
10795563|NCT03643432|11955948|FG000|STARTED|Overall Study||27
10795564|NCT03643432|11955949|FG001|STARTED|Overall Study||21
10795565|NCT03643432|11955948|FG000|COMPLETED|Overall Study||26
10795566|NCT03643432|11955949|FG001|COMPLETED|Overall Study||21
10795567|NCT03643432|11955948|FG000|NOT COMPLETED|Overall Study||1
10795568|NCT03643432|11955949|FG001|NOT COMPLETED|Overall Study||0
10795569|NCT03643575|11955955|FG000|STARTED|Period 1||5
10795570|NCT03643575|11955956|FG001|STARTED|Period 1||5
10795571|NCT03643575|11955957|FG002|STARTED|Period 1||5
10795572|NCT03643575|11955958|FG003|STARTED|Period 1||5
10795573|NCT03643575|11955959|FG004|STARTED|Period 1||5
10795574|NCT03643575|11955960|FG005|STARTED|Period 1||5
10795575|NCT03643575|11955955|FG000|COMPLETED|Period 1||5
10795576|NCT03643575|11955956|FG001|COMPLETED|Period 1||5
10795577|NCT03643575|11955957|FG002|COMPLETED|Period 1||5
10795578|NCT03643575|11955958|FG003|COMPLETED|Period 1||5
10795579|NCT03643575|11955959|FG004|COMPLETED|Period 1||5
10663999|NCT02278640|11825878|FG000|STARTED|Overall Study||40
10664000|NCT02278640|11825878|FG000|COMPLETED|Overall Study||40
10795580|NCT03643575|11955960|FG005|COMPLETED|Period 1||5
10795581|NCT03643575|11955955|FG000|NOT COMPLETED|Period 1||0
10795582|NCT03643575|11955956|FG001|NOT COMPLETED|Period 1||0
10795583|NCT03643575|11955957|FG002|NOT COMPLETED|Period 1||0
10795584|NCT03643575|11955958|FG003|NOT COMPLETED|Period 1||0
10664001|NCT02278640|11825878|FG000|NOT COMPLETED|Overall Study||0
10664002|NCT02278783|11825882|FG000|STARTED|Overall Study||1
10664003|NCT02278783|11825882|FG000|COMPLETED|Overall Study||1
10664004|NCT02278783|11825882|FG000|NOT COMPLETED|Overall Study||0
10664005|NCT02278939|11825888|FG000|STARTED|Overall Study||33
10664006|NCT02278939|11825889|FG001|STARTED|Overall Study||34
10664007|NCT02278939|11825888|FG000|COMPLETED|Overall Study||28
10664008|NCT02278939|11825889|FG001|COMPLETED|Overall Study||33
10664009|NCT02278939|11825888|FG000|NOT COMPLETED|Overall Study||5
10664010|NCT02278939|11825889|FG001|NOT COMPLETED|Overall Study||1
10664011|NCT02278952|11825895|FG000|STARTED|Overall Study|The number of biopsy procedures performed during the time the patient was enrolled in the study.|50
10664012|NCT02278952|11825895|FG000|COMPLETED|Overall Study|The number of biopsy samples assayed during the time the patient was enrolled in the study.|44
10664013|NCT02278952|11825895|FG000|NOT COMPLETED|Overall Study||6
10664014|NCT02279043|11825908|FG000|STARTED|Overall Study||175
10795585|NCT03643575|11955959|FG004|NOT COMPLETED|Period 1||0
10795586|NCT03643575|11955960|FG005|NOT COMPLETED|Period 1||0
10795587|NCT03643575|11955955|FG000|STARTED|Washout: 7 Days||5
10795588|NCT03643575|11955956|FG001|STARTED|Washout: 7 Days||5
10795589|NCT03643575|11955957|FG002|STARTED|Washout: 7 Days||5
10795590|NCT03643575|11955958|FG003|STARTED|Washout: 7 Days||5
10795591|NCT03643575|11955959|FG004|STARTED|Washout: 7 Days||5
10795592|NCT03643575|11955960|FG005|STARTED|Washout: 7 Days||5
10795593|NCT03643575|11955955|FG000|COMPLETED|Washout: 7 Days||4
10795594|NCT03643575|11955956|FG001|COMPLETED|Washout: 7 Days||5
10795595|NCT03643575|11955957|FG002|COMPLETED|Washout: 7 Days||5
10795596|NCT03643575|11955958|FG003|COMPLETED|Washout: 7 Days||4
10795597|NCT03643575|11955959|FG004|COMPLETED|Washout: 7 Days||5
10795598|NCT03643575|11955960|FG005|COMPLETED|Washout: 7 Days||5
10795599|NCT03643575|11955955|FG000|NOT COMPLETED|Washout: 7 Days||1
10795600|NCT03643575|11955956|FG001|NOT COMPLETED|Washout: 7 Days||0
10795601|NCT03643575|11955957|FG002|NOT COMPLETED|Washout: 7 Days||0
10795602|NCT03643575|11955958|FG003|NOT COMPLETED|Washout: 7 Days||1
10795603|NCT03643575|11955959|FG004|NOT COMPLETED|Washout: 7 Days||0
10795604|NCT03643575|11955960|FG005|NOT COMPLETED|Washout: 7 Days||0
10795605|NCT03643575|11955955|FG000|STARTED|Period 2||4
10795606|NCT03643575|11955956|FG001|STARTED|Period 2||5
10795607|NCT03643575|11955957|FG002|STARTED|Period 2||5
10795608|NCT03643575|11955958|FG003|STARTED|Period 2||4
10795609|NCT03643575|11955959|FG004|STARTED|Period 2||5
10795610|NCT03643575|11955960|FG005|STARTED|Period 2||5
10795611|NCT03643575|11955955|FG000|COMPLETED|Period 2||4
10795612|NCT03643575|11955956|FG001|COMPLETED|Period 2||5
10795613|NCT03643575|11955957|FG002|COMPLETED|Period 2||5
10795614|NCT03643575|11955958|FG003|COMPLETED|Period 2||4
10795615|NCT03643575|11955959|FG004|COMPLETED|Period 2||5
10795616|NCT03643575|11955960|FG005|COMPLETED|Period 2||5
10795617|NCT03643575|11955955|FG000|NOT COMPLETED|Period 2||0
10795618|NCT03643575|11955956|FG001|NOT COMPLETED|Period 2||0
10795619|NCT03643575|11955957|FG002|NOT COMPLETED|Period 2||0
10795620|NCT03643575|11955958|FG003|NOT COMPLETED|Period 2||0
10795621|NCT03643575|11955959|FG004|NOT COMPLETED|Period 2||0
10795622|NCT03643575|11955960|FG005|NOT COMPLETED|Period 2||0
10795623|NCT03643575|11955955|FG000|STARTED|Washout: 7 Days||4
10795624|NCT03643575|11955956|FG001|STARTED|Washout: 7 Days||5
10795625|NCT03643575|11955957|FG002|STARTED|Washout: 7 Days||5
10795626|NCT03643575|11955958|FG003|STARTED|Washout: 7 Days||4
10795627|NCT03643575|11955959|FG004|STARTED|Washout: 7 Days||5
10795628|NCT03643575|11955960|FG005|STARTED|Washout: 7 Days||5
10795629|NCT03643575|11955955|FG000|COMPLETED|Washout: 7 Days||4
10795630|NCT03643575|11955956|FG001|COMPLETED|Washout: 7 Days||4
10795631|NCT03643575|11955957|FG002|COMPLETED|Washout: 7 Days||5
10795632|NCT03643575|11955958|FG003|COMPLETED|Washout: 7 Days||4
10795633|NCT03643575|11955959|FG004|COMPLETED|Washout: 7 Days||5
10795634|NCT03643575|11955960|FG005|COMPLETED|Washout: 7 Days||5
10795635|NCT03643575|11955955|FG000|NOT COMPLETED|Washout: 7 Days||0
10795636|NCT03643575|11955956|FG001|NOT COMPLETED|Washout: 7 Days||1
10795637|NCT03643575|11955957|FG002|NOT COMPLETED|Washout: 7 Days||0
10795638|NCT03643575|11955958|FG003|NOT COMPLETED|Washout: 7 Days||0
10795639|NCT03643575|11955959|FG004|NOT COMPLETED|Washout: 7 Days||0
10795640|NCT03643575|11955960|FG005|NOT COMPLETED|Washout: 7 Days||0
10795641|NCT03643575|11955955|FG000|STARTED|Period 3||4
10795642|NCT03643575|11955956|FG001|STARTED|Period 3||4
10795643|NCT03643575|11955957|FG002|STARTED|Period 3||5
10795644|NCT03643575|11955958|FG003|STARTED|Period 3||4
10795645|NCT03643575|11955959|FG004|STARTED|Period 3||5
10795646|NCT03643575|11955960|FG005|STARTED|Period 3||5
10795647|NCT03643575|11955955|FG000|COMPLETED|Period 3||4
10795648|NCT03643575|11955956|FG001|COMPLETED|Period 3||4
10795649|NCT03643575|11955957|FG002|COMPLETED|Period 3||5
10795650|NCT03643575|11955958|FG003|COMPLETED|Period 3||4
10795651|NCT03643575|11955959|FG004|COMPLETED|Period 3||5
10795652|NCT03643575|11955960|FG005|COMPLETED|Period 3||5
10664015|NCT02279043|11825909|FG001|STARTED|Overall Study||315
10795653|NCT03643575|11955955|FG000|NOT COMPLETED|Period 3||0
10795654|NCT03643575|11955956|FG001|NOT COMPLETED|Period 3||0
10795655|NCT03643575|11955957|FG002|NOT COMPLETED|Period 3||0
10795656|NCT03643575|11955958|FG003|NOT COMPLETED|Period 3||0
10795657|NCT03643575|11955959|FG004|NOT COMPLETED|Period 3||0
10795658|NCT03643575|11955960|FG005|NOT COMPLETED|Period 3||0
10795659|NCT03643692|11955968|FG000|STARTED|Overall Study||12
10795660|NCT03643692|11955968|FG000|COMPLETED|Overall Study||12
10795661|NCT03643692|11955968|FG000|NOT COMPLETED|Overall Study||0
10795662|NCT03643952|11955972|FG000|STARTED|Overall Study||18
10795663|NCT03643952|11955972|FG000|COMPLETED|Overall Study||17
10664016|NCT02279043|11825910|FG002|STARTED|Overall Study||140
10664017|NCT02279043|11825908|FG000|COMPLETED|Overall Study||128
10664018|NCT02279043|11825909|FG001|COMPLETED|Overall Study||226
10664019|NCT02279043|11825910|FG002|COMPLETED|Overall Study||140
10664020|NCT02279043|11825908|FG000|NOT COMPLETED|Overall Study||47
10664021|NCT02279043|11825909|FG001|NOT COMPLETED|Overall Study||89
10664022|NCT02279043|11825910|FG002|NOT COMPLETED|Overall Study||0
10664023|NCT02279082|11825916|FG000|STARTED|Overall Study|Intentions were to have 173 participants, but only 167 participants received study drug.|167
10664024|NCT02279082|11825916|FG000|COMPLETED|Overall Study||134
10664025|NCT02279082|11825916|FG000|NOT COMPLETED|Overall Study||33
10664026|NCT02279108|11825922|FG000|STARTED|Overall Study||50
10664027|NCT02279108|11825923|FG001|STARTED|Overall Study||50
10664028|NCT02279108|11825922|FG000|COMPLETED|Overall Study||50
10664029|NCT02279108|11825923|FG001|COMPLETED|Overall Study||49
10664030|NCT02279108|11825922|FG000|NOT COMPLETED|Overall Study||0
10664031|NCT02279108|11825923|FG001|NOT COMPLETED|Overall Study||1
10664032|NCT02279160|11825931|FG000|STARTED|Overall Study||40
10664033|NCT02279160|11825932|FG001|STARTED|Overall Study||21
10664034|NCT02279160|11825931|FG000|COMPLETED|Overall Study||34
10664035|NCT02279160|11825932|FG001|COMPLETED|Overall Study||19
10664036|NCT02279160|11825931|FG000|NOT COMPLETED|Overall Study||6
10664037|NCT02279160|11825932|FG001|NOT COMPLETED|Overall Study||2
10664038|NCT02279407|11825942|FG000|STARTED|Overall Study||22
10795664|NCT03643952|11955972|FG000|NOT COMPLETED|Overall Study||1
10795665|NCT03644095|11955984|FG000|STARTED|Period 1||15
10795666|NCT03644095|11955985|FG001|STARTED|Period 1||15
10795667|NCT03644095|11955984|FG000|COMPLETED|Period 1||15
10795668|NCT03644095|11955985|FG001|COMPLETED|Period 1||15
10795669|NCT03644095|11955984|FG000|NOT COMPLETED|Period 1||0
10795670|NCT03644095|11955985|FG001|NOT COMPLETED|Period 1||0
10795671|NCT03644095|11955984|FG000|STARTED|Washout (7 Days)||15
10795672|NCT03644095|11955985|FG001|STARTED|Washout (7 Days)||15
10795673|NCT03644095|11955984|FG000|COMPLETED|Washout (7 Days)||15
10795674|NCT03644095|11955985|FG001|COMPLETED|Washout (7 Days)||15
10795675|NCT03644095|11955984|FG000|NOT COMPLETED|Washout (7 Days)||0
10795676|NCT03644095|11955985|FG001|NOT COMPLETED|Washout (7 Days)||0
10795677|NCT03644095|11955984|FG000|STARTED|Period 2||15
10795678|NCT03644095|11955985|FG001|STARTED|Period 2||15
10795679|NCT03644095|11955984|FG000|COMPLETED|Period 2||15
10795680|NCT03644095|11955985|FG001|COMPLETED|Period 2||15
10795681|NCT03644095|11955984|FG000|NOT COMPLETED|Period 2||0
10795682|NCT03644095|11955985|FG001|NOT COMPLETED|Period 2||0
10795683|NCT03644108|11955991|FG000|STARTED|Overall Study||30
10795684|NCT03644108|11955991|FG000|COMPLETED|Overall Study||30
10795685|NCT03644108|11955991|FG000|NOT COMPLETED|Overall Study||0
10795686|NCT03644173|11955995|FG000|STARTED|Participants at Last Visit (Pre-surveys)||37
10795687|NCT03644173|11955995|FG000|COMPLETED|Participants at Last Visit (Pre-surveys)||16
10795688|NCT03644173|11955995|FG000|NOT COMPLETED|Participants at Last Visit (Pre-surveys)||21
10795689|NCT03644173|11955995|FG000|STARTED|Participants at the 1-month Follow up||16
10795690|NCT03644173|11955995|FG000|COMPLETED|Participants at the 1-month Follow up||12
10795691|NCT03644173|11955995|FG000|NOT COMPLETED|Participants at the 1-month Follow up||4
10795692|NCT03644173|11955995|FG000|STARTED|Participants at the 3-month Follow up||12
10795693|NCT03644173|11955995|FG000|COMPLETED|Participants at the 3-month Follow up||10
10795694|NCT03644173|11955995|FG000|NOT COMPLETED|Participants at the 3-month Follow up||2
10795695|NCT03644212|11956002|FG000|STARTED|Overall Study||63
10795696|NCT03644212|11956003|FG001|STARTED|Overall Study||16
10795697|NCT03644212|11956002|FG000|COMPLETED|Overall Study||63
10795698|NCT03644212|11956003|FG001|COMPLETED|Overall Study||16
10795699|NCT03644212|11956002|FG000|NOT COMPLETED|Overall Study||0
10795700|NCT03644212|11956003|FG001|NOT COMPLETED|Overall Study||0
10795701|NCT03645421|11956013|FG000|STARTED|Overall Study||16
10795702|NCT03645421|11956014|FG001|STARTED|Overall Study||15
10795703|NCT03645421|11956015|FG002|STARTED|Overall Study||15
10795704|NCT03645421|11956016|FG003|STARTED|Overall Study||15
10795705|NCT03645421|11956013|FG000|Received Investigational Product (IP)|Overall Study||16
10795706|NCT03645421|11956014|FG001|Received Investigational Product (IP)|Overall Study||15
10795707|NCT03645421|11956015|FG002|Received Investigational Product (IP)|Overall Study||15
10795708|NCT03645421|11956016|FG003|Received Investigational Product (IP)|Overall Study||15
10795709|NCT03645421|11956013|FG000|COMPLETED|Overall Study||16
10795710|NCT03645421|11956014|FG001|COMPLETED|Overall Study||15
10795711|NCT03645421|11956015|FG002|COMPLETED|Overall Study||10
10795712|NCT03645421|11956016|FG003|COMPLETED|Overall Study||11
10795713|NCT03645421|11956013|FG000|NOT COMPLETED|Overall Study||0
10795714|NCT03645421|11956014|FG001|NOT COMPLETED|Overall Study||0
10795715|NCT03645421|11956015|FG002|NOT COMPLETED|Overall Study||5
10795716|NCT03645421|11956016|FG003|NOT COMPLETED|Overall Study||4
10795717|NCT03645434|11956029|FG000|STARTED|Period 1||12
10795718|NCT03645434|11956030|FG001|STARTED|Period 1||13
10795719|NCT03645434|11956031|FG002|STARTED|Period 1||13
10795720|NCT03645434|11956032|FG003|STARTED|Period 1||11
10664039|NCT02279407|11825943|FG001|STARTED|Overall Study||21
10664040|NCT02279407|11825944|FG002|STARTED|Overall Study||20
10664041|NCT02279407|11825945|FG003|STARTED|Overall Study||21
10795721|NCT03645434|11956033|FG004|STARTED|Period 1||12
10795722|NCT03645434|11956034|FG005|STARTED|Period 1||12
10795723|NCT03645434|11956029|FG000|COMPLETED|Period 1||12
10795724|NCT03645434|11956030|FG001|COMPLETED|Period 1||13
10664042|NCT02279407|11825942|FG000|COMPLETED|Overall Study||20
10664043|NCT02279407|11825943|FG001|COMPLETED|Overall Study||20
10664044|NCT02279407|11825944|FG002|COMPLETED|Overall Study||15
10664045|NCT02279407|11825945|FG003|COMPLETED|Overall Study||20
10664046|NCT02279407|11825942|FG000|NOT COMPLETED|Overall Study||2
10664047|NCT02279407|11825943|FG001|NOT COMPLETED|Overall Study||1
10664048|NCT02279407|11825944|FG002|NOT COMPLETED|Overall Study||5
10664049|NCT02279407|11825945|FG003|NOT COMPLETED|Overall Study||1
10664050|NCT02279420|11825955|FG000|STARTED|Overall Study||73
10664051|NCT02279420|11825955|FG000|COMPLETED|Overall Study||50
10664052|NCT02279420|11825955|FG000|NOT COMPLETED|Overall Study||23
10664053|NCT02279498|11825961|FG000|STARTED|Overall Study||65
10664054|NCT02279498|11825962|FG001|STARTED|Overall Study||63
10664055|NCT02279498|11825961|FG000|COMPLETED|Overall Study||47
10664056|NCT02279498|11825962|FG001|COMPLETED|Overall Study||59
10664057|NCT02279498|11825961|FG000|NOT COMPLETED|Overall Study||18
10664058|NCT02279498|11825962|FG001|NOT COMPLETED|Overall Study||4
10664059|NCT02279524|11825972|FG000|STARTED|Overall Study||98
10795725|NCT03645434|11956031|FG002|COMPLETED|Period 1||13
10795726|NCT03645434|11956032|FG003|COMPLETED|Period 1||10
10795727|NCT03645434|11956033|FG004|COMPLETED|Period 1||11
10795728|NCT03645434|11956034|FG005|COMPLETED|Period 1||12
10795729|NCT03645434|11956029|FG000|NOT COMPLETED|Period 1||0
10795730|NCT03645434|11956030|FG001|NOT COMPLETED|Period 1||0
10795731|NCT03645434|11956031|FG002|NOT COMPLETED|Period 1||0
10795732|NCT03645434|11956032|FG003|NOT COMPLETED|Period 1||1
10795733|NCT03645434|11956033|FG004|NOT COMPLETED|Period 1||1
10795734|NCT03645434|11956034|FG005|NOT COMPLETED|Period 1||0
10795735|NCT03645434|11956029|FG000|STARTED|Period 2|2 subject discontinued as they did not meet stability or FEV1 variability.|10
10795736|NCT03645434|11956030|FG001|STARTED|Period 2||13
10795737|NCT03645434|11956031|FG002|STARTED|Period 2||13
10795738|NCT03645434|11956032|FG003|STARTED|Period 2||10
10664060|NCT02279524|11825973|FG001|STARTED|Overall Study||101
10664061|NCT02279524|11825974|FG002|STARTED|Overall Study||48
10664062|NCT02279524|11825972|FG000|COMPLETED|Overall Study||88
10664063|NCT02279524|11825973|FG001|COMPLETED|Overall Study||90
10664064|NCT02279524|11825974|FG002|COMPLETED|Overall Study||41
10664065|NCT02279524|11825972|FG000|NOT COMPLETED|Overall Study||10
10664066|NCT02279524|11825973|FG001|NOT COMPLETED|Overall Study||11
10664067|NCT02279524|11825974|FG002|NOT COMPLETED|Overall Study||7
10664068|NCT02279641|11825984|FG000|STARTED|Overall Study||6
10664069|NCT02279641|11825985|FG001|STARTED|Overall Study||6
10664070|NCT02279641|11825984|FG000|COMPLETED|Overall Study||6
10664071|NCT02279641|11825985|FG001|COMPLETED|Overall Study||6
10664072|NCT02279641|11825984|FG000|NOT COMPLETED|Overall Study||0
10664073|NCT02279641|11825985|FG001|NOT COMPLETED|Overall Study||0
10664074|NCT02279667|11826004|FG000|STARTED|Overall Study||6
10664075|NCT02279667|11826005|FG001|STARTED|Overall Study||6
10664076|NCT02279667|11826006|FG002|STARTED|Overall Study||6
10664077|NCT02279667|11826004|FG000|COMPLETED|Overall Study||6
10664078|NCT02279667|11826005|FG001|COMPLETED|Overall Study||6
10664079|NCT02279667|11826006|FG002|COMPLETED|Overall Study||6
10664080|NCT02279667|11826004|FG000|NOT COMPLETED|Overall Study||0
10664081|NCT02279667|11826005|FG001|NOT COMPLETED|Overall Study||0
10664082|NCT02279667|11826006|FG002|NOT COMPLETED|Overall Study||0
10664083|NCT02279732|11826017|FG000|STARTED|Overall Study||98
10664084|NCT02279732|11826018|FG001|STARTED|Overall Study||106
10664085|NCT02279732|11826017|FG000|COMPLETED|Overall Study||0
10664086|NCT02279732|11826018|FG001|COMPLETED|Overall Study||0
10664087|NCT02279732|11826017|FG000|NOT COMPLETED|Overall Study||98
10664088|NCT02279732|11826018|FG001|NOT COMPLETED|Overall Study||106
10664089|NCT02279862|11826026|FG000|STARTED|Overall Study||26
10664090|NCT02279862|11826027|FG001|STARTED|Overall Study||27
10664091|NCT02279862|11826026|FG000|Treated|Overall Study||25
10664092|NCT02279862|11826027|FG001|Treated|Overall Study||26
10664093|NCT02279862|11826026|FG000|COMPLETED|Overall Study|Completed treatment in induction period|0
10664094|NCT02279862|11826027|FG001|COMPLETED|Overall Study|Completed treatment in induction period|2
10664095|NCT02279862|11826026|FG000|NOT COMPLETED|Overall Study||26
10664096|NCT02279862|11826027|FG001|NOT COMPLETED|Overall Study||25
10664097|NCT02280044|11826035|FG000|STARTED|Overall Study||15
10664098|NCT02280044|11826036|FG001|STARTED|Overall Study||15
10664099|NCT02280044|11826035|FG000|COMPLETED|Overall Study||15
10664100|NCT02280044|11826036|FG001|COMPLETED|Overall Study||13
10664101|NCT02280044|11826035|FG000|NOT COMPLETED|Overall Study||0
10664102|NCT02280044|11826036|FG001|NOT COMPLETED|Overall Study||2
10664103|NCT02280096|11826044|FG000|STARTED|Overall Study||13
10664104|NCT02280096|11826045|FG001|STARTED|Overall Study||11
10664105|NCT02280096|11826044|FG000|COMPLETED|Overall Study||11
10664106|NCT02280096|11826045|FG001|COMPLETED|Overall Study||10
10664107|NCT02280096|11826044|FG000|NOT COMPLETED|Overall Study||2
10664108|NCT02280096|11826045|FG001|NOT COMPLETED|Overall Study||1
10664109|NCT02280122|11826062|FG000|STARTED|Overall Study||15
10664110|NCT02280122|11826063|FG001|STARTED|Overall Study||15
10795739|NCT03645434|11956033|FG004|STARTED|Period 2||11
10810878|NCT03784963|11972587|FG003|COMPLETED|Overall Study||0
10664111|NCT02280122|11826064|FG002|STARTED|Overall Study||30
10664112|NCT02280122|11826062|FG000|COMPLETED|Overall Study||15
10664113|NCT02280122|11826063|FG001|COMPLETED|Overall Study||15
10664114|NCT02280122|11826064|FG002|COMPLETED|Overall Study||30
10664115|NCT02280122|11826062|FG000|NOT COMPLETED|Overall Study||0
10664116|NCT02280122|11826063|FG001|NOT COMPLETED|Overall Study||0
10664117|NCT02280122|11826064|FG002|NOT COMPLETED|Overall Study||0
10664118|NCT02280187|11826070|FG000|STARTED|Overall Study||400
10664119|NCT02280187|11826070|FG000|COMPLETED|Overall Study||182
10664120|NCT02280187|11826070|FG000|NOT COMPLETED|Overall Study||218
10664121|NCT02280200|11826076|FG000|STARTED|Overall Study||15
10664122|NCT02280200|11826077|FG001|STARTED|Overall Study||13
10664123|NCT02280200|11826076|FG000|COMPLETED|Overall Study||12
10664124|NCT02280200|11826077|FG001|COMPLETED|Overall Study||10
10664125|NCT02280200|11826076|FG000|NOT COMPLETED|Overall Study||3
10664126|NCT02280200|11826077|FG001|NOT COMPLETED|Overall Study||3
10664127|NCT02280226|11826083|FG000|STARTED|Overall Study||17
10664128|NCT02280226|11826083|FG000|COMPLETED|Overall Study||17
10664129|NCT02280226|11826083|FG000|NOT COMPLETED|Overall Study||0
10664130|NCT02280291|11826091|FG000|STARTED|Overall Study||25
10664131|NCT02280291|11826092|FG001|STARTED|Overall Study||25
10664132|NCT02280291|11826093|FG002|STARTED|Overall Study||24
10664133|NCT02280291|11826094|FG003|STARTED|Overall Study||26
10664134|NCT02280291|11826091|FG000|COMPLETED|Overall Study||21
10664135|NCT02280291|11826092|FG001|COMPLETED|Overall Study||23
10664136|NCT02280291|11826093|FG002|COMPLETED|Overall Study||21
10664137|NCT02280291|11826094|FG003|COMPLETED|Overall Study||18
10664138|NCT02280291|11826091|FG000|NOT COMPLETED|Overall Study||4
10664139|NCT02280291|11826092|FG001|NOT COMPLETED|Overall Study||2
10664140|NCT02280291|11826093|FG002|NOT COMPLETED|Overall Study||3
10664141|NCT02280291|11826094|FG003|NOT COMPLETED|Overall Study||8
10664142|NCT02280304|11826108|FG000|STARTED|Overall Study||19
10664143|NCT02280304|11826109|FG001|STARTED|Overall Study||18
10664144|NCT02280304|11826108|FG000|COMPLETED|Overall Study||12
10664145|NCT02280304|11826109|FG001|COMPLETED|Overall Study|A non completer received the allocated intervention before being lost to follow-up.|10
10664146|NCT02280304|11826108|FG000|NOT COMPLETED|Overall Study||7
10664147|NCT02280304|11826109|FG001|NOT COMPLETED|Overall Study||8
10664148|NCT02280317|11826127|FG000|STARTED|Overall Study|Patients receiving at least one dose.|1
10664149|NCT02280317|11826128|FG001|STARTED|Overall Study|Patients receiving at least one dose.|1
10664150|NCT02280317|11826129|FG002|STARTED|Overall Study|Patients receiving at least one dose.|3
10664151|NCT02280317|11826130|FG003|STARTED|Overall Study|Patients receiving at least one dose.|5
10664152|NCT02280317|11826131|FG004|STARTED|Overall Study|Patients receiving at least one dose.|2
10664153|NCT02280317|11826127|FG000|COMPLETED|Overall Study|Patients completing six cycles.|1
10664154|NCT02280317|11826128|FG001|COMPLETED|Overall Study|Patients completing six cycles.|1
10664155|NCT02280317|11826129|FG002|COMPLETED|Overall Study|Patients completing six cycles.|0
10664156|NCT02280317|11826130|FG003|COMPLETED|Overall Study|Patients completing six cycles.|2
10664157|NCT02280317|11826131|FG004|COMPLETED|Overall Study|Patients completing six cycles.|0
10664158|NCT02280317|11826127|FG000|NOT COMPLETED|Overall Study||0
10664159|NCT02280317|11826128|FG001|NOT COMPLETED|Overall Study||0
10664160|NCT02280317|11826129|FG002|NOT COMPLETED|Overall Study||3
10664161|NCT02280317|11826130|FG003|NOT COMPLETED|Overall Study||3
10664162|NCT02280317|11826131|FG004|NOT COMPLETED|Overall Study||2
10664163|NCT02280408|11826158|FG000|STARTED|Overall Study||10
10664164|NCT02280408|11826159|FG001|STARTED|Overall Study||10
10664165|NCT02280408|11826160|FG002|STARTED|Overall Study||10
10664166|NCT02280408|11826161|FG003|STARTED|Overall Study||9
10664167|NCT02280408|11826158|FG000|Vaccination 1|Overall Study||10
10664168|NCT02280408|11826159|FG001|Vaccination 1|Overall Study||10
10664169|NCT02280408|11826160|FG002|Vaccination 1|Overall Study||10
10664170|NCT02280408|11826161|FG003|Vaccination 1|Overall Study||9
10664171|NCT02280408|11826158|FG000|Vaccination 2|Overall Study||10
10664172|NCT02280408|11826159|FG001|Vaccination 2|Overall Study||10
10664173|NCT02280408|11826160|FG002|Vaccination 2|Overall Study||10
10664174|NCT02280408|11826161|FG003|Vaccination 2|Overall Study||9
10664175|NCT02280408|11826158|FG000|COMPLETED|Overall Study||10
10664176|NCT02280408|11826159|FG001|COMPLETED|Overall Study||8
10664177|NCT02280408|11826160|FG002|COMPLETED|Overall Study||10
10664178|NCT02280408|11826161|FG003|COMPLETED|Overall Study||9
10664179|NCT02280408|11826158|FG000|NOT COMPLETED|Overall Study||0
10664180|NCT02280408|11826159|FG001|NOT COMPLETED|Overall Study||2
10664181|NCT02280408|11826160|FG002|NOT COMPLETED|Overall Study||0
10664182|NCT02280408|11826161|FG003|NOT COMPLETED|Overall Study||0
10664183|NCT02280421|11826173|FG000|STARTED|First Intervention(2 Weeks)||12
10664184|NCT02280421|11826174|FG001|STARTED|First Intervention(2 Weeks)||12
10664185|NCT02280421|11826173|FG000|Received Intervention|First Intervention(2 Weeks)||12
10664186|NCT02280421|11826174|FG001|Received Intervention|First Intervention(2 Weeks)||12
10664187|NCT02280421|11826173|FG000|COMPLETED|First Intervention(2 Weeks)||12
10664188|NCT02280421|11826174|FG001|COMPLETED|First Intervention(2 Weeks)||12
10664189|NCT02280421|11826173|FG000|NOT COMPLETED|First Intervention(2 Weeks)||0
10664190|NCT02280421|11826174|FG001|NOT COMPLETED|First Intervention(2 Weeks)||0
10664191|NCT02280421|11826173|FG000|STARTED|Washout (2 Weeks)||12
10664192|NCT02280421|11826174|FG001|STARTED|Washout (2 Weeks)||12
10664193|NCT02280421|11826173|FG000|COMPLETED|Washout (2 Weeks)||11
10664194|NCT02280421|11826174|FG001|COMPLETED|Washout (2 Weeks)||11
10664195|NCT02280421|11826173|FG000|NOT COMPLETED|Washout (2 Weeks)||1
10664196|NCT02280421|11826174|FG001|NOT COMPLETED|Washout (2 Weeks)||1
10664197|NCT02280421|11826173|FG000|STARTED|Second Intervention(2 Weeks)||12
10664198|NCT02280421|11826174|FG001|STARTED|Second Intervention(2 Weeks)||12
10664199|NCT02280421|11826173|FG000|Received Intervention|Second Intervention(2 Weeks)||12
10664200|NCT02280421|11826174|FG001|Received Intervention|Second Intervention(2 Weeks)||12
10664201|NCT02280421|11826173|FG000|COMPLETED|Second Intervention(2 Weeks)||12
10664202|NCT02280421|11826174|FG001|COMPLETED|Second Intervention(2 Weeks)||12
10664203|NCT02280421|11826173|FG000|NOT COMPLETED|Second Intervention(2 Weeks)||0
10664204|NCT02280421|11826174|FG001|NOT COMPLETED|Second Intervention(2 Weeks)||0
10664205|NCT02280473|11826194|FG000|STARTED|Overall Study||94
10664206|NCT02280473|11826195|FG001|STARTED|Overall Study||94
10664207|NCT02280473|11826194|FG000|COMPLETED|Overall Study||93
10664208|NCT02280473|11826195|FG001|COMPLETED|Overall Study||91
10664209|NCT02280473|11826194|FG000|NOT COMPLETED|Overall Study||1
10664210|NCT02280473|11826195|FG001|NOT COMPLETED|Overall Study||3
10664211|NCT02280499|11826201|FG000|STARTED|Overall Study||87
10664212|NCT02280499|11826201|FG000|COMPLETED|Overall Study||26
10664213|NCT02280499|11826201|FG000|NOT COMPLETED|Overall Study||61
10664214|NCT02280655|11826207|FG000|STARTED|Overall Study||25
10664215|NCT02280655|11826208|FG001|STARTED|Overall Study||18
10664216|NCT02280655|11826207|FG000|COMPLETED|Overall Study||25
10664217|NCT02280655|11826208|FG001|COMPLETED|Overall Study||18
10664218|NCT02280655|11826207|FG000|NOT COMPLETED|Overall Study||0
10664219|NCT02280655|11826208|FG001|NOT COMPLETED|Overall Study||0
10664220|NCT02280811|11826219|FG000|STARTED|Drug Administration||1
10664221|NCT02280811|11826220|FG001|STARTED|Drug Administration||2
10664222|NCT02280811|11826221|FG002|STARTED|Drug Administration||1
10664223|NCT02280811|11826222|FG003|STARTED|Drug Administration||6
10664224|NCT02280811|11826223|FG004|STARTED|Drug Administration||2
10664225|NCT02280811|11826219|FG000|COMPLETED|Drug Administration||1
10664226|NCT02280811|11826220|FG001|COMPLETED|Drug Administration||2
10664227|NCT02280811|11826221|FG002|COMPLETED|Drug Administration||1
10664228|NCT02280811|11826222|FG003|COMPLETED|Drug Administration||6
10664229|NCT02280811|11826223|FG004|COMPLETED|Drug Administration||2
10664230|NCT02280811|11826219|FG000|NOT COMPLETED|Drug Administration||0
10664231|NCT02280811|11826220|FG001|NOT COMPLETED|Drug Administration||0
10664232|NCT02280811|11826221|FG002|NOT COMPLETED|Drug Administration||0
10664233|NCT02280811|11826222|FG003|NOT COMPLETED|Drug Administration||0
10664234|NCT02280811|11826223|FG004|NOT COMPLETED|Drug Administration||0
10664235|NCT02280811|11826219|FG000|STARTED|Retreated at the MTD||0
10664236|NCT02280811|11826220|FG001|STARTED|Retreated at the MTD||0
10664237|NCT02280811|11826221|FG002|STARTED|Retreated at the MTD||0
10664238|NCT02280811|11826222|FG003|STARTED|Retreated at the MTD||0
10664239|NCT02280811|11826223|FG004|STARTED|Retreated at the MTD|Patient originally started in Grp1(HPV-16 E6mTCR PBL 1x10^9+HD IL-2) and was retreated at the MTD.|1
10664240|NCT02280811|11826219|FG000|COMPLETED|Retreated at the MTD||0
10664241|NCT02280811|11826220|FG001|COMPLETED|Retreated at the MTD||0
10664242|NCT02280811|11826221|FG002|COMPLETED|Retreated at the MTD||0
10664243|NCT02280811|11826222|FG003|COMPLETED|Retreated at the MTD||0
10664244|NCT02280811|11826223|FG004|COMPLETED|Retreated at the MTD||1
10664245|NCT02280811|11826219|FG000|NOT COMPLETED|Retreated at the MTD||0
10664246|NCT02280811|11826220|FG001|NOT COMPLETED|Retreated at the MTD||0
10664247|NCT02280811|11826221|FG002|NOT COMPLETED|Retreated at the MTD||0
10664248|NCT02280811|11826222|FG003|NOT COMPLETED|Retreated at the MTD||0
10664249|NCT02280811|11826223|FG004|NOT COMPLETED|Retreated at the MTD||0
10712138|NCT02667626|11877704|FG001|NOT COMPLETED|Overall Study||1
10712139|NCT02667704|11877713|FG000|STARTED|Treatment Period 1||13
10712140|NCT02667704|11877713|FG000|COMPLETED|Treatment Period 1||13
10712141|NCT02667704|11877713|FG000|NOT COMPLETED|Treatment Period 1||0
10712142|NCT02667704|11877713|FG000|STARTED|Treatment Period 2||13
10712143|NCT02667704|11877713|FG000|COMPLETED|Treatment Period 2||13
10712144|NCT02667704|11877713|FG000|NOT COMPLETED|Treatment Period 2||0
10712145|NCT02667821|11877720|FG000|STARTED|Overall Study||20
10712146|NCT02667821|11877720|FG000|COMPLETED|Overall Study||20
10712147|NCT02667821|11877720|FG000|NOT COMPLETED|Overall Study||0
10712148|NCT02667912|11877727|FG000|STARTED|Overall Study||28
10712149|NCT02667912|11877728|FG001|STARTED|Overall Study||27
10712150|NCT02667912|11877727|FG000|Six Months|Overall Study||27
10712151|NCT02667912|11877728|FG001|Six Months|Overall Study||24
10712152|NCT02667912|11877727|FG000|COMPLETED|Overall Study||23
10712153|NCT02667912|11877728|FG001|COMPLETED|Overall Study||24
10712154|NCT02667912|11877727|FG000|NOT COMPLETED|Overall Study||5
10712155|NCT02667912|11877728|FG001|NOT COMPLETED|Overall Study||3
10712156|NCT02667951|11877736|FG000|STARTED|Overall Study||66
10712157|NCT02667951|11877737|FG001|STARTED|Overall Study||63
10712158|NCT02667951|11877736|FG000|COMPLETED|Overall Study||45
10712159|NCT02667951|11877737|FG001|COMPLETED|Overall Study||40
10712160|NCT02667951|11877736|FG000|NOT COMPLETED|Overall Study||21
10712161|NCT02667951|11877737|FG001|NOT COMPLETED|Overall Study||23
10712162|NCT02668003|11877745|FG000|STARTED|Overall Study||501
10712163|NCT02668003|11877746|FG001|STARTED|Overall Study||501
10712164|NCT02668003|11877745|FG000|COMPLETED|Overall Study||500
10712165|NCT02668003|11877746|FG001|COMPLETED|Overall Study||496
10712166|NCT02668003|11877745|FG000|NOT COMPLETED|Overall Study||1
10712167|NCT02668003|11877746|FG001|NOT COMPLETED|Overall Study||5
10712168|NCT02668185|11877752|FG000|STARTED|Baseline Period (2 Weeks)||20
10712169|NCT02668185|11877753|FG001|STARTED|Baseline Period (2 Weeks)||17
10712170|NCT02668185|11877752|FG000|COMPLETED|Baseline Period (2 Weeks)||20
10712171|NCT02668185|11877753|FG001|COMPLETED|Baseline Period (2 Weeks)||17
10712172|NCT02668185|11877752|FG000|NOT COMPLETED|Baseline Period (2 Weeks)||0
10712173|NCT02668185|11877753|FG001|NOT COMPLETED|Baseline Period (2 Weeks)||0
10712174|NCT02668185|11877752|FG000|STARTED|First Intervention (4 Weeks)||20
10712175|NCT02668185|11877753|FG001|STARTED|First Intervention (4 Weeks)||17
10712176|NCT02668185|11877752|FG000|COMPLETED|First Intervention (4 Weeks)||18
10712177|NCT02668185|11877753|FG001|COMPLETED|First Intervention (4 Weeks)||17
10712178|NCT02668185|11877752|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2
10712179|NCT02668185|11877753|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
10664250|NCT02280863|11826239|FG000|STARTED|Android Platform||8
10664251|NCT02280863|11826240|FG001|STARTED|Android Platform||0
10664252|NCT02280863|11826239|FG000|COMPLETED|Android Platform||8
10664253|NCT02280863|11826240|FG001|COMPLETED|Android Platform||0
10664254|NCT02280863|11826239|FG000|NOT COMPLETED|Android Platform||0
10664255|NCT02280863|11826240|FG001|NOT COMPLETED|Android Platform||0
10664256|NCT02280863|11826239|FG000|STARTED|Integrated Platform|One additional participant was enrolled for part 2.|9
10664257|NCT02280863|11826240|FG001|STARTED|Integrated Platform||15
10664258|NCT02280863|11826239|FG000|COMPLETED|Integrated Platform||9
10664259|NCT02280863|11826240|FG001|COMPLETED|Integrated Platform||14
10664260|NCT02280863|11826239|FG000|NOT COMPLETED|Integrated Platform||0
10664261|NCT02280863|11826240|FG001|NOT COMPLETED|Integrated Platform||1
10664262|NCT02281136|11826250|FG000|STARTED|Overall Study||29
10664263|NCT02281136|11826250|FG000|COMPLETED|Overall Study||29
10664264|NCT02281136|11826250|FG000|NOT COMPLETED|Overall Study||0
10664265|NCT02281318|11826256|FG000|STARTED|Overall Study||277
10664266|NCT02281318|11826257|FG001|STARTED|Overall Study||274
10664267|NCT02281318|11826256|FG000|COMPLETED|Overall Study||263
10664268|NCT02281318|11826257|FG001|COMPLETED|Overall Study||269
10664269|NCT02281318|11826256|FG000|NOT COMPLETED|Overall Study||14
10664270|NCT02281318|11826257|FG001|NOT COMPLETED|Overall Study||5
10664271|NCT02281344|11826263|FG000|STARTED|Overall Study||6
10664272|NCT02281344|11826263|FG000|COMPLETED|Overall Study||6
10664273|NCT02281344|11826263|FG000|NOT COMPLETED|Overall Study||0
10664274|NCT02281357|11826269|FG000|STARTED|Overall Study||70
10664275|NCT02281357|11826270|FG001|STARTED|Overall Study||70
10664276|NCT02281357|11826269|FG000|COMPLETED|Overall Study||63
10664277|NCT02281357|11826270|FG001|COMPLETED|Overall Study||66
10664278|NCT02281357|11826269|FG000|NOT COMPLETED|Overall Study||7
10664279|NCT02281357|11826270|FG001|NOT COMPLETED|Overall Study||4
10664280|NCT02281409|11826280|FG000|STARTED|Overall Study||3
10664281|NCT02281409|11826281|FG001|STARTED|Overall Study||3
10664282|NCT02281409|11826282|FG002|STARTED|Overall Study||5
10664283|NCT02281409|11826283|FG003|STARTED|Overall Study||6
10664284|NCT02281409|11826280|FG000|COMPLETED|Overall Study||3
10664285|NCT02281409|11826281|FG001|COMPLETED|Overall Study||3
10664286|NCT02281409|11826282|FG002|COMPLETED|Overall Study||5
10664287|NCT02281409|11826283|FG003|COMPLETED|Overall Study||6
10664288|NCT02281409|11826280|FG000|NOT COMPLETED|Overall Study||0
10664289|NCT02281409|11826281|FG001|NOT COMPLETED|Overall Study||0
10664290|NCT02281409|11826282|FG002|NOT COMPLETED|Overall Study||0
10664291|NCT02281409|11826283|FG003|NOT COMPLETED|Overall Study||0
10664292|NCT02281422|11826299|FG000|STARTED|Overall Study||8
10664293|NCT02281422|11826300|FG001|STARTED|Overall Study||8
10664294|NCT02281422|11826301|FG002|STARTED|Overall Study||8
10664295|NCT02281422|11826302|FG003|STARTED|Overall Study||8
10664296|NCT02281422|11826303|FG004|STARTED|Overall Study||8
10664297|NCT02281422|11826299|FG000|COMPLETED|Overall Study||8
10664298|NCT02281422|11826300|FG001|COMPLETED|Overall Study||8
10664299|NCT02281422|11826301|FG002|COMPLETED|Overall Study||8
10664300|NCT02281422|11826302|FG003|COMPLETED|Overall Study||8
10664301|NCT02281422|11826303|FG004|COMPLETED|Overall Study||8
10664302|NCT02281422|11826299|FG000|NOT COMPLETED|Overall Study||0
10664303|NCT02281422|11826300|FG001|NOT COMPLETED|Overall Study||0
10664304|NCT02281422|11826301|FG002|NOT COMPLETED|Overall Study||0
10664305|NCT02281422|11826302|FG003|NOT COMPLETED|Overall Study||0
10664306|NCT02281422|11826303|FG004|NOT COMPLETED|Overall Study||0
10664307|NCT02281448|11826317|FG000|STARTED|Overall Study||10
10664308|NCT02281448|11826318|FG001|STARTED|Overall Study||10
10664309|NCT02281448|11826317|FG000|COMPLETED|Overall Study||8
10664310|NCT02281448|11826318|FG001|COMPLETED|Overall Study||9
10664311|NCT02281448|11826317|FG000|NOT COMPLETED|Overall Study||2
10664312|NCT02281448|11826318|FG001|NOT COMPLETED|Overall Study||1
10664313|NCT02281526|11826326|FG000|STARTED|Overall Study||9
10664314|NCT02281526|11826327|FG001|STARTED|Overall Study||8
10664315|NCT02281526|11826326|FG000|COMPLETED|Overall Study||8
10664316|NCT02281526|11826327|FG001|COMPLETED|Overall Study||8
10664317|NCT02281526|11826326|FG000|NOT COMPLETED|Overall Study||1
10664318|NCT02281526|11826327|FG001|NOT COMPLETED|Overall Study||0
10664319|NCT02281552|11826335|FG000|STARTED|Overall Study||104
10664320|NCT02281552|11826336|FG001|STARTED|Overall Study||105
10664321|NCT02281552|11826335|FG000|COMPLETED|Overall Study||100
10664322|NCT02281552|11826336|FG001|COMPLETED|Overall Study||95
10664323|NCT02281552|11826335|FG000|NOT COMPLETED|Overall Study||4
10664324|NCT02281552|11826336|FG001|NOT COMPLETED|Overall Study||10
10664325|NCT02281591|11826346|FG000|STARTED|Overall Study||8
10664326|NCT02281591|11826347|FG001|STARTED|Overall Study||8
10664327|NCT02281591|11826348|FG002|STARTED|Overall Study||8
10664328|NCT02281591|11826349|FG003|STARTED|Overall Study||8
10664329|NCT02281591|11826346|FG000|COMPLETED|Overall Study||8
10664330|NCT02281591|11826347|FG001|COMPLETED|Overall Study||8
10664331|NCT02281591|11826348|FG002|COMPLETED|Overall Study||8
10664332|NCT02281591|11826349|FG003|COMPLETED|Overall Study||8
10664333|NCT02281591|11826346|FG000|NOT COMPLETED|Overall Study||0
10664334|NCT02281591|11826347|FG001|NOT COMPLETED|Overall Study||0
10664335|NCT02281591|11826348|FG002|NOT COMPLETED|Overall Study||0
10664336|NCT02281591|11826349|FG003|NOT COMPLETED|Overall Study||0
10664337|NCT02281760|11826359|FG000|STARTED|Overall Study||6
10664338|NCT02281760|11826359|FG000|COMPLETED|Overall Study||5
10664339|NCT02281760|11826359|FG000|NOT COMPLETED|Overall Study||1
10664340|NCT02281773|11826368|FG000|STARTED|Overall Study||87
10664341|NCT02281773|11826369|FG001|STARTED|Overall Study|Started are the treated patients|85
10664342|NCT02281773|11826370|FG002|STARTED|Overall Study||85
10664343|NCT02281773|11826371|FG003|STARTED|Overall Study||86
10664344|NCT02281773|11826372|FG004|STARTED|Overall Study|Started are the treated patients|173
10664345|NCT02281773|11826368|FG000|COMPLETED|Overall Study||76
10664346|NCT02281773|11826369|FG001|COMPLETED|Overall Study||70
10664347|NCT02281773|11826370|FG002|COMPLETED|Overall Study||67
10664348|NCT02281773|11826371|FG003|COMPLETED|Overall Study||65
10664349|NCT02281773|11826372|FG004|COMPLETED|Overall Study||143
10664350|NCT02281773|11826368|FG000|NOT COMPLETED|Overall Study||11
10664351|NCT02281773|11826369|FG001|NOT COMPLETED|Overall Study||15
10664352|NCT02281773|11826370|FG002|NOT COMPLETED|Overall Study||18
10664353|NCT02281773|11826371|FG003|NOT COMPLETED|Overall Study||21
10664354|NCT02281773|11826372|FG004|NOT COMPLETED|Overall Study||30
10664355|NCT02281851|11826386|FG000|STARTED|Overall Study||4
10664356|NCT02281851|11826387|FG001|STARTED|Overall Study||10
10664357|NCT02281851|11826386|FG000|COMPLETED|Overall Study||4
10664358|NCT02281851|11826387|FG001|COMPLETED|Overall Study||10
10664359|NCT02281851|11826386|FG000|NOT COMPLETED|Overall Study||0
10664360|NCT02281851|11826387|FG001|NOT COMPLETED|Overall Study||0
10664361|NCT02282111|11826395|FG000|STARTED|Overall Study||26
10664362|NCT02282111|11826396|FG001|STARTED|Overall Study||30
10664363|NCT02282111|11826395|FG000|COMPLETED|Overall Study||19
10664364|NCT02282111|11826396|FG001|COMPLETED|Overall Study||22
10664365|NCT02282111|11826395|FG000|NOT COMPLETED|Overall Study||7
10664366|NCT02282111|11826396|FG001|NOT COMPLETED|Overall Study||8
10664367|NCT02282163|11826402|FG000|STARTED|Overall Study||13
10810879|NCT03784963|11972584|FG000|NOT COMPLETED|Overall Study||12
10664368|NCT02282163|11826402|FG000|COMPLETED|Overall Study||12
10664369|NCT02282163|11826402|FG000|NOT COMPLETED|Overall Study||1
10664370|NCT02282293|11826417|FG000|STARTED|Overall Study||100
10664371|NCT02282293|11826418|FG001|STARTED|Overall Study||100
10664372|NCT02282293|11826417|FG000|COMPLETED|Overall Study||97
10664373|NCT02282293|11826418|FG001|COMPLETED|Overall Study||97
10664374|NCT02282293|11826417|FG000|NOT COMPLETED|Overall Study||3
10664375|NCT02282293|11826418|FG001|NOT COMPLETED|Overall Study||3
10664376|NCT02282514|11826424|FG000|STARTED|Overall Study||23
10664377|NCT02282514|11826424|FG000|COMPLETED|Overall Study||23
10664378|NCT02282514|11826424|FG000|NOT COMPLETED|Overall Study||0
10664379|NCT02282527|11826430|FG000|STARTED|Overall Study||16
10664380|NCT02282527|11826431|FG001|STARTED|Overall Study||16
10664381|NCT02282527|11826430|FG000|COMPLETED|Overall Study||15
10664382|NCT02282527|11826431|FG001|COMPLETED|Overall Study||15
10664383|NCT02282527|11826430|FG000|NOT COMPLETED|Overall Study||1
10664384|NCT02282527|11826431|FG001|NOT COMPLETED|Overall Study||1
10664385|NCT02282605|11826443|FG000|STARTED|Overall Study||27
10664386|NCT02282605|11826444|FG001|STARTED|Overall Study||12
10664387|NCT02282605|11826445|FG002|STARTED|Overall Study||24
10664388|NCT02282605|11826443|FG000|COMPLETED|Overall Study||24
10664389|NCT02282605|11826444|FG001|COMPLETED|Overall Study||12
10664390|NCT02282605|11826445|FG002|COMPLETED|Overall Study||24
10664391|NCT02282605|11826443|FG000|NOT COMPLETED|Overall Study||3
10664392|NCT02282605|11826444|FG001|NOT COMPLETED|Overall Study||0
10664393|NCT02282605|11826445|FG002|NOT COMPLETED|Overall Study||0
10664394|NCT02282631|11826455|FG000|STARTED|Overall Study|The two dropouts happened on the 2nd and 3rd weeks post-baseline, respectively|14
10664395|NCT02282631|11826456|FG001|STARTED|Overall Study||15
10664396|NCT02282631|11826455|FG000|COMPLETED|Overall Study||12
10664397|NCT02282631|11826456|FG001|COMPLETED|Overall Study||15
10664398|NCT02282631|11826455|FG000|NOT COMPLETED|Overall Study||2
10664399|NCT02282631|11826456|FG001|NOT COMPLETED|Overall Study||0
10664400|NCT02282722|11826470|FG000|STARTED|Overall Study||94
10664401|NCT02282722|11826471|FG001|STARTED|Overall Study||92
10664402|NCT02282722|11826470|FG000|2-week Assessment|Overall Study||79
10664403|NCT02282722|11826471|FG001|2-week Assessment|Overall Study||75
10664404|NCT02282722|11826470|FG000|3-month Assessment|Overall Study||71
10664405|NCT02282722|11826471|FG001|3-month Assessment|Overall Study||73
10664406|NCT02282722|11826470|FG000|COMPLETED|Overall Study||71
10664407|NCT02282722|11826471|FG001|COMPLETED|Overall Study||73
10664408|NCT02282722|11826470|FG000|NOT COMPLETED|Overall Study||23
10664409|NCT02282722|11826471|FG001|NOT COMPLETED|Overall Study||19
10664410|NCT02282813|11826480|FG000|STARTED|Overall Study|ITT Population|103
10664411|NCT02282813|11826481|FG001|STARTED|Overall Study|ITT Population - not randomized or randomized to CTAP101 monotherapy|153
10664412|NCT02282813|11826482|FG002|STARTED|Overall Study|Randomization to take adjunctive treatment in addition to CTAP101 capsules began after week 12.|42
10664413|NCT02282813|11826480|FG000|COMPLETED|Overall Study||91
10664414|NCT02282813|11826481|FG001|COMPLETED|Overall Study||130
10664415|NCT02282813|11826482|FG002|COMPLETED|Overall Study||39
10664416|NCT02282813|11826480|FG000|NOT COMPLETED|Overall Study||12
10664417|NCT02282813|11826481|FG001|NOT COMPLETED|Overall Study||23
10664418|NCT02282813|11826482|FG002|NOT COMPLETED|Overall Study||3
10664419|NCT02282904|11826492|FG000|STARTED|Overall Study||7
10664420|NCT02282904|11826492|FG000|COMPLETED|Overall Study|Patient accrual was stopped early, and the protocol closed after completing followup|7
10664421|NCT02282904|11826492|FG000|NOT COMPLETED|Overall Study||0
10664422|NCT02282930|11826496|FG000|STARTED|Overall Study||20
10664423|NCT02282930|11826496|FG000|COMPLETED|Overall Study||19
10664424|NCT02282930|11826496|FG000|NOT COMPLETED|Overall Study||1
10664425|NCT02282982|11826500|FG000|STARTED|Overall Study||359
10664426|NCT02282982|11826500|FG000|Attended Visit 1|Overall Study||359
10664427|NCT02282982|11826500|FG000|Attended Visit 2|Overall Study||341
10664428|NCT02282982|11826500|FG000|Attended Visit 3|Overall Study||298
10664429|NCT02282982|11826500|FG000|Attended Visit 4|Overall Study||194
10664430|NCT02282982|11826500|FG000|Attended Visit 5|Overall Study||83
10664431|NCT02282982|11826500|FG000|Attended Follow-up Visit|Overall Study||349
10664432|NCT02282982|11826500|FG000|COMPLETED|Overall Study||153
10664433|NCT02282982|11826500|FG000|NOT COMPLETED|Overall Study||206
10664434|NCT02283268|11826504|FG000|STARTED|Overall Study||15
10810880|NCT03784963|11972585|FG001|NOT COMPLETED|Overall Study||10
10810881|NCT03784963|11972586|FG002|NOT COMPLETED|Overall Study||1
10664435|NCT02283268|11826504|FG000|COMPLETED|Overall Study||14
10664436|NCT02283268|11826504|FG000|NOT COMPLETED|Overall Study||1
10664437|NCT02283294|11826518|FG000|STARTED|Overall Study||41
10664438|NCT02283294|11826519|FG001|STARTED|Overall Study||47
10664439|NCT02283294|11826518|FG000|Received Allocated Treatment Intervention|Overall Study||38
10664440|NCT02283294|11826519|FG001|Received Allocated Treatment Intervention|Overall Study||31
10664441|NCT02283294|11826518|FG000|COMPLETED|Overall Study||38
10664442|NCT02283294|11826519|FG001|COMPLETED|Overall Study||39
10664443|NCT02283294|11826518|FG000|NOT COMPLETED|Overall Study||3
10664444|NCT02283294|11826519|FG001|NOT COMPLETED|Overall Study||8
10664445|NCT02283333|11826528|FG000|STARTED|Overall Study||77
10664446|NCT02283333|11826529|FG001|STARTED|Overall Study||78
10664447|NCT02283333|11826528|FG000|COMPLETED|Overall Study||63
10664448|NCT02283333|11826529|FG001|COMPLETED|Overall Study||64
10664449|NCT02283333|11826528|FG000|NOT COMPLETED|Overall Study||14
10664450|NCT02283333|11826529|FG001|NOT COMPLETED|Overall Study||14
10664451|NCT02283411|11826535|FG000|STARTED|Overall Study||156
10664452|NCT02283411|11826535|FG000|COMPLETED|Overall Study||125
10664453|NCT02283411|11826535|FG000|NOT COMPLETED|Overall Study||31
10664454|NCT02283528|11826541|FG000|STARTED|Overall Study||26
10664455|NCT02283528|11826542|FG001|STARTED|Overall Study||24
10664456|NCT02283528|11826541|FG000|COMPLETED|Overall Study||26
10664457|NCT02283528|11826542|FG001|COMPLETED|Overall Study||24
10664458|NCT02283528|11826541|FG000|NOT COMPLETED|Overall Study||0
10664459|NCT02283528|11826542|FG001|NOT COMPLETED|Overall Study||0
10664460|NCT02283658|11826548|FG000|STARTED|Overall Study||20
10664461|NCT02283658|11826548|FG000|COMPLETED|Overall Study||19
10664462|NCT02283658|11826548|FG000|NOT COMPLETED|Overall Study||1
10664463|NCT02283749|11826552|FG000|STARTED|Overall Study||5
10664464|NCT02283749|11826552|FG000|COMPLETED|Overall Study||5
10664465|NCT02283749|11826552|FG000|NOT COMPLETED|Overall Study||0
10664466|NCT02283762|11826558|FG000|STARTED|Main Treatment Phase (MT)||60
10664467|NCT02283762|11826559|FG001|STARTED|Main Treatment Phase (MT)||61
10664468|NCT02283762|11826558|FG000|COMPLETED|Main Treatment Phase (MT)||42
10664469|NCT02283762|11826559|FG001|COMPLETED|Main Treatment Phase (MT)||46
10664470|NCT02283762|11826558|FG000|NOT COMPLETED|Main Treatment Phase (MT)||18
10664471|NCT02283762|11826559|FG001|NOT COMPLETED|Main Treatment Phase (MT)||15
10664472|NCT02283762|11826558|FG000|STARTED|Long-term Extension Phase (LTE)||42
10664473|NCT02283762|11826559|FG001|STARTED|Long-term Extension Phase (LTE)|Of the 46 patients who completed the main treatment phase, 1 patient did not enter the LTE phase|45
10664474|NCT02283762|11826558|FG000|COMPLETED|Long-term Extension Phase (LTE)||32
10664475|NCT02283762|11826559|FG001|COMPLETED|Long-term Extension Phase (LTE)||31
10664476|NCT02283762|11826558|FG000|NOT COMPLETED|Long-term Extension Phase (LTE)||10
10664477|NCT02283762|11826559|FG001|NOT COMPLETED|Long-term Extension Phase (LTE)||14
10664478|NCT02283788|11826571|FG000|STARTED|Overall Study||17
10664479|NCT02283788|11826572|FG001|STARTED|Overall Study||17
10664480|NCT02283788|11826573|FG002|STARTED|Overall Study||17
10664481|NCT02283788|11826574|FG003|STARTED|Overall Study||16
10664482|NCT02283788|11826571|FG000|COMPLETED|Overall Study||16
10664483|NCT02283788|11826572|FG001|COMPLETED|Overall Study||13
10664484|NCT02283788|11826573|FG002|COMPLETED|Overall Study||12
10664485|NCT02283788|11826574|FG003|COMPLETED|Overall Study||14
10664486|NCT02283788|11826571|FG000|NOT COMPLETED|Overall Study||1
10664487|NCT02283788|11826572|FG001|NOT COMPLETED|Overall Study||4
10664488|NCT02283788|11826573|FG002|NOT COMPLETED|Overall Study||5
10664489|NCT02283788|11826574|FG003|NOT COMPLETED|Overall Study||2
10664490|NCT02283814|11826586|FG000|STARTED|Overall Study||16
10664491|NCT02283814|11826587|FG001|STARTED|Overall Study||16
10664492|NCT02283814|11826586|FG000|COMPLETED|Overall Study||13
10664493|NCT02283814|11826587|FG001|COMPLETED|Overall Study||14
10664494|NCT02283814|11826586|FG000|NOT COMPLETED|Overall Study||3
10664495|NCT02283814|11826587|FG001|NOT COMPLETED|Overall Study||2
10664496|NCT02283827|11826595|FG000|STARTED|Overall Study||16
10664497|NCT02283827|11826596|FG001|STARTED|Overall Study||16
10664498|NCT02283827|11826595|FG000|COMPLETED|Overall Study||15
10664499|NCT02283827|11826596|FG001|COMPLETED|Overall Study||13
10664500|NCT02283827|11826595|FG000|NOT COMPLETED|Overall Study||1
10664501|NCT02283827|11826596|FG001|NOT COMPLETED|Overall Study||3
10664502|NCT02283840|11826611|FG000|STARTED|Overall Study||20
10664503|NCT02283840|11826612|FG001|STARTED|Overall Study||20
10664504|NCT02283840|11826613|FG002|STARTED|Overall Study||20
10664505|NCT02283840|11826611|FG000|COMPLETED|Overall Study||20
10664506|NCT02283840|11826612|FG001|COMPLETED|Overall Study||19
10664507|NCT02283840|11826613|FG002|COMPLETED|Overall Study||20
10664508|NCT02283840|11826611|FG000|NOT COMPLETED|Overall Study||0
10664509|NCT02283840|11826612|FG001|NOT COMPLETED|Overall Study||1
10664510|NCT02283840|11826613|FG002|NOT COMPLETED|Overall Study||0
10664511|NCT02284009|11826626|FG000|STARTED|Overall Study||17
10664512|NCT02284009|11826627|FG001|STARTED|Overall Study||50
10664513|NCT02284009|11826626|FG000|COMPLETED|Overall Study||11
10664514|NCT02284009|11826627|FG001|COMPLETED|Overall Study||40
10664515|NCT02284009|11826626|FG000|NOT COMPLETED|Overall Study||6
10664516|NCT02284009|11826627|FG001|NOT COMPLETED|Overall Study||10
10664517|NCT02284126|11826637|FG000|STARTED|Overall Study||552
10664518|NCT02284126|11826638|FG001|STARTED|Overall Study||551
10664519|NCT02284126|11826637|FG000|COMPLETED|Overall Study||484
10664520|NCT02284126|11826638|FG001|COMPLETED|Overall Study||489
10664521|NCT02284126|11826637|FG000|NOT COMPLETED|Overall Study||68
10664522|NCT02284126|11826638|FG001|NOT COMPLETED|Overall Study||62
10664523|NCT02284165|11826647|FG000|STARTED|Overall Study||36448
10318778|NCT00217425|11453031|FG000|COMPLETED|Overall Study||9
10318779|NCT00217425|11453031|FG000|NOT COMPLETED|Overall Study||37
10318780|NCT00217438|11453037|FG000|STARTED|Overall Study||66
10318781|NCT00217438|11453038|FG001|STARTED|Overall Study||64
10318782|NCT00217438|11453037|FG000|COMPLETED|Overall Study||66
10318783|NCT00217438|11453038|FG001|COMPLETED|Overall Study|One patient did not complete Day 80-120 evaluation tests after returning to referring physician.|63
10664524|NCT02284165|11826648|FG001|STARTED|Overall Study||40272
10664525|NCT02284165|11826649|FG002|STARTED|Overall Study||70996
10664526|NCT02284165|11826647|FG000|COMPLETED|Overall Study||36448
10664527|NCT02284165|11826648|FG001|COMPLETED|Overall Study||40272
10664528|NCT02284165|11826649|FG002|COMPLETED|Overall Study||70996
10664529|NCT02284165|11826647|FG000|NOT COMPLETED|Overall Study||0
10664530|NCT02284165|11826648|FG001|NOT COMPLETED|Overall Study||0
10664531|NCT02284165|11826649|FG002|NOT COMPLETED|Overall Study||0
10664532|NCT02284178|11826657|FG000|STARTED|Overall Study||255
10664533|NCT02284178|11826658|FG001|STARTED|Overall Study||258
10664534|NCT02284178|11826657|FG000|COMPLETED|Overall Study||206
10664535|NCT02284178|11826658|FG001|COMPLETED|Overall Study||204
10664536|NCT02284178|11826657|FG000|NOT COMPLETED|Overall Study||49
10664537|NCT02284178|11826658|FG001|NOT COMPLETED|Overall Study||54
10664538|NCT02284243|11826666|FG000|STARTED|Overall Study||84
10664539|NCT02284243|11826667|FG001|STARTED|Overall Study||84
10664540|NCT02284243|11826666|FG000|COMPLETED|Overall Study||80
10664541|NCT02284243|11826667|FG001|COMPLETED|Overall Study||81
10664542|NCT02284243|11826666|FG000|NOT COMPLETED|Overall Study||4
10664543|NCT02284243|11826667|FG001|NOT COMPLETED|Overall Study||3
10664544|NCT02284347|11826673|FG000|STARTED|Overall Study||51
10664545|NCT02284347|11826673|FG000|COMPLETED|Overall Study||48
10664546|NCT02284347|11826673|FG000|NOT COMPLETED|Overall Study||3
10664547|NCT02284386|11826677|FG000|STARTED|Overall Study||15
10664548|NCT02284386|11826677|FG000|COMPLETED|Overall Study||15
10664549|NCT02284386|11826677|FG000|NOT COMPLETED|Overall Study||0
10664550|NCT02284399|11826683|FG000|STARTED|Overall Study||1414
10664551|NCT02284399|11826684|FG001|STARTED|Overall Study||3074
10664552|NCT02284399|11826683|FG000|COMPLETED|Overall Study||1414
10664553|NCT02284399|11826684|FG001|COMPLETED|Overall Study||3074
10664554|NCT02284399|11826683|FG000|NOT COMPLETED|Overall Study||0
10664555|NCT02284399|11826684|FG001|NOT COMPLETED|Overall Study||0
10664556|NCT02284464|11826694|FG000|STARTED|Overall Study||52
10664557|NCT02284464|11826695|FG001|STARTED|Overall Study||53
10664558|NCT02284464|11826694|FG000|COMPLETED|Overall Study||39
10664559|NCT02284464|11826695|FG001|COMPLETED|Overall Study||36
10664560|NCT02284464|11826694|FG000|NOT COMPLETED|Overall Study||13
10664561|NCT02284464|11826695|FG001|NOT COMPLETED|Overall Study||17
10664562|NCT02284516|11826703|FG000|STARTED|Overall Study||356
10664563|NCT02284516|11826704|FG001|STARTED|Overall Study||355
10664564|NCT02284516|11826703|FG000|Safety Population|Overall Study|Two placebo participants were considered for Lifitegrast arm; Placebo safety analysis set (N= 354).|354
10664565|NCT02284516|11826704|FG001|Safety Population|Overall Study|Two placebo participants were included in Lifitegrast arm for safety analysis set (N=357).|357
10664566|NCT02284516|11826703|FG000|COMPLETED|Overall Study||318
10664567|NCT02284516|11826704|FG001|COMPLETED|Overall Study||319
10664568|NCT02284516|11826703|FG000|NOT COMPLETED|Overall Study||38
10664569|NCT02284516|11826704|FG001|NOT COMPLETED|Overall Study||36
10664570|NCT02284555|11826710|FG000|STARTED|Overall Study||12
10664571|NCT02284555|11826710|FG000|COMPLETED|Overall Study||12
10664572|NCT02284555|11826710|FG000|NOT COMPLETED|Overall Study||0
10664573|NCT02284828|11826714|FG000|STARTED|Overall Study||26
10664574|NCT02284828|11826714|FG000|COMPLETED|Overall Study||22
10664575|NCT02284828|11826714|FG000|NOT COMPLETED|Overall Study||4
10664576|NCT02284854|11826723|FG000|STARTED|Overall Study||23
10664577|NCT02284854|11826724|FG001|STARTED|Overall Study||20
10664578|NCT02284854|11826723|FG000|COMPLETED|Overall Study||18
10664579|NCT02284854|11826724|FG001|COMPLETED|Overall Study||20
10664580|NCT02284854|11826723|FG000|NOT COMPLETED|Overall Study||5
10664581|NCT02284854|11826724|FG001|NOT COMPLETED|Overall Study||0
10664582|NCT02284867|11826739|FG000|STARTED|Overall Study||30
10664583|NCT02284867|11826740|FG001|STARTED|Overall Study||30
10664584|NCT02284867|11826739|FG000|COMPLETED|Overall Study||30
10664585|NCT02284867|11826740|FG001|COMPLETED|Overall Study||30
10664586|NCT02284867|11826739|FG000|NOT COMPLETED|Overall Study||0
10664587|NCT02284867|11826740|FG001|NOT COMPLETED|Overall Study||0
10664588|NCT02284880|11826748|FG000|STARTED|Overall Study||11
10664589|NCT02284880|11826749|FG001|STARTED|Overall Study||9
10664590|NCT02284880|11826750|FG002|STARTED|Overall Study||10
10664591|NCT02284880|11826751|FG003|STARTED|Overall Study||10
10664592|NCT02284880|11826748|FG000|First Period (4 Days)|Overall Study||11
10664593|NCT02284880|11826749|FG001|First Period (4 Days)|Overall Study||9
10664594|NCT02284880|11826750|FG002|First Period (4 Days)|Overall Study||10
10664595|NCT02284880|11826751|FG003|First Period (4 Days)|Overall Study||10
10664596|NCT02284880|11826748|FG000|Wash-out Period (7 Days)|Overall Study||11
10664597|NCT02284880|11826749|FG001|Wash-out Period (7 Days)|Overall Study||9
10664598|NCT02284880|11826750|FG002|Wash-out Period (7 Days)|Overall Study||10
10664599|NCT02284880|11826751|FG003|Wash-out Period (7 Days)|Overall Study||10
10664600|NCT02284880|11826748|FG000|Second Period (4 Days)|Overall Study||11
10664601|NCT02284880|11826749|FG001|Second Period (4 Days)|Overall Study||9
10664602|NCT02284880|11826750|FG002|Second Period (4 Days)|Overall Study||8
10664603|NCT02284880|11826751|FG003|Second Period (4 Days)|Overall Study||10
10664604|NCT02284880|11826748|FG000|COMPLETED|Overall Study||11
10664605|NCT02284880|11826749|FG001|COMPLETED|Overall Study||9
10664606|NCT02284880|11826750|FG002|COMPLETED|Overall Study||8
10664607|NCT02284880|11826751|FG003|COMPLETED|Overall Study||10
10664608|NCT02284880|11826748|FG000|NOT COMPLETED|Overall Study||0
10664609|NCT02284880|11826749|FG001|NOT COMPLETED|Overall Study||0
10664610|NCT02284880|11826750|FG002|NOT COMPLETED|Overall Study||2
10664611|NCT02284880|11826751|FG003|NOT COMPLETED|Overall Study||0
10664612|NCT02284893|11826763|FG000|STARTED|26 Week (Short Term)||232
10664613|NCT02284893|11826764|FG001|STARTED|26 Week (Short Term)||229
10664614|NCT02284893|11826763|FG000|COMPLETED|26 Week (Short Term)||213
10664615|NCT02284893|11826764|FG001|COMPLETED|26 Week (Short Term)||198
10664616|NCT02284893|11826763|FG000|NOT COMPLETED|26 Week (Short Term)||19
10664617|NCT02284893|11826764|FG001|NOT COMPLETED|26 Week (Short Term)||31
10664618|NCT02284893|11826763|FG000|STARTED|52 Week (Long Term)||209
10664619|NCT02284893|11826764|FG001|STARTED|52 Week (Long Term)||193
10664620|NCT02284893|11826763|FG000|COMPLETED|52 Week (Long Term)||198
10664621|NCT02284893|11826764|FG001|COMPLETED|52 Week (Long Term)||180
10664622|NCT02284893|11826763|FG000|NOT COMPLETED|52 Week (Long Term)||11
10664623|NCT02284893|11826764|FG001|NOT COMPLETED|52 Week (Long Term)||13
10664624|NCT02285010|11826772|FG000|STARTED|Overall Study||63
10664625|NCT02285010|11826773|FG001|STARTED|Overall Study||62
10664626|NCT02285010|11826772|FG000|COMPLETED|Overall Study||58
10664627|NCT02285010|11826773|FG001|COMPLETED|Overall Study||61
10664628|NCT02285010|11826772|FG000|NOT COMPLETED|Overall Study||5
10664629|NCT02285010|11826773|FG001|NOT COMPLETED|Overall Study||1
10664630|NCT02285023|11826779|FG000|STARTED|Overall Study||166
10664631|NCT02285023|11826779|FG000|COMPLETED|Overall Study||166
10664632|NCT02285023|11826779|FG000|NOT COMPLETED|Overall Study||0
10664633|NCT02285153|11826791|FG000|STARTED|Overall Study||7
10664634|NCT02285153|11826792|FG001|STARTED|Overall Study||8
10664635|NCT02285153|11826791|FG000|COMPLETED|Overall Study||6
10664636|NCT02285153|11826792|FG001|COMPLETED|Overall Study||8
10664637|NCT02285153|11826791|FG000|NOT COMPLETED|Overall Study||1
10664638|NCT02285153|11826792|FG001|NOT COMPLETED|Overall Study||0
10664639|NCT02285283|11826800|FG000|STARTED|Overall Study||29
10664640|NCT02285283|11826801|FG001|STARTED|Overall Study||29
10664641|NCT02285283|11826800|FG000|COMPLETED|Overall Study||25
10664642|NCT02285283|11826801|FG001|COMPLETED|Overall Study||20
10664643|NCT02285283|11826800|FG000|NOT COMPLETED|Overall Study||4
10664644|NCT02285283|11826801|FG001|NOT COMPLETED|Overall Study||9
10664645|NCT02285361|11826807|FG000|STARTED|Overall Study||1272
10664646|NCT02285361|11826807|FG000|COMPLETED|Overall Study||1221
10664647|NCT02285361|11826807|FG000|NOT COMPLETED|Overall Study||51
10664648|NCT02285634|11826815|FG000|STARTED|Overall Study||15
10664649|NCT02285634|11826816|FG001|STARTED|Overall Study||20
10664650|NCT02285634|11826817|FG002|STARTED|Overall Study||15
10664651|NCT02285634|11826818|FG003|STARTED|Overall Study||18
10664652|NCT02285634|11826815|FG000|COMPLETED|Overall Study||15
10664653|NCT02285634|11826816|FG001|COMPLETED|Overall Study||20
10664654|NCT02285634|11826817|FG002|COMPLETED|Overall Study||11
10664655|NCT02285634|11826818|FG003|COMPLETED|Overall Study||17
10664656|NCT02285634|11826815|FG000|NOT COMPLETED|Overall Study||0
10664657|NCT02285634|11826816|FG001|NOT COMPLETED|Overall Study||0
10664658|NCT02285634|11826817|FG002|NOT COMPLETED|Overall Study||4
10664659|NCT02285634|11826818|FG003|NOT COMPLETED|Overall Study||1
10664660|NCT02285777|11826831|FG000|STARTED|Overall Study||95
10664661|NCT02285777|11826832|FG001|STARTED|Overall Study||94
10664662|NCT02285777|11826831|FG000|COMPLETED|Overall Study||90
10664663|NCT02285777|11826832|FG001|COMPLETED|Overall Study||91
10664664|NCT02285777|11826831|FG000|NOT COMPLETED|Overall Study||5
10664665|NCT02285777|11826832|FG001|NOT COMPLETED|Overall Study||3
10664666|NCT02285855|11826840|FG000|STARTED|Overall Study||16
10795740|NCT03645434|11956034|FG005|STARTED|Period 2|1 subject completed Period 1 but not allowed to enter Period 2 due to physician decision.|11
10795741|NCT03645434|11956029|FG000|COMPLETED|Period 2||10
10795742|NCT03645434|11956030|FG001|COMPLETED|Period 2||13
10795743|NCT03645434|11956031|FG002|COMPLETED|Period 2||13
10795744|NCT03645434|11956032|FG003|COMPLETED|Period 2||10
10795745|NCT03645434|11956033|FG004|COMPLETED|Period 2||11
10795746|NCT03645434|11956034|FG005|COMPLETED|Period 2||11
10795747|NCT03645434|11956029|FG000|NOT COMPLETED|Period 2||0
10795748|NCT03645434|11956030|FG001|NOT COMPLETED|Period 2||0
10795749|NCT03645434|11956031|FG002|NOT COMPLETED|Period 2||0
10795750|NCT03645434|11956032|FG003|NOT COMPLETED|Period 2||0
10795751|NCT03645434|11956033|FG004|NOT COMPLETED|Period 2||0
10664667|NCT02285855|11826841|FG001|STARTED|Overall Study||2
10664668|NCT02285855|11826840|FG000|Randomized|Overall Study||16
10664669|NCT02285855|11826841|FG001|Randomized|Overall Study||2
10664670|NCT02285855|11826840|FG000|COMPLETED|Overall Study||14
10795752|NCT03645434|11956034|FG005|NOT COMPLETED|Period 2||0
10664671|NCT02285855|11826841|FG001|COMPLETED|Overall Study||1
10664672|NCT02285855|11826840|FG000|NOT COMPLETED|Overall Study||2
10664673|NCT02285855|11826841|FG001|NOT COMPLETED|Overall Study||1
10664674|NCT02285907|11826847|FG000|STARTED|Overall Study||21
10664675|NCT02285907|11826847|FG000|Began 1st Intervention|Overall Study||21
10664676|NCT02285907|11826847|FG000|Began 2nd Intervention|Overall Study||21
10795753|NCT03645434|11956029|FG000|STARTED|Period 3||10
10664677|NCT02285907|11826847|FG000|Began 3rd Intervention|Overall Study||21
10664678|NCT02285907|11826847|FG000|Began 4th Intervention|Overall Study||21
10664679|NCT02285907|11826847|FG000|COMPLETED|Overall Study||21
10664680|NCT02285907|11826847|FG000|NOT COMPLETED|Overall Study||0
10664681|NCT02285920|11826864|FG000|STARTED|Overall Study||51
10664682|NCT02285920|11826865|FG001|STARTED|Overall Study||27
10664683|NCT02285920|11826866|FG002|STARTED|Overall Study||26
10664684|NCT02285920|11826867|FG003|STARTED|Overall Study||25
10664685|NCT02285920|11826864|FG000|COMPLETED|Overall Study||47
10664686|NCT02285920|11826865|FG001|COMPLETED|Overall Study||23
10664687|NCT02285920|11826866|FG002|COMPLETED|Overall Study||21
10664688|NCT02285920|11826867|FG003|COMPLETED|Overall Study||24
10664689|NCT02285920|11826864|FG000|NOT COMPLETED|Overall Study||4
10664690|NCT02285920|11826865|FG001|NOT COMPLETED|Overall Study||4
10664691|NCT02285920|11826866|FG002|NOT COMPLETED|Overall Study||5
10664692|NCT02285920|11826867|FG003|NOT COMPLETED|Overall Study||1
10664693|NCT02285998|11826879|FG000|STARTED|Overall Study||4474
10664694|NCT02285998|11826880|FG001|STARTED|Overall Study||4489
10664695|NCT02285998|11826879|FG000|COMPLETED|Overall Study||4228
10664696|NCT02285998|11826880|FG001|COMPLETED|Overall Study||4236
10664697|NCT02285998|11826879|FG000|NOT COMPLETED|Overall Study||246
10664698|NCT02285998|11826880|FG001|NOT COMPLETED|Overall Study||253
10664699|NCT02286102|11826888|FG000|STARTED|Overall Study||36
10664700|NCT02286102|11826889|FG001|STARTED|Overall Study||34
10664701|NCT02286102|11826888|FG000|COMPLETED|Overall Study||35
10664702|NCT02286102|11826889|FG001|COMPLETED|Overall Study||33
10664703|NCT02286102|11826888|FG000|NOT COMPLETED|Overall Study||1
10664704|NCT02286102|11826889|FG001|NOT COMPLETED|Overall Study||1
10664705|NCT02286193|11826895|FG000|STARTED|Overall Study||622
10664706|NCT02286193|11826895|FG000|COMPLETED|Overall Study||418
10664707|NCT02286193|11826895|FG000|NOT COMPLETED|Overall Study||204
10664708|NCT02286466|11826902|FG000|STARTED|Overall Study||72
10664709|NCT02286466|11826903|FG001|STARTED|Overall Study||73
10664710|NCT02286466|11826902|FG000|Baseline Clinician Assessment|Overall Study||72
10664711|NCT02286466|11826903|FG001|Baseline Clinician Assessment|Overall Study||72
10664712|NCT02286466|11826902|FG000|Post Self-report|Overall Study||67
10664713|NCT02286466|11826903|FG001|Post Self-report|Overall Study||68
10664714|NCT02286466|11826902|FG000|COMPLETED|Overall Study||65
10664715|NCT02286466|11826903|FG001|COMPLETED|Overall Study||63
10664716|NCT02286466|11826902|FG000|NOT COMPLETED|Overall Study||7
10664717|NCT02286466|11826903|FG001|NOT COMPLETED|Overall Study||10
10664718|NCT02286518|11826923|FG000|STARTED|All Parts (16 Days)||6
10664719|NCT02286518|11826924|FG001|STARTED|All Parts (16 Days)||6
10664720|NCT02286518|11826925|FG002|STARTED|All Parts (16 Days)||6
10664721|NCT02286518|11826926|FG003|STARTED|All Parts (16 Days)||6
10664722|NCT02286518|11826927|FG004|STARTED|All Parts (16 Days)||6
10664723|NCT02286518|11826928|FG005|STARTED|All Parts (16 Days)||6
10664724|NCT02286518|11826929|FG006|STARTED|All Parts (16 Days)||6
10664725|NCT02286518|11826930|FG007|STARTED|All Parts (16 Days)||6
10664726|NCT02286518|11826931|FG008|STARTED|All Parts (16 Days)||6
10664727|NCT02286518|11826932|FG009|STARTED|All Parts (16 Days)||4
10664728|NCT02286518|11826933|FG010|STARTED|All Parts (16 Days)||6
10664729|NCT02286518|11826934|FG011|STARTED|All Parts (16 Days)||6
10664730|NCT02286518|11826935|FG012|STARTED|All Parts (16 Days)||6
10664731|NCT02286518|11826936|FG013|STARTED|All Parts (16 Days)||6
10664732|NCT02286518|11826923|FG000|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
10664733|NCT02286518|11826924|FG001|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
10664734|NCT02286518|11826925|FG002|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
10664735|NCT02286518|11826926|FG003|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
10664736|NCT02286518|11826927|FG004|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
10664737|NCT02286518|11826928|FG005|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
10664738|NCT02286518|11826929|FG006|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
10664739|NCT02286518|11826930|FG007|COMPLETED|All Parts (16 Days)|Only participants of Part 2 continued in next period.|6
10664740|NCT02286518|11826931|FG008|COMPLETED|All Parts (16 Days)|Only participants of Part 2 would continue in next period.|6
10664741|NCT02286518|11826932|FG009|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|4
10664742|NCT02286518|11826933|FG010|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
10664743|NCT02286518|11826934|FG011|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
10664744|NCT02286518|11826935|FG012|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
10664745|NCT02286518|11826936|FG013|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
10664746|NCT02286518|11826923|FG000|NOT COMPLETED|All Parts (16 Days)||0
10664747|NCT02286518|11826924|FG001|NOT COMPLETED|All Parts (16 Days)||0
10664748|NCT02286518|11826925|FG002|NOT COMPLETED|All Parts (16 Days)||0
10664749|NCT02286518|11826926|FG003|NOT COMPLETED|All Parts (16 Days)||0
10664750|NCT02286518|11826927|FG004|NOT COMPLETED|All Parts (16 Days)||0
10664751|NCT02286518|11826928|FG005|NOT COMPLETED|All Parts (16 Days)||0
10664752|NCT02286518|11826929|FG006|NOT COMPLETED|All Parts (16 Days)||0
10664753|NCT02286518|11826930|FG007|NOT COMPLETED|All Parts (16 Days)||0
10664754|NCT02286518|11826931|FG008|NOT COMPLETED|All Parts (16 Days)||0
10664755|NCT02286518|11826932|FG009|NOT COMPLETED|All Parts (16 Days)||0
10664756|NCT02286518|11826933|FG010|NOT COMPLETED|All Parts (16 Days)||0
10664757|NCT02286518|11826934|FG011|NOT COMPLETED|All Parts (16 Days)||0
10664758|NCT02286518|11826935|FG012|NOT COMPLETED|All Parts (16 Days)||0
10664759|NCT02286518|11826936|FG013|NOT COMPLETED|All Parts (16 Days)||0
10664760|NCT02286518|11826923|FG000|STARTED|Washout Crossover Period(Part 2:14 Days)||0
10664761|NCT02286518|11826924|FG001|STARTED|Washout Crossover Period(Part 2:14 Days)||0
10664762|NCT02286518|11826925|FG002|STARTED|Washout Crossover Period(Part 2:14 Days)||0
10664763|NCT02286518|11826926|FG003|STARTED|Washout Crossover Period(Part 2:14 Days)||0
10664764|NCT02286518|11826927|FG004|STARTED|Washout Crossover Period(Part 2:14 Days)||0
10664765|NCT02286518|11826928|FG005|STARTED|Washout Crossover Period(Part 2:14 Days)||0
10664766|NCT02286518|11826929|FG006|STARTED|Washout Crossover Period(Part 2:14 Days)||0
10664767|NCT02286518|11826930|FG007|STARTED|Washout Crossover Period(Part 2:14 Days)||6
10664768|NCT02286518|11826931|FG008|STARTED|Washout Crossover Period(Part 2:14 Days)||6
10664769|NCT02286518|11826932|FG009|STARTED|Washout Crossover Period(Part 2:14 Days)||0
10664770|NCT02286518|11826933|FG010|STARTED|Washout Crossover Period(Part 2:14 Days)||0
10664771|NCT02286518|11826934|FG011|STARTED|Washout Crossover Period(Part 2:14 Days)||0
10664772|NCT02286518|11826935|FG012|STARTED|Washout Crossover Period(Part 2:14 Days)||0
10664773|NCT02286518|11826936|FG013|STARTED|Washout Crossover Period(Part 2:14 Days)||0
10664774|NCT02286518|11826923|FG000|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10664775|NCT02286518|11826924|FG001|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10664776|NCT02286518|11826925|FG002|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10664777|NCT02286518|11826926|FG003|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10664778|NCT02286518|11826927|FG004|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10664779|NCT02286518|11826928|FG005|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10664780|NCT02286518|11826929|FG006|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10664781|NCT02286518|11826930|FG007|COMPLETED|Washout Crossover Period(Part 2:14 Days)||6
10664782|NCT02286518|11826931|FG008|COMPLETED|Washout Crossover Period(Part 2:14 Days)||6
10664783|NCT02286518|11826932|FG009|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10664784|NCT02286518|11826933|FG010|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10664785|NCT02286518|11826934|FG011|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10664786|NCT02286518|11826935|FG012|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10664787|NCT02286518|11826936|FG013|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10664788|NCT02286518|11826923|FG000|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10664789|NCT02286518|11826924|FG001|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10664790|NCT02286518|11826925|FG002|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10664867|NCT02286726|11826996|FG002|COMPLETED|Overall Study||16
10664791|NCT02286518|11826926|FG003|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10664792|NCT02286518|11826927|FG004|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10664793|NCT02286518|11826928|FG005|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10664794|NCT02286518|11826929|FG006|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10664795|NCT02286518|11826930|FG007|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10664796|NCT02286518|11826931|FG008|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10664797|NCT02286518|11826932|FG009|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10664798|NCT02286518|11826933|FG010|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10664799|NCT02286518|11826934|FG011|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10664800|NCT02286518|11826935|FG012|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10664801|NCT02286518|11826936|FG013|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
10664802|NCT02286518|11826923|FG000|STARTED|Crossover Treatment (Part 2: 3 Days)||0
10664803|NCT02286518|11826924|FG001|STARTED|Crossover Treatment (Part 2: 3 Days)||0
10664804|NCT02286518|11826925|FG002|STARTED|Crossover Treatment (Part 2: 3 Days)||0
10664805|NCT02286518|11826926|FG003|STARTED|Crossover Treatment (Part 2: 3 Days)||0
10664806|NCT02286518|11826927|FG004|STARTED|Crossover Treatment (Part 2: 3 Days)||0
10664807|NCT02286518|11826928|FG005|STARTED|Crossover Treatment (Part 2: 3 Days)||0
10664808|NCT02286518|11826929|FG006|STARTED|Crossover Treatment (Part 2: 3 Days)||0
10664809|NCT02286518|11826930|FG007|STARTED|Crossover Treatment (Part 2: 3 Days)||6
10664810|NCT02286518|11826931|FG008|STARTED|Crossover Treatment (Part 2: 3 Days)||6
10664811|NCT02286518|11826932|FG009|STARTED|Crossover Treatment (Part 2: 3 Days)||0
10664812|NCT02286518|11826933|FG010|STARTED|Crossover Treatment (Part 2: 3 Days)||0
10664813|NCT02286518|11826934|FG011|STARTED|Crossover Treatment (Part 2: 3 Days)||0
10664814|NCT02286518|11826935|FG012|STARTED|Crossover Treatment (Part 2: 3 Days)||0
10664815|NCT02286518|11826936|FG013|STARTED|Crossover Treatment (Part 2: 3 Days)||0
10664816|NCT02286518|11826923|FG000|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10664817|NCT02286518|11826924|FG001|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10664818|NCT02286518|11826925|FG002|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10664819|NCT02286518|11826926|FG003|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10664820|NCT02286518|11826927|FG004|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10664821|NCT02286518|11826928|FG005|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10664822|NCT02286518|11826929|FG006|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10664823|NCT02286518|11826930|FG007|COMPLETED|Crossover Treatment (Part 2: 3 Days)||6
10664824|NCT02286518|11826931|FG008|COMPLETED|Crossover Treatment (Part 2: 3 Days)||6
10712180|NCT02668185|11877752|FG000|STARTED|Washout Period (2 Weeks)||18
10664825|NCT02286518|11826932|FG009|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10664826|NCT02286518|11826933|FG010|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10664827|NCT02286518|11826934|FG011|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10664828|NCT02286518|11826935|FG012|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10664829|NCT02286518|11826936|FG013|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10664830|NCT02286518|11826923|FG000|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10664831|NCT02286518|11826924|FG001|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10664832|NCT02286518|11826925|FG002|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10664833|NCT02286518|11826926|FG003|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10664834|NCT02286518|11826927|FG004|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10664835|NCT02286518|11826928|FG005|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10664836|NCT02286518|11826929|FG006|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10664837|NCT02286518|11826930|FG007|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10664838|NCT02286518|11826931|FG008|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10664839|NCT02286518|11826932|FG009|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10664840|NCT02286518|11826933|FG010|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10664841|NCT02286518|11826934|FG011|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10664842|NCT02286518|11826935|FG012|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10664843|NCT02286518|11826936|FG013|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
10664844|NCT02286713|11826984|FG000|STARTED|One Week Follow-Up||259
10664845|NCT02286713|11826985|FG001|STARTED|One Week Follow-Up||257
10664846|NCT02286713|11826984|FG000|COMPLETED|One Week Follow-Up||235
10664847|NCT02286713|11826985|FG001|COMPLETED|One Week Follow-Up||233
10664848|NCT02286713|11826984|FG000|NOT COMPLETED|One Week Follow-Up||24
10664849|NCT02286713|11826985|FG001|NOT COMPLETED|One Week Follow-Up||24
10664850|NCT02286713|11826984|FG000|STARTED|Three Month Follow-Up||252
10664851|NCT02286713|11826985|FG001|STARTED|Three Month Follow-Up||254
10664852|NCT02286713|11826984|FG000|COMPLETED|Three Month Follow-Up||224
10664853|NCT02286713|11826985|FG001|COMPLETED|Three Month Follow-Up||228
10664854|NCT02286713|11826984|FG000|NOT COMPLETED|Three Month Follow-Up||28
10664855|NCT02286713|11826985|FG001|NOT COMPLETED|Three Month Follow-Up||26
10664856|NCT02286713|11826984|FG000|STARTED|Six Month Follow-Up||250
10664857|NCT02286713|11826985|FG001|STARTED|Six Month Follow-Up||252
10664858|NCT02286713|11826984|FG000|COMPLETED|Six Month Follow-Up||218
10664859|NCT02286713|11826985|FG001|COMPLETED|Six Month Follow-Up||225
10664860|NCT02286713|11826984|FG000|NOT COMPLETED|Six Month Follow-Up||32
10664861|NCT02286713|11826985|FG001|NOT COMPLETED|Six Month Follow-Up||27
10664862|NCT02286726|11826994|FG000|STARTED|Overall Study||16
10664863|NCT02286726|11826995|FG001|STARTED|Overall Study||24
10664864|NCT02286726|11826996|FG002|STARTED|Overall Study||16
10664865|NCT02286726|11826994|FG000|COMPLETED|Overall Study||16
10664866|NCT02286726|11826995|FG001|COMPLETED|Overall Study||24
10664868|NCT02286726|11826994|FG000|NOT COMPLETED|Overall Study||0
10664869|NCT02286726|11826995|FG001|NOT COMPLETED|Overall Study||0
10664870|NCT02286726|11826996|FG002|NOT COMPLETED|Overall Study||0
10664871|NCT02286843|11827004|FG000|STARTED|Overall Study||49
10664872|NCT02286843|11827004|FG000|COMPLETED|Overall Study||43
10664873|NCT02286843|11827004|FG000|NOT COMPLETED|Overall Study||6
10664874|NCT02286895|11827010|FG000|STARTED|Randomized and Vaccinated||300
10664875|NCT02286895|11827011|FG001|STARTED|Randomized and Vaccinated||300
10664876|NCT02286895|11827010|FG000|COMPLETED|Randomized and Vaccinated||300
10664877|NCT02286895|11827011|FG001|COMPLETED|Randomized and Vaccinated||300
10664878|NCT02286895|11827010|FG000|NOT COMPLETED|Randomized and Vaccinated||0
10664879|NCT02286895|11827011|FG001|NOT COMPLETED|Randomized and Vaccinated||0
10664880|NCT02286895|11827010|FG000|STARTED|Assessed for Measles Seroconversion||300
10664881|NCT02286895|11827011|FG001|STARTED|Assessed for Measles Seroconversion||300
10664882|NCT02286895|11827010|FG000|COMPLETED|Assessed for Measles Seroconversion||252
10664883|NCT02286895|11827011|FG001|COMPLETED|Assessed for Measles Seroconversion||261
10664884|NCT02286895|11827010|FG000|NOT COMPLETED|Assessed for Measles Seroconversion||48
10664885|NCT02286895|11827011|FG001|NOT COMPLETED|Assessed for Measles Seroconversion||39
10664886|NCT02286921|11827019|FG000|STARTED|Overall Study||94
10664887|NCT02286921|11827020|FG001|STARTED|Overall Study||101
10664888|NCT02286921|11827019|FG000|COMPLETED|Overall Study||94
10664889|NCT02286921|11827020|FG001|COMPLETED|Overall Study||101
10664890|NCT02286921|11827019|FG000|NOT COMPLETED|Overall Study||0
10664891|NCT02286921|11827020|FG001|NOT COMPLETED|Overall Study||0
10664892|NCT02286947|11827026|FG000|STARTED|Overall Study||24
10664893|NCT02286947|11827026|FG000|COMPLETED|Overall Study||22
10664894|NCT02286947|11827026|FG000|NOT COMPLETED|Overall Study||2
10664895|NCT02286960|11827034|FG000|STARTED|Overall Study||19
10664896|NCT02286960|11827035|FG001|STARTED|Overall Study||17
10664897|NCT02286960|11827034|FG000|COMPLETED|Overall Study||16
10664898|NCT02286960|11827035|FG001|COMPLETED|Overall Study||14
10664899|NCT02286960|11827034|FG000|NOT COMPLETED|Overall Study||3
10664900|NCT02286960|11827035|FG001|NOT COMPLETED|Overall Study||3
10664901|NCT02287038|11827043|FG000|STARTED|Overall Study||23
10664902|NCT02287038|11827044|FG001|STARTED|Overall Study||21
10664903|NCT02287038|11827043|FG000|COMPLETED|Overall Study||18
10664904|NCT02287038|11827044|FG001|COMPLETED|Overall Study||18
10664905|NCT02287038|11827043|FG000|NOT COMPLETED|Overall Study||5
10664906|NCT02287038|11827044|FG001|NOT COMPLETED|Overall Study||3
10664907|NCT02287350|11827052|FG000|STARTED|Overall Study||51
10664908|NCT02287350|11827052|FG000|COMPLETED|Overall Study||48
10664909|NCT02287350|11827052|FG000|NOT COMPLETED|Overall Study||3
10664910|NCT02287376|11827056|FG000|STARTED|Overall Study||25
10664911|NCT02287376|11827056|FG000|COMPLETED|Overall Study||25
10664912|NCT02287376|11827056|FG000|NOT COMPLETED|Overall Study||0
10664913|NCT02287402|11827060|FG000|STARTED|Treatment Period||197
10664914|NCT02287402|11827060|FG000|COMPLETED|Treatment Period||170
10664915|NCT02287402|11827060|FG000|NOT COMPLETED|Treatment Period||27
10664916|NCT02287402|11827060|FG000|STARTED|Follow-up|64 participants who completed the Treatment Period did not continue to Follow-up.|106
10664917|NCT02287402|11827060|FG000|COMPLETED|Follow-up||103
10664918|NCT02287402|11827060|FG000|NOT COMPLETED|Follow-up||3
10664919|NCT02287415|11827064|FG000|STARTED|Overall Study||13
10664920|NCT02287415|11827064|FG000|COMPLETED|Overall Study||13
10664921|NCT02287415|11827064|FG000|NOT COMPLETED|Overall Study||0
10664922|NCT02287467|11827070|FG000|STARTED|Overall Study||168
10664923|NCT02287467|11827071|FG001|STARTED|Overall Study||161
10664924|NCT02287467|11827070|FG000|COMPLETED|Overall Study||156
10664925|NCT02287467|11827071|FG001|COMPLETED|Overall Study||152
10664926|NCT02287467|11827070|FG000|NOT COMPLETED|Overall Study||12
10664927|NCT02287467|11827071|FG001|NOT COMPLETED|Overall Study||9
10664928|NCT02287610|11827080|FG000|STARTED|Overall Study||64
10664929|NCT02287610|11827080|FG000|Per Protocol Follow-Up|Overall Study||56
10664930|NCT02287610|11827080|FG000|COMPLETED|Overall Study||48
10664931|NCT02287610|11827080|FG000|NOT COMPLETED|Overall Study||16
10664932|NCT02287623|11827086|FG000|STARTED|Overall Study||30
10664933|NCT02287623|11827087|FG001|STARTED|Overall Study||30
10664934|NCT02287623|11827086|FG000|COMPLETED|Overall Study||30
10664935|NCT02287623|11827087|FG001|COMPLETED|Overall Study||29
10664936|NCT02287623|11827086|FG000|NOT COMPLETED|Overall Study||0
10664937|NCT02287623|11827087|FG001|NOT COMPLETED|Overall Study||1
10664938|NCT02287675|11827095|FG000|STARTED|Overall Study||22
10664939|NCT02287675|11827096|FG001|STARTED|Overall Study||18
10664940|NCT02287675|11827095|FG000|COMPLETED|Overall Study||22
10664941|NCT02287675|11827096|FG001|COMPLETED|Overall Study||18
10664942|NCT02287675|11827095|FG000|NOT COMPLETED|Overall Study||0
10664943|NCT02287675|11827096|FG001|NOT COMPLETED|Overall Study||0
10664944|NCT02287688|11827102|FG000|STARTED|Overall Study||138
10664945|NCT02287688|11827102|FG000|COMPLETED|Overall Study||138
10664946|NCT02287688|11827102|FG000|NOT COMPLETED|Overall Study||0
10664947|NCT02287779|11827114|FG000|STARTED|Overall Study||21
10664948|NCT02287779|11827115|FG001|STARTED|Overall Study||9
10664949|NCT02287779|11827116|FG002|STARTED|Overall Study||9
10664950|NCT02287779|11827117|FG003|STARTED|Overall Study||9
10664951|NCT02287779|11827118|FG004|STARTED|Overall Study||9
10664952|NCT02287779|11827119|FG005|STARTED|Overall Study||9
10664953|NCT02287779|11827120|FG006|STARTED|Overall Study||9
10664954|NCT02287779|11827121|FG007|STARTED|Overall Study||9
10664955|NCT02287779|11827114|FG000|COMPLETED|Overall Study||21
10664956|NCT02287779|11827115|FG001|COMPLETED|Overall Study||9
10664957|NCT02287779|11827116|FG002|COMPLETED|Overall Study||9
10664958|NCT02287779|11827117|FG003|COMPLETED|Overall Study||9
10664959|NCT02287779|11827118|FG004|COMPLETED|Overall Study||9
10664960|NCT02287779|11827119|FG005|COMPLETED|Overall Study||9
10664961|NCT02287779|11827120|FG006|COMPLETED|Overall Study||9
10664962|NCT02287779|11827121|FG007|COMPLETED|Overall Study||9
10664963|NCT02287779|11827114|FG000|NOT COMPLETED|Overall Study||0
10664964|NCT02287779|11827115|FG001|NOT COMPLETED|Overall Study||0
10664965|NCT02287779|11827116|FG002|NOT COMPLETED|Overall Study||0
10664966|NCT02287779|11827117|FG003|NOT COMPLETED|Overall Study||0
10664967|NCT02287779|11827118|FG004|NOT COMPLETED|Overall Study||0
10664968|NCT02287779|11827119|FG005|NOT COMPLETED|Overall Study||0
10664969|NCT02287779|11827120|FG006|NOT COMPLETED|Overall Study||0
10664970|NCT02287779|11827121|FG007|NOT COMPLETED|Overall Study||0
10664971|NCT02287883|11827145|FG000|STARTED|Overall Study||1081
10664972|NCT02287883|11827146|FG001|STARTED|Overall Study||1095
10664973|NCT02287883|11827145|FG000|One-year Follow-up Survey|Overall Study||622
10664974|NCT02287883|11827146|FG001|One-year Follow-up Survey|Overall Study||669
10664975|NCT02287883|11827145|FG000|COMPLETED|Overall Study||622
10664976|NCT02287883|11827146|FG001|COMPLETED|Overall Study||669
10664977|NCT02287883|11827145|FG000|NOT COMPLETED|Overall Study||459
10664978|NCT02287883|11827146|FG001|NOT COMPLETED|Overall Study||426
10664979|NCT02287896|11827154|FG000|STARTED|Screening Visit V1||36
10664980|NCT02287896|11827155|FG001|STARTED|Screening Visit V1||26
10664981|NCT02287896|11827154|FG000|COMPLETED|Screening Visit V1||36
10664982|NCT02287896|11827155|FG001|COMPLETED|Screening Visit V1||26
10664983|NCT02287896|11827154|FG000|NOT COMPLETED|Screening Visit V1||0
10664984|NCT02287896|11827155|FG001|NOT COMPLETED|Screening Visit V1||0
10664985|NCT02287896|11827154|FG000|STARTED|First Injection Visit||36
10664986|NCT02287896|11827155|FG001|STARTED|First Injection Visit||26
10664987|NCT02287896|11827154|FG000|COMPLETED|First Injection Visit||36
10664988|NCT02287896|11827155|FG001|COMPLETED|First Injection Visit||26
10664989|NCT02287896|11827154|FG000|NOT COMPLETED|First Injection Visit||0
10664990|NCT02287896|11827155|FG001|NOT COMPLETED|First Injection Visit||0
10664991|NCT02287896|11827154|FG000|STARTED|Second Injection Visit||36
10664992|NCT02287896|11827155|FG001|STARTED|Second Injection Visit||26
10664993|NCT02287896|11827154|FG000|COMPLETED|Second Injection Visit||36
10664994|NCT02287896|11827155|FG001|COMPLETED|Second Injection Visit||25
10664995|NCT02287896|11827154|FG000|NOT COMPLETED|Second Injection Visit||0
10664996|NCT02287896|11827155|FG001|NOT COMPLETED|Second Injection Visit||1
10664997|NCT02287909|11827171|FG000|STARTED|Overall Study||20
10664998|NCT02287909|11827172|FG001|STARTED|Overall Study||20
10664999|NCT02287909|11827173|FG002|STARTED|Overall Study||20
10665000|NCT02287909|11827174|FG003|STARTED|Overall Study||20
10665001|NCT02287909|11827171|FG000|COMPLETED|Overall Study||18
10665002|NCT02287909|11827172|FG001|COMPLETED|Overall Study||19
10665003|NCT02287909|11827173|FG002|COMPLETED|Overall Study||20
10665004|NCT02287909|11827174|FG003|COMPLETED|Overall Study||19
10665005|NCT02287909|11827171|FG000|NOT COMPLETED|Overall Study||2
10665006|NCT02287909|11827172|FG001|NOT COMPLETED|Overall Study||1
10665007|NCT02287909|11827173|FG002|NOT COMPLETED|Overall Study||0
10665008|NCT02287909|11827174|FG003|NOT COMPLETED|Overall Study||1
10665009|NCT02287922|11827188|FG000|STARTED|Overall Study||62
10665010|NCT02287922|11827189|FG001|STARTED|Overall Study||62
10665011|NCT02287922|11827190|FG002|STARTED|Overall Study||63
10665012|NCT02287922|11827191|FG003|STARTED|Overall Study||64
10665013|NCT02287922|11827188|FG000|COMPLETED|Overall Study||59
10665014|NCT02287922|11827189|FG001|COMPLETED|Overall Study||60
10665015|NCT02287922|11827190|FG002|COMPLETED|Overall Study||56
10665016|NCT02287922|11827191|FG003|COMPLETED|Overall Study||57
10665017|NCT02287922|11827188|FG000|NOT COMPLETED|Overall Study||3
10665018|NCT02287922|11827189|FG001|NOT COMPLETED|Overall Study||2
10665019|NCT02287922|11827190|FG002|NOT COMPLETED|Overall Study||7
10665020|NCT02287922|11827191|FG003|NOT COMPLETED|Overall Study||7
10665021|NCT02288091|11827202|FG000|STARTED|Overall Study||32
10665022|NCT02288091|11827202|FG000|Randomized/Treated|Overall Study||25
10665023|NCT02288091|11827202|FG000|COMPLETED|Overall Study||24
10665024|NCT02288091|11827202|FG000|NOT COMPLETED|Overall Study||8
10665025|NCT02288156|11827210|FG000|STARTED|Overall Study||20
10665026|NCT02288156|11827211|FG001|STARTED|Overall Study||20
10665027|NCT02288156|11827212|FG002|STARTED|Overall Study||20
10665028|NCT02288156|11827213|FG003|STARTED|Overall Study||20
10665029|NCT02288156|11827210|FG000|COMPLETED|Overall Study||16
10665030|NCT02288156|11827211|FG001|COMPLETED|Overall Study||16
10665031|NCT02288156|11827212|FG002|COMPLETED|Overall Study||18
10665032|NCT02288156|11827213|FG003|COMPLETED|Overall Study||18
10665033|NCT02288156|11827210|FG000|NOT COMPLETED|Overall Study||4
10665034|NCT02288156|11827211|FG001|NOT COMPLETED|Overall Study||4
10665035|NCT02288156|11827212|FG002|NOT COMPLETED|Overall Study||2
10665036|NCT02288156|11827213|FG003|NOT COMPLETED|Overall Study||2
10665037|NCT02288182|11827227|FG000|STARTED|Overall Study||25
10665038|NCT02288182|11827228|FG001|STARTED|Overall Study||27
10665039|NCT02288182|11827227|FG000|COMPLETED|Overall Study||25
10665040|NCT02288182|11827228|FG001|COMPLETED|Overall Study||25
10665041|NCT02288182|11827227|FG000|NOT COMPLETED|Overall Study||0
10665042|NCT02288182|11827228|FG001|NOT COMPLETED|Overall Study||2
10665043|NCT02288273|11827238|FG000|STARTED|Overall Study||61
10665044|NCT02288273|11827239|FG001|STARTED|Overall Study||56
10665045|NCT02288273|11827238|FG000|COMPLETED|Overall Study||53
10665046|NCT02288273|11827239|FG001|COMPLETED|Overall Study||48
10665047|NCT02288273|11827238|FG000|NOT COMPLETED|Overall Study||8
10665048|NCT02288273|11827239|FG001|NOT COMPLETED|Overall Study||8
10665049|NCT02288312|11827248|FG000|STARTED|Overall Study||6
10665050|NCT02288312|11827249|FG001|STARTED|Overall Study||6
10665051|NCT02288312|11827250|FG002|STARTED|Overall Study||6
10665052|NCT02288312|11827248|FG000|COMPLETED|Overall Study||5
10665053|NCT02288312|11827249|FG001|COMPLETED|Overall Study||6
10665054|NCT02288312|11827250|FG002|COMPLETED|Overall Study||6
10665055|NCT02288312|11827248|FG000|NOT COMPLETED|Overall Study||1
10665056|NCT02288312|11827249|FG001|NOT COMPLETED|Overall Study||0
10665057|NCT02288312|11827250|FG002|NOT COMPLETED|Overall Study||0
10665058|NCT02288325|11827258|FG000|STARTED|Run-in Period||644
10665059|NCT02288325|11827259|FG001|STARTED|Run-in Period||0
10665060|NCT02288325|11827260|FG002|STARTED|Run-in Period||0
10665061|NCT02288325|11827258|FG000|COMPLETED|Run-in Period||499
10665062|NCT02288325|11827259|FG001|COMPLETED|Run-in Period||0
10665063|NCT02288325|11827260|FG002|COMPLETED|Run-in Period||0
10665064|NCT02288325|11827258|FG000|NOT COMPLETED|Run-in Period||145
10665065|NCT02288325|11827259|FG001|NOT COMPLETED|Run-in Period||0
10665066|NCT02288325|11827260|FG002|NOT COMPLETED|Run-in Period||0
10665067|NCT02288325|11827258|FG000|STARTED|Stabilization Period|70 participants did not enter Stabilization Period (69 did not meet entry criteria; 1 other reason)|429
10665068|NCT02288325|11827259|FG001|STARTED|Stabilization Period||0
10665069|NCT02288325|11827260|FG002|STARTED|Stabilization Period||0
10665070|NCT02288325|11827258|FG000|COMPLETED|Stabilization Period||331
10665071|NCT02288325|11827259|FG001|COMPLETED|Stabilization Period||0
10665072|NCT02288325|11827260|FG002|COMPLETED|Stabilization Period||0
10665073|NCT02288325|11827258|FG000|NOT COMPLETED|Stabilization Period||98
10665074|NCT02288325|11827259|FG001|NOT COMPLETED|Stabilization Period||0
10665075|NCT02288325|11827260|FG002|NOT COMPLETED|Stabilization Period||0
10665076|NCT02288325|11827258|FG000|STARTED|Double-blind Treatment Period||0
10665077|NCT02288325|11827259|FG001|STARTED|Double-blind Treatment Period|7 participants did not enter Double-Blind Period (2 did not meet entry criteria; 5 other reasons)|159
10665078|NCT02288325|11827260|FG002|STARTED|Double-blind Treatment Period|7 participants did not enter Double-Blind Period (2 did not meet entry criteria; 5 other reasons)|165
10665079|NCT02288325|11827258|FG000|COMPLETED|Double-blind Treatment Period||0
10665080|NCT02288325|11827259|FG001|COMPLETED|Double-blind Treatment Period||135
10665081|NCT02288325|11827260|FG002|COMPLETED|Double-blind Treatment Period||139
10665082|NCT02288325|11827258|FG000|NOT COMPLETED|Double-blind Treatment Period||0
10665083|NCT02288325|11827259|FG001|NOT COMPLETED|Double-blind Treatment Period||24
10665084|NCT02288325|11827260|FG002|NOT COMPLETED|Double-blind Treatment Period||26
10665085|NCT02288364|11827269|FG000|STARTED|Overall Study||42
10665086|NCT02288364|11827270|FG001|STARTED|Overall Study||44
10665087|NCT02288364|11827269|FG000|COMPLETED|Overall Study||42
10665088|NCT02288364|11827270|FG001|COMPLETED|Overall Study||44
10665089|NCT02288364|11827269|FG000|NOT COMPLETED|Overall Study||0
10665090|NCT02288364|11827270|FG001|NOT COMPLETED|Overall Study||0
10665091|NCT02288377|11827278|FG000|STARTED|Overall Study||26
10665092|NCT02288377|11827279|FG001|STARTED|Overall Study||27
10665093|NCT02288377|11827278|FG000|COMPLETED|Overall Study||25
10665094|NCT02288377|11827279|FG001|COMPLETED|Overall Study||27
10665095|NCT02288377|11827278|FG000|NOT COMPLETED|Overall Study||1
10665096|NCT02288377|11827279|FG001|NOT COMPLETED|Overall Study||0
10665097|NCT02288559|11827289|FG000|STARTED|Overall Study||10
10665098|NCT02288559|11827290|FG001|STARTED|Overall Study||11
10665099|NCT02288559|11827291|FG002|STARTED|Overall Study||46
10665100|NCT02288559|11827292|FG003|STARTED|Overall Study||22
10665101|NCT02288559|11827289|FG000|COMPLETED|Overall Study||9
10665102|NCT02288559|11827290|FG001|COMPLETED|Overall Study||10
10665103|NCT02288559|11827291|FG002|COMPLETED|Overall Study||35
10665104|NCT02288559|11827292|FG003|COMPLETED|Overall Study||20
10665105|NCT02288559|11827289|FG000|NOT COMPLETED|Overall Study||1
10665106|NCT02288559|11827290|FG001|NOT COMPLETED|Overall Study||1
10665107|NCT02288559|11827291|FG002|NOT COMPLETED|Overall Study||11
10665108|NCT02288559|11827292|FG003|NOT COMPLETED|Overall Study||2
10712181|NCT02668185|11877753|FG001|STARTED|Washout Period (2 Weeks)||17
10712182|NCT02668185|11877752|FG000|COMPLETED|Washout Period (2 Weeks)||17
10712183|NCT02668185|11877753|FG001|COMPLETED|Washout Period (2 Weeks)||15
10712184|NCT02668185|11877752|FG000|NOT COMPLETED|Washout Period (2 Weeks)||1
10712185|NCT02668185|11877753|FG001|NOT COMPLETED|Washout Period (2 Weeks)||2
10712186|NCT02668185|11877752|FG000|STARTED|Second Intervention (4 Weeks)||17
10712187|NCT02668185|11877753|FG001|STARTED|Second Intervention (4 Weeks)||15
10712188|NCT02668185|11877752|FG000|COMPLETED|Second Intervention (4 Weeks)||16
10712189|NCT02668185|11877753|FG001|COMPLETED|Second Intervention (4 Weeks)||12
10712190|NCT02668185|11877752|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1
10712191|NCT02668185|11877753|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||3
10712192|NCT02668185|11877752|FG000|STARTED|Moitoring Period (2 Weeks)||16
10712193|NCT02668185|11877753|FG001|STARTED|Moitoring Period (2 Weeks)||12
10712194|NCT02668185|11877752|FG000|COMPLETED|Moitoring Period (2 Weeks)||16
10712195|NCT02668185|11877753|FG001|COMPLETED|Moitoring Period (2 Weeks)||12
10712196|NCT02668185|11877752|FG000|NOT COMPLETED|Moitoring Period (2 Weeks)||0
10712197|NCT02668185|11877753|FG001|NOT COMPLETED|Moitoring Period (2 Weeks)||0
10712198|NCT02668198|11877759|FG000|STARTED|Overall Study||230
10712199|NCT02668198|11877759|FG000|COMPLETED|Overall Study||230
10712200|NCT02668198|11877759|FG000|NOT COMPLETED|Overall Study||0
10712201|NCT02668302|11877766|FG000|STARTED|Overall Study||20
10712202|NCT02668302|11877767|FG001|STARTED|Overall Study||20
10712203|NCT02668302|11877766|FG000|COMPLETED|Overall Study||19
10712204|NCT02668302|11877767|FG001|COMPLETED|Overall Study||20
10712205|NCT02668302|11877766|FG000|NOT COMPLETED|Overall Study||1
10712206|NCT02668302|11877767|FG001|NOT COMPLETED|Overall Study||0
10712207|NCT02668393|11877775|FG000|STARTED|Overall Study||7
10712208|NCT02668393|11877776|FG001|STARTED|Overall Study||7
10712209|NCT02668393|11877775|FG000|COMPLETED|Overall Study||0
10712210|NCT02668393|11877776|FG001|COMPLETED|Overall Study||1
10712211|NCT02668393|11877775|FG000|NOT COMPLETED|Overall Study||7
10712212|NCT02668393|11877776|FG001|NOT COMPLETED|Overall Study||6
10712213|NCT02668432|11877785|FG000|STARTED|Overall Study||5
10712214|NCT02668432|11877786|FG001|STARTED|Overall Study||4
10712215|NCT02668432|11877785|FG000|COMPLETED|Overall Study||5
10712216|NCT02668432|11877786|FG001|COMPLETED|Overall Study||4
10712217|NCT02668432|11877785|FG000|NOT COMPLETED|Overall Study||0
10712218|NCT02668432|11877786|FG001|NOT COMPLETED|Overall Study||0
10712219|NCT02668640|11877792|FG000|STARTED|Overall Study||55
10712220|NCT02668640|11877792|FG000|COMPLETED|Overall Study||41
10712221|NCT02668640|11877792|FG000|NOT COMPLETED|Overall Study||14
10712222|NCT02668692|11877798|FG000|STARTED|Overall Study||101
10712223|NCT02668692|11877799|FG001|STARTED|Overall Study||105
10712224|NCT02668692|11877798|FG000|COMPLETED|Overall Study||100
10712225|NCT02668692|11877799|FG001|COMPLETED|Overall Study||105
10712226|NCT02668692|11877798|FG000|NOT COMPLETED|Overall Study||1
10712227|NCT02668692|11877799|FG001|NOT COMPLETED|Overall Study||0
10712228|NCT02668952|11877807|FG000|STARTED|Overall Study||16
10712229|NCT02668952|11877808|FG001|STARTED|Overall Study||14
10712230|NCT02668952|11877807|FG000|COMPLETED|Overall Study||16
10712231|NCT02668952|11877808|FG001|COMPLETED|Overall Study||14
10712232|NCT02668952|11877807|FG000|NOT COMPLETED|Overall Study||0
10712233|NCT02668952|11877808|FG001|NOT COMPLETED|Overall Study||0
10712234|NCT02669017|11877823|FG000|STARTED|Overall Study||4
10712235|NCT02669017|11877824|FG001|STARTED|Overall Study||4
10712236|NCT02669017|11877825|FG002|STARTED|Overall Study||4
10712237|NCT02669017|11877826|FG003|STARTED|Overall Study||5
10712238|NCT02669017|11877827|FG004|STARTED|Overall Study||16
10712239|NCT02669017|11877828|FG005|STARTED|Overall Study||26
10712240|NCT02669017|11877829|FG006|STARTED|Overall Study||19
10712241|NCT02669017|11877830|FG007|STARTED|Overall Study||69
10712242|NCT02669017|11877831|FG008|STARTED|Overall Study||36
10712243|NCT02669017|11877823|FG000|COMPLETED|Overall Study||3
10712244|NCT02669017|11877824|FG001|COMPLETED|Overall Study||2
10712245|NCT02669017|11877825|FG002|COMPLETED|Overall Study||2
10712246|NCT02669017|11877826|FG003|COMPLETED|Overall Study||1
10712247|NCT02669017|11877827|FG004|COMPLETED|Overall Study||4
10712248|NCT02669017|11877828|FG005|COMPLETED|Overall Study||7
10712249|NCT02669017|11877829|FG006|COMPLETED|Overall Study||8
10665109|NCT02288819|11827304|FG000|STARTED|Overall Study||50
10665110|NCT02288819|11827304|FG000|COMPLETED|Overall Study||50
10665111|NCT02288819|11827304|FG000|NOT COMPLETED|Overall Study||0
10665112|NCT02289079|11827310|FG000|STARTED|Overall Study||30
10665113|NCT02289079|11827311|FG001|STARTED|Overall Study||30
10665114|NCT02289079|11827310|FG000|COMPLETED|Overall Study||28
10665115|NCT02289079|11827311|FG001|COMPLETED|Overall Study||29
10665116|NCT02289079|11827310|FG000|NOT COMPLETED|Overall Study||2
10665117|NCT02289079|11827311|FG001|NOT COMPLETED|Overall Study||1
10665118|NCT02289105|11827319|FG000|STARTED|Overall Study||642
10665119|NCT02289105|11827320|FG001|STARTED|Overall Study||637
10665120|NCT02289105|11827319|FG000|COMPLETED|Overall Study||642
10665121|NCT02289105|11827320|FG001|COMPLETED|Overall Study||637
10665122|NCT02289105|11827319|FG000|NOT COMPLETED|Overall Study||0
10665123|NCT02289105|11827320|FG001|NOT COMPLETED|Overall Study||0
10665124|NCT02289157|11827328|FG000|STARTED|Overall Study||222
10665125|NCT02289157|11827329|FG001|STARTED|Overall Study||219
10665126|NCT02289157|11827328|FG000|No Post op Check or Follow up Phone Call|Overall Study||2
10665127|NCT02289157|11827329|FG001|No Post op Check or Follow up Phone Call|Overall Study||4
10665128|NCT02289157|11827328|FG000|COMPLETED|Overall Study||222
10665129|NCT02289157|11827329|FG001|COMPLETED|Overall Study||219
10665130|NCT02289157|11827328|FG000|NOT COMPLETED|Overall Study||0
10665131|NCT02289157|11827329|FG001|NOT COMPLETED|Overall Study||0
10665132|NCT02289222|11827335|FG000|STARTED|Overall Study||48
10665133|NCT02289222|11827335|FG000|COMPLETED|Overall Study||48
10665134|NCT02289222|11827335|FG000|NOT COMPLETED|Overall Study||0
10665135|NCT02289352|11827342|FG000|STARTED|Overall Study||199
10665136|NCT02289352|11827343|FG001|STARTED|Overall Study||199
10665137|NCT02289352|11827344|FG002|STARTED|Overall Study||64
10665138|NCT02289352|11827342|FG000|Safety Population|Overall Study||199
10665139|NCT02289352|11827343|FG001|Safety Population|Overall Study||199
10665140|NCT02289352|11827344|FG002|Safety Population|Overall Study||64
10665141|NCT02289352|11827342|FG000|mITT Population|Overall Study||191
10665142|NCT02289352|11827343|FG001|mITT Population|Overall Study||193
10665143|NCT02289352|11827344|FG002|mITT Population|Overall Study||58
10665144|NCT02289352|11827342|FG000|PP Population|Overall Study||173
10665145|NCT02289352|11827343|FG001|PP Population|Overall Study||173
10665146|NCT02289352|11827344|FG002|PP Population|Overall Study||54
10665147|NCT02289352|11827342|FG000|COMPLETED|Overall Study||198
10665148|NCT02289352|11827343|FG001|COMPLETED|Overall Study||198
10665149|NCT02289352|11827344|FG002|COMPLETED|Overall Study||64
10665150|NCT02289352|11827342|FG000|NOT COMPLETED|Overall Study||1
10665151|NCT02289352|11827343|FG001|NOT COMPLETED|Overall Study||1
10665152|NCT02289352|11827344|FG002|NOT COMPLETED|Overall Study||0
10665153|NCT02289417|11827356|FG000|STARTED|Placebo-Controlled Phase Weeks 0-12||58
10665154|NCT02289417|11827357|FG001|STARTED|Placebo-Controlled Phase Weeks 0-12||57
10665155|NCT02289417|11827358|FG002|STARTED|Placebo-Controlled Phase Weeks 0-12||55
10665156|NCT02289417|11827359|FG003|STARTED|Placebo-Controlled Phase Weeks 0-12||0
10665157|NCT02289417|11827360|FG004|STARTED|Placebo-Controlled Phase Weeks 0-12||0
10665158|NCT02289417|11827361|FG005|STARTED|Placebo-Controlled Phase Weeks 0-12||0
10665159|NCT02289417|11827362|FG006|STARTED|Placebo-Controlled Phase Weeks 0-12||0
10665160|NCT02289417|11827363|FG007|STARTED|Placebo-Controlled Phase Weeks 0-12||0
10665161|NCT02289417|11827364|FG008|STARTED|Placebo-Controlled Phase Weeks 0-12||0
10665162|NCT02289417|11827356|FG000|COMPLETED|Placebo-Controlled Phase Weeks 0-12||51
10665163|NCT02289417|11827357|FG001|COMPLETED|Placebo-Controlled Phase Weeks 0-12||53
10665164|NCT02289417|11827358|FG002|COMPLETED|Placebo-Controlled Phase Weeks 0-12||52
10665165|NCT02289417|11827359|FG003|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
10665166|NCT02289417|11827360|FG004|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
10665167|NCT02289417|11827361|FG005|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
10665168|NCT02289417|11827362|FG006|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
10665169|NCT02289417|11827363|FG007|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
10665170|NCT02289417|11827364|FG008|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
10665171|NCT02289417|11827356|FG000|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||7
10665172|NCT02289417|11827357|FG001|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||4
10665173|NCT02289417|11827358|FG002|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||3
10665174|NCT02289417|11827359|FG003|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
10665175|NCT02289417|11827360|FG004|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
10665176|NCT02289417|11827361|FG005|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
10665177|NCT02289417|11827362|FG006|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
10665178|NCT02289417|11827363|FG007|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
10665179|NCT02289417|11827364|FG008|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
10665180|NCT02289417|11827356|FG000|STARTED|Active Treatment Phase Weeks 12-52||0
10665181|NCT02289417|11827357|FG001|STARTED|Active Treatment Phase Weeks 12-52||41
10665182|NCT02289417|11827358|FG002|STARTED|Active Treatment Phase Weeks 12-52||42
10665183|NCT02289417|11827359|FG003|STARTED|Active Treatment Phase Weeks 12-52||26
10665184|NCT02289417|11827360|FG004|STARTED|Active Treatment Phase Weeks 12-52||25
10665185|NCT02289417|11827361|FG005|STARTED|Active Treatment Phase Weeks 12-52|1 participant went only to Week 20|12
10665186|NCT02289417|11827362|FG006|STARTED|Active Treatment Phase Weeks 12-52|Week 12 TMS were missing for 3 participants|7
10665187|NCT02289417|11827363|FG007|STARTED|Active Treatment Phase Weeks 12-52||0
10665188|NCT02289417|11827364|FG008|STARTED|Active Treatment Phase Weeks 12-52||0
10665189|NCT02289417|11827356|FG000|COMPLETED|Active Treatment Phase Weeks 12-52||0
10665190|NCT02289417|11827357|FG001|COMPLETED|Active Treatment Phase Weeks 12-52||39
10665191|NCT02289417|11827358|FG002|COMPLETED|Active Treatment Phase Weeks 12-52||32
10665192|NCT02289417|11827359|FG003|COMPLETED|Active Treatment Phase Weeks 12-52||17
10665193|NCT02289417|11827360|FG004|COMPLETED|Active Treatment Phase Weeks 12-52||20
10665194|NCT02289417|11827361|FG005|COMPLETED|Active Treatment Phase Weeks 12-52||7
10665195|NCT02289417|11827362|FG006|COMPLETED|Active Treatment Phase Weeks 12-52||5
10665196|NCT02289417|11827363|FG007|COMPLETED|Active Treatment Phase Weeks 12-52||0
10665197|NCT02289417|11827364|FG008|COMPLETED|Active Treatment Phase Weeks 12-52||0
10665198|NCT02289417|11827356|FG000|NOT COMPLETED|Active Treatment Phase Weeks 12-52||0
10665199|NCT02289417|11827357|FG001|NOT COMPLETED|Active Treatment Phase Weeks 12-52||2
10665200|NCT02289417|11827358|FG002|NOT COMPLETED|Active Treatment Phase Weeks 12-52||10
10665201|NCT02289417|11827359|FG003|NOT COMPLETED|Active Treatment Phase Weeks 12-52||9
10665202|NCT02289417|11827360|FG004|NOT COMPLETED|Active Treatment Phase Weeks 12-52||5
10665203|NCT02289417|11827361|FG005|NOT COMPLETED|Active Treatment Phase Weeks 12-52||5
10665204|NCT02289417|11827362|FG006|NOT COMPLETED|Active Treatment Phase Weeks 12-52||2
10665205|NCT02289417|11827363|FG007|NOT COMPLETED|Active Treatment Phase Weeks 12-52||0
10665206|NCT02289417|11827364|FG008|NOT COMPLETED|Active Treatment Phase Weeks 12-52||0
10665207|NCT02289417|11827356|FG000|STARTED|Extension Phase Weeks 52-104||0
10665208|NCT02289417|11827357|FG001|STARTED|Extension Phase Weeks 52-104||0
10665209|NCT02289417|11827358|FG002|STARTED|Extension Phase Weeks 52-104||0
10665210|NCT02289417|11827359|FG003|STARTED|Extension Phase Weeks 52-104||0
10665211|NCT02289417|11827360|FG004|STARTED|Extension Phase Weeks 52-104||0
10665212|NCT02289417|11827361|FG005|STARTED|Extension Phase Weeks 52-104||0
10665213|NCT02289417|11827362|FG006|STARTED|Extension Phase Weeks 52-104||0
10665214|NCT02289417|11827363|FG007|STARTED|Extension Phase Weeks 52-104||45
10665215|NCT02289417|11827364|FG008|STARTED|Extension Phase Weeks 52-104||54
10665216|NCT02289417|11827356|FG000|COMPLETED|Extension Phase Weeks 52-104||0
10665217|NCT02289417|11827357|FG001|COMPLETED|Extension Phase Weeks 52-104||0
10665218|NCT02289417|11827358|FG002|COMPLETED|Extension Phase Weeks 52-104||0
10665219|NCT02289417|11827359|FG003|COMPLETED|Extension Phase Weeks 52-104||0
10665220|NCT02289417|11827360|FG004|COMPLETED|Extension Phase Weeks 52-104||0
10665221|NCT02289417|11827361|FG005|COMPLETED|Extension Phase Weeks 52-104||0
10665222|NCT02289417|11827362|FG006|COMPLETED|Extension Phase Weeks 52-104||0
10665223|NCT02289417|11827363|FG007|COMPLETED|Extension Phase Weeks 52-104||38
10665224|NCT02289417|11827364|FG008|COMPLETED|Extension Phase Weeks 52-104||48
10665225|NCT02289417|11827356|FG000|NOT COMPLETED|Extension Phase Weeks 52-104||0
10665226|NCT02289417|11827357|FG001|NOT COMPLETED|Extension Phase Weeks 52-104||0
10665227|NCT02289417|11827358|FG002|NOT COMPLETED|Extension Phase Weeks 52-104||0
10665228|NCT02289417|11827359|FG003|NOT COMPLETED|Extension Phase Weeks 52-104||0
10665229|NCT02289417|11827360|FG004|NOT COMPLETED|Extension Phase Weeks 52-104||0
10665230|NCT02289417|11827361|FG005|NOT COMPLETED|Extension Phase Weeks 52-104||0
10665231|NCT02289417|11827362|FG006|NOT COMPLETED|Extension Phase Weeks 52-104||0
10665232|NCT02289417|11827363|FG007|NOT COMPLETED|Extension Phase Weeks 52-104||7
10665233|NCT02289417|11827364|FG008|NOT COMPLETED|Extension Phase Weeks 52-104||6
10665234|NCT02289456|11827380|FG000|STARTED|Induction Period||40
10665235|NCT02289456|11827380|FG000|Treated Population|Induction Period||40
10665236|NCT02289456|11827380|FG000|COMPLETED|Induction Period||16
10665237|NCT02289456|11827380|FG000|NOT COMPLETED|Induction Period||24
10665238|NCT02289456|11827380|FG000|STARTED|Monotherapy Period||16
10665239|NCT02289456|11827380|FG000|COMPLETED|Monotherapy Period||0
10665240|NCT02289456|11827380|FG000|NOT COMPLETED|Monotherapy Period||16
10665241|NCT02289469|11827391|FG000|STARTED|Overall Study||250
10665242|NCT02289469|11827392|FG001|STARTED|Overall Study||244
10665243|NCT02289469|11827391|FG000|COMPLETED|Overall Study||244
10665244|NCT02289469|11827392|FG001|COMPLETED|Overall Study||244
10665245|NCT02289469|11827391|FG000|NOT COMPLETED|Overall Study||6
10665246|NCT02289469|11827392|FG001|NOT COMPLETED|Overall Study||0
10665247|NCT02289690|11827408|FG000|STARTED|Overall Study||4
10665248|NCT02289690|11827409|FG001|STARTED|Overall Study||3
10665249|NCT02289690|11827410|FG002|STARTED|Overall Study||4
10665250|NCT02289690|11827411|FG003|STARTED|Overall Study||3
10665251|NCT02289690|11827412|FG004|STARTED|Overall Study||8
10665252|NCT02289690|11827413|FG005|STARTED|Overall Study||14
10665253|NCT02289690|11827414|FG006|STARTED|Overall Study||4
10665254|NCT02289690|11827415|FG007|STARTED|Overall Study||61
10665255|NCT02289690|11827416|FG008|STARTED|Overall Study||59
10665256|NCT02289690|11827417|FG009|STARTED|Overall Study||61
10665257|NCT02289690|11827408|FG000|Received Study Drug|Overall Study||4
10665258|NCT02289690|11827409|FG001|Received Study Drug|Overall Study||3
10665259|NCT02289690|11827410|FG002|Received Study Drug|Overall Study||4
10665260|NCT02289690|11827411|FG003|Received Study Drug|Overall Study||3
10665261|NCT02289690|11827412|FG004|Received Study Drug|Overall Study||8
10665262|NCT02289690|11827413|FG005|Received Study Drug|Overall Study||14
10665263|NCT02289690|11827414|FG006|Received Study Drug|Overall Study||4
10665264|NCT02289690|11827415|FG007|Received Study Drug|Overall Study||60
10665265|NCT02289690|11827416|FG008|Received Study Drug|Overall Study||58
10665266|NCT02289690|11827417|FG009|Received Study Drug|Overall Study||60
10665267|NCT02289690|11827408|FG000|COMPLETED|Overall Study||0
10665268|NCT02289690|11827409|FG001|COMPLETED|Overall Study||0
10665269|NCT02289690|11827410|FG002|COMPLETED|Overall Study||0
10665270|NCT02289690|11827411|FG003|COMPLETED|Overall Study||0
10665271|NCT02289690|11827412|FG004|COMPLETED|Overall Study||0
10665272|NCT02289690|11827413|FG005|COMPLETED|Overall Study||0
10665273|NCT02289690|11827414|FG006|COMPLETED|Overall Study||0
10665274|NCT02289690|11827415|FG007|COMPLETED|Overall Study||0
10665275|NCT02289690|11827416|FG008|COMPLETED|Overall Study||0
10665276|NCT02289690|11827417|FG009|COMPLETED|Overall Study||0
10665277|NCT02289690|11827408|FG000|NOT COMPLETED|Overall Study||4
10665278|NCT02289690|11827409|FG001|NOT COMPLETED|Overall Study||3
10665279|NCT02289690|11827410|FG002|NOT COMPLETED|Overall Study||4
10665280|NCT02289690|11827411|FG003|NOT COMPLETED|Overall Study||3
10665281|NCT02289690|11827412|FG004|NOT COMPLETED|Overall Study||8
10665282|NCT02289690|11827413|FG005|NOT COMPLETED|Overall Study||14
10665283|NCT02289690|11827414|FG006|NOT COMPLETED|Overall Study||4
10665284|NCT02289690|11827415|FG007|NOT COMPLETED|Overall Study||61
10665285|NCT02289690|11827416|FG008|NOT COMPLETED|Overall Study||59
10665286|NCT02289690|11827417|FG009|NOT COMPLETED|Overall Study||61
10665287|NCT02289729|11827453|FG000|STARTED|Overall Study||59
10665288|NCT02289729|11827453|FG000|COMPLETED|Overall Study||53
10665289|NCT02289729|11827453|FG000|NOT COMPLETED|Overall Study||6
10665290|NCT02289742|11827459|FG000|STARTED|First Wear Period||11
10665291|NCT02289742|11827460|FG001|STARTED|First Wear Period||12
10665292|NCT02289742|11827461|FG002|STARTED|First Wear Period||12
10665293|NCT02289742|11827462|FG003|STARTED|First Wear Period||10
10665294|NCT02289742|11827459|FG000|Treated|First Wear Period||11
10665295|NCT02289742|11827460|FG001|Treated|First Wear Period||11
10665296|NCT02289742|11827461|FG002|Treated|First Wear Period||12
10665297|NCT02289742|11827462|FG003|Treated|First Wear Period||9
10665298|NCT02289742|11827459|FG000|COMPLETED|First Wear Period||11
10665299|NCT02289742|11827460|FG001|COMPLETED|First Wear Period||11
10665300|NCT02289742|11827461|FG002|COMPLETED|First Wear Period||11
10665301|NCT02289742|11827462|FG003|COMPLETED|First Wear Period||9
10665302|NCT02289742|11827459|FG000|NOT COMPLETED|First Wear Period||0
10665303|NCT02289742|11827460|FG001|NOT COMPLETED|First Wear Period||1
10665304|NCT02289742|11827461|FG002|NOT COMPLETED|First Wear Period||1
10665305|NCT02289742|11827462|FG003|NOT COMPLETED|First Wear Period||1
10665306|NCT02289742|11827459|FG000|STARTED|Second Wear Period||11
10665307|NCT02289742|11827460|FG001|STARTED|Second Wear Period||11
10665308|NCT02289742|11827461|FG002|STARTED|Second Wear Period||11
10665309|NCT02289742|11827462|FG003|STARTED|Second Wear Period||9
10665310|NCT02289742|11827459|FG000|COMPLETED|Second Wear Period||11
10665311|NCT02289742|11827460|FG001|COMPLETED|Second Wear Period||11
10665312|NCT02289742|11827461|FG002|COMPLETED|Second Wear Period||11
10665313|NCT02289742|11827462|FG003|COMPLETED|Second Wear Period||9
10665314|NCT02289742|11827459|FG000|NOT COMPLETED|Second Wear Period||0
10665315|NCT02289742|11827460|FG001|NOT COMPLETED|Second Wear Period||0
10665316|NCT02289742|11827461|FG002|NOT COMPLETED|Second Wear Period||0
10665317|NCT02289742|11827462|FG003|NOT COMPLETED|Second Wear Period||0
10665318|NCT02289742|11827459|FG000|STARTED|Third Wear Period||11
10665319|NCT02289742|11827460|FG001|STARTED|Third Wear Period||11
10665320|NCT02289742|11827461|FG002|STARTED|Third Wear Period||11
10665321|NCT02289742|11827462|FG003|STARTED|Third Wear Period||9
10665322|NCT02289742|11827459|FG000|COMPLETED|Third Wear Period||11
10665323|NCT02289742|11827460|FG001|COMPLETED|Third Wear Period||10
10665324|NCT02289742|11827461|FG002|COMPLETED|Third Wear Period||11
10665325|NCT02289742|11827462|FG003|COMPLETED|Third Wear Period||8
10665326|NCT02289742|11827459|FG000|NOT COMPLETED|Third Wear Period||0
10665327|NCT02289742|11827460|FG001|NOT COMPLETED|Third Wear Period||1
10665328|NCT02289742|11827461|FG002|NOT COMPLETED|Third Wear Period||0
10665329|NCT02289742|11827462|FG003|NOT COMPLETED|Third Wear Period||1
10665330|NCT02289755|11827476|FG000|STARTED|Baseline Period [No Treatment, 3 Days]||16
10665331|NCT02289755|11827476|FG000|COMPLETED|Baseline Period [No Treatment, 3 Days]||16
10665332|NCT02289755|11827476|FG000|NOT COMPLETED|Baseline Period [No Treatment, 3 Days]||0
10665333|NCT02289755|11827476|FG000|STARTED|ALLN-177 Treatment Period [4 Days]||16
10665334|NCT02289755|11827476|FG000|COMPLETED|ALLN-177 Treatment Period [4 Days]||16
10665335|NCT02289755|11827476|FG000|NOT COMPLETED|ALLN-177 Treatment Period [4 Days]||0
10665336|NCT02289755|11827476|FG000|STARTED|Follow up Period [4 Days]||16
10665337|NCT02289755|11827476|FG000|COMPLETED|Follow up Period [4 Days]||16
10665338|NCT02289755|11827476|FG000|NOT COMPLETED|Follow up Period [4 Days]||0
10665339|NCT02289820|11827487|FG000|STARTED|Overall Study||39
10665340|NCT02289820|11827488|FG001|STARTED|Overall Study||20
10665341|NCT02289820|11827489|FG002|STARTED|Overall Study||44
10665342|NCT02289820|11827490|FG003|STARTED|Overall Study||39
10665343|NCT02289820|11827491|FG004|STARTED|Overall Study||40
10665344|NCT02289820|11827492|FG005|STARTED|Overall Study||40
10665345|NCT02289820|11827493|FG006|STARTED|Overall Study||39
10665346|NCT02289820|11827487|FG000|COMPLETED|Overall Study||37
10665347|NCT02289820|11827488|FG001|COMPLETED|Overall Study||18
10665348|NCT02289820|11827489|FG002|COMPLETED|Overall Study||38
10665349|NCT02289820|11827490|FG003|COMPLETED|Overall Study||37
10665350|NCT02289820|11827491|FG004|COMPLETED|Overall Study||40
10665351|NCT02289820|11827492|FG005|COMPLETED|Overall Study||39
10665352|NCT02289820|11827493|FG006|COMPLETED|Overall Study||37
10665353|NCT02289820|11827487|FG000|NOT COMPLETED|Overall Study||2
10665354|NCT02289820|11827488|FG001|NOT COMPLETED|Overall Study||2
10665355|NCT02289820|11827489|FG002|NOT COMPLETED|Overall Study||6
10665356|NCT02289820|11827490|FG003|NOT COMPLETED|Overall Study||2
10665357|NCT02289820|11827491|FG004|NOT COMPLETED|Overall Study||0
10665358|NCT02289820|11827492|FG005|NOT COMPLETED|Overall Study||1
10665359|NCT02289820|11827493|FG006|NOT COMPLETED|Overall Study||2
10665360|NCT02289833|11827515|FG000|STARTED|Overall Study||29
10665361|NCT02289833|11827516|FG001|STARTED|Overall Study||20
10665362|NCT02289833|11827515|FG000|COMPLETED|Overall Study||2
10665363|NCT02289833|11827516|FG001|COMPLETED|Overall Study||3
10665364|NCT02289833|11827515|FG000|NOT COMPLETED|Overall Study||27
10665365|NCT02289833|11827516|FG001|NOT COMPLETED|Overall Study||17
10665366|NCT02289898|11827527|FG000|STARTED|Overall Study||68
10665367|NCT02289898|11827528|FG001|STARTED|Overall Study||71
10665368|NCT02289898|11827529|FG002|STARTED|Overall Study||65
10665369|NCT02289898|11827527|FG000|COMPLETED|Overall Study||16
10665370|NCT02289898|11827528|FG001|COMPLETED|Overall Study||18
10665371|NCT02289898|11827529|FG002|COMPLETED|Overall Study||9
10665372|NCT02289898|11827527|FG000|NOT COMPLETED|Overall Study||52
10665373|NCT02289898|11827528|FG001|NOT COMPLETED|Overall Study||53
10665374|NCT02289898|11827529|FG002|NOT COMPLETED|Overall Study||56
10665375|NCT02289950|11827538|FG000|STARTED|Overall Study||142
10665376|NCT02289950|11827539|FG001|STARTED|Overall Study||72
10665377|NCT02289950|11827538|FG000|Treated|Overall Study|1 participant randomized to placebo group but was treated with farletuzumab, and was analyzed in the farletuzumab group in safety analysis set.|140
10665378|NCT02289950|11827539|FG001|Treated|Overall Study||71
10665379|NCT02289950|11827538|FG000|COMPLETED|Overall Study||0
10665380|NCT02289950|11827539|FG001|COMPLETED|Overall Study||0
10665381|NCT02289950|11827538|FG000|NOT COMPLETED|Overall Study||142
10665382|NCT02289950|11827539|FG001|NOT COMPLETED|Overall Study||72
10665383|NCT02289963|11827547|FG000|STARTED|Overall Study|Randomized|102
10665384|NCT02289963|11827548|FG001|STARTED|Overall Study|Randomized|97
10665385|NCT02289963|11827547|FG000|Treated|Overall Study||102
10665386|NCT02289963|11827548|FG001|Treated|Overall Study||97
10665387|NCT02289963|11827547|FG000|COMPLETED|Overall Study||97
10665388|NCT02289963|11827548|FG001|COMPLETED|Overall Study||87
10665389|NCT02289963|11827547|FG000|NOT COMPLETED|Overall Study||5
10665390|NCT02289963|11827548|FG001|NOT COMPLETED|Overall Study||10
10665391|NCT02289989|11827556|FG000|STARTED|Overall Study||0
10665392|NCT02289989|11827557|FG001|STARTED|Overall Study||1
10665393|NCT02289989|11827556|FG000|COMPLETED|Overall Study||0
10665394|NCT02289989|11827557|FG001|COMPLETED|Overall Study||1
10665395|NCT02289989|11827556|FG000|NOT COMPLETED|Overall Study||0
10665396|NCT02289989|11827557|FG001|NOT COMPLETED|Overall Study||0
10665397|NCT02290028|11827563|FG000|STARTED|Overall Study||2226
10665398|NCT02290028|11827563|FG000|COMPLETED|Overall Study||0
10665399|NCT02290028|11827563|FG000|NOT COMPLETED|Overall Study||2226
10665400|NCT02290106|11827572|FG000|STARTED|Overall Study||25
10665401|NCT02290106|11827573|FG001|STARTED|Overall Study||25
10665402|NCT02290106|11827572|FG000|COMPLETED|Overall Study||24
10665403|NCT02290106|11827573|FG001|COMPLETED|Overall Study||23
10665404|NCT02290106|11827572|FG000|NOT COMPLETED|Overall Study||1
10665405|NCT02290106|11827573|FG001|NOT COMPLETED|Overall Study||2
10665406|NCT02290184|11827581|FG000|STARTED|Overall Study||22
10665407|NCT02290184|11827582|FG001|STARTED|Overall Study||23
10665408|NCT02290184|11827581|FG000|3-month Follow-up|Overall Study|Completed initial 3-month intervention and now transition to a 3-month maintenance phase|22
10665409|NCT02290184|11827582|FG001|3-month Follow-up|Overall Study|Completed initial 3-month control period and transition to receive the 3-month intervention|23
10665410|NCT02290184|11827581|FG000|COMPLETED|Overall Study|6-month follow-up visit - completed the 3-month maintenance phase and completed study|22
10665411|NCT02290184|11827582|FG001|COMPLETED|Overall Study|6-month follow up visit - completed 3-month intervention and competed study|23
10665412|NCT02290184|11827581|FG000|NOT COMPLETED|Overall Study||0
10665413|NCT02290184|11827582|FG001|NOT COMPLETED|Overall Study||0
10665414|NCT02290223|11827596|FG000|STARTED|Baseline||189
10665415|NCT02290223|11827597|FG001|STARTED|Baseline||187
10665416|NCT02290223|11827596|FG000|COMPLETED|Baseline||189
10665417|NCT02290223|11827597|FG001|COMPLETED|Baseline||187
10665418|NCT02290223|11827596|FG000|NOT COMPLETED|Baseline||0
10665419|NCT02290223|11827597|FG001|NOT COMPLETED|Baseline||0
10665420|NCT02290223|11827596|FG000|STARTED|6 Months||189
10665421|NCT02290223|11827597|FG001|STARTED|6 Months||187
10665422|NCT02290223|11827596|FG000|COMPLETED|6 Months||173
10665423|NCT02290223|11827597|FG001|COMPLETED|6 Months||181
10665424|NCT02290223|11827596|FG000|NOT COMPLETED|6 Months||16
10665425|NCT02290223|11827597|FG001|NOT COMPLETED|6 Months||6
10665426|NCT02290223|11827596|FG000|STARTED|12 Months|All participants were contacted at 12 mo, unless deceased or withdrawn (n=7).|182
10665427|NCT02290223|11827597|FG001|STARTED|12 Months|All participants were contacted at 12 mo, unless deceased or withdrawn (n=0).|187
10665428|NCT02290223|11827596|FG000|COMPLETED|12 Months||166
10665429|NCT02290223|11827597|FG001|COMPLETED|12 Months||176
10665430|NCT02290223|11827596|FG000|NOT COMPLETED|12 Months||16
10665431|NCT02290223|11827597|FG001|NOT COMPLETED|12 Months||11
10665432|NCT02290340|11827607|FG000|STARTED|Overall Study||18
10665433|NCT02290340|11827608|FG001|STARTED|Overall Study||8
10665434|NCT02290340|11827609|FG002|STARTED|Overall Study||31
10665435|NCT02290340|11827610|FG003|STARTED|Overall Study||32
10665436|NCT02290340|11827607|FG000|COMPLETED|Overall Study||16
10665437|NCT02290340|11827608|FG001|COMPLETED|Overall Study||8
10665438|NCT02290340|11827609|FG002|COMPLETED|Overall Study||31
10665439|NCT02290340|11827610|FG003|COMPLETED|Overall Study||30
10665440|NCT02290340|11827607|FG000|NOT COMPLETED|Overall Study||2
10665441|NCT02290340|11827608|FG001|NOT COMPLETED|Overall Study||0
10665442|NCT02290340|11827609|FG002|NOT COMPLETED|Overall Study||0
10665443|NCT02290340|11827610|FG003|NOT COMPLETED|Overall Study||2
10665444|NCT02290405|11827625|FG000|STARTED|Overall Study||36
10665445|NCT02290405|11827626|FG001|STARTED|Overall Study||53
10665446|NCT02290405|11827625|FG000|COMPLETED|Overall Study||35
10665447|NCT02290405|11827626|FG001|COMPLETED|Overall Study||53
10665448|NCT02290405|11827625|FG000|NOT COMPLETED|Overall Study||1
10665449|NCT02290405|11827626|FG001|NOT COMPLETED|Overall Study||0
10665450|NCT02290444|11827634|FG000|STARTED|Overall Study||30
10665451|NCT02290444|11827635|FG001|STARTED|Overall Study||34
10665452|NCT02290444|11827634|FG000|COMPLETED|Overall Study||29
10665453|NCT02290444|11827635|FG001|COMPLETED|Overall Study||32
10665454|NCT02290444|11827634|FG000|NOT COMPLETED|Overall Study||1
10665455|NCT02290444|11827635|FG001|NOT COMPLETED|Overall Study||2
10665456|NCT02290509|11827643|FG000|STARTED|Overall Study||1011
10665457|NCT02290509|11827644|FG001|STARTED|Overall Study||339
10665458|NCT02290509|11827643|FG000|COMPLETED|Overall Study||962
10665459|NCT02290509|11827644|FG001|COMPLETED|Overall Study||325
10665460|NCT02290509|11827643|FG000|NOT COMPLETED|Overall Study||49
10665461|NCT02290509|11827644|FG001|NOT COMPLETED|Overall Study||14
10665462|NCT02290574|11827650|FG000|STARTED|Overall Study||14
10665463|NCT02290574|11827650|FG000|COMPLETED|Overall Study||13
10665464|NCT02290574|11827650|FG000|NOT COMPLETED|Overall Study||1
10665465|NCT02290613|11827657|FG000|STARTED|Overall Study||19
10665466|NCT02290613|11827658|FG001|STARTED|Overall Study||19
10665467|NCT02290613|11827657|FG000|COMPLETED|Overall Study||17
10665468|NCT02290613|11827658|FG001|COMPLETED|Overall Study||15
10665469|NCT02290613|11827657|FG000|NOT COMPLETED|Overall Study||2
10665470|NCT02290613|11827658|FG001|NOT COMPLETED|Overall Study||4
10665471|NCT02290691|11827666|FG000|STARTED|Overall Study||496
10665472|NCT02290691|11827667|FG001|STARTED|Overall Study||488
10665473|NCT02290691|11827666|FG000|COMPLETED|Overall Study||488
10665474|NCT02290691|11827667|FG001|COMPLETED|Overall Study||479
10665475|NCT02290691|11827666|FG000|NOT COMPLETED|Overall Study||8
10665476|NCT02290691|11827667|FG001|NOT COMPLETED|Overall Study||9
10665477|NCT02290821|11827675|FG000|STARTED|Overall Study||109
10665478|NCT02290821|11827676|FG001|STARTED|Overall Study||106
10665479|NCT02290821|11827675|FG000|COMPLETED|Overall Study||103
10665480|NCT02290821|11827676|FG001|COMPLETED|Overall Study||103
10665481|NCT02290821|11827675|FG000|NOT COMPLETED|Overall Study||6
10665482|NCT02290821|11827676|FG001|NOT COMPLETED|Overall Study||3
10665483|NCT02290873|11827685|FG000|STARTED|Overall Study||298
10665484|NCT02290873|11827686|FG001|STARTED|Overall Study||60
10665485|NCT02290873|11827687|FG002|STARTED|Overall Study||103
10665486|NCT02290873|11827685|FG000|Modified Intention to Treat (mITT)|Overall Study||296
10665487|NCT02290873|11827686|FG001|Modified Intention to Treat (mITT)|Overall Study||60
10665488|NCT02290873|11827687|FG002|Modified Intention to Treat (mITT)|Overall Study||102
10665489|NCT02290873|11827685|FG000|Safety Population|Overall Study||296
10665490|NCT02290873|11827686|FG001|Safety Population|Overall Study||60
10665491|NCT02290873|11827687|FG002|Safety Population|Overall Study||102
10665492|NCT02290873|11827685|FG000|COMPLETED|Overall Study||296
10665493|NCT02290873|11827686|FG001|COMPLETED|Overall Study||59
10665494|NCT02290873|11827687|FG002|COMPLETED|Overall Study||101
10665495|NCT02290873|11827685|FG000|NOT COMPLETED|Overall Study||2
10665496|NCT02290873|11827686|FG001|NOT COMPLETED|Overall Study||1
10665497|NCT02290873|11827687|FG002|NOT COMPLETED|Overall Study||2
10665498|NCT02290925|11827698|FG000|STARTED|First Period of Three Months||62
10665499|NCT02290925|11827699|FG001|STARTED|First Period of Three Months||71
10665500|NCT02290925|11827698|FG000|COMPLETED|First Period of Three Months||58
10665501|NCT02290925|11827699|FG001|COMPLETED|First Period of Three Months||69
10665502|NCT02290925|11827698|FG000|NOT COMPLETED|First Period of Three Months||4
10665503|NCT02290925|11827699|FG001|NOT COMPLETED|First Period of Three Months||2
10665504|NCT02290925|11827698|FG000|STARTED|Second Period of 3 Months||58
10665505|NCT02290925|11827699|FG001|STARTED|Second Period of 3 Months||69
10665506|NCT02290925|11827698|FG000|COMPLETED|Second Period of 3 Months||57
10665507|NCT02290925|11827699|FG001|COMPLETED|Second Period of 3 Months||65
10665508|NCT02290925|11827698|FG000|NOT COMPLETED|Second Period of 3 Months||1
10665509|NCT02290925|11827699|FG001|NOT COMPLETED|Second Period of 3 Months||4
10665510|NCT02291016|11827709|FG000|STARTED|Visit 1||2
10665511|NCT02291016|11827710|FG001|STARTED|Visit 1||5
10665512|NCT02291016|11827709|FG000|COMPLETED|Visit 1||2
10665513|NCT02291016|11827710|FG001|COMPLETED|Visit 1||5
10665514|NCT02291016|11827709|FG000|NOT COMPLETED|Visit 1||0
10665515|NCT02291016|11827710|FG001|NOT COMPLETED|Visit 1||0
10665516|NCT02291016|11827709|FG000|STARTED|Visit 2||2
10665517|NCT02291016|11827710|FG001|STARTED|Visit 2||5
10665518|NCT02291016|11827709|FG000|COMPLETED|Visit 2|Patients did not meet visit 2 FEV1 criteria ( 15% or closer to value at visit 1)|1
10665519|NCT02291016|11827710|FG001|COMPLETED|Visit 2||5
10665520|NCT02291016|11827709|FG000|NOT COMPLETED|Visit 2||1
10665521|NCT02291016|11827710|FG001|NOT COMPLETED|Visit 2||0
10665522|NCT02291029|11827723|FG000|STARTED|Overall Study||8
10665523|NCT02291029|11827724|FG001|STARTED|Overall Study||4
10665524|NCT02291029|11827725|FG002|STARTED|Overall Study||21
10665525|NCT02291029|11827726|FG003|STARTED|Overall Study||11
10665526|NCT02291029|11827727|FG004|STARTED|Overall Study||13
10665527|NCT02291029|11827728|FG005|STARTED|Overall Study||12
10665528|NCT02291029|11827723|FG000|COMPLETED|Overall Study||8
10665529|NCT02291029|11827724|FG001|COMPLETED|Overall Study||3
10665530|NCT02291029|11827725|FG002|COMPLETED|Overall Study||20
10665531|NCT02291029|11827726|FG003|COMPLETED|Overall Study||11
10665532|NCT02291029|11827727|FG004|COMPLETED|Overall Study||13
10665533|NCT02291029|11827728|FG005|COMPLETED|Overall Study||12
10665534|NCT02291029|11827723|FG000|NOT COMPLETED|Overall Study||0
10665535|NCT02291029|11827724|FG001|NOT COMPLETED|Overall Study||1
10665536|NCT02291029|11827725|FG002|NOT COMPLETED|Overall Study||1
10665537|NCT02291029|11827726|FG003|NOT COMPLETED|Overall Study||0
10665538|NCT02291029|11827727|FG004|NOT COMPLETED|Overall Study||0
10665539|NCT02291029|11827728|FG005|NOT COMPLETED|Overall Study||0
10665540|NCT02291133|11827742|FG000|STARTED|Overall Study||25
10665541|NCT02291133|11827742|FG000|COMPLETED|Overall Study||24
10665542|NCT02291133|11827742|FG000|NOT COMPLETED|Overall Study||1
10665543|NCT02291237|11827748|FG000|STARTED|Overall Study||86
10665544|NCT02291237|11827749|FG001|STARTED|Overall Study||86
10665545|NCT02291237|11827748|FG000|COMPLETED|Overall Study||0
10665546|NCT02291237|11827749|FG001|COMPLETED|Overall Study||0
10665547|NCT02291237|11827748|FG000|NOT COMPLETED|Overall Study||86
10665548|NCT02291237|11827749|FG001|NOT COMPLETED|Overall Study||86
10665549|NCT02291289|11827759|FG000|STARTED|Induction Treatment||60
10665550|NCT02291289|11827760|FG001|STARTED|Induction Treatment||0
10665551|NCT02291289|11827761|FG002|STARTED|Induction Treatment||0
10665552|NCT02291289|11827762|FG003|STARTED|Induction Treatment||445
10665553|NCT02291289|11827763|FG004|STARTED|Induction Treatment||0
10665554|NCT02291289|11827764|FG005|STARTED|Induction Treatment||0
10665555|NCT02291289|11827765|FG006|STARTED|Induction Treatment||5
10665556|NCT02291289|11827766|FG007|STARTED|Induction Treatment||0
10665557|NCT02291289|11827767|FG008|STARTED|Induction Treatment||0
10665558|NCT02291289|11827768|FG009|STARTED|Induction Treatment||99
10665559|NCT02291289|11827769|FG010|STARTED|Induction Treatment||0
10665560|NCT02291289|11827770|FG011|STARTED|Induction Treatment||0
10665561|NCT02291289|11827759|FG000|COMPLETED|Induction Treatment||58
10665562|NCT02291289|11827760|FG001|COMPLETED|Induction Treatment||0
10665563|NCT02291289|11827761|FG002|COMPLETED|Induction Treatment||0
10665564|NCT02291289|11827762|FG003|COMPLETED|Induction Treatment||436
10665565|NCT02291289|11827763|FG004|COMPLETED|Induction Treatment||0
10665566|NCT02291289|11827764|FG005|COMPLETED|Induction Treatment||0
10665567|NCT02291289|11827765|FG006|COMPLETED|Induction Treatment||5
10665568|NCT02291289|11827766|FG007|COMPLETED|Induction Treatment||0
10665569|NCT02291289|11827767|FG008|COMPLETED|Induction Treatment||0
10665570|NCT02291289|11827768|FG009|COMPLETED|Induction Treatment||98
10665571|NCT02291289|11827769|FG010|COMPLETED|Induction Treatment||0
10665572|NCT02291289|11827770|FG011|COMPLETED|Induction Treatment||0
10665573|NCT02291289|11827759|FG000|NOT COMPLETED|Induction Treatment||2
10665574|NCT02291289|11827760|FG001|NOT COMPLETED|Induction Treatment||0
10665575|NCT02291289|11827761|FG002|NOT COMPLETED|Induction Treatment||0
10665576|NCT02291289|11827762|FG003|NOT COMPLETED|Induction Treatment||9
10665577|NCT02291289|11827763|FG004|NOT COMPLETED|Induction Treatment||0
10665578|NCT02291289|11827764|FG005|NOT COMPLETED|Induction Treatment||0
10665579|NCT02291289|11827765|FG006|NOT COMPLETED|Induction Treatment||0
10665580|NCT02291289|11827766|FG007|NOT COMPLETED|Induction Treatment||0
10795754|NCT03645434|11956030|FG001|STARTED|Period 3||13
10795755|NCT03645434|11956031|FG002|STARTED|Period 3|2 subjects discontinued as they did not meet FEV1 stability criteria or pfts variability criteria.|11
10795756|NCT03645434|11956032|FG003|STARTED|Period 3||10
10795757|NCT03645434|11956033|FG004|STARTED|Period 3||11
10665581|NCT02291289|11827767|FG008|NOT COMPLETED|Induction Treatment||0
10665582|NCT02291289|11827768|FG009|NOT COMPLETED|Induction Treatment||1
10665583|NCT02291289|11827769|FG010|NOT COMPLETED|Induction Treatment||0
10665584|NCT02291289|11827770|FG011|NOT COMPLETED|Induction Treatment||0
10665585|NCT02291289|11827759|FG000|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0
10665586|NCT02291289|11827760|FG001|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|40
10665663|NCT02291510|11827832|FG003|STARTED|Overall Study||5
10665587|NCT02291289|11827761|FG002|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|20
10665588|NCT02291289|11827762|FG003|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0
10665589|NCT02291289|11827763|FG004|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|297
10665590|NCT02291289|11827764|FG005|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|148
10665591|NCT02291289|11827765|FG006|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0
10665592|NCT02291289|11827766|FG007|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|3
10665593|NCT02291289|11827767|FG008|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|2
10665594|NCT02291289|11827768|FG009|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0
10665595|NCT02291289|11827769|FG010|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|65
10665596|NCT02291289|11827770|FG011|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|34
10665597|NCT02291289|11827759|FG000|Dosed|Maintenance Treatment Phase||0
10665598|NCT02291289|11827760|FG001|Dosed|Maintenance Treatment Phase||40
10665599|NCT02291289|11827761|FG002|Dosed|Maintenance Treatment Phase||18
10665600|NCT02291289|11827762|FG003|Dosed|Maintenance Treatment Phase||0
10665601|NCT02291289|11827763|FG004|Dosed|Maintenance Treatment Phase||293
10665602|NCT02291289|11827764|FG005|Dosed|Maintenance Treatment Phase||143
10665603|NCT02291289|11827765|FG006|Dosed|Maintenance Treatment Phase||0
10665604|NCT02291289|11827766|FG007|Dosed|Maintenance Treatment Phase||3
10665605|NCT02291289|11827767|FG008|Dosed|Maintenance Treatment Phase||2
10665606|NCT02291289|11827768|FG009|Dosed|Maintenance Treatment Phase||0
10665607|NCT02291289|11827769|FG010|Dosed|Maintenance Treatment Phase||64
10665608|NCT02291289|11827770|FG011|Dosed|Maintenance Treatment Phase||34
10665609|NCT02291289|11827759|FG000|COMPLETED|Maintenance Treatment Phase||0
10665610|NCT02291289|11827760|FG001|COMPLETED|Maintenance Treatment Phase||16
10665611|NCT02291289|11827761|FG002|COMPLETED|Maintenance Treatment Phase||4
10665612|NCT02291289|11827762|FG003|COMPLETED|Maintenance Treatment Phase||0
10665613|NCT02291289|11827763|FG004|COMPLETED|Maintenance Treatment Phase||45
10665614|NCT02291289|11827764|FG005|COMPLETED|Maintenance Treatment Phase||19
10665615|NCT02291289|11827765|FG006|COMPLETED|Maintenance Treatment Phase||0
10665616|NCT02291289|11827766|FG007|COMPLETED|Maintenance Treatment Phase||1
10665617|NCT02291289|11827767|FG008|COMPLETED|Maintenance Treatment Phase||0
10665618|NCT02291289|11827768|FG009|COMPLETED|Maintenance Treatment Phase||0
10665619|NCT02291289|11827769|FG010|COMPLETED|Maintenance Treatment Phase||34
10665620|NCT02291289|11827770|FG011|COMPLETED|Maintenance Treatment Phase||18
10665621|NCT02291289|11827759|FG000|NOT COMPLETED|Maintenance Treatment Phase||0
10665622|NCT02291289|11827760|FG001|NOT COMPLETED|Maintenance Treatment Phase||24
10665623|NCT02291289|11827761|FG002|NOT COMPLETED|Maintenance Treatment Phase||16
10665624|NCT02291289|11827762|FG003|NOT COMPLETED|Maintenance Treatment Phase||0
10665625|NCT02291289|11827763|FG004|NOT COMPLETED|Maintenance Treatment Phase||252
10665626|NCT02291289|11827764|FG005|NOT COMPLETED|Maintenance Treatment Phase||129
10665627|NCT02291289|11827765|FG006|NOT COMPLETED|Maintenance Treatment Phase||0
10665628|NCT02291289|11827766|FG007|NOT COMPLETED|Maintenance Treatment Phase||2
10665629|NCT02291289|11827767|FG008|NOT COMPLETED|Maintenance Treatment Phase||2
10665630|NCT02291289|11827768|FG009|NOT COMPLETED|Maintenance Treatment Phase||0
10665631|NCT02291289|11827769|FG010|NOT COMPLETED|Maintenance Treatment Phase||31
10665632|NCT02291289|11827770|FG011|NOT COMPLETED|Maintenance Treatment Phase||16
10665633|NCT02291302|11827799|FG000|STARTED|Overall Study||59
10665634|NCT02291302|11827800|FG001|STARTED|Overall Study||59
10665635|NCT02291302|11827801|FG002|STARTED|Overall Study||59
10665636|NCT02291302|11827802|FG003|STARTED|Overall Study||59
10665637|NCT02291302|11827799|FG000|COMPLETED|Overall Study||59
10665638|NCT02291302|11827800|FG001|COMPLETED|Overall Study||59
10665639|NCT02291302|11827801|FG002|COMPLETED|Overall Study||59
10665640|NCT02291302|11827802|FG003|COMPLETED|Overall Study||59
10665641|NCT02291302|11827799|FG000|NOT COMPLETED|Overall Study||0
10665642|NCT02291302|11827800|FG001|NOT COMPLETED|Overall Study||0
10665643|NCT02291302|11827801|FG002|NOT COMPLETED|Overall Study||0
10665644|NCT02291302|11827802|FG003|NOT COMPLETED|Overall Study||0
10665645|NCT02291419|11827814|FG000|STARTED|Overall Study||1
10665646|NCT02291419|11827815|FG001|STARTED|Overall Study||5
10665647|NCT02291419|11827814|FG000|COMPLETED|Overall Study||0
10665648|NCT02291419|11827815|FG001|COMPLETED|Overall Study||0
10665649|NCT02291419|11827814|FG000|NOT COMPLETED|Overall Study||1
10665650|NCT02291419|11827815|FG001|NOT COMPLETED|Overall Study||5
10665651|NCT02291432|11827821|FG000|STARTED|Overall Study||25
10665652|NCT02291432|11827821|FG000|Muscle Biopsy|Overall Study||25
10665653|NCT02291432|11827821|FG000|AMDC Injection|Overall Study||23
10665654|NCT02291432|11827821|FG000|1-Month Follow Up|Overall Study||23
10665655|NCT02291432|11827821|FG000|3-Month Follow Up|Overall Study||23
10665656|NCT02291432|11827821|FG000|6-Month Follow Up|Overall Study||23
10665657|NCT02291432|11827821|FG000|12-Month Follow Up|Overall Study||23
10665658|NCT02291432|11827821|FG000|COMPLETED|Overall Study||23
10665659|NCT02291432|11827821|FG000|NOT COMPLETED|Overall Study||2
10665660|NCT02291510|11827829|FG000|STARTED|Overall Study||5
10665661|NCT02291510|11827830|FG001|STARTED|Overall Study||5
10665662|NCT02291510|11827831|FG002|STARTED|Overall Study||5
10665664|NCT02291510|11827829|FG000|Completed Treatment A|Overall Study||5
10665665|NCT02291510|11827830|FG001|Completed Treatment A|Overall Study||5
10665666|NCT02291510|11827831|FG002|Completed Treatment A|Overall Study||5
10665667|NCT02291510|11827832|FG003|Completed Treatment A|Overall Study||5
10665668|NCT02291510|11827829|FG000|Completed Treatment B|Overall Study||5
10665669|NCT02291510|11827830|FG001|Completed Treatment B|Overall Study||5
10665670|NCT02291510|11827831|FG002|Completed Treatment B|Overall Study||5
10665671|NCT02291510|11827832|FG003|Completed Treatment B|Overall Study||4
10665672|NCT02291510|11827829|FG000|Completed Treatment C|Overall Study||5
10665673|NCT02291510|11827830|FG001|Completed Treatment C|Overall Study||5
10665674|NCT02291510|11827831|FG002|Completed Treatment C|Overall Study||5
10665675|NCT02291510|11827832|FG003|Completed Treatment C|Overall Study||4
10665676|NCT02291510|11827829|FG000|Completed Treatment D|Overall Study||5
10665677|NCT02291510|11827830|FG001|Completed Treatment D|Overall Study||5
10665678|NCT02291510|11827831|FG002|Completed Treatment D|Overall Study||5
10665679|NCT02291510|11827832|FG003|Completed Treatment D|Overall Study||5
10665680|NCT02291510|11827829|FG000|COMPLETED|Overall Study||5
10665681|NCT02291510|11827830|FG001|COMPLETED|Overall Study||5
10795758|NCT03645434|11956034|FG005|STARTED|Period 3||11
10795759|NCT03645434|11956029|FG000|COMPLETED|Period 3||10
10795760|NCT03645434|11956030|FG001|COMPLETED|Period 3||13
10795761|NCT03645434|11956031|FG002|COMPLETED|Period 3||11
10795762|NCT03645434|11956032|FG003|COMPLETED|Period 3||10
10795763|NCT03645434|11956033|FG004|COMPLETED|Period 3||11
10795764|NCT03645434|11956034|FG005|COMPLETED|Period 3||11
10665682|NCT02291510|11827831|FG002|COMPLETED|Overall Study||5
10665683|NCT02291510|11827832|FG003|COMPLETED|Overall Study||4
10665684|NCT02291510|11827829|FG000|NOT COMPLETED|Overall Study||0
10665685|NCT02291510|11827830|FG001|NOT COMPLETED|Overall Study||0
10665686|NCT02291510|11827831|FG002|NOT COMPLETED|Overall Study||0
10665687|NCT02291510|11827832|FG003|NOT COMPLETED|Overall Study||1
10665688|NCT02291549|11827844|FG000|STARTED|Overall Study||201
10665689|NCT02291549|11827845|FG001|STARTED|Overall Study||99
10665690|NCT02291549|11827844|FG000|COMPLETED|Overall Study||200
10795765|NCT03645434|11956029|FG000|NOT COMPLETED|Period 3||0
10795766|NCT03645434|11956030|FG001|NOT COMPLETED|Period 3||0
10665691|NCT02291549|11827845|FG001|COMPLETED|Overall Study||98
10665692|NCT02291549|11827844|FG000|NOT COMPLETED|Overall Study||1
10665693|NCT02291549|11827845|FG001|NOT COMPLETED|Overall Study||1
10665694|NCT02291601|11827853|FG000|STARTED|Abdomen||638
10665695|NCT02291601|11827854|FG001|STARTED|Abdomen||108
10665696|NCT02291601|11827855|FG002|STARTED|Abdomen||642
10665697|NCT02291601|11827853|FG000|COMPLETED|Abdomen|638 participants received CHG cloth|305
10665698|NCT02291601|11827854|FG001|COMPLETED|Abdomen|108 participants received vehicle|54
10665699|NCT02291601|11827855|FG002|COMPLETED|Abdomen|642 participants received comparator CHG|303
10665700|NCT02291601|11827853|FG000|NOT COMPLETED|Abdomen||333
10665701|NCT02291601|11827854|FG001|NOT COMPLETED|Abdomen||54
10665702|NCT02291601|11827855|FG002|NOT COMPLETED|Abdomen||339
10665703|NCT02291601|11827853|FG000|STARTED|Groin||520
10665704|NCT02291601|11827854|FG001|STARTED|Groin||93
10665705|NCT02291601|11827855|FG002|STARTED|Groin||515
10665706|NCT02291601|11827853|FG000|COMPLETED|Groin|520 participants received CHG cloth|337
10665707|NCT02291601|11827854|FG001|COMPLETED|Groin|93 participants received vehicle|63
10665708|NCT02291601|11827855|FG002|COMPLETED|Groin|515 participants received Comparator CHG|338
10665709|NCT02291601|11827853|FG000|NOT COMPLETED|Groin||183
10665710|NCT02291601|11827854|FG001|NOT COMPLETED|Groin||30
10665711|NCT02291601|11827855|FG002|NOT COMPLETED|Groin||177
10665712|NCT02291614|11827877|FG000|STARTED|Overall Study||3
10665713|NCT02291614|11827878|FG001|STARTED|Overall Study||3
10665714|NCT02291614|11827879|FG002|STARTED|Overall Study||3
10665715|NCT02291614|11827880|FG003|STARTED|Overall Study||5
10665716|NCT02291614|11827881|FG004|STARTED|Overall Study||3
10665717|NCT02291614|11827882|FG005|STARTED|Overall Study||3
10665718|NCT02291614|11827883|FG006|STARTED|Overall Study||6
10665719|NCT02291614|11827884|FG007|STARTED|Overall Study||3
10665720|NCT02291614|11827885|FG008|STARTED|Overall Study||3
10665721|NCT02291614|11827886|FG009|STARTED|Overall Study||11
10665722|NCT02291614|11827887|FG010|STARTED|Overall Study||2
10665723|NCT02291614|11827877|FG000|Received AMG 211|Overall Study||3
10665724|NCT02291614|11827878|FG001|Received AMG 211|Overall Study||3
10665725|NCT02291614|11827879|FG002|Received AMG 211|Overall Study||3
10665726|NCT02291614|11827880|FG003|Received AMG 211|Overall Study||5
10665727|NCT02291614|11827881|FG004|Received AMG 211|Overall Study||3
10665728|NCT02291614|11827882|FG005|Received AMG 211|Overall Study||3
10665729|NCT02291614|11827883|FG006|Received AMG 211|Overall Study||6
10665730|NCT02291614|11827884|FG007|Received AMG 211|Overall Study||3
10665731|NCT02291614|11827885|FG008|Received AMG 211|Overall Study||3
10665732|NCT02291614|11827886|FG009|Received AMG 211|Overall Study||10
10665733|NCT02291614|11827887|FG010|Received AMG 211|Overall Study||2
10665734|NCT02291614|11827877|FG000|COMPLETED|Overall Study||3
10665735|NCT02291614|11827878|FG001|COMPLETED|Overall Study||2
10665736|NCT02291614|11827879|FG002|COMPLETED|Overall Study||2
10795767|NCT03645434|11956031|FG002|NOT COMPLETED|Period 3||0
10795768|NCT03645434|11956032|FG003|NOT COMPLETED|Period 3||0
10795769|NCT03645434|11956033|FG004|NOT COMPLETED|Period 3||0
10795770|NCT03645434|11956034|FG005|NOT COMPLETED|Period 3||0
10665737|NCT02291614|11827880|FG003|COMPLETED|Overall Study||4
10665738|NCT02291614|11827881|FG004|COMPLETED|Overall Study||2
10665739|NCT02291614|11827882|FG005|COMPLETED|Overall Study||2
10665740|NCT02291614|11827883|FG006|COMPLETED|Overall Study||5
10665741|NCT02291614|11827884|FG007|COMPLETED|Overall Study||2
10665742|NCT02291614|11827885|FG008|COMPLETED|Overall Study||3
10665743|NCT02291614|11827886|FG009|COMPLETED|Overall Study||9
10665744|NCT02291614|11827887|FG010|COMPLETED|Overall Study||0
10665745|NCT02291614|11827877|FG000|NOT COMPLETED|Overall Study||0
10665746|NCT02291614|11827878|FG001|NOT COMPLETED|Overall Study||1
10665747|NCT02291614|11827879|FG002|NOT COMPLETED|Overall Study||1
10665748|NCT02291614|11827880|FG003|NOT COMPLETED|Overall Study||1
10665749|NCT02291614|11827881|FG004|NOT COMPLETED|Overall Study||1
10665750|NCT02291614|11827882|FG005|NOT COMPLETED|Overall Study||1
10665751|NCT02291614|11827883|FG006|NOT COMPLETED|Overall Study||1
10665752|NCT02291614|11827884|FG007|NOT COMPLETED|Overall Study||1
10665753|NCT02291614|11827885|FG008|NOT COMPLETED|Overall Study||0
10665754|NCT02291614|11827886|FG009|NOT COMPLETED|Overall Study||2
10665755|NCT02291614|11827887|FG010|NOT COMPLETED|Overall Study||2
10665756|NCT02291679|11827920|FG000|STARTED|Overall Study||401
10665757|NCT02291679|11827921|FG001|STARTED|Overall Study||411
10665758|NCT02291679|11827922|FG002|STARTED|Overall Study||411
10665759|NCT02291679|11827920|FG000|COMPLETED|Overall Study||357
10665760|NCT02291679|11827921|FG001|COMPLETED|Overall Study||369
10665761|NCT02291679|11827922|FG002|COMPLETED|Overall Study||352
10665762|NCT02291679|11827920|FG000|NOT COMPLETED|Overall Study||44
10665763|NCT02291679|11827921|FG001|NOT COMPLETED|Overall Study||42
10665764|NCT02291679|11827922|FG002|NOT COMPLETED|Overall Study||59
10665765|NCT02291718|11827932|FG000|STARTED|Overall Study||50
10665766|NCT02291718|11827933|FG001|STARTED|Overall Study||50
10665767|NCT02291718|11827934|FG002|STARTED|Overall Study||50
10665768|NCT02291718|11827932|FG000|COMPLETED|Overall Study||50
10665769|NCT02291718|11827933|FG001|COMPLETED|Overall Study||50
10665770|NCT02291718|11827934|FG002|COMPLETED|Overall Study||50
10665771|NCT02291718|11827932|FG000|NOT COMPLETED|Overall Study||0
10665772|NCT02291718|11827933|FG001|NOT COMPLETED|Overall Study||0
10665773|NCT02291718|11827934|FG002|NOT COMPLETED|Overall Study||0
10665774|NCT02291861|11827946|FG000|STARTED|Overall Study||74
10665775|NCT02291861|11827947|FG001|STARTED|Overall Study||75
10665776|NCT02291861|11827948|FG002|STARTED|Overall Study||74
10665777|NCT02291861|11827949|FG003|STARTED|Overall Study||75
10665778|NCT02291861|11827946|FG000|Safety Population|Overall Study||72
10665779|NCT02291861|11827947|FG001|Safety Population|Overall Study||74
10665780|NCT02291861|11827948|FG002|Safety Population|Overall Study||73
10665781|NCT02291861|11827949|FG003|Safety Population|Overall Study||74
10665782|NCT02291861|11827946|FG000|Modified Intent to Treat Pop (mITT)|Overall Study||58
10665783|NCT02291861|11827947|FG001|Modified Intent to Treat Pop (mITT)|Overall Study||60
10665784|NCT02291861|11827948|FG002|Modified Intent to Treat Pop (mITT)|Overall Study||49
10665785|NCT02291861|11827949|FG003|Modified Intent to Treat Pop (mITT)|Overall Study||55
10665786|NCT02291861|11827946|FG000|COMPLETED|Overall Study||67
10665787|NCT02291861|11827947|FG001|COMPLETED|Overall Study||67
10665788|NCT02291861|11827948|FG002|COMPLETED|Overall Study||65
10665789|NCT02291861|11827949|FG003|COMPLETED|Overall Study||65
10665790|NCT02291861|11827946|FG000|NOT COMPLETED|Overall Study||7
10665791|NCT02291861|11827947|FG001|NOT COMPLETED|Overall Study||8
10665792|NCT02291861|11827948|FG002|NOT COMPLETED|Overall Study||9
10665793|NCT02291861|11827949|FG003|NOT COMPLETED|Overall Study||10
10665794|NCT02291913|11827959|FG000|STARTED|Overall Study||48
10665795|NCT02291913|11827959|FG000|COMPLETED|Overall Study||0
10665796|NCT02291913|11827959|FG000|NOT COMPLETED|Overall Study||48
10665797|NCT02292082|11827965|FG000|STARTED|Overall Study||56
10665798|NCT02292082|11827966|FG001|STARTED|Overall Study||55
10665799|NCT02292082|11827965|FG000|COMPLETED|Overall Study||56
10665800|NCT02292082|11827966|FG001|COMPLETED|Overall Study||55
10665801|NCT02292082|11827965|FG000|NOT COMPLETED|Overall Study||0
10665802|NCT02292082|11827966|FG001|NOT COMPLETED|Overall Study||0
10665803|NCT02292186|11827972|FG000|STARTED|Overall Study||25
10665804|NCT02292186|11827972|FG000|COMPLETED|Overall Study||7
10665805|NCT02292186|11827972|FG000|NOT COMPLETED|Overall Study||18
10665806|NCT02292212|11827976|FG000|STARTED|Pre-ViE Phase||17
10665807|NCT02292212|11827976|FG000|COMPLETED|Pre-ViE Phase||17
10665808|NCT02292212|11827976|FG000|NOT COMPLETED|Pre-ViE Phase||0
10665809|NCT02292212|11827976|FG000|STARTED|ViE Phase||17
10665810|NCT02292212|11827976|FG000|COMPLETED|ViE Phase||14
10665811|NCT02292212|11827976|FG000|NOT COMPLETED|ViE Phase||3
10665812|NCT02292212|11827976|FG000|STARTED|Post-ViE Phase||14
10665813|NCT02292212|11827976|FG000|COMPLETED|Post-ViE Phase||14
10665814|NCT02292212|11827976|FG000|NOT COMPLETED|Post-ViE Phase||0
10665815|NCT02292433|11827990|FG000|STARTED|First Intervention Period (7 Days)||4
10665816|NCT02292433|11827991|FG001|STARTED|First Intervention Period (7 Days)||4
10665817|NCT02292433|11827992|FG002|STARTED|First Intervention Period (7 Days)||4
10665818|NCT02292433|11827990|FG000|COMPLETED|First Intervention Period (7 Days)||4
10665819|NCT02292433|11827991|FG001|COMPLETED|First Intervention Period (7 Days)||4
10665820|NCT02292433|11827992|FG002|COMPLETED|First Intervention Period (7 Days)||4
10665821|NCT02292433|11827990|FG000|NOT COMPLETED|First Intervention Period (7 Days)||0
10665822|NCT02292433|11827991|FG001|NOT COMPLETED|First Intervention Period (7 Days)||0
10665823|NCT02292433|11827992|FG002|NOT COMPLETED|First Intervention Period (7 Days)||0
10665824|NCT02292433|11827990|FG000|STARTED|First Washout Period (7 to 14 Days)||4
10665825|NCT02292433|11827991|FG001|STARTED|First Washout Period (7 to 14 Days)||4
10665826|NCT02292433|11827992|FG002|STARTED|First Washout Period (7 to 14 Days)||4
10665827|NCT02292433|11827990|FG000|COMPLETED|First Washout Period (7 to 14 Days)||4
10665828|NCT02292433|11827991|FG001|COMPLETED|First Washout Period (7 to 14 Days)||4
10665914|NCT02292927|11828083|FG001|STARTED|Overall Study||12
10665829|NCT02292433|11827992|FG002|COMPLETED|First Washout Period (7 to 14 Days)||4
10665830|NCT02292433|11827990|FG000|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
10665831|NCT02292433|11827991|FG001|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
10665832|NCT02292433|11827992|FG002|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
10665833|NCT02292433|11827990|FG000|STARTED|Second Intervention Period (7 Days)||4
10665834|NCT02292433|11827991|FG001|STARTED|Second Intervention Period (7 Days)||4
10665835|NCT02292433|11827992|FG002|STARTED|Second Intervention Period (7 Days)||4
10665836|NCT02292433|11827990|FG000|COMPLETED|Second Intervention Period (7 Days)||4
10665837|NCT02292433|11827991|FG001|COMPLETED|Second Intervention Period (7 Days)||4
10665838|NCT02292433|11827992|FG002|COMPLETED|Second Intervention Period (7 Days)||4
10665839|NCT02292433|11827990|FG000|NOT COMPLETED|Second Intervention Period (7 Days)||0
10665840|NCT02292433|11827991|FG001|NOT COMPLETED|Second Intervention Period (7 Days)||0
10665841|NCT02292433|11827992|FG002|NOT COMPLETED|Second Intervention Period (7 Days)||0
10665842|NCT02292433|11827990|FG000|STARTED|Second Washout Period (7 to 14 Days)||4
10665843|NCT02292433|11827991|FG001|STARTED|Second Washout Period (7 to 14 Days)||4
10665844|NCT02292433|11827992|FG002|STARTED|Second Washout Period (7 to 14 Days)||4
10665845|NCT02292433|11827990|FG000|COMPLETED|Second Washout Period (7 to 14 Days)||4
10665846|NCT02292433|11827991|FG001|COMPLETED|Second Washout Period (7 to 14 Days)||4
10665847|NCT02292433|11827992|FG002|COMPLETED|Second Washout Period (7 to 14 Days)||4
10665848|NCT02292433|11827990|FG000|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
10665849|NCT02292433|11827991|FG001|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
10665850|NCT02292433|11827992|FG002|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
10665851|NCT02292433|11827990|FG000|STARTED|Third Intervention Period (7 Days)||4
10665852|NCT02292433|11827991|FG001|STARTED|Third Intervention Period (7 Days)||4
10665853|NCT02292433|11827992|FG002|STARTED|Third Intervention Period (7 Days)||4
10665854|NCT02292433|11827990|FG000|COMPLETED|Third Intervention Period (7 Days)||4
10665855|NCT02292433|11827991|FG001|COMPLETED|Third Intervention Period (7 Days)||4
10665856|NCT02292433|11827992|FG002|COMPLETED|Third Intervention Period (7 Days)||4
10665857|NCT02292433|11827990|FG000|NOT COMPLETED|Third Intervention Period (7 Days)||0
10665858|NCT02292433|11827991|FG001|NOT COMPLETED|Third Intervention Period (7 Days)||0
10665859|NCT02292433|11827992|FG002|NOT COMPLETED|Third Intervention Period (7 Days)||0
10665860|NCT02292446|11828000|FG000|STARTED|Overall Study||161
10665861|NCT02292446|11828000|FG000|COMPLETED|Overall Study||141
10665862|NCT02292446|11828000|FG000|NOT COMPLETED|Overall Study||20
10665863|NCT02292537|11828009|FG000|STARTED|Overall Study||42
10665864|NCT02292537|11828010|FG001|STARTED|Overall Study||84
10665865|NCT02292537|11828009|FG000|Completed Treatment|Overall Study||42
10665866|NCT02292537|11828010|FG001|Completed Treatment|Overall Study|1 participant completed the study but did not complete treatments due to early study closure|83
10665867|NCT02292537|11828009|FG000|COMPLETED|Overall Study||42
10665868|NCT02292537|11828010|FG001|COMPLETED|Overall Study||84
10665869|NCT02292537|11828009|FG000|NOT COMPLETED|Overall Study||0
10665870|NCT02292537|11828010|FG001|NOT COMPLETED|Overall Study||0
10665871|NCT02292719|11828022|FG000|STARTED|Overall Study||9
10665872|NCT02292719|11828023|FG001|STARTED|Overall Study||11
10665873|NCT02292719|11828024|FG002|STARTED|Overall Study||10
10665874|NCT02292719|11828025|FG003|STARTED|Overall Study||9
10665875|NCT02292719|11828026|FG004|STARTED|Overall Study||21
10665876|NCT02292719|11828027|FG005|STARTED|Overall Study||10
10665877|NCT02292719|11828022|FG000|COMPLETED|Overall Study||9
10665878|NCT02292719|11828023|FG001|COMPLETED|Overall Study||11
10665879|NCT02292719|11828024|FG002|COMPLETED|Overall Study||9
10665880|NCT02292719|11828025|FG003|COMPLETED|Overall Study||8
10665881|NCT02292719|11828026|FG004|COMPLETED|Overall Study||20
10665882|NCT02292719|11828027|FG005|COMPLETED|Overall Study||10
10665883|NCT02292719|11828022|FG000|NOT COMPLETED|Overall Study||0
10665884|NCT02292719|11828023|FG001|NOT COMPLETED|Overall Study||0
10665885|NCT02292719|11828024|FG002|NOT COMPLETED|Overall Study||1
10665886|NCT02292719|11828025|FG003|NOT COMPLETED|Overall Study||1
10665887|NCT02292719|11828026|FG004|NOT COMPLETED|Overall Study||1
10665888|NCT02292719|11828027|FG005|NOT COMPLETED|Overall Study||0
10665889|NCT02292771|11828043|FG000|STARTED|Overall Study||47
10665890|NCT02292771|11828044|FG001|STARTED|Overall Study||50
10665891|NCT02292771|11828043|FG000|COMPLETED|Overall Study||43
10665892|NCT02292771|11828044|FG001|COMPLETED|Overall Study||48
10665893|NCT02292771|11828043|FG000|NOT COMPLETED|Overall Study||4
10665894|NCT02292771|11828044|FG001|NOT COMPLETED|Overall Study||2
10665895|NCT02292784|11828057|FG000|STARTED|Overall Study||5
10665896|NCT02292784|11828058|FG001|STARTED|Overall Study||44
10665897|NCT02292784|11828059|FG002|STARTED|Overall Study||49
10665898|NCT02292784|11828057|FG000|COMPLETED|Overall Study||4
10665899|NCT02292784|11828058|FG001|COMPLETED|Overall Study||24
10665900|NCT02292784|11828059|FG002|COMPLETED|Overall Study||28
10665901|NCT02292784|11828057|FG000|NOT COMPLETED|Overall Study||1
10665902|NCT02292784|11828058|FG001|NOT COMPLETED|Overall Study||20
10665903|NCT02292784|11828059|FG002|NOT COMPLETED|Overall Study||21
10665904|NCT02292849|11828070|FG000|STARTED|Overall Study||11
10665905|NCT02292849|11828071|FG001|STARTED|Overall Study||8
10665906|NCT02292849|11828072|FG002|STARTED|Overall Study||10
10665907|NCT02292849|11828070|FG000|COMPLETED|Overall Study||7
10665908|NCT02292849|11828071|FG001|COMPLETED|Overall Study||6
10665909|NCT02292849|11828072|FG002|COMPLETED|Overall Study||8
10665910|NCT02292849|11828070|FG000|NOT COMPLETED|Overall Study||4
10665911|NCT02292849|11828071|FG001|NOT COMPLETED|Overall Study||2
10665912|NCT02292849|11828072|FG002|NOT COMPLETED|Overall Study||2
10665913|NCT02292927|11828082|FG000|STARTED|Overall Study||13
10665915|NCT02292927|11828082|FG000|COMPLETED|Overall Study||0
10665916|NCT02292927|11828083|FG001|COMPLETED|Overall Study||5
10665917|NCT02292927|11828082|FG000|NOT COMPLETED|Overall Study||13
10665918|NCT02292927|11828083|FG001|NOT COMPLETED|Overall Study||7
10665919|NCT02292940|11828094|FG000|STARTED|Overall Study||165477
10665920|NCT02292940|11828095|FG001|STARTED|Overall Study||3000
10665921|NCT02292940|11828094|FG000|COMPLETED|Overall Study||165477
10665922|NCT02292940|11828095|FG001|COMPLETED|Overall Study||1824
10665923|NCT02292940|11828094|FG000|NOT COMPLETED|Overall Study||0
10665924|NCT02292940|11828095|FG001|NOT COMPLETED|Overall Study||1176
10665925|NCT02293044|11828102|FG000|STARTED|Overall Study||15
10665926|NCT02293044|11828102|FG000|COMPLETED|Overall Study||15
10665927|NCT02293044|11828102|FG000|NOT COMPLETED|Overall Study||0
10665928|NCT02293096|11828106|FG000|STARTED|Overall Study||140
10665929|NCT02293096|11828106|FG000|COMPLETED|Overall Study||140
10665930|NCT02293096|11828106|FG000|NOT COMPLETED|Overall Study||0
10665931|NCT02293395|11828112|FG000|STARTED|Overall Study||1519
10665932|NCT02293395|11828113|FG001|STARTED|Overall Study||1518
10665933|NCT02293395|11828112|FG000|Treated|Overall Study||1510
10665934|NCT02293395|11828113|FG001|Treated|Overall Study||1506
10665935|NCT02293395|11828112|FG000|COMPLETED|Overall Study||1510
10665936|NCT02293395|11828113|FG001|COMPLETED|Overall Study||1511
10665937|NCT02293395|11828112|FG000|NOT COMPLETED|Overall Study||9
10665938|NCT02293395|11828113|FG001|NOT COMPLETED|Overall Study||7
10665939|NCT02293460|11828119|FG000|STARTED|Overall Study||43
10665940|NCT02293460|11828119|FG000|COMPLETED|Overall Study||37
10665941|NCT02293460|11828119|FG000|NOT COMPLETED|Overall Study||6
10665942|NCT02293499|11828126|FG000|STARTED|Baseline - Enrollment||152
10665943|NCT02293499|11828127|FG001|STARTED|Baseline - Enrollment||168
10665944|NCT02293499|11828128|FG002|STARTED|Baseline - Enrollment||51
10665945|NCT02293499|11828126|FG000|COMPLETED|Baseline - Enrollment||152
10665946|NCT02293499|11828127|FG001|COMPLETED|Baseline - Enrollment||168
10665947|NCT02293499|11828128|FG002|COMPLETED|Baseline - Enrollment||51
10665948|NCT02293499|11828126|FG000|NOT COMPLETED|Baseline - Enrollment||0
10665949|NCT02293499|11828127|FG001|NOT COMPLETED|Baseline - Enrollment||0
10665950|NCT02293499|11828128|FG002|NOT COMPLETED|Baseline - Enrollment||0
10665951|NCT02293499|11828126|FG000|STARTED|Training - Peer Leaders Only|Participant number carried over from previous time point.|0
10665952|NCT02293499|11828127|FG001|STARTED|Training - Peer Leaders Only|Participant number carried over from previous time point.|0
10665953|NCT02293499|11828128|FG002|STARTED|Training - Peer Leaders Only||51
10665954|NCT02293499|11828126|FG000|COMPLETED|Training - Peer Leaders Only||0
10665955|NCT02293499|11828127|FG001|COMPLETED|Training - Peer Leaders Only||0
10795771|NCT03645785|11956042|FG000|STARTED|Day 1 (Normal Fluid Intake and Diet)||23
10795772|NCT03645785|11956042|FG000|COMPLETED|Day 1 (Normal Fluid Intake and Diet)||23
10795773|NCT03645785|11956042|FG000|NOT COMPLETED|Day 1 (Normal Fluid Intake and Diet)||0
10795774|NCT03645785|11956042|FG000|STARTED|Day 2-4 (Double Fluid and Add Citrate)||23
10795775|NCT03645785|11956042|FG000|COMPLETED|Day 2-4 (Double Fluid and Add Citrate)||23
10665956|NCT02293499|11828128|FG002|COMPLETED|Training - Peer Leaders Only||41
10665957|NCT02293499|11828126|FG000|NOT COMPLETED|Training - Peer Leaders Only||0
10665958|NCT02293499|11828127|FG001|NOT COMPLETED|Training - Peer Leaders Only||0
10665959|NCT02293499|11828128|FG002|NOT COMPLETED|Training - Peer Leaders Only||10
10665960|NCT02293499|11828126|FG000|STARTED|Intervention - Camp|By design, they did not participate in the previous period.|152
10665961|NCT02293499|11828127|FG001|STARTED|Intervention - Camp|By design, they did not participate in the previous period.|168
10665962|NCT02293499|11828128|FG002|STARTED|Intervention - Camp||41
10665963|NCT02293499|11828126|FG000|COMPLETED|Intervention - Camp||125
10665964|NCT02293499|11828127|FG001|COMPLETED|Intervention - Camp||134
10665965|NCT02293499|11828128|FG002|COMPLETED|Intervention - Camp||35
10665966|NCT02293499|11828126|FG000|NOT COMPLETED|Intervention - Camp||27
10665967|NCT02293499|11828127|FG001|NOT COMPLETED|Intervention - Camp||34
10665968|NCT02293499|11828128|FG002|NOT COMPLETED|Intervention - Camp||6
10665969|NCT02293499|11828126|FG000|STARTED|3 Month Follow Up||149
10665970|NCT02293499|11828127|FG001|STARTED|3 Month Follow Up||162
10665971|NCT02293499|11828128|FG002|STARTED|3 Month Follow Up||39
10665972|NCT02293499|11828126|FG000|COMPLETED|3 Month Follow Up||134
10665973|NCT02293499|11828127|FG001|COMPLETED|3 Month Follow Up||147
10665974|NCT02293499|11828128|FG002|COMPLETED|3 Month Follow Up||29
10665975|NCT02293499|11828126|FG000|NOT COMPLETED|3 Month Follow Up||15
10665976|NCT02293499|11828127|FG001|NOT COMPLETED|3 Month Follow Up||15
10665977|NCT02293499|11828128|FG002|NOT COMPLETED|3 Month Follow Up||10
10665978|NCT02293499|11828126|FG000|STARTED|6 Month Follow Up||148
10665979|NCT02293499|11828127|FG001|STARTED|6 Month Follow Up||162
10665980|NCT02293499|11828128|FG002|STARTED|6 Month Follow Up||35
10665981|NCT02293499|11828126|FG000|COMPLETED|6 Month Follow Up||131
10665982|NCT02293499|11828127|FG001|COMPLETED|6 Month Follow Up||135
10665983|NCT02293499|11828128|FG002|COMPLETED|6 Month Follow Up||28
10665984|NCT02293499|11828126|FG000|NOT COMPLETED|6 Month Follow Up||17
10665985|NCT02293499|11828127|FG001|NOT COMPLETED|6 Month Follow Up||27
10665986|NCT02293499|11828128|FG002|NOT COMPLETED|6 Month Follow Up||7
10665987|NCT02293499|11828126|FG000|STARTED|9 Month Follow Up||148
10665988|NCT02293499|11828127|FG001|STARTED|9 Month Follow Up||162
10665989|NCT02293499|11828128|FG002|STARTED|9 Month Follow Up||34
10665990|NCT02293499|11828126|FG000|COMPLETED|9 Month Follow Up||122
10665991|NCT02293499|11828127|FG001|COMPLETED|9 Month Follow Up||134
10665992|NCT02293499|11828128|FG002|COMPLETED|9 Month Follow Up||30
10665993|NCT02293499|11828126|FG000|NOT COMPLETED|9 Month Follow Up||26
10665994|NCT02293499|11828127|FG001|NOT COMPLETED|9 Month Follow Up||28
10665995|NCT02293499|11828128|FG002|NOT COMPLETED|9 Month Follow Up||4
10665996|NCT02293499|11828126|FG000|STARTED|12 Month Follow Up||146
10665997|NCT02293499|11828127|FG001|STARTED|12 Month Follow Up||162
10665998|NCT02293499|11828128|FG002|STARTED|12 Month Follow Up||34
10665999|NCT02293499|11828126|FG000|COMPLETED|12 Month Follow Up||120
10666000|NCT02293499|11828127|FG001|COMPLETED|12 Month Follow Up||136
10666001|NCT02293499|11828128|FG002|COMPLETED|12 Month Follow Up||28
10666002|NCT02293499|11828126|FG000|NOT COMPLETED|12 Month Follow Up||26
10666003|NCT02293499|11828127|FG001|NOT COMPLETED|12 Month Follow Up||26
10666004|NCT02293499|11828128|FG002|NOT COMPLETED|12 Month Follow Up||6
10666005|NCT02293499|11828126|FG000|STARTED|15 Month Follow Up||146
10666006|NCT02293499|11828127|FG001|STARTED|15 Month Follow Up||161
10666007|NCT02293499|11828128|FG002|STARTED|15 Month Follow Up||34
10666008|NCT02293499|11828126|FG000|COMPLETED|15 Month Follow Up||124
10666009|NCT02293499|11828127|FG001|COMPLETED|15 Month Follow Up||139
10666010|NCT02293499|11828128|FG002|COMPLETED|15 Month Follow Up||27
10666011|NCT02293499|11828126|FG000|NOT COMPLETED|15 Month Follow Up||22
10666012|NCT02293499|11828127|FG001|NOT COMPLETED|15 Month Follow Up||22
10666013|NCT02293499|11828128|FG002|NOT COMPLETED|15 Month Follow Up||7
10666014|NCT02293512|11828141|FG000|STARTED|Overall Study||10
10666015|NCT02293512|11828142|FG001|STARTED|Overall Study||10
10666016|NCT02293512|11828143|FG002|STARTED|Overall Study||10
10666017|NCT02293512|11828144|FG003|STARTED|Overall Study||10
10666018|NCT02293512|11828141|FG000|COMPLETED|Overall Study||6
10666019|NCT02293512|11828142|FG001|COMPLETED|Overall Study||4
10666020|NCT02293512|11828143|FG002|COMPLETED|Overall Study||7
10666021|NCT02293512|11828144|FG003|COMPLETED|Overall Study||8
10666022|NCT02293512|11828141|FG000|NOT COMPLETED|Overall Study||4
10666023|NCT02293512|11828142|FG001|NOT COMPLETED|Overall Study||6
10666024|NCT02293512|11828143|FG002|NOT COMPLETED|Overall Study||3
10666025|NCT02293512|11828144|FG003|NOT COMPLETED|Overall Study||2
10666026|NCT02293538|11828156|FG000|STARTED|Overall Study||73
10666027|NCT02293538|11828157|FG001|STARTED|Overall Study||71
10666028|NCT02293538|11828156|FG000|COMPLETED|Overall Study||72
10666029|NCT02293538|11828157|FG001|COMPLETED|Overall Study||69
10666030|NCT02293538|11828156|FG000|NOT COMPLETED|Overall Study||1
10666031|NCT02293538|11828157|FG001|NOT COMPLETED|Overall Study||2
10666032|NCT02293798|11828164|FG000|STARTED|Overall Study|2 units of SERI Mesh placed in each patient|13
10666033|NCT02293798|11828164|FG000|COMPLETED|Overall Study|2 units of SERI Mesh placed in each patient|13
10666034|NCT02293798|11828164|FG000|NOT COMPLETED|Overall Study||0
10666035|NCT02293837|11828172|FG000|STARTED|Overall Study||54
10666036|NCT02293837|11828173|FG001|STARTED|Overall Study||27
10666037|NCT02293837|11828174|FG002|STARTED|Overall Study|1 randomized adult was never treated|35
10666038|NCT02293837|11828175|FG003|STARTED|Overall Study||20
10666039|NCT02293837|11828172|FG000|COMPLETED|Overall Study||51
10666040|NCT02293837|11828173|FG001|COMPLETED|Overall Study||23
10666041|NCT02293837|11828174|FG002|COMPLETED|Overall Study||31
10666042|NCT02293837|11828175|FG003|COMPLETED|Overall Study||19
10666043|NCT02293837|11828172|FG000|NOT COMPLETED|Overall Study||3
10666044|NCT02293837|11828173|FG001|NOT COMPLETED|Overall Study||4
10666045|NCT02293837|11828174|FG002|NOT COMPLETED|Overall Study||4
10666046|NCT02293837|11828175|FG003|NOT COMPLETED|Overall Study||1
10666047|NCT02293863|11828192|FG000|STARTED|Overall Study||56
10666048|NCT02293863|11828193|FG001|STARTED|Overall Study||55
10666049|NCT02293863|11828194|FG002|STARTED|Overall Study||47
10666050|NCT02293863|11828192|FG000|COMPLETED|Overall Study||47
10666051|NCT02293863|11828193|FG001|COMPLETED|Overall Study||42
10666052|NCT02293863|11828194|FG002|COMPLETED|Overall Study||38
10666053|NCT02293863|11828192|FG000|NOT COMPLETED|Overall Study||9
10666054|NCT02293863|11828193|FG001|NOT COMPLETED|Overall Study||13
10666055|NCT02293863|11828194|FG002|NOT COMPLETED|Overall Study||9
10666056|NCT02293902|11828207|FG000|STARTED|Double-Blind Period (Up to Week 24)||82
10666057|NCT02293902|11828208|FG001|STARTED|Double-Blind Period (Up to Week 24)||81
10666058|NCT02293902|11828209|FG002|STARTED|Double-Blind Period (Up to Week 24)||80
10666059|NCT02293902|11828210|FG003|STARTED|Double-Blind Period (Up to Week 24)||0
10666060|NCT02293902|11828211|FG004|STARTED|Double-Blind Period (Up to Week 24)||0
10666061|NCT02293902|11828207|FG000|Treated|Double-Blind Period (Up to Week 24)||81
10666062|NCT02293902|11828208|FG001|Treated|Double-Blind Period (Up to Week 24)||81
10666063|NCT02293902|11828209|FG002|Treated|Double-Blind Period (Up to Week 24)||80
10666064|NCT02293902|11828210|FG003|Treated|Double-Blind Period (Up to Week 24)||0
10666065|NCT02293902|11828211|FG004|Treated|Double-Blind Period (Up to Week 24)||0
10666066|NCT02293902|11828207|FG000|Rescued|Double-Blind Period (Up to Week 24)||44
10666067|NCT02293902|11828208|FG001|Rescued|Double-Blind Period (Up to Week 24)||6
10666068|NCT02293902|11828209|FG002|Rescued|Double-Blind Period (Up to Week 24)||8
10666069|NCT02293902|11828210|FG003|Rescued|Double-Blind Period (Up to Week 24)||0
10666070|NCT02293902|11828211|FG004|Rescued|Double-Blind Period (Up to Week 24)||0
10666071|NCT02293902|11828207|FG000|COMPLETED|Double-Blind Period (Up to Week 24)|42 rescued and 29 not rescued completed.|71
10666072|NCT02293902|11828208|FG001|COMPLETED|Double-Blind Period (Up to Week 24)|6 rescued and 68 not rescued completed.|74
10666073|NCT02293902|11828209|FG002|COMPLETED|Double-Blind Period (Up to Week 24)|8 rescued and 62 not rescued completed.|70
10666074|NCT02293902|11828210|FG003|COMPLETED|Double-Blind Period (Up to Week 24)||0
10666075|NCT02293902|11828211|FG004|COMPLETED|Double-Blind Period (Up to Week 24)||0
10666076|NCT02293902|11828207|FG000|NOT COMPLETED|Double-Blind Period (Up to Week 24)||11
10666077|NCT02293902|11828208|FG001|NOT COMPLETED|Double-Blind Period (Up to Week 24)||7
10666078|NCT02293902|11828209|FG002|NOT COMPLETED|Double-Blind Period (Up to Week 24)||10
10666079|NCT02293902|11828210|FG003|NOT COMPLETED|Double-Blind Period (Up to Week 24)||0
10666080|NCT02293902|11828211|FG004|NOT COMPLETED|Double-Blind Period (Up to Week 24)||0
10666081|NCT02293902|11828207|FG000|STARTED|Single-Blind Period (Week 25 to Week 52)||0
10666082|NCT02293902|11828208|FG001|STARTED|Single-Blind Period (Week 25 to Week 52)|68 participants not rescued continued same treatment and 6 rescued continued open label treatment.|74
10666083|NCT02293902|11828209|FG002|STARTED|Single-Blind Period (Week 25 to Week 52)|62 participants not rescued continued same treatment and 8 rescued continued open label treatment.|70
10666084|NCT02293902|11828210|FG003|STARTED|Single-Blind Period (Week 25 to Week 52)|14 participants not rescued were switched and 20 rescued continued open label treatment.|34
10666085|NCT02293902|11828211|FG004|STARTED|Single-Blind Period (Week 25 to Week 52)|15 participants not rescued were switched and 22 rescued continued open label treatment.|37
10666086|NCT02293902|11828207|FG000|COMPLETED|Single-Blind Period (Week 25 to Week 52)||0
10666087|NCT02293902|11828208|FG001|COMPLETED|Single-Blind Period (Week 25 to Week 52)|5 rescued and 61 not rescued completed.|66
10666088|NCT02293902|11828209|FG002|COMPLETED|Single-Blind Period (Week 25 to Week 52)|8 rescued and 60 not rescued completed.|68
10666089|NCT02293902|11828210|FG003|COMPLETED|Single-Blind Period (Week 25 to Week 52)|20 rescued and 13 not rescued completed.|33
10666090|NCT02293902|11828211|FG004|COMPLETED|Single-Blind Period (Week 25 to Week 52)|18 rescued and 13 not rescued completed.|31
10666091|NCT02293902|11828207|FG000|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||0
10666092|NCT02293902|11828208|FG001|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||8
10666093|NCT02293902|11828209|FG002|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||2
10666094|NCT02293902|11828210|FG003|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||1
10666095|NCT02293902|11828211|FG004|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||6
10666096|NCT02293993|11828233|FG000|STARTED|Course 1 (DLT Evaluation Period)||4
10666097|NCT02293993|11828234|FG001|STARTED|Course 1 (DLT Evaluation Period)||6
10666098|NCT02293993|11828235|FG002|STARTED|Course 1 (DLT Evaluation Period)||7
10666099|NCT02293993|11828236|FG003|STARTED|Course 1 (DLT Evaluation Period)||4
10666100|NCT02293993|11828233|FG000|COMPLETED|Course 1 (DLT Evaluation Period)||3
10666101|NCT02293993|11828234|FG001|COMPLETED|Course 1 (DLT Evaluation Period)||6
10666102|NCT02293993|11828235|FG002|COMPLETED|Course 1 (DLT Evaluation Period)||7
10666103|NCT02293993|11828236|FG003|COMPLETED|Course 1 (DLT Evaluation Period)||3
10666104|NCT02293993|11828233|FG000|NOT COMPLETED|Course 1 (DLT Evaluation Period)||1
10666105|NCT02293993|11828234|FG001|NOT COMPLETED|Course 1 (DLT Evaluation Period)||0
10666106|NCT02293993|11828235|FG002|NOT COMPLETED|Course 1 (DLT Evaluation Period)||0
10666107|NCT02293993|11828236|FG003|NOT COMPLETED|Course 1 (DLT Evaluation Period)||1
10666108|NCT02293993|11828233|FG000|STARTED|Course ≥2 (Extended Treatment Period)||2
10666109|NCT02293993|11828234|FG001|STARTED|Course ≥2 (Extended Treatment Period)||5
10666110|NCT02293993|11828235|FG002|STARTED|Course ≥2 (Extended Treatment Period)||6
10666111|NCT02293993|11828236|FG003|STARTED|Course ≥2 (Extended Treatment Period)||3
10666112|NCT02293993|11828233|FG000|COMPLETED|Course ≥2 (Extended Treatment Period)||0
10666113|NCT02293993|11828234|FG001|COMPLETED|Course ≥2 (Extended Treatment Period)||0
10666114|NCT02293993|11828235|FG002|COMPLETED|Course ≥2 (Extended Treatment Period)||1
10666115|NCT02293993|11828236|FG003|COMPLETED|Course ≥2 (Extended Treatment Period)||2
10666116|NCT02293993|11828233|FG000|NOT COMPLETED|Course ≥2 (Extended Treatment Period)||2
10666117|NCT02293993|11828234|FG001|NOT COMPLETED|Course ≥2 (Extended Treatment Period)||5
10666118|NCT02293993|11828235|FG002|NOT COMPLETED|Course ≥2 (Extended Treatment Period)||5
10666119|NCT02293993|11828236|FG003|NOT COMPLETED|Course ≥2 (Extended Treatment Period)||1
10666120|NCT02294019|11828254|FG000|STARTED|Overall Study||738
10666121|NCT02294019|11828254|FG000|COMPLETED|Overall Study||635
10666122|NCT02294019|11828254|FG000|NOT COMPLETED|Overall Study||103
10666123|NCT02294058|11828261|FG000|STARTED|Overall Study||448
10666124|NCT02294058|11828262|FG001|STARTED|Overall Study||451
10666125|NCT02294058|11828263|FG002|STARTED|Overall Study||447
10666126|NCT02294058|11828261|FG000|Safety Population|Overall Study||445
10666127|NCT02294058|11828262|FG001|Safety Population|Overall Study||453
10666128|NCT02294058|11828263|FG002|Safety Population|Overall Study||448
10666129|NCT02294058|11828261|FG000|COMPLETED|Overall Study||412
10666130|NCT02294058|11828262|FG001|COMPLETED|Overall Study||425
10666131|NCT02294058|11828263|FG002|COMPLETED|Overall Study||418
10666132|NCT02294058|11828261|FG000|NOT COMPLETED|Overall Study||36
10666133|NCT02294058|11828262|FG001|NOT COMPLETED|Overall Study||26
10666134|NCT02294058|11828263|FG002|NOT COMPLETED|Overall Study||29
10666135|NCT02294175|11828274|FG000|STARTED|Overall Study||23
10666136|NCT02294175|11828275|FG001|STARTED|Overall Study||22
10666137|NCT02294175|11828274|FG000|COMPLETED|Overall Study||18
10666138|NCT02294175|11828275|FG001|COMPLETED|Overall Study||16
10666139|NCT02294175|11828274|FG000|NOT COMPLETED|Overall Study||5
10666140|NCT02294175|11828275|FG001|NOT COMPLETED|Overall Study||6
10666141|NCT02294227|11828284|FG000|STARTED|Overall Study||114
10666142|NCT02294227|11828285|FG001|STARTED|Overall Study||113
10666143|NCT02294227|11828286|FG002|STARTED|Overall Study||114
10666144|NCT02294227|11828284|FG000|COMPLETED|Overall Study||89
10666145|NCT02294227|11828285|FG001|COMPLETED|Overall Study||88
10666146|NCT02294227|11828286|FG002|COMPLETED|Overall Study||95
10666147|NCT02294227|11828284|FG000|NOT COMPLETED|Overall Study||25
10666148|NCT02294227|11828285|FG001|NOT COMPLETED|Overall Study||25
10666149|NCT02294227|11828286|FG002|NOT COMPLETED|Overall Study||19
10666150|NCT02294253|11828296|FG000|STARTED|Overall Study||30
10666151|NCT02294253|11828296|FG000|COMPLETED|Overall Study||15
10666152|NCT02294253|11828296|FG000|NOT COMPLETED|Overall Study||15
10666153|NCT02294318|11828302|FG000|STARTED|Overall Study||24
10666154|NCT02294318|11828303|FG001|STARTED|Overall Study||23
10666155|NCT02294318|11828302|FG000|COMPLETED|Overall Study||21
10666156|NCT02294318|11828303|FG001|COMPLETED|Overall Study||21
10666157|NCT02294318|11828302|FG000|NOT COMPLETED|Overall Study||3
10666158|NCT02294318|11828303|FG001|NOT COMPLETED|Overall Study||2
10666159|NCT02294396|11828313|FG000|STARTED|Overall Study||167
10666160|NCT02294396|11828314|FG001|STARTED|Overall Study||161
10795776|NCT03645785|11956042|FG000|NOT COMPLETED|Day 2-4 (Double Fluid and Add Citrate)||0
10795777|NCT03645811|11956061|FG000|STARTED|Overall Study||32
10795778|NCT03645811|11956062|FG001|STARTED|Overall Study||32
10795779|NCT03645811|11956063|FG002|STARTED|Overall Study||32
10795780|NCT03645811|11956061|FG000|COMPLETED|Overall Study||30
10795781|NCT03645811|11956062|FG001|COMPLETED|Overall Study||30
10795782|NCT03645811|11956063|FG002|COMPLETED|Overall Study||30
10795783|NCT03645811|11956061|FG000|NOT COMPLETED|Overall Study||2
10795784|NCT03645811|11956062|FG001|NOT COMPLETED|Overall Study||2
10666161|NCT02294396|11828315|FG002|STARTED|Overall Study||161
10666162|NCT02294396|11828316|FG003|STARTED|Overall Study||160
10666163|NCT02294396|11828313|FG000|COMPLETED|Overall Study||127
10666164|NCT02294396|11828314|FG001|COMPLETED|Overall Study||128
10795785|NCT03645811|11956063|FG002|NOT COMPLETED|Overall Study||2
10795786|NCT03645954|11956073|FG000|STARTED|Overall Study||40
10666165|NCT02294396|11828315|FG002|COMPLETED|Overall Study||126
10666166|NCT02294396|11828316|FG003|COMPLETED|Overall Study||123
10666167|NCT02294396|11828313|FG000|NOT COMPLETED|Overall Study||40
10666168|NCT02294396|11828314|FG001|NOT COMPLETED|Overall Study||33
10666169|NCT02294396|11828315|FG002|NOT COMPLETED|Overall Study||35
10666170|NCT02294396|11828316|FG003|NOT COMPLETED|Overall Study||37
10666171|NCT02294474|11828328|FG000|STARTED|Overall Study||253
10666172|NCT02294474|11828329|FG001|STARTED|Overall Study||252
10666173|NCT02294474|11828328|FG000|COMPLETED|Overall Study||228
10666174|NCT02294474|11828329|FG001|COMPLETED|Overall Study||230
10666175|NCT02294474|11828328|FG000|NOT COMPLETED|Overall Study||25
10666176|NCT02294474|11828329|FG001|NOT COMPLETED|Overall Study||22
10666177|NCT02294604|11828339|FG000|STARTED|Overall Study||80
10666178|NCT02294604|11828340|FG001|STARTED|Overall Study||80
10666179|NCT02294604|11828341|FG002|STARTED|Overall Study||80
10666180|NCT02294604|11828339|FG000|COMPLETED|Overall Study||79
10666181|NCT02294604|11828340|FG001|COMPLETED|Overall Study||77
10666182|NCT02294604|11828341|FG002|COMPLETED|Overall Study||80
10666183|NCT02294604|11828339|FG000|NOT COMPLETED|Overall Study||1
10666184|NCT02294604|11828340|FG001|NOT COMPLETED|Overall Study||3
10666185|NCT02294604|11828341|FG002|NOT COMPLETED|Overall Study||0
10666186|NCT02294630|11828353|FG000|STARTED|Overall Study||37
10666187|NCT02294630|11828354|FG001|STARTED|Overall Study||38
10666188|NCT02294630|11828355|FG002|STARTED|Overall Study||35
10666189|NCT02294630|11828356|FG003|STARTED|Overall Study||39
10795787|NCT03645954|11956074|FG001|STARTED|Overall Study||40
10795788|NCT03645954|11956073|FG000|COMPLETED|Overall Study||37
10795789|NCT03645954|11956074|FG001|COMPLETED|Overall Study||40
10795790|NCT03645954|11956073|FG000|NOT COMPLETED|Overall Study||3
10666190|NCT02294630|11828353|FG000|COMPLETED|Overall Study||37
10666191|NCT02294630|11828354|FG001|COMPLETED|Overall Study||38
10666192|NCT02294630|11828355|FG002|COMPLETED|Overall Study||35
10666193|NCT02294630|11828356|FG003|COMPLETED|Overall Study||39
10666194|NCT02294630|11828353|FG000|NOT COMPLETED|Overall Study||0
10666195|NCT02294630|11828354|FG001|NOT COMPLETED|Overall Study||0
10666196|NCT02294630|11828355|FG002|NOT COMPLETED|Overall Study||0
10666197|NCT02294630|11828356|FG003|NOT COMPLETED|Overall Study||0
10666198|NCT02294682|11828368|FG000|STARTED|Overall Study||53
10666199|NCT02294682|11828369|FG001|STARTED|Overall Study||53
10666200|NCT02294682|11828368|FG000|COMPLETED|Overall Study||52
10666201|NCT02294682|11828369|FG001|COMPLETED|Overall Study||53
10666202|NCT02294682|11828368|FG000|NOT COMPLETED|Overall Study||1
10666203|NCT02294682|11828369|FG001|NOT COMPLETED|Overall Study||0
10666204|NCT02294734|11828377|FG000|STARTED|Overall Study||63
10666205|NCT02294734|11828378|FG001|STARTED|Overall Study||63
10666206|NCT02294734|11828377|FG000|COMPLETED|Overall Study||49
10666207|NCT02294734|11828378|FG001|COMPLETED|Overall Study||55
10666208|NCT02294734|11828377|FG000|NOT COMPLETED|Overall Study||14
10666209|NCT02294734|11828378|FG001|NOT COMPLETED|Overall Study||8
10666210|NCT02294773|11828388|FG000|STARTED|Overall Study||7
10666211|NCT02294773|11828389|FG001|STARTED|Overall Study||6
10666212|NCT02294773|11828388|FG000|COMPLETED|Overall Study||7
10666213|NCT02294773|11828389|FG001|COMPLETED|Overall Study||4
10666214|NCT02294773|11828388|FG000|NOT COMPLETED|Overall Study||0
10666215|NCT02294773|11828389|FG001|NOT COMPLETED|Overall Study||2
10666216|NCT02294786|11828397|FG000|STARTED|Overall Study||30
10666217|NCT02294786|11828398|FG001|STARTED|Overall Study||32
10666218|NCT02294786|11828397|FG000|Safety Population|Overall Study|One subject randomized to Octreotide received only 0.1 mg dose.|29
10666219|NCT02294786|11828398|FG001|Safety Population|Overall Study|The subject was included in the No-Octreotide arm.|33
10666220|NCT02294786|11828397|FG000|ITT Population|Overall Study||30
10666221|NCT02294786|11828398|FG001|ITT Population|Overall Study||32
10666222|NCT02294786|11828397|FG000|COMPLETED|Overall Study||19
10666223|NCT02294786|11828398|FG001|COMPLETED|Overall Study||18
10666224|NCT02294786|11828397|FG000|NOT COMPLETED|Overall Study||11
10666225|NCT02294786|11828398|FG001|NOT COMPLETED|Overall Study||14
10666226|NCT02295020|11828407|FG000|STARTED|Overall Study||20
10666227|NCT02295020|11828408|FG001|STARTED|Overall Study||20
10666228|NCT02295020|11828407|FG000|COMPLETED|Overall Study||17
10666229|NCT02295020|11828408|FG001|COMPLETED|Overall Study||17
10666230|NCT02295020|11828407|FG000|NOT COMPLETED|Overall Study||3
10666231|NCT02295020|11828408|FG001|NOT COMPLETED|Overall Study||3
10666232|NCT02295280|11828422|FG000|STARTED|Overall Study||35
10666233|NCT02295280|11828423|FG001|STARTED|Overall Study||35
10666234|NCT02295280|11828422|FG000|COMPLETED|Overall Study||35
10666235|NCT02295280|11828423|FG001|COMPLETED|Overall Study||34
10666236|NCT02295280|11828422|FG000|NOT COMPLETED|Overall Study||0
10666237|NCT02295280|11828423|FG001|NOT COMPLETED|Overall Study||1
10666238|NCT02295553|11828433|FG000|STARTED|Overall Study||14
10666239|NCT02295553|11828434|FG001|STARTED|Overall Study||14
10666240|NCT02295553|11828435|FG002|STARTED|Overall Study||14
10666241|NCT02295553|11828436|FG003|STARTED|Overall Study||14
10666242|NCT02295553|11828433|FG000|COMPLETED|Overall Study||14
10666243|NCT02295553|11828434|FG001|COMPLETED|Overall Study||14
10666244|NCT02295553|11828435|FG002|COMPLETED|Overall Study||13
10666245|NCT02295553|11828436|FG003|COMPLETED|Overall Study||13
10666246|NCT02295553|11828433|FG000|NOT COMPLETED|Overall Study||0
10666247|NCT02295553|11828434|FG001|NOT COMPLETED|Overall Study||0
10666248|NCT02295553|11828435|FG002|NOT COMPLETED|Overall Study||1
10666249|NCT02295553|11828436|FG003|NOT COMPLETED|Overall Study||1
10666250|NCT02295644|11828450|FG000|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
10666251|NCT02295644|11828451|FG001|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
10666252|NCT02295644|11828452|FG002|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
10666253|NCT02295644|11828453|FG003|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
10666254|NCT02295644|11828450|FG000|COMPLETED|Overall Study||7
10666255|NCT02295644|11828451|FG001|COMPLETED|Overall Study||7
10666256|NCT02295644|11828452|FG002|COMPLETED|Overall Study||6
10666257|NCT02295644|11828453|FG003|COMPLETED|Overall Study||5
10666258|NCT02295644|11828450|FG000|NOT COMPLETED|Overall Study||0
10666259|NCT02295644|11828451|FG001|NOT COMPLETED|Overall Study||0
10666260|NCT02295644|11828452|FG002|NOT COMPLETED|Overall Study||1
10666261|NCT02295644|11828453|FG003|NOT COMPLETED|Overall Study||2
10666262|NCT02295735|11828465|FG000|STARTED|Overall Study||238
10666263|NCT02295735|11828466|FG001|STARTED|Overall Study||237
10666264|NCT02295735|11828465|FG000|COMPLETED|Overall Study||212
10666265|NCT02295735|11828466|FG001|COMPLETED|Overall Study||210
10666266|NCT02295735|11828465|FG000|NOT COMPLETED|Overall Study||26
10666267|NCT02295735|11828466|FG001|NOT COMPLETED|Overall Study||27
10666268|NCT02295774|11828472|FG000|STARTED|Overall Study||13
10666269|NCT02295774|11828472|FG000|COMPLETED|Overall Study||10
10666270|NCT02295774|11828472|FG000|NOT COMPLETED|Overall Study||3
10666271|NCT02295995|11828479|FG000|STARTED|Overall Study||36
10666272|NCT02295995|11828480|FG001|STARTED|Overall Study||18
10666273|NCT02295995|11828479|FG000|COMPLETED|Overall Study||31
10666274|NCT02295995|11828480|FG001|COMPLETED|Overall Study||17
10666275|NCT02295995|11828479|FG000|NOT COMPLETED|Overall Study||5
10666276|NCT02295995|11828480|FG001|NOT COMPLETED|Overall Study||1
10666277|NCT02296099|11828489|FG000|STARTED|Overall Study||57
10666278|NCT02296099|11828490|FG001|STARTED|Overall Study||57
10666279|NCT02296099|11828489|FG000|COMPLETED|Overall Study||54
10666280|NCT02296099|11828490|FG001|COMPLETED|Overall Study||55
10666281|NCT02296099|11828489|FG000|NOT COMPLETED|Overall Study||3
10666282|NCT02296099|11828490|FG001|NOT COMPLETED|Overall Study||2
10666283|NCT02296112|11828496|FG000|STARTED|Overall Study||9
10666284|NCT02296112|11828496|FG000|COMPLETED|Overall Study||0
10666285|NCT02296112|11828496|FG000|NOT COMPLETED|Overall Study||9
10666286|NCT02296138|11828507|FG000|STARTED|Overall Study||3952
10666287|NCT02296138|11828508|FG001|STARTED|Overall Study||3951
10666288|NCT02296138|11828507|FG000|Treated|Overall Study||3941
10666289|NCT02296138|11828508|FG001|Treated|Overall Study||3939
10666290|NCT02296138|11828507|FG000|COMPLETED|Overall Study||3291
10666291|NCT02296138|11828508|FG001|COMPLETED|Overall Study||3451
10666292|NCT02296138|11828507|FG000|NOT COMPLETED|Overall Study||661
10666293|NCT02296138|11828508|FG001|NOT COMPLETED|Overall Study||500
10666294|NCT02296164|11828514|FG000|STARTED|Overall Study|2 patients not eligible as were not on Valchlor at time of study start|298
10666295|NCT02296164|11828514|FG000|COMPLETED|Overall Study||188
10666296|NCT02296164|11828514|FG000|NOT COMPLETED|Overall Study||110
10666297|NCT02296190|11828524|FG000|STARTED|Overall Study||35
10666298|NCT02296190|11828525|FG001|STARTED|Overall Study||41
10795791|NCT03645954|11956074|FG001|NOT COMPLETED|Overall Study||0
10795792|NCT03646305|11956084|FG000|STARTED|Overall Study||32
10666299|NCT02296190|11828526|FG002|STARTED|Overall Study||35
10666300|NCT02296190|11828527|FG003|STARTED|Overall Study||43
10666301|NCT02296190|11828528|FG004|STARTED|Overall Study||36
10666302|NCT02296190|11828529|FG005|STARTED|Overall Study||9
10666303|NCT02296190|11828524|FG000|COMPLETED|Overall Study||21
10666304|NCT02296190|11828525|FG001|COMPLETED|Overall Study||20
10666305|NCT02296190|11828526|FG002|COMPLETED|Overall Study||23
10666306|NCT02296190|11828527|FG003|COMPLETED|Overall Study||20
10666307|NCT02296190|11828528|FG004|COMPLETED|Overall Study||20
10666308|NCT02296190|11828529|FG005|COMPLETED|Overall Study||9
10666309|NCT02296190|11828524|FG000|NOT COMPLETED|Overall Study||14
10666310|NCT02296190|11828525|FG001|NOT COMPLETED|Overall Study||21
10666311|NCT02296190|11828526|FG002|NOT COMPLETED|Overall Study||12
10666312|NCT02296190|11828527|FG003|NOT COMPLETED|Overall Study||23
10666313|NCT02296190|11828528|FG004|NOT COMPLETED|Overall Study||16
10666314|NCT02296190|11828529|FG005|NOT COMPLETED|Overall Study||0
10666315|NCT02296242|11828547|FG000|STARTED|Overall Study||5
10666316|NCT02296242|11828548|FG001|STARTED|Overall Study||6
10666317|NCT02296242|11828549|FG002|STARTED|Overall Study||7
10666318|NCT02296242|11828550|FG003|STARTED|Overall Study||14
10666319|NCT02296242|11828551|FG004|STARTED|Overall Study||21
10666320|NCT02296242|11828547|FG000|COMPLETED|Overall Study||0
10666321|NCT02296242|11828548|FG001|COMPLETED|Overall Study||0
10666322|NCT02296242|11828549|FG002|COMPLETED|Overall Study||0
10666323|NCT02296242|11828550|FG003|COMPLETED|Overall Study||0
10666324|NCT02296242|11828551|FG004|COMPLETED|Overall Study||0
10666325|NCT02296242|11828547|FG000|NOT COMPLETED|Overall Study||5
10666326|NCT02296242|11828548|FG001|NOT COMPLETED|Overall Study||6
10666327|NCT02296242|11828549|FG002|NOT COMPLETED|Overall Study||7
10666328|NCT02296242|11828550|FG003|NOT COMPLETED|Overall Study||14
10666329|NCT02296242|11828551|FG004|NOT COMPLETED|Overall Study||21
10712250|NCT02669017|11877830|FG007|COMPLETED|Overall Study||7
10712251|NCT02669017|11877831|FG008|COMPLETED|Overall Study||11
10712252|NCT02669017|11877823|FG000|NOT COMPLETED|Overall Study||1
10712253|NCT02669017|11877824|FG001|NOT COMPLETED|Overall Study||2
10712254|NCT02669017|11877825|FG002|NOT COMPLETED|Overall Study||2
10712255|NCT02669017|11877826|FG003|NOT COMPLETED|Overall Study||4
10712256|NCT02669017|11877827|FG004|NOT COMPLETED|Overall Study||12
10712257|NCT02669017|11877828|FG005|NOT COMPLETED|Overall Study||19
10712258|NCT02669017|11877829|FG006|NOT COMPLETED|Overall Study||11
10712259|NCT02669017|11877830|FG007|NOT COMPLETED|Overall Study||62
10712260|NCT02669017|11877831|FG008|NOT COMPLETED|Overall Study||25
10712261|NCT02669043|11877859|FG000|STARTED|Overall Study||8
10712262|NCT02669043|11877859|FG000|COMPLETED|Overall Study||4
10712263|NCT02669043|11877859|FG000|NOT COMPLETED|Overall Study||4
10712264|NCT02669082|11877863|FG000|STARTED|Overall Study||26
10712265|NCT02669082|11877863|FG000|COMPLETED|Overall Study||25
10712266|NCT02669082|11877863|FG000|NOT COMPLETED|Overall Study||1
10712267|NCT02669095|11877869|FG000|STARTED|Overall Study||75
10712268|NCT02669095|11877870|FG001|STARTED|Overall Study||75
10712269|NCT02669095|11877869|FG000|COMPLETED|Overall Study||74
10712270|NCT02669095|11877870|FG001|COMPLETED|Overall Study||72
10712271|NCT02669095|11877869|FG000|NOT COMPLETED|Overall Study||1
10666330|NCT02296320|11828574|FG000|STARTED|Overall Study||102
10666331|NCT02296320|11828575|FG001|STARTED|Overall Study||15
10666332|NCT02296320|11828576|FG002|STARTED|Overall Study||96
10666333|NCT02296320|11828574|FG000|Treated|Overall Study||100
10666334|NCT02296320|11828575|FG001|Treated|Overall Study||15
10666335|NCT02296320|11828576|FG002|Treated|Overall Study||96
10666336|NCT02296320|11828574|FG000|COMPLETED|Overall Study||67
10666337|NCT02296320|11828575|FG001|COMPLETED|Overall Study||10
10666338|NCT02296320|11828576|FG002|COMPLETED|Overall Study||59
10666339|NCT02296320|11828574|FG000|NOT COMPLETED|Overall Study||35
10666340|NCT02296320|11828575|FG001|NOT COMPLETED|Overall Study||5
10666341|NCT02296320|11828576|FG002|NOT COMPLETED|Overall Study||37
10666342|NCT02296346|11828588|FG000|STARTED|Overall Study||7
10666343|NCT02296346|11828589|FG001|STARTED|Overall Study||6
10666344|NCT02296346|11828588|FG000|COMPLETED|Overall Study||2
10666345|NCT02296346|11828589|FG001|COMPLETED|Overall Study||0
10666346|NCT02296346|11828588|FG000|NOT COMPLETED|Overall Study||5
10666347|NCT02296346|11828589|FG001|NOT COMPLETED|Overall Study||6
10666348|NCT02296424|11828599|FG000|STARTED|Part 1|16 patients immediately went into Part II|84
10666349|NCT02296424|11828600|FG001|STARTED|Part 1||98
10666350|NCT02296424|11828601|FG002|STARTED|Part 1||0
10666351|NCT02296424|11828602|FG003|STARTED|Part 1||0
10666352|NCT02296424|11828599|FG000|COMPLETED|Part 1||61
10666353|NCT02296424|11828600|FG001|COMPLETED|Part 1||65
10666354|NCT02296424|11828601|FG002|COMPLETED|Part 1||0
10666355|NCT02296424|11828602|FG003|COMPLETED|Part 1||0
10666356|NCT02296424|11828599|FG000|NOT COMPLETED|Part 1||23
10666357|NCT02296424|11828600|FG001|NOT COMPLETED|Part 1||33
10666358|NCT02296424|11828601|FG002|NOT COMPLETED|Part 1||0
10666359|NCT02296424|11828602|FG003|NOT COMPLETED|Part 1||0
10666360|NCT02296424|11828599|FG000|STARTED|Part 2||0
10666361|NCT02296424|11828600|FG001|STARTED|Part 2||0
10666362|NCT02296424|11828601|FG002|STARTED|Part 2||38
10666363|NCT02296424|11828602|FG003|STARTED|Part 2||37
10666364|NCT02296424|11828599|FG000|COMPLETED|Part 2||0
10666365|NCT02296424|11828600|FG001|COMPLETED|Part 2||0
10666366|NCT02296424|11828601|FG002|COMPLETED|Part 2||35
10666367|NCT02296424|11828602|FG003|COMPLETED|Part 2||37
10666368|NCT02296424|11828599|FG000|NOT COMPLETED|Part 2||0
10666369|NCT02296424|11828600|FG001|NOT COMPLETED|Part 2||0
10666370|NCT02296424|11828601|FG002|NOT COMPLETED|Part 2||3
10666371|NCT02296424|11828602|FG003|NOT COMPLETED|Part 2||0
10666372|NCT02296476|11828613|FG000|STARTED|Overall Study||6
10666373|NCT02296476|11828614|FG001|STARTED|Overall Study||4
10666374|NCT02296476|11828615|FG002|STARTED|Overall Study||2
10666375|NCT02296476|11828613|FG000|COMPLETED|Overall Study||0
10666376|NCT02296476|11828614|FG001|COMPLETED|Overall Study||0
10666377|NCT02296476|11828615|FG002|COMPLETED|Overall Study||0
10666378|NCT02296476|11828613|FG000|NOT COMPLETED|Overall Study||6
10666379|NCT02296476|11828614|FG001|NOT COMPLETED|Overall Study||4
10666380|NCT02296476|11828615|FG002|NOT COMPLETED|Overall Study||2
10666381|NCT02296502|11828627|FG000|STARTED|Overall Study||248
10666382|NCT02296502|11828628|FG001|STARTED|Overall Study||1
10666383|NCT02296502|11828629|FG002|STARTED|Overall Study||30
10666384|NCT02296502|11828630|FG003|STARTED|Overall Study||160
10666385|NCT02296502|11828627|FG000|COMPLETED|Overall Study||248
10666386|NCT02296502|11828628|FG001|COMPLETED|Overall Study||1
10666387|NCT02296502|11828629|FG002|COMPLETED|Overall Study||30
10666388|NCT02296502|11828630|FG003|COMPLETED|Overall Study||160
10666389|NCT02296502|11828627|FG000|NOT COMPLETED|Overall Study||0
10666390|NCT02296502|11828628|FG001|NOT COMPLETED|Overall Study||0
10666391|NCT02296502|11828629|FG002|NOT COMPLETED|Overall Study||0
10666392|NCT02296502|11828630|FG003|NOT COMPLETED|Overall Study||0
10666393|NCT02296606|11828643|FG000|STARTED|Overall Study||127
10666394|NCT02296606|11828643|FG000|COMPLETED|Overall Study||127
10666395|NCT02296606|11828643|FG000|NOT COMPLETED|Overall Study||0
10666396|NCT02296775|11828650|FG000|STARTED|Treatment and Evaluation||91
10666397|NCT02296775|11828651|FG001|STARTED|Treatment and Evaluation||92
10666398|NCT02296775|11828652|FG002|STARTED|Treatment and Evaluation||93
10666399|NCT02296775|11828650|FG000|COMPLETED|Treatment and Evaluation||87
10666400|NCT02296775|11828651|FG001|COMPLETED|Treatment and Evaluation||84
10666401|NCT02296775|11828652|FG002|COMPLETED|Treatment and Evaluation||83
10666402|NCT02296775|11828650|FG000|NOT COMPLETED|Treatment and Evaluation||4
10666403|NCT02296775|11828651|FG001|NOT COMPLETED|Treatment and Evaluation||8
10666404|NCT02296775|11828652|FG002|NOT COMPLETED|Treatment and Evaluation||10
10666405|NCT02296775|11828650|FG000|STARTED|Recovery and Follow-up||87
10666406|NCT02296775|11828651|FG001|STARTED|Recovery and Follow-up||84
10666407|NCT02296775|11828652|FG002|STARTED|Recovery and Follow-up||83
10666408|NCT02296775|11828650|FG000|COMPLETED|Recovery and Follow-up||82
10666409|NCT02296775|11828651|FG001|COMPLETED|Recovery and Follow-up||79
10666410|NCT02296775|11828652|FG002|COMPLETED|Recovery and Follow-up||79
10666411|NCT02296775|11828650|FG000|NOT COMPLETED|Recovery and Follow-up||5
10666412|NCT02296775|11828651|FG001|NOT COMPLETED|Recovery and Follow-up||5
10666413|NCT02296775|11828652|FG002|NOT COMPLETED|Recovery and Follow-up||4
10666414|NCT02296840|11828662|FG000|STARTED|Overall Study||18
10666415|NCT02296840|11828663|FG001|STARTED|Overall Study||27
10666416|NCT02296840|11828662|FG000|COMPLETED|Overall Study||9
10666417|NCT02296840|11828663|FG001|COMPLETED|Overall Study||8
10666418|NCT02296840|11828662|FG000|NOT COMPLETED|Overall Study||9
10666419|NCT02296840|11828663|FG001|NOT COMPLETED|Overall Study||19
10666420|NCT02296853|11828671|FG000|STARTED|Overall Study||10
10666421|NCT02296853|11828672|FG001|STARTED|Overall Study||10
10666422|NCT02296853|11828671|FG000|COMPLETED|Overall Study||10
10666423|NCT02296853|11828672|FG001|COMPLETED|Overall Study||10
10666424|NCT02296853|11828671|FG000|NOT COMPLETED|Overall Study||0
10666425|NCT02296853|11828672|FG001|NOT COMPLETED|Overall Study||0
10666426|NCT02296892|11828681|FG000|STARTED|Overall Study||310
10666427|NCT02296892|11828682|FG001|STARTED|Overall Study||63
10666428|NCT02296892|11828683|FG002|STARTED|Overall Study||73
10666429|NCT02296892|11828681|FG000|Safety Population|Overall Study||303
10666430|NCT02296892|11828682|FG001|Safety Population|Overall Study||59
10666431|NCT02296892|11828683|FG002|Safety Population|Overall Study||69
10666432|NCT02296892|11828681|FG000|Complete Trial Treatment Period|Overall Study||303
10666433|NCT02296892|11828682|FG001|Complete Trial Treatment Period|Overall Study||59
10666434|NCT02296892|11828683|FG002|Complete Trial Treatment Period|Overall Study||69
10666435|NCT02296892|11828681|FG000|COMPLETED|Overall Study||298
10666436|NCT02296892|11828682|FG001|COMPLETED|Overall Study||59
10666437|NCT02296892|11828683|FG002|COMPLETED|Overall Study||68
10666438|NCT02296892|11828681|FG000|NOT COMPLETED|Overall Study||12
10666439|NCT02296892|11828682|FG001|NOT COMPLETED|Overall Study||4
10666440|NCT02296892|11828683|FG002|NOT COMPLETED|Overall Study||5
10666441|NCT02296931|11828693|FG000|STARTED|Overall Study||10
10666442|NCT02296931|11828694|FG001|STARTED|Overall Study||24
10666443|NCT02296931|11828693|FG000|COMPLETED|Overall Study||10
10666444|NCT02296931|11828694|FG001|COMPLETED|Overall Study||22
10666445|NCT02296931|11828693|FG000|NOT COMPLETED|Overall Study||0
10666446|NCT02296931|11828694|FG001|NOT COMPLETED|Overall Study||2
10666447|NCT02297100|11828702|FG000|STARTED|Overall Study||13
10666448|NCT02297100|11828703|FG001|STARTED|Overall Study||14
10666449|NCT02297100|11828702|FG000|COMPLETED|Overall Study||13
10666450|NCT02297100|11828703|FG001|COMPLETED|Overall Study||14
10666451|NCT02297100|11828702|FG000|NOT COMPLETED|Overall Study||0
10666452|NCT02297100|11828703|FG001|NOT COMPLETED|Overall Study||0
10666453|NCT02297308|11828709|FG000|STARTED|Overall Study||90
10666454|NCT02297308|11828709|FG000|COMPLETED|Overall Study||90
10666455|NCT02297308|11828709|FG000|NOT COMPLETED|Overall Study||0
10666468|NCT02297516|11828734|FG000|STARTED|Single Treatment Phase (6 Months)||32
10666469|NCT02297516|11828735|FG001|STARTED|Single Treatment Phase (6 Months)||33
10666470|NCT02297516|11828734|FG000|COMPLETED|Single Treatment Phase (6 Months)||31
10666471|NCT02297516|11828735|FG001|COMPLETED|Single Treatment Phase (6 Months)||31
10666472|NCT02297516|11828734|FG000|NOT COMPLETED|Single Treatment Phase (6 Months)||1
10666473|NCT02297516|11828735|FG001|NOT COMPLETED|Single Treatment Phase (6 Months)||2
10666474|NCT02297516|11828734|FG000|STARTED|Combination Treatment Phase (up to 18 m)||31
10666475|NCT02297516|11828735|FG001|STARTED|Combination Treatment Phase (up to 18 m)||31
10666476|NCT02297516|11828734|FG000|COMPLETED|Combination Treatment Phase (up to 18 m)||31
10666477|NCT02297516|11828735|FG001|COMPLETED|Combination Treatment Phase (up to 18 m)||30
10666478|NCT02297516|11828734|FG000|NOT COMPLETED|Combination Treatment Phase (up to 18 m)||0
10666479|NCT02297516|11828735|FG001|NOT COMPLETED|Combination Treatment Phase (up to 18 m)||1
10666480|NCT02297815|11828750|FG000|STARTED|Overall Study||1604
10666481|NCT02297815|11828751|FG001|STARTED|Overall Study||868
10666482|NCT02297815|11828750|FG000|5-10 Day Interview|Overall Study||1604
10666483|NCT02297815|11828751|FG001|5-10 Day Interview|Overall Study||868
10666484|NCT02297815|11828750|FG000|14-20 Day Interview|Overall Study||1368
10666485|NCT02297815|11828751|FG001|14-20 Day Interview|Overall Study||728
10666486|NCT02297815|11828750|FG000|COMPLETED|Overall Study||1368
10666487|NCT02297815|11828751|FG001|COMPLETED|Overall Study||728
10666488|NCT02297815|11828750|FG000|NOT COMPLETED|Overall Study||236
10666489|NCT02297815|11828751|FG001|NOT COMPLETED|Overall Study||140
10666490|NCT02297841|11828759|FG000|STARTED|Overall Study||209
10666491|NCT02297841|11828759|FG000|Induction Phase|Overall Study||209
10666492|NCT02297841|11828759|FG000|Challenge Phase|Overall Study||201
10666493|NCT02297841|11828759|FG000|COMPLETED|Overall Study||201
10666494|NCT02297841|11828759|FG000|NOT COMPLETED|Overall Study||8
10666495|NCT02298023|11828766|FG000|STARTED|Overall Study||8
10666496|NCT02298023|11828767|FG001|STARTED|Overall Study||8
10666497|NCT02298023|11828768|FG002|STARTED|Overall Study||8
10666498|NCT02298023|11828766|FG000|Intervention|Overall Study|Withdrawal by participant before intervention.|7
10666499|NCT02298023|11828767|FG001|Intervention|Overall Study||8
10666500|NCT02298023|11828768|FG002|Intervention|Overall Study||8
10666501|NCT02298023|11828766|FG000|COMPLETED|Overall Study||7
10666502|NCT02298023|11828767|FG001|COMPLETED|Overall Study||8
10666503|NCT02298023|11828768|FG002|COMPLETED|Overall Study||8
10666504|NCT02298023|11828766|FG000|NOT COMPLETED|Overall Study||1
10666505|NCT02298023|11828767|FG001|NOT COMPLETED|Overall Study||0
10666506|NCT02298023|11828768|FG002|NOT COMPLETED|Overall Study||0
10666507|NCT02298179|11828791|FG000|STARTED|Overall Study||24
10666508|NCT02298179|11828792|FG001|STARTED|Overall Study||24
10666509|NCT02298179|11828793|FG002|STARTED|Overall Study||24
10666510|NCT02298179|11828794|FG003|STARTED|Overall Study||24
10666511|NCT02298179|11828795|FG004|STARTED|Overall Study||24
10666512|NCT02298179|11828796|FG005|STARTED|Overall Study||24
10666513|NCT02298179|11828797|FG006|STARTED|Overall Study||24
10666514|NCT02298179|11828798|FG007|STARTED|Overall Study||24
10666515|NCT02298179|11828799|FG008|STARTED|Overall Study||24
10666516|NCT02298179|11828800|FG009|STARTED|Overall Study||24
10666517|NCT02298179|11828801|FG010|STARTED|Overall Study||24
10666518|NCT02298179|11828802|FG011|STARTED|Overall Study||24
10666519|NCT02298179|11828791|FG000|COMPLETED|Overall Study||24
10666520|NCT02298179|11828792|FG001|COMPLETED|Overall Study||24
10666521|NCT02298179|11828793|FG002|COMPLETED|Overall Study||23
10666522|NCT02298179|11828794|FG003|COMPLETED|Overall Study||24
10666523|NCT02298179|11828795|FG004|COMPLETED|Overall Study||24
10666524|NCT02298179|11828796|FG005|COMPLETED|Overall Study||24
10666525|NCT02298179|11828797|FG006|COMPLETED|Overall Study||24
10666526|NCT02298179|11828798|FG007|COMPLETED|Overall Study||23
10666527|NCT02298179|11828799|FG008|COMPLETED|Overall Study||24
10666528|NCT02298179|11828800|FG009|COMPLETED|Overall Study||24
10666529|NCT02298179|11828801|FG010|COMPLETED|Overall Study||24
10666530|NCT02298179|11828802|FG011|COMPLETED|Overall Study||24
10666531|NCT02298179|11828791|FG000|NOT COMPLETED|Overall Study||0
10666532|NCT02298179|11828792|FG001|NOT COMPLETED|Overall Study||0
10666533|NCT02298179|11828793|FG002|NOT COMPLETED|Overall Study||1
10666534|NCT02298179|11828794|FG003|NOT COMPLETED|Overall Study||0
10666535|NCT02298179|11828795|FG004|NOT COMPLETED|Overall Study||0
10666536|NCT02298179|11828796|FG005|NOT COMPLETED|Overall Study||0
10666537|NCT02298179|11828797|FG006|NOT COMPLETED|Overall Study||0
10666538|NCT02298179|11828798|FG007|NOT COMPLETED|Overall Study||1
10666539|NCT02298179|11828799|FG008|NOT COMPLETED|Overall Study||0
10666540|NCT02298179|11828800|FG009|NOT COMPLETED|Overall Study||0
10666541|NCT02298179|11828801|FG010|NOT COMPLETED|Overall Study||0
10666542|NCT02298179|11828802|FG011|NOT COMPLETED|Overall Study||0
10666543|NCT02298192|11828830|FG000|STARTED|Overall Study||210
10666544|NCT02298192|11828831|FG001|STARTED|Overall Study||210
10666545|NCT02298192|11828830|FG000|COMPLETED|Overall Study||191
10666546|NCT02298192|11828831|FG001|COMPLETED|Overall Study||204
10666547|NCT02298192|11828830|FG000|NOT COMPLETED|Overall Study||19
10666548|NCT02298192|11828831|FG001|NOT COMPLETED|Overall Study||6
10666549|NCT02298322|11828837|FG000|STARTED|Overall Study||60
10666550|NCT02298322|11828837|FG000|COMPLETED|Overall Study||60
10666551|NCT02298322|11828837|FG000|NOT COMPLETED|Overall Study||0
10666552|NCT02298361|11828847|FG000|STARTED|Overall Study||2240
10666553|NCT02298361|11828848|FG001|STARTED|Overall Study||12784
10666554|NCT02298361|11828849|FG002|STARTED|Overall Study||12227
10666555|NCT02298361|11828847|FG000|COMPLETED|Overall Study||2240
10666556|NCT02298361|11828848|FG001|COMPLETED|Overall Study||12784
10666557|NCT02298361|11828849|FG002|COMPLETED|Overall Study||12227
10666558|NCT02298361|11828847|FG000|NOT COMPLETED|Overall Study||0
10666559|NCT02298361|11828848|FG001|NOT COMPLETED|Overall Study||0
10666560|NCT02298361|11828849|FG002|NOT COMPLETED|Overall Study||0
10666561|NCT02298491|11828857|FG000|STARTED|Overall Study||4
10666562|NCT02298491|11828857|FG000|COMPLETED|Overall Study||3
10666563|NCT02298491|11828857|FG000|NOT COMPLETED|Overall Study||1
10666564|NCT02298803|11828863|FG000|STARTED|Overall Study||30
10666565|NCT02298803|11828863|FG000|COMPLETED|Overall Study||30
10666566|NCT02298803|11828863|FG000|NOT COMPLETED|Overall Study||0
10666567|NCT02298842|11828874|FG000|STARTED|First Platelet Donation (Day 0)||44
10666568|NCT02298842|11828875|FG001|STARTED|First Platelet Donation (Day 0)||41
10666569|NCT02298842|11828874|FG000|COMPLETED|First Platelet Donation (Day 0)||38
10666570|NCT02298842|11828875|FG001|COMPLETED|First Platelet Donation (Day 0)||36
10666571|NCT02298842|11828874|FG000|NOT COMPLETED|First Platelet Donation (Day 0)||6
10666572|NCT02298842|11828875|FG001|NOT COMPLETED|First Platelet Donation (Day 0)||5
10666573|NCT02298842|11828874|FG000|STARTED|Second Platelet Donation (Day 6-8)||38
10666574|NCT02298842|11828875|FG001|STARTED|Second Platelet Donation (Day 6-8)||36
10666575|NCT02298842|11828874|FG000|COMPLETED|Second Platelet Donation (Day 6-8)||30
10666576|NCT02298842|11828875|FG001|COMPLETED|Second Platelet Donation (Day 6-8)||30
10666577|NCT02298842|11828874|FG000|NOT COMPLETED|Second Platelet Donation (Day 6-8)||8
10666578|NCT02298842|11828875|FG001|NOT COMPLETED|Second Platelet Donation (Day 6-8)||6
10666579|NCT02298868|11828883|FG000|STARTED|Overall Study||10
10666580|NCT02298868|11828883|FG000|COMPLETED|Overall Study||7
10666581|NCT02298868|11828883|FG000|NOT COMPLETED|Overall Study||3
10795793|NCT03646305|11956085|FG001|STARTED|Overall Study||35
10795794|NCT03646305|11956086|FG002|STARTED|Overall Study||33
10795795|NCT03646305|11956087|FG003|STARTED|Overall Study||33
10795796|NCT03646305|11956084|FG000|Received Treatment|Overall Study||31
10795797|NCT03646305|11956085|FG001|Received Treatment|Overall Study||35
10795798|NCT03646305|11956086|FG002|Received Treatment|Overall Study||32
10795799|NCT03646305|11956087|FG003|Received Treatment|Overall Study||32
10666582|NCT02298933|11828887|FG000|STARTED|Overall Study||10
10666583|NCT02298933|11828887|FG000|COMPLETED|Overall Study||10
10666584|NCT02298933|11828887|FG000|NOT COMPLETED|Overall Study||0
10666585|NCT02298946|11828893|FG000|STARTED|Overall Study||8
10666586|NCT02298946|11828894|FG001|STARTED|Overall Study||9
10666587|NCT02298946|11828893|FG000|COMPLETED|Overall Study||4
10666588|NCT02298946|11828894|FG001|COMPLETED|Overall Study||8
10666589|NCT02298946|11828893|FG000|NOT COMPLETED|Overall Study||4
10666590|NCT02298946|11828894|FG001|NOT COMPLETED|Overall Study||1
10666591|NCT02299050|11828901|FG000|STARTED|Overall Study||23
10666592|NCT02299050|11828901|FG000|COMPLETED|Overall Study||15
10795800|NCT03646305|11956084|FG000|No Treatment Recieved|Overall Study||1
10666593|NCT02299050|11828901|FG000|NOT COMPLETED|Overall Study||8
10666594|NCT02299076|11828907|FG000|STARTED|Overall Study||230
10666595|NCT02299076|11828908|FG001|STARTED|Overall Study||226
10666596|NCT02299076|11828907|FG000|COMPLETED|Overall Study||210
10666597|NCT02299076|11828908|FG001|COMPLETED|Overall Study||212
10666598|NCT02299076|11828907|FG000|NOT COMPLETED|Overall Study||20
10666599|NCT02299076|11828908|FG001|NOT COMPLETED|Overall Study||14
10666600|NCT02299089|11828918|FG000|STARTED|Overall Study||3
10666601|NCT02299089|11828919|FG001|STARTED|Overall Study||4
10666602|NCT02299089|11828920|FG002|STARTED|Overall Study||1
10666603|NCT02299089|11828921|FG003|STARTED|Overall Study||4
10666604|NCT02299089|11828918|FG000|COMPLETED|Overall Study||3
10666605|NCT02299089|11828919|FG001|COMPLETED|Overall Study||4
10666606|NCT02299089|11828920|FG002|COMPLETED|Overall Study||1
10666607|NCT02299089|11828921|FG003|COMPLETED|Overall Study||4
10666608|NCT02299089|11828918|FG000|NOT COMPLETED|Overall Study||0
10666609|NCT02299089|11828919|FG001|NOT COMPLETED|Overall Study||0
10666610|NCT02299089|11828920|FG002|NOT COMPLETED|Overall Study||0
10666611|NCT02299089|11828921|FG003|NOT COMPLETED|Overall Study||0
10666612|NCT02299141|11828941|FG000|STARTED|Overall Study||20
10666613|NCT02299141|11828941|FG000|COMPLETED|Overall Study||20
10666614|NCT02299141|11828941|FG000|NOT COMPLETED|Overall Study||0
10666615|NCT02299167|11828952|FG000|STARTED|Overall Study||35
10666616|NCT02299167|11828952|FG000|Dural Puncture|Overall Study||24
10666617|NCT02299167|11828952|FG000|Success Rate|Overall Study||24
10666618|NCT02299167|11828952|FG000|Adverse Effects|Overall Study||24
10666619|NCT02299167|11828952|FG000|COMPLETED|Overall Study||24
10666620|NCT02299167|11828952|FG000|NOT COMPLETED|Overall Study||11
10666621|NCT02299258|11828958|FG000|STARTED|Overall Study||32
10666622|NCT02299258|11828959|FG001|STARTED|Overall Study||31
10666623|NCT02299258|11828958|FG000|COMPLETED|Overall Study||31
10666624|NCT02299258|11828959|FG001|COMPLETED|Overall Study||30
10666625|NCT02299258|11828958|FG000|NOT COMPLETED|Overall Study||1
10666626|NCT02299258|11828959|FG001|NOT COMPLETED|Overall Study||1
10666627|NCT02299297|11828965|FG000|STARTED|Overall Study||12
10666628|NCT02299297|11828965|FG000|COMPLETED|Overall Study||11
10666629|NCT02299297|11828965|FG000|NOT COMPLETED|Overall Study||1
10666630|NCT02299336|11828969|FG000|STARTED|Overall Study||60
10666631|NCT02299336|11828969|FG000|COMPLETED|Overall Study||46
10666632|NCT02299336|11828969|FG000|NOT COMPLETED|Overall Study||14
10666633|NCT02299349|11828975|FG000|STARTED|Overall Study||35
10666634|NCT02299349|11828976|FG001|STARTED|Overall Study||35
10666635|NCT02299349|11828975|FG000|COMPLETED|Overall Study||35
10666636|NCT02299349|11828976|FG001|COMPLETED|Overall Study||35
10666637|NCT02299349|11828975|FG000|NOT COMPLETED|Overall Study||0
10666638|NCT02299349|11828976|FG001|NOT COMPLETED|Overall Study||0
10666639|NCT02299375|11828984|FG000|STARTED|Overall Study||94
10666640|NCT02299375|11828985|FG001|STARTED|Overall Study||90
10666641|NCT02299375|11828984|FG000|COMPLETED|Overall Study||14
10666642|NCT02299375|11828985|FG001|COMPLETED|Overall Study||10
10666643|NCT02299375|11828984|FG000|NOT COMPLETED|Overall Study||80
10666644|NCT02299375|11828985|FG001|NOT COMPLETED|Overall Study||80
10666645|NCT02299388|11828994|FG000|STARTED|Overall Study||6
10666646|NCT02299388|11828995|FG001|STARTED|Overall Study||5
10666647|NCT02299388|11828994|FG000|COMPLETED|Overall Study||6
10666648|NCT02299388|11828995|FG001|COMPLETED|Overall Study||4
10666649|NCT02299388|11828994|FG000|NOT COMPLETED|Overall Study||0
10666650|NCT02299388|11828995|FG001|NOT COMPLETED|Overall Study||1
10666651|NCT02299427|11829003|FG000|STARTED|Overall Study||35
10666652|NCT02299427|11829004|FG001|STARTED|Overall Study||34
10666653|NCT02299427|11829003|FG000|COMPLETED|Overall Study||12
10666654|NCT02299427|11829004|FG001|COMPLETED|Overall Study||31
10666655|NCT02299427|11829003|FG000|NOT COMPLETED|Overall Study||23
10666656|NCT02299427|11829004|FG001|NOT COMPLETED|Overall Study||3
10666657|NCT02299479|11829010|FG000|STARTED|Overall Study||20
10666658|NCT02299479|11829010|FG000|COMPLETED|Overall Study||18
10666659|NCT02299479|11829010|FG000|NOT COMPLETED|Overall Study||2
10666660|NCT02299570|11829017|FG000|STARTED|Overall Study||45
10666661|NCT02299570|11829018|FG001|STARTED|Overall Study||44
10666662|NCT02299570|11829019|FG002|STARTED|Overall Study||44
10666663|NCT02299570|11829017|FG000|COMPLETED|Overall Study||31
10666664|NCT02299570|11829018|FG001|COMPLETED|Overall Study||35
10666665|NCT02299570|11829019|FG002|COMPLETED|Overall Study||25
10666666|NCT02299570|11829017|FG000|NOT COMPLETED|Overall Study||14
10666667|NCT02299570|11829018|FG001|NOT COMPLETED|Overall Study||9
10666668|NCT02299570|11829019|FG002|NOT COMPLETED|Overall Study||19
10666669|NCT02299635|11829032|FG000|STARTED|Overall Study||19
10666670|NCT02299635|11829032|FG000|COMPLETED|Overall Study||0
10666671|NCT02299635|11829032|FG000|NOT COMPLETED|Overall Study||19
10666672|NCT02299791|11829038|FG000|STARTED|Overall Study||2053
10666673|NCT02299791|11829039|FG001|STARTED|Overall Study||2803
10666674|NCT02299791|11829038|FG000|COMPLETED|Overall Study||2053
10666675|NCT02299791|11829039|FG001|COMPLETED|Overall Study||2803
10666676|NCT02299791|11829038|FG000|NOT COMPLETED|Overall Study||0
10666677|NCT02299791|11829039|FG001|NOT COMPLETED|Overall Study||0
10666678|NCT02299869|11829049|FG000|STARTED|Overall Study||10
10666679|NCT02299869|11829050|FG001|STARTED|Overall Study||10
10666680|NCT02299869|11829051|FG002|STARTED|Overall Study||10
10666681|NCT02299869|11829052|FG003|STARTED|Overall Study||10
10666682|NCT02299869|11829049|FG000|COMPLETED|Overall Study||10
10666683|NCT02299869|11829050|FG001|COMPLETED|Overall Study||10
10666684|NCT02299869|11829051|FG002|COMPLETED|Overall Study||10
10666685|NCT02299869|11829052|FG003|COMPLETED|Overall Study||10
10666686|NCT02299869|11829049|FG000|NOT COMPLETED|Overall Study||0
10666687|NCT02299869|11829050|FG001|NOT COMPLETED|Overall Study||0
10666688|NCT02299869|11829051|FG002|NOT COMPLETED|Overall Study||0
10666689|NCT02299869|11829052|FG003|NOT COMPLETED|Overall Study||0
10666690|NCT02300025|11829063|FG000|STARTED|Overall Study||10
10666691|NCT02300025|11829064|FG001|STARTED|Overall Study||6
10666692|NCT02300025|11829065|FG002|STARTED|Overall Study||6
10666693|NCT02300025|11829066|FG003|STARTED|Overall Study||6
10666694|NCT02300025|11829063|FG000|COMPLETED|Overall Study||10
10666695|NCT02300025|11829064|FG001|COMPLETED|Overall Study||6
10666696|NCT02300025|11829065|FG002|COMPLETED|Overall Study||6
10666697|NCT02300025|11829066|FG003|COMPLETED|Overall Study||6
10666698|NCT02300025|11829063|FG000|NOT COMPLETED|Overall Study||0
10666699|NCT02300025|11829064|FG001|NOT COMPLETED|Overall Study||0
10666700|NCT02300025|11829065|FG002|NOT COMPLETED|Overall Study||0
10666701|NCT02300025|11829066|FG003|NOT COMPLETED|Overall Study||0
10666702|NCT02300077|11829080|FG000|STARTED|Overall Study||21
10666703|NCT02300077|11829081|FG001|STARTED|Overall Study||18
10666704|NCT02300077|11829082|FG002|STARTED|Overall Study||21
10666705|NCT02300077|11829080|FG000|COMPLETED|Overall Study||21
10666706|NCT02300077|11829081|FG001|COMPLETED|Overall Study||18
10666707|NCT02300077|11829082|FG002|COMPLETED|Overall Study||21
10666708|NCT02300077|11829080|FG000|NOT COMPLETED|Overall Study||0
10666709|NCT02300077|11829081|FG001|NOT COMPLETED|Overall Study||0
10666710|NCT02300077|11829082|FG002|NOT COMPLETED|Overall Study||0
10666711|NCT02300103|11829090|FG000|STARTED|Overall Study||69
10666712|NCT02300103|11829090|FG000|COMPLETED|Overall Study||63
10666713|NCT02300103|11829090|FG000|NOT COMPLETED|Overall Study||6
10666714|NCT02300129|11829094|FG000|STARTED|Period 1 Session 1 (Day 1)||11
10666715|NCT02300129|11829095|FG001|STARTED|Period 1 Session 1 (Day 1)||5
10666716|NCT02300129|11829096|FG002|STARTED|Period 1 Session 1 (Day 1)||7
10666717|NCT02300129|11829097|FG003|STARTED|Period 1 Session 1 (Day 1)||11
10666718|NCT02300129|11829094|FG000|COMPLETED|Period 1 Session 1 (Day 1)||11
10666719|NCT02300129|11829095|FG001|COMPLETED|Period 1 Session 1 (Day 1)||5
10666720|NCT02300129|11829096|FG002|COMPLETED|Period 1 Session 1 (Day 1)||7
10666721|NCT02300129|11829097|FG003|COMPLETED|Period 1 Session 1 (Day 1)||11
10666722|NCT02300129|11829094|FG000|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
10666723|NCT02300129|11829095|FG001|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
10666724|NCT02300129|11829096|FG002|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
10666725|NCT02300129|11829097|FG003|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
10666726|NCT02300129|11829094|FG000|STARTED|Period 1 Session 2 (Day 3)||11
10666727|NCT02300129|11829095|FG001|STARTED|Period 1 Session 2 (Day 3)|Withdrawal consent of 1 subject between Day 1 and Day 3|5
10666728|NCT02300129|11829096|FG002|STARTED|Period 1 Session 2 (Day 3)||7
10666729|NCT02300129|11829097|FG003|STARTED|Period 1 Session 2 (Day 3)||11
10666730|NCT02300129|11829094|FG000|COMPLETED|Period 1 Session 2 (Day 3)||11
10666731|NCT02300129|11829095|FG001|COMPLETED|Period 1 Session 2 (Day 3)||4
10666732|NCT02300129|11829096|FG002|COMPLETED|Period 1 Session 2 (Day 3)||7
10666733|NCT02300129|11829097|FG003|COMPLETED|Period 1 Session 2 (Day 3)||11
10666734|NCT02300129|11829094|FG000|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
10666735|NCT02300129|11829095|FG001|NOT COMPLETED|Period 1 Session 2 (Day 3)||1
10666736|NCT02300129|11829096|FG002|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
10666737|NCT02300129|11829097|FG003|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
10666738|NCT02300129|11829094|FG000|STARTED|Period 1 Session 3 (Day 5)||11
10666739|NCT02300129|11829095|FG001|STARTED|Period 1 Session 3 (Day 5)||4
10666740|NCT02300129|11829096|FG002|STARTED|Period 1 Session 3 (Day 5)||7
10666741|NCT02300129|11829097|FG003|STARTED|Period 1 Session 3 (Day 5)||11
10666742|NCT02300129|11829094|FG000|COMPLETED|Period 1 Session 3 (Day 5)||11
10666743|NCT02300129|11829095|FG001|COMPLETED|Period 1 Session 3 (Day 5)||4
10666744|NCT02300129|11829096|FG002|COMPLETED|Period 1 Session 3 (Day 5)||7
10666745|NCT02300129|11829097|FG003|COMPLETED|Period 1 Session 3 (Day 5)||11
10666746|NCT02300129|11829094|FG000|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
10666747|NCT02300129|11829095|FG001|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
10666748|NCT02300129|11829096|FG002|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
10666749|NCT02300129|11829097|FG003|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
10666750|NCT02300129|11829094|FG000|STARTED|Period 2 Treatment 1 (2 Weeks)||11
10666751|NCT02300129|11829095|FG001|STARTED|Period 2 Treatment 1 (2 Weeks)||4
10666752|NCT02300129|11829096|FG002|STARTED|Period 2 Treatment 1 (2 Weeks)||7
10666753|NCT02300129|11829097|FG003|STARTED|Period 2 Treatment 1 (2 Weeks)|Withdrawal consent of 1 subject between the Period 1 and Period 2|11
10666754|NCT02300129|11829094|FG000|COMPLETED|Period 2 Treatment 1 (2 Weeks)||10
10666755|NCT02300129|11829095|FG001|COMPLETED|Period 2 Treatment 1 (2 Weeks)||4
10666756|NCT02300129|11829096|FG002|COMPLETED|Period 2 Treatment 1 (2 Weeks)||7
10666757|NCT02300129|11829097|FG003|COMPLETED|Period 2 Treatment 1 (2 Weeks)||10
10666758|NCT02300129|11829094|FG000|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||1
10666759|NCT02300129|11829095|FG001|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||0
10666760|NCT02300129|11829096|FG002|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||0
10666761|NCT02300129|11829097|FG003|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||1
10666762|NCT02300129|11829094|FG000|STARTED|Period 2 Treatment 2 (2 Weeks)||10
10666763|NCT02300129|11829095|FG001|STARTED|Period 2 Treatment 2 (2 Weeks)||4
10666764|NCT02300129|11829096|FG002|STARTED|Period 2 Treatment 2 (2 Weeks)||7
10666765|NCT02300129|11829097|FG003|STARTED|Period 2 Treatment 2 (2 Weeks)||10
10666766|NCT02300129|11829094|FG000|COMPLETED|Period 2 Treatment 2 (2 Weeks)||10
10666767|NCT02300129|11829095|FG001|COMPLETED|Period 2 Treatment 2 (2 Weeks)||4
10666768|NCT02300129|11829096|FG002|COMPLETED|Period 2 Treatment 2 (2 Weeks)||7
10666769|NCT02300129|11829097|FG003|COMPLETED|Period 2 Treatment 2 (2 Weeks)||10
10712272|NCT02669095|11877870|FG001|NOT COMPLETED|Overall Study||3
10666770|NCT02300129|11829094|FG000|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
10666771|NCT02300129|11829095|FG001|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
10666772|NCT02300129|11829096|FG002|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
10666773|NCT02300129|11829097|FG003|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
10666774|NCT02300220|11829109|FG000|STARTED|Overall Study||72
10666775|NCT02300220|11829110|FG001|STARTED|Overall Study||72
10666776|NCT02300220|11829109|FG000|COMPLETED|Overall Study||68
10666777|NCT02300220|11829110|FG001|COMPLETED|Overall Study||65
10666778|NCT02300220|11829109|FG000|NOT COMPLETED|Overall Study||4
10666779|NCT02300220|11829110|FG001|NOT COMPLETED|Overall Study||7
10666780|NCT02300259|11829119|FG000|STARTED|Period 1||16
10666781|NCT02300259|11829120|FG001|STARTED|Period 1||16
10666782|NCT02300259|11829121|FG002|STARTED|Period 1||16
10666783|NCT02300259|11829119|FG000|Received at Least One Dose of Study Drug|Period 1||16
10666784|NCT02300259|11829120|FG001|Received at Least One Dose of Study Drug|Period 1||16
10666785|NCT02300259|11829121|FG002|Received at Least One Dose of Study Drug|Period 1||16
10666786|NCT02300259|11829119|FG000|COMPLETED|Period 1||16
10666787|NCT02300259|11829120|FG001|COMPLETED|Period 1||16
10666788|NCT02300259|11829121|FG002|COMPLETED|Period 1||14
10666789|NCT02300259|11829119|FG000|NOT COMPLETED|Period 1||0
10666790|NCT02300259|11829120|FG001|NOT COMPLETED|Period 1||0
10666791|NCT02300259|11829121|FG002|NOT COMPLETED|Period 1||2
10666792|NCT02300259|11829119|FG000|STARTED|Period 2||16
10666793|NCT02300259|11829120|FG001|STARTED|Period 2|There was no period 2 for Group 2.|0
10666794|NCT02300259|11829121|FG002|STARTED|Period 2||14
10666795|NCT02300259|11829119|FG000|COMPLETED|Period 2||15
10666796|NCT02300259|11829120|FG001|COMPLETED|Period 2||0
10666797|NCT02300259|11829121|FG002|COMPLETED|Period 2||13
10666798|NCT02300259|11829119|FG000|NOT COMPLETED|Period 2||1
10666799|NCT02300259|11829120|FG001|NOT COMPLETED|Period 2||0
10666800|NCT02300259|11829121|FG002|NOT COMPLETED|Period 2||1
10666801|NCT02300285|11829142|FG000|STARTED|Overall Study||3
10666802|NCT02300285|11829143|FG001|STARTED|Overall Study||3
10666803|NCT02300285|11829142|FG000|COMPLETED|Overall Study||3
10666804|NCT02300285|11829143|FG001|COMPLETED|Overall Study||3
10666805|NCT02300285|11829142|FG000|NOT COMPLETED|Overall Study||0
10666806|NCT02300285|11829143|FG001|NOT COMPLETED|Overall Study||0
10666807|NCT02300298|11829149|FG000|STARTED|Disposition for Nintedanib||10
10666808|NCT02300298|11829150|FG001|STARTED|Disposition for Nintedanib||0
10666809|NCT02300298|11829149|FG000|COMPLETED|Disposition for Nintedanib||0
10666810|NCT02300298|11829150|FG001|COMPLETED|Disposition for Nintedanib||0
10666811|NCT02300298|11829149|FG000|NOT COMPLETED|Disposition for Nintedanib||10
10666812|NCT02300298|11829150|FG001|NOT COMPLETED|Disposition for Nintedanib||0
10666813|NCT02300298|11829149|FG000|STARTED|Disposition for Docetaxel||0
10666814|NCT02300298|11829150|FG001|STARTED|Disposition for Docetaxel||10
10666815|NCT02300298|11829149|FG000|COMPLETED|Disposition for Docetaxel||0
10666816|NCT02300298|11829150|FG001|COMPLETED|Disposition for Docetaxel||0
10666817|NCT02300298|11829149|FG000|NOT COMPLETED|Disposition for Docetaxel||0
10666818|NCT02300298|11829150|FG001|NOT COMPLETED|Disposition for Docetaxel||10
10666819|NCT02300311|11829156|FG000|STARTED|Overall Study||69
10666820|NCT02300311|11829157|FG001|STARTED|Overall Study||69
10666821|NCT02300311|11829156|FG000|COMPLETED|Overall Study||50
10666822|NCT02300311|11829157|FG001|COMPLETED|Overall Study||69
10666823|NCT02300311|11829156|FG000|NOT COMPLETED|Overall Study||19
10666824|NCT02300311|11829157|FG001|NOT COMPLETED|Overall Study||0
10666825|NCT02300545|11829163|FG000|STARTED|Overall Study||56
10666826|NCT02300545|11829163|FG000|COMPLETED|Overall Study||56
10666827|NCT02300545|11829163|FG000|NOT COMPLETED|Overall Study||0
10666828|NCT02300558|11829167|FG000|STARTED|Single Blind Phase (24 Weeks)||41
10666829|NCT02300558|11829167|FG000|COMPLETED|Single Blind Phase (24 Weeks)||35
10666830|NCT02300558|11829167|FG000|NOT COMPLETED|Single Blind Phase (24 Weeks)||6
10666831|NCT02300558|11829167|FG000|STARTED|Open-Label (OL) Extension Phase||32
10666832|NCT02300558|11829167|FG000|COMPLETED|Open-Label (OL) Extension Phase||0
10666833|NCT02300558|11829167|FG000|NOT COMPLETED|Open-Label (OL) Extension Phase||32
10666834|NCT02300610|11829178|FG000|STARTED|Overall Study||3
10666835|NCT02300610|11829179|FG001|STARTED|Overall Study||3
10666836|NCT02300610|11829180|FG002|STARTED|Overall Study||4
10666837|NCT02300610|11829178|FG000|COMPLETED|Overall Study||2
10666838|NCT02300610|11829179|FG001|COMPLETED|Overall Study||3
10666839|NCT02300610|11829180|FG002|COMPLETED|Overall Study||3
10666840|NCT02300610|11829178|FG000|NOT COMPLETED|Overall Study||1
10666841|NCT02300610|11829179|FG001|NOT COMPLETED|Overall Study||0
10666842|NCT02300610|11829180|FG002|NOT COMPLETED|Overall Study||1
10666843|NCT02300727|11829196|FG000|STARTED|Overall Study||0
10666844|NCT02300727|11829197|FG001|STARTED|Overall Study||0
10666845|NCT02300727|11829198|FG002|STARTED|Overall Study||3
10666846|NCT02300727|11829199|FG003|STARTED|Overall Study||3
10666847|NCT02300727|11829200|FG004|STARTED|Overall Study||0
10666848|NCT02300727|11829201|FG005|STARTED|Overall Study||0
10666849|NCT02300727|11829196|FG000|COMPLETED|Overall Study||0
10666850|NCT02300727|11829197|FG001|COMPLETED|Overall Study||0
10666851|NCT02300727|11829198|FG002|COMPLETED|Overall Study||3
10666852|NCT02300727|11829199|FG003|COMPLETED|Overall Study||2
10666853|NCT02300727|11829200|FG004|COMPLETED|Overall Study||0
10666854|NCT02300727|11829201|FG005|COMPLETED|Overall Study||0
10666855|NCT02300727|11829196|FG000|NOT COMPLETED|Overall Study||0
10666856|NCT02300727|11829197|FG001|NOT COMPLETED|Overall Study||0
10666857|NCT02300727|11829198|FG002|NOT COMPLETED|Overall Study||0
10666858|NCT02300727|11829199|FG003|NOT COMPLETED|Overall Study||1
10666859|NCT02300727|11829200|FG004|NOT COMPLETED|Overall Study||0
10666860|NCT02300727|11829201|FG005|NOT COMPLETED|Overall Study||0
10666861|NCT02300987|11829217|FG000|STARTED|Primary Phase : Prior to Cross-over||8
10666862|NCT02300987|11829218|FG001|STARTED|Primary Phase : Prior to Cross-over||2
10666863|NCT02300987|11829217|FG000|COMPLETED|Primary Phase : Prior to Cross-over||2
10666864|NCT02300987|11829218|FG001|COMPLETED|Primary Phase : Prior to Cross-over||0
10666865|NCT02300987|11829217|FG000|NOT COMPLETED|Primary Phase : Prior to Cross-over||6
10666866|NCT02300987|11829218|FG001|NOT COMPLETED|Primary Phase : Prior to Cross-over||2
10666867|NCT02300987|11829217|FG000|STARTED|Secondary Phase : Cross-over to LEE011||1
10666868|NCT02300987|11829218|FG001|STARTED|Secondary Phase : Cross-over to LEE011||2
10666869|NCT02300987|11829217|FG000|COMPLETED|Secondary Phase : Cross-over to LEE011||0
10666870|NCT02300987|11829218|FG001|COMPLETED|Secondary Phase : Cross-over to LEE011||1
10666871|NCT02300987|11829217|FG000|NOT COMPLETED|Secondary Phase : Cross-over to LEE011||1
10666872|NCT02300987|11829218|FG001|NOT COMPLETED|Secondary Phase : Cross-over to LEE011||1
10666873|NCT02301039|11829228|FG000|STARTED|Overall Study||42
10666874|NCT02301039|11829229|FG001|STARTED|Overall Study||42
10666875|NCT02301039|11829230|FG002|STARTED|Overall Study||60
10666876|NCT02301039|11829228|FG000|COMPLETED|Overall Study||42
10666877|NCT02301039|11829229|FG001|COMPLETED|Overall Study||42
10666878|NCT02301039|11829230|FG002|COMPLETED|Overall Study||60
10666879|NCT02301039|11829228|FG000|NOT COMPLETED|Overall Study||0
10666880|NCT02301039|11829229|FG001|NOT COMPLETED|Overall Study||0
10666881|NCT02301039|11829230|FG002|NOT COMPLETED|Overall Study||0
10666882|NCT02301143|11829238|FG000|STARTED|Induction Period||107
10666883|NCT02301143|11829239|FG001|STARTED|Induction Period||0
10666884|NCT02301143|11829238|FG000|COMPLETED|Induction Period||62
10666885|NCT02301143|11829239|FG001|COMPLETED|Induction Period||0
10666886|NCT02301143|11829238|FG000|NOT COMPLETED|Induction Period||45
10666887|NCT02301143|11829239|FG001|NOT COMPLETED|Induction Period||0
10666888|NCT02301143|11829238|FG000|STARTED|Investigator's Choice||0
10666889|NCT02301143|11829239|FG001|STARTED|Investigator's Choice|12 participants continued nab-Paclitaxel/Gemcitabine; 18 started chemoradiation;17 underwent surgery|47
10666890|NCT02301143|11829238|FG000|COMPLETED|Investigator's Choice||0
10666891|NCT02301143|11829239|FG001|COMPLETED|Investigator's Choice|3 participants completed nab-Paclitaxel+Gemcitabine,18 completed chemoradiation,16 had surgery.|37
10666892|NCT02301143|11829238|FG000|NOT COMPLETED|Investigator's Choice||0
10666893|NCT02301143|11829239|FG001|NOT COMPLETED|Investigator's Choice||10
10666894|NCT02301169|11829252|FG000|STARTED|Overall Study||21
10666895|NCT02301169|11829253|FG001|STARTED|Overall Study||21
10666896|NCT02301169|11829252|FG000|COMPLETED|Overall Study||20
10666897|NCT02301169|11829253|FG001|COMPLETED|Overall Study||21
10666898|NCT02301169|11829252|FG000|NOT COMPLETED|Overall Study||1
10666899|NCT02301169|11829253|FG001|NOT COMPLETED|Overall Study||0
10666900|NCT02301299|11829259|FG000|STARTED|Overall Study||1322
10666901|NCT02301299|11829259|FG000|COMPLETED|Overall Study||1322
10666902|NCT02301299|11829259|FG000|NOT COMPLETED|Overall Study||0
10666903|NCT02301364|11829266|FG000|STARTED|Overall Study||4
10666904|NCT02301364|11829266|FG000|COMPLETED|Overall Study||4
10666905|NCT02301364|11829266|FG000|NOT COMPLETED|Overall Study||0
10666906|NCT02301377|11829272|FG000|STARTED|Overall Study||3
10666907|NCT02301377|11829273|FG001|STARTED|Overall Study||2
10666908|NCT02301377|11829272|FG000|COMPLETED|Overall Study||3
10666909|NCT02301377|11829273|FG001|COMPLETED|Overall Study||2
10666910|NCT02301377|11829272|FG000|NOT COMPLETED|Overall Study||0
10666911|NCT02301377|11829273|FG001|NOT COMPLETED|Overall Study||0
10666912|NCT02301390|11829281|FG000|STARTED|Overall Study||27
10666913|NCT02301390|11829282|FG001|STARTED|Overall Study||26
10666914|NCT02301390|11829281|FG000|COMPLETED|Overall Study||17
10666915|NCT02301390|11829282|FG001|COMPLETED|Overall Study||13
10666916|NCT02301390|11829281|FG000|NOT COMPLETED|Overall Study||10
10666917|NCT02301390|11829282|FG001|NOT COMPLETED|Overall Study||13
10666918|NCT02301403|11829290|FG000|STARTED|Overall Study||315
10666919|NCT02301403|11829291|FG001|STARTED|Overall Study||308
10666920|NCT02301403|11829290|FG000|COMPLETED|Overall Study||287
10666921|NCT02301403|11829291|FG001|COMPLETED|Overall Study||267
10666922|NCT02301403|11829290|FG000|NOT COMPLETED|Overall Study||28
10666923|NCT02301403|11829291|FG001|NOT COMPLETED|Overall Study||41
10666924|NCT02301416|11829299|FG000|STARTED|Overall Study||25
10666925|NCT02301416|11829300|FG001|STARTED|Overall Study||40
10666926|NCT02301416|11829299|FG000|COMPLETED|Overall Study||15
10666927|NCT02301416|11829300|FG001|COMPLETED|Overall Study||40
10666928|NCT02301416|11829299|FG000|NOT COMPLETED|Overall Study||10
10666929|NCT02301416|11829300|FG001|NOT COMPLETED|Overall Study||0
10666930|NCT02301429|11829306|FG000|STARTED|Overall Study||16
10666931|NCT02301429|11829306|FG000|COMPLETED|Overall Study||13
10666932|NCT02301429|11829306|FG000|NOT COMPLETED|Overall Study||3
10666933|NCT02301546|11829312|FG000|STARTED|Short-term Effectiveness (~13 Weeks)||73
10666934|NCT02301546|11829313|FG001|STARTED|Short-term Effectiveness (~13 Weeks)||73
10666935|NCT02301546|11829312|FG000|COMPLETED|Short-term Effectiveness (~13 Weeks)||55
10666936|NCT02301546|11829313|FG001|COMPLETED|Short-term Effectiveness (~13 Weeks)||58
10666937|NCT02301546|11829312|FG000|NOT COMPLETED|Short-term Effectiveness (~13 Weeks)||18
10666938|NCT02301546|11829313|FG001|NOT COMPLETED|Short-term Effectiveness (~13 Weeks)||15
10666939|NCT02301546|11829312|FG000|STARTED|Long Term Effectiveness (~1 Year)||55
10666940|NCT02301546|11829313|FG001|STARTED|Long Term Effectiveness (~1 Year)||58
10666941|NCT02301546|11829312|FG000|COMPLETED|Long Term Effectiveness (~1 Year)||43
10666942|NCT02301546|11829313|FG001|COMPLETED|Long Term Effectiveness (~1 Year)||51
10666943|NCT02301546|11829312|FG000|NOT COMPLETED|Long Term Effectiveness (~1 Year)||12
10666944|NCT02301546|11829313|FG001|NOT COMPLETED|Long Term Effectiveness (~1 Year)||7
10666945|NCT02301624|11829321|FG000|STARTED|Blind Induction Phase||56
10666946|NCT02301624|11829322|FG001|STARTED|Blind Induction Phase||61
10666947|NCT02301624|11829321|FG000|Received at Least 1 Dose of Study Drug|Blind Induction Phase||56
10666948|NCT02301624|11829322|FG001|Received at Least 1 Dose of Study Drug|Blind Induction Phase||61
10666949|NCT02301624|11829321|FG000|COMPLETED|Blind Induction Phase||55
10666950|NCT02301624|11829322|FG001|COMPLETED|Blind Induction Phase||61
10666951|NCT02301624|11829321|FG000|NOT COMPLETED|Blind Induction Phase||1
10666952|NCT02301624|11829322|FG001|NOT COMPLETED|Blind Induction Phase||0
10666953|NCT02301624|11829321|FG000|STARTED|Open-label Maintenance Phase||55
10666954|NCT02301624|11829322|FG001|STARTED|Open-label Maintenance Phase||61
10666955|NCT02301624|11829321|FG000|Received at Least 1 Dose of Study Drug|Open-label Maintenance Phase||55
10666956|NCT02301624|11829322|FG001|Received at Least 1 Dose of Study Drug|Open-label Maintenance Phase||61
10666957|NCT02301624|11829321|FG000|COMPLETED|Open-label Maintenance Phase||43
10666958|NCT02301624|11829322|FG001|COMPLETED|Open-label Maintenance Phase||44
10666959|NCT02301624|11829321|FG000|NOT COMPLETED|Open-label Maintenance Phase||12
10666960|NCT02301624|11829322|FG001|NOT COMPLETED|Open-label Maintenance Phase||17
10666961|NCT02301793|11829331|FG000|STARTED|Pre Education Study Period|Nurses had not been randomized|
10666962|NCT02301793|11829332|FG001|STARTED|Pre Education Study Period|Nurses had not been randomized|
10666963|NCT02301793|11829331|FG000|COMPLETED|Pre Education Study Period|Nurses had not been randomized|
10666964|NCT02301793|11829332|FG001|COMPLETED|Pre Education Study Period|Nurses had not been randomized|
10666965|NCT02301793|11829331|FG000|NOT COMPLETED|Pre Education Study Period||
10666966|NCT02301793|11829332|FG001|NOT COMPLETED|Pre Education Study Period||
10666967|NCT02301793|11829331|FG000|STARTED|During and Post Education Study Period||488
10666968|NCT02301793|11829332|FG001|STARTED|During and Post Education Study Period||445
10666969|NCT02301793|11829331|FG000|COMPLETED|During and Post Education Study Period||405
10666970|NCT02301793|11829332|FG001|COMPLETED|During and Post Education Study Period||396
10666971|NCT02301793|11829331|FG000|NOT COMPLETED|During and Post Education Study Period||83
10666972|NCT02301793|11829332|FG001|NOT COMPLETED|During and Post Education Study Period||49
10666973|NCT02301897|11829341|FG000|STARTED|Treatment Course 1||12
10666974|NCT02301897|11829342|FG001|STARTED|Treatment Course 1||17
10666975|NCT02301897|11829343|FG002|STARTED|Treatment Course 1||14
10666976|NCT02301897|11829341|FG000|COMPLETED|Treatment Course 1||9
10666977|NCT02301897|11829342|FG001|COMPLETED|Treatment Course 1||14
10666978|NCT02301897|11829343|FG002|COMPLETED|Treatment Course 1||8
10666979|NCT02301897|11829341|FG000|NOT COMPLETED|Treatment Course 1||3
10666980|NCT02301897|11829342|FG001|NOT COMPLETED|Treatment Course 1||3
10666981|NCT02301897|11829343|FG002|NOT COMPLETED|Treatment Course 1||6
10666982|NCT02301897|11829341|FG000|STARTED|Treatment Course 2||9
10666983|NCT02301897|11829342|FG001|STARTED|Treatment Course 2||14
10666984|NCT02301897|11829343|FG002|STARTED|Treatment Course 2||8
10666985|NCT02301897|11829341|FG000|COMPLETED|Treatment Course 2||8
10666986|NCT02301897|11829342|FG001|COMPLETED|Treatment Course 2||9
10666987|NCT02301897|11829343|FG002|COMPLETED|Treatment Course 2||7
10666988|NCT02301897|11829341|FG000|NOT COMPLETED|Treatment Course 2||1
10666989|NCT02301897|11829342|FG001|NOT COMPLETED|Treatment Course 2||5
10666990|NCT02301897|11829343|FG002|NOT COMPLETED|Treatment Course 2||1
10666991|NCT02301936|11829353|FG000|STARTED|Overall Study||9
10666992|NCT02301936|11829354|FG001|STARTED|Overall Study||1
10666993|NCT02301936|11829353|FG000|COMPLETED|Overall Study||8
10666994|NCT02301936|11829354|FG001|COMPLETED|Overall Study||1
10666995|NCT02301936|11829353|FG000|NOT COMPLETED|Overall Study||1
10666996|NCT02301936|11829354|FG001|NOT COMPLETED|Overall Study||0
10666997|NCT02301975|11829363|FG000|STARTED|Overall Study||504
10666998|NCT02301975|11829364|FG001|STARTED|Overall Study||501
10666999|NCT02301975|11829365|FG002|STARTED|Overall Study||499
10667000|NCT02301975|11829363|FG000|COMPLETED|Overall Study||473
10667001|NCT02301975|11829364|FG001|COMPLETED|Overall Study||476
10667002|NCT02301975|11829365|FG002|COMPLETED|Overall Study||477
10667003|NCT02301975|11829363|FG000|NOT COMPLETED|Overall Study||31
10667004|NCT02301975|11829364|FG001|NOT COMPLETED|Overall Study||25
10667005|NCT02301975|11829365|FG002|NOT COMPLETED|Overall Study||22
10667006|NCT02301988|11829375|FG000|STARTED|Overall Study||76
10667007|NCT02301988|11829376|FG001|STARTED|Overall Study||75
10667008|NCT02301988|11829375|FG000|COMPLETED|Overall Study||66
10667009|NCT02301988|11829376|FG001|COMPLETED|Overall Study||66
10667010|NCT02301988|11829375|FG000|NOT COMPLETED|Overall Study||10
10667011|NCT02301988|11829376|FG001|NOT COMPLETED|Overall Study||9
10667012|NCT02302066|11829386|FG000|STARTED|Overall Study||201
10667013|NCT02302066|11829387|FG001|STARTED|Overall Study||398
10667014|NCT02302066|11829388|FG002|STARTED|Overall Study||1002
10667015|NCT02302066|11829389|FG003|STARTED|Overall Study||199
10667016|NCT02302066|11829386|FG000|Safety Analysis Set|Overall Study||200
10667017|NCT02302066|11829387|FG001|Safety Analysis Set|Overall Study||398
10667018|NCT02302066|11829388|FG002|Safety Analysis Set|Overall Study||998
10667019|NCT02302066|11829389|FG003|Safety Analysis Set|Overall Study||198
10667020|NCT02302066|11829386|FG000|Immunogenicity Subset|Overall Study||92
10667021|NCT02302066|11829387|FG001|Immunogenicity Subset|Overall Study||187
10667022|NCT02302066|11829388|FG002|Immunogenicity Subset|Overall Study||192
10667023|NCT02302066|11829389|FG003|Immunogenicity Subset|Overall Study||94
10667024|NCT02302066|11829386|FG000|Per-Protocol Set (PPS)|Overall Study||83
10667025|NCT02302066|11829387|FG001|Per-Protocol Set (PPS)|Overall Study||171
10667026|NCT02302066|11829388|FG002|Per-Protocol Set (PPS)|Overall Study||174
10667027|NCT02302066|11829389|FG003|Per-Protocol Set (PPS)|Overall Study||81
10667028|NCT02302066|11829386|FG000|COMPLETED|Overall Study||168
10667029|NCT02302066|11829387|FG001|COMPLETED|Overall Study||323
10667030|NCT02302066|11829388|FG002|COMPLETED|Overall Study||830
10667031|NCT02302066|11829389|FG003|COMPLETED|Overall Study||158
10667032|NCT02302066|11829386|FG000|NOT COMPLETED|Overall Study||33
10667033|NCT02302066|11829387|FG001|NOT COMPLETED|Overall Study||75
10667034|NCT02302066|11829388|FG002|NOT COMPLETED|Overall Study||172
10667035|NCT02302066|11829389|FG003|NOT COMPLETED|Overall Study||41
10667036|NCT02302092|11829411|FG000|STARTED|Overall Study||6
10667037|NCT02302092|11829412|FG001|STARTED|Overall Study||7
10667038|NCT02302092|11829411|FG000|COMPLETED|Overall Study||6
10667039|NCT02302092|11829412|FG001|COMPLETED|Overall Study||7
10667040|NCT02302092|11829411|FG000|NOT COMPLETED|Overall Study||0
10667041|NCT02302092|11829412|FG001|NOT COMPLETED|Overall Study||0
10667042|NCT02302157|11829423|FG000|STARTED|Overall Study||3
10667043|NCT02302157|11829424|FG001|STARTED|Overall Study||6
10667044|NCT02302157|11829425|FG002|STARTED|Overall Study||6
10667045|NCT02302157|11829426|FG003|STARTED|Overall Study||6
10667046|NCT02302157|11829427|FG004|STARTED|Overall Study||4
10667047|NCT02302157|11829423|FG000|COMPLETED|Overall Study||3
10667048|NCT02302157|11829424|FG001|COMPLETED|Overall Study||6
10667049|NCT02302157|11829425|FG002|COMPLETED|Overall Study||6
10667050|NCT02302157|11829426|FG003|COMPLETED|Overall Study||6
10667051|NCT02302157|11829427|FG004|COMPLETED|Overall Study||4
10667052|NCT02302157|11829423|FG000|NOT COMPLETED|Overall Study||0
10667053|NCT02302157|11829424|FG001|NOT COMPLETED|Overall Study||0
10667054|NCT02302157|11829425|FG002|NOT COMPLETED|Overall Study||0
10667055|NCT02302157|11829426|FG003|NOT COMPLETED|Overall Study||0
10667056|NCT02302157|11829427|FG004|NOT COMPLETED|Overall Study||0
10667063|NCT02302339|11829457|FG000|STARTED|Overall Study||62
10667064|NCT02302339|11829458|FG001|STARTED|Overall Study||34
10667065|NCT02302339|11829459|FG002|STARTED|Overall Study||29
10667066|NCT02302339|11829460|FG003|STARTED|Overall Study||7
10667067|NCT02302339|11829457|FG000|COMPLETED|Overall Study||61
10667068|NCT02302339|11829458|FG001|COMPLETED|Overall Study||32
10667069|NCT02302339|11829459|FG002|COMPLETED|Overall Study||28
10667070|NCT02302339|11829460|FG003|COMPLETED|Overall Study||7
10667071|NCT02302339|11829457|FG000|NOT COMPLETED|Overall Study||1
10667072|NCT02302339|11829458|FG001|NOT COMPLETED|Overall Study||2
10667073|NCT02302339|11829459|FG002|NOT COMPLETED|Overall Study||1
10667074|NCT02302339|11829460|FG003|NOT COMPLETED|Overall Study||0
10667075|NCT02302365|11829471|FG000|STARTED|0-2 Hour Period|Data were collected from 58 WBCD procedures performed in 43 subjects - Full and Safety Analysis Sets|43
10667076|NCT02302365|11829471|FG000|COMPLETED|0-2 Hour Period|The Per-protocol Analysis Set comprised 54 procedures performed in 41 subjects|41
10667077|NCT02302365|11829471|FG000|NOT COMPLETED|0-2 Hour Period||2
10667078|NCT02302365|11829471|FG000|STARTED|0-24 Hour Period|2 of 3 study sites collected additional safety data; 32 pts. 0-24 hour data, 43 pts. 0-2 hour data|32
10667079|NCT02302365|11829471|FG000|COMPLETED|0-24 Hour Period||32
10667080|NCT02302365|11829471|FG000|NOT COMPLETED|0-24 Hour Period||0
10667081|NCT02302716|11829481|FG000|STARTED|Overall Study||249
10667082|NCT02302716|11829482|FG001|STARTED|Overall Study||244
10667083|NCT02302716|11829481|FG000|Received at Least 1 Dose of Study Drug|Overall Study||249
10667084|NCT02302716|11829482|FG001|Received at Least 1 Dose of Study Drug|Overall Study||244
10667085|NCT02302716|11829481|FG000|COMPLETED|Overall Study||230
10667086|NCT02302716|11829482|FG001|COMPLETED|Overall Study||225
10667087|NCT02302716|11829481|FG000|NOT COMPLETED|Overall Study||19
10667088|NCT02302716|11829482|FG001|NOT COMPLETED|Overall Study||19
10667089|NCT02302807|11829490|FG000|STARTED|Overall Study||464
10667090|NCT02302807|11829491|FG001|STARTED|Overall Study||467
10667091|NCT02302807|11829490|FG000|Received Treatment|Overall Study||443
10667092|NCT02302807|11829491|FG001|Received Treatment|Overall Study||459
10667093|NCT02302807|11829490|FG000|COMPLETED|Overall Study|Participants still on chemotherapy were discontinued where that treatment was available locally.|0
10667094|NCT02302807|11829491|FG001|COMPLETED|Overall Study|Participants still receiving atezolizumab had opportunity to continue treatment in extension study.|0
10667095|NCT02302807|11829490|FG000|NOT COMPLETED|Overall Study||464
10667096|NCT02302807|11829491|FG001|NOT COMPLETED|Overall Study||467
10667097|NCT02302846|11829510|FG000|STARTED|Overall Study||5
10667098|NCT02302846|11829510|FG000|COMPLETED|Overall Study||4
10667099|NCT02302846|11829510|FG000|NOT COMPLETED|Overall Study||1
10667100|NCT02303041|11829516|FG000|STARTED|Overall Study||4
10667101|NCT02303041|11829517|FG001|STARTED|Overall Study||6
10667102|NCT02303041|11829516|FG000|COMPLETED|Overall Study||3
10667103|NCT02303041|11829517|FG001|COMPLETED|Overall Study||4
10667104|NCT02303041|11829516|FG000|NOT COMPLETED|Overall Study||1
10667105|NCT02303041|11829517|FG001|NOT COMPLETED|Overall Study||2
10667106|NCT02303093|11829523|FG000|STARTED|Overall Study||344
10667107|NCT02303093|11829523|FG000|COMPLETED|Overall Study||344
10667108|NCT02303093|11829523|FG000|NOT COMPLETED|Overall Study||0
10667109|NCT02303184|11829541|FG000|STARTED|Overall Study||23
10667110|NCT02303184|11829542|FG001|STARTED|Overall Study||23
10667111|NCT02303184|11829541|FG000|COMPLETED|Overall Study||23
10667112|NCT02303184|11829542|FG001|COMPLETED|Overall Study||23
10667113|NCT02303184|11829541|FG000|NOT COMPLETED|Overall Study||0
10667114|NCT02303184|11829542|FG001|NOT COMPLETED|Overall Study||0
10667115|NCT02303262|11829548|FG000|STARTED|Overall Study||20
10667116|NCT02303262|11829548|FG000|COMPLETED|Overall Study||18
10667117|NCT02303262|11829548|FG000|NOT COMPLETED|Overall Study||2
10667118|NCT02303574|11829564|FG000|STARTED|Part 1a (Fasted State)- SAD||6
10667119|NCT02303574|11829565|FG001|STARTED|Part 1a (Fasted State)- SAD||6
10667120|NCT02303574|11829566|FG002|STARTED|Part 1a (Fasted State)- SAD||6
10667121|NCT02303574|11829567|FG003|STARTED|Part 1a (Fasted State)- SAD||6
10667122|NCT02303574|11829568|FG004|STARTED|Part 1a (Fasted State)- SAD||6
10667123|NCT02303574|11829569|FG005|STARTED|Part 1a (Fasted State)- SAD||0
10667124|NCT02303574|11829570|FG006|STARTED|Part 1a (Fasted State)- SAD||0
10667125|NCT02303574|11829571|FG007|STARTED|Part 1a (Fasted State)- SAD||0
10667126|NCT02303574|11829572|FG008|STARTED|Part 1a (Fasted State)- SAD||0
10667127|NCT02303574|11829573|FG009|STARTED|Part 1a (Fasted State)- SAD|Participants received AZD7986 matching placebo on Day 1 in fasted state.|15
10667128|NCT02303574|11829564|FG000|COMPLETED|Part 1a (Fasted State)- SAD||6
10667129|NCT02303574|11829565|FG001|COMPLETED|Part 1a (Fasted State)- SAD||6
10667130|NCT02303574|11829566|FG002|COMPLETED|Part 1a (Fasted State)- SAD||5
10667131|NCT02303574|11829567|FG003|COMPLETED|Part 1a (Fasted State)- SAD||6
10667132|NCT02303574|11829568|FG004|COMPLETED|Part 1a (Fasted State)- SAD||6
10667133|NCT02303574|11829569|FG005|COMPLETED|Part 1a (Fasted State)- SAD||0
10667134|NCT02303574|11829570|FG006|COMPLETED|Part 1a (Fasted State)- SAD||0
10667135|NCT02303574|11829571|FG007|COMPLETED|Part 1a (Fasted State)- SAD||0
10667136|NCT02303574|11829572|FG008|COMPLETED|Part 1a (Fasted State)- SAD||0
10667137|NCT02303574|11829573|FG009|COMPLETED|Part 1a (Fasted State)- SAD||15
10667138|NCT02303574|11829564|FG000|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
10667139|NCT02303574|11829565|FG001|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
10667140|NCT02303574|11829566|FG002|NOT COMPLETED|Part 1a (Fasted State)- SAD||1
10667141|NCT02303574|11829567|FG003|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
10667142|NCT02303574|11829568|FG004|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
10667143|NCT02303574|11829569|FG005|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
10667144|NCT02303574|11829570|FG006|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
10667145|NCT02303574|11829571|FG007|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
10667146|NCT02303574|11829572|FG008|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
10667147|NCT02303574|11829573|FG009|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
10667148|NCT02303574|11829564|FG000|STARTED|Part 1b (Fed State) - SAD||0
10667149|NCT02303574|11829565|FG001|STARTED|Part 1b (Fed State) - SAD||0
10667150|NCT02303574|11829566|FG002|STARTED|Part 1b (Fed State) - SAD||0
10667151|NCT02303574|11829567|FG003|STARTED|Part 1b (Fed State) - SAD||0
10667152|NCT02303574|11829568|FG004|STARTED|Part 1b (Fed State) - SAD||0
10667153|NCT02303574|11829569|FG005|STARTED|Part 1b (Fed State) - SAD||5
10667154|NCT02303574|11829570|FG006|STARTED|Part 1b (Fed State) - SAD||0
10667155|NCT02303574|11829571|FG007|STARTED|Part 1b (Fed State) - SAD||0
10667156|NCT02303574|11829572|FG008|STARTED|Part 1b (Fed State) - SAD||0
10667157|NCT02303574|11829573|FG009|STARTED|Part 1b (Fed State) - SAD|Participants received AZD7986 matching placebo on Day 1 in fed state.|3
10667158|NCT02303574|11829564|FG000|COMPLETED|Part 1b (Fed State) - SAD||0
10667159|NCT02303574|11829565|FG001|COMPLETED|Part 1b (Fed State) - SAD||0
10667160|NCT02303574|11829566|FG002|COMPLETED|Part 1b (Fed State) - SAD||0
10667161|NCT02303574|11829567|FG003|COMPLETED|Part 1b (Fed State) - SAD||0
10667162|NCT02303574|11829568|FG004|COMPLETED|Part 1b (Fed State) - SAD||0
10667163|NCT02303574|11829569|FG005|COMPLETED|Part 1b (Fed State) - SAD||5
10667164|NCT02303574|11829570|FG006|COMPLETED|Part 1b (Fed State) - SAD||0
10667165|NCT02303574|11829571|FG007|COMPLETED|Part 1b (Fed State) - SAD||0
10667166|NCT02303574|11829572|FG008|COMPLETED|Part 1b (Fed State) - SAD||0
10667167|NCT02303574|11829573|FG009|COMPLETED|Part 1b (Fed State) - SAD||3
10667168|NCT02303574|11829564|FG000|NOT COMPLETED|Part 1b (Fed State) - SAD||0
10667169|NCT02303574|11829565|FG001|NOT COMPLETED|Part 1b (Fed State) - SAD||0
10667170|NCT02303574|11829566|FG002|NOT COMPLETED|Part 1b (Fed State) - SAD||0
10667171|NCT02303574|11829567|FG003|NOT COMPLETED|Part 1b (Fed State) - SAD||0
10667172|NCT02303574|11829568|FG004|NOT COMPLETED|Part 1b (Fed State) - SAD||0
10667173|NCT02303574|11829569|FG005|NOT COMPLETED|Part 1b (Fed State) - SAD||0
10667174|NCT02303574|11829570|FG006|NOT COMPLETED|Part 1b (Fed State) - SAD||0
10667175|NCT02303574|11829571|FG007|NOT COMPLETED|Part 1b (Fed State) - SAD||0
10667176|NCT02303574|11829572|FG008|NOT COMPLETED|Part 1b (Fed State) - SAD||0
10667177|NCT02303574|11829573|FG009|NOT COMPLETED|Part 1b (Fed State) - SAD||0
10667178|NCT02303574|11829564|FG000|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
10667179|NCT02303574|11829565|FG001|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
10667180|NCT02303574|11829566|FG002|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
10667181|NCT02303574|11829567|FG003|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
10667182|NCT02303574|11829568|FG004|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
10667183|NCT02303574|11829569|FG005|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
10667184|NCT02303574|11829570|FG006|STARTED|Part 2 - Multiple Ascending Dose (MAD)||6
10667185|NCT02303574|11829571|FG007|STARTED|Part 2 - Multiple Ascending Dose (MAD)||8
10667186|NCT02303574|11829572|FG008|STARTED|Part 2 - Multiple Ascending Dose (MAD)||10
10667187|NCT02303574|11829573|FG009|STARTED|Part 2 - Multiple Ascending Dose (MAD)|Participants took AZD7986 matching placebo for 28 days (fasted/fed state, based on part 1b results)|12
10667188|NCT02303574|11829564|FG000|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
10667189|NCT02303574|11829565|FG001|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
10667190|NCT02303574|11829566|FG002|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
10667191|NCT02303574|11829567|FG003|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
10667192|NCT02303574|11829568|FG004|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
10667193|NCT02303574|11829569|FG005|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
10667194|NCT02303574|11829570|FG006|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||6
10667195|NCT02303574|11829571|FG007|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||7
10667196|NCT02303574|11829572|FG008|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||10
10667197|NCT02303574|11829573|FG009|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||12
10667198|NCT02303574|11829564|FG000|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
10667199|NCT02303574|11829565|FG001|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
10667200|NCT02303574|11829566|FG002|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
10667201|NCT02303574|11829567|FG003|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
10667202|NCT02303574|11829568|FG004|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
10667203|NCT02303574|11829569|FG005|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
10667204|NCT02303574|11829570|FG006|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
10667205|NCT02303574|11829571|FG007|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||1
10667206|NCT02303574|11829572|FG008|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
10667207|NCT02303574|11829573|FG009|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
10667208|NCT02303704|11829608|FG000|STARTED|Overall Study||220
10667209|NCT02303704|11829609|FG001|STARTED|Overall Study||228
10667210|NCT02303704|11829608|FG000|COMPLETED|Overall Study||215
10667211|NCT02303704|11829609|FG001|COMPLETED|Overall Study||219
10667212|NCT02303704|11829608|FG000|NOT COMPLETED|Overall Study||5
10667213|NCT02303704|11829609|FG001|NOT COMPLETED|Overall Study||9
10667214|NCT02303743|11829617|FG000|STARTED|Overall Study||108
10667215|NCT02303743|11829618|FG001|STARTED|Overall Study||152
10667216|NCT02303743|11829617|FG000|COMPLETED|Overall Study||108
10667217|NCT02303743|11829618|FG001|COMPLETED|Overall Study||152
10667218|NCT02303743|11829617|FG000|NOT COMPLETED|Overall Study||0
10667219|NCT02303743|11829618|FG001|NOT COMPLETED|Overall Study||0
10667220|NCT02303977|11829624|FG000|STARTED|Overall Study||37
10667221|NCT02303977|11829624|FG000|COMPLETED|Overall Study||37
10667222|NCT02303977|11829624|FG000|NOT COMPLETED|Overall Study||0
10667223|NCT02303990|11829629|FG000|STARTED|Overall Study||59
10667224|NCT02303990|11829629|FG000|COMPLETED|Overall Study||59
10667225|NCT02303990|11829629|FG000|NOT COMPLETED|Overall Study||0
10667226|NCT02304159|11829635|FG000|STARTED|Overall Study||21
10667227|NCT02304159|11829636|FG001|STARTED|Overall Study||18
10667228|NCT02304159|11829635|FG000|COMPLETED|Overall Study||19
10667229|NCT02304159|11829636|FG001|COMPLETED|Overall Study||16
10667230|NCT02304159|11829635|FG000|NOT COMPLETED|Overall Study||2
10667231|NCT02304159|11829636|FG001|NOT COMPLETED|Overall Study||2
10667232|NCT02304380|11829648|FG000|STARTED|Pediatric Claims Data Analysis (Aim 3)||0
10667233|NCT02304380|11829649|FG001|STARTED|Pediatric Claims Data Analysis (Aim 3)||0
10667234|NCT02304380|11829650|FG002|STARTED|Pediatric Claims Data Analysis (Aim 3)||0
10667235|NCT02304380|11829651|FG003|STARTED|Pediatric Claims Data Analysis (Aim 3)||0
10667236|NCT02304380|11829652|FG004|STARTED|Pediatric Claims Data Analysis (Aim 3)||17356
10667237|NCT02304380|11829653|FG005|STARTED|Pediatric Claims Data Analysis (Aim 3)||47026
10667238|NCT02304380|11829648|FG000|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
10667239|NCT02304380|11829649|FG001|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
10667240|NCT02304380|11829650|FG002|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
10667241|NCT02304380|11829651|FG003|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
10667242|NCT02304380|11829652|FG004|COMPLETED|Pediatric Claims Data Analysis (Aim 3)|2,096 Caregivers of the 17,356 claims were included in the Caregiver Survey.|17356
10667243|NCT02304380|11829653|FG005|COMPLETED|Pediatric Claims Data Analysis (Aim 3)|Not included in any other portion of the study.|47026
10667244|NCT02304380|11829648|FG000|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
10667245|NCT02304380|11829649|FG001|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
10667246|NCT02304380|11829650|FG002|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
10667247|NCT02304380|11829651|FG003|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
10795801|NCT03646305|11956085|FG001|No Treatment Recieved|Overall Study||0
10795802|NCT03646305|11956086|FG002|No Treatment Recieved|Overall Study||1
10795803|NCT03646305|11956087|FG003|No Treatment Recieved|Overall Study||1
10795804|NCT03646305|11956084|FG000|COMPLETED|Overall Study||27
10795805|NCT03646305|11956085|FG001|COMPLETED|Overall Study||33
10795806|NCT03646305|11956086|FG002|COMPLETED|Overall Study||31
10795807|NCT03646305|11956087|FG003|COMPLETED|Overall Study||31
10795808|NCT03646305|11956084|FG000|NOT COMPLETED|Overall Study||5
10795809|NCT03646305|11956085|FG001|NOT COMPLETED|Overall Study||2
10795810|NCT03646305|11956086|FG002|NOT COMPLETED|Overall Study||2
10795811|NCT03646305|11956087|FG003|NOT COMPLETED|Overall Study||2
10795812|NCT03646656|11956103|FG000|STARTED|Overall Study||12
10795813|NCT03646656|11956104|FG001|STARTED|Overall Study||3
10795814|NCT03646656|11956103|FG000|Attended 1st Group Session|Overall Study||10
10795815|NCT03646656|11956104|FG001|Attended 1st Group Session|Overall Study||3
10795816|NCT03646656|11956103|FG000|COMPLETED|Overall Study||9
10795817|NCT03646656|11956104|FG001|COMPLETED|Overall Study||3
10795818|NCT03646656|11956103|FG000|NOT COMPLETED|Overall Study||3
10795819|NCT03646656|11956104|FG001|NOT COMPLETED|Overall Study||0
10667248|NCT02304380|11829652|FG004|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
10795820|NCT03647033|11956116|FG000|STARTED|Overall Study||16
10795821|NCT03647033|11956117|FG001|STARTED|Overall Study||16
10795822|NCT03647033|11956116|FG000|COMPLETED|Overall Study||16
10795823|NCT03647033|11956117|FG001|COMPLETED|Overall Study||16
10795824|NCT03647033|11956116|FG000|NOT COMPLETED|Overall Study||0
10667249|NCT02304380|11829653|FG005|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
10667250|NCT02304380|11829648|FG000|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
10667251|NCT02304380|11829649|FG001|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
10667252|NCT02304380|11829650|FG002|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
10667253|NCT02304380|11829651|FG003|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||2096
10667254|NCT02304380|11829652|FG004|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
10667255|NCT02304380|11829653|FG005|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
10667256|NCT02304380|11829648|FG000|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
10667257|NCT02304380|11829649|FG001|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
10667258|NCT02304380|11829650|FG002|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
10667259|NCT02304380|11829651|FG003|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)|68 Caregivers/Patients of the 2,062 surveyed were included in the Interviews and Focus Group .|2062
10667260|NCT02304380|11829652|FG004|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
10667261|NCT02304380|11829653|FG005|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
10667262|NCT02304380|11829648|FG000|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
10667263|NCT02304380|11829649|FG001|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
10667264|NCT02304380|11829650|FG002|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
10667265|NCT02304380|11829651|FG003|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||34
10667266|NCT02304380|11829652|FG004|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
10667267|NCT02304380|11829653|FG005|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
10667268|NCT02304380|11829648|FG000|STARTED|Interviews & Focus Groups (Aim 1)||0
10667269|NCT02304380|11829649|FG001|STARTED|Interviews & Focus Groups (Aim 1)||35
10667270|NCT02304380|11829650|FG002|STARTED|Interviews & Focus Groups (Aim 1)||33
10667271|NCT02304380|11829651|FG003|STARTED|Interviews & Focus Groups (Aim 1)||0
10667272|NCT02304380|11829652|FG004|STARTED|Interviews & Focus Groups (Aim 1)||0
10667273|NCT02304380|11829653|FG005|STARTED|Interviews & Focus Groups (Aim 1)||0
10667274|NCT02304380|11829648|FG000|COMPLETED|Interviews & Focus Groups (Aim 1)||0
10667275|NCT02304380|11829649|FG001|COMPLETED|Interviews & Focus Groups (Aim 1)||35
10667276|NCT02304380|11829650|FG002|COMPLETED|Interviews & Focus Groups (Aim 1)||33
10667277|NCT02304380|11829651|FG003|COMPLETED|Interviews & Focus Groups (Aim 1)||0
10667278|NCT02304380|11829652|FG004|COMPLETED|Interviews & Focus Groups (Aim 1)||0
10667279|NCT02304380|11829653|FG005|COMPLETED|Interviews & Focus Groups (Aim 1)||0
10667280|NCT02304380|11829648|FG000|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
10667281|NCT02304380|11829649|FG001|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
10667282|NCT02304380|11829650|FG002|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
10667283|NCT02304380|11829651|FG003|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
10667284|NCT02304380|11829652|FG004|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
10667285|NCT02304380|11829653|FG005|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
10667286|NCT02304380|11829648|FG000|STARTED|ACO Stakeholder Interviews (Aim 1)||24
10667287|NCT02304380|11829649|FG001|STARTED|ACO Stakeholder Interviews (Aim 1)||0
10667288|NCT02304380|11829650|FG002|STARTED|ACO Stakeholder Interviews (Aim 1)||0
10667289|NCT02304380|11829651|FG003|STARTED|ACO Stakeholder Interviews (Aim 1)||0
10667290|NCT02304380|11829652|FG004|STARTED|ACO Stakeholder Interviews (Aim 1)||0
10667291|NCT02304380|11829653|FG005|STARTED|ACO Stakeholder Interviews (Aim 1)||0
10667292|NCT02304380|11829648|FG000|COMPLETED|ACO Stakeholder Interviews (Aim 1)||24
10667293|NCT02304380|11829649|FG001|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
10667294|NCT02304380|11829650|FG002|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
10667295|NCT02304380|11829651|FG003|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
10667296|NCT02304380|11829652|FG004|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
10667297|NCT02304380|11829653|FG005|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
10667298|NCT02304380|11829648|FG000|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
10667299|NCT02304380|11829649|FG001|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
10667300|NCT02304380|11829650|FG002|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
10667301|NCT02304380|11829651|FG003|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
10667302|NCT02304380|11829652|FG004|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
10667303|NCT02304380|11829653|FG005|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
10667304|NCT02304406|11829667|FG000|STARTED|Overall Study||449
10667305|NCT02304406|11829667|FG000|COMPLETED|Overall Study||449
10667306|NCT02304406|11829667|FG000|NOT COMPLETED|Overall Study||0
10667307|NCT02304432|11829671|FG000|STARTED|Open Label DCS||2
10667308|NCT02304432|11829672|FG001|STARTED|Open Label DCS||0
10667309|NCT02304432|11829673|FG002|STARTED|Open Label DCS||0
10667310|NCT02304432|11829674|FG003|STARTED|Open Label DCS||0
10667311|NCT02304432|11829671|FG000|COMPLETED|Open Label DCS||2
10667312|NCT02304432|11829672|FG001|COMPLETED|Open Label DCS||0
10667313|NCT02304432|11829673|FG002|COMPLETED|Open Label DCS||0
10667314|NCT02304432|11829674|FG003|COMPLETED|Open Label DCS||0
10667315|NCT02304432|11829671|FG000|NOT COMPLETED|Open Label DCS||0
10667316|NCT02304432|11829672|FG001|NOT COMPLETED|Open Label DCS||0
10667317|NCT02304432|11829673|FG002|NOT COMPLETED|Open Label DCS||0
10667318|NCT02304432|11829674|FG003|NOT COMPLETED|Open Label DCS||0
10667319|NCT02304432|11829671|FG000|STARTED|Double-Blind DCS Placebo Crossover||0
10667320|NCT02304432|11829672|FG001|STARTED|Double-Blind DCS Placebo Crossover||1
10667321|NCT02304432|11829673|FG002|STARTED|Double-Blind DCS Placebo Crossover||1
10667322|NCT02304432|11829674|FG003|STARTED|Double-Blind DCS Placebo Crossover||0
10667323|NCT02304432|11829671|FG000|COMPLETED|Double-Blind DCS Placebo Crossover||0
10667324|NCT02304432|11829672|FG001|COMPLETED|Double-Blind DCS Placebo Crossover||1
10667325|NCT02304432|11829673|FG002|COMPLETED|Double-Blind DCS Placebo Crossover||1
10667326|NCT02304432|11829674|FG003|COMPLETED|Double-Blind DCS Placebo Crossover||0
10667327|NCT02304432|11829671|FG000|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
10667328|NCT02304432|11829672|FG001|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
10667329|NCT02304432|11829673|FG002|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
10667330|NCT02304432|11829674|FG003|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
10667331|NCT02304432|11829671|FG000|STARTED|Second Open Label DCS||0
10667332|NCT02304432|11829672|FG001|STARTED|Second Open Label DCS||0
10667333|NCT02304432|11829673|FG002|STARTED|Second Open Label DCS||0
10667334|NCT02304432|11829674|FG003|STARTED|Second Open Label DCS||2
10667335|NCT02304432|11829671|FG000|COMPLETED|Second Open Label DCS||0
10667336|NCT02304432|11829672|FG001|COMPLETED|Second Open Label DCS||0
10667337|NCT02304432|11829673|FG002|COMPLETED|Second Open Label DCS||0
10667338|NCT02304432|11829674|FG003|COMPLETED|Second Open Label DCS||2
10667339|NCT02304432|11829671|FG000|NOT COMPLETED|Second Open Label DCS||0
10667340|NCT02304432|11829672|FG001|NOT COMPLETED|Second Open Label DCS||0
10667341|NCT02304432|11829673|FG002|NOT COMPLETED|Second Open Label DCS||0
10667342|NCT02304432|11829674|FG003|NOT COMPLETED|Second Open Label DCS||0
10667343|NCT02304484|11829689|FG000|STARTED|Overall Study||770
10667344|NCT02304484|11829689|FG000|COMPLETED|Overall Study||745
10667345|NCT02304484|11829689|FG000|NOT COMPLETED|Overall Study||25
10667346|NCT02304705|11829695|FG000|STARTED|Overall Study||16
10667347|NCT02304705|11829696|FG001|STARTED|Overall Study||17
10667348|NCT02304705|11829695|FG000|COMPLETED|Overall Study||12
10667349|NCT02304705|11829696|FG001|COMPLETED|Overall Study||10
10667350|NCT02304705|11829695|FG000|NOT COMPLETED|Overall Study||4
10667351|NCT02304705|11829696|FG001|NOT COMPLETED|Overall Study||7
10712273|NCT02669121|11877878|FG000|STARTED|Overall Study||2377
10712274|NCT02669121|11877879|FG001|STARTED|Overall Study||2371
10712275|NCT02669121|11877878|FG000|Treated (Safety Analysis Set)|Overall Study||2357
10795825|NCT03647033|11956117|FG001|NOT COMPLETED|Overall Study||0
10795826|NCT03647046|11956123|FG000|STARTED|Overall Study||12
10795827|NCT03647046|11956123|FG000|COMPLETED|Overall Study||8
10795828|NCT03647046|11956123|FG000|NOT COMPLETED|Overall Study||4
10712276|NCT02669121|11877879|FG001|Treated (Safety Analysis Set)|Overall Study||2355
10712277|NCT02669121|11877878|FG000|COMPLETED|Overall Study||2087
10712278|NCT02669121|11877879|FG001|COMPLETED|Overall Study||2089
10712279|NCT02669121|11877878|FG000|NOT COMPLETED|Overall Study||290
10712280|NCT02669121|11877879|FG001|NOT COMPLETED|Overall Study||282
10712281|NCT02669264|11877892|FG000|STARTED|Overall Study||5
10712282|NCT02669264|11877893|FG001|STARTED|Overall Study||7
10712283|NCT02669264|11877894|FG002|STARTED|Overall Study||3
10712284|NCT02669264|11877895|FG003|STARTED|Overall Study||4
10712285|NCT02669264|11877896|FG004|STARTED|Overall Study||5
10712286|NCT02669264|11877897|FG005|STARTED|Overall Study||6
10712287|NCT02669264|11877898|FG006|STARTED|Overall Study||5
10712288|NCT02669264|11877892|FG000|COMPLETED|Overall Study||0
10712289|NCT02669264|11877893|FG001|COMPLETED|Overall Study||1
10712290|NCT02669264|11877894|FG002|COMPLETED|Overall Study||0
10712291|NCT02669264|11877895|FG003|COMPLETED|Overall Study||1
10712292|NCT02669264|11877896|FG004|COMPLETED|Overall Study||0
10712293|NCT02669264|11877897|FG005|COMPLETED|Overall Study||0
10712294|NCT02669264|11877898|FG006|COMPLETED|Overall Study||0
10712295|NCT02669264|11877892|FG000|NOT COMPLETED|Overall Study||5
10712296|NCT02669264|11877893|FG001|NOT COMPLETED|Overall Study||6
10712297|NCT02669264|11877894|FG002|NOT COMPLETED|Overall Study||3
10712298|NCT02669264|11877895|FG003|NOT COMPLETED|Overall Study||3
10712299|NCT02669264|11877896|FG004|NOT COMPLETED|Overall Study||5
10795835|NCT03647475|11956138|FG000|STARTED|Overall Study||752
10795836|NCT03647475|11956138|FG000|NCT03647475 - Included in One Month Clear Analysis Population|Overall Study||601
10795837|NCT03647475|11956138|FG000|NCT03344653- Included in One Month Clear Analysis Population|Overall Study||905
10712300|NCT02669264|11877897|FG005|NOT COMPLETED|Overall Study||6
10712301|NCT02669264|11877898|FG006|NOT COMPLETED|Overall Study||5
10795838|NCT03647475|11956138|FG000|COMPLETED|Overall Study||75
10795839|NCT03647475|11956138|FG000|NOT COMPLETED|Overall Study||677
10795840|NCT03647709|11956142|FG000|STARTED|Overall Study||400
10795841|NCT03647709|11956142|FG000|COMPLETED|Overall Study||386
10795842|NCT03647709|11956142|FG000|NOT COMPLETED|Overall Study||14
10712302|NCT02669329|11877916|FG000|STARTED|Overall Study||30
10712303|NCT02669329|11877916|FG000|COMPLETED|Overall Study||30
10712304|NCT02669329|11877916|FG000|NOT COMPLETED|Overall Study||0
10712305|NCT02669407|11877920|FG000|STARTED|Overall Study||14
10712306|NCT02669407|11877920|FG000|COMPLETED|Overall Study||11
10712307|NCT02669407|11877920|FG000|NOT COMPLETED|Overall Study||3
10712308|NCT02669433|11877927|FG000|STARTED|Overall Study||91
10712309|NCT02669433|11877928|FG001|STARTED|Overall Study||89
10712310|NCT02669433|11877929|FG002|STARTED|Overall Study||89
10712311|NCT02669433|11877927|FG000|Safety Population|Overall Study||91
10712312|NCT02669433|11877928|FG001|Safety Population|Overall Study||89
10712313|NCT02669433|11877929|FG002|Safety Population|Overall Study||88
10712314|NCT02669433|11877927|FG000|Intent to Treat (ITT) Population|Overall Study||89
10795843|NCT03648853|11956148|FG000|STARTED|Overall Study||12
10795844|NCT03648853|11956148|FG000|COMPLETED|Overall Study||12
10667352|NCT02304757|11829704|FG000|STARTED|Overall Study||70
10667353|NCT02304757|11829705|FG001|STARTED|Overall Study||72
10667354|NCT02304757|11829704|FG000|COMPLETED|Overall Study||70
10667355|NCT02304757|11829705|FG001|COMPLETED|Overall Study||72
10667356|NCT02304757|11829704|FG000|NOT COMPLETED|Overall Study||0
10667357|NCT02304757|11829705|FG001|NOT COMPLETED|Overall Study||0
10667358|NCT02304926|11829713|FG000|STARTED|Overall Study||22
10667359|NCT02304926|11829714|FG001|STARTED|Overall Study||20
10667360|NCT02304926|11829713|FG000|COMPLETED|Overall Study||20
10667361|NCT02304926|11829714|FG001|COMPLETED|Overall Study||19
10667362|NCT02304926|11829713|FG000|NOT COMPLETED|Overall Study||2
10667363|NCT02304926|11829714|FG001|NOT COMPLETED|Overall Study||1
10667364|NCT02305017|11829724|FG000|STARTED|Overall Study||14
10667365|NCT02305017|11829725|FG001|STARTED|Overall Study||14
10667366|NCT02305017|11829724|FG000|COMPLETED|Overall Study||14
10667367|NCT02305017|11829725|FG001|COMPLETED|Overall Study||14
10667368|NCT02305017|11829724|FG000|NOT COMPLETED|Overall Study||0
10667369|NCT02305017|11829725|FG001|NOT COMPLETED|Overall Study||0
10667370|NCT02305238|11829738|FG000|STARTED|Overall Study||124
10667371|NCT02305238|11829739|FG001|STARTED|Overall Study||123
10667372|NCT02305238|11829740|FG002|STARTED|Overall Study||8
10667373|NCT02305238|11829738|FG000|Treated|Overall Study||124
10667374|NCT02305238|11829739|FG001|Treated|Overall Study||123
10667375|NCT02305238|11829740|FG002|Treated|Overall Study||7
10667376|NCT02305238|11829738|FG000|Randomized|Overall Study||124
10667377|NCT02305238|11829739|FG001|Randomized|Overall Study||123
10667378|NCT02305238|11829740|FG002|Randomized|Overall Study||0
10667379|NCT02305238|11829738|FG000|BCVA Post-randomization Assessment|Overall Study||123
10667380|NCT02305238|11829739|FG001|BCVA Post-randomization Assessment|Overall Study||123
10667381|NCT02305238|11829740|FG002|BCVA Post-randomization Assessment|Overall Study||0
10667382|NCT02305238|11829738|FG000|COMPLETED|Overall Study||108
10667383|NCT02305238|11829739|FG001|COMPLETED|Overall Study||104
10667384|NCT02305238|11829740|FG002|COMPLETED|Overall Study||0
10667385|NCT02305238|11829738|FG000|NOT COMPLETED|Overall Study||16
10667386|NCT02305238|11829739|FG001|NOT COMPLETED|Overall Study||19
10667387|NCT02305238|11829740|FG002|NOT COMPLETED|Overall Study||8
10667388|NCT02305277|11829753|FG000|STARTED|Overall Study||15
10667389|NCT02305277|11829754|FG001|STARTED|Overall Study||14
10667390|NCT02305277|11829755|FG002|STARTED|Overall Study||14
10667391|NCT02305277|11829756|FG003|STARTED|Overall Study||14
10667392|NCT02305277|11829757|FG004|STARTED|Overall Study||14
10667393|NCT02305277|11829758|FG005|STARTED|Overall Study||14
10667394|NCT02305277|11829753|FG000|Received CM|Overall Study||15
10667395|NCT02305277|11829754|FG001|Received CM|Overall Study||14
10667396|NCT02305277|11829755|FG002|Received CM|Overall Study||14
10667397|NCT02305277|11829756|FG003|Received CM|Overall Study||14
10667398|NCT02305277|11829757|FG004|Received CM|Overall Study||14
10795845|NCT03648853|11956148|FG000|NOT COMPLETED|Overall Study||0
10795846|NCT03648879|11956152|FG000|STARTED|Overall Study||37
10795847|NCT03648879|11956152|FG000|COMPLETED|Overall Study||36
10795848|NCT03648879|11956152|FG000|NOT COMPLETED|Overall Study||1
10795849|NCT03649412|11956158|FG000|STARTED|Part A, Period 1 (4 Days)||16
10795850|NCT03649412|11956159|FG001|STARTED|Part A, Period 1 (4 Days)||0
10795851|NCT03649412|11956158|FG000|COMPLETED|Part A, Period 1 (4 Days)||16
10795852|NCT03649412|11956159|FG001|COMPLETED|Part A, Period 1 (4 Days)||0
10795853|NCT03649412|11956158|FG000|NOT COMPLETED|Part A, Period 1 (4 Days)||0
10795854|NCT03649412|11956159|FG001|NOT COMPLETED|Part A, Period 1 (4 Days)||0
10795855|NCT03649412|11956158|FG000|STARTED|Part A, Washout Period 1 (7 Days)||16
10795856|NCT03649412|11956159|FG001|STARTED|Part A, Washout Period 1 (7 Days)||0
10795857|NCT03649412|11956158|FG000|COMPLETED|Part A, Washout Period 1 (7 Days)||15
10795858|NCT03649412|11956159|FG001|COMPLETED|Part A, Washout Period 1 (7 Days)||0
10795859|NCT03649412|11956158|FG000|NOT COMPLETED|Part A, Washout Period 1 (7 Days)||1
10795860|NCT03649412|11956159|FG001|NOT COMPLETED|Part A, Washout Period 1 (7 Days)||0
10795861|NCT03649412|11956158|FG000|STARTED|Part A, Period 2 (3 Days)|1 Replacement par. was enrolled & dosed|16
10795862|NCT03649412|11956159|FG001|STARTED|Part A, Period 2 (3 Days)||0
10795863|NCT03649412|11956158|FG000|COMPLETED|Part A, Period 2 (3 Days)||16
10795864|NCT03649412|11956159|FG001|COMPLETED|Part A, Period 2 (3 Days)||0
10795865|NCT03649412|11956158|FG000|NOT COMPLETED|Part A, Period 2 (3 Days)||0
10795866|NCT03649412|11956159|FG001|NOT COMPLETED|Part A, Period 2 (3 Days)||0
10795867|NCT03649412|11956158|FG000|STARTED|Part A, Washout Period 2 (7 Days)||16
10795868|NCT03649412|11956159|FG001|STARTED|Part A, Washout Period 2 (7 Days)||0
10795869|NCT03649412|11956158|FG000|COMPLETED|Part A, Washout Period 2 (7 Days)||16
10795870|NCT03649412|11956159|FG001|COMPLETED|Part A, Washout Period 2 (7 Days)||0
10667399|NCT02305277|11829758|FG005|Received CM|Overall Study||14
10667400|NCT02305277|11829753|FG000|Received TBM|Overall Study||15
10667401|NCT02305277|11829754|FG001|Received TBM|Overall Study||14
10667402|NCT02305277|11829755|FG002|Received TBM|Overall Study||14
10667403|NCT02305277|11829756|FG003|Received TBM|Overall Study||14
10667404|NCT02305277|11829757|FG004|Received TBM|Overall Study||14
10667405|NCT02305277|11829758|FG005|Received TBM|Overall Study||14
10667406|NCT02305277|11829753|FG000|COMPLETED|Overall Study||14
10667407|NCT02305277|11829754|FG001|COMPLETED|Overall Study||14
10667408|NCT02305277|11829755|FG002|COMPLETED|Overall Study||14
10667409|NCT02305277|11829756|FG003|COMPLETED|Overall Study||14
10667410|NCT02305277|11829757|FG004|COMPLETED|Overall Study||13
10667411|NCT02305277|11829758|FG005|COMPLETED|Overall Study||14
10667412|NCT02305277|11829753|FG000|NOT COMPLETED|Overall Study||1
10667413|NCT02305277|11829754|FG001|NOT COMPLETED|Overall Study||0
10667414|NCT02305277|11829755|FG002|NOT COMPLETED|Overall Study||0
10667415|NCT02305277|11829756|FG003|NOT COMPLETED|Overall Study||0
10667416|NCT02305277|11829757|FG004|NOT COMPLETED|Overall Study||1
10667417|NCT02305277|11829758|FG005|NOT COMPLETED|Overall Study||0
10667418|NCT02305316|11829774|FG000|STARTED|Overall Study||14
10667419|NCT02305316|11829775|FG001|STARTED|Overall Study||14
10667420|NCT02305316|11829774|FG000|COMPLETED|Overall Study||14
10667421|NCT02305316|11829775|FG001|COMPLETED|Overall Study||14
10667422|NCT02305316|11829774|FG000|NOT COMPLETED|Overall Study||0
10667423|NCT02305316|11829775|FG001|NOT COMPLETED|Overall Study||0
10667424|NCT02305329|11829785|FG000|STARTED|Overall Study||14
10667425|NCT02305329|11829786|FG001|STARTED|Overall Study||14
10667426|NCT02305329|11829787|FG002|STARTED|Overall Study||14
10667427|NCT02305329|11829788|FG003|STARTED|Overall Study||14
10667428|NCT02305329|11829785|FG000|Period 1|Overall Study||14
10667429|NCT02305329|11829786|FG001|Period 1|Overall Study||14
10667430|NCT02305329|11829787|FG002|Period 1|Overall Study||14
10667431|NCT02305329|11829788|FG003|Period 1|Overall Study||14
10667432|NCT02305329|11829785|FG000|Period 2|Overall Study||14
10667433|NCT02305329|11829786|FG001|Period 2|Overall Study||13
10667434|NCT02305329|11829787|FG002|Period 2|Overall Study||14
10667435|NCT02305329|11829788|FG003|Period 2|Overall Study||14
10667436|NCT02305329|11829785|FG000|COMPLETED|Overall Study||14
10667437|NCT02305329|11829786|FG001|COMPLETED|Overall Study||13
10667438|NCT02305329|11829787|FG002|COMPLETED|Overall Study||14
10667439|NCT02305329|11829788|FG003|COMPLETED|Overall Study||14
10667440|NCT02305329|11829785|FG000|NOT COMPLETED|Overall Study||0
10667441|NCT02305329|11829786|FG001|NOT COMPLETED|Overall Study||1
10667442|NCT02305329|11829787|FG002|NOT COMPLETED|Overall Study||0
10667443|NCT02305329|11829788|FG003|NOT COMPLETED|Overall Study||0
10667444|NCT02305381|11829801|FG000|STARTED|Overall Study||132
10667445|NCT02305381|11829802|FG001|STARTED|Overall Study||132
10667446|NCT02305381|11829803|FG002|STARTED|Overall Study||133
10667447|NCT02305381|11829801|FG000|Exposed|Overall Study||132
10667448|NCT02305381|11829802|FG001|Exposed|Overall Study||131
10667449|NCT02305381|11829803|FG002|Exposed|Overall Study||133
10667450|NCT02305381|11829801|FG000|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|14
10667451|NCT02305381|11829802|FG001|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial|16
10667452|NCT02305381|11829803|FG002|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|13
10667453|NCT02305381|11829801|FG000|COMPLETED|Overall Study|Subjects who completed the trial.|127
10667454|NCT02305381|11829802|FG001|COMPLETED|Overall Study|Subjects who completed the trial.|127
10667455|NCT02305381|11829803|FG002|COMPLETED|Overall Study|Subjects who completed the trial.|126
10667456|NCT02305381|11829801|FG000|NOT COMPLETED|Overall Study||5
10667457|NCT02305381|11829802|FG001|NOT COMPLETED|Overall Study||5
10795871|NCT03649412|11956158|FG000|NOT COMPLETED|Part A, Washout Period 2 (7 Days)||0
10795872|NCT03649412|11956159|FG001|NOT COMPLETED|Part A, Washout Period 2 (7 Days)||0
10795873|NCT03649412|11956158|FG000|STARTED|Part A, Period 3 (4 Days)||16
10795874|NCT03649412|11956159|FG001|STARTED|Part A, Period 3 (4 Days)||0
10795875|NCT03649412|11956158|FG000|COMPLETED|Part A, Period 3 (4 Days)||16
10795876|NCT03649412|11956159|FG001|COMPLETED|Part A, Period 3 (4 Days)||0
10795877|NCT03649412|11956158|FG000|NOT COMPLETED|Part A, Period 3 (4 Days)||0
10795878|NCT03649412|11956159|FG001|NOT COMPLETED|Part A, Period 3 (4 Days)||0
10795879|NCT03649412|11956158|FG000|STARTED|Part A, Washout Period 3 (7 Days)||16
10667458|NCT02305381|11829803|FG002|NOT COMPLETED|Overall Study||7
10667459|NCT02305446|11829811|FG000|STARTED|Overall Study||55
10667460|NCT02305446|11829811|FG000|COMPLETED|Overall Study||54
10667461|NCT02305446|11829811|FG000|NOT COMPLETED|Overall Study||1
10667462|NCT02305563|11829820|FG000|STARTED|Treatment Period||3
10667463|NCT02305563|11829821|FG001|STARTED|Treatment Period||3
10667464|NCT02305563|11829822|FG002|STARTED|Treatment Period||26
10667465|NCT02305563|11829823|FG003|STARTED|Treatment Period||14
10667466|NCT02305563|11829824|FG004|STARTED|Treatment Period||24
10667467|NCT02305563|11829820|FG000|COMPLETED|Treatment Period|At the time of the Phase 1 lock, 1 participant was still continuing on treatment|1
10667468|NCT02305563|11829821|FG001|COMPLETED|Treatment Period|At the time of the Phase 1 lock, 1 participant was still continuing on treatment|1
10667469|NCT02305563|11829822|FG002|COMPLETED|Treatment Period||0
10667470|NCT02305563|11829823|FG003|COMPLETED|Treatment Period||0
10667471|NCT02305563|11829824|FG004|COMPLETED|Treatment Period||0
10667472|NCT02305563|11829820|FG000|NOT COMPLETED|Treatment Period||2
10667473|NCT02305563|11829821|FG001|NOT COMPLETED|Treatment Period||2
10667474|NCT02305563|11829822|FG002|NOT COMPLETED|Treatment Period||26
10667475|NCT02305563|11829823|FG003|NOT COMPLETED|Treatment Period||14
10667476|NCT02305563|11829824|FG004|NOT COMPLETED|Treatment Period||24
10667477|NCT02305563|11829820|FG000|STARTED|Follow-up Period||3
10795880|NCT03649412|11956159|FG001|STARTED|Part A, Washout Period 3 (7 Days)||0
10667478|NCT02305563|11829821|FG001|STARTED|Follow-up Period||3
10667479|NCT02305563|11829822|FG002|STARTED|Follow-up Period||11
10667480|NCT02305563|11829823|FG003|STARTED|Follow-up Period||6
10667481|NCT02305563|11829824|FG004|STARTED|Follow-up Period||12
10667482|NCT02305563|11829820|FG000|COMPLETED|Follow-up Period||0
10667483|NCT02305563|11829821|FG001|COMPLETED|Follow-up Period||0
10667484|NCT02305563|11829822|FG002|COMPLETED|Follow-up Period||0
10667485|NCT02305563|11829823|FG003|COMPLETED|Follow-up Period||0
10667486|NCT02305563|11829824|FG004|COMPLETED|Follow-up Period||0
10667487|NCT02305563|11829820|FG000|NOT COMPLETED|Follow-up Period||3
10667488|NCT02305563|11829821|FG001|NOT COMPLETED|Follow-up Period||3
10667489|NCT02305563|11829822|FG002|NOT COMPLETED|Follow-up Period||11
10667490|NCT02305563|11829823|FG003|NOT COMPLETED|Follow-up Period||6
10667491|NCT02305563|11829824|FG004|NOT COMPLETED|Follow-up Period||12
10667492|NCT02305732|11829840|FG000|STARTED|Overall Study||90
10667493|NCT02305732|11829840|FG000|COMPLETED|Overall Study||72
10667494|NCT02305732|11829840|FG000|NOT COMPLETED|Overall Study||18
10667495|NCT02305758|11829847|FG000|STARTED|Overall Study||65
10667496|NCT02305758|11829848|FG001|STARTED|Overall Study||65
10667497|NCT02305758|11829847|FG000|COMPLETED|Overall Study||0
10667498|NCT02305758|11829848|FG001|COMPLETED|Overall Study||0
10667499|NCT02305758|11829847|FG000|NOT COMPLETED|Overall Study||65
10667500|NCT02305758|11829848|FG001|NOT COMPLETED|Overall Study||65
10667501|NCT02305797|11829856|FG000|STARTED|Overall Study||247
10667502|NCT02305797|11829857|FG001|STARTED|Overall Study||248
10667503|NCT02305797|11829856|FG000|COMPLETED|Overall Study||202
10667504|NCT02305797|11829857|FG001|COMPLETED|Overall Study||210
10667505|NCT02305797|11829856|FG000|NOT COMPLETED|Overall Study||45
10667506|NCT02305797|11829857|FG001|NOT COMPLETED|Overall Study||38
10667507|NCT02305849|11829866|FG000|STARTED|Overall Study||175
10667508|NCT02305849|11829867|FG001|STARTED|Overall Study||174
10667509|NCT02305849|11829868|FG002|STARTED|Overall Study||85
10667510|NCT02305849|11829869|FG003|STARTED|Overall Study||85
10667511|NCT02305849|11829866|FG000|COMPLETED|Overall Study||148
10667512|NCT02305849|11829867|FG001|COMPLETED|Overall Study||146
10667513|NCT02305849|11829868|FG002|COMPLETED|Overall Study||67
10667514|NCT02305849|11829869|FG003|COMPLETED|Overall Study||66
10667515|NCT02305849|11829866|FG000|NOT COMPLETED|Overall Study||27
10667516|NCT02305849|11829867|FG001|NOT COMPLETED|Overall Study||28
10667517|NCT02305849|11829868|FG002|NOT COMPLETED|Overall Study||18
10667518|NCT02305849|11829869|FG003|NOT COMPLETED|Overall Study||19
10667519|NCT02305888|11829903|FG000|STARTED|Overall Study||63
10667520|NCT02305888|11829904|FG001|STARTED|Overall Study||63
10667521|NCT02305888|11829905|FG002|STARTED|Overall Study||63
10667522|NCT02305888|11829903|FG000|COMPLETED|Overall Study||63
10667523|NCT02305888|11829904|FG001|COMPLETED|Overall Study||62
10667524|NCT02305888|11829905|FG002|COMPLETED|Overall Study||62
10667525|NCT02305888|11829903|FG000|NOT COMPLETED|Overall Study||0
10667526|NCT02305888|11829904|FG001|NOT COMPLETED|Overall Study||1
10667527|NCT02305888|11829905|FG002|NOT COMPLETED|Overall Study||1
10667528|NCT02306265|11829913|FG000|STARTED|Overall Study||250
10667529|NCT02306265|11829913|FG000|COMPLETED|Overall Study||249
10667530|NCT02306265|11829913|FG000|NOT COMPLETED|Overall Study||1
10667531|NCT02306694|11829918|FG000|STARTED|Overall Study||16
10667532|NCT02306694|11829918|FG000|COMPLETED|Overall Study||12
10667533|NCT02306694|11829918|FG000|NOT COMPLETED|Overall Study||4
10667534|NCT02306759|11829924|FG000|STARTED|Overall Study||30
10667535|NCT02306759|11829925|FG001|STARTED|Overall Study||30
10667536|NCT02306759|11829924|FG000|COMPLETED|Overall Study||30
10667537|NCT02306759|11829925|FG001|COMPLETED|Overall Study||30
10667538|NCT02306759|11829924|FG000|NOT COMPLETED|Overall Study||0
10667539|NCT02306759|11829925|FG001|NOT COMPLETED|Overall Study||0
10667540|NCT02306850|11829933|FG000|STARTED|Overall Study||10
10667541|NCT02306850|11829933|FG000|COMPLETED|Overall Study||8
10667542|NCT02306850|11829933|FG000|NOT COMPLETED|Overall Study||2
10667543|NCT02306928|11829938|FG000|STARTED|Overall Study||15
10667544|NCT02306928|11829938|FG000|COMPLETED|Overall Study||15
10667545|NCT02306928|11829938|FG000|NOT COMPLETED|Overall Study||0
10667546|NCT02307123|11829942|FG000|STARTED|Overall Study||483
10667547|NCT02307123|11829942|FG000|COMPLETED|Overall Study||483
10667548|NCT02307123|11829942|FG000|NOT COMPLETED|Overall Study||0
10667549|NCT02307266|11829949|FG000|STARTED|Overall Study||33
10667550|NCT02307266|11829950|FG001|STARTED|Overall Study||33
10667551|NCT02307266|11829951|FG002|STARTED|Overall Study||31
10667552|NCT02307266|11829949|FG000|COMPLETED|Overall Study||25
10667553|NCT02307266|11829950|FG001|COMPLETED|Overall Study||32
10667554|NCT02307266|11829951|FG002|COMPLETED|Overall Study||25
10667555|NCT02307266|11829949|FG000|NOT COMPLETED|Overall Study||8
10667556|NCT02307266|11829950|FG001|NOT COMPLETED|Overall Study||1
10667557|NCT02307266|11829951|FG002|NOT COMPLETED|Overall Study||6
10667558|NCT02307318|11829959|FG000|STARTED|Overall Study||51
10667559|NCT02307318|11829959|FG000|COMPLETED|Overall Study||51
10667560|NCT02307318|11829959|FG000|NOT COMPLETED|Overall Study||0
10667561|NCT02307370|11829963|FG000|STARTED|Overall Study||44
10667562|NCT02307370|11829963|FG000|30 Day Follow-up|Overall Study||40
10667563|NCT02307370|11829963|FG000|180 Day Patient Telephone Contact|Overall Study||25
10667564|NCT02307370|11829963|FG000|COMPLETED|Overall Study||25
10667565|NCT02307370|11829963|FG000|NOT COMPLETED|Overall Study||19
10667566|NCT02307513|11829971|FG000|STARTED|Placebo Controlled Phase (Weeks 0-12)||103
10667567|NCT02307513|11829972|FG001|STARTED|Placebo Controlled Phase (Weeks 0-12)||104
10667568|NCT02307513|11829971|FG000|COMPLETED|Placebo Controlled Phase (Weeks 0-12)||83
10667569|NCT02307513|11829972|FG001|COMPLETED|Placebo Controlled Phase (Weeks 0-12)||96
10667570|NCT02307513|11829971|FG000|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-12)||20
10667571|NCT02307513|11829972|FG001|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-12)||8
10667572|NCT02307513|11829971|FG000|STARTED|Active Treatment Phase (Weeks 13-64)||83
10667573|NCT02307513|11829972|FG001|STARTED|Active Treatment Phase (Weeks 13-64)|1 participant completed Week 12; did not enter into active treatment|95
10667574|NCT02307513|11829971|FG000|COMPLETED|Active Treatment Phase (Weeks 13-64)||68
10667575|NCT02307513|11829972|FG001|COMPLETED|Active Treatment Phase (Weeks 13-64)||75
10667576|NCT02307513|11829971|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 13-64)||15
10667577|NCT02307513|11829972|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 13-64)||20
10667578|NCT02307513|11829971|FG000|STARTED|Long-term Extension||2
10667579|NCT02307513|11829972|FG001|STARTED|Long-term Extension||0
10667580|NCT02307513|11829971|FG000|COMPLETED|Long-term Extension||1
10667581|NCT02307513|11829972|FG001|COMPLETED|Long-term Extension||0
10667582|NCT02307513|11829971|FG000|NOT COMPLETED|Long-term Extension||1
10667583|NCT02307513|11829972|FG001|NOT COMPLETED|Long-term Extension||0
10667584|NCT02307526|11829982|FG000|STARTED|Day 1 - No Drug||10
10667585|NCT02307526|11829982|FG000|COMPLETED|Day 1 - No Drug||10
10667586|NCT02307526|11829982|FG000|NOT COMPLETED|Day 1 - No Drug||0
10667587|NCT02307526|11829982|FG000|STARTED|Day 2 - 60 mg of Pyridostigmine||10
10667588|NCT02307526|11829982|FG000|COMPLETED|Day 2 - 60 mg of Pyridostigmine||10
10667589|NCT02307526|11829982|FG000|NOT COMPLETED|Day 2 - 60 mg of Pyridostigmine||0
10667590|NCT02307552|11829988|FG000|STARTED|Overall Study||1
10795881|NCT03649412|11956158|FG000|COMPLETED|Part A, Washout Period 3 (7 Days)||16
10795882|NCT03649412|11956159|FG001|COMPLETED|Part A, Washout Period 3 (7 Days)||0
10795883|NCT03649412|11956158|FG000|NOT COMPLETED|Part A, Washout Period 3 (7 Days)||0
10795884|NCT03649412|11956159|FG001|NOT COMPLETED|Part A, Washout Period 3 (7 Days)||0
10795885|NCT03649412|11956158|FG000|STARTED|Part A, Period 4 (4 Days)||16
10795886|NCT03649412|11956159|FG001|STARTED|Part A, Period 4 (4 Days)||0
10795887|NCT03649412|11956158|FG000|COMPLETED|Part A, Period 4 (4 Days)||16
10795888|NCT03649412|11956159|FG001|COMPLETED|Part A, Period 4 (4 Days)||0
10795889|NCT03649412|11956158|FG000|NOT COMPLETED|Part A, Period 4 (4 Days)||0
10795890|NCT03649412|11956159|FG001|NOT COMPLETED|Part A, Period 4 (4 Days)||0
10795891|NCT03649412|11956158|FG000|STARTED|Part A, Washout Period 4 (7 Days)||16
10795892|NCT03649412|11956159|FG001|STARTED|Part A, Washout Period 4 (7 Days)||0
10795893|NCT03649412|11956158|FG000|COMPLETED|Part A, Washout Period 4 (7 Days)||14
10795894|NCT03649412|11956159|FG001|COMPLETED|Part A, Washout Period 4 (7 Days)||0
10795895|NCT03649412|11956158|FG000|NOT COMPLETED|Part A, Washout Period 4 (7 Days)||2
10795896|NCT03649412|11956159|FG001|NOT COMPLETED|Part A, Washout Period 4 (7 Days)||0
10795897|NCT03649412|11956158|FG000|STARTED|Part A, Period 5 (4 Days)|Two participant did not start in Period 5|12
10795898|NCT03649412|11956159|FG001|STARTED|Part A, Period 5 (4 Days)||0
10795899|NCT03649412|11956158|FG000|COMPLETED|Part A, Period 5 (4 Days)||12
10795900|NCT03649412|11956159|FG001|COMPLETED|Part A, Period 5 (4 Days)||0
10795901|NCT03649412|11956158|FG000|NOT COMPLETED|Part A, Period 5 (4 Days)||0
10795902|NCT03649412|11956159|FG001|NOT COMPLETED|Part A, Period 5 (4 Days)||0
10795903|NCT03649412|11956158|FG000|STARTED|Part A, Washout Period 5 (7 Days)||12
10795904|NCT03649412|11956159|FG001|STARTED|Part A, Washout Period 5 (7 Days)||0
10795905|NCT03649412|11956158|FG000|COMPLETED|Part A, Washout Period 5 (7 Days)||11
10795906|NCT03649412|11956159|FG001|COMPLETED|Part A, Washout Period 5 (7 Days)||0
10795907|NCT03649412|11956158|FG000|NOT COMPLETED|Part A, Washout Period 5 (7 Days)||1
10795908|NCT03649412|11956159|FG001|NOT COMPLETED|Part A, Washout Period 5 (7 Days)||0
10795909|NCT03649412|11956158|FG000|STARTED|Part A, Period 6 (4 Days)|1 of the participant who did not start Period 5 directly joined into Period 6|12
10795910|NCT03649412|11956159|FG001|STARTED|Part A, Period 6 (4 Days)||0
10795911|NCT03649412|11956158|FG000|COMPLETED|Part A, Period 6 (4 Days)||12
10795912|NCT03649412|11956159|FG001|COMPLETED|Part A, Period 6 (4 Days)||0
10795913|NCT03649412|11956158|FG000|NOT COMPLETED|Part A, Period 6 (4 Days)||0
10795914|NCT03649412|11956159|FG001|NOT COMPLETED|Part A, Period 6 (4 Days)||0
10795915|NCT03649412|11956158|FG000|STARTED|Part B, Period 1 (4 Days)|Participants in Part A did not enter Part B|0
10795916|NCT03649412|11956159|FG001|STARTED|Part B, Period 1 (4 Days)|16 new participants enrolled in Part B|16
10795917|NCT03649412|11956158|FG000|COMPLETED|Part B, Period 1 (4 Days)||0
10795918|NCT03649412|11956159|FG001|COMPLETED|Part B, Period 1 (4 Days)||16
10795919|NCT03649412|11956158|FG000|NOT COMPLETED|Part B, Period 1 (4 Days)||0
10795920|NCT03649412|11956159|FG001|NOT COMPLETED|Part B, Period 1 (4 Days)||0
10667591|NCT02307552|11829988|FG000|COMPLETED|Overall Study||1
10667592|NCT02307552|11829988|FG000|NOT COMPLETED|Overall Study||0
10667593|NCT02307682|11829995|FG000|STARTED|Overall Study||360
10667594|NCT02307682|11829996|FG001|STARTED|Overall Study||361
10667595|NCT02307682|11829997|FG002|STARTED|Overall Study||361
10667596|NCT02307682|11829995|FG000|Randomized and Treated|Overall Study||358
10667597|NCT02307682|11829996|FG001|Randomized and Treated|Overall Study||360
10667598|NCT02307682|11829997|FG002|Randomized and Treated|Overall Study||360
10667599|NCT02307682|11829995|FG000|COMPLETED|Overall Study||310
10667600|NCT02307682|11829996|FG001|COMPLETED|Overall Study||304
10667601|NCT02307682|11829997|FG002|COMPLETED|Overall Study||297
10667602|NCT02307682|11829995|FG000|NOT COMPLETED|Overall Study||50
10667603|NCT02307682|11829996|FG001|NOT COMPLETED|Overall Study||57
10667604|NCT02307682|11829997|FG002|NOT COMPLETED|Overall Study||64
10667605|NCT02307838|11830008|FG000|STARTED|Overall Study||56
10667606|NCT02307838|11830009|FG001|STARTED|Overall Study||64
10667607|NCT02307838|11830010|FG002|STARTED|Overall Study||55
10667608|NCT02307838|11830008|FG000|COMPLETED|Overall Study||56
10667609|NCT02307838|11830009|FG001|COMPLETED|Overall Study||64
10667610|NCT02307838|11830010|FG002|COMPLETED|Overall Study||55
10795921|NCT03649412|11956158|FG000|STARTED|Part B, Washout Period 1 (7 Days)||0
10795922|NCT03649412|11956159|FG001|STARTED|Part B, Washout Period 1 (7 Days)||16
10795923|NCT03649412|11956158|FG000|COMPLETED|Part B, Washout Period 1 (7 Days)||0
10795924|NCT03649412|11956159|FG001|COMPLETED|Part B, Washout Period 1 (7 Days)||15
10667611|NCT02307838|11830008|FG000|NOT COMPLETED|Overall Study||0
10795925|NCT03649412|11956158|FG000|NOT COMPLETED|Part B, Washout Period 1 (7 Days)||0
10667612|NCT02307838|11830009|FG001|NOT COMPLETED|Overall Study||0
10667613|NCT02307838|11830010|FG002|NOT COMPLETED|Overall Study||0
10667614|NCT02307916|11830021|FG000|STARTED|Overall Study||42
10667615|NCT02307916|11830022|FG001|STARTED|Overall Study||15
10667616|NCT02307916|11830021|FG000|COMPLETED|Overall Study||40
10667617|NCT02307916|11830022|FG001|COMPLETED|Overall Study||14
10667618|NCT02307916|11830021|FG000|NOT COMPLETED|Overall Study||2
10667619|NCT02307916|11830022|FG001|NOT COMPLETED|Overall Study||1
10667620|NCT02308007|11830031|FG000|STARTED|Overall Study||159
10667621|NCT02308007|11830032|FG001|STARTED|Overall Study||159
10667622|NCT02308007|11830033|FG002|STARTED|Overall Study||157
10667623|NCT02308007|11830031|FG000|COMPLETED|Overall Study||83
10667624|NCT02308007|11830032|FG001|COMPLETED|Overall Study||84
10667625|NCT02308007|11830033|FG002|COMPLETED|Overall Study||82
10667626|NCT02308007|11830031|FG000|NOT COMPLETED|Overall Study||76
10667627|NCT02308007|11830032|FG001|NOT COMPLETED|Overall Study||75
10667628|NCT02308007|11830033|FG002|NOT COMPLETED|Overall Study||75
10667629|NCT02308020|11830047|FG000|STARTED|Overall Study||27
10667630|NCT02308020|11830048|FG001|STARTED|Overall Study||58
10667631|NCT02308020|11830049|FG002|STARTED|Overall Study||9
10667632|NCT02308020|11830050|FG003|STARTED|Overall Study||28
10667633|NCT02308020|11830051|FG004|STARTED|Overall Study||23
10667634|NCT02308020|11830052|FG005|STARTED|Overall Study||17
10667635|NCT02308020|11830047|FG000|Received at Least One Dose of Study Drug|Overall Study||27
10667636|NCT02308020|11830048|FG001|Received at Least One Dose of Study Drug|Overall Study||58
10667637|NCT02308020|11830049|FG002|Received at Least One Dose of Study Drug|Overall Study||9
10667638|NCT02308020|11830050|FG003|Received at Least One Dose of Study Drug|Overall Study||28
10667639|NCT02308020|11830051|FG004|Received at Least One Dose of Study Drug|Overall Study||23
10667640|NCT02308020|11830052|FG005|Received at Least One Dose of Study Drug|Overall Study||17
10667641|NCT02308020|11830047|FG000|COMPLETED|Overall Study||23
10667642|NCT02308020|11830048|FG001|COMPLETED|Overall Study||38
10667643|NCT02308020|11830049|FG002|COMPLETED|Overall Study||6
10667644|NCT02308020|11830050|FG003|COMPLETED|Overall Study||24
10667645|NCT02308020|11830051|FG004|COMPLETED|Overall Study||19
10667646|NCT02308020|11830052|FG005|COMPLETED|Overall Study||12
10667647|NCT02308020|11830047|FG000|NOT COMPLETED|Overall Study||4
10667648|NCT02308020|11830048|FG001|NOT COMPLETED|Overall Study||20
10667649|NCT02308020|11830049|FG002|NOT COMPLETED|Overall Study||3
10667650|NCT02308020|11830050|FG003|NOT COMPLETED|Overall Study||4
10667651|NCT02308020|11830051|FG004|NOT COMPLETED|Overall Study||4
10667652|NCT02308020|11830052|FG005|NOT COMPLETED|Overall Study||5
10667653|NCT02308033|11830074|FG000|STARTED|Overall Study||102
10795926|NCT03649412|11956159|FG001|NOT COMPLETED|Part B, Washout Period 1 (7 Days)||1
10795927|NCT03649412|11956158|FG000|STARTED|Part B, Period 2 (4 Days)||0
10667654|NCT02308033|11830075|FG001|STARTED|Overall Study||102
10667655|NCT02308033|11830074|FG000|COMPLETED|Overall Study||76
10667656|NCT02308033|11830075|FG001|COMPLETED|Overall Study||83
10667657|NCT02308033|11830074|FG000|NOT COMPLETED|Overall Study||26
10667658|NCT02308033|11830075|FG001|NOT COMPLETED|Overall Study||19
10667659|NCT02308046|11830083|FG000|STARTED|Overall Study||107
10667660|NCT02308046|11830084|FG001|STARTED|Overall Study||105
10667661|NCT02308046|11830083|FG000|COMPLETED|Overall Study||73
10667662|NCT02308046|11830084|FG001|COMPLETED|Overall Study||67
10667663|NCT02308046|11830083|FG000|NOT COMPLETED|Overall Study||34
10667664|NCT02308046|11830084|FG001|NOT COMPLETED|Overall Study||38
10667665|NCT02308124|11830093|FG000|STARTED|Overall Study||29
10667666|NCT02308124|11830094|FG001|STARTED|Overall Study||29
10667667|NCT02308124|11830095|FG002|STARTED|Overall Study||29
10667668|NCT02308124|11830093|FG000|COMPLETED|Overall Study||23
10667669|NCT02308124|11830094|FG001|COMPLETED|Overall Study||21
10667670|NCT02308124|11830095|FG002|COMPLETED|Overall Study||21
10667671|NCT02308124|11830093|FG000|NOT COMPLETED|Overall Study||6
10667672|NCT02308124|11830094|FG001|NOT COMPLETED|Overall Study||8
10667673|NCT02308124|11830095|FG002|NOT COMPLETED|Overall Study||8
10667674|NCT02308163|11830107|FG000|STARTED|Overall Study||104
10667675|NCT02308163|11830108|FG001|STARTED|Overall Study||102
10667676|NCT02308163|11830109|FG002|STARTED|Overall Study||50
10667677|NCT02308163|11830110|FG003|STARTED|Overall Study||52
10667678|NCT02308163|11830111|FG004|STARTED|Overall Study||201
10667679|NCT02308163|11830107|FG000|COMPLETED|Overall Study||73
10667680|NCT02308163|11830108|FG001|COMPLETED|Overall Study||84
10667681|NCT02308163|11830109|FG002|COMPLETED|Overall Study||36
10667682|NCT02308163|11830110|FG003|COMPLETED|Overall Study||39
10667683|NCT02308163|11830111|FG004|COMPLETED|Overall Study||167
10667684|NCT02308163|11830107|FG000|NOT COMPLETED|Overall Study||31
10667685|NCT02308163|11830108|FG001|NOT COMPLETED|Overall Study||18
10667686|NCT02308163|11830109|FG002|NOT COMPLETED|Overall Study||14
10667687|NCT02308163|11830110|FG003|NOT COMPLETED|Overall Study||13
10667688|NCT02308163|11830111|FG004|NOT COMPLETED|Overall Study||34
10667689|NCT02308189|11830140|FG000|STARTED|Overall Study||17
10667690|NCT02308189|11830141|FG001|STARTED|Overall Study||15
10667691|NCT02308189|11830140|FG000|COMPLETED|Overall Study||16
10667692|NCT02308189|11830141|FG001|COMPLETED|Overall Study||14
10667693|NCT02308189|11830140|FG000|NOT COMPLETED|Overall Study||1
10667694|NCT02308189|11830141|FG001|NOT COMPLETED|Overall Study||1
10667695|NCT02308228|11830149|FG000|STARTED|Overall Study||54
10667696|NCT02308228|11830150|FG001|STARTED|Overall Study||55
10667697|NCT02308228|11830149|FG000|COMPLETED|Overall Study||46
10667698|NCT02308228|11830150|FG001|COMPLETED|Overall Study||48
10667699|NCT02308228|11830149|FG000|NOT COMPLETED|Overall Study||8
10667700|NCT02308228|11830150|FG001|NOT COMPLETED|Overall Study||7
10667701|NCT02308371|11830158|FG000|STARTED|Overall Study|Started enrollment and recruitment 11/26/2014|50
10667702|NCT02308371|11830159|FG001|STARTED|Overall Study|Consider eligible for retrospective enrollment if admitted after 4/1/2012|50
10667703|NCT02308371|11830158|FG000|COMPLETED|Overall Study|Ended enrollment and recruitment 3/1/2016|50
10667704|NCT02308371|11830159|FG001|COMPLETED|Overall Study|Consider eligible for retrospective enrollment if admitted up until 10/15/2012|50
10667705|NCT02308371|11830158|FG000|NOT COMPLETED|Overall Study||0
10667706|NCT02308371|11830159|FG001|NOT COMPLETED|Overall Study||0
10667707|NCT02308501|11830169|FG000|STARTED|Overall Study|25 participants received one drop of Lastacaft in one eye and Tears Naturale in the other eye.|25
10667708|NCT02308501|11830170|FG001|STARTED|Overall Study||25
10667709|NCT02308501|11830169|FG000|Randomized Participant Eyes|Overall Study||25
10667710|NCT02308501|11830170|FG001|Randomized Participant Eyes|Overall Study||25
10667711|NCT02308501|11830169|FG000|COMPLETED|Overall Study||25
10667712|NCT02308501|11830170|FG001|COMPLETED|Overall Study||25
10667713|NCT02308501|11830169|FG000|NOT COMPLETED|Overall Study||0
10667714|NCT02308501|11830170|FG001|NOT COMPLETED|Overall Study||0
10667715|NCT02308540|11830188|FG000|STARTED|Overall Study||17
10667716|NCT02308540|11830189|FG001|STARTED|Overall Study||17
10667717|NCT02308540|11830190|FG002|STARTED|Overall Study||56
10667718|NCT02308540|11830191|FG003|STARTED|Overall Study||56
10667719|NCT02308540|11830192|FG004|STARTED|Overall Study||100
10667720|NCT02308540|11830193|FG005|STARTED|Overall Study||100
10667721|NCT02308540|11830188|FG000|Randomized|Overall Study||17
10667722|NCT02308540|11830189|FG001|Randomized|Overall Study||17
10667723|NCT02308540|11830190|FG002|Randomized|Overall Study||56
10667724|NCT02308540|11830191|FG003|Randomized|Overall Study||56
10667725|NCT02308540|11830192|FG004|Randomized|Overall Study||100
10667726|NCT02308540|11830193|FG005|Randomized|Overall Study||100
10667727|NCT02308540|11830188|FG000|Vaccinated|Overall Study||17
10667728|NCT02308540|11830189|FG001|Vaccinated|Overall Study||17
10667729|NCT02308540|11830190|FG002|Vaccinated|Overall Study||56
10667730|NCT02308540|11830191|FG003|Vaccinated|Overall Study||56
10667731|NCT02308540|11830192|FG004|Vaccinated|Overall Study||100
10667732|NCT02308540|11830193|FG005|Vaccinated|Overall Study||100
10667733|NCT02308540|11830188|FG000|COMPLETED|Overall Study||17
10667734|NCT02308540|11830189|FG001|COMPLETED|Overall Study||17
10667735|NCT02308540|11830190|FG002|COMPLETED|Overall Study||56
10667736|NCT02308540|11830191|FG003|COMPLETED|Overall Study||56
10667737|NCT02308540|11830192|FG004|COMPLETED|Overall Study||100
10667738|NCT02308540|11830193|FG005|COMPLETED|Overall Study||99
10667739|NCT02308540|11830188|FG000|NOT COMPLETED|Overall Study||0
10667740|NCT02308540|11830189|FG001|NOT COMPLETED|Overall Study||0
10667741|NCT02308540|11830190|FG002|NOT COMPLETED|Overall Study||0
10667742|NCT02308540|11830191|FG003|NOT COMPLETED|Overall Study||0
10667743|NCT02308540|11830192|FG004|NOT COMPLETED|Overall Study||0
10667744|NCT02308540|11830193|FG005|NOT COMPLETED|Overall Study||1
10667745|NCT02308696|11830244|FG000|STARTED|Overall Study||222
10667746|NCT02308696|11830245|FG001|STARTED|Overall Study||234
10667747|NCT02308696|11830244|FG000|COMPLETED|Overall Study||169
10667748|NCT02308696|11830245|FG001|COMPLETED|Overall Study||203
10667749|NCT02308696|11830244|FG000|NOT COMPLETED|Overall Study||53
10667750|NCT02308696|11830245|FG001|NOT COMPLETED|Overall Study||31
10667751|NCT02308748|11830251|FG000|STARTED|Period 1||2
10667752|NCT02308748|11830252|FG001|STARTED|Period 1||2
10667753|NCT02308748|11830253|FG002|STARTED|Period 1||2
10667754|NCT02308748|11830254|FG003|STARTED|Period 1||2
10667755|NCT02308748|11830255|FG004|STARTED|Period 1||2
10667756|NCT02308748|11830256|FG005|STARTED|Period 1||3
10667757|NCT02308748|11830257|FG006|STARTED|Period 1||2
10667758|NCT02308748|11830258|FG007|STARTED|Period 1||2
10667759|NCT02308748|11830259|FG008|STARTED|Period 1||2
10667760|NCT02308748|11830260|FG009|STARTED|Period 1||3
10667761|NCT02308748|11830251|FG000|COMPLETED|Period 1||2
10667762|NCT02308748|11830252|FG001|COMPLETED|Period 1||2
10667763|NCT02308748|11830253|FG002|COMPLETED|Period 1|One subject withdraw consent before starting Period 2|1
10667764|NCT02308748|11830254|FG003|COMPLETED|Period 1||2
10667765|NCT02308748|11830255|FG004|COMPLETED|Period 1||2
10667766|NCT02308748|11830256|FG005|COMPLETED|Period 1||3
10667767|NCT02308748|11830257|FG006|COMPLETED|Period 1||2
10667768|NCT02308748|11830258|FG007|COMPLETED|Period 1||2
10667769|NCT02308748|11830259|FG008|COMPLETED|Period 1||2
10667770|NCT02308748|11830260|FG009|COMPLETED|Period 1||3
10667771|NCT02308748|11830251|FG000|NOT COMPLETED|Period 1||0
10667772|NCT02308748|11830252|FG001|NOT COMPLETED|Period 1||0
10667773|NCT02308748|11830253|FG002|NOT COMPLETED|Period 1||1
10667774|NCT02308748|11830254|FG003|NOT COMPLETED|Period 1||0
10667775|NCT02308748|11830255|FG004|NOT COMPLETED|Period 1||0
10667776|NCT02308748|11830256|FG005|NOT COMPLETED|Period 1||0
10667777|NCT02308748|11830257|FG006|NOT COMPLETED|Period 1||0
10667778|NCT02308748|11830258|FG007|NOT COMPLETED|Period 1||0
10667779|NCT02308748|11830259|FG008|NOT COMPLETED|Period 1||0
10667780|NCT02308748|11830260|FG009|NOT COMPLETED|Period 1||0
10667781|NCT02308748|11830251|FG000|STARTED|Period 2||2
10667782|NCT02308748|11830252|FG001|STARTED|Period 2||2
10667783|NCT02308748|11830253|FG002|STARTED|Period 2||1
10667784|NCT02308748|11830254|FG003|STARTED|Period 2||2
10667785|NCT02308748|11830255|FG004|STARTED|Period 2||2
10667786|NCT02308748|11830256|FG005|STARTED|Period 2||3
10667787|NCT02308748|11830257|FG006|STARTED|Period 2||2
10667788|NCT02308748|11830258|FG007|STARTED|Period 2||2
10667789|NCT02308748|11830259|FG008|STARTED|Period 2||2
10667790|NCT02308748|11830260|FG009|STARTED|Period 2||3
10667791|NCT02308748|11830251|FG000|COMPLETED|Period 2||2
10667792|NCT02308748|11830252|FG001|COMPLETED|Period 2||2
10667793|NCT02308748|11830253|FG002|COMPLETED|Period 2||1
10667794|NCT02308748|11830254|FG003|COMPLETED|Period 2||2
10667795|NCT02308748|11830255|FG004|COMPLETED|Period 2||2
10667796|NCT02308748|11830256|FG005|COMPLETED|Period 2||3
10667797|NCT02308748|11830257|FG006|COMPLETED|Period 2||2
10667798|NCT02308748|11830258|FG007|COMPLETED|Period 2||1
10667799|NCT02308748|11830259|FG008|COMPLETED|Period 2||2
10667800|NCT02308748|11830260|FG009|COMPLETED|Period 2||3
10795928|NCT03649412|11956159|FG001|STARTED|Part B, Period 2 (4 Days)||15
10795929|NCT03649412|11956158|FG000|COMPLETED|Part B, Period 2 (4 Days)||0
10795930|NCT03649412|11956159|FG001|COMPLETED|Part B, Period 2 (4 Days)||15
10795931|NCT03649412|11956158|FG000|NOT COMPLETED|Part B, Period 2 (4 Days)||0
10795932|NCT03649412|11956159|FG001|NOT COMPLETED|Part B, Period 2 (4 Days)||0
10795933|NCT03649412|11956158|FG000|STARTED|Part B, Washout Period 2 (7 Days)||0
10795934|NCT03649412|11956159|FG001|STARTED|Part B, Washout Period 2 (7 Days)||15
10795935|NCT03649412|11956158|FG000|COMPLETED|Part B, Washout Period 2 (7 Days)||0
10795936|NCT03649412|11956159|FG001|COMPLETED|Part B, Washout Period 2 (7 Days)||15
10795937|NCT03649412|11956158|FG000|NOT COMPLETED|Part B, Washout Period 2 (7 Days)||0
10795938|NCT03649412|11956159|FG001|NOT COMPLETED|Part B, Washout Period 2 (7 Days)||0
10795939|NCT03649412|11956158|FG000|STARTED|Part B, Period 3 (4 Days)||0
10795940|NCT03649412|11956159|FG001|STARTED|Part B, Period 3 (4 Days)||15
10795941|NCT03649412|11956158|FG000|COMPLETED|Part B, Period 3 (4 Days)||0
10667801|NCT02308748|11830251|FG000|NOT COMPLETED|Period 2||0
10667802|NCT02308748|11830252|FG001|NOT COMPLETED|Period 2||0
10667803|NCT02308748|11830253|FG002|NOT COMPLETED|Period 2||0
10667804|NCT02308748|11830254|FG003|NOT COMPLETED|Period 2||0
10667805|NCT02308748|11830255|FG004|NOT COMPLETED|Period 2||0
10667806|NCT02308748|11830256|FG005|NOT COMPLETED|Period 2||0
10667807|NCT02308748|11830257|FG006|NOT COMPLETED|Period 2||0
10667808|NCT02308748|11830258|FG007|NOT COMPLETED|Period 2||1
10667809|NCT02308748|11830259|FG008|NOT COMPLETED|Period 2||0
10667810|NCT02308748|11830260|FG009|NOT COMPLETED|Period 2||0
10667811|NCT02308748|11830251|FG000|STARTED|Period 3||2
10667812|NCT02308748|11830252|FG001|STARTED|Period 3||2
10667813|NCT02308748|11830253|FG002|STARTED|Period 3||1
10667814|NCT02308748|11830254|FG003|STARTED|Period 3||2
10667815|NCT02308748|11830255|FG004|STARTED|Period 3||2
10667816|NCT02308748|11830256|FG005|STARTED|Period 3||3
10667817|NCT02308748|11830257|FG006|STARTED|Period 3||2
10667818|NCT02308748|11830258|FG007|STARTED|Period 3||1
10667819|NCT02308748|11830259|FG008|STARTED|Period 3||2
10667820|NCT02308748|11830260|FG009|STARTED|Period 3||3
10667821|NCT02308748|11830251|FG000|COMPLETED|Period 3||2
10667822|NCT02308748|11830252|FG001|COMPLETED|Period 3||2
10667823|NCT02308748|11830253|FG002|COMPLETED|Period 3||1
10667824|NCT02308748|11830254|FG003|COMPLETED|Period 3||2
10667825|NCT02308748|11830255|FG004|COMPLETED|Period 3||2
10667826|NCT02308748|11830256|FG005|COMPLETED|Period 3||3
10667827|NCT02308748|11830257|FG006|COMPLETED|Period 3||2
10667828|NCT02308748|11830258|FG007|COMPLETED|Period 3||1
10667829|NCT02308748|11830259|FG008|COMPLETED|Period 3||2
10667830|NCT02308748|11830260|FG009|COMPLETED|Period 3||2
10667831|NCT02308748|11830251|FG000|NOT COMPLETED|Period 3||0
10667832|NCT02308748|11830252|FG001|NOT COMPLETED|Period 3||0
10667833|NCT02308748|11830253|FG002|NOT COMPLETED|Period 3||0
10667834|NCT02308748|11830254|FG003|NOT COMPLETED|Period 3||0
10667835|NCT02308748|11830255|FG004|NOT COMPLETED|Period 3||0
10667836|NCT02308748|11830256|FG005|NOT COMPLETED|Period 3||0
10667837|NCT02308748|11830257|FG006|NOT COMPLETED|Period 3||0
10667838|NCT02308748|11830258|FG007|NOT COMPLETED|Period 3||0
10667839|NCT02308748|11830259|FG008|NOT COMPLETED|Period 3||0
10667840|NCT02308748|11830260|FG009|NOT COMPLETED|Period 3||1
10667841|NCT02308748|11830251|FG000|STARTED|Period 4||2
10667842|NCT02308748|11830252|FG001|STARTED|Period 4||2
10667843|NCT02308748|11830253|FG002|STARTED|Period 4||1
10667844|NCT02308748|11830254|FG003|STARTED|Period 4||2
10667845|NCT02308748|11830255|FG004|STARTED|Period 4||2
10667846|NCT02308748|11830256|FG005|STARTED|Period 4||3
10667847|NCT02308748|11830257|FG006|STARTED|Period 4||2
10667848|NCT02308748|11830258|FG007|STARTED|Period 4||1
10667849|NCT02308748|11830259|FG008|STARTED|Period 4||2
10667850|NCT02308748|11830260|FG009|STARTED|Period 4||2
10667851|NCT02308748|11830251|FG000|COMPLETED|Period 4||2
10667852|NCT02308748|11830252|FG001|COMPLETED|Period 4||2
10667853|NCT02308748|11830253|FG002|COMPLETED|Period 4||1
10667854|NCT02308748|11830254|FG003|COMPLETED|Period 4||2
10667855|NCT02308748|11830255|FG004|COMPLETED|Period 4||2
10667856|NCT02308748|11830256|FG005|COMPLETED|Period 4||3
10667857|NCT02308748|11830257|FG006|COMPLETED|Period 4||2
10667858|NCT02308748|11830258|FG007|COMPLETED|Period 4||1
10667859|NCT02308748|11830259|FG008|COMPLETED|Period 4||2
10667860|NCT02308748|11830260|FG009|COMPLETED|Period 4||2
10667861|NCT02308748|11830251|FG000|NOT COMPLETED|Period 4||0
10667862|NCT02308748|11830252|FG001|NOT COMPLETED|Period 4||0
10667863|NCT02308748|11830253|FG002|NOT COMPLETED|Period 4||0
10667864|NCT02308748|11830254|FG003|NOT COMPLETED|Period 4||0
10667865|NCT02308748|11830255|FG004|NOT COMPLETED|Period 4||0
10667866|NCT02308748|11830256|FG005|NOT COMPLETED|Period 4||0
10667867|NCT02308748|11830257|FG006|NOT COMPLETED|Period 4||0
10667868|NCT02308748|11830258|FG007|NOT COMPLETED|Period 4||0
10667869|NCT02308748|11830259|FG008|NOT COMPLETED|Period 4||0
10667870|NCT02308748|11830260|FG009|NOT COMPLETED|Period 4||0
10667871|NCT02308748|11830251|FG000|STARTED|Period 5||2
10667872|NCT02308748|11830252|FG001|STARTED|Period 5||2
10795942|NCT03649412|11956159|FG001|COMPLETED|Part B, Period 3 (4 Days)||15
10667873|NCT02308748|11830253|FG002|STARTED|Period 5||1
10667874|NCT02308748|11830254|FG003|STARTED|Period 5||2
10667875|NCT02308748|11830255|FG004|STARTED|Period 5||2
10667876|NCT02308748|11830256|FG005|STARTED|Period 5||3
10667877|NCT02308748|11830257|FG006|STARTED|Period 5||2
10667878|NCT02308748|11830258|FG007|STARTED|Period 5||1
10667879|NCT02308748|11830259|FG008|STARTED|Period 5||2
10667880|NCT02308748|11830260|FG009|STARTED|Period 5||2
10667881|NCT02308748|11830251|FG000|COMPLETED|Period 5||1
10667882|NCT02308748|11830252|FG001|COMPLETED|Period 5||2
10667883|NCT02308748|11830253|FG002|COMPLETED|Period 5||1
10667884|NCT02308748|11830254|FG003|COMPLETED|Period 5||2
10667885|NCT02308748|11830255|FG004|COMPLETED|Period 5||2
10667886|NCT02308748|11830256|FG005|COMPLETED|Period 5||3
10667887|NCT02308748|11830257|FG006|COMPLETED|Period 5||2
10667888|NCT02308748|11830258|FG007|COMPLETED|Period 5||1
10667889|NCT02308748|11830259|FG008|COMPLETED|Period 5||1
10667890|NCT02308748|11830260|FG009|COMPLETED|Period 5||2
10667891|NCT02308748|11830251|FG000|NOT COMPLETED|Period 5||1
10667892|NCT02308748|11830252|FG001|NOT COMPLETED|Period 5||0
10667893|NCT02308748|11830253|FG002|NOT COMPLETED|Period 5||0
10667894|NCT02308748|11830254|FG003|NOT COMPLETED|Period 5||0
10667895|NCT02308748|11830255|FG004|NOT COMPLETED|Period 5||0
10667896|NCT02308748|11830256|FG005|NOT COMPLETED|Period 5||0
10667897|NCT02308748|11830257|FG006|NOT COMPLETED|Period 5||0
10667898|NCT02308748|11830258|FG007|NOT COMPLETED|Period 5||0
10667899|NCT02308748|11830259|FG008|NOT COMPLETED|Period 5||1
10667900|NCT02308748|11830260|FG009|NOT COMPLETED|Period 5||0
10667901|NCT02308787|11830272|FG000|STARTED|Overall Study|Data were collected from 20 PLTD procedures performed in 12 subjects|12
10667902|NCT02308787|11830272|FG000|COMPLETED|Overall Study|Data were collected from 20 PLTD procedures performed in 12 subjects|12
10667903|NCT02308787|11830272|FG000|NOT COMPLETED|Overall Study||0
10667904|NCT02308839|11830276|FG000|STARTED|Overall Study||181
10667905|NCT02308839|11830276|FG000|COMPLETED|Overall Study||72
10667906|NCT02308839|11830276|FG000|NOT COMPLETED|Overall Study||109
10667907|NCT02309099|11830282|FG000|STARTED|Overall Study||7
10667908|NCT02309099|11830283|FG001|STARTED|Overall Study||3
10667909|NCT02309099|11830282|FG000|Cochlear Implantation|Overall Study||7
10667910|NCT02309099|11830283|FG001|Cochlear Implantation|Overall Study||3
10667911|NCT02309099|11830282|FG000|Initial Activation|Overall Study||7
10667912|NCT02309099|11830283|FG001|Initial Activation|Overall Study||3
10667913|NCT02309099|11830282|FG000|Cochlear Implant Use/Follow-Up|Overall Study|5 participants completed cochlear implant use/follow-up (2 did not complete due to adverse event)|5
10667914|NCT02309099|11830283|FG001|Cochlear Implant Use/Follow-Up|Overall Study||3
10667915|NCT02309099|11830282|FG000|COMPLETED|Overall Study|5 participants completed the study (2 did not complete due to adverse event)|5
10667916|NCT02309099|11830283|FG001|COMPLETED|Overall Study||3
10667917|NCT02309099|11830282|FG000|NOT COMPLETED|Overall Study||2
10667918|NCT02309099|11830283|FG001|NOT COMPLETED|Overall Study||0
10667919|NCT02309112|11830292|FG000|STARTED|Overall Study||5
10667920|NCT02309112|11830293|FG001|STARTED|Overall Study||5
10667921|NCT02309112|11830294|FG002|STARTED|Overall Study||5
10667922|NCT02309112|11830292|FG000|Completed Yoga Intervention|Overall Study||4
10667923|NCT02309112|11830293|FG001|Completed Yoga Intervention|Overall Study||5
10667924|NCT02309112|11830294|FG002|Completed Yoga Intervention|Overall Study||4
10667925|NCT02309112|11830292|FG000|COMPLETED|Overall Study||4
10667926|NCT02309112|11830293|FG001|COMPLETED|Overall Study||4
10667927|NCT02309112|11830294|FG002|COMPLETED|Overall Study||4
10667928|NCT02309112|11830292|FG000|NOT COMPLETED|Overall Study||1
10667929|NCT02309112|11830293|FG001|NOT COMPLETED|Overall Study||1
10667930|NCT02309112|11830294|FG002|NOT COMPLETED|Overall Study||1
10667931|NCT02309138|11830306|FG000|STARTED|Overall Study||460
10667932|NCT02309138|11830307|FG001|STARTED|Overall Study||461
10667933|NCT02309138|11830306|FG000|COMPLETED|Overall Study||412
10667934|NCT02309138|11830307|FG001|COMPLETED|Overall Study||443
10667935|NCT02309138|11830306|FG000|NOT COMPLETED|Overall Study||48
10667936|NCT02309138|11830307|FG001|NOT COMPLETED|Overall Study||18
10667937|NCT02309294|11830323|FG000|STARTED|Overall Study||43
10667938|NCT02309294|11830323|FG000|COMPLETED|Overall Study||41
10667939|NCT02309294|11830323|FG000|NOT COMPLETED|Overall Study||2
10667940|NCT02309359|11830332|FG000|STARTED|Overall Study||69
10667941|NCT02309359|11830333|FG001|STARTED|Overall Study||70
10667942|NCT02309359|11830334|FG002|STARTED|Overall Study||68
10667943|NCT02309359|11830335|FG003|STARTED|Overall Study||69
10667944|NCT02309359|11830336|FG004|STARTED|Overall Study||69
10667945|NCT02309359|11830332|FG000|COMPLETED|Overall Study||57
10667946|NCT02309359|11830333|FG001|COMPLETED|Overall Study||62
10667947|NCT02309359|11830334|FG002|COMPLETED|Overall Study||57
10667948|NCT02309359|11830335|FG003|COMPLETED|Overall Study||57
10667949|NCT02309359|11830336|FG004|COMPLETED|Overall Study||60
10667950|NCT02309359|11830332|FG000|NOT COMPLETED|Overall Study||12
10667951|NCT02309359|11830333|FG001|NOT COMPLETED|Overall Study||8
10667952|NCT02309359|11830334|FG002|NOT COMPLETED|Overall Study||11
10667953|NCT02309359|11830335|FG003|NOT COMPLETED|Overall Study||12
10667954|NCT02309359|11830336|FG004|NOT COMPLETED|Overall Study||9
10667955|NCT02309372|11830351|FG000|STARTED|Overall Study||27
10667956|NCT02309372|11830352|FG001|STARTED|Overall Study||27
10667957|NCT02309372|11830351|FG000|COMPLETED|Overall Study||24
10667958|NCT02309372|11830352|FG001|COMPLETED|Overall Study||25
10667959|NCT02309372|11830351|FG000|NOT COMPLETED|Overall Study||3
10667960|NCT02309372|11830352|FG001|NOT COMPLETED|Overall Study||2
10667961|NCT02309411|11830361|FG000|STARTED|Overall Study||25
10667962|NCT02309411|11830362|FG001|STARTED|Overall Study||15
10667963|NCT02309411|11830363|FG002|STARTED|Overall Study||6
10667964|NCT02309411|11830361|FG000|COMPLETED|Overall Study||23
10667965|NCT02309411|11830362|FG001|COMPLETED|Overall Study||14
10667966|NCT02309411|11830363|FG002|COMPLETED|Overall Study||6
10667967|NCT02309411|11830361|FG000|NOT COMPLETED|Overall Study||2
10667968|NCT02309411|11830362|FG001|NOT COMPLETED|Overall Study||1
10667969|NCT02309411|11830363|FG002|NOT COMPLETED|Overall Study||0
10667970|NCT02309489|11830372|FG000|STARTED|Overall Study||583
10667971|NCT02309489|11830373|FG001|STARTED|Overall Study||561
10667972|NCT02309489|11830372|FG000|Follow-up at 3 Months Postpartum|Overall Study||560
10667973|NCT02309489|11830373|FG001|Follow-up at 3 Months Postpartum|Overall Study||541
10667974|NCT02309489|11830372|FG000|COMPLETED|Overall Study||568
10667975|NCT02309489|11830373|FG001|COMPLETED|Overall Study||547
10667976|NCT02309489|11830372|FG000|NOT COMPLETED|Overall Study||15
10667977|NCT02309489|11830373|FG001|NOT COMPLETED|Overall Study||14
10667978|NCT02309515|11830381|FG000|STARTED|Overall Study||5
10667979|NCT02309515|11830382|FG001|STARTED|Overall Study||7
10667980|NCT02309515|11830381|FG000|COMPLETED|Overall Study||5
10667981|NCT02309515|11830382|FG001|COMPLETED|Overall Study||6
10667982|NCT02309515|11830381|FG000|NOT COMPLETED|Overall Study||0
10667983|NCT02309515|11830382|FG001|NOT COMPLETED|Overall Study||1
10667984|NCT02309723|11830391|FG000|STARTED|Overall Study||129
10667985|NCT02309723|11830392|FG001|STARTED|Overall Study||128
10667986|NCT02309723|11830393|FG002|STARTED|Overall Study||129
10667987|NCT02309723|11830391|FG000|COMPLETED|Overall Study||105
10667988|NCT02309723|11830392|FG001|COMPLETED|Overall Study||105
10667989|NCT02309723|11830393|FG002|COMPLETED|Overall Study||105
10667990|NCT02309723|11830391|FG000|NOT COMPLETED|Overall Study||24
10667991|NCT02309723|11830392|FG001|NOT COMPLETED|Overall Study||23
10667992|NCT02309723|11830393|FG002|NOT COMPLETED|Overall Study||24
10667993|NCT02309944|11830403|FG000|STARTED|Overall Study||38
10667994|NCT02309944|11830404|FG001|STARTED|Overall Study||43
10667995|NCT02309944|11830403|FG000|COMPLETED|Overall Study||38
10667996|NCT02309944|11830404|FG001|COMPLETED|Overall Study||43
10667997|NCT02309944|11830403|FG000|NOT COMPLETED|Overall Study||0
10667998|NCT02309944|11830404|FG001|NOT COMPLETED|Overall Study||0
10667999|NCT02310100|11830410|FG000|STARTED|Overall Study|First enrollment|178
10668000|NCT02310100|11830410|FG000|COMPLETED|Overall Study||160
10668001|NCT02310100|11830410|FG000|NOT COMPLETED|Overall Study||18
10668002|NCT02310126|11830417|FG000|STARTED|Period 1 (15 Minutes)||94
10668003|NCT02310126|11830418|FG001|STARTED|Period 1 (15 Minutes)||97
10668004|NCT02310126|11830417|FG000|Hyperopes|Period 1 (15 Minutes)||38
10668005|NCT02310126|11830418|FG001|Hyperopes|Period 1 (15 Minutes)||33
10668006|NCT02310126|11830417|FG000|Myopes|Period 1 (15 Minutes)||56
10668007|NCT02310126|11830418|FG001|Myopes|Period 1 (15 Minutes)||64
10668008|NCT02310126|11830417|FG000|COMPLETED|Period 1 (15 Minutes)||94
10668009|NCT02310126|11830418|FG001|COMPLETED|Period 1 (15 Minutes)||95
10668010|NCT02310126|11830417|FG000|NOT COMPLETED|Period 1 (15 Minutes)||0
10668011|NCT02310126|11830418|FG001|NOT COMPLETED|Period 1 (15 Minutes)||2
10668012|NCT02310126|11830417|FG000|STARTED|Period 2 (15 Minutes)||94
10668013|NCT02310126|11830418|FG001|STARTED|Period 2 (15 Minutes)||95
10668014|NCT02310126|11830417|FG000|Hyperopes|Period 2 (15 Minutes)||38
10668015|NCT02310126|11830418|FG001|Hyperopes|Period 2 (15 Minutes)||32
10668016|NCT02310126|11830417|FG000|Myopes|Period 2 (15 Minutes)||56
10668017|NCT02310126|11830418|FG001|Myopes|Period 2 (15 Minutes)||63
10668018|NCT02310126|11830417|FG000|COMPLETED|Period 2 (15 Minutes)||94
10668019|NCT02310126|11830418|FG001|COMPLETED|Period 2 (15 Minutes)||95
10668020|NCT02310126|11830417|FG000|NOT COMPLETED|Period 2 (15 Minutes)||0
10668021|NCT02310126|11830418|FG001|NOT COMPLETED|Period 2 (15 Minutes)||0
10668022|NCT02310568|11830429|FG000|STARTED|Stage 1 ( 4 Weeks)||15
10668023|NCT02310568|11830430|FG001|STARTED|Stage 1 ( 4 Weeks)||15
10668024|NCT02310568|11830431|FG002|STARTED|Stage 1 ( 4 Weeks)||15
10668025|NCT02310568|11830432|FG003|STARTED|Stage 1 ( 4 Weeks)||24
10668026|NCT02310568|11830433|FG004|STARTED|Stage 1 ( 4 Weeks)||21
10668027|NCT02310568|11830429|FG000|COMPLETED|Stage 1 ( 4 Weeks)||12
10668028|NCT02310568|11830430|FG001|COMPLETED|Stage 1 ( 4 Weeks)||13
10668029|NCT02310568|11830431|FG002|COMPLETED|Stage 1 ( 4 Weeks)||14
10668030|NCT02310568|11830432|FG003|COMPLETED|Stage 1 ( 4 Weeks)||22
10668031|NCT02310568|11830433|FG004|COMPLETED|Stage 1 ( 4 Weeks)||20
10668032|NCT02310568|11830429|FG000|NOT COMPLETED|Stage 1 ( 4 Weeks)||3
10668033|NCT02310568|11830430|FG001|NOT COMPLETED|Stage 1 ( 4 Weeks)||2
10668034|NCT02310568|11830431|FG002|NOT COMPLETED|Stage 1 ( 4 Weeks)||1
10668035|NCT02310568|11830432|FG003|NOT COMPLETED|Stage 1 ( 4 Weeks)||2
10668036|NCT02310568|11830433|FG004|NOT COMPLETED|Stage 1 ( 4 Weeks)||1
10668037|NCT02310568|11830429|FG000|STARTED|Stage 2 (4 Weeks)||12
10668038|NCT02310568|11830430|FG001|STARTED|Stage 2 (4 Weeks)||13
10668039|NCT02310568|11830431|FG002|STARTED|Stage 2 (4 Weeks)||14
10668040|NCT02310568|11830432|FG003|STARTED|Stage 2 (4 Weeks)||22
10668041|NCT02310568|11830433|FG004|STARTED|Stage 2 (4 Weeks)||20
10668042|NCT02310568|11830429|FG000|COMPLETED|Stage 2 (4 Weeks)||11
10668043|NCT02310568|11830430|FG001|COMPLETED|Stage 2 (4 Weeks)||12
10668044|NCT02310568|11830431|FG002|COMPLETED|Stage 2 (4 Weeks)||13
10668045|NCT02310568|11830432|FG003|COMPLETED|Stage 2 (4 Weeks)||17
10668046|NCT02310568|11830433|FG004|COMPLETED|Stage 2 (4 Weeks)||19
10668047|NCT02310568|11830429|FG000|NOT COMPLETED|Stage 2 (4 Weeks)||1
10668048|NCT02310568|11830430|FG001|NOT COMPLETED|Stage 2 (4 Weeks)||1
10668049|NCT02310568|11830431|FG002|NOT COMPLETED|Stage 2 (4 Weeks)||1
10668050|NCT02310568|11830432|FG003|NOT COMPLETED|Stage 2 (4 Weeks)||5
10668051|NCT02310568|11830433|FG004|NOT COMPLETED|Stage 2 (4 Weeks)||1
10668052|NCT02310581|11830455|FG000|STARTED|Overall Study||9
10668053|NCT02310581|11830456|FG001|STARTED|Overall Study||11
10668054|NCT02310581|11830457|FG002|STARTED|Overall Study||10
10668055|NCT02310581|11830458|FG003|STARTED|Overall Study||10
10668056|NCT02310581|11830455|FG000|COMPLETED|Overall Study||6
10668057|NCT02310581|11830456|FG001|COMPLETED|Overall Study||9
10668058|NCT02310581|11830457|FG002|COMPLETED|Overall Study||9
10668059|NCT02310581|11830458|FG003|COMPLETED|Overall Study||9
10668060|NCT02310581|11830455|FG000|NOT COMPLETED|Overall Study||3
10668061|NCT02310581|11830456|FG001|NOT COMPLETED|Overall Study||2
10668062|NCT02310581|11830457|FG002|NOT COMPLETED|Overall Study||1
10668063|NCT02310581|11830458|FG003|NOT COMPLETED|Overall Study||1
10668064|NCT02310646|11830470|FG000|STARTED|First Intervention (Day 1 - Day 7)||109
10668065|NCT02310646|11830471|FG001|STARTED|First Intervention (Day 1 - Day 7)||104
10668066|NCT02310646|11830470|FG000|COMPLETED|First Intervention (Day 1 - Day 7)||107
10668067|NCT02310646|11830471|FG001|COMPLETED|First Intervention (Day 1 - Day 7)||104
10668068|NCT02310646|11830470|FG000|NOT COMPLETED|First Intervention (Day 1 - Day 7)||2
10668069|NCT02310646|11830471|FG001|NOT COMPLETED|First Intervention (Day 1 - Day 7)||0
10668070|NCT02310646|11830470|FG000|STARTED|Second Intervention (Day 8 - Day 14)||107
10668071|NCT02310646|11830471|FG001|STARTED|Second Intervention (Day 8 - Day 14)||104
10668072|NCT02310646|11830470|FG000|COMPLETED|Second Intervention (Day 8 - Day 14)||107
10668073|NCT02310646|11830471|FG001|COMPLETED|Second Intervention (Day 8 - Day 14)||104
10668074|NCT02310646|11830470|FG000|NOT COMPLETED|Second Intervention (Day 8 - Day 14)||0
10668075|NCT02310646|11830471|FG001|NOT COMPLETED|Second Intervention (Day 8 - Day 14)||0
10668076|NCT02310672|11830493|FG000|STARTED|Overall Study||87
10668077|NCT02310672|11830493|FG000|COMPLETED|Overall Study||72
10668078|NCT02310672|11830493|FG000|NOT COMPLETED|Overall Study||15
10668079|NCT02310750|11830508|FG000|STARTED|HP Period 1||7
10668080|NCT02310750|11830509|FG001|STARTED|HP Period 1||6
10668081|NCT02310750|11830510|FG002|STARTED|HP Period 1||6
10668082|NCT02310750|11830511|FG003|STARTED|HP Period 1||6
10668083|NCT02310750|11830512|FG004|STARTED|HP Period 1||8
10668084|NCT02310750|11830513|FG005|STARTED|HP Period 1||8
10668085|NCT02310750|11830514|FG006|STARTED|HP Period 1||13
10668086|NCT02310750|11830515|FG007|STARTED|HP Period 1||0
10668087|NCT02310750|11830516|FG008|STARTED|HP Period 1||0
10668088|NCT02310750|11830517|FG009|STARTED|HP Period 1||0
10668089|NCT02310750|11830518|FG010|STARTED|HP Period 1||2
10668090|NCT02310750|11830519|FG011|STARTED|HP Period 1||2
10668091|NCT02310750|11830520|FG012|STARTED|HP Period 1||2
10668092|NCT02310750|11830521|FG013|STARTED|HP Period 1||2
10668093|NCT02310750|11830522|FG014|STARTED|HP Period 1||2
10668094|NCT02310750|11830523|FG015|STARTED|HP Period 1||2
10668095|NCT02310750|11830508|FG000|COMPLETED|HP Period 1||6
10668096|NCT02310750|11830509|FG001|COMPLETED|HP Period 1||6
10668097|NCT02310750|11830510|FG002|COMPLETED|HP Period 1||6
10668098|NCT02310750|11830511|FG003|COMPLETED|HP Period 1||5
10668099|NCT02310750|11830512|FG004|COMPLETED|HP Period 1||8
10668100|NCT02310750|11830513|FG005|COMPLETED|HP Period 1||8
10668101|NCT02310750|11830514|FG006|COMPLETED|HP Period 1||12
10318784|NCT00217438|11453037|FG000|NOT COMPLETED|Overall Study||0
10318785|NCT00217438|11453038|FG001|NOT COMPLETED|Overall Study||1
10318786|NCT00217464|11453044|FG000|STARTED|Overall Study||17
10318787|NCT00217464|11453044|FG000|COMPLETED|Overall Study||0
10318788|NCT00217464|11453044|FG000|NOT COMPLETED|Overall Study||17
10318789|NCT00217490|11453052|FG000|STARTED|Overall Study||154
10318790|NCT00217490|11453053|FG001|STARTED|Overall Study||153
10668102|NCT02310750|11830515|FG007|COMPLETED|HP Period 1||0
10668103|NCT02310750|11830516|FG008|COMPLETED|HP Period 1||0
10668104|NCT02310750|11830517|FG009|COMPLETED|HP Period 1||0
10795943|NCT03649412|11956158|FG000|NOT COMPLETED|Part B, Period 3 (4 Days)||0
10795944|NCT03649412|11956159|FG001|NOT COMPLETED|Part B, Period 3 (4 Days)||0
10795945|NCT03649412|11956158|FG000|STARTED|Part B, Washout Period 3 (7 Days)||0
10795946|NCT03649412|11956159|FG001|STARTED|Part B, Washout Period 3 (7 Days)||15
10795947|NCT03649412|11956158|FG000|COMPLETED|Part B, Washout Period 3 (7 Days)||0
10795948|NCT03649412|11956159|FG001|COMPLETED|Part B, Washout Period 3 (7 Days)||15
10795949|NCT03649412|11956158|FG000|NOT COMPLETED|Part B, Washout Period 3 (7 Days)||0
10795950|NCT03649412|11956159|FG001|NOT COMPLETED|Part B, Washout Period 3 (7 Days)||0
10795951|NCT03649412|11956158|FG000|STARTED|Part B, Period 4 (4 Days)||0
10668105|NCT02310750|11830518|FG010|COMPLETED|HP Period 1||2
10668106|NCT02310750|11830519|FG011|COMPLETED|HP Period 1||2
10668107|NCT02310750|11830520|FG012|COMPLETED|HP Period 1||2
10668108|NCT02310750|11830521|FG013|COMPLETED|HP Period 1||2
10668109|NCT02310750|11830522|FG014|COMPLETED|HP Period 1||2
10668110|NCT02310750|11830523|FG015|COMPLETED|HP Period 1||2
10668111|NCT02310750|11830508|FG000|NOT COMPLETED|HP Period 1||1
10668112|NCT02310750|11830509|FG001|NOT COMPLETED|HP Period 1||0
10668113|NCT02310750|11830510|FG002|NOT COMPLETED|HP Period 1||0
10668114|NCT02310750|11830511|FG003|NOT COMPLETED|HP Period 1||1
10668115|NCT02310750|11830512|FG004|NOT COMPLETED|HP Period 1||0
10668116|NCT02310750|11830513|FG005|NOT COMPLETED|HP Period 1||0
10668117|NCT02310750|11830514|FG006|NOT COMPLETED|HP Period 1||1
10668118|NCT02310750|11830515|FG007|NOT COMPLETED|HP Period 1||0
10668119|NCT02310750|11830516|FG008|NOT COMPLETED|HP Period 1||0
10668120|NCT02310750|11830517|FG009|NOT COMPLETED|HP Period 1||0
10668121|NCT02310750|11830518|FG010|NOT COMPLETED|HP Period 1||0
10795952|NCT03649412|11956159|FG001|STARTED|Part B, Period 4 (4 Days)||15
10318791|NCT00217490|11453054|FG002|STARTED|Overall Study||155
10318792|NCT00217490|11453055|FG003|STARTED|Overall Study||153
10668122|NCT02310750|11830519|FG011|NOT COMPLETED|HP Period 1||0
10668123|NCT02310750|11830520|FG012|NOT COMPLETED|HP Period 1||0
10668124|NCT02310750|11830521|FG013|NOT COMPLETED|HP Period 1||0
10668125|NCT02310750|11830522|FG014|NOT COMPLETED|HP Period 1||0
10668126|NCT02310750|11830523|FG015|NOT COMPLETED|HP Period 1||0
10668127|NCT02310750|11830508|FG000|STARTED|HP Washout 1||0
10668128|NCT02310750|11830509|FG001|STARTED|HP Washout 1||0
10668129|NCT02310750|11830510|FG002|STARTED|HP Washout 1||6
10668130|NCT02310750|11830511|FG003|STARTED|HP Washout 1||5
10668131|NCT02310750|11830512|FG004|STARTED|HP Washout 1||8
10668132|NCT02310750|11830513|FG005|STARTED|HP Washout 1||8
10668133|NCT02310750|11830514|FG006|STARTED|HP Washout 1||12
10668134|NCT02310750|11830515|FG007|STARTED|HP Washout 1||0
10668135|NCT02310750|11830516|FG008|STARTED|HP Washout 1||0
10668136|NCT02310750|11830517|FG009|STARTED|HP Washout 1||0
10668137|NCT02310750|11830518|FG010|STARTED|HP Washout 1||2
10668138|NCT02310750|11830519|FG011|STARTED|HP Washout 1||2
10668139|NCT02310750|11830520|FG012|STARTED|HP Washout 1||2
10668140|NCT02310750|11830521|FG013|STARTED|HP Washout 1||2
10795953|NCT03649412|11956158|FG000|COMPLETED|Part B, Period 4 (4 Days)||0
10795954|NCT03649412|11956159|FG001|COMPLETED|Part B, Period 4 (4 Days)||15
10795955|NCT03649412|11956158|FG000|NOT COMPLETED|Part B, Period 4 (4 Days)||0
10795956|NCT03649412|11956159|FG001|NOT COMPLETED|Part B, Period 4 (4 Days)||0
10795957|NCT03649412|11956158|FG000|STARTED|Part B, Washout Period 4 (7 Days)||0
10795958|NCT03649412|11956159|FG001|STARTED|Part B, Washout Period 4 (7 Days)||15
10668141|NCT02310750|11830522|FG014|STARTED|HP Washout 1||2
10668142|NCT02310750|11830523|FG015|STARTED|HP Washout 1||2
10668143|NCT02310750|11830508|FG000|COMPLETED|HP Washout 1||0
10668144|NCT02310750|11830509|FG001|COMPLETED|HP Washout 1||0
10668145|NCT02310750|11830510|FG002|COMPLETED|HP Washout 1||5
10668146|NCT02310750|11830511|FG003|COMPLETED|HP Washout 1||4
10668147|NCT02310750|11830512|FG004|COMPLETED|HP Washout 1||6
10668148|NCT02310750|11830513|FG005|COMPLETED|HP Washout 1||6
10668149|NCT02310750|11830514|FG006|COMPLETED|HP Washout 1||9
10668150|NCT02310750|11830515|FG007|COMPLETED|HP Washout 1||0
10668151|NCT02310750|11830516|FG008|COMPLETED|HP Washout 1||0
10668152|NCT02310750|11830517|FG009|COMPLETED|HP Washout 1||0
10668153|NCT02310750|11830518|FG010|COMPLETED|HP Washout 1||2
10668154|NCT02310750|11830519|FG011|COMPLETED|HP Washout 1||2
10668155|NCT02310750|11830520|FG012|COMPLETED|HP Washout 1||2
10668156|NCT02310750|11830521|FG013|COMPLETED|HP Washout 1||2
10668157|NCT02310750|11830522|FG014|COMPLETED|HP Washout 1||2
10668158|NCT02310750|11830523|FG015|COMPLETED|HP Washout 1||2
10668159|NCT02310750|11830508|FG000|NOT COMPLETED|HP Washout 1||0
10668160|NCT02310750|11830509|FG001|NOT COMPLETED|HP Washout 1||0
10668161|NCT02310750|11830510|FG002|NOT COMPLETED|HP Washout 1||1
10668162|NCT02310750|11830511|FG003|NOT COMPLETED|HP Washout 1||1
10668163|NCT02310750|11830512|FG004|NOT COMPLETED|HP Washout 1||2
10668164|NCT02310750|11830513|FG005|NOT COMPLETED|HP Washout 1||2
10668165|NCT02310750|11830514|FG006|NOT COMPLETED|HP Washout 1||3
10668166|NCT02310750|11830515|FG007|NOT COMPLETED|HP Washout 1||0
10668167|NCT02310750|11830516|FG008|NOT COMPLETED|HP Washout 1||0
10668168|NCT02310750|11830517|FG009|NOT COMPLETED|HP Washout 1||0
10668169|NCT02310750|11830518|FG010|NOT COMPLETED|HP Washout 1||0
10668170|NCT02310750|11830519|FG011|NOT COMPLETED|HP Washout 1||0
10668171|NCT02310750|11830520|FG012|NOT COMPLETED|HP Washout 1||0
10668172|NCT02310750|11830521|FG013|NOT COMPLETED|HP Washout 1||0
10668173|NCT02310750|11830522|FG014|NOT COMPLETED|HP Washout 1||0
10668174|NCT02310750|11830523|FG015|NOT COMPLETED|HP Washout 1||0
10668175|NCT02310750|11830508|FG000|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
10668176|NCT02310750|11830509|FG001|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
10668177|NCT02310750|11830510|FG002|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||5
10668178|NCT02310750|11830511|FG003|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
10668179|NCT02310750|11830512|FG004|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
10668180|NCT02310750|11830513|FG005|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
10668181|NCT02310750|11830514|FG006|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
10668182|NCT02310750|11830515|FG007|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
10668183|NCT02310750|11830516|FG008|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||14
10795959|NCT03649412|11956158|FG000|COMPLETED|Part B, Washout Period 4 (7 Days)||0
10795960|NCT03649412|11956159|FG001|COMPLETED|Part B, Washout Period 4 (7 Days)||15
10668184|NCT02310750|11830517|FG009|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||7
10668185|NCT02310750|11830518|FG010|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
10668186|NCT02310750|11830519|FG011|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
10668187|NCT02310750|11830520|FG012|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
10668188|NCT02310750|11830521|FG013|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
10318793|NCT00217490|11453052|FG000|COMPLETED|Overall Study||137
10318794|NCT00217490|11453053|FG001|COMPLETED|Overall Study||128
10318795|NCT00217490|11453054|FG002|COMPLETED|Overall Study||131
10318796|NCT00217490|11453055|FG003|COMPLETED|Overall Study||130
10318797|NCT00217490|11453052|FG000|NOT COMPLETED|Overall Study||17
10318798|NCT00217490|11453053|FG001|NOT COMPLETED|Overall Study||25
10318799|NCT00217490|11453054|FG002|NOT COMPLETED|Overall Study||24
10318800|NCT00217490|11453055|FG003|NOT COMPLETED|Overall Study||23
10318801|NCT00217581|11453069|FG000|STARTED|Overall Study||39
10668189|NCT02310750|11830522|FG014|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
10795961|NCT03649412|11956158|FG000|NOT COMPLETED|Part B, Washout Period 4 (7 Days)||0
10318802|NCT00217581|11453069|FG000|COMPLETED|Overall Study||38
10318803|NCT00217581|11453069|FG000|NOT COMPLETED|Overall Study||1
10318804|NCT00217594|11453074|FG000|STARTED|Overall Study||31
10668190|NCT02310750|11830523|FG015|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
10668191|NCT02310750|11830508|FG000|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
10668192|NCT02310750|11830509|FG001|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
10668193|NCT02310750|11830510|FG002|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||5
10668194|NCT02310750|11830511|FG003|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||3
10668195|NCT02310750|11830512|FG004|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
10668196|NCT02310750|11830513|FG005|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
10668197|NCT02310750|11830514|FG006|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
10668198|NCT02310750|11830515|FG007|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||7
10668199|NCT02310750|11830516|FG008|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
10668200|NCT02310750|11830517|FG009|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
10668201|NCT02310750|11830518|FG010|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
10668202|NCT02310750|11830519|FG011|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
10668203|NCT02310750|11830520|FG012|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
10668204|NCT02310750|11830521|FG013|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
10668205|NCT02310750|11830522|FG014|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
10668206|NCT02310750|11830523|FG015|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
10668207|NCT02310750|11830508|FG000|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
10668208|NCT02310750|11830509|FG001|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
10668209|NCT02310750|11830510|FG002|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
10668210|NCT02310750|11830511|FG003|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||1
10668211|NCT02310750|11830512|FG004|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
10668212|NCT02310750|11830513|FG005|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
10668213|NCT02310750|11830514|FG006|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
10668214|NCT02310750|11830515|FG007|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
10668215|NCT02310750|11830516|FG008|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||8
10668216|NCT02310750|11830517|FG009|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||3
10668217|NCT02310750|11830518|FG010|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
10668218|NCT02310750|11830519|FG011|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
10668219|NCT02310750|11830520|FG012|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
10668220|NCT02310750|11830521|FG013|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
10668221|NCT02310750|11830522|FG014|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
10668222|NCT02310750|11830523|FG015|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
10668223|NCT02310750|11830508|FG000|STARTED|HP Washout 2||0
10668224|NCT02310750|11830509|FG001|STARTED|HP Washout 2||0
10668225|NCT02310750|11830510|FG002|STARTED|HP Washout 2||0
10668226|NCT02310750|11830511|FG003|STARTED|HP Washout 2||0
10668227|NCT02310750|11830512|FG004|STARTED|HP Washout 2||6
10668228|NCT02310750|11830513|FG005|STARTED|HP Washout 2||0
10668229|NCT02310750|11830514|FG006|STARTED|HP Washout 2||9
10668230|NCT02310750|11830515|FG007|STARTED|HP Washout 2||0
10668231|NCT02310750|11830516|FG008|STARTED|HP Washout 2||0
10668232|NCT02310750|11830517|FG009|STARTED|HP Washout 2||0
10668233|NCT02310750|11830518|FG010|STARTED|HP Washout 2||2
10668234|NCT02310750|11830519|FG011|STARTED|HP Washout 2||2
10668235|NCT02310750|11830520|FG012|STARTED|HP Washout 2||2
10668236|NCT02310750|11830521|FG013|STARTED|HP Washout 2||2
10668237|NCT02310750|11830522|FG014|STARTED|HP Washout 2||2
10668238|NCT02310750|11830523|FG015|STARTED|HP Washout 2||2
10668239|NCT02310750|11830508|FG000|COMPLETED|HP Washout 2||0
10668240|NCT02310750|11830509|FG001|COMPLETED|HP Washout 2||0
10668241|NCT02310750|11830510|FG002|COMPLETED|HP Washout 2||0
10668242|NCT02310750|11830511|FG003|COMPLETED|HP Washout 2||0
10668243|NCT02310750|11830512|FG004|COMPLETED|HP Washout 2||5
10668244|NCT02310750|11830513|FG005|COMPLETED|HP Washout 2||0
10668245|NCT02310750|11830514|FG006|COMPLETED|HP Washout 2||2
10668246|NCT02310750|11830515|FG007|COMPLETED|HP Washout 2||0
10668247|NCT02310750|11830516|FG008|COMPLETED|HP Washout 2||0
10668248|NCT02310750|11830517|FG009|COMPLETED|HP Washout 2||0
10668249|NCT02310750|11830518|FG010|COMPLETED|HP Washout 2||2
10668250|NCT02310750|11830519|FG011|COMPLETED|HP Washout 2||2
10668251|NCT02310750|11830520|FG012|COMPLETED|HP Washout 2||2
10668252|NCT02310750|11830521|FG013|COMPLETED|HP Washout 2||2
10668253|NCT02310750|11830522|FG014|COMPLETED|HP Washout 2||2
10668254|NCT02310750|11830523|FG015|COMPLETED|HP Washout 2||2
10668255|NCT02310750|11830508|FG000|NOT COMPLETED|HP Washout 2||0
10668256|NCT02310750|11830509|FG001|NOT COMPLETED|HP Washout 2||0
10668257|NCT02310750|11830510|FG002|NOT COMPLETED|HP Washout 2||0
10668258|NCT02310750|11830511|FG003|NOT COMPLETED|HP Washout 2||0
10668259|NCT02310750|11830512|FG004|NOT COMPLETED|HP Washout 2||1
10668260|NCT02310750|11830513|FG005|NOT COMPLETED|HP Washout 2||0
10668261|NCT02310750|11830514|FG006|NOT COMPLETED|HP Washout 2||7
10668262|NCT02310750|11830515|FG007|NOT COMPLETED|HP Washout 2||0
10668263|NCT02310750|11830516|FG008|NOT COMPLETED|HP Washout 2||0
10668264|NCT02310750|11830517|FG009|NOT COMPLETED|HP Washout 2||0
10668265|NCT02310750|11830518|FG010|NOT COMPLETED|HP Washout 2||0
10668266|NCT02310750|11830519|FG011|NOT COMPLETED|HP Washout 2||0
10668267|NCT02310750|11830520|FG012|NOT COMPLETED|HP Washout 2||0
10668268|NCT02310750|11830521|FG013|NOT COMPLETED|HP Washout 2||0
10668269|NCT02310750|11830522|FG014|NOT COMPLETED|HP Washout 2||0
10668270|NCT02310750|11830523|FG015|NOT COMPLETED|HP Washout 2||0
10668271|NCT02310750|11830508|FG000|STARTED|HP MAD and Fasted/Fed||0
10668272|NCT02310750|11830509|FG001|STARTED|HP MAD and Fasted/Fed||0
10668273|NCT02310750|11830510|FG002|STARTED|HP MAD and Fasted/Fed||0
10668274|NCT02310750|11830511|FG003|STARTED|HP MAD and Fasted/Fed||0
10668275|NCT02310750|11830512|FG004|STARTED|HP MAD and Fasted/Fed||5
10668276|NCT02310750|11830513|FG005|STARTED|HP MAD and Fasted/Fed||0
10668277|NCT02310750|11830514|FG006|STARTED|HP MAD and Fasted/Fed||2
10668278|NCT02310750|11830515|FG007|STARTED|HP MAD and Fasted/Fed||0
10668279|NCT02310750|11830516|FG008|STARTED|HP MAD and Fasted/Fed||0
10668280|NCT02310750|11830517|FG009|STARTED|HP MAD and Fasted/Fed||0
10668281|NCT02310750|11830518|FG010|STARTED|HP MAD and Fasted/Fed||2
10668282|NCT02310750|11830519|FG011|STARTED|HP MAD and Fasted/Fed||2
10668283|NCT02310750|11830520|FG012|STARTED|HP MAD and Fasted/Fed||2
10668284|NCT02310750|11830521|FG013|STARTED|HP MAD and Fasted/Fed||2
10668285|NCT02310750|11830522|FG014|STARTED|HP MAD and Fasted/Fed||2
10668286|NCT02310750|11830523|FG015|STARTED|HP MAD and Fasted/Fed||2
10668287|NCT02310750|11830508|FG000|COMPLETED|HP MAD and Fasted/Fed||0
10668288|NCT02310750|11830509|FG001|COMPLETED|HP MAD and Fasted/Fed||0
10668289|NCT02310750|11830510|FG002|COMPLETED|HP MAD and Fasted/Fed||0
10668290|NCT02310750|11830511|FG003|COMPLETED|HP MAD and Fasted/Fed||0
10668291|NCT02310750|11830512|FG004|COMPLETED|HP MAD and Fasted/Fed||4
10668292|NCT02310750|11830513|FG005|COMPLETED|HP MAD and Fasted/Fed||0
10668293|NCT02310750|11830514|FG006|COMPLETED|HP MAD and Fasted/Fed||2
10668294|NCT02310750|11830515|FG007|COMPLETED|HP MAD and Fasted/Fed||0
10668295|NCT02310750|11830516|FG008|COMPLETED|HP MAD and Fasted/Fed||0
10668296|NCT02310750|11830517|FG009|COMPLETED|HP MAD and Fasted/Fed||0
10668297|NCT02310750|11830518|FG010|COMPLETED|HP MAD and Fasted/Fed||2
10668298|NCT02310750|11830519|FG011|COMPLETED|HP MAD and Fasted/Fed||2
10668299|NCT02310750|11830520|FG012|COMPLETED|HP MAD and Fasted/Fed||2
10668300|NCT02310750|11830521|FG013|COMPLETED|HP MAD and Fasted/Fed||2
10668301|NCT02310750|11830522|FG014|COMPLETED|HP MAD and Fasted/Fed||2
10668302|NCT02310750|11830523|FG015|COMPLETED|HP MAD and Fasted/Fed||2
10668303|NCT02310750|11830508|FG000|NOT COMPLETED|HP MAD and Fasted/Fed||0
10668304|NCT02310750|11830509|FG001|NOT COMPLETED|HP MAD and Fasted/Fed||0
10668305|NCT02310750|11830510|FG002|NOT COMPLETED|HP MAD and Fasted/Fed||0
10668306|NCT02310750|11830511|FG003|NOT COMPLETED|HP MAD and Fasted/Fed||0
10668307|NCT02310750|11830512|FG004|NOT COMPLETED|HP MAD and Fasted/Fed||1
10668308|NCT02310750|11830513|FG005|NOT COMPLETED|HP MAD and Fasted/Fed||0
10668309|NCT02310750|11830514|FG006|NOT COMPLETED|HP MAD and Fasted/Fed||0
10668310|NCT02310750|11830515|FG007|NOT COMPLETED|HP MAD and Fasted/Fed||0
10668311|NCT02310750|11830516|FG008|NOT COMPLETED|HP MAD and Fasted/Fed||0
10668312|NCT02310750|11830517|FG009|NOT COMPLETED|HP MAD and Fasted/Fed||0
10668313|NCT02310750|11830518|FG010|NOT COMPLETED|HP MAD and Fasted/Fed||0
10668314|NCT02310750|11830519|FG011|NOT COMPLETED|HP MAD and Fasted/Fed||0
10668315|NCT02310750|11830520|FG012|NOT COMPLETED|HP MAD and Fasted/Fed||0
10668316|NCT02310750|11830521|FG013|NOT COMPLETED|HP MAD and Fasted/Fed||0
10668317|NCT02310750|11830522|FG014|NOT COMPLETED|HP MAD and Fasted/Fed||0
10668318|NCT02310750|11830523|FG015|NOT COMPLETED|HP MAD and Fasted/Fed||0
10668319|NCT02310763|11830607|FG000|STARTED|Period 1 (Weeks 1 to 48)||41
10668320|NCT02310763|11830608|FG001|STARTED|Period 1 (Weeks 1 to 48)||39
10795962|NCT03649412|11956159|FG001|NOT COMPLETED|Part B, Washout Period 4 (7 Days)||0
10795963|NCT03649412|11956158|FG000|STARTED|Part B, Period 5 (4 Days)||0
10795964|NCT03649412|11956159|FG001|STARTED|Part B, Period 5 (4 Days)|One participant did not start in Period 5|14
10795965|NCT03649412|11956158|FG000|COMPLETED|Part B, Period 5 (4 Days)||0
10668321|NCT02310763|11830609|FG002|STARTED|Period 1 (Weeks 1 to 48)||40
10668322|NCT02310763|11830607|FG000|COMPLETED|Period 1 (Weeks 1 to 48)||38
10668323|NCT02310763|11830608|FG001|COMPLETED|Period 1 (Weeks 1 to 48)||37
10668324|NCT02310763|11830609|FG002|COMPLETED|Period 1 (Weeks 1 to 48)||38
10668325|NCT02310763|11830607|FG000|NOT COMPLETED|Period 1 (Weeks 1 to 48)||3
10668326|NCT02310763|11830608|FG001|NOT COMPLETED|Period 1 (Weeks 1 to 48)||2
10668327|NCT02310763|11830609|FG002|NOT COMPLETED|Period 1 (Weeks 1 to 48)||2
10668328|NCT02310763|11830607|FG000|STARTED|Period 2 (Weeks 49 to 96)||38
10668329|NCT02310763|11830608|FG001|STARTED|Period 2 (Weeks 49 to 96)||37
10668330|NCT02310763|11830609|FG002|STARTED|Period 2 (Weeks 49 to 96)||38
10668331|NCT02310763|11830607|FG000|COMPLETED|Period 2 (Weeks 49 to 96)||22
10668332|NCT02310763|11830608|FG001|COMPLETED|Period 2 (Weeks 49 to 96)||21
10668333|NCT02310763|11830609|FG002|COMPLETED|Period 2 (Weeks 49 to 96)||22
10668334|NCT02310763|11830607|FG000|NOT COMPLETED|Period 2 (Weeks 49 to 96)||16
10668335|NCT02310763|11830608|FG001|NOT COMPLETED|Period 2 (Weeks 49 to 96)||16
10668336|NCT02310763|11830609|FG002|NOT COMPLETED|Period 2 (Weeks 49 to 96)||16
10668337|NCT02310776|11830635|FG000|STARTED|Overall Study||501
10668338|NCT02310776|11830635|FG000|COMPLETED|Overall Study||501
10668339|NCT02310776|11830635|FG000|NOT COMPLETED|Overall Study||0
10668340|NCT02310789|11830639|FG000|STARTED|Overall Study||8
10668341|NCT02310789|11830639|FG000|COMPLETED|Overall Study||7
10668342|NCT02310789|11830639|FG000|NOT COMPLETED|Overall Study||1
10668343|NCT02310906|11830647|FG000|STARTED|Part 1: Double Blind Phase (12 Weeks)||4
10668344|NCT02310906|11830648|FG001|STARTED|Part 1: Double Blind Phase (12 Weeks)||8
10668345|NCT02310906|11830649|FG002|STARTED|Part 1: Double Blind Phase (12 Weeks)||0
10668346|NCT02310906|11830650|FG003|STARTED|Part 1: Double Blind Phase (12 Weeks)||0
10668347|NCT02310906|11830647|FG000|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
10668348|NCT02310906|11830648|FG001|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8
10668349|NCT02310906|11830649|FG002|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
10668350|NCT02310906|11830650|FG003|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
10668351|NCT02310906|11830647|FG000|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
10668352|NCT02310906|11830648|FG001|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8
10668353|NCT02310906|11830649|FG002|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
10668354|NCT02310906|11830650|FG003|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
10668355|NCT02310906|11830647|FG000|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
10668356|NCT02310906|11830648|FG001|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8
10668357|NCT02310906|11830649|FG002|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
10668358|NCT02310906|11830650|FG003|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
10668359|NCT02310906|11830647|FG000|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
10668360|NCT02310906|11830648|FG001|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8
10668361|NCT02310906|11830649|FG002|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
10668362|NCT02310906|11830650|FG003|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
10668363|NCT02310906|11830647|FG000|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||4
10668364|NCT02310906|11830648|FG001|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||8
10668365|NCT02310906|11830649|FG002|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
10668366|NCT02310906|11830650|FG003|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
10668367|NCT02310906|11830647|FG000|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
10668368|NCT02310906|11830648|FG001|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
10668369|NCT02310906|11830649|FG002|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
10668370|NCT02310906|11830650|FG003|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
10668371|NCT02310906|11830647|FG000|STARTED|Part 2: Open Label Phase (168 Weeks)||0
10668372|NCT02310906|11830648|FG001|STARTED|Part 2: Open Label Phase (168 Weeks)||0
10668373|NCT02310906|11830649|FG002|STARTED|Part 2: Open Label Phase (168 Weeks)|4 participants from Part 1(Placebo) + 8 participants from Part 1(Golodirsen) +13 new participants|25
10668374|NCT02310906|11830650|FG003|STARTED|Part 2: Open Label Phase (168 Weeks)||14
10668375|NCT02310906|11830647|FG000|COMPLETED|Part 2: Open Label Phase (168 Weeks)||0
10668376|NCT02310906|11830648|FG001|COMPLETED|Part 2: Open Label Phase (168 Weeks)||0
10668377|NCT02310906|11830649|FG002|COMPLETED|Part 2: Open Label Phase (168 Weeks)||23
10668378|NCT02310906|11830650|FG003|COMPLETED|Part 2: Open Label Phase (168 Weeks)||6
10668379|NCT02310906|11830647|FG000|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||0
10668380|NCT02310906|11830648|FG001|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||0
10668381|NCT02310906|11830649|FG002|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||2
10668382|NCT02310906|11830650|FG003|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||8
10668383|NCT02311153|11830673|FG000|STARTED|Overall Study||53
10668384|NCT02311153|11830674|FG001|STARTED|Overall Study||49
10668385|NCT02311153|11830673|FG000|COMPLETED|Overall Study||48
10668386|NCT02311153|11830674|FG001|COMPLETED|Overall Study||42
10668387|NCT02311153|11830673|FG000|NOT COMPLETED|Overall Study||5
10668388|NCT02311153|11830674|FG001|NOT COMPLETED|Overall Study||7
10668389|NCT02311309|11830683|FG000|STARTED|Overall Study|There were 863 patients with no peroperative bleeding in the 1439 patients studied|541
10668390|NCT02311309|11830684|FG001|STARTED|Overall Study|There were 863 patients with no peroperative bleeding in the 1439 patients studied|35
10668391|NCT02311309|11830685|FG002|STARTED|Overall Study||863
10668392|NCT02311309|11830683|FG000|COMPLETED|Overall Study||541
10668393|NCT02311309|11830684|FG001|COMPLETED|Overall Study||35
10668394|NCT02311309|11830685|FG002|COMPLETED|Overall Study||863
10668395|NCT02311309|11830683|FG000|NOT COMPLETED|Overall Study||0
10668396|NCT02311309|11830684|FG001|NOT COMPLETED|Overall Study||0
10668397|NCT02311309|11830685|FG002|NOT COMPLETED|Overall Study||0
10668398|NCT02311361|11830697|FG000|STARTED|Overall Study||14
10668399|NCT02311361|11830698|FG001|STARTED|Overall Study||11
10668400|NCT02311361|11830699|FG002|STARTED|Overall Study||19
10668401|NCT02311361|11830700|FG003|STARTED|Overall Study||21
10668402|NCT02311361|11830697|FG000|Received Radiation Therapy Only|Overall Study||0
10668403|NCT02311361|11830698|FG001|Received Radiation Therapy Only|Overall Study||1
10668404|NCT02311361|11830699|FG002|Received Radiation Therapy Only|Overall Study||1
10668405|NCT02311361|11830700|FG003|Received Radiation Therapy Only|Overall Study||1
10668406|NCT02311361|11830697|FG000|COMPLETED|Overall Study||14
10668407|NCT02311361|11830698|FG001|COMPLETED|Overall Study||10
10668408|NCT02311361|11830699|FG002|COMPLETED|Overall Study||19
10668409|NCT02311361|11830700|FG003|COMPLETED|Overall Study||20
10668410|NCT02311361|11830697|FG000|NOT COMPLETED|Overall Study||0
10668411|NCT02311361|11830698|FG001|NOT COMPLETED|Overall Study||1
10795966|NCT03649412|11956159|FG001|COMPLETED|Part B, Period 5 (4 Days)||14
10795967|NCT03649412|11956158|FG000|NOT COMPLETED|Part B, Period 5 (4 Days)||0
10795968|NCT03649412|11956159|FG001|NOT COMPLETED|Part B, Period 5 (4 Days)||0
10795969|NCT03649412|11956158|FG000|STARTED|Part B, Washout Period 5 (7 Days)||0
10795970|NCT03649412|11956159|FG001|STARTED|Part B, Washout Period 5 (7 Days)||14
10795971|NCT03649412|11956158|FG000|COMPLETED|Part B, Washout Period 5 (7 Days)||0
10795972|NCT03649412|11956159|FG001|COMPLETED|Part B, Washout Period 5 (7 Days)||13
10795973|NCT03649412|11956158|FG000|NOT COMPLETED|Part B, Washout Period 5 (7 Days)||0
10795974|NCT03649412|11956159|FG001|NOT COMPLETED|Part B, Washout Period 5 (7 Days)||1
10795975|NCT03649412|11956158|FG000|STARTED|Part B, Period 6 (4days)||0
10668412|NCT02311361|11830699|FG002|NOT COMPLETED|Overall Study||0
10668413|NCT02311361|11830700|FG003|NOT COMPLETED|Overall Study||1
10668414|NCT02311881|11830717|FG000|STARTED|Overall Study|Started refers to all randomized participants.|235
10668415|NCT02311881|11830718|FG001|STARTED|Overall Study|Started refers to all randomized participants.|236
10668416|NCT02311881|11830719|FG002|STARTED|Overall Study|Started refers to all randomized participants.|237
10795976|NCT03649412|11956159|FG001|STARTED|Part B, Period 6 (4days)|Participant who did not start Period 5 directly joined into Period 6|14
10668417|NCT02311881|11830717|FG000|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|234
10668418|NCT02311881|11830718|FG001|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|236
10668419|NCT02311881|11830719|FG002|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|237
10668420|NCT02311881|11830717|FG000|COMPLETED|Overall Study||200
10668421|NCT02311881|11830718|FG001|COMPLETED|Overall Study||193
10668422|NCT02311881|11830719|FG002|COMPLETED|Overall Study||196
10668423|NCT02311881|11830717|FG000|NOT COMPLETED|Overall Study||35
10668424|NCT02311881|11830718|FG001|NOT COMPLETED|Overall Study||43
10668425|NCT02311881|11830719|FG002|NOT COMPLETED|Overall Study||41
10668426|NCT02311894|11830730|FG000|STARTED|Overall Study||82
10668427|NCT02311894|11830730|FG000|Modified ITT Population|Overall Study||81
10668428|NCT02311894|11830730|FG000|COMPLETED|Overall Study||78
10668429|NCT02311894|11830730|FG000|NOT COMPLETED|Overall Study||4
10668430|NCT02311907|11830736|FG000|STARTED|Overall Study||94
10668431|NCT02311907|11830737|FG001|STARTED|Overall Study||91
10668432|NCT02311907|11830736|FG000|COMPLETED|Overall Study||94
10668433|NCT02311907|11830737|FG001|COMPLETED|Overall Study||91
10668434|NCT02311907|11830736|FG000|NOT COMPLETED|Overall Study||0
10668435|NCT02311907|11830737|FG001|NOT COMPLETED|Overall Study||0
10668436|NCT02311933|11830745|FG000|STARTED|Overall Study||41
10668437|NCT02311933|11830746|FG001|STARTED|Overall Study||40
10668438|NCT02311933|11830745|FG000|COMPLETED|Overall Study||41
10668439|NCT02311933|11830746|FG001|COMPLETED|Overall Study||40
10668440|NCT02311933|11830745|FG000|NOT COMPLETED|Overall Study||0
10668441|NCT02311933|11830746|FG001|NOT COMPLETED|Overall Study||0
10668442|NCT02311972|11830754|FG000|STARTED|Overall Study||12
10668443|NCT02311972|11830755|FG001|STARTED|Overall Study||8
10668444|NCT02311972|11830754|FG000|COMPLETED|Overall Study||12
10668445|NCT02311972|11830755|FG001|COMPLETED|Overall Study||8
10668446|NCT02311972|11830754|FG000|NOT COMPLETED|Overall Study||0
10668447|NCT02311972|11830755|FG001|NOT COMPLETED|Overall Study||0
10668448|NCT02312063|11830764|FG000|STARTED|Overall Study||23
10668449|NCT02312063|11830765|FG001|STARTED|Overall Study||25
10668450|NCT02312063|11830764|FG000|COMPLETED|Overall Study||23
10668451|NCT02312063|11830765|FG001|COMPLETED|Overall Study||24
10668452|NCT02312063|11830764|FG000|NOT COMPLETED|Overall Study||0
10668453|NCT02312063|11830765|FG001|NOT COMPLETED|Overall Study||1
10795977|NCT03649412|11956158|FG000|COMPLETED|Part B, Period 6 (4days)||0
10795978|NCT03649412|11956159|FG001|COMPLETED|Part B, Period 6 (4days)||14
10795979|NCT03649412|11956158|FG000|NOT COMPLETED|Part B, Period 6 (4days)||0
10795980|NCT03649412|11956159|FG001|NOT COMPLETED|Part B, Period 6 (4days)||0
10668454|NCT02312154|11830772|FG000|STARTED|Overall Study||25
10668455|NCT02312154|11830772|FG000|COMPLETED|Overall Study||24
10668456|NCT02312154|11830772|FG000|NOT COMPLETED|Overall Study||1
10668457|NCT02312206|11830779|FG000|STARTED|Overall Study||130
10668458|NCT02312206|11830780|FG001|STARTED|Overall Study||130
10668459|NCT02312206|11830779|FG000|Informed Consent Obtained|Overall Study||130
10668460|NCT02312206|11830780|FG001|Informed Consent Obtained|Overall Study||130
10668461|NCT02312206|11830779|FG000|COMPLETED|Overall Study||0
10668462|NCT02312206|11830780|FG001|COMPLETED|Overall Study||0
10668463|NCT02312206|11830779|FG000|NOT COMPLETED|Overall Study||130
10668464|NCT02312206|11830780|FG001|NOT COMPLETED|Overall Study||130
10668465|NCT02312219|11830788|FG000|STARTED|Overall Study||13
10668466|NCT02312219|11830789|FG001|STARTED|Overall Study||22
10668467|NCT02312219|11830788|FG000|COMPLETED|Overall Study||12
10668468|NCT02312219|11830789|FG001|COMPLETED|Overall Study||16
10668469|NCT02312219|11830788|FG000|NOT COMPLETED|Overall Study||1
10668470|NCT02312219|11830789|FG001|NOT COMPLETED|Overall Study||6
10668471|NCT02312310|11830799|FG000|STARTED|Overall Study||53
10668472|NCT02312310|11830800|FG001|STARTED|Overall Study||53
10668473|NCT02312310|11830801|FG002|STARTED|Overall Study||53
10668474|NCT02312310|11830802|FG003|STARTED|Overall Study||52
10668475|NCT02312310|11830799|FG000|COMPLETED|Overall Study||51
10668476|NCT02312310|11830800|FG001|COMPLETED|Overall Study||51
10668477|NCT02312310|11830801|FG002|COMPLETED|Overall Study||50
10668478|NCT02312310|11830802|FG003|COMPLETED|Overall Study||52
10668479|NCT02312310|11830799|FG000|NOT COMPLETED|Overall Study||2
10668480|NCT02312310|11830800|FG001|NOT COMPLETED|Overall Study||2
10668481|NCT02312310|11830801|FG002|NOT COMPLETED|Overall Study||3
10668482|NCT02312310|11830802|FG003|NOT COMPLETED|Overall Study||0
10668483|NCT02312622|11830819|FG000|STARTED|Overall Study||12
10668484|NCT02312622|11830820|FG001|STARTED|Overall Study||3
10668485|NCT02312622|11830821|FG002|STARTED|Overall Study||12
10668486|NCT02312622|11830819|FG000|COMPLETED|Overall Study||12
10668487|NCT02312622|11830820|FG001|COMPLETED|Overall Study||3
10668488|NCT02312622|11830821|FG002|COMPLETED|Overall Study||12
10668489|NCT02312622|11830819|FG000|NOT COMPLETED|Overall Study||0
10668490|NCT02312622|11830820|FG001|NOT COMPLETED|Overall Study||0
10668491|NCT02312622|11830821|FG002|NOT COMPLETED|Overall Study||0
10668492|NCT02312687|11830832|FG000|STARTED|Overall Study||20
10668493|NCT02312687|11830832|FG000|COMPLETED|Overall Study||19
10668494|NCT02312687|11830832|FG000|NOT COMPLETED|Overall Study||1
10668495|NCT02312713|11830839|FG000|STARTED|Overall Study||140
10668496|NCT02312713|11830840|FG001|STARTED|Overall Study||142
10668497|NCT02312713|11830841|FG002|STARTED|Overall Study||68
10668498|NCT02312713|11830839|FG000|COMPLETED|Overall Study||129
10668499|NCT02312713|11830840|FG001|COMPLETED|Overall Study||112
10668500|NCT02312713|11830841|FG002|COMPLETED|Overall Study||63
10668501|NCT02312713|11830839|FG000|NOT COMPLETED|Overall Study||11
10668502|NCT02312713|11830840|FG001|NOT COMPLETED|Overall Study||30
10668503|NCT02312713|11830841|FG002|NOT COMPLETED|Overall Study||5
10668504|NCT02312726|11830849|FG000|STARTED|Overall Study||38
10668505|NCT02312726|11830850|FG001|STARTED|Overall Study||30
10668506|NCT02312726|11830851|FG002|STARTED|Overall Study||67
10668507|NCT02312726|11830849|FG000|COMPLETED|Overall Study||38
10668508|NCT02312726|11830850|FG001|COMPLETED|Overall Study||30
10668509|NCT02312726|11830851|FG002|COMPLETED|Overall Study||0
10668510|NCT02312726|11830849|FG000|NOT COMPLETED|Overall Study||0
10668511|NCT02312726|11830850|FG001|NOT COMPLETED|Overall Study||0
10668512|NCT02312726|11830851|FG002|NOT COMPLETED|Overall Study||67
10668513|NCT02312739|11830860|FG000|STARTED|Overall Study||36
10668514|NCT02312739|11830861|FG001|STARTED|Overall Study||36
10668515|NCT02312739|11830860|FG000|Withdrawn Prior to Procedure|Overall Study||6
10668516|NCT02312739|11830861|FG001|Withdrawn Prior to Procedure|Overall Study||2
10668517|NCT02312739|11830860|FG000|COMPLETED|Overall Study||30
10668518|NCT02312739|11830861|FG001|COMPLETED|Overall Study||34
10668519|NCT02312739|11830860|FG000|NOT COMPLETED|Overall Study||6
10668520|NCT02312739|11830861|FG001|NOT COMPLETED|Overall Study||2
10668521|NCT02312765|11830869|FG000|STARTED|Overall Study||74
10668522|NCT02312765|11830870|FG001|STARTED|Overall Study||72
10668523|NCT02312765|11830869|FG000|COMPLETED|Overall Study||19
10668524|NCT02312765|11830870|FG001|COMPLETED|Overall Study||36
10668525|NCT02312765|11830869|FG000|NOT COMPLETED|Overall Study||55
10668526|NCT02312765|11830870|FG001|NOT COMPLETED|Overall Study||36
10668527|NCT02312856|11830876|FG000|STARTED|Overall Study||34
10668528|NCT02312856|11830876|FG000|COMPLETED|Overall Study||30
10668529|NCT02312856|11830876|FG000|NOT COMPLETED|Overall Study||4
10668530|NCT02312882|11830880|FG000|STARTED|Overall Study||40
10668531|NCT02312882|11830880|FG000|COMPLETED|Overall Study||36
10668532|NCT02312882|11830880|FG000|NOT COMPLETED|Overall Study||4
10668533|NCT02312934|11830886|FG000|STARTED|Overall Study||11
10668534|NCT02312934|11830887|FG001|STARTED|Overall Study||11
10668535|NCT02312934|11830886|FG000|COMPLETED|Overall Study||9
10668536|NCT02312934|11830887|FG001|COMPLETED|Overall Study||11
10668537|NCT02312934|11830886|FG000|NOT COMPLETED|Overall Study||2
10668538|NCT02312934|11830887|FG001|NOT COMPLETED|Overall Study||0
10668539|NCT02312986|11830894|FG000|STARTED|Overall Study||1
10668540|NCT02312986|11830894|FG000|COMPLETED|Overall Study||1
10668541|NCT02312986|11830894|FG000|NOT COMPLETED|Overall Study||0
10668542|NCT02313155|11830900|FG000|STARTED|Overall Study||55
10668543|NCT02313155|11830901|FG001|STARTED|Overall Study||55
10668544|NCT02313155|11830900|FG000|COMPLETED|Overall Study||55
10668545|NCT02313155|11830901|FG001|COMPLETED|Overall Study||54
10668546|NCT02313155|11830900|FG000|NOT COMPLETED|Overall Study||0
10668547|NCT02313155|11830901|FG001|NOT COMPLETED|Overall Study||1
10668548|NCT02313233|11830909|FG000|STARTED|Overall Study||20
10668549|NCT02313233|11830910|FG001|STARTED|Overall Study||21
10668550|NCT02313233|11830909|FG000|COMPLETED|Overall Study||18
10668551|NCT02313233|11830910|FG001|COMPLETED|Overall Study||18
10668552|NCT02313233|11830909|FG000|NOT COMPLETED|Overall Study||2
10668553|NCT02313233|11830910|FG001|NOT COMPLETED|Overall Study||3
10668554|NCT02313454|11830918|FG000|STARTED|Treatment 1||9
10668555|NCT02313454|11830919|FG001|STARTED|Treatment 1||11
10668556|NCT02313454|11830918|FG000|COMPLETED|Treatment 1||9
10668557|NCT02313454|11830919|FG001|COMPLETED|Treatment 1||11
10668558|NCT02313454|11830918|FG000|NOT COMPLETED|Treatment 1||0
10668559|NCT02313454|11830919|FG001|NOT COMPLETED|Treatment 1||0
10668560|NCT02313454|11830918|FG000|STARTED|Treatment 2|1 participant did not receive the second application.|8
10668561|NCT02313454|11830919|FG001|STARTED|Treatment 2|1 participant did not receive the second application.|10
10668562|NCT02313454|11830918|FG000|COMPLETED|Treatment 2||8
10668563|NCT02313454|11830919|FG001|COMPLETED|Treatment 2||10
10668564|NCT02313454|11830918|FG000|NOT COMPLETED|Treatment 2||0
10668565|NCT02313454|11830919|FG001|NOT COMPLETED|Treatment 2||0
10668566|NCT02313506|11830927|FG000|STARTED|Overall Study||17
10668567|NCT02313506|11830928|FG001|STARTED|Overall Study||17
10668568|NCT02313506|11830927|FG000|COMPLETED|Overall Study||17
10668569|NCT02313506|11830928|FG001|COMPLETED|Overall Study||17
10668570|NCT02313506|11830927|FG000|NOT COMPLETED|Overall Study||0
10668571|NCT02313506|11830928|FG001|NOT COMPLETED|Overall Study||0
10668572|NCT02313558|11830937|FG000|STARTED|Overall Study||50
10668573|NCT02313558|11830938|FG001|STARTED|Overall Study||50
10668574|NCT02313558|11830937|FG000|COMPLETED|Overall Study||44
10668575|NCT02313558|11830938|FG001|COMPLETED|Overall Study||46
10668576|NCT02313558|11830937|FG000|NOT COMPLETED|Overall Study||6
10668577|NCT02313558|11830938|FG001|NOT COMPLETED|Overall Study||4
10668578|NCT02313597|11830946|FG000|STARTED|Overall Study||40
10668579|NCT02313597|11830947|FG001|STARTED|Overall Study||40
10668580|NCT02313597|11830946|FG000|COMPLETED|Overall Study||40
10668581|NCT02313597|11830947|FG001|COMPLETED|Overall Study||40
10668582|NCT02313597|11830946|FG000|NOT COMPLETED|Overall Study||0
10668583|NCT02313597|11830947|FG001|NOT COMPLETED|Overall Study||0
10668584|NCT02313675|11830957|FG000|STARTED|Overall Study||11
10668585|NCT02313675|11830958|FG001|STARTED|Overall Study||11
10668586|NCT02313675|11830959|FG002|STARTED|Overall Study||11
10668587|NCT02313675|11830960|FG003|STARTED|Overall Study||11
10668588|NCT02313675|11830957|FG000|COMPLETED|Overall Study||11
10668589|NCT02313675|11830958|FG001|COMPLETED|Overall Study||11
10668590|NCT02313675|11830959|FG002|COMPLETED|Overall Study||11
10668591|NCT02313675|11830960|FG003|COMPLETED|Overall Study||11
10668592|NCT02313675|11830957|FG000|NOT COMPLETED|Overall Study||0
10668593|NCT02313675|11830958|FG001|NOT COMPLETED|Overall Study||0
10668594|NCT02313675|11830959|FG002|NOT COMPLETED|Overall Study||0
10668595|NCT02313675|11830960|FG003|NOT COMPLETED|Overall Study||0
10668596|NCT02313766|11830973|FG000|STARTED|Overall Study||50
10668597|NCT02313766|11830974|FG001|STARTED|Overall Study||50
10668598|NCT02313766|11830975|FG002|STARTED|Overall Study||50
10668599|NCT02313766|11830973|FG000|COMPLETED|Overall Study||49
10668600|NCT02313766|11830974|FG001|COMPLETED|Overall Study||47
10668601|NCT02313766|11830975|FG002|COMPLETED|Overall Study||50
10668602|NCT02313766|11830973|FG000|NOT COMPLETED|Overall Study||1
10668603|NCT02313766|11830974|FG001|NOT COMPLETED|Overall Study||3
10668604|NCT02313766|11830975|FG002|NOT COMPLETED|Overall Study||0
10668605|NCT02313909|11830985|FG000|STARTED|Overall Study||3609
10668606|NCT02313909|11830986|FG001|STARTED|Overall Study||3604
10668607|NCT02313909|11830985|FG000|Treated|Overall Study||3562
10668608|NCT02313909|11830986|FG001|Treated|Overall Study||3559
10668609|NCT02313909|11830985|FG000|COMPLETED|Overall Study||3552
10668610|NCT02313909|11830986|FG001|COMPLETED|Overall Study||3554
10668611|NCT02313909|11830985|FG000|NOT COMPLETED|Overall Study||57
10668612|NCT02313909|11830986|FG001|NOT COMPLETED|Overall Study||50
10668613|NCT02314000|11830994|FG000|STARTED|Overall Study||75
10668614|NCT02314000|11830995|FG001|STARTED|Overall Study||65
10668615|NCT02314000|11830994|FG000|COMPLETED|Overall Study||62
10668616|NCT02314000|11830995|FG001|COMPLETED|Overall Study||57
10668617|NCT02314000|11830994|FG000|NOT COMPLETED|Overall Study||13
10668618|NCT02314000|11830995|FG001|NOT COMPLETED|Overall Study||8
10712315|NCT02669433|11877928|FG001|Intent to Treat (ITT) Population|Overall Study||89
10712316|NCT02669433|11877929|FG002|Intent to Treat (ITT) Population|Overall Study||87
10712317|NCT02669433|11877927|FG000|Per-Protocol Population|Overall Study||78
10712318|NCT02669433|11877928|FG001|Per-Protocol Population|Overall Study||79
10712319|NCT02669433|11877929|FG002|Per-Protocol Population|Overall Study||82
10712320|NCT02669433|11877927|FG000|Completers Population|Overall Study||73
10712321|NCT02669433|11877928|FG001|Completers Population|Overall Study||72
10712322|NCT02669433|11877929|FG002|Completers Population|Overall Study||69
10712323|NCT02669433|11877927|FG000|UPDRS Primary Population|Overall Study||87
10712324|NCT02669433|11877928|FG001|UPDRS Primary Population|Overall Study||87
10712325|NCT02669433|11877929|FG002|UPDRS Primary Population|Overall Study||84
10712326|NCT02669433|11877927|FG000|COMPLETED|Overall Study||76
10712327|NCT02669433|11877928|FG001|COMPLETED|Overall Study||75
10712328|NCT02669433|11877929|FG002|COMPLETED|Overall Study||74
10712329|NCT02669433|11877927|FG000|NOT COMPLETED|Overall Study||15
10712330|NCT02669433|11877928|FG001|NOT COMPLETED|Overall Study||14
10712331|NCT02669433|11877929|FG002|NOT COMPLETED|Overall Study||15
10712332|NCT02669615|11877937|FG000|STARTED|Overall Study||24
10712333|NCT02669615|11877937|FG000|COMPLETED|Overall Study||24
10795990|NCT03649646|11956215|FG000|STARTED|Overall Study||4542
10795991|NCT03649646|11956215|FG000|COMPLETED|Overall Study||4075
10795992|NCT03649646|11956215|FG000|NOT COMPLETED|Overall Study||467
10795993|NCT03649750|11956219|FG000|STARTED|Period 1||12
10795994|NCT03649750|11956220|FG001|STARTED|Period 1||24
10795995|NCT03649750|11956219|FG000|COMPLETED|Period 1||12
10712334|NCT02669615|11877937|FG000|NOT COMPLETED|Overall Study||0
10712335|NCT02669667|11877948|FG000|STARTED|Overall Study||12
10712336|NCT02669667|11877949|FG001|STARTED|Overall Study||4
10712337|NCT02669667|11877950|FG002|STARTED|Overall Study||4
10712338|NCT02669667|11877951|FG003|STARTED|Overall Study||6
10712339|NCT02669667|11877952|FG004|STARTED|Overall Study||6
10712340|NCT02669667|11877953|FG005|STARTED|Overall Study||6
10712341|NCT02669667|11877954|FG006|STARTED|Overall Study||6
10712342|NCT02669667|11877948|FG000|COMPLETED|Overall Study||12
10712343|NCT02669667|11877949|FG001|COMPLETED|Overall Study||4
10712344|NCT02669667|11877950|FG002|COMPLETED|Overall Study||4
10712345|NCT02669667|11877951|FG003|COMPLETED|Overall Study||6
10712346|NCT02669667|11877952|FG004|COMPLETED|Overall Study||6
10712347|NCT02669667|11877953|FG005|COMPLETED|Overall Study||5
10712348|NCT02669667|11877954|FG006|COMPLETED|Overall Study||6
10712349|NCT02669667|11877948|FG000|NOT COMPLETED|Overall Study||0
10712350|NCT02669667|11877949|FG001|NOT COMPLETED|Overall Study||0
10712351|NCT02669667|11877950|FG002|NOT COMPLETED|Overall Study||0
10795996|NCT03649750|11956220|FG001|COMPLETED|Period 1||24
10712352|NCT02669667|11877951|FG003|NOT COMPLETED|Overall Study||0
10795997|NCT03649750|11956219|FG000|NOT COMPLETED|Period 1||0
10795998|NCT03649750|11956220|FG001|NOT COMPLETED|Period 1||0
10668619|NCT02314026|11831002|FG000|STARTED|Overall Study||135
10668620|NCT02314026|11831002|FG000|COMPLETED|Overall Study||107
10668621|NCT02314026|11831002|FG000|NOT COMPLETED|Overall Study||28
10668622|NCT02314052|11831006|FG000|STARTED|Cycle One||3
10668623|NCT02314052|11831007|FG001|STARTED|Cycle One||3
10668624|NCT02314052|11831008|FG002|STARTED|Cycle One||3
10668625|NCT02314052|11831009|FG003|STARTED|Cycle One||3
10668626|NCT02314052|11831010|FG004|STARTED|Cycle One||6
10668627|NCT02314052|11831011|FG005|STARTED|Cycle One||3
10668628|NCT02314052|11831006|FG000|COMPLETED|Cycle One||3
10668629|NCT02314052|11831007|FG001|COMPLETED|Cycle One||3
10795999|NCT03649750|11956219|FG000|STARTED|Washout: 7 Days||12
10796000|NCT03649750|11956220|FG001|STARTED|Washout: 7 Days||24
10796001|NCT03649750|11956219|FG000|COMPLETED|Washout: 7 Days||12
10796002|NCT03649750|11956220|FG001|COMPLETED|Washout: 7 Days||24
10796003|NCT03649750|11956219|FG000|NOT COMPLETED|Washout: 7 Days||0
10796004|NCT03649750|11956220|FG001|NOT COMPLETED|Washout: 7 Days||0
10796005|NCT03649750|11956219|FG000|STARTED|Period 2||12
10796006|NCT03649750|11956220|FG001|STARTED|Period 2||24
10796007|NCT03649750|11956219|FG000|COMPLETED|Period 2||12
10796008|NCT03649750|11956220|FG001|COMPLETED|Period 2||24
10796009|NCT03649750|11956219|FG000|NOT COMPLETED|Period 2||0
10796010|NCT03649750|11956220|FG001|NOT COMPLETED|Period 2||0
10796011|NCT03649815|11956227|FG000|STARTED|Overall Study||38
10796012|NCT03649815|11956227|FG000|COMPLETED|Overall Study||38
10796013|NCT03649815|11956227|FG000|NOT COMPLETED|Overall Study||0
10796014|NCT03649867|11956231|FG000|STARTED|Overall Study||13
10796015|NCT03649867|11956231|FG000|COMPLETED|Overall Study||13
10796016|NCT03649867|11956231|FG000|NOT COMPLETED|Overall Study||0
10796017|NCT03649932|11956238|FG000|STARTED|Overall Study||14
10796018|NCT03649932|11956239|FG001|STARTED|Overall Study||14
10796019|NCT03649932|11956240|FG002|STARTED|Overall Study||14
10796020|NCT03649932|11956238|FG000|COMPLETED|Overall Study||14
10796021|NCT03649932|11956239|FG001|COMPLETED|Overall Study||13
10796022|NCT03649932|11956240|FG002|COMPLETED|Overall Study||13
10796023|NCT03649932|11956238|FG000|NOT COMPLETED|Overall Study||0
10796024|NCT03649932|11956239|FG001|NOT COMPLETED|Overall Study||1
10796025|NCT03649932|11956240|FG002|NOT COMPLETED|Overall Study||1
10796026|NCT03650192|11956248|FG000|STARTED|Overall Study||40
10796027|NCT03650192|11956248|FG000|COMPLETED|Overall Study||40
10796028|NCT03650192|11956248|FG000|NOT COMPLETED|Overall Study||0
10796029|NCT03650387|11956252|FG000|STARTED|Overall Study||207
10796030|NCT03650387|11956252|FG000|COMPLETED|Overall Study||173
10796031|NCT03650387|11956252|FG000|NOT COMPLETED|Overall Study||34
10796032|NCT03650400|11956267|FG000|STARTED|Overall Study||6
10796033|NCT03650400|11956268|FG001|STARTED|Overall Study||5
10796034|NCT03650400|11956267|FG000|COMPLETED|Overall Study||6
10796035|NCT03650400|11956268|FG001|COMPLETED|Overall Study||0
10796036|NCT03650400|11956267|FG000|NOT COMPLETED|Overall Study||0
10796037|NCT03650400|11956268|FG001|NOT COMPLETED|Overall Study||5
10796038|NCT03650452|11956276|FG000|STARTED|Overall Study||70
10796039|NCT03650452|11956277|FG001|STARTED|Overall Study||71
10796040|NCT03650452|11956276|FG000|COMPLETED|Overall Study||60
10796041|NCT03650452|11956277|FG001|COMPLETED|Overall Study||66
10796042|NCT03650452|11956276|FG000|NOT COMPLETED|Overall Study||10
10796043|NCT03650452|11956277|FG001|NOT COMPLETED|Overall Study||5
10796044|NCT03650842|11956283|FG000|STARTED|Overall Study||25
10796045|NCT03650842|11956283|FG000|COMPLETED|Overall Study||25
10796046|NCT03650842|11956283|FG000|NOT COMPLETED|Overall Study||0
10796047|NCT03651479|11956289|FG000|STARTED|Overall Study||20
10796048|NCT03651479|11956290|FG001|STARTED|Overall Study||20
10796049|NCT03651479|11956289|FG000|COMPLETED|Overall Study||20
10796050|NCT03651479|11956290|FG001|COMPLETED|Overall Study||20
10796051|NCT03651479|11956289|FG000|NOT COMPLETED|Overall Study||0
10796052|NCT03651479|11956290|FG001|NOT COMPLETED|Overall Study||0
10796053|NCT03651856|11956296|FG000|STARTED|Overall Study||10
10796054|NCT03651856|11956296|FG000|COMPLETED|Overall Study||10
10668630|NCT02314052|11831008|FG002|COMPLETED|Cycle One||3
10668631|NCT02314052|11831009|FG003|COMPLETED|Cycle One||2
10796055|NCT03651856|11956296|FG000|NOT COMPLETED|Overall Study||0
10796056|NCT03652610|11956302|FG000|STARTED|Overall Study||490
10796057|NCT03652610|11956303|FG001|STARTED|Overall Study||489
10796058|NCT03652610|11956302|FG000|COMPLETED|Overall Study||486
10796059|NCT03652610|11956303|FG001|COMPLETED|Overall Study||484
10796060|NCT03652610|11956302|FG000|NOT COMPLETED|Overall Study||4
10796061|NCT03652610|11956303|FG001|NOT COMPLETED|Overall Study||5
10796062|NCT03652662|11956311|FG000|STARTED|Overall Study||18
10796063|NCT03652662|11956312|FG001|STARTED|Overall Study||16
10796064|NCT03652662|11956311|FG000|COMPLETED|Overall Study||15
10796065|NCT03652662|11956312|FG001|COMPLETED|Overall Study||15
10796066|NCT03652662|11956311|FG000|NOT COMPLETED|Overall Study||3
10796067|NCT03652662|11956312|FG001|NOT COMPLETED|Overall Study||1
10668632|NCT02314052|11831010|FG004|COMPLETED|Cycle One||6
10668633|NCT02314052|11831011|FG005|COMPLETED|Cycle One||3
10668634|NCT02314052|11831006|FG000|NOT COMPLETED|Cycle One||0
10668635|NCT02314052|11831007|FG001|NOT COMPLETED|Cycle One||0
10668636|NCT02314052|11831008|FG002|NOT COMPLETED|Cycle One||0
10796068|NCT03652675|11956320|FG000|STARTED|Overall Study||16
10796069|NCT03652675|11956321|FG001|STARTED|Overall Study||15
10796070|NCT03652675|11956320|FG000|COMPLETED|Overall Study||12
10796071|NCT03652675|11956321|FG001|COMPLETED|Overall Study||11
10796072|NCT03652675|11956320|FG000|NOT COMPLETED|Overall Study||4
10796073|NCT03652675|11956321|FG001|NOT COMPLETED|Overall Study||4
10796074|NCT03652818|11956332|FG000|STARTED|Overall Study||24
10796075|NCT03652818|11956333|FG001|STARTED|Overall Study||23
10668637|NCT02314052|11831009|FG003|NOT COMPLETED|Cycle One||1
10668638|NCT02314052|11831010|FG004|NOT COMPLETED|Cycle One||0
10668639|NCT02314052|11831011|FG005|NOT COMPLETED|Cycle One||0
10668640|NCT02314052|11831006|FG000|STARTED|Cycle Two||3
10668641|NCT02314052|11831007|FG001|STARTED|Cycle Two||3
10668642|NCT02314052|11831008|FG002|STARTED|Cycle Two||3
10668643|NCT02314052|11831009|FG003|STARTED|Cycle Two||2
10668644|NCT02314052|11831010|FG004|STARTED|Cycle Two||6
10668645|NCT02314052|11831011|FG005|STARTED|Cycle Two||3
10668646|NCT02314052|11831006|FG000|COMPLETED|Cycle Two||3
10668647|NCT02314052|11831007|FG001|COMPLETED|Cycle Two||2
10668648|NCT02314052|11831008|FG002|COMPLETED|Cycle Two||2
10668649|NCT02314052|11831009|FG003|COMPLETED|Cycle Two||1
10668650|NCT02314052|11831010|FG004|COMPLETED|Cycle Two||2
10668651|NCT02314052|11831011|FG005|COMPLETED|Cycle Two||3
10668652|NCT02314052|11831006|FG000|NOT COMPLETED|Cycle Two||0
10668653|NCT02314052|11831007|FG001|NOT COMPLETED|Cycle Two||1
10668654|NCT02314052|11831008|FG002|NOT COMPLETED|Cycle Two||1
10668655|NCT02314052|11831009|FG003|NOT COMPLETED|Cycle Two||1
10668656|NCT02314052|11831010|FG004|NOT COMPLETED|Cycle Two||4
10668657|NCT02314052|11831011|FG005|NOT COMPLETED|Cycle Two||0
10668658|NCT02314052|11831006|FG000|STARTED|Cycle Three||3
10668659|NCT02314052|11831007|FG001|STARTED|Cycle Three||2
10668660|NCT02314052|11831008|FG002|STARTED|Cycle Three||2
10668661|NCT02314052|11831009|FG003|STARTED|Cycle Three||1
10668662|NCT02314052|11831010|FG004|STARTED|Cycle Three||2
10668663|NCT02314052|11831011|FG005|STARTED|Cycle Three||3
10668664|NCT02314052|11831006|FG000|COMPLETED|Cycle Three||3
10668665|NCT02314052|11831007|FG001|COMPLETED|Cycle Three|1 of 2 completers in cohort 2 (subject 02-005) only completed 1 of 2 infusions during this cycle|2
10668666|NCT02314052|11831008|FG002|COMPLETED|Cycle Three||2
10668667|NCT02314052|11831009|FG003|COMPLETED|Cycle Three||1
10668668|NCT02314052|11831010|FG004|COMPLETED|Cycle Three||2
10668669|NCT02314052|11831011|FG005|COMPLETED|Cycle Three||3
10668670|NCT02314052|11831006|FG000|NOT COMPLETED|Cycle Three||0
10668671|NCT02314052|11831007|FG001|NOT COMPLETED|Cycle Three||0
10668672|NCT02314052|11831008|FG002|NOT COMPLETED|Cycle Three||0
10668673|NCT02314052|11831009|FG003|NOT COMPLETED|Cycle Three||0
10668674|NCT02314052|11831010|FG004|NOT COMPLETED|Cycle Three||0
10668675|NCT02314052|11831011|FG005|NOT COMPLETED|Cycle Three||0
10668676|NCT02314052|11831006|FG000|STARTED|Cycle Four||3
10668677|NCT02314052|11831007|FG001|STARTED|Cycle Four||2
10668678|NCT02314052|11831008|FG002|STARTED|Cycle Four||2
10668679|NCT02314052|11831009|FG003|STARTED|Cycle Four||1
10668680|NCT02314052|11831010|FG004|STARTED|Cycle Four||2
10668681|NCT02314052|11831011|FG005|STARTED|Cycle Four||3
10668682|NCT02314052|11831006|FG000|COMPLETED|Cycle Four||0
10668683|NCT02314052|11831007|FG001|COMPLETED|Cycle Four||2
10668684|NCT02314052|11831008|FG002|COMPLETED|Cycle Four||1
10668685|NCT02314052|11831009|FG003|COMPLETED|Cycle Four||0
10668686|NCT02314052|11831010|FG004|COMPLETED|Cycle Four||2
10668687|NCT02314052|11831011|FG005|COMPLETED|Cycle Four||0
10668688|NCT02314052|11831006|FG000|NOT COMPLETED|Cycle Four||3
10668689|NCT02314052|11831007|FG001|NOT COMPLETED|Cycle Four||0
10668690|NCT02314052|11831008|FG002|NOT COMPLETED|Cycle Four||1
10668691|NCT02314052|11831009|FG003|NOT COMPLETED|Cycle Four||1
10668692|NCT02314052|11831010|FG004|NOT COMPLETED|Cycle Four||0
10668693|NCT02314052|11831011|FG005|NOT COMPLETED|Cycle Four||3
10668694|NCT02314052|11831006|FG000|STARTED|Cycle Five||0
10668695|NCT02314052|11831007|FG001|STARTED|Cycle Five||2
10668696|NCT02314052|11831008|FG002|STARTED|Cycle Five||1
10668697|NCT02314052|11831009|FG003|STARTED|Cycle Five|subject missed cycle four but returned for cycle 5|1
10668698|NCT02314052|11831010|FG004|STARTED|Cycle Five||2
10668699|NCT02314052|11831011|FG005|STARTED|Cycle Five||0
10668700|NCT02314052|11831006|FG000|COMPLETED|Cycle Five||0
10668701|NCT02314052|11831007|FG001|COMPLETED|Cycle Five||0
10668702|NCT02314052|11831008|FG002|COMPLETED|Cycle Five||0
10668703|NCT02314052|11831009|FG003|COMPLETED|Cycle Five|subject missed cycle four but returned for cycle 5|1
10668704|NCT02314052|11831010|FG004|COMPLETED|Cycle Five||2
10668705|NCT02314052|11831011|FG005|COMPLETED|Cycle Five||0
10668706|NCT02314052|11831006|FG000|NOT COMPLETED|Cycle Five||0
10668707|NCT02314052|11831007|FG001|NOT COMPLETED|Cycle Five||2
10668708|NCT02314052|11831008|FG002|NOT COMPLETED|Cycle Five||1
10668709|NCT02314052|11831009|FG003|NOT COMPLETED|Cycle Five||0
10668710|NCT02314052|11831010|FG004|NOT COMPLETED|Cycle Five||0
10668711|NCT02314052|11831011|FG005|NOT COMPLETED|Cycle Five||0
10668712|NCT02314052|11831006|FG000|STARTED|Cycles 6 -10.5||0
10668713|NCT02314052|11831007|FG001|STARTED|Cycles 6 -10.5||0
10668714|NCT02314052|11831008|FG002|STARTED|Cycles 6 -10.5||0
10668715|NCT02314052|11831009|FG003|STARTED|Cycles 6 -10.5||1
10668716|NCT02314052|11831010|FG004|STARTED|Cycles 6 -10.5||2
10668717|NCT02314052|11831011|FG005|STARTED|Cycles 6 -10.5||0
10668718|NCT02314052|11831006|FG000|COMPLETED|Cycles 6 -10.5||0
10668719|NCT02314052|11831007|FG001|COMPLETED|Cycles 6 -10.5||0
10668720|NCT02314052|11831008|FG002|COMPLETED|Cycles 6 -10.5||0
10668721|NCT02314052|11831009|FG003|COMPLETED|Cycles 6 -10.5||1
10668722|NCT02314052|11831010|FG004|COMPLETED|Cycles 6 -10.5|Subject 02-014 only completed 1 of 2 doses in cycle 6|2
10668723|NCT02314052|11831011|FG005|COMPLETED|Cycles 6 -10.5||0
10668724|NCT02314052|11831006|FG000|NOT COMPLETED|Cycles 6 -10.5||0
10668725|NCT02314052|11831007|FG001|NOT COMPLETED|Cycles 6 -10.5||0
10668726|NCT02314052|11831008|FG002|NOT COMPLETED|Cycles 6 -10.5||0
10668727|NCT02314052|11831009|FG003|NOT COMPLETED|Cycles 6 -10.5||0
10668728|NCT02314052|11831010|FG004|NOT COMPLETED|Cycles 6 -10.5||0
10668729|NCT02314052|11831011|FG005|NOT COMPLETED|Cycles 6 -10.5||0
10668730|NCT02314104|11831028|FG000|STARTED|Overall Study||71
10668731|NCT02314104|11831029|FG001|STARTED|Overall Study||78
10668732|NCT02314104|11831030|FG002|STARTED|Overall Study||71
10668733|NCT02314104|11831028|FG000|COMPLETED|Overall Study||57
10668734|NCT02314104|11831029|FG001|COMPLETED|Overall Study||58
10668735|NCT02314104|11831030|FG002|COMPLETED|Overall Study||53
10668736|NCT02314104|11831028|FG000|NOT COMPLETED|Overall Study||14
10668737|NCT02314104|11831029|FG001|NOT COMPLETED|Overall Study||20
10668738|NCT02314104|11831030|FG002|NOT COMPLETED|Overall Study||18
10668739|NCT02314117|11831040|FG000|STARTED|Overall Study||326
10668740|NCT02314117|11831041|FG001|STARTED|Overall Study||319
10668741|NCT02314117|11831040|FG000|Received at Least One Dose of Study Drug|Overall Study||323
10668742|NCT02314117|11831041|FG001|Received at Least One Dose of Study Drug|Overall Study||315
10668743|NCT02314117|11831040|FG000|COMPLETED|Overall Study||314
10668744|NCT02314117|11831041|FG001|COMPLETED|Overall Study||303
10668745|NCT02314117|11831040|FG000|NOT COMPLETED|Overall Study||12
10668746|NCT02314117|11831041|FG001|NOT COMPLETED|Overall Study||16
10668747|NCT02314143|11831051|FG000|STARTED|Overall Study||16
10668748|NCT02314143|11831052|FG001|STARTED|Overall Study||16
10668749|NCT02314143|11831053|FG002|STARTED|Overall Study||16
10668750|NCT02314143|11831051|FG000|COMPLETED|Overall Study||8
10668751|NCT02314143|11831052|FG001|COMPLETED|Overall Study||6
10668752|NCT02314143|11831053|FG002|COMPLETED|Overall Study||7
10668753|NCT02314143|11831051|FG000|NOT COMPLETED|Overall Study||8
10668754|NCT02314143|11831052|FG001|NOT COMPLETED|Overall Study||10
10668755|NCT02314143|11831053|FG002|NOT COMPLETED|Overall Study||9
10668756|NCT02314247|11831064|FG000|STARTED|Overall Study||9
10668757|NCT02314247|11831065|FG001|STARTED|Overall Study||6
10668758|NCT02314247|11831066|FG002|STARTED|Overall Study||1
10668759|NCT02314247|11831064|FG000|COMPLETED|Overall Study||0
10668760|NCT02314247|11831065|FG001|COMPLETED|Overall Study||0
10668761|NCT02314247|11831066|FG002|COMPLETED|Overall Study||0
10668762|NCT02314247|11831064|FG000|NOT COMPLETED|Overall Study||9
10668763|NCT02314247|11831065|FG001|NOT COMPLETED|Overall Study||6
10668764|NCT02314247|11831066|FG002|NOT COMPLETED|Overall Study||1
10668765|NCT02314260|11831076|FG000|STARTED|Overall Study||80
10668766|NCT02314260|11831076|FG000|COMPLETED|Overall Study||80
10668767|NCT02314260|11831076|FG000|NOT COMPLETED|Overall Study||0
10668768|NCT02314403|11831080|FG000|STARTED|Overall Study||2
10668769|NCT02314403|11831080|FG000|COMPLETED|Overall Study||2
10668770|NCT02314403|11831080|FG000|NOT COMPLETED|Overall Study||0
10668771|NCT02314520|11831086|FG000|STARTED|Overall Study||72
10668772|NCT02314520|11831087|FG001|STARTED|Overall Study||80
10668773|NCT02314520|11831086|FG000|COMPLETED|Overall Study||72
10668774|NCT02314520|11831087|FG001|COMPLETED|Overall Study||80
10668775|NCT02314520|11831086|FG000|NOT COMPLETED|Overall Study||0
10668776|NCT02314520|11831087|FG001|NOT COMPLETED|Overall Study||0
10668777|NCT02314546|11831096|FG000|STARTED|Overall Study||5
10668778|NCT02314546|11831097|FG001|STARTED|Overall Study||5
10668779|NCT02314546|11831098|FG002|STARTED|Overall Study||5
10668780|NCT02314546|11831096|FG000|COMPLETED|Overall Study||5
10668781|NCT02314546|11831097|FG001|COMPLETED|Overall Study||5
10668782|NCT02314546|11831098|FG002|COMPLETED|Overall Study||5
10668783|NCT02314546|11831096|FG000|NOT COMPLETED|Overall Study||0
10668784|NCT02314546|11831097|FG001|NOT COMPLETED|Overall Study||0
10668785|NCT02314546|11831098|FG002|NOT COMPLETED|Overall Study||0
10668786|NCT02314598|11831107|FG000|STARTED|Overall Study||46
10668787|NCT02314598|11831107|FG000|COMPLETED|Overall Study||46
10668788|NCT02314598|11831107|FG000|NOT COMPLETED|Overall Study||0
10668789|NCT02314637|11831113|FG000|STARTED|Overall Study||151
10668790|NCT02314637|11831114|FG001|STARTED|Overall Study||89
10668791|NCT02314637|11831113|FG000|COMPLETED|Overall Study||135
10668792|NCT02314637|11831114|FG001|COMPLETED|Overall Study||75
10668793|NCT02314637|11831113|FG000|NOT COMPLETED|Overall Study||16
10668794|NCT02314637|11831114|FG001|NOT COMPLETED|Overall Study||14
10668795|NCT02314689|11831120|FG000|STARTED|Overall Study||4
10668796|NCT02314689|11831120|FG000|COMPLETED|Overall Study|Target citrulline level reached with first 4 subjects enrolled at initial IV citrulline of 20 mg/kg|4
10668797|NCT02314689|11831120|FG000|NOT COMPLETED|Overall Study||0
10668798|NCT02314728|11831126|FG000|STARTED|Overall Study||117
10668799|NCT02314728|11831127|FG001|STARTED|Overall Study||113
10668800|NCT02314728|11831126|FG000|COMPLETED|Overall Study||116
10668801|NCT02314728|11831127|FG001|COMPLETED|Overall Study||112
10668802|NCT02314728|11831126|FG000|NOT COMPLETED|Overall Study||1
10668803|NCT02314728|11831127|FG001|NOT COMPLETED|Overall Study||1
10668804|NCT02314780|11831138|FG000|STARTED|Overall Study||9
10668805|NCT02314780|11831139|FG001|STARTED|Overall Study||10
10668806|NCT02314780|11831140|FG002|STARTED|Overall Study||8
10668807|NCT02314780|11831138|FG000|COMPLETED|Overall Study||9
10668808|NCT02314780|11831139|FG001|COMPLETED|Overall Study||7
10668809|NCT02314780|11831140|FG002|COMPLETED|Overall Study||8
10668810|NCT02314780|11831138|FG000|NOT COMPLETED|Overall Study||0
10668811|NCT02314780|11831139|FG001|NOT COMPLETED|Overall Study||3
10668812|NCT02314780|11831140|FG002|NOT COMPLETED|Overall Study||0
10668813|NCT02314936|11831152|FG000|STARTED|Overall Study||48
10668814|NCT02314936|11831153|FG001|STARTED|Overall Study||48
10668815|NCT02314936|11831154|FG002|STARTED|Overall Study||48
10668816|NCT02314936|11831155|FG003|STARTED|Overall Study||48
10668817|NCT02314936|11831152|FG000|COMPLETED|Overall Study||48
10668818|NCT02314936|11831153|FG001|COMPLETED|Overall Study||48
10668819|NCT02314936|11831154|FG002|COMPLETED|Overall Study||46
10668820|NCT02314936|11831155|FG003|COMPLETED|Overall Study||48
10668821|NCT02314936|11831152|FG000|NOT COMPLETED|Overall Study||0
10668822|NCT02314936|11831153|FG001|NOT COMPLETED|Overall Study||0
10668823|NCT02314936|11831154|FG002|NOT COMPLETED|Overall Study||2
10668824|NCT02314936|11831155|FG003|NOT COMPLETED|Overall Study||0
10668825|NCT02315170|11831165|FG000|STARTED|Overall Study||50
10668826|NCT02315170|11831166|FG001|STARTED|Overall Study||50
10668827|NCT02315170|11831165|FG000|COMPLETED|Overall Study||50
10668828|NCT02315170|11831166|FG001|COMPLETED|Overall Study||50
10668829|NCT02315170|11831165|FG000|NOT COMPLETED|Overall Study||0
10668830|NCT02315170|11831166|FG001|NOT COMPLETED|Overall Study||0
10668831|NCT02315261|11831172|FG000|STARTED|Overall Study||364
10668832|NCT02315261|11831172|FG000|COMPLETED|Overall Study||364
10668833|NCT02315261|11831172|FG000|NOT COMPLETED|Overall Study||0
10668834|NCT02315352|11831178|FG000|STARTED|First Intervention (Day 1)||24
10668835|NCT02315352|11831179|FG001|STARTED|First Intervention (Day 1)||24
10668836|NCT02315352|11831180|FG002|STARTED|First Intervention (Day 1)||0
10668837|NCT02315352|11831181|FG003|STARTED|First Intervention (Day 1)||0
10668838|NCT02315352|11831182|FG004|STARTED|First Intervention (Day 1)||0
10668839|NCT02315352|11831183|FG005|STARTED|First Intervention (Day 1)||0
10668840|NCT02315352|11831184|FG006|STARTED|First Intervention (Day 1)||0
10668841|NCT02315352|11831185|FG007|STARTED|First Intervention (Day 1)||0
10668842|NCT02315352|11831178|FG000|COMPLETED|First Intervention (Day 1)||24
10668843|NCT02315352|11831179|FG001|COMPLETED|First Intervention (Day 1)||24
10668844|NCT02315352|11831180|FG002|COMPLETED|First Intervention (Day 1)||0
10668845|NCT02315352|11831181|FG003|COMPLETED|First Intervention (Day 1)||0
10668846|NCT02315352|11831182|FG004|COMPLETED|First Intervention (Day 1)||0
10668847|NCT02315352|11831183|FG005|COMPLETED|First Intervention (Day 1)||0
10668848|NCT02315352|11831184|FG006|COMPLETED|First Intervention (Day 1)||0
10668849|NCT02315352|11831185|FG007|COMPLETED|First Intervention (Day 1)||0
10668850|NCT02315352|11831178|FG000|NOT COMPLETED|First Intervention (Day 1)||0
10668851|NCT02315352|11831179|FG001|NOT COMPLETED|First Intervention (Day 1)||0
10668852|NCT02315352|11831180|FG002|NOT COMPLETED|First Intervention (Day 1)||0
10668853|NCT02315352|11831181|FG003|NOT COMPLETED|First Intervention (Day 1)||0
10668854|NCT02315352|11831182|FG004|NOT COMPLETED|First Intervention (Day 1)||0
10668855|NCT02315352|11831183|FG005|NOT COMPLETED|First Intervention (Day 1)||0
10668856|NCT02315352|11831184|FG006|NOT COMPLETED|First Intervention (Day 1)||0
10668857|NCT02315352|11831185|FG007|NOT COMPLETED|First Intervention (Day 1)||0
10668858|NCT02315352|11831178|FG000|STARTED|Second Intervention (Day 1)||24
10668859|NCT02315352|11831179|FG001|STARTED|Second Intervention (Day 1)||24
10668860|NCT02315352|11831180|FG002|STARTED|Second Intervention (Day 1)||0
10668861|NCT02315352|11831181|FG003|STARTED|Second Intervention (Day 1)||0
10668862|NCT02315352|11831182|FG004|STARTED|Second Intervention (Day 1)||0
10668863|NCT02315352|11831183|FG005|STARTED|Second Intervention (Day 1)||0
10668864|NCT02315352|11831184|FG006|STARTED|Second Intervention (Day 1)||0
10668865|NCT02315352|11831185|FG007|STARTED|Second Intervention (Day 1)||0
10668866|NCT02315352|11831178|FG000|COMPLETED|Second Intervention (Day 1)|Out of 24 subjects completing this period, 1 discontinued before assignment to any sequence on Day 2|24
10668867|NCT02315352|11831179|FG001|COMPLETED|Second Intervention (Day 1)||24
10668868|NCT02315352|11831180|FG002|COMPLETED|Second Intervention (Day 1)||0
10668869|NCT02315352|11831181|FG003|COMPLETED|Second Intervention (Day 1)||0
10668870|NCT02315352|11831182|FG004|COMPLETED|Second Intervention (Day 1)||0
10668871|NCT02315352|11831183|FG005|COMPLETED|Second Intervention (Day 1)||0
10668872|NCT02315352|11831184|FG006|COMPLETED|Second Intervention (Day 1)||0
10668873|NCT02315352|11831185|FG007|COMPLETED|Second Intervention (Day 1)||0
10668874|NCT02315352|11831178|FG000|NOT COMPLETED|Second Intervention (Day 1)||0
10668875|NCT02315352|11831179|FG001|NOT COMPLETED|Second Intervention (Day 1)||0
10668876|NCT02315352|11831180|FG002|NOT COMPLETED|Second Intervention (Day 1)||0
10668877|NCT02315352|11831181|FG003|NOT COMPLETED|Second Intervention (Day 1)||0
10668878|NCT02315352|11831182|FG004|NOT COMPLETED|Second Intervention (Day 1)||0
10668879|NCT02315352|11831183|FG005|NOT COMPLETED|Second Intervention (Day 1)||0
10668880|NCT02315352|11831184|FG006|NOT COMPLETED|Second Intervention (Day 1)||0
10668881|NCT02315352|11831185|FG007|NOT COMPLETED|Second Intervention (Day 1)||0
10668882|NCT02315352|11831178|FG000|STARTED|Third Intervention (Day 2)||0
10668883|NCT02315352|11831179|FG001|STARTED|Third Intervention (Day 2)||0
10668884|NCT02315352|11831180|FG002|STARTED|Third Intervention (Day 2)||7
10668885|NCT02315352|11831181|FG003|STARTED|Third Intervention (Day 2)||8
10668886|NCT02315352|11831182|FG004|STARTED|Third Intervention (Day 2)||8
10668887|NCT02315352|11831183|FG005|STARTED|Third Intervention (Day 2)||7
10668888|NCT02315352|11831184|FG006|STARTED|Third Intervention (Day 2)||9
10668889|NCT02315352|11831185|FG007|STARTED|Third Intervention (Day 2)||8
10668890|NCT02315352|11831178|FG000|COMPLETED|Third Intervention (Day 2)||0
10668891|NCT02315352|11831179|FG001|COMPLETED|Third Intervention (Day 2)||0
10668892|NCT02315352|11831180|FG002|COMPLETED|Third Intervention (Day 2)||7
10668893|NCT02315352|11831181|FG003|COMPLETED|Third Intervention (Day 2)||8
10668894|NCT02315352|11831182|FG004|COMPLETED|Third Intervention (Day 2)||8
10668895|NCT02315352|11831183|FG005|COMPLETED|Third Intervention (Day 2)||7
10668896|NCT02315352|11831184|FG006|COMPLETED|Third Intervention (Day 2)||9
10668897|NCT02315352|11831185|FG007|COMPLETED|Third Intervention (Day 2)||8
10668898|NCT02315352|11831178|FG000|NOT COMPLETED|Third Intervention (Day 2)||0
10668899|NCT02315352|11831179|FG001|NOT COMPLETED|Third Intervention (Day 2)||0
10668900|NCT02315352|11831180|FG002|NOT COMPLETED|Third Intervention (Day 2)||0
10668901|NCT02315352|11831181|FG003|NOT COMPLETED|Third Intervention (Day 2)||0
10668902|NCT02315352|11831182|FG004|NOT COMPLETED|Third Intervention (Day 2)||0
10668903|NCT02315352|11831183|FG005|NOT COMPLETED|Third Intervention (Day 2)||0
10668904|NCT02315352|11831184|FG006|NOT COMPLETED|Third Intervention (Day 2)||0
10668905|NCT02315352|11831185|FG007|NOT COMPLETED|Third Intervention (Day 2)||0
10668906|NCT02315352|11831178|FG000|STARTED|Fourth Intervention (Day 2)||0
10668907|NCT02315352|11831179|FG001|STARTED|Fourth Intervention (Day 2)||0
10668908|NCT02315352|11831180|FG002|STARTED|Fourth Intervention (Day 2)||7
10668909|NCT02315352|11831181|FG003|STARTED|Fourth Intervention (Day 2)||8
10668910|NCT02315352|11831182|FG004|STARTED|Fourth Intervention (Day 2)||8
10668911|NCT02315352|11831183|FG005|STARTED|Fourth Intervention (Day 2)||7
10668912|NCT02315352|11831184|FG006|STARTED|Fourth Intervention (Day 2)||9
10668913|NCT02315352|11831185|FG007|STARTED|Fourth Intervention (Day 2)||8
10668914|NCT02315352|11831178|FG000|COMPLETED|Fourth Intervention (Day 2)||0
10668915|NCT02315352|11831179|FG001|COMPLETED|Fourth Intervention (Day 2)||0
10668916|NCT02315352|11831180|FG002|COMPLETED|Fourth Intervention (Day 2)||7
10668917|NCT02315352|11831181|FG003|COMPLETED|Fourth Intervention (Day 2)||8
10668918|NCT02315352|11831182|FG004|COMPLETED|Fourth Intervention (Day 2)||8
10668919|NCT02315352|11831183|FG005|COMPLETED|Fourth Intervention (Day 2)||7
10668920|NCT02315352|11831184|FG006|COMPLETED|Fourth Intervention (Day 2)||9
10668921|NCT02315352|11831185|FG007|COMPLETED|Fourth Intervention (Day 2)||8
10668922|NCT02315352|11831178|FG000|NOT COMPLETED|Fourth Intervention (Day 2)||0
10796076|NCT03652818|11956334|FG002|STARTED|Overall Study||22
10796077|NCT03652818|11956335|FG003|STARTED|Overall Study||23
10796078|NCT03652818|11956336|FG004|STARTED|Overall Study||23
10796079|NCT03652818|11956332|FG000|COMPLETED|Overall Study||22
10796080|NCT03652818|11956333|FG001|COMPLETED|Overall Study||22
10796081|NCT03652818|11956334|FG002|COMPLETED|Overall Study||20
10796082|NCT03652818|11956335|FG003|COMPLETED|Overall Study||22
10796083|NCT03652818|11956336|FG004|COMPLETED|Overall Study||22
10796084|NCT03652818|11956332|FG000|NOT COMPLETED|Overall Study||2
10796085|NCT03652818|11956333|FG001|NOT COMPLETED|Overall Study||1
10796086|NCT03652818|11956334|FG002|NOT COMPLETED|Overall Study||2
10796087|NCT03652818|11956335|FG003|NOT COMPLETED|Overall Study||1
10796088|NCT03652818|11956336|FG004|NOT COMPLETED|Overall Study||1
10796089|NCT03653208|11956357|FG000|STARTED|Overall Study||3
10796090|NCT03653208|11956358|FG001|STARTED|Overall Study||3
10796091|NCT03653208|11956359|FG002|STARTED|Overall Study||6
10796092|NCT03653208|11956360|FG003|STARTED|Overall Study||6
10796093|NCT03653208|11956361|FG004|STARTED|Overall Study||6
10796094|NCT03653208|11956362|FG005|STARTED|Overall Study||6
10796095|NCT03653208|11956363|FG006|STARTED|Overall Study||6
10796096|NCT03653208|11956364|FG007|STARTED|Overall Study||6
10796097|NCT03653208|11956365|FG008|STARTED|Overall Study||14
10796098|NCT03653208|11956357|FG000|COMPLETED|Overall Study||3
10796099|NCT03653208|11956358|FG001|COMPLETED|Overall Study||3
10796100|NCT03653208|11956359|FG002|COMPLETED|Overall Study||6
10796101|NCT03653208|11956360|FG003|COMPLETED|Overall Study||6
10796102|NCT03653208|11956361|FG004|COMPLETED|Overall Study||5
10796103|NCT03653208|11956362|FG005|COMPLETED|Overall Study||6
10796104|NCT03653208|11956363|FG006|COMPLETED|Overall Study||6
10796105|NCT03653208|11956364|FG007|COMPLETED|Overall Study||5
10796106|NCT03653208|11956365|FG008|COMPLETED|Overall Study||13
10796107|NCT03653208|11956357|FG000|NOT COMPLETED|Overall Study||0
10796108|NCT03653208|11956358|FG001|NOT COMPLETED|Overall Study||0
10796109|NCT03653208|11956359|FG002|NOT COMPLETED|Overall Study||0
10796110|NCT03653208|11956360|FG003|NOT COMPLETED|Overall Study||0
10796111|NCT03653208|11956361|FG004|NOT COMPLETED|Overall Study||1
10796112|NCT03653208|11956362|FG005|NOT COMPLETED|Overall Study||0
10796113|NCT03653208|11956363|FG006|NOT COMPLETED|Overall Study||0
10796114|NCT03653208|11956364|FG007|NOT COMPLETED|Overall Study||1
10796115|NCT03653208|11956365|FG008|NOT COMPLETED|Overall Study||1
10796116|NCT03653351|11956387|FG000|STARTED|Overall Study||14
10796117|NCT03653351|11956388|FG001|STARTED|Overall Study||12
10796118|NCT03653351|11956387|FG000|COMPLETED|Overall Study||13
10796119|NCT03653351|11956388|FG001|COMPLETED|Overall Study||10
10796120|NCT03653351|11956387|FG000|NOT COMPLETED|Overall Study||1
10796121|NCT03653351|11956388|FG001|NOT COMPLETED|Overall Study||2
10796122|NCT03653416|11956396|FG000|STARTED|Overall Study||52
10796123|NCT03653416|11956397|FG001|STARTED|Overall Study||47
10796124|NCT03653416|11956396|FG000|COMPLETED|Overall Study||46
10796125|NCT03653416|11956397|FG001|COMPLETED|Overall Study||46
10796126|NCT03653416|11956396|FG000|NOT COMPLETED|Overall Study||6
10796127|NCT03653416|11956397|FG001|NOT COMPLETED|Overall Study||1
10796128|NCT03653429|11956405|FG000|STARTED|Overall Study||49
10796129|NCT03653429|11956406|FG001|STARTED|Overall Study||51
10796130|NCT03653429|11956405|FG000|COMPLETED|Overall Study||45
10796131|NCT03653429|11956406|FG001|COMPLETED|Overall Study||41
10796132|NCT03653429|11956405|FG000|NOT COMPLETED|Overall Study||4
10796133|NCT03653429|11956406|FG001|NOT COMPLETED|Overall Study||10
10796134|NCT03654326|11956414|FG000|STARTED|Overall Study||94
10796135|NCT03654326|11956415|FG001|STARTED|Overall Study||93
10668923|NCT02315352|11831179|FG001|NOT COMPLETED|Fourth Intervention (Day 2)||0
10668924|NCT02315352|11831180|FG002|NOT COMPLETED|Fourth Intervention (Day 2)||0
10668925|NCT02315352|11831181|FG003|NOT COMPLETED|Fourth Intervention (Day 2)||0
10668926|NCT02315352|11831182|FG004|NOT COMPLETED|Fourth Intervention (Day 2)||0
10668927|NCT02315352|11831183|FG005|NOT COMPLETED|Fourth Intervention (Day 2)||0
10668928|NCT02315352|11831184|FG006|NOT COMPLETED|Fourth Intervention (Day 2)||0
10796136|NCT03654326|11956414|FG000|COMPLETED|Overall Study||88
10796137|NCT03654326|11956415|FG001|COMPLETED|Overall Study||87
10796138|NCT03654326|11956414|FG000|NOT COMPLETED|Overall Study||6
10796139|NCT03654326|11956415|FG001|NOT COMPLETED|Overall Study||6
10796140|NCT03654417|11956423|FG000|STARTED|Overall Study||19
10668929|NCT02315352|11831185|FG007|NOT COMPLETED|Fourth Intervention (Day 2)||0
10668930|NCT02315352|11831178|FG000|STARTED|Fifth Intervention (Day 2)||0
10668931|NCT02315352|11831179|FG001|STARTED|Fifth Intervention (Day 2)||0
10668932|NCT02315352|11831180|FG002|STARTED|Fifth Intervention (Day 2)||7
10668933|NCT02315352|11831181|FG003|STARTED|Fifth Intervention (Day 2)||8
10668934|NCT02315352|11831182|FG004|STARTED|Fifth Intervention (Day 2)||8
10668935|NCT02315352|11831183|FG005|STARTED|Fifth Intervention (Day 2)||7
10668936|NCT02315352|11831184|FG006|STARTED|Fifth Intervention (Day 2)||9
10668937|NCT02315352|11831185|FG007|STARTED|Fifth Intervention (Day 2)||8
10668938|NCT02315352|11831178|FG000|COMPLETED|Fifth Intervention (Day 2)||0
10668939|NCT02315352|11831179|FG001|COMPLETED|Fifth Intervention (Day 2)||0
10668940|NCT02315352|11831180|FG002|COMPLETED|Fifth Intervention (Day 2)||7
10668941|NCT02315352|11831181|FG003|COMPLETED|Fifth Intervention (Day 2)||8
10668942|NCT02315352|11831182|FG004|COMPLETED|Fifth Intervention (Day 2)||8
10668943|NCT02315352|11831183|FG005|COMPLETED|Fifth Intervention (Day 2)||7
10668944|NCT02315352|11831184|FG006|COMPLETED|Fifth Intervention (Day 2)||9
10668945|NCT02315352|11831185|FG007|COMPLETED|Fifth Intervention (Day 2)||8
10668946|NCT02315352|11831178|FG000|NOT COMPLETED|Fifth Intervention (Day 2)||0
10668947|NCT02315352|11831179|FG001|NOT COMPLETED|Fifth Intervention (Day 2)||0
10668948|NCT02315352|11831180|FG002|NOT COMPLETED|Fifth Intervention (Day 2)||0
10668949|NCT02315352|11831181|FG003|NOT COMPLETED|Fifth Intervention (Day 2)||0
10668950|NCT02315352|11831182|FG004|NOT COMPLETED|Fifth Intervention (Day 2)||0
10668951|NCT02315352|11831183|FG005|NOT COMPLETED|Fifth Intervention (Day 2)||0
10668952|NCT02315352|11831184|FG006|NOT COMPLETED|Fifth Intervention (Day 2)||0
10668953|NCT02315352|11831185|FG007|NOT COMPLETED|Fifth Intervention (Day 2)||0
10668954|NCT02315430|11831197|FG000|STARTED|Overall Study||13
10668955|NCT02315430|11831197|FG000|COMPLETED|Overall Study||13
10668956|NCT02315430|11831197|FG000|NOT COMPLETED|Overall Study||0
10668957|NCT02315560|11831201|FG000|STARTED|Overall Study||25
10668958|NCT02315560|11831201|FG000|COMPLETED|Overall Study||22
10668959|NCT02315560|11831201|FG000|NOT COMPLETED|Overall Study||3
10668960|NCT02315625|11831207|FG000|STARTED|First Intervention||14
10668961|NCT02315625|11831208|FG001|STARTED|First Intervention||2
10668962|NCT02315625|11831207|FG000|COMPLETED|First Intervention||13
10668963|NCT02315625|11831208|FG001|COMPLETED|First Intervention||2
10668964|NCT02315625|11831207|FG000|NOT COMPLETED|First Intervention||1
10668965|NCT02315625|11831208|FG001|NOT COMPLETED|First Intervention||0
10668966|NCT02315625|11831207|FG000|STARTED|Second Intervention||13
10668967|NCT02315625|11831208|FG001|STARTED|Second Intervention||2
10668968|NCT02315625|11831207|FG000|COMPLETED|Second Intervention||9
10668969|NCT02315625|11831208|FG001|COMPLETED|Second Intervention||1
10668970|NCT02315625|11831207|FG000|NOT COMPLETED|Second Intervention||4
10668971|NCT02315625|11831208|FG001|NOT COMPLETED|Second Intervention||1
10668972|NCT02315664|11831218|FG000|STARTED|Overall Study||30
10668973|NCT02315664|11831219|FG001|STARTED|Overall Study||31
10668974|NCT02315664|11831218|FG000|COMPLETED|Overall Study||29
10668975|NCT02315664|11831219|FG001|COMPLETED|Overall Study||27
10668976|NCT02315664|11831218|FG000|NOT COMPLETED|Overall Study||1
10668977|NCT02315664|11831219|FG001|NOT COMPLETED|Overall Study||4
10668978|NCT02315755|11831225|FG000|STARTED|Overall Study||102
10668979|NCT02315755|11831225|FG000|COMPLETED|Overall Study|Participants who died, were considered as 'completed'.|102
10668980|NCT02315755|11831225|FG000|NOT COMPLETED|Overall Study||0
10668981|NCT02315872|11831231|FG000|STARTED|Overall Study||4
10668982|NCT02315872|11831232|FG001|STARTED|Overall Study||4
10668983|NCT02315872|11831231|FG000|COMPLETED|Overall Study||1
10668984|NCT02315872|11831232|FG001|COMPLETED|Overall Study||3
10668985|NCT02315872|11831231|FG000|NOT COMPLETED|Overall Study||3
10668986|NCT02315872|11831232|FG001|NOT COMPLETED|Overall Study||1
10668987|NCT02315989|11831238|FG000|STARTED|Overall Study||6
10668988|NCT02315989|11831238|FG000|COMPLETED|Overall Study||6
10668989|NCT02315989|11831238|FG000|NOT COMPLETED|Overall Study||0
10669002|NCT02316223|11831260|FG000|STARTED|Overall Study||134
10669003|NCT02316223|11831261|FG001|STARTED|Overall Study||133
10669004|NCT02316223|11831262|FG002|STARTED|Overall Study||139
10669005|NCT02316223|11831260|FG000|COMPLETED|Overall Study||90
10669006|NCT02316223|11831261|FG001|COMPLETED|Overall Study||76
10669007|NCT02316223|11831262|FG002|COMPLETED|Overall Study||95
10669008|NCT02316223|11831260|FG000|NOT COMPLETED|Overall Study||44
10669009|NCT02316223|11831261|FG001|NOT COMPLETED|Overall Study||57
10669010|NCT02316223|11831262|FG002|NOT COMPLETED|Overall Study||44
10669045|NCT02316548|11831310|FG000|NOT COMPLETED|Overall Study||0
10669011|NCT02316353|11831272|FG000|STARTED|Overall Study|7 subjects assigned to the CSL830 (40) Arm, were titrated up to the 60 IU/kg arm during the study|63
10669012|NCT02316353|11831273|FG001|STARTED|Overall Study||63
10669013|NCT02316353|11831272|FG000|COMPLETED|Overall Study||55
10669014|NCT02316353|11831273|FG001|COMPLETED|Overall Study||55
10669015|NCT02316353|11831272|FG000|NOT COMPLETED|Overall Study||8
10669016|NCT02316353|11831273|FG001|NOT COMPLETED|Overall Study||8
10669017|NCT02316366|11831284|FG000|STARTED|Overall Study||40
10669018|NCT02316366|11831285|FG001|STARTED|Overall Study||40
10669019|NCT02316366|11831284|FG000|COMPLETED|Overall Study||40
10669020|NCT02316366|11831285|FG001|COMPLETED|Overall Study||40
10669021|NCT02316366|11831284|FG000|NOT COMPLETED|Overall Study||0
10669022|NCT02316366|11831285|FG001|NOT COMPLETED|Overall Study||0
10669023|NCT02316470|11831295|FG000|STARTED|Overall Study||148
10669024|NCT02316470|11831296|FG001|STARTED|Overall Study||152
10669025|NCT02316470|11831297|FG002|STARTED|Overall Study||152
10669026|NCT02316470|11831298|FG003|STARTED|Overall Study||48
10669027|NCT02316470|11831295|FG000|COMPLETED|Overall Study||143
10669028|NCT02316470|11831296|FG001|COMPLETED|Overall Study||146
10669029|NCT02316470|11831297|FG002|COMPLETED|Overall Study||147
10669030|NCT02316470|11831298|FG003|COMPLETED|Overall Study||46
10669031|NCT02316470|11831295|FG000|NOT COMPLETED|Overall Study||5
10669032|NCT02316470|11831296|FG001|NOT COMPLETED|Overall Study||6
10669033|NCT02316470|11831297|FG002|NOT COMPLETED|Overall Study||5
10669034|NCT02316470|11831298|FG003|NOT COMPLETED|Overall Study||2
10669035|NCT02316548|11831310|FG000|STARTED|Overall Study|Randomized|6
10796141|NCT03654417|11956424|FG001|STARTED|Overall Study||18
10796142|NCT03654417|11956423|FG000|COMPLETED|Overall Study||19
10796143|NCT03654417|11956424|FG001|COMPLETED|Overall Study||18
10796144|NCT03654417|11956423|FG000|NOT COMPLETED|Overall Study||0
10796145|NCT03654417|11956424|FG001|NOT COMPLETED|Overall Study||0
10796146|NCT03654560|11956432|FG000|STARTED|Overall Study||118
10796147|NCT03654560|11956433|FG001|STARTED|Overall Study||118
10796148|NCT03654560|11956432|FG000|COMPLETED|Overall Study||114
10796149|NCT03654560|11956433|FG001|COMPLETED|Overall Study||117
10796150|NCT03654560|11956432|FG000|NOT COMPLETED|Overall Study||4
10796151|NCT03654560|11956433|FG001|NOT COMPLETED|Overall Study||1
10796152|NCT03655080|11956439|FG000|STARTED|Overall Study||2
10796153|NCT03655080|11956439|FG000|COMPLETED|Overall Study||2
10796154|NCT03655080|11956439|FG000|NOT COMPLETED|Overall Study||0
10796155|NCT03655106|11956445|FG000|STARTED|Overall Study||135
10796156|NCT03655106|11956446|FG001|STARTED|Overall Study||135
10796157|NCT03655106|11956445|FG000|COMPLETED|Overall Study||126
10796158|NCT03655106|11956446|FG001|COMPLETED|Overall Study||131
10796159|NCT03655106|11956445|FG000|NOT COMPLETED|Overall Study||9
10796160|NCT03655106|11956446|FG001|NOT COMPLETED|Overall Study||4
10796161|NCT03655301|11956452|FG000|STARTED|Overall Study||13
10796162|NCT03655301|11956452|FG000|COMPLETED|Overall Study||13
10796163|NCT03655301|11956452|FG000|NOT COMPLETED|Overall Study||0
10796164|NCT03655405|11956458|FG000|STARTED|Overall Study||32
10796165|NCT03655405|11956459|FG001|STARTED|Overall Study||30
10796166|NCT03655405|11956458|FG000|COMPLETED|Overall Study||27
10796167|NCT03655405|11956459|FG001|COMPLETED|Overall Study||25
10796168|NCT03655405|11956458|FG000|NOT COMPLETED|Overall Study||5
10796169|NCT03655405|11956459|FG001|NOT COMPLETED|Overall Study||5
10796170|NCT03655444|11956467|FG000|STARTED|Overall Study||3
10796171|NCT03655444|11956468|FG001|STARTED|Overall Study||3
10796172|NCT03655444|11956467|FG000|COMPLETED|Overall Study||3
10796173|NCT03655444|11956468|FG001|COMPLETED|Overall Study||3
10796174|NCT03655444|11956467|FG000|NOT COMPLETED|Overall Study||0
10796175|NCT03655444|11956468|FG001|NOT COMPLETED|Overall Study||0
10796176|NCT03655951|11956476|FG000|STARTED|Overall Study||358
10796177|NCT03655951|11956477|FG001|STARTED|Overall Study||372
10796178|NCT03655951|11956476|FG000|Completed Pretest|Overall Study||344
10796179|NCT03655951|11956477|FG001|Completed Pretest|Overall Study||366
10796180|NCT03655951|11956476|FG000|COMPLETED|Overall Study||319
10796181|NCT03655951|11956477|FG001|COMPLETED|Overall Study||351
10796182|NCT03655951|11956476|FG000|NOT COMPLETED|Overall Study||39
10796183|NCT03655951|11956477|FG001|NOT COMPLETED|Overall Study||21
10796184|NCT03656939|11956483|FG000|STARTED|Overall Study||21240
10796185|NCT03656939|11956483|FG000|Main Study Cohort|Overall Study||21240
10796186|NCT03656939|11956483|FG000|Main Study Cohort: Participants Who Received Dose 1|Overall Study||20318
10796187|NCT03656939|11956483|FG000|Main Study Cohort: Participants Who Received Dose 2|Overall Study||19387
10796188|NCT03656939|11956483|FG000|Main Study Cohort: Participants Who Received Dose 3|Overall Study||18415
10796189|NCT03656939|11956483|FG000|Main Study Cohort: Participants Who Received Dose 4|Overall Study||12944
10796190|NCT03656939|11956483|FG000|Prospective Study Cohort|Overall Study||2300
10796191|NCT03656939|11956483|FG000|Prospective Study Cohort: Participants Who Received Dose 1|Overall Study||2300
10796192|NCT03656939|11956483|FG000|Prospective Study Cohort: Participants Who Received Dose 2|Overall Study||2203
10796193|NCT03656939|11956483|FG000|Prospective Study Cohort: Participants Who Received Dose 3|Overall Study||2047
10669036|NCT02316548|11831311|FG001|STARTED|Overall Study|Randomized|7
10669037|NCT02316548|11831310|FG000|Eligible Population|Overall Study||6
10669038|NCT02316548|11831311|FG001|Eligible Population|Overall Study||6
10669039|NCT02316548|11831310|FG000|Eligible With Disease Assessment|Overall Study||4
10669040|NCT02316548|11831311|FG001|Eligible With Disease Assessment|Overall Study||1
10669041|NCT02316548|11831310|FG000|Eligible With Adverse Event Data|Overall Study||4
10669042|NCT02316548|11831311|FG001|Eligible With Adverse Event Data|Overall Study||2
10669043|NCT02316548|11831310|FG000|COMPLETED|Overall Study|Eligible patients on study until study termination|6
10669044|NCT02316548|11831311|FG001|COMPLETED|Overall Study|Eligible patients on study until study termination|6
10669046|NCT02316548|11831311|FG001|NOT COMPLETED|Overall Study||1
10669047|NCT02316613|11831317|FG000|STARTED|Overall Study||260
10669048|NCT02316613|11831317|FG000|Safety Population|Overall Study||255
10669049|NCT02316613|11831317|FG000|Overall Population|Overall Study||241
10669050|NCT02316613|11831317|FG000|COMPLETED|Overall Study||156
10669051|NCT02316613|11831317|FG000|NOT COMPLETED|Overall Study||104
10669052|NCT02316678|11831334|FG000|STARTED|Overall Study||1879
10669053|NCT02316678|11831335|FG001|STARTED|Overall Study||7694
10796194|NCT03656939|11956483|FG000|Prospective Study Cohort: Participants Who Received Dose 4|Overall Study||1291
10796195|NCT03656939|11956483|FG000|COMPLETED|Overall Study||21240
10796196|NCT03656939|11956483|FG000|NOT COMPLETED|Overall Study||0
10796197|NCT03657095|11956491|FG000|STARTED|Overall Study||59
10796198|NCT03657095|11956492|FG001|STARTED|Overall Study||53
10796199|NCT03657095|11956491|FG000|Received at Least 1 Dose of Study Drug|Overall Study||59
10796200|NCT03657095|11956492|FG001|Received at Least 1 Dose of Study Drug|Overall Study||53
10796201|NCT03657095|11956491|FG000|COMPLETED|Overall Study||0
10669054|NCT02316678|11831334|FG000|COMPLETED|Overall Study||1879
10669055|NCT02316678|11831335|FG001|COMPLETED|Overall Study||7694
10669056|NCT02316678|11831334|FG000|NOT COMPLETED|Overall Study||0
10669057|NCT02316678|11831335|FG001|NOT COMPLETED|Overall Study||0
10669058|NCT02316717|11831344|FG000|STARTED|Overall Study||43
10669059|NCT02316717|11831345|FG001|STARTED|Overall Study||46
10669060|NCT02316717|11831346|FG002|STARTED|Overall Study||44
10669061|NCT02316717|11831344|FG000|COMPLETED|Overall Study||32
10669062|NCT02316717|11831345|FG001|COMPLETED|Overall Study||39
10669063|NCT02316717|11831346|FG002|COMPLETED|Overall Study||41
10669064|NCT02316717|11831344|FG000|NOT COMPLETED|Overall Study||11
10669065|NCT02316717|11831345|FG001|NOT COMPLETED|Overall Study||7
10669066|NCT02316717|11831346|FG002|NOT COMPLETED|Overall Study||3
10669067|NCT02316769|11831359|FG000|STARTED|Overall Study||33
10669068|NCT02316769|11831360|FG001|STARTED|Overall Study||33
10669069|NCT02316769|11831359|FG000|COMPLETED|Overall Study||31
10669070|NCT02316769|11831360|FG001|COMPLETED|Overall Study||33
10796202|NCT03657095|11956492|FG001|COMPLETED|Overall Study||0
10796203|NCT03657095|11956491|FG000|NOT COMPLETED|Overall Study||59
10796204|NCT03657095|11956492|FG001|NOT COMPLETED|Overall Study||53
10796205|NCT03657134|11956498|FG000|STARTED|Overall Study||20
10796206|NCT03657134|11956498|FG000|COMPLETED|Overall Study||20
10796207|NCT03657134|11956498|FG000|NOT COMPLETED|Overall Study||0
10810882|NCT03784963|11972587|FG003|NOT COMPLETED|Overall Study||0
10810883|NCT03771274|11972597|FG000|STARTED|Overall Study||39
10810884|NCT03771274|11972597|FG000|COMPLETED|Overall Study||39
10810885|NCT03771274|11972597|FG000|NOT COMPLETED|Overall Study||0
10810886|NCT03787472|11972601|FG000|STARTED|Period 1||23
10810887|NCT03787472|11972602|FG001|STARTED|Period 1||22
10810888|NCT03787472|11972601|FG000|COMPLETED|Period 1||23
10810889|NCT03787472|11972602|FG001|COMPLETED|Period 1||22
10810890|NCT03787472|11972601|FG000|NOT COMPLETED|Period 1||0
10810891|NCT03787472|11972602|FG001|NOT COMPLETED|Period 1||0
10810892|NCT03787472|11972601|FG000|STARTED|Period 2||23
10810893|NCT03787472|11972602|FG001|STARTED|Period 2||22
10810894|NCT03787472|11972601|FG000|COMPLETED|Period 2||23
10810895|NCT03787472|11972602|FG001|COMPLETED|Period 2||22
10810896|NCT03787472|11972601|FG000|NOT COMPLETED|Period 2||0
10810897|NCT03787472|11972602|FG001|NOT COMPLETED|Period 2||0
10810898|NCT03787212|11972608|FG000|STARTED|Period 1||2
10669071|NCT02316769|11831359|FG000|NOT COMPLETED|Overall Study||2
10669072|NCT02316769|11831360|FG001|NOT COMPLETED|Overall Study||0
10669073|NCT02316847|11831368|FG000|STARTED|Overall Study||9
10669074|NCT02316847|11831369|FG001|STARTED|Overall Study||99
10669075|NCT02316847|11831368|FG000|COMPLETED|Overall Study||0
10810899|NCT03787212|11972609|FG001|STARTED|Period 1||2
10810900|NCT03787212|11972608|FG000|COMPLETED|Period 1||2
10810901|NCT03787212|11972609|FG001|COMPLETED|Period 1||2
10810902|NCT03787212|11972608|FG000|NOT COMPLETED|Period 1||0
10810903|NCT03787212|11972609|FG001|NOT COMPLETED|Period 1||0
10810904|NCT03787212|11972608|FG000|STARTED|Period 1||2
10810905|NCT03787212|11972609|FG001|STARTED|Period 1||2
10810906|NCT03787212|11972608|FG000|COMPLETED|Period 1||0
10810907|NCT03787212|11972609|FG001|COMPLETED|Period 1||0
10810908|NCT03787212|11972608|FG000|NOT COMPLETED|Period 1||2
10810909|NCT03787212|11972609|FG001|NOT COMPLETED|Period 1||2
10810910|NCT03784001|11972618|FG000|STARTED|Overall Study||46
10810911|NCT03784001|11972619|FG001|STARTED|Overall Study||38
10810912|NCT03784001|11972620|FG002|STARTED|Overall Study||41
10810913|NCT03784001|11972618|FG000|COMPLETED|Overall Study||44
10810914|NCT03784001|11972619|FG001|COMPLETED|Overall Study||38
10810915|NCT03784001|11972620|FG002|COMPLETED|Overall Study||40
10810916|NCT03784001|11972618|FG000|NOT COMPLETED|Overall Study||2
10810917|NCT03784001|11972619|FG001|NOT COMPLETED|Overall Study||0
10810918|NCT03784001|11972620|FG002|NOT COMPLETED|Overall Study||1
10810919|NCT03783702|11972630|FG000|STARTED|Overall Study||56
10669076|NCT02316847|11831369|FG001|COMPLETED|Overall Study||13
10669077|NCT02316847|11831368|FG000|NOT COMPLETED|Overall Study||9
10810920|NCT03783702|11972631|FG001|STARTED|Overall Study||62
10810921|NCT03783702|11972630|FG000|COMPLETED|Overall Study||49
10669078|NCT02316847|11831369|FG001|NOT COMPLETED|Overall Study||86
10669079|NCT02317016|11831377|FG000|STARTED|Part A: Day 1-3 (Rosuvastatin Alone)||44
10669080|NCT02317016|11831377|FG000|COMPLETED|Part A: Day 1-3 (Rosuvastatin Alone)||44
10669081|NCT02317016|11831377|FG000|NOT COMPLETED|Part A: Day 1-3 (Rosuvastatin Alone)||0
10669082|NCT02317016|11831377|FG000|STARTED|Part A: Day 4-31 (AZD9291 Alone)||44
10669083|NCT02317016|11831377|FG000|COMPLETED|Part A: Day 4-31 (AZD9291 Alone)||43
10669084|NCT02317016|11831377|FG000|NOT COMPLETED|Part A: Day 4-31 (AZD9291 Alone)||1
10669085|NCT02317016|11831377|FG000|STARTED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||43
10669086|NCT02317016|11831377|FG000|COMPLETED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||41
10669087|NCT02317016|11831377|FG000|NOT COMPLETED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||2
10669088|NCT02317016|11831377|FG000|STARTED|Part B: Day 35 to End Part B (AZD9291)|41 completed Part A + 1 entered Part B without completing Part A (due to AE) = 42 started Part B|42
10669089|NCT02317016|11831377|FG000|COMPLETED|Part B: Day 35 to End Part B (AZD9291)||11
10669090|NCT02317016|11831377|FG000|NOT COMPLETED|Part B: Day 35 to End Part B (AZD9291)||31
10669091|NCT02317042|11831385|FG000|STARTED|Overall Study||11
10669092|NCT02317042|11831386|FG001|STARTED|Overall Study||14
10669093|NCT02317042|11831385|FG000|COMPLETED|Overall Study||11
10669094|NCT02317042|11831386|FG001|COMPLETED|Overall Study||14
10669095|NCT02317042|11831385|FG000|NOT COMPLETED|Overall Study||0
10669096|NCT02317042|11831386|FG001|NOT COMPLETED|Overall Study||0
10669097|NCT02317432|11831396|FG000|STARTED|Overall Study||153
10669098|NCT02317432|11831397|FG001|STARTED|Overall Study||154
10669099|NCT02317432|11831396|FG000|Completed CBT|Overall Study||118
10669100|NCT02317432|11831397|FG001|Completed CBT|Overall Study|Participants in Enhanced Usual Care did not receive CBT sessions.|0
10669101|NCT02317432|11831396|FG000|Completed InVEST|Overall Study||63
10669102|NCT02317432|11831397|FG001|Completed InVEST|Overall Study|Participants in Enhanced Usual Care did not receive InVEST sessions.|0
10669103|NCT02317432|11831396|FG000|Completed CBT + InVEST Exercise|Overall Study||122
10669104|NCT02317432|11831397|FG001|Completed CBT + InVEST Exercise|Overall Study|Participants in Enhanced Usual Care did not receive either CBT or InVEST sessions.|0
10669105|NCT02317432|11831396|FG000|Completed Enhanced Usual Care|Overall Study|Participants in CBT + InVEST exercise did not receive Enhanced Usual Care.|0
10669106|NCT02317432|11831397|FG001|Completed Enhanced Usual Care|Overall Study||148
10669107|NCT02317432|11831396|FG000|COMPLETED|Overall Study||122
10669108|NCT02317432|11831397|FG001|COMPLETED|Overall Study||148
10669109|NCT02317432|11831396|FG000|NOT COMPLETED|Overall Study||31
10669110|NCT02317432|11831397|FG001|NOT COMPLETED|Overall Study||6
10669111|NCT02317510|11831405|FG000|STARTED|Overall Study||25
10669112|NCT02317510|11831406|FG001|STARTED|Overall Study||25
10669113|NCT02317510|11831405|FG000|COMPLETED|Overall Study||25
10669114|NCT02317510|11831406|FG001|COMPLETED|Overall Study||24
10669115|NCT02317510|11831405|FG000|NOT COMPLETED|Overall Study||0
10669116|NCT02317510|11831406|FG001|NOT COMPLETED|Overall Study||1
10669117|NCT02317549|11831417|FG000|STARTED|Overall Study||5
10669118|NCT02317549|11831418|FG001|STARTED|Overall Study||3
10669119|NCT02317549|11831417|FG000|COMPLETED|Overall Study||5
10669120|NCT02317549|11831418|FG001|COMPLETED|Overall Study||3
10669121|NCT02317549|11831417|FG000|NOT COMPLETED|Overall Study||0
10669122|NCT02317549|11831418|FG001|NOT COMPLETED|Overall Study||0
10669123|NCT02317562|11831424|FG000|STARTED|Overall Study||19
10796220|NCT03657277|11956521|FG000|STARTED|Overall Study||46
10796221|NCT03657277|11956521|FG000|COMPLETED|Overall Study||35
10796222|NCT03657277|11956521|FG000|NOT COMPLETED|Overall Study||11
10796223|NCT03657407|11956527|FG000|STARTED|Overall Study||29
10796224|NCT03657407|11956528|FG001|STARTED|Overall Study||27
10796225|NCT03657407|11956527|FG000|COMPLETED|Overall Study||29
10796226|NCT03657407|11956528|FG001|COMPLETED|Overall Study||27
10796227|NCT03657407|11956527|FG000|NOT COMPLETED|Overall Study||0
10796228|NCT03657407|11956528|FG001|NOT COMPLETED|Overall Study||0
10796229|NCT03658811|11956534|FG000|STARTED|Overall Study||19
10796230|NCT03658811|11956534|FG000|COMPLETED|Overall Study||16
10796231|NCT03658811|11956534|FG000|NOT COMPLETED|Overall Study||3
10669124|NCT02317562|11831424|FG000|COMPLETED|Overall Study||5
10669125|NCT02317562|11831424|FG000|NOT COMPLETED|Overall Study||14
10669126|NCT02317575|11831428|FG000|STARTED|Period 1||5
10669127|NCT02317575|11831429|FG001|STARTED|Period 1||6
10669128|NCT02317575|11831430|FG002|STARTED|Period 1||6
10669129|NCT02317575|11831431|FG003|STARTED|Period 1||6
10669130|NCT02317575|11831432|FG004|STARTED|Period 1||6
10669131|NCT02317575|11831428|FG000|Received at Least 1 Dose of Study Drug|Period 1||5
10669132|NCT02317575|11831429|FG001|Received at Least 1 Dose of Study Drug|Period 1||5
10669133|NCT02317575|11831430|FG002|Received at Least 1 Dose of Study Drug|Period 1||6
10669134|NCT02317575|11831431|FG003|Received at Least 1 Dose of Study Drug|Period 1||6
10669135|NCT02317575|11831432|FG004|Received at Least 1 Dose of Study Drug|Period 1||6
10669136|NCT02317575|11831428|FG000|COMPLETED|Period 1||4
10669137|NCT02317575|11831429|FG001|COMPLETED|Period 1||5
10669138|NCT02317575|11831430|FG002|COMPLETED|Period 1||6
10669139|NCT02317575|11831431|FG003|COMPLETED|Period 1||6
10669140|NCT02317575|11831432|FG004|COMPLETED|Period 1||6
10669141|NCT02317575|11831428|FG000|NOT COMPLETED|Period 1||1
10669142|NCT02317575|11831429|FG001|NOT COMPLETED|Period 1||1
10669143|NCT02317575|11831430|FG002|NOT COMPLETED|Period 1||0
10669144|NCT02317575|11831431|FG003|NOT COMPLETED|Period 1||0
10669145|NCT02317575|11831432|FG004|NOT COMPLETED|Period 1||0
10669146|NCT02317575|11831428|FG000|STARTED|Period 2||4
10669147|NCT02317575|11831429|FG001|STARTED|Period 2||5
10796232|NCT03658876|11956540|FG000|STARTED|Overall Study||88
10796233|NCT03658876|11956541|FG001|STARTED|Overall Study||96
10669148|NCT02317575|11831430|FG002|STARTED|Period 2||6
10669149|NCT02317575|11831431|FG003|STARTED|Period 2||6
10669150|NCT02317575|11831432|FG004|STARTED|Period 2||6
10669151|NCT02317575|11831428|FG000|COMPLETED|Period 2||4
10669152|NCT02317575|11831429|FG001|COMPLETED|Period 2||5
10669153|NCT02317575|11831430|FG002|COMPLETED|Period 2||6
10669154|NCT02317575|11831431|FG003|COMPLETED|Period 2||6
10669155|NCT02317575|11831432|FG004|COMPLETED|Period 2||6
10669156|NCT02317575|11831428|FG000|NOT COMPLETED|Period 2||0
10669157|NCT02317575|11831429|FG001|NOT COMPLETED|Period 2||0
10669158|NCT02317575|11831430|FG002|NOT COMPLETED|Period 2||0
10669159|NCT02317575|11831431|FG003|NOT COMPLETED|Period 2||0
10669160|NCT02317575|11831432|FG004|NOT COMPLETED|Period 2||0
10669161|NCT02317575|11831428|FG000|STARTED|Period 3||4
10669162|NCT02317575|11831429|FG001|STARTED|Period 3||5
10669163|NCT02317575|11831430|FG002|STARTED|Period 3||6
10669164|NCT02317575|11831431|FG003|STARTED|Period 3||6
10669165|NCT02317575|11831432|FG004|STARTED|Period 3||6
10669166|NCT02317575|11831428|FG000|COMPLETED|Period 3||4
10669167|NCT02317575|11831429|FG001|COMPLETED|Period 3||5
10669168|NCT02317575|11831430|FG002|COMPLETED|Period 3||6
10669169|NCT02317575|11831431|FG003|COMPLETED|Period 3||6
10669170|NCT02317575|11831432|FG004|COMPLETED|Period 3||6
10669171|NCT02317575|11831428|FG000|NOT COMPLETED|Period 3||0
10669172|NCT02317575|11831429|FG001|NOT COMPLETED|Period 3||0
10669173|NCT02317575|11831430|FG002|NOT COMPLETED|Period 3||0
10669174|NCT02317575|11831431|FG003|NOT COMPLETED|Period 3||0
10669175|NCT02317575|11831432|FG004|NOT COMPLETED|Period 3||0
10669176|NCT02317575|11831428|FG000|STARTED|Period 4||4
10669177|NCT02317575|11831429|FG001|STARTED|Period 4||5
10669178|NCT02317575|11831430|FG002|STARTED|Period 4||6
10669179|NCT02317575|11831431|FG003|STARTED|Period 4||6
10669180|NCT02317575|11831432|FG004|STARTED|Period 4||6
10669181|NCT02317575|11831428|FG000|COMPLETED|Period 4||4
10669182|NCT02317575|11831429|FG001|COMPLETED|Period 4||5
10669183|NCT02317575|11831430|FG002|COMPLETED|Period 4||6
10669184|NCT02317575|11831431|FG003|COMPLETED|Period 4||6
10669185|NCT02317575|11831432|FG004|COMPLETED|Period 4||6
10669186|NCT02317575|11831428|FG000|NOT COMPLETED|Period 4||0
10669187|NCT02317575|11831429|FG001|NOT COMPLETED|Period 4||0
10669188|NCT02317575|11831430|FG002|NOT COMPLETED|Period 4||0
10669189|NCT02317575|11831431|FG003|NOT COMPLETED|Period 4||0
10669190|NCT02317575|11831432|FG004|NOT COMPLETED|Period 4||0
10669191|NCT02317575|11831428|FG000|STARTED|Period 5||4
10669192|NCT02317575|11831429|FG001|STARTED|Period 5||5
10669193|NCT02317575|11831430|FG002|STARTED|Period 5||6
10669194|NCT02317575|11831431|FG003|STARTED|Period 5||6
10669195|NCT02317575|11831432|FG004|STARTED|Period 5||6
10669196|NCT02317575|11831428|FG000|COMPLETED|Period 5||4
10669197|NCT02317575|11831429|FG001|COMPLETED|Period 5||5
10669198|NCT02317575|11831430|FG002|COMPLETED|Period 5||6
10796234|NCT03658876|11956540|FG000|COMPLETED|Overall Study||76
10796235|NCT03658876|11956541|FG001|COMPLETED|Overall Study||84
10796236|NCT03658876|11956540|FG000|NOT COMPLETED|Overall Study||12
10796237|NCT03658876|11956541|FG001|NOT COMPLETED|Overall Study||12
10796244|NCT03660787|11956559|FG000|STARTED|Overall Study||26
10796245|NCT03660787|11956560|FG001|STARTED|Overall Study||26
10796246|NCT03660787|11956561|FG002|STARTED|Overall Study||26
10796247|NCT03660787|11956562|FG003|STARTED|Overall Study||26
10796248|NCT03660787|11956559|FG000|COMPLETED|Overall Study||25
10796249|NCT03660787|11956560|FG001|COMPLETED|Overall Study||25
10796250|NCT03660787|11956561|FG002|COMPLETED|Overall Study||25
10796251|NCT03660787|11956562|FG003|COMPLETED|Overall Study||26
10796252|NCT03660787|11956559|FG000|NOT COMPLETED|Overall Study||1
10796253|NCT03660787|11956560|FG001|NOT COMPLETED|Overall Study||1
10796254|NCT03660787|11956561|FG002|NOT COMPLETED|Overall Study||1
10669199|NCT02317575|11831431|FG003|COMPLETED|Period 5||6
10796255|NCT03660787|11956562|FG003|NOT COMPLETED|Overall Study||0
10796256|NCT03661346|11956574|FG000|STARTED|Overall Study|Esmolol administration|13
10796257|NCT03661346|11956575|FG001|STARTED|Overall Study||15
10796258|NCT03661346|11956574|FG000|COMPLETED|Overall Study||13
10669200|NCT02317575|11831432|FG004|COMPLETED|Period 5||6
10669201|NCT02317575|11831428|FG000|NOT COMPLETED|Period 5||0
10669202|NCT02317575|11831429|FG001|NOT COMPLETED|Period 5||0
10669203|NCT02317575|11831430|FG002|NOT COMPLETED|Period 5||0
10669204|NCT02317575|11831431|FG003|NOT COMPLETED|Period 5||0
10669205|NCT02317575|11831432|FG004|NOT COMPLETED|Period 5||0
10669206|NCT02317614|11831452|FG000|STARTED|Overall Study||26
10669207|NCT02317614|11831453|FG001|STARTED|Overall Study||25
10669208|NCT02317614|11831452|FG000|COMPLETED|Overall Study||23
10669209|NCT02317614|11831453|FG001|COMPLETED|Overall Study||23
10669210|NCT02317614|11831452|FG000|NOT COMPLETED|Overall Study||3
10796259|NCT03661346|11956575|FG001|COMPLETED|Overall Study||15
10669211|NCT02317614|11831453|FG001|NOT COMPLETED|Overall Study||2
10669212|NCT02317692|11831461|FG000|STARTED|Overall Study||69
10669213|NCT02317692|11831462|FG001|STARTED|Overall Study||77
10669214|NCT02317692|11831461|FG000|COMPLETED|Overall Study||63
10669215|NCT02317692|11831462|FG001|COMPLETED|Overall Study||77
10669216|NCT02317692|11831461|FG000|NOT COMPLETED|Overall Study||6
10669217|NCT02317692|11831462|FG001|NOT COMPLETED|Overall Study||0
10669218|NCT02317744|11831470|FG000|STARTED|Overall Study||12
10669219|NCT02317744|11831471|FG001|STARTED|Overall Study||10
10669220|NCT02317744|11831470|FG000|Completed Treatment|Overall Study||10
10669221|NCT02317744|11831471|FG001|Completed Treatment|Overall Study||7
10669222|NCT02317744|11831470|FG000|COMPLETED|Overall Study|One NB participant stopped the treatment but completed assessments.|11
10669223|NCT02317744|11831471|FG001|COMPLETED|Overall Study|One Placebo participant stopped the treatment but completed assessments.|8
10669224|NCT02317744|11831470|FG000|NOT COMPLETED|Overall Study||1
10669225|NCT02317744|11831471|FG001|NOT COMPLETED|Overall Study||2
10669226|NCT02317809|11831477|FG000|STARTED|First Intervention Period (8 Days)||17
10669227|NCT02317809|11831478|FG001|STARTED|First Intervention Period (8 Days)||17
10669228|NCT02317809|11831477|FG000|COMPLETED|First Intervention Period (8 Days)||14
10669229|NCT02317809|11831478|FG001|COMPLETED|First Intervention Period (8 Days)||17
10669318|NCT02318706|11831584|FG004|COMPLETED|Open-label Extension Phase||172
10669230|NCT02317809|11831477|FG000|NOT COMPLETED|First Intervention Period (8 Days)||3
10669231|NCT02317809|11831478|FG001|NOT COMPLETED|First Intervention Period (8 Days)||0
10669232|NCT02317809|11831477|FG000|STARTED|Second Intervention Period (8 Days)||14
10669233|NCT02317809|11831478|FG001|STARTED|Second Intervention Period (8 Days)||17
10669234|NCT02317809|11831477|FG000|COMPLETED|Second Intervention Period (8 Days)||14
10669235|NCT02317809|11831478|FG001|COMPLETED|Second Intervention Period (8 Days)||17
10669236|NCT02317809|11831477|FG000|NOT COMPLETED|Second Intervention Period (8 Days)||0
10669237|NCT02317809|11831478|FG001|NOT COMPLETED|Second Intervention Period (8 Days)||0
10669238|NCT02318134|11831489|FG000|STARTED|Overall Study||30
10669239|NCT02318134|11831490|FG001|STARTED|Overall Study||30
10669240|NCT02318134|11831489|FG000|COMPLETED|Overall Study||28
10669241|NCT02318134|11831490|FG001|COMPLETED|Overall Study||29
10669242|NCT02318134|11831489|FG000|NOT COMPLETED|Overall Study||2
10669243|NCT02318134|11831490|FG001|NOT COMPLETED|Overall Study||1
10669244|NCT02318303|11831505|FG000|STARTED|Overall Study||159
10669245|NCT02318303|11831506|FG001|STARTED|Overall Study||158
10669246|NCT02318303|11831507|FG002|STARTED|Overall Study||160
10669247|NCT02318303|11831508|FG003|STARTED|Overall Study||158
10669248|NCT02318303|11831509|FG004|STARTED|Overall Study||157
10669249|NCT02318303|11831510|FG005|STARTED|Overall Study||159
10669250|NCT02318303|11831511|FG006|STARTED|Overall Study||160
10669251|NCT02318303|11831505|FG000|COMPLETED|Overall Study||155
10669252|NCT02318303|11831506|FG001|COMPLETED|Overall Study||155
10669253|NCT02318303|11831507|FG002|COMPLETED|Overall Study||157
10669254|NCT02318303|11831508|FG003|COMPLETED|Overall Study||155
10669255|NCT02318303|11831509|FG004|COMPLETED|Overall Study||152
10669256|NCT02318303|11831510|FG005|COMPLETED|Overall Study||153
10669257|NCT02318303|11831511|FG006|COMPLETED|Overall Study||158
10669258|NCT02318303|11831505|FG000|NOT COMPLETED|Overall Study||4
10669259|NCT02318303|11831506|FG001|NOT COMPLETED|Overall Study||3
10669260|NCT02318303|11831507|FG002|NOT COMPLETED|Overall Study||3
10669261|NCT02318303|11831508|FG003|NOT COMPLETED|Overall Study||3
10669262|NCT02318303|11831509|FG004|NOT COMPLETED|Overall Study||5
10669263|NCT02318303|11831510|FG005|NOT COMPLETED|Overall Study||6
10669264|NCT02318303|11831511|FG006|NOT COMPLETED|Overall Study||2
10669265|NCT02318368|11831529|FG000|STARTED|Overall Study||7
10669266|NCT02318368|11831530|FG001|STARTED|Overall Study||3
10669267|NCT02318368|11831529|FG000|COMPLETED|Overall Study||0
10669268|NCT02318368|11831530|FG001|COMPLETED|Overall Study||0
10669269|NCT02318368|11831529|FG000|NOT COMPLETED|Overall Study||7
10669270|NCT02318368|11831530|FG001|NOT COMPLETED|Overall Study||3
10669271|NCT02318550|11831536|FG000|STARTED|Overall Study||262
10669272|NCT02318550|11831536|FG000|COMPLETED|Overall Study||262
10669273|NCT02318550|11831536|FG000|NOT COMPLETED|Overall Study||0
10669274|NCT02318602|11831543|FG000|STARTED|Overall Study||9
10669275|NCT02318602|11831544|FG001|STARTED|Overall Study||26
10669276|NCT02318602|11831545|FG002|STARTED|Overall Study||17
10669277|NCT02318602|11831543|FG000|COMPLETED|Overall Study||8
10669278|NCT02318602|11831544|FG001|COMPLETED|Overall Study||22
10669279|NCT02318602|11831545|FG002|COMPLETED|Overall Study||15
10669280|NCT02318602|11831543|FG000|NOT COMPLETED|Overall Study||1
10669281|NCT02318602|11831544|FG001|NOT COMPLETED|Overall Study||4
10669282|NCT02318602|11831545|FG002|NOT COMPLETED|Overall Study||2
10669283|NCT02318667|11831559|FG000|STARTED|Overall Study||38
10669284|NCT02318667|11831559|FG000|COMPLETED|Overall Study||29
10669285|NCT02318667|11831559|FG000|NOT COMPLETED|Overall Study||9
10669286|NCT02318693|11831569|FG000|STARTED|Overall Study||26
10669287|NCT02318693|11831570|FG001|STARTED|Overall Study||27
10669288|NCT02318693|11831569|FG000|Treated|Overall Study||26
10669289|NCT02318693|11831570|FG001|Treated|Overall Study|1 randomized participant did not receive treatment.|26
10669290|NCT02318693|11831569|FG000|COMPLETED|Overall Study||26
10669291|NCT02318693|11831570|FG001|COMPLETED|Overall Study||26
10669292|NCT02318693|11831569|FG000|NOT COMPLETED|Overall Study||0
10669293|NCT02318693|11831570|FG001|NOT COMPLETED|Overall Study||1
10669294|NCT02318706|11831580|FG000|STARTED|Double-blind Phase||334
10669295|NCT02318706|11831581|FG001|STARTED|Double-blind Phase||166
10669296|NCT02318706|11831582|FG002|STARTED|Double-blind Phase||168
10669297|NCT02318706|11831583|FG003|STARTED|Double-blind Phase||166
10669298|NCT02318706|11831584|FG004|STARTED|Double-blind Phase||0
10669299|NCT02318706|11831580|FG000|COMPLETED|Double-blind Phase||309
10669300|NCT02318706|11831581|FG001|COMPLETED|Double-blind Phase||154
10669301|NCT02318706|11831582|FG002|COMPLETED|Double-blind Phase||150
10669302|NCT02318706|11831583|FG003|COMPLETED|Double-blind Phase||142
10669303|NCT02318706|11831584|FG004|COMPLETED|Double-blind Phase||0
10669304|NCT02318706|11831580|FG000|NOT COMPLETED|Double-blind Phase||25
10669305|NCT02318706|11831581|FG001|NOT COMPLETED|Double-blind Phase||12
10669306|NCT02318706|11831582|FG002|NOT COMPLETED|Double-blind Phase||18
10669307|NCT02318706|11831583|FG003|NOT COMPLETED|Double-blind Phase||24
10669308|NCT02318706|11831584|FG004|NOT COMPLETED|Double-blind Phase||0
10669309|NCT02318706|11831580|FG000|STARTED|Open-label Extension Phase||0
10669310|NCT02318706|11831581|FG001|STARTED|Open-label Extension Phase||0
10669311|NCT02318706|11831582|FG002|STARTED|Open-label Extension Phase||0
10669312|NCT02318706|11831583|FG003|STARTED|Open-label Extension Phase||0
10669313|NCT02318706|11831584|FG004|STARTED|Open-label Extension Phase|A portion of participants who completed the double-blind phase enrolled in the open-label extension.|214
10669314|NCT02318706|11831580|FG000|COMPLETED|Open-label Extension Phase||0
10669315|NCT02318706|11831581|FG001|COMPLETED|Open-label Extension Phase||0
10669316|NCT02318706|11831582|FG002|COMPLETED|Open-label Extension Phase||0
10669317|NCT02318706|11831583|FG003|COMPLETED|Open-label Extension Phase||0
10669319|NCT02318706|11831580|FG000|NOT COMPLETED|Open-label Extension Phase||0
10669320|NCT02318706|11831581|FG001|NOT COMPLETED|Open-label Extension Phase||0
10669321|NCT02318706|11831582|FG002|NOT COMPLETED|Open-label Extension Phase||0
10669322|NCT02318706|11831583|FG003|NOT COMPLETED|Open-label Extension Phase||0
10669323|NCT02318706|11831584|FG004|NOT COMPLETED|Open-label Extension Phase||42
10669324|NCT02318719|11831600|FG000|STARTED|Double-blind Phase||304
10669325|NCT02318719|11831601|FG001|STARTED|Double-blind Phase||153
10669326|NCT02318719|11831602|FG002|STARTED|Double-blind Phase||153
10669327|NCT02318719|11831603|FG003|STARTED|Double-blind Phase||155
10669328|NCT02318719|11831604|FG004|STARTED|Double-blind Phase||0
10669329|NCT02318719|11831600|FG000|Did Not Receive Treatment|Double-blind Phase||1
10669330|NCT02318719|11831601|FG001|Did Not Receive Treatment|Double-blind Phase||1
10796260|NCT03661346|11956574|FG000|NOT COMPLETED|Overall Study||0
10796261|NCT03661346|11956575|FG001|NOT COMPLETED|Overall Study||0
10796262|NCT03661541|11956584|FG000|STARTED|Overall Study||12
10796263|NCT03661541|11956585|FG001|STARTED|Overall Study||12
10796264|NCT03661541|11956586|FG002|STARTED|Overall Study||12
10796265|NCT03661541|11956584|FG000|COMPLETED|Overall Study||10
10796266|NCT03661541|11956585|FG001|COMPLETED|Overall Study||10
10796267|NCT03661541|11956586|FG002|COMPLETED|Overall Study||10
10796268|NCT03661541|11956584|FG000|NOT COMPLETED|Overall Study||2
10796269|NCT03661541|11956585|FG001|NOT COMPLETED|Overall Study||2
10796270|NCT03661541|11956586|FG002|NOT COMPLETED|Overall Study||2
10796271|NCT03661697|11956600|FG000|STARTED|Overall Study||7
10796272|NCT03661697|11956601|FG001|STARTED|Overall Study||7
10796273|NCT03661697|11956600|FG000|COMPLETED|Overall Study||7
10796274|NCT03661697|11956601|FG001|COMPLETED|Overall Study||7
10796275|NCT03661697|11956600|FG000|NOT COMPLETED|Overall Study||0
10796276|NCT03661697|11956601|FG001|NOT COMPLETED|Overall Study||0
10796277|NCT03661762|11956607|FG000|STARTED|Overall Study||18
10796278|NCT03661762|11956607|FG000|COMPLETED|Overall Study||10
10796279|NCT03661762|11956607|FG000|NOT COMPLETED|Overall Study||8
10796280|NCT03661814|11956614|FG000|STARTED|Overall Study||2
10796281|NCT03661814|11956615|FG001|STARTED|Overall Study||5
10796282|NCT03661814|11956614|FG000|COMPLETED|Overall Study||2
10796283|NCT03661814|11956615|FG001|COMPLETED|Overall Study||5
10796284|NCT03661814|11956614|FG000|NOT COMPLETED|Overall Study||0
10796285|NCT03661814|11956615|FG001|NOT COMPLETED|Overall Study||0
10796286|NCT03661983|11956621|FG000|STARTED|Open Label Stabilization Phase||36
10669331|NCT02318719|11831602|FG002|Did Not Receive Treatment|Double-blind Phase||0
10669332|NCT02318719|11831603|FG003|Did Not Receive Treatment|Double-blind Phase||0
10669333|NCT02318719|11831604|FG004|Did Not Receive Treatment|Double-blind Phase||0
10669334|NCT02318719|11831600|FG000|COMPLETED|Double-blind Phase||266
10669335|NCT02318719|11831601|FG001|COMPLETED|Double-blind Phase||137
10669336|NCT02318719|11831602|FG002|COMPLETED|Double-blind Phase||128
10669337|NCT02318719|11831603|FG003|COMPLETED|Double-blind Phase||140
10669338|NCT02318719|11831604|FG004|COMPLETED|Double-blind Phase||0
10669339|NCT02318719|11831600|FG000|NOT COMPLETED|Double-blind Phase||38
10669340|NCT02318719|11831601|FG001|NOT COMPLETED|Double-blind Phase||16
10669341|NCT02318719|11831602|FG002|NOT COMPLETED|Double-blind Phase||25
10669342|NCT02318719|11831603|FG003|NOT COMPLETED|Double-blind Phase||15
10669343|NCT02318719|11831604|FG004|NOT COMPLETED|Double-blind Phase||0
10669344|NCT02318719|11831600|FG000|STARTED|Open-label Extension Phase||0
10669345|NCT02318719|11831601|FG001|STARTED|Open-label Extension Phase||0
10669346|NCT02318719|11831602|FG002|STARTED|Open-label Extension Phase||0
10669347|NCT02318719|11831603|FG003|STARTED|Open-label Extension Phase||0
10669348|NCT02318719|11831604|FG004|STARTED|Open-label Extension Phase|A portion of participants who completed the double-blind phase enrolled in the open-label extension.|239
10669349|NCT02318719|11831600|FG000|COMPLETED|Open-label Extension Phase||0
10669350|NCT02318719|11831601|FG001|COMPLETED|Open-label Extension Phase||0
10669351|NCT02318719|11831602|FG002|COMPLETED|Open-label Extension Phase||0
10669352|NCT02318719|11831603|FG003|COMPLETED|Open-label Extension Phase||0
10669353|NCT02318719|11831604|FG004|COMPLETED|Open-label Extension Phase||184
10669354|NCT02318719|11831600|FG000|NOT COMPLETED|Open-label Extension Phase||0
10669355|NCT02318719|11831601|FG001|NOT COMPLETED|Open-label Extension Phase||0
10669356|NCT02318719|11831602|FG002|NOT COMPLETED|Open-label Extension Phase||0
10669357|NCT02318719|11831603|FG003|NOT COMPLETED|Open-label Extension Phase||0
10669358|NCT02318719|11831604|FG004|NOT COMPLETED|Open-label Extension Phase||55
10796287|NCT03661983|11956622|FG001|STARTED|Open Label Stabilization Phase||0
10796288|NCT03661983|11956623|FG002|STARTED|Open Label Stabilization Phase||0
10669359|NCT02318797|11831618|FG000|STARTED|Overall Study||516
10669360|NCT02318797|11831619|FG001|STARTED|Overall Study||713
10669361|NCT02318797|11831618|FG000|COMPLETED|Overall Study||428
10669362|NCT02318797|11831619|FG001|COMPLETED|Overall Study||611
10669363|NCT02318797|11831618|FG000|NOT COMPLETED|Overall Study||88
10669364|NCT02318797|11831619|FG001|NOT COMPLETED|Overall Study||102
10669365|NCT02318940|11831627|FG000|STARTED|Overall Study|in the last patient we lost the record.|50
10669366|NCT02318940|11831628|FG001|STARTED|Overall Study||50
10669367|NCT02318940|11831627|FG000|COMPLETED|Overall Study||49
10669368|NCT02318940|11831628|FG001|COMPLETED|Overall Study||50
10669369|NCT02318940|11831627|FG000|NOT COMPLETED|Overall Study||1
10669370|NCT02318940|11831628|FG001|NOT COMPLETED|Overall Study||0
10669371|NCT02318979|11831636|FG000|STARTED|Overall Study||15
10669372|NCT02318979|11831637|FG001|STARTED|Overall Study||15
10669373|NCT02318979|11831636|FG000|COMPLETED|Overall Study||15
10669374|NCT02318979|11831637|FG001|COMPLETED|Overall Study||15
10669375|NCT02318979|11831636|FG000|NOT COMPLETED|Overall Study||0
10669376|NCT02318979|11831637|FG001|NOT COMPLETED|Overall Study||0
10669377|NCT02318992|11831650|FG000|STARTED|Overall Study||27
10669378|NCT02318992|11831651|FG001|STARTED|Overall Study||27
10669379|NCT02318992|11831652|FG002|STARTED|Overall Study||24
10669380|NCT02318992|11831650|FG000|COMPLETED|Overall Study||25
10669381|NCT02318992|11831651|FG001|COMPLETED|Overall Study||25
10669382|NCT02318992|11831652|FG002|COMPLETED|Overall Study||20
10669383|NCT02318992|11831650|FG000|NOT COMPLETED|Overall Study||2
10669384|NCT02318992|11831651|FG001|NOT COMPLETED|Overall Study||2
10669385|NCT02318992|11831652|FG002|NOT COMPLETED|Overall Study||4
10669386|NCT02319031|11831662|FG000|STARTED|Treatment Period||24
10669387|NCT02319031|11831663|FG001|STARTED|Treatment Period||26
10669388|NCT02319031|11831662|FG000|COMPLETED|Treatment Period||23
10669389|NCT02319031|11831663|FG001|COMPLETED|Treatment Period||26
10669390|NCT02319031|11831662|FG000|NOT COMPLETED|Treatment Period||1
10669391|NCT02319031|11831663|FG001|NOT COMPLETED|Treatment Period||0
10669392|NCT02319031|11831662|FG000|STARTED|Follow-Up Period||23
10669393|NCT02319031|11831663|FG001|STARTED|Follow-Up Period||26
10669394|NCT02319031|11831662|FG000|COMPLETED|Follow-Up Period||23
10669395|NCT02319031|11831663|FG001|COMPLETED|Follow-Up Period||26
10669396|NCT02319031|11831662|FG000|NOT COMPLETED|Follow-Up Period||0
10669397|NCT02319031|11831663|FG001|NOT COMPLETED|Follow-Up Period||0
10669398|NCT02319044|11831672|FG000|STARTED|Overall Study||133
10669399|NCT02319044|11831673|FG001|STARTED|Overall Study||67
10669400|NCT02319044|11831674|FG002|STARTED|Overall Study||67
10669401|NCT02319044|11831672|FG000|COMPLETED|Overall Study||11
10669402|NCT02319044|11831673|FG001|COMPLETED|Overall Study||7
10669403|NCT02319044|11831674|FG002|COMPLETED|Overall Study||0
10669404|NCT02319044|11831672|FG000|NOT COMPLETED|Overall Study||122
10669405|NCT02319044|11831673|FG001|NOT COMPLETED|Overall Study||60
10669406|NCT02319044|11831674|FG002|NOT COMPLETED|Overall Study||67
10669407|NCT02319148|11831686|FG000|STARTED|First Intervention Period||22
10669408|NCT02319148|11831687|FG001|STARTED|First Intervention Period||0
10669409|NCT02319148|11831688|FG002|STARTED|First Intervention Period||0
10669410|NCT02319148|11831689|FG003|STARTED|First Intervention Period||0
10669411|NCT02319148|11831686|FG000|COMPLETED|First Intervention Period||22
10669412|NCT02319148|11831687|FG001|COMPLETED|First Intervention Period||0
10669413|NCT02319148|11831688|FG002|COMPLETED|First Intervention Period||0
10669414|NCT02319148|11831689|FG003|COMPLETED|First Intervention Period||0
10669415|NCT02319148|11831686|FG000|NOT COMPLETED|First Intervention Period||0
10669416|NCT02319148|11831687|FG001|NOT COMPLETED|First Intervention Period||0
10669417|NCT02319148|11831688|FG002|NOT COMPLETED|First Intervention Period||0
10669418|NCT02319148|11831689|FG003|NOT COMPLETED|First Intervention Period||0
10669419|NCT02319148|11831686|FG000|STARTED|Washout Period 4 Days||22
10669420|NCT02319148|11831687|FG001|STARTED|Washout Period 4 Days||0
10669421|NCT02319148|11831688|FG002|STARTED|Washout Period 4 Days||0
10669422|NCT02319148|11831689|FG003|STARTED|Washout Period 4 Days||0
10669423|NCT02319148|11831686|FG000|COMPLETED|Washout Period 4 Days||22
10669424|NCT02319148|11831687|FG001|COMPLETED|Washout Period 4 Days||0
10669425|NCT02319148|11831688|FG002|COMPLETED|Washout Period 4 Days||0
10669426|NCT02319148|11831689|FG003|COMPLETED|Washout Period 4 Days||0
10669427|NCT02319148|11831686|FG000|NOT COMPLETED|Washout Period 4 Days||0
10669428|NCT02319148|11831687|FG001|NOT COMPLETED|Washout Period 4 Days||0
10669429|NCT02319148|11831688|FG002|NOT COMPLETED|Washout Period 4 Days||0
10669430|NCT02319148|11831689|FG003|NOT COMPLETED|Washout Period 4 Days||0
10669431|NCT02319148|11831686|FG000|STARTED|Second Intervention Period||0
10669432|NCT02319148|11831687|FG001|STARTED|Second Intervention Period||7
10669433|NCT02319148|11831688|FG002|STARTED|Second Intervention Period||7
10669434|NCT02319148|11831689|FG003|STARTED|Second Intervention Period||8
10669435|NCT02319148|11831686|FG000|COMPLETED|Second Intervention Period||0
10669436|NCT02319148|11831687|FG001|COMPLETED|Second Intervention Period||6
10669437|NCT02319148|11831688|FG002|COMPLETED|Second Intervention Period||6
10669438|NCT02319148|11831689|FG003|COMPLETED|Second Intervention Period||6
10669439|NCT02319148|11831686|FG000|NOT COMPLETED|Second Intervention Period||0
10669440|NCT02319148|11831687|FG001|NOT COMPLETED|Second Intervention Period||1
10669441|NCT02319148|11831688|FG002|NOT COMPLETED|Second Intervention Period||1
10669442|NCT02319148|11831689|FG003|NOT COMPLETED|Second Intervention Period||2
10669443|NCT02319174|11831708|FG000|STARTED|Overall Study||43
10669444|NCT02319174|11831708|FG000|COMPLETED|Overall Study||42
10669445|NCT02319174|11831708|FG000|NOT COMPLETED|Overall Study||1
10669446|NCT02319304|11831713|FG000|STARTED|Overall Study||3
10669447|NCT02319304|11831713|FG000|COMPLETED|Overall Study||2
10669448|NCT02319304|11831713|FG000|NOT COMPLETED|Overall Study||1
10669449|NCT02319317|11831719|FG000|STARTED|Overall Study||31
10669450|NCT02319317|11831720|FG001|STARTED|Overall Study||29
10669451|NCT02319317|11831719|FG000|COMPLETED|Overall Study||31
10669452|NCT02319317|11831720|FG001|COMPLETED|Overall Study||29
10669453|NCT02319317|11831719|FG000|NOT COMPLETED|Overall Study||0
10669454|NCT02319317|11831720|FG001|NOT COMPLETED|Overall Study||0
10669455|NCT02319369|11831739|FG000|STARTED|Overall Study||7
10669456|NCT02319369|11831740|FG001|STARTED|Overall Study||6
10669457|NCT02319369|11831741|FG002|STARTED|Overall Study||11
10669458|NCT02319369|11831742|FG003|STARTED|Overall Study||8
10669459|NCT02319369|11831743|FG004|STARTED|Overall Study||5
10669460|NCT02319369|11831744|FG005|STARTED|Overall Study||7
10669461|NCT02319369|11831745|FG006|STARTED|Overall Study||3
10669462|NCT02319369|11831746|FG007|STARTED|Overall Study||6
10669463|NCT02319369|11831747|FG008|STARTED|Overall Study||4
10669464|NCT02319369|11831748|FG009|STARTED|Overall Study||9
10669465|NCT02319369|11831749|FG010|STARTED|Overall Study||3
10669466|NCT02319369|11831750|FG011|STARTED|Overall Study||4
10669467|NCT02319369|11831751|FG012|STARTED|Overall Study||1
10669468|NCT02319369|11831739|FG000|COMPLETED|Overall Study||7
10669469|NCT02319369|11831740|FG001|COMPLETED|Overall Study||6
10669470|NCT02319369|11831741|FG002|COMPLETED|Overall Study||11
10669471|NCT02319369|11831742|FG003|COMPLETED|Overall Study||8
10669472|NCT02319369|11831743|FG004|COMPLETED|Overall Study||5
10669473|NCT02319369|11831744|FG005|COMPLETED|Overall Study||7
10796289|NCT03661983|11956624|FG003|STARTED|Open Label Stabilization Phase||0
10796290|NCT03661983|11956621|FG000|COMPLETED|Open Label Stabilization Phase||25
10796291|NCT03661983|11956622|FG001|COMPLETED|Open Label Stabilization Phase||0
10796292|NCT03661983|11956623|FG002|COMPLETED|Open Label Stabilization Phase||0
10796293|NCT03661983|11956624|FG003|COMPLETED|Open Label Stabilization Phase||0
10796294|NCT03661983|11956621|FG000|NOT COMPLETED|Open Label Stabilization Phase||11
10796295|NCT03661983|11956622|FG001|NOT COMPLETED|Open Label Stabilization Phase||0
10796296|NCT03661983|11956623|FG002|NOT COMPLETED|Open Label Stabilization Phase||0
10796297|NCT03661983|11956624|FG003|NOT COMPLETED|Open Label Stabilization Phase||0
10796298|NCT03661983|11956621|FG000|STARTED|Double-blind Randomized Phase||0
10796299|NCT03661983|11956622|FG001|STARTED|Double-blind Randomized Phase||9
10796300|NCT03661983|11956623|FG002|STARTED|Double-blind Randomized Phase||8
10796301|NCT03661983|11956624|FG003|STARTED|Double-blind Randomized Phase||8
10796302|NCT03661983|11956621|FG000|COMPLETED|Double-blind Randomized Phase||0
10796303|NCT03661983|11956622|FG001|COMPLETED|Double-blind Randomized Phase||7
10796304|NCT03661983|11956623|FG002|COMPLETED|Double-blind Randomized Phase||7
10796305|NCT03661983|11956624|FG003|COMPLETED|Double-blind Randomized Phase||0
10796306|NCT03661983|11956621|FG000|NOT COMPLETED|Double-blind Randomized Phase||0
10796307|NCT03661983|11956622|FG001|NOT COMPLETED|Double-blind Randomized Phase||2
10796308|NCT03661983|11956623|FG002|NOT COMPLETED|Double-blind Randomized Phase||1
10796309|NCT03661983|11956624|FG003|NOT COMPLETED|Double-blind Randomized Phase||8
10796313|NCT03662139|11956639|FG000|STARTED|Overall Study||16
10796314|NCT03662139|11956640|FG001|STARTED|Overall Study||16
10796315|NCT03662139|11956639|FG000|COMPLETED|Overall Study||16
10796316|NCT03662139|11956640|FG001|COMPLETED|Overall Study||16
10796317|NCT03662139|11956639|FG000|NOT COMPLETED|Overall Study||0
10796318|NCT03662139|11956640|FG001|NOT COMPLETED|Overall Study||0
10796319|NCT03662282|11956648|FG000|STARTED|Overall Study||2
10796320|NCT03662282|11956648|FG000|COMPLETED|Overall Study||2
10796321|NCT03662282|11956648|FG000|NOT COMPLETED|Overall Study||0
10796322|NCT03662334|11956654|FG000|STARTED|Part 1: Treatment Period 1||0
10796323|NCT03662334|11956655|FG001|STARTED|Part 1: Treatment Period 1||0
10796324|NCT03662334|11956654|FG000|COMPLETED|Part 1: Treatment Period 1||0
10796325|NCT03662334|11956655|FG001|COMPLETED|Part 1: Treatment Period 1||0
10796326|NCT03662334|11956654|FG000|NOT COMPLETED|Part 1: Treatment Period 1||0
10796327|NCT03662334|11956655|FG001|NOT COMPLETED|Part 1: Treatment Period 1||0
10796328|NCT03662334|11956654|FG000|STARTED|Part 1: Treatment Period 2||0
10796329|NCT03662334|11956655|FG001|STARTED|Part 1: Treatment Period 2||0
10796330|NCT03662334|11956654|FG000|COMPLETED|Part 1: Treatment Period 2||0
10796331|NCT03662334|11956655|FG001|COMPLETED|Part 1: Treatment Period 2||0
10796332|NCT03662334|11956654|FG000|NOT COMPLETED|Part 1: Treatment Period 2||0
10796333|NCT03662334|11956655|FG001|NOT COMPLETED|Part 1: Treatment Period 2||0
10796334|NCT03662334|11956654|FG000|STARTED|Part 2: Treatment Period 1 (2 Days)|Part 1 of the study was not conducted. Participants were enrolled starting with Part 2.|7
10796335|NCT03662334|11956655|FG001|STARTED|Part 2: Treatment Period 1 (2 Days)|Part 1 of the study was not conducted. Participants were enrolled starting with Part 2.|7
10796336|NCT03662334|11956654|FG000|COMPLETED|Part 2: Treatment Period 1 (2 Days)||7
10796337|NCT03662334|11956655|FG001|COMPLETED|Part 2: Treatment Period 1 (2 Days)||7
10669474|NCT02319369|11831745|FG006|COMPLETED|Overall Study||3
10669475|NCT02319369|11831746|FG007|COMPLETED|Overall Study||6
10669476|NCT02319369|11831747|FG008|COMPLETED|Overall Study||4
10669477|NCT02319369|11831748|FG009|COMPLETED|Overall Study||9
10669478|NCT02319369|11831749|FG010|COMPLETED|Overall Study||3
10669479|NCT02319369|11831750|FG011|COMPLETED|Overall Study||4
10669480|NCT02319369|11831751|FG012|COMPLETED|Overall Study||1
10669481|NCT02319369|11831739|FG000|NOT COMPLETED|Overall Study||0
10669482|NCT02319369|11831740|FG001|NOT COMPLETED|Overall Study||0
10669483|NCT02319369|11831741|FG002|NOT COMPLETED|Overall Study||0
10669484|NCT02319369|11831742|FG003|NOT COMPLETED|Overall Study||0
10669485|NCT02319369|11831743|FG004|NOT COMPLETED|Overall Study||0
10669486|NCT02319369|11831744|FG005|NOT COMPLETED|Overall Study||0
10669487|NCT02319369|11831745|FG006|NOT COMPLETED|Overall Study||0
10669488|NCT02319369|11831746|FG007|NOT COMPLETED|Overall Study||0
10669489|NCT02319369|11831747|FG008|NOT COMPLETED|Overall Study||0
10669490|NCT02319369|11831748|FG009|NOT COMPLETED|Overall Study||0
10669491|NCT02319369|11831749|FG010|NOT COMPLETED|Overall Study||0
10669492|NCT02319369|11831750|FG011|NOT COMPLETED|Overall Study||0
10669493|NCT02319369|11831751|FG012|NOT COMPLETED|Overall Study||0
10669494|NCT02319486|11831789|FG000|STARTED|Overall Study||26
10669495|NCT02319486|11831789|FG000|COMPLETED|Overall Study||26
10669496|NCT02319486|11831789|FG000|NOT COMPLETED|Overall Study||0
10669497|NCT02319525|11831797|FG000|STARTED|Overall Study||153
10669498|NCT02319525|11831798|FG001|STARTED|Overall Study||148
10669499|NCT02319525|11831797|FG000|Primary Research Completion|Overall Study||151
10669500|NCT02319525|11831798|FG001|Primary Research Completion|Overall Study||147
10669501|NCT02319525|11831797|FG000|COMPLETED|Overall Study||151
10669502|NCT02319525|11831798|FG001|COMPLETED|Overall Study||147
10669503|NCT02319525|11831797|FG000|NOT COMPLETED|Overall Study||2
10669504|NCT02319525|11831798|FG001|NOT COMPLETED|Overall Study||1
10669505|NCT02319642|11831806|FG000|STARTED|Overall Study||95
10669506|NCT02319642|11831807|FG001|STARTED|Overall Study||251
10669507|NCT02319642|11831806|FG000|COMPLETED|Overall Study||91
10669508|NCT02319642|11831807|FG001|COMPLETED|Overall Study||245
10669509|NCT02319642|11831806|FG000|NOT COMPLETED|Overall Study||4
10669510|NCT02319642|11831807|FG001|NOT COMPLETED|Overall Study||6
10669511|NCT02319668|11831817|FG000|STARTED|Overall Study||19
10669512|NCT02319668|11831818|FG001|STARTED|Overall Study||19
10669513|NCT02319668|11831817|FG000|COMPLETED|Overall Study||19
10669514|NCT02319668|11831818|FG001|COMPLETED|Overall Study||17
10669515|NCT02319668|11831817|FG000|NOT COMPLETED|Overall Study||0
10669516|NCT02319668|11831818|FG001|NOT COMPLETED|Overall Study||2
10669517|NCT02319759|11831829|FG000|STARTED|Week 0 - 16||49
10669518|NCT02319759|11831830|FG001|STARTED|Week 0 - 16||0
10669519|NCT02319759|11831831|FG002|STARTED|Week 0 - 16||100
10669520|NCT02319759|11831832|FG003|STARTED|Week 0 - 16||0
10669521|NCT02319759|11831833|FG004|STARTED|Week 0 - 16||0
10669522|NCT02319759|11831829|FG000|COMPLETED|Week 0 - 16||48
10669523|NCT02319759|11831830|FG001|COMPLETED|Week 0 - 16||0
10669524|NCT02319759|11831831|FG002|COMPLETED|Week 0 - 16||99
10669525|NCT02319759|11831832|FG003|COMPLETED|Week 0 - 16||0
10669526|NCT02319759|11831833|FG004|COMPLETED|Week 0 - 16||0
10669527|NCT02319759|11831829|FG000|NOT COMPLETED|Week 0 - 16||1
10669528|NCT02319759|11831830|FG001|NOT COMPLETED|Week 0 - 16||0
10669529|NCT02319759|11831831|FG002|NOT COMPLETED|Week 0 - 16||1
10669530|NCT02319759|11831832|FG003|NOT COMPLETED|Week 0 - 16||0
10669531|NCT02319759|11831833|FG004|NOT COMPLETED|Week 0 - 16||0
10669532|NCT02319759|11831829|FG000|STARTED|Week 16 - 24||31
10669533|NCT02319759|11831830|FG001|STARTED|Week 16 - 24||0
10669534|NCT02319759|11831831|FG002|STARTED|Week 16 - 24||89
10669535|NCT02319759|11831832|FG003|STARTED|Week 16 - 24||17
10669536|NCT02319759|11831833|FG004|STARTED|Week 16 - 24||10
10669537|NCT02319759|11831829|FG000|COMPLETED|Week 16 - 24||29
10669538|NCT02319759|11831830|FG001|COMPLETED|Week 16 - 24||0
10669539|NCT02319759|11831831|FG002|COMPLETED|Week 16 - 24||86
10669540|NCT02319759|11831832|FG003|COMPLETED|Week 16 - 24||17
10669541|NCT02319759|11831833|FG004|COMPLETED|Week 16 - 24||10
10669542|NCT02319759|11831829|FG000|NOT COMPLETED|Week 16 - 24||2
10669543|NCT02319759|11831830|FG001|NOT COMPLETED|Week 16 - 24||0
10669544|NCT02319759|11831831|FG002|NOT COMPLETED|Week 16 - 24||3
10669545|NCT02319759|11831832|FG003|NOT COMPLETED|Week 16 - 24||0
10669546|NCT02319759|11831833|FG004|NOT COMPLETED|Week 16 - 24||0
10669547|NCT02319759|11831829|FG000|STARTED|Week 24 - 56||0
10669548|NCT02319759|11831830|FG001|STARTED|Week 24 - 56||29
10669549|NCT02319759|11831831|FG002|STARTED|Week 24 - 56||86
10669550|NCT02319759|11831832|FG003|STARTED|Week 24 - 56||17
10669551|NCT02319759|11831833|FG004|STARTED|Week 24 - 56||10
10669552|NCT02319759|11831829|FG000|COMPLETED|Week 24 - 56||0
10669553|NCT02319759|11831830|FG001|COMPLETED|Week 24 - 56||28
10669554|NCT02319759|11831831|FG002|COMPLETED|Week 24 - 56||84
10669555|NCT02319759|11831832|FG003|COMPLETED|Week 24 - 56||15
10669556|NCT02319759|11831833|FG004|COMPLETED|Week 24 - 56||8
10669557|NCT02319759|11831829|FG000|NOT COMPLETED|Week 24 - 56||0
10669558|NCT02319759|11831830|FG001|NOT COMPLETED|Week 24 - 56||1
10669559|NCT02319759|11831831|FG002|NOT COMPLETED|Week 24 - 56||2
10669560|NCT02319759|11831832|FG003|NOT COMPLETED|Week 24 - 56||2
10669561|NCT02319759|11831833|FG004|NOT COMPLETED|Week 24 - 56||2
10669562|NCT02319824|11831846|FG000|STARTED|Overall Study||2
10669563|NCT02319824|11831846|FG000|COMPLETED|Overall Study||2
10669564|NCT02319824|11831846|FG000|NOT COMPLETED|Overall Study||0
10669565|NCT02319967|11831854|FG000|STARTED|Overall Study||126
10669566|NCT02319967|11831855|FG001|STARTED|Overall Study||126
10669567|NCT02319967|11831856|FG002|STARTED|Overall Study||121
10669568|NCT02319967|11831854|FG000|COMPLETED|Overall Study||78
10669569|NCT02319967|11831855|FG001|COMPLETED|Overall Study||82
10669570|NCT02319967|11831856|FG002|COMPLETED|Overall Study||76
10669571|NCT02319967|11831854|FG000|NOT COMPLETED|Overall Study||48
10669572|NCT02319967|11831855|FG001|NOT COMPLETED|Overall Study||44
10669573|NCT02319967|11831856|FG002|NOT COMPLETED|Overall Study||45
10669574|NCT02320058|11831866|FG000|STARTED|Overall Study||101
10669575|NCT02320058|11831867|FG001|STARTED|Overall Study||18
10669576|NCT02320058|11831866|FG000|COMPLETED|Overall Study||59
10669577|NCT02320058|11831867|FG001|COMPLETED|Overall Study||5
10669578|NCT02320058|11831866|FG000|NOT COMPLETED|Overall Study||42
10669579|NCT02320058|11831867|FG001|NOT COMPLETED|Overall Study||13
10669580|NCT02320123|11831875|FG000|STARTED|Overall Study||10
10669581|NCT02320123|11831876|FG001|STARTED|Overall Study||12
10669582|NCT02320123|11831875|FG000|COMPLETED|Overall Study||0
10669583|NCT02320123|11831876|FG001|COMPLETED|Overall Study||1
10669584|NCT02320123|11831875|FG000|NOT COMPLETED|Overall Study||10
10669585|NCT02320123|11831876|FG001|NOT COMPLETED|Overall Study||11
10669586|NCT02320149|11831888|FG000|STARTED|Overall Study||483
10669587|NCT02320149|11831889|FG001|STARTED|Overall Study||485
10669588|NCT02320149|11831888|FG000|COMPLETED|Overall Study||420
10669589|NCT02320149|11831889|FG001|COMPLETED|Overall Study||405
10669590|NCT02320149|11831888|FG000|NOT COMPLETED|Overall Study||63
10669591|NCT02320149|11831889|FG001|NOT COMPLETED|Overall Study||80
10669592|NCT02320175|11831897|FG000|STARTED|Overall Study|Patients (n=1574); Parents (n=1222); Physicians (n=478); Nurses (n=264).|3538
10669593|NCT02320175|11831898|FG001|STARTED|Overall Study|Patients (n=1532); Parents (n=926); Physicians (n=311); Nurses (n=171).|2940
10669594|NCT02320175|11831897|FG000|COMPLETED|Overall Study|Patients (n=1574); Parents (n=1222); Physicians (n=478); Nurses (n=264).|3538
10669595|NCT02320175|11831898|FG001|COMPLETED|Overall Study|Patients (n=1532); Parents (n=926); Physicians (n=311); Nurses (n=171).|2940
10669596|NCT02320175|11831897|FG000|NOT COMPLETED|Overall Study||0
10669597|NCT02320175|11831898|FG001|NOT COMPLETED|Overall Study||0
10669598|NCT02320214|11831907|FG000|STARTED|Overall Study||30
10669599|NCT02320214|11831907|FG000|COMPLETED|Overall Study||30
10669600|NCT02320214|11831907|FG000|NOT COMPLETED|Overall Study||0
10669601|NCT02320227|11831911|FG000|STARTED|Overall Study||30
10669602|NCT02320227|11831911|FG000|COMPLETED|Overall Study||30
10669603|NCT02320227|11831911|FG000|NOT COMPLETED|Overall Study||0
10669604|NCT02320253|11831919|FG000|STARTED|Overall Study||69
10669605|NCT02320253|11831920|FG001|STARTED|Overall Study||70
10669606|NCT02320253|11831921|FG002|STARTED|Overall Study||72
10669607|NCT02320253|11831919|FG000|COMPLETED|Overall Study||63
10669608|NCT02320253|11831920|FG001|COMPLETED|Overall Study||68
10669609|NCT02320253|11831921|FG002|COMPLETED|Overall Study||70
10669610|NCT02320253|11831919|FG000|NOT COMPLETED|Overall Study||6
10669611|NCT02320253|11831920|FG001|NOT COMPLETED|Overall Study||2
10669612|NCT02320253|11831921|FG002|NOT COMPLETED|Overall Study||2
10669613|NCT02320487|11831929|FG000|STARTED|Overall Study||102
10669614|NCT02320487|11831929|FG000|COMPLETED|Overall Study|Completed = completed the 6-cycle Treatment Period.|81
10669615|NCT02320487|11831929|FG000|NOT COMPLETED|Overall Study||21
10669616|NCT02320695|11831933|FG000|STARTED|Overall Study||60
10669617|NCT02320695|11831933|FG000|Saline|Overall Study||60
10669618|NCT02320695|11831933|FG000|Alcohol|Overall Study||60
10669619|NCT02320695|11831933|FG000|Pain Relieving Cream|Overall Study||59
10669620|NCT02320695|11831933|FG000|Antibiotic/Pain Relieving Ointment|Overall Study||60
10669621|NCT02320695|11831933|FG000|Original Ointment|Overall Study||60
10669622|NCT02320695|11831933|FG000|Pain Relief Ointment|Overall Study||60
10669623|NCT02320695|11831933|FG000|COMPLETED|Overall Study||60
10669624|NCT02320695|11831933|FG000|NOT COMPLETED|Overall Study||0
10669625|NCT02320721|11831944|FG000|STARTED|Overall Study||508
10669626|NCT02320721|11831945|FG001|STARTED|Overall Study||506
10669627|NCT02320721|11831944|FG000|Treated (Safety Population)|Overall Study||508
10669628|NCT02320721|11831945|FG001|Treated (Safety Population)|Overall Study||505
10669629|NCT02320721|11831944|FG000|COMPLETED|Overall Study||481
10669630|NCT02320721|11831945|FG001|COMPLETED|Overall Study||472
10669631|NCT02320721|11831944|FG000|NOT COMPLETED|Overall Study||27
10669632|NCT02320721|11831945|FG001|NOT COMPLETED|Overall Study||34
10669633|NCT02320812|11831951|FG000|STARTED|Overall Study||28
10669634|NCT02320812|11831951|FG000|COMPLETED|Overall Study||28
10669635|NCT02320812|11831951|FG000|NOT COMPLETED|Overall Study||0
10669636|NCT02320838|11831959|FG000|STARTED|First Intervention (1 Day)||8
10669637|NCT02320838|11831960|FG001|STARTED|First Intervention (1 Day)||8
10669638|NCT02320838|11831961|FG002|STARTED|First Intervention (1 Day)||8
10669639|NCT02320838|11831962|FG003|STARTED|First Intervention (1 Day)||7
10669640|NCT02320838|11831963|FG004|STARTED|First Intervention (1 Day)||7
10669641|NCT02320838|11831959|FG000|COMPLETED|First Intervention (1 Day)||8
10669642|NCT02320838|11831960|FG001|COMPLETED|First Intervention (1 Day)||8
10669643|NCT02320838|11831961|FG002|COMPLETED|First Intervention (1 Day)||8
10669644|NCT02320838|11831962|FG003|COMPLETED|First Intervention (1 Day)||7
10796338|NCT03662334|11956654|FG000|NOT COMPLETED|Part 2: Treatment Period 1 (2 Days)||0
10796339|NCT03662334|11956655|FG001|NOT COMPLETED|Part 2: Treatment Period 1 (2 Days)||0
10796340|NCT03662334|11956654|FG000|STARTED|Part 2: Treatment Period 2 (2 Days)||7
10796341|NCT03662334|11956655|FG001|STARTED|Part 2: Treatment Period 2 (2 Days)||7
10669645|NCT02320838|11831963|FG004|COMPLETED|First Intervention (1 Day)||7
10669646|NCT02320838|11831959|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10669647|NCT02320838|11831960|FG001|NOT COMPLETED|First Intervention (1 Day)||0
10669648|NCT02320838|11831961|FG002|NOT COMPLETED|First Intervention (1 Day)||0
10669649|NCT02320838|11831962|FG003|NOT COMPLETED|First Intervention (1 Day)||0
10669650|NCT02320838|11831963|FG004|NOT COMPLETED|First Intervention (1 Day)||0
10669651|NCT02320838|11831959|FG000|STARTED|Washout (1 Day)||8
10669652|NCT02320838|11831960|FG001|STARTED|Washout (1 Day)||8
10669653|NCT02320838|11831961|FG002|STARTED|Washout (1 Day)||8
10669654|NCT02320838|11831962|FG003|STARTED|Washout (1 Day)||7
10669655|NCT02320838|11831963|FG004|STARTED|Washout (1 Day)||7
10669656|NCT02320838|11831959|FG000|COMPLETED|Washout (1 Day)||8
10796342|NCT03662334|11956654|FG000|COMPLETED|Part 2: Treatment Period 2 (2 Days)||6
10669657|NCT02320838|11831960|FG001|COMPLETED|Washout (1 Day)||8
10669658|NCT02320838|11831961|FG002|COMPLETED|Washout (1 Day)||8
10669659|NCT02320838|11831962|FG003|COMPLETED|Washout (1 Day)||7
10669660|NCT02320838|11831963|FG004|COMPLETED|Washout (1 Day)||7
10669661|NCT02320838|11831959|FG000|NOT COMPLETED|Washout (1 Day)||0
10669662|NCT02320838|11831960|FG001|NOT COMPLETED|Washout (1 Day)||0
10669663|NCT02320838|11831961|FG002|NOT COMPLETED|Washout (1 Day)||0
10669664|NCT02320838|11831962|FG003|NOT COMPLETED|Washout (1 Day)||0
10669665|NCT02320838|11831963|FG004|NOT COMPLETED|Washout (1 Day)||0
10669666|NCT02320838|11831959|FG000|STARTED|Second Intervention (1 Day)||8
10669667|NCT02320838|11831960|FG001|STARTED|Second Intervention (1 Day)||8
10669668|NCT02320838|11831961|FG002|STARTED|Second Intervention (1 Day)||8
10669669|NCT02320838|11831962|FG003|STARTED|Second Intervention (1 Day)||7
10669670|NCT02320838|11831963|FG004|STARTED|Second Intervention (1 Day)||7
10669671|NCT02320838|11831959|FG000|COMPLETED|Second Intervention (1 Day)||8
10669672|NCT02320838|11831960|FG001|COMPLETED|Second Intervention (1 Day)||8
10669673|NCT02320838|11831961|FG002|COMPLETED|Second Intervention (1 Day)||8
10669674|NCT02320838|11831962|FG003|COMPLETED|Second Intervention (1 Day)||7
10796343|NCT03662334|11956655|FG001|COMPLETED|Part 2: Treatment Period 2 (2 Days)||7
10796344|NCT03662334|11956654|FG000|NOT COMPLETED|Part 2: Treatment Period 2 (2 Days)||1
10796345|NCT03662334|11956655|FG001|NOT COMPLETED|Part 2: Treatment Period 2 (2 Days)||0
10796346|NCT03662334|11956654|FG000|STARTED|Part 3: Treatment Period 1|Part 3 of the study was not conducted. No participants were enrolled in this part of the study.|0
10796347|NCT03662334|11956655|FG001|STARTED|Part 3: Treatment Period 1|Part 3 of the study was not conducted. No participants were enrolled in this part of the study.|0
10796348|NCT03662334|11956654|FG000|COMPLETED|Part 3: Treatment Period 1||0
10796349|NCT03662334|11956655|FG001|COMPLETED|Part 3: Treatment Period 1||0
10796350|NCT03662334|11956654|FG000|NOT COMPLETED|Part 3: Treatment Period 1||0
10796351|NCT03662334|11956655|FG001|NOT COMPLETED|Part 3: Treatment Period 1||0
10796352|NCT03662334|11956654|FG000|STARTED|Part 3: Treatment Period 2||0
10796353|NCT03662334|11956655|FG001|STARTED|Part 3: Treatment Period 2||0
10796354|NCT03662334|11956654|FG000|COMPLETED|Part 3: Treatment Period 2||0
10796355|NCT03662334|11956655|FG001|COMPLETED|Part 3: Treatment Period 2||0
10796356|NCT03662334|11956654|FG000|NOT COMPLETED|Part 3: Treatment Period 2||0
10796357|NCT03662334|11956655|FG001|NOT COMPLETED|Part 3: Treatment Period 2||0
10796358|NCT03662360|11956663|FG000|STARTED|Overall Study||16
10796359|NCT03662360|11956664|FG001|STARTED|Overall Study||16
10796360|NCT03662360|11956663|FG000|COMPLETED|Overall Study||16
10796361|NCT03662360|11956664|FG001|COMPLETED|Overall Study||14
10796362|NCT03662360|11956663|FG000|NOT COMPLETED|Overall Study||0
10796363|NCT03662360|11956664|FG001|NOT COMPLETED|Overall Study||2
10796364|NCT03662750|11956671|FG000|STARTED|Overall Study||3
10796365|NCT03662750|11956671|FG000|COMPLETED|Overall Study||2
10796366|NCT03662750|11956671|FG000|NOT COMPLETED|Overall Study||1
10796367|NCT03662789|11956677|FG000|STARTED|Overall Study|Baseline|52
10796368|NCT03662789|11956678|FG001|STARTED|Overall Study|Baseline|50
10796369|NCT03662789|11956677|FG000|COMPLETED|Overall Study|Follow-up at 6 months|47
10796370|NCT03662789|11956678|FG001|COMPLETED|Overall Study|Follow-up at 6 months|43
10796371|NCT03662789|11956677|FG000|NOT COMPLETED|Overall Study||5
10796372|NCT03662789|11956678|FG001|NOT COMPLETED|Overall Study||7
10796373|NCT03662997|11956688|FG000|STARTED|Overall Study||11
10796374|NCT03662997|11956689|FG001|STARTED|Overall Study||10
10796375|NCT03662997|11956690|FG002|STARTED|Overall Study||11
10796376|NCT03662997|11956691|FG003|STARTED|Overall Study||8
10796377|NCT03662997|11956688|FG000|COMPLETED|Overall Study||11
10796378|NCT03662997|11956689|FG001|COMPLETED|Overall Study||8
10796379|NCT03662997|11956690|FG002|COMPLETED|Overall Study||11
10796380|NCT03662997|11956691|FG003|COMPLETED|Overall Study||8
10796381|NCT03662997|11956688|FG000|NOT COMPLETED|Overall Study||0
10796382|NCT03662997|11956689|FG001|NOT COMPLETED|Overall Study||2
10796383|NCT03662997|11956690|FG002|NOT COMPLETED|Overall Study||0
10796384|NCT03662997|11956691|FG003|NOT COMPLETED|Overall Study||0
10796385|NCT03663101|11956707|FG000|STARTED|Overall Study||4
10796386|NCT03663101|11956708|FG001|STARTED|Overall Study||3
10796387|NCT03663101|11956709|FG002|STARTED|Overall Study||5
10796388|NCT03663101|11956710|FG003|STARTED|Overall Study||4
10796389|NCT03663101|11956707|FG000|COMPLETED|Overall Study||4
10796390|NCT03663101|11956708|FG001|COMPLETED|Overall Study||3
10796391|NCT03663101|11956709|FG002|COMPLETED|Overall Study||5
10796392|NCT03663101|11956710|FG003|COMPLETED|Overall Study||4
10796393|NCT03663101|11956707|FG000|NOT COMPLETED|Overall Study||0
10796394|NCT03663101|11956708|FG001|NOT COMPLETED|Overall Study||0
10796395|NCT03663101|11956709|FG002|NOT COMPLETED|Overall Study||0
10796396|NCT03663101|11956710|FG003|NOT COMPLETED|Overall Study||0
10669675|NCT02320838|11831963|FG004|COMPLETED|Second Intervention (1 Day)||7
10669676|NCT02320838|11831959|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10669677|NCT02320838|11831960|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10796403|NCT03663231|11956731|FG000|STARTED|First Intervention||16
10796404|NCT03663231|11956732|FG001|STARTED|First Intervention||13
10796405|NCT03663231|11956731|FG000|COMPLETED|First Intervention||14
10669678|NCT02320838|11831961|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
10669679|NCT02320838|11831962|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
10669680|NCT02320838|11831963|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
10669681|NCT02320838|11831959|FG000|STARTED|Washout (1 Day)||8
10669682|NCT02320838|11831960|FG001|STARTED|Washout (1 Day)||8
10669683|NCT02320838|11831961|FG002|STARTED|Washout (1 Day)||8
10669684|NCT02320838|11831962|FG003|STARTED|Washout (1 Day)||7
10669685|NCT02320838|11831963|FG004|STARTED|Washout (1 Day)||7
10669686|NCT02320838|11831959|FG000|COMPLETED|Washout (1 Day)||8
10669687|NCT02320838|11831960|FG001|COMPLETED|Washout (1 Day)||8
10669688|NCT02320838|11831961|FG002|COMPLETED|Washout (1 Day)||8
10669689|NCT02320838|11831962|FG003|COMPLETED|Washout (1 Day)||7
10669690|NCT02320838|11831963|FG004|COMPLETED|Washout (1 Day)||7
10669691|NCT02320838|11831959|FG000|NOT COMPLETED|Washout (1 Day)||0
10669692|NCT02320838|11831960|FG001|NOT COMPLETED|Washout (1 Day)||0
10669693|NCT02320838|11831961|FG002|NOT COMPLETED|Washout (1 Day)||0
10669694|NCT02320838|11831962|FG003|NOT COMPLETED|Washout (1 Day)||0
10669695|NCT02320838|11831963|FG004|NOT COMPLETED|Washout (1 Day)||0
10796406|NCT03663231|11956732|FG001|COMPLETED|First Intervention||12
10796407|NCT03663231|11956731|FG000|NOT COMPLETED|First Intervention||2
10669696|NCT02320838|11831959|FG000|STARTED|Third Intervention (1 Day)||8
10669697|NCT02320838|11831960|FG001|STARTED|Third Intervention (1 Day)||8
10669698|NCT02320838|11831961|FG002|STARTED|Third Intervention (1 Day)||8
10669699|NCT02320838|11831962|FG003|STARTED|Third Intervention (1 Day)||7
10669700|NCT02320838|11831963|FG004|STARTED|Third Intervention (1 Day)||7
10669701|NCT02320838|11831959|FG000|COMPLETED|Third Intervention (1 Day)||8
10669702|NCT02320838|11831960|FG001|COMPLETED|Third Intervention (1 Day)||8
10669703|NCT02320838|11831961|FG002|COMPLETED|Third Intervention (1 Day)||8
10669704|NCT02320838|11831962|FG003|COMPLETED|Third Intervention (1 Day)||7
10669705|NCT02320838|11831963|FG004|COMPLETED|Third Intervention (1 Day)||7
10669706|NCT02320838|11831959|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
10669707|NCT02320838|11831960|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
10669708|NCT02320838|11831961|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
10669709|NCT02320838|11831962|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
10669710|NCT02320838|11831963|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
10669711|NCT02320903|11831974|FG000|STARTED|Overall Study||24
10669712|NCT02320903|11831975|FG001|STARTED|Overall Study||32
10669713|NCT02320903|11831976|FG002|STARTED|Overall Study||32
10669714|NCT02320903|11831974|FG000|COMPLETED|Overall Study||16
10669715|NCT02320903|11831975|FG001|COMPLETED|Overall Study||16
10669716|NCT02320903|11831976|FG002|COMPLETED|Overall Study||16
10669717|NCT02320903|11831974|FG000|NOT COMPLETED|Overall Study||8
10669718|NCT02320903|11831975|FG001|NOT COMPLETED|Overall Study||16
10669719|NCT02320903|11831976|FG002|NOT COMPLETED|Overall Study||16
10669720|NCT02321098|11831988|FG000|STARTED|12 Weeks Treament||26
10669721|NCT02321098|11831989|FG001|STARTED|12 Weeks Treament||24
10669722|NCT02321098|11831990|FG002|STARTED|12 Weeks Treament||0
10669723|NCT02321098|11831988|FG000|COMPLETED|12 Weeks Treament||25
10669724|NCT02321098|11831989|FG001|COMPLETED|12 Weeks Treament||23
10669725|NCT02321098|11831990|FG002|COMPLETED|12 Weeks Treament||0
10669726|NCT02321098|11831988|FG000|NOT COMPLETED|12 Weeks Treament||1
10669727|NCT02321098|11831989|FG001|NOT COMPLETED|12 Weeks Treament||1
10669728|NCT02321098|11831990|FG002|NOT COMPLETED|12 Weeks Treament||0
10669729|NCT02321098|11831988|FG000|STARTED|Additional 15 Months Treatment||0
10669730|NCT02321098|11831989|FG001|STARTED|Additional 15 Months Treatment||0
10669731|NCT02321098|11831990|FG002|STARTED|Additional 15 Months Treatment||29
10669732|NCT02321098|11831988|FG000|COMPLETED|Additional 15 Months Treatment||0
10669733|NCT02321098|11831989|FG001|COMPLETED|Additional 15 Months Treatment||0
10669734|NCT02321098|11831990|FG002|COMPLETED|Additional 15 Months Treatment||21
10669735|NCT02321098|11831988|FG000|NOT COMPLETED|Additional 15 Months Treatment||0
10669736|NCT02321098|11831989|FG001|NOT COMPLETED|Additional 15 Months Treatment||0
10669737|NCT02321098|11831990|FG002|NOT COMPLETED|Additional 15 Months Treatment||8
10669738|NCT02321111|11831999|FG000|STARTED|Infusion1||1
10669739|NCT02321111|11832000|FG001|STARTED|Infusion1||4
10669740|NCT02321111|11832001|FG002|STARTED|Infusion1||4
10669741|NCT02321111|11832002|FG003|STARTED|Infusion1||1
10669742|NCT02321111|11832003|FG004|STARTED|Infusion1||0
10669743|NCT02321111|11832004|FG005|STARTED|Infusion1||0
10669744|NCT02321111|11831999|FG000|COMPLETED|Infusion1||1
10669745|NCT02321111|11832000|FG001|COMPLETED|Infusion1||4
10669746|NCT02321111|11832001|FG002|COMPLETED|Infusion1||4
10669747|NCT02321111|11832002|FG003|COMPLETED|Infusion1||1
10669748|NCT02321111|11832003|FG004|COMPLETED|Infusion1||0
10669749|NCT02321111|11832004|FG005|COMPLETED|Infusion1||0
10669750|NCT02321111|11831999|FG000|NOT COMPLETED|Infusion1||0
10669751|NCT02321111|11832000|FG001|NOT COMPLETED|Infusion1||0
10669752|NCT02321111|11832001|FG002|NOT COMPLETED|Infusion1||0
10669753|NCT02321111|11832002|FG003|NOT COMPLETED|Infusion1||0
10669754|NCT02321111|11832003|FG004|NOT COMPLETED|Infusion1||0
10669755|NCT02321111|11832004|FG005|NOT COMPLETED|Infusion1||0
10669756|NCT02321111|11831999|FG000|STARTED|Washout1 (3-4weeks Between Infusions)||1
10669757|NCT02321111|11832000|FG001|STARTED|Washout1 (3-4weeks Between Infusions)||4
10669758|NCT02321111|11832001|FG002|STARTED|Washout1 (3-4weeks Between Infusions)||4
10712353|NCT02669667|11877952|FG004|NOT COMPLETED|Overall Study||0
10712354|NCT02669667|11877953|FG005|NOT COMPLETED|Overall Study||1
10712355|NCT02669667|11877954|FG006|NOT COMPLETED|Overall Study||0
10712356|NCT02669758|11877976|FG000|STARTED|Overall Study||277
10712357|NCT02669758|11877976|FG000|COMPLETED|Overall Study||183
10712358|NCT02669758|11877976|FG000|NOT COMPLETED|Overall Study||94
10669759|NCT02321111|11832002|FG003|STARTED|Washout1 (3-4weeks Between Infusions)||1
10669760|NCT02321111|11832003|FG004|STARTED|Washout1 (3-4weeks Between Infusions)||0
10669761|NCT02321111|11832004|FG005|STARTED|Washout1 (3-4weeks Between Infusions)||0
10669762|NCT02321111|11831999|FG000|COMPLETED|Washout1 (3-4weeks Between Infusions)||1
10669763|NCT02321111|11832000|FG001|COMPLETED|Washout1 (3-4weeks Between Infusions)||4
10669764|NCT02321111|11832001|FG002|COMPLETED|Washout1 (3-4weeks Between Infusions)||4
10669765|NCT02321111|11832002|FG003|COMPLETED|Washout1 (3-4weeks Between Infusions)||1
10669766|NCT02321111|11832003|FG004|COMPLETED|Washout1 (3-4weeks Between Infusions)||0
10669767|NCT02321111|11832004|FG005|COMPLETED|Washout1 (3-4weeks Between Infusions)||0
10669768|NCT02321111|11831999|FG000|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
10669769|NCT02321111|11832000|FG001|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
10669770|NCT02321111|11832001|FG002|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
10669771|NCT02321111|11832002|FG003|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
10669772|NCT02321111|11832003|FG004|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
10669773|NCT02321111|11832004|FG005|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
10669774|NCT02321111|11831999|FG000|STARTED|Infusion2||1
10669775|NCT02321111|11832000|FG001|STARTED|Infusion2||4
10669776|NCT02321111|11832001|FG002|STARTED|Infusion2||4
10669777|NCT02321111|11832002|FG003|STARTED|Infusion2||1
10669778|NCT02321111|11832003|FG004|STARTED|Infusion2||0
10669779|NCT02321111|11832004|FG005|STARTED|Infusion2||0
10669780|NCT02321111|11831999|FG000|COMPLETED|Infusion2||1
10669781|NCT02321111|11832000|FG001|COMPLETED|Infusion2||4
10669782|NCT02321111|11832001|FG002|COMPLETED|Infusion2||4
10669783|NCT02321111|11832002|FG003|COMPLETED|Infusion2||1
10669784|NCT02321111|11832003|FG004|COMPLETED|Infusion2||0
10669785|NCT02321111|11832004|FG005|COMPLETED|Infusion2||0
10669786|NCT02321111|11831999|FG000|NOT COMPLETED|Infusion2||0
10669787|NCT02321111|11832000|FG001|NOT COMPLETED|Infusion2||0
10669788|NCT02321111|11832001|FG002|NOT COMPLETED|Infusion2||0
10669789|NCT02321111|11832002|FG003|NOT COMPLETED|Infusion2||0
10669790|NCT02321111|11832003|FG004|NOT COMPLETED|Infusion2||0
10669791|NCT02321111|11832004|FG005|NOT COMPLETED|Infusion2||0
10669792|NCT02321111|11831999|FG000|STARTED|Washout2 (3-4weeks Between Infusions)||1
10669793|NCT02321111|11832000|FG001|STARTED|Washout2 (3-4weeks Between Infusions)||4
10669794|NCT02321111|11832001|FG002|STARTED|Washout2 (3-4weeks Between Infusions)||4
10669795|NCT02321111|11832002|FG003|STARTED|Washout2 (3-4weeks Between Infusions)||1
10669796|NCT02321111|11832003|FG004|STARTED|Washout2 (3-4weeks Between Infusions)||0
10669797|NCT02321111|11832004|FG005|STARTED|Washout2 (3-4weeks Between Infusions)||0
10669798|NCT02321111|11831999|FG000|COMPLETED|Washout2 (3-4weeks Between Infusions)||1
10669799|NCT02321111|11832000|FG001|COMPLETED|Washout2 (3-4weeks Between Infusions)||4
10669800|NCT02321111|11832001|FG002|COMPLETED|Washout2 (3-4weeks Between Infusions)||4
10669801|NCT02321111|11832002|FG003|COMPLETED|Washout2 (3-4weeks Between Infusions)||1
10669802|NCT02321111|11832003|FG004|COMPLETED|Washout2 (3-4weeks Between Infusions)||0
10669803|NCT02321111|11832004|FG005|COMPLETED|Washout2 (3-4weeks Between Infusions)||0
10669804|NCT02321111|11831999|FG000|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
10669805|NCT02321111|11832000|FG001|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
10669806|NCT02321111|11832001|FG002|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
10669807|NCT02321111|11832002|FG003|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
10669808|NCT02321111|11832003|FG004|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
10669809|NCT02321111|11832004|FG005|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
10669810|NCT02321111|11831999|FG000|STARTED|Infusion3||1
10669811|NCT02321111|11832000|FG001|STARTED|Infusion3||4
10669812|NCT02321111|11832001|FG002|STARTED|Infusion3||4
10669813|NCT02321111|11832002|FG003|STARTED|Infusion3||1
10669814|NCT02321111|11832003|FG004|STARTED|Infusion3||0
10669815|NCT02321111|11832004|FG005|STARTED|Infusion3||0
10669816|NCT02321111|11831999|FG000|COMPLETED|Infusion3||1
10669817|NCT02321111|11832000|FG001|COMPLETED|Infusion3||4
10669818|NCT02321111|11832001|FG002|COMPLETED|Infusion3||4
10669819|NCT02321111|11832002|FG003|COMPLETED|Infusion3||1
10669820|NCT02321111|11832003|FG004|COMPLETED|Infusion3||0
10669821|NCT02321111|11832004|FG005|COMPLETED|Infusion3||0
10669822|NCT02321111|11831999|FG000|NOT COMPLETED|Infusion3||0
10318805|NCT00217594|11453074|FG000|COMPLETED|Overall Study||31
10318806|NCT00217594|11453074|FG000|NOT COMPLETED|Overall Study||0
10318807|NCT00217620|11453078|FG000|STARTED|Overall Study||51
10318808|NCT00217620|11453078|FG000|Eligible|Overall Study||38
10318809|NCT00217620|11453078|FG000|Eligible and Began Protocol Therapy|Overall Study||37
10669823|NCT02321111|11832000|FG001|NOT COMPLETED|Infusion3||0
10669824|NCT02321111|11832001|FG002|NOT COMPLETED|Infusion3||0
10669825|NCT02321111|11832002|FG003|NOT COMPLETED|Infusion3||0
10669826|NCT02321111|11832003|FG004|NOT COMPLETED|Infusion3||0
10669827|NCT02321111|11832004|FG005|NOT COMPLETED|Infusion3||0
10669828|NCT02321319|11832012|FG000|STARTED|Overall Study||5
10669829|NCT02321319|11832012|FG000|COMPLETED|Overall Study||0
10669830|NCT02321319|11832012|FG000|NOT COMPLETED|Overall Study||5
10669837|NCT02321462|11832028|FG000|STARTED|Overall Study||147
10669838|NCT02321462|11832029|FG001|STARTED|Overall Study||149
10318810|NCT00217620|11453078|FG000|COMPLETED|Overall Study||0
10669839|NCT02321462|11832028|FG000|ITT Population|Overall Study||146
10669840|NCT02321462|11832029|FG001|ITT Population|Overall Study||148
10669841|NCT02321462|11832028|FG000|Treated Patients|Overall Study||147
10669842|NCT02321462|11832029|FG001|Treated Patients|Overall Study||147
10669843|NCT02321462|11832028|FG000|Safety Population|Overall Study||147
10669844|NCT02321462|11832029|FG001|Safety Population|Overall Study||147
10669845|NCT02321462|11832028|FG000|COMPLETED|Overall Study||141
10669846|NCT02321462|11832029|FG001|COMPLETED|Overall Study||146
10669847|NCT02321462|11832028|FG000|NOT COMPLETED|Overall Study||6
10669848|NCT02321462|11832029|FG001|NOT COMPLETED|Overall Study||3
10669849|NCT02321527|11832036|FG000|STARTED|Overall Study||21
10669850|NCT02321527|11832036|FG000|COMPLETED|Overall Study||20
10669851|NCT02321527|11832036|FG000|NOT COMPLETED|Overall Study||1
10669852|NCT02321748|11832042|FG000|STARTED|Overall Study||12
10669853|NCT02321748|11832043|FG001|STARTED|Overall Study||12
10669854|NCT02321748|11832042|FG000|First Intervention (4 Days)|Overall Study||12
10669855|NCT02321748|11832043|FG001|First Intervention (4 Days)|Overall Study||12
10669856|NCT02321748|11832042|FG000|Wasout (2weeks)|Overall Study||12
10669857|NCT02321748|11832043|FG001|Wasout (2weeks)|Overall Study||12
10669858|NCT02321748|11832042|FG000|Second Intervention (4 Days)|Overall Study||12
10669859|NCT02321748|11832043|FG001|Second Intervention (4 Days)|Overall Study||12
10669860|NCT02321748|11832042|FG000|COMPLETED|Overall Study||12
10669861|NCT02321748|11832043|FG001|COMPLETED|Overall Study||12
10669862|NCT02321748|11832042|FG000|NOT COMPLETED|Overall Study||0
10669863|NCT02321748|11832043|FG001|NOT COMPLETED|Overall Study||0
10669864|NCT02321800|11832054|FG000|STARTED|Overall Study||303
10669865|NCT02321800|11832055|FG001|STARTED|Overall Study||149
10669866|NCT02321800|11832054|FG000|Received Study Drug|Overall Study||300
10669867|NCT02321800|11832055|FG001|Received Study Drug|Overall Study||148
10669868|NCT02321800|11832054|FG000|COMPLETED|Overall Study||283
10669869|NCT02321800|11832055|FG001|COMPLETED|Overall Study||138
10669870|NCT02321800|11832054|FG000|NOT COMPLETED|Overall Study||20
10669871|NCT02321800|11832055|FG001|NOT COMPLETED|Overall Study||11
10669872|NCT02321930|11832061|FG000|STARTED|Overall Study||25
10669873|NCT02321930|11832061|FG000|COMPLETED|Overall Study||24
10669874|NCT02321930|11832061|FG000|NOT COMPLETED|Overall Study||1
10669875|NCT02322021|11832069|FG000|STARTED|Core Phase||17
10669876|NCT02322021|11832070|FG001|STARTED|Core Phase||17
10669877|NCT02322021|11832071|FG002|STARTED|Core Phase||19
10669878|NCT02322021|11832072|FG003|STARTED|Core Phase||17
10669879|NCT02322021|11832073|FG004|STARTED|Core Phase||0
10669880|NCT02322021|11832069|FG000|COMPLETED|Core Phase||12
10669881|NCT02322021|11832070|FG001|COMPLETED|Core Phase||9
10669882|NCT02322021|11832071|FG002|COMPLETED|Core Phase||10
10669883|NCT02322021|11832072|FG003|COMPLETED|Core Phase||12
10669884|NCT02322021|11832073|FG004|COMPLETED|Core Phase||0
10669885|NCT02322021|11832069|FG000|NOT COMPLETED|Core Phase||5
10669886|NCT02322021|11832070|FG001|NOT COMPLETED|Core Phase||8
10669887|NCT02322021|11832071|FG002|NOT COMPLETED|Core Phase||9
10669888|NCT02322021|11832072|FG003|NOT COMPLETED|Core Phase||5
10669889|NCT02322021|11832073|FG004|NOT COMPLETED|Core Phase||0
10669890|NCT02322021|11832069|FG000|STARTED|Extension Phase||0
10669891|NCT02322021|11832070|FG001|STARTED|Extension Phase||0
10669892|NCT02322021|11832071|FG002|STARTED|Extension Phase||0
10669893|NCT02322021|11832072|FG003|STARTED|Extension Phase||0
10669894|NCT02322021|11832073|FG004|STARTED|Extension Phase|Participants who completed Core Phase, were eligible and gave consent, entered Extension Phase.|41
10669895|NCT02322021|11832069|FG000|COMPLETED|Extension Phase||0
10669896|NCT02322021|11832070|FG001|COMPLETED|Extension Phase||0
10669897|NCT02322021|11832071|FG002|COMPLETED|Extension Phase||0
10669898|NCT02322021|11832072|FG003|COMPLETED|Extension Phase||0
10669899|NCT02322021|11832073|FG004|COMPLETED|Extension Phase||0
10669900|NCT02322021|11832069|FG000|NOT COMPLETED|Extension Phase||0
10669901|NCT02322021|11832070|FG001|NOT COMPLETED|Extension Phase||0
10669902|NCT02322021|11832071|FG002|NOT COMPLETED|Extension Phase||0
10669903|NCT02322021|11832072|FG003|NOT COMPLETED|Extension Phase||0
10669904|NCT02322021|11832073|FG004|NOT COMPLETED|Extension Phase||41
10669905|NCT02322047|11832092|FG000|STARTED|Overall Study||8
10669906|NCT02322047|11832093|FG001|STARTED|Overall Study||7
10669907|NCT02322047|11832094|FG002|STARTED|Overall Study||7
10669908|NCT02322047|11832095|FG003|STARTED|Overall Study||9
10669909|NCT02322047|11832092|FG000|COMPLETED|Overall Study||6
10669910|NCT02322047|11832093|FG001|COMPLETED|Overall Study||6
10669911|NCT02322047|11832094|FG002|COMPLETED|Overall Study||6
10669912|NCT02322047|11832095|FG003|COMPLETED|Overall Study||7
10669913|NCT02322047|11832092|FG000|NOT COMPLETED|Overall Study||2
10669914|NCT02322047|11832093|FG001|NOT COMPLETED|Overall Study||1
10669915|NCT02322047|11832094|FG002|NOT COMPLETED|Overall Study||1
10669916|NCT02322047|11832095|FG003|NOT COMPLETED|Overall Study||2
10669917|NCT02322125|11832105|FG000|STARTED|Overall Study||12
10669918|NCT02322125|11832105|FG000|COMPLETED|Overall Study||10
10669919|NCT02322125|11832105|FG000|NOT COMPLETED|Overall Study||2
10712359|NCT02669784|11877982|FG000|STARTED|Overall Study||18
10712360|NCT02669784|11877983|FG001|STARTED|Overall Study||16
10712361|NCT02669784|11877982|FG000|COMPLETED|Overall Study||18
10712362|NCT02669784|11877983|FG001|COMPLETED|Overall Study||16
10712363|NCT02669784|11877982|FG000|NOT COMPLETED|Overall Study||0
10712364|NCT02669784|11877983|FG001|NOT COMPLETED|Overall Study||0
10712365|NCT02669849|11877992|FG000|STARTED|Overall Study||29
10712366|NCT02669849|11877993|FG001|STARTED|Overall Study||6
10712367|NCT02669849|11877994|FG002|STARTED|Overall Study||32
10712368|NCT02669849|11877992|FG000|COMPLETED|Overall Study||11
10712369|NCT02669849|11877993|FG001|COMPLETED|Overall Study||4
10669920|NCT02322190|11832109|FG000|STARTED|Overall Study||5
10669921|NCT02322190|11832110|FG001|STARTED|Overall Study||0
10669922|NCT02322190|11832109|FG000|COMPLETED|Overall Study||4
10669923|NCT02322190|11832110|FG001|COMPLETED|Overall Study||0
10669924|NCT02322190|11832109|FG000|NOT COMPLETED|Overall Study||1
10669925|NCT02322190|11832110|FG001|NOT COMPLETED|Overall Study||0
10669926|NCT02322216|11832117|FG000|STARTED|Overall Study||126
10669927|NCT02322216|11832118|FG001|STARTED|Overall Study||127
10669928|NCT02322216|11832117|FG000|Treated (Safety Set)|Overall Study||126
10669929|NCT02322216|11832118|FG001|Treated (Safety Set)|Overall Study||126
10669930|NCT02322216|11832117|FG000|Per Protocol Set (PPS)|Overall Study||123
10669931|NCT02322216|11832118|FG001|Per Protocol Set (PPS)|Overall Study||122
10669932|NCT02322216|11832117|FG000|COMPLETED|Overall Study||124
10669933|NCT02322216|11832118|FG001|COMPLETED|Overall Study||123
10669934|NCT02322216|11832117|FG000|NOT COMPLETED|Overall Study||2
10669935|NCT02322216|11832118|FG001|NOT COMPLETED|Overall Study||4
10669936|NCT02322229|11832125|FG000|STARTED|Overall Study||52
10669937|NCT02322229|11832125|FG000|COMPLETED|Overall Study||50
10669938|NCT02322229|11832125|FG000|NOT COMPLETED|Overall Study||2
10669939|NCT02322242|11832132|FG000|STARTED|Overall Study||92
10669940|NCT02322242|11832133|FG001|STARTED|Overall Study||90
10669941|NCT02322242|11832132|FG000|Primary Outcome|Overall Study||92
10669942|NCT02322242|11832133|FG001|Primary Outcome|Overall Study||90
10669943|NCT02322242|11832132|FG000|1 Week Follow-up|Overall Study|2 lost to follow-up for secondary outcomes|90
10669944|NCT02322242|11832133|FG001|1 Week Follow-up|Overall Study|1 lost to follow-up for secondary outcomes|89
10669945|NCT02322242|11832132|FG000|COMPLETED|Overall Study||92
10669946|NCT02322242|11832133|FG001|COMPLETED|Overall Study||90
10669947|NCT02322242|11832132|FG000|NOT COMPLETED|Overall Study||0
10669948|NCT02322242|11832133|FG001|NOT COMPLETED|Overall Study||0
10669949|NCT02322281|11832142|FG000|STARTED|Overall Study||53
10669950|NCT02322281|11832143|FG001|STARTED|Overall Study||22
10669951|NCT02322281|11832144|FG002|STARTED|Overall Study||74
10669952|NCT02322281|11832142|FG000|Crossed Over to Rociletinib 500 mg BID|Overall Study||0
10669953|NCT02322281|11832143|FG001|Crossed Over to Rociletinib 500 mg BID|Overall Study||0
10669954|NCT02322281|11832144|FG002|Crossed Over to Rociletinib 500 mg BID|Overall Study||36
10669955|NCT02322281|11832142|FG000|Crossed Over to Rociletinib 625 mg BID|Overall Study||0
10669956|NCT02322281|11832143|FG001|Crossed Over to Rociletinib 625 mg BID|Overall Study||0
10669957|NCT02322281|11832144|FG002|Crossed Over to Rociletinib 625 mg BID|Overall Study||3
10669958|NCT02322281|11832142|FG000|COMPLETED|Overall Study|Patients who are off study for any reason.|0
10669959|NCT02322281|11832143|FG001|COMPLETED|Overall Study|Patients who are off study for any reason.|0
10669960|NCT02322281|11832144|FG002|COMPLETED|Overall Study|Patients who are off study for any reason.|0
10669961|NCT02322281|11832142|FG000|NOT COMPLETED|Overall Study||53
10669962|NCT02322281|11832143|FG001|NOT COMPLETED|Overall Study||22
10669963|NCT02322281|11832144|FG002|NOT COMPLETED|Overall Study||74
10669964|NCT02322320|11832157|FG000|STARTED|Overall Study||98
10669965|NCT02322320|11832158|FG001|STARTED|Overall Study||86
10669966|NCT02322320|11832159|FG002|STARTED|Overall Study||89
10669967|NCT02322320|11832157|FG000|COMPLETED|Overall Study||98
10669968|NCT02322320|11832158|FG001|COMPLETED|Overall Study||86
10669969|NCT02322320|11832159|FG002|COMPLETED|Overall Study||89
10669970|NCT02322320|11832157|FG000|NOT COMPLETED|Overall Study||0
10669971|NCT02322320|11832158|FG001|NOT COMPLETED|Overall Study||0
10669972|NCT02322320|11832159|FG002|NOT COMPLETED|Overall Study||0
10669973|NCT02322333|11832169|FG000|STARTED|Overall Study||80
10669974|NCT02322333|11832170|FG001|STARTED|Overall Study||77
10669975|NCT02322333|11832169|FG000|COMPLETED|Overall Study||63
10669976|NCT02322333|11832170|FG001|COMPLETED|Overall Study||61
10669977|NCT02322333|11832169|FG000|NOT COMPLETED|Overall Study||17
10669978|NCT02322333|11832170|FG001|NOT COMPLETED|Overall Study||16
10669979|NCT02322411|11832178|FG000|STARTED|Overall Study||14
10669980|NCT02322411|11832179|FG001|STARTED|Overall Study||16
10669981|NCT02322411|11832178|FG000|Randomized|Overall Study||14
10669982|NCT02322411|11832179|FG001|Randomized|Overall Study||16
10669983|NCT02322411|11832178|FG000|All Baseline Measures Analyzed|Overall Study||13
10669984|NCT02322411|11832179|FG001|All Baseline Measures Analyzed|Overall Study||16
10669985|NCT02322411|11832178|FG000|COMPLETED|Overall Study||9
10669986|NCT02322411|11832179|FG001|COMPLETED|Overall Study||9
10669987|NCT02322411|11832178|FG000|NOT COMPLETED|Overall Study||5
10669988|NCT02322411|11832179|FG001|NOT COMPLETED|Overall Study||7
10669989|NCT02322528|11832185|FG000|STARTED|Overall Study||10
10669990|NCT02322528|11832185|FG000|COMPLETED|Overall Study||10
10669991|NCT02322528|11832185|FG000|NOT COMPLETED|Overall Study||0
10669992|NCT02322749|11832189|FG000|STARTED|Period 1||8
10669993|NCT02322749|11832190|FG001|STARTED|Period 1||8
10669994|NCT02322749|11832191|FG002|STARTED|Period 1||8
10669995|NCT02322749|11832192|FG003|STARTED|Period 1||8
10669996|NCT02322749|11832193|FG004|STARTED|Period 1||8
10669997|NCT02322749|11832194|FG005|STARTED|Period 1||8
10669998|NCT02322749|11832189|FG000|COMPLETED|Period 1||8
10669999|NCT02322749|11832190|FG001|COMPLETED|Period 1||8
10670000|NCT02322749|11832191|FG002|COMPLETED|Period 1||8
10670001|NCT02322749|11832192|FG003|COMPLETED|Period 1||8
10670002|NCT02322749|11832193|FG004|COMPLETED|Period 1||8
10670003|NCT02322749|11832194|FG005|COMPLETED|Period 1||8
10670004|NCT02322749|11832189|FG000|NOT COMPLETED|Period 1||0
10670005|NCT02322749|11832190|FG001|NOT COMPLETED|Period 1||0
10670006|NCT02322749|11832191|FG002|NOT COMPLETED|Period 1||0
10670007|NCT02322749|11832192|FG003|NOT COMPLETED|Period 1||0
10670008|NCT02322749|11832193|FG004|NOT COMPLETED|Period 1||0
10670009|NCT02322749|11832194|FG005|NOT COMPLETED|Period 1||0
10670010|NCT02322749|11832189|FG000|STARTED|Period 2||8
10670011|NCT02322749|11832190|FG001|STARTED|Period 2||8
10670012|NCT02322749|11832191|FG002|STARTED|Period 2||8
10670013|NCT02322749|11832192|FG003|STARTED|Period 2||8
10670014|NCT02322749|11832193|FG004|STARTED|Period 2||8
10670015|NCT02322749|11832194|FG005|STARTED|Period 2||8
10670016|NCT02322749|11832189|FG000|COMPLETED|Period 2||8
10670017|NCT02322749|11832190|FG001|COMPLETED|Period 2||8
10670018|NCT02322749|11832191|FG002|COMPLETED|Period 2||8
10670019|NCT02322749|11832192|FG003|COMPLETED|Period 2||6
10670020|NCT02322749|11832193|FG004|COMPLETED|Period 2||8
10670021|NCT02322749|11832194|FG005|COMPLETED|Period 2||8
10670022|NCT02322749|11832189|FG000|NOT COMPLETED|Period 2||0
10670023|NCT02322749|11832190|FG001|NOT COMPLETED|Period 2||0
10670024|NCT02322749|11832191|FG002|NOT COMPLETED|Period 2||0
10670025|NCT02322749|11832192|FG003|NOT COMPLETED|Period 2||2
10670026|NCT02322749|11832193|FG004|NOT COMPLETED|Period 2||0
10670027|NCT02322749|11832194|FG005|NOT COMPLETED|Period 2||0
10670028|NCT02322749|11832189|FG000|STARTED|Period 3||8
10670029|NCT02322749|11832190|FG001|STARTED|Period 3||8
10670030|NCT02322749|11832191|FG002|STARTED|Period 3||8
10670031|NCT02322749|11832192|FG003|STARTED|Period 3||6
10670032|NCT02322749|11832193|FG004|STARTED|Period 3||8
10670033|NCT02322749|11832194|FG005|STARTED|Period 3||8
10670034|NCT02322749|11832189|FG000|COMPLETED|Period 3||8
10670035|NCT02322749|11832190|FG001|COMPLETED|Period 3||8
10670036|NCT02322749|11832191|FG002|COMPLETED|Period 3||7
10670037|NCT02322749|11832192|FG003|COMPLETED|Period 3||6
10670038|NCT02322749|11832193|FG004|COMPLETED|Period 3||8
10670039|NCT02322749|11832194|FG005|COMPLETED|Period 3||8
10670040|NCT02322749|11832189|FG000|NOT COMPLETED|Period 3||0
10670041|NCT02322749|11832190|FG001|NOT COMPLETED|Period 3||0
10670042|NCT02322749|11832191|FG002|NOT COMPLETED|Period 3||1
10670043|NCT02322749|11832192|FG003|NOT COMPLETED|Period 3||0
10670044|NCT02322749|11832193|FG004|NOT COMPLETED|Period 3||0
10670045|NCT02322749|11832194|FG005|NOT COMPLETED|Period 3||0
10670046|NCT02322775|11832205|FG000|STARTED|Overall Study||106
10670047|NCT02322775|11832206|FG001|STARTED|Overall Study||105
10670048|NCT02322775|11832205|FG000|COMPLETED|Overall Study||101
10670049|NCT02322775|11832206|FG001|COMPLETED|Overall Study||99
10670050|NCT02322775|11832205|FG000|NOT COMPLETED|Overall Study||5
10670051|NCT02322775|11832206|FG001|NOT COMPLETED|Overall Study||6
10670052|NCT02322788|11832212|FG000|STARTED|Visit 3||15
10670053|NCT02322788|11832213|FG001|STARTED|Visit 3||15
10670054|NCT02322788|11832214|FG002|STARTED|Visit 3||14
10670055|NCT02322788|11832215|FG003|STARTED|Visit 3||16
10670056|NCT02322788|11832212|FG000|COMPLETED|Visit 3||15
10670057|NCT02322788|11832213|FG001|COMPLETED|Visit 3||15
10670058|NCT02322788|11832214|FG002|COMPLETED|Visit 3||14
10670059|NCT02322788|11832215|FG003|COMPLETED|Visit 3||16
10670060|NCT02322788|11832212|FG000|NOT COMPLETED|Visit 3||0
10670061|NCT02322788|11832213|FG001|NOT COMPLETED|Visit 3||0
10670062|NCT02322788|11832214|FG002|NOT COMPLETED|Visit 3||0
10670063|NCT02322788|11832215|FG003|NOT COMPLETED|Visit 3||0
10670064|NCT02322788|11832212|FG000|STARTED|Visit 4||15
10670065|NCT02322788|11832213|FG001|STARTED|Visit 4||14
10670066|NCT02322788|11832214|FG002|STARTED|Visit 4||16
10670067|NCT02322788|11832215|FG003|STARTED|Visit 4||15
10670068|NCT02322788|11832212|FG000|COMPLETED|Visit 4||15
10670069|NCT02322788|11832213|FG001|COMPLETED|Visit 4||14
10670070|NCT02322788|11832214|FG002|COMPLETED|Visit 4||16
10670071|NCT02322788|11832215|FG003|COMPLETED|Visit 4||15
10670072|NCT02322788|11832212|FG000|NOT COMPLETED|Visit 4||0
10670073|NCT02322788|11832213|FG001|NOT COMPLETED|Visit 4||0
10670074|NCT02322788|11832214|FG002|NOT COMPLETED|Visit 4||0
10670075|NCT02322788|11832215|FG003|NOT COMPLETED|Visit 4||0
10670076|NCT02322788|11832212|FG000|STARTED|Visit 5||16
10670077|NCT02322788|11832213|FG001|STARTED|Visit 5||15
10670078|NCT02322788|11832214|FG002|STARTED|Visit 5||15
10670079|NCT02322788|11832215|FG003|STARTED|Visit 5||14
10670080|NCT02322788|11832212|FG000|COMPLETED|Visit 5||16
10670081|NCT02322788|11832213|FG001|COMPLETED|Visit 5||15
10670082|NCT02322788|11832214|FG002|COMPLETED|Visit 5||15
10670083|NCT02322788|11832215|FG003|COMPLETED|Visit 5||14
10670084|NCT02322788|11832212|FG000|NOT COMPLETED|Visit 5||0
10670085|NCT02322788|11832213|FG001|NOT COMPLETED|Visit 5||0
10670086|NCT02322788|11832214|FG002|NOT COMPLETED|Visit 5||0
10670087|NCT02322788|11832215|FG003|NOT COMPLETED|Visit 5||0
10670088|NCT02322788|11832212|FG000|STARTED|Visit 6||14
10670089|NCT02322788|11832213|FG001|STARTED|Visit 6||16
10670090|NCT02322788|11832214|FG002|STARTED|Visit 6||15
10670091|NCT02322788|11832215|FG003|STARTED|Visit 6||15
10670092|NCT02322788|11832212|FG000|COMPLETED|Visit 6||14
10670093|NCT02322788|11832213|FG001|COMPLETED|Visit 6||16
10670094|NCT02322788|11832214|FG002|COMPLETED|Visit 6||15
10670095|NCT02322788|11832215|FG003|COMPLETED|Visit 6||15
10670096|NCT02322788|11832212|FG000|NOT COMPLETED|Visit 6||0
10670097|NCT02322788|11832213|FG001|NOT COMPLETED|Visit 6||0
10670098|NCT02322788|11832214|FG002|NOT COMPLETED|Visit 6||0
10670099|NCT02322788|11832215|FG003|NOT COMPLETED|Visit 6||0
10670100|NCT02322814|11832230|FG000|STARTED|Overall Study||16
10670101|NCT02322814|11832231|FG001|STARTED|Overall Study||43
10670102|NCT02322814|11832232|FG002|STARTED|Overall Study||47
10670103|NCT02322814|11832233|FG003|STARTED|Overall Study||32
10670104|NCT02322814|11832234|FG004|STARTED|Overall Study||31
10670105|NCT02322814|11832230|FG000|COMPLETED|Overall Study||0
10670106|NCT02322814|11832231|FG001|COMPLETED|Overall Study||0
10670107|NCT02322814|11832232|FG002|COMPLETED|Overall Study||0
10670108|NCT02322814|11832233|FG003|COMPLETED|Overall Study||0
10670109|NCT02322814|11832234|FG004|COMPLETED|Overall Study||0
10670110|NCT02322814|11832230|FG000|NOT COMPLETED|Overall Study||16
10670111|NCT02322814|11832231|FG001|NOT COMPLETED|Overall Study||43
10670112|NCT02322814|11832232|FG002|NOT COMPLETED|Overall Study||47
10670113|NCT02322814|11832233|FG003|NOT COMPLETED|Overall Study||32
10670114|NCT02322814|11832234|FG004|NOT COMPLETED|Overall Study||31
10670115|NCT02322866|11832247|FG000|STARTED|Overall Study||515
10670116|NCT02322866|11832248|FG001|STARTED|Overall Study||519
10670117|NCT02322866|11832247|FG000|COMPLETED|Overall Study||444
10670118|NCT02322866|11832248|FG001|COMPLETED|Overall Study||433
10670119|NCT02322866|11832247|FG000|NOT COMPLETED|Overall Study||71
10670120|NCT02322866|11832248|FG001|NOT COMPLETED|Overall Study||86
10670121|NCT02322879|11832256|FG000|STARTED|First Intervention||11
10670122|NCT02322879|11832257|FG001|STARTED|First Intervention||10
10670123|NCT02322879|11832256|FG000|COMPLETED|First Intervention||10
10670124|NCT02322879|11832257|FG001|COMPLETED|First Intervention||10
10670125|NCT02322879|11832256|FG000|NOT COMPLETED|First Intervention||1
10670126|NCT02322879|11832257|FG001|NOT COMPLETED|First Intervention||0
10670127|NCT02322879|11832256|FG000|STARTED|Washout||10
10670128|NCT02322879|11832257|FG001|STARTED|Washout||10
10670129|NCT02322879|11832256|FG000|COMPLETED|Washout||10
10670130|NCT02322879|11832257|FG001|COMPLETED|Washout||10
10670131|NCT02322879|11832256|FG000|NOT COMPLETED|Washout||0
10670132|NCT02322879|11832257|FG001|NOT COMPLETED|Washout||0
10670133|NCT02322879|11832256|FG000|STARTED|Second Intervention||10
10670134|NCT02322879|11832257|FG001|STARTED|Second Intervention||10
10670135|NCT02322879|11832256|FG000|COMPLETED|Second Intervention||10
10670136|NCT02322879|11832257|FG001|COMPLETED|Second Intervention||10
10670137|NCT02322879|11832256|FG000|NOT COMPLETED|Second Intervention||0
10670138|NCT02322879|11832257|FG001|NOT COMPLETED|Second Intervention||0
10670139|NCT02322892|11832265|FG000|STARTED|Overall Study|Number randomized|35
10670140|NCT02322892|11832266|FG001|STARTED|Overall Study|Number randomized|34
10670141|NCT02322892|11832265|FG000|COMPLETED|Overall Study|Received placebo|33
10670142|NCT02322892|11832266|FG001|COMPLETED|Overall Study|Received thiamine|31
10670143|NCT02322892|11832265|FG000|NOT COMPLETED|Overall Study||2
10670144|NCT02322892|11832266|FG001|NOT COMPLETED|Overall Study||3
10670145|NCT02323048|11832277|FG000|STARTED|Overall Study||25
10670146|NCT02323048|11832278|FG001|STARTED|Overall Study||26
10670147|NCT02323048|11832279|FG002|STARTED|Overall Study||23
10670148|NCT02323048|11832280|FG003|STARTED|Overall Study||7
10670149|NCT02323048|11832281|FG004|STARTED|Overall Study||9
10670150|NCT02323048|11832277|FG000|COMPLETED|Overall Study||24
10670151|NCT02323048|11832278|FG001|COMPLETED|Overall Study||24
10670152|NCT02323048|11832279|FG002|COMPLETED|Overall Study||23
10670153|NCT02323048|11832280|FG003|COMPLETED|Overall Study||7
10670154|NCT02323048|11832281|FG004|COMPLETED|Overall Study||9
10670155|NCT02323048|11832277|FG000|NOT COMPLETED|Overall Study||1
10670156|NCT02323048|11832278|FG001|NOT COMPLETED|Overall Study||2
10670157|NCT02323048|11832279|FG002|NOT COMPLETED|Overall Study||0
10670158|NCT02323048|11832280|FG003|NOT COMPLETED|Overall Study||0
10796408|NCT03663231|11956732|FG001|NOT COMPLETED|First Intervention||1
10796409|NCT03663231|11956731|FG000|STARTED|Washout||14
10796410|NCT03663231|11956732|FG001|STARTED|Washout||12
10796411|NCT03663231|11956731|FG000|COMPLETED|Washout||14
10796412|NCT03663231|11956732|FG001|COMPLETED|Washout||12
10796413|NCT03663231|11956731|FG000|NOT COMPLETED|Washout||0
10796414|NCT03663231|11956732|FG001|NOT COMPLETED|Washout||0
10796415|NCT03663231|11956731|FG000|STARTED|Second Intervention||14
10796416|NCT03663231|11956732|FG001|STARTED|Second Intervention||12
10796417|NCT03663231|11956731|FG000|COMPLETED|Second Intervention||14
10796418|NCT03663231|11956732|FG001|COMPLETED|Second Intervention||12
10796419|NCT03663231|11956731|FG000|NOT COMPLETED|Second Intervention||0
10796420|NCT03663231|11956732|FG001|NOT COMPLETED|Second Intervention||0
10796421|NCT03663283|11956740|FG000|STARTED|Overall Study||52
10796422|NCT03663283|11956741|FG001|STARTED|Overall Study||52
10796423|NCT03663283|11956740|FG000|COMPLETED|Overall Study||52
10796424|NCT03663283|11956741|FG001|COMPLETED|Overall Study||52
10796425|NCT03663283|11956740|FG000|NOT COMPLETED|Overall Study||0
10670159|NCT02323048|11832281|FG004|NOT COMPLETED|Overall Study||0
10670160|NCT02323113|11832300|FG000|STARTED|Overall Study||4
10670161|NCT02323113|11832301|FG001|STARTED|Overall Study||7
10670162|NCT02323113|11832302|FG002|STARTED|Overall Study||4
10670163|NCT02323113|11832303|FG003|STARTED|Overall Study||5
10670164|NCT02323113|11832304|FG004|STARTED|Overall Study||9
10670165|NCT02323113|11832305|FG005|STARTED|Overall Study||8
10670166|NCT02323113|11832306|FG006|STARTED|Overall Study||6
10670167|NCT02323113|11832307|FG007|STARTED|Overall Study||0
10670168|NCT02323113|11832300|FG000|COMPLETED|Overall Study||0
10796426|NCT03663283|11956741|FG001|NOT COMPLETED|Overall Study||0
10796427|NCT03663569|11956747|FG000|STARTED|Overall Study||4819
10796428|NCT03663569|11956747|FG000|COMPLETED|Overall Study||4756
10796429|NCT03663569|11956747|FG000|NOT COMPLETED|Overall Study||63
10796430|NCT03663582|11956751|FG000|STARTED|Overall Study||7
10796431|NCT03663582|11956751|FG000|COMPLETED|Overall Study||6
10796432|NCT03663582|11956751|FG000|NOT COMPLETED|Overall Study||1
10796433|NCT03663816|11956755|FG000|STARTED|Overall Study||15
10670169|NCT02323113|11832301|FG001|COMPLETED|Overall Study||0
10670170|NCT02323113|11832302|FG002|COMPLETED|Overall Study||0
10670171|NCT02323113|11832303|FG003|COMPLETED|Overall Study||0
10796434|NCT03663816|11956755|FG000|COMPLETED|Overall Study||15
10796435|NCT03663816|11956755|FG000|NOT COMPLETED|Overall Study||0
10796436|NCT03664193|11956759|FG000|STARTED|Overall Study||30
10796437|NCT03664193|11956759|FG000|COMPLETED|Overall Study||30
10670172|NCT02323113|11832304|FG004|COMPLETED|Overall Study||0
10670173|NCT02323113|11832305|FG005|COMPLETED|Overall Study||0
10670174|NCT02323113|11832306|FG006|COMPLETED|Overall Study||0
10670175|NCT02323113|11832307|FG007|COMPLETED|Overall Study||0
10670176|NCT02323113|11832300|FG000|NOT COMPLETED|Overall Study||4
10670177|NCT02323113|11832301|FG001|NOT COMPLETED|Overall Study||7
10670178|NCT02323113|11832302|FG002|NOT COMPLETED|Overall Study||4
10670179|NCT02323113|11832303|FG003|NOT COMPLETED|Overall Study||5
10670180|NCT02323113|11832304|FG004|NOT COMPLETED|Overall Study||9
10670181|NCT02323113|11832305|FG005|NOT COMPLETED|Overall Study||8
10670182|NCT02323113|11832306|FG006|NOT COMPLETED|Overall Study||6
10670183|NCT02323113|11832307|FG007|NOT COMPLETED|Overall Study||0
10670184|NCT02323204|11832330|FG000|STARTED|Baseline Survey Completion||155
10318811|NCT00217620|11453078|FG000|NOT COMPLETED|Overall Study||51
10318812|NCT00217672|11453086|FG000|STARTED|Allocation||69
10338423|NCT00369629|11475278|FG000|NOT COMPLETED|Follow up for 1 Year||2
10670185|NCT02323204|11832331|FG001|STARTED|Baseline Survey Completion||155
10670186|NCT02323204|11832332|FG002|STARTED|Baseline Survey Completion||159
10670187|NCT02323204|11832333|FG003|STARTED|Baseline Survey Completion||159
10670188|NCT02323204|11832330|FG000|COMPLETED|Baseline Survey Completion||145
10670189|NCT02323204|11832331|FG001|COMPLETED|Baseline Survey Completion||146
10670190|NCT02323204|11832332|FG002|COMPLETED|Baseline Survey Completion||154
10670191|NCT02323204|11832333|FG003|COMPLETED|Baseline Survey Completion||156
10670192|NCT02323204|11832330|FG000|NOT COMPLETED|Baseline Survey Completion||10
10670193|NCT02323204|11832331|FG001|NOT COMPLETED|Baseline Survey Completion||9
10670194|NCT02323204|11832332|FG002|NOT COMPLETED|Baseline Survey Completion||5
10670195|NCT02323204|11832333|FG003|NOT COMPLETED|Baseline Survey Completion||3
10670196|NCT02323204|11832330|FG000|STARTED|6-week Follow-up Survey Completion||145
10670197|NCT02323204|11832331|FG001|STARTED|6-week Follow-up Survey Completion||146
10670198|NCT02323204|11832332|FG002|STARTED|6-week Follow-up Survey Completion||154
10670199|NCT02323204|11832333|FG003|STARTED|6-week Follow-up Survey Completion||156
10670200|NCT02323204|11832330|FG000|COMPLETED|6-week Follow-up Survey Completion||104
10670201|NCT02323204|11832331|FG001|COMPLETED|6-week Follow-up Survey Completion||110
10670202|NCT02323204|11832332|FG002|COMPLETED|6-week Follow-up Survey Completion||112
10670203|NCT02323204|11832333|FG003|COMPLETED|6-week Follow-up Survey Completion||119
10670204|NCT02323204|11832330|FG000|NOT COMPLETED|6-week Follow-up Survey Completion||41
10670205|NCT02323204|11832331|FG001|NOT COMPLETED|6-week Follow-up Survey Completion||36
10670206|NCT02323204|11832332|FG002|NOT COMPLETED|6-week Follow-up Survey Completion||42
10670207|NCT02323204|11832333|FG003|NOT COMPLETED|6-week Follow-up Survey Completion||37
10670208|NCT02323204|11832330|FG000|STARTED|6-week Follow-up Intervention Booster|Child participants did not receive intervention booster training.|0
10670209|NCT02323204|11832331|FG001|STARTED|6-week Follow-up Intervention Booster|Received intervention-specific booster training via phone between 6-weeks and 1 year post-enrollment|146
10670210|NCT02323204|11832332|FG002|STARTED|6-week Follow-up Intervention Booster|Child participants did not receive intervention booster training.|0
10670211|NCT02323204|11832333|FG003|STARTED|6-week Follow-up Intervention Booster|Received intervention-specific booster training via phone between 6-weeks and 1 year post-enrollment|156
10670212|NCT02323204|11832330|FG000|COMPLETED|6-week Follow-up Intervention Booster||0
10670213|NCT02323204|11832331|FG001|COMPLETED|6-week Follow-up Intervention Booster||103
10670214|NCT02323204|11832332|FG002|COMPLETED|6-week Follow-up Intervention Booster||0
10670215|NCT02323204|11832333|FG003|COMPLETED|6-week Follow-up Intervention Booster||120
10670216|NCT02323204|11832330|FG000|NOT COMPLETED|6-week Follow-up Intervention Booster||0
10670217|NCT02323204|11832331|FG001|NOT COMPLETED|6-week Follow-up Intervention Booster||43
10670218|NCT02323204|11832332|FG002|NOT COMPLETED|6-week Follow-up Intervention Booster||0
10670219|NCT02323204|11832333|FG003|NOT COMPLETED|6-week Follow-up Intervention Booster||36
10670220|NCT02323204|11832330|FG000|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|145
10670221|NCT02323204|11832331|FG001|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|146
10670222|NCT02323204|11832332|FG002|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|154
10670223|NCT02323204|11832333|FG003|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|156
10670224|NCT02323204|11832330|FG000|COMPLETED|3-month Follow-up Survey Completion||91
10670225|NCT02323204|11832331|FG001|COMPLETED|3-month Follow-up Survey Completion||99
10670226|NCT02323204|11832332|FG002|COMPLETED|3-month Follow-up Survey Completion||113
10670227|NCT02323204|11832333|FG003|COMPLETED|3-month Follow-up Survey Completion||112
10670228|NCT02323204|11832330|FG000|NOT COMPLETED|3-month Follow-up Survey Completion||54
10670229|NCT02323204|11832331|FG001|NOT COMPLETED|3-month Follow-up Survey Completion||47
10670230|NCT02323204|11832332|FG002|NOT COMPLETED|3-month Follow-up Survey Completion||41
10670231|NCT02323204|11832333|FG003|NOT COMPLETED|3-month Follow-up Survey Completion||44
10670232|NCT02323204|11832330|FG000|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|145
10670233|NCT02323204|11832331|FG001|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|146
10670234|NCT02323204|11832332|FG002|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|154
10670235|NCT02323204|11832333|FG003|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|156
10670236|NCT02323204|11832330|FG000|COMPLETED|6-month Follow-up Survey Completion||96
10670237|NCT02323204|11832331|FG001|COMPLETED|6-month Follow-up Survey Completion||96
10670238|NCT02323204|11832332|FG002|COMPLETED|6-month Follow-up Survey Completion||113
10670239|NCT02323204|11832333|FG003|COMPLETED|6-month Follow-up Survey Completion||112
10670240|NCT02323204|11832330|FG000|NOT COMPLETED|6-month Follow-up Survey Completion||49
10670241|NCT02323204|11832331|FG001|NOT COMPLETED|6-month Follow-up Survey Completion||50
10670242|NCT02323204|11832332|FG002|NOT COMPLETED|6-month Follow-up Survey Completion||41
10670243|NCT02323204|11832333|FG003|NOT COMPLETED|6-month Follow-up Survey Completion||44
10670244|NCT02323217|11832343|FG000|STARTED|Overall Study||18
10670245|NCT02323217|11832343|FG000|COMPLETED|Overall Study||18
10670246|NCT02323217|11832343|FG000|NOT COMPLETED|Overall Study||0
10670247|NCT02323334|11832357|FG000|STARTED|Period 1||4
10670248|NCT02323334|11832358|FG001|STARTED|Period 1||4
10670249|NCT02323334|11832359|FG002|STARTED|Period 1||4
10670250|NCT02323334|11832360|FG003|STARTED|Period 1||4
10670251|NCT02323334|11832361|FG004|STARTED|Period 1||4
10670252|NCT02323334|11832362|FG005|STARTED|Period 1||4
10670253|NCT02323334|11832363|FG006|STARTED|Period 1||6
10670254|NCT02323334|11832364|FG007|STARTED|Period 1||6
10670255|NCT02323334|11832365|FG008|STARTED|Period 1||5
10670256|NCT02323334|11832366|FG009|STARTED|Period 1||7
10670257|NCT02323334|11832367|FG010|STARTED|Period 1||5
10670258|NCT02323334|11832368|FG011|STARTED|Period 1||3
10670259|NCT02323334|11832369|FG012|STARTED|Period 1||9
10670260|NCT02323334|11832370|FG013|STARTED|Period 1||9
10670261|NCT02323334|11832371|FG014|STARTED|Period 1||9
10670262|NCT02323334|11832372|FG015|STARTED|Period 1||9
10670263|NCT02323334|11832373|FG016|STARTED|Period 1||2
10670264|NCT02323334|11832357|FG000|Received at Least One Dose of Study Drug|Period 1||4
10670265|NCT02323334|11832358|FG001|Received at Least One Dose of Study Drug|Period 1||4
10670266|NCT02323334|11832359|FG002|Received at Least One Dose of Study Drug|Period 1||4
10670267|NCT02323334|11832360|FG003|Received at Least One Dose of Study Drug|Period 1||4
10670268|NCT02323334|11832361|FG004|Received at Least One Dose of Study Drug|Period 1||4
10670269|NCT02323334|11832362|FG005|Received at Least One Dose of Study Drug|Period 1||4
10670270|NCT02323334|11832363|FG006|Received at Least One Dose of Study Drug|Period 1||6
10670271|NCT02323334|11832364|FG007|Received at Least One Dose of Study Drug|Period 1||6
10670272|NCT02323334|11832365|FG008|Received at Least One Dose of Study Drug|Period 1||5
10796438|NCT03664193|11956759|FG000|NOT COMPLETED|Overall Study||0
10796439|NCT03664544|11956765|FG000|STARTED|Overall Study||6
10796440|NCT03664544|11956766|FG001|STARTED|Overall Study||6
10796441|NCT03664544|11956765|FG000|COMPLETED|Overall Study||6
10796442|NCT03664544|11956766|FG001|COMPLETED|Overall Study||6
10796443|NCT03664544|11956765|FG000|NOT COMPLETED|Overall Study||0
10796444|NCT03664544|11956766|FG001|NOT COMPLETED|Overall Study||0
10796445|NCT03665155|11956775|FG000|STARTED|Overall Study||3
10796446|NCT03665155|11956776|FG001|STARTED|Overall Study||7
10796447|NCT03665155|11956777|FG002|STARTED|Overall Study||1
10796448|NCT03665155|11956775|FG000|COMPLETED|Overall Study||3
10796449|NCT03665155|11956776|FG001|COMPLETED|Overall Study||7
10796450|NCT03665155|11956777|FG002|COMPLETED|Overall Study||1
10796451|NCT03665155|11956775|FG000|NOT COMPLETED|Overall Study||0
10796452|NCT03665155|11956776|FG001|NOT COMPLETED|Overall Study||0
10796453|NCT03665155|11956777|FG002|NOT COMPLETED|Overall Study||0
10796454|NCT03666026|11956787|FG000|STARTED|Overall Study||41070
10796455|NCT03666026|11956788|FG001|STARTED|Overall Study||41055
10796456|NCT03666026|11956789|FG002|STARTED|Overall Study||41046
10796457|NCT03666026|11956790|FG003|STARTED|Overall Study||41034
10796458|NCT03666026|11956787|FG000|COMPLETED|Overall Study||41070
10796459|NCT03666026|11956788|FG001|COMPLETED|Overall Study||41055
10796460|NCT03666026|11956789|FG002|COMPLETED|Overall Study||41046
10796461|NCT03666026|11956790|FG003|COMPLETED|Overall Study||41034
10796462|NCT03666026|11956787|FG000|NOT COMPLETED|Overall Study||0
10796463|NCT03666026|11956788|FG001|NOT COMPLETED|Overall Study||0
10796464|NCT03666026|11956789|FG002|NOT COMPLETED|Overall Study||0
10796465|NCT03666026|11956790|FG003|NOT COMPLETED|Overall Study||0
10796466|NCT03666663|11956804|FG000|STARTED|Overall Study||3
10796467|NCT03666663|11956805|FG001|STARTED|Overall Study||1
10796468|NCT03666663|11956806|FG002|STARTED|Overall Study||3
10670273|NCT02323334|11832366|FG009|Received at Least One Dose of Study Drug|Period 1||7
10670274|NCT02323334|11832367|FG010|Received at Least One Dose of Study Drug|Period 1||5
10670275|NCT02323334|11832368|FG011|Received at Least One Dose of Study Drug|Period 1||3
10670276|NCT02323334|11832369|FG012|Received at Least One Dose of Study Drug|Period 1||9
10670277|NCT02323334|11832370|FG013|Received at Least One Dose of Study Drug|Period 1||9
10670278|NCT02323334|11832371|FG014|Received at Least One Dose of Study Drug|Period 1||9
10670279|NCT02323334|11832372|FG015|Received at Least One Dose of Study Drug|Period 1||9
10670280|NCT02323334|11832373|FG016|Received at Least One Dose of Study Drug|Period 1||2
10670281|NCT02323334|11832357|FG000|COMPLETED|Period 1||4
10670282|NCT02323334|11832358|FG001|COMPLETED|Period 1||4
10670283|NCT02323334|11832359|FG002|COMPLETED|Period 1||4
10670284|NCT02323334|11832360|FG003|COMPLETED|Period 1||4
10670285|NCT02323334|11832361|FG004|COMPLETED|Period 1||4
10670286|NCT02323334|11832362|FG005|COMPLETED|Period 1||4
10670287|NCT02323334|11832363|FG006|COMPLETED|Period 1||6
10670288|NCT02323334|11832364|FG007|COMPLETED|Period 1||6
10670289|NCT02323334|11832365|FG008|COMPLETED|Period 1||5
10670290|NCT02323334|11832366|FG009|COMPLETED|Period 1||7
10670291|NCT02323334|11832367|FG010|COMPLETED|Period 1||5
10670292|NCT02323334|11832368|FG011|COMPLETED|Period 1||3
10670293|NCT02323334|11832369|FG012|COMPLETED|Period 1||9
10670294|NCT02323334|11832370|FG013|COMPLETED|Period 1||9
10670295|NCT02323334|11832371|FG014|COMPLETED|Period 1||9
10670296|NCT02323334|11832372|FG015|COMPLETED|Period 1||9
10670297|NCT02323334|11832373|FG016|COMPLETED|Period 1||2
10670298|NCT02323334|11832357|FG000|NOT COMPLETED|Period 1||0
10670299|NCT02323334|11832358|FG001|NOT COMPLETED|Period 1||0
10670300|NCT02323334|11832359|FG002|NOT COMPLETED|Period 1||0
10670301|NCT02323334|11832360|FG003|NOT COMPLETED|Period 1||0
10670302|NCT02323334|11832361|FG004|NOT COMPLETED|Period 1||0
10670303|NCT02323334|11832362|FG005|NOT COMPLETED|Period 1||0
10670304|NCT02323334|11832363|FG006|NOT COMPLETED|Period 1||0
10670305|NCT02323334|11832364|FG007|NOT COMPLETED|Period 1||0
10670306|NCT02323334|11832365|FG008|NOT COMPLETED|Period 1||0
10455303|NCT01001221|11603334|FG004|Completed 1st Treatment Cycle|Overall Study||0
10670307|NCT02323334|11832366|FG009|NOT COMPLETED|Period 1||0
10670308|NCT02323334|11832367|FG010|NOT COMPLETED|Period 1||0
10670309|NCT02323334|11832368|FG011|NOT COMPLETED|Period 1||0
10670310|NCT02323334|11832369|FG012|NOT COMPLETED|Period 1||0
10670311|NCT02323334|11832370|FG013|NOT COMPLETED|Period 1||0
10670312|NCT02323334|11832371|FG014|NOT COMPLETED|Period 1||0
10670313|NCT02323334|11832372|FG015|NOT COMPLETED|Period 1||0
10670314|NCT02323334|11832373|FG016|NOT COMPLETED|Period 1||0
10670315|NCT02323334|11832357|FG000|STARTED|Period 2||4
10670316|NCT02323334|11832358|FG001|STARTED|Period 2||4
10670317|NCT02323334|11832359|FG002|STARTED|Period 2||4
10670318|NCT02323334|11832360|FG003|STARTED|Period 2||4
10670319|NCT02323334|11832361|FG004|STARTED|Period 2||4
10670320|NCT02323334|11832362|FG005|STARTED|Period 2||4
10670321|NCT02323334|11832363|FG006|STARTED|Period 2||6
10670322|NCT02323334|11832364|FG007|STARTED|Period 2||6
10670323|NCT02323334|11832365|FG008|STARTED|Period 2|Part B was a single period conducted in parallel to Part A and received last dose in Period 1.|0
10670324|NCT02323334|11832366|FG009|STARTED|Period 2|Part B was a single period conducted in parallel to Part A and received last dose in Period 1.|0
10670325|NCT02323334|11832367|FG010|STARTED|Period 2|Part B was a single period conducted in parallel to Part A and received last dose in Period 1.|0
10670326|NCT02323334|11832368|FG011|STARTED|Period 2|Part B was a single period conducted in parallel to Part A and received last dose in Period 1.|0
10670327|NCT02323334|11832369|FG012|STARTED|Period 2|Part C was a single period conducted in parallel to Part A and received last dose in Period 1.|0
10670328|NCT02323334|11832370|FG013|STARTED|Period 2|Part C was a single period conducted in parallel to Part A and received last dose in Period 1.|0
10670329|NCT02323334|11832371|FG014|STARTED|Period 2|Part C was a single period conducted in parallel to Part A and received last dose in Period 1.|0
10670330|NCT02323334|11832372|FG015|STARTED|Period 2|Part C was a single period conducted in parallel to Part A and received last dose in Period 1.|0
10670331|NCT02323334|11832373|FG016|STARTED|Period 2|Part D was a single period conducted in parallel to Part A and received last dose in Period 1.|0
10796469|NCT03666663|11956807|FG003|STARTED|Overall Study||3
10796470|NCT03666663|11956804|FG000|COMPLETED|Overall Study||3
10796471|NCT03666663|11956805|FG001|COMPLETED|Overall Study||1
10796472|NCT03666663|11956806|FG002|COMPLETED|Overall Study||1
10796473|NCT03666663|11956807|FG003|COMPLETED|Overall Study||1
10796474|NCT03666663|11956804|FG000|NOT COMPLETED|Overall Study||0
10796475|NCT03666663|11956805|FG001|NOT COMPLETED|Overall Study||0
10796476|NCT03666663|11956806|FG002|NOT COMPLETED|Overall Study||2
10796477|NCT03666663|11956807|FG003|NOT COMPLETED|Overall Study||2
10796478|NCT03666858|11956817|FG000|STARTED|Cohort 1|All participants with TTH who had reported at least one headache and Neosaldina intake.|216
10796479|NCT03666858|11956818|FG001|STARTED|Cohort 1||0
10796480|NCT03666858|11956817|FG000|COMPLETED|Cohort 1||215
10796481|NCT03666858|11956818|FG001|COMPLETED|Cohort 1||0
10796482|NCT03666858|11956817|FG000|NOT COMPLETED|Cohort 1||1
10796483|NCT03666858|11956818|FG001|NOT COMPLETED|Cohort 1||0
10796484|NCT03666858|11956817|FG000|STARTED|Cohort 2||0
10796485|NCT03666858|11956818|FG001|STARTED|Cohort 2|Cohort 1 participants with pain intensity at 0,120minutes after Neosaldina/0 pain before 120minutes.|138
10796486|NCT03666858|11956817|FG000|COMPLETED|Cohort 2||0
10796487|NCT03666858|11956818|FG001|COMPLETED|Cohort 2||137
10796488|NCT03666858|11956817|FG000|NOT COMPLETED|Cohort 2||0
10796489|NCT03666858|11956818|FG001|NOT COMPLETED|Cohort 2||1
10796490|NCT03667053|11956827|FG000|STARTED|Overall Study||21
10796491|NCT03667053|11956828|FG001|STARTED|Overall Study||11
10796492|NCT03667053|11956829|FG002|STARTED|Overall Study||10
10796493|NCT03667053|11956827|FG000|Randomized and Treated|Overall Study||20
10796494|NCT03667053|11956828|FG001|Randomized and Treated|Overall Study||11
10670332|NCT02323334|11832357|FG000|COMPLETED|Period 2||4
10670333|NCT02323334|11832358|FG001|COMPLETED|Period 2||4
10670334|NCT02323334|11832359|FG002|COMPLETED|Period 2||4
10670335|NCT02323334|11832360|FG003|COMPLETED|Period 2||4
10670336|NCT02323334|11832361|FG004|COMPLETED|Period 2||4
10670337|NCT02323334|11832362|FG005|COMPLETED|Period 2||4
10670338|NCT02323334|11832363|FG006|COMPLETED|Period 2||6
10670339|NCT02323334|11832364|FG007|COMPLETED|Period 2||6
10670340|NCT02323334|11832365|FG008|COMPLETED|Period 2||0
10670341|NCT02323334|11832366|FG009|COMPLETED|Period 2||0
10670342|NCT02323334|11832367|FG010|COMPLETED|Period 2||0
10670343|NCT02323334|11832368|FG011|COMPLETED|Period 2||0
10670344|NCT02323334|11832369|FG012|COMPLETED|Period 2||0
10670345|NCT02323334|11832370|FG013|COMPLETED|Period 2||0
10670346|NCT02323334|11832371|FG014|COMPLETED|Period 2||0
10670347|NCT02323334|11832372|FG015|COMPLETED|Period 2||0
10796495|NCT03667053|11956829|FG002|Randomized and Treated|Overall Study||10
10796496|NCT03667053|11956827|FG000|COMPLETED|Overall Study||20
10670348|NCT02323334|11832373|FG016|COMPLETED|Period 2||0
10796497|NCT03667053|11956828|FG001|COMPLETED|Overall Study||11
10796498|NCT03667053|11956829|FG002|COMPLETED|Overall Study||10
10670349|NCT02323334|11832357|FG000|NOT COMPLETED|Period 2||0
10670350|NCT02323334|11832358|FG001|NOT COMPLETED|Period 2||0
10670351|NCT02323334|11832359|FG002|NOT COMPLETED|Period 2||0
10670352|NCT02323334|11832360|FG003|NOT COMPLETED|Period 2||0
10670353|NCT02323334|11832361|FG004|NOT COMPLETED|Period 2||0
10670354|NCT02323334|11832362|FG005|NOT COMPLETED|Period 2||0
10670355|NCT02323334|11832363|FG006|NOT COMPLETED|Period 2||0
10670356|NCT02323334|11832364|FG007|NOT COMPLETED|Period 2||0
10670357|NCT02323334|11832365|FG008|NOT COMPLETED|Period 2||0
10670358|NCT02323334|11832366|FG009|NOT COMPLETED|Period 2||0
10670359|NCT02323334|11832367|FG010|NOT COMPLETED|Period 2||0
10670360|NCT02323334|11832368|FG011|NOT COMPLETED|Period 2||0
10670361|NCT02323334|11832369|FG012|NOT COMPLETED|Period 2||0
10670362|NCT02323334|11832370|FG013|NOT COMPLETED|Period 2||0
10670363|NCT02323334|11832371|FG014|NOT COMPLETED|Period 2||0
10670364|NCT02323334|11832372|FG015|NOT COMPLETED|Period 2||0
10670365|NCT02323334|11832373|FG016|NOT COMPLETED|Period 2||0
10670366|NCT02323334|11832357|FG000|STARTED|Period 3||4
10670367|NCT02323334|11832358|FG001|STARTED|Period 3||4
10670368|NCT02323334|11832359|FG002|STARTED|Period 3||4
10670369|NCT02323334|11832360|FG003|STARTED|Period 3||4
10670370|NCT02323334|11832361|FG004|STARTED|Period 3||4
10670371|NCT02323334|11832362|FG005|STARTED|Period 3||4
10670372|NCT02323334|11832363|FG006|STARTED|Period 3|Part A Cohort 3 Food Effect participated in Period 1 and Period 2 only.|0
10670373|NCT02323334|11832364|FG007|STARTED|Period 3|Part A Cohort 3 Food Effect participated in Period 1 and Period 2 only.|0
10670374|NCT02323334|11832365|FG008|STARTED|Period 3||0
10670375|NCT02323334|11832366|FG009|STARTED|Period 3||0
10670376|NCT02323334|11832367|FG010|STARTED|Period 3||0
10670377|NCT02323334|11832368|FG011|STARTED|Period 3||0
10670378|NCT02323334|11832369|FG012|STARTED|Period 3||0
10670379|NCT02323334|11832370|FG013|STARTED|Period 3||0
10670380|NCT02323334|11832371|FG014|STARTED|Period 3||0
10670381|NCT02323334|11832372|FG015|STARTED|Period 3||0
10670382|NCT02323334|11832373|FG016|STARTED|Period 3||0
10670383|NCT02323334|11832357|FG000|COMPLETED|Period 3||3
10670384|NCT02323334|11832358|FG001|COMPLETED|Period 3||4
10670385|NCT02323334|11832359|FG002|COMPLETED|Period 3||3
10670386|NCT02323334|11832360|FG003|COMPLETED|Period 3||4
10670387|NCT02323334|11832361|FG004|COMPLETED|Period 3||4
10670388|NCT02323334|11832362|FG005|COMPLETED|Period 3||4
10670389|NCT02323334|11832363|FG006|COMPLETED|Period 3||0
10670390|NCT02323334|11832364|FG007|COMPLETED|Period 3||0
10670391|NCT02323334|11832365|FG008|COMPLETED|Period 3||0
10670392|NCT02323334|11832366|FG009|COMPLETED|Period 3||0
10670393|NCT02323334|11832367|FG010|COMPLETED|Period 3||0
10670394|NCT02323334|11832368|FG011|COMPLETED|Period 3||0
10670395|NCT02323334|11832369|FG012|COMPLETED|Period 3||0
10670396|NCT02323334|11832370|FG013|COMPLETED|Period 3||0
10670397|NCT02323334|11832371|FG014|COMPLETED|Period 3||0
10670398|NCT02323334|11832372|FG015|COMPLETED|Period 3||0
10670399|NCT02323334|11832373|FG016|COMPLETED|Period 3||0
10670400|NCT02323334|11832357|FG000|NOT COMPLETED|Period 3||1
10670401|NCT02323334|11832358|FG001|NOT COMPLETED|Period 3||0
10670402|NCT02323334|11832359|FG002|NOT COMPLETED|Period 3||1
10670403|NCT02323334|11832360|FG003|NOT COMPLETED|Period 3||0
10670404|NCT02323334|11832361|FG004|NOT COMPLETED|Period 3||0
10670405|NCT02323334|11832362|FG005|NOT COMPLETED|Period 3||0
10670406|NCT02323334|11832363|FG006|NOT COMPLETED|Period 3||0
10670407|NCT02323334|11832364|FG007|NOT COMPLETED|Period 3||0
10670408|NCT02323334|11832365|FG008|NOT COMPLETED|Period 3||0
10670409|NCT02323334|11832366|FG009|NOT COMPLETED|Period 3||0
10670410|NCT02323334|11832367|FG010|NOT COMPLETED|Period 3||0
10670411|NCT02323334|11832368|FG011|NOT COMPLETED|Period 3||0
10670412|NCT02323334|11832369|FG012|NOT COMPLETED|Period 3||0
10670413|NCT02323334|11832370|FG013|NOT COMPLETED|Period 3||0
10670414|NCT02323334|11832371|FG014|NOT COMPLETED|Period 3||0
10670415|NCT02323334|11832372|FG015|NOT COMPLETED|Period 3||0
10670416|NCT02323334|11832373|FG016|NOT COMPLETED|Period 3||0
10796499|NCT03667053|11956827|FG000|NOT COMPLETED|Overall Study||1
10796500|NCT03667053|11956828|FG001|NOT COMPLETED|Overall Study||0
10796501|NCT03667053|11956829|FG002|NOT COMPLETED|Overall Study||0
10796502|NCT03667547|11956844|FG000|STARTED|Overall Study||12
10796503|NCT03667547|11956844|FG000|COMPLETED|Overall Study||12
10796504|NCT03667547|11956844|FG000|NOT COMPLETED|Overall Study||0
10796505|NCT03668600|11956848|FG000|STARTED|Overall Study||230
10670417|NCT02323334|11832357|FG000|STARTED|Period 4||3
10670418|NCT02323334|11832358|FG001|STARTED|Period 4||4
10670419|NCT02323334|11832359|FG002|STARTED|Period 4||3
10670420|NCT02323334|11832360|FG003|STARTED|Period 4||4
10670421|NCT02323334|11832361|FG004|STARTED|Period 4||4
10670422|NCT02323334|11832362|FG005|STARTED|Period 4||4
10670423|NCT02323334|11832363|FG006|STARTED|Period 4||0
10670424|NCT02323334|11832364|FG007|STARTED|Period 4||0
10670425|NCT02323334|11832365|FG008|STARTED|Period 4||0
10796506|NCT03668600|11956848|FG000|COMPLETED|Overall Study||0
10796507|NCT03668600|11956848|FG000|NOT COMPLETED|Overall Study||230
10670426|NCT02323334|11832366|FG009|STARTED|Period 4||0
10670427|NCT02323334|11832367|FG010|STARTED|Period 4||0
10670428|NCT02323334|11832368|FG011|STARTED|Period 4||0
10670429|NCT02323334|11832369|FG012|STARTED|Period 4||0
10670430|NCT02323334|11832370|FG013|STARTED|Period 4||0
10670431|NCT02323334|11832371|FG014|STARTED|Period 4||0
10670432|NCT02323334|11832372|FG015|STARTED|Period 4||0
10670433|NCT02323334|11832373|FG016|STARTED|Period 4||0
10670434|NCT02323334|11832357|FG000|COMPLETED|Period 4||3
10670435|NCT02323334|11832358|FG001|COMPLETED|Period 4||4
10670436|NCT02323334|11832359|FG002|COMPLETED|Period 4||3
10670437|NCT02323334|11832360|FG003|COMPLETED|Period 4||4
10670438|NCT02323334|11832361|FG004|COMPLETED|Period 4||4
10670439|NCT02323334|11832362|FG005|COMPLETED|Period 4||4
10670440|NCT02323334|11832363|FG006|COMPLETED|Period 4||0
10670441|NCT02323334|11832364|FG007|COMPLETED|Period 4||0
10670442|NCT02323334|11832365|FG008|COMPLETED|Period 4||0
10670443|NCT02323334|11832366|FG009|COMPLETED|Period 4||0
10670444|NCT02323334|11832367|FG010|COMPLETED|Period 4||0
10670445|NCT02323334|11832368|FG011|COMPLETED|Period 4||0
10670446|NCT02323334|11832369|FG012|COMPLETED|Period 4||0
10670447|NCT02323334|11832370|FG013|COMPLETED|Period 4||0
10670448|NCT02323334|11832371|FG014|COMPLETED|Period 4||0
10670449|NCT02323334|11832372|FG015|COMPLETED|Period 4||0
10670450|NCT02323334|11832373|FG016|COMPLETED|Period 4||0
10670451|NCT02323334|11832357|FG000|NOT COMPLETED|Period 4||0
10670452|NCT02323334|11832358|FG001|NOT COMPLETED|Period 4||0
10670453|NCT02323334|11832359|FG002|NOT COMPLETED|Period 4||0
10670454|NCT02323334|11832360|FG003|NOT COMPLETED|Period 4||0
10670455|NCT02323334|11832361|FG004|NOT COMPLETED|Period 4||0
10670456|NCT02323334|11832362|FG005|NOT COMPLETED|Period 4||0
10670457|NCT02323334|11832363|FG006|NOT COMPLETED|Period 4||0
10670458|NCT02323334|11832364|FG007|NOT COMPLETED|Period 4||0
10670459|NCT02323334|11832365|FG008|NOT COMPLETED|Period 4||0
10670460|NCT02323334|11832366|FG009|NOT COMPLETED|Period 4||0
10670461|NCT02323334|11832367|FG010|NOT COMPLETED|Period 4||0
10670462|NCT02323334|11832368|FG011|NOT COMPLETED|Period 4||0
10670463|NCT02323334|11832369|FG012|NOT COMPLETED|Period 4||0
10670464|NCT02323334|11832370|FG013|NOT COMPLETED|Period 4||0
10670465|NCT02323334|11832371|FG014|NOT COMPLETED|Period 4||0
10670466|NCT02323334|11832372|FG015|NOT COMPLETED|Period 4||0
10670467|NCT02323334|11832373|FG016|NOT COMPLETED|Period 4||0
10670468|NCT02323646|11832438|FG000|STARTED|Treatment Course 1||14
10670469|NCT02323646|11832439|FG001|STARTED|Treatment Course 1||13
10670470|NCT02323646|11832440|FG002|STARTED|Treatment Course 1||15
10670471|NCT02323646|11832438|FG000|COMPLETED|Treatment Course 1||11
10670472|NCT02323646|11832439|FG001|COMPLETED|Treatment Course 1||10
10670473|NCT02323646|11832440|FG002|COMPLETED|Treatment Course 1||12
10670474|NCT02323646|11832438|FG000|NOT COMPLETED|Treatment Course 1||3
10670475|NCT02323646|11832439|FG001|NOT COMPLETED|Treatment Course 1||3
10670476|NCT02323646|11832440|FG002|NOT COMPLETED|Treatment Course 1||3
10670477|NCT02323646|11832438|FG000|STARTED|Treatment Course 2||11
10670478|NCT02323646|11832439|FG001|STARTED|Treatment Course 2||10
10670479|NCT02323646|11832440|FG002|STARTED|Treatment Course 2||12
10796508|NCT03668613|11956854|FG000|STARTED|Overall Study||42
10796509|NCT03668613|11956855|FG001|STARTED|Overall Study||42
10796510|NCT03668613|11956854|FG000|COMPLETED|Overall Study||42
10796511|NCT03668613|11956855|FG001|COMPLETED|Overall Study||39
10796512|NCT03668613|11956854|FG000|NOT COMPLETED|Overall Study||0
10796513|NCT03668613|11956855|FG001|NOT COMPLETED|Overall Study||3
10796514|NCT03669081|11956864|FG000|STARTED|Overall Study||34
10796515|NCT03669081|11956865|FG001|STARTED|Overall Study||30
10796516|NCT03669081|11956864|FG000|COMPLETED|Overall Study||33
10796517|NCT03669081|11956865|FG001|COMPLETED|Overall Study||29
10796518|NCT03669081|11956864|FG000|NOT COMPLETED|Overall Study||1
10796519|NCT03669081|11956865|FG001|NOT COMPLETED|Overall Study||1
10796520|NCT03669354|11956875|FG000|STARTED|Overall Study||73
10796521|NCT03669354|11956876|FG001|STARTED|Overall Study||22
10796522|NCT03669354|11956877|FG002|STARTED|Overall Study||47
10796523|NCT03669354|11956878|FG003|STARTED|Overall Study||53
10796524|NCT03669354|11956875|FG000|COMPLETED|Overall Study||73
10796525|NCT03669354|11956876|FG001|COMPLETED|Overall Study||22
10796526|NCT03669354|11956877|FG002|COMPLETED|Overall Study||47
10796527|NCT03669354|11956878|FG003|COMPLETED|Overall Study||53
10796528|NCT03669354|11956875|FG000|NOT COMPLETED|Overall Study||0
10796529|NCT03669354|11956876|FG001|NOT COMPLETED|Overall Study||0
10455304|NCT01001221|11603330|FG000|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
10455305|NCT01001221|11603331|FG001|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
10455306|NCT01001221|11603332|FG002|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
10455307|NCT01001221|11603333|FG003|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
10455308|NCT01001221|11603334|FG004|COMPLETED|Overall Study||0
10455309|NCT01001221|11603330|FG000|NOT COMPLETED|Overall Study||5
10455310|NCT01001221|11603331|FG001|NOT COMPLETED|Overall Study||5
10670480|NCT02323646|11832438|FG000|COMPLETED|Treatment Course 2||10
10670481|NCT02323646|11832439|FG001|COMPLETED|Treatment Course 2||9
10796530|NCT03669354|11956877|FG002|NOT COMPLETED|Overall Study||0
10796531|NCT03669354|11956878|FG003|NOT COMPLETED|Overall Study||0
10796532|NCT03669549|11956889|FG000|STARTED|Overall Study||15
10796533|NCT03669549|11956889|FG000|COMPLETED|Overall Study||9
10670482|NCT02323646|11832440|FG002|COMPLETED|Treatment Course 2||9
10670483|NCT02323646|11832438|FG000|NOT COMPLETED|Treatment Course 2||1
10670484|NCT02323646|11832439|FG001|NOT COMPLETED|Treatment Course 2||1
10670485|NCT02323646|11832440|FG002|NOT COMPLETED|Treatment Course 2||3
10796534|NCT03669549|11956889|FG000|NOT COMPLETED|Overall Study||6
10796535|NCT03669861|11956897|FG000|STARTED|Overall Study||10
10796536|NCT03669861|11956897|FG000|COMPLETED|Overall Study||3
10670486|NCT02323854|11832448|FG000|STARTED|Overall Study||15
10670487|NCT02323854|11832448|FG000|COMPLETED|Overall Study||15
10796537|NCT03669861|11956897|FG000|NOT COMPLETED|Overall Study||7
10796538|NCT03670017|11956901|FG000|STARTED|Overall Study||68
10796539|NCT03670017|11956901|FG000|COMPLETED|Overall Study||50
10796540|NCT03670017|11956901|FG000|NOT COMPLETED|Overall Study||18
10670488|NCT02323854|11832448|FG000|NOT COMPLETED|Overall Study||0
10670489|NCT02324049|11832452|FG000|STARTED|Part A||11
10670490|NCT02324049|11832452|FG000|Safety Analysis Set|Part A|Participants with informed consent, confirmed MPS IIIB diagnosis, and received any amount of SBC-103|11
10670491|NCT02324049|11832452|FG000|COMPLETED|Part A||11
10670492|NCT02324049|11832452|FG000|NOT COMPLETED|Part A||0
10670493|NCT02324049|11832452|FG000|STARTED|Part B||11
10670494|NCT02324049|11832452|FG000|Safety Analysis Set|Part B||11
10670495|NCT02324049|11832452|FG000|COMPLETED|Part B||11
10670496|NCT02324049|11832452|FG000|NOT COMPLETED|Part B||0
10670497|NCT02324049|11832452|FG000|STARTED|Part C||11
10670498|NCT02324049|11832452|FG000|Safety Analysis Set|Part C||11
10670499|NCT02324049|11832452|FG000|COMPLETED|Part C||0
10670500|NCT02324049|11832452|FG000|NOT COMPLETED|Part C||11
10670501|NCT02324075|11832458|FG000|STARTED|Overall Study||612
10670502|NCT02324075|11832459|FG001|STARTED|Overall Study||614
10670503|NCT02324075|11832458|FG000|COMPLETED|Overall Study||609
10670504|NCT02324075|11832459|FG001|COMPLETED|Overall Study||605
10670505|NCT02324075|11832458|FG000|NOT COMPLETED|Overall Study||3
10670506|NCT02324075|11832459|FG001|NOT COMPLETED|Overall Study||9
10670507|NCT02324153|11832468|FG000|STARTED|Overall Study||41
10796541|NCT03670030|11956905|FG000|STARTED|Overall Study||5
10796542|NCT03670030|11956905|FG000|COMPLETED|Overall Study||5
10796543|NCT03670030|11956905|FG000|NOT COMPLETED|Overall Study||0
10796544|NCT03670160|11956911|FG000|STARTED|Overall Study||11
10796545|NCT03670160|11956912|FG001|STARTED|Overall Study||14
10796546|NCT03670160|11956911|FG000|COMPLETED|Overall Study||11
10796547|NCT03670160|11956912|FG001|COMPLETED|Overall Study||14
10796548|NCT03670160|11956911|FG000|NOT COMPLETED|Overall Study||0
10796549|NCT03670160|11956912|FG001|NOT COMPLETED|Overall Study||0
10796550|NCT03670264|11956921|FG000|STARTED|Overall Study||5
10796551|NCT03670264|11956922|FG001|STARTED|Overall Study||5
10796552|NCT03670264|11956923|FG002|STARTED|Overall Study||5
10796553|NCT03670264|11956921|FG000|COMPLETED|Overall Study||5
10796554|NCT03670264|11956922|FG001|COMPLETED|Overall Study||5
10796555|NCT03670264|11956923|FG002|COMPLETED|Overall Study||5
10796556|NCT03670264|11956921|FG000|NOT COMPLETED|Overall Study||0
10796557|NCT03670264|11956922|FG001|NOT COMPLETED|Overall Study||0
10796558|NCT03670264|11956923|FG002|NOT COMPLETED|Overall Study||0
10796559|NCT03670537|11956931|FG000|STARTED|Overall Study||102
10796560|NCT03670537|11956931|FG000|COMPLETED|Overall Study||101
10796561|NCT03670537|11956931|FG000|NOT COMPLETED|Overall Study||1
10796562|NCT03670641|11956935|FG000|STARTED|Overall Study||10
10796563|NCT03670641|11956935|FG000|COMPLETED|Overall Study|3 participants were lost to follow up by 12 months|7
10796564|NCT03670641|11956935|FG000|NOT COMPLETED|Overall Study||3
10670508|NCT02324153|11832469|FG001|STARTED|Overall Study||39
10670509|NCT02324153|11832468|FG000|COMPLETED|Overall Study||33
10670510|NCT02324153|11832469|FG001|COMPLETED|Overall Study||38
10670511|NCT02324153|11832468|FG000|NOT COMPLETED|Overall Study||8
10670512|NCT02324153|11832469|FG001|NOT COMPLETED|Overall Study||1
10670513|NCT02324205|11832475|FG000|STARTED|Overall Study||196
10670514|NCT02324205|11832475|FG000|COMPLETED|Overall Study||159
10670515|NCT02324205|11832475|FG000|NOT COMPLETED|Overall Study||37
10670516|NCT02324270|11832482|FG000|STARTED|Overall Study||218
10670517|NCT02324270|11832483|FG001|STARTED|Overall Study||219
10796581|NCT03672006|11956960|FG000|STARTED|Overall Study||10
10796582|NCT03672006|11956961|FG001|STARTED|Overall Study||10
10796583|NCT03672006|11956960|FG000|COMPLETED|Overall Study||10
10796584|NCT03672006|11956961|FG001|COMPLETED|Overall Study||9
10670518|NCT02324270|11832484|FG002|STARTED|Overall Study||221
10670519|NCT02324270|11832482|FG000|Safety Population|Overall Study||214
10670520|NCT02324270|11832483|FG001|Safety Population|Overall Study||216
10670521|NCT02324270|11832484|FG002|Safety Population|Overall Study||217
10670522|NCT02324270|11832482|FG000|mITT Population|Overall Study||214
10670523|NCT02324270|11832483|FG001|mITT Population|Overall Study||216
10796585|NCT03672006|11956960|FG000|NOT COMPLETED|Overall Study||0
10796586|NCT03672006|11956961|FG001|NOT COMPLETED|Overall Study||1
10796587|NCT03672032|11956971|FG000|STARTED|Overall Study||67
10796588|NCT03672032|11956972|FG001|STARTED|Overall Study||67
10796589|NCT03672032|11956971|FG000|COMPLETED|Overall Study||67
10796590|NCT03672032|11956972|FG001|COMPLETED|Overall Study||67
10670524|NCT02324270|11832484|FG002|mITT Population|Overall Study||217
10670525|NCT02324270|11832482|FG000|PP Population|Overall Study||180
10670526|NCT02324270|11832483|FG001|PP Population|Overall Study||177
10796591|NCT03672032|11956971|FG000|NOT COMPLETED|Overall Study||0
10670527|NCT02324270|11832484|FG002|PP Population|Overall Study||171
10670528|NCT02324270|11832482|FG000|COMPLETED|Overall Study||213
10670529|NCT02324270|11832483|FG001|COMPLETED|Overall Study||212
10670530|NCT02324270|11832484|FG002|COMPLETED|Overall Study||216
10670531|NCT02324270|11832482|FG000|NOT COMPLETED|Overall Study||5
10670532|NCT02324270|11832483|FG001|NOT COMPLETED|Overall Study||7
10670533|NCT02324270|11832484|FG002|NOT COMPLETED|Overall Study||5
10670534|NCT02324335|11832494|FG000|STARTED|Overall Study||30
10670535|NCT02324335|11832495|FG001|STARTED|Overall Study||29
10670536|NCT02324335|11832494|FG000|COMPLETED|Overall Study||21
10670537|NCT02324335|11832495|FG001|COMPLETED|Overall Study||20
10670538|NCT02324335|11832494|FG000|NOT COMPLETED|Overall Study||9
10670539|NCT02324335|11832495|FG001|NOT COMPLETED|Overall Study||9
10670540|NCT02324361|11832503|FG000|STARTED|Overall Study||24
10670541|NCT02324361|11832504|FG001|STARTED|Overall Study||24
10670542|NCT02324361|11832503|FG000|COMPLETED|Overall Study||19
10670543|NCT02324361|11832504|FG001|COMPLETED|Overall Study||22
10670544|NCT02324361|11832503|FG000|NOT COMPLETED|Overall Study||5
10670545|NCT02324361|11832504|FG001|NOT COMPLETED|Overall Study||2
10670546|NCT02324465|11832512|FG000|STARTED|Overall Study||18
10670547|NCT02324465|11832513|FG001|STARTED|Overall Study||22
10796592|NCT03672032|11956972|FG001|NOT COMPLETED|Overall Study||0
10796593|NCT03672097|11956978|FG000|STARTED|Period 1||204
10796594|NCT03672097|11956978|FG000|COMPLETED|Period 1||200
10796595|NCT03672097|11956978|FG000|NOT COMPLETED|Period 1||4
10796596|NCT03672097|11956978|FG000|STARTED|Period 2||200
10796597|NCT03672097|11956978|FG000|COMPLETED|Period 2||196
10796598|NCT03672097|11956978|FG000|NOT COMPLETED|Period 2||4
10796599|NCT03672370|11956982|FG000|STARTED|Overall Study|11 hips did not receive the study devices acc. to the protocol and therefore had to be excluded.|89
10796600|NCT03672370|11956982|FG000|COMPLETED|Overall Study||42
10796601|NCT03672370|11956982|FG000|NOT COMPLETED|Overall Study||47
10796602|NCT03672396|11956986|FG000|STARTED|Overall Study||22
10796603|NCT03672396|11956986|FG000|COMPLETED|Overall Study||16
10796604|NCT03672396|11956986|FG000|NOT COMPLETED|Overall Study||6
10796605|NCT03673670|11956996|FG000|STARTED|Treatment Period 1 (3 Days)||14
10796606|NCT03673670|11956997|FG001|STARTED|Treatment Period 1 (3 Days)||14
10796607|NCT03673670|11956998|FG002|STARTED|Treatment Period 1 (3 Days)||13
10796608|NCT03673670|11956999|FG003|STARTED|Treatment Period 1 (3 Days)||12
10796609|NCT03673670|11957000|FG004|STARTED|Treatment Period 1 (3 Days)||13
10796610|NCT03673670|11957001|FG005|STARTED|Treatment Period 1 (3 Days)||13
10796611|NCT03673670|11956996|FG000|COMPLETED|Treatment Period 1 (3 Days)||13
10796612|NCT03673670|11956997|FG001|COMPLETED|Treatment Period 1 (3 Days)||14
10796613|NCT03673670|11956998|FG002|COMPLETED|Treatment Period 1 (3 Days)||12
10796614|NCT03673670|11956999|FG003|COMPLETED|Treatment Period 1 (3 Days)||12
10796615|NCT03673670|11957000|FG004|COMPLETED|Treatment Period 1 (3 Days)||13
10796616|NCT03673670|11957001|FG005|COMPLETED|Treatment Period 1 (3 Days)||11
10796617|NCT03673670|11956996|FG000|NOT COMPLETED|Treatment Period 1 (3 Days)||1
10796618|NCT03673670|11956997|FG001|NOT COMPLETED|Treatment Period 1 (3 Days)||0
10796619|NCT03673670|11956998|FG002|NOT COMPLETED|Treatment Period 1 (3 Days)||1
10796620|NCT03673670|11956999|FG003|NOT COMPLETED|Treatment Period 1 (3 Days)||0
10796621|NCT03673670|11957000|FG004|NOT COMPLETED|Treatment Period 1 (3 Days)||0
10796622|NCT03673670|11957001|FG005|NOT COMPLETED|Treatment Period 1 (3 Days)||2
10796623|NCT03673670|11956996|FG000|STARTED|Washout Period 1 (7-14 Days)||13
10796624|NCT03673670|11956997|FG001|STARTED|Washout Period 1 (7-14 Days)||14
10796625|NCT03673670|11956998|FG002|STARTED|Washout Period 1 (7-14 Days)||12
10796626|NCT03673670|11956999|FG003|STARTED|Washout Period 1 (7-14 Days)||12
10796627|NCT03673670|11957000|FG004|STARTED|Washout Period 1 (7-14 Days)||13
10796628|NCT03673670|11957001|FG005|STARTED|Washout Period 1 (7-14 Days)||11
10796629|NCT03673670|11956996|FG000|COMPLETED|Washout Period 1 (7-14 Days)||13
10796630|NCT03673670|11956997|FG001|COMPLETED|Washout Period 1 (7-14 Days)||14
10796631|NCT03673670|11956998|FG002|COMPLETED|Washout Period 1 (7-14 Days)||12
10796632|NCT03673670|11956999|FG003|COMPLETED|Washout Period 1 (7-14 Days)||12
10796633|NCT03673670|11957000|FG004|COMPLETED|Washout Period 1 (7-14 Days)||13
10796634|NCT03673670|11957001|FG005|COMPLETED|Washout Period 1 (7-14 Days)||11
10796635|NCT03673670|11956996|FG000|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
10796636|NCT03673670|11956997|FG001|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
10796637|NCT03673670|11956998|FG002|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
10796638|NCT03673670|11956999|FG003|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
10796639|NCT03673670|11957000|FG004|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
10796640|NCT03673670|11957001|FG005|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
10670548|NCT02324465|11832512|FG000|COMPLETED|Overall Study||18
10670549|NCT02324465|11832513|FG001|COMPLETED|Overall Study||21
10670550|NCT02324465|11832512|FG000|NOT COMPLETED|Overall Study||0
10796641|NCT03673670|11956996|FG000|STARTED|Treatment Period 2 (3 Days)||13
10796642|NCT03673670|11956997|FG001|STARTED|Treatment Period 2 (3 Days)||14
10796643|NCT03673670|11956998|FG002|STARTED|Treatment Period 2 (3 Days)||12
10670551|NCT02324465|11832513|FG001|NOT COMPLETED|Overall Study||1
10670555|NCT02324543|11832532|FG000|STARTED|Overall Study||6
10670556|NCT02324543|11832533|FG001|STARTED|Overall Study||6
10670557|NCT02324543|11832534|FG002|STARTED|Overall Study||3
10670558|NCT02324543|11832535|FG003|STARTED|Overall Study||4
10670559|NCT02324543|11832536|FG004|STARTED|Overall Study||4
10670560|NCT02324543|11832537|FG005|STARTED|Overall Study||24
10670561|NCT02324543|11832532|FG000|COMPLETED|Overall Study||6
10670562|NCT02324543|11832533|FG001|COMPLETED|Overall Study||6
10670563|NCT02324543|11832534|FG002|COMPLETED|Overall Study||3
10670564|NCT02324543|11832535|FG003|COMPLETED|Overall Study||4
10670565|NCT02324543|11832536|FG004|COMPLETED|Overall Study||4
10670566|NCT02324543|11832537|FG005|COMPLETED|Overall Study||24
10670567|NCT02324543|11832532|FG000|NOT COMPLETED|Overall Study||0
10796644|NCT03673670|11956999|FG003|STARTED|Treatment Period 2 (3 Days)||12
10796645|NCT03673670|11957000|FG004|STARTED|Treatment Period 2 (3 Days)||13
10796646|NCT03673670|11957001|FG005|STARTED|Treatment Period 2 (3 Days)||11
10796647|NCT03673670|11956996|FG000|COMPLETED|Treatment Period 2 (3 Days)||13
10796648|NCT03673670|11956997|FG001|COMPLETED|Treatment Period 2 (3 Days)||14
10796649|NCT03673670|11956998|FG002|COMPLETED|Treatment Period 2 (3 Days)||11
10796650|NCT03673670|11956999|FG003|COMPLETED|Treatment Period 2 (3 Days)||12
10796651|NCT03673670|11957000|FG004|COMPLETED|Treatment Period 2 (3 Days)||12
10796652|NCT03673670|11957001|FG005|COMPLETED|Treatment Period 2 (3 Days)||11
10796653|NCT03673670|11956996|FG000|NOT COMPLETED|Treatment Period 2 (3 Days)||0
10796654|NCT03673670|11956997|FG001|NOT COMPLETED|Treatment Period 2 (3 Days)||0
10796655|NCT03673670|11956998|FG002|NOT COMPLETED|Treatment Period 2 (3 Days)||1
10796656|NCT03673670|11956999|FG003|NOT COMPLETED|Treatment Period 2 (3 Days)||0
10796657|NCT03673670|11957000|FG004|NOT COMPLETED|Treatment Period 2 (3 Days)||1
10796658|NCT03673670|11957001|FG005|NOT COMPLETED|Treatment Period 2 (3 Days)||0
10796659|NCT03673670|11956996|FG000|STARTED|Washout Period 2 (7-14 Days)||13
10796660|NCT03673670|11956997|FG001|STARTED|Washout Period 2 (7-14 Days)||14
10796661|NCT03673670|11956998|FG002|STARTED|Washout Period 2 (7-14 Days)||11
10796662|NCT03673670|11956999|FG003|STARTED|Washout Period 2 (7-14 Days)||12
10796663|NCT03673670|11957000|FG004|STARTED|Washout Period 2 (7-14 Days)||12
10796664|NCT03673670|11957001|FG005|STARTED|Washout Period 2 (7-14 Days)||11
10796665|NCT03673670|11956996|FG000|COMPLETED|Washout Period 2 (7-14 Days)||13
10796666|NCT03673670|11956997|FG001|COMPLETED|Washout Period 2 (7-14 Days)||14
10796667|NCT03673670|11956998|FG002|COMPLETED|Washout Period 2 (7-14 Days)||11
10796668|NCT03673670|11956999|FG003|COMPLETED|Washout Period 2 (7-14 Days)||12
10796669|NCT03673670|11957000|FG004|COMPLETED|Washout Period 2 (7-14 Days)||11
10796670|NCT03673670|11957001|FG005|COMPLETED|Washout Period 2 (7-14 Days)||11
10796671|NCT03673670|11956996|FG000|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
10796672|NCT03673670|11956997|FG001|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
10796673|NCT03673670|11956998|FG002|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
10796674|NCT03673670|11956999|FG003|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
10796675|NCT03673670|11957000|FG004|NOT COMPLETED|Washout Period 2 (7-14 Days)||1
10796676|NCT03673670|11957001|FG005|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
10796677|NCT03673670|11956996|FG000|STARTED|Treatment Period 3 (3 Days)||13
10796678|NCT03673670|11956997|FG001|STARTED|Treatment Period 3 (3 Days)||14
10796679|NCT03673670|11956998|FG002|STARTED|Treatment Period 3 (3 Days)||11
10796680|NCT03673670|11956999|FG003|STARTED|Treatment Period 3 (3 Days)||12
10796681|NCT03673670|11957000|FG004|STARTED|Treatment Period 3 (3 Days)||11
10796682|NCT03673670|11957001|FG005|STARTED|Treatment Period 3 (3 Days)||11
10796683|NCT03673670|11956996|FG000|COMPLETED|Treatment Period 3 (3 Days)||13
10796684|NCT03673670|11956997|FG001|COMPLETED|Treatment Period 3 (3 Days)||14
10796685|NCT03673670|11956998|FG002|COMPLETED|Treatment Period 3 (3 Days)||11
10796686|NCT03673670|11956999|FG003|COMPLETED|Treatment Period 3 (3 Days)||12
10796687|NCT03673670|11957000|FG004|COMPLETED|Treatment Period 3 (3 Days)||10
10796688|NCT03673670|11957001|FG005|COMPLETED|Treatment Period 3 (3 Days)||11
10796689|NCT03673670|11956996|FG000|NOT COMPLETED|Treatment Period 3 (3 Days)||0
10796690|NCT03673670|11956997|FG001|NOT COMPLETED|Treatment Period 3 (3 Days)||0
10796691|NCT03673670|11956998|FG002|NOT COMPLETED|Treatment Period 3 (3 Days)||0
10796692|NCT03673670|11956999|FG003|NOT COMPLETED|Treatment Period 3 (3 Days)||0
10796693|NCT03673670|11957000|FG004|NOT COMPLETED|Treatment Period 3 (3 Days)||1
10796694|NCT03673670|11957001|FG005|NOT COMPLETED|Treatment Period 3 (3 Days)||0
10796695|NCT03674177|11957022|FG000|STARTED|Overall Study||124
10796696|NCT03674177|11957023|FG001|STARTED|Overall Study||126
10796697|NCT03674177|11957024|FG002|STARTED|Overall Study||126
10796698|NCT03674177|11957025|FG003|STARTED|Overall Study||126
10796699|NCT03674177|11957022|FG000|COMPLETED|Overall Study||122
10796700|NCT03674177|11957023|FG001|COMPLETED|Overall Study||125
10796701|NCT03674177|11957024|FG002|COMPLETED|Overall Study||126
10796702|NCT03674177|11957025|FG003|COMPLETED|Overall Study||124
10796703|NCT03674177|11957022|FG000|NOT COMPLETED|Overall Study||2
10796704|NCT03674177|11957023|FG001|NOT COMPLETED|Overall Study||1
10796705|NCT03674177|11957024|FG002|NOT COMPLETED|Overall Study||0
10796706|NCT03674177|11957025|FG003|NOT COMPLETED|Overall Study||2
10796707|NCT03674281|11957038|FG000|STARTED|Overall Study||18
10796708|NCT03674281|11957039|FG001|STARTED|Overall Study||16
10796709|NCT03674281|11957040|FG002|STARTED|Overall Study||16
10670568|NCT02324543|11832533|FG001|NOT COMPLETED|Overall Study||0
10670569|NCT02324543|11832534|FG002|NOT COMPLETED|Overall Study||0
10670570|NCT02324543|11832535|FG003|NOT COMPLETED|Overall Study||0
10670571|NCT02324543|11832536|FG004|NOT COMPLETED|Overall Study||0
10670572|NCT02324543|11832537|FG005|NOT COMPLETED|Overall Study||0
10670573|NCT02324569|11832549|FG000|STARTED|Overall Study||116
10670574|NCT02324569|11832550|FG001|STARTED|Overall Study||124
10670575|NCT02324569|11832549|FG000|COMPLETED|Overall Study||100
10670576|NCT02324569|11832550|FG001|COMPLETED|Overall Study||103
10670577|NCT02324569|11832549|FG000|NOT COMPLETED|Overall Study||16
10670578|NCT02324569|11832550|FG001|NOT COMPLETED|Overall Study||21
10670579|NCT02324660|11832556|FG000|STARTED|Overall Study||169
10670580|NCT02324660|11832556|FG000|COMPLETED|Overall Study||137
10796710|NCT03674281|11957038|FG000|COMPLETED|Overall Study||15
10796711|NCT03674281|11957039|FG001|COMPLETED|Overall Study||13
10796712|NCT03674281|11957040|FG002|COMPLETED|Overall Study||13
10796713|NCT03674281|11957038|FG000|NOT COMPLETED|Overall Study||3
10796714|NCT03674281|11957039|FG001|NOT COMPLETED|Overall Study||3
10796715|NCT03674281|11957040|FG002|NOT COMPLETED|Overall Study||3
10796716|NCT03674970|11957059|FG000|STARTED|Overall Study||15
10796717|NCT03674970|11957060|FG001|STARTED|Overall Study||15
10796718|NCT03674970|11957061|FG002|STARTED|Overall Study||15
10796719|NCT03674970|11957059|FG000|COMPLETED|Overall Study||12
10796720|NCT03674970|11957060|FG001|COMPLETED|Overall Study||8
10796721|NCT03674970|11957061|FG002|COMPLETED|Overall Study||12
10796722|NCT03674970|11957059|FG000|NOT COMPLETED|Overall Study||3
10796723|NCT03674970|11957060|FG001|NOT COMPLETED|Overall Study||7
10796724|NCT03674970|11957061|FG002|NOT COMPLETED|Overall Study||3
10796725|NCT03675451|11957069|FG000|STARTED|Overall Study||20
10796726|NCT03675451|11957069|FG000|COMPLETED|Overall Study||20
10796727|NCT03675451|11957069|FG000|NOT COMPLETED|Overall Study||0
10796728|NCT03675581|11957080|FG000|STARTED|Period 1: Microgynon Alone||17
10796729|NCT03675581|11957080|FG000|COMPLETED|Period 1: Microgynon Alone||17
10796730|NCT03675581|11957080|FG000|NOT COMPLETED|Period 1: Microgynon Alone||0
10796731|NCT03675581|11957080|FG000|STARTED|Period 2: Microgynon + Nintedanib||17
10796732|NCT03675581|11957080|FG000|COMPLETED|Period 2: Microgynon + Nintedanib||17
10796733|NCT03675581|11957080|FG000|NOT COMPLETED|Period 2: Microgynon + Nintedanib||0
10796734|NCT03675685|11957088|FG000|STARTED|Overall Study||12
10796735|NCT03675685|11957088|FG000|COMPLETED|Overall Study||12
10796736|NCT03675685|11957088|FG000|NOT COMPLETED|Overall Study||0
10796737|NCT03675776|11957099|FG000|STARTED|Double Blind Treatment Period||15
10796738|NCT03675776|11957100|FG001|STARTED|Double Blind Treatment Period||17
10796739|NCT03675776|11957101|FG002|STARTED|Double Blind Treatment Period||18
10796740|NCT03675776|11957099|FG000|COMPLETED|Double Blind Treatment Period||9
10796741|NCT03675776|11957100|FG001|COMPLETED|Double Blind Treatment Period||11
10796742|NCT03675776|11957101|FG002|COMPLETED|Double Blind Treatment Period||10
10796743|NCT03675776|11957099|FG000|NOT COMPLETED|Double Blind Treatment Period||6
10796744|NCT03675776|11957100|FG001|NOT COMPLETED|Double Blind Treatment Period||6
10796745|NCT03675776|11957101|FG002|NOT COMPLETED|Double Blind Treatment Period||8
10796746|NCT03675776|11957099|FG000|STARTED|Safety Follow-up Period||6
10796747|NCT03675776|11957100|FG001|STARTED|Safety Follow-up Period||8
10796748|NCT03675776|11957101|FG002|STARTED|Safety Follow-up Period||7
10796749|NCT03675776|11957099|FG000|COMPLETED|Safety Follow-up Period||6
10796750|NCT03675776|11957100|FG001|COMPLETED|Safety Follow-up Period||8
10796751|NCT03675776|11957101|FG002|COMPLETED|Safety Follow-up Period||7
10796752|NCT03675776|11957099|FG000|NOT COMPLETED|Safety Follow-up Period||0
10796753|NCT03675776|11957100|FG001|NOT COMPLETED|Safety Follow-up Period||0
10796754|NCT03675776|11957101|FG002|NOT COMPLETED|Safety Follow-up Period||0
10796755|NCT03676270|11957109|FG000|STARTED|Overall Study||6915
10796756|NCT03676270|11957109|FG000|COMPLETED|Overall Study||6915
10796757|NCT03676270|11957109|FG000|NOT COMPLETED|Overall Study||0
10796758|NCT03676634|11957113|FG000|STARTED|Overall Study||32
10796759|NCT03676634|11957113|FG000|Screening|Overall Study||32
10796760|NCT03676634|11957113|FG000|Participants Received rBV A/B Injection|Overall Study||32
10796761|NCT03676634|11957113|FG000|Participants Included in the Plasma-donating Population|Overall Study||32
10796762|NCT03676634|11957113|FG000|Participants Completed Follow up|Overall Study||32
10796763|NCT03676634|11957113|FG000|COMPLETED|Overall Study||29
10796764|NCT03676634|11957113|FG000|NOT COMPLETED|Overall Study||3
10796765|NCT03676725|11957123|FG000|STARTED|Overall Study||23
10796766|NCT03676725|11957124|FG001|STARTED|Overall Study||14
10796767|NCT03676725|11957125|FG002|STARTED|Overall Study||22
10796768|NCT03676725|11957126|FG003|STARTED|Overall Study||5
10796769|NCT03676725|11957127|FG004|STARTED|Overall Study||15
10796770|NCT03676725|11957128|FG005|STARTED|Overall Study||11
10670581|NCT02324660|11832556|FG000|NOT COMPLETED|Overall Study||32
10796771|NCT03676725|11957123|FG000|COMPLETED|Overall Study||23
10796772|NCT03676725|11957124|FG001|COMPLETED|Overall Study||14
10796773|NCT03676725|11957125|FG002|COMPLETED|Overall Study||22
10796774|NCT03676725|11957126|FG003|COMPLETED|Overall Study||5
10796775|NCT03676725|11957127|FG004|COMPLETED|Overall Study||15
10796776|NCT03676725|11957128|FG005|COMPLETED|Overall Study||11
10796777|NCT03676725|11957123|FG000|NOT COMPLETED|Overall Study||0
10796778|NCT03676725|11957124|FG001|NOT COMPLETED|Overall Study||0
10796779|NCT03676725|11957125|FG002|NOT COMPLETED|Overall Study||0
10796780|NCT03676725|11957126|FG003|NOT COMPLETED|Overall Study||0
10796781|NCT03676725|11957127|FG004|NOT COMPLETED|Overall Study||0
10796782|NCT03676725|11957128|FG005|NOT COMPLETED|Overall Study||0
10796783|NCT03676803|11957139|FG000|STARTED|Overall Study||15
10796784|NCT03676803|11957140|FG001|STARTED|Overall Study||16
10670582|NCT02324673|11832564|FG000|STARTED|Overall Study||20
10670583|NCT02324673|11832565|FG001|STARTED|Overall Study||20
10670584|NCT02324673|11832566|FG002|STARTED|Overall Study||21
10796785|NCT03676803|11957139|FG000|COMPLETED|Overall Study||15
10670585|NCT02324673|11832564|FG000|COMPLETED|Overall Study||20
10670586|NCT02324673|11832565|FG001|COMPLETED|Overall Study||20
10670587|NCT02324673|11832566|FG002|COMPLETED|Overall Study||21
10670588|NCT02324673|11832564|FG000|NOT COMPLETED|Overall Study||0
10670589|NCT02324673|11832565|FG001|NOT COMPLETED|Overall Study||0
10670590|NCT02324673|11832566|FG002|NOT COMPLETED|Overall Study||0
10670591|NCT02324699|11832574|FG000|STARTED|Overall Study||1
10670592|NCT02324699|11832574|FG000|COMPLETED|Overall Study||0
10670593|NCT02324699|11832574|FG000|NOT COMPLETED|Overall Study||1
10670594|NCT02324842|11832581|FG000|STARTED|Overall Study||15
10670595|NCT02324842|11832582|FG001|STARTED|Overall Study||15
10670596|NCT02324842|11832583|FG002|STARTED|Overall Study||15
10670597|NCT02324842|11832581|FG000|COMPLETED|Overall Study||14
10670598|NCT02324842|11832582|FG001|COMPLETED|Overall Study||14
10670599|NCT02324842|11832583|FG002|COMPLETED|Overall Study||13
10670600|NCT02324842|11832581|FG000|NOT COMPLETED|Overall Study||1
10670601|NCT02324842|11832582|FG001|NOT COMPLETED|Overall Study||1
10670602|NCT02324842|11832583|FG002|NOT COMPLETED|Overall Study||2
10670603|NCT02324920|11832593|FG000|STARTED|Overall Study||64
10670604|NCT02324920|11832594|FG001|STARTED|Overall Study||64
10670605|NCT02324920|11832593|FG000|COMPLETED|Overall Study||63
10670606|NCT02324920|11832594|FG001|COMPLETED|Overall Study||64
10670607|NCT02324920|11832593|FG000|NOT COMPLETED|Overall Study||1
10670608|NCT02324920|11832594|FG001|NOT COMPLETED|Overall Study||0
10670609|NCT02324972|11832602|FG000|STARTED|Overall Study||26
10670610|NCT02324972|11832603|FG001|STARTED|Overall Study||28
10670611|NCT02324972|11832602|FG000|COMPLETED|Overall Study||19
10670612|NCT02324972|11832603|FG001|COMPLETED|Overall Study||23
10670613|NCT02324972|11832602|FG000|NOT COMPLETED|Overall Study||7
10670614|NCT02324972|11832603|FG001|NOT COMPLETED|Overall Study||5
10670615|NCT02325219|11832612|FG000|STARTED|Controlled Period (Week 0 - 16)||64
10670616|NCT02325219|11832613|FG001|STARTED|Controlled Period (Week 0 - 16)||65
10670617|NCT02325219|11832614|FG002|STARTED|Controlled Period (Week 0 - 16)||63
10670618|NCT02325219|11832615|FG003|STARTED|Controlled Period (Week 0 - 16)||0
10670619|NCT02325219|11832616|FG004|STARTED|Controlled Period (Week 0 - 16)||0
10670620|NCT02325219|11832612|FG000|COMPLETED|Controlled Period (Week 0 - 16)||52
10670621|NCT02325219|11832613|FG001|COMPLETED|Controlled Period (Week 0 - 16)||63
10670622|NCT02325219|11832614|FG002|COMPLETED|Controlled Period (Week 0 - 16)||62
10670623|NCT02325219|11832615|FG003|COMPLETED|Controlled Period (Week 0 - 16)||0
10670624|NCT02325219|11832616|FG004|COMPLETED|Controlled Period (Week 0 - 16)||0
10670625|NCT02325219|11832612|FG000|NOT COMPLETED|Controlled Period (Week 0 - 16)||12
10796786|NCT03676803|11957140|FG001|COMPLETED|Overall Study||16
10796787|NCT03676803|11957139|FG000|NOT COMPLETED|Overall Study||0
10796788|NCT03676803|11957140|FG001|NOT COMPLETED|Overall Study||0
10796789|NCT03676972|11957148|FG000|STARTED|Overall Study||60
10796790|NCT03676972|11957148|FG000|COMPLETED|Overall Study||58
10796791|NCT03676972|11957148|FG000|NOT COMPLETED|Overall Study||2
10796792|NCT03677089|11957152|FG000|STARTED|Overall Study||148
10796793|NCT03677089|11957152|FG000|Baseline/Pre-Intervention|Overall Study||137
10796794|NCT03677089|11957152|FG000|Mid-Intervention|Overall Study||120
10796795|NCT03677089|11957152|FG000|Post-Intervention|Overall Study||117
10796796|NCT03677089|11957152|FG000|Follow-Up|Overall Study||114
10796797|NCT03677089|11957152|FG000|COMPLETED|Overall Study||114
10796798|NCT03677089|11957152|FG000|NOT COMPLETED|Overall Study||34
10796799|NCT03677245|11957160|FG000|STARTED|Overall Study||8
10796800|NCT03677245|11957160|FG000|COMPLETED|Overall Study||8
10796801|NCT03677245|11957160|FG000|NOT COMPLETED|Overall Study||0
10796802|NCT03677375|11957165|FG000|STARTED|Overall Study||93
10796803|NCT03677375|11957165|FG000|COMPLETED|Overall Study||81
10796804|NCT03677375|11957165|FG000|NOT COMPLETED|Overall Study||12
10796805|NCT03677401|11957171|FG000|STARTED|Overall Study||148
10796806|NCT03677401|11957172|FG001|STARTED|Overall Study||147
10796807|NCT03677401|11957171|FG000|COMPLETED|Overall Study||138
10796808|NCT03677401|11957172|FG001|COMPLETED|Overall Study||129
10796809|NCT03677401|11957171|FG000|NOT COMPLETED|Overall Study||10
10796810|NCT03677401|11957172|FG001|NOT COMPLETED|Overall Study||18
10796814|NCT03678103|11957182|FG000|STARTED|Overall Study||30
10796815|NCT03678103|11957182|FG000|COMPLETED|Overall Study||26
10796816|NCT03678103|11957182|FG000|NOT COMPLETED|Overall Study||4
10796817|NCT03678285|11957186|FG000|STARTED|Overall Study||42
10796818|NCT03678285|11957186|FG000|Started Workout|Overall Study||40
10796819|NCT03678285|11957186|FG000|COMPLETED|Overall Study||38
10796820|NCT03678285|11957186|FG000|NOT COMPLETED|Overall Study||4
10796821|NCT03678311|11957190|FG000|STARTED|Overall Study||9
10796822|NCT03678311|11957190|FG000|COMPLETED|Overall Study||9
10796823|NCT03678311|11957190|FG000|NOT COMPLETED|Overall Study||0
10796824|NCT03678870|11957196|FG000|STARTED|Overall Study||97
10670626|NCT02325219|11832613|FG001|NOT COMPLETED|Controlled Period (Week 0 - 16)||2
10670627|NCT02325219|11832614|FG002|NOT COMPLETED|Controlled Period (Week 0 - 16)||1
10670628|NCT02325219|11832615|FG003|NOT COMPLETED|Controlled Period (Week 0 - 16)||0
10670629|NCT02325219|11832616|FG004|NOT COMPLETED|Controlled Period (Week 0 - 16)||0
10670630|NCT02325219|11832612|FG000|STARTED|After Controlled Period (Week 16 - 52)||0
10670631|NCT02325219|11832613|FG001|STARTED|After Controlled Period (Week 16 - 52)||63
10796825|NCT03678870|11957197|FG001|STARTED|Overall Study||99
10670632|NCT02325219|11832614|FG002|STARTED|After Controlled Period (Week 16 - 52)||62
10670633|NCT02325219|11832615|FG003|STARTED|After Controlled Period (Week 16 - 52)|Participants who completed CP and re-randomized to Guselkumab 50 mg.|26
10670634|NCT02325219|11832616|FG004|STARTED|After Controlled Period (Week 16 - 52)|Participants who completed CP and re-randomized to Guselkumab 100 mg.|26
10670635|NCT02325219|11832612|FG000|COMPLETED|After Controlled Period (Week 16 - 52)||0
10670636|NCT02325219|11832613|FG001|COMPLETED|After Controlled Period (Week 16 - 52)||60
10670637|NCT02325219|11832614|FG002|COMPLETED|After Controlled Period (Week 16 - 52)||62
10670638|NCT02325219|11832615|FG003|COMPLETED|After Controlled Period (Week 16 - 52)||26
10670639|NCT02325219|11832616|FG004|COMPLETED|After Controlled Period (Week 16 - 52)||25
10670640|NCT02325219|11832612|FG000|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0
10670641|NCT02325219|11832613|FG001|NOT COMPLETED|After Controlled Period (Week 16 - 52)||3
10670642|NCT02325219|11832614|FG002|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0
10670643|NCT02325219|11832615|FG003|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0
10670644|NCT02325219|11832616|FG004|NOT COMPLETED|After Controlled Period (Week 16 - 52)||1
10670645|NCT02325401|11832632|FG000|STARTED|Overall Study||6
10670646|NCT02325401|11832633|FG001|STARTED|Overall Study||9
10670647|NCT02325401|11832634|FG002|STARTED|Overall Study||5
10670648|NCT02325401|11832632|FG000|COMPLETED|Overall Study||6
10670649|NCT02325401|11832633|FG001|COMPLETED|Overall Study||8
10670650|NCT02325401|11832634|FG002|COMPLETED|Overall Study||4
10670651|NCT02325401|11832632|FG000|NOT COMPLETED|Overall Study||0
10670652|NCT02325401|11832633|FG001|NOT COMPLETED|Overall Study||1
10796826|NCT03678870|11957196|FG000|COMPLETED|Overall Study||84
10796827|NCT03678870|11957197|FG001|COMPLETED|Overall Study||91
10796828|NCT03678870|11957196|FG000|NOT COMPLETED|Overall Study||13
10796829|NCT03678870|11957197|FG001|NOT COMPLETED|Overall Study||8
10796830|NCT03679494|11957205|FG000|STARTED|Overall Study||67
10796831|NCT03679494|11957206|FG001|STARTED|Overall Study||63
10796832|NCT03679494|11957205|FG000|COMPLETED|Overall Study||67
10796833|NCT03679494|11957206|FG001|COMPLETED|Overall Study||63
10796834|NCT03679494|11957205|FG000|NOT COMPLETED|Overall Study||0
10796835|NCT03679494|11957206|FG001|NOT COMPLETED|Overall Study||0
10796836|NCT03679741|11957212|FG000|STARTED|Period 1||59
10796837|NCT03679741|11957213|FG001|STARTED|Period 1||61
10796838|NCT03679741|11957212|FG000|COMPLETED|Period 1||57
10796839|NCT03679741|11957213|FG001|COMPLETED|Period 1||58
10796840|NCT03679741|11957212|FG000|NOT COMPLETED|Period 1||2
10796841|NCT03679741|11957213|FG001|NOT COMPLETED|Period 1||3
10796842|NCT03679741|11957212|FG000|STARTED|Period 2||57
10796843|NCT03679741|11957213|FG001|STARTED|Period 2||58
10796844|NCT03679741|11957212|FG000|COMPLETED|Period 2||54
10796845|NCT03679741|11957213|FG001|COMPLETED|Period 2||56
10796846|NCT03679741|11957212|FG000|NOT COMPLETED|Period 2||3
10796847|NCT03679741|11957213|FG001|NOT COMPLETED|Period 2||2
10796848|NCT03679741|11957212|FG000|STARTED|Period 3||54
10796849|NCT03679741|11957213|FG001|STARTED|Period 3||56
10796850|NCT03679741|11957212|FG000|COMPLETED|Period 3||54
10796851|NCT03679741|11957213|FG001|COMPLETED|Period 3||56
10796852|NCT03679741|11957212|FG000|NOT COMPLETED|Period 3||0
10796853|NCT03679741|11957213|FG001|NOT COMPLETED|Period 3||0
10796854|NCT03679975|11957219|FG000|STARTED|Overall Study||9
10796855|NCT03679975|11957219|FG000|COMPLETED|Overall Study||9
10796856|NCT03679975|11957219|FG000|NOT COMPLETED|Overall Study||0
10796857|NCT03680105|11957232|FG000|STARTED|Overall Study||8
10796858|NCT03680105|11957233|FG001|STARTED|Overall Study||8
10796859|NCT03680105|11957234|FG002|STARTED|Overall Study||8
10796860|NCT03680105|11957235|FG003|STARTED|Overall Study||8
10796861|NCT03680105|11957236|FG004|STARTED|Overall Study||8
10796862|NCT03680105|11957237|FG005|STARTED|Overall Study||12
10796863|NCT03680105|11957238|FG006|STARTED|Overall Study||8
10796864|NCT03680105|11957239|FG007|STARTED|Overall Study||8
10796865|NCT03680105|11957240|FG008|STARTED|Overall Study||8
10796866|NCT03680105|11957232|FG000|COMPLETED|Overall Study||8
10796867|NCT03680105|11957233|FG001|COMPLETED|Overall Study||8
10796868|NCT03680105|11957234|FG002|COMPLETED|Overall Study||8
10796869|NCT03680105|11957235|FG003|COMPLETED|Overall Study||8
10796870|NCT03680105|11957236|FG004|COMPLETED|Overall Study||8
10796871|NCT03680105|11957237|FG005|COMPLETED|Overall Study||12
10796872|NCT03680105|11957238|FG006|COMPLETED|Overall Study||8
10670653|NCT02325401|11832634|FG002|NOT COMPLETED|Overall Study||1
10670654|NCT02325414|11832650|FG000|STARTED|Overall Study||30
10670655|NCT02325414|11832651|FG001|STARTED|Overall Study||30
10670656|NCT02325414|11832650|FG000|COMPLETED|Overall Study||22
10670657|NCT02325414|11832651|FG001|COMPLETED|Overall Study||24
10670658|NCT02325414|11832650|FG000|NOT COMPLETED|Overall Study||8
10796873|NCT03680105|11957239|FG007|COMPLETED|Overall Study||8
10796874|NCT03680105|11957240|FG008|COMPLETED|Overall Study||8
10796875|NCT03680105|11957232|FG000|NOT COMPLETED|Overall Study||0
10796876|NCT03680105|11957233|FG001|NOT COMPLETED|Overall Study||0
10796877|NCT03680105|11957234|FG002|NOT COMPLETED|Overall Study||0
10796878|NCT03680105|11957235|FG003|NOT COMPLETED|Overall Study||0
10796879|NCT03680105|11957236|FG004|NOT COMPLETED|Overall Study||0
10796880|NCT03680105|11957237|FG005|NOT COMPLETED|Overall Study||0
10796881|NCT03680105|11957238|FG006|NOT COMPLETED|Overall Study||0
10796882|NCT03680105|11957239|FG007|NOT COMPLETED|Overall Study||0
10796883|NCT03680105|11957240|FG008|NOT COMPLETED|Overall Study||0
10796884|NCT03680521|11957266|FG000|STARTED|Overall Study||7
10670659|NCT02325414|11832651|FG001|NOT COMPLETED|Overall Study||6
10670660|NCT02325518|11832661|FG000|STARTED|Overall Study||98
10796885|NCT03680521|11957267|FG001|STARTED|Overall Study||13
10796886|NCT03680521|11957266|FG000|COMPLETED|Overall Study||0
10670661|NCT02325518|11832662|FG001|STARTED|Overall Study||103
10670662|NCT02325518|11832661|FG000|Safety Set|Overall Study||98
10670663|NCT02325518|11832662|FG001|Safety Set|Overall Study||103
10670664|NCT02325518|11832661|FG000|Full Analysis Set (FAS)|Overall Study||98
10670665|NCT02325518|11832662|FG001|Full Analysis Set (FAS)|Overall Study||101
10670666|NCT02325518|11832661|FG000|Per Protocol Set (PPS)|Overall Study||92
10670667|NCT02325518|11832662|FG001|Per Protocol Set (PPS)|Overall Study||97
10670668|NCT02325518|11832661|FG000|COMPLETED|Overall Study||94
10670669|NCT02325518|11832662|FG001|COMPLETED|Overall Study||100
10670670|NCT02325518|11832661|FG000|NOT COMPLETED|Overall Study||4
10670671|NCT02325518|11832662|FG001|NOT COMPLETED|Overall Study||3
10670672|NCT02325687|11832672|FG000|STARTED|Overall Study||16
10796887|NCT03680521|11957267|FG001|COMPLETED|Overall Study||2
10796888|NCT03680521|11957266|FG000|NOT COMPLETED|Overall Study||7
10796889|NCT03680521|11957267|FG001|NOT COMPLETED|Overall Study||11
10796890|NCT03680742|11957276|FG000|STARTED|Overall Study||34
10796891|NCT03680742|11957276|FG000|COMPLETED|Overall Study||32
10796892|NCT03680742|11957276|FG000|NOT COMPLETED|Overall Study||2
10796893|NCT03681093|11957283|FG000|STARTED|Overall Study||32
10796894|NCT03681093|11957284|FG001|STARTED|Overall Study||34
10796895|NCT03681093|11957285|FG002|STARTED|Overall Study||32
10796896|NCT03681093|11957283|FG000|Full Analysis Set (FAS)|Overall Study||31
10796897|NCT03681093|11957284|FG001|Full Analysis Set (FAS)|Overall Study||32
10796898|NCT03681093|11957285|FG002|Full Analysis Set (FAS)|Overall Study||28
10796899|NCT03681093|11957283|FG000|Safety Analysis Set (SAF)|Overall Study||32
10796900|NCT03681093|11957284|FG001|Safety Analysis Set (SAF)|Overall Study||34
10796901|NCT03681093|11957285|FG002|Safety Analysis Set (SAF)|Overall Study||32
10796902|NCT03681093|11957283|FG000|COMPLETED|Overall Study||32
10796903|NCT03681093|11957284|FG001|COMPLETED|Overall Study||32
10796904|NCT03681093|11957285|FG002|COMPLETED|Overall Study||31
10796905|NCT03681093|11957283|FG000|NOT COMPLETED|Overall Study||0
10796906|NCT03681093|11957284|FG001|NOT COMPLETED|Overall Study||2
10796907|NCT03681093|11957285|FG002|NOT COMPLETED|Overall Study||1
10796908|NCT03681119|11957295|FG000|STARTED|Overall Study||72
10796909|NCT03681119|11957296|FG001|STARTED|Overall Study||11
10796910|NCT03681119|11957295|FG000|COMPLETED|Overall Study||66
10796911|NCT03681119|11957296|FG001|COMPLETED|Overall Study||11
10796912|NCT03681119|11957295|FG000|NOT COMPLETED|Overall Study||6
10796913|NCT03681119|11957296|FG001|NOT COMPLETED|Overall Study||0
10796914|NCT03681353|11957300|FG000|STARTED|Overall Study||25
10796915|NCT03681353|11957300|FG000|COMPLETED|Overall Study||18
10796916|NCT03681353|11957300|FG000|NOT COMPLETED|Overall Study||7
10796917|NCT03681405|11957306|FG000|STARTED|Overall Study||14
10796918|NCT03681405|11957307|FG001|STARTED|Overall Study||17
10796919|NCT03681405|11957306|FG000|COMPLETED|Overall Study||13
10796920|NCT03681405|11957307|FG001|COMPLETED|Overall Study||17
10796921|NCT03681405|11957306|FG000|NOT COMPLETED|Overall Study||1
10796922|NCT03681405|11957307|FG001|NOT COMPLETED|Overall Study||0
10796923|NCT03681808|11957317|FG000|STARTED|Overall Study||123
10796924|NCT03681808|11957318|FG001|STARTED|Overall Study||119
10796925|NCT03681808|11957317|FG000|COMPLETED|Overall Study||109
10796926|NCT03681808|11957318|FG001|COMPLETED|Overall Study||102
10796927|NCT03681808|11957317|FG000|NOT COMPLETED|Overall Study||14
10796928|NCT03681808|11957318|FG001|NOT COMPLETED|Overall Study||17
10796929|NCT03681886|11957324|FG000|STARTED|Overall Study||78
10796930|NCT03681886|11957324|FG000|Successful Implantation|Overall Study||76
10796931|NCT03681886|11957324|FG000|Failed Implantation|Overall Study||2
10796932|NCT03681886|11957324|FG000|Underwent Optic Exchange|Overall Study||4
10796933|NCT03681886|11957324|FG000|COMPLETED|Overall Study||76
10796934|NCT03681886|11957324|FG000|NOT COMPLETED|Overall Study||2
10796935|NCT03681951|11957353|FG000|STARTED|Part1: Monotherapy DE (Up to Day 95)||8
10796936|NCT03681951|11957354|FG001|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID"|0
10796937|NCT03681951|11957355|FG002|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID."|0
10796938|NCT03681951|11957356|FG003|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID"|0
10796939|NCT03681951|11957357|FG004|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID"|0
10796940|NCT03681951|11957358|FG005|STARTED|Part1: Monotherapy DE (Up to Day 95)|Part 2 was not initiated as this study was terminated during Part 1|0
10796941|NCT03681951|11957359|FG006|STARTED|Part1: Monotherapy DE (Up to Day 95)|Part 3 was not initiated as this study was terminated during Part 1|0
10670673|NCT02325687|11832673|FG001|STARTED|Overall Study||15
10670674|NCT02325687|11832674|FG002|STARTED|Overall Study||19
10670675|NCT02325687|11832672|FG000|COMPLETED|Overall Study||12
10670676|NCT02325687|11832673|FG001|COMPLETED|Overall Study||12
10670677|NCT02325687|11832674|FG002|COMPLETED|Overall Study||13
10670678|NCT02325687|11832672|FG000|NOT COMPLETED|Overall Study||4
10670679|NCT02325687|11832673|FG001|NOT COMPLETED|Overall Study||3
10796942|NCT03681951|11957360|FG007|STARTED|Part1: Monotherapy DE (Up to Day 95)|Part 4 was not initiated as this study was terminated during Part 1|0
10796943|NCT03681951|11957353|FG000|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
10796944|NCT03681951|11957354|FG001|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
10796945|NCT03681951|11957355|FG002|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
10670680|NCT02325687|11832674|FG002|NOT COMPLETED|Overall Study||6
10670681|NCT02325713|11832698|FG000|STARTED|Intervention Period 1 (2 Days)||2
10670682|NCT02325713|11832699|FG001|STARTED|Intervention Period 1 (2 Days)||2
10670683|NCT02325713|11832700|FG002|STARTED|Intervention Period 1 (2 Days)||2
10670684|NCT02325713|11832701|FG003|STARTED|Intervention Period 1 (2 Days)||2
10670685|NCT02325713|11832702|FG004|STARTED|Intervention Period 1 (2 Days)||2
10670686|NCT02325713|11832703|FG005|STARTED|Intervention Period 1 (2 Days)||2
10670687|NCT02325713|11832704|FG006|STARTED|Intervention Period 1 (2 Days)||2
10670688|NCT02325713|11832705|FG007|STARTED|Intervention Period 1 (2 Days)||2
10670689|NCT02325713|11832706|FG008|STARTED|Intervention Period 1 (2 Days)||2
10670690|NCT02325713|11832707|FG009|STARTED|Intervention Period 1 (2 Days)||2
10670691|NCT02325713|11832708|FG010|STARTED|Intervention Period 1 (2 Days)||2
10670692|NCT02325713|11832709|FG011|STARTED|Intervention Period 1 (2 Days)||2
10670693|NCT02325713|11832710|FG012|STARTED|Intervention Period 1 (2 Days)||2
10670694|NCT02325713|11832711|FG013|STARTED|Intervention Period 1 (2 Days)||2
10670695|NCT02325713|11832712|FG014|STARTED|Intervention Period 1 (2 Days)||2
10670696|NCT02325713|11832713|FG015|STARTED|Intervention Period 1 (2 Days)||2
10670697|NCT02325713|11832698|FG000|COMPLETED|Intervention Period 1 (2 Days)||2
10670698|NCT02325713|11832699|FG001|COMPLETED|Intervention Period 1 (2 Days)||2
10670699|NCT02325713|11832700|FG002|COMPLETED|Intervention Period 1 (2 Days)||2
10670700|NCT02325713|11832701|FG003|COMPLETED|Intervention Period 1 (2 Days)||2
10670701|NCT02325713|11832702|FG004|COMPLETED|Intervention Period 1 (2 Days)||2
10670702|NCT02325713|11832703|FG005|COMPLETED|Intervention Period 1 (2 Days)||2
10670703|NCT02325713|11832704|FG006|COMPLETED|Intervention Period 1 (2 Days)||2
10670704|NCT02325713|11832705|FG007|COMPLETED|Intervention Period 1 (2 Days)||2
10670705|NCT02325713|11832706|FG008|COMPLETED|Intervention Period 1 (2 Days)||2
10670706|NCT02325713|11832707|FG009|COMPLETED|Intervention Period 1 (2 Days)||2
10670707|NCT02325713|11832708|FG010|COMPLETED|Intervention Period 1 (2 Days)||1
10670708|NCT02325713|11832709|FG011|COMPLETED|Intervention Period 1 (2 Days)||2
10670709|NCT02325713|11832710|FG012|COMPLETED|Intervention Period 1 (2 Days)||2
10670710|NCT02325713|11832711|FG013|COMPLETED|Intervention Period 1 (2 Days)||2
10670711|NCT02325713|11832712|FG014|COMPLETED|Intervention Period 1 (2 Days)||2
10670712|NCT02325713|11832713|FG015|COMPLETED|Intervention Period 1 (2 Days)||2
10670713|NCT02325713|11832698|FG000|NOT COMPLETED|Intervention Period 1 (2 Days)||0
10670714|NCT02325713|11832699|FG001|NOT COMPLETED|Intervention Period 1 (2 Days)||0
10670715|NCT02325713|11832700|FG002|NOT COMPLETED|Intervention Period 1 (2 Days)||0
10670716|NCT02325713|11832701|FG003|NOT COMPLETED|Intervention Period 1 (2 Days)||0
10670717|NCT02325713|11832702|FG004|NOT COMPLETED|Intervention Period 1 (2 Days)||0
10670718|NCT02325713|11832703|FG005|NOT COMPLETED|Intervention Period 1 (2 Days)||0
10670719|NCT02325713|11832704|FG006|NOT COMPLETED|Intervention Period 1 (2 Days)||0
10670720|NCT02325713|11832705|FG007|NOT COMPLETED|Intervention Period 1 (2 Days)||0
10670721|NCT02325713|11832706|FG008|NOT COMPLETED|Intervention Period 1 (2 Days)||0
10670722|NCT02325713|11832707|FG009|NOT COMPLETED|Intervention Period 1 (2 Days)||0
10670723|NCT02325713|11832708|FG010|NOT COMPLETED|Intervention Period 1 (2 Days)||1
10670724|NCT02325713|11832709|FG011|NOT COMPLETED|Intervention Period 1 (2 Days)||0
10670725|NCT02325713|11832710|FG012|NOT COMPLETED|Intervention Period 1 (2 Days)||0
10670726|NCT02325713|11832711|FG013|NOT COMPLETED|Intervention Period 1 (2 Days)||0
10670727|NCT02325713|11832712|FG014|NOT COMPLETED|Intervention Period 1 (2 Days)||0
10670728|NCT02325713|11832713|FG015|NOT COMPLETED|Intervention Period 1 (2 Days)||0
10670729|NCT02325713|11832698|FG000|STARTED|Intervention Period 2 (2 Days)||2
10670730|NCT02325713|11832699|FG001|STARTED|Intervention Period 2 (2 Days)||2
10670731|NCT02325713|11832700|FG002|STARTED|Intervention Period 2 (2 Days)||2
10670732|NCT02325713|11832701|FG003|STARTED|Intervention Period 2 (2 Days)||2
10670733|NCT02325713|11832702|FG004|STARTED|Intervention Period 2 (2 Days)||2
10670734|NCT02325713|11832703|FG005|STARTED|Intervention Period 2 (2 Days)||2
10670735|NCT02325713|11832704|FG006|STARTED|Intervention Period 2 (2 Days)||2
10796946|NCT03681951|11957356|FG003|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
10796947|NCT03681951|11957357|FG004|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
10796948|NCT03681951|11957358|FG005|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
10796949|NCT03681951|11957359|FG006|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
10796950|NCT03681951|11957360|FG007|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
10796951|NCT03681951|11957353|FG000|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||8
10796952|NCT03681951|11957354|FG001|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
10796953|NCT03681951|11957355|FG002|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
10796954|NCT03681951|11957356|FG003|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
10670736|NCT02325713|11832705|FG007|STARTED|Intervention Period 2 (2 Days)||2
10670737|NCT02325713|11832706|FG008|STARTED|Intervention Period 2 (2 Days)||2
10670738|NCT02325713|11832707|FG009|STARTED|Intervention Period 2 (2 Days)||2
10670739|NCT02325713|11832708|FG010|STARTED|Intervention Period 2 (2 Days)||1
10670740|NCT02325713|11832709|FG011|STARTED|Intervention Period 2 (2 Days)||2
10670741|NCT02325713|11832710|FG012|STARTED|Intervention Period 2 (2 Days)||2
10670742|NCT02325713|11832711|FG013|STARTED|Intervention Period 2 (2 Days)||2
10670743|NCT02325713|11832712|FG014|STARTED|Intervention Period 2 (2 Days)||2
10670744|NCT02325713|11832713|FG015|STARTED|Intervention Period 2 (2 Days)||2
10670745|NCT02325713|11832698|FG000|COMPLETED|Intervention Period 2 (2 Days)||1
10670746|NCT02325713|11832699|FG001|COMPLETED|Intervention Period 2 (2 Days)||2
10670747|NCT02325713|11832700|FG002|COMPLETED|Intervention Period 2 (2 Days)||2
10670748|NCT02325713|11832701|FG003|COMPLETED|Intervention Period 2 (2 Days)||2
10670749|NCT02325713|11832702|FG004|COMPLETED|Intervention Period 2 (2 Days)||2
10796955|NCT03681951|11957357|FG004|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
10796956|NCT03681951|11957358|FG005|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
10670750|NCT02325713|11832703|FG005|COMPLETED|Intervention Period 2 (2 Days)||2
10670751|NCT02325713|11832704|FG006|COMPLETED|Intervention Period 2 (2 Days)||2
10670752|NCT02325713|11832705|FG007|COMPLETED|Intervention Period 2 (2 Days)||2
10670753|NCT02325713|11832706|FG008|COMPLETED|Intervention Period 2 (2 Days)||2
10670754|NCT02325713|11832707|FG009|COMPLETED|Intervention Period 2 (2 Days)||2
10670755|NCT02325713|11832708|FG010|COMPLETED|Intervention Period 2 (2 Days)||1
10670756|NCT02325713|11832709|FG011|COMPLETED|Intervention Period 2 (2 Days)||2
10670757|NCT02325713|11832710|FG012|COMPLETED|Intervention Period 2 (2 Days)||2
10670758|NCT02325713|11832711|FG013|COMPLETED|Intervention Period 2 (2 Days)||2
10670759|NCT02325713|11832712|FG014|COMPLETED|Intervention Period 2 (2 Days)||2
10670760|NCT02325713|11832713|FG015|COMPLETED|Intervention Period 2 (2 Days)||2
10670761|NCT02325713|11832698|FG000|NOT COMPLETED|Intervention Period 2 (2 Days)||1
10670762|NCT02325713|11832699|FG001|NOT COMPLETED|Intervention Period 2 (2 Days)||0
10670763|NCT02325713|11832700|FG002|NOT COMPLETED|Intervention Period 2 (2 Days)||0
10670764|NCT02325713|11832701|FG003|NOT COMPLETED|Intervention Period 2 (2 Days)||0
10670765|NCT02325713|11832702|FG004|NOT COMPLETED|Intervention Period 2 (2 Days)||0
10670766|NCT02325713|11832703|FG005|NOT COMPLETED|Intervention Period 2 (2 Days)||0
10670767|NCT02325713|11832704|FG006|NOT COMPLETED|Intervention Period 2 (2 Days)||0
10670768|NCT02325713|11832705|FG007|NOT COMPLETED|Intervention Period 2 (2 Days)||0
10670769|NCT02325713|11832706|FG008|NOT COMPLETED|Intervention Period 2 (2 Days)||0
10670770|NCT02325713|11832707|FG009|NOT COMPLETED|Intervention Period 2 (2 Days)||0
10670771|NCT02325713|11832708|FG010|NOT COMPLETED|Intervention Period 2 (2 Days)||0
10670772|NCT02325713|11832709|FG011|NOT COMPLETED|Intervention Period 2 (2 Days)||0
10670773|NCT02325713|11832710|FG012|NOT COMPLETED|Intervention Period 2 (2 Days)||0
10670774|NCT02325713|11832711|FG013|NOT COMPLETED|Intervention Period 2 (2 Days)||0
10670775|NCT02325713|11832712|FG014|NOT COMPLETED|Intervention Period 2 (2 Days)||0
10670776|NCT02325713|11832713|FG015|NOT COMPLETED|Intervention Period 2 (2 Days)||0
10670777|NCT02325713|11832698|FG000|STARTED|Intervention Period 3 (2 Days)||1
10670778|NCT02325713|11832699|FG001|STARTED|Intervention Period 3 (2 Days)||2
10670779|NCT02325713|11832700|FG002|STARTED|Intervention Period 3 (2 Days)||2
10670780|NCT02325713|11832701|FG003|STARTED|Intervention Period 3 (2 Days)||2
10670781|NCT02325713|11832702|FG004|STARTED|Intervention Period 3 (2 Days)||2
10670782|NCT02325713|11832703|FG005|STARTED|Intervention Period 3 (2 Days)||2
10670783|NCT02325713|11832704|FG006|STARTED|Intervention Period 3 (2 Days)||2
10670784|NCT02325713|11832705|FG007|STARTED|Intervention Period 3 (2 Days)||2
10670785|NCT02325713|11832706|FG008|STARTED|Intervention Period 3 (2 Days)||2
10796957|NCT03681951|11957359|FG006|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
10796958|NCT03681951|11957360|FG007|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
10796959|NCT03681951|11957353|FG000|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
10796960|NCT03681951|11957354|FG001|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
10796961|NCT03681951|11957355|FG002|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
10796962|NCT03681951|11957356|FG003|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
10670786|NCT02325713|11832707|FG009|STARTED|Intervention Period 3 (2 Days)||2
10670787|NCT02325713|11832708|FG010|STARTED|Intervention Period 3 (2 Days)||1
10670788|NCT02325713|11832709|FG011|STARTED|Intervention Period 3 (2 Days)||2
10670789|NCT02325713|11832710|FG012|STARTED|Intervention Period 3 (2 Days)||2
10670790|NCT02325713|11832711|FG013|STARTED|Intervention Period 3 (2 Days)||2
10670791|NCT02325713|11832712|FG014|STARTED|Intervention Period 3 (2 Days)||2
10670792|NCT02325713|11832713|FG015|STARTED|Intervention Period 3 (2 Days)||2
10670793|NCT02325713|11832698|FG000|COMPLETED|Intervention Period 3 (2 Days)||1
10670794|NCT02325713|11832699|FG001|COMPLETED|Intervention Period 3 (2 Days)||2
10670795|NCT02325713|11832700|FG002|COMPLETED|Intervention Period 3 (2 Days)||2
10670796|NCT02325713|11832701|FG003|COMPLETED|Intervention Period 3 (2 Days)||2
10670797|NCT02325713|11832702|FG004|COMPLETED|Intervention Period 3 (2 Days)||2
10670798|NCT02325713|11832703|FG005|COMPLETED|Intervention Period 3 (2 Days)||2
10670799|NCT02325713|11832704|FG006|COMPLETED|Intervention Period 3 (2 Days)||2
10670800|NCT02325713|11832705|FG007|COMPLETED|Intervention Period 3 (2 Days)||2
10670801|NCT02325713|11832706|FG008|COMPLETED|Intervention Period 3 (2 Days)||2
10670802|NCT02325713|11832707|FG009|COMPLETED|Intervention Period 3 (2 Days)||1
10670803|NCT02325713|11832708|FG010|COMPLETED|Intervention Period 3 (2 Days)||1
10670804|NCT02325713|11832709|FG011|COMPLETED|Intervention Period 3 (2 Days)||2
10670805|NCT02325713|11832710|FG012|COMPLETED|Intervention Period 3 (2 Days)||2
10670806|NCT02325713|11832711|FG013|COMPLETED|Intervention Period 3 (2 Days)||2
10670807|NCT02325713|11832712|FG014|COMPLETED|Intervention Period 3 (2 Days)||2
10670808|NCT02325713|11832713|FG015|COMPLETED|Intervention Period 3 (2 Days)||2
10670809|NCT02325713|11832698|FG000|NOT COMPLETED|Intervention Period 3 (2 Days)||0
10670810|NCT02325713|11832699|FG001|NOT COMPLETED|Intervention Period 3 (2 Days)||0
10670811|NCT02325713|11832700|FG002|NOT COMPLETED|Intervention Period 3 (2 Days)||0
10670812|NCT02325713|11832701|FG003|NOT COMPLETED|Intervention Period 3 (2 Days)||0
10670813|NCT02325713|11832702|FG004|NOT COMPLETED|Intervention Period 3 (2 Days)||0
10670814|NCT02325713|11832703|FG005|NOT COMPLETED|Intervention Period 3 (2 Days)||0
10670815|NCT02325713|11832704|FG006|NOT COMPLETED|Intervention Period 3 (2 Days)||0
10670816|NCT02325713|11832705|FG007|NOT COMPLETED|Intervention Period 3 (2 Days)||0
10670817|NCT02325713|11832706|FG008|NOT COMPLETED|Intervention Period 3 (2 Days)||0
10670818|NCT02325713|11832707|FG009|NOT COMPLETED|Intervention Period 3 (2 Days)||1
10670819|NCT02325713|11832708|FG010|NOT COMPLETED|Intervention Period 3 (2 Days)||0
10670820|NCT02325713|11832709|FG011|NOT COMPLETED|Intervention Period 3 (2 Days)||0
10670821|NCT02325713|11832710|FG012|NOT COMPLETED|Intervention Period 3 (2 Days)||0
10796963|NCT03681951|11957357|FG004|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
10796964|NCT03681951|11957358|FG005|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
10796965|NCT03681951|11957359|FG006|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
10796966|NCT03681951|11957360|FG007|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
10796967|NCT03681951|11957353|FG000|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
10796968|NCT03681951|11957354|FG001|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
10796969|NCT03681951|11957355|FG002|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
10796970|NCT03681951|11957356|FG003|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
10796971|NCT03681951|11957357|FG004|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
10796972|NCT03681951|11957358|FG005|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
10796973|NCT03681951|11957359|FG006|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
10796974|NCT03681951|11957360|FG007|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
10796975|NCT03681951|11957353|FG000|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
10796976|NCT03681951|11957354|FG001|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
10796977|NCT03681951|11957355|FG002|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
10796978|NCT03681951|11957356|FG003|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
10796979|NCT03681951|11957357|FG004|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
10796980|NCT03681951|11957358|FG005|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
10796981|NCT03681951|11957359|FG006|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
10796982|NCT03681951|11957360|FG007|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
10796983|NCT03681951|11957353|FG000|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
10796984|NCT03681951|11957354|FG001|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
10796985|NCT03681951|11957355|FG002|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
10796986|NCT03681951|11957356|FG003|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
10796987|NCT03681951|11957357|FG004|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
10796988|NCT03681951|11957358|FG005|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
10796989|NCT03681951|11957359|FG006|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
10796990|NCT03681951|11957360|FG007|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
10796991|NCT03681951|11957353|FG000|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
10796992|NCT03681951|11957354|FG001|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
10796993|NCT03681951|11957355|FG002|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
10796994|NCT03681951|11957356|FG003|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
10796995|NCT03681951|11957357|FG004|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
10796996|NCT03681951|11957358|FG005|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
10796997|NCT03681951|11957359|FG006|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
10796998|NCT03681951|11957360|FG007|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
10796999|NCT03681951|11957353|FG000|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
10797000|NCT03681951|11957354|FG001|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
10797001|NCT03681951|11957355|FG002|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
10797002|NCT03681951|11957356|FG003|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
10797003|NCT03681951|11957357|FG004|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
10797004|NCT03681951|11957358|FG005|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
10797005|NCT03681951|11957359|FG006|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
10797006|NCT03681951|11957360|FG007|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
10797007|NCT03681951|11957353|FG000|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
10797008|NCT03681951|11957354|FG001|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
10797009|NCT03681951|11957355|FG002|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
10797010|NCT03681951|11957356|FG003|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
10797011|NCT03681951|11957357|FG004|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
10797012|NCT03681951|11957358|FG005|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
10797013|NCT03681951|11957359|FG006|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
10797014|NCT03681951|11957360|FG007|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
10797015|NCT03681951|11957353|FG000|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
10797016|NCT03681951|11957354|FG001|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
10797017|NCT03681951|11957355|FG002|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
10797018|NCT03681951|11957356|FG003|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
10797019|NCT03681951|11957357|FG004|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
10797020|NCT03681951|11957358|FG005|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
10797021|NCT03681951|11957359|FG006|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
10797022|NCT03681951|11957360|FG007|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
10670822|NCT02325713|11832711|FG013|NOT COMPLETED|Intervention Period 3 (2 Days)||0
10670823|NCT02325713|11832712|FG014|NOT COMPLETED|Intervention Period 3 (2 Days)||0
10670824|NCT02325713|11832713|FG015|NOT COMPLETED|Intervention Period 3 (2 Days)||0
10670825|NCT02325713|11832698|FG000|STARTED|Intervention Period 4 (2 Days)||1
10670826|NCT02325713|11832699|FG001|STARTED|Intervention Period 4 (2 Days)||2
10670827|NCT02325713|11832700|FG002|STARTED|Intervention Period 4 (2 Days)||2
10670828|NCT02325713|11832701|FG003|STARTED|Intervention Period 4 (2 Days)||2
10670829|NCT02325713|11832702|FG004|STARTED|Intervention Period 4 (2 Days)||2
10670830|NCT02325713|11832703|FG005|STARTED|Intervention Period 4 (2 Days)||2
10670831|NCT02325713|11832704|FG006|STARTED|Intervention Period 4 (2 Days)||2
10670832|NCT02325713|11832705|FG007|STARTED|Intervention Period 4 (2 Days)||2
10670833|NCT02325713|11832706|FG008|STARTED|Intervention Period 4 (2 Days)||2
10670834|NCT02325713|11832707|FG009|STARTED|Intervention Period 4 (2 Days)||1
10670835|NCT02325713|11832708|FG010|STARTED|Intervention Period 4 (2 Days)||1
10670836|NCT02325713|11832709|FG011|STARTED|Intervention Period 4 (2 Days)||2
10670837|NCT02325713|11832710|FG012|STARTED|Intervention Period 4 (2 Days)||2
10670838|NCT02325713|11832711|FG013|STARTED|Intervention Period 4 (2 Days)||2
10670839|NCT02325713|11832712|FG014|STARTED|Intervention Period 4 (2 Days)||2
10670840|NCT02325713|11832713|FG015|STARTED|Intervention Period 4 (2 Days)||2
10670841|NCT02325713|11832698|FG000|COMPLETED|Intervention Period 4 (2 Days)||1
10670842|NCT02325713|11832699|FG001|COMPLETED|Intervention Period 4 (2 Days)||2
10670843|NCT02325713|11832700|FG002|COMPLETED|Intervention Period 4 (2 Days)||2
10670844|NCT02325713|11832701|FG003|COMPLETED|Intervention Period 4 (2 Days)||2
10670845|NCT02325713|11832702|FG004|COMPLETED|Intervention Period 4 (2 Days)||2
10670846|NCT02325713|11832703|FG005|COMPLETED|Intervention Period 4 (2 Days)||2
10670847|NCT02325713|11832704|FG006|COMPLETED|Intervention Period 4 (2 Days)||2
10670848|NCT02325713|11832705|FG007|COMPLETED|Intervention Period 4 (2 Days)||2
10670849|NCT02325713|11832706|FG008|COMPLETED|Intervention Period 4 (2 Days)||2
10670850|NCT02325713|11832707|FG009|COMPLETED|Intervention Period 4 (2 Days)||1
10797023|NCT03681951|11957353|FG000|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
10670851|NCT02325713|11832708|FG010|COMPLETED|Intervention Period 4 (2 Days)||1
10797024|NCT03681951|11957354|FG001|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
10797025|NCT03681951|11957355|FG002|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
10797026|NCT03681951|11957356|FG003|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
10797027|NCT03681951|11957357|FG004|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
10797028|NCT03681951|11957358|FG005|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
10797029|NCT03681951|11957359|FG006|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
10797030|NCT03681951|11957360|FG007|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
10797031|NCT03682107|11957388|FG000|STARTED|Overall Study||10
10797032|NCT03682107|11957389|FG001|STARTED|Overall Study||10
10797033|NCT03682107|11957390|FG002|STARTED|Overall Study||10
10797034|NCT03682107|11957391|FG003|STARTED|Overall Study||10
10797035|NCT03682107|11957392|FG004|STARTED|Overall Study||8
10670852|NCT02325713|11832709|FG011|COMPLETED|Intervention Period 4 (2 Days)||2
10670853|NCT02325713|11832710|FG012|COMPLETED|Intervention Period 4 (2 Days)||2
10670854|NCT02325713|11832711|FG013|COMPLETED|Intervention Period 4 (2 Days)||2
10670855|NCT02325713|11832712|FG014|COMPLETED|Intervention Period 4 (2 Days)||2
10670856|NCT02325713|11832713|FG015|COMPLETED|Intervention Period 4 (2 Days)||2
10670857|NCT02325713|11832698|FG000|NOT COMPLETED|Intervention Period 4 (2 Days)||0
10670858|NCT02325713|11832699|FG001|NOT COMPLETED|Intervention Period 4 (2 Days)||0
10670859|NCT02325713|11832700|FG002|NOT COMPLETED|Intervention Period 4 (2 Days)||0
10670860|NCT02325713|11832701|FG003|NOT COMPLETED|Intervention Period 4 (2 Days)||0
10670861|NCT02325713|11832702|FG004|NOT COMPLETED|Intervention Period 4 (2 Days)||0
10670862|NCT02325713|11832703|FG005|NOT COMPLETED|Intervention Period 4 (2 Days)||0
10670863|NCT02325713|11832704|FG006|NOT COMPLETED|Intervention Period 4 (2 Days)||0
10670864|NCT02325713|11832705|FG007|NOT COMPLETED|Intervention Period 4 (2 Days)||0
10670865|NCT02325713|11832706|FG008|NOT COMPLETED|Intervention Period 4 (2 Days)||0
10670866|NCT02325713|11832707|FG009|NOT COMPLETED|Intervention Period 4 (2 Days)||0
10670867|NCT02325713|11832708|FG010|NOT COMPLETED|Intervention Period 4 (2 Days)||0
10670868|NCT02325713|11832709|FG011|NOT COMPLETED|Intervention Period 4 (2 Days)||0
10670869|NCT02325713|11832710|FG012|NOT COMPLETED|Intervention Period 4 (2 Days)||0
10670870|NCT02325713|11832711|FG013|NOT COMPLETED|Intervention Period 4 (2 Days)||0
10670871|NCT02325713|11832712|FG014|NOT COMPLETED|Intervention Period 4 (2 Days)||0
10670872|NCT02325713|11832713|FG015|NOT COMPLETED|Intervention Period 4 (2 Days)||0
10670873|NCT02325739|11832739|FG000|STARTED|Phase I Part||11
10670874|NCT02325739|11832740|FG001|STARTED|Phase I Part||6
10670875|NCT02325739|11832741|FG002|STARTED|Phase I Part||5
10670876|NCT02325739|11832742|FG003|STARTED|Phase I Part||26
10670877|NCT02325739|11832743|FG004|STARTED|Phase I Part||19
10670878|NCT02325739|11832744|FG005|STARTED|Phase I Part||7
10670879|NCT02325739|11832745|FG006|STARTED|Phase I Part||6
10670880|NCT02325739|11832746|FG007|STARTED|Phase I Part||6
10670881|NCT02325739|11832747|FG008|STARTED|Phase I Part||0
10670882|NCT02325739|11832748|FG009|STARTED|Phase I Part||0
10670883|NCT02325739|11832749|FG010|STARTED|Phase I Part||0
10670884|NCT02325739|11832739|FG000|COMPLETED|Phase I Part||0
10670885|NCT02325739|11832740|FG001|COMPLETED|Phase I Part||0
10670886|NCT02325739|11832741|FG002|COMPLETED|Phase I Part||0
10670887|NCT02325739|11832742|FG003|COMPLETED|Phase I Part||0
10670888|NCT02325739|11832743|FG004|COMPLETED|Phase I Part||0
10670889|NCT02325739|11832744|FG005|COMPLETED|Phase I Part||0
10670890|NCT02325739|11832745|FG006|COMPLETED|Phase I Part||0
10670891|NCT02325739|11832746|FG007|COMPLETED|Phase I Part||0
10670892|NCT02325739|11832747|FG008|COMPLETED|Phase I Part||0
10670893|NCT02325739|11832748|FG009|COMPLETED|Phase I Part||0
10670894|NCT02325739|11832749|FG010|COMPLETED|Phase I Part||0
10670895|NCT02325739|11832739|FG000|NOT COMPLETED|Phase I Part||11
10670896|NCT02325739|11832740|FG001|NOT COMPLETED|Phase I Part||6
10797036|NCT03682107|11957388|FG000|COMPLETED|Overall Study||10
10797037|NCT03682107|11957389|FG001|COMPLETED|Overall Study||9
10797038|NCT03682107|11957390|FG002|COMPLETED|Overall Study||10
10670897|NCT02325739|11832741|FG002|NOT COMPLETED|Phase I Part||5
10670898|NCT02325739|11832742|FG003|NOT COMPLETED|Phase I Part||26
10670899|NCT02325739|11832743|FG004|NOT COMPLETED|Phase I Part||19
10670900|NCT02325739|11832744|FG005|NOT COMPLETED|Phase I Part||7
10670901|NCT02325739|11832745|FG006|NOT COMPLETED|Phase I Part||6
10670902|NCT02325739|11832746|FG007|NOT COMPLETED|Phase I Part||6
10670903|NCT02325739|11832747|FG008|NOT COMPLETED|Phase I Part||0
10670904|NCT02325739|11832748|FG009|NOT COMPLETED|Phase I Part||0
10670905|NCT02325739|11832749|FG010|NOT COMPLETED|Phase I Part||0
10670906|NCT02325739|11832739|FG000|STARTED|Phase II Part||0
10670907|NCT02325739|11832740|FG001|STARTED|Phase II Part||0
10670908|NCT02325739|11832741|FG002|STARTED|Phase II Part||0
10670909|NCT02325739|11832742|FG003|STARTED|Phase II Part||0
10670910|NCT02325739|11832743|FG004|STARTED|Phase II Part||0
10670911|NCT02325739|11832744|FG005|STARTED|Phase II Part||0
10670912|NCT02325739|11832745|FG006|STARTED|Phase II Part||0
10670913|NCT02325739|11832746|FG007|STARTED|Phase II Part||0
10670914|NCT02325739|11832747|FG008|STARTED|Phase II Part||30
10670915|NCT02325739|11832748|FG009|STARTED|Phase II Part||36
10670916|NCT02325739|11832749|FG010|STARTED|Phase II Part||20
10670917|NCT02325739|11832739|FG000|COMPLETED|Phase II Part||0
10670918|NCT02325739|11832740|FG001|COMPLETED|Phase II Part||0
10670919|NCT02325739|11832741|FG002|COMPLETED|Phase II Part||0
10670920|NCT02325739|11832742|FG003|COMPLETED|Phase II Part||0
10670921|NCT02325739|11832743|FG004|COMPLETED|Phase II Part||0
10670922|NCT02325739|11832744|FG005|COMPLETED|Phase II Part||0
10670923|NCT02325739|11832745|FG006|COMPLETED|Phase II Part||0
10670924|NCT02325739|11832746|FG007|COMPLETED|Phase II Part||0
10670925|NCT02325739|11832747|FG008|COMPLETED|Phase II Part||0
10670926|NCT02325739|11832748|FG009|COMPLETED|Phase II Part||0
10670927|NCT02325739|11832749|FG010|COMPLETED|Phase II Part||0
10670928|NCT02325739|11832739|FG000|NOT COMPLETED|Phase II Part||0
10670929|NCT02325739|11832740|FG001|NOT COMPLETED|Phase II Part||0
10670930|NCT02325739|11832741|FG002|NOT COMPLETED|Phase II Part||0
10670931|NCT02325739|11832742|FG003|NOT COMPLETED|Phase II Part||0
10670932|NCT02325739|11832743|FG004|NOT COMPLETED|Phase II Part||0
10670933|NCT02325739|11832744|FG005|NOT COMPLETED|Phase II Part||0
10670934|NCT02325739|11832745|FG006|NOT COMPLETED|Phase II Part||0
10670935|NCT02325739|11832746|FG007|NOT COMPLETED|Phase II Part||0
10670936|NCT02325739|11832747|FG008|NOT COMPLETED|Phase II Part||30
10670937|NCT02325739|11832748|FG009|NOT COMPLETED|Phase II Part||36
10670938|NCT02325739|11832749|FG010|NOT COMPLETED|Phase II Part||20
10670939|NCT02325791|11832798|FG000|STARTED|Overall Study||23
10670940|NCT02325791|11832799|FG001|STARTED|Overall Study||383
10670941|NCT02325791|11832800|FG002|STARTED|Overall Study||385
10670942|NCT02325791|11832801|FG003|STARTED|Overall Study||381
10670943|NCT02325791|11832798|FG000|COMPLETED|Overall Study||23
10670944|NCT02325791|11832799|FG001|COMPLETED|Overall Study||358
10670945|NCT02325791|11832800|FG002|COMPLETED|Overall Study||360
10670946|NCT02325791|11832801|FG003|COMPLETED|Overall Study||355
10670947|NCT02325791|11832798|FG000|NOT COMPLETED|Overall Study||0
10670948|NCT02325791|11832799|FG001|NOT COMPLETED|Overall Study||25
10670949|NCT02325791|11832800|FG002|NOT COMPLETED|Overall Study||25
10670950|NCT02325791|11832801|FG003|NOT COMPLETED|Overall Study||26
10670951|NCT02325856|11832816|FG000|STARTED|Overall Study||148
10670952|NCT02325856|11832817|FG001|STARTED|Overall Study||150
10670953|NCT02325856|11832816|FG000|COMPLETED|Overall Study||128
10670954|NCT02325856|11832817|FG001|COMPLETED|Overall Study||123
10670955|NCT02325856|11832816|FG000|NOT COMPLETED|Overall Study||20
10670956|NCT02325856|11832817|FG001|NOT COMPLETED|Overall Study||27
10670957|NCT02326025|11832825|FG000|STARTED|Overall Study||25
10670958|NCT02326025|11832826|FG001|STARTED|Overall Study||24
10670959|NCT02326025|11832825|FG000|Received at Least 1 Dose of Study Drug|Overall Study||25
10670960|NCT02326025|11832826|FG001|Received at Least 1 Dose of Study Drug|Overall Study||24
10670961|NCT02326025|11832825|FG000|COMPLETED|Overall Study||20
10670962|NCT02326025|11832826|FG001|COMPLETED|Overall Study||19
10670963|NCT02326025|11832825|FG000|NOT COMPLETED|Overall Study||5
10670964|NCT02326025|11832826|FG001|NOT COMPLETED|Overall Study||5
10670965|NCT02326220|11832847|FG000|STARTED|Double-blind Treatment Period|Out of 21 participants, 9 participants entered in open label treatment period|21
10670966|NCT02326220|11832848|FG001|STARTED|Double-blind Treatment Period|Out of 41 participants, 20 participants entered in open label treatment period.|41
10670967|NCT02326220|11832849|FG002|STARTED|Double-blind Treatment Period||0
10670968|NCT02326220|11832847|FG000|COMPLETED|Double-blind Treatment Period||20
10670969|NCT02326220|11832848|FG001|COMPLETED|Double-blind Treatment Period||37
10670970|NCT02326220|11832849|FG002|COMPLETED|Double-blind Treatment Period||0
10670971|NCT02326220|11832847|FG000|NOT COMPLETED|Double-blind Treatment Period||1
10670972|NCT02326220|11832848|FG001|NOT COMPLETED|Double-blind Treatment Period||4
10670973|NCT02326220|11832849|FG002|NOT COMPLETED|Double-blind Treatment Period||0
10670974|NCT02326220|11832847|FG000|STARTED|Open-label Treatment Period||0
10670975|NCT02326220|11832848|FG001|STARTED|Open-label Treatment Period||0
10670976|NCT02326220|11832849|FG002|STARTED|Open-label Treatment Period|29 participants: 9 from Placebo and 20 from Alirocumab 150 mg arm entered in open-label period.|29
10670977|NCT02326220|11832847|FG000|COMPLETED|Open-label Treatment Period||0
10670978|NCT02326220|11832848|FG001|COMPLETED|Open-label Treatment Period||0
10670979|NCT02326220|11832849|FG002|COMPLETED|Open-label Treatment Period||27
10670980|NCT02326220|11832847|FG000|NOT COMPLETED|Open-label Treatment Period||0
10670981|NCT02326220|11832848|FG001|NOT COMPLETED|Open-label Treatment Period||0
10670982|NCT02326220|11832849|FG002|NOT COMPLETED|Open-label Treatment Period||2
10670983|NCT02326233|11832861|FG000|STARTED|Overall Study||95
10670984|NCT02326233|11832862|FG001|STARTED|Overall Study||95
10670985|NCT02326233|11832861|FG000|COMPLETED|Overall Study||95
10670986|NCT02326233|11832862|FG001|COMPLETED|Overall Study||94
10670987|NCT02326233|11832861|FG000|NOT COMPLETED|Overall Study||0
10670988|NCT02326233|11832862|FG001|NOT COMPLETED|Overall Study||1
10670989|NCT02326272|11832871|FG000|STARTED|Initial Period (Week 0 to Week 16)||49
10670990|NCT02326272|11832872|FG001|STARTED|Initial Period (Week 0 to Week 16)||91
10670991|NCT02326272|11832873|FG002|STARTED|Initial Period (Week 0 to Week 16)||87
10670992|NCT02326272|11832874|FG003|STARTED|Initial Period (Week 0 to Week 16)||0
10670993|NCT02326272|11832875|FG004|STARTED|Initial Period (Week 0 to Week 16)||0
10670994|NCT02326272|11832876|FG005|STARTED|Initial Period (Week 0 to Week 16)||0
10670995|NCT02326272|11832877|FG006|STARTED|Initial Period (Week 0 to Week 16)||0
10670996|NCT02326272|11832878|FG007|STARTED|Initial Period (Week 0 to Week 16)||0
10670997|NCT02326272|11832879|FG008|STARTED|Initial Period (Week 0 to Week 16)||0
10670998|NCT02326272|11832880|FG009|STARTED|Initial Period (Week 0 to Week 16)||0
10670999|NCT02326272|11832881|FG010|STARTED|Initial Period (Week 0 to Week 16)||0
10671000|NCT02326272|11832882|FG011|STARTED|Initial Period (Week 0 to Week 16)||0
10671001|NCT02326272|11832883|FG012|STARTED|Initial Period (Week 0 to Week 16)||0
10671002|NCT02326272|11832884|FG013|STARTED|Initial Period (Week 0 to Week 16)||0
10671003|NCT02326272|11832885|FG014|STARTED|Initial Period (Week 0 to Week 16)||0
10671004|NCT02326272|11832871|FG000|Completed Week 16|Initial Period (Week 0 to Week 16)||45
10671005|NCT02326272|11832872|FG001|Completed Week 16|Initial Period (Week 0 to Week 16)||84
10671006|NCT02326272|11832873|FG002|Completed Week 16|Initial Period (Week 0 to Week 16)||83
10671007|NCT02326272|11832874|FG003|Completed Week 16|Initial Period (Week 0 to Week 16)||0
10671008|NCT02326272|11832875|FG004|Completed Week 16|Initial Period (Week 0 to Week 16)||0
10671009|NCT02326272|11832876|FG005|Completed Week 16|Initial Period (Week 0 to Week 16)||0
10671010|NCT02326272|11832877|FG006|Completed Week 16|Initial Period (Week 0 to Week 16)||0
10671011|NCT02326272|11832878|FG007|Completed Week 16|Initial Period (Week 0 to Week 16)||0
10671012|NCT02326272|11832879|FG008|Completed Week 16|Initial Period (Week 0 to Week 16)||0
10671013|NCT02326272|11832880|FG009|Completed Week 16|Initial Period (Week 0 to Week 16)||0
10671014|NCT02326272|11832881|FG010|Completed Week 16|Initial Period (Week 0 to Week 16)||0
10671015|NCT02326272|11832882|FG011|Completed Week 16|Initial Period (Week 0 to Week 16)||0
10671016|NCT02326272|11832883|FG012|Completed Week 16|Initial Period (Week 0 to Week 16)||0
10671017|NCT02326272|11832884|FG013|Completed Week 16|Initial Period (Week 0 to Week 16)||0
10671018|NCT02326272|11832885|FG014|Completed Week 16|Initial Period (Week 0 to Week 16)||0
10671019|NCT02326272|11832871|FG000|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||45
10671020|NCT02326272|11832872|FG001|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||84
10671021|NCT02326272|11832873|FG002|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||81
10671022|NCT02326272|11832874|FG003|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
10671023|NCT02326272|11832875|FG004|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
10671024|NCT02326272|11832876|FG005|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
10671025|NCT02326272|11832877|FG006|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
10671026|NCT02326272|11832878|FG007|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
10671027|NCT02326272|11832879|FG008|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
10671028|NCT02326272|11832880|FG009|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
10671029|NCT02326272|11832881|FG010|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
10671030|NCT02326272|11832882|FG011|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
10671031|NCT02326272|11832883|FG012|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
10671032|NCT02326272|11832884|FG013|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
10671033|NCT02326272|11832885|FG014|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
10671034|NCT02326272|11832871|FG000|COMPLETED|Initial Period (Week 0 to Week 16)||45
10671035|NCT02326272|11832872|FG001|COMPLETED|Initial Period (Week 0 to Week 16)||84
10671036|NCT02326272|11832873|FG002|COMPLETED|Initial Period (Week 0 to Week 16)||81
10671037|NCT02326272|11832874|FG003|COMPLETED|Initial Period (Week 0 to Week 16)||0
10671038|NCT02326272|11832875|FG004|COMPLETED|Initial Period (Week 0 to Week 16)||0
10671039|NCT02326272|11832876|FG005|COMPLETED|Initial Period (Week 0 to Week 16)||0
10671040|NCT02326272|11832877|FG006|COMPLETED|Initial Period (Week 0 to Week 16)||0
10671041|NCT02326272|11832878|FG007|COMPLETED|Initial Period (Week 0 to Week 16)||0
10671042|NCT02326272|11832879|FG008|COMPLETED|Initial Period (Week 0 to Week 16)||0
10671043|NCT02326272|11832880|FG009|COMPLETED|Initial Period (Week 0 to Week 16)||0
10671044|NCT02326272|11832881|FG010|COMPLETED|Initial Period (Week 0 to Week 16)||0
10671045|NCT02326272|11832882|FG011|COMPLETED|Initial Period (Week 0 to Week 16)||0
10671046|NCT02326272|11832883|FG012|COMPLETED|Initial Period (Week 0 to Week 16)||0
10671047|NCT02326272|11832884|FG013|COMPLETED|Initial Period (Week 0 to Week 16)||0
10671048|NCT02326272|11832885|FG014|COMPLETED|Initial Period (Week 0 to Week 16)||0
10671049|NCT02326272|11832871|FG000|NOT COMPLETED|Initial Period (Week 0 to Week 16)||4
10671050|NCT02326272|11832872|FG001|NOT COMPLETED|Initial Period (Week 0 to Week 16)||7
10671051|NCT02326272|11832873|FG002|NOT COMPLETED|Initial Period (Week 0 to Week 16)||6
10671052|NCT02326272|11832874|FG003|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10671053|NCT02326272|11832875|FG004|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10671054|NCT02326272|11832876|FG005|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10671055|NCT02326272|11832877|FG006|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10671056|NCT02326272|11832878|FG007|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10671057|NCT02326272|11832879|FG008|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10797039|NCT03682107|11957391|FG003|COMPLETED|Overall Study||10
10797040|NCT03682107|11957392|FG004|COMPLETED|Overall Study||8
10797041|NCT03682107|11957388|FG000|NOT COMPLETED|Overall Study||0
10797042|NCT03682107|11957389|FG001|NOT COMPLETED|Overall Study||1
10797043|NCT03682107|11957390|FG002|NOT COMPLETED|Overall Study||0
10797044|NCT03682107|11957391|FG003|NOT COMPLETED|Overall Study||0
10797045|NCT03682107|11957392|FG004|NOT COMPLETED|Overall Study||0
10797046|NCT03682120|11957408|FG000|STARTED|Overall Study||105
10797047|NCT03682120|11957409|FG001|STARTED|Overall Study||105
10797048|NCT03682120|11957410|FG002|STARTED|Overall Study||105
10671058|NCT02326272|11832880|FG009|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10671059|NCT02326272|11832881|FG010|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10671060|NCT02326272|11832882|FG011|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10671061|NCT02326272|11832883|FG012|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10671062|NCT02326272|11832884|FG013|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10671063|NCT02326272|11832885|FG014|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10671064|NCT02326272|11832871|FG000|STARTED|Maintenance Period (Week 16 to Week 48)||0
10671065|NCT02326272|11832872|FG001|STARTED|Maintenance Period (Week 16 to Week 48)||0
10671066|NCT02326272|11832873|FG002|STARTED|Maintenance Period (Week 16 to Week 48)||0
10671067|NCT02326272|11832874|FG003|STARTED|Maintenance Period (Week 16 to Week 48)||6
10671068|NCT02326272|11832875|FG004|STARTED|Maintenance Period (Week 16 to Week 48)||5
10671069|NCT02326272|11832876|FG005|STARTED|Maintenance Period (Week 16 to Week 48)||76
10671070|NCT02326272|11832877|FG006|STARTED|Maintenance Period (Week 16 to Week 48)||69
10671071|NCT02326272|11832878|FG007|STARTED|Maintenance Period (Week 16 to Week 48)||34
10671072|NCT02326272|11832879|FG008|STARTED|Maintenance Period (Week 16 to Week 48)||8
10671073|NCT02326272|11832880|FG009|STARTED|Maintenance Period (Week 16 to Week 48)||12
10671074|NCT02326272|11832881|FG010|STARTED|Maintenance Period (Week 16 to Week 48)||0
10671075|NCT02326272|11832882|FG011|STARTED|Maintenance Period (Week 16 to Week 48)||0
10671076|NCT02326272|11832883|FG012|STARTED|Maintenance Period (Week 16 to Week 48)||0
10671077|NCT02326272|11832884|FG013|STARTED|Maintenance Period (Week 16 to Week 48)||0
10671078|NCT02326272|11832885|FG014|STARTED|Maintenance Period (Week 16 to Week 48)||0
10671079|NCT02326272|11832871|FG000|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
10671080|NCT02326272|11832872|FG001|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
10671081|NCT02326272|11832873|FG002|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
10671082|NCT02326272|11832874|FG003|Completed Week 48|Maintenance Period (Week 16 to Week 48)||5
10671083|NCT02326272|11832875|FG004|Completed Week 48|Maintenance Period (Week 16 to Week 48)||3
10671084|NCT02326272|11832876|FG005|Completed Week 48|Maintenance Period (Week 16 to Week 48)||64
10671085|NCT02326272|11832877|FG006|Completed Week 48|Maintenance Period (Week 16 to Week 48)||61
10671086|NCT02326272|11832878|FG007|Completed Week 48|Maintenance Period (Week 16 to Week 48)||27
10671087|NCT02326272|11832879|FG008|Completed Week 48|Maintenance Period (Week 16 to Week 48)||3
10671088|NCT02326272|11832880|FG009|Completed Week 48|Maintenance Period (Week 16 to Week 48)||10
10671089|NCT02326272|11832881|FG010|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
10671090|NCT02326272|11832882|FG011|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
10671091|NCT02326272|11832883|FG012|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
10671092|NCT02326272|11832884|FG013|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
10671093|NCT02326272|11832885|FG014|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
10671094|NCT02326272|11832871|FG000|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10671095|NCT02326272|11832872|FG001|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10671096|NCT02326272|11832873|FG002|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10671097|NCT02326272|11832874|FG003|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||5
10671098|NCT02326272|11832875|FG004|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||3
10671099|NCT02326272|11832876|FG005|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||63
10671100|NCT02326272|11832877|FG006|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||60
10671101|NCT02326272|11832878|FG007|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||27
10671102|NCT02326272|11832879|FG008|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||3
10671103|NCT02326272|11832880|FG009|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||10
10671104|NCT02326272|11832881|FG010|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10671105|NCT02326272|11832882|FG011|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10671106|NCT02326272|11832883|FG012|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10671107|NCT02326272|11832884|FG013|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10671108|NCT02326272|11832885|FG014|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10671109|NCT02326272|11832871|FG000|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10671110|NCT02326272|11832872|FG001|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10671111|NCT02326272|11832873|FG002|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10671112|NCT02326272|11832874|FG003|COMPLETED|Maintenance Period (Week 16 to Week 48)||5
10797049|NCT03682120|11957411|FG003|STARTED|Overall Study||57
10797050|NCT03682120|11957408|FG000|COMPLETED|Overall Study||92
10797051|NCT03682120|11957409|FG001|COMPLETED|Overall Study||97
10671113|NCT02326272|11832875|FG004|COMPLETED|Maintenance Period (Week 16 to Week 48)||3
10671114|NCT02326272|11832876|FG005|COMPLETED|Maintenance Period (Week 16 to Week 48)||63
10671115|NCT02326272|11832877|FG006|COMPLETED|Maintenance Period (Week 16 to Week 48)||60
10671116|NCT02326272|11832878|FG007|COMPLETED|Maintenance Period (Week 16 to Week 48)||27
10671117|NCT02326272|11832879|FG008|COMPLETED|Maintenance Period (Week 16 to Week 48)||3
10671118|NCT02326272|11832880|FG009|COMPLETED|Maintenance Period (Week 16 to Week 48)||10
10671119|NCT02326272|11832881|FG010|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10671120|NCT02326272|11832882|FG011|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10671121|NCT02326272|11832883|FG012|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10671122|NCT02326272|11832884|FG013|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10671123|NCT02326272|11832885|FG014|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10671124|NCT02326272|11832871|FG000|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10671125|NCT02326272|11832872|FG001|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10671126|NCT02326272|11832873|FG002|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10671127|NCT02326272|11832874|FG003|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
10671128|NCT02326272|11832875|FG004|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
10671129|NCT02326272|11832876|FG005|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||13
10671130|NCT02326272|11832877|FG006|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||9
10671131|NCT02326272|11832878|FG007|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||7
10671132|NCT02326272|11832879|FG008|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
10671133|NCT02326272|11832880|FG009|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
10671134|NCT02326272|11832881|FG010|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10671135|NCT02326272|11832882|FG011|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10671136|NCT02326272|11832883|FG012|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10671137|NCT02326272|11832884|FG013|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10671138|NCT02326272|11832885|FG014|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10671139|NCT02326272|11832871|FG000|STARTED|Open-label Period (Week 48 to Week 144)||0
10671140|NCT02326272|11832872|FG001|STARTED|Open-label Period (Week 48 to Week 144)||0
10671141|NCT02326272|11832873|FG002|STARTED|Open-label Period (Week 48 to Week 144)||0
10671142|NCT02326272|11832874|FG003|STARTED|Open-label Period (Week 48 to Week 144)||0
10671143|NCT02326272|11832875|FG004|STARTED|Open-label Period (Week 48 to Week 144)||0
10671144|NCT02326272|11832876|FG005|STARTED|Open-label Period (Week 48 to Week 144)||0
10671145|NCT02326272|11832877|FG006|STARTED|Open-label Period (Week 48 to Week 144)||0
10671146|NCT02326272|11832878|FG007|STARTED|Open-label Period (Week 48 to Week 144)||0
10671147|NCT02326272|11832879|FG008|STARTED|Open-label Period (Week 48 to Week 144)||0
10671148|NCT02326272|11832880|FG009|STARTED|Open-label Period (Week 48 to Week 144)||0
10797059|NCT03682302|11957428|FG001|STARTED|Overall Study||30
10671149|NCT02326272|11832881|FG010|STARTED|Open-label Period (Week 48 to Week 144)||5
10671150|NCT02326272|11832882|FG011|STARTED|Open-label Period (Week 48 to Week 144)||66
10671151|NCT02326272|11832883|FG012|STARTED|Open-label Period (Week 48 to Week 144)||59
10671152|NCT02326272|11832884|FG013|STARTED|Open-label Period (Week 48 to Week 144)||1
10671153|NCT02326272|11832885|FG014|STARTED|Open-label Period (Week 48 to Week 144)||40
10671154|NCT02326272|11832871|FG000|COMPLETED|Open-label Period (Week 48 to Week 144)||0
10671155|NCT02326272|11832872|FG001|COMPLETED|Open-label Period (Week 48 to Week 144)||0
10671156|NCT02326272|11832873|FG002|COMPLETED|Open-label Period (Week 48 to Week 144)||0
10671157|NCT02326272|11832874|FG003|COMPLETED|Open-label Period (Week 48 to Week 144)||0
10671158|NCT02326272|11832875|FG004|COMPLETED|Open-label Period (Week 48 to Week 144)||0
10671159|NCT02326272|11832876|FG005|COMPLETED|Open-label Period (Week 48 to Week 144)||0
10671160|NCT02326272|11832877|FG006|COMPLETED|Open-label Period (Week 48 to Week 144)||0
10671161|NCT02326272|11832878|FG007|COMPLETED|Open-label Period (Week 48 to Week 144)||0
10671162|NCT02326272|11832879|FG008|COMPLETED|Open-label Period (Week 48 to Week 144)||0
10671163|NCT02326272|11832880|FG009|COMPLETED|Open-label Period (Week 48 to Week 144)||0
10671164|NCT02326272|11832881|FG010|COMPLETED|Open-label Period (Week 48 to Week 144)||2
10671165|NCT02326272|11832882|FG011|COMPLETED|Open-label Period (Week 48 to Week 144)||51
10671166|NCT02326272|11832883|FG012|COMPLETED|Open-label Period (Week 48 to Week 144)||48
10671167|NCT02326272|11832884|FG013|COMPLETED|Open-label Period (Week 48 to Week 144)||1
10671168|NCT02326272|11832885|FG014|COMPLETED|Open-label Period (Week 48 to Week 144)||31
10671169|NCT02326272|11832871|FG000|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
10671170|NCT02326272|11832872|FG001|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
10671171|NCT02326272|11832873|FG002|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
10671172|NCT02326272|11832874|FG003|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
10671173|NCT02326272|11832875|FG004|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
10671174|NCT02326272|11832876|FG005|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
10671175|NCT02326272|11832877|FG006|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
10671176|NCT02326272|11832878|FG007|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
10671177|NCT02326272|11832879|FG008|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
10671178|NCT02326272|11832880|FG009|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
10671179|NCT02326272|11832881|FG010|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||3
10671180|NCT02326272|11832882|FG011|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||15
10671181|NCT02326272|11832883|FG012|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||11
10671182|NCT02326272|11832884|FG013|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
10671183|NCT02326272|11832885|FG014|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||9
10671184|NCT02326298|11832897|FG000|STARTED|Initial Period (Week 0 to Week 16)||51
10671185|NCT02326298|11832898|FG001|STARTED|Initial Period (Week 0 to Week 16)||95
10671186|NCT02326298|11832899|FG002|STARTED|Initial Period (Week 0 to Week 16)||88
10671187|NCT02326298|11832900|FG003|STARTED|Initial Period (Week 0 to Week 16)||0
10671188|NCT02326298|11832901|FG004|STARTED|Initial Period (Week 0 to Week 16)||0
10671189|NCT02326298|11832902|FG005|STARTED|Initial Period (Week 0 to Week 16)||0
10671190|NCT02326298|11832903|FG006|STARTED|Initial Period (Week 0 to Week 16)||0
10671191|NCT02326298|11832904|FG007|STARTED|Initial Period (Week 0 to Week 16)||0
10671192|NCT02326298|11832905|FG008|STARTED|Initial Period (Week 0 to Week 16)||0
10671193|NCT02326298|11832906|FG009|STARTED|Initial Period (Week 0 to Week 16)||0
10671194|NCT02326298|11832907|FG010|STARTED|Initial Period (Week 0 to Week 16)||0
10671195|NCT02326298|11832908|FG011|STARTED|Initial Period (Week 0 to Week 16)||0
10671196|NCT02326298|11832909|FG012|STARTED|Initial Period (Week 0 to Week 16)||0
10671197|NCT02326298|11832910|FG013|STARTED|Initial Period (Week 0 to Week 16)||0
10671198|NCT02326298|11832897|FG000|Completed Week 16|Initial Period (Week 0 to Week 16)||46
10671199|NCT02326298|11832898|FG001|Completed Week 16|Initial Period (Week 0 to Week 16)||92
10671200|NCT02326298|11832899|FG002|Completed Week 16|Initial Period (Week 0 to Week 16)||87
10671201|NCT02326298|11832900|FG003|Completed Week 16|Initial Period (Week 0 to Week 16)||0
10671202|NCT02326298|11832901|FG004|Completed Week 16|Initial Period (Week 0 to Week 16)||0
10671203|NCT02326298|11832902|FG005|Completed Week 16|Initial Period (Week 0 to Week 16)||0
10671204|NCT02326298|11832903|FG006|Completed Week 16|Initial Period (Week 0 to Week 16)||0
10671205|NCT02326298|11832904|FG007|Completed Week 16|Initial Period (Week 0 to Week 16)||0
10671206|NCT02326298|11832905|FG008|Completed Week 16|Initial Period (Week 0 to Week 16)||0
10671207|NCT02326298|11832906|FG009|Completed Week 16|Initial Period (Week 0 to Week 16)||0
10671208|NCT02326298|11832907|FG010|Completed Week 16|Initial Period (Week 0 to Week 16)||0
10671209|NCT02326298|11832908|FG011|Completed Week 16|Initial Period (Week 0 to Week 16)||0
10671210|NCT02326298|11832909|FG012|Completed Week 16|Initial Period (Week 0 to Week 16)||0
10671211|NCT02326298|11832910|FG013|Completed Week 16|Initial Period (Week 0 to Week 16)||0
10671212|NCT02326298|11832897|FG000|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||46
10671213|NCT02326298|11832898|FG001|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||92
10671214|NCT02326298|11832899|FG002|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||85
10671215|NCT02326298|11832900|FG003|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
10671216|NCT02326298|11832901|FG004|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
10671217|NCT02326298|11832902|FG005|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
10671218|NCT02326298|11832903|FG006|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
10671219|NCT02326298|11832904|FG007|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
10671220|NCT02326298|11832905|FG008|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
10671221|NCT02326298|11832906|FG009|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
10671222|NCT02326298|11832907|FG010|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
10671223|NCT02326298|11832908|FG011|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
10671224|NCT02326298|11832909|FG012|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
10671225|NCT02326298|11832910|FG013|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
10671226|NCT02326298|11832897|FG000|COMPLETED|Initial Period (Week 0 to Week 16)||46
10671227|NCT02326298|11832898|FG001|COMPLETED|Initial Period (Week 0 to Week 16)||92
10671228|NCT02326298|11832899|FG002|COMPLETED|Initial Period (Week 0 to Week 16)||85
10671229|NCT02326298|11832900|FG003|COMPLETED|Initial Period (Week 0 to Week 16)||0
10671230|NCT02326298|11832901|FG004|COMPLETED|Initial Period (Week 0 to Week 16)||0
10671231|NCT02326298|11832902|FG005|COMPLETED|Initial Period (Week 0 to Week 16)||0
10671232|NCT02326298|11832903|FG006|COMPLETED|Initial Period (Week 0 to Week 16)||0
10671233|NCT02326298|11832904|FG007|COMPLETED|Initial Period (Week 0 to Week 16)||0
10671234|NCT02326298|11832905|FG008|COMPLETED|Initial Period (Week 0 to Week 16)||0
10671235|NCT02326298|11832906|FG009|COMPLETED|Initial Period (Week 0 to Week 16)||0
10671236|NCT02326298|11832907|FG010|COMPLETED|Initial Period (Week 0 to Week 16)||0
10671237|NCT02326298|11832908|FG011|COMPLETED|Initial Period (Week 0 to Week 16)||0
10671238|NCT02326298|11832909|FG012|COMPLETED|Initial Period (Week 0 to Week 16)||0
10671239|NCT02326298|11832910|FG013|COMPLETED|Initial Period (Week 0 to Week 16)||0
10671240|NCT02326298|11832897|FG000|NOT COMPLETED|Initial Period (Week 0 to Week 16)||5
10671241|NCT02326298|11832898|FG001|NOT COMPLETED|Initial Period (Week 0 to Week 16)||3
10671242|NCT02326298|11832899|FG002|NOT COMPLETED|Initial Period (Week 0 to Week 16)||3
10671243|NCT02326298|11832900|FG003|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10671244|NCT02326298|11832901|FG004|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10671245|NCT02326298|11832902|FG005|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10671246|NCT02326298|11832903|FG006|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10671247|NCT02326298|11832904|FG007|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10671248|NCT02326298|11832905|FG008|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10671249|NCT02326298|11832906|FG009|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10671250|NCT02326298|11832907|FG010|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10671251|NCT02326298|11832908|FG011|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10671252|NCT02326298|11832909|FG012|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10671253|NCT02326298|11832910|FG013|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10671254|NCT02326298|11832897|FG000|STARTED|Maintenance Period (Week 16 to Week 48)||0
10671255|NCT02326298|11832898|FG001|STARTED|Maintenance Period (Week 16 to Week 48)||0
10671256|NCT02326298|11832899|FG002|STARTED|Maintenance Period (Week 16 to Week 48)||0
10671257|NCT02326298|11832900|FG003|STARTED|Maintenance Period (Week 16 to Week 48)||3
10671258|NCT02326298|11832901|FG004|STARTED|Maintenance Period (Week 16 to Week 48)||5
10671259|NCT02326298|11832902|FG005|STARTED|Maintenance Period (Week 16 to Week 48)||74
10671260|NCT02326298|11832903|FG006|STARTED|Maintenance Period (Week 16 to Week 48)||77
10671261|NCT02326298|11832904|FG007|STARTED|Maintenance Period (Week 16 to Week 48)||38
10671262|NCT02326298|11832905|FG008|STARTED|Maintenance Period (Week 16 to Week 48)||18
10671263|NCT02326298|11832906|FG009|STARTED|Maintenance Period (Week 16 to Week 48)||8
10671264|NCT02326298|11832907|FG010|STARTED|Maintenance Period (Week 16 to Week 48)||0
10671265|NCT02326298|11832908|FG011|STARTED|Maintenance Period (Week 16 to Week 48)||0
10671266|NCT02326298|11832909|FG012|STARTED|Maintenance Period (Week 16 to Week 48)||0
10671267|NCT02326298|11832910|FG013|STARTED|Maintenance Period (Week 16 to Week 48)||0
10671268|NCT02326298|11832897|FG000|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
10671269|NCT02326298|11832898|FG001|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
10671270|NCT02326298|11832899|FG002|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
10671271|NCT02326298|11832900|FG003|Completed Week 48|Maintenance Period (Week 16 to Week 48)||3
10671272|NCT02326298|11832901|FG004|Completed Week 48|Maintenance Period (Week 16 to Week 48)||5
10671273|NCT02326298|11832902|FG005|Completed Week 48|Maintenance Period (Week 16 to Week 48)||71
10671274|NCT02326298|11832903|FG006|Completed Week 48|Maintenance Period (Week 16 to Week 48)||70
10671275|NCT02326298|11832904|FG007|Completed Week 48|Maintenance Period (Week 16 to Week 48)||33
10671276|NCT02326298|11832905|FG008|Completed Week 48|Maintenance Period (Week 16 to Week 48)||13
10671277|NCT02326298|11832906|FG009|Completed Week 48|Maintenance Period (Week 16 to Week 48)||7
10671278|NCT02326298|11832907|FG010|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
10671279|NCT02326298|11832908|FG011|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
10671280|NCT02326298|11832909|FG012|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
10671281|NCT02326298|11832910|FG013|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
10671282|NCT02326298|11832897|FG000|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10671283|NCT02326298|11832898|FG001|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10671284|NCT02326298|11832899|FG002|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10671285|NCT02326298|11832900|FG003|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||3
10671286|NCT02326298|11832901|FG004|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||5
10671287|NCT02326298|11832902|FG005|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||69
10671288|NCT02326298|11832903|FG006|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||70
10671289|NCT02326298|11832904|FG007|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||33
10671290|NCT02326298|11832905|FG008|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||13
10671291|NCT02326298|11832906|FG009|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||7
10671292|NCT02326298|11832907|FG010|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10671293|NCT02326298|11832908|FG011|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10671294|NCT02326298|11832909|FG012|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10671295|NCT02326298|11832910|FG013|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10671296|NCT02326298|11832897|FG000|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10671297|NCT02326298|11832898|FG001|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10671298|NCT02326298|11832899|FG002|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10671299|NCT02326298|11832900|FG003|COMPLETED|Maintenance Period (Week 16 to Week 48)||3
10671300|NCT02326298|11832901|FG004|COMPLETED|Maintenance Period (Week 16 to Week 48)||5
10671301|NCT02326298|11832902|FG005|COMPLETED|Maintenance Period (Week 16 to Week 48)||69
10671302|NCT02326298|11832903|FG006|COMPLETED|Maintenance Period (Week 16 to Week 48)||70
10671303|NCT02326298|11832904|FG007|COMPLETED|Maintenance Period (Week 16 to Week 48)||33
10671304|NCT02326298|11832905|FG008|COMPLETED|Maintenance Period (Week 16 to Week 48)||13
10671305|NCT02326298|11832906|FG009|COMPLETED|Maintenance Period (Week 16 to Week 48)||7
10671306|NCT02326298|11832907|FG010|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10671307|NCT02326298|11832908|FG011|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10671308|NCT02326298|11832909|FG012|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10671309|NCT02326298|11832910|FG013|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10671310|NCT02326298|11832897|FG000|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10671311|NCT02326298|11832898|FG001|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10671312|NCT02326298|11832899|FG002|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10671313|NCT02326298|11832900|FG003|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10671314|NCT02326298|11832901|FG004|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10797052|NCT03682120|11957410|FG002|COMPLETED|Overall Study||97
10797053|NCT03682120|11957411|FG003|COMPLETED|Overall Study||55
10797054|NCT03682120|11957408|FG000|NOT COMPLETED|Overall Study||13
10797055|NCT03682120|11957409|FG001|NOT COMPLETED|Overall Study||8
10797056|NCT03682120|11957410|FG002|NOT COMPLETED|Overall Study||8
10797057|NCT03682120|11957411|FG003|NOT COMPLETED|Overall Study||2
10671315|NCT02326298|11832902|FG005|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
10712370|NCT02669849|11877994|FG002|COMPLETED|Overall Study||8
10797058|NCT03682302|11957427|FG000|STARTED|Overall Study||31
10671316|NCT02326298|11832903|FG006|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||7
10671317|NCT02326298|11832904|FG007|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
10671318|NCT02326298|11832905|FG008|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
10671319|NCT02326298|11832906|FG009|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
10671320|NCT02326298|11832907|FG010|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10671321|NCT02326298|11832908|FG011|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10671322|NCT02326298|11832909|FG012|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10671323|NCT02326298|11832910|FG013|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10671324|NCT02326298|11832897|FG000|STARTED|Open-label Period (Week 48 to Week 144)||0
10671325|NCT02326298|11832898|FG001|STARTED|Open-label Period (Week 48 to Week 144)||0
10671326|NCT02326298|11832899|FG002|STARTED|Open-label Period (Week 48 to Week 144)||0
10671327|NCT02326298|11832900|FG003|STARTED|Open-label Period (Week 48 to Week 144)||0
10671328|NCT02326298|11832901|FG004|STARTED|Open-label Period (Week 48 to Week 144)||0
10671329|NCT02326298|11832902|FG005|STARTED|Open-label Period (Week 48 to Week 144)||0
10671330|NCT02326298|11832903|FG006|STARTED|Open-label Period (Week 48 to Week 144)||0
10671331|NCT02326298|11832904|FG007|STARTED|Open-label Period (Week 48 to Week 144)||0
10671332|NCT02326298|11832905|FG008|STARTED|Open-label Period (Week 48 to Week 144)||0
10671333|NCT02326298|11832906|FG009|STARTED|Open-label Period (Week 48 to Week 144)||0
10671334|NCT02326298|11832907|FG010|STARTED|Open-label Period (Week 48 to Week 144)||3
10671335|NCT02326298|11832908|FG011|STARTED|Open-label Period (Week 48 to Week 144)||74
10671336|NCT02326298|11832909|FG012|STARTED|Open-label Period (Week 48 to Week 144)||70
10671337|NCT02326298|11832910|FG013|STARTED|Open-label Period (Week 48 to Week 144)||53
10671338|NCT02326298|11832897|FG000|COMPLETED|Open-label Period (Week 48 to Week 144)||0
10671339|NCT02326298|11832898|FG001|COMPLETED|Open-label Period (Week 48 to Week 144)||0
10671340|NCT02326298|11832899|FG002|COMPLETED|Open-label Period (Week 48 to Week 144)||0
10671341|NCT02326298|11832900|FG003|COMPLETED|Open-label Period (Week 48 to Week 144)||0
10671342|NCT02326298|11832901|FG004|COMPLETED|Open-label Period (Week 48 to Week 144)||0
10671343|NCT02326298|11832902|FG005|COMPLETED|Open-label Period (Week 48 to Week 144)||0
10671344|NCT02326298|11832903|FG006|COMPLETED|Open-label Period (Week 48 to Week 144)||0
10671345|NCT02326298|11832904|FG007|COMPLETED|Open-label Period (Week 48 to Week 144)||0
10671346|NCT02326298|11832905|FG008|COMPLETED|Open-label Period (Week 48 to Week 144)||0
10671347|NCT02326298|11832906|FG009|COMPLETED|Open-label Period (Week 48 to Week 144)||0
10671348|NCT02326298|11832907|FG010|COMPLETED|Open-label Period (Week 48 to Week 144)||3
10671349|NCT02326298|11832908|FG011|COMPLETED|Open-label Period (Week 48 to Week 144)||54
10671350|NCT02326298|11832909|FG012|COMPLETED|Open-label Period (Week 48 to Week 144)||51
10671351|NCT02326298|11832910|FG013|COMPLETED|Open-label Period (Week 48 to Week 144)||44
10671352|NCT02326298|11832897|FG000|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
10671353|NCT02326298|11832898|FG001|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
10671354|NCT02326298|11832899|FG002|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
10671355|NCT02326298|11832900|FG003|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
10671356|NCT02326298|11832901|FG004|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
10671357|NCT02326298|11832902|FG005|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
10671358|NCT02326298|11832903|FG006|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
10671359|NCT02326298|11832904|FG007|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
10671360|NCT02326298|11832905|FG008|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
10671361|NCT02326298|11832906|FG009|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
10671362|NCT02326298|11832907|FG010|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
10671363|NCT02326298|11832908|FG011|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||20
10671364|NCT02326298|11832909|FG012|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||19
10671365|NCT02326298|11832910|FG013|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||9
10671366|NCT02326363|11832921|FG000|STARTED|Overall Study||98
10671367|NCT02326363|11832922|FG001|STARTED|Overall Study||106
10671368|NCT02326363|11832921|FG000|COMPLETED|Overall Study||47
10671369|NCT02326363|11832922|FG001|COMPLETED|Overall Study||50
10671370|NCT02326363|11832921|FG000|NOT COMPLETED|Overall Study||51
10671371|NCT02326363|11832922|FG001|NOT COMPLETED|Overall Study||56
10671372|NCT02326467|11832930|FG000|STARTED|Overall Study||10
10671373|NCT02326467|11832930|FG000|COMPLETED|Overall Study||9
10671374|NCT02326467|11832930|FG000|NOT COMPLETED|Overall Study||1
10671375|NCT02326597|11832937|FG000|STARTED|Overall Study||60
10671376|NCT02326597|11832938|FG001|STARTED|Overall Study||60
10671377|NCT02326597|11832937|FG000|COMPLETED|Overall Study||18
10671378|NCT02326597|11832938|FG001|COMPLETED|Overall Study||28
10671379|NCT02326597|11832937|FG000|NOT COMPLETED|Overall Study||42
10671380|NCT02326597|11832938|FG001|NOT COMPLETED|Overall Study||32
10671381|NCT02326649|11832946|FG000|STARTED|Overall Study||33
10671382|NCT02326649|11832946|FG000|COMPLETED|Overall Study||21
10671383|NCT02326649|11832946|FG000|NOT COMPLETED|Overall Study||12
10671384|NCT02326805|11832952|FG000|STARTED|Overall Study||106
10671385|NCT02326805|11832953|FG001|STARTED|Overall Study||48
10671386|NCT02326805|11832952|FG000|COMPLETED|Overall Study||103
10671387|NCT02326805|11832953|FG001|COMPLETED|Overall Study||47
10671388|NCT02326805|11832952|FG000|NOT COMPLETED|Overall Study||3
10671389|NCT02326805|11832953|FG001|NOT COMPLETED|Overall Study||1
10671390|NCT02326844|11832959|FG000|STARTED|Overall Study||3
10671391|NCT02326844|11832959|FG000|COMPLETED|Overall Study||3
10671392|NCT02326844|11832959|FG000|NOT COMPLETED|Overall Study||0
10671393|NCT02326883|11832966|FG000|STARTED|Overall Study||6314
10671394|NCT02326883|11832967|FG001|STARTED|Overall Study||6312
10671395|NCT02326883|11832968|FG002|STARTED|Overall Study||6256
10671396|NCT02326883|11832966|FG000|COMPLETED|Overall Study||6230
10671397|NCT02326883|11832967|FG001|COMPLETED|Overall Study||6227
10671398|NCT02326883|11832968|FG002|COMPLETED|Overall Study||6187
10671399|NCT02326883|11832966|FG000|NOT COMPLETED|Overall Study||84
10671400|NCT02326883|11832967|FG001|NOT COMPLETED|Overall Study||85
10671401|NCT02326883|11832968|FG002|NOT COMPLETED|Overall Study||69
10671402|NCT02327013|11832979|FG000|STARTED|Overall Study||49
10671403|NCT02327013|11832980|FG001|STARTED|Overall Study||45
10671404|NCT02327013|11832981|FG002|STARTED|Overall Study||96
10671405|NCT02327013|11832982|FG003|STARTED|Overall Study||21
10671406|NCT02327013|11832983|FG004|STARTED|Overall Study||16
10671407|NCT02327013|11832979|FG000|COMPLETED|Overall Study||36
10671408|NCT02327013|11832980|FG001|COMPLETED|Overall Study||29
10671409|NCT02327013|11832981|FG002|COMPLETED|Overall Study||54
10671410|NCT02327013|11832982|FG003|COMPLETED|Overall Study||20
10671411|NCT02327013|11832983|FG004|COMPLETED|Overall Study||12
10671412|NCT02327013|11832979|FG000|NOT COMPLETED|Overall Study||13
10671413|NCT02327013|11832980|FG001|NOT COMPLETED|Overall Study||16
10671414|NCT02327013|11832981|FG002|NOT COMPLETED|Overall Study||42
10671415|NCT02327013|11832982|FG003|NOT COMPLETED|Overall Study||1
10671416|NCT02327013|11832983|FG004|NOT COMPLETED|Overall Study||4
10671417|NCT02327052|11833003|FG000|STARTED|Overall Study||58
10671418|NCT02327052|11833003|FG000|COMPLETED|Overall Study||58
10671419|NCT02327052|11833003|FG000|NOT COMPLETED|Overall Study||0
10671420|NCT02327117|11833009|FG000|STARTED|Overall Study||45
10671421|NCT02327117|11833010|FG001|STARTED|Overall Study||45
10671422|NCT02327117|11833009|FG000|COMPLETED|Overall Study||45
10671423|NCT02327117|11833010|FG001|COMPLETED|Overall Study||45
10671424|NCT02327117|11833009|FG000|NOT COMPLETED|Overall Study||0
10671425|NCT02327117|11833010|FG001|NOT COMPLETED|Overall Study||0
10671426|NCT02327130|11833016|FG000|STARTED|Overall Study||32
10671427|NCT02327130|11833016|FG000|COMPLETED|Overall Study||20
10671428|NCT02327130|11833016|FG000|NOT COMPLETED|Overall Study||12
10671429|NCT02327143|11833023|FG000|STARTED|Day 1: Time 0 Hrs to 6 Hrs||11
10671430|NCT02327143|11833024|FG001|STARTED|Day 1: Time 0 Hrs to 6 Hrs||0
10671431|NCT02327143|11833023|FG000|COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||11
10671432|NCT02327143|11833024|FG001|COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0
10671433|NCT02327143|11833023|FG000|NOT COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0
10671434|NCT02327143|11833024|FG001|NOT COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0
10671435|NCT02327143|11833023|FG000|STARTED|Day 1: Time 6 Hrs - to Day 9||0
10671436|NCT02327143|11833024|FG001|STARTED|Day 1: Time 6 Hrs - to Day 9||11
10671437|NCT02327143|11833023|FG000|COMPLETED|Day 1: Time 6 Hrs - to Day 9||0
10671438|NCT02327143|11833024|FG001|COMPLETED|Day 1: Time 6 Hrs - to Day 9||11
10671439|NCT02327143|11833023|FG000|NOT COMPLETED|Day 1: Time 6 Hrs - to Day 9||0
10671440|NCT02327143|11833024|FG001|NOT COMPLETED|Day 1: Time 6 Hrs - to Day 9||0
10671441|NCT02327169|11833045|FG000|STARTED|Overall Study||4
10671442|NCT02327169|11833046|FG001|STARTED|Overall Study||3
10671443|NCT02327169|11833047|FG002|STARTED|Overall Study||7
10797060|NCT03682302|11957429|FG002|STARTED|Overall Study|1 subject enrolled in Group 2, not treated, and surgery type unknown. Subject is not counted here.|6
10797061|NCT03682302|11957430|FG003|STARTED|Overall Study|1 subject enrolled in Group 2, not treated, and surgery type unknown. Subject is not counted here.|30
10797062|NCT03682302|11957427|FG000|COMPLETED|Overall Study||30
10797063|NCT03682302|11957428|FG001|COMPLETED|Overall Study||28
10797064|NCT03682302|11957429|FG002|COMPLETED|Overall Study||5
10797065|NCT03682302|11957430|FG003|COMPLETED|Overall Study||28
10797066|NCT03682302|11957427|FG000|NOT COMPLETED|Overall Study||1
10797067|NCT03682302|11957428|FG001|NOT COMPLETED|Overall Study||2
10671444|NCT02327169|11833048|FG003|STARTED|Overall Study||3
10671445|NCT02327169|11833049|FG004|STARTED|Overall Study||8
10671446|NCT02327169|11833050|FG005|STARTED|Overall Study||4
10671447|NCT02327169|11833051|FG006|STARTED|Overall Study||3
10671448|NCT02327169|11833052|FG007|STARTED|Overall Study||4
10671449|NCT02327169|11833053|FG008|STARTED|Overall Study||6
10671450|NCT02327169|11833054|FG009|STARTED|Overall Study||8
10671451|NCT02327169|11833055|FG010|STARTED|Overall Study||6
10671452|NCT02327169|11833056|FG011|STARTED|Overall Study||7
10671453|NCT02327169|11833057|FG012|STARTED|Overall Study||1
10671454|NCT02327169|11833058|FG013|STARTED|Overall Study||7
10671455|NCT02327169|11833059|FG014|STARTED|Overall Study||10
10671456|NCT02327169|11833045|FG000|COMPLETED|Overall Study||0
10671457|NCT02327169|11833046|FG001|COMPLETED|Overall Study||0
10671458|NCT02327169|11833047|FG002|COMPLETED|Overall Study||0
10671459|NCT02327169|11833048|FG003|COMPLETED|Overall Study||0
10671460|NCT02327169|11833049|FG004|COMPLETED|Overall Study||0
10671461|NCT02327169|11833050|FG005|COMPLETED|Overall Study||0
10671462|NCT02327169|11833051|FG006|COMPLETED|Overall Study||0
10671463|NCT02327169|11833052|FG007|COMPLETED|Overall Study||0
10671464|NCT02327169|11833053|FG008|COMPLETED|Overall Study||0
10671465|NCT02327169|11833054|FG009|COMPLETED|Overall Study||0
10671466|NCT02327169|11833055|FG010|COMPLETED|Overall Study||0
10671467|NCT02327169|11833056|FG011|COMPLETED|Overall Study||0
10671468|NCT02327169|11833057|FG012|COMPLETED|Overall Study||0
10671469|NCT02327169|11833058|FG013|COMPLETED|Overall Study||0
10671470|NCT02327169|11833059|FG014|COMPLETED|Overall Study||0
10671471|NCT02327169|11833045|FG000|NOT COMPLETED|Overall Study||4
10671472|NCT02327169|11833046|FG001|NOT COMPLETED|Overall Study||3
10671473|NCT02327169|11833047|FG002|NOT COMPLETED|Overall Study||7
10671474|NCT02327169|11833048|FG003|NOT COMPLETED|Overall Study||3
10671475|NCT02327169|11833049|FG004|NOT COMPLETED|Overall Study||8
10671476|NCT02327169|11833050|FG005|NOT COMPLETED|Overall Study||4
10671477|NCT02327169|11833051|FG006|NOT COMPLETED|Overall Study||3
10671478|NCT02327169|11833052|FG007|NOT COMPLETED|Overall Study||4
10671479|NCT02327169|11833053|FG008|NOT COMPLETED|Overall Study||6
10671480|NCT02327169|11833054|FG009|NOT COMPLETED|Overall Study||8
10671481|NCT02327169|11833055|FG010|NOT COMPLETED|Overall Study||6
10671482|NCT02327169|11833056|FG011|NOT COMPLETED|Overall Study||7
10671483|NCT02327169|11833057|FG012|NOT COMPLETED|Overall Study||1
10671484|NCT02327169|11833058|FG013|NOT COMPLETED|Overall Study||7
10671485|NCT02327169|11833059|FG014|NOT COMPLETED|Overall Study||10
10671486|NCT02327260|11833104|FG000|STARTED|Overall Study||20
10671487|NCT02327260|11833105|FG001|STARTED|Overall Study||24
10671488|NCT02327260|11833106|FG002|STARTED|Overall Study||17
10671489|NCT02327260|11833104|FG000|COMPLETED|Overall Study||14
10671490|NCT02327260|11833105|FG001|COMPLETED|Overall Study||20
10671491|NCT02327260|11833106|FG002|COMPLETED|Overall Study||15
10671492|NCT02327260|11833104|FG000|NOT COMPLETED|Overall Study||6
10671493|NCT02327260|11833105|FG001|NOT COMPLETED|Overall Study||4
10671494|NCT02327260|11833106|FG002|NOT COMPLETED|Overall Study||2
10671495|NCT02327325|11833118|FG000|STARTED|Overall Study||20
10671496|NCT02327325|11833119|FG001|STARTED|Overall Study||20
10671497|NCT02327325|11833120|FG002|STARTED|Overall Study||20
10671498|NCT02327325|11833118|FG000|COMPLETED|Overall Study||19
10671499|NCT02327325|11833119|FG001|COMPLETED|Overall Study||16
10671500|NCT02327325|11833120|FG002|COMPLETED|Overall Study||15
10671501|NCT02327325|11833118|FG000|NOT COMPLETED|Overall Study||1
10671502|NCT02327325|11833119|FG001|NOT COMPLETED|Overall Study||4
10671503|NCT02327325|11833120|FG002|NOT COMPLETED|Overall Study||5
10671504|NCT02327351|11833128|FG000|STARTED|Overall Study||98
10671505|NCT02327351|11833128|FG000|COMPLETED|Overall Study||98
10671506|NCT02327351|11833128|FG000|NOT COMPLETED|Overall Study||0
10671507|NCT02327429|11833136|FG000|STARTED|Overall Study||19
10671508|NCT02327429|11833136|FG000|COMPLETED|Overall Study||17
10671509|NCT02327429|11833136|FG000|NOT COMPLETED|Overall Study||2
10671510|NCT02327741|11833142|FG000|STARTED|Overall Study||502
10671511|NCT02327741|11833143|FG001|STARTED|Overall Study||508
10671512|NCT02327741|11833142|FG000|COMPLETED|Overall Study||502
10671513|NCT02327741|11833143|FG001|COMPLETED|Overall Study||508
10671514|NCT02327741|11833142|FG000|NOT COMPLETED|Overall Study||0
10671515|NCT02327741|11833143|FG001|NOT COMPLETED|Overall Study||0
10671516|NCT02328027|11833151|FG000|STARTED|Overall Study||5
10671517|NCT02328027|11833152|FG001|STARTED|Overall Study||11
10671518|NCT02328027|11833151|FG000|COMPLETED|Overall Study||5
10671519|NCT02328027|11833152|FG001|COMPLETED|Overall Study||10
10671520|NCT02328027|11833151|FG000|NOT COMPLETED|Overall Study||0
10671521|NCT02328027|11833152|FG001|NOT COMPLETED|Overall Study||1
10671522|NCT02328040|11833159|FG000|STARTED|First Intervention (2 Days)||8
10671523|NCT02328040|11833160|FG001|STARTED|First Intervention (2 Days)||9
10671524|NCT02328040|11833159|FG000|COMPLETED|First Intervention (2 Days)||7
10671525|NCT02328040|11833160|FG001|COMPLETED|First Intervention (2 Days)||8
10671526|NCT02328040|11833159|FG000|NOT COMPLETED|First Intervention (2 Days)||1
10671527|NCT02328040|11833160|FG001|NOT COMPLETED|First Intervention (2 Days)||1
10671528|NCT02328040|11833159|FG000|STARTED|Second Intervention (2 Days)||7
10671529|NCT02328040|11833160|FG001|STARTED|Second Intervention (2 Days)||8
10671530|NCT02328040|11833159|FG000|COMPLETED|Second Intervention (2 Days)||7
10671531|NCT02328040|11833160|FG001|COMPLETED|Second Intervention (2 Days)||8
10671532|NCT02328040|11833159|FG000|NOT COMPLETED|Second Intervention (2 Days)||0
10671533|NCT02328040|11833160|FG001|NOT COMPLETED|Second Intervention (2 Days)||0
10671534|NCT02328326|11833168|FG000|STARTED|Overall Study|3 participant dyads withdrew before 6-month follow up. 3 more care partners withdrew and 1 died.|246
10671535|NCT02328326|11833169|FG001|STARTED|Overall Study|1 participant dyad withdrew from the study between assignment to control arm and 6-month follow up.|232
10671536|NCT02328326|11833168|FG000|6-month Follow Up|Overall Study|We were unable to reach 15 participants. 1 patient died, 1 care partner withdrew before completion.|221
10671537|NCT02328326|11833169|FG001|6-month Follow Up|Overall Study|We were unable to reach 9 participants. 1 patient died, 1 care partner withdrew before completion.|221
10671538|NCT02328326|11833168|FG000|COMPLETED|Overall Study||224
10671539|NCT02328326|11833169|FG001|COMPLETED|Overall Study||224
10671540|NCT02328326|11833168|FG000|NOT COMPLETED|Overall Study||22
10671541|NCT02328326|11833169|FG001|NOT COMPLETED|Overall Study||8
10671542|NCT02328404|11833179|FG000|STARTED|Overall Study||30
10671543|NCT02328404|11833180|FG001|STARTED|Overall Study||30
10671544|NCT02328404|11833179|FG000|COMPLETED|Overall Study||29
10671545|NCT02328404|11833180|FG001|COMPLETED|Overall Study||29
10671546|NCT02328404|11833179|FG000|NOT COMPLETED|Overall Study||1
10671547|NCT02328404|11833180|FG001|NOT COMPLETED|Overall Study||1
10671548|NCT02328547|11833192|FG000|STARTED|First Intervention (12 Weeks)||25
10671549|NCT02328547|11833193|FG001|STARTED|First Intervention (12 Weeks)||23
10671550|NCT02328547|11833192|FG000|COMPLETED|First Intervention (12 Weeks)||22
10671551|NCT02328547|11833193|FG001|COMPLETED|First Intervention (12 Weeks)||23
10671552|NCT02328547|11833192|FG000|NOT COMPLETED|First Intervention (12 Weeks)||3
10671553|NCT02328547|11833193|FG001|NOT COMPLETED|First Intervention (12 Weeks)||0
10671554|NCT02328547|11833192|FG000|STARTED|Second Intervention (12 Weeks)||22
10671555|NCT02328547|11833193|FG001|STARTED|Second Intervention (12 Weeks)||23
10671556|NCT02328547|11833192|FG000|COMPLETED|Second Intervention (12 Weeks)||22
10671557|NCT02328547|11833193|FG001|COMPLETED|Second Intervention (12 Weeks)||23
10671558|NCT02328547|11833192|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0
10671559|NCT02328547|11833193|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||0
10671560|NCT02328755|11833207|FG000|STARTED|Overall Study||3
10671561|NCT02328755|11833208|FG001|STARTED|Overall Study||33
10671562|NCT02328755|11833207|FG000|COMPLETED|Overall Study|Evaluable for the phase II primary endpoint of relapse at 6-months post-HCT|0
10671563|NCT02328755|11833208|FG001|COMPLETED|Overall Study||31
10671564|NCT02328755|11833207|FG000|NOT COMPLETED|Overall Study||3
10671565|NCT02328755|11833208|FG001|NOT COMPLETED|Overall Study||2
10671566|NCT02328807|11833220|FG000|STARTED|Overall Study||6
10671567|NCT02328807|11833220|FG000|COMPLETED|Overall Study||6
10671568|NCT02328807|11833220|FG000|NOT COMPLETED|Overall Study||0
10671569|NCT02328937|11833226|FG000|STARTED|Period 1||7
10671570|NCT02328937|11833227|FG001|STARTED|Period 1||6
10671571|NCT02328937|11833228|FG002|STARTED|Period 1||7
10671572|NCT02328937|11833229|FG003|STARTED|Period 1||6
10671573|NCT02328937|11833230|FG004|STARTED|Period 1||6
10671574|NCT02328937|11833231|FG005|STARTED|Period 1||6
10671575|NCT02328937|11833226|FG000|COMPLETED|Period 1||7
10671576|NCT02328937|11833227|FG001|COMPLETED|Period 1||6
10671577|NCT02328937|11833228|FG002|COMPLETED|Period 1||7
10671578|NCT02328937|11833229|FG003|COMPLETED|Period 1||5
10671579|NCT02328937|11833230|FG004|COMPLETED|Period 1||6
10671580|NCT02328937|11833231|FG005|COMPLETED|Period 1||6
10671581|NCT02328937|11833226|FG000|NOT COMPLETED|Period 1||0
10671582|NCT02328937|11833227|FG001|NOT COMPLETED|Period 1||0
10671583|NCT02328937|11833228|FG002|NOT COMPLETED|Period 1||0
10671584|NCT02328937|11833229|FG003|NOT COMPLETED|Period 1||1
10671585|NCT02328937|11833230|FG004|NOT COMPLETED|Period 1||0
10671586|NCT02328937|11833231|FG005|NOT COMPLETED|Period 1||0
10671587|NCT02328937|11833226|FG000|STARTED|Period 2||7
10671588|NCT02328937|11833227|FG001|STARTED|Period 2||6
10671589|NCT02328937|11833228|FG002|STARTED|Period 2||7
10671590|NCT02328937|11833229|FG003|STARTED|Period 2||5
10671591|NCT02328937|11833230|FG004|STARTED|Period 2||6
10671592|NCT02328937|11833231|FG005|STARTED|Period 2||6
10671593|NCT02328937|11833226|FG000|COMPLETED|Period 2||7
10671594|NCT02328937|11833227|FG001|COMPLETED|Period 2||6
10671595|NCT02328937|11833228|FG002|COMPLETED|Period 2||6
10671596|NCT02328937|11833229|FG003|COMPLETED|Period 2||5
10671597|NCT02328937|11833230|FG004|COMPLETED|Period 2||6
10671598|NCT02328937|11833231|FG005|COMPLETED|Period 2||6
10671599|NCT02328937|11833226|FG000|NOT COMPLETED|Period 2||0
10671600|NCT02328937|11833227|FG001|NOT COMPLETED|Period 2||0
10671601|NCT02328937|11833228|FG002|NOT COMPLETED|Period 2||1
10671602|NCT02328937|11833229|FG003|NOT COMPLETED|Period 2||0
10671603|NCT02328937|11833230|FG004|NOT COMPLETED|Period 2||0
10671604|NCT02328937|11833231|FG005|NOT COMPLETED|Period 2||0
10671605|NCT02328937|11833226|FG000|STARTED|Period 3||7
10671606|NCT02328937|11833227|FG001|STARTED|Period 3||6
10671607|NCT02328937|11833228|FG002|STARTED|Period 3||6
10671608|NCT02328937|11833229|FG003|STARTED|Period 3||5
10671609|NCT02328937|11833230|FG004|STARTED|Period 3||6
10671610|NCT02328937|11833231|FG005|STARTED|Period 3||6
10671611|NCT02328937|11833226|FG000|COMPLETED|Period 3||7
10671612|NCT02328937|11833227|FG001|COMPLETED|Period 3||6
10671613|NCT02328937|11833228|FG002|COMPLETED|Period 3||6
10671614|NCT02328937|11833229|FG003|COMPLETED|Period 3||5
10671615|NCT02328937|11833230|FG004|COMPLETED|Period 3||6
10671616|NCT02328937|11833231|FG005|COMPLETED|Period 3||6
10671617|NCT02328937|11833226|FG000|NOT COMPLETED|Period 3||0
10671618|NCT02328937|11833227|FG001|NOT COMPLETED|Period 3||0
10797068|NCT03682302|11957429|FG002|NOT COMPLETED|Overall Study||1
10797069|NCT03682302|11957430|FG003|NOT COMPLETED|Overall Study||2
10797070|NCT03682705|11957446|FG000|STARTED|Overall Study||19
10797071|NCT03682705|11957447|FG001|STARTED|Overall Study||62
10797072|NCT03682705|11957448|FG002|STARTED|Overall Study||41
10797073|NCT03682705|11957449|FG003|STARTED|Overall Study||39
10797074|NCT03682705|11957450|FG004|STARTED|Overall Study||41
10797075|NCT03682705|11957451|FG005|STARTED|Overall Study||40
10797076|NCT03682705|11957446|FG000|COMPLETED|Overall Study||17
10797077|NCT03682705|11957447|FG001|COMPLETED|Overall Study||58
10797078|NCT03682705|11957448|FG002|COMPLETED|Overall Study||38
10797079|NCT03682705|11957449|FG003|COMPLETED|Overall Study||34
10797080|NCT03682705|11957450|FG004|COMPLETED|Overall Study||35
10797081|NCT03682705|11957451|FG005|COMPLETED|Overall Study||38
10797082|NCT03682705|11957446|FG000|NOT COMPLETED|Overall Study||2
10671619|NCT02328937|11833228|FG002|NOT COMPLETED|Period 3||0
10671620|NCT02328937|11833229|FG003|NOT COMPLETED|Period 3||0
10671621|NCT02328937|11833230|FG004|NOT COMPLETED|Period 3||0
10671622|NCT02328937|11833231|FG005|NOT COMPLETED|Period 3||0
10671623|NCT02329015|11833241|FG000|STARTED|Overall Study||48
10671624|NCT02329015|11833242|FG001|STARTED|Overall Study||64
10671625|NCT02329015|11833241|FG000|COMPLETED|Overall Study||48
10671626|NCT02329015|11833242|FG001|COMPLETED|Overall Study||64
10671627|NCT02329015|11833241|FG000|NOT COMPLETED|Overall Study||0
10671628|NCT02329015|11833242|FG001|NOT COMPLETED|Overall Study||0
10671629|NCT02329223|11833251|FG000|STARTED|Overall Study||73
10671630|NCT02329223|11833252|FG001|STARTED|Overall Study||71
10671631|NCT02329223|11833253|FG002|STARTED|Overall Study||74
10671632|NCT02329223|11833251|FG000|Full Analysis Set|Overall Study||73
10671633|NCT02329223|11833252|FG001|Full Analysis Set|Overall Study||70
10797083|NCT03682705|11957447|FG001|NOT COMPLETED|Overall Study||4
10797084|NCT03682705|11957448|FG002|NOT COMPLETED|Overall Study||3
10797085|NCT03682705|11957449|FG003|NOT COMPLETED|Overall Study||5
10797086|NCT03682705|11957450|FG004|NOT COMPLETED|Overall Study||6
10797087|NCT03682705|11957451|FG005|NOT COMPLETED|Overall Study||2
10797088|NCT03682809|11957467|FG000|STARTED|Overall Study||22
10797089|NCT03682809|11957468|FG001|STARTED|Overall Study||24
10671634|NCT02329223|11833253|FG002|Full Analysis Set|Overall Study||74
10671635|NCT02329223|11833251|FG000|Safety Set|Overall Study||73
10671636|NCT02329223|11833252|FG001|Safety Set|Overall Study||71
10671637|NCT02329223|11833253|FG002|Safety Set|Overall Study||74
10671638|NCT02329223|11833251|FG000|COMPLETED|Overall Study||72
10671639|NCT02329223|11833252|FG001|COMPLETED|Overall Study||68
10671640|NCT02329223|11833253|FG002|COMPLETED|Overall Study||68
10671641|NCT02329223|11833251|FG000|NOT COMPLETED|Overall Study||1
10671642|NCT02329223|11833252|FG001|NOT COMPLETED|Overall Study||3
10671643|NCT02329223|11833253|FG002|NOT COMPLETED|Overall Study||6
10671644|NCT02329431|11833263|FG000|STARTED|Overall Study||92
10671645|NCT02329431|11833264|FG001|STARTED|Overall Study||89
10671646|NCT02329431|11833263|FG000|Baseline Interview|Overall Study||87
10671647|NCT02329431|11833264|FG001|Baseline Interview|Overall Study||85
10671648|NCT02329431|11833263|FG000|COMPLETED|Overall Study||72
10671649|NCT02329431|11833264|FG001|COMPLETED|Overall Study||76
10671650|NCT02329431|11833263|FG000|NOT COMPLETED|Overall Study||20
10671651|NCT02329431|11833264|FG001|NOT COMPLETED|Overall Study||13
10671652|NCT02329587|11833272|FG000|STARTED|Baseline Thru Post-treatment Assessment||5
10671653|NCT02329587|11833273|FG001|STARTED|Baseline Thru Post-treatment Assessment||7
10671654|NCT02329587|11833272|FG000|Completed All Intervention Sessions|Baseline Thru Post-treatment Assessment||3
10671655|NCT02329587|11833273|FG001|Completed All Intervention Sessions|Baseline Thru Post-treatment Assessment||4
10671656|NCT02329587|11833272|FG000|COMPLETED|Baseline Thru Post-treatment Assessment||4
10671657|NCT02329587|11833273|FG001|COMPLETED|Baseline Thru Post-treatment Assessment||6
10797090|NCT03682809|11957467|FG000|COMPLETED|Overall Study||22
10797091|NCT03682809|11957468|FG001|COMPLETED|Overall Study||24
10797092|NCT03682809|11957467|FG000|NOT COMPLETED|Overall Study||0
10797093|NCT03682809|11957468|FG001|NOT COMPLETED|Overall Study||0
10797094|NCT03682965|11957476|FG000|STARTED|Overall Study||11
10797095|NCT03682965|11957477|FG001|STARTED|Overall Study||10
10797096|NCT03682965|11957476|FG000|COMPLETED|Overall Study||11
10797097|NCT03682965|11957477|FG001|COMPLETED|Overall Study||10
10671658|NCT02329587|11833272|FG000|NOT COMPLETED|Baseline Thru Post-treatment Assessment||1
10671659|NCT02329587|11833273|FG001|NOT COMPLETED|Baseline Thru Post-treatment Assessment||1
10671660|NCT02329587|11833272|FG000|STARTED|1-month Follow-up||4
10671661|NCT02329587|11833273|FG001|STARTED|1-month Follow-up||6
10671662|NCT02329587|11833272|FG000|COMPLETED|1-month Follow-up||4
10671663|NCT02329587|11833273|FG001|COMPLETED|1-month Follow-up||5
10671664|NCT02329587|11833272|FG000|NOT COMPLETED|1-month Follow-up||0
10671665|NCT02329587|11833273|FG001|NOT COMPLETED|1-month Follow-up||1
10671666|NCT02329600|11833282|FG000|STARTED|Overall Study||10
10671667|NCT02329600|11833283|FG001|STARTED|Overall Study||15
10671668|NCT02329600|11833284|FG002|STARTED|Overall Study||15
10671669|NCT02329600|11833282|FG000|COMPLETED|Overall Study||10
10671670|NCT02329600|11833283|FG001|COMPLETED|Overall Study||15
10671671|NCT02329600|11833284|FG002|COMPLETED|Overall Study||15
10671672|NCT02329600|11833282|FG000|NOT COMPLETED|Overall Study||0
10671673|NCT02329600|11833283|FG001|NOT COMPLETED|Overall Study||0
10671674|NCT02329600|11833284|FG002|NOT COMPLETED|Overall Study||0
10671675|NCT02329730|11833296|FG000|STARTED|Overall Study||14
10671676|NCT02329730|11833297|FG001|STARTED|Overall Study||14
10671677|NCT02329730|11833298|FG002|STARTED|Overall Study||14
10671678|NCT02329730|11833299|FG003|STARTED|Overall Study||14
10671679|NCT02329730|11833300|FG004|STARTED|Overall Study||14
10671680|NCT02329730|11833301|FG005|STARTED|Overall Study||14
10671681|NCT02329730|11833302|FG006|STARTED|Overall Study||14
10671682|NCT02329730|11833303|FG007|STARTED|Overall Study||14
10671683|NCT02329730|11833304|FG008|STARTED|Overall Study||8
10671684|NCT02329730|11833305|FG009|STARTED|Overall Study||8
10671685|NCT02329730|11833306|FG010|STARTED|Overall Study||8
10671686|NCT02329730|11833307|FG011|STARTED|Overall Study||8
10671687|NCT02329730|11833296|FG000|COMPLETED|Overall Study||14
10671688|NCT02329730|11833297|FG001|COMPLETED|Overall Study||14
10671689|NCT02329730|11833298|FG002|COMPLETED|Overall Study||14
10671690|NCT02329730|11833299|FG003|COMPLETED|Overall Study||14
10671691|NCT02329730|11833300|FG004|COMPLETED|Overall Study||11
10671692|NCT02329730|11833301|FG005|COMPLETED|Overall Study||12
10671693|NCT02329730|11833302|FG006|COMPLETED|Overall Study||13
10671694|NCT02329730|11833303|FG007|COMPLETED|Overall Study||13
10671695|NCT02329730|11833304|FG008|COMPLETED|Overall Study||7
10671696|NCT02329730|11833305|FG009|COMPLETED|Overall Study||7
10671697|NCT02329730|11833306|FG010|COMPLETED|Overall Study||8
10671698|NCT02329730|11833307|FG011|COMPLETED|Overall Study||8
10671699|NCT02329730|11833296|FG000|NOT COMPLETED|Overall Study||0
10671700|NCT02329730|11833297|FG001|NOT COMPLETED|Overall Study||0
10671701|NCT02329730|11833298|FG002|NOT COMPLETED|Overall Study||0
10671702|NCT02329730|11833299|FG003|NOT COMPLETED|Overall Study||0
10671703|NCT02329730|11833300|FG004|NOT COMPLETED|Overall Study||3
10671704|NCT02329730|11833301|FG005|NOT COMPLETED|Overall Study||2
10671705|NCT02329730|11833302|FG006|NOT COMPLETED|Overall Study||1
10671706|NCT02329730|11833303|FG007|NOT COMPLETED|Overall Study||1
10671707|NCT02329730|11833304|FG008|NOT COMPLETED|Overall Study||1
10671708|NCT02329730|11833305|FG009|NOT COMPLETED|Overall Study||1
10671709|NCT02329730|11833306|FG010|NOT COMPLETED|Overall Study||0
10671710|NCT02329730|11833307|FG011|NOT COMPLETED|Overall Study||0
10671711|NCT02329743|11833328|FG000|STARTED|Overall Study||84
10671712|NCT02329743|11833329|FG001|STARTED|Overall Study||87
10797098|NCT03682965|11957476|FG000|NOT COMPLETED|Overall Study||0
10671713|NCT02329743|11833330|FG002|STARTED|Overall Study||85
10671714|NCT02329743|11833328|FG000|COMPLETED|Overall Study||78
10671715|NCT02329743|11833329|FG001|COMPLETED|Overall Study||80
10671716|NCT02329743|11833330|FG002|COMPLETED|Overall Study||77
10671717|NCT02329743|11833328|FG000|NOT COMPLETED|Overall Study||6
10671718|NCT02329743|11833329|FG001|NOT COMPLETED|Overall Study||7
10671719|NCT02329743|11833330|FG002|NOT COMPLETED|Overall Study||8
10671720|NCT02329964|11833340|FG000|STARTED|Overall Study||40
10671721|NCT02329964|11833341|FG001|STARTED|Overall Study||40
10671722|NCT02329964|11833340|FG000|COMPLETED|Overall Study||40
10671723|NCT02329964|11833341|FG001|COMPLETED|Overall Study||40
10671724|NCT02329964|11833340|FG000|NOT COMPLETED|Overall Study||0
10671725|NCT02329964|11833341|FG001|NOT COMPLETED|Overall Study||0
10671726|NCT02330055|11833349|FG000|STARTED|Overall Study||50
10671727|NCT02330055|11833350|FG001|STARTED|Overall Study||49
10671728|NCT02330055|11833349|FG000|COMPLETED|Overall Study||40
10671729|NCT02330055|11833350|FG001|COMPLETED|Overall Study||40
10671730|NCT02330055|11833349|FG000|NOT COMPLETED|Overall Study||10
10671731|NCT02330055|11833350|FG001|NOT COMPLETED|Overall Study||9
10671732|NCT02330081|11833356|FG000|STARTED|Overall Study||22
10671733|NCT02330081|11833356|FG000|COMPLETED|Overall Study||14
10671734|NCT02330081|11833356|FG000|NOT COMPLETED|Overall Study||8
10671735|NCT02330094|11833365|FG000|STARTED|Overall Study||8
10671736|NCT02330094|11833366|FG001|STARTED|Overall Study||8
10671737|NCT02330094|11833365|FG000|COMPLETED|Overall Study||8
10671738|NCT02330094|11833366|FG001|COMPLETED|Overall Study||8
10671739|NCT02330094|11833365|FG000|NOT COMPLETED|Overall Study||0
10671740|NCT02330094|11833366|FG001|NOT COMPLETED|Overall Study||0
10671741|NCT02330172|11833374|FG000|STARTED|Overall Study||22
10671742|NCT02330172|11833375|FG001|STARTED|Overall Study||22
10671743|NCT02330172|11833374|FG000|COMPLETED|Overall Study||19
10671744|NCT02330172|11833375|FG001|COMPLETED|Overall Study||21
10671745|NCT02330172|11833374|FG000|NOT COMPLETED|Overall Study||3
10671746|NCT02330172|11833375|FG001|NOT COMPLETED|Overall Study||1
10671747|NCT02330276|11833384|FG000|STARTED|Overall Study||4
10671748|NCT02330276|11833385|FG001|STARTED|Overall Study||4
10671749|NCT02330276|11833386|FG002|STARTED|Overall Study||4
10671750|NCT02330276|11833384|FG000|COMPLETED|Overall Study||4
10671751|NCT02330276|11833385|FG001|COMPLETED|Overall Study||4
10671752|NCT02330276|11833386|FG002|COMPLETED|Overall Study||4
10671753|NCT02330276|11833384|FG000|NOT COMPLETED|Overall Study||0
10671754|NCT02330276|11833385|FG001|NOT COMPLETED|Overall Study||0
10671755|NCT02330276|11833386|FG002|NOT COMPLETED|Overall Study||0
10671756|NCT02330341|11833396|FG000|STARTED|Overall Study||12
10671757|NCT02330341|11833397|FG001|STARTED|Overall Study||12
10671758|NCT02330341|11833396|FG000|COMPLETED|Overall Study||12
10671759|NCT02330341|11833397|FG001|COMPLETED|Overall Study||11
10671760|NCT02330341|11833396|FG000|NOT COMPLETED|Overall Study||0
10671761|NCT02330341|11833397|FG001|NOT COMPLETED|Overall Study||1
10671762|NCT02330523|11833405|FG000|STARTED|Overall Study||21
10671763|NCT02330523|11833406|FG001|STARTED|Overall Study||19
10671764|NCT02330523|11833405|FG000|COMPLETED|Overall Study||21
10671765|NCT02330523|11833406|FG001|COMPLETED|Overall Study||19
10671766|NCT02330523|11833405|FG000|NOT COMPLETED|Overall Study||0
10671767|NCT02330523|11833406|FG001|NOT COMPLETED|Overall Study||0
10671768|NCT02330549|11833414|FG000|STARTED|Overall Study||20
10671769|NCT02330549|11833415|FG001|STARTED|Overall Study||25
10671770|NCT02330549|11833414|FG000|COMPLETED|Overall Study||16
10671771|NCT02330549|11833415|FG001|COMPLETED|Overall Study||24
10671772|NCT02330549|11833414|FG000|NOT COMPLETED|Overall Study||4
10671773|NCT02330549|11833415|FG001|NOT COMPLETED|Overall Study||1
10671774|NCT02330588|11833426|FG000|STARTED|Overall Study||44
10671775|NCT02330588|11833427|FG001|STARTED|Overall Study||43
10671776|NCT02330588|11833428|FG002|STARTED|Overall Study||46
10671777|NCT02330588|11833429|FG003|STARTED|Overall Study||46
10671778|NCT02330588|11833430|FG004|STARTED|Overall Study||47
10671779|NCT02330588|11833426|FG000|COMPLETED|Overall Study||28
10671780|NCT02330588|11833427|FG001|COMPLETED|Overall Study||25
10671781|NCT02330588|11833428|FG002|COMPLETED|Overall Study||31
10671782|NCT02330588|11833429|FG003|COMPLETED|Overall Study||24
10671783|NCT02330588|11833430|FG004|COMPLETED|Overall Study||28
10671784|NCT02330588|11833426|FG000|NOT COMPLETED|Overall Study||16
10671785|NCT02330588|11833427|FG001|NOT COMPLETED|Overall Study||18
10671786|NCT02330588|11833428|FG002|NOT COMPLETED|Overall Study||15
10671787|NCT02330588|11833429|FG003|NOT COMPLETED|Overall Study||22
10671788|NCT02330588|11833430|FG004|NOT COMPLETED|Overall Study||19
10671789|NCT02330627|11833452|FG000|STARTED|Overall Study||16
10671790|NCT02330627|11833453|FG001|STARTED|Overall Study||13
10671791|NCT02330627|11833452|FG000|COMPLETED|Overall Study||15
10671792|NCT02330627|11833453|FG001|COMPLETED|Overall Study||12
10671793|NCT02330627|11833452|FG000|NOT COMPLETED|Overall Study||1
10671794|NCT02330627|11833453|FG001|NOT COMPLETED|Overall Study||1
10671795|NCT02330978|11833459|FG000|STARTED|The First Patient Included at Study||1
10671796|NCT02330978|11833459|FG000|COMPLETED|The First Patient Included at Study||1
10671797|NCT02330978|11833459|FG000|NOT COMPLETED|The First Patient Included at Study||0
10671798|NCT02330978|11833459|FG000|STARTED|The Second Patient Included at Study||1
10712371|NCT02669849|11877992|FG000|NOT COMPLETED|Overall Study||18
10671799|NCT02330978|11833459|FG000|COMPLETED|The Second Patient Included at Study||1
10671800|NCT02330978|11833459|FG000|NOT COMPLETED|The Second Patient Included at Study||0
10671801|NCT02331095|11833465|FG000|STARTED|Overall Study||11
10671802|NCT02331095|11833466|FG001|STARTED|Overall Study||10
10671803|NCT02331095|11833465|FG000|COMPLETED|Overall Study||7
10671804|NCT02331095|11833466|FG001|COMPLETED|Overall Study||9
10671805|NCT02331095|11833465|FG000|NOT COMPLETED|Overall Study||4
10671806|NCT02331095|11833466|FG001|NOT COMPLETED|Overall Study||1
10712372|NCT02669849|11877993|FG001|NOT COMPLETED|Overall Study||2
10712373|NCT02669849|11877994|FG002|NOT COMPLETED|Overall Study||24
10712374|NCT02669862|11878005|FG000|STARTED|Overall Study||33
10712375|NCT02669862|11878006|FG001|STARTED|Overall Study||34
10712376|NCT02669862|11878007|FG002|STARTED|Overall Study||31
10712377|NCT02669862|11878005|FG000|COMPLETED|Overall Study||31
10712378|NCT02669862|11878006|FG001|COMPLETED|Overall Study||29
10712379|NCT02669862|11878007|FG002|COMPLETED|Overall Study||26
10712380|NCT02669862|11878005|FG000|NOT COMPLETED|Overall Study||2
10712381|NCT02669862|11878006|FG001|NOT COMPLETED|Overall Study||5
10712382|NCT02669862|11878007|FG002|NOT COMPLETED|Overall Study||5
10712383|NCT02669914|11878021|FG000|STARTED|Overall Study||4
10712384|NCT02669914|11878022|FG001|STARTED|Overall Study||0
10712385|NCT02669914|11878023|FG002|STARTED|Overall Study||0
10712386|NCT02669914|11878021|FG000|COMPLETED|Overall Study||4
10712387|NCT02669914|11878022|FG001|COMPLETED|Overall Study||0
10712388|NCT02669914|11878023|FG002|COMPLETED|Overall Study||0
10712389|NCT02669914|11878021|FG000|NOT COMPLETED|Overall Study||0
10712390|NCT02669914|11878022|FG001|NOT COMPLETED|Overall Study||0
10712391|NCT02669914|11878023|FG002|NOT COMPLETED|Overall Study||0
10712392|NCT02669940|11878033|FG000|STARTED|Overall Study||63
10712393|NCT02669940|11878034|FG001|STARTED|Overall Study||95
10712394|NCT02669940|11878033|FG000|COMPLETED|Overall Study||62
10712395|NCT02669940|11878034|FG001|COMPLETED|Overall Study||92
10712396|NCT02669940|11878033|FG000|NOT COMPLETED|Overall Study||1
10712397|NCT02669940|11878034|FG001|NOT COMPLETED|Overall Study||3
10712398|NCT02670083|11878049|FG000|STARTED|Overall Study||409
10712399|NCT02670083|11878050|FG001|STARTED|Overall Study||404
10712400|NCT02670083|11878049|FG000|COMPLETED|Overall Study||88
10712401|NCT02670083|11878050|FG001|COMPLETED|Overall Study||85
10712402|NCT02670083|11878049|FG000|NOT COMPLETED|Overall Study||321
10712403|NCT02670083|11878050|FG001|NOT COMPLETED|Overall Study||319
10712404|NCT02670122|11878057|FG000|STARTED|Overall Study||131
10712405|NCT02670122|11878057|FG000|COMPLETED|Overall Study|18 patients recieved liver transplantation|127
10712406|NCT02670122|11878057|FG000|NOT COMPLETED|Overall Study||4
10712407|NCT02670330|11878070|FG000|STARTED|Overall Study||75
10712408|NCT02670330|11878071|FG001|STARTED|Overall Study||77
10712409|NCT02670330|11878070|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||75
10712410|NCT02670330|11878071|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||77
10712411|NCT02670330|11878070|FG000|COMPLETED|Overall Study||0
10712412|NCT02670330|11878071|FG001|COMPLETED|Overall Study||0
10712413|NCT02670330|11878070|FG000|NOT COMPLETED|Overall Study||75
10712414|NCT02670330|11878071|FG001|NOT COMPLETED|Overall Study||77
10712415|NCT02670343|11878077|FG000|STARTED|Overall Study||8
10712416|NCT02670343|11878077|FG000|COMPLETED|Overall Study||8
10712417|NCT02670343|11878077|FG000|NOT COMPLETED|Overall Study||0
10713871|NCT02683083|11879411|FG000|NOT COMPLETED|Overall Study||0
10713872|NCT02683109|11879417|FG000|STARTED|Overall Study||110
10713873|NCT02683109|11879418|FG001|STARTED|Overall Study||111
10713874|NCT02683109|11879417|FG000|COMPLETED|Overall Study||109
10713875|NCT02683109|11879418|FG001|COMPLETED|Overall Study||111
10713876|NCT02683109|11879417|FG000|NOT COMPLETED|Overall Study||1
10713877|NCT02683109|11879418|FG001|NOT COMPLETED|Overall Study||0
10713878|NCT02683161|11879425|FG000|STARTED|Overall Study||5
10713879|NCT02683161|11879425|FG000|COMPLETED|Overall Study||5
10713880|NCT02683161|11879425|FG000|NOT COMPLETED|Overall Study||0
10713881|NCT02683174|11879429|FG000|STARTED|Overall Study||86
10713882|NCT02683174|11879429|FG000|COMPLETED|Overall Study||86
10713883|NCT02683174|11879429|FG000|NOT COMPLETED|Overall Study||0
10713884|NCT02683187|11879434|FG000|STARTED|Overall Study||40
10713885|NCT02683187|11879434|FG000|COMPLETED|Overall Study||32
10713886|NCT02683187|11879434|FG000|NOT COMPLETED|Overall Study||8
10713887|NCT02683421|11879446|FG000|STARTED|Overall Study||5
10713888|NCT02683421|11879447|FG001|STARTED|Overall Study||4
10713889|NCT02683421|11879448|FG002|STARTED|Overall Study||4
10713890|NCT02683421|11879449|FG003|STARTED|Overall Study||5
10713891|NCT02683421|11879446|FG000|COMPLETED|Overall Study||5
10713892|NCT02683421|11879447|FG001|COMPLETED|Overall Study||4
10713893|NCT02683421|11879448|FG002|COMPLETED|Overall Study||4
10713894|NCT02683421|11879449|FG003|COMPLETED|Overall Study||5
10713895|NCT02683421|11879446|FG000|NOT COMPLETED|Overall Study||0
10713896|NCT02683421|11879447|FG001|NOT COMPLETED|Overall Study||0
10713897|NCT02683421|11879448|FG002|NOT COMPLETED|Overall Study||0
10713898|NCT02683421|11879449|FG003|NOT COMPLETED|Overall Study||0
10713899|NCT02683525|11879459|FG000|STARTED|Overall Study||37
10713900|NCT02683525|11879459|FG000|COMPLETED|Overall Study||29
10713901|NCT02683525|11879459|FG000|NOT COMPLETED|Overall Study||8
10713902|NCT02683577|11879466|FG000|STARTED|Overall Study||8
10713903|NCT02683577|11879467|FG001|STARTED|Overall Study||8
10713904|NCT02683577|11879468|FG002|STARTED|Overall Study||8
10713905|NCT02683577|11879466|FG000|COMPLETED|Overall Study||8
10713906|NCT02683577|11879467|FG001|COMPLETED|Overall Study||8
10713907|NCT02683577|11879468|FG002|COMPLETED|Overall Study||8
10713908|NCT02683577|11879466|FG000|NOT COMPLETED|Overall Study||0
10671807|NCT02331108|11833482|FG000|STARTED|Overall Study||51
10671808|NCT02331108|11833483|FG001|STARTED|Overall Study||52
10671809|NCT02331108|11833484|FG002|STARTED|Overall Study||51
10671810|NCT02331108|11833485|FG003|STARTED|Overall Study||51
10671811|NCT02331108|11833486|FG004|STARTED|Overall Study||52
10671812|NCT02331108|11833487|FG005|STARTED|Overall Study||52
10671813|NCT02331108|11833482|FG000|COMPLETED|Overall Study||50
10671814|NCT02331108|11833483|FG001|COMPLETED|Overall Study||50
10671815|NCT02331108|11833484|FG002|COMPLETED|Overall Study||50
10671816|NCT02331108|11833485|FG003|COMPLETED|Overall Study||50
10671817|NCT02331108|11833486|FG004|COMPLETED|Overall Study||50
10671818|NCT02331108|11833487|FG005|COMPLETED|Overall Study||50
10671819|NCT02331108|11833482|FG000|NOT COMPLETED|Overall Study||1
10671820|NCT02331108|11833483|FG001|NOT COMPLETED|Overall Study||2
10671821|NCT02331108|11833484|FG002|NOT COMPLETED|Overall Study||1
10671822|NCT02331108|11833485|FG003|NOT COMPLETED|Overall Study||1
10671823|NCT02331108|11833486|FG004|NOT COMPLETED|Overall Study||2
10671824|NCT02331108|11833487|FG005|NOT COMPLETED|Overall Study||2
10671825|NCT02331368|11833503|FG000|STARTED|Overall Study||32
10671826|NCT02331368|11833503|FG000|COMPLETED|Overall Study||29
10671827|NCT02331368|11833503|FG000|NOT COMPLETED|Overall Study||3
10671828|NCT02331394|11833507|FG000|STARTED|Overall Study||15
10671829|NCT02331394|11833507|FG000|COMPLETED|Overall Study|14 patients, 1 dropped out|14
10671830|NCT02331394|11833507|FG000|NOT COMPLETED|Overall Study||1
10671831|NCT02331407|11833518|FG000|STARTED|Overall Study||9
10671832|NCT02331407|11833518|FG000|COMPLETED|Overall Study||9
10671833|NCT02331407|11833518|FG000|NOT COMPLETED|Overall Study||0
10671834|NCT02331446|11833526|FG000|STARTED|Overall Study||9
10671835|NCT02331446|11833527|FG001|STARTED|Overall Study||11
10671836|NCT02331446|11833528|FG002|STARTED|Overall Study||11
10671837|NCT02331446|11833529|FG003|STARTED|Overall Study||11
10671838|NCT02331446|11833526|FG000|COMPLETED|Overall Study||5
10671839|NCT02331446|11833527|FG001|COMPLETED|Overall Study||6
10671840|NCT02331446|11833528|FG002|COMPLETED|Overall Study||8
10671841|NCT02331446|11833529|FG003|COMPLETED|Overall Study||8
10671842|NCT02331446|11833526|FG000|NOT COMPLETED|Overall Study||4
10671843|NCT02331446|11833527|FG001|NOT COMPLETED|Overall Study||5
10671844|NCT02331446|11833528|FG002|NOT COMPLETED|Overall Study||3
10671845|NCT02331446|11833529|FG003|NOT COMPLETED|Overall Study||3
10671846|NCT02331589|11833541|FG000|STARTED|Overall Study||39
10671847|NCT02331589|11833542|FG001|STARTED|Overall Study||36
10671848|NCT02331589|11833541|FG000|COMPLETED|Overall Study||34
10671849|NCT02331589|11833542|FG001|COMPLETED|Overall Study||31
10671850|NCT02331589|11833541|FG000|NOT COMPLETED|Overall Study||5
10671851|NCT02331589|11833542|FG001|NOT COMPLETED|Overall Study||5
10671852|NCT02331680|11833551|FG000|STARTED|Overall Study||40
10671853|NCT02331680|11833552|FG001|STARTED|Overall Study||40
10671854|NCT02331680|11833553|FG002|STARTED|Overall Study||44
10671855|NCT02331680|11833551|FG000|COMPLETED|Overall Study||34
10671856|NCT02331680|11833552|FG001|COMPLETED|Overall Study||36
10671857|NCT02331680|11833553|FG002|COMPLETED|Overall Study||29
10671858|NCT02331680|11833551|FG000|NOT COMPLETED|Overall Study||6
10671859|NCT02331680|11833552|FG001|NOT COMPLETED|Overall Study||4
10671860|NCT02331680|11833553|FG002|NOT COMPLETED|Overall Study||15
10671861|NCT02331940|11833563|FG000|STARTED|Overall Study||100
10671862|NCT02331940|11833564|FG001|STARTED|Overall Study||100
10671863|NCT02331940|11833563|FG000|COMPLETED|Overall Study||93
10671864|NCT02331940|11833564|FG001|COMPLETED|Overall Study||95
10671865|NCT02331940|11833563|FG000|NOT COMPLETED|Overall Study||7
10671866|NCT02331940|11833564|FG001|NOT COMPLETED|Overall Study||5
10671867|NCT02331992|11833570|FG000|STARTED|Overall Study||34
10671868|NCT02331992|11833570|FG000|COMPLETED|Overall Study||34
10671869|NCT02331992|11833570|FG000|NOT COMPLETED|Overall Study||0
10671870|NCT02332239|11833576|FG000|STARTED|Overall Study||58
10671871|NCT02332239|11833577|FG001|STARTED|Overall Study||58
10671872|NCT02332239|11833576|FG000|COMPLETED|Overall Study||54
10671873|NCT02332239|11833577|FG001|COMPLETED|Overall Study||52
10671874|NCT02332239|11833576|FG000|NOT COMPLETED|Overall Study||4
10671875|NCT02332239|11833577|FG001|NOT COMPLETED|Overall Study||6
10671876|NCT02332291|11833587|FG000|STARTED|Phase 1: Blinded Escitalopram or Placebo||63
10671877|NCT02332291|11833588|FG001|STARTED|Phase 1: Blinded Escitalopram or Placebo||32
10671878|NCT02332291|11833587|FG000|COMPLETED|Phase 1: Blinded Escitalopram or Placebo||59
10671879|NCT02332291|11833588|FG001|COMPLETED|Phase 1: Blinded Escitalopram or Placebo||23
10671880|NCT02332291|11833587|FG000|NOT COMPLETED|Phase 1: Blinded Escitalopram or Placebo||4
10671881|NCT02332291|11833588|FG001|NOT COMPLETED|Phase 1: Blinded Escitalopram or Placebo||9
10671882|NCT02332291|11833587|FG000|STARTED|Phase 2: Open-Label Bupropion||22
10671883|NCT02332291|11833588|FG001|STARTED|Phase 2: Open-Label Bupropion||19
10671884|NCT02332291|11833587|FG000|COMPLETED|Phase 2: Open-Label Bupropion||19
10671885|NCT02332291|11833588|FG001|COMPLETED|Phase 2: Open-Label Bupropion||11
10671886|NCT02332291|11833587|FG000|NOT COMPLETED|Phase 2: Open-Label Bupropion||3
10671887|NCT02332291|11833588|FG001|NOT COMPLETED|Phase 2: Open-Label Bupropion||8
10671888|NCT02332707|11833616|FG000|STARTED|Overall Study||23
10671889|NCT02332707|11833617|FG001|STARTED|Overall Study||24
10671890|NCT02332707|11833618|FG002|STARTED|Overall Study||16
10671891|NCT02332707|11833619|FG003|STARTED|Overall Study||14
10671892|NCT02332707|11833620|FG004|STARTED|Overall Study||23
10671893|NCT02332707|11833621|FG005|STARTED|Overall Study||23
10671894|NCT02332707|11833622|FG006|STARTED|Overall Study||15
10671895|NCT02332707|11833623|FG007|STARTED|Overall Study||16
10671896|NCT02332707|11833624|FG008|STARTED|Overall Study||48
10671897|NCT02332707|11833625|FG009|STARTED|Overall Study||31
10671898|NCT02332707|11833626|FG010|STARTED|Overall Study||31
10671899|NCT02332707|11833627|FG011|STARTED|Overall Study||35
10671900|NCT02332707|11833628|FG012|STARTED|Overall Study||40
10671901|NCT02332707|11833629|FG013|STARTED|Overall Study||15
10671902|NCT02332707|11833630|FG014|STARTED|Overall Study||16
10671903|NCT02332707|11833631|FG015|STARTED|Overall Study||26
10671904|NCT02332707|11833632|FG016|STARTED|Overall Study||30
10671905|NCT02332707|11833633|FG017|STARTED|Overall Study||16
10671906|NCT02332707|11833616|FG000|COMPLETED|Overall Study||23
10671907|NCT02332707|11833617|FG001|COMPLETED|Overall Study||24
10671908|NCT02332707|11833618|FG002|COMPLETED|Overall Study||15
10671909|NCT02332707|11833619|FG003|COMPLETED|Overall Study||13
10671910|NCT02332707|11833620|FG004|COMPLETED|Overall Study||23
10671911|NCT02332707|11833621|FG005|COMPLETED|Overall Study||22
10671912|NCT02332707|11833622|FG006|COMPLETED|Overall Study||15
10797099|NCT03682965|11957477|FG001|NOT COMPLETED|Overall Study||0
10797100|NCT03683576|11957487|FG000|STARTED|Overall Study||120
10797101|NCT03683576|11957488|FG001|STARTED|Overall Study||120
10671913|NCT02332707|11833623|FG007|COMPLETED|Overall Study||16
10671914|NCT02332707|11833624|FG008|COMPLETED|Overall Study||48
10671915|NCT02332707|11833625|FG009|COMPLETED|Overall Study||28
10671916|NCT02332707|11833626|FG010|COMPLETED|Overall Study||29
10671917|NCT02332707|11833627|FG011|COMPLETED|Overall Study||35
10671918|NCT02332707|11833628|FG012|COMPLETED|Overall Study||35
10671919|NCT02332707|11833629|FG013|COMPLETED|Overall Study||15
10671920|NCT02332707|11833630|FG014|COMPLETED|Overall Study||16
10671921|NCT02332707|11833631|FG015|COMPLETED|Overall Study||26
10671922|NCT02332707|11833632|FG016|COMPLETED|Overall Study||30
10671923|NCT02332707|11833633|FG017|COMPLETED|Overall Study||16
10671924|NCT02332707|11833616|FG000|NOT COMPLETED|Overall Study||0
10671925|NCT02332707|11833617|FG001|NOT COMPLETED|Overall Study||0
10671926|NCT02332707|11833618|FG002|NOT COMPLETED|Overall Study||1
10671927|NCT02332707|11833619|FG003|NOT COMPLETED|Overall Study||1
10671928|NCT02332707|11833620|FG004|NOT COMPLETED|Overall Study||0
10671929|NCT02332707|11833621|FG005|NOT COMPLETED|Overall Study||1
10671930|NCT02332707|11833622|FG006|NOT COMPLETED|Overall Study||0
10671931|NCT02332707|11833623|FG007|NOT COMPLETED|Overall Study||0
10671932|NCT02332707|11833624|FG008|NOT COMPLETED|Overall Study||0
10671933|NCT02332707|11833625|FG009|NOT COMPLETED|Overall Study||3
10671934|NCT02332707|11833626|FG010|NOT COMPLETED|Overall Study||2
10671935|NCT02332707|11833627|FG011|NOT COMPLETED|Overall Study||0
10671936|NCT02332707|11833628|FG012|NOT COMPLETED|Overall Study||5
10671937|NCT02332707|11833629|FG013|NOT COMPLETED|Overall Study||0
10671938|NCT02332707|11833630|FG014|NOT COMPLETED|Overall Study||0
10671939|NCT02332707|11833631|FG015|NOT COMPLETED|Overall Study||0
10671940|NCT02332707|11833632|FG016|NOT COMPLETED|Overall Study||0
10671941|NCT02332707|11833633|FG017|NOT COMPLETED|Overall Study||0
10671942|NCT02332720|11833694|FG000|STARTED|Part A and Part B||21
10671943|NCT02332720|11833695|FG001|STARTED|Part A and Part B||21
10671944|NCT02332720|11833696|FG002|STARTED|Part A and Part B||22
10671945|NCT02332720|11833697|FG003|STARTED|Part A and Part B||22
10671946|NCT02332720|11833698|FG004|STARTED|Part A and Part B||16
10671947|NCT02332720|11833699|FG005|STARTED|Part A and Part B||36
10671948|NCT02332720|11833700|FG006|STARTED|Part A and Part B||37
10671949|NCT02332720|11833701|FG007|STARTED|Part A and Part B||35
10671950|NCT02332720|11833702|FG008|STARTED|Part A and Part B||15
10671951|NCT02332720|11833703|FG009|STARTED|Part A and Part B||14
10671952|NCT02332720|11833704|FG010|STARTED|Part A and Part B||14
10671953|NCT02332720|11833705|FG011|STARTED|Part A and Part B||15
10671954|NCT02332720|11833706|FG012|STARTED|Part A and Part B||16
10671955|NCT02332720|11833707|FG013|STARTED|Part A and Part B||13
10671956|NCT02332720|11833708|FG014|STARTED|Part A and Part B||16
10671957|NCT02332720|11833709|FG015|STARTED|Part A and Part B||14
10797102|NCT03683576|11957489|FG002|STARTED|Overall Study||118
10671958|NCT02332720|11833710|FG016|STARTED|Part A and Part B||15
10671959|NCT02332720|11833711|FG017|STARTED|Part A and Part B||14
10671960|NCT02332720|11833712|FG018|STARTED|Part A and Part B||21
10671961|NCT02332720|11833713|FG019|STARTED|Part A and Part B||25
10671962|NCT02332720|11833714|FG020|STARTED|Part A and Part B||7
10671963|NCT02332720|11833715|FG021|STARTED|Part A and Part B||0
10671964|NCT02332720|11833716|FG022|STARTED|Part A and Part B||4
10671965|NCT02332720|11833694|FG000|Treated|Part A and Part B||21
10671966|NCT02332720|11833695|FG001|Treated|Part A and Part B||21
10671967|NCT02332720|11833696|FG002|Treated|Part A and Part B||22
10671968|NCT02332720|11833697|FG003|Treated|Part A and Part B||22
10671969|NCT02332720|11833698|FG004|Treated|Part A and Part B||16
10671970|NCT02332720|11833699|FG005|Treated|Part A and Part B||36
10671971|NCT02332720|11833700|FG006|Treated|Part A and Part B||37
10671972|NCT02332720|11833701|FG007|Treated|Part A and Part B||35
10671973|NCT02332720|11833702|FG008|Treated|Part A and Part B||15
10671974|NCT02332720|11833703|FG009|Treated|Part A and Part B||14
10671975|NCT02332720|11833704|FG010|Treated|Part A and Part B||14
10671976|NCT02332720|11833705|FG011|Treated|Part A and Part B||15
10671977|NCT02332720|11833706|FG012|Treated|Part A and Part B||16
10671978|NCT02332720|11833707|FG013|Treated|Part A and Part B||13
10671979|NCT02332720|11833708|FG014|Treated|Part A and Part B||16
10671980|NCT02332720|11833709|FG015|Treated|Part A and Part B||14
10671981|NCT02332720|11833710|FG016|Treated|Part A and Part B||15
10797103|NCT03683576|11957490|FG003|STARTED|Overall Study||122
10797104|NCT03683576|11957487|FG000|COMPLETED|Overall Study||114
10797105|NCT03683576|11957488|FG001|COMPLETED|Overall Study||116
10797106|NCT03683576|11957489|FG002|COMPLETED|Overall Study||106
10797107|NCT03683576|11957490|FG003|COMPLETED|Overall Study||114
10671982|NCT02332720|11833711|FG017|Treated|Part A and Part B||14
10671983|NCT02332720|11833712|FG018|Treated|Part A and Part B||20
10671984|NCT02332720|11833713|FG019|Treated|Part A and Part B||25
10671985|NCT02332720|11833714|FG020|Treated|Part A and Part B||7
10671986|NCT02332720|11833715|FG021|Treated|Part A and Part B||0
10671987|NCT02332720|11833716|FG022|Treated|Part A and Part B||4
10671988|NCT02332720|11833694|FG000|COMPLETED|Part A and Part B||20
10671989|NCT02332720|11833695|FG001|COMPLETED|Part A and Part B||21
10671990|NCT02332720|11833696|FG002|COMPLETED|Part A and Part B||22
10671991|NCT02332720|11833697|FG003|COMPLETED|Part A and Part B||22
10671992|NCT02332720|11833698|FG004|COMPLETED|Part A and Part B||16
10671993|NCT02332720|11833699|FG005|COMPLETED|Part A and Part B||33
10671994|NCT02332720|11833700|FG006|COMPLETED|Part A and Part B||36
10671995|NCT02332720|11833701|FG007|COMPLETED|Part A and Part B||34
10671996|NCT02332720|11833702|FG008|COMPLETED|Part A and Part B||15
10671997|NCT02332720|11833703|FG009|COMPLETED|Part A and Part B||14
10671998|NCT02332720|11833704|FG010|COMPLETED|Part A and Part B||14
10671999|NCT02332720|11833705|FG011|COMPLETED|Part A and Part B||15
10672000|NCT02332720|11833706|FG012|COMPLETED|Part A and Part B||16
10672001|NCT02332720|11833707|FG013|COMPLETED|Part A and Part B||13
10672002|NCT02332720|11833708|FG014|COMPLETED|Part A and Part B||16
10672003|NCT02332720|11833709|FG015|COMPLETED|Part A and Part B||13
10672004|NCT02332720|11833710|FG016|COMPLETED|Part A and Part B||15
10672005|NCT02332720|11833711|FG017|COMPLETED|Part A and Part B||13
10672006|NCT02332720|11833712|FG018|COMPLETED|Part A and Part B||20
10672007|NCT02332720|11833713|FG019|COMPLETED|Part A and Part B||24
10672008|NCT02332720|11833714|FG020|COMPLETED|Part A and Part B||7
10672009|NCT02332720|11833715|FG021|COMPLETED|Part A and Part B||0
10672010|NCT02332720|11833716|FG022|COMPLETED|Part A and Part B||4
10672011|NCT02332720|11833694|FG000|NOT COMPLETED|Part A and Part B||1
10672012|NCT02332720|11833695|FG001|NOT COMPLETED|Part A and Part B||0
10672013|NCT02332720|11833696|FG002|NOT COMPLETED|Part A and Part B||0
10672014|NCT02332720|11833697|FG003|NOT COMPLETED|Part A and Part B||0
10672015|NCT02332720|11833698|FG004|NOT COMPLETED|Part A and Part B||0
10672016|NCT02332720|11833699|FG005|NOT COMPLETED|Part A and Part B||3
10672017|NCT02332720|11833700|FG006|NOT COMPLETED|Part A and Part B||1
10672018|NCT02332720|11833701|FG007|NOT COMPLETED|Part A and Part B||1
10672019|NCT02332720|11833702|FG008|NOT COMPLETED|Part A and Part B||0
10672020|NCT02332720|11833703|FG009|NOT COMPLETED|Part A and Part B||0
10672021|NCT02332720|11833704|FG010|NOT COMPLETED|Part A and Part B||0
10672022|NCT02332720|11833705|FG011|NOT COMPLETED|Part A and Part B||0
10672023|NCT02332720|11833706|FG012|NOT COMPLETED|Part A and Part B||0
10672024|NCT02332720|11833707|FG013|NOT COMPLETED|Part A and Part B||0
10672025|NCT02332720|11833708|FG014|NOT COMPLETED|Part A and Part B||0
10672026|NCT02332720|11833709|FG015|NOT COMPLETED|Part A and Part B||1
10672027|NCT02332720|11833710|FG016|NOT COMPLETED|Part A and Part B||0
10672028|NCT02332720|11833711|FG017|NOT COMPLETED|Part A and Part B||1
10672029|NCT02332720|11833712|FG018|NOT COMPLETED|Part A and Part B||1
10672030|NCT02332720|11833713|FG019|NOT COMPLETED|Part A and Part B||1
10672031|NCT02332720|11833714|FG020|NOT COMPLETED|Part A and Part B||0
10672032|NCT02332720|11833715|FG021|NOT COMPLETED|Part A and Part B||0
10672033|NCT02332720|11833716|FG022|NOT COMPLETED|Part A and Part B||0
10672034|NCT02332720|11833694|FG000|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|2
10672035|NCT02332720|11833695|FG001|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|1
10672036|NCT02332720|11833696|FG002|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|3
10672037|NCT02332720|11833697|FG003|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|2
10672038|NCT02332720|11833698|FG004|STARTED|Part C|Part B participants were not included in Part C.|0
10672039|NCT02332720|11833699|FG005|STARTED|Part C|Part B participants were not included in Part C.|0
10672040|NCT02332720|11833700|FG006|STARTED|Part C|Part B participants were not included in Part C.|0
10672041|NCT02332720|11833701|FG007|STARTED|Part C|Part B participants were not included in Part C.|0
10672042|NCT02332720|11833702|FG008|STARTED|Part C|Part B participants were not included in Part C.|0
10672043|NCT02332720|11833703|FG009|STARTED|Part C|Part B participants were not included in Part C.|0
10672044|NCT02332720|11833704|FG010|STARTED|Part C|Part B participants were not included in Part C.|0
10672045|NCT02332720|11833705|FG011|STARTED|Part C|Part B participants were not included in Part C.|0
10672046|NCT02332720|11833706|FG012|STARTED|Part C|Part B participants were not included in Part C.|0
10672047|NCT02332720|11833707|FG013|STARTED|Part C|Part B participants were not included in Part C.|0
10672048|NCT02332720|11833708|FG014|STARTED|Part C|Part B participants were not included in Part C.|0
10672049|NCT02332720|11833709|FG015|STARTED|Part C|Part B participants were not included in Part C.|0
10672050|NCT02332720|11833710|FG016|STARTED|Part C|Part B participants were not included in Part C.|0
10672051|NCT02332720|11833711|FG017|STARTED|Part C|Part B participants were not included in Part C.|0
10672052|NCT02332720|11833712|FG018|STARTED|Part C|Part B participants were not included in Part C.|0
10672053|NCT02332720|11833713|FG019|STARTED|Part C|Part B participants were not included in Part C.|0
10672054|NCT02332720|11833714|FG020|STARTED|Part C|Part B participants were not included in Part C.|0
10672055|NCT02332720|11833715|FG021|STARTED|Part C||0
10672056|NCT02332720|11833716|FG022|STARTED|Part C|Part B participants were not included in Part C.|0
10672057|NCT02332720|11833694|FG000|COMPLETED|Part C||2
10672058|NCT02332720|11833695|FG001|COMPLETED|Part C||1
10672059|NCT02332720|11833696|FG002|COMPLETED|Part C||3
10672060|NCT02332720|11833697|FG003|COMPLETED|Part C||2
10672061|NCT02332720|11833698|FG004|COMPLETED|Part C||0
10672062|NCT02332720|11833699|FG005|COMPLETED|Part C||0
10672063|NCT02332720|11833700|FG006|COMPLETED|Part C||0
10672064|NCT02332720|11833701|FG007|COMPLETED|Part C||0
10672065|NCT02332720|11833702|FG008|COMPLETED|Part C||0
10672066|NCT02332720|11833703|FG009|COMPLETED|Part C||0
10672067|NCT02332720|11833704|FG010|COMPLETED|Part C||0
10672068|NCT02332720|11833705|FG011|COMPLETED|Part C||0
10672069|NCT02332720|11833706|FG012|COMPLETED|Part C||0
10672070|NCT02332720|11833707|FG013|COMPLETED|Part C||0
10672071|NCT02332720|11833708|FG014|COMPLETED|Part C||0
10672072|NCT02332720|11833709|FG015|COMPLETED|Part C||0
10672073|NCT02332720|11833710|FG016|COMPLETED|Part C||0
10672074|NCT02332720|11833711|FG017|COMPLETED|Part C||0
10672075|NCT02332720|11833712|FG018|COMPLETED|Part C||0
10672076|NCT02332720|11833713|FG019|COMPLETED|Part C||0
10672077|NCT02332720|11833714|FG020|COMPLETED|Part C||0
10672078|NCT02332720|11833715|FG021|COMPLETED|Part C||0
10672079|NCT02332720|11833716|FG022|COMPLETED|Part C||0
10672080|NCT02332720|11833694|FG000|NOT COMPLETED|Part C||0
10672081|NCT02332720|11833695|FG001|NOT COMPLETED|Part C||0
10672082|NCT02332720|11833696|FG002|NOT COMPLETED|Part C||0
10672083|NCT02332720|11833697|FG003|NOT COMPLETED|Part C||0
10672084|NCT02332720|11833698|FG004|NOT COMPLETED|Part C||0
10672085|NCT02332720|11833699|FG005|NOT COMPLETED|Part C||0
10672086|NCT02332720|11833700|FG006|NOT COMPLETED|Part C||0
10672087|NCT02332720|11833701|FG007|NOT COMPLETED|Part C||0
10672088|NCT02332720|11833702|FG008|NOT COMPLETED|Part C||0
10672089|NCT02332720|11833703|FG009|NOT COMPLETED|Part C||0
10672090|NCT02332720|11833704|FG010|NOT COMPLETED|Part C||0
10672091|NCT02332720|11833705|FG011|NOT COMPLETED|Part C||0
10672092|NCT02332720|11833706|FG012|NOT COMPLETED|Part C||0
10672093|NCT02332720|11833707|FG013|NOT COMPLETED|Part C||0
10672094|NCT02332720|11833708|FG014|NOT COMPLETED|Part C||0
10672095|NCT02332720|11833709|FG015|NOT COMPLETED|Part C||0
10672096|NCT02332720|11833710|FG016|NOT COMPLETED|Part C||0
10672097|NCT02332720|11833711|FG017|NOT COMPLETED|Part C||0
10672098|NCT02332720|11833712|FG018|NOT COMPLETED|Part C||0
10672099|NCT02332720|11833713|FG019|NOT COMPLETED|Part C||0
10672100|NCT02332720|11833714|FG020|NOT COMPLETED|Part C||0
10672101|NCT02332720|11833715|FG021|NOT COMPLETED|Part C||0
10672102|NCT02332720|11833716|FG022|NOT COMPLETED|Part C||0
10672103|NCT02332798|11833781|FG000|STARTED|Overall Study||13
10672104|NCT02332798|11833782|FG001|STARTED|Overall Study||14
10672105|NCT02332798|11833783|FG002|STARTED|Overall Study||12
10672106|NCT02332798|11833781|FG000|COMPLETED|Overall Study||12
10672107|NCT02332798|11833782|FG001|COMPLETED|Overall Study||12
10672108|NCT02332798|11833783|FG002|COMPLETED|Overall Study||11
10672109|NCT02332798|11833781|FG000|NOT COMPLETED|Overall Study||1
10672110|NCT02332798|11833782|FG001|NOT COMPLETED|Overall Study||2
10672111|NCT02332798|11833783|FG002|NOT COMPLETED|Overall Study||1
10672112|NCT02332824|11833797|FG000|STARTED|Overall Study||67
10672113|NCT02332824|11833798|FG001|STARTED|Overall Study||67
10672114|NCT02332824|11833799|FG002|STARTED|Overall Study||74
10672115|NCT02332824|11833800|FG003|STARTED|Overall Study||68
10672116|NCT02332824|11833801|FG004|STARTED|Overall Study||69
10672117|NCT02332824|11833802|FG005|STARTED|Overall Study||70
10672118|NCT02332824|11833797|FG000|COMPLETED|Overall Study||61
10672119|NCT02332824|11833798|FG001|COMPLETED|Overall Study||66
10672120|NCT02332824|11833799|FG002|COMPLETED|Overall Study||72
10672121|NCT02332824|11833800|FG003|COMPLETED|Overall Study||66
10672122|NCT02332824|11833801|FG004|COMPLETED|Overall Study||65
10672123|NCT02332824|11833802|FG005|COMPLETED|Overall Study||69
10672124|NCT02332824|11833797|FG000|NOT COMPLETED|Overall Study||6
10672125|NCT02332824|11833798|FG001|NOT COMPLETED|Overall Study||1
10672126|NCT02332824|11833799|FG002|NOT COMPLETED|Overall Study||2
10672127|NCT02332824|11833800|FG003|NOT COMPLETED|Overall Study||2
10672128|NCT02332824|11833801|FG004|NOT COMPLETED|Overall Study||4
10672129|NCT02332824|11833802|FG005|NOT COMPLETED|Overall Study||1
10672130|NCT02332863|11833818|FG000|STARTED|Overall Study||22
10672131|NCT02332863|11833819|FG001|STARTED|Overall Study||22
10672132|NCT02332863|11833818|FG000|COMPLETED|Overall Study||22
10672133|NCT02332863|11833819|FG001|COMPLETED|Overall Study||22
10672134|NCT02332863|11833818|FG000|NOT COMPLETED|Overall Study||0
10672135|NCT02332863|11833819|FG001|NOT COMPLETED|Overall Study||0
10672136|NCT02332876|11833827|FG000|STARTED|Overall Study||43
10672137|NCT02332876|11833828|FG001|STARTED|Overall Study||44
10672138|NCT02332876|11833827|FG000|COMPLETED|Overall Study||42
10672139|NCT02332876|11833828|FG001|COMPLETED|Overall Study||43
10672140|NCT02332876|11833827|FG000|NOT COMPLETED|Overall Study||1
10672141|NCT02332876|11833828|FG001|NOT COMPLETED|Overall Study||1
10672142|NCT02332889|11833834|FG000|STARTED|Overall Study||1
10672143|NCT02332889|11833834|FG000|COMPLETED|Overall Study||0
10672144|NCT02332889|11833834|FG000|NOT COMPLETED|Overall Study||1
10672145|NCT02332902|11833838|FG000|STARTED|Overall Study||24
10672146|NCT02332902|11833838|FG000|COMPLETED|Overall Study||17
10672147|NCT02332902|11833838|FG000|NOT COMPLETED|Overall Study||7
10797108|NCT03683576|11957487|FG000|NOT COMPLETED|Overall Study||6
10797109|NCT03683576|11957488|FG001|NOT COMPLETED|Overall Study||4
10797110|NCT03683576|11957489|FG002|NOT COMPLETED|Overall Study||12
10797111|NCT03683576|11957490|FG003|NOT COMPLETED|Overall Study||8
10797112|NCT03683719|11957505|FG000|STARTED|Overall Study||52
10797113|NCT03683719|11957506|FG001|STARTED|Overall Study||51
10672154|NCT02333045|11833855|FG000|STARTED|Overall Study||1
10672155|NCT02333045|11833856|FG001|STARTED|Overall Study||3
10672156|NCT02333045|11833855|FG000|COMPLETED|Overall Study||1
10672157|NCT02333045|11833856|FG001|COMPLETED|Overall Study||3
10672158|NCT02333045|11833855|FG000|NOT COMPLETED|Overall Study||0
10672159|NCT02333045|11833856|FG001|NOT COMPLETED|Overall Study||0
10672160|NCT02333071|11833864|FG000|STARTED|Core Study||326
10672161|NCT02333071|11833865|FG001|STARTED|Core Study||327
10672162|NCT02333071|11833864|FG000|Received Intervention|Core Study||319
10672163|NCT02333071|11833865|FG001|Received Intervention|Core Study||324
10672164|NCT02333071|11833864|FG000|COMPLETED|Core Study||274
10672165|NCT02333071|11833865|FG001|COMPLETED|Core Study||190
10672166|NCT02333071|11833864|FG000|NOT COMPLETED|Core Study||52
10672167|NCT02333071|11833865|FG001|NOT COMPLETED|Core Study||137
10672168|NCT02333071|11833864|FG000|STARTED|Open Label Extension||239
10672169|NCT02333071|11833865|FG001|STARTED|Open Label Extension||124
10672170|NCT02333071|11833864|FG000|COMPLETED|Open Label Extension||95
10672171|NCT02333071|11833865|FG001|COMPLETED|Open Label Extension||49
10672172|NCT02333071|11833864|FG000|NOT COMPLETED|Open Label Extension||144
10672173|NCT02333071|11833865|FG001|NOT COMPLETED|Open Label Extension||75
10672174|NCT02333331|11833880|FG000|STARTED|Overall Study||19
10672175|NCT02333331|11833881|FG001|STARTED|Overall Study||18
10672176|NCT02333331|11833882|FG002|STARTED|Overall Study||113
10672177|NCT02333331|11833883|FG003|STARTED|Overall Study||67
10672178|NCT02333331|11833880|FG000|COMPLETED|Overall Study||17
10672179|NCT02333331|11833881|FG001|COMPLETED|Overall Study||12
10672180|NCT02333331|11833882|FG002|COMPLETED|Overall Study||95
10672181|NCT02333331|11833883|FG003|COMPLETED|Overall Study||64
10672182|NCT02333331|11833880|FG000|NOT COMPLETED|Overall Study||2
10672183|NCT02333331|11833881|FG001|NOT COMPLETED|Overall Study||6
10672184|NCT02333331|11833882|FG002|NOT COMPLETED|Overall Study||18
10672185|NCT02333331|11833883|FG003|NOT COMPLETED|Overall Study||3
10672186|NCT02333383|11833893|FG000|STARTED|Overall Study||201
10672187|NCT02333383|11833893|FG000|COMPLETED|Overall Study||160
10672188|NCT02333383|11833893|FG000|NOT COMPLETED|Overall Study||41
10672189|NCT02333487|11833900|FG000|STARTED|Overall Study||6
10672190|NCT02333487|11833901|FG001|STARTED|Overall Study||8
10672191|NCT02333487|11833902|FG002|STARTED|Overall Study||8
10672192|NCT02333487|11833900|FG000|COMPLETED|Overall Study||6
10672193|NCT02333487|11833901|FG001|COMPLETED|Overall Study||6
10672194|NCT02333487|11833902|FG002|COMPLETED|Overall Study||8
10672195|NCT02333487|11833900|FG000|NOT COMPLETED|Overall Study||0
10672196|NCT02333487|11833901|FG001|NOT COMPLETED|Overall Study||2
10672197|NCT02333487|11833902|FG002|NOT COMPLETED|Overall Study||0
10672198|NCT02333630|11833913|FG000|STARTED|Overall Study||100
10672199|NCT02333630|11833914|FG001|STARTED|Overall Study||100
10672200|NCT02333630|11833913|FG000|COMPLETED|Overall Study||95
10672201|NCT02333630|11833914|FG001|COMPLETED|Overall Study||98
10672202|NCT02333630|11833913|FG000|NOT COMPLETED|Overall Study||5
10672203|NCT02333630|11833914|FG001|NOT COMPLETED|Overall Study||2
10672204|NCT02334059|11833927|FG000|STARTED|Overall Study||37
10672205|NCT02334059|11833928|FG001|STARTED|Overall Study||34
10672206|NCT02334059|11833929|FG002|STARTED|Overall Study||37
10672207|NCT02334059|11833927|FG000|COMPLETED|Overall Study||37
10672208|NCT02334059|11833928|FG001|COMPLETED|Overall Study||34
10672209|NCT02334059|11833929|FG002|COMPLETED|Overall Study||37
10672210|NCT02334059|11833927|FG000|NOT COMPLETED|Overall Study||0
10672211|NCT02334059|11833928|FG001|NOT COMPLETED|Overall Study||0
10672212|NCT02334059|11833929|FG002|NOT COMPLETED|Overall Study||0
10672213|NCT02334215|11833940|FG000|STARTED|Overall Study||75
10672214|NCT02334215|11833941|FG001|STARTED|Overall Study||74
10672215|NCT02334215|11833942|FG002|STARTED|Overall Study||76
10672216|NCT02334215|11833940|FG000|COMPLETED|Overall Study||68
10672217|NCT02334215|11833941|FG001|COMPLETED|Overall Study||68
10672218|NCT02334215|11833942|FG002|COMPLETED|Overall Study||61
10672219|NCT02334215|11833940|FG000|NOT COMPLETED|Overall Study||7
10672220|NCT02334215|11833941|FG001|NOT COMPLETED|Overall Study||6
10672221|NCT02334215|11833942|FG002|NOT COMPLETED|Overall Study||15
10672222|NCT02334267|11833952|FG000|STARTED|Overall Study||6
10672223|NCT02334267|11833953|FG001|STARTED|Overall Study||5
10672224|NCT02334267|11833952|FG000|COMPLETED|Overall Study||5
10672225|NCT02334267|11833953|FG001|COMPLETED|Overall Study||5
10672226|NCT02334267|11833952|FG000|NOT COMPLETED|Overall Study||1
10672227|NCT02334267|11833953|FG001|NOT COMPLETED|Overall Study||0
10672228|NCT02334306|11833967|FG000|STARTED|Double-blind Period||16
10797114|NCT03683719|11957507|FG002|STARTED|Overall Study||52
10797115|NCT03683719|11957508|FG003|STARTED|Overall Study||53
10797116|NCT03683719|11957509|FG004|STARTED|Overall Study||50
10797117|NCT03683719|11957505|FG000|COMPLETED|Overall Study||40
10797118|NCT03683719|11957506|FG001|COMPLETED|Overall Study||38
10797119|NCT03683719|11957507|FG002|COMPLETED|Overall Study||44
10797120|NCT03683719|11957508|FG003|COMPLETED|Overall Study||46
10797121|NCT03683719|11957509|FG004|COMPLETED|Overall Study||36
10797122|NCT03683719|11957505|FG000|NOT COMPLETED|Overall Study||12
10797123|NCT03683719|11957506|FG001|NOT COMPLETED|Overall Study||13
10797124|NCT03683719|11957507|FG002|NOT COMPLETED|Overall Study||8
10672229|NCT02334306|11833968|FG001|STARTED|Double-blind Period||16
10672230|NCT02334306|11833967|FG000|COMPLETED|Double-blind Period||15
10672231|NCT02334306|11833968|FG001|COMPLETED|Double-blind Period||14
10672232|NCT02334306|11833967|FG000|NOT COMPLETED|Double-blind Period||1
10672233|NCT02334306|11833968|FG001|NOT COMPLETED|Double-blind Period||2
10672234|NCT02334306|11833967|FG000|STARTED|Open-label Period||15
10672235|NCT02334306|11833968|FG001|STARTED|Open-label Period||14
10672236|NCT02334306|11833967|FG000|COMPLETED|Open-label Period||15
10797125|NCT03683719|11957508|FG003|NOT COMPLETED|Overall Study||7
10797126|NCT03683719|11957509|FG004|NOT COMPLETED|Overall Study||14
10797127|NCT03683758|11957523|FG000|STARTED|Overall Study||11
10672237|NCT02334306|11833968|FG001|COMPLETED|Open-label Period||14
10672238|NCT02334306|11833967|FG000|NOT COMPLETED|Open-label Period||0
10672239|NCT02334306|11833968|FG001|NOT COMPLETED|Open-label Period||0
10672240|NCT02334358|11833975|FG000|STARTED|Overall Study||503
10672241|NCT02334358|11833975|FG000|COMPLETED|Overall Study||494
10672242|NCT02334358|11833975|FG000|NOT COMPLETED|Overall Study||9
10672243|NCT02334384|11833981|FG000|STARTED|Overall Study||4
10672244|NCT02334384|11833982|FG001|STARTED|Overall Study||2
10672245|NCT02334384|11833981|FG000|COMPLETED|Overall Study||3
10672246|NCT02334384|11833982|FG001|COMPLETED|Overall Study||1
10672247|NCT02334384|11833981|FG000|NOT COMPLETED|Overall Study||1
10672248|NCT02334384|11833982|FG001|NOT COMPLETED|Overall Study||1
10672249|NCT02334423|11833990|FG000|STARTED|Overall Study||246
10672250|NCT02334423|11833991|FG001|STARTED|Overall Study||84
10672251|NCT02334423|11833990|FG000|COMPLETED|Overall Study||236
10672252|NCT02334423|11833991|FG001|COMPLETED|Overall Study||81
10672253|NCT02334423|11833990|FG000|NOT COMPLETED|Overall Study||10
10672254|NCT02334423|11833991|FG001|NOT COMPLETED|Overall Study||3
10672255|NCT02334436|11833999|FG000|STARTED|Overall Study||246
10672256|NCT02334436|11834000|FG001|STARTED|Overall Study||78
10672257|NCT02334436|11833999|FG000|COMPLETED|Overall Study||237
10672258|NCT02334436|11834000|FG001|COMPLETED|Overall Study||77
10672259|NCT02334436|11833999|FG000|NOT COMPLETED|Overall Study||9
10672260|NCT02334436|11834000|FG001|NOT COMPLETED|Overall Study||1
10672261|NCT02334527|11834006|FG000|STARTED|Overall Study||12
10672262|NCT02334527|11834006|FG000|COMPLETED|Overall Study||12
10672263|NCT02334527|11834006|FG000|NOT COMPLETED|Overall Study||0
10672264|NCT02334683|11834016|FG000|STARTED|First 12 Week Period||10
10672265|NCT02334683|11834017|FG001|STARTED|First 12 Week Period||10
10672266|NCT02334683|11834016|FG000|COMPLETED|First 12 Week Period||9
10672267|NCT02334683|11834017|FG001|COMPLETED|First 12 Week Period||10
10672268|NCT02334683|11834016|FG000|NOT COMPLETED|First 12 Week Period||1
10672269|NCT02334683|11834017|FG001|NOT COMPLETED|First 12 Week Period||0
10672270|NCT02334683|11834016|FG000|STARTED|Second 12 Week Period||9
10672271|NCT02334683|11834017|FG001|STARTED|Second 12 Week Period||10
10672272|NCT02334683|11834016|FG000|COMPLETED|Second 12 Week Period||9
10672273|NCT02334683|11834017|FG001|COMPLETED|Second 12 Week Period||9
10672274|NCT02334683|11834016|FG000|NOT COMPLETED|Second 12 Week Period||0
10672275|NCT02334683|11834017|FG001|NOT COMPLETED|Second 12 Week Period||1
10672276|NCT02334748|11834023|FG000|STARTED|Overall Study||31
10672277|NCT02334748|11834023|FG000|COMPLETED|Overall Study||23
10672278|NCT02334748|11834023|FG000|NOT COMPLETED|Overall Study||8
10672279|NCT02334787|11834031|FG000|STARTED|Overall Study||8
10672280|NCT02334787|11834032|FG001|STARTED|Overall Study||8
10672281|NCT02334787|11834033|FG002|STARTED|Overall Study||8
10672282|NCT02334787|11834034|FG003|STARTED|Overall Study||8
10672283|NCT02334787|11834031|FG000|COMPLETED|Overall Study||8
10672284|NCT02334787|11834032|FG001|COMPLETED|Overall Study||8
10672285|NCT02334787|11834033|FG002|COMPLETED|Overall Study||8
10672286|NCT02334787|11834034|FG003|COMPLETED|Overall Study||8
10672287|NCT02334787|11834031|FG000|NOT COMPLETED|Overall Study||0
10672288|NCT02334787|11834032|FG001|NOT COMPLETED|Overall Study||0
10672289|NCT02334787|11834033|FG002|NOT COMPLETED|Overall Study||0
10672290|NCT02334787|11834034|FG003|NOT COMPLETED|Overall Study||0
10672291|NCT02334800|11834054|FG000|STARTED|Overall Study||7
10672292|NCT02334800|11834055|FG001|STARTED|Overall Study||7
10672293|NCT02334800|11834056|FG002|STARTED|Overall Study||7
10672294|NCT02334800|11834057|FG003|STARTED|Overall Study||7
10672295|NCT02334800|11834054|FG000|Received Treatment|Overall Study||7
10672296|NCT02334800|11834055|FG001|Received Treatment|Overall Study||7
10672297|NCT02334800|11834056|FG002|Received Treatment|Overall Study||7
10672298|NCT02334800|11834057|FG003|Received Treatment|Overall Study||7
10672299|NCT02334800|11834054|FG000|COMPLETED|Overall Study||7
10672300|NCT02334800|11834055|FG001|COMPLETED|Overall Study||7
10672301|NCT02334800|11834056|FG002|COMPLETED|Overall Study||7
10672302|NCT02334800|11834057|FG003|COMPLETED|Overall Study||7
10672303|NCT02334800|11834054|FG000|NOT COMPLETED|Overall Study||0
10672304|NCT02334800|11834055|FG001|NOT COMPLETED|Overall Study||0
10672305|NCT02334800|11834056|FG002|NOT COMPLETED|Overall Study||0
10672306|NCT02334800|11834057|FG003|NOT COMPLETED|Overall Study||0
10672307|NCT02334813|11834069|FG000|STARTED|Overall Study||12
10672308|NCT02334813|11834070|FG001|STARTED|Overall Study||14
10672309|NCT02334813|11834069|FG000|COMPLETED|Overall Study||9
10672310|NCT02334813|11834070|FG001|COMPLETED|Overall Study||13
10672311|NCT02334813|11834069|FG000|NOT COMPLETED|Overall Study||3
10672312|NCT02334813|11834070|FG001|NOT COMPLETED|Overall Study||1
10672313|NCT02334982|11834083|FG000|STARTED|Overall Study||6
10672314|NCT02334982|11834084|FG001|STARTED|Overall Study||5
10672315|NCT02334982|11834085|FG002|STARTED|Overall Study||6
10672316|NCT02334982|11834086|FG003|STARTED|Overall Study||6
10672317|NCT02334982|11834087|FG004|STARTED|Overall Study||6
10672318|NCT02334982|11834088|FG005|STARTED|Overall Study||6
10672319|NCT02334982|11834089|FG006|STARTED|Overall Study||12
10672320|NCT02334982|11834083|FG000|COMPLETED|Overall Study||6
10672321|NCT02334982|11834084|FG001|COMPLETED|Overall Study||5
10672322|NCT02334982|11834085|FG002|COMPLETED|Overall Study||6
10672323|NCT02334982|11834086|FG003|COMPLETED|Overall Study||6
10672324|NCT02334982|11834087|FG004|COMPLETED|Overall Study||6
10672325|NCT02334982|11834088|FG005|COMPLETED|Overall Study||6
10672326|NCT02334982|11834089|FG006|COMPLETED|Overall Study||12
10672327|NCT02334982|11834083|FG000|NOT COMPLETED|Overall Study||0
10672328|NCT02334982|11834084|FG001|NOT COMPLETED|Overall Study||0
10672329|NCT02334982|11834085|FG002|NOT COMPLETED|Overall Study||0
10672330|NCT02334982|11834086|FG003|NOT COMPLETED|Overall Study||0
10672331|NCT02334982|11834087|FG004|NOT COMPLETED|Overall Study||0
10672332|NCT02334982|11834088|FG005|NOT COMPLETED|Overall Study||0
10672333|NCT02334982|11834089|FG006|NOT COMPLETED|Overall Study||0
10672334|NCT02335125|11834118|FG000|STARTED|Overall Study||20
10672335|NCT02335125|11834119|FG001|STARTED|Overall Study||20
10672336|NCT02335125|11834118|FG000|COMPLETED|Overall Study||20
10672337|NCT02335125|11834119|FG001|COMPLETED|Overall Study||20
10672338|NCT02335125|11834118|FG000|NOT COMPLETED|Overall Study||0
10672339|NCT02335125|11834119|FG001|NOT COMPLETED|Overall Study||0
10672340|NCT02335216|11834125|FG000|STARTED|Overall Study||22
10672341|NCT02335216|11834125|FG000|Received Trial System|Overall Study||16
10672342|NCT02335216|11834125|FG000|Received Permanent System|Overall Study||13
10672343|NCT02335216|11834125|FG000|COMPLETED|Overall Study||9
10672344|NCT02335216|11834125|FG000|NOT COMPLETED|Overall Study||13
10672345|NCT02335229|11834129|FG000|STARTED|Overall Study||30
10672346|NCT02335229|11834129|FG000|Received Trial System|Overall Study||10
10672347|NCT02335229|11834129|FG000|Received Permanent System|Overall Study||26
10672348|NCT02335229|11834129|FG000|COMPLETED|Overall Study||23
10672349|NCT02335229|11834129|FG000|NOT COMPLETED|Overall Study||7
10672350|NCT02335294|11834139|FG000|STARTED|Overall Study||39
10672351|NCT02335294|11834140|FG001|STARTED|Overall Study||42
10672352|NCT02335294|11834141|FG002|STARTED|Overall Study||19
10672353|NCT02335294|11834142|FG003|STARTED|Overall Study||39
10672354|NCT02335294|11834143|FG004|STARTED|Overall Study||41
10672355|NCT02335294|11834144|FG005|STARTED|Overall Study||20
10672356|NCT02335294|11834139|FG000|COMPLETED|Overall Study||36
10672357|NCT02335294|11834140|FG001|COMPLETED|Overall Study||38
10672358|NCT02335294|11834141|FG002|COMPLETED|Overall Study||18
10672359|NCT02335294|11834142|FG003|COMPLETED|Overall Study||36
10672360|NCT02335294|11834143|FG004|COMPLETED|Overall Study||39
10672361|NCT02335294|11834144|FG005|COMPLETED|Overall Study||19
10672362|NCT02335294|11834139|FG000|NOT COMPLETED|Overall Study||3
10672363|NCT02335294|11834140|FG001|NOT COMPLETED|Overall Study||4
10672364|NCT02335294|11834141|FG002|NOT COMPLETED|Overall Study||1
10672365|NCT02335294|11834142|FG003|NOT COMPLETED|Overall Study||3
10672366|NCT02335294|11834143|FG004|NOT COMPLETED|Overall Study||2
10672367|NCT02335294|11834144|FG005|NOT COMPLETED|Overall Study||1
10672368|NCT02335346|11834158|FG000|STARTED|Overall Study||93
10672369|NCT02335346|11834158|FG000|Received At Least 1 Dose of Study Drug|Overall Study||93
10672370|NCT02335346|11834158|FG000|COMPLETED|Overall Study||81
10672371|NCT02335346|11834158|FG000|NOT COMPLETED|Overall Study||12
10672372|NCT02335450|11834162|FG000|STARTED|Overall Study||5
10672373|NCT02335450|11834162|FG000|COMPLETED|Overall Study||4
10797128|NCT03683758|11957524|FG001|STARTED|Overall Study||10
10797129|NCT03683758|11957523|FG000|COMPLETED|Overall Study||8
10797130|NCT03683758|11957524|FG001|COMPLETED|Overall Study||7
10797131|NCT03683758|11957523|FG000|NOT COMPLETED|Overall Study||3
10672374|NCT02335450|11834162|FG000|NOT COMPLETED|Overall Study||1
10672375|NCT02335489|11834172|FG000|STARTED|Overall Study||10
10672376|NCT02335489|11834172|FG000|Received Trial System|Overall Study||9
10672377|NCT02335489|11834172|FG000|Receiving Permanent System|Overall Study||8
10672378|NCT02335489|11834172|FG000|COMPLETED|Overall Study||0
10672379|NCT02335489|11834172|FG000|NOT COMPLETED|Overall Study||10
10672380|NCT02335502|11834176|FG000|STARTED|Overall Study||66
10672381|NCT02335502|11834176|FG000|Received Trial System|Overall Study||65
10672382|NCT02335502|11834176|FG000|Receiving Permanent System|Overall Study||56
10672383|NCT02335502|11834176|FG000|COMPLETED|Overall Study||49
10672384|NCT02335502|11834176|FG000|NOT COMPLETED|Overall Study||17
10672385|NCT02335710|11834182|FG000|STARTED|Overall Study||40
10672386|NCT02335710|11834183|FG001|STARTED|Overall Study||10
10672387|NCT02335710|11834182|FG000|COMPLETED|Overall Study||40
10672388|NCT02335710|11834183|FG001|COMPLETED|Overall Study||10
10672389|NCT02335710|11834182|FG000|NOT COMPLETED|Overall Study||0
10672390|NCT02335710|11834183|FG001|NOT COMPLETED|Overall Study||0
10672391|NCT02335905|11834189|FG000|STARTED|Overall Study||11
10672392|NCT02335905|11834189|FG000|COMPLETED|Overall Study||7
10672393|NCT02335905|11834189|FG000|NOT COMPLETED|Overall Study||4
10672394|NCT02335983|11834199|FG000|STARTED|Overall Study||10
10672395|NCT02335983|11834200|FG001|STARTED|Overall Study||12
10672396|NCT02335983|11834201|FG002|STARTED|Overall Study||34
10672397|NCT02335983|11834202|FG003|STARTED|Overall Study||9
10672398|NCT02335983|11834203|FG004|STARTED|Overall Study||9
10672399|NCT02335983|11834204|FG005|STARTED|Overall Study||33
10672400|NCT02335983|11834199|FG000|COMPLETED|Overall Study||2
10672401|NCT02335983|11834200|FG001|COMPLETED|Overall Study||3
10672402|NCT02335983|11834201|FG002|COMPLETED|Overall Study||2
10672403|NCT02335983|11834202|FG003|COMPLETED|Overall Study||0
10672404|NCT02335983|11834203|FG004|COMPLETED|Overall Study||1
10672405|NCT02335983|11834204|FG005|COMPLETED|Overall Study||1
10672406|NCT02335983|11834199|FG000|NOT COMPLETED|Overall Study||8
10672407|NCT02335983|11834200|FG001|NOT COMPLETED|Overall Study||9
10672408|NCT02335983|11834201|FG002|NOT COMPLETED|Overall Study||32
10672409|NCT02335983|11834202|FG003|NOT COMPLETED|Overall Study||9
10672410|NCT02335983|11834203|FG004|NOT COMPLETED|Overall Study||8
10672411|NCT02335983|11834204|FG005|NOT COMPLETED|Overall Study||32
10672412|NCT02336074|11834229|FG000|STARTED|Overall Study||30
10797132|NCT03683758|11957524|FG001|NOT COMPLETED|Overall Study||3
10797133|NCT03683901|11957530|FG000|STARTED|Overall Study||10
10797134|NCT03683901|11957530|FG000|COMPLETED|Overall Study||10
10797135|NCT03683901|11957530|FG000|NOT COMPLETED|Overall Study||0
10672413|NCT02336074|11834230|FG001|STARTED|Overall Study||30
10672414|NCT02336074|11834229|FG000|COMPLETED|Overall Study||30
10672415|NCT02336074|11834230|FG001|COMPLETED|Overall Study||28
10672416|NCT02336074|11834229|FG000|NOT COMPLETED|Overall Study||0
10672417|NCT02336074|11834230|FG001|NOT COMPLETED|Overall Study||2
10672418|NCT02336165|11834246|FG000|STARTED|Overall Study||40
10672419|NCT02336165|11834247|FG001|STARTED|Overall Study||31
10672420|NCT02336165|11834248|FG002|STARTED|Overall Study||33
10672421|NCT02336165|11834249|FG003|STARTED|Overall Study||33
10672422|NCT02336165|11834250|FG004|STARTED|Overall Study||22
10672423|NCT02336165|11834246|FG000|COMPLETED|Overall Study||6
10672424|NCT02336165|11834247|FG001|COMPLETED|Overall Study||6
10672425|NCT02336165|11834248|FG002|COMPLETED|Overall Study||2
10672426|NCT02336165|11834249|FG003|COMPLETED|Overall Study||2
10672427|NCT02336165|11834250|FG004|COMPLETED|Overall Study||0
10672428|NCT02336165|11834246|FG000|NOT COMPLETED|Overall Study||34
10672429|NCT02336165|11834247|FG001|NOT COMPLETED|Overall Study||25
10672430|NCT02336165|11834248|FG002|NOT COMPLETED|Overall Study||31
10672431|NCT02336165|11834249|FG003|NOT COMPLETED|Overall Study||31
10672432|NCT02336165|11834250|FG004|NOT COMPLETED|Overall Study||22
10672433|NCT02336178|11834266|FG000|STARTED|Overall Study||70
10797136|NCT03684044|11957538|FG000|STARTED|Overall Study||239
10797137|NCT03684044|11957539|FG001|STARTED|Overall Study||124
10797138|NCT03684044|11957538|FG000|COMPLETED|Overall Study||217
10672434|NCT02336178|11834266|FG000|COMPLETED|Overall Study||66
10672435|NCT02336178|11834266|FG000|NOT COMPLETED|Overall Study||4
10672436|NCT02336282|11834278|FG000|STARTED|Overall Study||33
10672437|NCT02336282|11834278|FG000|COMPLETED|Overall Study||28
10672438|NCT02336282|11834278|FG000|NOT COMPLETED|Overall Study||5
10672439|NCT02336360|11834290|FG000|STARTED|Overall Study||6
10672440|NCT02336360|11834290|FG000|COMPLETED|Overall Study||6
10672441|NCT02336360|11834290|FG000|NOT COMPLETED|Overall Study||0
10672442|NCT02336373|11834294|FG000|STARTED|Overall Study||32
10672443|NCT02336373|11834294|FG000|COMPLETED|Overall Study||14
10672444|NCT02336373|11834294|FG000|NOT COMPLETED|Overall Study||18
10672445|NCT02336438|11834300|FG000|STARTED|Overall Study||11
10672446|NCT02336438|11834300|FG000|COMPLETED|Overall Study||10
10672447|NCT02336438|11834300|FG000|NOT COMPLETED|Overall Study||1
10672448|NCT02336451|11834309|FG000|STARTED|Overall Study||42
10672449|NCT02336451|11834310|FG001|STARTED|Overall Study||40
10672450|NCT02336451|11834311|FG002|STARTED|Overall Study||12
10672451|NCT02336451|11834312|FG003|STARTED|Overall Study||44
10672452|NCT02336451|11834313|FG004|STARTED|Overall Study||18
10672453|NCT02336451|11834309|FG000|COMPLETED|Overall Study||0
10672454|NCT02336451|11834310|FG001|COMPLETED|Overall Study||0
10672455|NCT02336451|11834311|FG002|COMPLETED|Overall Study||0
10672456|NCT02336451|11834312|FG003|COMPLETED|Overall Study||0
10672457|NCT02336451|11834313|FG004|COMPLETED|Overall Study||0
10672458|NCT02336451|11834309|FG000|NOT COMPLETED|Overall Study||42
10672459|NCT02336451|11834310|FG001|NOT COMPLETED|Overall Study||40
10672460|NCT02336451|11834311|FG002|NOT COMPLETED|Overall Study||12
10797139|NCT03684044|11957539|FG001|COMPLETED|Overall Study||104
10797140|NCT03684044|11957538|FG000|NOT COMPLETED|Overall Study||22
10797141|NCT03684044|11957539|FG001|NOT COMPLETED|Overall Study||20
10797142|NCT03684265|11957547|FG000|STARTED|Treatment Period 1||13
10797143|NCT03684265|11957548|FG001|STARTED|Treatment Period 1||13
10797144|NCT03684265|11957547|FG000|COMPLETED|Treatment Period 1||13
10797145|NCT03684265|11957548|FG001|COMPLETED|Treatment Period 1||13
10672461|NCT02336451|11834312|FG003|NOT COMPLETED|Overall Study||44
10672462|NCT02336451|11834313|FG004|NOT COMPLETED|Overall Study||18
10672463|NCT02336555|11834329|FG000|STARTED|Treatment Period 1 (28 Days)||18
10672464|NCT02336555|11834330|FG001|STARTED|Treatment Period 1 (28 Days)||17
10672465|NCT02336555|11834329|FG000|COMPLETED|Treatment Period 1 (28 Days)||16
10672466|NCT02336555|11834330|FG001|COMPLETED|Treatment Period 1 (28 Days)||16
10672467|NCT02336555|11834329|FG000|NOT COMPLETED|Treatment Period 1 (28 Days)||2
10797146|NCT03684265|11957547|FG000|NOT COMPLETED|Treatment Period 1||0
10797147|NCT03684265|11957548|FG001|NOT COMPLETED|Treatment Period 1||0
10672468|NCT02336555|11834330|FG001|NOT COMPLETED|Treatment Period 1 (28 Days)||1
10672469|NCT02336555|11834329|FG000|STARTED|Treatment Period 2 (28 Days)||16
10672470|NCT02336555|11834330|FG001|STARTED|Treatment Period 2 (28 Days)||16
10672471|NCT02336555|11834329|FG000|COMPLETED|Treatment Period 2 (28 Days)||16
10672472|NCT02336555|11834330|FG001|COMPLETED|Treatment Period 2 (28 Days)||15
10672473|NCT02336555|11834329|FG000|NOT COMPLETED|Treatment Period 2 (28 Days)||0
10672474|NCT02336555|11834330|FG001|NOT COMPLETED|Treatment Period 2 (28 Days)||1
10672475|NCT02336594|11834340|FG000|STARTED|Overall Study||3
10672476|NCT02336594|11834341|FG001|STARTED|Overall Study||4
10672477|NCT02336594|11834342|FG002|STARTED|Overall Study||4
10672478|NCT02336594|11834343|FG003|STARTED|Overall Study||4
10672479|NCT02336594|11834340|FG000|COMPLETED|Overall Study||3
10672480|NCT02336594|11834341|FG001|COMPLETED|Overall Study||4
10672481|NCT02336594|11834342|FG002|COMPLETED|Overall Study||4
10672482|NCT02336594|11834343|FG003|COMPLETED|Overall Study||4
10672483|NCT02336594|11834340|FG000|NOT COMPLETED|Overall Study||0
10672484|NCT02336594|11834341|FG001|NOT COMPLETED|Overall Study||0
10672485|NCT02336594|11834342|FG002|NOT COMPLETED|Overall Study||0
10672486|NCT02336594|11834343|FG003|NOT COMPLETED|Overall Study||0
10672487|NCT02336607|11834360|FG000|STARTED|Overall Study||85
10672488|NCT02336607|11834361|FG001|STARTED|Overall Study||85
10672489|NCT02336607|11834362|FG002|STARTED|Overall Study||92
10672490|NCT02336607|11834363|FG003|STARTED|Overall Study||267
10672491|NCT02336607|11834360|FG000|Patients Included in ITT Population|Overall Study||84
10672492|NCT02336607|11834361|FG001|Patients Included in ITT Population|Overall Study||84
10672493|NCT02336607|11834362|FG002|Patients Included in ITT Population|Overall Study||91
10672494|NCT02336607|11834363|FG003|Patients Included in ITT Population|Overall Study||222
10672495|NCT02336607|11834360|FG000|Patients Included in PP Population|Overall Study||78
10672496|NCT02336607|11834361|FG001|Patients Included in PP Population|Overall Study||75
10672497|NCT02336607|11834362|FG002|Patients Included in PP Population|Overall Study||75
10672498|NCT02336607|11834363|FG003|Patients Included in PP Population|Overall Study||162
10672499|NCT02336607|11834360|FG000|Patients Included in Safety Population|Overall Study||85
10672500|NCT02336607|11834361|FG001|Patients Included in Safety Population|Overall Study||85
10672501|NCT02336607|11834362|FG002|Patients Included in Safety Population|Overall Study||92
10672502|NCT02336607|11834363|FG003|Patients Included in Safety Population|Overall Study||260
10672503|NCT02336607|11834360|FG000|COMPLETED|Overall Study||81
10672504|NCT02336607|11834361|FG001|COMPLETED|Overall Study||75
10672505|NCT02336607|11834362|FG002|COMPLETED|Overall Study||86
10672506|NCT02336607|11834363|FG003|COMPLETED|Overall Study||180
10672507|NCT02336607|11834360|FG000|NOT COMPLETED|Overall Study||4
10672508|NCT02336607|11834361|FG001|NOT COMPLETED|Overall Study||10
10672509|NCT02336607|11834362|FG002|NOT COMPLETED|Overall Study||6
10672510|NCT02336607|11834363|FG003|NOT COMPLETED|Overall Study||87
10672511|NCT02336737|11834373|FG000|STARTED|Overall Study||160
10672512|NCT02336737|11834373|FG000|COMPLETED|Overall Study||147
10672513|NCT02336737|11834373|FG000|NOT COMPLETED|Overall Study||13
10672514|NCT02336815|11834380|FG000|STARTED|Overall Study||79
10672515|NCT02336815|11834381|FG001|STARTED|Overall Study||123
10672516|NCT02336815|11834380|FG000|COMPLETED|Overall Study||0
10672517|NCT02336815|11834381|FG001|COMPLETED|Overall Study||0
10672518|NCT02336815|11834380|FG000|NOT COMPLETED|Overall Study||79
10672519|NCT02336815|11834381|FG001|NOT COMPLETED|Overall Study||123
10672520|NCT02336958|11834391|FG000|STARTED|Overall Study||20
10672521|NCT02336958|11834392|FG001|STARTED|Overall Study||20
10672522|NCT02336958|11834391|FG000|COMPLETED|Overall Study||20
10672523|NCT02336958|11834392|FG001|COMPLETED|Overall Study||20
10672524|NCT02336958|11834391|FG000|NOT COMPLETED|Overall Study||0
10672525|NCT02336958|11834392|FG001|NOT COMPLETED|Overall Study||0
10672526|NCT02337062|11834400|FG000|STARTED|Overall Study||572
10672527|NCT02337062|11834401|FG001|STARTED|Overall Study||575
10672528|NCT02337062|11834400|FG000|COMPLETED|Overall Study||555
10672529|NCT02337062|11834401|FG001|COMPLETED|Overall Study||556
10672530|NCT02337062|11834400|FG000|NOT COMPLETED|Overall Study||17
10672531|NCT02337062|11834401|FG001|NOT COMPLETED|Overall Study||19
10672532|NCT02337218|11834411|FG000|STARTED|Overall Study||17
10672533|NCT02337218|11834412|FG001|STARTED|Overall Study||11
10672534|NCT02337218|11834411|FG000|COMPLETED|Overall Study||17
10672535|NCT02337218|11834412|FG001|COMPLETED|Overall Study||11
10672536|NCT02337218|11834411|FG000|NOT COMPLETED|Overall Study||0
10672537|NCT02337218|11834412|FG001|NOT COMPLETED|Overall Study||0
10672538|NCT02337361|11834420|FG000|STARTED|Baseline Assessment||99
10672539|NCT02337361|11834421|FG001|STARTED|Baseline Assessment||86
10672540|NCT02337361|11834420|FG000|COMPLETED|Baseline Assessment||99
10672541|NCT02337361|11834421|FG001|COMPLETED|Baseline Assessment||86
10672542|NCT02337361|11834420|FG000|NOT COMPLETED|Baseline Assessment||0
10672543|NCT02337361|11834421|FG001|NOT COMPLETED|Baseline Assessment||0
10672544|NCT02337361|11834420|FG000|STARTED|3-month Follow-up||99
10672545|NCT02337361|11834421|FG001|STARTED|3-month Follow-up||86
10672546|NCT02337361|11834420|FG000|COMPLETED|3-month Follow-up||80
10672547|NCT02337361|11834421|FG001|COMPLETED|3-month Follow-up||72
10672548|NCT02337361|11834420|FG000|NOT COMPLETED|3-month Follow-up||19
10672549|NCT02337361|11834421|FG001|NOT COMPLETED|3-month Follow-up||14
10672550|NCT02337361|11834420|FG000|STARTED|6-month Follow-up||80
10672551|NCT02337361|11834421|FG001|STARTED|6-month Follow-up||72
10672552|NCT02337361|11834420|FG000|COMPLETED|6-month Follow-up||78
10672553|NCT02337361|11834421|FG001|COMPLETED|6-month Follow-up||68
10672554|NCT02337361|11834420|FG000|NOT COMPLETED|6-month Follow-up||2
10672555|NCT02337361|11834421|FG001|NOT COMPLETED|6-month Follow-up||4
10672556|NCT02337387|11834432|FG000|STARTED|Overall Study||14
10672557|NCT02337387|11834433|FG001|STARTED|Overall Study||8
10672558|NCT02337387|11834434|FG002|STARTED|Overall Study||3
10672559|NCT02337387|11834435|FG003|STARTED|Overall Study||3
10672560|NCT02337387|11834432|FG000|Received at Least 1 Dose of Study Drug|Overall Study||14
10672561|NCT02337387|11834433|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
10672562|NCT02337387|11834434|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
10672563|NCT02337387|11834435|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
10672564|NCT02337387|11834432|FG000|COMPLETED|Overall Study||0
10672565|NCT02337387|11834433|FG001|COMPLETED|Overall Study||0
10672566|NCT02337387|11834434|FG002|COMPLETED|Overall Study||0
10672567|NCT02337387|11834435|FG003|COMPLETED|Overall Study||0
10672568|NCT02337387|11834432|FG000|NOT COMPLETED|Overall Study||14
10672569|NCT02337387|11834433|FG001|NOT COMPLETED|Overall Study||8
10672570|NCT02337387|11834434|FG002|NOT COMPLETED|Overall Study||3
10672571|NCT02337387|11834435|FG003|NOT COMPLETED|Overall Study||3
10672572|NCT02337465|11834445|FG000|STARTED|Overall Study||30
10672573|NCT02337465|11834445|FG000|COMPLETED|Overall Study||30
10672574|NCT02337465|11834445|FG000|NOT COMPLETED|Overall Study||0
10672575|NCT02337478|11834449|FG000|STARTED|Overall Study||5
10672576|NCT02337478|11834449|FG000|COMPLETED|Overall Study||0
10672577|NCT02337478|11834449|FG000|NOT COMPLETED|Overall Study||5
10672578|NCT02337491|11834455|FG000|STARTED|Overall Study||50
10672579|NCT02337491|11834456|FG001|STARTED|Overall Study||30
10672580|NCT02337491|11834455|FG000|COMPLETED|Overall Study||0
10672581|NCT02337491|11834456|FG001|COMPLETED|Overall Study||0
10672582|NCT02337491|11834455|FG000|NOT COMPLETED|Overall Study||50
10672583|NCT02337491|11834456|FG001|NOT COMPLETED|Overall Study||30
10672584|NCT02337517|11834463|FG000|STARTED|Overall Study||6
10672585|NCT02337517|11834463|FG000|COMPLETED|Overall Study||6
10672586|NCT02337517|11834463|FG000|NOT COMPLETED|Overall Study||0
10672587|NCT02337530|11834470|FG000|STARTED|Overall Study||20
10672588|NCT02337530|11834471|FG001|STARTED|Overall Study||21
10672589|NCT02337530|11834472|FG002|STARTED|Overall Study||21
10672590|NCT02337530|11834470|FG000|COMPLETED|Overall Study||20
10672591|NCT02337530|11834471|FG001|COMPLETED|Overall Study||21
10672592|NCT02337530|11834472|FG002|COMPLETED|Overall Study||21
10672593|NCT02337530|11834470|FG000|NOT COMPLETED|Overall Study||0
10672594|NCT02337530|11834471|FG001|NOT COMPLETED|Overall Study||0
10672595|NCT02337530|11834472|FG002|NOT COMPLETED|Overall Study||0
10672596|NCT02337907|11834486|FG000|STARTED|Overall Study||55
10672597|NCT02337907|11834487|FG001|STARTED|Overall Study||53
10672598|NCT02337907|11834488|FG002|STARTED|Overall Study||55
10672599|NCT02337907|11834489|FG003|STARTED|Overall Study||55
10672600|NCT02337907|11834490|FG004|STARTED|Overall Study||106
10672601|NCT02337907|11834491|FG005|STARTED|Overall Study||5
10672602|NCT02337907|11834486|FG000|COMPLETED|Overall Study||51
10672603|NCT02337907|11834487|FG001|COMPLETED|Overall Study||49
10672604|NCT02337907|11834488|FG002|COMPLETED|Overall Study||54
10672605|NCT02337907|11834489|FG003|COMPLETED|Overall Study||51
10672606|NCT02337907|11834490|FG004|COMPLETED|Overall Study||96
10672607|NCT02337907|11834491|FG005|COMPLETED|Overall Study||4
10672608|NCT02337907|11834486|FG000|NOT COMPLETED|Overall Study||4
10672609|NCT02337907|11834487|FG001|NOT COMPLETED|Overall Study||4
10672610|NCT02337907|11834488|FG002|NOT COMPLETED|Overall Study||1
10672611|NCT02337907|11834489|FG003|NOT COMPLETED|Overall Study||4
10672612|NCT02337907|11834490|FG004|NOT COMPLETED|Overall Study||10
10672613|NCT02337907|11834491|FG005|NOT COMPLETED|Overall Study||1
10672614|NCT02337933|11834508|FG000|STARTED|Overall Study||12
10672615|NCT02337933|11834509|FG001|STARTED|Overall Study||12
10672616|NCT02337933|11834508|FG000|COMPLETED|Overall Study||12
10672617|NCT02337933|11834509|FG001|COMPLETED|Overall Study||12
10672618|NCT02337933|11834508|FG000|NOT COMPLETED|Overall Study||0
10672619|NCT02337933|11834509|FG001|NOT COMPLETED|Overall Study||0
10672620|NCT02337946|11834515|FG000|STARTED|Protocol Treatment 1 Period||164
10672621|NCT02337946|11834516|FG001|STARTED|Protocol Treatment 1 Period||0
10672622|NCT02337946|11834517|FG002|STARTED|Protocol Treatment 1 Period||0
10672623|NCT02337946|11834515|FG000|COMPLETED|Protocol Treatment 1 Period||114
10672624|NCT02337946|11834516|FG001|COMPLETED|Protocol Treatment 1 Period||0
10672625|NCT02337946|11834517|FG002|COMPLETED|Protocol Treatment 1 Period||0
10672626|NCT02337946|11834515|FG000|NOT COMPLETED|Protocol Treatment 1 Period||50
10672627|NCT02337946|11834516|FG001|NOT COMPLETED|Protocol Treatment 1 Period||0
10672628|NCT02337946|11834517|FG002|NOT COMPLETED|Protocol Treatment 1 Period||0
10455311|NCT01001221|11603332|FG002|NOT COMPLETED|Overall Study||3
10455312|NCT01001221|11603333|FG003|NOT COMPLETED|Overall Study||6
10455313|NCT01001221|11603334|FG004|NOT COMPLETED|Overall Study||0
10455314|NCT01001299|11603345|FG000|STARTED|Overall Study||25
10455315|NCT01001299|11603345|FG000|COMPLETED|Overall Study||0
10455316|NCT01001299|11603345|FG000|NOT COMPLETED|Overall Study||25
10455317|NCT01001325|11603351|FG000|STARTED|Overall Study||234
10455318|NCT01001325|11603352|FG001|STARTED|Overall Study||234
10672629|NCT02337946|11834515|FG000|STARTED|In-between Period||114
10672630|NCT02337946|11834516|FG001|STARTED|In-between Period||0
10672631|NCT02337946|11834517|FG002|STARTED|In-between Period||0
10672632|NCT02337946|11834515|FG000|COMPLETED|In-between Period||113
10672633|NCT02337946|11834516|FG001|COMPLETED|In-between Period||0
10672634|NCT02337946|11834517|FG002|COMPLETED|In-between Period||0
10672635|NCT02337946|11834515|FG000|NOT COMPLETED|In-between Period||1
10672636|NCT02337946|11834516|FG001|NOT COMPLETED|In-between Period||0
10672637|NCT02337946|11834517|FG002|NOT COMPLETED|In-between Period||0
10672638|NCT02337946|11834515|FG000|STARTED|Protocol Treatment 2 Period||0
10672639|NCT02337946|11834516|FG001|STARTED|Protocol Treatment 2 Period||56
10672640|NCT02337946|11834517|FG002|STARTED|Protocol Treatment 2 Period||57
10672641|NCT02337946|11834515|FG000|Safety Population|Protocol Treatment 2 Period||0
10672642|NCT02337946|11834516|FG001|Safety Population|Protocol Treatment 2 Period||56
10672643|NCT02337946|11834517|FG002|Safety Population|Protocol Treatment 2 Period||54
10672644|NCT02337946|11834515|FG000|COMPLETED|Protocol Treatment 2 Period||0
10672645|NCT02337946|11834516|FG001|COMPLETED|Protocol Treatment 2 Period||5
10672646|NCT02337946|11834517|FG002|COMPLETED|Protocol Treatment 2 Period||7
10672647|NCT02337946|11834515|FG000|NOT COMPLETED|Protocol Treatment 2 Period||0
10672648|NCT02337946|11834516|FG001|NOT COMPLETED|Protocol Treatment 2 Period||51
10672649|NCT02337946|11834517|FG002|NOT COMPLETED|Protocol Treatment 2 Period||50
10672650|NCT02337959|11834526|FG000|STARTED|Overall Study||10
10672651|NCT02337959|11834527|FG001|STARTED|Overall Study||10
10672652|NCT02337959|11834528|FG002|STARTED|Overall Study||7
10672653|NCT02337959|11834526|FG000|COMPLETED|Overall Study||10
10672654|NCT02337959|11834527|FG001|COMPLETED|Overall Study||7
10672655|NCT02337959|11834528|FG002|COMPLETED|Overall Study||7
10672656|NCT02337959|11834526|FG000|NOT COMPLETED|Overall Study||0
10672657|NCT02337959|11834527|FG001|NOT COMPLETED|Overall Study||3
10672658|NCT02337959|11834528|FG002|NOT COMPLETED|Overall Study||0
10672659|NCT02338076|11834536|FG000|STARTED|Overall Study||20
10672660|NCT02338076|11834536|FG000|COMPLETED|Overall Study||20
10672661|NCT02338076|11834536|FG000|NOT COMPLETED|Overall Study||0
10672662|NCT02338154|11834542|FG000|STARTED|Overall Study||516
10672663|NCT02338154|11834542|FG000|Enrolled Cohort (Intent to Treat)|Overall Study||516
10672664|NCT02338154|11834542|FG000|INTUITY (Study Valve Cohort)|Overall Study||493
10672665|NCT02338154|11834542|FG000|COMPLETED|Overall Study||373
10672666|NCT02338154|11834542|FG000|NOT COMPLETED|Overall Study||143
10672667|NCT02338193|11834557|FG000|STARTED|Overall Study||20
10672668|NCT02338193|11834558|FG001|STARTED|Overall Study||21
10672669|NCT02338193|11834559|FG002|STARTED|Overall Study||25
10672670|NCT02338193|11834557|FG000|COMPLETED|Overall Study||17
10672671|NCT02338193|11834558|FG001|COMPLETED|Overall Study||17
10672672|NCT02338193|11834559|FG002|COMPLETED|Overall Study||15
10672673|NCT02338193|11834557|FG000|NOT COMPLETED|Overall Study||3
10672674|NCT02338193|11834558|FG001|NOT COMPLETED|Overall Study||4
10672675|NCT02338193|11834559|FG002|NOT COMPLETED|Overall Study||10
10672676|NCT02338336|11834569|FG000|STARTED|Overall Study||26
10672677|NCT02338336|11834570|FG001|STARTED|Overall Study||17
10672678|NCT02338336|11834571|FG002|STARTED|Overall Study||7
10672679|NCT02338336|11834572|FG003|STARTED|Overall Study||4
10672680|NCT02338336|11834569|FG000|COMPLETED|Overall Study||24
10672681|NCT02338336|11834570|FG001|COMPLETED|Overall Study||17
10672682|NCT02338336|11834571|FG002|COMPLETED|Overall Study||7
10672683|NCT02338336|11834572|FG003|COMPLETED|Overall Study||4
10672684|NCT02338336|11834569|FG000|NOT COMPLETED|Overall Study||2
10672685|NCT02338336|11834570|FG001|NOT COMPLETED|Overall Study||0
10672686|NCT02338336|11834571|FG002|NOT COMPLETED|Overall Study||0
10672687|NCT02338336|11834572|FG003|NOT COMPLETED|Overall Study||0
10672688|NCT02338362|11834580|FG000|STARTED|Overall Study||11
10672689|NCT02338362|11834581|FG001|STARTED|Overall Study||11
10672690|NCT02338362|11834580|FG000|COMPLETED|Overall Study||10
10672691|NCT02338362|11834581|FG001|COMPLETED|Overall Study||10
10672692|NCT02338362|11834580|FG000|NOT COMPLETED|Overall Study||1
10672693|NCT02338362|11834581|FG001|NOT COMPLETED|Overall Study||1
10672694|NCT02338492|11834587|FG000|STARTED|Overall Study||81
10672695|NCT02338492|11834587|FG000|Enrolled|Overall Study||81
10672696|NCT02338492|11834587|FG000|Device Implanted|Overall Study||79
10672697|NCT02338492|11834587|FG000|Treatment Failure|Overall Study||2
10672698|NCT02338492|11834587|FG000|COMPLETED|Overall Study||36
10672699|NCT02338492|11834587|FG000|NOT COMPLETED|Overall Study||45
10672700|NCT02338713|11834591|FG000|STARTED|Overall Study||27
10672701|NCT02338713|11834591|FG000|COMPLETED|Overall Study||27
10672702|NCT02338713|11834591|FG000|NOT COMPLETED|Overall Study||0
10672703|NCT02338843|11834599|FG000|STARTED|Overall Study||163
10672704|NCT02338843|11834600|FG001|STARTED|Overall Study||158
10672705|NCT02338843|11834599|FG000|COMPLETED|Overall Study||119
10672706|NCT02338843|11834600|FG001|COMPLETED|Overall Study||100
10672707|NCT02338843|11834599|FG000|NOT COMPLETED|Overall Study||44
10672708|NCT02338843|11834600|FG001|NOT COMPLETED|Overall Study||58
10672709|NCT02338882|11834608|FG000|STARTED|Overall Study||50
10672710|NCT02338882|11834609|FG001|STARTED|Overall Study||50
10672711|NCT02338882|11834608|FG000|COMPLETED|Overall Study||43
10672712|NCT02338882|11834609|FG001|COMPLETED|Overall Study||47
10672713|NCT02338882|11834608|FG000|NOT COMPLETED|Overall Study||7
10672714|NCT02338882|11834609|FG001|NOT COMPLETED|Overall Study||3
10672715|NCT02338960|11834620|FG000|STARTED|Core Study||306
10672716|NCT02338960|11834621|FG001|STARTED|Core Study||308
10672717|NCT02338960|11834620|FG000|Received Intervention|Core Study||303
10672718|NCT02338960|11834621|FG001|Received Intervention|Core Study||301
10672719|NCT02338960|11834620|FG000|COMPLETED|Core Study||219
10672720|NCT02338960|11834621|FG001|COMPLETED|Core Study||173
10672721|NCT02338960|11834620|FG000|NOT COMPLETED|Core Study||87
10672722|NCT02338960|11834621|FG001|NOT COMPLETED|Core Study||135
10672723|NCT02338960|11834620|FG000|STARTED|Open Label Extension||191
10672724|NCT02338960|11834621|FG001|STARTED|Open Label Extension||130
10672725|NCT02338960|11834620|FG000|COMPLETED|Open Label Extension||77
10672726|NCT02338960|11834621|FG001|COMPLETED|Open Label Extension||51
10672727|NCT02338960|11834620|FG000|NOT COMPLETED|Open Label Extension||114
10672728|NCT02338960|11834621|FG001|NOT COMPLETED|Open Label Extension||79
10672729|NCT02338973|11834632|FG000|STARTED|Overall Study||4
10672730|NCT02338973|11834632|FG000|Rod-cone Dystrophy (RCD)|Overall Study||2
10672731|NCT02338973|11834632|FG000|Enhanced S-Cone Syndrome (ESCS)|Overall Study||2
10672732|NCT02338973|11834632|FG000|COMPLETED|Overall Study||4
10672733|NCT02338973|11834632|FG000|NOT COMPLETED|Overall Study||0
10672734|NCT02338999|11834715|FG000|STARTED|First Intervention||39
10672735|NCT02338999|11834716|FG001|STARTED|First Intervention||41
10672736|NCT02338999|11834715|FG000|COMPLETED|First Intervention||36
10672737|NCT02338999|11834716|FG001|COMPLETED|First Intervention||40
10672738|NCT02338999|11834715|FG000|NOT COMPLETED|First Intervention||3
10672739|NCT02338999|11834716|FG001|NOT COMPLETED|First Intervention||1
10672740|NCT02338999|11834715|FG000|STARTED|Washout Period||36
10672741|NCT02338999|11834716|FG001|STARTED|Washout Period||40
10672742|NCT02338999|11834715|FG000|COMPLETED|Washout Period||36
10672743|NCT02338999|11834716|FG001|COMPLETED|Washout Period||38
10672744|NCT02338999|11834715|FG000|NOT COMPLETED|Washout Period||0
10672745|NCT02338999|11834716|FG001|NOT COMPLETED|Washout Period||2
10672746|NCT02338999|11834715|FG000|STARTED|Second Intervention||36
10672747|NCT02338999|11834716|FG001|STARTED|Second Intervention||38
10672748|NCT02338999|11834715|FG000|COMPLETED|Second Intervention||36
10672749|NCT02338999|11834716|FG001|COMPLETED|Second Intervention||36
10672750|NCT02338999|11834715|FG000|NOT COMPLETED|Second Intervention||0
10672751|NCT02338999|11834716|FG001|NOT COMPLETED|Second Intervention||2
10672752|NCT02339038|11834722|FG000|STARTED|Overall Study||600
10672753|NCT02339038|11834722|FG000|COMPLETED|Overall Study||0
10672754|NCT02339038|11834722|FG000|NOT COMPLETED|Overall Study||600
10672755|NCT02339155|11834728|FG000|STARTED|Overall Study||287
10672756|NCT02339155|11834729|FG001|STARTED|Overall Study||286
10672757|NCT02339155|11834728|FG000|Received Study Treatment|Overall Study||286
10672758|NCT02339155|11834729|FG001|Received Study Treatment|Overall Study||280
10672759|NCT02339155|11834728|FG000|COMPLETED|Overall Study||272
10672760|NCT02339155|11834729|FG001|COMPLETED|Overall Study||265
10672761|NCT02339155|11834728|FG000|NOT COMPLETED|Overall Study||15
10672762|NCT02339155|11834729|FG001|NOT COMPLETED|Overall Study||21
10672763|NCT02339246|11834739|FG000|STARTED|First Intervention (7 Days)||0
10672764|NCT02339246|11834740|FG001|STARTED|First Intervention (7 Days)||0
10672765|NCT02339246|11834741|FG002|STARTED|First Intervention (7 Days)||31
10672766|NCT02339246|11834739|FG000|COMPLETED|First Intervention (7 Days)||0
10672767|NCT02339246|11834740|FG001|COMPLETED|First Intervention (7 Days)||0
10672768|NCT02339246|11834741|FG002|COMPLETED|First Intervention (7 Days)||31
10672769|NCT02339246|11834739|FG000|NOT COMPLETED|First Intervention (7 Days)||0
10672770|NCT02339246|11834740|FG001|NOT COMPLETED|First Intervention (7 Days)||0
10672771|NCT02339246|11834741|FG002|NOT COMPLETED|First Intervention (7 Days)||0
10672772|NCT02339246|11834739|FG000|STARTED|Second Intervention (7 Days)||16
10672773|NCT02339246|11834740|FG001|STARTED|Second Intervention (7 Days)||15
10672774|NCT02339246|11834741|FG002|STARTED|Second Intervention (7 Days)||0
10672775|NCT02339246|11834739|FG000|COMPLETED|Second Intervention (7 Days)||16
10672776|NCT02339246|11834740|FG001|COMPLETED|Second Intervention (7 Days)||15
10672777|NCT02339246|11834741|FG002|COMPLETED|Second Intervention (7 Days)||0
10672778|NCT02339246|11834739|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
10672779|NCT02339246|11834740|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
10672780|NCT02339246|11834741|FG002|NOT COMPLETED|Second Intervention (7 Days)||0
10672781|NCT02339246|11834739|FG000|STARTED|Third Period (7 Days)||15
10672782|NCT02339246|11834740|FG001|STARTED|Third Period (7 Days)||16
10672783|NCT02339246|11834741|FG002|STARTED|Third Period (7 Days)||0
10672784|NCT02339246|11834739|FG000|COMPLETED|Third Period (7 Days)||15
10672785|NCT02339246|11834740|FG001|COMPLETED|Third Period (7 Days)||16
10672786|NCT02339246|11834741|FG002|COMPLETED|Third Period (7 Days)||0
10672787|NCT02339246|11834739|FG000|NOT COMPLETED|Third Period (7 Days)||0
10672788|NCT02339246|11834740|FG001|NOT COMPLETED|Third Period (7 Days)||0
10672789|NCT02339246|11834741|FG002|NOT COMPLETED|Third Period (7 Days)||0
10672790|NCT02339285|11834752|FG000|STARTED|Overall Study||10
10672791|NCT02339285|11834753|FG001|STARTED|Overall Study||11
10672792|NCT02339285|11834754|FG002|STARTED|Overall Study||11
10672793|NCT02339285|11834752|FG000|Completed Intervention|Overall Study||10
10672794|NCT02339285|11834753|FG001|Completed Intervention|Overall Study||10
10672795|NCT02339285|11834754|FG002|Completed Intervention|Overall Study||10
10672796|NCT02339285|11834752|FG000|2 Week Follow-up|Overall Study||9
10672797|NCT02339285|11834753|FG001|2 Week Follow-up|Overall Study||10
10672798|NCT02339285|11834754|FG002|2 Week Follow-up|Overall Study||10
10672799|NCT02339285|11834752|FG000|4 Week Follow-up Visit|Overall Study||9
10672800|NCT02339285|11834753|FG001|4 Week Follow-up Visit|Overall Study||8
10672801|NCT02339285|11834754|FG002|4 Week Follow-up Visit|Overall Study||9
10672802|NCT02339285|11834752|FG000|COMPLETED|Overall Study||9
10672803|NCT02339285|11834753|FG001|COMPLETED|Overall Study||8
10672804|NCT02339285|11834754|FG002|COMPLETED|Overall Study||9
10672805|NCT02339285|11834752|FG000|NOT COMPLETED|Overall Study||1
10672806|NCT02339285|11834753|FG001|NOT COMPLETED|Overall Study||3
10672807|NCT02339285|11834754|FG002|NOT COMPLETED|Overall Study||2
10672808|NCT02339389|11834762|FG000|STARTED|Overall Study||57
10672809|NCT02339389|11834762|FG000|COMPLETED|Overall Study||41
10672810|NCT02339389|11834762|FG000|NOT COMPLETED|Overall Study||16
10672811|NCT02339415|11834769|FG000|STARTED|First Period||22
10672812|NCT02339415|11834770|FG001|STARTED|First Period||22
10672813|NCT02339415|11834769|FG000|Received at Least One Dose|First Period||21
10672814|NCT02339415|11834770|FG001|Received at Least One Dose|First Period||20
10672815|NCT02339415|11834769|FG000|COMPLETED|First Period||20
10672816|NCT02339415|11834770|FG001|COMPLETED|First Period||20
10672817|NCT02339415|11834769|FG000|NOT COMPLETED|First Period||2
10672818|NCT02339415|11834770|FG001|NOT COMPLETED|First Period||2
10672819|NCT02339415|11834769|FG000|STARTED|Washout||20
10672820|NCT02339415|11834770|FG001|STARTED|Washout||20
10672821|NCT02339415|11834769|FG000|COMPLETED|Washout||20
10672822|NCT02339415|11834770|FG001|COMPLETED|Washout||20
10672823|NCT02339415|11834769|FG000|NOT COMPLETED|Washout||0
10672824|NCT02339415|11834770|FG001|NOT COMPLETED|Washout||0
10672825|NCT02339415|11834769|FG000|STARTED|Second Period||20
10672826|NCT02339415|11834770|FG001|STARTED|Second Period||20
10672827|NCT02339415|11834769|FG000|COMPLETED|Second Period||19
10672828|NCT02339415|11834770|FG001|COMPLETED|Second Period||18
10672829|NCT02339415|11834769|FG000|NOT COMPLETED|Second Period||1
10672830|NCT02339415|11834770|FG001|NOT COMPLETED|Second Period||2
10672849|NCT02339545|11834785|FG000|STARTED|Overall Study||15
10672850|NCT02339545|11834785|FG000|COMPLETED|Overall Study||15
10672851|NCT02339545|11834785|FG000|NOT COMPLETED|Overall Study||0
10672852|NCT02339558|11834790|FG000|STARTED|Overall Study||45
10672853|NCT02339558|11834790|FG000|COMPLETED|Overall Study||45
10672854|NCT02339558|11834790|FG000|NOT COMPLETED|Overall Study||0
10712418|NCT02670382|11878081|FG000|STARTED|Placebo lead-in Phase||12
10712419|NCT02670382|11878082|FG001|STARTED|Placebo lead-in Phase||12
10712420|NCT02670382|11878081|FG000|COMPLETED|Placebo lead-in Phase|Two enrolled subjects randomized to receive EPA as the first intervention decided to stop participation during the placebo lead-in phase. Therefore, only 10 subjects continued to the EPA and then DHA supplementation phases. No data were collected from these two subjects.|10
10712421|NCT02670382|11878082|FG001|COMPLETED|Placebo lead-in Phase|One enrolled subjects randomized to receive EDHA as the first intervention decided to stop participation during the placebo lead-in phase. Therefore, only 11 subjects continued to the DHA and then EPA supplementation phases. No data were collected from this subject.|11
10712422|NCT02670382|11878081|FG000|NOT COMPLETED|Placebo lead-in Phase||2
10712423|NCT02670382|11878082|FG001|NOT COMPLETED|Placebo lead-in Phase||1
10712424|NCT02670382|11878081|FG000|STARTED|First Active Intervention|Only 10 of the 12 enrolled subjects randomized to receive EPA as the first supplementation completed the lead-in placebo phase and then entered the EPA supplementation phase.|10
10712425|NCT02670382|11878082|FG001|STARTED|First Active Intervention|Only 11 of the 12 enrolled subjects randomized to receive DHA as the first supplementation completed the lead-in placebo phase and then entered the EDHA supplementation phase.|11
10712426|NCT02670382|11878081|FG000|COMPLETED|First Active Intervention||10
10712427|NCT02670382|11878082|FG001|COMPLETED|First Active Intervention||11
10712428|NCT02670382|11878081|FG000|NOT COMPLETED|First Active Intervention||0
10712429|NCT02670382|11878082|FG001|NOT COMPLETED|First Active Intervention||0
10712430|NCT02670382|11878081|FG000|STARTED|Second Active Intervention||10
10712431|NCT02670382|11878082|FG001|STARTED|Second Active Intervention||11
10712432|NCT02670382|11878081|FG000|COMPLETED|Second Active Intervention||10
10712433|NCT02670382|11878082|FG001|COMPLETED|Second Active Intervention||11
10712434|NCT02670382|11878081|FG000|NOT COMPLETED|Second Active Intervention||0
10712435|NCT02670382|11878082|FG001|NOT COMPLETED|Second Active Intervention||0
10712436|NCT02670473|11878090|FG000|STARTED|Overall Study||35
10712437|NCT02670473|11878090|FG000|COMPLETED|Overall Study||34
10712438|NCT02670473|11878090|FG000|NOT COMPLETED|Overall Study||1
10712439|NCT02670538|11878106|FG000|STARTED|Overall Study||167
10712440|NCT02670538|11878107|FG001|STARTED|Overall Study||168
10712441|NCT02670538|11878108|FG002|STARTED|Overall Study||158
10712442|NCT02670538|11878106|FG000|Safety Population : Received Study Drug|Overall Study||165
10712443|NCT02670538|11878107|FG001|Safety Population : Received Study Drug|Overall Study||167
10712444|NCT02670538|11878108|FG002|Safety Population : Received Study Drug|Overall Study||158
10712445|NCT02670538|11878106|FG000|Intent-to-Treat Population|Overall Study||163
10712446|NCT02670538|11878107|FG001|Intent-to-Treat Population|Overall Study||162
10712447|NCT02670538|11878108|FG002|Intent-to-Treat Population|Overall Study||153
10712448|NCT02670538|11878106|FG000|COMPLETED|Overall Study||135
10712449|NCT02670538|11878107|FG001|COMPLETED|Overall Study||136
10712450|NCT02670538|11878108|FG002|COMPLETED|Overall Study||128
10712451|NCT02670538|11878106|FG000|NOT COMPLETED|Overall Study||32
10712452|NCT02670538|11878107|FG001|NOT COMPLETED|Overall Study||32
10672855|NCT02339584|11834796|FG000|STARTED|Overall Study||188
10672856|NCT02339584|11834797|FG001|STARTED|Overall Study||191
10672857|NCT02339584|11834796|FG000|COMPLETED|Overall Study||173
10672858|NCT02339584|11834797|FG001|COMPLETED|Overall Study||176
10672859|NCT02339584|11834796|FG000|NOT COMPLETED|Overall Study||15
10672860|NCT02339584|11834797|FG001|NOT COMPLETED|Overall Study||15
10672861|NCT02339831|11834805|FG000|STARTED|Overall Study||58
10672862|NCT02339831|11834806|FG001|STARTED|Overall Study||52
10672863|NCT02339831|11834805|FG000|Lost to Follow Up|Overall Study||20
10672864|NCT02339831|11834806|FG001|Lost to Follow Up|Overall Study||7
10672865|NCT02339831|11834805|FG000|COMPLETED|Overall Study||38
10672866|NCT02339831|11834806|FG001|COMPLETED|Overall Study||45
10672867|NCT02339831|11834805|FG000|NOT COMPLETED|Overall Study||20
10672868|NCT02339831|11834806|FG001|NOT COMPLETED|Overall Study||7
10672869|NCT02339909|11834815|FG000|STARTED|Overall Study||524
10672870|NCT02339909|11834816|FG001|STARTED|Overall Study||375
10672871|NCT02339909|11834817|FG002|STARTED|Overall Study||375
10672872|NCT02339909|11834815|FG000|COMPLETED|Overall Study||435
10672873|NCT02339909|11834816|FG001|COMPLETED|Overall Study||312
10672874|NCT02339909|11834817|FG002|COMPLETED|Overall Study||304
10672875|NCT02339909|11834815|FG000|NOT COMPLETED|Overall Study||89
10672876|NCT02339909|11834816|FG001|NOT COMPLETED|Overall Study||63
10672877|NCT02339909|11834817|FG002|NOT COMPLETED|Overall Study||71
10672878|NCT02340000|11834827|FG000|STARTED|Time Period 1||90
10672879|NCT02340000|11834828|FG001|STARTED|Time Period 1||89
10672880|NCT02340000|11834827|FG000|COMPLETED|Time Period 1||78
10672881|NCT02340000|11834828|FG001|COMPLETED|Time Period 1||74
10672882|NCT02340000|11834827|FG000|NOT COMPLETED|Time Period 1||12
10672883|NCT02340000|11834828|FG001|NOT COMPLETED|Time Period 1||15
10672884|NCT02340000|11834827|FG000|STARTED|Time Period 2||69
10672885|NCT02340000|11834828|FG001|STARTED|Time Period 2||67
10672886|NCT02340000|11834827|FG000|COMPLETED|Time Period 2||50
10672887|NCT02340000|11834828|FG001|COMPLETED|Time Period 2||52
10672888|NCT02340000|11834827|FG000|NOT COMPLETED|Time Period 2||19
10672889|NCT02340000|11834828|FG001|NOT COMPLETED|Time Period 2||15
10672890|NCT02340078|11834841|FG000|STARTED|Overall Study||62
10672891|NCT02340078|11834841|FG000|COMPLETED|Overall Study||61
10672892|NCT02340078|11834841|FG000|NOT COMPLETED|Overall Study||1
10672893|NCT02340091|11834846|FG000|STARTED|Overall Study|All Study Participants|62
10672894|NCT02340091|11834846|FG000|COMPLETED|Overall Study||60
10672895|NCT02340091|11834846|FG000|NOT COMPLETED|Overall Study||2
10672896|NCT02340104|11834851|FG000|STARTED|Overall Study||8
10672897|NCT02340104|11834851|FG000|COMPLETED|Overall Study||8
10672898|NCT02340104|11834851|FG000|NOT COMPLETED|Overall Study||0
10672899|NCT02340156|11834856|FG000|STARTED|Overall Study||1
10672900|NCT02340156|11834856|FG000|COMPLETED|Overall Study||1
10672901|NCT02340156|11834856|FG000|NOT COMPLETED|Overall Study||0
10672902|NCT02340299|11834862|FG000|STARTED|Overall Study||4
10672903|NCT02340299|11834863|FG001|STARTED|Overall Study||2
10672904|NCT02340299|11834862|FG000|COMPLETED|Overall Study||4
10672905|NCT02340299|11834863|FG001|COMPLETED|Overall Study||2
10672906|NCT02340299|11834862|FG000|NOT COMPLETED|Overall Study||0
10672907|NCT02340299|11834863|FG001|NOT COMPLETED|Overall Study||0
10672908|NCT02340338|11834876|FG000|STARTED|Overall Study|2 vaccine + 1 placebo|2
10672909|NCT02340338|11834877|FG001|STARTED|Overall Study|2 vaccine + 1 placebo|2
10672910|NCT02340338|11834878|FG002|STARTED|Overall Study|3 vaccine + 1 placebo|3
10672911|NCT02340338|11834879|FG003|STARTED|Overall Study|9 vaccine + 3 placebo|9
10672912|NCT02340338|11834880|FG004|STARTED|Overall Study|9 vaccine + 3 placebo|9
10672913|NCT02340338|11834881|FG005|STARTED|Overall Study|9 vaccine + 3 placebo|9
10672914|NCT02340338|11834882|FG006|STARTED|Overall Study|Placebos were randomly assigned to dose groups 1-6, included in the 46 participants.|12
10672915|NCT02340338|11834876|FG000|COMPLETED|Overall Study||2
10672916|NCT02340338|11834877|FG001|COMPLETED|Overall Study||2
10672917|NCT02340338|11834878|FG002|COMPLETED|Overall Study||3
10672918|NCT02340338|11834879|FG003|COMPLETED|Overall Study||9
10672919|NCT02340338|11834880|FG004|COMPLETED|Overall Study||9
10672920|NCT02340338|11834881|FG005|COMPLETED|Overall Study|1 withdrew voluntarily after the first immunization; safety and serum assessment completed.|9
10672921|NCT02340338|11834882|FG006|COMPLETED|Overall Study||12
10672922|NCT02340338|11834876|FG000|NOT COMPLETED|Overall Study||0
10672923|NCT02340338|11834877|FG001|NOT COMPLETED|Overall Study||0
10672924|NCT02340338|11834878|FG002|NOT COMPLETED|Overall Study||0
10672925|NCT02340338|11834879|FG003|NOT COMPLETED|Overall Study||0
10672926|NCT02340338|11834880|FG004|NOT COMPLETED|Overall Study||0
10672927|NCT02340338|11834881|FG005|NOT COMPLETED|Overall Study||0
10672928|NCT02340338|11834882|FG006|NOT COMPLETED|Overall Study||0
10672929|NCT02340520|11834898|FG000|STARTED|Overall Study||11
10672930|NCT02340520|11834898|FG000|COMPLETED|Overall Study||8
10672931|NCT02340520|11834898|FG000|NOT COMPLETED|Overall Study||3
10672932|NCT02340663|11834904|FG000|STARTED|Overall Study||35
10672933|NCT02340663|11834905|FG001|STARTED|Overall Study||32
10672934|NCT02340663|11834904|FG000|Clinical Exam, Impressions|Overall Study||35
10672935|NCT02340663|11834905|FG001|Clinical Exam, Impressions|Overall Study||32
10672936|NCT02340663|11834904|FG000|Splint Delivery, Assessments|Overall Study||33
10672937|NCT02340663|11834905|FG001|Splint Delivery, Assessments|Overall Study||31
10672938|NCT02340663|11834904|FG000|1 Week Follow-up, Assessments|Overall Study||33
10672939|NCT02340663|11834905|FG001|1 Week Follow-up, Assessments|Overall Study||31
10672940|NCT02340663|11834904|FG000|4 Month Follow-up, Assessments|Overall Study||30
10672941|NCT02340663|11834905|FG001|4 Month Follow-up, Assessments|Overall Study||31
10672942|NCT02340663|11834904|FG000|COMPLETED|Overall Study||30
10672943|NCT02340663|11834905|FG001|COMPLETED|Overall Study||31
10672944|NCT02340663|11834904|FG000|NOT COMPLETED|Overall Study||5
10672945|NCT02340663|11834905|FG001|NOT COMPLETED|Overall Study||1
10672946|NCT02340715|11834911|FG000|STARTED|Overall Study|158|158
10672947|NCT02340715|11834911|FG000|COMPLETED|Overall Study|158|158
10672948|NCT02340715|11834911|FG000|NOT COMPLETED|Overall Study||0
10672949|NCT02340767|11834924|FG000|STARTED|Overall Study||28
10672950|NCT02340767|11834925|FG001|STARTED|Overall Study||28
10672951|NCT02340767|11834926|FG002|STARTED|Overall Study||29
10672952|NCT02340767|11834927|FG003|STARTED|Overall Study||500
10672953|NCT02340767|11834928|FG004|STARTED|Overall Study||474
10672954|NCT02340767|11834929|FG005|STARTED|Overall Study||526
10672955|NCT02340767|11834930|FG006|STARTED|Overall Study||525
10672956|NCT02340767|11834931|FG007|STARTED|Overall Study||444
10672957|NCT02340767|11834932|FG008|STARTED|Overall Study||531
10672958|NCT02340767|11834924|FG000|COMPLETED|Overall Study||28
10672959|NCT02340767|11834925|FG001|COMPLETED|Overall Study||28
10672960|NCT02340767|11834926|FG002|COMPLETED|Overall Study||29
10672961|NCT02340767|11834927|FG003|COMPLETED|Overall Study||500
10672962|NCT02340767|11834928|FG004|COMPLETED|Overall Study||474
10672963|NCT02340767|11834929|FG005|COMPLETED|Overall Study||526
10672964|NCT02340767|11834930|FG006|COMPLETED|Overall Study||525
10672965|NCT02340767|11834931|FG007|COMPLETED|Overall Study||444
10672966|NCT02340767|11834932|FG008|COMPLETED|Overall Study||531
10672967|NCT02340767|11834924|FG000|NOT COMPLETED|Overall Study||0
10672968|NCT02340767|11834925|FG001|NOT COMPLETED|Overall Study||0
10672969|NCT02340767|11834926|FG002|NOT COMPLETED|Overall Study||0
10672970|NCT02340767|11834927|FG003|NOT COMPLETED|Overall Study||0
10672971|NCT02340767|11834928|FG004|NOT COMPLETED|Overall Study||0
10672972|NCT02340767|11834929|FG005|NOT COMPLETED|Overall Study||0
10672973|NCT02340767|11834930|FG006|NOT COMPLETED|Overall Study||0
10672974|NCT02340767|11834931|FG007|NOT COMPLETED|Overall Study||0
10672975|NCT02340767|11834932|FG008|NOT COMPLETED|Overall Study||0
10672976|NCT02340780|11834947|FG000|STARTED|Overall Study|A total of 14 patients enrolled, one patient was found ineligible after the enrollment.|14
10672977|NCT02340780|11834947|FG000|COMPLETED|Overall Study||13
10672978|NCT02340780|11834947|FG000|NOT COMPLETED|Overall Study||1
10672979|NCT02340806|11834953|FG000|STARTED|Overall Study||108
10672980|NCT02340806|11834954|FG001|STARTED|Overall Study||112
10672981|NCT02340806|11834953|FG000|COMPLETED|Overall Study||102
10672982|NCT02340806|11834954|FG001|COMPLETED|Overall Study||108
10672983|NCT02340806|11834953|FG000|NOT COMPLETED|Overall Study||6
10672984|NCT02340806|11834954|FG001|NOT COMPLETED|Overall Study||4
10672985|NCT02340819|11834960|FG000|STARTED|Overall Study||11
10672986|NCT02340819|11834960|FG000|Started Stage 2|Overall Study||11
10672987|NCT02340819|11834960|FG000|Completed Stage 2|Overall Study||9
10672988|NCT02340819|11834960|FG000|Started Stage 3|Overall Study||8
10672989|NCT02340819|11834960|FG000|Completed Stage 3|Overall Study||7
10672990|NCT02340819|11834960|FG000|Started Stage 4|Overall Study||7
10672991|NCT02340819|11834960|FG000|Completed Stage 4|Overall Study||7
10672992|NCT02340819|11834960|FG000|COMPLETED|Overall Study||7
10672993|NCT02340819|11834960|FG000|NOT COMPLETED|Overall Study||4
10672994|NCT02340949|11834966|FG000|STARTED|Overall Study||115
10672995|NCT02340949|11834967|FG001|STARTED|Overall Study||65
10672996|NCT02340949|11834966|FG000|COMPLETED|Overall Study||99
10672997|NCT02340949|11834967|FG001|COMPLETED|Overall Study||61
10672998|NCT02340949|11834966|FG000|NOT COMPLETED|Overall Study||16
10672999|NCT02340949|11834967|FG001|NOT COMPLETED|Overall Study||4
10673000|NCT02340962|11834975|FG000|STARTED|Overall Study||13
10673001|NCT02340962|11834976|FG001|STARTED|Overall Study||12
10673002|NCT02340962|11834975|FG000|COMPLETED|Overall Study||12
10673003|NCT02340962|11834976|FG001|COMPLETED|Overall Study||12
10673004|NCT02340962|11834975|FG000|NOT COMPLETED|Overall Study||1
10673005|NCT02340962|11834976|FG001|NOT COMPLETED|Overall Study||0
10673006|NCT02340975|11834988|FG000|STARTED|Overall Study||6
10673007|NCT02340975|11834989|FG001|STARTED|Overall Study||27
10673008|NCT02340975|11834990|FG002|STARTED|Overall Study||24
10673009|NCT02340975|11834991|FG003|STARTED|Overall Study||12
10673010|NCT02340975|11834992|FG004|STARTED|Overall Study||25
10673011|NCT02340975|11834993|FG005|STARTED|Overall Study||19
10673012|NCT02340975|11834988|FG000|COMPLETED|Overall Study||0
10673013|NCT02340975|11834989|FG001|COMPLETED|Overall Study||0
10673014|NCT02340975|11834990|FG002|COMPLETED|Overall Study||0
10673015|NCT02340975|11834991|FG003|COMPLETED|Overall Study||0
10673016|NCT02340975|11834992|FG004|COMPLETED|Overall Study||0
10673017|NCT02340975|11834993|FG005|COMPLETED|Overall Study||0
10673018|NCT02340975|11834988|FG000|NOT COMPLETED|Overall Study||6
10673019|NCT02340975|11834989|FG001|NOT COMPLETED|Overall Study||27
10673020|NCT02340975|11834990|FG002|NOT COMPLETED|Overall Study||24
10673021|NCT02340975|11834991|FG003|NOT COMPLETED|Overall Study||12
10673022|NCT02340975|11834992|FG004|NOT COMPLETED|Overall Study||25
10673023|NCT02340975|11834993|FG005|NOT COMPLETED|Overall Study||19
10673024|NCT02341144|11835010|FG000|STARTED|Overall Study||30
10673025|NCT02341144|11835011|FG001|STARTED|Overall Study||31
10673026|NCT02341144|11835010|FG000|COMPLETED|Overall Study||28
10673027|NCT02341144|11835011|FG001|COMPLETED|Overall Study||30
10673028|NCT02341144|11835010|FG000|NOT COMPLETED|Overall Study||2
10673029|NCT02341144|11835011|FG001|NOT COMPLETED|Overall Study||1
10673030|NCT02341417|11835020|FG000|STARTED|Overall Study||13
10673031|NCT02341417|11835021|FG001|STARTED|Overall Study||14
10673032|NCT02341417|11835022|FG002|STARTED|Overall Study||1
10673033|NCT02341417|11835020|FG000|COMPLETED|Overall Study||11
10673034|NCT02341417|11835021|FG001|COMPLETED|Overall Study||12
10673035|NCT02341417|11835022|FG002|COMPLETED|Overall Study||0
10673036|NCT02341417|11835020|FG000|NOT COMPLETED|Overall Study||2
10673037|NCT02341417|11835021|FG001|NOT COMPLETED|Overall Study||2
10673038|NCT02341417|11835022|FG002|NOT COMPLETED|Overall Study||1
10673039|NCT02341456|11835034|FG000|STARTED|Overall Study||7
10673040|NCT02341456|11835035|FG001|STARTED|Overall Study||6
10673041|NCT02341456|11835036|FG002|STARTED|Overall Study||6
10673042|NCT02341456|11835034|FG000|COMPLETED|Overall Study||3
10673043|NCT02341456|11835035|FG001|COMPLETED|Overall Study||0
10673044|NCT02341456|11835036|FG002|COMPLETED|Overall Study||2
10673045|NCT02341456|11835034|FG000|NOT COMPLETED|Overall Study||4
10673046|NCT02341456|11835035|FG001|NOT COMPLETED|Overall Study||6
10673047|NCT02341456|11835036|FG002|NOT COMPLETED|Overall Study||4
10673048|NCT02341482|11835044|FG000|STARTED|Overall Study||13
10673049|NCT02341482|11835044|FG000|COMPLETED|Overall Study||12
10673050|NCT02341482|11835044|FG000|NOT COMPLETED|Overall Study||1
10673051|NCT02341599|11835058|FG000|STARTED|Overall Study||8
10673052|NCT02341599|11835059|FG001|STARTED|Overall Study||8
10673053|NCT02341599|11835060|FG002|STARTED|Overall Study||8
10673054|NCT02341599|11835061|FG003|STARTED|Overall Study||8
10673055|NCT02341599|11835062|FG004|STARTED|Overall Study||8
10673056|NCT02341599|11835058|FG000|COMPLETED|Overall Study||8
10673057|NCT02341599|11835059|FG001|COMPLETED|Overall Study||8
10673058|NCT02341599|11835060|FG002|COMPLETED|Overall Study||8
10673059|NCT02341599|11835061|FG003|COMPLETED|Overall Study||8
10673060|NCT02341599|11835062|FG004|COMPLETED|Overall Study||8
10673061|NCT02341599|11835058|FG000|NOT COMPLETED|Overall Study||0
10673062|NCT02341599|11835059|FG001|NOT COMPLETED|Overall Study||0
10673063|NCT02341599|11835060|FG002|NOT COMPLETED|Overall Study||0
10673064|NCT02341599|11835061|FG003|NOT COMPLETED|Overall Study||0
10673065|NCT02341599|11835062|FG004|NOT COMPLETED|Overall Study||0
10673066|NCT02341859|11835077|FG000|STARTED|First Intervention (1 Day)||10
10673067|NCT02341859|11835078|FG001|STARTED|First Intervention (1 Day)||9
10673068|NCT02341859|11835077|FG000|COMPLETED|First Intervention (1 Day)||10
10673069|NCT02341859|11835078|FG001|COMPLETED|First Intervention (1 Day)||9
10673070|NCT02341859|11835077|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10673071|NCT02341859|11835078|FG001|NOT COMPLETED|First Intervention (1 Day)||0
10673072|NCT02341859|11835077|FG000|STARTED|Second Intervention (1 Day)||10
10673073|NCT02341859|11835078|FG001|STARTED|Second Intervention (1 Day)||9
10673074|NCT02341859|11835077|FG000|COMPLETED|Second Intervention (1 Day)||10
10673075|NCT02341859|11835078|FG001|COMPLETED|Second Intervention (1 Day)||9
10673076|NCT02341859|11835077|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10673077|NCT02341859|11835078|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10673078|NCT02342015|11835091|FG000|STARTED|Overall Study||20
10797148|NCT03684265|11957547|FG000|STARTED|Washout Period of 1 Week||13
10797149|NCT03684265|11957548|FG001|STARTED|Washout Period of 1 Week||13
10797150|NCT03684265|11957547|FG000|COMPLETED|Washout Period of 1 Week||13
10797151|NCT03684265|11957548|FG001|COMPLETED|Washout Period of 1 Week||13
10797152|NCT03684265|11957547|FG000|NOT COMPLETED|Washout Period of 1 Week||0
10797153|NCT03684265|11957548|FG001|NOT COMPLETED|Washout Period of 1 Week||0
10797154|NCT03684265|11957547|FG000|STARTED|Treatment Period 2||13
10797155|NCT03684265|11957548|FG001|STARTED|Treatment Period 2||13
10797156|NCT03684265|11957547|FG000|COMPLETED|Treatment Period 2||13
10797157|NCT03684265|11957548|FG001|COMPLETED|Treatment Period 2||13
10797158|NCT03684265|11957547|FG000|NOT COMPLETED|Treatment Period 2||0
10797159|NCT03684265|11957548|FG001|NOT COMPLETED|Treatment Period 2||0
10810922|NCT03783702|11972631|FG001|COMPLETED|Overall Study||51
10810923|NCT03783702|11972630|FG000|NOT COMPLETED|Overall Study||7
10810924|NCT03783702|11972631|FG001|NOT COMPLETED|Overall Study||11
10810925|NCT03781479|11972640|FG000|STARTED|Overall Study||6
10810926|NCT03781479|11972641|FG001|STARTED|Overall Study||6
10810927|NCT03781479|11972642|FG002|STARTED|Overall Study||1
10810928|NCT03781479|11972640|FG000|COMPLETED|Overall Study||6
10810929|NCT03781479|11972641|FG001|COMPLETED|Overall Study||6
10810930|NCT03781479|11972642|FG002|COMPLETED|Overall Study||0
10810931|NCT03781479|11972640|FG000|NOT COMPLETED|Overall Study||0
10810932|NCT03781479|11972641|FG001|NOT COMPLETED|Overall Study||0
10810933|NCT03781479|11972642|FG002|NOT COMPLETED|Overall Study||1
10810934|NCT03781037|11972648|FG000|STARTED|Overall Study||18
10810935|NCT03781037|11972648|FG000|COMPLETED|Overall Study||18
10810936|NCT03781037|11972648|FG000|NOT COMPLETED|Overall Study||0
10810937|NCT03784079|11972660|FG000|STARTED|Part 1: Up to Day 24||6
10810938|NCT03784079|11972661|FG001|STARTED|Part 1: Up to Day 24||6
10810939|NCT03784079|11972662|FG002|STARTED|Part 1: Up to Day 24||2
10673079|NCT02342015|11835091|FG000|COMPLETED|Overall Study||20
10673080|NCT02342015|11835091|FG000|NOT COMPLETED|Overall Study||0
10673081|NCT02342171|11835097|FG000|STARTED|Overall Study||99
10673082|NCT02342171|11835098|FG001|STARTED|Overall Study||507
10673083|NCT02342171|11835097|FG000|COMPLETED|Overall Study||84
10673084|NCT02342171|11835098|FG001|COMPLETED|Overall Study||418
10673085|NCT02342171|11835097|FG000|NOT COMPLETED|Overall Study||15
10673086|NCT02342171|11835098|FG001|NOT COMPLETED|Overall Study||89
10673087|NCT02342197|11835105|FG000|STARTED|Overall Study||30
10673088|NCT02342197|11835106|FG001|STARTED|Overall Study||30
10673089|NCT02342197|11835105|FG000|COMPLETED|Overall Study||27
10673090|NCT02342197|11835106|FG001|COMPLETED|Overall Study||28
10673091|NCT02342197|11835105|FG000|NOT COMPLETED|Overall Study||3
10673092|NCT02342197|11835106|FG001|NOT COMPLETED|Overall Study||2
10810940|NCT03784079|11972663|FG003|STARTED|Part 1: Up to Day 24||0
10810941|NCT03784079|11972664|FG004|STARTED|Part 1: Up to Day 24||0
10673093|NCT02342223|11835112|FG000|STARTED|Overall Study||20
10673094|NCT02342223|11835112|FG000|COMPLETED|Overall Study||19
10673095|NCT02342223|11835112|FG000|NOT COMPLETED|Overall Study||1
10673096|NCT02342288|11835118|FG000|STARTED|Overall Study|16 patients were not randomized to either arm.|30
10673097|NCT02342288|11835119|FG001|STARTED|Overall Study|various issues listed below caused removal of subjects|33
10673098|NCT02342288|11835118|FG000|COMPLETED|Overall Study||25
10673099|NCT02342288|11835119|FG001|COMPLETED|Overall Study||27
10673100|NCT02342288|11835118|FG000|NOT COMPLETED|Overall Study||5
10673101|NCT02342288|11835119|FG001|NOT COMPLETED|Overall Study||6
10673102|NCT02342314|11835127|FG000|STARTED|Part A||6
10673103|NCT02342314|11835128|FG001|STARTED|Part A||3
10673104|NCT02342314|11835129|FG002|STARTED|Part A||3
10673105|NCT02342314|11835130|FG003|STARTED|Part A||3
10673106|NCT02342314|11835131|FG004|STARTED|Part A||6
10673107|NCT02342314|11835132|FG005|STARTED|Part A||3
10673108|NCT02342314|11835133|FG006|STARTED|Part A||0
10673109|NCT02342314|11835134|FG007|STARTED|Part A||0
10673110|NCT02342314|11835135|FG008|STARTED|Part A||0
10673111|NCT02342314|11835136|FG009|STARTED|Part A||0
10673112|NCT02342314|11835137|FG010|STARTED|Part A||0
10673113|NCT02342314|11835138|FG011|STARTED|Part A||0
10673114|NCT02342314|11835139|FG012|STARTED|Part A||0
10673115|NCT02342314|11835140|FG013|STARTED|Part A||0
10673116|NCT02342314|11835141|FG014|STARTED|Part A||0
10673117|NCT02342314|11835142|FG015|STARTED|Part A||0
10673118|NCT02342314|11835143|FG016|STARTED|Part A||0
10673119|NCT02342314|11835127|FG000|COMPLETED|Part A||6
10673120|NCT02342314|11835128|FG001|COMPLETED|Part A||3
10673121|NCT02342314|11835129|FG002|COMPLETED|Part A||3
10673122|NCT02342314|11835130|FG003|COMPLETED|Part A||3
10673123|NCT02342314|11835131|FG004|COMPLETED|Part A||6
10673124|NCT02342314|11835132|FG005|COMPLETED|Part A||3
10673125|NCT02342314|11835133|FG006|COMPLETED|Part A||0
10673126|NCT02342314|11835134|FG007|COMPLETED|Part A||0
10673127|NCT02342314|11835135|FG008|COMPLETED|Part A||0
10673128|NCT02342314|11835136|FG009|COMPLETED|Part A||0
10673129|NCT02342314|11835137|FG010|COMPLETED|Part A||0
10673130|NCT02342314|11835138|FG011|COMPLETED|Part A||0
10673131|NCT02342314|11835139|FG012|COMPLETED|Part A||0
10673132|NCT02342314|11835140|FG013|COMPLETED|Part A||0
10673133|NCT02342314|11835141|FG014|COMPLETED|Part A||0
10673134|NCT02342314|11835142|FG015|COMPLETED|Part A||0
10673135|NCT02342314|11835143|FG016|COMPLETED|Part A||0
10673136|NCT02342314|11835127|FG000|NOT COMPLETED|Part A||0
10673137|NCT02342314|11835128|FG001|NOT COMPLETED|Part A||0
10673138|NCT02342314|11835129|FG002|NOT COMPLETED|Part A||0
10673139|NCT02342314|11835130|FG003|NOT COMPLETED|Part A||0
10673140|NCT02342314|11835131|FG004|NOT COMPLETED|Part A||0
10673141|NCT02342314|11835132|FG005|NOT COMPLETED|Part A||0
10673142|NCT02342314|11835133|FG006|NOT COMPLETED|Part A||0
10673143|NCT02342314|11835134|FG007|NOT COMPLETED|Part A||0
10673144|NCT02342314|11835135|FG008|NOT COMPLETED|Part A||0
10673145|NCT02342314|11835136|FG009|NOT COMPLETED|Part A||0
10673146|NCT02342314|11835137|FG010|NOT COMPLETED|Part A||0
10673147|NCT02342314|11835138|FG011|NOT COMPLETED|Part A||0
10673148|NCT02342314|11835139|FG012|NOT COMPLETED|Part A||0
10673149|NCT02342314|11835140|FG013|NOT COMPLETED|Part A||0
10673150|NCT02342314|11835141|FG014|NOT COMPLETED|Part A||0
10673151|NCT02342314|11835142|FG015|NOT COMPLETED|Part A||0
10673152|NCT02342314|11835143|FG016|NOT COMPLETED|Part A||0
10673153|NCT02342314|11835127|FG000|STARTED|Part B|Participants received placebo in Part A.|0
10673154|NCT02342314|11835128|FG001|STARTED|Part B|Participants received LY3143753 in Part A.|0
10673155|NCT02342314|11835129|FG002|STARTED|Part B|Participants received LY3143753 in Part A.|0
10673156|NCT02342314|11835130|FG003|STARTED|Part B|Participants received LY3143753 in Part A.|0
10673157|NCT02342314|11835131|FG004|STARTED|Part B|Participants received LY3143753 in Part A.|0
10673158|NCT02342314|11835132|FG005|STARTED|Part B|Participants received LY3143753 in Part A.|0
10673159|NCT02342314|11835133|FG006|STARTED|Part B|Participants received placebo in Part B.|11
10673160|NCT02342314|11835134|FG007|STARTED|Part B|Participants received LY3185643 in Part B.|3
10673161|NCT02342314|11835135|FG008|STARTED|Part B|Participants received LY3185643 in Part B.|3
10673162|NCT02342314|11835136|FG009|STARTED|Part B|Participants received LY3185643 in Part B.|3
10673163|NCT02342314|11835137|FG010|STARTED|Part B|Participants received LY3185643 in Part B.|3
10673164|NCT02342314|11835138|FG011|STARTED|Part B|Participants received LY3185643 in Part B.|3
10673165|NCT02342314|11835139|FG012|STARTED|Part B|Participants received LY3185643 in Part B.|3
10673166|NCT02342314|11835140|FG013|STARTED|Part B|Participants received LY3185643 in Part B.|3
10673167|NCT02342314|11835141|FG014|STARTED|Part B|Participants received LY3185643 in Part B.|3
10673168|NCT02342314|11835142|FG015|STARTED|Part B|Participants received LY3185643 in Part B.|3
10673169|NCT02342314|11835143|FG016|STARTED|Part B|Participants received rGlucagon in Part B.|6
10673170|NCT02342314|11835127|FG000|COMPLETED|Part B||0
10673171|NCT02342314|11835128|FG001|COMPLETED|Part B||0
10673172|NCT02342314|11835129|FG002|COMPLETED|Part B||0
10673173|NCT02342314|11835130|FG003|COMPLETED|Part B||0
10673174|NCT02342314|11835131|FG004|COMPLETED|Part B||0
10673175|NCT02342314|11835132|FG005|COMPLETED|Part B||0
10673176|NCT02342314|11835133|FG006|COMPLETED|Part B||11
10673177|NCT02342314|11835134|FG007|COMPLETED|Part B||3
10673178|NCT02342314|11835135|FG008|COMPLETED|Part B||3
10673179|NCT02342314|11835136|FG009|COMPLETED|Part B||3
10673180|NCT02342314|11835137|FG010|COMPLETED|Part B||3
10673181|NCT02342314|11835138|FG011|COMPLETED|Part B||3
10673182|NCT02342314|11835139|FG012|COMPLETED|Part B||3
10673183|NCT02342314|11835140|FG013|COMPLETED|Part B||3
10673184|NCT02342314|11835141|FG014|COMPLETED|Part B||3
10673185|NCT02342314|11835142|FG015|COMPLETED|Part B||3
10673186|NCT02342314|11835143|FG016|COMPLETED|Part B||6
10673187|NCT02342314|11835127|FG000|NOT COMPLETED|Part B||0
10673188|NCT02342314|11835128|FG001|NOT COMPLETED|Part B||0
10673189|NCT02342314|11835129|FG002|NOT COMPLETED|Part B||0
10673190|NCT02342314|11835130|FG003|NOT COMPLETED|Part B||0
10673191|NCT02342314|11835131|FG004|NOT COMPLETED|Part B||0
10673192|NCT02342314|11835132|FG005|NOT COMPLETED|Part B||0
10673193|NCT02342314|11835133|FG006|NOT COMPLETED|Part B||0
10673194|NCT02342314|11835134|FG007|NOT COMPLETED|Part B||0
10673195|NCT02342314|11835135|FG008|NOT COMPLETED|Part B||0
10673196|NCT02342314|11835136|FG009|NOT COMPLETED|Part B||0
10673197|NCT02342314|11835137|FG010|NOT COMPLETED|Part B||0
10673198|NCT02342314|11835138|FG011|NOT COMPLETED|Part B||0
10673199|NCT02342314|11835139|FG012|NOT COMPLETED|Part B||0
10673200|NCT02342314|11835140|FG013|NOT COMPLETED|Part B||0
10673201|NCT02342314|11835141|FG014|NOT COMPLETED|Part B||0
10673202|NCT02342314|11835142|FG015|NOT COMPLETED|Part B||0
10673203|NCT02342314|11835143|FG016|NOT COMPLETED|Part B||0
10673204|NCT02342327|11835216|FG000|STARTED|Overall Study||60
10673205|NCT02342327|11835217|FG001|STARTED|Overall Study||62
10673206|NCT02342327|11835216|FG000|Completed Quit Day Visit|Overall Study||54
10673207|NCT02342327|11835217|FG001|Completed Quit Day Visit|Overall Study||53
10673208|NCT02342327|11835216|FG000|COMPLETED|Overall Study||39
10673209|NCT02342327|11835217|FG001|COMPLETED|Overall Study||40
10673210|NCT02342327|11835216|FG000|NOT COMPLETED|Overall Study||21
10673211|NCT02342327|11835217|FG001|NOT COMPLETED|Overall Study||22
10673212|NCT02342379|11835223|FG000|STARTED|Overall Study||35
10673213|NCT02342379|11835223|FG000|COMPLETED|Overall Study||35
10673214|NCT02342379|11835223|FG000|NOT COMPLETED|Overall Study||0
10673215|NCT02342418|11835229|FG000|STARTED|Overall Study||9
10673216|NCT02342418|11835230|FG001|STARTED|Overall Study||10
10673217|NCT02342418|11835229|FG000|COMPLETED|Overall Study||9
10673218|NCT02342418|11835230|FG001|COMPLETED|Overall Study||9
10673219|NCT02342418|11835229|FG000|NOT COMPLETED|Overall Study||0
10673220|NCT02342418|11835230|FG001|NOT COMPLETED|Overall Study||1
10673221|NCT02342535|11835236|FG000|STARTED|Overall Study|30 women who participated in the aerobic exercise class and 38 children.|68
10673222|NCT02342535|11835236|FG000|COMPLETED|Overall Study|30 women in aerobic class and 38 kids in kids exercise class|68
10673223|NCT02342535|11835236|FG000|NOT COMPLETED|Overall Study||0
10673224|NCT02342548|11835243|FG000|STARTED|Overall Study||51
10673225|NCT02342548|11835244|FG001|STARTED|Overall Study||71
10673226|NCT02342548|11835245|FG002|STARTED|Overall Study||66
10673227|NCT02342548|11835243|FG000|COMPLETED|Overall Study||17
10673228|NCT02342548|11835244|FG001|COMPLETED|Overall Study||9
10673229|NCT02342548|11835245|FG002|COMPLETED|Overall Study||23
10673230|NCT02342548|11835243|FG000|NOT COMPLETED|Overall Study||34
10673231|NCT02342548|11835244|FG001|NOT COMPLETED|Overall Study||62
10673232|NCT02342548|11835245|FG002|NOT COMPLETED|Overall Study||43
10673233|NCT02342561|11835253|FG000|STARTED|Overall Study||20
10673234|NCT02342561|11835253|FG000|COMPLETED|Overall Study||20
10673235|NCT02342561|11835253|FG000|NOT COMPLETED|Overall Study||0
10673236|NCT02342639|11835263|FG000|STARTED|Overall Study||19
10673237|NCT02342639|11835264|FG001|STARTED|Overall Study||19
10673238|NCT02342639|11835263|FG000|COMPLETED|Overall Study||17
10673239|NCT02342639|11835264|FG001|COMPLETED|Overall Study||14
10673240|NCT02342639|11835263|FG000|NOT COMPLETED|Overall Study||2
10673241|NCT02342639|11835264|FG001|NOT COMPLETED|Overall Study||5
10673242|NCT02342678|11835274|FG000|STARTED|Overall Study||28
10673243|NCT02342678|11835275|FG001|STARTED|Overall Study||28
10673244|NCT02342678|11835274|FG000|COMPLETED|Overall Study||27
10673245|NCT02342678|11835275|FG001|COMPLETED|Overall Study||23
10673246|NCT02342678|11835274|FG000|NOT COMPLETED|Overall Study||1
10673247|NCT02342678|11835275|FG001|NOT COMPLETED|Overall Study||5
10673248|NCT02342704|11835283|FG000|STARTED|Overall Study|Safety Population: randomized participants who received at least 1 dose of study treatment.|54
10673249|NCT02342704|11835284|FG001|STARTED|Overall Study|Safety Population: randomized participants who received at least 1 dose of study treatment.|54
10673250|NCT02342704|11835283|FG000|COMPLETED|Overall Study||1
10673251|NCT02342704|11835284|FG001|COMPLETED|Overall Study||3
10673252|NCT02342704|11835283|FG000|NOT COMPLETED|Overall Study||53
10673253|NCT02342704|11835284|FG001|NOT COMPLETED|Overall Study||51
10673254|NCT02342743|11835290|FG000|STARTED|Baseline Period||73
10673255|NCT02342743|11835290|FG000|COMPLETED|Baseline Period||58
10673256|NCT02342743|11835290|FG000|NOT COMPLETED|Baseline Period||15
10673257|NCT02342743|11835290|FG000|STARTED|Treatment Period|7 patients didn't meet inclusion criteria for treatment period, evaluated at the end of the baseline|58
10673258|NCT02342743|11835290|FG000|COMPLETED|Treatment Period||47
10673259|NCT02342743|11835290|FG000|NOT COMPLETED|Treatment Period||11
10673260|NCT02342886|11835299|FG000|STARTED|Overall Study||65
10673261|NCT02342886|11835300|FG001|STARTED|Overall Study||71
10673262|NCT02342886|11835301|FG002|STARTED|Overall Study||67
10673263|NCT02342886|11835302|FG003|STARTED|Overall Study||68
10673264|NCT02342886|11835303|FG004|STARTED|Overall Study||13
10673265|NCT02342886|11835299|FG000|Completed Month 12 Follow-Up|Overall Study||43
10673266|NCT02342886|11835300|FG001|Completed Month 12 Follow-Up|Overall Study||52
10673267|NCT02342886|11835301|FG002|Completed Month 12 Follow-Up|Overall Study||49
10673268|NCT02342886|11835302|FG003|Completed Month 12 Follow-Up|Overall Study||57
10673269|NCT02342886|11835303|FG004|Completed Month 12 Follow-Up|Overall Study||10
10673270|NCT02342886|11835299|FG000|Completed Month 24 Follow-Up|Overall Study||40
10673271|NCT02342886|11835300|FG001|Completed Month 24 Follow-Up|Overall Study||47
10673272|NCT02342886|11835301|FG002|Completed Month 24 Follow-Up|Overall Study||46
10673273|NCT02342886|11835302|FG003|Completed Month 24 Follow-Up|Overall Study||53
10673274|NCT02342886|11835303|FG004|Completed Month 24 Follow-Up|Overall Study||10
10673275|NCT02342886|11835299|FG000|COMPLETED|Overall Study||57
10673276|NCT02342886|11835300|FG001|COMPLETED|Overall Study||63
10673277|NCT02342886|11835301|FG002|COMPLETED|Overall Study||52
10673278|NCT02342886|11835302|FG003|COMPLETED|Overall Study||59
10673279|NCT02342886|11835303|FG004|COMPLETED|Overall Study||10
10673280|NCT02342886|11835299|FG000|NOT COMPLETED|Overall Study||8
10673281|NCT02342886|11835300|FG001|NOT COMPLETED|Overall Study||8
10673282|NCT02342886|11835301|FG002|NOT COMPLETED|Overall Study||15
10673283|NCT02342886|11835302|FG003|NOT COMPLETED|Overall Study||9
10673284|NCT02342886|11835303|FG004|NOT COMPLETED|Overall Study||3
10673285|NCT02343003|11835317|FG000|STARTED|Overall Study||76
10673286|NCT02343003|11835318|FG001|STARTED|Overall Study||75
10673287|NCT02343003|11835317|FG000|COMPLETED|Overall Study||58
10673288|NCT02343003|11835318|FG001|COMPLETED|Overall Study||68
10673289|NCT02343003|11835317|FG000|NOT COMPLETED|Overall Study||18
10673290|NCT02343003|11835318|FG001|NOT COMPLETED|Overall Study||7
10673291|NCT02343081|11835326|FG000|STARTED|First Intervention (Day 3)||8
10673292|NCT02343081|11835327|FG001|STARTED|First Intervention (Day 3)||8
10673293|NCT02343081|11835326|FG000|Received Intervention|First Intervention (Day 3)||8
10673294|NCT02343081|11835327|FG001|Received Intervention|First Intervention (Day 3)||8
10673295|NCT02343081|11835326|FG000|COMPLETED|First Intervention (Day 3)||8
10673296|NCT02343081|11835327|FG001|COMPLETED|First Intervention (Day 3)||8
10673297|NCT02343081|11835326|FG000|NOT COMPLETED|First Intervention (Day 3)||0
10673298|NCT02343081|11835327|FG001|NOT COMPLETED|First Intervention (Day 3)||0
10673299|NCT02343081|11835326|FG000|STARTED|Washout (10 Hours)||8
10673300|NCT02343081|11835327|FG001|STARTED|Washout (10 Hours)||8
10673301|NCT02343081|11835326|FG000|COMPLETED|Washout (10 Hours)||8
10673302|NCT02343081|11835327|FG001|COMPLETED|Washout (10 Hours)||8
10673303|NCT02343081|11835326|FG000|NOT COMPLETED|Washout (10 Hours)||0
10673304|NCT02343081|11835327|FG001|NOT COMPLETED|Washout (10 Hours)||0
10673305|NCT02343081|11835326|FG000|STARTED|Second Intervention (Day 4)||8
10673306|NCT02343081|11835327|FG001|STARTED|Second Intervention (Day 4)||8
10673307|NCT02343081|11835326|FG000|Received Intervention|Second Intervention (Day 4)||8
10673308|NCT02343081|11835327|FG001|Received Intervention|Second Intervention (Day 4)||8
10673309|NCT02343081|11835326|FG000|COMPLETED|Second Intervention (Day 4)||8
10673310|NCT02343081|11835327|FG001|COMPLETED|Second Intervention (Day 4)||8
10673311|NCT02343081|11835326|FG000|NOT COMPLETED|Second Intervention (Day 4)||0
10673312|NCT02343081|11835327|FG001|NOT COMPLETED|Second Intervention (Day 4)||0
10673313|NCT02343276|11835335|FG000|STARTED|Overall Study||164
10673314|NCT02343276|11835336|FG001|STARTED|Overall Study||164
10673315|NCT02343276|11835335|FG000|COMPLETED|Overall Study||164
10673316|NCT02343276|11835336|FG001|COMPLETED|Overall Study||164
10673317|NCT02343276|11835335|FG000|NOT COMPLETED|Overall Study||0
10673318|NCT02343276|11835336|FG001|NOT COMPLETED|Overall Study||0
10673319|NCT02343380|11835344|FG000|STARTED|Overall Study|Morning test (first week)|10
10673320|NCT02343380|11835345|FG001|STARTED|Overall Study|Evening test (first week)|10
10673321|NCT02343380|11835344|FG000|COMPLETED|Overall Study|Evening test (second week)|10
10673322|NCT02343380|11835345|FG001|COMPLETED|Overall Study|Morning test (second week)|10
10673323|NCT02343380|11835344|FG000|NOT COMPLETED|Overall Study||0
10673324|NCT02343380|11835345|FG001|NOT COMPLETED|Overall Study||0
10673325|NCT02343406|11835366|FG000|STARTED|Overall Study||88
10673326|NCT02343406|11835367|FG001|STARTED|Overall Study||86
10673327|NCT02343406|11835368|FG002|STARTED|Overall Study||60
10673328|NCT02343406|11835369|FG003|STARTED|Overall Study||26
10673329|NCT02343406|11835370|FG004|STARTED|Overall Study||6
10673330|NCT02343406|11835366|FG000|COMPLETED|Overall Study||0
10673331|NCT02343406|11835367|FG001|COMPLETED|Overall Study||0
10673332|NCT02343406|11835368|FG002|COMPLETED|Overall Study||2
10673333|NCT02343406|11835369|FG003|COMPLETED|Overall Study||0
10673334|NCT02343406|11835370|FG004|COMPLETED|Overall Study||1
10673335|NCT02343406|11835366|FG000|NOT COMPLETED|Overall Study||88
10673336|NCT02343406|11835367|FG001|NOT COMPLETED|Overall Study||86
10673337|NCT02343406|11835368|FG002|NOT COMPLETED|Overall Study||58
10673338|NCT02343406|11835369|FG003|NOT COMPLETED|Overall Study||26
10673339|NCT02343406|11835370|FG004|NOT COMPLETED|Overall Study||5
10673340|NCT02343458|11835385|FG000|STARTED|Overall Study||555
10673341|NCT02343458|11835386|FG001|STARTED|Overall Study||483
10673342|NCT02343458|11835387|FG002|STARTED|Overall Study||480
10673343|NCT02343458|11835388|FG003|STARTED|Overall Study||238
10673344|NCT02343458|11835385|FG000|COMPLETED|Overall Study||494
10673345|NCT02343458|11835386|FG001|COMPLETED|Overall Study||417
10673346|NCT02343458|11835387|FG002|COMPLETED|Overall Study||417
10673347|NCT02343458|11835388|FG003|COMPLETED|Overall Study||200
10673348|NCT02343458|11835385|FG000|NOT COMPLETED|Overall Study||61
10673349|NCT02343458|11835386|FG001|NOT COMPLETED|Overall Study||66
10673350|NCT02343458|11835387|FG002|NOT COMPLETED|Overall Study||63
10673351|NCT02343458|11835388|FG003|NOT COMPLETED|Overall Study||38
10673352|NCT02343575|11835400|FG000|STARTED|Overall Study||1
10673353|NCT02343575|11835401|FG001|STARTED|Overall Study||2
10673354|NCT02343575|11835400|FG000|COMPLETED|Overall Study||1
10673355|NCT02343575|11835401|FG001|COMPLETED|Overall Study||2
10673356|NCT02343575|11835400|FG000|NOT COMPLETED|Overall Study||0
10673357|NCT02343575|11835401|FG001|NOT COMPLETED|Overall Study||0
10673358|NCT02343627|11835409|FG000|STARTED|Overall Study||35
10673359|NCT02343627|11835410|FG001|STARTED|Overall Study||12
10673360|NCT02343627|11835409|FG000|COMPLETED|Overall Study||23
10673361|NCT02343627|11835410|FG001|COMPLETED|Overall Study||11
10673362|NCT02343627|11835409|FG000|NOT COMPLETED|Overall Study||12
10673363|NCT02343627|11835410|FG001|NOT COMPLETED|Overall Study||1
10673364|NCT02343939|11835425|FG000|STARTED|Overall Study||3
10673365|NCT02343939|11835426|FG001|STARTED|Overall Study||50
10673366|NCT02343939|11835427|FG002|STARTED|Overall Study||5
10673367|NCT02343939|11835428|FG003|STARTED|Overall Study||6
10673368|NCT02343939|11835429|FG004|STARTED|Overall Study||8
10673369|NCT02343939|11835430|FG005|STARTED|Overall Study||17
10673370|NCT02343939|11835431|FG006|STARTED|Overall Study||15
10673371|NCT02343939|11835432|FG007|STARTED|Overall Study||37
10673372|NCT02343939|11835433|FG008|STARTED|Overall Study||7
10673373|NCT02343939|11835425|FG000|COMPLETED|Overall Study||0
10673374|NCT02343939|11835426|FG001|COMPLETED|Overall Study||2
10673375|NCT02343939|11835427|FG002|COMPLETED|Overall Study||0
10673376|NCT02343939|11835428|FG003|COMPLETED|Overall Study||0
10673377|NCT02343939|11835429|FG004|COMPLETED|Overall Study||0
10673378|NCT02343939|11835430|FG005|COMPLETED|Overall Study||0
10673379|NCT02343939|11835431|FG006|COMPLETED|Overall Study||0
10673380|NCT02343939|11835432|FG007|COMPLETED|Overall Study||0
10673381|NCT02343939|11835433|FG008|COMPLETED|Overall Study||0
10673382|NCT02343939|11835425|FG000|NOT COMPLETED|Overall Study||3
10673383|NCT02343939|11835426|FG001|NOT COMPLETED|Overall Study||48
10673384|NCT02343939|11835427|FG002|NOT COMPLETED|Overall Study||5
10673385|NCT02343939|11835428|FG003|NOT COMPLETED|Overall Study||6
10673386|NCT02343939|11835429|FG004|NOT COMPLETED|Overall Study||8
10673387|NCT02343939|11835430|FG005|NOT COMPLETED|Overall Study||17
10673388|NCT02343939|11835431|FG006|NOT COMPLETED|Overall Study||15
10673389|NCT02343939|11835432|FG007|NOT COMPLETED|Overall Study||37
10673390|NCT02343939|11835433|FG008|NOT COMPLETED|Overall Study||7
10673391|NCT02344004|11835469|FG000|STARTED|Overall Study||224
10673392|NCT02344004|11835470|FG001|STARTED|Overall Study||112
10673393|NCT02344004|11835469|FG000|COMPLETED|Overall Study||163
10673394|NCT02344004|11835470|FG001|COMPLETED|Overall Study||98
10673395|NCT02344004|11835469|FG000|NOT COMPLETED|Overall Study||61
10673396|NCT02344004|11835470|FG001|NOT COMPLETED|Overall Study||14
10673397|NCT02344173|11835477|FG000|STARTED|Enrollment||2035
10673398|NCT02344173|11835477|FG000|COMPLETED|Enrollment||2035
10673399|NCT02344173|11835477|FG000|NOT COMPLETED|Enrollment||0
10673400|NCT02344173|11835477|FG000|STARTED|Procedure||2035
10673401|NCT02344173|11835477|FG000|COMPLETED|Procedure||2028
10673402|NCT02344173|11835477|FG000|NOT COMPLETED|Procedure||7
10673403|NCT02344173|11835477|FG000|STARTED|12-month Visit||2028
10673404|NCT02344173|11835477|FG000|COMPLETED|12-month Visit||1932
10673405|NCT02344173|11835477|FG000|NOT COMPLETED|12-month Visit||96
10673406|NCT02344225|11835486|FG000|STARTED|Overall Study||6
10673407|NCT02344225|11835487|FG001|STARTED|Overall Study||3
10673408|NCT02344225|11835488|FG002|STARTED|Overall Study||5
10673409|NCT02344225|11835486|FG000|COMPLETED|Overall Study||6
10673410|NCT02344225|11835487|FG001|COMPLETED|Overall Study||3
10673411|NCT02344225|11835488|FG002|COMPLETED|Overall Study||5
10673412|NCT02344225|11835486|FG000|NOT COMPLETED|Overall Study||0
10673413|NCT02344225|11835487|FG001|NOT COMPLETED|Overall Study||0
10673414|NCT02344225|11835488|FG002|NOT COMPLETED|Overall Study||0
10673415|NCT02344238|11835499|FG000|STARTED|Overall Study||20
10673416|NCT02344238|11835500|FG001|STARTED|Overall Study||20
10673417|NCT02344238|11835501|FG002|STARTED|Overall Study||20
10673418|NCT02344238|11835499|FG000|COMPLETED|Overall Study||20
10673419|NCT02344238|11835500|FG001|COMPLETED|Overall Study||20
10673420|NCT02344238|11835501|FG002|COMPLETED|Overall Study||20
10673421|NCT02344238|11835499|FG000|NOT COMPLETED|Overall Study||0
10673422|NCT02344238|11835500|FG001|NOT COMPLETED|Overall Study||0
10673423|NCT02344238|11835501|FG002|NOT COMPLETED|Overall Study||0
10673424|NCT02344251|11835512|FG000|STARTED|Overall Study||20
10673425|NCT02344251|11835513|FG001|STARTED|Overall Study||20
10673426|NCT02344251|11835512|FG000|COMPLETED|Overall Study||20
10673427|NCT02344251|11835513|FG001|COMPLETED|Overall Study||20
10673428|NCT02344251|11835512|FG000|NOT COMPLETED|Overall Study||0
10673429|NCT02344251|11835513|FG001|NOT COMPLETED|Overall Study||0
10673430|NCT02344316|11835523|FG000|STARTED|Overall Study||13
10673431|NCT02344316|11835524|FG001|STARTED|Overall Study||13
10673432|NCT02344316|11835523|FG000|COMPLETED|Overall Study||12
10673433|NCT02344316|11835524|FG001|COMPLETED|Overall Study||11
10673434|NCT02344316|11835523|FG000|NOT COMPLETED|Overall Study||1
10673435|NCT02344316|11835524|FG001|NOT COMPLETED|Overall Study||2
10673436|NCT02344342|11835537|FG000|STARTED|Overall Study||13
10673437|NCT02344342|11835538|FG001|STARTED|Overall Study||11
10673438|NCT02344342|11835539|FG002|STARTED|Overall Study||14
10673439|NCT02344342|11835540|FG003|STARTED|Overall Study||13
10673440|NCT02344342|11835537|FG000|COMPLETED|Overall Study||2
10673441|NCT02344342|11835538|FG001|COMPLETED|Overall Study||2
10673442|NCT02344342|11835539|FG002|COMPLETED|Overall Study||0
10673443|NCT02344342|11835540|FG003|COMPLETED|Overall Study||3
10673444|NCT02344342|11835537|FG000|NOT COMPLETED|Overall Study||11
10673445|NCT02344342|11835538|FG001|NOT COMPLETED|Overall Study||9
10673446|NCT02344342|11835539|FG002|NOT COMPLETED|Overall Study||14
10673447|NCT02344342|11835540|FG003|NOT COMPLETED|Overall Study||10
10673448|NCT02344407|11835557|FG000|STARTED|Overall Study||500
10673449|NCT02344407|11835558|FG001|STARTED|Overall Study||500
10673450|NCT02344407|11835559|FG002|STARTED|Overall Study||500
10673451|NCT02344407|11835557|FG000|COMPLETED|Overall Study||492
10673452|NCT02344407|11835558|FG001|COMPLETED|Overall Study||491
10673453|NCT02344407|11835559|FG002|COMPLETED|Overall Study||494
10673454|NCT02344407|11835557|FG000|NOT COMPLETED|Overall Study||8
10673455|NCT02344407|11835558|FG001|NOT COMPLETED|Overall Study||9
10673456|NCT02344407|11835559|FG002|NOT COMPLETED|Overall Study||6
10673531|NCT02345031|11835606|FG000|COMPLETED|Overall Study||37
10673457|NCT02344576|11835571|FG000|STARTED|Enrollment|Includes 7 patients who agreed to medical record review only and were excluded from further analysis|142
10673458|NCT02344576|11835572|FG001|STARTED|Enrollment|Includes 8 patients who agreed to medical record review only and were excluded from further analysis|121
10673459|NCT02344576|11835573|FG002|STARTED|Enrollment||111
10673460|NCT02344576|11835574|FG003|STARTED|Enrollment||71
10673461|NCT02344576|11835571|FG000|Agreed to Survey Data Collection|Enrollment||135
10673462|NCT02344576|11835572|FG001|Agreed to Survey Data Collection|Enrollment||113
10673463|NCT02344576|11835573|FG002|Agreed to Survey Data Collection|Enrollment||111
10673464|NCT02344576|11835574|FG003|Agreed to Survey Data Collection|Enrollment||71
10673465|NCT02344576|11835571|FG000|COMPLETED|Enrollment||135
10673466|NCT02344576|11835572|FG001|COMPLETED|Enrollment||113
10673467|NCT02344576|11835573|FG002|COMPLETED|Enrollment||111
10673468|NCT02344576|11835574|FG003|COMPLETED|Enrollment||71
10673469|NCT02344576|11835571|FG000|NOT COMPLETED|Enrollment||7
10673470|NCT02344576|11835572|FG001|NOT COMPLETED|Enrollment||8
10673471|NCT02344576|11835573|FG002|NOT COMPLETED|Enrollment||0
10673472|NCT02344576|11835574|FG003|NOT COMPLETED|Enrollment||0
10673473|NCT02344576|11835571|FG000|STARTED|1-Month Follow-Up||135
10673474|NCT02344576|11835572|FG001|STARTED|1-Month Follow-Up||113
10673475|NCT02344576|11835573|FG002|STARTED|1-Month Follow-Up||111
10673476|NCT02344576|11835574|FG003|STARTED|1-Month Follow-Up||71
10673477|NCT02344576|11835571|FG000|Completed 1-Month Survey|1-Month Follow-Up||104
10673478|NCT02344576|11835572|FG001|Completed 1-Month Survey|1-Month Follow-Up||79
10673479|NCT02344576|11835573|FG002|Completed 1-Month Survey|1-Month Follow-Up||89
10673480|NCT02344576|11835574|FG003|Completed 1-Month Survey|1-Month Follow-Up||53
10673481|NCT02344576|11835571|FG000|COMPLETED|1-Month Follow-Up|Includes 13 patients who were still enrolled at 1-month but did not complete the 1-month survey.|117
10673482|NCT02344576|11835572|FG001|COMPLETED|1-Month Follow-Up|Includes 7 patients who were still enrolled at 1-month but did not complete the 1-month survey.|86
10673483|NCT02344576|11835573|FG002|COMPLETED|1-Month Follow-Up|Includes 3 caregivers who were still enrolled at 1-month but did not complete the 1-month survey.|92
10673484|NCT02344576|11835574|FG003|COMPLETED|1-Month Follow-Up|Includes 5 caregivers who were still enrolled at 1-month but did not complete the 1-month survey.|58
10673485|NCT02344576|11835571|FG000|NOT COMPLETED|1-Month Follow-Up||18
10673486|NCT02344576|11835572|FG001|NOT COMPLETED|1-Month Follow-Up||27
10673487|NCT02344576|11835573|FG002|NOT COMPLETED|1-Month Follow-Up||19
10673488|NCT02344576|11835574|FG003|NOT COMPLETED|1-Month Follow-Up||13
10673489|NCT02344576|11835571|FG000|STARTED|6-Month Follow-Up||117
10673490|NCT02344576|11835572|FG001|STARTED|6-Month Follow-Up||86
10673491|NCT02344576|11835573|FG002|STARTED|6-Month Follow-Up||92
10673492|NCT02344576|11835574|FG003|STARTED|6-Month Follow-Up||58
10673493|NCT02344576|11835571|FG000|Completed 6-Month Survey|6-Month Follow-Up||98
10673494|NCT02344576|11835572|FG001|Completed 6-Month Survey|6-Month Follow-Up||67
10673495|NCT02344576|11835573|FG002|Completed 6-Month Survey|6-Month Follow-Up||78
10673496|NCT02344576|11835574|FG003|Completed 6-Month Survey|6-Month Follow-Up||50
10673497|NCT02344576|11835571|FG000|COMPLETED|6-Month Follow-Up||98
10673498|NCT02344576|11835572|FG001|COMPLETED|6-Month Follow-Up||67
10673499|NCT02344576|11835573|FG002|COMPLETED|6-Month Follow-Up||78
10673500|NCT02344576|11835574|FG003|COMPLETED|6-Month Follow-Up||50
10673501|NCT02344576|11835571|FG000|NOT COMPLETED|6-Month Follow-Up||19
10673502|NCT02344576|11835572|FG001|NOT COMPLETED|6-Month Follow-Up||19
10673503|NCT02344576|11835573|FG002|NOT COMPLETED|6-Month Follow-Up||14
10673504|NCT02344576|11835574|FG003|NOT COMPLETED|6-Month Follow-Up||8
10673505|NCT02344576|11835571|FG000|STARTED|12-Month Medical Record Follow-Up||98
10673506|NCT02344576|11835572|FG001|STARTED|12-Month Medical Record Follow-Up||67
10673507|NCT02344576|11835573|FG002|STARTED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|78
10673508|NCT02344576|11835574|FG003|STARTED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|50
10673509|NCT02344576|11835571|FG000|COMPLETED|12-Month Medical Record Follow-Up||98
10673510|NCT02344576|11835572|FG001|COMPLETED|12-Month Medical Record Follow-Up||67
10673511|NCT02344576|11835573|FG002|COMPLETED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|78
10673512|NCT02344576|11835574|FG003|COMPLETED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|50
10673513|NCT02344576|11835571|FG000|NOT COMPLETED|12-Month Medical Record Follow-Up||0
10673514|NCT02344576|11835572|FG001|NOT COMPLETED|12-Month Medical Record Follow-Up||0
10673515|NCT02344576|11835573|FG002|NOT COMPLETED|12-Month Medical Record Follow-Up||0
10673516|NCT02344576|11835574|FG003|NOT COMPLETED|12-Month Medical Record Follow-Up||0
10673517|NCT02344628|11835588|FG000|STARTED|Overall Study||291
10673518|NCT02344628|11835589|FG001|STARTED|Overall Study||292
10673519|NCT02344628|11835588|FG000|COMPLETED|Overall Study|4/52 clinical data was available for 283. Serological data 6/12 for 212. Both were available for 200|200
10673520|NCT02344628|11835589|FG001|COMPLETED|Overall Study|4/52 clinical data was available for 286. Serological data 6/12 for 218. Both were available for 206|206
10673521|NCT02344628|11835588|FG000|NOT COMPLETED|Overall Study||91
10673522|NCT02344628|11835589|FG001|NOT COMPLETED|Overall Study||86
10673523|NCT02344745|11835597|FG000|STARTED|Overall Study||40
10673524|NCT02344745|11835598|FG001|STARTED|Overall Study||40
10673525|NCT02344745|11835597|FG000|COMPLETED|Overall Study||38
10673526|NCT02344745|11835598|FG001|COMPLETED|Overall Study||40
10673527|NCT02344745|11835597|FG000|NOT COMPLETED|Overall Study||2
10673528|NCT02344745|11835598|FG001|NOT COMPLETED|Overall Study||0
10673529|NCT02345031|11835606|FG000|STARTED|Overall Study||38
10673530|NCT02345031|11835607|FG001|STARTED|Overall Study||40
10673532|NCT02345031|11835607|FG001|COMPLETED|Overall Study||39
10673533|NCT02345031|11835606|FG000|NOT COMPLETED|Overall Study||1
10673534|NCT02345031|11835607|FG001|NOT COMPLETED|Overall Study||1
10673535|NCT02345161|11835617|FG000|STARTED|Overall Study||911
10673536|NCT02345161|11835618|FG001|STARTED|Overall Study||899
10673537|NCT02345161|11835617|FG000|COMPLETED|Overall Study||866
10673538|NCT02345161|11835618|FG001|COMPLETED|Overall Study||842
10673539|NCT02345161|11835617|FG000|NOT COMPLETED|Overall Study||45
10673540|NCT02345161|11835618|FG001|NOT COMPLETED|Overall Study||57
10673541|NCT02345226|11835631|FG000|STARTED|Double-Blind Phase||440
10673542|NCT02345226|11835632|FG001|STARTED|Double-Blind Phase||441
10673543|NCT02345226|11835631|FG000|COMPLETED|Double-Blind Phase||371
10673544|NCT02345226|11835632|FG001|COMPLETED|Double-Blind Phase||370
10673545|NCT02345226|11835631|FG000|NOT COMPLETED|Double-Blind Phase||69
10673546|NCT02345226|11835632|FG001|NOT COMPLETED|Double-Blind Phase||71
10673547|NCT02345226|11835631|FG000|STARTED|Open-Label Extension Phase|346 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|25
10673548|NCT02345226|11835632|FG001|STARTED|Open-Label Extension Phase|349 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|21
10673549|NCT02345226|11835631|FG000|COMPLETED|Open-Label Extension Phase||25
10673550|NCT02345226|11835632|FG001|COMPLETED|Open-Label Extension Phase||20
10673551|NCT02345226|11835631|FG000|NOT COMPLETED|Open-Label Extension Phase||0
10673552|NCT02345226|11835632|FG001|NOT COMPLETED|Open-Label Extension Phase||1
10673553|NCT02345252|11835642|FG000|STARTED|Double-Blind Phase||316
10673554|NCT02345252|11835643|FG001|STARTED|Double-Blind Phase||316
10673555|NCT02345252|11835642|FG000|COMPLETED|Double-Blind Phase||276
10673556|NCT02345252|11835643|FG001|COMPLETED|Double-Blind Phase||267
10673557|NCT02345252|11835642|FG000|NOT COMPLETED|Double-Blind Phase||40
10673558|NCT02345252|11835643|FG001|NOT COMPLETED|Double-Blind Phase||49
10673559|NCT02345252|11835642|FG000|STARTED|Open-Label Extension Phase|257 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|19
10673560|NCT02345252|11835643|FG001|STARTED|Open-Label Extension Phase|250 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|17
10673561|NCT02345252|11835642|FG000|COMPLETED|Open-Label Extension Phase||19
10673562|NCT02345252|11835643|FG001|COMPLETED|Open-Label Extension Phase||17
10673563|NCT02345252|11835642|FG000|NOT COMPLETED|Open-Label Extension Phase||0
10673564|NCT02345252|11835643|FG001|NOT COMPLETED|Open-Label Extension Phase||0
10673565|NCT02345330|11835651|FG000|STARTED|Overall Study||4
10673566|NCT02345330|11835651|FG000|COMPLETED|Overall Study||1
10673567|NCT02345330|11835651|FG000|NOT COMPLETED|Overall Study||3
10673568|NCT02345434|11835657|FG000|STARTED|Overall Study||763
10673569|NCT02345434|11835658|FG001|STARTED|Overall Study||762
10673570|NCT02345434|11835657|FG000|COMPLETED|Overall Study||758
10673571|NCT02345434|11835658|FG001|COMPLETED|Overall Study||760
10673572|NCT02345434|11835657|FG000|NOT COMPLETED|Overall Study||5
10673573|NCT02345434|11835658|FG001|NOT COMPLETED|Overall Study||2
10673574|NCT02345486|11835666|FG000|STARTED|Overall Study||454
10673575|NCT02345486|11835667|FG001|STARTED|Overall Study||520
10673576|NCT02345486|11835666|FG000|COMPLETED|Overall Study||454
10673577|NCT02345486|11835667|FG001|COMPLETED|Overall Study||520
10673578|NCT02345486|11835666|FG000|NOT COMPLETED|Overall Study||0
10673579|NCT02345486|11835667|FG001|NOT COMPLETED|Overall Study||0
10673580|NCT02345512|11835673|FG000|STARTED|Overall Study||11
10673581|NCT02345512|11835673|FG000|COMPLETED|Overall Study||9
10673582|NCT02345512|11835673|FG000|NOT COMPLETED|Overall Study||2
10673583|NCT02345642|11835684|FG000|STARTED|Overall Study||10
10673584|NCT02345642|11835685|FG001|STARTED|Overall Study||10
10673585|NCT02345642|11835684|FG000|COMPLETED|Overall Study||10
10673586|NCT02345642|11835685|FG001|COMPLETED|Overall Study||10
10673587|NCT02345642|11835684|FG000|NOT COMPLETED|Overall Study||0
10673588|NCT02345642|11835685|FG001|NOT COMPLETED|Overall Study||0
10673589|NCT02345720|11835691|FG000|STARTED|Overall Study||20
10673590|NCT02345720|11835691|FG000|COMPLETED|Overall Study||20
10673591|NCT02345720|11835691|FG000|NOT COMPLETED|Overall Study||0
10673592|NCT02345811|11835695|FG000|STARTED|First Intervention||17
10673593|NCT02345811|11835696|FG001|STARTED|First Intervention||17
10673594|NCT02345811|11835695|FG000|COMPLETED|First Intervention||16
10673595|NCT02345811|11835696|FG001|COMPLETED|First Intervention||16
10673596|NCT02345811|11835695|FG000|NOT COMPLETED|First Intervention||1
10673597|NCT02345811|11835696|FG001|NOT COMPLETED|First Intervention||1
10673598|NCT02345811|11835695|FG000|STARTED|Second Intervention||16
10673599|NCT02345811|11835696|FG001|STARTED|Second Intervention||16
10673600|NCT02345811|11835695|FG000|COMPLETED|Second Intervention||16
10673601|NCT02345811|11835696|FG001|COMPLETED|Second Intervention||16
10673602|NCT02345811|11835695|FG000|NOT COMPLETED|Second Intervention||0
10673603|NCT02345811|11835696|FG001|NOT COMPLETED|Second Intervention||0
10673604|NCT02345889|11835708|FG000|STARTED|Overall Study||316
10673605|NCT02345889|11835709|FG001|STARTED|Overall Study||316
10673606|NCT02345889|11835710|FG002|STARTED|Overall Study||315
10673607|NCT02345889|11835711|FG003|STARTED|Overall Study||315
10673608|NCT02345889|11835708|FG000|COMPLETED|Overall Study||295
10673609|NCT02345889|11835709|FG001|COMPLETED|Overall Study||299
10673610|NCT02345889|11835710|FG002|COMPLETED|Overall Study||295
10673611|NCT02345889|11835711|FG003|COMPLETED|Overall Study||299
10673612|NCT02345889|11835708|FG000|NOT COMPLETED|Overall Study||21
10673613|NCT02345889|11835709|FG001|NOT COMPLETED|Overall Study||17
10673614|NCT02345889|11835710|FG002|NOT COMPLETED|Overall Study||20
10673615|NCT02345889|11835711|FG003|NOT COMPLETED|Overall Study||16
10673616|NCT02346136|11835723|FG000|STARTED|Overall Study||93
10673617|NCT02346136|11835724|FG001|STARTED|Overall Study||87
10673618|NCT02346136|11835723|FG000|COMPLETED|Overall Study||71
10673619|NCT02346136|11835724|FG001|COMPLETED|Overall Study||64
10673620|NCT02346136|11835723|FG000|NOT COMPLETED|Overall Study||22
10673621|NCT02346136|11835724|FG001|NOT COMPLETED|Overall Study||23
10673622|NCT02346240|11835734|FG000|STARTED|Initial Period (Baseline to Week 16)||57
10673623|NCT02346240|11835735|FG001|STARTED|Initial Period (Baseline to Week 16)||170
10673624|NCT02346240|11835736|FG002|STARTED|Initial Period (Baseline to Week 16)||165
10673625|NCT02346240|11835737|FG003|STARTED|Initial Period (Baseline to Week 16)||167
10673626|NCT02346240|11835738|FG004|STARTED|Initial Period (Baseline to Week 16)||0
10673627|NCT02346240|11835739|FG005|STARTED|Initial Period (Baseline to Week 16)||0
10673628|NCT02346240|11835740|FG006|STARTED|Initial Period (Baseline to Week 16)||0
10673629|NCT02346240|11835741|FG007|STARTED|Initial Period (Baseline to Week 16)||0
10673630|NCT02346240|11835742|FG008|STARTED|Initial Period (Baseline to Week 16)||0
10673631|NCT02346240|11835743|FG009|STARTED|Initial Period (Baseline to Week 16)||0
10673632|NCT02346240|11835744|FG010|STARTED|Initial Period (Baseline to Week 16)||0
10673633|NCT02346240|11835745|FG011|STARTED|Initial Period (Baseline to Week 16)||0
10673634|NCT02346240|11835746|FG012|STARTED|Initial Period (Baseline to Week 16)||0
10673635|NCT02346240|11835747|FG013|STARTED|Initial Period (Baseline to Week 16)||0
10673636|NCT02346240|11835748|FG014|STARTED|Initial Period (Baseline to Week 16)||0
10673637|NCT02346240|11835749|FG015|STARTED|Initial Period (Baseline to Week 16)||0
10673638|NCT02346240|11835750|FG016|STARTED|Initial Period (Baseline to Week 16)||0
10673639|NCT02346240|11835751|FG017|STARTED|Initial Period (Baseline to Week 16)||0
10673640|NCT02346240|11835752|FG018|STARTED|Initial Period (Baseline to Week 16)||0
10673641|NCT02346240|11835753|FG019|STARTED|Initial Period (Baseline to Week 16)||0
10673642|NCT02346240|11835754|FG020|STARTED|Initial Period (Baseline to Week 16)||0
10673643|NCT02346240|11835755|FG021|STARTED|Initial Period (Baseline to Week 16)||0
10673644|NCT02346240|11835756|FG022|STARTED|Initial Period (Baseline to Week 16)||0
10673645|NCT02346240|11835757|FG023|STARTED|Initial Period (Baseline to Week 16)||0
10673646|NCT02346240|11835734|FG000|Completed Week 16|Initial Period (Baseline to Week 16)||55
10673647|NCT02346240|11835735|FG001|Completed Week 16|Initial Period (Baseline to Week 16)||159
10673648|NCT02346240|11835736|FG002|Completed Week 16|Initial Period (Baseline to Week 16)||159
10673649|NCT02346240|11835737|FG003|Completed Week 16|Initial Period (Baseline to Week 16)||162
10673650|NCT02346240|11835738|FG004|Completed Week 16|Initial Period (Baseline to Week 16)||0
10673651|NCT02346240|11835739|FG005|Completed Week 16|Initial Period (Baseline to Week 16)||0
10673652|NCT02346240|11835740|FG006|Completed Week 16|Initial Period (Baseline to Week 16)||0
10673653|NCT02346240|11835741|FG007|Completed Week 16|Initial Period (Baseline to Week 16)||0
10673654|NCT02346240|11835742|FG008|Completed Week 16|Initial Period (Baseline to Week 16)||0
10673655|NCT02346240|11835743|FG009|Completed Week 16|Initial Period (Baseline to Week 16)||0
10673656|NCT02346240|11835744|FG010|Completed Week 16|Initial Period (Baseline to Week 16)||0
10673657|NCT02346240|11835745|FG011|Completed Week 16|Initial Period (Baseline to Week 16)||0
10673658|NCT02346240|11835746|FG012|Completed Week 16|Initial Period (Baseline to Week 16)||0
10673659|NCT02346240|11835747|FG013|Completed Week 16|Initial Period (Baseline to Week 16)||0
10673660|NCT02346240|11835748|FG014|Completed Week 16|Initial Period (Baseline to Week 16)||0
10673661|NCT02346240|11835749|FG015|Completed Week 16|Initial Period (Baseline to Week 16)||0
10673662|NCT02346240|11835750|FG016|Completed Week 16|Initial Period (Baseline to Week 16)||0
10673663|NCT02346240|11835751|FG017|Completed Week 16|Initial Period (Baseline to Week 16)||0
10673664|NCT02346240|11835752|FG018|Completed Week 16|Initial Period (Baseline to Week 16)||0
10673665|NCT02346240|11835753|FG019|Completed Week 16|Initial Period (Baseline to Week 16)||0
10673666|NCT02346240|11835754|FG020|Completed Week 16|Initial Period (Baseline to Week 16)||0
10673667|NCT02346240|11835755|FG021|Completed Week 16|Initial Period (Baseline to Week 16)||0
10673668|NCT02346240|11835756|FG022|Completed Week 16|Initial Period (Baseline to Week 16)||0
10673669|NCT02346240|11835757|FG023|Completed Week 16|Initial Period (Baseline to Week 16)||0
10673670|NCT02346240|11835734|FG000|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||55
10673671|NCT02346240|11835735|FG001|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||159
10673672|NCT02346240|11835736|FG002|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||159
10673673|NCT02346240|11835737|FG003|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||160
10673674|NCT02346240|11835738|FG004|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
10673675|NCT02346240|11835739|FG005|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
10673676|NCT02346240|11835740|FG006|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
10673677|NCT02346240|11835741|FG007|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
10673678|NCT02346240|11835742|FG008|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
10673679|NCT02346240|11835743|FG009|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
10673680|NCT02346240|11835744|FG010|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
10673681|NCT02346240|11835745|FG011|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
10712453|NCT02670538|11878108|FG002|NOT COMPLETED|Overall Study||30
10797160|NCT03684642|11957557|FG000|STARTED|Overall Study||303
10797161|NCT03684642|11957558|FG001|STARTED|Overall Study||302
10797162|NCT03684642|11957559|FG002|STARTED|Overall Study||303
10797163|NCT03684642|11957557|FG000|Treated|Overall Study||303
10797164|NCT03684642|11957558|FG001|Treated|Overall Study||302
10797165|NCT03684642|11957559|FG002|Treated|Overall Study||302
10673745|NCT02346240|11835737|FG003|STARTED|Maintenance Period (Week 16 to Week 48)||0
10797166|NCT03684642|11957557|FG000|Safety Population|Overall Study|For safety analysis participants are included in the treatment group that they are exposed for longer duration. 10 participants randomized to Efpeglenatide 6 mg received 4 mg dose for longer duration, and considered in the Efpeglenatide 4 mg group for safety analysis.|313
10797167|NCT03684642|11957558|FG001|Safety Population|Overall Study||292
10797168|NCT03684642|11957559|FG002|Safety Population|Overall Study||302
10797169|NCT03684642|11957557|FG000|COMPLETED|Overall Study||200
10797170|NCT03684642|11957558|FG001|COMPLETED|Overall Study||169
10673682|NCT02346240|11835746|FG012|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
10673683|NCT02346240|11835747|FG013|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
10673684|NCT02346240|11835748|FG014|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
10673685|NCT02346240|11835749|FG015|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
10673686|NCT02346240|11835750|FG016|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
10673687|NCT02346240|11835751|FG017|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
10673688|NCT02346240|11835752|FG018|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
10673689|NCT02346240|11835753|FG019|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
10673690|NCT02346240|11835754|FG020|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
10673691|NCT02346240|11835755|FG021|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
10673692|NCT02346240|11835756|FG022|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
10673693|NCT02346240|11835757|FG023|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
10673694|NCT02346240|11835734|FG000|COMPLETED|Initial Period (Baseline to Week 16)||55
10673695|NCT02346240|11835735|FG001|COMPLETED|Initial Period (Baseline to Week 16)||159
10673696|NCT02346240|11835736|FG002|COMPLETED|Initial Period (Baseline to Week 16)||159
10673697|NCT02346240|11835737|FG003|COMPLETED|Initial Period (Baseline to Week 16)||160
10673698|NCT02346240|11835738|FG004|COMPLETED|Initial Period (Baseline to Week 16)||0
10673699|NCT02346240|11835739|FG005|COMPLETED|Initial Period (Baseline to Week 16)||0
10673700|NCT02346240|11835740|FG006|COMPLETED|Initial Period (Baseline to Week 16)||0
10673701|NCT02346240|11835741|FG007|COMPLETED|Initial Period (Baseline to Week 16)||0
10673702|NCT02346240|11835742|FG008|COMPLETED|Initial Period (Baseline to Week 16)||0
10673703|NCT02346240|11835743|FG009|COMPLETED|Initial Period (Baseline to Week 16)||0
10673704|NCT02346240|11835744|FG010|COMPLETED|Initial Period (Baseline to Week 16)||0
10673705|NCT02346240|11835745|FG011|COMPLETED|Initial Period (Baseline to Week 16)||0
10673706|NCT02346240|11835746|FG012|COMPLETED|Initial Period (Baseline to Week 16)||0
10673707|NCT02346240|11835747|FG013|COMPLETED|Initial Period (Baseline to Week 16)||0
10673708|NCT02346240|11835748|FG014|COMPLETED|Initial Period (Baseline to Week 16)||0
10673709|NCT02346240|11835749|FG015|COMPLETED|Initial Period (Baseline to Week 16)||0
10673710|NCT02346240|11835750|FG016|COMPLETED|Initial Period (Baseline to Week 16)||0
10673711|NCT02346240|11835751|FG017|COMPLETED|Initial Period (Baseline to Week 16)||0
10673712|NCT02346240|11835752|FG018|COMPLETED|Initial Period (Baseline to Week 16)||0
10673713|NCT02346240|11835753|FG019|COMPLETED|Initial Period (Baseline to Week 16)||0
10673714|NCT02346240|11835754|FG020|COMPLETED|Initial Period (Baseline to Week 16)||0
10673715|NCT02346240|11835755|FG021|COMPLETED|Initial Period (Baseline to Week 16)||0
10673716|NCT02346240|11835756|FG022|COMPLETED|Initial Period (Baseline to Week 16)||0
10673717|NCT02346240|11835757|FG023|COMPLETED|Initial Period (Baseline to Week 16)||0
10673718|NCT02346240|11835734|FG000|NOT COMPLETED|Initial Period (Baseline to Week 16)||2
10673719|NCT02346240|11835735|FG001|NOT COMPLETED|Initial Period (Baseline to Week 16)||11
10673720|NCT02346240|11835736|FG002|NOT COMPLETED|Initial Period (Baseline to Week 16)||6
10673721|NCT02346240|11835737|FG003|NOT COMPLETED|Initial Period (Baseline to Week 16)||7
10673722|NCT02346240|11835738|FG004|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
10673723|NCT02346240|11835739|FG005|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
10673724|NCT02346240|11835740|FG006|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
10673725|NCT02346240|11835741|FG007|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
10673726|NCT02346240|11835742|FG008|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
10673727|NCT02346240|11835743|FG009|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
10673728|NCT02346240|11835744|FG010|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
10673729|NCT02346240|11835745|FG011|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
10673730|NCT02346240|11835746|FG012|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
10673731|NCT02346240|11835747|FG013|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
10673732|NCT02346240|11835748|FG014|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
10673733|NCT02346240|11835749|FG015|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
10673734|NCT02346240|11835750|FG016|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
10673735|NCT02346240|11835751|FG017|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
10673736|NCT02346240|11835752|FG018|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
10673737|NCT02346240|11835753|FG019|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
10673738|NCT02346240|11835754|FG020|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
10673739|NCT02346240|11835755|FG021|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
10673740|NCT02346240|11835756|FG022|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
10673741|NCT02346240|11835757|FG023|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
10673742|NCT02346240|11835734|FG000|STARTED|Maintenance Period (Week 16 to Week 48)||0
10673743|NCT02346240|11835735|FG001|STARTED|Maintenance Period (Week 16 to Week 48)||0
10673744|NCT02346240|11835736|FG002|STARTED|Maintenance Period (Week 16 to Week 48)||0
10673746|NCT02346240|11835738|FG004|STARTED|Maintenance Period (Week 16 to Week 48)||2
10673747|NCT02346240|11835739|FG005|STARTED|Maintenance Period (Week 16 to Week 48)||24
10673748|NCT02346240|11835740|FG006|STARTED|Maintenance Period (Week 16 to Week 48)||50
10673749|NCT02346240|11835741|FG007|STARTED|Maintenance Period (Week 16 to Week 48)||22
10673750|NCT02346240|11835742|FG008|STARTED|Maintenance Period (Week 16 to Week 48)||44
10673751|NCT02346240|11835743|FG009|STARTED|Maintenance Period (Week 16 to Week 48)||44
10673752|NCT02346240|11835744|FG010|STARTED|Maintenance Period (Week 16 to Week 48)||25
10673753|NCT02346240|11835745|FG011|STARTED|Maintenance Period (Week 16 to Week 48)||50
10673754|NCT02346240|11835746|FG012|STARTED|Maintenance Period (Week 16 to Week 48)||49
10673755|NCT02346240|11835747|FG013|STARTED|Maintenance Period (Week 16 to Week 48)||53
10673756|NCT02346240|11835748|FG014|STARTED|Maintenance Period (Week 16 to Week 48)||85
10673757|NCT02346240|11835749|FG015|STARTED|Maintenance Period (Week 16 to Week 48)||49
10673758|NCT02346240|11835750|FG016|STARTED|Maintenance Period (Week 16 to Week 48)||36
10673759|NCT02346240|11835751|FG017|STARTED|Maintenance Period (Week 16 to Week 48)||0
10673760|NCT02346240|11835752|FG018|STARTED|Maintenance Period (Week 16 to Week 48)||0
10673761|NCT02346240|11835753|FG019|STARTED|Maintenance Period (Week 16 to Week 48)||0
10673762|NCT02346240|11835754|FG020|STARTED|Maintenance Period (Week 16 to Week 48)||0
10673763|NCT02346240|11835755|FG021|STARTED|Maintenance Period (Week 16 to Week 48)||0
10673764|NCT02346240|11835756|FG022|STARTED|Maintenance Period (Week 16 to Week 48)||0
10673765|NCT02346240|11835757|FG023|STARTED|Maintenance Period (Week 16 to Week 48)||0
10673766|NCT02346240|11835734|FG000|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
10673767|NCT02346240|11835735|FG001|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
10673768|NCT02346240|11835736|FG002|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
10673769|NCT02346240|11835737|FG003|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
10673770|NCT02346240|11835738|FG004|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||2
10673771|NCT02346240|11835739|FG005|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||23
10673772|NCT02346240|11835740|FG006|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||48
10673773|NCT02346240|11835741|FG007|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||20
10673774|NCT02346240|11835742|FG008|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||40
10673775|NCT02346240|11835743|FG009|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||43
10673776|NCT02346240|11835744|FG010|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||23
10673777|NCT02346240|11835745|FG011|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||47
10673778|NCT02346240|11835746|FG012|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||49
10673779|NCT02346240|11835747|FG013|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||46
10673780|NCT02346240|11835748|FG014|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||71
10673781|NCT02346240|11835749|FG015|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||36
10673782|NCT02346240|11835750|FG016|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||30
10673783|NCT02346240|11835751|FG017|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
10673784|NCT02346240|11835752|FG018|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
10673785|NCT02346240|11835753|FG019|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
10673786|NCT02346240|11835754|FG020|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
10673787|NCT02346240|11835755|FG021|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
10673788|NCT02346240|11835756|FG022|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
10673789|NCT02346240|11835757|FG023|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
10673790|NCT02346240|11835734|FG000|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10673791|NCT02346240|11835735|FG001|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10673792|NCT02346240|11835736|FG002|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10673793|NCT02346240|11835737|FG003|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10673794|NCT02346240|11835738|FG004|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||2
10673795|NCT02346240|11835739|FG005|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||23
10673796|NCT02346240|11835740|FG006|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||48
10673797|NCT02346240|11835741|FG007|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||20
10673798|NCT02346240|11835742|FG008|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||40
10673799|NCT02346240|11835743|FG009|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||43
10673800|NCT02346240|11835744|FG010|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||23
10673801|NCT02346240|11835745|FG011|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||47
10673802|NCT02346240|11835746|FG012|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||49
10673803|NCT02346240|11835747|FG013|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||45
10673804|NCT02346240|11835748|FG014|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||68
10673805|NCT02346240|11835749|FG015|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||35
10673806|NCT02346240|11835750|FG016|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||29
10673807|NCT02346240|11835751|FG017|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10673808|NCT02346240|11835752|FG018|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10673809|NCT02346240|11835753|FG019|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10673810|NCT02346240|11835754|FG020|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10673811|NCT02346240|11835755|FG021|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10673812|NCT02346240|11835756|FG022|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10673813|NCT02346240|11835757|FG023|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
10673814|NCT02346240|11835734|FG000|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10673815|NCT02346240|11835735|FG001|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10673816|NCT02346240|11835736|FG002|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10673817|NCT02346240|11835737|FG003|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10673818|NCT02346240|11835738|FG004|COMPLETED|Maintenance Period (Week 16 to Week 48)||2
10673819|NCT02346240|11835739|FG005|COMPLETED|Maintenance Period (Week 16 to Week 48)||23
10673820|NCT02346240|11835740|FG006|COMPLETED|Maintenance Period (Week 16 to Week 48)||48
10673821|NCT02346240|11835741|FG007|COMPLETED|Maintenance Period (Week 16 to Week 48)||20
10673822|NCT02346240|11835742|FG008|COMPLETED|Maintenance Period (Week 16 to Week 48)||40
10673823|NCT02346240|11835743|FG009|COMPLETED|Maintenance Period (Week 16 to Week 48)||43
10673824|NCT02346240|11835744|FG010|COMPLETED|Maintenance Period (Week 16 to Week 48)||23
10673825|NCT02346240|11835745|FG011|COMPLETED|Maintenance Period (Week 16 to Week 48)||47
10673826|NCT02346240|11835746|FG012|COMPLETED|Maintenance Period (Week 16 to Week 48)||49
10673827|NCT02346240|11835747|FG013|COMPLETED|Maintenance Period (Week 16 to Week 48)|1 subject completed the Maintenance Period but did not enter the Open-Label Period.|45
10673828|NCT02346240|11835748|FG014|COMPLETED|Maintenance Period (Week 16 to Week 48)|3 subjects completed the Maintenance Period but did not enter the Open-Label Period.|68
10673829|NCT02346240|11835749|FG015|COMPLETED|Maintenance Period (Week 16 to Week 48)|1 subject completed the Maintenance Period but did not enter the Open-Label Period.|35
10673830|NCT02346240|11835750|FG016|COMPLETED|Maintenance Period (Week 16 to Week 48)|1 subject completed the Maintenance Period but did not enter the Open-Label Period.|29
10673831|NCT02346240|11835751|FG017|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10673832|NCT02346240|11835752|FG018|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10673833|NCT02346240|11835753|FG019|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10673834|NCT02346240|11835754|FG020|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10673835|NCT02346240|11835755|FG021|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10673836|NCT02346240|11835756|FG022|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10673837|NCT02346240|11835757|FG023|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10673838|NCT02346240|11835734|FG000|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10673839|NCT02346240|11835735|FG001|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10673840|NCT02346240|11835736|FG002|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10673841|NCT02346240|11835737|FG003|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10673842|NCT02346240|11835738|FG004|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10673843|NCT02346240|11835739|FG005|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
10673844|NCT02346240|11835740|FG006|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
10673845|NCT02346240|11835741|FG007|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
10673846|NCT02346240|11835742|FG008|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||4
10673847|NCT02346240|11835743|FG009|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
10673848|NCT02346240|11835744|FG010|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
10673849|NCT02346240|11835745|FG011|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||3
10673850|NCT02346240|11835746|FG012|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10673851|NCT02346240|11835747|FG013|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||8
10673852|NCT02346240|11835748|FG014|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||17
10673853|NCT02346240|11835749|FG015|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||14
10673854|NCT02346240|11835750|FG016|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||7
10673855|NCT02346240|11835751|FG017|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10673856|NCT02346240|11835752|FG018|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10673857|NCT02346240|11835753|FG019|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10673858|NCT02346240|11835754|FG020|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10673859|NCT02346240|11835755|FG021|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10673860|NCT02346240|11835756|FG022|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10673861|NCT02346240|11835757|FG023|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
10673862|NCT02346240|11835734|FG000|STARTED|Open-Label Period (Week 48 to Week 144)||0
10673863|NCT02346240|11835735|FG001|STARTED|Open-Label Period (Week 48 to Week 144)||0
10673864|NCT02346240|11835736|FG002|STARTED|Open-Label Period (Week 48 to Week 144)||0
10673865|NCT02346240|11835737|FG003|STARTED|Open-Label Period (Week 48 to Week 144)||0
10673866|NCT02346240|11835738|FG004|STARTED|Open-Label Period (Week 48 to Week 144)||0
10673867|NCT02346240|11835739|FG005|STARTED|Open-Label Period (Week 48 to Week 144)||0
10673868|NCT02346240|11835740|FG006|STARTED|Open-Label Period (Week 48 to Week 144)||0
10673869|NCT02346240|11835741|FG007|STARTED|Open-Label Period (Week 48 to Week 144)||0
10673870|NCT02346240|11835742|FG008|STARTED|Open-Label Period (Week 48 to Week 144)||0
10712454|NCT02670551|11878119|FG000|STARTED|Overall Study||163
10673871|NCT02346240|11835743|FG009|STARTED|Open-Label Period (Week 48 to Week 144)||0
10673872|NCT02346240|11835744|FG010|STARTED|Open-Label Period (Week 48 to Week 144)||0
10673873|NCT02346240|11835745|FG011|STARTED|Open-Label Period (Week 48 to Week 144)||0
10673874|NCT02346240|11835746|FG012|STARTED|Open-Label Period (Week 48 to Week 144)||0
10673875|NCT02346240|11835747|FG013|STARTED|Open-Label Period (Week 48 to Week 144)||0
10673876|NCT02346240|11835748|FG014|STARTED|Open-Label Period (Week 48 to Week 144)||0
10673877|NCT02346240|11835749|FG015|STARTED|Open-Label Period (Week 48 to Week 144)||0
10673878|NCT02346240|11835750|FG016|STARTED|Open-Label Period (Week 48 to Week 144)||0
10673879|NCT02346240|11835751|FG017|STARTED|Open-Label Period (Week 48 to Week 144)||34
10673880|NCT02346240|11835752|FG018|STARTED|Open-Label Period (Week 48 to Week 144)||122
10673881|NCT02346240|11835753|FG019|STARTED|Open-Label Period (Week 48 to Week 144)||41
10673882|NCT02346240|11835754|FG020|STARTED|Open-Label Period (Week 48 to Week 144)||48
10673883|NCT02346240|11835755|FG021|STARTED|Open-Label Period (Week 48 to Week 144)||177
10673884|NCT02346240|11835756|FG022|STARTED|Open-Label Period (Week 48 to Week 144)||34
10673885|NCT02346240|11835757|FG023|STARTED|Open-Label Period (Week 48 to Week 144)||16
10673886|NCT02346240|11835734|FG000|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10673887|NCT02346240|11835735|FG001|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10673888|NCT02346240|11835736|FG002|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10673889|NCT02346240|11835737|FG003|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10673890|NCT02346240|11835738|FG004|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10673891|NCT02346240|11835739|FG005|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10673892|NCT02346240|11835740|FG006|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10673893|NCT02346240|11835741|FG007|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10673894|NCT02346240|11835742|FG008|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10673895|NCT02346240|11835743|FG009|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10673896|NCT02346240|11835744|FG010|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10673897|NCT02346240|11835745|FG011|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10673898|NCT02346240|11835746|FG012|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10673899|NCT02346240|11835747|FG013|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10673900|NCT02346240|11835748|FG014|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10673901|NCT02346240|11835749|FG015|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10673902|NCT02346240|11835750|FG016|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10673903|NCT02346240|11835751|FG017|COMPLETED|Open-Label Period (Week 48 to Week 144)||31
10673904|NCT02346240|11835752|FG018|COMPLETED|Open-Label Period (Week 48 to Week 144)||105
10673905|NCT02346240|11835753|FG019|COMPLETED|Open-Label Period (Week 48 to Week 144)||34
10673906|NCT02346240|11835754|FG020|COMPLETED|Open-Label Period (Week 48 to Week 144)||45
10673907|NCT02346240|11835755|FG021|COMPLETED|Open-Label Period (Week 48 to Week 144)||146
10673908|NCT02346240|11835756|FG022|COMPLETED|Open-Label Period (Week 48 to Week 144)||27
10673909|NCT02346240|11835757|FG023|COMPLETED|Open-Label Period (Week 48 to Week 144)||8
10673910|NCT02346240|11835734|FG000|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10673911|NCT02346240|11835735|FG001|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10673912|NCT02346240|11835736|FG002|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10673913|NCT02346240|11835737|FG003|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10673914|NCT02346240|11835738|FG004|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10673915|NCT02346240|11835739|FG005|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10673916|NCT02346240|11835740|FG006|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10673917|NCT02346240|11835741|FG007|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10673918|NCT02346240|11835742|FG008|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10673919|NCT02346240|11835743|FG009|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10673920|NCT02346240|11835744|FG010|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10673921|NCT02346240|11835745|FG011|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10673922|NCT02346240|11835746|FG012|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10673923|NCT02346240|11835747|FG013|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10673924|NCT02346240|11835748|FG014|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10673925|NCT02346240|11835749|FG015|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10673926|NCT02346240|11835750|FG016|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
10673927|NCT02346240|11835751|FG017|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||3
10673928|NCT02346240|11835752|FG018|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||17
10673929|NCT02346240|11835753|FG019|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||7
10673930|NCT02346240|11835754|FG020|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||3
10673931|NCT02346240|11835755|FG021|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||31
10673932|NCT02346240|11835756|FG022|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||7
10673933|NCT02346240|11835757|FG023|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||8
10673934|NCT02346370|11835782|FG000|STARTED|Overall Study||8
10673935|NCT02346370|11835783|FG001|STARTED|Overall Study||4
10673936|NCT02346370|11835784|FG002|STARTED|Overall Study||4
10673937|NCT02346370|11835782|FG000|COMPLETED|Overall Study||0
10673938|NCT02346370|11835783|FG001|COMPLETED|Overall Study||0
10673939|NCT02346370|11835784|FG002|COMPLETED|Overall Study||0
10673940|NCT02346370|11835782|FG000|NOT COMPLETED|Overall Study||8
10673941|NCT02346370|11835783|FG001|NOT COMPLETED|Overall Study||4
10673942|NCT02346370|11835784|FG002|NOT COMPLETED|Overall Study||4
10673943|NCT02346383|11835794|FG000|STARTED|Overall Study||40
10673944|NCT02346383|11835794|FG000|COMPLETED|Overall Study||40
10673945|NCT02346383|11835794|FG000|NOT COMPLETED|Overall Study||0
10673946|NCT02346461|11835804|FG000|STARTED|Overall Study||6
10673947|NCT02346461|11835805|FG001|STARTED|Overall Study||6
10673948|NCT02346461|11835804|FG000|COMPLETED|Overall Study||6
10673949|NCT02346461|11835805|FG001|COMPLETED|Overall Study||6
10673950|NCT02346461|11835804|FG000|NOT COMPLETED|Overall Study||0
10673951|NCT02346461|11835805|FG001|NOT COMPLETED|Overall Study||0
10673952|NCT02346643|11835812|FG000|STARTED|Overall Study||41
10673953|NCT02346643|11835812|FG000|Received Trial System|Overall Study||29
10673954|NCT02346643|11835812|FG000|Received Permanent System|Overall Study||31
10673955|NCT02346643|11835812|FG000|COMPLETED|Overall Study||6
10673956|NCT02346643|11835812|FG000|NOT COMPLETED|Overall Study||35
10673957|NCT02346708|11835818|FG000|STARTED|Overall Study||24
10673958|NCT02346708|11835819|FG001|STARTED|Overall Study||25
10673959|NCT02346708|11835818|FG000|COMPLETED|Overall Study||22
10673960|NCT02346708|11835819|FG001|COMPLETED|Overall Study||24
10673961|NCT02346708|11835818|FG000|NOT COMPLETED|Overall Study||2
10673962|NCT02346708|11835819|FG001|NOT COMPLETED|Overall Study||1
10673963|NCT02346721|11835826|FG000|STARTED|Overall Study||111
10673964|NCT02346721|11835826|FG000|COMPLETED|Overall Study||107
10673965|NCT02346721|11835826|FG000|NOT COMPLETED|Overall Study||4
10673966|NCT02346903|11835832|FG000|STARTED|Overall Study||99
10673967|NCT02346903|11835832|FG000|COMPLETED|Overall Study||99
10673968|NCT02346903|11835832|FG000|NOT COMPLETED|Overall Study||0
10673969|NCT02346916|11835836|FG000|STARTED|Overall Study||20
10673970|NCT02346916|11835836|FG000|COMPLETED|Overall Study||20
10673971|NCT02346916|11835836|FG000|NOT COMPLETED|Overall Study||0
10673972|NCT02347072|11835840|FG000|STARTED|Overall Study||80
10673973|NCT02347072|11835840|FG000|GFF MDI 14.4/9.6 µg|Overall Study||75
10673974|NCT02347072|11835840|FG000|Placebo MDI|Overall Study||72
10673975|NCT02347072|11835840|FG000|Spiriva Respimat 5 µg|Overall Study||73
10673976|NCT02347072|11835840|FG000|COMPLETED|Overall Study||62
10673977|NCT02347072|11835840|FG000|NOT COMPLETED|Overall Study||18
10673978|NCT02347085|11835848|FG000|STARTED|Overall Study||43
10673979|NCT02347085|11835848|FG000|GFF MDI 14.4/9.6 µg|Overall Study||40
10673980|NCT02347085|11835848|FG000|Placebo MDI|Overall Study||40
10673981|NCT02347085|11835848|FG000|COMPLETED|Overall Study||33
10673982|NCT02347085|11835848|FG000|NOT COMPLETED|Overall Study||10
10673983|NCT02347098|11835856|FG000|STARTED|Overall Study||63
10673984|NCT02347098|11835857|FG001|STARTED|Overall Study||66
10673985|NCT02347098|11835856|FG000|COMPLETED|Overall Study||56
10673986|NCT02347098|11835857|FG001|COMPLETED|Overall Study||58
10673987|NCT02347098|11835856|FG000|NOT COMPLETED|Overall Study||7
10673988|NCT02347098|11835857|FG001|NOT COMPLETED|Overall Study||8
10673989|NCT02347124|11835865|FG000|STARTED|Overall Study||360
10673990|NCT02347124|11835866|FG001|STARTED|Overall Study||358
10673991|NCT02347124|11835865|FG000|2 Month Follow-up|Overall Study||298
10673992|NCT02347124|11835866|FG001|2 Month Follow-up|Overall Study||275
10673993|NCT02347124|11835865|FG000|COMPLETED|Overall Study||267
10673994|NCT02347124|11835866|FG001|COMPLETED|Overall Study||259
10673995|NCT02347124|11835865|FG000|NOT COMPLETED|Overall Study||93
10673996|NCT02347124|11835866|FG001|NOT COMPLETED|Overall Study||99
10673997|NCT02347176|11835876|FG000|STARTED|Overall Study||51
10673998|NCT02347176|11835877|FG001|STARTED|Overall Study||50
10673999|NCT02347176|11835878|FG002|STARTED|Overall Study||51
10674000|NCT02347176|11835879|FG003|STARTED|Overall Study||52
10674001|NCT02347176|11835876|FG000|COMPLETED|Overall Study||39
10674002|NCT02347176|11835877|FG001|COMPLETED|Overall Study||40
10674003|NCT02347176|11835878|FG002|COMPLETED|Overall Study||43
10674004|NCT02347176|11835879|FG003|COMPLETED|Overall Study||48
10674005|NCT02347176|11835876|FG000|NOT COMPLETED|Overall Study||12
10674006|NCT02347176|11835877|FG001|NOT COMPLETED|Overall Study||10
10674007|NCT02347176|11835878|FG002|NOT COMPLETED|Overall Study||8
10674008|NCT02347176|11835879|FG003|NOT COMPLETED|Overall Study||4
10674009|NCT02347189|11835889|FG000|STARTED|Overall Study||39
10674010|NCT02347189|11835889|FG000|Catheterized|Overall Study||39
10674011|NCT02347189|11835889|FG000|Implanted|Overall Study||30
10674012|NCT02347189|11835889|FG000|Implanted > 24 Hours|Overall Study||30
10674013|NCT02347189|11835889|FG000|COMPLETED|Overall Study||28
10674014|NCT02347189|11835889|FG000|NOT COMPLETED|Overall Study||11
10674015|NCT02347332|11835906|FG000|STARTED|Overall Study||230
10674016|NCT02347332|11835907|FG001|STARTED|Overall Study||229
10674017|NCT02347332|11835906|FG000|COMPLETED|Overall Study|6 patients: suicide(1), unknown cause(5 - 4 at home +1 in city hospital).|0
10674018|NCT02347332|11835907|FG001|COMPLETED|Overall Study|6 patients: unknown cause(2home), PDsuspect(1home+1hosp), sudden death(1home), hypercapnie(1hosp).|0
10674019|NCT02347332|11835906|FG000|NOT COMPLETED|Overall Study||230
10674020|NCT02347332|11835907|FG001|NOT COMPLETED|Overall Study||229
10674021|NCT02347345|11835916|FG000|STARTED|Overall Study||10
10674022|NCT02347345|11835917|FG001|STARTED|Overall Study||12
10674023|NCT02347345|11835918|FG002|STARTED|Overall Study||12
10674024|NCT02347345|11835916|FG000|COMPLETED|Overall Study||10
10674025|NCT02347345|11835917|FG001|COMPLETED|Overall Study||12
10674026|NCT02347345|11835918|FG002|COMPLETED|Overall Study||12
10674027|NCT02347345|11835916|FG000|NOT COMPLETED|Overall Study||0
10674028|NCT02347345|11835917|FG001|NOT COMPLETED|Overall Study||0
10674029|NCT02347345|11835918|FG002|NOT COMPLETED|Overall Study||0
10674030|NCT02347410|11835929|FG000|STARTED|Overall Study||102
10674031|NCT02347410|11835929|FG000|COMPLETED|Overall Study||98
10674032|NCT02347410|11835929|FG000|NOT COMPLETED|Overall Study||4
10674033|NCT02347488|11835939|FG000|STARTED|Overall Study||30
10674034|NCT02347488|11835939|FG000|COMPLETED|Overall Study||30
10674035|NCT02347488|11835939|FG000|NOT COMPLETED|Overall Study||0
10674036|NCT02347605|11835951|FG000|STARTED|Overall Study||10
10674037|NCT02347605|11835952|FG001|STARTED|Overall Study||10
10674038|NCT02347605|11835953|FG002|STARTED|Overall Study||8
10674039|NCT02347605|11835954|FG003|STARTED|Overall Study||10
10674040|NCT02347605|11835955|FG004|STARTED|Overall Study||9
10674041|NCT02347605|11835956|FG005|STARTED|Overall Study||9
10674042|NCT02347605|11835951|FG000|Completed Lab 1|Overall Study||10
10674043|NCT02347605|11835952|FG001|Completed Lab 1|Overall Study||10
10674044|NCT02347605|11835953|FG002|Completed Lab 1|Overall Study||8
10674045|NCT02347605|11835954|FG003|Completed Lab 1|Overall Study||10
10674046|NCT02347605|11835955|FG004|Completed Lab 1|Overall Study||8
10674047|NCT02347605|11835956|FG005|Completed Lab 1|Overall Study||9
10674048|NCT02347605|11835951|FG000|Completed Lab 2|Overall Study||7
10674049|NCT02347605|11835952|FG001|Completed Lab 2|Overall Study||7
10674050|NCT02347605|11835953|FG002|Completed Lab 2|Overall Study||7
10674051|NCT02347605|11835954|FG003|Completed Lab 2|Overall Study||7
10674052|NCT02347605|11835955|FG004|Completed Lab 2|Overall Study||6
10674053|NCT02347605|11835956|FG005|Completed Lab 2|Overall Study||8
10674054|NCT02347605|11835951|FG000|COMPLETED|Overall Study||7
10674055|NCT02347605|11835952|FG001|COMPLETED|Overall Study||7
10674056|NCT02347605|11835953|FG002|COMPLETED|Overall Study||7
10674057|NCT02347605|11835954|FG003|COMPLETED|Overall Study||6
10674058|NCT02347605|11835955|FG004|COMPLETED|Overall Study||6
10674059|NCT02347605|11835956|FG005|COMPLETED|Overall Study||7
10674060|NCT02347605|11835951|FG000|NOT COMPLETED|Overall Study||3
10674061|NCT02347605|11835952|FG001|NOT COMPLETED|Overall Study||3
10674062|NCT02347605|11835953|FG002|NOT COMPLETED|Overall Study||1
10674063|NCT02347605|11835954|FG003|NOT COMPLETED|Overall Study||4
10674064|NCT02347605|11835955|FG004|NOT COMPLETED|Overall Study||3
10674065|NCT02347605|11835956|FG005|NOT COMPLETED|Overall Study||2
10674066|NCT02347631|11835966|FG000|STARTED|Washout 1 (1 Month)||61
10674067|NCT02347631|11835967|FG001|STARTED|Washout 1 (1 Month)||57
10674068|NCT02347631|11835966|FG000|COMPLETED|Washout 1 (1 Month)||61
10674069|NCT02347631|11835967|FG001|COMPLETED|Washout 1 (1 Month)||57
10674070|NCT02347631|11835966|FG000|NOT COMPLETED|Washout 1 (1 Month)||0
10674071|NCT02347631|11835967|FG001|NOT COMPLETED|Washout 1 (1 Month)||0
10674072|NCT02347631|11835966|FG000|STARTED|First Intervention (2 Months)||61
10674073|NCT02347631|11835967|FG001|STARTED|First Intervention (2 Months)||57
10674074|NCT02347631|11835966|FG000|COMPLETED|First Intervention (2 Months)||54
10674075|NCT02347631|11835967|FG001|COMPLETED|First Intervention (2 Months)||51
10674076|NCT02347631|11835966|FG000|NOT COMPLETED|First Intervention (2 Months)||7
10674077|NCT02347631|11835967|FG001|NOT COMPLETED|First Intervention (2 Months)||6
10674078|NCT02347631|11835966|FG000|STARTED|Washout 2 (1 Month)||54
10674079|NCT02347631|11835967|FG001|STARTED|Washout 2 (1 Month)||51
10674080|NCT02347631|11835966|FG000|COMPLETED|Washout 2 (1 Month)||52
10674081|NCT02347631|11835967|FG001|COMPLETED|Washout 2 (1 Month)||48
10674082|NCT02347631|11835966|FG000|NOT COMPLETED|Washout 2 (1 Month)||2
10674083|NCT02347631|11835967|FG001|NOT COMPLETED|Washout 2 (1 Month)||3
10674084|NCT02347631|11835966|FG000|STARTED|Second Intervention (2 Months)||52
10674085|NCT02347631|11835967|FG001|STARTED|Second Intervention (2 Months)||48
10674086|NCT02347631|11835966|FG000|COMPLETED|Second Intervention (2 Months)||39
10674087|NCT02347631|11835967|FG001|COMPLETED|Second Intervention (2 Months)||44
10674088|NCT02347631|11835966|FG000|NOT COMPLETED|Second Intervention (2 Months)||13
10674089|NCT02347631|11835967|FG001|NOT COMPLETED|Second Intervention (2 Months)||4
10674090|NCT02347657|11835977|FG000|STARTED|Overall Study||259
10674091|NCT02347657|11835978|FG001|STARTED|Overall Study||251
10674092|NCT02347657|11835977|FG000|Treated|Overall Study||258
10674093|NCT02347657|11835978|FG001|Treated|Overall Study||251
10674094|NCT02347657|11835977|FG000|COMPLETED|Overall Study||241
10674095|NCT02347657|11835978|FG001|COMPLETED|Overall Study||236
10674096|NCT02347657|11835977|FG000|NOT COMPLETED|Overall Study||18
10674097|NCT02347657|11835978|FG001|NOT COMPLETED|Overall Study||15
10674098|NCT02347761|11835988|FG000|STARTED|All Collected||218
10674099|NCT02347761|11835989|FG001|STARTED|All Collected||217
10674100|NCT02347761|11835990|FG002|STARTED|All Collected||218
10674101|NCT02347761|11835988|FG000|COMPLETED|All Collected||201
10674102|NCT02347761|11835989|FG001|COMPLETED|All Collected||203
10674103|NCT02347761|11835990|FG002|COMPLETED|All Collected||191
10674104|NCT02347761|11835988|FG000|NOT COMPLETED|All Collected||17
10674105|NCT02347761|11835989|FG001|NOT COMPLETED|All Collected||14
10674106|NCT02347761|11835990|FG002|NOT COMPLETED|All Collected||27
10674107|NCT02347761|11835988|FG000|STARTED|On Study Treatment||218
10674108|NCT02347761|11835989|FG001|STARTED|On Study Treatment||217
10674109|NCT02347761|11835990|FG002|STARTED|On Study Treatment||218
10797171|NCT03684642|11957559|FG002|COMPLETED|Overall Study||197
10797172|NCT03684642|11957557|FG000|NOT COMPLETED|Overall Study||103
10797173|NCT03684642|11957558|FG001|NOT COMPLETED|Overall Study||133
10797174|NCT03684642|11957559|FG002|NOT COMPLETED|Overall Study||106
10674110|NCT02347761|11835988|FG000|COMPLETED|On Study Treatment||191
10797175|NCT03684928|11957567|FG000|STARTED|First Intervention||23
10797176|NCT03684928|11957568|FG001|STARTED|First Intervention||22
10674111|NCT02347761|11835989|FG001|COMPLETED|On Study Treatment||194
10674112|NCT02347761|11835990|FG002|COMPLETED|On Study Treatment||176
10674113|NCT02347761|11835988|FG000|NOT COMPLETED|On Study Treatment||27
10674114|NCT02347761|11835989|FG001|NOT COMPLETED|On Study Treatment||23
10674115|NCT02347761|11835990|FG002|NOT COMPLETED|On Study Treatment||42
10674116|NCT02347774|11836001|FG000|STARTED|Study Participation||214
10674117|NCT02347774|11836002|FG001|STARTED|Study Participation||214
10712455|NCT02670551|11878120|FG001|STARTED|Overall Study||160
10797177|NCT03684928|11957567|FG000|COMPLETED|First Intervention||23
10797178|NCT03684928|11957568|FG001|COMPLETED|First Intervention||19
10797179|NCT03684928|11957567|FG000|NOT COMPLETED|First Intervention||0
10797180|NCT03684928|11957568|FG001|NOT COMPLETED|First Intervention||3
10797181|NCT03684928|11957567|FG000|STARTED|Second Intervention|Two participants discontinued between the first intervention and second intervention.|21
10797182|NCT03684928|11957568|FG001|STARTED|Second Intervention||19
10797183|NCT03684928|11957567|FG000|COMPLETED|Second Intervention||20
10797184|NCT03684928|11957568|FG001|COMPLETED|Second Intervention||19
10797185|NCT03684928|11957567|FG000|NOT COMPLETED|Second Intervention||1
10674144|NCT02347787|11836013|FG000|NOT COMPLETED|9 Month Follow-Up||61
10674118|NCT02347774|11836003|FG002|STARTED|Study Participation|One subject randomized in error to the placebo arm was never dosed .|213
10674119|NCT02347774|11836001|FG000|COMPLETED|Study Participation||199
10674120|NCT02347774|11836002|FG001|COMPLETED|Study Participation||193
10674121|NCT02347774|11836003|FG002|COMPLETED|Study Participation||188
10674122|NCT02347774|11836001|FG000|NOT COMPLETED|Study Participation||15
10674123|NCT02347774|11836002|FG001|NOT COMPLETED|Study Participation||21
10797186|NCT03684928|11957568|FG001|NOT COMPLETED|Second Intervention||0
10797187|NCT03685344|11957578|FG000|STARTED|Overall Study||3
10797188|NCT03685344|11957579|FG001|STARTED|Overall Study||3
10797189|NCT03685344|11957580|FG002|STARTED|Overall Study||7
10797190|NCT03685344|11957581|FG003|STARTED|Overall Study||0
10797191|NCT03685344|11957578|FG000|Received Treatment|Overall Study||3
10797192|NCT03685344|11957579|FG001|Received Treatment|Overall Study||3
10797193|NCT03685344|11957580|FG002|Received Treatment|Overall Study||7
10797194|NCT03685344|11957581|FG003|Received Treatment|Overall Study||0
10797195|NCT03685344|11957578|FG000|COMPLETED|Overall Study||0
10797196|NCT03685344|11957579|FG001|COMPLETED|Overall Study||0
10797197|NCT03685344|11957580|FG002|COMPLETED|Overall Study||0
10797198|NCT03685344|11957581|FG003|COMPLETED|Overall Study||0
10797199|NCT03685344|11957578|FG000|NOT COMPLETED|Overall Study||3
10797200|NCT03685344|11957579|FG001|NOT COMPLETED|Overall Study||3
10797201|NCT03685344|11957580|FG002|NOT COMPLETED|Overall Study||7
10797202|NCT03685344|11957581|FG003|NOT COMPLETED|Overall Study||0
10797203|NCT03685396|11957593|FG000|STARTED|Overall Study||21
10797204|NCT03685396|11957594|FG001|STARTED|Overall Study||21
10797205|NCT03685396|11957593|FG000|COMPLETED|Overall Study||21
10797206|NCT03685396|11957594|FG001|COMPLETED|Overall Study||21
10797207|NCT03685396|11957593|FG000|NOT COMPLETED|Overall Study||0
10797208|NCT03685396|11957594|FG001|NOT COMPLETED|Overall Study||0
10797209|NCT03685643|11957602|FG000|STARTED|Overall Study||290
10797210|NCT03685643|11957603|FG001|STARTED|Overall Study||288
10797211|NCT03685643|11957602|FG000|COMPLETED|Overall Study||276
10797212|NCT03685643|11957603|FG001|COMPLETED|Overall Study||266
10797213|NCT03685643|11957602|FG000|NOT COMPLETED|Overall Study||14
10797214|NCT03685643|11957603|FG001|NOT COMPLETED|Overall Study||22
10797215|NCT03685968|11957612|FG000|STARTED|Overall Study||75
10797216|NCT03685968|11957613|FG001|STARTED|Overall Study||75
10797217|NCT03685968|11957614|FG002|STARTED|Overall Study||75
10797218|NCT03685968|11957612|FG000|COMPLETED|Overall Study||75
10797219|NCT03685968|11957613|FG001|COMPLETED|Overall Study||75
10797220|NCT03685968|11957614|FG002|COMPLETED|Overall Study||75
10797221|NCT03685968|11957612|FG000|NOT COMPLETED|Overall Study||0
10797222|NCT03685968|11957613|FG001|NOT COMPLETED|Overall Study||0
10797223|NCT03685968|11957614|FG002|NOT COMPLETED|Overall Study||0
10797224|NCT03686033|11957622|FG000|STARTED|Treatment Period 1 (1 Day)||1
10797225|NCT03686033|11957623|FG001|STARTED|Treatment Period 1 (1 Day)||1
10797226|NCT03686033|11957624|FG002|STARTED|Treatment Period 1 (1 Day)||1
10797227|NCT03686033|11957625|FG003|STARTED|Treatment Period 1 (1 Day)||1
10797228|NCT03686033|11957626|FG004|STARTED|Treatment Period 1 (1 Day)||1
10797229|NCT03686033|11957627|FG005|STARTED|Treatment Period 1 (1 Day)||0
10797230|NCT03686033|11957622|FG000|COMPLETED|Treatment Period 1 (1 Day)||1
10797231|NCT03686033|11957623|FG001|COMPLETED|Treatment Period 1 (1 Day)||1
10797232|NCT03686033|11957624|FG002|COMPLETED|Treatment Period 1 (1 Day)||1
10797233|NCT03686033|11957625|FG003|COMPLETED|Treatment Period 1 (1 Day)||1
10797234|NCT03686033|11957626|FG004|COMPLETED|Treatment Period 1 (1 Day)||1
10797235|NCT03686033|11957627|FG005|COMPLETED|Treatment Period 1 (1 Day)||0
10797236|NCT03686033|11957622|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0
10797237|NCT03686033|11957623|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0
10797238|NCT03686033|11957624|FG002|NOT COMPLETED|Treatment Period 1 (1 Day)||0
10797239|NCT03686033|11957625|FG003|NOT COMPLETED|Treatment Period 1 (1 Day)||0
10797240|NCT03686033|11957626|FG004|NOT COMPLETED|Treatment Period 1 (1 Day)||0
10797241|NCT03686033|11957627|FG005|NOT COMPLETED|Treatment Period 1 (1 Day)||0
10797242|NCT03686033|11957622|FG000|STARTED|Washout Phase (at Least 2 Weeks)||1
10797243|NCT03686033|11957623|FG001|STARTED|Washout Phase (at Least 2 Weeks)||1
10797244|NCT03686033|11957624|FG002|STARTED|Washout Phase (at Least 2 Weeks)||1
10797245|NCT03686033|11957625|FG003|STARTED|Washout Phase (at Least 2 Weeks)||1
10797246|NCT03686033|11957626|FG004|STARTED|Washout Phase (at Least 2 Weeks)||1
10797247|NCT03686033|11957627|FG005|STARTED|Washout Phase (at Least 2 Weeks)||0
10797248|NCT03686033|11957622|FG000|COMPLETED|Washout Phase (at Least 2 Weeks)||1
10797249|NCT03686033|11957623|FG001|COMPLETED|Washout Phase (at Least 2 Weeks)||1
10797250|NCT03686033|11957624|FG002|COMPLETED|Washout Phase (at Least 2 Weeks)||1
10797251|NCT03686033|11957625|FG003|COMPLETED|Washout Phase (at Least 2 Weeks)||1
10797252|NCT03686033|11957626|FG004|COMPLETED|Washout Phase (at Least 2 Weeks)||1
10674124|NCT02347774|11836003|FG002|NOT COMPLETED|Study Participation||25
10674125|NCT02347774|11836001|FG000|STARTED|On Study Treatment||214
10674126|NCT02347774|11836002|FG001|STARTED|On Study Treatment||214
10797253|NCT03686033|11957627|FG005|COMPLETED|Washout Phase (at Least 2 Weeks)||0
10674127|NCT02347774|11836003|FG002|STARTED|On Study Treatment|One subject randomized in error to the placebo arm was never dosed .|213
10674128|NCT02347774|11836001|FG000|COMPLETED|On Study Treatment||190
10674129|NCT02347774|11836002|FG001|COMPLETED|On Study Treatment||183
10674130|NCT02347774|11836003|FG002|COMPLETED|On Study Treatment||177
10674131|NCT02347774|11836001|FG000|NOT COMPLETED|On Study Treatment||24
10674132|NCT02347774|11836002|FG001|NOT COMPLETED|On Study Treatment||31
10674133|NCT02347774|11836003|FG002|NOT COMPLETED|On Study Treatment||36
10712456|NCT02670551|11878121|FG002|STARTED|Overall Study||165
10712457|NCT02670551|11878119|FG000|Received Treatment (Safety Population)|Overall Study||158
10712458|NCT02670551|11878120|FG001|Received Treatment (Safety Population)|Overall Study||157
10712459|NCT02670551|11878121|FG002|Received Treatment (Safety Population)|Overall Study||165
10712460|NCT02670551|11878119|FG000|COMPLETED|Overall Study||135
10712461|NCT02670551|11878120|FG001|COMPLETED|Overall Study||134
10712462|NCT02670551|11878121|FG002|COMPLETED|Overall Study||134
10712463|NCT02670551|11878119|FG000|NOT COMPLETED|Overall Study||28
10712464|NCT02670551|11878120|FG001|NOT COMPLETED|Overall Study||26
10712465|NCT02670551|11878121|FG002|NOT COMPLETED|Overall Study||31
10712466|NCT02670629|11878131|FG000|STARTED|Overall Study||29
10712467|NCT02670629|11878132|FG001|STARTED|Overall Study||29
10712468|NCT02670629|11878131|FG000|COMPLETED|Overall Study||29
10797254|NCT03686033|11957622|FG000|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
10797255|NCT03686033|11957623|FG001|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
10797256|NCT03686033|11957624|FG002|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
10797257|NCT03686033|11957625|FG003|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
10797258|NCT03686033|11957626|FG004|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
10712469|NCT02670629|11878132|FG001|COMPLETED|Overall Study||29
10712470|NCT02670629|11878131|FG000|NOT COMPLETED|Overall Study||0
10712471|NCT02670629|11878132|FG001|NOT COMPLETED|Overall Study||0
10712472|NCT02670811|11878140|FG000|STARTED|Overall Study||18
10712473|NCT02670811|11878141|FG001|STARTED|Overall Study||18
10712474|NCT02670811|11878140|FG000|COMPLETED|Overall Study||17
10712475|NCT02670811|11878141|FG001|COMPLETED|Overall Study||18
10712476|NCT02670811|11878140|FG000|NOT COMPLETED|Overall Study||1
10712477|NCT02670811|11878141|FG001|NOT COMPLETED|Overall Study||0
10712478|NCT02670915|11878150|FG000|STARTED|Overall Study||260
10712479|NCT02670915|11878151|FG001|STARTED|Overall Study||259
10712480|NCT02670915|11878152|FG002|STARTED|Overall Study||258
10712481|NCT02670915|11878150|FG000|COMPLETED|Overall Study||256
10712482|NCT02670915|11878151|FG001|COMPLETED|Overall Study||251
10712483|NCT02670915|11878152|FG002|COMPLETED|Overall Study||253
10712484|NCT02670915|11878150|FG000|NOT COMPLETED|Overall Study||4
10712485|NCT02670915|11878151|FG001|NOT COMPLETED|Overall Study||8
10712486|NCT02670915|11878152|FG002|NOT COMPLETED|Overall Study||5
10712487|NCT02670928|11878162|FG000|STARTED|Overall Study||100
10712488|NCT02670928|11878163|FG001|STARTED|Overall Study||30
10712489|NCT02670928|11878162|FG000|COMPLETED|Overall Study||90
10712490|NCT02670928|11878163|FG001|COMPLETED|Overall Study||29
10712491|NCT02670928|11878162|FG000|NOT COMPLETED|Overall Study||10
10712492|NCT02670928|11878163|FG001|NOT COMPLETED|Overall Study||1
10712493|NCT02671032|11878169|FG000|STARTED|Overall Study||12
10712494|NCT02671032|11878169|FG000|COMPLETED|Overall Study||12
10712495|NCT02671032|11878169|FG000|NOT COMPLETED|Overall Study||0
10712496|NCT02671266|11878175|FG000|STARTED|Overall Study||20
10712497|NCT02671266|11878176|FG001|STARTED|Overall Study||21
10712498|NCT02671266|11878175|FG000|BDD Participants|Overall Study||9
10712499|NCT02671266|11878176|FG001|BDD Participants|Overall Study||9
10712500|NCT02671266|11878175|FG000|OCD Participants|Overall Study||2
10712501|NCT02671266|11878176|FG001|OCD Participants|Overall Study||3
10712502|NCT02671266|11878175|FG000|Healthy Participants|Overall Study||8
10712503|NCT02671266|11878176|FG001|Healthy Participants|Overall Study||8
10712504|NCT02671266|11878175|FG000|COMPLETED|Overall Study||19
10712505|NCT02671266|11878176|FG001|COMPLETED|Overall Study||20
10712506|NCT02671266|11878175|FG000|NOT COMPLETED|Overall Study||1
10712507|NCT02671266|11878176|FG001|NOT COMPLETED|Overall Study||1
10712508|NCT02671422|11878182|FG000|STARTED|Overall Study||260
10712509|NCT02671422|11878182|FG000|Not Treated With Vargatef®|Overall Study||3
10712510|NCT02671422|11878182|FG000|COMPLETED|Overall Study||0
10712511|NCT02671422|11878182|FG000|NOT COMPLETED|Overall Study||260
10712512|NCT02671500|11878186|FG000|STARTED|Overall Study||375
10712513|NCT02671500|11878186|FG000|COMPLETED|Overall Study||361
10712514|NCT02671500|11878186|FG000|NOT COMPLETED|Overall Study||14
10712515|NCT02671760|11878194|FG000|STARTED|Overall Study||13
10712516|NCT02671760|11878195|FG001|STARTED|Overall Study||13
10712517|NCT02671760|11878196|FG002|STARTED|Overall Study||13
10712518|NCT02671760|11878194|FG000|COMPLETED|Overall Study||13
10712519|NCT02671760|11878195|FG001|COMPLETED|Overall Study|1 Subject could not be contacted for f/u phone call. Data included in safety and efficacy analyses.|12
10712520|NCT02671760|11878196|FG002|COMPLETED|Overall Study||13
10712521|NCT02671760|11878194|FG000|NOT COMPLETED|Overall Study||0
10712522|NCT02671760|11878195|FG001|NOT COMPLETED|Overall Study||1
10712523|NCT02671760|11878196|FG002|NOT COMPLETED|Overall Study||0
10712524|NCT02672111|11878206|FG000|STARTED|Overall Study||190
10712525|NCT02672111|11878207|FG001|STARTED|Overall Study||37
10712526|NCT02672111|11878206|FG000|Completed Treatment|Overall Study||138
10712527|NCT02672111|11878207|FG001|Completed Treatment|Overall Study||29
10712528|NCT02672111|11878206|FG000|COMPLETED|Overall Study||132
10712529|NCT02672111|11878207|FG001|COMPLETED|Overall Study||25
10712530|NCT02672111|11878206|FG000|NOT COMPLETED|Overall Study||58
10712531|NCT02672111|11878207|FG001|NOT COMPLETED|Overall Study||12
10674134|NCT02347787|11836013|FG000|STARTED|6 Month Follow-Up||288
10674135|NCT02347787|11836014|FG001|STARTED|6 Month Follow-Up||304
10674136|NCT02347787|11836013|FG000|COMPLETED|6 Month Follow-Up||222
10674137|NCT02347787|11836014|FG001|COMPLETED|6 Month Follow-Up||248
10674138|NCT02347787|11836013|FG000|NOT COMPLETED|6 Month Follow-Up||66
10674139|NCT02347787|11836014|FG001|NOT COMPLETED|6 Month Follow-Up||56
10674140|NCT02347787|11836013|FG000|STARTED|9 Month Follow-Up||288
10674141|NCT02347787|11836014|FG001|STARTED|9 Month Follow-Up||304
10674142|NCT02347787|11836013|FG000|COMPLETED|9 Month Follow-Up||227
10674143|NCT02347787|11836014|FG001|COMPLETED|9 Month Follow-Up||233
10674145|NCT02347787|11836014|FG001|NOT COMPLETED|9 Month Follow-Up||71
10674146|NCT02347813|11836027|FG000|STARTED|First Intervention, 24 Weeks||6
10674147|NCT02347813|11836028|FG001|STARTED|First Intervention, 24 Weeks||6
10674148|NCT02347813|11836027|FG000|COMPLETED|First Intervention, 24 Weeks||4
10674149|NCT02347813|11836028|FG001|COMPLETED|First Intervention, 24 Weeks||4
10674150|NCT02347813|11836027|FG000|NOT COMPLETED|First Intervention, 24 Weeks||2
10674151|NCT02347813|11836028|FG001|NOT COMPLETED|First Intervention, 24 Weeks||2
10674152|NCT02347813|11836027|FG000|STARTED|Second Intervention, 24 Weeks||4
10674153|NCT02347813|11836028|FG001|STARTED|Second Intervention, 24 Weeks||4
10674154|NCT02347813|11836027|FG000|COMPLETED|Second Intervention, 24 Weeks||4
10674155|NCT02347813|11836028|FG001|COMPLETED|Second Intervention, 24 Weeks||4
10674156|NCT02347813|11836027|FG000|NOT COMPLETED|Second Intervention, 24 Weeks||0
10674157|NCT02347813|11836028|FG001|NOT COMPLETED|Second Intervention, 24 Weeks||0
10674167|NCT02348385|11836046|FG000|STARTED|Overall Study||24
10674168|NCT02348385|11836047|FG001|STARTED|Overall Study||25
10674169|NCT02348385|11836046|FG000|COMPLETED|Overall Study||24
10674170|NCT02348385|11836047|FG001|COMPLETED|Overall Study||25
10674171|NCT02348385|11836046|FG000|NOT COMPLETED|Overall Study||0
10674172|NCT02348385|11836047|FG001|NOT COMPLETED|Overall Study||0
10674173|NCT02348489|11836057|FG000|STARTED|Overall Study||408
10674174|NCT02348489|11836058|FG001|STARTED|Overall Study||407
10674175|NCT02348489|11836057|FG000|COMPLETED|Overall Study||55
10674176|NCT02348489|11836058|FG001|COMPLETED|Overall Study||40
10674177|NCT02348489|11836057|FG000|NOT COMPLETED|Overall Study||353
10674178|NCT02348489|11836058|FG001|NOT COMPLETED|Overall Study||367
10674179|NCT02348593|11836070|FG000|STARTED|Overall Study||59
10674180|NCT02348593|11836071|FG001|STARTED|Overall Study||59
10674181|NCT02348593|11836072|FG002|STARTED|Overall Study||59
10674182|NCT02348593|11836073|FG003|STARTED|Overall Study||59
10674183|NCT02348593|11836070|FG000|COMPLETED|Overall Study||49
10674184|NCT02348593|11836071|FG001|COMPLETED|Overall Study||51
10674185|NCT02348593|11836072|FG002|COMPLETED|Overall Study||43
10674186|NCT02348593|11836073|FG003|COMPLETED|Overall Study||52
10674187|NCT02348593|11836070|FG000|NOT COMPLETED|Overall Study||10
10674188|NCT02348593|11836071|FG001|NOT COMPLETED|Overall Study||8
10674189|NCT02348593|11836072|FG002|NOT COMPLETED|Overall Study||16
10674190|NCT02348593|11836073|FG003|NOT COMPLETED|Overall Study||7
10674191|NCT02348606|11836088|FG000|STARTED|Overall Study||58
10674192|NCT02348606|11836089|FG001|STARTED|Overall Study||62
10674193|NCT02348606|11836090|FG002|STARTED|Overall Study||117
10674194|NCT02348606|11836091|FG003|STARTED|Overall Study||118
10674195|NCT02348606|11836092|FG004|STARTED|Overall Study||119
10674196|NCT02348606|11836088|FG000|COMPLETED|Overall Study||49
10674197|NCT02348606|11836089|FG001|COMPLETED|Overall Study||54
10674198|NCT02348606|11836090|FG002|COMPLETED|Overall Study||106
10674199|NCT02348606|11836091|FG003|COMPLETED|Overall Study||94
10674200|NCT02348606|11836092|FG004|COMPLETED|Overall Study||101
10674201|NCT02348606|11836088|FG000|NOT COMPLETED|Overall Study||9
10674202|NCT02348606|11836089|FG001|NOT COMPLETED|Overall Study||8
10674203|NCT02348606|11836090|FG002|NOT COMPLETED|Overall Study||11
10674204|NCT02348606|11836091|FG003|NOT COMPLETED|Overall Study||24
10674205|NCT02348606|11836092|FG004|NOT COMPLETED|Overall Study||18
10674206|NCT02348619|11836104|FG000|STARTED|Titration Phase||174
10674207|NCT02348619|11836105|FG001|STARTED|Titration Phase||0
10674208|NCT02348619|11836104|FG000|COMPLETED|Titration Phase||157
10674209|NCT02348619|11836105|FG001|COMPLETED|Titration Phase||0
10674210|NCT02348619|11836104|FG000|NOT COMPLETED|Titration Phase||17
10674211|NCT02348619|11836105|FG001|NOT COMPLETED|Titration Phase||0
10674212|NCT02348619|11836104|FG000|STARTED|Stable-Dose Phase||157
10674213|NCT02348619|11836105|FG001|STARTED|Stable-Dose Phase||0
10674214|NCT02348619|11836104|FG000|COMPLETED|Stable-Dose Phase||124
10674215|NCT02348619|11836105|FG001|COMPLETED|Stable-Dose Phase||0
10674216|NCT02348619|11836104|FG000|NOT COMPLETED|Stable-Dose Phase||33
10674217|NCT02348619|11836105|FG001|NOT COMPLETED|Stable-Dose Phase||0
10674218|NCT02348619|11836104|FG000|STARTED|Double-Blind Withdrawal Phase||62
10674219|NCT02348619|11836105|FG001|STARTED|Double-Blind Withdrawal Phase||62
10674220|NCT02348619|11836104|FG000|COMPLETED|Double-Blind Withdrawal Phase||60
10674221|NCT02348619|11836105|FG001|COMPLETED|Double-Blind Withdrawal Phase||62
10674222|NCT02348619|11836104|FG000|NOT COMPLETED|Double-Blind Withdrawal Phase||2
10674223|NCT02348619|11836105|FG001|NOT COMPLETED|Double-Blind Withdrawal Phase||0
10674224|NCT02348632|11836111|FG000|STARTED|Open-label Period||643
10674225|NCT02348632|11836112|FG001|STARTED|Open-label Period||0
10674226|NCT02348632|11836111|FG000|COMPLETED|Open-label Period||458
10674227|NCT02348632|11836112|FG001|COMPLETED|Open-label Period||0
10674228|NCT02348632|11836111|FG000|NOT COMPLETED|Open-label Period||185
10674229|NCT02348632|11836112|FG001|NOT COMPLETED|Open-label Period||0
10674230|NCT02348632|11836111|FG000|STARTED|Randomized Withdrawal Period||140
10674231|NCT02348632|11836112|FG001|STARTED|Randomized Withdrawal Period||142
10674232|NCT02348632|11836111|FG000|COMPLETED|Randomized Withdrawal Period||137
10674233|NCT02348632|11836112|FG001|COMPLETED|Randomized Withdrawal Period||141
10674234|NCT02348632|11836111|FG000|NOT COMPLETED|Randomized Withdrawal Period||3
10674235|NCT02348632|11836112|FG001|NOT COMPLETED|Randomized Withdrawal Period||1
10674236|NCT02348658|11836118|FG000|STARTED|Period 1 (7 Days)||6
10674237|NCT02348658|11836119|FG001|STARTED|Period 1 (7 Days)||6
10674238|NCT02348658|11836118|FG000|COMPLETED|Period 1 (7 Days)||6
10674239|NCT02348658|11836119|FG001|COMPLETED|Period 1 (7 Days)||6
10674240|NCT02348658|11836118|FG000|NOT COMPLETED|Period 1 (7 Days)||0
10674241|NCT02348658|11836119|FG001|NOT COMPLETED|Period 1 (7 Days)||0
10674242|NCT02348658|11836118|FG000|STARTED|Washout Period (22 Days)||6
10674243|NCT02348658|11836119|FG001|STARTED|Washout Period (22 Days)||6
10674244|NCT02348658|11836118|FG000|COMPLETED|Washout Period (22 Days)||6
10674245|NCT02348658|11836119|FG001|COMPLETED|Washout Period (22 Days)||6
10674246|NCT02348658|11836118|FG000|NOT COMPLETED|Washout Period (22 Days)||0
10674247|NCT02348658|11836119|FG001|NOT COMPLETED|Washout Period (22 Days)||0
10674248|NCT02348658|11836118|FG000|STARTED|Period 2 (7 Days)||6
10674249|NCT02348658|11836119|FG001|STARTED|Period 2 (7 Days)||6
10674250|NCT02348658|11836118|FG000|COMPLETED|Period 2 (7 Days)||6
10674251|NCT02348658|11836119|FG001|COMPLETED|Period 2 (7 Days)||6
10674252|NCT02348658|11836118|FG000|NOT COMPLETED|Period 2 (7 Days)||0
10674253|NCT02348658|11836119|FG001|NOT COMPLETED|Period 2 (7 Days)||0
10674254|NCT02348684|11836125|FG000|STARTED|Overall Study||20
10674255|NCT02348684|11836125|FG000|COMPLETED|Overall Study||20
10674256|NCT02348684|11836125|FG000|NOT COMPLETED|Overall Study||0
10674257|NCT02348723|11836131|FG000|STARTED|Overall Study||338
10674258|NCT02348723|11836132|FG001|STARTED|Overall Study||338
10674259|NCT02348723|11836131|FG000|COMPLETED|Overall Study||310
10674260|NCT02348723|11836132|FG001|COMPLETED|Overall Study||312
10674261|NCT02348723|11836131|FG000|NOT COMPLETED|Overall Study||28
10674262|NCT02348723|11836132|FG001|NOT COMPLETED|Overall Study||26
10674263|NCT02348775|11836140|FG000|STARTED|Overall Study||8
10674264|NCT02348775|11836141|FG001|STARTED|Overall Study||8
10674265|NCT02348775|11836140|FG000|COMPLETED|Overall Study||8
10674266|NCT02348775|11836141|FG001|COMPLETED|Overall Study||8
10674267|NCT02348775|11836140|FG000|NOT COMPLETED|Overall Study||0
10674268|NCT02348775|11836141|FG001|NOT COMPLETED|Overall Study||0
10674269|NCT02348840|11836151|FG000|STARTED|Overall Study||23
10674270|NCT02348840|11836152|FG001|STARTED|Overall Study||21
10674271|NCT02348840|11836153|FG002|STARTED|Overall Study||425
10674272|NCT02348840|11836154|FG003|STARTED|Overall Study||374
10674273|NCT02348840|11836151|FG000|COMPLETED|Overall Study||21
10674274|NCT02348840|11836152|FG001|COMPLETED|Overall Study||20
10674275|NCT02348840|11836153|FG002|COMPLETED|Overall Study||425
10674276|NCT02348840|11836154|FG003|COMPLETED|Overall Study||374
10674277|NCT02348840|11836151|FG000|NOT COMPLETED|Overall Study||2
10674278|NCT02348840|11836152|FG001|NOT COMPLETED|Overall Study||1
10674279|NCT02348840|11836153|FG002|NOT COMPLETED|Overall Study||0
10674280|NCT02348840|11836154|FG003|NOT COMPLETED|Overall Study||0
10674281|NCT02348918|11836173|FG000|STARTED|Overall Study||39
10674282|NCT02348918|11836174|FG001|STARTED|Overall Study||33
10674283|NCT02348918|11836175|FG002|STARTED|Overall Study||42
10674284|NCT02348918|11836176|FG003|STARTED|Overall Study||24
10797259|NCT03686033|11957627|FG005|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
10674285|NCT02348918|11836177|FG004|STARTED|Overall Study||19
10674286|NCT02348918|11836178|FG005|STARTED|Overall Study||17
10674287|NCT02348918|11836179|FG006|STARTED|Overall Study||13
10674288|NCT02348918|11836180|FG007|STARTED|Overall Study||16
10674289|NCT02348918|11836181|FG008|STARTED|Overall Study||15
10674290|NCT02348918|11836173|FG000|COMPLETED|Overall Study||39
10674291|NCT02348918|11836174|FG001|COMPLETED|Overall Study||33
10674292|NCT02348918|11836175|FG002|COMPLETED|Overall Study||42
10674293|NCT02348918|11836176|FG003|COMPLETED|Overall Study||24
10674294|NCT02348918|11836177|FG004|COMPLETED|Overall Study||19
10674295|NCT02348918|11836178|FG005|COMPLETED|Overall Study||17
10674296|NCT02348918|11836179|FG006|COMPLETED|Overall Study||13
10674297|NCT02348918|11836180|FG007|COMPLETED|Overall Study||16
10674298|NCT02348918|11836181|FG008|COMPLETED|Overall Study||15
10674299|NCT02348918|11836173|FG000|NOT COMPLETED|Overall Study||0
10674300|NCT02348918|11836174|FG001|NOT COMPLETED|Overall Study||0
10674301|NCT02348918|11836175|FG002|NOT COMPLETED|Overall Study||0
10674302|NCT02348918|11836176|FG003|NOT COMPLETED|Overall Study||0
10674303|NCT02348918|11836177|FG004|NOT COMPLETED|Overall Study||0
10674304|NCT02348918|11836178|FG005|NOT COMPLETED|Overall Study||0
10674305|NCT02348918|11836179|FG006|NOT COMPLETED|Overall Study||0
10674306|NCT02348918|11836180|FG007|NOT COMPLETED|Overall Study||0
10674307|NCT02348918|11836181|FG008|NOT COMPLETED|Overall Study||0
10674308|NCT02349048|11836203|FG000|STARTED|Overall Study||59
10674309|NCT02349048|11836204|FG001|STARTED|Overall Study||9
10674310|NCT02349048|11836203|FG000|COMPLETED|Overall Study||54
10674311|NCT02349048|11836204|FG001|COMPLETED|Overall Study||9
10674312|NCT02349048|11836203|FG000|NOT COMPLETED|Overall Study||5
10674313|NCT02349048|11836204|FG001|NOT COMPLETED|Overall Study||0
10674314|NCT02349061|11836212|FG000|STARTED|Main Study: PCP (Up to Week 24)||42
10674315|NCT02349061|11836213|FG001|STARTED|Main Study: PCP (Up to Week 24)||60
10674316|NCT02349061|11836214|FG002|STARTED|Main Study: PCP (Up to Week 24)||0
10674317|NCT02349061|11836212|FG000|COMPLETED|Main Study: PCP (Up to Week 24)||33
10674318|NCT02349061|11836213|FG001|COMPLETED|Main Study: PCP (Up to Week 24)||56
10797260|NCT03686033|11957622|FG000|STARTED|Treatment Period 2 (1 Day)||1
10797261|NCT03686033|11957623|FG001|STARTED|Treatment Period 2 (1 Day)||1
10797262|NCT03686033|11957624|FG002|STARTED|Treatment Period 2 (1 Day)||1
10797263|NCT03686033|11957625|FG003|STARTED|Treatment Period 2 (1 Day)||1
10797264|NCT03686033|11957626|FG004|STARTED|Treatment Period 2 (1 Day)||1
10674319|NCT02349061|11836214|FG002|COMPLETED|Main Study: PCP (Up to Week 24)||0
10674320|NCT02349061|11836212|FG000|NOT COMPLETED|Main Study: PCP (Up to Week 24)||9
10674321|NCT02349061|11836213|FG001|NOT COMPLETED|Main Study: PCP (Up to Week 24)||4
10674322|NCT02349061|11836214|FG002|NOT COMPLETED|Main Study: PCP (Up to Week 24)||0
10674323|NCT02349061|11836212|FG000|STARTED|Main Study: Week 24 to 56||0
10674324|NCT02349061|11836213|FG001|STARTED|Main Study: Week 24 to 56||56
10674325|NCT02349061|11836214|FG002|STARTED|Main Study: Week 24 to 56||33
10674326|NCT02349061|11836212|FG000|COMPLETED|Main Study: Week 24 to 56||0
10674327|NCT02349061|11836213|FG001|COMPLETED|Main Study: Week 24 to 56||53
10674328|NCT02349061|11836214|FG002|COMPLETED|Main Study: Week 24 to 56||30
10674329|NCT02349061|11836212|FG000|NOT COMPLETED|Main Study: Week 24 to 56||0
10674330|NCT02349061|11836213|FG001|NOT COMPLETED|Main Study: Week 24 to 56||3
10674331|NCT02349061|11836214|FG002|NOT COMPLETED|Main Study: Week 24 to 56||3
10674332|NCT02349061|11836212|FG000|STARTED|Study Extension (Week 56 to Week 120)||0
10674333|NCT02349061|11836213|FG001|STARTED|Study Extension (Week 56 to Week 120)|Who met study extension inclusion criteria received open-label ustekinumab SC through Week 104.|29
10674334|NCT02349061|11836214|FG002|STARTED|Study Extension (Week 56 to Week 120)|Who met study extension inclusion criteria received open-label ustekinumab SC through Week 104.|17
10674335|NCT02349061|11836212|FG000|COMPLETED|Study Extension (Week 56 to Week 120)||0
10674336|NCT02349061|11836213|FG001|COMPLETED|Study Extension (Week 56 to Week 120)||24
10674337|NCT02349061|11836214|FG002|COMPLETED|Study Extension (Week 56 to Week 120)||14
10674338|NCT02349061|11836212|FG000|NOT COMPLETED|Study Extension (Week 56 to Week 120)||0
10674339|NCT02349061|11836213|FG001|NOT COMPLETED|Study Extension (Week 56 to Week 120)||5
10674340|NCT02349061|11836214|FG002|NOT COMPLETED|Study Extension (Week 56 to Week 120)||3
10674341|NCT02349152|11836226|FG000|STARTED|Overall Study||60
10674342|NCT02349152|11836227|FG001|STARTED|Overall Study||56
10674343|NCT02349152|11836226|FG000|COMPLETED|Overall Study||54
10797265|NCT03686033|11957627|FG005|STARTED|Treatment Period 2 (1 Day)||0
10797266|NCT03686033|11957622|FG000|COMPLETED|Treatment Period 2 (1 Day)||1
10797267|NCT03686033|11957623|FG001|COMPLETED|Treatment Period 2 (1 Day)||1
10797268|NCT03686033|11957624|FG002|COMPLETED|Treatment Period 2 (1 Day)||1
10797269|NCT03686033|11957625|FG003|COMPLETED|Treatment Period 2 (1 Day)||1
10797270|NCT03686033|11957626|FG004|COMPLETED|Treatment Period 2 (1 Day)||0
10797271|NCT03686033|11957627|FG005|COMPLETED|Treatment Period 2 (1 Day)||0
10797272|NCT03686033|11957622|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0
10797273|NCT03686033|11957623|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0
10797274|NCT03686033|11957624|FG002|NOT COMPLETED|Treatment Period 2 (1 Day)||0
10797275|NCT03686033|11957625|FG003|NOT COMPLETED|Treatment Period 2 (1 Day)||0
10797276|NCT03686033|11957626|FG004|NOT COMPLETED|Treatment Period 2 (1 Day)||1
10797277|NCT03686033|11957627|FG005|NOT COMPLETED|Treatment Period 2 (1 Day)||0
10797278|NCT03686033|11957622|FG000|STARTED|Washout Phase (at Least 2 Weeks)||1
10797279|NCT03686033|11957623|FG001|STARTED|Washout Phase (at Least 2 Weeks)||1
10797280|NCT03686033|11957624|FG002|STARTED|Washout Phase (at Least 2 Weeks)||1
10674344|NCT02349152|11836227|FG001|COMPLETED|Overall Study||52
10674345|NCT02349152|11836226|FG000|NOT COMPLETED|Overall Study||6
10674346|NCT02349152|11836227|FG001|NOT COMPLETED|Overall Study||4
10674347|NCT02349178|11836233|FG000|STARTED|Overall Study||6
10674348|NCT02349178|11836233|FG000|COMPLETED|Overall Study||6
10674349|NCT02349178|11836233|FG000|NOT COMPLETED|Overall Study||0
10674350|NCT02349295|11836240|FG000|STARTED|Double Blind Treatment (Week 0-24)||123
10674351|NCT02349295|11836241|FG001|STARTED|Double Blind Treatment (Week 0-24)||122
10674352|NCT02349295|11836242|FG002|STARTED|Double Blind Treatment (Week 0-24)||118
10674353|NCT02349295|11836243|FG003|STARTED|Double Blind Treatment (Week 0-24)||0
10674354|NCT02349295|11836244|FG004|STARTED|Double Blind Treatment (Week 0-24)||0
10674355|NCT02349295|11836245|FG005|STARTED|Double Blind Treatment (Week 0-24)||0
10674356|NCT02349295|11836246|FG006|STARTED|Double Blind Treatment (Week 0-24)||0
10674357|NCT02349295|11836247|FG007|STARTED|Double Blind Treatment (Week 0-24)||0
10674358|NCT02349295|11836248|FG008|STARTED|Double Blind Treatment (Week 0-24)||0
10674359|NCT02349295|11836249|FG009|STARTED|Double Blind Treatment (Week 0-24)||0
10674360|NCT02349295|11836250|FG010|STARTED|Double Blind Treatment (Week 0-24)||0
10797281|NCT03686033|11957625|FG003|STARTED|Washout Phase (at Least 2 Weeks)||1
10797282|NCT03686033|11957626|FG004|STARTED|Washout Phase (at Least 2 Weeks)||0
10797283|NCT03686033|11957627|FG005|STARTED|Washout Phase (at Least 2 Weeks)||0
10797284|NCT03686033|11957622|FG000|COMPLETED|Washout Phase (at Least 2 Weeks)||1
10797285|NCT03686033|11957623|FG001|COMPLETED|Washout Phase (at Least 2 Weeks)||1
10797286|NCT03686033|11957624|FG002|COMPLETED|Washout Phase (at Least 2 Weeks)||1
10797287|NCT03686033|11957625|FG003|COMPLETED|Washout Phase (at Least 2 Weeks)||1
10674361|NCT02349295|11836251|FG011|STARTED|Double Blind Treatment (Week 0-24)||0
10674362|NCT02349295|11836252|FG012|STARTED|Double Blind Treatment (Week 0-24)||0
10674363|NCT02349295|11836253|FG013|STARTED|Double Blind Treatment (Week 0-24)||0
10674364|NCT02349295|11836240|FG000|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||123
10674365|NCT02349295|11836241|FG001|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||122
10674366|NCT02349295|11836242|FG002|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||118
10674367|NCT02349295|11836243|FG003|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
10674368|NCT02349295|11836244|FG004|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
10674369|NCT02349295|11836245|FG005|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
10674602|NCT02349542|11836381|FG000|STARTED|Overall Study||20
10674370|NCT02349295|11836246|FG006|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
10674371|NCT02349295|11836247|FG007|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
10674372|NCT02349295|11836248|FG008|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
10674373|NCT02349295|11836249|FG009|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
10674374|NCT02349295|11836250|FG010|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
10674375|NCT02349295|11836251|FG011|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
10674376|NCT02349295|11836252|FG012|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
10674377|NCT02349295|11836253|FG013|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
10674378|NCT02349295|11836240|FG000|COMPLETED|Double Blind Treatment (Week 0-24)||109
10674379|NCT02349295|11836241|FG001|COMPLETED|Double Blind Treatment (Week 0-24)||111
10674380|NCT02349295|11836242|FG002|COMPLETED|Double Blind Treatment (Week 0-24)||94
10674381|NCT02349295|11836243|FG003|COMPLETED|Double Blind Treatment (Week 0-24)||0
10674382|NCT02349295|11836244|FG004|COMPLETED|Double Blind Treatment (Week 0-24)||0
10674383|NCT02349295|11836245|FG005|COMPLETED|Double Blind Treatment (Week 0-24)||0
10674384|NCT02349295|11836246|FG006|COMPLETED|Double Blind Treatment (Week 0-24)||0
10674385|NCT02349295|11836247|FG007|COMPLETED|Double Blind Treatment (Week 0-24)||0
10674386|NCT02349295|11836248|FG008|COMPLETED|Double Blind Treatment (Week 0-24)||0
10674387|NCT02349295|11836249|FG009|COMPLETED|Double Blind Treatment (Week 0-24)||0
10674388|NCT02349295|11836250|FG010|COMPLETED|Double Blind Treatment (Week 0-24)||0
10674389|NCT02349295|11836251|FG011|COMPLETED|Double Blind Treatment (Week 0-24)||0
10674390|NCT02349295|11836252|FG012|COMPLETED|Double Blind Treatment (Week 0-24)||0
10674391|NCT02349295|11836253|FG013|COMPLETED|Double Blind Treatment (Week 0-24)||0
10674392|NCT02349295|11836240|FG000|NOT COMPLETED|Double Blind Treatment (Week 0-24)||14
10674393|NCT02349295|11836241|FG001|NOT COMPLETED|Double Blind Treatment (Week 0-24)||11
10674394|NCT02349295|11836242|FG002|NOT COMPLETED|Double Blind Treatment (Week 0-24)||24
10674395|NCT02349295|11836243|FG003|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
10674396|NCT02349295|11836244|FG004|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
10674397|NCT02349295|11836245|FG005|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
10674398|NCT02349295|11836246|FG006|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
10674399|NCT02349295|11836247|FG007|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
10674400|NCT02349295|11836248|FG008|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
10674401|NCT02349295|11836249|FG009|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
10674402|NCT02349295|11836250|FG010|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
10674403|NCT02349295|11836251|FG011|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
10674404|NCT02349295|11836252|FG012|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
10674405|NCT02349295|11836253|FG013|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
10674406|NCT02349295|11836240|FG000|STARTED|IR (Week 16-24)|Only IR participants were included.|0
10674407|NCT02349295|11836241|FG001|STARTED|IR (Week 16-24)|Only IR participants were included.|0
10674408|NCT02349295|11836242|FG002|STARTED|IR (Week 16-24)|Only IR participants were included.|0
10674409|NCT02349295|11836243|FG003|STARTED|IR (Week 16-24)|IR from ixekizumab 80 mg Q2W only.|17
10674410|NCT02349295|11836244|FG004|STARTED|IR (Week 16-24)|IR from ixekizumab 80 mg Q4W only.|15
10674411|NCT02349295|11836245|FG005|STARTED|IR (Week 16-24)|IR from placebo who re-randomized (1:1) to ixekizumab 80 mg Q2W.|16
10674412|NCT02349295|11836246|FG006|STARTED|IR (Week 16-24)|IR from placebo who re-randomized (1:1) to ixekizumab 80 mg Q4W.|16
10674413|NCT02349295|11836247|FG007|STARTED|IR (Week 16-24)||0
10674414|NCT02349295|11836248|FG008|STARTED|IR (Week 16-24)||0
10674415|NCT02349295|11836249|FG009|STARTED|IR (Week 16-24)||0
10674416|NCT02349295|11836250|FG010|STARTED|IR (Week 16-24)||0
10674417|NCT02349295|11836251|FG011|STARTED|IR (Week 16-24)||0
10674418|NCT02349295|11836252|FG012|STARTED|IR (Week 16-24)||0
10674419|NCT02349295|11836253|FG013|STARTED|IR (Week 16-24)||0
10674420|NCT02349295|11836240|FG000|COMPLETED|IR (Week 16-24)||0
10674421|NCT02349295|11836241|FG001|COMPLETED|IR (Week 16-24)||0
10674422|NCT02349295|11836242|FG002|COMPLETED|IR (Week 16-24)||0
10674423|NCT02349295|11836243|FG003|COMPLETED|IR (Week 16-24)||16
10674424|NCT02349295|11836244|FG004|COMPLETED|IR (Week 16-24)||15
10674425|NCT02349295|11836245|FG005|COMPLETED|IR (Week 16-24)||16
10674426|NCT02349295|11836246|FG006|COMPLETED|IR (Week 16-24)||16
10674427|NCT02349295|11836247|FG007|COMPLETED|IR (Week 16-24)||0
10674428|NCT02349295|11836248|FG008|COMPLETED|IR (Week 16-24)||0
10674429|NCT02349295|11836249|FG009|COMPLETED|IR (Week 16-24)||0
10674430|NCT02349295|11836250|FG010|COMPLETED|IR (Week 16-24)||0
10674431|NCT02349295|11836251|FG011|COMPLETED|IR (Week 16-24)||0
10674432|NCT02349295|11836252|FG012|COMPLETED|IR (Week 16-24)||0
10674433|NCT02349295|11836253|FG013|COMPLETED|IR (Week 16-24)||0
10674434|NCT02349295|11836240|FG000|NOT COMPLETED|IR (Week 16-24)||0
10674435|NCT02349295|11836241|FG001|NOT COMPLETED|IR (Week 16-24)||0
10674436|NCT02349295|11836242|FG002|NOT COMPLETED|IR (Week 16-24)||0
10674437|NCT02349295|11836243|FG003|NOT COMPLETED|IR (Week 16-24)||1
10674438|NCT02349295|11836244|FG004|NOT COMPLETED|IR (Week 16-24)||0
10674439|NCT02349295|11836245|FG005|NOT COMPLETED|IR (Week 16-24)||0
10674440|NCT02349295|11836246|FG006|NOT COMPLETED|IR (Week 16-24)||0
10674441|NCT02349295|11836247|FG007|NOT COMPLETED|IR (Week 16-24)||0
10674442|NCT02349295|11836248|FG008|NOT COMPLETED|IR (Week 16-24)||0
10674443|NCT02349295|11836249|FG009|NOT COMPLETED|IR (Week 16-24)||0
10674444|NCT02349295|11836250|FG010|NOT COMPLETED|IR (Week 16-24)||0
10674445|NCT02349295|11836251|FG011|NOT COMPLETED|IR (Week 16-24)||0
10674446|NCT02349295|11836252|FG012|NOT COMPLETED|IR (Week 16-24)||0
10674447|NCT02349295|11836253|FG013|NOT COMPLETED|IR (Week 16-24)||0
10674448|NCT02349295|11836240|FG000|STARTED|Long-Term Extension Period (Week 24-156)||0
10674449|NCT02349295|11836241|FG001|STARTED|Long-Term Extension Period (Week 24-156)||0
10674450|NCT02349295|11836242|FG002|STARTED|Long-Term Extension Period (Week 24-156)||0
10674451|NCT02349295|11836243|FG003|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0
10674452|NCT02349295|11836244|FG004|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0
10674453|NCT02349295|11836245|FG005|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0
10674454|NCT02349295|11836246|FG006|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0
10674455|NCT02349295|11836247|FG007|STARTED|Long-Term Extension Period (Week 24-156)|IxeQ2W participants who entered the long-term extension period.|107
10674456|NCT02349295|11836248|FG008|STARTED|Long-Term Extension Period (Week 24-156)|IxeQ4W participants who entered the long-term extension period.|111
10674457|NCT02349295|11836249|FG009|STARTED|Long-Term Extension Period (Week 24-156)|Placebo/IxeQ2W participants who entered the long-term extension period.|46
10674458|NCT02349295|11836250|FG010|STARTED|Long-Term Extension Period (Week 24-156)|Placebo/IxeQ4W participants who entered the long-term extension period.|46
10674459|NCT02349295|11836251|FG011|STARTED|Long-Term Extension Period (Week 24-156)||0
10674460|NCT02349295|11836252|FG012|STARTED|Long-Term Extension Period (Week 24-156)||0
10674461|NCT02349295|11836253|FG013|STARTED|Long-Term Extension Period (Week 24-156)||0
10674462|NCT02349295|11836240|FG000|COMPLETED|Long-Term Extension Period (Week 24-156)||0
10674463|NCT02349295|11836241|FG001|COMPLETED|Long-Term Extension Period (Week 24-156)||0
10674464|NCT02349295|11836242|FG002|COMPLETED|Long-Term Extension Period (Week 24-156)||0
10674465|NCT02349295|11836243|FG003|COMPLETED|Long-Term Extension Period (Week 24-156)||0
10674466|NCT02349295|11836244|FG004|COMPLETED|Long-Term Extension Period (Week 24-156)||0
10674467|NCT02349295|11836245|FG005|COMPLETED|Long-Term Extension Period (Week 24-156)||0
10674468|NCT02349295|11836246|FG006|COMPLETED|Long-Term Extension Period (Week 24-156)||0
10674469|NCT02349295|11836247|FG007|COMPLETED|Long-Term Extension Period (Week 24-156)||55
10674470|NCT02349295|11836248|FG008|COMPLETED|Long-Term Extension Period (Week 24-156)||70
10674471|NCT02349295|11836249|FG009|COMPLETED|Long-Term Extension Period (Week 24-156)||20
10674472|NCT02349295|11836250|FG010|COMPLETED|Long-Term Extension Period (Week 24-156)||23
10674473|NCT02349295|11836251|FG011|COMPLETED|Long-Term Extension Period (Week 24-156)||0
10674474|NCT02349295|11836252|FG012|COMPLETED|Long-Term Extension Period (Week 24-156)||0
10674475|NCT02349295|11836253|FG013|COMPLETED|Long-Term Extension Period (Week 24-156)||0
10674476|NCT02349295|11836240|FG000|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
10674477|NCT02349295|11836241|FG001|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
10674478|NCT02349295|11836242|FG002|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
10674479|NCT02349295|11836243|FG003|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
10674480|NCT02349295|11836244|FG004|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
10674481|NCT02349295|11836245|FG005|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
10674482|NCT02349295|11836246|FG006|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
10674483|NCT02349295|11836247|FG007|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||52
10674484|NCT02349295|11836248|FG008|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||41
10674485|NCT02349295|11836249|FG009|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||26
10674486|NCT02349295|11836250|FG010|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||23
10674487|NCT02349295|11836251|FG011|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
10674488|NCT02349295|11836252|FG012|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
10674489|NCT02349295|11836253|FG013|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
10674490|NCT02349295|11836240|FG000|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
10674491|NCT02349295|11836241|FG001|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
10674492|NCT02349295|11836242|FG002|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
10674493|NCT02349295|11836243|FG003|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
10674494|NCT02349295|11836244|FG004|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
10674495|NCT02349295|11836245|FG005|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
10674496|NCT02349295|11836246|FG006|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
10674497|NCT02349295|11836247|FG007|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0
10674498|NCT02349295|11836248|FG008|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0
10674499|NCT02349295|11836249|FG009|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0
10674500|NCT02349295|11836250|FG010|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0
10674501|NCT02349295|11836251|FG011|STARTED|Follow-Up Period (Up to 12-24 Weeks)|IxeQ2W participants who entered post-treatment follow-up.|142
10674502|NCT02349295|11836252|FG012|STARTED|Follow-Up Period (Up to 12-24 Weeks)|IxeQ4W participants who entered post-treatment follow-up.|145
10712532|NCT02672176|11878216|FG000|STARTED|Overall Study||161
10674503|NCT02349295|11836253|FG013|STARTED|Follow-Up Period (Up to 12-24 Weeks)|PBO participants who entered post-treatment follow-up.|17
10674504|NCT02349295|11836240|FG000|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
10674505|NCT02349295|11836241|FG001|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
10674506|NCT02349295|11836242|FG002|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
10674507|NCT02349295|11836243|FG003|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
10674508|NCT02349295|11836244|FG004|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
10674509|NCT02349295|11836245|FG005|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
10674510|NCT02349295|11836246|FG006|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
10674511|NCT02349295|11836247|FG007|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
10674512|NCT02349295|11836248|FG008|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
10674513|NCT02349295|11836249|FG009|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
10674514|NCT02349295|11836250|FG010|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
10674515|NCT02349295|11836251|FG011|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||133
10674516|NCT02349295|11836252|FG012|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||137
10674517|NCT02349295|11836253|FG013|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||16
10674518|NCT02349295|11836240|FG000|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
10674519|NCT02349295|11836241|FG001|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
10674520|NCT02349295|11836242|FG002|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
10674521|NCT02349295|11836243|FG003|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
10674522|NCT02349295|11836244|FG004|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
10674523|NCT02349295|11836245|FG005|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
10674524|NCT02349295|11836246|FG006|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
10674525|NCT02349295|11836247|FG007|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
10674526|NCT02349295|11836248|FG008|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
10674527|NCT02349295|11836249|FG009|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
10674528|NCT02349295|11836250|FG010|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
10674529|NCT02349295|11836251|FG011|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||9
10674530|NCT02349295|11836252|FG012|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||8
10674531|NCT02349295|11836253|FG013|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||1
10674532|NCT02349360|11836280|FG000|STARTED|Overall Study||21
10674533|NCT02349360|11836281|FG001|STARTED|Overall Study||21
10674534|NCT02349360|11836280|FG000|COMPLETED|Overall Study||21
10674535|NCT02349360|11836281|FG001|COMPLETED|Overall Study||20
10674536|NCT02349360|11836280|FG000|NOT COMPLETED|Overall Study||0
10674537|NCT02349360|11836281|FG001|NOT COMPLETED|Overall Study||1
10674538|NCT02349412|11836289|FG000|STARTED|Overall Study||202
10674539|NCT02349412|11836290|FG001|STARTED|Overall Study||203
10674540|NCT02349412|11836289|FG000|Completed Week-12 QOL Assessment Measure|Overall Study||92
10674541|NCT02349412|11836290|FG001|Completed Week-12 QOL Assessment Measure|Overall Study||101
10674542|NCT02349412|11836289|FG000|Completed Week-24 QOL Assessment Measure|Overall Study||68
10674543|NCT02349412|11836290|FG001|Completed Week-24 QOL Assessment Measure|Overall Study||80
10674544|NCT02349412|11836289|FG000|COMPLETED|Overall Study||195
10674545|NCT02349412|11836290|FG001|COMPLETED|Overall Study||196
10674546|NCT02349412|11836289|FG000|NOT COMPLETED|Overall Study||7
10674547|NCT02349412|11836290|FG001|NOT COMPLETED|Overall Study||7
10674548|NCT02349425|11836300|FG000|STARTED|Period 1||15
10674549|NCT02349425|11836301|FG001|STARTED|Period 1||14
10674550|NCT02349425|11836302|FG002|STARTED|Period 1||15
10674551|NCT02349425|11836303|FG003|STARTED|Period 1||15
10674552|NCT02349425|11836300|FG000|COMPLETED|Period 1||14
10674553|NCT02349425|11836301|FG001|COMPLETED|Period 1||13
10674554|NCT02349425|11836302|FG002|COMPLETED|Period 1||15
10674555|NCT02349425|11836303|FG003|COMPLETED|Period 1||15
10674556|NCT02349425|11836300|FG000|NOT COMPLETED|Period 1||1
10674557|NCT02349425|11836301|FG001|NOT COMPLETED|Period 1||1
10674558|NCT02349425|11836302|FG002|NOT COMPLETED|Period 1||0
10674559|NCT02349425|11836303|FG003|NOT COMPLETED|Period 1||0
10674560|NCT02349425|11836300|FG000|STARTED|Period 2||14
10674561|NCT02349425|11836301|FG001|STARTED|Period 2||13
10674562|NCT02349425|11836302|FG002|STARTED|Period 2||15
10674563|NCT02349425|11836303|FG003|STARTED|Period 2||15
10674564|NCT02349425|11836300|FG000|COMPLETED|Period 2||14
10674565|NCT02349425|11836301|FG001|COMPLETED|Period 2||12
10674566|NCT02349425|11836302|FG002|COMPLETED|Period 2||14
10674567|NCT02349425|11836303|FG003|COMPLETED|Period 2||15
10674568|NCT02349425|11836300|FG000|NOT COMPLETED|Period 2||0
10674569|NCT02349425|11836301|FG001|NOT COMPLETED|Period 2||1
10674570|NCT02349425|11836302|FG002|NOT COMPLETED|Period 2||1
10674571|NCT02349425|11836303|FG003|NOT COMPLETED|Period 2||0
10674572|NCT02349438|11836341|FG000|STARTED|Period 1||11
10674573|NCT02349438|11836342|FG001|STARTED|Period 1||10
10674574|NCT02349438|11836341|FG000|COMPLETED|Period 1||11
10674575|NCT02349438|11836342|FG001|COMPLETED|Period 1||10
10674576|NCT02349438|11836341|FG000|NOT COMPLETED|Period 1||0
10674577|NCT02349438|11836342|FG001|NOT COMPLETED|Period 1||0
10674578|NCT02349438|11836341|FG000|STARTED|Period 2||11
10674579|NCT02349438|11836342|FG001|STARTED|Period 2||10
10674580|NCT02349438|11836341|FG000|COMPLETED|Period 2||11
10674581|NCT02349438|11836342|FG001|COMPLETED|Period 2||10
10674582|NCT02349438|11836341|FG000|NOT COMPLETED|Period 2||0
10674583|NCT02349438|11836342|FG001|NOT COMPLETED|Period 2||0
10674584|NCT02349451|11836352|FG000|STARTED|Overall Study||24
10674585|NCT02349451|11836353|FG001|STARTED|Overall Study||72
10674586|NCT02349451|11836354|FG002|STARTED|Overall Study||71
10674587|NCT02349451|11836355|FG003|STARTED|Overall Study||73
10674588|NCT02349451|11836352|FG000|COMPLETED|Overall Study||24
10674589|NCT02349451|11836353|FG001|COMPLETED|Overall Study||71
10674590|NCT02349451|11836354|FG002|COMPLETED|Overall Study||69
10674591|NCT02349451|11836355|FG003|COMPLETED|Overall Study||72
10674592|NCT02349451|11836352|FG000|NOT COMPLETED|Overall Study||0
10674593|NCT02349451|11836353|FG001|NOT COMPLETED|Overall Study||1
10674594|NCT02349451|11836354|FG002|NOT COMPLETED|Overall Study||2
10674595|NCT02349451|11836355|FG003|NOT COMPLETED|Overall Study||1
10674596|NCT02349477|11836370|FG000|STARTED|Overall Study||44
10674597|NCT02349477|11836371|FG001|STARTED|Overall Study||46
10674598|NCT02349477|11836370|FG000|COMPLETED|Overall Study||31
10674599|NCT02349477|11836371|FG001|COMPLETED|Overall Study||28
10674600|NCT02349477|11836370|FG000|NOT COMPLETED|Overall Study||13
10674601|NCT02349477|11836371|FG001|NOT COMPLETED|Overall Study||18
10674603|NCT02349542|11836381|FG000|COMPLETED|Overall Study||15
10674604|NCT02349542|11836381|FG000|NOT COMPLETED|Overall Study||5
10674605|NCT02349633|11836399|FG000|STARTED|Overall Study||4
10674606|NCT02349633|11836400|FG001|STARTED|Overall Study||3
10674607|NCT02349633|11836401|FG002|STARTED|Overall Study||4
10674608|NCT02349633|11836402|FG003|STARTED|Overall Study||4
10674609|NCT02349633|11836403|FG004|STARTED|Overall Study||3
10674610|NCT02349633|11836404|FG005|STARTED|Overall Study||4
10674611|NCT02349633|11836405|FG006|STARTED|Overall Study||4
10674612|NCT02349633|11836406|FG007|STARTED|Overall Study||29
10674613|NCT02349633|11836407|FG008|STARTED|Overall Study||5
10674614|NCT02349633|11836408|FG009|STARTED|Overall Study||5
10674615|NCT02349633|11836409|FG010|STARTED|Overall Study|No participants were enrolled in this cohort/arm prior to study termination.|0
10674616|NCT02349633|11836410|FG011|STARTED|Overall Study|No participants were enrolled in this cohort/arm prior to study termination.|0
10674617|NCT02349633|11836411|FG012|STARTED|Overall Study|No participants were enrolled in this cohort/arm prior to study termination.|0
10674618|NCT02349633|11836412|FG013|STARTED|Overall Study|No participants were enrolled in this cohort/arm prior to study termination.|0
10674619|NCT02349633|11836399|FG000|COMPLETED|Overall Study||4
10674620|NCT02349633|11836400|FG001|COMPLETED|Overall Study||2
10674621|NCT02349633|11836401|FG002|COMPLETED|Overall Study||4
10674622|NCT02349633|11836402|FG003|COMPLETED|Overall Study||2
10674623|NCT02349633|11836403|FG004|COMPLETED|Overall Study||1
10674624|NCT02349633|11836404|FG005|COMPLETED|Overall Study||3
10674625|NCT02349633|11836405|FG006|COMPLETED|Overall Study||3
10674626|NCT02349633|11836406|FG007|COMPLETED|Overall Study||13
10674627|NCT02349633|11836407|FG008|COMPLETED|Overall Study||3
10674628|NCT02349633|11836408|FG009|COMPLETED|Overall Study||0
10674629|NCT02349633|11836409|FG010|COMPLETED|Overall Study||0
10674630|NCT02349633|11836410|FG011|COMPLETED|Overall Study||0
10674631|NCT02349633|11836411|FG012|COMPLETED|Overall Study||0
10674632|NCT02349633|11836412|FG013|COMPLETED|Overall Study||0
10674633|NCT02349633|11836399|FG000|NOT COMPLETED|Overall Study||0
10674634|NCT02349633|11836400|FG001|NOT COMPLETED|Overall Study||1
10674635|NCT02349633|11836401|FG002|NOT COMPLETED|Overall Study||0
10674636|NCT02349633|11836402|FG003|NOT COMPLETED|Overall Study||2
10674637|NCT02349633|11836403|FG004|NOT COMPLETED|Overall Study||2
10674638|NCT02349633|11836404|FG005|NOT COMPLETED|Overall Study||1
10674639|NCT02349633|11836405|FG006|NOT COMPLETED|Overall Study||1
10674640|NCT02349633|11836406|FG007|NOT COMPLETED|Overall Study||16
10674641|NCT02349633|11836407|FG008|NOT COMPLETED|Overall Study||2
10674642|NCT02349633|11836408|FG009|NOT COMPLETED|Overall Study||5
10674643|NCT02349633|11836409|FG010|NOT COMPLETED|Overall Study||0
10674644|NCT02349633|11836410|FG011|NOT COMPLETED|Overall Study||0
10674645|NCT02349633|11836411|FG012|NOT COMPLETED|Overall Study||0
10674646|NCT02349633|11836412|FG013|NOT COMPLETED|Overall Study||0
10674647|NCT02349646|11836473|FG000|STARTED|Overall Study||33
10674648|NCT02349646|11836473|FG000|Received Trial System|Overall Study||24
10674649|NCT02349646|11836473|FG000|Receive Permanent System|Overall Study||27
10674650|NCT02349646|11836473|FG000|COMPLETED|Overall Study||16
10674651|NCT02349646|11836473|FG000|NOT COMPLETED|Overall Study||17
10674652|NCT02349685|11836480|FG000|STARTED|Overall Study||89
10674653|NCT02349685|11836481|FG001|STARTED|Overall Study||89
10674654|NCT02349685|11836482|FG002|STARTED|Overall Study||41
10674655|NCT02349685|11836480|FG000|COMPLETED|Overall Study||84
10674656|NCT02349685|11836481|FG001|COMPLETED|Overall Study||87
10674657|NCT02349685|11836482|FG002|COMPLETED|Overall Study||37
10674658|NCT02349685|11836480|FG000|NOT COMPLETED|Overall Study||5
10674659|NCT02349685|11836481|FG001|NOT COMPLETED|Overall Study||2
10674660|NCT02349685|11836482|FG002|NOT COMPLETED|Overall Study||4
10674661|NCT02349711|11836492|FG000|STARTED|Overall Study||87
10674662|NCT02349711|11836493|FG001|STARTED|Overall Study||86
10674663|NCT02349711|11836492|FG000|COMPLETED|Overall Study||84
10674664|NCT02349711|11836493|FG001|COMPLETED|Overall Study||84
10674665|NCT02349711|11836492|FG000|NOT COMPLETED|Overall Study||3
10674666|NCT02349711|11836493|FG001|NOT COMPLETED|Overall Study||2
10674667|NCT02349789|11836499|FG000|STARTED|Overall Study||11
10674668|NCT02349789|11836499|FG000|COMPLETED|Overall Study||9
10674669|NCT02349789|11836499|FG000|NOT COMPLETED|Overall Study||2
10674670|NCT02350127|11836505|FG000|STARTED|4-Month Assessment||44
10674671|NCT02350127|11836506|FG001|STARTED|4-Month Assessment||44
10674672|NCT02350127|11836505|FG000|Completed Baseline|4-Month Assessment|Withdrew prior to baseline due to time constraints (n=1) and lack of interest (n=1)|42
10674673|NCT02350127|11836506|FG001|Completed Baseline|4-Month Assessment|Withdrew prior to baseline due to health issue (n=1)|43
10674674|NCT02350127|11836505|FG000|COMPLETED|4-Month Assessment||33
10674675|NCT02350127|11836506|FG001|COMPLETED|4-Month Assessment||35
10674676|NCT02350127|11836505|FG000|NOT COMPLETED|4-Month Assessment||11
10674677|NCT02350127|11836506|FG001|NOT COMPLETED|4-Month Assessment||9
10674678|NCT02350127|11836505|FG000|STARTED|8-Month Assessment||33
10674679|NCT02350127|11836506|FG001|STARTED|8-Month Assessment||35
10674680|NCT02350127|11836505|FG000|COMPLETED|8-Month Assessment||27
10674681|NCT02350127|11836506|FG001|COMPLETED|8-Month Assessment||26
10674682|NCT02350127|11836505|FG000|NOT COMPLETED|8-Month Assessment||6
10674683|NCT02350127|11836506|FG001|NOT COMPLETED|8-Month Assessment||9
10674684|NCT02350309|11836519|FG000|STARTED|Treatment Period 1 (2 Days)||12
10674685|NCT02350309|11836520|FG001|STARTED|Treatment Period 1 (2 Days)||11
10674686|NCT02350309|11836521|FG002|STARTED|Treatment Period 1 (2 Days)||11
10674687|NCT02350309|11836522|FG003|STARTED|Treatment Period 1 (2 Days)||11
10674688|NCT02350309|11836523|FG004|STARTED|Treatment Period 1 (2 Days)||12
10674689|NCT02350309|11836524|FG005|STARTED|Treatment Period 1 (2 Days)||12
10674690|NCT02350309|11836519|FG000|COMPLETED|Treatment Period 1 (2 Days)||12
10674691|NCT02350309|11836520|FG001|COMPLETED|Treatment Period 1 (2 Days)||11
10674692|NCT02350309|11836521|FG002|COMPLETED|Treatment Period 1 (2 Days)||10
10674693|NCT02350309|11836522|FG003|COMPLETED|Treatment Period 1 (2 Days)||11
10674694|NCT02350309|11836523|FG004|COMPLETED|Treatment Period 1 (2 Days)||12
10674695|NCT02350309|11836524|FG005|COMPLETED|Treatment Period 1 (2 Days)||12
10674696|NCT02350309|11836519|FG000|NOT COMPLETED|Treatment Period 1 (2 Days)||0
10674697|NCT02350309|11836520|FG001|NOT COMPLETED|Treatment Period 1 (2 Days)||0
10674698|NCT02350309|11836521|FG002|NOT COMPLETED|Treatment Period 1 (2 Days)||1
10674699|NCT02350309|11836522|FG003|NOT COMPLETED|Treatment Period 1 (2 Days)||0
10674700|NCT02350309|11836523|FG004|NOT COMPLETED|Treatment Period 1 (2 Days)||0
10674701|NCT02350309|11836524|FG005|NOT COMPLETED|Treatment Period 1 (2 Days)||0
10674702|NCT02350309|11836519|FG000|STARTED|Washout Period 1 (12-16 Days)||12
10674703|NCT02350309|11836520|FG001|STARTED|Washout Period 1 (12-16 Days)||11
10674704|NCT02350309|11836521|FG002|STARTED|Washout Period 1 (12-16 Days)||10
10674705|NCT02350309|11836522|FG003|STARTED|Washout Period 1 (12-16 Days)||11
10674706|NCT02350309|11836523|FG004|STARTED|Washout Period 1 (12-16 Days)||12
10674707|NCT02350309|11836524|FG005|STARTED|Washout Period 1 (12-16 Days)||12
10674708|NCT02350309|11836519|FG000|COMPLETED|Washout Period 1 (12-16 Days)||12
10674709|NCT02350309|11836520|FG001|COMPLETED|Washout Period 1 (12-16 Days)||11
10674710|NCT02350309|11836521|FG002|COMPLETED|Washout Period 1 (12-16 Days)||10
10674711|NCT02350309|11836522|FG003|COMPLETED|Washout Period 1 (12-16 Days)||11
10674712|NCT02350309|11836523|FG004|COMPLETED|Washout Period 1 (12-16 Days)||12
10674713|NCT02350309|11836524|FG005|COMPLETED|Washout Period 1 (12-16 Days)||12
10674714|NCT02350309|11836519|FG000|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
10674715|NCT02350309|11836520|FG001|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
10674716|NCT02350309|11836521|FG002|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
10674717|NCT02350309|11836522|FG003|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
10674718|NCT02350309|11836523|FG004|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
10674719|NCT02350309|11836524|FG005|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
10674720|NCT02350309|11836519|FG000|STARTED|Treatment Period 2 (2 Days)||12
10674721|NCT02350309|11836520|FG001|STARTED|Treatment Period 2 (2 Days)||11
10674722|NCT02350309|11836521|FG002|STARTED|Treatment Period 2 (2 Days)||10
10674723|NCT02350309|11836522|FG003|STARTED|Treatment Period 2 (2 Days)||11
10674724|NCT02350309|11836523|FG004|STARTED|Treatment Period 2 (2 Days)||12
10674725|NCT02350309|11836524|FG005|STARTED|Treatment Period 2 (2 Days)||12
10674726|NCT02350309|11836519|FG000|COMPLETED|Treatment Period 2 (2 Days)||12
10674727|NCT02350309|11836520|FG001|COMPLETED|Treatment Period 2 (2 Days)||11
10674728|NCT02350309|11836521|FG002|COMPLETED|Treatment Period 2 (2 Days)||10
10674729|NCT02350309|11836522|FG003|COMPLETED|Treatment Period 2 (2 Days)||11
10674730|NCT02350309|11836523|FG004|COMPLETED|Treatment Period 2 (2 Days)||12
10674731|NCT02350309|11836524|FG005|COMPLETED|Treatment Period 2 (2 Days)||12
10674732|NCT02350309|11836519|FG000|NOT COMPLETED|Treatment Period 2 (2 Days)||0
10674733|NCT02350309|11836520|FG001|NOT COMPLETED|Treatment Period 2 (2 Days)||0
10674734|NCT02350309|11836521|FG002|NOT COMPLETED|Treatment Period 2 (2 Days)||0
10674735|NCT02350309|11836522|FG003|NOT COMPLETED|Treatment Period 2 (2 Days)||0
10674736|NCT02350309|11836523|FG004|NOT COMPLETED|Treatment Period 2 (2 Days)||0
10674737|NCT02350309|11836524|FG005|NOT COMPLETED|Treatment Period 2 (2 Days)||0
10674738|NCT02350309|11836519|FG000|STARTED|Washout Period 2 (12-16 Days)||12
10674739|NCT02350309|11836520|FG001|STARTED|Washout Period 2 (12-16 Days)||11
10674740|NCT02350309|11836521|FG002|STARTED|Washout Period 2 (12-16 Days)||10
10674741|NCT02350309|11836522|FG003|STARTED|Washout Period 2 (12-16 Days)||11
10674742|NCT02350309|11836523|FG004|STARTED|Washout Period 2 (12-16 Days)||12
10674743|NCT02350309|11836524|FG005|STARTED|Washout Period 2 (12-16 Days)||12
10674744|NCT02350309|11836519|FG000|COMPLETED|Washout Period 2 (12-16 Days)||12
10674745|NCT02350309|11836520|FG001|COMPLETED|Washout Period 2 (12-16 Days)||11
10674746|NCT02350309|11836521|FG002|COMPLETED|Washout Period 2 (12-16 Days)||10
10674747|NCT02350309|11836522|FG003|COMPLETED|Washout Period 2 (12-16 Days)||11
10674748|NCT02350309|11836523|FG004|COMPLETED|Washout Period 2 (12-16 Days)||12
10674749|NCT02350309|11836524|FG005|COMPLETED|Washout Period 2 (12-16 Days)||12
10674750|NCT02350309|11836519|FG000|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
10674751|NCT02350309|11836520|FG001|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
10674752|NCT02350309|11836521|FG002|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
10674753|NCT02350309|11836522|FG003|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
10674754|NCT02350309|11836523|FG004|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
10674755|NCT02350309|11836524|FG005|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
10674756|NCT02350309|11836519|FG000|STARTED|Treatment Period 3 (2 Days)||12
10674757|NCT02350309|11836520|FG001|STARTED|Treatment Period 3 (2 Days)||11
10674758|NCT02350309|11836521|FG002|STARTED|Treatment Period 3 (2 Days)||10
10674759|NCT02350309|11836522|FG003|STARTED|Treatment Period 3 (2 Days)||11
10674760|NCT02350309|11836523|FG004|STARTED|Treatment Period 3 (2 Days)||12
10674761|NCT02350309|11836524|FG005|STARTED|Treatment Period 3 (2 Days)||12
10674762|NCT02350309|11836519|FG000|COMPLETED|Treatment Period 3 (2 Days)||12
10674763|NCT02350309|11836520|FG001|COMPLETED|Treatment Period 3 (2 Days)||11
10674764|NCT02350309|11836521|FG002|COMPLETED|Treatment Period 3 (2 Days)||10
10674765|NCT02350309|11836522|FG003|COMPLETED|Treatment Period 3 (2 Days)||11
10674766|NCT02350309|11836523|FG004|COMPLETED|Treatment Period 3 (2 Days)||12
10674767|NCT02350309|11836524|FG005|COMPLETED|Treatment Period 3 (2 Days)||12
10674768|NCT02350309|11836519|FG000|NOT COMPLETED|Treatment Period 3 (2 Days)||0
10674769|NCT02350309|11836520|FG001|NOT COMPLETED|Treatment Period 3 (2 Days)||0
10674770|NCT02350309|11836521|FG002|NOT COMPLETED|Treatment Period 3 (2 Days)||0
10674771|NCT02350309|11836522|FG003|NOT COMPLETED|Treatment Period 3 (2 Days)||0
10674772|NCT02350309|11836523|FG004|NOT COMPLETED|Treatment Period 3 (2 Days)||0
10674773|NCT02350309|11836524|FG005|NOT COMPLETED|Treatment Period 3 (2 Days)||0
10674774|NCT02350309|11836519|FG000|STARTED|Washout Period 3 (12-16 Days)||12
10674775|NCT02350309|11836520|FG001|STARTED|Washout Period 3 (12-16 Days)||11
10674776|NCT02350309|11836521|FG002|STARTED|Washout Period 3 (12-16 Days)||10
10674777|NCT02350309|11836522|FG003|STARTED|Washout Period 3 (12-16 Days)||11
10674778|NCT02350309|11836523|FG004|STARTED|Washout Period 3 (12-16 Days)||12
10674779|NCT02350309|11836524|FG005|STARTED|Washout Period 3 (12-16 Days)||12
10674780|NCT02350309|11836519|FG000|COMPLETED|Washout Period 3 (12-16 Days)||12
10674781|NCT02350309|11836520|FG001|COMPLETED|Washout Period 3 (12-16 Days)||11
10674782|NCT02350309|11836521|FG002|COMPLETED|Washout Period 3 (12-16 Days)||10
10674783|NCT02350309|11836522|FG003|COMPLETED|Washout Period 3 (12-16 Days)||11
10674784|NCT02350309|11836523|FG004|COMPLETED|Washout Period 3 (12-16 Days)||12
10674785|NCT02350309|11836524|FG005|COMPLETED|Washout Period 3 (12-16 Days)||12
10674786|NCT02350309|11836519|FG000|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
10674787|NCT02350309|11836520|FG001|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
10674788|NCT02350309|11836521|FG002|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
10674789|NCT02350309|11836522|FG003|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
10674790|NCT02350309|11836523|FG004|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
10674791|NCT02350309|11836524|FG005|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
10674792|NCT02350309|11836519|FG000|STARTED|Treatment Period 4 (2 Days)||12
10674793|NCT02350309|11836520|FG001|STARTED|Treatment Period 4 (2 Days)||11
10674794|NCT02350309|11836521|FG002|STARTED|Treatment Period 4 (2 Days)||10
10674795|NCT02350309|11836522|FG003|STARTED|Treatment Period 4 (2 Days)||11
10674796|NCT02350309|11836523|FG004|STARTED|Treatment Period 4 (2 Days)||12
10674797|NCT02350309|11836524|FG005|STARTED|Treatment Period 4 (2 Days)||12
10674798|NCT02350309|11836519|FG000|COMPLETED|Treatment Period 4 (2 Days)||12
10674799|NCT02350309|11836520|FG001|COMPLETED|Treatment Period 4 (2 Days)||11
10674800|NCT02350309|11836521|FG002|COMPLETED|Treatment Period 4 (2 Days)||10
10674801|NCT02350309|11836522|FG003|COMPLETED|Treatment Period 4 (2 Days)||11
10674802|NCT02350309|11836523|FG004|COMPLETED|Treatment Period 4 (2 Days)||12
10674803|NCT02350309|11836524|FG005|COMPLETED|Treatment Period 4 (2 Days)||11
10674804|NCT02350309|11836519|FG000|NOT COMPLETED|Treatment Period 4 (2 Days)||0
10674805|NCT02350309|11836520|FG001|NOT COMPLETED|Treatment Period 4 (2 Days)||0
10674806|NCT02350309|11836521|FG002|NOT COMPLETED|Treatment Period 4 (2 Days)||0
10674807|NCT02350309|11836522|FG003|NOT COMPLETED|Treatment Period 4 (2 Days)||0
10797288|NCT03686033|11957626|FG004|COMPLETED|Washout Phase (at Least 2 Weeks)||0
10797289|NCT03686033|11957627|FG005|COMPLETED|Washout Phase (at Least 2 Weeks)||0
10797290|NCT03686033|11957622|FG000|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
10797291|NCT03686033|11957623|FG001|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
10797292|NCT03686033|11957624|FG002|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
10797293|NCT03686033|11957625|FG003|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
10797294|NCT03686033|11957626|FG004|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
10797295|NCT03686033|11957627|FG005|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
10797296|NCT03686033|11957622|FG000|STARTED|Treatment Period 3 (1 Day)||1
10797297|NCT03686033|11957623|FG001|STARTED|Treatment Period 3 (1 Day)||1
10797298|NCT03686033|11957624|FG002|STARTED|Treatment Period 3 (1 Day)||1
10797299|NCT03686033|11957625|FG003|STARTED|Treatment Period 3 (1 Day)||1
10797300|NCT03686033|11957626|FG004|STARTED|Treatment Period 3 (1 Day)||0
10797301|NCT03686033|11957627|FG005|STARTED|Treatment Period 3 (1 Day)||0
10797302|NCT03686033|11957622|FG000|COMPLETED|Treatment Period 3 (1 Day)||1
10797303|NCT03686033|11957623|FG001|COMPLETED|Treatment Period 3 (1 Day)||1
10797304|NCT03686033|11957624|FG002|COMPLETED|Treatment Period 3 (1 Day)||1
10797305|NCT03686033|11957625|FG003|COMPLETED|Treatment Period 3 (1 Day)||1
10797306|NCT03686033|11957626|FG004|COMPLETED|Treatment Period 3 (1 Day)||0
10674808|NCT02350309|11836523|FG004|NOT COMPLETED|Treatment Period 4 (2 Days)||0
10674809|NCT02350309|11836524|FG005|NOT COMPLETED|Treatment Period 4 (2 Days)||1
10797307|NCT03686033|11957627|FG005|COMPLETED|Treatment Period 3 (1 Day)||0
10797308|NCT03686033|11957622|FG000|NOT COMPLETED|Treatment Period 3 (1 Day)||0
10797309|NCT03686033|11957623|FG001|NOT COMPLETED|Treatment Period 3 (1 Day)||0
10797310|NCT03686033|11957624|FG002|NOT COMPLETED|Treatment Period 3 (1 Day)||0
10674810|NCT02350478|11836541|FG000|STARTED|Overall Study||25
10674811|NCT02350478|11836542|FG001|STARTED|Overall Study||24
10674812|NCT02350478|11836541|FG000|COMPLETED|Overall Study||20
10674813|NCT02350478|11836542|FG001|COMPLETED|Overall Study||23
10674814|NCT02350478|11836541|FG000|NOT COMPLETED|Overall Study||5
10674815|NCT02350478|11836542|FG001|NOT COMPLETED|Overall Study||1
10674816|NCT02350569|11836548|FG000|STARTED|Main Study (LDV/SOF 4 Weeks)||16
10674817|NCT02350569|11836548|FG000|COMPLETED|Main Study (LDV/SOF 4 Weeks)|1 participant discontinued treatment, but completed follow-up visits and study.|16
10674818|NCT02350569|11836548|FG000|NOT COMPLETED|Main Study (LDV/SOF 4 Weeks)||0
10674819|NCT02350569|11836548|FG000|STARTED|Retreatment (LDV/SOF 12 Weeks)|1 completed treatment (Main Study), experienced virologic failure, and entered Retreatment Phase|1
10674820|NCT02350569|11836548|FG000|COMPLETED|Retreatment (LDV/SOF 12 Weeks)||1
10674821|NCT02350569|11836548|FG000|NOT COMPLETED|Retreatment (LDV/SOF 12 Weeks)||0
10674822|NCT02350647|11836556|FG000|STARTED|Overall Study||32
10674823|NCT02350647|11836557|FG001|STARTED|Overall Study||32
10674824|NCT02350647|11836556|FG000|COMPLETED|Overall Study||26
10674825|NCT02350647|11836557|FG001|COMPLETED|Overall Study||26
10674826|NCT02350647|11836556|FG000|NOT COMPLETED|Overall Study||6
10674827|NCT02350647|11836557|FG001|NOT COMPLETED|Overall Study||6
10674828|NCT02350660|11836565|FG000|STARTED|Overall Study||7
10674829|NCT02350660|11836566|FG001|STARTED|Overall Study||17
10674830|NCT02350660|11836565|FG000|COMPLETED|Overall Study||7
10674831|NCT02350660|11836566|FG001|COMPLETED|Overall Study||17
10674832|NCT02350660|11836565|FG000|NOT COMPLETED|Overall Study||0
10674833|NCT02350660|11836566|FG001|NOT COMPLETED|Overall Study||0
10674834|NCT02350816|11836576|FG000|STARTED|Overall Study||7
10674835|NCT02350816|11836577|FG001|STARTED|Overall Study||6
10674836|NCT02350816|11836578|FG002|STARTED|Overall Study||2
10674837|NCT02350816|11836579|FG003|STARTED|Overall Study||2
10674838|NCT02350816|11836576|FG000|COMPLETED|Overall Study||7
10674839|NCT02350816|11836577|FG001|COMPLETED|Overall Study||6
10674840|NCT02350816|11836578|FG002|COMPLETED|Overall Study||2
10674841|NCT02350816|11836579|FG003|COMPLETED|Overall Study||2
10674842|NCT02350816|11836576|FG000|NOT COMPLETED|Overall Study||0
10674843|NCT02350816|11836577|FG001|NOT COMPLETED|Overall Study||0
10674844|NCT02350816|11836578|FG002|NOT COMPLETED|Overall Study||0
10674845|NCT02350816|11836579|FG003|NOT COMPLETED|Overall Study||0
10674846|NCT02350881|11836589|FG000|STARTED|Overall Study|64 patients were included (6 bilateral)|64
10674847|NCT02350881|11836589|FG000|COMPLETED|Overall Study|64 patients were completed (6 bilateral)|64
10674848|NCT02350881|11836589|FG000|NOT COMPLETED|Overall Study||0
10674849|NCT02350998|11836614|FG000|STARTED|Overall Study||33
10674850|NCT02350998|11836614|FG000|COMPLETED|Overall Study||33
10674851|NCT02350998|11836614|FG000|NOT COMPLETED|Overall Study||0
10674852|NCT02351037|11836623|FG000|STARTED|Overall Study||7
10674853|NCT02351037|11836624|FG001|STARTED|Overall Study||21
10674854|NCT02351037|11836625|FG002|STARTED|Overall Study||8
10674855|NCT02351037|11836623|FG000|COMPLETED|Overall Study||7
10674856|NCT02351037|11836624|FG001|COMPLETED|Overall Study||21
10674857|NCT02351037|11836625|FG002|COMPLETED|Overall Study||8
10674858|NCT02351037|11836623|FG000|NOT COMPLETED|Overall Study||0
10674859|NCT02351037|11836624|FG001|NOT COMPLETED|Overall Study||0
10674860|NCT02351037|11836625|FG002|NOT COMPLETED|Overall Study||0
10674861|NCT02351115|11836638|FG000|STARTED|Overall Study||1
10674862|NCT02351115|11836639|FG001|STARTED|Overall Study||1
10674863|NCT02351115|11836640|FG002|STARTED|Overall Study||1
10674864|NCT02351115|11836641|FG003|STARTED|Overall Study||1
10674865|NCT02351115|11836642|FG004|STARTED|Overall Study||1
10674866|NCT02351115|11836638|FG000|COMPLETED|Overall Study||1
10674867|NCT02351115|11836639|FG001|COMPLETED|Overall Study||1
10674868|NCT02351115|11836640|FG002|COMPLETED|Overall Study||1
10674869|NCT02351115|11836641|FG003|COMPLETED|Overall Study||1
10674870|NCT02351115|11836642|FG004|COMPLETED|Overall Study||1
10674871|NCT02351115|11836638|FG000|NOT COMPLETED|Overall Study||0
10674872|NCT02351115|11836639|FG001|NOT COMPLETED|Overall Study||0
10674873|NCT02351115|11836640|FG002|NOT COMPLETED|Overall Study||0
10674874|NCT02351115|11836641|FG003|NOT COMPLETED|Overall Study||0
10674875|NCT02351115|11836642|FG004|NOT COMPLETED|Overall Study||0
10674876|NCT02351167|11836658|FG000|STARTED|Overall Study||275
10674877|NCT02351167|11836659|FG001|STARTED|Overall Study||274
10674878|NCT02351167|11836660|FG002|STARTED|Overall Study||273
10674879|NCT02351167|11836658|FG000|COMPLETED|Overall Study||256
10674880|NCT02351167|11836659|FG001|COMPLETED|Overall Study||256
10674881|NCT02351167|11836660|FG002|COMPLETED|Overall Study||252
10674882|NCT02351167|11836658|FG000|NOT COMPLETED|Overall Study||19
10674883|NCT02351167|11836659|FG001|NOT COMPLETED|Overall Study||18
10674884|NCT02351167|11836660|FG002|NOT COMPLETED|Overall Study||21
10674885|NCT02351258|11836669|FG000|STARTED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
10674886|NCT02351258|11836670|FG001|STARTED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
10674887|NCT02351258|11836669|FG000|COMPLETED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
10674888|NCT02351258|11836670|FG001|COMPLETED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
10674889|NCT02351258|11836669|FG000|NOT COMPLETED|Intervention 1 (12 Months)||
10674890|NCT02351258|11836670|FG001|NOT COMPLETED|Intervention 1 (12 Months)||
10674891|NCT02351258|11836669|FG000|STARTED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|
10674892|NCT02351258|11836670|FG001|STARTED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|
10712533|NCT02672176|11878217|FG001|STARTED|Overall Study||158
10674893|NCT02351258|11836669|FG000|COMPLETED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|
10674894|NCT02351258|11836670|FG001|COMPLETED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|
10674895|NCT02351258|11836669|FG000|NOT COMPLETED|Washout (2-3 Months)||
10674896|NCT02351258|11836670|FG001|NOT COMPLETED|Washout (2-3 Months)||
10674897|NCT02351258|11836669|FG000|STARTED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
10674898|NCT02351258|11836670|FG001|STARTED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
10674899|NCT02351258|11836669|FG000|COMPLETED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
10674900|NCT02351258|11836670|FG001|COMPLETED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
10674901|NCT02351258|11836669|FG000|NOT COMPLETED|Intervention 2 (12 Months)||
10674902|NCT02351258|11836670|FG001|NOT COMPLETED|Intervention 2 (12 Months)||
10674903|NCT02351271|11836677|FG000|STARTED|Overall Study||68
10674904|NCT02351271|11836678|FG001|STARTED|Overall Study||62
10674905|NCT02351271|11836677|FG000|COMPLETED|Overall Study||68
10674906|NCT02351271|11836678|FG001|COMPLETED|Overall Study||62
10674907|NCT02351271|11836677|FG000|NOT COMPLETED|Overall Study||0
10674908|NCT02351271|11836678|FG001|NOT COMPLETED|Overall Study||0
10674909|NCT02351349|11836688|FG000|STARTED|Overall Study||6
10674910|NCT02351349|11836689|FG001|STARTED|Overall Study||8
10797311|NCT03686033|11957625|FG003|NOT COMPLETED|Treatment Period 3 (1 Day)||0
10797312|NCT03686033|11957626|FG004|NOT COMPLETED|Treatment Period 3 (1 Day)||0
10797313|NCT03686033|11957627|FG005|NOT COMPLETED|Treatment Period 3 (1 Day)||0
10797314|NCT03686033|11957622|FG000|STARTED|Washout Phase (at Least 2 Weeks)||1
10797315|NCT03686033|11957623|FG001|STARTED|Washout Phase (at Least 2 Weeks)||1
10797316|NCT03686033|11957624|FG002|STARTED|Washout Phase (at Least 2 Weeks)||1
10797317|NCT03686033|11957625|FG003|STARTED|Washout Phase (at Least 2 Weeks)||1
10797318|NCT03686033|11957626|FG004|STARTED|Washout Phase (at Least 2 Weeks)||0
10797319|NCT03686033|11957627|FG005|STARTED|Washout Phase (at Least 2 Weeks)||0
10797320|NCT03686033|11957622|FG000|COMPLETED|Washout Phase (at Least 2 Weeks)||1
10797321|NCT03686033|11957623|FG001|COMPLETED|Washout Phase (at Least 2 Weeks)||1
10797322|NCT03686033|11957624|FG002|COMPLETED|Washout Phase (at Least 2 Weeks)||1
10797323|NCT03686033|11957625|FG003|COMPLETED|Washout Phase (at Least 2 Weeks)||1
10797324|NCT03686033|11957626|FG004|COMPLETED|Washout Phase (at Least 2 Weeks)||0
10797325|NCT03686033|11957627|FG005|COMPLETED|Washout Phase (at Least 2 Weeks)||0
10797326|NCT03686033|11957622|FG000|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
10674911|NCT02351349|11836688|FG000|COMPLETED|Overall Study||4
10674912|NCT02351349|11836689|FG001|COMPLETED|Overall Study||5
10674913|NCT02351349|11836688|FG000|NOT COMPLETED|Overall Study||2
10674914|NCT02351349|11836689|FG001|NOT COMPLETED|Overall Study||3
10674915|NCT02351505|11836700|FG000|STARTED|Overall Study||1
10674916|NCT02351505|11836700|FG000|COMPLETED|Overall Study||1
10674917|NCT02351505|11836700|FG000|NOT COMPLETED|Overall Study||0
10674918|NCT02351700|11836707|FG000|STARTED|Overall Study||28
10674919|NCT02351700|11836708|FG001|STARTED|Overall Study||34
10674920|NCT02351700|11836707|FG000|COMPLETED|Overall Study||28
10674921|NCT02351700|11836708|FG001|COMPLETED|Overall Study||34
10674922|NCT02351700|11836707|FG000|NOT COMPLETED|Overall Study||0
10674923|NCT02351700|11836708|FG001|NOT COMPLETED|Overall Study||0
10674924|NCT02351739|11836718|FG000|STARTED|Overall Study||38
10674925|NCT02351739|11836719|FG001|STARTED|Overall Study||40
10674926|NCT02351739|11836718|FG000|Enrolled|Overall Study||38
10674927|NCT02351739|11836719|FG001|Enrolled|Overall Study||40
10674928|NCT02351739|11836718|FG000|Received Study Medication|Overall Study||35
10674929|NCT02351739|11836719|FG001|Received Study Medication|Overall Study||40
10674930|NCT02351739|11836718|FG000|Discontinued Study|Overall Study||38
10674931|NCT02351739|11836719|FG001|Discontinued Study|Overall Study||40
10674932|NCT02351739|11836718|FG000|COMPLETED|Overall Study||0
10674933|NCT02351739|11836719|FG001|COMPLETED|Overall Study||0
10674934|NCT02351739|11836718|FG000|NOT COMPLETED|Overall Study||38
10674935|NCT02351739|11836719|FG001|NOT COMPLETED|Overall Study||40
10674936|NCT02351817|11836725|FG000|STARTED|Baseline Period||5
10797327|NCT03686033|11957623|FG001|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
10674937|NCT02351817|11836726|FG001|STARTED|Baseline Period||5
10674938|NCT02351817|11836725|FG000|COMPLETED|Baseline Period||5
10674939|NCT02351817|11836726|FG001|COMPLETED|Baseline Period||5
10674940|NCT02351817|11836725|FG000|NOT COMPLETED|Baseline Period||0
10674941|NCT02351817|11836726|FG001|NOT COMPLETED|Baseline Period||0
10674942|NCT02351817|11836725|FG000|STARTED|Period 1||5
10674943|NCT02351817|11836726|FG001|STARTED|Period 1||5
10674944|NCT02351817|11836725|FG000|COMPLETED|Period 1||4
10674945|NCT02351817|11836726|FG001|COMPLETED|Period 1||2
10674946|NCT02351817|11836725|FG000|NOT COMPLETED|Period 1||1
10674947|NCT02351817|11836726|FG001|NOT COMPLETED|Period 1||3
10674948|NCT02351817|11836725|FG000|STARTED|Period 2|Subjects who did not complete Period 1 as planned were allowed to continue to Period 2|5
10674949|NCT02351817|11836726|FG001|STARTED|Period 2|Subjects who did not complete Period 1 as planned were allowed to continue to Period 2|5
10674950|NCT02351817|11836725|FG000|COMPLETED|Period 2||4
10674951|NCT02351817|11836726|FG001|COMPLETED|Period 2||3
10674952|NCT02351817|11836725|FG000|NOT COMPLETED|Period 2||1
10674953|NCT02351817|11836726|FG001|NOT COMPLETED|Period 2||2
10674954|NCT02351934|11836735|FG000|STARTED|Allocation||62
10674955|NCT02351934|11836736|FG001|STARTED|Allocation||61
10674956|NCT02351934|11836735|FG000|Received Allocation|Allocation||56
10674957|NCT02351934|11836736|FG001|Received Allocation|Allocation||61
10674958|NCT02351934|11836735|FG000|COMPLETED|Allocation||56
10674959|NCT02351934|11836736|FG001|COMPLETED|Allocation||61
10674960|NCT02351934|11836735|FG000|NOT COMPLETED|Allocation||6
10674961|NCT02351934|11836736|FG001|NOT COMPLETED|Allocation||0
10674962|NCT02351934|11836735|FG000|STARTED|Follow-Up||56
10674963|NCT02351934|11836736|FG001|STARTED|Follow-Up||61
10674964|NCT02351934|11836735|FG000|COMPLETED|Follow-Up||44
10674965|NCT02351934|11836736|FG001|COMPLETED|Follow-Up||51
10674966|NCT02351934|11836735|FG000|NOT COMPLETED|Follow-Up||12
10674967|NCT02351934|11836736|FG001|NOT COMPLETED|Follow-Up||10
10674968|NCT02351960|11836744|FG000|STARTED|Overall Study||208
10674969|NCT02351960|11836745|FG001|STARTED|Overall Study||88
10674970|NCT02351960|11836744|FG000|COMPLETED|Overall Study||197
10674971|NCT02351960|11836745|FG001|COMPLETED|Overall Study||76
10674972|NCT02351960|11836744|FG000|NOT COMPLETED|Overall Study||11
10674973|NCT02351960|11836745|FG001|NOT COMPLETED|Overall Study||12
10674974|NCT02352259|11836752|FG000|STARTED|Overall Study||23
10674975|NCT02352259|11836752|FG000|COMPLETED|Overall Study||23
10674976|NCT02352259|11836752|FG000|NOT COMPLETED|Overall Study||0
10674977|NCT02352298|11836756|FG000|STARTED|Overall Study||52
10674978|NCT02352298|11836756|FG000|COMPLETED|Overall Study||52
10674979|NCT02352298|11836756|FG000|NOT COMPLETED|Overall Study||0
10674980|NCT02352363|11836763|FG000|STARTED|Overall Study||278
10674981|NCT02352363|11836764|FG001|STARTED|Overall Study||130
10674982|NCT02352363|11836763|FG000|COMPLETED|Overall Study||271
10674983|NCT02352363|11836764|FG001|COMPLETED|Overall Study||127
10674984|NCT02352363|11836763|FG000|NOT COMPLETED|Overall Study||7
10674985|NCT02352363|11836764|FG001|NOT COMPLETED|Overall Study||3
10674986|NCT02352493|11836788|FG000|STARTED|Overall Study||8
10674987|NCT02352493|11836789|FG001|STARTED|Overall Study||3
10674988|NCT02352493|11836790|FG002|STARTED|Overall Study||3
10674989|NCT02352493|11836791|FG003|STARTED|Overall Study||3
10674990|NCT02352493|11836792|FG004|STARTED|Overall Study||3
10674991|NCT02352493|11836793|FG005|STARTED|Overall Study||3
10674992|NCT02352493|11836794|FG006|STARTED|Overall Study||3
10674993|NCT02352493|11836795|FG007|STARTED|Overall Study||3
10674994|NCT02352493|11836796|FG008|STARTED|Overall Study||3
10674995|NCT02352493|11836797|FG009|STARTED|Overall Study||6
10674996|NCT02352493|11836798|FG010|STARTED|Overall Study||3
10674997|NCT02352493|11836799|FG011|STARTED|Overall Study||3
10674998|NCT02352493|11836800|FG012|STARTED|Overall Study||3
10674999|NCT02352493|11836801|FG013|STARTED|Overall Study||3
10675000|NCT02352493|11836802|FG014|STARTED|Overall Study||3
10675001|NCT02352493|11836803|FG015|STARTED|Overall Study||3
10675002|NCT02352493|11836804|FG016|STARTED|Overall Study||3
10675003|NCT02352493|11836805|FG017|STARTED|Overall Study||3
10675004|NCT02352493|11836788|FG000|COMPLETED|Overall Study||8
10675005|NCT02352493|11836789|FG001|COMPLETED|Overall Study||3
10675006|NCT02352493|11836790|FG002|COMPLETED|Overall Study||3
10675007|NCT02352493|11836791|FG003|COMPLETED|Overall Study||3
10675008|NCT02352493|11836792|FG004|COMPLETED|Overall Study||3
10675009|NCT02352493|11836793|FG005|COMPLETED|Overall Study||3
10675010|NCT02352493|11836794|FG006|COMPLETED|Overall Study||2
10675011|NCT02352493|11836795|FG007|COMPLETED|Overall Study||3
10675012|NCT02352493|11836796|FG008|COMPLETED|Overall Study||1
10675013|NCT02352493|11836797|FG009|COMPLETED|Overall Study||5
10675014|NCT02352493|11836798|FG010|COMPLETED|Overall Study||3
10675015|NCT02352493|11836799|FG011|COMPLETED|Overall Study||3
10675016|NCT02352493|11836800|FG012|COMPLETED|Overall Study||2
10675017|NCT02352493|11836801|FG013|COMPLETED|Overall Study||1
10675018|NCT02352493|11836802|FG014|COMPLETED|Overall Study||2
10675019|NCT02352493|11836803|FG015|COMPLETED|Overall Study||3
10675020|NCT02352493|11836804|FG016|COMPLETED|Overall Study||3
10675021|NCT02352493|11836805|FG017|COMPLETED|Overall Study||3
10675022|NCT02352493|11836788|FG000|NOT COMPLETED|Overall Study||0
10675023|NCT02352493|11836789|FG001|NOT COMPLETED|Overall Study||0
10675024|NCT02352493|11836790|FG002|NOT COMPLETED|Overall Study||0
10675025|NCT02352493|11836791|FG003|NOT COMPLETED|Overall Study||0
10675026|NCT02352493|11836792|FG004|NOT COMPLETED|Overall Study||0
10675027|NCT02352493|11836793|FG005|NOT COMPLETED|Overall Study||0
10675028|NCT02352493|11836794|FG006|NOT COMPLETED|Overall Study||1
10675029|NCT02352493|11836795|FG007|NOT COMPLETED|Overall Study||0
10675030|NCT02352493|11836796|FG008|NOT COMPLETED|Overall Study||2
10675031|NCT02352493|11836797|FG009|NOT COMPLETED|Overall Study||1
10675032|NCT02352493|11836798|FG010|NOT COMPLETED|Overall Study||0
10675033|NCT02352493|11836799|FG011|NOT COMPLETED|Overall Study||0
10675034|NCT02352493|11836800|FG012|NOT COMPLETED|Overall Study||1
10675035|NCT02352493|11836801|FG013|NOT COMPLETED|Overall Study||2
10675036|NCT02352493|11836802|FG014|NOT COMPLETED|Overall Study||1
10675037|NCT02352493|11836803|FG015|NOT COMPLETED|Overall Study||0
10675038|NCT02352493|11836804|FG016|NOT COMPLETED|Overall Study||0
10675039|NCT02352493|11836805|FG017|NOT COMPLETED|Overall Study||0
10675040|NCT02352779|11836863|FG000|STARTED|Overall Study||37
10675041|NCT02352779|11836864|FG001|STARTED|Overall Study||36
10675042|NCT02352779|11836865|FG002|STARTED|Overall Study||35
10675043|NCT02352779|11836863|FG000|COMPLETED|Overall Study||29
10675044|NCT02352779|11836864|FG001|COMPLETED|Overall Study||35
10675045|NCT02352779|11836865|FG002|COMPLETED|Overall Study||33
10675046|NCT02352779|11836863|FG000|NOT COMPLETED|Overall Study||8
10675047|NCT02352779|11836864|FG001|NOT COMPLETED|Overall Study||1
10675048|NCT02352779|11836865|FG002|NOT COMPLETED|Overall Study||2
10675049|NCT02352831|11836875|FG000|STARTED|Overall Study||6
10675050|NCT02352831|11836876|FG001|STARTED|Overall Study||10
10675051|NCT02352831|11836875|FG000|COMPLETED|Overall Study||6
10675052|NCT02352831|11836876|FG001|COMPLETED|Overall Study||10
10675053|NCT02352831|11836875|FG000|NOT COMPLETED|Overall Study||0
10675054|NCT02352831|11836876|FG001|NOT COMPLETED|Overall Study||0
10675055|NCT02352844|11836884|FG000|STARTED|Overall Study||12
10675056|NCT02352844|11836884|FG000|COMPLETED|Overall Study||12
10675057|NCT02352844|11836884|FG000|NOT COMPLETED|Overall Study||0
10675058|NCT02352922|11836890|FG000|STARTED|Overall Study||32
10675059|NCT02352922|11836891|FG001|STARTED|Overall Study||32
10675060|NCT02352922|11836890|FG000|COMPLETED|Overall Study|completed POD14 Survey|28
10675061|NCT02352922|11836891|FG001|COMPLETED|Overall Study|Completed POD14 survey|28
10675062|NCT02352922|11836890|FG000|NOT COMPLETED|Overall Study||4
10675063|NCT02352922|11836891|FG001|NOT COMPLETED|Overall Study||4
10675064|NCT02352974|11836897|FG000|STARTED|Main Study||12
10675065|NCT02352974|11836897|FG000|COMPLETED|Main Study||12
10675066|NCT02352974|11836897|FG000|NOT COMPLETED|Main Study||0
10675067|NCT02352974|11836897|FG000|STARTED|Extension|Only 3 out of the 12 patients who completed the main study continued in to the extension period.|3
10675068|NCT02352974|11836897|FG000|COMPLETED|Extension||3
10675069|NCT02352974|11836897|FG000|NOT COMPLETED|Extension||0
10675070|NCT02353091|11836903|FG000|STARTED|Overall Study||13
10675071|NCT02353091|11836904|FG001|STARTED|Overall Study||13
10675072|NCT02353091|11836903|FG000|COMPLETED|Overall Study||13
10675073|NCT02353091|11836904|FG001|COMPLETED|Overall Study||13
10675074|NCT02353091|11836903|FG000|NOT COMPLETED|Overall Study||0
10675075|NCT02353091|11836904|FG001|NOT COMPLETED|Overall Study||0
10675076|NCT02353169|11836923|FG000|STARTED|Overall Study||15
10675077|NCT02353169|11836924|FG001|STARTED|Overall Study||18
10675078|NCT02353169|11836925|FG002|STARTED|Overall Study||16
10675079|NCT02353169|11836926|FG003|STARTED|Overall Study||15
10675080|NCT02353169|11836923|FG000|COMPLETED|Overall Study||12
10675081|NCT02353169|11836924|FG001|COMPLETED|Overall Study||12
10675082|NCT02353169|11836925|FG002|COMPLETED|Overall Study||12
10675083|NCT02353169|11836926|FG003|COMPLETED|Overall Study||12
10675084|NCT02353169|11836923|FG000|NOT COMPLETED|Overall Study||3
10675085|NCT02353169|11836924|FG001|NOT COMPLETED|Overall Study||6
10675086|NCT02353169|11836925|FG002|NOT COMPLETED|Overall Study||4
10675087|NCT02353169|11836926|FG003|NOT COMPLETED|Overall Study||3
10675088|NCT02353299|11836936|FG000|STARTED|First Intervention (1 Night)||13
10675089|NCT02353299|11836937|FG001|STARTED|First Intervention (1 Night)||13
10675090|NCT02353299|11836938|FG002|STARTED|First Intervention (1 Night)||13
10675091|NCT02353299|11836939|FG003|STARTED|First Intervention (1 Night)||13
10675092|NCT02353299|11836936|FG000|COMPLETED|First Intervention (1 Night)||13
10675093|NCT02353299|11836937|FG001|COMPLETED|First Intervention (1 Night)||13
10675094|NCT02353299|11836938|FG002|COMPLETED|First Intervention (1 Night)||13
10675095|NCT02353299|11836939|FG003|COMPLETED|First Intervention (1 Night)||13
10675096|NCT02353299|11836936|FG000|NOT COMPLETED|First Intervention (1 Night)||0
10675097|NCT02353299|11836937|FG001|NOT COMPLETED|First Intervention (1 Night)||0
10675098|NCT02353299|11836938|FG002|NOT COMPLETED|First Intervention (1 Night)||0
10675099|NCT02353299|11836939|FG003|NOT COMPLETED|First Intervention (1 Night)||0
10675100|NCT02353299|11836936|FG000|STARTED|Second Intervention (1 Night)||13
10675101|NCT02353299|11836937|FG001|STARTED|Second Intervention (1 Night)||13
10675102|NCT02353299|11836938|FG002|STARTED|Second Intervention (1 Night)||13
10675103|NCT02353299|11836939|FG003|STARTED|Second Intervention (1 Night)||13
10675104|NCT02353299|11836936|FG000|COMPLETED|Second Intervention (1 Night)||13
10675105|NCT02353299|11836937|FG001|COMPLETED|Second Intervention (1 Night)||13
10675106|NCT02353299|11836938|FG002|COMPLETED|Second Intervention (1 Night)||13
10675107|NCT02353299|11836939|FG003|COMPLETED|Second Intervention (1 Night)||13
10675108|NCT02353299|11836936|FG000|NOT COMPLETED|Second Intervention (1 Night)||0
10675109|NCT02353299|11836937|FG001|NOT COMPLETED|Second Intervention (1 Night)||0
10675110|NCT02353299|11836938|FG002|NOT COMPLETED|Second Intervention (1 Night)||0
10675111|NCT02353299|11836939|FG003|NOT COMPLETED|Second Intervention (1 Night)||0
10675112|NCT02353299|11836936|FG000|STARTED|Third Intervention (1 Night)||13
10675113|NCT02353299|11836937|FG001|STARTED|Third Intervention (1 Night)||13
10675114|NCT02353299|11836938|FG002|STARTED|Third Intervention (1 Night)||13
10675115|NCT02353299|11836939|FG003|STARTED|Third Intervention (1 Night)||13
10675116|NCT02353299|11836936|FG000|COMPLETED|Third Intervention (1 Night)||13
10675117|NCT02353299|11836937|FG001|COMPLETED|Third Intervention (1 Night)||13
10675118|NCT02353299|11836938|FG002|COMPLETED|Third Intervention (1 Night)||13
10675119|NCT02353299|11836939|FG003|COMPLETED|Third Intervention (1 Night)||13
10675120|NCT02353299|11836936|FG000|NOT COMPLETED|Third Intervention (1 Night)||0
10675121|NCT02353299|11836937|FG001|NOT COMPLETED|Third Intervention (1 Night)||0
10675122|NCT02353299|11836938|FG002|NOT COMPLETED|Third Intervention (1 Night)||0
10675123|NCT02353299|11836939|FG003|NOT COMPLETED|Third Intervention (1 Night)||0
10675124|NCT02353299|11836936|FG000|STARTED|Fourth Intervention (1 Night)||13
10675125|NCT02353299|11836937|FG001|STARTED|Fourth Intervention (1 Night)|One patient withdrawn from study prior to start of fourth intervention.|12
10675126|NCT02353299|11836938|FG002|STARTED|Fourth Intervention (1 Night)||13
10675127|NCT02353299|11836939|FG003|STARTED|Fourth Intervention (1 Night)||13
10675128|NCT02353299|11836936|FG000|COMPLETED|Fourth Intervention (1 Night)||13
10675129|NCT02353299|11836937|FG001|COMPLETED|Fourth Intervention (1 Night)||12
10675130|NCT02353299|11836938|FG002|COMPLETED|Fourth Intervention (1 Night)||13
10675131|NCT02353299|11836939|FG003|COMPLETED|Fourth Intervention (1 Night)||13
10675132|NCT02353299|11836936|FG000|NOT COMPLETED|Fourth Intervention (1 Night)||0
10675133|NCT02353299|11836937|FG001|NOT COMPLETED|Fourth Intervention (1 Night)||0
10675134|NCT02353299|11836938|FG002|NOT COMPLETED|Fourth Intervention (1 Night)||0
10675135|NCT02353299|11836939|FG003|NOT COMPLETED|Fourth Intervention (1 Night)||0
10675136|NCT02353442|11836959|FG000|STARTED|Overall Study||28
10675137|NCT02353442|11836960|FG001|STARTED|Overall Study||31
10675138|NCT02353442|11836959|FG000|COMPLETED|Overall Study||25
10675139|NCT02353442|11836960|FG001|COMPLETED|Overall Study||27
10675140|NCT02353442|11836959|FG000|NOT COMPLETED|Overall Study||3
10675141|NCT02353442|11836960|FG001|NOT COMPLETED|Overall Study||4
10675142|NCT02353754|11836968|FG000|STARTED|Overall Study||12
10675143|NCT02353754|11836969|FG001|STARTED|Overall Study||0
10675144|NCT02353754|11836968|FG000|COMPLETED|Overall Study||10
10675145|NCT02353754|11836969|FG001|COMPLETED|Overall Study||0
10675146|NCT02353754|11836968|FG000|NOT COMPLETED|Overall Study||2
10675147|NCT02353754|11836969|FG001|NOT COMPLETED|Overall Study||0
10675148|NCT02353780|11836978|FG000|STARTED|Overall Study||3
10675149|NCT02353780|11836979|FG001|STARTED|Overall Study||3
10675150|NCT02353780|11836980|FG002|STARTED|Overall Study||3
10675151|NCT02353780|11836978|FG000|COMPLETED|Overall Study||3
10675152|NCT02353780|11836979|FG001|COMPLETED|Overall Study||3
10675153|NCT02353780|11836980|FG002|COMPLETED|Overall Study||3
10675154|NCT02353780|11836978|FG000|NOT COMPLETED|Overall Study||0
10675155|NCT02353780|11836979|FG001|NOT COMPLETED|Overall Study||0
10675156|NCT02353780|11836980|FG002|NOT COMPLETED|Overall Study||0
10675157|NCT02353806|11836988|FG000|STARTED|Overall Study||16
10675158|NCT02353806|11836988|FG000|COMPLETED|Overall Study||6
10675159|NCT02353806|11836988|FG000|NOT COMPLETED|Overall Study||10
10675166|NCT02354092|11837005|FG000|STARTED|Overall Study||7
10675167|NCT02354092|11837006|FG001|STARTED|Overall Study||7
10675168|NCT02354092|11837005|FG000|COMPLETED|Overall Study||7
10675169|NCT02354092|11837006|FG001|COMPLETED|Overall Study||7
10675170|NCT02354092|11837005|FG000|NOT COMPLETED|Overall Study||0
10675171|NCT02354092|11837006|FG001|NOT COMPLETED|Overall Study||0
10675172|NCT02354144|11837014|FG000|STARTED|Overall Study||127
10675173|NCT02354144|11837015|FG001|STARTED|Overall Study||128
10675174|NCT02354144|11837014|FG000|COMPLETED|Overall Study|Participants completed all 7 study visits.|48
10675175|NCT02354144|11837015|FG001|COMPLETED|Overall Study|Participants completed all 7 study visits.|51
10675176|NCT02354144|11837014|FG000|NOT COMPLETED|Overall Study||79
10675177|NCT02354144|11837015|FG001|NOT COMPLETED|Overall Study||77
10675178|NCT02354222|11837023|FG000|STARTED|Overall Study||77
10675179|NCT02354222|11837024|FG001|STARTED|Overall Study||77
10675180|NCT02354222|11837023|FG000|COMPLETED|Overall Study||73
10675181|NCT02354222|11837024|FG001|COMPLETED|Overall Study||66
10675182|NCT02354222|11837023|FG000|NOT COMPLETED|Overall Study||4
10675183|NCT02354222|11837024|FG001|NOT COMPLETED|Overall Study||11
10675184|NCT02354235|11837032|FG000|STARTED|Overall Study||70
10675185|NCT02354235|11837033|FG001|STARTED|Overall Study||68
10675186|NCT02354235|11837032|FG000|COMPLETED|Overall Study||67
10675187|NCT02354235|11837033|FG001|COMPLETED|Overall Study||61
10675188|NCT02354235|11837032|FG000|NOT COMPLETED|Overall Study||3
10675189|NCT02354235|11837033|FG001|NOT COMPLETED|Overall Study||7
10675190|NCT02354339|11837041|FG000|STARTED|Overall Study||12
10675191|NCT02354339|11837042|FG001|STARTED|Overall Study||12
10675192|NCT02354339|11837041|FG000|COMPLETED|Overall Study||12
10675193|NCT02354339|11837042|FG001|COMPLETED|Overall Study||12
10675194|NCT02354339|11837041|FG000|NOT COMPLETED|Overall Study||0
10675195|NCT02354339|11837042|FG001|NOT COMPLETED|Overall Study||0
10675196|NCT02354352|11837050|FG000|STARTED|Overall Study||26
10675197|NCT02354352|11837051|FG001|STARTED|Overall Study||26
10675198|NCT02354352|11837050|FG000|2 Weeks|Overall Study||26
10675199|NCT02354352|11837051|FG001|2 Weeks|Overall Study||25
10675200|NCT02354352|11837050|FG000|1 Month|Overall Study||24
10675201|NCT02354352|11837051|FG001|1 Month|Overall Study||23
10675202|NCT02354352|11837050|FG000|2 Months|Overall Study||24
10675203|NCT02354352|11837051|FG001|2 Months|Overall Study||22
10675204|NCT02354352|11837050|FG000|3 Months|Overall Study||25
10675205|NCT02354352|11837051|FG001|3 Months|Overall Study||23
10675206|NCT02354352|11837050|FG000|6 Months|Overall Study||25
10675207|NCT02354352|11837051|FG001|6 Months|Overall Study||23
10675208|NCT02354352|11837050|FG000|9 Months|Overall Study||25
10675209|NCT02354352|11837051|FG001|9 Months|Overall Study||23
10675210|NCT02354352|11837050|FG000|COMPLETED|Overall Study||23
10675211|NCT02354352|11837051|FG001|COMPLETED|Overall Study||23
10675212|NCT02354352|11837050|FG000|NOT COMPLETED|Overall Study||3
10675213|NCT02354352|11837051|FG001|NOT COMPLETED|Overall Study||3
10675214|NCT02354378|11837059|FG000|STARTED|Overall Study||64
10675215|NCT02354378|11837060|FG001|STARTED|Overall Study||20
10675216|NCT02354378|11837059|FG000|COMPLETED|Overall Study||30
10675217|NCT02354378|11837060|FG001|COMPLETED|Overall Study||16
10675218|NCT02354378|11837059|FG000|NOT COMPLETED|Overall Study||34
10675219|NCT02354378|11837060|FG001|NOT COMPLETED|Overall Study||4
10675220|NCT02354417|11837066|FG000|STARTED|Overall Study||3
10675221|NCT02354417|11837066|FG000|COMPLETED|Overall Study||2
10675222|NCT02354417|11837066|FG000|NOT COMPLETED|Overall Study||1
10675223|NCT02354443|11837070|FG000|STARTED|Overall Study||1
10675224|NCT02354443|11837070|FG000|COMPLETED|Overall Study||1
10675225|NCT02354443|11837070|FG000|NOT COMPLETED|Overall Study||0
10675226|NCT02354482|11837074|FG000|STARTED|Patient Communication and Care||2158
10675227|NCT02354482|11837074|FG000|COMPLETED|Patient Communication and Care||2158
10675228|NCT02354482|11837074|FG000|NOT COMPLETED|Patient Communication and Care||0
10675229|NCT02354482|11837074|FG000|STARTED|Home-Based Trust and Plain Language||1979
10675230|NCT02354482|11837074|FG000|COMPLETED|Home-Based Trust and Plain Language||1979
10675231|NCT02354482|11837074|FG000|NOT COMPLETED|Home-Based Trust and Plain Language||0
10675232|NCT02354482|11837074|FG000|STARTED|Hospital-Based Trust and Plain Language||2090
10675233|NCT02354482|11837074|FG000|COMPLETED|Hospital-Based Trust and Plain Language||2090
10675234|NCT02354482|11837074|FG000|NOT COMPLETED|Hospital-Based Trust and Plain Language||0
10675235|NCT02354482|11837074|FG000|STARTED|Patient/Family Caregiver Assessment||3093
10675236|NCT02354482|11837074|FG000|COMPLETED|Patient/Family Caregiver Assessment||3093
10675237|NCT02354482|11837074|FG000|NOT COMPLETED|Patient/Family Caregiver Assessment||0
10675238|NCT02354482|11837074|FG000|STARTED|Assessment and Teach Back||508
10675239|NCT02354482|11837074|FG000|COMPLETED|Assessment and Teach Back||508
10675240|NCT02354482|11837074|FG000|NOT COMPLETED|Assessment and Teach Back||0
10675241|NCT02354482|11837074|FG000|STARTED|Reference||2042
10675242|NCT02354482|11837074|FG000|COMPLETED|Reference||2042
10675243|NCT02354482|11837074|FG000|NOT COMPLETED|Reference||0
10675244|NCT02354508|11837091|FG000|STARTED|Period 1: Core Phase||41
10675245|NCT02354508|11837092|FG001|STARTED|Period 1: Core Phase||29
10675246|NCT02354508|11837093|FG002|STARTED|Period 1: Core Phase||53
10675247|NCT02354508|11837091|FG000|COMPLETED|Period 1: Core Phase||39
10675248|NCT02354508|11837092|FG001|COMPLETED|Period 1: Core Phase||27
10675249|NCT02354508|11837093|FG002|COMPLETED|Period 1: Core Phase||47
10675250|NCT02354508|11837091|FG000|NOT COMPLETED|Period 1: Core Phase||2
10675251|NCT02354508|11837092|FG001|NOT COMPLETED|Period 1: Core Phase||2
10675252|NCT02354508|11837093|FG002|NOT COMPLETED|Period 1: Core Phase||6
10675253|NCT02354508|11837091|FG000|STARTED|Period 2: Extension Phase|not all patients who completed the Core phase went into the Extension phase|26
10675254|NCT02354508|11837092|FG001|STARTED|Period 2: Extension Phase|not all patients who completed the Core phase went into the Extension phase|23
10675255|NCT02354508|11837093|FG002|STARTED|Period 2: Extension Phase|not all patients who completed the Core phase went into the Extension phase|39
10675256|NCT02354508|11837091|FG000|COMPLETED|Period 2: Extension Phase||20
10675257|NCT02354508|11837092|FG001|COMPLETED|Period 2: Extension Phase||19
10675258|NCT02354508|11837093|FG002|COMPLETED|Period 2: Extension Phase||36
10675259|NCT02354508|11837091|FG000|NOT COMPLETED|Period 2: Extension Phase||6
10675260|NCT02354508|11837092|FG001|NOT COMPLETED|Period 2: Extension Phase||4
10675261|NCT02354508|11837093|FG002|NOT COMPLETED|Period 2: Extension Phase||3
10675262|NCT02354508|11837091|FG000|STARTED|Period 3: Post-treatment Follow up Phase||26
10675263|NCT02354508|11837092|FG001|STARTED|Period 3: Post-treatment Follow up Phase||23
10675264|NCT02354508|11837093|FG002|STARTED|Period 3: Post-treatment Follow up Phase||39
10675265|NCT02354508|11837091|FG000|Entered Post-treatment f/up Discontinued|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, discontinued|4
10675266|NCT02354508|11837092|FG001|Entered Post-treatment f/up Discontinued|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, discontinued|3
10675267|NCT02354508|11837093|FG002|Entered Post-treatment f/up Discontinued|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, discontinued|3
10675268|NCT02354508|11837091|FG000|COMPLETED|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, completed|22
10675269|NCT02354508|11837092|FG001|COMPLETED|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, completed|20
10675270|NCT02354508|11837093|FG002|COMPLETED|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, completed|36
10675271|NCT02354508|11837091|FG000|NOT COMPLETED|Period 3: Post-treatment Follow up Phase||4
10675272|NCT02354508|11837092|FG001|NOT COMPLETED|Period 3: Post-treatment Follow up Phase||3
10675273|NCT02354508|11837093|FG002|NOT COMPLETED|Period 3: Post-treatment Follow up Phase||3
10675274|NCT02354534|11837146|FG000|STARTED|Overall Study||3
10675275|NCT02354534|11837147|FG001|STARTED|Overall Study||9
10675276|NCT02354534|11837148|FG002|STARTED|Overall Study||10
10675277|NCT02354534|11837149|FG003|STARTED|Overall Study||8
10675278|NCT02354534|11837146|FG000|COMPLETED|Overall Study||3
10675279|NCT02354534|11837147|FG001|COMPLETED|Overall Study||9
10675280|NCT02354534|11837148|FG002|COMPLETED|Overall Study||9
10675281|NCT02354534|11837149|FG003|COMPLETED|Overall Study||8
10675282|NCT02354534|11837146|FG000|NOT COMPLETED|Overall Study||0
10675283|NCT02354534|11837147|FG001|NOT COMPLETED|Overall Study||0
10675284|NCT02354534|11837148|FG002|NOT COMPLETED|Overall Study||1
10675285|NCT02354534|11837149|FG003|NOT COMPLETED|Overall Study||0
10675290|NCT02354599|11837169|FG000|STARTED|Overall Study||6
10675291|NCT02354599|11837170|FG001|STARTED|Overall Study||6
10675292|NCT02354599|11837171|FG002|STARTED|Overall Study||6
10675293|NCT02354599|11837172|FG003|STARTED|Overall Study||6
10675294|NCT02354599|11837173|FG004|STARTED|Overall Study||2
10675295|NCT02354599|11837174|FG005|STARTED|Overall Study||6
10675296|NCT02354599|11837169|FG000|COMPLETED|Overall Study||5
10675297|NCT02354599|11837170|FG001|COMPLETED|Overall Study||5
10675298|NCT02354599|11837171|FG002|COMPLETED|Overall Study||6
10675299|NCT02354599|11837172|FG003|COMPLETED|Overall Study||6
10675300|NCT02354599|11837173|FG004|COMPLETED|Overall Study||2
10675301|NCT02354599|11837174|FG005|COMPLETED|Overall Study||5
10675302|NCT02354599|11837169|FG000|NOT COMPLETED|Overall Study||1
10675303|NCT02354599|11837170|FG001|NOT COMPLETED|Overall Study||1
10675304|NCT02354599|11837171|FG002|NOT COMPLETED|Overall Study||0
10675305|NCT02354599|11837172|FG003|NOT COMPLETED|Overall Study||0
10675306|NCT02354599|11837173|FG004|NOT COMPLETED|Overall Study||0
10675307|NCT02354599|11837174|FG005|NOT COMPLETED|Overall Study||1
10675308|NCT02354690|11837194|FG000|STARTED|Overall Study||13
10675309|NCT02354690|11837194|FG000|COMPLETED|Overall Study||12
10675310|NCT02354690|11837194|FG000|NOT COMPLETED|Overall Study||1
10675311|NCT02354781|11837198|FG000|STARTED|Overall Study||3
10675312|NCT02354781|11837198|FG000|COMPLETED|Overall Study||3
10675313|NCT02354781|11837198|FG000|NOT COMPLETED|Overall Study||0
10675314|NCT02354833|11837205|FG000|STARTED|Overall Study||38
10675315|NCT02354833|11837206|FG001|STARTED|Overall Study||43
10675316|NCT02354833|11837205|FG000|COMPLETED|Overall Study||38
10675317|NCT02354833|11837206|FG001|COMPLETED|Overall Study||43
10675318|NCT02354833|11837205|FG000|NOT COMPLETED|Overall Study||0
10675319|NCT02354833|11837206|FG001|NOT COMPLETED|Overall Study||0
10675320|NCT02354859|11837216|FG000|STARTED|Overall Study||60
10675321|NCT02354859|11837217|FG001|STARTED|Overall Study||59
10675322|NCT02354859|11837216|FG000|COMPLETED|Overall Study||60
10675323|NCT02354859|11837217|FG001|COMPLETED|Overall Study||57
10675324|NCT02354859|11837216|FG000|NOT COMPLETED|Overall Study||0
10675325|NCT02354859|11837217|FG001|NOT COMPLETED|Overall Study||2
10675326|NCT02354924|11837225|FG000|STARTED|Overall Study||40
10675327|NCT02354924|11837226|FG001|STARTED|Overall Study||20
10675328|NCT02354924|11837225|FG000|COMPLETED|Overall Study||40
10675329|NCT02354924|11837226|FG001|COMPLETED|Overall Study||20
10675330|NCT02354924|11837225|FG000|NOT COMPLETED|Overall Study||0
10675331|NCT02354924|11837226|FG001|NOT COMPLETED|Overall Study||0
10675332|NCT02354976|11837237|FG000|STARTED|Overall Study||25
10675333|NCT02354976|11837238|FG001|STARTED|Overall Study||27
10675334|NCT02354976|11837239|FG002|STARTED|Overall Study||26
10675335|NCT02354976|11837237|FG000|COMPLETED|Overall Study||23
10675336|NCT02354976|11837238|FG001|COMPLETED|Overall Study||26
10675337|NCT02354976|11837239|FG002|COMPLETED|Overall Study||23
10675338|NCT02354976|11837237|FG000|NOT COMPLETED|Overall Study||2
10675339|NCT02354976|11837238|FG001|NOT COMPLETED|Overall Study||1
10675340|NCT02354976|11837239|FG002|NOT COMPLETED|Overall Study||3
10675341|NCT02355028|11837249|FG000|STARTED|Overall Study||47
10675342|NCT02355028|11837250|FG001|STARTED|Overall Study||46
10675343|NCT02355028|11837249|FG000|Treated|Overall Study||46
10675344|NCT02355028|11837250|FG001|Treated|Overall Study||45
10675345|NCT02355028|11837249|FG000|COMPLETED|Overall Study||36
10675346|NCT02355028|11837250|FG001|COMPLETED|Overall Study||41
10675347|NCT02355028|11837249|FG000|NOT COMPLETED|Overall Study||11
10675348|NCT02355028|11837250|FG001|NOT COMPLETED|Overall Study||5
10675349|NCT02355067|11837263|FG000|STARTED|Overall Study||20
10675350|NCT02355067|11837264|FG001|STARTED|Overall Study||20
10675351|NCT02355067|11837263|FG000|COMPLETED|Overall Study||12
10675352|NCT02355067|11837264|FG001|COMPLETED|Overall Study||12
10675353|NCT02355067|11837263|FG000|NOT COMPLETED|Overall Study||8
10675354|NCT02355067|11837264|FG001|NOT COMPLETED|Overall Study||8
10675355|NCT02355158|11837270|FG000|STARTED|Overall Study||197
10675356|NCT02355158|11837270|FG000|COMPLETED|Overall Study||47
10675357|NCT02355158|11837270|FG000|NOT COMPLETED|Overall Study||150
10675358|NCT02355210|11837280|FG000|STARTED|Overall Study||19
10675359|NCT02355210|11837281|FG001|STARTED|Overall Study||18
10675360|NCT02355210|11837282|FG002|STARTED|Overall Study||16
10675361|NCT02355210|11837283|FG003|STARTED|Overall Study||17
10675362|NCT02355210|11837284|FG004|STARTED|Overall Study||19
10675363|NCT02355210|11837285|FG005|STARTED|Overall Study||18
10675364|NCT02355210|11837280|FG000|COMPLETED|Overall Study||19
10675365|NCT02355210|11837281|FG001|COMPLETED|Overall Study||18
10675366|NCT02355210|11837282|FG002|COMPLETED|Overall Study||16
10675367|NCT02355210|11837283|FG003|COMPLETED|Overall Study||17
10675368|NCT02355210|11837284|FG004|COMPLETED|Overall Study||19
10675369|NCT02355210|11837285|FG005|COMPLETED|Overall Study||18
10675370|NCT02355210|11837280|FG000|NOT COMPLETED|Overall Study||0
10675371|NCT02355210|11837281|FG001|NOT COMPLETED|Overall Study||0
10675372|NCT02355210|11837282|FG002|NOT COMPLETED|Overall Study||0
10675373|NCT02355210|11837283|FG003|NOT COMPLETED|Overall Study||0
10675374|NCT02355210|11837284|FG004|NOT COMPLETED|Overall Study||0
10675375|NCT02355210|11837285|FG005|NOT COMPLETED|Overall Study||0
10675376|NCT02355275|11837299|FG000|STARTED|Overall Study||22
10675377|NCT02355275|11837299|FG000|COMPLETED|Overall Study||14
10675378|NCT02355275|11837299|FG000|NOT COMPLETED|Overall Study||8
10675379|NCT02355665|11837305|FG000|STARTED|Overall Study||601
10675380|NCT02355665|11837306|FG001|STARTED|Overall Study||597
10675381|NCT02355665|11837305|FG000|COMPLETED|Overall Study||352
10675382|NCT02355665|11837306|FG001|COMPLETED|Overall Study||365
10675383|NCT02355665|11837305|FG000|NOT COMPLETED|Overall Study||249
10675384|NCT02355665|11837306|FG001|NOT COMPLETED|Overall Study||232
10675385|NCT02355691|11837314|FG000|STARTED|Overall Study||7
10675386|NCT02355691|11837315|FG001|STARTED|Overall Study||9
10675387|NCT02355691|11837314|FG000|1st Postop Visit|Overall Study||7
10675388|NCT02355691|11837315|FG001|1st Postop Visit|Overall Study||9
10675389|NCT02355691|11837314|FG000|2nd Postop Visit|Overall Study||7
10675390|NCT02355691|11837315|FG001|2nd Postop Visit|Overall Study||9
10675391|NCT02355691|11837314|FG000|COMPLETED|Overall Study||0
10675392|NCT02355691|11837315|FG001|COMPLETED|Overall Study||0
10675393|NCT02355691|11837314|FG000|NOT COMPLETED|Overall Study||7
10675394|NCT02355691|11837315|FG001|NOT COMPLETED|Overall Study||9
10675395|NCT02355743|11837321|FG000|STARTED|Overall Study||8
10675396|NCT02355743|11837321|FG000|COMPLETED|Overall Study||6
10675397|NCT02355743|11837321|FG000|NOT COMPLETED|Overall Study||2
10675398|NCT02355821|11837327|FG000|STARTED|Overall Study||57
10675399|NCT02355821|11837328|FG001|STARTED|Overall Study||57
10675400|NCT02355821|11837327|FG000|COMPLETED|Overall Study||57
10675401|NCT02355821|11837328|FG001|COMPLETED|Overall Study||57
10675402|NCT02355821|11837327|FG000|NOT COMPLETED|Overall Study||0
10675403|NCT02355821|11837328|FG001|NOT COMPLETED|Overall Study||0
10675404|NCT02355886|11837336|FG000|STARTED|Overall Study||13
10675405|NCT02355886|11837337|FG001|STARTED|Overall Study||12
10675406|NCT02355886|11837336|FG000|COMPLETED|Overall Study||13
10675407|NCT02355886|11837337|FG001|COMPLETED|Overall Study||12
10675408|NCT02355886|11837336|FG000|NOT COMPLETED|Overall Study||0
10675409|NCT02355886|11837337|FG001|NOT COMPLETED|Overall Study||0
10712534|NCT02672176|11878216|FG000|COMPLETED|Overall Study||155
10712535|NCT02672176|11878217|FG001|COMPLETED|Overall Study||132
10712536|NCT02672176|11878216|FG000|NOT COMPLETED|Overall Study||6
10712537|NCT02672176|11878217|FG001|NOT COMPLETED|Overall Study||26
10712538|NCT02672423|11878229|FG000|STARTED|Period 1||7
10712539|NCT02672423|11878230|FG001|STARTED|Period 1||7
10712540|NCT02672423|11878231|FG002|STARTED|Period 1||14
10712541|NCT02672423|11878232|FG003|STARTED|Period 1||15
10712542|NCT02672423|11878233|FG004|STARTED|Period 1||15
10712543|NCT02672423|11878234|FG005|STARTED|Period 1||15
10712544|NCT02672423|11878235|FG006|STARTED|Period 1||15
10712545|NCT02672423|11878236|FG007|STARTED|Period 1||15
10712546|NCT02672423|11878237|FG008|STARTED|Period 1||12
10712547|NCT02672423|11878238|FG009|STARTED|Period 1||12
10712548|NCT02672423|11878229|FG000|Received at Least One Dose of Study Drug|Period 1||7
10712549|NCT02672423|11878230|FG001|Received at Least One Dose of Study Drug|Period 1||7
10712550|NCT02672423|11878231|FG002|Received at Least One Dose of Study Drug|Period 1||14
10712551|NCT02672423|11878232|FG003|Received at Least One Dose of Study Drug|Period 1||15
10712552|NCT02672423|11878233|FG004|Received at Least One Dose of Study Drug|Period 1||15
10712553|NCT02672423|11878234|FG005|Received at Least One Dose of Study Drug|Period 1||15
10712554|NCT02672423|11878235|FG006|Received at Least One Dose of Study Drug|Period 1||15
10712555|NCT02672423|11878236|FG007|Received at Least One Dose of Study Drug|Period 1||15
10712556|NCT02672423|11878237|FG008|Received at Least One Dose of Study Drug|Period 1||12
10712557|NCT02672423|11878238|FG009|Received at Least One Dose of Study Drug|Period 1||12
10712558|NCT02672423|11878229|FG000|COMPLETED|Period 1||7
10712559|NCT02672423|11878230|FG001|COMPLETED|Period 1||7
10712560|NCT02672423|11878231|FG002|COMPLETED|Period 1||14
10712561|NCT02672423|11878232|FG003|COMPLETED|Period 1||15
10712562|NCT02672423|11878233|FG004|COMPLETED|Period 1||14
10712563|NCT02672423|11878234|FG005|COMPLETED|Period 1||15
10712564|NCT02672423|11878235|FG006|COMPLETED|Period 1||15
10712565|NCT02672423|11878236|FG007|COMPLETED|Period 1||15
10712566|NCT02672423|11878237|FG008|COMPLETED|Period 1||12
10712567|NCT02672423|11878238|FG009|COMPLETED|Period 1||12
10712568|NCT02672423|11878229|FG000|NOT COMPLETED|Period 1||0
10712569|NCT02672423|11878230|FG001|NOT COMPLETED|Period 1||0
10712570|NCT02672423|11878231|FG002|NOT COMPLETED|Period 1||0
10712571|NCT02672423|11878232|FG003|NOT COMPLETED|Period 1||0
10712572|NCT02672423|11878233|FG004|NOT COMPLETED|Period 1||1
10712573|NCT02672423|11878234|FG005|NOT COMPLETED|Period 1||0
10712574|NCT02672423|11878235|FG006|NOT COMPLETED|Period 1||0
10712575|NCT02672423|11878236|FG007|NOT COMPLETED|Period 1||0
10712576|NCT02672423|11878237|FG008|NOT COMPLETED|Period 1||0
10712577|NCT02672423|11878238|FG009|NOT COMPLETED|Period 1||0
10712578|NCT02672423|11878229|FG000|STARTED|Washout 1||7
10712579|NCT02672423|11878230|FG001|STARTED|Washout 1||7
10712580|NCT02672423|11878231|FG002|STARTED|Washout 1||14
10712581|NCT02672423|11878232|FG003|STARTED|Washout 1||15
10712582|NCT02672423|11878233|FG004|STARTED|Washout 1||14
10712583|NCT02672423|11878234|FG005|STARTED|Washout 1||15
10712584|NCT02672423|11878235|FG006|STARTED|Washout 1||15
10712585|NCT02672423|11878236|FG007|STARTED|Washout 1||15
10712586|NCT02672423|11878237|FG008|STARTED|Washout 1||12
10712587|NCT02672423|11878238|FG009|STARTED|Washout 1||12
10712588|NCT02672423|11878229|FG000|COMPLETED|Washout 1||7
10712589|NCT02672423|11878230|FG001|COMPLETED|Washout 1||7
10712590|NCT02672423|11878231|FG002|COMPLETED|Washout 1||14
10712591|NCT02672423|11878232|FG003|COMPLETED|Washout 1||15
10712592|NCT02672423|11878233|FG004|COMPLETED|Washout 1||14
10712593|NCT02672423|11878234|FG005|COMPLETED|Washout 1||15
10712594|NCT02672423|11878235|FG006|COMPLETED|Washout 1||15
10712595|NCT02672423|11878236|FG007|COMPLETED|Washout 1||15
10712596|NCT02672423|11878237|FG008|COMPLETED|Washout 1||12
10712597|NCT02672423|11878238|FG009|COMPLETED|Washout 1||12
10712598|NCT02672423|11878229|FG000|NOT COMPLETED|Washout 1||0
10712599|NCT02672423|11878230|FG001|NOT COMPLETED|Washout 1||0
10712600|NCT02672423|11878231|FG002|NOT COMPLETED|Washout 1||0
10712601|NCT02672423|11878232|FG003|NOT COMPLETED|Washout 1||0
10712602|NCT02672423|11878233|FG004|NOT COMPLETED|Washout 1||0
10712603|NCT02672423|11878234|FG005|NOT COMPLETED|Washout 1||0
10712604|NCT02672423|11878235|FG006|NOT COMPLETED|Washout 1||0
10712605|NCT02672423|11878236|FG007|NOT COMPLETED|Washout 1||0
10712606|NCT02672423|11878237|FG008|NOT COMPLETED|Washout 1||0
10712607|NCT02672423|11878238|FG009|NOT COMPLETED|Washout 1||0
10712608|NCT02672423|11878229|FG000|STARTED|Period 2||7
10712609|NCT02672423|11878230|FG001|STARTED|Period 2||7
10712610|NCT02672423|11878231|FG002|STARTED|Period 2||14
10675410|NCT02355977|11837346|FG000|STARTED|Overall Study||21
10675411|NCT02355977|11837347|FG001|STARTED|Overall Study||26
10675412|NCT02355977|11837348|FG002|STARTED|Overall Study||23
10675413|NCT02355977|11837346|FG000|COMPLETED|Overall Study||21
10675414|NCT02355977|11837347|FG001|COMPLETED|Overall Study||26
10675415|NCT02355977|11837348|FG002|COMPLETED|Overall Study||23
10675416|NCT02355977|11837346|FG000|NOT COMPLETED|Overall Study||0
10675417|NCT02355977|11837347|FG001|NOT COMPLETED|Overall Study||0
10675418|NCT02355977|11837348|FG002|NOT COMPLETED|Overall Study||0
10675419|NCT02356003|11837356|FG000|STARTED|Overall Study||10
10675420|NCT02356003|11837356|FG000|COMPLETED|Overall Study||10
10675421|NCT02356003|11837356|FG000|NOT COMPLETED|Overall Study||0
10675422|NCT02356107|11837361|FG000|STARTED|Overall Study||15
10675423|NCT02356107|11837361|FG000|COMPLETED|Overall Study||12
10675424|NCT02356107|11837361|FG000|NOT COMPLETED|Overall Study||3
10675425|NCT02356198|11837367|FG000|STARTED|Overall Study||104
10675426|NCT02356198|11837368|FG001|STARTED|Overall Study||105
10675427|NCT02356198|11837367|FG000|COMPLETED|Overall Study||102
10675428|NCT02356198|11837368|FG001|COMPLETED|Overall Study||98
10675429|NCT02356198|11837367|FG000|NOT COMPLETED|Overall Study||2
10675430|NCT02356198|11837368|FG001|NOT COMPLETED|Overall Study||7
10675431|NCT02356211|11837376|FG000|STARTED|Overall Study||57
10675432|NCT02356211|11837377|FG001|STARTED|Overall Study||52
10675433|NCT02356211|11837376|FG000|COMPLETED|Overall Study||54
10675434|NCT02356211|11837377|FG001|COMPLETED|Overall Study||42
10675435|NCT02356211|11837376|FG000|NOT COMPLETED|Overall Study||3
10675436|NCT02356211|11837377|FG001|NOT COMPLETED|Overall Study||10
10675437|NCT02356471|11837383|FG000|STARTED|Overall Study||34
10675438|NCT02356471|11837383|FG000|COMPLETED|Overall Study||28
10675439|NCT02356471|11837383|FG000|NOT COMPLETED|Overall Study||6
10675440|NCT02356484|11837387|FG000|STARTED|Overall Study||138
10675441|NCT02356484|11837387|FG000|COMPLETED|Overall Study||138
10675442|NCT02356484|11837387|FG000|NOT COMPLETED|Overall Study||0
10675443|NCT02356562|11837393|FG000|STARTED|Overall Study||22
10675444|NCT02356562|11837394|FG001|STARTED|Overall Study||7
10675445|NCT02356562|11837393|FG000|COMPLETED|Overall Study||20
10675446|NCT02356562|11837394|FG001|COMPLETED|Overall Study||6
10675447|NCT02356562|11837393|FG000|NOT COMPLETED|Overall Study||2
10675448|NCT02356562|11837394|FG001|NOT COMPLETED|Overall Study||1
10675449|NCT02356588|11837403|FG000|STARTED|Overall Study||107
10675450|NCT02356588|11837404|FG001|STARTED|Overall Study||54
10675451|NCT02356588|11837403|FG000|COMPLETED|Overall Study||102
10675452|NCT02356588|11837404|FG001|COMPLETED|Overall Study||41
10675453|NCT02356588|11837403|FG000|NOT COMPLETED|Overall Study||5
10675454|NCT02356588|11837404|FG001|NOT COMPLETED|Overall Study||13
10675455|NCT02356692|11837410|FG000|STARTED|Overall Study||60
10675456|NCT02356692|11837411|FG001|STARTED|Overall Study||60
10675457|NCT02356692|11837410|FG000|COMPLETED|Overall Study||60
10675458|NCT02356692|11837411|FG001|COMPLETED|Overall Study||60
10675459|NCT02356692|11837410|FG000|NOT COMPLETED|Overall Study||0
10675460|NCT02356692|11837411|FG001|NOT COMPLETED|Overall Study||0
10675461|NCT02356783|11837421|FG000|STARTED|Overall Study||16
10675462|NCT02356783|11837422|FG001|STARTED|Overall Study||17
10675463|NCT02356783|11837421|FG000|COMPLETED|Overall Study||15
10675464|NCT02356783|11837422|FG001|COMPLETED|Overall Study||14
10675465|NCT02356783|11837421|FG000|NOT COMPLETED|Overall Study||1
10675466|NCT02356783|11837422|FG001|NOT COMPLETED|Overall Study||3
10675467|NCT02356887|11837428|FG000|STARTED|Overall Study||12
10675468|NCT02356887|11837428|FG000|COMPLETED|Overall Study||10
10675469|NCT02356887|11837428|FG000|NOT COMPLETED|Overall Study||2
10675470|NCT02356900|11837440|FG000|STARTED|Overall Study||11
10675471|NCT02356900|11837441|FG001|STARTED|Overall Study||10
10675472|NCT02356900|11837440|FG000|COMPLETED|Overall Study||11
10675473|NCT02356900|11837441|FG001|COMPLETED|Overall Study||10
10675474|NCT02356900|11837440|FG000|NOT COMPLETED|Overall Study||0
10675475|NCT02356900|11837441|FG001|NOT COMPLETED|Overall Study||0
10675476|NCT02357043|11837447|FG000|STARTED|Overall Study||368
10675477|NCT02357043|11837447|FG000|COMPLETED|Overall Study||368
10675478|NCT02357043|11837447|FG000|NOT COMPLETED|Overall Study||0
10675479|NCT02357134|11837455|FG000|STARTED|Overall Study||11
10675480|NCT02357134|11837456|FG001|STARTED|Overall Study||11
10675481|NCT02357134|11837457|FG002|STARTED|Overall Study||12
10675482|NCT02357134|11837458|FG003|STARTED|Overall Study||11
10675483|NCT02357134|11837455|FG000|COMPLETED|Overall Study||10
10675484|NCT02357134|11837456|FG001|COMPLETED|Overall Study||11
10675485|NCT02357134|11837457|FG002|COMPLETED|Overall Study||12
10675486|NCT02357134|11837458|FG003|COMPLETED|Overall Study||11
10675487|NCT02357134|11837455|FG000|NOT COMPLETED|Overall Study||1
10675488|NCT02357134|11837456|FG001|NOT COMPLETED|Overall Study||0
10675489|NCT02357134|11837457|FG002|NOT COMPLETED|Overall Study||0
10675490|NCT02357134|11837458|FG003|NOT COMPLETED|Overall Study||0
10675491|NCT02357147|11837470|FG000|STARTED|Combination Treatment Phase||52
10675492|NCT02357147|11837471|FG001|STARTED|Combination Treatment Phase||56
10675493|NCT02357147|11837470|FG000|Treated|Combination Treatment Phase||52
10675494|NCT02357147|11837471|FG001|Treated|Combination Treatment Phase||54
10675495|NCT02357147|11837470|FG000|COMPLETED|Combination Treatment Phase||26
10675496|NCT02357147|11837471|FG001|COMPLETED|Combination Treatment Phase||29
10675497|NCT02357147|11837470|FG000|NOT COMPLETED|Combination Treatment Phase||26
10675498|NCT02357147|11837471|FG001|NOT COMPLETED|Combination Treatment Phase||27
10675499|NCT02357147|11837470|FG000|STARTED|Maintenance Treatment Phase||26
10675500|NCT02357147|11837471|FG001|STARTED|Maintenance Treatment Phase||29
10675501|NCT02357147|11837470|FG000|Treated|Maintenance Treatment Phase||25
10675502|NCT02357147|11837471|FG001|Treated|Maintenance Treatment Phase||29
10675503|NCT02357147|11837470|FG000|COMPLETED|Maintenance Treatment Phase||0
10675504|NCT02357147|11837471|FG001|COMPLETED|Maintenance Treatment Phase||0
10675505|NCT02357147|11837470|FG000|NOT COMPLETED|Maintenance Treatment Phase||26
10675506|NCT02357147|11837471|FG001|NOT COMPLETED|Maintenance Treatment Phase||29
10675507|NCT02357173|11837484|FG000|STARTED|Overall Study||25
10675508|NCT02357173|11837485|FG001|STARTED|Overall Study||21
10675509|NCT02357173|11837486|FG002|STARTED|Overall Study||22
10675510|NCT02357173|11837484|FG000|COMPLETED|Overall Study||19
10675511|NCT02357173|11837485|FG001|COMPLETED|Overall Study||15
10675512|NCT02357173|11837486|FG002|COMPLETED|Overall Study||16
10675513|NCT02357173|11837484|FG000|NOT COMPLETED|Overall Study||6
10675514|NCT02357173|11837485|FG001|NOT COMPLETED|Overall Study||6
10675515|NCT02357173|11837486|FG002|NOT COMPLETED|Overall Study||6
10675516|NCT02357264|11837496|FG000|STARTED|Overall Study||56
10675517|NCT02357264|11837497|FG001|STARTED|Overall Study||130
10675518|NCT02357264|11837496|FG000|COMPLETED|Overall Study||56
10675519|NCT02357264|11837497|FG001|COMPLETED|Overall Study||130
10675520|NCT02357264|11837496|FG000|NOT COMPLETED|Overall Study||0
10675521|NCT02357264|11837497|FG001|NOT COMPLETED|Overall Study||0
10675522|NCT02357290|11837503|FG000|STARTED|Overall Study||40
10675523|NCT02357290|11837503|FG000|Exposed|Overall Study||26
10675524|NCT02357290|11837503|FG000|COMPLETED|Overall Study||14
10675525|NCT02357290|11837503|FG000|NOT COMPLETED|Overall Study||26
10675526|NCT02357342|11837509|FG000|STARTED|First 6 Months||20
10675527|NCT02357342|11837510|FG001|STARTED|First 6 Months||20
10675528|NCT02357342|11837509|FG000|COMPLETED|First 6 Months|2 patients died. Neither deaths were study drug related.|18
10675529|NCT02357342|11837510|FG001|COMPLETED|First 6 Months||20
10675530|NCT02357342|11837509|FG000|NOT COMPLETED|First 6 Months||2
10675531|NCT02357342|11837510|FG001|NOT COMPLETED|First 6 Months||0
10675532|NCT02357342|11837509|FG000|STARTED|Extension Study||4
10675533|NCT02357342|11837510|FG001|STARTED|Extension Study||9
10675534|NCT02357342|11837509|FG000|COMPLETED|Extension Study||4
10675535|NCT02357342|11837510|FG001|COMPLETED|Extension Study||9
10675536|NCT02357342|11837509|FG000|NOT COMPLETED|Extension Study||0
10675537|NCT02357342|11837510|FG001|NOT COMPLETED|Extension Study||0
10675538|NCT02357368|11837520|FG000|STARTED|Overall Study||19
10675539|NCT02357368|11837521|FG001|STARTED|Overall Study||18
10675540|NCT02357368|11837522|FG002|STARTED|Overall Study||14
10675541|NCT02357368|11837523|FG003|STARTED|Overall Study||8
10675542|NCT02357368|11837520|FG000|COMPLETED|Overall Study||13
10675543|NCT02357368|11837521|FG001|COMPLETED|Overall Study||15
10675544|NCT02357368|11837522|FG002|COMPLETED|Overall Study||13
10675545|NCT02357368|11837523|FG003|COMPLETED|Overall Study||5
10675546|NCT02357368|11837520|FG000|NOT COMPLETED|Overall Study||6
10675547|NCT02357368|11837521|FG001|NOT COMPLETED|Overall Study||3
10675548|NCT02357368|11837522|FG002|NOT COMPLETED|Overall Study||1
10675549|NCT02357368|11837523|FG003|NOT COMPLETED|Overall Study||3
10675550|NCT02357394|11837535|FG000|STARTED|Overall Study||4
10675551|NCT02357394|11837536|FG001|STARTED|Overall Study||3
10675552|NCT02357394|11837535|FG000|COMPLETED|Overall Study||4
10675553|NCT02357394|11837536|FG001|COMPLETED|Overall Study||3
10675554|NCT02357394|11837535|FG000|NOT COMPLETED|Overall Study||0
10675555|NCT02357394|11837536|FG001|NOT COMPLETED|Overall Study||0
10675556|NCT02357420|11837546|FG000|STARTED|Overall Study||104
10675557|NCT02357420|11837547|FG001|STARTED|Overall Study||98
10675558|NCT02357420|11837548|FG002|STARTED|Overall Study||109
10675559|NCT02357420|11837549|FG003|STARTED|Overall Study||82
10675560|NCT02357420|11837546|FG000|Full Analysis Set (FAS)|Overall Study||104
10675561|NCT02357420|11837547|FG001|Full Analysis Set (FAS)|Overall Study||98
10675562|NCT02357420|11837548|FG002|Full Analysis Set (FAS)|Overall Study||109
10675563|NCT02357420|11837549|FG003|Full Analysis Set (FAS)|Overall Study|1 participant from safety set did not enter FAS.|81
10675564|NCT02357420|11837546|FG000|COMPLETED|Overall Study|3 participants who discontinued prematurely were included in completed as they fulfilled Visit 8.|92
10675565|NCT02357420|11837547|FG001|COMPLETED|Overall Study|1 participant who discontinued prematurely was included in completed as he/she fulfilled Visit 8.|86
10675566|NCT02357420|11837548|FG002|COMPLETED|Overall Study|1 participant who discontinued prematurely was included in completed as he/she fulfilled Visit 8.|93
10675567|NCT02357420|11837549|FG003|COMPLETED|Overall Study||63
10675568|NCT02357420|11837546|FG000|NOT COMPLETED|Overall Study||12
10675569|NCT02357420|11837547|FG001|NOT COMPLETED|Overall Study||12
10675570|NCT02357420|11837548|FG002|NOT COMPLETED|Overall Study||16
10675571|NCT02357420|11837549|FG003|NOT COMPLETED|Overall Study||19
10675572|NCT02357459|11837562|FG000|STARTED|Overall Study||161
10675573|NCT02357459|11837563|FG001|STARTED|Overall Study||163
10675574|NCT02357459|11837564|FG002|STARTED|Overall Study||162
10675575|NCT02357459|11837562|FG000|COMPLETED|Overall Study||144
10675576|NCT02357459|11837563|FG001|COMPLETED|Overall Study||149
10675577|NCT02357459|11837564|FG002|COMPLETED|Overall Study||150
10675578|NCT02357459|11837562|FG000|NOT COMPLETED|Overall Study||17
10675579|NCT02357459|11837563|FG001|NOT COMPLETED|Overall Study||14
10675580|NCT02357459|11837564|FG002|NOT COMPLETED|Overall Study||12
10675581|NCT02357485|11837575|FG000|STARTED|Overall Study|6 subjects, 8 knees ( 2 bilateral & 4 unilateral)|6
10675582|NCT02357485|11837575|FG000|COMPLETED|Overall Study||6
10675583|NCT02357485|11837575|FG000|NOT COMPLETED|Overall Study||0
10675584|NCT02357576|11837582|FG000|STARTED|Treatment Period||12
10675585|NCT02357576|11837583|FG001|STARTED|Treatment Period||9
10675586|NCT02357576|11837582|FG000|COMPLETED|Treatment Period||12
10675587|NCT02357576|11837583|FG001|COMPLETED|Treatment Period||7
10675588|NCT02357576|11837582|FG000|NOT COMPLETED|Treatment Period||0
10675589|NCT02357576|11837583|FG001|NOT COMPLETED|Treatment Period||2
10675590|NCT02357576|11837582|FG000|STARTED|Neurodevelopmental Outcome Follow Up|1 patient exited the study after treatment completion and before returning for follow up visits.|11
10675591|NCT02357576|11837583|FG001|STARTED|Neurodevelopmental Outcome Follow Up||7
10675592|NCT02357576|11837582|FG000|COMPLETED|Neurodevelopmental Outcome Follow Up||6
10675593|NCT02357576|11837583|FG001|COMPLETED|Neurodevelopmental Outcome Follow Up||2
10675594|NCT02357576|11837582|FG000|NOT COMPLETED|Neurodevelopmental Outcome Follow Up||5
10675595|NCT02357576|11837583|FG001|NOT COMPLETED|Neurodevelopmental Outcome Follow Up||5
10675596|NCT02357706|11837589|FG000|STARTED|Overall Study||10
10675597|NCT02357706|11837590|FG001|STARTED|Overall Study||10
10675598|NCT02357706|11837589|FG000|COMPLETED|Overall Study||10
10675599|NCT02357706|11837590|FG001|COMPLETED|Overall Study||10
10675600|NCT02357706|11837589|FG000|NOT COMPLETED|Overall Study||0
10675601|NCT02357706|11837590|FG001|NOT COMPLETED|Overall Study||0
10675602|NCT02357758|11837602|FG000|STARTED|Overall Study||25
10675603|NCT02357758|11837603|FG001|STARTED|Overall Study||20
10675604|NCT02357758|11837604|FG002|STARTED|Overall Study||12
10675605|NCT02357758|11837602|FG000|COMPLETED|Overall Study||9
10675606|NCT02357758|11837603|FG001|COMPLETED|Overall Study||20
10675607|NCT02357758|11837604|FG002|COMPLETED|Overall Study||5
10675608|NCT02357758|11837602|FG000|NOT COMPLETED|Overall Study||16
10675609|NCT02357758|11837603|FG001|NOT COMPLETED|Overall Study||0
10675610|NCT02357758|11837604|FG002|NOT COMPLETED|Overall Study||7
10675611|NCT02357836|11837612|FG000|STARTED|Overall Study||13
10675612|NCT02357836|11837612|FG000|COMPLETED|Overall Study||13
10675613|NCT02357836|11837612|FG000|NOT COMPLETED|Overall Study||0
10675614|NCT02357901|11837620|FG000|STARTED|Run-In Period (Days -14 to Day -1)|Received at least one dose of SUBOXONE sublingual film.|665
10675615|NCT02357901|11837621|FG001|STARTED|Run-In Period (Days -14 to Day -1)||0
10675616|NCT02357901|11837622|FG002|STARTED|Run-In Period (Days -14 to Day -1)||0
10675617|NCT02357901|11837623|FG003|STARTED|Run-In Period (Days -14 to Day -1)||0
10675618|NCT02357901|11837620|FG000|COMPLETED|Run-In Period (Days -14 to Day -1)||504
10675619|NCT02357901|11837621|FG001|COMPLETED|Run-In Period (Days -14 to Day -1)||0
10675620|NCT02357901|11837622|FG002|COMPLETED|Run-In Period (Days -14 to Day -1)||0
10675621|NCT02357901|11837623|FG003|COMPLETED|Run-In Period (Days -14 to Day -1)||0
10675622|NCT02357901|11837620|FG000|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||161
10675623|NCT02357901|11837621|FG001|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
10675624|NCT02357901|11837622|FG002|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
10675625|NCT02357901|11837623|FG003|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
10675626|NCT02357901|11837620|FG000|STARTED|Treatment Period (Day 1 to Week 24)||0
10675627|NCT02357901|11837621|FG001|STARTED|Treatment Period (Day 1 to Week 24)||203
10675628|NCT02357901|11837622|FG002|STARTED|Treatment Period (Day 1 to Week 24)||201
10675629|NCT02357901|11837623|FG003|STARTED|Treatment Period (Day 1 to Week 24)||100
10675630|NCT02357901|11837620|FG000|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||0
10675631|NCT02357901|11837621|FG001|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||203
10675632|NCT02357901|11837622|FG002|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||201
10675633|NCT02357901|11837623|FG003|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||100
10675634|NCT02357901|11837620|FG000|Full Analysis Set|Treatment Period (Day 1 to Week 24)||0
10675635|NCT02357901|11837621|FG001|Full Analysis Set|Treatment Period (Day 1 to Week 24)||194
10675636|NCT02357901|11837622|FG002|Full Analysis Set|Treatment Period (Day 1 to Week 24)||196
10675637|NCT02357901|11837623|FG003|Full Analysis Set|Treatment Period (Day 1 to Week 24)||99
10675638|NCT02357901|11837620|FG000|COMPLETED|Treatment Period (Day 1 to Week 24)||0
10675639|NCT02357901|11837621|FG001|COMPLETED|Treatment Period (Day 1 to Week 24)||125
10675640|NCT02357901|11837622|FG002|COMPLETED|Treatment Period (Day 1 to Week 24)||129
10675641|NCT02357901|11837623|FG003|COMPLETED|Treatment Period (Day 1 to Week 24)||34
10675642|NCT02357901|11837620|FG000|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||0
10675643|NCT02357901|11837621|FG001|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||78
10675644|NCT02357901|11837622|FG002|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||72
10675645|NCT02357901|11837623|FG003|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||66
10675646|NCT02357940|11837633|FG000|STARTED|Overall Study||9
10675647|NCT02357940|11837634|FG001|STARTED|Overall Study||32
10675648|NCT02357940|11837633|FG000|COMPLETED|Overall Study||9
10675649|NCT02357940|11837634|FG001|COMPLETED|Overall Study||30
10675650|NCT02357940|11837633|FG000|NOT COMPLETED|Overall Study||0
10675651|NCT02357940|11837634|FG001|NOT COMPLETED|Overall Study||2
10675652|NCT02357979|11837642|FG000|STARTED|Overall Study||60
10675653|NCT02357979|11837643|FG001|STARTED|Overall Study||60
10675654|NCT02357979|11837642|FG000|COMPLETED|Overall Study||55
10675655|NCT02357979|11837643|FG001|COMPLETED|Overall Study||55
10675656|NCT02357979|11837642|FG000|NOT COMPLETED|Overall Study||5
10675657|NCT02357979|11837643|FG001|NOT COMPLETED|Overall Study||5
10675658|NCT02358044|11837651|FG000|STARTED|Overall Study||129
10675659|NCT02358044|11837652|FG001|STARTED|Overall Study||128
10675660|NCT02358044|11837651|FG000|Treated|Overall Study||129
10675661|NCT02358044|11837652|FG001|Treated|Overall Study||126
10675662|NCT02358044|11837651|FG000|COMPLETED|Overall Study|Completed = Completed Follow-up Week 24 (end of study)|127
10675663|NCT02358044|11837652|FG001|COMPLETED|Overall Study|Completed = Completed Follow-up Week 24 (end of study)|121
10675664|NCT02358044|11837651|FG000|NOT COMPLETED|Overall Study||2
10675665|NCT02358044|11837652|FG001|NOT COMPLETED|Overall Study||7
10675666|NCT02358135|11837660|FG000|STARTED|Overall Study||150
10675667|NCT02358135|11837661|FG001|STARTED|Overall Study||150
10675668|NCT02358135|11837660|FG000|Randomized|Overall Study||148
10675669|NCT02358135|11837661|FG001|Randomized|Overall Study||148
10675670|NCT02358135|11837660|FG000|COMPLETED|Overall Study||135
10675671|NCT02358135|11837661|FG001|COMPLETED|Overall Study||131
10675672|NCT02358135|11837660|FG000|NOT COMPLETED|Overall Study||15
10675673|NCT02358135|11837661|FG001|NOT COMPLETED|Overall Study||19
10675674|NCT02358343|11837672|FG000|STARTED|Screening Intervention|90 completed engagement interview|92
10675675|NCT02358343|11837673|FG001|STARTED|Screening Intervention|89 completed control visit|92
10675676|NCT02358343|11837674|FG002|STARTED|Screening Intervention||0
10675677|NCT02358343|11837675|FG003|STARTED|Screening Intervention||0
10675678|NCT02358343|11837676|FG004|STARTED|Screening Intervention||0
10675679|NCT02358343|11837672|FG000|COMPLETED|Screening Intervention||86
10675680|NCT02358343|11837673|FG001|COMPLETED|Screening Intervention||84
10675681|NCT02358343|11837674|FG002|COMPLETED|Screening Intervention||0
10675682|NCT02358343|11837675|FG003|COMPLETED|Screening Intervention||0
10675683|NCT02358343|11837676|FG004|COMPLETED|Screening Intervention||0
10675684|NCT02358343|11837672|FG000|NOT COMPLETED|Screening Intervention||6
10675685|NCT02358343|11837673|FG001|NOT COMPLETED|Screening Intervention||8
10675686|NCT02358343|11837674|FG002|NOT COMPLETED|Screening Intervention||0
10675687|NCT02358343|11837675|FG003|NOT COMPLETED|Screening Intervention||0
10675688|NCT02358343|11837676|FG004|NOT COMPLETED|Screening Intervention||0
10675770|NCT02358876|11837734|FG000|STARTED|Overall Study||32
10675689|NCT02358343|11837672|FG000|STARTED|Comparative Efficacy Trial / Observation|Participants enrolled in screening intervention enrolled in comparative efficacy trial|0
10675690|NCT02358343|11837673|FG001|STARTED|Comparative Efficacy Trial / Observation|Participants enrolled in screening intervention enrolled in comparative efficacy trial|0
10675691|NCT02358343|11837674|FG002|STARTED|Comparative Efficacy Trial / Observation|44 completed treatment|60
10675692|NCT02358343|11837675|FG003|STARTED|Comparative Efficacy Trial / Observation|47 completed treatment|60
10675693|NCT02358343|11837676|FG004|STARTED|Comparative Efficacy Trial / Observation||20
10675694|NCT02358343|11837672|FG000|COMPLETED|Comparative Efficacy Trial / Observation||0
10675695|NCT02358343|11837673|FG001|COMPLETED|Comparative Efficacy Trial / Observation||0
10675696|NCT02358343|11837674|FG002|COMPLETED|Comparative Efficacy Trial / Observation||55
10675697|NCT02358343|11837675|FG003|COMPLETED|Comparative Efficacy Trial / Observation||58
10675698|NCT02358343|11837676|FG004|COMPLETED|Comparative Efficacy Trial / Observation||18
10675699|NCT02358343|11837672|FG000|NOT COMPLETED|Comparative Efficacy Trial / Observation||0
10675700|NCT02358343|11837673|FG001|NOT COMPLETED|Comparative Efficacy Trial / Observation||0
10675701|NCT02358343|11837674|FG002|NOT COMPLETED|Comparative Efficacy Trial / Observation||5
10675702|NCT02358343|11837675|FG003|NOT COMPLETED|Comparative Efficacy Trial / Observation||2
10675703|NCT02358343|11837676|FG004|NOT COMPLETED|Comparative Efficacy Trial / Observation||2
10675704|NCT02358369|11837690|FG000|STARTED|Pre-Randomization Washout Period||156
10675705|NCT02358369|11837691|FG001|STARTED|Pre-Randomization Washout Period||0
10675706|NCT02358369|11837692|FG002|STARTED|Pre-Randomization Washout Period||0
10675707|NCT02358369|11837693|FG003|STARTED|Pre-Randomization Washout Period||0
10675708|NCT02358369|11837694|FG004|STARTED|Pre-Randomization Washout Period||0
10675709|NCT02358369|11837690|FG000|COMPLETED|Pre-Randomization Washout Period||121
10675710|NCT02358369|11837691|FG001|COMPLETED|Pre-Randomization Washout Period||0
10675711|NCT02358369|11837692|FG002|COMPLETED|Pre-Randomization Washout Period||0
10675712|NCT02358369|11837693|FG003|COMPLETED|Pre-Randomization Washout Period||0
10675713|NCT02358369|11837694|FG004|COMPLETED|Pre-Randomization Washout Period||0
10675714|NCT02358369|11837690|FG000|NOT COMPLETED|Pre-Randomization Washout Period||35
10675715|NCT02358369|11837691|FG001|NOT COMPLETED|Pre-Randomization Washout Period||0
10675716|NCT02358369|11837692|FG002|NOT COMPLETED|Pre-Randomization Washout Period||0
10675717|NCT02358369|11837693|FG003|NOT COMPLETED|Pre-Randomization Washout Period||0
10675718|NCT02358369|11837694|FG004|NOT COMPLETED|Pre-Randomization Washout Period||0
10675719|NCT02358369|11837690|FG000|STARTED|Treatment Period A/B||0
10675720|NCT02358369|11837691|FG001|STARTED|Treatment Period A/B||40
10675721|NCT02358369|11837692|FG002|STARTED|Treatment Period A/B||40
10675722|NCT02358369|11837693|FG003|STARTED|Treatment Period A/B||41
10675723|NCT02358369|11837694|FG004|STARTED|Treatment Period A/B||0
10675724|NCT02358369|11837690|FG000|COMPLETED|Treatment Period A/B||0
10675725|NCT02358369|11837691|FG001|COMPLETED|Treatment Period A/B||38
10675726|NCT02358369|11837692|FG002|COMPLETED|Treatment Period A/B||38
10675727|NCT02358369|11837693|FG003|COMPLETED|Treatment Period A/B||37
10675728|NCT02358369|11837694|FG004|COMPLETED|Treatment Period A/B||0
10675729|NCT02358369|11837690|FG000|NOT COMPLETED|Treatment Period A/B||0
10675730|NCT02358369|11837691|FG001|NOT COMPLETED|Treatment Period A/B||2
10675731|NCT02358369|11837692|FG002|NOT COMPLETED|Treatment Period A/B||2
10675732|NCT02358369|11837693|FG003|NOT COMPLETED|Treatment Period A/B||4
10675733|NCT02358369|11837694|FG004|NOT COMPLETED|Treatment Period A/B||0
10675734|NCT02358369|11837690|FG000|STARTED|Treatment Period C||0
10675735|NCT02358369|11837691|FG001|STARTED|Treatment Period C||0
10675736|NCT02358369|11837692|FG002|STARTED|Treatment Period C||0
10675737|NCT02358369|11837693|FG003|STARTED|Treatment Period C||0
10675738|NCT02358369|11837694|FG004|STARTED|Treatment Period C||113
10675739|NCT02358369|11837690|FG000|COMPLETED|Treatment Period C||0
10675740|NCT02358369|11837691|FG001|COMPLETED|Treatment Period C||0
10675741|NCT02358369|11837692|FG002|COMPLETED|Treatment Period C||0
10675742|NCT02358369|11837693|FG003|COMPLETED|Treatment Period C||0
10675743|NCT02358369|11837694|FG004|COMPLETED|Treatment Period C||106
10675744|NCT02358369|11837690|FG000|NOT COMPLETED|Treatment Period C||0
10675745|NCT02358369|11837691|FG001|NOT COMPLETED|Treatment Period C||0
10675746|NCT02358369|11837692|FG002|NOT COMPLETED|Treatment Period C||0
10675747|NCT02358369|11837693|FG003|NOT COMPLETED|Treatment Period C||0
10675748|NCT02358369|11837694|FG004|NOT COMPLETED|Treatment Period C||7
10675749|NCT02358473|11837704|FG000|STARTED|Overall Study||13
10675750|NCT02358473|11837704|FG000|COMPLETED|Overall Study||0
10675751|NCT02358473|11837704|FG000|NOT COMPLETED|Overall Study||13
10675752|NCT02358603|11837710|FG000|STARTED|Overall Study||40
10675753|NCT02358603|11837711|FG001|STARTED|Overall Study||8
10675754|NCT02358603|11837710|FG000|COMPLETED|Overall Study||40
10675755|NCT02358603|11837711|FG001|COMPLETED|Overall Study||8
10675756|NCT02358603|11837710|FG000|NOT COMPLETED|Overall Study||0
10675757|NCT02358603|11837711|FG001|NOT COMPLETED|Overall Study||0
10675758|NCT02358668|11837720|FG000|STARTED|Overall Study||24
10675759|NCT02358668|11837721|FG001|STARTED|Overall Study||24
10675760|NCT02358668|11837722|FG002|STARTED|Overall Study||12
10675761|NCT02358668|11837720|FG000|COMPLETED|Overall Study||22
10675762|NCT02358668|11837721|FG001|COMPLETED|Overall Study||23
10675763|NCT02358668|11837722|FG002|COMPLETED|Overall Study||12
10675764|NCT02358668|11837720|FG000|NOT COMPLETED|Overall Study||2
10675765|NCT02358668|11837721|FG001|NOT COMPLETED|Overall Study||1
10675766|NCT02358668|11837722|FG002|NOT COMPLETED|Overall Study||0
10675767|NCT02358863|11837730|FG000|STARTED|Overall Study||13
10675768|NCT02358863|11837730|FG000|COMPLETED|Overall Study||10
10675769|NCT02358863|11837730|FG000|NOT COMPLETED|Overall Study||3
10675771|NCT02358876|11837734|FG000|COMPLETED|Overall Study|All 32 participants completed the in-clinic portion and 30 out of the 32 completed the home portion.|30
10675772|NCT02358876|11837734|FG000|NOT COMPLETED|Overall Study||2
10675773|NCT02358889|11837741|FG000|STARTED|Overall Study||30
10675774|NCT02358889|11837742|FG001|STARTED|Overall Study||30
10675775|NCT02358889|11837743|FG002|STARTED|Overall Study||28
10675776|NCT02358889|11837741|FG000|COMPLETED|Overall Study||30
10675777|NCT02358889|11837742|FG001|COMPLETED|Overall Study||28
10675778|NCT02358889|11837743|FG002|COMPLETED|Overall Study||27
10675779|NCT02358889|11837741|FG000|NOT COMPLETED|Overall Study||0
10675780|NCT02358889|11837742|FG001|NOT COMPLETED|Overall Study||2
10675781|NCT02358889|11837743|FG002|NOT COMPLETED|Overall Study||1
10675782|NCT02359006|11837753|FG000|STARTED|Overall Study||14
10675783|NCT02359006|11837754|FG001|STARTED|Overall Study||13
10675784|NCT02359006|11837753|FG000|COMPLETED|Overall Study||10
10675785|NCT02359006|11837754|FG001|COMPLETED|Overall Study||10
10675786|NCT02359006|11837753|FG000|NOT COMPLETED|Overall Study||4
10675787|NCT02359006|11837754|FG001|NOT COMPLETED|Overall Study||3
10675791|NCT02359045|11837768|FG000|STARTED|Overall Study||40
10675792|NCT02359045|11837769|FG001|STARTED|Overall Study||42
10675793|NCT02359045|11837768|FG000|COMPLETED|Overall Study||36
10675794|NCT02359045|11837769|FG001|COMPLETED|Overall Study||39
10675795|NCT02359045|11837768|FG000|NOT COMPLETED|Overall Study||4
10675796|NCT02359045|11837769|FG001|NOT COMPLETED|Overall Study||3
10675797|NCT02359058|11837788|FG000|STARTED|Overall Study||6
10675798|NCT02359058|11837789|FG001|STARTED|Overall Study||6
10675799|NCT02359058|11837790|FG002|STARTED|Overall Study||6
10675800|NCT02359058|11837788|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
10675801|NCT02359058|11837789|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
10675802|NCT02359058|11837790|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
10675803|NCT02359058|11837788|FG000|COMPLETED|Overall Study||6
10675804|NCT02359058|11837789|FG001|COMPLETED|Overall Study||6
10675805|NCT02359058|11837790|FG002|COMPLETED|Overall Study||6
10675806|NCT02359058|11837788|FG000|NOT COMPLETED|Overall Study||0
10675807|NCT02359058|11837789|FG001|NOT COMPLETED|Overall Study||0
10675808|NCT02359058|11837790|FG002|NOT COMPLETED|Overall Study||0
10675809|NCT02359110|11837801|FG000|STARTED|Overall Study||55
10675810|NCT02359110|11837802|FG001|STARTED|Overall Study||54
10675811|NCT02359110|11837801|FG000|COMPLETED|Overall Study||55
10675812|NCT02359110|11837802|FG001|COMPLETED|Overall Study||54
10675813|NCT02359110|11837801|FG000|NOT COMPLETED|Overall Study||0
10675814|NCT02359110|11837802|FG001|NOT COMPLETED|Overall Study||0
10675815|NCT02359305|11837810|FG000|STARTED|Overall Study||34
10675816|NCT02359305|11837811|FG001|STARTED|Overall Study||34
10675817|NCT02359305|11837810|FG000|COMPLETED|Overall Study||34
10675818|NCT02359305|11837811|FG001|COMPLETED|Overall Study||34
10675819|NCT02359305|11837810|FG000|NOT COMPLETED|Overall Study||0
10675820|NCT02359305|11837811|FG001|NOT COMPLETED|Overall Study||0
10675821|NCT02359435|11837819|FG000|STARTED|Overall Study||220
10675822|NCT02359435|11837820|FG001|STARTED|Overall Study||220
10675823|NCT02359435|11837819|FG000|COMPLETED|Overall Study||216
10675824|NCT02359435|11837820|FG001|COMPLETED|Overall Study||216
10675825|NCT02359435|11837819|FG000|NOT COMPLETED|Overall Study||4
10675826|NCT02359435|11837820|FG001|NOT COMPLETED|Overall Study||4
10675827|NCT02359552|11837828|FG000|STARTED|Overall Study||25
10675828|NCT02359552|11837829|FG001|STARTED|Overall Study||25
10675829|NCT02359552|11837828|FG000|COMPLETED|Overall Study||22
10675830|NCT02359552|11837829|FG001|COMPLETED|Overall Study||21
10675831|NCT02359552|11837828|FG000|NOT COMPLETED|Overall Study||3
10675832|NCT02359552|11837829|FG001|NOT COMPLETED|Overall Study||4
10675833|NCT02359851|11837835|FG000|STARTED|Overall Study||5
10675834|NCT02359851|11837835|FG000|COMPLETED|Overall Study||3
10675835|NCT02359851|11837835|FG000|NOT COMPLETED|Overall Study||2
10675836|NCT02359877|11837843|FG000|STARTED|Overall Study||34
10675837|NCT02359877|11837844|FG001|STARTED|Overall Study||6
10675838|NCT02359877|11837845|FG002|STARTED|Overall Study||6
10675839|NCT02359877|11837846|FG003|STARTED|Overall Study||14
10675840|NCT02359877|11837843|FG000|COMPLETED|Overall Study||33
10675841|NCT02359877|11837844|FG001|COMPLETED|Overall Study||6
10675842|NCT02359877|11837845|FG002|COMPLETED|Overall Study||6
10675843|NCT02359877|11837846|FG003|COMPLETED|Overall Study||11
10675844|NCT02359877|11837843|FG000|NOT COMPLETED|Overall Study||1
10675845|NCT02359877|11837844|FG001|NOT COMPLETED|Overall Study||0
10675846|NCT02359877|11837845|FG002|NOT COMPLETED|Overall Study||0
10675847|NCT02359877|11837846|FG003|NOT COMPLETED|Overall Study||3
10675848|NCT02359890|11837874|FG000|STARTED|Overall Study|Patients who enrolled in the study are those who signed informed consent forms.|165
10675849|NCT02359890|11837874|FG000|Safety Population|Overall Study|Enrolled subjects who had the study catheter inserted|159
10675850|NCT02359890|11837874|FG000|mITT Population|Overall Study|Enrolled subjects who met the inclusion/exclusion criteria and had the study catheter inserted|155
10675851|NCT02359890|11837874|FG000|Per-Protocol (PP) Population|Overall Study|Subjects part of mITT population who had undergone RF ablation.|155
10675852|NCT02359890|11837874|FG000|COMPLETED|Overall Study||155
10675853|NCT02359890|11837874|FG000|NOT COMPLETED|Overall Study||10
10675854|NCT02359903|11837880|FG000|STARTED|Overall Study||45
10675855|NCT02359903|11837881|FG001|STARTED|Overall Study||45
10675856|NCT02359903|11837880|FG000|COMPLETED|Overall Study||45
10675857|NCT02359903|11837881|FG001|COMPLETED|Overall Study||43
10675858|NCT02359903|11837880|FG000|NOT COMPLETED|Overall Study||0
10675859|NCT02359903|11837881|FG001|NOT COMPLETED|Overall Study||2
10797328|NCT03686033|11957624|FG002|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
10797329|NCT03686033|11957625|FG003|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
10797330|NCT03686033|11957626|FG004|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
10797331|NCT03686033|11957627|FG005|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
10797332|NCT03686033|11957622|FG000|STARTED|Treatment Period 4 (1 Day)||1
10797333|NCT03686033|11957623|FG001|STARTED|Treatment Period 4 (1 Day)||1
10797334|NCT03686033|11957624|FG002|STARTED|Treatment Period 4 (1 Day)||1
10797335|NCT03686033|11957625|FG003|STARTED|Treatment Period 4 (1 Day)||1
10797336|NCT03686033|11957626|FG004|STARTED|Treatment Period 4 (1 Day)||0
10797337|NCT03686033|11957627|FG005|STARTED|Treatment Period 4 (1 Day)||0
10797338|NCT03686033|11957622|FG000|COMPLETED|Treatment Period 4 (1 Day)||1
10797339|NCT03686033|11957623|FG001|COMPLETED|Treatment Period 4 (1 Day)||1
10797340|NCT03686033|11957624|FG002|COMPLETED|Treatment Period 4 (1 Day)||1
10797341|NCT03686033|11957625|FG003|COMPLETED|Treatment Period 4 (1 Day)||1
10797342|NCT03686033|11957626|FG004|COMPLETED|Treatment Period 4 (1 Day)||0
10797343|NCT03686033|11957627|FG005|COMPLETED|Treatment Period 4 (1 Day)||0
10797344|NCT03686033|11957622|FG000|NOT COMPLETED|Treatment Period 4 (1 Day)||0
10797345|NCT03686033|11957623|FG001|NOT COMPLETED|Treatment Period 4 (1 Day)||0
10797346|NCT03686033|11957624|FG002|NOT COMPLETED|Treatment Period 4 (1 Day)||0
10797347|NCT03686033|11957625|FG003|NOT COMPLETED|Treatment Period 4 (1 Day)||0
10797348|NCT03686033|11957626|FG004|NOT COMPLETED|Treatment Period 4 (1 Day)||0
10797349|NCT03686033|11957627|FG005|NOT COMPLETED|Treatment Period 4 (1 Day)||0
10797350|NCT03686176|11957644|FG000|STARTED|Overall Study||19
10797351|NCT03686176|11957645|FG001|STARTED|Overall Study||25
10797352|NCT03686176|11957646|FG002|STARTED|Overall Study||20
10797353|NCT03686176|11957644|FG000|COMPLETED|Overall Study||17
10797354|NCT03686176|11957645|FG001|COMPLETED|Overall Study||25
10797355|NCT03686176|11957646|FG002|COMPLETED|Overall Study||20
10675860|NCT02359916|11837894|FG000|STARTED|Overall Study|The number of unique individuals in this study is unknown|
10675861|NCT02359916|11837895|FG001|STARTED|Overall Study|The number of unique individuals in this study is unknown|
10675862|NCT02359916|11837896|FG002|STARTED|Overall Study|The number of unique individuals in this study is unknown|
10675863|NCT02359916|11837897|FG003|STARTED|Overall Study|The number of unique individuals in this study is unknown|
10675864|NCT02359916|11837898|FG004|STARTED|Overall Study|The number of unique individuals in this study is unknown|
10675865|NCT02359916|11837899|FG005|STARTED|Overall Study|The number of unique individuals in this study is unknown|
10675866|NCT02359916|11837900|FG006|STARTED|Overall Study|The number of unique individuals in this study is unknown|
10675867|NCT02359916|11837894|FG000|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
10675868|NCT02359916|11837895|FG001|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
10675869|NCT02359916|11837896|FG002|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
10675870|NCT02359916|11837897|FG003|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
10675871|NCT02359916|11837898|FG004|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
10675872|NCT02359916|11837899|FG005|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
10675873|NCT02359916|11837900|FG006|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
10675874|NCT02359916|11837894|FG000|NOT COMPLETED|Overall Study||
10675875|NCT02359916|11837895|FG001|NOT COMPLETED|Overall Study||
10675876|NCT02359916|11837896|FG002|NOT COMPLETED|Overall Study||
10675877|NCT02359916|11837897|FG003|NOT COMPLETED|Overall Study||
10675878|NCT02359916|11837898|FG004|NOT COMPLETED|Overall Study||
10675879|NCT02359916|11837899|FG005|NOT COMPLETED|Overall Study||
10675880|NCT02359916|11837900|FG006|NOT COMPLETED|Overall Study||
10675881|NCT02359955|11837917|FG000|STARTED|Overall Study||10
10675882|NCT02359955|11837918|FG001|STARTED|Overall Study||10
10675883|NCT02359955|11837917|FG000|COMPLETED|Overall Study||10
10675884|NCT02359955|11837918|FG001|COMPLETED|Overall Study||10
10675885|NCT02359955|11837917|FG000|NOT COMPLETED|Overall Study||0
10675886|NCT02359955|11837918|FG001|NOT COMPLETED|Overall Study||0
10675887|NCT02360085|11837934|FG000|STARTED|Overall Study||65
10675888|NCT02360085|11837934|FG000|COMPLETED|Overall Study||49
10675889|NCT02360085|11837934|FG000|NOT COMPLETED|Overall Study||16
10675890|NCT02360098|11837947|FG000|STARTED|Overall Study||36
10675891|NCT02360098|11837947|FG000|COMPLETED|Overall Study||29
10675892|NCT02360098|11837947|FG000|NOT COMPLETED|Overall Study||7
10675893|NCT02360124|11837955|FG000|STARTED|Overall Study||108
10675894|NCT02360124|11837956|FG001|STARTED|Overall Study||107
10675895|NCT02360124|11837957|FG002|STARTED|Overall Study||108
10675896|NCT02360124|11837955|FG000|COMPLETED|Overall Study||80
10675897|NCT02360124|11837956|FG001|COMPLETED|Overall Study||95
10675898|NCT02360124|11837957|FG002|COMPLETED|Overall Study||82
10675899|NCT02360124|11837955|FG000|NOT COMPLETED|Overall Study||28
10675900|NCT02360124|11837956|FG001|NOT COMPLETED|Overall Study||12
10675901|NCT02360124|11837957|FG002|NOT COMPLETED|Overall Study||26
10675902|NCT02360215|11837969|FG000|STARTED|Overall Study||257
10675903|NCT02360215|11837970|FG001|STARTED|Overall Study||261
10675904|NCT02360215|11837969|FG000|All Randomized Participants|Overall Study||257
10675905|NCT02360215|11837970|FG001|All Randomized Participants|Overall Study||261
10675906|NCT02360215|11837969|FG000|Started Protocol Treatment|Overall Study||232
10675907|NCT02360215|11837970|FG001|Started Protocol Treatment|Overall Study||223
10675908|NCT02360215|11837969|FG000|MDASI-BT Symptom Score|Overall Study||249
10675909|NCT02360215|11837970|FG001|MDASI-BT Symptom Score|Overall Study||251
10675910|NCT02360215|11837969|FG000|MDASI-BT Intererence Score|Overall Study||248
10675911|NCT02360215|11837970|FG001|MDASI-BT Intererence Score|Overall Study||251
10675912|NCT02360215|11837969|FG000|MDASI-BT Cognitive Factor Score|Overall Study||249
10675913|NCT02360215|11837970|FG001|MDASI-BT Cognitive Factor Score|Overall Study||251
10675914|NCT02360215|11837969|FG000|MDASI-BT Neurologic Factor Score|Overall Study||249
10675915|NCT02360215|11837970|FG001|MDASI-BT Neurologic Factor Score|Overall Study||251
10675916|NCT02360215|11837969|FG000|HVLT-R Total Recall|Overall Study||256
10675917|NCT02360215|11837970|FG001|HVLT-R Total Recall|Overall Study||259
10675918|NCT02360215|11837969|FG000|HVLT-R Delayed Recall|Overall Study||256
10675919|NCT02360215|11837970|FG001|HVLT-R Delayed Recall|Overall Study||259
10675920|NCT02360215|11837969|FG000|HVLT-R Recognition|Overall Study||255
10675921|NCT02360215|11837970|FG001|HVLT-R Recognition|Overall Study||259
10675922|NCT02360215|11837969|FG000|Trail Making Test (TMT) Part A|Overall Study||256
10675923|NCT02360215|11837970|FG001|Trail Making Test (TMT) Part A|Overall Study||260
10675924|NCT02360215|11837969|FG000|TMT Part B|Overall Study||250
10675925|NCT02360215|11837970|FG001|TMT Part B|Overall Study||257
10675926|NCT02360215|11837969|FG000|Controlled Oral Word Association (COWA)|Overall Study||257
10675927|NCT02360215|11837970|FG001|Controlled Oral Word Association (COWA)|Overall Study||261
10675928|NCT02360215|11837969|FG000|Clinical Trial Battery Composite Score|Overall Study||255
10675929|NCT02360215|11837970|FG001|Clinical Trial Battery Composite Score|Overall Study||259
10675930|NCT02360215|11837969|FG000|EQ-5D-5L Index at 2 Months|Overall Study||142
10675931|NCT02360215|11837970|FG001|EQ-5D-5L Index at 2 Months|Overall Study||125
10675932|NCT02360215|11837969|FG000|EQ-5D-5L Index at 4 Months|Overall Study||110
10675933|NCT02360215|11837970|FG001|EQ-5D-5L Index at 4 Months|Overall Study||96
10675934|NCT02360215|11837969|FG000|EQ-5D-5L Index at 6 Months|Overall Study||79
10675935|NCT02360215|11837970|FG001|EQ-5D-5L Index at 6 Months|Overall Study||70
10675936|NCT02360215|11837969|FG000|EQ-5D-5L Index at 12 Months|Overall Study||56
10675937|NCT02360215|11837970|FG001|EQ-5D-5L Index at 12 Months|Overall Study||45
10675938|NCT02360215|11837969|FG000|EQ-5D-5L VAS at 2 Months|Overall Study||139
10675939|NCT02360215|11837970|FG001|EQ-5D-5L VAS at 2 Months|Overall Study||123
10675940|NCT02360215|11837969|FG000|EQ-5D-5L VAS at 4 Months|Overall Study||104
10675941|NCT02360215|11837970|FG001|EQ-5D-5L VAS at 4 Months|Overall Study||193
10675942|NCT02360215|11837969|FG000|EQ-5D-5L VAS at 6 Months|Overall Study||76
10675943|NCT02360215|11837970|FG001|EQ-5D-5L VAS at 6 Months|Overall Study||69
10675944|NCT02360215|11837969|FG000|EQ-5D-5L VAS at 12 Months|Overall Study||57
10675945|NCT02360215|11837970|FG001|EQ-5D-5L VAS at 12 Months|Overall Study||48
10675946|NCT02360215|11837969|FG000|COMPLETED|Overall Study||257
10675947|NCT02360215|11837970|FG001|COMPLETED|Overall Study||261
10675948|NCT02360215|11837969|FG000|NOT COMPLETED|Overall Study||0
10675949|NCT02360215|11837970|FG001|NOT COMPLETED|Overall Study||0
10675950|NCT02360228|11837980|FG000|STARTED|Overall Study||9
10675951|NCT02360228|11837981|FG001|STARTED|Overall Study||8
10675952|NCT02360228|11837982|FG002|STARTED|Overall Study||8
10675953|NCT02360228|11837980|FG000|COMPLETED|Overall Study||8
10675954|NCT02360228|11837981|FG001|COMPLETED|Overall Study||7
10675955|NCT02360228|11837982|FG002|COMPLETED|Overall Study||7
10675956|NCT02360228|11837980|FG000|NOT COMPLETED|Overall Study||1
10675957|NCT02360228|11837981|FG001|NOT COMPLETED|Overall Study||1
10675958|NCT02360228|11837982|FG002|NOT COMPLETED|Overall Study||1
10675959|NCT02360293|11837992|FG000|STARTED|Overall Study||178
10675960|NCT02360293|11837993|FG001|STARTED|Overall Study||179
10675961|NCT02360293|11837992|FG000|6month f/u Survey|Overall Study||110
10675962|NCT02360293|11837993|FG001|6month f/u Survey|Overall Study||105
10675963|NCT02360293|11837992|FG000|6month Physical Activity|Overall Study||122
10675964|NCT02360293|11837993|FG001|6month Physical Activity|Overall Study||108
10675965|NCT02360293|11837992|FG000|12month f/u Survey|Overall Study||102
10675966|NCT02360293|11837993|FG001|12month f/u Survey|Overall Study||83
10675967|NCT02360293|11837992|FG000|12month Physical Activity|Overall Study||68
10675968|NCT02360293|11837993|FG001|12month Physical Activity|Overall Study||59
10675969|NCT02360293|11837992|FG000|COMPLETED|Overall Study||102
10675970|NCT02360293|11837993|FG001|COMPLETED|Overall Study||83
10675971|NCT02360293|11837992|FG000|NOT COMPLETED|Overall Study||76
10675972|NCT02360293|11837993|FG001|NOT COMPLETED|Overall Study||96
10675973|NCT02360319|11838001|FG000|STARTED|Overall Study||255
10675974|NCT02360319|11838002|FG001|STARTED|Overall Study||234
10675975|NCT02360319|11838001|FG000|COMPLETED|Overall Study||167
10675976|NCT02360319|11838002|FG001|COMPLETED|Overall Study||173
10675977|NCT02360319|11838001|FG000|NOT COMPLETED|Overall Study||88
10675978|NCT02360319|11838002|FG001|NOT COMPLETED|Overall Study||61
10675979|NCT02360371|11838010|FG000|STARTED|Overall Study||13
10675980|NCT02360371|11838011|FG001|STARTED|Overall Study||84
10675981|NCT02360371|11838010|FG000|Placebo (Oral)|Overall Study||13
10675982|NCT02360371|11838011|FG001|Placebo (Oral)|Overall Study||69
10675983|NCT02360371|11838010|FG000|Hydromorphone (Oral) 2mg|Overall Study||13
10675984|NCT02360371|11838011|FG001|Hydromorphone (Oral) 2mg|Overall Study||69
10675985|NCT02360371|11838010|FG000|Hydromorphone (Oral) 4mg|Overall Study||13
10675986|NCT02360371|11838011|FG001|Hydromorphone (Oral) 4mg|Overall Study||69
10675987|NCT02360371|11838010|FG000|Hydromorphone (Oral) 8mg|Overall Study||13
10675988|NCT02360371|11838011|FG001|Hydromorphone (Oral) 8mg|Overall Study||69
10675989|NCT02360371|11838010|FG000|COMPLETED|Overall Study||13
10675990|NCT02360371|11838011|FG001|COMPLETED|Overall Study||69
10675991|NCT02360371|11838010|FG000|NOT COMPLETED|Overall Study||0
10675992|NCT02360371|11838011|FG001|NOT COMPLETED|Overall Study||15
10675993|NCT02360397|11838021|FG000|STARTED|Overall Study||6
10675994|NCT02360397|11838021|FG000|COMPLETED|Overall Study||2
10675995|NCT02360397|11838021|FG000|NOT COMPLETED|Overall Study||4
10675996|NCT02360475|11838030|FG000|STARTED|Overall Study||126
10675997|NCT02360475|11838031|FG001|STARTED|Overall Study||124
10675998|NCT02360475|11838032|FG002|STARTED|Overall Study||125
10675999|NCT02360475|11838033|FG003|STARTED|Overall Study||125
10676000|NCT02360475|11838030|FG000|COMPLETED|Overall Study||122
10676001|NCT02360475|11838031|FG001|COMPLETED|Overall Study||111
10676002|NCT02360475|11838032|FG002|COMPLETED|Overall Study||117
10676003|NCT02360475|11838033|FG003|COMPLETED|Overall Study||120
10676004|NCT02360475|11838030|FG000|NOT COMPLETED|Overall Study||4
10676005|NCT02360475|11838031|FG001|NOT COMPLETED|Overall Study||13
10676006|NCT02360475|11838032|FG002|NOT COMPLETED|Overall Study||8
10676007|NCT02360475|11838033|FG003|NOT COMPLETED|Overall Study||5
10676008|NCT02360488|11838045|FG000|STARTED|Overall Study||62
10676009|NCT02360488|11838046|FG001|STARTED|Overall Study||62
10676010|NCT02360488|11838045|FG000|COMPLETED|Overall Study||59
10676011|NCT02360488|11838046|FG001|COMPLETED|Overall Study||55
10676012|NCT02360488|11838045|FG000|NOT COMPLETED|Overall Study||3
10676013|NCT02360488|11838046|FG001|NOT COMPLETED|Overall Study||7
10676014|NCT02360605|11838054|FG000|STARTED|Overall Study||311
10676015|NCT02360605|11838055|FG001|STARTED|Overall Study||309
10676016|NCT02360605|11838054|FG000|COMPLETED|Overall Study||300
10676017|NCT02360605|11838055|FG001|COMPLETED|Overall Study||291
10676018|NCT02360605|11838054|FG000|NOT COMPLETED|Overall Study||11
10676019|NCT02360605|11838055|FG001|NOT COMPLETED|Overall Study||18
10676020|NCT02360631|11838065|FG000|STARTED|Overall Study||300
10676021|NCT02360631|11838066|FG001|STARTED|Overall Study||200
10676022|NCT02360631|11838065|FG000|Week 12|Overall Study||249
10676023|NCT02360631|11838066|FG001|Week 12|Overall Study||165
10676024|NCT02360631|11838065|FG000|COMPLETED|Overall Study||267
10676025|NCT02360631|11838066|FG001|COMPLETED|Overall Study||174
10676026|NCT02360631|11838065|FG000|NOT COMPLETED|Overall Study||33
10676027|NCT02360631|11838066|FG001|NOT COMPLETED|Overall Study||26
10676028|NCT02360774|11838074|FG000|STARTED|Overall Study||15
10676029|NCT02360774|11838075|FG001|STARTED|Overall Study||15
10676030|NCT02360774|11838074|FG000|COMPLETED|Overall Study||12
10676031|NCT02360774|11838075|FG001|COMPLETED|Overall Study||13
10676032|NCT02360774|11838074|FG000|NOT COMPLETED|Overall Study||3
10676033|NCT02360774|11838075|FG001|NOT COMPLETED|Overall Study||2
10676034|NCT02360995|11838086|FG000|STARTED|Overall Study||43
10676035|NCT02360995|11838087|FG001|STARTED|Overall Study||43
10676036|NCT02360995|11838088|FG002|STARTED|Overall Study||43
10676037|NCT02360995|11838086|FG000|COMPLETED|Overall Study||41
10676038|NCT02360995|11838087|FG001|COMPLETED|Overall Study||42
10676039|NCT02360995|11838088|FG002|COMPLETED|Overall Study||41
10676040|NCT02360995|11838086|FG000|NOT COMPLETED|Overall Study||2
10676041|NCT02360995|11838087|FG001|NOT COMPLETED|Overall Study||1
10676042|NCT02360995|11838088|FG002|NOT COMPLETED|Overall Study||2
10676043|NCT02361216|11838098|FG000|STARTED|3 Day Treatment and 8 Week Follow/up||552
10676044|NCT02361216|11838099|FG001|STARTED|3 Day Treatment and 8 Week Follow/up||177
10676045|NCT02361216|11838098|FG000|COMPLETED|3 Day Treatment and 8 Week Follow/up||541
10676046|NCT02361216|11838099|FG001|COMPLETED|3 Day Treatment and 8 Week Follow/up||158
10676047|NCT02361216|11838098|FG000|NOT COMPLETED|3 Day Treatment and 8 Week Follow/up||11
10676048|NCT02361216|11838099|FG001|NOT COMPLETED|3 Day Treatment and 8 Week Follow/up||19
10676049|NCT02361216|11838098|FG000|STARTED|12-month Follow-up||541
10676050|NCT02361216|11838099|FG001|STARTED|12-month Follow-up|1 of the 158 subjects did not receive treatment and was also excluded from the 12-month follow-up.|157
10676051|NCT02361216|11838098|FG000|COMPLETED|12-month Follow-up||489
10676052|NCT02361216|11838099|FG001|COMPLETED|12-month Follow-up||130
10676053|NCT02361216|11838098|FG000|NOT COMPLETED|12-month Follow-up||52
10676054|NCT02361216|11838099|FG001|NOT COMPLETED|12-month Follow-up||27
10676055|NCT02361307|11838110|FG000|STARTED|Overall Study||18
10676056|NCT02361307|11838111|FG001|STARTED|Overall Study||18
10676057|NCT02361307|11838110|FG000|COMPLETED|Overall Study||18
10676058|NCT02361307|11838111|FG001|COMPLETED|Overall Study||17
10676059|NCT02361307|11838110|FG000|NOT COMPLETED|Overall Study||0
10676060|NCT02361307|11838111|FG001|NOT COMPLETED|Overall Study||1
10676061|NCT02361476|11838119|FG000|STARTED|Overall Study||191
10676062|NCT02361476|11838120|FG001|STARTED|Overall Study||188
10676063|NCT02361476|11838119|FG000|COMPLETED|Overall Study||191
10676064|NCT02361476|11838120|FG001|COMPLETED|Overall Study||188
10676065|NCT02361476|11838119|FG000|NOT COMPLETED|Overall Study||0
10676066|NCT02361476|11838120|FG001|NOT COMPLETED|Overall Study||0
10676067|NCT02361736|11838128|FG000|STARTED|Overall Study||60
10676068|NCT02361736|11838129|FG001|STARTED|Overall Study||60
10676069|NCT02361736|11838128|FG000|COMPLETED|Overall Study||59
10676070|NCT02361736|11838129|FG001|COMPLETED|Overall Study||59
10676071|NCT02361736|11838128|FG000|NOT COMPLETED|Overall Study||1
10676072|NCT02361736|11838129|FG001|NOT COMPLETED|Overall Study||1
10676073|NCT02361762|11838137|FG000|STARTED|Overall Study||35
10676074|NCT02361762|11838138|FG001|STARTED|Overall Study||35
10676075|NCT02361762|11838137|FG000|COMPLETED|Overall Study||35
10676076|NCT02361762|11838138|FG001|COMPLETED|Overall Study||33
10676077|NCT02361762|11838137|FG000|NOT COMPLETED|Overall Study||0
10676078|NCT02361762|11838138|FG001|NOT COMPLETED|Overall Study||2
10676079|NCT02362048|11838146|FG000|STARTED|Overall Study|37 enrolled but only 35 received study medication.|37
10676080|NCT02362048|11838147|FG001|STARTED|Overall Study|40 enrolled but only 38 received study medication.|40
10676081|NCT02362048|11838146|FG000|Enrolled|Overall Study||37
10676082|NCT02362048|11838147|FG001|Enrolled|Overall Study||40
10676083|NCT02362048|11838146|FG000|Received Study Medication|Overall Study||35
10676084|NCT02362048|11838147|FG001|Received Study Medication|Overall Study||38
10676085|NCT02362048|11838146|FG000|Discontinued Study|Overall Study||37
10676086|NCT02362048|11838147|FG001|Discontinued Study|Overall Study||40
10676087|NCT02362048|11838146|FG000|COMPLETED|Overall Study||0
10676088|NCT02362048|11838147|FG001|COMPLETED|Overall Study||0
10676089|NCT02362048|11838146|FG000|NOT COMPLETED|Overall Study||37
10676090|NCT02362048|11838147|FG001|NOT COMPLETED|Overall Study||40
10676091|NCT02362191|11838153|FG000|STARTED|Overall Study||5
10676092|NCT02362191|11838153|FG000|COMPLETED|Overall Study||3
10676093|NCT02362191|11838153|FG000|NOT COMPLETED|Overall Study||2
10676094|NCT02362269|11838159|FG000|STARTED|Overall Study||83
10676095|NCT02362269|11838160|FG001|STARTED|Overall Study||86
10676096|NCT02362269|11838159|FG000|COMPLETED|Overall Study||82
10676097|NCT02362269|11838160|FG001|COMPLETED|Overall Study||80
10676098|NCT02362269|11838159|FG000|NOT COMPLETED|Overall Study||1
10676099|NCT02362269|11838160|FG001|NOT COMPLETED|Overall Study||6
10676100|NCT02362282|11838168|FG000|STARTED|Overall Study||5
10676101|NCT02362282|11838169|FG001|STARTED|Overall Study||7
10676102|NCT02362282|11838168|FG000|COMPLETED|Overall Study||4
10676103|NCT02362282|11838169|FG001|COMPLETED|Overall Study||7
10676104|NCT02362282|11838168|FG000|NOT COMPLETED|Overall Study||1
10676105|NCT02362282|11838169|FG001|NOT COMPLETED|Overall Study||0
10676106|NCT02362321|11838177|FG000|STARTED|Overall Study||10
10676107|NCT02362321|11838178|FG001|STARTED|Overall Study||10
10676108|NCT02362321|11838177|FG000|COMPLETED|Overall Study||6
10676109|NCT02362321|11838178|FG001|COMPLETED|Overall Study||10
10676110|NCT02362321|11838177|FG000|NOT COMPLETED|Overall Study||4
10676111|NCT02362321|11838178|FG001|NOT COMPLETED|Overall Study||0
10676112|NCT02362360|11838184|FG000|STARTED|Period 1||26
10676113|NCT02362360|11838185|FG001|STARTED|Period 1||26
10676114|NCT02362360|11838184|FG000|COMPLETED|Period 1||23
10676115|NCT02362360|11838185|FG001|COMPLETED|Period 1||25
10676116|NCT02362360|11838184|FG000|NOT COMPLETED|Period 1||3
10676117|NCT02362360|11838185|FG001|NOT COMPLETED|Period 1||1
10676118|NCT02362360|11838184|FG000|STARTED|Period 2||23
10676119|NCT02362360|11838185|FG001|STARTED|Period 2||25
10676120|NCT02362360|11838184|FG000|COMPLETED|Period 2||23
10676121|NCT02362360|11838185|FG001|COMPLETED|Period 2||25
10676122|NCT02362360|11838184|FG000|NOT COMPLETED|Period 2||0
10676123|NCT02362360|11838185|FG001|NOT COMPLETED|Period 2||0
10676124|NCT02362373|11838191|FG000|STARTED|Overall Study||20
10676125|NCT02362373|11838191|FG000|COMPLETED|Overall Study||20
10676126|NCT02362373|11838191|FG000|NOT COMPLETED|Overall Study||0
10676127|NCT02362412|11838195|FG000|STARTED|Treatment Period II||9
10676128|NCT02362412|11838196|FG001|STARTED|Treatment Period II||11
10676129|NCT02362412|11838195|FG000|TREATED|Treatment Period II||9
10676130|NCT02362412|11838196|FG001|TREATED|Treatment Period II||11
10676131|NCT02362412|11838195|FG000|COMPLETED|Treatment Period II||9
10676132|NCT02362412|11838196|FG001|COMPLETED|Treatment Period II||11
10676133|NCT02362412|11838195|FG000|NOT COMPLETED|Treatment Period II||0
10676134|NCT02362412|11838196|FG001|NOT COMPLETED|Treatment Period II||0
10676135|NCT02362412|11838195|FG000|STARTED|Treatment Period III||9
10676136|NCT02362412|11838196|FG001|STARTED|Treatment Period III||11
10676137|NCT02362412|11838195|FG000|TREATED|Treatment Period III||9
10676138|NCT02362412|11838196|FG001|TREATED|Treatment Period III||11
10676139|NCT02362412|11838195|FG000|COMPLETED|Treatment Period III||9
10676140|NCT02362412|11838196|FG001|COMPLETED|Treatment Period III||10
10676141|NCT02362412|11838195|FG000|NOT COMPLETED|Treatment Period III||0
10676142|NCT02362412|11838196|FG001|NOT COMPLETED|Treatment Period III||1
10676143|NCT02362425|11838212|FG000|STARTED|Phase 1 (up to 6 Months)||53
10676144|NCT02362425|11838213|FG001|STARTED|Phase 1 (up to 6 Months)||10
10676145|NCT02362425|11838214|FG002|STARTED|Phase 1 (up to 6 Months)||0
10676146|NCT02362425|11838215|FG003|STARTED|Phase 1 (up to 6 Months)||0
10676147|NCT02362425|11838212|FG000|COMPLETED|Phase 1 (up to 6 Months)||37
10676148|NCT02362425|11838213|FG001|COMPLETED|Phase 1 (up to 6 Months)||10
10676149|NCT02362425|11838214|FG002|COMPLETED|Phase 1 (up to 6 Months)||0
10676150|NCT02362425|11838215|FG003|COMPLETED|Phase 1 (up to 6 Months)||0
10676151|NCT02362425|11838212|FG000|NOT COMPLETED|Phase 1 (up to 6 Months)||16
10676152|NCT02362425|11838213|FG001|NOT COMPLETED|Phase 1 (up to 6 Months)||0
10676153|NCT02362425|11838214|FG002|NOT COMPLETED|Phase 1 (up to 6 Months)||0
10676154|NCT02362425|11838215|FG003|NOT COMPLETED|Phase 1 (up to 6 Months)||0
10676155|NCT02362425|11838212|FG000|STARTED|Phase 2 (up to 6 Months, Randomized)||0
10574538|NCT01678911|11729784|FG000|NOT COMPLETED|Second Intervention||2
10574539|NCT01678911|11729785|FG001|NOT COMPLETED|Second Intervention||0
10574540|NCT01678924|11729795|FG000|STARTED|Overall Study||64
10574541|NCT01678924|11729796|FG001|STARTED|Overall Study||63
10574542|NCT01678924|11729797|FG002|STARTED|Overall Study||30
10574543|NCT01678924|11729798|FG003|STARTED|Overall Study||123
10574544|NCT01678924|11729795|FG000|COMPLETED|Overall Study||54
10574545|NCT01678924|11729796|FG001|COMPLETED|Overall Study||51
10574546|NCT01678924|11729797|FG002|COMPLETED|Overall Study||28
10574547|NCT01678924|11729798|FG003|COMPLETED|Overall Study||105
10574548|NCT01678924|11729795|FG000|NOT COMPLETED|Overall Study||10
10574549|NCT01678924|11729796|FG001|NOT COMPLETED|Overall Study||12
10574550|NCT01678924|11729797|FG002|NOT COMPLETED|Overall Study||2
10574551|NCT01678924|11729798|FG003|NOT COMPLETED|Overall Study||18
10574552|NCT01678976|11729811|FG000|STARTED|First Period||6
10574553|NCT01678976|11729812|FG001|STARTED|First Period||7
10574554|NCT01678976|11729811|FG000|COMPLETED|First Period||6
10574555|NCT01678976|11729812|FG001|COMPLETED|First Period||6
10574556|NCT01678976|11729811|FG000|NOT COMPLETED|First Period||0
10574557|NCT01678976|11729812|FG001|NOT COMPLETED|First Period||1
10574558|NCT01678976|11729811|FG000|STARTED|Second Period||6
10574559|NCT01678976|11729812|FG001|STARTED|Second Period||6
10574560|NCT01678976|11729811|FG000|COMPLETED|Second Period||6
10574561|NCT01678976|11729812|FG001|COMPLETED|Second Period||6
10574562|NCT01678976|11729811|FG000|NOT COMPLETED|Second Period||0
10574563|NCT01678976|11729812|FG001|NOT COMPLETED|Second Period||0
10574564|NCT01679002|11729824|FG000|STARTED|Overall Study||4
10574565|NCT01679002|11729825|FG001|STARTED|Overall Study||4
10574566|NCT01679002|11729826|FG002|STARTED|Overall Study||4
10574567|NCT01679002|11729824|FG000|BIA 2-093 900 mg Once-daily Period|Overall Study||4
10574568|NCT01679002|11729825|FG001|BIA 2-093 900 mg Once-daily Period|Overall Study||3
10574569|NCT01679002|11729826|FG002|BIA 2-093 900 mg Once-daily Period|Overall Study||4
10574570|NCT01679002|11729824|FG000|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
10574571|NCT01679002|11729825|FG001|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
10574572|NCT01679002|11729826|FG002|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
10574573|NCT01679002|11729824|FG000|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||3
10574574|NCT01679002|11729825|FG001|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||4
10574575|NCT01679002|11729826|FG002|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||4
10574576|NCT01679002|11729824|FG000|COMPLETED|Overall Study||3
10574577|NCT01679002|11729825|FG001|COMPLETED|Overall Study||3
10574578|NCT01679002|11729826|FG002|COMPLETED|Overall Study||4
10574579|NCT01679002|11729824|FG000|NOT COMPLETED|Overall Study||1
10574580|NCT01679002|11729825|FG001|NOT COMPLETED|Overall Study||1
10574581|NCT01679002|11729826|FG002|NOT COMPLETED|Overall Study||0
10574582|NCT01679028|11729840|FG000|STARTED|Overall Study||2
10574583|NCT01679028|11729841|FG001|STARTED|Overall Study||4
10574584|NCT01679028|11729842|FG002|STARTED|Overall Study||2
10574585|NCT01679028|11729843|FG003|STARTED|Overall Study||4
10574586|NCT01679028|11729844|FG004|STARTED|Overall Study||2
10574587|NCT01679028|11729845|FG005|STARTED|Overall Study||6
10574588|NCT01679028|11729840|FG000|COMPLETED|Overall Study||2
10574589|NCT01679028|11729841|FG001|COMPLETED|Overall Study||4
10574590|NCT01679028|11729842|FG002|COMPLETED|Overall Study||2
10574591|NCT01679028|11729843|FG003|COMPLETED|Overall Study||4
10574592|NCT01679028|11729844|FG004|COMPLETED|Overall Study||2
10574593|NCT01679028|11729845|FG005|COMPLETED|Overall Study||6
10574594|NCT01679028|11729840|FG000|NOT COMPLETED|Overall Study||0
10574595|NCT01679028|11729841|FG001|NOT COMPLETED|Overall Study||0
10574596|NCT01679028|11729842|FG002|NOT COMPLETED|Overall Study||0
10574597|NCT01679028|11729843|FG003|NOT COMPLETED|Overall Study||0
10574598|NCT01679028|11729844|FG004|NOT COMPLETED|Overall Study||0
10574599|NCT01679028|11729845|FG005|NOT COMPLETED|Overall Study||0
10574600|NCT01679197|11729859|FG000|STARTED|Overall Study||23
10574601|NCT01679197|11729859|FG000|COMPLETED|Overall Study||19
10574602|NCT01679197|11729859|FG000|NOT COMPLETED|Overall Study||4
10574603|NCT01679236|11729871|FG000|STARTED|Overall Study||30
10574604|NCT01679236|11729872|FG001|STARTED|Overall Study||25
10574605|NCT01679236|11729871|FG000|COMPLETED|Overall Study||15
10574606|NCT01679236|11729872|FG001|COMPLETED|Overall Study||10
10574607|NCT01679236|11729871|FG000|NOT COMPLETED|Overall Study||15
10574608|NCT01679236|11729872|FG001|NOT COMPLETED|Overall Study||15
10574609|NCT01679301|11729878|FG000|STARTED|Screening Period||11
10574610|NCT01679301|11729879|FG001|STARTED|Screening Period||0
10574611|NCT01679301|11729880|FG002|STARTED|Screening Period||0
10574612|NCT01679301|11729878|FG000|COMPLETED|Screening Period||8
10574613|NCT01679301|11729879|FG001|COMPLETED|Screening Period||0
10574614|NCT01679301|11729880|FG002|COMPLETED|Screening Period||0
10574615|NCT01679301|11729878|FG000|NOT COMPLETED|Screening Period||3
10574616|NCT01679301|11729879|FG001|NOT COMPLETED|Screening Period||0
10574617|NCT01679301|11729880|FG002|NOT COMPLETED|Screening Period||0
10676156|NCT02362425|11838213|FG001|STARTED|Phase 2 (up to 6 Months, Randomized)||0
10676157|NCT02362425|11838214|FG002|STARTED|Phase 2 (up to 6 Months, Randomized)||16
10676158|NCT02362425|11838215|FG003|STARTED|Phase 2 (up to 6 Months, Randomized)||17
10676159|NCT02362425|11838212|FG000|COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
10676160|NCT02362425|11838213|FG001|COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
10676161|NCT02362425|11838214|FG002|COMPLETED|Phase 2 (up to 6 Months, Randomized)||15
10676162|NCT02362425|11838215|FG003|COMPLETED|Phase 2 (up to 6 Months, Randomized)||14
10676163|NCT02362425|11838212|FG000|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
10676164|NCT02362425|11838213|FG001|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
10676165|NCT02362425|11838214|FG002|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||1
10676166|NCT02362425|11838215|FG003|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||3
10676177|NCT02362646|11838237|FG000|STARTED|Overall Study||106
10676178|NCT02362646|11838238|FG001|STARTED|Overall Study||53
10676179|NCT02362646|11838237|FG000|COMPLETED|Overall Study||68
10676180|NCT02362646|11838238|FG001|COMPLETED|Overall Study||29
10676181|NCT02362646|11838237|FG000|NOT COMPLETED|Overall Study||38
10676182|NCT02362646|11838238|FG001|NOT COMPLETED|Overall Study||24
10676183|NCT02362672|11838248|FG000|STARTED|Titration Phase||1189
10676184|NCT02362672|11838249|FG001|STARTED|Titration Phase||0
10676185|NCT02362672|11838250|FG002|STARTED|Titration Phase||0
10676186|NCT02362672|11838248|FG000|COMPLETED|Titration Phase||610
10676187|NCT02362672|11838249|FG001|COMPLETED|Titration Phase||0
10676188|NCT02362672|11838250|FG002|COMPLETED|Titration Phase||0
10676189|NCT02362672|11838248|FG000|NOT COMPLETED|Titration Phase||579
10676190|NCT02362672|11838249|FG001|NOT COMPLETED|Titration Phase||0
10676191|NCT02362672|11838250|FG002|NOT COMPLETED|Titration Phase||0
10676192|NCT02362672|11838248|FG000|STARTED|Double-blind Maintenance Phase||0
10676193|NCT02362672|11838249|FG001|STARTED|Double-blind Maintenance Phase||309
10676194|NCT02362672|11838250|FG002|STARTED|Double-blind Maintenance Phase||301
10676195|NCT02362672|11838248|FG000|COMPLETED|Double-blind Maintenance Phase||0
10676196|NCT02362672|11838249|FG001|COMPLETED|Double-blind Maintenance Phase||249
10676197|NCT02362672|11838250|FG002|COMPLETED|Double-blind Maintenance Phase||242
10676198|NCT02362672|11838248|FG000|NOT COMPLETED|Double-blind Maintenance Phase||0
10676199|NCT02362672|11838249|FG001|NOT COMPLETED|Double-blind Maintenance Phase||60
10676200|NCT02362672|11838250|FG002|NOT COMPLETED|Double-blind Maintenance Phase||59
10676201|NCT02362724|11838261|FG000|STARTED|Overall Study||59
10676202|NCT02362724|11838262|FG001|STARTED|Overall Study||30
10676203|NCT02362724|11838261|FG000|COMPLETED|Overall Study||53
10676204|NCT02362724|11838262|FG001|COMPLETED|Overall Study||29
10676205|NCT02362724|11838261|FG000|NOT COMPLETED|Overall Study||6
10676206|NCT02362724|11838262|FG001|NOT COMPLETED|Overall Study||1
10676207|NCT02362789|11838270|FG000|STARTED|Run-in Phase (Week 0 to 16)||130
10676208|NCT02362789|11838271|FG001|STARTED|Run-in Phase (Week 0 to 16)||0
10676209|NCT02362789|11838272|FG002|STARTED|Run-in Phase (Week 0 to 16)||0
10676210|NCT02362789|11838270|FG000|COMPLETED|Run-in Phase (Week 0 to 16)||128
10797356|NCT03686176|11957644|FG000|NOT COMPLETED|Overall Study||2
10676211|NCT02362789|11838271|FG001|COMPLETED|Run-in Phase (Week 0 to 16)||0
10676212|NCT02362789|11838272|FG002|COMPLETED|Run-in Phase (Week 0 to 16)||0
10676213|NCT02362789|11838270|FG000|NOT COMPLETED|Run-in Phase (Week 0 to 16)||2
10676214|NCT02362789|11838271|FG001|NOT COMPLETED|Run-in Phase (Week 0 to 16)||0
10676215|NCT02362789|11838272|FG002|NOT COMPLETED|Run-in Phase (Week 0 to 16)||0
10676216|NCT02362789|11838270|FG000|STARTED|Randomized Withdrawal (Wk 16 to 32)|N/A. Run-in phase completed.|0
10676217|NCT02362789|11838271|FG001|STARTED|Randomized Withdrawal (Wk 16 to 32)|Subjects achieving PASI reduction by 98-100% vs. baseline during Run-In|42
10676218|NCT02362789|11838272|FG002|STARTED|Randomized Withdrawal (Wk 16 to 32)|Subjects achieving PASI reduction by 98-100% vs. baseline during Run-In|38
10676219|NCT02362789|11838270|FG000|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||0
10676220|NCT02362789|11838271|FG001|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||38
10676221|NCT02362789|11838272|FG002|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||26
10676222|NCT02362789|11838270|FG000|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||0
10676223|NCT02362789|11838271|FG001|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||4
10676224|NCT02362789|11838272|FG002|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||12
10676225|NCT02363270|11838281|FG000|STARTED|Overall Study||24
10676226|NCT02363270|11838282|FG001|STARTED|Overall Study||24
10676227|NCT02363270|11838281|FG000|COMPLETED|Overall Study||24
10676228|NCT02363270|11838282|FG001|COMPLETED|Overall Study||24
10676229|NCT02363270|11838281|FG000|NOT COMPLETED|Overall Study||0
10676230|NCT02363270|11838282|FG001|NOT COMPLETED|Overall Study||0
10676231|NCT02363283|11838288|FG000|STARTED|Overall Study||37
10676232|NCT02363283|11838288|FG000|COMPLETED|Overall Study||35
10797357|NCT03686176|11957645|FG001|NOT COMPLETED|Overall Study||0
10676233|NCT02363283|11838288|FG000|NOT COMPLETED|Overall Study||2
10676234|NCT02363322|11838294|FG000|STARTED|Overall Study||36
10676235|NCT02363322|11838295|FG001|STARTED|Overall Study||36
10676236|NCT02363322|11838294|FG000|COMPLETED|Overall Study||35
10676237|NCT02363322|11838295|FG001|COMPLETED|Overall Study||36
10676238|NCT02363322|11838294|FG000|NOT COMPLETED|Overall Study||1
10676239|NCT02363322|11838295|FG001|NOT COMPLETED|Overall Study||0
10676240|NCT02363439|11838301|FG000|STARTED|Overall Study||5
10676241|NCT02363439|11838301|FG000|COMPLETED|Overall Study||1
10676242|NCT02363439|11838301|FG000|NOT COMPLETED|Overall Study||4
10676243|NCT02363478|11838305|FG000|STARTED|Overall Study||30
10676244|NCT02363478|11838305|FG000|COMPLETED|Overall Study||22
10676245|NCT02363478|11838305|FG000|NOT COMPLETED|Overall Study||8
10676246|NCT02363621|11838312|FG000|STARTED|Overall Study||51
10676247|NCT02363621|11838313|FG001|STARTED|Overall Study||50
10676248|NCT02363621|11838312|FG000|COMPLETED|Overall Study||50
10676249|NCT02363621|11838313|FG001|COMPLETED|Overall Study||50
10676250|NCT02363621|11838312|FG000|NOT COMPLETED|Overall Study||1
10676251|NCT02363621|11838313|FG001|NOT COMPLETED|Overall Study||0
10676252|NCT02363686|11838319|FG000|STARTED|Overall Study||248
10676253|NCT02363686|11838319|FG000|COMPLETED|Overall Study||213
10676254|NCT02363686|11838319|FG000|NOT COMPLETED|Overall Study||35
10676255|NCT02363738|11838325|FG000|STARTED|Overall Study||29
10676256|NCT02363738|11838326|FG001|STARTED|Overall Study||31
10676257|NCT02363738|11838325|FG000|COMPLETED|Overall Study||21
10676258|NCT02363738|11838326|FG001|COMPLETED|Overall Study||26
10676259|NCT02363738|11838325|FG000|NOT COMPLETED|Overall Study||8
10676260|NCT02363738|11838326|FG001|NOT COMPLETED|Overall Study||5
10676261|NCT02363803|11838334|FG000|STARTED|Period 1||17
10676262|NCT02363803|11838335|FG001|STARTED|Period 1||17
10676263|NCT02363803|11838334|FG000|COMPLETED|Period 1||17
10676264|NCT02363803|11838335|FG001|COMPLETED|Period 1||17
10676265|NCT02363803|11838334|FG000|NOT COMPLETED|Period 1||0
10676266|NCT02363803|11838335|FG001|NOT COMPLETED|Period 1||0
10676267|NCT02363803|11838334|FG000|STARTED|Period 2||17
10676268|NCT02363803|11838335|FG001|STARTED|Period 2|One participant did not return for Period 2 treatment|16
10676269|NCT02363803|11838334|FG000|COMPLETED|Period 2||17
10676270|NCT02363803|11838335|FG001|COMPLETED|Period 2||16
10676271|NCT02363803|11838334|FG000|NOT COMPLETED|Period 2||0
10676272|NCT02363803|11838335|FG001|NOT COMPLETED|Period 2||0
10676273|NCT02363907|11838347|FG000|STARTED|Overall Study||30
10676274|NCT02363907|11838347|FG000|COMPLETED|Overall Study||30
10676275|NCT02363907|11838347|FG000|NOT COMPLETED|Overall Study||0
10712611|NCT02672423|11878232|FG003|STARTED|Period 2||15
10712612|NCT02672423|11878233|FG004|STARTED|Period 2||14
10712613|NCT02672423|11878234|FG005|STARTED|Period 2||15
10712614|NCT02672423|11878235|FG006|STARTED|Period 2||15
10712615|NCT02672423|11878236|FG007|STARTED|Period 2||15
10712616|NCT02672423|11878237|FG008|STARTED|Period 2||12
10712617|NCT02672423|11878238|FG009|STARTED|Period 2||12
10712618|NCT02672423|11878229|FG000|COMPLETED|Period 2||7
10712619|NCT02672423|11878230|FG001|COMPLETED|Period 2||7
10712620|NCT02672423|11878231|FG002|COMPLETED|Period 2||13
10712621|NCT02672423|11878232|FG003|COMPLETED|Period 2||15
10712622|NCT02672423|11878233|FG004|COMPLETED|Period 2||14
10712623|NCT02672423|11878234|FG005|COMPLETED|Period 2||15
10712624|NCT02672423|11878235|FG006|COMPLETED|Period 2||15
10712625|NCT02672423|11878236|FG007|COMPLETED|Period 2||15
10712626|NCT02672423|11878237|FG008|COMPLETED|Period 2||12
10712627|NCT02672423|11878238|FG009|COMPLETED|Period 2||12
10712628|NCT02672423|11878229|FG000|NOT COMPLETED|Period 2||0
10712629|NCT02672423|11878230|FG001|NOT COMPLETED|Period 2||0
10712630|NCT02672423|11878231|FG002|NOT COMPLETED|Period 2||1
10712631|NCT02672423|11878232|FG003|NOT COMPLETED|Period 2||0
10712632|NCT02672423|11878233|FG004|NOT COMPLETED|Period 2||0
10712633|NCT02672423|11878234|FG005|NOT COMPLETED|Period 2||0
10712634|NCT02672423|11878235|FG006|NOT COMPLETED|Period 2||0
10712635|NCT02672423|11878236|FG007|NOT COMPLETED|Period 2||0
10712636|NCT02672423|11878237|FG008|NOT COMPLETED|Period 2||0
10712637|NCT02672423|11878238|FG009|NOT COMPLETED|Period 2||0
10712638|NCT02672423|11878229|FG000|STARTED|Washout 2||7
10712639|NCT02672423|11878230|FG001|STARTED|Washout 2||7
10712640|NCT02672423|11878231|FG002|STARTED|Washout 2||13
10712641|NCT02672423|11878232|FG003|STARTED|Washout 2||15
10712642|NCT02672423|11878233|FG004|STARTED|Washout 2||14
10712643|NCT02672423|11878234|FG005|STARTED|Washout 2||15
10712644|NCT02672423|11878235|FG006|STARTED|Washout 2||15
10712645|NCT02672423|11878236|FG007|STARTED|Washout 2||15
10712646|NCT02672423|11878237|FG008|STARTED|Washout 2||12
10712647|NCT02672423|11878238|FG009|STARTED|Washout 2||12
10712648|NCT02672423|11878229|FG000|COMPLETED|Washout 2||7
10712649|NCT02672423|11878230|FG001|COMPLETED|Washout 2||7
10712650|NCT02672423|11878231|FG002|COMPLETED|Washout 2||13
10712651|NCT02672423|11878232|FG003|COMPLETED|Washout 2||15
10712652|NCT02672423|11878233|FG004|COMPLETED|Washout 2||14
10712653|NCT02672423|11878234|FG005|COMPLETED|Washout 2||15
10712654|NCT02672423|11878235|FG006|COMPLETED|Washout 2||15
10712655|NCT02672423|11878236|FG007|COMPLETED|Washout 2||15
10712656|NCT02672423|11878237|FG008|COMPLETED|Washout 2||12
10712657|NCT02672423|11878238|FG009|COMPLETED|Washout 2||12
10712658|NCT02672423|11878229|FG000|NOT COMPLETED|Washout 2||0
10712659|NCT02672423|11878230|FG001|NOT COMPLETED|Washout 2||0
10712660|NCT02672423|11878231|FG002|NOT COMPLETED|Washout 2||0
10712661|NCT02672423|11878232|FG003|NOT COMPLETED|Washout 2||0
10712662|NCT02672423|11878233|FG004|NOT COMPLETED|Washout 2||0
10712663|NCT02672423|11878234|FG005|NOT COMPLETED|Washout 2||0
10712664|NCT02672423|11878235|FG006|NOT COMPLETED|Washout 2||0
10712665|NCT02672423|11878236|FG007|NOT COMPLETED|Washout 2||0
10712666|NCT02672423|11878237|FG008|NOT COMPLETED|Washout 2||0
10712667|NCT02672423|11878238|FG009|NOT COMPLETED|Washout 2||0
10712668|NCT02672423|11878229|FG000|STARTED|Period 3|Part A was a 2-period study design.|0
10712669|NCT02672423|11878230|FG001|STARTED|Period 3|Part A was a 2-period study design.|0
10712670|NCT02672423|11878231|FG002|STARTED|Period 3||13
10676276|NCT02363933|11838351|FG000|STARTED|Overall Study||8
10676277|NCT02363933|11838351|FG000|COMPLETED|Overall Study||2
10676278|NCT02363933|11838351|FG000|NOT COMPLETED|Overall Study||6
10676279|NCT02363946|11838368|FG000|STARTED|Overall Study||4
10676280|NCT02363946|11838369|FG001|STARTED|Overall Study||4
10676281|NCT02363946|11838370|FG002|STARTED|Overall Study||4
10676282|NCT02363946|11838371|FG003|STARTED|Overall Study||4
10676283|NCT02363946|11838372|FG004|STARTED|Overall Study||4
10676284|NCT02363946|11838373|FG005|STARTED|Overall Study||4
10676285|NCT02363946|11838374|FG006|STARTED|Overall Study||4
10676286|NCT02363946|11838375|FG007|STARTED|Overall Study||4
10676287|NCT02363946|11838376|FG008|STARTED|Overall Study||4
10676288|NCT02363946|11838377|FG009|STARTED|Overall Study||18
10676289|NCT02363946|11838378|FG010|STARTED|Overall Study||4
10676290|NCT02363946|11838379|FG011|STARTED|Overall Study||3
10676291|NCT02363946|11838380|FG012|STARTED|Overall Study||4
10676292|NCT02363946|11838368|FG000|COMPLETED|Overall Study||4
10676293|NCT02363946|11838369|FG001|COMPLETED|Overall Study||4
10676294|NCT02363946|11838370|FG002|COMPLETED|Overall Study||4
10676295|NCT02363946|11838371|FG003|COMPLETED|Overall Study||4
10676296|NCT02363946|11838372|FG004|COMPLETED|Overall Study||4
10676297|NCT02363946|11838373|FG005|COMPLETED|Overall Study||4
10676298|NCT02363946|11838374|FG006|COMPLETED|Overall Study||4
10676299|NCT02363946|11838375|FG007|COMPLETED|Overall Study||3
10676300|NCT02363946|11838376|FG008|COMPLETED|Overall Study||4
10676301|NCT02363946|11838377|FG009|COMPLETED|Overall Study||18
10676302|NCT02363946|11838378|FG010|COMPLETED|Overall Study||4
10676303|NCT02363946|11838379|FG011|COMPLETED|Overall Study||3
10676304|NCT02363946|11838380|FG012|COMPLETED|Overall Study||4
10676305|NCT02363946|11838368|FG000|NOT COMPLETED|Overall Study||0
10676306|NCT02363946|11838369|FG001|NOT COMPLETED|Overall Study||0
10676307|NCT02363946|11838370|FG002|NOT COMPLETED|Overall Study||0
10676308|NCT02363946|11838371|FG003|NOT COMPLETED|Overall Study||0
10676309|NCT02363946|11838372|FG004|NOT COMPLETED|Overall Study||0
10676310|NCT02363946|11838373|FG005|NOT COMPLETED|Overall Study||0
10676311|NCT02363946|11838374|FG006|NOT COMPLETED|Overall Study||0
10797358|NCT03686176|11957646|FG002|NOT COMPLETED|Overall Study||0
10797359|NCT03687125|11957656|FG000|STARTED|Overall Study||3
10797360|NCT03687125|11957657|FG001|STARTED|Overall Study||3
10797361|NCT03687125|11957656|FG000|COMPLETED|Overall Study||0
10797362|NCT03687125|11957657|FG001|COMPLETED|Overall Study||2
10676312|NCT02363946|11838375|FG007|NOT COMPLETED|Overall Study||1
10676313|NCT02363946|11838376|FG008|NOT COMPLETED|Overall Study||0
10676314|NCT02363946|11838377|FG009|NOT COMPLETED|Overall Study||0
10676315|NCT02363946|11838378|FG010|NOT COMPLETED|Overall Study||0
10676316|NCT02363946|11838379|FG011|NOT COMPLETED|Overall Study||0
10676317|NCT02363946|11838380|FG012|NOT COMPLETED|Overall Study||0
10676318|NCT02363959|11838410|FG000|STARTED|Overall Study||10
10676319|NCT02363959|11838411|FG001|STARTED|Overall Study||10
10676320|NCT02363959|11838410|FG000|COMPLETED|Overall Study||9
10676321|NCT02363959|11838411|FG001|COMPLETED|Overall Study||10
10676322|NCT02363959|11838410|FG000|NOT COMPLETED|Overall Study||1
10676323|NCT02363959|11838411|FG001|NOT COMPLETED|Overall Study||0
10676324|NCT02363972|11838417|FG000|STARTED|Overall Study||103
10676325|NCT02363972|11838417|FG000|COMPLETED|Overall Study||77
10676326|NCT02363972|11838417|FG000|NOT COMPLETED|Overall Study||26
10676327|NCT02364037|11838423|FG000|STARTED|Overall Study||502
10676328|NCT02364037|11838424|FG001|STARTED|Overall Study||506
10676329|NCT02364037|11838423|FG000|COMPLETED|Overall Study||458
10676330|NCT02364037|11838424|FG001|COMPLETED|Overall Study||453
10676331|NCT02364037|11838423|FG000|NOT COMPLETED|Overall Study||44
10676332|NCT02364037|11838424|FG001|NOT COMPLETED|Overall Study||53
10676333|NCT02364076|11838430|FG000|STARTED|Overall Study||45
10676334|NCT02364076|11838430|FG000|COMPLETED|Overall Study||40
10676335|NCT02364076|11838430|FG000|NOT COMPLETED|Overall Study||5
10676336|NCT02364180|11838434|FG000|STARTED|Overall Study||11
10676337|NCT02364180|11838434|FG000|COMPLETED|Overall Study||10
10676338|NCT02364180|11838434|FG000|NOT COMPLETED|Overall Study||1
10676339|NCT02364271|11838440|FG000|STARTED|Overall Study||479
10676340|NCT02364271|11838441|FG001|STARTED|Overall Study||123
10676341|NCT02364271|11838440|FG000|COMPLETED|Overall Study||479
10676342|NCT02364271|11838441|FG001|COMPLETED|Overall Study||123
10676343|NCT02364271|11838440|FG000|NOT COMPLETED|Overall Study||0
10676344|NCT02364271|11838441|FG001|NOT COMPLETED|Overall Study||0
10676345|NCT02364336|11838450|FG000|STARTED|Overall Study||1
10676346|NCT02364336|11838451|FG001|STARTED|Overall Study||12
10676347|NCT02364336|11838450|FG000|6 Hours Post First Peginterferon Inject|Overall Study||1
10676348|NCT02364336|11838451|FG001|6 Hours Post First Peginterferon Inject|Overall Study||12
10676349|NCT02364336|11838450|FG000|End of Peginterferon Treatment|Overall Study||1
10676350|NCT02364336|11838451|FG001|End of Peginterferon Treatment|Overall Study||11
10676351|NCT02364336|11838450|FG000|24 Weeks After End of Peginterferon|Overall Study||1
10676352|NCT02364336|11838451|FG001|24 Weeks After End of Peginterferon|Overall Study||11
10676353|NCT02364336|11838450|FG000|48 Weeks After End of Peginterferon|Overall Study||1
10676354|NCT02364336|11838451|FG001|48 Weeks After End of Peginterferon|Overall Study||10
10676355|NCT02364336|11838450|FG000|COMPLETED|Overall Study||1
10676356|NCT02364336|11838451|FG001|COMPLETED|Overall Study||11
10676357|NCT02364336|11838450|FG000|NOT COMPLETED|Overall Study||0
10676358|NCT02364336|11838451|FG001|NOT COMPLETED|Overall Study||1
10676359|NCT02364388|11838458|FG000|STARTED|Overall Study||217
10797363|NCT03687125|11957656|FG000|NOT COMPLETED|Overall Study||3
10797364|NCT03687125|11957657|FG001|NOT COMPLETED|Overall Study||1
10676360|NCT02364388|11838458|FG000|Biopsied|Overall Study||209
10676361|NCT02364388|11838458|FG000|Excluded|Overall Study||8
10676362|NCT02364388|11838458|FG000|COMPLETED|Overall Study||209
10676363|NCT02364388|11838458|FG000|NOT COMPLETED|Overall Study||8
10676364|NCT02364570|11838462|FG000|STARTED|Overall Study||1
10676365|NCT02364570|11838463|FG001|STARTED|Overall Study||1
10676366|NCT02364570|11838464|FG002|STARTED|Overall Study||2
10676367|NCT02364570|11838465|FG003|STARTED|Overall Study||1
10676368|NCT02364570|11838466|FG004|STARTED|Overall Study||1
10676369|NCT02364570|11838467|FG005|STARTED|Overall Study||1
10676370|NCT02364570|11838468|FG006|STARTED|Overall Study||2
10676371|NCT02364570|11838469|FG007|STARTED|Overall Study||1
10676372|NCT02364570|11838470|FG008|STARTED|Overall Study||2
10676373|NCT02364570|11838471|FG009|STARTED|Overall Study||1
10676374|NCT02364570|11838472|FG010|STARTED|Overall Study||1
10676375|NCT02364570|11838473|FG011|STARTED|Overall Study||1
10676376|NCT02364570|11838474|FG012|STARTED|Overall Study||1
10676377|NCT02364570|11838475|FG013|STARTED|Overall Study||2
10676378|NCT02364570|11838476|FG014|STARTED|Overall Study||1
10676379|NCT02364570|11838477|FG015|STARTED|Overall Study||1
10676380|NCT02364570|11838462|FG000|COMPLETED|Overall Study||1
10676381|NCT02364570|11838463|FG001|COMPLETED|Overall Study||1
10676382|NCT02364570|11838464|FG002|COMPLETED|Overall Study||2
10676383|NCT02364570|11838465|FG003|COMPLETED|Overall Study||1
10676384|NCT02364570|11838466|FG004|COMPLETED|Overall Study||1
10676385|NCT02364570|11838467|FG005|COMPLETED|Overall Study||1
10676386|NCT02364570|11838468|FG006|COMPLETED|Overall Study||2
10676387|NCT02364570|11838469|FG007|COMPLETED|Overall Study||1
10676388|NCT02364570|11838470|FG008|COMPLETED|Overall Study||2
10676389|NCT02364570|11838471|FG009|COMPLETED|Overall Study||1
10676390|NCT02364570|11838472|FG010|COMPLETED|Overall Study||1
10676391|NCT02364570|11838473|FG011|COMPLETED|Overall Study||1
10676392|NCT02364570|11838474|FG012|COMPLETED|Overall Study||1
10797365|NCT03687372|11957667|FG000|STARTED|Overall Study||254
10797366|NCT03687372|11957668|FG001|STARTED|Overall Study||249
10797367|NCT03687372|11957667|FG000|COMPLETED|Overall Study||237
10797368|NCT03687372|11957668|FG001|COMPLETED|Overall Study||210
10797369|NCT03687372|11957667|FG000|NOT COMPLETED|Overall Study||17
10797370|NCT03687372|11957668|FG001|NOT COMPLETED|Overall Study||39
10676393|NCT02364570|11838475|FG013|COMPLETED|Overall Study||2
10676394|NCT02364570|11838476|FG014|COMPLETED|Overall Study||1
10797371|NCT03687450|11957678|FG000|STARTED|Overall Study||38
10797372|NCT03687450|11957679|FG001|STARTED|Overall Study||18
10797373|NCT03687450|11957678|FG000|Post-Program Follow-Up|Overall Study|1 withdrew, 9 lost to follow-up|28
10797374|NCT03687450|11957679|FG001|Post-Program Follow-Up|Overall Study|3 lost to follow-up|15
10797375|NCT03687450|11957678|FG000|Two-month Follow-up|Overall Study|2 lost to follow-up|26
10797376|NCT03687450|11957679|FG001|Two-month Follow-up|Overall Study|2 lost to follow-up (N.B. 1 participant completed 2-month follow-up but not post-program follow-up)|16
10797377|NCT03687450|11957678|FG000|COMPLETED|Overall Study||26
10797378|NCT03687450|11957679|FG001|COMPLETED|Overall Study||16
10797379|NCT03687450|11957678|FG000|NOT COMPLETED|Overall Study||12
10797380|NCT03687450|11957679|FG001|NOT COMPLETED|Overall Study||2
10797381|NCT03687684|11957694|FG000|STARTED|Overall Study||4
10797382|NCT03687684|11957695|FG001|STARTED|Overall Study||2
10797383|NCT03687684|11957696|FG002|STARTED|Overall Study||2
10797384|NCT03687684|11957697|FG003|STARTED|Overall Study||6
10797385|NCT03687684|11957698|FG004|STARTED|Overall Study||6
10797386|NCT03687684|11957699|FG005|STARTED|Overall Study||6
10797387|NCT03687684|11957700|FG006|STARTED|Overall Study||6
10797388|NCT03687684|11957701|FG007|STARTED|Overall Study||2
10797389|NCT03687684|11957702|FG008|STARTED|Overall Study||6
10797390|NCT03687684|11957694|FG000|COMPLETED|Overall Study||4
10797391|NCT03687684|11957695|FG001|COMPLETED|Overall Study||2
10797392|NCT03687684|11957696|FG002|COMPLETED|Overall Study||2
10797393|NCT03687684|11957697|FG003|COMPLETED|Overall Study||6
10797394|NCT03687684|11957698|FG004|COMPLETED|Overall Study||6
10797395|NCT03687684|11957699|FG005|COMPLETED|Overall Study||6
10797396|NCT03687684|11957700|FG006|COMPLETED|Overall Study||6
10797397|NCT03687684|11957701|FG007|COMPLETED|Overall Study||2
10797398|NCT03687684|11957702|FG008|COMPLETED|Overall Study||6
10797399|NCT03687684|11957694|FG000|NOT COMPLETED|Overall Study||0
10797400|NCT03687684|11957695|FG001|NOT COMPLETED|Overall Study||0
10797401|NCT03687684|11957696|FG002|NOT COMPLETED|Overall Study||0
10797402|NCT03687684|11957697|FG003|NOT COMPLETED|Overall Study||0
10797403|NCT03687684|11957698|FG004|NOT COMPLETED|Overall Study||0
10797404|NCT03687684|11957699|FG005|NOT COMPLETED|Overall Study||0
10676395|NCT02364570|11838477|FG015|COMPLETED|Overall Study||1
10676396|NCT02364570|11838462|FG000|NOT COMPLETED|Overall Study||0
10676397|NCT02364570|11838463|FG001|NOT COMPLETED|Overall Study||0
10676398|NCT02364570|11838464|FG002|NOT COMPLETED|Overall Study||0
10797405|NCT03687684|11957700|FG006|NOT COMPLETED|Overall Study||0
10797406|NCT03687684|11957701|FG007|NOT COMPLETED|Overall Study||0
10797407|NCT03687684|11957702|FG008|NOT COMPLETED|Overall Study||0
10676399|NCT02364570|11838465|FG003|NOT COMPLETED|Overall Study||0
10676400|NCT02364570|11838466|FG004|NOT COMPLETED|Overall Study||0
10676401|NCT02364570|11838467|FG005|NOT COMPLETED|Overall Study||0
10676402|NCT02364570|11838468|FG006|NOT COMPLETED|Overall Study||0
10676403|NCT02364570|11838469|FG007|NOT COMPLETED|Overall Study||0
10676404|NCT02364570|11838470|FG008|NOT COMPLETED|Overall Study||0
10797411|NCT03687827|11957738|FG000|STARTED|Treatment Period 1||249
10676405|NCT02364570|11838471|FG009|NOT COMPLETED|Overall Study||0
10676406|NCT02364570|11838472|FG010|NOT COMPLETED|Overall Study||0
10676407|NCT02364570|11838473|FG011|NOT COMPLETED|Overall Study||0
10676408|NCT02364570|11838474|FG012|NOT COMPLETED|Overall Study||0
10676409|NCT02364570|11838475|FG013|NOT COMPLETED|Overall Study||0
10676410|NCT02364570|11838476|FG014|NOT COMPLETED|Overall Study||0
10676411|NCT02364570|11838477|FG015|NOT COMPLETED|Overall Study||0
10676412|NCT02364700|11838487|FG000|STARTED|Overall Study||12
10676413|NCT02364700|11838487|FG000|COMPLETED|Overall Study||12
10676414|NCT02364700|11838487|FG000|NOT COMPLETED|Overall Study||0
10676415|NCT02364778|11838493|FG000|STARTED|Overall Study||30
10676416|NCT02364778|11838493|FG000|COMPLETED|Overall Study||30
10676417|NCT02364778|11838493|FG000|NOT COMPLETED|Overall Study||0
10676418|NCT02364947|11838502|FG000|STARTED|Overall Study||248
10676419|NCT02364947|11838503|FG001|STARTED|Overall Study||184
10676420|NCT02364947|11838504|FG002|STARTED|Overall Study||245
10676421|NCT02364947|11838502|FG000|COMPLETED|Overall Study||189
10676422|NCT02364947|11838503|FG001|COMPLETED|Overall Study||139
10676423|NCT02364947|11838504|FG002|COMPLETED|Overall Study||219
10676424|NCT02364947|11838502|FG000|NOT COMPLETED|Overall Study||59
10676425|NCT02364947|11838503|FG001|NOT COMPLETED|Overall Study||45
10676426|NCT02364947|11838504|FG002|NOT COMPLETED|Overall Study||26
10676427|NCT02364999|11838514|FG000|STARTED|Overall Study||358
10676428|NCT02364999|11838515|FG001|STARTED|Overall Study||361
10676429|NCT02364999|11838514|FG000|Received Treatment|Overall Study||356
10676430|NCT02364999|11838515|FG001|Received Treatment|Overall Study||358
10676431|NCT02364999|11838514|FG000|COMPLETED|Overall Study||193
10676432|NCT02364999|11838515|FG001|COMPLETED|Overall Study||188
10676433|NCT02364999|11838514|FG000|NOT COMPLETED|Overall Study||165
10676434|NCT02364999|11838515|FG001|NOT COMPLETED|Overall Study||173
10676435|NCT02365064|11838524|FG000|STARTED|Overall Study||31
10676436|NCT02365064|11838525|FG001|STARTED|Overall Study||47
10676437|NCT02365064|11838524|FG000|Included in ITT Analysis|Overall Study||29
10676438|NCT02365064|11838525|FG001|Included in ITT Analysis|Overall Study||32
10676439|NCT02365064|11838524|FG000|COMPLETED|Overall Study||21
10676440|NCT02365064|11838525|FG001|COMPLETED|Overall Study||19
10676441|NCT02365064|11838524|FG000|NOT COMPLETED|Overall Study||10
10676442|NCT02365064|11838525|FG001|NOT COMPLETED|Overall Study||28
10676443|NCT02365285|11838535|FG000|STARTED|Overall Study||7
10676444|NCT02365285|11838536|FG001|STARTED|Overall Study||6
10676445|NCT02365285|11838537|FG002|STARTED|Overall Study||7
10676446|NCT02365285|11838538|FG003|STARTED|Overall Study||3
10676447|NCT02365285|11838535|FG000|COMPLETED|Overall Study||7
10676448|NCT02365285|11838536|FG001|COMPLETED|Overall Study||5
10676449|NCT02365285|11838537|FG002|COMPLETED|Overall Study||6
10676450|NCT02365285|11838538|FG003|COMPLETED|Overall Study||1
10676451|NCT02365285|11838535|FG000|NOT COMPLETED|Overall Study||0
10676452|NCT02365285|11838536|FG001|NOT COMPLETED|Overall Study||1
10676453|NCT02365285|11838537|FG002|NOT COMPLETED|Overall Study||1
10676454|NCT02365285|11838538|FG003|NOT COMPLETED|Overall Study||2
10676455|NCT02365298|11838550|FG000|STARTED|Period 1||14
10676456|NCT02365298|11838551|FG001|STARTED|Period 1||14
10676457|NCT02365298|11838550|FG000|COMPLETED|Period 1||14
10676458|NCT02365298|11838551|FG001|COMPLETED|Period 1||14
10676459|NCT02365298|11838550|FG000|NOT COMPLETED|Period 1||0
10676460|NCT02365298|11838551|FG001|NOT COMPLETED|Period 1||0
10676461|NCT02365298|11838550|FG000|STARTED|Period 2||14
10676462|NCT02365298|11838551|FG001|STARTED|Period 2||14
10676463|NCT02365298|11838550|FG000|COMPLETED|Period 2||12
10676464|NCT02365298|11838551|FG001|COMPLETED|Period 2||12
10676465|NCT02365298|11838550|FG000|NOT COMPLETED|Period 2||2
10676466|NCT02365298|11838551|FG001|NOT COMPLETED|Period 2||2
10676467|NCT02365480|11838559|FG000|STARTED|Overall Study||14
10676468|NCT02365480|11838560|FG001|STARTED|Overall Study||4
10676469|NCT02365480|11838559|FG000|COMPLETED|Overall Study||12
10676470|NCT02365480|11838560|FG001|COMPLETED|Overall Study||4
10676471|NCT02365480|11838559|FG000|NOT COMPLETED|Overall Study||2
10676472|NCT02365480|11838560|FG001|NOT COMPLETED|Overall Study||0
10676473|NCT02365506|11838569|FG000|STARTED|Overall Study||4
10676474|NCT02365506|11838570|FG001|STARTED|Overall Study||4
10676475|NCT02365506|11838571|FG002|STARTED|Overall Study||5
10676476|NCT02365506|11838569|FG000|COMPLETED|Overall Study||4
10676477|NCT02365506|11838570|FG001|COMPLETED|Overall Study||4
10676478|NCT02365506|11838571|FG002|COMPLETED|Overall Study||4
10676479|NCT02365506|11838569|FG000|NOT COMPLETED|Overall Study||0
10676480|NCT02365506|11838570|FG001|NOT COMPLETED|Overall Study||0
10676481|NCT02365506|11838571|FG002|NOT COMPLETED|Overall Study||1
10676482|NCT02365519|11838581|FG000|STARTED|Vehicle Run-In||213
10676483|NCT02365519|11838582|FG001|STARTED|Vehicle Run-In||0
10676484|NCT02365519|11838583|FG002|STARTED|Vehicle Run-In||0
10676485|NCT02365519|11838581|FG000|COMPLETED|Vehicle Run-In||134
10676486|NCT02365519|11838582|FG001|COMPLETED|Vehicle Run-In||0
10676487|NCT02365519|11838583|FG002|COMPLETED|Vehicle Run-In||0
10676488|NCT02365519|11838581|FG000|NOT COMPLETED|Vehicle Run-In||79
10676489|NCT02365519|11838582|FG001|NOT COMPLETED|Vehicle Run-In||0
10676490|NCT02365519|11838583|FG002|NOT COMPLETED|Vehicle Run-In||0
10676491|NCT02365519|11838581|FG000|STARTED|Randomized and Treated||0
10676492|NCT02365519|11838582|FG001|STARTED|Randomized and Treated||69
10676493|NCT02365519|11838583|FG002|STARTED|Randomized and Treated||65
10676494|NCT02365519|11838581|FG000|COMPLETED|Randomized and Treated||0
10676495|NCT02365519|11838582|FG001|COMPLETED|Randomized and Treated||67
10676496|NCT02365519|11838583|FG002|COMPLETED|Randomized and Treated||64
10676497|NCT02365519|11838581|FG000|NOT COMPLETED|Randomized and Treated||0
10676498|NCT02365519|11838582|FG001|NOT COMPLETED|Randomized and Treated||2
10676499|NCT02365519|11838583|FG002|NOT COMPLETED|Randomized and Treated||1
10676500|NCT02365558|11838592|FG000|STARTED|Period 1 (Day 1 Through Day 7)||34
10676501|NCT02365558|11838593|FG001|STARTED|Period 1 (Day 1 Through Day 7)||0
10676502|NCT02365558|11838592|FG000|Received at Least One Dose of Study Drug|Period 1 (Day 1 Through Day 7)||34
10676503|NCT02365558|11838593|FG001|Received at Least One Dose of Study Drug|Period 1 (Day 1 Through Day 7)||0
10676504|NCT02365558|11838592|FG000|COMPLETED|Period 1 (Day 1 Through Day 7)||33
10676505|NCT02365558|11838593|FG001|COMPLETED|Period 1 (Day 1 Through Day 7)||0
10676506|NCT02365558|11838592|FG000|NOT COMPLETED|Period 1 (Day 1 Through Day 7)||1
10676507|NCT02365558|11838593|FG001|NOT COMPLETED|Period 1 (Day 1 Through Day 7)||0
10676508|NCT02365558|11838592|FG000|STARTED|Period 2 (Day 8 Through Day 20)|Participants move to Evacetrapib + Omeprazole for Period 2.|0
10676509|NCT02365558|11838593|FG001|STARTED|Period 2 (Day 8 Through Day 20)|Participants completed Period 1 and entered Evacetrapib + Omeprazole for Period 2.|33
10676510|NCT02365558|11838592|FG000|COMPLETED|Period 2 (Day 8 Through Day 20)||0
10676511|NCT02365558|11838593|FG001|COMPLETED|Period 2 (Day 8 Through Day 20)||32
10797412|NCT03687827|11957739|FG001|STARTED|Treatment Period 1||249
10797413|NCT03687827|11957738|FG000|Full Analysis Set (FAS)|Treatment Period 1||249
10797414|NCT03687827|11957739|FG001|Full Analysis Set (FAS)|Treatment Period 1||249
10797415|NCT03687827|11957738|FG000|Safety Analysis Set (SAS)|Treatment Period 1||249
10797416|NCT03687827|11957739|FG001|Safety Analysis Set (SAS)|Treatment Period 1||249
10797417|NCT03687827|11957738|FG000|Per Protocol Set|Treatment Period 1||219
10797418|NCT03687827|11957739|FG001|Per Protocol Set|Treatment Period 1||229
10797419|NCT03687827|11957738|FG000|COMPLETED|Treatment Period 1||235
10797420|NCT03687827|11957739|FG001|COMPLETED|Treatment Period 1||241
10797421|NCT03687827|11957738|FG000|NOT COMPLETED|Treatment Period 1||14
10797422|NCT03687827|11957739|FG001|NOT COMPLETED|Treatment Period 1||8
10797423|NCT03687827|11957738|FG000|STARTED|Treatment Period 2||235
10797424|NCT03687827|11957739|FG001|STARTED|Treatment Period 2||241
10797425|NCT03687827|11957738|FG000|COMPLETED|Treatment Period 2||230
10797426|NCT03687827|11957739|FG001|COMPLETED|Treatment Period 2||238
10797427|NCT03687827|11957738|FG000|NOT COMPLETED|Treatment Period 2||5
10797428|NCT03687827|11957739|FG001|NOT COMPLETED|Treatment Period 2||3
10797429|NCT03687970|11957747|FG000|STARTED|Overall Study||22
10797430|NCT03687970|11957748|FG001|STARTED|Overall Study||20
10797431|NCT03687970|11957747|FG000|COMPLETED|Overall Study||20
10797432|NCT03687970|11957748|FG001|COMPLETED|Overall Study||20
10797433|NCT03687970|11957747|FG000|NOT COMPLETED|Overall Study||2
10797434|NCT03687970|11957748|FG001|NOT COMPLETED|Overall Study||0
10797435|NCT03688282|11957756|FG000|STARTED|Sham Treatment for 30 Minutes||18
10797436|NCT03688282|11957756|FG000|COMPLETED|Sham Treatment for 30 Minutes||17
10797437|NCT03688282|11957756|FG000|NOT COMPLETED|Sham Treatment for 30 Minutes||1
10797438|NCT03688282|11957756|FG000|STARTED|Washout (7 Days)||17
10797439|NCT03688282|11957756|FG000|COMPLETED|Washout (7 Days)||17
10797440|NCT03688282|11957756|FG000|NOT COMPLETED|Washout (7 Days)||0
10797441|NCT03688282|11957756|FG000|STARTED|Active Treatment for 30 Minutes||17
10797442|NCT03688282|11957756|FG000|COMPLETED|Active Treatment for 30 Minutes||17
10797443|NCT03688282|11957756|FG000|NOT COMPLETED|Active Treatment for 30 Minutes||0
10797444|NCT03688542|11957764|FG000|STARTED|Overall Study|No individual participants were recruited, only nursing homes.|
10797445|NCT03688542|11957765|FG001|STARTED|Overall Study|No individual participants were recruited, only nursing homes.|
10797446|NCT03688542|11957764|FG000|COMPLETED|Overall Study|No individual participants were recruited, only nursing homes.|
10797447|NCT03688542|11957765|FG001|COMPLETED|Overall Study|"1 nursing home withdrew from the study.~No individual participants were recruited, only nursing homes."|
10797448|NCT03688542|11957764|FG000|NOT COMPLETED|Overall Study||
10797449|NCT03688542|11957765|FG001|NOT COMPLETED|Overall Study||
10797450|NCT03688620|11957774|FG000|STARTED|Overall Study||329
10797451|NCT03688620|11957775|FG001|STARTED|Overall Study||278
10797452|NCT03688620|11957776|FG002|STARTED|Overall Study||453
10797453|NCT03688620|11957774|FG000|COMPLETED|Overall Study||313
10797454|NCT03688620|11957775|FG001|COMPLETED|Overall Study||277
10797455|NCT03688620|11957776|FG002|COMPLETED|Overall Study||445
10797456|NCT03688620|11957774|FG000|NOT COMPLETED|Overall Study||16
10797457|NCT03688620|11957775|FG001|NOT COMPLETED|Overall Study||1
10797458|NCT03688620|11957776|FG002|NOT COMPLETED|Overall Study||8
10797459|NCT03688685|11957786|FG000|STARTED|Overall Study||25
10797460|NCT03688685|11957786|FG000|COMPLETED|Overall Study||21
10797461|NCT03688685|11957786|FG000|NOT COMPLETED|Overall Study||4
10797462|NCT03688711|11957792|FG000|STARTED|Overall Study||34
10797463|NCT03688711|11957793|FG001|STARTED|Overall Study||11
10797464|NCT03688711|11957792|FG000|COMPLETED|Overall Study||34
10797465|NCT03688711|11957793|FG001|COMPLETED|Overall Study||10
10797466|NCT03688711|11957792|FG000|NOT COMPLETED|Overall Study||0
10797467|NCT03688711|11957793|FG001|NOT COMPLETED|Overall Study||1
10797468|NCT03688880|11957801|FG000|STARTED|Overall Study||29
10797469|NCT03688880|11957802|FG001|STARTED|Overall Study||60
10797470|NCT03688880|11957801|FG000|COMPLETED|Overall Study||15
10797471|NCT03688880|11957802|FG001|COMPLETED|Overall Study||29
10797472|NCT03688880|11957801|FG000|NOT COMPLETED|Overall Study||14
10676512|NCT02365558|11838592|FG000|NOT COMPLETED|Period 2 (Day 8 Through Day 20)||0
10676513|NCT02365558|11838593|FG001|NOT COMPLETED|Period 2 (Day 8 Through Day 20)||1
10676514|NCT02365584|11838604|FG000|STARTED|Overall Study||21
10676515|NCT02365584|11838605|FG001|STARTED|Overall Study||22
10676516|NCT02365584|11838604|FG000|COMPLETED|Overall Study||9
10676517|NCT02365584|11838605|FG001|COMPLETED|Overall Study||8
10797473|NCT03688880|11957802|FG001|NOT COMPLETED|Overall Study||31
10676518|NCT02365584|11838604|FG000|NOT COMPLETED|Overall Study||12
10676519|NCT02365584|11838605|FG001|NOT COMPLETED|Overall Study||14
10676520|NCT02365636|11838614|FG000|STARTED|Overall Study||100
10676521|NCT02365636|11838615|FG001|STARTED|Overall Study||100
10676522|NCT02365636|11838616|FG002|STARTED|Overall Study||100
10676523|NCT02365636|11838614|FG000|Safety Population|Overall Study||100
10676524|NCT02365636|11838615|FG001|Safety Population|Overall Study|2 terminated prior to treatment due to 1) prohibited concomitant medication 2) exclusion criteria|98
10676525|NCT02365636|11838616|FG002|Safety Population|Overall Study||100
10676526|NCT02365636|11838614|FG000|Full Analysis Set|Overall Study||100
10676527|NCT02365636|11838615|FG001|Full Analysis Set|Overall Study||98
10676528|NCT02365636|11838616|FG002|Full Analysis Set|Overall Study||100
10676529|NCT02365636|11838614|FG000|COMPLETED|Overall Study||94
10676530|NCT02365636|11838615|FG001|COMPLETED|Overall Study||93
10676531|NCT02365636|11838616|FG002|COMPLETED|Overall Study||97
10676532|NCT02365636|11838614|FG000|NOT COMPLETED|Overall Study||6
10676533|NCT02365636|11838615|FG001|NOT COMPLETED|Overall Study||7
10676534|NCT02365636|11838616|FG002|NOT COMPLETED|Overall Study||3
10676535|NCT02365714|11838624|FG000|STARTED|Overall Study||2
10676536|NCT02365714|11838624|FG000|COMPLETED|Overall Study||2
10676537|NCT02365714|11838624|FG000|NOT COMPLETED|Overall Study||0
10676538|NCT02365870|11838630|FG000|STARTED|Overall Study||1
10676539|NCT02365870|11838631|FG001|STARTED|Overall Study||3
10676540|NCT02365870|11838630|FG000|COMPLETED|Overall Study||1
10676541|NCT02365870|11838631|FG001|COMPLETED|Overall Study||3
10676542|NCT02365870|11838630|FG000|NOT COMPLETED|Overall Study||0
10676543|NCT02365870|11838631|FG001|NOT COMPLETED|Overall Study||0
10676544|NCT02365961|11838639|FG000|STARTED|Overall Study||41
10797474|NCT03689452|11957810|FG000|STARTED|Overall Study||15
10797475|NCT03689452|11957811|FG001|STARTED|Overall Study||15
10797476|NCT03689452|11957810|FG000|COMPLETED|Overall Study||14
10797477|NCT03689452|11957811|FG001|COMPLETED|Overall Study||14
10797478|NCT03689452|11957810|FG000|NOT COMPLETED|Overall Study||1
10797479|NCT03689452|11957811|FG001|NOT COMPLETED|Overall Study||1
10797480|NCT03689504|11957819|FG000|STARTED|Overall Study||70
10797481|NCT03689504|11957820|FG001|STARTED|Overall Study||70
10797482|NCT03689504|11957819|FG000|COMPLETED|Overall Study||65
10797483|NCT03689504|11957820|FG001|COMPLETED|Overall Study||70
10797484|NCT03689504|11957819|FG000|NOT COMPLETED|Overall Study||5
10797485|NCT03689504|11957820|FG001|NOT COMPLETED|Overall Study||0
10797486|NCT03690375|11957828|FG000|STARTED|Overall Study||10
10797487|NCT03690375|11957829|FG001|STARTED|Overall Study||10
10797488|NCT03690375|11957828|FG000|COMPLETED|Overall Study||10
10797489|NCT03690375|11957829|FG001|COMPLETED|Overall Study||10
10797490|NCT03690375|11957828|FG000|NOT COMPLETED|Overall Study||0
10797491|NCT03690375|11957829|FG001|NOT COMPLETED|Overall Study||0
10797492|NCT03691779|11957838|FG000|STARTED|Part A (15 Days)||16
10797493|NCT03691779|11957839|FG001|STARTED|Part A (15 Days)||0
10797494|NCT03691779|11957838|FG000|COMPLETED|Part A (15 Days)||16
10797495|NCT03691779|11957839|FG001|COMPLETED|Part A (15 Days)||0
10797496|NCT03691779|11957838|FG000|NOT COMPLETED|Part A (15 Days)||0
10797497|NCT03691779|11957839|FG001|NOT COMPLETED|Part A (15 Days)||0
10797498|NCT03691779|11957838|FG000|STARTED|Part B (24 Weeks)||0
10797499|NCT03691779|11957839|FG001|STARTED|Part B (24 Weeks)|Out of the 16 participants from Part A, 11 participants also participated in Part B of the study.|66
10797500|NCT03691779|11957838|FG000|COMPLETED|Part B (24 Weeks)||0
10797501|NCT03691779|11957839|FG001|COMPLETED|Part B (24 Weeks)||64
10797502|NCT03691779|11957838|FG000|NOT COMPLETED|Part B (24 Weeks)||0
10797503|NCT03691779|11957839|FG001|NOT COMPLETED|Part B (24 Weeks)||2
10797504|NCT03691831|11957848|FG000|STARTED|Overall Study||251
10797505|NCT03691831|11957849|FG001|STARTED|Overall Study||251
10797506|NCT03691831|11957848|FG000|COMPLETED|Overall Study||224
10797507|NCT03691831|11957849|FG001|COMPLETED|Overall Study||220
10797508|NCT03691831|11957848|FG000|NOT COMPLETED|Overall Study||27
10797509|NCT03691831|11957849|FG001|NOT COMPLETED|Overall Study||31
10797510|NCT03691844|11957859|FG000|STARTED|Overall Study||121
10797511|NCT03691844|11957860|FG001|STARTED|Overall Study||121
10797512|NCT03691844|11957861|FG002|STARTED|Overall Study||121
10797513|NCT03691844|11957862|FG003|STARTED|Overall Study||81
10797514|NCT03691844|11957859|FG000|COMPLETED|Overall Study||114
10797515|NCT03691844|11957860|FG001|COMPLETED|Overall Study||109
10797516|NCT03691844|11957861|FG002|COMPLETED|Overall Study||108
10797517|NCT03691844|11957862|FG003|COMPLETED|Overall Study||70
10797518|NCT03691844|11957859|FG000|NOT COMPLETED|Overall Study||7
10797519|NCT03691844|11957860|FG001|NOT COMPLETED|Overall Study||12
10797520|NCT03691844|11957861|FG002|NOT COMPLETED|Overall Study||13
10797521|NCT03691844|11957862|FG003|NOT COMPLETED|Overall Study||11
10797522|NCT03691948|11957876|FG000|STARTED|Overall Study||27
10797523|NCT03691948|11957877|FG001|STARTED|Overall Study||33
10797524|NCT03691948|11957876|FG000|COMPLETED|Overall Study||26
10797525|NCT03691948|11957877|FG001|COMPLETED|Overall Study||30
10797526|NCT03691948|11957876|FG000|NOT COMPLETED|Overall Study||1
10797527|NCT03691948|11957877|FG001|NOT COMPLETED|Overall Study||3
10797528|NCT03692676|11957888|FG000|STARTED|Overall Study||10365
10797529|NCT03692676|11957889|FG001|STARTED|Overall Study||51142
10797530|NCT03692676|11957890|FG002|STARTED|Overall Study||49479
10676545|NCT02365961|11838640|FG001|STARTED|Overall Study||43
10676546|NCT02365961|11838639|FG000|COMPLETED|Overall Study||41
10676547|NCT02365961|11838640|FG001|COMPLETED|Overall Study||43
10676548|NCT02365961|11838639|FG000|NOT COMPLETED|Overall Study||0
10676549|NCT02365961|11838640|FG001|NOT COMPLETED|Overall Study||0
10676550|NCT02366091|11838650|FG000|STARTED|Overall Study||24
10797531|NCT03692676|11957891|FG003|STARTED|Overall Study||5147
10676551|NCT02366091|11838651|FG001|STARTED|Overall Study||23
10676552|NCT02366091|11838652|FG002|STARTED|Overall Study||24
10676553|NCT02366091|11838653|FG003|STARTED|Overall Study||23
10676554|NCT02366091|11838650|FG000|COMPLETED|Overall Study||21
10676555|NCT02366091|11838651|FG001|COMPLETED|Overall Study||16
10676556|NCT02366091|11838652|FG002|COMPLETED|Overall Study||21
10676557|NCT02366091|11838653|FG003|COMPLETED|Overall Study||22
10676558|NCT02366091|11838650|FG000|NOT COMPLETED|Overall Study||3
10676559|NCT02366091|11838651|FG001|NOT COMPLETED|Overall Study||7
10797532|NCT03692676|11957888|FG000|COMPLETED|Overall Study||940
10797533|NCT03692676|11957889|FG001|COMPLETED|Overall Study||3704
10797534|NCT03692676|11957890|FG002|COMPLETED|Overall Study||11135
10797535|NCT03692676|11957891|FG003|COMPLETED|Overall Study||1561
10797536|NCT03692676|11957888|FG000|NOT COMPLETED|Overall Study||9425
10797537|NCT03692676|11957889|FG001|NOT COMPLETED|Overall Study||47438
10797538|NCT03692676|11957890|FG002|NOT COMPLETED|Overall Study||38344
10797539|NCT03692676|11957891|FG003|NOT COMPLETED|Overall Study||3586
10797540|NCT03693625|11957903|FG000|STARTED|Overall Study||23
10797541|NCT03693625|11957904|FG001|STARTED|Overall Study||8
10797542|NCT03693625|11957903|FG000|COMPLETED|Overall Study||0
10797543|NCT03693625|11957904|FG001|COMPLETED|Overall Study||0
10797544|NCT03693625|11957903|FG000|NOT COMPLETED|Overall Study||23
10797545|NCT03693625|11957904|FG001|NOT COMPLETED|Overall Study||8
10797546|NCT03693742|11957912|FG000|STARTED|Overall Study||7
10797547|NCT03693742|11957913|FG001|STARTED|Overall Study||3
10797548|NCT03693742|11957912|FG000|COMPLETED|Overall Study||7
10797549|NCT03693742|11957913|FG001|COMPLETED|Overall Study||3
10797550|NCT03693742|11957912|FG000|NOT COMPLETED|Overall Study||0
10797551|NCT03693742|11957913|FG001|NOT COMPLETED|Overall Study||0
10797552|NCT03693937|11957921|FG000|STARTED|Overall Study||776
10797553|NCT03693937|11957921|FG000|COMPLETED|Overall Study||776
10797554|NCT03693937|11957921|FG000|NOT COMPLETED|Overall Study||0
10797555|NCT03693950|11957927|FG000|STARTED|Overall Study||29
10797556|NCT03693950|11957928|FG001|STARTED|Overall Study||28
10797557|NCT03693950|11957927|FG000|COMPLETED|Overall Study||28
10797558|NCT03693950|11957928|FG001|COMPLETED|Overall Study||28
10797559|NCT03693950|11957927|FG000|NOT COMPLETED|Overall Study||1
10797560|NCT03693950|11957928|FG001|NOT COMPLETED|Overall Study||0
10797561|NCT03693989|11957936|FG000|STARTED|Overall Study||88
10797562|NCT03693989|11957937|FG001|STARTED|Overall Study||90
10797563|NCT03693989|11957936|FG000|COMPLETED|Overall Study||85
10797564|NCT03693989|11957937|FG001|COMPLETED|Overall Study||86
10797565|NCT03693989|11957936|FG000|NOT COMPLETED|Overall Study||3
10797566|NCT03693989|11957937|FG001|NOT COMPLETED|Overall Study||4
10797567|NCT03694197|11957943|FG000|STARTED|Overall Study||1385
10797568|NCT03694197|11957943|FG000|COMPLETED|Overall Study||0
10797569|NCT03694197|11957943|FG000|NOT COMPLETED|Overall Study||1385
10797570|NCT03694210|11957947|FG000|STARTED|Overall Study||37
10797571|NCT03694210|11957947|FG000|COMPLETED|Overall Study||29
10797572|NCT03694210|11957947|FG000|NOT COMPLETED|Overall Study||8
10797573|NCT03694548|11957955|FG000|STARTED|Part A Survey||18
10797574|NCT03694548|11957956|FG001|STARTED|Part A Survey||17
10797575|NCT03694548|11957957|FG002|STARTED|Part A Survey||0
10797576|NCT03694548|11957955|FG000|COMPLETED|Part A Survey||15
10797577|NCT03694548|11957956|FG001|COMPLETED|Part A Survey||14
10797578|NCT03694548|11957957|FG002|COMPLETED|Part A Survey||0
10797579|NCT03694548|11957955|FG000|NOT COMPLETED|Part A Survey||3
10797580|NCT03694548|11957956|FG001|NOT COMPLETED|Part A Survey||3
10797581|NCT03694548|11957957|FG002|NOT COMPLETED|Part A Survey||0
10797582|NCT03694548|11957955|FG000|STARTED|Part B Yoga Program||0
10797583|NCT03694548|11957956|FG001|STARTED|Part B Yoga Program||0
10797584|NCT03694548|11957957|FG002|STARTED|Part B Yoga Program||12
10797585|NCT03694548|11957955|FG000|COMPLETED|Part B Yoga Program||0
10797586|NCT03694548|11957956|FG001|COMPLETED|Part B Yoga Program||0
10797587|NCT03694548|11957957|FG002|COMPLETED|Part B Yoga Program||1
10797588|NCT03694548|11957955|FG000|NOT COMPLETED|Part B Yoga Program||0
10797589|NCT03694548|11957956|FG001|NOT COMPLETED|Part B Yoga Program||0
10797590|NCT03694548|11957957|FG002|NOT COMPLETED|Part B Yoga Program||11
10797591|NCT03694613|11957967|FG000|STARTED|Overall Study||65
10797592|NCT03694613|11957967|FG000|COMPLETED|Overall Study|65 samples were collected and analyzed. at least 3 ml were collected.|65
10797593|NCT03694613|11957967|FG000|NOT COMPLETED|Overall Study||0
10797594|NCT03694925|11957983|FG000|STARTED|Overall Study||30
10797595|NCT03694925|11957984|FG001|STARTED|Overall Study||73
10797596|NCT03694925|11957985|FG002|STARTED|Overall Study||53
10797597|NCT03694925|11957983|FG000|COMPLETED|Overall Study||30
10797598|NCT03694925|11957984|FG001|COMPLETED|Overall Study||70
10797599|NCT03694925|11957985|FG002|COMPLETED|Overall Study||53
10797600|NCT03694925|11957983|FG000|NOT COMPLETED|Overall Study||0
10676560|NCT02366091|11838652|FG002|NOT COMPLETED|Overall Study||3
10797601|NCT03694925|11957984|FG001|NOT COMPLETED|Overall Study||3
10797602|NCT03694925|11957985|FG002|NOT COMPLETED|Overall Study||0
10797603|NCT03695094|11957997|FG000|STARTED|Overall Study||16
10797604|NCT03695094|11957998|FG001|STARTED|Overall Study||15
10797605|NCT03695094|11957997|FG000|COMPLETED|Overall Study||14
10797606|NCT03695094|11957998|FG001|COMPLETED|Overall Study||14
10676561|NCT02366091|11838653|FG003|NOT COMPLETED|Overall Study||1
10676562|NCT02366130|11838663|FG000|STARTED|Overall Study||45
10676563|NCT02366130|11838663|FG000|COMPLETED|Overall Study||36
10797607|NCT03695094|11957997|FG000|NOT COMPLETED|Overall Study||2
10797608|NCT03695094|11957998|FG001|NOT COMPLETED|Overall Study||1
10797609|NCT03695367|11958008|FG000|STARTED|Overall Study||33
10797610|NCT03695367|11958009|FG001|STARTED|Overall Study||30
10676564|NCT02366130|11838663|FG000|NOT COMPLETED|Overall Study||9
10676565|NCT02366143|11838670|FG000|STARTED|Overall Study||400
10676566|NCT02366143|11838671|FG001|STARTED|Overall Study||400
10676567|NCT02366143|11838672|FG002|STARTED|Overall Study||402
10676568|NCT02366143|11838670|FG000|COMPLETED|Overall Study||0
10676569|NCT02366143|11838671|FG001|COMPLETED|Overall Study||0
10676570|NCT02366143|11838672|FG002|COMPLETED|Overall Study||0
10676571|NCT02366143|11838670|FG000|NOT COMPLETED|Overall Study||400
10676572|NCT02366143|11838671|FG001|NOT COMPLETED|Overall Study||400
10676573|NCT02366143|11838672|FG002|NOT COMPLETED|Overall Study||402
10676574|NCT02366195|11838684|FG000|STARTED|Overall Study||112
10676575|NCT02366195|11838684|FG000|Received Study Drug|Overall Study||111
10676576|NCT02366195|11838684|FG000|COMPLETED|Overall Study||58
10676577|NCT02366195|11838684|FG000|NOT COMPLETED|Overall Study||54
10676578|NCT02366312|11838690|FG000|STARTED|Overall Study||1
10676579|NCT02366312|11838691|FG001|STARTED|Overall Study||1
10676580|NCT02366312|11838690|FG000|COMPLETED|Overall Study||1
10676581|NCT02366312|11838691|FG001|COMPLETED|Overall Study|The subject did not attend the 2-year post-treatment visit (last visit).|0
10676582|NCT02366312|11838690|FG000|NOT COMPLETED|Overall Study||0
10676583|NCT02366312|11838691|FG001|NOT COMPLETED|Overall Study||1
10676584|NCT02366338|11838700|FG000|STARTED|Overall Study||73
10676585|NCT02366338|11838701|FG001|STARTED|Overall Study||39
10676586|NCT02366338|11838702|FG002|STARTED|Overall Study||36
10676587|NCT02366338|11838700|FG000|COMPLETED|Overall Study||73
10676588|NCT02366338|11838701|FG001|COMPLETED|Overall Study||39
10676589|NCT02366338|11838702|FG002|COMPLETED|Overall Study||36
10676590|NCT02366338|11838700|FG000|NOT COMPLETED|Overall Study||0
10676591|NCT02366338|11838701|FG001|NOT COMPLETED|Overall Study||0
10676592|NCT02366338|11838702|FG002|NOT COMPLETED|Overall Study||0
10676593|NCT02366468|11838712|FG000|STARTED|Overall Study||68
10676594|NCT02366468|11838713|FG001|STARTED|Overall Study||67
10676595|NCT02366468|11838712|FG000|Full Analysis Set (FAS)|Overall Study||67
10676596|NCT02366468|11838713|FG001|Full Analysis Set (FAS)|Overall Study||66
10676597|NCT02366468|11838712|FG000|Per Protocol Set (PPS)|Overall Study||62
10676598|NCT02366468|11838713|FG001|Per Protocol Set (PPS)|Overall Study||61
10676599|NCT02366468|11838712|FG000|COMPLETED|Overall Study||62
10676600|NCT02366468|11838713|FG001|COMPLETED|Overall Study||58
10676601|NCT02366468|11838712|FG000|NOT COMPLETED|Overall Study||6
10676602|NCT02366468|11838713|FG001|NOT COMPLETED|Overall Study||9
10676603|NCT02366611|11838721|FG000|STARTED|Overall Study||10
10676604|NCT02366611|11838722|FG001|STARTED|Overall Study||1
10676605|NCT02366611|11838721|FG000|COMPLETED|Overall Study||8
10676606|NCT02366611|11838722|FG001|COMPLETED|Overall Study||1
10676607|NCT02366611|11838721|FG000|NOT COMPLETED|Overall Study||2
10676608|NCT02366611|11838722|FG001|NOT COMPLETED|Overall Study||0
10676609|NCT02366637|11838729|FG000|STARTED|First Intervention Period||7
10676610|NCT02366637|11838730|FG001|STARTED|First Intervention Period||6
10676611|NCT02366637|11838729|FG000|COMPLETED|First Intervention Period||1
10676612|NCT02366637|11838730|FG001|COMPLETED|First Intervention Period||1
10676613|NCT02366637|11838729|FG000|NOT COMPLETED|First Intervention Period||6
10676614|NCT02366637|11838730|FG001|NOT COMPLETED|First Intervention Period||5
10676615|NCT02366637|11838729|FG000|STARTED|Washout Period 28 to 49 Days||1
10676616|NCT02366637|11838730|FG001|STARTED|Washout Period 28 to 49 Days||1
10676617|NCT02366637|11838729|FG000|COMPLETED|Washout Period 28 to 49 Days||1
10676618|NCT02366637|11838730|FG001|COMPLETED|Washout Period 28 to 49 Days||1
10676619|NCT02366637|11838729|FG000|NOT COMPLETED|Washout Period 28 to 49 Days||0
10676620|NCT02366637|11838730|FG001|NOT COMPLETED|Washout Period 28 to 49 Days||0
10676621|NCT02366637|11838729|FG000|STARTED|Second Intervention Period||1
10676622|NCT02366637|11838730|FG001|STARTED|Second Intervention Period||1
10676623|NCT02366637|11838729|FG000|COMPLETED|Second Intervention Period||0
10676624|NCT02366637|11838730|FG001|COMPLETED|Second Intervention Period||0
10676625|NCT02366637|11838729|FG000|NOT COMPLETED|Second Intervention Period||1
10676626|NCT02366637|11838730|FG001|NOT COMPLETED|Second Intervention Period||1
10797611|NCT03695367|11958008|FG000|COMPLETED|Overall Study||32
10797612|NCT03695367|11958009|FG001|COMPLETED|Overall Study||26
10797613|NCT03695367|11958008|FG000|NOT COMPLETED|Overall Study||1
10797614|NCT03695367|11958009|FG001|NOT COMPLETED|Overall Study||4
10797615|NCT03695393|11958017|FG000|STARTED|Overall Study||67
10797616|NCT03695393|11958018|FG001|STARTED|Overall Study||33
10797617|NCT03695393|11958017|FG000|1-month|Overall Study||66
10797618|NCT03695393|11958018|FG001|1-month|Overall Study||32
10797619|NCT03695393|11958017|FG000|6-month|Overall Study||64
10797620|NCT03695393|11958018|FG001|6-month|Overall Study||31
10797621|NCT03695393|11958017|FG000|COMPLETED|Overall Study||64
10797622|NCT03695393|11958018|FG001|COMPLETED|Overall Study||31
10797623|NCT03695393|11958017|FG000|NOT COMPLETED|Overall Study||3
10797624|NCT03695393|11958018|FG001|NOT COMPLETED|Overall Study||2
10797625|NCT03695913|11958024|FG000|STARTED|Overall Study||15
10318813|NCT00217672|11453087|FG001|STARTED|Allocation|When bevacizumab became available, study converted to a 1-arm open-label trial with just bevacizumab|7
10318814|NCT00217672|11453086|FG000|COMPLETED|Allocation||67
10318815|NCT00217672|11453087|FG001|COMPLETED|Allocation||7
10318816|NCT00217672|11453086|FG000|NOT COMPLETED|Allocation||2
10318817|NCT00217672|11453087|FG001|NOT COMPLETED|Allocation||0
10797626|NCT03695913|11958024|FG000|COMPLETED|Overall Study||15
10797627|NCT03695913|11958024|FG000|NOT COMPLETED|Overall Study||0
10797628|NCT03696108|11958030|FG000|STARTED|Overall Study||84
10797629|NCT03696108|11958031|FG001|STARTED|Overall Study||85
10797630|NCT03696108|11958030|FG000|COMPLETED|Overall Study||80
10676627|NCT02366663|11838738|FG000|STARTED|Overall Study||2
10676628|NCT02366663|11838739|FG001|STARTED|Overall Study||1
10676629|NCT02366663|11838738|FG000|COMPLETED|Overall Study||2
10676630|NCT02366663|11838739|FG001|COMPLETED|Overall Study||1
10676631|NCT02366663|11838738|FG000|NOT COMPLETED|Overall Study||0
10676632|NCT02366663|11838739|FG001|NOT COMPLETED|Overall Study||0
10676633|NCT02366689|11838748|FG000|STARTED|Overall Study||60
10676634|NCT02366689|11838749|FG001|STARTED|Overall Study||58
10676635|NCT02366689|11838750|FG002|STARTED|Overall Study||61
10676636|NCT02366689|11838748|FG000|COMPLETED|Overall Study||56
10676637|NCT02366689|11838749|FG001|COMPLETED|Overall Study||55
10676638|NCT02366689|11838750|FG002|COMPLETED|Overall Study||59
10676639|NCT02366689|11838748|FG000|NOT COMPLETED|Overall Study||4
10676640|NCT02366689|11838749|FG001|NOT COMPLETED|Overall Study||3
10676641|NCT02366689|11838750|FG002|NOT COMPLETED|Overall Study||2
10676642|NCT02366767|11838760|FG000|STARTED|Overall Study||11
10676643|NCT02366767|11838761|FG001|STARTED|Overall Study||10
10676644|NCT02366767|11838760|FG000|COMPLETED|Overall Study||10
10676645|NCT02366767|11838761|FG001|COMPLETED|Overall Study||10
10676646|NCT02366767|11838760|FG000|NOT COMPLETED|Overall Study||1
10676647|NCT02366767|11838761|FG001|NOT COMPLETED|Overall Study||0
10676648|NCT02366845|11838769|FG000|STARTED|Overall Study||25
10676649|NCT02366845|11838770|FG001|STARTED|Overall Study||25
10676650|NCT02366845|11838769|FG000|COMPLETED|Overall Study||25
10676651|NCT02366845|11838770|FG001|COMPLETED|Overall Study||25
10676652|NCT02366845|11838769|FG000|NOT COMPLETED|Overall Study||0
10676653|NCT02366845|11838770|FG001|NOT COMPLETED|Overall Study||0
10676654|NCT02366871|11838778|FG000|STARTED|Overall Study||204
10797631|NCT03696108|11958031|FG001|COMPLETED|Overall Study||79
10797632|NCT03696108|11958030|FG000|NOT COMPLETED|Overall Study||4
10797633|NCT03696108|11958031|FG001|NOT COMPLETED|Overall Study||6
10797634|NCT03696342|11958039|FG000|STARTED|Overall Study||23
10797635|NCT03696342|11958040|FG001|STARTED|Overall Study||23
10797636|NCT03696342|11958039|FG000|COMPLETED|Overall Study||22
10797637|NCT03696342|11958040|FG001|COMPLETED|Overall Study||23
10797638|NCT03696342|11958039|FG000|NOT COMPLETED|Overall Study||1
10797639|NCT03696342|11958040|FG001|NOT COMPLETED|Overall Study||0
10797640|NCT03696576|11958048|FG000|STARTED|Overall Study||13
10797641|NCT03696576|11958049|FG001|STARTED|Overall Study||11
10797642|NCT03696576|11958048|FG000|COMPLETED|Overall Study||10
10797643|NCT03696576|11958049|FG001|COMPLETED|Overall Study||6
10797644|NCT03696576|11958048|FG000|NOT COMPLETED|Overall Study||3
10797645|NCT03696576|11958049|FG001|NOT COMPLETED|Overall Study||5
10797646|NCT03696589|11958055|FG000|STARTED|Overall Study||13
10797647|NCT03696589|11958055|FG000|COMPLETED|Overall Study||12
10797648|NCT03696589|11958055|FG000|NOT COMPLETED|Overall Study||1
10797649|NCT03696758|11958068|FG000|STARTED|First Intervention||3
10797650|NCT03696758|11958069|FG001|STARTED|First Intervention||6
10797651|NCT03696758|11958068|FG000|COMPLETED|First Intervention||3
10797652|NCT03696758|11958069|FG001|COMPLETED|First Intervention||6
10797653|NCT03696758|11958068|FG000|NOT COMPLETED|First Intervention||0
10797654|NCT03696758|11958069|FG001|NOT COMPLETED|First Intervention||0
10797655|NCT03696758|11958068|FG000|STARTED|Wash Out>12 Hours||3
10797656|NCT03696758|11958069|FG001|STARTED|Wash Out>12 Hours||6
10797657|NCT03696758|11958068|FG000|COMPLETED|Wash Out>12 Hours||3
10797658|NCT03696758|11958069|FG001|COMPLETED|Wash Out>12 Hours||6
10797659|NCT03696758|11958068|FG000|NOT COMPLETED|Wash Out>12 Hours||0
10797660|NCT03696758|11958069|FG001|NOT COMPLETED|Wash Out>12 Hours||0
10797661|NCT03696758|11958068|FG000|STARTED|Second Intervention||3
10797662|NCT03696758|11958069|FG001|STARTED|Second Intervention||6
10797663|NCT03696758|11958068|FG000|COMPLETED|Second Intervention||3
10797664|NCT03696758|11958069|FG001|COMPLETED|Second Intervention||6
10797665|NCT03696758|11958068|FG000|NOT COMPLETED|Second Intervention||0
10797666|NCT03696758|11958069|FG001|NOT COMPLETED|Second Intervention||0
10797667|NCT03697083|11958078|FG000|STARTED|Overall Study||262
10797668|NCT03697083|11958079|FG001|STARTED|Overall Study||260
10797669|NCT03697083|11958080|FG002|STARTED|Overall Study||255
10797670|NCT03697083|11958078|FG000|COMPLETED|Overall Study||262
10797671|NCT03697083|11958079|FG001|COMPLETED|Overall Study||250
10797672|NCT03697083|11958080|FG002|COMPLETED|Overall Study||255
10797673|NCT03697083|11958078|FG000|NOT COMPLETED|Overall Study||0
10797674|NCT03697083|11958079|FG001|NOT COMPLETED|Overall Study||10
10797675|NCT03697083|11958080|FG002|NOT COMPLETED|Overall Study||0
10797676|NCT03697122|11958088|FG000|STARTED|Overall Study||14
10797677|NCT03697122|11958088|FG000|COMPLETED|Overall Study||14
10676655|NCT02366871|11838779|FG001|STARTED|Overall Study||196
10676656|NCT02366871|11838778|FG000|COMPLETED|Overall Study||204
10676657|NCT02366871|11838779|FG001|COMPLETED|Overall Study||196
10676658|NCT02366871|11838778|FG000|NOT COMPLETED|Overall Study||0
10797678|NCT03697122|11958088|FG000|NOT COMPLETED|Overall Study||0
10797679|NCT03697252|11958094|FG000|STARTED|Overall Study||90
10797680|NCT03697252|11958095|FG001|STARTED|Overall Study||92
10797681|NCT03697252|11958094|FG000|COMPLETED|Overall Study||72
10797682|NCT03697252|11958095|FG001|COMPLETED|Overall Study||73
10797683|NCT03697252|11958094|FG000|NOT COMPLETED|Overall Study||18
10797684|NCT03697252|11958095|FG001|NOT COMPLETED|Overall Study||19
10676659|NCT02366871|11838779|FG001|NOT COMPLETED|Overall Study||0
10676660|NCT02366910|11838785|FG000|STARTED|Overall Study||26
10676661|NCT02366910|11838785|FG000|COMPLETED|Overall Study||21
10676662|NCT02366910|11838785|FG000|NOT COMPLETED|Overall Study||5
10676663|NCT02366923|11838791|FG000|STARTED|Overall Study||28
10676664|NCT02366923|11838791|FG000|COMPLETED|Overall Study||22
10676665|NCT02366923|11838791|FG000|NOT COMPLETED|Overall Study||6
10676666|NCT02366936|11838796|FG000|STARTED|Overall Study||32
10676667|NCT02366936|11838796|FG000|COMPLETED|Overall Study||24
10676668|NCT02366936|11838796|FG000|NOT COMPLETED|Overall Study||8
10676669|NCT02367014|11838804|FG000|STARTED|Overall Study||9
10676670|NCT02367014|11838805|FG001|STARTED|Overall Study||9
10676671|NCT02367014|11838806|FG002|STARTED|Overall Study||9
10676672|NCT02367014|11838807|FG003|STARTED|Overall Study||9
10676673|NCT02367014|11838804|FG000|COMPLETED|Overall Study||9
10676674|NCT02367014|11838805|FG001|COMPLETED|Overall Study||9
10676675|NCT02367014|11838806|FG002|COMPLETED|Overall Study||9
10676676|NCT02367014|11838807|FG003|COMPLETED|Overall Study||9
10676677|NCT02367014|11838804|FG000|NOT COMPLETED|Overall Study||0
10676678|NCT02367014|11838805|FG001|NOT COMPLETED|Overall Study||0
10676679|NCT02367014|11838806|FG002|NOT COMPLETED|Overall Study||0
10676680|NCT02367014|11838807|FG003|NOT COMPLETED|Overall Study||0
10676681|NCT02367066|11838821|FG000|STARTED|Overall Study||10
10676682|NCT02367066|11838822|FG001|STARTED|Overall Study||10
10676683|NCT02367066|11838821|FG000|COMPLETED|Overall Study||10
10676684|NCT02367066|11838822|FG001|COMPLETED|Overall Study||10
10676685|NCT02367066|11838821|FG000|NOT COMPLETED|Overall Study||0
10676686|NCT02367066|11838822|FG001|NOT COMPLETED|Overall Study||0
10676687|NCT02367131|11838833|FG000|STARTED|Overall Study|Started are the treated patients|423
10676688|NCT02367131|11838833|FG000|COMPLETED|Overall Study||201
10676689|NCT02367131|11838833|FG000|NOT COMPLETED|Overall Study||222
10676690|NCT02367352|11838837|FG000|STARTED|Overall Study||9
10676691|NCT02367352|11838838|FG001|STARTED|Overall Study||0
10676692|NCT02367352|11838839|FG002|STARTED|Overall Study||0
10676693|NCT02367352|11838837|FG000|COMPLETED|Overall Study||0
10676694|NCT02367352|11838838|FG001|COMPLETED|Overall Study||0
10676695|NCT02367352|11838839|FG002|COMPLETED|Overall Study||0
10676696|NCT02367352|11838837|FG000|NOT COMPLETED|Overall Study||9
10676697|NCT02367352|11838838|FG001|NOT COMPLETED|Overall Study||0
10676698|NCT02367352|11838839|FG002|NOT COMPLETED|Overall Study||0
10676699|NCT02367391|11838847|FG000|STARTED|Overall Study||76
10676700|NCT02367391|11838848|FG001|STARTED|Overall Study||76
10676701|NCT02367391|11838847|FG000|COMPLETED|Overall Study||74
10676702|NCT02367391|11838848|FG001|COMPLETED|Overall Study||76
10676703|NCT02367391|11838847|FG000|NOT COMPLETED|Overall Study||2
10676704|NCT02367391|11838848|FG001|NOT COMPLETED|Overall Study||0
10676705|NCT02367430|11838854|FG000|STARTED|Overall Study||14
10676706|NCT02367430|11838854|FG000|COMPLETED|Overall Study||11
10676707|NCT02367430|11838854|FG000|NOT COMPLETED|Overall Study||3
10676708|NCT02367521|11838860|FG000|STARTED|Overall Study||17
10676709|NCT02367521|11838861|FG001|STARTED|Overall Study||17
10676710|NCT02367521|11838860|FG000|COMPLETED|Overall Study||13
10797685|NCT03697460|11958101|FG000|STARTED|Overall Study||12
10797686|NCT03697460|11958101|FG000|COMPLETED|Overall Study||9
10797687|NCT03697460|11958101|FG000|NOT COMPLETED|Overall Study||3
10797688|NCT03697993|11958107|FG000|STARTED|Overall Study||32
10797689|NCT03697993|11958108|FG001|STARTED|Overall Study||30
10797690|NCT03697993|11958107|FG000|Initiated Treatment|Overall Study||30
10797691|NCT03697993|11958108|FG001|Initiated Treatment|Overall Study||28
10797692|NCT03697993|11958107|FG000|Switched Treatment|Overall Study||0
10797693|NCT03697993|11958108|FG001|Switched Treatment|Overall Study|Five (5) participants switched to Fosfomycin; 1 participant switched to Cefixime.|6
10797694|NCT03697993|11958107|FG000|Treated With at Least Two Dose of Fosfomycin|Overall Study||27
10797695|NCT03697993|11958108|FG001|Treated With at Least Two Dose of Fosfomycin|Overall Study||4
10797696|NCT03697993|11958107|FG000|COMPLETED|Overall Study||22
10797697|NCT03697993|11958108|FG001|COMPLETED|Overall Study||25
10797698|NCT03697993|11958107|FG000|NOT COMPLETED|Overall Study||10
10797699|NCT03697993|11958108|FG001|NOT COMPLETED|Overall Study||5
10797700|NCT03698331|11958117|FG000|STARTED|Overall Study||44
10797701|NCT03698331|11958118|FG001|STARTED|Overall Study||45
10797702|NCT03698331|11958117|FG000|Entered Withdrawal Period|Overall Study||42
10797703|NCT03698331|11958118|FG001|Entered Withdrawal Period|Overall Study||39
10797704|NCT03698331|11958117|FG000|COMPLETED|Overall Study||40
10797705|NCT03698331|11958118|FG001|COMPLETED|Overall Study||39
10797706|NCT03698331|11958117|FG000|NOT COMPLETED|Overall Study||4
10797707|NCT03698331|11958118|FG001|NOT COMPLETED|Overall Study||6
10797708|NCT03698591|11958126|FG000|STARTED|Overall Study||20
10797709|NCT03698591|11958127|FG001|STARTED|Overall Study||20
10797710|NCT03698591|11958126|FG000|COMPLETED|Overall Study||15
10797711|NCT03698591|11958127|FG001|COMPLETED|Overall Study||15
10676711|NCT02367521|11838861|FG001|COMPLETED|Overall Study||17
10676712|NCT02367521|11838860|FG000|NOT COMPLETED|Overall Study||4
10676713|NCT02367521|11838861|FG001|NOT COMPLETED|Overall Study||0
10676714|NCT02367599|11838869|FG000|STARTED|Overall Study||48
10676715|NCT02367599|11838870|FG001|STARTED|Overall Study||48
10676716|NCT02367599|11838869|FG000|COMPLETED|Overall Study||48
10676717|NCT02367599|11838870|FG001|COMPLETED|Overall Study||48
10676718|NCT02367599|11838869|FG000|NOT COMPLETED|Overall Study||0
10676719|NCT02367599|11838870|FG001|NOT COMPLETED|Overall Study||0
10676720|NCT02367716|11838876|FG000|STARTED|Overall Study||121
10676721|NCT02367716|11838876|FG000|COMPLETED|Overall Study||120
10676722|NCT02367716|11838876|FG000|NOT COMPLETED|Overall Study||1
10676723|NCT02367729|11838883|FG000|STARTED|Overall Study||60
10676724|NCT02367729|11838884|FG001|STARTED|Overall Study||55
10676725|NCT02367729|11838883|FG000|COMPLETED|Overall Study||57
10676726|NCT02367729|11838884|FG001|COMPLETED|Overall Study||47
10676727|NCT02367729|11838883|FG000|NOT COMPLETED|Overall Study||3
10676728|NCT02367729|11838884|FG001|NOT COMPLETED|Overall Study||8
10676729|NCT02367781|11838893|FG000|STARTED|Overall Study||483
10676730|NCT02367781|11838894|FG001|STARTED|Overall Study||240
10676731|NCT02367781|11838893|FG000|COMPLETED|Overall Study||0
10676732|NCT02367781|11838894|FG001|COMPLETED|Overall Study||0
10676733|NCT02367781|11838893|FG000|NOT COMPLETED|Overall Study||483
10676734|NCT02367781|11838894|FG001|NOT COMPLETED|Overall Study||240
10676735|NCT02367820|11838906|FG000|STARTED|Overall Study||638
10676736|NCT02367820|11838906|FG000|COMPLETED|Overall Study||402
10676737|NCT02367820|11838906|FG000|NOT COMPLETED|Overall Study||236
10676738|NCT02367833|11838919|FG000|STARTED|Overall Study||9
10676739|NCT02367833|11838920|FG001|STARTED|Overall Study||9
10676740|NCT02367833|11838921|FG002|STARTED|Overall Study||8
10676741|NCT02367833|11838919|FG000|COMPLETED|Overall Study||8
10676742|NCT02367833|11838920|FG001|COMPLETED|Overall Study||8
10676743|NCT02367833|11838921|FG002|COMPLETED|Overall Study||8
10676744|NCT02367833|11838919|FG000|NOT COMPLETED|Overall Study||1
10676745|NCT02367833|11838920|FG001|NOT COMPLETED|Overall Study||1
10676746|NCT02367833|11838921|FG002|NOT COMPLETED|Overall Study||0
10676747|NCT02367859|11838929|FG000|STARTED|Overall Study||1
10676748|NCT02367859|11838929|FG000|COMPLETED|Overall Study||1
10676749|NCT02367859|11838929|FG000|NOT COMPLETED|Overall Study||0
10676750|NCT02367872|11838941|FG000|STARTED|Overall Study||6
10676751|NCT02367872|11838942|FG001|STARTED|Overall Study||6
10676752|NCT02367872|11838943|FG002|STARTED|Overall Study||6
10676753|NCT02367872|11838944|FG003|STARTED|Overall Study||6
10676754|NCT02367872|11838945|FG004|STARTED|Overall Study||6
10676755|NCT02367872|11838946|FG005|STARTED|Overall Study||6
10676756|NCT02367872|11838947|FG006|STARTED|Overall Study||6
10676757|NCT02367872|11838948|FG007|STARTED|Overall Study||6
10797712|NCT03698591|11958126|FG000|NOT COMPLETED|Overall Study||5
10797713|NCT03698591|11958127|FG001|NOT COMPLETED|Overall Study||5
10797714|NCT03699124|11958136|FG000|STARTED|Overall Study||377
10797715|NCT03699124|11958137|FG001|STARTED|Overall Study||375
10797716|NCT03699124|11958138|FG002|STARTED|Overall Study||377
10797717|NCT03699124|11958136|FG000|COMPLETED|Overall Study||332
10797718|NCT03699124|11958137|FG001|COMPLETED|Overall Study||335
10797719|NCT03699124|11958138|FG002|COMPLETED|Overall Study||337
10797720|NCT03699124|11958136|FG000|NOT COMPLETED|Overall Study||45
10797721|NCT03699124|11958137|FG001|NOT COMPLETED|Overall Study||40
10797722|NCT03699124|11958138|FG002|NOT COMPLETED|Overall Study||40
10797723|NCT03700320|11958148|FG000|STARTED|Overall Study||198
10797724|NCT03700320|11958149|FG001|STARTED|Overall Study||546
10797725|NCT03700320|11958148|FG000|Safety Population; Received Treatment|Overall Study||196
10797726|NCT03700320|11958149|FG001|Safety Population; Received Treatment|Overall Study||543
10797727|NCT03700320|11958148|FG000|Entered Safety Follow-up|Overall Study||159
10797728|NCT03700320|11958149|FG001|Entered Safety Follow-up|Overall Study||472
10797729|NCT03700320|11958148|FG000|COMPLETED|Overall Study||136
10797730|NCT03700320|11958149|FG001|COMPLETED|Overall Study||373
10797731|NCT03700320|11958148|FG000|NOT COMPLETED|Overall Study||62
10797732|NCT03700320|11958149|FG001|NOT COMPLETED|Overall Study||173
10797733|NCT03700372|11958155|FG000|STARTED|Overall Study||7
10797734|NCT03700372|11958155|FG000|COMPLETED|Overall Study||7
10797735|NCT03700372|11958155|FG000|NOT COMPLETED|Overall Study||0
10797736|NCT03700385|11958159|FG000|STARTED|Overall Study||40
10797737|NCT03700385|11958159|FG000|COMPLETED|Overall Study||39
10797738|NCT03700385|11958159|FG000|NOT COMPLETED|Overall Study||1
10797739|NCT03700671|11958165|FG000|STARTED|Overall Study||21
10797740|NCT03700671|11958166|FG001|STARTED|Overall Study||21
10676758|NCT02367872|11838941|FG000|COMPLETED|Overall Study||6
10676759|NCT02367872|11838942|FG001|COMPLETED|Overall Study||6
10676760|NCT02367872|11838943|FG002|COMPLETED|Overall Study||6
10676761|NCT02367872|11838944|FG003|COMPLETED|Overall Study||6
10676762|NCT02367872|11838945|FG004|COMPLETED|Overall Study||6
10676763|NCT02367872|11838946|FG005|COMPLETED|Overall Study||6
10676764|NCT02367872|11838947|FG006|COMPLETED|Overall Study||6
10676765|NCT02367872|11838948|FG007|COMPLETED|Overall Study||6
10676766|NCT02367872|11838941|FG000|NOT COMPLETED|Overall Study||0
10676767|NCT02367872|11838942|FG001|NOT COMPLETED|Overall Study||0
10676768|NCT02367872|11838943|FG002|NOT COMPLETED|Overall Study||0
10676769|NCT02367872|11838944|FG003|NOT COMPLETED|Overall Study||0
10676770|NCT02367872|11838945|FG004|NOT COMPLETED|Overall Study||0
10676771|NCT02367872|11838946|FG005|NOT COMPLETED|Overall Study||0
10676772|NCT02367872|11838947|FG006|NOT COMPLETED|Overall Study||0
10676773|NCT02367872|11838948|FG007|NOT COMPLETED|Overall Study||0
10676774|NCT02367885|11838978|FG000|STARTED|Overall Study||33
10676775|NCT02367885|11838979|FG001|STARTED|Overall Study||33
10676776|NCT02367885|11838980|FG002|STARTED|Overall Study||33
10676777|NCT02367885|11838978|FG000|COMPLETED|Overall Study||31
10676778|NCT02367885|11838979|FG001|COMPLETED|Overall Study||33
10676779|NCT02367885|11838980|FG002|COMPLETED|Overall Study||33
10676780|NCT02367885|11838978|FG000|NOT COMPLETED|Overall Study||2
10676781|NCT02367885|11838979|FG001|NOT COMPLETED|Overall Study||0
10797741|NCT03700671|11958165|FG000|COMPLETED|Overall Study||20
10676782|NCT02367885|11838980|FG002|NOT COMPLETED|Overall Study||0
10797742|NCT03700671|11958166|FG001|COMPLETED|Overall Study||19
10676783|NCT02367911|11838993|FG000|STARTED|Overall Study||71
10676784|NCT02367911|11838994|FG001|STARTED|Overall Study||73
10676785|NCT02367911|11838993|FG000|COMPLETED|Overall Study||66
10676786|NCT02367911|11838994|FG001|COMPLETED|Overall Study||69
10676787|NCT02367911|11838993|FG000|NOT COMPLETED|Overall Study||5
10676788|NCT02367911|11838994|FG001|NOT COMPLETED|Overall Study||4
10676789|NCT02368093|11839002|FG000|STARTED|Overall Study||24
10676790|NCT02368093|11839003|FG001|STARTED|Overall Study||24
10676791|NCT02368093|11839002|FG000|COMPLETED|Overall Study||24
10676792|NCT02368093|11839003|FG001|COMPLETED|Overall Study||24
10676793|NCT02368093|11839002|FG000|NOT COMPLETED|Overall Study||0
10676794|NCT02368093|11839003|FG001|NOT COMPLETED|Overall Study||0
10676795|NCT02368210|11839011|FG000|STARTED|Overall Study||75
10676796|NCT02368210|11839012|FG001|STARTED|Overall Study||76
10676797|NCT02368210|11839011|FG000|COMPLETED|Overall Study||74
10676798|NCT02368210|11839012|FG001|COMPLETED|Overall Study||75
10676799|NCT02368210|11839011|FG000|NOT COMPLETED|Overall Study||1
10676800|NCT02368210|11839012|FG001|NOT COMPLETED|Overall Study||1
10676801|NCT02368314|11839020|FG000|STARTED|Overall Study||64
10676802|NCT02368314|11839021|FG001|STARTED|Overall Study||60
10676803|NCT02368314|11839020|FG000|COMPLETED|Overall Study||61
10676804|NCT02368314|11839021|FG001|COMPLETED|Overall Study||57
10676805|NCT02368314|11839020|FG000|NOT COMPLETED|Overall Study||3
10676806|NCT02368314|11839021|FG001|NOT COMPLETED|Overall Study||3
10676807|NCT02368431|11839029|FG000|STARTED|Overall Study||46
10676808|NCT02368431|11839030|FG001|STARTED|Overall Study||46
10676809|NCT02368431|11839029|FG000|COMPLETED|Overall Study||22
10676810|NCT02368431|11839030|FG001|COMPLETED|Overall Study||27
10676811|NCT02368431|11839029|FG000|NOT COMPLETED|Overall Study||24
10676812|NCT02368431|11839030|FG001|NOT COMPLETED|Overall Study||19
10676813|NCT02368457|11839038|FG000|STARTED|Overall Study||12
10676814|NCT02368457|11839039|FG001|STARTED|Overall Study||12
10676815|NCT02368457|11839038|FG000|COMPLETED|Overall Study||12
10676816|NCT02368457|11839039|FG001|COMPLETED|Overall Study||12
10676817|NCT02368457|11839038|FG000|NOT COMPLETED|Overall Study||0
10676818|NCT02368457|11839039|FG001|NOT COMPLETED|Overall Study||0
10676819|NCT02368691|11839046|FG000|STARTED|Overall Study|32 subjects were enrolled and received at least one dose of study drug|32
10676820|NCT02368691|11839046|FG000|COMPLETED|Overall Study||0
10676821|NCT02368691|11839046|FG000|NOT COMPLETED|Overall Study||32
10676822|NCT02369068|11839052|FG000|STARTED|1 Month||10
10676823|NCT02369068|11839053|FG001|STARTED|1 Month||11
10676824|NCT02369068|11839052|FG000|COMPLETED|1 Month||9
10676825|NCT02369068|11839053|FG001|COMPLETED|1 Month||10
10676826|NCT02369068|11839052|FG000|NOT COMPLETED|1 Month||1
10676827|NCT02369068|11839053|FG001|NOT COMPLETED|1 Month||1
10676828|NCT02369068|11839052|FG000|STARTED|3 Months||9
10676829|NCT02369068|11839053|FG001|STARTED|3 Months||10
10676830|NCT02369068|11839052|FG000|COMPLETED|3 Months||9
10676831|NCT02369068|11839053|FG001|COMPLETED|3 Months||8
10676832|NCT02369068|11839052|FG000|NOT COMPLETED|3 Months||0
10676833|NCT02369068|11839053|FG001|NOT COMPLETED|3 Months||2
10676834|NCT02369068|11839052|FG000|STARTED|6 Months||9
10676835|NCT02369068|11839053|FG001|STARTED|6 Months||8
10676836|NCT02369068|11839052|FG000|COMPLETED|6 Months||9
10676837|NCT02369068|11839053|FG001|COMPLETED|6 Months||7
10676838|NCT02369068|11839052|FG000|NOT COMPLETED|6 Months||0
10676839|NCT02369068|11839053|FG001|NOT COMPLETED|6 Months||1
10676840|NCT02369159|11839061|FG000|STARTED|Overall Study||114
10676841|NCT02369159|11839062|FG001|STARTED|Overall Study||23
10676842|NCT02369159|11839061|FG000|ITT Population|Overall Study||114
10676843|NCT02369159|11839062|FG001|ITT Population|Overall Study||23
10676844|NCT02369159|11839061|FG000|Safety Population|Overall Study||107
10676845|NCT02369159|11839062|FG001|Safety Population|Overall Study||23
10676846|NCT02369159|11839061|FG000|ITTI Population|Overall Study||81
10676847|NCT02369159|11839062|FG001|ITTI Population|Overall Study||16
10676848|NCT02369159|11839061|FG000|E-R Population|Overall Study||80
10676849|NCT02369159|11839062|FG001|E-R Population|Overall Study|Milestone only applied to Peramivir group|0
10676850|NCT02369159|11839061|FG000|COMPLETED|Overall Study||106
10676851|NCT02369159|11839062|FG001|COMPLETED|Overall Study||21
10676852|NCT02369159|11839061|FG000|NOT COMPLETED|Overall Study||8
10676853|NCT02369159|11839062|FG001|NOT COMPLETED|Overall Study||2
10676854|NCT02369172|11839079|FG000|STARTED|Overall Study||24
10676855|NCT02369172|11839079|FG000|COMPLETED|Overall Study||24
10676856|NCT02369172|11839079|FG000|NOT COMPLETED|Overall Study||0
10797743|NCT03700671|11958165|FG000|NOT COMPLETED|Overall Study||1
10797744|NCT03700671|11958166|FG001|NOT COMPLETED|Overall Study||2
10797745|NCT03700736|11958176|FG000|STARTED|Overall Study||30
10797746|NCT03700736|11958177|FG001|STARTED|Overall Study||32
10797747|NCT03700736|11958176|FG000|COMPLETED|Overall Study||27
10676857|NCT02369211|11839103|FG000|STARTED|Overall Study||43
10676858|NCT02369211|11839104|FG001|STARTED|Overall Study||43
10676859|NCT02369211|11839103|FG000|COMPLETED|Overall Study||43
10676860|NCT02369211|11839104|FG001|COMPLETED|Overall Study||41
10676861|NCT02369211|11839103|FG000|NOT COMPLETED|Overall Study||0
10676862|NCT02369211|11839104|FG001|NOT COMPLETED|Overall Study||2
10676863|NCT02369341|11839112|FG000|STARTED|Overall Study||63
10676864|NCT02369341|11839113|FG001|STARTED|Overall Study||57
10676865|NCT02369341|11839112|FG000|COMPLETED|Overall Study||62
10676866|NCT02369341|11839113|FG001|COMPLETED|Overall Study||57
10676867|NCT02369341|11839112|FG000|NOT COMPLETED|Overall Study||1
10676868|NCT02369341|11839113|FG001|NOT COMPLETED|Overall Study||0
10676872|NCT02369510|11839130|FG000|STARTED|Overall Study||23
10676873|NCT02369510|11839131|FG001|STARTED|Overall Study||22
10676874|NCT02369510|11839132|FG002|STARTED|Overall Study||23
10676875|NCT02369510|11839130|FG000|COMPLETED|Overall Study||21
10676876|NCT02369510|11839131|FG001|COMPLETED|Overall Study||19
10676877|NCT02369510|11839132|FG002|COMPLETED|Overall Study||17
10797748|NCT03700736|11958177|FG001|COMPLETED|Overall Study||25
10797749|NCT03700736|11958176|FG000|NOT COMPLETED|Overall Study||3
10797750|NCT03700736|11958177|FG001|NOT COMPLETED|Overall Study||7
10797751|NCT03700892|11958188|FG000|STARTED|Baseline||15
10797752|NCT03700892|11958189|FG001|STARTED|Baseline||0
10797753|NCT03700892|11958190|FG002|STARTED|Baseline||4
10797754|NCT03700892|11958188|FG000|COMPLETED|Baseline||15
10797755|NCT03700892|11958189|FG001|COMPLETED|Baseline||0
10797756|NCT03700892|11958190|FG002|COMPLETED|Baseline||4
10797757|NCT03700892|11958188|FG000|NOT COMPLETED|Baseline||0
10797758|NCT03700892|11958189|FG001|NOT COMPLETED|Baseline||0
10797759|NCT03700892|11958190|FG002|NOT COMPLETED|Baseline||0
10797760|NCT03700892|11958188|FG000|STARTED|First Intervention (Single 1-Day Visit)||1
10676878|NCT02369510|11839130|FG000|NOT COMPLETED|Overall Study||2
10676879|NCT02369510|11839131|FG001|NOT COMPLETED|Overall Study||3
10676880|NCT02369510|11839132|FG002|NOT COMPLETED|Overall Study||6
10676881|NCT02369796|11839145|FG000|STARTED|Overall Study||3
10676882|NCT02369796|11839146|FG001|STARTED|Overall Study||3
10676883|NCT02369796|11839147|FG002|STARTED|Overall Study||3
10676884|NCT02369796|11839148|FG003|STARTED|Overall Study||3
10676885|NCT02369796|11839149|FG004|STARTED|Overall Study||3
10676886|NCT02369796|11839145|FG000|COMPLETED|Overall Study||3
10676887|NCT02369796|11839146|FG001|COMPLETED|Overall Study||3
10676888|NCT02369796|11839147|FG002|COMPLETED|Overall Study||3
10676889|NCT02369796|11839148|FG003|COMPLETED|Overall Study||3
10676890|NCT02369796|11839149|FG004|COMPLETED|Overall Study||3
10676891|NCT02369796|11839145|FG000|NOT COMPLETED|Overall Study||0
10676892|NCT02369796|11839146|FG001|NOT COMPLETED|Overall Study||0
10676893|NCT02369796|11839147|FG002|NOT COMPLETED|Overall Study||0
10676894|NCT02369796|11839148|FG003|NOT COMPLETED|Overall Study||0
10676895|NCT02369796|11839149|FG004|NOT COMPLETED|Overall Study||0
10676896|NCT02369835|11839163|FG000|STARTED|Overall Study||64
10676897|NCT02369835|11839164|FG001|STARTED|Overall Study||68
10676898|NCT02369835|11839163|FG000|COMPLETED|Overall Study|Reasons that participants did not complete for the Primary Outcome are not available.|53
10676899|NCT02369835|11839164|FG001|COMPLETED|Overall Study|Reasons that participants did not complete for the Primary Outcome are not available.|55
10676900|NCT02369835|11839163|FG000|NOT COMPLETED|Overall Study||11
10676901|NCT02369835|11839164|FG001|NOT COMPLETED|Overall Study||13
10676902|NCT02369848|11839170|FG000|STARTED|Overall Study||60
10676903|NCT02369848|11839170|FG000|30 Day Primary Safety Endpoint|Overall Study||58
10676904|NCT02369848|11839170|FG000|12 Month Primary Endpoint|Overall Study||30
10676905|NCT02369848|11839170|FG000|COMPLETED|Overall Study||56
10676906|NCT02369848|11839170|FG000|NOT COMPLETED|Overall Study||4
10676907|NCT02369874|11839177|FG000|STARTED|Overall Study||247
10797761|NCT03700892|11958189|FG001|STARTED|First Intervention (Single 1-Day Visit)||4
10797762|NCT03700892|11958190|FG002|STARTED|First Intervention (Single 1-Day Visit)||0
10797763|NCT03700892|11958188|FG000|COMPLETED|First Intervention (Single 1-Day Visit)||1
10797764|NCT03700892|11958189|FG001|COMPLETED|First Intervention (Single 1-Day Visit)||4
10797765|NCT03700892|11958190|FG002|COMPLETED|First Intervention (Single 1-Day Visit)||0
10797766|NCT03700892|11958188|FG000|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0
10797767|NCT03700892|11958189|FG001|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0
10797768|NCT03700892|11958190|FG002|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0
10797769|NCT03700892|11958188|FG000|STARTED|Washout (2-3 Weeks)||1
10797770|NCT03700892|11958189|FG001|STARTED|Washout (2-3 Weeks)||4
10797771|NCT03700892|11958190|FG002|STARTED|Washout (2-3 Weeks)||0
10797772|NCT03700892|11958188|FG000|COMPLETED|Washout (2-3 Weeks)||1
10676908|NCT02369874|11839178|FG001|STARTED|Overall Study||240
10676909|NCT02369874|11839179|FG002|STARTED|Overall Study||249
10676910|NCT02369874|11839177|FG000|Received Treatment|Overall Study||246
10676911|NCT02369874|11839178|FG001|Received Treatment|Overall Study||237
10676912|NCT02369874|11839179|FG002|Received Treatment|Overall Study||240
10676913|NCT02369874|11839177|FG000|COMPLETED|Overall Study||203
10676914|NCT02369874|11839178|FG001|COMPLETED|Overall Study||183
10676915|NCT02369874|11839179|FG002|COMPLETED|Overall Study||188
10676916|NCT02369874|11839177|FG000|NOT COMPLETED|Overall Study||44
10676917|NCT02369874|11839178|FG001|NOT COMPLETED|Overall Study||57
10676918|NCT02369874|11839179|FG002|NOT COMPLETED|Overall Study||61
10676919|NCT02369900|11839189|FG000|STARTED|Overall Study||18
10676920|NCT02369900|11839190|FG001|STARTED|Overall Study||22
10676921|NCT02369900|11839189|FG000|COMPLETED|Overall Study||18
10676922|NCT02369900|11839190|FG001|COMPLETED|Overall Study||22
10676923|NCT02369900|11839189|FG000|NOT COMPLETED|Overall Study||0
10676924|NCT02369900|11839190|FG001|NOT COMPLETED|Overall Study||0
10676925|NCT02370004|11839196|FG000|STARTED|Overall Study||11
10676926|NCT02370004|11839196|FG000|COMPLETED|Overall Study||10
10676927|NCT02370004|11839196|FG000|NOT COMPLETED|Overall Study||1
10676928|NCT02370043|11839205|FG000|STARTED|Overall Study||3
10676929|NCT02370043|11839206|FG001|STARTED|Overall Study||3
10676930|NCT02370043|11839207|FG002|STARTED|Overall Study||3
10676931|NCT02370043|11839208|FG003|STARTED|Overall Study||3
10676932|NCT02370043|11839209|FG004|STARTED|Overall Study||3
10797773|NCT03700892|11958189|FG001|COMPLETED|Washout (2-3 Weeks)||4
10797774|NCT03700892|11958190|FG002|COMPLETED|Washout (2-3 Weeks)||0
10797775|NCT03700892|11958188|FG000|NOT COMPLETED|Washout (2-3 Weeks)||0
10797776|NCT03700892|11958189|FG001|NOT COMPLETED|Washout (2-3 Weeks)||0
10797777|NCT03700892|11958190|FG002|NOT COMPLETED|Washout (2-3 Weeks)||0
10676933|NCT02370043|11839210|FG005|STARTED|Overall Study||4
10676934|NCT02370043|11839205|FG000|COMPLETED|Overall Study||3
10676935|NCT02370043|11839206|FG001|COMPLETED|Overall Study||3
10797778|NCT03700892|11958188|FG000|STARTED|Second Intervention (Single 1-Day Visit)||1
10676936|NCT02370043|11839207|FG002|COMPLETED|Overall Study||3
10676937|NCT02370043|11839208|FG003|COMPLETED|Overall Study||3
10676938|NCT02370043|11839209|FG004|COMPLETED|Overall Study||2
10676939|NCT02370043|11839210|FG005|COMPLETED|Overall Study||3
10676940|NCT02370043|11839205|FG000|NOT COMPLETED|Overall Study||0
10676941|NCT02370043|11839206|FG001|NOT COMPLETED|Overall Study||0
10676942|NCT02370043|11839207|FG002|NOT COMPLETED|Overall Study||0
10676943|NCT02370043|11839208|FG003|NOT COMPLETED|Overall Study||0
10676944|NCT02370043|11839209|FG004|NOT COMPLETED|Overall Study||1
10676945|NCT02370043|11839210|FG005|NOT COMPLETED|Overall Study||1
10676946|NCT02370056|11839240|FG000|STARTED|Overall Study||27
10676947|NCT02370056|11839241|FG001|STARTED|Overall Study||26
10676948|NCT02370056|11839240|FG000|COMPLETED|Overall Study||27
10676949|NCT02370056|11839241|FG001|COMPLETED|Overall Study||26
10676950|NCT02370056|11839240|FG000|NOT COMPLETED|Overall Study||0
10676951|NCT02370056|11839241|FG001|NOT COMPLETED|Overall Study||0
10676952|NCT02370095|11839249|FG000|STARTED|Overall Study||10
10676953|NCT02370095|11839250|FG001|STARTED|Overall Study||4
10676954|NCT02370095|11839249|FG000|COMPLETED|Overall Study||10
10676955|NCT02370095|11839250|FG001|COMPLETED|Overall Study||3
10676956|NCT02370095|11839249|FG000|NOT COMPLETED|Overall Study||0
10676957|NCT02370095|11839250|FG001|NOT COMPLETED|Overall Study||1
10676958|NCT02370121|11839258|FG000|STARTED|Overall Study||12
10676959|NCT02370121|11839259|FG001|STARTED|Overall Study||12
10676960|NCT02370121|11839258|FG000|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
10676961|NCT02370121|11839259|FG001|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
10676962|NCT02370121|11839258|FG000|NOT COMPLETED|Overall Study||1
10676963|NCT02370121|11839259|FG001|NOT COMPLETED|Overall Study||1
10676964|NCT02370160|11839265|FG000|STARTED|Overall Study||9
10676965|NCT02370160|11839266|FG001|STARTED|Overall Study||6
10676966|NCT02370160|11839267|FG002|STARTED|Overall Study||3
10676967|NCT02370160|11839265|FG000|COMPLETED|Overall Study||6
10676968|NCT02370160|11839266|FG001|COMPLETED|Overall Study||2
10676969|NCT02370160|11839267|FG002|COMPLETED|Overall Study||2
10676970|NCT02370160|11839265|FG000|NOT COMPLETED|Overall Study||3
10676971|NCT02370160|11839266|FG001|NOT COMPLETED|Overall Study||4
10676972|NCT02370160|11839267|FG002|NOT COMPLETED|Overall Study||1
10797779|NCT03700892|11958189|FG001|STARTED|Second Intervention (Single 1-Day Visit)||4
10797780|NCT03700892|11958190|FG002|STARTED|Second Intervention (Single 1-Day Visit)||0
10797781|NCT03700892|11958188|FG000|Received Intervention|Second Intervention (Single 1-Day Visit)||1
10797782|NCT03700892|11958189|FG001|Received Intervention|Second Intervention (Single 1-Day Visit)||3
10797783|NCT03700892|11958190|FG002|Received Intervention|Second Intervention (Single 1-Day Visit)||0
10797784|NCT03700892|11958188|FG000|COMPLETED|Second Intervention (Single 1-Day Visit)||1
10797785|NCT03700892|11958189|FG001|COMPLETED|Second Intervention (Single 1-Day Visit)||3
10797786|NCT03700892|11958190|FG002|COMPLETED|Second Intervention (Single 1-Day Visit)||0
10797787|NCT03700892|11958188|FG000|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0
10797788|NCT03700892|11958189|FG001|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||1
10797789|NCT03700892|11958190|FG002|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0
10797790|NCT03701061|11958201|FG000|STARTED|Overall Study||9
10797791|NCT03701061|11958202|FG001|STARTED|Overall Study||3
10797792|NCT03701061|11958201|FG000|COMPLETED|Overall Study||9
10797793|NCT03701061|11958202|FG001|COMPLETED|Overall Study||3
10797794|NCT03701061|11958201|FG000|NOT COMPLETED|Overall Study||0
10797795|NCT03701061|11958202|FG001|NOT COMPLETED|Overall Study||0
10797796|NCT03701074|11958210|FG000|STARTED|Overall Study||1
10797797|NCT03701074|11958211|FG001|STARTED|Overall Study||0
10797798|NCT03701074|11958210|FG000|COMPLETED|Overall Study|Treatment was withdrawn after the 10th dose of oral medication (acetaminophen), on day 3 of treatment, as the infant developed mild abdominal distension which was as per the study protocol|0
10797799|NCT03701074|11958211|FG001|COMPLETED|Overall Study||0
10797800|NCT03701074|11958210|FG000|NOT COMPLETED|Overall Study||1
10797801|NCT03701074|11958211|FG001|NOT COMPLETED|Overall Study||0
10797802|NCT03702010|11958219|FG000|STARTED|First Stimulation (5 Days)||13
10797803|NCT03702010|11958220|FG001|STARTED|First Stimulation (5 Days)||14
10797804|NCT03702010|11958219|FG000|COMPLETED|First Stimulation (5 Days)||13
10676985|NCT02370251|11839293|FG000|STARTED|Overall Study||63
10676986|NCT02370251|11839293|FG000|COMPLETED|Overall Study||52
10676987|NCT02370251|11839293|FG000|NOT COMPLETED|Overall Study||11
10676988|NCT02370368|11839299|FG000|STARTED|Overall Study||14
10676989|NCT02370368|11839300|FG001|STARTED|Overall Study||13
10676990|NCT02370368|11839299|FG000|COMPLETED|Overall Study||8
10676991|NCT02370368|11839300|FG001|COMPLETED|Overall Study||7
10676992|NCT02370368|11839299|FG000|NOT COMPLETED|Overall Study||6
10676993|NCT02370368|11839300|FG001|NOT COMPLETED|Overall Study||6
10676994|NCT02370394|11839308|FG000|STARTED|Overall Study||28
10676995|NCT02370394|11839309|FG001|STARTED|Overall Study||25
10676996|NCT02370394|11839308|FG000|COMPLETED|Overall Study||26
10676997|NCT02370394|11839309|FG001|COMPLETED|Overall Study||23
10797805|NCT03702010|11958220|FG001|COMPLETED|First Stimulation (5 Days)||14
10797806|NCT03702010|11958219|FG000|NOT COMPLETED|First Stimulation (5 Days)||0
10797807|NCT03702010|11958220|FG001|NOT COMPLETED|First Stimulation (5 Days)||0
10797808|NCT03702010|11958219|FG000|STARTED|Washout + Second Stimulation (2+5days)||13
10797809|NCT03702010|11958220|FG001|STARTED|Washout + Second Stimulation (2+5days)||14
10797810|NCT03702010|11958219|FG000|COMPLETED|Washout + Second Stimulation (2+5days)||13
10797811|NCT03702010|11958220|FG001|COMPLETED|Washout + Second Stimulation (2+5days)||14
10797812|NCT03702010|11958219|FG000|NOT COMPLETED|Washout + Second Stimulation (2+5days)||0
10797813|NCT03702010|11958220|FG001|NOT COMPLETED|Washout + Second Stimulation (2+5days)||0
10797814|NCT03702010|11958219|FG000|STARTED|Follow-up (30days)||13
10797815|NCT03702010|11958220|FG001|STARTED|Follow-up (30days)||14
10797816|NCT03702010|11958219|FG000|COMPLETED|Follow-up (30days)||11
10797817|NCT03702010|11958220|FG001|COMPLETED|Follow-up (30days)||12
10797818|NCT03702010|11958219|FG000|NOT COMPLETED|Follow-up (30days)||2
10797819|NCT03702010|11958220|FG001|NOT COMPLETED|Follow-up (30days)||2
10797820|NCT03702166|11958232|FG000|STARTED|Overall Study||10
10797821|NCT03702166|11958232|FG000|COMPLETED|Overall Study||8
10797822|NCT03702166|11958232|FG000|NOT COMPLETED|Overall Study||2
10797823|NCT03702608|11958237|FG000|STARTED|Overall Study||50
10797824|NCT03702608|11958237|FG000|COMPLETED|Overall Study||50
10797825|NCT03702608|11958237|FG000|NOT COMPLETED|Overall Study||0
10797826|NCT03703336|11958243|FG000|STARTED|Overall Study||552
10797827|NCT03703336|11958244|FG001|STARTED|Overall Study||273
10797828|NCT03703336|11958243|FG000|Received Dose 1|Overall Study||552
10797829|NCT03703336|11958244|FG001|Received Dose 1|Overall Study||273
10797830|NCT03703336|11958243|FG000|Received Dose 2|Overall Study||518
10797831|NCT03703336|11958244|FG001|Received Dose 2|Overall Study||263
10797832|NCT03703336|11958243|FG000|Safety Population|Overall Study||551
10797833|NCT03703336|11958244|FG001|Safety Population|Overall Study||274
10797834|NCT03703336|11958243|FG000|COMPLETED|Overall Study||514
10797835|NCT03703336|11958244|FG001|COMPLETED|Overall Study||259
10797836|NCT03703336|11958243|FG000|NOT COMPLETED|Overall Study||38
10797837|NCT03703336|11958244|FG001|NOT COMPLETED|Overall Study||14
10797838|NCT03703817|11958252|FG000|STARTED|Overall Study||288
10797839|NCT03703817|11958253|FG001|STARTED|Overall Study||133
10797840|NCT03703817|11958252|FG000|COMPLETED|Overall Study||281
10797841|NCT03703817|11958253|FG001|COMPLETED|Overall Study||129
10797842|NCT03703817|11958252|FG000|NOT COMPLETED|Overall Study||7
10797843|NCT03703817|11958253|FG001|NOT COMPLETED|Overall Study||4
10797844|NCT03704194|11958261|FG000|STARTED|Overall Study||8
10797845|NCT03704194|11958262|FG001|STARTED|Overall Study||9
10797846|NCT03704194|11958261|FG000|COMPLETED|Overall Study||8
10797847|NCT03704194|11958262|FG001|COMPLETED|Overall Study||8
10797848|NCT03704194|11958261|FG000|NOT COMPLETED|Overall Study||0
10797849|NCT03704194|11958262|FG001|NOT COMPLETED|Overall Study||1
10797850|NCT03704376|11958272|FG000|STARTED|Overall Study||42
10797851|NCT03704376|11958273|FG001|STARTED|Overall Study||44
10797852|NCT03704376|11958272|FG000|COMPLETED|Overall Study||38
10797853|NCT03704376|11958273|FG001|COMPLETED|Overall Study||40
10797854|NCT03704376|11958272|FG000|NOT COMPLETED|Overall Study||4
10797855|NCT03704376|11958273|FG001|NOT COMPLETED|Overall Study||4
10797856|NCT03704467|11958279|FG000|STARTED|Overall Study||3
10797857|NCT03704467|11958279|FG000|COMPLETED|Overall Study||3
10797858|NCT03704467|11958279|FG000|NOT COMPLETED|Overall Study||0
10797859|NCT03705273|11958285|FG000|STARTED|Overall Study|Planned enrollment of 110 participants in the arm was not achieved due to lack of study personnel.|20
10797860|NCT03705273|11958286|FG001|STARTED|Overall Study|Planned enrollment of 110 participants in the arm was not achieved due to lack of study personnel.|20
10797861|NCT03705273|11958285|FG000|COMPLETED|Overall Study||20
10797862|NCT03705273|11958286|FG001|COMPLETED|Overall Study||20
10797863|NCT03705273|11958285|FG000|NOT COMPLETED|Overall Study||0
10797864|NCT03705273|11958286|FG001|NOT COMPLETED|Overall Study||0
10797865|NCT03705481|11958292|FG000|STARTED|Overall Study||5
10797866|NCT03705481|11958292|FG000|COMPLETED|Overall Study||5
10797867|NCT03705481|11958292|FG000|NOT COMPLETED|Overall Study||0
10797868|NCT03705494|11958301|FG000|STARTED|Overall Study||10
10797869|NCT03705494|11958302|FG001|STARTED|Overall Study||10
10797870|NCT03705494|11958301|FG000|COMPLETED|Overall Study||3
10797871|NCT03705494|11958302|FG001|COMPLETED|Overall Study||7
10797872|NCT03705494|11958301|FG000|NOT COMPLETED|Overall Study||7
10797873|NCT03705494|11958302|FG001|NOT COMPLETED|Overall Study||3
10676998|NCT02370394|11839308|FG000|NOT COMPLETED|Overall Study||2
10797880|NCT03706040|11958320|FG000|STARTED|Period A (Week 0 to Week 16)||34
10797881|NCT03706040|11958321|FG001|STARTED|Period A (Week 0 to Week 16)||69
10797882|NCT03706040|11958322|FG002|STARTED|Period A (Week 0 to Week 16)||69
10797883|NCT03706040|11958323|FG003|STARTED|Period A (Week 0 to Week 16)||0
10797884|NCT03706040|11958324|FG004|STARTED|Period A (Week 0 to Week 16)||0
10797885|NCT03706040|11958325|FG005|STARTED|Period A (Week 0 to Week 16)||0
10797886|NCT03706040|11958326|FG006|STARTED|Period A (Week 0 to Week 16)||0
10676999|NCT02370394|11839309|FG001|NOT COMPLETED|Overall Study||2
10677000|NCT02370407|11839318|FG000|STARTED|Overall Study||20
10677001|NCT02370407|11839319|FG001|STARTED|Overall Study||20
10677002|NCT02370407|11839318|FG000|COMPLETED|Overall Study||20
10677003|NCT02370407|11839319|FG001|COMPLETED|Overall Study||20
10677004|NCT02370407|11839318|FG000|NOT COMPLETED|Overall Study||0
10677005|NCT02370407|11839319|FG001|NOT COMPLETED|Overall Study||0
10677006|NCT02370420|11839331|FG000|STARTED|Overall Study||29
10677007|NCT02370420|11839332|FG001|STARTED|Overall Study||27
10677008|NCT02370420|11839331|FG000|COMPLETED|Overall Study||15
10677009|NCT02370420|11839332|FG001|COMPLETED|Overall Study||15
10677010|NCT02370420|11839331|FG000|NOT COMPLETED|Overall Study||14
10677011|NCT02370420|11839332|FG001|NOT COMPLETED|Overall Study||12
10677012|NCT02370498|11839340|FG000|STARTED|Overall Study||296
10677013|NCT02370498|11839341|FG001|STARTED|Overall Study||296
10677014|NCT02370498|11839340|FG000|Treated|Overall Study||294
10677015|NCT02370498|11839341|FG001|Treated|Overall Study||276
10677016|NCT02370498|11839340|FG000|PD-L1 Positive Participants|Overall Study||196
10677017|NCT02370498|11839341|FG001|PD-L1 Positive Participants|Overall Study||199
10677018|NCT02370498|11839340|FG000|COMPLETED|Overall Study||0
10677019|NCT02370498|11839341|FG001|COMPLETED|Overall Study||0
10677020|NCT02370498|11839340|FG000|NOT COMPLETED|Overall Study||296
10677021|NCT02370498|11839341|FG001|NOT COMPLETED|Overall Study||296
10677022|NCT02370511|11839351|FG000|STARTED|Overall Study||31
10677023|NCT02370511|11839352|FG001|STARTED|Overall Study||30
10677024|NCT02370511|11839353|FG002|STARTED|Overall Study||30
10677025|NCT02370511|11839351|FG000|COMPLETED|Overall Study||19
10677026|NCT02370511|11839352|FG001|COMPLETED|Overall Study||19
10677027|NCT02370511|11839353|FG002|COMPLETED|Overall Study||29
10677028|NCT02370511|11839351|FG000|NOT COMPLETED|Overall Study||12
10677029|NCT02370511|11839352|FG001|NOT COMPLETED|Overall Study||11
10677030|NCT02370511|11839353|FG002|NOT COMPLETED|Overall Study||1
10677031|NCT02370537|11839364|FG000|STARTED|Part A (Open-label Recruitment)||16
10677032|NCT02370537|11839365|FG001|STARTED|Part A (Open-label Recruitment)||16
10677033|NCT02370537|11839366|FG002|STARTED|Part A (Open-label Recruitment)||283
10677034|NCT02370537|11839364|FG000|COMPLETED|Part A (Open-label Recruitment)||16
10677035|NCT02370537|11839365|FG001|COMPLETED|Part A (Open-label Recruitment)||15
10677036|NCT02370537|11839366|FG002|COMPLETED|Part A (Open-label Recruitment)||282
10677037|NCT02370537|11839364|FG000|NOT COMPLETED|Part A (Open-label Recruitment)||0
10677038|NCT02370537|11839365|FG001|NOT COMPLETED|Part A (Open-label Recruitment)||1
10677039|NCT02370537|11839366|FG002|NOT COMPLETED|Part A (Open-label Recruitment)||1
10677040|NCT02370537|11839364|FG000|STARTED|Part B||16
10677041|NCT02370537|11839365|FG001|STARTED|Part B||15
10677042|NCT02370537|11839366|FG002|STARTED|Part B||282
10677043|NCT02370537|11839364|FG000|Eligible for Randomisation|Part B||15
10797887|NCT03706040|11958320|FG000|Received Study Drug|Period A (Week 0 to Week 16)||34
10797888|NCT03706040|11958321|FG001|Received Study Drug|Period A (Week 0 to Week 16)||69
10797889|NCT03706040|11958322|FG002|Received Study Drug|Period A (Week 0 to Week 16)||69
10797890|NCT03706040|11958323|FG003|Received Study Drug|Period A (Week 0 to Week 16)||0
10797891|NCT03706040|11958324|FG004|Received Study Drug|Period A (Week 0 to Week 16)||0
10797892|NCT03706040|11958325|FG005|Received Study Drug|Period A (Week 0 to Week 16)||0
10797893|NCT03706040|11958326|FG006|Received Study Drug|Period A (Week 0 to Week 16)||0
10797894|NCT03706040|11958320|FG000|COMPLETED|Period A (Week 0 to Week 16)||25
10797895|NCT03706040|11958321|FG001|COMPLETED|Period A (Week 0 to Week 16)||61
10797896|NCT03706040|11958322|FG002|COMPLETED|Period A (Week 0 to Week 16)||58
10797897|NCT03706040|11958323|FG003|COMPLETED|Period A (Week 0 to Week 16)||0
10797898|NCT03706040|11958324|FG004|COMPLETED|Period A (Week 0 to Week 16)||0
10797899|NCT03706040|11958325|FG005|COMPLETED|Period A (Week 0 to Week 16)||0
10797900|NCT03706040|11958326|FG006|COMPLETED|Period A (Week 0 to Week 16)||0
10797901|NCT03706040|11958320|FG000|NOT COMPLETED|Period A (Week 0 to Week 16)||9
10797902|NCT03706040|11958321|FG001|NOT COMPLETED|Period A (Week 0 to Week 16)||8
10797903|NCT03706040|11958322|FG002|NOT COMPLETED|Period A (Week 0 to Week 16)||11
10797904|NCT03706040|11958323|FG003|NOT COMPLETED|Period A (Week 0 to Week 16)||0
10797905|NCT03706040|11958324|FG004|NOT COMPLETED|Period A (Week 0 to Week 16)||0
10797906|NCT03706040|11958325|FG005|NOT COMPLETED|Period A (Week 0 to Week 16)||0
10797907|NCT03706040|11958326|FG006|NOT COMPLETED|Period A (Week 0 to Week 16)||0
10797908|NCT03706040|11958320|FG000|STARTED|Period B (Week 16 to Week 52)||0
10797909|NCT03706040|11958321|FG001|STARTED|Period B (Week 16 to Week 52)||0
10797910|NCT03706040|11958322|FG002|STARTED|Period B (Week 16 to Week 52)||0
10797911|NCT03706040|11958323|FG003|STARTED|Period B (Week 16 to Week 52)||13
10797912|NCT03706040|11958324|FG004|STARTED|Period B (Week 16 to Week 52)||12
10677044|NCT02370537|11839365|FG001|Eligible for Randomisation|Part B||13
10677045|NCT02370537|11839366|FG002|Eligible for Randomisation|Part B||23
10677046|NCT02370537|11839364|FG000|Period 1 Sequence AB|Part B||8
10677047|NCT02370537|11839365|FG001|Period 1 Sequence AB|Part B||6
10677048|NCT02370537|11839366|FG002|Period 1 Sequence AB|Part B||11
10677049|NCT02370537|11839364|FG000|Period 1 Sequence BA|Part B||7
10677050|NCT02370537|11839365|FG001|Period 1 Sequence BA|Part B||7
10677051|NCT02370537|11839366|FG002|Period 1 Sequence BA|Part B||12
10677052|NCT02370537|11839364|FG000|Period 2 Sequence AB|Part B||8
10677053|NCT02370537|11839365|FG001|Period 2 Sequence AB|Part B||5
10677054|NCT02370537|11839366|FG002|Period 2 Sequence AB|Part B||11
10797913|NCT03706040|11958325|FG005|STARTED|Period B (Week 16 to Week 52)||61
10797914|NCT03706040|11958326|FG006|STARTED|Period B (Week 16 to Week 52)||58
10677055|NCT02370537|11839364|FG000|Period 2 Sequence BA|Part B||7
10677056|NCT02370537|11839365|FG001|Period 2 Sequence BA|Part B||7
10677057|NCT02370537|11839366|FG002|Period 2 Sequence BA|Part B||12
10677058|NCT02370537|11839364|FG000|COMPLETED|Part B||15
10677059|NCT02370537|11839365|FG001|COMPLETED|Part B||12
10677060|NCT02370537|11839366|FG002|COMPLETED|Part B||23
10677061|NCT02370537|11839364|FG000|NOT COMPLETED|Part B||1
10677062|NCT02370537|11839365|FG001|NOT COMPLETED|Part B||3
10677063|NCT02370537|11839366|FG002|NOT COMPLETED|Part B||259
10677064|NCT02370602|11839389|FG000|STARTED|Overall Study||1
10677065|NCT02370602|11839390|FG001|STARTED|Overall Study||2
10677066|NCT02370602|11839391|FG002|STARTED|Overall Study||2
10677067|NCT02370602|11839392|FG003|STARTED|Overall Study||3
10677068|NCT02370602|11839393|FG004|STARTED|Overall Study||3
10677069|NCT02370602|11839394|FG005|STARTED|Overall Study||2
10677070|NCT02370602|11839389|FG000|COMPLETED|Overall Study||0
10677071|NCT02370602|11839390|FG001|COMPLETED|Overall Study||2
10677072|NCT02370602|11839391|FG002|COMPLETED|Overall Study||2
10677073|NCT02370602|11839392|FG003|COMPLETED|Overall Study||3
10677074|NCT02370602|11839393|FG004|COMPLETED|Overall Study||3
10677075|NCT02370602|11839394|FG005|COMPLETED|Overall Study||2
10677076|NCT02370602|11839389|FG000|NOT COMPLETED|Overall Study||1
10677077|NCT02370602|11839390|FG001|NOT COMPLETED|Overall Study||0
10677078|NCT02370602|11839391|FG002|NOT COMPLETED|Overall Study||0
10677079|NCT02370602|11839392|FG003|NOT COMPLETED|Overall Study||0
10677080|NCT02370602|11839393|FG004|NOT COMPLETED|Overall Study||0
10677081|NCT02370602|11839394|FG005|NOT COMPLETED|Overall Study||0
10677082|NCT02370615|11839413|FG000|STARTED|Overall Study||16
10677083|NCT02370615|11839414|FG001|STARTED|Overall Study||18
10677084|NCT02370615|11839413|FG000|COMPLETED|Overall Study||15
10677085|NCT02370615|11839414|FG001|COMPLETED|Overall Study||18
10677086|NCT02370615|11839413|FG000|NOT COMPLETED|Overall Study||1
10677087|NCT02370615|11839414|FG001|NOT COMPLETED|Overall Study||0
10677088|NCT02370641|11839429|FG000|STARTED|Overall Study||18
10677089|NCT02370641|11839430|FG001|STARTED|Overall Study||8
10677090|NCT02370641|11839429|FG000|COMPLETED|Overall Study||14
10677091|NCT02370641|11839430|FG001|COMPLETED|Overall Study||6
10677092|NCT02370641|11839429|FG000|NOT COMPLETED|Overall Study||4
10677093|NCT02370641|11839430|FG001|NOT COMPLETED|Overall Study||2
10677094|NCT02370667|11839439|FG000|STARTED|Overall Study||10
10677095|NCT02370667|11839440|FG001|STARTED|Overall Study||11
10677096|NCT02370667|11839441|FG002|STARTED|Overall Study||10
10677097|NCT02370667|11839439|FG000|COMPLETED|Overall Study||10
10677098|NCT02370667|11839440|FG001|COMPLETED|Overall Study||10
10677099|NCT02370667|11839441|FG002|COMPLETED|Overall Study||10
10677100|NCT02370667|11839439|FG000|NOT COMPLETED|Overall Study||0
10677101|NCT02370667|11839440|FG001|NOT COMPLETED|Overall Study||1
10677102|NCT02370667|11839441|FG002|NOT COMPLETED|Overall Study||0
10677103|NCT02370693|11839452|FG000|STARTED|Overall Study||3
10677104|NCT02370693|11839453|FG001|STARTED|Overall Study||4
10677105|NCT02370693|11839452|FG000|COMPLETED|Overall Study||2
10677106|NCT02370693|11839453|FG001|COMPLETED|Overall Study||3
10677107|NCT02370693|11839452|FG000|NOT COMPLETED|Overall Study||1
10677108|NCT02370693|11839453|FG001|NOT COMPLETED|Overall Study||1
10677109|NCT02370784|11839461|FG000|STARTED|Overall Study||10
10677110|NCT02370784|11839462|FG001|STARTED|Overall Study||14
10677111|NCT02370784|11839461|FG000|COMPLETED|Overall Study||10
10677112|NCT02370784|11839462|FG001|COMPLETED|Overall Study||13
10677113|NCT02370784|11839461|FG000|NOT COMPLETED|Overall Study||0
10677114|NCT02370784|11839462|FG001|NOT COMPLETED|Overall Study||1
10712671|NCT02672423|11878232|FG003|STARTED|Period 3||15
10712672|NCT02672423|11878233|FG004|STARTED|Period 3||14
10712673|NCT02672423|11878234|FG005|STARTED|Period 3||15
10712674|NCT02672423|11878235|FG006|STARTED|Period 3||15
10712675|NCT02672423|11878236|FG007|STARTED|Period 3||15
10712676|NCT02672423|11878237|FG008|STARTED|Period 3|Part C was a 2-period study design.|0
10712677|NCT02672423|11878238|FG009|STARTED|Period 3|Part C was a 2-period study design.|0
10712678|NCT02672423|11878229|FG000|COMPLETED|Period 3||0
10712679|NCT02672423|11878230|FG001|COMPLETED|Period 3||0
10712680|NCT02672423|11878231|FG002|COMPLETED|Period 3||13
10712681|NCT02672423|11878232|FG003|COMPLETED|Period 3||15
10712682|NCT02672423|11878233|FG004|COMPLETED|Period 3||14
10712683|NCT02672423|11878234|FG005|COMPLETED|Period 3||14
10712684|NCT02672423|11878235|FG006|COMPLETED|Period 3||15
10712685|NCT02672423|11878236|FG007|COMPLETED|Period 3||14
10712686|NCT02672423|11878237|FG008|COMPLETED|Period 3||0
10712687|NCT02672423|11878238|FG009|COMPLETED|Period 3||0
10712688|NCT02672423|11878229|FG000|NOT COMPLETED|Period 3||0
10712689|NCT02672423|11878230|FG001|NOT COMPLETED|Period 3||0
10712690|NCT02672423|11878231|FG002|NOT COMPLETED|Period 3||0
10712691|NCT02672423|11878232|FG003|NOT COMPLETED|Period 3||0
10712692|NCT02672423|11878233|FG004|NOT COMPLETED|Period 3||0
10712693|NCT02672423|11878234|FG005|NOT COMPLETED|Period 3||1
10712694|NCT02672423|11878235|FG006|NOT COMPLETED|Period 3||0
10712695|NCT02672423|11878236|FG007|NOT COMPLETED|Period 3||1
10712696|NCT02672423|11878237|FG008|NOT COMPLETED|Period 3||0
10712697|NCT02672423|11878238|FG009|NOT COMPLETED|Period 3||0
10712698|NCT02672514|11878261|FG000|STARTED|Overall Study||53
10712699|NCT02672514|11878262|FG001|STARTED|Overall Study||51
10712700|NCT02672514|11878261|FG000|COMPLETED|Overall Study||53
10712701|NCT02672514|11878262|FG001|COMPLETED|Overall Study||51
10712702|NCT02672514|11878261|FG000|NOT COMPLETED|Overall Study||0
10712703|NCT02672514|11878262|FG001|NOT COMPLETED|Overall Study||0
10712704|NCT02672553|11878270|FG000|STARTED|Overall Study||51
10712705|NCT02672553|11878271|FG001|STARTED|Overall Study||49
10713909|NCT02683577|11879467|FG001|NOT COMPLETED|Overall Study||0
10677115|NCT02370810|11839472|FG000|STARTED|Overall Study||73
10677116|NCT02370810|11839473|FG001|STARTED|Overall Study||73
10677117|NCT02370810|11839472|FG000|COMPLETED|Overall Study||50
10677118|NCT02370810|11839473|FG001|COMPLETED|Overall Study||54
10677119|NCT02370810|11839472|FG000|NOT COMPLETED|Overall Study||23
10677120|NCT02370810|11839473|FG001|NOT COMPLETED|Overall Study||19
10677124|NCT02371187|11839487|FG000|STARTED|Overall Study||18
10677125|NCT02371187|11839488|FG001|STARTED|Overall Study||19
10677126|NCT02371187|11839487|FG000|COMPLETED|Overall Study||15
10677127|NCT02371187|11839488|FG001|COMPLETED|Overall Study||15
10677128|NCT02371187|11839487|FG000|NOT COMPLETED|Overall Study||3
10677129|NCT02371187|11839488|FG001|NOT COMPLETED|Overall Study||4
10677130|NCT02371252|11839496|FG000|STARTED|Overall Study||70
10677131|NCT02371252|11839497|FG001|STARTED|Overall Study||70
10677132|NCT02371252|11839496|FG000|COMPLETED|Overall Study||70
10677133|NCT02371252|11839497|FG001|COMPLETED|Overall Study||70
10677134|NCT02371252|11839496|FG000|NOT COMPLETED|Overall Study||0
10677135|NCT02371252|11839497|FG001|NOT COMPLETED|Overall Study||0
10677136|NCT02371356|11839508|FG000|STARTED|Overall Study||1320
10677137|NCT02371356|11839509|FG001|STARTED|Overall Study||7354
10677138|NCT02371356|11839510|FG002|STARTED|Overall Study||2804
10677139|NCT02371356|11839511|FG003|STARTED|Overall Study||7423
10677140|NCT02371356|11839512|FG004|STARTED|Overall Study||72183
10677141|NCT02371356|11839508|FG000|COMPLETED|Overall Study||1320
10677142|NCT02371356|11839509|FG001|COMPLETED|Overall Study||7354
10677143|NCT02371356|11839510|FG002|COMPLETED|Overall Study||2804
10677144|NCT02371356|11839511|FG003|COMPLETED|Overall Study||7423
10797915|NCT03706040|11958320|FG000|Received Study Drug|Period B (Week 16 to Week 52)||0
10797916|NCT03706040|11958321|FG001|Received Study Drug|Period B (Week 16 to Week 52)||0
10797917|NCT03706040|11958322|FG002|Received Study Drug|Period B (Week 16 to Week 52)||0
10797918|NCT03706040|11958323|FG003|Received Study Drug|Period B (Week 16 to Week 52)||13
10797919|NCT03706040|11958324|FG004|Received Study Drug|Period B (Week 16 to Week 52)||11
10797920|NCT03706040|11958325|FG005|Received Study Drug|Period B (Week 16 to Week 52)||61
10797921|NCT03706040|11958326|FG006|Received Study Drug|Period B (Week 16 to Week 52)||57
10797922|NCT03706040|11958320|FG000|COMPLETED|Period B (Week 16 to Week 52)||0
10797923|NCT03706040|11958321|FG001|COMPLETED|Period B (Week 16 to Week 52)||0
10797924|NCT03706040|11958322|FG002|COMPLETED|Period B (Week 16 to Week 52)||0
10797925|NCT03706040|11958323|FG003|COMPLETED|Period B (Week 16 to Week 52)||5
10797926|NCT03706040|11958324|FG004|COMPLETED|Period B (Week 16 to Week 52)||3
10797927|NCT03706040|11958325|FG005|COMPLETED|Period B (Week 16 to Week 52)||33
10797928|NCT03706040|11958326|FG006|COMPLETED|Period B (Week 16 to Week 52)||30
10797929|NCT03706040|11958320|FG000|NOT COMPLETED|Period B (Week 16 to Week 52)||0
10797930|NCT03706040|11958321|FG001|NOT COMPLETED|Period B (Week 16 to Week 52)||0
10797931|NCT03706040|11958322|FG002|NOT COMPLETED|Period B (Week 16 to Week 52)||0
10797932|NCT03706040|11958323|FG003|NOT COMPLETED|Period B (Week 16 to Week 52)||8
10797933|NCT03706040|11958324|FG004|NOT COMPLETED|Period B (Week 16 to Week 52)||9
10797934|NCT03706040|11958325|FG005|NOT COMPLETED|Period B (Week 16 to Week 52)||28
10797935|NCT03706040|11958326|FG006|NOT COMPLETED|Period B (Week 16 to Week 52)||28
10797936|NCT03706313|11958344|FG000|STARTED|Overall Study||20
10797937|NCT03706313|11958345|FG001|STARTED|Overall Study||20
10797938|NCT03706313|11958344|FG000|COMPLETED|Overall Study||20
10797939|NCT03706313|11958345|FG001|COMPLETED|Overall Study||20
10797940|NCT03706313|11958344|FG000|NOT COMPLETED|Overall Study||0
10797941|NCT03706313|11958345|FG001|NOT COMPLETED|Overall Study||0
10797947|NCT03706469|11958359|FG000|STARTED|Overall Study||4
10797948|NCT03706469|11958360|FG001|STARTED|Overall Study||4
10797949|NCT03706469|11958361|FG002|STARTED|Overall Study||4
10797950|NCT03706469|11958362|FG003|STARTED|Overall Study||4
10797951|NCT03706469|11958359|FG000|COMPLETED|Overall Study||4
10797952|NCT03706469|11958360|FG001|COMPLETED|Overall Study||4
10797953|NCT03706469|11958361|FG002|COMPLETED|Overall Study||4
10797954|NCT03706469|11958362|FG003|COMPLETED|Overall Study||4
10797955|NCT03706469|11958359|FG000|NOT COMPLETED|Overall Study||0
10797956|NCT03706469|11958360|FG001|NOT COMPLETED|Overall Study||0
10797957|NCT03706469|11958361|FG002|NOT COMPLETED|Overall Study||0
10797958|NCT03706469|11958362|FG003|NOT COMPLETED|Overall Study||0
10797959|NCT03707041|11958379|FG000|STARTED|Overall Study||6
10797960|NCT03707041|11958380|FG001|STARTED|Overall Study||2
10677145|NCT02371356|11839512|FG004|COMPLETED|Overall Study||72183
10677146|NCT02371356|11839508|FG000|NOT COMPLETED|Overall Study||0
10677147|NCT02371356|11839509|FG001|NOT COMPLETED|Overall Study||0
10677148|NCT02371356|11839510|FG002|NOT COMPLETED|Overall Study||0
10677149|NCT02371356|11839511|FG003|NOT COMPLETED|Overall Study||0
10677150|NCT02371356|11839512|FG004|NOT COMPLETED|Overall Study||0
10677151|NCT02371395|11839524|FG000|STARTED|Overall Study||1000
10677152|NCT02371395|11839524|FG000|COMPLETED|Overall Study||1000
10677153|NCT02371395|11839524|FG000|NOT COMPLETED|Overall Study||0
10677154|NCT02371616|11839530|FG000|STARTED|Overall Study||150
10677155|NCT02371616|11839531|FG001|STARTED|Overall Study||154
10797961|NCT03707041|11958381|FG002|STARTED|Overall Study||9
10797962|NCT03707041|11958382|FG003|STARTED|Overall Study||3
10677156|NCT02371616|11839530|FG000|COMPLETED|Overall Study||146
10677157|NCT02371616|11839531|FG001|COMPLETED|Overall Study||147
10677158|NCT02371616|11839530|FG000|NOT COMPLETED|Overall Study||4
10677159|NCT02371616|11839531|FG001|NOT COMPLETED|Overall Study||7
10677160|NCT02371629|11839539|FG000|STARTED|Overall Study||388
10677161|NCT02371629|11839540|FG001|STARTED|Overall Study||388
10677162|NCT02371629|11839539|FG000|COMPLETED|Overall Study||362
10677163|NCT02371629|11839540|FG001|COMPLETED|Overall Study||363
10677164|NCT02371629|11839539|FG000|NOT COMPLETED|Overall Study||26
10677165|NCT02371629|11839540|FG001|NOT COMPLETED|Overall Study||25
10677166|NCT02371668|11839548|FG000|STARTED|Overall Study||49
10677167|NCT02371668|11839549|FG001|STARTED|Overall Study||42
10677168|NCT02371668|11839548|FG000|COMPLETED|Overall Study||49
10677169|NCT02371668|11839549|FG001|COMPLETED|Overall Study||42
10677170|NCT02371668|11839548|FG000|NOT COMPLETED|Overall Study||0
10797963|NCT03707041|11958383|FG004|STARTED|Overall Study||9
10797964|NCT03707041|11958384|FG005|STARTED|Overall Study||3
10797965|NCT03707041|11958379|FG000|COMPLETED|Overall Study||6
10797966|NCT03707041|11958380|FG001|COMPLETED|Overall Study||2
10797967|NCT03707041|11958381|FG002|COMPLETED|Overall Study||9
10797968|NCT03707041|11958382|FG003|COMPLETED|Overall Study||3
10797969|NCT03707041|11958383|FG004|COMPLETED|Overall Study||9
10797970|NCT03707041|11958384|FG005|COMPLETED|Overall Study||3
10797971|NCT03707041|11958379|FG000|NOT COMPLETED|Overall Study||0
10797972|NCT03707041|11958380|FG001|NOT COMPLETED|Overall Study||0
10797973|NCT03707041|11958381|FG002|NOT COMPLETED|Overall Study||0
10797974|NCT03707041|11958382|FG003|NOT COMPLETED|Overall Study||0
10797975|NCT03707041|11958383|FG004|NOT COMPLETED|Overall Study||0
10797976|NCT03707041|11958384|FG005|NOT COMPLETED|Overall Study||0
10797977|NCT03707522|11958403|FG000|STARTED|Overall Study||31
10797978|NCT03707522|11958404|FG001|STARTED|Overall Study||36
10797979|NCT03707522|11958405|FG002|STARTED|Overall Study||52
10797980|NCT03707522|11958406|FG003|STARTED|Overall Study||43
10797981|NCT03707522|11958403|FG000|COMPLETED|Overall Study||7
10797982|NCT03707522|11958404|FG001|COMPLETED|Overall Study||9
10797983|NCT03707522|11958405|FG002|COMPLETED|Overall Study||11
10797984|NCT03707522|11958406|FG003|COMPLETED|Overall Study||7
10797985|NCT03707522|11958403|FG000|NOT COMPLETED|Overall Study||24
10797986|NCT03707522|11958404|FG001|NOT COMPLETED|Overall Study||27
10797987|NCT03707522|11958405|FG002|NOT COMPLETED|Overall Study||41
10797988|NCT03707522|11958406|FG003|NOT COMPLETED|Overall Study||36
10797989|NCT03707587|11958418|FG000|STARTED|Overall Study||7
10797990|NCT03707587|11958419|FG001|STARTED|Overall Study||2
10797991|NCT03707587|11958418|FG000|COMPLETED|Overall Study||7
10797992|NCT03707587|11958419|FG001|COMPLETED|Overall Study||1
10797993|NCT03707587|11958418|FG000|NOT COMPLETED|Overall Study||0
10797994|NCT03707587|11958419|FG001|NOT COMPLETED|Overall Study||1
10797995|NCT03707821|11958427|FG000|STARTED|Overall Study||125
10797996|NCT03707821|11958428|FG001|STARTED|Overall Study||126
10797997|NCT03707821|11958427|FG000|COMPLETED|Overall Study||123
10797998|NCT03707821|11958428|FG001|COMPLETED|Overall Study||125
10797999|NCT03707821|11958427|FG000|NOT COMPLETED|Overall Study||2
10798000|NCT03707821|11958428|FG001|NOT COMPLETED|Overall Study||1
10798001|NCT03707912|11958436|FG000|STARTED|Overall Study||104
10798002|NCT03707912|11958437|FG001|STARTED|Overall Study||100
10798003|NCT03707912|11958436|FG000|COMPLETED|Overall Study||103
10798004|NCT03707912|11958437|FG001|COMPLETED|Overall Study||100
10798005|NCT03707912|11958436|FG000|NOT COMPLETED|Overall Study||1
10798006|NCT03707912|11958437|FG001|NOT COMPLETED|Overall Study||0
10798007|NCT03708211|11958445|FG000|STARTED|Overall Study||12
10798008|NCT03708211|11958446|FG001|STARTED|Overall Study||8
10798009|NCT03708211|11958445|FG000|COMPLETED|Overall Study||0
10677171|NCT02371668|11839549|FG001|NOT COMPLETED|Overall Study||0
10677172|NCT02371746|11839562|FG000|STARTED|Overall Study||7
10677173|NCT02371746|11839563|FG001|STARTED|Overall Study||10
10677174|NCT02371746|11839564|FG002|STARTED|Overall Study||2
10677175|NCT02371746|11839565|FG003|STARTED|Overall Study||2
10677176|NCT02371746|11839566|FG004|STARTED|Overall Study||5
10677177|NCT02371746|11839567|FG005|STARTED|Overall Study||6
10677178|NCT02371746|11839568|FG006|STARTED|Overall Study||9
10677179|NCT02371746|11839562|FG000|COMPLETED|Overall Study||7
10677180|NCT02371746|11839563|FG001|COMPLETED|Overall Study||10
10677181|NCT02371746|11839564|FG002|COMPLETED|Overall Study||2
10677182|NCT02371746|11839565|FG003|COMPLETED|Overall Study||2
10677183|NCT02371746|11839566|FG004|COMPLETED|Overall Study||5
10677184|NCT02371746|11839567|FG005|COMPLETED|Overall Study||6
10677185|NCT02371746|11839568|FG006|COMPLETED|Overall Study||8
10677186|NCT02371746|11839562|FG000|NOT COMPLETED|Overall Study||0
10798010|NCT03708211|11958446|FG001|COMPLETED|Overall Study||0
10798011|NCT03708211|11958445|FG000|NOT COMPLETED|Overall Study||12
10798012|NCT03708211|11958446|FG001|NOT COMPLETED|Overall Study||8
10798013|NCT03708367|11958456|FG000|STARTED|Overall Study||59
10798014|NCT03708367|11958457|FG001|STARTED|Overall Study||58
10798015|NCT03708367|11958456|FG000|COMPLETED|Overall Study||58
10798016|NCT03708367|11958457|FG001|COMPLETED|Overall Study||57
10798017|NCT03708367|11958456|FG000|NOT COMPLETED|Overall Study||1
10677187|NCT02371746|11839563|FG001|NOT COMPLETED|Overall Study||0
10677188|NCT02371746|11839564|FG002|NOT COMPLETED|Overall Study||0
10677189|NCT02371746|11839565|FG003|NOT COMPLETED|Overall Study||0
10677190|NCT02371746|11839566|FG004|NOT COMPLETED|Overall Study||0
10677191|NCT02371746|11839567|FG005|NOT COMPLETED|Overall Study||0
10677192|NCT02371746|11839568|FG006|NOT COMPLETED|Overall Study||1
10677193|NCT02371759|11839592|FG000|STARTED|Overall Study||32
10677194|NCT02371759|11839593|FG001|STARTED|Overall Study||31
10677195|NCT02371759|11839594|FG002|STARTED|Overall Study||33
10677196|NCT02371759|11839595|FG003|STARTED|Overall Study||31
10677197|NCT02371759|11839596|FG004|STARTED|Overall Study||27
10677198|NCT02371759|11839597|FG005|STARTED|Overall Study||26
10677199|NCT02371759|11839598|FG006|STARTED|Overall Study||25
10677200|NCT02371759|11839599|FG007|STARTED|Overall Study||28
10677201|NCT02371759|11839592|FG000|COMPLETED|Overall Study||29
10677202|NCT02371759|11839593|FG001|COMPLETED|Overall Study||30
10677203|NCT02371759|11839594|FG002|COMPLETED|Overall Study||32
10677204|NCT02371759|11839595|FG003|COMPLETED|Overall Study||31
10677205|NCT02371759|11839596|FG004|COMPLETED|Overall Study||24
10677206|NCT02371759|11839597|FG005|COMPLETED|Overall Study||25
10677207|NCT02371759|11839598|FG006|COMPLETED|Overall Study||25
10677208|NCT02371759|11839599|FG007|COMPLETED|Overall Study||24
10677209|NCT02371759|11839592|FG000|NOT COMPLETED|Overall Study||3
10677210|NCT02371759|11839593|FG001|NOT COMPLETED|Overall Study||1
10677211|NCT02371759|11839594|FG002|NOT COMPLETED|Overall Study||1
10798018|NCT03708367|11958457|FG001|NOT COMPLETED|Overall Study||1
10798019|NCT03708393|11958464|FG000|STARTED|Overall Study||155
10798020|NCT03708393|11958464|FG000|COMPLETED|Overall Study||155
10798021|NCT03708393|11958464|FG000|NOT COMPLETED|Overall Study||0
10798022|NCT03708562|11958473|FG000|STARTED|Overall Study||24
10798023|NCT03708562|11958473|FG000|COMPLETED|Overall Study||12
10798024|NCT03708562|11958473|FG000|NOT COMPLETED|Overall Study||12
10798025|NCT03708744|11958477|FG000|STARTED|Overall Study||7
10798026|NCT03708744|11958478|FG001|STARTED|Overall Study||6
10798027|NCT03708744|11958479|FG002|STARTED|Overall Study||5
10798028|NCT03708744|11958480|FG003|STARTED|Overall Study||6
10798029|NCT03708744|11958477|FG000|COMPLETED|Overall Study||7
10798030|NCT03708744|11958478|FG001|COMPLETED|Overall Study||6
10798031|NCT03708744|11958479|FG002|COMPLETED|Overall Study||4
10798032|NCT03708744|11958480|FG003|COMPLETED|Overall Study||6
10798033|NCT03708744|11958477|FG000|NOT COMPLETED|Overall Study||0
10798034|NCT03708744|11958478|FG001|NOT COMPLETED|Overall Study||0
10798035|NCT03708744|11958479|FG002|NOT COMPLETED|Overall Study||1
10798036|NCT03708744|11958480|FG003|NOT COMPLETED|Overall Study||0
10798037|NCT03708770|11958490|FG000|STARTED|Overall Study||32
10798038|NCT03708770|11958490|FG000|COMPLETED|Overall Study||22
10798039|NCT03708770|11958490|FG000|NOT COMPLETED|Overall Study||10
10798040|NCT03709602|11958497|FG000|STARTED|Overall Study|Adolescents recruited for qualitative interviews.|16
10798041|NCT03709602|11958498|FG001|STARTED|Overall Study|Parents recruited for qualitative interviews.|16
10798042|NCT03709602|11958499|FG002|STARTED|Overall Study|Cohort of adolescents created from the EHR data for the quantitative portion of the study.|3044
10798043|NCT03709602|11958497|FG000|COMPLETED|Overall Study|Adolescents recruited for qualitative interviews.|16
10798044|NCT03709602|11958498|FG001|COMPLETED|Overall Study|Parents recruited for qualitative interviews.|16
10798045|NCT03709602|11958499|FG002|COMPLETED|Overall Study|Cohort of adolescents created from the EHR data for the quantitative portion of the study.|3044
10798046|NCT03709602|11958497|FG000|NOT COMPLETED|Overall Study||0
10798047|NCT03709602|11958498|FG001|NOT COMPLETED|Overall Study||0
10798048|NCT03709602|11958499|FG002|NOT COMPLETED|Overall Study||0
10798049|NCT03709654|11958507|FG000|STARTED|Overall Study||23
10798050|NCT03709654|11958508|FG001|STARTED|Overall Study||13
10798051|NCT03709654|11958507|FG000|COMPLETED|Overall Study||20
10798052|NCT03709654|11958508|FG001|COMPLETED|Overall Study||11
10798053|NCT03709654|11958507|FG000|NOT COMPLETED|Overall Study||3
10798054|NCT03709654|11958508|FG001|NOT COMPLETED|Overall Study||2
10798055|NCT03709810|11958514|FG000|STARTED|Treatment Period 1 (Visit 2)||24
10798056|NCT03709810|11958515|FG001|STARTED|Treatment Period 1 (Visit 2)||24
10798057|NCT03709810|11958514|FG000|COMPLETED|Treatment Period 1 (Visit 2)||24
10798058|NCT03709810|11958515|FG001|COMPLETED|Treatment Period 1 (Visit 2)||24
10798059|NCT03709810|11958514|FG000|NOT COMPLETED|Treatment Period 1 (Visit 2)||0
10798060|NCT03709810|11958515|FG001|NOT COMPLETED|Treatment Period 1 (Visit 2)||0
10798061|NCT03709810|11958514|FG000|STARTED|Treatment Period 2 (Visit 3)||24
10798062|NCT03709810|11958515|FG001|STARTED|Treatment Period 2 (Visit 3)||24
10798063|NCT03709810|11958514|FG000|COMPLETED|Treatment Period 2 (Visit 3)||24
10798064|NCT03709810|11958515|FG001|COMPLETED|Treatment Period 2 (Visit 3)||24
10798065|NCT03709810|11958514|FG000|NOT COMPLETED|Treatment Period 2 (Visit 3)||0
10798066|NCT03709810|11958515|FG001|NOT COMPLETED|Treatment Period 2 (Visit 3)||0
10798067|NCT03709823|11958527|FG000|STARTED|Overall Study||51
10798068|NCT03709823|11958528|FG001|STARTED|Overall Study||50
10798069|NCT03709823|11958529|FG002|STARTED|Overall Study||25
10798070|NCT03709823|11958530|FG003|STARTED|Overall Study||52
10798071|NCT03709823|11958531|FG004|STARTED|Overall Study||50
10798072|NCT03709823|11958532|FG005|STARTED|Overall Study||26
10798073|NCT03709823|11958527|FG000|COMPLETED|Overall Study||48
10798074|NCT03709823|11958528|FG001|COMPLETED|Overall Study||45
10798075|NCT03709823|11958529|FG002|COMPLETED|Overall Study||22
10798076|NCT03709823|11958530|FG003|COMPLETED|Overall Study||50
10798077|NCT03709823|11958531|FG004|COMPLETED|Overall Study||49
10677212|NCT02371759|11839595|FG003|NOT COMPLETED|Overall Study||0
10677213|NCT02371759|11839596|FG004|NOT COMPLETED|Overall Study||3
10798078|NCT03709823|11958532|FG005|COMPLETED|Overall Study||26
10677214|NCT02371759|11839597|FG005|NOT COMPLETED|Overall Study||1
10677215|NCT02371759|11839598|FG006|NOT COMPLETED|Overall Study||0
10677216|NCT02371759|11839599|FG007|NOT COMPLETED|Overall Study||4
10677217|NCT02371785|11839617|FG000|STARTED|Overall Study||20
10677218|NCT02371785|11839617|FG000|COMPLETED|Overall Study||20
10677219|NCT02371785|11839617|FG000|NOT COMPLETED|Overall Study||0
10677220|NCT02371850|11839627|FG000|STARTED|Overall Study||10
10677221|NCT02371850|11839627|FG000|COMPLETED|Overall Study||10
10677222|NCT02371850|11839627|FG000|NOT COMPLETED|Overall Study||0
10677223|NCT02371876|11839638|FG000|STARTED|Overall Study||134
10677224|NCT02371876|11839638|FG000|COMPLETED|Overall Study||134
10677225|NCT02371876|11839638|FG000|NOT COMPLETED|Overall Study||0
10677226|NCT02371980|11839646|FG000|STARTED|Open-label Period||1106
10677227|NCT02371980|11839647|FG001|STARTED|Open-label Period||0
10677228|NCT02371980|11839648|FG002|STARTED|Open-label Period||0
10677229|NCT02371980|11839649|FG003|STARTED|Open-label Period||0
10677230|NCT02371980|11839650|FG004|STARTED|Open-label Period||0
10677231|NCT02371980|11839646|FG000|COMPLETED|Open-label Period||580
10677232|NCT02371980|11839647|FG001|COMPLETED|Open-label Period||0
10677233|NCT02371980|11839648|FG002|COMPLETED|Open-label Period||0
10677234|NCT02371980|11839649|FG003|COMPLETED|Open-label Period||0
10798079|NCT03709823|11958527|FG000|NOT COMPLETED|Overall Study||3
10798080|NCT03709823|11958528|FG001|NOT COMPLETED|Overall Study||5
10798081|NCT03709823|11958529|FG002|NOT COMPLETED|Overall Study||3
10798082|NCT03709823|11958530|FG003|NOT COMPLETED|Overall Study||2
10798083|NCT03709823|11958531|FG004|NOT COMPLETED|Overall Study||1
10798084|NCT03709823|11958532|FG005|NOT COMPLETED|Overall Study||0
10798085|NCT03710083|11958549|FG000|STARTED|Overall Study||66
10798086|NCT03710083|11958549|FG000|COMPLETED|Overall Study||63
10798087|NCT03710083|11958549|FG000|NOT COMPLETED|Overall Study||3
10798088|NCT03710161|11958555|FG000|STARTED|Overall Study||3
10798089|NCT03710161|11958556|FG001|STARTED|Overall Study||2
10798090|NCT03710161|11958555|FG000|COMPLETED|Overall Study|Study halted due to COVID pandemic|0
10798091|NCT03710161|11958556|FG001|COMPLETED|Overall Study|Study halted due to COVID pandemic|0
10798092|NCT03710161|11958555|FG000|NOT COMPLETED|Overall Study||3
10798093|NCT03710161|11958556|FG001|NOT COMPLETED|Overall Study||2
10798094|NCT03710187|11958564|FG000|STARTED|Overall Study||41
10798095|NCT03710187|11958565|FG001|STARTED|Overall Study||43
10798096|NCT03710187|11958564|FG000|COMPLETED|Overall Study||41
10798097|NCT03710187|11958565|FG001|COMPLETED|Overall Study||43
10798098|NCT03710187|11958564|FG000|NOT COMPLETED|Overall Study||0
10798099|NCT03710187|11958565|FG001|NOT COMPLETED|Overall Study||0
10798100|NCT03710577|11958573|FG000|STARTED|First Intervention||8
10798101|NCT03710577|11958574|FG001|STARTED|First Intervention||4
10798102|NCT03710577|11958573|FG000|COMPLETED|First Intervention||8
10798103|NCT03710577|11958574|FG001|COMPLETED|First Intervention||4
10798104|NCT03710577|11958573|FG000|NOT COMPLETED|First Intervention||0
10798105|NCT03710577|11958574|FG001|NOT COMPLETED|First Intervention||0
10798106|NCT03710577|11958573|FG000|STARTED|Time Between Sessions (2-5 Days)||8
10798107|NCT03710577|11958574|FG001|STARTED|Time Between Sessions (2-5 Days)||4
10798108|NCT03710577|11958573|FG000|COMPLETED|Time Between Sessions (2-5 Days)||8
10798109|NCT03710577|11958574|FG001|COMPLETED|Time Between Sessions (2-5 Days)||4
10798110|NCT03710577|11958573|FG000|NOT COMPLETED|Time Between Sessions (2-5 Days)||0
10798111|NCT03710577|11958574|FG001|NOT COMPLETED|Time Between Sessions (2-5 Days)||0
10798112|NCT03710577|11958573|FG000|STARTED|Second Intervention||8
10798113|NCT03710577|11958574|FG001|STARTED|Second Intervention||4
10798114|NCT03710577|11958573|FG000|COMPLETED|Second Intervention||8
10798115|NCT03710577|11958574|FG001|COMPLETED|Second Intervention||4
10798116|NCT03710577|11958573|FG000|NOT COMPLETED|Second Intervention||0
10798117|NCT03710577|11958574|FG001|NOT COMPLETED|Second Intervention||0
10798118|NCT03710590|11958582|FG000|STARTED|Overall Study||22
10798119|NCT03710590|11958583|FG001|STARTED|Overall Study||23
10798120|NCT03710590|11958582|FG000|Session 1: ECIG Lab Session 15 Watts, 10 mg Nicotine|Overall Study||12
10798121|NCT03710590|11958583|FG001|Session 1: ECIG Lab Session 15 Watts, 10 mg Nicotine|Overall Study||15
10798122|NCT03710590|11958582|FG000|Session 2: ECIG Lab Session 15 Watts, 15 mg Nicotine|Overall Study||12
10798123|NCT03710590|11958583|FG001|Session 2: ECIG Lab Session 15 Watts, 15 mg Nicotine|Overall Study||15
10798124|NCT03710590|11958582|FG000|Session 3: ECIG Lab Session 15 Watts, 30 mg Nicotine|Overall Study||12
10798125|NCT03710590|11958583|FG001|Session 3: ECIG Lab Session 15 Watts, 30 mg Nicotine|Overall Study||15
10798126|NCT03710590|11958582|FG000|Session 4: ECIG Lab Session 30 Watts, 10 mg Nicotine|Overall Study||12
10798127|NCT03710590|11958583|FG001|Session 4: ECIG Lab Session 30 Watts, 10 mg Nicotine|Overall Study||15
10798128|NCT03710590|11958582|FG000|Session 5: ECIG Lab Session 30 Watts, 15 mg Nicotine|Overall Study||12
10798129|NCT03710590|11958583|FG001|Session 5: ECIG Lab Session 30 Watts, 15 mg Nicotine|Overall Study||15
10798130|NCT03710590|11958582|FG000|Session 6: ECIG Lab Session 30 Watts, 30 mg Nicotine|Overall Study||12
10798131|NCT03710590|11958583|FG001|Session 6: ECIG Lab Session 30 Watts, 30 mg Nicotine|Overall Study||15
10798132|NCT03710590|11958582|FG000|COMPLETED|Overall Study||12
10798133|NCT03710590|11958583|FG001|COMPLETED|Overall Study||15
10798134|NCT03710590|11958582|FG000|NOT COMPLETED|Overall Study||10
10798135|NCT03710590|11958583|FG001|NOT COMPLETED|Overall Study||8
10810942|NCT03784079|11972665|FG005|STARTED|Part 1: Up to Day 24||0
10810943|NCT03784079|11972666|FG006|STARTED|Part 1: Up to Day 24||0
10810944|NCT03784079|11972660|FG000|COMPLETED|Part 1: Up to Day 24||6
10810945|NCT03784079|11972661|FG001|COMPLETED|Part 1: Up to Day 24||6
10810946|NCT03784079|11972662|FG002|COMPLETED|Part 1: Up to Day 24||2
10810947|NCT03784079|11972663|FG003|COMPLETED|Part 1: Up to Day 24||0
10810948|NCT03784079|11972664|FG004|COMPLETED|Part 1: Up to Day 24||0
10810949|NCT03784079|11972665|FG005|COMPLETED|Part 1: Up to Day 24||0
10677235|NCT02371980|11839650|FG004|COMPLETED|Open-label Period||0
10677236|NCT02371980|11839646|FG000|NOT COMPLETED|Open-label Period||526
10677237|NCT02371980|11839647|FG001|NOT COMPLETED|Open-label Period||0
10677238|NCT02371980|11839648|FG002|NOT COMPLETED|Open-label Period||0
10677239|NCT02371980|11839649|FG003|NOT COMPLETED|Open-label Period||0
10677240|NCT02371980|11839650|FG004|NOT COMPLETED|Open-label Period||0
10677241|NCT02371980|11839646|FG000|STARTED|Double-blind Period||0
10677242|NCT02371980|11839647|FG001|STARTED|Double-blind Period||151
10677243|NCT02371980|11839648|FG002|STARTED|Double-blind Period||140
10677244|NCT02371980|11839649|FG003|STARTED|Double-blind Period||145
10677245|NCT02371980|11839650|FG004|STARTED|Double-blind Period||144
10677246|NCT02371980|11839646|FG000|COMPLETED|Double-blind Period||0
10677247|NCT02371980|11839647|FG001|COMPLETED|Double-blind Period||70
10677248|NCT02371980|11839648|FG002|COMPLETED|Double-blind Period||84
10677249|NCT02371980|11839649|FG003|COMPLETED|Double-blind Period||96
10677250|NCT02371980|11839650|FG004|COMPLETED|Double-blind Period||86
10798136|NCT03710889|11958589|FG000|STARTED|Overall Study||23
10798137|NCT03710889|11958589|FG000|Received at Least 1 Dose of Study Drug|Overall Study||23
10798138|NCT03710889|11958589|FG000|Bone-Biopsy Population|Overall Study||19
10798139|NCT03710889|11958589|FG000|COMPLETED|Overall Study||20
10798140|NCT03710889|11958589|FG000|NOT COMPLETED|Overall Study||3
10798141|NCT03711396|11958593|FG000|STARTED|Overall Study||13
10798142|NCT03711396|11958594|FG001|STARTED|Overall Study||13
10798143|NCT03711396|11958593|FG000|COMPLETED|Overall Study||13
10798144|NCT03711396|11958594|FG001|COMPLETED|Overall Study||13
10798145|NCT03711396|11958593|FG000|NOT COMPLETED|Overall Study||0
10798146|NCT03711396|11958594|FG001|NOT COMPLETED|Overall Study||0
10798147|NCT03711578|11958601|FG000|STARTED|Overall Study||20
10798148|NCT03711578|11958601|FG000|COMPLETED|Overall Study||20
10798149|NCT03711578|11958601|FG000|NOT COMPLETED|Overall Study||0
10798150|NCT03712189|11958607|FG000|STARTED|Overall Study||15
10798151|NCT03712189|11958608|FG001|STARTED|Overall Study||15
10798152|NCT03712189|11958607|FG000|COMPLETED|Overall Study||15
10798153|NCT03712189|11958608|FG001|COMPLETED|Overall Study||15
10798154|NCT03712189|11958607|FG000|NOT COMPLETED|Overall Study||0
10798155|NCT03712189|11958608|FG001|NOT COMPLETED|Overall Study||0
10798156|NCT03712280|11958618|FG000|STARTED|Overall Study||12
10798157|NCT03712280|11958619|FG001|STARTED|Overall Study||12
10798158|NCT03712280|11958620|FG002|STARTED|Overall Study||13
10798159|NCT03712280|11958621|FG003|STARTED|Overall Study||13
10798160|NCT03712280|11958618|FG000|Safety Population|Overall Study||12
10798161|NCT03712280|11958619|FG001|Safety Population|Overall Study||11
10798162|NCT03712280|11958620|FG002|Safety Population|Overall Study||13
10798163|NCT03712280|11958621|FG003|Safety Population|Overall Study||12
10798164|NCT03712280|11958618|FG000|Modified Intent to Treat Population|Overall Study||12
10798165|NCT03712280|11958619|FG001|Modified Intent to Treat Population|Overall Study||11
10798166|NCT03712280|11958620|FG002|Modified Intent to Treat Population|Overall Study||13
10798167|NCT03712280|11958621|FG003|Modified Intent to Treat Population|Overall Study||12
10798168|NCT03712280|11958618|FG000|Completed 5 Day Treatment|Overall Study||11
10798169|NCT03712280|11958619|FG001|Completed 5 Day Treatment|Overall Study||11
10798170|NCT03712280|11958620|FG002|Completed 5 Day Treatment|Overall Study||12
10798171|NCT03712280|11958621|FG003|Completed 5 Day Treatment|Overall Study||12
10798172|NCT03712280|11958618|FG000|COMPLETED|Overall Study||11
10798173|NCT03712280|11958619|FG001|COMPLETED|Overall Study||11
10798174|NCT03712280|11958620|FG002|COMPLETED|Overall Study||12
10798175|NCT03712280|11958621|FG003|COMPLETED|Overall Study||12
10798176|NCT03712280|11958618|FG000|NOT COMPLETED|Overall Study||1
10798177|NCT03712280|11958619|FG001|NOT COMPLETED|Overall Study||1
10798178|NCT03712280|11958620|FG002|NOT COMPLETED|Overall Study||1
10798179|NCT03712280|11958621|FG003|NOT COMPLETED|Overall Study||1
10798180|NCT03712449|11958633|FG000|STARTED|Overall Study||13
10798181|NCT03712449|11958634|FG001|STARTED|Overall Study||46
10798182|NCT03712449|11958633|FG000|Full Analysis Population|Overall Study||13
10798183|NCT03712449|11958634|FG001|Full Analysis Population|Overall Study||45
10798184|NCT03712449|11958633|FG000|COMPLETED|Overall Study||13
10798185|NCT03712449|11958634|FG001|COMPLETED|Overall Study||45
10677251|NCT02371980|11839646|FG000|NOT COMPLETED|Double-blind Period||0
10677252|NCT02371980|11839647|FG001|NOT COMPLETED|Double-blind Period||81
10677253|NCT02371980|11839648|FG002|NOT COMPLETED|Double-blind Period||56
10677254|NCT02371980|11839649|FG003|NOT COMPLETED|Double-blind Period||49
10677255|NCT02371980|11839650|FG004|NOT COMPLETED|Double-blind Period||58
10798186|NCT03712449|11958633|FG000|NOT COMPLETED|Overall Study||0
10798187|NCT03712449|11958634|FG001|NOT COMPLETED|Overall Study||1
10798188|NCT03712852|11958643|FG000|STARTED|Overall Study||20
10798189|NCT03712852|11958644|FG001|STARTED|Overall Study||20
10798190|NCT03712852|11958645|FG002|STARTED|Overall Study||20
10798191|NCT03712852|11958643|FG000|COMPLETED|Overall Study||20
10798192|NCT03712852|11958644|FG001|COMPLETED|Overall Study||20
10798193|NCT03712852|11958645|FG002|COMPLETED|Overall Study||20
10677256|NCT02372006|11839664|FG000|STARTED|Overall Study||8
10677257|NCT02372006|11839665|FG001|STARTED|Overall Study||9
10677258|NCT02372006|11839666|FG002|STARTED|Overall Study||39
10798194|NCT03712852|11958643|FG000|NOT COMPLETED|Overall Study||0
10798195|NCT03712852|11958644|FG001|NOT COMPLETED|Overall Study||0
10798196|NCT03712852|11958645|FG002|NOT COMPLETED|Overall Study||0
10798197|NCT03712917|11958656|FG000|STARTED|Overall Study||40
10798198|NCT03712917|11958657|FG001|STARTED|Overall Study||40
10798199|NCT03712917|11958658|FG002|STARTED|Overall Study||40
10798200|NCT03712917|11958656|FG000|COMPLETED|Overall Study||31
10798201|NCT03712917|11958657|FG001|COMPLETED|Overall Study||32
10798202|NCT03712917|11958658|FG002|COMPLETED|Overall Study||31
10798203|NCT03712917|11958656|FG000|NOT COMPLETED|Overall Study||9
10798204|NCT03712917|11958657|FG001|NOT COMPLETED|Overall Study||8
10677259|NCT02372006|11839664|FG000|COMPLETED|Overall Study||0
10677260|NCT02372006|11839665|FG001|COMPLETED|Overall Study||0
10677261|NCT02372006|11839666|FG002|COMPLETED|Overall Study||0
10677262|NCT02372006|11839664|FG000|NOT COMPLETED|Overall Study||8
10677263|NCT02372006|11839665|FG001|NOT COMPLETED|Overall Study||9
10677264|NCT02372006|11839666|FG002|NOT COMPLETED|Overall Study||39
10677265|NCT02372058|11839675|FG000|STARTED|Overall Study||103
10677266|NCT02372058|11839675|FG000|COMPLETED|Overall Study||100
10677267|NCT02372058|11839675|FG000|NOT COMPLETED|Overall Study||3
10677268|NCT02372071|11839681|FG000|STARTED|Overall Study||111
10677269|NCT02372071|11839681|FG000|COMPLETED|Overall Study||93
10677270|NCT02372071|11839681|FG000|NOT COMPLETED|Overall Study||18
10677271|NCT02372097|11839688|FG000|STARTED|First Intervention Period (8 Days)||12
10677272|NCT02372097|11839689|FG001|STARTED|First Intervention Period (8 Days)||12
10677273|NCT02372097|11839688|FG000|COMPLETED|First Intervention Period (8 Days)||12
10677274|NCT02372097|11839689|FG001|COMPLETED|First Intervention Period (8 Days)||12
10677275|NCT02372097|11839688|FG000|NOT COMPLETED|First Intervention Period (8 Days)||0
10677276|NCT02372097|11839689|FG001|NOT COMPLETED|First Intervention Period (8 Days)||0
10677277|NCT02372097|11839688|FG000|STARTED|Wash Out Period (13 Days)||12
10677278|NCT02372097|11839689|FG001|STARTED|Wash Out Period (13 Days)||12
10677279|NCT02372097|11839688|FG000|COMPLETED|Wash Out Period (13 Days)||12
10677280|NCT02372097|11839689|FG001|COMPLETED|Wash Out Period (13 Days)||12
10677281|NCT02372097|11839688|FG000|NOT COMPLETED|Wash Out Period (13 Days)||0
10677282|NCT02372097|11839689|FG001|NOT COMPLETED|Wash Out Period (13 Days)||0
10677283|NCT02372097|11839688|FG000|STARTED|Second Intervention Period (8 Days)||12
10677284|NCT02372097|11839689|FG001|STARTED|Second Intervention Period (8 Days)||12
10677285|NCT02372097|11839688|FG000|COMPLETED|Second Intervention Period (8 Days)||12
10677286|NCT02372097|11839689|FG001|COMPLETED|Second Intervention Period (8 Days)||12
10677287|NCT02372097|11839688|FG000|NOT COMPLETED|Second Intervention Period (8 Days)||0
10677288|NCT02372097|11839689|FG001|NOT COMPLETED|Second Intervention Period (8 Days)||0
10677289|NCT02372253|11839697|FG000|STARTED|Overall Study||13
10677290|NCT02372253|11839698|FG001|STARTED|Overall Study||13
10677291|NCT02372253|11839697|FG000|COMPLETED|Overall Study||11
10677292|NCT02372253|11839698|FG001|COMPLETED|Overall Study||13
10677293|NCT02372253|11839697|FG000|NOT COMPLETED|Overall Study||2
10677294|NCT02372253|11839698|FG001|NOT COMPLETED|Overall Study||0
10798205|NCT03712917|11958658|FG002|NOT COMPLETED|Overall Study||9
10798206|NCT03712930|11958666|FG000|STARTED|Overall Study||13
10798207|NCT03712930|11958666|FG000|COMPLETED|Overall Study||0
10798208|NCT03712930|11958666|FG000|NOT COMPLETED|Overall Study||13
10798209|NCT03713398|11958672|FG000|STARTED|Overall Study||50
10798210|NCT03713398|11958673|FG001|STARTED|Overall Study||50
10798211|NCT03713398|11958672|FG000|COMPLETED|Overall Study||24
10798212|NCT03713398|11958673|FG001|COMPLETED|Overall Study||23
10798213|NCT03713398|11958672|FG000|NOT COMPLETED|Overall Study||26
10798214|NCT03713398|11958673|FG001|NOT COMPLETED|Overall Study||27
10798215|NCT03714022|11958681|FG000|STARTED|Overall Study||70
10798216|NCT03714022|11958682|FG001|STARTED|Overall Study||70
10798217|NCT03714022|11958681|FG000|COMPLETED|Overall Study||66
10798218|NCT03714022|11958682|FG001|COMPLETED|Overall Study||67
10798219|NCT03714022|11958681|FG000|NOT COMPLETED|Overall Study||4
10798220|NCT03714022|11958682|FG001|NOT COMPLETED|Overall Study||3
10798221|NCT03714256|11958690|FG000|STARTED|Overall Study||14
10798222|NCT03714256|11958691|FG001|STARTED|Overall Study||19
10318818|NCT00217672|11453086|FG000|STARTED|Treatment||67
10318819|NCT00217672|11453087|FG001|STARTED|Treatment|When bevacizumab became available, study converted to a 1-arm open-label trial with just bevacizumab|7
10318820|NCT00217672|11453086|FG000|COMPLETED|Treatment||0
10318821|NCT00217672|11453087|FG001|COMPLETED|Treatment||0
10318822|NCT00217672|11453086|FG000|NOT COMPLETED|Treatment||67
10677295|NCT02372344|11839706|FG000|STARTED|Period 1 (Visit 2)||14
10677296|NCT02372344|11839707|FG001|STARTED|Period 1 (Visit 2)||14
10677297|NCT02372344|11839708|FG002|STARTED|Period 1 (Visit 2)||14
10318823|NCT00217672|11453087|FG001|NOT COMPLETED|Treatment||7
10338424|NCT00369629|11475279|FG001|NOT COMPLETED|Follow up for 1 Year||2
10677298|NCT02372344|11839706|FG000|COMPLETED|Period 1 (Visit 2)||14
10677299|NCT02372344|11839707|FG001|COMPLETED|Period 1 (Visit 2)||14
10677300|NCT02372344|11839708|FG002|COMPLETED|Period 1 (Visit 2)||14
10677301|NCT02372344|11839706|FG000|NOT COMPLETED|Period 1 (Visit 2)||0
10677302|NCT02372344|11839707|FG001|NOT COMPLETED|Period 1 (Visit 2)||0
10798223|NCT03714256|11958690|FG000|COMPLETED|Overall Study||14
10677303|NCT02372344|11839708|FG002|NOT COMPLETED|Period 1 (Visit 2)||0
10677304|NCT02372344|11839706|FG000|STARTED|Period 2 (Visit 3)||14
10677305|NCT02372344|11839707|FG001|STARTED|Period 2 (Visit 3)||14
10677306|NCT02372344|11839708|FG002|STARTED|Period 2 (Visit 3)||14
10677307|NCT02372344|11839706|FG000|COMPLETED|Period 2 (Visit 3)||14
10677308|NCT02372344|11839707|FG001|COMPLETED|Period 2 (Visit 3)||14
10677309|NCT02372344|11839708|FG002|COMPLETED|Period 2 (Visit 3)||14
10677310|NCT02372344|11839706|FG000|NOT COMPLETED|Period 2 (Visit 3)||0
10677311|NCT02372344|11839707|FG001|NOT COMPLETED|Period 2 (Visit 3)||0
10677312|NCT02372344|11839708|FG002|NOT COMPLETED|Period 2 (Visit 3)||0
10798224|NCT03714256|11958691|FG001|COMPLETED|Overall Study||19
10798225|NCT03714256|11958690|FG000|NOT COMPLETED|Overall Study||0
10798226|NCT03714256|11958691|FG001|NOT COMPLETED|Overall Study||0
10798227|NCT03714659|11958697|FG000|STARTED|Overall Study||20
10798228|NCT03714659|11958697|FG000|COMPLETED|Overall Study||19
10798229|NCT03714659|11958697|FG000|NOT COMPLETED|Overall Study||1
10798230|NCT03714672|11958705|FG000|STARTED|Overall Study||209
10798231|NCT03714672|11958706|FG001|STARTED|Overall Study||206
10798232|NCT03714672|11958707|FG002|STARTED|Overall Study||206
10798233|NCT03714672|11958708|FG003|STARTED|Overall Study||208
10798234|NCT03714672|11958705|FG000|Safety Set|Overall Study||208
10798235|NCT03714672|11958706|FG001|Safety Set|Overall Study||205
10798236|NCT03714672|11958707|FG002|Safety Set|Overall Study||206
10798237|NCT03714672|11958708|FG003|Safety Set|Overall Study||207
10798238|NCT03714672|11958705|FG000|COMPLETED|Overall Study||207
10798239|NCT03714672|11958706|FG001|COMPLETED|Overall Study||202
10798240|NCT03714672|11958707|FG002|COMPLETED|Overall Study||202
10798241|NCT03714672|11958708|FG003|COMPLETED|Overall Study||207
10798242|NCT03714672|11958705|FG000|NOT COMPLETED|Overall Study||2
10798243|NCT03714672|11958706|FG001|NOT COMPLETED|Overall Study||4
10798244|NCT03714672|11958707|FG002|NOT COMPLETED|Overall Study||4
10798245|NCT03714672|11958708|FG003|NOT COMPLETED|Overall Study||1
10798246|NCT03714919|11958719|FG000|STARTED|Overall Study||10
10798247|NCT03714919|11958719|FG000|COMPLETED|Overall Study||10
10798248|NCT03714919|11958719|FG000|NOT COMPLETED|Overall Study||0
10798249|NCT03715426|11958725|FG000|STARTED|Overall Study||133
10798250|NCT03715426|11958726|FG001|STARTED|Overall Study||117
10798251|NCT03715426|11958725|FG000|1-Month Follow-Up Survey|Overall Study||113
10798252|NCT03715426|11958726|FG001|1-Month Follow-Up Survey|Overall Study||97
10798253|NCT03715426|11958725|FG000|4-Month Follow-Up Survey|Overall Study||112
10798254|NCT03715426|11958726|FG001|4-Month Follow-Up Survey|Overall Study||92
10798255|NCT03715426|11958725|FG000|COMPLETED|Overall Study||112
10798256|NCT03715426|11958726|FG001|COMPLETED|Overall Study||92
10798257|NCT03715426|11958725|FG000|NOT COMPLETED|Overall Study||21
10798258|NCT03715426|11958726|FG001|NOT COMPLETED|Overall Study||25
10798259|NCT03715452|11958732|FG000|STARTED|Overall Study||114
10798260|NCT03715452|11958732|FG000|COMPLETED|Overall Study||114
10798261|NCT03715452|11958732|FG000|NOT COMPLETED|Overall Study||0
10798262|NCT03715530|11958739|FG000|STARTED|Overall Study||33
10798263|NCT03715530|11958740|FG001|STARTED|Overall Study||42
10798264|NCT03715530|11958741|FG002|STARTED|Overall Study||87
10798265|NCT03715530|11958739|FG000|COMPLETED|Overall Study||30
10798266|NCT03715530|11958740|FG001|COMPLETED|Overall Study||41
10798267|NCT03715530|11958741|FG002|COMPLETED|Overall Study||85
10798268|NCT03715530|11958739|FG000|NOT COMPLETED|Overall Study||3
10798269|NCT03715530|11958740|FG001|NOT COMPLETED|Overall Study||1
10798270|NCT03715530|11958741|FG002|NOT COMPLETED|Overall Study||2
10798271|NCT03715803|11958751|FG000|STARTED|Overall Study||91
10798272|NCT03715803|11958752|FG001|STARTED|Overall Study||126
10798273|NCT03715803|11958751|FG000|COMPLETED|Overall Study||91
10798274|NCT03715803|11958752|FG001|COMPLETED|Overall Study||126
10798275|NCT03715803|11958751|FG000|NOT COMPLETED|Overall Study||0
10798276|NCT03715803|11958752|FG001|NOT COMPLETED|Overall Study||0
10798277|NCT03716024|11958760|FG000|STARTED|Overall Study||118
10798278|NCT03716024|11958761|FG001|STARTED|Overall Study||116
10798279|NCT03716024|11958760|FG000|COMPLETED|Overall Study||107
10798280|NCT03716024|11958761|FG001|COMPLETED|Overall Study||98
10798281|NCT03716024|11958760|FG000|NOT COMPLETED|Overall Study||11
10798282|NCT03716024|11958761|FG001|NOT COMPLETED|Overall Study||18
10798283|NCT03716050|11958775|FG000|STARTED|Overall Study||2
10798284|NCT03716050|11958776|FG001|STARTED|Overall Study||4
10798285|NCT03716050|11958777|FG002|STARTED|Overall Study||1
10798286|NCT03716050|11958778|FG003|STARTED|Overall Study||3
10798287|NCT03716050|11958779|FG004|STARTED|Overall Study||1
10798288|NCT03716050|11958780|FG005|STARTED|Overall Study||0
10677313|NCT02372344|11839706|FG000|STARTED|Period 3 (Visit 4)||14
10677314|NCT02372344|11839707|FG001|STARTED|Period 3 (Visit 4)||14
10677315|NCT02372344|11839708|FG002|STARTED|Period 3 (Visit 4)||14
10677316|NCT02372344|11839706|FG000|COMPLETED|Period 3 (Visit 4)||14
10677317|NCT02372344|11839707|FG001|COMPLETED|Period 3 (Visit 4)||14
10677318|NCT02372344|11839708|FG002|COMPLETED|Period 3 (Visit 4)||14
10798289|NCT03716050|11958781|FG006|STARTED|Overall Study||4
10798290|NCT03716050|11958782|FG007|STARTED|Overall Study||2
10798291|NCT03716050|11958775|FG000|COMPLETED|Overall Study||2
10798292|NCT03716050|11958776|FG001|COMPLETED|Overall Study||4
10798293|NCT03716050|11958777|FG002|COMPLETED|Overall Study||0
10798294|NCT03716050|11958778|FG003|COMPLETED|Overall Study||1
10798295|NCT03716050|11958779|FG004|COMPLETED|Overall Study||1
10798296|NCT03716050|11958780|FG005|COMPLETED|Overall Study||0
10798297|NCT03716050|11958781|FG006|COMPLETED|Overall Study||4
10798298|NCT03716050|11958782|FG007|COMPLETED|Overall Study||0
10798299|NCT03716050|11958775|FG000|NOT COMPLETED|Overall Study||0
10677319|NCT02372344|11839706|FG000|NOT COMPLETED|Period 3 (Visit 4)||0
10677320|NCT02372344|11839707|FG001|NOT COMPLETED|Period 3 (Visit 4)||0
10677321|NCT02372344|11839708|FG002|NOT COMPLETED|Period 3 (Visit 4)||0
10677322|NCT02372383|11839718|FG000|STARTED|First Intervention (1 Day)||10
10677323|NCT02372383|11839719|FG001|STARTED|First Intervention (1 Day)||11
10677324|NCT02372383|11839720|FG002|STARTED|First Intervention (1 Day)||10
10677325|NCT02372383|11839718|FG000|COMPLETED|First Intervention (1 Day)||10
10677326|NCT02372383|11839719|FG001|COMPLETED|First Intervention (1 Day)||10
10677327|NCT02372383|11839720|FG002|COMPLETED|First Intervention (1 Day)||10
10677328|NCT02372383|11839718|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10677329|NCT02372383|11839719|FG001|NOT COMPLETED|First Intervention (1 Day)||1
10677330|NCT02372383|11839720|FG002|NOT COMPLETED|First Intervention (1 Day)||0
10677331|NCT02372383|11839718|FG000|STARTED|Washout (14 Days)||10
10677332|NCT02372383|11839719|FG001|STARTED|Washout (14 Days)||10
10677333|NCT02372383|11839720|FG002|STARTED|Washout (14 Days)||10
10677334|NCT02372383|11839718|FG000|COMPLETED|Washout (14 Days)||10
10677335|NCT02372383|11839719|FG001|COMPLETED|Washout (14 Days)||10
10677336|NCT02372383|11839720|FG002|COMPLETED|Washout (14 Days)||10
10677337|NCT02372383|11839718|FG000|NOT COMPLETED|Washout (14 Days)||0
10677338|NCT02372383|11839719|FG001|NOT COMPLETED|Washout (14 Days)||0
10677339|NCT02372383|11839720|FG002|NOT COMPLETED|Washout (14 Days)||0
10677340|NCT02372383|11839718|FG000|STARTED|Second Intervention (1 Day)||10
10677341|NCT02372383|11839719|FG001|STARTED|Second Intervention (1 Day)||10
10677342|NCT02372383|11839720|FG002|STARTED|Second Intervention (1 Day)||10
10677343|NCT02372383|11839718|FG000|COMPLETED|Second Intervention (1 Day)||10
10677344|NCT02372383|11839719|FG001|COMPLETED|Second Intervention (1 Day)||10
10677345|NCT02372383|11839720|FG002|COMPLETED|Second Intervention (1 Day)||10
10677346|NCT02372383|11839718|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10798300|NCT03716050|11958776|FG001|NOT COMPLETED|Overall Study||0
10798301|NCT03716050|11958777|FG002|NOT COMPLETED|Overall Study||1
10798302|NCT03716050|11958778|FG003|NOT COMPLETED|Overall Study||2
10798303|NCT03716050|11958779|FG004|NOT COMPLETED|Overall Study||0
10798304|NCT03716050|11958780|FG005|NOT COMPLETED|Overall Study||0
10798305|NCT03716050|11958781|FG006|NOT COMPLETED|Overall Study||0
10798306|NCT03716050|11958782|FG007|NOT COMPLETED|Overall Study||2
10798307|NCT03716076|11958801|FG000|STARTED|Overall Study||25
10798308|NCT03716076|11958802|FG001|STARTED|Overall Study||25
10798309|NCT03716076|11958801|FG000|COMPLETED|Overall Study||22
10798310|NCT03716076|11958802|FG001|COMPLETED|Overall Study||19
10798311|NCT03716076|11958801|FG000|NOT COMPLETED|Overall Study||3
10798312|NCT03716076|11958802|FG001|NOT COMPLETED|Overall Study||6
10798313|NCT03717012|11958810|FG000|STARTED|Overall Study||9
10455319|NCT01001325|11603351|FG000|COMPLETED|Overall Study||216
10455320|NCT01001325|11603352|FG001|COMPLETED|Overall Study||224
10455321|NCT01001325|11603351|FG000|NOT COMPLETED|Overall Study||18
10455322|NCT01001325|11603352|FG001|NOT COMPLETED|Overall Study||10
10798314|NCT03717012|11958811|FG001|STARTED|Overall Study||10
10798315|NCT03717012|11958810|FG000|COMPLETED|Overall Study||8
10798316|NCT03717012|11958811|FG001|COMPLETED|Overall Study||4
10798317|NCT03717012|11958810|FG000|NOT COMPLETED|Overall Study||1
10798318|NCT03717012|11958811|FG001|NOT COMPLETED|Overall Study||6
10798319|NCT03717051|11958819|FG000|STARTED|Overall Study||352
10798320|NCT03717051|11958820|FG001|STARTED|Overall Study||482
10798321|NCT03717051|11958819|FG000|COMPLETED|Overall Study||352
10798322|NCT03717051|11958820|FG001|COMPLETED|Overall Study||482
10798323|NCT03717051|11958819|FG000|NOT COMPLETED|Overall Study||0
10798324|NCT03717051|11958820|FG001|NOT COMPLETED|Overall Study||0
10798325|NCT03717064|11958826|FG000|STARTED|Period 1||18
10798326|NCT03717064|11958826|FG000|COMPLETED|Period 1||18
10798327|NCT03717064|11958826|FG000|NOT COMPLETED|Period 1||0
10798328|NCT03717064|11958826|FG000|STARTED|Period 2||18
10798329|NCT03717064|11958826|FG000|COMPLETED|Period 2||17
10798330|NCT03717064|11958826|FG000|NOT COMPLETED|Period 2||1
10798331|NCT03717506|11958833|FG000|STARTED|Overall Study||496
10798332|NCT03717506|11958834|FG001|STARTED|Overall Study||491
10798333|NCT03717506|11958835|FG002|STARTED|Overall Study||249
10798334|NCT03717506|11958833|FG000|COMPLETED|Overall Study||447
10798335|NCT03717506|11958834|FG001|COMPLETED|Overall Study||441
10798336|NCT03717506|11958835|FG002|COMPLETED|Overall Study||222
10798337|NCT03717506|11958833|FG000|NOT COMPLETED|Overall Study||49
10798338|NCT03717506|11958834|FG001|NOT COMPLETED|Overall Study||50
10798339|NCT03717506|11958835|FG002|NOT COMPLETED|Overall Study||27
10798340|NCT03718871|11958845|FG000|STARTED|Overall Study||250
10798341|NCT03718871|11958846|FG001|STARTED|Overall Study||250
10798342|NCT03718871|11958845|FG000|COMPLETED|Overall Study||250
10677347|NCT02372383|11839719|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10677348|NCT02372383|11839720|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
10677349|NCT02372396|11839732|FG000|STARTED|Overall Study||17
10677350|NCT02372396|11839733|FG001|STARTED|Overall Study||20
10677351|NCT02372396|11839732|FG000|Began Intervention|Overall Study||14
10798343|NCT03718871|11958846|FG001|COMPLETED|Overall Study||250
10798344|NCT03718871|11958845|FG000|NOT COMPLETED|Overall Study||0
10677352|NCT02372396|11839733|FG001|Began Intervention|Overall Study||14
10798345|NCT03718871|11958846|FG001|NOT COMPLETED|Overall Study||0
10798346|NCT03719300|11958853|FG000|STARTED|Overall Study||32
10798347|NCT03719300|11958853|FG000|COMPLETED|Overall Study||32
10798348|NCT03719300|11958853|FG000|NOT COMPLETED|Overall Study||0
10677353|NCT02372396|11839732|FG000|COMPLETED|Overall Study||10
10677354|NCT02372396|11839733|FG001|COMPLETED|Overall Study||11
10677355|NCT02372396|11839732|FG000|NOT COMPLETED|Overall Study||7
10677356|NCT02372396|11839733|FG001|NOT COMPLETED|Overall Study||9
10677357|NCT02372682|11839741|FG000|STARTED|Overall Study||78
10677358|NCT02372682|11839742|FG001|STARTED|Overall Study||93
10677359|NCT02372682|11839741|FG000|COMPLETED|Overall Study||70
10677360|NCT02372682|11839742|FG001|COMPLETED|Overall Study||79
10677361|NCT02372682|11839741|FG000|NOT COMPLETED|Overall Study||8
10677362|NCT02372682|11839742|FG001|NOT COMPLETED|Overall Study||14
10677363|NCT02372799|11839758|FG000|STARTED|Treatment Period||186
10677364|NCT02372799|11839759|FG001|STARTED|Treatment Period||187
10677365|NCT02372799|11839760|FG002|STARTED|Treatment Period||97
10798349|NCT03719378|11958859|FG000|STARTED|Overall Study||75
10798350|NCT03719378|11958860|FG001|STARTED|Overall Study||75
10677366|NCT02372799|11839758|FG000|COMPLETED|Treatment Period||152
10677367|NCT02372799|11839759|FG001|COMPLETED|Treatment Period||155
10677368|NCT02372799|11839760|FG002|COMPLETED|Treatment Period||82
10677369|NCT02372799|11839758|FG000|NOT COMPLETED|Treatment Period||34
10677370|NCT02372799|11839759|FG001|NOT COMPLETED|Treatment Period||32
10677371|NCT02372799|11839760|FG002|NOT COMPLETED|Treatment Period||15
10677372|NCT02372799|11839758|FG000|STARTED|Down-taper Period||152
10677373|NCT02372799|11839759|FG001|STARTED|Down-taper Period||159
10798351|NCT03719378|11958859|FG000|COMPLETED|Overall Study||65
10798352|NCT03719378|11958860|FG001|COMPLETED|Overall Study||65
10798353|NCT03719378|11958859|FG000|NOT COMPLETED|Overall Study||10
10798354|NCT03719378|11958860|FG001|NOT COMPLETED|Overall Study||10
10798355|NCT03719586|11958870|FG000|STARTED|Overall Study||177
10798356|NCT03719586|11958871|FG001|STARTED|Overall Study||176
10677374|NCT02372799|11839760|FG002|STARTED|Down-taper Period||82
10677375|NCT02372799|11839758|FG000|COMPLETED|Down-taper Period||151
10677376|NCT02372799|11839759|FG001|COMPLETED|Down-taper Period||157
10677377|NCT02372799|11839760|FG002|COMPLETED|Down-taper Period||80
10677378|NCT02372799|11839758|FG000|NOT COMPLETED|Down-taper Period||1
10677379|NCT02372799|11839759|FG001|NOT COMPLETED|Down-taper Period||2
10677380|NCT02372799|11839760|FG002|NOT COMPLETED|Down-taper Period||2
10677381|NCT02373098|11839770|FG000|STARTED|Overall Study||66
10798357|NCT03719586|11958872|FG002|STARTED|Overall Study|The REGN-EB3 arm was added in 1/2019 after the trial had initially begun in November 2018.|158
10798358|NCT03719586|11958873|FG003|STARTED|Overall Study||169
10798359|NCT03719586|11958870|FG000|COMPLETED|Overall Study|in 8/2019 the DSMB recommended further randomization only occur to the MAb114 and REGN-EB3 arms.|169
10798360|NCT03719586|11958871|FG001|COMPLETED|Overall Study|in 8/2019 the DSMB recommended further randomization only occur to the MAb114 and REGN-EB3 arms.|169
10677382|NCT02373098|11839771|FG001|STARTED|Overall Study||60
10677383|NCT02373098|11839770|FG000|COMPLETED|Overall Study||54
10677384|NCT02373098|11839771|FG001|COMPLETED|Overall Study||60
10677385|NCT02373098|11839770|FG000|NOT COMPLETED|Overall Study||12
10677386|NCT02373098|11839771|FG001|NOT COMPLETED|Overall Study||0
10677387|NCT02373124|11839783|FG000|STARTED|Overall Study||4
10677388|NCT02373124|11839783|FG000|COMPLETED|Overall Study||3
10798361|NCT03719586|11958872|FG002|COMPLETED|Overall Study|in 8/2019 the DSMB recommended further randomization only occur to the MAb114 and REGN-EB3 arms.|154
10798362|NCT03719586|11958873|FG003|COMPLETED|Overall Study|in 8/2019 the DSMB recommended further randomization only occur to the MAb114 and REGN-EB3 arms.|169
10798363|NCT03719586|11958870|FG000|NOT COMPLETED|Overall Study||8
10798364|NCT03719586|11958871|FG001|NOT COMPLETED|Overall Study||7
10798365|NCT03719586|11958872|FG002|NOT COMPLETED|Overall Study||4
10798366|NCT03719586|11958873|FG003|NOT COMPLETED|Overall Study||0
10798367|NCT03719612|11958883|FG000|STARTED|Overall Study||160
10798368|NCT03719612|11958883|FG000|COMPLETED|Overall Study||148
10798369|NCT03719612|11958883|FG000|NOT COMPLETED|Overall Study||12
10798370|NCT03719677|11958889|FG000|STARTED|Overall Study||7
10798371|NCT03719677|11958889|FG000|COMPLETED|Overall Study||7
10798372|NCT03719677|11958889|FG000|NOT COMPLETED|Overall Study||0
10798373|NCT03719885|11958893|FG000|STARTED|Overall Study||55
10798374|NCT03719885|11958893|FG000|COMPLETED|Overall Study||35
10798375|NCT03719885|11958893|FG000|NOT COMPLETED|Overall Study||20
10798376|NCT03720119|11958899|FG000|STARTED|Overall Study||78
10798377|NCT03720119|11958899|FG000|COMPLETED|Overall Study||69
10798378|NCT03720119|11958899|FG000|NOT COMPLETED|Overall Study||9
10798379|NCT03720470|11958907|FG000|STARTED|Treatment Period: First Part 16 Weeks||131
10798380|NCT03720470|11958908|FG001|STARTED|Treatment Period: First Part 16 Weeks||0
10798381|NCT03720470|11958909|FG002|STARTED|Treatment Period: First Part 16 Weeks||0
10798382|NCT03720470|11958910|FG003|STARTED|Treatment Period: First Part 16 Weeks||238
10798383|NCT03720470|11958911|FG004|STARTED|Treatment Period: First Part 16 Weeks||226
10798384|NCT03720470|11958912|FG005|STARTED|Treatment Period: First Part 16 Weeks||243
10798385|NCT03720470|11958907|FG000|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||131
10798386|NCT03720470|11958908|FG001|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||0
10798387|NCT03720470|11958909|FG002|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||0
10798388|NCT03720470|11958910|FG003|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||238
10798389|NCT03720470|11958911|FG004|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||226
10798390|NCT03720470|11958912|FG005|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||242
10798391|NCT03720470|11958907|FG000|Full Analysis Set|Treatment Period: First Part 16 Weeks||131
10798392|NCT03720470|11958908|FG001|Full Analysis Set|Treatment Period: First Part 16 Weeks||0
10798393|NCT03720470|11958909|FG002|Full Analysis Set|Treatment Period: First Part 16 Weeks||0
10798394|NCT03720470|11958910|FG003|Full Analysis Set|Treatment Period: First Part 16 Weeks||238
10798395|NCT03720470|11958911|FG004|Full Analysis Set|Treatment Period: First Part 16 Weeks||226
10798396|NCT03720470|11958912|FG005|Full Analysis Set|Treatment Period: First Part 16 Weeks||242
10798397|NCT03720470|11958907|FG000|COMPLETED|Treatment Period: First Part 16 Weeks||117
10798398|NCT03720470|11958908|FG001|COMPLETED|Treatment Period: First Part 16 Weeks||0
10798399|NCT03720470|11958909|FG002|COMPLETED|Treatment Period: First Part 16 Weeks||0
10798400|NCT03720470|11958910|FG003|COMPLETED|Treatment Period: First Part 16 Weeks||217
10798401|NCT03720470|11958911|FG004|COMPLETED|Treatment Period: First Part 16 Weeks||208
10798402|NCT03720470|11958912|FG005|COMPLETED|Treatment Period: First Part 16 Weeks||223
10798403|NCT03720470|11958907|FG000|NOT COMPLETED|Treatment Period: First Part 16 Weeks||14
10798404|NCT03720470|11958908|FG001|NOT COMPLETED|Treatment Period: First Part 16 Weeks||0
10798405|NCT03720470|11958909|FG002|NOT COMPLETED|Treatment Period: First Part 16 Weeks||0
10798406|NCT03720470|11958910|FG003|NOT COMPLETED|Treatment Period: First Part 16 Weeks||21
10798407|NCT03720470|11958911|FG004|NOT COMPLETED|Treatment Period: First Part 16 Weeks||18
10798408|NCT03720470|11958912|FG005|NOT COMPLETED|Treatment Period: First Part 16 Weeks||20
10798409|NCT03720470|11958907|FG000|STARTED|Treatment Period: Final 4 Weeks|Participants received placebo till Week 16 then allocated to receive PF-04965842 post Week 16.|0
10798410|NCT03720470|11958908|FG001|STARTED|Treatment Period: Final 4 Weeks|Participants received placebo till Week 16 then allocated to receive PF-04965842 post Week 16.|60
10798411|NCT03720470|11958909|FG002|STARTED|Treatment Period: Final 4 Weeks|Participants received placebo till Week 16 then allocated to receive PF-04965842 post Week 16.|57
10798412|NCT03720470|11958910|FG003|STARTED|Treatment Period: Final 4 Weeks||217
10798413|NCT03720470|11958911|FG004|STARTED|Treatment Period: Final 4 Weeks||208
10798414|NCT03720470|11958912|FG005|STARTED|Treatment Period: Final 4 Weeks||223
10798415|NCT03720470|11958907|FG000|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||0
10798416|NCT03720470|11958908|FG001|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||60
10798417|NCT03720470|11958909|FG002|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||57
10798418|NCT03720470|11958910|FG003|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||217
10798419|NCT03720470|11958911|FG004|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||208
10677389|NCT02373124|11839783|FG000|NOT COMPLETED|Overall Study||1
10677390|NCT02373137|11839789|FG000|STARTED|Overall Study||19
10677391|NCT02373137|11839790|FG001|STARTED|Overall Study||19
10677392|NCT02373137|11839789|FG000|3-Month Follow-Up|Overall Study||19
10677393|NCT02373137|11839790|FG001|3-Month Follow-Up|Overall Study||19
10677394|NCT02373137|11839789|FG000|6-Month Follow-Up|Overall Study||19
10677395|NCT02373137|11839790|FG001|6-Month Follow-Up|Overall Study||18
10677396|NCT02373137|11839789|FG000|12-Month Follow-Up|Overall Study||19
10677397|NCT02373137|11839790|FG001|12-Month Follow-Up|Overall Study||19
10677398|NCT02373137|11839789|FG000|COMPLETED|Overall Study||18
10677399|NCT02373137|11839790|FG001|COMPLETED|Overall Study||18
10677400|NCT02373137|11839789|FG000|NOT COMPLETED|Overall Study||1
10677401|NCT02373137|11839790|FG001|NOT COMPLETED|Overall Study||1
10677402|NCT02373202|11839801|FG000|STARTED|Overall Study||15
10677403|NCT02373202|11839802|FG001|STARTED|Overall Study||15
10677404|NCT02373202|11839803|FG002|STARTED|Overall Study||30
10798420|NCT03720470|11958912|FG005|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||223
10798421|NCT03720470|11958907|FG000|Full Analysis Set|Treatment Period: Final 4 Weeks||0
10798422|NCT03720470|11958908|FG001|Full Analysis Set|Treatment Period: Final 4 Weeks||60
10798423|NCT03720470|11958909|FG002|Full Analysis Set|Treatment Period: Final 4 Weeks||57
10798424|NCT03720470|11958910|FG003|Full Analysis Set|Treatment Period: Final 4 Weeks||217
10798425|NCT03720470|11958911|FG004|Full Analysis Set|Treatment Period: Final 4 Weeks||208
10798426|NCT03720470|11958912|FG005|Full Analysis Set|Treatment Period: Final 4 Weeks||223
10798427|NCT03720470|11958907|FG000|COMPLETED|Treatment Period: Final 4 Weeks||0
10798428|NCT03720470|11958908|FG001|COMPLETED|Treatment Period: Final 4 Weeks||58
10798429|NCT03720470|11958909|FG002|COMPLETED|Treatment Period: Final 4 Weeks||55
10798430|NCT03720470|11958910|FG003|COMPLETED|Treatment Period: Final 4 Weeks||210
10798431|NCT03720470|11958911|FG004|COMPLETED|Treatment Period: Final 4 Weeks||204
10798432|NCT03720470|11958912|FG005|COMPLETED|Treatment Period: Final 4 Weeks||218
10798433|NCT03720470|11958907|FG000|NOT COMPLETED|Treatment Period: Final 4 Weeks||0
10798434|NCT03720470|11958908|FG001|NOT COMPLETED|Treatment Period: Final 4 Weeks||2
10798435|NCT03720470|11958909|FG002|NOT COMPLETED|Treatment Period: Final 4 Weeks||2
10798436|NCT03720470|11958910|FG003|NOT COMPLETED|Treatment Period: Final 4 Weeks||7
10798437|NCT03720470|11958911|FG004|NOT COMPLETED|Treatment Period: Final 4 Weeks||4
10798438|NCT03720470|11958912|FG005|NOT COMPLETED|Treatment Period: Final 4 Weeks||5
10677405|NCT02373202|11839804|FG003|STARTED|Overall Study||31
10677406|NCT02373202|11839801|FG000|COMPLETED|Overall Study||13
10677407|NCT02373202|11839802|FG001|COMPLETED|Overall Study||9
10677408|NCT02373202|11839803|FG002|COMPLETED|Overall Study||27
10677409|NCT02373202|11839804|FG003|COMPLETED|Overall Study||30
10677410|NCT02373202|11839801|FG000|NOT COMPLETED|Overall Study||2
10677411|NCT02373202|11839802|FG001|NOT COMPLETED|Overall Study||6
10677412|NCT02373202|11839803|FG002|NOT COMPLETED|Overall Study||3
10677413|NCT02373202|11839804|FG003|NOT COMPLETED|Overall Study||1
10677414|NCT02373371|11839816|FG000|STARTED|Overall Study||13
10677415|NCT02373371|11839817|FG001|STARTED|Overall Study||13
10677416|NCT02373371|11839816|FG000|COMPLETED|Overall Study||13
10677417|NCT02373371|11839817|FG001|COMPLETED|Overall Study||13
10677418|NCT02373371|11839816|FG000|NOT COMPLETED|Overall Study||0
10677419|NCT02373371|11839817|FG001|NOT COMPLETED|Overall Study||0
10677420|NCT02373813|11839826|FG000|STARTED|Run-In Period||371
10677421|NCT02373813|11839827|FG001|STARTED|Run-In Period||0
10677422|NCT02373813|11839828|FG002|STARTED|Run-In Period||0
10677423|NCT02373813|11839829|FG003|STARTED|Run-In Period||0
10677424|NCT02373813|11839826|FG000|Treated|Run-In Period||368
10677425|NCT02373813|11839827|FG001|Treated|Run-In Period||0
10677426|NCT02373813|11839828|FG002|Treated|Run-In Period||0
10677427|NCT02373813|11839829|FG003|Treated|Run-In Period||0
10677428|NCT02373813|11839826|FG000|COMPLETED|Run-In Period|1 participant who completed the run-in period had no end of study case report form.|255
10677429|NCT02373813|11839827|FG001|COMPLETED|Run-In Period||0
10677430|NCT02373813|11839828|FG002|COMPLETED|Run-In Period||0
10677431|NCT02373813|11839829|FG003|COMPLETED|Run-In Period||0
10677432|NCT02373813|11839826|FG000|NOT COMPLETED|Run-In Period||116
10677433|NCT02373813|11839827|FG001|NOT COMPLETED|Run-In Period||0
10677434|NCT02373813|11839828|FG002|NOT COMPLETED|Run-In Period||0
10798439|NCT03720652|11958934|FG000|STARTED|Overall Study||12
10798440|NCT03720652|11958935|FG001|STARTED|Overall Study||27
10677435|NCT02373813|11839829|FG003|NOT COMPLETED|Run-In Period||0
10677436|NCT02373813|11839826|FG000|STARTED|Double-Blind Treatment Period||0
10677437|NCT02373813|11839827|FG001|STARTED|Double-Blind Treatment Period||101
10677438|NCT02373813|11839828|FG002|STARTED|Double-Blind Treatment Period||101
10677439|NCT02373813|11839829|FG003|STARTED|Double-Blind Treatment Period||51
10677440|NCT02373813|11839826|FG000|Received Investigational Product (IP)|Double-Blind Treatment Period||0
10677441|NCT02373813|11839827|FG001|Received Investigational Product (IP)|Double-Blind Treatment Period||101
10677442|NCT02373813|11839828|FG002|Received Investigational Product (IP)|Double-Blind Treatment Period||100
10677443|NCT02373813|11839829|FG003|Received Investigational Product (IP)|Double-Blind Treatment Period||51
10677444|NCT02373813|11839826|FG000|Received Rescue Treatment|Double-Blind Treatment Period||0
10677445|NCT02373813|11839827|FG001|Received Rescue Treatment|Double-Blind Treatment Period||52
10677446|NCT02373813|11839828|FG002|Received Rescue Treatment|Double-Blind Treatment Period||36
10677447|NCT02373813|11839829|FG003|Received Rescue Treatment|Double-Blind Treatment Period||15
10677448|NCT02373813|11839826|FG000|COMPLETED|Double-Blind Treatment Period||0
10677449|NCT02373813|11839827|FG001|COMPLETED|Double-Blind Treatment Period||88
10677450|NCT02373813|11839828|FG002|COMPLETED|Double-Blind Treatment Period||92
10677451|NCT02373813|11839829|FG003|COMPLETED|Double-Blind Treatment Period||47
10677452|NCT02373813|11839826|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
10677453|NCT02373813|11839827|FG001|NOT COMPLETED|Double-Blind Treatment Period||13
10677454|NCT02373813|11839828|FG002|NOT COMPLETED|Double-Blind Treatment Period||9
10677455|NCT02373813|11839829|FG003|NOT COMPLETED|Double-Blind Treatment Period||4
10677456|NCT02373852|11839840|FG000|STARTED|Overall Study|Includes patients from a previous retrospective study NCT01042444|12
10677457|NCT02373852|11839840|FG000|COMPLETED|Overall Study||11
10677458|NCT02373852|11839840|FG000|NOT COMPLETED|Overall Study||1
10798441|NCT03720652|11958934|FG000|Baseline Interview|Overall Study||12
10798442|NCT03720652|11958935|FG001|Baseline Interview|Overall Study||22
10798443|NCT03720652|11958934|FG000|Start Intervention|Overall Study||11
10798444|NCT03720652|11958935|FG001|Start Intervention|Overall Study||21
10798445|NCT03720652|11958934|FG000|Complete Intervention|Overall Study||10
10798446|NCT03720652|11958935|FG001|Complete Intervention|Overall Study||20
10798447|NCT03720652|11958934|FG000|3-Month Follow Up Interview|Overall Study||10
10798448|NCT03720652|11958935|FG001|3-Month Follow Up Interview|Overall Study||19
10798449|NCT03720652|11958934|FG000|6-Month Follow Up Interview|Overall Study||10
10798450|NCT03720652|11958935|FG001|6-Month Follow Up Interview|Overall Study||16
10798451|NCT03720652|11958934|FG000|COMPLETED|Overall Study||10
10798452|NCT03720652|11958935|FG001|COMPLETED|Overall Study||16
10798453|NCT03720652|11958934|FG000|NOT COMPLETED|Overall Study||2
10798454|NCT03720652|11958935|FG001|NOT COMPLETED|Overall Study||11
10798455|NCT03720847|11958943|FG000|STARTED|Condition 1||15
10798456|NCT03720847|11958944|FG001|STARTED|Condition 1||15
10798457|NCT03720847|11958943|FG000|COMPLETED|Condition 1||15
10798458|NCT03720847|11958944|FG001|COMPLETED|Condition 1||15
10798459|NCT03720847|11958943|FG000|NOT COMPLETED|Condition 1||0
10798460|NCT03720847|11958944|FG001|NOT COMPLETED|Condition 1||0
10798461|NCT03720847|11958943|FG000|STARTED|Washout||15
10798462|NCT03720847|11958944|FG001|STARTED|Washout||15
10798463|NCT03720847|11958943|FG000|COMPLETED|Washout||14
10798464|NCT03720847|11958944|FG001|COMPLETED|Washout||13
10798465|NCT03720847|11958943|FG000|NOT COMPLETED|Washout||1
10798466|NCT03720847|11958944|FG001|NOT COMPLETED|Washout||2
10798467|NCT03720847|11958943|FG000|STARTED|Condition 2||14
10798468|NCT03720847|11958944|FG001|STARTED|Condition 2||13
10798469|NCT03720847|11958943|FG000|COMPLETED|Condition 2||14
10798470|NCT03720847|11958944|FG001|COMPLETED|Condition 2||13
10798471|NCT03720847|11958943|FG000|NOT COMPLETED|Condition 2||0
10798472|NCT03720847|11958944|FG001|NOT COMPLETED|Condition 2||0
10798473|NCT03720938|11958953|FG000|STARTED|Overall Study||242
10798474|NCT03720938|11958954|FG001|STARTED|Overall Study||676
10798475|NCT03720938|11958953|FG000|COMPLETED|Overall Study||53
10798476|NCT03720938|11958954|FG001|COMPLETED|Overall Study||53
10798477|NCT03720938|11958953|FG000|NOT COMPLETED|Overall Study||189
10798478|NCT03720938|11958954|FG001|NOT COMPLETED|Overall Study||623
10677459|NCT02374060|11839847|FG000|STARTED|Overall Study||65
10798503|NCT03721549|11958985|FG000|STARTED|Overall Study||8
10798504|NCT03721549|11958986|FG001|STARTED|Overall Study||8
10798505|NCT03721549|11958985|FG000|COMPLETED|Overall Study||7
10798506|NCT03721549|11958986|FG001|COMPLETED|Overall Study||8
10798507|NCT03721549|11958985|FG000|NOT COMPLETED|Overall Study||1
10798508|NCT03721549|11958986|FG001|NOT COMPLETED|Overall Study||0
10798509|NCT03722030|11958994|FG000|STARTED|Overall Study||20
10798510|NCT03722030|11958995|FG001|STARTED|Overall Study||20
10677460|NCT02374060|11839848|FG001|STARTED|Overall Study||63
10677461|NCT02374060|11839849|FG002|STARTED|Overall Study||64
10677462|NCT02374060|11839847|FG000|COMPLETED|Overall Study||63
10677463|NCT02374060|11839848|FG001|COMPLETED|Overall Study||62
10677464|NCT02374060|11839849|FG002|COMPLETED|Overall Study||61
10677465|NCT02374060|11839847|FG000|NOT COMPLETED|Overall Study||2
10677466|NCT02374060|11839848|FG001|NOT COMPLETED|Overall Study||1
10677467|NCT02374060|11839849|FG002|NOT COMPLETED|Overall Study||3
10677468|NCT02374099|11839859|FG000|STARTED|Overall Study||48
10677469|NCT02374099|11839860|FG001|STARTED|Overall Study||49
10677470|NCT02374099|11839859|FG000|Participants Treated|Overall Study|2 participants randomized, but not treated|46
10677471|NCT02374099|11839860|FG001|Participants Treated|Overall Study|1 participant randomized, but not treated|48
10677472|NCT02374099|11839859|FG000|COMPLETED|Overall Study||0
10677473|NCT02374099|11839860|FG001|COMPLETED|Overall Study||0
10677474|NCT02374099|11839859|FG000|NOT COMPLETED|Overall Study||48
10677475|NCT02374099|11839860|FG001|NOT COMPLETED|Overall Study||49
10677476|NCT02374138|11839868|FG000|STARTED|Six Month Follow Up||110
10677477|NCT02374138|11839869|FG001|STARTED|Six Month Follow Up||107
10677478|NCT02374138|11839868|FG000|COMPLETED|Six Month Follow Up|6 Month Follow Up|102
10677479|NCT02374138|11839869|FG001|COMPLETED|Six Month Follow Up|6 Month Follow Up|93
10677480|NCT02374138|11839868|FG000|NOT COMPLETED|Six Month Follow Up||8
10677481|NCT02374138|11839869|FG001|NOT COMPLETED|Six Month Follow Up||14
10677482|NCT02374138|11839868|FG000|STARTED|Twelve Month FollowUp||110
10677483|NCT02374138|11839869|FG001|STARTED|Twelve Month FollowUp||107
10677484|NCT02374138|11839868|FG000|COMPLETED|Twelve Month FollowUp||101
10677485|NCT02374138|11839869|FG001|COMPLETED|Twelve Month FollowUp||95
10677486|NCT02374138|11839868|FG000|NOT COMPLETED|Twelve Month FollowUp||9
10677487|NCT02374138|11839869|FG001|NOT COMPLETED|Twelve Month FollowUp||12
10677488|NCT02374164|11839879|FG000|STARTED|Treatment Period 1||12
10677489|NCT02374164|11839880|FG001|STARTED|Treatment Period 1||12
10677490|NCT02374164|11839881|FG002|STARTED|Treatment Period 1||12
10677491|NCT02374164|11839879|FG000|COMPLETED|Treatment Period 1||12
10798511|NCT03722030|11958994|FG000|COMPLETED|Overall Study||19
10798512|NCT03722030|11958995|FG001|COMPLETED|Overall Study||20
10798513|NCT03722030|11958994|FG000|NOT COMPLETED|Overall Study||1
10798514|NCT03722030|11958995|FG001|NOT COMPLETED|Overall Study||0
10798515|NCT03722238|11959004|FG000|STARTED|Overall Study||608
10798516|NCT03722238|11959005|FG001|STARTED|Overall Study||5
10798517|NCT03722238|11959004|FG000|Safety Set|Overall Study||198
10798518|NCT03722238|11959005|FG001|Safety Set|Overall Study||5
10798519|NCT03722238|11959004|FG000|Actual Drug Users|Overall Study||179
10798520|NCT03722238|11959005|FG001|Actual Drug Users|Overall Study||5
10798521|NCT03722238|11959004|FG000|COMPLETED|Overall Study||143
10798522|NCT03722238|11959005|FG001|COMPLETED|Overall Study||4
10798523|NCT03722238|11959004|FG000|NOT COMPLETED|Overall Study||465
10798524|NCT03722238|11959005|FG001|NOT COMPLETED|Overall Study||1
10798525|NCT03722264|11959011|FG000|STARTED|Overall Study||12
10798526|NCT03722264|11959011|FG000|COMPLETED|Overall Study||9
10798527|NCT03722264|11959011|FG000|NOT COMPLETED|Overall Study||3
10798528|NCT03722446|11959019|FG000|STARTED|Overall Study||135
10798529|NCT03722446|11959020|FG001|STARTED|Overall Study||122
10798530|NCT03722446|11959019|FG000|COMPLETED|Overall Study||120
10798531|NCT03722446|11959020|FG001|COMPLETED|Overall Study||120
10798532|NCT03722446|11959019|FG000|NOT COMPLETED|Overall Study||15
10798533|NCT03722446|11959020|FG001|NOT COMPLETED|Overall Study||2
10798534|NCT03722524|11959026|FG000|STARTED|Overall Study||1247
10798535|NCT03722524|11959026|FG000|COMPLETED|Overall Study||1148
10798536|NCT03722524|11959026|FG000|NOT COMPLETED|Overall Study||99
10798537|NCT03722576|11959030|FG000|STARTED|Overall Study||18
10798538|NCT03722576|11959030|FG000|COMPLETED|Overall Study||11
10798539|NCT03722576|11959030|FG000|NOT COMPLETED|Overall Study||7
10798540|NCT03722784|11959036|FG000|STARTED|Overall Study||58
10798541|NCT03722784|11959037|FG001|STARTED|Overall Study||30
10798542|NCT03722784|11959036|FG000|COMPLETED|Overall Study||56
10798543|NCT03722784|11959037|FG001|COMPLETED|Overall Study||28
10798544|NCT03722784|11959036|FG000|NOT COMPLETED|Overall Study||2
10798545|NCT03722784|11959037|FG001|NOT COMPLETED|Overall Study||2
10798546|NCT03723915|11959044|FG000|STARTED|Screening||17
10798547|NCT03723915|11959044|FG000|COMPLETED|Screening||15
10798548|NCT03723915|11959044|FG000|NOT COMPLETED|Screening||2
10798549|NCT03723915|11959044|FG000|STARTED|On Treatment||15
10798550|NCT03723915|11959044|FG000|Registered on Study|On Treatment||15
10677492|NCT02374164|11839880|FG001|COMPLETED|Treatment Period 1||12
10677493|NCT02374164|11839881|FG002|COMPLETED|Treatment Period 1||12
10677494|NCT02374164|11839879|FG000|NOT COMPLETED|Treatment Period 1||0
10677495|NCT02374164|11839880|FG001|NOT COMPLETED|Treatment Period 1||0
10677496|NCT02374164|11839881|FG002|NOT COMPLETED|Treatment Period 1||0
10677497|NCT02374164|11839879|FG000|STARTED|Treatment Period 2||12
10798551|NCT03723915|11959044|FG000|Received First Dose of Study Drugs|On Treatment||13
10798552|NCT03723915|11959044|FG000|COMPLETED|On Treatment||13
10798553|NCT03723915|11959044|FG000|NOT COMPLETED|On Treatment||2
10798554|NCT03723915|11959044|FG000|STARTED|Survival Follow-up||13
10798555|NCT03723915|11959044|FG000|COMPLETED|Survival Follow-up||13
10798556|NCT03723915|11959044|FG000|NOT COMPLETED|Survival Follow-up||0
10798557|NCT03724812|11959048|FG000|STARTED|Overall Study||46
10677498|NCT02374164|11839880|FG001|STARTED|Treatment Period 2||12
10798558|NCT03724812|11959048|FG000|Discharge|Overall Study||46
10677499|NCT02374164|11839881|FG002|STARTED|Treatment Period 2||12
10798559|NCT03724812|11959048|FG000|30 Day Follow-Up|Overall Study||45
10798560|NCT03724812|11959048|FG000|6 Month Follow-Up|Overall Study||42
10798561|NCT03724812|11959048|FG000|12-Month Follow-Up|Overall Study||42
10677500|NCT02374164|11839879|FG000|COMPLETED|Treatment Period 2||12
10677501|NCT02374164|11839880|FG001|COMPLETED|Treatment Period 2||12
10677502|NCT02374164|11839881|FG002|COMPLETED|Treatment Period 2||12
10677503|NCT02374164|11839879|FG000|NOT COMPLETED|Treatment Period 2||0
10677504|NCT02374164|11839880|FG001|NOT COMPLETED|Treatment Period 2||0
10677505|NCT02374164|11839881|FG002|NOT COMPLETED|Treatment Period 2||0
10677506|NCT02374164|11839879|FG000|STARTED|Treatment Period 3||12
10677507|NCT02374164|11839880|FG001|STARTED|Treatment Period 3|One participant was Lost-to-Follow-Up prior to treatment A.|11
10677508|NCT02374164|11839881|FG002|STARTED|Treatment Period 3||12
10677509|NCT02374164|11839879|FG000|COMPLETED|Treatment Period 3||12
10677510|NCT02374164|11839880|FG001|COMPLETED|Treatment Period 3||11
10677511|NCT02374164|11839881|FG002|COMPLETED|Treatment Period 3||12
10677512|NCT02374164|11839879|FG000|NOT COMPLETED|Treatment Period 3||0
10677513|NCT02374164|11839880|FG001|NOT COMPLETED|Treatment Period 3||0
10677514|NCT02374164|11839881|FG002|NOT COMPLETED|Treatment Period 3||0
10677515|NCT02374255|11839893|FG000|STARTED|Overall Study||155
10677516|NCT02374255|11839894|FG001|STARTED|Overall Study||110
10677517|NCT02374255|11839895|FG002|STARTED|Overall Study||11
10677518|NCT02374255|11839896|FG003|STARTED|Overall Study||11
10677519|NCT02374255|11839893|FG000|COMPLETED|Overall Study||153
10677520|NCT02374255|11839894|FG001|COMPLETED|Overall Study||110
10677521|NCT02374255|11839895|FG002|COMPLETED|Overall Study||11
10677522|NCT02374255|11839896|FG003|COMPLETED|Overall Study||11
10677523|NCT02374255|11839893|FG000|NOT COMPLETED|Overall Study||2
10677524|NCT02374255|11839894|FG001|NOT COMPLETED|Overall Study||0
10677525|NCT02374255|11839895|FG002|NOT COMPLETED|Overall Study||0
10798562|NCT03724812|11959048|FG000|COMPLETED|Overall Study||42
10798563|NCT03724812|11959048|FG000|NOT COMPLETED|Overall Study||4
10798564|NCT03725982|11959055|FG000|STARTED|First Intervention||20
10798565|NCT03725982|11959056|FG001|STARTED|First Intervention||19
10798566|NCT03725982|11959055|FG000|COMPLETED|First Intervention||19
10798567|NCT03725982|11959056|FG001|COMPLETED|First Intervention||17
10798568|NCT03725982|11959055|FG000|NOT COMPLETED|First Intervention||1
10798569|NCT03725982|11959056|FG001|NOT COMPLETED|First Intervention||2
10798570|NCT03725982|11959055|FG000|STARTED|Second Intervention||19
10798571|NCT03725982|11959056|FG001|STARTED|Second Intervention||17
10798572|NCT03725982|11959055|FG000|COMPLETED|Second Intervention||19
10798573|NCT03725982|11959056|FG001|COMPLETED|Second Intervention||17
10798574|NCT03725982|11959055|FG000|NOT COMPLETED|Second Intervention||0
10798575|NCT03725982|11959056|FG001|NOT COMPLETED|Second Intervention||0
10798582|NCT03736967|11959081|FG000|STARTED|Overall Study||51
10798583|NCT03736967|11959082|FG001|STARTED|Overall Study||52
10798584|NCT03736967|11959083|FG002|STARTED|Overall Study||51
10798585|NCT03736967|11959084|FG003|STARTED|Overall Study||52
10798586|NCT03736967|11959081|FG000|Treated|Overall Study||50
10677526|NCT02374255|11839896|FG003|NOT COMPLETED|Overall Study||0
10798587|NCT03736967|11959082|FG001|Treated|Overall Study||52
10798588|NCT03736967|11959083|FG002|Treated|Overall Study||51
10798589|NCT03736967|11959084|FG003|Treated|Overall Study||52
10798590|NCT03736967|11959081|FG000|COMPLETED|Overall Study||20
10798591|NCT03736967|11959082|FG001|COMPLETED|Overall Study||24
10798592|NCT03736967|11959083|FG002|COMPLETED|Overall Study||27
10798593|NCT03736967|11959084|FG003|COMPLETED|Overall Study||22
10798594|NCT03736967|11959081|FG000|NOT COMPLETED|Overall Study||31
10798595|NCT03736967|11959082|FG001|NOT COMPLETED|Overall Study||28
10798596|NCT03736967|11959083|FG002|NOT COMPLETED|Overall Study||24
10798597|NCT03736967|11959084|FG003|NOT COMPLETED|Overall Study||30
10798598|NCT03739840|11959101|FG000|STARTED|Treatment Period: Wk0-16||56
10798599|NCT03739840|11959102|FG001|STARTED|Treatment Period: Wk0-16||60
10798600|NCT03739840|11959103|FG002|STARTED|Treatment Period: Wk0-16||57
10798601|NCT03739840|11959104|FG003|STARTED|Treatment Period: Wk0-16||59
10798602|NCT03739840|11959101|FG000|Completed Titration and Stabilization|Treatment Period: Wk0-16||54
10798603|NCT03739840|11959102|FG001|Completed Titration and Stabilization|Treatment Period: Wk0-16||58
10798604|NCT03739840|11959103|FG002|Completed Titration and Stabilization|Treatment Period: Wk0-16||51
10798605|NCT03739840|11959104|FG003|Completed Titration and Stabilization|Treatment Period: Wk0-16||54
10798606|NCT03739840|11959101|FG000|Completed Maintenance Period|Treatment Period: Wk0-16||46
10798607|NCT03739840|11959102|FG001|Completed Maintenance Period|Treatment Period: Wk0-16||44
10798608|NCT03739840|11959103|FG002|Completed Maintenance Period|Treatment Period: Wk0-16||44
10798609|NCT03739840|11959104|FG003|Completed Maintenance Period|Treatment Period: Wk0-16||36
10798610|NCT03739840|11959101|FG000|COMPLETED|Treatment Period: Wk0-16||46
10798611|NCT03739840|11959102|FG001|COMPLETED|Treatment Period: Wk0-16||44
10798612|NCT03739840|11959103|FG002|COMPLETED|Treatment Period: Wk0-16||44
10798613|NCT03739840|11959104|FG003|COMPLETED|Treatment Period: Wk0-16||36
10677527|NCT02374307|11839914|FG000|STARTED|3-months Follow-up||77
10677528|NCT02374307|11839915|FG001|STARTED|3-months Follow-up||78
10677529|NCT02374307|11839914|FG000|COMPLETED|3-months Follow-up||69
10677530|NCT02374307|11839915|FG001|COMPLETED|3-months Follow-up||69
10677531|NCT02374307|11839914|FG000|NOT COMPLETED|3-months Follow-up||8
10677532|NCT02374307|11839915|FG001|NOT COMPLETED|3-months Follow-up||9
10677533|NCT02374307|11839914|FG000|STARTED|6-months Follow-up|5 subjects missed the first follow-up, but continued the study and were assessed at 6 months.|74
10677534|NCT02374307|11839915|FG001|STARTED|6-months Follow-up|1 subject missed the first follow-up, but continued the study and was assessed at 6 months.|70
10677535|NCT02374307|11839914|FG000|COMPLETED|6-months Follow-up||71
10677536|NCT02374307|11839915|FG001|COMPLETED|6-months Follow-up||64
10677537|NCT02374307|11839914|FG000|NOT COMPLETED|6-months Follow-up||3
10677538|NCT02374307|11839915|FG001|NOT COMPLETED|6-months Follow-up||6
10677539|NCT02374346|11839921|FG000|STARTED|Overall Study||494
10677540|NCT02374346|11839921|FG000|COMPLETED|Overall Study||446
10798614|NCT03739840|11959101|FG000|NOT COMPLETED|Treatment Period: Wk0-16||10
10798615|NCT03739840|11959102|FG001|NOT COMPLETED|Treatment Period: Wk0-16||16
10798616|NCT03739840|11959103|FG002|NOT COMPLETED|Treatment Period: Wk0-16||13
10798617|NCT03739840|11959104|FG003|NOT COMPLETED|Treatment Period: Wk0-16||23
10798618|NCT03739840|11959101|FG000|STARTED|Post-Treatment Period: Wk16-23||46
10798619|NCT03739840|11959102|FG001|STARTED|Post-Treatment Period: Wk16-23||44
10798620|NCT03739840|11959103|FG002|STARTED|Post-Treatment Period: Wk16-23||44
10798621|NCT03739840|11959104|FG003|STARTED|Post-Treatment Period: Wk16-23||36
10798622|NCT03739840|11959101|FG000|Started Conversion Period|Post-Treatment Period: Wk16-23||33
10798623|NCT03739840|11959102|FG001|Started Conversion Period|Post-Treatment Period: Wk16-23||31
10798624|NCT03739840|11959103|FG002|Started Conversion Period|Post-Treatment Period: Wk16-23||29
10798625|NCT03739840|11959104|FG003|Started Conversion Period|Post-Treatment Period: Wk16-23||28
10798626|NCT03739840|11959101|FG000|Completed Conversion Period|Post-Treatment Period: Wk16-23||33
10798627|NCT03739840|11959102|FG001|Completed Conversion Period|Post-Treatment Period: Wk16-23||31
10798628|NCT03739840|11959103|FG002|Completed Conversion Period|Post-Treatment Period: Wk16-23||29
10798629|NCT03739840|11959104|FG003|Completed Conversion Period|Post-Treatment Period: Wk16-23||28
10798630|NCT03739840|11959101|FG000|Started Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||19
10798631|NCT03739840|11959102|FG001|Started Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||18
10798632|NCT03739840|11959103|FG002|Started Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||21
10798633|NCT03739840|11959104|FG003|Started Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||13
10798634|NCT03739840|11959101|FG000|Completed Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||15
10798635|NCT03739840|11959102|FG001|Completed Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||16
10798636|NCT03739840|11959103|FG002|Completed Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||18
10798637|NCT03739840|11959104|FG003|Completed Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||12
10798638|NCT03739840|11959101|FG000|Enrolled in EP0093|Post-Treatment Period: Wk16-23||27
10798639|NCT03739840|11959102|FG001|Enrolled in EP0093|Post-Treatment Period: Wk16-23||26
10798640|NCT03739840|11959103|FG002|Enrolled in EP0093|Post-Treatment Period: Wk16-23||23
10798641|NCT03739840|11959104|FG003|Enrolled in EP0093|Post-Treatment Period: Wk16-23||23
10798642|NCT03739840|11959101|FG000|COMPLETED|Post-Treatment Period: Wk16-23||42
10798643|NCT03739840|11959102|FG001|COMPLETED|Post-Treatment Period: Wk16-23||42
10798644|NCT03739840|11959103|FG002|COMPLETED|Post-Treatment Period: Wk16-23||41
10798645|NCT03739840|11959104|FG003|COMPLETED|Post-Treatment Period: Wk16-23||35
10798646|NCT03739840|11959101|FG000|NOT COMPLETED|Post-Treatment Period: Wk16-23||4
10798647|NCT03739840|11959102|FG001|NOT COMPLETED|Post-Treatment Period: Wk16-23||2
10798648|NCT03739840|11959103|FG002|NOT COMPLETED|Post-Treatment Period: Wk16-23||3
10798649|NCT03739840|11959104|FG003|NOT COMPLETED|Post-Treatment Period: Wk16-23||1
10798650|NCT03739983|11959126|FG000|STARTED|Overall Study||2
10798651|NCT03739983|11959126|FG000|COMPLETED|Overall Study||2
10798652|NCT03739983|11959126|FG000|NOT COMPLETED|Overall Study||0
10798653|NCT03746002|11959132|FG000|STARTED|Overall Study||1
10798654|NCT03746002|11959133|FG001|STARTED|Overall Study||2
10798655|NCT03746002|11959132|FG000|COMPLETED|Overall Study||1
10798656|NCT03746002|11959133|FG001|COMPLETED|Overall Study||2
10798657|NCT03746002|11959132|FG000|NOT COMPLETED|Overall Study||0
10798658|NCT03746002|11959133|FG001|NOT COMPLETED|Overall Study||0
10798659|NCT03748771|11959139|FG000|STARTED|Overall Study||20
10798660|NCT03748771|11959139|FG000|COMPLETED|Overall Study||20
10798661|NCT03748771|11959139|FG000|NOT COMPLETED|Overall Study||0
10798662|NCT03752177|11959147|FG000|STARTED|Overall Study||3
10798663|NCT03752177|11959148|FG001|STARTED|Overall Study||3
10798664|NCT03752177|11959149|FG002|STARTED|Overall Study||3
10798665|NCT03752177|11959150|FG003|STARTED|Overall Study||3
10798666|NCT03752177|11959147|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
10798667|NCT03752177|11959148|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
10798668|NCT03752177|11959149|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
10798669|NCT03752177|11959150|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
10798670|NCT03752177|11959147|FG000|COMPLETED|Overall Study||3
10798671|NCT03752177|11959148|FG001|COMPLETED|Overall Study||3
10798672|NCT03752177|11959149|FG002|COMPLETED|Overall Study||3
10798673|NCT03752177|11959150|FG003|COMPLETED|Overall Study||3
10798674|NCT03752177|11959147|FG000|NOT COMPLETED|Overall Study||0
10798675|NCT03752177|11959148|FG001|NOT COMPLETED|Overall Study||0
10798676|NCT03752177|11959149|FG002|NOT COMPLETED|Overall Study||0
10798677|NCT03752177|11959150|FG003|NOT COMPLETED|Overall Study||0
10798678|NCT03753763|11959163|FG000|STARTED|Overall Study||32
10798679|NCT03753763|11959164|FG001|STARTED|Overall Study||17
10798680|NCT03753763|11959163|FG000|COMPLETED|Overall Study||26
10677541|NCT02374346|11839921|FG000|NOT COMPLETED|Overall Study||48
10677542|NCT02374398|11839931|FG000|STARTED|Overall Study||31
10677543|NCT02374398|11839932|FG001|STARTED|Overall Study||32
10677544|NCT02374398|11839933|FG002|STARTED|Overall Study||32
10677545|NCT02374398|11839934|FG003|STARTED|Overall Study||32
10677546|NCT02374398|11839931|FG000|COMPLETED|Overall Study||29
10677547|NCT02374398|11839932|FG001|COMPLETED|Overall Study||31
10677548|NCT02374398|11839933|FG002|COMPLETED|Overall Study||29
10677549|NCT02374398|11839934|FG003|COMPLETED|Overall Study||32
10677550|NCT02374398|11839931|FG000|NOT COMPLETED|Overall Study||2
10677551|NCT02374398|11839932|FG001|NOT COMPLETED|Overall Study||1
10677552|NCT02374398|11839933|FG002|NOT COMPLETED|Overall Study||3
10677553|NCT02374398|11839934|FG003|NOT COMPLETED|Overall Study||0
10677554|NCT02374463|11839947|FG000|STARTED|Overall Study||15
10677555|NCT02374463|11839948|FG001|STARTED|Overall Study||12
10677556|NCT02374463|11839947|FG000|COMPLETED|Overall Study||12
10677557|NCT02374463|11839948|FG001|COMPLETED|Overall Study||9
10677558|NCT02374463|11839947|FG000|NOT COMPLETED|Overall Study||3
10677559|NCT02374463|11839948|FG001|NOT COMPLETED|Overall Study||3
10677560|NCT02374593|11839957|FG000|STARTED|Overall Study||24
10677561|NCT02374593|11839958|FG001|STARTED|Overall Study||44
10677562|NCT02374593|11839957|FG000|COMPLETED|Overall Study||22
10677563|NCT02374593|11839958|FG001|COMPLETED|Overall Study||44
10677564|NCT02374593|11839957|FG000|NOT COMPLETED|Overall Study||2
10677565|NCT02374593|11839958|FG001|NOT COMPLETED|Overall Study||0
10677566|NCT02374671|11839971|FG000|STARTED|Observation (Deferred Implantation)||0
10677567|NCT02374671|11839972|FG001|STARTED|Observation (Deferred Implantation)||0
10677568|NCT02374671|11839973|FG002|STARTED|Observation (Deferred Implantation)||31
10677569|NCT02374671|11839971|FG000|COMPLETED|Observation (Deferred Implantation)||0
10677570|NCT02374671|11839972|FG001|COMPLETED|Observation (Deferred Implantation)||0
10677571|NCT02374671|11839973|FG002|COMPLETED|Observation (Deferred Implantation)||26
10677572|NCT02374671|11839971|FG000|NOT COMPLETED|Observation (Deferred Implantation)||0
10677573|NCT02374671|11839972|FG001|NOT COMPLETED|Observation (Deferred Implantation)||0
10677574|NCT02374671|11839973|FG002|NOT COMPLETED|Observation (Deferred Implantation)||5
10677575|NCT02374671|11839971|FG000|STARTED|Implantation- Nonrandomized & Randomized|(8) subjects were unilaterally implanted|306
10677576|NCT02374671|11839972|FG001|STARTED|Implantation- Nonrandomized & Randomized|(1) subject was unilaterally implanted|28
10677577|NCT02374671|11839973|FG002|STARTED|Implantation- Nonrandomized & Randomized|(3) subjects were unilaterally implanted|26
10677578|NCT02374671|11839971|FG000|COMPLETED|Implantation- Nonrandomized & Randomized||281
10677579|NCT02374671|11839972|FG001|COMPLETED|Implantation- Nonrandomized & Randomized||27
10677580|NCT02374671|11839973|FG002|COMPLETED|Implantation- Nonrandomized & Randomized|(1) unilaterally implanted subject discontinued (1 eye)|23
10677581|NCT02374671|11839971|FG000|NOT COMPLETED|Implantation- Nonrandomized & Randomized||25
10677582|NCT02374671|11839972|FG001|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1
10677583|NCT02374671|11839973|FG002|NOT COMPLETED|Implantation- Nonrandomized & Randomized||3
10677584|NCT02374918|11839983|FG000|STARTED|Overall Study||17
10677585|NCT02374918|11839984|FG001|STARTED|Overall Study||18
10677586|NCT02374918|11839985|FG002|STARTED|Overall Study||22
10677587|NCT02374918|11839986|FG003|STARTED|Overall Study||20
10677588|NCT02374918|11839983|FG000|COMPLETED|Overall Study||14
10677589|NCT02374918|11839984|FG001|COMPLETED|Overall Study||17
10677590|NCT02374918|11839985|FG002|COMPLETED|Overall Study||18
10677591|NCT02374918|11839986|FG003|COMPLETED|Overall Study||18
10677592|NCT02374918|11839983|FG000|NOT COMPLETED|Overall Study||3
10677593|NCT02374918|11839984|FG001|NOT COMPLETED|Overall Study||1
10677594|NCT02374918|11839985|FG002|NOT COMPLETED|Overall Study||4
10677595|NCT02374918|11839986|FG003|NOT COMPLETED|Overall Study||2
10677596|NCT02374957|11839996|FG000|STARTED|Overall Study||11
10677597|NCT02374957|11839997|FG001|STARTED|Overall Study||9
10677598|NCT02374957|11839996|FG000|COMPLETED|Overall Study||10
10677599|NCT02374957|11839997|FG001|COMPLETED|Overall Study||9
10677600|NCT02374957|11839996|FG000|NOT COMPLETED|Overall Study||1
10677601|NCT02374957|11839997|FG001|NOT COMPLETED|Overall Study||0
10677602|NCT02375347|11840003|FG000|STARTED|Overall Study||13
10677603|NCT02375347|11840003|FG000|COMPLETED|Overall Study||12
10677604|NCT02375347|11840003|FG000|NOT COMPLETED|Overall Study||1
10677605|NCT02375373|11840007|FG000|STARTED|Overall Study||12
10677606|NCT02375373|11840007|FG000|COMPLETED|Overall Study||1
10677607|NCT02375373|11840007|FG000|NOT COMPLETED|Overall Study||11
10677608|NCT02375698|11840013|FG000|STARTED|Overall Study||16
10677609|NCT02375698|11840014|FG001|STARTED|Overall Study||6
10677610|NCT02375698|11840013|FG000|COMPLETED|Overall Study||14
10677611|NCT02375698|11840014|FG001|COMPLETED|Overall Study||4
10677612|NCT02375698|11840013|FG000|NOT COMPLETED|Overall Study||2
10677613|NCT02375698|11840014|FG001|NOT COMPLETED|Overall Study||2
10677614|NCT02375724|11840022|FG000|STARTED|Overall Study||135
10677615|NCT02375724|11840023|FG001|STARTED|Overall Study||134
10677616|NCT02375724|11840022|FG000|COMPLETED|Overall Study||129
10677617|NCT02375724|11840023|FG001|COMPLETED|Overall Study||128
10677618|NCT02375724|11840022|FG000|NOT COMPLETED|Overall Study||6
10677619|NCT02375724|11840023|FG001|NOT COMPLETED|Overall Study||6
10677620|NCT02375971|11840032|FG000|STARTED|Treatment (Day 1 - Baseline)||74
10677621|NCT02375971|11840033|FG001|STARTED|Treatment (Day 1 - Baseline)||77
10677622|NCT02375971|11840034|FG002|STARTED|Treatment (Day 1 - Baseline)||74
10677623|NCT02375971|11840032|FG000|Safety Set|Treatment (Day 1 - Baseline)||73
10677624|NCT02375971|11840033|FG001|Safety Set|Treatment (Day 1 - Baseline)||76
10677625|NCT02375971|11840034|FG002|Safety Set|Treatment (Day 1 - Baseline)||69
10677626|NCT02375971|11840032|FG000|VEGF Set|Treatment (Day 1 - Baseline)||19
10677627|NCT02375971|11840033|FG001|VEGF Set|Treatment (Day 1 - Baseline)||26
10677628|NCT02375971|11840034|FG002|VEGF Set|Treatment (Day 1 - Baseline)||51
10677629|NCT02375971|11840032|FG000|PK Set|Treatment (Day 1 - Baseline)||49
10677630|NCT02375971|11840033|FG001|PK Set|Treatment (Day 1 - Baseline)||46
10677631|NCT02375971|11840034|FG002|PK Set|Treatment (Day 1 - Baseline)||0
10677632|NCT02375971|11840032|FG000|COMPLETED|Treatment (Day 1 - Baseline)||73
10677633|NCT02375971|11840033|FG001|COMPLETED|Treatment (Day 1 - Baseline)||76
10677634|NCT02375971|11840034|FG002|COMPLETED|Treatment (Day 1 - Baseline)||69
10677635|NCT02375971|11840032|FG000|NOT COMPLETED|Treatment (Day 1 - Baseline)||1
10677636|NCT02375971|11840033|FG001|NOT COMPLETED|Treatment (Day 1 - Baseline)||1
10677637|NCT02375971|11840034|FG002|NOT COMPLETED|Treatment (Day 1 - Baseline)||5
10677638|NCT02375971|11840032|FG000|STARTED|Follow-Up Phase (up to Day 169)||73
10677639|NCT02375971|11840033|FG001|STARTED|Follow-Up Phase (up to Day 169)||76
10677640|NCT02375971|11840034|FG002|STARTED|Follow-Up Phase (up to Day 169)||69
10677641|NCT02375971|11840032|FG000|COMPLETED|Follow-Up Phase (up to Day 169)||66
10677642|NCT02375971|11840033|FG001|COMPLETED|Follow-Up Phase (up to Day 169)||71
10677643|NCT02375971|11840034|FG002|COMPLETED|Follow-Up Phase (up to Day 169)||64
10677644|NCT02375971|11840032|FG000|NOT COMPLETED|Follow-Up Phase (up to Day 169)||7
10677645|NCT02375971|11840033|FG001|NOT COMPLETED|Follow-Up Phase (up to Day 169)||5
10677646|NCT02375971|11840034|FG002|NOT COMPLETED|Follow-Up Phase (up to Day 169)||5
10677647|NCT02375984|11840042|FG000|STARTED|Overall Study||1
10677648|NCT02375984|11840042|FG000|COMPLETED|Overall Study||1
10677649|NCT02375984|11840042|FG000|NOT COMPLETED|Overall Study||0
10677650|NCT02376010|11840048|FG000|STARTED|Overall Study||55
10798681|NCT03753763|11959164|FG001|COMPLETED|Overall Study||16
10798682|NCT03753763|11959163|FG000|NOT COMPLETED|Overall Study||6
10798683|NCT03753763|11959164|FG001|NOT COMPLETED|Overall Study||1
10798684|NCT03756571|11959172|FG000|STARTED|Overall Study||10
10798685|NCT03756571|11959173|FG001|STARTED|Overall Study||11
10798686|NCT03756571|11959172|FG000|COMPLETED|Overall Study||9
10798687|NCT03756571|11959173|FG001|COMPLETED|Overall Study||10
10798688|NCT03756571|11959172|FG000|NOT COMPLETED|Overall Study||1
10798689|NCT03756571|11959173|FG001|NOT COMPLETED|Overall Study||1
10798690|NCT03761537|11959181|FG000|STARTED|Overall Study||140
10798691|NCT03761537|11959182|FG001|STARTED|Overall Study||137
10798692|NCT03761537|11959181|FG000|COMPLETED|Overall Study||125
10798693|NCT03761537|11959182|FG001|COMPLETED|Overall Study||120
10798694|NCT03761537|11959181|FG000|NOT COMPLETED|Overall Study||15
10798695|NCT03761537|11959182|FG001|NOT COMPLETED|Overall Study||17
10798696|NCT03763877|11959200|FG000|STARTED|Overall Study||31
10798697|NCT03763877|11959201|FG001|STARTED|Overall Study||30
10798698|NCT03763877|11959202|FG002|STARTED|Overall Study||31
10798699|NCT03763877|11959203|FG003|STARTED|Overall Study||29
10798700|NCT03763877|11959200|FG000|Received at Least 1 Dose of Double-blind Study Treatment|Overall Study||31
10798701|NCT03763877|11959201|FG001|Received at Least 1 Dose of Double-blind Study Treatment|Overall Study||30
10798702|NCT03763877|11959202|FG002|Received at Least 1 Dose of Double-blind Study Treatment|Overall Study||30
10798703|NCT03763877|11959203|FG003|Received at Least 1 Dose of Double-blind Study Treatment|Overall Study||29
10798704|NCT03763877|11959200|FG000|Completed the Double-blind Period|Overall Study||27
10798705|NCT03763877|11959201|FG001|Completed the Double-blind Period|Overall Study||26
10798706|NCT03763877|11959202|FG002|Completed the Double-blind Period|Overall Study||25
10798707|NCT03763877|11959203|FG003|Completed the Double-blind Period|Overall Study||24
10798708|NCT03763877|11959200|FG000|COMPLETED|Overall Study||26
10798709|NCT03763877|11959201|FG001|COMPLETED|Overall Study||26
10798710|NCT03763877|11959202|FG002|COMPLETED|Overall Study||24
10798711|NCT03763877|11959203|FG003|COMPLETED|Overall Study||24
10798712|NCT03763877|11959200|FG000|NOT COMPLETED|Overall Study||5
10798713|NCT03763877|11959201|FG001|NOT COMPLETED|Overall Study||4
10798714|NCT03763877|11959202|FG002|NOT COMPLETED|Overall Study||7
10798715|NCT03763877|11959203|FG003|NOT COMPLETED|Overall Study||5
10798716|NCT03764007|11959217|FG000|STARTED|Overall Study||98
10798717|NCT03764007|11959217|FG000|Imaging Completed|Overall Study||98
10798718|NCT03764007|11959217|FG000|Underwent Parathyroidectomy Surgery|Overall Study||77
10798719|NCT03764007|11959217|FG000|COMPLETED|Overall Study||77
10798720|NCT03764007|11959217|FG000|NOT COMPLETED|Overall Study||21
10798721|NCT03772587|11959226|FG000|STARTED|Overall Study||14
10798722|NCT03772587|11959227|FG001|STARTED|Overall Study||14
10798723|NCT03772587|11959228|FG002|STARTED|Overall Study||13
10798724|NCT03772587|11959229|FG003|STARTED|Overall Study||13
10798725|NCT03772587|11959230|FG004|STARTED|Overall Study||14
10798726|NCT03772587|11959226|FG000|COMPLETED|Overall Study||13
10798727|NCT03772587|11959227|FG001|COMPLETED|Overall Study||14
10798728|NCT03772587|11959228|FG002|COMPLETED|Overall Study||12
10798729|NCT03772587|11959229|FG003|COMPLETED|Overall Study||12
10677651|NCT02376010|11840049|FG001|STARTED|Overall Study||55
10677652|NCT02376010|11840048|FG000|COMPLETED|Overall Study||46
10677653|NCT02376010|11840049|FG001|COMPLETED|Overall Study||51
10677654|NCT02376010|11840048|FG000|NOT COMPLETED|Overall Study||9
10677655|NCT02376010|11840049|FG001|NOT COMPLETED|Overall Study||4
10677656|NCT02376166|11840055|FG000|STARTED|Overall Study||15
10677657|NCT02376166|11840055|FG000|COMPLETED|Overall Study||12
10677658|NCT02376166|11840055|FG000|NOT COMPLETED|Overall Study||3
10677659|NCT02376179|11840059|FG000|STARTED|Overall Study||84
10677660|NCT02376179|11840059|FG000|COMPLETED|Overall Study||84
10798730|NCT03772587|11959230|FG004|COMPLETED|Overall Study||14
10798731|NCT03772587|11959226|FG000|NOT COMPLETED|Overall Study||1
10677661|NCT02376179|11840059|FG000|NOT COMPLETED|Overall Study||0
10677662|NCT02376257|11840066|FG000|STARTED|Overall Study||13
10677663|NCT02376257|11840067|FG001|STARTED|Overall Study||12
10677664|NCT02376257|11840068|FG002|STARTED|Overall Study||11
10677665|NCT02376257|11840066|FG000|COMPLETED|Overall Study||13
10677666|NCT02376257|11840067|FG001|COMPLETED|Overall Study||12
10677667|NCT02376257|11840068|FG002|COMPLETED|Overall Study||11
10677668|NCT02376257|11840066|FG000|NOT COMPLETED|Overall Study||0
10677669|NCT02376257|11840067|FG001|NOT COMPLETED|Overall Study||0
10677670|NCT02376257|11840068|FG002|NOT COMPLETED|Overall Study||0
10677671|NCT02376283|11840079|FG000|STARTED|Overall Study||27
10677672|NCT02376283|11840080|FG001|STARTED|Overall Study||30
10677673|NCT02376283|11840081|FG002|STARTED|Overall Study||30
10677674|NCT02376283|11840079|FG000|COMPLETED|Overall Study||27
10677675|NCT02376283|11840080|FG001|COMPLETED|Overall Study||30
10677676|NCT02376283|11840081|FG002|COMPLETED|Overall Study||30
10677677|NCT02376283|11840079|FG000|NOT COMPLETED|Overall Study||0
10677678|NCT02376283|11840080|FG001|NOT COMPLETED|Overall Study||0
10677679|NCT02376283|11840081|FG002|NOT COMPLETED|Overall Study||0
10677680|NCT02376361|11840092|FG000|STARTED|Overall Study||229
10677681|NCT02376361|11840093|FG001|STARTED|Overall Study||207
10677682|NCT02376361|11840092|FG000|COMPLETED|Overall Study||58
10677683|NCT02376361|11840093|FG001|COMPLETED|Overall Study||90
10677684|NCT02376361|11840092|FG000|NOT COMPLETED|Overall Study||171
10677685|NCT02376361|11840093|FG001|NOT COMPLETED|Overall Study||117
10677686|NCT02376530|11840103|FG000|STARTED|Overall Study||196
10677687|NCT02376530|11840104|FG001|STARTED|Overall Study||198
10677688|NCT02376530|11840105|FG002|STARTED|Overall Study||197
10677689|NCT02376530|11840106|FG003|STARTED|Overall Study||197
10677690|NCT02376530|11840103|FG000|COMPLETED|Overall Study||196
10677691|NCT02376530|11840104|FG001|COMPLETED|Overall Study||198
10677692|NCT02376530|11840105|FG002|COMPLETED|Overall Study||197
10677693|NCT02376530|11840106|FG003|COMPLETED|Overall Study||197
10677694|NCT02376530|11840103|FG000|NOT COMPLETED|Overall Study||0
10677695|NCT02376530|11840104|FG001|NOT COMPLETED|Overall Study||0
10677696|NCT02376530|11840105|FG002|NOT COMPLETED|Overall Study||0
10677697|NCT02376530|11840106|FG003|NOT COMPLETED|Overall Study||0
10677710|NCT02376998|11840129|FG000|STARTED|Overall Study||20
10677711|NCT02376998|11840129|FG000|COMPLETED|Overall Study||11
10677712|NCT02376998|11840129|FG000|NOT COMPLETED|Overall Study||9
10677713|NCT02377063|11840133|FG000|STARTED|Overall Study||25
10677714|NCT02377063|11840133|FG000|COMPLETED|Overall Study||20
10677715|NCT02377063|11840133|FG000|NOT COMPLETED|Overall Study||5
10798732|NCT03772587|11959227|FG001|NOT COMPLETED|Overall Study||0
10798733|NCT03772587|11959228|FG002|NOT COMPLETED|Overall Study||1
10798734|NCT03772587|11959229|FG003|NOT COMPLETED|Overall Study||1
10798735|NCT03772587|11959230|FG004|NOT COMPLETED|Overall Study||0
10798736|NCT03789292|11959254|FG000|STARTED|Treatment Period I (Week 0 to Week 26)||324
10798737|NCT03789292|11959255|FG001|STARTED|Treatment Period I (Week 0 to Week 26)||324
10798738|NCT03789292|11959256|FG002|STARTED|Treatment Period I (Week 0 to Week 26)||0
10798739|NCT03789292|11959254|FG000|COMPLETED|Treatment Period I (Week 0 to Week 26)||303
10798740|NCT03789292|11959255|FG001|COMPLETED|Treatment Period I (Week 0 to Week 26)||305
10798741|NCT03789292|11959256|FG002|COMPLETED|Treatment Period I (Week 0 to Week 26)||0
10798742|NCT03789292|11959254|FG000|NOT COMPLETED|Treatment Period I (Week 0 to Week 26)||21
10798743|NCT03789292|11959255|FG001|NOT COMPLETED|Treatment Period I (Week 0 to Week 26)||19
10798744|NCT03789292|11959256|FG002|NOT COMPLETED|Treatment Period I (Week 0 to Week 26)||0
10798745|NCT03789292|11959254|FG000|STARTED|Treatment Period II (Week 26 to Week 52)||303
10798746|NCT03789292|11959255|FG001|STARTED|Treatment Period II (Week 26 to Week 52)|Patients who had administrated Humira SC during Treatment Period 1 has been devided into 2 groups - maintaining Humira SC and switched to CT-P17.|153
10798747|NCT03789292|11959256|FG002|STARTED|Treatment Period II (Week 26 to Week 52)|Patients who had administrated Humira SC during Treatment Period 1 has been devided into 2 groups - maintaining Humira SC and switched to CT-P17.|152
10677716|NCT02377349|11840139|FG000|STARTED|Overall Study||341
10677717|NCT02377349|11840140|FG001|STARTED|Overall Study||346
10677718|NCT02377349|11840139|FG000|COMPLETED|Overall Study||325
10677719|NCT02377349|11840140|FG001|COMPLETED|Overall Study||335
10677720|NCT02377349|11840139|FG000|NOT COMPLETED|Overall Study||16
10677721|NCT02377349|11840140|FG001|NOT COMPLETED|Overall Study||11
10677722|NCT02377362|11840168|FG000|STARTED|Part A First Treatment||4
10677723|NCT02377362|11840169|FG001|STARTED|Part A First Treatment||4
10677724|NCT02377362|11840170|FG002|STARTED|Part A First Treatment||4
10677725|NCT02377362|11840171|FG003|STARTED|Part A First Treatment||4
10677726|NCT02377362|11840172|FG004|STARTED|Part A First Treatment||4
10677727|NCT02377362|11840173|FG005|STARTED|Part A First Treatment||4
10677728|NCT02377362|11840174|FG006|STARTED|Part A First Treatment||0
10677729|NCT02377362|11840175|FG007|STARTED|Part A First Treatment||0
10677730|NCT02377362|11840176|FG008|STARTED|Part A First Treatment||0
10677731|NCT02377362|11840177|FG009|STARTED|Part A First Treatment||0
10677732|NCT02377362|11840178|FG010|STARTED|Part A First Treatment||0
10677733|NCT02377362|11840179|FG011|STARTED|Part A First Treatment||0
10677734|NCT02377362|11840180|FG012|STARTED|Part A First Treatment||0
10677735|NCT02377362|11840168|FG000|COMPLETED|Part A First Treatment||4
10677736|NCT02377362|11840169|FG001|COMPLETED|Part A First Treatment||4
10677737|NCT02377362|11840170|FG002|COMPLETED|Part A First Treatment||4
10677738|NCT02377362|11840171|FG003|COMPLETED|Part A First Treatment||4
10677739|NCT02377362|11840172|FG004|COMPLETED|Part A First Treatment||4
10677740|NCT02377362|11840173|FG005|COMPLETED|Part A First Treatment||4
10677741|NCT02377362|11840174|FG006|COMPLETED|Part A First Treatment||0
10677742|NCT02377362|11840175|FG007|COMPLETED|Part A First Treatment||0
10677743|NCT02377362|11840176|FG008|COMPLETED|Part A First Treatment||0
10677744|NCT02377362|11840177|FG009|COMPLETED|Part A First Treatment||0
10677745|NCT02377362|11840178|FG010|COMPLETED|Part A First Treatment||0
10677746|NCT02377362|11840179|FG011|COMPLETED|Part A First Treatment||0
10677747|NCT02377362|11840180|FG012|COMPLETED|Part A First Treatment||0
10677748|NCT02377362|11840168|FG000|NOT COMPLETED|Part A First Treatment||0
10677749|NCT02377362|11840169|FG001|NOT COMPLETED|Part A First Treatment||0
10677750|NCT02377362|11840170|FG002|NOT COMPLETED|Part A First Treatment||0
10677751|NCT02377362|11840171|FG003|NOT COMPLETED|Part A First Treatment||0
10677752|NCT02377362|11840172|FG004|NOT COMPLETED|Part A First Treatment||0
10677753|NCT02377362|11840173|FG005|NOT COMPLETED|Part A First Treatment||0
10677754|NCT02377362|11840174|FG006|NOT COMPLETED|Part A First Treatment||0
10677755|NCT02377362|11840175|FG007|NOT COMPLETED|Part A First Treatment||0
10677756|NCT02377362|11840176|FG008|NOT COMPLETED|Part A First Treatment||0
10677757|NCT02377362|11840177|FG009|NOT COMPLETED|Part A First Treatment||0
10677758|NCT02377362|11840178|FG010|NOT COMPLETED|Part A First Treatment||0
10677759|NCT02377362|11840179|FG011|NOT COMPLETED|Part A First Treatment||0
10677760|NCT02377362|11840180|FG012|NOT COMPLETED|Part A First Treatment||0
10677761|NCT02377362|11840168|FG000|STARTED|Part A Second Treatment||4
10677762|NCT02377362|11840169|FG001|STARTED|Part A Second Treatment||4
10677763|NCT02377362|11840170|FG002|STARTED|Part A Second Treatment||4
10677764|NCT02377362|11840171|FG003|STARTED|Part A Second Treatment||4
10677765|NCT02377362|11840172|FG004|STARTED|Part A Second Treatment||4
10677766|NCT02377362|11840173|FG005|STARTED|Part A Second Treatment||4
10677767|NCT02377362|11840174|FG006|STARTED|Part A Second Treatment||0
10677768|NCT02377362|11840175|FG007|STARTED|Part A Second Treatment||0
10677769|NCT02377362|11840176|FG008|STARTED|Part A Second Treatment||0
10677770|NCT02377362|11840177|FG009|STARTED|Part A Second Treatment||0
10677771|NCT02377362|11840178|FG010|STARTED|Part A Second Treatment||0
10677772|NCT02377362|11840179|FG011|STARTED|Part A Second Treatment||0
10677773|NCT02377362|11840180|FG012|STARTED|Part A Second Treatment||0
10677774|NCT02377362|11840168|FG000|COMPLETED|Part A Second Treatment||4
10677775|NCT02377362|11840169|FG001|COMPLETED|Part A Second Treatment||4
10677776|NCT02377362|11840170|FG002|COMPLETED|Part A Second Treatment||4
10677777|NCT02377362|11840171|FG003|COMPLETED|Part A Second Treatment||4
10677778|NCT02377362|11840172|FG004|COMPLETED|Part A Second Treatment||3
10677779|NCT02377362|11840173|FG005|COMPLETED|Part A Second Treatment||4
10677780|NCT02377362|11840174|FG006|COMPLETED|Part A Second Treatment||0
10677781|NCT02377362|11840175|FG007|COMPLETED|Part A Second Treatment||0
10677782|NCT02377362|11840176|FG008|COMPLETED|Part A Second Treatment||0
10677783|NCT02377362|11840177|FG009|COMPLETED|Part A Second Treatment||0
10677784|NCT02377362|11840178|FG010|COMPLETED|Part A Second Treatment||0
10677785|NCT02377362|11840179|FG011|COMPLETED|Part A Second Treatment||0
10677786|NCT02377362|11840180|FG012|COMPLETED|Part A Second Treatment||0
10677787|NCT02377362|11840168|FG000|NOT COMPLETED|Part A Second Treatment||0
10677788|NCT02377362|11840169|FG001|NOT COMPLETED|Part A Second Treatment||0
10677789|NCT02377362|11840170|FG002|NOT COMPLETED|Part A Second Treatment||0
10677790|NCT02377362|11840171|FG003|NOT COMPLETED|Part A Second Treatment||0
10677791|NCT02377362|11840172|FG004|NOT COMPLETED|Part A Second Treatment||1
10677792|NCT02377362|11840173|FG005|NOT COMPLETED|Part A Second Treatment||0
10677793|NCT02377362|11840174|FG006|NOT COMPLETED|Part A Second Treatment||0
10798748|NCT03789292|11959254|FG000|COMPLETED|Treatment Period II (Week 26 to Week 52)||287
10798749|NCT03789292|11959255|FG001|COMPLETED|Treatment Period II (Week 26 to Week 52)||147
10798750|NCT03789292|11959256|FG002|COMPLETED|Treatment Period II (Week 26 to Week 52)||143
10810950|NCT03784079|11972666|FG006|COMPLETED|Part 1: Up to Day 24||0
10677794|NCT02377362|11840175|FG007|NOT COMPLETED|Part A Second Treatment||0
10677795|NCT02377362|11840176|FG008|NOT COMPLETED|Part A Second Treatment||0
10677796|NCT02377362|11840177|FG009|NOT COMPLETED|Part A Second Treatment||0
10677797|NCT02377362|11840178|FG010|NOT COMPLETED|Part A Second Treatment||0
10677798|NCT02377362|11840179|FG011|NOT COMPLETED|Part A Second Treatment||0
10677799|NCT02377362|11840180|FG012|NOT COMPLETED|Part A Second Treatment||0
10677800|NCT02377362|11840168|FG000|STARTED|Part A Third Treatment||4
10677801|NCT02377362|11840169|FG001|STARTED|Part A Third Treatment||4
10677802|NCT02377362|11840170|FG002|STARTED|Part A Third Treatment||4
10677803|NCT02377362|11840171|FG003|STARTED|Part A Third Treatment||4
10677804|NCT02377362|11840172|FG004|STARTED|Part A Third Treatment||3
10677805|NCT02377362|11840173|FG005|STARTED|Part A Third Treatment||4
10677806|NCT02377362|11840174|FG006|STARTED|Part A Third Treatment||0
10677807|NCT02377362|11840175|FG007|STARTED|Part A Third Treatment||0
10677808|NCT02377362|11840176|FG008|STARTED|Part A Third Treatment||0
10677809|NCT02377362|11840177|FG009|STARTED|Part A Third Treatment||0
10677810|NCT02377362|11840178|FG010|STARTED|Part A Third Treatment||0
10798751|NCT03789292|11959254|FG000|NOT COMPLETED|Treatment Period II (Week 26 to Week 52)||16
10798752|NCT03789292|11959255|FG001|NOT COMPLETED|Treatment Period II (Week 26 to Week 52)||6
10798753|NCT03789292|11959256|FG002|NOT COMPLETED|Treatment Period II (Week 26 to Week 52)||9
10798754|NCT03799289|11959272|FG000|STARTED|Initial Weight Loss Program (Weeks 1-12)||30
10798755|NCT03799289|11959273|FG001|STARTED|Initial Weight Loss Program (Weeks 1-12)||30
10798756|NCT03799289|11959272|FG000|COMPLETED|Initial Weight Loss Program (Weeks 1-12)||24
10677811|NCT02377362|11840179|FG011|STARTED|Part A Third Treatment||0
10677812|NCT02377362|11840180|FG012|STARTED|Part A Third Treatment||0
10677813|NCT02377362|11840168|FG000|COMPLETED|Part A Third Treatment||4
10677814|NCT02377362|11840169|FG001|COMPLETED|Part A Third Treatment||4
10677815|NCT02377362|11840170|FG002|COMPLETED|Part A Third Treatment||4
10677816|NCT02377362|11840171|FG003|COMPLETED|Part A Third Treatment||0
10677817|NCT02377362|11840172|FG004|COMPLETED|Part A Third Treatment||0
10677818|NCT02377362|11840173|FG005|COMPLETED|Part A Third Treatment||0
10677819|NCT02377362|11840174|FG006|COMPLETED|Part A Third Treatment||0
10677820|NCT02377362|11840175|FG007|COMPLETED|Part A Third Treatment||0
10677821|NCT02377362|11840176|FG008|COMPLETED|Part A Third Treatment||0
10677822|NCT02377362|11840177|FG009|COMPLETED|Part A Third Treatment||0
10677823|NCT02377362|11840178|FG010|COMPLETED|Part A Third Treatment||0
10677824|NCT02377362|11840179|FG011|COMPLETED|Part A Third Treatment||0
10677825|NCT02377362|11840180|FG012|COMPLETED|Part A Third Treatment||0
10677826|NCT02377362|11840168|FG000|NOT COMPLETED|Part A Third Treatment||0
10677827|NCT02377362|11840169|FG001|NOT COMPLETED|Part A Third Treatment||0
10677828|NCT02377362|11840170|FG002|NOT COMPLETED|Part A Third Treatment||0
10677829|NCT02377362|11840171|FG003|NOT COMPLETED|Part A Third Treatment||4
10677830|NCT02377362|11840172|FG004|NOT COMPLETED|Part A Third Treatment||3
10677831|NCT02377362|11840173|FG005|NOT COMPLETED|Part A Third Treatment||4
10677832|NCT02377362|11840174|FG006|NOT COMPLETED|Part A Third Treatment||0
10677833|NCT02377362|11840175|FG007|NOT COMPLETED|Part A Third Treatment||0
10677834|NCT02377362|11840176|FG008|NOT COMPLETED|Part A Third Treatment||0
10677835|NCT02377362|11840177|FG009|NOT COMPLETED|Part A Third Treatment||0
10677836|NCT02377362|11840178|FG010|NOT COMPLETED|Part A Third Treatment||0
10677837|NCT02377362|11840179|FG011|NOT COMPLETED|Part A Third Treatment||0
10677838|NCT02377362|11840180|FG012|NOT COMPLETED|Part A Third Treatment||0
10677839|NCT02377362|11840168|FG000|STARTED|Part B Overall||0
10677840|NCT02377362|11840169|FG001|STARTED|Part B Overall||0
10677841|NCT02377362|11840170|FG002|STARTED|Part B Overall||0
10677842|NCT02377362|11840171|FG003|STARTED|Part B Overall||0
10677843|NCT02377362|11840172|FG004|STARTED|Part B Overall||0
10677844|NCT02377362|11840173|FG005|STARTED|Part B Overall||0
10677845|NCT02377362|11840174|FG006|STARTED|Part B Overall||6
10677846|NCT02377362|11840175|FG007|STARTED|Part B Overall||6
10677847|NCT02377362|11840176|FG008|STARTED|Part B Overall||6
10677848|NCT02377362|11840177|FG009|STARTED|Part B Overall||7
10677849|NCT02377362|11840178|FG010|STARTED|Part B Overall||6
10677850|NCT02377362|11840179|FG011|STARTED|Part B Overall||7
10677851|NCT02377362|11840180|FG012|STARTED|Part B Overall||12
10677852|NCT02377362|11840168|FG000|COMPLETED|Part B Overall||0
10677853|NCT02377362|11840169|FG001|COMPLETED|Part B Overall||0
10677854|NCT02377362|11840170|FG002|COMPLETED|Part B Overall||0
10677855|NCT02377362|11840171|FG003|COMPLETED|Part B Overall||0
10677856|NCT02377362|11840172|FG004|COMPLETED|Part B Overall||0
10677857|NCT02377362|11840173|FG005|COMPLETED|Part B Overall||0
10677858|NCT02377362|11840174|FG006|COMPLETED|Part B Overall||4
10677859|NCT02377362|11840175|FG007|COMPLETED|Part B Overall||5
10677860|NCT02377362|11840176|FG008|COMPLETED|Part B Overall||6
10677861|NCT02377362|11840177|FG009|COMPLETED|Part B Overall||6
10677862|NCT02377362|11840178|FG010|COMPLETED|Part B Overall||6
10677863|NCT02377362|11840179|FG011|COMPLETED|Part B Overall||6
10677864|NCT02377362|11840180|FG012|COMPLETED|Part B Overall||12
10677865|NCT02377362|11840168|FG000|NOT COMPLETED|Part B Overall||0
10677866|NCT02377362|11840169|FG001|NOT COMPLETED|Part B Overall||0
10677867|NCT02377362|11840170|FG002|NOT COMPLETED|Part B Overall||0
10677868|NCT02377362|11840171|FG003|NOT COMPLETED|Part B Overall||0
10677869|NCT02377362|11840172|FG004|NOT COMPLETED|Part B Overall||0
10677870|NCT02377362|11840173|FG005|NOT COMPLETED|Part B Overall||0
10798757|NCT03799289|11959273|FG001|COMPLETED|Initial Weight Loss Program (Weeks 1-12)||27
10798758|NCT03799289|11959272|FG000|NOT COMPLETED|Initial Weight Loss Program (Weeks 1-12)||6
10798759|NCT03799289|11959273|FG001|NOT COMPLETED|Initial Weight Loss Program (Weeks 1-12)||3
10798760|NCT03799289|11959272|FG000|STARTED|Maintenance Intervention (Weeks 13-24)||24
10677871|NCT02377362|11840174|FG006|NOT COMPLETED|Part B Overall||2
10677872|NCT02377362|11840175|FG007|NOT COMPLETED|Part B Overall||1
10798761|NCT03799289|11959273|FG001|STARTED|Maintenance Intervention (Weeks 13-24)||27
10798762|NCT03799289|11959272|FG000|COMPLETED|Maintenance Intervention (Weeks 13-24)||24
10677873|NCT02377362|11840176|FG008|NOT COMPLETED|Part B Overall||0
10677874|NCT02377362|11840177|FG009|NOT COMPLETED|Part B Overall||1
10677875|NCT02377362|11840178|FG010|NOT COMPLETED|Part B Overall||0
10677876|NCT02377362|11840179|FG011|NOT COMPLETED|Part B Overall||1
10677877|NCT02377362|11840180|FG012|NOT COMPLETED|Part B Overall||0
10677878|NCT02377427|11840220|FG000|STARTED|Part A (Up to Week 20)||26
10677879|NCT02377427|11840221|FG001|STARTED|Part A (Up to Week 20)||10
10677880|NCT02377427|11840222|FG002|STARTED|Part A (Up to Week 20)||0
10677881|NCT02377427|11840223|FG003|STARTED|Part A (Up to Week 20)||0
10677882|NCT02377427|11840224|FG004|STARTED|Part A (Up to Week 20)||0
10677883|NCT02377427|11840220|FG000|COMPLETED|Part A (Up to Week 20)||22
10677884|NCT02377427|11840221|FG001|COMPLETED|Part A (Up to Week 20)||10
10677885|NCT02377427|11840222|FG002|COMPLETED|Part A (Up to Week 20)||0
10677886|NCT02377427|11840223|FG003|COMPLETED|Part A (Up to Week 20)||0
10677887|NCT02377427|11840224|FG004|COMPLETED|Part A (Up to Week 20)||0
10677888|NCT02377427|11840220|FG000|NOT COMPLETED|Part A (Up to Week 20)||4
10677889|NCT02377427|11840221|FG001|NOT COMPLETED|Part A (Up to Week 20)||0
10677890|NCT02377427|11840222|FG002|NOT COMPLETED|Part A (Up to Week 20)||0
10677891|NCT02377427|11840223|FG003|NOT COMPLETED|Part A (Up to Week 20)||0
10677892|NCT02377427|11840224|FG004|NOT COMPLETED|Part A (Up to Week 20)||0
10677893|NCT02377427|11840220|FG000|STARTED|Part B (From Week 20 and up to Week 80)||0
10677894|NCT02377427|11840221|FG001|STARTED|Part B (From Week 20 and up to Week 80)||0
10677895|NCT02377427|11840222|FG002|STARTED|Part B (From Week 20 and up to Week 80)|Two participants of PartA chose not to continue in PartB;4 shifted to PartB Mepolizumab 40/100mg arm|16
10677896|NCT02377427|11840223|FG003|STARTED|Part B (From Week 20 and up to Week 80)||10
10677897|NCT02377427|11840224|FG004|STARTED|Part B (From Week 20 and up to Week 80)||4
10677898|NCT02377427|11840220|FG000|COMPLETED|Part B (From Week 20 and up to Week 80)||0
10677899|NCT02377427|11840221|FG001|COMPLETED|Part B (From Week 20 and up to Week 80)||0
10677900|NCT02377427|11840222|FG002|COMPLETED|Part B (From Week 20 and up to Week 80)||15
10677901|NCT02377427|11840223|FG003|COMPLETED|Part B (From Week 20 and up to Week 80)||10
10677902|NCT02377427|11840224|FG004|COMPLETED|Part B (From Week 20 and up to Week 80)||4
10677903|NCT02377427|11840220|FG000|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
10677904|NCT02377427|11840221|FG001|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
10677905|NCT02377427|11840222|FG002|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||1
10677906|NCT02377427|11840223|FG003|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
10677907|NCT02377427|11840224|FG004|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
10677908|NCT02377466|11840239|FG000|STARTED|Overall Study||13
10677909|NCT02377466|11840240|FG001|STARTED|Overall Study||12
10677910|NCT02377466|11840239|FG000|Treated|Overall Study||13
10677911|NCT02377466|11840240|FG001|Treated|Overall Study||10
10677912|NCT02377466|11840239|FG000|COMPLETED|Overall Study||13
10677913|NCT02377466|11840240|FG001|COMPLETED|Overall Study||10
10677914|NCT02377466|11840239|FG000|NOT COMPLETED|Overall Study||0
10677915|NCT02377466|11840240|FG001|NOT COMPLETED|Overall Study||2
10677916|NCT02377674|11840253|FG000|STARTED|Overall Study||5
10677917|NCT02377674|11840253|FG000|COMPLETED|Overall Study||5
10677918|NCT02377674|11840253|FG000|NOT COMPLETED|Overall Study||0
10677919|NCT02377700|11840257|FG000|STARTED|Overall Study||5
10677920|NCT02377700|11840257|FG000|COMPLETED|Overall Study||5
10677921|NCT02377700|11840257|FG000|NOT COMPLETED|Overall Study||0
10677922|NCT02377752|11840265|FG000|STARTED|Overall Study||7
10677923|NCT02377752|11840266|FG001|STARTED|Overall Study||6
10677924|NCT02377752|11840267|FG002|STARTED|Overall Study||6
10677925|NCT02377752|11840268|FG003|STARTED|Overall Study||6
10677926|NCT02377752|11840265|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7
10677927|NCT02377752|11840266|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
10677928|NCT02377752|11840267|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
10677929|NCT02377752|11840268|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
10677930|NCT02377752|11840265|FG000|COMPLETED|Overall Study||7
10677931|NCT02377752|11840266|FG001|COMPLETED|Overall Study||6
10677932|NCT02377752|11840267|FG002|COMPLETED|Overall Study||6
10677933|NCT02377752|11840268|FG003|COMPLETED|Overall Study||6
10677934|NCT02377752|11840265|FG000|NOT COMPLETED|Overall Study||0
10677935|NCT02377752|11840266|FG001|NOT COMPLETED|Overall Study||0
10798763|NCT03799289|11959273|FG001|COMPLETED|Maintenance Intervention (Weeks 13-24)||27
10798764|NCT03799289|11959272|FG000|NOT COMPLETED|Maintenance Intervention (Weeks 13-24)||0
10798765|NCT03799289|11959273|FG001|NOT COMPLETED|Maintenance Intervention (Weeks 13-24)||0
10798766|NCT03801408|11959279|FG000|STARTED|Overall Study||145
10798767|NCT03801408|11959279|FG000|COMPLETED|Overall Study||145
10798768|NCT03801408|11959279|FG000|NOT COMPLETED|Overall Study||0
10677936|NCT02377752|11840267|FG002|NOT COMPLETED|Overall Study||0
10677937|NCT02377752|11840268|FG003|NOT COMPLETED|Overall Study||0
10677938|NCT02377817|11840283|FG000|STARTED|Overall Study||13
10677939|NCT02377817|11840284|FG001|STARTED|Overall Study||10
10677940|NCT02377817|11840283|FG000|COMPLETED|Overall Study||10
10677941|NCT02377817|11840284|FG001|COMPLETED|Overall Study||10
10677942|NCT02377817|11840283|FG000|NOT COMPLETED|Overall Study||3
10677943|NCT02377817|11840284|FG001|NOT COMPLETED|Overall Study||0
10677944|NCT02377921|11840294|FG000|STARTED|Overall Study||45
10677945|NCT02377921|11840295|FG001|STARTED|Overall Study||44
10677946|NCT02377921|11840294|FG000|COMPLETED|Overall Study||44
10677947|NCT02377921|11840295|FG001|COMPLETED|Overall Study||43
10798769|NCT03805438|11959283|FG000|STARTED|Overall Study||47
10798770|NCT03805438|11959283|FG000|COMPLETED|Overall Study||45
10798771|NCT03805438|11959283|FG000|NOT COMPLETED|Overall Study||2
10798772|NCT03808948|11959287|FG000|STARTED|Overall Study||50
10798773|NCT03808948|11959287|FG000|COMPLETED|Overall Study||50
10677948|NCT02377921|11840294|FG000|NOT COMPLETED|Overall Study||1
10677949|NCT02377921|11840295|FG001|NOT COMPLETED|Overall Study||1
10677950|NCT02377947|11840301|FG000|STARTED|Overall Study||50
10677951|NCT02377947|11840301|FG000|COMPLETED|Overall Study||50
10677952|NCT02377947|11840301|FG000|NOT COMPLETED|Overall Study||0
10677953|NCT02377986|11840305|FG000|STARTED|Overall Study||5
10677954|NCT02377986|11840305|FG000|COMPLETED|Overall Study||5
10677955|NCT02377986|11840305|FG000|NOT COMPLETED|Overall Study||0
10677956|NCT02378025|11840311|FG000|STARTED|Overall Study||39
10798774|NCT03808948|11959287|FG000|NOT COMPLETED|Overall Study||0
10798775|NCT03810053|11959291|FG000|STARTED|Overall Study||290
10677957|NCT02378025|11840312|FG001|STARTED|Overall Study||36
10677958|NCT02378025|11840311|FG000|COMPLETED|Overall Study||26
10677959|NCT02378025|11840312|FG001|COMPLETED|Overall Study||15
10677960|NCT02378025|11840311|FG000|NOT COMPLETED|Overall Study||13
10677961|NCT02378025|11840312|FG001|NOT COMPLETED|Overall Study||21
10677962|NCT02378038|11840318|FG000|STARTED|Overall Study||5
10677963|NCT02378038|11840318|FG000|COMPLETED|Overall Study||0
10677964|NCT02378038|11840318|FG000|NOT COMPLETED|Overall Study||5
10677965|NCT02378207|11840326|FG000|STARTED|Overall Study||24
10677966|NCT02378207|11840327|FG001|STARTED|Overall Study||24
10677967|NCT02378207|11840328|FG002|STARTED|Overall Study||24
10677968|NCT02378207|11840329|FG003|STARTED|Overall Study||12
10677969|NCT02378207|11840326|FG000|COMPLETED|Overall Study||24
10677970|NCT02378207|11840327|FG001|COMPLETED|Overall Study||21
10677971|NCT02378207|11840328|FG002|COMPLETED|Overall Study||22
10677972|NCT02378207|11840329|FG003|COMPLETED|Overall Study||11
10677973|NCT02378207|11840326|FG000|NOT COMPLETED|Overall Study||0
10677974|NCT02378207|11840327|FG001|NOT COMPLETED|Overall Study||3
10677975|NCT02378207|11840328|FG002|NOT COMPLETED|Overall Study||2
10677976|NCT02378207|11840329|FG003|NOT COMPLETED|Overall Study||1
10677977|NCT02378220|11840341|FG000|STARTED|Overall Study||53
10677978|NCT02378220|11840342|FG001|STARTED|Overall Study||57
10677979|NCT02378220|11840341|FG000|COMPLETED|Overall Study||47
10677980|NCT02378220|11840342|FG001|COMPLETED|Overall Study||56
10677981|NCT02378220|11840341|FG000|NOT COMPLETED|Overall Study||6
10677982|NCT02378220|11840342|FG001|NOT COMPLETED|Overall Study||1
10677983|NCT02378402|11840352|FG000|STARTED|Overall Study||25
10677984|NCT02378402|11840353|FG001|STARTED|Overall Study||25
10677985|NCT02378402|11840354|FG002|STARTED|Overall Study||21
10677986|NCT02378402|11840352|FG000|COMPLETED|Overall Study||25
10677987|NCT02378402|11840353|FG001|COMPLETED|Overall Study||23
10677988|NCT02378402|11840354|FG002|COMPLETED|Overall Study||21
10677989|NCT02378402|11840352|FG000|NOT COMPLETED|Overall Study||0
10677990|NCT02378402|11840353|FG001|NOT COMPLETED|Overall Study||2
10677991|NCT02378402|11840354|FG002|NOT COMPLETED|Overall Study||0
10677992|NCT02378480|11840364|FG000|STARTED|Overall Study||329
10677993|NCT02378480|11840365|FG001|STARTED|Overall Study||326
10677994|NCT02378480|11840364|FG000|COMPLETED|Overall Study||301
10677995|NCT02378480|11840365|FG001|COMPLETED|Overall Study||294
10677996|NCT02378480|11840364|FG000|NOT COMPLETED|Overall Study||28
10677997|NCT02378480|11840365|FG001|NOT COMPLETED|Overall Study||32
10677998|NCT02378506|11840371|FG000|STARTED|Overall Study||188
10677999|NCT02378506|11840371|FG000|Treated|Overall Study||187
10678000|NCT02378506|11840371|FG000|COMPLETED|Overall Study||163
10678001|NCT02378506|11840371|FG000|NOT COMPLETED|Overall Study||25
10678002|NCT02378662|11840377|FG000|STARTED|Overall Study||2
10678003|NCT02378662|11840378|FG001|STARTED|Overall Study||0
10678004|NCT02378662|11840377|FG000|Harvesting|Overall Study||2
10678005|NCT02378662|11840378|FG001|Harvesting|Overall Study||0
10678006|NCT02378662|11840377|FG000|Implantation|Overall Study||2
10678007|NCT02378662|11840378|FG001|Implantation|Overall Study||0
10678008|NCT02378662|11840377|FG000|COMPLETED|Overall Study||0
10678009|NCT02378662|11840378|FG001|COMPLETED|Overall Study||0
10678010|NCT02378662|11840377|FG000|NOT COMPLETED|Overall Study||2
10678011|NCT02378662|11840378|FG001|NOT COMPLETED|Overall Study||0
10678012|NCT02378714|11840388|FG000|STARTED|Overall Study||68
10678013|NCT02378714|11840389|FG001|STARTED|Overall Study||68
10678014|NCT02378714|11840390|FG002|STARTED|Overall Study||81
10678015|NCT02378714|11840391|FG003|STARTED|Overall Study||83
10678016|NCT02378714|11840388|FG000|COMPLETED|Overall Study||39
10678017|NCT02378714|11840389|FG001|COMPLETED|Overall Study||29
10678018|NCT02378714|11840390|FG002|COMPLETED|Overall Study||51
10678019|NCT02378714|11840391|FG003|COMPLETED|Overall Study||51
10678020|NCT02378714|11840388|FG000|NOT COMPLETED|Overall Study||29
10678021|NCT02378714|11840389|FG001|NOT COMPLETED|Overall Study||39
10678022|NCT02378714|11840390|FG002|NOT COMPLETED|Overall Study||30
10678023|NCT02378714|11840391|FG003|NOT COMPLETED|Overall Study||32
10678024|NCT02378753|11840425|FG000|STARTED|Overall Study||4319
10678025|NCT02378753|11840426|FG001|STARTED|Overall Study||4332
10678026|NCT02378753|11840425|FG000|COMPLETED|Overall Study||4101
10678027|NCT02378753|11840426|FG001|COMPLETED|Overall Study||3637
10678028|NCT02378753|11840425|FG000|NOT COMPLETED|Overall Study||218
10678029|NCT02378753|11840426|FG001|NOT COMPLETED|Overall Study||695
10678030|NCT02378844|11840434|FG000|STARTED|Run-in Period||169
10678031|NCT02378844|11840435|FG001|STARTED|Run-in Period||172
10678032|NCT02378844|11840436|FG002|STARTED|Run-in Period||136
10678033|NCT02378844|11840434|FG000|COMPLETED|Run-in Period||165
10678034|NCT02378844|11840435|FG001|COMPLETED|Run-in Period||167
10678035|NCT02378844|11840436|FG002|COMPLETED|Run-in Period||0
10678036|NCT02378844|11840434|FG000|NOT COMPLETED|Run-in Period||4
10678037|NCT02378844|11840435|FG001|NOT COMPLETED|Run-in Period||5
10678038|NCT02378844|11840436|FG002|NOT COMPLETED|Run-in Period||136
10678039|NCT02378844|11840434|FG000|STARTED|Randomized Period (Double Blind)||165
10678040|NCT02378844|11840435|FG001|STARTED|Randomized Period (Double Blind)||167
10678041|NCT02378844|11840436|FG002|STARTED|Randomized Period (Double Blind)||0
10678042|NCT02378844|11840434|FG000|COMPLETED|Randomized Period (Double Blind)||142
10678043|NCT02378844|11840435|FG001|COMPLETED|Randomized Period (Double Blind)||135
10678044|NCT02378844|11840436|FG002|COMPLETED|Randomized Period (Double Blind)||0
10678045|NCT02378844|11840434|FG000|NOT COMPLETED|Randomized Period (Double Blind)||23
10678046|NCT02378844|11840435|FG001|NOT COMPLETED|Randomized Period (Double Blind)||32
10678047|NCT02378844|11840436|FG002|NOT COMPLETED|Randomized Period (Double Blind)||0
10678048|NCT02378844|11840434|FG000|STARTED|Open Label Period||142
10678049|NCT02378844|11840435|FG001|STARTED|Open Label Period||135
10678050|NCT02378844|11840436|FG002|STARTED|Open Label Period||0
10678051|NCT02378844|11840434|FG000|COMPLETED|Open Label Period||99
10678052|NCT02378844|11840435|FG001|COMPLETED|Open Label Period||87
10678053|NCT02378844|11840436|FG002|COMPLETED|Open Label Period||0
10678054|NCT02378844|11840434|FG000|NOT COMPLETED|Open Label Period||43
10678055|NCT02378844|11840435|FG001|NOT COMPLETED|Open Label Period||48
10678056|NCT02378844|11840436|FG002|NOT COMPLETED|Open Label Period||0
10678057|NCT02378883|11840446|FG000|STARTED|Enrollment|Participants consented and assessed for eligibility|121
10678058|NCT02378883|11840446|FG000|COMPLETED|Enrollment|Attempted with study device - intent to treat population|112
10678059|NCT02378883|11840446|FG000|NOT COMPLETED|Enrollment||9
10678060|NCT02378883|11840446|FG000|STARTED|Discharge||112
10678061|NCT02378883|11840446|FG000|COMPLETED|Discharge||112
10678062|NCT02378883|11840446|FG000|NOT COMPLETED|Discharge||0
10678063|NCT02378883|11840446|FG000|STARTED|30 Day Follow-Up||112
10678064|NCT02378883|11840446|FG000|COMPLETED|30 Day Follow-Up||106
10678065|NCT02378883|11840446|FG000|NOT COMPLETED|30 Day Follow-Up||6
10678066|NCT02378883|11840446|FG000|STARTED|12 Months Follow-Up|Two deaths occurred between 30 day FU and prior to 12 month FU.|46
10678067|NCT02378883|11840446|FG000|COMPLETED|12 Months Follow-Up||41
10678068|NCT02378883|11840446|FG000|NOT COMPLETED|12 Months Follow-Up||5
10678069|NCT02378935|11840458|FG000|STARTED|Overall Study||34
10678070|NCT02378935|11840459|FG001|STARTED|Overall Study||36
10678071|NCT02378935|11840460|FG002|STARTED|Overall Study||33
10678072|NCT02378935|11840461|FG003|STARTED|Overall Study||31
10678073|NCT02378935|11840462|FG004|STARTED|Overall Study||31
10678074|NCT02378935|11840463|FG005|STARTED|Overall Study||32
10798776|NCT03810053|11959291|FG000|COMPLETED|Overall Study||290
10798777|NCT03810053|11959291|FG000|NOT COMPLETED|Overall Study||0
10798778|NCT03817528|11959295|FG000|STARTED|Overall Study||4
10798779|NCT03817528|11959295|FG000|COMPLETED|Overall Study||1
10798780|NCT03817528|11959295|FG000|NOT COMPLETED|Overall Study||3
10678075|NCT02378935|11840464|FG006|STARTED|Overall Study||8
10678076|NCT02378935|11840458|FG000|COMPLETED|Overall Study||24
10678077|NCT02378935|11840459|FG001|COMPLETED|Overall Study||36
10678078|NCT02378935|11840460|FG002|COMPLETED|Overall Study||30
10678079|NCT02378935|11840461|FG003|COMPLETED|Overall Study||25
10678080|NCT02378935|11840462|FG004|COMPLETED|Overall Study||31
10678081|NCT02378935|11840463|FG005|COMPLETED|Overall Study||32
10678082|NCT02378935|11840464|FG006|COMPLETED|Overall Study||8
10678083|NCT02378935|11840458|FG000|NOT COMPLETED|Overall Study||10
10678084|NCT02378935|11840459|FG001|NOT COMPLETED|Overall Study||0
10678085|NCT02378935|11840460|FG002|NOT COMPLETED|Overall Study||3
10678086|NCT02378935|11840461|FG003|NOT COMPLETED|Overall Study||6
10678087|NCT02378935|11840462|FG004|NOT COMPLETED|Overall Study||0
10678088|NCT02378935|11840463|FG005|NOT COMPLETED|Overall Study||0
10678089|NCT02378935|11840464|FG006|NOT COMPLETED|Overall Study||0
10678090|NCT02378961|11840484|FG000|STARTED|Overall Study||33
10678091|NCT02378961|11840485|FG001|STARTED|Overall Study||30
10678092|NCT02378961|11840486|FG002|STARTED|Overall Study||36
10678093|NCT02378961|11840487|FG003|STARTED|Overall Study||29
10678094|NCT02378961|11840484|FG000|COMPLETED|Overall Study||29
10678095|NCT02378961|11840485|FG001|COMPLETED|Overall Study||28
10678096|NCT02378961|11840486|FG002|COMPLETED|Overall Study||35
10678097|NCT02378961|11840487|FG003|COMPLETED|Overall Study||28
10678098|NCT02378961|11840484|FG000|NOT COMPLETED|Overall Study||4
10678099|NCT02378961|11840485|FG001|NOT COMPLETED|Overall Study||2
10678100|NCT02378961|11840486|FG002|NOT COMPLETED|Overall Study||1
10678101|NCT02378961|11840487|FG003|NOT COMPLETED|Overall Study||1
10678102|NCT02379052|11840499|FG000|STARTED|Overall Study||24
10678103|NCT02379052|11840500|FG001|STARTED|Overall Study||23
10678104|NCT02379052|11840499|FG000|COMPLETED|Overall Study||18
10678105|NCT02379052|11840500|FG001|COMPLETED|Overall Study||18
10678106|NCT02379052|11840499|FG000|NOT COMPLETED|Overall Study||6
10678107|NCT02379052|11840500|FG001|NOT COMPLETED|Overall Study||5
10678108|NCT02379078|11840508|FG000|STARTED|Overall Study||111
10678109|NCT02379078|11840509|FG001|STARTED|Overall Study||114
10678110|NCT02379078|11840508|FG000|COMPLETED|Overall Study||72
10678111|NCT02379078|11840509|FG001|COMPLETED|Overall Study||79
10678112|NCT02379078|11840508|FG000|NOT COMPLETED|Overall Study||39
10678113|NCT02379078|11840509|FG001|NOT COMPLETED|Overall Study||35
10678114|NCT02379091|11840519|FG000|STARTED|Overall Study||27
10678115|NCT02379091|11840520|FG001|STARTED|Overall Study||28
10678116|NCT02379091|11840521|FG002|STARTED|Overall Study||25
10678117|NCT02379091|11840522|FG003|STARTED|Overall Study||28
10678118|NCT02379091|11840519|FG000|Full Analysis Set|Overall Study|One participant was excluded because of data collection issues.|26
10678119|NCT02379091|11840520|FG001|Full Analysis Set|Overall Study||28
10678120|NCT02379091|11840521|FG002|Full Analysis Set|Overall Study|One participant was excluded because of data collection issues.|24
10678121|NCT02379091|11840522|FG003|Full Analysis Set|Overall Study||28
10678122|NCT02379091|11840519|FG000|COMPLETED|Overall Study||15
10678123|NCT02379091|11840520|FG001|COMPLETED|Overall Study||18
10678124|NCT02379091|11840521|FG002|COMPLETED|Overall Study||18
10678125|NCT02379091|11840522|FG003|COMPLETED|Overall Study||14
10678126|NCT02379091|11840519|FG000|NOT COMPLETED|Overall Study||12
10678127|NCT02379091|11840520|FG001|NOT COMPLETED|Overall Study||10
10678128|NCT02379091|11840521|FG002|NOT COMPLETED|Overall Study||7
10678129|NCT02379091|11840522|FG003|NOT COMPLETED|Overall Study||14
10678130|NCT02379117|11840536|FG000|STARTED|Overall Study||30
10678131|NCT02379117|11840537|FG001|STARTED|Overall Study||31
10798781|NCT03817580|11959302|FG000|STARTED|Overall Study||57
10798782|NCT03817580|11959303|FG001|STARTED|Overall Study||56
10678132|NCT02379117|11840536|FG000|COMPLETED|Overall Study||30
10678133|NCT02379117|11840537|FG001|COMPLETED|Overall Study||31
10678134|NCT02379117|11840536|FG000|NOT COMPLETED|Overall Study||0
10678135|NCT02379117|11840537|FG001|NOT COMPLETED|Overall Study||0
10678136|NCT02379195|11840543|FG000|STARTED|Overall Study||12
10678137|NCT02379195|11840543|FG000|COMPLETED|Overall Study||12
10678138|NCT02379195|11840543|FG000|NOT COMPLETED|Overall Study||0
10678139|NCT02379221|11840547|FG000|STARTED|Overall Study||49
10678140|NCT02379221|11840547|FG000|COMPLETED|Overall Study||48
10678141|NCT02379221|11840547|FG000|NOT COMPLETED|Overall Study||1
10678142|NCT02379273|11840556|FG000|STARTED|Overall Study||35
10678143|NCT02379273|11840556|FG000|COMPLETED|Overall Study|Completed 5 years postactivation.|35
10678144|NCT02379273|11840556|FG000|NOT COMPLETED|Overall Study||0
10678145|NCT02379442|11840560|FG000|STARTED|Overall Study||1
10678146|NCT02379442|11840560|FG000|COMPLETED|Overall Study||1
10678147|NCT02379442|11840560|FG000|NOT COMPLETED|Overall Study||0
10678148|NCT02379637|11840566|FG000|STARTED|Overall Study||35
10678149|NCT02379637|11840567|FG001|STARTED|Overall Study||35
10678150|NCT02379637|11840566|FG000|COMPLETED|Overall Study||33
10678151|NCT02379637|11840567|FG001|COMPLETED|Overall Study||34
10678152|NCT02379637|11840566|FG000|NOT COMPLETED|Overall Study||2
10678153|NCT02379637|11840567|FG001|NOT COMPLETED|Overall Study||1
10678154|NCT02379728|11840575|FG000|STARTED|Overall Study||84
10678155|NCT02379728|11840576|FG001|STARTED|Overall Study||16
10678156|NCT02379728|11840577|FG002|STARTED|Overall Study||84
10678157|NCT02379728|11840578|FG003|STARTED|Overall Study||16
10678158|NCT02379728|11840575|FG000|COMPLETED|Overall Study||78
10678159|NCT02379728|11840576|FG001|COMPLETED|Overall Study||16
10678160|NCT02379728|11840577|FG002|COMPLETED|Overall Study||74
10678161|NCT02379728|11840578|FG003|COMPLETED|Overall Study||13
10678162|NCT02379728|11840575|FG000|NOT COMPLETED|Overall Study||6
10678163|NCT02379728|11840576|FG001|NOT COMPLETED|Overall Study||0
10678164|NCT02379728|11840577|FG002|NOT COMPLETED|Overall Study||10
10678165|NCT02379728|11840578|FG003|NOT COMPLETED|Overall Study||3
10678166|NCT02379858|11840589|FG000|STARTED|Overall Study||6
10678167|NCT02379858|11840590|FG001|STARTED|Overall Study||4
10678168|NCT02379858|11840589|FG000|COMPLETED|Overall Study||6
10678169|NCT02379858|11840590|FG001|COMPLETED|Overall Study||4
10678170|NCT02379858|11840589|FG000|NOT COMPLETED|Overall Study||0
10678171|NCT02379858|11840590|FG001|NOT COMPLETED|Overall Study||0
10678172|NCT02379923|11840596|FG000|STARTED|Overall Study||163
10678173|NCT02379923|11840596|FG000|COMPLETED|Overall Study||158
10678174|NCT02379923|11840596|FG000|NOT COMPLETED|Overall Study||5
10678175|NCT02380183|11840605|FG000|STARTED|Overall Study||36
10678176|NCT02380183|11840606|FG001|STARTED|Overall Study||34
10678177|NCT02380183|11840605|FG000|COMPLETED|Overall Study||36
10678178|NCT02380183|11840606|FG001|COMPLETED|Overall Study||34
10678179|NCT02380183|11840605|FG000|NOT COMPLETED|Overall Study||0
10678180|NCT02380183|11840606|FG001|NOT COMPLETED|Overall Study||0
10678181|NCT02380248|11840612|FG000|STARTED|Overall Study||200
10678182|NCT02380248|11840612|FG000|COMPLETED|Overall Study||186
10678183|NCT02380248|11840612|FG000|NOT COMPLETED|Overall Study||14
10712706|NCT02672553|11878270|FG000|Intent To Treated (ITT) Randomized Arm|Overall Study|Two (2) subjects randomized to Edwards INTUITY were intraoperative screen failures|49
10712707|NCT02672553|11878271|FG001|Intent To Treated (ITT) Randomized Arm|Overall Study|One (1) subject randomized to Control arm/group withdrew prior to study procedure|48
10712708|NCT02672553|11878270|FG000|As Treated (AT) Randomized Arm/Group|Overall Study||46
10712709|NCT02672553|11878271|FG001|As Treated (AT) Randomized Arm/Group|Overall Study||51
10712710|NCT02672553|11878270|FG000|As Intended (AI) Randomized Arm/Group|Overall Study||46
10712711|NCT02672553|11878271|FG001|As Intended (AI) Randomized Arm/Group|Overall Study||48
10712712|NCT02672553|11878270|FG000|COMPLETED|Overall Study||39
10712713|NCT02672553|11878271|FG001|COMPLETED|Overall Study||41
10712714|NCT02672553|11878270|FG000|NOT COMPLETED|Overall Study||12
10712715|NCT02672553|11878271|FG001|NOT COMPLETED|Overall Study||8
10712716|NCT02672852|11878280|FG000|STARTED|Part A1||100
10712717|NCT02672852|11878281|FG001|STARTED|Part A1||407
10712718|NCT02672852|11878282|FG002|STARTED|Part A1||0
10712719|NCT02672852|11878283|FG003|STARTED|Part A1||0
10712720|NCT02672852|11878284|FG004|STARTED|Part A1||0
10712721|NCT02672852|11878285|FG005|STARTED|Part A1||0
10712722|NCT02672852|11878286|FG006|STARTED|Part A1||0
10712723|NCT02672852|11878280|FG000|COMPLETED|Part A1||97
10712724|NCT02672852|11878281|FG001|COMPLETED|Part A1||403
10712725|NCT02672852|11878282|FG002|COMPLETED|Part A1||0
10712726|NCT02672852|11878283|FG003|COMPLETED|Part A1||0
10712727|NCT02672852|11878284|FG004|COMPLETED|Part A1||0
10712728|NCT02672852|11878285|FG005|COMPLETED|Part A1||0
10712729|NCT02672852|11878286|FG006|COMPLETED|Part A1||0
10712730|NCT02672852|11878280|FG000|NOT COMPLETED|Part A1||3
10712731|NCT02672852|11878281|FG001|NOT COMPLETED|Part A1||4
10712732|NCT02672852|11878282|FG002|NOT COMPLETED|Part A1||0
10712733|NCT02672852|11878283|FG003|NOT COMPLETED|Part A1||0
10712734|NCT02672852|11878284|FG004|NOT COMPLETED|Part A1||0
10712735|NCT02672852|11878285|FG005|NOT COMPLETED|Part A1||0
10712736|NCT02672852|11878286|FG006|NOT COMPLETED|Part A1||0
10712737|NCT02672852|11878280|FG000|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|0
10712738|NCT02672852|11878281|FG001|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|0
10712739|NCT02672852|11878282|FG002|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|93
10712740|NCT02672852|11878283|FG003|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|403
10712741|NCT02672852|11878284|FG004|STARTED|Part A2||0
10712742|NCT02672852|11878285|FG005|STARTED|Part A2||0
10678184|NCT02380261|11840617|FG000|STARTED|Overall Study||35
10678185|NCT02380261|11840617|FG000|COMPLETED|Overall Study||35
10678186|NCT02380261|11840617|FG000|NOT COMPLETED|Overall Study||0
10678187|NCT02380287|11840629|FG000|STARTED|Overall Study||1
10678188|NCT02380287|11840630|FG001|STARTED|Overall Study||3
10678189|NCT02380287|11840631|FG002|STARTED|Overall Study||3
10678190|NCT02380287|11840632|FG003|STARTED|Overall Study||3
10678191|NCT02380287|11840633|FG004|STARTED|Overall Study||3
10678192|NCT02380287|11840634|FG005|STARTED|Overall Study||3
10678193|NCT02380287|11840635|FG006|STARTED|Overall Study||3
10678194|NCT02380287|11840636|FG007|STARTED|Overall Study||3
10678195|NCT02380287|11840629|FG000|COMPLETED|Overall Study||1
10678196|NCT02380287|11840630|FG001|COMPLETED|Overall Study||3
10678197|NCT02380287|11840631|FG002|COMPLETED|Overall Study||2
10678198|NCT02380287|11840632|FG003|COMPLETED|Overall Study||3
10678199|NCT02380287|11840633|FG004|COMPLETED|Overall Study||3
10678200|NCT02380287|11840634|FG005|COMPLETED|Overall Study||3
10678201|NCT02380287|11840635|FG006|COMPLETED|Overall Study||3
10678202|NCT02380287|11840636|FG007|COMPLETED|Overall Study||3
10678203|NCT02380287|11840629|FG000|NOT COMPLETED|Overall Study||0
10678204|NCT02380287|11840630|FG001|NOT COMPLETED|Overall Study||0
10678205|NCT02380287|11840631|FG002|NOT COMPLETED|Overall Study||1
10678206|NCT02380287|11840632|FG003|NOT COMPLETED|Overall Study||0
10678207|NCT02380287|11840633|FG004|NOT COMPLETED|Overall Study||0
10678208|NCT02380287|11840634|FG005|NOT COMPLETED|Overall Study||0
10678209|NCT02380287|11840635|FG006|NOT COMPLETED|Overall Study||0
10678210|NCT02380287|11840636|FG007|NOT COMPLETED|Overall Study||0
10678211|NCT02380612|11840661|FG000|STARTED|Overall Study||30
10678212|NCT02380612|11840661|FG000|COMPLETED|Overall Study||27
10678213|NCT02380612|11840661|FG000|NOT COMPLETED|Overall Study||3
10678214|NCT02380677|11840680|FG000|STARTED|Overall Study||1
10678215|NCT02380677|11840681|FG001|STARTED|Overall Study||1
10678216|NCT02380677|11840682|FG002|STARTED|Overall Study||3
10678217|NCT02380677|11840683|FG003|STARTED|Overall Study||3
10678218|NCT02380677|11840684|FG004|STARTED|Overall Study||6
10678219|NCT02380677|11840685|FG005|STARTED|Overall Study||6
10678220|NCT02380677|11840686|FG006|STARTED|Overall Study||3
10678221|NCT02380677|11840687|FG007|STARTED|Overall Study||4
10678222|NCT02380677|11840688|FG008|STARTED|Overall Study||4
10678223|NCT02380677|11840689|FG009|STARTED|Overall Study||2
10678224|NCT02380677|11840690|FG010|STARTED|Overall Study||4
10678225|NCT02380677|11840691|FG011|STARTED|Overall Study||5
10678226|NCT02380677|11840680|FG000|COMPLETED|Overall Study||0
10678227|NCT02380677|11840681|FG001|COMPLETED|Overall Study||0
10678228|NCT02380677|11840682|FG002|COMPLETED|Overall Study||0
10678229|NCT02380677|11840683|FG003|COMPLETED|Overall Study||0
10678230|NCT02380677|11840684|FG004|COMPLETED|Overall Study||0
10678231|NCT02380677|11840685|FG005|COMPLETED|Overall Study||0
10678232|NCT02380677|11840686|FG006|COMPLETED|Overall Study||0
10678233|NCT02380677|11840687|FG007|COMPLETED|Overall Study||0
10678234|NCT02380677|11840688|FG008|COMPLETED|Overall Study||0
10678235|NCT02380677|11840689|FG009|COMPLETED|Overall Study||0
10678236|NCT02380677|11840690|FG010|COMPLETED|Overall Study||0
10678237|NCT02380677|11840691|FG011|COMPLETED|Overall Study||0
10678238|NCT02380677|11840680|FG000|NOT COMPLETED|Overall Study||1
10678239|NCT02380677|11840681|FG001|NOT COMPLETED|Overall Study||1
10678240|NCT02380677|11840682|FG002|NOT COMPLETED|Overall Study||3
10678241|NCT02380677|11840683|FG003|NOT COMPLETED|Overall Study||3
10678242|NCT02380677|11840684|FG004|NOT COMPLETED|Overall Study||6
10678243|NCT02380677|11840685|FG005|NOT COMPLETED|Overall Study||6
10678244|NCT02380677|11840686|FG006|NOT COMPLETED|Overall Study||3
10678245|NCT02380677|11840687|FG007|NOT COMPLETED|Overall Study||4
10678246|NCT02380677|11840688|FG008|NOT COMPLETED|Overall Study||4
10678247|NCT02380677|11840689|FG009|NOT COMPLETED|Overall Study||2
10678248|NCT02380677|11840690|FG010|NOT COMPLETED|Overall Study||4
10678249|NCT02380677|11840691|FG011|NOT COMPLETED|Overall Study||5
10678250|NCT02380690|11840721|FG000|STARTED|Overall Study||119
10678251|NCT02380690|11840722|FG001|STARTED|Overall Study||94
10678252|NCT02380690|11840721|FG000|COMPLETED|Overall Study||85
10678253|NCT02380690|11840722|FG001|COMPLETED|Overall Study||82
10678254|NCT02380690|11840721|FG000|NOT COMPLETED|Overall Study||34
10678255|NCT02380690|11840722|FG001|NOT COMPLETED|Overall Study||12
10678256|NCT02380703|11840730|FG000|STARTED|Overall Study||114
10678257|NCT02380703|11840731|FG001|STARTED|Overall Study||114
10678258|NCT02380703|11840730|FG000|Month 3|Overall Study||104
10678259|NCT02380703|11840731|FG001|Month 3|Overall Study||109
10678260|NCT02380703|11840730|FG000|Month 6|Overall Study||102
10678261|NCT02380703|11840731|FG001|Month 6|Overall Study||107
10678262|NCT02380703|11840730|FG000|Month 12|Overall Study||99
10678263|NCT02380703|11840731|FG001|Month 12|Overall Study||100
10678264|NCT02380703|11840730|FG000|COMPLETED|Overall Study||78
10678265|NCT02380703|11840731|FG001|COMPLETED|Overall Study||78
10678266|NCT02380703|11840730|FG000|NOT COMPLETED|Overall Study||36
10678267|NCT02380703|11840731|FG001|NOT COMPLETED|Overall Study||36
10678268|NCT02380742|11840739|FG000|STARTED|Overall Study||28
10678269|NCT02380742|11840740|FG001|STARTED|Overall Study||26
10678270|NCT02380742|11840739|FG000|COMPLETED|Overall Study||27
10678271|NCT02380742|11840740|FG001|COMPLETED|Overall Study||26
10678272|NCT02380742|11840739|FG000|NOT COMPLETED|Overall Study||1
10678273|NCT02380742|11840740|FG001|NOT COMPLETED|Overall Study||0
10678274|NCT02380859|11840748|FG000|STARTED|Overall Study||19
10678275|NCT02380859|11840749|FG001|STARTED|Overall Study||13
10678276|NCT02380859|11840748|FG000|COMPLETED|Overall Study||17
10678277|NCT02380859|11840749|FG001|COMPLETED|Overall Study||13
10678278|NCT02380859|11840748|FG000|NOT COMPLETED|Overall Study||2
10678279|NCT02380859|11840749|FG001|NOT COMPLETED|Overall Study||0
10678280|NCT02381015|11840759|FG000|STARTED|Visit 1 - Enrollment||175
10678281|NCT02381015|11840760|FG001|STARTED|Visit 1 - Enrollment||175
10678282|NCT02381015|11840761|FG002|STARTED|Visit 1 - Enrollment||175
10678283|NCT02381015|11840762|FG003|STARTED|Visit 1 - Enrollment||175
10678284|NCT02381015|11840759|FG000|COMPLETED|Visit 1 - Enrollment||175
10678285|NCT02381015|11840760|FG001|COMPLETED|Visit 1 - Enrollment||173
10678286|NCT02381015|11840761|FG002|COMPLETED|Visit 1 - Enrollment||175
10678287|NCT02381015|11840762|FG003|COMPLETED|Visit 1 - Enrollment||172
10678288|NCT02381015|11840759|FG000|NOT COMPLETED|Visit 1 - Enrollment||0
10678289|NCT02381015|11840760|FG001|NOT COMPLETED|Visit 1 - Enrollment||2
10678290|NCT02381015|11840761|FG002|NOT COMPLETED|Visit 1 - Enrollment||0
10678291|NCT02381015|11840762|FG003|NOT COMPLETED|Visit 1 - Enrollment||3
10678292|NCT02381015|11840759|FG000|STARTED|Visit 2 - Results DIsclosure||175
10678293|NCT02381015|11840760|FG001|STARTED|Visit 2 - Results DIsclosure||173
10678294|NCT02381015|11840761|FG002|STARTED|Visit 2 - Results DIsclosure||175
10678295|NCT02381015|11840762|FG003|STARTED|Visit 2 - Results DIsclosure||172
10678296|NCT02381015|11840759|FG000|COMPLETED|Visit 2 - Results DIsclosure||172
10678297|NCT02381015|11840760|FG001|COMPLETED|Visit 2 - Results DIsclosure||168
10678298|NCT02381015|11840761|FG002|COMPLETED|Visit 2 - Results DIsclosure||173
10678299|NCT02381015|11840762|FG003|COMPLETED|Visit 2 - Results DIsclosure||169
10678300|NCT02381015|11840759|FG000|NOT COMPLETED|Visit 2 - Results DIsclosure||3
10678301|NCT02381015|11840760|FG001|NOT COMPLETED|Visit 2 - Results DIsclosure||5
10678302|NCT02381015|11840761|FG002|NOT COMPLETED|Visit 2 - Results DIsclosure||2
10678303|NCT02381015|11840762|FG003|NOT COMPLETED|Visit 2 - Results DIsclosure||3
10678304|NCT02381015|11840759|FG000|STARTED|Visit 3 - 3 Months Followup||172
10678305|NCT02381015|11840760|FG001|STARTED|Visit 3 - 3 Months Followup||168
10678306|NCT02381015|11840761|FG002|STARTED|Visit 3 - 3 Months Followup||173
10678307|NCT02381015|11840762|FG003|STARTED|Visit 3 - 3 Months Followup||169
10678308|NCT02381015|11840759|FG000|COMPLETED|Visit 3 - 3 Months Followup||172
10678309|NCT02381015|11840760|FG001|COMPLETED|Visit 3 - 3 Months Followup||168
10678310|NCT02381015|11840761|FG002|COMPLETED|Visit 3 - 3 Months Followup||173
10678311|NCT02381015|11840762|FG003|COMPLETED|Visit 3 - 3 Months Followup||169
10678312|NCT02381015|11840759|FG000|NOT COMPLETED|Visit 3 - 3 Months Followup||0
10678313|NCT02381015|11840760|FG001|NOT COMPLETED|Visit 3 - 3 Months Followup||0
10678314|NCT02381015|11840761|FG002|NOT COMPLETED|Visit 3 - 3 Months Followup||0
10678315|NCT02381015|11840762|FG003|NOT COMPLETED|Visit 3 - 3 Months Followup||0
10678316|NCT02381015|11840759|FG000|STARTED|Year 3 Chart Review||172
10678317|NCT02381015|11840760|FG001|STARTED|Year 3 Chart Review||168
10678318|NCT02381015|11840761|FG002|STARTED|Year 3 Chart Review||173
10678319|NCT02381015|11840762|FG003|STARTED|Year 3 Chart Review||169
10678320|NCT02381015|11840759|FG000|COMPLETED|Year 3 Chart Review||125
10678321|NCT02381015|11840760|FG001|COMPLETED|Year 3 Chart Review||134
10678322|NCT02381015|11840761|FG002|COMPLETED|Year 3 Chart Review||115
10678323|NCT02381015|11840762|FG003|COMPLETED|Year 3 Chart Review||118
10678324|NCT02381015|11840759|FG000|NOT COMPLETED|Year 3 Chart Review||47
10678325|NCT02381015|11840760|FG001|NOT COMPLETED|Year 3 Chart Review||34
10678326|NCT02381015|11840761|FG002|NOT COMPLETED|Year 3 Chart Review||58
10678327|NCT02381015|11840762|FG003|NOT COMPLETED|Year 3 Chart Review||51
10678328|NCT02381288|11840781|FG000|STARTED|Overall Study||5
10678329|NCT02381288|11840782|FG001|STARTED|Overall Study||2
10678330|NCT02381288|11840783|FG002|STARTED|Overall Study||5
10678331|NCT02381288|11840784|FG003|STARTED|Overall Study||5
10678332|NCT02381288|11840781|FG000|COMPLETED|Overall Study||5
10678333|NCT02381288|11840782|FG001|COMPLETED|Overall Study||2
10678334|NCT02381288|11840783|FG002|COMPLETED|Overall Study||5
10678335|NCT02381288|11840784|FG003|COMPLETED|Overall Study||5
10678336|NCT02381288|11840781|FG000|NOT COMPLETED|Overall Study||0
10678337|NCT02381288|11840782|FG001|NOT COMPLETED|Overall Study||0
10678338|NCT02381288|11840783|FG002|NOT COMPLETED|Overall Study||0
10678339|NCT02381288|11840784|FG003|NOT COMPLETED|Overall Study||0
10678340|NCT02381392|11840799|FG000|STARTED|Overall Study||11
10678341|NCT02381392|11840800|FG001|STARTED|Overall Study||12
10678342|NCT02381392|11840799|FG000|COMPLETED|Overall Study||11
10678343|NCT02381392|11840800|FG001|COMPLETED|Overall Study||12
10678344|NCT02381392|11840799|FG000|NOT COMPLETED|Overall Study||0
10678345|NCT02381392|11840800|FG001|NOT COMPLETED|Overall Study||0
10678346|NCT02381418|11840806|FG000|STARTED|Overall Study||120
10678347|NCT02381418|11840806|FG000|COMPLETED|Overall Study||120
10678348|NCT02381418|11840806|FG000|NOT COMPLETED|Overall Study||0
10678349|NCT02381678|11840811|FG000|STARTED|Overall Study||54
10678350|NCT02381678|11840812|FG001|STARTED|Overall Study||139
10678351|NCT02381678|11840813|FG002|STARTED|Overall Study||32
10678352|NCT02381678|11840811|FG000|COMPLETED|Overall Study||54
10678353|NCT02381678|11840812|FG001|COMPLETED|Overall Study||139
10678354|NCT02381678|11840813|FG002|COMPLETED|Overall Study||32
10678355|NCT02381678|11840811|FG000|NOT COMPLETED|Overall Study||0
10678356|NCT02381678|11840812|FG001|NOT COMPLETED|Overall Study||0
10678357|NCT02381678|11840813|FG002|NOT COMPLETED|Overall Study||0
10678358|NCT02381795|11840819|FG000|STARTED|Overall Study||10
10678359|NCT02381795|11840819|FG000|COMPLETED|Overall Study||7
10678360|NCT02381795|11840819|FG000|NOT COMPLETED|Overall Study||3
10678361|NCT02382016|11840825|FG000|STARTED|Double-blind (DB) Treatment Period||43
10678362|NCT02382016|11840826|FG001|STARTED|Double-blind (DB) Treatment Period||42
10678363|NCT02382016|11840825|FG000|COMPLETED|Double-blind (DB) Treatment Period||39
10678364|NCT02382016|11840826|FG001|COMPLETED|Double-blind (DB) Treatment Period||41
10678365|NCT02382016|11840825|FG000|NOT COMPLETED|Double-blind (DB) Treatment Period||4
10678366|NCT02382016|11840826|FG001|NOT COMPLETED|Double-blind (DB) Treatment Period||1
10678367|NCT02382016|11840825|FG000|STARTED|Open-label (OL) Treatment Period||80
10678368|NCT02382016|11840826|FG001|STARTED|Open-label (OL) Treatment Period||0
10678369|NCT02382016|11840825|FG000|COMPLETED|Open-label (OL) Treatment Period||71
10678370|NCT02382016|11840826|FG001|COMPLETED|Open-label (OL) Treatment Period||0
10678371|NCT02382016|11840825|FG000|NOT COMPLETED|Open-label (OL) Treatment Period||9
10678372|NCT02382016|11840826|FG001|NOT COMPLETED|Open-label (OL) Treatment Period||0
10678373|NCT02382016|11840825|FG000|STARTED|OL Extension Period|Participants(French site) who completed DB,OL periods, consented receiving macitentan in OLE period.|33
10678374|NCT02382016|11840826|FG001|STARTED|OL Extension Period||0
10678375|NCT02382016|11840825|FG000|COMPLETED|OL Extension Period||27
10678376|NCT02382016|11840826|FG001|COMPLETED|OL Extension Period||0
10678377|NCT02382016|11840825|FG000|NOT COMPLETED|OL Extension Period||6
10678378|NCT02382016|11840826|FG001|NOT COMPLETED|OL Extension Period||0
10798783|NCT03817580|11959304|FG002|STARTED|Overall Study||57
10678379|NCT02382133|11840834|FG000|STARTED|Overall Study||43
10678380|NCT02382133|11840834|FG000|COMPLETED|Overall Study||10
10678381|NCT02382133|11840834|FG000|NOT COMPLETED|Overall Study||33
10678382|NCT02382276|11840841|FG000|STARTED|Overall Study||137
10678383|NCT02382276|11840842|FG001|STARTED|Overall Study||94
10678384|NCT02382276|11840843|FG002|STARTED|Overall Study||172
10678385|NCT02382276|11840841|FG000|COMPLETED|Overall Study||126
10678386|NCT02382276|11840842|FG001|COMPLETED|Overall Study||84
10678387|NCT02382276|11840843|FG002|COMPLETED|Overall Study||133
10678388|NCT02382276|11840841|FG000|NOT COMPLETED|Overall Study||11
10678389|NCT02382276|11840842|FG001|NOT COMPLETED|Overall Study||10
10678390|NCT02382276|11840843|FG002|NOT COMPLETED|Overall Study||39
10678391|NCT02382640|11840853|FG000|STARTED|Intervention Period 1 (3 Days)||9
10678392|NCT02382640|11840854|FG001|STARTED|Intervention Period 1 (3 Days)||9
10678393|NCT02382640|11840855|FG002|STARTED|Intervention Period 1 (3 Days)||9
10678394|NCT02382640|11840856|FG003|STARTED|Intervention Period 1 (3 Days)||9
10678395|NCT02382640|11840853|FG000|COMPLETED|Intervention Period 1 (3 Days)||9
10678396|NCT02382640|11840854|FG001|COMPLETED|Intervention Period 1 (3 Days)||9
10678397|NCT02382640|11840855|FG002|COMPLETED|Intervention Period 1 (3 Days)||9
10678398|NCT02382640|11840856|FG003|COMPLETED|Intervention Period 1 (3 Days)||9
10678399|NCT02382640|11840853|FG000|NOT COMPLETED|Intervention Period 1 (3 Days)||0
10678400|NCT02382640|11840854|FG001|NOT COMPLETED|Intervention Period 1 (3 Days)||0
10678401|NCT02382640|11840855|FG002|NOT COMPLETED|Intervention Period 1 (3 Days)||0
10678402|NCT02382640|11840856|FG003|NOT COMPLETED|Intervention Period 1 (3 Days)||0
10678403|NCT02382640|11840853|FG000|STARTED|Washout Period 1 (7 Days)||9
10678404|NCT02382640|11840854|FG001|STARTED|Washout Period 1 (7 Days)||9
10678405|NCT02382640|11840855|FG002|STARTED|Washout Period 1 (7 Days)||9
10678406|NCT02382640|11840856|FG003|STARTED|Washout Period 1 (7 Days)||9
10678407|NCT02382640|11840853|FG000|COMPLETED|Washout Period 1 (7 Days)||9
10678408|NCT02382640|11840854|FG001|COMPLETED|Washout Period 1 (7 Days)||9
10678409|NCT02382640|11840855|FG002|COMPLETED|Washout Period 1 (7 Days)||9
10678410|NCT02382640|11840856|FG003|COMPLETED|Washout Period 1 (7 Days)||9
10678411|NCT02382640|11840853|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
10678412|NCT02382640|11840854|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
10678413|NCT02382640|11840855|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
10678414|NCT02382640|11840856|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
10678415|NCT02382640|11840853|FG000|STARTED|Intervention Period 2 (3 Days)||9
10678416|NCT02382640|11840854|FG001|STARTED|Intervention Period 2 (3 Days)||9
10678417|NCT02382640|11840855|FG002|STARTED|Intervention Period 2 (3 Days)||9
10678418|NCT02382640|11840856|FG003|STARTED|Intervention Period 2 (3 Days)||9
10678419|NCT02382640|11840853|FG000|COMPLETED|Intervention Period 2 (3 Days)||9
10678420|NCT02382640|11840854|FG001|COMPLETED|Intervention Period 2 (3 Days)||9
10678421|NCT02382640|11840855|FG002|COMPLETED|Intervention Period 2 (3 Days)||9
10678422|NCT02382640|11840856|FG003|COMPLETED|Intervention Period 2 (3 Days)||9
10678423|NCT02382640|11840853|FG000|NOT COMPLETED|Intervention Period 2 (3 Days)||0
10678424|NCT02382640|11840854|FG001|NOT COMPLETED|Intervention Period 2 (3 Days)||0
10678425|NCT02382640|11840855|FG002|NOT COMPLETED|Intervention Period 2 (3 Days)||0
10678426|NCT02382640|11840856|FG003|NOT COMPLETED|Intervention Period 2 (3 Days)||0
10678427|NCT02382640|11840853|FG000|STARTED|Washout Period 2 (7 Days)||9
10678428|NCT02382640|11840854|FG001|STARTED|Washout Period 2 (7 Days)||9
10678429|NCT02382640|11840855|FG002|STARTED|Washout Period 2 (7 Days)||9
10678430|NCT02382640|11840856|FG003|STARTED|Washout Period 2 (7 Days)||9
10678431|NCT02382640|11840853|FG000|COMPLETED|Washout Period 2 (7 Days)||9
10678432|NCT02382640|11840854|FG001|COMPLETED|Washout Period 2 (7 Days)||9
10678433|NCT02382640|11840855|FG002|COMPLETED|Washout Period 2 (7 Days)||9
10678434|NCT02382640|11840856|FG003|COMPLETED|Washout Period 2 (7 Days)||9
10678435|NCT02382640|11840853|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
10678436|NCT02382640|11840854|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
10678437|NCT02382640|11840855|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
10678438|NCT02382640|11840856|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
10678439|NCT02382640|11840853|FG000|STARTED|Intervention Period 3 (3 Days)||9
10678440|NCT02382640|11840854|FG001|STARTED|Intervention Period 3 (3 Days)||9
10678441|NCT02382640|11840855|FG002|STARTED|Intervention Period 3 (3 Days)||9
10678442|NCT02382640|11840856|FG003|STARTED|Intervention Period 3 (3 Days)||9
10678443|NCT02382640|11840853|FG000|COMPLETED|Intervention Period 3 (3 Days)||9
10678444|NCT02382640|11840854|FG001|COMPLETED|Intervention Period 3 (3 Days)||9
10678445|NCT02382640|11840855|FG002|COMPLETED|Intervention Period 3 (3 Days)||9
10678446|NCT02382640|11840856|FG003|COMPLETED|Intervention Period 3 (3 Days)||9
10678447|NCT02382640|11840853|FG000|NOT COMPLETED|Intervention Period 3 (3 Days)||0
10678448|NCT02382640|11840854|FG001|NOT COMPLETED|Intervention Period 3 (3 Days)||0
10678449|NCT02382640|11840855|FG002|NOT COMPLETED|Intervention Period 3 (3 Days)||0
10678450|NCT02382640|11840856|FG003|NOT COMPLETED|Intervention Period 3 (3 Days)||0
10678451|NCT02382640|11840853|FG000|STARTED|Washout Period 3 (7 Days)||9
10678452|NCT02382640|11840854|FG001|STARTED|Washout Period 3 (7 Days)||9
10678453|NCT02382640|11840855|FG002|STARTED|Washout Period 3 (7 Days)||9
10678454|NCT02382640|11840856|FG003|STARTED|Washout Period 3 (7 Days)||9
10678455|NCT02382640|11840853|FG000|COMPLETED|Washout Period 3 (7 Days)||9
10678456|NCT02382640|11840854|FG001|COMPLETED|Washout Period 3 (7 Days)||9
10678457|NCT02382640|11840855|FG002|COMPLETED|Washout Period 3 (7 Days)||9
10678458|NCT02382640|11840856|FG003|COMPLETED|Washout Period 3 (7 Days)||9
10678459|NCT02382640|11840853|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
10678460|NCT02382640|11840854|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
10678461|NCT02382640|11840855|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
10678462|NCT02382640|11840856|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
10678463|NCT02382640|11840853|FG000|STARTED|Intervention Period 4 (3 Days)||9
10678464|NCT02382640|11840854|FG001|STARTED|Intervention Period 4 (3 Days)||9
10678465|NCT02382640|11840855|FG002|STARTED|Intervention Period 4 (3 Days)||9
10678466|NCT02382640|11840856|FG003|STARTED|Intervention Period 4 (3 Days)||9
10678467|NCT02382640|11840853|FG000|COMPLETED|Intervention Period 4 (3 Days)||8
10678468|NCT02382640|11840854|FG001|COMPLETED|Intervention Period 4 (3 Days)||9
10678469|NCT02382640|11840855|FG002|COMPLETED|Intervention Period 4 (3 Days)||9
10678470|NCT02382640|11840856|FG003|COMPLETED|Intervention Period 4 (3 Days)||9
10678471|NCT02382640|11840853|FG000|NOT COMPLETED|Intervention Period 4 (3 Days)||1
10678472|NCT02382640|11840854|FG001|NOT COMPLETED|Intervention Period 4 (3 Days)||0
10678473|NCT02382640|11840855|FG002|NOT COMPLETED|Intervention Period 4 (3 Days)||0
10678474|NCT02382640|11840856|FG003|NOT COMPLETED|Intervention Period 4 (3 Days)||0
10678475|NCT02382705|11840866|FG000|STARTED|Overall Study||57
10678476|NCT02382705|11840866|FG000|COMPLETED|Overall Study||33
10678477|NCT02382705|11840866|FG000|NOT COMPLETED|Overall Study||24
10678478|NCT02382744|11840872|FG000|STARTED|Overall Study||40
10678479|NCT02382744|11840873|FG001|STARTED|Overall Study||40
10678480|NCT02382744|11840872|FG000|Allocated|Overall Study||40
10678481|NCT02382744|11840873|FG001|Allocated|Overall Study||40
10678482|NCT02382744|11840872|FG000|Analyzed|Overall Study||40
10678483|NCT02382744|11840873|FG001|Analyzed|Overall Study||40
10678484|NCT02382744|11840872|FG000|COMPLETED|Overall Study||40
10678485|NCT02382744|11840873|FG001|COMPLETED|Overall Study||40
10678486|NCT02382744|11840872|FG000|NOT COMPLETED|Overall Study||0
10678487|NCT02382744|11840873|FG001|NOT COMPLETED|Overall Study||0
10678488|NCT02382796|11840883|FG000|STARTED|Overall Study||7
10678489|NCT02382796|11840883|FG000|COMPLETED|Overall Study||0
10678490|NCT02382796|11840883|FG000|NOT COMPLETED|Overall Study||7
10678491|NCT02382848|11840887|FG000|STARTED|First Intervention (3 Weeks)||3
10678492|NCT02382848|11840888|FG001|STARTED|First Intervention (3 Weeks)||5
10678493|NCT02382848|11840887|FG000|COMPLETED|First Intervention (3 Weeks)||3
10678494|NCT02382848|11840888|FG001|COMPLETED|First Intervention (3 Weeks)||5
10678495|NCT02382848|11840887|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0
10678496|NCT02382848|11840888|FG001|NOT COMPLETED|First Intervention (3 Weeks)||0
10678497|NCT02382848|11840887|FG000|STARTED|Washout (1 Week)||3
10678498|NCT02382848|11840888|FG001|STARTED|Washout (1 Week)||5
10678499|NCT02382848|11840887|FG000|COMPLETED|Washout (1 Week)||3
10678500|NCT02382848|11840888|FG001|COMPLETED|Washout (1 Week)||5
10678501|NCT02382848|11840887|FG000|NOT COMPLETED|Washout (1 Week)||0
10678502|NCT02382848|11840888|FG001|NOT COMPLETED|Washout (1 Week)||0
10678503|NCT02382848|11840887|FG000|STARTED|Second Intervention (3 Weeks)||3
10678504|NCT02382848|11840888|FG001|STARTED|Second Intervention (3 Weeks)||5
10678505|NCT02382848|11840887|FG000|COMPLETED|Second Intervention (3 Weeks)||3
10678506|NCT02382848|11840888|FG001|COMPLETED|Second Intervention (3 Weeks)||5
10678507|NCT02382848|11840887|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
10678508|NCT02382848|11840888|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
10678509|NCT02382913|11840904|FG000|STARTED|Overall Study||27
10678510|NCT02382913|11840905|FG001|STARTED|Overall Study||36
10678511|NCT02382913|11840906|FG002|STARTED|Overall Study||32
10678512|NCT02382913|11840907|FG003|STARTED|Overall Study||27
10678513|NCT02382913|11840908|FG004|STARTED|Overall Study||33
10678514|NCT02382913|11840909|FG005|STARTED|Overall Study||30
10678515|NCT02382913|11840910|FG006|STARTED|Overall Study||37
10798784|NCT03817580|11959302|FG000|COMPLETED|Overall Study||57
10798785|NCT03817580|11959303|FG001|COMPLETED|Overall Study||56
10798786|NCT03817580|11959304|FG002|COMPLETED|Overall Study||57
10798787|NCT03817580|11959302|FG000|NOT COMPLETED|Overall Study||0
10798788|NCT03817580|11959303|FG001|NOT COMPLETED|Overall Study||0
10798789|NCT03817580|11959304|FG002|NOT COMPLETED|Overall Study||0
10798790|NCT03828422|11959314|FG000|STARTED|Overall Study||40
10678516|NCT02382913|11840911|FG007|STARTED|Overall Study||30
10798791|NCT03828422|11959315|FG001|STARTED|Overall Study||42
10678517|NCT02382913|11840912|FG008|STARTED|Overall Study||30
10678518|NCT02382913|11840913|FG009|STARTED|Overall Study||33
10678519|NCT02382913|11840904|FG000|COMPLETED|Overall Study||27
10678520|NCT02382913|11840905|FG001|COMPLETED|Overall Study||36
10678521|NCT02382913|11840906|FG002|COMPLETED|Overall Study||32
10678522|NCT02382913|11840907|FG003|COMPLETED|Overall Study||27
10678523|NCT02382913|11840908|FG004|COMPLETED|Overall Study||33
10678524|NCT02382913|11840909|FG005|COMPLETED|Overall Study||30
10678525|NCT02382913|11840910|FG006|COMPLETED|Overall Study||37
10678526|NCT02382913|11840911|FG007|COMPLETED|Overall Study||30
10678527|NCT02382913|11840912|FG008|COMPLETED|Overall Study||30
10678528|NCT02382913|11840913|FG009|COMPLETED|Overall Study||33
10678529|NCT02382913|11840904|FG000|NOT COMPLETED|Overall Study||0
10678530|NCT02382913|11840905|FG001|NOT COMPLETED|Overall Study||0
10678531|NCT02382913|11840906|FG002|NOT COMPLETED|Overall Study||0
10678532|NCT02382913|11840907|FG003|NOT COMPLETED|Overall Study||0
10678533|NCT02382913|11840908|FG004|NOT COMPLETED|Overall Study||0
10678534|NCT02382913|11840909|FG005|NOT COMPLETED|Overall Study||0
10678535|NCT02382913|11840910|FG006|NOT COMPLETED|Overall Study||0
10678536|NCT02382913|11840911|FG007|NOT COMPLETED|Overall Study||0
10678537|NCT02382913|11840912|FG008|NOT COMPLETED|Overall Study||0
10678538|NCT02382913|11840913|FG009|NOT COMPLETED|Overall Study||0
10678539|NCT02382939|11840937|FG000|STARTED|Overall Study||31
10678540|NCT02382939|11840938|FG001|STARTED|Overall Study||61
10678541|NCT02382939|11840937|FG000|Exposed|Overall Study||31
10678542|NCT02382939|11840938|FG001|Exposed|Overall Study||61
10678543|NCT02382939|11840937|FG000|COMPLETED|Overall Study||28
10678544|NCT02382939|11840938|FG001|COMPLETED|Overall Study||58
10678545|NCT02382939|11840937|FG000|NOT COMPLETED|Overall Study||3
10678546|NCT02382939|11840938|FG001|NOT COMPLETED|Overall Study||3
10678547|NCT02382991|11840947|FG000|STARTED|Overall Study||17
10678548|NCT02382991|11840948|FG001|STARTED|Overall Study||18
10678549|NCT02382991|11840947|FG000|COMPLETED|Overall Study||15
10678550|NCT02382991|11840948|FG001|COMPLETED|Overall Study||15
10678551|NCT02382991|11840947|FG000|NOT COMPLETED|Overall Study||2
10678552|NCT02382991|11840948|FG001|NOT COMPLETED|Overall Study||3
10678553|NCT02383017|11840955|FG000|STARTED|Overall Study||15
10678554|NCT02383017|11840956|FG001|STARTED|Overall Study||13
10678555|NCT02383017|11840955|FG000|COMPLETED|Overall Study||10
10678556|NCT02383017|11840956|FG001|COMPLETED|Overall Study||11
10678557|NCT02383017|11840955|FG000|NOT COMPLETED|Overall Study||5
10678558|NCT02383017|11840956|FG001|NOT COMPLETED|Overall Study||2
10678559|NCT02383043|11840965|FG000|STARTED|Overall Study||9
10678560|NCT02383043|11840966|FG001|STARTED|Overall Study||5
10678561|NCT02383043|11840967|FG002|STARTED|Overall Study||4
10678562|NCT02383043|11840965|FG000|COMPLETED|Overall Study||7
10678563|NCT02383043|11840966|FG001|COMPLETED|Overall Study||5
10678564|NCT02383043|11840967|FG002|COMPLETED|Overall Study||4
10678565|NCT02383043|11840965|FG000|NOT COMPLETED|Overall Study||2
10678566|NCT02383043|11840966|FG001|NOT COMPLETED|Overall Study||0
10678567|NCT02383043|11840967|FG002|NOT COMPLETED|Overall Study||0
10678568|NCT02383056|11840978|FG000|STARTED|Overall Study||7
10678569|NCT02383056|11840979|FG001|STARTED|Overall Study||7
10678570|NCT02383056|11840978|FG000|COMPLETED|Overall Study||6
10678571|NCT02383056|11840979|FG001|COMPLETED|Overall Study||5
10678572|NCT02383056|11840978|FG000|NOT COMPLETED|Overall Study||1
10678573|NCT02383056|11840979|FG001|NOT COMPLETED|Overall Study||2
10678574|NCT02383173|11840987|FG000|STARTED|Overall Study||88
10678575|NCT02383173|11840988|FG001|STARTED|Overall Study||46
10678576|NCT02383173|11840987|FG000|COMPLETED|Overall Study||88
10678577|NCT02383173|11840988|FG001|COMPLETED|Overall Study||44
10678578|NCT02383173|11840987|FG000|NOT COMPLETED|Overall Study||0
10678579|NCT02383173|11840988|FG001|NOT COMPLETED|Overall Study||2
10678580|NCT02383355|11840996|FG000|STARTED|Overall Study||19
10678581|NCT02383355|11840997|FG001|STARTED|Overall Study||21
10678582|NCT02383355|11840996|FG000|COMPLETED|Overall Study||17
10678583|NCT02383355|11840997|FG001|COMPLETED|Overall Study||21
10678584|NCT02383355|11840996|FG000|NOT COMPLETED|Overall Study||2
10678585|NCT02383355|11840997|FG001|NOT COMPLETED|Overall Study||0
10678586|NCT02383420|11841006|FG000|STARTED|Overall Study||10
10678587|NCT02383420|11841007|FG001|STARTED|Overall Study||10
10678588|NCT02383420|11841008|FG002|STARTED|Overall Study||3
10678589|NCT02383420|11841006|FG000|COMPLETED|Overall Study||8
10678590|NCT02383420|11841007|FG001|COMPLETED|Overall Study||10
10678591|NCT02383420|11841008|FG002|COMPLETED|Overall Study||3
10678592|NCT02383420|11841006|FG000|NOT COMPLETED|Overall Study||2
10678593|NCT02383420|11841007|FG001|NOT COMPLETED|Overall Study||0
10678594|NCT02383420|11841008|FG002|NOT COMPLETED|Overall Study||0
10678595|NCT02383472|11841018|FG000|STARTED|Overall Study||23
10678596|NCT02383472|11841019|FG001|STARTED|Overall Study||30
10678597|NCT02383472|11841018|FG000|COMPLETED|Overall Study||22
10678598|NCT02383472|11841019|FG001|COMPLETED|Overall Study||29
10678599|NCT02383472|11841018|FG000|NOT COMPLETED|Overall Study||1
10678600|NCT02383472|11841019|FG001|NOT COMPLETED|Overall Study||1
10678601|NCT02383576|11841029|FG000|STARTED|Overall Study||94
10678602|NCT02383576|11841030|FG001|STARTED|Overall Study||91
10678603|NCT02383576|11841029|FG000|COMPLETED|Overall Study||31
10678604|NCT02383576|11841030|FG001|COMPLETED|Overall Study||46
10678605|NCT02383576|11841029|FG000|NOT COMPLETED|Overall Study||63
10678606|NCT02383576|11841030|FG001|NOT COMPLETED|Overall Study||45
10678607|NCT02383589|11841038|FG000|STARTED|Treatment Period||67
10678608|NCT02383589|11841039|FG001|STARTED|Treatment Period||68
10678609|NCT02383589|11841038|FG000|COMPLETED|Treatment Period||66
10678610|NCT02383589|11841039|FG001|COMPLETED|Treatment Period||58
10678611|NCT02383589|11841038|FG000|NOT COMPLETED|Treatment Period||1
10678612|NCT02383589|11841039|FG001|NOT COMPLETED|Treatment Period||10
10678613|NCT02383589|11841038|FG000|STARTED|Safety Follow-up (SFU)||66
10678614|NCT02383589|11841039|FG001|STARTED|Safety Follow-up (SFU)||58
10678615|NCT02383589|11841038|FG000|COMPLETED|Safety Follow-up (SFU)||59
10678616|NCT02383589|11841039|FG001|COMPLETED|Safety Follow-up (SFU)||53
10678617|NCT02383589|11841038|FG000|NOT COMPLETED|Safety Follow-up (SFU)||7
10678618|NCT02383589|11841039|FG001|NOT COMPLETED|Safety Follow-up (SFU)||5
10678619|NCT02383667|11841047|FG000|STARTED|Overall Study||20
10678620|NCT02383667|11841047|FG000|COMPLETED|Overall Study||20
10678621|NCT02383667|11841047|FG000|NOT COMPLETED|Overall Study||0
10678622|NCT02383706|11841051|FG000|STARTED|Overall Study||108
10678623|NCT02383706|11841051|FG000|COMPLETED|Overall Study||80
10678624|NCT02383706|11841051|FG000|NOT COMPLETED|Overall Study||28
10678625|NCT02383719|11841056|FG000|STARTED|Overall Study||18
10678626|NCT02383719|11841056|FG000|COMPLETED|Overall Study||18
10678627|NCT02383719|11841056|FG000|NOT COMPLETED|Overall Study||0
10678628|NCT02383758|11841062|FG000|STARTED|Overall Study||10
10678629|NCT02383758|11841063|FG001|STARTED|Overall Study||10
10678630|NCT02383758|11841062|FG000|COMPLETED|Overall Study||10
10678631|NCT02383758|11841063|FG001|COMPLETED|Overall Study||8
10678632|NCT02383758|11841062|FG000|NOT COMPLETED|Overall Study||0
10678633|NCT02383758|11841063|FG001|NOT COMPLETED|Overall Study||2
10678634|NCT02383862|11841071|FG000|STARTED|Baseline||151
10678635|NCT02383862|11841072|FG001|STARTED|Baseline||149
10678636|NCT02383862|11841071|FG000|COMPLETED|Baseline||151
10678637|NCT02383862|11841072|FG001|COMPLETED|Baseline||149
10678638|NCT02383862|11841071|FG000|NOT COMPLETED|Baseline||0
10678639|NCT02383862|11841072|FG001|NOT COMPLETED|Baseline||0
10678640|NCT02383862|11841071|FG000|STARTED|3 Month Follow up||151
10678641|NCT02383862|11841072|FG001|STARTED|3 Month Follow up||149
10678642|NCT02383862|11841071|FG000|COMPLETED|3 Month Follow up||128
10678643|NCT02383862|11841072|FG001|COMPLETED|3 Month Follow up||128
10678644|NCT02383862|11841071|FG000|NOT COMPLETED|3 Month Follow up||23
10678645|NCT02383862|11841072|FG001|NOT COMPLETED|3 Month Follow up||21
10678646|NCT02383940|11841087|FG000|STARTED|Overall Study||44
10678647|NCT02383940|11841088|FG001|STARTED|Overall Study||43
10678648|NCT02383940|11841087|FG000|Treated|Overall Study||42
10678649|NCT02383940|11841088|FG001|Treated|Overall Study||43
10678650|NCT02383940|11841087|FG000|COMPLETED|Overall Study||35
10678651|NCT02383940|11841088|FG001|COMPLETED|Overall Study||40
10678652|NCT02383940|11841087|FG000|NOT COMPLETED|Overall Study||9
10678653|NCT02383940|11841088|FG001|NOT COMPLETED|Overall Study||3
10678654|NCT02384044|11841096|FG000|STARTED|Overall Study||15
10678655|NCT02384044|11841097|FG001|STARTED|Overall Study||15
10678656|NCT02384044|11841096|FG000|COMPLETED|Overall Study||15
10678657|NCT02384044|11841097|FG001|COMPLETED|Overall Study||15
10678658|NCT02384044|11841096|FG000|NOT COMPLETED|Overall Study||0
10678659|NCT02384044|11841097|FG001|NOT COMPLETED|Overall Study||0
10678660|NCT02384070|11841106|FG000|STARTED|Overall Study||100
10678661|NCT02384070|11841107|FG001|STARTED|Overall Study||100
10678662|NCT02384070|11841108|FG002|STARTED|Overall Study||100
10678663|NCT02384070|11841106|FG000|COMPLETED|Overall Study||100
10678664|NCT02384070|11841107|FG001|COMPLETED|Overall Study||100
10678665|NCT02384070|11841108|FG002|COMPLETED|Overall Study||100
10678666|NCT02384070|11841106|FG000|NOT COMPLETED|Overall Study||0
10678667|NCT02384070|11841107|FG001|NOT COMPLETED|Overall Study||0
10678668|NCT02384070|11841108|FG002|NOT COMPLETED|Overall Study||0
10678669|NCT02384096|11841118|FG000|STARTED|First Intervention (7 Days)||5
10678670|NCT02384096|11841119|FG001|STARTED|First Intervention (7 Days)||7
10678671|NCT02384096|11841118|FG000|COMPLETED|First Intervention (7 Days)||4
10678672|NCT02384096|11841119|FG001|COMPLETED|First Intervention (7 Days)||7
10678673|NCT02384096|11841118|FG000|NOT COMPLETED|First Intervention (7 Days)||1
10678674|NCT02384096|11841119|FG001|NOT COMPLETED|First Intervention (7 Days)||0
10678675|NCT02384096|11841118|FG000|STARTED|Second Intervention (7 Days)||4
10678676|NCT02384096|11841119|FG001|STARTED|Second Intervention (7 Days)||7
10678677|NCT02384096|11841118|FG000|COMPLETED|Second Intervention (7 Days)||4
10678678|NCT02384096|11841119|FG001|COMPLETED|Second Intervention (7 Days)||6
10678679|NCT02384096|11841118|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
10678680|NCT02384096|11841119|FG001|NOT COMPLETED|Second Intervention (7 Days)||1
10678681|NCT02384200|11841126|FG000|STARTED|Overall Study||43
10678682|NCT02384200|11841127|FG001|STARTED|Overall Study||43
10678683|NCT02384200|11841126|FG000|COMPLETED|Overall Study||43
10678684|NCT02384200|11841127|FG001|COMPLETED|Overall Study||43
10678685|NCT02384200|11841126|FG000|NOT COMPLETED|Overall Study||0
10678686|NCT02384200|11841127|FG001|NOT COMPLETED|Overall Study||0
10678687|NCT02384382|11841133|FG000|STARTED|Overall Study||23
10678688|NCT02384382|11841133|FG000|COMPLETED|Overall Study||0
10678689|NCT02384382|11841133|FG000|NOT COMPLETED|Overall Study||23
10678690|NCT02384395|11841137|FG000|STARTED|Overall Study||40
10678691|NCT02384395|11841137|FG000|Enrolled|Overall Study||40
10678692|NCT02384395|11841137|FG000|Initiated Treatment|Overall Study||37
10678693|NCT02384395|11841137|FG000|Completed Week 24|Overall Study||34
10678694|NCT02384395|11841137|FG000|Completed Week 48|Overall Study||33
10678695|NCT02384395|11841137|FG000|Completed Week 96|Overall Study||30
10678696|NCT02384395|11841137|FG000|COMPLETED|Overall Study||30
10678697|NCT02384395|11841137|FG000|NOT COMPLETED|Overall Study||10
10678698|NCT02384460|11841143|FG000|STARTED|Overall Study||82
10678699|NCT02384460|11841144|FG001|STARTED|Overall Study||87
10678700|NCT02384460|11841143|FG000|Received at Least 1 Dose of Study Drug|Overall Study||82
10678701|NCT02384460|11841144|FG001|Received at Least 1 Dose of Study Drug|Overall Study||87
10678702|NCT02384460|11841143|FG000|COMPLETED|Overall Study||75
10678703|NCT02384460|11841144|FG001|COMPLETED|Overall Study||80
10678704|NCT02384460|11841143|FG000|NOT COMPLETED|Overall Study||7
10678705|NCT02384460|11841144|FG001|NOT COMPLETED|Overall Study||7
10678706|NCT02384538|11841152|FG000|STARTED|Overall Study||67
10678707|NCT02384538|11841153|FG001|STARTED|Overall Study||64
10678708|NCT02384538|11841152|FG000|COMPLETED|Overall Study||61
10678709|NCT02384538|11841153|FG001|COMPLETED|Overall Study||49
10678710|NCT02384538|11841152|FG000|NOT COMPLETED|Overall Study||6
10678711|NCT02384538|11841153|FG001|NOT COMPLETED|Overall Study||15
10678712|NCT02384941|11841162|FG000|STARTED|Overall Study||268
10678713|NCT02384941|11841163|FG001|STARTED|Overall Study||263
10678714|NCT02384941|11841164|FG002|STARTED|Overall Study||262
10678715|NCT02384941|11841162|FG000|COMPLETED|Overall Study||218
10678716|NCT02384941|11841163|FG001|COMPLETED|Overall Study||228
10678717|NCT02384941|11841164|FG002|COMPLETED|Overall Study||221
10678718|NCT02384941|11841162|FG000|NOT COMPLETED|Overall Study||50
10678719|NCT02384941|11841163|FG001|NOT COMPLETED|Overall Study||35
10678720|NCT02384941|11841164|FG002|NOT COMPLETED|Overall Study||41
10678721|NCT02385084|11841173|FG000|STARTED|Period 1||3
10678722|NCT02385084|11841174|FG001|STARTED|Period 1||3
10678723|NCT02385084|11841175|FG002|STARTED|Period 1||3
10678724|NCT02385084|11841176|FG003|STARTED|Period 1||3
10678725|NCT02385084|11841177|FG004|STARTED|Period 1||3
10678726|NCT02385084|11841178|FG005|STARTED|Period 1||3
10678727|NCT02385084|11841173|FG000|Received LY2409021|Period 1||3
10678728|NCT02385084|11841174|FG001|Received LY2409021|Period 1||3
10678729|NCT02385084|11841175|FG002|Received LY2409021|Period 1||3
10678730|NCT02385084|11841176|FG003|Received LY2409021|Period 1||3
10678731|NCT02385084|11841177|FG004|Received LY2409021|Period 1||3
10678732|NCT02385084|11841178|FG005|Received LY2409021|Period 1||3
10678733|NCT02385084|11841173|FG000|Washout|Period 1||3
10678734|NCT02385084|11841174|FG001|Washout|Period 1||3
10678735|NCT02385084|11841175|FG002|Washout|Period 1||3
10678736|NCT02385084|11841176|FG003|Washout|Period 1||3
10678737|NCT02385084|11841177|FG004|Washout|Period 1||3
10678738|NCT02385084|11841178|FG005|Washout|Period 1||3
10678739|NCT02385084|11841173|FG000|COMPLETED|Period 1||3
10678740|NCT02385084|11841174|FG001|COMPLETED|Period 1||3
10678741|NCT02385084|11841175|FG002|COMPLETED|Period 1||3
10678742|NCT02385084|11841176|FG003|COMPLETED|Period 1||3
10678743|NCT02385084|11841177|FG004|COMPLETED|Period 1||3
10678744|NCT02385084|11841178|FG005|COMPLETED|Period 1||3
10678745|NCT02385084|11841173|FG000|NOT COMPLETED|Period 1||0
10678746|NCT02385084|11841174|FG001|NOT COMPLETED|Period 1||0
10678747|NCT02385084|11841175|FG002|NOT COMPLETED|Period 1||0
10678748|NCT02385084|11841176|FG003|NOT COMPLETED|Period 1||0
10678749|NCT02385084|11841177|FG004|NOT COMPLETED|Period 1||0
10678750|NCT02385084|11841178|FG005|NOT COMPLETED|Period 1||0
10678751|NCT02385084|11841173|FG000|STARTED|Period 2|1 participant discontinued after Period 1 - physician decision. Did not enter Period 2.|2
10678752|NCT02385084|11841174|FG001|STARTED|Period 2||3
10678753|NCT02385084|11841175|FG002|STARTED|Period 2||3
10678754|NCT02385084|11841176|FG003|STARTED|Period 2||3
10678755|NCT02385084|11841177|FG004|STARTED|Period 2||3
10678756|NCT02385084|11841178|FG005|STARTED|Period 2||3
10678757|NCT02385084|11841173|FG000|Received LY2409021|Period 2||2
10678758|NCT02385084|11841174|FG001|Received LY2409021|Period 2||3
10678759|NCT02385084|11841175|FG002|Received LY2409021|Period 2||3
10678760|NCT02385084|11841176|FG003|Received LY2409021|Period 2||3
10678761|NCT02385084|11841177|FG004|Received LY2409021|Period 2||3
10678762|NCT02385084|11841178|FG005|Received LY2409021|Period 2||3
10678763|NCT02385084|11841173|FG000|Washout|Period 2||2
10678764|NCT02385084|11841174|FG001|Washout|Period 2||3
10678765|NCT02385084|11841175|FG002|Washout|Period 2||3
10678766|NCT02385084|11841176|FG003|Washout|Period 2||3
10678767|NCT02385084|11841177|FG004|Washout|Period 2||3
10678768|NCT02385084|11841178|FG005|Washout|Period 2||3
10678769|NCT02385084|11841173|FG000|COMPLETED|Period 2||2
10678770|NCT02385084|11841174|FG001|COMPLETED|Period 2||3
10678771|NCT02385084|11841175|FG002|COMPLETED|Period 2||2
10678772|NCT02385084|11841176|FG003|COMPLETED|Period 2||3
10678773|NCT02385084|11841177|FG004|COMPLETED|Period 2||3
10678774|NCT02385084|11841178|FG005|COMPLETED|Period 2||3
10678775|NCT02385084|11841173|FG000|NOT COMPLETED|Period 2||0
10678776|NCT02385084|11841174|FG001|NOT COMPLETED|Period 2||0
10678777|NCT02385084|11841175|FG002|NOT COMPLETED|Period 2||1
10678778|NCT02385084|11841176|FG003|NOT COMPLETED|Period 2||0
10678779|NCT02385084|11841177|FG004|NOT COMPLETED|Period 2||0
10678780|NCT02385084|11841178|FG005|NOT COMPLETED|Period 2||0
10678781|NCT02385084|11841173|FG000|STARTED|Period 3||2
10678782|NCT02385084|11841174|FG001|STARTED|Period 3||3
10678783|NCT02385084|11841175|FG002|STARTED|Period 3|1 participant discontinued after Period 2 - adverse event. Did not enter Period 3.|1
10678784|NCT02385084|11841176|FG003|STARTED|Period 3||3
10678785|NCT02385084|11841177|FG004|STARTED|Period 3|1 participant discontinued after Period 2 - adverse event. Did not enter Period 3.|2
10678786|NCT02385084|11841178|FG005|STARTED|Period 3||3
10678787|NCT02385084|11841173|FG000|Received LY2409021|Period 3||2
10678788|NCT02385084|11841174|FG001|Received LY2409021|Period 3||3
10678789|NCT02385084|11841175|FG002|Received LY2409021|Period 3||1
10678790|NCT02385084|11841176|FG003|Received LY2409021|Period 3||3
10678791|NCT02385084|11841177|FG004|Received LY2409021|Period 3||2
10678792|NCT02385084|11841178|FG005|Received LY2409021|Period 3||3
10678793|NCT02385084|11841173|FG000|Washout|Period 3||2
10678794|NCT02385084|11841174|FG001|Washout|Period 3||3
10678795|NCT02385084|11841175|FG002|Washout|Period 3||1
10678796|NCT02385084|11841176|FG003|Washout|Period 3||3
10678797|NCT02385084|11841177|FG004|Washout|Period 3||2
10678798|NCT02385084|11841178|FG005|Washout|Period 3||3
10678799|NCT02385084|11841173|FG000|COMPLETED|Period 3||2
10678800|NCT02385084|11841174|FG001|COMPLETED|Period 3||3
10678801|NCT02385084|11841175|FG002|COMPLETED|Period 3||1
10678802|NCT02385084|11841176|FG003|COMPLETED|Period 3||3
10678803|NCT02385084|11841177|FG004|COMPLETED|Period 3||2
10678804|NCT02385084|11841178|FG005|COMPLETED|Period 3||3
10678805|NCT02385084|11841173|FG000|NOT COMPLETED|Period 3||0
10678806|NCT02385084|11841174|FG001|NOT COMPLETED|Period 3||0
10678807|NCT02385084|11841175|FG002|NOT COMPLETED|Period 3||0
10678808|NCT02385084|11841176|FG003|NOT COMPLETED|Period 3||0
10678809|NCT02385084|11841177|FG004|NOT COMPLETED|Period 3||0
10678810|NCT02385084|11841178|FG005|NOT COMPLETED|Period 3||0
10678811|NCT02385097|11841189|FG000|STARTED|Overall Study||106
10678812|NCT02385097|11841190|FG001|STARTED|Overall Study||105
10678813|NCT02385097|11841189|FG000|COMPLETED|Overall Study||106
10678814|NCT02385097|11841190|FG001|COMPLETED|Overall Study||105
10678815|NCT02385097|11841189|FG000|NOT COMPLETED|Overall Study||0
10678816|NCT02385097|11841190|FG001|NOT COMPLETED|Overall Study||0
10678817|NCT02385240|11841199|FG000|STARTED|Overall Study||183
10678818|NCT02385240|11841200|FG001|STARTED|Overall Study||184
10678819|NCT02385240|11841201|FG002|STARTED|Overall Study||185
10678820|NCT02385240|11841199|FG000|COMPLETED|Overall Study||182
10678821|NCT02385240|11841200|FG001|COMPLETED|Overall Study||178
10678822|NCT02385240|11841201|FG002|COMPLETED|Overall Study||184
10678823|NCT02385240|11841199|FG000|NOT COMPLETED|Overall Study||1
10678824|NCT02385240|11841200|FG001|NOT COMPLETED|Overall Study||6
10678825|NCT02385240|11841201|FG002|NOT COMPLETED|Overall Study||1
10678826|NCT02385318|11841212|FG000|STARTED|Overall Study||204
10678827|NCT02385318|11841213|FG001|STARTED|Overall Study||210
10678828|NCT02385318|11841214|FG002|STARTED|Overall Study||105
10678829|NCT02385318|11841212|FG000|COMPLETED|Overall Study||200
10678830|NCT02385318|11841213|FG001|COMPLETED|Overall Study||203
10678831|NCT02385318|11841214|FG002|COMPLETED|Overall Study||99
10678832|NCT02385318|11841212|FG000|NOT COMPLETED|Overall Study||4
10678833|NCT02385318|11841213|FG001|NOT COMPLETED|Overall Study||7
10678834|NCT02385318|11841214|FG002|NOT COMPLETED|Overall Study||6
10678835|NCT02385526|11841225|FG000|STARTED|Overall Study||22
10678836|NCT02385526|11841226|FG001|STARTED|Overall Study||20
10678837|NCT02385526|11841227|FG002|STARTED|Overall Study||20
10678838|NCT02385526|11841225|FG000|COMPLETED|Overall Study||20
10678839|NCT02385526|11841226|FG001|COMPLETED|Overall Study||17
10678840|NCT02385526|11841227|FG002|COMPLETED|Overall Study||20
10678841|NCT02385526|11841225|FG000|NOT COMPLETED|Overall Study||2
10678842|NCT02385526|11841226|FG001|NOT COMPLETED|Overall Study||3
10678843|NCT02385526|11841227|FG002|NOT COMPLETED|Overall Study||0
10678844|NCT02385669|11841235|FG000|STARTED|Overall Study||3
10678845|NCT02385669|11841235|FG000|COMPLETED|Overall Study||1
10678846|NCT02385669|11841235|FG000|NOT COMPLETED|Overall Study||2
10678847|NCT02385708|11841241|FG000|STARTED|Overall Study||81
10678848|NCT02385708|11841242|FG001|STARTED|Overall Study||82
10678849|NCT02385708|11841241|FG000|Intervention Started|Overall Study||81
10678850|NCT02385708|11841242|FG001|Intervention Started|Overall Study||82
10678851|NCT02385708|11841241|FG000|COMPLETED|Overall Study||73
10678852|NCT02385708|11841242|FG001|COMPLETED|Overall Study||67
10678853|NCT02385708|11841241|FG000|NOT COMPLETED|Overall Study||8
10678854|NCT02385708|11841242|FG001|NOT COMPLETED|Overall Study||15
10678855|NCT02385721|11841248|FG000|STARTED|Overall Study||601
10678856|NCT02385721|11841248|FG000|COMPLETED|Overall Study||371
10678857|NCT02385721|11841248|FG000|NOT COMPLETED|Overall Study||230
10678858|NCT02385799|11841254|FG000|STARTED|Overall Study||26
10678859|NCT02385799|11841255|FG001|STARTED|Overall Study||32
10678860|NCT02385799|11841254|FG000|Completed End-of-Treatment Visit|Overall Study||21
10678861|NCT02385799|11841255|FG001|Completed End-of-Treatment Visit|Overall Study||26
10678862|NCT02385799|11841254|FG000|COMPLETED|Overall Study||21
10678863|NCT02385799|11841255|FG001|COMPLETED|Overall Study||24
10678864|NCT02385799|11841254|FG000|NOT COMPLETED|Overall Study||5
10678865|NCT02385799|11841255|FG001|NOT COMPLETED|Overall Study||8
10678866|NCT02386098|11841266|FG000|STARTED|Stage 1 (96 Weeks)||43
10678867|NCT02386098|11841267|FG001|STARTED|Stage 1 (96 Weeks)||43
10678868|NCT02386098|11841268|FG002|STARTED|Stage 1 (96 Weeks)||0
10678869|NCT02386098|11841269|FG003|STARTED|Stage 1 (96 Weeks)||0
10678870|NCT02386098|11841270|FG004|STARTED|Stage 1 (96 Weeks)||0
10678871|NCT02386098|11841266|FG000|COMPLETED|Stage 1 (96 Weeks)||0
10678872|NCT02386098|11841267|FG001|COMPLETED|Stage 1 (96 Weeks)||0
10678873|NCT02386098|11841268|FG002|COMPLETED|Stage 1 (96 Weeks)||0
10678874|NCT02386098|11841269|FG003|COMPLETED|Stage 1 (96 Weeks)||0
10678875|NCT02386098|11841270|FG004|COMPLETED|Stage 1 (96 Weeks)||0
10678876|NCT02386098|11841266|FG000|NOT COMPLETED|Stage 1 (96 Weeks)||43
10678877|NCT02386098|11841267|FG001|NOT COMPLETED|Stage 1 (96 Weeks)||43
10678878|NCT02386098|11841268|FG002|NOT COMPLETED|Stage 1 (96 Weeks)||0
10678879|NCT02386098|11841269|FG003|NOT COMPLETED|Stage 1 (96 Weeks)||0
10678880|NCT02386098|11841270|FG004|NOT COMPLETED|Stage 1 (96 Weeks)||0
10678881|NCT02386098|11841266|FG000|STARTED|Stage 2 (96 Weeks)||0
10678882|NCT02386098|11841267|FG001|STARTED|Stage 2 (96 Weeks)||0
10678883|NCT02386098|11841268|FG002|STARTED|Stage 2 (96 Weeks)||0
10678884|NCT02386098|11841269|FG003|STARTED|Stage 2 (96 Weeks)||0
10678885|NCT02386098|11841270|FG004|STARTED|Stage 2 (96 Weeks)||0
10678886|NCT02386098|11841266|FG000|COMPLETED|Stage 2 (96 Weeks)||0
10678887|NCT02386098|11841267|FG001|COMPLETED|Stage 2 (96 Weeks)||0
10678888|NCT02386098|11841268|FG002|COMPLETED|Stage 2 (96 Weeks)||0
10678889|NCT02386098|11841269|FG003|COMPLETED|Stage 2 (96 Weeks)||0
10678890|NCT02386098|11841270|FG004|COMPLETED|Stage 2 (96 Weeks)||0
10678891|NCT02386098|11841266|FG000|NOT COMPLETED|Stage 2 (96 Weeks)||0
10678892|NCT02386098|11841267|FG001|NOT COMPLETED|Stage 2 (96 Weeks)||0
10678893|NCT02386098|11841268|FG002|NOT COMPLETED|Stage 2 (96 Weeks)||0
10678894|NCT02386098|11841269|FG003|NOT COMPLETED|Stage 2 (96 Weeks)||0
10678895|NCT02386098|11841270|FG004|NOT COMPLETED|Stage 2 (96 Weeks)||0
10678896|NCT02386189|11841284|FG000|STARTED|Overall Study||30
10678897|NCT02386189|11841285|FG001|STARTED|Overall Study||33
10678898|NCT02386189|11841284|FG000|COMPLETED|Overall Study||26
10678899|NCT02386189|11841285|FG001|COMPLETED|Overall Study||30
10678900|NCT02386189|11841284|FG000|NOT COMPLETED|Overall Study||4
10678901|NCT02386189|11841285|FG001|NOT COMPLETED|Overall Study||3
10678902|NCT02386319|11841293|FG000|STARTED|Overall Study||18
10678903|NCT02386319|11841294|FG001|STARTED|Overall Study||18
10678904|NCT02386319|11841293|FG000|COMPLETED|Overall Study||16
10678905|NCT02386319|11841294|FG001|COMPLETED|Overall Study||17
10678906|NCT02386319|11841293|FG000|NOT COMPLETED|Overall Study||2
10678907|NCT02386319|11841294|FG001|NOT COMPLETED|Overall Study||1
10678908|NCT02386345|11841300|FG000|STARTED|Overall Study||299
10678909|NCT02386345|11841300|FG000|COMPLETED|Overall Study||197
10678910|NCT02386345|11841300|FG000|NOT COMPLETED|Overall Study||102
10678911|NCT02386605|11841306|FG000|STARTED|Overall Study||41
10678912|NCT02386605|11841307|FG001|STARTED|Overall Study||38
10678913|NCT02386605|11841306|FG000|COMPLETED|Overall Study||34
10678914|NCT02386605|11841307|FG001|COMPLETED|Overall Study||28
10678915|NCT02386605|11841306|FG000|NOT COMPLETED|Overall Study||7
10678916|NCT02386605|11841307|FG001|NOT COMPLETED|Overall Study||10
10678917|NCT02386995|11841313|FG000|STARTED|Overall Study||30
10678918|NCT02386995|11841313|FG000|COMPLETED|Overall Study||30
10678919|NCT02386995|11841313|FG000|NOT COMPLETED|Overall Study||0
10678920|NCT02387008|11841321|FG000|STARTED|Overall Study||2
10678921|NCT02387008|11841322|FG001|STARTED|Overall Study||0
10678922|NCT02387008|11841323|FG002|STARTED|Overall Study||4
10678923|NCT02387008|11841321|FG000|COMPLETED|Overall Study||2
10678924|NCT02387008|11841322|FG001|COMPLETED|Overall Study||0
10678925|NCT02387008|11841323|FG002|COMPLETED|Overall Study||4
10678926|NCT02387008|11841321|FG000|NOT COMPLETED|Overall Study||0
10678927|NCT02387008|11841322|FG001|NOT COMPLETED|Overall Study||0
10678928|NCT02387008|11841323|FG002|NOT COMPLETED|Overall Study||0
10678929|NCT02387164|11841333|FG000|STARTED|Overall Study||13
10678930|NCT02387164|11841334|FG001|STARTED|Overall Study||13
10678931|NCT02387164|11841333|FG000|COMPLETED|Overall Study||10
10678932|NCT02387164|11841334|FG001|COMPLETED|Overall Study||11
10678933|NCT02387164|11841333|FG000|NOT COMPLETED|Overall Study||3
10678934|NCT02387164|11841334|FG001|NOT COMPLETED|Overall Study||2
10678935|NCT02387216|11841342|FG000|STARTED|Overall Study||103
10678936|NCT02387216|11841343|FG001|STARTED|Overall Study||49
10678937|NCT02387216|11841342|FG000|COMPLETED|Overall Study||3
10678938|NCT02387216|11841343|FG001|COMPLETED|Overall Study||2
10678939|NCT02387216|11841342|FG000|NOT COMPLETED|Overall Study||100
10678940|NCT02387216|11841343|FG001|NOT COMPLETED|Overall Study||47
10678941|NCT02387268|11841349|FG000|STARTED|Overall Study||10
10678942|NCT02387268|11841349|FG000|COMPLETED|Overall Study||9
10678943|NCT02387268|11841349|FG000|NOT COMPLETED|Overall Study||1
10678944|NCT02387294|11841355|FG000|STARTED|Overall Study||60
10678945|NCT02387294|11841356|FG001|STARTED|Overall Study||60
10798792|NCT03828422|11959314|FG000|COMPLETED|Overall Study||36
10678946|NCT02387294|11841355|FG000|COMPLETED|Overall Study||60
10678947|NCT02387294|11841356|FG001|COMPLETED|Overall Study||60
10678948|NCT02387294|11841355|FG000|NOT COMPLETED|Overall Study||0
10678949|NCT02387294|11841356|FG001|NOT COMPLETED|Overall Study||0
10678950|NCT02387359|11841366|FG000|STARTED|Overall Study||354
10678951|NCT02387359|11841367|FG001|STARTED|Overall Study||351
10678952|NCT02387359|11841368|FG002|STARTED|Overall Study||349
10678953|NCT02387359|11841366|FG000|COMPLETED|Overall Study||295
10678954|NCT02387359|11841367|FG001|COMPLETED|Overall Study||309
10678955|NCT02387359|11841368|FG002|COMPLETED|Overall Study||293
10678956|NCT02387359|11841366|FG000|NOT COMPLETED|Overall Study||59
10678957|NCT02387359|11841367|FG001|NOT COMPLETED|Overall Study||42
10678958|NCT02387359|11841368|FG002|NOT COMPLETED|Overall Study||56
10678959|NCT02387372|11841378|FG000|STARTED|Overall Study||27
10678960|NCT02387372|11841379|FG001|STARTED|Overall Study||10
10678961|NCT02387372|11841378|FG000|Treated|Overall Study||26
10678962|NCT02387372|11841379|FG001|Treated|Overall Study||10
10678963|NCT02387372|11841378|FG000|COMPLETED|Overall Study||26
10678964|NCT02387372|11841379|FG001|COMPLETED|Overall Study||10
10678965|NCT02387372|11841378|FG000|NOT COMPLETED|Overall Study||1
10678966|NCT02387372|11841379|FG001|NOT COMPLETED|Overall Study||0
10678967|NCT02387476|11841395|FG000|STARTED|Overall Study||25
10678968|NCT02387476|11841396|FG001|STARTED|Overall Study||22
10678969|NCT02387476|11841395|FG000|COMPLETED|Overall Study||19
10678970|NCT02387476|11841396|FG001|COMPLETED|Overall Study||17
10678971|NCT02387476|11841395|FG000|NOT COMPLETED|Overall Study||6
10678972|NCT02387476|11841396|FG001|NOT COMPLETED|Overall Study||5
10678973|NCT02387502|11841407|FG000|STARTED|Overall Study||40
10798793|NCT03828422|11959315|FG001|COMPLETED|Overall Study||38
10678974|NCT02387502|11841408|FG001|STARTED|Overall Study||40
10678975|NCT02387502|11841409|FG002|STARTED|Overall Study||40
10678976|NCT02387502|11841407|FG000|COMPLETED|Overall Study||40
10678977|NCT02387502|11841408|FG001|COMPLETED|Overall Study||40
10678978|NCT02387502|11841409|FG002|COMPLETED|Overall Study||40
10678979|NCT02387502|11841407|FG000|NOT COMPLETED|Overall Study||0
10678980|NCT02387502|11841408|FG001|NOT COMPLETED|Overall Study||0
10678981|NCT02387502|11841409|FG002|NOT COMPLETED|Overall Study||0
10678982|NCT02387554|11841421|FG000|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|10
10678983|NCT02387554|11841422|FG001|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|7
10678984|NCT02387554|11841423|FG002|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|8
10678985|NCT02387554|11841424|FG003|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|8
10678986|NCT02387554|11841421|FG000|COMPLETED|Overall Study||7
10678987|NCT02387554|11841422|FG001|COMPLETED|Overall Study||7
10678988|NCT02387554|11841423|FG002|COMPLETED|Overall Study||6
10678989|NCT02387554|11841424|FG003|COMPLETED|Overall Study||6
10678990|NCT02387554|11841421|FG000|NOT COMPLETED|Overall Study||3
10678991|NCT02387554|11841422|FG001|NOT COMPLETED|Overall Study||0
10678992|NCT02387554|11841423|FG002|NOT COMPLETED|Overall Study||2
10678993|NCT02387554|11841424|FG003|NOT COMPLETED|Overall Study||2
10678994|NCT02387580|11841440|FG000|STARTED|Overall Study||8
10678995|NCT02387580|11841441|FG001|STARTED|Overall Study||8
10678996|NCT02387580|11841442|FG002|STARTED|Overall Study||8
10678997|NCT02387580|11841443|FG003|STARTED|Overall Study||8
10678998|NCT02387580|11841444|FG004|STARTED|Overall Study||8
10678999|NCT02387580|11841445|FG005|STARTED|Overall Study||8
10679000|NCT02387580|11841440|FG000|COMPLETED|Overall Study||8
10679001|NCT02387580|11841441|FG001|COMPLETED|Overall Study||8
10679002|NCT02387580|11841442|FG002|COMPLETED|Overall Study||8
10679003|NCT02387580|11841443|FG003|COMPLETED|Overall Study||7
10679004|NCT02387580|11841444|FG004|COMPLETED|Overall Study||8
10679005|NCT02387580|11841445|FG005|COMPLETED|Overall Study||8
10679006|NCT02387580|11841440|FG000|NOT COMPLETED|Overall Study||0
10679007|NCT02387580|11841441|FG001|NOT COMPLETED|Overall Study||0
10679008|NCT02387580|11841442|FG002|NOT COMPLETED|Overall Study||0
10679009|NCT02387580|11841443|FG003|NOT COMPLETED|Overall Study||1
10679010|NCT02387580|11841444|FG004|NOT COMPLETED|Overall Study||0
10679011|NCT02387580|11841445|FG005|NOT COMPLETED|Overall Study||0
10679012|NCT02387710|11841461|FG000|STARTED|First Study Night||9
10679013|NCT02387710|11841462|FG001|STARTED|First Study Night||9
10679014|NCT02387710|11841461|FG000|COMPLETED|First Study Night||9
10679015|NCT02387710|11841462|FG001|COMPLETED|First Study Night||9
10679016|NCT02387710|11841461|FG000|NOT COMPLETED|First Study Night||0
10679017|NCT02387710|11841462|FG001|NOT COMPLETED|First Study Night||0
10679018|NCT02387710|11841461|FG000|STARTED|Second Study Night||9
10679019|NCT02387710|11841462|FG001|STARTED|Second Study Night|2 patients did not come back for excessive sleep disruption due to the equipment|7
10679020|NCT02387710|11841461|FG000|COMPLETED|Second Study Night||9
10679021|NCT02387710|11841462|FG001|COMPLETED|Second Study Night||7
10679022|NCT02387710|11841461|FG000|NOT COMPLETED|Second Study Night||0
10679023|NCT02387710|11841462|FG001|NOT COMPLETED|Second Study Night||0
10679024|NCT02387749|11841470|FG000|STARTED|Overall Study||10
10679025|NCT02387749|11841470|FG000|COMPLETED|Overall Study||10
10679026|NCT02387749|11841470|FG000|NOT COMPLETED|Overall Study||0
10679027|NCT02387762|11841481|FG000|STARTED|Overall Study||16
10679028|NCT02387762|11841482|FG001|STARTED|Overall Study||15
10679029|NCT02387762|11841481|FG000|COMPLETED|Overall Study||15
10679030|NCT02387762|11841482|FG001|COMPLETED|Overall Study||15
10679031|NCT02387762|11841481|FG000|NOT COMPLETED|Overall Study||1
10679032|NCT02387762|11841482|FG001|NOT COMPLETED|Overall Study||0
10679033|NCT02387801|11841490|FG000|STARTED|Induction Dosing Period||6
10679034|NCT02387801|11841491|FG001|STARTED|Induction Dosing Period||6
10679035|NCT02387801|11841490|FG000|COMPLETED|Induction Dosing Period||6
10679036|NCT02387801|11841491|FG001|COMPLETED|Induction Dosing Period||6
10679037|NCT02387801|11841490|FG000|NOT COMPLETED|Induction Dosing Period||0
10679038|NCT02387801|11841491|FG001|NOT COMPLETED|Induction Dosing Period||0
10679039|NCT02387801|11841490|FG000|STARTED|Maintenance Dosing Period|All participants from Induction Dosing Period went to ixe Q4W arm during Maintenance Dosing Period.|0
10679040|NCT02387801|11841491|FG001|STARTED|Maintenance Dosing Period||12
10679041|NCT02387801|11841490|FG000|COMPLETED|Maintenance Dosing Period||0
10679042|NCT02387801|11841491|FG001|COMPLETED|Maintenance Dosing Period||12
10679043|NCT02387801|11841490|FG000|NOT COMPLETED|Maintenance Dosing Period||0
10679044|NCT02387801|11841491|FG001|NOT COMPLETED|Maintenance Dosing Period||0
10679045|NCT02387801|11841490|FG000|STARTED|Post-Treatment Follow-up||0
10679046|NCT02387801|11841491|FG001|STARTED|Post-Treatment Follow-up||12
10679047|NCT02387801|11841490|FG000|COMPLETED|Post-Treatment Follow-up||0
10679048|NCT02387801|11841491|FG001|COMPLETED|Post-Treatment Follow-up||12
10679049|NCT02387801|11841490|FG000|NOT COMPLETED|Post-Treatment Follow-up||0
10679050|NCT02387801|11841491|FG001|NOT COMPLETED|Post-Treatment Follow-up||0
10679051|NCT02387814|11841503|FG000|STARTED|Overall Study||10
10679052|NCT02387814|11841504|FG001|STARTED|Overall Study||9
10679053|NCT02387814|11841505|FG002|STARTED|Overall Study||10
10679054|NCT02387814|11841506|FG003|STARTED|Overall Study||6
10679055|NCT02387814|11841503|FG000|Received Abemaciclib|Overall Study||10
10679056|NCT02387814|11841504|FG001|Received Abemaciclib|Overall Study||9
10679057|NCT02387814|11841505|FG002|Received Abemaciclib|Overall Study||10
10679058|NCT02387814|11841506|FG003|Received Abemaciclib|Overall Study||6
10679059|NCT02387814|11841503|FG000|COMPLETED|Overall Study||10
10679060|NCT02387814|11841504|FG001|COMPLETED|Overall Study||9
10679061|NCT02387814|11841505|FG002|COMPLETED|Overall Study||10
10679062|NCT02387814|11841506|FG003|COMPLETED|Overall Study||6
10679063|NCT02387814|11841503|FG000|NOT COMPLETED|Overall Study||0
10679064|NCT02387814|11841504|FG001|NOT COMPLETED|Overall Study||0
10679065|NCT02387814|11841505|FG002|NOT COMPLETED|Overall Study||0
10679066|NCT02387814|11841506|FG003|NOT COMPLETED|Overall Study||0
10679067|NCT02387840|11841522|FG000|STARTED|Overall Study||4
10679068|NCT02387840|11841523|FG001|STARTED|Overall Study||6
10679069|NCT02387840|11841524|FG002|STARTED|Overall Study||6
10679070|NCT02387840|11841525|FG003|STARTED|Overall Study||8
10679071|NCT02387840|11841526|FG004|STARTED|Overall Study||4
10679072|NCT02387840|11841527|FG005|STARTED|Overall Study||6
10679073|NCT02387840|11841522|FG000|COMPLETED|Overall Study||4
10679074|NCT02387840|11841523|FG001|COMPLETED|Overall Study||6
10679075|NCT02387840|11841524|FG002|COMPLETED|Overall Study||6
10679076|NCT02387840|11841525|FG003|COMPLETED|Overall Study||8
10679077|NCT02387840|11841526|FG004|COMPLETED|Overall Study||4
10679078|NCT02387840|11841527|FG005|COMPLETED|Overall Study||5
10679079|NCT02387840|11841522|FG000|NOT COMPLETED|Overall Study||0
10679080|NCT02387840|11841523|FG001|NOT COMPLETED|Overall Study||0
10679081|NCT02387840|11841524|FG002|NOT COMPLETED|Overall Study||0
10679082|NCT02387840|11841525|FG003|NOT COMPLETED|Overall Study||0
10679083|NCT02387840|11841526|FG004|NOT COMPLETED|Overall Study||0
10679084|NCT02387840|11841527|FG005|NOT COMPLETED|Overall Study||1
10679085|NCT02387853|11841547|FG000|STARTED|Overall Study||106
10679086|NCT02387853|11841547|FG000|COMPLETED|Overall Study||103
10679087|NCT02387853|11841547|FG000|NOT COMPLETED|Overall Study||3
10679088|NCT02387957|11841554|FG000|STARTED|Overall Study||21
10679089|NCT02387957|11841555|FG001|STARTED|Overall Study||21
10679090|NCT02387957|11841556|FG002|STARTED|Overall Study||21
10679091|NCT02387957|11841554|FG000|COMPLETED|Overall Study|The study was discontinued|0
10679092|NCT02387957|11841555|FG001|COMPLETED|Overall Study|The study was discontinued|0
10679093|NCT02387957|11841556|FG002|COMPLETED|Overall Study|The study was discontinued|1
10679094|NCT02387957|11841554|FG000|NOT COMPLETED|Overall Study||21
10679095|NCT02387957|11841555|FG001|NOT COMPLETED|Overall Study||21
10679096|NCT02387957|11841556|FG002|NOT COMPLETED|Overall Study||20
10679097|NCT02387970|11841566|FG000|STARTED|Overall Study||27
10679098|NCT02387970|11841567|FG001|STARTED|Overall Study||25
10679099|NCT02387970|11841566|FG000|COMPLETED|Overall Study||26
10679100|NCT02387970|11841567|FG001|COMPLETED|Overall Study||23
10679101|NCT02387970|11841566|FG000|NOT COMPLETED|Overall Study||1
10679102|NCT02387970|11841567|FG001|NOT COMPLETED|Overall Study||2
10679103|NCT02387983|11841573|FG000|STARTED|Overall Study||65
10679104|NCT02387983|11841573|FG000|COMPLETED|Overall Study||58
10679105|NCT02387983|11841573|FG000|NOT COMPLETED|Overall Study||7
10679106|NCT02388074|11841577|FG000|STARTED|Overall Study||25
10679107|NCT02388074|11841577|FG000|COMPLETED|Overall Study||22
10679108|NCT02388074|11841577|FG000|NOT COMPLETED|Overall Study||3
10679109|NCT02388165|11841583|FG000|STARTED|Overall Study||1726
10679110|NCT02388165|11841584|FG001|STARTED|Overall Study||1724
10679111|NCT02388165|11841583|FG000|Vaccinated (Safety Population)|Overall Study||1708
10679112|NCT02388165|11841584|FG001|Vaccinated (Safety Population)|Overall Study||1709
10679113|NCT02388165|11841583|FG000|COMPLETED|Overall Study||1599
10679114|NCT02388165|11841584|FG001|COMPLETED|Overall Study||1594
10679115|NCT02388165|11841583|FG000|NOT COMPLETED|Overall Study||127
10679116|NCT02388165|11841584|FG001|NOT COMPLETED|Overall Study||130
10679117|NCT02388191|11841592|FG000|STARTED|Overall Study||59
10679118|NCT02388191|11841593|FG001|STARTED|Overall Study||60
10679119|NCT02388191|11841592|FG000|COMPLETED|Overall Study||58
10679120|NCT02388191|11841593|FG001|COMPLETED|Overall Study||60
10679121|NCT02388191|11841592|FG000|NOT COMPLETED|Overall Study||1
10679122|NCT02388191|11841593|FG001|NOT COMPLETED|Overall Study||0
10679123|NCT02388269|11841603|FG000|STARTED|Overall Study||41
10679124|NCT02388269|11841604|FG001|STARTED|Overall Study||40
10679125|NCT02388269|11841605|FG002|STARTED|Overall Study||10
10679126|NCT02388269|11841603|FG000|Randomised Period|Overall Study||41
10679127|NCT02388269|11841604|FG001|Randomised Period|Overall Study||40
10679128|NCT02388269|11841605|FG002|Randomised Period|Overall Study||0
10679129|NCT02388269|11841603|FG000|Open Label|Overall Study||37
10679130|NCT02388269|11841604|FG001|Open Label|Overall Study||38
10679131|NCT02388269|11841605|FG002|Open Label|Overall Study||0
10679132|NCT02388269|11841603|FG000|COMPLETED|Overall Study||32
10679133|NCT02388269|11841604|FG001|COMPLETED|Overall Study||38
10679134|NCT02388269|11841605|FG002|COMPLETED|Overall Study||0
10679135|NCT02388269|11841603|FG000|NOT COMPLETED|Overall Study||9
10679136|NCT02388269|11841604|FG001|NOT COMPLETED|Overall Study||2
10679137|NCT02388269|11841605|FG002|NOT COMPLETED|Overall Study||10
10679138|NCT02388295|11841632|FG000|STARTED|Dose Escalation Week 1|Number randomized to treatment|19
10679139|NCT02388295|11841633|FG001|STARTED|Dose Escalation Week 1|Number randomized to treatment|19
10679140|NCT02388295|11841634|FG002|STARTED|Dose Escalation Week 1|Number randomized to treatment|20
10679141|NCT02388295|11841632|FG000|COMPLETED|Dose Escalation Week 1||17
10679142|NCT02388295|11841633|FG001|COMPLETED|Dose Escalation Week 1||16
10679143|NCT02388295|11841634|FG002|COMPLETED|Dose Escalation Week 1||18
10679144|NCT02388295|11841632|FG000|NOT COMPLETED|Dose Escalation Week 1||2
10679145|NCT02388295|11841633|FG001|NOT COMPLETED|Dose Escalation Week 1||3
10679146|NCT02388295|11841634|FG002|NOT COMPLETED|Dose Escalation Week 1||2
10679147|NCT02388295|11841632|FG000|STARTED|Dose Escalation Week 2||17
10679148|NCT02388295|11841633|FG001|STARTED|Dose Escalation Week 2||16
10679149|NCT02388295|11841634|FG002|STARTED|Dose Escalation Week 2||18
10679150|NCT02388295|11841632|FG000|COMPLETED|Dose Escalation Week 2||16
10679151|NCT02388295|11841633|FG001|COMPLETED|Dose Escalation Week 2||14
10679152|NCT02388295|11841634|FG002|COMPLETED|Dose Escalation Week 2||17
10679153|NCT02388295|11841632|FG000|NOT COMPLETED|Dose Escalation Week 2||1
10679154|NCT02388295|11841633|FG001|NOT COMPLETED|Dose Escalation Week 2||2
10679155|NCT02388295|11841634|FG002|NOT COMPLETED|Dose Escalation Week 2||1
10679156|NCT02388295|11841632|FG000|STARTED|Treatment Weeks 3 to 12||16
10679157|NCT02388295|11841633|FG001|STARTED|Treatment Weeks 3 to 12||14
10679158|NCT02388295|11841634|FG002|STARTED|Treatment Weeks 3 to 12||17
10679159|NCT02388295|11841632|FG000|COMPLETED|Treatment Weeks 3 to 12||15
10679160|NCT02388295|11841633|FG001|COMPLETED|Treatment Weeks 3 to 12||13
10679161|NCT02388295|11841634|FG002|COMPLETED|Treatment Weeks 3 to 12||17
10679162|NCT02388295|11841632|FG000|NOT COMPLETED|Treatment Weeks 3 to 12||1
10679163|NCT02388295|11841633|FG001|NOT COMPLETED|Treatment Weeks 3 to 12||1
10679164|NCT02388295|11841634|FG002|NOT COMPLETED|Treatment Weeks 3 to 12||0
10679165|NCT02388321|11841644|FG000|STARTED|Overall Study||11
10679166|NCT02388321|11841645|FG001|STARTED|Overall Study||11
10679167|NCT02388321|11841644|FG000|COMPLETED|Overall Study||11
10679168|NCT02388321|11841645|FG001|COMPLETED|Overall Study||11
10679169|NCT02388321|11841644|FG000|NOT COMPLETED|Overall Study||0
10679170|NCT02388321|11841645|FG001|NOT COMPLETED|Overall Study||0
10679171|NCT02388347|11841656|FG000|STARTED|Overall Study||8
10679172|NCT02388347|11841657|FG001|STARTED|Overall Study||6
10679173|NCT02388347|11841658|FG002|STARTED|Overall Study||6
10679174|NCT02388347|11841659|FG003|STARTED|Overall Study||6
10679175|NCT02388347|11841660|FG004|STARTED|Overall Study||6
10679176|NCT02388347|11841656|FG000|COMPLETED|Overall Study||8
10679177|NCT02388347|11841657|FG001|COMPLETED|Overall Study||6
10679178|NCT02388347|11841658|FG002|COMPLETED|Overall Study||5
10679179|NCT02388347|11841659|FG003|COMPLETED|Overall Study||6
10679180|NCT02388347|11841660|FG004|COMPLETED|Overall Study||6
10679181|NCT02388347|11841656|FG000|NOT COMPLETED|Overall Study||0
10679182|NCT02388347|11841657|FG001|NOT COMPLETED|Overall Study||0
10679183|NCT02388347|11841658|FG002|NOT COMPLETED|Overall Study||1
10679184|NCT02388347|11841659|FG003|NOT COMPLETED|Overall Study||0
10679185|NCT02388347|11841660|FG004|NOT COMPLETED|Overall Study||0
10679186|NCT02388386|11841676|FG000|STARTED|Overall Study||10
10679187|NCT02388386|11841676|FG000|COMPLETED|Overall Study||10
10679188|NCT02388386|11841676|FG000|NOT COMPLETED|Overall Study||0
10679189|NCT02388568|11841686|FG000|STARTED|Overall Study||69
10679190|NCT02388568|11841687|FG001|STARTED|Overall Study||68
10679191|NCT02388568|11841686|FG000|COMPLETED|Overall Study||59
10679192|NCT02388568|11841687|FG001|COMPLETED|Overall Study||53
10679193|NCT02388568|11841686|FG000|NOT COMPLETED|Overall Study||10
10679194|NCT02388568|11841687|FG001|NOT COMPLETED|Overall Study||15
10679195|NCT02388633|11841693|FG000|STARTED|Overall Study||8
10679196|NCT02388633|11841693|FG000|COMPLETED|Overall Study||8
10679197|NCT02388633|11841693|FG000|NOT COMPLETED|Overall Study||0
10679198|NCT02388646|11841700|FG000|STARTED|Overall Study||20
10679199|NCT02388646|11841701|FG001|STARTED|Overall Study||20
10679200|NCT02388646|11841702|FG002|STARTED|Overall Study||20
10679201|NCT02388646|11841700|FG000|COMPLETED|Overall Study||16
10679202|NCT02388646|11841701|FG001|COMPLETED|Overall Study||19
10679203|NCT02388646|11841702|FG002|COMPLETED|Overall Study||14
10679204|NCT02388646|11841700|FG000|NOT COMPLETED|Overall Study||4
10679205|NCT02388646|11841701|FG001|NOT COMPLETED|Overall Study||1
10679206|NCT02388646|11841702|FG002|NOT COMPLETED|Overall Study||6
10679207|NCT02388724|11841712|FG000|STARTED|Overall Study||244
10679208|NCT02388724|11841713|FG001|STARTED|Overall Study||237
10679209|NCT02388724|11841712|FG000|Safety Set: Randomized But Not Treated|Overall Study||0
10798794|NCT03828422|11959314|FG000|NOT COMPLETED|Overall Study||4
10798795|NCT03828422|11959315|FG001|NOT COMPLETED|Overall Study||4
10798796|NCT03829228|11959322|FG000|STARTED|Overall Study||30
10798797|NCT03829228|11959322|FG000|COMPLETED|Overall Study||29
10798798|NCT03829228|11959322|FG000|NOT COMPLETED|Overall Study||1
10679210|NCT02388724|11841713|FG001|Safety Set: Randomized But Not Treated|Overall Study||2
10679211|NCT02388724|11841712|FG000|COMPLETED|Overall Study||232
10679212|NCT02388724|11841713|FG001|COMPLETED|Overall Study||224
10679213|NCT02388724|11841712|FG000|NOT COMPLETED|Overall Study||12
10679214|NCT02388724|11841713|FG001|NOT COMPLETED|Overall Study||13
10679215|NCT02388737|11841722|FG000|STARTED|Overall Study||235
10679216|NCT02388737|11841723|FG001|STARTED|Overall Study||226
10679217|NCT02388737|11841724|FG002|STARTED|Overall Study||242
10679218|NCT02388737|11841722|FG000|COMPLETED|Overall Study||181
10679219|NCT02388737|11841723|FG001|COMPLETED|Overall Study||166
10679220|NCT02388737|11841724|FG002|COMPLETED|Overall Study||180
10679221|NCT02388737|11841722|FG000|NOT COMPLETED|Overall Study||54
10679222|NCT02388737|11841723|FG001|NOT COMPLETED|Overall Study||60
10679223|NCT02388737|11841724|FG002|NOT COMPLETED|Overall Study||62
10679224|NCT02388763|11841732|FG000|STARTED|Habitual, 10 Days of Wear||32
10679225|NCT02388763|11841733|FG001|STARTED|Habitual, 10 Days of Wear||32
10679226|NCT02388763|11841732|FG000|COMPLETED|Habitual, 10 Days of Wear||31
10679227|NCT02388763|11841733|FG001|COMPLETED|Habitual, 10 Days of Wear||31
10679228|NCT02388763|11841732|FG000|NOT COMPLETED|Habitual, 10 Days of Wear||1
10679229|NCT02388763|11841733|FG001|NOT COMPLETED|Habitual, 10 Days of Wear||1
10798799|NCT03829618|11959329|FG000|STARTED|Overall Study||15
10798800|NCT03829618|11959330|FG001|STARTED|Overall Study||7
10798801|NCT03829618|11959331|FG002|STARTED|Overall Study||7
10679230|NCT02388763|11841732|FG000|STARTED|Period 1, 10 Days of Wear||31
10679231|NCT02388763|11841733|FG001|STARTED|Period 1, 10 Days of Wear||31
10679232|NCT02388763|11841732|FG000|COMPLETED|Period 1, 10 Days of Wear||30
10679233|NCT02388763|11841733|FG001|COMPLETED|Period 1, 10 Days of Wear||30
10679234|NCT02388763|11841732|FG000|NOT COMPLETED|Period 1, 10 Days of Wear||1
10679235|NCT02388763|11841733|FG001|NOT COMPLETED|Period 1, 10 Days of Wear||1
10679236|NCT02388763|11841732|FG000|STARTED|Period 2, 10 Days of Wear||30
10679237|NCT02388763|11841733|FG001|STARTED|Period 2, 10 Days of Wear||30
10679238|NCT02388763|11841732|FG000|COMPLETED|Period 2, 10 Days of Wear||30
10679239|NCT02388763|11841733|FG001|COMPLETED|Period 2, 10 Days of Wear||30
10679240|NCT02388763|11841732|FG000|NOT COMPLETED|Period 2, 10 Days of Wear||0
10679241|NCT02388763|11841733|FG001|NOT COMPLETED|Period 2, 10 Days of Wear||0
10679242|NCT02388815|11841742|FG000|STARTED|Overall Study||89
10679243|NCT02388815|11841742|FG000|COMPLETED|Overall Study||85
10679244|NCT02388815|11841742|FG000|NOT COMPLETED|Overall Study||4
10712743|NCT02672852|11878286|FG006|STARTED|Part A2||0
10712744|NCT02672852|11878280|FG000|COMPLETED|Part A2||0
10712745|NCT02672852|11878281|FG001|COMPLETED|Part A2||0
10712746|NCT02672852|11878282|FG002|COMPLETED|Part A2||83
10712747|NCT02672852|11878283|FG003|COMPLETED|Part A2||399
10712748|NCT02672852|11878284|FG004|COMPLETED|Part A2||0
10712749|NCT02672852|11878285|FG005|COMPLETED|Part A2||0
10712750|NCT02672852|11878286|FG006|COMPLETED|Part A2||0
10712751|NCT02672852|11878280|FG000|NOT COMPLETED|Part A2||0
10712752|NCT02672852|11878281|FG001|NOT COMPLETED|Part A2||0
10712753|NCT02672852|11878282|FG002|NOT COMPLETED|Part A2||10
10712754|NCT02672852|11878283|FG003|NOT COMPLETED|Part A2||4
10712755|NCT02672852|11878284|FG004|NOT COMPLETED|Part A2||0
10712756|NCT02672852|11878285|FG005|NOT COMPLETED|Part A2||0
10712757|NCT02672852|11878286|FG006|NOT COMPLETED|Part A2||0
10712758|NCT02672852|11878280|FG000|STARTED|Part B||0
10712759|NCT02672852|11878281|FG001|STARTED|Part B||0
10712760|NCT02672852|11878282|FG002|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|0
10712761|NCT02672852|11878283|FG003|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|0
10712762|NCT02672852|11878284|FG004|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|225
10712763|NCT02672852|11878285|FG005|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|111
10712764|NCT02672852|11878286|FG006|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|63
10712765|NCT02672852|11878280|FG000|COMPLETED|Part B||0
10712766|NCT02672852|11878281|FG001|COMPLETED|Part B||0
10712767|NCT02672852|11878282|FG002|COMPLETED|Part B||0
10712768|NCT02672852|11878283|FG003|COMPLETED|Part B||0
10712769|NCT02672852|11878284|FG004|COMPLETED|Part B||209
10712770|NCT02672852|11878285|FG005|COMPLETED|Part B||100
10712771|NCT02672852|11878286|FG006|COMPLETED|Part B||51
10712772|NCT02672852|11878280|FG000|NOT COMPLETED|Part B||0
10712773|NCT02672852|11878281|FG001|NOT COMPLETED|Part B||0
10712774|NCT02672852|11878282|FG002|NOT COMPLETED|Part B||0
10712775|NCT02672852|11878283|FG003|NOT COMPLETED|Part B||0
10712776|NCT02672852|11878284|FG004|NOT COMPLETED|Part B||16
10712777|NCT02672852|11878285|FG005|NOT COMPLETED|Part B||11
10712778|NCT02672852|11878286|FG006|NOT COMPLETED|Part B||12
10712779|NCT02673138|11878297|FG000|STARTED|Overall Study||10
10712780|NCT02673138|11878297|FG000|Started Day 1|Overall Study||10
10712781|NCT02673138|11878297|FG000|Ended Day 1|Overall Study||10
10712782|NCT02673138|11878297|FG000|Started Day 2|Overall Study||10
10712783|NCT02673138|11878297|FG000|Ended Day 2|Overall Study||10
10712784|NCT02673138|11878297|FG000|COMPLETED|Overall Study||10
10712785|NCT02673138|11878297|FG000|NOT COMPLETED|Overall Study||0
10712786|NCT02673372|11878305|FG000|STARTED|Overall Study||30
10712787|NCT02673372|11878306|FG001|STARTED|Overall Study||30
10712788|NCT02673372|11878305|FG000|COMPLETED|Overall Study||30
10712789|NCT02673372|11878306|FG001|COMPLETED|Overall Study||30
10712790|NCT02673372|11878305|FG000|NOT COMPLETED|Overall Study||0
10712791|NCT02673372|11878306|FG001|NOT COMPLETED|Overall Study||0
10712792|NCT02673489|11878314|FG000|STARTED|Treatment Period||54
10712793|NCT02673489|11878315|FG001|STARTED|Treatment Period||24
10712794|NCT02673489|11878314|FG000|COMPLETED|Treatment Period||49
10712795|NCT02673489|11878315|FG001|COMPLETED|Treatment Period||21
10712796|NCT02673489|11878314|FG000|NOT COMPLETED|Treatment Period||5
10712797|NCT02673489|11878315|FG001|NOT COMPLETED|Treatment Period||3
10712798|NCT02673489|11878314|FG000|STARTED|Follow Up Period||50
10712799|NCT02673489|11878315|FG001|STARTED|Follow Up Period||23
10712800|NCT02673489|11878314|FG000|COMPLETED|Follow Up Period||50
10712801|NCT02673489|11878315|FG001|COMPLETED|Follow Up Period||21
10712802|NCT02673489|11878314|FG000|NOT COMPLETED|Follow Up Period||0
10712803|NCT02673489|11878315|FG001|NOT COMPLETED|Follow Up Period||2
10712804|NCT02673515|11878324|FG000|STARTED|Overall Study||30
10712805|NCT02673515|11878325|FG001|STARTED|Overall Study||30
10712806|NCT02673515|11878324|FG000|COMPLETED|Overall Study||28
10712807|NCT02673515|11878325|FG001|COMPLETED|Overall Study||29
10712808|NCT02673515|11878324|FG000|NOT COMPLETED|Overall Study||2
10712809|NCT02673515|11878325|FG001|NOT COMPLETED|Overall Study||1
10712810|NCT02673541|11878333|FG000|STARTED|Overall Study||3
10712811|NCT02673541|11878334|FG001|STARTED|Overall Study||2
10712812|NCT02673541|11878333|FG000|COMPLETED|Overall Study||3
10712813|NCT02673541|11878334|FG001|COMPLETED|Overall Study||2
10712814|NCT02673541|11878333|FG000|NOT COMPLETED|Overall Study||0
10712815|NCT02673541|11878334|FG001|NOT COMPLETED|Overall Study||0
10712816|NCT02673619|11878344|FG000|STARTED|Overall Study||20
10712817|NCT02673619|11878345|FG001|STARTED|Overall Study||5
10712818|NCT02673619|11878346|FG002|STARTED|Overall Study||26
10679245|NCT02388880|11841746|FG000|STARTED|Overall Study||3
10679246|NCT02388880|11841746|FG000|COMPLETED|Overall Study||3
10679247|NCT02388880|11841746|FG000|NOT COMPLETED|Overall Study||0
10679248|NCT02388932|11841750|FG000|STARTED|Overall Study||3
10679249|NCT02388932|11841750|FG000|COMPLETED|Overall Study||2
10679250|NCT02388932|11841750|FG000|NOT COMPLETED|Overall Study||1
10679251|NCT02388997|11841757|FG000|STARTED|Overall Study||15
10679252|NCT02388997|11841758|FG001|STARTED|Overall Study||16
10679253|NCT02388997|11841757|FG000|COMPLETED|Overall Study||12
10679254|NCT02388997|11841758|FG001|COMPLETED|Overall Study||10
10679255|NCT02388997|11841757|FG000|NOT COMPLETED|Overall Study||3
10679256|NCT02388997|11841758|FG001|NOT COMPLETED|Overall Study||6
10679257|NCT02389088|11841764|FG000|STARTED|Overall Study - Phase I||9
10679258|NCT02389088|11841764|FG000|COMPLETED|Overall Study - Phase I||9
10679259|NCT02389088|11841764|FG000|NOT COMPLETED|Overall Study - Phase I||0
10679260|NCT02389088|11841764|FG000|STARTED|Phase II - All Study Participants||9
10679261|NCT02389088|11841764|FG000|COMPLETED|Phase II - All Study Participants||9
10679262|NCT02389088|11841764|FG000|NOT COMPLETED|Phase II - All Study Participants||0
10679263|NCT02389101|11841778|FG000|STARTED|Overall Study||21
10679264|NCT02389101|11841778|FG000|COMPLETED|Overall Study||21
10679265|NCT02389101|11841778|FG000|NOT COMPLETED|Overall Study||0
10679266|NCT02389361|11841784|FG000|STARTED|Overall Study||24
10679267|NCT02389361|11841785|FG001|STARTED|Overall Study||27
10679268|NCT02389361|11841784|FG000|COMPLETED|Overall Study||24
10679269|NCT02389361|11841785|FG001|COMPLETED|Overall Study||27
10679270|NCT02389361|11841784|FG000|NOT COMPLETED|Overall Study||0
10679271|NCT02389361|11841785|FG001|NOT COMPLETED|Overall Study||0
10679272|NCT02389452|11841791|FG000|STARTED|Overall Study||394
10679273|NCT02389452|11841791|FG000|Participants Received Repeat Injection|Overall Study|Repeat injection based on physician's assessment of efficacy and safety at Week 26, 39 or 52.|11
10679274|NCT02389452|11841791|FG000|COMPLETED|Overall Study||369
10679275|NCT02389452|11841791|FG000|NOT COMPLETED|Overall Study||25
10679276|NCT02389621|11841798|FG000|STARTED|Treatment Period||108
10679277|NCT02389621|11841799|FG001|STARTED|Treatment Period||107
10679278|NCT02389621|11841798|FG000|Received Study Drug|Treatment Period||107
10679279|NCT02389621|11841799|FG001|Received Study Drug|Treatment Period||107
10679280|NCT02389621|11841798|FG000|COMPLETED|Treatment Period||107
10679281|NCT02389621|11841799|FG001|COMPLETED|Treatment Period||106
10679282|NCT02389621|11841798|FG000|NOT COMPLETED|Treatment Period||1
10679283|NCT02389621|11841799|FG001|NOT COMPLETED|Treatment Period||1
10679284|NCT02389621|11841798|FG000|STARTED|Posttreatment Period||107
10679285|NCT02389621|11841799|FG001|STARTED|Posttreatment Period||106
10679286|NCT02389621|11841798|FG000|COMPLETED|Posttreatment Period||98
10679287|NCT02389621|11841799|FG001|COMPLETED|Posttreatment Period||102
10679288|NCT02389621|11841798|FG000|NOT COMPLETED|Posttreatment Period||9
10679289|NCT02389621|11841799|FG001|NOT COMPLETED|Posttreatment Period||4
10679290|NCT02389725|11841811|FG000|STARTED|Overall Study||59
10679291|NCT02389725|11841812|FG001|STARTED|Overall Study||60
10679292|NCT02389725|11841811|FG000|COMPLETED|Overall Study||59
10679293|NCT02389725|11841812|FG001|COMPLETED|Overall Study||60
10679294|NCT02389725|11841811|FG000|NOT COMPLETED|Overall Study||0
10679295|NCT02389725|11841812|FG001|NOT COMPLETED|Overall Study||0
10679296|NCT02389738|11841820|FG000|STARTED|Overall Study||6
10679297|NCT02389738|11841820|FG000|COMPLETED|Overall Study||5
10679298|NCT02389738|11841820|FG000|NOT COMPLETED|Overall Study||1
10679299|NCT02389764|11841824|FG000|STARTED|Overall Study||9
10679300|NCT02389764|11841824|FG000|COMPLETED|Overall Study||0
10679301|NCT02389764|11841824|FG000|NOT COMPLETED|Overall Study||9
10679302|NCT02389816|11841831|FG000|STARTED|Overall Study||164
10679303|NCT02389816|11841832|FG001|STARTED|Overall Study||165
10679304|NCT02389816|11841833|FG002|STARTED|Overall Study||164
10679305|NCT02389816|11841831|FG000|COMPLETED|Overall Study||149
10679306|NCT02389816|11841832|FG001|COMPLETED|Overall Study||152
10679307|NCT02389816|11841833|FG002|COMPLETED|Overall Study||152
10679308|NCT02389816|11841831|FG000|NOT COMPLETED|Overall Study||15
10679309|NCT02389816|11841832|FG001|NOT COMPLETED|Overall Study||13
10679310|NCT02389816|11841833|FG002|NOT COMPLETED|Overall Study||12
10679311|NCT02389829|11841843|FG000|STARTED|Overall Study||64
10679312|NCT02389829|11841844|FG001|STARTED|Overall Study||63
10679313|NCT02389829|11841843|FG000|COMPLETED|Overall Study||64
10679314|NCT02389829|11841844|FG001|COMPLETED|Overall Study||62
10679315|NCT02389829|11841843|FG000|NOT COMPLETED|Overall Study||0
10679316|NCT02389829|11841844|FG001|NOT COMPLETED|Overall Study||1
10679317|NCT02389881|11841857|FG000|STARTED|Overall Study||6
10679318|NCT02389881|11841858|FG001|STARTED|Overall Study||6
10679319|NCT02389881|11841859|FG002|STARTED|Overall Study||6
10679320|NCT02389881|11841860|FG003|STARTED|Overall Study||6
10679321|NCT02389881|11841861|FG004|STARTED|Overall Study||6
10679322|NCT02389881|11841862|FG005|STARTED|Overall Study||8
10679323|NCT02389881|11841863|FG006|STARTED|Overall Study||2
10679324|NCT02389881|11841857|FG000|COMPLETED|Overall Study||6
10679325|NCT02389881|11841858|FG001|COMPLETED|Overall Study||6
10679326|NCT02389881|11841859|FG002|COMPLETED|Overall Study||6
10679327|NCT02389881|11841860|FG003|COMPLETED|Overall Study||6
10679328|NCT02389881|11841861|FG004|COMPLETED|Overall Study||6
10679329|NCT02389881|11841862|FG005|COMPLETED|Overall Study||8
10679330|NCT02389881|11841863|FG006|COMPLETED|Overall Study||2
10679331|NCT02389881|11841857|FG000|NOT COMPLETED|Overall Study||0
10679332|NCT02389881|11841858|FG001|NOT COMPLETED|Overall Study||0
10679333|NCT02389881|11841859|FG002|NOT COMPLETED|Overall Study||0
10679334|NCT02389881|11841860|FG003|NOT COMPLETED|Overall Study||0
10679335|NCT02389881|11841861|FG004|NOT COMPLETED|Overall Study||0
10679336|NCT02389881|11841862|FG005|NOT COMPLETED|Overall Study||0
10679337|NCT02389881|11841863|FG006|NOT COMPLETED|Overall Study||0
10798802|NCT03829618|11959329|FG000|COMPLETED|Overall Study||15
10798803|NCT03829618|11959330|FG001|COMPLETED|Overall Study||7
10798804|NCT03829618|11959331|FG002|COMPLETED|Overall Study||7
10798805|NCT03829618|11959329|FG000|NOT COMPLETED|Overall Study||0
10798806|NCT03829618|11959330|FG001|NOT COMPLETED|Overall Study||0
10798807|NCT03829618|11959331|FG002|NOT COMPLETED|Overall Study||0
10798808|NCT03830333|11959341|FG000|STARTED|Overall Study||134
10798809|NCT03830333|11959342|FG001|STARTED|Overall Study||134
10798810|NCT03830333|11959341|FG000|Clinically Evaluable Population|Overall Study||105
10798811|NCT03830333|11959342|FG001|Clinically Evaluable Population|Overall Study||116
10679338|NCT02389894|11841882|FG000|STARTED|Overall Study||133
10679339|NCT02389894|11841883|FG001|STARTED|Overall Study||118
10679340|NCT02389894|11841884|FG002|STARTED|Overall Study||132
10679341|NCT02389894|11841882|FG000|COMPLETED|Overall Study||125
10679342|NCT02389894|11841883|FG001|COMPLETED|Overall Study||108
10679343|NCT02389894|11841884|FG002|COMPLETED|Overall Study||123
10679344|NCT02389894|11841882|FG000|NOT COMPLETED|Overall Study||8
10679345|NCT02389894|11841883|FG001|NOT COMPLETED|Overall Study||10
10679346|NCT02389894|11841884|FG002|NOT COMPLETED|Overall Study||9
10679347|NCT02389959|11841894|FG000|STARTED|Overall Study||20
10679348|NCT02389959|11841895|FG001|STARTED|Overall Study||20
10679349|NCT02389959|11841894|FG000|COMPLETED|Overall Study||18
10679350|NCT02389959|11841895|FG001|COMPLETED|Overall Study||19
10679351|NCT02389959|11841894|FG000|NOT COMPLETED|Overall Study||2
10679352|NCT02389959|11841895|FG001|NOT COMPLETED|Overall Study||1
10679353|NCT02389998|11841903|FG000|STARTED|Overall Study||16
10679354|NCT02389998|11841904|FG001|STARTED|Overall Study||15
10679355|NCT02389998|11841903|FG000|COMPLETED|Overall Study||15
10679356|NCT02389998|11841904|FG001|COMPLETED|Overall Study||15
10679357|NCT02389998|11841903|FG000|NOT COMPLETED|Overall Study||1
10679358|NCT02389998|11841904|FG001|NOT COMPLETED|Overall Study||0
10679359|NCT02390050|11841916|FG000|STARTED|Overall Study||72
10679360|NCT02390050|11841917|FG001|STARTED|Overall Study||72
10679361|NCT02390050|11841918|FG002|STARTED|Overall Study||72
10679362|NCT02390050|11841919|FG003|STARTED|Overall Study||76
10679363|NCT02390050|11841916|FG000|COMPLETED|Overall Study||65
10679364|NCT02390050|11841917|FG001|COMPLETED|Overall Study||67
10679365|NCT02390050|11841918|FG002|COMPLETED|Overall Study||68
10679366|NCT02390050|11841919|FG003|COMPLETED|Overall Study||69
10679367|NCT02390050|11841916|FG000|NOT COMPLETED|Overall Study||7
10679368|NCT02390050|11841917|FG001|NOT COMPLETED|Overall Study||5
10679369|NCT02390050|11841918|FG002|NOT COMPLETED|Overall Study||4
10679370|NCT02390050|11841919|FG003|NOT COMPLETED|Overall Study||7
10679371|NCT02390076|11841932|FG000|STARTED|Overall Study||18
10679372|NCT02390076|11841933|FG001|STARTED|Overall Study||18
10679373|NCT02390076|11841934|FG002|STARTED|Overall Study||15
10679374|NCT02390076|11841932|FG000|COMPLETED|Overall Study||16
10679375|NCT02390076|11841933|FG001|COMPLETED|Overall Study||17
10679376|NCT02390076|11841934|FG002|COMPLETED|Overall Study||11
10679377|NCT02390076|11841932|FG000|NOT COMPLETED|Overall Study||2
10679378|NCT02390076|11841933|FG001|NOT COMPLETED|Overall Study||1
10679379|NCT02390076|11841934|FG002|NOT COMPLETED|Overall Study||4
10679380|NCT02390167|11841942|FG000|STARTED|Overall Study||376
10679381|NCT02390167|11841942|FG000|With Diabetes|Overall Study||333
10679382|NCT02390167|11841942|FG000|Without Diabetes|Overall Study||43
10679383|NCT02390167|11841942|FG000|COMPLETED|Overall Study||375
10679384|NCT02390167|11841942|FG000|NOT COMPLETED|Overall Study||1
10679385|NCT02390219|11841950|FG000|STARTED|Overall Study||46
10679386|NCT02390219|11841950|FG000|COMPLETED|Overall Study||33
10679387|NCT02390219|11841950|FG000|NOT COMPLETED|Overall Study||13
10679388|NCT02390557|11841957|FG000|STARTED|Wave 1||160
10679389|NCT02390557|11841958|FG001|STARTED|Wave 1||156
10679390|NCT02390557|11841959|FG002|STARTED|Wave 1||135
10679391|NCT02390557|11841957|FG000|COMPLETED|Wave 1||160
10679392|NCT02390557|11841958|FG001|COMPLETED|Wave 1||156
10679393|NCT02390557|11841959|FG002|COMPLETED|Wave 1||135
10679394|NCT02390557|11841957|FG000|NOT COMPLETED|Wave 1||0
10679395|NCT02390557|11841958|FG001|NOT COMPLETED|Wave 1||0
10679396|NCT02390557|11841959|FG002|NOT COMPLETED|Wave 1||0
10679397|NCT02390557|11841957|FG000|STARTED|Wave 2||160
10679398|NCT02390557|11841958|FG001|STARTED|Wave 2||156
10679399|NCT02390557|11841959|FG002|STARTED|Wave 2||135
10679400|NCT02390557|11841957|FG000|COMPLETED|Wave 2||88
10679401|NCT02390557|11841958|FG001|COMPLETED|Wave 2||115
10679402|NCT02390557|11841959|FG002|COMPLETED|Wave 2||112
10679403|NCT02390557|11841957|FG000|NOT COMPLETED|Wave 2||72
10679404|NCT02390557|11841958|FG001|NOT COMPLETED|Wave 2||41
10679405|NCT02390557|11841959|FG002|NOT COMPLETED|Wave 2||23
10679406|NCT02390791|11841969|FG000|STARTED|Overall Study||40
10679407|NCT02390791|11841970|FG001|STARTED|Overall Study||45
10679408|NCT02390791|11841969|FG000|COMPLETED|Overall Study||40
10679409|NCT02390791|11841970|FG001|COMPLETED|Overall Study||45
10679410|NCT02390791|11841969|FG000|NOT COMPLETED|Overall Study||0
10679411|NCT02390791|11841970|FG001|NOT COMPLETED|Overall Study||0
10679412|NCT02390908|11841981|FG000|STARTED|Overall Study||40
10679413|NCT02390908|11841982|FG001|STARTED|Overall Study||22
10679414|NCT02390908|11841983|FG002|STARTED|Overall Study||22
10679415|NCT02390908|11841984|FG003|STARTED|Overall Study||90
10679416|NCT02390908|11841985|FG004|STARTED|Overall Study||120
10679417|NCT02390908|11841981|FG000|COMPLETED|Overall Study||40
10679418|NCT02390908|11841982|FG001|COMPLETED|Overall Study||22
10798812|NCT03830333|11959341|FG000|COMPLETED|Overall Study||126
10679419|NCT02390908|11841983|FG002|COMPLETED|Overall Study||22
10679420|NCT02390908|11841984|FG003|COMPLETED|Overall Study||90
10679421|NCT02390908|11841985|FG004|COMPLETED|Overall Study||120
10679422|NCT02390908|11841981|FG000|NOT COMPLETED|Overall Study||0
10679423|NCT02390908|11841982|FG001|NOT COMPLETED|Overall Study||0
10679424|NCT02390908|11841983|FG002|NOT COMPLETED|Overall Study||0
10679425|NCT02390908|11841984|FG003|NOT COMPLETED|Overall Study||0
10679426|NCT02390908|11841985|FG004|NOT COMPLETED|Overall Study||0
10679427|NCT02391038|11842002|FG000|STARTED|Overall Study||3
10679428|NCT02391038|11842003|FG001|STARTED|Overall Study||3
10679429|NCT02391038|11842004|FG002|STARTED|Overall Study||6
10679430|NCT02391038|11842002|FG000|COMPLETED|Overall Study||0
10679431|NCT02391038|11842003|FG001|COMPLETED|Overall Study||0
10679432|NCT02391038|11842004|FG002|COMPLETED|Overall Study||0
10679433|NCT02391038|11842002|FG000|NOT COMPLETED|Overall Study||3
10679434|NCT02391038|11842003|FG001|NOT COMPLETED|Overall Study||3
10679435|NCT02391038|11842004|FG002|NOT COMPLETED|Overall Study||6
10679436|NCT02391116|11842013|FG000|STARTED|Treatment||67
10679437|NCT02391116|11842013|FG000|Included in Per Protocol Set|Treatment||40
10679438|NCT02391116|11842013|FG000|COMPLETED|Treatment|Reasons for completion in this period included death (2), PD (50) and lack of efficacy (1)|53
10679439|NCT02391116|11842013|FG000|NOT COMPLETED|Treatment||14
10679440|NCT02391116|11842013|FG000|STARTED|Safety Follow-up|This period excludes 2 deaths on treatment and 9 participants entering active follow-up|56
10679441|NCT02391116|11842013|FG000|COMPLETED|Safety Follow-up|14 participants were considered completed due to death|43
10679442|NCT02391116|11842013|FG000|NOT COMPLETED|Safety Follow-up||13
10679443|NCT02391116|11842013|FG000|STARTED|Active Follow-up|This period incorporates safety follow-up with radiological|9
10679444|NCT02391116|11842013|FG000|COMPLETED|Active Follow-up|Reasons for completion in this period included death (2) and PD (4)|6
10679445|NCT02391116|11842013|FG000|NOT COMPLETED|Active Follow-up||3
10679446|NCT02391116|11842013|FG000|STARTED|Survival Follow-up|21 participants discontinued from treatment didn't enter due to withdrawal by subject (3) and death|46
10679447|NCT02391116|11842013|FG000|COMPLETED|Survival Follow-up|Reason for completed in this period included death (35) and clinical endpoint reached (7)|42
10679448|NCT02391116|11842013|FG000|NOT COMPLETED|Survival Follow-up||4
10679449|NCT02391311|11842026|FG000|STARTED|Overall Study||21
10679450|NCT02391311|11842027|FG001|STARTED|Overall Study||21
10679451|NCT02391311|11842026|FG000|COMPLETED|Overall Study||18
10679452|NCT02391311|11842027|FG001|COMPLETED|Overall Study||19
10679453|NCT02391311|11842026|FG000|NOT COMPLETED|Overall Study||3
10679454|NCT02391311|11842027|FG001|NOT COMPLETED|Overall Study||2
10679455|NCT02391337|11842035|FG000|STARTED|Baseline||80
10679456|NCT02391337|11842036|FG001|STARTED|Baseline||81
10679457|NCT02391337|11842035|FG000|COMPLETED|Baseline||80
10679458|NCT02391337|11842036|FG001|COMPLETED|Baseline||81
10679459|NCT02391337|11842035|FG000|NOT COMPLETED|Baseline||0
10679460|NCT02391337|11842036|FG001|NOT COMPLETED|Baseline||0
10679461|NCT02391337|11842035|FG000|STARTED|6 Months Follow-up||80
10679462|NCT02391337|11842036|FG001|STARTED|6 Months Follow-up||81
10679463|NCT02391337|11842035|FG000|COMPLETED|6 Months Follow-up||74
10679464|NCT02391337|11842036|FG001|COMPLETED|6 Months Follow-up||76
10679465|NCT02391337|11842035|FG000|NOT COMPLETED|6 Months Follow-up||6
10679466|NCT02391337|11842036|FG001|NOT COMPLETED|6 Months Follow-up||5
10679467|NCT02391337|11842035|FG000|STARTED|12 Months Follow-up||74
10679468|NCT02391337|11842036|FG001|STARTED|12 Months Follow-up||76
10679469|NCT02391337|11842035|FG000|COMPLETED|12 Months Follow-up||72
10679470|NCT02391337|11842036|FG001|COMPLETED|12 Months Follow-up||73
10679471|NCT02391337|11842035|FG000|NOT COMPLETED|12 Months Follow-up||2
10679472|NCT02391337|11842036|FG001|NOT COMPLETED|12 Months Follow-up||3
10679473|NCT02391350|11842044|FG000|STARTED|Overall Study||110
10679474|NCT02391350|11842045|FG001|STARTED|Overall Study||110
10679475|NCT02391350|11842044|FG000|4-week Follow-up|Overall Study||106
10679476|NCT02391350|11842045|FG001|4-week Follow-up|Overall Study||105
10679477|NCT02391350|11842044|FG000|6-month Follow-up|Overall Study||100
10679478|NCT02391350|11842045|FG001|6-month Follow-up|Overall Study||96
10679479|NCT02391350|11842044|FG000|COMPLETED|Overall Study||98
10679480|NCT02391350|11842045|FG001|COMPLETED|Overall Study||93
10679481|NCT02391350|11842044|FG000|NOT COMPLETED|Overall Study||12
10679482|NCT02391350|11842045|FG001|NOT COMPLETED|Overall Study||17
10679483|NCT02391363|11842053|FG000|STARTED|Overall Study||70
10679484|NCT02391363|11842054|FG001|STARTED|Overall Study||64
10679485|NCT02391363|11842053|FG000|COMPLETED|Overall Study||59
10679486|NCT02391363|11842054|FG001|COMPLETED|Overall Study||56
10679487|NCT02391363|11842053|FG000|NOT COMPLETED|Overall Study||11
10679488|NCT02391363|11842054|FG001|NOT COMPLETED|Overall Study||8
10679489|NCT02391545|11842062|FG000|STARTED|Overall Study||27
10679490|NCT02391545|11842063|FG001|STARTED|Overall Study||28
10679491|NCT02391545|11842062|FG000|COMPLETED|Overall Study||1
10679492|NCT02391545|11842063|FG001|COMPLETED|Overall Study||0
10679493|NCT02391545|11842062|FG000|NOT COMPLETED|Overall Study||26
10679494|NCT02391545|11842063|FG001|NOT COMPLETED|Overall Study||28
10679495|NCT02391584|11842072|FG000|STARTED|Primary Endpoint (6-weeks)||31
10679496|NCT02391584|11842073|FG001|STARTED|Primary Endpoint (6-weeks)||29
10679497|NCT02391584|11842072|FG000|COMPLETED|Primary Endpoint (6-weeks)||29
10679498|NCT02391584|11842073|FG001|COMPLETED|Primary Endpoint (6-weeks)||27
10679499|NCT02391584|11842072|FG000|NOT COMPLETED|Primary Endpoint (6-weeks)||2
10679500|NCT02391584|11842073|FG001|NOT COMPLETED|Primary Endpoint (6-weeks)||2
10679501|NCT02391584|11842072|FG000|STARTED|3 Month|Includes 30 balloon dilation and 23 crossover participants|53
10712819|NCT02673619|11878347|FG003|STARTED|Overall Study||7
10679502|NCT02391584|11842073|FG001|STARTED|3 Month|23 Crossover participants are included in balloon dilation arm for remainder of study visits.|0
10679503|NCT02391584|11842072|FG000|COMPLETED|3 Month||52
10679504|NCT02391584|11842073|FG001|COMPLETED|3 Month||0
10679505|NCT02391584|11842072|FG000|NOT COMPLETED|3 Month||1
10679506|NCT02391584|11842073|FG001|NOT COMPLETED|3 Month||0
10679507|NCT02391584|11842072|FG000|STARTED|6 Month||52
10679508|NCT02391584|11842073|FG001|STARTED|6 Month||0
10679509|NCT02391584|11842072|FG000|COMPLETED|6 Month||51
10679510|NCT02391584|11842073|FG001|COMPLETED|6 Month||0
10679511|NCT02391584|11842072|FG000|NOT COMPLETED|6 Month||1
10679512|NCT02391584|11842073|FG001|NOT COMPLETED|6 Month||0
10679513|NCT02391584|11842072|FG000|STARTED|12 Month (End of Study)||51
10679514|NCT02391584|11842073|FG001|STARTED|12 Month (End of Study)||0
10679515|NCT02391584|11842072|FG000|COMPLETED|12 Month (End of Study)||49
10679516|NCT02391584|11842073|FG001|COMPLETED|12 Month (End of Study)||0
10679517|NCT02391584|11842072|FG000|NOT COMPLETED|12 Month (End of Study)||2
10679518|NCT02391584|11842073|FG001|NOT COMPLETED|12 Month (End of Study)||0
10679519|NCT02391701|11842084|FG000|STARTED|Overall Study||367
10679520|NCT02391701|11842085|FG001|STARTED|Overall Study||353
10679521|NCT02391701|11842084|FG000|COMPLETED|Overall Study||346
10679522|NCT02391701|11842085|FG001|COMPLETED|Overall Study||315
10679523|NCT02391701|11842084|FG000|NOT COMPLETED|Overall Study||21
10679524|NCT02391701|11842085|FG001|NOT COMPLETED|Overall Study||38
10679525|NCT02391714|11842093|FG000|STARTED|Overall Study||40
10679526|NCT02391714|11842094|FG001|STARTED|Overall Study||40
10679527|NCT02391714|11842093|FG000|COMPLETED|Overall Study||40
10679528|NCT02391714|11842094|FG001|COMPLETED|Overall Study||40
10679529|NCT02391714|11842093|FG000|NOT COMPLETED|Overall Study||0
10679530|NCT02391714|11842094|FG001|NOT COMPLETED|Overall Study||0
10679531|NCT02391948|11842107|FG000|STARTED|Baseline||227
10679532|NCT02391948|11842108|FG001|STARTED|Baseline||161
10679533|NCT02391948|11842109|FG002|STARTED|Baseline||80
10679534|NCT02391948|11842110|FG003|STARTED|Baseline||129
10679535|NCT02391948|11842111|FG004|STARTED|Baseline||111
10679536|NCT02391948|11842107|FG000|COMPLETED|Baseline||227
10679537|NCT02391948|11842108|FG001|COMPLETED|Baseline||161
10679538|NCT02391948|11842109|FG002|COMPLETED|Baseline||80
10679539|NCT02391948|11842110|FG003|COMPLETED|Baseline||129
10679540|NCT02391948|11842111|FG004|COMPLETED|Baseline||111
10679541|NCT02391948|11842107|FG000|NOT COMPLETED|Baseline||0
10679542|NCT02391948|11842108|FG001|NOT COMPLETED|Baseline||0
10679543|NCT02391948|11842109|FG002|NOT COMPLETED|Baseline||0
10679544|NCT02391948|11842110|FG003|NOT COMPLETED|Baseline||0
10679545|NCT02391948|11842111|FG004|NOT COMPLETED|Baseline||0
10679546|NCT02391948|11842107|FG000|STARTED|6-month Assessment||227
10679547|NCT02391948|11842108|FG001|STARTED|6-month Assessment||161
10679548|NCT02391948|11842109|FG002|STARTED|6-month Assessment||80
10679549|NCT02391948|11842110|FG003|STARTED|6-month Assessment||129
10679550|NCT02391948|11842111|FG004|STARTED|6-month Assessment||111
10679551|NCT02391948|11842107|FG000|COMPLETED|6-month Assessment||148
10679552|NCT02391948|11842108|FG001|COMPLETED|6-month Assessment||105
10679553|NCT02391948|11842109|FG002|COMPLETED|6-month Assessment||49
10679554|NCT02391948|11842110|FG003|COMPLETED|6-month Assessment||84
10679555|NCT02391948|11842111|FG004|COMPLETED|6-month Assessment||85
10679556|NCT02391948|11842107|FG000|NOT COMPLETED|6-month Assessment||79
10679557|NCT02391948|11842108|FG001|NOT COMPLETED|6-month Assessment||56
10679558|NCT02391948|11842109|FG002|NOT COMPLETED|6-month Assessment||31
10679559|NCT02391948|11842110|FG003|NOT COMPLETED|6-month Assessment||45
10679560|NCT02391948|11842111|FG004|NOT COMPLETED|6-month Assessment||26
10679561|NCT02391948|11842107|FG000|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 77 of the Not Completed remained active.|225
10679562|NCT02391948|11842108|FG001|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 51 of the Not Completed remained active.|156
10679563|NCT02391948|11842109|FG002|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 28 of the Not Completed remained active.|77
10679564|NCT02391948|11842110|FG003|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 41 of the Not Completed remained active.|125
10679565|NCT02391948|11842111|FG004|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 24 of the Not Completed remained active.|109
10679566|NCT02391948|11842107|FG000|COMPLETED|12-month Assessment||217
10679567|NCT02391948|11842108|FG001|COMPLETED|12-month Assessment||147
10679568|NCT02391948|11842109|FG002|COMPLETED|12-month Assessment||73
10679569|NCT02391948|11842110|FG003|COMPLETED|12-month Assessment||116
10679570|NCT02391948|11842111|FG004|COMPLETED|12-month Assessment||103
10679571|NCT02391948|11842107|FG000|NOT COMPLETED|12-month Assessment||8
10679572|NCT02391948|11842108|FG001|NOT COMPLETED|12-month Assessment||9
10679573|NCT02391948|11842109|FG002|NOT COMPLETED|12-month Assessment||4
10679574|NCT02391948|11842110|FG003|NOT COMPLETED|12-month Assessment||9
10679575|NCT02391948|11842111|FG004|NOT COMPLETED|12-month Assessment||6
10679576|NCT02391948|11842107|FG000|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 2 of the Not Completed remained active.|219
10679577|NCT02391948|11842108|FG001|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 4 of the Not Completed remained active.|151
10679578|NCT02391948|11842109|FG002|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 1 of the Not Completed remained active.|74
10679579|NCT02391948|11842110|FG003|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 3 of the Not Completed remained active.|119
10679580|NCT02391948|11842111|FG004|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 2 of the Not Completed remained active.|105
10679581|NCT02391948|11842107|FG000|COMPLETED|18-month Assessment||147
10679582|NCT02391948|11842108|FG001|COMPLETED|18-month Assessment||101
10679583|NCT02391948|11842109|FG002|COMPLETED|18-month Assessment||48
10679584|NCT02391948|11842110|FG003|COMPLETED|18-month Assessment||83
10679585|NCT02391948|11842111|FG004|COMPLETED|18-month Assessment||75
10679586|NCT02391948|11842107|FG000|NOT COMPLETED|18-month Assessment||72
10679587|NCT02391948|11842108|FG001|NOT COMPLETED|18-month Assessment||50
10679588|NCT02391948|11842109|FG002|NOT COMPLETED|18-month Assessment||26
10679589|NCT02391948|11842110|FG003|NOT COMPLETED|18-month Assessment||36
10679590|NCT02391948|11842111|FG004|NOT COMPLETED|18-month Assessment||30
10679591|NCT02391948|11842107|FG000|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 2 of the Not Completed remained active.|149
10679592|NCT02391948|11842108|FG001|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 6 of the Not Completed remained active.|107
10679593|NCT02391948|11842109|FG002|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 3 of the Not Completed remained active.|51
10679594|NCT02391948|11842110|FG003|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 1 of the Not Completed remained active.|84
10679595|NCT02391948|11842111|FG004|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 4 of the Not Completed remained active.|79
10679596|NCT02391948|11842107|FG000|COMPLETED|24-month Assessment||135
10679597|NCT02391948|11842108|FG001|COMPLETED|24-month Assessment||97
10679598|NCT02391948|11842109|FG002|COMPLETED|24-month Assessment||48
10679599|NCT02391948|11842110|FG003|COMPLETED|24-month Assessment||75
10679600|NCT02391948|11842111|FG004|COMPLETED|24-month Assessment||69
10679601|NCT02391948|11842107|FG000|NOT COMPLETED|24-month Assessment||14
10679602|NCT02391948|11842108|FG001|NOT COMPLETED|24-month Assessment||10
10679603|NCT02391948|11842109|FG002|NOT COMPLETED|24-month Assessment||3
10679604|NCT02391948|11842110|FG003|NOT COMPLETED|24-month Assessment||9
10679605|NCT02391948|11842111|FG004|NOT COMPLETED|24-month Assessment||10
10679606|NCT02391961|11842128|FG000|STARTED|First Intervention (4 Weeks)||10
10679607|NCT02391961|11842129|FG001|STARTED|First Intervention (4 Weeks)||9
10679608|NCT02391961|11842128|FG000|COMPLETED|First Intervention (4 Weeks)||8
10679609|NCT02391961|11842129|FG001|COMPLETED|First Intervention (4 Weeks)||9
10679610|NCT02391961|11842128|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2
10679611|NCT02391961|11842129|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
10679612|NCT02391961|11842128|FG000|STARTED|Washout (2 Weeks)||8
10679613|NCT02391961|11842129|FG001|STARTED|Washout (2 Weeks)||9
10679614|NCT02391961|11842128|FG000|COMPLETED|Washout (2 Weeks)||7
10679615|NCT02391961|11842129|FG001|COMPLETED|Washout (2 Weeks)||8
10679616|NCT02391961|11842128|FG000|NOT COMPLETED|Washout (2 Weeks)||1
10679617|NCT02391961|11842129|FG001|NOT COMPLETED|Washout (2 Weeks)||1
10679618|NCT02391961|11842128|FG000|STARTED|Second Intervention (4 Weeks)||7
10679619|NCT02391961|11842129|FG001|STARTED|Second Intervention (4 Weeks)||8
10679620|NCT02391961|11842128|FG000|COMPLETED|Second Intervention (4 Weeks)||6
10679621|NCT02391961|11842129|FG001|COMPLETED|Second Intervention (4 Weeks)||7
10679622|NCT02391961|11842128|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1
10679691|NCT02392286|11842191|FG001|STARTED|Overall Study||8
10679623|NCT02391961|11842129|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1
10679624|NCT02391987|11842137|FG000|STARTED|Overall Study||54
10679625|NCT02391987|11842138|FG001|STARTED|Overall Study||58
10679626|NCT02391987|11842137|FG000|COMPLETED|Overall Study||54
10679627|NCT02391987|11842138|FG001|COMPLETED|Overall Study||58
10679628|NCT02391987|11842137|FG000|NOT COMPLETED|Overall Study||0
10679629|NCT02391987|11842138|FG001|NOT COMPLETED|Overall Study||0
10679630|NCT02392000|11842144|FG000|STARTED|Overall Study||38
10679631|NCT02392000|11842144|FG000|COMPLETED|Overall Study||11
10679632|NCT02392000|11842144|FG000|NOT COMPLETED|Overall Study||27
10679633|NCT02392104|11842149|FG000|STARTED|Overall Study|one participant enrolled but was removed prior to starting study protocol|50
10679634|NCT02392104|11842149|FG000|COMPLETED|Overall Study||39
10679635|NCT02392104|11842149|FG000|NOT COMPLETED|Overall Study||11
10679636|NCT02392195|11842153|FG000|STARTED|Overall Study||10
10679637|NCT02392195|11842153|FG000|COMPLETED|Overall Study||2
10679638|NCT02392195|11842153|FG000|NOT COMPLETED|Overall Study||8
10679639|NCT02392208|11842157|FG000|STARTED|Telavancin Before Hemodialysis||8
10679640|NCT02392208|11842157|FG000|COMPLETED|Telavancin Before Hemodialysis||8
10679641|NCT02392208|11842157|FG000|NOT COMPLETED|Telavancin Before Hemodialysis||0
10679642|NCT02392208|11842157|FG000|STARTED|Telavancin After Hemodialysis||8
10679643|NCT02392208|11842157|FG000|COMPLETED|Telavancin After Hemodialysis||8
10679644|NCT02392208|11842157|FG000|NOT COMPLETED|Telavancin After Hemodialysis||0
10679645|NCT02392234|11842168|FG000|STARTED|Treatment Period 1 (8 Weeks)||41
10798813|NCT03830333|11959342|FG001|COMPLETED|Overall Study||130
10798814|NCT03830333|11959341|FG000|NOT COMPLETED|Overall Study||8
10798815|NCT03830333|11959342|FG001|NOT COMPLETED|Overall Study||4
10798816|NCT03831880|11959350|FG000|STARTED|Period 1 (12 Weeks)||43
10798817|NCT03831880|11959351|FG001|STARTED|Period 1 (12 Weeks)||44
10798818|NCT03831880|11959350|FG000|COMPLETED|Period 1 (12 Weeks)||43
10798819|NCT03831880|11959351|FG001|COMPLETED|Period 1 (12 Weeks)||43
10798820|NCT03831880|11959350|FG000|NOT COMPLETED|Period 1 (12 Weeks)||0
10798821|NCT03831880|11959351|FG001|NOT COMPLETED|Period 1 (12 Weeks)||1
10798822|NCT03831880|11959350|FG000|STARTED|Period 2 (12 Weeks)||43
10798823|NCT03831880|11959351|FG001|STARTED|Period 2 (12 Weeks)||43
10798824|NCT03831880|11959350|FG000|COMPLETED|Period 2 (12 Weeks)||43
10798825|NCT03831880|11959351|FG001|COMPLETED|Period 2 (12 Weeks)||42
10798826|NCT03831880|11959350|FG000|NOT COMPLETED|Period 2 (12 Weeks)||0
10798827|NCT03831880|11959351|FG001|NOT COMPLETED|Period 2 (12 Weeks)||1
10679646|NCT02392234|11842169|FG001|STARTED|Treatment Period 1 (8 Weeks)||43
10679647|NCT02392234|11842170|FG002|STARTED|Treatment Period 1 (8 Weeks)||40
10679648|NCT02392234|11842171|FG003|STARTED|Treatment Period 1 (8 Weeks)||42
10679649|NCT02392234|11842172|FG004|STARTED|Treatment Period 1 (8 Weeks)||41
10679650|NCT02392234|11842173|FG005|STARTED|Treatment Period 1 (8 Weeks)||41
10679651|NCT02392234|11842168|FG000|Treated|Treatment Period 1 (8 Weeks)||41
10679652|NCT02392234|11842169|FG001|Treated|Treatment Period 1 (8 Weeks)||43
10679653|NCT02392234|11842170|FG002|Treated|Treatment Period 1 (8 Weeks)||39
10679654|NCT02392234|11842171|FG003|Treated|Treatment Period 1 (8 Weeks)||42
10679655|NCT02392234|11842172|FG004|Treated|Treatment Period 1 (8 Weeks)||40
10679656|NCT02392234|11842173|FG005|Treated|Treatment Period 1 (8 Weeks)||41
10679657|NCT02392234|11842168|FG000|COMPLETED|Treatment Period 1 (8 Weeks)||38
10679658|NCT02392234|11842169|FG001|COMPLETED|Treatment Period 1 (8 Weeks)||43
10679659|NCT02392234|11842170|FG002|COMPLETED|Treatment Period 1 (8 Weeks)||38
10679660|NCT02392234|11842171|FG003|COMPLETED|Treatment Period 1 (8 Weeks)||41
10679661|NCT02392234|11842172|FG004|COMPLETED|Treatment Period 1 (8 Weeks)||37
10679662|NCT02392234|11842173|FG005|COMPLETED|Treatment Period 1 (8 Weeks)||38
10679663|NCT02392234|11842168|FG000|NOT COMPLETED|Treatment Period 1 (8 Weeks)||3
10679664|NCT02392234|11842169|FG001|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0
10679665|NCT02392234|11842170|FG002|NOT COMPLETED|Treatment Period 1 (8 Weeks)||2
10679666|NCT02392234|11842171|FG003|NOT COMPLETED|Treatment Period 1 (8 Weeks)||1
10679667|NCT02392234|11842172|FG004|NOT COMPLETED|Treatment Period 1 (8 Weeks)||4
10679668|NCT02392234|11842173|FG005|NOT COMPLETED|Treatment Period 1 (8 Weeks)||3
10679669|NCT02392234|11842168|FG000|STARTED|Treatment Period 2 (8 Weeks)||38
10679670|NCT02392234|11842169|FG001|STARTED|Treatment Period 2 (8 Weeks)||43
10679671|NCT02392234|11842170|FG002|STARTED|Treatment Period 2 (8 Weeks)||38
10679672|NCT02392234|11842171|FG003|STARTED|Treatment Period 2 (8 Weeks)||41
10679673|NCT02392234|11842172|FG004|STARTED|Treatment Period 2 (8 Weeks)||37
10679674|NCT02392234|11842173|FG005|STARTED|Treatment Period 2 (8 Weeks)||38
10679675|NCT02392234|11842168|FG000|COMPLETED|Treatment Period 2 (8 Weeks)||37
10679676|NCT02392234|11842169|FG001|COMPLETED|Treatment Period 2 (8 Weeks)||43
10679677|NCT02392234|11842170|FG002|COMPLETED|Treatment Period 2 (8 Weeks)||38
10679678|NCT02392234|11842171|FG003|COMPLETED|Treatment Period 2 (8 Weeks)||41
10679679|NCT02392234|11842172|FG004|COMPLETED|Treatment Period 2 (8 Weeks)||37
10679680|NCT02392234|11842173|FG005|COMPLETED|Treatment Period 2 (8 Weeks)||38
10679681|NCT02392234|11842168|FG000|NOT COMPLETED|Treatment Period 2 (8 Weeks)||1
10679682|NCT02392234|11842169|FG001|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
10679683|NCT02392234|11842170|FG002|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
10679684|NCT02392234|11842171|FG003|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
10679685|NCT02392234|11842172|FG004|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
10679686|NCT02392234|11842173|FG005|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
10679687|NCT02392247|11842184|FG000|STARTED|Overall Study||52
10679688|NCT02392247|11842184|FG000|COMPLETED|Overall Study||50
10679689|NCT02392247|11842184|FG000|NOT COMPLETED|Overall Study||2
10679690|NCT02392286|11842190|FG000|STARTED|Overall Study||7
10679692|NCT02392286|11842190|FG000|COMPLETED|Overall Study||4
10679693|NCT02392286|11842191|FG001|COMPLETED|Overall Study||6
10679694|NCT02392286|11842190|FG000|NOT COMPLETED|Overall Study||3
10679695|NCT02392286|11842191|FG001|NOT COMPLETED|Overall Study||2
10679696|NCT02392351|11842199|FG000|STARTED|Overall Study||34
10679697|NCT02392351|11842200|FG001|STARTED|Overall Study||17
10679698|NCT02392351|11842199|FG000|COMPLETED|Overall Study|Primary endpoint: only observational results available.|0
10679699|NCT02392351|11842200|FG001|COMPLETED|Overall Study|Primary endpoint: only observational results available.|0
10679700|NCT02392351|11842199|FG000|NOT COMPLETED|Overall Study||34
10679701|NCT02392351|11842200|FG001|NOT COMPLETED|Overall Study||17
10679702|NCT02392403|11842206|FG000|STARTED|Overall Study||45
10679703|NCT02392403|11842206|FG000|COMPLETED|Overall Study||42
10679704|NCT02392403|11842206|FG000|NOT COMPLETED|Overall Study||3
10679705|NCT02392481|11842214|FG000|STARTED|Overall Study||10
10679706|NCT02392481|11842215|FG001|STARTED|Overall Study||12
10679707|NCT02392481|11842216|FG002|STARTED|Overall Study||20
10679708|NCT02392481|11842217|FG003|STARTED|Overall Study||27
10679709|NCT02392481|11842214|FG000|COMPLETED|Overall Study||10
10679710|NCT02392481|11842215|FG001|COMPLETED|Overall Study||12
10679711|NCT02392481|11842216|FG002|COMPLETED|Overall Study||18
10679712|NCT02392481|11842217|FG003|COMPLETED|Overall Study||25
10679713|NCT02392481|11842214|FG000|NOT COMPLETED|Overall Study||0
10679714|NCT02392481|11842215|FG001|NOT COMPLETED|Overall Study||0
10679715|NCT02392481|11842216|FG002|NOT COMPLETED|Overall Study||2
10679716|NCT02392481|11842217|FG003|NOT COMPLETED|Overall Study||2
10679717|NCT02392494|11842230|FG000|STARTED|Overall Study||3
10679718|NCT02392494|11842231|FG001|STARTED|Overall Study||3
10679719|NCT02392494|11842232|FG002|STARTED|Overall Study||3
10679720|NCT02392494|11842233|FG003|STARTED|Overall Study||0
10679721|NCT02392494|11842230|FG000|COMPLETED|Overall Study||3
10679722|NCT02392494|11842231|FG001|COMPLETED|Overall Study||3
10679723|NCT02392494|11842232|FG002|COMPLETED|Overall Study||3
10679724|NCT02392494|11842233|FG003|COMPLETED|Overall Study||0
10679725|NCT02392494|11842230|FG000|NOT COMPLETED|Overall Study||0
10679726|NCT02392494|11842231|FG001|NOT COMPLETED|Overall Study||0
10679727|NCT02392494|11842232|FG002|NOT COMPLETED|Overall Study||0
10679728|NCT02392494|11842233|FG003|NOT COMPLETED|Overall Study||0
10679729|NCT02392507|11842241|FG000|STARTED|Induction Regimen||54
10712820|NCT02673619|11878344|FG000|COMPLETED|Overall Study||18
10679730|NCT02392507|11842241|FG000|Received at Least 1 Dose of Study Drug|Induction Regimen||54
10679731|NCT02392507|11842241|FG000|COMPLETED|Induction Regimen||47
10679732|NCT02392507|11842241|FG000|NOT COMPLETED|Induction Regimen||7
10679733|NCT02392507|11842241|FG000|STARTED|Maintenance Regimen|After induction regimen participants with disease response are eligible for maintenance regimen.|34
10679734|NCT02392507|11842241|FG000|COMPLETED|Maintenance Regimen||32
10679735|NCT02392507|11842241|FG000|NOT COMPLETED|Maintenance Regimen||2
10679736|NCT02392559|11842252|FG000|STARTED|Overall Study||53
10679737|NCT02392559|11842253|FG001|STARTED|Overall Study||105
10679738|NCT02392559|11842252|FG000|Randomized and Dosed|Overall Study||53
10679739|NCT02392559|11842253|FG001|Randomized and Dosed|Overall Study||104
10679740|NCT02392559|11842252|FG000|COMPLETED|Overall Study||53
10679741|NCT02392559|11842253|FG001|COMPLETED|Overall Study||104
10679742|NCT02392559|11842252|FG000|NOT COMPLETED|Overall Study||0
10679743|NCT02392559|11842253|FG001|NOT COMPLETED|Overall Study||1
10679744|NCT02392611|11842269|FG000|STARTED|Overall Study||2
10679745|NCT02392611|11842270|FG001|STARTED|Overall Study||1
10679746|NCT02392611|11842271|FG002|STARTED|Overall Study||1
10679747|NCT02392611|11842272|FG003|STARTED|Overall Study||9
10679748|NCT02392611|11842273|FG004|STARTED|Overall Study||6
10679749|NCT02392611|11842274|FG005|STARTED|Overall Study||4
10679750|NCT02392611|11842275|FG006|STARTED|Overall Study||4
10679751|NCT02392611|11842276|FG007|STARTED|Overall Study||3
10679752|NCT02392611|11842277|FG008|STARTED|Overall Study||3
10679753|NCT02392611|11842269|FG000|COMPLETED|Overall Study||1
10679754|NCT02392611|11842270|FG001|COMPLETED|Overall Study||1
10679755|NCT02392611|11842271|FG002|COMPLETED|Overall Study||1
10679756|NCT02392611|11842272|FG003|COMPLETED|Overall Study||3
10679757|NCT02392611|11842273|FG004|COMPLETED|Overall Study||5
10679758|NCT02392611|11842274|FG005|COMPLETED|Overall Study||3
10679759|NCT02392611|11842275|FG006|COMPLETED|Overall Study||3
10679760|NCT02392611|11842276|FG007|COMPLETED|Overall Study||3
10679761|NCT02392611|11842277|FG008|COMPLETED|Overall Study||3
10679762|NCT02392611|11842269|FG000|NOT COMPLETED|Overall Study||1
10679763|NCT02392611|11842270|FG001|NOT COMPLETED|Overall Study||0
10679764|NCT02392611|11842271|FG002|NOT COMPLETED|Overall Study||0
10679765|NCT02392611|11842272|FG003|NOT COMPLETED|Overall Study||6
10679766|NCT02392611|11842273|FG004|NOT COMPLETED|Overall Study||1
10679767|NCT02392611|11842274|FG005|NOT COMPLETED|Overall Study||1
10679768|NCT02392611|11842275|FG006|NOT COMPLETED|Overall Study||1
10679769|NCT02392611|11842276|FG007|NOT COMPLETED|Overall Study||0
10679770|NCT02392611|11842277|FG008|NOT COMPLETED|Overall Study||0
10679771|NCT02392624|11842300|FG000|STARTED|Overall Study||71
10679772|NCT02392624|11842301|FG001|STARTED|Overall Study||81
10679773|NCT02392624|11842302|FG002|STARTED|Overall Study||53
10679774|NCT02392624|11842300|FG000|COMPLETED|Overall Study||0
10679775|NCT02392624|11842301|FG001|COMPLETED|Overall Study||66
10679776|NCT02392624|11842302|FG002|COMPLETED|Overall Study||40
10679777|NCT02392624|11842300|FG000|NOT COMPLETED|Overall Study||71
10679778|NCT02392624|11842301|FG001|NOT COMPLETED|Overall Study||15
10679779|NCT02392624|11842302|FG002|NOT COMPLETED|Overall Study||13
10679780|NCT02392767|11842312|FG000|STARTED|Overall Study||12
10679781|NCT02392767|11842313|FG001|STARTED|Overall Study||13
10679782|NCT02392767|11842312|FG000|COMPLETED|Overall Study||12
10679783|NCT02392767|11842313|FG001|COMPLETED|Overall Study||13
10679784|NCT02392767|11842312|FG000|NOT COMPLETED|Overall Study||0
10679785|NCT02392767|11842313|FG001|NOT COMPLETED|Overall Study||0
10679786|NCT02392806|11842323|FG000|STARTED|Overall Study||22
10679787|NCT02392806|11842324|FG001|STARTED|Overall Study||21
10679788|NCT02392806|11842323|FG000|COMPLETED|Overall Study||22
10679789|NCT02392806|11842324|FG001|COMPLETED|Overall Study||21
10679790|NCT02392806|11842323|FG000|NOT COMPLETED|Overall Study||0
10679791|NCT02392806|11842324|FG001|NOT COMPLETED|Overall Study||0
10679792|NCT02393209|11842332|FG000|STARTED|Overall Study||6
10679793|NCT02393209|11842333|FG001|STARTED|Overall Study||8
10679794|NCT02393209|11842334|FG002|STARTED|Overall Study||0
10679795|NCT02393209|11842335|FG003|STARTED|Overall Study||0
10679796|NCT02393209|11842332|FG000|COMPLETED|Overall Study||0
10679797|NCT02393209|11842333|FG001|COMPLETED|Overall Study||0
10679798|NCT02393209|11842334|FG002|COMPLETED|Overall Study||0
10679799|NCT02393209|11842335|FG003|COMPLETED|Overall Study||0
10679800|NCT02393209|11842332|FG000|NOT COMPLETED|Overall Study||6
10679801|NCT02393209|11842333|FG001|NOT COMPLETED|Overall Study||8
10679802|NCT02393209|11842334|FG002|NOT COMPLETED|Overall Study||0
10679803|NCT02393209|11842335|FG003|NOT COMPLETED|Overall Study||0
10679804|NCT02393339|11842346|FG000|STARTED|Overall Study||58
10679805|NCT02393339|11842347|FG001|STARTED|Overall Study||56
10679806|NCT02393339|11842346|FG000|COMPLETED|Overall Study||51
10679807|NCT02393339|11842347|FG001|COMPLETED|Overall Study||51
10679808|NCT02393339|11842346|FG000|NOT COMPLETED|Overall Study||7
10679809|NCT02393339|11842347|FG001|NOT COMPLETED|Overall Study||5
10679810|NCT02393378|11842355|FG000|STARTED|Overall Study||3
10679811|NCT02393378|11842356|FG001|STARTED|Overall Study||4
10679812|NCT02393378|11842355|FG000|COMPLETED|Overall Study||3
10679813|NCT02393378|11842356|FG001|COMPLETED|Overall Study||4
10679814|NCT02393378|11842355|FG000|NOT COMPLETED|Overall Study||0
10679815|NCT02393378|11842356|FG001|NOT COMPLETED|Overall Study||0
10679816|NCT02393417|11842366|FG000|STARTED|Overall Study||43
10679817|NCT02393417|11842367|FG001|STARTED|Overall Study||45
10679818|NCT02393417|11842368|FG002|STARTED|Overall Study||40
10679819|NCT02393417|11842369|FG003|STARTED|Overall Study||41
10679820|NCT02393417|11842366|FG000|Completed Treatment|Overall Study||30
10679821|NCT02393417|11842367|FG001|Completed Treatment|Overall Study||34
10679822|NCT02393417|11842368|FG002|Completed Treatment|Overall Study||32
10679823|NCT02393417|11842369|FG003|Completed Treatment|Overall Study||30
10679824|NCT02393417|11842366|FG000|COMPLETED|Overall Study||28
10679825|NCT02393417|11842367|FG001|COMPLETED|Overall Study||32
10679826|NCT02393417|11842368|FG002|COMPLETED|Overall Study||30
10679827|NCT02393417|11842369|FG003|COMPLETED|Overall Study||29
10679828|NCT02393417|11842366|FG000|NOT COMPLETED|Overall Study||15
10679829|NCT02393417|11842367|FG001|NOT COMPLETED|Overall Study||13
10679830|NCT02393417|11842368|FG002|NOT COMPLETED|Overall Study||10
10679831|NCT02393417|11842369|FG003|NOT COMPLETED|Overall Study||12
10679832|NCT02393547|11842380|FG000|STARTED|Overall Study||20
10679833|NCT02393547|11842380|FG000|COMPLETED|Overall Study||14
10679834|NCT02393547|11842380|FG000|NOT COMPLETED|Overall Study||6
10679835|NCT02393677|11842386|FG000|STARTED|Overall Study||40
10679836|NCT02393677|11842387|FG001|STARTED|Overall Study||40
10679837|NCT02393677|11842386|FG000|COMPLETED|Overall Study||40
10679838|NCT02393677|11842387|FG001|COMPLETED|Overall Study||40
10679839|NCT02393677|11842386|FG000|NOT COMPLETED|Overall Study||0
10679840|NCT02393677|11842387|FG001|NOT COMPLETED|Overall Study||0
10679841|NCT02393755|11842395|FG000|STARTED|Overall Study||3
10679842|NCT02393755|11842396|FG001|STARTED|Overall Study||39
10679843|NCT02393755|11842395|FG000|COMPLETED|Overall Study||3
10679844|NCT02393755|11842396|FG001|COMPLETED|Overall Study||32
10679845|NCT02393755|11842395|FG000|NOT COMPLETED|Overall Study||0
10679846|NCT02393755|11842396|FG001|NOT COMPLETED|Overall Study||7
10679847|NCT02393950|11842403|FG000|STARTED|Overall Study||9
10679848|NCT02393950|11842404|FG001|STARTED|Overall Study||9
10679849|NCT02393950|11842403|FG000|Period 1|Overall Study|6 subjects ODM-106 Capsule B 2 mg and 2 subjects on placebo|8
10679850|NCT02393950|11842404|FG001|Period 1|Overall Study|6 subjects ODM-106 Capsule B 100 mg (1 x 100mg) and 2 subjects on placebo|8
10679851|NCT02393950|11842403|FG000|Period 2|Overall Study|6 subjects ODM-106 Capsule B 10 mg and 2 subjects on placebo|8
10679852|NCT02393950|11842404|FG001|Period 2|Overall Study|6 subjects ODM-106 Capsule B 100 mg (10 x 10mg) and 2 subjects on placebo|8
10679853|NCT02393950|11842403|FG000|Period 3|Overall Study|6 subjects ODM-106 Capsule B 25 mg and 2 subjects on placebo|8
10679854|NCT02393950|11842404|FG001|Period 3|Overall Study|6 subjects ODM-106 Capsule B 200 mg (20 x 10mg) and 2 subjects on placebo|8
10679855|NCT02393950|11842403|FG000|Period 4|Overall Study|6 subjects ODM-106 Capsule B 50 mg and 2 subjects on placebo|8
10679856|NCT02393950|11842404|FG001|Period 4|Overall Study|6 subjects ODM-106 Capsule A 100 mg (10 x 10mg) and 2 subjects on placebo|8
10679857|NCT02393950|11842403|FG000|COMPLETED|Overall Study||8
10679858|NCT02393950|11842404|FG001|COMPLETED|Overall Study||8
10679859|NCT02393950|11842403|FG000|NOT COMPLETED|Overall Study||1
10679860|NCT02393950|11842404|FG001|NOT COMPLETED|Overall Study||1
10679861|NCT02394275|11842439|FG000|STARTED|Overall Study||140
10679862|NCT02394275|11842439|FG000|Safety Population|Overall Study||133
10679863|NCT02394275|11842439|FG000|Evaluable at 13 Weeks|Overall Study||133
10679864|NCT02394275|11842439|FG000|COMPLETED|Overall Study||111
10679865|NCT02394275|11842439|FG000|NOT COMPLETED|Overall Study||29
10679866|NCT02394340|11842444|FG000|STARTED|Overall Study||20
10679867|NCT02394340|11842444|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20
10679868|NCT02394340|11842444|FG000|COMPLETED|Overall Study||18
10679869|NCT02394340|11842444|FG000|NOT COMPLETED|Overall Study||2
10679870|NCT02394457|11842450|FG000|STARTED|Overall Study||15
10679871|NCT02394457|11842451|FG001|STARTED|Overall Study||13
10679872|NCT02394457|11842450|FG000|COMPLETED|Overall Study||15
10679873|NCT02394457|11842451|FG001|COMPLETED|Overall Study||13
10679874|NCT02394457|11842450|FG000|NOT COMPLETED|Overall Study||0
10679875|NCT02394457|11842451|FG001|NOT COMPLETED|Overall Study||0
10679876|NCT02394561|11842459|FG000|STARTED|CORE Phase||185
10679877|NCT02394561|11842460|FG001|STARTED|CORE Phase||246
10679878|NCT02394561|11842459|FG000|Full Analysis Set|CORE Phase||185
10679879|NCT02394561|11842460|FG001|Full Analysis Set|CORE Phase||246
10679880|NCT02394561|11842459|FG000|Safety Set|CORE Phase||185
10679881|NCT02394561|11842460|FG001|Safety Set|CORE Phase||246
10679882|NCT02394561|11842459|FG000|ITT Set|CORE Phase||184
10679883|NCT02394561|11842460|FG001|ITT Set|CORE Phase||246
10679884|NCT02394561|11842459|FG000|COMPLETED|CORE Phase||172
10679885|NCT02394561|11842460|FG001|COMPLETED|CORE Phase||227
10679886|NCT02394561|11842459|FG000|NOT COMPLETED|CORE Phase||13
10679887|NCT02394561|11842460|FG001|NOT COMPLETED|CORE Phase||19
10679888|NCT02394561|11842459|FG000|STARTED|Extension Phase||162
10679889|NCT02394561|11842460|FG001|STARTED|Extension Phase||219
10679890|NCT02394561|11842459|FG000|COMPLETED|Extension Phase||151
10679891|NCT02394561|11842460|FG001|COMPLETED|Extension Phase||207
10679892|NCT02394561|11842459|FG000|NOT COMPLETED|Extension Phase||11
10679893|NCT02394561|11842460|FG001|NOT COMPLETED|Extension Phase||12
10679894|NCT02394600|11842471|FG000|STARTED|Overall Study||47
10679895|NCT02394600|11842472|FG001|STARTED|Overall Study||46
10679896|NCT02394600|11842471|FG000|COMPLETED|Overall Study||43
10679897|NCT02394600|11842472|FG001|COMPLETED|Overall Study||44
10679898|NCT02394600|11842471|FG000|NOT COMPLETED|Overall Study||4
10679899|NCT02394600|11842472|FG001|NOT COMPLETED|Overall Study||2
10679900|NCT02394730|11842480|FG000|STARTED|Overall Study||34
10679901|NCT02394730|11842481|FG001|STARTED|Overall Study||31
10679902|NCT02394730|11842480|FG000|COMPLETED|Overall Study||33
10679903|NCT02394730|11842481|FG001|COMPLETED|Overall Study||30
10679904|NCT02394730|11842480|FG000|NOT COMPLETED|Overall Study||1
10679905|NCT02394730|11842481|FG001|NOT COMPLETED|Overall Study||1
10679906|NCT02394756|11842487|FG000|STARTED|Period 1||7
10679907|NCT02394756|11842488|FG001|STARTED|Period 1||7
10679908|NCT02394756|11842489|FG002|STARTED|Period 1||7
10679909|NCT02394756|11842490|FG003|STARTED|Period 1||7
10679910|NCT02394756|11842491|FG004|STARTED|Period 1||7
10679911|NCT02394756|11842492|FG005|STARTED|Period 1||7
10679912|NCT02394756|11842487|FG000|COMPLETED|Period 1||7
10679913|NCT02394756|11842488|FG001|COMPLETED|Period 1||6
10679914|NCT02394756|11842489|FG002|COMPLETED|Period 1||6
10679915|NCT02394756|11842490|FG003|COMPLETED|Period 1||6
10679916|NCT02394756|11842491|FG004|COMPLETED|Period 1||7
10679917|NCT02394756|11842492|FG005|COMPLETED|Period 1||6
10679918|NCT02394756|11842487|FG000|NOT COMPLETED|Period 1||0
10679919|NCT02394756|11842488|FG001|NOT COMPLETED|Period 1||1
10679920|NCT02394756|11842489|FG002|NOT COMPLETED|Period 1||1
10679921|NCT02394756|11842490|FG003|NOT COMPLETED|Period 1||1
10679922|NCT02394756|11842491|FG004|NOT COMPLETED|Period 1||0
10679923|NCT02394756|11842492|FG005|NOT COMPLETED|Period 1||1
10679924|NCT02394756|11842487|FG000|STARTED|Period 2||7
10679925|NCT02394756|11842488|FG001|STARTED|Period 2||6
10679926|NCT02394756|11842489|FG002|STARTED|Period 2||6
10679927|NCT02394756|11842490|FG003|STARTED|Period 2||6
10679928|NCT02394756|11842491|FG004|STARTED|Period 2||7
10679929|NCT02394756|11842492|FG005|STARTED|Period 2||6
10679930|NCT02394756|11842487|FG000|COMPLETED|Period 2||7
10679931|NCT02394756|11842488|FG001|COMPLETED|Period 2||6
10679932|NCT02394756|11842489|FG002|COMPLETED|Period 2||6
10679933|NCT02394756|11842490|FG003|COMPLETED|Period 2||6
10679934|NCT02394756|11842491|FG004|COMPLETED|Period 2||6
10679935|NCT02394756|11842492|FG005|COMPLETED|Period 2||6
10679936|NCT02394756|11842487|FG000|NOT COMPLETED|Period 2||0
10679937|NCT02394756|11842488|FG001|NOT COMPLETED|Period 2||0
10679938|NCT02394756|11842489|FG002|NOT COMPLETED|Period 2||0
10679939|NCT02394756|11842490|FG003|NOT COMPLETED|Period 2||0
10679940|NCT02394756|11842491|FG004|NOT COMPLETED|Period 2||1
10679941|NCT02394756|11842492|FG005|NOT COMPLETED|Period 2||0
10679942|NCT02394756|11842487|FG000|STARTED|Period 3||7
10679943|NCT02394756|11842488|FG001|STARTED|Period 3||6
10679944|NCT02394756|11842489|FG002|STARTED|Period 3||6
10679945|NCT02394756|11842490|FG003|STARTED|Period 3||6
10679946|NCT02394756|11842491|FG004|STARTED|Period 3||6
10679947|NCT02394756|11842492|FG005|STARTED|Period 3||6
10679948|NCT02394756|11842487|FG000|COMPLETED|Period 3||7
10679949|NCT02394756|11842488|FG001|COMPLETED|Period 3||6
10679950|NCT02394756|11842489|FG002|COMPLETED|Period 3||6
10679951|NCT02394756|11842490|FG003|COMPLETED|Period 3||6
10679952|NCT02394756|11842491|FG004|COMPLETED|Period 3||6
10679953|NCT02394756|11842492|FG005|COMPLETED|Period 3||6
10679954|NCT02394756|11842487|FG000|NOT COMPLETED|Period 3||0
10679955|NCT02394756|11842488|FG001|NOT COMPLETED|Period 3||0
10679956|NCT02394756|11842489|FG002|NOT COMPLETED|Period 3||0
10679957|NCT02394756|11842490|FG003|NOT COMPLETED|Period 3||0
10679958|NCT02394756|11842491|FG004|NOT COMPLETED|Period 3||0
10679959|NCT02394756|11842492|FG005|NOT COMPLETED|Period 3||0
10679969|NCT02394808|11842513|FG000|STARTED|Period 1||25
10679970|NCT02394808|11842514|FG001|STARTED|Period 1||29
10679971|NCT02394808|11842513|FG000|COMPLETED|Period 1||25
10679972|NCT02394808|11842514|FG001|COMPLETED|Period 1||28
10679973|NCT02394808|11842513|FG000|NOT COMPLETED|Period 1||0
10679974|NCT02394808|11842514|FG001|NOT COMPLETED|Period 1||1
10679975|NCT02394808|11842513|FG000|STARTED|Period 2||25
10679976|NCT02394808|11842514|FG001|STARTED|Period 2||28
10679977|NCT02394808|11842513|FG000|COMPLETED|Period 2||24
10679978|NCT02394808|11842514|FG001|COMPLETED|Period 2||28
10679979|NCT02394808|11842513|FG000|NOT COMPLETED|Period 2||1
10679980|NCT02394808|11842514|FG001|NOT COMPLETED|Period 2||0
10679981|NCT02394912|11842520|FG000|STARTED|Overall Study||21
10679982|NCT02394912|11842520|FG000|COMPLETED|Overall Study||21
10679983|NCT02394912|11842520|FG000|NOT COMPLETED|Overall Study||0
10679984|NCT02394925|11842526|FG000|STARTED|Overall Study||108
10679985|NCT02394925|11842526|FG000|COMPLETED|Overall Study||79
10679986|NCT02394925|11842526|FG000|NOT COMPLETED|Overall Study||29
10679987|NCT02394951|11842532|FG000|STARTED|Period I||12
10679988|NCT02394951|11842533|FG001|STARTED|Period I||14
10679989|NCT02394951|11842532|FG000|COMPLETED|Period I||11
10679990|NCT02394951|11842533|FG001|COMPLETED|Period I||13
10679991|NCT02394951|11842532|FG000|NOT COMPLETED|Period I||1
10679992|NCT02394951|11842533|FG001|NOT COMPLETED|Period I||1
10679993|NCT02394951|11842532|FG000|STARTED|Period II||11
10679994|NCT02394951|11842533|FG001|STARTED|Period II||13
10679995|NCT02394951|11842532|FG000|COMPLETED|Period II||11
10679996|NCT02394951|11842533|FG001|COMPLETED|Period II||9
10679997|NCT02394951|11842532|FG000|NOT COMPLETED|Period II||0
10679998|NCT02394951|11842533|FG001|NOT COMPLETED|Period II||4
10679999|NCT02395042|11842542|FG000|STARTED|Treatment 1 Period||12
10680000|NCT02395042|11842543|FG001|STARTED|Treatment 1 Period||31
10680001|NCT02395042|11842544|FG002|STARTED|Treatment 1 Period||16
10680002|NCT02395042|11842542|FG000|COMPLETED|Treatment 1 Period||9
10680003|NCT02395042|11842543|FG001|COMPLETED|Treatment 1 Period||25
10680004|NCT02395042|11842544|FG002|COMPLETED|Treatment 1 Period||14
10680005|NCT02395042|11842542|FG000|NOT COMPLETED|Treatment 1 Period||3
10680006|NCT02395042|11842543|FG001|NOT COMPLETED|Treatment 1 Period||6
10680007|NCT02395042|11842544|FG002|NOT COMPLETED|Treatment 1 Period||2
10680008|NCT02395042|11842542|FG000|STARTED|Treatment 2 Period|Not all participants participated in Treatment 2 Period.|10
10680009|NCT02395042|11842543|FG001|STARTED|Treatment 2 Period|Not all participants participated in Treatment 2 Period.|24
10680010|NCT02395042|11842544|FG002|STARTED|Treatment 2 Period|Not all participants participated in Treatment 2 Period.|13
10680011|NCT02395042|11842542|FG000|COMPLETED|Treatment 2 Period||9
10680012|NCT02395042|11842543|FG001|COMPLETED|Treatment 2 Period||23
10680013|NCT02395042|11842544|FG002|COMPLETED|Treatment 2 Period||13
10680014|NCT02395042|11842542|FG000|NOT COMPLETED|Treatment 2 Period||1
10680015|NCT02395042|11842543|FG001|NOT COMPLETED|Treatment 2 Period||1
10680016|NCT02395042|11842544|FG002|NOT COMPLETED|Treatment 2 Period||0
10680017|NCT02395055|11842557|FG000|STARTED|Overall Study||47
10680018|NCT02395055|11842558|FG001|STARTED|Overall Study||47
10680019|NCT02395055|11842557|FG000|COMPLETED|Overall Study||40
10680020|NCT02395055|11842558|FG001|COMPLETED|Overall Study||44
10680021|NCT02395055|11842557|FG000|NOT COMPLETED|Overall Study||7
10680022|NCT02395055|11842558|FG001|NOT COMPLETED|Overall Study||3
10680023|NCT02395081|11842567|FG000|STARTED|Overall Study||119
10680024|NCT02395081|11842568|FG001|STARTED|Overall Study||121
10680025|NCT02395081|11842569|FG002|STARTED|Overall Study||120
10680026|NCT02395081|11842567|FG000|COMPLETED|Overall Study||112
10680027|NCT02395081|11842568|FG001|COMPLETED|Overall Study||116
10680028|NCT02395081|11842569|FG002|COMPLETED|Overall Study||116
10680029|NCT02395081|11842567|FG000|NOT COMPLETED|Overall Study||7
10680030|NCT02395081|11842568|FG001|NOT COMPLETED|Overall Study||5
10680031|NCT02395081|11842569|FG002|NOT COMPLETED|Overall Study||4
10680032|NCT02395133|11842584|FG000|STARTED|Overall Study||83
10680033|NCT02395133|11842585|FG001|STARTED|Overall Study||84
10680034|NCT02395133|11842586|FG002|STARTED|Overall Study||86
10680035|NCT02395133|11842587|FG003|STARTED|Overall Study||169
10680036|NCT02395133|11842584|FG000|COMPLETED|Overall Study||69
10680037|NCT02395133|11842585|FG001|COMPLETED|Overall Study||75
10680038|NCT02395133|11842586|FG002|COMPLETED|Overall Study||76
10680039|NCT02395133|11842587|FG003|COMPLETED|Overall Study||155
10680040|NCT02395133|11842584|FG000|NOT COMPLETED|Overall Study||14
10680041|NCT02395133|11842585|FG001|NOT COMPLETED|Overall Study||9
10680042|NCT02395133|11842586|FG002|NOT COMPLETED|Overall Study||10
10680043|NCT02395133|11842587|FG003|NOT COMPLETED|Overall Study||14
10680044|NCT02395172|11842599|FG000|STARTED|Overall Study||396
10680045|NCT02395172|11842600|FG001|STARTED|Overall Study||396
10680046|NCT02395172|11842599|FG000|Treated|Overall Study||393
10680047|NCT02395172|11842600|FG001|Treated|Overall Study||365
10680048|NCT02395172|11842599|FG000|COMPLETED|Overall Study||393
10680049|NCT02395172|11842600|FG001|COMPLETED|Overall Study||365
10680050|NCT02395172|11842599|FG000|NOT COMPLETED|Overall Study||3
10680051|NCT02395172|11842600|FG001|NOT COMPLETED|Overall Study||31
10680052|NCT02395185|11842606|FG000|STARTED|Overall Study|32 guardians participated with these infants. one infant did not have a guardian participate.|33
10680053|NCT02395185|11842606|FG000|Sequence 1 (s,s,m,m,w,w)|Overall Study|one of the participants in this milestone did not have a guardian enrolled due to age.|2
10680054|NCT02395185|11842606|FG000|Sequence 2 (w,s,s,m,m,w)|Overall Study||2
10680055|NCT02395185|11842606|FG000|Sequence 3 (w,w,s,s,m,m)|Overall Study||2
10680056|NCT02395185|11842606|FG000|Sequence 4 (m,w,w,s,s,m)|Overall Study||2
10680057|NCT02395185|11842606|FG000|Sequence 5 (m,m,w,w,s,s)|Overall Study||2
10680058|NCT02395185|11842606|FG000|Sequence 6 (s,m,m,w,w,s)|Overall Study||2
10680059|NCT02395185|11842606|FG000|Sequence 7 (s,s,w,w,m,m)|Overall Study||2
10680060|NCT02395185|11842606|FG000|Sequence 8 (m,s,s,w,w,m)|Overall Study||2
10680061|NCT02395185|11842606|FG000|Sequence 9 (m,m,s,s,w,w)|Overall Study||2
10680062|NCT02395185|11842606|FG000|Sequence 10 (w,m,m,s,s,w)|Overall Study||2
10680063|NCT02395185|11842606|FG000|Sequence 11 (w,w,m,m,s,s)|Overall Study||2
10680064|NCT02395185|11842606|FG000|Sequence 12 (s,w,w,m,m,s)|Overall Study||2
10680065|NCT02395185|11842606|FG000|Sequence 13 (s,m,w,m,s,w)|Overall Study||2
10680066|NCT02395185|11842606|FG000|Sequence 14 (w,s,m,w,m,s)|Overall Study||2
10680067|NCT02395185|11842606|FG000|Sequence 15 (s,w,s,m,w,m)|Overall Study||2
10680068|NCT02395185|11842606|FG000|Sequence 16 (m,s,w,s,m,w)|Overall Study||1
10680069|NCT02395185|11842606|FG000|Sequence 17 (w,m,s,w,s,m)|Overall Study||1
10680070|NCT02395185|11842606|FG000|Sequence 18 (m,w,m,s,w,s)|Overall Study||1
10680071|NCT02395185|11842606|FG000|COMPLETED|Overall Study||33
10680072|NCT02395185|11842606|FG000|NOT COMPLETED|Overall Study||0
10680073|NCT02395302|11842614|FG000|STARTED|Overall Study||28
10680074|NCT02395302|11842614|FG000|COMPLETED|Overall Study||14
10680075|NCT02395302|11842614|FG000|NOT COMPLETED|Overall Study||14
10680076|NCT02395471|11842620|FG000|STARTED|Overall Study||129
10680077|NCT02395471|11842621|FG001|STARTED|Overall Study||62
10680078|NCT02395471|11842620|FG000|COMPLETED|Overall Study||122
10680079|NCT02395471|11842621|FG001|COMPLETED|Overall Study||59
10680080|NCT02395471|11842620|FG000|NOT COMPLETED|Overall Study||7
10680081|NCT02395471|11842621|FG001|NOT COMPLETED|Overall Study||3
10680082|NCT02395536|11842638|FG000|STARTED|Overall Study||264
10680083|NCT02395536|11842639|FG001|STARTED|Overall Study||257
10680084|NCT02395536|11842638|FG000|REVEAL LINQ Insertion|Overall Study||251
10680085|NCT02395536|11842639|FG001|REVEAL LINQ Insertion|Overall Study||231
10680086|NCT02395536|11842638|FG000|COMPLETED|Overall Study||244
10680087|NCT02395536|11842639|FG001|COMPLETED|Overall Study||227
10680088|NCT02395536|11842638|FG000|NOT COMPLETED|Overall Study||20
10680089|NCT02395536|11842639|FG001|NOT COMPLETED|Overall Study||30
10680090|NCT02395627|11842648|FG000|STARTED|Overall Study||18
10680091|NCT02395627|11842649|FG001|STARTED|Overall Study||16
10680092|NCT02395627|11842650|FG002|STARTED|Overall Study||4
10680093|NCT02395627|11842648|FG000|COMPLETED|Overall Study||15
10680094|NCT02395627|11842649|FG001|COMPLETED|Overall Study||13
10680095|NCT02395627|11842650|FG002|COMPLETED|Overall Study||4
10680096|NCT02395627|11842648|FG000|NOT COMPLETED|Overall Study||3
10680097|NCT02395627|11842649|FG001|NOT COMPLETED|Overall Study||3
10680098|NCT02395627|11842650|FG002|NOT COMPLETED|Overall Study||0
10680099|NCT02395653|11842660|FG000|STARTED|Overall Study||71
10680100|NCT02395653|11842660|FG000|Received at Least 1 Dose of Study Drug|Overall Study||61
10680101|NCT02395653|11842660|FG000|COMPLETED|Overall Study||59
10680102|NCT02395653|11842660|FG000|NOT COMPLETED|Overall Study||12
10680103|NCT02395692|11842664|FG000|STARTED|Overall Study||19
10680104|NCT02395692|11842665|FG001|STARTED|Overall Study||0
10680105|NCT02395692|11842664|FG000|COMPLETED|Overall Study||19
10680106|NCT02395692|11842665|FG001|COMPLETED|Overall Study||0
10680107|NCT02395692|11842664|FG000|NOT COMPLETED|Overall Study||0
10680108|NCT02395692|11842665|FG001|NOT COMPLETED|Overall Study||0
10680109|NCT02395822|11842672|FG000|STARTED|Overall Study||17
10680110|NCT02395822|11842672|FG000|COMPLETED|Overall Study||15
10680111|NCT02395822|11842672|FG000|NOT COMPLETED|Overall Study||2
10680112|NCT02395978|11842681|FG000|STARTED|Overall Study||6
10798828|NCT03831880|11959350|FG000|STARTED|Follow-up (5 Weeks)||43
10798829|NCT03831880|11959351|FG001|STARTED|Follow-up (5 Weeks)|1 participant who discontinued from Period 1 completed follow-up visit.|43
10798830|NCT03831880|11959350|FG000|COMPLETED|Follow-up (5 Weeks)||43
10798831|NCT03831880|11959351|FG001|COMPLETED|Follow-up (5 Weeks)||43
10798832|NCT03831880|11959350|FG000|NOT COMPLETED|Follow-up (5 Weeks)||0
10798833|NCT03831880|11959351|FG001|NOT COMPLETED|Follow-up (5 Weeks)||0
10680113|NCT02395978|11842682|FG001|STARTED|Overall Study||6
10680114|NCT02395978|11842683|FG002|STARTED|Overall Study||21
10680115|NCT02395978|11842684|FG003|STARTED|Overall Study||19
10680116|NCT02395978|11842685|FG004|STARTED|Overall Study||20
10680117|NCT02395978|11842681|FG000|COMPLETED|Overall Study||6
10680118|NCT02395978|11842682|FG001|COMPLETED|Overall Study||6
10680119|NCT02395978|11842683|FG002|COMPLETED|Overall Study||19
10680120|NCT02395978|11842684|FG003|COMPLETED|Overall Study||14
10680121|NCT02395978|11842685|FG004|COMPLETED|Overall Study||15
10680122|NCT02395978|11842681|FG000|NOT COMPLETED|Overall Study||0
10680123|NCT02395978|11842682|FG001|NOT COMPLETED|Overall Study||0
10680124|NCT02395978|11842683|FG002|NOT COMPLETED|Overall Study||2
10680125|NCT02395978|11842684|FG003|NOT COMPLETED|Overall Study||5
10680126|NCT02395978|11842685|FG004|NOT COMPLETED|Overall Study||5
10680127|NCT02395991|11842698|FG000|STARTED|Overall Study||60
10680128|NCT02395991|11842698|FG000|COMPLETED|Overall Study||59
10680129|NCT02395991|11842698|FG000|NOT COMPLETED|Overall Study||1
10680130|NCT02396147|11842705|FG000|STARTED|Period 1||27
10680131|NCT02396147|11842706|FG001|STARTED|Period 1||27
10680132|NCT02396147|11842705|FG000|COMPLETED|Period 1||27
10680133|NCT02396147|11842706|FG001|COMPLETED|Period 1||27
10680134|NCT02396147|11842705|FG000|NOT COMPLETED|Period 1||0
10680135|NCT02396147|11842706|FG001|NOT COMPLETED|Period 1||0
10680136|NCT02396147|11842705|FG000|STARTED|Period 2||27
10680137|NCT02396147|11842706|FG001|STARTED|Period 2||27
10680138|NCT02396147|11842705|FG000|COMPLETED|Period 2||27
10680139|NCT02396147|11842706|FG001|COMPLETED|Period 2||27
10680140|NCT02396147|11842705|FG000|NOT COMPLETED|Period 2||0
10680141|NCT02396147|11842706|FG001|NOT COMPLETED|Period 2||0
10680142|NCT02396147|11842705|FG000|STARTED|Period 3||27
10680143|NCT02396147|11842706|FG001|STARTED|Period 3||27
10680144|NCT02396147|11842705|FG000|COMPLETED|Period 3||27
10680145|NCT02396147|11842706|FG001|COMPLETED|Period 3||27
10680146|NCT02396147|11842705|FG000|NOT COMPLETED|Period 3||0
10680147|NCT02396147|11842706|FG001|NOT COMPLETED|Period 3||0
10680148|NCT02396160|11842722|FG000|STARTED|Overall Study||75
10798834|NCT03831945|11959361|FG000|STARTED|Overall Study||10
10798835|NCT03831945|11959362|FG001|STARTED|Overall Study||10
10798836|NCT03831945|11959361|FG000|COMPLETED|Overall Study||3
10680149|NCT02396160|11842723|FG001|STARTED|Overall Study||75
10680150|NCT02396160|11842722|FG000|COMPLETED|Overall Study||69
10680151|NCT02396160|11842723|FG001|COMPLETED|Overall Study||73
10680152|NCT02396160|11842722|FG000|NOT COMPLETED|Overall Study||6
10680153|NCT02396160|11842723|FG001|NOT COMPLETED|Overall Study||2
10680154|NCT02396212|11842729|FG000|STARTED|Overall Study||19
10680155|NCT02396212|11842729|FG000|COMPLETED|Overall Study||16
10680156|NCT02396212|11842729|FG000|NOT COMPLETED|Overall Study||3
10680163|NCT02396316|11842743|FG000|STARTED|Overall Study||27
10680164|NCT02396316|11842744|FG001|STARTED|Overall Study||27
10680165|NCT02396316|11842743|FG000|Treated|Overall Study||27
10680166|NCT02396316|11842744|FG001|Treated|Overall Study||27
10680167|NCT02396316|11842743|FG000|Received Sham Injection at Week 1|Overall Study||10
10680168|NCT02396316|11842744|FG001|Received Sham Injection at Week 1|Overall Study||0
10680169|NCT02396316|11842743|FG000|Received AFL Injection at Week 1|Overall Study||0
10680170|NCT02396316|11842744|FG001|Received AFL Injection at Week 1|Overall Study||22
10680171|NCT02396316|11842743|FG000|Received Active Injection at Week 5|Overall Study||4
10680172|NCT02396316|11842744|FG001|Received Active Injection at Week 5|Overall Study||4
10680173|NCT02396316|11842743|FG000|Received Active Injection at Week 9|Overall Study||2
10680174|NCT02396316|11842744|FG001|Received Active Injection at Week 9|Overall Study||1
10680175|NCT02396316|11842743|FG000|COMPLETED|Overall Study||20
10680176|NCT02396316|11842744|FG001|COMPLETED|Overall Study||22
10680177|NCT02396316|11842743|FG000|NOT COMPLETED|Overall Study||7
10680178|NCT02396316|11842744|FG001|NOT COMPLETED|Overall Study||5
10680179|NCT02396381|11842756|FG000|STARTED|Overall Study||488
10680180|NCT02396381|11842757|FG001|STARTED|Overall Study||496
10680181|NCT02396381|11842756|FG000|Full Analysis Set - As Exposed (FAS-EX)|Overall Study||414
10680182|NCT02396381|11842757|FG001|Full Analysis Set - As Exposed (FAS-EX)|Overall Study||443
10680183|NCT02396381|11842756|FG000|COMPLETED|Overall Study||381
10680184|NCT02396381|11842757|FG001|COMPLETED|Overall Study||422
10680185|NCT02396381|11842756|FG000|NOT COMPLETED|Overall Study||107
10680186|NCT02396381|11842757|FG001|NOT COMPLETED|Overall Study||74
10680187|NCT02396420|11842766|FG000|STARTED|Overall Study||2
10680188|NCT02396420|11842766|FG000|1 Month Post PAE|Overall Study||2
10680189|NCT02396420|11842766|FG000|3 Months Post PAE|Overall Study||2
10680190|NCT02396420|11842766|FG000|6 Months Post PAE|Overall Study||2
10680191|NCT02396420|11842766|FG000|COMPLETED|Overall Study||1
10680192|NCT02396420|11842766|FG000|NOT COMPLETED|Overall Study||1
10680193|NCT02396511|11842771|FG000|STARTED|Overall Study||2
10680194|NCT02396511|11842771|FG000|COMPLETED|Overall Study||2
10680195|NCT02396511|11842771|FG000|NOT COMPLETED|Overall Study||0
10680196|NCT02396537|11842777|FG000|STARTED|Overall Study||40
10680197|NCT02396537|11842778|FG001|STARTED|Overall Study||37
10680198|NCT02396537|11842777|FG000|COMPLETED|Overall Study||40
10680199|NCT02396537|11842778|FG001|COMPLETED|Overall Study||36
10680200|NCT02396537|11842777|FG000|NOT COMPLETED|Overall Study||0
10680201|NCT02396537|11842778|FG001|NOT COMPLETED|Overall Study||1
10680202|NCT02396732|11842786|FG000|STARTED|Overall Study||14
10680203|NCT02396732|11842787|FG001|STARTED|Overall Study||17
10680204|NCT02396732|11842786|FG000|COMPLETED|Overall Study||14
10680205|NCT02396732|11842787|FG001|COMPLETED|Overall Study||17
10680206|NCT02396732|11842786|FG000|NOT COMPLETED|Overall Study||0
10680207|NCT02396732|11842787|FG001|NOT COMPLETED|Overall Study||0
10680208|NCT02396745|11842793|FG000|STARTED|Overall Study||1
10680209|NCT02396745|11842793|FG000|COMPLETED|Overall Study||1
10680210|NCT02396745|11842793|FG000|NOT COMPLETED|Overall Study||0
10712821|NCT02673619|11878345|FG001|COMPLETED|Overall Study||4
10712822|NCT02673619|11878346|FG002|COMPLETED|Overall Study||23
10712823|NCT02673619|11878347|FG003|COMPLETED|Overall Study||7
10712824|NCT02673619|11878344|FG000|NOT COMPLETED|Overall Study||2
10712825|NCT02673619|11878345|FG001|NOT COMPLETED|Overall Study||1
10712826|NCT02673619|11878346|FG002|NOT COMPLETED|Overall Study||3
10712827|NCT02673619|11878347|FG003|NOT COMPLETED|Overall Study||0
10712828|NCT02673918|11878360|FG000|STARTED|Overall Study||35
10712829|NCT02673918|11878361|FG001|STARTED|Overall Study||24
10712830|NCT02673918|11878360|FG000|COMPLETED|Overall Study||29
10712831|NCT02673918|11878361|FG001|COMPLETED|Overall Study||20
10712832|NCT02673918|11878360|FG000|NOT COMPLETED|Overall Study||6
10712833|NCT02673918|11878361|FG001|NOT COMPLETED|Overall Study||4
10712834|NCT02673944|11878369|FG000|STARTED|Overall Study||10
10712835|NCT02673944|11878369|FG000|COMPLETED|Overall Study||10
10712836|NCT02673944|11878369|FG000|NOT COMPLETED|Overall Study||0
10712837|NCT02674334|11878376|FG000|STARTED|Overall Study||47
10712838|NCT02674334|11878377|FG001|STARTED|Overall Study||43
10712839|NCT02674334|11878376|FG000|COMPLETED|Overall Study||40
10712840|NCT02674334|11878377|FG001|COMPLETED|Overall Study||40
10712841|NCT02674334|11878376|FG000|NOT COMPLETED|Overall Study||7
10712842|NCT02674334|11878377|FG001|NOT COMPLETED|Overall Study||3
10712843|NCT02674386|11878386|FG000|STARTED|Overall Study||20
10712844|NCT02674386|11878387|FG001|STARTED|Overall Study||117
10712845|NCT02674386|11878388|FG002|STARTED|Overall Study||17
10712846|NCT02674386|11878386|FG000|Safety Analysis Set|Overall Study||20
10712847|NCT02674386|11878387|FG001|Safety Analysis Set|Overall Study||113
10712848|NCT02674386|11878388|FG002|Safety Analysis Set|Overall Study||17
10712849|NCT02674386|11878386|FG000|COMPLETED|Overall Study||20
10712850|NCT02674386|11878387|FG001|COMPLETED|Overall Study||107
10712851|NCT02674386|11878388|FG002|COMPLETED|Overall Study||16
10712852|NCT02674386|11878386|FG000|NOT COMPLETED|Overall Study||0
10712853|NCT02674386|11878387|FG001|NOT COMPLETED|Overall Study||10
10712854|NCT02674386|11878388|FG002|NOT COMPLETED|Overall Study||1
10712855|NCT02674399|11878403|FG000|STARTED|Overall Study||19
10712856|NCT02674399|11878404|FG001|STARTED|Overall Study||9
10712857|NCT02674399|11878403|FG000|COMPLETED|Overall Study||17
10712858|NCT02674399|11878404|FG001|COMPLETED|Overall Study||9
10712859|NCT02674399|11878403|FG000|NOT COMPLETED|Overall Study||2
10712860|NCT02674399|11878404|FG001|NOT COMPLETED|Overall Study||0
10712861|NCT02674412|11878410|FG000|STARTED|Overall Study||5
10712862|NCT02674412|11878411|FG001|STARTED|Overall Study||5
10712863|NCT02674412|11878410|FG000|COMPLETED|Overall Study||5
10712864|NCT02674412|11878411|FG001|COMPLETED|Overall Study||5
10712865|NCT02674412|11878410|FG000|NOT COMPLETED|Overall Study||0
10712866|NCT02674412|11878411|FG001|NOT COMPLETED|Overall Study||0
10712867|NCT02674477|11878420|FG000|STARTED|Overall Study||48
10712868|NCT02674477|11878421|FG001|STARTED|Overall Study||47
10712869|NCT02674477|11878420|FG000|COMPLETED|Overall Study||40
10712870|NCT02674477|11878421|FG001|COMPLETED|Overall Study||45
10712871|NCT02674477|11878420|FG000|NOT COMPLETED|Overall Study||8
10712872|NCT02674477|11878421|FG001|NOT COMPLETED|Overall Study||2
10712873|NCT02674568|11878427|FG000|STARTED|Overall Study|Enrolled and dosed.|339
10712874|NCT02674568|11878427|FG000|Delta-like Protein 3 (DLL3) High|Overall Study||238
10712875|NCT02674568|11878427|FG000|DLL3 Positive|Overall Study||287
10712876|NCT02674568|11878427|FG000|COMPLETED|Overall Study||0
10680211|NCT02396758|11842801|FG000|STARTED|Overall Study||38
10680212|NCT02396758|11842802|FG001|STARTED|Overall Study||37
10680213|NCT02396758|11842803|FG002|STARTED|Overall Study||38
10680214|NCT02396758|11842804|FG003|STARTED|Overall Study||18
10680215|NCT02396758|11842801|FG000|COMPLETED|Overall Study||26
10680216|NCT02396758|11842802|FG001|COMPLETED|Overall Study||31
10680217|NCT02396758|11842803|FG002|COMPLETED|Overall Study||34
10680218|NCT02396758|11842804|FG003|COMPLETED|Overall Study||13
10680219|NCT02396758|11842801|FG000|NOT COMPLETED|Overall Study||12
10680220|NCT02396758|11842802|FG001|NOT COMPLETED|Overall Study||6
10680221|NCT02396758|11842803|FG002|NOT COMPLETED|Overall Study||4
10680222|NCT02396758|11842804|FG003|NOT COMPLETED|Overall Study||5
10680223|NCT02396849|11842816|FG000|STARTED|Overall Study||29
10680224|NCT02396849|11842817|FG001|STARTED|Overall Study||30
10680225|NCT02396849|11842816|FG000|COMPLETED|Overall Study||27
10680226|NCT02396849|11842817|FG001|COMPLETED|Overall Study||28
10680227|NCT02396849|11842816|FG000|NOT COMPLETED|Overall Study||2
10680228|NCT02396849|11842817|FG001|NOT COMPLETED|Overall Study||2
10680229|NCT02396953|11842828|FG000|STARTED|Overall Study||9
10680230|NCT02396953|11842829|FG001|STARTED|Overall Study||9
10680231|NCT02396953|11842830|FG002|STARTED|Overall Study||10
10680232|NCT02396953|11842828|FG000|COMPLETED|Overall Study||5
10680233|NCT02396953|11842829|FG001|COMPLETED|Overall Study||6
10680234|NCT02396953|11842830|FG002|COMPLETED|Overall Study||7
10680235|NCT02396953|11842828|FG000|NOT COMPLETED|Overall Study||4
10680236|NCT02396953|11842829|FG001|NOT COMPLETED|Overall Study||3
10680237|NCT02396953|11842830|FG002|NOT COMPLETED|Overall Study||3
10680238|NCT02397057|11842847|FG000|STARTED|Overall Study|"Two Normal Saline participants received Injectafer. The data presented is considered accurate."|105
10680239|NCT02397057|11842848|FG001|STARTED|Overall Study||104
10680240|NCT02397057|11842847|FG000|COMPLETED|Overall Study||94
10680241|NCT02397057|11842848|FG001|COMPLETED|Overall Study||91
10680242|NCT02397057|11842847|FG000|NOT COMPLETED|Overall Study||11
10680243|NCT02397057|11842848|FG001|NOT COMPLETED|Overall Study||13
10680262|NCT02397122|11842869|FG000|STARTED|Overall Study||20
10680263|NCT02397122|11842870|FG001|STARTED|Overall Study||20
10680264|NCT02397122|11842869|FG000|COMPLETED|Overall Study||20
10680265|NCT02397122|11842870|FG001|COMPLETED|Overall Study||20
10680266|NCT02397122|11842869|FG000|NOT COMPLETED|Overall Study||0
10680267|NCT02397122|11842870|FG001|NOT COMPLETED|Overall Study||0
10680268|NCT02397265|11842880|FG000|STARTED|First Intervention of Three||2
10680269|NCT02397265|11842881|FG001|STARTED|First Intervention of Three||2
10680270|NCT02397265|11842882|FG002|STARTED|First Intervention of Three||2
10680271|NCT02397265|11842880|FG000|COMPLETED|First Intervention of Three||2
10680272|NCT02397265|11842881|FG001|COMPLETED|First Intervention of Three||2
10680273|NCT02397265|11842882|FG002|COMPLETED|First Intervention of Three||2
10680274|NCT02397265|11842880|FG000|NOT COMPLETED|First Intervention of Three||0
10680275|NCT02397265|11842881|FG001|NOT COMPLETED|First Intervention of Three||0
10680276|NCT02397265|11842882|FG002|NOT COMPLETED|First Intervention of Three||0
10680277|NCT02397265|11842880|FG000|STARTED|Second Intervention of Three||2
10680278|NCT02397265|11842881|FG001|STARTED|Second Intervention of Three||2
10680279|NCT02397265|11842882|FG002|STARTED|Second Intervention of Three||2
10680280|NCT02397265|11842880|FG000|COMPLETED|Second Intervention of Three||2
10680281|NCT02397265|11842881|FG001|COMPLETED|Second Intervention of Three||2
10680282|NCT02397265|11842882|FG002|COMPLETED|Second Intervention of Three||2
10680283|NCT02397265|11842880|FG000|NOT COMPLETED|Second Intervention of Three||0
10680284|NCT02397265|11842881|FG001|NOT COMPLETED|Second Intervention of Three||0
10680285|NCT02397265|11842882|FG002|NOT COMPLETED|Second Intervention of Three||0
10680286|NCT02397265|11842880|FG000|STARTED|Third Intervention of Three||2
10680287|NCT02397265|11842881|FG001|STARTED|Third Intervention of Three||2
10680288|NCT02397265|11842882|FG002|STARTED|Third Intervention of Three||2
10680289|NCT02397265|11842880|FG000|COMPLETED|Third Intervention of Three||2
10680290|NCT02397265|11842881|FG001|COMPLETED|Third Intervention of Three||2
10680291|NCT02397265|11842882|FG002|COMPLETED|Third Intervention of Three||2
10680292|NCT02397265|11842880|FG000|NOT COMPLETED|Third Intervention of Three||0
10680293|NCT02397265|11842881|FG001|NOT COMPLETED|Third Intervention of Three||0
10680294|NCT02397265|11842882|FG002|NOT COMPLETED|Third Intervention of Three||0
10680295|NCT02397278|11842892|FG000|STARTED|Overall Study||7
10680296|NCT02397278|11842893|FG001|STARTED|Overall Study||8
10680297|NCT02397278|11842892|FG000|COMPLETED|Overall Study||6
10680298|NCT02397278|11842893|FG001|COMPLETED|Overall Study||5
10680299|NCT02397278|11842892|FG000|NOT COMPLETED|Overall Study||1
10680300|NCT02397278|11842893|FG001|NOT COMPLETED|Overall Study||3
10680301|NCT02397291|11842901|FG000|STARTED|Overall Study||19
10680302|NCT02397291|11842902|FG001|STARTED|Overall Study||5
10680303|NCT02397291|11842901|FG000|COMPLETED|Overall Study||19
10680304|NCT02397291|11842902|FG001|COMPLETED|Overall Study||5
10680305|NCT02397291|11842901|FG000|NOT COMPLETED|Overall Study||0
10680306|NCT02397291|11842902|FG001|NOT COMPLETED|Overall Study||0
10680307|NCT02397408|11842908|FG000|STARTED|Overall Study||18
10680308|NCT02397408|11842908|FG000|Completed Surgery Per Protocol|Overall Study||16
10680309|NCT02397408|11842908|FG000|COMPLETED|Overall Study||12
10680310|NCT02397408|11842908|FG000|NOT COMPLETED|Overall Study||6
10680311|NCT02397447|11842914|FG000|STARTED|Overall Study||12
10680312|NCT02397447|11842915|FG001|STARTED|Overall Study||12
10680313|NCT02397447|11842914|FG000|COMPLETED|Overall Study||10
10680314|NCT02397447|11842915|FG001|COMPLETED|Overall Study||10
10680315|NCT02397447|11842914|FG000|NOT COMPLETED|Overall Study||2
10680316|NCT02397447|11842915|FG001|NOT COMPLETED|Overall Study||2
10680317|NCT02397460|11842929|FG000|STARTED|Treatment Period 1||7
10680318|NCT02397460|11842930|FG001|STARTED|Treatment Period 1||7
10680319|NCT02397460|11842931|FG002|STARTED|Treatment Period 1||6
10680320|NCT02397460|11842932|FG003|STARTED|Treatment Period 1||6
10680321|NCT02397460|11842933|FG004|STARTED|Treatment Period 1||6
10680322|NCT02397460|11842934|FG005|STARTED|Treatment Period 1||6
10680323|NCT02397460|11842935|FG006|STARTED|Treatment Period 1||6
10680324|NCT02397460|11842936|FG007|STARTED|Treatment Period 1||6
10680325|NCT02397460|11842929|FG000|COMPLETED|Treatment Period 1||7
10680326|NCT02397460|11842930|FG001|COMPLETED|Treatment Period 1||7
10680327|NCT02397460|11842931|FG002|COMPLETED|Treatment Period 1||6
10680328|NCT02397460|11842932|FG003|COMPLETED|Treatment Period 1||6
10680329|NCT02397460|11842933|FG004|COMPLETED|Treatment Period 1||6
10680330|NCT02397460|11842934|FG005|COMPLETED|Treatment Period 1||6
10680331|NCT02397460|11842935|FG006|COMPLETED|Treatment Period 1||6
10680332|NCT02397460|11842936|FG007|COMPLETED|Treatment Period 1||6
10680333|NCT02397460|11842929|FG000|NOT COMPLETED|Treatment Period 1||0
10680334|NCT02397460|11842930|FG001|NOT COMPLETED|Treatment Period 1||0
10680335|NCT02397460|11842931|FG002|NOT COMPLETED|Treatment Period 1||0
10680336|NCT02397460|11842932|FG003|NOT COMPLETED|Treatment Period 1||0
10680337|NCT02397460|11842933|FG004|NOT COMPLETED|Treatment Period 1||0
10680338|NCT02397460|11842934|FG005|NOT COMPLETED|Treatment Period 1||0
10680339|NCT02397460|11842935|FG006|NOT COMPLETED|Treatment Period 1||0
10680340|NCT02397460|11842936|FG007|NOT COMPLETED|Treatment Period 1||0
10680341|NCT02397460|11842929|FG000|STARTED|Treatment Period 2||7
10680342|NCT02397460|11842930|FG001|STARTED|Treatment Period 2||7
10680343|NCT02397460|11842931|FG002|STARTED|Treatment Period 2||6
10680344|NCT02397460|11842932|FG003|STARTED|Treatment Period 2||6
10680345|NCT02397460|11842933|FG004|STARTED|Treatment Period 2||6
10680346|NCT02397460|11842934|FG005|STARTED|Treatment Period 2||6
10680347|NCT02397460|11842935|FG006|STARTED|Treatment Period 2||6
10680348|NCT02397460|11842936|FG007|STARTED|Treatment Period 2||6
10680349|NCT02397460|11842929|FG000|COMPLETED|Treatment Period 2||7
10680350|NCT02397460|11842930|FG001|COMPLETED|Treatment Period 2||7
10680351|NCT02397460|11842931|FG002|COMPLETED|Treatment Period 2||6
10680352|NCT02397460|11842932|FG003|COMPLETED|Treatment Period 2||6
10680353|NCT02397460|11842933|FG004|COMPLETED|Treatment Period 2||6
10680354|NCT02397460|11842934|FG005|COMPLETED|Treatment Period 2||6
10680355|NCT02397460|11842935|FG006|COMPLETED|Treatment Period 2||6
10680356|NCT02397460|11842936|FG007|COMPLETED|Treatment Period 2||5
10680357|NCT02397460|11842929|FG000|NOT COMPLETED|Treatment Period 2||0
10680358|NCT02397460|11842930|FG001|NOT COMPLETED|Treatment Period 2||0
10680359|NCT02397460|11842931|FG002|NOT COMPLETED|Treatment Period 2||0
10680360|NCT02397460|11842932|FG003|NOT COMPLETED|Treatment Period 2||0
10680361|NCT02397460|11842933|FG004|NOT COMPLETED|Treatment Period 2||0
10680362|NCT02397460|11842934|FG005|NOT COMPLETED|Treatment Period 2||0
10680363|NCT02397460|11842935|FG006|NOT COMPLETED|Treatment Period 2||0
10680364|NCT02397460|11842936|FG007|NOT COMPLETED|Treatment Period 2||1
10680365|NCT02397460|11842929|FG000|STARTED|Treatment Period 3||7
10680366|NCT02397460|11842930|FG001|STARTED|Treatment Period 3||7
10680367|NCT02397460|11842931|FG002|STARTED|Treatment Period 3||6
10680368|NCT02397460|11842932|FG003|STARTED|Treatment Period 3||6
10680369|NCT02397460|11842933|FG004|STARTED|Treatment Period 3||6
10680370|NCT02397460|11842934|FG005|STARTED|Treatment Period 3||6
10680371|NCT02397460|11842935|FG006|STARTED|Treatment Period 3||6
10680372|NCT02397460|11842936|FG007|STARTED|Treatment Period 3||5
10798837|NCT03831945|11959362|FG001|COMPLETED|Overall Study||4
10798838|NCT03831945|11959361|FG000|NOT COMPLETED|Overall Study||7
10798839|NCT03831945|11959362|FG001|NOT COMPLETED|Overall Study||6
10798840|NCT03835728|11959370|FG000|STARTED|Overall Study||2
10798841|NCT03835728|11959371|FG001|STARTED|Overall Study||1
10680373|NCT02397460|11842929|FG000|COMPLETED|Treatment Period 3||7
10798842|NCT03835728|11959370|FG000|COMPLETED|Overall Study||2
10680374|NCT02397460|11842930|FG001|COMPLETED|Treatment Period 3||7
10680375|NCT02397460|11842931|FG002|COMPLETED|Treatment Period 3||6
10680376|NCT02397460|11842932|FG003|COMPLETED|Treatment Period 3||6
10680377|NCT02397460|11842933|FG004|COMPLETED|Treatment Period 3||6
10680378|NCT02397460|11842934|FG005|COMPLETED|Treatment Period 3||6
10798843|NCT03835728|11959371|FG001|COMPLETED|Overall Study||1
10798844|NCT03835728|11959370|FG000|NOT COMPLETED|Overall Study||0
10798845|NCT03835728|11959371|FG001|NOT COMPLETED|Overall Study||0
10798846|NCT03840174|11959381|FG000|STARTED|Overall Study||6
10798847|NCT03840174|11959382|FG001|STARTED|Overall Study||6
10798848|NCT03840174|11959383|FG002|STARTED|Overall Study||3
10798849|NCT03840174|11959384|FG003|STARTED|Overall Study||3
10798850|NCT03840174|11959381|FG000|Vaccination 1|Overall Study||6
10680379|NCT02397460|11842935|FG006|COMPLETED|Treatment Period 3||6
10680380|NCT02397460|11842936|FG007|COMPLETED|Treatment Period 3||5
10680381|NCT02397460|11842929|FG000|NOT COMPLETED|Treatment Period 3||0
10680382|NCT02397460|11842930|FG001|NOT COMPLETED|Treatment Period 3||0
10680383|NCT02397460|11842931|FG002|NOT COMPLETED|Treatment Period 3||0
10680384|NCT02397460|11842932|FG003|NOT COMPLETED|Treatment Period 3||0
10680385|NCT02397460|11842933|FG004|NOT COMPLETED|Treatment Period 3||0
10680386|NCT02397460|11842934|FG005|NOT COMPLETED|Treatment Period 3||0
10680387|NCT02397460|11842935|FG006|NOT COMPLETED|Treatment Period 3||0
10680388|NCT02397460|11842936|FG007|NOT COMPLETED|Treatment Period 3||0
10680389|NCT02397460|11842929|FG000|STARTED|Treatment Period 4||7
10680390|NCT02397460|11842930|FG001|STARTED|Treatment Period 4||7
10680391|NCT02397460|11842931|FG002|STARTED|Treatment Period 4||6
10680392|NCT02397460|11842932|FG003|STARTED|Treatment Period 4||6
10680393|NCT02397460|11842933|FG004|STARTED|Treatment Period 4||6
10680394|NCT02397460|11842934|FG005|STARTED|Treatment Period 4||6
10680395|NCT02397460|11842935|FG006|STARTED|Treatment Period 4||6
10680396|NCT02397460|11842936|FG007|STARTED|Treatment Period 4||5
10680397|NCT02397460|11842929|FG000|COMPLETED|Treatment Period 4||7
10680398|NCT02397460|11842930|FG001|COMPLETED|Treatment Period 4||6
10680399|NCT02397460|11842931|FG002|COMPLETED|Treatment Period 4||6
10680400|NCT02397460|11842932|FG003|COMPLETED|Treatment Period 4||6
10680401|NCT02397460|11842933|FG004|COMPLETED|Treatment Period 4||5
10680402|NCT02397460|11842934|FG005|COMPLETED|Treatment Period 4||6
10680403|NCT02397460|11842935|FG006|COMPLETED|Treatment Period 4||6
10680404|NCT02397460|11842936|FG007|COMPLETED|Treatment Period 4||5
10680405|NCT02397460|11842929|FG000|NOT COMPLETED|Treatment Period 4||0
10680406|NCT02397460|11842930|FG001|NOT COMPLETED|Treatment Period 4||1
10680407|NCT02397460|11842931|FG002|NOT COMPLETED|Treatment Period 4||0
10680408|NCT02397460|11842932|FG003|NOT COMPLETED|Treatment Period 4||0
10680409|NCT02397460|11842933|FG004|NOT COMPLETED|Treatment Period 4||1
10680410|NCT02397460|11842934|FG005|NOT COMPLETED|Treatment Period 4||0
10680411|NCT02397460|11842935|FG006|NOT COMPLETED|Treatment Period 4||0
10680412|NCT02397460|11842936|FG007|NOT COMPLETED|Treatment Period 4||0
10680413|NCT02397473|11843012|FG000|STARTED|Treatment Phase||57
10680414|NCT02397473|11843013|FG001|STARTED|Treatment Phase||52
10680415|NCT02397473|11843012|FG000|Received at Least One Dose of Study Drug|Treatment Phase||57
10680416|NCT02397473|11843013|FG001|Received at Least One Dose of Study Drug|Treatment Phase||49
10680417|NCT02397473|11843012|FG000|COMPLETED|Treatment Phase||45
10680418|NCT02397473|11843013|FG001|COMPLETED|Treatment Phase||45
10680419|NCT02397473|11843012|FG000|NOT COMPLETED|Treatment Phase||12
10680420|NCT02397473|11843013|FG001|NOT COMPLETED|Treatment Phase||7
10680474|NCT02397915|11843087|FG002|STARTED|Period 1||0
10680421|NCT02397473|11843012|FG000|STARTED|Post Treatment Follow-up Phase|Participants who discontinued treatment period had an option to enter post treatment phase.|50
10680422|NCT02397473|11843013|FG001|STARTED|Post Treatment Follow-up Phase||47
10680423|NCT02397473|11843012|FG000|COMPLETED|Post Treatment Follow-up Phase||47
10680424|NCT02397473|11843013|FG001|COMPLETED|Post Treatment Follow-up Phase||45
10680425|NCT02397473|11843012|FG000|NOT COMPLETED|Post Treatment Follow-up Phase||3
10680426|NCT02397473|11843013|FG001|NOT COMPLETED|Post Treatment Follow-up Phase||2
10680427|NCT02397564|11843022|FG000|STARTED|Overall Study||20
10680428|NCT02397564|11843022|FG000|COMPLETED|Overall Study||16
10680429|NCT02397564|11843022|FG000|NOT COMPLETED|Overall Study||4
10680430|NCT02397655|11843027|FG000|STARTED|Overall Study||12012
10680431|NCT02397655|11843027|FG000|COMPLETED|Overall Study||10711
10680432|NCT02397655|11843027|FG000|NOT COMPLETED|Overall Study||1301
10680433|NCT02397694|11843033|FG000|STARTED|Double-Blinded Phase||65
10680434|NCT02397694|11843034|FG001|STARTED|Double-Blinded Phase||33
10680435|NCT02397694|11843033|FG000|COMPLETED|Double-Blinded Phase||62
10680436|NCT02397694|11843034|FG001|COMPLETED|Double-Blinded Phase||30
10680437|NCT02397694|11843033|FG000|NOT COMPLETED|Double-Blinded Phase||3
10680438|NCT02397694|11843034|FG001|NOT COMPLETED|Double-Blinded Phase||3
10680439|NCT02397694|11843033|FG000|STARTED|Open Label Extension Phase||62
10680440|NCT02397694|11843034|FG001|STARTED|Open Label Extension Phase||30
10680441|NCT02397694|11843033|FG000|COMPLETED|Open Label Extension Phase||54
10680442|NCT02397694|11843034|FG001|COMPLETED|Open Label Extension Phase||29
10680443|NCT02397694|11843033|FG000|NOT COMPLETED|Open Label Extension Phase||8
10680444|NCT02397694|11843034|FG001|NOT COMPLETED|Open Label Extension Phase||1
10680445|NCT02397707|11843047|FG000|STARTED|Overall Study||14
10680446|NCT02397707|11843048|FG001|STARTED|Overall Study||10
10680447|NCT02397707|11843049|FG002|STARTED|Overall Study||9
10680448|NCT02397707|11843047|FG000|COMPLETED|Overall Study||14
10680449|NCT02397707|11843048|FG001|COMPLETED|Overall Study||10
10680450|NCT02397707|11843049|FG002|COMPLETED|Overall Study||9
10680451|NCT02397707|11843047|FG000|NOT COMPLETED|Overall Study||0
10680452|NCT02397707|11843048|FG001|NOT COMPLETED|Overall Study||0
10680453|NCT02397707|11843049|FG002|NOT COMPLETED|Overall Study||0
10680454|NCT02397785|11843060|FG000|STARTED|Overall Study||24
10680455|NCT02397785|11843061|FG001|STARTED|Overall Study||34
10680456|NCT02397785|11843060|FG000|COMPLETED|Overall Study||22
10680457|NCT02397785|11843061|FG001|COMPLETED|Overall Study||25
10798851|NCT03840174|11959382|FG001|Vaccination 1|Overall Study||6
10798852|NCT03840174|11959383|FG002|Vaccination 1|Overall Study||3
10798853|NCT03840174|11959384|FG003|Vaccination 1|Overall Study||3
10798854|NCT03840174|11959381|FG000|Vaccination 2|Overall Study||5
10798855|NCT03840174|11959382|FG001|Vaccination 2|Overall Study||6
10798856|NCT03840174|11959383|FG002|Vaccination 2|Overall Study||3
10798857|NCT03840174|11959384|FG003|Vaccination 2|Overall Study||3
10798858|NCT03840174|11959381|FG000|Vaccination 3|Overall Study||5
10798859|NCT03840174|11959382|FG001|Vaccination 3|Overall Study||6
10798860|NCT03840174|11959383|FG002|Vaccination 3|Overall Study||3
10798861|NCT03840174|11959384|FG003|Vaccination 3|Overall Study||3
10798862|NCT03840174|11959381|FG000|COMPLETED|Overall Study||5
10798863|NCT03840174|11959382|FG001|COMPLETED|Overall Study||6
10798864|NCT03840174|11959383|FG002|COMPLETED|Overall Study||3
10798865|NCT03840174|11959384|FG003|COMPLETED|Overall Study||3
10798866|NCT03840174|11959381|FG000|NOT COMPLETED|Overall Study||1
10798867|NCT03840174|11959382|FG001|NOT COMPLETED|Overall Study||0
10798868|NCT03840174|11959383|FG002|NOT COMPLETED|Overall Study||0
10798869|NCT03840174|11959384|FG003|NOT COMPLETED|Overall Study||0
10798870|NCT03848910|11959395|FG000|STARTED|Overall Study||11
10798871|NCT03848910|11959395|FG000|COMPLETED|Overall Study||11
10798872|NCT03848910|11959395|FG000|NOT COMPLETED|Overall Study||0
10798873|NCT03852524|11959402|FG000|STARTED|Overall Study||41
10798874|NCT03852524|11959403|FG001|STARTED|Overall Study||41
10798875|NCT03852524|11959402|FG000|COMPLETED|Overall Study||41
10798876|NCT03852524|11959403|FG001|COMPLETED|Overall Study||41
10798877|NCT03852524|11959402|FG000|NOT COMPLETED|Overall Study||0
10798878|NCT03852524|11959403|FG001|NOT COMPLETED|Overall Study||0
10798879|NCT03857841|11959413|FG000|STARTED|Overall Study||2
10798880|NCT03857841|11959414|FG001|STARTED|Overall Study||0
10798881|NCT03857841|11959415|FG002|STARTED|Overall Study||0
10798882|NCT03857841|11959416|FG003|STARTED|Overall Study||1
10798883|NCT03857841|11959413|FG000|COMPLETED|Overall Study||0
10798884|NCT03857841|11959414|FG001|COMPLETED|Overall Study||0
10798885|NCT03857841|11959415|FG002|COMPLETED|Overall Study||0
10798886|NCT03857841|11959416|FG003|COMPLETED|Overall Study||1
10798887|NCT03857841|11959413|FG000|NOT COMPLETED|Overall Study||2
10680458|NCT02397785|11843060|FG000|NOT COMPLETED|Overall Study||2
10680459|NCT02397785|11843061|FG001|NOT COMPLETED|Overall Study||9
10680460|NCT02397837|11843069|FG000|STARTED|Overall Study||33
10680461|NCT02397837|11843070|FG001|STARTED|Overall Study||30
10680462|NCT02397837|11843069|FG000|COMPLETED|Overall Study||26
10680463|NCT02397837|11843070|FG001|COMPLETED|Overall Study||24
10680464|NCT02397837|11843069|FG000|NOT COMPLETED|Overall Study||7
10680465|NCT02397837|11843070|FG001|NOT COMPLETED|Overall Study||6
10680466|NCT02397889|11843078|FG000|STARTED|Overall Study||15
10680467|NCT02397889|11843079|FG001|STARTED|Overall Study||15
10680468|NCT02397889|11843078|FG000|COMPLETED|Overall Study||14
10680469|NCT02397889|11843079|FG001|COMPLETED|Overall Study||15
10680470|NCT02397889|11843078|FG000|NOT COMPLETED|Overall Study||1
10680471|NCT02397889|11843079|FG001|NOT COMPLETED|Overall Study||0
10680472|NCT02397915|11843085|FG000|STARTED|Period 1||150
10680473|NCT02397915|11843086|FG001|STARTED|Period 1||150
10680475|NCT02397915|11843088|FG003|STARTED|Period 1||0
10680476|NCT02397915|11843085|FG000|COMPLETED|Period 1||149
10680477|NCT02397915|11843086|FG001|COMPLETED|Period 1||149
10680478|NCT02397915|11843087|FG002|COMPLETED|Period 1||0
10680479|NCT02397915|11843088|FG003|COMPLETED|Period 1||0
10680480|NCT02397915|11843085|FG000|NOT COMPLETED|Period 1||1
10680481|NCT02397915|11843086|FG001|NOT COMPLETED|Period 1||1
10680482|NCT02397915|11843087|FG002|NOT COMPLETED|Period 1||0
10680483|NCT02397915|11843088|FG003|NOT COMPLETED|Period 1||0
10680484|NCT02397915|11843085|FG000|STARTED|Period 2||0
10680485|NCT02397915|11843086|FG001|STARTED|Period 2||0
10680486|NCT02397915|11843087|FG002|STARTED|Period 2||149
10680487|NCT02397915|11843088|FG003|STARTED|Period 2||149
10680488|NCT02397915|11843085|FG000|COMPLETED|Period 2||0
10680489|NCT02397915|11843086|FG001|COMPLETED|Period 2||0
10680490|NCT02397915|11843087|FG002|COMPLETED|Period 2||149
10680491|NCT02397915|11843088|FG003|COMPLETED|Period 2||149
10680492|NCT02397915|11843085|FG000|NOT COMPLETED|Period 2||0
10680493|NCT02397915|11843086|FG001|NOT COMPLETED|Period 2||0
10680494|NCT02397915|11843087|FG002|NOT COMPLETED|Period 2||0
10798888|NCT03857841|11959414|FG001|NOT COMPLETED|Overall Study||0
10798889|NCT03857841|11959415|FG002|NOT COMPLETED|Overall Study||0
10680495|NCT02397915|11843088|FG003|NOT COMPLETED|Period 2||0
10680496|NCT02397954|11843096|FG000|STARTED|Overall Study||4
10680497|NCT02397954|11843096|FG000|COMPLETED|Overall Study||4
10680498|NCT02397954|11843096|FG000|NOT COMPLETED|Overall Study||0
10798890|NCT03857841|11959416|FG003|NOT COMPLETED|Overall Study||0
10798891|NCT03861780|11959429|FG000|STARTED|Overall Study||51
10798892|NCT03861780|11959430|FG001|STARTED|Overall Study||50
10798893|NCT03861780|11959431|FG002|STARTED|Overall Study||51
10798894|NCT03861780|11959429|FG000|COMPLETED|Overall Study||51
10798895|NCT03861780|11959430|FG001|COMPLETED|Overall Study||50
10798896|NCT03861780|11959431|FG002|COMPLETED|Overall Study||51
10680499|NCT02398188|11843102|FG000|STARTED|Overall Study||398
10680500|NCT02398188|11843103|FG001|STARTED|Overall Study||395
10680501|NCT02398188|11843102|FG000|COMPLETED|Overall Study||371
10680502|NCT02398188|11843103|FG001|COMPLETED|Overall Study||361
10680503|NCT02398188|11843102|FG000|NOT COMPLETED|Overall Study||27
10680504|NCT02398188|11843103|FG001|NOT COMPLETED|Overall Study||34
10680505|NCT02398227|11843111|FG000|STARTED|Overall Study||83
10680506|NCT02398227|11843112|FG001|STARTED|Overall Study||89
10680507|NCT02398227|11843111|FG000|COMPLETED|Overall Study||56
10680508|NCT02398227|11843112|FG001|COMPLETED|Overall Study||71
10680509|NCT02398227|11843111|FG000|NOT COMPLETED|Overall Study||27
10680510|NCT02398227|11843112|FG001|NOT COMPLETED|Overall Study||18
10680511|NCT02398409|11843120|FG000|STARTED|Overall Study||69
10680512|NCT02398409|11843121|FG001|STARTED|Overall Study||68
10798897|NCT03861780|11959429|FG000|NOT COMPLETED|Overall Study||0
10798898|NCT03861780|11959430|FG001|NOT COMPLETED|Overall Study||0
10798899|NCT03861780|11959431|FG002|NOT COMPLETED|Overall Study||0
10798900|NCT03862625|11959441|FG000|STARTED|Overall Study||15
10798901|NCT03862625|11959442|FG001|STARTED|Overall Study||15
10798902|NCT03862625|11959441|FG000|COMPLETED|Overall Study||15
10680513|NCT02398409|11843120|FG000|COMPLETED|Overall Study||67
10680514|NCT02398409|11843121|FG001|COMPLETED|Overall Study||63
10680515|NCT02398409|11843120|FG000|NOT COMPLETED|Overall Study||2
10680516|NCT02398409|11843121|FG001|NOT COMPLETED|Overall Study||5
10680517|NCT02399085|11843127|FG000|STARTED|Overall Study||81
10680518|NCT02399085|11843127|FG000|COMPLETED|Overall Study|30 patients completed the combination treatment on both study drugs (12 cycles).|30
10680519|NCT02399085|11843127|FG000|NOT COMPLETED|Overall Study||51
10680520|NCT02399163|11843131|FG000|STARTED|Overall Study||62
10680521|NCT02399163|11843131|FG000|COMPLETED|Overall Study||53
10680522|NCT02399163|11843131|FG000|NOT COMPLETED|Overall Study||9
10680523|NCT02399228|11843143|FG000|STARTED|Overall Study||13
10680524|NCT02399228|11843143|FG000|COMPLETED|Overall Study||7
10680525|NCT02399228|11843143|FG000|NOT COMPLETED|Overall Study||6
10680526|NCT02399254|11843147|FG000|STARTED|Overall Study||21
10680527|NCT02399254|11843147|FG000|COMPLETED|Overall Study||19
10680528|NCT02399254|11843147|FG000|NOT COMPLETED|Overall Study||2
10680529|NCT02399345|11843152|FG000|STARTED|Overall Study||10
10680530|NCT02399345|11843152|FG000|COMPLETED|Overall Study||10
10680531|NCT02399345|11843152|FG000|NOT COMPLETED|Overall Study||0
10680532|NCT02399475|11843158|FG000|STARTED|Overall Study||7
10680533|NCT02399475|11843159|FG001|STARTED|Overall Study||7
10680534|NCT02399475|11843158|FG000|COMPLETED|Overall Study||6
10680535|NCT02399475|11843159|FG001|COMPLETED|Overall Study||7
10680536|NCT02399475|11843158|FG000|NOT COMPLETED|Overall Study||1
10680537|NCT02399475|11843159|FG001|NOT COMPLETED|Overall Study||0
10680538|NCT02399917|11843168|FG000|STARTED|Overall Study||6
10680539|NCT02399917|11843169|FG001|STARTED|Overall Study||6
10680540|NCT02399917|11843170|FG002|STARTED|Overall Study||24
10680541|NCT02399917|11843168|FG000|COMPLETED|Overall Study||6
10680542|NCT02399917|11843169|FG001|COMPLETED|Overall Study||6
10680543|NCT02399917|11843170|FG002|COMPLETED|Overall Study||24
10680544|NCT02399917|11843168|FG000|NOT COMPLETED|Overall Study||0
10680545|NCT02399917|11843169|FG001|NOT COMPLETED|Overall Study||0
10680546|NCT02399917|11843170|FG002|NOT COMPLETED|Overall Study||0
10680547|NCT02400073|11843179|FG000|STARTED|Overall Study||122
10680548|NCT02400073|11843179|FG000|COMPLETED|Overall Study||111
10680549|NCT02400073|11843179|FG000|NOT COMPLETED|Overall Study||11
10680550|NCT02400307|11843185|FG000|STARTED|Overall Study||11
10680551|NCT02400307|11843186|FG001|STARTED|Overall Study||8
10680552|NCT02400307|11843185|FG000|COMPLETED|Overall Study||10
10680553|NCT02400307|11843186|FG001|COMPLETED|Overall Study||8
10680554|NCT02400307|11843185|FG000|NOT COMPLETED|Overall Study||1
10680555|NCT02400307|11843186|FG001|NOT COMPLETED|Overall Study||0
10680556|NCT02400333|11843196|FG000|STARTED|Overall Study||9
10680557|NCT02400333|11843197|FG001|STARTED|Overall Study||9
10680558|NCT02400333|11843198|FG002|STARTED|Overall Study||9
10680559|NCT02400333|11843199|FG003|STARTED|Overall Study||9
10680560|NCT02400333|11843196|FG000|COMPLETED|Overall Study||8
10680561|NCT02400333|11843197|FG001|COMPLETED|Overall Study||8
10680562|NCT02400333|11843198|FG002|COMPLETED|Overall Study||7
10680563|NCT02400333|11843199|FG003|COMPLETED|Overall Study||7
10680564|NCT02400333|11843196|FG000|NOT COMPLETED|Overall Study||1
10680565|NCT02400333|11843197|FG001|NOT COMPLETED|Overall Study||1
10680566|NCT02400333|11843198|FG002|NOT COMPLETED|Overall Study||2
10680567|NCT02400333|11843199|FG003|NOT COMPLETED|Overall Study||2
10680568|NCT02400346|11843210|FG000|STARTED|Overall Study||132
10680569|NCT02400346|11843210|FG000|COMPLETED|Overall Study||88
10680570|NCT02400346|11843210|FG000|NOT COMPLETED|Overall Study||44
10680571|NCT02400437|11843214|FG000|STARTED|Overall Study||26
10680572|NCT02400437|11843214|FG000|COMPLETED|Overall Study||26
10680573|NCT02400437|11843214|FG000|NOT COMPLETED|Overall Study||0
10680574|NCT02400463|11843220|FG000|STARTED|Overall Study||6
10798903|NCT03862625|11959442|FG001|COMPLETED|Overall Study||14
10798904|NCT03862625|11959441|FG000|NOT COMPLETED|Overall Study||0
10798905|NCT03862625|11959442|FG001|NOT COMPLETED|Overall Study||1
10798906|NCT03862755|11959448|FG000|STARTED|Overall Study||581
10680575|NCT02400463|11843220|FG000|COMPLETED|Overall Study||6
10680576|NCT02400463|11843220|FG000|NOT COMPLETED|Overall Study||0
10680577|NCT02400580|11843226|FG000|STARTED|Overall Study||91
10798907|NCT03862755|11959448|FG000|COMPLETED|Overall Study||581
10680578|NCT02400580|11843227|FG001|STARTED|Overall Study||92
10680579|NCT02400580|11843226|FG000|COMPLETED|Overall Study||89
10680580|NCT02400580|11843227|FG001|COMPLETED|Overall Study||91
10680581|NCT02400580|11843226|FG000|NOT COMPLETED|Overall Study||2
10680582|NCT02400580|11843227|FG001|NOT COMPLETED|Overall Study||1
10680583|NCT02400710|11843235|FG000|STARTED|Overall Study||10
10680584|NCT02400710|11843236|FG001|STARTED|Overall Study||10
10680585|NCT02400710|11843235|FG000|COMPLETED|Overall Study||10
10680586|NCT02400710|11843236|FG001|COMPLETED|Overall Study||10
10680587|NCT02400710|11843235|FG000|NOT COMPLETED|Overall Study||0
10680588|NCT02400710|11843236|FG001|NOT COMPLETED|Overall Study||0
10680589|NCT02400749|11843244|FG000|STARTED|Week 0 -16||50
10680590|NCT02400749|11843245|FG001|STARTED|Week 0 -16||50
10680591|NCT02400749|11843244|FG000|COMPLETED|Week 0 -16||39
10680592|NCT02400749|11843245|FG001|COMPLETED|Week 0 -16||44
10680593|NCT02400749|11843244|FG000|NOT COMPLETED|Week 0 -16||11
10680594|NCT02400749|11843245|FG001|NOT COMPLETED|Week 0 -16||6
10680595|NCT02400749|11843244|FG000|STARTED|Week 17 - 32||39
10680596|NCT02400749|11843245|FG001|STARTED|Week 17 - 32||44
10680597|NCT02400749|11843244|FG000|COMPLETED|Week 17 - 32||34
10798908|NCT03862755|11959448|FG000|NOT COMPLETED|Overall Study||0
10798909|NCT03869541|11959455|FG000|STARTED|Overall Study||40
10680598|NCT02400749|11843245|FG001|COMPLETED|Week 17 - 32||41
10680599|NCT02400749|11843244|FG000|NOT COMPLETED|Week 17 - 32||5
10680600|NCT02400749|11843245|FG001|NOT COMPLETED|Week 17 - 32||3
10680601|NCT02400905|11843251|FG000|STARTED|Overall Study||271
10680602|NCT02400905|11843251|FG000|30-Days Follow-up|Overall Study||268
10680603|NCT02400905|11843251|FG000|12-Months Follow-up|Overall Study||256
10680604|NCT02400905|11843251|FG000|24-Months Follow-up|Overall Study||225
10680605|NCT02400905|11843251|FG000|36 Months-Follow-up|Overall Study||208
10680606|NCT02400905|11843251|FG000|COMPLETED|Overall Study||208
10680607|NCT02400905|11843251|FG000|NOT COMPLETED|Overall Study||63
10680608|NCT02400996|11843256|FG000|STARTED|Overall Study||40
10680609|NCT02400996|11843256|FG000|COMPLETED|Overall Study||40
10680610|NCT02400996|11843256|FG000|NOT COMPLETED|Overall Study||0
10680611|NCT02401022|11843262|FG000|STARTED|Overall Study||104
10680612|NCT02401022|11843263|FG001|STARTED|Overall Study||110
10680613|NCT02401022|11843262|FG000|COMPLETED|Overall Study||89
10680614|NCT02401022|11843263|FG001|COMPLETED|Overall Study||90
10680615|NCT02401022|11843262|FG000|NOT COMPLETED|Overall Study||15
10680616|NCT02401022|11843263|FG001|NOT COMPLETED|Overall Study||20
10680617|NCT02401048|11843271|FG000|STARTED|Overall Study||27
10680618|NCT02401048|11843272|FG001|STARTED|Overall Study||34
10680619|NCT02401048|11843271|FG000|COMPLETED|Overall Study||5
10680620|NCT02401048|11843272|FG001|COMPLETED|Overall Study||4
10680621|NCT02401048|11843271|FG000|NOT COMPLETED|Overall Study||22
10680622|NCT02401048|11843272|FG001|NOT COMPLETED|Overall Study||30
10680623|NCT02401230|11843286|FG000|STARTED|Overall Study||26
10680624|NCT02401230|11843287|FG001|STARTED|Overall Study||25
10680625|NCT02401230|11843288|FG002|STARTED|Overall Study||25
10680626|NCT02401230|11843286|FG000|COMPLETED|Overall Study||20
10680627|NCT02401230|11843287|FG001|COMPLETED|Overall Study||19
10680628|NCT02401230|11843288|FG002|COMPLETED|Overall Study||21
10680629|NCT02401230|11843286|FG000|NOT COMPLETED|Overall Study||6
10680630|NCT02401230|11843287|FG001|NOT COMPLETED|Overall Study||6
10680631|NCT02401230|11843288|FG002|NOT COMPLETED|Overall Study||4
10680632|NCT02401256|11843300|FG000|STARTED|Overall Study||70
10680633|NCT02401256|11843300|FG000|Finished Phase 1|Overall Study||64
10680634|NCT02401256|11843300|FG000|Finished Phase 2|Overall Study||58
10680635|NCT02401256|11843300|FG000|Finished Phase 3|Overall Study||53
10680636|NCT02401256|11843300|FG000|Analysed|Overall Study|Volunteers that completed at least until Phase 2 inpatient visit (Volunteers with Efavirenz PK data)|61
10680637|NCT02401256|11843300|FG000|COMPLETED|Overall Study||53
10680638|NCT02401256|11843300|FG000|NOT COMPLETED|Overall Study||17
10680639|NCT02401412|11843308|FG000|STARTED|Overall Study||89
10680640|NCT02401412|11843309|FG001|STARTED|Overall Study||81
10680641|NCT02401412|11843308|FG000|Received Study Device|Overall Study||89
10680642|NCT02401412|11843309|FG001|Received Study Device|Overall Study||80
10680643|NCT02401412|11843308|FG000|COMPLETED|Overall Study||59
10680644|NCT02401412|11843309|FG001|COMPLETED|Overall Study||49
10680645|NCT02401412|11843308|FG000|NOT COMPLETED|Overall Study||30
10680646|NCT02401412|11843309|FG001|NOT COMPLETED|Overall Study||32
10680647|NCT02401464|11843319|FG000|STARTED|Intervention Period 1 (6 Days)||13
10680648|NCT02401464|11843320|FG001|STARTED|Intervention Period 1 (6 Days)||13
10680649|NCT02401464|11843321|FG002|STARTED|Intervention Period 1 (6 Days)||13
10680650|NCT02401464|11843322|FG003|STARTED|Intervention Period 1 (6 Days)||13
10680651|NCT02401464|11843319|FG000|COMPLETED|Intervention Period 1 (6 Days)||13
10680652|NCT02401464|11843320|FG001|COMPLETED|Intervention Period 1 (6 Days)||13
10680653|NCT02401464|11843321|FG002|COMPLETED|Intervention Period 1 (6 Days)||13
10680654|NCT02401464|11843322|FG003|COMPLETED|Intervention Period 1 (6 Days)||13
10680655|NCT02401464|11843319|FG000|NOT COMPLETED|Intervention Period 1 (6 Days)||0
10680656|NCT02401464|11843320|FG001|NOT COMPLETED|Intervention Period 1 (6 Days)||0
10798910|NCT03869541|11959456|FG001|STARTED|Overall Study||50
10680657|NCT02401464|11843321|FG002|NOT COMPLETED|Intervention Period 1 (6 Days)||0
10680658|NCT02401464|11843322|FG003|NOT COMPLETED|Intervention Period 1 (6 Days)||0
10680659|NCT02401464|11843319|FG000|STARTED|Washout Period (At Least 6 Days)||13
10680660|NCT02401464|11843320|FG001|STARTED|Washout Period (At Least 6 Days)||13
10680661|NCT02401464|11843321|FG002|STARTED|Washout Period (At Least 6 Days)||13
10680662|NCT02401464|11843322|FG003|STARTED|Washout Period (At Least 6 Days)||13
10680663|NCT02401464|11843319|FG000|COMPLETED|Washout Period (At Least 6 Days)||13
10680664|NCT02401464|11843320|FG001|COMPLETED|Washout Period (At Least 6 Days)||13
10680665|NCT02401464|11843321|FG002|COMPLETED|Washout Period (At Least 6 Days)||13
10680666|NCT02401464|11843322|FG003|COMPLETED|Washout Period (At Least 6 Days)||13
10680667|NCT02401464|11843319|FG000|NOT COMPLETED|Washout Period (At Least 6 Days)||0
10680668|NCT02401464|11843320|FG001|NOT COMPLETED|Washout Period (At Least 6 Days)||0
10680669|NCT02401464|11843321|FG002|NOT COMPLETED|Washout Period (At Least 6 Days)||0
10680670|NCT02401464|11843322|FG003|NOT COMPLETED|Washout Period (At Least 6 Days)||0
10680671|NCT02401464|11843319|FG000|STARTED|Intervention Period 2 (6 Days)||13
10680672|NCT02401464|11843320|FG001|STARTED|Intervention Period 2 (6 Days)||13
10680673|NCT02401464|11843321|FG002|STARTED|Intervention Period 2 (6 Days)||13
10680674|NCT02401464|11843322|FG003|STARTED|Intervention Period 2 (6 Days)||13
10680675|NCT02401464|11843319|FG000|COMPLETED|Intervention Period 2 (6 Days)||13
10680676|NCT02401464|11843320|FG001|COMPLETED|Intervention Period 2 (6 Days)||13
10680677|NCT02401464|11843321|FG002|COMPLETED|Intervention Period 2 (6 Days)||13
10680678|NCT02401464|11843322|FG003|COMPLETED|Intervention Period 2 (6 Days)||13
10680679|NCT02401464|11843319|FG000|NOT COMPLETED|Intervention Period 2 (6 Days)||0
10680680|NCT02401464|11843320|FG001|NOT COMPLETED|Intervention Period 2 (6 Days)||0
10680681|NCT02401464|11843321|FG002|NOT COMPLETED|Intervention Period 2 (6 Days)||0
10680682|NCT02401464|11843322|FG003|NOT COMPLETED|Intervention Period 2 (6 Days)||0
10680683|NCT02401529|11843336|FG000|STARTED|Overall Study||59
10680684|NCT02401529|11843337|FG001|STARTED|Overall Study||57
10680685|NCT02401529|11843336|FG000|COMPLETED|Overall Study||50
10680686|NCT02401529|11843337|FG001|COMPLETED|Overall Study||50
10680687|NCT02401529|11843336|FG000|NOT COMPLETED|Overall Study||9
10680688|NCT02401529|11843337|FG001|NOT COMPLETED|Overall Study||7
10680689|NCT02401542|11843347|FG000|STARTED|Overall Study||41
10680690|NCT02401542|11843348|FG001|STARTED|Overall Study||30
10680691|NCT02401542|11843349|FG002|STARTED|Overall Study||0
10680692|NCT02401542|11843347|FG000|COMPLETED|Overall Study||40
10680693|NCT02401542|11843348|FG001|COMPLETED|Overall Study||30
10680694|NCT02401542|11843349|FG002|COMPLETED|Overall Study||0
10680695|NCT02401542|11843347|FG000|NOT COMPLETED|Overall Study||1
10680696|NCT02401542|11843348|FG001|NOT COMPLETED|Overall Study||0
10680697|NCT02401542|11843349|FG002|NOT COMPLETED|Overall Study||0
10680698|NCT02401555|11843362|FG000|STARTED|Overall Study||87
10680699|NCT02401555|11843363|FG001|STARTED|Overall Study||212
10680700|NCT02401555|11843364|FG002|STARTED|Overall Study||120
10680701|NCT02401555|11843362|FG000|COMPLETED|Overall Study||87
10680702|NCT02401555|11843363|FG001|COMPLETED|Overall Study||212
10680703|NCT02401555|11843364|FG002|COMPLETED|Overall Study||120
10680704|NCT02401555|11843362|FG000|NOT COMPLETED|Overall Study||0
10680705|NCT02401555|11843363|FG001|NOT COMPLETED|Overall Study||0
10680706|NCT02401555|11843364|FG002|NOT COMPLETED|Overall Study||0
10680707|NCT02401672|11843374|FG000|STARTED|Overall Study||22
10680708|NCT02401672|11843375|FG001|STARTED|Overall Study||20
10680709|NCT02401672|11843374|FG000|COMPLETED|Overall Study||21
10680710|NCT02401672|11843375|FG001|COMPLETED|Overall Study||17
10680711|NCT02401672|11843374|FG000|NOT COMPLETED|Overall Study||1
10680712|NCT02401672|11843375|FG001|NOT COMPLETED|Overall Study||3
10318824|NCT00217672|11453086|FG000|STARTED|Follow-up|when bevacizumab became available, converted to a 1-arm open-label trial (67+7=74)|74
10318825|NCT00217672|11453087|FG001|STARTED|Follow-up||0
10318826|NCT00217672|11453086|FG000|COMPLETED|Follow-up||69
10318827|NCT00217672|11453087|FG001|COMPLETED|Follow-up||0
10318828|NCT00217672|11453086|FG000|NOT COMPLETED|Follow-up||5
10318829|NCT00217672|11453087|FG001|NOT COMPLETED|Follow-up||0
10318830|NCT00217724|11453091|FG000|STARTED|Course 1, (Glutamine/Placebo Arms)||8
10318831|NCT00217724|11453092|FG001|STARTED|Course 1, (Glutamine/Placebo Arms)||10
10318832|NCT00217724|11453091|FG000|COMPLETED|Course 1, (Glutamine/Placebo Arms)||5
10318833|NCT00217724|11453092|FG001|COMPLETED|Course 1, (Glutamine/Placebo Arms)||9
10318834|NCT00217724|11453091|FG000|NOT COMPLETED|Course 1, (Glutamine/Placebo Arms)||3
10318835|NCT00217724|11453092|FG001|NOT COMPLETED|Course 1, (Glutamine/Placebo Arms)||1
10318836|NCT00217724|11453091|FG000|STARTED|Course 2, (Glutamine/Placebo Crossover)||9
10318837|NCT00217724|11453092|FG001|STARTED|Course 2, (Glutamine/Placebo Crossover)||5
10318838|NCT00217724|11453091|FG000|COMPLETED|Course 2, (Glutamine/Placebo Crossover)||8
10318839|NCT00217724|11453092|FG001|COMPLETED|Course 2, (Glutamine/Placebo Crossover)||5
10318840|NCT00217724|11453091|FG000|NOT COMPLETED|Course 2, (Glutamine/Placebo Crossover)||1
10318841|NCT00217724|11453092|FG001|NOT COMPLETED|Course 2, (Glutamine/Placebo Crossover)||0
10318842|NCT00217971|11453100|FG000|STARTED|Overall Study||79
10318843|NCT00217971|11453101|FG001|STARTED|Overall Study||77
10318844|NCT00217971|11453100|FG000|COMPLETED|Overall Study||55
10318845|NCT00217971|11453101|FG001|COMPLETED|Overall Study||44
10318846|NCT00217971|11453100|FG000|NOT COMPLETED|Overall Study||24
10680713|NCT02401867|11843381|FG000|STARTED|Enrolled||150
10680714|NCT02401867|11843381|FG000|COMPLETED|Enrolled||150
10680715|NCT02401867|11843381|FG000|NOT COMPLETED|Enrolled||0
10680716|NCT02401867|11843381|FG000|STARTED|Specimen Collection||150
10680717|NCT02401867|11843381|FG000|COMPLETED|Specimen Collection|Completed both vaginal self-swab and provider-collected cervical swab|140
10680718|NCT02401867|11843381|FG000|NOT COMPLETED|Specimen Collection||10
10680719|NCT02401867|11843381|FG000|STARTED|Analysis||140
10680720|NCT02401867|11843381|FG000|COMPLETED|Analysis|Comparative analysis of vaginal HPV DNA results and cervical HPV DNA results|131
10680721|NCT02401867|11843381|FG000|NOT COMPLETED|Analysis||9
10680722|NCT02402062|11843386|FG000|STARTED|Overall Study||17
10680723|NCT02402062|11843386|FG000|COMPLETED|Overall Study||17
10680724|NCT02402062|11843386|FG000|NOT COMPLETED|Overall Study||0
10680725|NCT02402127|11843396|FG000|STARTED|First Wear Period (1 Day)||4
10680726|NCT02402127|11843397|FG001|STARTED|First Wear Period (1 Day)||4
10680727|NCT02402127|11843398|FG002|STARTED|First Wear Period (1 Day)||4
10680728|NCT02402127|11843399|FG003|STARTED|First Wear Period (1 Day)||4
10680729|NCT02402127|11843400|FG004|STARTED|First Wear Period (1 Day)||4
10680730|NCT02402127|11843401|FG005|STARTED|First Wear Period (1 Day)||4
10680731|NCT02402127|11843396|FG000|Randomized and Treated|First Wear Period (1 Day)||4
10318847|NCT00217971|11453101|FG001|NOT COMPLETED|Overall Study||33
10318848|NCT00218023|11453111|FG000|STARTED|Overall Study||22
10680732|NCT02402127|11843397|FG001|Randomized and Treated|First Wear Period (1 Day)||4
10680733|NCT02402127|11843398|FG002|Randomized and Treated|First Wear Period (1 Day)||4
10680734|NCT02402127|11843399|FG003|Randomized and Treated|First Wear Period (1 Day)||4
10680735|NCT02402127|11843400|FG004|Randomized and Treated|First Wear Period (1 Day)||4
10680736|NCT02402127|11843401|FG005|Randomized and Treated|First Wear Period (1 Day)||4
10680737|NCT02402127|11843396|FG000|COMPLETED|First Wear Period (1 Day)||4
10680738|NCT02402127|11843397|FG001|COMPLETED|First Wear Period (1 Day)||4
10680739|NCT02402127|11843398|FG002|COMPLETED|First Wear Period (1 Day)||4
10680740|NCT02402127|11843399|FG003|COMPLETED|First Wear Period (1 Day)||4
10680741|NCT02402127|11843400|FG004|COMPLETED|First Wear Period (1 Day)||4
10680742|NCT02402127|11843401|FG005|COMPLETED|First Wear Period (1 Day)||4
10680743|NCT02402127|11843396|FG000|NOT COMPLETED|First Wear Period (1 Day)||0
10680744|NCT02402127|11843397|FG001|NOT COMPLETED|First Wear Period (1 Day)||0
10680745|NCT02402127|11843398|FG002|NOT COMPLETED|First Wear Period (1 Day)||0
10680746|NCT02402127|11843399|FG003|NOT COMPLETED|First Wear Period (1 Day)||0
10680747|NCT02402127|11843400|FG004|NOT COMPLETED|First Wear Period (1 Day)||0
10680748|NCT02402127|11843401|FG005|NOT COMPLETED|First Wear Period (1 Day)||0
10680749|NCT02402127|11843396|FG000|STARTED|Second Wear Period (1 Day)||4
10680750|NCT02402127|11843397|FG001|STARTED|Second Wear Period (1 Day)||4
10680751|NCT02402127|11843398|FG002|STARTED|Second Wear Period (1 Day)||4
10680752|NCT02402127|11843399|FG003|STARTED|Second Wear Period (1 Day)||4
10680753|NCT02402127|11843400|FG004|STARTED|Second Wear Period (1 Day)||4
10680754|NCT02402127|11843401|FG005|STARTED|Second Wear Period (1 Day)||4
10680755|NCT02402127|11843396|FG000|COMPLETED|Second Wear Period (1 Day)||4
10680756|NCT02402127|11843397|FG001|COMPLETED|Second Wear Period (1 Day)||4
10680757|NCT02402127|11843398|FG002|COMPLETED|Second Wear Period (1 Day)||4
10680758|NCT02402127|11843399|FG003|COMPLETED|Second Wear Period (1 Day)||4
10680759|NCT02402127|11843400|FG004|COMPLETED|Second Wear Period (1 Day)||4
10680760|NCT02402127|11843401|FG005|COMPLETED|Second Wear Period (1 Day)||4
10680761|NCT02402127|11843396|FG000|NOT COMPLETED|Second Wear Period (1 Day)||0
10680762|NCT02402127|11843397|FG001|NOT COMPLETED|Second Wear Period (1 Day)||0
10680763|NCT02402127|11843398|FG002|NOT COMPLETED|Second Wear Period (1 Day)||0
10680764|NCT02402127|11843399|FG003|NOT COMPLETED|Second Wear Period (1 Day)||0
10680765|NCT02402127|11843400|FG004|NOT COMPLETED|Second Wear Period (1 Day)||0
10680766|NCT02402127|11843401|FG005|NOT COMPLETED|Second Wear Period (1 Day)||0
10680767|NCT02402127|11843396|FG000|STARTED|Third Wear Period (1 Day)||4
10680768|NCT02402127|11843397|FG001|STARTED|Third Wear Period (1 Day)||4
10680769|NCT02402127|11843398|FG002|STARTED|Third Wear Period (1 Day)||4
10680770|NCT02402127|11843399|FG003|STARTED|Third Wear Period (1 Day)||4
10680771|NCT02402127|11843400|FG004|STARTED|Third Wear Period (1 Day)||4
10680772|NCT02402127|11843401|FG005|STARTED|Third Wear Period (1 Day)||4
10680773|NCT02402127|11843396|FG000|COMPLETED|Third Wear Period (1 Day)||4
10680774|NCT02402127|11843397|FG001|COMPLETED|Third Wear Period (1 Day)||4
10680775|NCT02402127|11843398|FG002|COMPLETED|Third Wear Period (1 Day)||4
10680776|NCT02402127|11843399|FG003|COMPLETED|Third Wear Period (1 Day)||4
10680777|NCT02402127|11843400|FG004|COMPLETED|Third Wear Period (1 Day)||4
10680778|NCT02402127|11843401|FG005|COMPLETED|Third Wear Period (1 Day)||4
10680779|NCT02402127|11843396|FG000|NOT COMPLETED|Third Wear Period (1 Day)||0
10680780|NCT02402127|11843397|FG001|NOT COMPLETED|Third Wear Period (1 Day)||0
10680781|NCT02402127|11843398|FG002|NOT COMPLETED|Third Wear Period (1 Day)||0
10680782|NCT02402127|11843399|FG003|NOT COMPLETED|Third Wear Period (1 Day)||0
10680783|NCT02402127|11843400|FG004|NOT COMPLETED|Third Wear Period (1 Day)||0
10680784|NCT02402127|11843401|FG005|NOT COMPLETED|Third Wear Period (1 Day)||0
10680785|NCT02402153|11843412|FG000|STARTED|Overall Study||18
10680786|NCT02402153|11843412|FG000|COMPLETED|Overall Study||18
10680787|NCT02402153|11843412|FG000|NOT COMPLETED|Overall Study||0
10680788|NCT02402166|11843416|FG000|STARTED|Overall Study||24
10680789|NCT02402166|11843416|FG000|COMPLETED|Overall Study||19
10680790|NCT02402166|11843416|FG000|NOT COMPLETED|Overall Study||5
10680791|NCT02402218|11843437|FG000|STARTED|Overall Study||36
10680792|NCT02402218|11843438|FG001|STARTED|Overall Study||54
10680793|NCT02402218|11843439|FG002|STARTED|Overall Study||54
10680794|NCT02402218|11843437|FG000|Initiated Treatment With LDV/SOF|Overall Study||24
10680795|NCT02402218|11843438|FG001|Initiated Treatment With LDV/SOF|Overall Study||45
10680796|NCT02402218|11843439|FG002|Initiated Treatment With LDV/SOF|Overall Study||41
10680797|NCT02402218|11843437|FG000|Completed Treatment With LDV/SOF|Overall Study||23
10680798|NCT02402218|11843438|FG001|Completed Treatment With LDV/SOF|Overall Study||42
10680799|NCT02402218|11843439|FG002|Completed Treatment With LDV/SOF|Overall Study||39
10680800|NCT02402218|11843437|FG000|Achieved Sustained Virologic Response|Overall Study||22
10680801|NCT02402218|11843438|FG001|Achieved Sustained Virologic Response|Overall Study||41
10680802|NCT02402218|11843439|FG002|Achieved Sustained Virologic Response|Overall Study||37
10680803|NCT02402218|11843437|FG000|COMPLETED|Overall Study||22
10680804|NCT02402218|11843438|FG001|COMPLETED|Overall Study||41
10680805|NCT02402218|11843439|FG002|COMPLETED|Overall Study||37
10680806|NCT02402218|11843437|FG000|NOT COMPLETED|Overall Study||14
10680807|NCT02402218|11843438|FG001|NOT COMPLETED|Overall Study||13
10680808|NCT02402218|11843439|FG002|NOT COMPLETED|Overall Study||17
10680809|NCT02402296|11843449|FG000|STARTED|Overall Study||15
10680810|NCT02402296|11843450|FG001|STARTED|Overall Study||15
10680811|NCT02402296|11843449|FG000|COMPLETED|Overall Study||15
10680812|NCT02402296|11843450|FG001|COMPLETED|Overall Study||15
10680813|NCT02402296|11843449|FG000|NOT COMPLETED|Overall Study||0
10680814|NCT02402296|11843450|FG001|NOT COMPLETED|Overall Study||0
10680815|NCT02402322|11843459|FG000|STARTED|Pretreatment||27
10680816|NCT02402322|11843460|FG001|STARTED|Pretreatment||25
10680817|NCT02402322|11843461|FG002|STARTED|Pretreatment||25
10680818|NCT02402322|11843459|FG000|Posttreatment Measures|Pretreatment||24
10680819|NCT02402322|11843460|FG001|Posttreatment Measures|Pretreatment||24
10680820|NCT02402322|11843461|FG002|Posttreatment Measures|Pretreatment||24
10680821|NCT02402322|11843459|FG000|COMPLETED|Pretreatment||24
10680822|NCT02402322|11843460|FG001|COMPLETED|Pretreatment||24
10680823|NCT02402322|11843461|FG002|COMPLETED|Pretreatment||24
10680824|NCT02402322|11843459|FG000|NOT COMPLETED|Pretreatment||3
10680825|NCT02402322|11843460|FG001|NOT COMPLETED|Pretreatment||1
10680826|NCT02402322|11843461|FG002|NOT COMPLETED|Pretreatment||1
10680827|NCT02402322|11843459|FG000|STARTED|Follow-up||24
10680828|NCT02402322|11843460|FG001|STARTED|Follow-up||24
10680829|NCT02402322|11843461|FG002|STARTED|Follow-up|These individuals were not evaluated at this follow-up as they started an alternative treatment.|24
10680830|NCT02402322|11843459|FG000|COMPLETED|Follow-up||18
10680831|NCT02402322|11843460|FG001|COMPLETED|Follow-up||21
10680832|NCT02402322|11843461|FG002|COMPLETED|Follow-up||0
10680833|NCT02402322|11843459|FG000|NOT COMPLETED|Follow-up||6
10680834|NCT02402322|11843460|FG001|NOT COMPLETED|Follow-up||3
10680835|NCT02402322|11843461|FG002|NOT COMPLETED|Follow-up||24
10680836|NCT02402452|11843471|FG000|STARTED|Overall Study||10
10680837|NCT02402452|11843472|FG001|STARTED|Overall Study||10
10680838|NCT02402452|11843471|FG000|COMPLETED|Overall Study||10
10680839|NCT02402452|11843472|FG001|COMPLETED|Overall Study||10
10680840|NCT02402452|11843471|FG000|NOT COMPLETED|Overall Study||0
10680841|NCT02402452|11843472|FG001|NOT COMPLETED|Overall Study||0
10680842|NCT02402764|11843478|FG000|STARTED|Overall Study||10
10680843|NCT02402764|11843478|FG000|COMPLETED|Overall Study||10
10680844|NCT02402764|11843478|FG000|NOT COMPLETED|Overall Study||0
10680845|NCT02402881|11843484|FG000|STARTED|Pre-Intervention Study Period||2222
10680846|NCT02402881|11843485|FG001|STARTED|Pre-Intervention Study Period||5657
10680847|NCT02402881|11843484|FG000|COMPLETED|Pre-Intervention Study Period||2222
10680848|NCT02402881|11843485|FG001|COMPLETED|Pre-Intervention Study Period||5657
10680849|NCT02402881|11843484|FG000|NOT COMPLETED|Pre-Intervention Study Period||0
10680850|NCT02402881|11843485|FG001|NOT COMPLETED|Pre-Intervention Study Period||0
10680851|NCT02402881|11843484|FG000|STARTED|Post-Intervention Study Period||3111
10680852|NCT02402881|11843485|FG001|STARTED|Post-Intervention Study Period||8662
10680853|NCT02402881|11843484|FG000|COMPLETED|Post-Intervention Study Period||3111
10680854|NCT02402881|11843485|FG001|COMPLETED|Post-Intervention Study Period||8662
10680855|NCT02402881|11843484|FG000|NOT COMPLETED|Post-Intervention Study Period||0
10680856|NCT02402881|11843485|FG001|NOT COMPLETED|Post-Intervention Study Period||0
10680857|NCT02402907|11843493|FG000|STARTED|Overall Study||682
10680858|NCT02402907|11843494|FG001|STARTED|Overall Study||674
10680859|NCT02402907|11843493|FG000|COMPLETED|Overall Study||662
10680860|NCT02402907|11843494|FG001|COMPLETED|Overall Study||647
10680861|NCT02402907|11843493|FG000|NOT COMPLETED|Overall Study||20
10680862|NCT02402907|11843494|FG001|NOT COMPLETED|Overall Study||27
10680863|NCT02402933|11843500|FG000|STARTED|Overall Study||26
10680864|NCT02402933|11843500|FG000|Received at Least One Dose of Study Drug|Overall Study||22
10680865|NCT02402933|11843500|FG000|COMPLETED|Overall Study||12
10680866|NCT02402933|11843500|FG000|NOT COMPLETED|Overall Study||14
10680867|NCT02403180|11843506|FG000|STARTED|Pre-Treatment Period||36
10680868|NCT02403180|11843507|FG001|STARTED|Pre-Treatment Period||34
10680869|NCT02403180|11843506|FG000|COMPLETED|Pre-Treatment Period||36
10680870|NCT02403180|11843507|FG001|COMPLETED|Pre-Treatment Period||33
10680871|NCT02403180|11843506|FG000|NOT COMPLETED|Pre-Treatment Period||0
10680872|NCT02403180|11843507|FG001|NOT COMPLETED|Pre-Treatment Period||1
10680873|NCT02403180|11843506|FG000|STARTED|Period 1 (5 Days)||36
10680874|NCT02403180|11843507|FG001|STARTED|Period 1 (5 Days)||33
10680875|NCT02403180|11843506|FG000|Randomized|Period 1 (5 Days)||36
10680876|NCT02403180|11843507|FG001|Randomized|Period 1 (5 Days)||33
10680877|NCT02403180|11843506|FG000|COMPLETED|Period 1 (5 Days)||36
10680878|NCT02403180|11843507|FG001|COMPLETED|Period 1 (5 Days)||33
10680879|NCT02403180|11843506|FG000|NOT COMPLETED|Period 1 (5 Days)||0
10680880|NCT02403180|11843507|FG001|NOT COMPLETED|Period 1 (5 Days)||0
10680881|NCT02403180|11843506|FG000|STARTED|Period 2 (5 Days)||36
10680882|NCT02403180|11843507|FG001|STARTED|Period 2 (5 Days)||33
10680883|NCT02403180|11843506|FG000|COMPLETED|Period 2 (5 Days)||36
10680884|NCT02403180|11843507|FG001|COMPLETED|Period 2 (5 Days)||32
10680885|NCT02403180|11843506|FG000|NOT COMPLETED|Period 2 (5 Days)||0
10680886|NCT02403180|11843507|FG001|NOT COMPLETED|Period 2 (5 Days)||1
10680887|NCT02403206|11843515|FG000|STARTED|Overall Study||194
10680888|NCT02403206|11843516|FG001|STARTED|Overall Study||196
10680889|NCT02403206|11843515|FG000|Treated Prior to Randomization|Overall Study||0
10680890|NCT02403206|11843516|FG001|Treated Prior to Randomization|Overall Study||1
10680891|NCT02403206|11843515|FG000|Randomized and Treated|Overall Study||188
10680892|NCT02403206|11843516|FG001|Randomized and Treated|Overall Study||190
10680893|NCT02403206|11843515|FG000|COMPLETED|Overall Study||183
10680894|NCT02403206|11843516|FG001|COMPLETED|Overall Study||186
10680895|NCT02403206|11843515|FG000|NOT COMPLETED|Overall Study||11
10680896|NCT02403206|11843516|FG001|NOT COMPLETED|Overall Study||10
10680897|NCT02403271|11843523|FG000|STARTED|Period 1|All Phase 1b participants went on to participate in Phase 2.|7
10680898|NCT02403271|11843524|FG001|STARTED|Period 1||0
10680899|NCT02403271|11843523|FG000|COMPLETED|Period 1||6
10680900|NCT02403271|11843524|FG001|COMPLETED|Period 1||0
10680901|NCT02403271|11843523|FG000|NOT COMPLETED|Period 1||1
10680902|NCT02403271|11843524|FG001|NOT COMPLETED|Period 1||0
10680903|NCT02403271|11843523|FG000|STARTED|Period 2||0
10680904|NCT02403271|11843524|FG001|STARTED|Period 2|Phase 2 includes all subjects who participated in Phase 1b.|124
10680905|NCT02403271|11843523|FG000|COMPLETED|Period 2||0
10680906|NCT02403271|11843524|FG001|COMPLETED|Period 2||0
10680907|NCT02403271|11843523|FG000|NOT COMPLETED|Period 2||0
10680908|NCT02403271|11843524|FG001|NOT COMPLETED|Period 2||124
10680909|NCT02403479|11843532|FG000|STARTED|Overall Study||10
10680910|NCT02403479|11843533|FG001|STARTED|Overall Study||12
10680911|NCT02403479|11843532|FG000|COMPLETED|Overall Study||8
10680912|NCT02403479|11843533|FG001|COMPLETED|Overall Study||12
10680913|NCT02403479|11843532|FG000|NOT COMPLETED|Overall Study||2
10680914|NCT02403479|11843533|FG001|NOT COMPLETED|Overall Study||0
10680915|NCT02403622|11843541|FG000|STARTED|Overall Study||15
10680916|NCT02403622|11843541|FG000|COMPLETED|Overall Study||13
10680917|NCT02403622|11843541|FG000|NOT COMPLETED|Overall Study||2
10680918|NCT02403635|11843545|FG000|STARTED|Overall Study||27
10680919|NCT02403635|11843545|FG000|Screening (28 Days)|Overall Study||27
10680920|NCT02403635|11843545|FG000|Received the First Dose|Overall Study||18
10680921|NCT02403635|11843545|FG000|COMPLETED|Overall Study||18
10680922|NCT02403635|11843545|FG000|NOT COMPLETED|Overall Study||9
10680937|NCT02403817|11843585|FG000|STARTED|Overall Study||28
10680938|NCT02403817|11843586|FG001|STARTED|Overall Study||2
10680939|NCT02403817|11843585|FG000|COMPLETED|Overall Study||23
10680940|NCT02403817|11843586|FG001|COMPLETED|Overall Study||2
10680941|NCT02403817|11843585|FG000|NOT COMPLETED|Overall Study||5
10680942|NCT02403817|11843586|FG001|NOT COMPLETED|Overall Study||0
10680943|NCT02403830|11843592|FG000|STARTED|Visit 1||15
10680944|NCT02403830|11843593|FG001|STARTED|Visit 1||15
10680945|NCT02403830|11843592|FG000|COMPLETED|Visit 1||15
10680946|NCT02403830|11843593|FG001|COMPLETED|Visit 1||15
10680947|NCT02403830|11843592|FG000|NOT COMPLETED|Visit 1||0
10680948|NCT02403830|11843593|FG001|NOT COMPLETED|Visit 1||0
10680949|NCT02403830|11843592|FG000|STARTED|Visit 2|One subject completed visit 1 and then withdrew from the study for an adverse event (nausea).|14
10680950|NCT02403830|11843593|FG001|STARTED|Visit 2||15
10680951|NCT02403830|11843592|FG000|COMPLETED|Visit 2||14
10680952|NCT02403830|11843593|FG001|COMPLETED|Visit 2||15
10680953|NCT02403830|11843592|FG000|NOT COMPLETED|Visit 2||0
10680954|NCT02403830|11843593|FG001|NOT COMPLETED|Visit 2||0
10680955|NCT02403895|11843599|FG000|STARTED|Overall Study||11
10680956|NCT02403895|11843599|FG000|COMPLETED|Overall Study||11
10680957|NCT02403895|11843599|FG000|NOT COMPLETED|Overall Study||0
10680964|NCT02403999|11843615|FG000|STARTED|Overall Study||10
10680965|NCT02403999|11843616|FG001|STARTED|Overall Study||10
10680966|NCT02403999|11843617|FG002|STARTED|Overall Study||11
10680967|NCT02403999|11843615|FG000|COMPLETED|Overall Study||10
10680968|NCT02403999|11843616|FG001|COMPLETED|Overall Study||10
10680969|NCT02403999|11843617|FG002|COMPLETED|Overall Study||11
10680970|NCT02403999|11843615|FG000|NOT COMPLETED|Overall Study||0
10680971|NCT02403999|11843616|FG001|NOT COMPLETED|Overall Study||0
10680972|NCT02403999|11843617|FG002|NOT COMPLETED|Overall Study||0
10680973|NCT02404025|11843625|FG000|STARTED|Overall Study||10
10680974|NCT02404025|11843625|FG000|COMPLETED|Overall Study||6
10680975|NCT02404025|11843625|FG000|NOT COMPLETED|Overall Study||4
10680976|NCT02404103|11843631|FG000|STARTED|Overall Study||14
10680977|NCT02404103|11843632|FG001|STARTED|Overall Study||12
10680978|NCT02404103|11843631|FG000|COMPLETED|Overall Study||10
10680979|NCT02404103|11843632|FG001|COMPLETED|Overall Study||9
10680980|NCT02404103|11843631|FG000|NOT COMPLETED|Overall Study||4
10680981|NCT02404103|11843632|FG001|NOT COMPLETED|Overall Study||3
10680982|NCT02404168|11843648|FG000|STARTED|Overall Study||4
10680983|NCT02404168|11843648|FG000|COMPLETED|Overall Study||4
10680984|NCT02404168|11843648|FG000|NOT COMPLETED|Overall Study||0
10680985|NCT02404220|11843658|FG000|STARTED|Overall Study||5
10680986|NCT02404220|11843659|FG001|STARTED|Overall Study||8
10680987|NCT02404220|11843660|FG002|STARTED|Overall Study||7
10680988|NCT02404220|11843661|FG003|STARTED|Overall Study||10
10680989|NCT02404220|11843658|FG000|COMPLETED|Overall Study||0
10680990|NCT02404220|11843659|FG001|COMPLETED|Overall Study||0
10680991|NCT02404220|11843660|FG002|COMPLETED|Overall Study||0
10680992|NCT02404220|11843661|FG003|COMPLETED|Overall Study||0
10680993|NCT02404220|11843658|FG000|NOT COMPLETED|Overall Study||5
10680994|NCT02404220|11843659|FG001|NOT COMPLETED|Overall Study||8
10680995|NCT02404220|11843660|FG002|NOT COMPLETED|Overall Study||7
10680996|NCT02404220|11843661|FG003|NOT COMPLETED|Overall Study||10
10680997|NCT02404285|11843673|FG000|STARTED|Overall Study||33
10680998|NCT02404285|11843674|FG001|STARTED|Overall Study||35
10680999|NCT02404285|11843673|FG000|COMPLETED|Overall Study||31
10681000|NCT02404285|11843674|FG001|COMPLETED|Overall Study||33
10681001|NCT02404285|11843673|FG000|NOT COMPLETED|Overall Study||2
10681002|NCT02404285|11843674|FG001|NOT COMPLETED|Overall Study||2
10681003|NCT02404311|11843691|FG000|STARTED|Part A: Month 0-18||210
10681004|NCT02404311|11843692|FG001|STARTED|Part A: Month 0-18||42
10681005|NCT02404311|11843693|FG002|STARTED|Part A: Month 0-18||0
10681006|NCT02404311|11843694|FG003|STARTED|Part A: Month 0-18||0
10681007|NCT02404311|11843695|FG004|STARTED|Part A: Month 0-18||0
10681008|NCT02404311|11843691|FG000|Per Protocol|Part A: Month 0-18||185
10681009|NCT02404311|11843692|FG001|Per Protocol|Part A: Month 0-18||37
10681010|NCT02404311|11843693|FG002|Per Protocol|Part A: Month 0-18||0
10681011|NCT02404311|11843694|FG003|Per Protocol|Part A: Month 0-18||0
10681012|NCT02404311|11843695|FG004|Per Protocol|Part A: Month 0-18||0
10681013|NCT02404311|11843691|FG000|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||194
10681014|NCT02404311|11843692|FG001|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||37
10681015|NCT02404311|11843693|FG002|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||0
10681016|NCT02404311|11843694|FG003|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||0
10681017|NCT02404311|11843695|FG004|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||0
10681018|NCT02404311|11843691|FG000|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||186
10681019|NCT02404311|11843692|FG001|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||33
10681020|NCT02404311|11843693|FG002|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||0
10681021|NCT02404311|11843694|FG003|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||0
10681022|NCT02404311|11843695|FG004|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||0
10681023|NCT02404311|11843691|FG000|COMPLETED|Part A: Month 0-18||184
10681024|NCT02404311|11843692|FG001|COMPLETED|Part A: Month 0-18||36
10681025|NCT02404311|11843693|FG002|COMPLETED|Part A: Month 0-18||0
10681026|NCT02404311|11843694|FG003|COMPLETED|Part A: Month 0-18||0
10681027|NCT02404311|11843695|FG004|COMPLETED|Part A: Month 0-18||0
10681028|NCT02404311|11843691|FG000|NOT COMPLETED|Part A: Month 0-18||26
10681029|NCT02404311|11843692|FG001|NOT COMPLETED|Part A: Month 0-18||6
10681030|NCT02404311|11843693|FG002|NOT COMPLETED|Part A: Month 0-18||0
10681031|NCT02404311|11843694|FG003|NOT COMPLETED|Part A: Month 0-18||0
10681032|NCT02404311|11843695|FG004|NOT COMPLETED|Part A: Month 0-18||0
10681033|NCT02404311|11843691|FG000|STARTED|Part B: Month 30-36||0
10681034|NCT02404311|11843692|FG001|STARTED|Part B: Month 30-36||0
10681035|NCT02404311|11843693|FG002|STARTED|Part B: Month 30-36||32
10681036|NCT02404311|11843694|FG003|STARTED|Part B: Month 30-36||31
10681037|NCT02404311|11843695|FG004|STARTED|Part B: Month 30-36||7
10681038|NCT02404311|11843691|FG000|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||0
10681039|NCT02404311|11843692|FG001|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||0
10681040|NCT02404311|11843693|FG002|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||28
10681041|NCT02404311|11843694|FG003|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||30
10681042|NCT02404311|11843695|FG004|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||6
10681043|NCT02404311|11843691|FG000|COMPLETED|Part B: Month 30-36||0
10798911|NCT03869541|11959457|FG002|STARTED|Overall Study||10
10798912|NCT03869541|11959455|FG000|COMPLETED|Overall Study||40
10681044|NCT02404311|11843692|FG001|COMPLETED|Part B: Month 30-36||0
10681045|NCT02404311|11843693|FG002|COMPLETED|Part B: Month 30-36||32
10681046|NCT02404311|11843694|FG003|COMPLETED|Part B: Month 30-36||31
10681047|NCT02404311|11843695|FG004|COMPLETED|Part B: Month 30-36||7
10681048|NCT02404311|11843691|FG000|NOT COMPLETED|Part B: Month 30-36||0
10681049|NCT02404311|11843692|FG001|NOT COMPLETED|Part B: Month 30-36||0
10681050|NCT02404311|11843693|FG002|NOT COMPLETED|Part B: Month 30-36||0
10681051|NCT02404311|11843694|FG003|NOT COMPLETED|Part B: Month 30-36||0
10681052|NCT02404311|11843695|FG004|NOT COMPLETED|Part B: Month 30-36||0
10681053|NCT02404350|11843711|FG000|STARTED|Overall Study||222
10681054|NCT02404350|11843712|FG001|STARTED|Overall Study||220
10681055|NCT02404350|11843713|FG002|STARTED|Overall Study||222
10681056|NCT02404350|11843714|FG003|STARTED|Overall Study||332
10681057|NCT02404350|11843711|FG000|COMPLETED|Overall Study||207
10681058|NCT02404350|11843712|FG001|COMPLETED|Overall Study||214
10681059|NCT02404350|11843713|FG002|COMPLETED|Overall Study||216
10681060|NCT02404350|11843714|FG003|COMPLETED|Overall Study||295
10681061|NCT02404350|11843711|FG000|NOT COMPLETED|Overall Study||15
10681062|NCT02404350|11843712|FG001|NOT COMPLETED|Overall Study||6
10681063|NCT02404350|11843713|FG002|NOT COMPLETED|Overall Study||6
10681064|NCT02404350|11843714|FG003|NOT COMPLETED|Overall Study||37
10681065|NCT02404389|11843730|FG000|STARTED|Overall Study||20
10681066|NCT02404389|11843731|FG001|STARTED|Overall Study||20
10798913|NCT03869541|11959456|FG001|COMPLETED|Overall Study||50
10681067|NCT02404389|11843732|FG002|STARTED|Overall Study||11
10681068|NCT02404389|11843733|FG003|STARTED|Overall Study||10
10681069|NCT02404389|11843734|FG004|STARTED|Overall Study||21
10681070|NCT02404389|11843730|FG000|COMPLETED|Overall Study||18
10681071|NCT02404389|11843731|FG001|COMPLETED|Overall Study||20
10681072|NCT02404389|11843732|FG002|COMPLETED|Overall Study||10
10681073|NCT02404389|11843733|FG003|COMPLETED|Overall Study||9
10681074|NCT02404389|11843734|FG004|COMPLETED|Overall Study||18
10681075|NCT02404389|11843730|FG000|NOT COMPLETED|Overall Study||2
10681076|NCT02404389|11843731|FG001|NOT COMPLETED|Overall Study||0
10798914|NCT03869541|11959457|FG002|COMPLETED|Overall Study||10
10681077|NCT02404389|11843732|FG002|NOT COMPLETED|Overall Study||1
10681078|NCT02404389|11843733|FG003|NOT COMPLETED|Overall Study||1
10681079|NCT02404389|11843734|FG004|NOT COMPLETED|Overall Study||3
10455331|NCT01001403|11603369|FG000|STARTED|Overall Study||31
10455332|NCT01001403|11603370|FG001|STARTED|Overall Study||31
10455333|NCT01001403|11603369|FG000|COMPLETED|Overall Study||31
10455334|NCT01001403|11603370|FG001|COMPLETED|Overall Study||31
10455335|NCT01001403|11603369|FG000|NOT COMPLETED|Overall Study||0
10455336|NCT01001403|11603370|FG001|NOT COMPLETED|Overall Study||0
10681170|NCT02404493|11843813|FG000|STARTED|Overall Study||17
10681171|NCT02404493|11843814|FG001|STARTED|Overall Study||6
10681172|NCT02404493|11843813|FG000|COMPLETED|Overall Study||16
10681173|NCT02404493|11843814|FG001|COMPLETED|Overall Study||5
10681174|NCT02404493|11843813|FG000|NOT COMPLETED|Overall Study||1
10681175|NCT02404493|11843814|FG001|NOT COMPLETED|Overall Study||1
10681176|NCT02404532|11843820|FG000|STARTED|Overall Study||29
10681177|NCT02404532|11843820|FG000|COMPLETED|Overall Study||29
10681178|NCT02404532|11843820|FG000|NOT COMPLETED|Overall Study||0
10681179|NCT02404610|11843831|FG000|STARTED|Overall Study||54
10681180|NCT02404610|11843832|FG001|STARTED|Overall Study||53
10681181|NCT02404610|11843831|FG000|COMPLETED|Overall Study||54
10681182|NCT02404610|11843832|FG001|COMPLETED|Overall Study||53
10681183|NCT02404610|11843831|FG000|NOT COMPLETED|Overall Study||0
10681184|NCT02404610|11843832|FG001|NOT COMPLETED|Overall Study||0
10681185|NCT02404649|11843840|FG000|STARTED|Overall Study||17
10681186|NCT02404649|11843841|FG001|STARTED|Overall Study||16
10681187|NCT02404649|11843840|FG000|COMPLETED|Overall Study||16
10681188|NCT02404649|11843841|FG001|COMPLETED|Overall Study||14
10681189|NCT02404649|11843840|FG000|NOT COMPLETED|Overall Study||1
10681190|NCT02404649|11843841|FG001|NOT COMPLETED|Overall Study||2
10681191|NCT02404792|11843849|FG000|STARTED|Overall Study||32
10681192|NCT02404792|11843850|FG001|STARTED|Overall Study||37
10681193|NCT02404792|11843849|FG000|COMPLETED|Overall Study||27
10681194|NCT02404792|11843850|FG001|COMPLETED|Overall Study||29
10681195|NCT02404792|11843849|FG000|NOT COMPLETED|Overall Study||5
10681196|NCT02404792|11843850|FG001|NOT COMPLETED|Overall Study||8
10681197|NCT02404805|11843864|FG000|STARTED|Overall Study||5
10681198|NCT02404805|11843865|FG001|STARTED|Overall Study||3
10681199|NCT02404805|11843866|FG002|STARTED|Overall Study||5
10681200|NCT02404805|11843867|FG003|STARTED|Overall Study||5
10681201|NCT02404805|11843868|FG004|STARTED|Overall Study||3
10681202|NCT02404805|11843869|FG005|STARTED|Overall Study||4
10681203|NCT02404805|11843864|FG000|COMPLETED|Overall Study||4
10681204|NCT02404805|11843865|FG001|COMPLETED|Overall Study||3
10681205|NCT02404805|11843866|FG002|COMPLETED|Overall Study||5
10681206|NCT02404805|11843867|FG003|COMPLETED|Overall Study||5
10681207|NCT02404805|11843868|FG004|COMPLETED|Overall Study||3
10681208|NCT02404805|11843869|FG005|COMPLETED|Overall Study||4
10681209|NCT02404805|11843864|FG000|NOT COMPLETED|Overall Study||1
10681210|NCT02404805|11843865|FG001|NOT COMPLETED|Overall Study||0
10681211|NCT02404805|11843866|FG002|NOT COMPLETED|Overall Study||0
10681212|NCT02404805|11843867|FG003|NOT COMPLETED|Overall Study||0
10681213|NCT02404805|11843868|FG004|NOT COMPLETED|Overall Study||0
10681214|NCT02404805|11843869|FG005|NOT COMPLETED|Overall Study||0
10681215|NCT02405091|11843881|FG000|STARTED|Overall Study||49
10681216|NCT02405091|11843882|FG001|STARTED|Overall Study||107
10681217|NCT02405091|11843883|FG002|STARTED|Overall Study||11
10681218|NCT02405091|11843881|FG000|COMPLETED|Overall Study||20
10681219|NCT02405091|11843882|FG001|COMPLETED|Overall Study||74
10681220|NCT02405091|11843883|FG002|COMPLETED|Overall Study||9
10681221|NCT02405091|11843881|FG000|NOT COMPLETED|Overall Study||29
10681222|NCT02405091|11843882|FG001|NOT COMPLETED|Overall Study||33
10681223|NCT02405091|11843883|FG002|NOT COMPLETED|Overall Study||2
10681224|NCT02405195|11843894|FG000|STARTED|Overall Study||18
10681225|NCT02405195|11843894|FG000|COMPLETED|Overall Study||18
10681226|NCT02405195|11843894|FG000|NOT COMPLETED|Overall Study||0
10681227|NCT02405325|11843900|FG000|STARTED|Overall Study||267
10681228|NCT02405325|11843901|FG001|STARTED|Overall Study||209
10681229|NCT02405325|11843900|FG000|COMPLETED|Overall Study||203
10681230|NCT02405325|11843901|FG001|COMPLETED|Overall Study||175
10681231|NCT02405325|11843900|FG000|NOT COMPLETED|Overall Study||64
10681232|NCT02405325|11843901|FG001|NOT COMPLETED|Overall Study||34
10681233|NCT02405390|11843909|FG000|STARTED|Overall Study||46
10681234|NCT02405390|11843910|FG001|STARTED|Overall Study||46
10681235|NCT02405390|11843909|FG000|COMPLETED|Overall Study||46
10681236|NCT02405390|11843910|FG001|COMPLETED|Overall Study||46
10681237|NCT02405390|11843909|FG000|NOT COMPLETED|Overall Study||0
10681238|NCT02405390|11843910|FG001|NOT COMPLETED|Overall Study||0
10681239|NCT02405429|11843916|FG000|STARTED|Overall Study||49
10681240|NCT02405429|11843916|FG000|COMPLETED|Overall Study||49
10681241|NCT02405429|11843916|FG000|NOT COMPLETED|Overall Study||0
10681242|NCT02405442|11843924|FG000|STARTED|Double-Blind Phase (up to Week 8)||53
10681243|NCT02405442|11843925|FG001|STARTED|Double-Blind Phase (up to Week 8)||53
10681244|NCT02405442|11843926|FG002|STARTED|Double-Blind Phase (up to Week 8)||53
10681245|NCT02405442|11843927|FG003|STARTED|Double-Blind Phase (up to Week 8)||28
10681246|NCT02405442|11843924|FG000|COMPLETED|Double-Blind Phase (up to Week 8)||52
10681247|NCT02405442|11843925|FG001|COMPLETED|Double-Blind Phase (up to Week 8)||48
10681248|NCT02405442|11843926|FG002|COMPLETED|Double-Blind Phase (up to Week 8)||47
10681249|NCT02405442|11843927|FG003|COMPLETED|Double-Blind Phase (up to Week 8)||27
10681250|NCT02405442|11843924|FG000|NOT COMPLETED|Double-Blind Phase (up to Week 8)||1
10681251|NCT02405442|11843925|FG001|NOT COMPLETED|Double-Blind Phase (up to Week 8)||5
10681252|NCT02405442|11843926|FG002|NOT COMPLETED|Double-Blind Phase (up to Week 8)||6
10681253|NCT02405442|11843927|FG003|NOT COMPLETED|Double-Blind Phase (up to Week 8)||1
10681254|NCT02405442|11843924|FG000|STARTED|Open-Label Phase (up to Week 52)||52
10681255|NCT02405442|11843925|FG001|STARTED|Open-Label Phase (up to Week 52)||48
10681256|NCT02405442|11843926|FG002|STARTED|Open-Label Phase (up to Week 52)||47
10681257|NCT02405442|11843927|FG003|STARTED|Open-Label Phase (up to Week 52)|1 participant completed Double-Blind Phase, but did not continue in Open-Label Phase.|26
10681258|NCT02405442|11843924|FG000|COMPLETED|Open-Label Phase (up to Week 52)||4
10681259|NCT02405442|11843925|FG001|COMPLETED|Open-Label Phase (up to Week 52)||3
10681260|NCT02405442|11843926|FG002|COMPLETED|Open-Label Phase (up to Week 52)||2
10681261|NCT02405442|11843927|FG003|COMPLETED|Open-Label Phase (up to Week 52)||2
10681262|NCT02405442|11843924|FG000|NOT COMPLETED|Open-Label Phase (up to Week 52)||48
10681263|NCT02405442|11843925|FG001|NOT COMPLETED|Open-Label Phase (up to Week 52)||45
10681264|NCT02405442|11843926|FG002|NOT COMPLETED|Open-Label Phase (up to Week 52)||45
10681265|NCT02405442|11843927|FG003|NOT COMPLETED|Open-Label Phase (up to Week 52)||24
10681266|NCT02405442|11843924|FG000|STARTED|Extended Treatment Phase(up to Week 208)|1 participant completed Open-Label Phase, but did not continue in Extended Treatment Phase.|3
10681267|NCT02405442|11843925|FG001|STARTED|Extended Treatment Phase(up to Week 208)|1 participant completed Open-Label Phase, but did not continue in Extended Treatment Phase.|2
10681268|NCT02405442|11843926|FG002|STARTED|Extended Treatment Phase(up to Week 208)||2
10681269|NCT02405442|11843927|FG003|STARTED|Extended Treatment Phase(up to Week 208)||2
10681270|NCT02405442|11843924|FG000|COMPLETED|Extended Treatment Phase(up to Week 208)||0
10681271|NCT02405442|11843925|FG001|COMPLETED|Extended Treatment Phase(up to Week 208)||0
10681272|NCT02405442|11843926|FG002|COMPLETED|Extended Treatment Phase(up to Week 208)||0
10681273|NCT02405442|11843927|FG003|COMPLETED|Extended Treatment Phase(up to Week 208)||0
10681274|NCT02405442|11843924|FG000|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||3
10681275|NCT02405442|11843925|FG001|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||2
10681276|NCT02405442|11843926|FG002|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||2
10681277|NCT02405442|11843927|FG003|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||2
10712877|NCT02674568|11878427|FG000|NOT COMPLETED|Overall Study||339
10712878|NCT02674633|11878438|FG000|STARTED|Overall Study||180
10712879|NCT02674633|11878439|FG001|STARTED|Overall Study||168
10712880|NCT02674633|11878438|FG000|COMPLETED|Overall Study||175
10712881|NCT02674633|11878439|FG001|COMPLETED|Overall Study||164
10712882|NCT02674633|11878438|FG000|NOT COMPLETED|Overall Study||5
10712883|NCT02674633|11878439|FG001|NOT COMPLETED|Overall Study||4
10712884|NCT02674659|11878447|FG000|STARTED|Overall Study||43
10712885|NCT02674659|11878448|FG001|STARTED|Overall Study||44
10712886|NCT02674659|11878447|FG000|COMPLETED|Overall Study||39
10712887|NCT02674659|11878448|FG001|COMPLETED|Overall Study||40
10712888|NCT02674659|11878447|FG000|NOT COMPLETED|Overall Study||4
10712889|NCT02674659|11878448|FG001|NOT COMPLETED|Overall Study||4
10712890|NCT02674685|11878454|FG000|STARTED|Overall Study||237
10712891|NCT02674685|11878454|FG000|COMPLETED|Overall Study||233
10712892|NCT02674685|11878454|FG000|NOT COMPLETED|Overall Study||4
10712893|NCT02674854|11878461|FG000|STARTED|Overall Study||245
10712894|NCT02674854|11878462|FG001|STARTED|Overall Study||255
10712895|NCT02674854|11878463|FG002|STARTED|Overall Study||250
10712896|NCT02674854|11878461|FG000|COMPLETED|Overall Study||221
10712897|NCT02674854|11878462|FG001|COMPLETED|Overall Study||228
10712898|NCT02674854|11878463|FG002|COMPLETED|Overall Study||236
10712899|NCT02674854|11878461|FG000|NOT COMPLETED|Overall Study||24
10712900|NCT02674854|11878462|FG001|NOT COMPLETED|Overall Study||27
10712901|NCT02674854|11878463|FG002|NOT COMPLETED|Overall Study||14
10712902|NCT02675075|11878473|FG000|STARTED|Overall Study||15
10712903|NCT02675075|11878474|FG001|STARTED|Overall Study||19
10712904|NCT02675075|11878473|FG000|COMPLETED|Overall Study||12
10712905|NCT02675075|11878474|FG001|COMPLETED|Overall Study||19
10712906|NCT02675075|11878473|FG000|NOT COMPLETED|Overall Study||3
10712907|NCT02675075|11878474|FG001|NOT COMPLETED|Overall Study||0
10712908|NCT02675517|11878482|FG000|STARTED|Overall Study||1737
10712909|NCT02675517|11878482|FG000|COMPLETED|Overall Study||1578
10712910|NCT02675517|11878482|FG000|NOT COMPLETED|Overall Study||159
10712911|NCT02675543|11878488|FG000|STARTED|Overall Study||15
10712912|NCT02675543|11878489|FG001|STARTED|Overall Study||20
10712913|NCT02675543|11878488|FG000|COMPLETED|Overall Study||15
10712914|NCT02675543|11878489|FG001|COMPLETED|Overall Study||20
10712915|NCT02675543|11878488|FG000|NOT COMPLETED|Overall Study||0
10712916|NCT02675543|11878489|FG001|NOT COMPLETED|Overall Study||0
10712917|NCT02675634|11878495|FG000|STARTED|Test Period 1||10
10712918|NCT02675634|11878496|FG001|STARTED|Test Period 1||8
10712919|NCT02675634|11878497|FG002|STARTED|Test Period 1||9
10712920|NCT02675634|11878498|FG003|STARTED|Test Period 1||9
10712921|NCT02675634|11878499|FG004|STARTED|Test Period 1||10
10712922|NCT02675634|11878500|FG005|STARTED|Test Period 1||9
10712923|NCT02675634|11878495|FG000|COMPLETED|Test Period 1||10
10712924|NCT02675634|11878496|FG001|COMPLETED|Test Period 1||7
10712925|NCT02675634|11878497|FG002|COMPLETED|Test Period 1||8
10712926|NCT02675634|11878498|FG003|COMPLETED|Test Period 1||8
10681278|NCT02405780|11843945|FG000|STARTED|Period I||216
10681279|NCT02405780|11843946|FG001|STARTED|Period I||108
10681280|NCT02405780|11843947|FG002|STARTED|Period I||108
10681281|NCT02405780|11843948|FG003|STARTED|Period I||213
10681282|NCT02405780|11843945|FG000|COMPLETED|Period I||189
10681283|NCT02405780|11843946|FG001|COMPLETED|Period I||100
10681284|NCT02405780|11843947|FG002|COMPLETED|Period I||93
10681285|NCT02405780|11843948|FG003|COMPLETED|Period I||190
10681286|NCT02405780|11843945|FG000|NOT COMPLETED|Period I||27
10681287|NCT02405780|11843946|FG001|NOT COMPLETED|Period I||8
10681288|NCT02405780|11843947|FG002|NOT COMPLETED|Period I||15
10681289|NCT02405780|11843948|FG003|NOT COMPLETED|Period I||23
10681290|NCT02405780|11843945|FG000|STARTED|Period II||189
10681291|NCT02405780|11843946|FG001|STARTED|Period II||100
10681292|NCT02405780|11843947|FG002|STARTED|Period II||93
10681293|NCT02405780|11843948|FG003|STARTED|Period II||190
10681294|NCT02405780|11843945|FG000|COMPLETED|Period II||174
10798915|NCT03869541|11959455|FG000|NOT COMPLETED|Overall Study||0
10798916|NCT03869541|11959456|FG001|NOT COMPLETED|Overall Study||0
10798917|NCT03869541|11959457|FG002|NOT COMPLETED|Overall Study||0
10798918|NCT03877224|11959470|FG000|STARTED|Overall Study||253
10681295|NCT02405780|11843946|FG001|COMPLETED|Period II||88
10681296|NCT02405780|11843947|FG002|COMPLETED|Period II||81
10681297|NCT02405780|11843948|FG003|COMPLETED|Period II||172
10681298|NCT02405780|11843945|FG000|NOT COMPLETED|Period II||15
10681299|NCT02405780|11843946|FG001|NOT COMPLETED|Period II||12
10681300|NCT02405780|11843947|FG002|NOT COMPLETED|Period II||12
10681301|NCT02405780|11843948|FG003|NOT COMPLETED|Period II||18
10681302|NCT02405962|11843975|FG000|STARTED|Overall Study||84
10681303|NCT02405962|11843976|FG001|STARTED|Overall Study||84
10681304|NCT02405962|11843975|FG000|Post-intervention|Overall Study||80
10681305|NCT02405962|11843976|FG001|Post-intervention|Overall Study||81
10681306|NCT02405962|11843975|FG000|3 Months After the Intervention|Overall Study||80
10681307|NCT02405962|11843976|FG001|3 Months After the Intervention|Overall Study||79
10681308|NCT02405962|11843975|FG000|COMPLETED|Overall Study||83
10681309|NCT02405962|11843976|FG001|COMPLETED|Overall Study||79
10681310|NCT02405962|11843975|FG000|NOT COMPLETED|Overall Study||1
10681311|NCT02405962|11843976|FG001|NOT COMPLETED|Overall Study||5
10681312|NCT02406248|11843982|FG000|STARTED|Overall Study||108
10681313|NCT02406248|11843982|FG000|COMPLETED|Overall Study||99
10798919|NCT03877224|11959471|FG001|STARTED|Overall Study||251
10798920|NCT03877224|11959470|FG000|Treated|Overall Study||252
10798921|NCT03877224|11959471|FG001|Treated|Overall Study||249
10798922|NCT03877224|11959470|FG000|COMPLETED|Overall Study||248
10798923|NCT03877224|11959471|FG001|COMPLETED|Overall Study||243
10798924|NCT03877224|11959470|FG000|NOT COMPLETED|Overall Study||5
10798925|NCT03877224|11959471|FG001|NOT COMPLETED|Overall Study||8
10798926|NCT03883607|11959479|FG000|STARTED|Overall Study||5
10798927|NCT03883607|11959480|FG001|STARTED|Overall Study||5
10798928|NCT03883607|11959479|FG000|COMPLETED|Overall Study||5
10798929|NCT03883607|11959480|FG001|COMPLETED|Overall Study||5
10798930|NCT03883607|11959479|FG000|NOT COMPLETED|Overall Study||0
10798931|NCT03883607|11959480|FG001|NOT COMPLETED|Overall Study||0
10798932|NCT03885596|11959490|FG000|STARTED|Overall Study||9
10798933|NCT03885596|11959491|FG001|STARTED|Overall Study||9
10798934|NCT03885596|11959492|FG002|STARTED|Overall Study||9
10798935|NCT03885596|11959493|FG003|STARTED|Overall Study||9
10798936|NCT03885596|11959490|FG000|COMPLETED|Overall Study||7
10798937|NCT03885596|11959491|FG001|COMPLETED|Overall Study||8
10798938|NCT03885596|11959492|FG002|COMPLETED|Overall Study||9
10798939|NCT03885596|11959493|FG003|COMPLETED|Overall Study||9
10798940|NCT03885596|11959490|FG000|NOT COMPLETED|Overall Study||2
10798941|NCT03885596|11959491|FG001|NOT COMPLETED|Overall Study||1
10798942|NCT03885596|11959492|FG002|NOT COMPLETED|Overall Study||0
10798943|NCT03885596|11959493|FG003|NOT COMPLETED|Overall Study||0
10798944|NCT03885661|11959508|FG000|STARTED|Overall Study||12
10798945|NCT03885661|11959509|FG001|STARTED|Overall Study||8
10798946|NCT03885661|11959508|FG000|Baseline|Overall Study||12
10798947|NCT03885661|11959509|FG001|Baseline|Overall Study||8
10798948|NCT03885661|11959508|FG000|Treatment Visit (12 Week)|Overall Study||11
10798949|NCT03885661|11959509|FG001|Treatment Visit (12 Week)|Overall Study||7
10798950|NCT03885661|11959508|FG000|COMPLETED|Overall Study||11
10798951|NCT03885661|11959509|FG001|COMPLETED|Overall Study||7
10798952|NCT03885661|11959508|FG000|NOT COMPLETED|Overall Study||1
10798953|NCT03885661|11959509|FG001|NOT COMPLETED|Overall Study||1
10798954|NCT03886493|11959515|FG000|STARTED|Overall Study||7
10798955|NCT03886493|11959515|FG000|COMPLETED|Overall Study||6
10798956|NCT03886493|11959515|FG000|NOT COMPLETED|Overall Study||1
10681314|NCT02406248|11843982|FG000|NOT COMPLETED|Overall Study||9
10681315|NCT02406261|11843988|FG000|STARTED|Period 1||50
10681316|NCT02406261|11843989|FG001|STARTED|Period 1||32
10681317|NCT02406261|11843988|FG000|Received at Least One Dose of Study Drug|Period 1||50
10681318|NCT02406261|11843989|FG001|Received at Least One Dose of Study Drug|Period 1||32
10681319|NCT02406261|11843988|FG000|COMPLETED|Period 1||47
10798957|NCT03888235|11959522|FG000|STARTED|Overall Study|1 Participant dropped out after the first visit and was replaced.|21
10798958|NCT03888235|11959523|FG001|STARTED|Overall Study|1 participants dropped out after the first visit and was replaced|21
10681320|NCT02406261|11843989|FG001|COMPLETED|Period 1||32
10681321|NCT02406261|11843988|FG000|NOT COMPLETED|Period 1||3
10681322|NCT02406261|11843989|FG001|NOT COMPLETED|Period 1||0
10798959|NCT03888235|11959524|FG002|STARTED|Overall Study||20
10798960|NCT03888235|11959522|FG000|COMPLETED|Overall Study||20
10798961|NCT03888235|11959523|FG001|COMPLETED|Overall Study||20
10798962|NCT03888235|11959524|FG002|COMPLETED|Overall Study||20
10681323|NCT02406261|11843988|FG000|STARTED|Period 2|Cohort A participated in Period 1 only|0
10681324|NCT02406261|11843989|FG001|STARTED|Period 2||32
10681325|NCT02406261|11843988|FG000|COMPLETED|Period 2||0
10681326|NCT02406261|11843989|FG001|COMPLETED|Period 2||29
10681327|NCT02406261|11843988|FG000|NOT COMPLETED|Period 2||0
10681328|NCT02406261|11843989|FG001|NOT COMPLETED|Period 2||3
10681329|NCT02406443|11843998|FG000|STARTED|Overall Study||18
10681330|NCT02406443|11843999|FG001|STARTED|Overall Study||18
10681331|NCT02406443|11843998|FG000|COMPLETED|Overall Study||16
10681332|NCT02406443|11843999|FG001|COMPLETED|Overall Study||16
10681333|NCT02406443|11843998|FG000|NOT COMPLETED|Overall Study||2
10681334|NCT02406443|11843999|FG001|NOT COMPLETED|Overall Study||2
10681335|NCT02406495|11844005|FG000|STARTED|Overall Study||40
10681336|NCT02406495|11844005|FG000|COMPLETED|Overall Study||40
10681337|NCT02406495|11844005|FG000|NOT COMPLETED|Overall Study||0
10681338|NCT02406573|11844018|FG000|STARTED|Overall Study||30
10681339|NCT02406573|11844018|FG000|COMPLETED|Overall Study||30
10681340|NCT02406573|11844018|FG000|NOT COMPLETED|Overall Study||0
10681341|NCT02406586|11844025|FG000|STARTED|Overall Study||12
10681342|NCT02406586|11844026|FG001|STARTED|Overall Study||12
10681343|NCT02406586|11844027|FG002|STARTED|Overall Study||12
10681344|NCT02406586|11844025|FG000|COMPLETED|Overall Study||11
10681345|NCT02406586|11844026|FG001|COMPLETED|Overall Study||8
10681346|NCT02406586|11844027|FG002|COMPLETED|Overall Study||10
10681347|NCT02406586|11844025|FG000|NOT COMPLETED|Overall Study||1
10455337|NCT01001429|11603378|FG000|STARTED|Overall Study||39
10455338|NCT01001429|11603379|FG001|STARTED|Overall Study||38
10455339|NCT01001429|11603378|FG000|COMPLETED|Overall Study||39
10455340|NCT01001429|11603379|FG001|COMPLETED|Overall Study||37
10455341|NCT01001429|11603378|FG000|NOT COMPLETED|Overall Study||0
10455342|NCT01001429|11603379|FG001|NOT COMPLETED|Overall Study||1
10681348|NCT02406586|11844026|FG001|NOT COMPLETED|Overall Study||4
10681349|NCT02406586|11844027|FG002|NOT COMPLETED|Overall Study||2
10681350|NCT02406612|11844040|FG000|STARTED|Overall Study||26
10681351|NCT02406612|11844041|FG001|STARTED|Overall Study||21
10681352|NCT02406612|11844040|FG000|COMPLETED|Overall Study||22
10681353|NCT02406612|11844041|FG001|COMPLETED|Overall Study||17
10681354|NCT02406612|11844040|FG000|NOT COMPLETED|Overall Study||4
10681355|NCT02406612|11844041|FG001|NOT COMPLETED|Overall Study||4
10681356|NCT02406651|11844047|FG000|STARTED|Overall Study||30
10798963|NCT03888235|11959522|FG000|NOT COMPLETED|Overall Study||1
10798964|NCT03888235|11959523|FG001|NOT COMPLETED|Overall Study||1
10798965|NCT03888235|11959524|FG002|NOT COMPLETED|Overall Study||0
10798966|NCT03889158|11959557|FG000|STARTED|Overall Study||20
10798967|NCT03889158|11959558|FG001|STARTED|Overall Study||15
10798968|NCT03889158|11959557|FG000|COMPLETED|Overall Study||16
10798969|NCT03889158|11959558|FG001|COMPLETED|Overall Study||9
10798970|NCT03889158|11959557|FG000|NOT COMPLETED|Overall Study||4
10798971|NCT03889158|11959558|FG001|NOT COMPLETED|Overall Study||6
10798972|NCT03890419|11959568|FG000|STARTED|Overall Study||34
10798973|NCT03890419|11959569|FG001|STARTED|Overall Study||30
10798974|NCT03890419|11959570|FG002|STARTED|Overall Study||30
10798975|NCT03890419|11959568|FG000|COMPLETED|Overall Study||27
10798976|NCT03890419|11959569|FG001|COMPLETED|Overall Study||27
10798977|NCT03890419|11959570|FG002|COMPLETED|Overall Study||25
10798978|NCT03890419|11959568|FG000|NOT COMPLETED|Overall Study||7
10798979|NCT03890419|11959569|FG001|NOT COMPLETED|Overall Study||3
10798980|NCT03890419|11959570|FG002|NOT COMPLETED|Overall Study||5
10798981|NCT03900416|11959580|FG000|STARTED|Baseline||72
10798982|NCT03900416|11959581|FG001|STARTED|Baseline||80
10798983|NCT03900416|11959580|FG000|COMPLETED|Baseline||72
10798984|NCT03900416|11959581|FG001|COMPLETED|Baseline||80
10798985|NCT03900416|11959580|FG000|NOT COMPLETED|Baseline||0
10798986|NCT03900416|11959581|FG001|NOT COMPLETED|Baseline||0
10798987|NCT03900416|11959580|FG000|STARTED|Post||72
10798988|NCT03900416|11959581|FG001|STARTED|Post||80
10798989|NCT03900416|11959580|FG000|COMPLETED|Post||72
10798990|NCT03900416|11959581|FG001|COMPLETED|Post||80
10798991|NCT03900416|11959580|FG000|NOT COMPLETED|Post||0
10798992|NCT03900416|11959581|FG001|NOT COMPLETED|Post||0
10798993|NCT03900416|11959580|FG000|STARTED|Six Week Follow-up||72
10798994|NCT03900416|11959581|FG001|STARTED|Six Week Follow-up||80
10798995|NCT03900416|11959580|FG000|COMPLETED|Six Week Follow-up||70
10798996|NCT03900416|11959581|FG001|COMPLETED|Six Week Follow-up||80
10681357|NCT02406651|11844047|FG000|COMPLETED|Overall Study||27
10681358|NCT02406651|11844047|FG000|NOT COMPLETED|Overall Study||3
10681359|NCT02406677|11844054|FG000|STARTED|Overall Study||6436
10681360|NCT02406677|11844055|FG001|STARTED|Overall Study||4565
10681361|NCT02406677|11844054|FG000|COMPLETED|Overall Study||6135
10681362|NCT02406677|11844055|FG001|COMPLETED|Overall Study||3967
10681363|NCT02406677|11844054|FG000|NOT COMPLETED|Overall Study||301
10681364|NCT02406677|11844055|FG001|NOT COMPLETED|Overall Study||598
10681365|NCT02406742|11844068|FG000|STARTED|Overall Study||14
10681366|NCT02406742|11844069|FG001|STARTED|Overall Study||16
10681367|NCT02406742|11844070|FG002|STARTED|Overall Study||16
10681368|NCT02406742|11844068|FG000|Dose Escalation 1|Overall Study||3
10681369|NCT02406742|11844069|FG001|Dose Escalation 1|Overall Study||0
10798997|NCT03900416|11959580|FG000|NOT COMPLETED|Six Week Follow-up||2
10455343|NCT01001442|11603417|FG000|STARTED|Overall Study||4
10455344|NCT01001442|11603418|FG001|STARTED|Overall Study||3
10455345|NCT01001442|11603419|FG002|STARTED|Overall Study||4
10798998|NCT03900416|11959581|FG001|NOT COMPLETED|Six Week Follow-up||0
10798999|NCT03900416|11959580|FG000|STARTED|Twelve Week Follow-up||70
10799000|NCT03900416|11959581|FG001|STARTED|Twelve Week Follow-up||80
10681370|NCT02406742|11844070|FG002|Dose Escalation 1|Overall Study||0
10681371|NCT02406742|11844068|FG000|Dose Escalation 2|Overall Study||9
10681372|NCT02406742|11844069|FG001|Dose Escalation 2|Overall Study||5
10681373|NCT02406742|11844070|FG002|Dose Escalation 2|Overall Study||3
10681374|NCT02406742|11844068|FG000|Dose Escalation 3|Overall Study||2
10681375|NCT02406742|11844069|FG001|Dose Escalation 3|Overall Study||3
10681376|NCT02406742|11844070|FG002|Dose Escalation 3|Overall Study||3
10681377|NCT02406742|11844068|FG000|Dose Escalation 4|Overall Study||0
10681378|NCT02406742|11844069|FG001|Dose Escalation 4|Overall Study||3
10681379|NCT02406742|11844070|FG002|Dose Escalation 4|Overall Study||3
10681380|NCT02406742|11844068|FG000|Dose Escalation 5|Overall Study||0
10681381|NCT02406742|11844069|FG001|Dose Escalation 5|Overall Study||5
10681382|NCT02406742|11844070|FG002|Dose Escalation 5|Overall Study||5
10681383|NCT02406742|11844068|FG000|COMPLETED|Overall Study||0
10681384|NCT02406742|11844069|FG001|COMPLETED|Overall Study||0
10681385|NCT02406742|11844070|FG002|COMPLETED|Overall Study||0
10681386|NCT02406742|11844068|FG000|NOT COMPLETED|Overall Study||14
10681387|NCT02406742|11844069|FG001|NOT COMPLETED|Overall Study||16
10681388|NCT02406742|11844070|FG002|NOT COMPLETED|Overall Study||16
10681389|NCT02406859|11844081|FG000|STARTED|Part 1 - Manometric Parameters||15
10681390|NCT02406859|11844082|FG001|STARTED|Part 1 - Manometric Parameters||14
10681391|NCT02406859|11844083|FG002|STARTED|Part 1 - Manometric Parameters||21
10681392|NCT02406859|11844081|FG000|COMPLETED|Part 1 - Manometric Parameters||12
10681393|NCT02406859|11844082|FG001|COMPLETED|Part 1 - Manometric Parameters||13
10681394|NCT02406859|11844083|FG002|COMPLETED|Part 1 - Manometric Parameters||17
10681395|NCT02406859|11844081|FG000|NOT COMPLETED|Part 1 - Manometric Parameters||3
10681396|NCT02406859|11844082|FG001|NOT COMPLETED|Part 1 - Manometric Parameters||1
10681397|NCT02406859|11844083|FG002|NOT COMPLETED|Part 1 - Manometric Parameters||4
10681398|NCT02406859|11844081|FG000|STARTED|Part 2 - Biofeedback Training||12
10681399|NCT02406859|11844082|FG001|STARTED|Part 2 - Biofeedback Training||13
10681400|NCT02406859|11844083|FG002|STARTED|Part 2 - Biofeedback Training||17
10681401|NCT02406859|11844081|FG000|COMPLETED|Part 2 - Biofeedback Training||12
10681402|NCT02406859|11844082|FG001|COMPLETED|Part 2 - Biofeedback Training||13
10681403|NCT02406859|11844083|FG002|COMPLETED|Part 2 - Biofeedback Training||17
10681404|NCT02406859|11844081|FG000|NOT COMPLETED|Part 2 - Biofeedback Training||0
10681405|NCT02406859|11844082|FG001|NOT COMPLETED|Part 2 - Biofeedback Training||0
10681406|NCT02406859|11844083|FG002|NOT COMPLETED|Part 2 - Biofeedback Training||0
10681407|NCT02406885|11844102|FG000|STARTED|Overall Study||17
10681408|NCT02406885|11844103|FG001|STARTED|Overall Study||16
10681409|NCT02406885|11844102|FG000|COMPLETED|Overall Study||14
10681410|NCT02406885|11844103|FG001|COMPLETED|Overall Study||14
10681411|NCT02406885|11844102|FG000|NOT COMPLETED|Overall Study||3
10681412|NCT02406885|11844103|FG001|NOT COMPLETED|Overall Study||2
10681413|NCT02406937|11844112|FG000|STARTED|Overall Study||60
10681414|NCT02406937|11844113|FG001|STARTED|Overall Study||60
10681415|NCT02406937|11844114|FG002|STARTED|Overall Study||60
10681416|NCT02406937|11844112|FG000|COMPLETED|Overall Study||59
10681417|NCT02406937|11844113|FG001|COMPLETED|Overall Study||59
10681418|NCT02406937|11844114|FG002|COMPLETED|Overall Study||58
10681419|NCT02406937|11844112|FG000|NOT COMPLETED|Overall Study||1
10681420|NCT02406937|11844113|FG001|NOT COMPLETED|Overall Study||1
10681421|NCT02406937|11844114|FG002|NOT COMPLETED|Overall Study||2
10681422|NCT02407041|11844125|FG000|STARTED|Overall Study||5
10681423|NCT02407041|11844125|FG000|COMPLETED|Overall Study||5
10681424|NCT02407041|11844125|FG000|NOT COMPLETED|Overall Study||0
10681425|NCT02407054|11844132|FG000|STARTED|Overall Study||13
10681426|NCT02407054|11844133|FG001|STARTED|Overall Study||65
10681427|NCT02407054|11844134|FG002|STARTED|Overall Study||64
10681428|NCT02407054|11844132|FG000|Received at Least One Dose of Study Drug|Overall Study||13
10681429|NCT02407054|11844133|FG001|Received at Least One Dose of Study Drug|Overall Study||65
10681430|NCT02407054|11844134|FG002|Received at Least One Dose of Study Drug|Overall Study||64
10681431|NCT02407054|11844132|FG000|COMPLETED|Overall Study||6
10681432|NCT02407054|11844133|FG001|COMPLETED|Overall Study||47
10681433|NCT02407054|11844134|FG002|COMPLETED|Overall Study||57
10681434|NCT02407054|11844132|FG000|NOT COMPLETED|Overall Study||7
10681435|NCT02407054|11844133|FG001|NOT COMPLETED|Overall Study||18
10681436|NCT02407054|11844134|FG002|NOT COMPLETED|Overall Study||7
10681437|NCT02407132|11844145|FG000|STARTED|Immediate Post-intervention||110
10681438|NCT02407132|11844146|FG001|STARTED|Immediate Post-intervention||111
10681439|NCT02407132|11844145|FG000|COMPLETED|Immediate Post-intervention||107
10681440|NCT02407132|11844146|FG001|COMPLETED|Immediate Post-intervention||101
10681441|NCT02407132|11844145|FG000|NOT COMPLETED|Immediate Post-intervention||3
10681442|NCT02407132|11844146|FG001|NOT COMPLETED|Immediate Post-intervention||10
10681443|NCT02407132|11844145|FG000|STARTED|6 Months Post-intervention||107
10681444|NCT02407132|11844146|FG001|STARTED|6 Months Post-intervention||101
10681445|NCT02407132|11844145|FG000|COMPLETED|6 Months Post-intervention||96
10681446|NCT02407132|11844146|FG001|COMPLETED|6 Months Post-intervention||92
10681447|NCT02407132|11844145|FG000|NOT COMPLETED|6 Months Post-intervention||11
10681448|NCT02407132|11844146|FG001|NOT COMPLETED|6 Months Post-intervention||9
10681449|NCT02407132|11844145|FG000|STARTED|12 Months Post-intervention||96
10681450|NCT02407132|11844146|FG001|STARTED|12 Months Post-intervention||92
10681451|NCT02407132|11844145|FG000|COMPLETED|12 Months Post-intervention||83
10681452|NCT02407132|11844146|FG001|COMPLETED|12 Months Post-intervention||90
10681453|NCT02407132|11844145|FG000|NOT COMPLETED|12 Months Post-intervention||13
10681454|NCT02407132|11844146|FG001|NOT COMPLETED|12 Months Post-intervention||2
10681455|NCT02407223|11844155|FG000|STARTED|Overall Study||116
10681456|NCT02407223|11844156|FG001|STARTED|Overall Study||118
10681457|NCT02407223|11844157|FG002|STARTED|Overall Study||122
10681458|NCT02407223|11844155|FG000|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|22
10681459|NCT02407223|11844156|FG001|Early Escape at Week 16|Overall Study||0
10681460|NCT02407223|11844157|FG002|Early Escape at Week 16|Overall Study||0
10681461|NCT02407223|11844155|FG000|Cross Over at Week 24|Overall Study|Study discontinuation/completion reported under randomization group|60
10681462|NCT02407223|11844156|FG001|Cross Over at Week 24|Overall Study||0
10681463|NCT02407223|11844157|FG002|Cross Over at Week 24|Overall Study||0
10681464|NCT02407223|11844155|FG000|Qualified Re-randomization at Week 52|Overall Study||0
10681465|NCT02407223|11844156|FG001|Qualified Re-randomization at Week 52|Overall Study||3
10681466|NCT02407223|11844157|FG002|Qualified Re-randomization at Week 52|Overall Study||2
10681467|NCT02407223|11844155|FG000|COMPLETED|Overall Study||0
10681468|NCT02407223|11844156|FG001|COMPLETED|Overall Study||0
10681469|NCT02407223|11844157|FG002|COMPLETED|Overall Study||0
10681470|NCT02407223|11844155|FG000|NOT COMPLETED|Overall Study||116
10681471|NCT02407223|11844156|FG001|NOT COMPLETED|Overall Study||118
10681472|NCT02407223|11844157|FG002|NOT COMPLETED|Overall Study||122
10681473|NCT02407249|11844167|FG000|STARTED|Overall Study||73
10681474|NCT02407249|11844167|FG000|Treated|Overall Study||60
10681475|NCT02407249|11844167|FG000|COMPLETED|Overall Study||47
10681476|NCT02407249|11844167|FG000|NOT COMPLETED|Overall Study||26
10681477|NCT02407457|11844173|FG000|STARTED|Baseline||235
10681478|NCT02407457|11844174|FG001|STARTED|Baseline||220
10681479|NCT02407457|11844173|FG000|COMPLETED|Baseline||235
10681480|NCT02407457|11844174|FG001|COMPLETED|Baseline||220
10681481|NCT02407457|11844173|FG000|NOT COMPLETED|Baseline||0
10681482|NCT02407457|11844174|FG001|NOT COMPLETED|Baseline||0
10681483|NCT02407457|11844173|FG000|STARTED|1 Month||235
10681484|NCT02407457|11844174|FG001|STARTED|1 Month||220
10681485|NCT02407457|11844173|FG000|COMPLETED|1 Month||229
10681486|NCT02407457|11844174|FG001|COMPLETED|1 Month||213
10681487|NCT02407457|11844173|FG000|NOT COMPLETED|1 Month||6
10681488|NCT02407457|11844174|FG001|NOT COMPLETED|1 Month||7
10681489|NCT02407457|11844173|FG000|STARTED|6-Month||231
10681490|NCT02407457|11844174|FG001|STARTED|6-Month||219
10681491|NCT02407457|11844173|FG000|COMPLETED|6-Month||211
10681492|NCT02407457|11844174|FG001|COMPLETED|6-Month||194
10681493|NCT02407457|11844173|FG000|NOT COMPLETED|6-Month||20
10681494|NCT02407457|11844174|FG001|NOT COMPLETED|6-Month||25
10681495|NCT02407457|11844173|FG000|STARTED|1 Year||227
10681496|NCT02407457|11844174|FG001|STARTED|1 Year||208
10681497|NCT02407457|11844173|FG000|COMPLETED|1 Year||194
10681498|NCT02407457|11844174|FG001|COMPLETED|1 Year||180
10681499|NCT02407457|11844173|FG000|NOT COMPLETED|1 Year||33
10681500|NCT02407457|11844174|FG001|NOT COMPLETED|1 Year||28
10681501|NCT02407457|11844173|FG000|STARTED|2-year||218
10681502|NCT02407457|11844174|FG001|STARTED|2-year||194
10681503|NCT02407457|11844173|FG000|COMPLETED|2-year||184
10681504|NCT02407457|11844174|FG001|COMPLETED|2-year||159
10681505|NCT02407457|11844173|FG000|NOT COMPLETED|2-year||34
10681506|NCT02407457|11844174|FG001|NOT COMPLETED|2-year||35
10681507|NCT02407457|11844173|FG000|STARTED|3-year||198
10681508|NCT02407457|11844174|FG001|STARTED|3-year||175
10681509|NCT02407457|11844173|FG000|COMPLETED|3-year||156
10681510|NCT02407457|11844174|FG001|COMPLETED|3-year||137
10681511|NCT02407457|11844173|FG000|NOT COMPLETED|3-year||42
10681512|NCT02407457|11844174|FG001|NOT COMPLETED|3-year||38
10681513|NCT02407457|11844173|FG000|STARTED|4-year||181
10681514|NCT02407457|11844174|FG001|STARTED|4-year||156
10681515|NCT02407457|11844173|FG000|COMPLETED|4-year||100
10681516|NCT02407457|11844174|FG001|COMPLETED|4-year||95
10681517|NCT02407457|11844173|FG000|NOT COMPLETED|4-year||81
10681518|NCT02407457|11844174|FG001|NOT COMPLETED|4-year||61
10681519|NCT02407457|11844173|FG000|STARTED|5-year||123
10681520|NCT02407457|11844174|FG001|STARTED|5-year||113
10681521|NCT02407457|11844173|FG000|COMPLETED|5-year|Due to the time frame of the study - subjects have not passed 5-year.|31
10681522|NCT02407457|11844174|FG001|COMPLETED|5-year||36
10681523|NCT02407457|11844173|FG000|NOT COMPLETED|5-year||92
10681524|NCT02407457|11844174|FG001|NOT COMPLETED|5-year||77
10681525|NCT02407704|11844184|FG000|STARTED|Overall Study||2
10681526|NCT02407704|11844185|FG001|STARTED|Overall Study||3
10681527|NCT02407704|11844186|FG002|STARTED|Overall Study||5
10681528|NCT02407704|11844187|FG003|STARTED|Overall Study||5
10681529|NCT02407704|11844184|FG000|COMPLETED|Overall Study||2
10681530|NCT02407704|11844185|FG001|COMPLETED|Overall Study||3
10681531|NCT02407704|11844186|FG002|COMPLETED|Overall Study||4
10681532|NCT02407704|11844187|FG003|COMPLETED|Overall Study||2
10681533|NCT02407704|11844184|FG000|NOT COMPLETED|Overall Study||0
10681534|NCT02407704|11844185|FG001|NOT COMPLETED|Overall Study||0
10681535|NCT02407704|11844186|FG002|NOT COMPLETED|Overall Study||1
10681536|NCT02407704|11844187|FG003|NOT COMPLETED|Overall Study||3
10681537|NCT02407756|11844205|FG000|STARTED|Overall Study||20
10681538|NCT02407756|11844206|FG001|STARTED|Overall Study||18
10681539|NCT02407756|11844207|FG002|STARTED|Overall Study||20
10681540|NCT02407756|11844208|FG003|STARTED|Overall Study||19
10681541|NCT02407756|11844205|FG000|Treated|Overall Study||20
10681542|NCT02407756|11844206|FG001|Treated|Overall Study||18
10681543|NCT02407756|11844207|FG002|Treated|Overall Study||20
10681544|NCT02407756|11844208|FG003|Treated|Overall Study||19
10681545|NCT02407756|11844205|FG000|COMPLETED|Overall Study||20
10681546|NCT02407756|11844206|FG001|COMPLETED|Overall Study||18
10681547|NCT02407756|11844207|FG002|COMPLETED|Overall Study||20
10681548|NCT02407756|11844208|FG003|COMPLETED|Overall Study||19
10681549|NCT02407756|11844205|FG000|NOT COMPLETED|Overall Study||0
10681550|NCT02407756|11844206|FG001|NOT COMPLETED|Overall Study||0
10681551|NCT02407756|11844207|FG002|NOT COMPLETED|Overall Study||0
10681552|NCT02407756|11844208|FG003|NOT COMPLETED|Overall Study||0
10681553|NCT02407990|11844226|FG000|STARTED|Overall Study||3
10681554|NCT02407990|11844227|FG001|STARTED|Overall Study||26
10681555|NCT02407990|11844228|FG002|STARTED|Overall Study||26
10681556|NCT02407990|11844229|FG003|STARTED|Overall Study||7
10681557|NCT02407990|11844230|FG004|STARTED|Overall Study||21
10681558|NCT02407990|11844231|FG005|STARTED|Overall Study||20
10681559|NCT02407990|11844232|FG006|STARTED|Overall Study||13
10681560|NCT02407990|11844233|FG007|STARTED|Overall Study||335
10681561|NCT02407990|11844226|FG000|COMPLETED|Overall Study||0
10681562|NCT02407990|11844227|FG001|COMPLETED|Overall Study||0
10681563|NCT02407990|11844228|FG002|COMPLETED|Overall Study||0
10681564|NCT02407990|11844229|FG003|COMPLETED|Overall Study||0
10681565|NCT02407990|11844230|FG004|COMPLETED|Overall Study||0
10681566|NCT02407990|11844231|FG005|COMPLETED|Overall Study||0
10681567|NCT02407990|11844232|FG006|COMPLETED|Overall Study||0
10681568|NCT02407990|11844233|FG007|COMPLETED|Overall Study||0
10681569|NCT02407990|11844226|FG000|NOT COMPLETED|Overall Study||3
10681570|NCT02407990|11844227|FG001|NOT COMPLETED|Overall Study||26
10681571|NCT02407990|11844228|FG002|NOT COMPLETED|Overall Study||26
10681572|NCT02407990|11844229|FG003|NOT COMPLETED|Overall Study||7
10681573|NCT02407990|11844230|FG004|NOT COMPLETED|Overall Study||21
10681574|NCT02407990|11844231|FG005|NOT COMPLETED|Overall Study||20
10681575|NCT02407990|11844232|FG006|NOT COMPLETED|Overall Study||13
10681576|NCT02407990|11844233|FG007|NOT COMPLETED|Overall Study||335
10681577|NCT02408016|11844260|FG000|STARTED|Overall Study||6
10681578|NCT02408016|11844261|FG001|STARTED|Overall Study||4
10681579|NCT02408016|11844262|FG002|STARTED|Overall Study||0
10681580|NCT02408016|11844260|FG000|COMPLETED|Overall Study||0
10681581|NCT02408016|11844261|FG001|COMPLETED|Overall Study||1
10681582|NCT02408016|11844262|FG002|COMPLETED|Overall Study||0
10681583|NCT02408016|11844260|FG000|NOT COMPLETED|Overall Study||6
10681584|NCT02408016|11844261|FG001|NOT COMPLETED|Overall Study||3
10681585|NCT02408016|11844262|FG002|NOT COMPLETED|Overall Study||0
10681586|NCT02408120|11844272|FG000|STARTED|Overall Study||112
10681587|NCT02408120|11844273|FG001|STARTED|Overall Study||112
10681588|NCT02408120|11844272|FG000|COMPLETED|Overall Study||108
10681589|NCT02408120|11844273|FG001|COMPLETED|Overall Study||107
10681590|NCT02408120|11844272|FG000|NOT COMPLETED|Overall Study||4
10681591|NCT02408120|11844273|FG001|NOT COMPLETED|Overall Study||5
10681592|NCT02408198|11844281|FG000|STARTED|Overall Study||13
10681593|NCT02408198|11844282|FG001|STARTED|Overall Study||5
10681594|NCT02408198|11844281|FG000|COMPLETED|Overall Study||10
10681595|NCT02408198|11844282|FG001|COMPLETED|Overall Study||5
10681596|NCT02408198|11844281|FG000|NOT COMPLETED|Overall Study||3
10681597|NCT02408198|11844282|FG001|NOT COMPLETED|Overall Study||0
10681598|NCT02408263|11844288|FG000|STARTED|Overall Study||25
10681599|NCT02408263|11844289|FG001|STARTED|Overall Study||25
10681600|NCT02408263|11844288|FG000|COMPLETED|Overall Study||25
10681601|NCT02408263|11844289|FG001|COMPLETED|Overall Study||25
10681602|NCT02408263|11844288|FG000|NOT COMPLETED|Overall Study||0
10681603|NCT02408263|11844289|FG001|NOT COMPLETED|Overall Study||0
10681604|NCT02408445|11844296|FG000|STARTED|Overall Study||10
10681605|NCT02408445|11844297|FG001|STARTED|Overall Study||10
10681606|NCT02408445|11844296|FG000|COMPLETED|Overall Study||10
10681607|NCT02408445|11844297|FG001|COMPLETED|Overall Study||10
10799001|NCT03900416|11959580|FG000|COMPLETED|Twelve Week Follow-up||69
10799002|NCT03900416|11959581|FG001|COMPLETED|Twelve Week Follow-up||76
10799003|NCT03900416|11959580|FG000|NOT COMPLETED|Twelve Week Follow-up||1
10799004|NCT03900416|11959581|FG001|NOT COMPLETED|Twelve Week Follow-up||4
10799005|NCT03900416|11959580|FG000|STARTED|Six Month Follow-up||69
10799006|NCT03900416|11959581|FG001|STARTED|Six Month Follow-up||76
10799007|NCT03900416|11959580|FG000|COMPLETED|Six Month Follow-up||64
10799008|NCT03900416|11959581|FG001|COMPLETED|Six Month Follow-up||72
10799009|NCT03900416|11959580|FG000|NOT COMPLETED|Six Month Follow-up||5
10799010|NCT03900416|11959581|FG001|NOT COMPLETED|Six Month Follow-up||4
10799011|NCT03905863|11959589|FG000|STARTED|Overall Study||64
10799012|NCT03905863|11959590|FG001|STARTED|Overall Study||81
10799013|NCT03905863|11959589|FG000|COMPLETED|Overall Study||59
10799014|NCT03905863|11959590|FG001|COMPLETED|Overall Study||69
10799015|NCT03905863|11959589|FG000|NOT COMPLETED|Overall Study||5
10799016|NCT03905863|11959590|FG001|NOT COMPLETED|Overall Study||12
10799017|NCT03907033|11959598|FG000|STARTED|Overall Study||14
10799018|NCT03907033|11959599|FG001|STARTED|Overall Study||14
10799019|NCT03907033|11959598|FG000|COMPLETED|Overall Study||14
10681608|NCT02408445|11844296|FG000|NOT COMPLETED|Overall Study||0
10681609|NCT02408445|11844297|FG001|NOT COMPLETED|Overall Study||0
10681610|NCT02408484|11844302|FG000|STARTED|Overall Study||15
10681611|NCT02408484|11844302|FG000|SAF Population|Overall Study||14
10681612|NCT02408484|11844302|FG000|FAS Population|Overall Study||14
10681613|NCT02408484|11844302|FG000|PK Population|Overall Study||13
10681614|NCT02408484|11844302|FG000|firstBLEED Population|Overall Study||8
10681615|NCT02408484|11844302|FG000|BLEED Population|Overall Study||8
10681616|NCT02408484|11844302|FG000|SURG Population|Overall Study||3
10681617|NCT02408484|11844302|FG000|COMPLETED|Overall Study||11
10799020|NCT03907033|11959599|FG001|COMPLETED|Overall Study||14
10799021|NCT03907033|11959598|FG000|NOT COMPLETED|Overall Study||0
10799022|NCT03907033|11959599|FG001|NOT COMPLETED|Overall Study||0
10799023|NCT03909971|11959607|FG000|STARTED|Overall Study||67
10681618|NCT02408484|11844302|FG000|NOT COMPLETED|Overall Study||4
10681619|NCT02408523|11844324|FG000|STARTED|Overall Study||121
10681620|NCT02408523|11844325|FG001|STARTED|Overall Study||121
10681621|NCT02408523|11844324|FG000|Completed Treatment Period|Overall Study||110
10681622|NCT02408523|11844325|FG001|Completed Treatment Period|Overall Study||103
10681623|NCT02408523|11844324|FG000|Enrolled Transition Period|Overall Study||108
10681624|NCT02408523|11844325|FG001|Enrolled Transition Period|Overall Study||101
10681625|NCT02408523|11844324|FG000|Enrolled Taper Period|Overall Study||7
10681626|NCT02408523|11844325|FG001|Enrolled Taper Period|Overall Study||9
10681627|NCT02408523|11844324|FG000|Enrolled Safety Folllow-up Period|Overall Study||10
10681628|NCT02408523|11844325|FG001|Enrolled Safety Folllow-up Period|Overall Study||11
10681629|NCT02408523|11844324|FG000|COMPLETED|Overall Study||110
10681630|NCT02408523|11844325|FG001|COMPLETED|Overall Study||103
10681631|NCT02408523|11844324|FG000|NOT COMPLETED|Overall Study||11
10681632|NCT02408523|11844325|FG001|NOT COMPLETED|Overall Study||18
10681633|NCT02408692|11844342|FG000|STARTED|Overall Study||5
10681634|NCT02408692|11844343|FG001|STARTED|Overall Study||5
10681635|NCT02408692|11844344|FG002|STARTED|Overall Study||5
10681636|NCT02408692|11844342|FG000|COMPLETED|Overall Study||5
10681637|NCT02408692|11844343|FG001|COMPLETED|Overall Study||5
10681638|NCT02408692|11844344|FG002|COMPLETED|Overall Study||5
10681639|NCT02408692|11844342|FG000|NOT COMPLETED|Overall Study||0
10681640|NCT02408692|11844343|FG001|NOT COMPLETED|Overall Study||0
10681641|NCT02408692|11844344|FG002|NOT COMPLETED|Overall Study||0
10681642|NCT02408796|11844352|FG000|STARTED|Overall Study||39
10681643|NCT02408796|11844352|FG000|COMPLETED|Overall Study||39
10681644|NCT02408796|11844352|FG000|NOT COMPLETED|Overall Study||0
10681645|NCT02408965|11844358|FG000|STARTED|Overall Study||140
10681646|NCT02408965|11844359|FG001|STARTED|Overall Study||144
10681647|NCT02408965|11844358|FG000|COMPLETED|Overall Study||140
10681648|NCT02408965|11844359|FG001|COMPLETED|Overall Study||144
10681649|NCT02408965|11844358|FG000|NOT COMPLETED|Overall Study||0
10681650|NCT02408965|11844359|FG001|NOT COMPLETED|Overall Study||0
10681651|NCT02409277|11844368|FG000|STARTED|Overall Study||267
10681652|NCT02409277|11844369|FG001|STARTED|Overall Study||60
10681653|NCT02409277|11844370|FG002|STARTED|Overall Study||599
10681654|NCT02409277|11844368|FG000|3 Months Follow-up|Overall Study||178
10681655|NCT02409277|11844369|FG001|3 Months Follow-up|Overall Study||40
10681656|NCT02409277|11844370|FG002|3 Months Follow-up|Overall Study||599
10681657|NCT02409277|11844368|FG000|6 Months Follow-up|Overall Study||182
10681658|NCT02409277|11844369|FG001|6 Months Follow-up|Overall Study||42
10681659|NCT02409277|11844370|FG002|6 Months Follow-up|Overall Study||599
10681660|NCT02409277|11844368|FG000|12 Months Follow-up|Overall Study||167
10681661|NCT02409277|11844369|FG001|12 Months Follow-up|Overall Study||43
10681662|NCT02409277|11844370|FG002|12 Months Follow-up|Overall Study||599
10681663|NCT02409277|11844368|FG000|COMPLETED|Overall Study||167
10681664|NCT02409277|11844369|FG001|COMPLETED|Overall Study||43
10681665|NCT02409277|11844370|FG002|COMPLETED|Overall Study||599
10681666|NCT02409277|11844368|FG000|NOT COMPLETED|Overall Study||100
10681667|NCT02409277|11844369|FG001|NOT COMPLETED|Overall Study||17
10681668|NCT02409277|11844370|FG002|NOT COMPLETED|Overall Study||0
10681669|NCT02409329|11844398|FG000|STARTED|Overall Study||127
10681670|NCT02409329|11844399|FG001|STARTED|Overall Study||126
10681671|NCT02409329|11844400|FG002|STARTED|Overall Study||253
10681672|NCT02409329|11844398|FG000|COMPLETED|Overall Study||122
10681673|NCT02409329|11844399|FG001|COMPLETED|Overall Study||120
10681674|NCT02409329|11844400|FG002|COMPLETED|Overall Study||244
10681675|NCT02409329|11844398|FG000|NOT COMPLETED|Overall Study||5
10681676|NCT02409329|11844399|FG001|NOT COMPLETED|Overall Study||6
10681677|NCT02409329|11844400|FG002|NOT COMPLETED|Overall Study||9
10681678|NCT02409459|11844411|FG000|STARTED|Overall Study||41
10681679|NCT02409459|11844412|FG001|STARTED|Overall Study||40
10681680|NCT02409459|11844411|FG000|COMPLETED|Overall Study||40
10681681|NCT02409459|11844412|FG001|COMPLETED|Overall Study||39
10681682|NCT02409459|11844411|FG000|NOT COMPLETED|Overall Study||1
10681683|NCT02409459|11844412|FG001|NOT COMPLETED|Overall Study||1
10681684|NCT02409667|11844418|FG000|STARTED|Treatment Period 1, Baseline to Week 24||1647
10681685|NCT02409667|11844419|FG001|STARTED|Treatment Period 1, Baseline to Week 24||0
10681686|NCT02409667|11844420|FG002|STARTED|Treatment Period 1, Baseline to Week 24||0
10681687|NCT02409667|11844421|FG003|STARTED|Treatment Period 1, Baseline to Week 24||0
10681688|NCT02409667|11844422|FG004|STARTED|Treatment Period 1, Baseline to Week 24||0
10681689|NCT02409667|11844418|FG000|COMPLETED|Treatment Period 1, Baseline to Week 24||1526
10681690|NCT02409667|11844419|FG001|COMPLETED|Treatment Period 1, Baseline to Week 24||0
10681691|NCT02409667|11844420|FG002|COMPLETED|Treatment Period 1, Baseline to Week 24||0
10681692|NCT02409667|11844421|FG003|COMPLETED|Treatment Period 1, Baseline to Week 24||0
10681693|NCT02409667|11844422|FG004|COMPLETED|Treatment Period 1, Baseline to Week 24||0
10681694|NCT02409667|11844418|FG000|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||121
10681695|NCT02409667|11844419|FG001|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
10681696|NCT02409667|11844420|FG002|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
10681697|NCT02409667|11844421|FG003|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
10681698|NCT02409667|11844422|FG004|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
10681699|NCT02409667|11844418|FG000|STARTED|Treatment Period 2, Week 24 to Week 52)||0
10681700|NCT02409667|11844419|FG001|STARTED|Treatment Period 2, Week 24 to Week 52)||644
10681701|NCT02409667|11844420|FG002|STARTED|Treatment Period 2, Week 24 to Week 52)||662
10681702|NCT02409667|11844421|FG003|STARTED|Treatment Period 2, Week 24 to Week 52)||114
10681703|NCT02409667|11844422|FG004|STARTED|Treatment Period 2, Week 24 to Week 52)||93
10681704|NCT02409667|11844418|FG000|COMPLETED|Treatment Period 2, Week 24 to Week 52)||0
10681705|NCT02409667|11844419|FG001|COMPLETED|Treatment Period 2, Week 24 to Week 52)||621
10681706|NCT02409667|11844420|FG002|COMPLETED|Treatment Period 2, Week 24 to Week 52)||641
10681707|NCT02409667|11844421|FG003|COMPLETED|Treatment Period 2, Week 24 to Week 52)||106
10681708|NCT02409667|11844422|FG004|COMPLETED|Treatment Period 2, Week 24 to Week 52)||90
10681709|NCT02409667|11844418|FG000|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||0
10681710|NCT02409667|11844419|FG001|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||23
10681711|NCT02409667|11844420|FG002|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||21
10681712|NCT02409667|11844421|FG003|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||8
10681713|NCT02409667|11844422|FG004|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||3
10681714|NCT02409680|11844435|FG000|STARTED|Overall Study||5990
10681715|NCT02409680|11844436|FG001|STARTED|Overall Study||5986
10681716|NCT02409680|11844435|FG000|Treated|Overall Study||5943
10681717|NCT02409680|11844436|FG001|Treated|Overall Study||5936
10681718|NCT02409680|11844435|FG000|Included in mITT Analysis|Overall Study||5787
10681719|NCT02409680|11844436|FG001|Included in mITT Analysis|Overall Study||5771
10681720|NCT02409680|11844435|FG000|COMPLETED|Overall Study||5975
10681721|NCT02409680|11844436|FG001|COMPLETED|Overall Study||5956
10681722|NCT02409680|11844435|FG000|NOT COMPLETED|Overall Study||15
10681723|NCT02409680|11844436|FG001|NOT COMPLETED|Overall Study||30
10681724|NCT02409719|11844444|FG000|STARTED|Overall Study||31
10681725|NCT02409719|11844445|FG001|STARTED|Overall Study||45
10681726|NCT02409719|11844444|FG000|2 Weeks|Overall Study||28
10681727|NCT02409719|11844445|FG001|2 Weeks|Overall Study||42
10681728|NCT02409719|11844444|FG000|4 Weeks|Overall Study||28
10681729|NCT02409719|11844445|FG001|4 Weeks|Overall Study||42
10681730|NCT02409719|11844444|FG000|6 Weeks|Overall Study||28
10681731|NCT02409719|11844445|FG001|6 Weeks|Overall Study||42
10681732|NCT02409719|11844444|FG000|3 Months|Overall Study||28
10681733|NCT02409719|11844445|FG001|3 Months|Overall Study||42
10681734|NCT02409719|11844444|FG000|6 Months|Overall Study||28
10681735|NCT02409719|11844445|FG001|6 Months|Overall Study||42
10681736|NCT02409719|11844444|FG000|12 Months|Overall Study||28
10681737|NCT02409719|11844445|FG001|12 Months|Overall Study||42
10681738|NCT02409719|11844444|FG000|COMPLETED|Overall Study||28
10681739|NCT02409719|11844445|FG001|COMPLETED|Overall Study||42
10681740|NCT02409719|11844444|FG000|NOT COMPLETED|Overall Study||3
10681741|NCT02409719|11844445|FG001|NOT COMPLETED|Overall Study||3
10681742|NCT02409732|11844451|FG000|STARTED|Overall Study|First patient consented on 4/23/15|20
10681743|NCT02409732|11844451|FG000|COMPLETED|Overall Study||14
10681744|NCT02409732|11844451|FG000|NOT COMPLETED|Overall Study||6
10681745|NCT02409784|11844456|FG000|STARTED|Overall Study||10
10681746|NCT02409784|11844456|FG000|COMPLETED|Overall Study||10
10681747|NCT02409784|11844456|FG000|NOT COMPLETED|Overall Study||0
10681748|NCT02409914|11844461|FG000|STARTED|Overall Study||7
10681749|NCT02409914|11844461|FG000|COMPLETED|Overall Study||7
10681750|NCT02409914|11844461|FG000|NOT COMPLETED|Overall Study||0
10681751|NCT02409927|11844465|FG000|STARTED|Overall Study||10
10681752|NCT02409927|11844465|FG000|COMPLETED|Overall Study||10
10681753|NCT02409927|11844465|FG000|NOT COMPLETED|Overall Study||0
10681754|NCT02410018|11844471|FG000|STARTED|Overall Study||2
10681755|NCT02410018|11844472|FG001|STARTED|Overall Study||1
10681756|NCT02410018|11844471|FG000|COMPLETED|Overall Study||2
10681757|NCT02410018|11844472|FG001|COMPLETED|Overall Study||1
10681758|NCT02410018|11844471|FG000|NOT COMPLETED|Overall Study||0
10681759|NCT02410018|11844472|FG001|NOT COMPLETED|Overall Study||0
10681760|NCT02410161|11844480|FG000|STARTED|Overall Study||10
10681761|NCT02410161|11844481|FG001|STARTED|Overall Study||10
10681762|NCT02410161|11844480|FG000|COMPLETED|Overall Study||10
10681763|NCT02410161|11844481|FG001|COMPLETED|Overall Study||10
10681764|NCT02410161|11844480|FG000|NOT COMPLETED|Overall Study||0
10681765|NCT02410161|11844481|FG001|NOT COMPLETED|Overall Study||0
10681766|NCT02410200|11844487|FG000|STARTED|Overall Study||22
10681767|NCT02410200|11844487|FG000|COMPLETED|Overall Study||20
10681768|NCT02410200|11844487|FG000|NOT COMPLETED|Overall Study||2
10681775|NCT02410252|11844498|FG000|STARTED|Overall Study||25
10681776|NCT02410252|11844498|FG000|COMPLETED|Overall Study||19
10681777|NCT02410252|11844498|FG000|NOT COMPLETED|Overall Study||6
10681778|NCT02410278|11844506|FG000|STARTED|Run-in Period||102
10681779|NCT02410278|11844507|FG001|STARTED|Run-in Period||0
10681780|NCT02410278|11844508|FG002|STARTED|Run-in Period||0
10681781|NCT02410278|11844506|FG000|Received at Least 1 Dose of DMF|Run-in Period||98
10681782|NCT02410278|11844507|FG001|Received at Least 1 Dose of DMF|Run-in Period||0
10681783|NCT02410278|11844508|FG002|Received at Least 1 Dose of DMF|Run-in Period||0
10681784|NCT02410278|11844506|FG000|COMPLETED|Run-in Period||64
10681785|NCT02410278|11844507|FG001|COMPLETED|Run-in Period||0
10681786|NCT02410278|11844508|FG002|COMPLETED|Run-in Period||0
10681787|NCT02410278|11844506|FG000|NOT COMPLETED|Run-in Period||38
10681788|NCT02410278|11844507|FG001|NOT COMPLETED|Run-in Period||0
10681789|NCT02410278|11844508|FG002|NOT COMPLETED|Run-in Period||0
10681790|NCT02410278|11844506|FG000|STARTED|Study Treatment Period||0
10681791|NCT02410278|11844507|FG001|STARTED|Study Treatment Period||31
10681792|NCT02410278|11844508|FG002|STARTED|Study Treatment Period||33
10681793|NCT02410278|11844506|FG000|Modified Intent-to Treat(mITT)Population|Study Treatment Period||0
10681794|NCT02410278|11844507|FG001|Modified Intent-to Treat(mITT)Population|Study Treatment Period||30
10681795|NCT02410278|11844508|FG002|Modified Intent-to Treat(mITT)Population|Study Treatment Period||33
10681796|NCT02410278|11844506|FG000|Completed Randomized Study Treatment|Study Treatment Period||0
10681797|NCT02410278|11844507|FG001|Completed Randomized Study Treatment|Study Treatment Period||20
10681798|NCT02410278|11844508|FG002|Completed Randomized Study Treatment|Study Treatment Period||29
10681799|NCT02410278|11844506|FG000|COMPLETED|Study Treatment Period||0
10681800|NCT02410278|11844507|FG001|COMPLETED|Study Treatment Period||20
10681801|NCT02410278|11844508|FG002|COMPLETED|Study Treatment Period||29
10681802|NCT02410278|11844506|FG000|NOT COMPLETED|Study Treatment Period||0
10681803|NCT02410278|11844507|FG001|NOT COMPLETED|Study Treatment Period||11
10681804|NCT02410278|11844508|FG002|NOT COMPLETED|Study Treatment Period||4
10681805|NCT02410291|11844517|FG000|STARTED|Overall Study||29
10681806|NCT02410291|11844518|FG001|STARTED|Overall Study||29
10681807|NCT02410291|11844517|FG000|COMPLETED|Overall Study||29
10681808|NCT02410291|11844518|FG001|COMPLETED|Overall Study||29
10681809|NCT02410291|11844517|FG000|NOT COMPLETED|Overall Study||0
10681810|NCT02410291|11844518|FG001|NOT COMPLETED|Overall Study||0
10681811|NCT02410382|11844526|FG000|STARTED|Overall Study||0
10681812|NCT02410382|11844527|FG001|STARTED|Overall Study||0
10681813|NCT02410382|11844526|FG000|COMPLETED|Overall Study|Study was terminated by IRB - attempts made to obtain info were unsuccessful.|0
10681814|NCT02410382|11844527|FG001|COMPLETED|Overall Study||0
10681815|NCT02410382|11844526|FG000|NOT COMPLETED|Overall Study||0
10681816|NCT02410382|11844527|FG001|NOT COMPLETED|Overall Study||0
10681817|NCT02410629|11844535|FG000|STARTED|Overall Study||8
10681818|NCT02410629|11844536|FG001|STARTED|Overall Study||9
10681819|NCT02410629|11844535|FG000|COMPLETED|Overall Study|5 subjects from the music glove group were crossed over to conventional hand exercise group.|5
10681820|NCT02410629|11844536|FG001|COMPLETED|Overall Study|6 subjects from the conventional hand exercise group were crossed over to music glove group.|6
10681821|NCT02410629|11844535|FG000|NOT COMPLETED|Overall Study||3
10681822|NCT02410629|11844536|FG001|NOT COMPLETED|Overall Study||3
10681823|NCT02410707|11844542|FG000|STARTED|Overall Study||43
10681824|NCT02410707|11844542|FG000|COMPLETED|Overall Study||43
10681825|NCT02410707|11844542|FG000|NOT COMPLETED|Overall Study||0
10681826|NCT02410772|11844551|FG000|STARTED|Overall Study||829
10681827|NCT02410772|11844552|FG001|STARTED|Overall Study||838
10681828|NCT02410772|11844553|FG002|STARTED|Overall Study||849
10681829|NCT02410772|11844551|FG000|Microbiologically Eligible Analysis Population|Overall Study||768
10681830|NCT02410772|11844552|FG001|Microbiologically Eligible Analysis Population|Overall Study||784
10681831|NCT02410772|11844553|FG002|Microbiologically Eligible Analysis Population|Overall Study||791
10681832|NCT02410772|11844551|FG000|Assessable Population|Overall Study||726
10681833|NCT02410772|11844552|FG001|Assessable Population|Overall Study||752
10681834|NCT02410772|11844553|FG002|Assessable Population|Overall Study||756
10681835|NCT02410772|11844551|FG000|COMPLETED|Overall Study||726
10681836|NCT02410772|11844552|FG001|COMPLETED|Overall Study||752
10681837|NCT02410772|11844553|FG002|COMPLETED|Overall Study||756
10681838|NCT02410772|11844551|FG000|NOT COMPLETED|Overall Study||103
10681839|NCT02410772|11844552|FG001|NOT COMPLETED|Overall Study||86
10681840|NCT02410772|11844553|FG002|NOT COMPLETED|Overall Study||93
10681841|NCT02410798|11844561|FG000|STARTED|Overall Study||12
10681842|NCT02410798|11844561|FG000|COMPLETED|Overall Study||12
10681843|NCT02410798|11844561|FG000|NOT COMPLETED|Overall Study||0
10681844|NCT02410811|11844570|FG000|STARTED|Overall Study||5
10681845|NCT02410811|11844571|FG001|STARTED|Overall Study||10
10681846|NCT02410811|11844572|FG002|STARTED|Overall Study||11
10681847|NCT02410811|11844573|FG003|STARTED|Overall Study||7
10681848|NCT02410811|11844570|FG000|COMPLETED|Overall Study||5
10681849|NCT02410811|11844571|FG001|COMPLETED|Overall Study||10
10681850|NCT02410811|11844572|FG002|COMPLETED|Overall Study||10
10681851|NCT02410811|11844573|FG003|COMPLETED|Overall Study||7
10681852|NCT02410811|11844570|FG000|NOT COMPLETED|Overall Study||0
10681853|NCT02410811|11844571|FG001|NOT COMPLETED|Overall Study||0
10681854|NCT02410811|11844572|FG002|NOT COMPLETED|Overall Study||1
10681855|NCT02410811|11844573|FG003|NOT COMPLETED|Overall Study||0
10681856|NCT02410824|11844583|FG000|STARTED|First Intervention (One Week)||22
10681857|NCT02410824|11844584|FG001|STARTED|First Intervention (One Week)||23
10681858|NCT02410824|11844583|FG000|COMPLETED|First Intervention (One Week)||22
10681859|NCT02410824|11844584|FG001|COMPLETED|First Intervention (One Week)||22
10681860|NCT02410824|11844583|FG000|NOT COMPLETED|First Intervention (One Week)||0
10681861|NCT02410824|11844584|FG001|NOT COMPLETED|First Intervention (One Week)||1
10681862|NCT02410824|11844583|FG000|STARTED|Second Intervention (One Week)||22
10681863|NCT02410824|11844584|FG001|STARTED|Second Intervention (One Week)||22
10681864|NCT02410824|11844583|FG000|COMPLETED|Second Intervention (One Week)||22
10681865|NCT02410824|11844584|FG001|COMPLETED|Second Intervention (One Week)||22
10681866|NCT02410824|11844583|FG000|NOT COMPLETED|Second Intervention (One Week)||0
10681867|NCT02410824|11844584|FG001|NOT COMPLETED|Second Intervention (One Week)||0
10681868|NCT02410837|11844591|FG000|STARTED|Overall Study||1388
10681869|NCT02410837|11844591|FG000|Procedure|Overall Study||1388
10681870|NCT02410837|11844591|FG000|1-Month|Overall Study||1374
10681871|NCT02410837|11844591|FG000|12-Month|Overall Study||1121
10681872|NCT02410837|11844591|FG000|24-Month|Overall Study||900
10681873|NCT02410837|11844591|FG000|COMPLETED|Overall Study||900
10681874|NCT02410837|11844591|FG000|NOT COMPLETED|Overall Study||488
10681875|NCT02410967|11844597|FG000|STARTED|Treatment Phase (4 Weeks)||27
10681876|NCT02410967|11844598|FG001|STARTED|Treatment Phase (4 Weeks)||26
10681877|NCT02410967|11844597|FG000|COMPLETED|Treatment Phase (4 Weeks)||26
10681878|NCT02410967|11844598|FG001|COMPLETED|Treatment Phase (4 Weeks)||22
10681879|NCT02410967|11844597|FG000|NOT COMPLETED|Treatment Phase (4 Weeks)||1
10681880|NCT02410967|11844598|FG001|NOT COMPLETED|Treatment Phase (4 Weeks)||4
10681881|NCT02410967|11844597|FG000|STARTED|Follow-up Phase (8 Weeks)||26
10681882|NCT02410967|11844598|FG001|STARTED|Follow-up Phase (8 Weeks)||22
10681883|NCT02410967|11844597|FG000|COMPLETED|Follow-up Phase (8 Weeks)||22
10681884|NCT02410967|11844598|FG001|COMPLETED|Follow-up Phase (8 Weeks)||16
10681885|NCT02410967|11844597|FG000|NOT COMPLETED|Follow-up Phase (8 Weeks)||4
10681886|NCT02410967|11844598|FG001|NOT COMPLETED|Follow-up Phase (8 Weeks)||6
10681887|NCT02411084|11844606|FG000|STARTED|Overall Study||18
10681888|NCT02411084|11844607|FG001|STARTED|Overall Study||18
10681889|NCT02411084|11844606|FG000|COMPLETED|Overall Study||5
10681890|NCT02411084|11844607|FG001|COMPLETED|Overall Study||5
10681891|NCT02411084|11844606|FG000|NOT COMPLETED|Overall Study||13
10681892|NCT02411084|11844607|FG001|NOT COMPLETED|Overall Study||13
10681893|NCT02411110|11844615|FG000|STARTED|Treatment Period 1||65
10681894|NCT02411110|11844616|FG001|STARTED|Treatment Period 1||66
10681895|NCT02411110|11844615|FG000|COMPLETED|Treatment Period 1||56
10681896|NCT02411110|11844616|FG001|COMPLETED|Treatment Period 1||59
10681897|NCT02411110|11844615|FG000|NOT COMPLETED|Treatment Period 1||9
10681898|NCT02411110|11844616|FG001|NOT COMPLETED|Treatment Period 1||7
10681899|NCT02411110|11844615|FG000|STARTED|Treatment Period 2|Period 2 was optional.|50
10681900|NCT02411110|11844616|FG001|STARTED|Treatment Period 2|Period 2 was optional.|48
10681901|NCT02411110|11844615|FG000|COMPLETED|Treatment Period 2||49
10681902|NCT02411110|11844616|FG001|COMPLETED|Treatment Period 2||44
10681903|NCT02411110|11844615|FG000|NOT COMPLETED|Treatment Period 2||1
10681904|NCT02411110|11844616|FG001|NOT COMPLETED|Treatment Period 2||4
10681905|NCT02411201|11844624|FG000|STARTED|Overall Study||51
10681906|NCT02411201|11844624|FG000|COMPLETED|Overall Study||45
10681907|NCT02411201|11844624|FG000|NOT COMPLETED|Overall Study||6
10681908|NCT02411292|11844630|FG000|STARTED|Overall Study||110
10681909|NCT02411292|11844630|FG000|COMPLETED|Overall Study||89
10681910|NCT02411292|11844630|FG000|NOT COMPLETED|Overall Study||21
10681911|NCT02411396|11844636|FG000|STARTED|Overall Study||483
10681912|NCT02411396|11844636|FG000|COMPLETED|Overall Study||442
10681913|NCT02411396|11844636|FG000|NOT COMPLETED|Overall Study||41
10681914|NCT02411461|11844648|FG000|STARTED|Overall Study||16
10681915|NCT02411461|11844649|FG001|STARTED|Overall Study||8
10681916|NCT02411461|11844650|FG002|STARTED|Overall Study||15
10681917|NCT02411461|11844648|FG000|COMPLETED|Overall Study||16
10681918|NCT02411461|11844649|FG001|COMPLETED|Overall Study||8
10681919|NCT02411461|11844650|FG002|COMPLETED|Overall Study||15
10681920|NCT02411461|11844648|FG000|NOT COMPLETED|Overall Study||0
10681921|NCT02411461|11844649|FG001|NOT COMPLETED|Overall Study||0
10681922|NCT02411461|11844650|FG002|NOT COMPLETED|Overall Study||0
10681923|NCT02411539|11844660|FG000|STARTED|Overall Study||20
10681924|NCT02411539|11844661|FG001|STARTED|Overall Study||20
10681925|NCT02411539|11844660|FG000|COMPLETED|Overall Study||18
10681926|NCT02411539|11844661|FG001|COMPLETED|Overall Study||19
10681927|NCT02411539|11844660|FG000|NOT COMPLETED|Overall Study||2
10681928|NCT02411539|11844661|FG001|NOT COMPLETED|Overall Study||1
10681929|NCT02411565|11844672|FG000|STARTED|Overall Study||1
10681930|NCT02411565|11844673|FG001|STARTED|Overall Study||2
10681931|NCT02411565|11844672|FG000|COMPLETED|Overall Study||1
10681932|NCT02411565|11844673|FG001|COMPLETED|Overall Study||2
10681933|NCT02411565|11844672|FG000|NOT COMPLETED|Overall Study||0
10681934|NCT02411565|11844673|FG001|NOT COMPLETED|Overall Study||0
10681935|NCT02411578|11844681|FG000|STARTED|Crossover Trial Phase||8
10681936|NCT02411578|11844682|FG001|STARTED|Crossover Trial Phase||12
10681937|NCT02411578|11844681|FG000|COMPLETED|Crossover Trial Phase||8
10681938|NCT02411578|11844682|FG001|COMPLETED|Crossover Trial Phase||11
10681939|NCT02411578|11844681|FG000|NOT COMPLETED|Crossover Trial Phase||0
10681940|NCT02411578|11844682|FG001|NOT COMPLETED|Crossover Trial Phase||1
10681941|NCT02411578|11844681|FG000|STARTED|Extension Phase||8
10681942|NCT02411578|11844682|FG001|STARTED|Extension Phase|2 Crossover Trial participants could not continue due to study syringes expiration|9
10681943|NCT02411578|11844681|FG000|COMPLETED|Extension Phase||8
10681944|NCT02411578|11844682|FG001|COMPLETED|Extension Phase||9
10681945|NCT02411578|11844681|FG000|NOT COMPLETED|Extension Phase||0
10681946|NCT02411578|11844682|FG001|NOT COMPLETED|Extension Phase||0
10681947|NCT02411591|11844693|FG000|STARTED|Overall Study||3
10681948|NCT02411591|11844694|FG001|STARTED|Overall Study||57
10681949|NCT02411591|11844695|FG002|STARTED|Overall Study||6
10681950|NCT02411591|11844693|FG000|Part A|Overall Study||3
10681951|NCT02411591|11844694|FG001|Part A|Overall Study||6
10681952|NCT02411591|11844695|FG002|Part A|Overall Study||6
10681953|NCT02411591|11844693|FG000|Expansion Cohort Part B|Overall Study||0
10681954|NCT02411591|11844694|FG001|Expansion Cohort Part B|Overall Study||51
10681955|NCT02411591|11844695|FG002|Expansion Cohort Part B|Overall Study||0
10681956|NCT02411591|11844693|FG000|Progressive Disease|Overall Study||3
10681957|NCT02411591|11844694|FG001|Progressive Disease|Overall Study||42
10681958|NCT02411591|11844695|FG002|Progressive Disease|Overall Study||3
10681959|NCT02411591|11844693|FG000|Death|Overall Study||0
10681960|NCT02411591|11844694|FG001|Death|Overall Study||2
10681961|NCT02411591|11844695|FG002|Death|Overall Study||0
10681962|NCT02411591|11844693|FG000|COMPLETED|Overall Study||3
10681963|NCT02411591|11844694|FG001|COMPLETED|Overall Study||47
10681964|NCT02411591|11844695|FG002|COMPLETED|Overall Study||3
10681965|NCT02411591|11844693|FG000|NOT COMPLETED|Overall Study||0
10681966|NCT02411591|11844694|FG001|NOT COMPLETED|Overall Study||10
10681967|NCT02411591|11844695|FG002|NOT COMPLETED|Overall Study||3
10681968|NCT02411747|11844713|FG000|STARTED|Overall Study||16
10681969|NCT02411747|11844714|FG001|STARTED|Overall Study||16
10681970|NCT02411747|11844713|FG000|Simulation Training Completed|Overall Study||16
10681971|NCT02411747|11844714|FG001|Simulation Training Completed|Overall Study||16
10681972|NCT02411747|11844713|FG000|COMPLETED|Overall Study||13
10681973|NCT02411747|11844714|FG001|COMPLETED|Overall Study||12
10681974|NCT02411747|11844713|FG000|NOT COMPLETED|Overall Study||3
10681975|NCT02411747|11844714|FG001|NOT COMPLETED|Overall Study||4
10681976|NCT02411916|11844722|FG000|STARTED|Overall Study||73
10681977|NCT02411916|11844723|FG001|STARTED|Overall Study||70
10681978|NCT02411916|11844722|FG000|COMPLETED|Overall Study||73
10681979|NCT02411916|11844723|FG001|COMPLETED|Overall Study||70
10681980|NCT02411916|11844722|FG000|NOT COMPLETED|Overall Study||0
10681981|NCT02411916|11844723|FG001|NOT COMPLETED|Overall Study||0
10681982|NCT02411929|11844729|FG000|STARTED|Period 1||8
10681983|NCT02411929|11844729|FG000|COMPLETED|Period 1||8
10681984|NCT02411929|11844729|FG000|NOT COMPLETED|Period 1||0
10681985|NCT02411929|11844729|FG000|STARTED|Washout Period||8
10681986|NCT02411929|11844729|FG000|COMPLETED|Washout Period||8
10681987|NCT02411929|11844729|FG000|NOT COMPLETED|Washout Period||0
10681988|NCT02411929|11844729|FG000|STARTED|Period 2||8
10681989|NCT02411929|11844729|FG000|COMPLETED|Period 2||8
10681990|NCT02411929|11844729|FG000|NOT COMPLETED|Period 2||0
10681991|NCT02412098|11844741|FG000|STARTED|Overall Study||14
10681992|NCT02412098|11844742|FG001|STARTED|Overall Study||14
10681993|NCT02412098|11844743|FG002|STARTED|Overall Study||21
10681994|NCT02412098|11844741|FG000|COMPLETED|Overall Study||14
10681995|NCT02412098|11844742|FG001|COMPLETED|Overall Study||14
10681996|NCT02412098|11844743|FG002|COMPLETED|Overall Study||21
10681997|NCT02412098|11844741|FG000|NOT COMPLETED|Overall Study||0
10681998|NCT02412098|11844742|FG001|NOT COMPLETED|Overall Study||0
10681999|NCT02412098|11844743|FG002|NOT COMPLETED|Overall Study||0
10682000|NCT02412111|11844757|FG000|STARTED|Ivacaftor Run-in Period (4 Weeks)||156
10682001|NCT02412111|11844758|FG001|STARTED|Ivacaftor Run-in Period (4 Weeks)||0
10682002|NCT02412111|11844759|FG002|STARTED|Ivacaftor Run-in Period (4 Weeks)||0
10682003|NCT02412111|11844757|FG000|COMPLETED|Ivacaftor Run-in Period (4 Weeks)||153
10682004|NCT02412111|11844758|FG001|COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
10682005|NCT02412111|11844759|FG002|COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
10682006|NCT02412111|11844757|FG000|NOT COMPLETED|Ivacaftor Run-in Period (4 Weeks)||3
10682007|NCT02412111|11844758|FG001|NOT COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
10682008|NCT02412111|11844759|FG002|NOT COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
10682009|NCT02412111|11844757|FG000|STARTED|Active Comparator Period (8 Weeks)||0
10682010|NCT02412111|11844758|FG001|STARTED|Active Comparator Period (8 Weeks)||76
10682011|NCT02412111|11844759|FG002|STARTED|Active Comparator Period (8 Weeks)||75
10682012|NCT02412111|11844757|FG000|Full Analysis Set|Active Comparator Period (8 Weeks)||0
10682013|NCT02412111|11844758|FG001|Full Analysis Set|Active Comparator Period (8 Weeks)||76
10682014|NCT02412111|11844759|FG002|Full Analysis Set|Active Comparator Period (8 Weeks)||74
10682015|NCT02412111|11844757|FG000|COMPLETED|Active Comparator Period (8 Weeks)||0
10682016|NCT02412111|11844758|FG001|COMPLETED|Active Comparator Period (8 Weeks)||75
10682017|NCT02412111|11844759|FG002|COMPLETED|Active Comparator Period (8 Weeks)||69
10682018|NCT02412111|11844757|FG000|NOT COMPLETED|Active Comparator Period (8 Weeks)||0
10682019|NCT02412111|11844758|FG001|NOT COMPLETED|Active Comparator Period (8 Weeks)||1
10682020|NCT02412111|11844759|FG002|NOT COMPLETED|Active Comparator Period (8 Weeks)||6
10799024|NCT03909971|11959608|FG001|STARTED|Overall Study||42
10799025|NCT03909971|11959607|FG000|COMPLETED|Overall Study||57
10799026|NCT03909971|11959608|FG001|COMPLETED|Overall Study||20
10682039|NCT02412371|11844809|FG000|STARTED|Overall Study||7
10682040|NCT02412371|11844810|FG001|STARTED|Overall Study||9
10682041|NCT02412371|11844811|FG002|STARTED|Overall Study||7
10682042|NCT02412371|11844812|FG003|STARTED|Overall Study||8
10682043|NCT02412371|11844813|FG004|STARTED|Overall Study||12
10682044|NCT02412371|11844814|FG005|STARTED|Overall Study||5
10682045|NCT02412371|11844809|FG000|COMPLETED|Overall Study||0
10682046|NCT02412371|11844810|FG001|COMPLETED|Overall Study||0
10682047|NCT02412371|11844811|FG002|COMPLETED|Overall Study||0
10682048|NCT02412371|11844812|FG003|COMPLETED|Overall Study||0
10682049|NCT02412371|11844813|FG004|COMPLETED|Overall Study||0
10799027|NCT03909971|11959607|FG000|NOT COMPLETED|Overall Study||10
10682050|NCT02412371|11844814|FG005|COMPLETED|Overall Study||0
10682051|NCT02412371|11844809|FG000|NOT COMPLETED|Overall Study||7
10682052|NCT02412371|11844810|FG001|NOT COMPLETED|Overall Study||9
10682053|NCT02412371|11844811|FG002|NOT COMPLETED|Overall Study||7
10682054|NCT02412371|11844812|FG003|NOT COMPLETED|Overall Study||8
10682055|NCT02412371|11844813|FG004|NOT COMPLETED|Overall Study||12
10682056|NCT02412371|11844814|FG005|NOT COMPLETED|Overall Study||5
10682057|NCT02412436|11844829|FG000|STARTED|Overall Study||62
10682058|NCT02412436|11844829|FG000|COMPLETED|Overall Study||44
10682059|NCT02412436|11844829|FG000|NOT COMPLETED|Overall Study||18
10682060|NCT02412488|11844833|FG000|STARTED|Overall Study||192
10682061|NCT02412488|11844833|FG000|Reveal LINQ Implanted|Overall Study||191
10682062|NCT02412488|11844833|FG000|COMPLETED|Overall Study||174
10682063|NCT02412488|11844833|FG000|NOT COMPLETED|Overall Study||18
10682064|NCT02412501|11844837|FG000|STARTED|Overall Study||101
10682065|NCT02412501|11844837|FG000|COMPLETED|Overall Study||101
10682066|NCT02412501|11844837|FG000|NOT COMPLETED|Overall Study||0
10682067|NCT02412631|11844844|FG000|STARTED|Overall Study||44
10682068|NCT02412631|11844845|FG001|STARTED|Overall Study||40
10682069|NCT02412631|11844844|FG000|COMPLETED|Overall Study||18
10682070|NCT02412631|11844845|FG001|COMPLETED|Overall Study||16
10682071|NCT02412631|11844844|FG000|NOT COMPLETED|Overall Study||26
10682072|NCT02412631|11844845|FG001|NOT COMPLETED|Overall Study||24
10682073|NCT02412644|11844853|FG000|STARTED|Overall Study||21
10682074|NCT02412644|11844854|FG001|STARTED|Overall Study||8
10682075|NCT02412644|11844853|FG000|COMPLETED|Overall Study||6
10682076|NCT02412644|11844854|FG001|COMPLETED|Overall Study||4
10682077|NCT02412644|11844853|FG000|NOT COMPLETED|Overall Study||15
10682078|NCT02412644|11844854|FG001|NOT COMPLETED|Overall Study||4
10682079|NCT02412657|11844867|FG000|STARTED|Overall Study||25
10682080|NCT02412657|11844868|FG001|STARTED|Overall Study||25
10682081|NCT02412657|11844869|FG002|STARTED|Overall Study||25
10682082|NCT02412657|11844867|FG000|COMPLETED|Overall Study||24
10682083|NCT02412657|11844868|FG001|COMPLETED|Overall Study||23
10682084|NCT02412657|11844869|FG002|COMPLETED|Overall Study||22
10682085|NCT02412657|11844867|FG000|NOT COMPLETED|Overall Study||1
10682086|NCT02412657|11844868|FG001|NOT COMPLETED|Overall Study||2
10682087|NCT02412657|11844869|FG002|NOT COMPLETED|Overall Study||3
10682088|NCT02412722|11844883|FG000|STARTED|Overall Study||11
10682089|NCT02412722|11844884|FG001|STARTED|Overall Study||8
10682090|NCT02412722|11844885|FG002|STARTED|Overall Study||7
10682091|NCT02412722|11844886|FG003|STARTED|Overall Study||15
10682092|NCT02412722|11844887|FG004|STARTED|Overall Study||7
10682093|NCT02412722|11844888|FG005|STARTED|Overall Study||13
10682094|NCT02412722|11844883|FG000|Safety Population|Overall Study||11
10799028|NCT03909971|11959608|FG001|NOT COMPLETED|Overall Study||22
10799029|NCT03920215|11959619|FG000|STARTED|Overall Study||26
10799030|NCT03920215|11959620|FG001|STARTED|Overall Study||29
10799031|NCT03920215|11959621|FG002|STARTED|Overall Study||23
10799032|NCT03920215|11959622|FG003|STARTED|Overall Study||23
10799033|NCT03920215|11959619|FG000|COMPLETED|Overall Study||25
10799034|NCT03920215|11959620|FG001|COMPLETED|Overall Study||27
10799035|NCT03920215|11959621|FG002|COMPLETED|Overall Study||23
10799036|NCT03920215|11959622|FG003|COMPLETED|Overall Study||22
10799037|NCT03920215|11959619|FG000|NOT COMPLETED|Overall Study||1
10799038|NCT03920215|11959620|FG001|NOT COMPLETED|Overall Study||2
10799039|NCT03920215|11959621|FG002|NOT COMPLETED|Overall Study||0
10799040|NCT03920215|11959622|FG003|NOT COMPLETED|Overall Study||1
10799041|NCT03921151|11959634|FG000|STARTED|Overall Study||46
10799042|NCT03921151|11959635|FG001|STARTED|Overall Study||44
10799043|NCT03921151|11959634|FG000|COMPLETED|Overall Study||35
10799044|NCT03921151|11959635|FG001|COMPLETED|Overall Study||28
10799045|NCT03921151|11959634|FG000|NOT COMPLETED|Overall Study||11
10799046|NCT03921151|11959635|FG001|NOT COMPLETED|Overall Study||16
10810951|NCT03784079|11972660|FG000|NOT COMPLETED|Part 1: Up to Day 24||0
10810952|NCT03784079|11972661|FG001|NOT COMPLETED|Part 1: Up to Day 24||0
10810953|NCT03784079|11972662|FG002|NOT COMPLETED|Part 1: Up to Day 24||0
10810954|NCT03784079|11972663|FG003|NOT COMPLETED|Part 1: Up to Day 24||0
10810955|NCT03784079|11972664|FG004|NOT COMPLETED|Part 1: Up to Day 24||0
10810956|NCT03784079|11972665|FG005|NOT COMPLETED|Part 1: Up to Day 24||0
10810957|NCT03784079|11972666|FG006|NOT COMPLETED|Part 1: Up to Day 24||0
10810958|NCT03784079|11972660|FG000|STARTED|Part 2: Up to Day 12||0
10682095|NCT02412722|11844884|FG001|Safety Population|Overall Study||6
10682096|NCT02412722|11844885|FG002|Safety Population|Overall Study||7
10682097|NCT02412722|11844886|FG003|Safety Population|Overall Study||15
10682098|NCT02412722|11844887|FG004|Safety Population|Overall Study||7
10682099|NCT02412722|11844888|FG005|Safety Population|Overall Study||13
10682100|NCT02412722|11844883|FG000|COMPLETED|Overall Study||0
10682101|NCT02412722|11844884|FG001|COMPLETED|Overall Study||0
10682102|NCT02412722|11844885|FG002|COMPLETED|Overall Study||0
10682103|NCT02412722|11844886|FG003|COMPLETED|Overall Study||0
10682104|NCT02412722|11844887|FG004|COMPLETED|Overall Study||0
10682105|NCT02412722|11844888|FG005|COMPLETED|Overall Study||0
10682106|NCT02412722|11844883|FG000|NOT COMPLETED|Overall Study||11
10682107|NCT02412722|11844884|FG001|NOT COMPLETED|Overall Study||8
10682108|NCT02412722|11844885|FG002|NOT COMPLETED|Overall Study||7
10682109|NCT02412722|11844886|FG003|NOT COMPLETED|Overall Study||15
10682110|NCT02412722|11844887|FG004|NOT COMPLETED|Overall Study||7
10682111|NCT02412722|11844888|FG005|NOT COMPLETED|Overall Study||13
10682112|NCT02412761|11844922|FG000|STARTED|First Intervention (2 Weeks)||5
10682113|NCT02412761|11844923|FG001|STARTED|First Intervention (2 Weeks)||6
10682114|NCT02412761|11844924|FG002|STARTED|First Intervention (2 Weeks)||5
10682115|NCT02412761|11844925|FG003|STARTED|First Intervention (2 Weeks)||8
10682116|NCT02412761|11844926|FG004|STARTED|First Intervention (2 Weeks)||4
10682117|NCT02412761|11844927|FG005|STARTED|First Intervention (2 Weeks)||7
10682118|NCT02412761|11844922|FG000|COMPLETED|First Intervention (2 Weeks)||5
10682119|NCT02412761|11844923|FG001|COMPLETED|First Intervention (2 Weeks)||5
10682120|NCT02412761|11844924|FG002|COMPLETED|First Intervention (2 Weeks)||4
10682121|NCT02412761|11844925|FG003|COMPLETED|First Intervention (2 Weeks)||8
10682122|NCT02412761|11844926|FG004|COMPLETED|First Intervention (2 Weeks)||4
10682123|NCT02412761|11844927|FG005|COMPLETED|First Intervention (2 Weeks)||6
10682124|NCT02412761|11844922|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
10682125|NCT02412761|11844923|FG001|NOT COMPLETED|First Intervention (2 Weeks)||1
10682126|NCT02412761|11844924|FG002|NOT COMPLETED|First Intervention (2 Weeks)||1
10682127|NCT02412761|11844925|FG003|NOT COMPLETED|First Intervention (2 Weeks)||0
10682128|NCT02412761|11844926|FG004|NOT COMPLETED|First Intervention (2 Weeks)||0
10682129|NCT02412761|11844927|FG005|NOT COMPLETED|First Intervention (2 Weeks)||1
10682130|NCT02412761|11844922|FG000|STARTED|Second Intervention (2 Weeks)||5
10682131|NCT02412761|11844923|FG001|STARTED|Second Intervention (2 Weeks)||5
10682132|NCT02412761|11844924|FG002|STARTED|Second Intervention (2 Weeks)||4
10682133|NCT02412761|11844925|FG003|STARTED|Second Intervention (2 Weeks)||8
10682134|NCT02412761|11844926|FG004|STARTED|Second Intervention (2 Weeks)||4
10682135|NCT02412761|11844927|FG005|STARTED|Second Intervention (2 Weeks)||6
10682136|NCT02412761|11844922|FG000|COMPLETED|Second Intervention (2 Weeks)||5
10682137|NCT02412761|11844923|FG001|COMPLETED|Second Intervention (2 Weeks)||5
10682138|NCT02412761|11844924|FG002|COMPLETED|Second Intervention (2 Weeks)||4
10682139|NCT02412761|11844925|FG003|COMPLETED|Second Intervention (2 Weeks)||8
10682140|NCT02412761|11844926|FG004|COMPLETED|Second Intervention (2 Weeks)||4
10682141|NCT02412761|11844927|FG005|COMPLETED|Second Intervention (2 Weeks)||6
10682142|NCT02412761|11844922|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
10682143|NCT02412761|11844923|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
10682144|NCT02412761|11844924|FG002|NOT COMPLETED|Second Intervention (2 Weeks)||0
10682145|NCT02412761|11844925|FG003|NOT COMPLETED|Second Intervention (2 Weeks)||0
10682146|NCT02412761|11844926|FG004|NOT COMPLETED|Second Intervention (2 Weeks)||0
10682147|NCT02412761|11844927|FG005|NOT COMPLETED|Second Intervention (2 Weeks)||0
10682148|NCT02412761|11844922|FG000|STARTED|Third Intervention (2 Weeks)||5
10682149|NCT02412761|11844923|FG001|STARTED|Third Intervention (2 Weeks)||5
10682150|NCT02412761|11844924|FG002|STARTED|Third Intervention (2 Weeks)||4
10682151|NCT02412761|11844925|FG003|STARTED|Third Intervention (2 Weeks)||8
10682152|NCT02412761|11844926|FG004|STARTED|Third Intervention (2 Weeks)||4
10682153|NCT02412761|11844927|FG005|STARTED|Third Intervention (2 Weeks)||6
10682154|NCT02412761|11844922|FG000|COMPLETED|Third Intervention (2 Weeks)||5
10682155|NCT02412761|11844923|FG001|COMPLETED|Third Intervention (2 Weeks)||5
10682156|NCT02412761|11844924|FG002|COMPLETED|Third Intervention (2 Weeks)||4
10682157|NCT02412761|11844925|FG003|COMPLETED|Third Intervention (2 Weeks)||8
10682158|NCT02412761|11844926|FG004|COMPLETED|Third Intervention (2 Weeks)||4
10682159|NCT02412761|11844927|FG005|COMPLETED|Third Intervention (2 Weeks)||6
10682160|NCT02412761|11844922|FG000|NOT COMPLETED|Third Intervention (2 Weeks)||0
10682161|NCT02412761|11844923|FG001|NOT COMPLETED|Third Intervention (2 Weeks)||0
10682162|NCT02412761|11844924|FG002|NOT COMPLETED|Third Intervention (2 Weeks)||0
10682163|NCT02412761|11844925|FG003|NOT COMPLETED|Third Intervention (2 Weeks)||0
10682164|NCT02412761|11844926|FG004|NOT COMPLETED|Third Intervention (2 Weeks)||0
10682165|NCT02412761|11844927|FG005|NOT COMPLETED|Third Intervention (2 Weeks)||0
10682166|NCT02412852|11844939|FG000|STARTED|Overall Study||4
10682167|NCT02412852|11844940|FG001|STARTED|Overall Study||8
10682168|NCT02412852|11844941|FG002|STARTED|Overall Study||5
10682169|NCT02412852|11844942|FG003|STARTED|Overall Study||9
10682170|NCT02412852|11844939|FG000|COMPLETED|Overall Study||4
10682171|NCT02412852|11844940|FG001|COMPLETED|Overall Study||7
10682172|NCT02412852|11844941|FG002|COMPLETED|Overall Study||5
10682173|NCT02412852|11844942|FG003|COMPLETED|Overall Study||8
10682174|NCT02412852|11844939|FG000|NOT COMPLETED|Overall Study||0
10682175|NCT02412852|11844940|FG001|NOT COMPLETED|Overall Study||1
10682176|NCT02412852|11844941|FG002|NOT COMPLETED|Overall Study||0
10682177|NCT02412852|11844942|FG003|NOT COMPLETED|Overall Study||1
10682186|NCT02412956|11844961|FG000|STARTED|Overall Study||44
10682187|NCT02412956|11844962|FG001|STARTED|Overall Study||47
10682188|NCT02412956|11844963|FG002|STARTED|Overall Study||8
10682189|NCT02412956|11844961|FG000|COMPLETED|Overall Study||35
10682190|NCT02412956|11844962|FG001|COMPLETED|Overall Study||30
10682191|NCT02412956|11844963|FG002|COMPLETED|Overall Study||8
10682192|NCT02412956|11844961|FG000|NOT COMPLETED|Overall Study||9
10682193|NCT02412956|11844962|FG001|NOT COMPLETED|Overall Study||17
10682194|NCT02412956|11844963|FG002|NOT COMPLETED|Overall Study||0
10682195|NCT02412982|11844971|FG000|STARTED|Primary Endpoint||51
10682196|NCT02412982|11844972|FG001|STARTED|Primary Endpoint||52
10682197|NCT02412982|11844971|FG000|COMPLETED|Primary Endpoint||47
10682198|NCT02412982|11844972|FG001|COMPLETED|Primary Endpoint||49
10682199|NCT02412982|11844971|FG000|NOT COMPLETED|Primary Endpoint||4
10682200|NCT02412982|11844972|FG001|NOT COMPLETED|Primary Endpoint||3
10682201|NCT02412982|11844971|FG000|STARTED|Intervention Group: Randomization|Control group patients did not undergo randomization (see study protocol section)|0
10682202|NCT02412982|11844972|FG001|STARTED|Intervention Group: Randomization|52 patients in the intervention group underwent 1:1 randomization to the two intervention study arms: 26 patients in 40 mg every 12 hours with escalation to 50 mg every 12 hours and 26 patients in 30 mg every 8 hours.|52
10682203|NCT02412982|11844971|FG000|COMPLETED|Intervention Group: Randomization||0
10682204|NCT02412982|11844972|FG001|COMPLETED|Intervention Group: Randomization||51
10682205|NCT02412982|11844971|FG000|NOT COMPLETED|Intervention Group: Randomization||0
10682206|NCT02412982|11844972|FG001|NOT COMPLETED|Intervention Group: Randomization||1
10682207|NCT02413008|11844980|FG000|STARTED|Overall Study||50
10682208|NCT02413008|11844981|FG001|STARTED|Overall Study||11
10682209|NCT02413008|11844980|FG000|COMPLETED|Overall Study||43
10682210|NCT02413008|11844981|FG001|COMPLETED|Overall Study||9
10682211|NCT02413008|11844980|FG000|NOT COMPLETED|Overall Study||7
10682212|NCT02413008|11844981|FG001|NOT COMPLETED|Overall Study||2
10682213|NCT02413034|11844992|FG000|STARTED|Overall Study||14
10682214|NCT02413034|11844993|FG001|STARTED|Overall Study||14
10682215|NCT02413034|11844992|FG000|COMPLETED|Overall Study||14
10682216|NCT02413034|11844993|FG001|COMPLETED|Overall Study||14
10682217|NCT02413034|11844992|FG000|NOT COMPLETED|Overall Study||0
10682218|NCT02413034|11844993|FG001|NOT COMPLETED|Overall Study||0
10682219|NCT02413151|11845001|FG000|STARTED|Overall Study||32
10682220|NCT02413151|11845002|FG001|STARTED|Overall Study||30
10682221|NCT02413151|11845001|FG000|COMPLETED|Overall Study||22
10682222|NCT02413151|11845002|FG001|COMPLETED|Overall Study||28
10682223|NCT02413151|11845001|FG000|NOT COMPLETED|Overall Study||10
10682224|NCT02413151|11845002|FG001|NOT COMPLETED|Overall Study||2
10682225|NCT02413190|11845009|FG000|STARTED|Overall Study||94
10682226|NCT02413190|11845009|FG000|COMPLETED|Overall Study||94
10682227|NCT02413190|11845009|FG000|NOT COMPLETED|Overall Study||0
10682228|NCT02413203|11845015|FG000|STARTED|Overall Study||10
10682229|NCT02413203|11845016|FG001|STARTED|Overall Study||10
10682230|NCT02413203|11845015|FG000|COMPLETED|Overall Study||10
10682231|NCT02413203|11845016|FG001|COMPLETED|Overall Study||10
10682232|NCT02413203|11845015|FG000|NOT COMPLETED|Overall Study||0
10682233|NCT02413203|11845016|FG001|NOT COMPLETED|Overall Study||0
10682234|NCT02413229|11845030|FG000|STARTED|Overall Study||25
10682235|NCT02413229|11845031|FG001|STARTED|Overall Study||12
10682236|NCT02413229|11845032|FG002|STARTED|Overall Study||26
10682237|NCT02413229|11845033|FG003|STARTED|Overall Study||12
10682238|NCT02413229|11845034|FG004|STARTED|Overall Study||24
10682239|NCT02413229|11845035|FG005|STARTED|Overall Study||12
10682240|NCT02413229|11845036|FG006|STARTED|Overall Study||25
10682241|NCT02413229|11845037|FG007|STARTED|Overall Study||15
10682242|NCT02413229|11845030|FG000|COMPLETED|Overall Study||24
10682243|NCT02413229|11845031|FG001|COMPLETED|Overall Study||11
10682244|NCT02413229|11845032|FG002|COMPLETED|Overall Study||25
10682245|NCT02413229|11845033|FG003|COMPLETED|Overall Study||11
10682246|NCT02413229|11845034|FG004|COMPLETED|Overall Study||21
10682247|NCT02413229|11845035|FG005|COMPLETED|Overall Study||12
10682248|NCT02413229|11845036|FG006|COMPLETED|Overall Study||25
10682249|NCT02413229|11845037|FG007|COMPLETED|Overall Study||11
10682250|NCT02413229|11845030|FG000|NOT COMPLETED|Overall Study||1
10682251|NCT02413229|11845031|FG001|NOT COMPLETED|Overall Study||1
10682252|NCT02413229|11845032|FG002|NOT COMPLETED|Overall Study||1
10682253|NCT02413229|11845033|FG003|NOT COMPLETED|Overall Study||1
10682254|NCT02413229|11845034|FG004|NOT COMPLETED|Overall Study||3
10682255|NCT02413229|11845035|FG005|NOT COMPLETED|Overall Study||0
10682256|NCT02413229|11845036|FG006|NOT COMPLETED|Overall Study||0
10682257|NCT02413229|11845037|FG007|NOT COMPLETED|Overall Study||4
10682258|NCT02413255|11845072|FG000|STARTED|Overall Study||18
10682259|NCT02413255|11845073|FG001|STARTED|Overall Study||6
10682260|NCT02413255|11845074|FG002|STARTED|Overall Study||6
10682261|NCT02413255|11845075|FG003|STARTED|Overall Study||6
10682262|NCT02413255|11845076|FG004|STARTED|Overall Study||6
10682263|NCT02413255|11845077|FG005|STARTED|Overall Study||6
10682264|NCT02413255|11845078|FG006|STARTED|Overall Study||6
10682265|NCT02413255|11845079|FG007|STARTED|Overall Study||6
10682266|NCT02413255|11845080|FG008|STARTED|Overall Study||6
10682267|NCT02413255|11845081|FG009|STARTED|Overall Study||6
10682268|NCT02413255|11845082|FG010|STARTED|Overall Study||12
10682269|NCT02413255|11845083|FG011|STARTED|Overall Study||6
10682270|NCT02413255|11845084|FG012|STARTED|Overall Study||6
10682271|NCT02413255|11845085|FG013|STARTED|Overall Study||6
10682272|NCT02413255|11845086|FG014|STARTED|Overall Study||6
10682273|NCT02413255|11845087|FG015|STARTED|Overall Study||6
10682274|NCT02413255|11845088|FG016|STARTED|Overall Study||6
10682275|NCT02413255|11845072|FG000|COMPLETED|Overall Study||18
10682276|NCT02413255|11845073|FG001|COMPLETED|Overall Study||6
10682277|NCT02413255|11845074|FG002|COMPLETED|Overall Study||6
10682278|NCT02413255|11845075|FG003|COMPLETED|Overall Study||6
10682279|NCT02413255|11845076|FG004|COMPLETED|Overall Study||6
10682280|NCT02413255|11845077|FG005|COMPLETED|Overall Study||6
10682281|NCT02413255|11845078|FG006|COMPLETED|Overall Study||6
10682282|NCT02413255|11845079|FG007|COMPLETED|Overall Study||6
10682283|NCT02413255|11845080|FG008|COMPLETED|Overall Study||6
10682284|NCT02413255|11845081|FG009|COMPLETED|Overall Study||6
10682285|NCT02413255|11845082|FG010|COMPLETED|Overall Study||12
10682286|NCT02413255|11845083|FG011|COMPLETED|Overall Study||6
10682287|NCT02413255|11845084|FG012|COMPLETED|Overall Study||6
10682288|NCT02413255|11845085|FG013|COMPLETED|Overall Study||6
10682289|NCT02413255|11845086|FG014|COMPLETED|Overall Study||5
10682290|NCT02413255|11845087|FG015|COMPLETED|Overall Study||6
10682291|NCT02413255|11845088|FG016|COMPLETED|Overall Study||6
10682292|NCT02413255|11845072|FG000|NOT COMPLETED|Overall Study||0
10682293|NCT02413255|11845073|FG001|NOT COMPLETED|Overall Study||0
10682294|NCT02413255|11845074|FG002|NOT COMPLETED|Overall Study||0
10682295|NCT02413255|11845075|FG003|NOT COMPLETED|Overall Study||0
10682296|NCT02413255|11845076|FG004|NOT COMPLETED|Overall Study||0
10682297|NCT02413255|11845077|FG005|NOT COMPLETED|Overall Study||0
10682298|NCT02413255|11845078|FG006|NOT COMPLETED|Overall Study||0
10682299|NCT02413255|11845079|FG007|NOT COMPLETED|Overall Study||0
10682300|NCT02413255|11845080|FG008|NOT COMPLETED|Overall Study||0
10682301|NCT02413255|11845081|FG009|NOT COMPLETED|Overall Study||0
10682302|NCT02413255|11845082|FG010|NOT COMPLETED|Overall Study||0
10682303|NCT02413255|11845083|FG011|NOT COMPLETED|Overall Study||0
10682304|NCT02413255|11845084|FG012|NOT COMPLETED|Overall Study||0
10682305|NCT02413255|11845085|FG013|NOT COMPLETED|Overall Study||0
10682306|NCT02413255|11845086|FG014|NOT COMPLETED|Overall Study||1
10682307|NCT02413255|11845087|FG015|NOT COMPLETED|Overall Study||0
10682308|NCT02413255|11845088|FG016|NOT COMPLETED|Overall Study||0
10682309|NCT02413294|11845139|FG000|STARTED|Overall Study||12
10682310|NCT02413294|11845139|FG000|COMPLETED|Overall Study||11
10682311|NCT02413294|11845139|FG000|NOT COMPLETED|Overall Study||1
10682312|NCT02413320|11845145|FG000|STARTED|Overall Study||49
10682313|NCT02413320|11845146|FG001|STARTED|Overall Study||52
10682314|NCT02413320|11845145|FG000|COMPLETED|Overall Study||48
10799047|NCT03926039|11959643|FG000|STARTED|Overall Study||35
10799048|NCT03926039|11959644|FG001|STARTED|Overall Study||35
10799049|NCT03926039|11959643|FG000|COMPLETED|Overall Study||35
10799050|NCT03926039|11959644|FG001|COMPLETED|Overall Study||34
10799051|NCT03926039|11959643|FG000|NOT COMPLETED|Overall Study||0
10799052|NCT03926039|11959644|FG001|NOT COMPLETED|Overall Study||1
10799053|NCT03927911|11959656|FG000|STARTED|Overall Study||0
10799054|NCT03927911|11959657|FG001|STARTED|Overall Study||17
10682315|NCT02413320|11845146|FG001|COMPLETED|Overall Study||52
10682316|NCT02413320|11845145|FG000|NOT COMPLETED|Overall Study||1
10682317|NCT02413320|11845146|FG001|NOT COMPLETED|Overall Study||0
10682318|NCT02413333|11845156|FG000|STARTED|Period 1||66
10682319|NCT02413333|11845157|FG001|STARTED|Period 1||66
10682320|NCT02413333|11845156|FG000|Randomized and Treated|Period 1||66
10682321|NCT02413333|11845157|FG001|Randomized and Treated|Period 1||66
10682322|NCT02413333|11845156|FG000|COMPLETED|Period 1||65
10682323|NCT02413333|11845157|FG001|COMPLETED|Period 1||65
10682324|NCT02413333|11845156|FG000|NOT COMPLETED|Period 1||1
10682325|NCT02413333|11845157|FG001|NOT COMPLETED|Period 1||1
10682326|NCT02413333|11845156|FG000|STARTED|Period 2||65
10682327|NCT02413333|11845157|FG001|STARTED|Period 2||65
10682328|NCT02413333|11845156|FG000|COMPLETED|Period 2||64
10682329|NCT02413333|11845157|FG001|COMPLETED|Period 2||65
10682330|NCT02413333|11845156|FG000|NOT COMPLETED|Period 2||1
10682331|NCT02413333|11845157|FG001|NOT COMPLETED|Period 2||0
10712927|NCT02675634|11878499|FG004|COMPLETED|Test Period 1||10
10712928|NCT02675634|11878500|FG005|COMPLETED|Test Period 1||9
10712929|NCT02675634|11878495|FG000|NOT COMPLETED|Test Period 1||0
10712930|NCT02675634|11878496|FG001|NOT COMPLETED|Test Period 1||1
10712931|NCT02675634|11878497|FG002|NOT COMPLETED|Test Period 1||1
10712932|NCT02675634|11878498|FG003|NOT COMPLETED|Test Period 1||1
10712933|NCT02675634|11878499|FG004|NOT COMPLETED|Test Period 1||0
10712934|NCT02675634|11878500|FG005|NOT COMPLETED|Test Period 1||0
10712935|NCT02675634|11878495|FG000|STARTED|Test Period 2||10
10712936|NCT02675634|11878496|FG001|STARTED|Test Period 2||7
10712937|NCT02675634|11878497|FG002|STARTED|Test Period 2||8
10712938|NCT02675634|11878498|FG003|STARTED|Test Period 2||8
10712939|NCT02675634|11878499|FG004|STARTED|Test Period 2||10
10712940|NCT02675634|11878500|FG005|STARTED|Test Period 2||9
10712941|NCT02675634|11878495|FG000|COMPLETED|Test Period 2||9
10712942|NCT02675634|11878496|FG001|COMPLETED|Test Period 2||7
10712943|NCT02675634|11878497|FG002|COMPLETED|Test Period 2||8
10712944|NCT02675634|11878498|FG003|COMPLETED|Test Period 2||8
10712945|NCT02675634|11878499|FG004|COMPLETED|Test Period 2||10
10712946|NCT02675634|11878500|FG005|COMPLETED|Test Period 2||8
10712947|NCT02675634|11878495|FG000|NOT COMPLETED|Test Period 2||1
10712948|NCT02675634|11878496|FG001|NOT COMPLETED|Test Period 2||0
10712949|NCT02675634|11878497|FG002|NOT COMPLETED|Test Period 2||0
10712950|NCT02675634|11878498|FG003|NOT COMPLETED|Test Period 2||0
10712951|NCT02675634|11878499|FG004|NOT COMPLETED|Test Period 2||0
10712952|NCT02675634|11878500|FG005|NOT COMPLETED|Test Period 2||1
10712953|NCT02675634|11878495|FG000|STARTED|Test Period 3||9
10712954|NCT02675634|11878496|FG001|STARTED|Test Period 3||7
10712955|NCT02675634|11878497|FG002|STARTED|Test Period 3||8
10799055|NCT03927911|11959658|FG002|STARTED|Overall Study||0
10712956|NCT02675634|11878498|FG003|STARTED|Test Period 3||8
10712957|NCT02675634|11878499|FG004|STARTED|Test Period 3||10
10712958|NCT02675634|11878500|FG005|STARTED|Test Period 3||8
10712959|NCT02675634|11878495|FG000|COMPLETED|Test Period 3||9
10712960|NCT02675634|11878496|FG001|COMPLETED|Test Period 3||7
10712961|NCT02675634|11878497|FG002|COMPLETED|Test Period 3||8
10712962|NCT02675634|11878498|FG003|COMPLETED|Test Period 3||8
10712963|NCT02675634|11878499|FG004|COMPLETED|Test Period 3||10
10712964|NCT02675634|11878500|FG005|COMPLETED|Test Period 3||8
10682332|NCT02413346|11845165|FG000|STARTED|Overall Study||236
10682333|NCT02413346|11845166|FG001|STARTED|Overall Study||247
10682334|NCT02413346|11845165|FG000|COMPLETED|Overall Study||177
10682335|NCT02413346|11845166|FG001|COMPLETED|Overall Study||177
10682336|NCT02413346|11845165|FG000|NOT COMPLETED|Overall Study||59
10682337|NCT02413346|11845166|FG001|NOT COMPLETED|Overall Study||70
10682338|NCT02413372|11845175|FG000|STARTED|Treatment||25
10682339|NCT02413372|11845176|FG001|STARTED|Treatment||24
10682340|NCT02413372|11845177|FG002|STARTED|Treatment||26
10682341|NCT02413372|11845175|FG000|COMPLETED|Treatment||24
10682342|NCT02413372|11845176|FG001|COMPLETED|Treatment||22
10682343|NCT02413372|11845177|FG002|COMPLETED|Treatment||25
10682344|NCT02413372|11845175|FG000|NOT COMPLETED|Treatment||1
10682345|NCT02413372|11845176|FG001|NOT COMPLETED|Treatment||2
10682346|NCT02413372|11845177|FG002|NOT COMPLETED|Treatment||1
10682347|NCT02413372|11845175|FG000|STARTED|Follow-up||22
10682348|NCT02413372|11845176|FG001|STARTED|Follow-up||21
10682349|NCT02413372|11845177|FG002|STARTED|Follow-up||25
10682350|NCT02413372|11845175|FG000|COMPLETED|Follow-up||20
10682351|NCT02413372|11845176|FG001|COMPLETED|Follow-up||20
10682352|NCT02413372|11845177|FG002|COMPLETED|Follow-up||23
10682353|NCT02413372|11845175|FG000|NOT COMPLETED|Follow-up||2
10682354|NCT02413372|11845176|FG001|NOT COMPLETED|Follow-up||1
10682355|NCT02413372|11845177|FG002|NOT COMPLETED|Follow-up||2
10682356|NCT02413398|11845187|FG000|STARTED|Overall Study||160
10682357|NCT02413398|11845188|FG001|STARTED|Overall Study||161
10682358|NCT02413398|11845187|FG000|COMPLETED|Overall Study||156
10682359|NCT02413398|11845188|FG001|COMPLETED|Overall Study||154
10682360|NCT02413398|11845187|FG000|NOT COMPLETED|Overall Study||4
10682361|NCT02413398|11845188|FG001|NOT COMPLETED|Overall Study||7
10682362|NCT02413463|11845196|FG000|STARTED|Overall Study||30
10682363|NCT02413463|11845197|FG001|STARTED|Overall Study||30
10682364|NCT02413463|11845196|FG000|COMPLETED|Overall Study||25
10682365|NCT02413463|11845197|FG001|COMPLETED|Overall Study||28
10682366|NCT02413463|11845196|FG000|NOT COMPLETED|Overall Study||5
10682367|NCT02413463|11845197|FG001|NOT COMPLETED|Overall Study||2
10682368|NCT02413489|11845206|FG000|STARTED|Overall Study||15
10682369|NCT02413489|11845207|FG001|STARTED|Overall Study||16
10682370|NCT02413489|11845208|FG002|STARTED|Overall Study||5
10682371|NCT02413489|11845206|FG000|COMPLETED|Overall Study||0
10682372|NCT02413489|11845207|FG001|COMPLETED|Overall Study||0
10682373|NCT02413489|11845208|FG002|COMPLETED|Overall Study||0
10682374|NCT02413489|11845206|FG000|NOT COMPLETED|Overall Study||15
10682375|NCT02413489|11845207|FG001|NOT COMPLETED|Overall Study||16
10682376|NCT02413489|11845208|FG002|NOT COMPLETED|Overall Study||5
10682377|NCT02413580|11845216|FG000|STARTED|Overall Study||49
10682378|NCT02413580|11845216|FG000|COMPLETED|Overall Study||46
10682379|NCT02413580|11845216|FG000|NOT COMPLETED|Overall Study||3
10682380|NCT02413593|11845220|FG000|STARTED|Overall Study||111
10682381|NCT02413593|11845220|FG000|COMPLETED|Overall Study||107
10682382|NCT02413593|11845220|FG000|NOT COMPLETED|Overall Study||4
10682383|NCT02413684|11845224|FG000|STARTED|Overall Study||53
10682384|NCT02413684|11845224|FG000|COMPLETED|Overall Study||40
10682385|NCT02413684|11845224|FG000|NOT COMPLETED|Overall Study||13
10682386|NCT02413879|11845228|FG000|STARTED|Overall Study||86
10682387|NCT02413879|11845228|FG000|COMPLETED|Overall Study||86
10682388|NCT02413879|11845228|FG000|NOT COMPLETED|Overall Study||0
10682389|NCT02413918|11845232|FG000|STARTED|Overall Study||41
10682390|NCT02413918|11845232|FG000|COMPLETED|Overall Study||16
10682391|NCT02413918|11845232|FG000|NOT COMPLETED|Overall Study||25
10682392|NCT02413996|11845241|FG000|STARTED|Overall Study||44
10682393|NCT02413996|11845242|FG001|STARTED|Overall Study||41
10682394|NCT02413996|11845241|FG000|COMPLETED|Overall Study||35
10682395|NCT02413996|11845242|FG001|COMPLETED|Overall Study||39
10682396|NCT02413996|11845241|FG000|NOT COMPLETED|Overall Study||9
10682397|NCT02413996|11845242|FG001|NOT COMPLETED|Overall Study||2
10682398|NCT02414204|11845250|FG000|STARTED|Overall Study||2
10682399|NCT02414204|11845251|FG001|STARTED|Overall Study||2
10682400|NCT02414204|11845250|FG000|COMPLETED|Overall Study||2
10682401|NCT02414204|11845251|FG001|COMPLETED|Overall Study||2
10682402|NCT02414204|11845250|FG000|NOT COMPLETED|Overall Study||0
10682403|NCT02414204|11845251|FG001|NOT COMPLETED|Overall Study||0
10682404|NCT02414243|11845259|FG000|STARTED|Overall Study||19
10682405|NCT02414243|11845260|FG001|STARTED|Overall Study||21
10682406|NCT02414243|11845259|FG000|Moved to the Other Group|Overall Study||17
10682407|NCT02414243|11845260|FG001|Moved to the Other Group|Overall Study||20
10682408|NCT02414243|11845259|FG000|Entered Open Challenge at Home|Overall Study||17
10682409|NCT02414243|11845260|FG001|Entered Open Challenge at Home|Overall Study||20
10682410|NCT02414243|11845259|FG000|COMPLETED|Overall Study||13
10682411|NCT02414243|11845260|FG001|COMPLETED|Overall Study||17
10682412|NCT02414243|11845259|FG000|NOT COMPLETED|Overall Study||6
10682413|NCT02414243|11845260|FG001|NOT COMPLETED|Overall Study||4
10682414|NCT02414633|11845267|FG000|STARTED|Overall Study||148
10682415|NCT02414633|11845267|FG000|COMPLETED|Overall Study||148
10682416|NCT02414633|11845267|FG000|NOT COMPLETED|Overall Study||0
10682417|NCT02414828|11845275|FG000|STARTED|Overall Study||11
10682418|NCT02414828|11845276|FG001|STARTED|Overall Study||10
10682419|NCT02414828|11845277|FG002|STARTED|Overall Study||20
10682420|NCT02414828|11845278|FG003|STARTED|Overall Study||31
10682421|NCT02414828|11845275|FG000|COMPLETED|Overall Study||11
10682422|NCT02414828|11845276|FG001|COMPLETED|Overall Study||9
10682423|NCT02414828|11845277|FG002|COMPLETED|Overall Study||19
10682424|NCT02414828|11845278|FG003|COMPLETED|Overall Study||29
10682425|NCT02414828|11845275|FG000|NOT COMPLETED|Overall Study||0
10682426|NCT02414828|11845276|FG001|NOT COMPLETED|Overall Study||1
10682427|NCT02414828|11845277|FG002|NOT COMPLETED|Overall Study||1
10682428|NCT02414828|11845278|FG003|NOT COMPLETED|Overall Study||2
10682429|NCT02414841|11845291|FG000|STARTED|Overall Study||405
10682430|NCT02414841|11845292|FG001|STARTED|Overall Study||208
10682431|NCT02414841|11845291|FG000|COMPLETED|Overall Study||349
10682432|NCT02414841|11845292|FG001|COMPLETED|Overall Study||175
10682433|NCT02414841|11845291|FG000|NOT COMPLETED|Overall Study||56
10682434|NCT02414841|11845292|FG001|NOT COMPLETED|Overall Study||33
10682435|NCT02414854|11845304|FG000|STARTED|Overall Study||317
10682436|NCT02414854|11845305|FG001|STARTED|Overall Study||631
10682437|NCT02414854|11845306|FG002|STARTED|Overall Study||321
10682438|NCT02414854|11845307|FG003|STARTED|Overall Study||633
10682439|NCT02414854|11845304|FG000|Treated|Overall Study|2 got other treatment (1 each dupilumab 200+300) than assigned + were allocated to those in AE table|315
10682440|NCT02414854|11845305|FG001|Treated|Overall Study||629
10682441|NCT02414854|11845306|FG002|Treated|Overall Study||321
10682442|NCT02414854|11845307|FG003|Treated|Overall Study|1 got other treatment (dupilumab 200) than assigned + was allocated to that in AE table|632
10682443|NCT02414854|11845304|FG000|COMPLETED|Overall Study||295
10682444|NCT02414854|11845305|FG001|COMPLETED|Overall Study||586
10682445|NCT02414854|11845306|FG002|COMPLETED|Overall Study||301
10682446|NCT02414854|11845307|FG003|COMPLETED|Overall Study||582
10682447|NCT02414854|11845304|FG000|NOT COMPLETED|Overall Study||22
10682448|NCT02414854|11845305|FG001|NOT COMPLETED|Overall Study||45
10682449|NCT02414854|11845306|FG002|NOT COMPLETED|Overall Study||20
10682450|NCT02414854|11845307|FG003|NOT COMPLETED|Overall Study||51
10682451|NCT02414932|11845319|FG000|STARTED|Overall Study||3
10682452|NCT02414932|11845320|FG001|STARTED|Overall Study||3
10682453|NCT02414932|11845319|FG000|COMPLETED|Overall Study||0
10682454|NCT02414932|11845320|FG001|COMPLETED|Overall Study||0
10682455|NCT02414932|11845319|FG000|NOT COMPLETED|Overall Study||3
10682456|NCT02414932|11845320|FG001|NOT COMPLETED|Overall Study||3
10682457|NCT02414958|11845329|FG000|STARTED|Overall Study||243
10682458|NCT02414958|11845330|FG001|STARTED|Overall Study||243
10682459|NCT02414958|11845331|FG002|STARTED|Overall Study||244
10682460|NCT02414958|11845329|FG000|COMPLETED|Overall Study||211
10682461|NCT02414958|11845330|FG001|COMPLETED|Overall Study||223
10682462|NCT02414958|11845331|FG002|COMPLETED|Overall Study||230
10682463|NCT02414958|11845329|FG000|NOT COMPLETED|Overall Study||32
10682464|NCT02414958|11845330|FG001|NOT COMPLETED|Overall Study||20
10682465|NCT02414958|11845331|FG002|NOT COMPLETED|Overall Study||14
10682466|NCT02415127|11845341|FG000|STARTED|Overall Study||47
10682467|NCT02415127|11845342|FG001|STARTED|Overall Study||45
10682468|NCT02415127|11845341|FG000|COMPLETED|Overall Study||46
10682469|NCT02415127|11845342|FG001|COMPLETED|Overall Study||45
10682470|NCT02415127|11845341|FG000|NOT COMPLETED|Overall Study||1
10682471|NCT02415127|11845342|FG001|NOT COMPLETED|Overall Study||0
10682472|NCT02415244|11845350|FG000|STARTED|Overall Study||50
10682473|NCT02415244|11845351|FG001|STARTED|Overall Study||25
10682474|NCT02415244|11845350|FG000|COMPLETED|Overall Study||50
10682475|NCT02415244|11845351|FG001|COMPLETED|Overall Study||25
10682476|NCT02415244|11845350|FG000|NOT COMPLETED|Overall Study||0
10682477|NCT02415244|11845351|FG001|NOT COMPLETED|Overall Study||0
10682478|NCT02415400|11845361|FG000|STARTED|Overall Study||1153
10682479|NCT02415400|11845362|FG001|STARTED|Overall Study||1153
10682480|NCT02415400|11845363|FG002|STARTED|Overall Study||1154
10682481|NCT02415400|11845364|FG003|STARTED|Overall Study||1154
10682482|NCT02415400|11845361|FG000|COMPLETED|Overall Study||1087
10682483|NCT02415400|11845362|FG001|COMPLETED|Overall Study||1091
10682484|NCT02415400|11845363|FG002|COMPLETED|Overall Study||1069
10682485|NCT02415400|11845364|FG003|COMPLETED|Overall Study||1071
10682486|NCT02415400|11845361|FG000|NOT COMPLETED|Overall Study||66
10682487|NCT02415400|11845362|FG001|NOT COMPLETED|Overall Study||62
10682488|NCT02415400|11845363|FG002|NOT COMPLETED|Overall Study||85
10682489|NCT02415400|11845364|FG003|NOT COMPLETED|Overall Study||83
10682490|NCT02415439|11845391|FG000|STARTED|Overall Study||6
10682491|NCT02415439|11845392|FG001|STARTED|Overall Study||6
10682492|NCT02415439|11845393|FG002|STARTED|Overall Study||6
10682493|NCT02415439|11845394|FG003|STARTED|Overall Study||6
10682494|NCT02415439|11845395|FG004|STARTED|Overall Study||6
10682495|NCT02415439|11845396|FG005|STARTED|Overall Study||6
10682496|NCT02415439|11845397|FG006|STARTED|Overall Study||6
10682497|NCT02415439|11845398|FG007|STARTED|Overall Study||12
10682498|NCT02415439|11845399|FG008|STARTED|Overall Study||6
10682499|NCT02415439|11845400|FG009|STARTED|Overall Study||6
10682500|NCT02415439|11845401|FG010|STARTED|Overall Study||6
10682501|NCT02415439|11845402|FG011|STARTED|Overall Study||6
10682502|NCT02415439|11845403|FG012|STARTED|Overall Study||8
10682503|NCT02415439|11845391|FG000|COMPLETED|Overall Study||6
10682504|NCT02415439|11845392|FG001|COMPLETED|Overall Study||6
10682505|NCT02415439|11845393|FG002|COMPLETED|Overall Study||6
10682506|NCT02415439|11845394|FG003|COMPLETED|Overall Study||6
10682507|NCT02415439|11845395|FG004|COMPLETED|Overall Study||6
10682508|NCT02415439|11845396|FG005|COMPLETED|Overall Study||6
10682509|NCT02415439|11845397|FG006|COMPLETED|Overall Study||6
10682510|NCT02415439|11845398|FG007|COMPLETED|Overall Study||12
10682511|NCT02415439|11845399|FG008|COMPLETED|Overall Study||5
10682512|NCT02415439|11845400|FG009|COMPLETED|Overall Study||6
10682513|NCT02415439|11845401|FG010|COMPLETED|Overall Study||6
10682514|NCT02415439|11845402|FG011|COMPLETED|Overall Study||6
10682515|NCT02415439|11845403|FG012|COMPLETED|Overall Study||8
10682516|NCT02415439|11845391|FG000|NOT COMPLETED|Overall Study||0
10682517|NCT02415439|11845392|FG001|NOT COMPLETED|Overall Study||0
10682518|NCT02415439|11845393|FG002|NOT COMPLETED|Overall Study||0
10682519|NCT02415439|11845394|FG003|NOT COMPLETED|Overall Study||0
10682520|NCT02415439|11845395|FG004|NOT COMPLETED|Overall Study||0
10682521|NCT02415439|11845396|FG005|NOT COMPLETED|Overall Study||0
10799056|NCT03927911|11959659|FG003|STARTED|Overall Study||3
10799057|NCT03927911|11959660|FG004|STARTED|Overall Study||13
10799058|NCT03927911|11959661|FG005|STARTED|Overall Study||32
10799059|NCT03927911|11959656|FG000|COMPLETED|Overall Study||0
10318849|NCT00218023|11453112|FG001|STARTED|Overall Study||25
10318850|NCT00218023|11453113|FG002|STARTED|Overall Study||16
10318851|NCT00218023|11453114|FG003|STARTED|Overall Study||18
10318852|NCT00218023|11453111|FG000|Received Drug or Placebo in Phase II|Overall Study||18
10318853|NCT00218023|11453112|FG001|Received Drug or Placebo in Phase II|Overall Study||24
10682522|NCT02415439|11845397|FG006|NOT COMPLETED|Overall Study||0
10682523|NCT02415439|11845398|FG007|NOT COMPLETED|Overall Study||0
10682524|NCT02415439|11845399|FG008|NOT COMPLETED|Overall Study||1
10682525|NCT02415439|11845400|FG009|NOT COMPLETED|Overall Study||0
10682526|NCT02415439|11845401|FG010|NOT COMPLETED|Overall Study||0
10682527|NCT02415439|11845402|FG011|NOT COMPLETED|Overall Study||0
10682528|NCT02415439|11845403|FG012|NOT COMPLETED|Overall Study||0
10682529|NCT02415595|11845437|FG000|STARTED|Overall Study||50
10682530|NCT02415595|11845438|FG001|STARTED|Overall Study||52
10682531|NCT02415595|11845439|FG002|STARTED|Overall Study||51
10682532|NCT02415595|11845440|FG003|STARTED|Overall Study||53
10682533|NCT02415595|11845437|FG000|COMPLETED|Overall Study||0
10682534|NCT02415595|11845438|FG001|COMPLETED|Overall Study||0
10682535|NCT02415595|11845439|FG002|COMPLETED|Overall Study||0
10682536|NCT02415595|11845440|FG003|COMPLETED|Overall Study||0
10682537|NCT02415595|11845437|FG000|NOT COMPLETED|Overall Study||50
10682538|NCT02415595|11845438|FG001|NOT COMPLETED|Overall Study||52
10682539|NCT02415595|11845439|FG002|NOT COMPLETED|Overall Study||51
10682540|NCT02415595|11845440|FG003|NOT COMPLETED|Overall Study||53
10682541|NCT02415608|11845453|FG000|STARTED|Overall Study||3
10682542|NCT02415608|11845454|FG001|STARTED|Overall Study||1
10682543|NCT02415608|11845453|FG000|COMPLETED|Overall Study||3
10682544|NCT02415608|11845454|FG001|COMPLETED|Overall Study||1
10682545|NCT02415608|11845453|FG000|NOT COMPLETED|Overall Study||0
10318854|NCT00218023|11453113|FG002|Received Drug or Placebo in Phase II|Overall Study||15
10318855|NCT00218023|11453114|FG003|Received Drug or Placebo in Phase II|Overall Study||18
10318856|NCT00218023|11453111|FG000|COMPLETED|Overall Study||9
10318857|NCT00218023|11453112|FG001|COMPLETED|Overall Study||10
10318858|NCT00218023|11453113|FG002|COMPLETED|Overall Study||6
10318859|NCT00218023|11453114|FG003|COMPLETED|Overall Study||11
10318860|NCT00218023|11453111|FG000|NOT COMPLETED|Overall Study||13
10318861|NCT00218023|11453112|FG001|NOT COMPLETED|Overall Study||15
10318862|NCT00218023|11453113|FG002|NOT COMPLETED|Overall Study||10
10318863|NCT00218023|11453114|FG003|NOT COMPLETED|Overall Study||7
10318864|NCT00218062|11453128|FG000|STARTED|Overall Study||22
10318865|NCT00218062|11453129|FG001|STARTED|Overall Study||20
10318866|NCT00218062|11453130|FG002|STARTED|Overall Study||15
10318867|NCT00218062|11453131|FG003|STARTED|Overall Study||16
10318868|NCT00218062|11453128|FG000|Received First Dose of Study Medication|Overall Study||16
10318869|NCT00218062|11453129|FG001|Received First Dose of Study Medication|Overall Study||11
10318870|NCT00218062|11453130|FG002|Received First Dose of Study Medication|Overall Study||10
10318871|NCT00218062|11453131|FG003|Received First Dose of Study Medication|Overall Study||12
10318872|NCT00218062|11453128|FG000|COMPLETED|Overall Study||7
10318873|NCT00218062|11453129|FG001|COMPLETED|Overall Study||4
10318874|NCT00218062|11453130|FG002|COMPLETED|Overall Study||3
10318875|NCT00218062|11453131|FG003|COMPLETED|Overall Study||3
10318876|NCT00218062|11453128|FG000|NOT COMPLETED|Overall Study||15
10318877|NCT00218062|11453129|FG001|NOT COMPLETED|Overall Study||16
10318878|NCT00218062|11453130|FG002|NOT COMPLETED|Overall Study||12
10318879|NCT00218062|11453131|FG003|NOT COMPLETED|Overall Study||13
10318880|NCT00218257|11453141|FG000|STARTED|Intervention 1||23
10318881|NCT00218257|11453142|FG001|STARTED|Intervention 1||22
10318882|NCT00218257|11453141|FG000|COMPLETED|Intervention 1||23
10318883|NCT00218257|11453142|FG001|COMPLETED|Intervention 1||22
10318884|NCT00218257|11453141|FG000|NOT COMPLETED|Intervention 1||0
10318885|NCT00218257|11453142|FG001|NOT COMPLETED|Intervention 1||0
10318886|NCT00218257|11453141|FG000|STARTED|Period Between Visit 1 and 2||23
10318887|NCT00218257|11453142|FG001|STARTED|Period Between Visit 1 and 2||22
10682546|NCT02415608|11845454|FG001|NOT COMPLETED|Overall Study||0
10682547|NCT02415842|11845473|FG000|STARTED|Overall Study||29
10682548|NCT02415842|11845474|FG001|STARTED|Overall Study||29
10682549|NCT02415842|11845475|FG002|STARTED|Overall Study||29
10682550|NCT02415842|11845476|FG003|STARTED|Overall Study||27
10799060|NCT03927911|11959657|FG001|COMPLETED|Overall Study||15
10799061|NCT03927911|11959658|FG002|COMPLETED|Overall Study||0
10682551|NCT02415842|11845477|FG004|STARTED|Overall Study||30
10682552|NCT02415842|11845478|FG005|STARTED|Overall Study||30
10318888|NCT00218257|11453141|FG000|COMPLETED|Period Between Visit 1 and 2||19
10318889|NCT00218257|11453142|FG001|COMPLETED|Period Between Visit 1 and 2||19
10318890|NCT00218257|11453141|FG000|NOT COMPLETED|Period Between Visit 1 and 2||4
10318891|NCT00218257|11453142|FG001|NOT COMPLETED|Period Between Visit 1 and 2||3
10318892|NCT00218257|11453141|FG000|STARTED|Intervention 2||19
10318893|NCT00218257|11453142|FG001|STARTED|Intervention 2||19
10318894|NCT00218257|11453141|FG000|COMPLETED|Intervention 2||19
10318895|NCT00218257|11453142|FG001|COMPLETED|Intervention 2||19
10318896|NCT00218257|11453141|FG000|NOT COMPLETED|Intervention 2||0
10682553|NCT02415842|11845479|FG006|STARTED|Overall Study||30
10682554|NCT02415842|11845480|FG007|STARTED|Overall Study||26
10682555|NCT02415842|11845481|FG008|STARTED|Overall Study||29
10682556|NCT02415842|11845482|FG009|STARTED|Overall Study||53
10682557|NCT02415842|11845483|FG010|STARTED|Overall Study||49
10682558|NCT02415842|11845484|FG011|STARTED|Overall Study||33
10682559|NCT02415842|11845485|FG012|STARTED|Overall Study||20
10682560|NCT02415842|11845473|FG000|COMPLETED|Overall Study||29
10682561|NCT02415842|11845474|FG001|COMPLETED|Overall Study||29
10682562|NCT02415842|11845475|FG002|COMPLETED|Overall Study||29
10682563|NCT02415842|11845476|FG003|COMPLETED|Overall Study||27
10682564|NCT02415842|11845477|FG004|COMPLETED|Overall Study||30
10682565|NCT02415842|11845478|FG005|COMPLETED|Overall Study||30
10682566|NCT02415842|11845479|FG006|COMPLETED|Overall Study||30
10682567|NCT02415842|11845480|FG007|COMPLETED|Overall Study||26
10682568|NCT02415842|11845481|FG008|COMPLETED|Overall Study||29
10682569|NCT02415842|11845482|FG009|COMPLETED|Overall Study||53
10682570|NCT02415842|11845483|FG010|COMPLETED|Overall Study||49
10682571|NCT02415842|11845484|FG011|COMPLETED|Overall Study||33
10682572|NCT02415842|11845485|FG012|COMPLETED|Overall Study||20
10682573|NCT02415842|11845473|FG000|NOT COMPLETED|Overall Study||0
10682574|NCT02415842|11845474|FG001|NOT COMPLETED|Overall Study||0
10682575|NCT02415842|11845475|FG002|NOT COMPLETED|Overall Study||0
10682576|NCT02415842|11845476|FG003|NOT COMPLETED|Overall Study||0
10682577|NCT02415842|11845477|FG004|NOT COMPLETED|Overall Study||0
10682578|NCT02415842|11845478|FG005|NOT COMPLETED|Overall Study||0
10682579|NCT02415842|11845479|FG006|NOT COMPLETED|Overall Study||0
10682580|NCT02415842|11845480|FG007|NOT COMPLETED|Overall Study||0
10682581|NCT02415842|11845481|FG008|NOT COMPLETED|Overall Study||0
10682582|NCT02415842|11845482|FG009|NOT COMPLETED|Overall Study||0
10682583|NCT02415842|11845483|FG010|NOT COMPLETED|Overall Study||0
10682584|NCT02415842|11845484|FG011|NOT COMPLETED|Overall Study||0
10682585|NCT02415842|11845485|FG012|NOT COMPLETED|Overall Study||0
10682586|NCT02415855|11845532|FG000|STARTED|Overall Study||37
10682587|NCT02415855|11845533|FG001|STARTED|Overall Study||64
10682588|NCT02415855|11845532|FG000|COMPLETED|Overall Study||34
10682589|NCT02415855|11845533|FG001|COMPLETED|Overall Study||62
10682590|NCT02415855|11845532|FG000|NOT COMPLETED|Overall Study||3
10682591|NCT02415855|11845533|FG001|NOT COMPLETED|Overall Study||2
10682592|NCT02415959|11845544|FG000|STARTED|Overall Study||14
10682593|NCT02415959|11845545|FG001|STARTED|Overall Study||14
10682594|NCT02415959|11845546|FG002|STARTED|Overall Study||14
10682595|NCT02415959|11845547|FG003|STARTED|Overall Study||14
10682596|NCT02415959|11845548|FG004|STARTED|Overall Study||14
10682597|NCT02415959|11845544|FG000|COMPLETED|Overall Study||14
10682598|NCT02415959|11845545|FG001|COMPLETED|Overall Study||13
10682599|NCT02415959|11845546|FG002|COMPLETED|Overall Study||14
10682600|NCT02415959|11845547|FG003|COMPLETED|Overall Study||13
10682601|NCT02415959|11845548|FG004|COMPLETED|Overall Study||14
10682602|NCT02415959|11845544|FG000|NOT COMPLETED|Overall Study||0
10682603|NCT02415959|11845545|FG001|NOT COMPLETED|Overall Study||1
10682604|NCT02415959|11845546|FG002|NOT COMPLETED|Overall Study||0
10682605|NCT02415959|11845547|FG003|NOT COMPLETED|Overall Study||1
10682606|NCT02415959|11845548|FG004|NOT COMPLETED|Overall Study||0
10682607|NCT02415998|11845560|FG000|STARTED|Overall Study||25
10682608|NCT02415998|11845560|FG000|COMPLETED|Overall Study||20
10682609|NCT02415998|11845560|FG000|NOT COMPLETED|Overall Study||5
10682610|NCT02416102|11845567|FG000|STARTED|Overall Study||16
10682611|NCT02416102|11845568|FG001|STARTED|Overall Study||15
10682612|NCT02416102|11845569|FG002|STARTED|Overall Study||0
10682613|NCT02416102|11845567|FG000|COMPLETED|Overall Study||7
10682614|NCT02416102|11845568|FG001|COMPLETED|Overall Study||7
10682615|NCT02416102|11845569|FG002|COMPLETED|Overall Study||0
10682616|NCT02416102|11845567|FG000|NOT COMPLETED|Overall Study||9
10682617|NCT02416102|11845568|FG001|NOT COMPLETED|Overall Study||8
10682618|NCT02416102|11845569|FG002|NOT COMPLETED|Overall Study||0
10682619|NCT02416180|11845577|FG000|STARTED|Overall Study||111
10682620|NCT02416180|11845577|FG000|COMPLETED|Overall Study||110
10682621|NCT02416180|11845577|FG000|NOT COMPLETED|Overall Study||1
10682622|NCT02416193|11845583|FG000|STARTED|Overall Study||15
10682623|NCT02416193|11845584|FG001|STARTED|Overall Study||15
10682624|NCT02416193|11845583|FG000|COMPLETED|Overall Study||15
10682625|NCT02416193|11845584|FG001|COMPLETED|Overall Study||15
10682626|NCT02416193|11845583|FG000|NOT COMPLETED|Overall Study||0
10682627|NCT02416193|11845584|FG001|NOT COMPLETED|Overall Study||0
10682628|NCT02416453|11845601|FG000|STARTED|Overall Study||10
10682629|NCT02416453|11845602|FG001|STARTED|Overall Study||10
10682630|NCT02416453|11845603|FG002|STARTED|Overall Study||10
10682631|NCT02416453|11845604|FG003|STARTED|Overall Study||112
10682632|NCT02416453|11845605|FG004|STARTED|Overall Study||13
10682633|NCT02416453|11845606|FG005|STARTED|Overall Study||114
10682634|NCT02416453|11845607|FG006|STARTED|Overall Study||13
10682635|NCT02416453|11845608|FG007|STARTED|Overall Study||106
10682636|NCT02416453|11845609|FG008|STARTED|Overall Study||18
10682637|NCT02416453|11845610|FG009|STARTED|Overall Study||13
10682638|NCT02416453|11845611|FG010|STARTED|Overall Study||2
10682639|NCT02416453|11845601|FG000|COMPLETED|Overall Study||7
10682640|NCT02416453|11845602|FG001|COMPLETED|Overall Study||7
10682641|NCT02416453|11845603|FG002|COMPLETED|Overall Study||9
10682642|NCT02416453|11845604|FG003|COMPLETED|Overall Study||97
10682643|NCT02416453|11845605|FG004|COMPLETED|Overall Study||12
10682644|NCT02416453|11845606|FG005|COMPLETED|Overall Study||98
10682645|NCT02416453|11845607|FG006|COMPLETED|Overall Study||11
10682646|NCT02416453|11845608|FG007|COMPLETED|Overall Study||94
10682647|NCT02416453|11845609|FG008|COMPLETED|Overall Study||13
10682648|NCT02416453|11845610|FG009|COMPLETED|Overall Study||13
10682649|NCT02416453|11845611|FG010|COMPLETED|Overall Study||2
10682650|NCT02416453|11845601|FG000|NOT COMPLETED|Overall Study||3
10682651|NCT02416453|11845602|FG001|NOT COMPLETED|Overall Study||3
10682652|NCT02416453|11845603|FG002|NOT COMPLETED|Overall Study||1
10682653|NCT02416453|11845604|FG003|NOT COMPLETED|Overall Study||15
10682654|NCT02416453|11845605|FG004|NOT COMPLETED|Overall Study||1
10682655|NCT02416453|11845606|FG005|NOT COMPLETED|Overall Study||16
10682656|NCT02416453|11845607|FG006|NOT COMPLETED|Overall Study||2
10682657|NCT02416453|11845608|FG007|NOT COMPLETED|Overall Study||12
10682658|NCT02416453|11845609|FG008|NOT COMPLETED|Overall Study||5
10682659|NCT02416453|11845610|FG009|NOT COMPLETED|Overall Study||0
10682660|NCT02416453|11845611|FG010|NOT COMPLETED|Overall Study||0
10682676|NCT02416713|11845658|FG000|STARTED|Overall Study||8
10682677|NCT02416713|11845659|FG001|STARTED|Overall Study||9
10682678|NCT02416713|11845660|FG002|STARTED|Overall Study||8
10682679|NCT02416713|11845661|FG003|STARTED|Overall Study||10
10682680|NCT02416713|11845658|FG000|COMPLETED|Overall Study||8
10682681|NCT02416713|11845659|FG001|COMPLETED|Overall Study||9
10682682|NCT02416713|11845660|FG002|COMPLETED|Overall Study||8
10682683|NCT02416713|11845661|FG003|COMPLETED|Overall Study||10
10682684|NCT02416713|11845658|FG000|NOT COMPLETED|Overall Study||0
10682685|NCT02416713|11845659|FG001|NOT COMPLETED|Overall Study||0
10682686|NCT02416713|11845660|FG002|NOT COMPLETED|Overall Study||0
10682687|NCT02416713|11845661|FG003|NOT COMPLETED|Overall Study||0
10682688|NCT02416791|11845674|FG000|STARTED|6 Weeks||3
10682689|NCT02416791|11845675|FG001|STARTED|6 Weeks||3
10682690|NCT02416791|11845676|FG002|STARTED|6 Weeks||3
10682691|NCT02416791|11845674|FG000|COMPLETED|6 Weeks||3
10682692|NCT02416791|11845675|FG001|COMPLETED|6 Weeks||3
10682693|NCT02416791|11845676|FG002|COMPLETED|6 Weeks||3
10682694|NCT02416791|11845674|FG000|NOT COMPLETED|6 Weeks||0
10682695|NCT02416791|11845675|FG001|NOT COMPLETED|6 Weeks||0
10682696|NCT02416791|11845676|FG002|NOT COMPLETED|6 Weeks||0
10682697|NCT02416791|11845674|FG000|STARTED|6 Months||3
10682698|NCT02416791|11845675|FG001|STARTED|6 Months||3
10682699|NCT02416791|11845676|FG002|STARTED|6 Months||3
10682700|NCT02416791|11845674|FG000|COMPLETED|6 Months||3
10682701|NCT02416791|11845675|FG001|COMPLETED|6 Months||3
10682702|NCT02416791|11845676|FG002|COMPLETED|6 Months||2
10682703|NCT02416791|11845674|FG000|NOT COMPLETED|6 Months||0
10682704|NCT02416791|11845675|FG001|NOT COMPLETED|6 Months||0
10682705|NCT02416791|11845676|FG002|NOT COMPLETED|6 Months||1
10682706|NCT02416908|11845687|FG000|STARTED|Dose Escalation Phase||6
10682707|NCT02416908|11845688|FG001|STARTED|Dose Escalation Phase||0
10682708|NCT02416908|11845689|FG002|STARTED|Dose Escalation Phase||34
10682709|NCT02416908|11845690|FG003|STARTED|Dose Escalation Phase||0
10682710|NCT02416908|11845687|FG000|COMPLETED|Dose Escalation Phase||6
10682711|NCT02416908|11845688|FG001|COMPLETED|Dose Escalation Phase||0
10682712|NCT02416908|11845689|FG002|COMPLETED|Dose Escalation Phase||30
10682713|NCT02416908|11845690|FG003|COMPLETED|Dose Escalation Phase||0
10682714|NCT02416908|11845687|FG000|NOT COMPLETED|Dose Escalation Phase||0
10682715|NCT02416908|11845688|FG001|NOT COMPLETED|Dose Escalation Phase||0
10682716|NCT02416908|11845689|FG002|NOT COMPLETED|Dose Escalation Phase||4
10682717|NCT02416908|11845690|FG003|NOT COMPLETED|Dose Escalation Phase||0
10682718|NCT02416908|11845687|FG000|STARTED|Maintenance Phase||0
10682719|NCT02416908|11845688|FG001|STARTED|Maintenance Phase||0
10682720|NCT02416908|11845689|FG002|STARTED|Maintenance Phase||0
10682721|NCT02416908|11845690|FG003|STARTED|Maintenance Phase||2
10682722|NCT02416908|11845687|FG000|COMPLETED|Maintenance Phase||0
10682723|NCT02416908|11845688|FG001|COMPLETED|Maintenance Phase||0
10682724|NCT02416908|11845689|FG002|COMPLETED|Maintenance Phase||0
10682725|NCT02416908|11845690|FG003|COMPLETED|Maintenance Phase||2
10682726|NCT02416908|11845687|FG000|NOT COMPLETED|Maintenance Phase||0
10682727|NCT02416908|11845688|FG001|NOT COMPLETED|Maintenance Phase||0
10682728|NCT02416908|11845689|FG002|NOT COMPLETED|Maintenance Phase||0
10682729|NCT02416908|11845690|FG003|NOT COMPLETED|Maintenance Phase||0
10682730|NCT02416934|11845699|FG000|STARTED|Overall Study||36
10682731|NCT02416934|11845700|FG001|STARTED|Overall Study||38
10682732|NCT02416934|11845699|FG000|Double Blind (0-52 Weeks)|Overall Study||36
10682733|NCT02416934|11845700|FG001|Double Blind (0-52 Weeks)|Overall Study||38
10682734|NCT02416934|11845699|FG000|Last Participant Completed 1 yr|Overall Study||33
10682735|NCT02416934|11845700|FG001|Last Participant Completed 1 yr|Overall Study||31
10682736|NCT02416934|11845699|FG000|COMPLETED|Overall Study||33
10682737|NCT02416934|11845700|FG001|COMPLETED|Overall Study||31
10682738|NCT02416934|11845699|FG000|NOT COMPLETED|Overall Study||3
10682739|NCT02416934|11845700|FG001|NOT COMPLETED|Overall Study||7
10682740|NCT02416973|11845715|FG000|STARTED|Overall Study||14
10682741|NCT02416973|11845716|FG001|STARTED|Overall Study||13
10682742|NCT02416973|11845717|FG002|STARTED|Overall Study||14
10682743|NCT02416973|11845715|FG000|COMPLETED|Overall Study||13
10682744|NCT02416973|11845716|FG001|COMPLETED|Overall Study||10
10682745|NCT02416973|11845717|FG002|COMPLETED|Overall Study||13
10682746|NCT02416973|11845715|FG000|NOT COMPLETED|Overall Study||1
10682747|NCT02416973|11845716|FG001|NOT COMPLETED|Overall Study||3
10682748|NCT02416973|11845717|FG002|NOT COMPLETED|Overall Study||1
10682749|NCT02417064|11845728|FG000|STARTED|Double-blind Induction Phase (4 Weeks)||117
10682750|NCT02417064|11845729|FG001|STARTED|Double-blind Induction Phase (4 Weeks)||116
10682751|NCT02417064|11845730|FG002|STARTED|Double-blind Induction Phase (4 Weeks)||113
10682752|NCT02417064|11845728|FG000|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||115
10682753|NCT02417064|11845729|FG001|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||114
10682754|NCT02417064|11845730|FG002|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||113
10682755|NCT02417064|11845728|FG000|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||115
10682756|NCT02417064|11845729|FG001|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||116
10682757|NCT02417064|11845730|FG002|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||113
10682758|NCT02417064|11845728|FG000|COMPLETED|Double-blind Induction Phase (4 Weeks)||111
10682759|NCT02417064|11845729|FG001|COMPLETED|Double-blind Induction Phase (4 Weeks)||97
10682760|NCT02417064|11845730|FG002|COMPLETED|Double-blind Induction Phase (4 Weeks)||107
10682761|NCT02417064|11845728|FG000|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||6
10682762|NCT02417064|11845729|FG001|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||19
10682763|NCT02417064|11845730|FG002|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||6
10682764|NCT02417064|11845728|FG000|STARTED|Follow-up Phase (24 Weeks)||47
10682765|NCT02417064|11845729|FG001|STARTED|Follow-up Phase (24 Weeks)||52
10682766|NCT02417064|11845730|FG002|STARTED|Follow-up Phase (24 Weeks)||69
10682767|NCT02417064|11845728|FG000|COMPLETED|Follow-up Phase (24 Weeks)||8
10682768|NCT02417064|11845729|FG001|COMPLETED|Follow-up Phase (24 Weeks)||10
10682769|NCT02417064|11845730|FG002|COMPLETED|Follow-up Phase (24 Weeks)||18
10682770|NCT02417064|11845728|FG000|NOT COMPLETED|Follow-up Phase (24 Weeks)||39
10682771|NCT02417064|11845729|FG001|NOT COMPLETED|Follow-up Phase (24 Weeks)||42
10682772|NCT02417064|11845730|FG002|NOT COMPLETED|Follow-up Phase (24 Weeks)||51
10682773|NCT02417129|11845741|FG000|STARTED|Overall Study||2
10682774|NCT02417129|11845742|FG001|STARTED|Overall Study||0
10682775|NCT02417129|11845741|FG000|COMPLETED|Overall Study||2
10799062|NCT03927911|11959659|FG003|COMPLETED|Overall Study||1
10799063|NCT03927911|11959660|FG004|COMPLETED|Overall Study||13
10799064|NCT03927911|11959661|FG005|COMPLETED|Overall Study||25
10799065|NCT03927911|11959656|FG000|NOT COMPLETED|Overall Study||0
10799066|NCT03927911|11959657|FG001|NOT COMPLETED|Overall Study||2
10799067|NCT03927911|11959658|FG002|NOT COMPLETED|Overall Study||0
10799068|NCT03927911|11959659|FG003|NOT COMPLETED|Overall Study||2
10799069|NCT03927911|11959660|FG004|NOT COMPLETED|Overall Study||0
10799070|NCT03927911|11959661|FG005|NOT COMPLETED|Overall Study||7
10799071|NCT03937570|11959677|FG000|STARTED|Overall Study||13
10799072|NCT03937570|11959678|FG001|STARTED|Overall Study||14
10799073|NCT03937570|11959677|FG000|COMPLETED|Overall Study||13
10799074|NCT03937570|11959678|FG001|COMPLETED|Overall Study||14
10799075|NCT03937570|11959677|FG000|NOT COMPLETED|Overall Study||0
10799076|NCT03937570|11959678|FG001|NOT COMPLETED|Overall Study||0
10799077|NCT03938857|11959688|FG000|STARTED|Overall Study||6
10799078|NCT03938857|11959689|FG001|STARTED|Overall Study||12
10799079|NCT03938857|11959690|FG002|STARTED|Overall Study||12
10799080|NCT03938857|11959691|FG003|STARTED|Overall Study||0
10799081|NCT03938857|11959688|FG000|COMPLETED|Overall Study||5
10799082|NCT03938857|11959689|FG001|COMPLETED|Overall Study||12
10799083|NCT03938857|11959690|FG002|COMPLETED|Overall Study||12
10799084|NCT03938857|11959691|FG003|COMPLETED|Overall Study||0
10799085|NCT03938857|11959688|FG000|NOT COMPLETED|Overall Study||1
10799086|NCT03938857|11959689|FG001|NOT COMPLETED|Overall Study||0
10799087|NCT03938857|11959690|FG002|NOT COMPLETED|Overall Study||0
10799088|NCT03938857|11959691|FG003|NOT COMPLETED|Overall Study||0
10799089|NCT03941912|11959701|FG000|STARTED|Overall Study||44
10799090|NCT03941912|11959701|FG000|COMPLETED|Overall Study||44
10799091|NCT03941912|11959701|FG000|NOT COMPLETED|Overall Study||0
10799092|NCT03945981|11959705|FG000|STARTED|Overall Study||131
10799093|NCT03945981|11959705|FG000|COMPLETED|Overall Study||108
10799094|NCT03945981|11959705|FG000|NOT COMPLETED|Overall Study||23
10799095|NCT03950167|11959711|FG000|STARTED|Overall Study||25
10682776|NCT02417129|11845742|FG001|COMPLETED|Overall Study||0
10682777|NCT02417129|11845741|FG000|NOT COMPLETED|Overall Study||0
10682778|NCT02417129|11845742|FG001|NOT COMPLETED|Overall Study||0
10682779|NCT02417233|11845751|FG000|STARTED|Overall Study||169
10682780|NCT02417233|11845752|FG001|STARTED|Overall Study||289
10682781|NCT02417233|11845753|FG002|STARTED|Overall Study||298
10682782|NCT02417233|11845751|FG000|COMPLETED|Overall Study||133
10682783|NCT02417233|11845752|FG001|COMPLETED|Overall Study||238
10682784|NCT02417233|11845753|FG002|COMPLETED|Overall Study||239
10799096|NCT03950167|11959712|FG001|STARTED|Overall Study||25
10799097|NCT03950167|11959711|FG000|COMPLETED|Overall Study||24
10799098|NCT03950167|11959712|FG001|COMPLETED|Overall Study||22
10799099|NCT03950167|11959711|FG000|NOT COMPLETED|Overall Study||1
10799100|NCT03950167|11959712|FG001|NOT COMPLETED|Overall Study||3
10799101|NCT03954834|11959722|FG000|STARTED|Overall Study||121
10799102|NCT03954834|11959723|FG001|STARTED|Overall Study||121
10682785|NCT02417233|11845751|FG000|NOT COMPLETED|Overall Study||36
10682786|NCT02417233|11845752|FG001|NOT COMPLETED|Overall Study||51
10682787|NCT02417233|11845753|FG002|NOT COMPLETED|Overall Study||59
10682788|NCT02417246|11845764|FG000|STARTED|Phase 1 Brand Name Metoprolol ER||24
10682789|NCT02417246|11845765|FG001|STARTED|Phase 1 Brand Name Metoprolol ER||24
10682790|NCT02417246|11845764|FG000|COMPLETED|Phase 1 Brand Name Metoprolol ER||20
10682791|NCT02417246|11845765|FG001|COMPLETED|Phase 1 Brand Name Metoprolol ER||20
10682792|NCT02417246|11845764|FG000|NOT COMPLETED|Phase 1 Brand Name Metoprolol ER||4
10682793|NCT02417246|11845765|FG001|NOT COMPLETED|Phase 1 Brand Name Metoprolol ER||4
10682794|NCT02417246|11845764|FG000|STARTED|Phase 2 1st Generic Administered||20
10682795|NCT02417246|11845765|FG001|STARTED|Phase 2 1st Generic Administered||20
10682796|NCT02417246|11845764|FG000|COMPLETED|Phase 2 1st Generic Administered||19
10682797|NCT02417246|11845765|FG001|COMPLETED|Phase 2 1st Generic Administered||20
10682798|NCT02417246|11845764|FG000|NOT COMPLETED|Phase 2 1st Generic Administered||1
10682799|NCT02417246|11845765|FG001|NOT COMPLETED|Phase 2 1st Generic Administered||0
10682800|NCT02417246|11845764|FG000|STARTED|Phase 3 Brand Name Metoprolol ER #2||19
10682801|NCT02417246|11845765|FG001|STARTED|Phase 3 Brand Name Metoprolol ER #2||20
10682802|NCT02417246|11845764|FG000|COMPLETED|Phase 3 Brand Name Metoprolol ER #2||18
10682803|NCT02417246|11845765|FG001|COMPLETED|Phase 3 Brand Name Metoprolol ER #2||20
10682804|NCT02417246|11845764|FG000|NOT COMPLETED|Phase 3 Brand Name Metoprolol ER #2||1
10682805|NCT02417246|11845765|FG001|NOT COMPLETED|Phase 3 Brand Name Metoprolol ER #2||0
10682806|NCT02417246|11845764|FG000|STARTED|Phase 4 2nd Generic Administered||18
10682807|NCT02417246|11845765|FG001|STARTED|Phase 4 2nd Generic Administered||20
10682808|NCT02417246|11845764|FG000|COMPLETED|Phase 4 2nd Generic Administered||18
10682809|NCT02417246|11845765|FG001|COMPLETED|Phase 4 2nd Generic Administered||20
10682810|NCT02417246|11845764|FG000|NOT COMPLETED|Phase 4 2nd Generic Administered||0
10682811|NCT02417246|11845765|FG001|NOT COMPLETED|Phase 4 2nd Generic Administered||0
10682812|NCT02417376|11845775|FG000|STARTED|Overall Study||35
10682813|NCT02417376|11845776|FG001|STARTED|Overall Study||35
10682814|NCT02417376|11845775|FG000|COMPLETED|Overall Study||30
10682815|NCT02417376|11845776|FG001|COMPLETED|Overall Study||25
10682816|NCT02417376|11845775|FG000|NOT COMPLETED|Overall Study||5
10682817|NCT02417376|11845776|FG001|NOT COMPLETED|Overall Study||10
10682818|NCT02417441|11845784|FG000|STARTED|Overall Study||645
10682819|NCT02417441|11845785|FG001|STARTED|Overall Study||325
10682820|NCT02417441|11845784|FG000|COMPLETED|Overall Study||593
10682821|NCT02417441|11845785|FG001|COMPLETED|Overall Study||306
10682822|NCT02417441|11845784|FG000|NOT COMPLETED|Overall Study||52
10682823|NCT02417441|11845785|FG001|NOT COMPLETED|Overall Study||19
10682824|NCT02417532|11845792|FG000|STARTED|Overall Study||56
10682825|NCT02417532|11845792|FG000|COMPLETED|Overall Study||56
10682826|NCT02417532|11845792|FG000|NOT COMPLETED|Overall Study||0
10682827|NCT02417753|11845798|FG000|STARTED|Overall Study||1
10682828|NCT02417753|11845798|FG000|COMPLETED|Overall Study||0
10682829|NCT02417753|11845798|FG000|NOT COMPLETED|Overall Study||1
10682830|NCT02417831|11845802|FG000|STARTED|Period 1: Treatment Period 1 + Washout||17
10682831|NCT02417831|11845803|FG001|STARTED|Period 1: Treatment Period 1 + Washout||17
10682832|NCT02417831|11845802|FG000|COMPLETED|Period 1: Treatment Period 1 + Washout||17
10682833|NCT02417831|11845803|FG001|COMPLETED|Period 1: Treatment Period 1 + Washout||17
10682834|NCT02417831|11845802|FG000|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
10682835|NCT02417831|11845803|FG001|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
10682836|NCT02417831|11845802|FG000|STARTED|Period 2: Treatment Period 2 + Washout||17
10682837|NCT02417831|11845803|FG001|STARTED|Period 2: Treatment Period 2 + Washout||17
10682838|NCT02417831|11845802|FG000|COMPLETED|Period 2: Treatment Period 2 + Washout||17
10682839|NCT02417831|11845803|FG001|COMPLETED|Period 2: Treatment Period 2 + Washout||17
10682840|NCT02417831|11845802|FG000|NOT COMPLETED|Period 2: Treatment Period 2 + Washout||0
10682841|NCT02417831|11845803|FG001|NOT COMPLETED|Period 2: Treatment Period 2 + Washout||0
10682842|NCT02417844|11845809|FG000|STARTED|Overall Study||17
10682843|NCT02417844|11845810|FG001|STARTED|Overall Study||17
10682844|NCT02417844|11845809|FG000|COMPLETED|Overall Study||17
10682845|NCT02417844|11845810|FG001|COMPLETED|Overall Study||17
10682846|NCT02417844|11845809|FG000|NOT COMPLETED|Overall Study||0
10682847|NCT02417844|11845810|FG001|NOT COMPLETED|Overall Study||0
10682848|NCT02417935|11845818|FG000|STARTED|Treatment Period||151
10682849|NCT02417935|11845819|FG001|STARTED|Treatment Period||153
10682850|NCT02417935|11845818|FG000|Received at Least One Dose of Study Drug|Treatment Period||151
10682851|NCT02417935|11845819|FG001|Received at Least One Dose of Study Drug|Treatment Period||152
10682852|NCT02417935|11845818|FG000|COMPLETED|Treatment Period||130
10682853|NCT02417935|11845819|FG001|COMPLETED|Treatment Period||137
10682854|NCT02417935|11845818|FG000|NOT COMPLETED|Treatment Period||21
10682855|NCT02417935|11845819|FG001|NOT COMPLETED|Treatment Period||16
10682856|NCT02417935|11845818|FG000|STARTED|Tapering Period|Participants who discontinued treatment period had an option to enter the taper period|134
10682857|NCT02417935|11845819|FG001|STARTED|Tapering Period|Participants who discontinued treatment period had an option to enter the taper period|142
10682858|NCT02417935|11845818|FG000|COMPLETED|Tapering Period||134
10682859|NCT02417935|11845819|FG001|COMPLETED|Tapering Period||142
10682860|NCT02417935|11845818|FG000|NOT COMPLETED|Tapering Period||0
10682861|NCT02417935|11845819|FG001|NOT COMPLETED|Tapering Period||0
10682862|NCT02417961|11845825|FG000|STARTED|Overall Study||116
10682863|NCT02417961|11845825|FG000|COMPLETED|Overall Study||112
10682864|NCT02417961|11845825|FG000|NOT COMPLETED|Overall Study||4
10682865|NCT02418000|11845834|FG000|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||7
10682866|NCT02418000|11845835|FG001|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
10682867|NCT02418000|11845836|FG002|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
10682868|NCT02418000|11845837|FG003|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
10682869|NCT02418000|11845838|FG004|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
10682870|NCT02418000|11845834|FG000|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
10682871|NCT02418000|11845835|FG001|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
10682872|NCT02418000|11845836|FG002|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
10682873|NCT02418000|11845837|FG003|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
10682874|NCT02418000|11845838|FG004|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
10682875|NCT02418000|11845834|FG000|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||7
10682876|NCT02418000|11845835|FG001|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
10682877|NCT02418000|11845836|FG002|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
10682878|NCT02418000|11845837|FG003|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
10682879|NCT02418000|11845838|FG004|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
10682880|NCT02418000|11845834|FG000|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
10682881|NCT02418000|11845835|FG001|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||10
10682882|NCT02418000|11845836|FG002|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
10682883|NCT02418000|11845837|FG003|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
10682884|NCT02418000|11845838|FG004|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
10682885|NCT02418000|11845834|FG000|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
10682886|NCT02418000|11845835|FG001|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
10682887|NCT02418000|11845836|FG002|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
10682888|NCT02418000|11845837|FG003|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
10682889|NCT02418000|11845838|FG004|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
10682890|NCT02418000|11845834|FG000|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
10682891|NCT02418000|11845835|FG001|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||10
10682892|NCT02418000|11845836|FG002|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
10682893|NCT02418000|11845837|FG003|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
10682894|NCT02418000|11845838|FG004|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
10682895|NCT02418000|11845834|FG000|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
10682896|NCT02418000|11845835|FG001|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
10682897|NCT02418000|11845836|FG002|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||3
10682898|NCT02418000|11845837|FG003|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
10682899|NCT02418000|11845838|FG004|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
10682900|NCT02418000|11845834|FG000|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
10682901|NCT02418000|11845835|FG001|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
10682902|NCT02418000|11845836|FG002|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
10682903|NCT02418000|11845837|FG003|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
10682904|NCT02418000|11845838|FG004|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
10682905|NCT02418000|11845834|FG000|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
10682906|NCT02418000|11845835|FG001|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
10682907|NCT02418000|11845836|FG002|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||3
10682908|NCT02418000|11845837|FG003|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
10682909|NCT02418000|11845838|FG004|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
10682910|NCT02418000|11845834|FG000|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
10682911|NCT02418000|11845835|FG001|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
10682912|NCT02418000|11845836|FG002|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
10682913|NCT02418000|11845837|FG003|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||3
10682914|NCT02418000|11845838|FG004|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
10682915|NCT02418000|11845834|FG000|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
10682916|NCT02418000|11845835|FG001|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
10682917|NCT02418000|11845836|FG002|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
10682918|NCT02418000|11845837|FG003|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
10682919|NCT02418000|11845838|FG004|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
10682920|NCT02418000|11845834|FG000|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
10682921|NCT02418000|11845835|FG001|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
10682922|NCT02418000|11845836|FG002|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
10682923|NCT02418000|11845837|FG003|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||3
10682924|NCT02418000|11845838|FG004|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
10682925|NCT02418000|11845834|FG000|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
10682926|NCT02418000|11845835|FG001|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
10682927|NCT02418000|11845836|FG002|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
10682928|NCT02418000|11845837|FG003|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
10682929|NCT02418000|11845838|FG004|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||4
10682930|NCT02418000|11845834|FG000|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
10682931|NCT02418000|11845835|FG001|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
10682932|NCT02418000|11845836|FG002|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
10682933|NCT02418000|11845837|FG003|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
10682934|NCT02418000|11845838|FG004|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
10682935|NCT02418000|11845834|FG000|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
10682936|NCT02418000|11845835|FG001|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
10682937|NCT02418000|11845836|FG002|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
10682938|NCT02418000|11845837|FG003|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
10682939|NCT02418000|11845838|FG004|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||4
10682940|NCT02418026|11845864|FG000|STARTED|Overall Study||44
10682941|NCT02418026|11845865|FG001|STARTED|Overall Study||35
10682942|NCT02418026|11845864|FG000|COMPLETED|Overall Study||44
10682943|NCT02418026|11845865|FG001|COMPLETED|Overall Study||35
10682944|NCT02418026|11845864|FG000|NOT COMPLETED|Overall Study||0
10682945|NCT02418026|11845865|FG001|NOT COMPLETED|Overall Study||0
10682946|NCT02418156|11845871|FG000|STARTED|Overall Study||38
10682947|NCT02418156|11845871|FG000|COMPLETED|Overall Study||21
10682948|NCT02418156|11845871|FG000|NOT COMPLETED|Overall Study||17
10682949|NCT02418182|11845877|FG000|STARTED|Overall Study||49
10682950|NCT02418182|11845878|FG001|STARTED|Overall Study||50
10682951|NCT02418182|11845877|FG000|COMPLETED|Overall Study||31
10682952|NCT02418182|11845878|FG001|COMPLETED|Overall Study||33
10682953|NCT02418182|11845877|FG000|NOT COMPLETED|Overall Study||18
10682954|NCT02418182|11845878|FG001|NOT COMPLETED|Overall Study||17
10682955|NCT02418234|11845884|FG000|STARTED|Overall Study||314
10682956|NCT02418234|11845884|FG000|COMPLETED|Overall Study||314
10682957|NCT02418234|11845884|FG000|NOT COMPLETED|Overall Study||0
10455346|NCT01001442|11603420|FG003|STARTED|Overall Study||3
10455347|NCT01001442|11603421|FG004|STARTED|Overall Study||4
10455348|NCT01001442|11603422|FG005|STARTED|Overall Study||3
10455349|NCT01001442|11603423|FG006|STARTED|Overall Study||10
10455350|NCT01001442|11603424|FG007|STARTED|Overall Study||4
10682958|NCT02418312|11845894|FG000|STARTED|Overall Study||114
10682959|NCT02418312|11845895|FG001|STARTED|Overall Study||114
10682960|NCT02418312|11845894|FG000|COMPLETED|Overall Study||114
10682961|NCT02418312|11845895|FG001|COMPLETED|Overall Study||114
10682962|NCT02418312|11845894|FG000|NOT COMPLETED|Overall Study||0
10682963|NCT02418312|11845895|FG001|NOT COMPLETED|Overall Study||0
10682964|NCT02418455|11845901|FG000|STARTED|48-Week Treatment Period||8
10682965|NCT02418455|11845901|FG000|Emergency IND (eIND)|48-Week Treatment Period||1
10682966|NCT02418455|11845901|FG000|COMPLETED|48-Week Treatment Period||7
10682967|NCT02418455|11845901|FG000|NOT COMPLETED|48-Week Treatment Period||1
10682968|NCT02418455|11845901|FG000|STARTED|Continuation Period||7
10682969|NCT02418455|11845901|FG000|COMPLETED|Continuation Period||0
10682970|NCT02418455|11845901|FG000|NOT COMPLETED|Continuation Period||7
10682971|NCT02418468|11845909|FG000|STARTED|Overall Study||13
10682972|NCT02418468|11845910|FG001|STARTED|Overall Study||11
10682973|NCT02418468|11845909|FG000|COMPLETED|Overall Study||11
10682974|NCT02418468|11845910|FG001|COMPLETED|Overall Study||10
10682975|NCT02418468|11845909|FG000|NOT COMPLETED|Overall Study||2
10682976|NCT02418468|11845910|FG001|NOT COMPLETED|Overall Study||1
10682977|NCT02418546|11845919|FG000|STARTED|Overall Study||26
10682978|NCT02418546|11845920|FG001|STARTED|Overall Study||26
10682979|NCT02418546|11845921|FG002|STARTED|Overall Study||26
10682980|NCT02418546|11845919|FG000|COMPLETED|Overall Study||19
10682981|NCT02418546|11845920|FG001|COMPLETED|Overall Study||20
10682982|NCT02418546|11845921|FG002|COMPLETED|Overall Study||23
10682983|NCT02418546|11845919|FG000|NOT COMPLETED|Overall Study||7
10682984|NCT02418546|11845920|FG001|NOT COMPLETED|Overall Study||6
10682985|NCT02418546|11845921|FG002|NOT COMPLETED|Overall Study||3
10682986|NCT02418585|11845931|FG000|STARTED|Double Blind (DB) Phase (4 Weeks)||116
10682987|NCT02418585|11845932|FG001|STARTED|Double Blind (DB) Phase (4 Weeks)||111
10682988|NCT02418585|11845931|FG000|Safety Analysis Set|Double Blind (DB) Phase (4 Weeks)||115
10682989|NCT02418585|11845932|FG001|Safety Analysis Set|Double Blind (DB) Phase (4 Weeks)||109
10682990|NCT02418585|11845931|FG000|Full Analysis Set|Double Blind (DB) Phase (4 Weeks)||114
10682991|NCT02418585|11845932|FG001|Full Analysis Set|Double Blind (DB) Phase (4 Weeks)||109
10682992|NCT02418585|11845931|FG000|COMPLETED|Double Blind (DB) Phase (4 Weeks)||98
10682993|NCT02418585|11845932|FG001|COMPLETED|Double Blind (DB) Phase (4 Weeks)||99
10682994|NCT02418585|11845931|FG000|NOT COMPLETED|Double Blind (DB) Phase (4 Weeks)||18
10682995|NCT02418585|11845932|FG001|NOT COMPLETED|Double Blind (DB) Phase (4 Weeks)||12
10682996|NCT02418585|11845931|FG000|STARTED|Follow-up Phase (24 Weeks)||34
10682997|NCT02418585|11845932|FG001|STARTED|Follow-up Phase (24 Weeks)||52
10682998|NCT02418585|11845931|FG000|COMPLETED|Follow-up Phase (24 Weeks)||16
10682999|NCT02418585|11845932|FG001|COMPLETED|Follow-up Phase (24 Weeks)||27
10455351|NCT01001442|11603417|FG000|COMPLETED|Overall Study||4
10683000|NCT02418585|11845931|FG000|NOT COMPLETED|Follow-up Phase (24 Weeks)||18
10683001|NCT02418585|11845932|FG001|NOT COMPLETED|Follow-up Phase (24 Weeks)||25
10683002|NCT02418676|11845943|FG000|STARTED|Overall Study||5
10683003|NCT02418676|11845944|FG001|STARTED|Overall Study||5
10683004|NCT02418676|11845945|FG002|STARTED|Overall Study||5
10683005|NCT02418676|11845943|FG000|COMPLETED|Overall Study||5
10683006|NCT02418676|11845944|FG001|COMPLETED|Overall Study||5
10683007|NCT02418676|11845945|FG002|COMPLETED|Overall Study||5
10683008|NCT02418676|11845943|FG000|NOT COMPLETED|Overall Study||0
10683009|NCT02418676|11845944|FG001|NOT COMPLETED|Overall Study||0
10683010|NCT02418676|11845945|FG002|NOT COMPLETED|Overall Study||0
10683011|NCT02418754|11845956|FG000|STARTED|Period 1 (Day 1 to Week 12)||103
10683012|NCT02418754|11845957|FG001|STARTED|Period 1 (Day 1 to Week 12)||200
10683013|NCT02418754|11845958|FG002|STARTED|Period 1 (Day 1 to Week 12)||202
10683014|NCT02418754|11845959|FG003|STARTED|Period 1 (Day 1 to Week 12)||0
10683015|NCT02418754|11845960|FG004|STARTED|Period 1 (Day 1 to Week 12)||0
10683016|NCT02418754|11845956|FG000|COMPLETED|Period 1 (Day 1 to Week 12)||101
10683017|NCT02418754|11845957|FG001|COMPLETED|Period 1 (Day 1 to Week 12)||196
10683018|NCT02418754|11845958|FG002|COMPLETED|Period 1 (Day 1 to Week 12)||200
10683019|NCT02418754|11845959|FG003|COMPLETED|Period 1 (Day 1 to Week 12)||0
10683020|NCT02418754|11845960|FG004|COMPLETED|Period 1 (Day 1 to Week 12)||0
10683021|NCT02418754|11845956|FG000|NOT COMPLETED|Period 1 (Day 1 to Week 12)||2
10683022|NCT02418754|11845957|FG001|NOT COMPLETED|Period 1 (Day 1 to Week 12)||4
10683023|NCT02418754|11845958|FG002|NOT COMPLETED|Period 1 (Day 1 to Week 12)||2
10683024|NCT02418754|11845959|FG003|NOT COMPLETED|Period 1 (Day 1 to Week 12)||0
10683025|NCT02418754|11845960|FG004|NOT COMPLETED|Period 1 (Day 1 to Week 12)||0
10683026|NCT02418754|11845956|FG000|STARTED|Period 2 (Day 1 to Week 52/End of Study)||103
10683027|NCT02418754|11845957|FG001|STARTED|Period 2 (Day 1 to Week 52/End of Study)||106
10683028|NCT02418754|11845958|FG002|STARTED|Period 2 (Day 1 to Week 52/End of Study)||108
10683029|NCT02418754|11845959|FG003|STARTED|Period 2 (Day 1 to Week 52/End of Study)||94
10683030|NCT02418754|11845960|FG004|STARTED|Period 2 (Day 1 to Week 52/End of Study)||94
10683031|NCT02418754|11845956|FG000|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||70
10683032|NCT02418754|11845957|FG001|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||64
10683033|NCT02418754|11845958|FG002|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||71
10683034|NCT02418754|11845959|FG003|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||67
10683035|NCT02418754|11845960|FG004|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||67
10683036|NCT02418754|11845956|FG000|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||33
10683037|NCT02418754|11845957|FG001|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||42
10683038|NCT02418754|11845958|FG002|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||37
10683039|NCT02418754|11845959|FG003|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||27
10683040|NCT02418754|11845960|FG004|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||27
10683041|NCT02418819|11845974|FG000|STARTED|Overall Study||22
10683042|NCT02418819|11845975|FG001|STARTED|Overall Study||16
10683043|NCT02418819|11845976|FG002|STARTED|Overall Study||33
10683044|NCT02418819|11845977|FG003|STARTED|Overall Study||29
10683045|NCT02418819|11845974|FG000|COMPLETED|Overall Study||21
10683046|NCT02418819|11845975|FG001|COMPLETED|Overall Study||16
10683047|NCT02418819|11845976|FG002|COMPLETED|Overall Study||29
10683048|NCT02418819|11845977|FG003|COMPLETED|Overall Study||28
10683049|NCT02418819|11845974|FG000|NOT COMPLETED|Overall Study||1
10683050|NCT02418819|11845975|FG001|NOT COMPLETED|Overall Study||0
10683051|NCT02418819|11845976|FG002|NOT COMPLETED|Overall Study||4
10683052|NCT02418819|11845977|FG003|NOT COMPLETED|Overall Study||1
10683053|NCT02418845|11845989|FG000|STARTED|Overall Study||125
10683054|NCT02418845|11845990|FG001|STARTED|Overall Study||64
10683055|NCT02418845|11845989|FG000|COMPLETED|Overall Study||109
10683056|NCT02418845|11845990|FG001|COMPLETED|Overall Study||52
10683057|NCT02418845|11845989|FG000|NOT COMPLETED|Overall Study||16
10683058|NCT02418845|11845990|FG001|NOT COMPLETED|Overall Study||12
10683059|NCT02418910|11845996|FG000|STARTED|Overall Study||50
10683060|NCT02418910|11845996|FG000|COMPLETED|Overall Study||43
10683061|NCT02418910|11845996|FG000|NOT COMPLETED|Overall Study||7
10683062|NCT02418949|11846004|FG000|STARTED|Overall Study||23
10683063|NCT02418949|11846005|FG001|STARTED|Overall Study||22
10683064|NCT02418949|11846006|FG002|STARTED|Overall Study||26
10683065|NCT02418949|11846007|FG003|STARTED|Overall Study||25
10683066|NCT02418949|11846004|FG000|COMPLETED|Overall Study||20
10683067|NCT02418949|11846005|FG001|COMPLETED|Overall Study||21
10683068|NCT02418949|11846006|FG002|COMPLETED|Overall Study||23
10683069|NCT02418949|11846007|FG003|COMPLETED|Overall Study||24
10683070|NCT02418949|11846004|FG000|NOT COMPLETED|Overall Study||3
10683071|NCT02418949|11846005|FG001|NOT COMPLETED|Overall Study||1
10683072|NCT02418949|11846006|FG002|NOT COMPLETED|Overall Study||3
10683073|NCT02418949|11846007|FG003|NOT COMPLETED|Overall Study||1
10683074|NCT02419001|11846019|FG000|STARTED|Period 1- Ceftriaxone Without SYN-004||6
10683075|NCT02419001|11846020|FG001|STARTED|Period 1- Ceftriaxone Without SYN-004||5
10683076|NCT02419001|11846019|FG000|COMPLETED|Period 1- Ceftriaxone Without SYN-004|The Adverse Event (AE) was with ceftriaxone, not with Investigational Product (IP)|5
10683077|NCT02419001|11846020|FG001|COMPLETED|Period 1- Ceftriaxone Without SYN-004||5
10683078|NCT02419001|11846019|FG000|NOT COMPLETED|Period 1- Ceftriaxone Without SYN-004||1
10683079|NCT02419001|11846020|FG001|NOT COMPLETED|Period 1- Ceftriaxone Without SYN-004||0
10683080|NCT02419001|11846019|FG000|STARTED|Period 2- Ceftriaxone With SYN-004||5
10683081|NCT02419001|11846020|FG001|STARTED|Period 2- Ceftriaxone With SYN-004||5
10683082|NCT02419001|11846019|FG000|COMPLETED|Period 2- Ceftriaxone With SYN-004||5
10683083|NCT02419001|11846020|FG001|COMPLETED|Period 2- Ceftriaxone With SYN-004||5
10683084|NCT02419001|11846019|FG000|NOT COMPLETED|Period 2- Ceftriaxone With SYN-004||0
10683085|NCT02419001|11846020|FG001|NOT COMPLETED|Period 2- Ceftriaxone With SYN-004||0
10683086|NCT02419313|11846026|FG000|STARTED|First Intervention||18
10683087|NCT02419313|11846027|FG001|STARTED|First Intervention||15
10683088|NCT02419313|11846026|FG000|COMPLETED|First Intervention||16
10683089|NCT02419313|11846027|FG001|COMPLETED|First Intervention||15
10683090|NCT02419313|11846026|FG000|NOT COMPLETED|First Intervention||2
10683091|NCT02419313|11846027|FG001|NOT COMPLETED|First Intervention||0
10683092|NCT02419313|11846026|FG000|STARTED|Second Intervention||16
10683093|NCT02419313|11846027|FG001|STARTED|Second Intervention||15
10683094|NCT02419313|11846026|FG000|COMPLETED|Second Intervention||15
10683095|NCT02419313|11846027|FG001|COMPLETED|Second Intervention||15
10683096|NCT02419313|11846026|FG000|NOT COMPLETED|Second Intervention||1
10683097|NCT02419313|11846027|FG001|NOT COMPLETED|Second Intervention||0
10683098|NCT02419469|11846033|FG000|STARTED|Overall Study||1
10683099|NCT02419469|11846033|FG000|COMPLETED|Overall Study||0
10683100|NCT02419469|11846033|FG000|NOT COMPLETED|Overall Study||1
10683101|NCT02419508|11846039|FG000|STARTED|Overall Study||96
10683102|NCT02419508|11846040|FG001|STARTED|Overall Study||92
10683103|NCT02419508|11846039|FG000|Full Analysis Set|Overall Study||95
10683104|NCT02419508|11846040|FG001|Full Analysis Set|Overall Study||92
10683105|NCT02419508|11846039|FG000|Safety Analysis Set|Overall Study||95
10683106|NCT02419508|11846040|FG001|Safety Analysis Set|Overall Study||92
10683107|NCT02419508|11846039|FG000|COMPLETED|Overall Study||86
10683108|NCT02419508|11846040|FG001|COMPLETED|Overall Study||88
10683109|NCT02419508|11846039|FG000|NOT COMPLETED|Overall Study||10
10683110|NCT02419508|11846040|FG001|NOT COMPLETED|Overall Study||4
10683111|NCT02419521|11846046|FG000|STARTED|Overall Study||75
10683112|NCT02419521|11846046|FG000|COMPLETED|Overall Study||74
10683113|NCT02419521|11846046|FG000|NOT COMPLETED|Overall Study||1
10683114|NCT02419547|11846050|FG000|STARTED|Overall Study||11
10683115|NCT02419547|11846050|FG000|COMPLETED|Overall Study||11
10683116|NCT02419547|11846050|FG000|NOT COMPLETED|Overall Study||0
10683117|NCT02419573|11846056|FG000|STARTED|Overall Study||1499
10683118|NCT02419573|11846057|FG001|STARTED|Overall Study||1505
10683119|NCT02419573|11846056|FG000|COMPLETED|Overall Study||1495
10683120|NCT02419573|11846057|FG001|COMPLETED|Overall Study||1505
10683121|NCT02419573|11846056|FG000|NOT COMPLETED|Overall Study||4
10683122|NCT02419573|11846057|FG001|NOT COMPLETED|Overall Study||0
10683123|NCT02419612|11846065|FG000|STARTED|Short-term Treatment Period||227
10683124|NCT02419612|11846066|FG001|STARTED|Short-term Treatment Period||217
10683125|NCT02419612|11846065|FG000|Recevied Treatment|Short-term Treatment Period||227
10683126|NCT02419612|11846066|FG001|Recevied Treatment|Short-term Treatment Period||216
10683127|NCT02419612|11846065|FG000|COMPLETED|Short-term Treatment Period||210
10683128|NCT02419612|11846066|FG001|COMPLETED|Short-term Treatment Period||194
10683129|NCT02419612|11846065|FG000|NOT COMPLETED|Short-term Treatment Period||17
10683130|NCT02419612|11846066|FG001|NOT COMPLETED|Short-term Treatment Period||23
10683131|NCT02419612|11846065|FG000|STARTED|Long-term Treatment Period|Not all subjects who completed the previous period were eligible to enter the long-term period.|196
10683132|NCT02419612|11846066|FG001|STARTED|Long-term Treatment Period|Not all subjects who completed the previous period were eligible to enter the long-term period.|186
10683133|NCT02419612|11846065|FG000|Received Treatment|Long-term Treatment Period||196
10683134|NCT02419612|11846066|FG001|Received Treatment|Long-term Treatment Period||183
10683135|NCT02419612|11846065|FG000|COMPLETED|Long-term Treatment Period||174
10683136|NCT02419612|11846066|FG001|COMPLETED|Long-term Treatment Period||164
10683137|NCT02419612|11846065|FG000|NOT COMPLETED|Long-term Treatment Period||22
10683138|NCT02419612|11846066|FG001|NOT COMPLETED|Long-term Treatment Period||22
10683139|NCT02419690|11846074|FG000|STARTED|Overall Study||122
10683140|NCT02419690|11846075|FG001|STARTED|Overall Study||122
10683141|NCT02419690|11846074|FG000|COMPLETED|Overall Study||122
10683142|NCT02419690|11846075|FG001|COMPLETED|Overall Study||122
10683143|NCT02419690|11846074|FG000|NOT COMPLETED|Overall Study||0
10683144|NCT02419690|11846075|FG001|NOT COMPLETED|Overall Study||0
10683145|NCT02419755|11846083|FG000|STARTED|Overall Study||6
10683146|NCT02419755|11846084|FG001|STARTED|Overall Study||6
10683147|NCT02419755|11846083|FG000|COMPLETED|Overall Study||3
10683148|NCT02419755|11846084|FG001|COMPLETED|Overall Study||2
10683149|NCT02419755|11846083|FG000|NOT COMPLETED|Overall Study||3
10683150|NCT02419755|11846084|FG001|NOT COMPLETED|Overall Study||4
10683151|NCT02419924|11846090|FG000|STARTED|Overall Study||12
10683152|NCT02419924|11846090|FG000|COMPLETED|Overall Study||12
10683153|NCT02419924|11846090|FG000|NOT COMPLETED|Overall Study||0
10683154|NCT02419937|11846096|FG000|STARTED|Overall Study||12
10683155|NCT02419937|11846097|FG001|STARTED|Overall Study||16
10683156|NCT02419937|11846096|FG000|COMPLETED|Overall Study||11
10683157|NCT02419937|11846097|FG001|COMPLETED|Overall Study||16
10683158|NCT02419937|11846096|FG000|NOT COMPLETED|Overall Study||1
10683159|NCT02419937|11846097|FG001|NOT COMPLETED|Overall Study||0
10683160|NCT02420015|11846105|FG000|STARTED|Overall Study||21
10683161|NCT02420015|11846106|FG001|STARTED|Overall Study||13
10683162|NCT02420015|11846105|FG000|COMPLETED|Overall Study||21
10799103|NCT03954834|11959724|FG002|STARTED|Overall Study||121
10799104|NCT03954834|11959725|FG003|STARTED|Overall Study||115
10799105|NCT03954834|11959722|FG000|Received at Least One Dose of Study Drug|Overall Study||121
10799106|NCT03954834|11959723|FG001|Received at Least One Dose of Study Drug|Overall Study||121
10799107|NCT03954834|11959724|FG002|Received at Least One Dose of Study Drug|Overall Study||121
10799108|NCT03954834|11959725|FG003|Received at Least One Dose of Study Drug|Overall Study||115
10799109|NCT03954834|11959722|FG000|COMPLETED|Overall Study||114
10799110|NCT03954834|11959723|FG001|COMPLETED|Overall Study||112
10799111|NCT03954834|11959724|FG002|COMPLETED|Overall Study||103
10799112|NCT03954834|11959725|FG003|COMPLETED|Overall Study||99
10799113|NCT03954834|11959722|FG000|NOT COMPLETED|Overall Study||7
10799114|NCT03954834|11959723|FG001|NOT COMPLETED|Overall Study||9
10799115|NCT03954834|11959724|FG002|NOT COMPLETED|Overall Study||18
10799116|NCT03954834|11959725|FG003|NOT COMPLETED|Overall Study||16
10799117|NCT03958071|11959738|FG000|STARTED|Overall Study||347
10799118|NCT03958071|11959739|FG001|STARTED|Overall Study||423
10799119|NCT03958071|11959740|FG002|STARTED|Overall Study||12494
10799120|NCT03958071|11959738|FG000|COMPLETED|Overall Study||347
10799121|NCT03958071|11959739|FG001|COMPLETED|Overall Study||423
10799122|NCT03958071|11959740|FG002|COMPLETED|Overall Study||12494
10799123|NCT03958071|11959738|FG000|NOT COMPLETED|Overall Study||0
10799124|NCT03958071|11959739|FG001|NOT COMPLETED|Overall Study||0
10683163|NCT02420015|11846106|FG001|COMPLETED|Overall Study||13
10683164|NCT02420015|11846105|FG000|NOT COMPLETED|Overall Study||0
10683165|NCT02420015|11846106|FG001|NOT COMPLETED|Overall Study||0
10799125|NCT03958071|11959740|FG002|NOT COMPLETED|Overall Study||0
10683166|NCT02420041|11846114|FG000|STARTED|Overall Study||14
10799126|NCT03961529|11959752|FG000|STARTED|Overall Study||166
10799127|NCT03961529|11959753|FG001|STARTED|Overall Study||144
10799128|NCT03961529|11959754|FG002|STARTED|Overall Study||56
10683167|NCT02420041|11846115|FG001|STARTED|Overall Study||14
10683168|NCT02420041|11846114|FG000|COMPLETED|Overall Study||14
10683169|NCT02420041|11846115|FG001|COMPLETED|Overall Study||14
10683170|NCT02420041|11846114|FG000|NOT COMPLETED|Overall Study||0
10683171|NCT02420041|11846115|FG001|NOT COMPLETED|Overall Study||0
10683172|NCT02420093|11846123|FG000|STARTED|Overall Study||9
10683173|NCT02420093|11846124|FG001|STARTED|Overall Study||8
10683174|NCT02420093|11846123|FG000|COMPLETED|Overall Study||8
10683175|NCT02420093|11846124|FG001|COMPLETED|Overall Study||7
10683176|NCT02420093|11846123|FG000|NOT COMPLETED|Overall Study||1
10683177|NCT02420093|11846124|FG001|NOT COMPLETED|Overall Study||1
10683178|NCT02420210|11846130|FG000|STARTED|Overall Study||2
10683179|NCT02420210|11846130|FG000|COMPLETED|Overall Study||2
10683180|NCT02420210|11846130|FG000|NOT COMPLETED|Overall Study||0
10683181|NCT02420223|11846136|FG000|STARTED|Overall Study||12
10683182|NCT02420223|11846137|FG001|STARTED|Overall Study||13
10683183|NCT02420223|11846136|FG000|COMPLETED|Overall Study||11
10683184|NCT02420223|11846137|FG001|COMPLETED|Overall Study||11
10683185|NCT02420223|11846136|FG000|NOT COMPLETED|Overall Study||1
10683186|NCT02420223|11846137|FG001|NOT COMPLETED|Overall Study||2
10683187|NCT02420262|11846145|FG000|STARTED|Overall Study||252
10683188|NCT02420262|11846146|FG001|STARTED|Overall Study||254
10683189|NCT02420262|11846145|FG000|Exposed|Overall Study||252
10683190|NCT02420262|11846146|FG001|Exposed|Overall Study|One subject withdrew consent before exposure to trial product due to personal reasons.|253
10683191|NCT02420262|11846145|FG000|COMPLETED|Overall Study||250
10683192|NCT02420262|11846146|FG001|COMPLETED|Overall Study||249
10683193|NCT02420262|11846145|FG000|NOT COMPLETED|Overall Study||2
10683194|NCT02420262|11846146|FG001|NOT COMPLETED|Overall Study||5
10683195|NCT02420327|11846152|FG000|STARTED|Overall Study||43
10683196|NCT02420327|11846152|FG000|COMPLETED|Overall Study||27
10683197|NCT02420327|11846152|FG000|NOT COMPLETED|Overall Study||16
10683198|NCT02420353|11846164|FG000|STARTED|Overall Study||10
10683199|NCT02420353|11846165|FG001|STARTED|Overall Study||10
10683200|NCT02420353|11846164|FG000|Allocation to Intervention|Overall Study||10
10799129|NCT03961529|11959752|FG000|COMPLETED|Overall Study||124
10799130|NCT03961529|11959753|FG001|COMPLETED|Overall Study||127
10799131|NCT03961529|11959754|FG002|COMPLETED|Overall Study||51
10799132|NCT03961529|11959752|FG000|NOT COMPLETED|Overall Study||42
10683201|NCT02420353|11846165|FG001|Allocation to Intervention|Overall Study||10
10683202|NCT02420353|11846164|FG000|COMPLETED|Overall Study||10
10683203|NCT02420353|11846165|FG001|COMPLETED|Overall Study||9
10683204|NCT02420353|11846164|FG000|NOT COMPLETED|Overall Study||0
10683205|NCT02420353|11846165|FG001|NOT COMPLETED|Overall Study||1
10683206|NCT02420379|11846173|FG000|STARTED|Overall Study||26
10683207|NCT02420379|11846174|FG001|STARTED|Overall Study||7
10683208|NCT02420379|11846173|FG000|COMPLETED|Overall Study||25
10683209|NCT02420379|11846174|FG001|COMPLETED|Overall Study||3
10683210|NCT02420379|11846173|FG000|NOT COMPLETED|Overall Study||1
10683211|NCT02420379|11846174|FG001|NOT COMPLETED|Overall Study||4
10683212|NCT02420639|11846180|FG000|STARTED|Overall Study|Study obtained 12 patients|12
10683213|NCT02420639|11846180|FG000|COMPLETED|Overall Study|Total of 12 patients enrolled|12
10683214|NCT02420639|11846180|FG000|NOT COMPLETED|Overall Study||0
10683215|NCT02420691|11846184|FG000|STARTED|Overall Study||20
10683216|NCT02420691|11846184|FG000|COMPLETED|Overall Study||14
10683217|NCT02420691|11846184|FG000|NOT COMPLETED|Overall Study||6
10683218|NCT02420873|11846191|FG000|STARTED|Overall Study||9
10683219|NCT02420873|11846192|FG001|STARTED|Overall Study||0
10683220|NCT02420873|11846193|FG002|STARTED|Overall Study||0
10683221|NCT02420873|11846191|FG000|COMPLETED|Overall Study||9
10683222|NCT02420873|11846192|FG001|COMPLETED|Overall Study||0
10683223|NCT02420873|11846193|FG002|COMPLETED|Overall Study||0
10683224|NCT02420873|11846191|FG000|NOT COMPLETED|Overall Study||0
10683225|NCT02420873|11846192|FG001|NOT COMPLETED|Overall Study||0
10683226|NCT02420873|11846193|FG002|NOT COMPLETED|Overall Study||0
10683227|NCT02420951|11846203|FG000|STARTED|Overall Study||25
10683228|NCT02420951|11846204|FG001|STARTED|Overall Study||25
10683229|NCT02420951|11846203|FG000|COMPLETED|Overall Study||25
10683230|NCT02420951|11846204|FG001|COMPLETED|Overall Study||25
10683231|NCT02420951|11846203|FG000|NOT COMPLETED|Overall Study||0
10683232|NCT02420951|11846204|FG001|NOT COMPLETED|Overall Study||0
10683233|NCT02421055|11846212|FG000|STARTED|Overall Study||34
10683234|NCT02421055|11846213|FG001|STARTED|Overall Study||50
10683235|NCT02421055|11846214|FG002|STARTED|Overall Study||74
10683236|NCT02421055|11846212|FG000|Pre-operative Serum Sample (Minimum)|Overall Study||34
10683237|NCT02421055|11846213|FG001|Pre-operative Serum Sample (Minimum)|Overall Study||50
10683238|NCT02421055|11846214|FG002|Pre-operative Serum Sample (Minimum)|Overall Study||74
10683239|NCT02421055|11846212|FG000|Pre-operative Complete Sample Set|Overall Study||23
10683240|NCT02421055|11846213|FG001|Pre-operative Complete Sample Set|Overall Study||22
10683241|NCT02421055|11846214|FG002|Pre-operative Complete Sample Set|Overall Study||36
10683242|NCT02421055|11846212|FG000|Post-operative Serum Sample (Minimum)|Overall Study||0
10683243|NCT02421055|11846213|FG001|Post-operative Serum Sample (Minimum)|Overall Study||23
10683244|NCT02421055|11846214|FG002|Post-operative Serum Sample (Minimum)|Overall Study||26
10683245|NCT02421055|11846212|FG000|Post-operative Complete Sample Set|Overall Study||0
10683246|NCT02421055|11846213|FG001|Post-operative Complete Sample Set|Overall Study||13
10683247|NCT02421055|11846214|FG002|Post-operative Complete Sample Set|Overall Study||14
10683248|NCT02421055|11846212|FG000|COMPLETED|Overall Study||0
10683249|NCT02421055|11846213|FG001|COMPLETED|Overall Study||50
10683250|NCT02421055|11846214|FG002|COMPLETED|Overall Study||74
10683251|NCT02421055|11846212|FG000|NOT COMPLETED|Overall Study||34
10683252|NCT02421055|11846213|FG001|NOT COMPLETED|Overall Study||0
10683253|NCT02421055|11846214|FG002|NOT COMPLETED|Overall Study||0
10683254|NCT02421094|11846225|FG000|STARTED|Overall Study||15
10683255|NCT02421094|11846226|FG001|STARTED|Overall Study||15
10683256|NCT02421094|11846225|FG000|COMPLETED|Overall Study||15
10683257|NCT02421094|11846226|FG001|COMPLETED|Overall Study||15
10683258|NCT02421094|11846225|FG000|NOT COMPLETED|Overall Study||0
10683259|NCT02421094|11846226|FG001|NOT COMPLETED|Overall Study||0
10683260|NCT02421120|11846232|FG000|STARTED|Overall Study||21
10683261|NCT02421120|11846232|FG000|COMPLETED|Overall Study||20
10683262|NCT02421120|11846232|FG000|NOT COMPLETED|Overall Study||1
10683263|NCT02421146|11846240|FG000|STARTED|Overall Study||2
10683264|NCT02421146|11846241|FG001|STARTED|Overall Study||4
10683265|NCT02421146|11846242|FG002|STARTED|Overall Study||3
10683266|NCT02421146|11846243|FG003|STARTED|Overall Study||3
10683267|NCT02421146|11846240|FG000|COMPLETED|Overall Study||2
10683268|NCT02421146|11846241|FG001|COMPLETED|Overall Study||4
10683269|NCT02421146|11846242|FG002|COMPLETED|Overall Study||3
10683270|NCT02421146|11846243|FG003|COMPLETED|Overall Study||3
10683271|NCT02421146|11846240|FG000|NOT COMPLETED|Overall Study||0
10683272|NCT02421146|11846241|FG001|NOT COMPLETED|Overall Study||0
10683273|NCT02421146|11846242|FG002|NOT COMPLETED|Overall Study||0
10683274|NCT02421146|11846243|FG003|NOT COMPLETED|Overall Study||0
10799133|NCT03961529|11959753|FG001|NOT COMPLETED|Overall Study||17
10799134|NCT03961529|11959754|FG002|NOT COMPLETED|Overall Study||5
10799135|NCT03968159|11959764|FG000|STARTED|Overall Study||148
10799136|NCT03968159|11959765|FG001|STARTED|Overall Study||150
10799137|NCT03968159|11959764|FG000|COMPLETED|Overall Study||135
10799138|NCT03968159|11959765|FG001|COMPLETED|Overall Study||135
10799139|NCT03968159|11959764|FG000|NOT COMPLETED|Overall Study||13
10799140|NCT03968159|11959765|FG001|NOT COMPLETED|Overall Study||15
10799141|NCT03968965|11959773|FG000|STARTED|Overall Study||32
10799142|NCT03968965|11959774|FG001|STARTED|Overall Study||32
10799143|NCT03968965|11959773|FG000|COMPLETED|Overall Study||32
10799144|NCT03968965|11959774|FG001|COMPLETED|Overall Study||30
10799145|NCT03968965|11959773|FG000|NOT COMPLETED|Overall Study||0
10799146|NCT03968965|11959774|FG001|NOT COMPLETED|Overall Study||2
10799147|NCT03970824|11959783|FG000|STARTED|Overall Study||103
10799148|NCT03970824|11959784|FG001|STARTED|Overall Study||103
10799149|NCT03970824|11959785|FG002|STARTED|Overall Study||106
10799150|NCT03970824|11959783|FG000|COMPLETED|Overall Study||101
10799151|NCT03970824|11959784|FG001|COMPLETED|Overall Study||100
10799152|NCT03970824|11959785|FG002|COMPLETED|Overall Study||102
10799153|NCT03970824|11959783|FG000|NOT COMPLETED|Overall Study||2
10799154|NCT03970824|11959784|FG001|NOT COMPLETED|Overall Study||3
10799155|NCT03970824|11959785|FG002|NOT COMPLETED|Overall Study||4
10799156|NCT03978403|11959797|FG000|STARTED|Overall Study||6
10799157|NCT03978403|11959798|FG001|STARTED|Overall Study||6
10799158|NCT03978403|11959799|FG002|STARTED|Overall Study||6
10799159|NCT03978403|11959800|FG003|STARTED|Overall Study||6
10799160|NCT03978403|11959797|FG000|COMPLETED|Overall Study||6
10799161|NCT03978403|11959798|FG001|COMPLETED|Overall Study||6
10799162|NCT03978403|11959799|FG002|COMPLETED|Overall Study||6
10799163|NCT03978403|11959800|FG003|COMPLETED|Overall Study||6
10799164|NCT03978403|11959797|FG000|NOT COMPLETED|Overall Study||0
10799165|NCT03978403|11959798|FG001|NOT COMPLETED|Overall Study||0
10799166|NCT03978403|11959799|FG002|NOT COMPLETED|Overall Study||0
10799167|NCT03978403|11959800|FG003|NOT COMPLETED|Overall Study||0
10799168|NCT03979807|11959813|FG000|STARTED|Overall Study||3876
10799169|NCT03979807|11959814|FG001|STARTED|Overall Study||7420
10799170|NCT03979807|11959813|FG000|COMPLETED|Overall Study||3876
10799171|NCT03979807|11959814|FG001|COMPLETED|Overall Study||7420
10683315|NCT02421211|11846272|FG000|STARTED|Overall Study||20
10683316|NCT02421211|11846273|FG001|STARTED|Overall Study||20
10683317|NCT02421211|11846272|FG000|COMPLETED|Overall Study||20
10683318|NCT02421211|11846273|FG001|COMPLETED|Overall Study||20
10683319|NCT02421211|11846272|FG000|NOT COMPLETED|Overall Study||0
10683320|NCT02421211|11846273|FG001|NOT COMPLETED|Overall Study||0
10683321|NCT02421224|11846292|FG000|STARTED|Overall Study||444
10683322|NCT02421224|11846293|FG001|STARTED|Overall Study||397
10683323|NCT02421224|11846294|FG002|STARTED|Overall Study||508
10683324|NCT02421224|11846295|FG003|STARTED|Overall Study||482
10683325|NCT02421224|11846296|FG004|STARTED|Overall Study||495
10683326|NCT02421224|11846297|FG005|STARTED|Overall Study||515
10683327|NCT02421224|11846298|FG006|STARTED|Overall Study||489
10683328|NCT02421224|11846299|FG007|STARTED|Overall Study||364
10683329|NCT02421224|11846300|FG008|STARTED|Overall Study||496
10683330|NCT02421224|11846292|FG000|COMPLETED|Overall Study||442
10683331|NCT02421224|11846293|FG001|COMPLETED|Overall Study||394
10683332|NCT02421224|11846294|FG002|COMPLETED|Overall Study||507
10683333|NCT02421224|11846295|FG003|COMPLETED|Overall Study||479
10683334|NCT02421224|11846296|FG004|COMPLETED|Overall Study||491
10683335|NCT02421224|11846297|FG005|COMPLETED|Overall Study||513
10683336|NCT02421224|11846298|FG006|COMPLETED|Overall Study||489
10683337|NCT02421224|11846299|FG007|COMPLETED|Overall Study||362
10683338|NCT02421224|11846300|FG008|COMPLETED|Overall Study||495
10683339|NCT02421224|11846292|FG000|NOT COMPLETED|Overall Study||2
10683340|NCT02421224|11846293|FG001|NOT COMPLETED|Overall Study||3
10683341|NCT02421224|11846294|FG002|NOT COMPLETED|Overall Study||1
10683342|NCT02421224|11846295|FG003|NOT COMPLETED|Overall Study||3
10683343|NCT02421224|11846296|FG004|NOT COMPLETED|Overall Study||4
10683344|NCT02421224|11846297|FG005|NOT COMPLETED|Overall Study||2
10683345|NCT02421224|11846298|FG006|NOT COMPLETED|Overall Study||0
10683346|NCT02421224|11846299|FG007|NOT COMPLETED|Overall Study||2
10683347|NCT02421224|11846300|FG008|NOT COMPLETED|Overall Study||1
10683348|NCT02421354|11846320|FG000|STARTED|Overall Study||8
10683349|NCT02421354|11846320|FG000|COMPLETED|Overall Study||8
10683350|NCT02421354|11846320|FG000|NOT COMPLETED|Overall Study||0
10712965|NCT02675634|11878495|FG000|NOT COMPLETED|Test Period 3||0
10712966|NCT02675634|11878496|FG001|NOT COMPLETED|Test Period 3||0
10712967|NCT02675634|11878497|FG002|NOT COMPLETED|Test Period 3||0
10712968|NCT02675634|11878498|FG003|NOT COMPLETED|Test Period 3||0
10712969|NCT02675634|11878499|FG004|NOT COMPLETED|Test Period 3||0
10712970|NCT02675634|11878500|FG005|NOT COMPLETED|Test Period 3||0
10712971|NCT02675764|11878510|FG000|STARTED|Overall Study||6
10712972|NCT02675764|11878511|FG001|STARTED|Overall Study||6
10712973|NCT02675764|11878510|FG000|COMPLETED|Overall Study||6
10712974|NCT02675764|11878511|FG001|COMPLETED|Overall Study||6
10712975|NCT02675764|11878510|FG000|NOT COMPLETED|Overall Study||0
10712976|NCT02675764|11878511|FG001|NOT COMPLETED|Overall Study||0
10712977|NCT02675907|11878519|FG000|STARTED|Treatment Phase (48 Hours Post-Dose 1)||100
10712978|NCT02675907|11878520|FG001|STARTED|Treatment Phase (48 Hours Post-Dose 1)||101
10712979|NCT02675907|11878519|FG000|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||95
10712980|NCT02675907|11878520|FG001|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||96
10712981|NCT02675907|11878519|FG000|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||5
10712982|NCT02675907|11878520|FG001|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||5
10712983|NCT02675907|11878519|FG000|STARTED|Study Overall||100
10712984|NCT02675907|11878520|FG001|STARTED|Study Overall||101
10712985|NCT02675907|11878519|FG000|COMPLETED|Study Overall||97
10712986|NCT02675907|11878520|FG001|COMPLETED|Study Overall||97
10712987|NCT02675907|11878519|FG000|NOT COMPLETED|Study Overall||3
10712988|NCT02675907|11878520|FG001|NOT COMPLETED|Study Overall||4
10712989|NCT02675998|11878530|FG000|STARTED|8-Week Treatment Period||74
10712990|NCT02675998|11878531|FG001|STARTED|8-Week Treatment Period||73
10712991|NCT02675998|11878532|FG002|STARTED|8-Week Treatment Period||72
10799172|NCT03979807|11959813|FG000|NOT COMPLETED|Overall Study||0
10799173|NCT03979807|11959814|FG001|NOT COMPLETED|Overall Study||0
10799174|NCT03980470|11959820|FG000|STARTED|Overall Study||50
10799175|NCT03980470|11959820|FG000|COMPLETED|Overall Study||50
10799176|NCT03980470|11959820|FG000|NOT COMPLETED|Overall Study||0
10799177|NCT03982069|11959831|FG000|STARTED|Overall Study||108
10799178|NCT03982069|11959832|FG001|STARTED|Overall Study||110
10799179|NCT03982069|11959833|FG002|STARTED|Overall Study||127
10799180|NCT03982069|11959834|FG003|STARTED|Overall Study||120
10799181|NCT03982069|11959831|FG000|COMPLETED|Overall Study||98
10799182|NCT03982069|11959832|FG001|COMPLETED|Overall Study||100
10799183|NCT03982069|11959833|FG002|COMPLETED|Overall Study||118
10799184|NCT03982069|11959834|FG003|COMPLETED|Overall Study||112
10799185|NCT03982069|11959831|FG000|NOT COMPLETED|Overall Study||10
10799186|NCT03982069|11959832|FG001|NOT COMPLETED|Overall Study||10
10799187|NCT03982069|11959833|FG002|NOT COMPLETED|Overall Study||9
10799188|NCT03982069|11959834|FG003|NOT COMPLETED|Overall Study||8
10799189|NCT03984812|11959853|FG000|STARTED|Part 1 (Up to Day 28)||6
10799190|NCT03984812|11959854|FG001|STARTED|Part 1 (Up to Day 28)||6
10799191|NCT03984812|11959855|FG002|STARTED|Part 1 (Up to Day 28)||6
10799192|NCT03984812|11959856|FG003|STARTED|Part 1 (Up to Day 28)||6
10799193|NCT03984812|11959857|FG004|STARTED|Part 1 (Up to Day 28)|No participants were enrolled in this arm as the study was terminated due to non-safety reasons.|0
10799194|NCT03984812|11959858|FG005|STARTED|Part 1 (Up to Day 28)|No participants were enrolled in this arm as the study was terminated due to non-safety reasons.|0
10799195|NCT03984812|11959859|FG006|STARTED|Part 1 (Up to Day 28)|No participants were enrolled in this arm as the study was terminated due to non-safety reasons.|0
10799196|NCT03984812|11959860|FG007|STARTED|Part 1 (Up to Day 28)||0
10799197|NCT03984812|11959861|FG008|STARTED|Part 1 (Up to Day 28)||0
10799198|NCT03984812|11959862|FG009|STARTED|Part 1 (Up to Day 28)||0
10799199|NCT03984812|11959863|FG010|STARTED|Part 1 (Up to Day 28)||0
10799200|NCT03984812|11959853|FG000|COMPLETED|Part 1 (Up to Day 28)||6
10799201|NCT03984812|11959854|FG001|COMPLETED|Part 1 (Up to Day 28)||6
10799202|NCT03984812|11959855|FG002|COMPLETED|Part 1 (Up to Day 28)||5
10799203|NCT03984812|11959856|FG003|COMPLETED|Part 1 (Up to Day 28)||6
10799204|NCT03984812|11959857|FG004|COMPLETED|Part 1 (Up to Day 28)||0
10799205|NCT03984812|11959858|FG005|COMPLETED|Part 1 (Up to Day 28)||0
10799206|NCT03984812|11959859|FG006|COMPLETED|Part 1 (Up to Day 28)||0
10799207|NCT03984812|11959860|FG007|COMPLETED|Part 1 (Up to Day 28)||0
10799208|NCT03984812|11959861|FG008|COMPLETED|Part 1 (Up to Day 28)||0
10799209|NCT03984812|11959862|FG009|COMPLETED|Part 1 (Up to Day 28)||0
10712992|NCT02675998|11878533|FG003|STARTED|8-Week Treatment Period||0
10712993|NCT02675998|11878530|FG000|COMPLETED|8-Week Treatment Period||57
10799210|NCT03984812|11959863|FG010|COMPLETED|Part 1 (Up to Day 28)||0
10799211|NCT03984812|11959853|FG000|NOT COMPLETED|Part 1 (Up to Day 28)||0
10799212|NCT03984812|11959854|FG001|NOT COMPLETED|Part 1 (Up to Day 28)||0
10799213|NCT03984812|11959855|FG002|NOT COMPLETED|Part 1 (Up to Day 28)||1
10799214|NCT03984812|11959856|FG003|NOT COMPLETED|Part 1 (Up to Day 28)||0
10712994|NCT02675998|11878531|FG001|COMPLETED|8-Week Treatment Period||54
10799215|NCT03984812|11959857|FG004|NOT COMPLETED|Part 1 (Up to Day 28)||0
10799216|NCT03984812|11959858|FG005|NOT COMPLETED|Part 1 (Up to Day 28)||0
10799217|NCT03984812|11959859|FG006|NOT COMPLETED|Part 1 (Up to Day 28)||0
10799218|NCT03984812|11959860|FG007|NOT COMPLETED|Part 1 (Up to Day 28)||0
10799219|NCT03984812|11959861|FG008|NOT COMPLETED|Part 1 (Up to Day 28)||0
10799220|NCT03984812|11959862|FG009|NOT COMPLETED|Part 1 (Up to Day 28)||0
10712995|NCT02675998|11878532|FG002|COMPLETED|8-Week Treatment Period||53
10683351|NCT02421419|11846327|FG000|STARTED|Overall Study||6
10683352|NCT02421419|11846328|FG001|STARTED|Overall Study||11
10683353|NCT02421419|11846329|FG002|STARTED|Overall Study||9
10683354|NCT02421419|11846327|FG000|COMPLETED|Overall Study||6
10683355|NCT02421419|11846328|FG001|COMPLETED|Overall Study||11
10683356|NCT02421419|11846329|FG002|COMPLETED|Overall Study||8
10683357|NCT02421419|11846327|FG000|NOT COMPLETED|Overall Study||0
10683358|NCT02421419|11846328|FG001|NOT COMPLETED|Overall Study||0
10683359|NCT02421419|11846329|FG002|NOT COMPLETED|Overall Study||1
10683360|NCT02421510|11846340|FG000|STARTED|Overall Study||258
10683361|NCT02421510|11846341|FG001|STARTED|Overall Study||261
10683362|NCT02421510|11846342|FG002|STARTED|Overall Study||263
10683363|NCT02421510|11846340|FG000|Completed the 24 Week Treatment Period|Overall Study||236
10683364|NCT02421510|11846341|FG001|Completed the 24 Week Treatment Period|Overall Study||239
10683365|NCT02421510|11846342|FG002|Completed the 24 Week Treatment Period|Overall Study||240
10683366|NCT02421510|11846340|FG000|COMPLETED|Overall Study||225
10683367|NCT02421510|11846341|FG001|COMPLETED|Overall Study||226
10683368|NCT02421510|11846342|FG002|COMPLETED|Overall Study||227
10683369|NCT02421510|11846340|FG000|NOT COMPLETED|Overall Study||33
10683370|NCT02421510|11846341|FG001|NOT COMPLETED|Overall Study||35
10683371|NCT02421510|11846342|FG002|NOT COMPLETED|Overall Study||36
10683372|NCT02421588|11846352|FG000|STARTED|Overall Study||221
10683373|NCT02421588|11846353|FG001|STARTED|Overall Study||221
10683374|NCT02421588|11846352|FG000|COMPLETED|Overall Study||0
10683375|NCT02421588|11846353|FG001|COMPLETED|Overall Study||0
10683376|NCT02421588|11846352|FG000|NOT COMPLETED|Overall Study||221
10683377|NCT02421588|11846353|FG001|NOT COMPLETED|Overall Study||221
10683378|NCT02421601|11846359|FG000|STARTED|Overall Study||991
10683379|NCT02421601|11846359|FG000|COMPLETED|Overall Study||909
10683380|NCT02421601|11846359|FG000|NOT COMPLETED|Overall Study||82
10683381|NCT02421666|11846365|FG000|STARTED|Overall Study Baseline||272
10683382|NCT02421666|11846366|FG001|STARTED|Overall Study Baseline||260
10683383|NCT02421666|11846365|FG000|COMPLETED|Overall Study Baseline||272
10683384|NCT02421666|11846366|FG001|COMPLETED|Overall Study Baseline||260
10683385|NCT02421666|11846365|FG000|NOT COMPLETED|Overall Study Baseline||0
10683386|NCT02421666|11846366|FG001|NOT COMPLETED|Overall Study Baseline||0
10683387|NCT02421666|11846365|FG000|STARTED|6-month Follow-up||272
10683388|NCT02421666|11846366|FG001|STARTED|6-month Follow-up||260
10683389|NCT02421666|11846365|FG000|COMPLETED|6-month Follow-up||259
10683390|NCT02421666|11846366|FG001|COMPLETED|6-month Follow-up||247
10683391|NCT02421666|11846365|FG000|NOT COMPLETED|6-month Follow-up||13
10683392|NCT02421666|11846366|FG001|NOT COMPLETED|6-month Follow-up||13
10683393|NCT02421666|11846365|FG000|STARTED|12-month Follow-up||259
10683394|NCT02421666|11846366|FG001|STARTED|12-month Follow-up||247
10683395|NCT02421666|11846365|FG000|COMPLETED|12-month Follow-up||248
10683396|NCT02421666|11846366|FG001|COMPLETED|12-month Follow-up||231
10683397|NCT02421666|11846365|FG000|NOT COMPLETED|12-month Follow-up||11
10683398|NCT02421666|11846366|FG001|NOT COMPLETED|12-month Follow-up||16
10683399|NCT02421757|11846374|FG000|STARTED|Overall Study||11
10683400|NCT02421757|11846375|FG001|STARTED|Overall Study||9
10683401|NCT02421757|11846374|FG000|COMPLETED|Overall Study||11
10683402|NCT02421757|11846375|FG001|COMPLETED|Overall Study||9
10683403|NCT02421757|11846374|FG000|NOT COMPLETED|Overall Study||0
10683404|NCT02421757|11846375|FG001|NOT COMPLETED|Overall Study||0
10683405|NCT02421887|11846383|FG000|STARTED|Overall Study||85
10683406|NCT02421887|11846384|FG001|STARTED|Overall Study||86
10683407|NCT02421887|11846383|FG000|COMPLETED|Overall Study||68
10683408|NCT02421887|11846384|FG001|COMPLETED|Overall Study||77
10683409|NCT02421887|11846383|FG000|NOT COMPLETED|Overall Study||17
10683410|NCT02421887|11846384|FG001|NOT COMPLETED|Overall Study||9
10683411|NCT02421952|11846390|FG000|STARTED|Overall Study||208
10683412|NCT02421952|11846390|FG000|Excluded From PACU and Post-Analysis|Overall Study||16
10683413|NCT02421952|11846390|FG000|Included in PACU Analysis|Overall Study||192
10683414|NCT02421952|11846390|FG000|COMPLETED|Overall Study||99
10683415|NCT02421952|11846390|FG000|NOT COMPLETED|Overall Study||109
10683416|NCT02422186|11846399|FG000|STARTED|Double-blind Induction Phase (4 Weeks)||72
10683417|NCT02422186|11846400|FG001|STARTED|Double-blind Induction Phase (4 Weeks)||66
10683418|NCT02422186|11846399|FG000|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||72
10683419|NCT02422186|11846400|FG001|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||65
10683420|NCT02422186|11846399|FG000|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||72
10683421|NCT02422186|11846400|FG001|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||65
10683422|NCT02422186|11846399|FG000|COMPLETED|Double-blind Induction Phase (4 Weeks)||62
10683423|NCT02422186|11846400|FG001|COMPLETED|Double-blind Induction Phase (4 Weeks)||60
10683424|NCT02422186|11846399|FG000|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||10
10683425|NCT02422186|11846400|FG001|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||6
10683426|NCT02422186|11846399|FG000|STARTED|Follow-up Phase (2 Weeks)||12
10683427|NCT02422186|11846400|FG001|STARTED|Follow-up Phase (2 Weeks)||3
10683428|NCT02422186|11846399|FG000|COMPLETED|Follow-up Phase (2 Weeks)||8
10683429|NCT02422186|11846400|FG001|COMPLETED|Follow-up Phase (2 Weeks)||3
10683430|NCT02422186|11846399|FG000|NOT COMPLETED|Follow-up Phase (2 Weeks)||4
10683431|NCT02422186|11846400|FG001|NOT COMPLETED|Follow-up Phase (2 Weeks)||0
10683432|NCT02422264|11846410|FG000|STARTED|Overall Study||296
10683433|NCT02422264|11846411|FG001|STARTED|Overall Study||305
10683434|NCT02422264|11846410|FG000|COMPLETED|Overall Study||291
10683435|NCT02422264|11846411|FG001|COMPLETED|Overall Study||301
10683436|NCT02422264|11846410|FG000|NOT COMPLETED|Overall Study||5
10683437|NCT02422264|11846411|FG001|NOT COMPLETED|Overall Study||4
10683438|NCT02422290|11846417|FG000|STARTED|Overall Study||5
10683439|NCT02422290|11846417|FG000|COMPLETED|Overall Study||5
10683440|NCT02422290|11846417|FG000|NOT COMPLETED|Overall Study||0
10683441|NCT02422511|11846429|FG000|STARTED|Overall Study||255
10683442|NCT02422511|11846430|FG001|STARTED|Overall Study||128
10683443|NCT02422511|11846431|FG002|STARTED|Overall Study||257
10683444|NCT02422511|11846432|FG003|STARTED|Overall Study||129
10683445|NCT02422511|11846433|FG004|STARTED|Overall Study||66
10683446|NCT02422511|11846434|FG005|STARTED|Overall Study||33
10683447|NCT02422511|11846435|FG006|STARTED|Overall Study||68
10683448|NCT02422511|11846436|FG007|STARTED|Overall Study||34
10683449|NCT02422511|11846429|FG000|Received Disclosure|Overall Study||158
10683450|NCT02422511|11846430|FG001|Received Disclosure|Overall Study|Newborns did not receive disclosure|79
10683451|NCT02422511|11846431|FG002|Received Disclosure|Overall Study||194
10683452|NCT02422511|11846432|FG003|Received Disclosure|Overall Study||97
10683453|NCT02422511|11846433|FG004|Received Disclosure|Overall Study||43
10683454|NCT02422511|11846434|FG005|Received Disclosure|Overall Study||21
10683455|NCT02422511|11846435|FG006|Received Disclosure|Overall Study||38
10683456|NCT02422511|11846436|FG007|Received Disclosure|Overall Study||19
10683457|NCT02422511|11846429|FG000|COMPLETED|Overall Study||143
10683458|NCT02422511|11846430|FG001|COMPLETED|Overall Study|Newborns did not complete survey|0
10683459|NCT02422511|11846431|FG002|COMPLETED|Overall Study||168
10683460|NCT02422511|11846432|FG003|COMPLETED|Overall Study|Newborns did not complete survey|0
10683461|NCT02422511|11846433|FG004|COMPLETED|Overall Study||39
10683462|NCT02422511|11846434|FG005|COMPLETED|Overall Study|Newborns did not complete survey|0
10683463|NCT02422511|11846435|FG006|COMPLETED|Overall Study||38
10683464|NCT02422511|11846436|FG007|COMPLETED|Overall Study|Newborns did not complete survey|0
10683465|NCT02422511|11846429|FG000|NOT COMPLETED|Overall Study||112
10683466|NCT02422511|11846430|FG001|NOT COMPLETED|Overall Study||128
10683467|NCT02422511|11846431|FG002|NOT COMPLETED|Overall Study||89
10683468|NCT02422511|11846432|FG003|NOT COMPLETED|Overall Study||129
10683469|NCT02422511|11846433|FG004|NOT COMPLETED|Overall Study||27
10683470|NCT02422511|11846434|FG005|NOT COMPLETED|Overall Study||33
10683471|NCT02422511|11846435|FG006|NOT COMPLETED|Overall Study||30
10683472|NCT02422511|11846436|FG007|NOT COMPLETED|Overall Study||34
10683473|NCT02422940|11846456|FG000|STARTED|Overall Study||152
10683474|NCT02422940|11846457|FG001|STARTED|Overall Study||142
10683475|NCT02422940|11846456|FG000|COMPLETED|Overall Study||31
10683476|NCT02422940|11846457|FG001|COMPLETED|Overall Study||21
10683477|NCT02422940|11846456|FG000|NOT COMPLETED|Overall Study||121
10683478|NCT02422940|11846457|FG001|NOT COMPLETED|Overall Study||121
10683479|NCT02423109|11846463|FG000|STARTED|Lens 1||19
10683480|NCT02423109|11846464|FG001|STARTED|Lens 1||14
10683481|NCT02423109|11846463|FG000|COMPLETED|Lens 1||18
10683482|NCT02423109|11846464|FG001|COMPLETED|Lens 1||14
10683483|NCT02423109|11846463|FG000|NOT COMPLETED|Lens 1||1
10683484|NCT02423109|11846464|FG001|NOT COMPLETED|Lens 1||0
10683485|NCT02423109|11846463|FG000|STARTED|Lens 2||18
10683486|NCT02423109|11846464|FG001|STARTED|Lens 2||14
10683487|NCT02423109|11846463|FG000|COMPLETED|Lens 2||18
10683488|NCT02423109|11846464|FG001|COMPLETED|Lens 2||14
10683489|NCT02423109|11846463|FG000|NOT COMPLETED|Lens 2||0
10683490|NCT02423109|11846464|FG001|NOT COMPLETED|Lens 2||0
10683491|NCT02423122|11846474|FG000|STARTED|Overall Study||9
10683492|NCT02423122|11846475|FG001|STARTED|Overall Study||7
10683493|NCT02423122|11846474|FG000|COMPLETED|Overall Study||9
10683494|NCT02423122|11846475|FG001|COMPLETED|Overall Study||7
10683495|NCT02423122|11846474|FG000|NOT COMPLETED|Overall Study||0
10683496|NCT02423122|11846475|FG001|NOT COMPLETED|Overall Study||0
10683497|NCT02423200|11846483|FG000|STARTED|Overall Study||8
10683498|NCT02423200|11846484|FG001|STARTED|Overall Study||1
10683499|NCT02423200|11846483|FG000|COMPLETED|Overall Study||7
10683500|NCT02423200|11846484|FG001|COMPLETED|Overall Study||1
10683501|NCT02423200|11846483|FG000|NOT COMPLETED|Overall Study||1
10683502|NCT02423200|11846484|FG001|NOT COMPLETED|Overall Study||0
10683503|NCT02423291|11846491|FG000|STARTED|Overall Study|Patients enrolled|15
10683504|NCT02423291|11846491|FG000|COMPLETED|Overall Study|Patients that have completed therapy|0
10683505|NCT02423291|11846491|FG000|NOT COMPLETED|Overall Study||15
10683506|NCT02423317|11846497|FG000|STARTED|Overall Study||30
10683507|NCT02423317|11846498|FG001|STARTED|Overall Study||30
10683508|NCT02423317|11846497|FG000|COMPLETED|Overall Study||30
10683509|NCT02423317|11846498|FG001|COMPLETED|Overall Study||30
10683510|NCT02423317|11846497|FG000|NOT COMPLETED|Overall Study||0
10683511|NCT02423317|11846498|FG001|NOT COMPLETED|Overall Study||0
10683512|NCT02423343|11846510|FG000|STARTED|Overall Study||3
10683513|NCT02423343|11846511|FG001|STARTED|Overall Study||5
10683514|NCT02423343|11846512|FG002|STARTED|Overall Study||3
10683515|NCT02423343|11846513|FG003|STARTED|Overall Study||4
10683516|NCT02423343|11846514|FG004|STARTED|Overall Study||25
10683517|NCT02423343|11846515|FG005|STARTED|Overall Study||1
10683518|NCT02423343|11846510|FG000|Received at Least One Dose of Study Drug|Overall Study||3
10683519|NCT02423343|11846511|FG001|Received at Least One Dose of Study Drug|Overall Study||5
10683520|NCT02423343|11846512|FG002|Received at Least One Dose of Study Drug|Overall Study||3
10683521|NCT02423343|11846513|FG003|Received at Least One Dose of Study Drug|Overall Study||4
10683522|NCT02423343|11846514|FG004|Received at Least One Dose of Study Drug|Overall Study||25
10683523|NCT02423343|11846515|FG005|Received at Least One Dose of Study Drug|Overall Study||1
10683524|NCT02423343|11846510|FG000|COMPLETED|Overall Study||3
10683525|NCT02423343|11846511|FG001|COMPLETED|Overall Study||4
10683526|NCT02423343|11846512|FG002|COMPLETED|Overall Study||3
10683527|NCT02423343|11846513|FG003|COMPLETED|Overall Study||4
10683528|NCT02423343|11846514|FG004|COMPLETED|Overall Study||20
10683529|NCT02423343|11846515|FG005|COMPLETED|Overall Study||1
10683530|NCT02423343|11846510|FG000|NOT COMPLETED|Overall Study||0
10683531|NCT02423343|11846511|FG001|NOT COMPLETED|Overall Study||1
10683532|NCT02423343|11846512|FG002|NOT COMPLETED|Overall Study||0
10683533|NCT02423343|11846513|FG003|NOT COMPLETED|Overall Study||0
10683534|NCT02423343|11846514|FG004|NOT COMPLETED|Overall Study||5
10683535|NCT02423343|11846515|FG005|NOT COMPLETED|Overall Study||0
10683536|NCT02423408|11846545|FG000|STARTED|Overall Study||83
10683537|NCT02423408|11846546|FG001|STARTED|Overall Study||82
10683538|NCT02423408|11846545|FG000|COMPLETED|Overall Study||82
10683539|NCT02423408|11846546|FG001|COMPLETED|Overall Study||80
10683540|NCT02423408|11846545|FG000|NOT COMPLETED|Overall Study||1
10683541|NCT02423408|11846546|FG001|NOT COMPLETED|Overall Study||2
10683542|NCT02423447|11846552|FG000|STARTED|Overall Study||13
10683543|NCT02423447|11846553|FG001|STARTED|Overall Study||12
10683544|NCT02423447|11846552|FG000|COMPLETED|Overall Study||13
10683545|NCT02423447|11846553|FG001|COMPLETED|Overall Study||12
10683546|NCT02423447|11846552|FG000|NOT COMPLETED|Overall Study||0
10683547|NCT02423447|11846553|FG001|NOT COMPLETED|Overall Study||0
10683548|NCT02423577|11846564|FG000|STARTED|Overall Study||53
10683549|NCT02423577|11846565|FG001|STARTED|Overall Study||26
10683550|NCT02423577|11846564|FG000|COMPLETED|Overall Study||53
10683551|NCT02423577|11846565|FG001|COMPLETED|Overall Study||26
10683552|NCT02423577|11846564|FG000|NOT COMPLETED|Overall Study||0
10683553|NCT02423577|11846565|FG001|NOT COMPLETED|Overall Study||0
10683554|NCT02423798|11846571|FG000|STARTED|Overall Study||24
10683555|NCT02423798|11846571|FG000|COMPLETED|Overall Study||21
10683556|NCT02423798|11846571|FG000|NOT COMPLETED|Overall Study||3
10683557|NCT02423980|11846576|FG000|STARTED|Overall Study||7
10683558|NCT02423980|11846576|FG000|COMPLETED|Overall Study||7
10683559|NCT02423980|11846576|FG000|NOT COMPLETED|Overall Study||0
10683560|NCT02423993|11846586|FG000|STARTED|Overall Study||19
10683561|NCT02423993|11846587|FG001|STARTED|Overall Study||16
10683562|NCT02423993|11846588|FG002|STARTED|Overall Study||23
10683563|NCT02423993|11846589|FG003|STARTED|Overall Study||19
10683564|NCT02423993|11846586|FG000|COMPLETED|Overall Study||19
10683565|NCT02423993|11846587|FG001|COMPLETED|Overall Study||16
10683566|NCT02423993|11846588|FG002|COMPLETED|Overall Study||23
10683567|NCT02423993|11846589|FG003|COMPLETED|Overall Study||19
10683568|NCT02423993|11846586|FG000|NOT COMPLETED|Overall Study||0
10683569|NCT02423993|11846587|FG001|NOT COMPLETED|Overall Study||0
10683570|NCT02423993|11846588|FG002|NOT COMPLETED|Overall Study||0
10683571|NCT02423993|11846589|FG003|NOT COMPLETED|Overall Study||0
10683572|NCT02424097|11846601|FG000|STARTED|Overall Study||20
10683573|NCT02424097|11846602|FG001|STARTED|Overall Study||20
10683574|NCT02424097|11846601|FG000|COMPLETED|Overall Study||19
10683575|NCT02424097|11846602|FG001|COMPLETED|Overall Study||18
10683576|NCT02424097|11846601|FG000|NOT COMPLETED|Overall Study||1
10683577|NCT02424097|11846602|FG001|NOT COMPLETED|Overall Study||2
10683578|NCT02424149|11846610|FG000|STARTED|Overall Study||54
10683579|NCT02424149|11846611|FG001|STARTED|Overall Study||53
10683580|NCT02424149|11846610|FG000|COMPLETED|Overall Study||52
10683581|NCT02424149|11846611|FG001|COMPLETED|Overall Study||52
10683582|NCT02424149|11846610|FG000|NOT COMPLETED|Overall Study||2
10683583|NCT02424149|11846611|FG001|NOT COMPLETED|Overall Study||1
10683584|NCT02424175|11846617|FG000|STARTED|Overall Study||10
10683585|NCT02424175|11846617|FG000|COMPLETED|Overall Study||10
10683586|NCT02424175|11846617|FG000|NOT COMPLETED|Overall Study||0
10683587|NCT02424253|11846623|FG000|STARTED|Overall Study||65
10683588|NCT02424253|11846624|FG001|STARTED|Overall Study||33
10683589|NCT02424253|11846623|FG000|COMPLETED|Overall Study||54
10683590|NCT02424253|11846624|FG001|COMPLETED|Overall Study||24
10683591|NCT02424253|11846623|FG000|NOT COMPLETED|Overall Study||11
10683592|NCT02424253|11846624|FG001|NOT COMPLETED|Overall Study||9
10683593|NCT02424344|11846632|FG000|STARTED|Overall Study||134
10683594|NCT02424344|11846633|FG001|STARTED|Overall Study||133
10683595|NCT02424344|11846632|FG000|COMPLETED|Overall Study||127
10683596|NCT02424344|11846633|FG001|COMPLETED|Overall Study||123
10683597|NCT02424344|11846632|FG000|NOT COMPLETED|Overall Study||7
10683598|NCT02424344|11846633|FG001|NOT COMPLETED|Overall Study||10
10683599|NCT02424357|11846641|FG000|STARTED|Overall Study||35
10683600|NCT02424357|11846642|FG001|STARTED|Overall Study||30
10683601|NCT02424357|11846641|FG000|COMPLETED|Overall Study||35
10683602|NCT02424357|11846642|FG001|COMPLETED|Overall Study||30
10683603|NCT02424357|11846641|FG000|NOT COMPLETED|Overall Study||0
10683604|NCT02424357|11846642|FG001|NOT COMPLETED|Overall Study||0
10683605|NCT02424383|11846650|FG000|STARTED|Overall Study||1005
10683606|NCT02424383|11846650|FG000|Per-Protocol Population|Overall Study||966
10683607|NCT02424383|11846650|FG000|COMPLETED|Overall Study||629
10683608|NCT02424383|11846650|FG000|NOT COMPLETED|Overall Study||376
10683609|NCT02424526|11846656|FG000|STARTED|Overall Study||9
10683610|NCT02424526|11846657|FG001|STARTED|Overall Study||10
10683611|NCT02424526|11846656|FG000|COMPLETED|Overall Study||9
10683612|NCT02424526|11846657|FG001|COMPLETED|Overall Study||10
10683613|NCT02424526|11846656|FG000|NOT COMPLETED|Overall Study||0
10683614|NCT02424526|11846657|FG001|NOT COMPLETED|Overall Study||0
10683615|NCT02424539|11846668|FG000|STARTED|Overall Study||120
10683616|NCT02424539|11846669|FG001|STARTED|Overall Study||119
10683617|NCT02424539|11846670|FG002|STARTED|Overall Study||119
10683618|NCT02424539|11846668|FG000|COMPLETED|Overall Study||106
10683619|NCT02424539|11846669|FG001|COMPLETED|Overall Study||111
10683620|NCT02424539|11846670|FG002|COMPLETED|Overall Study||111
10683621|NCT02424539|11846668|FG000|NOT COMPLETED|Overall Study||14
10683622|NCT02424539|11846669|FG001|NOT COMPLETED|Overall Study||8
10683623|NCT02424539|11846670|FG002|NOT COMPLETED|Overall Study||8
10683624|NCT02424578|11846680|FG000|STARTED|Overall Study||15
10683625|NCT02424578|11846681|FG001|STARTED|Overall Study||15
10683626|NCT02424578|11846680|FG000|COMPLETED|Overall Study||15
10683627|NCT02424578|11846681|FG001|COMPLETED|Overall Study||14
10683628|NCT02424578|11846680|FG000|NOT COMPLETED|Overall Study||0
10683629|NCT02424578|11846681|FG001|NOT COMPLETED|Overall Study||1
10683630|NCT02424591|11846689|FG000|STARTED|Overall Study||22
10683631|NCT02424591|11846690|FG001|STARTED|Overall Study||23
10683632|NCT02424591|11846689|FG000|COMPLETED|Overall Study||20
10683633|NCT02424591|11846690|FG001|COMPLETED|Overall Study||20
10683634|NCT02424591|11846689|FG000|NOT COMPLETED|Overall Study||2
10683635|NCT02424591|11846690|FG001|NOT COMPLETED|Overall Study||3
10683636|NCT02424630|11846698|FG000|STARTED|Overall Study||25
10683637|NCT02424630|11846699|FG001|STARTED|Overall Study||27
10683638|NCT02424630|11846698|FG000|COMPLETED|Overall Study||24
10683639|NCT02424630|11846699|FG001|COMPLETED|Overall Study||24
10683640|NCT02424630|11846698|FG000|NOT COMPLETED|Overall Study||1
10683641|NCT02424630|11846699|FG001|NOT COMPLETED|Overall Study||3
10683642|NCT02424734|11846708|FG000|STARTED|Overall Study||4
10683643|NCT02424734|11846709|FG001|STARTED|Overall Study||5
10683644|NCT02424734|11846710|FG002|STARTED|Overall Study||2
10683645|NCT02424734|11846708|FG000|Treated|Overall Study||4
10683646|NCT02424734|11846709|FG001|Treated|Overall Study||5
10683647|NCT02424734|11846710|FG002|Treated|Overall Study||2
10683648|NCT02424734|11846708|FG000|COMPLETED|Overall Study||2
10683649|NCT02424734|11846709|FG001|COMPLETED|Overall Study||3
10683650|NCT02424734|11846710|FG002|COMPLETED|Overall Study||2
10683651|NCT02424734|11846708|FG000|NOT COMPLETED|Overall Study||2
10683652|NCT02424734|11846709|FG001|NOT COMPLETED|Overall Study||2
10683653|NCT02424734|11846710|FG002|NOT COMPLETED|Overall Study||0
10683654|NCT02424799|11846725|FG000|STARTED|Part A (Up to Day 11)||9
10683655|NCT02424799|11846726|FG001|STARTED|Part A (Up to Day 11)||8
10683656|NCT02424799|11846727|FG002|STARTED|Part A (Up to Day 11)||0
10683657|NCT02424799|11846728|FG003|STARTED|Part A (Up to Day 11)||0
10683658|NCT02424799|11846729|FG004|STARTED|Part A (Up to Day 11)||0
10683659|NCT02424799|11846730|FG005|STARTED|Part A (Up to Day 11)||0
10683660|NCT02424799|11846725|FG000|COMPLETED|Part A (Up to Day 11)||9
10683661|NCT02424799|11846726|FG001|COMPLETED|Part A (Up to Day 11)||8
10683662|NCT02424799|11846727|FG002|COMPLETED|Part A (Up to Day 11)||0
10683663|NCT02424799|11846728|FG003|COMPLETED|Part A (Up to Day 11)||0
10683664|NCT02424799|11846729|FG004|COMPLETED|Part A (Up to Day 11)||0
10683665|NCT02424799|11846730|FG005|COMPLETED|Part A (Up to Day 11)||0
10683666|NCT02424799|11846725|FG000|NOT COMPLETED|Part A (Up to Day 11)||0
10683667|NCT02424799|11846726|FG001|NOT COMPLETED|Part A (Up to Day 11)||0
10683668|NCT02424799|11846727|FG002|NOT COMPLETED|Part A (Up to Day 11)||0
10683669|NCT02424799|11846728|FG003|NOT COMPLETED|Part A (Up to Day 11)||0
10683670|NCT02424799|11846729|FG004|NOT COMPLETED|Part A (Up to Day 11)||0
10683671|NCT02424799|11846730|FG005|NOT COMPLETED|Part A (Up to Day 11)||0
10683672|NCT02424799|11846725|FG000|STARTED|Part B (Up to Day 19)||0
10683673|NCT02424799|11846726|FG001|STARTED|Part B (Up to Day 19)||0
10683674|NCT02424799|11846727|FG002|STARTED|Part B (Up to Day 19)||3
10683675|NCT02424799|11846728|FG003|STARTED|Part B (Up to Day 19)||9
10683676|NCT02424799|11846729|FG004|STARTED|Part B (Up to Day 19)||0
10683677|NCT02424799|11846730|FG005|STARTED|Part B (Up to Day 19)||0
10683678|NCT02424799|11846725|FG000|COMPLETED|Part B (Up to Day 19)||0
10683679|NCT02424799|11846726|FG001|COMPLETED|Part B (Up to Day 19)||0
10683680|NCT02424799|11846727|FG002|COMPLETED|Part B (Up to Day 19)||3
10683681|NCT02424799|11846728|FG003|COMPLETED|Part B (Up to Day 19)||9
10683682|NCT02424799|11846729|FG004|COMPLETED|Part B (Up to Day 19)||0
10683683|NCT02424799|11846730|FG005|COMPLETED|Part B (Up to Day 19)||0
10683684|NCT02424799|11846725|FG000|NOT COMPLETED|Part B (Up to Day 19)||0
10683685|NCT02424799|11846726|FG001|NOT COMPLETED|Part B (Up to Day 19)||0
10683686|NCT02424799|11846727|FG002|NOT COMPLETED|Part B (Up to Day 19)||0
10683687|NCT02424799|11846728|FG003|NOT COMPLETED|Part B (Up to Day 19)||0
10683688|NCT02424799|11846729|FG004|NOT COMPLETED|Part B (Up to Day 19)||0
10683689|NCT02424799|11846730|FG005|NOT COMPLETED|Part B (Up to Day 19)||0
10683690|NCT02424799|11846725|FG000|STARTED|Part C (Up to Day 23)||0
10683691|NCT02424799|11846726|FG001|STARTED|Part C (Up to Day 23)||0
10683692|NCT02424799|11846727|FG002|STARTED|Part C (Up to Day 23)||0
10683693|NCT02424799|11846728|FG003|STARTED|Part C (Up to Day 23)||0
10683694|NCT02424799|11846729|FG004|STARTED|Part C (Up to Day 23)||1
10683695|NCT02424799|11846730|FG005|STARTED|Part C (Up to Day 23)||4
10683696|NCT02424799|11846725|FG000|COMPLETED|Part C (Up to Day 23)||0
10683697|NCT02424799|11846726|FG001|COMPLETED|Part C (Up to Day 23)||0
10683698|NCT02424799|11846727|FG002|COMPLETED|Part C (Up to Day 23)||0
10683699|NCT02424799|11846728|FG003|COMPLETED|Part C (Up to Day 23)||0
10683700|NCT02424799|11846729|FG004|COMPLETED|Part C (Up to Day 23)||1
10683701|NCT02424799|11846730|FG005|COMPLETED|Part C (Up to Day 23)||4
10683702|NCT02424799|11846725|FG000|NOT COMPLETED|Part C (Up to Day 23)||0
10683703|NCT02424799|11846726|FG001|NOT COMPLETED|Part C (Up to Day 23)||0
10683704|NCT02424799|11846727|FG002|NOT COMPLETED|Part C (Up to Day 23)||0
10683705|NCT02424799|11846728|FG003|NOT COMPLETED|Part C (Up to Day 23)||0
10683706|NCT02424799|11846729|FG004|NOT COMPLETED|Part C (Up to Day 23)||0
10683707|NCT02424799|11846730|FG005|NOT COMPLETED|Part C (Up to Day 23)||0
10683708|NCT02424968|11846762|FG000|STARTED|Overall Study||18
10683709|NCT02424968|11846762|FG000|COMPLETED|Overall Study||18
10683710|NCT02424968|11846762|FG000|NOT COMPLETED|Overall Study||0
10683711|NCT02425098|11846768|FG000|STARTED|Overall Study||176
10683712|NCT02425098|11846769|FG001|STARTED|Overall Study||175
10683713|NCT02425098|11846768|FG000|COMPLETED|Overall Study||163
10683714|NCT02425098|11846769|FG001|COMPLETED|Overall Study||159
10683715|NCT02425098|11846768|FG000|NOT COMPLETED|Overall Study||13
10683716|NCT02425098|11846769|FG001|NOT COMPLETED|Overall Study||16
10683717|NCT02425111|11846775|FG000|STARTED|Part A: Treatment Period||101
10683718|NCT02425111|11846775|FG000|COMPLETED|Part A: Treatment Period||78
10683719|NCT02425111|11846775|FG000|NOT COMPLETED|Part A: Treatment Period||23
10683720|NCT02425111|11846775|FG000|STARTED|Part B: Treatment Extension Period||56
10683721|NCT02425111|11846775|FG000|COMPLETED|Part B: Treatment Extension Period||46
10683722|NCT02425111|11846775|FG000|NOT COMPLETED|Part B: Treatment Extension Period||10
10683723|NCT02425449|11846785|FG000|STARTED|Overall Study||0
10683724|NCT02425449|11846786|FG001|STARTED|Overall Study||4
10683725|NCT02425449|11846787|FG002|STARTED|Overall Study||5
10683726|NCT02425449|11846788|FG003|STARTED|Overall Study||5
10683727|NCT02425449|11846789|FG004|STARTED|Overall Study||5
10683728|NCT02425449|11846785|FG000|COMPLETED|Overall Study||0
10683729|NCT02425449|11846786|FG001|COMPLETED|Overall Study||4
10683730|NCT02425449|11846787|FG002|COMPLETED|Overall Study||5
10683731|NCT02425449|11846788|FG003|COMPLETED|Overall Study||5
10683732|NCT02425449|11846789|FG004|COMPLETED|Overall Study||5
10683733|NCT02425449|11846785|FG000|NOT COMPLETED|Overall Study||0
10683734|NCT02425449|11846786|FG001|NOT COMPLETED|Overall Study||0
10683735|NCT02425449|11846787|FG002|NOT COMPLETED|Overall Study||0
10683736|NCT02425449|11846788|FG003|NOT COMPLETED|Overall Study||0
10683737|NCT02425449|11846789|FG004|NOT COMPLETED|Overall Study||0
10683744|NCT02425956|11846811|FG000|STARTED|Overall Study||21
10683745|NCT02425956|11846811|FG000|COMPLETED|Overall Study||21
10683746|NCT02425956|11846811|FG000|NOT COMPLETED|Overall Study||0
10683747|NCT02426086|11846817|FG000|STARTED|Overall Study||48
10683748|NCT02426086|11846818|FG001|STARTED|Overall Study||59
10683749|NCT02426086|11846817|FG000|Treated|Overall Study||48
10683750|NCT02426086|11846818|FG001|Treated|Overall Study||59
10683751|NCT02426086|11846817|FG000|COMPLETED|Overall Study||0
10683752|NCT02426086|11846818|FG001|COMPLETED|Overall Study||0
10683753|NCT02426086|11846817|FG000|NOT COMPLETED|Overall Study||48
10683754|NCT02426086|11846818|FG001|NOT COMPLETED|Overall Study||59
10683755|NCT02426138|11846831|FG000|STARTED|First Intervention (12 Weeks)||21
10683756|NCT02426138|11846832|FG001|STARTED|First Intervention (12 Weeks)||23
10683757|NCT02426138|11846831|FG000|COMPLETED|First Intervention (12 Weeks)||20
10799221|NCT03984812|11959863|FG010|NOT COMPLETED|Part 1 (Up to Day 28)||0
10799222|NCT03984812|11959853|FG000|STARTED|Part 2 (Up to Day 49)||0
10799223|NCT03984812|11959854|FG001|STARTED|Part 2 (Up to Day 49)||0
10799224|NCT03984812|11959855|FG002|STARTED|Part 2 (Up to Day 49)||0
10799225|NCT03984812|11959856|FG003|STARTED|Part 2 (Up to Day 49)||0
10799226|NCT03984812|11959857|FG004|STARTED|Part 2 (Up to Day 49)||0
10799227|NCT03984812|11959858|FG005|STARTED|Part 2 (Up to Day 49)||0
10799228|NCT03984812|11959859|FG006|STARTED|Part 2 (Up to Day 49)||0
10799229|NCT03984812|11959860|FG007|STARTED|Part 2 (Up to Day 49)|No participants were enrolled in Part 2 as the study was terminated due to non-safety reasons.|0
10799230|NCT03984812|11959861|FG008|STARTED|Part 2 (Up to Day 49)|No participants were enrolled in Part 2 as the study was terminated due to non-safety reasons.|0
10799231|NCT03984812|11959862|FG009|STARTED|Part 2 (Up to Day 49)|No participants were enrolled in Part 2 as the study was terminated due to non-safety reasons.|0
10799232|NCT03984812|11959863|FG010|STARTED|Part 2 (Up to Day 49)|No participants were enrolled in Part 2 as the study was terminated due to non-safety reasons.|0
10683758|NCT02426138|11846832|FG001|COMPLETED|First Intervention (12 Weeks)||22
10683759|NCT02426138|11846831|FG000|NOT COMPLETED|First Intervention (12 Weeks)||1
10683760|NCT02426138|11846832|FG001|NOT COMPLETED|First Intervention (12 Weeks)||1
10799233|NCT03984812|11959853|FG000|COMPLETED|Part 2 (Up to Day 49)||0
10799234|NCT03984812|11959854|FG001|COMPLETED|Part 2 (Up to Day 49)||0
10799235|NCT03984812|11959855|FG002|COMPLETED|Part 2 (Up to Day 49)||0
10799236|NCT03984812|11959856|FG003|COMPLETED|Part 2 (Up to Day 49)||0
10799237|NCT03984812|11959857|FG004|COMPLETED|Part 2 (Up to Day 49)||0
10799238|NCT03984812|11959858|FG005|COMPLETED|Part 2 (Up to Day 49)||0
10683761|NCT02426138|11846831|FG000|STARTED|Second Intervention (12 Weeks)||20
10683762|NCT02426138|11846832|FG001|STARTED|Second Intervention (12 Weeks)||22
10683763|NCT02426138|11846831|FG000|COMPLETED|Second Intervention (12 Weeks)||20
10683764|NCT02426138|11846832|FG001|COMPLETED|Second Intervention (12 Weeks)||22
10683765|NCT02426138|11846831|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0
10683766|NCT02426138|11846832|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||0
10683767|NCT02426138|11846831|FG000|STARTED|Intent to Treat Population Milestone||20
10683768|NCT02426138|11846832|FG001|STARTED|Intent to Treat Population Milestone||22
10683769|NCT02426138|11846831|FG000|COMPLETED|Intent to Treat Population Milestone||20
10683770|NCT02426138|11846832|FG001|COMPLETED|Intent to Treat Population Milestone||22
10683771|NCT02426138|11846831|FG000|NOT COMPLETED|Intent to Treat Population Milestone||0
10683772|NCT02426138|11846832|FG001|NOT COMPLETED|Intent to Treat Population Milestone||0
10683773|NCT02426476|11846842|FG000|STARTED|Overall Study||57
10683774|NCT02426476|11846843|FG001|STARTED|Overall Study||56
10683775|NCT02426476|11846842|FG000|COMPLETED|Overall Study||38
10683776|NCT02426476|11846843|FG001|COMPLETED|Overall Study||39
10683777|NCT02426476|11846842|FG000|NOT COMPLETED|Overall Study||19
10683778|NCT02426476|11846843|FG001|NOT COMPLETED|Overall Study||17
10683779|NCT02426541|11846853|FG000|STARTED|Overall Study||16
10683780|NCT02426541|11846854|FG001|STARTED|Overall Study||16
10683781|NCT02426541|11846853|FG000|COMPLETED|Overall Study||15
10683782|NCT02426541|11846854|FG001|COMPLETED|Overall Study||16
10683783|NCT02426541|11846853|FG000|NOT COMPLETED|Overall Study||1
10683784|NCT02426541|11846854|FG001|NOT COMPLETED|Overall Study||0
10683785|NCT02426580|11846862|FG000|STARTED|Overall Study|April 2015|70
10683786|NCT02426580|11846863|FG001|STARTED|Overall Study|January 2014|70
10683787|NCT02426580|11846862|FG000|COMPLETED|Overall Study|the last patient enrolled in this group in April 2017|59
10683788|NCT02426580|11846863|FG001|COMPLETED|Overall Study|the last patient in this group enrolled in April 2017|54
10683789|NCT02426580|11846862|FG000|NOT COMPLETED|Overall Study||11
10683790|NCT02426580|11846863|FG001|NOT COMPLETED|Overall Study||16
10683791|NCT02426918|11846872|FG000|STARTED|Overall Study||110
10683792|NCT02426918|11846873|FG001|STARTED|Overall Study||109
10683793|NCT02426918|11846874|FG002|STARTED|Overall Study||111
10683794|NCT02426918|11846872|FG000|Safety Population|Overall Study||110
10683795|NCT02426918|11846873|FG001|Safety Population|Overall Study||107
10683796|NCT02426918|11846874|FG002|Safety Population|Overall Study||107
10683797|NCT02426918|11846872|FG000|COMPLETED|Overall Study||93
10683798|NCT02426918|11846873|FG001|COMPLETED|Overall Study||90
10683799|NCT02426918|11846874|FG002|COMPLETED|Overall Study||97
10683800|NCT02426918|11846872|FG000|NOT COMPLETED|Overall Study||17
10683801|NCT02426918|11846873|FG001|NOT COMPLETED|Overall Study||19
10683802|NCT02426918|11846874|FG002|NOT COMPLETED|Overall Study||14
10683803|NCT02427100|11846884|FG000|STARTED|Overall Study||15
10799239|NCT03984812|11959859|FG006|COMPLETED|Part 2 (Up to Day 49)||0
10799240|NCT03984812|11959860|FG007|COMPLETED|Part 2 (Up to Day 49)||0
10799241|NCT03984812|11959861|FG008|COMPLETED|Part 2 (Up to Day 49)||0
10799242|NCT03984812|11959862|FG009|COMPLETED|Part 2 (Up to Day 49)||0
10799243|NCT03984812|11959863|FG010|COMPLETED|Part 2 (Up to Day 49)||0
10799244|NCT03984812|11959853|FG000|NOT COMPLETED|Part 2 (Up to Day 49)||0
10799245|NCT03984812|11959854|FG001|NOT COMPLETED|Part 2 (Up to Day 49)||0
10799246|NCT03984812|11959855|FG002|NOT COMPLETED|Part 2 (Up to Day 49)||0
10799247|NCT03984812|11959856|FG003|NOT COMPLETED|Part 2 (Up to Day 49)||0
10799248|NCT03984812|11959857|FG004|NOT COMPLETED|Part 2 (Up to Day 49)||0
10799249|NCT03984812|11959858|FG005|NOT COMPLETED|Part 2 (Up to Day 49)||0
10799250|NCT03984812|11959859|FG006|NOT COMPLETED|Part 2 (Up to Day 49)||0
10799251|NCT03984812|11959860|FG007|NOT COMPLETED|Part 2 (Up to Day 49)||0
10799252|NCT03984812|11959861|FG008|NOT COMPLETED|Part 2 (Up to Day 49)||0
10799253|NCT03984812|11959862|FG009|NOT COMPLETED|Part 2 (Up to Day 49)||0
10799254|NCT03984812|11959863|FG010|NOT COMPLETED|Part 2 (Up to Day 49)||0
10799261|NCT03998163|11959899|FG000|STARTED|Overall Study||222
10799262|NCT03998163|11959899|FG000|COMPLETED|Overall Study||197
10799263|NCT03998163|11959899|FG000|NOT COMPLETED|Overall Study||25
10799264|NCT04000373|11959903|FG000|STARTED|Overall Study||5
10799265|NCT04000373|11959903|FG000|COMPLETED|Overall Study||5
10799266|NCT04000373|11959903|FG000|NOT COMPLETED|Overall Study||0
10799267|NCT04001517|11959910|FG000|STARTED|Overall Study||20
10799268|NCT04001517|11959911|FG001|STARTED|Overall Study||26
10799269|NCT04001517|11959912|FG002|STARTED|Overall Study||27
10799270|NCT04001517|11959913|FG003|STARTED|Overall Study||18
10799271|NCT04001517|11959910|FG000|COMPLETED|Overall Study||20
10683804|NCT02427100|11846885|FG001|STARTED|Overall Study||17
10683805|NCT02427100|11846884|FG000|COMPLETED|Overall Study||15
10683806|NCT02427100|11846885|FG001|COMPLETED|Overall Study||15
10683807|NCT02427100|11846884|FG000|NOT COMPLETED|Overall Study||0
10683808|NCT02427100|11846885|FG001|NOT COMPLETED|Overall Study||2
10683809|NCT02427399|11846896|FG000|STARTED|Overall Study||220
10683810|NCT02427399|11846897|FG001|STARTED|Overall Study||220
10683811|NCT02427399|11846898|FG002|STARTED|Overall Study||220
10683812|NCT02427399|11846899|FG003|STARTED|Overall Study||220
10683813|NCT02427399|11846900|FG004|STARTED|Overall Study||220
10683814|NCT02427399|11846896|FG000|COMPLETED|Overall Study||206
10683815|NCT02427399|11846897|FG001|COMPLETED|Overall Study||204
10683816|NCT02427399|11846898|FG002|COMPLETED|Overall Study||208
10683817|NCT02427399|11846899|FG003|COMPLETED|Overall Study||202
10799272|NCT04001517|11959911|FG001|COMPLETED|Overall Study||20
10799273|NCT04001517|11959912|FG002|COMPLETED|Overall Study||26
10799274|NCT04001517|11959913|FG003|COMPLETED|Overall Study||15
10799275|NCT04001517|11959910|FG000|NOT COMPLETED|Overall Study||0
10683818|NCT02427399|11846900|FG004|COMPLETED|Overall Study||205
10683819|NCT02427399|11846896|FG000|NOT COMPLETED|Overall Study||14
10683820|NCT02427399|11846897|FG001|NOT COMPLETED|Overall Study||16
10683821|NCT02427399|11846898|FG002|NOT COMPLETED|Overall Study||12
10799276|NCT04001517|11959911|FG001|NOT COMPLETED|Overall Study||6
10799277|NCT04001517|11959912|FG002|NOT COMPLETED|Overall Study||1
10799278|NCT04001517|11959913|FG003|NOT COMPLETED|Overall Study||3
10799279|NCT04006171|11959926|FG000|STARTED|Overall Study||48
10683822|NCT02427399|11846899|FG003|NOT COMPLETED|Overall Study||18
10683823|NCT02427399|11846900|FG004|NOT COMPLETED|Overall Study||15
10683824|NCT02427477|11846914|FG000|STARTED|Period 1||60
10683825|NCT02427477|11846915|FG001|STARTED|Period 1||60
10683826|NCT02427477|11846914|FG000|COMPLETED|Period 1||59
10683827|NCT02427477|11846915|FG001|COMPLETED|Period 1||60
10683828|NCT02427477|11846914|FG000|NOT COMPLETED|Period 1||1
10683829|NCT02427477|11846915|FG001|NOT COMPLETED|Period 1||0
10683830|NCT02427477|11846914|FG000|STARTED|Period 2||59
10683831|NCT02427477|11846915|FG001|STARTED|Period 2||60
10683832|NCT02427477|11846914|FG000|COMPLETED|Period 2||59
10683833|NCT02427477|11846915|FG001|COMPLETED|Period 2||60
10683834|NCT02427477|11846914|FG000|NOT COMPLETED|Period 2||0
10683835|NCT02427477|11846915|FG001|NOT COMPLETED|Period 2||0
10683836|NCT02427477|11846914|FG000|STARTED|Period 3||59
10683837|NCT02427477|11846915|FG001|STARTED|Period 3||60
10683838|NCT02427477|11846914|FG000|COMPLETED|Period 3||59
10683839|NCT02427477|11846915|FG001|COMPLETED|Period 3||60
10683840|NCT02427477|11846914|FG000|NOT COMPLETED|Period 3||0
10683841|NCT02427477|11846915|FG001|NOT COMPLETED|Period 3||0
10683842|NCT02427607|11846921|FG000|STARTED|Overall Study||7
10683843|NCT02427607|11846921|FG000|COMPLETED|Overall Study||6
10683844|NCT02427607|11846921|FG000|NOT COMPLETED|Overall Study||1
10683845|NCT02427646|11846927|FG000|STARTED|Overall Study||24
10683846|NCT02427646|11846928|FG001|STARTED|Overall Study||28
10683847|NCT02427646|11846927|FG000|COMPLETED|Overall Study||16
10683848|NCT02427646|11846928|FG001|COMPLETED|Overall Study||14
10683849|NCT02427646|11846927|FG000|NOT COMPLETED|Overall Study||8
10683850|NCT02427646|11846928|FG001|NOT COMPLETED|Overall Study||14
10683851|NCT02427672|11846938|FG000|STARTED|Overall Study||40
10683852|NCT02427672|11846939|FG001|STARTED|Overall Study||44
10683853|NCT02427672|11846938|FG000|COMPLETED|Overall Study||39
10683854|NCT02427672|11846939|FG001|COMPLETED|Overall Study||42
10683855|NCT02427672|11846938|FG000|NOT COMPLETED|Overall Study||1
10683856|NCT02427672|11846939|FG001|NOT COMPLETED|Overall Study||2
10683857|NCT02427737|11846947|FG000|STARTED|OSU Baseline Q4FY15||4158
10683858|NCT02427737|11846948|FG001|STARTED|OSU Baseline Q4FY15||3446
10683859|NCT02427737|11846947|FG000|COMPLETED|OSU Baseline Q4FY15||3940
10683860|NCT02427737|11846948|FG001|COMPLETED|OSU Baseline Q4FY15||3230
10683861|NCT02427737|11846947|FG000|NOT COMPLETED|OSU Baseline Q4FY15||218
10683862|NCT02427737|11846948|FG001|NOT COMPLETED|OSU Baseline Q4FY15||216
10683863|NCT02427737|11846947|FG000|STARTED|OSU Q1FY16 (First Post-Training Quarter)||4030
10683864|NCT02427737|11846948|FG001|STARTED|OSU Q1FY16 (First Post-Training Quarter)||3246
10683865|NCT02427737|11846947|FG000|COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||3815
10683866|NCT02427737|11846948|FG001|COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||3032
10683867|NCT02427737|11846947|FG000|NOT COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||215
10799280|NCT04006171|11959927|FG001|STARTED|Overall Study||42
10799281|NCT04006171|11959926|FG000|COMPLETED|Overall Study||36
10799282|NCT04006171|11959927|FG001|COMPLETED|Overall Study||30
10799283|NCT04006171|11959926|FG000|NOT COMPLETED|Overall Study||12
10799284|NCT04006171|11959927|FG001|NOT COMPLETED|Overall Study||12
10799285|NCT04011436|11959936|FG000|STARTED|Overall Study||20
10799286|NCT04011436|11959937|FG001|STARTED|Overall Study||20
10799287|NCT04011436|11959936|FG000|COMPLETED|Overall Study||19
10799288|NCT04011436|11959937|FG001|COMPLETED|Overall Study||19
10799289|NCT04011436|11959936|FG000|NOT COMPLETED|Overall Study||1
10799290|NCT04011436|11959937|FG001|NOT COMPLETED|Overall Study||1
10799291|NCT04011592|11959945|FG000|STARTED|Overall Study||1
10799292|NCT04011592|11959946|FG001|STARTED|Overall Study||0
10799293|NCT04011592|11959945|FG000|COMPLETED|Overall Study||1
10799294|NCT04011592|11959946|FG001|COMPLETED|Overall Study||0
10799295|NCT04011592|11959945|FG000|NOT COMPLETED|Overall Study||0
10799296|NCT04011592|11959946|FG001|NOT COMPLETED|Overall Study||0
10799297|NCT04013529|11959954|FG000|STARTED|Overall Study||20
10799298|NCT04013529|11959955|FG001|STARTED|Overall Study||20
10799299|NCT04013529|11959954|FG000|COMPLETED|Overall Study||19
10799300|NCT04013529|11959955|FG001|COMPLETED|Overall Study||19
10799301|NCT04013529|11959954|FG000|NOT COMPLETED|Overall Study||1
10799302|NCT04013529|11959955|FG001|NOT COMPLETED|Overall Study||1
10799303|NCT04016324|11959961|FG000|STARTED|Overall Study||110
10683868|NCT02427737|11846948|FG001|NOT COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||214
10683869|NCT02427737|11846947|FG000|STARTED|OSU Q2FY16(Second Post Training Quarter)||4121
10683870|NCT02427737|11846948|FG001|STARTED|OSU Q2FY16(Second Post Training Quarter)||3070
10683871|NCT02427737|11846947|FG000|COMPLETED|OSU Q2FY16(Second Post Training Quarter)||3907
10683872|NCT02427737|11846948|FG001|COMPLETED|OSU Q2FY16(Second Post Training Quarter)||2857
10683873|NCT02427737|11846947|FG000|NOT COMPLETED|OSU Q2FY16(Second Post Training Quarter)||214
10683874|NCT02427737|11846948|FG001|NOT COMPLETED|OSU Q2FY16(Second Post Training Quarter)||213
10683875|NCT02427737|11846947|FG000|STARTED|OSU Q3FY16 (Third Post Training Quarter)||4148
10683876|NCT02427737|11846948|FG001|STARTED|OSU Q3FY16 (Third Post Training Quarter)||2931
10683877|NCT02427737|11846947|FG000|COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||3928
10683878|NCT02427737|11846948|FG001|COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||2716
10683879|NCT02427737|11846947|FG000|NOT COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||220
10683880|NCT02427737|11846948|FG001|NOT COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||215
10683881|NCT02427737|11846947|FG000|STARTED|Duke Pre- and Post-Training Groups|Note this is a pre-training to post-training comparison.|9658
10799304|NCT04016324|11959961|FG000|COMPLETED|Overall Study||107
10799305|NCT04016324|11959961|FG000|NOT COMPLETED|Overall Study||3
10799306|NCT04017910|11959966|FG000|STARTED|Overall Study||17
10799307|NCT04017910|11959966|FG000|COMPLETED|Overall Study||17
10683882|NCT02427737|11846948|FG001|STARTED|Duke Pre- and Post-Training Groups|Note Control=Baseline|4446
10683883|NCT02427737|11846947|FG000|COMPLETED|Duke Pre- and Post-Training Groups||8879
10683884|NCT02427737|11846948|FG001|COMPLETED|Duke Pre- and Post-Training Groups||4051
10683885|NCT02427737|11846947|FG000|NOT COMPLETED|Duke Pre- and Post-Training Groups||779
10683886|NCT02427737|11846948|FG001|NOT COMPLETED|Duke Pre- and Post-Training Groups||395
10683887|NCT02427750|11846964|FG000|STARTED|Overall Study||63
10683888|NCT02427750|11846965|FG001|STARTED|Overall Study||63
10683889|NCT02427750|11846964|FG000|COMPLETED|Overall Study||63
10683890|NCT02427750|11846965|FG001|COMPLETED|Overall Study||63
10683891|NCT02427750|11846964|FG000|NOT COMPLETED|Overall Study||0
10683892|NCT02427750|11846965|FG001|NOT COMPLETED|Overall Study||0
10683893|NCT02427802|11846975|FG000|STARTED|Overall Study||305
10683894|NCT02427802|11846976|FG001|STARTED|Overall Study||154
10683895|NCT02427802|11846977|FG002|STARTED|Overall Study||153
10683896|NCT02427802|11846975|FG000|COMPLETED|Overall Study||246
10683897|NCT02427802|11846976|FG001|COMPLETED|Overall Study||120
10683898|NCT02427802|11846977|FG002|COMPLETED|Overall Study||110
10683899|NCT02427802|11846975|FG000|NOT COMPLETED|Overall Study||59
10683900|NCT02427802|11846976|FG001|NOT COMPLETED|Overall Study||34
10683901|NCT02427802|11846977|FG002|NOT COMPLETED|Overall Study||43
10683902|NCT02427841|11846985|FG000|STARTED|Overall Study||19
10683903|NCT02427841|11846985|FG000|COMPLETED|Overall Study||11
10683904|NCT02427841|11846985|FG000|NOT COMPLETED|Overall Study||8
10683905|NCT02427984|11846992|FG000|STARTED|Overall Study||53
10683906|NCT02427984|11846993|FG001|STARTED|Overall Study||45
10683907|NCT02427984|11846994|FG002|STARTED|Overall Study||50
10683908|NCT02427984|11846992|FG000|COMPLETED|Overall Study||40
10683909|NCT02427984|11846993|FG001|COMPLETED|Overall Study||40
10683910|NCT02427984|11846994|FG002|COMPLETED|Overall Study||32
10683911|NCT02427984|11846992|FG000|NOT COMPLETED|Overall Study||13
10683912|NCT02427984|11846993|FG001|NOT COMPLETED|Overall Study||5
10683913|NCT02427984|11846994|FG002|NOT COMPLETED|Overall Study||18
10683914|NCT02428296|11847003|FG000|STARTED|Overall Study||39
10683915|NCT02428296|11847003|FG000|Treated|Overall Study||39
10683916|NCT02428296|11847003|FG000|COMPLETED|Overall Study|Number of participants who completed the full course of treatment.|30
10683917|NCT02428296|11847003|FG000|NOT COMPLETED|Overall Study||9
10683918|NCT02428309|11847010|FG000|STARTED|Overall Study||1
10683919|NCT02428309|11847010|FG000|COMPLETED|Overall Study|The enrolled participant completed treatment and was followed through week 152, per protocol.|1
10683920|NCT02428309|11847010|FG000|NOT COMPLETED|Overall Study||0
10683921|NCT02428413|11847017|FG000|STARTED|Overall Study||64
10683922|NCT02428413|11847018|FG001|STARTED|Overall Study||61
10683923|NCT02428413|11847017|FG000|COMPLETED|Overall Study||56
10683924|NCT02428413|11847018|FG001|COMPLETED|Overall Study||52
10683925|NCT02428413|11847017|FG000|NOT COMPLETED|Overall Study||8
10683926|NCT02428413|11847018|FG001|NOT COMPLETED|Overall Study||9
10683927|NCT02428478|11847024|FG000|STARTED|First Study Night||9
10683928|NCT02428478|11847025|FG001|STARTED|First Study Night||8
10683929|NCT02428478|11847024|FG000|COMPLETED|First Study Night||9
10683930|NCT02428478|11847025|FG001|COMPLETED|First Study Night||8
10683931|NCT02428478|11847024|FG000|NOT COMPLETED|First Study Night||0
10683932|NCT02428478|11847025|FG001|NOT COMPLETED|First Study Night||0
10683933|NCT02428478|11847024|FG000|STARTED|Second Study Night|1 participant did not return for the second study night|8
10683934|NCT02428478|11847025|FG001|STARTED|Second Study Night|2 participants did not return for the second study night|6
10683935|NCT02428478|11847024|FG000|COMPLETED|Second Study Night||8
10683936|NCT02428478|11847025|FG001|COMPLETED|Second Study Night||6
10683937|NCT02428478|11847024|FG000|NOT COMPLETED|Second Study Night||0
10683938|NCT02428478|11847025|FG001|NOT COMPLETED|Second Study Night||0
10683939|NCT02428595|11847031|FG000|STARTED|Fitting||137
10683940|NCT02428595|11847031|FG000|COMPLETED|Fitting||73
10683941|NCT02428595|11847031|FG000|NOT COMPLETED|Fitting||64
10683942|NCT02428595|11847031|FG000|STARTED|Treatment||73
10683943|NCT02428595|11847031|FG000|COMPLETED|Treatment||54
10683944|NCT02428595|11847031|FG000|NOT COMPLETED|Treatment||19
10683945|NCT02428608|11847044|FG000|STARTED|Overall Study||570
10683946|NCT02428608|11847044|FG000|COMPLETED|Overall Study||487
10683947|NCT02428608|11847044|FG000|NOT COMPLETED|Overall Study||83
10683948|NCT02428699|11847049|FG000|STARTED|Period 1||25
10683949|NCT02428699|11847050|FG001|STARTED|Period 1||25
10683950|NCT02428699|11847049|FG000|COMPLETED|Period 1||25
10683951|NCT02428699|11847050|FG001|COMPLETED|Period 1||25
10683952|NCT02428699|11847049|FG000|NOT COMPLETED|Period 1||0
10683953|NCT02428699|11847050|FG001|NOT COMPLETED|Period 1||0
10683954|NCT02428699|11847049|FG000|STARTED|Washout Period 1||25
10683955|NCT02428699|11847050|FG001|STARTED|Washout Period 1||25
10683956|NCT02428699|11847049|FG000|COMPLETED|Washout Period 1||24
10683957|NCT02428699|11847050|FG001|COMPLETED|Washout Period 1||23
10683958|NCT02428699|11847049|FG000|NOT COMPLETED|Washout Period 1||1
10683959|NCT02428699|11847050|FG001|NOT COMPLETED|Washout Period 1||2
10683960|NCT02428699|11847049|FG000|STARTED|Period 2||24
10683961|NCT02428699|11847050|FG001|STARTED|Period 2||23
10683962|NCT02428699|11847049|FG000|COMPLETED|Period 2||24
10683963|NCT02428699|11847050|FG001|COMPLETED|Period 2||23
10683964|NCT02428699|11847049|FG000|NOT COMPLETED|Period 2||0
10683965|NCT02428699|11847050|FG001|NOT COMPLETED|Period 2||0
10683966|NCT02428855|11847061|FG000|STARTED|Overall Study||8
10683967|NCT02428855|11847061|FG000|COMPLETED|Overall Study||6
10683968|NCT02428855|11847061|FG000|NOT COMPLETED|Overall Study||2
10683969|NCT02429115|11847071|FG000|STARTED|Overall Study||52
10683970|NCT02429115|11847072|FG001|STARTED|Overall Study||52
10683971|NCT02429115|11847073|FG002|STARTED|Overall Study||51
10683972|NCT02429115|11847074|FG003|STARTED|Overall Study||29
10683973|NCT02429115|11847075|FG004|STARTED|Overall Study||29
10683974|NCT02429115|11847076|FG005|STARTED|Overall Study||28
10683975|NCT02429115|11847071|FG000|COMPLETED|Overall Study||40
10683976|NCT02429115|11847072|FG001|COMPLETED|Overall Study||42
10683977|NCT02429115|11847073|FG002|COMPLETED|Overall Study||35
10683978|NCT02429115|11847074|FG003|COMPLETED|Overall Study||21
10683979|NCT02429115|11847075|FG004|COMPLETED|Overall Study||22
10683980|NCT02429115|11847076|FG005|COMPLETED|Overall Study||27
10683981|NCT02429115|11847071|FG000|NOT COMPLETED|Overall Study||12
10683982|NCT02429115|11847072|FG001|NOT COMPLETED|Overall Study||10
10683983|NCT02429115|11847073|FG002|NOT COMPLETED|Overall Study||16
10683984|NCT02429115|11847074|FG003|NOT COMPLETED|Overall Study||8
10683985|NCT02429115|11847075|FG004|NOT COMPLETED|Overall Study||7
10683986|NCT02429115|11847076|FG005|NOT COMPLETED|Overall Study||1
10683987|NCT02429258|11847092|FG000|STARTED|Overall Study||50
10683988|NCT02429258|11847093|FG001|STARTED|Overall Study||50
10683989|NCT02429258|11847092|FG000|COMPLETED|Overall Study||48
10683990|NCT02429258|11847093|FG001|COMPLETED|Overall Study||49
10683991|NCT02429258|11847092|FG000|NOT COMPLETED|Overall Study||2
10683992|NCT02429258|11847093|FG001|NOT COMPLETED|Overall Study||1
10683993|NCT02429310|11847101|FG000|STARTED|Overall Study||22
10683994|NCT02429310|11847102|FG001|STARTED|Overall Study||20
10683995|NCT02429310|11847101|FG000|COMPLETED|Overall Study||20
10683996|NCT02429310|11847102|FG001|COMPLETED|Overall Study||17
10683997|NCT02429310|11847101|FG000|NOT COMPLETED|Overall Study||2
10683998|NCT02429310|11847102|FG001|NOT COMPLETED|Overall Study||3
10683999|NCT02429427|11847110|FG000|STARTED|Overall Study||1763
10684000|NCT02429427|11847111|FG001|STARTED|Overall Study||876
10684001|NCT02429427|11847110|FG000|COMPLETED|Overall Study||1392
10684002|NCT02429427|11847111|FG001|COMPLETED|Overall Study||697
10684003|NCT02429427|11847110|FG000|NOT COMPLETED|Overall Study||371
10684004|NCT02429427|11847111|FG001|NOT COMPLETED|Overall Study||179
10684005|NCT02429778|11847119|FG000|STARTED|Overall Study||20
10684006|NCT02429778|11847120|FG001|STARTED|Overall Study||20
10684007|NCT02429778|11847119|FG000|COMPLETED|Overall Study||13
10684008|NCT02429778|11847120|FG001|COMPLETED|Overall Study||20
10684009|NCT02429778|11847119|FG000|NOT COMPLETED|Overall Study||7
10684010|NCT02429778|11847120|FG001|NOT COMPLETED|Overall Study||0
10684011|NCT02429856|11847128|FG000|STARTED|Overall Study||49
10684012|NCT02429856|11847129|FG001|STARTED|Overall Study||51
10684013|NCT02429856|11847128|FG000|COMPLETED|Overall Study||30
10684014|NCT02429856|11847129|FG001|COMPLETED|Overall Study||32
10684015|NCT02429856|11847128|FG000|NOT COMPLETED|Overall Study||19
10684016|NCT02429856|11847129|FG001|NOT COMPLETED|Overall Study||19
10684017|NCT02429869|11847137|FG000|STARTED|Overall Study||10
10684018|NCT02429869|11847137|FG000|COMPLETED|Overall Study||10
10684019|NCT02429869|11847137|FG000|NOT COMPLETED|Overall Study||0
10799308|NCT04017910|11959966|FG000|NOT COMPLETED|Overall Study||0
10799309|NCT04018066|11959970|FG000|STARTED|Overall Study|34 participants were enrolled in the study|34
10799310|NCT04018066|11959970|FG000|COMPLETED|Overall Study|30 participants completed the study protocol.|30
10799311|NCT04018066|11959970|FG000|NOT COMPLETED|Overall Study||4
10799312|NCT04018794|11959975|FG000|STARTED|Overall Study|N=15 students participants completed the open trial of usability/feasibility of the intervention and completed quantitative ratings of usability before and after using the program.|15
10799313|NCT04018794|11959975|FG000|COMPLETED|Overall Study|N=15 students participants completed the open trial of usability/feasibility of the intervention and completed quantitative ratings of usability before and after using the program.|15
10799314|NCT04018794|11959975|FG000|NOT COMPLETED|Overall Study||0
10799315|NCT04032327|11959981|FG000|STARTED|Overall Study||60
10799316|NCT04032327|11959982|FG001|STARTED|Overall Study||60
10799317|NCT04032327|11959981|FG000|COMPLETED|Overall Study||60
10799318|NCT04032327|11959982|FG001|COMPLETED|Overall Study||60
10799319|NCT04032327|11959981|FG000|NOT COMPLETED|Overall Study||0
10799320|NCT04032327|11959982|FG001|NOT COMPLETED|Overall Study||0
10799321|NCT04033640|11959990|FG000|STARTED|Overall Study||1736
10799322|NCT04033640|11959991|FG001|STARTED|Overall Study||18
10799323|NCT04033640|11959990|FG000|COMPLETED|Overall Study||1736
10799324|NCT04033640|11959991|FG001|COMPLETED|Overall Study||18
10799325|NCT04033640|11959990|FG000|NOT COMPLETED|Overall Study||0
10799326|NCT04033640|11959991|FG001|NOT COMPLETED|Overall Study||0
10799327|NCT04036292|11960000|FG000|STARTED|Overall Study||260
10799328|NCT04036292|11960001|FG001|STARTED|Overall Study||246
10799329|NCT04036292|11960002|FG002|STARTED|Overall Study||252
10799330|NCT04036292|11960000|FG000|COMPLETED|Overall Study||239
10799331|NCT04036292|11960001|FG001|COMPLETED|Overall Study||212
10799332|NCT04036292|11960002|FG002|COMPLETED|Overall Study||228
10799333|NCT04036292|11960000|FG000|NOT COMPLETED|Overall Study||21
10799334|NCT04036292|11960001|FG001|NOT COMPLETED|Overall Study||34
10799335|NCT04036292|11960002|FG002|NOT COMPLETED|Overall Study||24
10684020|NCT02429934|11847143|FG000|STARTED|Overall Study||15
10684021|NCT02429934|11847144|FG001|STARTED|Overall Study||13
10684022|NCT02429934|11847143|FG000|COMPLETED|Overall Study||11
10684023|NCT02429934|11847144|FG001|COMPLETED|Overall Study||10
10684024|NCT02429934|11847143|FG000|NOT COMPLETED|Overall Study||4
10684025|NCT02429934|11847144|FG001|NOT COMPLETED|Overall Study||3
10684026|NCT02430090|11847155|FG000|STARTED|Overall Study||15
10684027|NCT02430090|11847156|FG001|STARTED|Overall Study||15
10684028|NCT02430090|11847157|FG002|STARTED|Overall Study||15
10684029|NCT02430090|11847155|FG000|COMPLETED|Overall Study||15
10684030|NCT02430090|11847156|FG001|COMPLETED|Overall Study||15
10684031|NCT02430090|11847157|FG002|COMPLETED|Overall Study||15
10684032|NCT02430090|11847155|FG000|NOT COMPLETED|Overall Study||0
10684033|NCT02430090|11847156|FG001|NOT COMPLETED|Overall Study||0
10684034|NCT02430090|11847157|FG002|NOT COMPLETED|Overall Study||0
10684035|NCT02430311|11847167|FG000|STARTED|Part A||20
10684036|NCT02430311|11847168|FG001|STARTED|Part A||16
10684037|NCT02430311|11847167|FG000|Received Olaparib|Part A||20
10684038|NCT02430311|11847168|FG001|Received Olaparib|Part A||16
10684039|NCT02430311|11847167|FG000|Received Paclitaxel|Part A|Cohort 1 patients are planned to receive olaparib monotherapy|0
10684040|NCT02430311|11847168|FG001|Received Paclitaxel|Part A||16
10684041|NCT02430311|11847167|FG000|COMPLETED|Part A||19
10684042|NCT02430311|11847168|FG001|COMPLETED|Part A||15
10684043|NCT02430311|11847167|FG000|NOT COMPLETED|Part A||1
10684044|NCT02430311|11847168|FG001|NOT COMPLETED|Part A||1
10684045|NCT02430311|11847167|FG000|STARTED|Part B||19
10684046|NCT02430311|11847168|FG001|STARTED|Part B||15
10684047|NCT02430311|11847167|FG000|Received Olaparib|Part B||19
10684048|NCT02430311|11847168|FG001|Received Olaparib|Part B||15
10684049|NCT02430311|11847167|FG000|Received Paclitaxel|Part B|Cohort 1 patients are planned to receive olaparib monotherapy|0
10684050|NCT02430311|11847168|FG001|Received Paclitaxel|Part B||14
10684051|NCT02430311|11847167|FG000|COMPLETED|Part B||9
10684052|NCT02430311|11847168|FG001|COMPLETED|Part B||7
10684053|NCT02430311|11847167|FG000|NOT COMPLETED|Part B||10
10684054|NCT02430311|11847168|FG001|NOT COMPLETED|Part B||8
10684055|NCT02430337|11847185|FG000|STARTED|Overall Study||11
10684056|NCT02430337|11847186|FG001|STARTED|Overall Study||20
10684057|NCT02430337|11847185|FG000|COMPLETED|Overall Study||11
10684058|NCT02430337|11847186|FG001|COMPLETED|Overall Study||20
10684059|NCT02430337|11847185|FG000|NOT COMPLETED|Overall Study||0
10684060|NCT02430337|11847186|FG001|NOT COMPLETED|Overall Study||0
10684061|NCT02430389|11847196|FG000|STARTED|Overall Study||10
10684062|NCT02430389|11847197|FG001|STARTED|Overall Study||10
10684063|NCT02430389|11847196|FG000|COMPLETED|Overall Study||10
10684064|NCT02430389|11847197|FG001|COMPLETED|Overall Study||10
10684065|NCT02430389|11847196|FG000|NOT COMPLETED|Overall Study||0
10684066|NCT02430389|11847197|FG001|NOT COMPLETED|Overall Study||0
10684070|NCT02430818|11847214|FG000|STARTED|Overall Study||7
10684071|NCT02430818|11847215|FG001|STARTED|Overall Study||6
10684072|NCT02430818|11847214|FG000|COMPLETED|Overall Study||7
10684073|NCT02430818|11847215|FG001|COMPLETED|Overall Study||6
10684074|NCT02430818|11847214|FG000|NOT COMPLETED|Overall Study||0
10684075|NCT02430818|11847215|FG001|NOT COMPLETED|Overall Study||0
10684076|NCT02430870|11847233|FG000|STARTED|Part 1||6
10684077|NCT02430870|11847234|FG001|STARTED|Part 1||6
10684078|NCT02430870|11847235|FG002|STARTED|Part 1||4
10684079|NCT02430870|11847236|FG003|STARTED|Part 1||0
10684080|NCT02430870|11847237|FG004|STARTED|Part 1||0
10684081|NCT02430870|11847238|FG005|STARTED|Part 1||0
10684082|NCT02430870|11847239|FG006|STARTED|Part 1||0
10684083|NCT02430870|11847240|FG007|STARTED|Part 1||0
10684084|NCT02430870|11847233|FG000|COMPLETED|Part 1||6
10684085|NCT02430870|11847234|FG001|COMPLETED|Part 1||6
10684086|NCT02430870|11847235|FG002|COMPLETED|Part 1||4
10684087|NCT02430870|11847236|FG003|COMPLETED|Part 1||0
10684088|NCT02430870|11847237|FG004|COMPLETED|Part 1||0
10684089|NCT02430870|11847238|FG005|COMPLETED|Part 1||0
10684090|NCT02430870|11847239|FG006|COMPLETED|Part 1||0
10684091|NCT02430870|11847240|FG007|COMPLETED|Part 1||0
10684092|NCT02430870|11847233|FG000|NOT COMPLETED|Part 1||0
10684093|NCT02430870|11847234|FG001|NOT COMPLETED|Part 1||0
10684094|NCT02430870|11847235|FG002|NOT COMPLETED|Part 1||0
10684095|NCT02430870|11847236|FG003|NOT COMPLETED|Part 1||0
10684096|NCT02430870|11847237|FG004|NOT COMPLETED|Part 1||0
10684097|NCT02430870|11847238|FG005|NOT COMPLETED|Part 1||0
10684098|NCT02430870|11847239|FG006|NOT COMPLETED|Part 1||0
10684099|NCT02430870|11847240|FG007|NOT COMPLETED|Part 1||0
10684100|NCT02430870|11847233|FG000|STARTED|Part 2||0
10684101|NCT02430870|11847234|FG001|STARTED|Part 2||0
10684102|NCT02430870|11847235|FG002|STARTED|Part 2||0
10684103|NCT02430870|11847236|FG003|STARTED|Part 2||6
10684104|NCT02430870|11847237|FG004|STARTED|Part 2||6
10684105|NCT02430870|11847238|FG005|STARTED|Part 2||6
10684106|NCT02430870|11847239|FG006|STARTED|Part 2||6
10684107|NCT02430870|11847240|FG007|STARTED|Part 2||8
10684108|NCT02430870|11847233|FG000|COMPLETED|Part 2||0
10684109|NCT02430870|11847234|FG001|COMPLETED|Part 2||0
10684110|NCT02430870|11847235|FG002|COMPLETED|Part 2||0
10684111|NCT02430870|11847236|FG003|COMPLETED|Part 2||6
10684112|NCT02430870|11847237|FG004|COMPLETED|Part 2||6
10684113|NCT02430870|11847238|FG005|COMPLETED|Part 2||6
10684114|NCT02430870|11847239|FG006|COMPLETED|Part 2||5
10684115|NCT02430870|11847240|FG007|COMPLETED|Part 2||7
10684116|NCT02430870|11847233|FG000|NOT COMPLETED|Part 2||0
10684117|NCT02430870|11847234|FG001|NOT COMPLETED|Part 2||0
10684118|NCT02430870|11847235|FG002|NOT COMPLETED|Part 2||0
10684119|NCT02430870|11847236|FG003|NOT COMPLETED|Part 2||0
10684120|NCT02430870|11847237|FG004|NOT COMPLETED|Part 2||0
10684121|NCT02430870|11847238|FG005|NOT COMPLETED|Part 2||0
10684122|NCT02430870|11847239|FG006|NOT COMPLETED|Part 2||1
10684123|NCT02430870|11847240|FG007|NOT COMPLETED|Part 2||1
10684124|NCT02431052|11847263|FG000|STARTED|Overall Study||53
10684125|NCT02431052|11847264|FG001|STARTED|Overall Study||50
10684126|NCT02431052|11847265|FG002|STARTED|Overall Study||106
10684127|NCT02431052|11847266|FG003|STARTED|Overall Study||110
10684128|NCT02431052|11847267|FG004|STARTED|Overall Study||101
10684129|NCT02431052|11847263|FG000|COMPLETED|Overall Study||42
10684130|NCT02431052|11847264|FG001|COMPLETED|Overall Study||46
10684131|NCT02431052|11847265|FG002|COMPLETED|Overall Study||94
10684132|NCT02431052|11847266|FG003|COMPLETED|Overall Study||94
10684133|NCT02431052|11847267|FG004|COMPLETED|Overall Study||86
10684134|NCT02431052|11847263|FG000|NOT COMPLETED|Overall Study||11
10684135|NCT02431052|11847264|FG001|NOT COMPLETED|Overall Study||4
10684136|NCT02431052|11847265|FG002|NOT COMPLETED|Overall Study||12
10684137|NCT02431052|11847266|FG003|NOT COMPLETED|Overall Study||16
10684138|NCT02431052|11847267|FG004|NOT COMPLETED|Overall Study||15
10684139|NCT02431260|11847298|FG000|STARTED|Overall Study||4
10684140|NCT02431260|11847299|FG001|STARTED|Overall Study||5
10684141|NCT02431260|11847300|FG002|STARTED|Overall Study||6
10684142|NCT02431260|11847301|FG003|STARTED|Overall Study||5
10684143|NCT02431260|11847302|FG004|STARTED|Overall Study||3
10684144|NCT02431260|11847303|FG005|STARTED|Overall Study||4
10684145|NCT02431260|11847304|FG006|STARTED|Overall Study||4
10684146|NCT02431260|11847305|FG007|STARTED|Overall Study||3
10684147|NCT02431260|11847306|FG008|STARTED|Overall Study||8
10684148|NCT02431260|11847307|FG009|STARTED|Overall Study||8
10684149|NCT02431260|11847308|FG010|STARTED|Overall Study||4
10684150|NCT02431260|11847309|FG011|STARTED|Overall Study||4
10684151|NCT02431260|11847310|FG012|STARTED|Overall Study||10
10684152|NCT02431260|11847311|FG013|STARTED|Overall Study||1
10684153|NCT02431260|11847298|FG000|COMPLETED|Overall Study||0
10684154|NCT02431260|11847299|FG001|COMPLETED|Overall Study||0
10684155|NCT02431260|11847300|FG002|COMPLETED|Overall Study||0
10684156|NCT02431260|11847301|FG003|COMPLETED|Overall Study||0
10684157|NCT02431260|11847302|FG004|COMPLETED|Overall Study||0
10684158|NCT02431260|11847303|FG005|COMPLETED|Overall Study||0
10684159|NCT02431260|11847304|FG006|COMPLETED|Overall Study||0
10684160|NCT02431260|11847305|FG007|COMPLETED|Overall Study||0
10684161|NCT02431260|11847306|FG008|COMPLETED|Overall Study||0
10684162|NCT02431260|11847307|FG009|COMPLETED|Overall Study||0
10684163|NCT02431260|11847308|FG010|COMPLETED|Overall Study||0
10684164|NCT02431260|11847309|FG011|COMPLETED|Overall Study||0
10684165|NCT02431260|11847310|FG012|COMPLETED|Overall Study||0
10684166|NCT02431260|11847311|FG013|COMPLETED|Overall Study||0
10684167|NCT02431260|11847298|FG000|NOT COMPLETED|Overall Study||4
10684168|NCT02431260|11847299|FG001|NOT COMPLETED|Overall Study||5
10684169|NCT02431260|11847300|FG002|NOT COMPLETED|Overall Study||6
10684170|NCT02431260|11847301|FG003|NOT COMPLETED|Overall Study||5
10684171|NCT02431260|11847302|FG004|NOT COMPLETED|Overall Study||3
10684172|NCT02431260|11847303|FG005|NOT COMPLETED|Overall Study||4
10684173|NCT02431260|11847304|FG006|NOT COMPLETED|Overall Study||4
10684174|NCT02431260|11847305|FG007|NOT COMPLETED|Overall Study||3
10684175|NCT02431260|11847306|FG008|NOT COMPLETED|Overall Study||8
10684176|NCT02431260|11847307|FG009|NOT COMPLETED|Overall Study||8
10684177|NCT02431260|11847308|FG010|NOT COMPLETED|Overall Study||4
10684178|NCT02431260|11847309|FG011|NOT COMPLETED|Overall Study||4
10684179|NCT02431260|11847310|FG012|NOT COMPLETED|Overall Study||10
10684180|NCT02431260|11847311|FG013|NOT COMPLETED|Overall Study||1
10684181|NCT02431273|11847354|FG000|STARTED|TDF (Single IVR)||6
10684182|NCT02431273|11847354|FG000|COMPLETED|TDF (Single IVR)||6
10684183|NCT02431273|11847354|FG000|NOT COMPLETED|TDF (Single IVR)||0
10684184|NCT02431273|11847354|FG000|STARTED|TDF-FTC (Dual IVR)||6
10684185|NCT02431273|11847354|FG000|COMPLETED|TDF-FTC (Dual IVR)||6
10684186|NCT02431273|11847354|FG000|NOT COMPLETED|TDF-FTC (Dual IVR)||0
10684187|NCT02431273|11847354|FG000|STARTED|TDF-FTC-MVC (Triple IVR)||6
10684188|NCT02431273|11847354|FG000|COMPLETED|TDF-FTC-MVC (Triple IVR)||6
10684189|NCT02431273|11847354|FG000|NOT COMPLETED|TDF-FTC-MVC (Triple IVR)||0
10684190|NCT02431299|11847364|FG000|STARTED|Overall Study||236
10684191|NCT02431299|11847365|FG001|STARTED|Overall Study||63
10684192|NCT02431299|11847364|FG000|COMPLETED|Overall Study||183
10684193|NCT02431299|11847365|FG001|COMPLETED|Overall Study||62
10684194|NCT02431299|11847364|FG000|NOT COMPLETED|Overall Study||53
10684195|NCT02431299|11847365|FG001|NOT COMPLETED|Overall Study||1
10684196|NCT02431364|11847376|FG000|STARTED|Overall Study||8
10684197|NCT02431364|11847377|FG001|STARTED|Overall Study||6
10684198|NCT02431364|11847378|FG002|STARTED|Overall Study||6
10684199|NCT02431364|11847379|FG003|STARTED|Overall Study||7
10684200|NCT02431364|11847380|FG004|STARTED|Overall Study||6
10684201|NCT02431364|11847376|FG000|Treated|Overall Study||8
10684202|NCT02431364|11847377|FG001|Treated|Overall Study||6
10684203|NCT02431364|11847378|FG002|Treated|Overall Study||6
10684204|NCT02431364|11847379|FG003|Treated|Overall Study||6
10684205|NCT02431364|11847380|FG004|Treated|Overall Study||6
10684206|NCT02431364|11847376|FG000|COMPLETED|Overall Study||8
10684207|NCT02431364|11847377|FG001|COMPLETED|Overall Study||5
10684208|NCT02431364|11847378|FG002|COMPLETED|Overall Study||6
10684209|NCT02431364|11847379|FG003|COMPLETED|Overall Study||6
10684210|NCT02431364|11847380|FG004|COMPLETED|Overall Study||6
10684211|NCT02431364|11847376|FG000|NOT COMPLETED|Overall Study||0
10684212|NCT02431364|11847377|FG001|NOT COMPLETED|Overall Study||1
10684213|NCT02431364|11847378|FG002|NOT COMPLETED|Overall Study||0
10684214|NCT02431364|11847379|FG003|NOT COMPLETED|Overall Study||1
10684215|NCT02431364|11847380|FG004|NOT COMPLETED|Overall Study||0
10684216|NCT02431455|11847398|FG000|STARTED|Overall Study||112
10684217|NCT02431455|11847399|FG001|STARTED|Overall Study||112
10684218|NCT02431455|11847398|FG000|COMPLETED|Overall Study||112
10684219|NCT02431455|11847399|FG001|COMPLETED|Overall Study||112
10684220|NCT02431455|11847398|FG000|NOT COMPLETED|Overall Study||0
10684221|NCT02431455|11847399|FG001|NOT COMPLETED|Overall Study||0
10684222|NCT02431468|11847408|FG000|STARTED|Overall Study||46
10684223|NCT02431468|11847409|FG001|STARTED|Overall Study||47
10684224|NCT02431468|11847410|FG002|STARTED|Overall Study||48
10684225|NCT02431468|11847408|FG000|COMPLETED|Overall Study||38
10684226|NCT02431468|11847409|FG001|COMPLETED|Overall Study||29
10684227|NCT02431468|11847410|FG002|COMPLETED|Overall Study||39
10684228|NCT02431468|11847408|FG000|NOT COMPLETED|Overall Study||8
10684229|NCT02431468|11847409|FG001|NOT COMPLETED|Overall Study||18
10684230|NCT02431468|11847410|FG002|NOT COMPLETED|Overall Study||9
10684231|NCT02431533|11847426|FG000|STARTED|Overall Study||25
10684232|NCT02431533|11847427|FG001|STARTED|Overall Study||25
10684233|NCT02431533|11847426|FG000|COMPLETED|Overall Study||23
10684234|NCT02431533|11847427|FG001|COMPLETED|Overall Study||22
10684235|NCT02431533|11847426|FG000|NOT COMPLETED|Overall Study||2
10684236|NCT02431533|11847427|FG001|NOT COMPLETED|Overall Study||3
10684237|NCT02431559|11847437|FG000|STARTED|Overall Study||3
10684238|NCT02431559|11847438|FG001|STARTED|Overall Study||4
10684239|NCT02431559|11847439|FG002|STARTED|Overall Study||6
10684240|NCT02431559|11847440|FG003|STARTED|Overall Study||40
10684241|NCT02431559|11847437|FG000|COMPLETED|Overall Study||1
10684242|NCT02431559|11847438|FG001|COMPLETED|Overall Study||1
10684243|NCT02431559|11847439|FG002|COMPLETED|Overall Study||2
10684244|NCT02431559|11847440|FG003|COMPLETED|Overall Study||9
10684245|NCT02431559|11847437|FG000|NOT COMPLETED|Overall Study||2
10684246|NCT02431559|11847438|FG001|NOT COMPLETED|Overall Study||3
10684247|NCT02431559|11847439|FG002|NOT COMPLETED|Overall Study||4
10684248|NCT02431559|11847440|FG003|NOT COMPLETED|Overall Study||31
10684249|NCT02431572|11847453|FG000|STARTED|Overall Study||1
10684250|NCT02431572|11847454|FG001|STARTED|Overall Study||1
10684251|NCT02431572|11847455|FG002|STARTED|Overall Study||9
10684252|NCT02431572|11847453|FG000|COMPLETED|Overall Study||0
10684253|NCT02431572|11847454|FG001|COMPLETED|Overall Study||1
10684254|NCT02431572|11847455|FG002|COMPLETED|Overall Study||9
10684255|NCT02431572|11847453|FG000|NOT COMPLETED|Overall Study||1
10684256|NCT02431572|11847454|FG001|NOT COMPLETED|Overall Study||0
10684257|NCT02431572|11847455|FG002|NOT COMPLETED|Overall Study||0
10684258|NCT02431598|11847463|FG000|STARTED|Overall Study||6
10684259|NCT02431598|11847464|FG001|STARTED|Overall Study||9
10684260|NCT02431598|11847465|FG002|STARTED|Overall Study||9
10684261|NCT02431598|11847466|FG003|STARTED|Overall Study||7
10684262|NCT02431598|11847467|FG004|STARTED|Overall Study||7
10684263|NCT02431598|11847468|FG005|STARTED|Overall Study||6
10799336|NCT04041440|11960015|FG000|STARTED|Overall Study||12
10799337|NCT04041440|11960016|FG001|STARTED|Overall Study||22
10799338|NCT04041440|11960015|FG000|COMPLETED|Overall Study||12
10799339|NCT04041440|11960016|FG001|COMPLETED|Overall Study||20
10799340|NCT04041440|11960015|FG000|NOT COMPLETED|Overall Study||0
10799341|NCT04041440|11960016|FG001|NOT COMPLETED|Overall Study||2
10799342|NCT04041570|11960025|FG000|STARTED|Overall Study||20
10799343|NCT04041570|11960026|FG001|STARTED|Overall Study||20
10799344|NCT04041570|11960025|FG000|COMPLETED|Overall Study||20
10799345|NCT04041570|11960026|FG001|COMPLETED|Overall Study||18
10799346|NCT04041570|11960025|FG000|NOT COMPLETED|Overall Study||0
10799347|NCT04041570|11960026|FG001|NOT COMPLETED|Overall Study||2
10799348|NCT04043143|11960035|FG000|STARTED|Overall Study||29
10799349|NCT04043143|11960036|FG001|STARTED|Overall Study||27
10799350|NCT04043143|11960035|FG000|COMPLETED|Overall Study||23
10799351|NCT04043143|11960036|FG001|COMPLETED|Overall Study||22
10799352|NCT04043143|11960035|FG000|NOT COMPLETED|Overall Study||6
10799353|NCT04043143|11960036|FG001|NOT COMPLETED|Overall Study||5
10799354|NCT04049123|11960042|FG000|STARTED|Period 1||5
10799355|NCT04049123|11960043|FG001|STARTED|Period 1||5
10799356|NCT04049123|11960044|FG002|STARTED|Period 1||5
10799357|NCT04049123|11960042|FG000|Received at Least One Dose of Study Drug|Period 1||5
10799358|NCT04049123|11960043|FG001|Received at Least One Dose of Study Drug|Period 1||5
10799359|NCT04049123|11960044|FG002|Received at Least One Dose of Study Drug|Period 1||5
10799360|NCT04049123|11960042|FG000|COMPLETED|Period 1||5
10799361|NCT04049123|11960043|FG001|COMPLETED|Period 1||5
10684264|NCT02431598|11847463|FG000|COMPLETED|Overall Study||6
10684265|NCT02431598|11847464|FG001|COMPLETED|Overall Study||9
10684266|NCT02431598|11847465|FG002|COMPLETED|Overall Study||9
10684267|NCT02431598|11847466|FG003|COMPLETED|Overall Study||7
10684268|NCT02431598|11847467|FG004|COMPLETED|Overall Study||7
10684269|NCT02431598|11847468|FG005|COMPLETED|Overall Study||6
10799362|NCT04049123|11960044|FG002|COMPLETED|Period 1||5
10799363|NCT04049123|11960042|FG000|NOT COMPLETED|Period 1||0
10799364|NCT04049123|11960043|FG001|NOT COMPLETED|Period 1||0
10799365|NCT04049123|11960044|FG002|NOT COMPLETED|Period 1||0
10799366|NCT04049123|11960042|FG000|STARTED|Period 2||5
10684270|NCT02431598|11847463|FG000|NOT COMPLETED|Overall Study||0
10684271|NCT02431598|11847464|FG001|NOT COMPLETED|Overall Study||0
10684272|NCT02431598|11847465|FG002|NOT COMPLETED|Overall Study||0
10684273|NCT02431598|11847466|FG003|NOT COMPLETED|Overall Study||0
10684274|NCT02431598|11847467|FG004|NOT COMPLETED|Overall Study||0
10684275|NCT02431598|11847468|FG005|NOT COMPLETED|Overall Study||0
10684276|NCT02431637|11847485|FG000|STARTED|Overall Study||6
10684277|NCT02431637|11847485|FG000|COMPLETED|Overall Study||6
10684278|NCT02431637|11847485|FG000|NOT COMPLETED|Overall Study||0
10684279|NCT02431650|11847491|FG000|STARTED|Overall Study||5
10684280|NCT02431650|11847492|FG001|STARTED|Overall Study||6
10799367|NCT04049123|11960043|FG001|STARTED|Period 2||5
10684281|NCT02431650|11847491|FG000|COMPLETED|Overall Study||5
10684282|NCT02431650|11847492|FG001|COMPLETED|Overall Study||6
10684283|NCT02431650|11847491|FG000|NOT COMPLETED|Overall Study||0
10684284|NCT02431650|11847492|FG001|NOT COMPLETED|Overall Study||0
10684285|NCT02431676|11847501|FG000|STARTED|Overall Study||40
10684286|NCT02431676|11847502|FG001|STARTED|Overall Study||39
10684287|NCT02431676|11847503|FG002|STARTED|Overall Study||42
10684288|NCT02431676|11847501|FG000|COMPLETED|Overall Study||40
10684289|NCT02431676|11847502|FG001|COMPLETED|Overall Study||38
10684290|NCT02431676|11847503|FG002|COMPLETED|Overall Study||40
10684291|NCT02431676|11847501|FG000|NOT COMPLETED|Overall Study||0
10684292|NCT02431676|11847502|FG001|NOT COMPLETED|Overall Study||1
10684293|NCT02431676|11847503|FG002|NOT COMPLETED|Overall Study||2
10684294|NCT02431741|11847511|FG000|STARTED|Overall Study||14
10684295|NCT02431741|11847511|FG000|COMPLETED|Overall Study||14
10684296|NCT02431741|11847511|FG000|NOT COMPLETED|Overall Study||0
10712996|NCT02675998|11878533|FG003|COMPLETED|8-Week Treatment Period||0
10712997|NCT02675998|11878530|FG000|NOT COMPLETED|8-Week Treatment Period||17
10712998|NCT02675998|11878531|FG001|NOT COMPLETED|8-Week Treatment Period||19
10712999|NCT02675998|11878532|FG002|NOT COMPLETED|8-Week Treatment Period||19
10713000|NCT02675998|11878533|FG003|NOT COMPLETED|8-Week Treatment Period||0
10713001|NCT02675998|11878530|FG000|STARTED|4-Week Randomized Withdrawal Period||25
10713002|NCT02675998|11878531|FG001|STARTED|4-Week Randomized Withdrawal Period||23
10713003|NCT02675998|11878532|FG002|STARTED|4-Week Randomized Withdrawal Period||34
10713004|NCT02675998|11878533|FG003|STARTED|4-Week Randomized Withdrawal Period||82
10713005|NCT02675998|11878530|FG000|COMPLETED|4-Week Randomized Withdrawal Period||24
10713006|NCT02675998|11878531|FG001|COMPLETED|4-Week Randomized Withdrawal Period||22
10713007|NCT02675998|11878532|FG002|COMPLETED|4-Week Randomized Withdrawal Period||32
10713008|NCT02675998|11878533|FG003|COMPLETED|4-Week Randomized Withdrawal Period||74
10713009|NCT02675998|11878530|FG000|NOT COMPLETED|4-Week Randomized Withdrawal Period||1
10713010|NCT02675998|11878531|FG001|NOT COMPLETED|4-Week Randomized Withdrawal Period||1
10713011|NCT02675998|11878532|FG002|NOT COMPLETED|4-Week Randomized Withdrawal Period||2
10713012|NCT02675998|11878533|FG003|NOT COMPLETED|4-Week Randomized Withdrawal Period||8
10713013|NCT02676375|11878546|FG000|STARTED|Overall Study||14
10713014|NCT02676375|11878547|FG001|STARTED|Overall Study||14
10713015|NCT02676375|11878548|FG002|STARTED|Overall Study||14
10713016|NCT02676375|11878546|FG000|COMPLETED|Overall Study||13
10713017|NCT02676375|11878547|FG001|COMPLETED|Overall Study||10
10713018|NCT02676375|11878548|FG002|COMPLETED|Overall Study||11
10713019|NCT02676375|11878546|FG000|NOT COMPLETED|Overall Study||1
10713020|NCT02676375|11878547|FG001|NOT COMPLETED|Overall Study||4
10713021|NCT02676375|11878548|FG002|NOT COMPLETED|Overall Study||3
10713022|NCT02676466|11878564|FG000|STARTED|Overall Study||109
10713023|NCT02676466|11878565|FG001|STARTED|Overall Study||71
10713024|NCT02676466|11878566|FG002|STARTED|Overall Study||26
10713025|NCT02676466|11878567|FG003|STARTED|Overall Study||17
10713026|NCT02676466|11878568|FG004|STARTED|Overall Study||26
10713027|NCT02676466|11878569|FG005|STARTED|Overall Study||13
10713028|NCT02676466|11878570|FG006|STARTED|Overall Study||13
10713029|NCT02676466|11878571|FG007|STARTED|Overall Study||14
10713030|NCT02676466|11878564|FG000|COMPLETED|Overall Study||105
10713031|NCT02676466|11878565|FG001|COMPLETED|Overall Study||66
10713032|NCT02676466|11878566|FG002|COMPLETED|Overall Study||24
10713033|NCT02676466|11878567|FG003|COMPLETED|Overall Study||17
10713034|NCT02676466|11878568|FG004|COMPLETED|Overall Study||23
10713035|NCT02676466|11878569|FG005|COMPLETED|Overall Study||12
10713036|NCT02676466|11878570|FG006|COMPLETED|Overall Study||12
10713037|NCT02676466|11878571|FG007|COMPLETED|Overall Study||13
10713038|NCT02676466|11878564|FG000|NOT COMPLETED|Overall Study||4
10713039|NCT02676466|11878565|FG001|NOT COMPLETED|Overall Study||5
10713040|NCT02676466|11878566|FG002|NOT COMPLETED|Overall Study||2
10713041|NCT02676466|11878567|FG003|NOT COMPLETED|Overall Study||0
10713042|NCT02676466|11878568|FG004|NOT COMPLETED|Overall Study||3
10713043|NCT02676466|11878569|FG005|NOT COMPLETED|Overall Study||1
10713044|NCT02676466|11878570|FG006|NOT COMPLETED|Overall Study||1
10713045|NCT02676466|11878571|FG007|NOT COMPLETED|Overall Study||1
10713046|NCT02676778|11878596|FG000|STARTED|Overall Study||17
10713047|NCT02676778|11878597|FG001|STARTED|Overall Study||19
10713048|NCT02676778|11878598|FG002|STARTED|Overall Study||1
10713049|NCT02676778|11878596|FG000|COMPLETED|Overall Study||0
10713050|NCT02676778|11878597|FG001|COMPLETED|Overall Study||7
10713051|NCT02676778|11878598|FG002|COMPLETED|Overall Study||0
10713052|NCT02676778|11878596|FG000|NOT COMPLETED|Overall Study||17
10713053|NCT02676778|11878597|FG001|NOT COMPLETED|Overall Study||12
10713054|NCT02676778|11878598|FG002|NOT COMPLETED|Overall Study||1
10713055|NCT02676843|11878607|FG000|STARTED|Overall Study||7
10713056|NCT02676843|11878607|FG000|COMPLETED|Overall Study||7
10713057|NCT02676843|11878607|FG000|NOT COMPLETED|Overall Study||0
10713058|NCT02676882|11878614|FG000|STARTED|Overall Study||13
10713059|NCT02676882|11878615|FG001|STARTED|Overall Study||7
10713060|NCT02676882|11878614|FG000|Evaluable|Overall Study||11
10713061|NCT02676882|11878615|FG001|Evaluable|Overall Study||6
10713062|NCT02676882|11878614|FG000|COMPLETED|Overall Study||10
10713063|NCT02676882|11878615|FG001|COMPLETED|Overall Study||5
10713064|NCT02676882|11878614|FG000|NOT COMPLETED|Overall Study||3
10713065|NCT02676882|11878615|FG001|NOT COMPLETED|Overall Study||2
10713066|NCT02676895|11878624|FG000|STARTED|Overall Study||22
10713067|NCT02676895|11878625|FG001|STARTED|Overall Study||26
10713068|NCT02676895|11878626|FG002|STARTED|Overall Study||24
10713069|NCT02676895|11878624|FG000|COMPLETED|Overall Study||20
10684297|NCT02431754|11847517|FG000|STARTED|Period 1 (8 Weeks)||85
10684298|NCT02431754|11847518|FG001|STARTED|Period 1 (8 Weeks)||86
10684299|NCT02431754|11847517|FG000|Received at Least One Dose of Study Drug|Period 1 (8 Weeks)||85
10684300|NCT02431754|11847518|FG001|Received at Least One Dose of Study Drug|Period 1 (8 Weeks)||86
10684301|NCT02431754|11847517|FG000|COMPLETED|Period 1 (8 Weeks)||79
10684302|NCT02431754|11847518|FG001|COMPLETED|Period 1 (8 Weeks)||82
10684303|NCT02431754|11847517|FG000|NOT COMPLETED|Period 1 (8 Weeks)||6
10684304|NCT02431754|11847518|FG001|NOT COMPLETED|Period 1 (8 Weeks)||4
10684305|NCT02431754|11847517|FG000|STARTED|Wash-out Period (4 Weeks)||79
10684306|NCT02431754|11847518|FG001|STARTED|Wash-out Period (4 Weeks)||82
10684307|NCT02431754|11847517|FG000|COMPLETED|Wash-out Period (4 Weeks)||75
10684308|NCT02431754|11847518|FG001|COMPLETED|Wash-out Period (4 Weeks)||82
10684309|NCT02431754|11847517|FG000|NOT COMPLETED|Wash-out Period (4 Weeks)||4
10684310|NCT02431754|11847518|FG001|NOT COMPLETED|Wash-out Period (4 Weeks)||0
10684311|NCT02431754|11847517|FG000|STARTED|Period 2 (8 Weeks)||75
10684312|NCT02431754|11847518|FG001|STARTED|Period 2 (8 Weeks)||82
10684313|NCT02431754|11847517|FG000|COMPLETED|Period 2 (8 Weeks)||74
10684314|NCT02431754|11847518|FG001|COMPLETED|Period 2 (8 Weeks)||78
10684315|NCT02431754|11847517|FG000|NOT COMPLETED|Period 2 (8 Weeks)||1
10684316|NCT02431754|11847518|FG001|NOT COMPLETED|Period 2 (8 Weeks)||4
10684317|NCT02431793|11847529|FG000|STARTED|Overall Study||202
10684318|NCT02431793|11847530|FG001|STARTED|Overall Study||243
10799368|NCT04049123|11960044|FG002|STARTED|Period 2||5
10799369|NCT04049123|11960042|FG000|COMPLETED|Period 2||5
10799370|NCT04049123|11960043|FG001|COMPLETED|Period 2||5
10799371|NCT04049123|11960044|FG002|COMPLETED|Period 2||5
10799372|NCT04049123|11960042|FG000|NOT COMPLETED|Period 2||0
10799373|NCT04049123|11960043|FG001|NOT COMPLETED|Period 2||0
10799374|NCT04049123|11960044|FG002|NOT COMPLETED|Period 2||0
10799375|NCT04049123|11960042|FG000|STARTED|Period 3||5
10799376|NCT04049123|11960043|FG001|STARTED|Period 3||5
10799377|NCT04049123|11960044|FG002|STARTED|Period 3||5
10799378|NCT04049123|11960042|FG000|COMPLETED|Period 3||5
10799379|NCT04049123|11960043|FG001|COMPLETED|Period 3||5
10799380|NCT04049123|11960044|FG002|COMPLETED|Period 3||5
10799381|NCT04049123|11960042|FG000|NOT COMPLETED|Period 3||0
10799382|NCT04049123|11960043|FG001|NOT COMPLETED|Period 3||0
10799383|NCT04049123|11960044|FG002|NOT COMPLETED|Period 3||0
10799384|NCT04051463|11960054|FG000|STARTED|Overall Study||15
10799385|NCT04051463|11960055|FG001|STARTED|Overall Study||14
10799386|NCT04051463|11960054|FG000|COMPLETED|Overall Study||13
10799387|NCT04051463|11960055|FG001|COMPLETED|Overall Study||13
10799388|NCT04051463|11960054|FG000|NOT COMPLETED|Overall Study||2
10799389|NCT04051463|11960055|FG001|NOT COMPLETED|Overall Study||1
10799390|NCT04052204|11960061|FG000|STARTED|Overall Study||3
10799391|NCT04052204|11960062|FG001|STARTED|Overall Study|Arm was not tested due to study termination.|0
10799392|NCT04052204|11960063|FG002|STARTED|Overall Study|Arm was not tested due to study termination.|0
10799393|NCT04052204|11960061|FG000|COMPLETED|Overall Study||0
10799394|NCT04052204|11960062|FG001|COMPLETED|Overall Study||0
10799395|NCT04052204|11960063|FG002|COMPLETED|Overall Study||0
10799396|NCT04052204|11960061|FG000|NOT COMPLETED|Overall Study||3
10799397|NCT04052204|11960062|FG001|NOT COMPLETED|Overall Study||0
10799398|NCT04052204|11960063|FG002|NOT COMPLETED|Overall Study||0
10799399|NCT04054661|11960067|FG000|STARTED|Overall Study||229
10799400|NCT04054661|11960067|FG000|Enrolled in Repeatability Sub-study|Overall Study||15
10799401|NCT04054661|11960067|FG000|Enrolled in Sample Stability Sub-study|Overall Study||3
10799402|NCT04054661|11960067|FG000|COMPLETED|Overall Study||229
10799403|NCT04054661|11960067|FG000|NOT COMPLETED|Overall Study||0
10799404|NCT04067011|11960083|FG000|STARTED|Overall Study||70
10799405|NCT04067011|11960084|FG001|STARTED|Overall Study||71
10799406|NCT04067011|11960085|FG002|STARTED|Overall Study||69
10799407|NCT04067011|11960083|FG000|COMPLETED|Overall Study||51
10799408|NCT04067011|11960084|FG001|COMPLETED|Overall Study||58
10799409|NCT04067011|11960085|FG002|COMPLETED|Overall Study||61
10799410|NCT04067011|11960083|FG000|NOT COMPLETED|Overall Study||19
10799411|NCT04067011|11960084|FG001|NOT COMPLETED|Overall Study||13
10799412|NCT04067011|11960085|FG002|NOT COMPLETED|Overall Study||8
10799413|NCT04072159|11960097|FG000|STARTED|Overall Study||16
10799414|NCT04072159|11960098|FG001|STARTED|Overall Study||17
10799415|NCT04072159|11960097|FG000|COMPLETED|Overall Study||8
10799416|NCT04072159|11960098|FG001|COMPLETED|Overall Study||11
10799417|NCT04072159|11960097|FG000|NOT COMPLETED|Overall Study||8
10799418|NCT04072159|11960098|FG001|NOT COMPLETED|Overall Study||6
10799419|NCT04085341|11960108|FG000|STARTED|Overall Study||10
10799420|NCT04085341|11960109|FG001|STARTED|Overall Study||11
10799421|NCT04085341|11960108|FG000|COMPLETED|Overall Study||10
10684319|NCT02431793|11847531|FG002|STARTED|Overall Study||207
10684320|NCT02431793|11847529|FG000|Completed T1 (3-5 Days Post Enrollment)|Overall Study||136
10684321|NCT02431793|11847530|FG001|Completed T1 (3-5 Days Post Enrollment)|Overall Study||180
10684322|NCT02431793|11847531|FG002|Completed T1 (3-5 Days Post Enrollment)|Overall Study||143
10684323|NCT02431793|11847529|FG000|Completed T2 (7-14 Days Post Enrollment)|Overall Study||95
10799422|NCT04085341|11960109|FG001|COMPLETED|Overall Study||11
10799423|NCT04085341|11960108|FG000|NOT COMPLETED|Overall Study||0
10799424|NCT04085341|11960109|FG001|NOT COMPLETED|Overall Study||0
10799425|NCT04094870|11960117|FG000|STARTED|Overall Study||40
10799426|NCT04094870|11960118|FG001|STARTED|Overall Study||40
10799427|NCT04094870|11960117|FG000|COMPLETED|Overall Study||39
10799428|NCT04094870|11960118|FG001|COMPLETED|Overall Study||39
10799429|NCT04094870|11960117|FG000|NOT COMPLETED|Overall Study||1
10684324|NCT02431793|11847530|FG001|Completed T2 (7-14 Days Post Enrollment)|Overall Study||141
10684325|NCT02431793|11847531|FG002|Completed T2 (7-14 Days Post Enrollment)|Overall Study||107
10684326|NCT02431793|11847529|FG000|Completed T3 (30 Days Post Enrollment)|Overall Study||85
10684327|NCT02431793|11847530|FG001|Completed T3 (30 Days Post Enrollment)|Overall Study||113
10684328|NCT02431793|11847531|FG002|Completed T3 (30 Days Post Enrollment)|Overall Study||93
10684329|NCT02431793|11847529|FG000|COMPLETED|Overall Study||83
10684330|NCT02431793|11847530|FG001|COMPLETED|Overall Study||109
10684331|NCT02431793|11847531|FG002|COMPLETED|Overall Study||90
10684332|NCT02431793|11847529|FG000|NOT COMPLETED|Overall Study||119
10684333|NCT02431793|11847530|FG001|NOT COMPLETED|Overall Study||134
10684334|NCT02431793|11847531|FG002|NOT COMPLETED|Overall Study||117
10684335|NCT02431806|11847543|FG000|STARTED|Double-blind Treatment Period||142
10684336|NCT02431806|11847544|FG001|STARTED|Double-blind Treatment Period||136
10684337|NCT02431806|11847545|FG002|STARTED|Double-blind Treatment Period||139
10684338|NCT02431806|11847546|FG003|STARTED|Double-blind Treatment Period||135
10684339|NCT02431806|11847543|FG000|Safety Population|Double-blind Treatment Period||141
10684340|NCT02431806|11847544|FG001|Safety Population|Double-blind Treatment Period||134
10684341|NCT02431806|11847545|FG002|Safety Population|Double-blind Treatment Period||138
10684342|NCT02431806|11847546|FG003|Safety Population|Double-blind Treatment Period||134
10684343|NCT02431806|11847543|FG000|COMPLETED|Double-blind Treatment Period||117
10684344|NCT02431806|11847544|FG001|COMPLETED|Double-blind Treatment Period||115
10684345|NCT02431806|11847545|FG002|COMPLETED|Double-blind Treatment Period||107
10684346|NCT02431806|11847546|FG003|COMPLETED|Double-blind Treatment Period||109
10684347|NCT02431806|11847543|FG000|NOT COMPLETED|Double-blind Treatment Period||25
10684348|NCT02431806|11847544|FG001|NOT COMPLETED|Double-blind Treatment Period||21
10684349|NCT02431806|11847545|FG002|NOT COMPLETED|Double-blind Treatment Period||32
10684350|NCT02431806|11847546|FG003|NOT COMPLETED|Double-blind Treatment Period||26
10684351|NCT02431806|11847543|FG000|STARTED|Double-blind Down-taper Period||111
10684352|NCT02431806|11847544|FG001|STARTED|Double-blind Down-taper Period||109
10684353|NCT02431806|11847545|FG002|STARTED|Double-blind Down-taper Period||104
10684354|NCT02431806|11847546|FG003|STARTED|Double-blind Down-taper Period||107
10684355|NCT02431806|11847543|FG000|COMPLETED|Double-blind Down-taper Period||111
10799430|NCT04094870|11960118|FG001|NOT COMPLETED|Overall Study||1
10799431|NCT04096482|11960131|FG000|STARTED|Overall Study||6
10799432|NCT04096482|11960131|FG000|COMPLETED|Overall Study||6
10799433|NCT04096482|11960131|FG000|NOT COMPLETED|Overall Study||0
10799434|NCT04098172|11960137|FG000|STARTED|Overall Study||39
10799435|NCT04098172|11960137|FG000|COMPLETED|Overall Study||39
10799436|NCT04098172|11960137|FG000|NOT COMPLETED|Overall Study||0
10799437|NCT04103515|11960144|FG000|STARTED|Overall Study||25
10799438|NCT04103515|11960145|FG001|STARTED|Overall Study||25
10799439|NCT04103515|11960144|FG000|COMPLETED|Overall Study||25
10799440|NCT04103515|11960145|FG001|COMPLETED|Overall Study||25
10799441|NCT04103515|11960144|FG000|NOT COMPLETED|Overall Study||0
10799442|NCT04103515|11960145|FG001|NOT COMPLETED|Overall Study||0
10799443|NCT04111276|11960151|FG000|STARTED|Overall Study||23
10684356|NCT02431806|11847544|FG001|COMPLETED|Double-blind Down-taper Period||109
10799444|NCT04111276|11960151|FG000|COMPLETED|Overall Study||20
10799445|NCT04111276|11960151|FG000|NOT COMPLETED|Overall Study||3
10799446|NCT04123405|11960159|FG000|STARTED|Overall Study||235
10799447|NCT04123405|11960160|FG001|STARTED|Overall Study||238
10799448|NCT04123405|11960161|FG002|STARTED|Overall Study||238
10799449|NCT04123405|11960162|FG003|STARTED|Overall Study||233
10799450|NCT04123405|11960159|FG000|Full Analysis Set|Overall Study||235
10799451|NCT04123405|11960160|FG001|Full Analysis Set|Overall Study||236
10799452|NCT04123405|11960161|FG002|Full Analysis Set|Overall Study||238
10799453|NCT04123405|11960162|FG003|Full Analysis Set|Overall Study||230
10799454|NCT04123405|11960159|FG000|Per-protocol Set|Overall Study||213
10799455|NCT04123405|11960160|FG001|Per-protocol Set|Overall Study||215
10684357|NCT02431806|11847545|FG002|COMPLETED|Double-blind Down-taper Period||104
10684358|NCT02431806|11847546|FG003|COMPLETED|Double-blind Down-taper Period||107
10684359|NCT02431806|11847543|FG000|NOT COMPLETED|Double-blind Down-taper Period||0
10799456|NCT04123405|11960161|FG002|Per-protocol Set|Overall Study||212
10799457|NCT04123405|11960162|FG003|Per-protocol Set|Overall Study||207
10799458|NCT04123405|11960159|FG000|Safety Set|Overall Study||235
10799459|NCT04123405|11960160|FG001|Safety Set|Overall Study||238
10684360|NCT02431806|11847544|FG001|NOT COMPLETED|Double-blind Down-taper Period||0
10684361|NCT02431806|11847545|FG002|NOT COMPLETED|Double-blind Down-taper Period||0
10684362|NCT02431806|11847546|FG003|NOT COMPLETED|Double-blind Down-taper Period||0
10684363|NCT02432040|11847558|FG000|STARTED|Overall Study||14
10684364|NCT02432040|11847559|FG001|STARTED|Overall Study||14
10684365|NCT02432040|11847558|FG000|COMPLETED|Overall Study||6
10684366|NCT02432040|11847559|FG001|COMPLETED|Overall Study||8
10684367|NCT02432040|11847558|FG000|NOT COMPLETED|Overall Study||8
10684368|NCT02432040|11847559|FG001|NOT COMPLETED|Overall Study||6
10684369|NCT02432105|11847568|FG000|STARTED|Overall Study||164
10684370|NCT02432105|11847569|FG001|STARTED|Overall Study||110
10684371|NCT02432105|11847570|FG002|STARTED|Overall Study||111
10684372|NCT02432105|11847568|FG000|COMPLETED|Overall Study||162
10684373|NCT02432105|11847569|FG001|COMPLETED|Overall Study||108
10684374|NCT02432105|11847570|FG002|COMPLETED|Overall Study||108
10684375|NCT02432105|11847568|FG000|NOT COMPLETED|Overall Study||2
10684376|NCT02432105|11847569|FG001|NOT COMPLETED|Overall Study||2
10684377|NCT02432105|11847570|FG002|NOT COMPLETED|Overall Study||3
10684378|NCT02432144|11847579|FG000|STARTED|Overall Study||12
10684379|NCT02432144|11847579|FG000|COMPLETED|Overall Study||11
10684380|NCT02432144|11847579|FG000|NOT COMPLETED|Overall Study||1
10684381|NCT02432183|11847587|FG000|STARTED|Overall Study||44
10684382|NCT02432183|11847588|FG001|STARTED|Overall Study||47
10684383|NCT02432183|11847589|FG002|STARTED|Overall Study||26
10684384|NCT02432183|11847590|FG003|STARTED|Overall Study||17
10684385|NCT02432183|11847587|FG000|COMPLETED|Overall Study||44
10684386|NCT02432183|11847588|FG001|COMPLETED|Overall Study||47
10684387|NCT02432183|11847589|FG002|COMPLETED|Overall Study||26
10684388|NCT02432183|11847590|FG003|COMPLETED|Overall Study||17
10684389|NCT02432183|11847587|FG000|NOT COMPLETED|Overall Study||0
10684390|NCT02432183|11847588|FG001|NOT COMPLETED|Overall Study||0
10684391|NCT02432183|11847589|FG002|NOT COMPLETED|Overall Study||0
10684392|NCT02432183|11847590|FG003|NOT COMPLETED|Overall Study||0
10684393|NCT02432235|11847612|FG000|STARTED|Overall Study||2
10684394|NCT02432235|11847613|FG001|STARTED|Overall Study||2
10684395|NCT02432235|11847614|FG002|STARTED|Overall Study||2
10318897|NCT00218257|11453142|FG001|NOT COMPLETED|Intervention 2||0
10318898|NCT00218296|11453153|FG000|STARTED|Overall Study||163
10684396|NCT02432235|11847615|FG003|STARTED|Overall Study||3
10684397|NCT02432235|11847616|FG004|STARTED|Overall Study||2
10684398|NCT02432235|11847617|FG005|STARTED|Overall Study||20
10684399|NCT02432235|11847618|FG006|STARTED|Overall Study||41
10684400|NCT02432235|11847619|FG007|STARTED|Overall Study||29
10684401|NCT02432235|11847620|FG008|STARTED|Overall Study||26
10684402|NCT02432235|11847621|FG009|STARTED|Overall Study||3
10684403|NCT02432235|11847622|FG010|STARTED|Overall Study||2
10684404|NCT02432235|11847623|FG011|STARTED|Overall Study||1
10684405|NCT02432235|11847612|FG000|COMPLETED|Overall Study||1
10684406|NCT02432235|11847613|FG001|COMPLETED|Overall Study||0
10684407|NCT02432235|11847614|FG002|COMPLETED|Overall Study||0
10684408|NCT02432235|11847615|FG003|COMPLETED|Overall Study||1
10684409|NCT02432235|11847616|FG004|COMPLETED|Overall Study||0
10684410|NCT02432235|11847617|FG005|COMPLETED|Overall Study||8
10684411|NCT02432235|11847618|FG006|COMPLETED|Overall Study||23
10684412|NCT02432235|11847619|FG007|COMPLETED|Overall Study||9
10684413|NCT02432235|11847620|FG008|COMPLETED|Overall Study||5
10684414|NCT02432235|11847621|FG009|COMPLETED|Overall Study||0
10684415|NCT02432235|11847622|FG010|COMPLETED|Overall Study||1
10684416|NCT02432235|11847623|FG011|COMPLETED|Overall Study||0
10684417|NCT02432235|11847612|FG000|NOT COMPLETED|Overall Study||1
10684418|NCT02432235|11847613|FG001|NOT COMPLETED|Overall Study||2
10684419|NCT02432235|11847614|FG002|NOT COMPLETED|Overall Study||2
10684420|NCT02432235|11847615|FG003|NOT COMPLETED|Overall Study||2
10684421|NCT02432235|11847616|FG004|NOT COMPLETED|Overall Study||2
10799460|NCT04123405|11960161|FG002|Safety Set|Overall Study||238
10799461|NCT04123405|11960162|FG003|Safety Set|Overall Study||233
10799462|NCT04123405|11960159|FG000|COMPLETED|Overall Study||231
10799463|NCT04123405|11960160|FG001|COMPLETED|Overall Study||231
10799464|NCT04123405|11960161|FG002|COMPLETED|Overall Study||235
10799465|NCT04123405|11960162|FG003|COMPLETED|Overall Study||225
10684422|NCT02432235|11847617|FG005|NOT COMPLETED|Overall Study||12
10684423|NCT02432235|11847618|FG006|NOT COMPLETED|Overall Study||18
10684424|NCT02432235|11847619|FG007|NOT COMPLETED|Overall Study||20
10684425|NCT02432235|11847620|FG008|NOT COMPLETED|Overall Study||21
10684426|NCT02432235|11847621|FG009|NOT COMPLETED|Overall Study||3
10684427|NCT02432235|11847622|FG010|NOT COMPLETED|Overall Study||1
10684428|NCT02432235|11847623|FG011|NOT COMPLETED|Overall Study||1
10684429|NCT02432287|11847653|FG000|STARTED|First Intervention||8
10684430|NCT02432287|11847654|FG001|STARTED|First Intervention||8
10684431|NCT02432287|11847653|FG000|COMPLETED|First Intervention||8
10684432|NCT02432287|11847654|FG001|COMPLETED|First Intervention||7
10684433|NCT02432287|11847653|FG000|NOT COMPLETED|First Intervention||0
10684434|NCT02432287|11847654|FG001|NOT COMPLETED|First Intervention||1
10684435|NCT02432287|11847653|FG000|STARTED|Washout Period||7
10684436|NCT02432287|11847654|FG001|STARTED|Washout Period||7
10684437|NCT02432287|11847653|FG000|COMPLETED|Washout Period||7
10684438|NCT02432287|11847654|FG001|COMPLETED|Washout Period||7
10684439|NCT02432287|11847653|FG000|NOT COMPLETED|Washout Period||0
10799466|NCT04123405|11960159|FG000|NOT COMPLETED|Overall Study||4
10684440|NCT02432287|11847654|FG001|NOT COMPLETED|Washout Period||0
10684441|NCT02432287|11847653|FG000|STARTED|Second Intervention||7
10684442|NCT02432287|11847654|FG001|STARTED|Second Intervention||7
10684443|NCT02432287|11847653|FG000|COMPLETED|Second Intervention||7
10684444|NCT02432287|11847654|FG001|COMPLETED|Second Intervention||7
10684445|NCT02432287|11847653|FG000|NOT COMPLETED|Second Intervention||0
10684446|NCT02432287|11847654|FG001|NOT COMPLETED|Second Intervention||0
10684447|NCT02432300|11847662|FG000|STARTED|Overall Study||17
10684448|NCT02432300|11847662|FG000|COMPLETED|Overall Study||13
10684449|NCT02432300|11847662|FG000|NOT COMPLETED|Overall Study||4
10684450|NCT02432456|11847668|FG000|STARTED|Overall Study||75
10684451|NCT02432456|11847669|FG001|STARTED|Overall Study||75
10684452|NCT02432456|11847668|FG000|COMPLETED|Overall Study||75
10684453|NCT02432456|11847669|FG001|COMPLETED|Overall Study||75
10684454|NCT02432456|11847668|FG000|NOT COMPLETED|Overall Study||0
10684455|NCT02432456|11847669|FG001|NOT COMPLETED|Overall Study||0
10684456|NCT02432703|11847677|FG000|STARTED|Overall Study||75
10684457|NCT02432703|11847678|FG001|STARTED|Overall Study||74
10684458|NCT02432703|11847677|FG000|COMPLETED|Overall Study||53
10684459|NCT02432703|11847678|FG001|COMPLETED|Overall Study||56
10684460|NCT02432703|11847677|FG000|NOT COMPLETED|Overall Study||22
10684461|NCT02432703|11847678|FG001|NOT COMPLETED|Overall Study||18
10684462|NCT02432716|11847684|FG000|STARTED|Overall Study||6
10684463|NCT02432716|11847685|FG001|STARTED|Overall Study||6
10684464|NCT02432716|11847684|FG000|COMPLETED|Overall Study||6
10684465|NCT02432716|11847685|FG001|COMPLETED|Overall Study||6
10684466|NCT02432716|11847684|FG000|NOT COMPLETED|Overall Study||0
10684467|NCT02432716|11847685|FG001|NOT COMPLETED|Overall Study||0
10684468|NCT02432729|11847693|FG000|STARTED|Month 3 Visit||720
10684469|NCT02432729|11847693|FG000|COMPLETED|Month 3 Visit||718
10684470|NCT02432729|11847693|FG000|NOT COMPLETED|Month 3 Visit||2
10684471|NCT02432729|11847693|FG000|STARTED|Month 6 Visit||718
10684472|NCT02432729|11847693|FG000|COMPLETED|Month 6 Visit||632
10684473|NCT02432729|11847693|FG000|NOT COMPLETED|Month 6 Visit||86
10684474|NCT02432729|11847693|FG000|STARTED|Month 12 Visit||632
10684475|NCT02432729|11847693|FG000|COMPLETED|Month 12 Visit||436
10684476|NCT02432729|11847693|FG000|NOT COMPLETED|Month 12 Visit||196
10684480|NCT02433080|11847705|FG000|STARTED|Overall Study||26
10684481|NCT02433080|11847706|FG001|STARTED|Overall Study||28
10684482|NCT02433080|11847705|FG000|8 Weeks|Overall Study||25
10684483|NCT02433080|11847706|FG001|8 Weeks|Overall Study||24
10684484|NCT02433080|11847705|FG000|COMPLETED|Overall Study||25
10684485|NCT02433080|11847706|FG001|COMPLETED|Overall Study||24
10799467|NCT04123405|11960160|FG001|NOT COMPLETED|Overall Study||7
10799468|NCT04123405|11960161|FG002|NOT COMPLETED|Overall Study||3
10799469|NCT04123405|11960162|FG003|NOT COMPLETED|Overall Study||8
10799470|NCT04128527|11960172|FG000|STARTED|Overall Study||16
10455352|NCT01001442|11603418|FG001|COMPLETED|Overall Study||3
10455353|NCT01001442|11603419|FG002|COMPLETED|Overall Study||4
10455354|NCT01001442|11603420|FG003|COMPLETED|Overall Study||3
10455355|NCT01001442|11603421|FG004|COMPLETED|Overall Study||2
10455356|NCT01001442|11603422|FG005|COMPLETED|Overall Study||3
10455357|NCT01001442|11603423|FG006|COMPLETED|Overall Study||6
10455358|NCT01001442|11603424|FG007|COMPLETED|Overall Study||2
10684486|NCT02433080|11847705|FG000|NOT COMPLETED|Overall Study||1
10799471|NCT04128527|11960172|FG000|COMPLETED|Overall Study||16
10799472|NCT04128527|11960172|FG000|NOT COMPLETED|Overall Study||0
10799473|NCT04132973|11960176|FG000|STARTED|Overall Study||34
10799474|NCT04132973|11960176|FG000|Completed Intervention|Overall Study||11
10799475|NCT04132973|11960176|FG000|COMPLETED|Overall Study||8
10799476|NCT04132973|11960176|FG000|NOT COMPLETED|Overall Study||26
10799477|NCT04133415|11960180|FG000|STARTED|Overall Study||20
10799478|NCT04133415|11960180|FG000|COMPLETED|Overall Study||20
10799479|NCT04133415|11960180|FG000|NOT COMPLETED|Overall Study||0
10799480|NCT04138758|11960186|FG000|STARTED|Overall Study||2600
10799481|NCT04138758|11960187|FG001|STARTED|Overall Study||40353
10799482|NCT04138758|11960186|FG000|COMPLETED|Overall Study||2600
10799483|NCT04138758|11960187|FG001|COMPLETED|Overall Study||40353
10799484|NCT04138758|11960186|FG000|NOT COMPLETED|Overall Study||0
10799485|NCT04138758|11960187|FG001|NOT COMPLETED|Overall Study||0
10455359|NCT01001442|11603417|FG000|NOT COMPLETED|Overall Study||0
10684487|NCT02433080|11847706|FG001|NOT COMPLETED|Overall Study||4
10684488|NCT02433288|11847715|FG000|STARTED|Overall Study||443
10684489|NCT02433288|11847716|FG001|STARTED|Overall Study||442
10684490|NCT02433288|11847715|FG000|COMPLETED|Overall Study||320
10684491|NCT02433288|11847716|FG001|COMPLETED|Overall Study||316
10684492|NCT02433288|11847715|FG000|NOT COMPLETED|Overall Study||123
10684493|NCT02433288|11847716|FG001|NOT COMPLETED|Overall Study||126
10684494|NCT02433340|11847726|FG000|STARTED|Overall Study||42
10799486|NCT04147715|11960205|FG000|STARTED|Overall Study||12
10799487|NCT04147715|11960206|FG001|STARTED|Overall Study||6
10684495|NCT02433340|11847727|FG001|STARTED|Overall Study||37
10684496|NCT02433340|11847728|FG002|STARTED|Overall Study||39
10684497|NCT02433340|11847729|FG003|STARTED|Overall Study||40
10684498|NCT02433340|11847726|FG000|COMPLETED|Overall Study||40
10684499|NCT02433340|11847727|FG001|COMPLETED|Overall Study||35
10684500|NCT02433340|11847728|FG002|COMPLETED|Overall Study||37
10684501|NCT02433340|11847729|FG003|COMPLETED|Overall Study||38
10684502|NCT02433340|11847726|FG000|NOT COMPLETED|Overall Study||2
10684503|NCT02433340|11847727|FG001|NOT COMPLETED|Overall Study||2
10684504|NCT02433340|11847728|FG002|NOT COMPLETED|Overall Study||2
10684505|NCT02433340|11847729|FG003|NOT COMPLETED|Overall Study||2
10684506|NCT02433366|11847743|FG000|STARTED|Overall Study||411
10684507|NCT02433366|11847744|FG001|STARTED|Overall Study||802
10684508|NCT02433366|11847743|FG000|COMPLETED|Overall Study||411
10684509|NCT02433366|11847744|FG001|COMPLETED|Overall Study||802
10684510|NCT02433366|11847743|FG000|NOT COMPLETED|Overall Study||0
10684511|NCT02433366|11847744|FG001|NOT COMPLETED|Overall Study||0
10684512|NCT02433379|11847750|FG000|STARTED|Overall Study||1173
10684513|NCT02433379|11847750|FG000|COMPLETED|Overall Study||852
10684514|NCT02433379|11847750|FG000|NOT COMPLETED|Overall Study||321
10684515|NCT02433483|11847756|FG000|STARTED|Overall Study||2
10684516|NCT02433483|11847756|FG000|COMPLETED|Overall Study||0
10684517|NCT02433483|11847756|FG000|NOT COMPLETED|Overall Study||2
10684518|NCT02433496|11847763|FG000|STARTED|Overall Study|This includes patients (29956) and providers (34).|29990
10684519|NCT02433496|11847764|FG001|STARTED|Overall Study|This includes patients (13296) and providers (13).|13309
10684520|NCT02433496|11847765|FG002|STARTED|Overall Study|This includes patients (9813) and providers (20).|9833
10684521|NCT02433496|11847763|FG000|COMPLETED|Overall Study|This includes patients (29956) and providers (34).|29990
10684522|NCT02433496|11847764|FG001|COMPLETED|Overall Study|This includes patients (13296) and providers (13).|13309
10684523|NCT02433496|11847765|FG002|COMPLETED|Overall Study|This includes patients (9813) and providers (20).|9833
10799488|NCT04147715|11960207|FG002|STARTED|Overall Study||6
10799489|NCT04147715|11960208|FG003|STARTED|Overall Study||8
10799490|NCT04147715|11960209|FG004|STARTED|Overall Study||6
10799491|NCT04147715|11960210|FG005|STARTED|Overall Study||6
10799492|NCT04147715|11960211|FG006|STARTED|Overall Study||6
10799493|NCT04147715|11960212|FG007|STARTED|Overall Study||4
10799494|NCT04147715|11960213|FG008|STARTED|Overall Study||8
10799495|NCT04147715|11960214|FG009|STARTED|Overall Study||8
10799496|NCT04147715|11960215|FG010|STARTED|Overall Study||14
10799497|NCT04147715|11960216|FG011|STARTED|Overall Study||14
10799498|NCT04147715|11960205|FG000|COMPLETED|Overall Study||12
10799499|NCT04147715|11960206|FG001|COMPLETED|Overall Study||6
10799500|NCT04147715|11960207|FG002|COMPLETED|Overall Study||6
10799501|NCT04147715|11960208|FG003|COMPLETED|Overall Study||8
10799502|NCT04147715|11960209|FG004|COMPLETED|Overall Study||6
10799503|NCT04147715|11960210|FG005|COMPLETED|Overall Study||6
10799504|NCT04147715|11960211|FG006|COMPLETED|Overall Study||6
10799505|NCT04147715|11960212|FG007|COMPLETED|Overall Study||2
10799506|NCT04147715|11960213|FG008|COMPLETED|Overall Study||7
10799507|NCT04147715|11960214|FG009|COMPLETED|Overall Study||8
10799508|NCT04147715|11960215|FG010|COMPLETED|Overall Study||14
10799509|NCT04147715|11960216|FG011|COMPLETED|Overall Study||14
10799510|NCT04147715|11960205|FG000|NOT COMPLETED|Overall Study||0
10799511|NCT04147715|11960206|FG001|NOT COMPLETED|Overall Study||0
10799512|NCT04147715|11960207|FG002|NOT COMPLETED|Overall Study||0
10799513|NCT04147715|11960208|FG003|NOT COMPLETED|Overall Study||0
10799514|NCT04147715|11960209|FG004|NOT COMPLETED|Overall Study||0
10799515|NCT04147715|11960210|FG005|NOT COMPLETED|Overall Study||0
10799516|NCT04147715|11960211|FG006|NOT COMPLETED|Overall Study||0
10799517|NCT04147715|11960212|FG007|NOT COMPLETED|Overall Study||2
10799518|NCT04147715|11960213|FG008|NOT COMPLETED|Overall Study||1
10799519|NCT04147715|11960214|FG009|NOT COMPLETED|Overall Study||0
10799520|NCT04147715|11960215|FG010|NOT COMPLETED|Overall Study||0
10799521|NCT04147715|11960216|FG011|NOT COMPLETED|Overall Study||0
10799522|NCT04154605|11960290|FG000|STARTED|Overall Study||68
10799523|NCT04154605|11960291|FG001|STARTED|Overall Study||65
10799524|NCT04154605|11960290|FG000|COMPLETED|Overall Study||65
10684524|NCT02433496|11847763|FG000|NOT COMPLETED|Overall Study||0
10684525|NCT02433496|11847764|FG001|NOT COMPLETED|Overall Study||0
10684526|NCT02433496|11847765|FG002|NOT COMPLETED|Overall Study||0
10684527|NCT02433613|11847772|FG000|STARTED|Overall Study||1071
10684528|NCT02433613|11847772|FG000|COMPLETED|Overall Study||1054
10684529|NCT02433613|11847772|FG000|NOT COMPLETED|Overall Study||17
10799525|NCT04154605|11960291|FG001|COMPLETED|Overall Study||63
10799526|NCT04154605|11960290|FG000|NOT COMPLETED|Overall Study||3
10799527|NCT04154605|11960291|FG001|NOT COMPLETED|Overall Study||2
10684530|NCT02433665|11847778|FG000|STARTED|Overall Study||77
10684531|NCT02433665|11847779|FG001|STARTED|Overall Study||79
10799528|NCT04160091|11960301|FG000|STARTED|Overall Study||7
10684532|NCT02433665|11847778|FG000|COMPLETED|Overall Study||77
10684533|NCT02433665|11847779|FG001|COMPLETED|Overall Study||79
10684534|NCT02433665|11847778|FG000|NOT COMPLETED|Overall Study||0
10684535|NCT02433665|11847779|FG001|NOT COMPLETED|Overall Study||0
10684536|NCT02433678|11847787|FG000|STARTED|Overall Study||26
10684537|NCT02433678|11847788|FG001|STARTED|Overall Study||26
10684538|NCT02433678|11847787|FG000|COMPLETED|Overall Study||25
10684539|NCT02433678|11847788|FG001|COMPLETED|Overall Study||24
10684540|NCT02433678|11847787|FG000|NOT COMPLETED|Overall Study||1
10684541|NCT02433678|11847788|FG001|NOT COMPLETED|Overall Study||2
10684542|NCT02433834|11847794|FG000|STARTED|Overall Study||248
10684543|NCT02433834|11847794|FG000|GP MDI 28.8 µg|Overall Study||112
10684544|NCT02433834|11847794|FG000|GP MDI 14.4 µg|Overall Study||230
10684545|NCT02433834|11847794|FG000|GP MDI 7.2 µg|Overall Study||228
10684546|NCT02433834|11847794|FG000|GP MDI 3.6 µg|Overall Study||118
10684547|NCT02433834|11847794|FG000|GP MDI 1.9 µg|Overall Study||107
10684548|NCT02433834|11847794|FG000|Placebo MDI|Overall Study||174
10684549|NCT02433834|11847794|FG000|SAL 50 µg|Overall Study||167
10684550|NCT02433834|11847794|FG000|COMPLETED|Overall Study|Subject PT001101-040014 did not complete Period 4 but completed the study. CSR states 210 completed.|211
10684551|NCT02433834|11847794|FG000|NOT COMPLETED|Overall Study||37
10684552|NCT02433977|11847810|FG000|STARTED|Overall Study||6
10684553|NCT02433977|11847810|FG000|COMPLETED|Overall Study||6
10684554|NCT02433977|11847810|FG000|NOT COMPLETED|Overall Study||0
10684558|NCT02434328|11847820|FG000|STARTED|Overall Study||372
10684559|NCT02434328|11847821|FG001|STARTED|Overall Study||371
10684560|NCT02434328|11847820|FG000|Randomized and Treated|Overall Study||370
10684561|NCT02434328|11847821|FG001|Randomized and Treated|Overall Study||369
10684562|NCT02434328|11847820|FG000|COMPLETED|Overall Study||342
10684563|NCT02434328|11847821|FG001|COMPLETED|Overall Study||329
10684564|NCT02434328|11847820|FG000|NOT COMPLETED|Overall Study||30
10684565|NCT02434328|11847821|FG001|NOT COMPLETED|Overall Study||42
10684566|NCT02434471|11847828|FG000|STARTED|Overall Study||34
10684567|NCT02434471|11847828|FG000|COMPLETED|Overall Study||25
10684568|NCT02434471|11847828|FG000|NOT COMPLETED|Overall Study||9
10684569|NCT02434497|11847833|FG000|STARTED|Overall Study||9
10684570|NCT02434497|11847833|FG000|COMPLETED|Overall Study||4
10684571|NCT02434497|11847833|FG000|NOT COMPLETED|Overall Study||5
10684572|NCT02434523|11847841|FG000|STARTED|Overall Study||15
10684573|NCT02434523|11847842|FG001|STARTED|Overall Study||15
10684574|NCT02434523|11847841|FG000|COMPLETED|Overall Study||10
10684575|NCT02434523|11847842|FG001|COMPLETED|Overall Study||9
10684576|NCT02434523|11847841|FG000|NOT COMPLETED|Overall Study||5
10684577|NCT02434523|11847842|FG001|NOT COMPLETED|Overall Study||6
10684578|NCT02434770|11847853|FG000|STARTED|Week 1 to Week 18||250
10684579|NCT02434770|11847854|FG001|STARTED|Week 1 to Week 18||250
10684580|NCT02434770|11847855|FG002|STARTED|Week 1 to Week 18||250
10684581|NCT02434770|11847853|FG000|Received at Least One Vaccination|Week 1 to Week 18||249
10684582|NCT02434770|11847854|FG001|Received at Least One Vaccination|Week 1 to Week 18||250
10684583|NCT02434770|11847855|FG002|Received at Least One Vaccination|Week 1 to Week 18||250
10684584|NCT02434770|11847853|FG000|COMPLETED|Week 1 to Week 18||235
10684585|NCT02434770|11847854|FG001|COMPLETED|Week 1 to Week 18||228
10684586|NCT02434770|11847855|FG002|COMPLETED|Week 1 to Week 18||233
10684587|NCT02434770|11847853|FG000|NOT COMPLETED|Week 1 to Week 18||15
10684588|NCT02434770|11847854|FG001|NOT COMPLETED|Week 1 to Week 18||22
10684589|NCT02434770|11847855|FG002|NOT COMPLETED|Week 1 to Week 18||17
10684590|NCT02434770|11847853|FG000|STARTED|Week 18 to Week||235
10684591|NCT02434770|11847854|FG001|STARTED|Week 18 to Week||228
10684592|NCT02434770|11847855|FG002|STARTED|Week 18 to Week||233
10684593|NCT02434770|11847853|FG000|COMPLETED|Week 18 to Week||227
10684594|NCT02434770|11847854|FG001|COMPLETED|Week 18 to Week||220
10684595|NCT02434770|11847855|FG002|COMPLETED|Week 18 to Week||227
10684596|NCT02434770|11847853|FG000|NOT COMPLETED|Week 18 to Week||8
10799529|NCT04160091|11960302|FG001|STARTED|Overall Study||3
10799530|NCT04160091|11960303|FG002|STARTED|Overall Study||5
10799531|NCT04160091|11960304|FG003|STARTED|Overall Study||4
10799532|NCT04160091|11960301|FG000|COMPLETED|Overall Study||0
10799533|NCT04160091|11960302|FG001|COMPLETED|Overall Study||0
10684597|NCT02434770|11847854|FG001|NOT COMPLETED|Week 18 to Week||8
10684598|NCT02434770|11847855|FG002|NOT COMPLETED|Week 18 to Week||6
10684599|NCT02434939|11847867|FG000|STARTED|Overall Study||120
10684600|NCT02434939|11847868|FG001|STARTED|Overall Study||120
10684601|NCT02434939|11847867|FG000|COMPLETED|Overall Study||83
10684602|NCT02434939|11847868|FG001|COMPLETED|Overall Study||71
10799534|NCT04160091|11960303|FG002|COMPLETED|Overall Study||0
10684603|NCT02434939|11847867|FG000|NOT COMPLETED|Overall Study||37
10684604|NCT02434939|11847868|FG001|NOT COMPLETED|Overall Study||49
10684605|NCT02435069|11847875|FG000|STARTED|Preoperative Baseline Phase||5
10684606|NCT02435069|11847876|FG001|STARTED|Preoperative Baseline Phase||0
10684607|NCT02435069|11847877|FG002|STARTED|Preoperative Baseline Phase||0
10684608|NCT02435069|11847878|FG003|STARTED|Preoperative Baseline Phase||0
10684609|NCT02435069|11847879|FG004|STARTED|Preoperative Baseline Phase||0
10684610|NCT02435069|11847875|FG000|COMPLETED|Preoperative Baseline Phase||5
10799535|NCT04160091|11960304|FG003|COMPLETED|Overall Study||0
10684611|NCT02435069|11847876|FG001|COMPLETED|Preoperative Baseline Phase||0
10684612|NCT02435069|11847877|FG002|COMPLETED|Preoperative Baseline Phase||0
10684613|NCT02435069|11847878|FG003|COMPLETED|Preoperative Baseline Phase||0
10684614|NCT02435069|11847879|FG004|COMPLETED|Preoperative Baseline Phase||0
10684615|NCT02435069|11847875|FG000|NOT COMPLETED|Preoperative Baseline Phase||0
10684616|NCT02435069|11847876|FG001|NOT COMPLETED|Preoperative Baseline Phase||0
10684617|NCT02435069|11847877|FG002|NOT COMPLETED|Preoperative Baseline Phase||0
10684618|NCT02435069|11847878|FG003|NOT COMPLETED|Preoperative Baseline Phase||0
10684619|NCT02435069|11847879|FG004|NOT COMPLETED|Preoperative Baseline Phase||0
10684620|NCT02435069|11847875|FG000|STARTED|Dose Response - First Intervention||0
10684621|NCT02435069|11847876|FG001|STARTED|Dose Response - First Intervention||3
10684622|NCT02435069|11847877|FG002|STARTED|Dose Response - First Intervention||2
10684623|NCT02435069|11847878|FG003|STARTED|Dose Response - First Intervention||0
10799536|NCT04160091|11960301|FG000|NOT COMPLETED|Overall Study||7
10799537|NCT04160091|11960302|FG001|NOT COMPLETED|Overall Study||3
10799538|NCT04160091|11960303|FG002|NOT COMPLETED|Overall Study||5
10799539|NCT04160091|11960304|FG003|NOT COMPLETED|Overall Study||4
10799540|NCT04160260|11960314|FG000|STARTED|Overall Study||18
10799541|NCT04160260|11960314|FG000|COMPLETED|Overall Study||18
10799542|NCT04160260|11960314|FG000|NOT COMPLETED|Overall Study||0
10799543|NCT04164758|11960321|FG000|STARTED|Overall Study||4
10799544|NCT04164758|11960322|FG001|STARTED|Overall Study||4
10799545|NCT04164758|11960323|FG002|STARTED|Overall Study||3
10799546|NCT04164758|11960321|FG000|COMPLETED|Overall Study||3
10799547|NCT04164758|11960322|FG001|COMPLETED|Overall Study||3
10799548|NCT04164758|11960323|FG002|COMPLETED|Overall Study||3
10799549|NCT04164758|11960321|FG000|NOT COMPLETED|Overall Study||1
10799550|NCT04164758|11960322|FG001|NOT COMPLETED|Overall Study||1
10799551|NCT04164758|11960323|FG002|NOT COMPLETED|Overall Study||0
10799552|NCT04165031|11960337|FG000|STARTED|Overall Study||2
10799553|NCT04165031|11960338|FG001|STARTED|Overall Study||1
10799554|NCT04165031|11960339|FG002|STARTED|Overall Study||2
10799555|NCT04165031|11960340|FG003|STARTED|Overall Study||0
10799556|NCT04165031|11960341|FG004|STARTED|Overall Study||0
10799557|NCT04165031|11960342|FG005|STARTED|Overall Study||0
10799558|NCT04165031|11960337|FG000|Received at Least One Dose of Study Drug|Overall Study||2
10799559|NCT04165031|11960338|FG001|Received at Least One Dose of Study Drug|Overall Study||1
10799560|NCT04165031|11960339|FG002|Received at Least One Dose of Study Drug|Overall Study||2
10799561|NCT04165031|11960340|FG003|Received at Least One Dose of Study Drug|Overall Study||0
10799562|NCT04165031|11960341|FG004|Received at Least One Dose of Study Drug|Overall Study||0
10799563|NCT04165031|11960342|FG005|Received at Least One Dose of Study Drug|Overall Study||0
10799564|NCT04165031|11960337|FG000|COMPLETED|Overall Study||1
10799565|NCT04165031|11960338|FG001|COMPLETED|Overall Study||0
10799566|NCT04165031|11960339|FG002|COMPLETED|Overall Study||1
10799567|NCT04165031|11960340|FG003|COMPLETED|Overall Study||0
10799568|NCT04165031|11960341|FG004|COMPLETED|Overall Study||0
10799569|NCT04165031|11960342|FG005|COMPLETED|Overall Study||0
10799570|NCT04165031|11960337|FG000|NOT COMPLETED|Overall Study||1
10799571|NCT04165031|11960338|FG001|NOT COMPLETED|Overall Study||1
10799572|NCT04165031|11960339|FG002|NOT COMPLETED|Overall Study||1
10799573|NCT04165031|11960340|FG003|NOT COMPLETED|Overall Study||0
10799574|NCT04165031|11960341|FG004|NOT COMPLETED|Overall Study||0
10799575|NCT04165031|11960342|FG005|NOT COMPLETED|Overall Study||0
10799576|NCT04166032|11960357|FG000|STARTED|Overall Study||15
10799577|NCT04166032|11960357|FG000|COMPLETED|Overall Study||14
10799578|NCT04166032|11960357|FG000|NOT COMPLETED|Overall Study||1
10799579|NCT04171414|11960361|FG000|STARTED|Overall Study||62
10799580|NCT04171414|11960361|FG000|COMPLETED|Overall Study||60
10799581|NCT04171414|11960361|FG000|NOT COMPLETED|Overall Study||2
10799582|NCT04175808|11960365|FG000|STARTED|Part A||70
10799583|NCT04175808|11960366|FG001|STARTED|Part A||0
10799584|NCT04175808|11960367|FG002|STARTED|Part A||0
10799585|NCT04175808|11960368|FG003|STARTED|Part A||0
10799586|NCT04175808|11960369|FG004|STARTED|Part A||0
10799587|NCT04175808|11960370|FG005|STARTED|Part A||0
10799588|NCT04175808|11960371|FG006|STARTED|Part A||0
10799589|NCT04175808|11960365|FG000|COMPLETED|Part A||68
10799590|NCT04175808|11960366|FG001|COMPLETED|Part A||0
10799591|NCT04175808|11960367|FG002|COMPLETED|Part A||0
10799592|NCT04175808|11960368|FG003|COMPLETED|Part A||0
10799593|NCT04175808|11960369|FG004|COMPLETED|Part A||0
10799594|NCT04175808|11960370|FG005|COMPLETED|Part A||0
10799595|NCT04175808|11960371|FG006|COMPLETED|Part A||0
10799596|NCT04175808|11960365|FG000|NOT COMPLETED|Part A||2
10799597|NCT04175808|11960366|FG001|NOT COMPLETED|Part A||0
10799598|NCT04175808|11960367|FG002|NOT COMPLETED|Part A||0
10799599|NCT04175808|11960368|FG003|NOT COMPLETED|Part A||0
10799600|NCT04175808|11960369|FG004|NOT COMPLETED|Part A||0
10799601|NCT04175808|11960370|FG005|NOT COMPLETED|Part A||0
10799602|NCT04175808|11960371|FG006|NOT COMPLETED|Part A||0
10799603|NCT04175808|11960365|FG000|STARTED|Part B||0
10799604|NCT04175808|11960366|FG001|STARTED|Part B||10
10684624|NCT02435069|11847879|FG004|STARTED|Dose Response - First Intervention||0
10684625|NCT02435069|11847875|FG000|COMPLETED|Dose Response - First Intervention||0
10799605|NCT04175808|11960367|FG002|STARTED|Part B||10
10799606|NCT04175808|11960368|FG003|STARTED|Part B||10
10799607|NCT04175808|11960369|FG004|STARTED|Part B||10
10799608|NCT04175808|11960370|FG005|STARTED|Part B||10
10799609|NCT04175808|11960371|FG006|STARTED|Part B||10
10799610|NCT04175808|11960365|FG000|COMPLETED|Part B||0
10799611|NCT04175808|11960366|FG001|COMPLETED|Part B||10
10799612|NCT04175808|11960367|FG002|COMPLETED|Part B||10
10684626|NCT02435069|11847876|FG001|COMPLETED|Dose Response - First Intervention||2
10684627|NCT02435069|11847877|FG002|COMPLETED|Dose Response - First Intervention||1
10684628|NCT02435069|11847878|FG003|COMPLETED|Dose Response - First Intervention||0
10684629|NCT02435069|11847879|FG004|COMPLETED|Dose Response - First Intervention||0
10684630|NCT02435069|11847875|FG000|NOT COMPLETED|Dose Response - First Intervention||0
10684631|NCT02435069|11847876|FG001|NOT COMPLETED|Dose Response - First Intervention||1
10684632|NCT02435069|11847877|FG002|NOT COMPLETED|Dose Response - First Intervention||1
10684633|NCT02435069|11847878|FG003|NOT COMPLETED|Dose Response - First Intervention||0
10684634|NCT02435069|11847879|FG004|NOT COMPLETED|Dose Response - First Intervention||0
10684635|NCT02435069|11847875|FG000|STARTED|Effectiveness - Second Intervention||0
10684636|NCT02435069|11847876|FG001|STARTED|Effectiveness - Second Intervention||0
10684637|NCT02435069|11847877|FG002|STARTED|Effectiveness - Second Intervention||0
10684638|NCT02435069|11847878|FG003|STARTED|Effectiveness - Second Intervention||1
10684639|NCT02435069|11847879|FG004|STARTED|Effectiveness - Second Intervention||1
10684640|NCT02435069|11847875|FG000|COMPLETED|Effectiveness - Second Intervention||0
10684641|NCT02435069|11847876|FG001|COMPLETED|Effectiveness - Second Intervention||0
10684642|NCT02435069|11847877|FG002|COMPLETED|Effectiveness - Second Intervention||0
10684643|NCT02435069|11847878|FG003|COMPLETED|Effectiveness - Second Intervention||1
10684644|NCT02435069|11847879|FG004|COMPLETED|Effectiveness - Second Intervention||0
10684645|NCT02435069|11847875|FG000|NOT COMPLETED|Effectiveness - Second Intervention||0
10684646|NCT02435069|11847876|FG001|NOT COMPLETED|Effectiveness - Second Intervention||0
10684647|NCT02435069|11847877|FG002|NOT COMPLETED|Effectiveness - Second Intervention||0
10684648|NCT02435069|11847878|FG003|NOT COMPLETED|Effectiveness - Second Intervention||0
10684649|NCT02435069|11847879|FG004|NOT COMPLETED|Effectiveness - Second Intervention||1
10684650|NCT02435147|11847899|FG000|STARTED|Overall Study||86
10684651|NCT02435147|11847899|FG000|COMPLETED|Overall Study||75
10684652|NCT02435147|11847899|FG000|NOT COMPLETED|Overall Study||11
10684653|NCT02435277|11847907|FG000|STARTED|Overall Study||12
10684654|NCT02435277|11847908|FG001|STARTED|Overall Study||16
10684655|NCT02435277|11847909|FG002|STARTED|Overall Study||11
10684656|NCT02435277|11847910|FG003|STARTED|Overall Study||11
10684657|NCT02435277|11847907|FG000|COMPLETED|Overall Study||10
10684658|NCT02435277|11847908|FG001|COMPLETED|Overall Study||15
10684659|NCT02435277|11847909|FG002|COMPLETED|Overall Study||11
10684660|NCT02435277|11847910|FG003|COMPLETED|Overall Study||11
10684661|NCT02435277|11847907|FG000|NOT COMPLETED|Overall Study||2
10684662|NCT02435277|11847908|FG001|NOT COMPLETED|Overall Study||1
10684663|NCT02435277|11847909|FG002|NOT COMPLETED|Overall Study||0
10799613|NCT04175808|11960368|FG003|COMPLETED|Part B||10
10799614|NCT04175808|11960369|FG004|COMPLETED|Part B||10
10799615|NCT04175808|11960370|FG005|COMPLETED|Part B||10
10799616|NCT04175808|11960371|FG006|COMPLETED|Part B||10
10799617|NCT04175808|11960365|FG000|NOT COMPLETED|Part B||0
10799618|NCT04175808|11960366|FG001|NOT COMPLETED|Part B||0
10799619|NCT04175808|11960367|FG002|NOT COMPLETED|Part B||0
10799620|NCT04175808|11960368|FG003|NOT COMPLETED|Part B||0
10799621|NCT04175808|11960369|FG004|NOT COMPLETED|Part B||0
10799622|NCT04175808|11960370|FG005|NOT COMPLETED|Part B||0
10799623|NCT04175808|11960371|FG006|NOT COMPLETED|Part B||0
10799624|NCT04178720|11960389|FG000|STARTED|Overall Study||40
10799625|NCT04178720|11960390|FG001|STARTED|Overall Study||78
10799626|NCT04178720|11960389|FG000|COMPLETED|Overall Study||38
10799627|NCT04178720|11960390|FG001|COMPLETED|Overall Study||77
10799628|NCT04178720|11960389|FG000|NOT COMPLETED|Overall Study||2
10799629|NCT04178720|11960390|FG001|NOT COMPLETED|Overall Study||1
10799630|NCT04184297|11960401|FG000|STARTED|Overall Study||2864
10799631|NCT04184297|11960402|FG001|STARTED|Overall Study||24326
10799632|NCT04184297|11960401|FG000|COMPLETED|Overall Study||2864
10799633|NCT04184297|11960402|FG001|COMPLETED|Overall Study||24326
10799634|NCT04184297|11960401|FG000|NOT COMPLETED|Overall Study||0
10799635|NCT04184297|11960402|FG001|NOT COMPLETED|Overall Study||0
10799636|NCT04189848|11960408|FG000|STARTED|Treatment Period 1 (Day 1)||26
10799637|NCT04189848|11960409|FG001|STARTED|Treatment Period 1 (Day 1)||26
10799638|NCT04189848|11960410|FG002|STARTED|Treatment Period 1 (Day 1)||25
10799639|NCT04189848|11960411|FG003|STARTED|Treatment Period 1 (Day 1)||27
10799640|NCT04189848|11960408|FG000|COMPLETED|Treatment Period 1 (Day 1)||26
10799641|NCT04189848|11960409|FG001|COMPLETED|Treatment Period 1 (Day 1)||26
10799642|NCT04189848|11960410|FG002|COMPLETED|Treatment Period 1 (Day 1)||25
10799643|NCT04189848|11960411|FG003|COMPLETED|Treatment Period 1 (Day 1)||27
10799644|NCT04189848|11960408|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10799645|NCT04189848|11960409|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10799646|NCT04189848|11960410|FG002|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10799647|NCT04189848|11960411|FG003|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10799648|NCT04189848|11960408|FG000|STARTED|Treatment Period 2 (Day 1)||26
10799649|NCT04189848|11960409|FG001|STARTED|Treatment Period 2 (Day 1)||26
10799650|NCT04189848|11960410|FG002|STARTED|Treatment Period 2 (Day 1)||25
10799651|NCT04189848|11960411|FG003|STARTED|Treatment Period 2 (Day 1)||27
10799652|NCT04189848|11960408|FG000|COMPLETED|Treatment Period 2 (Day 1)||26
10799653|NCT04189848|11960409|FG001|COMPLETED|Treatment Period 2 (Day 1)||26
10799654|NCT04189848|11960410|FG002|COMPLETED|Treatment Period 2 (Day 1)||25
10799655|NCT04189848|11960411|FG003|COMPLETED|Treatment Period 2 (Day 1)||27
10799656|NCT04189848|11960408|FG000|NOT COMPLETED|Treatment Period 2 (Day 1)||0
10799657|NCT04189848|11960409|FG001|NOT COMPLETED|Treatment Period 2 (Day 1)||0
10799658|NCT04189848|11960410|FG002|NOT COMPLETED|Treatment Period 2 (Day 1)||0
10684664|NCT02435277|11847910|FG003|NOT COMPLETED|Overall Study||0
10684665|NCT02435381|11847920|FG000|STARTED|Overall Study||5
10684666|NCT02435381|11847921|FG001|STARTED|Overall Study||6
10684667|NCT02435381|11847920|FG000|COMPLETED|Overall Study||3
10684668|NCT02435381|11847921|FG001|COMPLETED|Overall Study||5
10684669|NCT02435381|11847920|FG000|NOT COMPLETED|Overall Study||2
10684670|NCT02435381|11847921|FG001|NOT COMPLETED|Overall Study||1
10684671|NCT02435524|11847939|FG000|STARTED|Baseline Survey||1111
10684672|NCT02435524|11847940|FG001|STARTED|Baseline Survey||1177
10684673|NCT02435524|11847939|FG000|COMPLETED|Baseline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1111
10684674|NCT02435524|11847940|FG001|COMPLETED|Baseline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1177
10684675|NCT02435524|11847939|FG000|NOT COMPLETED|Baseline Survey||0
10684676|NCT02435524|11847940|FG001|NOT COMPLETED|Baseline Survey||0
10684677|NCT02435524|11847939|FG000|STARTED|Endline Survey||1092
10684678|NCT02435524|11847940|FG001|STARTED|Endline Survey||1161
10684679|NCT02435524|11847939|FG000|COMPLETED|Endline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1092
10684680|NCT02435524|11847940|FG001|COMPLETED|Endline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1161
10684681|NCT02435524|11847939|FG000|NOT COMPLETED|Endline Survey||0
10684682|NCT02435524|11847940|FG001|NOT COMPLETED|Endline Survey||0
10684683|NCT02435680|11847949|FG000|STARTED|Overall Study||21
10684684|NCT02435680|11847950|FG001|STARTED|Overall Study||13
10684685|NCT02435680|11847951|FG002|STARTED|Overall Study||16
10684686|NCT02435680|11847949|FG000|COMPLETED|Overall Study||0
10684687|NCT02435680|11847950|FG001|COMPLETED|Overall Study||0
10684688|NCT02435680|11847951|FG002|COMPLETED|Overall Study||0
10684689|NCT02435680|11847949|FG000|NOT COMPLETED|Overall Study||21
10684690|NCT02435680|11847950|FG001|NOT COMPLETED|Overall Study||13
10684691|NCT02435680|11847951|FG002|NOT COMPLETED|Overall Study||16
10684692|NCT02435706|11847965|FG000|STARTED|Overall Study||18
10684693|NCT02435706|11847966|FG001|STARTED|Overall Study||21
10684694|NCT02435706|11847965|FG000|COMPLETED|Overall Study||16
10684695|NCT02435706|11847966|FG001|COMPLETED|Overall Study||20
10684696|NCT02435706|11847965|FG000|NOT COMPLETED|Overall Study||2
10684697|NCT02435706|11847966|FG001|NOT COMPLETED|Overall Study||1
10684698|NCT02435836|11847972|FG000|STARTED|Overall Study||631
10684699|NCT02435836|11847972|FG000|COMPLETED|Overall Study||0
10684700|NCT02435836|11847972|FG000|NOT COMPLETED|Overall Study||631
10684701|NCT02435901|11847976|FG000|STARTED|Overall Study||29
10684702|NCT02435901|11847976|FG000|COMPLETED|Overall Study||29
10684703|NCT02435901|11847976|FG000|NOT COMPLETED|Overall Study||0
10684704|NCT02435914|11847985|FG000|STARTED|Overall Study||58
10684705|NCT02435914|11847986|FG001|STARTED|Overall Study||59
10684706|NCT02435914|11847987|FG002|STARTED|Overall Study||60
10684707|NCT02435914|11847988|FG003|STARTED|Overall Study||59
10684708|NCT02435914|11847985|FG000|COMPLETED|Overall Study||57
10684709|NCT02435914|11847986|FG001|COMPLETED|Overall Study||58
10684710|NCT02435914|11847987|FG002|COMPLETED|Overall Study||59
10684711|NCT02435914|11847988|FG003|COMPLETED|Overall Study||59
10684712|NCT02435914|11847985|FG000|NOT COMPLETED|Overall Study||1
10684713|NCT02435914|11847986|FG001|NOT COMPLETED|Overall Study||1
10684714|NCT02435914|11847987|FG002|NOT COMPLETED|Overall Study||1
10684715|NCT02435914|11847988|FG003|NOT COMPLETED|Overall Study||0
10684716|NCT02435966|11848001|FG000|STARTED|Overall Study||47
10684717|NCT02435966|11848002|FG001|STARTED|Overall Study||54
10684718|NCT02435966|11848003|FG002|STARTED|Overall Study||30
10684719|NCT02435966|11848001|FG000|First Intervention|Overall Study||47
10684720|NCT02435966|11848002|FG001|First Intervention|Overall Study||54
10684721|NCT02435966|11848003|FG002|First Intervention|Overall Study||30
10684722|NCT02435966|11848001|FG000|Second Intervention|Overall Study||47
10684723|NCT02435966|11848002|FG001|Second Intervention|Overall Study||53
10684724|NCT02435966|11848003|FG002|Second Intervention|Overall Study||30
10684725|NCT02435966|11848001|FG000|Follow-up|Overall Study||47
10684726|NCT02435966|11848002|FG001|Follow-up|Overall Study||53
10684727|NCT02435966|11848003|FG002|Follow-up|Overall Study||30
10684728|NCT02435966|11848001|FG000|COMPLETED|Overall Study||47
10684729|NCT02435966|11848002|FG001|COMPLETED|Overall Study||53
10684730|NCT02435966|11848003|FG002|COMPLETED|Overall Study||30
10684731|NCT02435966|11848001|FG000|NOT COMPLETED|Overall Study||0
10684732|NCT02435966|11848002|FG001|NOT COMPLETED|Overall Study||1
10684733|NCT02435966|11848003|FG002|NOT COMPLETED|Overall Study||0
10684734|NCT02435992|11848016|FG000|STARTED|Overall Study||429
10684735|NCT02435992|11848017|FG001|STARTED|Overall Study||216
10684736|NCT02435992|11848018|FG002|STARTED|Overall Study||367
10684737|NCT02435992|11848019|FG003|STARTED|Overall Study||0
10684738|NCT02435992|11848020|FG004|STARTED|Overall Study||0
10684739|NCT02435992|11848016|FG000|Transition to Maintenance Period|Overall Study||233
10684740|NCT02435992|11848017|FG001|Transition to Maintenance Period|Overall Study||69
10684741|NCT02435992|11848018|FG002|Transition to Maintenance Period|Overall Study||224
10684742|NCT02435992|11848019|FG003|Transition to Maintenance Period|Overall Study||0
10684743|NCT02435992|11848020|FG004|Transition to Maintenance Period|Overall Study||0
10684744|NCT02435992|11848016|FG000|Treated in Maintenance Period|Overall Study||0
10684745|NCT02435992|11848017|FG001|Treated in Maintenance Period|Overall Study||69
10684746|NCT02435992|11848018|FG002|Treated in Maintenance Period|Overall Study||0
10684747|NCT02435992|11848019|FG003|Treated in Maintenance Period|Overall Study|Randomized from cohort 1 and 2 RCP1063 treatment|230
10684748|NCT02435992|11848020|FG004|Treated in Maintenance Period|Overall Study|Randomized from cohort 1 and 2 RCP1063 treatment|227
10684749|NCT02435992|11848016|FG000|COMPLETED|Overall Study||401
10684750|NCT02435992|11848017|FG001|COMPLETED|Overall Study||192
10684751|NCT02435992|11848018|FG002|COMPLETED|Overall Study||324
10684752|NCT02435992|11848019|FG003|COMPLETED|Overall Study||0
10684753|NCT02435992|11848020|FG004|COMPLETED|Overall Study||0
10684754|NCT02435992|11848016|FG000|NOT COMPLETED|Overall Study||28
10684755|NCT02435992|11848017|FG001|NOT COMPLETED|Overall Study||24
10684756|NCT02435992|11848018|FG002|NOT COMPLETED|Overall Study||43
10684757|NCT02435992|11848019|FG003|NOT COMPLETED|Overall Study||0
10684758|NCT02435992|11848020|FG004|NOT COMPLETED|Overall Study||0
10684759|NCT02436005|11848032|FG000|STARTED|First Intervention||12
10684760|NCT02436005|11848033|FG001|STARTED|First Intervention||13
10684761|NCT02436005|11848032|FG000|COMPLETED|First Intervention||12
10684762|NCT02436005|11848033|FG001|COMPLETED|First Intervention||13
10684763|NCT02436005|11848032|FG000|NOT COMPLETED|First Intervention||0
10684764|NCT02436005|11848033|FG001|NOT COMPLETED|First Intervention||0
10684765|NCT02436005|11848032|FG000|STARTED|Second Intervention||12
10684766|NCT02436005|11848033|FG001|STARTED|Second Intervention||13
10684767|NCT02436005|11848032|FG000|COMPLETED|Second Intervention||12
10684768|NCT02436005|11848033|FG001|COMPLETED|Second Intervention||12
10684769|NCT02436005|11848032|FG000|NOT COMPLETED|Second Intervention||0
10684770|NCT02436005|11848033|FG001|NOT COMPLETED|Second Intervention||1
10684771|NCT02436031|11848039|FG000|STARTED|First Study Night||8
10684772|NCT02436031|11848040|FG001|STARTED|First Study Night||8
10684773|NCT02436031|11848039|FG000|COMPLETED|First Study Night||8
10684774|NCT02436031|11848040|FG001|COMPLETED|First Study Night||8
10684775|NCT02436031|11848039|FG000|NOT COMPLETED|First Study Night||0
10684776|NCT02436031|11848040|FG001|NOT COMPLETED|First Study Night||0
10684777|NCT02436031|11848039|FG000|STARTED|Second Study Night|1 participant did not tolerate the study setup so did not participate in the second study night|7
10684778|NCT02436031|11848040|FG001|STARTED|Second Study Night||8
10684779|NCT02436031|11848039|FG000|COMPLETED|Second Study Night||7
10684780|NCT02436031|11848040|FG001|COMPLETED|Second Study Night||8
10684781|NCT02436031|11848039|FG000|NOT COMPLETED|Second Study Night||0
10684782|NCT02436031|11848040|FG001|NOT COMPLETED|Second Study Night||0
10684783|NCT02436135|11848048|FG000|STARTED|Overall Study||6
10684784|NCT02436135|11848049|FG001|STARTED|Overall Study||4
10684785|NCT02436135|11848048|FG000|COMPLETED|Overall Study||0
10684786|NCT02436135|11848049|FG001|COMPLETED|Overall Study||0
10684787|NCT02436135|11848048|FG000|NOT COMPLETED|Overall Study||6
10684788|NCT02436135|11848049|FG001|NOT COMPLETED|Overall Study||4
10684789|NCT02436200|11848055|FG000|STARTED|Overall Study||21
10684790|NCT02436200|11848055|FG000|COMPLETED|Overall Study||20
10684791|NCT02436200|11848055|FG000|NOT COMPLETED|Overall Study||1
10684792|NCT02436239|11848063|FG000|STARTED|Open-Lable Treatment Period||122
10684793|NCT02436239|11848064|FG001|STARTED|Open-Lable Treatment Period||131
10684794|NCT02436239|11848065|FG002|STARTED|Open-Lable Treatment Period||65
10684795|NCT02436239|11848066|FG003|STARTED|Open-Lable Treatment Period||12
10684796|NCT02436239|11848063|FG000|COMPLETED|Open-Lable Treatment Period||89
10684797|NCT02436239|11848064|FG001|COMPLETED|Open-Lable Treatment Period||97
10684798|NCT02436239|11848065|FG002|COMPLETED|Open-Lable Treatment Period||38
10684799|NCT02436239|11848066|FG003|COMPLETED|Open-Lable Treatment Period||7
10684800|NCT02436239|11848063|FG000|NOT COMPLETED|Open-Lable Treatment Period||33
10684801|NCT02436239|11848064|FG001|NOT COMPLETED|Open-Lable Treatment Period||34
10684802|NCT02436239|11848065|FG002|NOT COMPLETED|Open-Lable Treatment Period||27
10684803|NCT02436239|11848066|FG003|NOT COMPLETED|Open-Lable Treatment Period||5
10684804|NCT02436239|11848063|FG000|STARTED|Down-Taper Period|Enrollment permitted for participants who had not completed previous open-label treatment period.|90
10684805|NCT02436239|11848064|FG001|STARTED|Down-Taper Period|Enrollment permitted for participants who had not completed previous open-label treatment period.|103
10684806|NCT02436239|11848065|FG002|STARTED|Down-Taper Period|Enrollment permitted for participants who had not completed previous open-label treatment period.|44
10684807|NCT02436239|11848066|FG003|STARTED|Down-Taper Period|One participant who completed the open-label treatment period did not enter the down-taper period.|6
10684808|NCT02436239|11848063|FG000|COMPLETED|Down-Taper Period||86
10684809|NCT02436239|11848064|FG001|COMPLETED|Down-Taper Period||99
10684810|NCT02436239|11848065|FG002|COMPLETED|Down-Taper Period||43
10684811|NCT02436239|11848066|FG003|COMPLETED|Down-Taper Period||4
10684812|NCT02436239|11848063|FG000|NOT COMPLETED|Down-Taper Period||4
10684813|NCT02436239|11848064|FG001|NOT COMPLETED|Down-Taper Period||4
10684814|NCT02436239|11848065|FG002|NOT COMPLETED|Down-Taper Period||1
10684815|NCT02436239|11848066|FG003|NOT COMPLETED|Down-Taper Period||2
10799659|NCT04189848|11960411|FG003|NOT COMPLETED|Treatment Period 2 (Day 1)||0
10799660|NCT04210232|11960416|FG000|STARTED|Overall Study||54
10799661|NCT04210232|11960416|FG000|COMPLETED|Overall Study||54
10799662|NCT04210232|11960416|FG000|NOT COMPLETED|Overall Study||0
10799663|NCT04211909|11960422|FG000|STARTED|Overall Study||54
10799664|NCT04211909|11960423|FG001|STARTED|Overall Study||33
10799665|NCT04211909|11960422|FG000|COMPLETED|Overall Study||54
10684816|NCT02436304|11848079|FG000|STARTED|Overall Study||153
10684817|NCT02436304|11848080|FG001|STARTED|Overall Study||102
10684818|NCT02436304|11848081|FG002|STARTED|Overall Study||101
10799666|NCT04211909|11960423|FG001|COMPLETED|Overall Study||33
10799667|NCT04211909|11960422|FG000|NOT COMPLETED|Overall Study||0
10684819|NCT02436304|11848079|FG000|COMPLETED|Overall Study||153
10684820|NCT02436304|11848080|FG001|COMPLETED|Overall Study||100
10799668|NCT04211909|11960423|FG001|NOT COMPLETED|Overall Study||0
10684821|NCT02436304|11848081|FG002|COMPLETED|Overall Study||100
10684822|NCT02436304|11848079|FG000|NOT COMPLETED|Overall Study||0
10684823|NCT02436304|11848080|FG001|NOT COMPLETED|Overall Study||2
10684824|NCT02436304|11848081|FG002|NOT COMPLETED|Overall Study||1
10684825|NCT02436330|11848092|FG000|STARTED|Cohort 1||14
10684826|NCT02436330|11848093|FG001|STARTED|Cohort 1||4
10684827|NCT02436330|11848092|FG000|COMPLETED|Cohort 1||9
10684828|NCT02436330|11848093|FG001|COMPLETED|Cohort 1||1
10799669|NCT04218110|11960433|FG000|STARTED|Overall Study||82
10799670|NCT04218110|11960434|FG001|STARTED|Overall Study||81
10799671|NCT04218110|11960435|FG002|STARTED|Overall Study||83
10684829|NCT02436330|11848092|FG000|NOT COMPLETED|Cohort 1||5
10684830|NCT02436330|11848093|FG001|NOT COMPLETED|Cohort 1||3
10684831|NCT02436330|11848092|FG000|STARTED|Cohort 2||14
10684832|NCT02436330|11848093|FG001|STARTED|Cohort 2||10
10684833|NCT02436330|11848092|FG000|COMPLETED|Cohort 2||10
10684834|NCT02436330|11848093|FG001|COMPLETED|Cohort 2||7
10684835|NCT02436330|11848092|FG000|NOT COMPLETED|Cohort 2||4
10684836|NCT02436330|11848093|FG001|NOT COMPLETED|Cohort 2||3
10684837|NCT02436330|11848092|FG000|STARTED|Cohort 3||12
10684838|NCT02436330|11848093|FG001|STARTED|Cohort 3|Enrollment too low to have control group. All subjects in this cohort received intervention.|0
10684839|NCT02436330|11848092|FG000|COMPLETED|Cohort 3||7
10684840|NCT02436330|11848093|FG001|COMPLETED|Cohort 3||0
10684841|NCT02436330|11848092|FG000|NOT COMPLETED|Cohort 3||5
10684842|NCT02436330|11848093|FG001|NOT COMPLETED|Cohort 3||0
10684843|NCT02436330|11848092|FG000|STARTED|Cohort 4||6
10684844|NCT02436330|11848093|FG001|STARTED|Cohort 4|Enrollment too low to have control group. All subjects in this cohort received intervention.|0
10684845|NCT02436330|11848092|FG000|COMPLETED|Cohort 4||4
10684846|NCT02436330|11848093|FG001|COMPLETED|Cohort 4||0
10684847|NCT02436330|11848092|FG000|NOT COMPLETED|Cohort 4||2
10684848|NCT02436330|11848093|FG001|NOT COMPLETED|Cohort 4||0
10684849|NCT02436330|11848092|FG000|STARTED|Cohort 5||10
10684850|NCT02436330|11848093|FG001|STARTED|Cohort 5||5
10684851|NCT02436330|11848092|FG000|COMPLETED|Cohort 5||4
10684852|NCT02436330|11848093|FG001|COMPLETED|Cohort 5||1
10684853|NCT02436330|11848092|FG000|NOT COMPLETED|Cohort 5||6
10684854|NCT02436330|11848093|FG001|NOT COMPLETED|Cohort 5||4
10684855|NCT02436330|11848092|FG000|STARTED|Cohort 6||4
10684856|NCT02436330|11848093|FG001|STARTED|Cohort 6||5
10684857|NCT02436330|11848092|FG000|COMPLETED|Cohort 6||1
10684858|NCT02436330|11848093|FG001|COMPLETED|Cohort 6||4
10684859|NCT02436330|11848092|FG000|NOT COMPLETED|Cohort 6||3
10684860|NCT02436330|11848093|FG001|NOT COMPLETED|Cohort 6||1
10684861|NCT02436356|11848108|FG000|STARTED|Overall Study||33
10684862|NCT02436356|11848109|FG001|STARTED|Overall Study||11
10684863|NCT02436356|11848110|FG002|STARTED|Overall Study||4
10684864|NCT02436356|11848108|FG000|High Energy Fracture|Overall Study||14
10684865|NCT02436356|11848109|FG001|High Energy Fracture|Overall Study||0
10684866|NCT02436356|11848110|FG002|High Energy Fracture|Overall Study||4
10684867|NCT02436356|11848108|FG000|Low Energy Fracture|Overall Study||19
10684868|NCT02436356|11848109|FG001|Low Energy Fracture|Overall Study||0
10684869|NCT02436356|11848110|FG002|Low Energy Fracture|Overall Study||0
10684870|NCT02436356|11848108|FG000|COMPLETED|Overall Study||28
10684871|NCT02436356|11848109|FG001|COMPLETED|Overall Study||10
10684872|NCT02436356|11848110|FG002|COMPLETED|Overall Study||2
10684873|NCT02436356|11848108|FG000|NOT COMPLETED|Overall Study||5
10684874|NCT02436356|11848109|FG001|NOT COMPLETED|Overall Study||1
10799672|NCT04218110|11960436|FG003|STARTED|Overall Study||83
10799673|NCT04218110|11960433|FG000|Received Treatment|Overall Study||82
10799674|NCT04218110|11960434|FG001|Received Treatment|Overall Study||81
10799675|NCT04218110|11960435|FG002|Received Treatment|Overall Study||83
10799676|NCT04218110|11960436|FG003|Received Treatment|Overall Study||82
10799677|NCT04218110|11960433|FG000|COMPLETED|Overall Study||82
10799678|NCT04218110|11960434|FG001|COMPLETED|Overall Study||81
10799679|NCT04218110|11960435|FG002|COMPLETED|Overall Study||83
10799680|NCT04218110|11960436|FG003|COMPLETED|Overall Study||82
10799681|NCT04218110|11960433|FG000|NOT COMPLETED|Overall Study||0
10799682|NCT04218110|11960434|FG001|NOT COMPLETED|Overall Study||0
10799683|NCT04218110|11960435|FG002|NOT COMPLETED|Overall Study||0
10799684|NCT04218110|11960436|FG003|NOT COMPLETED|Overall Study||1
10799685|NCT04222725|11960450|FG000|STARTED|Overall Study||8
10799686|NCT04222725|11960451|FG001|STARTED|Overall Study||10
10799687|NCT04222725|11960452|FG002|STARTED|Overall Study||9
10684875|NCT02436356|11848110|FG002|NOT COMPLETED|Overall Study||2
10684876|NCT02436408|11848123|FG000|STARTED|Overall Study||35
10684877|NCT02436408|11848123|FG000|COMPLETED|Overall Study||34
10684878|NCT02436408|11848123|FG000|NOT COMPLETED|Overall Study||1
10684879|NCT02436577|11848133|FG000|STARTED|Overall Study||7
10684880|NCT02436577|11848134|FG001|STARTED|Overall Study||7
10684881|NCT02436577|11848135|FG002|STARTED|Overall Study||7
10799688|NCT04222725|11960453|FG003|STARTED|Overall Study||10
10799689|NCT04222725|11960450|FG000|COMPLETED|Overall Study||8
10799690|NCT04222725|11960451|FG001|COMPLETED|Overall Study||9
10799691|NCT04222725|11960452|FG002|COMPLETED|Overall Study||9
10799692|NCT04222725|11960453|FG003|COMPLETED|Overall Study||10
10799693|NCT04222725|11960450|FG000|NOT COMPLETED|Overall Study||0
10799694|NCT04222725|11960451|FG001|NOT COMPLETED|Overall Study||1
10799695|NCT04222725|11960452|FG002|NOT COMPLETED|Overall Study||0
10799696|NCT04222725|11960453|FG003|NOT COMPLETED|Overall Study||0
10799697|NCT04223843|11960467|FG000|STARTED|Overall Study||55
10684882|NCT02436577|11848136|FG003|STARTED|Overall Study||7
10684883|NCT02436577|11848137|FG004|STARTED|Overall Study||7
10684884|NCT02436577|11848138|FG005|STARTED|Overall Study||7
10684885|NCT02436577|11848133|FG000|COMPLETED|Overall Study||7
10684886|NCT02436577|11848134|FG001|COMPLETED|Overall Study||6
10799698|NCT04223843|11960468|FG001|STARTED|Overall Study||55
10799699|NCT04223843|11960469|FG002|STARTED|Overall Study||51
10799700|NCT04223843|11960470|FG003|STARTED|Overall Study||52
10684887|NCT02436577|11848135|FG002|COMPLETED|Overall Study||7
10684888|NCT02436577|11848136|FG003|COMPLETED|Overall Study||7
10684889|NCT02436577|11848137|FG004|COMPLETED|Overall Study||7
10684890|NCT02436577|11848138|FG005|COMPLETED|Overall Study||7
10684891|NCT02436577|11848133|FG000|NOT COMPLETED|Overall Study||0
10684892|NCT02436577|11848134|FG001|NOT COMPLETED|Overall Study||1
10684893|NCT02436577|11848135|FG002|NOT COMPLETED|Overall Study||0
10684894|NCT02436577|11848136|FG003|NOT COMPLETED|Overall Study||0
10684895|NCT02436577|11848137|FG004|NOT COMPLETED|Overall Study||0
10684896|NCT02436577|11848138|FG005|NOT COMPLETED|Overall Study||0
10684897|NCT02436668|11848148|FG000|STARTED|Overall Study||213
10684898|NCT02436668|11848149|FG001|STARTED|Overall Study||211
10684899|NCT02436668|11848148|FG000|COMPLETED|Overall Study||212
10684900|NCT02436668|11848149|FG001|COMPLETED|Overall Study||207
10684901|NCT02436668|11848148|FG000|NOT COMPLETED|Overall Study||1
10684902|NCT02436668|11848149|FG001|NOT COMPLETED|Overall Study||4
10684903|NCT02436681|11848158|FG000|STARTED|Overall Study||41
10684904|NCT02436681|11848158|FG000|COMPLETED|Overall Study||27
10684905|NCT02436681|11848158|FG000|NOT COMPLETED|Overall Study||14
10684906|NCT02436759|11848164|FG000|STARTED|Overall Study||94
10684907|NCT02436759|11848165|FG001|STARTED|Overall Study||46
10684908|NCT02436759|11848164|FG000|Subjects Randomized|Overall Study||94
10684909|NCT02436759|11848165|FG001|Subjects Randomized|Overall Study||46
10684910|NCT02436759|11848164|FG000|Subjects Treated|Overall Study||94
10684911|NCT02436759|11848165|FG001|Subjects Treated|Overall Study||46
10684912|NCT02436759|11848164|FG000|COMPLETED|Overall Study||90
10684913|NCT02436759|11848165|FG001|COMPLETED|Overall Study||45
10684914|NCT02436759|11848164|FG000|NOT COMPLETED|Overall Study||4
10799701|NCT04223843|11960467|FG000|COMPLETED|Overall Study||55
10799702|NCT04223843|11960468|FG001|COMPLETED|Overall Study||55
10799703|NCT04223843|11960469|FG002|COMPLETED|Overall Study||51
10799704|NCT04223843|11960470|FG003|COMPLETED|Overall Study||52
10799705|NCT04223843|11960467|FG000|NOT COMPLETED|Overall Study||0
10799706|NCT04223843|11960468|FG001|NOT COMPLETED|Overall Study||0
10799707|NCT04223843|11960469|FG002|NOT COMPLETED|Overall Study||0
10799708|NCT04223843|11960470|FG003|NOT COMPLETED|Overall Study||0
10799709|NCT04229303|11960487|FG000|STARTED|Overall Study||6
10799710|NCT04229303|11960488|FG001|STARTED|Overall Study||6
10799711|NCT04229303|11960489|FG002|STARTED|Overall Study||6
10799712|NCT04229303|11960490|FG003|STARTED|Overall Study||6
10799713|NCT04229303|11960491|FG004|STARTED|Overall Study||6
10799714|NCT04229303|11960492|FG005|STARTED|Overall Study||6
10799715|NCT04229303|11960493|FG006|STARTED|Overall Study||6
10799716|NCT04229303|11960494|FG007|STARTED|Overall Study||8
10799717|NCT04229303|11960495|FG008|STARTED|Overall Study||8
10799718|NCT04229303|11960487|FG000|COMPLETED|Overall Study||6
10799719|NCT04229303|11960488|FG001|COMPLETED|Overall Study||6
10799720|NCT04229303|11960489|FG002|COMPLETED|Overall Study||6
10799721|NCT04229303|11960490|FG003|COMPLETED|Overall Study||6
10799722|NCT04229303|11960491|FG004|COMPLETED|Overall Study||6
10799723|NCT04229303|11960492|FG005|COMPLETED|Overall Study||6
10799724|NCT04229303|11960493|FG006|COMPLETED|Overall Study||6
10799725|NCT04229303|11960494|FG007|COMPLETED|Overall Study||8
10799726|NCT04229303|11960495|FG008|COMPLETED|Overall Study||8
10799727|NCT04229303|11960487|FG000|NOT COMPLETED|Overall Study||0
10799728|NCT04229303|11960488|FG001|NOT COMPLETED|Overall Study||0
10799729|NCT04229303|11960489|FG002|NOT COMPLETED|Overall Study||0
10799730|NCT04229303|11960490|FG003|NOT COMPLETED|Overall Study||0
10799731|NCT04229303|11960491|FG004|NOT COMPLETED|Overall Study||0
10799732|NCT04229303|11960492|FG005|NOT COMPLETED|Overall Study||0
10799733|NCT04229303|11960493|FG006|NOT COMPLETED|Overall Study||0
10799734|NCT04229303|11960494|FG007|NOT COMPLETED|Overall Study||0
10799735|NCT04229303|11960495|FG008|NOT COMPLETED|Overall Study||0
10799736|NCT04243421|11960523|FG000|STARTED|Overall Study||30
10799737|NCT04243421|11960523|FG000|COMPLETED|Overall Study||30
10799738|NCT04243421|11960523|FG000|NOT COMPLETED|Overall Study||0
10799739|NCT04256603|11960530|FG000|STARTED|Overall Study||21
10799740|NCT04256603|11960531|FG001|STARTED|Overall Study||6
10799741|NCT04256603|11960530|FG000|COMPLETED|Overall Study||21
10799742|NCT04256603|11960531|FG001|COMPLETED|Overall Study||6
10799743|NCT04256603|11960530|FG000|NOT COMPLETED|Overall Study||0
10799744|NCT04256603|11960531|FG001|NOT COMPLETED|Overall Study||0
10684915|NCT02436759|11848165|FG001|NOT COMPLETED|Overall Study||1
10799745|NCT04258995|11960539|FG000|STARTED|Overall Study||76
10684916|NCT02436811|11848174|FG000|STARTED|Overall Study||60
10684917|NCT02436811|11848175|FG001|STARTED|Overall Study||60
10684918|NCT02436811|11848176|FG002|STARTED|Overall Study||60
10684919|NCT02436811|11848174|FG000|COMPLETED|Overall Study||58
10684920|NCT02436811|11848175|FG001|COMPLETED|Overall Study||51
10684921|NCT02436811|11848176|FG002|COMPLETED|Overall Study||53
10684922|NCT02436811|11848174|FG000|NOT COMPLETED|Overall Study||2
10684923|NCT02436811|11848175|FG001|NOT COMPLETED|Overall Study||9
10799746|NCT04258995|11960540|FG001|STARTED|Overall Study||75
10799747|NCT04258995|11960539|FG000|Vaccinated|Overall Study||76
10799748|NCT04258995|11960540|FG001|Vaccinated|Overall Study||75
10799749|NCT04258995|11960539|FG000|COMPLETED|Overall Study||75
10799750|NCT04258995|11960540|FG001|COMPLETED|Overall Study||74
10799751|NCT04258995|11960539|FG000|NOT COMPLETED|Overall Study||1
10799752|NCT04258995|11960540|FG001|NOT COMPLETED|Overall Study||1
10799753|NCT04280445|11960546|FG000|STARTED|Overall Study||3
10684924|NCT02436811|11848176|FG002|NOT COMPLETED|Overall Study||7
10684925|NCT02436876|11848188|FG000|STARTED|Overall Study||6
10684926|NCT02436876|11848189|FG001|STARTED|Overall Study||9
10684927|NCT02436876|11848190|FG002|STARTED|Overall Study||7
10684928|NCT02436876|11848191|FG003|STARTED|Overall Study||7
10684929|NCT02436876|11848188|FG000|Treated|Overall Study||6
10684930|NCT02436876|11848189|FG001|Treated|Overall Study||6
10684931|NCT02436876|11848190|FG002|Treated|Overall Study||6
10684932|NCT02436876|11848191|FG003|Treated|Overall Study||7
10684933|NCT02436876|11848188|FG000|COMPLETED|Overall Study||5
10684934|NCT02436876|11848189|FG001|COMPLETED|Overall Study||5
10684935|NCT02436876|11848190|FG002|COMPLETED|Overall Study||5
10684936|NCT02436876|11848191|FG003|COMPLETED|Overall Study||5
10684937|NCT02436876|11848188|FG000|NOT COMPLETED|Overall Study||1
10684938|NCT02436876|11848189|FG001|NOT COMPLETED|Overall Study||4
10684939|NCT02436876|11848190|FG002|NOT COMPLETED|Overall Study||2
10684940|NCT02436876|11848191|FG003|NOT COMPLETED|Overall Study||2
10684941|NCT02436889|11848208|FG000|STARTED|Overall Study||12
10684942|NCT02436889|11848209|FG001|STARTED|Overall Study||11
10684943|NCT02436889|11848208|FG000|COMPLETED|Overall Study||11
10684944|NCT02436889|11848209|FG001|COMPLETED|Overall Study||10
10684945|NCT02436889|11848208|FG000|NOT COMPLETED|Overall Study||1
10684946|NCT02436889|11848209|FG001|NOT COMPLETED|Overall Study||1
10684947|NCT02436915|11848217|FG000|STARTED|Overall Study||9
10684948|NCT02436915|11848218|FG001|STARTED|Overall Study||10
10684949|NCT02436915|11848217|FG000|COMPLETED|Overall Study||9
10684950|NCT02436915|11848218|FG001|COMPLETED|Overall Study||9
10684951|NCT02436915|11848217|FG000|NOT COMPLETED|Overall Study||0
10684952|NCT02436915|11848218|FG001|NOT COMPLETED|Overall Study||1
10684953|NCT02437084|11848226|FG000|STARTED|Overall Study||75
10684954|NCT02437084|11848226|FG000|COMPLETED|Overall Study||72
10684955|NCT02437084|11848226|FG000|NOT COMPLETED|Overall Study||3
10684956|NCT02437162|11848233|FG000|STARTED|Overall Study||116
10684957|NCT02437162|11848234|FG001|STARTED|Overall Study||116
10684958|NCT02437162|11848235|FG002|STARTED|Overall Study||115
10684959|NCT02437162|11848233|FG000|Treated|Overall Study||116
10799754|NCT04280445|11960546|FG000|COMPLETED|Overall Study||3
10799755|NCT04280445|11960546|FG000|NOT COMPLETED|Overall Study||0
10799756|NCT04285489|11960550|FG000|STARTED|Overall Study||130
10799757|NCT04285489|11960550|FG000|COMPLETED|Overall Study|all subjects finished the study before Jul 1, 2020.|130
10799758|NCT04285489|11960550|FG000|NOT COMPLETED|Overall Study||0
10799759|NCT04290494|11960557|FG000|STARTED|Overall Study||10968
10799760|NCT04290494|11960558|FG001|STARTED|Overall Study||17823
10799761|NCT04290494|11960559|FG002|STARTED|Overall Study||13397
10799762|NCT04290494|11960557|FG000|COMPLETED|Overall Study||10968
10799763|NCT04290494|11960558|FG001|COMPLETED|Overall Study||17823
10799764|NCT04290494|11960559|FG002|COMPLETED|Overall Study||13397
10799765|NCT04290494|11960557|FG000|NOT COMPLETED|Overall Study||0
10799766|NCT04290494|11960558|FG001|NOT COMPLETED|Overall Study||0
10799767|NCT04290494|11960559|FG002|NOT COMPLETED|Overall Study||0
10799768|NCT04303156|11960569|FG000|STARTED|Overall Study||6
10799769|NCT04303156|11960570|FG001|STARTED|Overall Study||6
10799770|NCT04303156|11960569|FG000|COMPLETED|Overall Study||6
10799771|NCT04303156|11960570|FG001|COMPLETED|Overall Study||6
10799772|NCT04303156|11960569|FG000|NOT COMPLETED|Overall Study||0
10799773|NCT04303156|11960570|FG001|NOT COMPLETED|Overall Study||0
10799774|NCT04317040|11960579|FG000|STARTED|Overall Study||116
10799775|NCT04317040|11960580|FG001|STARTED|Overall Study||118
10799776|NCT04317040|11960579|FG000|Treated|Overall Study||114
10799777|NCT04317040|11960580|FG001|Treated|Overall Study||115
10799778|NCT04317040|11960579|FG000|COMPLETED|Overall Study||98
10799779|NCT04317040|11960580|FG001|COMPLETED|Overall Study||98
10799780|NCT04317040|11960579|FG000|NOT COMPLETED|Overall Study||18
10799781|NCT04317040|11960580|FG001|NOT COMPLETED|Overall Study||20
10799782|NCT04317313|11960588|FG000|STARTED|Overall Study||100
10799783|NCT04317313|11960589|FG001|STARTED|Overall Study||52
10799784|NCT04317313|11960588|FG000|COMPLETED|Overall Study||100
10799785|NCT04317313|11960589|FG001|COMPLETED|Overall Study||52
10799786|NCT04317313|11960588|FG000|NOT COMPLETED|Overall Study||0
10799787|NCT04317313|11960589|FG001|NOT COMPLETED|Overall Study||0
10799788|NCT04319159|11960597|FG000|STARTED|Overall Study||48
10799789|NCT04319159|11960597|FG000|COMPLETED|Overall Study||32
10799790|NCT04319159|11960597|FG000|NOT COMPLETED|Overall Study||16
10799791|NCT04321239|11960605|FG000|STARTED|Overall Study||25
10799792|NCT04321239|11960606|FG001|STARTED|Overall Study||26
10799793|NCT04321239|11960605|FG000|COMPLETED|Overall Study||22
10684960|NCT02437162|11848234|FG001|Treated|Overall Study||116
10684961|NCT02437162|11848235|FG002|Treated|Overall Study||114
10684962|NCT02437162|11848233|FG000|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|26
10684963|NCT02437162|11848234|FG001|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|21
10799794|NCT04321239|11960606|FG001|COMPLETED|Overall Study||24
10799795|NCT04321239|11960605|FG000|NOT COMPLETED|Overall Study||3
10799796|NCT04321239|11960606|FG001|NOT COMPLETED|Overall Study||2
10799797|NCT04323852|11960614|FG000|STARTED|Overall Study||35
10684964|NCT02437162|11848235|FG002|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|14
10684965|NCT02437162|11848233|FG000|Cross Over at Week 24|Overall Study|Out of 87: crossed over to Ustekinumab 45 mg (n=44) and Ustekinumab 90 mg (n=43)|87
10684966|NCT02437162|11848234|FG001|Cross Over at Week 24|Overall Study||0
10799798|NCT04323852|11960615|FG001|STARTED|Overall Study||35
10799799|NCT04323852|11960614|FG000|COMPLETED|Overall Study||35
10684967|NCT02437162|11848235|FG002|Cross Over at Week 24|Overall Study||0
10684968|NCT02437162|11848233|FG000|COMPLETED|Overall Study||9
10684969|NCT02437162|11848234|FG001|COMPLETED|Overall Study||8
10684970|NCT02437162|11848235|FG002|COMPLETED|Overall Study||6
10684971|NCT02437162|11848233|FG000|NOT COMPLETED|Overall Study||107
10684972|NCT02437162|11848234|FG001|NOT COMPLETED|Overall Study||108
10684973|NCT02437162|11848235|FG002|NOT COMPLETED|Overall Study||109
10684974|NCT02437188|11848250|FG000|STARTED|Overall Study||44
10684975|NCT02437188|11848251|FG001|STARTED|Overall Study||44
10684976|NCT02437188|11848250|FG000|COMPLETED|Overall Study||40
10684977|NCT02437188|11848251|FG001|COMPLETED|Overall Study||35
10684978|NCT02437188|11848250|FG000|NOT COMPLETED|Overall Study||4
10799800|NCT04323852|11960615|FG001|COMPLETED|Overall Study||35
10799801|NCT04323852|11960614|FG000|NOT COMPLETED|Overall Study||0
10799802|NCT04323852|11960615|FG001|NOT COMPLETED|Overall Study||0
10799803|NCT04327843|11960621|FG000|STARTED|Baseline Assessment||19
10799804|NCT04327843|11960621|FG000|COMPLETED|Baseline Assessment||19
10799805|NCT04327843|11960621|FG000|NOT COMPLETED|Baseline Assessment||0
10799806|NCT04327843|11960621|FG000|STARTED|Week 13 Assessment||19
10799807|NCT04327843|11960621|FG000|COMPLETED|Week 13 Assessment||19
10799808|NCT04327843|11960621|FG000|NOT COMPLETED|Week 13 Assessment||0
10799809|NCT04327843|11960621|FG000|STARTED|Week 25 Assessment||19
10799810|NCT04327843|11960621|FG000|COMPLETED|Week 25 Assessment||18
10799811|NCT04327843|11960621|FG000|NOT COMPLETED|Week 25 Assessment||1
10799812|NCT04331899|11960627|FG000|STARTED|Trial Period (28 Days)||60
10799813|NCT04331899|11960628|FG001|STARTED|Trial Period (28 Days)||60
10799814|NCT04331899|11960627|FG000|COMPLETED|Trial Period (28 Days)||58
10799815|NCT04331899|11960628|FG001|COMPLETED|Trial Period (28 Days)||58
10799816|NCT04331899|11960627|FG000|NOT COMPLETED|Trial Period (28 Days)||2
10799817|NCT04331899|11960628|FG001|NOT COMPLETED|Trial Period (28 Days)||2
10799818|NCT04331899|11960627|FG000|STARTED|Follow-up Period (10 Months)|16 participants who completed the trial period did not continue in the follow-up period.|42
10799819|NCT04331899|11960628|FG001|STARTED|Follow-up Period (10 Months)|15 participants who completed the trial period did not continue in the follow-up period.|43
10799820|NCT04331899|11960627|FG000|COMPLETED|Follow-up Period (10 Months)||42
10799821|NCT04331899|11960628|FG001|COMPLETED|Follow-up Period (10 Months)||43
10799822|NCT04331899|11960627|FG000|NOT COMPLETED|Follow-up Period (10 Months)||0
10799823|NCT04331899|11960628|FG001|NOT COMPLETED|Follow-up Period (10 Months)||0
10799824|NCT04334148|11960636|FG000|STARTED|Overall Study||683
10799825|NCT04334148|11960637|FG001|STARTED|Overall Study||677
10799826|NCT04334148|11960636|FG000|COMPLETED|Overall Study||683
10799827|NCT04334148|11960637|FG001|COMPLETED|Overall Study||676
10799828|NCT04334148|11960636|FG000|NOT COMPLETED|Overall Study||0
10799829|NCT04334148|11960637|FG001|NOT COMPLETED|Overall Study||1
10799830|NCT04343287|11960645|FG000|STARTED|Overall Study||108
10799831|NCT04343287|11960646|FG001|STARTED|Overall Study||112
10799832|NCT04343287|11960645|FG000|COMPLETED|Overall Study||108
10799833|NCT04343287|11960646|FG001|COMPLETED|Overall Study||111
10799834|NCT04343287|11960645|FG000|NOT COMPLETED|Overall Study||0
10799835|NCT04343287|11960646|FG001|NOT COMPLETED|Overall Study||1
10799836|NCT04347954|11960657|FG000|STARTED|Overall Study||15
10799837|NCT04347954|11960658|FG001|STARTED|Overall Study||15
10799838|NCT04347954|11960659|FG002|STARTED|Overall Study||17
10799839|NCT04347954|11960657|FG000|Received Allocated Intervention|Overall Study||12
10799840|NCT04347954|11960658|FG001|Received Allocated Intervention|Overall Study||15
10799841|NCT04347954|11960659|FG002|Received Allocated Intervention|Overall Study||14
10799842|NCT04347954|11960657|FG000|Negative PCR Swab at Baseline|Overall Study||1
10799843|NCT04347954|11960658|FG001|Negative PCR Swab at Baseline|Overall Study||3
10799844|NCT04347954|11960659|FG002|Negative PCR Swab at Baseline|Overall Study||1
10799845|NCT04347954|11960657|FG000|COMPLETED|Overall Study||12
10799846|NCT04347954|11960658|FG001|COMPLETED|Overall Study||14
10799847|NCT04347954|11960659|FG002|COMPLETED|Overall Study||14
10799848|NCT04347954|11960657|FG000|NOT COMPLETED|Overall Study||3
10799849|NCT04347954|11960658|FG001|NOT COMPLETED|Overall Study||1
10799850|NCT04347954|11960659|FG002|NOT COMPLETED|Overall Study||3
10799851|NCT04349098|11960669|FG000|STARTED|Overall Study||103
10799852|NCT04349098|11960670|FG001|STARTED|Overall Study||87
10799853|NCT04349098|11960669|FG000|Treated|Overall Study||102
10799854|NCT04349098|11960670|FG001|Treated|Overall Study||86
10799855|NCT04349098|11960669|FG000|COMPLETED|Overall Study||65
10799856|NCT04349098|11960670|FG001|COMPLETED|Overall Study||61
10799857|NCT04349098|11960669|FG000|NOT COMPLETED|Overall Study||38
10799858|NCT04349098|11960670|FG001|NOT COMPLETED|Overall Study||26
10799859|NCT04353037|11960680|FG000|STARTED|Overall Study||6
10799860|NCT04353037|11960681|FG001|STARTED|Overall Study||3
10799861|NCT04353037|11960682|FG002|STARTED|Overall Study||13
10684979|NCT02437188|11848251|FG001|NOT COMPLETED|Overall Study||9
10799862|NCT04353037|11960683|FG003|STARTED|Overall Study||17
10799863|NCT04353037|11960680|FG000|COMPLETED|Overall Study||6
10799864|NCT04353037|11960681|FG001|COMPLETED|Overall Study||0
10799865|NCT04353037|11960682|FG002|COMPLETED|Overall Study||6
10799866|NCT04353037|11960683|FG003|COMPLETED|Overall Study||7
10799867|NCT04353037|11960680|FG000|NOT COMPLETED|Overall Study||0
10799868|NCT04353037|11960681|FG001|NOT COMPLETED|Overall Study||3
10684980|NCT02437253|11848262|FG000|STARTED|Overall Study||1
10799869|NCT04353037|11960682|FG002|NOT COMPLETED|Overall Study||7
10799870|NCT04353037|11960683|FG003|NOT COMPLETED|Overall Study||10
10684981|NCT02437253|11848263|FG001|STARTED|Overall Study||1
10684982|NCT02437253|11848262|FG000|COMPLETED|Overall Study||1
10684983|NCT02437253|11848263|FG001|COMPLETED|Overall Study||1
10684984|NCT02437253|11848262|FG000|NOT COMPLETED|Overall Study||0
10684985|NCT02437253|11848263|FG001|NOT COMPLETED|Overall Study||0
10684986|NCT02437305|11848273|FG000|STARTED|Overall Study||50
10684987|NCT02437305|11848274|FG001|STARTED|Overall Study||50
10684988|NCT02437305|11848273|FG000|COMPLETED|Overall Study||32
10799871|NCT04355117|11960695|FG000|STARTED|Overall Study||71
10799872|NCT04355117|11960695|FG000|COMPLETED|Overall Study||71
10799873|NCT04355117|11960695|FG000|NOT COMPLETED|Overall Study||0
10799874|NCT04355767|11960703|FG000|STARTED|Overall Study||257
10799875|NCT04355767|11960704|FG001|STARTED|Overall Study||254
10799876|NCT04355767|11960703|FG000|Intention-to-treat Population|Overall Study||257
10799877|NCT04355767|11960704|FG001|Intention-to-treat Population|Overall Study||254
10799878|NCT04355767|11960703|FG000|Had Data for 15-day Outcome|Overall Study||257
10799879|NCT04355767|11960704|FG001|Had Data for 15-day Outcome|Overall Study||254
10799880|NCT04355767|11960703|FG000|COMPLETED|Overall Study||250
10799881|NCT04355767|11960704|FG001|COMPLETED|Overall Study||251
10799882|NCT04355767|11960703|FG000|NOT COMPLETED|Overall Study||7
10799883|NCT04355767|11960704|FG001|NOT COMPLETED|Overall Study||3
10799884|NCT04356573|11960712|FG000|STARTED|Overall Study||7
10799885|NCT04356573|11960713|FG001|STARTED|Overall Study||6
10799886|NCT04356573|11960712|FG000|COMPLETED|Overall Study||6
10799887|NCT04356573|11960713|FG001|COMPLETED|Overall Study||6
10799888|NCT04356573|11960712|FG000|NOT COMPLETED|Overall Study||1
10799889|NCT04356573|11960713|FG001|NOT COMPLETED|Overall Study||0
10799890|NCT04357379|11960719|FG000|STARTED|Overall Study||10
10799891|NCT04357379|11960719|FG000|COMPLETED|Overall Study||10
10799892|NCT04357379|11960719|FG000|NOT COMPLETED|Overall Study||0
10799893|NCT04358068|11960725|FG000|STARTED|Overall Study||9
10799894|NCT04358068|11960726|FG001|STARTED|Overall Study||11
10799895|NCT04358068|11960725|FG000|COMPLETED|Overall Study||7
10799896|NCT04358068|11960726|FG001|COMPLETED|Overall Study||9
10799897|NCT04358068|11960725|FG000|NOT COMPLETED|Overall Study||2
10799898|NCT04358068|11960726|FG001|NOT COMPLETED|Overall Study||2
10799899|NCT04366349|11960738|FG000|STARTED|Overall Study||13
10799900|NCT04366349|11960739|FG001|STARTED|Overall Study||18
10799901|NCT04366349|11960740|FG002|STARTED|Overall Study||18
10799902|NCT04366349|11960741|FG003|STARTED|Overall Study||4
10799903|NCT04366349|11960742|FG004|STARTED|Overall Study||6
10799904|NCT04366349|11960743|FG005|STARTED|Overall Study||6
10799905|NCT04366349|11960738|FG000|COMPLETED|Overall Study||12
10799906|NCT04366349|11960739|FG001|COMPLETED|Overall Study||18
10799907|NCT04366349|11960740|FG002|COMPLETED|Overall Study||18
10799908|NCT04366349|11960741|FG003|COMPLETED|Overall Study||4
10799909|NCT04366349|11960742|FG004|COMPLETED|Overall Study||6
10799910|NCT04366349|11960743|FG005|COMPLETED|Overall Study||6
10799911|NCT04366349|11960738|FG000|NOT COMPLETED|Overall Study||1
10799912|NCT04366349|11960739|FG001|NOT COMPLETED|Overall Study||0
10799913|NCT04366349|11960740|FG002|NOT COMPLETED|Overall Study||0
10799914|NCT04366349|11960741|FG003|NOT COMPLETED|Overall Study||0
10799915|NCT04366349|11960742|FG004|NOT COMPLETED|Overall Study||0
10799916|NCT04366349|11960743|FG005|NOT COMPLETED|Overall Study||0
10799917|NCT04369885|11960761|FG000|STARTED|Overall Study||12
10318899|NCT00218296|11453154|FG001|STARTED|Overall Study||169
10318900|NCT00218296|11453153|FG000|Attended Visti|Overall Study||97
10318901|NCT00218296|11453154|FG001|Attended Visti|Overall Study||102
10318902|NCT00218296|11453153|FG000|COMPLETED|Overall Study||52
10318903|NCT00218296|11453154|FG001|COMPLETED|Overall Study||48
10318904|NCT00218296|11453153|FG000|NOT COMPLETED|Overall Study||111
10318905|NCT00218296|11453154|FG001|NOT COMPLETED|Overall Study||121
10799918|NCT04369885|11960761|FG000|COMPLETED|Overall Study||10
10799919|NCT04369885|11960761|FG000|NOT COMPLETED|Overall Study||2
10799920|NCT04373421|11960768|FG000|STARTED|Overall Study||30
10799921|NCT04373421|11960769|FG001|STARTED|Overall Study||30
10799922|NCT04373421|11960770|FG002|STARTED|Overall Study||30
10799923|NCT04373421|11960768|FG000|COMPLETED|Overall Study||26
10799924|NCT04373421|11960769|FG001|COMPLETED|Overall Study||26
10684989|NCT02437305|11848274|FG001|COMPLETED|Overall Study||38
10684990|NCT02437305|11848273|FG000|NOT COMPLETED|Overall Study||18
10684991|NCT02437305|11848274|FG001|NOT COMPLETED|Overall Study||12
10684992|NCT02437344|11848280|FG000|STARTED|Overall Study||16
10684993|NCT02437344|11848280|FG000|COMPLETED|Overall Study||15
10684994|NCT02437344|11848280|FG000|NOT COMPLETED|Overall Study||1
10684995|NCT02437383|11848286|FG000|STARTED|Overall Study||100
10684996|NCT02437383|11848287|FG001|STARTED|Overall Study||100
10684997|NCT02437383|11848286|FG000|COMPLETED|Overall Study||87
10684998|NCT02437383|11848287|FG001|COMPLETED|Overall Study||87
10684999|NCT02437383|11848286|FG000|NOT COMPLETED|Overall Study||13
10685000|NCT02437383|11848287|FG001|NOT COMPLETED|Overall Study||13
10685001|NCT02437409|11848293|FG000|STARTED|Overall Study|Eventually 100 evaluable patients, attrition rate of 15%|115
10685002|NCT02437409|11848293|FG000|COMPLETED|Overall Study|In total 100 patients fulfilled the in-and exclusion criteria,15 patients were excluded/discontinued|100
10685003|NCT02437409|11848293|FG000|NOT COMPLETED|Overall Study||15
10685004|NCT02437487|11848300|FG000|STARTED|Overall Study||59
10799925|NCT04373421|11960770|FG002|COMPLETED|Overall Study||29
10799926|NCT04373421|11960768|FG000|NOT COMPLETED|Overall Study||4
10799927|NCT04373421|11960769|FG001|NOT COMPLETED|Overall Study||4
10799928|NCT04373421|11960770|FG002|NOT COMPLETED|Overall Study||1
10338425|NCT00369629|11475280|FG002|NOT COMPLETED|Follow up for 1 Year||3
10338426|NCT00369629|11475281|FG003|NOT COMPLETED|Follow up for 1 Year||0
10685005|NCT02437487|11848301|FG001|STARTED|Overall Study||30
10685006|NCT02437487|11848300|FG000|Actual Treatment Received|Overall Study||60
10685007|NCT02437487|11848301|FG001|Actual Treatment Received|Overall Study||29
10685008|NCT02437487|11848300|FG000|Intention-to-Treat Population|Overall Study||59
10685009|NCT02437487|11848301|FG001|Intention-to-Treat Population|Overall Study||30
10685010|NCT02437487|11848300|FG000|COMPLETED|Overall Study||32
10685011|NCT02437487|11848301|FG001|COMPLETED|Overall Study||16
10685012|NCT02437487|11848300|FG000|NOT COMPLETED|Overall Study||27
10685013|NCT02437487|11848301|FG001|NOT COMPLETED|Overall Study||14
10685014|NCT02437513|11848307|FG000|STARTED|Overall Study||2
10685015|NCT02437513|11848307|FG000|COMPLETED|Overall Study||0
10685016|NCT02437513|11848307|FG000|NOT COMPLETED|Overall Study||2
10685017|NCT02437669|11848311|FG000|STARTED|Overall Study||35
10685018|NCT02437669|11848311|FG000|COMPLETED|Overall Study||35
10685019|NCT02437669|11848311|FG000|NOT COMPLETED|Overall Study||0
10685020|NCT02437864|11848318|FG000|STARTED|Overall Study||200
10685021|NCT02437864|11848319|FG001|STARTED|Overall Study||160
10685022|NCT02437864|11848318|FG000|COMPLETED|Overall Study||196
10685023|NCT02437864|11848319|FG001|COMPLETED|Overall Study||160
10685024|NCT02437864|11848318|FG000|NOT COMPLETED|Overall Study||4
10685025|NCT02437864|11848319|FG001|NOT COMPLETED|Overall Study||0
10685026|NCT02437890|11848330|FG000|STARTED|Overall Study||62
10685027|NCT02437890|11848331|FG001|STARTED|Overall Study||64
10685028|NCT02437890|11848332|FG002|STARTED|Overall Study||62
10685029|NCT02437890|11848333|FG003|STARTED|Overall Study||62
10685030|NCT02437890|11848334|FG004|STARTED|Overall Study||62
10685031|NCT02437890|11848330|FG000|COMPLETED|Overall Study||54
10685032|NCT02437890|11848331|FG001|COMPLETED|Overall Study||48
10685033|NCT02437890|11848332|FG002|COMPLETED|Overall Study||47
10685034|NCT02437890|11848333|FG003|COMPLETED|Overall Study||40
10685035|NCT02437890|11848334|FG004|COMPLETED|Overall Study||46
10685036|NCT02437890|11848330|FG000|NOT COMPLETED|Overall Study||8
10685037|NCT02437890|11848331|FG001|NOT COMPLETED|Overall Study||16
10685038|NCT02437890|11848332|FG002|NOT COMPLETED|Overall Study||15
10685039|NCT02437890|11848333|FG003|NOT COMPLETED|Overall Study||22
10685040|NCT02437890|11848334|FG004|NOT COMPLETED|Overall Study||16
10685041|NCT02437903|11848350|FG000|STARTED|Overall Study||30
10685042|NCT02437903|11848350|FG000|COMPLETED|Overall Study||25
10685043|NCT02437903|11848350|FG000|NOT COMPLETED|Overall Study||5
10685044|NCT02438137|11848357|FG000|STARTED|Overall Study||44
10685045|NCT02438137|11848358|FG001|STARTED|Overall Study||21
10799929|NCT04381728|11960781|FG000|STARTED|Overall Study||23
10799930|NCT04381728|11960781|FG000|COMPLETED|Overall Study||23
10799931|NCT04381728|11960781|FG000|NOT COMPLETED|Overall Study||0
10810959|NCT03784079|11972661|FG001|STARTED|Part 2: Up to Day 12||0
10810960|NCT03784079|11972662|FG002|STARTED|Part 2: Up to Day 12||0
10810961|NCT03784079|11972663|FG003|STARTED|Part 2: Up to Day 12||6
10810962|NCT03784079|11972664|FG004|STARTED|Part 2: Up to Day 12||6
10810963|NCT03784079|11972665|FG005|STARTED|Part 2: Up to Day 12||6
10810964|NCT03784079|11972666|FG006|STARTED|Part 2: Up to Day 12||2
10810965|NCT03784079|11972660|FG000|COMPLETED|Part 2: Up to Day 12||0
10810966|NCT03784079|11972661|FG001|COMPLETED|Part 2: Up to Day 12||0
10810967|NCT03784079|11972662|FG002|COMPLETED|Part 2: Up to Day 12||0
10810968|NCT03784079|11972663|FG003|COMPLETED|Part 2: Up to Day 12||6
10810969|NCT03784079|11972664|FG004|COMPLETED|Part 2: Up to Day 12||6
10810970|NCT03784079|11972665|FG005|COMPLETED|Part 2: Up to Day 12||6
10810971|NCT03784079|11972666|FG006|COMPLETED|Part 2: Up to Day 12||2
10810972|NCT03784079|11972660|FG000|NOT COMPLETED|Part 2: Up to Day 12||0
10810973|NCT03784079|11972661|FG001|NOT COMPLETED|Part 2: Up to Day 12||0
10810974|NCT03784079|11972662|FG002|NOT COMPLETED|Part 2: Up to Day 12||0
10810975|NCT03784079|11972663|FG003|NOT COMPLETED|Part 2: Up to Day 12||0
10810976|NCT03784079|11972664|FG004|NOT COMPLETED|Part 2: Up to Day 12||0
10685046|NCT02438137|11848357|FG000|COMPLETED|Overall Study||36
10685047|NCT02438137|11848358|FG001|COMPLETED|Overall Study||15
10685048|NCT02438137|11848357|FG000|NOT COMPLETED|Overall Study||8
10685049|NCT02438137|11848358|FG001|NOT COMPLETED|Overall Study||6
10685050|NCT02438280|11848368|FG000|STARTED|Overall Study||14
10685051|NCT02438280|11848369|FG001|STARTED|Overall Study||13
10685052|NCT02438280|11848368|FG000|COMPLETED|Overall Study||13
10685053|NCT02438280|11848369|FG001|COMPLETED|Overall Study||13
10685054|NCT02438280|11848368|FG000|NOT COMPLETED|Overall Study||1
10685055|NCT02438280|11848369|FG001|NOT COMPLETED|Overall Study||0
10685056|NCT02438371|11848378|FG000|STARTED|Overall Study||24
10685057|NCT02438371|11848379|FG001|STARTED|Overall Study||25
10685058|NCT02438371|11848378|FG000|Received Intervention|Overall Study||24
10810977|NCT03784079|11972665|FG005|NOT COMPLETED|Part 2: Up to Day 12||0
10810978|NCT03784079|11972666|FG006|NOT COMPLETED|Part 2: Up to Day 12||0
10810979|NCT03783039|11972689|FG000|STARTED|Overall Study||119
10810980|NCT03783039|11972690|FG001|STARTED|Overall Study||115
10685059|NCT02438371|11848379|FG001|Received Intervention|Overall Study||25
10685060|NCT02438371|11848378|FG000|COMPLETED|Overall Study||20
10810981|NCT03783039|11972689|FG000|COMPLETED|Overall Study||117
10810982|NCT03783039|11972690|FG001|COMPLETED|Overall Study||114
10810983|NCT03783039|11972689|FG000|NOT COMPLETED|Overall Study||2
10810984|NCT03783039|11972690|FG001|NOT COMPLETED|Overall Study||1
10685061|NCT02438371|11848379|FG001|COMPLETED|Overall Study||22
10685062|NCT02438371|11848378|FG000|NOT COMPLETED|Overall Study||4
10799938|NCT04394845|11960794|FG000|STARTED|Overall Study||6
10799939|NCT04394845|11960794|FG000|COMPLETED|Overall Study||6
10799940|NCT04394845|11960794|FG000|NOT COMPLETED|Overall Study||0
10799941|NCT04398732|11960800|FG000|STARTED|Overall Study||486
10799942|NCT04398732|11960800|FG000|COMPLETED|Overall Study||436
10799943|NCT04398732|11960800|FG000|NOT COMPLETED|Overall Study||50
10799944|NCT04401293|11960808|FG000|STARTED|Overall Study||130
10799945|NCT04401293|11960809|FG001|STARTED|Overall Study||127
10799946|NCT04401293|11960808|FG000|COMPLETED|Overall Study||129
10799947|NCT04401293|11960809|FG001|COMPLETED|Overall Study||124
10799948|NCT04401293|11960808|FG000|NOT COMPLETED|Overall Study||1
10799949|NCT04401293|11960809|FG001|NOT COMPLETED|Overall Study||3
10799950|NCT04411628|11960819|FG000|STARTED|Overall Study||7
10799951|NCT04411628|11960820|FG001|STARTED|Overall Study||6
10799952|NCT04411628|11960821|FG002|STARTED|Overall Study||7
10799953|NCT04411628|11960822|FG003|STARTED|Overall Study||6
10799954|NCT04411628|11960819|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
10799955|NCT04411628|11960820|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
10799956|NCT04411628|11960821|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
10799957|NCT04411628|11960822|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
10799958|NCT04411628|11960819|FG000|COMPLETED|Overall Study||6
10799959|NCT04411628|11960820|FG001|COMPLETED|Overall Study||4
10799960|NCT04411628|11960821|FG002|COMPLETED|Overall Study||5
10799961|NCT04411628|11960822|FG003|COMPLETED|Overall Study||6
10799962|NCT04411628|11960819|FG000|NOT COMPLETED|Overall Study||1
10799963|NCT04411628|11960820|FG001|NOT COMPLETED|Overall Study||2
10799964|NCT04411628|11960821|FG002|NOT COMPLETED|Overall Study||2
10799965|NCT04411628|11960822|FG003|NOT COMPLETED|Overall Study||0
10799966|NCT04418947|11960840|FG000|STARTED|Overall Study||1108
10799967|NCT04418947|11960841|FG001|STARTED|Overall Study||1351
10799968|NCT04418947|11960842|FG002|STARTED|Overall Study||1351
10799969|NCT04418947|11960843|FG003|STARTED|Overall Study||3655
10799970|NCT04418947|11960844|FG004|STARTED|Overall Study||3655
10799971|NCT04418947|11960840|FG000|COMPLETED|Overall Study||1108
10799972|NCT04418947|11960841|FG001|COMPLETED|Overall Study||1351
10799973|NCT04418947|11960842|FG002|COMPLETED|Overall Study||1351
10799974|NCT04418947|11960843|FG003|COMPLETED|Overall Study||3655
10799975|NCT04418947|11960844|FG004|COMPLETED|Overall Study||3655
10799976|NCT04418947|11960840|FG000|NOT COMPLETED|Overall Study||0
10799977|NCT04418947|11960841|FG001|NOT COMPLETED|Overall Study||0
10799978|NCT04418947|11960842|FG002|NOT COMPLETED|Overall Study||0
10799979|NCT04418947|11960843|FG003|NOT COMPLETED|Overall Study||0
10799980|NCT04418947|11960844|FG004|NOT COMPLETED|Overall Study||0
10799981|NCT04420273|11960858|FG000|STARTED|Overall Study||501
10799982|NCT04420273|11960859|FG001|STARTED|Overall Study||499
10799983|NCT04420273|11960858|FG000|COMPLETED|Overall Study||390
10799984|NCT04420273|11960859|FG001|COMPLETED|Overall Study||414
10799985|NCT04420273|11960858|FG000|NOT COMPLETED|Overall Study||111
10799986|NCT04420273|11960859|FG001|NOT COMPLETED|Overall Study||85
10799987|NCT04420572|11960867|FG000|STARTED|Overall Study||33
10799988|NCT04420572|11960868|FG001|STARTED|Overall Study||30
10799989|NCT04420572|11960867|FG000|COMPLETED|Overall Study||33
10799990|NCT04420572|11960868|FG001|COMPLETED|Overall Study||30
10799991|NCT04420572|11960867|FG000|NOT COMPLETED|Overall Study||0
10799992|NCT04420572|11960868|FG001|NOT COMPLETED|Overall Study||0
10799993|NCT04428411|11960874|FG000|STARTED|Overall Study||486
10799994|NCT04428411|11960874|FG000|Participants With Difficult to Treat Sites|Overall Study||397
10799995|NCT04428411|11960874|FG000|Participants Without Difficulty to Treat Sites|Overall Study||89
10799996|NCT04428411|11960874|FG000|Participants Adherent to Treatment|Overall Study||417
10799997|NCT04428411|11960874|FG000|Participants Not Adherent to Treatment|Overall Study||69
10799998|NCT04428411|11960874|FG000|COMPLETED|Overall Study||372
10799999|NCT04428411|11960874|FG000|NOT COMPLETED|Overall Study||114
10800000|NCT04435184|11960883|FG000|STARTED|Overall Study||25
10800001|NCT04435184|11960884|FG001|STARTED|Overall Study||25
10800002|NCT04435184|11960883|FG000|COMPLETED|Overall Study||22
10800003|NCT04435184|11960884|FG001|COMPLETED|Overall Study||20
10800004|NCT04435184|11960883|FG000|NOT COMPLETED|Overall Study||3
10800005|NCT04435184|11960884|FG001|NOT COMPLETED|Overall Study||5
10800006|NCT04476784|11960892|FG000|STARTED|First Wear Period (30 Days ± 2 Days)||31
10800007|NCT04476784|11960893|FG001|STARTED|First Wear Period (30 Days ± 2 Days)||35
10800008|NCT04476784|11960892|FG000|COMPLETED|First Wear Period (30 Days ± 2 Days)||30
10800009|NCT04476784|11960893|FG001|COMPLETED|First Wear Period (30 Days ± 2 Days)||35
10800010|NCT04476784|11960892|FG000|NOT COMPLETED|First Wear Period (30 Days ± 2 Days)||1
10800011|NCT04476784|11960893|FG001|NOT COMPLETED|First Wear Period (30 Days ± 2 Days)||0
10800012|NCT04476784|11960892|FG000|STARTED|Second Wear Period (30 Days ± 2 Days)||30
10800013|NCT04476784|11960893|FG001|STARTED|Second Wear Period (30 Days ± 2 Days)||35
10800014|NCT04476784|11960892|FG000|COMPLETED|Second Wear Period (30 Days ± 2 Days)||30
10800015|NCT04476784|11960893|FG001|COMPLETED|Second Wear Period (30 Days ± 2 Days)||35
10800016|NCT04476784|11960892|FG000|NOT COMPLETED|Second Wear Period (30 Days ± 2 Days)||0
10800017|NCT04476784|11960893|FG001|NOT COMPLETED|Second Wear Period (30 Days ± 2 Days)||0
10800018|NCT04484207|11960905|FG000|STARTED|Overall Study||86
10800019|NCT04484207|11960906|FG001|STARTED|Overall Study||44
10800020|NCT04484207|11960907|FG002|STARTED|Overall Study||42
10800021|NCT04484207|11960905|FG000|14-Day Follow-Up|Overall Study||69
10800022|NCT04484207|11960906|FG001|14-Day Follow-Up|Overall Study||40
10800023|NCT04484207|11960907|FG002|14-Day Follow-Up|Overall Study||33
10800024|NCT04484207|11960905|FG000|30-Day Follow-Up|Overall Study||65
10685063|NCT02438371|11848379|FG001|NOT COMPLETED|Overall Study||3
10685064|NCT02438384|11848388|FG000|STARTED|Overall Study||25
10685065|NCT02438384|11848389|FG001|STARTED|Overall Study||25
10685066|NCT02438384|11848390|FG002|STARTED|Overall Study||25
10685067|NCT02438384|11848388|FG000|COMPLETED|Overall Study||17
10685068|NCT02438384|11848389|FG001|COMPLETED|Overall Study||19
10685069|NCT02438384|11848390|FG002|COMPLETED|Overall Study||21
10685070|NCT02438384|11848388|FG000|NOT COMPLETED|Overall Study||8
10685071|NCT02438384|11848389|FG001|NOT COMPLETED|Overall Study||6
10685072|NCT02438384|11848390|FG002|NOT COMPLETED|Overall Study||4
10685073|NCT02438423|11848402|FG000|STARTED|Overall Study||25
10685074|NCT02438423|11848403|FG001|STARTED|Overall Study||25
10685075|NCT02438423|11848404|FG002|STARTED|Overall Study||25
10685076|NCT02438423|11848405|FG003|STARTED|Overall Study||25
10685077|NCT02438423|11848402|FG000|COMPLETED|Overall Study||25
10685078|NCT02438423|11848403|FG001|COMPLETED|Overall Study||25
10685079|NCT02438423|11848404|FG002|COMPLETED|Overall Study||25
10685080|NCT02438423|11848405|FG003|COMPLETED|Overall Study||25
10685081|NCT02438423|11848402|FG000|NOT COMPLETED|Overall Study||0
10685082|NCT02438423|11848403|FG001|NOT COMPLETED|Overall Study||0
10685083|NCT02438423|11848404|FG002|NOT COMPLETED|Overall Study||0
10685084|NCT02438423|11848405|FG003|NOT COMPLETED|Overall Study||0
10685085|NCT02438475|11848419|FG000|STARTED|Overall Study||104
10685086|NCT02438475|11848420|FG001|STARTED|Overall Study||104
10685087|NCT02438475|11848419|FG000|COMPLETED|Overall Study||102
10685088|NCT02438475|11848420|FG001|COMPLETED|Overall Study||104
10800025|NCT04484207|11960906|FG001|30-Day Follow-Up|Overall Study||34
10800026|NCT04484207|11960907|FG002|30-Day Follow-Up|Overall Study||31
10800027|NCT04484207|11960905|FG000|COMPLETED|Overall Study||65
10800028|NCT04484207|11960906|FG001|COMPLETED|Overall Study||34
10800029|NCT04484207|11960907|FG002|COMPLETED|Overall Study||31
10800030|NCT04484207|11960905|FG000|NOT COMPLETED|Overall Study||21
10800031|NCT04484207|11960906|FG001|NOT COMPLETED|Overall Study||10
10800032|NCT04484207|11960907|FG002|NOT COMPLETED|Overall Study||11
10800033|NCT04485455|11960918|FG000|STARTED|Overall Study||5
10800034|NCT04485455|11960918|FG000|COMPLETED|Overall Study||5
10800035|NCT04485455|11960918|FG000|NOT COMPLETED|Overall Study||0
10800036|NCT04495283|11960925|FG000|STARTED|Overall Study||35
10800037|NCT04495283|11960926|FG001|STARTED|Overall Study||35
10800038|NCT04495283|11960927|FG002|STARTED|Overall Study||17
10800039|NCT04495283|11960925|FG000|COMPLETED|Overall Study||34
10800040|NCT04495283|11960926|FG001|COMPLETED|Overall Study||34
10800041|NCT04495283|11960927|FG002|COMPLETED|Overall Study||14
10800042|NCT04495283|11960925|FG000|NOT COMPLETED|Overall Study||1
10800043|NCT04495283|11960926|FG001|NOT COMPLETED|Overall Study||1
10800044|NCT04495283|11960927|FG002|NOT COMPLETED|Overall Study||3
10800045|NCT04497948|11960938|FG000|STARTED|Overall Study||9
10800046|NCT04497948|11960938|FG000|COMPLETED|Overall Study||7
10800047|NCT04497948|11960938|FG000|NOT COMPLETED|Overall Study||2
10800048|NCT04501640|11960950|FG000|STARTED|Period 1 (5 Days)||6
10800049|NCT04501640|11960951|FG001|STARTED|Period 1 (5 Days)||6
10800050|NCT04501640|11960952|FG002|STARTED|Period 1 (5 Days)||6
10800051|NCT04501640|11960953|FG003|STARTED|Period 1 (5 Days)||6
10800052|NCT04501640|11960950|FG000|COMPLETED|Period 1 (5 Days)||6
10800053|NCT04501640|11960951|FG001|COMPLETED|Period 1 (5 Days)||6
10800054|NCT04501640|11960952|FG002|COMPLETED|Period 1 (5 Days)||6
10800055|NCT04501640|11960953|FG003|COMPLETED|Period 1 (5 Days)||6
10800056|NCT04501640|11960950|FG000|NOT COMPLETED|Period 1 (5 Days)||0
10800057|NCT04501640|11960951|FG001|NOT COMPLETED|Period 1 (5 Days)||0
10800058|NCT04501640|11960952|FG002|NOT COMPLETED|Period 1 (5 Days)||0
10800059|NCT04501640|11960953|FG003|NOT COMPLETED|Period 1 (5 Days)||0
10800060|NCT04501640|11960950|FG000|STARTED|Washout Period (10 Days)||6
10800061|NCT04501640|11960951|FG001|STARTED|Washout Period (10 Days)||6
10800062|NCT04501640|11960952|FG002|STARTED|Washout Period (10 Days)||6
10800063|NCT04501640|11960953|FG003|STARTED|Washout Period (10 Days)||6
10800064|NCT04501640|11960950|FG000|COMPLETED|Washout Period (10 Days)||6
10800065|NCT04501640|11960951|FG001|COMPLETED|Washout Period (10 Days)||6
10800066|NCT04501640|11960952|FG002|COMPLETED|Washout Period (10 Days)||6
10800067|NCT04501640|11960953|FG003|COMPLETED|Washout Period (10 Days)||6
10800068|NCT04501640|11960950|FG000|NOT COMPLETED|Washout Period (10 Days)||0
10685089|NCT02438475|11848419|FG000|NOT COMPLETED|Overall Study||2
10685090|NCT02438475|11848420|FG001|NOT COMPLETED|Overall Study||0
10685091|NCT02438540|11848428|FG000|STARTED|Overall Study||19
10685092|NCT02438540|11848429|FG001|STARTED|Overall Study||20
10800069|NCT04501640|11960951|FG001|NOT COMPLETED|Washout Period (10 Days)||0
10800070|NCT04501640|11960952|FG002|NOT COMPLETED|Washout Period (10 Days)||0
10800071|NCT04501640|11960953|FG003|NOT COMPLETED|Washout Period (10 Days)||0
10800072|NCT04501640|11960950|FG000|STARTED|Period 2 (5 Days)||6
10685093|NCT02438540|11848428|FG000|COMPLETED|Overall Study||19
10685094|NCT02438540|11848429|FG001|COMPLETED|Overall Study||20
10800073|NCT04501640|11960951|FG001|STARTED|Period 2 (5 Days)||6
10800074|NCT04501640|11960952|FG002|STARTED|Period 2 (5 Days)||6
10800075|NCT04501640|11960953|FG003|STARTED|Period 2 (5 Days)||6
10800076|NCT04501640|11960950|FG000|COMPLETED|Period 2 (5 Days)||6
10800077|NCT04501640|11960951|FG001|COMPLETED|Period 2 (5 Days)||6
10685095|NCT02438540|11848428|FG000|NOT COMPLETED|Overall Study||0
10685096|NCT02438540|11848429|FG001|NOT COMPLETED|Overall Study||0
10685097|NCT02438787|11848439|FG000|STARTED|Overall Study||104
10685098|NCT02438787|11848440|FG001|STARTED|Overall Study||106
10685099|NCT02438787|11848441|FG002|STARTED|Overall Study||105
10685100|NCT02438787|11848439|FG000|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|21
10685101|NCT02438787|11848440|FG001|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|21
10685102|NCT02438787|11848441|FG002|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|20
10685103|NCT02438787|11848439|FG000|Cross Over at Week 24|Overall Study|Out of 43: crossed over to Ustekinumab 45 mg (n=21) and Ustekinumab 90 mg (n=22)|43
10685104|NCT02438787|11848440|FG001|Cross Over at Week 24|Overall Study||0
10685105|NCT02438787|11848441|FG002|Cross Over at Week 24|Overall Study||0
10685106|NCT02438787|11848439|FG000|COMPLETED|Overall Study||23
10685107|NCT02438787|11848440|FG001|COMPLETED|Overall Study||23
10685108|NCT02438787|11848441|FG002|COMPLETED|Overall Study||22
10685109|NCT02438787|11848439|FG000|NOT COMPLETED|Overall Study||81
10685110|NCT02438787|11848440|FG001|NOT COMPLETED|Overall Study||83
10685111|NCT02438787|11848441|FG002|NOT COMPLETED|Overall Study||83
10685112|NCT02438813|11848454|FG000|STARTED|Overall Study||1029
10685113|NCT02438813|11848454|FG000|Received Treatment for SMF|Overall Study||676
10685114|NCT02438813|11848454|FG000|Did Not ReceiveTreatment for SMF|Overall Study||353
10685115|NCT02438813|11848454|FG000|COMPLETED|Overall Study||504
10685116|NCT02438813|11848454|FG000|NOT COMPLETED|Overall Study||525
10685117|NCT02438826|11848470|FG000|STARTED|Double-Blind Treatment Phase||123
10685118|NCT02438826|11848471|FG001|STARTED|Double-Blind Treatment Phase||117
10685119|NCT02438826|11848472|FG002|STARTED|Double-Blind Treatment Phase||0
10685120|NCT02438826|11848473|FG003|STARTED|Double-Blind Treatment Phase||0
10685121|NCT02438826|11848470|FG000|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||120
10685122|NCT02438826|11848471|FG001|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||117
10685123|NCT02438826|11848472|FG002|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||0
10685124|NCT02438826|11848473|FG003|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||0
10685125|NCT02438826|11848470|FG000|COMPLETED|Double-Blind Treatment Phase||117
10685126|NCT02438826|11848471|FG001|COMPLETED|Double-Blind Treatment Phase||113
10685127|NCT02438826|11848472|FG002|COMPLETED|Double-Blind Treatment Phase||0
10685128|NCT02438826|11848473|FG003|COMPLETED|Double-Blind Treatment Phase||0
10685129|NCT02438826|11848470|FG000|NOT COMPLETED|Double-Blind Treatment Phase||6
10685130|NCT02438826|11848471|FG001|NOT COMPLETED|Double-Blind Treatment Phase||4
10685131|NCT02438826|11848472|FG002|NOT COMPLETED|Double-Blind Treatment Phase||0
10685132|NCT02438826|11848473|FG003|NOT COMPLETED|Double-Blind Treatment Phase||0
10685133|NCT02438826|11848470|FG000|STARTED|Open-Label Treatment Phase|This period is optional phase, one participant chose not to enter the open-label phase.|116
10685134|NCT02438826|11848471|FG001|STARTED|Open-Label Treatment Phase||113
10685135|NCT02438826|11848472|FG002|STARTED|Open-Label Treatment Phase||0
10685136|NCT02438826|11848473|FG003|STARTED|Open-Label Treatment Phase||0
10685137|NCT02438826|11848470|FG000|COMPLETED|Open-Label Treatment Phase||72
10685138|NCT02438826|11848471|FG001|COMPLETED|Open-Label Treatment Phase||80
10685139|NCT02438826|11848472|FG002|COMPLETED|Open-Label Treatment Phase||0
10685140|NCT02438826|11848473|FG003|COMPLETED|Open-Label Treatment Phase||0
10685141|NCT02438826|11848470|FG000|NOT COMPLETED|Open-Label Treatment Phase||44
10685142|NCT02438826|11848471|FG001|NOT COMPLETED|Open-Label Treatment Phase||33
10685143|NCT02438826|11848472|FG002|NOT COMPLETED|Open-Label Treatment Phase||0
10685144|NCT02438826|11848473|FG003|NOT COMPLETED|Open-Label Treatment Phase||0
10685145|NCT02438826|11848470|FG000|STARTED|Post-Treatment Phase|Participants who discontinued Open-Label Treatment also had the option to enter Post-Treatment Phase|93
10685146|NCT02438826|11848471|FG001|STARTED|Post-Treatment Phase|Participants who discontinued Open-Label Treatment also had the option to enter Post-Treatment Phase|93
10713073|NCT02676895|11878625|FG001|NOT COMPLETED|Overall Study||3
10685147|NCT02438826|11848472|FG002|STARTED|Post-Treatment Phase|Participants entered from Double-Blind Treatment Phase.|2
10685148|NCT02438826|11848473|FG003|STARTED|Post-Treatment Phase|Participants entered from Double-Blind Treatment Phase.|4
10685149|NCT02438826|11848470|FG000|COMPLETED|Post-Treatment Phase||84
10685150|NCT02438826|11848471|FG001|COMPLETED|Post-Treatment Phase||92
10685151|NCT02438826|11848472|FG002|COMPLETED|Post-Treatment Phase||2
10685152|NCT02438826|11848473|FG003|COMPLETED|Post-Treatment Phase||4
10685153|NCT02438826|11848470|FG000|NOT COMPLETED|Post-Treatment Phase||9
10685154|NCT02438826|11848471|FG001|NOT COMPLETED|Post-Treatment Phase||1
10685155|NCT02438826|11848472|FG002|NOT COMPLETED|Post-Treatment Phase||0
10685156|NCT02438826|11848473|FG003|NOT COMPLETED|Post-Treatment Phase||0
10685157|NCT02439138|11848488|FG000|STARTED|Overall Study||5
10685158|NCT02439138|11848488|FG000|COMPLETED|Overall Study||2
10685159|NCT02439138|11848488|FG000|NOT COMPLETED|Overall Study||3
10685160|NCT02439164|11848494|FG000|STARTED|Overall Study||18
10685161|NCT02439164|11848495|FG001|STARTED|Overall Study||18
10685162|NCT02439164|11848494|FG000|COMPLETED|Overall Study||18
10685163|NCT02439164|11848495|FG001|COMPLETED|Overall Study||18
10685164|NCT02439164|11848494|FG000|NOT COMPLETED|Overall Study||0
10685165|NCT02439164|11848495|FG001|NOT COMPLETED|Overall Study||0
10685166|NCT02439281|11848504|FG000|STARTED|Overall Study||24
10685167|NCT02439281|11848505|FG001|STARTED|Overall Study||26
10685168|NCT02439281|11848504|FG000|COMPLETED|Overall Study||24
10685169|NCT02439281|11848505|FG001|COMPLETED|Overall Study||26
10685170|NCT02439281|11848504|FG000|NOT COMPLETED|Overall Study||0
10685171|NCT02439281|11848505|FG001|NOT COMPLETED|Overall Study||0
10685172|NCT02439320|11848516|FG000|STARTED|Overall Study||744
10685173|NCT02439320|11848517|FG001|STARTED|Overall Study||745
10685174|NCT02439320|11848518|FG002|STARTED|Overall Study||742
10685175|NCT02439320|11848516|FG000|Confirmed Eligibility|Overall Study||710
10685176|NCT02439320|11848517|FG001|Confirmed Eligibility|Overall Study||695
10685177|NCT02439320|11848518|FG002|Confirmed Eligibility|Overall Study||705
10685178|NCT02439320|11848516|FG000|1st Dose (by 4 Hours Migraine Onset)|Overall Study||630
10685179|NCT02439320|11848517|FG001|1st Dose (by 4 Hours Migraine Onset)|Overall Study||609
10685180|NCT02439320|11848518|FG002|1st Dose (by 4 Hours Migraine Onset)|Overall Study||617
10685181|NCT02439320|11848516|FG000|2nd Dose (After 2 Hour Assessment)|Overall Study||289
10685182|NCT02439320|11848517|FG001|2nd Dose (After 2 Hour Assessment)|Overall Study||238
10685183|NCT02439320|11848518|FG002|2nd Dose (After 2 Hour Assessment)|Overall Study||401
10685184|NCT02439320|11848516|FG000|COMPLETED|Overall Study||648
10685185|NCT02439320|11848517|FG001|COMPLETED|Overall Study||631
10685186|NCT02439320|11848518|FG002|COMPLETED|Overall Study||643
10685187|NCT02439320|11848516|FG000|NOT COMPLETED|Overall Study||96
10685188|NCT02439320|11848517|FG001|NOT COMPLETED|Overall Study||114
10685189|NCT02439320|11848518|FG002|NOT COMPLETED|Overall Study||99
10685190|NCT02439710|11848532|FG000|STARTED|Overall Study||656
10685191|NCT02439710|11848532|FG000|COMPLETED|Overall Study||656
10685192|NCT02439710|11848532|FG000|NOT COMPLETED|Overall Study||0
10685193|NCT02439814|11848538|FG000|STARTED|Overall Study||11
10685194|NCT02439814|11848539|FG001|STARTED|Overall Study||10
10685195|NCT02439814|11848538|FG000|COMPLETED|Overall Study||11
10685196|NCT02439814|11848539|FG001|COMPLETED|Overall Study||10
10685197|NCT02439814|11848538|FG000|NOT COMPLETED|Overall Study||0
10685198|NCT02439814|11848539|FG001|NOT COMPLETED|Overall Study||0
10685199|NCT02439879|11848547|FG000|STARTED|Overall Study||16
10685200|NCT02439879|11848548|FG001|STARTED|Overall Study||17
10685201|NCT02439879|11848547|FG000|COMPLETED|Overall Study||16
10685202|NCT02439879|11848548|FG001|COMPLETED|Overall Study||17
10685203|NCT02439879|11848547|FG000|NOT COMPLETED|Overall Study||0
10685204|NCT02439879|11848548|FG001|NOT COMPLETED|Overall Study||0
10685205|NCT02440022|11848556|FG000|STARTED|Overall Study||141
10685206|NCT02440022|11848557|FG001|STARTED|Overall Study||144
10685207|NCT02440022|11848556|FG000|COMPLETED|Overall Study||114
10685208|NCT02440022|11848557|FG001|COMPLETED|Overall Study||131
10685209|NCT02440022|11848556|FG000|NOT COMPLETED|Overall Study||27
10685210|NCT02440022|11848557|FG001|NOT COMPLETED|Overall Study||13
10685211|NCT02440139|11848563|FG000|STARTED|Overall Study|12 radiologists read 324 CT cases|12
10685212|NCT02440139|11848563|FG000|COMPLETED|Overall Study|12 radiologists read 324 CT cases|12
10685213|NCT02440139|11848563|FG000|NOT COMPLETED|Overall Study||0
10685214|NCT02440178|11848571|FG000|STARTED|Overall Study||66
10685215|NCT02440178|11848571|FG000|COMPLETED|Overall Study||46
10685216|NCT02440178|11848571|FG000|NOT COMPLETED|Overall Study||20
10685217|NCT02440204|11848580|FG000|STARTED|Overall Study||22
10685218|NCT02440204|11848581|FG001|STARTED|Overall Study||24
10685219|NCT02440204|11848582|FG002|STARTED|Overall Study||22
10685220|NCT02440204|11848580|FG000|COMPLETED|Overall Study||22
10685221|NCT02440204|11848581|FG001|COMPLETED|Overall Study||24
10685222|NCT02440204|11848582|FG002|COMPLETED|Overall Study||22
10685223|NCT02440204|11848580|FG000|NOT COMPLETED|Overall Study||0
10685224|NCT02440204|11848581|FG001|NOT COMPLETED|Overall Study||0
10685225|NCT02440204|11848582|FG002|NOT COMPLETED|Overall Study||0
10685226|NCT02440308|11848590|FG000|STARTED|Overall Study||10
10685227|NCT02440308|11848590|FG000|COMPLETED|Overall Study||10
10685228|NCT02440308|11848590|FG000|NOT COMPLETED|Overall Study||0
10685229|NCT02440334|11848594|FG000|STARTED|Overall Study||53
10685230|NCT02440334|11848594|FG000|COMPLETED|Overall Study||53
10685231|NCT02440334|11848594|FG000|NOT COMPLETED|Overall Study||0
10713070|NCT02676895|11878625|FG001|COMPLETED|Overall Study||23
10713071|NCT02676895|11878626|FG002|COMPLETED|Overall Study||21
10713072|NCT02676895|11878624|FG000|NOT COMPLETED|Overall Study||2
10713074|NCT02676895|11878626|FG002|NOT COMPLETED|Overall Study||3
10713075|NCT02677116|11878644|FG000|STARTED|Overall Study||10
10713076|NCT02677116|11878645|FG001|STARTED|Overall Study||11
10713077|NCT02677116|11878646|FG002|STARTED|Overall Study||9
10713078|NCT02677116|11878647|FG003|STARTED|Overall Study||10
10713079|NCT02677116|11878648|FG004|STARTED|Overall Study||1
10713080|NCT02677116|11878649|FG005|STARTED|Overall Study||13
10713081|NCT02677116|11878650|FG006|STARTED|Overall Study||6
10713082|NCT02677116|11878651|FG007|STARTED|Overall Study||4
10713083|NCT02677116|11878652|FG008|STARTED|Overall Study||4
10713084|NCT02677116|11878644|FG000|Cycle 1 Olaratumab Alone|Overall Study||10
10713085|NCT02677116|11878645|FG001|Cycle 1 Olaratumab Alone|Overall Study||11
10713086|NCT02677116|11878646|FG002|Cycle 1 Olaratumab Alone|Overall Study||9
10713087|NCT02677116|11878647|FG003|Cycle 1 Olaratumab Alone|Overall Study||10
10713088|NCT02677116|11878648|FG004|Cycle 1 Olaratumab Alone|Overall Study||1
10713089|NCT02677116|11878649|FG005|Cycle 1 Olaratumab Alone|Overall Study||13
10713090|NCT02677116|11878650|FG006|Cycle 1 Olaratumab Alone|Overall Study||6
10713091|NCT02677116|11878651|FG007|Cycle 1 Olaratumab Alone|Overall Study||4
10713092|NCT02677116|11878652|FG008|Cycle 1 Olaratumab Alone|Overall Study||4
10713093|NCT02677116|11878644|FG000|Progressive Disease|Overall Study||7
10713094|NCT02677116|11878645|FG001|Progressive Disease|Overall Study||7
10713095|NCT02677116|11878646|FG002|Progressive Disease|Overall Study||6
10713096|NCT02677116|11878647|FG003|Progressive Disease|Overall Study||7
10713097|NCT02677116|11878648|FG004|Progressive Disease|Overall Study||0
10713098|NCT02677116|11878649|FG005|Progressive Disease|Overall Study||9
10713099|NCT02677116|11878650|FG006|Progressive Disease|Overall Study||2
10713100|NCT02677116|11878651|FG007|Progressive Disease|Overall Study||2
10713101|NCT02677116|11878652|FG008|Progressive Disease|Overall Study||2
10713102|NCT02677116|11878644|FG000|COMPLETED|Overall Study||7
10713103|NCT02677116|11878645|FG001|COMPLETED|Overall Study||7
10713104|NCT02677116|11878646|FG002|COMPLETED|Overall Study||6
10685232|NCT02440451|11848598|FG000|STARTED|Overall Study||15
10685233|NCT02440451|11848598|FG000|COMPLETED|Overall Study||15
10685234|NCT02440451|11848598|FG000|NOT COMPLETED|Overall Study||0
10685235|NCT02440568|11848606|FG000|STARTED|Overall Study||5
10685236|NCT02440568|11848607|FG001|STARTED|Overall Study||4
10685237|NCT02440568|11848608|FG002|STARTED|Overall Study||10
10685238|NCT02440568|11848609|FG003|STARTED|Overall Study||3
10685239|NCT02440568|11848606|FG000|COMPLETED|Overall Study||1
10685240|NCT02440568|11848607|FG001|COMPLETED|Overall Study||1
10685241|NCT02440568|11848608|FG002|COMPLETED|Overall Study||5
10685242|NCT02440568|11848609|FG003|COMPLETED|Overall Study||1
10685243|NCT02440568|11848606|FG000|NOT COMPLETED|Overall Study||4
10685244|NCT02440568|11848607|FG001|NOT COMPLETED|Overall Study||3
10685245|NCT02440568|11848608|FG002|NOT COMPLETED|Overall Study||5
10685246|NCT02440568|11848609|FG003|NOT COMPLETED|Overall Study||2
10685247|NCT02440594|11848628|FG000|STARTED|Overall Study||509
10685248|NCT02440594|11848629|FG001|STARTED|Overall Study||509
10685249|NCT02440594|11848630|FG002|STARTED|Overall Study||436
10685250|NCT02440594|11848631|FG003|STARTED|Overall Study||429
10685251|NCT02440594|11848632|FG004|STARTED|Overall Study||55
10685252|NCT02440594|11848633|FG005|STARTED|Overall Study||54
10685253|NCT02440594|11848634|FG006|STARTED|Overall Study||150
10685254|NCT02440594|11848635|FG007|STARTED|Overall Study||290
10685255|NCT02440594|11848628|FG000|COMPLETED|Overall Study||377
10685256|NCT02440594|11848629|FG001|COMPLETED|Overall Study||401
10685257|NCT02440594|11848630|FG002|COMPLETED|Overall Study||319
10685258|NCT02440594|11848631|FG003|COMPLETED|Overall Study||340
10685259|NCT02440594|11848632|FG004|COMPLETED|Overall Study||46
10685260|NCT02440594|11848633|FG005|COMPLETED|Overall Study||47
10685261|NCT02440594|11848634|FG006|COMPLETED|Overall Study||113
10685262|NCT02440594|11848635|FG007|COMPLETED|Overall Study||234
10685263|NCT02440594|11848628|FG000|NOT COMPLETED|Overall Study||132
10685264|NCT02440594|11848629|FG001|NOT COMPLETED|Overall Study||108
10685265|NCT02440594|11848630|FG002|NOT COMPLETED|Overall Study||117
10685266|NCT02440594|11848631|FG003|NOT COMPLETED|Overall Study||89
10685267|NCT02440594|11848632|FG004|NOT COMPLETED|Overall Study||9
10685268|NCT02440594|11848633|FG005|NOT COMPLETED|Overall Study||7
10685269|NCT02440594|11848634|FG006|NOT COMPLETED|Overall Study||37
10685270|NCT02440594|11848635|FG007|NOT COMPLETED|Overall Study||56
10685271|NCT02440633|11848660|FG000|STARTED|Overall Study||8
10685272|NCT02440633|11848660|FG000|COMPLETED|Overall Study||8
10685273|NCT02440633|11848660|FG000|NOT COMPLETED|Overall Study||0
10685274|NCT02440659|11848670|FG000|STARTED|Overall Study||1997
10685275|NCT02440659|11848671|FG001|STARTED|Overall Study||949
10685276|NCT02440659|11848670|FG000|COMPLETED|Overall Study||1346
10685277|NCT02440659|11848671|FG001|COMPLETED|Overall Study||614
10685278|NCT02440659|11848670|FG000|NOT COMPLETED|Overall Study||651
10685279|NCT02440659|11848671|FG001|NOT COMPLETED|Overall Study||335
10685280|NCT02440789|11848677|FG000|STARTED|Overall Study||32
10685281|NCT02440789|11848677|FG000|Initiated Sirolimus|Overall Study||30
10685282|NCT02440789|11848677|FG000|Completed 20 Weeks of Sirolimus|Overall Study||16
10685283|NCT02440789|11848677|FG000|COMPLETED|Overall Study||28
10685284|NCT02440789|11848677|FG000|NOT COMPLETED|Overall Study||4
10685285|NCT02441062|11848681|FG000|STARTED|Overall Study||122
10685286|NCT02441062|11848681|FG000|COMPLETED|Overall Study||122
10685287|NCT02441062|11848681|FG000|NOT COMPLETED|Overall Study||0
10685288|NCT02441114|11848685|FG000|STARTED|Period1||10
10685289|NCT02441114|11848685|FG000|COMPLETED|Period1||10
10685290|NCT02441114|11848685|FG000|NOT COMPLETED|Period1||0
10685291|NCT02441114|11848685|FG000|STARTED|Washout1||10
10685292|NCT02441114|11848685|FG000|COMPLETED|Washout1||10
10685293|NCT02441114|11848685|FG000|NOT COMPLETED|Washout1||0
10685294|NCT02441114|11848685|FG000|STARTED|Period2||10
10685295|NCT02441114|11848685|FG000|COMPLETED|Period2||10
10685296|NCT02441114|11848685|FG000|NOT COMPLETED|Period2||0
10685297|NCT02441114|11848685|FG000|STARTED|Washout2||10
10685298|NCT02441114|11848685|FG000|COMPLETED|Washout2||6
10685299|NCT02441114|11848685|FG000|NOT COMPLETED|Washout2||4
10685300|NCT02441114|11848685|FG000|STARTED|Period3||6
10685301|NCT02441114|11848685|FG000|COMPLETED|Period3||6
10685302|NCT02441114|11848685|FG000|NOT COMPLETED|Period3||0
10685303|NCT02441179|11848691|FG000|STARTED|Overall Study||18
10685304|NCT02441179|11848692|FG001|STARTED|Overall Study||17
10685305|NCT02441179|11848691|FG000|COMPLETED|Overall Study||17
10685306|NCT02441179|11848692|FG001|COMPLETED|Overall Study||16
10685307|NCT02441179|11848691|FG000|NOT COMPLETED|Overall Study||1
10685308|NCT02441179|11848692|FG001|NOT COMPLETED|Overall Study||1
10685309|NCT02441218|11848701|FG000|STARTED|Overall Study||3241
10685310|NCT02441218|11848702|FG001|STARTED|Overall Study||3264
10685311|NCT02441218|11848701|FG000|COMPLETED|Overall Study||2663
10685312|NCT02441218|11848702|FG001|COMPLETED|Overall Study||2652
10685313|NCT02441218|11848701|FG000|NOT COMPLETED|Overall Study||578
10685314|NCT02441218|11848702|FG001|NOT COMPLETED|Overall Study||612
10685315|NCT02441283|11848708|FG000|STARTED|Overall Study||377
10685316|NCT02441283|11848708|FG000|COMPLETED|Overall Study||287
10685317|NCT02441283|11848708|FG000|NOT COMPLETED|Overall Study||90
10685318|NCT02441309|11848715|FG000|STARTED|Overall Study||3
10685319|NCT02441309|11848716|FG001|STARTED|Overall Study||2
10685320|NCT02441309|11848717|FG002|STARTED|Overall Study||3
10685321|NCT02441309|11848715|FG000|Received Allocated Intervention|Overall Study||1
10685322|NCT02441309|11848716|FG001|Received Allocated Intervention|Overall Study||2
10685323|NCT02441309|11848717|FG002|Received Allocated Intervention|Overall Study||3
10685324|NCT02441309|11848715|FG000|COMPLETED|Overall Study||0
10685325|NCT02441309|11848716|FG001|COMPLETED|Overall Study||0
10685326|NCT02441309|11848717|FG002|COMPLETED|Overall Study||0
10685327|NCT02441309|11848715|FG000|NOT COMPLETED|Overall Study||3
10685328|NCT02441309|11848716|FG001|NOT COMPLETED|Overall Study||2
10685329|NCT02441309|11848717|FG002|NOT COMPLETED|Overall Study||3
10685330|NCT02441517|11848728|FG000|STARTED|Overall Study||4
10685331|NCT02441517|11848728|FG000|Received Treatment|Overall Study||4
10685332|NCT02441517|11848728|FG000|COMPLETED|Overall Study||0
10685333|NCT02441517|11848728|FG000|NOT COMPLETED|Overall Study||4
10685334|NCT02441946|11848735|FG000|STARTED|Cycle 1 Period 1 (2 Weeks)||74
10685335|NCT02441946|11848736|FG001|STARTED|Cycle 1 Period 1 (2 Weeks)||76
10685336|NCT02441946|11848737|FG002|STARTED|Cycle 1 Period 1 (2 Weeks)||74
10685337|NCT02441946|11848735|FG000|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)||74
10685338|NCT02441946|11848736|FG001|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)|1 participant did not receive drug due to an error in randomization.|75
10685339|NCT02441946|11848737|FG002|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)||74
10685340|NCT02441946|11848735|FG000|COMPLETED|Cycle 1 Period 1 (2 Weeks)||72
10685341|NCT02441946|11848736|FG001|COMPLETED|Cycle 1 Period 1 (2 Weeks)||71
10685342|NCT02441946|11848737|FG002|COMPLETED|Cycle 1 Period 1 (2 Weeks)||74
10685343|NCT02441946|11848735|FG000|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||2
10685344|NCT02441946|11848736|FG001|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||5
10685345|NCT02441946|11848737|FG002|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
10685346|NCT02441946|11848735|FG000|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned to abemaciclib + anastrozole post cycle 1.|217
10685347|NCT02441946|11848736|FG001|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned abemaciclib + anastrozole post cycle 1.|0
10685348|NCT02441946|11848737|FG002|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned abemaciclib + anastrozole post cycle 1.|0
10685349|NCT02441946|11848735|FG000|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||217
10685350|NCT02441946|11848736|FG001|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||0
10685351|NCT02441946|11848737|FG002|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||0
10685352|NCT02441946|11848735|FG000|Progressive Disease|Cycle 2-5 Period 2 (14 Weeks)||5
10685353|NCT02441946|11848736|FG001|Progressive Disease|Cycle 2-5 Period 2 (14 Weeks)||0
10685354|NCT02441946|11848737|FG002|Progressive Disease|Cycle 2-5 Period 2 (14 Weeks)||0
10685355|NCT02441946|11848735|FG000|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||190
10685356|NCT02441946|11848736|FG001|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
10685357|NCT02441946|11848737|FG002|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
10685358|NCT02441946|11848735|FG000|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||27
10685359|NCT02441946|11848736|FG001|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
10685360|NCT02441946|11848737|FG002|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
10685361|NCT02441946|11848735|FG000|STARTED|Extension Period (8 Weeks)|All participants who did not discontinue continued to the extension period.|42
10685362|NCT02441946|11848736|FG001|STARTED|Extension Period (8 Weeks)||0
10685363|NCT02441946|11848737|FG002|STARTED|Extension Period (8 Weeks)||0
10685364|NCT02441946|11848735|FG000|COMPLETED|Extension Period (8 Weeks)||40
10685365|NCT02441946|11848736|FG001|COMPLETED|Extension Period (8 Weeks)||0
10685366|NCT02441946|11848737|FG002|COMPLETED|Extension Period (8 Weeks)||0
10685367|NCT02441946|11848735|FG000|NOT COMPLETED|Extension Period (8 Weeks)||2
10685368|NCT02441946|11848736|FG001|NOT COMPLETED|Extension Period (8 Weeks)||0
10685369|NCT02441946|11848737|FG002|NOT COMPLETED|Extension Period (8 Weeks)||0
10685370|NCT02442206|11848750|FG000|STARTED|Period 1||30
10685371|NCT02442206|11848751|FG001|STARTED|Period 1||32
10685372|NCT02442206|11848750|FG000|COMPLETED|Period 1||29
10685373|NCT02442206|11848751|FG001|COMPLETED|Period 1||29
10685374|NCT02442206|11848750|FG000|NOT COMPLETED|Period 1||1
10685375|NCT02442206|11848751|FG001|NOT COMPLETED|Period 1||3
10685376|NCT02442206|11848750|FG000|STARTED|Period 2||29
10685377|NCT02442206|11848751|FG001|STARTED|Period 2||29
10685378|NCT02442206|11848750|FG000|COMPLETED|Period 2||28
10685379|NCT02442206|11848751|FG001|COMPLETED|Period 2||29
10685380|NCT02442206|11848750|FG000|NOT COMPLETED|Period 2||1
10685381|NCT02442206|11848751|FG001|NOT COMPLETED|Period 2||0
10685382|NCT02442271|11848758|FG000|STARTED|Overall Study||222
10685383|NCT02442271|11848758|FG000|COMPLETED|Overall Study||218
10685384|NCT02442271|11848758|FG000|NOT COMPLETED|Overall Study||4
10685385|NCT02442284|11848776|FG000|STARTED|Overall Study||99
10685386|NCT02442284|11848776|FG000|COMPLETED|Overall Study||92
10685387|NCT02442284|11848776|FG000|NOT COMPLETED|Overall Study||7
10685388|NCT02442310|11848780|FG000|STARTED|Overall Study||20
10685389|NCT02442310|11848780|FG000|COMPLETED|Overall Study||17
10685390|NCT02442310|11848780|FG000|NOT COMPLETED|Overall Study||3
10685391|NCT02442336|11848790|FG000|STARTED|Overall Study||80
10685392|NCT02442336|11848790|FG000|Developmental Phase|Overall Study||6
10685393|NCT02442336|11848790|FG000|Evaluation Phase|Overall Study||74
10685394|NCT02442336|11848790|FG000|Provided Access to Intervention|Overall Study||55
10685395|NCT02442336|11848790|FG000|COMPLETED|Overall Study||44
10685396|NCT02442336|11848790|FG000|NOT COMPLETED|Overall Study||36
10685397|NCT02442622|11848796|FG000|STARTED|Overall Study||15
10685398|NCT02442622|11848797|FG001|STARTED|Overall Study||17
10685399|NCT02442622|11848796|FG000|COMPLETED|Overall Study||12
10685400|NCT02442622|11848797|FG001|COMPLETED|Overall Study||16
10685401|NCT02442622|11848796|FG000|NOT COMPLETED|Overall Study||3
10685402|NCT02442622|11848797|FG001|NOT COMPLETED|Overall Study||1
10685403|NCT02442687|11848806|FG000|STARTED|Overall Study||21
10685404|NCT02442687|11848807|FG001|STARTED|Overall Study||22
10685405|NCT02442687|11848808|FG002|STARTED|Overall Study||22
10685406|NCT02442687|11848806|FG000|COMPLETED|Overall Study||13
10685407|NCT02442687|11848807|FG001|COMPLETED|Overall Study||11
10685408|NCT02442687|11848808|FG002|COMPLETED|Overall Study||19
10685409|NCT02442687|11848806|FG000|NOT COMPLETED|Overall Study||8
10685410|NCT02442687|11848807|FG001|NOT COMPLETED|Overall Study||11
10685411|NCT02442687|11848808|FG002|NOT COMPLETED|Overall Study||3
10685412|NCT02442700|11848819|FG000|STARTED|First 12 Weeks||12
10685413|NCT02442700|11848820|FG001|STARTED|First 12 Weeks||12
10685414|NCT02442700|11848819|FG000|COMPLETED|First 12 Weeks||12
10685415|NCT02442700|11848820|FG001|COMPLETED|First 12 Weeks||12
10685416|NCT02442700|11848819|FG000|NOT COMPLETED|First 12 Weeks||0
10685417|NCT02442700|11848820|FG001|NOT COMPLETED|First 12 Weeks||0
10685418|NCT02442700|11848819|FG000|STARTED|Later 12 Weeks||12
10685419|NCT02442700|11848820|FG001|STARTED|Later 12 Weeks||12
10685420|NCT02442700|11848819|FG000|COMPLETED|Later 12 Weeks||12
10685421|NCT02442700|11848820|FG001|COMPLETED|Later 12 Weeks||12
10685422|NCT02442700|11848819|FG000|NOT COMPLETED|Later 12 Weeks||0
10685423|NCT02442700|11848820|FG001|NOT COMPLETED|Later 12 Weeks||0
10685424|NCT02442804|11848828|FG000|STARTED|Overall Study||8
10685425|NCT02442804|11848829|FG001|STARTED|Overall Study||8
10685426|NCT02442804|11848828|FG000|COMPLETED|Overall Study||7
10685427|NCT02442804|11848829|FG001|COMPLETED|Overall Study||7
10685428|NCT02442804|11848828|FG000|NOT COMPLETED|Overall Study||1
10685429|NCT02442804|11848829|FG001|NOT COMPLETED|Overall Study||1
10685430|NCT02442830|11848837|FG000|STARTED|Overall Study||42
10685431|NCT02442830|11848838|FG001|STARTED|Overall Study||45
10685432|NCT02442830|11848837|FG000|COMPLETED|Overall Study||42
10685433|NCT02442830|11848838|FG001|COMPLETED|Overall Study||44
10685434|NCT02442830|11848837|FG000|NOT COMPLETED|Overall Study||0
10685435|NCT02442830|11848838|FG001|NOT COMPLETED|Overall Study||1
10685436|NCT02442856|11848845|FG000|STARTED|Overall Study||21
10685437|NCT02442856|11848845|FG000|COMPLETED|Overall Study||21
10685438|NCT02442856|11848845|FG000|NOT COMPLETED|Overall Study||0
10685439|NCT02442869|11848855|FG000|STARTED|Overall Study||18
10685440|NCT02442869|11848856|FG001|STARTED|Overall Study||29
10685441|NCT02442869|11848857|FG002|STARTED|Overall Study||6
10685442|NCT02442869|11848858|FG003|STARTED|Overall Study||2
10685443|NCT02442869|11848859|FG004|STARTED|Overall Study||5
10685444|NCT02442869|11848860|FG005|STARTED|Overall Study||2
10685445|NCT02442869|11848855|FG000|COMPLETED|Overall Study||13
10685446|NCT02442869|11848856|FG001|COMPLETED|Overall Study||20
10685447|NCT02442869|11848857|FG002|COMPLETED|Overall Study||6
10685448|NCT02442869|11848858|FG003|COMPLETED|Overall Study||1
10685449|NCT02442869|11848859|FG004|COMPLETED|Overall Study||3
10685450|NCT02442869|11848860|FG005|COMPLETED|Overall Study||2
10685451|NCT02442869|11848855|FG000|NOT COMPLETED|Overall Study||5
10685452|NCT02442869|11848856|FG001|NOT COMPLETED|Overall Study||9
10685453|NCT02442869|11848857|FG002|NOT COMPLETED|Overall Study||0
10685454|NCT02442869|11848858|FG003|NOT COMPLETED|Overall Study||1
10685455|NCT02442869|11848859|FG004|NOT COMPLETED|Overall Study||2
10685456|NCT02442869|11848860|FG005|NOT COMPLETED|Overall Study||0
10685457|NCT02443103|11848884|FG000|STARTED|Overall Study||4
10685458|NCT02443103|11848884|FG000|COMPLETED|Overall Study||1
10685459|NCT02443103|11848884|FG000|NOT COMPLETED|Overall Study||3
10685460|NCT02443155|11848892|FG000|STARTED|Overall Study||77
10685461|NCT02443155|11848893|FG001|STARTED|Overall Study||77
10685462|NCT02443155|11848894|FG002|STARTED|Overall Study||76
10685463|NCT02443155|11848895|FG003|STARTED|Overall Study||77
10685464|NCT02443155|11848892|FG000|Full Analysis Set|Overall Study||77
10685465|NCT02443155|11848893|FG001|Full Analysis Set|Overall Study||77
10685466|NCT02443155|11848894|FG002|Full Analysis Set|Overall Study||76
10685467|NCT02443155|11848895|FG003|Full Analysis Set|Overall Study||77
10685468|NCT02443155|11848892|FG000|PK Analysis Set|Overall Study||21
10685469|NCT02443155|11848893|FG001|PK Analysis Set|Overall Study||21
10685470|NCT02443155|11848894|FG002|PK Analysis Set|Overall Study||22
10685471|NCT02443155|11848895|FG003|PK Analysis Set|Overall Study||20
10685472|NCT02443155|11848892|FG000|Safety Analysis Set|Overall Study||77
10685473|NCT02443155|11848893|FG001|Safety Analysis Set|Overall Study||77
10685474|NCT02443155|11848894|FG002|Safety Analysis Set|Overall Study||76
10685475|NCT02443155|11848895|FG003|Safety Analysis Set|Overall Study||77
10685476|NCT02443155|11848892|FG000|COMPLETED|Overall Study||65
10685477|NCT02443155|11848893|FG001|COMPLETED|Overall Study||63
10685478|NCT02443155|11848894|FG002|COMPLETED|Overall Study||67
10685479|NCT02443155|11848895|FG003|COMPLETED|Overall Study||61
10685480|NCT02443155|11848892|FG000|NOT COMPLETED|Overall Study||12
10685481|NCT02443155|11848893|FG001|NOT COMPLETED|Overall Study||14
10685482|NCT02443155|11848894|FG002|NOT COMPLETED|Overall Study||9
10685483|NCT02443155|11848895|FG003|NOT COMPLETED|Overall Study||16
10685484|NCT02443298|11848908|FG000|STARTED|Overall Study||105
10685485|NCT02443298|11848909|FG001|STARTED|Overall Study||109
10685486|NCT02443298|11848908|FG000|COMPLETED|Overall Study||101
10685487|NCT02443298|11848909|FG001|COMPLETED|Overall Study||104
10685488|NCT02443298|11848908|FG000|NOT COMPLETED|Overall Study||4
10685489|NCT02443298|11848909|FG001|NOT COMPLETED|Overall Study||5
10685490|NCT02443337|11848917|FG000|STARTED|Overall Study||15
10685491|NCT02443337|11848918|FG001|STARTED|Overall Study||16
10685492|NCT02443337|11848917|FG000|Received at Least One Dose of Study Drug|Overall Study||15
10685493|NCT02443337|11848918|FG001|Received at Least One Dose of Study Drug|Overall Study||16
10685494|NCT02443337|11848917|FG000|COMPLETED|Overall Study||10
10685495|NCT02443337|11848918|FG001|COMPLETED|Overall Study||14
10685496|NCT02443337|11848917|FG000|NOT COMPLETED|Overall Study||5
10685497|NCT02443337|11848918|FG001|NOT COMPLETED|Overall Study||2
10685498|NCT02443402|11848931|FG000|STARTED|Overall Study||36
10685499|NCT02443402|11848932|FG001|STARTED|Overall Study||31
10685500|NCT02443402|11848931|FG000|COMPLETED|Overall Study||32
10685501|NCT02443402|11848932|FG001|COMPLETED|Overall Study||28
10685502|NCT02443402|11848931|FG000|NOT COMPLETED|Overall Study||4
10685503|NCT02443402|11848932|FG001|NOT COMPLETED|Overall Study||3
10685504|NCT02443519|11848940|FG000|STARTED|Overall Study||31
10685505|NCT02443519|11848941|FG001|STARTED|Overall Study||29
10685506|NCT02443519|11848940|FG000|COMPLETED|Overall Study||29
10685507|NCT02443519|11848941|FG001|COMPLETED|Overall Study||26
10685508|NCT02443519|11848940|FG000|NOT COMPLETED|Overall Study||2
10685509|NCT02443519|11848941|FG001|NOT COMPLETED|Overall Study||3
10685510|NCT02443571|11848950|FG000|STARTED|Overall Study||596
10685511|NCT02443571|11848951|FG001|STARTED|Overall Study||95
10685512|NCT02443571|11848952|FG002|STARTED|Overall Study||23
10685513|NCT02443571|11848950|FG000|COMPLETED|Overall Study||596
10685514|NCT02443571|11848951|FG001|COMPLETED|Overall Study||95
10685515|NCT02443571|11848952|FG002|COMPLETED|Overall Study||23
10685516|NCT02443571|11848950|FG000|NOT COMPLETED|Overall Study||0
10685517|NCT02443571|11848951|FG001|NOT COMPLETED|Overall Study||0
10685518|NCT02443571|11848952|FG002|NOT COMPLETED|Overall Study||0
10685519|NCT02443688|11848963|FG000|STARTED|Overall Study||66
10685520|NCT02443688|11848964|FG001|STARTED|Overall Study||67
10685521|NCT02443688|11848965|FG002|STARTED|Overall Study||67
10685522|NCT02443688|11848963|FG000|COMPLETED|Overall Study||54
10685523|NCT02443688|11848964|FG001|COMPLETED|Overall Study||58
10685524|NCT02443688|11848965|FG002|COMPLETED|Overall Study||55
10685525|NCT02443688|11848963|FG000|NOT COMPLETED|Overall Study||12
10685526|NCT02443688|11848964|FG001|NOT COMPLETED|Overall Study||9
10685527|NCT02443688|11848965|FG002|NOT COMPLETED|Overall Study||12
10685528|NCT02443740|11848981|FG000|STARTED|Intervention Period 1 (3 Days)||2
10685529|NCT02443740|11848982|FG001|STARTED|Intervention Period 1 (3 Days)||2
10685530|NCT02443740|11848983|FG002|STARTED|Intervention Period 1 (3 Days)||2
10685531|NCT02443740|11848984|FG003|STARTED|Intervention Period 1 (3 Days)||3
10685532|NCT02443740|11848985|FG004|STARTED|Intervention Period 1 (3 Days)||2
10685533|NCT02443740|11848986|FG005|STARTED|Intervention Period 1 (3 Days)||4
10685534|NCT02443740|11848987|FG006|STARTED|Intervention Period 1 (3 Days)||3
10685535|NCT02443740|11848988|FG007|STARTED|Intervention Period 1 (3 Days)||2
10685536|NCT02443740|11848989|FG008|STARTED|Intervention Period 1 (3 Days)||6
10685537|NCT02443740|11848990|FG009|STARTED|Intervention Period 1 (3 Days)||3
10685538|NCT02443740|11848991|FG010|STARTED|Intervention Period 1 (3 Days)||3
10685539|NCT02443740|11848981|FG000|COMPLETED|Intervention Period 1 (3 Days)||1
10685540|NCT02443740|11848982|FG001|COMPLETED|Intervention Period 1 (3 Days)||2
10685541|NCT02443740|11848983|FG002|COMPLETED|Intervention Period 1 (3 Days)||2
10685542|NCT02443740|11848984|FG003|COMPLETED|Intervention Period 1 (3 Days)||3
10685543|NCT02443740|11848985|FG004|COMPLETED|Intervention Period 1 (3 Days)||2
10685544|NCT02443740|11848986|FG005|COMPLETED|Intervention Period 1 (3 Days)||2
10685545|NCT02443740|11848987|FG006|COMPLETED|Intervention Period 1 (3 Days)||2
10685546|NCT02443740|11848988|FG007|COMPLETED|Intervention Period 1 (3 Days)||2
10685547|NCT02443740|11848989|FG008|COMPLETED|Intervention Period 1 (3 Days)||6
10685548|NCT02443740|11848990|FG009|COMPLETED|Intervention Period 1 (3 Days)||3
10685549|NCT02443740|11848991|FG010|COMPLETED|Intervention Period 1 (3 Days)||3
10685550|NCT02443740|11848981|FG000|NOT COMPLETED|Intervention Period 1 (3 Days)||1
10685551|NCT02443740|11848982|FG001|NOT COMPLETED|Intervention Period 1 (3 Days)||0
10685552|NCT02443740|11848983|FG002|NOT COMPLETED|Intervention Period 1 (3 Days)||0
10685553|NCT02443740|11848984|FG003|NOT COMPLETED|Intervention Period 1 (3 Days)||0
10685554|NCT02443740|11848985|FG004|NOT COMPLETED|Intervention Period 1 (3 Days)||0
10685555|NCT02443740|11848986|FG005|NOT COMPLETED|Intervention Period 1 (3 Days)||2
10685630|NCT02443740|11848984|FG003|STARTED|Washout Period 2 (7 Days)||3
10685556|NCT02443740|11848987|FG006|NOT COMPLETED|Intervention Period 1 (3 Days)||1
10685557|NCT02443740|11848988|FG007|NOT COMPLETED|Intervention Period 1 (3 Days)||0
10685558|NCT02443740|11848989|FG008|NOT COMPLETED|Intervention Period 1 (3 Days)||0
10685559|NCT02443740|11848990|FG009|NOT COMPLETED|Intervention Period 1 (3 Days)||0
10685560|NCT02443740|11848991|FG010|NOT COMPLETED|Intervention Period 1 (3 Days)||0
10685561|NCT02443740|11848981|FG000|STARTED|Washout Period 1 (7 Days)||1
10685562|NCT02443740|11848982|FG001|STARTED|Washout Period 1 (7 Days)||2
10685563|NCT02443740|11848983|FG002|STARTED|Washout Period 1 (7 Days)||2
10685564|NCT02443740|11848984|FG003|STARTED|Washout Period 1 (7 Days)||3
10685565|NCT02443740|11848985|FG004|STARTED|Washout Period 1 (7 Days)||2
10685566|NCT02443740|11848986|FG005|STARTED|Washout Period 1 (7 Days)||2
10685567|NCT02443740|11848987|FG006|STARTED|Washout Period 1 (7 Days)||2
10685568|NCT02443740|11848988|FG007|STARTED|Washout Period 1 (7 Days)||2
10685569|NCT02443740|11848989|FG008|STARTED|Washout Period 1 (7 Days)||0
10685570|NCT02443740|11848990|FG009|STARTED|Washout Period 1 (7 Days)||3
10685571|NCT02443740|11848991|FG010|STARTED|Washout Period 1 (7 Days)||3
10685572|NCT02443740|11848981|FG000|COMPLETED|Washout Period 1 (7 Days)||1
10685573|NCT02443740|11848982|FG001|COMPLETED|Washout Period 1 (7 Days)||2
10685574|NCT02443740|11848983|FG002|COMPLETED|Washout Period 1 (7 Days)||2
10685575|NCT02443740|11848984|FG003|COMPLETED|Washout Period 1 (7 Days)||3
10685576|NCT02443740|11848985|FG004|COMPLETED|Washout Period 1 (7 Days)||2
10685577|NCT02443740|11848986|FG005|COMPLETED|Washout Period 1 (7 Days)||2
10685578|NCT02443740|11848987|FG006|COMPLETED|Washout Period 1 (7 Days)||2
10685579|NCT02443740|11848988|FG007|COMPLETED|Washout Period 1 (7 Days)||2
10685580|NCT02443740|11848989|FG008|COMPLETED|Washout Period 1 (7 Days)||0
10685581|NCT02443740|11848990|FG009|COMPLETED|Washout Period 1 (7 Days)||3
10685582|NCT02443740|11848991|FG010|COMPLETED|Washout Period 1 (7 Days)||3
10800078|NCT04501640|11960952|FG002|COMPLETED|Period 2 (5 Days)||6
10800079|NCT04501640|11960953|FG003|COMPLETED|Period 2 (5 Days)||6
10800080|NCT04501640|11960950|FG000|NOT COMPLETED|Period 2 (5 Days)||0
10800081|NCT04501640|11960951|FG001|NOT COMPLETED|Period 2 (5 Days)||0
10800082|NCT04501640|11960952|FG002|NOT COMPLETED|Period 2 (5 Days)||0
10800083|NCT04501640|11960953|FG003|NOT COMPLETED|Period 2 (5 Days)||0
10800084|NCT04501952|11960965|FG000|STARTED|Overall Study||292
10800085|NCT04501952|11960966|FG001|STARTED|Overall Study||292
10685583|NCT02443740|11848981|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
10685584|NCT02443740|11848982|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
10685585|NCT02443740|11848983|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
10685586|NCT02443740|11848984|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
10685587|NCT02443740|11848985|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
10685588|NCT02443740|11848986|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
10685589|NCT02443740|11848987|FG006|NOT COMPLETED|Washout Period 1 (7 Days)||0
10685590|NCT02443740|11848988|FG007|NOT COMPLETED|Washout Period 1 (7 Days)||0
10685591|NCT02443740|11848989|FG008|NOT COMPLETED|Washout Period 1 (7 Days)||0
10685592|NCT02443740|11848990|FG009|NOT COMPLETED|Washout Period 1 (7 Days)||0
10685593|NCT02443740|11848991|FG010|NOT COMPLETED|Washout Period 1 (7 Days)||0
10685594|NCT02443740|11848981|FG000|STARTED|Intervention Period 2 (3 Days)||1
10685595|NCT02443740|11848982|FG001|STARTED|Intervention Period 2 (3 Days)||2
10685596|NCT02443740|11848983|FG002|STARTED|Intervention Period 2 (3 Days)||2
10685597|NCT02443740|11848984|FG003|STARTED|Intervention Period 2 (3 Days)||3
10685598|NCT02443740|11848985|FG004|STARTED|Intervention Period 2 (3 Days)||2
10685599|NCT02443740|11848986|FG005|STARTED|Intervention Period 2 (3 Days)||2
10685600|NCT02443740|11848987|FG006|STARTED|Intervention Period 2 (3 Days)||2
10685601|NCT02443740|11848988|FG007|STARTED|Intervention Period 2 (3 Days)||2
10685602|NCT02443740|11848989|FG008|STARTED|Intervention Period 2 (3 Days)||0
10685603|NCT02443740|11848990|FG009|STARTED|Intervention Period 2 (3 Days)||3
10685604|NCT02443740|11848991|FG010|STARTED|Intervention Period 2 (3 Days)||3
10685605|NCT02443740|11848981|FG000|COMPLETED|Intervention Period 2 (3 Days)||1
10685606|NCT02443740|11848982|FG001|COMPLETED|Intervention Period 2 (3 Days)||2
10685607|NCT02443740|11848983|FG002|COMPLETED|Intervention Period 2 (3 Days)||2
10685608|NCT02443740|11848984|FG003|COMPLETED|Intervention Period 2 (3 Days)||3
10685609|NCT02443740|11848985|FG004|COMPLETED|Intervention Period 2 (3 Days)||2
10685610|NCT02443740|11848986|FG005|COMPLETED|Intervention Period 2 (3 Days)||2
10685611|NCT02443740|11848987|FG006|COMPLETED|Intervention Period 2 (3 Days)||2
10685612|NCT02443740|11848988|FG007|COMPLETED|Intervention Period 2 (3 Days)||2
10685613|NCT02443740|11848989|FG008|COMPLETED|Intervention Period 2 (3 Days)||0
10685614|NCT02443740|11848990|FG009|COMPLETED|Intervention Period 2 (3 Days)||3
10685615|NCT02443740|11848991|FG010|COMPLETED|Intervention Period 2 (3 Days)||3
10685616|NCT02443740|11848981|FG000|NOT COMPLETED|Intervention Period 2 (3 Days)||0
10685617|NCT02443740|11848982|FG001|NOT COMPLETED|Intervention Period 2 (3 Days)||0
10685618|NCT02443740|11848983|FG002|NOT COMPLETED|Intervention Period 2 (3 Days)||0
10685619|NCT02443740|11848984|FG003|NOT COMPLETED|Intervention Period 2 (3 Days)||0
10685620|NCT02443740|11848985|FG004|NOT COMPLETED|Intervention Period 2 (3 Days)||0
10685621|NCT02443740|11848986|FG005|NOT COMPLETED|Intervention Period 2 (3 Days)||0
10685622|NCT02443740|11848987|FG006|NOT COMPLETED|Intervention Period 2 (3 Days)||0
10685623|NCT02443740|11848988|FG007|NOT COMPLETED|Intervention Period 2 (3 Days)||0
10685624|NCT02443740|11848989|FG008|NOT COMPLETED|Intervention Period 2 (3 Days)||0
10685625|NCT02443740|11848990|FG009|NOT COMPLETED|Intervention Period 2 (3 Days)||0
10685626|NCT02443740|11848991|FG010|NOT COMPLETED|Intervention Period 2 (3 Days)||0
10685627|NCT02443740|11848981|FG000|STARTED|Washout Period 2 (7 Days)||1
10685628|NCT02443740|11848982|FG001|STARTED|Washout Period 2 (7 Days)||2
10685629|NCT02443740|11848983|FG002|STARTED|Washout Period 2 (7 Days)||2
10685631|NCT02443740|11848985|FG004|STARTED|Washout Period 2 (7 Days)||2
10685632|NCT02443740|11848986|FG005|STARTED|Washout Period 2 (7 Days)||2
10685633|NCT02443740|11848987|FG006|STARTED|Washout Period 2 (7 Days)||2
10685634|NCT02443740|11848988|FG007|STARTED|Washout Period 2 (7 Days)||2
10685635|NCT02443740|11848989|FG008|STARTED|Washout Period 2 (7 Days)||0
10685636|NCT02443740|11848990|FG009|STARTED|Washout Period 2 (7 Days)||0
10685637|NCT02443740|11848991|FG010|STARTED|Washout Period 2 (7 Days)||0
10685638|NCT02443740|11848981|FG000|COMPLETED|Washout Period 2 (7 Days)||1
10685639|NCT02443740|11848982|FG001|COMPLETED|Washout Period 2 (7 Days)||2
10685640|NCT02443740|11848983|FG002|COMPLETED|Washout Period 2 (7 Days)||2
10685641|NCT02443740|11848984|FG003|COMPLETED|Washout Period 2 (7 Days)||3
10685642|NCT02443740|11848985|FG004|COMPLETED|Washout Period 2 (7 Days)||2
10685643|NCT02443740|11848986|FG005|COMPLETED|Washout Period 2 (7 Days)||2
10685644|NCT02443740|11848987|FG006|COMPLETED|Washout Period 2 (7 Days)||2
10800086|NCT04501952|11960965|FG000|COMPLETED|Overall Study||266
10800087|NCT04501952|11960966|FG001|COMPLETED|Overall Study||272
10800088|NCT04501952|11960965|FG000|NOT COMPLETED|Overall Study||26
10685645|NCT02443740|11848988|FG007|COMPLETED|Washout Period 2 (7 Days)||2
10685646|NCT02443740|11848989|FG008|COMPLETED|Washout Period 2 (7 Days)||0
10685647|NCT02443740|11848990|FG009|COMPLETED|Washout Period 2 (7 Days)||0
10685648|NCT02443740|11848991|FG010|COMPLETED|Washout Period 2 (7 Days)||0
10685649|NCT02443740|11848981|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
10685650|NCT02443740|11848982|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
10685651|NCT02443740|11848983|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
10685652|NCT02443740|11848984|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
10685653|NCT02443740|11848985|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
10685654|NCT02443740|11848986|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
10685655|NCT02443740|11848987|FG006|NOT COMPLETED|Washout Period 2 (7 Days)||0
10685656|NCT02443740|11848988|FG007|NOT COMPLETED|Washout Period 2 (7 Days)||0
10685657|NCT02443740|11848989|FG008|NOT COMPLETED|Washout Period 2 (7 Days)||0
10685658|NCT02443740|11848990|FG009|NOT COMPLETED|Washout Period 2 (7 Days)||0
10685659|NCT02443740|11848991|FG010|NOT COMPLETED|Washout Period 2 (7 Days)||0
10685660|NCT02443740|11848981|FG000|STARTED|Intervention Period 3 (3 Days)||1
10685661|NCT02443740|11848982|FG001|STARTED|Intervention Period 3 (3 Days)||2
10685662|NCT02443740|11848983|FG002|STARTED|Intervention Period 3 (3 Days)||2
10685663|NCT02443740|11848984|FG003|STARTED|Intervention Period 3 (3 Days)||3
10685664|NCT02443740|11848985|FG004|STARTED|Intervention Period 3 (3 Days)||2
10685665|NCT02443740|11848986|FG005|STARTED|Intervention Period 3 (3 Days)||2
10685666|NCT02443740|11848987|FG006|STARTED|Intervention Period 3 (3 Days)||2
10685667|NCT02443740|11848988|FG007|STARTED|Intervention Period 3 (3 Days)||2
10685668|NCT02443740|11848989|FG008|STARTED|Intervention Period 3 (3 Days)||0
10685669|NCT02443740|11848990|FG009|STARTED|Intervention Period 3 (3 Days)||0
10685670|NCT02443740|11848991|FG010|STARTED|Intervention Period 3 (3 Days)||0
10685671|NCT02443740|11848981|FG000|COMPLETED|Intervention Period 3 (3 Days)||1
10685672|NCT02443740|11848982|FG001|COMPLETED|Intervention Period 3 (3 Days)||2
10685673|NCT02443740|11848983|FG002|COMPLETED|Intervention Period 3 (3 Days)||2
10685674|NCT02443740|11848984|FG003|COMPLETED|Intervention Period 3 (3 Days)||3
10685675|NCT02443740|11848985|FG004|COMPLETED|Intervention Period 3 (3 Days)||2
10685676|NCT02443740|11848986|FG005|COMPLETED|Intervention Period 3 (3 Days)||2
10685677|NCT02443740|11848987|FG006|COMPLETED|Intervention Period 3 (3 Days)||2
10685678|NCT02443740|11848988|FG007|COMPLETED|Intervention Period 3 (3 Days)||2
10685679|NCT02443740|11848989|FG008|COMPLETED|Intervention Period 3 (3 Days)||0
10685680|NCT02443740|11848990|FG009|COMPLETED|Intervention Period 3 (3 Days)||0
10685681|NCT02443740|11848991|FG010|COMPLETED|Intervention Period 3 (3 Days)||0
10685682|NCT02443740|11848981|FG000|NOT COMPLETED|Intervention Period 3 (3 Days)||0
10685683|NCT02443740|11848982|FG001|NOT COMPLETED|Intervention Period 3 (3 Days)||0
10685684|NCT02443740|11848983|FG002|NOT COMPLETED|Intervention Period 3 (3 Days)||0
10685685|NCT02443740|11848984|FG003|NOT COMPLETED|Intervention Period 3 (3 Days)||0
10685686|NCT02443740|11848985|FG004|NOT COMPLETED|Intervention Period 3 (3 Days)||0
10685687|NCT02443740|11848986|FG005|NOT COMPLETED|Intervention Period 3 (3 Days)||0
10685688|NCT02443740|11848987|FG006|NOT COMPLETED|Intervention Period 3 (3 Days)||0
10685689|NCT02443740|11848988|FG007|NOT COMPLETED|Intervention Period 3 (3 Days)||0
10685690|NCT02443740|11848989|FG008|NOT COMPLETED|Intervention Period 3 (3 Days)||0
10685691|NCT02443740|11848990|FG009|NOT COMPLETED|Intervention Period 3 (3 Days)||0
10685692|NCT02443740|11848991|FG010|NOT COMPLETED|Intervention Period 3 (3 Days)||0
10685693|NCT02443740|11848981|FG000|STARTED|Washout Period 3 (7 Days)||1
10685694|NCT02443740|11848982|FG001|STARTED|Washout Period 3 (7 Days)||2
10685695|NCT02443740|11848983|FG002|STARTED|Washout Period 3 (7 Days)||2
10685696|NCT02443740|11848984|FG003|STARTED|Washout Period 3 (7 Days)||3
10685697|NCT02443740|11848985|FG004|STARTED|Washout Period 3 (7 Days)||2
10685698|NCT02443740|11848986|FG005|STARTED|Washout Period 3 (7 Days)||2
10685699|NCT02443740|11848987|FG006|STARTED|Washout Period 3 (7 Days)||2
10685700|NCT02443740|11848988|FG007|STARTED|Washout Period 3 (7 Days)||2
10685701|NCT02443740|11848989|FG008|STARTED|Washout Period 3 (7 Days)||0
10685702|NCT02443740|11848990|FG009|STARTED|Washout Period 3 (7 Days)||0
10685703|NCT02443740|11848991|FG010|STARTED|Washout Period 3 (7 Days)||0
10685704|NCT02443740|11848981|FG000|COMPLETED|Washout Period 3 (7 Days)||1
10685705|NCT02443740|11848982|FG001|COMPLETED|Washout Period 3 (7 Days)||2
10685706|NCT02443740|11848983|FG002|COMPLETED|Washout Period 3 (7 Days)||2
10685707|NCT02443740|11848984|FG003|COMPLETED|Washout Period 3 (7 Days)||3
10685708|NCT02443740|11848985|FG004|COMPLETED|Washout Period 3 (7 Days)||2
10685709|NCT02443740|11848986|FG005|COMPLETED|Washout Period 3 (7 Days)||2
10685710|NCT02443740|11848987|FG006|COMPLETED|Washout Period 3 (7 Days)||2
10685711|NCT02443740|11848988|FG007|COMPLETED|Washout Period 3 (7 Days)||2
10685712|NCT02443740|11848989|FG008|COMPLETED|Washout Period 3 (7 Days)||0
10685713|NCT02443740|11848990|FG009|COMPLETED|Washout Period 3 (7 Days)||0
10685714|NCT02443740|11848991|FG010|COMPLETED|Washout Period 3 (7 Days)||0
10685715|NCT02443740|11848981|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
10685716|NCT02443740|11848982|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
10685717|NCT02443740|11848983|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
10685718|NCT02443740|11848984|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
10685719|NCT02443740|11848985|FG004|NOT COMPLETED|Washout Period 3 (7 Days)||0
10685720|NCT02443740|11848986|FG005|NOT COMPLETED|Washout Period 3 (7 Days)||0
10685721|NCT02443740|11848987|FG006|NOT COMPLETED|Washout Period 3 (7 Days)||0
10685722|NCT02443740|11848988|FG007|NOT COMPLETED|Washout Period 3 (7 Days)||0
10685723|NCT02443740|11848989|FG008|NOT COMPLETED|Washout Period 3 (7 Days)||0
10685724|NCT02443740|11848990|FG009|NOT COMPLETED|Washout Period 3 (7 Days)||0
10685725|NCT02443740|11848991|FG010|NOT COMPLETED|Washout Period 3 (7 Days)||0
10685726|NCT02443740|11848981|FG000|STARTED|Intervention Period 4 (3 Days)||1
10685727|NCT02443740|11848982|FG001|STARTED|Intervention Period 4 (3 Days)||2
10685728|NCT02443740|11848983|FG002|STARTED|Intervention Period 4 (3 Days)||2
10685729|NCT02443740|11848984|FG003|STARTED|Intervention Period 4 (3 Days)||3
10685730|NCT02443740|11848985|FG004|STARTED|Intervention Period 4 (3 Days)||2
10685731|NCT02443740|11848986|FG005|STARTED|Intervention Period 4 (3 Days)||2
10685732|NCT02443740|11848987|FG006|STARTED|Intervention Period 4 (3 Days)||2
10685733|NCT02443740|11848988|FG007|STARTED|Intervention Period 4 (3 Days)||2
10685734|NCT02443740|11848989|FG008|STARTED|Intervention Period 4 (3 Days)||0
10685735|NCT02443740|11848990|FG009|STARTED|Intervention Period 4 (3 Days)||0
10685736|NCT02443740|11848991|FG010|STARTED|Intervention Period 4 (3 Days)||0
10685737|NCT02443740|11848981|FG000|COMPLETED|Intervention Period 4 (3 Days)||1
10685738|NCT02443740|11848982|FG001|COMPLETED|Intervention Period 4 (3 Days)||2
10685739|NCT02443740|11848983|FG002|COMPLETED|Intervention Period 4 (3 Days)||2
10685740|NCT02443740|11848984|FG003|COMPLETED|Intervention Period 4 (3 Days)||3
10685741|NCT02443740|11848985|FG004|COMPLETED|Intervention Period 4 (3 Days)||2
10685742|NCT02443740|11848986|FG005|COMPLETED|Intervention Period 4 (3 Days)||2
10685743|NCT02443740|11848987|FG006|COMPLETED|Intervention Period 4 (3 Days)||2
10685744|NCT02443740|11848988|FG007|COMPLETED|Intervention Period 4 (3 Days)||2
10685745|NCT02443740|11848989|FG008|COMPLETED|Intervention Period 4 (3 Days)||0
10685746|NCT02443740|11848990|FG009|COMPLETED|Intervention Period 4 (3 Days)||0
10685747|NCT02443740|11848991|FG010|COMPLETED|Intervention Period 4 (3 Days)||0
10685748|NCT02443740|11848981|FG000|NOT COMPLETED|Intervention Period 4 (3 Days)||0
10685749|NCT02443740|11848982|FG001|NOT COMPLETED|Intervention Period 4 (3 Days)||0
10685750|NCT02443740|11848983|FG002|NOT COMPLETED|Intervention Period 4 (3 Days)||0
10685751|NCT02443740|11848984|FG003|NOT COMPLETED|Intervention Period 4 (3 Days)||0
10685752|NCT02443740|11848985|FG004|NOT COMPLETED|Intervention Period 4 (3 Days)||0
10685753|NCT02443740|11848986|FG005|NOT COMPLETED|Intervention Period 4 (3 Days)||0
10685754|NCT02443740|11848987|FG006|NOT COMPLETED|Intervention Period 4 (3 Days)||0
10685755|NCT02443740|11848988|FG007|NOT COMPLETED|Intervention Period 4 (3 Days)||0
10685756|NCT02443740|11848989|FG008|NOT COMPLETED|Intervention Period 4 (3 Days)||0
10685757|NCT02443740|11848990|FG009|NOT COMPLETED|Intervention Period 4 (3 Days)||0
10685758|NCT02443740|11848991|FG010|NOT COMPLETED|Intervention Period 4 (3 Days)||0
10685759|NCT02443792|11849023|FG000|STARTED|Overall Study||50
10685760|NCT02443792|11849024|FG001|STARTED|Overall Study||25
10685761|NCT02443792|11849023|FG000|COMPLETED|Overall Study||43
10685762|NCT02443792|11849024|FG001|COMPLETED|Overall Study||23
10685763|NCT02443792|11849023|FG000|NOT COMPLETED|Overall Study||7
10685764|NCT02443792|11849024|FG001|NOT COMPLETED|Overall Study||2
10800089|NCT04501952|11960966|FG001|NOT COMPLETED|Overall Study||20
10800090|NCT04504032|11960975|FG000|STARTED|Overall Study||246
10800091|NCT04504032|11960976|FG001|STARTED|Overall Study||251
10800092|NCT04504032|11960975|FG000|COMPLETED|Overall Study||210
10800093|NCT04504032|11960976|FG001|COMPLETED|Overall Study||223
10800094|NCT04504032|11960975|FG000|NOT COMPLETED|Overall Study||36
10685765|NCT02443805|11849032|FG000|STARTED|Overall Study||802
10685766|NCT02443805|11849033|FG001|STARTED|Overall Study||805
10685767|NCT02443805|11849032|FG000|COMPLETED|Overall Study||589
10685768|NCT02443805|11849033|FG001|COMPLETED|Overall Study||678
10685769|NCT02443805|11849032|FG000|NOT COMPLETED|Overall Study||213
10685770|NCT02443805|11849033|FG001|NOT COMPLETED|Overall Study||127
10685771|NCT02443883|11849043|FG000|STARTED|Overall Study||40
10685772|NCT02443883|11849044|FG001|STARTED|Overall Study||42
10685773|NCT02443883|11849045|FG002|STARTED|Overall Study||41
10685774|NCT02443883|11849046|FG003|STARTED|Overall Study||41
10685775|NCT02443883|11849043|FG000|Received at Least One Dose of Study Drug|Overall Study||38
10685776|NCT02443883|11849044|FG001|Received at Least One Dose of Study Drug|Overall Study||42
10685777|NCT02443883|11849045|FG002|Received at Least One Dose of Study Drug|Overall Study||41
10685778|NCT02443883|11849046|FG003|Received at Least One Dose of Study Drug|Overall Study||40
10685779|NCT02443883|11849043|FG000|COMPLETED|Overall Study||34
10685780|NCT02443883|11849044|FG001|COMPLETED|Overall Study||38
10685781|NCT02443883|11849045|FG002|COMPLETED|Overall Study||40
10685782|NCT02443883|11849046|FG003|COMPLETED|Overall Study||36
10685783|NCT02443883|11849043|FG000|NOT COMPLETED|Overall Study||6
10685784|NCT02443883|11849044|FG001|NOT COMPLETED|Overall Study||4
10685785|NCT02443883|11849045|FG002|NOT COMPLETED|Overall Study||1
10685786|NCT02443883|11849046|FG003|NOT COMPLETED|Overall Study||5
10685787|NCT02444143|11849058|FG000|STARTED|Overall Study||10
10685788|NCT02444143|11849059|FG001|STARTED|Overall Study||10
10685789|NCT02444143|11849058|FG000|COMPLETED|Overall Study||10
10685790|NCT02444143|11849059|FG001|COMPLETED|Overall Study|1 patient withdrawal|9
10685791|NCT02444143|11849058|FG000|NOT COMPLETED|Overall Study||0
10685792|NCT02444143|11849059|FG001|NOT COMPLETED|Overall Study||1
10685793|NCT02444182|11849069|FG000|STARTED|Overall Study||54
10685794|NCT02444182|11849070|FG001|STARTED|Overall Study||54
10685795|NCT02444182|11849069|FG000|COMPLETED|Overall Study||52
10685796|NCT02444182|11849070|FG001|COMPLETED|Overall Study||49
10685797|NCT02444182|11849069|FG000|NOT COMPLETED|Overall Study||2
10685798|NCT02444182|11849070|FG001|NOT COMPLETED|Overall Study||5
10685799|NCT02444234|11849076|FG000|STARTED|First Intervention (3 Days)||6
10685800|NCT02444234|11849077|FG001|STARTED|First Intervention (3 Days)||5
10685801|NCT02444234|11849076|FG000|COMPLETED|First Intervention (3 Days)||6
10685802|NCT02444234|11849077|FG001|COMPLETED|First Intervention (3 Days)||5
10685803|NCT02444234|11849076|FG000|NOT COMPLETED|First Intervention (3 Days)||0
10685804|NCT02444234|11849077|FG001|NOT COMPLETED|First Intervention (3 Days)||0
10685805|NCT02444234|11849076|FG000|STARTED|Washout (2 Day Minimum)||6
10685806|NCT02444234|11849077|FG001|STARTED|Washout (2 Day Minimum)||5
10685807|NCT02444234|11849076|FG000|COMPLETED|Washout (2 Day Minimum)||6
10685808|NCT02444234|11849077|FG001|COMPLETED|Washout (2 Day Minimum)||5
10685809|NCT02444234|11849076|FG000|NOT COMPLETED|Washout (2 Day Minimum)||0
10685810|NCT02444234|11849077|FG001|NOT COMPLETED|Washout (2 Day Minimum)||0
10685811|NCT02444234|11849076|FG000|STARTED|Second Intervention (3 Days)||6
10685812|NCT02444234|11849077|FG001|STARTED|Second Intervention (3 Days)||5
10685813|NCT02444234|11849076|FG000|COMPLETED|Second Intervention (3 Days)||6
10685814|NCT02444234|11849077|FG001|COMPLETED|Second Intervention (3 Days)||5
10685815|NCT02444234|11849076|FG000|NOT COMPLETED|Second Intervention (3 Days)||0
10685816|NCT02444234|11849077|FG001|NOT COMPLETED|Second Intervention (3 Days)||0
10685817|NCT02444533|11849087|FG000|STARTED|Overall Study||17
10685818|NCT02444533|11849088|FG001|STARTED|Overall Study||22
10685819|NCT02444533|11849087|FG000|COMPLETED|Overall Study||15
10685820|NCT02444533|11849088|FG001|COMPLETED|Overall Study||18
10685821|NCT02444533|11849087|FG000|NOT COMPLETED|Overall Study||2
10685822|NCT02444533|11849088|FG001|NOT COMPLETED|Overall Study||4
10685823|NCT02444663|11849094|FG000|STARTED|Clinician Valgus||9
10685824|NCT02444663|11849094|FG000|COMPLETED|Clinician Valgus||9
10685825|NCT02444663|11849094|FG000|NOT COMPLETED|Clinician Valgus||0
10685826|NCT02444663|11849094|FG000|STARTED|Clinician Varus||9
10685827|NCT02444663|11849094|FG000|COMPLETED|Clinician Varus||9
10685828|NCT02444663|11849094|FG000|NOT COMPLETED|Clinician Varus||0
10685829|NCT02444663|11849094|FG000|STARTED|Device Valgus 0N||9
10685830|NCT02444663|11849094|FG000|COMPLETED|Device Valgus 0N||9
10685831|NCT02444663|11849094|FG000|NOT COMPLETED|Device Valgus 0N||0
10685832|NCT02444663|11849094|FG000|STARTED|Device Valgus 10N||9
10685833|NCT02444663|11849094|FG000|COMPLETED|Device Valgus 10N||9
10685834|NCT02444663|11849094|FG000|NOT COMPLETED|Device Valgus 10N||0
10685835|NCT02444663|11849094|FG000|STARTED|Device Valgus 20N||9
10685836|NCT02444663|11849094|FG000|COMPLETED|Device Valgus 20N||9
10685837|NCT02444663|11849094|FG000|NOT COMPLETED|Device Valgus 20N||0
10685838|NCT02444663|11849094|FG000|STARTED|Device Valgus 30N||9
10685839|NCT02444663|11849094|FG000|COMPLETED|Device Valgus 30N||9
10685840|NCT02444663|11849094|FG000|NOT COMPLETED|Device Valgus 30N||0
10685841|NCT02444663|11849094|FG000|STARTED|Device Varus 0N||9
10685842|NCT02444663|11849094|FG000|COMPLETED|Device Varus 0N||9
10685843|NCT02444663|11849094|FG000|NOT COMPLETED|Device Varus 0N||0
10685844|NCT02444663|11849094|FG000|STARTED|Device Varus 10N||9
10685845|NCT02444663|11849094|FG000|COMPLETED|Device Varus 10N||9
10685846|NCT02444663|11849094|FG000|NOT COMPLETED|Device Varus 10N||0
10685847|NCT02444663|11849094|FG000|STARTED|Device Varus 20N||9
10685848|NCT02444663|11849094|FG000|COMPLETED|Device Varus 20N||9
10685849|NCT02444663|11849094|FG000|NOT COMPLETED|Device Varus 20N||0
10685850|NCT02444663|11849094|FG000|STARTED|Device Varus 30N||9
10685851|NCT02444663|11849094|FG000|COMPLETED|Device Varus 30N||9
10685852|NCT02444663|11849094|FG000|NOT COMPLETED|Device Varus 30N||0
10685853|NCT02444715|11849118|FG000|STARTED|Overall Study||46
10685854|NCT02444715|11849119|FG001|STARTED|Overall Study||48
10685855|NCT02444715|11849118|FG000|COMPLETED|Overall Study||36
10685856|NCT02444715|11849119|FG001|COMPLETED|Overall Study||32
10685857|NCT02444715|11849118|FG000|NOT COMPLETED|Overall Study||10
10685858|NCT02444715|11849119|FG001|NOT COMPLETED|Overall Study||16
10685859|NCT02444793|11849130|FG000|STARTED|Overall Study||11
10685860|NCT02444793|11849131|FG001|STARTED|Overall Study||6
10685861|NCT02444793|11849132|FG002|STARTED|Overall Study||4
10685862|NCT02444793|11849133|FG003|STARTED|Overall Study||3
10685863|NCT02444793|11849130|FG000|COMPLETED|Overall Study||0
10685864|NCT02444793|11849131|FG001|COMPLETED|Overall Study||0
10685865|NCT02444793|11849132|FG002|COMPLETED|Overall Study||0
10685866|NCT02444793|11849133|FG003|COMPLETED|Overall Study||0
10685867|NCT02444793|11849130|FG000|NOT COMPLETED|Overall Study||11
10685868|NCT02444793|11849131|FG001|NOT COMPLETED|Overall Study||6
10685869|NCT02444793|11849132|FG002|NOT COMPLETED|Overall Study||4
10685870|NCT02444793|11849133|FG003|NOT COMPLETED|Overall Study||3
10685871|NCT02444936|11849146|FG000|STARTED|Overall Study||10
10685872|NCT02444936|11849147|FG001|STARTED|Overall Study||12
10685873|NCT02444936|11849146|FG000|COMPLETED|Overall Study||10
10685874|NCT02444936|11849147|FG001|COMPLETED|Overall Study||12
10685875|NCT02444936|11849146|FG000|NOT COMPLETED|Overall Study||0
10685876|NCT02444936|11849147|FG001|NOT COMPLETED|Overall Study||0
10685877|NCT02444988|11849155|FG000|STARTED|Overall Study||2646
10685878|NCT02444988|11849156|FG001|STARTED|Overall Study||2735
10685879|NCT02444988|11849155|FG000|COMPLETED|Overall Study||2646
10685880|NCT02444988|11849156|FG001|COMPLETED|Overall Study||2735
10685881|NCT02444988|11849155|FG000|NOT COMPLETED|Overall Study||0
10685882|NCT02444988|11849156|FG001|NOT COMPLETED|Overall Study||0
10685883|NCT02445014|11849162|FG000|STARTED|Overall Study||3
10685884|NCT02445014|11849162|FG000|COMPLETED|Overall Study||3
10685885|NCT02445014|11849162|FG000|NOT COMPLETED|Overall Study||0
10685886|NCT02445027|11849166|FG000|STARTED|Overall Study||60
10685887|NCT02445027|11849166|FG000|COMPLETED|Overall Study||45
10685888|NCT02445027|11849166|FG000|NOT COMPLETED|Overall Study||15
10685889|NCT02445196|11849172|FG000|STARTED|Overall Study||62
10685890|NCT02445196|11849173|FG001|STARTED|Overall Study||58
10685891|NCT02445196|11849172|FG000|COMPLETED|Overall Study||51
10685892|NCT02445196|11849173|FG001|COMPLETED|Overall Study||52
10685893|NCT02445196|11849172|FG000|NOT COMPLETED|Overall Study||11
10685894|NCT02445196|11849173|FG001|NOT COMPLETED|Overall Study||6
10685895|NCT02445287|11849181|FG000|STARTED|Overall Study||35
10685896|NCT02445287|11849182|FG001|STARTED|Overall Study||13
10685897|NCT02445287|11849181|FG000|COMPLETED|Overall Study||35
10685898|NCT02445287|11849182|FG001|COMPLETED|Overall Study||13
10685899|NCT02445287|11849181|FG000|NOT COMPLETED|Overall Study||0
10685900|NCT02445287|11849182|FG001|NOT COMPLETED|Overall Study||0
10685901|NCT02445326|11849195|FG000|STARTED|Overall Study||35
10685902|NCT02445326|11849196|FG001|STARTED|Overall Study||38
10685903|NCT02445326|11849195|FG000|COMPLETED|Overall Study||33
10685904|NCT02445326|11849196|FG001|COMPLETED|Overall Study||37
10685905|NCT02445326|11849195|FG000|NOT COMPLETED|Overall Study||2
10685906|NCT02445326|11849196|FG001|NOT COMPLETED|Overall Study||1
10685907|NCT02445573|11849204|FG000|STARTED|Overall Study||40
10685908|NCT02445573|11849205|FG001|STARTED|Overall Study||40
10685909|NCT02445573|11849204|FG000|COMPLETED|Overall Study||39
10685910|NCT02445573|11849205|FG001|COMPLETED|Overall Study||38
10685911|NCT02445573|11849204|FG000|NOT COMPLETED|Overall Study||1
10685912|NCT02445573|11849205|FG001|NOT COMPLETED|Overall Study||2
10685913|NCT02445586|11849211|FG000|STARTED|Overall Study||52
10685914|NCT02445586|11849211|FG000|Received at Least One Dose of Study Drug|Overall Study||52
10685915|NCT02445586|11849211|FG000|COMPLETED|Overall Study||13
10685916|NCT02445586|11849211|FG000|NOT COMPLETED|Overall Study||39
10685917|NCT02445625|11849215|FG000|STARTED|Overall Study||15
10685918|NCT02445625|11849215|FG000|COMPLETED|Overall Study||15
10685919|NCT02445625|11849215|FG000|NOT COMPLETED|Overall Study||0
10685920|NCT02445755|11849220|FG000|STARTED|Overall Study|Neonates will be tested with 3 transcutaneous (TcB) devices +/-30 minutes of routine bilirubin labs|113
10685921|NCT02445755|11849220|FG000|COMPLETED|Overall Study||100
10685922|NCT02445755|11849220|FG000|NOT COMPLETED|Overall Study||13
10685923|NCT02445794|11849231|FG000|STARTED|Overall Study||6
10685924|NCT02445794|11849232|FG001|STARTED|Overall Study||3
10685925|NCT02445794|11849233|FG002|STARTED|Overall Study||7
10685926|NCT02445794|11849234|FG003|STARTED|Overall Study||3
10685927|NCT02445794|11849231|FG000|COMPLETED|Overall Study||6
10685928|NCT02445794|11849232|FG001|COMPLETED|Overall Study||3
10685929|NCT02445794|11849233|FG002|COMPLETED|Overall Study||5
10685930|NCT02445794|11849234|FG003|COMPLETED|Overall Study||3
10685931|NCT02445794|11849231|FG000|NOT COMPLETED|Overall Study||0
10685932|NCT02445794|11849232|FG001|NOT COMPLETED|Overall Study||0
10685933|NCT02445794|11849233|FG002|NOT COMPLETED|Overall Study||2
10685934|NCT02445794|11849234|FG003|NOT COMPLETED|Overall Study||0
10685935|NCT02445807|11849251|FG000|STARTED|Overall Study||176
10685936|NCT02445807|11849252|FG001|STARTED|Overall Study||89
10685937|NCT02445807|11849251|FG000|COMPLETED|Overall Study||176
10685938|NCT02445807|11849252|FG001|COMPLETED|Overall Study||89
10685939|NCT02445807|11849251|FG000|NOT COMPLETED|Overall Study||0
10685940|NCT02445807|11849252|FG001|NOT COMPLETED|Overall Study||0
10685941|NCT02445859|11849260|FG000|STARTED|Overall Study||45
10685942|NCT02445859|11849261|FG001|STARTED|Overall Study||45
10685943|NCT02445859|11849260|FG000|COMPLETED|Overall Study||43
10685944|NCT02445859|11849261|FG001|COMPLETED|Overall Study||42
10685945|NCT02445859|11849260|FG000|NOT COMPLETED|Overall Study||2
10685946|NCT02445859|11849261|FG001|NOT COMPLETED|Overall Study||3
10685947|NCT02445911|11849271|FG000|STARTED|Overall Study||20
10685948|NCT02445911|11849272|FG001|STARTED|Overall Study||20
10685949|NCT02445911|11849273|FG002|STARTED|Overall Study||21
10685950|NCT02445911|11849274|FG003|STARTED|Overall Study||20
10685951|NCT02445911|11849271|FG000|COMPLETED|Overall Study||20
10685952|NCT02445911|11849272|FG001|COMPLETED|Overall Study||20
10685953|NCT02445911|11849273|FG002|COMPLETED|Overall Study||21
10685954|NCT02445911|11849274|FG003|COMPLETED|Overall Study||20
10685955|NCT02445911|11849271|FG000|NOT COMPLETED|Overall Study||0
10685956|NCT02445911|11849272|FG001|NOT COMPLETED|Overall Study||0
10685957|NCT02445911|11849273|FG002|NOT COMPLETED|Overall Study||0
10685958|NCT02445911|11849274|FG003|NOT COMPLETED|Overall Study||0
10685959|NCT02445963|11849288|FG000|STARTED|Overall Study||9
10685960|NCT02445963|11849289|FG001|STARTED|Overall Study||9
10685961|NCT02445963|11849290|FG002|STARTED|Overall Study||10
10685962|NCT02445963|11849291|FG003|STARTED|Overall Study||10
10685963|NCT02445963|11849288|FG000|COMPLETED|Overall Study||7
10685964|NCT02445963|11849289|FG001|COMPLETED|Overall Study||9
10685965|NCT02445963|11849290|FG002|COMPLETED|Overall Study||9
10685966|NCT02445963|11849291|FG003|COMPLETED|Overall Study||10
10685967|NCT02445963|11849288|FG000|NOT COMPLETED|Overall Study||2
10685968|NCT02445963|11849289|FG001|NOT COMPLETED|Overall Study||0
10685969|NCT02445963|11849290|FG002|NOT COMPLETED|Overall Study||1
10685970|NCT02445963|11849291|FG003|NOT COMPLETED|Overall Study||0
10685971|NCT02446015|11849305|FG000|STARTED|Overall Study||34
10685972|NCT02446015|11849306|FG001|STARTED|Overall Study||63
10685973|NCT02446015|11849305|FG000|COMPLETED|Overall Study||33
10685974|NCT02446015|11849306|FG001|COMPLETED|Overall Study||62
10685975|NCT02446015|11849305|FG000|NOT COMPLETED|Overall Study||1
10685976|NCT02446015|11849306|FG001|NOT COMPLETED|Overall Study||1
10685977|NCT02446171|11849317|FG000|STARTED|Overall Study||11
10685978|NCT02446171|11849318|FG001|STARTED|Overall Study||11
10685979|NCT02446171|11849319|FG002|STARTED|Overall Study||11
10685980|NCT02446171|11849320|FG003|STARTED|Overall Study||11
10685981|NCT02446171|11849317|FG000|COMPLETED|Overall Study||11
10685982|NCT02446171|11849318|FG001|COMPLETED|Overall Study||11
10685983|NCT02446171|11849319|FG002|COMPLETED|Overall Study||9
10685984|NCT02446171|11849320|FG003|COMPLETED|Overall Study||11
10685985|NCT02446171|11849317|FG000|NOT COMPLETED|Overall Study||0
10685986|NCT02446171|11849318|FG001|NOT COMPLETED|Overall Study||0
10685987|NCT02446171|11849319|FG002|NOT COMPLETED|Overall Study||2
10685988|NCT02446171|11849320|FG003|NOT COMPLETED|Overall Study||0
10685989|NCT02446223|11849332|FG000|STARTED|Overall Study||21
10685990|NCT02446223|11849332|FG000|COMPLETED|Overall Study||20
10685991|NCT02446223|11849332|FG000|NOT COMPLETED|Overall Study||1
10685992|NCT02446314|11849340|FG000|STARTED|Zero to Twelve Weeks.||30
10685993|NCT02446314|11849341|FG001|STARTED|Zero to Twelve Weeks.||30
10685994|NCT02446314|11849342|FG002|STARTED|Zero to Twelve Weeks.||31
10685995|NCT02446314|11849343|FG003|STARTED|Zero to Twelve Weeks.||31
10685996|NCT02446314|11849340|FG000|COMPLETED|Zero to Twelve Weeks.||27
10685997|NCT02446314|11849341|FG001|COMPLETED|Zero to Twelve Weeks.||29
10685998|NCT02446314|11849342|FG002|COMPLETED|Zero to Twelve Weeks.||31
10685999|NCT02446314|11849343|FG003|COMPLETED|Zero to Twelve Weeks.||29
10686000|NCT02446314|11849340|FG000|NOT COMPLETED|Zero to Twelve Weeks.||3
10686001|NCT02446314|11849341|FG001|NOT COMPLETED|Zero to Twelve Weeks.||1
10686002|NCT02446314|11849342|FG002|NOT COMPLETED|Zero to Twelve Weeks.||0
10686003|NCT02446314|11849343|FG003|NOT COMPLETED|Zero to Twelve Weeks.||2
10686004|NCT02446314|11849340|FG000|STARTED|Thirteen to Twenty Four Weeks||27
10686005|NCT02446314|11849341|FG001|STARTED|Thirteen to Twenty Four Weeks||29
10686006|NCT02446314|11849342|FG002|STARTED|Thirteen to Twenty Four Weeks||31
10686007|NCT02446314|11849343|FG003|STARTED|Thirteen to Twenty Four Weeks||29
10686008|NCT02446314|11849340|FG000|COMPLETED|Thirteen to Twenty Four Weeks||27
10686009|NCT02446314|11849341|FG001|COMPLETED|Thirteen to Twenty Four Weeks||28
10686010|NCT02446314|11849342|FG002|COMPLETED|Thirteen to Twenty Four Weeks||29
10686011|NCT02446314|11849343|FG003|COMPLETED|Thirteen to Twenty Four Weeks||28
10686012|NCT02446314|11849340|FG000|NOT COMPLETED|Thirteen to Twenty Four Weeks||0
10686013|NCT02446314|11849341|FG001|NOT COMPLETED|Thirteen to Twenty Four Weeks||1
10686014|NCT02446314|11849342|FG002|NOT COMPLETED|Thirteen to Twenty Four Weeks||2
10686015|NCT02446314|11849343|FG003|NOT COMPLETED|Thirteen to Twenty Four Weeks||1
10686016|NCT02446418|11849359|FG000|STARTED|Overall Study||210
10686017|NCT02446418|11849360|FG001|STARTED|Overall Study||210
10686018|NCT02446418|11849359|FG000|COMPLETED|Overall Study||192
10686019|NCT02446418|11849360|FG001|COMPLETED|Overall Study||194
10686020|NCT02446418|11849359|FG000|NOT COMPLETED|Overall Study||18
10686021|NCT02446418|11849360|FG001|NOT COMPLETED|Overall Study||16
10686022|NCT02446483|11849366|FG000|STARTED|Period 1: Intervention Period 1||30
10686023|NCT02446483|11849367|FG001|STARTED|Period 1: Intervention Period 1||30
10686024|NCT02446483|11849366|FG000|COMPLETED|Period 1: Intervention Period 1||30
10686025|NCT02446483|11849367|FG001|COMPLETED|Period 1: Intervention Period 1||30
10686026|NCT02446483|11849366|FG000|NOT COMPLETED|Period 1: Intervention Period 1||0
10686027|NCT02446483|11849367|FG001|NOT COMPLETED|Period 1: Intervention Period 1||0
10686028|NCT02446483|11849366|FG000|STARTED|Period 2: Washout Period (7 Days)||30
10686029|NCT02446483|11849367|FG001|STARTED|Period 2: Washout Period (7 Days)||30
10686030|NCT02446483|11849366|FG000|COMPLETED|Period 2: Washout Period (7 Days)||30
10686031|NCT02446483|11849367|FG001|COMPLETED|Period 2: Washout Period (7 Days)||30
10686032|NCT02446483|11849366|FG000|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
10686033|NCT02446483|11849367|FG001|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
10686034|NCT02446483|11849366|FG000|STARTED|Period 3: Intervention Period 2||30
10686035|NCT02446483|11849367|FG001|STARTED|Period 3: Intervention Period 2||30
10686036|NCT02446483|11849366|FG000|COMPLETED|Period 3: Intervention Period 2||30
10686037|NCT02446483|11849367|FG001|COMPLETED|Period 3: Intervention Period 2||30
10686038|NCT02446483|11849366|FG000|NOT COMPLETED|Period 3: Intervention Period 2||0
10686039|NCT02446483|11849367|FG001|NOT COMPLETED|Period 3: Intervention Period 2||0
10686040|NCT02446496|11849373|FG000|STARTED|Overall Study||24
10686041|NCT02446496|11849373|FG000|COMPLETED|Overall Study||24
10686042|NCT02446496|11849373|FG000|NOT COMPLETED|Overall Study||0
10686043|NCT02446613|11849381|FG000|STARTED|Overall Study||6
10686044|NCT02446613|11849382|FG001|STARTED|Overall Study||10
10686045|NCT02446613|11849381|FG000|COMPLETED|Overall Study||6
10686046|NCT02446613|11849382|FG001|COMPLETED|Overall Study||10
10686047|NCT02446613|11849381|FG000|NOT COMPLETED|Overall Study||0
10686048|NCT02446613|11849382|FG001|NOT COMPLETED|Overall Study||0
10686049|NCT02446691|11849392|FG000|STARTED|Overall Study||128
10686050|NCT02446691|11849392|FG000|COMPLETED|Overall Study||117
10686051|NCT02446691|11849392|FG000|NOT COMPLETED|Overall Study||11
10686052|NCT02446717|11849401|FG000|STARTED|Overall Study||6
10686053|NCT02446717|11849402|FG001|STARTED|Overall Study||22
10686054|NCT02446717|11849403|FG002|STARTED|Overall Study||22
10686055|NCT02446717|11849404|FG003|STARTED|Overall Study||44
10686056|NCT02446717|11849405|FG004|STARTED|Overall Study||47
10686057|NCT02446717|11849401|FG000|COMPLETED|Overall Study||6
10686058|NCT02446717|11849402|FG001|COMPLETED|Overall Study||21
10686059|NCT02446717|11849403|FG002|COMPLETED|Overall Study||20
10686060|NCT02446717|11849404|FG003|COMPLETED|Overall Study||43
10686061|NCT02446717|11849405|FG004|COMPLETED|Overall Study||46
10686062|NCT02446717|11849401|FG000|NOT COMPLETED|Overall Study||0
10686063|NCT02446717|11849402|FG001|NOT COMPLETED|Overall Study||1
10686064|NCT02446717|11849403|FG002|NOT COMPLETED|Overall Study||2
10686065|NCT02446717|11849404|FG003|NOT COMPLETED|Overall Study||1
10686066|NCT02446717|11849405|FG004|NOT COMPLETED|Overall Study||1
10686067|NCT02446743|11849419|FG000|STARTED|Overall Study||276
10686068|NCT02446743|11849420|FG001|STARTED|Overall Study||255
10686069|NCT02446743|11849419|FG000|COMPLETED|Overall Study||271
10686070|NCT02446743|11849420|FG001|COMPLETED|Overall Study||250
10686071|NCT02446743|11849419|FG000|NOT COMPLETED|Overall Study||5
10686072|NCT02446743|11849420|FG001|NOT COMPLETED|Overall Study||5
10686073|NCT02446769|11849435|FG000|STARTED|Screening Period||18
10686074|NCT02446769|11849436|FG001|STARTED|Screening Period||0
10686075|NCT02446769|11849437|FG002|STARTED|Screening Period||0
10686076|NCT02446769|11849435|FG000|COMPLETED|Screening Period||7
10686077|NCT02446769|11849436|FG001|COMPLETED|Screening Period||0
10686078|NCT02446769|11849437|FG002|COMPLETED|Screening Period||0
10686079|NCT02446769|11849435|FG000|NOT COMPLETED|Screening Period||11
10686080|NCT02446769|11849436|FG001|NOT COMPLETED|Screening Period||0
10686081|NCT02446769|11849437|FG002|NOT COMPLETED|Screening Period||0
10686082|NCT02446769|11849435|FG000|STARTED|Study Period||0
10686083|NCT02446769|11849436|FG001|STARTED|Study Period||4
10686084|NCT02446769|11849437|FG002|STARTED|Study Period||3
10686085|NCT02446769|11849435|FG000|COMPLETED|Study Period||0
10686086|NCT02446769|11849436|FG001|COMPLETED|Study Period||2
10686087|NCT02446769|11849437|FG002|COMPLETED|Study Period||3
10686088|NCT02446769|11849435|FG000|NOT COMPLETED|Study Period||0
10686089|NCT02446769|11849436|FG001|NOT COMPLETED|Study Period||2
10686090|NCT02446769|11849437|FG002|NOT COMPLETED|Study Period||0
10686091|NCT02446847|11849446|FG000|STARTED|Overall Study||8
10686092|NCT02446847|11849447|FG001|STARTED|Overall Study||8
10686093|NCT02446847|11849446|FG000|COMPLETED|Overall Study||8
10686094|NCT02446847|11849447|FG001|COMPLETED|Overall Study||6
10686095|NCT02446847|11849446|FG000|NOT COMPLETED|Overall Study||0
10686096|NCT02446847|11849447|FG001|NOT COMPLETED|Overall Study||2
10686097|NCT02446886|11849455|FG000|STARTED|Overall Study||8
10686098|NCT02446886|11849456|FG001|STARTED|Overall Study||7
10686099|NCT02446886|11849455|FG000|COMPLETED|Overall Study||6
10686100|NCT02446886|11849456|FG001|COMPLETED|Overall Study||3
10686101|NCT02446886|11849455|FG000|NOT COMPLETED|Overall Study||2
10686102|NCT02446886|11849456|FG001|NOT COMPLETED|Overall Study||4
10686103|NCT02446899|11849465|FG000|STARTED|Overall Study||181
10686104|NCT02446899|11849466|FG001|STARTED|Overall Study||184
10686105|NCT02446899|11849465|FG000|Received Study Drug|Overall Study||180
10686106|NCT02446899|11849466|FG001|Received Study Drug|Overall Study||182
10686107|NCT02446899|11849465|FG000|COMPLETED|Overall Study||156
10686108|NCT02446899|11849466|FG001|COMPLETED|Overall Study||136
10686109|NCT02446899|11849465|FG000|NOT COMPLETED|Overall Study||25
10686110|NCT02446899|11849466|FG001|NOT COMPLETED|Overall Study||48
10686111|NCT02446912|11849475|FG000|STARTED|Overall Study||93
10686112|NCT02446912|11849476|FG001|STARTED|Overall Study||180
10686113|NCT02446912|11849477|FG002|STARTED|Overall Study||184
10686114|NCT02446912|11849475|FG000|Participants Who Completed Week 52|Overall Study||80
10686115|NCT02446912|11849476|FG001|Participants Who Completed Week 52|Overall Study||153
10686116|NCT02446912|11849477|FG002|Participants Who Completed Week 52|Overall Study||157
10686117|NCT02446912|11849475|FG000|COMPLETED|Overall Study||75
10686118|NCT02446912|11849476|FG001|COMPLETED|Overall Study||145
10686119|NCT02446912|11849477|FG002|COMPLETED|Overall Study||149
10686120|NCT02446912|11849475|FG000|NOT COMPLETED|Overall Study||18
10686121|NCT02446912|11849476|FG001|NOT COMPLETED|Overall Study||35
10686122|NCT02446912|11849477|FG002|NOT COMPLETED|Overall Study||35
10686123|NCT02446990|11849487|FG000|STARTED|Overall Study||9550
10686124|NCT02446990|11849488|FG001|STARTED|Overall Study||9552
10686125|NCT02446990|11849487|FG000|COMPLETED|Overall Study||8830
10686126|NCT02446990|11849488|FG001|COMPLETED|Overall Study||8894
10686127|NCT02446990|11849487|FG000|NOT COMPLETED|Overall Study||720
10686128|NCT02446990|11849488|FG001|NOT COMPLETED|Overall Study||658
10686129|NCT02447003|11849496|FG000|STARTED|Overall Study||170
10686130|NCT02447003|11849497|FG001|STARTED|Overall Study||84
10686131|NCT02447003|11849496|FG000|COMPLETED|Overall Study||0
10686132|NCT02447003|11849497|FG001|COMPLETED|Overall Study||0
10686133|NCT02447003|11849496|FG000|NOT COMPLETED|Overall Study||170
10686134|NCT02447003|11849497|FG001|NOT COMPLETED|Overall Study||84
10686135|NCT02447029|11849507|FG000|STARTED|Overall Study||72
10686136|NCT02447029|11849508|FG001|STARTED|Overall Study||70
10686137|NCT02447029|11849507|FG000|Treated|Overall Study||69
10686138|NCT02447029|11849508|FG001|Treated|Overall Study||68
10686139|NCT02447029|11849507|FG000|COMPLETED|Overall Study||69
10686140|NCT02447029|11849508|FG001|COMPLETED|Overall Study||68
10686141|NCT02447029|11849507|FG000|NOT COMPLETED|Overall Study||3
10686142|NCT02447029|11849508|FG001|NOT COMPLETED|Overall Study||2
10686143|NCT02447081|11849514|FG000|STARTED|Overall Study||1088
10686144|NCT02447081|11849514|FG000|COMPLETED|Overall Study||864
10686145|NCT02447081|11849514|FG000|NOT COMPLETED|Overall Study||224
10686146|NCT02447172|11849521|FG000|STARTED|Overall Study||262
10686147|NCT02447172|11849522|FG001|STARTED|Overall Study||130
10686148|NCT02447172|11849523|FG002|STARTED|Overall Study||132
10686149|NCT02447172|11849521|FG000|COMPLETED|Overall Study||231
10686150|NCT02447172|11849522|FG001|COMPLETED|Overall Study||115
10686151|NCT02447172|11849523|FG002|COMPLETED|Overall Study||114
10686152|NCT02447172|11849521|FG000|NOT COMPLETED|Overall Study||31
10686153|NCT02447172|11849522|FG001|NOT COMPLETED|Overall Study||15
10686154|NCT02447172|11849523|FG002|NOT COMPLETED|Overall Study||18
10686155|NCT02447250|11849531|FG000|STARTED|First Dose (180 mcg Albuterol)||14
10686156|NCT02447250|11849531|FG000|COMPLETED|First Dose (180 mcg Albuterol)||14
10686157|NCT02447250|11849531|FG000|NOT COMPLETED|First Dose (180 mcg Albuterol)||0
10686158|NCT02447250|11849531|FG000|STARTED|Second Dose (270 mcg Albuterol)||14
10686159|NCT02447250|11849531|FG000|COMPLETED|Second Dose (270 mcg Albuterol)||13
10686160|NCT02447250|11849531|FG000|NOT COMPLETED|Second Dose (270 mcg Albuterol)||1
10686161|NCT02447250|11849531|FG000|STARTED|Third Dose (360 mcg Albuterol)||13
10686162|NCT02447250|11849531|FG000|COMPLETED|Third Dose (360 mcg Albuterol)||8
10686163|NCT02447250|11849531|FG000|NOT COMPLETED|Third Dose (360 mcg Albuterol)||5
10686164|NCT02447302|11849539|FG000|STARTED|Overall Study||52
10686165|NCT02447302|11849540|FG001|STARTED|Overall Study||50
10686166|NCT02447302|11849541|FG002|STARTED|Overall Study||54
10686167|NCT02447302|11849539|FG000|COMPLETED|Overall Study||47
10686168|NCT02447302|11849540|FG001|COMPLETED|Overall Study||46
10686169|NCT02447302|11849541|FG002|COMPLETED|Overall Study||48
10686170|NCT02447302|11849539|FG000|NOT COMPLETED|Overall Study||5
10686171|NCT02447302|11849540|FG001|NOT COMPLETED|Overall Study||4
10686172|NCT02447302|11849541|FG002|NOT COMPLETED|Overall Study||6
10686173|NCT02447328|11849549|FG000|STARTED|Overall Study|Enrolment 85 Screening Failure 2 starting study drug 83|83
10686174|NCT02447328|11849549|FG000|COMPLETED|Overall Study||82
10686175|NCT02447328|11849549|FG000|NOT COMPLETED|Overall Study||1
10686176|NCT02447432|11849555|FG000|STARTED|Epoch 001||160
10686177|NCT02447432|11849556|FG001|STARTED|Epoch 001||160
10686178|NCT02447432|11849555|FG000|COMPLETED|Epoch 001||155
10686179|NCT02447432|11849556|FG001|COMPLETED|Epoch 001||147
10686180|NCT02447432|11849555|FG000|NOT COMPLETED|Epoch 001||5
10686181|NCT02447432|11849556|FG001|NOT COMPLETED|Epoch 001||13
10686182|NCT02447432|11849555|FG000|STARTED|Epoch 002||152
10686183|NCT02447432|11849556|FG001|STARTED|Epoch 002||145
10686184|NCT02447432|11849555|FG000|COMPLETED|Epoch 002||152
10686185|NCT02447432|11849556|FG001|COMPLETED|Epoch 002||145
10686186|NCT02447432|11849555|FG000|NOT COMPLETED|Epoch 002||0
10686187|NCT02447432|11849556|FG001|NOT COMPLETED|Epoch 002||0
10686188|NCT02447458|11849568|FG000|STARTED|Overall Study||5
10686189|NCT02447458|11849569|FG001|STARTED|Overall Study||6
10686190|NCT02447458|11849570|FG002|STARTED|Overall Study||6
10686191|NCT02447458|11849571|FG003|STARTED|Overall Study||6
10686192|NCT02447458|11849572|FG004|STARTED|Overall Study||6
10686193|NCT02447458|11849573|FG005|STARTED|Overall Study||10
10686194|NCT02447458|11849568|FG000|COMPLETED|Overall Study||5
10686195|NCT02447458|11849569|FG001|COMPLETED|Overall Study||6
10686196|NCT02447458|11849570|FG002|COMPLETED|Overall Study||5
10686197|NCT02447458|11849571|FG003|COMPLETED|Overall Study||6
10686198|NCT02447458|11849572|FG004|COMPLETED|Overall Study||6
10686199|NCT02447458|11849573|FG005|COMPLETED|Overall Study||10
10686200|NCT02447458|11849568|FG000|NOT COMPLETED|Overall Study||0
10686201|NCT02447458|11849569|FG001|NOT COMPLETED|Overall Study||0
10686202|NCT02447458|11849570|FG002|NOT COMPLETED|Overall Study||1
10686203|NCT02447458|11849571|FG003|NOT COMPLETED|Overall Study||0
10686204|NCT02447458|11849572|FG004|NOT COMPLETED|Overall Study||0
10686205|NCT02447458|11849573|FG005|NOT COMPLETED|Overall Study||0
10686206|NCT02447497|11849596|FG000|STARTED|Overall Study||25
10686207|NCT02447497|11849597|FG001|STARTED|Overall Study||25
10686208|NCT02447497|11849598|FG002|STARTED|Overall Study||23
10686209|NCT02447497|11849599|FG003|STARTED|Overall Study||23
10686210|NCT02447497|11849596|FG000|COMPLETED|Overall Study||19
10686211|NCT02447497|11849597|FG001|COMPLETED|Overall Study||19
10686212|NCT02447497|11849598|FG002|COMPLETED|Overall Study||21
10686213|NCT02447497|11849599|FG003|COMPLETED|Overall Study||21
10686214|NCT02447497|11849596|FG000|NOT COMPLETED|Overall Study||6
10686215|NCT02447497|11849597|FG001|NOT COMPLETED|Overall Study||6
10686216|NCT02447497|11849598|FG002|NOT COMPLETED|Overall Study||2
10686217|NCT02447497|11849599|FG003|NOT COMPLETED|Overall Study||2
10686218|NCT02447575|11849617|FG000|STARTED|Overall Study|23 subjects were enrolled in the study: http://dx.doi.org/10.1016/j.chest.2016.08.017|23
10686219|NCT02447575|11849617|FG000|COMPLETED|Overall Study||23
10686220|NCT02447575|11849617|FG000|NOT COMPLETED|Overall Study||0
10686221|NCT02447744|11849623|FG000|STARTED|Overall Study|6 subjects are enrolled in the mindfulness program after serving on the waiting list control group|21
10686222|NCT02447744|11849624|FG001|STARTED|Overall Study||22
10686223|NCT02447744|11849623|FG000|COMPLETED|Overall Study||15
10686224|NCT02447744|11849624|FG001|COMPLETED|Overall Study||21
10686225|NCT02447744|11849623|FG000|NOT COMPLETED|Overall Study||6
10686226|NCT02447744|11849624|FG001|NOT COMPLETED|Overall Study||1
10686227|NCT02447848|11849630|FG000|STARTED|Overall Study||76
10686228|NCT02447848|11849630|FG000|COMPLETED|Overall Study||65
10686229|NCT02447848|11849630|FG000|NOT COMPLETED|Overall Study||11
10686230|NCT02447926|11849634|FG000|STARTED|Overall Study||1
10686231|NCT02447926|11849634|FG000|COMPLETED|Overall Study||1
10686232|NCT02447926|11849634|FG000|NOT COMPLETED|Overall Study||0
10686233|NCT02447952|11849638|FG000|STARTED|Overall Study||25
10686234|NCT02447952|11849638|FG000|COMPLETED|Overall Study||18
10686235|NCT02447952|11849638|FG000|NOT COMPLETED|Overall Study||7
10686236|NCT02447991|11849644|FG000|STARTED|Overall Study||45
10686237|NCT02447991|11849645|FG001|STARTED|Overall Study||89
10686238|NCT02447991|11849644|FG000|COMPLETED|Overall Study||35
10686239|NCT02447991|11849645|FG001|COMPLETED|Overall Study||59
10686240|NCT02447991|11849644|FG000|NOT COMPLETED|Overall Study||10
10686241|NCT02447991|11849645|FG001|NOT COMPLETED|Overall Study||30
10686242|NCT02448043|11849657|FG000|STARTED|Overall Study||23
10686243|NCT02448043|11849658|FG001|STARTED|Overall Study||22
10686244|NCT02448043|11849657|FG000|COMPLETED|Overall Study||20
10686245|NCT02448043|11849658|FG001|COMPLETED|Overall Study||18
10686246|NCT02448043|11849657|FG000|NOT COMPLETED|Overall Study||3
10686247|NCT02448043|11849658|FG001|NOT COMPLETED|Overall Study||4
10686248|NCT02448303|11849669|FG000|STARTED|Overall Study||38
10686249|NCT02448303|11849670|FG001|STARTED|Overall Study||36
10686250|NCT02448303|11849669|FG000|Enrolled|Overall Study||38
10686251|NCT02448303|11849670|FG001|Enrolled|Overall Study||36
10686252|NCT02448303|11849669|FG000|Received Study Medication|Overall Study||33
10686253|NCT02448303|11849670|FG001|Received Study Medication|Overall Study||35
10686254|NCT02448303|11849669|FG000|Discontinued Study|Overall Study||38
10686255|NCT02448303|11849670|FG001|Discontinued Study|Overall Study||36
10686256|NCT02448303|11849669|FG000|COMPLETED|Overall Study||0
10686257|NCT02448303|11849670|FG001|COMPLETED|Overall Study||0
10686258|NCT02448303|11849669|FG000|NOT COMPLETED|Overall Study||38
10686259|NCT02448303|11849670|FG001|NOT COMPLETED|Overall Study||36
10686260|NCT02448368|11849678|FG000|STARTED|Overall Study||2
10686261|NCT02448368|11849679|FG001|STARTED|Overall Study||2
10686262|NCT02448368|11849680|FG002|STARTED|Overall Study||2
10686263|NCT02448368|11849681|FG003|STARTED|Overall Study||2
10574618|NCT01679301|11729878|FG000|STARTED|Study Period||0
10574619|NCT01679301|11729879|FG001|STARTED|Study Period||4
10574620|NCT01679301|11729880|FG002|STARTED|Study Period||4
10686264|NCT02448368|11849682|FG004|STARTED|Overall Study||2
10686265|NCT02448368|11849683|FG005|STARTED|Overall Study||2
10686266|NCT02448368|11849684|FG006|STARTED|Overall Study||2
10686267|NCT02448368|11849685|FG007|STARTED|Overall Study||2
10686268|NCT02448368|11849686|FG008|STARTED|Overall Study||2
10686269|NCT02448368|11849687|FG009|STARTED|Overall Study||2
10686270|NCT02448368|11849688|FG010|STARTED|Overall Study||5
10686271|NCT02448368|11849689|FG011|STARTED|Overall Study||5
10686272|NCT02448368|11849690|FG012|STARTED|Overall Study||5
10686273|NCT02448368|11849678|FG000|COMPLETED|Overall Study||2
10686274|NCT02448368|11849679|FG001|COMPLETED|Overall Study||2
10686275|NCT02448368|11849680|FG002|COMPLETED|Overall Study||2
10686276|NCT02448368|11849681|FG003|COMPLETED|Overall Study||2
10686277|NCT02448368|11849682|FG004|COMPLETED|Overall Study||2
10686278|NCT02448368|11849683|FG005|COMPLETED|Overall Study||2
10686279|NCT02448368|11849684|FG006|COMPLETED|Overall Study||2
10686280|NCT02448368|11849685|FG007|COMPLETED|Overall Study||2
10686281|NCT02448368|11849686|FG008|COMPLETED|Overall Study||2
10686282|NCT02448368|11849687|FG009|COMPLETED|Overall Study||2
10686283|NCT02448368|11849688|FG010|COMPLETED|Overall Study||5
10686284|NCT02448368|11849689|FG011|COMPLETED|Overall Study||5
10686285|NCT02448368|11849690|FG012|COMPLETED|Overall Study||5
10686286|NCT02448368|11849678|FG000|NOT COMPLETED|Overall Study||0
10686287|NCT02448368|11849679|FG001|NOT COMPLETED|Overall Study||0
10800095|NCT04504032|11960976|FG001|NOT COMPLETED|Overall Study||28
10800096|NCT04507763|11960982|FG000|STARTED|Overall Study||763
10800097|NCT04507763|11960982|FG000|COMPLETED|Overall Study||562
10686288|NCT02448368|11849680|FG002|NOT COMPLETED|Overall Study||0
10686289|NCT02448368|11849681|FG003|NOT COMPLETED|Overall Study||0
10686290|NCT02448368|11849682|FG004|NOT COMPLETED|Overall Study||0
10686291|NCT02448368|11849683|FG005|NOT COMPLETED|Overall Study||0
10686292|NCT02448368|11849684|FG006|NOT COMPLETED|Overall Study||0
10686293|NCT02448368|11849685|FG007|NOT COMPLETED|Overall Study||0
10686294|NCT02448368|11849686|FG008|NOT COMPLETED|Overall Study||0
10686295|NCT02448368|11849687|FG009|NOT COMPLETED|Overall Study||0
10686296|NCT02448368|11849688|FG010|NOT COMPLETED|Overall Study||0
10686297|NCT02448368|11849689|FG011|NOT COMPLETED|Overall Study||0
10686298|NCT02448368|11849690|FG012|NOT COMPLETED|Overall Study||0
10686299|NCT02448446|11849717|FG000|STARTED|Overall Study||13
10686300|NCT02448446|11849718|FG001|STARTED|Overall Study||12
10686301|NCT02448446|11849717|FG000|COMPLETED|Overall Study||12
10686302|NCT02448446|11849718|FG001|COMPLETED|Overall Study||12
10686303|NCT02448446|11849717|FG000|NOT COMPLETED|Overall Study||1
10686304|NCT02448446|11849718|FG001|NOT COMPLETED|Overall Study||0
10686305|NCT02448537|11849727|FG000|STARTED|Overall Study||20
10686306|NCT02448537|11849728|FG001|STARTED|Overall Study||10
10686307|NCT02448537|11849729|FG002|STARTED|Overall Study||12
10686308|NCT02448537|11849727|FG000|COMPLETED|Overall Study||19
10686309|NCT02448537|11849728|FG001|COMPLETED|Overall Study||9
10686310|NCT02448537|11849729|FG002|COMPLETED|Overall Study||11
10686311|NCT02448537|11849727|FG000|NOT COMPLETED|Overall Study||1
10686312|NCT02448537|11849728|FG001|NOT COMPLETED|Overall Study||1
10686313|NCT02448537|11849729|FG002|NOT COMPLETED|Overall Study||1
10686314|NCT02448563|11849741|FG000|STARTED|Overall Study|Randomized after completing Visit 2|32
10686315|NCT02448563|11849742|FG001|STARTED|Overall Study|Randomized after completing Visit 2|30
10686316|NCT02448563|11849741|FG000|COMPLETED|Overall Study||16
10686317|NCT02448563|11849742|FG001|COMPLETED|Overall Study||19
10686318|NCT02448563|11849741|FG000|NOT COMPLETED|Overall Study||16
10686319|NCT02448563|11849742|FG001|NOT COMPLETED|Overall Study||11
10713105|NCT02677116|11878647|FG003|COMPLETED|Overall Study||7
10713106|NCT02677116|11878648|FG004|COMPLETED|Overall Study||0
10713107|NCT02677116|11878649|FG005|COMPLETED|Overall Study||9
10713108|NCT02677116|11878650|FG006|COMPLETED|Overall Study||2
10713109|NCT02677116|11878651|FG007|COMPLETED|Overall Study||2
10800098|NCT04507763|11960982|FG000|NOT COMPLETED|Overall Study||201
10574621|NCT01679301|11729878|FG000|COMPLETED|Study Period||0
10574622|NCT01679301|11729879|FG001|COMPLETED|Study Period||4
10574623|NCT01679301|11729880|FG002|COMPLETED|Study Period||4
10574624|NCT01679301|11729878|FG000|NOT COMPLETED|Study Period||0
10574625|NCT01679301|11729879|FG001|NOT COMPLETED|Study Period||0
10574626|NCT01679301|11729880|FG002|NOT COMPLETED|Study Period||0
10574627|NCT01679314|11729888|FG000|STARTED|Overall Study||26
10574628|NCT01679314|11729889|FG001|STARTED|Overall Study||28
10574629|NCT01679314|11729888|FG000|COMPLETED|Overall Study||24
10800099|NCT04507867|11960991|FG000|STARTED|Overall Study||40
10713110|NCT02677116|11878652|FG008|COMPLETED|Overall Study||2
10713111|NCT02677116|11878644|FG000|NOT COMPLETED|Overall Study||3
10713112|NCT02677116|11878645|FG001|NOT COMPLETED|Overall Study||4
10713113|NCT02677116|11878646|FG002|NOT COMPLETED|Overall Study||3
10713114|NCT02677116|11878647|FG003|NOT COMPLETED|Overall Study||3
10800100|NCT04507867|11960992|FG001|STARTED|Overall Study||40
10686320|NCT02448641|11849755|FG000|STARTED|Overall Study||55
10686321|NCT02448641|11849756|FG001|STARTED|Overall Study||56
10686322|NCT02448641|11849757|FG002|STARTED|Overall Study||52
10686323|NCT02448641|11849755|FG000|COMPLETED|Overall Study||54
10686324|NCT02448641|11849756|FG001|COMPLETED|Overall Study||51
10686325|NCT02448641|11849757|FG002|COMPLETED|Overall Study||48
10686326|NCT02448641|11849755|FG000|NOT COMPLETED|Overall Study||1
10686327|NCT02448641|11849756|FG001|NOT COMPLETED|Overall Study||5
10686328|NCT02448641|11849757|FG002|NOT COMPLETED|Overall Study||4
10686329|NCT02448654|11849774|FG000|STARTED|Overall Study||19
10686330|NCT02448654|11849775|FG001|STARTED|Overall Study||17
10686331|NCT02448654|11849774|FG000|Started Pills (Tolcapone or Placebo)|Overall Study||17
10686332|NCT02448654|11849775|FG001|Started Pills (Tolcapone or Placebo)|Overall Study||15
10686333|NCT02448654|11849774|FG000|COMPLETED|Overall Study||16
10686334|NCT02448654|11849775|FG001|COMPLETED|Overall Study||13
10686335|NCT02448654|11849774|FG000|NOT COMPLETED|Overall Study||3
10686336|NCT02448654|11849775|FG001|NOT COMPLETED|Overall Study||4
10686337|NCT02448706|11849781|FG000|STARTED|Overall Study||25
10686338|NCT02448706|11849782|FG001|STARTED|Overall Study||24
10686339|NCT02448706|11849781|FG000|Withdrew for Personal Reasons|Overall Study||1
10686340|NCT02448706|11849782|FG001|Withdrew for Personal Reasons|Overall Study||1
10686341|NCT02448706|11849781|FG000|Completed Baseline Testing|Overall Study||24
10686342|NCT02448706|11849782|FG001|Completed Baseline Testing|Overall Study||23
10686343|NCT02448706|11849781|FG000|COMPLETED|Overall Study||20
10686344|NCT02448706|11849782|FG001|COMPLETED|Overall Study||20
10686345|NCT02448706|11849781|FG000|NOT COMPLETED|Overall Study||5
10686346|NCT02448706|11849782|FG001|NOT COMPLETED|Overall Study||4
10686347|NCT02448719|11849801|FG000|STARTED|Overall Study||12
10686348|NCT02448719|11849802|FG001|STARTED|Overall Study||6
10686349|NCT02448719|11849803|FG002|STARTED|Overall Study||6
10686350|NCT02448719|11849804|FG003|STARTED|Overall Study||6
10686351|NCT02448719|11849805|FG004|STARTED|Overall Study||6
10686352|NCT02448719|11849806|FG005|STARTED|Overall Study||6
10686353|NCT02448719|11849807|FG006|STARTED|Overall Study||6
10686354|NCT02448719|11849808|FG007|STARTED|Overall Study||6
10686355|NCT02448719|11849809|FG008|STARTED|Overall Study||6
10686356|NCT02448719|11849810|FG009|STARTED|Overall Study||6
10686357|NCT02448719|11849811|FG010|STARTED|Overall Study||6
10686358|NCT02448719|11849801|FG000|COMPLETED|Overall Study||12
10686359|NCT02448719|11849802|FG001|COMPLETED|Overall Study||6
10686360|NCT02448719|11849803|FG002|COMPLETED|Overall Study||6
10686361|NCT02448719|11849804|FG003|COMPLETED|Overall Study||6
10686362|NCT02448719|11849805|FG004|COMPLETED|Overall Study||5
10686363|NCT02448719|11849806|FG005|COMPLETED|Overall Study||6
10686364|NCT02448719|11849807|FG006|COMPLETED|Overall Study||6
10686365|NCT02448719|11849808|FG007|COMPLETED|Overall Study||6
10686366|NCT02448719|11849809|FG008|COMPLETED|Overall Study||6
10686367|NCT02448719|11849810|FG009|COMPLETED|Overall Study||6
10686368|NCT02448719|11849811|FG010|COMPLETED|Overall Study||6
10686369|NCT02448719|11849801|FG000|NOT COMPLETED|Overall Study||0
10686370|NCT02448719|11849802|FG001|NOT COMPLETED|Overall Study||0
10686371|NCT02448719|11849803|FG002|NOT COMPLETED|Overall Study||0
10686372|NCT02448719|11849804|FG003|NOT COMPLETED|Overall Study||0
10686373|NCT02448719|11849805|FG004|NOT COMPLETED|Overall Study||1
10686374|NCT02448719|11849806|FG005|NOT COMPLETED|Overall Study||0
10686375|NCT02448719|11849807|FG006|NOT COMPLETED|Overall Study||0
10686376|NCT02448719|11849808|FG007|NOT COMPLETED|Overall Study||0
10686377|NCT02448719|11849809|FG008|NOT COMPLETED|Overall Study||0
10686378|NCT02448719|11849810|FG009|NOT COMPLETED|Overall Study||0
10686379|NCT02448719|11849811|FG010|NOT COMPLETED|Overall Study||0
10686383|NCT02448810|11849885|FG000|STARTED|Overall Study||3
10686384|NCT02448810|11849886|FG001|STARTED|Overall Study||3
10686385|NCT02448810|11849887|FG002|STARTED|Overall Study||3
10686386|NCT02448810|11849888|FG003|STARTED|Overall Study||3
10686387|NCT02448810|11849889|FG004|STARTED|Overall Study||31
10686388|NCT02448810|11849890|FG005|STARTED|Overall Study||16
10686389|NCT02448810|11849891|FG006|STARTED|Overall Study||18
10686390|NCT02448810|11849892|FG007|STARTED|Overall Study||8
10686391|NCT02448810|11849885|FG000|Treated|Overall Study||3
10686392|NCT02448810|11849886|FG001|Treated|Overall Study||3
10686393|NCT02448810|11849887|FG002|Treated|Overall Study||3
10686394|NCT02448810|11849888|FG003|Treated|Overall Study||3
10686395|NCT02448810|11849889|FG004|Treated|Overall Study||29
10686396|NCT02448810|11849890|FG005|Treated|Overall Study||13
10686397|NCT02448810|11849891|FG006|Treated|Overall Study||18
10686398|NCT02448810|11849892|FG007|Treated|Overall Study||7
10686399|NCT02448810|11849885|FG000|COMPLETED|Overall Study||0
10686400|NCT02448810|11849886|FG001|COMPLETED|Overall Study||0
10686401|NCT02448810|11849887|FG002|COMPLETED|Overall Study||0
10686402|NCT02448810|11849888|FG003|COMPLETED|Overall Study||0
10686403|NCT02448810|11849889|FG004|COMPLETED|Overall Study||0
10686404|NCT02448810|11849890|FG005|COMPLETED|Overall Study||0
10686405|NCT02448810|11849891|FG006|COMPLETED|Overall Study||0
10686406|NCT02448810|11849892|FG007|COMPLETED|Overall Study||0
10686407|NCT02448810|11849885|FG000|NOT COMPLETED|Overall Study||3
10686408|NCT02448810|11849886|FG001|NOT COMPLETED|Overall Study||3
10686409|NCT02448810|11849887|FG002|NOT COMPLETED|Overall Study||3
10686410|NCT02448810|11849888|FG003|NOT COMPLETED|Overall Study||3
10686411|NCT02448810|11849889|FG004|NOT COMPLETED|Overall Study||31
10686412|NCT02448810|11849890|FG005|NOT COMPLETED|Overall Study||16
10686413|NCT02448810|11849891|FG006|NOT COMPLETED|Overall Study||18
10686414|NCT02448810|11849892|FG007|NOT COMPLETED|Overall Study||8
10686415|NCT02448862|11849916|FG000|STARTED|Overall Study||4525
10686416|NCT02448862|11849917|FG001|STARTED|Overall Study||6050
10686417|NCT02448862|11849916|FG000|COMPLETED|Overall Study||4525
10686418|NCT02448862|11849917|FG001|COMPLETED|Overall Study||6050
10686419|NCT02448862|11849916|FG000|NOT COMPLETED|Overall Study||0
10686420|NCT02448862|11849917|FG001|NOT COMPLETED|Overall Study||0
10686421|NCT02448875|11849926|FG000|STARTED|Overall Study||60
10686422|NCT02448875|11849927|FG001|STARTED|Overall Study||21
10686423|NCT02448875|11849928|FG002|STARTED|Overall Study||61
10686424|NCT02448875|11849926|FG000|Completed Dose Selection Phase|Overall Study||20
10686425|NCT02448875|11849927|FG001|Completed Dose Selection Phase|Overall Study||21
10686426|NCT02448875|11849928|FG002|Completed Dose Selection Phase|Overall Study||20
10686427|NCT02448875|11849926|FG000|Full Analysis Set|Overall Study||60
10686428|NCT02448875|11849927|FG001|Full Analysis Set|Overall Study||21
10686429|NCT02448875|11849928|FG002|Full Analysis Set|Overall Study||61
10686430|NCT02448875|11849926|FG000|Safety Analysis Set|Overall Study||60
10686431|NCT02448875|11849927|FG001|Safety Analysis Set|Overall Study||21
10686432|NCT02448875|11849928|FG002|Safety Analysis Set|Overall Study||61
10686433|NCT02448875|11849926|FG000|COMPLETED|Overall Study||53
10686434|NCT02448875|11849927|FG001|COMPLETED|Overall Study||20
10686435|NCT02448875|11849928|FG002|COMPLETED|Overall Study||60
10686436|NCT02448875|11849926|FG000|NOT COMPLETED|Overall Study||7
10686437|NCT02448875|11849927|FG001|NOT COMPLETED|Overall Study||1
10686438|NCT02448875|11849928|FG002|NOT COMPLETED|Overall Study||1
10686439|NCT02448914|11849939|FG000|STARTED|First Intervention (1 Day)||6
10686440|NCT02448914|11849940|FG001|STARTED|First Intervention (1 Day)||5
10686441|NCT02448914|11849939|FG000|COMPLETED|First Intervention (1 Day)||6
10686442|NCT02448914|11849940|FG001|COMPLETED|First Intervention (1 Day)||5
10686443|NCT02448914|11849939|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10686444|NCT02448914|11849940|FG001|NOT COMPLETED|First Intervention (1 Day)||0
10686445|NCT02448914|11849939|FG000|STARTED|Second Intervention (1 Day)||6
10686446|NCT02448914|11849940|FG001|STARTED|Second Intervention (1 Day)||5
10686447|NCT02448914|11849939|FG000|COMPLETED|Second Intervention (1 Day)||6
10686448|NCT02448914|11849940|FG001|COMPLETED|Second Intervention (1 Day)||5
10686449|NCT02448914|11849939|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10686450|NCT02448914|11849940|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10686451|NCT02449018|11849949|FG000|STARTED|Overall Study||64
10686452|NCT02449018|11849950|FG001|STARTED|Overall Study||28
10686453|NCT02449018|11849949|FG000|COMPLETED|Overall Study||52
10686454|NCT02449018|11849950|FG001|COMPLETED|Overall Study||26
10686455|NCT02449018|11849949|FG000|NOT COMPLETED|Overall Study||12
10686456|NCT02449018|11849950|FG001|NOT COMPLETED|Overall Study||2
10686457|NCT02449044|11849956|FG000|STARTED|Overall Study||111
10686458|NCT02449044|11849956|FG000|COMPLETED|Overall Study|Participants who completed Weeks 58, 106 and 216 visit.|47
10686459|NCT02449044|11849956|FG000|NOT COMPLETED|Overall Study||64
10686460|NCT02449174|11849962|FG000|STARTED|Overall Study||36
10686461|NCT02449174|11849963|FG001|STARTED|Overall Study||32
10686462|NCT02449174|11849962|FG000|COMPLETED|Overall Study||36
10686463|NCT02449174|11849963|FG001|COMPLETED|Overall Study||32
10686464|NCT02449174|11849962|FG000|NOT COMPLETED|Overall Study||0
10686465|NCT02449174|11849963|FG001|NOT COMPLETED|Overall Study||0
10686466|NCT02449291|11849972|FG000|STARTED|Overall Study||191
10686467|NCT02449291|11849973|FG001|STARTED|Overall Study||188
10686468|NCT02449291|11849974|FG002|STARTED|Overall Study||181
10686469|NCT02449291|11849972|FG000|COMPLETED|Overall Study||186
10686470|NCT02449291|11849973|FG001|COMPLETED|Overall Study||186
10686471|NCT02449291|11849974|FG002|COMPLETED|Overall Study||180
10686472|NCT02449291|11849972|FG000|NOT COMPLETED|Overall Study||5
10686473|NCT02449291|11849973|FG001|NOT COMPLETED|Overall Study||2
10686474|NCT02449291|11849974|FG002|NOT COMPLETED|Overall Study||1
10686475|NCT02449356|11849987|FG000|STARTED|Overall Study||30
10686476|NCT02449356|11849988|FG001|STARTED|Overall Study||30
10686477|NCT02449356|11849987|FG000|COMPLETED|Overall Study||30
10686478|NCT02449356|11849988|FG001|COMPLETED|Overall Study||30
10686479|NCT02449356|11849987|FG000|NOT COMPLETED|Overall Study||0
10686480|NCT02449356|11849988|FG001|NOT COMPLETED|Overall Study||0
10686481|NCT02449434|11849998|FG000|STARTED|Overall Study||300
10686482|NCT02449434|11849999|FG001|STARTED|Overall Study||300
10686483|NCT02449434|11849998|FG000|COMPLETED|Overall Study||300
10686484|NCT02449434|11849999|FG001|COMPLETED|Overall Study||300
10686485|NCT02449434|11849998|FG000|NOT COMPLETED|Overall Study||0
10686486|NCT02449434|11849999|FG001|NOT COMPLETED|Overall Study||0
10686487|NCT02449473|11850007|FG000|STARTED|Overall Study||39
10686488|NCT02449473|11850008|FG001|STARTED|Overall Study||40
10686489|NCT02449473|11850007|FG000|COMPLETED|Overall Study||39
10686490|NCT02449473|11850008|FG001|COMPLETED|Overall Study||40
10686491|NCT02449473|11850007|FG000|NOT COMPLETED|Overall Study||0
10686492|NCT02449473|11850008|FG001|NOT COMPLETED|Overall Study||0
10686493|NCT02449798|11850014|FG000|STARTED|Overall Study||120
10686494|NCT02449798|11850014|FG000|COMPLETED|Overall Study||120
10686495|NCT02449798|11850014|FG000|NOT COMPLETED|Overall Study||0
10686496|NCT02449889|11850021|FG000|STARTED|Overall Study||58
10686497|NCT02449889|11850022|FG001|STARTED|Overall Study||58
10686498|NCT02449889|11850023|FG002|STARTED|Overall Study||60
10686499|NCT02449889|11850021|FG000|COMPLETED|Overall Study||57
10686500|NCT02449889|11850022|FG001|COMPLETED|Overall Study||52
10686501|NCT02449889|11850023|FG002|COMPLETED|Overall Study||59
10686502|NCT02449889|11850021|FG000|NOT COMPLETED|Overall Study||1
10686503|NCT02449889|11850022|FG001|NOT COMPLETED|Overall Study||6
10686504|NCT02449889|11850023|FG002|NOT COMPLETED|Overall Study||1
10686505|NCT02449902|11850033|FG000|STARTED|Overall Study||24
10686506|NCT02449902|11850034|FG001|STARTED|Overall Study||26
10686507|NCT02449902|11850033|FG000|COMPLETED|Overall Study||24
10686508|NCT02449902|11850034|FG001|COMPLETED|Overall Study||24
10686509|NCT02449902|11850033|FG000|NOT COMPLETED|Overall Study||0
10686510|NCT02449902|11850034|FG001|NOT COMPLETED|Overall Study||2
10686511|NCT02449915|11850044|FG000|STARTED|Overall Study||35
10686512|NCT02449915|11850045|FG001|STARTED|Overall Study||35
10686513|NCT02449915|11850044|FG000|COMPLETED|Overall Study||33
10686514|NCT02449915|11850045|FG001|COMPLETED|Overall Study||31
10686515|NCT02449915|11850044|FG000|NOT COMPLETED|Overall Study||2
10686516|NCT02449915|11850045|FG001|NOT COMPLETED|Overall Study||4
10686517|NCT02450383|11850053|FG000|STARTED|Overall Study||10
10686518|NCT02450383|11850054|FG001|STARTED|Overall Study||10
10686519|NCT02450383|11850053|FG000|COMPLETED|Overall Study||10
10686520|NCT02450383|11850054|FG001|COMPLETED|Overall Study||10
10686521|NCT02450383|11850053|FG000|NOT COMPLETED|Overall Study||0
10686522|NCT02450383|11850054|FG001|NOT COMPLETED|Overall Study||0
10686523|NCT02450487|11850060|FG000|STARTED|Overall Study||105
10686524|NCT02450487|11850060|FG000|COMPLETED|Overall Study||102
10686525|NCT02450487|11850060|FG000|NOT COMPLETED|Overall Study||3
10686526|NCT02450526|11850069|FG000|STARTED|DB Period (Cycle 1)||325
10686527|NCT02450526|11850070|FG001|STARTED|DB Period (Cycle 1)||66
10686528|NCT02450526|11850071|FG002|STARTED|DB Period (Cycle 1)||107
10686529|NCT02450526|11850072|FG003|STARTED|DB Period (Cycle 1)||22
10686530|NCT02450526|11850073|FG004|STARTED|DB Period (Cycle 1)|This arm was not included in DB Period (Cycle 1).|0
10686531|NCT02450526|11850069|FG000|Safety Population|DB Period (Cycle 1)||326
10686532|NCT02450526|11850070|FG001|Safety Population|DB Period (Cycle 1)||66
10686533|NCT02450526|11850071|FG002|Safety Population|DB Period (Cycle 1)||107
10686534|NCT02450526|11850072|FG003|Safety Population|DB Period (Cycle 1)||21
10686535|NCT02450526|11850073|FG004|Safety Population|DB Period (Cycle 1)||0
10686536|NCT02450526|11850069|FG000|COMPLETED|DB Period (Cycle 1)||294
10686537|NCT02450526|11850070|FG001|COMPLETED|DB Period (Cycle 1)||63
10686538|NCT02450526|11850071|FG002|COMPLETED|DB Period (Cycle 1)||97
10686539|NCT02450526|11850072|FG003|COMPLETED|DB Period (Cycle 1)||20
10686540|NCT02450526|11850073|FG004|COMPLETED|DB Period (Cycle 1)|This arm was not included in DB Period (Cycle 1).|0
10686541|NCT02450526|11850069|FG000|NOT COMPLETED|DB Period (Cycle 1)||31
10686542|NCT02450526|11850070|FG001|NOT COMPLETED|DB Period (Cycle 1)||3
10686543|NCT02450526|11850071|FG002|NOT COMPLETED|DB Period (Cycle 1)||10
10686544|NCT02450526|11850072|FG003|NOT COMPLETED|DB Period (Cycle 1)||2
10686545|NCT02450526|11850073|FG004|NOT COMPLETED|DB Period (Cycle 1)||0
10686546|NCT02450526|11850069|FG000|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
10686547|NCT02450526|11850070|FG001|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
10686548|NCT02450526|11850071|FG002|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
10686549|NCT02450526|11850072|FG003|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
10686550|NCT02450526|11850073|FG004|STARTED|OL Period (Cycles 2-5)|Nine subjects completed the DB Period but were not eligible for retreatment in the OL Period.|465
10686551|NCT02450526|11850069|FG000|Safety Population|OL Period (Cycles 2-5)||0
10686552|NCT02450526|11850070|FG001|Safety Population|OL Period (Cycles 2-5)||0
10686553|NCT02450526|11850071|FG002|Safety Population|OL Period (Cycles 2-5)||0
10686554|NCT02450526|11850072|FG003|Safety Population|OL Period (Cycles 2-5)||0
10686555|NCT02450526|11850073|FG004|Safety Population|OL Period (Cycles 2-5)||465
10686556|NCT02450526|11850069|FG000|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
10686557|NCT02450526|11850070|FG001|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
10686558|NCT02450526|11850071|FG002|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
10686559|NCT02450526|11850072|FG003|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
10686560|NCT02450526|11850073|FG004|Discontinued During Cycle 2|OL Period (Cycles 2-5)||28
10686561|NCT02450526|11850069|FG000|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
10686562|NCT02450526|11850070|FG001|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
10686563|NCT02450526|11850071|FG002|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
10686564|NCT02450526|11850072|FG003|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
10686565|NCT02450526|11850073|FG004|Discontinued During Cycle 3|OL Period (Cycles 2-5)||11
10686566|NCT02450526|11850069|FG000|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
10686567|NCT02450526|11850070|FG001|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
10686568|NCT02450526|11850071|FG002|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
10686569|NCT02450526|11850072|FG003|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
10686570|NCT02450526|11850073|FG004|Discontinued During Cycle 4|OL Period (Cycles 2-5)||2
10686571|NCT02450526|11850069|FG000|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
10686572|NCT02450526|11850070|FG001|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
10686573|NCT02450526|11850071|FG002|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
10686574|NCT02450526|11850072|FG003|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
10686575|NCT02450526|11850073|FG004|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
10686576|NCT02450526|11850069|FG000|COMPLETED|OL Period (Cycles 2-5)||0
10686577|NCT02450526|11850070|FG001|COMPLETED|OL Period (Cycles 2-5)||0
10686578|NCT02450526|11850071|FG002|COMPLETED|OL Period (Cycles 2-5)||0
10686579|NCT02450526|11850072|FG003|COMPLETED|OL Period (Cycles 2-5)||0
10686580|NCT02450526|11850073|FG004|COMPLETED|OL Period (Cycles 2-5)||424
10686581|NCT02450526|11850069|FG000|NOT COMPLETED|OL Period (Cycles 2-5)||0
10686582|NCT02450526|11850070|FG001|NOT COMPLETED|OL Period (Cycles 2-5)||0
10686583|NCT02450526|11850071|FG002|NOT COMPLETED|OL Period (Cycles 2-5)||0
10686584|NCT02450526|11850072|FG003|NOT COMPLETED|OL Period (Cycles 2-5)||0
10686585|NCT02450526|11850073|FG004|NOT COMPLETED|OL Period (Cycles 2-5)||41
10686586|NCT02450539|11850095|FG000|STARTED|Overall Study||106
10686587|NCT02450539|11850096|FG001|STARTED|Overall Study||53
10686588|NCT02450539|11850095|FG000|Received at Least One Dose of Study Drug|Overall Study||106
10686589|NCT02450539|11850096|FG001|Received at Least One Dose of Study Drug|Overall Study||52
10686590|NCT02450539|11850095|FG000|COMPLETED|Overall Study||90
10686591|NCT02450539|11850096|FG001|COMPLETED|Overall Study||46
10686592|NCT02450539|11850095|FG000|NOT COMPLETED|Overall Study||16
10686593|NCT02450539|11850096|FG001|NOT COMPLETED|Overall Study||7
10686594|NCT02450552|11850108|FG000|STARTED|Overall Study||19
10686595|NCT02450552|11850109|FG001|STARTED|Overall Study||23
10686596|NCT02450552|11850110|FG002|STARTED|Overall Study||23
10686597|NCT02450552|11850108|FG000|COMPLETED|Overall Study||14
10686598|NCT02450552|11850109|FG001|COMPLETED|Overall Study||23
10686599|NCT02450552|11850110|FG002|COMPLETED|Overall Study||18
10686600|NCT02450552|11850108|FG000|NOT COMPLETED|Overall Study||5
10686601|NCT02450552|11850109|FG001|NOT COMPLETED|Overall Study||0
10686602|NCT02450552|11850110|FG002|NOT COMPLETED|Overall Study||5
10686603|NCT02450578|11850122|FG000|STARTED|Overall Study||6
10686604|NCT02450578|11850123|FG001|STARTED|Overall Study||6
10686605|NCT02450578|11850124|FG002|STARTED|Overall Study||6
10686606|NCT02450578|11850125|FG003|STARTED|Overall Study||4
10686607|NCT02450578|11850122|FG000|COMPLETED|Overall Study||5
10686608|NCT02450578|11850123|FG001|COMPLETED|Overall Study||6
10686609|NCT02450578|11850124|FG002|COMPLETED|Overall Study||6
10686610|NCT02450578|11850125|FG003|COMPLETED|Overall Study||4
10686611|NCT02450578|11850122|FG000|NOT COMPLETED|Overall Study||1
10686612|NCT02450578|11850123|FG001|NOT COMPLETED|Overall Study||0
10686613|NCT02450578|11850124|FG002|NOT COMPLETED|Overall Study||0
10686614|NCT02450578|11850125|FG003|NOT COMPLETED|Overall Study||0
10686615|NCT02450747|11850139|FG000|STARTED|Overall Study||39
10686616|NCT02450747|11850139|FG000|COMPLETED|Overall Study||39
10686617|NCT02450747|11850139|FG000|NOT COMPLETED|Overall Study||0
10686618|NCT02450799|11850150|FG000|STARTED|Overall Study||31
10686619|NCT02450799|11850151|FG001|STARTED|Overall Study||37
10686620|NCT02450799|11850152|FG002|STARTED|Overall Study||30
10686621|NCT02450799|11850150|FG000|COMPLETED|Overall Study||31
10686622|NCT02450799|11850151|FG001|COMPLETED|Overall Study||37
10686623|NCT02450799|11850152|FG002|COMPLETED|Overall Study||30
10686624|NCT02450799|11850150|FG000|NOT COMPLETED|Overall Study||0
10686625|NCT02450799|11850151|FG001|NOT COMPLETED|Overall Study||0
10686626|NCT02450799|11850152|FG002|NOT COMPLETED|Overall Study||0
10686627|NCT02450903|11850163|FG000|STARTED|Overall Study||20
10686628|NCT02450903|11850163|FG000|Entered Post-treatment Effic. f/u Phase|Overall Study||4
10686629|NCT02450903|11850163|FG000|Entered Survival Follow-up Phase|Overall Study||15
10686630|NCT02450903|11850163|FG000|COMPLETED|Overall Study||0
10686631|NCT02450903|11850163|FG000|NOT COMPLETED|Overall Study||20
10686632|NCT02451007|11850167|FG000|STARTED|Overall Study||39
10686633|NCT02451007|11850167|FG000|COMPLETED|Overall Study||32
10686634|NCT02451007|11850167|FG000|NOT COMPLETED|Overall Study||7
10686635|NCT02451124|11850171|FG000|STARTED|Overall Study||156
10686636|NCT02451124|11850171|FG000|COMPLETED|Overall Study||155
10686637|NCT02451124|11850171|FG000|NOT COMPLETED|Overall Study||1
10686638|NCT02451137|11850181|FG000|STARTED|Overall Study||1651
10686639|NCT02451137|11850182|FG001|STARTED|Overall Study||1653
10686640|NCT02451137|11850181|FG000|Treated|Overall Study||1632
10686641|NCT02451137|11850182|FG001|Treated|Overall Study||1626
10686642|NCT02451137|11850181|FG000|Safety Population|Overall Study|4 participants received Standard of Care instead of Toujeo.|1637
10686643|NCT02451137|11850182|FG001|Safety Population|Overall Study|9 participants received Toujeo instead of Standard of Care.|1621
10686644|NCT02451137|11850181|FG000|COMPLETED|Overall Study||1405
10686645|NCT02451137|11850182|FG001|COMPLETED|Overall Study||1355
10686646|NCT02451137|11850181|FG000|NOT COMPLETED|Overall Study||246
10686647|NCT02451137|11850182|FG001|NOT COMPLETED|Overall Study||298
10686648|NCT02451150|11850190|FG000|STARTED|Overall Study||3
10686649|NCT02451150|11850191|FG001|STARTED|Overall Study||3
10686650|NCT02451150|11850190|FG000|COMPLETED|Overall Study||3
10686651|NCT02451150|11850191|FG001|COMPLETED|Overall Study||3
10686652|NCT02451150|11850190|FG000|NOT COMPLETED|Overall Study||0
10686653|NCT02451150|11850191|FG001|NOT COMPLETED|Overall Study||0
10686654|NCT02451202|11850199|FG000|STARTED|Overall Study||51
10686655|NCT02451202|11850200|FG001|STARTED|Overall Study||51
10686656|NCT02451202|11850199|FG000|COMPLETED|Overall Study||49
10686657|NCT02451202|11850200|FG001|COMPLETED|Overall Study||48
10686658|NCT02451202|11850199|FG000|NOT COMPLETED|Overall Study||2
10686659|NCT02451202|11850200|FG001|NOT COMPLETED|Overall Study||3
10686660|NCT02451488|11850210|FG000|STARTED|Overall Study||4
10686661|NCT02451488|11850211|FG001|STARTED|Overall Study||4
10686662|NCT02451488|11850210|FG000|COMPLETED|Overall Study||4
10686663|NCT02451488|11850211|FG001|COMPLETED|Overall Study||4
10686664|NCT02451488|11850210|FG000|NOT COMPLETED|Overall Study||0
10686665|NCT02451488|11850211|FG001|NOT COMPLETED|Overall Study||0
10686666|NCT02451514|11850220|FG000|STARTED|Overall Study||33
10686667|NCT02451514|11850221|FG001|STARTED|Overall Study||46
10686668|NCT02451514|11850222|FG002|STARTED|Overall Study||50
10686669|NCT02451514|11850220|FG000|COMPLETED|Overall Study||33
10686670|NCT02451514|11850221|FG001|COMPLETED|Overall Study||46
10686671|NCT02451514|11850222|FG002|COMPLETED|Overall Study||50
10686672|NCT02451514|11850220|FG000|NOT COMPLETED|Overall Study||0
10686673|NCT02451514|11850221|FG001|NOT COMPLETED|Overall Study||0
10686674|NCT02451514|11850222|FG002|NOT COMPLETED|Overall Study||0
10686675|NCT02451670|11850240|FG000|STARTED|Overall Study||5264
10686676|NCT02451670|11850241|FG001|STARTED|Overall Study||5083
10686677|NCT02451670|11850240|FG000|COMPLETED|Overall Study||4550
10686678|NCT02451670|11850241|FG001|COMPLETED|Overall Study||4387
10686679|NCT02451670|11850240|FG000|NOT COMPLETED|Overall Study||714
10686680|NCT02451670|11850241|FG001|NOT COMPLETED|Overall Study||696
10686681|NCT02451696|11850249|FG000|STARTED|Overall Study||5
10686682|NCT02451696|11850250|FG001|STARTED|Overall Study||10
10686683|NCT02451696|11850249|FG000|COMPLETED|Overall Study||4
10686684|NCT02451696|11850250|FG001|COMPLETED|Overall Study||10
10686685|NCT02451696|11850249|FG000|NOT COMPLETED|Overall Study||1
10686686|NCT02451696|11850250|FG001|NOT COMPLETED|Overall Study||0
10686687|NCT02451839|11850258|FG000|STARTED|Overall Study||72
10686688|NCT02451839|11850259|FG001|STARTED|Overall Study||59
10686689|NCT02451839|11850260|FG002|STARTED|Overall Study||37
10686690|NCT02451839|11850258|FG000|Baseline WHODAS Data Recorded|Overall Study||70
10686691|NCT02451839|11850259|FG001|Baseline WHODAS Data Recorded|Overall Study||57
10686692|NCT02451839|11850260|FG002|Baseline WHODAS Data Recorded|Overall Study||37
10686693|NCT02451839|11850258|FG000|COMPLETED|Overall Study||44
10686694|NCT02451839|11850259|FG001|COMPLETED|Overall Study||40
10686695|NCT02451839|11850260|FG002|COMPLETED|Overall Study||30
10686696|NCT02451839|11850258|FG000|NOT COMPLETED|Overall Study||28
10686697|NCT02451839|11850259|FG001|NOT COMPLETED|Overall Study||19
10686698|NCT02451839|11850260|FG002|NOT COMPLETED|Overall Study||7
10686699|NCT02451917|11850270|FG000|STARTED|First Intervention (24 Weeks)||16
10686700|NCT02451917|11850271|FG001|STARTED|First Intervention (24 Weeks)||18
10686701|NCT02451917|11850270|FG000|COMPLETED|First Intervention (24 Weeks)||14
10686702|NCT02451917|11850271|FG001|COMPLETED|First Intervention (24 Weeks)||15
10686703|NCT02451917|11850270|FG000|NOT COMPLETED|First Intervention (24 Weeks)||2
10686704|NCT02451917|11850271|FG001|NOT COMPLETED|First Intervention (24 Weeks)||3
10686705|NCT02451917|11850270|FG000|STARTED|Second Intervention (24 Weeks)||14
10686706|NCT02451917|11850271|FG001|STARTED|Second Intervention (24 Weeks)||15
10686707|NCT02451917|11850270|FG000|COMPLETED|Second Intervention (24 Weeks)||14
10686708|NCT02451917|11850271|FG001|COMPLETED|Second Intervention (24 Weeks)||15
10686709|NCT02451917|11850270|FG000|NOT COMPLETED|Second Intervention (24 Weeks)||0
10686710|NCT02451917|11850271|FG001|NOT COMPLETED|Second Intervention (24 Weeks)||0
10686711|NCT02451930|11850283|FG000|STARTED|Overall Study||3
10686712|NCT02451930|11850284|FG001|STARTED|Overall Study||68
10686713|NCT02451930|11850283|FG000|Received at Least One Dose of Study Drug|Overall Study||3
10686714|NCT02451930|11850284|FG001|Received at Least One Dose of Study Drug|Overall Study||68
10686715|NCT02451930|11850283|FG000|Part A Cohort 2 Participants|Overall Study||0
10686716|NCT02451930|11850284|FG001|Part A Cohort 2 Participants|Overall Study||6
10686717|NCT02451930|11850283|FG000|Part B Participants|Overall Study||0
10686718|NCT02451930|11850284|FG001|Part B Participants|Overall Study||55
10686719|NCT02451930|11850283|FG000|Part C Participants|Overall Study||0
10686720|NCT02451930|11850284|FG001|Part C Participants|Overall Study||7
10686721|NCT02451930|11850283|FG000|COMPLETED|Overall Study||1
10686722|NCT02451930|11850284|FG001|COMPLETED|Overall Study||38
10686723|NCT02451930|11850283|FG000|NOT COMPLETED|Overall Study||2
10686724|NCT02451930|11850284|FG001|NOT COMPLETED|Overall Study||30
10686725|NCT02451995|11850302|FG000|STARTED|Overall Study||42
10686726|NCT02451995|11850303|FG001|STARTED|Overall Study||41
10686727|NCT02451995|11850302|FG000|COMPLETED|Overall Study||42
10686728|NCT02451995|11850303|FG001|COMPLETED|Overall Study||41
10686729|NCT02451995|11850302|FG000|NOT COMPLETED|Overall Study||0
10686730|NCT02451995|11850303|FG001|NOT COMPLETED|Overall Study||0
10686731|NCT02452034|11850315|FG000|STARTED|Overall Study||16
10686732|NCT02452034|11850316|FG001|STARTED|Overall Study||21
10686733|NCT02452034|11850317|FG002|STARTED|Overall Study||15
10686734|NCT02452034|11850318|FG003|STARTED|Overall Study||17
10686735|NCT02452034|11850319|FG004|STARTED|Overall Study||20
10686736|NCT02452034|11850320|FG005|STARTED|Overall Study||29
10686737|NCT02452034|11850315|FG000|Treated|Overall Study||14
10686738|NCT02452034|11850316|FG001|Treated|Overall Study||21
10686739|NCT02452034|11850317|FG002|Treated|Overall Study||15
10686740|NCT02452034|11850318|FG003|Treated|Overall Study||16
10686741|NCT02452034|11850319|FG004|Treated|Overall Study||20
10686742|NCT02452034|11850320|FG005|Treated|Overall Study||29
10686743|NCT02452034|11850315|FG000|COMPLETED|Overall Study||14
10686744|NCT02452034|11850316|FG001|COMPLETED|Overall Study||20
10686745|NCT02452034|11850317|FG002|COMPLETED|Overall Study||14
10686746|NCT02452034|11850318|FG003|COMPLETED|Overall Study||16
10686747|NCT02452034|11850319|FG004|COMPLETED|Overall Study||19
10686748|NCT02452034|11850320|FG005|COMPLETED|Overall Study||26
10686749|NCT02452034|11850315|FG000|NOT COMPLETED|Overall Study||2
10686750|NCT02452034|11850316|FG001|NOT COMPLETED|Overall Study||1
10686751|NCT02452034|11850317|FG002|NOT COMPLETED|Overall Study||1
10686752|NCT02452034|11850318|FG003|NOT COMPLETED|Overall Study||1
10686753|NCT02452034|11850319|FG004|NOT COMPLETED|Overall Study||1
10686754|NCT02452034|11850320|FG005|NOT COMPLETED|Overall Study||3
10686755|NCT02452047|11850337|FG000|STARTED|Overall Study||31
10686756|NCT02452047|11850338|FG001|STARTED|Overall Study||16
10686757|NCT02452047|11850339|FG002|STARTED|Overall Study||3
10686758|NCT02452047|11850337|FG000|COMPLETED|Overall Study||27
10686759|NCT02452047|11850338|FG001|COMPLETED|Overall Study||11
10686760|NCT02452047|11850339|FG002|COMPLETED|Overall Study||1
10686761|NCT02452047|11850337|FG000|NOT COMPLETED|Overall Study||4
10686762|NCT02452047|11850338|FG001|NOT COMPLETED|Overall Study||5
10686763|NCT02452047|11850339|FG002|NOT COMPLETED|Overall Study||2
10686764|NCT02452060|11850349|FG000|STARTED|Overall Study||46
10686765|NCT02452060|11850350|FG001|STARTED|Overall Study||44
10686766|NCT02452060|11850349|FG000|COMPLETED|Overall Study||46
10686767|NCT02452060|11850350|FG001|COMPLETED|Overall Study||44
10686768|NCT02452060|11850349|FG000|NOT COMPLETED|Overall Study||0
10686769|NCT02452060|11850350|FG001|NOT COMPLETED|Overall Study||0
10686770|NCT02452190|11850358|FG000|STARTED|Overall Study||232
10686771|NCT02452190|11850359|FG001|STARTED|Overall Study||236
10686772|NCT02452190|11850358|FG000|Intent to Treat (ITT) Population|Overall Study||230
10686773|NCT02452190|11850359|FG001|Intent to Treat (ITT) Population|Overall Study||234
10686774|NCT02452190|11850358|FG000|Safety Population|Overall Study||231
10686775|NCT02452190|11850359|FG001|Safety Population|Overall Study||237
10686776|NCT02452190|11850358|FG000|COMPLETED|Overall Study||197
10686777|NCT02452190|11850359|FG001|COMPLETED|Overall Study||212
10686778|NCT02452190|11850358|FG000|NOT COMPLETED|Overall Study||35
10686779|NCT02452190|11850359|FG001|NOT COMPLETED|Overall Study||24
10686780|NCT02452320|11850367|FG000|STARTED|Overall Study||64
10686781|NCT02452320|11850368|FG001|STARTED|Overall Study||64
10686782|NCT02452320|11850367|FG000|COMPLETED|Overall Study||64
10686783|NCT02452320|11850368|FG001|COMPLETED|Overall Study||63
10686784|NCT02452320|11850367|FG000|NOT COMPLETED|Overall Study||0
10686785|NCT02452320|11850368|FG001|NOT COMPLETED|Overall Study||1
10686786|NCT02452346|11850374|FG000|STARTED|Overall Study||12
10686787|NCT02452346|11850374|FG000|COMPLETED|Overall Study||3
10686788|NCT02452346|11850374|FG000|NOT COMPLETED|Overall Study||9
10686789|NCT02452424|11850389|FG000|STARTED|Overall Study||4
10686790|NCT02452424|11850390|FG001|STARTED|Overall Study||3
10686791|NCT02452424|11850391|FG002|STARTED|Overall Study||7
10686792|NCT02452424|11850392|FG003|STARTED|Overall Study||9
10686793|NCT02452424|11850393|FG004|STARTED|Overall Study||4
10686794|NCT02452424|11850394|FG005|STARTED|Overall Study||6
10686795|NCT02452424|11850395|FG006|STARTED|Overall Study||13
10686796|NCT02452424|11850396|FG007|STARTED|Overall Study||8
10686797|NCT02452424|11850397|FG008|STARTED|Overall Study||15
10686798|NCT02452424|11850398|FG009|STARTED|Overall Study||3
10686799|NCT02452424|11850399|FG010|STARTED|Overall Study||6
10686800|NCT02452424|11850389|FG000|COMPLETED|Overall Study||2
10686801|NCT02452424|11850390|FG001|COMPLETED|Overall Study||0
10686802|NCT02452424|11850391|FG002|COMPLETED|Overall Study||0
10686803|NCT02452424|11850392|FG003|COMPLETED|Overall Study||1
10686804|NCT02452424|11850393|FG004|COMPLETED|Overall Study||2
10686805|NCT02452424|11850394|FG005|COMPLETED|Overall Study||5
10686806|NCT02452424|11850395|FG006|COMPLETED|Overall Study||3
10686807|NCT02452424|11850396|FG007|COMPLETED|Overall Study||4
10686808|NCT02452424|11850397|FG008|COMPLETED|Overall Study||9
10686809|NCT02452424|11850398|FG009|COMPLETED|Overall Study||1
10686810|NCT02452424|11850399|FG010|COMPLETED|Overall Study||4
10686811|NCT02452424|11850389|FG000|NOT COMPLETED|Overall Study||2
10686812|NCT02452424|11850390|FG001|NOT COMPLETED|Overall Study||3
10686813|NCT02452424|11850391|FG002|NOT COMPLETED|Overall Study||7
10686814|NCT02452424|11850392|FG003|NOT COMPLETED|Overall Study||8
10686815|NCT02452424|11850393|FG004|NOT COMPLETED|Overall Study||2
10800101|NCT04507867|11960991|FG000|COMPLETED|Overall Study||33
10800102|NCT04507867|11960992|FG001|COMPLETED|Overall Study||39
10800103|NCT04507867|11960991|FG000|NOT COMPLETED|Overall Study||7
10800104|NCT04507867|11960992|FG001|NOT COMPLETED|Overall Study||1
10800105|NCT04525079|11961019|FG000|STARTED|Overall Study||6
10686816|NCT02452424|11850394|FG005|NOT COMPLETED|Overall Study||1
10686817|NCT02452424|11850395|FG006|NOT COMPLETED|Overall Study||10
10686818|NCT02452424|11850396|FG007|NOT COMPLETED|Overall Study||4
10686819|NCT02452424|11850397|FG008|NOT COMPLETED|Overall Study||6
10686820|NCT02452424|11850398|FG009|NOT COMPLETED|Overall Study||2
10686821|NCT02452424|11850399|FG010|NOT COMPLETED|Overall Study||2
10686822|NCT02452463|11850428|FG000|STARTED|Overall Study||5
10686823|NCT02452463|11850429|FG001|STARTED|Overall Study||3
10686824|NCT02452463|11850430|FG002|STARTED|Overall Study|"No participants were enrolled in the Arm III (Nintedanib, Durvalumab) Arm."|0
10686825|NCT02452463|11850428|FG000|COMPLETED|Overall Study||3
10686826|NCT02452463|11850429|FG001|COMPLETED|Overall Study||1
10686827|NCT02452463|11850430|FG002|COMPLETED|Overall Study||0
10686828|NCT02452463|11850428|FG000|NOT COMPLETED|Overall Study||2
10686829|NCT02452463|11850429|FG001|NOT COMPLETED|Overall Study||2
10686830|NCT02452463|11850430|FG002|NOT COMPLETED|Overall Study||0
10686831|NCT02452476|11850440|FG000|STARTED|Overall Study||64
10686832|NCT02452476|11850441|FG001|STARTED|Overall Study||59
10686833|NCT02452476|11850440|FG000|COMPLETED|Overall Study||53
10686834|NCT02452476|11850441|FG001|COMPLETED|Overall Study||49
10686835|NCT02452476|11850440|FG000|NOT COMPLETED|Overall Study||11
10686836|NCT02452476|11850441|FG001|NOT COMPLETED|Overall Study||10
10686837|NCT02452528|11850449|FG000|STARTED|Overall Study||2
10686838|NCT02452528|11850450|FG001|STARTED|Overall Study||2
10686839|NCT02452528|11850449|FG000|COMPLETED|Overall Study||1
10686840|NCT02452528|11850450|FG001|COMPLETED|Overall Study||1
10686841|NCT02452528|11850449|FG000|NOT COMPLETED|Overall Study||1
10686842|NCT02452528|11850450|FG001|NOT COMPLETED|Overall Study||1
10800106|NCT04525079|11961020|FG001|STARTED|Overall Study||6
10800107|NCT04525079|11961021|FG002|STARTED|Overall Study||6
10686843|NCT02452762|11850458|FG000|STARTED|Overall Study||45
10686844|NCT02452762|11850459|FG001|STARTED|Overall Study||22
10686845|NCT02452762|11850458|FG000|COMPLETED|Overall Study||40
10686846|NCT02452762|11850459|FG001|COMPLETED|Overall Study||19
10800108|NCT04525079|11961022|FG003|STARTED|Overall Study||6
10800109|NCT04525079|11961023|FG004|STARTED|Overall Study||8
10686847|NCT02452762|11850458|FG000|NOT COMPLETED|Overall Study||5
10686848|NCT02452762|11850459|FG001|NOT COMPLETED|Overall Study||3
10686849|NCT02452866|11850466|FG000|STARTED|Overall Study||325
10686850|NCT02452866|11850466|FG000|COMPLETED|Overall Study||321
10686851|NCT02452866|11850466|FG000|NOT COMPLETED|Overall Study||4
10686852|NCT02452892|11850474|FG000|STARTED|Week 1 Initial Randommization||41
10686853|NCT02452892|11850475|FG001|STARTED|Week 1 Initial Randommization||40
10686854|NCT02452892|11850476|FG002|STARTED|Week 1 Initial Randommization||41
10686855|NCT02452892|11850477|FG003|STARTED|Week 1 Initial Randommization||0
10686856|NCT02452892|11850474|FG000|COMPLETED|Week 1 Initial Randommization||40
10686857|NCT02452892|11850475|FG001|COMPLETED|Week 1 Initial Randommization||40
10686858|NCT02452892|11850476|FG002|COMPLETED|Week 1 Initial Randommization||40
10686859|NCT02452892|11850477|FG003|COMPLETED|Week 1 Initial Randommization||0
10686860|NCT02452892|11850474|FG000|NOT COMPLETED|Week 1 Initial Randommization||1
10686861|NCT02452892|11850475|FG001|NOT COMPLETED|Week 1 Initial Randommization||0
10686862|NCT02452892|11850476|FG002|NOT COMPLETED|Week 1 Initial Randommization||1
10686863|NCT02452892|11850477|FG003|NOT COMPLETED|Week 1 Initial Randommization||0
10686864|NCT02452892|11850474|FG000|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that started LFMS sham (27), LFMS 20min (19), and LFMS 60min (19)|65
10686865|NCT02452892|11850475|FG001|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (0), LFMS 20min (7), and LFMS 60min(0).|7
10686866|NCT02452892|11850476|FG002|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (0),LFMS 20min (0), LFMS 60min (7)|7
10686867|NCT02452892|11850477|FG003|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (13), LFMS 20min (14), and LFMS 60 min (14).|41
10686868|NCT02452892|11850474|FG000|Non-reponders|Week 2 Stratification & Re-Randomization||38
10686869|NCT02452892|11850475|FG001|Non-reponders|Week 2 Stratification & Re-Randomization||0
10686870|NCT02452892|11850476|FG002|Non-reponders|Week 2 Stratification & Re-Randomization||0
10686871|NCT02452892|11850477|FG003|Non-reponders|Week 2 Stratification & Re-Randomization||41
10686872|NCT02452892|11850474|FG000|Responders|Week 2 Stratification & Re-Randomization||27
10686873|NCT02452892|11850475|FG001|Responders|Week 2 Stratification & Re-Randomization||7
10686874|NCT02452892|11850476|FG002|Responders|Week 2 Stratification & Re-Randomization||7
10686875|NCT02452892|11850477|FG003|Responders|Week 2 Stratification & Re-Randomization||0
10686876|NCT02452892|11850474|FG000|COMPLETED|Week 2 Stratification & Re-Randomization||63
10686877|NCT02452892|11850475|FG001|COMPLETED|Week 2 Stratification & Re-Randomization||7
10686878|NCT02452892|11850476|FG002|COMPLETED|Week 2 Stratification & Re-Randomization||7
10686879|NCT02452892|11850477|FG003|COMPLETED|Week 2 Stratification & Re-Randomization||39
10686880|NCT02452892|11850474|FG000|NOT COMPLETED|Week 2 Stratification & Re-Randomization||2
10686881|NCT02452892|11850475|FG001|NOT COMPLETED|Week 2 Stratification & Re-Randomization||0
10686882|NCT02452892|11850476|FG002|NOT COMPLETED|Week 2 Stratification & Re-Randomization||0
10686883|NCT02452892|11850477|FG003|NOT COMPLETED|Week 2 Stratification & Re-Randomization||2
10686884|NCT02452892|11850474|FG000|STARTED|Follow-up||63
10686885|NCT02452892|11850475|FG001|STARTED|Follow-up||7
10686886|NCT02452892|11850476|FG002|STARTED|Follow-up||7
10686887|NCT02452892|11850477|FG003|STARTED|Follow-up||39
10686888|NCT02452892|11850474|FG000|COMPLETED|Follow-up||62
10686889|NCT02452892|11850475|FG001|COMPLETED|Follow-up||7
10686890|NCT02452892|11850476|FG002|COMPLETED|Follow-up||7
10686891|NCT02452892|11850477|FG003|COMPLETED|Follow-up||38
10686892|NCT02452892|11850474|FG000|NOT COMPLETED|Follow-up||1
10686893|NCT02452892|11850475|FG001|NOT COMPLETED|Follow-up||0
10686894|NCT02452892|11850476|FG002|NOT COMPLETED|Follow-up||0
10686895|NCT02452892|11850477|FG003|NOT COMPLETED|Follow-up||1
10686896|NCT02452931|11850490|FG000|STARTED|Overall Study||64
10686897|NCT02452931|11850490|FG000|COMPLETED|Overall Study||60
10686898|NCT02452931|11850490|FG000|NOT COMPLETED|Overall Study||4
10686899|NCT02452944|11850496|FG000|STARTED|Overall Study||31
10686900|NCT02452944|11850497|FG001|STARTED|Overall Study||31
10686901|NCT02452944|11850496|FG000|COMPLETED|Overall Study||31
10686902|NCT02452944|11850497|FG001|COMPLETED|Overall Study||31
10686903|NCT02452944|11850496|FG000|NOT COMPLETED|Overall Study||0
10686904|NCT02452944|11850497|FG001|NOT COMPLETED|Overall Study||0
10686905|NCT02453048|11850510|FG000|STARTED|Overall Study||12
10686906|NCT02453048|11850511|FG001|STARTED|Overall Study||12
10686907|NCT02453048|11850512|FG002|STARTED|Overall Study||12
10686908|NCT02453048|11850513|FG003|STARTED|Overall Study||12
10686909|NCT02453048|11850514|FG004|STARTED|Overall Study||6
10686910|NCT02453048|11850510|FG000|6-month Follow-up|Overall Study||12
10686911|NCT02453048|11850511|FG001|6-month Follow-up|Overall Study||12
10686912|NCT02453048|11850512|FG002|6-month Follow-up|Overall Study||12
10686913|NCT02453048|11850513|FG003|6-month Follow-up|Overall Study||12
10686914|NCT02453048|11850514|FG004|6-month Follow-up|Overall Study||6
10686915|NCT02453048|11850510|FG000|COMPLETED|Overall Study||12
10686916|NCT02453048|11850511|FG001|COMPLETED|Overall Study||11
10686917|NCT02453048|11850512|FG002|COMPLETED|Overall Study||10
10686918|NCT02453048|11850513|FG003|COMPLETED|Overall Study||12
10686919|NCT02453048|11850514|FG004|COMPLETED|Overall Study||0
10686920|NCT02453048|11850510|FG000|NOT COMPLETED|Overall Study||0
10686921|NCT02453048|11850511|FG001|NOT COMPLETED|Overall Study||1
10800110|NCT04525079|11961019|FG000|COMPLETED|Overall Study||6
10686922|NCT02453048|11850512|FG002|NOT COMPLETED|Overall Study||2
10686923|NCT02453048|11850513|FG003|NOT COMPLETED|Overall Study||0
10686924|NCT02453048|11850514|FG004|NOT COMPLETED|Overall Study||6
10686925|NCT02453113|11850526|FG000|STARTED|Overall Study||10
10686926|NCT02453113|11850526|FG000|COMPLETED|Overall Study||10
10686927|NCT02453113|11850526|FG000|NOT COMPLETED|Overall Study||0
10686928|NCT02453191|11850530|FG000|STARTED|Overall Study||30
10686929|NCT02453191|11850530|FG000|COMPLETED|Overall Study||29
10686930|NCT02453191|11850530|FG000|NOT COMPLETED|Overall Study||1
10686931|NCT02453256|11850536|FG000|STARTED|Double Blind Period||106
10686932|NCT02453256|11850537|FG001|STARTED|Double Blind Period||104
10686933|NCT02453256|11850536|FG000|COMPLETED|Double Blind Period||93
10686934|NCT02453256|11850537|FG001|COMPLETED|Double Blind Period||95
10686935|NCT02453256|11850536|FG000|NOT COMPLETED|Double Blind Period||13
10686936|NCT02453256|11850537|FG001|NOT COMPLETED|Double Blind Period||9
10686937|NCT02453256|11850536|FG000|STARTED|Open Label Period||89
10686938|NCT02453256|11850537|FG001|STARTED|Open Label Period||92
10686939|NCT02453256|11850536|FG000|COMPLETED|Open Label Period||82
10686940|NCT02453256|11850537|FG001|COMPLETED|Open Label Period||85
10686941|NCT02453256|11850536|FG000|NOT COMPLETED|Open Label Period||7
10686942|NCT02453256|11850537|FG001|NOT COMPLETED|Open Label Period||7
10686955|NCT02453321|11850568|FG000|STARTED|Overall Study||20
10686956|NCT02453321|11850569|FG001|STARTED|Overall Study||21
10686957|NCT02453321|11850570|FG002|STARTED|Overall Study||21
10686958|NCT02453321|11850568|FG000|COMPLETED|Overall Study||19
10686959|NCT02453321|11850569|FG001|COMPLETED|Overall Study||19
10686960|NCT02453321|11850570|FG002|COMPLETED|Overall Study||19
10686961|NCT02453321|11850568|FG000|NOT COMPLETED|Overall Study||1
10686962|NCT02453321|11850569|FG001|NOT COMPLETED|Overall Study||2
10686963|NCT02453321|11850570|FG002|NOT COMPLETED|Overall Study||2
10686964|NCT02453334|11850583|FG000|STARTED|Overall Study||122
10686965|NCT02453334|11850584|FG001|STARTED|Overall Study||122
10686966|NCT02453334|11850583|FG000|COMPLETED|Overall Study||81
10686967|NCT02453334|11850584|FG001|COMPLETED|Overall Study||82
10686968|NCT02453334|11850583|FG000|NOT COMPLETED|Overall Study||41
10686969|NCT02453334|11850584|FG001|NOT COMPLETED|Overall Study||40
10686970|NCT02453347|11850590|FG000|STARTED|Overall Study||6
10686971|NCT02453347|11850590|FG000|COMPLETED|Overall Study||6
10686972|NCT02453347|11850590|FG000|NOT COMPLETED|Overall Study||0
10686973|NCT02453360|11850597|FG000|STARTED|Overall Study||20
10686974|NCT02453360|11850598|FG001|STARTED|Overall Study||20
10686975|NCT02453360|11850599|FG002|STARTED|Overall Study||20
10686976|NCT02453360|11850597|FG000|COMPLETED|Overall Study||20
10686977|NCT02453360|11850598|FG001|COMPLETED|Overall Study||20
10686978|NCT02453360|11850599|FG002|COMPLETED|Overall Study||20
10686979|NCT02453360|11850597|FG000|NOT COMPLETED|Overall Study||0
10686980|NCT02453360|11850598|FG001|NOT COMPLETED|Overall Study||0
10686981|NCT02453360|11850599|FG002|NOT COMPLETED|Overall Study||0
10686982|NCT02453386|11850610|FG000|STARTED|Overall Study||151
10686983|NCT02453386|11850611|FG001|STARTED|Overall Study||149
10686984|NCT02453386|11850612|FG002|STARTED|Overall Study||149
10686985|NCT02453386|11850610|FG000|COMPLETED|Overall Study||102
10686986|NCT02453386|11850611|FG001|COMPLETED|Overall Study||100
10686987|NCT02453386|11850612|FG002|COMPLETED|Overall Study||108
10686988|NCT02453386|11850610|FG000|NOT COMPLETED|Overall Study||49
10686989|NCT02453386|11850611|FG001|NOT COMPLETED|Overall Study||49
10686990|NCT02453386|11850612|FG002|NOT COMPLETED|Overall Study||41
10800111|NCT04525079|11961020|FG001|COMPLETED|Overall Study||6
10686991|NCT02453555|11850629|FG000|STARTED|24-week Double-blind Treatment Period|Started are treated subjects.|182
10686992|NCT02453555|11850630|FG001|STARTED|24-week Double-blind Treatment Period|Started are treated subjects.|93
10686993|NCT02453555|11850631|FG002|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
10686994|NCT02453555|11850632|FG003|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
10686995|NCT02453555|11850633|FG004|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
10686996|NCT02453555|11850634|FG005|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
10686997|NCT02453555|11850629|FG000|COMPLETED|24-week Double-blind Treatment Period||177
10686998|NCT02453555|11850630|FG001|COMPLETED|24-week Double-blind Treatment Period||86
10686999|NCT02453555|11850631|FG002|COMPLETED|24-week Double-blind Treatment Period||0
10687000|NCT02453555|11850632|FG003|COMPLETED|24-week Double-blind Treatment Period||0
10687001|NCT02453555|11850633|FG004|COMPLETED|24-week Double-blind Treatment Period||0
10687002|NCT02453555|11850634|FG005|COMPLETED|24-week Double-blind Treatment Period||0
10687003|NCT02453555|11850629|FG000|NOT COMPLETED|24-week Double-blind Treatment Period||5
10687004|NCT02453555|11850630|FG001|NOT COMPLETED|24-week Double-blind Treatment Period||7
10687005|NCT02453555|11850631|FG002|NOT COMPLETED|24-week Double-blind Treatment Period||0
10687006|NCT02453555|11850632|FG003|NOT COMPLETED|24-week Double-blind Treatment Period||0
10687007|NCT02453555|11850633|FG004|NOT COMPLETED|24-week Double-blind Treatment Period||0
10687008|NCT02453555|11850634|FG005|NOT COMPLETED|24-week Double-blind Treatment Period||0
10687009|NCT02453555|11850629|FG000|STARTED|Extension Period|This reporting group is not applicable in this period.|0
10687010|NCT02453555|11850630|FG001|STARTED|Extension Period|This reporting group is not applicable in this period.|0
10687011|NCT02453555|11850631|FG002|STARTED|Extension Period||126
10687012|NCT02453555|11850632|FG003|STARTED|Extension Period||51
10687013|NCT02453555|11850633|FG004|STARTED|Extension Period||80
10687014|NCT02453555|11850634|FG005|STARTED|Extension Period||6
10800112|NCT04525079|11961021|FG002|COMPLETED|Overall Study||6
10800113|NCT04525079|11961022|FG003|COMPLETED|Overall Study||6
10687015|NCT02453555|11850629|FG000|COMPLETED|Extension Period||0
10687016|NCT02453555|11850630|FG001|COMPLETED|Extension Period||0
10687017|NCT02453555|11850631|FG002|COMPLETED|Extension Period||123
10687018|NCT02453555|11850632|FG003|COMPLETED|Extension Period||49
10687019|NCT02453555|11850633|FG004|COMPLETED|Extension Period||79
10687020|NCT02453555|11850634|FG005|COMPLETED|Extension Period||5
10687021|NCT02453555|11850629|FG000|NOT COMPLETED|Extension Period||0
10687022|NCT02453555|11850630|FG001|NOT COMPLETED|Extension Period||0
10687023|NCT02453555|11850631|FG002|NOT COMPLETED|Extension Period||3
10687024|NCT02453555|11850632|FG003|NOT COMPLETED|Extension Period||2
10687025|NCT02453555|11850633|FG004|NOT COMPLETED|Extension Period||1
10687026|NCT02453555|11850634|FG005|NOT COMPLETED|Extension Period||1
10687027|NCT02453581|11850644|FG000|STARTED|Overall Study||8
10687028|NCT02453581|11850645|FG001|STARTED|Overall Study||8
10687029|NCT02453581|11850646|FG002|STARTED|Overall Study||8
10687030|NCT02453581|11850644|FG000|COMPLETED|Overall Study||8
10687031|NCT02453581|11850645|FG001|COMPLETED|Overall Study||8
10687032|NCT02453581|11850646|FG002|COMPLETED|Overall Study||8
10687033|NCT02453581|11850644|FG000|NOT COMPLETED|Overall Study||0
10687034|NCT02453581|11850645|FG001|NOT COMPLETED|Overall Study||0
10687035|NCT02453581|11850646|FG002|NOT COMPLETED|Overall Study||0
10687036|NCT02453672|11850666|FG000|STARTED|Overall Study||40
10687037|NCT02453672|11850667|FG001|STARTED|Overall Study||40
10687038|NCT02453672|11850668|FG002|STARTED|Overall Study||39
10687039|NCT02453672|11850666|FG000|COMPLETED|Overall Study||37
10687040|NCT02453672|11850667|FG001|COMPLETED|Overall Study||38
10687041|NCT02453672|11850668|FG002|COMPLETED|Overall Study||38
10687042|NCT02453672|11850666|FG000|NOT COMPLETED|Overall Study||3
10687043|NCT02453672|11850667|FG001|NOT COMPLETED|Overall Study||2
10687044|NCT02453672|11850668|FG002|NOT COMPLETED|Overall Study||1
10687045|NCT02453685|11850678|FG000|STARTED|Overall Study||168
10687046|NCT02453685|11850679|FG001|STARTED|Overall Study||167
10687047|NCT02453685|11850678|FG000|Exposed|Overall Study||166
10687048|NCT02453685|11850679|FG001|Exposed|Overall Study||166
10687049|NCT02453685|11850678|FG000|COMPLETED|Overall Study||149
10687050|NCT02453685|11850679|FG001|COMPLETED|Overall Study||155
10687051|NCT02453685|11850678|FG000|NOT COMPLETED|Overall Study||19
10687052|NCT02453685|11850679|FG001|NOT COMPLETED|Overall Study||12
10687053|NCT02453711|11850694|FG000|STARTED|Overall Study||103
10687054|NCT02453711|11850695|FG001|STARTED|Overall Study||102
10687055|NCT02453711|11850696|FG002|STARTED|Overall Study||103
10687056|NCT02453711|11850697|FG003|STARTED|Overall Study||103
10687057|NCT02453711|11850698|FG004|STARTED|Overall Study||102
10687058|NCT02453711|11850699|FG005|STARTED|Overall Study||102
10687059|NCT02453711|11850700|FG006|STARTED|Overall Study||103
10687060|NCT02453711|11850701|FG007|STARTED|Overall Study||103
10687061|NCT02453711|11850702|FG008|STARTED|Overall Study||136
10687062|NCT02453711|11850694|FG000|Full Analysis Set|Overall Study||103
10687063|NCT02453711|11850695|FG001|Full Analysis Set|Overall Study||102
10687064|NCT02453711|11850696|FG002|Full Analysis Set|Overall Study||103
10687065|NCT02453711|11850697|FG003|Full Analysis Set|Overall Study||103
10687066|NCT02453711|11850698|FG004|Full Analysis Set|Overall Study||102
10687067|NCT02453711|11850699|FG005|Full Analysis Set|Overall Study||102
10687068|NCT02453711|11850700|FG006|Full Analysis Set|Overall Study||103
10687069|NCT02453711|11850701|FG007|Full Analysis Set|Overall Study||103
10687070|NCT02453711|11850702|FG008|Full Analysis Set|Overall Study||136
10687071|NCT02453711|11850694|FG000|Safety Analysis Set|Overall Study||103
10687072|NCT02453711|11850695|FG001|Safety Analysis Set|Overall Study||102
10687073|NCT02453711|11850696|FG002|Safety Analysis Set|Overall Study||103
10687074|NCT02453711|11850697|FG003|Safety Analysis Set|Overall Study||103
10687075|NCT02453711|11850698|FG004|Safety Analysis Set|Overall Study||102
10687076|NCT02453711|11850699|FG005|Safety Analysis Set|Overall Study||102
10687077|NCT02453711|11850700|FG006|Safety Analysis Set|Overall Study||103
10687078|NCT02453711|11850701|FG007|Safety Analysis Set|Overall Study||103
10687079|NCT02453711|11850702|FG008|Safety Analysis Set|Overall Study||136
10687080|NCT02453711|11850694|FG000|COMPLETED|Overall Study||92
10687081|NCT02453711|11850695|FG001|COMPLETED|Overall Study||95
10687082|NCT02453711|11850696|FG002|COMPLETED|Overall Study||94
10687083|NCT02453711|11850697|FG003|COMPLETED|Overall Study||96
10687084|NCT02453711|11850698|FG004|COMPLETED|Overall Study||100
10687085|NCT02453711|11850699|FG005|COMPLETED|Overall Study||96
10687086|NCT02453711|11850700|FG006|COMPLETED|Overall Study||100
10687087|NCT02453711|11850701|FG007|COMPLETED|Overall Study||96
10687088|NCT02453711|11850702|FG008|COMPLETED|Overall Study||123
10687089|NCT02453711|11850694|FG000|NOT COMPLETED|Overall Study||11
10687090|NCT02453711|11850695|FG001|NOT COMPLETED|Overall Study||7
10687091|NCT02453711|11850696|FG002|NOT COMPLETED|Overall Study||9
10687092|NCT02453711|11850697|FG003|NOT COMPLETED|Overall Study||7
10687093|NCT02453711|11850698|FG004|NOT COMPLETED|Overall Study||2
10687094|NCT02453711|11850699|FG005|NOT COMPLETED|Overall Study||6
10687095|NCT02453711|11850700|FG006|NOT COMPLETED|Overall Study||3
10687096|NCT02453711|11850701|FG007|NOT COMPLETED|Overall Study||7
10687097|NCT02453711|11850702|FG008|NOT COMPLETED|Overall Study||13
10687098|NCT02453750|11850722|FG000|STARTED|Overall Study||21
10687099|NCT02453750|11850722|FG000|COMPLETED|Overall Study||21
10687100|NCT02453750|11850722|FG000|NOT COMPLETED|Overall Study||0
10687101|NCT02453841|11850729|FG000|STARTED|Overall Study||30
10687102|NCT02453841|11850729|FG000|COMPLETED|Overall Study||27
10687103|NCT02453841|11850729|FG000|NOT COMPLETED|Overall Study||3
10687104|NCT02454075|11850733|FG000|STARTED|Overall Study||3
10687105|NCT02454075|11850733|FG000|COMPLETED|Overall Study||3
10687106|NCT02454075|11850733|FG000|NOT COMPLETED|Overall Study||0
10687107|NCT02454101|11850741|FG000|STARTED|Overall Study||150
10687108|NCT02454101|11850742|FG001|STARTED|Overall Study||150
10687109|NCT02454101|11850741|FG000|COMPLETED|Overall Study||145
10687110|NCT02454101|11850742|FG001|COMPLETED|Overall Study||143
10800114|NCT04525079|11961023|FG004|COMPLETED|Overall Study||8
10800115|NCT04525079|11961019|FG000|NOT COMPLETED|Overall Study||0
10800116|NCT04525079|11961020|FG001|NOT COMPLETED|Overall Study||0
10800117|NCT04525079|11961021|FG002|NOT COMPLETED|Overall Study||0
10800118|NCT04525079|11961022|FG003|NOT COMPLETED|Overall Study||0
10800119|NCT04525079|11961023|FG004|NOT COMPLETED|Overall Study||0
10800120|NCT04527978|11961037|FG000|STARTED|First Wear Period (8 -0/+3 Days)||27
10800121|NCT04527978|11961038|FG001|STARTED|First Wear Period (8 -0/+3 Days)||28
10800122|NCT04527978|11961037|FG000|COMPLETED|First Wear Period (8 -0/+3 Days)||26
10687111|NCT02454101|11850741|FG000|NOT COMPLETED|Overall Study||5
10687112|NCT02454101|11850742|FG001|NOT COMPLETED|Overall Study||7
10687113|NCT02454127|11850752|FG000|STARTED|Overall Study||40
10687114|NCT02454127|11850753|FG001|STARTED|Overall Study||40
10687115|NCT02454127|11850754|FG002|STARTED|Overall Study||40
10687116|NCT02454127|11850755|FG003|STARTED|Overall Study||40
10687117|NCT02454127|11850752|FG000|COMPLETED|Overall Study||21
10687118|NCT02454127|11850753|FG001|COMPLETED|Overall Study||26
10687119|NCT02454127|11850754|FG002|COMPLETED|Overall Study||26
10687120|NCT02454127|11850755|FG003|COMPLETED|Overall Study||20
10687121|NCT02454127|11850752|FG000|NOT COMPLETED|Overall Study||19
10687122|NCT02454127|11850753|FG001|NOT COMPLETED|Overall Study||14
10800123|NCT04527978|11961038|FG001|COMPLETED|First Wear Period (8 -0/+3 Days)||28
10800124|NCT04527978|11961037|FG000|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||1
10800125|NCT04527978|11961038|FG001|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||0
10800126|NCT04527978|11961037|FG000|STARTED|Second Wear Period (8 -0/+3 Days)||26
10800127|NCT04527978|11961038|FG001|STARTED|Second Wear Period (8 -0/+3 Days)||28
10800128|NCT04527978|11961037|FG000|COMPLETED|Second Wear Period (8 -0/+3 Days)||26
10687123|NCT02454127|11850754|FG002|NOT COMPLETED|Overall Study||14
10687124|NCT02454127|11850755|FG003|NOT COMPLETED|Overall Study||20
10687125|NCT02454153|11850767|FG000|STARTED|Overall Study||92
10687126|NCT02454153|11850768|FG001|STARTED|Overall Study||92
10687127|NCT02454153|11850767|FG000|COMPLETED|Overall Study||92
10687128|NCT02454153|11850768|FG001|COMPLETED|Overall Study||92
10687129|NCT02454153|11850767|FG000|NOT COMPLETED|Overall Study||0
10687130|NCT02454153|11850768|FG001|NOT COMPLETED|Overall Study||0
10687131|NCT02454179|11850777|FG000|STARTED|Overall Study||39
10687132|NCT02454179|11850778|FG001|STARTED|Overall Study||39
10687133|NCT02454179|11850777|FG000|Enrolled|Overall Study||39
10687134|NCT02454179|11850778|FG001|Enrolled|Overall Study||39
10687135|NCT02454179|11850777|FG000|Received Study Medication|Overall Study||39
10687136|NCT02454179|11850778|FG001|Received Study Medication|Overall Study||37
10687137|NCT02454179|11850777|FG000|Discontinue Study|Overall Study||39
10687138|NCT02454179|11850778|FG001|Discontinue Study|Overall Study||39
10687139|NCT02454179|11850777|FG000|COMPLETED|Overall Study||0
10687140|NCT02454179|11850778|FG001|COMPLETED|Overall Study||0
10687141|NCT02454179|11850777|FG000|NOT COMPLETED|Overall Study||39
10687142|NCT02454179|11850778|FG001|NOT COMPLETED|Overall Study||39
10687143|NCT02454283|11850786|FG000|STARTED|Overall Study||26
10687144|NCT02454283|11850787|FG001|STARTED|Overall Study||15
10687145|NCT02454283|11850786|FG000|COMPLETED|Overall Study||26
10687146|NCT02454283|11850787|FG001|COMPLETED|Overall Study||15
10687147|NCT02454283|11850786|FG000|NOT COMPLETED|Overall Study||0
10687148|NCT02454283|11850787|FG001|NOT COMPLETED|Overall Study||0
10687149|NCT02454296|11850795|FG000|STARTED|Overall Study||20
10687150|NCT02454296|11850796|FG001|STARTED|Overall Study||21
10687151|NCT02454296|11850795|FG000|COMPLETED|Overall Study||20
10687152|NCT02454296|11850796|FG001|COMPLETED|Overall Study||21
10687153|NCT02454296|11850795|FG000|NOT COMPLETED|Overall Study||0
10687154|NCT02454296|11850796|FG001|NOT COMPLETED|Overall Study||0
10687155|NCT02454478|11850804|FG000|STARTED|Overall Study||7
10687156|NCT02454478|11850804|FG000|COMPLETED|Overall Study||6
10687157|NCT02454478|11850804|FG000|NOT COMPLETED|Overall Study||1
10800129|NCT04527978|11961038|FG001|COMPLETED|Second Wear Period (8 -0/+3 Days)||28
10800130|NCT04527978|11961037|FG000|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||0
10800131|NCT04527978|11961038|FG001|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||0
10687158|NCT02454530|11850810|FG000|STARTED|Overall Study||552
10687159|NCT02454530|11850811|FG001|STARTED|Overall Study||608
10687160|NCT02454530|11850810|FG000|COMPLETED|Overall Study||482
10687161|NCT02454530|11850811|FG001|COMPLETED|Overall Study||481
10687162|NCT02454530|11850810|FG000|NOT COMPLETED|Overall Study||70
10687163|NCT02454530|11850811|FG001|NOT COMPLETED|Overall Study||127
10687164|NCT02454608|11850821|FG000|STARTED|Double-Blind Period||15
10687165|NCT02454608|11850822|FG001|STARTED|Double-Blind Period||14
10687166|NCT02454608|11850823|FG002|STARTED|Double-Blind Period|This arm is not part of this period of the study|0
10687167|NCT02454608|11850821|FG000|COMPLETED|Double-Blind Period||15
10687168|NCT02454608|11850822|FG001|COMPLETED|Double-Blind Period||12
10687169|NCT02454608|11850823|FG002|COMPLETED|Double-Blind Period|This arm is not part of this period of the study|0
10687170|NCT02454608|11850821|FG000|NOT COMPLETED|Double-Blind Period||0
10687171|NCT02454608|11850822|FG001|NOT COMPLETED|Double-Blind Period||2
10687172|NCT02454608|11850823|FG002|NOT COMPLETED|Double-Blind Period||0
10687173|NCT02454608|11850821|FG000|STARTED|Open Label Period|This arm is not part of this period of the study|0
10687174|NCT02454608|11850822|FG001|STARTED|Open Label Period|This arm is not part of this period of the study|0
10687175|NCT02454608|11850823|FG002|STARTED|Open Label Period||29
10687176|NCT02454608|11850821|FG000|COMPLETED|Open Label Period|This arm is not part of this period of the study|0
10687177|NCT02454608|11850822|FG001|COMPLETED|Open Label Period|This arm is not part of this period of the study|0
10687178|NCT02454608|11850823|FG002|COMPLETED|Open Label Period||10
10687179|NCT02454608|11850821|FG000|NOT COMPLETED|Open Label Period||0
10687180|NCT02454608|11850822|FG001|NOT COMPLETED|Open Label Period||0
10687181|NCT02454608|11850823|FG002|NOT COMPLETED|Open Label Period||19
10687182|NCT02454959|11850831|FG000|STARTED|Overall Study||79
10687183|NCT02454959|11850831|FG000|GFF MDI (PT003) With Aerochamber|Overall Study||73
10687184|NCT02454959|11850831|FG000|GFF MDI (PT003) Without Aerochamber|Overall Study||77
10687185|NCT02454959|11850831|FG000|COMPLETED|Overall Study||70
10687186|NCT02454959|11850831|FG000|NOT COMPLETED|Overall Study||9
10687187|NCT02454972|11850846|FG000|STARTED|Overall Study||19
10687188|NCT02454972|11850847|FG001|STARTED|Overall Study||19
10687189|NCT02454972|11850848|FG002|STARTED|Overall Study||76
10687190|NCT02454972|11850849|FG003|STARTED|Overall Study||29
10687191|NCT02454972|11850850|FG004|STARTED|Overall Study||24
10687192|NCT02454972|11850851|FG005|STARTED|Overall Study||15
10687193|NCT02454972|11850852|FG006|STARTED|Overall Study||21
10687194|NCT02454972|11850853|FG007|STARTED|Overall Study||32
10687195|NCT02454972|11850854|FG008|STARTED|Overall Study||110
10687196|NCT02454972|11850846|FG000|Treated|Overall Study||19
10687197|NCT02454972|11850847|FG001|Treated|Overall Study||19
10687198|NCT02454972|11850848|FG002|Treated|Overall Study||73
10687199|NCT02454972|11850849|FG003|Treated|Overall Study||28
10687200|NCT02454972|11850850|FG004|Treated|Overall Study||23
10687201|NCT02454972|11850851|FG005|Treated|Overall Study||15
10687202|NCT02454972|11850852|FG006|Treated|Overall Study||21
10687203|NCT02454972|11850853|FG007|Treated|Overall Study||32
10687204|NCT02454972|11850854|FG008|Treated|Overall Study||105
10687205|NCT02454972|11850846|FG000|COMPLETED|Overall Study||0
10687206|NCT02454972|11850847|FG001|COMPLETED|Overall Study||0
10687207|NCT02454972|11850848|FG002|COMPLETED|Overall Study||0
10687208|NCT02454972|11850849|FG003|COMPLETED|Overall Study||0
10687209|NCT02454972|11850850|FG004|COMPLETED|Overall Study||0
10687210|NCT02454972|11850851|FG005|COMPLETED|Overall Study||0
10687211|NCT02454972|11850852|FG006|COMPLETED|Overall Study||0
10687212|NCT02454972|11850853|FG007|COMPLETED|Overall Study||0
10687213|NCT02454972|11850854|FG008|COMPLETED|Overall Study||0
10687214|NCT02454972|11850846|FG000|NOT COMPLETED|Overall Study||19
10687215|NCT02454972|11850847|FG001|NOT COMPLETED|Overall Study||19
10687216|NCT02454972|11850848|FG002|NOT COMPLETED|Overall Study||76
10687217|NCT02454972|11850849|FG003|NOT COMPLETED|Overall Study||29
10687218|NCT02454972|11850850|FG004|NOT COMPLETED|Overall Study||24
10687219|NCT02454972|11850851|FG005|NOT COMPLETED|Overall Study||15
10687220|NCT02454972|11850852|FG006|NOT COMPLETED|Overall Study||21
10687221|NCT02454972|11850853|FG007|NOT COMPLETED|Overall Study||32
10687222|NCT02454972|11850854|FG008|NOT COMPLETED|Overall Study||110
10687223|NCT02455050|11850870|FG000|STARTED|Treatment Period 1||20
10687224|NCT02455050|11850871|FG001|STARTED|Treatment Period 1||19
10687225|NCT02455050|11850872|FG002|STARTED|Treatment Period 1||20
10687226|NCT02455050|11850873|FG003|STARTED|Treatment Period 1||20
10687227|NCT02455050|11850870|FG000|COMPLETED|Treatment Period 1||19
10687228|NCT02455050|11850871|FG001|COMPLETED|Treatment Period 1||18
10687229|NCT02455050|11850872|FG002|COMPLETED|Treatment Period 1||19
10687230|NCT02455050|11850873|FG003|COMPLETED|Treatment Period 1||18
10687231|NCT02455050|11850870|FG000|NOT COMPLETED|Treatment Period 1||1
10687232|NCT02455050|11850871|FG001|NOT COMPLETED|Treatment Period 1||1
10687233|NCT02455050|11850872|FG002|NOT COMPLETED|Treatment Period 1||1
10687234|NCT02455050|11850873|FG003|NOT COMPLETED|Treatment Period 1||2
10687235|NCT02455050|11850870|FG000|STARTED|Treatment Period 2||19
10687236|NCT02455050|11850871|FG001|STARTED|Treatment Period 2||18
10687237|NCT02455050|11850872|FG002|STARTED|Treatment Period 2||19
10687238|NCT02455050|11850873|FG003|STARTED|Treatment Period 2||18
10687239|NCT02455050|11850870|FG000|COMPLETED|Treatment Period 2||18
10687240|NCT02455050|11850871|FG001|COMPLETED|Treatment Period 2||18
10687241|NCT02455050|11850872|FG002|COMPLETED|Treatment Period 2||17
10687242|NCT02455050|11850873|FG003|COMPLETED|Treatment Period 2||17
10687243|NCT02455050|11850870|FG000|NOT COMPLETED|Treatment Period 2||1
10687244|NCT02455050|11850871|FG001|NOT COMPLETED|Treatment Period 2||0
10687245|NCT02455050|11850872|FG002|NOT COMPLETED|Treatment Period 2||2
10687246|NCT02455050|11850873|FG003|NOT COMPLETED|Treatment Period 2||1
10687247|NCT02455076|11850898|FG000|STARTED|Inpatient||47
10687248|NCT02455076|11850899|FG001|STARTED|Inpatient||51
10687249|NCT02455076|11850900|FG002|STARTED|Inpatient||52
10687250|NCT02455076|11850901|FG003|STARTED|Inpatient||0
10687251|NCT02455076|11850902|FG004|STARTED|Inpatient||0
10687252|NCT02455076|11850898|FG000|COMPLETED|Inpatient||43
10687253|NCT02455076|11850899|FG001|COMPLETED|Inpatient||50
10687254|NCT02455076|11850900|FG002|COMPLETED|Inpatient||52
10687255|NCT02455076|11850901|FG003|COMPLETED|Inpatient||0
10687256|NCT02455076|11850902|FG004|COMPLETED|Inpatient||0
10687257|NCT02455076|11850898|FG000|NOT COMPLETED|Inpatient||4
10687258|NCT02455076|11850899|FG001|NOT COMPLETED|Inpatient||1
10687259|NCT02455076|11850900|FG002|NOT COMPLETED|Inpatient||0
10687260|NCT02455076|11850901|FG003|NOT COMPLETED|Inpatient||0
10687261|NCT02455076|11850902|FG004|NOT COMPLETED|Inpatient||0
10687262|NCT02455076|11850898|FG000|STARTED|Outpatient||0
10687263|NCT02455076|11850899|FG001|STARTED|Outpatient||0
10687264|NCT02455076|11850900|FG002|STARTED|Outpatient||0
10687265|NCT02455076|11850901|FG003|STARTED|Outpatient||48
10687266|NCT02455076|11850902|FG004|STARTED|Outpatient||55
10687267|NCT02455076|11850898|FG000|COMPLETED|Outpatient||0
10687268|NCT02455076|11850899|FG001|COMPLETED|Outpatient||0
10687269|NCT02455076|11850900|FG002|COMPLETED|Outpatient||0
10687270|NCT02455076|11850901|FG003|COMPLETED|Outpatient||42
10687271|NCT02455076|11850902|FG004|COMPLETED|Outpatient||43
10687272|NCT02455076|11850898|FG000|NOT COMPLETED|Outpatient||0
10687273|NCT02455076|11850899|FG001|NOT COMPLETED|Outpatient||0
10687274|NCT02455076|11850900|FG002|NOT COMPLETED|Outpatient||0
10687275|NCT02455076|11850901|FG003|NOT COMPLETED|Outpatient||6
10687276|NCT02455076|11850902|FG004|NOT COMPLETED|Outpatient||12
10687277|NCT02455167|11850914|FG000|STARTED|Overall Study||4
10687278|NCT02455167|11850914|FG000|COMPLETED|Overall Study||4
10687279|NCT02455167|11850914|FG000|NOT COMPLETED|Overall Study||0
10687280|NCT02455336|11850920|FG000|STARTED|Overall Study||15
10687281|NCT02455336|11850921|FG001|STARTED|Overall Study||8
10687282|NCT02455336|11850920|FG000|COMPLETED|Overall Study||10
10687283|NCT02455336|11850921|FG001|COMPLETED|Overall Study||6
10687284|NCT02455336|11850920|FG000|NOT COMPLETED|Overall Study||5
10687285|NCT02455336|11850921|FG001|NOT COMPLETED|Overall Study||2
10687286|NCT02455388|11850929|FG000|STARTED|Overall Study||18
10687287|NCT02455388|11850930|FG001|STARTED|Overall Study||15
10687288|NCT02455388|11850931|FG002|STARTED|Overall Study||337
10687289|NCT02455388|11850929|FG000|COMPLETED|Overall Study||17
10687290|NCT02455388|11850930|FG001|COMPLETED|Overall Study||15
10687291|NCT02455388|11850931|FG002|COMPLETED|Overall Study||326
10687292|NCT02455388|11850929|FG000|NOT COMPLETED|Overall Study||1
10687293|NCT02455388|11850930|FG001|NOT COMPLETED|Overall Study||0
10687294|NCT02455388|11850931|FG002|NOT COMPLETED|Overall Study||11
10687295|NCT02455453|11850939|FG000|STARTED|Overall Study||47
10687296|NCT02455453|11850939|FG000|COMPLETED|Overall Study||47
10687297|NCT02455453|11850939|FG000|NOT COMPLETED|Overall Study||0
10687298|NCT02455518|11850947|FG000|STARTED|Overall Study||104
10687299|NCT02455518|11850948|FG001|STARTED|Overall Study||104
10687300|NCT02455518|11850949|FG002|STARTED|Overall Study||104
10687301|NCT02455518|11850950|FG003|STARTED|Overall Study||104
10687302|NCT02455518|11850947|FG000|COMPLETED|Overall Study||104
10687303|NCT02455518|11850948|FG001|COMPLETED|Overall Study||103
10687304|NCT02455518|11850949|FG002|COMPLETED|Overall Study||103
10687305|NCT02455518|11850950|FG003|COMPLETED|Overall Study||101
10687306|NCT02455518|11850947|FG000|NOT COMPLETED|Overall Study||0
10687307|NCT02455518|11850948|FG001|NOT COMPLETED|Overall Study||1
10687308|NCT02455518|11850949|FG002|NOT COMPLETED|Overall Study||1
10687309|NCT02455518|11850950|FG003|NOT COMPLETED|Overall Study||3
10687310|NCT02456103|11850960|FG000|STARTED|Overall Study||246
10687311|NCT02456103|11850960|FG000|As-Treated Population|Overall Study||245
10687312|NCT02456103|11850960|FG000|Intent-to-treat (ITT) Population|Overall Study||244
10687313|NCT02456103|11850960|FG000|COMPLETED|Overall Study||0
10687314|NCT02456103|11850960|FG000|NOT COMPLETED|Overall Study||246
10687315|NCT02456636|11850967|FG000|STARTED|Overall Study||478
10687316|NCT02456636|11850968|FG001|STARTED|Overall Study||479
10687317|NCT02456636|11850969|FG002|STARTED|Overall Study||475
10687318|NCT02456636|11850967|FG000|6 Month|Overall Study||474
10687319|NCT02456636|11850968|FG001|6 Month|Overall Study||474
10687320|NCT02456636|11850969|FG002|6 Month|Overall Study||468
10687321|NCT02456636|11850967|FG000|18 Month|Overall Study||467
10687322|NCT02456636|11850968|FG001|18 Month|Overall Study||463
10687323|NCT02456636|11850969|FG002|18 Month|Overall Study||461
10687324|NCT02456636|11850967|FG000|COMPLETED|Overall Study||410
10687325|NCT02456636|11850968|FG001|COMPLETED|Overall Study||410
10687326|NCT02456636|11850969|FG002|COMPLETED|Overall Study||400
10687327|NCT02456636|11850967|FG000|NOT COMPLETED|Overall Study||68
10687328|NCT02456636|11850968|FG001|NOT COMPLETED|Overall Study||69
10687329|NCT02456636|11850969|FG002|NOT COMPLETED|Overall Study||75
10687330|NCT02456662|11850979|FG000|STARTED|Overall Study||159
10687331|NCT02456662|11850980|FG001|STARTED|Overall Study||160
10687332|NCT02456662|11850979|FG000|COMPLETED|Overall Study||157
10687333|NCT02456662|11850980|FG001|COMPLETED|Overall Study||159
10687334|NCT02456662|11850979|FG000|NOT COMPLETED|Overall Study||2
10687335|NCT02456662|11850980|FG001|NOT COMPLETED|Overall Study||1
10687336|NCT02456727|11850988|FG000|STARTED|Overall Study||389
10687337|NCT02456727|11850989|FG001|STARTED|Overall Study||390
10687338|NCT02456727|11850988|FG000|Initiated Treatment|Overall Study||346
10687339|NCT02456727|11850989|FG001|Initiated Treatment|Overall Study||360
10687340|NCT02456727|11850988|FG000|6 Week|Overall Study||298
10687341|NCT02456727|11850989|FG001|6 Week|Overall Study||320
10687342|NCT02456727|11850988|FG000|12 Week|Overall Study||295
10687343|NCT02456727|11850989|FG001|12 Week|Overall Study||310
10687344|NCT02456727|11850988|FG000|24 Week|Overall Study||280
10687345|NCT02456727|11850989|FG001|24 Week|Overall Study||284
10687346|NCT02456727|11850988|FG000|COMPLETED|Overall Study||280
10687347|NCT02456727|11850989|FG001|COMPLETED|Overall Study||284
10687348|NCT02456727|11850988|FG000|NOT COMPLETED|Overall Study||109
10687349|NCT02456727|11850989|FG001|NOT COMPLETED|Overall Study||106
10687350|NCT02456896|11851013|FG000|STARTED|Overall Study||25
10687351|NCT02456896|11851014|FG001|STARTED|Overall Study||25
10687352|NCT02456896|11851013|FG000|COMPLETED|Overall Study||19
10687353|NCT02456896|11851014|FG001|COMPLETED|Overall Study||21
10687354|NCT02456896|11851013|FG000|NOT COMPLETED|Overall Study||6
10687355|NCT02456896|11851014|FG001|NOT COMPLETED|Overall Study||4
10687356|NCT02456909|11851022|FG000|STARTED|Overall Study||88
10687357|NCT02456909|11851023|FG001|STARTED|Overall Study||88
10687358|NCT02456909|11851022|FG000|COMPLETED|Overall Study||64
10687359|NCT02456909|11851023|FG001|COMPLETED|Overall Study||61
10687360|NCT02456909|11851022|FG000|NOT COMPLETED|Overall Study||24
10687361|NCT02456909|11851023|FG001|NOT COMPLETED|Overall Study||27
10687362|NCT02457065|11851031|FG000|STARTED|Overall Study||27
10687363|NCT02457065|11851032|FG001|STARTED|Overall Study||27
10687364|NCT02457065|11851031|FG000|COMPLETED|Overall Study||18
10687365|NCT02457065|11851032|FG001|COMPLETED|Overall Study||16
10687366|NCT02457065|11851031|FG000|NOT COMPLETED|Overall Study||9
10687367|NCT02457065|11851032|FG001|NOT COMPLETED|Overall Study||11
10713115|NCT02677116|11878648|FG004|NOT COMPLETED|Overall Study||1
10713116|NCT02677116|11878649|FG005|NOT COMPLETED|Overall Study||4
10713117|NCT02677116|11878650|FG006|NOT COMPLETED|Overall Study||4
10713118|NCT02677116|11878651|FG007|NOT COMPLETED|Overall Study||2
10713119|NCT02677116|11878652|FG008|NOT COMPLETED|Overall Study||2
10713120|NCT02677220|11878695|FG000|STARTED|Overall Study||1
10713121|NCT02677220|11878695|FG000|COMPLETED|Overall Study||0
10713122|NCT02677220|11878695|FG000|NOT COMPLETED|Overall Study||1
10713123|NCT02677428|11878702|FG000|STARTED|Overall Study||63
10713124|NCT02677428|11878703|FG001|STARTED|Overall Study||55
10713125|NCT02677428|11878702|FG000|COMPLETED|Overall Study||63
10713126|NCT02677428|11878703|FG001|COMPLETED|Overall Study||55
10713127|NCT02677428|11878702|FG000|NOT COMPLETED|Overall Study||0
10713128|NCT02677428|11878703|FG001|NOT COMPLETED|Overall Study||0
10713129|NCT02677493|11878712|FG000|STARTED|Overall Study||1197
10713130|NCT02677493|11878713|FG001|STARTED|Overall Study||298
10713131|NCT02677493|11878714|FG002|STARTED|Overall Study||299
10713132|NCT02677493|11878712|FG000|COMPLETED|Overall Study||1186
10713133|NCT02677493|11878713|FG001|COMPLETED|Overall Study||296
10713134|NCT02677493|11878714|FG002|COMPLETED|Overall Study||296
10713135|NCT02677493|11878712|FG000|NOT COMPLETED|Overall Study||11
10713136|NCT02677493|11878713|FG001|NOT COMPLETED|Overall Study||2
10713137|NCT02677493|11878714|FG002|NOT COMPLETED|Overall Study||3
10713138|NCT02677623|11878729|FG000|STARTED|Overall Study||33
10713139|NCT02677623|11878730|FG001|STARTED|Overall Study||32
10713140|NCT02677623|11878731|FG002|STARTED|Overall Study||32
10713141|NCT02677623|11878732|FG003|STARTED|Overall Study||33
10713142|NCT02677623|11878729|FG000|COMPLETED|Overall Study||33
10713143|NCT02677623|11878730|FG001|COMPLETED|Overall Study||32
10713144|NCT02677623|11878731|FG002|COMPLETED|Overall Study||32
10713145|NCT02677623|11878732|FG003|COMPLETED|Overall Study||33
10713146|NCT02677623|11878729|FG000|NOT COMPLETED|Overall Study||0
10713147|NCT02677623|11878730|FG001|NOT COMPLETED|Overall Study||0
10713148|NCT02677623|11878731|FG002|NOT COMPLETED|Overall Study||0
10713149|NCT02677623|11878732|FG003|NOT COMPLETED|Overall Study||0
10713150|NCT02677701|11878744|FG000|STARTED|Overall Study||62
10713151|NCT02677701|11878745|FG001|STARTED|Overall Study||57
10713152|NCT02677701|11878744|FG000|Treated|Overall Study||61
10713153|NCT02677701|11878745|FG001|Treated|Overall Study||54
10713154|NCT02677701|11878744|FG000|COMPLETED|Overall Study||56
10713155|NCT02677701|11878745|FG001|COMPLETED|Overall Study||52
10713156|NCT02677701|11878744|FG000|NOT COMPLETED|Overall Study||6
10713157|NCT02677701|11878745|FG001|NOT COMPLETED|Overall Study||5
10713158|NCT02677714|11878753|FG000|STARTED|Overall Study||12
10713159|NCT02677714|11878754|FG001|STARTED|Overall Study||2
10713160|NCT02677714|11878753|FG000|COMPLETED|Overall Study||10
10713161|NCT02677714|11878754|FG001|COMPLETED|Overall Study||2
10713162|NCT02677714|11878753|FG000|NOT COMPLETED|Overall Study||2
10713163|NCT02677714|11878754|FG001|NOT COMPLETED|Overall Study||0
10713164|NCT02677740|11878762|FG000|STARTED|Overall Study||7
10713165|NCT02677740|11878763|FG001|STARTED|Overall Study||1
10713166|NCT02677740|11878762|FG000|COMPLETED|Overall Study||7
10713167|NCT02677740|11878763|FG001|COMPLETED|Overall Study||1
10713168|NCT02677740|11878762|FG000|NOT COMPLETED|Overall Study||0
10713169|NCT02677740|11878763|FG001|NOT COMPLETED|Overall Study||0
10713170|NCT02677753|11878771|FG000|STARTED|Overall Study||37
10713171|NCT02677753|11878772|FG001|STARTED|Overall Study||38
10713172|NCT02677753|11878771|FG000|COMPLETED|Overall Study||36
10713173|NCT02677753|11878772|FG001|COMPLETED|Overall Study||38
10713174|NCT02677753|11878771|FG000|NOT COMPLETED|Overall Study||1
10713175|NCT02677753|11878772|FG001|NOT COMPLETED|Overall Study||0
10713176|NCT02677766|11878780|FG000|STARTED|Overall Study||20
10713177|NCT02677766|11878781|FG001|STARTED|Overall Study||20
10713178|NCT02677766|11878780|FG000|COMPLETED|Overall Study||15
10687368|NCT02457182|11851040|FG000|STARTED|Overall Study||9
10687369|NCT02457182|11851041|FG001|STARTED|Overall Study||11
10687370|NCT02457182|11851040|FG000|COMPLETED|Overall Study||8
10687371|NCT02457182|11851041|FG001|COMPLETED|Overall Study||11
10687372|NCT02457182|11851040|FG000|NOT COMPLETED|Overall Study||1
10687373|NCT02457182|11851041|FG001|NOT COMPLETED|Overall Study||0
10687374|NCT02457195|11851047|FG000|STARTED|Overall Study||50
10687375|NCT02457195|11851047|FG000|COMPLETED|Overall Study||41
10687376|NCT02457195|11851047|FG000|NOT COMPLETED|Overall Study||9
10687377|NCT02457247|11851055|FG000|STARTED|Period 1||68
10687378|NCT02457247|11851056|FG001|STARTED|Period 1||70
10687379|NCT02457247|11851057|FG002|STARTED|Period 1||68
10687380|NCT02457247|11851058|FG003|STARTED|Period 1||70
10687381|NCT02457247|11851055|FG000|COMPLETED|Period 1||66
10687382|NCT02457247|11851056|FG001|COMPLETED|Period 1||68
10687383|NCT02457247|11851057|FG002|COMPLETED|Period 1||68
10687384|NCT02457247|11851058|FG003|COMPLETED|Period 1||70
10687385|NCT02457247|11851055|FG000|NOT COMPLETED|Period 1||2
10687386|NCT02457247|11851056|FG001|NOT COMPLETED|Period 1||2
10687387|NCT02457247|11851057|FG002|NOT COMPLETED|Period 1||0
10687388|NCT02457247|11851058|FG003|NOT COMPLETED|Period 1||0
10687389|NCT02457247|11851055|FG000|STARTED|Period 2||66
10687390|NCT02457247|11851056|FG001|STARTED|Period 2||68
10687391|NCT02457247|11851057|FG002|STARTED|Period 2||68
10687392|NCT02457247|11851058|FG003|STARTED|Period 2||70
10687393|NCT02457247|11851055|FG000|COMPLETED|Period 2||64
10687394|NCT02457247|11851056|FG001|COMPLETED|Period 2||65
10687395|NCT02457247|11851057|FG002|COMPLETED|Period 2||68
10687396|NCT02457247|11851058|FG003|COMPLETED|Period 2||70
10687397|NCT02457247|11851055|FG000|NOT COMPLETED|Period 2||2
10687398|NCT02457247|11851056|FG001|NOT COMPLETED|Period 2||3
10687399|NCT02457247|11851057|FG002|NOT COMPLETED|Period 2||0
10687400|NCT02457247|11851058|FG003|NOT COMPLETED|Period 2||0
10687401|NCT02457260|11851077|FG000|STARTED|Overall Study||12
10687402|NCT02457260|11851078|FG001|STARTED|Overall Study||7
10687403|NCT02457260|11851079|FG002|STARTED|Overall Study||2
10687404|NCT02457260|11851077|FG000|COMPLETED|Overall Study||10
10687405|NCT02457260|11851078|FG001|COMPLETED|Overall Study||4
10687406|NCT02457260|11851079|FG002|COMPLETED|Overall Study||1
10687407|NCT02457260|11851077|FG000|NOT COMPLETED|Overall Study||2
10687408|NCT02457260|11851078|FG001|NOT COMPLETED|Overall Study||3
10687409|NCT02457260|11851079|FG002|NOT COMPLETED|Overall Study||1
10687410|NCT02457325|11851090|FG000|STARTED|First Intervention (1 Day)||25
10687411|NCT02457325|11851091|FG001|STARTED|First Intervention (1 Day)||25
10687412|NCT02457325|11851090|FG000|COMPLETED|First Intervention (1 Day)||23
10687413|NCT02457325|11851091|FG001|COMPLETED|First Intervention (1 Day)||23
10687414|NCT02457325|11851090|FG000|NOT COMPLETED|First Intervention (1 Day)||2
10687415|NCT02457325|11851091|FG001|NOT COMPLETED|First Intervention (1 Day)||2
10687416|NCT02457325|11851090|FG000|STARTED|Washout (1-2 Months)||23
10687417|NCT02457325|11851091|FG001|STARTED|Washout (1-2 Months)||23
10687418|NCT02457325|11851090|FG000|COMPLETED|Washout (1-2 Months)||23
10687419|NCT02457325|11851091|FG001|COMPLETED|Washout (1-2 Months)||23
10687420|NCT02457325|11851090|FG000|NOT COMPLETED|Washout (1-2 Months)||0
10687421|NCT02457325|11851091|FG001|NOT COMPLETED|Washout (1-2 Months)||0
10687422|NCT02457325|11851090|FG000|STARTED|Second Intervention (1 Day)||23
10687423|NCT02457325|11851091|FG001|STARTED|Second Intervention (1 Day)||23
10687424|NCT02457325|11851090|FG000|COMPLETED|Second Intervention (1 Day)||23
10687425|NCT02457325|11851091|FG001|COMPLETED|Second Intervention (1 Day)||23
10687426|NCT02457325|11851090|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10687427|NCT02457325|11851091|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10687428|NCT02457403|11851099|FG000|STARTED|Overall Study|34 participants|34
10687429|NCT02457403|11851100|FG001|STARTED|Overall Study|34 historic controls|34
10687430|NCT02457403|11851099|FG000|COMPLETED|Overall Study||34
10687431|NCT02457403|11851100|FG001|COMPLETED|Overall Study||34
10687432|NCT02457403|11851099|FG000|NOT COMPLETED|Overall Study||0
10687433|NCT02457403|11851100|FG001|NOT COMPLETED|Overall Study||0
10687434|NCT02457520|11851108|FG000|STARTED|Active Treatment Phase|All subjects received treatment according to the same regimen.|201
10687435|NCT02457520|11851108|FG000|COMPLETED|Active Treatment Phase||167
10687436|NCT02457520|11851108|FG000|NOT COMPLETED|Active Treatment Phase||34
10687437|NCT02457520|11851108|FG000|STARTED|Post-treatment Period||167
10687438|NCT02457520|11851108|FG000|COMPLETED|Post-treatment Period||119
10687439|NCT02457520|11851108|FG000|NOT COMPLETED|Post-treatment Period||48
10687440|NCT02457546|11851140|FG000|STARTED|Overall Study||114
10687441|NCT02457546|11851141|FG001|STARTED|Overall Study||120
10687442|NCT02457546|11851140|FG000|COMPLETED|Overall Study||105
10687443|NCT02457546|11851141|FG001|COMPLETED|Overall Study||116
10687444|NCT02457546|11851140|FG000|NOT COMPLETED|Overall Study||9
10687445|NCT02457546|11851141|FG001|NOT COMPLETED|Overall Study||4
10687446|NCT02457611|11851147|FG000|STARTED|Overall Study||26
10687447|NCT02457611|11851147|FG000|COMPLETED|Overall Study||23
10687448|NCT02457611|11851147|FG000|NOT COMPLETED|Overall Study||3
10687449|NCT02457637|11851151|FG000|STARTED|Recruitment|2600 is the number of inpatients who met our eligibility.|2600
10687450|NCT02457637|11851151|FG000|COMPLETED|Recruitment|2361 patients were excluded according to our exclusion criteria,2600 patients remained.|2600
10687451|NCT02457637|11851151|FG000|NOT COMPLETED|Recruitment||0
10687452|NCT02457637|11851151|FG000|STARTED|28-Days Hospitalization and Observation||2600
10687453|NCT02457637|11851151|FG000|Liver Transplantation|28-Days Hospitalization and Observation||124
10687454|NCT02457637|11851151|FG000|Death|28-Days Hospitalization and Observation||74
10713179|NCT02677766|11878781|FG001|COMPLETED|Overall Study||17
10687455|NCT02457637|11851151|FG000|COMPLETED|28-Days Hospitalization and Observation|Death and receiving Liver transplantation are two end points of our observation.|2600
10687456|NCT02457637|11851151|FG000|NOT COMPLETED|28-Days Hospitalization and Observation||0
10687457|NCT02457637|11851151|FG000|STARTED|Clinic or Telephone Follow-up||2600
10687545|NCT02458469|11851251|FG004|STARTED|First Washout (2 Weeks)||1
10687458|NCT02457637|11851151|FG000|One-year Liver Transplantation|Clinic or Telephone Follow-up||182
10687459|NCT02457637|11851151|FG000|One-year Death|Clinic or Telephone Follow-up||475
10687460|NCT02457637|11851151|FG000|COMPLETED|Clinic or Telephone Follow-up||2529
10687461|NCT02457637|11851151|FG000|NOT COMPLETED|Clinic or Telephone Follow-up||71
10687462|NCT02457728|11851156|FG000|STARTED|Overall Study||34
10687463|NCT02457728|11851156|FG000|COMPLETED|Overall Study||34
10687464|NCT02457728|11851156|FG000|NOT COMPLETED|Overall Study||0
10687465|NCT02457793|11851166|FG000|STARTED|Overall Study||1
10687466|NCT02457793|11851167|FG001|STARTED|Overall Study||5
10687467|NCT02457793|11851168|FG002|STARTED|Overall Study||3
10687468|NCT02457793|11851169|FG003|STARTED|Overall Study||5
10687469|NCT02457793|11851170|FG004|STARTED|Overall Study||4
10687470|NCT02457793|11851171|FG005|STARTED|Overall Study||6
10687471|NCT02457793|11851166|FG000|COMPLETED|Overall Study||0
10687472|NCT02457793|11851167|FG001|COMPLETED|Overall Study||1
10687473|NCT02457793|11851168|FG002|COMPLETED|Overall Study||0
10687474|NCT02457793|11851169|FG003|COMPLETED|Overall Study||0
10687475|NCT02457793|11851170|FG004|COMPLETED|Overall Study||0
10687476|NCT02457793|11851171|FG005|COMPLETED|Overall Study||0
10687477|NCT02457793|11851166|FG000|NOT COMPLETED|Overall Study||1
10687478|NCT02457793|11851167|FG001|NOT COMPLETED|Overall Study||4
10687479|NCT02457793|11851168|FG002|NOT COMPLETED|Overall Study||3
10687480|NCT02457793|11851169|FG003|NOT COMPLETED|Overall Study||5
10687481|NCT02457793|11851170|FG004|NOT COMPLETED|Overall Study||4
10687482|NCT02457793|11851171|FG005|NOT COMPLETED|Overall Study||6
10687483|NCT02457819|11851186|FG000|STARTED|Overall Study||237
10687484|NCT02457819|11851186|FG000|Safety Population|Overall Study||236
10687485|NCT02457819|11851186|FG000|COMPLETED|Overall Study||138
10687486|NCT02457819|11851186|FG000|NOT COMPLETED|Overall Study||99
10687487|NCT02457897|11851190|FG000|STARTED|Part 1 Short-term (2 Weeks) Study||7
10687488|NCT02457897|11851190|FG000|COMPLETED|Part 1 Short-term (2 Weeks) Study||7
10687489|NCT02457897|11851190|FG000|NOT COMPLETED|Part 1 Short-term (2 Weeks) Study||0
10687490|NCT02457897|11851190|FG000|STARTED|Part 2 Long-term (6 Month) Study|Two patients were not eligible for Part 2 study because their HbA1c was less than 7.|5
10687491|NCT02457897|11851190|FG000|COMPLETED|Part 2 Long-term (6 Month) Study||5
10687492|NCT02457897|11851190|FG000|NOT COMPLETED|Part 2 Long-term (6 Month) Study||0
10687493|NCT02458092|11851196|FG000|STARTED|Overall Study||20
10687494|NCT02458092|11851197|FG001|STARTED|Overall Study||10
10687495|NCT02458092|11851196|FG000|COMPLETED|Overall Study||19
10687496|NCT02458092|11851197|FG001|COMPLETED|Overall Study||10
10687497|NCT02458092|11851196|FG000|NOT COMPLETED|Overall Study||1
10687498|NCT02458092|11851197|FG001|NOT COMPLETED|Overall Study||0
10687499|NCT02458235|11851204|FG000|STARTED|Overall Study||17
10687500|NCT02458235|11851204|FG000|COMPLETED|Overall Study||17
10687501|NCT02458235|11851204|FG000|NOT COMPLETED|Overall Study||0
10687502|NCT02458287|11851212|FG000|STARTED|Overall Study||50
10687503|NCT02458287|11851213|FG001|STARTED|Overall Study||100
10687504|NCT02458287|11851214|FG002|STARTED|Overall Study||49
10687505|NCT02458287|11851215|FG003|STARTED|Overall Study||100
10687506|NCT02458287|11851212|FG000|COMPLETED|Overall Study||50
10687507|NCT02458287|11851213|FG001|COMPLETED|Overall Study||96
10687508|NCT02458287|11851214|FG002|COMPLETED|Overall Study||46
10687509|NCT02458287|11851215|FG003|COMPLETED|Overall Study||97
10687510|NCT02458287|11851212|FG000|NOT COMPLETED|Overall Study||0
10687511|NCT02458287|11851213|FG001|NOT COMPLETED|Overall Study||4
10687512|NCT02458287|11851214|FG002|NOT COMPLETED|Overall Study||3
10687513|NCT02458287|11851215|FG003|NOT COMPLETED|Overall Study||3
10687514|NCT02458352|11851231|FG000|STARTED|Overall Study||105
10687515|NCT02458352|11851231|FG000|COMPLETED|Overall Study||105
10687516|NCT02458352|11851231|FG000|NOT COMPLETED|Overall Study||0
10687517|NCT02458365|11851239|FG000|STARTED|Overall Study||2000
10687518|NCT02458365|11851240|FG001|STARTED|Overall Study||1901
10687519|NCT02458365|11851239|FG000|COMPLETED|Overall Study||1723
10687520|NCT02458365|11851240|FG001|COMPLETED|Overall Study||1607
10687521|NCT02458365|11851239|FG000|NOT COMPLETED|Overall Study||277
10687522|NCT02458365|11851240|FG001|NOT COMPLETED|Overall Study||294
10687523|NCT02458469|11851247|FG000|STARTED|First Intervention (2 Weeks)||3
10687524|NCT02458469|11851248|FG001|STARTED|First Intervention (2 Weeks)||2
10687525|NCT02458469|11851249|FG002|STARTED|First Intervention (2 Weeks)||3
10687526|NCT02458469|11851250|FG003|STARTED|First Intervention (2 Weeks)||0
10687527|NCT02458469|11851251|FG004|STARTED|First Intervention (2 Weeks)||1
10687528|NCT02458469|11851252|FG005|STARTED|First Intervention (2 Weeks)||2
10687529|NCT02458469|11851247|FG000|COMPLETED|First Intervention (2 Weeks)||2
10687530|NCT02458469|11851248|FG001|COMPLETED|First Intervention (2 Weeks)||2
10687531|NCT02458469|11851249|FG002|COMPLETED|First Intervention (2 Weeks)||2
10687532|NCT02458469|11851250|FG003|COMPLETED|First Intervention (2 Weeks)||0
10687533|NCT02458469|11851251|FG004|COMPLETED|First Intervention (2 Weeks)||1
10687534|NCT02458469|11851252|FG005|COMPLETED|First Intervention (2 Weeks)||2
10687535|NCT02458469|11851247|FG000|NOT COMPLETED|First Intervention (2 Weeks)||1
10687536|NCT02458469|11851248|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
10687537|NCT02458469|11851249|FG002|NOT COMPLETED|First Intervention (2 Weeks)||1
10687538|NCT02458469|11851250|FG003|NOT COMPLETED|First Intervention (2 Weeks)||0
10687539|NCT02458469|11851251|FG004|NOT COMPLETED|First Intervention (2 Weeks)||0
10687540|NCT02458469|11851252|FG005|NOT COMPLETED|First Intervention (2 Weeks)||0
10687541|NCT02458469|11851247|FG000|STARTED|First Washout (2 Weeks)||2
10687542|NCT02458469|11851248|FG001|STARTED|First Washout (2 Weeks)||2
10687543|NCT02458469|11851249|FG002|STARTED|First Washout (2 Weeks)||2
10687544|NCT02458469|11851250|FG003|STARTED|First Washout (2 Weeks)||0
10687546|NCT02458469|11851252|FG005|STARTED|First Washout (2 Weeks)||2
10687547|NCT02458469|11851247|FG000|COMPLETED|First Washout (2 Weeks)||2
10687548|NCT02458469|11851248|FG001|COMPLETED|First Washout (2 Weeks)||2
10687549|NCT02458469|11851249|FG002|COMPLETED|First Washout (2 Weeks)||2
10687550|NCT02458469|11851250|FG003|COMPLETED|First Washout (2 Weeks)||0
10687551|NCT02458469|11851251|FG004|COMPLETED|First Washout (2 Weeks)||1
10687552|NCT02458469|11851252|FG005|COMPLETED|First Washout (2 Weeks)||2
10687553|NCT02458469|11851247|FG000|NOT COMPLETED|First Washout (2 Weeks)||0
10687554|NCT02458469|11851248|FG001|NOT COMPLETED|First Washout (2 Weeks)||0
10687555|NCT02458469|11851249|FG002|NOT COMPLETED|First Washout (2 Weeks)||0
10687556|NCT02458469|11851250|FG003|NOT COMPLETED|First Washout (2 Weeks)||0
10687557|NCT02458469|11851251|FG004|NOT COMPLETED|First Washout (2 Weeks)||0
10687558|NCT02458469|11851252|FG005|NOT COMPLETED|First Washout (2 Weeks)||0
10687559|NCT02458469|11851247|FG000|STARTED|Second Intervention (2 Weeks)||2
10687560|NCT02458469|11851248|FG001|STARTED|Second Intervention (2 Weeks)||2
10687561|NCT02458469|11851249|FG002|STARTED|Second Intervention (2 Weeks)||2
10687562|NCT02458469|11851250|FG003|STARTED|Second Intervention (2 Weeks)||0
10687563|NCT02458469|11851251|FG004|STARTED|Second Intervention (2 Weeks)||1
10687564|NCT02458469|11851252|FG005|STARTED|Second Intervention (2 Weeks)||2
10687565|NCT02458469|11851247|FG000|COMPLETED|Second Intervention (2 Weeks)||2
10687566|NCT02458469|11851248|FG001|COMPLETED|Second Intervention (2 Weeks)||2
10687567|NCT02458469|11851249|FG002|COMPLETED|Second Intervention (2 Weeks)||2
10687568|NCT02458469|11851250|FG003|COMPLETED|Second Intervention (2 Weeks)||0
10687569|NCT02458469|11851251|FG004|COMPLETED|Second Intervention (2 Weeks)||1
10687570|NCT02458469|11851252|FG005|COMPLETED|Second Intervention (2 Weeks)||1
10687571|NCT02458469|11851247|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
10687572|NCT02458469|11851248|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
10687573|NCT02458469|11851249|FG002|NOT COMPLETED|Second Intervention (2 Weeks)||0
10687574|NCT02458469|11851250|FG003|NOT COMPLETED|Second Intervention (2 Weeks)||0
10687575|NCT02458469|11851251|FG004|NOT COMPLETED|Second Intervention (2 Weeks)||0
10687576|NCT02458469|11851252|FG005|NOT COMPLETED|Second Intervention (2 Weeks)||1
10687577|NCT02458469|11851247|FG000|STARTED|Second Washout (2 Weeks)||2
10687578|NCT02458469|11851248|FG001|STARTED|Second Washout (2 Weeks)||2
10687579|NCT02458469|11851249|FG002|STARTED|Second Washout (2 Weeks)||2
10687580|NCT02458469|11851250|FG003|STARTED|Second Washout (2 Weeks)||0
10687581|NCT02458469|11851251|FG004|STARTED|Second Washout (2 Weeks)||1
10687582|NCT02458469|11851252|FG005|STARTED|Second Washout (2 Weeks)||1
10687583|NCT02458469|11851247|FG000|COMPLETED|Second Washout (2 Weeks)||2
10687584|NCT02458469|11851248|FG001|COMPLETED|Second Washout (2 Weeks)||2
10687585|NCT02458469|11851249|FG002|COMPLETED|Second Washout (2 Weeks)||2
10687586|NCT02458469|11851250|FG003|COMPLETED|Second Washout (2 Weeks)||0
10687587|NCT02458469|11851251|FG004|COMPLETED|Second Washout (2 Weeks)||1
10687588|NCT02458469|11851252|FG005|COMPLETED|Second Washout (2 Weeks)||1
10687589|NCT02458469|11851247|FG000|NOT COMPLETED|Second Washout (2 Weeks)||0
10687590|NCT02458469|11851248|FG001|NOT COMPLETED|Second Washout (2 Weeks)||0
10687591|NCT02458469|11851249|FG002|NOT COMPLETED|Second Washout (2 Weeks)||0
10687592|NCT02458469|11851250|FG003|NOT COMPLETED|Second Washout (2 Weeks)||0
10687593|NCT02458469|11851251|FG004|NOT COMPLETED|Second Washout (2 Weeks)||0
10687594|NCT02458469|11851252|FG005|NOT COMPLETED|Second Washout (2 Weeks)||0
10687595|NCT02458469|11851247|FG000|STARTED|Third Intervention (2 Weeks)||2
10687596|NCT02458469|11851248|FG001|STARTED|Third Intervention (2 Weeks)||2
10687597|NCT02458469|11851249|FG002|STARTED|Third Intervention (2 Weeks)||2
10687598|NCT02458469|11851250|FG003|STARTED|Third Intervention (2 Weeks)||0
10687599|NCT02458469|11851251|FG004|STARTED|Third Intervention (2 Weeks)||1
10687600|NCT02458469|11851252|FG005|STARTED|Third Intervention (2 Weeks)||1
10687601|NCT02458469|11851247|FG000|COMPLETED|Third Intervention (2 Weeks)||2
10687602|NCT02458469|11851248|FG001|COMPLETED|Third Intervention (2 Weeks)||2
10687603|NCT02458469|11851249|FG002|COMPLETED|Third Intervention (2 Weeks)||2
10687604|NCT02458469|11851250|FG003|COMPLETED|Third Intervention (2 Weeks)||0
10687605|NCT02458469|11851251|FG004|COMPLETED|Third Intervention (2 Weeks)||1
10687606|NCT02458469|11851252|FG005|COMPLETED|Third Intervention (2 Weeks)||1
10687607|NCT02458469|11851247|FG000|NOT COMPLETED|Third Intervention (2 Weeks)||0
10687608|NCT02458469|11851248|FG001|NOT COMPLETED|Third Intervention (2 Weeks)||0
10687609|NCT02458469|11851249|FG002|NOT COMPLETED|Third Intervention (2 Weeks)||0
10687610|NCT02458469|11851250|FG003|NOT COMPLETED|Third Intervention (2 Weeks)||0
10687611|NCT02458469|11851251|FG004|NOT COMPLETED|Third Intervention (2 Weeks)||0
10687612|NCT02458469|11851252|FG005|NOT COMPLETED|Third Intervention (2 Weeks)||0
10687613|NCT02458638|11851260|FG000|STARTED|Overall Study||474
10687614|NCT02458638|11851260|FG000|COMPLETED|Overall Study||15
10687615|NCT02458638|11851260|FG000|NOT COMPLETED|Overall Study||459
10687616|NCT02458690|11851266|FG000|STARTED|Overall Study||107
10687617|NCT02458690|11851267|FG001|STARTED|Overall Study||109
10687618|NCT02458690|11851266|FG000|COMPLETED|Overall Study||99
10687619|NCT02458690|11851267|FG001|COMPLETED|Overall Study||100
10687620|NCT02458690|11851266|FG000|NOT COMPLETED|Overall Study||8
10687621|NCT02458690|11851267|FG001|NOT COMPLETED|Overall Study||9
10687622|NCT02458768|11851275|FG000|STARTED|Overall Study||57
10687623|NCT02458768|11851276|FG001|STARTED|Overall Study||55
10687624|NCT02458768|11851275|FG000|COMPLETED|Overall Study||50
10687625|NCT02458768|11851276|FG001|COMPLETED|Overall Study||50
10687626|NCT02458768|11851275|FG000|NOT COMPLETED|Overall Study||7
10687627|NCT02458768|11851276|FG001|NOT COMPLETED|Overall Study||5
10687628|NCT02459093|11851284|FG000|STARTED|Overall Study||275
10687629|NCT02459093|11851285|FG001|STARTED|Overall Study||275
10687630|NCT02459093|11851284|FG000|COMPLETED|Overall Study||263
10687631|NCT02459093|11851285|FG001|COMPLETED|Overall Study||257
10687632|NCT02459093|11851284|FG000|NOT COMPLETED|Overall Study||12
10687633|NCT02459093|11851285|FG001|NOT COMPLETED|Overall Study||18
10687634|NCT02459119|11851291|FG000|STARTED|Overall Study||17
10687635|NCT02459119|11851291|FG000|COMPLETED|Overall Study||17
10687636|NCT02459119|11851291|FG000|NOT COMPLETED|Overall Study||0
10687637|NCT02459197|11851297|FG000|STARTED|Overall Study||58
10687638|NCT02459197|11851298|FG001|STARTED|Overall Study||56
10687639|NCT02459197|11851297|FG000|COMPLETED|Overall Study||58
10687640|NCT02459197|11851298|FG001|COMPLETED|Overall Study||55
10687641|NCT02459197|11851297|FG000|NOT COMPLETED|Overall Study||0
10687642|NCT02459197|11851298|FG001|NOT COMPLETED|Overall Study||1
10687643|NCT02459262|11851315|FG000|STARTED|Overall Study||8
10687644|NCT02459262|11851316|FG001|STARTED|Overall Study||8
10687645|NCT02459262|11851317|FG002|STARTED|Overall Study||8
10687646|NCT02459262|11851318|FG003|STARTED|Overall Study||8
10687647|NCT02459262|11851319|FG004|STARTED|Overall Study||8
10687648|NCT02459262|11851320|FG005|STARTED|Overall Study||8
10687649|NCT02459262|11851321|FG006|STARTED|Overall Study||12
10687650|NCT02459262|11851322|FG007|STARTED|Overall Study||45
10687651|NCT02459262|11851323|FG008|STARTED|Overall Study||45
10687652|NCT02459262|11851324|FG009|STARTED|Overall Study||45
10687653|NCT02459262|11851325|FG010|STARTED|Overall Study||45
10687654|NCT02459262|11851315|FG000|COMPLETED|Overall Study||8
10687655|NCT02459262|11851316|FG001|COMPLETED|Overall Study||8
10687656|NCT02459262|11851317|FG002|COMPLETED|Overall Study||8
10687657|NCT02459262|11851318|FG003|COMPLETED|Overall Study||8
10687658|NCT02459262|11851319|FG004|COMPLETED|Overall Study||8
10687659|NCT02459262|11851320|FG005|COMPLETED|Overall Study||8
10687660|NCT02459262|11851321|FG006|COMPLETED|Overall Study||12
10687661|NCT02459262|11851322|FG007|COMPLETED|Overall Study||45
10687662|NCT02459262|11851323|FG008|COMPLETED|Overall Study||45
10687663|NCT02459262|11851324|FG009|COMPLETED|Overall Study||44
10687664|NCT02459262|11851325|FG010|COMPLETED|Overall Study||45
10687665|NCT02459262|11851315|FG000|NOT COMPLETED|Overall Study||0
10687666|NCT02459262|11851316|FG001|NOT COMPLETED|Overall Study||0
10687667|NCT02459262|11851317|FG002|NOT COMPLETED|Overall Study||0
10687668|NCT02459262|11851318|FG003|NOT COMPLETED|Overall Study||0
10687669|NCT02459262|11851319|FG004|NOT COMPLETED|Overall Study||0
10687670|NCT02459262|11851320|FG005|NOT COMPLETED|Overall Study||0
10687671|NCT02459262|11851321|FG006|NOT COMPLETED|Overall Study||0
10687672|NCT02459262|11851322|FG007|NOT COMPLETED|Overall Study||0
10687673|NCT02459262|11851323|FG008|NOT COMPLETED|Overall Study||0
10687674|NCT02459262|11851324|FG009|NOT COMPLETED|Overall Study||1
10687675|NCT02459262|11851325|FG010|NOT COMPLETED|Overall Study||0
10687676|NCT02459275|11851351|FG000|STARTED|Overall Study||19
10687677|NCT02459275|11851352|FG001|STARTED|Overall Study||17
10687678|NCT02459275|11851351|FG000|COMPLETED|Overall Study||19
10687679|NCT02459275|11851352|FG001|COMPLETED|Overall Study||17
10687680|NCT02459275|11851351|FG000|NOT COMPLETED|Overall Study||0
10687681|NCT02459275|11851352|FG001|NOT COMPLETED|Overall Study||0
10687682|NCT02459418|11851360|FG000|STARTED|Overall Study||21
10687683|NCT02459418|11851361|FG001|STARTED|Overall Study||21
10687684|NCT02459418|11851360|FG000|Received First Treatment|Overall Study||21
10687685|NCT02459418|11851361|FG001|Received First Treatment|Overall Study||21
10687686|NCT02459418|11851360|FG000|Received Second Treatment|Overall Study||13
10687687|NCT02459418|11851361|FG001|Received Second Treatment|Overall Study||15
10687688|NCT02459418|11851360|FG000|COMPLETED|Overall Study||13
10687689|NCT02459418|11851361|FG001|COMPLETED|Overall Study||15
10687690|NCT02459418|11851360|FG000|NOT COMPLETED|Overall Study||8
10687691|NCT02459418|11851361|FG001|NOT COMPLETED|Overall Study||6
10687692|NCT02459587|11851372|FG000|STARTED|3-Month Follow-up Assessment||157
10687693|NCT02459587|11851373|FG001|STARTED|3-Month Follow-up Assessment||150
10687694|NCT02459587|11851372|FG000|COMPLETED|3-Month Follow-up Assessment||125
10687695|NCT02459587|11851373|FG001|COMPLETED|3-Month Follow-up Assessment||119
10687696|NCT02459587|11851372|FG000|NOT COMPLETED|3-Month Follow-up Assessment||32
10687697|NCT02459587|11851373|FG001|NOT COMPLETED|3-Month Follow-up Assessment||31
10687698|NCT02459587|11851372|FG000|STARTED|6-month Follow-up Assessment|Total excludes participants who withdrew participation or were deceased prior to follow-up.|152
10687699|NCT02459587|11851373|FG001|STARTED|6-month Follow-up Assessment|Total excludes participants who withdrew participation or were deceased prior to follow-up.|141
10687700|NCT02459587|11851372|FG000|COMPLETED|6-month Follow-up Assessment||128
10687701|NCT02459587|11851373|FG001|COMPLETED|6-month Follow-up Assessment||116
10687702|NCT02459587|11851372|FG000|NOT COMPLETED|6-month Follow-up Assessment||24
10687703|NCT02459587|11851373|FG001|NOT COMPLETED|6-month Follow-up Assessment||25
10687704|NCT02459587|11851372|FG000|STARTED|12-month Follow-up Assessment|Total excludes participants who withdrew participation or were deceased prior to follow-up.|149
10687705|NCT02459587|11851373|FG001|STARTED|12-month Follow-up Assessment|Total excludes participants who withdrew participation or were deceased prior to follow-up.|138
10687706|NCT02459587|11851372|FG000|COMPLETED|12-month Follow-up Assessment||127
10687707|NCT02459587|11851373|FG001|COMPLETED|12-month Follow-up Assessment||111
10687708|NCT02459587|11851372|FG000|NOT COMPLETED|12-month Follow-up Assessment||22
10687709|NCT02459587|11851373|FG001|NOT COMPLETED|12-month Follow-up Assessment||27
10687710|NCT02459665|11851384|FG000|STARTED|Overall Study||17
10687711|NCT02459665|11851385|FG001|STARTED|Overall Study||17
10687712|NCT02459665|11851386|FG002|STARTED|Overall Study||17
10687713|NCT02459665|11851387|FG003|STARTED|Overall Study||17
10687714|NCT02459665|11851384|FG000|Day 7 Visit|Overall Study||17
10687715|NCT02459665|11851385|FG001|Day 7 Visit|Overall Study||17
10687716|NCT02459665|11851386|FG002|Day 7 Visit|Overall Study||17
10687717|NCT02459665|11851387|FG003|Day 7 Visit|Overall Study||16
10687718|NCT02459665|11851384|FG000|Month 1 Visit|Overall Study||17
10687719|NCT02459665|11851385|FG001|Month 1 Visit|Overall Study||17
10687720|NCT02459665|11851386|FG002|Month 1 Visit|Overall Study||17
10687721|NCT02459665|11851387|FG003|Month 1 Visit|Overall Study||16
10687722|NCT02459665|11851384|FG000|Month 2 Visit|Overall Study||17
10687723|NCT02459665|11851385|FG001|Month 2 Visit|Overall Study||16
10687724|NCT02459665|11851386|FG002|Month 2 Visit|Overall Study||17
10687725|NCT02459665|11851387|FG003|Month 2 Visit|Overall Study||16
10687726|NCT02459665|11851384|FG000|Month 6 Visit|Overall Study||17
10687727|NCT02459665|11851385|FG001|Month 6 Visit|Overall Study||16
10687728|NCT02459665|11851386|FG002|Month 6 Visit|Overall Study||16
10687729|NCT02459665|11851387|FG003|Month 6 Visit|Overall Study||15
10687730|NCT02459665|11851384|FG000|COMPLETED|Overall Study||17
10687731|NCT02459665|11851385|FG001|COMPLETED|Overall Study||16
10687732|NCT02459665|11851386|FG002|COMPLETED|Overall Study||16
10687733|NCT02459665|11851387|FG003|COMPLETED|Overall Study||15
10687734|NCT02459665|11851384|FG000|NOT COMPLETED|Overall Study||0
10687735|NCT02459665|11851385|FG001|NOT COMPLETED|Overall Study||1
10687736|NCT02459665|11851386|FG002|NOT COMPLETED|Overall Study||1
10800132|NCT04528017|11961049|FG000|STARTED|First Wear Period (8 -0/+3 Days)||27
10800133|NCT04528017|11961050|FG001|STARTED|First Wear Period (8 -0/+3 Days)||28
10800134|NCT04528017|11961049|FG000|COMPLETED|First Wear Period (8 -0/+3 Days)||27
10687737|NCT02459665|11851387|FG003|NOT COMPLETED|Overall Study||2
10687738|NCT02459795|11851407|FG000|STARTED|Overall Study||187
10687739|NCT02459795|11851408|FG001|STARTED|Overall Study||189
10687740|NCT02459795|11851409|FG002|STARTED|Overall Study||93
10687741|NCT02459795|11851407|FG000|COMPLETED|Overall Study||181
10687742|NCT02459795|11851408|FG001|COMPLETED|Overall Study||186
10687743|NCT02459795|11851409|FG002|COMPLETED|Overall Study||92
10687744|NCT02459795|11851407|FG000|NOT COMPLETED|Overall Study||6
10687745|NCT02459795|11851408|FG001|NOT COMPLETED|Overall Study||3
10687746|NCT02459795|11851409|FG002|NOT COMPLETED|Overall Study||1
10687747|NCT02459899|11851421|FG000|STARTED|Overall Study||36
10687748|NCT02459899|11851422|FG001|STARTED|Overall Study||35
10687749|NCT02459899|11851423|FG002|STARTED|Overall Study||35
10687750|NCT02459899|11851424|FG003|STARTED|Overall Study||35
10687751|NCT02459899|11851421|FG000|COMPLETED|Overall Study||33
10687752|NCT02459899|11851422|FG001|COMPLETED|Overall Study||29
10687753|NCT02459899|11851423|FG002|COMPLETED|Overall Study||35
10687754|NCT02459899|11851424|FG003|COMPLETED|Overall Study||33
10687755|NCT02459899|11851421|FG000|NOT COMPLETED|Overall Study||3
10687756|NCT02459899|11851422|FG001|NOT COMPLETED|Overall Study||6
10687757|NCT02459899|11851423|FG002|NOT COMPLETED|Overall Study||0
10687758|NCT02459899|11851424|FG003|NOT COMPLETED|Overall Study||2
10687759|NCT02459951|11851434|FG000|STARTED|Overall Study||10
10687760|NCT02459951|11851434|FG000|COMPLETED|Overall Study||9
10687761|NCT02459951|11851434|FG000|NOT COMPLETED|Overall Study||1
10687762|NCT02459964|11851442|FG000|STARTED|Overall Study||42
10687763|NCT02459964|11851443|FG001|STARTED|Overall Study||40
10687764|NCT02459964|11851444|FG002|STARTED|Overall Study||2
10687765|NCT02459964|11851442|FG000|COMPLETED|Overall Study||42
10687766|NCT02459964|11851443|FG001|COMPLETED|Overall Study||40
10687767|NCT02459964|11851444|FG002|COMPLETED|Overall Study||0
10687768|NCT02459964|11851442|FG000|NOT COMPLETED|Overall Study||0
10687769|NCT02459964|11851443|FG001|NOT COMPLETED|Overall Study||0
10687770|NCT02459964|11851444|FG002|NOT COMPLETED|Overall Study||2
10687771|NCT02460172|11851451|FG000|STARTED|Overall Study||25
10687772|NCT02460172|11851451|FG000|COMPLETED|Overall Study||25
10687773|NCT02460172|11851451|FG000|NOT COMPLETED|Overall Study||0
10687774|NCT02460263|11851457|FG000|STARTED|In-Center Period||30
10687775|NCT02460263|11851457|FG000|COMPLETED|In-Center Period||30
10687776|NCT02460263|11851457|FG000|NOT COMPLETED|In-Center Period||0
10687777|NCT02460263|11851457|FG000|STARTED|Transition Period||30
10687778|NCT02460263|11851457|FG000|COMPLETED|Transition Period||28
10687779|NCT02460263|11851457|FG000|NOT COMPLETED|Transition Period||2
10687780|NCT02460263|11851457|FG000|STARTED|In-Home Period||28
10687781|NCT02460263|11851457|FG000|COMPLETED|In-Home Period||28
10687782|NCT02460263|11851457|FG000|NOT COMPLETED|In-Home Period||0
10687783|NCT02460380|11851467|FG000|STARTED|Overall Study||45
10800135|NCT04528017|11961050|FG001|COMPLETED|First Wear Period (8 -0/+3 Days)||28
10687784|NCT02460380|11851468|FG001|STARTED|Overall Study||23
10687785|NCT02460380|11851467|FG000|COMPLETED|Overall Study||35
10687786|NCT02460380|11851468|FG001|COMPLETED|Overall Study||18
10687787|NCT02460380|11851467|FG000|NOT COMPLETED|Overall Study||10
10687788|NCT02460380|11851468|FG001|NOT COMPLETED|Overall Study||5
10687789|NCT02460562|11851477|FG000|STARTED|Overall Study||74
10687790|NCT02460562|11851478|FG001|STARTED|Overall Study||76
10687791|NCT02460562|11851477|FG000|COMPLETED|Overall Study||59
10687792|NCT02460562|11851478|FG001|COMPLETED|Overall Study||60
10687793|NCT02460562|11851477|FG000|NOT COMPLETED|Overall Study||15
10687794|NCT02460562|11851478|FG001|NOT COMPLETED|Overall Study||16
10687795|NCT02460575|11851486|FG000|STARTED|Overall Study||40
10687796|NCT02460575|11851487|FG001|STARTED|Overall Study||20
10687797|NCT02460575|11851486|FG000|COMPLETED|Overall Study||39
10687798|NCT02460575|11851487|FG001|COMPLETED|Overall Study||20
10687799|NCT02460575|11851486|FG000|NOT COMPLETED|Overall Study||1
10687800|NCT02460575|11851487|FG001|NOT COMPLETED|Overall Study||0
10687801|NCT02460666|11851495|FG000|STARTED|Overall Study||89
10687802|NCT02460666|11851496|FG001|STARTED|Overall Study||89
10687803|NCT02460666|11851495|FG000|COMPLETED|Overall Study||62
10687804|NCT02460666|11851496|FG001|COMPLETED|Overall Study||63
10687805|NCT02460666|11851495|FG000|NOT COMPLETED|Overall Study||27
10687806|NCT02460666|11851496|FG001|NOT COMPLETED|Overall Study||26
10687807|NCT02460679|11851502|FG000|STARTED|Overall Study||19
10687808|NCT02460679|11851502|FG000|Received at Least 1 Dose of Study Drug|Overall Study||19
10687809|NCT02460679|11851502|FG000|COMPLETED|Overall Study||14
10687810|NCT02460679|11851502|FG000|NOT COMPLETED|Overall Study||5
10687811|NCT02460822|11851506|FG000|STARTED|Overall Study||16
10687812|NCT02460822|11851506|FG000|COMPLETED|Overall Study||15
10687813|NCT02460822|11851506|FG000|NOT COMPLETED|Overall Study||1
10687814|NCT02460978|11851513|FG000|STARTED|Overall Study||271
10687815|NCT02460978|11851514|FG001|STARTED|Overall Study||270
10687816|NCT02460978|11851515|FG002|STARTED|Overall Study||272
10687817|NCT02460978|11851513|FG000|COMPLETED|Overall Study||244
10687818|NCT02460978|11851514|FG001|COMPLETED|Overall Study||245
10687819|NCT02460978|11851515|FG002|COMPLETED|Overall Study||239
10687820|NCT02460978|11851513|FG000|NOT COMPLETED|Overall Study||27
10687821|NCT02460978|11851514|FG001|NOT COMPLETED|Overall Study||25
10687822|NCT02460978|11851515|FG002|NOT COMPLETED|Overall Study||33
10687823|NCT02460991|11851525|FG000|STARTED|Overall Study||0
10687824|NCT02460991|11851526|FG001|STARTED|Overall Study||2
10687825|NCT02460991|11851525|FG000|COMPLETED|Overall Study||0
10687826|NCT02460991|11851526|FG001|COMPLETED|Overall Study||0
10687827|NCT02460991|11851525|FG000|NOT COMPLETED|Overall Study||0
10687828|NCT02460991|11851526|FG001|NOT COMPLETED|Overall Study||2
10687829|NCT02461134|11851537|FG000|STARTED|Overall Study||1
10687830|NCT02461134|11851537|FG000|COMPLETED|Overall Study||0
10687831|NCT02461134|11851537|FG000|NOT COMPLETED|Overall Study||1
10687832|NCT02461160|11851554|FG000|STARTED|Overall Study||8
10687833|NCT02461160|11851555|FG001|STARTED|Overall Study||6
10687834|NCT02461160|11851556|FG002|STARTED|Overall Study||6
10687835|NCT02461160|11851557|FG003|STARTED|Overall Study||12
10687836|NCT02461160|11851558|FG004|STARTED|Overall Study||6
10687837|NCT02461160|11851559|FG005|STARTED|Overall Study||6
10687838|NCT02461160|11851560|FG006|STARTED|Overall Study||6
10687839|NCT02461160|11851561|FG007|STARTED|Overall Study||6
10687840|NCT02461160|11851562|FG008|STARTED|Overall Study||12
10687841|NCT02461160|11851563|FG009|STARTED|Overall Study||4
10687842|NCT02461160|11851564|FG010|STARTED|Overall Study||4
10687843|NCT02461160|11851565|FG011|STARTED|Overall Study||4
10687844|NCT02461160|11851566|FG012|STARTED|Overall Study||8
10687845|NCT02461160|11851554|FG000|COMPLETED|Overall Study||8
10687846|NCT02461160|11851555|FG001|COMPLETED|Overall Study||6
10687847|NCT02461160|11851556|FG002|COMPLETED|Overall Study||6
10687848|NCT02461160|11851557|FG003|COMPLETED|Overall Study||12
10687849|NCT02461160|11851558|FG004|COMPLETED|Overall Study||6
10687850|NCT02461160|11851559|FG005|COMPLETED|Overall Study||6
10687851|NCT02461160|11851560|FG006|COMPLETED|Overall Study||6
10687852|NCT02461160|11851561|FG007|COMPLETED|Overall Study||5
10687853|NCT02461160|11851562|FG008|COMPLETED|Overall Study||12
10687854|NCT02461160|11851563|FG009|COMPLETED|Overall Study||4
10687855|NCT02461160|11851564|FG010|COMPLETED|Overall Study||4
10687856|NCT02461160|11851565|FG011|COMPLETED|Overall Study||4
10687857|NCT02461160|11851566|FG012|COMPLETED|Overall Study||8
10687858|NCT02461160|11851554|FG000|NOT COMPLETED|Overall Study||0
10800136|NCT04528017|11961049|FG000|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||0
10800137|NCT04528017|11961050|FG001|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||0
10800138|NCT04528017|11961049|FG000|STARTED|Second Wear Period (8 -0/+3 Days)||27
10800139|NCT04528017|11961050|FG001|STARTED|Second Wear Period (8 -0/+3 Days)||28
10687859|NCT02461160|11851555|FG001|NOT COMPLETED|Overall Study||0
10687860|NCT02461160|11851556|FG002|NOT COMPLETED|Overall Study||0
10687861|NCT02461160|11851557|FG003|NOT COMPLETED|Overall Study||0
10687862|NCT02461160|11851558|FG004|NOT COMPLETED|Overall Study||0
10800140|NCT04528017|11961049|FG000|COMPLETED|Second Wear Period (8 -0/+3 Days)||27
10810985|NCT03783130|11972700|FG000|STARTED|Overall Study||3
10687863|NCT02461160|11851559|FG005|NOT COMPLETED|Overall Study||0
10687864|NCT02461160|11851560|FG006|NOT COMPLETED|Overall Study||0
10687865|NCT02461160|11851561|FG007|NOT COMPLETED|Overall Study||1
10687866|NCT02461160|11851562|FG008|NOT COMPLETED|Overall Study||0
10687867|NCT02461160|11851563|FG009|NOT COMPLETED|Overall Study||0
10687868|NCT02461160|11851564|FG010|NOT COMPLETED|Overall Study||0
10687869|NCT02461160|11851565|FG011|NOT COMPLETED|Overall Study||0
10687870|NCT02461160|11851566|FG012|NOT COMPLETED|Overall Study||0
10687871|NCT02461290|11851615|FG000|STARTED|Overall Study||99
10687872|NCT02461290|11851615|FG000|COMPLETED|Overall Study||89
10687873|NCT02461290|11851615|FG000|NOT COMPLETED|Overall Study||10
10687874|NCT02461433|11851621|FG000|STARTED|Overall Study||1
10687875|NCT02461433|11851622|FG001|STARTED|Overall Study||1
10687876|NCT02461433|11851621|FG000|COMPLETED|Overall Study||1
10687877|NCT02461433|11851622|FG001|COMPLETED|Overall Study||1
10687878|NCT02461433|11851621|FG000|NOT COMPLETED|Overall Study||0
10687879|NCT02461433|11851622|FG001|NOT COMPLETED|Overall Study||0
10687880|NCT02461563|11851632|FG000|STARTED|Overall Study||3
10687881|NCT02461563|11851633|FG001|STARTED|Overall Study||3
10687882|NCT02461563|11851634|FG002|STARTED|Overall Study||3
10687883|NCT02461563|11851635|FG003|STARTED|Overall Study||3
10687884|NCT02461563|11851632|FG000|COMPLETED|Overall Study||3
10687885|NCT02461563|11851633|FG001|COMPLETED|Overall Study||3
10687886|NCT02461563|11851634|FG002|COMPLETED|Overall Study||3
10687887|NCT02461563|11851635|FG003|COMPLETED|Overall Study||3
10687888|NCT02461563|11851632|FG000|NOT COMPLETED|Overall Study||0
10687889|NCT02461563|11851633|FG001|NOT COMPLETED|Overall Study||0
10687890|NCT02461563|11851634|FG002|NOT COMPLETED|Overall Study||0
10687891|NCT02461563|11851635|FG003|NOT COMPLETED|Overall Study||0
10687892|NCT02461589|11851661|FG000|STARTED|Overall Study||64
10687893|NCT02461589|11851662|FG001|STARTED|Overall Study||63
10687894|NCT02461589|11851663|FG002|STARTED|Overall Study||65
10687895|NCT02461589|11851664|FG003|STARTED|Overall Study||63
10687896|NCT02461589|11851665|FG004|STARTED|Overall Study||64
10687897|NCT02461589|11851666|FG005|STARTED|Overall Study||64
10687898|NCT02461589|11851667|FG006|STARTED|Overall Study||64
10687899|NCT02461589|11851668|FG007|STARTED|Overall Study||65
10687900|NCT02461589|11851669|FG008|STARTED|Overall Study||129
10687901|NCT02461589|11851670|FG009|STARTED|Overall Study||65
10687902|NCT02461589|11851661|FG000|Exposed|Overall Study||64
10687903|NCT02461589|11851662|FG001|Exposed|Overall Study||63
10687904|NCT02461589|11851663|FG002|Exposed|Overall Study||65
10687905|NCT02461589|11851664|FG003|Exposed|Overall Study||63
10687906|NCT02461589|11851665|FG004|Exposed|Overall Study||64
10687907|NCT02461589|11851666|FG005|Exposed|Overall Study||64
10687908|NCT02461589|11851667|FG006|Exposed|Overall Study||64
10687909|NCT02461589|11851668|FG007|Exposed|Overall Study||65
10687910|NCT02461589|11851669|FG008|Exposed|Overall Study||129
10687911|NCT02461589|11851670|FG009|Exposed|Overall Study||64
10687912|NCT02461589|11851661|FG000|COMPLETED|Overall Study||58
10687913|NCT02461589|11851662|FG001|COMPLETED|Overall Study||61
10687914|NCT02461589|11851663|FG002|COMPLETED|Overall Study||60
10687915|NCT02461589|11851664|FG003|COMPLETED|Overall Study||58
10800141|NCT04528017|11961050|FG001|COMPLETED|Second Wear Period (8 -0/+3 Days)||28
10800142|NCT04528017|11961049|FG000|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||0
10800143|NCT04528017|11961050|FG001|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||0
10800144|NCT04529109|11961059|FG000|STARTED|Period 1||27
10687916|NCT02461589|11851665|FG004|COMPLETED|Overall Study||62
10687917|NCT02461589|11851666|FG005|COMPLETED|Overall Study||61
10687918|NCT02461589|11851667|FG006|COMPLETED|Overall Study||58
10687919|NCT02461589|11851668|FG007|COMPLETED|Overall Study||60
10687920|NCT02461589|11851669|FG008|COMPLETED|Overall Study||123
10687921|NCT02461589|11851670|FG009|COMPLETED|Overall Study||60
10687922|NCT02461589|11851661|FG000|NOT COMPLETED|Overall Study||6
10687923|NCT02461589|11851662|FG001|NOT COMPLETED|Overall Study||2
10687924|NCT02461589|11851663|FG002|NOT COMPLETED|Overall Study||5
10687925|NCT02461589|11851664|FG003|NOT COMPLETED|Overall Study||5
10687926|NCT02461589|11851665|FG004|NOT COMPLETED|Overall Study||2
10687927|NCT02461589|11851666|FG005|NOT COMPLETED|Overall Study||3
10687928|NCT02461589|11851667|FG006|NOT COMPLETED|Overall Study||6
10687929|NCT02461589|11851668|FG007|NOT COMPLETED|Overall Study||5
10687930|NCT02461589|11851669|FG008|NOT COMPLETED|Overall Study||6
10687931|NCT02461589|11851670|FG009|NOT COMPLETED|Overall Study||5
10687932|NCT02461628|11851694|FG000|STARTED|Overall Study||3733
10687933|NCT02461628|11851695|FG001|STARTED|Overall Study||3632
10687934|NCT02461628|11851694|FG000|Baseline Survey|Overall Study||1038
10687935|NCT02461628|11851695|FG001|Baseline Survey|Overall Study||974
10687936|NCT02461628|11851694|FG000|6 Month Survey|Overall Study||814
10687937|NCT02461628|11851695|FG001|6 Month Survey|Overall Study||832
10687938|NCT02461628|11851694|FG000|12 Month Survey|Overall Study||882
10687939|NCT02461628|11851695|FG001|12 Month Survey|Overall Study||914
10687940|NCT02461628|11851694|FG000|18 Month Survey|Overall Study||995
10687941|NCT02461628|11851695|FG001|18 Month Survey|Overall Study||905
10687942|NCT02461628|11851694|FG000|COMPLETED|Overall Study||3729
10687943|NCT02461628|11851695|FG001|COMPLETED|Overall Study||3625
10687944|NCT02461628|11851694|FG000|NOT COMPLETED|Overall Study||4
10800145|NCT04529109|11961060|FG001|STARTED|Period 1||29
10800146|NCT04529109|11961059|FG000|COMPLETED|Period 1||27
10800147|NCT04529109|11961060|FG001|COMPLETED|Period 1||28
10687945|NCT02461628|11851695|FG001|NOT COMPLETED|Overall Study||7
10687946|NCT02461693|11851703|FG000|STARTED|Overall Study||103
10687947|NCT02461693|11851704|FG001|STARTED|Overall Study||102
10800148|NCT04529109|11961059|FG000|NOT COMPLETED|Period 1||0
10687948|NCT02461693|11851703|FG000|COMPLETED|Overall Study||103
10687949|NCT02461693|11851704|FG001|COMPLETED|Overall Study||102
10687950|NCT02461693|11851703|FG000|NOT COMPLETED|Overall Study||0
10687951|NCT02461693|11851704|FG001|NOT COMPLETED|Overall Study||0
10687952|NCT02461745|11851712|FG000|STARTED|Overall Study||130
10687953|NCT02461745|11851713|FG001|STARTED|Overall Study||70
10687954|NCT02461745|11851712|FG000|COMPLETED|Overall Study||116
10687955|NCT02461745|11851713|FG001|COMPLETED|Overall Study||66
10687956|NCT02461745|11851712|FG000|NOT COMPLETED|Overall Study||14
10687957|NCT02461745|11851713|FG001|NOT COMPLETED|Overall Study||4
10687958|NCT02461758|11851725|FG000|STARTED|Overall Study||20
10687959|NCT02461758|11851726|FG001|STARTED|Overall Study||20
10687960|NCT02461758|11851727|FG002|STARTED|Overall Study||26
10687961|NCT02461758|11851728|FG003|STARTED|Overall Study||15
10687962|NCT02461758|11851725|FG000|COMPLETED|Overall Study||20
10687963|NCT02461758|11851726|FG001|COMPLETED|Overall Study||19
10687964|NCT02461758|11851727|FG002|COMPLETED|Overall Study||25
10687965|NCT02461758|11851728|FG003|COMPLETED|Overall Study||15
10687966|NCT02461758|11851725|FG000|NOT COMPLETED|Overall Study||0
10687967|NCT02461758|11851726|FG001|NOT COMPLETED|Overall Study||1
10687968|NCT02461758|11851727|FG002|NOT COMPLETED|Overall Study||1
10687969|NCT02461758|11851728|FG003|NOT COMPLETED|Overall Study||0
10687970|NCT02461771|11851744|FG000|STARTED|Overall Study||3
10687971|NCT02461771|11851745|FG001|STARTED|Overall Study||3
10687972|NCT02461771|11851746|FG002|STARTED|Overall Study||7
10687973|NCT02461771|11851744|FG000|COMPLETED|Overall Study||3
10687974|NCT02461771|11851745|FG001|COMPLETED|Overall Study||3
10687975|NCT02461771|11851746|FG002|COMPLETED|Overall Study||7
10687976|NCT02461771|11851744|FG000|NOT COMPLETED|Overall Study||0
10687977|NCT02461771|11851745|FG001|NOT COMPLETED|Overall Study||0
10687978|NCT02461771|11851746|FG002|NOT COMPLETED|Overall Study||0
10687979|NCT02461966|11851757|FG000|STARTED|Overall Study||160
10687980|NCT02461966|11851758|FG001|STARTED|Overall Study||80
10687981|NCT02461966|11851759|FG002|STARTED|Overall Study||60
10687982|NCT02461966|11851757|FG000|COMPLETED|Overall Study||160
10687983|NCT02461966|11851758|FG001|COMPLETED|Overall Study||80
10687984|NCT02461966|11851759|FG002|COMPLETED|Overall Study||60
10687985|NCT02461966|11851757|FG000|NOT COMPLETED|Overall Study||0
10687986|NCT02461966|11851758|FG001|NOT COMPLETED|Overall Study||0
10687987|NCT02461966|11851759|FG002|NOT COMPLETED|Overall Study||0
10687988|NCT02461992|11851767|FG000|STARTED|Overall Study||13
10687989|NCT02461992|11851767|FG000|COMPLETED|Overall Study||13
10687990|NCT02461992|11851767|FG000|NOT COMPLETED|Overall Study||0
10687991|NCT02462057|11851776|FG000|STARTED|Overall Study||791
10687992|NCT02462057|11851777|FG001|STARTED|Overall Study||793
10687993|NCT02462057|11851778|FG002|STARTED|Overall Study||812
10687994|NCT02462057|11851779|FG003|STARTED|Overall Study||752
10687995|NCT02462057|11851780|FG004|STARTED|Overall Study||758
10687996|NCT02462057|11851776|FG000|COMPLETED|Overall Study||737
10687997|NCT02462057|11851777|FG001|COMPLETED|Overall Study||753
10687998|NCT02462057|11851778|FG002|COMPLETED|Overall Study||766
10687999|NCT02462057|11851779|FG003|COMPLETED|Overall Study||701
10688000|NCT02462057|11851780|FG004|COMPLETED|Overall Study||708
10688001|NCT02462057|11851776|FG000|NOT COMPLETED|Overall Study||54
10688002|NCT02462057|11851777|FG001|NOT COMPLETED|Overall Study||40
10688003|NCT02462057|11851778|FG002|NOT COMPLETED|Overall Study||46
10688004|NCT02462057|11851779|FG003|NOT COMPLETED|Overall Study||51
10688005|NCT02462057|11851780|FG004|NOT COMPLETED|Overall Study||50
10688006|NCT02462070|11851794|FG000|STARTED|Overall Study||135
10688007|NCT02462070|11851795|FG001|STARTED|Overall Study||68
10688008|NCT02462070|11851794|FG000|COMPLETED|Overall Study||112
10688009|NCT02462070|11851795|FG001|COMPLETED|Overall Study||57
10688010|NCT02462070|11851794|FG000|NOT COMPLETED|Overall Study||23
10688011|NCT02462070|11851795|FG001|NOT COMPLETED|Overall Study||11
10688012|NCT02462083|11851801|FG000|STARTED|Overall Study||555
10688013|NCT02462083|11851801|FG000|Safety Population|Overall Study||550
10688014|NCT02462083|11851801|FG000|COMPLETED|Overall Study||136
10688015|NCT02462083|11851801|FG000|NOT COMPLETED|Overall Study||419
10688016|NCT02462122|11851807|FG000|STARTED|Overall Study||141
10688017|NCT02462122|11851808|FG001|STARTED|Overall Study||74
10688018|NCT02462122|11851807|FG000|COMPLETED|Overall Study||120
10688019|NCT02462122|11851808|FG001|COMPLETED|Overall Study||61
10688020|NCT02462122|11851807|FG000|NOT COMPLETED|Overall Study||21
10688021|NCT02462122|11851808|FG001|NOT COMPLETED|Overall Study||13
10688022|NCT02462148|11851817|FG000|STARTED|Overall Study||37
10688023|NCT02462148|11851818|FG001|STARTED|Overall Study||36
10688024|NCT02462148|11851819|FG002|STARTED|Overall Study||12
10688025|NCT02462148|11851817|FG000|COMPLETED|Overall Study||36
10688026|NCT02462148|11851818|FG001|COMPLETED|Overall Study||36
10688027|NCT02462148|11851819|FG002|COMPLETED|Overall Study||12
10688028|NCT02462148|11851817|FG000|NOT COMPLETED|Overall Study||1
10688029|NCT02462148|11851818|FG001|NOT COMPLETED|Overall Study||0
10688030|NCT02462148|11851819|FG002|NOT COMPLETED|Overall Study||0
10688031|NCT02462291|11851832|FG000|STARTED|Overall Study||82
10688032|NCT02462291|11851833|FG001|STARTED|Overall Study||81
10688033|NCT02462291|11851832|FG000|COMPLETED|Overall Study||77
10688034|NCT02462291|11851833|FG001|COMPLETED|Overall Study||75
10688035|NCT02462291|11851832|FG000|NOT COMPLETED|Overall Study||5
10688036|NCT02462291|11851833|FG001|NOT COMPLETED|Overall Study||6
10688037|NCT02462382|11851843|FG000|STARTED|Overall Study||24
10688038|NCT02462382|11851844|FG001|STARTED|Overall Study||27
10688039|NCT02462382|11851843|FG000|COMPLETED|Overall Study||24
10688040|NCT02462382|11851844|FG001|COMPLETED|Overall Study||27
10688041|NCT02462382|11851843|FG000|NOT COMPLETED|Overall Study||0
10688042|NCT02462382|11851844|FG001|NOT COMPLETED|Overall Study||0
10688043|NCT02462473|11851850|FG000|STARTED|Overall Study||9
10688044|NCT02462473|11851850|FG000|COMPLETED|Overall Study||5
10688045|NCT02462473|11851850|FG000|NOT COMPLETED|Overall Study||4
10688046|NCT02462486|11851857|FG000|STARTED|Overall Study||316
10688047|NCT02462486|11851858|FG001|STARTED|Overall Study||315
10688048|NCT02462486|11851859|FG002|STARTED|Overall Study||318
10688049|NCT02462486|11851857|FG000|COMPLETED|Overall Study||222
10688050|NCT02462486|11851858|FG001|COMPLETED|Overall Study||223
10688051|NCT02462486|11851859|FG002|COMPLETED|Overall Study||266
10688052|NCT02462486|11851857|FG000|NOT COMPLETED|Overall Study||94
10688053|NCT02462486|11851858|FG001|NOT COMPLETED|Overall Study||92
10688054|NCT02462486|11851859|FG002|NOT COMPLETED|Overall Study||52
10688055|NCT02462720|11851867|FG000|STARTED|Part 1||18
10688056|NCT02462720|11851868|FG001|STARTED|Part 1||17
10688057|NCT02462720|11851867|FG000|COMPLETED|Part 1||18
10688058|NCT02462720|11851868|FG001|COMPLETED|Part 1||17
10688059|NCT02462720|11851867|FG000|NOT COMPLETED|Part 1||0
10688060|NCT02462720|11851868|FG001|NOT COMPLETED|Part 1||0
10688061|NCT02462720|11851867|FG000|STARTED|Part 2||18
10688062|NCT02462720|11851868|FG001|STARTED|Part 2||17
10688063|NCT02462720|11851867|FG000|COMPLETED|Part 2||17
10688064|NCT02462720|11851868|FG001|COMPLETED|Part 2||16
10688065|NCT02462720|11851867|FG000|NOT COMPLETED|Part 2||1
10688066|NCT02462720|11851868|FG001|NOT COMPLETED|Part 2||1
10688067|NCT02462759|11851878|FG000|STARTED|Part 1: Double Blind||7
10688068|NCT02462759|11851879|FG001|STARTED|Part 1: Double Blind||14
10688069|NCT02462759|11851880|FG002|STARTED|Part 1: Double Blind||0
10688070|NCT02462759|11851878|FG000|COMPLETED|Part 1: Double Blind||6
10688071|NCT02462759|11851879|FG001|COMPLETED|Part 1: Double Blind||14
10688072|NCT02462759|11851880|FG002|COMPLETED|Part 1: Double Blind||0
10688073|NCT02462759|11851878|FG000|NOT COMPLETED|Part 1: Double Blind||1
10688074|NCT02462759|11851879|FG001|NOT COMPLETED|Part 1: Double Blind||0
10688075|NCT02462759|11851880|FG002|NOT COMPLETED|Part 1: Double Blind||0
10688076|NCT02462759|11851878|FG000|STARTED|Part 2: Open-Label Phase||0
10688077|NCT02462759|11851879|FG001|STARTED|Part 2: Open-Label Phase||0
10688078|NCT02462759|11851880|FG002|STARTED|Part 2: Open-Label Phase||20
10688079|NCT02462759|11851878|FG000|COMPLETED|Part 2: Open-Label Phase||0
10688080|NCT02462759|11851879|FG001|COMPLETED|Part 2: Open-Label Phase||0
10688081|NCT02462759|11851880|FG002|COMPLETED|Part 2: Open-Label Phase||20
10688082|NCT02462759|11851878|FG000|NOT COMPLETED|Part 2: Open-Label Phase||0
10688083|NCT02462759|11851879|FG001|NOT COMPLETED|Part 2: Open-Label Phase||0
10688084|NCT02462759|11851880|FG002|NOT COMPLETED|Part 2: Open-Label Phase||0
10688085|NCT02462928|11851894|FG000|STARTED|Overall Study||314
10688086|NCT02462928|11851895|FG001|STARTED|Overall Study||313
10688087|NCT02462928|11851896|FG002|STARTED|Overall Study||312
10688088|NCT02462928|11851894|FG000|COMPLETED|Overall Study||224
10688089|NCT02462928|11851895|FG001|COMPLETED|Overall Study||221
10688090|NCT02462928|11851896|FG002|COMPLETED|Overall Study||255
10688091|NCT02462928|11851894|FG000|NOT COMPLETED|Overall Study||90
10688092|NCT02462928|11851895|FG001|NOT COMPLETED|Overall Study||92
10688093|NCT02462928|11851896|FG002|NOT COMPLETED|Overall Study||57
10688094|NCT02462967|11851907|FG000|STARTED|Overall Study||54
10688095|NCT02462967|11851908|FG001|STARTED|Overall Study||54
10688096|NCT02462967|11851909|FG002|STARTED|Overall Study||54
10688097|NCT02462967|11851907|FG000|COMPLETED|Overall Study||52
10688098|NCT02462967|11851908|FG001|COMPLETED|Overall Study||48
10688099|NCT02462967|11851909|FG002|COMPLETED|Overall Study||51
10688100|NCT02462967|11851907|FG000|NOT COMPLETED|Overall Study||2
10688101|NCT02462967|11851908|FG001|NOT COMPLETED|Overall Study||6
10688102|NCT02462967|11851909|FG002|NOT COMPLETED|Overall Study||3
10688103|NCT02463032|11851919|FG000|STARTED|Overall Study||72
10688104|NCT02463032|11851920|FG001|STARTED|Overall Study||64
10688105|NCT02463032|11851919|FG000|COMPLETED|Overall Study||1
10688106|NCT02463032|11851920|FG001|COMPLETED|Overall Study||0
10688107|NCT02463032|11851919|FG000|NOT COMPLETED|Overall Study||71
10688108|NCT02463032|11851920|FG001|NOT COMPLETED|Overall Study||64
10688109|NCT02463071|11851929|FG000|STARTED|Overall Study||152
10688110|NCT02463071|11851930|FG001|STARTED|Overall Study||154
10688111|NCT02463071|11851931|FG002|STARTED|Overall Study||77
10688112|NCT02463071|11851929|FG000|COMPLETED|Overall Study||140
10688113|NCT02463071|11851930|FG001|COMPLETED|Overall Study||138
10688114|NCT02463071|11851931|FG002|COMPLETED|Overall Study||71
10688115|NCT02463071|11851929|FG000|NOT COMPLETED|Overall Study||12
10688116|NCT02463071|11851930|FG001|NOT COMPLETED|Overall Study||16
10688117|NCT02463071|11851931|FG002|NOT COMPLETED|Overall Study||6
10688118|NCT02463097|11851939|FG000|STARTED|Overall Study||124
10688119|NCT02463097|11851939|FG000|COMPLETED|Overall Study||123
10688120|NCT02463097|11851939|FG000|NOT COMPLETED|Overall Study||1
10688121|NCT02463227|11851943|FG000|STARTED|Overall Study||14
10688122|NCT02463227|11851943|FG000|COMPLETED|Overall Study||14
10688123|NCT02463227|11851943|FG000|NOT COMPLETED|Overall Study||0
10688124|NCT02463331|11851949|FG000|STARTED|Overall Study||26
10688125|NCT02463331|11851950|FG001|STARTED|Overall Study||31
10688126|NCT02463331|11851949|FG000|COMPLETED|Overall Study||10
10688127|NCT02463331|11851950|FG001|COMPLETED|Overall Study||25
10688128|NCT02463331|11851949|FG000|NOT COMPLETED|Overall Study||16
10688129|NCT02463331|11851950|FG001|NOT COMPLETED|Overall Study||6
10688130|NCT02463357|11851961|FG000|STARTED|Overall Study||20
10688131|NCT02463357|11851962|FG001|STARTED|Overall Study||20
10688132|NCT02463357|11851963|FG002|STARTED|Overall Study||20
10688133|NCT02463357|11851964|FG003|STARTED|Overall Study||19
10688134|NCT02463357|11851965|FG004|STARTED|Overall Study||20
10688135|NCT02463357|11851961|FG000|COMPLETED|Overall Study||19
10688136|NCT02463357|11851962|FG001|COMPLETED|Overall Study||20
10688137|NCT02463357|11851963|FG002|COMPLETED|Overall Study||20
10688138|NCT02463357|11851964|FG003|COMPLETED|Overall Study||19
10688139|NCT02463357|11851965|FG004|COMPLETED|Overall Study||19
10688140|NCT02463357|11851961|FG000|NOT COMPLETED|Overall Study||1
10688141|NCT02463357|11851962|FG001|NOT COMPLETED|Overall Study||0
10688142|NCT02463357|11851963|FG002|NOT COMPLETED|Overall Study||0
10688143|NCT02463357|11851964|FG003|NOT COMPLETED|Overall Study||0
10688144|NCT02463357|11851965|FG004|NOT COMPLETED|Overall Study||1
10688145|NCT02463409|11851977|FG000|STARTED|Overall Study||6
10688146|NCT02463409|11851977|FG000|COMPLETED|Overall Study||4
10688147|NCT02463409|11851977|FG000|NOT COMPLETED|Overall Study||2
10688148|NCT02463487|11851983|FG000|STARTED|Overall Study||75
10688149|NCT02463487|11851984|FG001|STARTED|Overall Study||75
10688150|NCT02463487|11851983|FG000|COMPLETED|Overall Study||65
10688151|NCT02463487|11851984|FG001|COMPLETED|Overall Study||65
10688152|NCT02463487|11851983|FG000|NOT COMPLETED|Overall Study||10
10688153|NCT02463487|11851984|FG001|NOT COMPLETED|Overall Study||10
10688154|NCT02463799|11851992|FG000|STARTED|Overall Study||16
10688155|NCT02463799|11851993|FG001|STARTED|Overall Study||16
10800149|NCT04529109|11961060|FG001|NOT COMPLETED|Period 1||1
10800150|NCT04529109|11961059|FG000|STARTED|Period 2||27
10800151|NCT04529109|11961060|FG001|STARTED|Period 2||28
10800152|NCT04529109|11961059|FG000|COMPLETED|Period 2||27
10800153|NCT04529109|11961060|FG001|COMPLETED|Period 2||28
10688156|NCT02463799|11851992|FG000|COMPLETED|Overall Study||16
10688157|NCT02463799|11851993|FG001|COMPLETED|Overall Study||16
10688158|NCT02463799|11851992|FG000|NOT COMPLETED|Overall Study||0
10688159|NCT02463799|11851993|FG001|NOT COMPLETED|Overall Study||0
10688160|NCT02464033|11851999|FG000|STARTED|Overall Study||20
10688161|NCT02464033|11851999|FG000|COMPLETED|Overall Study||20
10688162|NCT02464033|11851999|FG000|NOT COMPLETED|Overall Study||0
10688163|NCT02464059|11852004|FG000|STARTED|Overall Study||23
10688164|NCT02464059|11852004|FG000|COMPLETED|Overall Study||17
10688165|NCT02464059|11852004|FG000|NOT COMPLETED|Overall Study||6
10688166|NCT02464163|11852012|FG000|STARTED|Overall Study||102
10688167|NCT02464163|11852013|FG001|STARTED|Overall Study||102
10688168|NCT02464163|11852014|FG002|STARTED|Overall Study||102
10688169|NCT02464163|11852015|FG003|STARTED|Overall Study||101
10688170|NCT02464163|11852012|FG000|COMPLETED|Overall Study||99
10688171|NCT02464163|11852013|FG001|COMPLETED|Overall Study||94
10688172|NCT02464163|11852014|FG002|COMPLETED|Overall Study||97
10688173|NCT02464163|11852015|FG003|COMPLETED|Overall Study||96
10688174|NCT02464163|11852012|FG000|NOT COMPLETED|Overall Study||3
10688175|NCT02464163|11852013|FG001|NOT COMPLETED|Overall Study||8
10688176|NCT02464163|11852014|FG002|NOT COMPLETED|Overall Study||5
10688177|NCT02464163|11852015|FG003|NOT COMPLETED|Overall Study||5
10688178|NCT02464176|11852028|FG000|STARTED|Overall Study||50
10688179|NCT02464176|11852029|FG001|STARTED|Overall Study||50
10688180|NCT02464176|11852030|FG002|STARTED|Overall Study||15
10688181|NCT02464176|11852028|FG000|COMPLETED|Overall Study||50
10688182|NCT02464176|11852029|FG001|COMPLETED|Overall Study||50
10688183|NCT02464176|11852030|FG002|COMPLETED|Overall Study||15
10688184|NCT02464176|11852028|FG000|NOT COMPLETED|Overall Study||0
10688185|NCT02464176|11852029|FG001|NOT COMPLETED|Overall Study||0
10688186|NCT02464176|11852030|FG002|NOT COMPLETED|Overall Study||0
10688187|NCT02464449|11852040|FG000|STARTED|Overall Study||166
10688188|NCT02464449|11852041|FG001|STARTED|Overall Study||112
10688189|NCT02464449|11852040|FG000|COMPLETED|Overall Study||151
10688190|NCT02464449|11852041|FG001|COMPLETED|Overall Study||100
10688191|NCT02464449|11852040|FG000|NOT COMPLETED|Overall Study||15
10688192|NCT02464449|11852041|FG001|NOT COMPLETED|Overall Study||12
10688193|NCT02464540|11852047|FG000|STARTED|Overall Study||11
10688194|NCT02464540|11852048|FG001|STARTED|Overall Study||11
10688195|NCT02464540|11852047|FG000|COMPLETED|Overall Study||11
10688196|NCT02464540|11852048|FG001|COMPLETED|Overall Study||11
10688197|NCT02464540|11852047|FG000|NOT COMPLETED|Overall Study||0
10688198|NCT02464540|11852048|FG001|NOT COMPLETED|Overall Study||0
10688199|NCT02464657|11852057|FG000|STARTED|Overall Study||3
10688200|NCT02464657|11852058|FG001|STARTED|Overall Study||2
10688201|NCT02464657|11852059|FG002|STARTED|Overall Study||39
10688202|NCT02464657|11852057|FG000|COMPLETED|Overall Study||3
10688203|NCT02464657|11852058|FG001|COMPLETED|Overall Study||2
10688204|NCT02464657|11852059|FG002|COMPLETED|Overall Study||39
10688205|NCT02464657|11852057|FG000|NOT COMPLETED|Overall Study||0
10688206|NCT02464657|11852058|FG001|NOT COMPLETED|Overall Study||0
10688207|NCT02464657|11852059|FG002|NOT COMPLETED|Overall Study||0
10688208|NCT02464917|11852070|FG000|STARTED|Overall Study||35
10688209|NCT02464917|11852071|FG001|STARTED|Overall Study||35
10688210|NCT02464917|11852070|FG000|COMPLETED|Overall Study||35
10688211|NCT02464917|11852071|FG001|COMPLETED|Overall Study||35
10688212|NCT02464917|11852070|FG000|NOT COMPLETED|Overall Study||0
10688213|NCT02464917|11852071|FG001|NOT COMPLETED|Overall Study||0
10688214|NCT02465034|11852079|FG000|STARTED|Overall Study||19
10688215|NCT02465034|11852080|FG001|STARTED|Overall Study||26
10688216|NCT02465034|11852079|FG000|Started PAS|Overall Study||12
10688217|NCT02465034|11852080|FG001|Started PAS|Overall Study||21
10688218|NCT02465034|11852079|FG000|Completed PAS|Overall Study||9
10688219|NCT02465034|11852080|FG001|Completed PAS|Overall Study||20
10688220|NCT02465034|11852079|FG000|Started CC-PAS|Overall Study||16
10688221|NCT02465034|11852080|FG001|Started CC-PAS|Overall Study||0
10688222|NCT02465034|11852079|FG000|Completed CC-PAS|Overall Study||16
10688223|NCT02465034|11852080|FG001|Completed CC-PAS|Overall Study||0
10688224|NCT02465034|11852079|FG000|COMPLETED|Overall Study||16
10688225|NCT02465034|11852080|FG001|COMPLETED|Overall Study||20
10688226|NCT02465034|11852079|FG000|NOT COMPLETED|Overall Study||3
10688227|NCT02465034|11852080|FG001|NOT COMPLETED|Overall Study||6
10688228|NCT02465073|11852097|FG000|STARTED|Overall Study||17
10800154|NCT04529109|11961059|FG000|NOT COMPLETED|Period 2||0
10688229|NCT02465073|11852098|FG001|STARTED|Overall Study||16
10688230|NCT02465073|11852099|FG002|STARTED|Overall Study||16
10688231|NCT02465073|11852097|FG000|COMPLETED|Overall Study||15
10688232|NCT02465073|11852098|FG001|COMPLETED|Overall Study||15
10688233|NCT02465073|11852099|FG002|COMPLETED|Overall Study||15
10688234|NCT02465073|11852097|FG000|NOT COMPLETED|Overall Study||2
10688235|NCT02465073|11852098|FG001|NOT COMPLETED|Overall Study||1
10688236|NCT02465073|11852099|FG002|NOT COMPLETED|Overall Study||1
10800155|NCT04529109|11961060|FG001|NOT COMPLETED|Period 2||0
10688237|NCT02465099|11852109|FG000|STARTED|Overall Study||45
10688238|NCT02465099|11852110|FG001|STARTED|Overall Study||19
10688239|NCT02465099|11852109|FG000|COMPLETED|Overall Study||45
10688240|NCT02465099|11852110|FG001|COMPLETED|Overall Study||19
10688241|NCT02465099|11852109|FG000|NOT COMPLETED|Overall Study||0
10688242|NCT02465099|11852110|FG001|NOT COMPLETED|Overall Study||0
10688243|NCT02465203|11852119|FG000|STARTED|Overall Study||56
10688244|NCT02465203|11852120|FG001|STARTED|Overall Study||36
10688245|NCT02465203|11852121|FG002|STARTED|Overall Study||13
10688246|NCT02465203|11852119|FG000|COMPLETED|Overall Study||0
10688247|NCT02465203|11852120|FG001|COMPLETED|Overall Study||0
10688248|NCT02465203|11852121|FG002|COMPLETED|Overall Study||0
10688249|NCT02465203|11852119|FG000|NOT COMPLETED|Overall Study||56
10688250|NCT02465203|11852120|FG001|NOT COMPLETED|Overall Study||36
10688251|NCT02465203|11852121|FG002|NOT COMPLETED|Overall Study||13
10688252|NCT02465216|11852133|FG000|STARTED|Overall Study||15
10688253|NCT02465216|11852134|FG001|STARTED|Overall Study||5
10688254|NCT02465216|11852135|FG002|STARTED|Overall Study||14
10688255|NCT02465216|11852136|FG003|STARTED|Overall Study||14
10688256|NCT02465216|11852137|FG004|STARTED|Overall Study||12
10688257|NCT02465216|11852133|FG000|COMPLETED|Overall Study||12
10688258|NCT02465216|11852134|FG001|COMPLETED|Overall Study||5
10688259|NCT02465216|11852135|FG002|COMPLETED|Overall Study||13
10688260|NCT02465216|11852136|FG003|COMPLETED|Overall Study||12
10688261|NCT02465216|11852137|FG004|COMPLETED|Overall Study||9
10688262|NCT02465216|11852133|FG000|NOT COMPLETED|Overall Study||3
10688263|NCT02465216|11852134|FG001|NOT COMPLETED|Overall Study||0
10688264|NCT02465216|11852135|FG002|NOT COMPLETED|Overall Study||1
10688265|NCT02465216|11852136|FG003|NOT COMPLETED|Overall Study||2
10688266|NCT02465216|11852137|FG004|NOT COMPLETED|Overall Study||3
10688267|NCT02465372|11852151|FG000|STARTED|Overall Study||349
10688268|NCT02465372|11852152|FG001|STARTED|Overall Study||250
10688269|NCT02465372|11852151|FG000|COMPLETED|Overall Study||227
10688270|NCT02465372|11852152|FG001|COMPLETED|Overall Study||153
10688271|NCT02465372|11852151|FG000|NOT COMPLETED|Overall Study||122
10688272|NCT02465372|11852152|FG001|NOT COMPLETED|Overall Study||97
10688273|NCT02465437|11852162|FG000|STARTED|Overall Study||9
10688274|NCT02465437|11852163|FG001|STARTED|Overall Study||9
10688275|NCT02465437|11852164|FG002|STARTED|Overall Study||9
10688276|NCT02465437|11852165|FG003|STARTED|Overall Study||15
10688277|NCT02465437|11852162|FG000|COMPLETED|Overall Study||8
10688278|NCT02465437|11852163|FG001|COMPLETED|Overall Study||8
10688279|NCT02465437|11852164|FG002|COMPLETED|Overall Study||8
10688280|NCT02465437|11852165|FG003|COMPLETED|Overall Study||14
10688281|NCT02465437|11852162|FG000|NOT COMPLETED|Overall Study||1
10688282|NCT02465437|11852163|FG001|NOT COMPLETED|Overall Study||1
10688283|NCT02465437|11852164|FG002|NOT COMPLETED|Overall Study||1
10688284|NCT02465437|11852165|FG003|NOT COMPLETED|Overall Study||1
10688285|NCT02465450|11852176|FG000|STARTED|Treatment Period 1||26
10688286|NCT02465450|11852177|FG001|STARTED|Treatment Period 1||24
10688287|NCT02465450|11852178|FG002|STARTED|Treatment Period 1||35
10688288|NCT02465450|11852179|FG003|STARTED|Treatment Period 1||0
10688289|NCT02465450|11852180|FG004|STARTED|Treatment Period 1||0
10688290|NCT02465450|11852181|FG005|STARTED|Treatment Period 1||0
10688291|NCT02465450|11852176|FG000|COMPLETED|Treatment Period 1||24
10688292|NCT02465450|11852177|FG001|COMPLETED|Treatment Period 1||23
10688293|NCT02465450|11852178|FG002|COMPLETED|Treatment Period 1||34
10688294|NCT02465450|11852179|FG003|COMPLETED|Treatment Period 1||0
10688295|NCT02465450|11852180|FG004|COMPLETED|Treatment Period 1||0
10688296|NCT02465450|11852181|FG005|COMPLETED|Treatment Period 1||0
10688297|NCT02465450|11852176|FG000|NOT COMPLETED|Treatment Period 1||2
10688298|NCT02465450|11852177|FG001|NOT COMPLETED|Treatment Period 1||1
10688299|NCT02465450|11852178|FG002|NOT COMPLETED|Treatment Period 1||1
10688300|NCT02465450|11852179|FG003|NOT COMPLETED|Treatment Period 1||0
10688301|NCT02465450|11852180|FG004|NOT COMPLETED|Treatment Period 1||0
10688302|NCT02465450|11852181|FG005|NOT COMPLETED|Treatment Period 1||0
10688303|NCT02465450|11852176|FG000|STARTED|Treatment Period 2||0
10688304|NCT02465450|11852177|FG001|STARTED|Treatment Period 2||0
10688305|NCT02465450|11852178|FG002|STARTED|Treatment Period 2||0
10688306|NCT02465450|11852179|FG003|STARTED|Treatment Period 2||30
10688307|NCT02465450|11852180|FG004|STARTED|Treatment Period 2||28
10688308|NCT02465450|11852181|FG005|STARTED|Treatment Period 2||23
10688309|NCT02465450|11852176|FG000|COMPLETED|Treatment Period 2||0
10688310|NCT02465450|11852177|FG001|COMPLETED|Treatment Period 2||0
10688311|NCT02465450|11852178|FG002|COMPLETED|Treatment Period 2||0
10688312|NCT02465450|11852179|FG003|COMPLETED|Treatment Period 2||27
10688313|NCT02465450|11852180|FG004|COMPLETED|Treatment Period 2||24
10688314|NCT02465450|11852181|FG005|COMPLETED|Treatment Period 2||23
10688315|NCT02465450|11852176|FG000|NOT COMPLETED|Treatment Period 2||0
10688316|NCT02465450|11852177|FG001|NOT COMPLETED|Treatment Period 2||0
10688317|NCT02465450|11852178|FG002|NOT COMPLETED|Treatment Period 2||0
10688318|NCT02465450|11852179|FG003|NOT COMPLETED|Treatment Period 2||3
10688319|NCT02465450|11852180|FG004|NOT COMPLETED|Treatment Period 2||4
10688320|NCT02465450|11852181|FG005|NOT COMPLETED|Treatment Period 2||0
10688321|NCT02465463|11852201|FG000|STARTED|Overall Study||8
10688322|NCT02465463|11852202|FG001|STARTED|Overall Study||5
10688323|NCT02465463|11852201|FG000|COMPLETED|Overall Study||4
10688324|NCT02465463|11852202|FG001|COMPLETED|Overall Study||4
10688325|NCT02465463|11852201|FG000|NOT COMPLETED|Overall Study||4
10688326|NCT02465463|11852202|FG001|NOT COMPLETED|Overall Study||1
10688327|NCT02465489|11852209|FG000|STARTED|Overall Study||20
10688328|NCT02465489|11852209|FG000|COMPLETED|Overall Study||15
10688329|NCT02465489|11852209|FG000|NOT COMPLETED|Overall Study||5
10688330|NCT02465515|11852223|FG000|STARTED|Overall Study||4732
10688331|NCT02465515|11852224|FG001|STARTED|Overall Study||4731
10688332|NCT02465515|11852223|FG000|COMPLETED|Overall Study||4578
10688333|NCT02465515|11852224|FG001|COMPLETED|Overall Study||4620
10688334|NCT02465515|11852223|FG000|NOT COMPLETED|Overall Study||154
10688335|NCT02465515|11852224|FG001|NOT COMPLETED|Overall Study||111
10688336|NCT02465528|11852234|FG000|STARTED|Overall Study||1
10688337|NCT02465528|11852235|FG001|STARTED|Overall Study||4
10688338|NCT02465528|11852236|FG002|STARTED|Overall Study||12
10688339|NCT02465528|11852237|FG003|STARTED|Overall Study||5
10688340|NCT02465528|11852234|FG000|COMPLETED|Overall Study||0
10688341|NCT02465528|11852235|FG001|COMPLETED|Overall Study||0
10688342|NCT02465528|11852236|FG002|COMPLETED|Overall Study||0
10688343|NCT02465528|11852237|FG003|COMPLETED|Overall Study||0
10688344|NCT02465528|11852234|FG000|NOT COMPLETED|Overall Study||1
10688345|NCT02465528|11852235|FG001|NOT COMPLETED|Overall Study||4
10688346|NCT02465528|11852236|FG002|NOT COMPLETED|Overall Study||12
10688347|NCT02465528|11852237|FG003|NOT COMPLETED|Overall Study||5
10713180|NCT02677766|11878780|FG000|NOT COMPLETED|Overall Study||5
10713181|NCT02677766|11878781|FG001|NOT COMPLETED|Overall Study||3
10713182|NCT02677779|11878789|FG000|STARTED|Overall Study||10
10713183|NCT02677779|11878790|FG001|STARTED|Overall Study||10
10713184|NCT02677779|11878789|FG000|COMPLETED|Overall Study||10
10713185|NCT02677779|11878790|FG001|COMPLETED|Overall Study||10
10713186|NCT02677779|11878789|FG000|NOT COMPLETED|Overall Study||0
10713187|NCT02677779|11878790|FG001|NOT COMPLETED|Overall Study||0
10713188|NCT02677844|11878798|FG000|STARTED|Period 1||5
10713189|NCT02677844|11878799|FG001|STARTED|Period 1||5
10713190|NCT02677844|11878800|FG002|STARTED|Period 1||5
10713191|NCT02677844|11878801|FG003|STARTED|Period 1||5
10713192|NCT02677844|11878802|FG004|STARTED|Period 1||0
10713193|NCT02677844|11878803|FG005|STARTED|Period 1||0
10713194|NCT02677844|11878804|FG006|STARTED|Period 1||0
10713195|NCT02677844|11878798|FG000|COMPLETED|Period 1||5
10713196|NCT02677844|11878799|FG001|COMPLETED|Period 1||5
10713197|NCT02677844|11878800|FG002|COMPLETED|Period 1||5
10713198|NCT02677844|11878801|FG003|COMPLETED|Period 1||5
10713199|NCT02677844|11878802|FG004|COMPLETED|Period 1||0
10713200|NCT02677844|11878803|FG005|COMPLETED|Period 1||0
10713201|NCT02677844|11878804|FG006|COMPLETED|Period 1||0
10713202|NCT02677844|11878798|FG000|NOT COMPLETED|Period 1||0
10713203|NCT02677844|11878799|FG001|NOT COMPLETED|Period 1||0
10713204|NCT02677844|11878800|FG002|NOT COMPLETED|Period 1||0
10713205|NCT02677844|11878801|FG003|NOT COMPLETED|Period 1||0
10713206|NCT02677844|11878802|FG004|NOT COMPLETED|Period 1||0
10713207|NCT02677844|11878803|FG005|NOT COMPLETED|Period 1||0
10713208|NCT02677844|11878804|FG006|NOT COMPLETED|Period 1||0
10713209|NCT02677844|11878798|FG000|STARTED|Period 2||5
10713210|NCT02677844|11878799|FG001|STARTED|Period 2||5
10713211|NCT02677844|11878800|FG002|STARTED|Period 2||5
10713212|NCT02677844|11878801|FG003|STARTED|Period 2||5
10713213|NCT02677844|11878802|FG004|STARTED|Period 2||0
10713214|NCT02677844|11878803|FG005|STARTED|Period 2||0
10713215|NCT02677844|11878804|FG006|STARTED|Period 2||0
10713216|NCT02677844|11878798|FG000|COMPLETED|Period 2||5
10713217|NCT02677844|11878799|FG001|COMPLETED|Period 2||5
10713218|NCT02677844|11878800|FG002|COMPLETED|Period 2||5
10713219|NCT02677844|11878801|FG003|COMPLETED|Period 2||5
10713220|NCT02677844|11878802|FG004|COMPLETED|Period 2||0
10713221|NCT02677844|11878803|FG005|COMPLETED|Period 2||0
10713222|NCT02677844|11878804|FG006|COMPLETED|Period 2||0
10713223|NCT02677844|11878798|FG000|NOT COMPLETED|Period 2||0
10713224|NCT02677844|11878799|FG001|NOT COMPLETED|Period 2||0
10713225|NCT02677844|11878800|FG002|NOT COMPLETED|Period 2||0
10713226|NCT02677844|11878801|FG003|NOT COMPLETED|Period 2||0
10713227|NCT02677844|11878802|FG004|NOT COMPLETED|Period 2||0
10713228|NCT02677844|11878803|FG005|NOT COMPLETED|Period 2||0
10713229|NCT02677844|11878804|FG006|NOT COMPLETED|Period 2||0
10713230|NCT02677844|11878798|FG000|STARTED|Period 3||5
10713231|NCT02677844|11878799|FG001|STARTED|Period 3||5
10713232|NCT02677844|11878800|FG002|STARTED|Period 3||5
10713233|NCT02677844|11878801|FG003|STARTED|Period 3||5
10713234|NCT02677844|11878802|FG004|STARTED|Period 3||0
10713235|NCT02677844|11878803|FG005|STARTED|Period 3||0
10713236|NCT02677844|11878804|FG006|STARTED|Period 3||0
10713237|NCT02677844|11878798|FG000|COMPLETED|Period 3||5
10713238|NCT02677844|11878799|FG001|COMPLETED|Period 3||5
10713239|NCT02677844|11878800|FG002|COMPLETED|Period 3||5
10713240|NCT02677844|11878801|FG003|COMPLETED|Period 3||4
10713241|NCT02677844|11878802|FG004|COMPLETED|Period 3||0
10713242|NCT02677844|11878803|FG005|COMPLETED|Period 3||0
10713243|NCT02677844|11878804|FG006|COMPLETED|Period 3||0
10713244|NCT02677844|11878798|FG000|NOT COMPLETED|Period 3||0
10713245|NCT02677844|11878799|FG001|NOT COMPLETED|Period 3||0
10713246|NCT02677844|11878800|FG002|NOT COMPLETED|Period 3||0
10713247|NCT02677844|11878801|FG003|NOT COMPLETED|Period 3||1
10713248|NCT02677844|11878802|FG004|NOT COMPLETED|Period 3||0
10713249|NCT02677844|11878803|FG005|NOT COMPLETED|Period 3||0
10713250|NCT02677844|11878804|FG006|NOT COMPLETED|Period 3||0
10713251|NCT02677844|11878798|FG000|STARTED|Period 4||5
10713252|NCT02677844|11878799|FG001|STARTED|Period 4||5
10713253|NCT02677844|11878800|FG002|STARTED|Period 4||5
10713254|NCT02677844|11878801|FG003|STARTED|Period 4||4
10713255|NCT02677844|11878802|FG004|STARTED|Period 4||0
10713256|NCT02677844|11878803|FG005|STARTED|Period 4||0
10713257|NCT02677844|11878804|FG006|STARTED|Period 4||0
10688348|NCT02465567|11852253|FG000|STARTED|Overall Study||2157
10688349|NCT02465567|11852254|FG001|STARTED|Overall Study||2137
10688350|NCT02465567|11852255|FG002|STARTED|Overall Study||2143
10688351|NCT02465567|11852256|FG003|STARTED|Overall Study||2151
10688352|NCT02465567|11852253|FG000|COMPLETED|Overall Study||1708
10688353|NCT02465567|11852254|FG001|COMPLETED|Overall Study||1713
10688354|NCT02465567|11852255|FG002|COMPLETED|Overall Study||1580
10688355|NCT02465567|11852256|FG003|COMPLETED|Overall Study||1643
10688356|NCT02465567|11852253|FG000|NOT COMPLETED|Overall Study||449
10688357|NCT02465567|11852254|FG001|NOT COMPLETED|Overall Study||424
10688358|NCT02465567|11852255|FG002|NOT COMPLETED|Overall Study||563
10688359|NCT02465567|11852256|FG003|NOT COMPLETED|Overall Study||508
10688360|NCT02465632|11852269|FG000|STARTED|Overall Study||440
10688361|NCT02465632|11852270|FG001|STARTED|Overall Study||440
10688362|NCT02465632|11852271|FG002|STARTED|Overall Study||220
10688363|NCT02465632|11852269|FG000|COMPLETED|Overall Study||409
10688364|NCT02465632|11852270|FG001|COMPLETED|Overall Study||417
10688365|NCT02465632|11852271|FG002|COMPLETED|Overall Study||203
10688366|NCT02465632|11852269|FG000|NOT COMPLETED|Overall Study||31
10688367|NCT02465632|11852270|FG001|NOT COMPLETED|Overall Study||23
10688368|NCT02465632|11852271|FG002|NOT COMPLETED|Overall Study||17
10688369|NCT02465866|11852280|FG000|STARTED|Period 1||5
10688370|NCT02465866|11852281|FG001|STARTED|Period 1||5
10688371|NCT02465866|11852282|FG002|STARTED|Period 1||5
10688372|NCT02465866|11852283|FG003|STARTED|Period 1||5
10688373|NCT02465866|11852280|FG000|COMPLETED|Period 1||5
10688374|NCT02465866|11852281|FG001|COMPLETED|Period 1||5
10688375|NCT02465866|11852282|FG002|COMPLETED|Period 1||5
10688376|NCT02465866|11852283|FG003|COMPLETED|Period 1||5
10688377|NCT02465866|11852280|FG000|NOT COMPLETED|Period 1||0
10688378|NCT02465866|11852281|FG001|NOT COMPLETED|Period 1||0
10688379|NCT02465866|11852282|FG002|NOT COMPLETED|Period 1||0
10688380|NCT02465866|11852283|FG003|NOT COMPLETED|Period 1||0
10688381|NCT02465866|11852280|FG000|STARTED|Period 1: Washout (14 Days)||5
10688382|NCT02465866|11852281|FG001|STARTED|Period 1: Washout (14 Days)||5
10688383|NCT02465866|11852282|FG002|STARTED|Period 1: Washout (14 Days)||5
10688384|NCT02465866|11852283|FG003|STARTED|Period 1: Washout (14 Days)||5
10688385|NCT02465866|11852280|FG000|COMPLETED|Period 1: Washout (14 Days)||5
10688386|NCT02465866|11852281|FG001|COMPLETED|Period 1: Washout (14 Days)||5
10688387|NCT02465866|11852282|FG002|COMPLETED|Period 1: Washout (14 Days)||5
10688388|NCT02465866|11852283|FG003|COMPLETED|Period 1: Washout (14 Days)||5
10688389|NCT02465866|11852280|FG000|NOT COMPLETED|Period 1: Washout (14 Days)||0
10688390|NCT02465866|11852281|FG001|NOT COMPLETED|Period 1: Washout (14 Days)||0
10688391|NCT02465866|11852282|FG002|NOT COMPLETED|Period 1: Washout (14 Days)||0
10688392|NCT02465866|11852283|FG003|NOT COMPLETED|Period 1: Washout (14 Days)||0
10688393|NCT02465866|11852280|FG000|STARTED|Period 2||5
10688394|NCT02465866|11852281|FG001|STARTED|Period 2||5
10688395|NCT02465866|11852282|FG002|STARTED|Period 2||5
10688396|NCT02465866|11852283|FG003|STARTED|Period 2||5
10688397|NCT02465866|11852280|FG000|COMPLETED|Period 2||5
10688398|NCT02465866|11852281|FG001|COMPLETED|Period 2||5
10688399|NCT02465866|11852282|FG002|COMPLETED|Period 2||5
10688400|NCT02465866|11852283|FG003|COMPLETED|Period 2||5
10688401|NCT02465866|11852280|FG000|NOT COMPLETED|Period 2||0
10688402|NCT02465866|11852281|FG001|NOT COMPLETED|Period 2||0
10688403|NCT02465866|11852282|FG002|NOT COMPLETED|Period 2||0
10688404|NCT02465866|11852283|FG003|NOT COMPLETED|Period 2||0
10688405|NCT02465866|11852280|FG000|STARTED|Period 2: Washout (14 Days)||5
10688406|NCT02465866|11852281|FG001|STARTED|Period 2: Washout (14 Days)||5
10688407|NCT02465866|11852282|FG002|STARTED|Period 2: Washout (14 Days)||5
10688408|NCT02465866|11852283|FG003|STARTED|Period 2: Washout (14 Days)||5
10688409|NCT02465866|11852280|FG000|COMPLETED|Period 2: Washout (14 Days)||5
10688410|NCT02465866|11852281|FG001|COMPLETED|Period 2: Washout (14 Days)||5
10688411|NCT02465866|11852282|FG002|COMPLETED|Period 2: Washout (14 Days)||5
10688412|NCT02465866|11852283|FG003|COMPLETED|Period 2: Washout (14 Days)||5
10688413|NCT02465866|11852280|FG000|NOT COMPLETED|Period 2: Washout (14 Days)||0
10688414|NCT02465866|11852281|FG001|NOT COMPLETED|Period 2: Washout (14 Days)||0
10688415|NCT02465866|11852282|FG002|NOT COMPLETED|Period 2: Washout (14 Days)||0
10688416|NCT02465866|11852283|FG003|NOT COMPLETED|Period 2: Washout (14 Days)||0
10688417|NCT02465866|11852280|FG000|STARTED|Period 3||5
10688418|NCT02465866|11852281|FG001|STARTED|Period 3||5
10688419|NCT02465866|11852282|FG002|STARTED|Period 3||5
10688420|NCT02465866|11852283|FG003|STARTED|Period 3||5
10688421|NCT02465866|11852280|FG000|COMPLETED|Period 3||5
10688422|NCT02465866|11852281|FG001|COMPLETED|Period 3||4
10688423|NCT02465866|11852282|FG002|COMPLETED|Period 3||5
10688424|NCT02465866|11852283|FG003|COMPLETED|Period 3||5
10688425|NCT02465866|11852280|FG000|NOT COMPLETED|Period 3||0
10688426|NCT02465866|11852281|FG001|NOT COMPLETED|Period 3||1
10688427|NCT02465866|11852282|FG002|NOT COMPLETED|Period 3||0
10688428|NCT02465866|11852283|FG003|NOT COMPLETED|Period 3||0
10688429|NCT02465866|11852280|FG000|STARTED|Period 3: Washout (14 Days)||5
10688430|NCT02465866|11852281|FG001|STARTED|Period 3: Washout (14 Days)||4
10688431|NCT02465866|11852282|FG002|STARTED|Period 3: Washout (14 Days)||5
10688432|NCT02465866|11852283|FG003|STARTED|Period 3: Washout (14 Days)||5
10688433|NCT02465866|11852280|FG000|COMPLETED|Period 3: Washout (14 Days)||5
10688434|NCT02465866|11852281|FG001|COMPLETED|Period 3: Washout (14 Days)||4
10688435|NCT02465866|11852282|FG002|COMPLETED|Period 3: Washout (14 Days)||5
10688436|NCT02465866|11852283|FG003|COMPLETED|Period 3: Washout (14 Days)||5
10688437|NCT02465866|11852280|FG000|NOT COMPLETED|Period 3: Washout (14 Days)||0
10688438|NCT02465866|11852281|FG001|NOT COMPLETED|Period 3: Washout (14 Days)||0
10688439|NCT02465866|11852282|FG002|NOT COMPLETED|Period 3: Washout (14 Days)||0
10688440|NCT02465866|11852283|FG003|NOT COMPLETED|Period 3: Washout (14 Days)||0
10688441|NCT02465866|11852280|FG000|STARTED|Period 4||5
10688442|NCT02465866|11852281|FG001|STARTED|Period 4||4
10688443|NCT02465866|11852282|FG002|STARTED|Period 4||5
10688444|NCT02465866|11852283|FG003|STARTED|Period 4||5
10688445|NCT02465866|11852280|FG000|COMPLETED|Period 4||5
10688446|NCT02465866|11852281|FG001|COMPLETED|Period 4||4
10688447|NCT02465866|11852282|FG002|COMPLETED|Period 4||5
10688448|NCT02465866|11852283|FG003|COMPLETED|Period 4||5
10688449|NCT02465866|11852280|FG000|NOT COMPLETED|Period 4||0
10688450|NCT02465866|11852281|FG001|NOT COMPLETED|Period 4||0
10688451|NCT02465866|11852282|FG002|NOT COMPLETED|Period 4||0
10688452|NCT02465866|11852283|FG003|NOT COMPLETED|Period 4||0
10688453|NCT02465866|11852280|FG000|STARTED|Period 4: Washout (14 Days)||5
10688454|NCT02465866|11852281|FG001|STARTED|Period 4: Washout (14 Days)||4
10688455|NCT02465866|11852282|FG002|STARTED|Period 4: Washout (14 Days)||5
10688456|NCT02465866|11852283|FG003|STARTED|Period 4: Washout (14 Days)||5
10688457|NCT02465866|11852280|FG000|COMPLETED|Period 4: Washout (14 Days)||5
10688458|NCT02465866|11852281|FG001|COMPLETED|Period 4: Washout (14 Days)||4
10688459|NCT02465866|11852282|FG002|COMPLETED|Period 4: Washout (14 Days)||5
10688460|NCT02465866|11852283|FG003|COMPLETED|Period 4: Washout (14 Days)||5
10688461|NCT02465866|11852280|FG000|NOT COMPLETED|Period 4: Washout (14 Days)||0
10688462|NCT02465866|11852281|FG001|NOT COMPLETED|Period 4: Washout (14 Days)||0
10688463|NCT02465866|11852282|FG002|NOT COMPLETED|Period 4: Washout (14 Days)||0
10688464|NCT02465866|11852283|FG003|NOT COMPLETED|Period 4: Washout (14 Days)||0
10688465|NCT02465931|11852295|FG000|STARTED|Overall Study||55
10688466|NCT02465931|11852296|FG001|STARTED|Overall Study||56
10800156|NCT04536571|11961066|FG000|STARTED|First Intervention||11
10800157|NCT04536571|11961067|FG001|STARTED|First Intervention||16
10800158|NCT04536571|11961066|FG000|COMPLETED|First Intervention||11
10800159|NCT04536571|11961067|FG001|COMPLETED|First Intervention||16
10800160|NCT04536571|11961066|FG000|NOT COMPLETED|First Intervention||0
10800161|NCT04536571|11961067|FG001|NOT COMPLETED|First Intervention||0
10800162|NCT04536571|11961066|FG000|STARTED|Second Intervention||11
10800163|NCT04536571|11961067|FG001|STARTED|Second Intervention||16
10800164|NCT04536571|11961066|FG000|COMPLETED|Second Intervention||11
10800165|NCT04536571|11961067|FG001|COMPLETED|Second Intervention||16
10800166|NCT04536571|11961066|FG000|NOT COMPLETED|Second Intervention||0
10800167|NCT04536571|11961067|FG001|NOT COMPLETED|Second Intervention||0
10688467|NCT02465931|11852295|FG000|COMPLETED|Overall Study||44
10688468|NCT02465931|11852296|FG001|COMPLETED|Overall Study||45
10688469|NCT02465931|11852295|FG000|NOT COMPLETED|Overall Study||11
10688470|NCT02465931|11852296|FG001|NOT COMPLETED|Overall Study||11
10800168|NCT04544787|11961084|FG000|STARTED|Overall Study||50
10800169|NCT04544787|11961085|FG001|STARTED|Overall Study||50
10800170|NCT04544787|11961086|FG002|STARTED|Overall Study||50
10800171|NCT04544787|11961087|FG003|STARTED|Overall Study||50
10800172|NCT04544787|11961088|FG004|STARTED|Overall Study||17
10800173|NCT04544787|11961089|FG005|STARTED|Overall Study||16
10800174|NCT04544787|11961090|FG006|STARTED|Overall Study||17
10800175|NCT04544787|11961084|FG000|Received First Dose of Vaccine|Overall Study||50
10800176|NCT04544787|11961085|FG001|Received First Dose of Vaccine|Overall Study||50
10800177|NCT04544787|11961086|FG002|Received First Dose of Vaccine|Overall Study||50
10800178|NCT04544787|11961087|FG003|Received First Dose of Vaccine|Overall Study||50
10800179|NCT04544787|11961088|FG004|Received First Dose of Vaccine|Overall Study||17
10800180|NCT04544787|11961089|FG005|Received First Dose of Vaccine|Overall Study||16
10800181|NCT04544787|11961090|FG006|Received First Dose of Vaccine|Overall Study||17
10800182|NCT04544787|11961084|FG000|Received Second Dose of Vaccine|Overall Study||0
10800183|NCT04544787|11961085|FG001|Received Second Dose of Vaccine|Overall Study||49
10800184|NCT04544787|11961086|FG002|Received Second Dose of Vaccine|Overall Study||0
10800185|NCT04544787|11961087|FG003|Received Second Dose of Vaccine|Overall Study||49
10800186|NCT04544787|11961088|FG004|Received Second Dose of Vaccine|Overall Study||17
10800187|NCT04544787|11961089|FG005|Received Second Dose of Vaccine|Overall Study||15
10800188|NCT04544787|11961090|FG006|Received Second Dose of Vaccine|Overall Study||16
10800189|NCT04544787|11961084|FG000|COMPLETED|Overall Study||50
10800190|NCT04544787|11961085|FG001|COMPLETED|Overall Study||50
10800191|NCT04544787|11961086|FG002|COMPLETED|Overall Study||50
10800192|NCT04544787|11961087|FG003|COMPLETED|Overall Study||50
10800193|NCT04544787|11961088|FG004|COMPLETED|Overall Study||17
10800194|NCT04544787|11961089|FG005|COMPLETED|Overall Study||16
10800195|NCT04544787|11961090|FG006|COMPLETED|Overall Study||17
10800196|NCT04544787|11961084|FG000|NOT COMPLETED|Overall Study||0
10800197|NCT04544787|11961085|FG001|NOT COMPLETED|Overall Study||0
10800198|NCT04544787|11961086|FG002|NOT COMPLETED|Overall Study||0
10800199|NCT04544787|11961087|FG003|NOT COMPLETED|Overall Study||0
10800200|NCT04544787|11961088|FG004|NOT COMPLETED|Overall Study||0
10800201|NCT04544787|11961089|FG005|NOT COMPLETED|Overall Study||0
10800202|NCT04544787|11961090|FG006|NOT COMPLETED|Overall Study||0
10688474|NCT02466087|11852306|FG000|STARTED|First Intervention: Weeks 1-6||62
10688475|NCT02466087|11852307|FG001|STARTED|First Intervention: Weeks 1-6||64
10688476|NCT02466087|11852306|FG000|COMPLETED|First Intervention: Weeks 1-6||55
10688477|NCT02466087|11852307|FG001|COMPLETED|First Intervention: Weeks 1-6||57
10688478|NCT02466087|11852306|FG000|NOT COMPLETED|First Intervention: Weeks 1-6||7
10688479|NCT02466087|11852307|FG001|NOT COMPLETED|First Intervention: Weeks 1-6||7
10688480|NCT02466087|11852306|FG000|STARTED|Second Intervention: Weeks 7-12||55
10688481|NCT02466087|11852307|FG001|STARTED|Second Intervention: Weeks 7-12||57
10688482|NCT02466087|11852306|FG000|COMPLETED|Second Intervention: Weeks 7-12||55
10688483|NCT02466087|11852307|FG001|COMPLETED|Second Intervention: Weeks 7-12||57
10688484|NCT02466087|11852306|FG000|NOT COMPLETED|Second Intervention: Weeks 7-12||0
10688485|NCT02466087|11852307|FG001|NOT COMPLETED|Second Intervention: Weeks 7-12||0
10688486|NCT02466126|11852316|FG000|STARTED|Baseline||109
10688487|NCT02466126|11852317|FG001|STARTED|Baseline||80
10688488|NCT02466126|11852316|FG000|COMPLETED|Baseline||109
10688489|NCT02466126|11852317|FG001|COMPLETED|Baseline||80
10688490|NCT02466126|11852316|FG000|NOT COMPLETED|Baseline||0
10688491|NCT02466126|11852317|FG001|NOT COMPLETED|Baseline||0
10688492|NCT02466126|11852316|FG000|STARTED|4 Month Assessment||109
10688493|NCT02466126|11852317|FG001|STARTED|4 Month Assessment||80
10688494|NCT02466126|11852316|FG000|COMPLETED|4 Month Assessment||93
10688495|NCT02466126|11852317|FG001|COMPLETED|4 Month Assessment||71
10688496|NCT02466126|11852316|FG000|NOT COMPLETED|4 Month Assessment||16
10688497|NCT02466126|11852317|FG001|NOT COMPLETED|4 Month Assessment||9
10688498|NCT02466126|11852316|FG000|STARTED|8 Month Assessment||93
10688499|NCT02466126|11852317|FG001|STARTED|8 Month Assessment||71
10688500|NCT02466126|11852316|FG000|COMPLETED|8 Month Assessment||86
10688501|NCT02466126|11852317|FG001|COMPLETED|8 Month Assessment||68
10688502|NCT02466126|11852316|FG000|NOT COMPLETED|8 Month Assessment||7
10688503|NCT02466126|11852317|FG001|NOT COMPLETED|8 Month Assessment||3
10688504|NCT02466126|11852316|FG000|STARTED|12 Month Assessment||86
10688505|NCT02466126|11852317|FG001|STARTED|12 Month Assessment||68
10688506|NCT02466126|11852316|FG000|COMPLETED|12 Month Assessment||85
10688507|NCT02466126|11852317|FG001|COMPLETED|12 Month Assessment||66
10688508|NCT02466126|11852316|FG000|NOT COMPLETED|12 Month Assessment||1
10688509|NCT02466126|11852317|FG001|NOT COMPLETED|12 Month Assessment||2
10688510|NCT02466230|11852323|FG000|STARTED|Overall Study||28
10688511|NCT02466230|11852323|FG000|COMPLETED|Overall Study||28
10688512|NCT02466230|11852323|FG000|NOT COMPLETED|Overall Study||0
10688513|NCT02466386|11852327|FG000|STARTED|Overall Study||113
10688514|NCT02466386|11852327|FG000|COMPLETED|Overall Study||69
10688515|NCT02466386|11852327|FG000|NOT COMPLETED|Overall Study||44
10688516|NCT02466399|11852333|FG000|STARTED|Overall Study||53
10688517|NCT02466399|11852334|FG001|STARTED|Overall Study||27
10688518|NCT02466399|11852333|FG000|COMPLETED|Overall Study||51
10688519|NCT02466399|11852334|FG001|COMPLETED|Overall Study||27
10688520|NCT02466399|11852333|FG000|NOT COMPLETED|Overall Study||2
10688521|NCT02466399|11852334|FG001|NOT COMPLETED|Overall Study||0
10688522|NCT02466412|11852342|FG000|STARTED|Washout Period of 1 Day (Day -1)||24
10688523|NCT02466412|11852343|FG001|STARTED|Washout Period of 1 Day (Day -1)||24
10688524|NCT02466412|11852342|FG000|COMPLETED|Washout Period of 1 Day (Day -1)||24
10688525|NCT02466412|11852343|FG001|COMPLETED|Washout Period of 1 Day (Day -1)||24
10688526|NCT02466412|11852342|FG000|NOT COMPLETED|Washout Period of 1 Day (Day -1)||0
10688527|NCT02466412|11852343|FG001|NOT COMPLETED|Washout Period of 1 Day (Day -1)||0
10688528|NCT02466412|11852342|FG000|STARTED|First Intervention (Day 1)||24
10688529|NCT02466412|11852343|FG001|STARTED|First Intervention (Day 1)||24
10688530|NCT02466412|11852342|FG000|COMPLETED|First Intervention (Day 1)||24
10688531|NCT02466412|11852343|FG001|COMPLETED|First Intervention (Day 1)||24
10688532|NCT02466412|11852342|FG000|NOT COMPLETED|First Intervention (Day 1)||0
10688533|NCT02466412|11852343|FG001|NOT COMPLETED|First Intervention (Day 1)||0
10688534|NCT02466412|11852342|FG000|STARTED|Washout Period of 1 Day (Day 2)||24
10688535|NCT02466412|11852343|FG001|STARTED|Washout Period of 1 Day (Day 2)||24
10688536|NCT02466412|11852342|FG000|COMPLETED|Washout Period of 1 Day (Day 2)||24
10688537|NCT02466412|11852343|FG001|COMPLETED|Washout Period of 1 Day (Day 2)||24
10688538|NCT02466412|11852342|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
10688539|NCT02466412|11852343|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
10688540|NCT02466412|11852342|FG000|STARTED|Second Intervention (Day 3)||24
10688541|NCT02466412|11852343|FG001|STARTED|Second Intervention (Day 3)||24
10688542|NCT02466412|11852342|FG000|COMPLETED|Second Intervention (Day 3)||24
10688543|NCT02466412|11852343|FG001|COMPLETED|Second Intervention (Day 3)||24
10688544|NCT02466412|11852342|FG000|NOT COMPLETED|Second Intervention (Day 3)||0
10688545|NCT02466412|11852343|FG001|NOT COMPLETED|Second Intervention (Day 3)||0
10688546|NCT02466425|11852352|FG000|STARTED|Overall Study||132
10688547|NCT02466425|11852353|FG001|STARTED|Overall Study||132
10688548|NCT02466425|11852352|FG000|Treated|Overall Study||131
10688549|NCT02466425|11852353|FG001|Treated|Overall Study||132
10688550|NCT02466425|11852352|FG000|COMPLETED|Overall Study||118
10688551|NCT02466425|11852353|FG001|COMPLETED|Overall Study||116
10688552|NCT02466425|11852352|FG000|NOT COMPLETED|Overall Study||14
10688553|NCT02466425|11852353|FG001|NOT COMPLETED|Overall Study||16
10688554|NCT02466516|11852364|FG000|STARTED|Overall Study||20
10688555|NCT02466516|11852365|FG001|STARTED|Overall Study||22
10688556|NCT02466516|11852366|FG002|STARTED|Overall Study||10
10688557|NCT02466516|11852367|FG003|STARTED|Overall Study||10
10688558|NCT02466516|11852368|FG004|STARTED|Overall Study||10
10688559|NCT02466516|11852364|FG000|COMPLETED|Overall Study||16
10688560|NCT02466516|11852365|FG001|COMPLETED|Overall Study||21
10688561|NCT02466516|11852366|FG002|COMPLETED|Overall Study||9
10688562|NCT02466516|11852367|FG003|COMPLETED|Overall Study||10
10688563|NCT02466516|11852368|FG004|COMPLETED|Overall Study||10
10688564|NCT02466516|11852364|FG000|NOT COMPLETED|Overall Study||4
10688565|NCT02466516|11852365|FG001|NOT COMPLETED|Overall Study||1
10688566|NCT02466516|11852366|FG002|NOT COMPLETED|Overall Study||1
10688567|NCT02466516|11852367|FG003|NOT COMPLETED|Overall Study||0
10688568|NCT02466516|11852368|FG004|NOT COMPLETED|Overall Study||0
10688569|NCT02466555|11852380|FG000|STARTED|Overall Study||30
10688570|NCT02466555|11852380|FG000|COMPLETED|Overall Study||28
10688571|NCT02466555|11852380|FG000|NOT COMPLETED|Overall Study||2
10688572|NCT02466646|11852388|FG000|STARTED|Overall Study||14
10688573|NCT02466646|11852389|FG001|STARTED|Overall Study||14
10688574|NCT02466646|11852390|FG002|STARTED|Overall Study||14
10688575|NCT02466646|11852388|FG000|COMPLETED|Overall Study||14
10688576|NCT02466646|11852389|FG001|COMPLETED|Overall Study||14
10688577|NCT02466646|11852390|FG002|COMPLETED|Overall Study||14
10688578|NCT02466646|11852388|FG000|NOT COMPLETED|Overall Study||0
10688579|NCT02466646|11852389|FG001|NOT COMPLETED|Overall Study||0
10688580|NCT02466646|11852390|FG002|NOT COMPLETED|Overall Study||0
10688581|NCT02466659|11852403|FG000|STARTED|Overall Study||5
10688582|NCT02466659|11852404|FG001|STARTED|Overall Study||3
10688583|NCT02466659|11852403|FG000|COMPLETED|Overall Study||0
10688584|NCT02466659|11852404|FG001|COMPLETED|Overall Study||1
10688585|NCT02466659|11852403|FG000|NOT COMPLETED|Overall Study||5
10688586|NCT02466659|11852404|FG001|NOT COMPLETED|Overall Study||2
10688587|NCT02466958|11852412|FG000|STARTED|Overall Study||17
10688588|NCT02466958|11852413|FG001|STARTED|Overall Study||12
10688589|NCT02466958|11852412|FG000|COMPLETED|Overall Study||7
10688590|NCT02466958|11852413|FG001|COMPLETED|Overall Study||9
10688591|NCT02466958|11852412|FG000|NOT COMPLETED|Overall Study||10
10688592|NCT02466958|11852413|FG001|NOT COMPLETED|Overall Study||3
10688593|NCT02467075|11852421|FG000|STARTED|Initial CT Scan||0
10688594|NCT02467075|11852422|FG001|STARTED|Initial CT Scan||1
10688595|NCT02467075|11852421|FG000|COMPLETED|Initial CT Scan||0
10688596|NCT02467075|11852422|FG001|COMPLETED|Initial CT Scan||1
10688597|NCT02467075|11852421|FG000|NOT COMPLETED|Initial CT Scan||0
10688598|NCT02467075|11852422|FG001|NOT COMPLETED|Initial CT Scan||0
10688599|NCT02467075|11852421|FG000|STARTED|48 Hour Follow-up||0
10688600|NCT02467075|11852422|FG001|STARTED|48 Hour Follow-up||1
10688601|NCT02467075|11852421|FG000|COMPLETED|48 Hour Follow-up||0
10688602|NCT02467075|11852422|FG001|COMPLETED|48 Hour Follow-up||1
10688603|NCT02467075|11852421|FG000|NOT COMPLETED|48 Hour Follow-up||0
10688604|NCT02467075|11852422|FG001|NOT COMPLETED|48 Hour Follow-up||0
10688605|NCT02467075|11852421|FG000|STARTED|72 Hour Follow-up||0
10688606|NCT02467075|11852422|FG001|STARTED|72 Hour Follow-up||1
10688607|NCT02467075|11852421|FG000|COMPLETED|72 Hour Follow-up||0
10688608|NCT02467075|11852422|FG001|COMPLETED|72 Hour Follow-up||1
10688609|NCT02467075|11852421|FG000|NOT COMPLETED|72 Hour Follow-up||0
10688610|NCT02467075|11852422|FG001|NOT COMPLETED|72 Hour Follow-up||0
10688611|NCT02467075|11852421|FG000|STARTED|30 Day Follow-up||0
10688612|NCT02467075|11852422|FG001|STARTED|30 Day Follow-up||1
10688613|NCT02467075|11852421|FG000|COMPLETED|30 Day Follow-up||0
10688614|NCT02467075|11852422|FG001|COMPLETED|30 Day Follow-up||1
10688615|NCT02467075|11852421|FG000|NOT COMPLETED|30 Day Follow-up||0
10688616|NCT02467075|11852422|FG001|NOT COMPLETED|30 Day Follow-up||0
10688617|NCT02467166|11852430|FG000|STARTED|Overall Study||36
10688618|NCT02467166|11852430|FG000|COMPLETED|Overall Study||36
10688619|NCT02467166|11852430|FG000|NOT COMPLETED|Overall Study||0
10688620|NCT02467179|11852436|FG000|STARTED|Overall Study||25
10688621|NCT02467179|11852437|FG001|STARTED|Overall Study||25
10688622|NCT02467179|11852436|FG000|COMPLETED|Overall Study||25
10688623|NCT02467179|11852437|FG001|COMPLETED|Overall Study||25
10688624|NCT02467179|11852436|FG000|NOT COMPLETED|Overall Study||0
10688625|NCT02467179|11852437|FG001|NOT COMPLETED|Overall Study||0
10688626|NCT02467192|11852443|FG000|STARTED|Overall Study||203
10688627|NCT02467192|11852443|FG000|COMPLETED|Overall Study||200
10688628|NCT02467192|11852443|FG000|NOT COMPLETED|Overall Study||3
10688629|NCT02467387|11852451|FG000|STARTED|First Intervention||11
10688630|NCT02467387|11852452|FG001|STARTED|First Intervention||12
10688631|NCT02467387|11852451|FG000|Received Treatment as Randomized|First Intervention||10
10688632|NCT02467387|11852452|FG001|Received Treatment as Randomized|First Intervention||12
10688633|NCT02467387|11852451|FG000|COMPLETED|First Intervention||10
10688634|NCT02467387|11852452|FG001|COMPLETED|First Intervention||12
10688635|NCT02467387|11852451|FG000|NOT COMPLETED|First Intervention||1
10688636|NCT02467387|11852452|FG001|NOT COMPLETED|First Intervention||0
10688637|NCT02467387|11852451|FG000|STARTED|Second Intervention||10
10688638|NCT02467387|11852452|FG001|STARTED|Second Intervention||12
10688639|NCT02467387|11852451|FG000|COMPLETED|Second Intervention||7
10688640|NCT02467387|11852452|FG001|COMPLETED|Second Intervention||12
10688641|NCT02467387|11852451|FG000|NOT COMPLETED|Second Intervention||3
10688642|NCT02467387|11852452|FG001|NOT COMPLETED|Second Intervention||0
10688643|NCT02467465|11852462|FG000|STARTED|Overall Study||15
10688644|NCT02467465|11852463|FG001|STARTED|Overall Study||15
10688645|NCT02467465|11852462|FG000|COMPLETED|Overall Study||15
10688646|NCT02467465|11852463|FG001|COMPLETED|Overall Study||15
10688647|NCT02467465|11852462|FG000|NOT COMPLETED|Overall Study||0
10688648|NCT02467465|11852463|FG001|NOT COMPLETED|Overall Study||0
10688649|NCT02467491|11852471|FG000|STARTED|Overall Study||12
10688650|NCT02467491|11852471|FG000|COMPLETED|Overall Study||12
10688651|NCT02467491|11852471|FG000|NOT COMPLETED|Overall Study||0
10688652|NCT02467504|11852477|FG000|STARTED|Overall Study||23
10688653|NCT02467504|11852478|FG001|STARTED|Overall Study||24
10688654|NCT02467504|11852477|FG000|COMPLETED|Overall Study||17
10688655|NCT02467504|11852478|FG001|COMPLETED|Overall Study||23
10688656|NCT02467504|11852477|FG000|NOT COMPLETED|Overall Study||6
10688657|NCT02467504|11852478|FG001|NOT COMPLETED|Overall Study||1
10688658|NCT02467621|11852486|FG000|STARTED|Overall Study||1645
10688659|NCT02467621|11852487|FG001|STARTED|Overall Study||1653
10688660|NCT02467621|11852486|FG000|COMPLETED|Overall Study||1644
10688661|NCT02467621|11852487|FG001|COMPLETED|Overall Study||1647
10688662|NCT02467621|11852486|FG000|NOT COMPLETED|Overall Study||1
10688663|NCT02467621|11852487|FG001|NOT COMPLETED|Overall Study||6
10688664|NCT02467777|11852495|FG000|STARTED|Overall Study||23
10688665|NCT02467777|11852496|FG001|STARTED|Overall Study||27
10688666|NCT02467777|11852495|FG000|COMPLETED|Overall Study||23
10688667|NCT02467777|11852496|FG001|COMPLETED|Overall Study||27
10688668|NCT02467777|11852495|FG000|NOT COMPLETED|Overall Study||0
10688669|NCT02467777|11852496|FG001|NOT COMPLETED|Overall Study||0
10688670|NCT02467842|11852505|FG000|STARTED|Overall Study||752
10688671|NCT02467842|11852506|FG001|STARTED|Overall Study||373
10688672|NCT02467842|11852507|FG002|STARTED|Overall Study||378
10688673|NCT02467842|11852505|FG000|COMPLETED|Overall Study||752
10688674|NCT02467842|11852506|FG001|COMPLETED|Overall Study||373
10688675|NCT02467842|11852507|FG002|COMPLETED|Overall Study||378
10688676|NCT02467842|11852505|FG000|NOT COMPLETED|Overall Study||0
10688677|NCT02467842|11852506|FG001|NOT COMPLETED|Overall Study||0
10688678|NCT02467842|11852507|FG002|NOT COMPLETED|Overall Study||0
10688679|NCT02468154|11852519|FG000|STARTED|Overall Study||29
10688680|NCT02468154|11852520|FG001|STARTED|Overall Study||28
10688681|NCT02468154|11852519|FG000|COMPLETED|Overall Study||29
10688682|NCT02468154|11852520|FG001|COMPLETED|Overall Study||28
10688683|NCT02468154|11852519|FG000|NOT COMPLETED|Overall Study||0
10688684|NCT02468154|11852520|FG001|NOT COMPLETED|Overall Study||0
10688685|NCT02468193|11852526|FG000|STARTED|Overall Study||9
10688686|NCT02468193|11852526|FG000|Completed Week-12 (Study Period I)|Overall Study||7
10688687|NCT02468193|11852526|FG000|Discontinued at or Prior to Week-12|Overall Study||2
10688688|NCT02468193|11852526|FG000|Completed Week-12, Did Not Enter Per. II|Overall Study||3
10688689|NCT02468193|11852526|FG000|Completed Week-12, Entered Study Per. II|Overall Study||4
10688690|NCT02468193|11852526|FG000|Completed Week-48 (Study Period II)|Overall Study||2
10688691|NCT02468193|11852526|FG000|Discontinued at or Prior to Week48|Overall Study||2
10688692|NCT02468193|11852526|FG000|Compl. Wk-48, Didn't Enter Opt. Ext. Per|Overall Study||0
10688693|NCT02468193|11852526|FG000|Compl. Wk-48, Entered Opt. Ext. Period|Overall Study||2
10688694|NCT02468193|11852526|FG000|Completed Optional Extension Period|Overall Study||0
10688695|NCT02468193|11852526|FG000|Discontinued Study in Optional Ext. Per.|Overall Study||2
10688696|NCT02468193|11852526|FG000|COMPLETED|Overall Study||3
10688697|NCT02468193|11852526|FG000|NOT COMPLETED|Overall Study||6
10688698|NCT02468557|11852546|FG000|STARTED|Overall Study||16
10688699|NCT02468557|11852546|FG000|COMPLETED|Overall Study||0
10688700|NCT02468557|11852546|FG000|NOT COMPLETED|Overall Study||16
10688701|NCT02468570|11852556|FG000|STARTED|Overall Study||6
10688702|NCT02468570|11852557|FG001|STARTED|Overall Study||3
10688703|NCT02468570|11852556|FG000|COMPLETED|Overall Study||6
10688704|NCT02468570|11852557|FG001|COMPLETED|Overall Study||3
10688705|NCT02468570|11852556|FG000|NOT COMPLETED|Overall Study||0
10688706|NCT02468570|11852557|FG001|NOT COMPLETED|Overall Study||0
10688707|NCT02468648|11852563|FG000|STARTED|Overall Study||72
10688708|NCT02468648|11852563|FG000|COMPLETED|Overall Study||71
10688709|NCT02468648|11852563|FG000|NOT COMPLETED|Overall Study||1
10688710|NCT02468674|11852576|FG000|STARTED|Overall Study||5
10688711|NCT02468674|11852577|FG001|STARTED|Overall Study||5
10688712|NCT02468674|11852578|FG002|STARTED|Overall Study||5
10688713|NCT02468674|11852579|FG003|STARTED|Overall Study||4
10688714|NCT02468674|11852580|FG004|STARTED|Overall Study||7
10688715|NCT02468674|11852581|FG005|STARTED|Overall Study||7
10688716|NCT02468674|11852582|FG006|STARTED|Overall Study||15
10688717|NCT02468674|11852583|FG007|STARTED|Overall Study||69
10688718|NCT02468674|11852584|FG008|STARTED|Overall Study||43
10688719|NCT02468674|11852576|FG000|COMPLETED|Overall Study||4
10688720|NCT02468674|11852577|FG001|COMPLETED|Overall Study||5
10688721|NCT02468674|11852578|FG002|COMPLETED|Overall Study||5
10688722|NCT02468674|11852579|FG003|COMPLETED|Overall Study||3
10688723|NCT02468674|11852580|FG004|COMPLETED|Overall Study||6
10688724|NCT02468674|11852581|FG005|COMPLETED|Overall Study||6
10688725|NCT02468674|11852582|FG006|COMPLETED|Overall Study||14
10688726|NCT02468674|11852583|FG007|COMPLETED|Overall Study||65
10688727|NCT02468674|11852584|FG008|COMPLETED|Overall Study||40
10688728|NCT02468674|11852576|FG000|NOT COMPLETED|Overall Study||1
10688729|NCT02468674|11852577|FG001|NOT COMPLETED|Overall Study||0
10688730|NCT02468674|11852578|FG002|NOT COMPLETED|Overall Study||0
10688731|NCT02468674|11852579|FG003|NOT COMPLETED|Overall Study||1
10800203|NCT04555031|11961129|FG000|STARTED|Overall Study||10
10800204|NCT04555031|11961129|FG000|COMPLETED|Overall Study||10
10800205|NCT04555031|11961129|FG000|NOT COMPLETED|Overall Study||0
10688732|NCT02468674|11852580|FG004|NOT COMPLETED|Overall Study||1
10688733|NCT02468674|11852581|FG005|NOT COMPLETED|Overall Study||1
10688734|NCT02468674|11852582|FG006|NOT COMPLETED|Overall Study||1
10688735|NCT02468674|11852583|FG007|NOT COMPLETED|Overall Study||4
10688736|NCT02468674|11852584|FG008|NOT COMPLETED|Overall Study||3
10800206|NCT04559282|11961136|FG000|STARTED|Intervention 1 (Day 0)||8
10688737|NCT02468700|11852606|FG000|STARTED|Overall Study||22
10688738|NCT02468700|11852607|FG001|STARTED|Overall Study||21
10688739|NCT02468700|11852606|FG000|COMPLETED|Overall Study||20
10688740|NCT02468700|11852607|FG001|COMPLETED|Overall Study||19
10688741|NCT02468700|11852606|FG000|NOT COMPLETED|Overall Study||2
10688742|NCT02468700|11852607|FG001|NOT COMPLETED|Overall Study||2
10688743|NCT02468804|11852615|FG000|STARTED|Overall Study||37
10688744|NCT02468804|11852616|FG001|STARTED|Overall Study||58
10688745|NCT02468804|11852615|FG000|COMPLETED|Overall Study||36
10688746|NCT02468804|11852616|FG001|COMPLETED|Overall Study||50
10688747|NCT02468804|11852615|FG000|NOT COMPLETED|Overall Study||1
10688748|NCT02468804|11852616|FG001|NOT COMPLETED|Overall Study||8
10688749|NCT02468830|11852622|FG000|STARTED|Overall Study||58
10688750|NCT02468830|11852622|FG000|COMPLETED|Overall Study||55
10688751|NCT02468830|11852622|FG000|NOT COMPLETED|Overall Study||3
10688752|NCT02468934|11852626|FG000|STARTED|Overall Study||27
10688753|NCT02468934|11852626|FG000|Enrolled/Received Leads|Overall Study||24
10688754|NCT02468934|11852626|FG000|Underwent Total Knee Arthroplasty|Overall Study||20
10688755|NCT02468934|11852626|FG000|COMPLETED|Overall Study||20
10688756|NCT02468934|11852626|FG000|NOT COMPLETED|Overall Study||7
10688757|NCT02469038|11852634|FG000|STARTED|Overall Study||26
10688758|NCT02469038|11852635|FG001|STARTED|Overall Study||24
10688759|NCT02469038|11852634|FG000|COMPLETED|Overall Study||22
10688760|NCT02469038|11852635|FG001|COMPLETED|Overall Study||19
10688761|NCT02469038|11852634|FG000|NOT COMPLETED|Overall Study||4
10688762|NCT02469038|11852635|FG001|NOT COMPLETED|Overall Study||5
10688763|NCT02469064|11852643|FG000|STARTED|Overall Study||64
10688764|NCT02469064|11852644|FG001|STARTED|Overall Study||62
10688765|NCT02469064|11852643|FG000|COMPLETED|Overall Study||63
10688766|NCT02469064|11852644|FG001|COMPLETED|Overall Study||59
10688767|NCT02469064|11852643|FG000|NOT COMPLETED|Overall Study||1
10688768|NCT02469064|11852644|FG001|NOT COMPLETED|Overall Study||3
10688769|NCT02469077|11852652|FG000|STARTED|Pre Randomization - Pre Intervention||44
10688770|NCT02469077|11852653|FG001|STARTED|Pre Randomization - Pre Intervention||49
10688771|NCT02469077|11852652|FG000|Pre Intervention Placebo|Pre Randomization - Pre Intervention||44
10688772|NCT02469077|11852653|FG001|Pre Intervention Placebo|Pre Randomization - Pre Intervention||49
10688773|NCT02469077|11852652|FG000|Pre Intervention Morpine|Pre Randomization - Pre Intervention||44
10688774|NCT02469077|11852653|FG001|Pre Intervention Morpine|Pre Randomization - Pre Intervention||49
10688775|NCT02469077|11852652|FG000|Pre Intervention Naloxone|Pre Randomization - Pre Intervention||44
10688776|NCT02469077|11852653|FG001|Pre Intervention Naloxone|Pre Randomization - Pre Intervention||49
10688777|NCT02469077|11852652|FG000|COMPLETED|Pre Randomization - Pre Intervention||44
10688778|NCT02469077|11852653|FG001|COMPLETED|Pre Randomization - Pre Intervention||49
10688779|NCT02469077|11852652|FG000|NOT COMPLETED|Pre Randomization - Pre Intervention||0
10688780|NCT02469077|11852653|FG001|NOT COMPLETED|Pre Randomization - Pre Intervention||0
10688781|NCT02469077|11852652|FG000|STARTED|Post Randomization/Intervention Period||44
10688782|NCT02469077|11852653|FG001|STARTED|Post Randomization/Intervention Period||49
10688783|NCT02469077|11852652|FG000|COMPLETED|Post Randomization/Intervention Period||40
10688784|NCT02469077|11852653|FG001|COMPLETED|Post Randomization/Intervention Period||45
10688785|NCT02469077|11852652|FG000|NOT COMPLETED|Post Randomization/Intervention Period||4
10688786|NCT02469077|11852653|FG001|NOT COMPLETED|Post Randomization/Intervention Period||4
10688787|NCT02469077|11852652|FG000|STARTED|Post Intervention /Followup||40
10688788|NCT02469077|11852653|FG001|STARTED|Post Intervention /Followup||45
10688789|NCT02469077|11852652|FG000|Post Intervention Placebo|Post Intervention /Followup||39
10688790|NCT02469077|11852653|FG001|Post Intervention Placebo|Post Intervention /Followup||45
10688791|NCT02469077|11852652|FG000|Post Intervention Morphine|Post Intervention /Followup||40
10688792|NCT02469077|11852653|FG001|Post Intervention Morphine|Post Intervention /Followup||45
10688793|NCT02469077|11852652|FG000|Post Intervention Naloxone|Post Intervention /Followup||39
10688794|NCT02469077|11852653|FG001|Post Intervention Naloxone|Post Intervention /Followup||44
10688795|NCT02469077|11852652|FG000|COMPLETED|Post Intervention /Followup||38
10688796|NCT02469077|11852653|FG001|COMPLETED|Post Intervention /Followup||44
10688797|NCT02469077|11852652|FG000|NOT COMPLETED|Post Intervention /Followup||2
10688798|NCT02469077|11852653|FG001|NOT COMPLETED|Post Intervention /Followup||1
10688799|NCT02469090|11852665|FG000|STARTED|Period 1: Dose Titration Phase||141
10688800|NCT02469090|11852666|FG001|STARTED|Period 1: Dose Titration Phase||0
10688801|NCT02469090|11852667|FG002|STARTED|Period 1: Dose Titration Phase||0
10688802|NCT02469090|11852665|FG000|COMPLETED|Period 1: Dose Titration Phase||109
10688803|NCT02469090|11852666|FG001|COMPLETED|Period 1: Dose Titration Phase||0
10688804|NCT02469090|11852667|FG002|COMPLETED|Period 1: Dose Titration Phase||0
10688805|NCT02469090|11852665|FG000|NOT COMPLETED|Period 1: Dose Titration Phase||32
10688806|NCT02469090|11852666|FG001|NOT COMPLETED|Period 1: Dose Titration Phase||0
10688807|NCT02469090|11852667|FG002|NOT COMPLETED|Period 1: Dose Titration Phase||0
10688808|NCT02469090|11852665|FG000|STARTED|Period 2: Maintenance Treatment Phase|Subjects who completed the Titration Phase were eligible to proceed to Maintenance Treatment Phase|0
10688809|NCT02469090|11852666|FG001|STARTED|Period 2: Maintenance Treatment Phase|subjects who completed the Titration Phase and were randomized to Placebo in the Maintenance Phase|55
10688810|NCT02469090|11852667|FG002|STARTED|Period 2: Maintenance Treatment Phase|subjects who completed the Titration Phase and were randomized to APL-130277 Maintenance Phase|54
10688811|NCT02469090|11852665|FG000|COMPLETED|Period 2: Maintenance Treatment Phase||0
10688812|NCT02469090|11852666|FG001|COMPLETED|Period 2: Maintenance Treatment Phase||46
10688813|NCT02469090|11852667|FG002|COMPLETED|Period 2: Maintenance Treatment Phase||34
10688814|NCT02469090|11852665|FG000|NOT COMPLETED|Period 2: Maintenance Treatment Phase||0
10688815|NCT02469090|11852666|FG001|NOT COMPLETED|Period 2: Maintenance Treatment Phase||9
10688816|NCT02469090|11852667|FG002|NOT COMPLETED|Period 2: Maintenance Treatment Phase||20
10688817|NCT02469116|11852674|FG000|STARTED|Overall Study||18
10688818|NCT02469116|11852674|FG000|COMPLETED|Overall Study||18
10688819|NCT02469116|11852674|FG000|NOT COMPLETED|Overall Study||0
10688820|NCT02469168|11852680|FG000|STARTED|Overall Study||1
10688821|NCT02469168|11852681|FG001|STARTED|Overall Study||0
10688822|NCT02469168|11852680|FG000|COMPLETED|Overall Study||0
10688823|NCT02469168|11852681|FG001|COMPLETED|Overall Study||0
10688824|NCT02469168|11852680|FG000|NOT COMPLETED|Overall Study||1
10688825|NCT02469168|11852681|FG001|NOT COMPLETED|Overall Study||0
10688826|NCT02469246|11852689|FG000|STARTED|Double-Blind Phase||285
10688827|NCT02469246|11852690|FG001|STARTED|Double-Blind Phase||282
10688828|NCT02469246|11852689|FG000|COMPLETED|Double-Blind Phase||218
10688829|NCT02469246|11852690|FG001|COMPLETED|Double-Blind Phase||226
10688830|NCT02469246|11852689|FG000|NOT COMPLETED|Double-Blind Phase||67
10688831|NCT02469246|11852690|FG001|NOT COMPLETED|Double-Blind Phase||56
10688832|NCT02469246|11852689|FG000|STARTED|Open-Label Extension (OLE)|Only participants in countries where F/TAF was not commercially available were eligible for the OLE.|6
10688833|NCT02469246|11852690|FG001|STARTED|Open-Label Extension (OLE)|Only participants in countries where F/TAF was not commercially available were eligible for the OLE.|5
10688834|NCT02469246|11852689|FG000|COMPLETED|Open-Label Extension (OLE)||6
10688835|NCT02469246|11852690|FG001|COMPLETED|Open-Label Extension (OLE)||5
10688836|NCT02469246|11852689|FG000|NOT COMPLETED|Open-Label Extension (OLE)||0
10688837|NCT02469246|11852690|FG001|NOT COMPLETED|Open-Label Extension (OLE)||0
10688838|NCT02469298|11852702|FG000|STARTED|Overall Study||15
10688839|NCT02469298|11852703|FG001|STARTED|Overall Study||7
10688840|NCT02469298|11852704|FG002|STARTED|Overall Study||16
10688841|NCT02469298|11852705|FG003|STARTED|Overall Study||7
10688842|NCT02469298|11852702|FG000|COMPLETED|Overall Study||14
10688843|NCT02469298|11852703|FG001|COMPLETED|Overall Study||6
10688844|NCT02469298|11852704|FG002|COMPLETED|Overall Study||14
10688845|NCT02469298|11852705|FG003|COMPLETED|Overall Study||5
10688846|NCT02469298|11852702|FG000|NOT COMPLETED|Overall Study||1
10688847|NCT02469298|11852703|FG001|NOT COMPLETED|Overall Study||1
10688848|NCT02469298|11852704|FG002|NOT COMPLETED|Overall Study||2
10688849|NCT02469298|11852705|FG003|NOT COMPLETED|Overall Study||2
10688850|NCT02469389|11852724|FG000|STARTED|Overall Study||53
10688851|NCT02469389|11852725|FG001|STARTED|Overall Study||52
10688852|NCT02469389|11852724|FG000|Completed 12-week Assessment|Overall Study|13 lost to contact or refused|40
10688853|NCT02469389|11852725|FG001|Completed 12-week Assessment|Overall Study|8 lost to contact or refused|44
10688854|NCT02469389|11852724|FG000|Completed 24-week Assessment|Overall Study|16 lost to contact or refused|37
10688855|NCT02469389|11852725|FG001|Completed 24-week Assessment|Overall Study|6 lost to contact or refused|46
10688856|NCT02469389|11852724|FG000|COMPLETED|Overall Study||37
10688857|NCT02469389|11852725|FG001|COMPLETED|Overall Study||44
10688858|NCT02469389|11852724|FG000|NOT COMPLETED|Overall Study||16
10688859|NCT02469389|11852725|FG001|NOT COMPLETED|Overall Study||8
10688860|NCT02469597|11852733|FG000|STARTED|Overall Study||22
10688861|NCT02469597|11852734|FG001|STARTED|Overall Study||24
10688862|NCT02469597|11852733|FG000|COMPLETED|Overall Study||22
10688863|NCT02469597|11852734|FG001|COMPLETED|Overall Study||24
10688864|NCT02469597|11852733|FG000|NOT COMPLETED|Overall Study||0
10688865|NCT02469597|11852734|FG001|NOT COMPLETED|Overall Study||0
10688866|NCT02469610|11852742|FG000|STARTED|Overall Study||34
10688867|NCT02469610|11852743|FG001|STARTED|Overall Study||31
10688868|NCT02469610|11852742|FG000|COMPLETED|Overall Study||30
10688869|NCT02469610|11852743|FG001|COMPLETED|Overall Study||30
10688870|NCT02469610|11852742|FG000|NOT COMPLETED|Overall Study||4
10688871|NCT02469610|11852743|FG001|NOT COMPLETED|Overall Study||1
10688872|NCT02469623|11852749|FG000|STARTED|Overall Study||85
10688873|NCT02469623|11852749|FG000|COMPLETED|Overall Study||72
10688874|NCT02469623|11852749|FG000|NOT COMPLETED|Overall Study||13
10688875|NCT02469701|11852754|FG000|STARTED|Overall Study||10
10688876|NCT02469701|11852754|FG000|COMPLETED|Overall Study||10
10688877|NCT02469701|11852754|FG000|NOT COMPLETED|Overall Study||0
10688878|NCT02469714|11852760|FG000|STARTED|Overall Study||55
10688879|NCT02469714|11852761|FG001|STARTED|Overall Study||55
10688880|NCT02469714|11852760|FG000|4 Month Follow-Up|Overall Study||50
10688881|NCT02469714|11852761|FG001|4 Month Follow-Up|Overall Study||51
10688882|NCT02469714|11852760|FG000|8 Month Follow-Up|Overall Study||49
10688883|NCT02469714|11852761|FG001|8 Month Follow-Up|Overall Study||50
10688884|NCT02469714|11852760|FG000|COMPLETED|Overall Study||47
10688885|NCT02469714|11852761|FG001|COMPLETED|Overall Study||50
10688886|NCT02469714|11852760|FG000|NOT COMPLETED|Overall Study||8
10688887|NCT02469714|11852761|FG001|NOT COMPLETED|Overall Study||5
10688888|NCT02469857|11852769|FG000|STARTED|Overall Study||143
10688889|NCT02469857|11852770|FG001|STARTED|Overall Study||147
10688890|NCT02469857|11852769|FG000|COMPLETED|Overall Study||118
10688891|NCT02469857|11852770|FG001|COMPLETED|Overall Study||115
10688892|NCT02469857|11852769|FG000|NOT COMPLETED|Overall Study||25
10688893|NCT02469857|11852770|FG001|NOT COMPLETED|Overall Study||32
10688894|NCT02469870|11852780|FG000|STARTED|Overall Study||77
10688895|NCT02469870|11852781|FG001|STARTED|Overall Study||79
10688896|NCT02469870|11852780|FG000|COMPLETED|Overall Study||73
10688897|NCT02469870|11852781|FG001|COMPLETED|Overall Study||72
10688898|NCT02469870|11852780|FG000|NOT COMPLETED|Overall Study||4
10688899|NCT02469870|11852781|FG001|NOT COMPLETED|Overall Study||7
10688900|NCT02469896|11852792|FG000|STARTED|Overall Study||8
10688901|NCT02469896|11852793|FG001|STARTED|Overall Study||14
10688902|NCT02469896|11852792|FG000|COMPLETED|Overall Study||6
10688903|NCT02469896|11852793|FG001|COMPLETED|Overall Study||14
10688904|NCT02469896|11852792|FG000|NOT COMPLETED|Overall Study||2
10688905|NCT02469896|11852793|FG001|NOT COMPLETED|Overall Study||0
10688906|NCT02469961|11852805|FG000|STARTED|Overall Study||25
10688907|NCT02469961|11852806|FG001|STARTED|Overall Study||25
10688908|NCT02469961|11852805|FG000|COMPLETED|Overall Study||21
10688909|NCT02469961|11852806|FG001|COMPLETED|Overall Study||24
10688910|NCT02469961|11852805|FG000|NOT COMPLETED|Overall Study||4
10688911|NCT02469961|11852806|FG001|NOT COMPLETED|Overall Study||1
10688912|NCT02470234|11852820|FG000|STARTED|Overall Study||5
10688913|NCT02470234|11852821|FG001|STARTED|Overall Study||3
10688914|NCT02470234|11852822|FG002|STARTED|Overall Study||2
10688915|NCT02470234|11852820|FG000|COMPLETED|Overall Study||5
10688916|NCT02470234|11852821|FG001|COMPLETED|Overall Study||3
10688917|NCT02470234|11852822|FG002|COMPLETED|Overall Study||2
10688918|NCT02470234|11852820|FG000|NOT COMPLETED|Overall Study||0
10688919|NCT02470234|11852821|FG001|NOT COMPLETED|Overall Study||0
10688920|NCT02470234|11852822|FG002|NOT COMPLETED|Overall Study||0
10688921|NCT02470312|11852837|FG000|STARTED|Overall Study||147
10688922|NCT02470312|11852838|FG001|STARTED|Overall Study||431
10688923|NCT02470312|11852837|FG000|COMPLETED|Overall Study||142
10688924|NCT02470312|11852838|FG001|COMPLETED|Overall Study||419
10688925|NCT02470312|11852837|FG000|NOT COMPLETED|Overall Study||5
10688926|NCT02470312|11852838|FG001|NOT COMPLETED|Overall Study||12
10688927|NCT02470390|11852846|FG000|STARTED|Overall Study||6
10688928|NCT02470390|11852847|FG001|STARTED|Overall Study||7
10688929|NCT02470390|11852846|FG000|COMPLETED|Overall Study||6
10688930|NCT02470390|11852847|FG001|COMPLETED|Overall Study||6
10688931|NCT02470390|11852846|FG000|NOT COMPLETED|Overall Study||0
10688932|NCT02470390|11852847|FG001|NOT COMPLETED|Overall Study||1
10688933|NCT02470403|11852860|FG000|STARTED|Overall Study||44
10688934|NCT02470403|11852861|FG001|STARTED|Overall Study||44
10688935|NCT02470403|11852862|FG002|STARTED|Overall Study||40
10688936|NCT02470403|11852863|FG003|STARTED|Overall Study||43
10688937|NCT02470403|11852864|FG004|STARTED|Overall Study||10
10688938|NCT02470403|11852860|FG000|Dysglycemic|Overall Study||24
10688939|NCT02470403|11852861|FG001|Dysglycemic|Overall Study||24
10688940|NCT02470403|11852862|FG002|Dysglycemic|Overall Study||20
10688941|NCT02470403|11852863|FG003|Dysglycemic|Overall Study||20
10688942|NCT02470403|11852864|FG004|Dysglycemic|Overall Study||5
10688943|NCT02470403|11852860|FG000|Normoglycemic|Overall Study||20
10688944|NCT02470403|11852861|FG001|Normoglycemic|Overall Study||20
10688945|NCT02470403|11852862|FG002|Normoglycemic|Overall Study||20
10688946|NCT02470403|11852863|FG003|Normoglycemic|Overall Study||23
10688947|NCT02470403|11852864|FG004|Normoglycemic|Overall Study||5
10688948|NCT02470403|11852860|FG000|COMPLETED|Overall Study||42
10688949|NCT02470403|11852861|FG001|COMPLETED|Overall Study||43
10688950|NCT02470403|11852862|FG002|COMPLETED|Overall Study||40
10688951|NCT02470403|11852863|FG003|COMPLETED|Overall Study||39
10688952|NCT02470403|11852864|FG004|COMPLETED|Overall Study||10
10688953|NCT02470403|11852860|FG000|NOT COMPLETED|Overall Study||2
10688954|NCT02470403|11852861|FG001|NOT COMPLETED|Overall Study||1
10688955|NCT02470403|11852862|FG002|NOT COMPLETED|Overall Study||0
10688956|NCT02470403|11852863|FG003|NOT COMPLETED|Overall Study||4
10688957|NCT02470403|11852864|FG004|NOT COMPLETED|Overall Study||0
10688958|NCT02470429|11852881|FG000|STARTED|Overall Study||50
10688959|NCT02470429|11852882|FG001|STARTED|Overall Study||49
10688960|NCT02470429|11852881|FG000|COMPLETED|Overall Study||48
10688961|NCT02470429|11852882|FG001|COMPLETED|Overall Study||49
10688962|NCT02470429|11852881|FG000|NOT COMPLETED|Overall Study||2
10688963|NCT02470429|11852882|FG001|NOT COMPLETED|Overall Study||0
10688964|NCT02470494|11852889|FG000|STARTED|Overall Study||46
10688965|NCT02470494|11852889|FG000|COMPLETED|Overall Study||41
10688966|NCT02470494|11852889|FG000|NOT COMPLETED|Overall Study||5
10688967|NCT02470741|11852895|FG000|STARTED|Overall Study||6
10688968|NCT02470741|11852896|FG001|STARTED|Overall Study||6
10688969|NCT02470741|11852895|FG000|COMPLETED|Overall Study||3
10688970|NCT02470741|11852896|FG001|COMPLETED|Overall Study||4
10688971|NCT02470741|11852895|FG000|NOT COMPLETED|Overall Study||3
10688972|NCT02470741|11852896|FG001|NOT COMPLETED|Overall Study||2
10688973|NCT02470754|11852902|FG000|STARTED|Overall Study||19
10688974|NCT02470754|11852903|FG001|STARTED|Overall Study||19
10688975|NCT02470754|11852902|FG000|COMPLETED|Overall Study||17
10688976|NCT02470754|11852903|FG001|COMPLETED|Overall Study||19
10688977|NCT02470754|11852902|FG000|NOT COMPLETED|Overall Study||2
10688978|NCT02470754|11852903|FG001|NOT COMPLETED|Overall Study||0
10688979|NCT02470806|11852911|FG000|STARTED|Overall Study||80
10688980|NCT02470806|11852912|FG001|STARTED|Overall Study|The Safety analysis included 164, ITT was 161, and Per Protocol was 115 subjects (total both arms).|84
10688981|NCT02470806|11852911|FG000|COMPLETED|Overall Study||62
10688982|NCT02470806|11852912|FG001|COMPLETED|Overall Study||42
10688983|NCT02470806|11852911|FG000|NOT COMPLETED|Overall Study||18
10688984|NCT02470806|11852912|FG001|NOT COMPLETED|Overall Study||42
10688985|NCT02470910|11852918|FG000|STARTED|Overall Study||15
10688986|NCT02470910|11852918|FG000|COMPLETED|Overall Study||15
10688987|NCT02470910|11852918|FG000|NOT COMPLETED|Overall Study||0
10688988|NCT02470949|11852925|FG000|STARTED|First Intervention||4
10688989|NCT02470949|11852926|FG001|STARTED|First Intervention||5
10688990|NCT02470949|11852925|FG000|COMPLETED|First Intervention||4
10688991|NCT02470949|11852926|FG001|COMPLETED|First Intervention||5
10688992|NCT02470949|11852925|FG000|NOT COMPLETED|First Intervention||0
10688993|NCT02470949|11852926|FG001|NOT COMPLETED|First Intervention||0
10688994|NCT02470949|11852925|FG000|STARTED|Washout Period for a Minimum of 4 Weeks||4
10800207|NCT04559282|11961137|FG001|STARTED|Intervention 1 (Day 0)||8
10800208|NCT04559282|11961136|FG000|COMPLETED|Intervention 1 (Day 0)||8
10688995|NCT02470949|11852926|FG001|STARTED|Washout Period for a Minimum of 4 Weeks||5
10688996|NCT02470949|11852925|FG000|COMPLETED|Washout Period for a Minimum of 4 Weeks||4
10688997|NCT02470949|11852926|FG001|COMPLETED|Washout Period for a Minimum of 4 Weeks||5
10688998|NCT02470949|11852925|FG000|NOT COMPLETED|Washout Period for a Minimum of 4 Weeks||0
10688999|NCT02470949|11852926|FG001|NOT COMPLETED|Washout Period for a Minimum of 4 Weeks||0
10689000|NCT02470949|11852925|FG000|STARTED|Second Intervention||4
10689001|NCT02470949|11852926|FG001|STARTED|Second Intervention||2
10689002|NCT02470949|11852925|FG000|COMPLETED|Second Intervention||4
10689003|NCT02470949|11852926|FG001|COMPLETED|Second Intervention||2
10689004|NCT02470949|11852925|FG000|NOT COMPLETED|Second Intervention||0
10689005|NCT02470949|11852926|FG001|NOT COMPLETED|Second Intervention||0
10689006|NCT02471014|11852936|FG000|STARTED|Overall Study||25
10689007|NCT02471014|11852937|FG001|STARTED|Overall Study||25
10689008|NCT02471014|11852936|FG000|COMPLETED|Overall Study||23
10689009|NCT02471014|11852937|FG001|COMPLETED|Overall Study||23
10689010|NCT02471014|11852936|FG000|NOT COMPLETED|Overall Study||2
10689011|NCT02471014|11852937|FG001|NOT COMPLETED|Overall Study||2
10689012|NCT02471183|11852943|FG000|STARTED|Main Treatment Period||34
10689013|NCT02471183|11852943|FG000|COMPLETED|Main Treatment Period||32
10689014|NCT02471183|11852943|FG000|NOT COMPLETED|Main Treatment Period||2
10689015|NCT02471183|11852943|FG000|STARTED|Extended Treatment Period||32
10689016|NCT02471183|11852943|FG000|COMPLETED|Extended Treatment Period||31
10689017|NCT02471183|11852943|FG000|NOT COMPLETED|Extended Treatment Period||1
10689018|NCT02471313|11852947|FG000|STARTED|Overall Study||3
10689019|NCT02471313|11852947|FG000|COMPLETED|Overall Study||3
10689020|NCT02471313|11852947|FG000|NOT COMPLETED|Overall Study||0
10689021|NCT02471326|11852951|FG000|STARTED|Overall Study||10
10689022|NCT02471326|11852951|FG000|COMPLETED|Overall Study||9
10689023|NCT02471326|11852951|FG000|NOT COMPLETED|Overall Study||1
10689024|NCT02471404|11852958|FG000|STARTED|Overall Study||314
10689025|NCT02471404|11852959|FG001|STARTED|Overall Study||312
10689026|NCT02471404|11852960|FG002|STARTED|Overall Study||313
10689027|NCT02471404|11852958|FG000|COMPLETED|Overall Study||281
10689028|NCT02471404|11852959|FG001|COMPLETED|Overall Study||298
10689029|NCT02471404|11852960|FG002|COMPLETED|Overall Study||288
10689030|NCT02471404|11852958|FG000|NOT COMPLETED|Overall Study||33
10689031|NCT02471404|11852959|FG001|NOT COMPLETED|Overall Study||14
10689032|NCT02471404|11852960|FG002|NOT COMPLETED|Overall Study||25
10689033|NCT02471521|11852970|FG000|STARTED|Overall Study||60
10689034|NCT02471521|11852971|FG001|STARTED|Overall Study||60
10689035|NCT02471521|11852970|FG000|COMPLETED|Overall Study||60
10689036|NCT02471521|11852971|FG001|COMPLETED|Overall Study||52
10689037|NCT02471521|11852970|FG000|NOT COMPLETED|Overall Study||0
10689038|NCT02471521|11852971|FG001|NOT COMPLETED|Overall Study||8
10689039|NCT02471586|11852980|FG000|STARTED|Overall Study||158
10689040|NCT02471586|11852981|FG001|STARTED|Overall Study||146
10689041|NCT02471586|11852982|FG002|STARTED|Overall Study||146
10689042|NCT02471586|11852980|FG000|COMPLETED|Overall Study||153
10689043|NCT02471586|11852981|FG001|COMPLETED|Overall Study||136
10689044|NCT02471586|11852982|FG002|COMPLETED|Overall Study||142
10689045|NCT02471586|11852980|FG000|NOT COMPLETED|Overall Study||5
10689046|NCT02471586|11852981|FG001|NOT COMPLETED|Overall Study||10
10689047|NCT02471586|11852982|FG002|NOT COMPLETED|Overall Study||4
10689048|NCT02471612|11852992|FG000|STARTED|Overall Study||159
10689049|NCT02471612|11852992|FG000|COMPLETED|Overall Study||157
10689050|NCT02471612|11852992|FG000|NOT COMPLETED|Overall Study||2
10689051|NCT02471651|11853011|FG000|STARTED|Overall Study||20
10689052|NCT02471651|11853012|FG001|STARTED|Overall Study||20
10689053|NCT02471651|11853011|FG000|COMPLETED|Overall Study||15
10689054|NCT02471651|11853012|FG001|COMPLETED|Overall Study||15
10689055|NCT02471651|11853011|FG000|NOT COMPLETED|Overall Study||5
10689056|NCT02471651|11853012|FG001|NOT COMPLETED|Overall Study||5
10689057|NCT02471716|11853023|FG000|STARTED|Overall Study||3
10689058|NCT02471716|11853024|FG001|STARTED|Overall Study||3
10689059|NCT02471716|11853025|FG002|STARTED|Overall Study||3
10689060|NCT02471716|11853026|FG003|STARTED|Overall Study||33
10689061|NCT02471716|11853027|FG004|STARTED|Overall Study||24
10689062|NCT02471716|11853023|FG000|COMPLETED|Overall Study||3
10689063|NCT02471716|11853024|FG001|COMPLETED|Overall Study||2
10689064|NCT02471716|11853025|FG002|COMPLETED|Overall Study||3
10689065|NCT02471716|11853026|FG003|COMPLETED|Overall Study||18
10800209|NCT04559282|11961137|FG001|COMPLETED|Intervention 1 (Day 0)||8
10689066|NCT02471716|11853027|FG004|COMPLETED|Overall Study||8
10689067|NCT02471716|11853023|FG000|NOT COMPLETED|Overall Study||0
10689068|NCT02471716|11853024|FG001|NOT COMPLETED|Overall Study||1
10689069|NCT02471716|11853025|FG002|NOT COMPLETED|Overall Study||0
10689070|NCT02471716|11853026|FG003|NOT COMPLETED|Overall Study||15
10689071|NCT02471716|11853027|FG004|NOT COMPLETED|Overall Study||16
10689072|NCT02471755|11853043|FG000|STARTED|Overall Study||45
10689073|NCT02471755|11853044|FG001|STARTED|Overall Study||45
10689074|NCT02471755|11853043|FG000|COMPLETED|Overall Study||44
10689075|NCT02471755|11853044|FG001|COMPLETED|Overall Study||44
10689076|NCT02471755|11853043|FG000|NOT COMPLETED|Overall Study||1
10689077|NCT02471755|11853044|FG001|NOT COMPLETED|Overall Study||1
10689078|NCT02472145|11853053|FG000|STARTED|Overall Study||10
10689079|NCT02472145|11853054|FG001|STARTED|Overall Study||159
10689080|NCT02472145|11853055|FG002|STARTED|Overall Study||157
10689081|NCT02472145|11853053|FG000|Treated|Overall Study||10
10689082|NCT02472145|11853054|FG001|Treated|Overall Study||156
10689083|NCT02472145|11853055|FG002|Treated|Overall Study||156
10689084|NCT02472145|11853053|FG000|Safety|Overall Study||10
10689085|NCT02472145|11853054|FG001|Safety|Overall Study|9 participants who received decitabine,not JNJ-56022473 included,3 untreated participant excluded.|165
10689086|NCT02472145|11853055|FG002|Safety|Overall Study|1 participant who was not treated and 9 participants who received only decitabine were excluded.|147
10689087|NCT02472145|11853053|FG000|COMPLETED|Overall Study||0
10689088|NCT02472145|11853054|FG001|COMPLETED|Overall Study||0
10689089|NCT02472145|11853055|FG002|COMPLETED|Overall Study||0
10689090|NCT02472145|11853053|FG000|NOT COMPLETED|Overall Study||10
10689091|NCT02472145|11853054|FG001|NOT COMPLETED|Overall Study||159
10689092|NCT02472145|11853055|FG002|NOT COMPLETED|Overall Study||157
10689093|NCT02472223|11853064|FG000|STARTED|Overall Study||16
10689094|NCT02472223|11853065|FG001|STARTED|Overall Study||12
10689095|NCT02472223|11853064|FG000|COMPLETED|Overall Study||10
10689096|NCT02472223|11853065|FG001|COMPLETED|Overall Study||7
10689097|NCT02472223|11853064|FG000|NOT COMPLETED|Overall Study||6
10689098|NCT02472223|11853065|FG001|NOT COMPLETED|Overall Study||5
10689099|NCT02472262|11853074|FG000|STARTED|Overall Study||117
10689100|NCT02472262|11853075|FG001|STARTED|Overall Study||120
10689101|NCT02472262|11853076|FG002|STARTED|Overall Study||118
10689102|NCT02472262|11853074|FG000|COMPLETED|Overall Study||99
10689103|NCT02472262|11853075|FG001|COMPLETED|Overall Study||99
10689104|NCT02472262|11853076|FG002|COMPLETED|Overall Study||93
10689105|NCT02472262|11853074|FG000|NOT COMPLETED|Overall Study||18
10689106|NCT02472262|11853075|FG001|NOT COMPLETED|Overall Study||21
10689107|NCT02472262|11853076|FG002|NOT COMPLETED|Overall Study||25
10689108|NCT02472314|11853086|FG000|STARTED|Overall Study||34
10689109|NCT02472314|11853087|FG001|STARTED|Overall Study||36
10689110|NCT02472314|11853086|FG000|COMPLETED|Overall Study||34
10689111|NCT02472314|11853087|FG001|COMPLETED|Overall Study||36
10689112|NCT02472314|11853086|FG000|NOT COMPLETED|Overall Study||0
10689113|NCT02472314|11853087|FG001|NOT COMPLETED|Overall Study||0
10689114|NCT02472353|11853095|FG000|STARTED|Overall Study||14
10689115|NCT02472353|11853096|FG001|STARTED|Overall Study||16
10689116|NCT02472353|11853095|FG000|COMPLETED|Overall Study||10
10689117|NCT02472353|11853096|FG001|COMPLETED|Overall Study||10
10689118|NCT02472353|11853095|FG000|NOT COMPLETED|Overall Study||4
10689119|NCT02472353|11853096|FG001|NOT COMPLETED|Overall Study||6
10689120|NCT02472366|11853104|FG000|STARTED|Overall Study|6 subjects receiving ILUVIEN, 7 eyes receiving ILUVIEN|6
10689121|NCT02472366|11853105|FG001|STARTED|Overall Study||10
10689122|NCT02472366|11853104|FG000|COMPLETED|Overall Study||5
10689123|NCT02472366|11853105|FG001|COMPLETED|Overall Study||10
10689124|NCT02472366|11853104|FG000|NOT COMPLETED|Overall Study||1
10689125|NCT02472366|11853105|FG001|NOT COMPLETED|Overall Study||0
10689126|NCT02472405|11853111|FG000|STARTED|Overall Study||18
10689127|NCT02472405|11853111|FG000|COMPLETED|Overall Study||8
10689128|NCT02472405|11853111|FG000|NOT COMPLETED|Overall Study||10
10689129|NCT02472457|11853119|FG000|STARTED|Overall Study|1 subject followed the Specific Carbohydrate Diet|8
10689130|NCT02472457|11853120|FG001|STARTED|Overall Study||11
10689131|NCT02472457|11853119|FG000|COMPLETED|Overall Study||8
10689132|NCT02472457|11853120|FG001|COMPLETED|Overall Study||10
10689133|NCT02472457|11853119|FG000|NOT COMPLETED|Overall Study||0
10689134|NCT02472457|11853120|FG001|NOT COMPLETED|Overall Study||1
10689135|NCT02472522|11853128|FG000|STARTED|Overall Study||50
10689136|NCT02472522|11853129|FG001|STARTED|Overall Study||50
10689137|NCT02472522|11853128|FG000|COMPLETED|Overall Study||50
10689138|NCT02472522|11853129|FG001|COMPLETED|Overall Study||50
10689139|NCT02472522|11853128|FG000|NOT COMPLETED|Overall Study||0
10689140|NCT02472522|11853129|FG001|NOT COMPLETED|Overall Study||0
10689141|NCT02472652|11853137|FG000|STARTED|Overall Study||2
10689142|NCT02472652|11853137|FG000|COMPLETED|Overall Study||1
10689143|NCT02472652|11853137|FG000|NOT COMPLETED|Overall Study||1
10689144|NCT02472730|11853143|FG000|STARTED|Overall Study||110
10689145|NCT02472730|11853144|FG001|STARTED|Overall Study||109
10689146|NCT02472730|11853143|FG000|COMPLETED|Overall Study||101
10689147|NCT02472730|11853144|FG001|COMPLETED|Overall Study||102
10689148|NCT02472730|11853143|FG000|NOT COMPLETED|Overall Study||9
10689149|NCT02472730|11853144|FG001|NOT COMPLETED|Overall Study||7
10689150|NCT02472756|11853150|FG000|STARTED|Induction (Approximately 6 Months)||41
10689151|NCT02472756|11853150|FG000|Treated|Induction (Approximately 6 Months)||40
10689152|NCT02472756|11853150|FG000|COMPLETED|Induction (Approximately 6 Months)||39
10689153|NCT02472756|11853150|FG000|NOT COMPLETED|Induction (Approximately 6 Months)||2
10689154|NCT02472756|11853150|FG000|STARTED|Maintenance (Approximately 2 Years)|Out of 39 participants who completed induction period, 19 did not continue in maintenance period.|20
10689155|NCT02472756|11853150|FG000|COMPLETED|Maintenance (Approximately 2 Years)||10
10689156|NCT02472756|11853150|FG000|NOT COMPLETED|Maintenance (Approximately 2 Years)||10
10689157|NCT02472795|11853159|FG000|STARTED|Overall Study||12
10689158|NCT02472795|11853160|FG001|STARTED|Overall Study||12
10689159|NCT02472795|11853161|FG002|STARTED|Overall Study||13
10689160|NCT02472795|11853162|FG003|STARTED|Overall Study||13
10689161|NCT02472795|11853163|FG004|STARTED|Overall Study||17
10689162|NCT02472795|11853159|FG000|Pharmacodynamic Set|Overall Study||12
10689163|NCT02472795|11853160|FG001|Pharmacodynamic Set|Overall Study||10
10689164|NCT02472795|11853161|FG002|Pharmacodynamic Set|Overall Study||13
10689165|NCT02472795|11853162|FG003|Pharmacodynamic Set|Overall Study||13
10689166|NCT02472795|11853163|FG004|Pharmacodynamic Set|Overall Study||16
10689167|NCT02472795|11853159|FG000|Modified Pharmacodynamic Analysis Set|Overall Study||12
10689168|NCT02472795|11853160|FG001|Modified Pharmacodynamic Analysis Set|Overall Study||10
10689169|NCT02472795|11853161|FG002|Modified Pharmacodynamic Analysis Set|Overall Study||13
10689170|NCT02472795|11853162|FG003|Modified Pharmacodynamic Analysis Set|Overall Study||9
10689171|NCT02472795|11853163|FG004|Modified Pharmacodynamic Analysis Set|Overall Study||16
10689172|NCT02472795|11853159|FG000|COMPLETED|Overall Study||12
10689173|NCT02472795|11853160|FG001|COMPLETED|Overall Study||11
10689174|NCT02472795|11853161|FG002|COMPLETED|Overall Study||13
10689175|NCT02472795|11853162|FG003|COMPLETED|Overall Study||13
10689176|NCT02472795|11853163|FG004|COMPLETED|Overall Study||14
10689177|NCT02472795|11853159|FG000|NOT COMPLETED|Overall Study||0
10689178|NCT02472795|11853160|FG001|NOT COMPLETED|Overall Study||1
10689179|NCT02472795|11853161|FG002|NOT COMPLETED|Overall Study||0
10689180|NCT02472795|11853162|FG003|NOT COMPLETED|Overall Study||0
10689181|NCT02472795|11853163|FG004|NOT COMPLETED|Overall Study||3
10689182|NCT02472847|11853177|FG000|STARTED|Overall Study||24
10689183|NCT02472847|11853178|FG001|STARTED|Overall Study||26
10689184|NCT02472847|11853177|FG000|COMPLETED|Overall Study||23
10689185|NCT02472847|11853178|FG001|COMPLETED|Overall Study||21
10689186|NCT02472847|11853177|FG000|NOT COMPLETED|Overall Study||1
10689187|NCT02472847|11853178|FG001|NOT COMPLETED|Overall Study||5
10689188|NCT02472886|11853187|FG000|STARTED|Overall Study||67
10689189|NCT02472886|11853188|FG001|STARTED|Overall Study||59
10689190|NCT02472886|11853189|FG002|STARTED|Overall Study||27
10689191|NCT02472886|11853187|FG000|COMPLETED|Overall Study||67
10689192|NCT02472886|11853188|FG001|COMPLETED|Overall Study||57
10689193|NCT02472886|11853189|FG002|COMPLETED|Overall Study||26
10689194|NCT02472886|11853187|FG000|NOT COMPLETED|Overall Study||0
10689195|NCT02472886|11853188|FG001|NOT COMPLETED|Overall Study||2
10689196|NCT02472886|11853189|FG002|NOT COMPLETED|Overall Study||1
10689197|NCT02472977|11853205|FG000|STARTED|Overall Study||6
10689198|NCT02472977|11853206|FG001|STARTED|Overall Study||27
10689199|NCT02472977|11853207|FG002|STARTED|Overall Study||8
10689200|NCT02472977|11853205|FG000|COMPLETED|Overall Study||0
10689201|NCT02472977|11853206|FG001|COMPLETED|Overall Study||0
10689202|NCT02472977|11853207|FG002|COMPLETED|Overall Study||0
10689203|NCT02472977|11853205|FG000|NOT COMPLETED|Overall Study||6
10689204|NCT02472977|11853206|FG001|NOT COMPLETED|Overall Study||27
10689205|NCT02472977|11853207|FG002|NOT COMPLETED|Overall Study||8
10689206|NCT02473250|11853215|FG000|STARTED|Overall Study||40
10689207|NCT02473250|11853215|FG000|COMPLETED|Overall Study||20
10689208|NCT02473250|11853215|FG000|NOT COMPLETED|Overall Study||20
10689209|NCT02473289|11853222|FG000|STARTED|Overall Study||99
10689210|NCT02473289|11853223|FG001|STARTED|Overall Study||94
10689211|NCT02473289|11853222|FG000|COMPLETED|Overall Study||88
10689212|NCT02473289|11853223|FG001|COMPLETED|Overall Study||81
10689213|NCT02473289|11853222|FG000|NOT COMPLETED|Overall Study||11
10689214|NCT02473289|11853223|FG001|NOT COMPLETED|Overall Study||13
10689215|NCT02473367|11853229|FG000|STARTED|Period 1||20
10689216|NCT02473367|11853229|FG000|COMPLETED|Period 1||20
10689217|NCT02473367|11853229|FG000|NOT COMPLETED|Period 1||0
10689218|NCT02473367|11853229|FG000|STARTED|Wait 1||20
10689219|NCT02473367|11853229|FG000|COMPLETED|Wait 1||19
10689220|NCT02473367|11853229|FG000|NOT COMPLETED|Wait 1||1
10689221|NCT02473367|11853229|FG000|STARTED|Period 2||19
10689222|NCT02473367|11853229|FG000|COMPLETED|Period 2||19
10689223|NCT02473367|11853229|FG000|NOT COMPLETED|Period 2||0
10689224|NCT02473367|11853229|FG000|STARTED|Wait 2||19
10689225|NCT02473367|11853229|FG000|COMPLETED|Wait 2||19
10689226|NCT02473367|11853229|FG000|NOT COMPLETED|Wait 2||0
10689227|NCT02473367|11853229|FG000|STARTED|Period 3||19
10689228|NCT02473367|11853229|FG000|COMPLETED|Period 3||19
10689229|NCT02473367|11853229|FG000|NOT COMPLETED|Period 3||0
10689230|NCT02473367|11853229|FG000|STARTED|Wait 3||19
10689231|NCT02473367|11853229|FG000|COMPLETED|Wait 3||19
10689232|NCT02473367|11853229|FG000|NOT COMPLETED|Wait 3||0
10689233|NCT02473367|11853229|FG000|STARTED|Period 4||19
10689234|NCT02473367|11853229|FG000|COMPLETED|Period 4||18
10689235|NCT02473367|11853229|FG000|NOT COMPLETED|Period 4||1
10689236|NCT02473393|11853243|FG000|STARTED|Overall Study||5
10689237|NCT02473393|11853244|FG001|STARTED|Overall Study||12
10689238|NCT02473393|11853245|FG002|STARTED|Overall Study||13
10689239|NCT02473393|11853246|FG003|STARTED|Overall Study||13
10689240|NCT02473393|11853243|FG000|COMPLETED|Overall Study||5
10689241|NCT02473393|11853244|FG001|COMPLETED|Overall Study||12
10689242|NCT02473393|11853245|FG002|COMPLETED|Overall Study||11
10689243|NCT02473393|11853246|FG003|COMPLETED|Overall Study||12
10689244|NCT02473393|11853243|FG000|NOT COMPLETED|Overall Study||0
10689245|NCT02473393|11853244|FG001|NOT COMPLETED|Overall Study||0
10689246|NCT02473393|11853245|FG002|NOT COMPLETED|Overall Study||2
10689247|NCT02473393|11853246|FG003|NOT COMPLETED|Overall Study||1
10689248|NCT02473471|11853256|FG000|STARTED|Overall Study||35
10689249|NCT02473471|11853256|FG000|Received Allocated Intervention|Overall Study||33
10689250|NCT02473471|11853256|FG000|Randomized Not Treated|Overall Study||2
10689251|NCT02473471|11853256|FG000|COMPLETED|Overall Study||32
10689252|NCT02473471|11853256|FG000|NOT COMPLETED|Overall Study||3
10689253|NCT02473510|11853268|FG000|STARTED|Overall Study||60
10689254|NCT02473510|11853269|FG001|STARTED|Overall Study||240
10689255|NCT02473510|11853268|FG000|COMPLETED|Overall Study||59
10689256|NCT02473510|11853269|FG001|COMPLETED|Overall Study||238
10689257|NCT02473510|11853268|FG000|NOT COMPLETED|Overall Study||1
10689258|NCT02473510|11853269|FG001|NOT COMPLETED|Overall Study||2
10713258|NCT02677844|11878798|FG000|COMPLETED|Period 4||5
10713259|NCT02677844|11878799|FG001|COMPLETED|Period 4||5
10713260|NCT02677844|11878800|FG002|COMPLETED|Period 4||5
10713261|NCT02677844|11878801|FG003|COMPLETED|Period 4||4
10689259|NCT02473614|11853275|FG000|STARTED|First Intervention (3 Weeks)||6
10689260|NCT02473614|11853276|FG001|STARTED|First Intervention (3 Weeks)||5
10689261|NCT02473614|11853275|FG000|COMPLETED|First Intervention (3 Weeks)||5
10689262|NCT02473614|11853276|FG001|COMPLETED|First Intervention (3 Weeks)||5
10689263|NCT02473614|11853275|FG000|NOT COMPLETED|First Intervention (3 Weeks)||1
10689264|NCT02473614|11853276|FG001|NOT COMPLETED|First Intervention (3 Weeks)||0
10689265|NCT02473614|11853275|FG000|STARTED|Wash Out Period (3 Weeks)||5
10689266|NCT02473614|11853276|FG001|STARTED|Wash Out Period (3 Weeks)||5
10689267|NCT02473614|11853275|FG000|COMPLETED|Wash Out Period (3 Weeks)||5
10689268|NCT02473614|11853276|FG001|COMPLETED|Wash Out Period (3 Weeks)||5
10689269|NCT02473614|11853275|FG000|NOT COMPLETED|Wash Out Period (3 Weeks)||0
10689270|NCT02473614|11853276|FG001|NOT COMPLETED|Wash Out Period (3 Weeks)||0
10689271|NCT02473614|11853275|FG000|STARTED|Second Intervention (3 Weeks)||5
10689272|NCT02473614|11853276|FG001|STARTED|Second Intervention (3 Weeks)||5
10689273|NCT02473614|11853275|FG000|COMPLETED|Second Intervention (3 Weeks)||5
10689274|NCT02473614|11853276|FG001|COMPLETED|Second Intervention (3 Weeks)||5
10689275|NCT02473614|11853275|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
10689276|NCT02473614|11853276|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
10689277|NCT02473640|11853283|FG000|STARTED|Treatment Period 1||15
10689278|NCT02473640|11853283|FG000|COMPLETED|Treatment Period 1||14
10689279|NCT02473640|11853283|FG000|NOT COMPLETED|Treatment Period 1||1
10689280|NCT02473640|11853283|FG000|STARTED|Run-in Phase||14
10689281|NCT02473640|11853283|FG000|COMPLETED|Run-in Phase||14
10689282|NCT02473640|11853283|FG000|NOT COMPLETED|Run-in Phase||0
10689283|NCT02473640|11853283|FG000|STARTED|Treatment Period 2||14
10689284|NCT02473640|11853283|FG000|COMPLETED|Treatment Period 2||14
10689285|NCT02473640|11853283|FG000|NOT COMPLETED|Treatment Period 2||0
10689286|NCT02473718|11853292|FG000|STARTED|Overall Study||41
10689287|NCT02473718|11853293|FG001|STARTED|Overall Study||41
10689288|NCT02473718|11853292|FG000|COMPLETED|Overall Study||41
10689289|NCT02473718|11853293|FG001|COMPLETED|Overall Study||41
10689290|NCT02473718|11853292|FG000|NOT COMPLETED|Overall Study||0
10689291|NCT02473718|11853293|FG001|NOT COMPLETED|Overall Study||0
10689292|NCT02473783|11853301|FG000|STARTED|Overall Study||20
10689293|NCT02473783|11853302|FG001|STARTED|Overall Study||17
10689294|NCT02473783|11853301|FG000|COMPLETED|Overall Study||20
10689295|NCT02473783|11853302|FG001|COMPLETED|Overall Study||17
10689296|NCT02473783|11853301|FG000|NOT COMPLETED|Overall Study||0
10689297|NCT02473783|11853302|FG001|NOT COMPLETED|Overall Study||0
10689298|NCT02473913|11853311|FG000|STARTED|Overall Study||11
10689299|NCT02473913|11853312|FG001|STARTED|Overall Study||11
10689300|NCT02473913|11853311|FG000|COMPLETED|Overall Study||8
10689301|NCT02473913|11853312|FG001|COMPLETED|Overall Study||8
10689302|NCT02473913|11853311|FG000|NOT COMPLETED|Overall Study||3
10689303|NCT02473913|11853312|FG001|NOT COMPLETED|Overall Study||3
10689304|NCT02473952|11853320|FG000|STARTED|Overall Study||30
10689305|NCT02473952|11853321|FG001|STARTED|Overall Study||32
10689306|NCT02473952|11853320|FG000|COMPLETED|Overall Study||28
10689307|NCT02473952|11853321|FG001|COMPLETED|Overall Study||24
10689308|NCT02473952|11853320|FG000|NOT COMPLETED|Overall Study||2
10689309|NCT02473952|11853321|FG001|NOT COMPLETED|Overall Study||8
10689310|NCT02473965|11853329|FG000|STARTED|Overall Study||30
10689311|NCT02473965|11853330|FG001|STARTED|Overall Study||30
10689312|NCT02473965|11853329|FG000|COMPLETED|Overall Study||18
10689313|NCT02473965|11853330|FG001|COMPLETED|Overall Study||20
10689314|NCT02473965|11853329|FG000|NOT COMPLETED|Overall Study||12
10689315|NCT02473965|11853330|FG001|NOT COMPLETED|Overall Study||10
10689316|NCT02473991|11853336|FG000|STARTED|Overall Study||395
10689317|NCT02473991|11853336|FG000|COMPLETED|Overall Study||395
10689318|NCT02473991|11853336|FG000|NOT COMPLETED|Overall Study||0
10689319|NCT02474069|11853340|FG000|STARTED|Selection Phase (SP)||772
10689320|NCT02474069|11853341|FG001|STARTED|Selection Phase (SP)||0
10689321|NCT02474069|11853342|FG002|STARTED|Selection Phase (SP)||0
10689322|NCT02474069|11853340|FG000|COMPLETED|Selection Phase (SP)||749
10689323|NCT02474069|11853341|FG001|COMPLETED|Selection Phase (SP)||0
10689324|NCT02474069|11853342|FG002|COMPLETED|Selection Phase (SP)||0
10689325|NCT02474069|11853340|FG000|NOT COMPLETED|Selection Phase (SP)||23
10689326|NCT02474069|11853341|FG001|NOT COMPLETED|Selection Phase (SP)||0
10689327|NCT02474069|11853342|FG002|NOT COMPLETED|Selection Phase (SP)||0
10689328|NCT02474069|11853340|FG000|STARTED|Comparative Dosing Phase (CDP)||0
10689329|NCT02474069|11853341|FG001|STARTED|Comparative Dosing Phase (CDP)||162
10689330|NCT02474069|11853342|FG002|STARTED|Comparative Dosing Phase (CDP)||163
10689331|NCT02474069|11853340|FG000|COMPLETED|Comparative Dosing Phase (CDP)||0
10689332|NCT02474069|11853341|FG001|COMPLETED|Comparative Dosing Phase (CDP)||153
10689333|NCT02474069|11853342|FG002|COMPLETED|Comparative Dosing Phase (CDP)||157
10689334|NCT02474069|11853340|FG000|NOT COMPLETED|Comparative Dosing Phase (CDP)||0
10689335|NCT02474069|11853341|FG001|NOT COMPLETED|Comparative Dosing Phase (CDP)||9
10689336|NCT02474069|11853342|FG002|NOT COMPLETED|Comparative Dosing Phase (CDP)||6
10689337|NCT02474082|11853354|FG000|STARTED|Overall Study||105
10689338|NCT02474082|11853355|FG001|STARTED|Overall Study||97
10689339|NCT02474082|11853354|FG000|Full Analysis Set (FAS)|Overall Study||105
10689340|NCT02474082|11853355|FG001|Full Analysis Set (FAS)|Overall Study||95
10689341|NCT02474082|11853354|FG000|COMPLETED|Overall Study||99
10689342|NCT02474082|11853355|FG001|COMPLETED|Overall Study||43
10689343|NCT02474082|11853354|FG000|NOT COMPLETED|Overall Study||6
10689344|NCT02474082|11853355|FG001|NOT COMPLETED|Overall Study||54
10689345|NCT02474199|11853363|FG000|STARTED|Overall Study||5
10689346|NCT02474199|11853364|FG001|STARTED|Overall Study|Insufficient numbers of darTregs for infusion (4 of these 5 participants)|5
10689347|NCT02474199|11853365|FG002|STARTED|Overall Study||2
10689348|NCT02474199|11853366|FG003|STARTED|Overall Study||3
10689349|NCT02474199|11853363|FG000|COMPLETED|Overall Study||3
10689350|NCT02474199|11853364|FG001|COMPLETED|Overall Study||2
10689351|NCT02474199|11853365|FG002|COMPLETED|Overall Study||0
10689352|NCT02474199|11853366|FG003|COMPLETED|Overall Study||0
10689353|NCT02474199|11853363|FG000|NOT COMPLETED|Overall Study||2
10689354|NCT02474199|11853364|FG001|NOT COMPLETED|Overall Study||3
10689355|NCT02474199|11853365|FG002|NOT COMPLETED|Overall Study||2
10689356|NCT02474199|11853366|FG003|NOT COMPLETED|Overall Study||3
10689357|NCT02474355|11853373|FG000|STARTED|Overall Study||3014
10689358|NCT02474355|11853373|FG000|COMPLETED|Overall Study||1386
10689359|NCT02474355|11853373|FG000|NOT COMPLETED|Overall Study||1628
10689360|NCT02474407|11853377|FG000|STARTED|First Intervention (14 Days)||39
10689361|NCT02474407|11853378|FG001|STARTED|First Intervention (14 Days)||39
10689362|NCT02474407|11853377|FG000|COMPLETED|First Intervention (14 Days)||39
10689363|NCT02474407|11853378|FG001|COMPLETED|First Intervention (14 Days)||39
10689364|NCT02474407|11853377|FG000|NOT COMPLETED|First Intervention (14 Days)||0
10689365|NCT02474407|11853378|FG001|NOT COMPLETED|First Intervention (14 Days)||0
10689366|NCT02474407|11853377|FG000|STARTED|Washout (14 Days)||39
10689367|NCT02474407|11853378|FG001|STARTED|Washout (14 Days)||39
10689368|NCT02474407|11853377|FG000|COMPLETED|Washout (14 Days)||39
10689369|NCT02474407|11853378|FG001|COMPLETED|Washout (14 Days)||39
10689370|NCT02474407|11853377|FG000|NOT COMPLETED|Washout (14 Days)||0
10689371|NCT02474407|11853378|FG001|NOT COMPLETED|Washout (14 Days)||0
10689372|NCT02474407|11853377|FG000|STARTED|Second Intervention (14 Days)||39
10689373|NCT02474407|11853378|FG001|STARTED|Second Intervention (14 Days)||39
10689374|NCT02474407|11853377|FG000|COMPLETED|Second Intervention (14 Days)||39
10689375|NCT02474407|11853378|FG001|COMPLETED|Second Intervention (14 Days)||39
10689376|NCT02474407|11853377|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
10689377|NCT02474407|11853378|FG001|NOT COMPLETED|Second Intervention (14 Days)||0
10689378|NCT02474498|11853407|FG000|STARTED|Overall Study||13
10689379|NCT02474498|11853408|FG001|STARTED|Overall Study||14
10689380|NCT02474498|11853409|FG002|STARTED|Overall Study||14
10689381|NCT02474498|11853407|FG000|COMPLETED|Overall Study||13
10689382|NCT02474498|11853408|FG001|COMPLETED|Overall Study||14
10689383|NCT02474498|11853409|FG002|COMPLETED|Overall Study||14
10689384|NCT02474498|11853407|FG000|NOT COMPLETED|Overall Study||0
10689385|NCT02474498|11853408|FG001|NOT COMPLETED|Overall Study||0
10689386|NCT02474498|11853409|FG002|NOT COMPLETED|Overall Study||0
10689387|NCT02474589|11853423|FG000|STARTED|Overall Study||359
10689388|NCT02474589|11853424|FG001|STARTED|Overall Study||90
10689389|NCT02474589|11853423|FG000|COMPLETED|Overall Study||334
10689390|NCT02474589|11853424|FG001|COMPLETED|Overall Study||85
10689391|NCT02474589|11853423|FG000|NOT COMPLETED|Overall Study||25
10689392|NCT02474589|11853424|FG001|NOT COMPLETED|Overall Study||5
10689393|NCT02474901|11853432|FG000|STARTED|Overall Study||45
10689394|NCT02474901|11853433|FG001|STARTED|Overall Study||56
10689395|NCT02474901|11853432|FG000|COMPLETED|Overall Study||44
10689396|NCT02474901|11853433|FG001|COMPLETED|Overall Study||56
10689397|NCT02474901|11853432|FG000|NOT COMPLETED|Overall Study||1
10689398|NCT02474901|11853433|FG001|NOT COMPLETED|Overall Study||0
10689399|NCT02475031|11853441|FG000|STARTED|Overall Study||35
10689400|NCT02475031|11853442|FG001|STARTED|Overall Study||35
10689401|NCT02475031|11853441|FG000|COMPLETED|Overall Study||35
10689402|NCT02475031|11853442|FG001|COMPLETED|Overall Study||35
10689403|NCT02475031|11853441|FG000|NOT COMPLETED|Overall Study||0
10689404|NCT02475031|11853442|FG001|NOT COMPLETED|Overall Study||0
10689405|NCT02475070|11853452|FG000|STARTED|Overall Study||17
10689406|NCT02475070|11853453|FG001|STARTED|Overall Study||11
10689407|NCT02475070|11853452|FG000|COMPLETED|Overall Study||17
10689408|NCT02475070|11853453|FG001|COMPLETED|Overall Study||11
10689409|NCT02475070|11853452|FG000|NOT COMPLETED|Overall Study||0
10689410|NCT02475070|11853453|FG001|NOT COMPLETED|Overall Study||0
10689411|NCT02475265|11853460|FG000|STARTED|Overall Study||11
10689412|NCT02475265|11853460|FG000|COMPLETED|Overall Study||8
10689413|NCT02475265|11853460|FG000|NOT COMPLETED|Overall Study||3
10689414|NCT02475278|11853464|FG000|STARTED|Overall Study||50
10689415|NCT02475278|11853464|FG000|COMPLETED|Overall Study||48
10689416|NCT02475278|11853464|FG000|NOT COMPLETED|Overall Study||2
10689417|NCT02475369|11853468|FG000|STARTED|Run-in Washout Period #1 (7 Days)||10
10689418|NCT02475369|11853469|FG001|STARTED|Run-in Washout Period #1 (7 Days)||11
10689419|NCT02475369|11853468|FG000|COMPLETED|Run-in Washout Period #1 (7 Days)||3
10689420|NCT02475369|11853469|FG001|COMPLETED|Run-in Washout Period #1 (7 Days)||9
10689421|NCT02475369|11853468|FG000|NOT COMPLETED|Run-in Washout Period #1 (7 Days)||7
10689422|NCT02475369|11853469|FG001|NOT COMPLETED|Run-in Washout Period #1 (7 Days)||2
10689423|NCT02475369|11853468|FG000|STARTED|Treatment Period #1 (10 Days)||3
10689424|NCT02475369|11853469|FG001|STARTED|Treatment Period #1 (10 Days)||9
10689425|NCT02475369|11853468|FG000|COMPLETED|Treatment Period #1 (10 Days)||3
10689426|NCT02475369|11853469|FG001|COMPLETED|Treatment Period #1 (10 Days)||9
10689427|NCT02475369|11853468|FG000|NOT COMPLETED|Treatment Period #1 (10 Days)||0
10689428|NCT02475369|11853469|FG001|NOT COMPLETED|Treatment Period #1 (10 Days)||0
10689429|NCT02475369|11853468|FG000|STARTED|Run-in Washout Period #2 (7 Days)||3
10689430|NCT02475369|11853469|FG001|STARTED|Run-in Washout Period #2 (7 Days)||9
10689431|NCT02475369|11853468|FG000|COMPLETED|Run-in Washout Period #2 (7 Days)||3
10689432|NCT02475369|11853469|FG001|COMPLETED|Run-in Washout Period #2 (7 Days)||9
10689433|NCT02475369|11853468|FG000|NOT COMPLETED|Run-in Washout Period #2 (7 Days)||0
10689434|NCT02475369|11853469|FG001|NOT COMPLETED|Run-in Washout Period #2 (7 Days)||0
10689435|NCT02475369|11853468|FG000|STARTED|Treatment Period #2 (10 Days)||3
10689436|NCT02475369|11853469|FG001|STARTED|Treatment Period #2 (10 Days)||9
10689437|NCT02475369|11853468|FG000|COMPLETED|Treatment Period #2 (10 Days)||3
10689438|NCT02475369|11853469|FG001|COMPLETED|Treatment Period #2 (10 Days)||9
10689439|NCT02475369|11853468|FG000|NOT COMPLETED|Treatment Period #2 (10 Days)||0
10689440|NCT02475369|11853469|FG001|NOT COMPLETED|Treatment Period #2 (10 Days)||0
10689441|NCT02475395|11853482|FG000|STARTED|Overall Study||258
10689442|NCT02475395|11853483|FG001|STARTED|Overall Study||14
10689443|NCT02475395|11853482|FG000|COMPLETED|Overall Study||228
10689444|NCT02475395|11853483|FG001|COMPLETED|Overall Study||11
10689445|NCT02475395|11853482|FG000|NOT COMPLETED|Overall Study||30
10689446|NCT02475395|11853483|FG001|NOT COMPLETED|Overall Study||3
10689447|NCT02475564|11853491|FG000|STARTED|Overall Study||22
10689448|NCT02475564|11853492|FG001|STARTED|Overall Study||22
10689449|NCT02475564|11853491|FG000|COMPLETED|Overall Study||18
10689450|NCT02475564|11853492|FG001|COMPLETED|Overall Study||21
10689451|NCT02475564|11853491|FG000|NOT COMPLETED|Overall Study||4
10689452|NCT02475564|11853492|FG001|NOT COMPLETED|Overall Study||1
10689453|NCT02475629|11853498|FG000|STARTED|Overall Study||40
10689454|NCT02475629|11853498|FG000|COMPLETED|Overall Study||31
10689455|NCT02475629|11853498|FG000|NOT COMPLETED|Overall Study||9
10689456|NCT02475655|11853504|FG000|STARTED|Overall Study||40
10689457|NCT02475655|11853505|FG001|STARTED|Overall Study||20
10689458|NCT02475655|11853504|FG000|COMPLETED|Overall Study||40
10689459|NCT02475655|11853505|FG001|COMPLETED|Overall Study||19
10689460|NCT02475655|11853504|FG000|NOT COMPLETED|Overall Study||0
10689461|NCT02475655|11853505|FG001|NOT COMPLETED|Overall Study||1
10689462|NCT02475733|11853513|FG000|STARTED|Overall Study||61
10689463|NCT02475733|11853514|FG001|STARTED|Overall Study||22
10689464|NCT02475733|11853513|FG000|COMPLETED|Overall Study||59
10689465|NCT02475733|11853514|FG001|COMPLETED|Overall Study||22
10689466|NCT02475733|11853513|FG000|NOT COMPLETED|Overall Study||2
10689467|NCT02475733|11853514|FG001|NOT COMPLETED|Overall Study||0
10689468|NCT02475837|11853522|FG000|STARTED|Overall Study||6
10689469|NCT02475837|11853523|FG001|STARTED|Overall Study||7
10689470|NCT02475837|11853522|FG000|COMPLETED|Overall Study||6
10689471|NCT02475837|11853523|FG001|COMPLETED|Overall Study||7
10689472|NCT02475837|11853522|FG000|NOT COMPLETED|Overall Study||0
10689473|NCT02475837|11853523|FG001|NOT COMPLETED|Overall Study||0
10689474|NCT02475850|11853531|FG000|STARTED|Overall Study||2802
10689475|NCT02475850|11853532|FG001|STARTED|Overall Study||2649
10689476|NCT02475850|11853531|FG000|COMPLETED|Overall Study||2209
10689477|NCT02475850|11853532|FG001|COMPLETED|Overall Study||2165
10689478|NCT02475850|11853531|FG000|NOT COMPLETED|Overall Study||593
10689479|NCT02475850|11853532|FG001|NOT COMPLETED|Overall Study||484
10689480|NCT02475954|11853541|FG000|STARTED|Overall Study||87
10689481|NCT02475954|11853542|FG001|STARTED|Overall Study||87
10689482|NCT02475954|11853541|FG000|COMPLETED|Overall Study||73
10689483|NCT02475954|11853542|FG001|COMPLETED|Overall Study||75
10689484|NCT02475954|11853541|FG000|NOT COMPLETED|Overall Study||14
10689485|NCT02475954|11853542|FG001|NOT COMPLETED|Overall Study||12
10689486|NCT02475980|11853549|FG000|STARTED|Overall Study||13
10689487|NCT02475980|11853549|FG000|COMPLETED|Overall Study||8
10689488|NCT02475980|11853549|FG000|NOT COMPLETED|Overall Study||5
10689489|NCT02476032|11853556|FG000|STARTED|Overall Study||20
10689490|NCT02476032|11853557|FG001|STARTED|Overall Study||20
10689491|NCT02476032|11853558|FG002|STARTED|Overall Study||20
10689492|NCT02476032|11853556|FG000|COMPLETED|Overall Study||20
10689493|NCT02476032|11853557|FG001|COMPLETED|Overall Study||19
10689494|NCT02476032|11853558|FG002|COMPLETED|Overall Study||19
10689495|NCT02476032|11853556|FG000|NOT COMPLETED|Overall Study||0
10689496|NCT02476032|11853557|FG001|NOT COMPLETED|Overall Study||1
10689497|NCT02476032|11853558|FG002|NOT COMPLETED|Overall Study||1
10689498|NCT02476175|11853569|FG000|STARTED|Overall Study||35
10689499|NCT02476175|11853569|FG000|COMPLETED|Overall Study||33
10689500|NCT02476175|11853569|FG000|NOT COMPLETED|Overall Study||2
10689501|NCT02476357|11853575|FG000|STARTED|Overall Study||40
10689502|NCT02476357|11853576|FG001|STARTED|Overall Study||40
10689503|NCT02476357|11853575|FG000|COMPLETED|Overall Study||40
10689504|NCT02476357|11853576|FG001|COMPLETED|Overall Study||40
10689505|NCT02476357|11853575|FG000|NOT COMPLETED|Overall Study||0
10689506|NCT02476357|11853576|FG001|NOT COMPLETED|Overall Study||0
10689507|NCT02476422|11853586|FG000|STARTED|Overall Study|"started = Randomized Set/Full analysis set/Safety set"|166
10689508|NCT02476422|11853587|FG001|STARTED|Overall Study||162
10689509|NCT02476422|11853586|FG000|COMPLETED|Overall Study||166
10689510|NCT02476422|11853587|FG001|COMPLETED|Overall Study||161
10689511|NCT02476422|11853586|FG000|NOT COMPLETED|Overall Study||0
10689512|NCT02476422|11853587|FG001|NOT COMPLETED|Overall Study||1
10689513|NCT02476448|11853597|FG000|STARTED|Overall Study|one given phenazopyridine pre-op and was analyzed in her randomization group per intention to treat|44
10689514|NCT02476448|11853598|FG001|STARTED|Overall Study||44
10689515|NCT02476448|11853599|FG002|STARTED|Overall Study||44
10689516|NCT02476448|11853600|FG003|STARTED|Overall Study||44
10689517|NCT02476448|11853597|FG000|COMPLETED|Overall Study||44
10689518|NCT02476448|11853598|FG001|COMPLETED|Overall Study||44
10689519|NCT02476448|11853599|FG002|COMPLETED|Overall Study||44
10689520|NCT02476448|11853600|FG003|COMPLETED|Overall Study||44
10689521|NCT02476448|11853597|FG000|NOT COMPLETED|Overall Study||0
10689522|NCT02476448|11853598|FG001|NOT COMPLETED|Overall Study||0
10689523|NCT02476448|11853599|FG002|NOT COMPLETED|Overall Study||0
10689524|NCT02476448|11853600|FG003|NOT COMPLETED|Overall Study||0
10689525|NCT02476565|11853612|FG000|STARTED|Overall Study||20
10689526|NCT02476565|11853613|FG001|STARTED|Overall Study||19
10689527|NCT02476565|11853612|FG000|COMPLETED|Overall Study||20
10689528|NCT02476565|11853613|FG001|COMPLETED|Overall Study||19
10689529|NCT02476565|11853612|FG000|NOT COMPLETED|Overall Study||0
10689530|NCT02476565|11853613|FG001|NOT COMPLETED|Overall Study||0
10689531|NCT02476578|11853621|FG000|STARTED|Overall Study||4310
10689532|NCT02476578|11853622|FG001|STARTED|Overall Study||4274
10689533|NCT02476578|11853621|FG000|Died Before Email Was Sent|Overall Study||35
10689534|NCT02476578|11853622|FG001|Died Before Email Was Sent|Overall Study||43
10689535|NCT02476578|11853621|FG000|Left Before End of Trial|Overall Study||6
10689536|NCT02476578|11853622|FG001|Left Before End of Trial|Overall Study||13
10689537|NCT02476578|11853621|FG000|COMPLETED|Overall Study||4269
10689538|NCT02476578|11853622|FG001|COMPLETED|Overall Study||4218
10689539|NCT02476578|11853621|FG000|NOT COMPLETED|Overall Study||41
10689540|NCT02476578|11853622|FG001|NOT COMPLETED|Overall Study||56
10689541|NCT02476617|11853628|FG000|STARTED|Overall Study||25
10689542|NCT02476617|11853628|FG000|COMPLETED|Overall Study||23
10689543|NCT02476617|11853628|FG000|NOT COMPLETED|Overall Study||2
10689544|NCT02476890|11853636|FG000|STARTED|Overall Study|Crossover study|6
10689545|NCT02476890|11853637|FG001|STARTED|Overall Study|Crossover study|6
10689546|NCT02476890|11853638|FG002|STARTED|Overall Study|Crossover study|12
10689547|NCT02476890|11853639|FG003|STARTED|Overall Study|Crossover study|12
10689548|NCT02476890|11853636|FG000|Washout|Overall Study||6
10689549|NCT02476890|11853637|FG001|Washout|Overall Study||6
10689550|NCT02476890|11853638|FG002|Washout|Overall Study||12
10689551|NCT02476890|11853639|FG003|Washout|Overall Study||12
10689552|NCT02476890|11853636|FG000|COMPLETED|Overall Study||6
10689553|NCT02476890|11853637|FG001|COMPLETED|Overall Study||6
10689554|NCT02476890|11853638|FG002|COMPLETED|Overall Study||12
10689555|NCT02476890|11853639|FG003|COMPLETED|Overall Study||12
10689556|NCT02476890|11853636|FG000|NOT COMPLETED|Overall Study||0
10689557|NCT02476890|11853637|FG001|NOT COMPLETED|Overall Study||0
10689558|NCT02476890|11853638|FG002|NOT COMPLETED|Overall Study||0
10689559|NCT02476890|11853639|FG003|NOT COMPLETED|Overall Study||0
10689560|NCT02477020|11853653|FG000|STARTED|Overall Study||81
10689561|NCT02477020|11853654|FG001|STARTED|Overall Study||83
10689562|NCT02477020|11853653|FG000|COMPLETED|Overall Study|Completed = participants who completed study treatment.|51
10689563|NCT02477020|11853654|FG001|COMPLETED|Overall Study|Completed = participants who completed study treatment.|55
10689564|NCT02477020|11853653|FG000|NOT COMPLETED|Overall Study||30
10689565|NCT02477020|11853654|FG001|NOT COMPLETED|Overall Study||28
10689566|NCT02477111|11853660|FG000|STARTED|Overall Study||150
10689567|NCT02477111|11853660|FG000|COMPLETED|Overall Study|All participants who were assessed for one year|139
10689568|NCT02477111|11853660|FG000|NOT COMPLETED|Overall Study||11
10689569|NCT02477215|11853670|FG000|STARTED|Dose Escalation Phase||4
10689570|NCT02477215|11853671|FG001|STARTED|Dose Escalation Phase||8
10689571|NCT02477215|11853672|FG002|STARTED|Dose Escalation Phase||6
10689572|NCT02477215|11853670|FG000|COMPLETED|Dose Escalation Phase||3
10689573|NCT02477215|11853671|FG001|COMPLETED|Dose Escalation Phase||6
10689574|NCT02477215|11853672|FG002|COMPLETED|Dose Escalation Phase||6
10689575|NCT02477215|11853670|FG000|NOT COMPLETED|Dose Escalation Phase||1
10689576|NCT02477215|11853671|FG001|NOT COMPLETED|Dose Escalation Phase||2
10689577|NCT02477215|11853672|FG002|NOT COMPLETED|Dose Escalation Phase||0
10689578|NCT02477215|11853670|FG000|STARTED|Fixed Dose Phase|No subjects were started in this group as it was not the optimal dose.|0
10689579|NCT02477215|11853671|FG001|STARTED|Fixed Dose Phase|Subjects in Period 1 did not continue into Period 2. This is a new subject population.|20
10689580|NCT02477215|11853672|FG002|STARTED|Fixed Dose Phase|No subjects were started in this group as it was not the optimal dose.|0
10689581|NCT02477215|11853670|FG000|COMPLETED|Fixed Dose Phase||0
10689582|NCT02477215|11853671|FG001|COMPLETED|Fixed Dose Phase||13
10689583|NCT02477215|11853672|FG002|COMPLETED|Fixed Dose Phase||0
10689584|NCT02477215|11853670|FG000|NOT COMPLETED|Fixed Dose Phase||0
10689585|NCT02477215|11853671|FG001|NOT COMPLETED|Fixed Dose Phase||7
10689586|NCT02477215|11853672|FG002|NOT COMPLETED|Fixed Dose Phase||0
10689587|NCT02477319|11853687|FG000|STARTED|Overall Study||55
10689588|NCT02477319|11853688|FG001|STARTED|Overall Study||40
10689589|NCT02477319|11853689|FG002|STARTED|Overall Study||164
10689590|NCT02477319|11853690|FG003|STARTED|Overall Study||193
10689591|NCT02477319|11853687|FG000|COMPLETED|Overall Study||55
10689592|NCT02477319|11853688|FG001|COMPLETED|Overall Study||37
10689593|NCT02477319|11853689|FG002|COMPLETED|Overall Study||149
10689594|NCT02477319|11853690|FG003|COMPLETED|Overall Study||171
10689595|NCT02477319|11853687|FG000|NOT COMPLETED|Overall Study||0
10689596|NCT02477319|11853688|FG001|NOT COMPLETED|Overall Study||3
10689597|NCT02477319|11853689|FG002|NOT COMPLETED|Overall Study||15
10689598|NCT02477319|11853690|FG003|NOT COMPLETED|Overall Study||22
10689599|NCT02477332|11853703|FG000|STARTED|Overall Study||43
10689600|NCT02477332|11853704|FG001|STARTED|Overall Study||84
10689601|NCT02477332|11853705|FG002|STARTED|Overall Study||85
10689602|NCT02477332|11853706|FG003|STARTED|Overall Study||85
10689603|NCT02477332|11853707|FG004|STARTED|Overall Study||43
10689604|NCT02477332|11853708|FG005|STARTED|Overall Study||42
10689605|NCT02477332|11853703|FG000|COMPLETED|Overall Study||40
10689606|NCT02477332|11853704|FG001|COMPLETED|Overall Study||77
10689607|NCT02477332|11853705|FG002|COMPLETED|Overall Study||73
10689608|NCT02477332|11853706|FG003|COMPLETED|Overall Study||72
10689609|NCT02477332|11853707|FG004|COMPLETED|Overall Study||39
10689610|NCT02477332|11853708|FG005|COMPLETED|Overall Study||37
10689611|NCT02477332|11853703|FG000|NOT COMPLETED|Overall Study||3
10689612|NCT02477332|11853704|FG001|NOT COMPLETED|Overall Study||7
10689613|NCT02477332|11853705|FG002|NOT COMPLETED|Overall Study||12
10689614|NCT02477332|11853706|FG003|NOT COMPLETED|Overall Study||13
10689615|NCT02477332|11853707|FG004|NOT COMPLETED|Overall Study||4
10689616|NCT02477332|11853708|FG005|NOT COMPLETED|Overall Study||5
10689617|NCT02477423|11853726|FG000|STARTED|Overall Study||12
10689618|NCT02477423|11853727|FG001|STARTED|Overall Study||15
10689619|NCT02477423|11853726|FG000|COMPLETED|Overall Study||11
10689620|NCT02477423|11853727|FG001|COMPLETED|Overall Study||11
10689621|NCT02477423|11853726|FG000|NOT COMPLETED|Overall Study||1
10689622|NCT02477423|11853727|FG001|NOT COMPLETED|Overall Study||4
10689623|NCT02477527|11853733|FG000|STARTED|Overall Study||27
10689624|NCT02477527|11853733|FG000|COMPLETED|Overall Study||21
10689625|NCT02477527|11853733|FG000|NOT COMPLETED|Overall Study||6
10689626|NCT02477553|11853739|FG000|STARTED|Overall Study||364
10689627|NCT02477553|11853740|FG001|STARTED|Overall Study||364
10689628|NCT02477553|11853739|FG000|COMPLETED|Overall Study||344
10689629|NCT02477553|11853740|FG001|COMPLETED|Overall Study||344
10689630|NCT02477553|11853739|FG000|NOT COMPLETED|Overall Study||20
10689631|NCT02477553|11853740|FG001|NOT COMPLETED|Overall Study||20
10689632|NCT02477605|11853748|FG000|STARTED|Overall Study||68
10689633|NCT02477605|11853749|FG001|STARTED|Overall Study||68
10689634|NCT02477605|11853748|FG000|Randomized and Treated|Overall Study||67
10689635|NCT02477605|11853749|FG001|Randomized and Treated|Overall Study||68
10689636|NCT02477605|11853748|FG000|COMPLETED|Overall Study||67
10689637|NCT02477605|11853749|FG001|COMPLETED|Overall Study||64
10689638|NCT02477605|11853748|FG000|NOT COMPLETED|Overall Study||1
10689639|NCT02477605|11853749|FG001|NOT COMPLETED|Overall Study||4
10689640|NCT02477670|11853761|FG000|STARTED|Stage 1||47
10689641|NCT02477670|11853762|FG001|STARTED|Stage 1||80
10689642|NCT02477670|11853763|FG002|STARTED|Stage 1||0
10689643|NCT02477670|11853764|FG003|STARTED|Stage 1||0
10689644|NCT02477670|11853765|FG004|STARTED|Stage 1||0
10689645|NCT02477670|11853766|FG005|STARTED|Stage 1||0
10689646|NCT02477670|11853767|FG006|STARTED|Stage 1||0
10689647|NCT02477670|11853761|FG000|COMPLETED|Stage 1||43
10689648|NCT02477670|11853762|FG001|COMPLETED|Stage 1||67
10689649|NCT02477670|11853763|FG002|COMPLETED|Stage 1||0
10689650|NCT02477670|11853764|FG003|COMPLETED|Stage 1||0
10689651|NCT02477670|11853765|FG004|COMPLETED|Stage 1||0
10689652|NCT02477670|11853766|FG005|COMPLETED|Stage 1||0
10689653|NCT02477670|11853767|FG006|COMPLETED|Stage 1||0
10689654|NCT02477670|11853761|FG000|NOT COMPLETED|Stage 1||4
10689655|NCT02477670|11853762|FG001|NOT COMPLETED|Stage 1||13
10689656|NCT02477670|11853763|FG002|NOT COMPLETED|Stage 1||0
10689657|NCT02477670|11853764|FG003|NOT COMPLETED|Stage 1||0
10689658|NCT02477670|11853765|FG004|NOT COMPLETED|Stage 1||0
10689659|NCT02477670|11853766|FG005|NOT COMPLETED|Stage 1||0
10689660|NCT02477670|11853767|FG006|NOT COMPLETED|Stage 1||0
10689661|NCT02477670|11853761|FG000|STARTED|Stage 2||0
10689662|NCT02477670|11853762|FG001|STARTED|Stage 2||0
10689663|NCT02477670|11853763|FG002|STARTED|Stage 2||30
10689664|NCT02477670|11853764|FG003|STARTED|Stage 2||33
10689665|NCT02477670|11853765|FG004|STARTED|Stage 2||2
10689666|NCT02477670|11853766|FG005|STARTED|Stage 2||1
10689667|NCT02477670|11853767|FG006|STARTED|Stage 2||42
10689668|NCT02477670|11853761|FG000|COMPLETED|Stage 2||0
10689669|NCT02477670|11853762|FG001|COMPLETED|Stage 2||0
10689670|NCT02477670|11853763|FG002|COMPLETED|Stage 2||28
10689671|NCT02477670|11853764|FG003|COMPLETED|Stage 2||32
10689672|NCT02477670|11853765|FG004|COMPLETED|Stage 2||2
10689673|NCT02477670|11853766|FG005|COMPLETED|Stage 2||1
10689674|NCT02477670|11853767|FG006|COMPLETED|Stage 2||42
10689675|NCT02477670|11853761|FG000|NOT COMPLETED|Stage 2||0
10689676|NCT02477670|11853762|FG001|NOT COMPLETED|Stage 2||0
10689677|NCT02477670|11853763|FG002|NOT COMPLETED|Stage 2||2
10689678|NCT02477670|11853764|FG003|NOT COMPLETED|Stage 2||1
10689679|NCT02477670|11853765|FG004|NOT COMPLETED|Stage 2||0
10689680|NCT02477670|11853766|FG005|NOT COMPLETED|Stage 2||0
10689681|NCT02477670|11853767|FG006|NOT COMPLETED|Stage 2||0
10689682|NCT02477709|11853778|FG000|STARTED|Overall Study||6
10689683|NCT02477709|11853778|FG000|COMPLETED|Overall Study||6
10689684|NCT02477709|11853778|FG000|NOT COMPLETED|Overall Study||0
10689685|NCT02477800|11853785|FG000|STARTED|Placebo-Controlled Period||545
10689686|NCT02477800|11853786|FG001|STARTED|Placebo-Controlled Period||547
10689687|NCT02477800|11853787|FG002|STARTED|Placebo-Controlled Period||555
10689688|NCT02477800|11853788|FG003|STARTED|Placebo-Controlled Period||0
10689689|NCT02477800|11853789|FG004|STARTED|Placebo-Controlled Period||0
10689690|NCT02477800|11853790|FG005|STARTED|Placebo-Controlled Period||0
10689691|NCT02477800|11853791|FG006|STARTED|Placebo-Controlled Period||0
10689692|NCT02477800|11853785|FG000|COMPLETED|Placebo-Controlled Period||325
10689693|NCT02477800|11853786|FG001|COMPLETED|Placebo-Controlled Period||325
10689694|NCT02477800|11853787|FG002|COMPLETED|Placebo-Controlled Period||288
10689695|NCT02477800|11853788|FG003|COMPLETED|Placebo-Controlled Period||0
10689696|NCT02477800|11853789|FG004|COMPLETED|Placebo-Controlled Period||0
10689697|NCT02477800|11853790|FG005|COMPLETED|Placebo-Controlled Period||0
10689698|NCT02477800|11853791|FG006|COMPLETED|Placebo-Controlled Period||0
10689699|NCT02477800|11853785|FG000|NOT COMPLETED|Placebo-Controlled Period||220
10689700|NCT02477800|11853786|FG001|NOT COMPLETED|Placebo-Controlled Period||222
10689701|NCT02477800|11853787|FG002|NOT COMPLETED|Placebo-Controlled Period||267
10689702|NCT02477800|11853788|FG003|NOT COMPLETED|Placebo-Controlled Period||0
10689703|NCT02477800|11853789|FG004|NOT COMPLETED|Placebo-Controlled Period||0
10689704|NCT02477800|11853790|FG005|NOT COMPLETED|Placebo-Controlled Period||0
10689705|NCT02477800|11853791|FG006|NOT COMPLETED|Placebo-Controlled Period||0
10689706|NCT02477800|11853785|FG000|STARTED|Long Term Extension Period||0
10689707|NCT02477800|11853786|FG001|STARTED|Long Term Extension Period||0
10689708|NCT02477800|11853787|FG002|STARTED|Long Term Extension Period||0
10689709|NCT02477800|11853788|FG003|STARTED|Long Term Extension Period|12 PC completers did not enter LTE.|150
10689710|NCT02477800|11853789|FG004|STARTED|Long Term Extension Period|11 PC completers did not enter LTE.|152
10689711|NCT02477800|11853790|FG005|STARTED|Long Term Extension Period|26 PC completers did not enter LTE.|299
10689712|NCT02477800|11853791|FG006|STARTED|Long Term Extension Period|37 PC completers did not enter LTE.|251
10689713|NCT02477800|11853785|FG000|COMPLETED|Long Term Extension Period||0
10689714|NCT02477800|11853786|FG001|COMPLETED|Long Term Extension Period||0
10689715|NCT02477800|11853787|FG002|COMPLETED|Long Term Extension Period||0
10689716|NCT02477800|11853788|FG003|COMPLETED|Long Term Extension Period||0
10689717|NCT02477800|11853789|FG004|COMPLETED|Long Term Extension Period||0
10689718|NCT02477800|11853790|FG005|COMPLETED|Long Term Extension Period||0
10689719|NCT02477800|11853791|FG006|COMPLETED|Long Term Extension Period||0
10689720|NCT02477800|11853785|FG000|NOT COMPLETED|Long Term Extension Period||0
10689721|NCT02477800|11853786|FG001|NOT COMPLETED|Long Term Extension Period||0
10689722|NCT02477800|11853787|FG002|NOT COMPLETED|Long Term Extension Period||0
10689723|NCT02477800|11853788|FG003|NOT COMPLETED|Long Term Extension Period||150
10689724|NCT02477800|11853789|FG004|NOT COMPLETED|Long Term Extension Period||152
10689725|NCT02477800|11853790|FG005|NOT COMPLETED|Long Term Extension Period||299
10689726|NCT02477800|11853791|FG006|NOT COMPLETED|Long Term Extension Period||251
10689727|NCT02477839|11853805|FG000|STARTED|Overall Study||127
10689728|NCT02477839|11853806|FG001|STARTED|Overall Study||128
10689729|NCT02477839|11853805|FG000|Completed Transition Period|Overall Study||124
10689730|NCT02477839|11853806|FG001|Completed Transition Period|Overall Study||117
10689731|NCT02477839|11853805|FG000|Completed Taper After Maintenance|Overall Study||0
10689732|NCT02477839|11853806|FG001|Completed Taper After Maintenance|Overall Study||1
10689733|NCT02477839|11853805|FG000|COMPLETED|Overall Study||124
10689734|NCT02477839|11853806|FG001|COMPLETED|Overall Study||118
10689735|NCT02477839|11853805|FG000|NOT COMPLETED|Overall Study||3
10689736|NCT02477839|11853806|FG001|NOT COMPLETED|Overall Study||10
10689737|NCT02478164|11853814|FG000|STARTED|Overall Study|17 participants enrolled. 15 of 17 received ponatinib as 2 participants withdrew prior to ponatinib.|15
10689738|NCT02478164|11853814|FG000|COMPLETED|Overall Study||0
10689739|NCT02478164|11853814|FG000|NOT COMPLETED|Overall Study||15
10689740|NCT02478359|11853820|FG000|STARTED|Overall Study||1349
10689741|NCT02478359|11853821|FG001|STARTED|Overall Study||1358
10689742|NCT02478359|11853820|FG000|Intention-to-treat Population Month 12|Overall Study|Disenrolled from health plan: 106|1243
10689743|NCT02478359|11853821|FG001|Intention-to-treat Population Month 12|Overall Study|Disenrolled from health plan: 65|1293
10689744|NCT02478359|11853820|FG000|COMPLETED|Overall Study||1243
10689745|NCT02478359|11853821|FG001|COMPLETED|Overall Study||1293
10689746|NCT02478359|11853820|FG000|NOT COMPLETED|Overall Study||106
10689747|NCT02478359|11853821|FG001|NOT COMPLETED|Overall Study||65
10689748|NCT02478372|11853831|FG000|STARTED|Overall Study||121
10689749|NCT02478372|11853832|FG001|STARTED|Overall Study||121
10689750|NCT02478372|11853831|FG000|Recieved Allocation Intervention|Overall Study||109
10689751|NCT02478372|11853832|FG001|Recieved Allocation Intervention|Overall Study||113
10689752|NCT02478372|11853831|FG000|Reviewed at Six Weeks|Overall Study|Routine follow up at six weeks - one patient refused to attend|108
10689753|NCT02478372|11853832|FG001|Reviewed at Six Weeks|Overall Study|Routine follow up at six weeks|113
10689754|NCT02478372|11853831|FG000|Reviewed at One Year|Overall Study|Routine follow up at one year|108
10689755|NCT02478372|11853832|FG001|Reviewed at One Year|Overall Study|Routine folow up at one year - four patients did not attend, two patients died|107
10689756|NCT02478372|11853831|FG000|COMPLETED|Overall Study||108
10689757|NCT02478372|11853832|FG001|COMPLETED|Overall Study||107
10689758|NCT02478372|11853831|FG000|NOT COMPLETED|Overall Study||13
10689759|NCT02478372|11853832|FG001|NOT COMPLETED|Overall Study||14
10689760|NCT02478398|11853840|FG000|STARTED|Overall Study||513
10689761|NCT02478398|11853841|FG001|STARTED|Overall Study||512
10689762|NCT02478398|11853840|FG000|Treated|Overall Study||512
10689763|NCT02478398|11853841|FG001|Treated|Overall Study||510
10689764|NCT02478398|11853840|FG000|COMPLETED|Overall Study||461
10689765|NCT02478398|11853841|FG001|COMPLETED|Overall Study||491
10689766|NCT02478398|11853840|FG000|NOT COMPLETED|Overall Study||52
10689767|NCT02478398|11853841|FG001|NOT COMPLETED|Overall Study||21
10689768|NCT02478463|11853848|FG000|STARTED|Treatment Period 1 (Up to Day 29)||19
10689769|NCT02478463|11853848|FG000|COMPLETED|Treatment Period 1 (Up to Day 29)||18
10689770|NCT02478463|11853848|FG000|NOT COMPLETED|Treatment Period 1 (Up to Day 29)||1
10689771|NCT02478463|11853848|FG000|STARTED|Washout Period (Up to 42 Days)||18
10689772|NCT02478463|11853848|FG000|COMPLETED|Washout Period (Up to 42 Days)||17
10689773|NCT02478463|11853848|FG000|NOT COMPLETED|Washout Period (Up to 42 Days)||1
10689774|NCT02478463|11853848|FG000|STARTED|Treatment Period 2 (Up to 52 Weeks)||17
10689775|NCT02478463|11853848|FG000|COMPLETED|Treatment Period 2 (Up to 52 Weeks)||16
10689776|NCT02478463|11853848|FG000|NOT COMPLETED|Treatment Period 2 (Up to 52 Weeks)||1
10689777|NCT02478489|11853856|FG000|STARTED|Overall Study||123
10689778|NCT02478489|11853857|FG001|STARTED|Overall Study||125
10689779|NCT02478489|11853856|FG000|COMPLETED|Overall Study||108
10689780|NCT02478489|11853857|FG001|COMPLETED|Overall Study||109
10689781|NCT02478489|11853856|FG000|NOT COMPLETED|Overall Study||15
10689782|NCT02478489|11853857|FG001|NOT COMPLETED|Overall Study||16
10689783|NCT02478580|11853865|FG000|STARTED|Overall Study||34
10689784|NCT02478580|11853866|FG001|STARTED|Overall Study||33
10689785|NCT02478580|11853865|FG000|COMPLETED|Overall Study||34
10689786|NCT02478580|11853866|FG001|COMPLETED|Overall Study||33
10689787|NCT02478580|11853865|FG000|NOT COMPLETED|Overall Study||0
10689788|NCT02478580|11853866|FG001|NOT COMPLETED|Overall Study||0
10689789|NCT02478632|11853876|FG000|STARTED|Early Switch Phase (Up to Week 52)||53
10689790|NCT02478632|11853877|FG001|STARTED|Early Switch Phase (Up to Week 52)||49
10689791|NCT02478632|11853876|FG000|COMPLETED|Early Switch Phase (Up to Week 52)||49
10689792|NCT02478632|11853877|FG001|COMPLETED|Early Switch Phase (Up to Week 52)||44
10689793|NCT02478632|11853876|FG000|NOT COMPLETED|Early Switch Phase (Up to Week 52)||4
10689794|NCT02478632|11853877|FG001|NOT COMPLETED|Early Switch Phase (Up to Week 52)||5
10689795|NCT02478632|11853876|FG000|STARTED|Late Switch Phase (Week 52 to Week 148)||49
10689796|NCT02478632|11853877|FG001|STARTED|Late Switch Phase (Week 52 to Week 148)||44
10689797|NCT02478632|11853876|FG000|COMPLETED|Late Switch Phase (Week 52 to Week 148)||42
10689798|NCT02478632|11853877|FG001|COMPLETED|Late Switch Phase (Week 52 to Week 148)||40
10689799|NCT02478632|11853876|FG000|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||7
10689800|NCT02478632|11853877|FG001|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||4
10689801|NCT02478671|11853886|FG000|STARTED|Overall Study||4
10689802|NCT02478671|11853886|FG000|COMPLETED|Overall Study||4
10689803|NCT02478671|11853886|FG000|NOT COMPLETED|Overall Study||0
10689804|NCT02479139|11853897|FG000|STARTED|Overall Study||27
10689805|NCT02479139|11853898|FG001|STARTED|Overall Study||22
10689806|NCT02479139|11853899|FG002|STARTED|Overall Study||28
10689807|NCT02479139|11853900|FG003|STARTED|Overall Study||21
10689808|NCT02479139|11853901|FG004|STARTED|Overall Study||22
10689809|NCT02479139|11853902|FG005|STARTED|Overall Study||25
10689810|NCT02479139|11853897|FG000|COMPLETED|Overall Study||19
10689811|NCT02479139|11853898|FG001|COMPLETED|Overall Study||12
10689812|NCT02479139|11853899|FG002|COMPLETED|Overall Study||21
10689813|NCT02479139|11853900|FG003|COMPLETED|Overall Study||14
10689814|NCT02479139|11853901|FG004|COMPLETED|Overall Study||17
10689815|NCT02479139|11853902|FG005|COMPLETED|Overall Study||19
10689816|NCT02479139|11853897|FG000|NOT COMPLETED|Overall Study||8
10689817|NCT02479139|11853898|FG001|NOT COMPLETED|Overall Study||10
10689818|NCT02479139|11853899|FG002|NOT COMPLETED|Overall Study||7
10689819|NCT02479139|11853900|FG003|NOT COMPLETED|Overall Study||7
10689820|NCT02479139|11853901|FG004|NOT COMPLETED|Overall Study||5
10689821|NCT02479139|11853902|FG005|NOT COMPLETED|Overall Study||6
10689822|NCT02479412|11853925|FG000|STARTED|Overall Study||6
10689823|NCT02479412|11853926|FG001|STARTED|Overall Study||6
10689824|NCT02479412|11853927|FG002|STARTED|Overall Study||6
10689825|NCT02479412|11853928|FG003|STARTED|Overall Study||7
10689826|NCT02479412|11853929|FG004|STARTED|Overall Study||6
10689827|NCT02479412|11853930|FG005|STARTED|Overall Study||5
10689828|NCT02479412|11853931|FG006|STARTED|Overall Study||6
10689829|NCT02479412|11853932|FG007|STARTED|Overall Study||5
10689830|NCT02479412|11853933|FG008|STARTED|Overall Study||7
10689831|NCT02479412|11853925|FG000|COMPLETED|Overall Study||6
10689832|NCT02479412|11853926|FG001|COMPLETED|Overall Study||6
10689833|NCT02479412|11853927|FG002|COMPLETED|Overall Study||4
10689834|NCT02479412|11853928|FG003|COMPLETED|Overall Study||6
10689835|NCT02479412|11853929|FG004|COMPLETED|Overall Study||5
10689836|NCT02479412|11853930|FG005|COMPLETED|Overall Study||5
10689837|NCT02479412|11853931|FG006|COMPLETED|Overall Study||6
10689838|NCT02479412|11853932|FG007|COMPLETED|Overall Study||4
10689839|NCT02479412|11853933|FG008|COMPLETED|Overall Study||6
10689840|NCT02479412|11853925|FG000|NOT COMPLETED|Overall Study||0
10689841|NCT02479412|11853926|FG001|NOT COMPLETED|Overall Study||0
10689842|NCT02479412|11853927|FG002|NOT COMPLETED|Overall Study||2
10689843|NCT02479412|11853928|FG003|NOT COMPLETED|Overall Study||1
10689844|NCT02479412|11853929|FG004|NOT COMPLETED|Overall Study||1
10689845|NCT02479412|11853930|FG005|NOT COMPLETED|Overall Study||0
10689846|NCT02479412|11853931|FG006|NOT COMPLETED|Overall Study||0
10689847|NCT02479412|11853932|FG007|NOT COMPLETED|Overall Study||1
10689848|NCT02479412|11853933|FG008|NOT COMPLETED|Overall Study||1
10689849|NCT02479763|11853951|FG000|STARTED|Overall Study||53
10689850|NCT02479763|11853952|FG001|STARTED|Overall Study||53
10689851|NCT02479763|11853951|FG000|COMPLETED|Overall Study||50
10689852|NCT02479763|11853952|FG001|COMPLETED|Overall Study||50
10689853|NCT02479763|11853951|FG000|NOT COMPLETED|Overall Study||3
10689854|NCT02479763|11853952|FG001|NOT COMPLETED|Overall Study||3
10689855|NCT02479802|11853958|FG000|STARTED|Overall Study||13
10689856|NCT02479802|11853958|FG000|COMPLETED|Overall Study||11
10689857|NCT02479802|11853958|FG000|NOT COMPLETED|Overall Study||2
10689858|NCT02479880|11853964|FG000|STARTED|Overall Study||15
10689859|NCT02479880|11853965|FG001|STARTED|Overall Study||15
10689860|NCT02479880|11853964|FG000|COMPLETED|Overall Study||2
10689861|NCT02479880|11853965|FG001|COMPLETED|Overall Study||2
10689862|NCT02479880|11853964|FG000|NOT COMPLETED|Overall Study||13
10689863|NCT02479880|11853965|FG001|NOT COMPLETED|Overall Study||13
10689864|NCT02480010|11853973|FG000|STARTED|Overall Study||35
10689865|NCT02480010|11853974|FG001|STARTED|Overall Study||33
10689866|NCT02480010|11853973|FG000|COMPLETED|Overall Study||0
10689867|NCT02480010|11853974|FG001|COMPLETED|Overall Study||0
10689868|NCT02480010|11853973|FG000|NOT COMPLETED|Overall Study||35
10689869|NCT02480010|11853974|FG001|NOT COMPLETED|Overall Study||33
10689870|NCT02480114|11853982|FG000|STARTED|Overall Study||41
10689871|NCT02480114|11853983|FG001|STARTED|Overall Study||38
10689872|NCT02480114|11853982|FG000|COMPLETED|Overall Study||32
10689873|NCT02480114|11853983|FG001|COMPLETED|Overall Study||30
10689874|NCT02480114|11853982|FG000|NOT COMPLETED|Overall Study||9
10689875|NCT02480114|11853983|FG001|NOT COMPLETED|Overall Study||8
10689876|NCT02480153|11853991|FG000|STARTED|Period 1: First Dose to Week 26 Pre-dose||297
10689877|NCT02480153|11853992|FG001|STARTED|Period 1: First Dose to Week 26 Pre-dose||300
10689878|NCT02480153|11853993|FG002|STARTED|Period 1: First Dose to Week 26 Pre-dose||0
10689879|NCT02480153|11853991|FG000|Received Treatment|Period 1: First Dose to Week 26 Pre-dose||297
10689880|NCT02480153|11853992|FG001|Received Treatment|Period 1: First Dose to Week 26 Pre-dose||299
10689881|NCT02480153|11853993|FG002|Received Treatment|Period 1: First Dose to Week 26 Pre-dose||0
10689882|NCT02480153|11853991|FG000|COMPLETED|Period 1: First Dose to Week 26 Pre-dose||293
10689883|NCT02480153|11853992|FG001|COMPLETED|Period 1: First Dose to Week 26 Pre-dose||284
10689884|NCT02480153|11853993|FG002|COMPLETED|Period 1: First Dose to Week 26 Pre-dose||0
10689885|NCT02480153|11853991|FG000|NOT COMPLETED|Period 1: First Dose to Week 26 Pre-dose||4
10689886|NCT02480153|11853992|FG001|NOT COMPLETED|Period 1: First Dose to Week 26 Pre-dose||16
10689887|NCT02480153|11853993|FG002|NOT COMPLETED|Period 1: First Dose to Week 26 Pre-dose||0
10689888|NCT02480153|11853991|FG000|STARTED|Period 2: Week 26 to Week 52 Pre-dose||283
10689889|NCT02480153|11853992|FG001|STARTED|Period 2: Week 26 to Week 52 Pre-dose||135
10689890|NCT02480153|11853993|FG002|STARTED|Period 2: Week 26 to Week 52 Pre-dose||134
10689891|NCT02480153|11853991|FG000|Received Treatment|Period 2: Week 26 to Week 52 Pre-dose||283
10689892|NCT02480153|11853992|FG001|Received Treatment|Period 2: Week 26 to Week 52 Pre-dose||135
10689893|NCT02480153|11853993|FG002|Received Treatment|Period 2: Week 26 to Week 52 Pre-dose||133
10689894|NCT02480153|11853991|FG000|COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||263
10689895|NCT02480153|11853992|FG001|COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||122
10689896|NCT02480153|11853993|FG002|COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||127
10689897|NCT02480153|11853991|FG000|NOT COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||20
10689898|NCT02480153|11853992|FG001|NOT COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||13
10689899|NCT02480153|11853993|FG002|NOT COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||7
10689900|NCT02480153|11853991|FG000|STARTED|Period 3: Week 52 Dosing to Week 78||259
10689901|NCT02480153|11853992|FG001|STARTED|Period 3: Week 52 Dosing to Week 78||121
10689902|NCT02480153|11853993|FG002|STARTED|Period 3: Week 52 Dosing to Week 78||127
10689903|NCT02480153|11853991|FG000|Received Treatment|Period 3: Week 52 Dosing to Week 78||258
10689904|NCT02480153|11853992|FG001|Received Treatment|Period 3: Week 52 Dosing to Week 78||120
10689905|NCT02480153|11853993|FG002|Received Treatment|Period 3: Week 52 Dosing to Week 78||127
10689906|NCT02480153|11853991|FG000|COMPLETED|Period 3: Week 52 Dosing to Week 78||252
10689907|NCT02480153|11853992|FG001|COMPLETED|Period 3: Week 52 Dosing to Week 78||118
10689908|NCT02480153|11853993|FG002|COMPLETED|Period 3: Week 52 Dosing to Week 78||123
10689909|NCT02480153|11853991|FG000|NOT COMPLETED|Period 3: Week 52 Dosing to Week 78||7
10689910|NCT02480153|11853992|FG001|NOT COMPLETED|Period 3: Week 52 Dosing to Week 78||3
10689911|NCT02480153|11853993|FG002|NOT COMPLETED|Period 3: Week 52 Dosing to Week 78||4
10689912|NCT02480166|11854019|FG000|STARTED|Overall Study||20
10689913|NCT02480166|11854020|FG001|STARTED|Overall Study||36
10689914|NCT02480166|11854021|FG002|STARTED|Overall Study||4
10689915|NCT02480166|11854019|FG000|COMPLETED|Overall Study||20
10689916|NCT02480166|11854020|FG001|COMPLETED|Overall Study||36
10689917|NCT02480166|11854021|FG002|COMPLETED|Overall Study||4
10689918|NCT02480166|11854019|FG000|NOT COMPLETED|Overall Study||0
10689919|NCT02480166|11854020|FG001|NOT COMPLETED|Overall Study||0
10689920|NCT02480166|11854021|FG002|NOT COMPLETED|Overall Study||0
10689921|NCT02480439|11854033|FG000|STARTED|Treatment Period 1||8
10689922|NCT02480439|11854034|FG001|STARTED|Treatment Period 1||8
10689923|NCT02480439|11854035|FG002|STARTED|Treatment Period 1||8
10689924|NCT02480439|11854033|FG000|COMPLETED|Treatment Period 1||8
10689925|NCT02480439|11854034|FG001|COMPLETED|Treatment Period 1||8
10689926|NCT02480439|11854035|FG002|COMPLETED|Treatment Period 1||8
10689927|NCT02480439|11854033|FG000|NOT COMPLETED|Treatment Period 1||0
10689928|NCT02480439|11854034|FG001|NOT COMPLETED|Treatment Period 1||0
10689929|NCT02480439|11854035|FG002|NOT COMPLETED|Treatment Period 1||0
10689930|NCT02480439|11854033|FG000|STARTED|Treatment Period 2||8
10689931|NCT02480439|11854034|FG001|STARTED|Treatment Period 2|1 Participant was withdrawn due to an Adverse Event after completing Period 1.|7
10689932|NCT02480439|11854035|FG002|STARTED|Treatment Period 2||8
10689933|NCT02480439|11854033|FG000|COMPLETED|Treatment Period 2||8
10689934|NCT02480439|11854034|FG001|COMPLETED|Treatment Period 2||7
10689935|NCT02480439|11854035|FG002|COMPLETED|Treatment Period 2||8
10689936|NCT02480439|11854033|FG000|NOT COMPLETED|Treatment Period 2||0
10689937|NCT02480439|11854034|FG001|NOT COMPLETED|Treatment Period 2||0
10800210|NCT04559282|11961136|FG000|NOT COMPLETED|Intervention 1 (Day 0)||0
10800211|NCT04559282|11961137|FG001|NOT COMPLETED|Intervention 1 (Day 0)||0
10800212|NCT04559282|11961136|FG000|STARTED|Intervention 2 (Day 7)||8
10800213|NCT04559282|11961137|FG001|STARTED|Intervention 2 (Day 7)||8
10800214|NCT04559282|11961136|FG000|COMPLETED|Intervention 2 (Day 7)||8
10800215|NCT04559282|11961137|FG001|COMPLETED|Intervention 2 (Day 7)||8
10800216|NCT04559282|11961136|FG000|NOT COMPLETED|Intervention 2 (Day 7)||0
10800217|NCT04559282|11961137|FG001|NOT COMPLETED|Intervention 2 (Day 7)||0
10800218|NCT04559282|11961136|FG000|STARTED|Intervention 3 (Day 14)||8
10800219|NCT04559282|11961137|FG001|STARTED|Intervention 3 (Day 14)||8
10800220|NCT04559282|11961136|FG000|COMPLETED|Intervention 3 (Day 14)||8
10800221|NCT04559282|11961137|FG001|COMPLETED|Intervention 3 (Day 14)||8
10800222|NCT04559282|11961136|FG000|NOT COMPLETED|Intervention 3 (Day 14)||0
10689938|NCT02480439|11854035|FG002|NOT COMPLETED|Treatment Period 2||0
10689939|NCT02480439|11854033|FG000|STARTED|Treatment Period 3||8
10689940|NCT02480439|11854034|FG001|STARTED|Treatment Period 3||7
10689941|NCT02480439|11854035|FG002|STARTED|Treatment Period 3|1 Participant was withdrawn due to an Adverse Event after completing Period 2.|7
10689942|NCT02480439|11854033|FG000|COMPLETED|Treatment Period 3||8
10689943|NCT02480439|11854034|FG001|COMPLETED|Treatment Period 3||7
10689944|NCT02480439|11854035|FG002|COMPLETED|Treatment Period 3||7
10689945|NCT02480439|11854033|FG000|NOT COMPLETED|Treatment Period 3||0
10689946|NCT02480439|11854034|FG001|NOT COMPLETED|Treatment Period 3||0
10689947|NCT02480439|11854035|FG002|NOT COMPLETED|Treatment Period 3||0
10689948|NCT02480582|11854043|FG000|STARTED|Overall Study||7
10689949|NCT02480582|11854044|FG001|STARTED|Overall Study||7
10689950|NCT02480582|11854045|FG002|STARTED|Overall Study||7
10689951|NCT02480582|11854046|FG003|STARTED|Overall Study||7
10689952|NCT02480582|11854047|FG004|STARTED|Overall Study||7
10689953|NCT02480582|11854048|FG005|STARTED|Overall Study||7
10689954|NCT02480582|11854043|FG000|COMPLETED|Overall Study||7
10689955|NCT02480582|11854044|FG001|COMPLETED|Overall Study||7
10689956|NCT02480582|11854045|FG002|COMPLETED|Overall Study||7
10689957|NCT02480582|11854046|FG003|COMPLETED|Overall Study||7
10689958|NCT02480582|11854047|FG004|COMPLETED|Overall Study||7
10689959|NCT02480582|11854048|FG005|COMPLETED|Overall Study||7
10689960|NCT02480582|11854043|FG000|NOT COMPLETED|Overall Study||0
10689961|NCT02480582|11854044|FG001|NOT COMPLETED|Overall Study||0
10689962|NCT02480582|11854045|FG002|NOT COMPLETED|Overall Study||0
10689963|NCT02480582|11854046|FG003|NOT COMPLETED|Overall Study||0
10689964|NCT02480582|11854047|FG004|NOT COMPLETED|Overall Study||0
10689965|NCT02480582|11854048|FG005|NOT COMPLETED|Overall Study||0
10689966|NCT02480621|11854063|FG000|STARTED|Randomization||44
10689967|NCT02480621|11854064|FG001|STARTED|Randomization||40
10689968|NCT02480621|11854063|FG000|COMPLETED|Randomization||43
10689969|NCT02480621|11854064|FG001|COMPLETED|Randomization||39
10689970|NCT02480621|11854063|FG000|NOT COMPLETED|Randomization||1
10689971|NCT02480621|11854064|FG001|NOT COMPLETED|Randomization||1
10689972|NCT02480621|11854063|FG000|STARTED|Follow Up||43
10689973|NCT02480621|11854064|FG001|STARTED|Follow Up||39
10689974|NCT02480621|11854063|FG000|COMPLETED|Follow Up||39
10689975|NCT02480621|11854064|FG001|COMPLETED|Follow Up||37
10689976|NCT02480621|11854063|FG000|NOT COMPLETED|Follow Up||4
10689977|NCT02480621|11854064|FG001|NOT COMPLETED|Follow Up||2
10689978|NCT02480712|11854070|FG000|STARTED|Overall Study||107
10689979|NCT02480712|11854070|FG000|COMPLETED|Overall Study||96
10689980|NCT02480712|11854070|FG000|NOT COMPLETED|Overall Study||11
10689981|NCT02480764|11854083|FG000|STARTED|Overall Study||199
10689982|NCT02480764|11854084|FG001|STARTED|Overall Study||209
10689983|NCT02480764|11854085|FG002|STARTED|Overall Study||204
10689984|NCT02480764|11854083|FG000|COMPLETED|Overall Study||189
10689985|NCT02480764|11854084|FG001|COMPLETED|Overall Study||189
10689986|NCT02480764|11854085|FG002|COMPLETED|Overall Study||183
10689987|NCT02480764|11854083|FG000|NOT COMPLETED|Overall Study||10
10689988|NCT02480764|11854084|FG001|NOT COMPLETED|Overall Study||20
10689989|NCT02480764|11854085|FG002|NOT COMPLETED|Overall Study||21
10689990|NCT02480920|11854093|FG000|STARTED|Overall Study||2738
10689991|NCT02480920|11854093|FG000|COMPLETED|Overall Study||2738
10689992|NCT02480920|11854093|FG000|NOT COMPLETED|Overall Study||0
10689993|NCT02480998|11854099|FG000|STARTED|Overall Study||56
10689994|NCT02480998|11854100|FG001|STARTED|Overall Study||28
10689995|NCT02480998|11854099|FG000|COMPLETED|Overall Study||56
10689996|NCT02480998|11854100|FG001|COMPLETED|Overall Study||28
10689997|NCT02480998|11854099|FG000|NOT COMPLETED|Overall Study||0
10689998|NCT02480998|11854100|FG001|NOT COMPLETED|Overall Study||0
10689999|NCT02481050|11854108|FG000|STARTED|Overall Study||58
10690000|NCT02481050|11854108|FG000|COMPLETED|Overall Study||0
10690001|NCT02481050|11854108|FG000|NOT COMPLETED|Overall Study||58
10690002|NCT02481141|11854114|FG000|STARTED|Overall Study||35
10690003|NCT02481141|11854115|FG001|STARTED|Overall Study||18
10690004|NCT02481141|11854114|FG000|COMPLETED|Overall Study||26
10690005|NCT02481141|11854115|FG001|COMPLETED|Overall Study||13
10690006|NCT02481141|11854114|FG000|NOT COMPLETED|Overall Study||9
10690007|NCT02481141|11854115|FG001|NOT COMPLETED|Overall Study||5
10690008|NCT02481206|11854144|FG000|STARTED|Overall Study||34
10690009|NCT02481206|11854145|FG001|STARTED|Overall Study||32
10690010|NCT02481206|11854144|FG000|COMPLETED|Overall Study||29
10690011|NCT02481206|11854145|FG001|COMPLETED|Overall Study||31
10690012|NCT02481206|11854144|FG000|NOT COMPLETED|Overall Study||5
10690013|NCT02481206|11854145|FG001|NOT COMPLETED|Overall Study||1
10690014|NCT02481219|11854155|FG000|STARTED|Overall Study||60
10690015|NCT02481219|11854156|FG001|STARTED|Overall Study||62
10690016|NCT02481219|11854155|FG000|COMPLETED|Overall Study||58
10690017|NCT02481219|11854156|FG001|COMPLETED|Overall Study||61
10690018|NCT02481219|11854155|FG000|NOT COMPLETED|Overall Study||2
10690019|NCT02481219|11854156|FG001|NOT COMPLETED|Overall Study||1
10690020|NCT02481258|11854168|FG000|STARTED|Overall Study||12
10690021|NCT02481258|11854169|FG001|STARTED|Overall Study||11
10690022|NCT02481258|11854168|FG000|COMPLETED|Overall Study||12
10690023|NCT02481258|11854169|FG001|COMPLETED|Overall Study||11
10690024|NCT02481258|11854168|FG000|NOT COMPLETED|Overall Study||0
10690025|NCT02481258|11854169|FG001|NOT COMPLETED|Overall Study||0
10690026|NCT02481297|11854179|FG000|STARTED|Overall Study||1
10690027|NCT02481297|11854180|FG001|STARTED|Overall Study||6
10690028|NCT02481297|11854179|FG000|COMPLETED|Overall Study||1
10690029|NCT02481297|11854180|FG001|COMPLETED|Overall Study||6
10690030|NCT02481297|11854179|FG000|NOT COMPLETED|Overall Study||0
10690031|NCT02481297|11854180|FG001|NOT COMPLETED|Overall Study||0
10690032|NCT02481375|11854190|FG000|STARTED|Overall Study||206
10690033|NCT02481375|11854191|FG001|STARTED|Overall Study||202
10690034|NCT02481375|11854192|FG002|STARTED|Overall Study||201
10690035|NCT02481375|11854193|FG003|STARTED|Overall Study||200
10690036|NCT02481375|11854190|FG000|COMPLETED|Overall Study||192
10690037|NCT02481375|11854191|FG001|COMPLETED|Overall Study||191
10690038|NCT02481375|11854192|FG002|COMPLETED|Overall Study||191
10800223|NCT04559282|11961137|FG001|NOT COMPLETED|Intervention 3 (Day 14)||0
10800224|NCT04574297|11961150|FG000|STARTED|Overall Study||180
10800225|NCT04574297|11961151|FG001|STARTED|Overall Study||263
10800226|NCT04574297|11961152|FG002|STARTED|Overall Study||230
10800227|NCT04574297|11961153|FG003|STARTED|Overall Study||125
10800228|NCT04574297|11961150|FG000|COMPLETED|Overall Study||180
10800229|NCT04574297|11961151|FG001|COMPLETED|Overall Study||263
10800230|NCT04574297|11961152|FG002|COMPLETED|Overall Study||230
10800231|NCT04574297|11961153|FG003|COMPLETED|Overall Study||125
10690039|NCT02481375|11854193|FG003|COMPLETED|Overall Study||186
10690040|NCT02481375|11854190|FG000|NOT COMPLETED|Overall Study||14
10690041|NCT02481375|11854191|FG001|NOT COMPLETED|Overall Study||11
10690042|NCT02481375|11854192|FG002|NOT COMPLETED|Overall Study||10
10690043|NCT02481375|11854193|FG003|NOT COMPLETED|Overall Study||14
10690044|NCT02481440|11854203|FG000|STARTED|Overall Study||102
10690045|NCT02481440|11854203|FG000|COMPLETED|Overall Study||41
10690046|NCT02481440|11854203|FG000|NOT COMPLETED|Overall Study||61
10690047|NCT02481505|11854210|FG000|STARTED|Overall Study||15
10690048|NCT02481505|11854211|FG001|STARTED|Overall Study||15
10690049|NCT02481505|11854212|FG002|STARTED|Overall Study||15
10690050|NCT02481505|11854210|FG000|COMPLETED|Overall Study||15
10690051|NCT02481505|11854211|FG001|COMPLETED|Overall Study||15
10690052|NCT02481505|11854212|FG002|COMPLETED|Overall Study||15
10690053|NCT02481505|11854210|FG000|NOT COMPLETED|Overall Study||0
10690054|NCT02481505|11854211|FG001|NOT COMPLETED|Overall Study||0
10690055|NCT02481505|11854212|FG002|NOT COMPLETED|Overall Study||0
10690056|NCT02481557|11854222|FG000|STARTED|Overall Study||17
10690057|NCT02481557|11854223|FG001|STARTED|Overall Study||19
10690058|NCT02481557|11854222|FG000|COMPLETED|Overall Study||17
10690059|NCT02481557|11854223|FG001|COMPLETED|Overall Study||19
10690060|NCT02481557|11854222|FG000|NOT COMPLETED|Overall Study||0
10690061|NCT02481557|11854223|FG001|NOT COMPLETED|Overall Study||0
10690062|NCT02481596|11854232|FG000|STARTED|Overall Study||126
10690063|NCT02481596|11854233|FG001|STARTED|Overall Study||127
10690064|NCT02481596|11854234|FG002|STARTED|Overall Study||253
10690065|NCT02481596|11854232|FG000|COMPLETED|Overall Study||123
10690066|NCT02481596|11854233|FG001|COMPLETED|Overall Study||126
10690067|NCT02481596|11854234|FG002|COMPLETED|Overall Study||245
10690068|NCT02481596|11854232|FG000|NOT COMPLETED|Overall Study||3
10690069|NCT02481596|11854233|FG001|NOT COMPLETED|Overall Study||1
10690070|NCT02481596|11854234|FG002|NOT COMPLETED|Overall Study||8
10690071|NCT02481713|11854244|FG000|STARTED|Overall Study||56
10690072|NCT02481713|11854245|FG001|STARTED|Overall Study||58
10690073|NCT02481713|11854244|FG000|COMPLETED|Overall Study||40
10690074|NCT02481713|11854245|FG001|COMPLETED|Overall Study||42
10690075|NCT02481713|11854244|FG000|NOT COMPLETED|Overall Study||16
10690076|NCT02481713|11854245|FG001|NOT COMPLETED|Overall Study||16
10690077|NCT02481869|11854253|FG000|STARTED|Overall Study||5
10690078|NCT02481869|11854254|FG001|STARTED|Overall Study||6
10690079|NCT02481869|11854253|FG000|COMPLETED|Overall Study||0
10690080|NCT02481869|11854254|FG001|COMPLETED|Overall Study||2
10690081|NCT02481869|11854253|FG000|NOT COMPLETED|Overall Study||5
10690082|NCT02481869|11854254|FG001|NOT COMPLETED|Overall Study||4
10690083|NCT02481934|11854261|FG000|STARTED|Overall Study||5
10690084|NCT02481934|11854261|FG000|COMPLETED|Overall Study||3
10690085|NCT02481934|11854261|FG000|NOT COMPLETED|Overall Study||2
10690086|NCT02481947|11854267|FG000|STARTED|Overall Study||230
10690087|NCT02481947|11854268|FG001|STARTED|Overall Study||229
10690088|NCT02481947|11854267|FG000|COMPLETED|Overall Study||184
10690089|NCT02481947|11854268|FG001|COMPLETED|Overall Study||193
10690090|NCT02481947|11854267|FG000|NOT COMPLETED|Overall Study||46
10690091|NCT02481947|11854268|FG001|NOT COMPLETED|Overall Study||36
10690092|NCT02482025|11854276|FG000|STARTED|Overall Study||122
10690093|NCT02482025|11854277|FG001|STARTED|Overall Study||118
10690094|NCT02482025|11854276|FG000|COMPLETED|Overall Study||122
10800232|NCT04574297|11961150|FG000|NOT COMPLETED|Overall Study||0
10800233|NCT04574297|11961151|FG001|NOT COMPLETED|Overall Study||0
10800234|NCT04574297|11961152|FG002|NOT COMPLETED|Overall Study||0
10800235|NCT04574297|11961153|FG003|NOT COMPLETED|Overall Study||0
10800236|NCT04580290|11961165|FG000|STARTED|Overall Study||88
10800237|NCT04580290|11961166|FG001|STARTED|Overall Study||32
10800238|NCT04580290|11961165|FG000|COMPLETED|Overall Study||88
10800239|NCT04580290|11961166|FG001|COMPLETED|Overall Study||32
10800240|NCT04580290|11961165|FG000|NOT COMPLETED|Overall Study||0
10800241|NCT04580290|11961166|FG001|NOT COMPLETED|Overall Study||0
10800242|NCT04601103|11961175|FG000|STARTED|Overall Study||18
10800243|NCT04601103|11961176|FG001|STARTED|Overall Study||18
10800244|NCT04601103|11961177|FG002|STARTED|Overall Study||17
10690095|NCT02482025|11854277|FG001|COMPLETED|Overall Study||118
10690096|NCT02482025|11854276|FG000|NOT COMPLETED|Overall Study||0
10690097|NCT02482025|11854277|FG001|NOT COMPLETED|Overall Study||0
10690098|NCT02482129|11854285|FG000|STARTED|Overall Study||32
10690099|NCT02482129|11854286|FG001|STARTED|Overall Study||11
10690100|NCT02482129|11854285|FG000|Treated, as Randomized|Overall Study||30
10690101|NCT02482129|11854286|FG001|Treated, as Randomized|Overall Study||9
10690102|NCT02482129|11854285|FG000|COMPLETED|Overall Study||26
10690103|NCT02482129|11854286|FG001|COMPLETED|Overall Study||9
10690104|NCT02482129|11854285|FG000|NOT COMPLETED|Overall Study||6
10690105|NCT02482129|11854286|FG001|NOT COMPLETED|Overall Study||2
10690106|NCT02482298|11854297|FG000|STARTED|Overall Study||30
10690107|NCT02482298|11854298|FG001|STARTED|Overall Study||27
10690108|NCT02482298|11854299|FG002|STARTED|Overall Study||30
10690109|NCT02482298|11854297|FG000|COMPLETED|Overall Study||28
10690110|NCT02482298|11854298|FG001|COMPLETED|Overall Study||24
10690111|NCT02482298|11854299|FG002|COMPLETED|Overall Study||27
10690112|NCT02482298|11854297|FG000|NOT COMPLETED|Overall Study||2
10690113|NCT02482298|11854298|FG001|NOT COMPLETED|Overall Study||3
10690114|NCT02482298|11854299|FG002|NOT COMPLETED|Overall Study||3
10690115|NCT02482428|11854312|FG000|STARTED|Overall Study||24
10690116|NCT02482428|11854313|FG001|STARTED|Overall Study||22
10690117|NCT02482428|11854314|FG002|STARTED|Overall Study||10
10690118|NCT02482428|11854315|FG003|STARTED|Overall Study||10
10690119|NCT02482428|11854316|FG004|STARTED|Overall Study||22
10690120|NCT02482428|11854312|FG000|COMPLETED|Overall Study||15
10690121|NCT02482428|11854313|FG001|COMPLETED|Overall Study||10
10690122|NCT02482428|11854314|FG002|COMPLETED|Overall Study||9
10690123|NCT02482428|11854315|FG003|COMPLETED|Overall Study||8
10690124|NCT02482428|11854316|FG004|COMPLETED|Overall Study||15
10690125|NCT02482428|11854312|FG000|NOT COMPLETED|Overall Study||9
10690126|NCT02482428|11854313|FG001|NOT COMPLETED|Overall Study||12
10690127|NCT02482428|11854314|FG002|NOT COMPLETED|Overall Study||1
10690128|NCT02482428|11854315|FG003|NOT COMPLETED|Overall Study||2
10690129|NCT02482428|11854316|FG004|NOT COMPLETED|Overall Study||7
10690130|NCT02482571|11854330|FG000|STARTED|Overall Study||25
10690131|NCT02482571|11854330|FG000|COMPLETED|Overall Study||17
10690132|NCT02482571|11854330|FG000|NOT COMPLETED|Overall Study||8
10690133|NCT02482610|11854335|FG000|STARTED|Overall Study||4
10690134|NCT02482610|11854336|FG001|STARTED|Overall Study||5
10690135|NCT02482610|11854337|FG002|STARTED|Overall Study||2
10690136|NCT02482610|11854338|FG003|STARTED|Overall Study||3
10690137|NCT02482610|11854339|FG004|STARTED|Overall Study||3
10690138|NCT02482610|11854340|FG005|STARTED|Overall Study||5
10690139|NCT02482610|11854335|FG000|COMPLETED|Overall Study||4
10690140|NCT02482610|11854336|FG001|COMPLETED|Overall Study||5
10690141|NCT02482610|11854337|FG002|COMPLETED|Overall Study||2
10690142|NCT02482610|11854338|FG003|COMPLETED|Overall Study||3
10690143|NCT02482610|11854339|FG004|COMPLETED|Overall Study||3
10690144|NCT02482610|11854340|FG005|COMPLETED|Overall Study||5
10690145|NCT02482610|11854335|FG000|NOT COMPLETED|Overall Study||0
10690146|NCT02482610|11854336|FG001|NOT COMPLETED|Overall Study||0
10690147|NCT02482610|11854337|FG002|NOT COMPLETED|Overall Study||0
10690148|NCT02482610|11854338|FG003|NOT COMPLETED|Overall Study||0
10690149|NCT02482610|11854339|FG004|NOT COMPLETED|Overall Study||0
10690150|NCT02482610|11854340|FG005|NOT COMPLETED|Overall Study||0
10690151|NCT02482675|11854351|FG000|STARTED|Overall Study||1
10690152|NCT02482675|11854352|FG001|STARTED|Overall Study||1
10690153|NCT02482675|11854353|FG002|STARTED|Overall Study||1
10690154|NCT02482675|11854354|FG003|STARTED|Overall Study||1
10690155|NCT02482675|11854355|FG004|STARTED|Overall Study||1
10690156|NCT02482675|11854356|FG005|STARTED|Overall Study||1
10690157|NCT02482675|11854357|FG006|STARTED|Overall Study||1
10690158|NCT02482675|11854358|FG007|STARTED|Overall Study||1
10690159|NCT02482675|11854359|FG008|STARTED|Overall Study||1
10690160|NCT02482675|11854360|FG009|STARTED|Overall Study||1
10690161|NCT02482675|11854361|FG010|STARTED|Overall Study||1
10690162|NCT02482675|11854362|FG011|STARTED|Overall Study||1
10690163|NCT02482675|11854363|FG012|STARTED|Overall Study||1
10690164|NCT02482675|11854364|FG013|STARTED|Overall Study||1
10690165|NCT02482675|11854365|FG014|STARTED|Overall Study||1
10690166|NCT02482675|11854366|FG015|STARTED|Overall Study||1
10690167|NCT02482675|11854367|FG016|STARTED|Overall Study||1
10690168|NCT02482675|11854368|FG017|STARTED|Overall Study||1
10690169|NCT02482675|11854369|FG018|STARTED|Overall Study||1
10690170|NCT02482675|11854370|FG019|STARTED|Overall Study||1
10690171|NCT02482675|11854371|FG020|STARTED|Overall Study||1
10690172|NCT02482675|11854372|FG021|STARTED|Overall Study||1
10690173|NCT02482675|11854373|FG022|STARTED|Overall Study||1
10690174|NCT02482675|11854351|FG000|COMPLETED|Overall Study||1
10690175|NCT02482675|11854352|FG001|COMPLETED|Overall Study||1
10690176|NCT02482675|11854353|FG002|COMPLETED|Overall Study||1
10690177|NCT02482675|11854354|FG003|COMPLETED|Overall Study||1
10690178|NCT02482675|11854355|FG004|COMPLETED|Overall Study||1
10690179|NCT02482675|11854356|FG005|COMPLETED|Overall Study||1
10690180|NCT02482675|11854357|FG006|COMPLETED|Overall Study||1
10690181|NCT02482675|11854358|FG007|COMPLETED|Overall Study||1
10690182|NCT02482675|11854359|FG008|COMPLETED|Overall Study||1
10690183|NCT02482675|11854360|FG009|COMPLETED|Overall Study||1
10690184|NCT02482675|11854361|FG010|COMPLETED|Overall Study||1
10690185|NCT02482675|11854362|FG011|COMPLETED|Overall Study||1
10690186|NCT02482675|11854363|FG012|COMPLETED|Overall Study||1
10690187|NCT02482675|11854364|FG013|COMPLETED|Overall Study||1
10690188|NCT02482675|11854365|FG014|COMPLETED|Overall Study||1
10690189|NCT02482675|11854366|FG015|COMPLETED|Overall Study||1
10690190|NCT02482675|11854367|FG016|COMPLETED|Overall Study||1
10690191|NCT02482675|11854368|FG017|COMPLETED|Overall Study||1
10690192|NCT02482675|11854369|FG018|COMPLETED|Overall Study||1
10690193|NCT02482675|11854370|FG019|COMPLETED|Overall Study||1
10690194|NCT02482675|11854371|FG020|COMPLETED|Overall Study||1
10690195|NCT02482675|11854372|FG021|COMPLETED|Overall Study||1
10690196|NCT02482675|11854373|FG022|COMPLETED|Overall Study||1
10690197|NCT02482675|11854351|FG000|NOT COMPLETED|Overall Study||0
10690198|NCT02482675|11854352|FG001|NOT COMPLETED|Overall Study||0
10690199|NCT02482675|11854353|FG002|NOT COMPLETED|Overall Study||0
10690200|NCT02482675|11854354|FG003|NOT COMPLETED|Overall Study||0
10800245|NCT04601103|11961175|FG000|COMPLETED|Overall Study||0
10800246|NCT04601103|11961176|FG001|COMPLETED|Overall Study||0
10800247|NCT04601103|11961177|FG002|COMPLETED|Overall Study||0
10800248|NCT04601103|11961175|FG000|NOT COMPLETED|Overall Study||18
10800249|NCT04601103|11961176|FG001|NOT COMPLETED|Overall Study||18
10800250|NCT04601103|11961177|FG002|NOT COMPLETED|Overall Study||17
10800251|NCT04617574|11961187|FG000|STARTED|Overall Study||30
10800252|NCT04617574|11961188|FG001|STARTED|Overall Study||30
10800253|NCT04617574|11961187|FG000|COMPLETED|Overall Study||30
10800254|NCT04617574|11961188|FG001|COMPLETED|Overall Study||30
10800255|NCT04617574|11961187|FG000|NOT COMPLETED|Overall Study||0
10800256|NCT04617574|11961188|FG001|NOT COMPLETED|Overall Study||0
10690201|NCT02482675|11854355|FG004|NOT COMPLETED|Overall Study||0
10690202|NCT02482675|11854356|FG005|NOT COMPLETED|Overall Study||0
10690203|NCT02482675|11854357|FG006|NOT COMPLETED|Overall Study||0
10690204|NCT02482675|11854358|FG007|NOT COMPLETED|Overall Study||0
10690205|NCT02482675|11854359|FG008|NOT COMPLETED|Overall Study||0
10690206|NCT02482675|11854360|FG009|NOT COMPLETED|Overall Study||0
10690207|NCT02482675|11854361|FG010|NOT COMPLETED|Overall Study||0
10690208|NCT02482675|11854362|FG011|NOT COMPLETED|Overall Study||0
10690209|NCT02482675|11854363|FG012|NOT COMPLETED|Overall Study||0
10690210|NCT02482675|11854364|FG013|NOT COMPLETED|Overall Study||0
10690211|NCT02482675|11854365|FG014|NOT COMPLETED|Overall Study||0
10690212|NCT02482675|11854366|FG015|NOT COMPLETED|Overall Study||0
10690213|NCT02482675|11854367|FG016|NOT COMPLETED|Overall Study||0
10690214|NCT02482675|11854368|FG017|NOT COMPLETED|Overall Study||0
10690215|NCT02482675|11854369|FG018|NOT COMPLETED|Overall Study||0
10690216|NCT02482675|11854370|FG019|NOT COMPLETED|Overall Study||0
10690217|NCT02482675|11854371|FG020|NOT COMPLETED|Overall Study||0
10690218|NCT02482675|11854372|FG021|NOT COMPLETED|Overall Study||0
10690219|NCT02482675|11854373|FG022|NOT COMPLETED|Overall Study||0
10690220|NCT02482805|11854386|FG000|STARTED|Overall Study||26
10690221|NCT02482805|11854387|FG001|STARTED|Overall Study||27
10690222|NCT02482805|11854388|FG002|STARTED|Overall Study||20
10690223|NCT02482805|11854386|FG000|COMPLETED|Overall Study||22
10690224|NCT02482805|11854387|FG001|COMPLETED|Overall Study||23
10690225|NCT02482805|11854388|FG002|COMPLETED|Overall Study||20
10690226|NCT02482805|11854386|FG000|NOT COMPLETED|Overall Study||4
10690227|NCT02482805|11854387|FG001|NOT COMPLETED|Overall Study||4
10690228|NCT02482805|11854388|FG002|NOT COMPLETED|Overall Study||0
10713262|NCT02677844|11878802|FG004|COMPLETED|Period 4||0
10713263|NCT02677844|11878803|FG005|COMPLETED|Period 4||0
10713264|NCT02677844|11878804|FG006|COMPLETED|Period 4||0
10713265|NCT02677844|11878798|FG000|NOT COMPLETED|Period 4||0
10713266|NCT02677844|11878799|FG001|NOT COMPLETED|Period 4||0
10713267|NCT02677844|11878800|FG002|NOT COMPLETED|Period 4||0
10713268|NCT02677844|11878801|FG003|NOT COMPLETED|Period 4||0
10713269|NCT02677844|11878802|FG004|NOT COMPLETED|Period 4||0
10713270|NCT02677844|11878803|FG005|NOT COMPLETED|Period 4||0
10800257|NCT04658797|11961196|FG000|STARTED|Overall Study||15
10800258|NCT04658797|11961197|FG001|STARTED|Overall Study||15
10800259|NCT04658797|11961196|FG000|COMPLETED|Overall Study||15
10800260|NCT04658797|11961197|FG001|COMPLETED|Overall Study||15
10800261|NCT04658797|11961196|FG000|NOT COMPLETED|Overall Study||0
10800262|NCT04658797|11961197|FG001|NOT COMPLETED|Overall Study||0
10800263|NCT04664855|11961205|FG000|STARTED|Overall Study||23
10800264|NCT04664855|11961206|FG001|STARTED|Overall Study||24
10800265|NCT04664855|11961205|FG000|COMPLETED|Overall Study||23
10800266|NCT04664855|11961206|FG001|COMPLETED|Overall Study||22
10800267|NCT04664855|11961205|FG000|NOT COMPLETED|Overall Study||0
10800268|NCT04664855|11961206|FG001|NOT COMPLETED|Overall Study||2
10713271|NCT02677844|11878804|FG006|NOT COMPLETED|Period 4||0
10713272|NCT02677844|11878798|FG000|STARTED|Period 4 (DDI)||0
10713273|NCT02677844|11878799|FG001|STARTED|Period 4 (DDI)||0
10713274|NCT02677844|11878800|FG002|STARTED|Period 4 (DDI)||0
10713275|NCT02677844|11878801|FG003|STARTED|Period 4 (DDI)||0
10713276|NCT02677844|11878802|FG004|STARTED|Period 4 (DDI)||7
10713277|NCT02677844|11878803|FG005|STARTED|Period 4 (DDI)||4
10713278|NCT02677844|11878804|FG006|STARTED|Period 4 (DDI)||4
10713279|NCT02677844|11878798|FG000|COMPLETED|Period 4 (DDI)||0
10713280|NCT02677844|11878799|FG001|COMPLETED|Period 4 (DDI)||0
10713281|NCT02677844|11878800|FG002|COMPLETED|Period 4 (DDI)||0
10713282|NCT02677844|11878801|FG003|COMPLETED|Period 4 (DDI)||0
10800269|NCT04701658|11961212|FG000|STARTED|Overall Study||109
10800270|NCT04701658|11961212|FG000|Received Single Dose of Bamlanivimab|Overall Study||109
10800271|NCT04701658|11961212|FG000|COMPLETED|Overall Study||103
10800272|NCT04701658|11961212|FG000|NOT COMPLETED|Overall Study||6
10800273|NCT04706416|11961218|FG000|STARTED|Overall Study||50
10800274|NCT04706416|11961219|FG001|STARTED|Overall Study||100
10800275|NCT04706416|11961218|FG000|COMPLETED|Overall Study||48
10800276|NCT04706416|11961219|FG001|COMPLETED|Overall Study||100
10800277|NCT04706416|11961218|FG000|NOT COMPLETED|Overall Study||2
10713283|NCT02677844|11878802|FG004|COMPLETED|Period 4 (DDI)||7
10713284|NCT02677844|11878803|FG005|COMPLETED|Period 4 (DDI)||4
10713285|NCT02677844|11878804|FG006|COMPLETED|Period 4 (DDI)||4
10713286|NCT02677844|11878798|FG000|NOT COMPLETED|Period 4 (DDI)||0
10713287|NCT02677844|11878799|FG001|NOT COMPLETED|Period 4 (DDI)||0
10713288|NCT02677844|11878800|FG002|NOT COMPLETED|Period 4 (DDI)||0
10713289|NCT02677844|11878801|FG003|NOT COMPLETED|Period 4 (DDI)||0
10713290|NCT02677844|11878802|FG004|NOT COMPLETED|Period 4 (DDI)||0
10800278|NCT04706416|11961219|FG001|NOT COMPLETED|Overall Study||0
10690229|NCT02482870|11854396|FG000|STARTED|Period 1 - First 60 Patients||30
10690230|NCT02482870|11854397|FG001|STARTED|Period 1 - First 60 Patients||30
10690231|NCT02482870|11854396|FG000|COMPLETED|Period 1 - First 60 Patients||30
10690232|NCT02482870|11854397|FG001|COMPLETED|Period 1 - First 60 Patients||30
10690233|NCT02482870|11854396|FG000|NOT COMPLETED|Period 1 - First 60 Patients||0
10690234|NCT02482870|11854397|FG001|NOT COMPLETED|Period 1 - First 60 Patients||0
10690235|NCT02482870|11854396|FG000|STARTED|Period 2 - Rest of the Study||186
10690236|NCT02482870|11854397|FG001|STARTED|Period 2 - Rest of the Study||202
10690237|NCT02482870|11854396|FG000|COMPLETED|Period 2 - Rest of the Study||186
10690238|NCT02482870|11854397|FG001|COMPLETED|Period 2 - Rest of the Study||202
10690239|NCT02482870|11854396|FG000|NOT COMPLETED|Period 2 - Rest of the Study||0
10690240|NCT02482870|11854397|FG001|NOT COMPLETED|Period 2 - Rest of the Study||0
10690241|NCT02482935|11854411|FG000|STARTED|Period 1||15
10690242|NCT02482935|11854412|FG001|STARTED|Period 1||15
10690243|NCT02482935|11854411|FG000|Received Abemaciclib|Period 1||15
10690244|NCT02482935|11854412|FG001|Received Abemaciclib|Period 1||15
10690245|NCT02482935|11854411|FG000|Washout|Period 1||15
10690246|NCT02482935|11854412|FG001|Washout|Period 1||15
10690247|NCT02482935|11854411|FG000|COMPLETED|Period 1||14
10690248|NCT02482935|11854412|FG001|COMPLETED|Period 1||15
10690249|NCT02482935|11854411|FG000|NOT COMPLETED|Period 1||1
10690250|NCT02482935|11854412|FG001|NOT COMPLETED|Period 1||0
10690251|NCT02482935|11854411|FG000|STARTED|Period 2||14
10690252|NCT02482935|11854412|FG001|STARTED|Period 2||15
10690253|NCT02482935|11854411|FG000|Received Abemaciclib|Period 2||14
10690254|NCT02482935|11854412|FG001|Received Abemaciclib|Period 2||15
10690255|NCT02482935|11854411|FG000|Follow-up|Period 2||14
10690256|NCT02482935|11854412|FG001|Follow-up|Period 2||15
10690257|NCT02482935|11854411|FG000|COMPLETED|Period 2||14
10690258|NCT02482935|11854412|FG001|COMPLETED|Period 2||15
10690259|NCT02482935|11854411|FG000|NOT COMPLETED|Period 2||0
10690260|NCT02482935|11854412|FG001|NOT COMPLETED|Period 2||0
10690261|NCT02483000|11854418|FG000|STARTED|Overall Study||3
10690262|NCT02483000|11854418|FG000|COMPLETED|Overall Study||3
10690263|NCT02483000|11854418|FG000|NOT COMPLETED|Overall Study||0
10690264|NCT02483416|11854427|FG000|STARTED|Overall Study||21
10690265|NCT02483416|11854428|FG001|STARTED|Overall Study||7
10690266|NCT02483416|11854427|FG000|COMPLETED|Overall Study||18
10690267|NCT02483416|11854428|FG001|COMPLETED|Overall Study||6
10690268|NCT02483416|11854427|FG000|NOT COMPLETED|Overall Study||3
10690269|NCT02483416|11854428|FG001|NOT COMPLETED|Overall Study||1
10690270|NCT02483520|11854437|FG000|STARTED|Overall Study||92
10690271|NCT02483520|11854438|FG001|STARTED|Overall Study||97
10690272|NCT02483520|11854437|FG000|Caregivers|Overall Study||50
10690273|NCT02483520|11854438|FG001|Caregivers|Overall Study||56
10690274|NCT02483520|11854437|FG000|Persons With Dementia|Overall Study||42
10690275|NCT02483520|11854438|FG001|Persons With Dementia|Overall Study||41
10690276|NCT02483520|11854437|FG000|COMPLETED|Overall Study||81
10690277|NCT02483520|11854438|FG001|COMPLETED|Overall Study||73
10690278|NCT02483520|11854437|FG000|NOT COMPLETED|Overall Study||11
10690279|NCT02483520|11854438|FG001|NOT COMPLETED|Overall Study||24
10690280|NCT02483572|11854446|FG000|STARTED|Overall Study||2
10690281|NCT02483572|11854447|FG001|STARTED|Overall Study||2
10690282|NCT02483572|11854446|FG000|COMPLETED|Overall Study||0
10690283|NCT02483572|11854447|FG001|COMPLETED|Overall Study||1
10690284|NCT02483572|11854446|FG000|NOT COMPLETED|Overall Study||2
10690285|NCT02483572|11854447|FG001|NOT COMPLETED|Overall Study||1
10690286|NCT02483611|11854456|FG000|STARTED|Overall Study||16
10690287|NCT02483611|11854457|FG001|STARTED|Overall Study||16
10690288|NCT02483611|11854458|FG002|STARTED|Overall Study||16
10690289|NCT02483611|11854456|FG000|COMPLETED|Overall Study||16
10690290|NCT02483611|11854457|FG001|COMPLETED|Overall Study||16
10690291|NCT02483611|11854458|FG002|COMPLETED|Overall Study|One patient required decurarization|15
10690292|NCT02483611|11854456|FG000|NOT COMPLETED|Overall Study||0
10690293|NCT02483611|11854457|FG001|NOT COMPLETED|Overall Study||0
10690294|NCT02483611|11854458|FG002|NOT COMPLETED|Overall Study||1
10690295|NCT02483676|11854468|FG000|STARTED|Overall Study||23
10690296|NCT02483676|11854469|FG001|STARTED|Overall Study||22
10690297|NCT02483676|11854468|FG000|COMPLETED|Overall Study||17
10690298|NCT02483676|11854469|FG001|COMPLETED|Overall Study||17
10690299|NCT02483676|11854468|FG000|NOT COMPLETED|Overall Study||6
10690300|NCT02483676|11854469|FG001|NOT COMPLETED|Overall Study||5
10690301|NCT02483975|11854477|FG000|STARTED|Overall Study||56
10690302|NCT02483975|11854478|FG001|STARTED|Overall Study||55
10690303|NCT02483975|11854477|FG000|COMPLETED|Overall Study||54
10690304|NCT02483975|11854478|FG001|COMPLETED|Overall Study|Subject reported as not completed due to AE was discontinued due to exacerbation, was not an AE/SAE|53
10690305|NCT02483975|11854477|FG000|NOT COMPLETED|Overall Study||2
10690306|NCT02483975|11854478|FG001|NOT COMPLETED|Overall Study||2
10690307|NCT02484092|11854487|FG000|STARTED|Overall Study||15
10690308|NCT02484092|11854487|FG000|COMPLETED|Overall Study||15
10690309|NCT02484092|11854487|FG000|NOT COMPLETED|Overall Study||0
10690310|NCT02484222|11854491|FG000|STARTED|Overall Study||80
10690311|NCT02484222|11854491|FG000|COMPLETED|Overall Study||77
10690312|NCT02484222|11854491|FG000|NOT COMPLETED|Overall Study||3
10690313|NCT02484547|11854500|FG000|STARTED|Placebo-Controlled Period||548
10690314|NCT02484547|11854501|FG001|STARTED|Placebo-Controlled Period||543
10690315|NCT02484547|11854502|FG002|STARTED|Placebo-Controlled Period||547
10690316|NCT02484547|11854503|FG003|STARTED|Placebo-Controlled Period||0
10690317|NCT02484547|11854504|FG004|STARTED|Placebo-Controlled Period||0
10690318|NCT02484547|11854505|FG005|STARTED|Placebo-Controlled Period||0
10690319|NCT02484547|11854506|FG006|STARTED|Placebo-Controlled Period||0
10690320|NCT02484547|11854500|FG000|COMPLETED|Placebo-Controlled Period||288
10690321|NCT02484547|11854501|FG001|COMPLETED|Placebo-Controlled Period||291
10690322|NCT02484547|11854502|FG002|COMPLETED|Placebo-Controlled Period||295
10690323|NCT02484547|11854503|FG003|COMPLETED|Placebo-Controlled Period||0
10690324|NCT02484547|11854504|FG004|COMPLETED|Placebo-Controlled Period||0
10690325|NCT02484547|11854505|FG005|COMPLETED|Placebo-Controlled Period||0
10690326|NCT02484547|11854506|FG006|COMPLETED|Placebo-Controlled Period||0
10690327|NCT02484547|11854500|FG000|NOT COMPLETED|Placebo-Controlled Period||260
10690328|NCT02484547|11854501|FG001|NOT COMPLETED|Placebo-Controlled Period||252
10690329|NCT02484547|11854502|FG002|NOT COMPLETED|Placebo-Controlled Period||252
10690330|NCT02484547|11854503|FG003|NOT COMPLETED|Placebo-Controlled Period||0
10690331|NCT02484547|11854504|FG004|NOT COMPLETED|Placebo-Controlled Period||0
10690332|NCT02484547|11854505|FG005|NOT COMPLETED|Placebo-Controlled Period||0
10690333|NCT02484547|11854506|FG006|NOT COMPLETED|Placebo-Controlled Period||0
10690334|NCT02484547|11854500|FG000|STARTED|Long-Term Extension Period||0
10690335|NCT02484547|11854501|FG001|STARTED|Long-Term Extension Period||0
10690336|NCT02484547|11854502|FG002|STARTED|Long-Term Extension Period||0
10690337|NCT02484547|11854503|FG003|STARTED|Long-Term Extension Period|11 PC completers did not enter LTE.|131
10690338|NCT02484547|11854504|FG004|STARTED|Long-Term Extension Period|14 PC completers did not enter LTE.|132
10690339|NCT02484547|11854505|FG005|STARTED|Long-Term Extension Period|40 PC completers did not enter LTE.|251
10690340|NCT02484547|11854506|FG006|STARTED|Long-Term Extension Period|38 PC completers did not enter LTE.|257
10690341|NCT02484547|11854500|FG000|COMPLETED|Long-Term Extension Period||0
10690342|NCT02484547|11854501|FG001|COMPLETED|Long-Term Extension Period||0
10690343|NCT02484547|11854502|FG002|COMPLETED|Long-Term Extension Period||0
10690344|NCT02484547|11854503|FG003|COMPLETED|Long-Term Extension Period||0
10690345|NCT02484547|11854504|FG004|COMPLETED|Long-Term Extension Period||0
10690346|NCT02484547|11854505|FG005|COMPLETED|Long-Term Extension Period||0
10690347|NCT02484547|11854506|FG006|COMPLETED|Long-Term Extension Period||0
10690348|NCT02484547|11854500|FG000|NOT COMPLETED|Long-Term Extension Period||0
10690349|NCT02484547|11854501|FG001|NOT COMPLETED|Long-Term Extension Period||0
10690350|NCT02484547|11854502|FG002|NOT COMPLETED|Long-Term Extension Period||0
10690351|NCT02484547|11854503|FG003|NOT COMPLETED|Long-Term Extension Period||131
10690352|NCT02484547|11854504|FG004|NOT COMPLETED|Long-Term Extension Period||132
10690353|NCT02484547|11854505|FG005|NOT COMPLETED|Long-Term Extension Period||251
10690354|NCT02484547|11854506|FG006|NOT COMPLETED|Long-Term Extension Period||257
10690355|NCT02484651|11854520|FG000|STARTED|Overall Study|35 patients were randomized|35
10690356|NCT02484651|11854521|FG001|STARTED|Overall Study|35 patients were randomized|35
10690357|NCT02484651|11854520|FG000|End of Clinical Study|Overall Study||35
10690358|NCT02484651|11854521|FG001|End of Clinical Study|Overall Study||35
10690359|NCT02484651|11854520|FG000|Data Analysis|Overall Study||32
10690360|NCT02484651|11854521|FG001|Data Analysis|Overall Study||31
10690361|NCT02484651|11854520|FG000|COMPLETED|Overall Study||32
10690362|NCT02484651|11854521|FG001|COMPLETED|Overall Study||31
10690363|NCT02484651|11854520|FG000|NOT COMPLETED|Overall Study||3
10690364|NCT02484651|11854521|FG001|NOT COMPLETED|Overall Study||4
10690365|NCT02484690|11854533|FG000|STARTED|Overall Study||68
10690366|NCT02484690|11854534|FG001|STARTED|Overall Study||46
10690367|NCT02484690|11854535|FG002|STARTED|Overall Study||39
10690368|NCT02484690|11854536|FG003|STARTED|Overall Study||46
10690369|NCT02484690|11854537|FG004|STARTED|Overall Study||64
10690370|NCT02484690|11854533|FG000|Received at Least One Dose of Study Drug|Overall Study||67
10690371|NCT02484690|11854534|FG001|Received at Least One Dose of Study Drug|Overall Study||46
10690372|NCT02484690|11854535|FG002|Received at Least One Dose of Study Drug|Overall Study||39
10690373|NCT02484690|11854536|FG003|Received at Least One Dose of Study Drug|Overall Study||46
10690374|NCT02484690|11854537|FG004|Received at Least One Dose of Study Drug|Overall Study||64
10690375|NCT02484690|11854533|FG000|COMPLETED|Overall Study||64
10690376|NCT02484690|11854534|FG001|COMPLETED|Overall Study||40
10690377|NCT02484690|11854535|FG002|COMPLETED|Overall Study||36
10690378|NCT02484690|11854536|FG003|COMPLETED|Overall Study||44
10690379|NCT02484690|11854537|FG004|COMPLETED|Overall Study||58
10690380|NCT02484690|11854533|FG000|NOT COMPLETED|Overall Study||4
10690381|NCT02484690|11854534|FG001|NOT COMPLETED|Overall Study||6
10690382|NCT02484690|11854535|FG002|NOT COMPLETED|Overall Study||3
10690383|NCT02484690|11854536|FG003|NOT COMPLETED|Overall Study||2
10690384|NCT02484690|11854537|FG004|NOT COMPLETED|Overall Study||6
10690385|NCT02484729|11854560|FG000|STARTED|Overall Study||16
10690386|NCT02484729|11854561|FG001|STARTED|Overall Study||6
10690387|NCT02484729|11854562|FG002|STARTED|Overall Study||6
10690388|NCT02484729|11854563|FG003|STARTED|Overall Study||6
10690389|NCT02484729|11854564|FG004|STARTED|Overall Study||5
10690390|NCT02484729|11854565|FG005|STARTED|Overall Study||6
10690391|NCT02484729|11854566|FG006|STARTED|Overall Study||5
10690392|NCT02484729|11854567|FG007|STARTED|Overall Study||6
10690393|NCT02484729|11854568|FG008|STARTED|Overall Study||6
10690394|NCT02484729|11854569|FG009|STARTED|Overall Study||8
10690395|NCT02484729|11854560|FG000|COMPLETED|Overall Study||16
10690396|NCT02484729|11854561|FG001|COMPLETED|Overall Study||6
10690397|NCT02484729|11854562|FG002|COMPLETED|Overall Study||6
10690398|NCT02484729|11854563|FG003|COMPLETED|Overall Study||6
10690399|NCT02484729|11854564|FG004|COMPLETED|Overall Study||5
10690400|NCT02484729|11854565|FG005|COMPLETED|Overall Study||6
10690401|NCT02484729|11854566|FG006|COMPLETED|Overall Study||5
10690402|NCT02484729|11854567|FG007|COMPLETED|Overall Study||6
10690403|NCT02484729|11854568|FG008|COMPLETED|Overall Study||6
10690404|NCT02484729|11854569|FG009|COMPLETED|Overall Study||7
10690405|NCT02484729|11854560|FG000|NOT COMPLETED|Overall Study||0
10690406|NCT02484729|11854561|FG001|NOT COMPLETED|Overall Study||0
10690407|NCT02484729|11854562|FG002|NOT COMPLETED|Overall Study||0
10690408|NCT02484729|11854563|FG003|NOT COMPLETED|Overall Study||0
10690409|NCT02484729|11854564|FG004|NOT COMPLETED|Overall Study||0
10690410|NCT02484729|11854565|FG005|NOT COMPLETED|Overall Study||0
10690411|NCT02484729|11854566|FG006|NOT COMPLETED|Overall Study||0
10690412|NCT02484729|11854567|FG007|NOT COMPLETED|Overall Study||0
10690413|NCT02484729|11854568|FG008|NOT COMPLETED|Overall Study||0
10690414|NCT02484729|11854569|FG009|NOT COMPLETED|Overall Study||1
10690415|NCT02484807|11854609|FG000|STARTED|Overall Study||39
10690416|NCT02484807|11854610|FG001|STARTED|Overall Study||7
10690417|NCT02484807|11854611|FG002|STARTED|Overall Study||19
10690418|NCT02484807|11854612|FG003|STARTED|Overall Study||21
10690419|NCT02484807|11854613|FG004|STARTED|Overall Study||33
10690420|NCT02484807|11854614|FG005|STARTED|Overall Study||6
10690421|NCT02484807|11854609|FG000|COMPLETED|Overall Study||39
10690422|NCT02484807|11854610|FG001|COMPLETED|Overall Study||7
10690423|NCT02484807|11854611|FG002|COMPLETED|Overall Study||19
10690424|NCT02484807|11854612|FG003|COMPLETED|Overall Study||21
10690425|NCT02484807|11854613|FG004|COMPLETED|Overall Study||33
10690426|NCT02484807|11854614|FG005|COMPLETED|Overall Study||6
10690427|NCT02484807|11854609|FG000|NOT COMPLETED|Overall Study||0
10690428|NCT02484807|11854610|FG001|NOT COMPLETED|Overall Study||0
10690429|NCT02484807|11854611|FG002|NOT COMPLETED|Overall Study||0
10690430|NCT02484807|11854612|FG003|NOT COMPLETED|Overall Study||0
10690431|NCT02484807|11854613|FG004|NOT COMPLETED|Overall Study||0
10690432|NCT02484807|11854614|FG005|NOT COMPLETED|Overall Study||0
10690433|NCT02484859|11854631|FG000|STARTED|Overall Study||44
10690434|NCT02484859|11854632|FG001|STARTED|Overall Study||44
10690435|NCT02484859|11854631|FG000|COMPLETED|Overall Study||44
10690436|NCT02484859|11854632|FG001|COMPLETED|Overall Study||44
10690437|NCT02484859|11854631|FG000|NOT COMPLETED|Overall Study||0
10690438|NCT02484859|11854632|FG001|NOT COMPLETED|Overall Study||0
10690439|NCT02484898|11854640|FG000|STARTED|Overall Study||200
10690440|NCT02484898|11854640|FG000|COMPLETED|Overall Study||182
10690441|NCT02484898|11854640|FG000|NOT COMPLETED|Overall Study||18
10690442|NCT02484911|11854646|FG000|STARTED|Overall Study||60
10690443|NCT02484911|11854647|FG001|STARTED|Overall Study||60
10690444|NCT02484911|11854646|FG000|COMPLETED|Overall Study||56
10690445|NCT02484911|11854647|FG001|COMPLETED|Overall Study||58
10690446|NCT02484911|11854646|FG000|NOT COMPLETED|Overall Study||4
10690447|NCT02484911|11854647|FG001|NOT COMPLETED|Overall Study||2
10690448|NCT02485158|11854654|FG000|STARTED|Overall Study||28
10690449|NCT02485158|11854654|FG000|COMPLETED|Overall Study||24
10690450|NCT02485158|11854654|FG000|NOT COMPLETED|Overall Study||4
10690451|NCT02485301|11854665|FG000|STARTED|Overall Study||1509
10690452|NCT02485301|11854666|FG001|STARTED|Overall Study||1504
10690453|NCT02485301|11854665|FG000|COMPLETED|Overall Study||1471
10690454|NCT02485301|11854666|FG001|COMPLETED|Overall Study||1455
10690455|NCT02485301|11854665|FG000|NOT COMPLETED|Overall Study||38
10690456|NCT02485301|11854666|FG001|NOT COMPLETED|Overall Study||49
10690457|NCT02485353|11854672|FG000|STARTED|Overall Study||2
10690458|NCT02485353|11854672|FG000|COMPLETED|Overall Study||0
10690459|NCT02485353|11854672|FG000|NOT COMPLETED|Overall Study||2
10690460|NCT02485483|11854678|FG000|STARTED|Overall Study||277
10690461|NCT02485483|11854679|FG001|STARTED|Overall Study||1015
10690462|NCT02485483|11854678|FG000|COMPLETED|Overall Study||223
10690463|NCT02485483|11854679|FG001|COMPLETED|Overall Study||1015
10690464|NCT02485483|11854678|FG000|NOT COMPLETED|Overall Study||54
10690465|NCT02485483|11854679|FG001|NOT COMPLETED|Overall Study||0
10690466|NCT02485561|11854688|FG000|STARTED|Overall Study||161
10690467|NCT02485561|11854689|FG001|STARTED|Overall Study||157
10690468|NCT02485561|11854690|FG002|STARTED|Overall Study||159
10690469|NCT02485561|11854688|FG000|Completed 1 mo Survey|Overall Study||145
10690470|NCT02485561|11854689|FG001|Completed 1 mo Survey|Overall Study||138
10690471|NCT02485561|11854690|FG002|Completed 1 mo Survey|Overall Study||144
10690472|NCT02485561|11854688|FG000|COMPLETED|Overall Study||133
10690473|NCT02485561|11854689|FG001|COMPLETED|Overall Study||118
10690474|NCT02485561|11854690|FG002|COMPLETED|Overall Study||136
10690475|NCT02485561|11854688|FG000|NOT COMPLETED|Overall Study||28
10690476|NCT02485561|11854689|FG001|NOT COMPLETED|Overall Study||39
10690477|NCT02485561|11854690|FG002|NOT COMPLETED|Overall Study||23
10690478|NCT02485704|11854700|FG000|STARTED|Overall Study||154
10690479|NCT02485704|11854701|FG001|STARTED|Overall Study||126
10690480|NCT02485704|11854700|FG000|COMPLETED|Overall Study||149
10690481|NCT02485704|11854701|FG001|COMPLETED|Overall Study||118
10690482|NCT02485704|11854700|FG000|NOT COMPLETED|Overall Study||5
10690483|NCT02485704|11854701|FG001|NOT COMPLETED|Overall Study||8
10690484|NCT02485717|11854710|FG000|STARTED|Overall Study||142
10690485|NCT02485717|11854711|FG001|STARTED|Overall Study||129
10690486|NCT02485717|11854712|FG002|STARTED|Overall Study||20
10690487|NCT02485717|11854710|FG000|COMPLETED|Overall Study||136
10690488|NCT02485717|11854711|FG001|COMPLETED|Overall Study||127
10690489|NCT02485717|11854712|FG002|COMPLETED|Overall Study||19
10690490|NCT02485717|11854710|FG000|NOT COMPLETED|Overall Study||6
10690491|NCT02485717|11854711|FG001|NOT COMPLETED|Overall Study||2
10690492|NCT02485717|11854712|FG002|NOT COMPLETED|Overall Study||1
10690493|NCT02485834|11854720|FG000|STARTED|Overall Study||3
10690494|NCT02485834|11854721|FG001|STARTED|Overall Study||2
10690495|NCT02485834|11854720|FG000|COMPLETED|Overall Study||3
10690496|NCT02485834|11854721|FG001|COMPLETED|Overall Study||2
10690497|NCT02485834|11854720|FG000|NOT COMPLETED|Overall Study||0
10690498|NCT02485834|11854721|FG001|NOT COMPLETED|Overall Study||0
10690499|NCT02485912|11854728|FG000|STARTED|Overall Study||20
10690500|NCT02485912|11854729|FG001|STARTED|Overall Study||20
10690501|NCT02485912|11854728|FG000|COMPLETED|Overall Study||20
10690502|NCT02485912|11854729|FG001|COMPLETED|Overall Study||20
10690503|NCT02485912|11854728|FG000|NOT COMPLETED|Overall Study||0
10690504|NCT02485912|11854729|FG001|NOT COMPLETED|Overall Study||0
10690505|NCT02485925|11854735|FG000|STARTED|Overall Study||200
10690506|NCT02485925|11854735|FG000|Safety Population|Overall Study||200
10690507|NCT02485925|11854735|FG000|Intent to Treat (ITT) Population|Overall Study||193
10690508|NCT02485925|11854735|FG000|Per-Protocol Population|Overall Study||166
10690509|NCT02485925|11854735|FG000|COMPLETED|Overall Study||185
10690510|NCT02485925|11854735|FG000|NOT COMPLETED|Overall Study||15
10690511|NCT02485964|11854739|FG000|STARTED|Overall Study||10
10690512|NCT02485964|11854739|FG000|COMPLETED|Overall Study||10
10690513|NCT02485964|11854739|FG000|NOT COMPLETED|Overall Study||0
10690514|NCT02486016|11854743|FG000|STARTED|Overall Study|Same 10 volunteers completed Apotex, Duragesic and Mylan arms of the study; crossover study.|10
10690515|NCT02486016|11854743|FG000|COMPLETED|Overall Study||10
10690516|NCT02486016|11854743|FG000|NOT COMPLETED|Overall Study||0
10690517|NCT02486211|11854753|FG000|STARTED|Overall Study||7
10690518|NCT02486211|11854754|FG001|STARTED|Overall Study||7
10690519|NCT02486211|11854753|FG000|COMPLETED|Overall Study||6
10690520|NCT02486211|11854754|FG001|COMPLETED|Overall Study||7
10690521|NCT02486211|11854753|FG000|NOT COMPLETED|Overall Study||1
10690522|NCT02486211|11854754|FG001|NOT COMPLETED|Overall Study||0
10690523|NCT02486263|11854763|FG000|STARTED|Overall Study||40
10690524|NCT02486263|11854764|FG001|STARTED|Overall Study||36
10690525|NCT02486263|11854763|FG000|COMPLETED|Overall Study||37
10690526|NCT02486263|11854764|FG001|COMPLETED|Overall Study||35
10690527|NCT02486263|11854763|FG000|NOT COMPLETED|Overall Study||3
10690528|NCT02486263|11854764|FG001|NOT COMPLETED|Overall Study||1
10690529|NCT02486302|11854772|FG000|STARTED|Overall Study||1534
10690530|NCT02486302|11854772|FG000|Treated|Overall Study||1523
10690531|NCT02486302|11854772|FG000|COMPLETED|Overall Study||858
10455360|NCT01001442|11603418|FG001|NOT COMPLETED|Overall Study||0
10455361|NCT01001442|11603419|FG002|NOT COMPLETED|Overall Study||0
10455362|NCT01001442|11603420|FG003|NOT COMPLETED|Overall Study||0
10455363|NCT01001442|11603421|FG004|NOT COMPLETED|Overall Study||2
10455364|NCT01001442|11603422|FG005|NOT COMPLETED|Overall Study||0
10455365|NCT01001442|11603423|FG006|NOT COMPLETED|Overall Study||4
10455366|NCT01001442|11603424|FG007|NOT COMPLETED|Overall Study||2
10455367|NCT01001494|11603449|FG000|STARTED|Overall Study|280 patients were randomized, but baseline data was missing from 3 patients in one center|277
10455368|NCT01001494|11603450|FG001|STARTED|Overall Study|272 patients were randomized, but baseline data was missing from 3 patients in one center|269
10690532|NCT02486302|11854772|FG000|NOT COMPLETED|Overall Study||676
10690533|NCT02486328|11854787|FG000|STARTED|Overall Study||52
10690534|NCT02486328|11854788|FG001|STARTED|Overall Study||51
10690535|NCT02486328|11854787|FG000|COMPLETED|Overall Study||50
10690536|NCT02486328|11854788|FG001|COMPLETED|Overall Study||50
10690537|NCT02486328|11854787|FG000|NOT COMPLETED|Overall Study||2
10690538|NCT02486328|11854788|FG001|NOT COMPLETED|Overall Study||1
10690539|NCT02486406|11854798|FG000|STARTED|Overall Study||12
10690540|NCT02486406|11854799|FG001|STARTED|Overall Study||26
10690541|NCT02486406|11854800|FG002|STARTED|Overall Study||12
10690542|NCT02486406|11854801|FG003|STARTED|Overall Study||14
10690543|NCT02486406|11854798|FG000|COMPLETED|Overall Study||10
10690544|NCT02486406|11854799|FG001|COMPLETED|Overall Study||23
10690545|NCT02486406|11854800|FG002|COMPLETED|Overall Study||10
10690546|NCT02486406|11854801|FG003|COMPLETED|Overall Study||10
10690547|NCT02486406|11854798|FG000|NOT COMPLETED|Overall Study||2
10690548|NCT02486406|11854799|FG001|NOT COMPLETED|Overall Study||3
10690549|NCT02486406|11854800|FG002|NOT COMPLETED|Overall Study||2
10690550|NCT02486406|11854801|FG003|NOT COMPLETED|Overall Study||4
10690551|NCT02486588|11854839|FG000|STARTED|Overall Study||1188
10690552|NCT02486588|11854840|FG001|STARTED|Overall Study||1252
10690553|NCT02486588|11854841|FG002|STARTED|Overall Study||1220
10690554|NCT02486588|11854842|FG003|STARTED|Overall Study||1206
10690555|NCT02486588|11854843|FG004|STARTED|Overall Study||1243
10690556|NCT02486588|11854844|FG005|STARTED|Overall Study||1205
10690557|NCT02486588|11854839|FG000|COMPLETED|Overall Study||450
10690558|NCT02486588|11854840|FG001|COMPLETED|Overall Study||502
10690559|NCT02486588|11854841|FG002|COMPLETED|Overall Study||465
10690560|NCT02486588|11854842|FG003|COMPLETED|Overall Study||468
10690561|NCT02486588|11854843|FG004|COMPLETED|Overall Study||497
10690562|NCT02486588|11854844|FG005|COMPLETED|Overall Study||459
10690563|NCT02486588|11854839|FG000|NOT COMPLETED|Overall Study||738
10690564|NCT02486588|11854840|FG001|NOT COMPLETED|Overall Study||750
10690565|NCT02486588|11854841|FG002|NOT COMPLETED|Overall Study||755
10690566|NCT02486588|11854842|FG003|NOT COMPLETED|Overall Study||738
10690567|NCT02486588|11854843|FG004|NOT COMPLETED|Overall Study||746
10690568|NCT02486588|11854844|FG005|NOT COMPLETED|Overall Study||746
10690569|NCT02486627|11854865|FG000|STARTED|Overall Study||306
10690570|NCT02486627|11854866|FG001|STARTED|Overall Study||303
10690571|NCT02486627|11854865|FG000|COMPLETED|Overall Study||299
10690572|NCT02486627|11854866|FG001|COMPLETED|Overall Study||294
10455369|NCT01001494|11603451|FG002|STARTED|Overall Study|276 patients were randomized, but baseline data was missing from 3 patients in one center|273
10690573|NCT02486627|11854865|FG000|NOT COMPLETED|Overall Study||7
10690574|NCT02486627|11854866|FG001|NOT COMPLETED|Overall Study||9
10690575|NCT02486653|11854874|FG000|STARTED|Overall Study||76
10690576|NCT02486653|11854875|FG001|STARTED|Overall Study||75
10690577|NCT02486653|11854874|FG000|COMPLETED|Overall Study||70
10690578|NCT02486653|11854875|FG001|COMPLETED|Overall Study||71
10690579|NCT02486653|11854874|FG000|NOT COMPLETED|Overall Study||6
10690580|NCT02486653|11854875|FG001|NOT COMPLETED|Overall Study||4
10690581|NCT02486692|11854883|FG000|STARTED|Overall Study||30
10690582|NCT02486692|11854884|FG001|STARTED|Overall Study||30
10690583|NCT02486692|11854883|FG000|COMPLETED|Overall Study||26
10690584|NCT02486692|11854884|FG001|COMPLETED|Overall Study||23
10690585|NCT02486692|11854883|FG000|NOT COMPLETED|Overall Study||4
10690586|NCT02486692|11854884|FG001|NOT COMPLETED|Overall Study||7
10690587|NCT02486757|11854890|FG000|STARTED|Overall Study||6
10690588|NCT02486757|11854890|FG000|COMPLETED|Overall Study||5
10690589|NCT02486757|11854890|FG000|NOT COMPLETED|Overall Study||1
10690590|NCT02486796|11854896|FG000|STARTED|Overall Study||3
10690591|NCT02486796|11854897|FG001|STARTED|Overall Study||2
10690592|NCT02486796|11854896|FG000|COMPLETED|Overall Study||1
10690593|NCT02486796|11854897|FG001|COMPLETED|Overall Study||1
10690594|NCT02486796|11854896|FG000|NOT COMPLETED|Overall Study||2
10690595|NCT02486796|11854897|FG001|NOT COMPLETED|Overall Study||1
10690596|NCT02486939|11854905|FG000|STARTED|Overall Study||225
10690597|NCT02486939|11854906|FG001|STARTED|Overall Study||134
10690598|NCT02486939|11854905|FG000|COMPLETED|Overall Study||224
10690599|NCT02486939|11854906|FG001|COMPLETED|Overall Study||132
10690600|NCT02486939|11854905|FG000|NOT COMPLETED|Overall Study||1
10690601|NCT02486939|11854906|FG001|NOT COMPLETED|Overall Study||2
10690602|NCT02486952|11854912|FG000|STARTED|Overall Study||154
10690603|NCT02486952|11854912|FG000|Started Induction Therapy|Overall Study||151
10690604|NCT02486952|11854912|FG000|COMPLETED|Overall Study||104
10690605|NCT02486952|11854912|FG000|NOT COMPLETED|Overall Study||50
10690606|NCT02487030|11854923|FG000|STARTED|Overall Study||43
10690607|NCT02487030|11854924|FG001|STARTED|Overall Study||42
10690608|NCT02487030|11854925|FG002|STARTED|Overall Study||43
10690609|NCT02487030|11854926|FG003|STARTED|Overall Study||42
10690610|NCT02487030|11854927|FG004|STARTED|Overall Study||36
10690611|NCT02487030|11854928|FG005|STARTED|Overall Study||38
10690612|NCT02487030|11854929|FG006|STARTED|Overall Study||11
10690613|NCT02487030|11854923|FG000|COMPLETED|Overall Study||41
10690614|NCT02487030|11854924|FG001|COMPLETED|Overall Study||38
10690615|NCT02487030|11854925|FG002|COMPLETED|Overall Study||41
10690616|NCT02487030|11854926|FG003|COMPLETED|Overall Study||40
10690617|NCT02487030|11854927|FG004|COMPLETED|Overall Study||34
10690618|NCT02487030|11854928|FG005|COMPLETED|Overall Study||37
10690619|NCT02487030|11854929|FG006|COMPLETED|Overall Study||11
10690620|NCT02487030|11854923|FG000|NOT COMPLETED|Overall Study||2
10690621|NCT02487030|11854924|FG001|NOT COMPLETED|Overall Study||4
10690622|NCT02487030|11854925|FG002|NOT COMPLETED|Overall Study||2
10690623|NCT02487030|11854926|FG003|NOT COMPLETED|Overall Study||2
10690624|NCT02487030|11854927|FG004|NOT COMPLETED|Overall Study||2
10690625|NCT02487030|11854928|FG005|NOT COMPLETED|Overall Study||1
10690626|NCT02487030|11854929|FG006|NOT COMPLETED|Overall Study||0
10690627|NCT02487056|11854946|FG000|STARTED|Overall Study||1622
10690628|NCT02487056|11854946|FG000|COMPLETED|Overall Study||1606
10690629|NCT02487056|11854946|FG000|NOT COMPLETED|Overall Study||16
10690630|NCT02487199|11854953|FG000|STARTED|Overall Study||13
10690631|NCT02487199|11854954|FG001|STARTED|Overall Study||5
10690632|NCT02487199|11854953|FG000|COMPLETED|Overall Study||13
10690633|NCT02487199|11854954|FG001|COMPLETED|Overall Study||4
10690634|NCT02487199|11854953|FG000|NOT COMPLETED|Overall Study||0
10690635|NCT02487199|11854954|FG001|NOT COMPLETED|Overall Study||1
10690636|NCT02487225|11854962|FG000|STARTED|Overall Study||45
10690637|NCT02487225|11854963|FG001|STARTED|Overall Study||38
10690638|NCT02487225|11854962|FG000|COMPLETED|Overall Study||18
10690639|NCT02487225|11854963|FG001|COMPLETED|Overall Study||8
10690640|NCT02487225|11854962|FG000|NOT COMPLETED|Overall Study||27
10690641|NCT02487225|11854963|FG001|NOT COMPLETED|Overall Study||30
10690642|NCT02487303|11854972|FG000|STARTED|Overall Study||49
10690643|NCT02487303|11854973|FG001|STARTED|Overall Study||51
10690644|NCT02487303|11854974|FG002|STARTED|Overall Study||48
10690645|NCT02487303|11854972|FG000|COMPLETED|Overall Study||47
10690646|NCT02487303|11854973|FG001|COMPLETED|Overall Study||47
10690647|NCT02487303|11854974|FG002|COMPLETED|Overall Study||47
10690648|NCT02487303|11854972|FG000|NOT COMPLETED|Overall Study||2
10690649|NCT02487303|11854973|FG001|NOT COMPLETED|Overall Study||4
10690650|NCT02487303|11854974|FG002|NOT COMPLETED|Overall Study||1
10690651|NCT02487446|11854985|FG000|STARTED|Period 1||178
10690652|NCT02487446|11854986|FG001|STARTED|Period 1||179
10690653|NCT02487446|11854985|FG000|COMPLETED|Period 1||165
10690654|NCT02487446|11854986|FG001|COMPLETED|Period 1||171
10690655|NCT02487446|11854985|FG000|NOT COMPLETED|Period 1||13
10690656|NCT02487446|11854986|FG001|NOT COMPLETED|Period 1||8
10690657|NCT02487446|11854985|FG000|STARTED|Washout||165
10690658|NCT02487446|11854986|FG001|STARTED|Washout||171
10690659|NCT02487446|11854985|FG000|COMPLETED|Washout||162
10690660|NCT02487446|11854986|FG001|COMPLETED|Washout||163
10690661|NCT02487446|11854985|FG000|NOT COMPLETED|Washout||3
10690662|NCT02487446|11854986|FG001|NOT COMPLETED|Washout||8
10690663|NCT02487446|11854985|FG000|STARTED|Period 2||162
10690664|NCT02487446|11854986|FG001|STARTED|Period 2||163
10690665|NCT02487446|11854985|FG000|COMPLETED|Period 2||154
10690666|NCT02487446|11854986|FG001|COMPLETED|Period 2||158
10690667|NCT02487446|11854985|FG000|NOT COMPLETED|Period 2||8
10690668|NCT02487446|11854986|FG001|NOT COMPLETED|Period 2||5
10690669|NCT02487472|11854993|FG000|STARTED|Overall Study||101
10690670|NCT02487472|11854993|FG000|COMPLETED|Overall Study||90
10690671|NCT02487472|11854993|FG000|NOT COMPLETED|Overall Study||11
10690672|NCT02487485|11855001|FG000|STARTED|Overall Study||12
10690673|NCT02487485|11855002|FG001|STARTED|Overall Study||11
10690674|NCT02487485|11855001|FG000|COMPLETED|Overall Study||9
10690675|NCT02487485|11855002|FG001|COMPLETED|Overall Study||8
10690676|NCT02487485|11855001|FG000|NOT COMPLETED|Overall Study||3
10690677|NCT02487485|11855002|FG001|NOT COMPLETED|Overall Study||3
10690678|NCT02487498|11855008|FG000|STARTED|Period: Period 1||178
10690679|NCT02487498|11855009|FG001|STARTED|Period: Period 1||177
10690680|NCT02487498|11855008|FG000|COMPLETED|Period: Period 1||172
10690681|NCT02487498|11855009|FG001|COMPLETED|Period: Period 1||166
10690682|NCT02487498|11855008|FG000|NOT COMPLETED|Period: Period 1||6
10690683|NCT02487498|11855009|FG001|NOT COMPLETED|Period: Period 1||11
10690684|NCT02487498|11855008|FG000|STARTED|Period: Washout||172
10690685|NCT02487498|11855009|FG001|STARTED|Period: Washout||166
10690686|NCT02487498|11855008|FG000|COMPLETED|Period: Washout||170
10690687|NCT02487498|11855009|FG001|COMPLETED|Period: Washout||159
10690688|NCT02487498|11855008|FG000|NOT COMPLETED|Period: Washout||2
10690689|NCT02487498|11855009|FG001|NOT COMPLETED|Period: Washout||7
10690690|NCT02487498|11855008|FG000|STARTED|Period: Period 2||170
10690691|NCT02487498|11855009|FG001|STARTED|Period: Period 2||159
10690692|NCT02487498|11855008|FG000|COMPLETED|Period: Period 2||164
10455370|NCT01001494|11603449|FG000|COMPLETED|Overall Study||253
10455371|NCT01001494|11603450|FG001|COMPLETED|Overall Study||252
10455372|NCT01001494|11603451|FG002|COMPLETED|Overall Study||232
10455373|NCT01001494|11603449|FG000|NOT COMPLETED|Overall Study||24
10455374|NCT01001494|11603450|FG001|NOT COMPLETED|Overall Study||17
10455375|NCT01001494|11603451|FG002|NOT COMPLETED|Overall Study||41
10455376|NCT01001520|11603459|FG000|STARTED|Medication Period 1||22
10455377|NCT01001520|11603460|FG001|STARTED|Medication Period 1||24
10455378|NCT01001520|11603459|FG000|COMPLETED|Medication Period 1||18
10455379|NCT01001520|11603460|FG001|COMPLETED|Medication Period 1||17
10455380|NCT01001520|11603459|FG000|NOT COMPLETED|Medication Period 1||4
10455381|NCT01001520|11603460|FG001|NOT COMPLETED|Medication Period 1||7
10455382|NCT01001520|11603459|FG000|STARTED|Washout Period||18
10455383|NCT01001520|11603460|FG001|STARTED|Washout Period||17
10455384|NCT01001520|11603459|FG000|COMPLETED|Washout Period||16
10690693|NCT02487498|11855009|FG001|COMPLETED|Period: Period 2||154
10690694|NCT02487498|11855008|FG000|NOT COMPLETED|Period: Period 2||6
10690695|NCT02487498|11855009|FG001|NOT COMPLETED|Period: Period 2||5
10690696|NCT02487563|11855019|FG000|STARTED|Overall Study||32
10690697|NCT02487563|11855020|FG001|STARTED|Overall Study||33
10690698|NCT02487563|11855021|FG002|STARTED|Overall Study||32
10690699|NCT02487563|11855019|FG000|COMPLETED|Overall Study||30
10690700|NCT02487563|11855020|FG001|COMPLETED|Overall Study||30
10690701|NCT02487563|11855021|FG002|COMPLETED|Overall Study||31
10690702|NCT02487563|11855019|FG000|NOT COMPLETED|Overall Study||2
10690703|NCT02487563|11855020|FG001|NOT COMPLETED|Overall Study||3
10690704|NCT02487563|11855021|FG002|NOT COMPLETED|Overall Study||1
10690705|NCT02487771|11855034|FG000|STARTED|Overall Study||91
10690706|NCT02487771|11855035|FG001|STARTED|Overall Study||99
10690707|NCT02487771|11855034|FG000|COMPLETED|Overall Study||81
10690708|NCT02487771|11855035|FG001|COMPLETED|Overall Study||85
10690709|NCT02487771|11855034|FG000|NOT COMPLETED|Overall Study||10
10690710|NCT02487771|11855035|FG001|NOT COMPLETED|Overall Study||14
10690711|NCT02487810|11855043|FG000|STARTED|Overall Study||98
10690712|NCT02487810|11855044|FG001|STARTED|Overall Study||102
10690713|NCT02487810|11855043|FG000|COMPLETED|Overall Study||97
10690714|NCT02487810|11855044|FG001|COMPLETED|Overall Study||102
10690715|NCT02487810|11855043|FG000|NOT COMPLETED|Overall Study||1
10690716|NCT02487810|11855044|FG001|NOT COMPLETED|Overall Study||0
10690729|NCT02488005|11855067|FG000|STARTED|Overall Study||15
10690730|NCT02488005|11855067|FG000|COMPLETED|Overall Study||13
10690731|NCT02488005|11855067|FG000|NOT COMPLETED|Overall Study||2
10690732|NCT02488018|11855071|FG000|STARTED|Overall Study||10
10690733|NCT02488018|11855071|FG000|COMPLETED|Overall Study||10
10455385|NCT01001520|11603460|FG001|COMPLETED|Washout Period||16
10455386|NCT01001520|11603459|FG000|NOT COMPLETED|Washout Period||2
10455387|NCT01001520|11603460|FG001|NOT COMPLETED|Washout Period||1
10455388|NCT01001520|11603459|FG000|STARTED|Medication Period 2||16
10690734|NCT02488018|11855071|FG000|NOT COMPLETED|Overall Study||0
10690735|NCT02488070|11855075|FG000|STARTED|Overall Study||10
10690736|NCT02488070|11855075|FG000|COMPLETED|Overall Study||10
10690737|NCT02488070|11855075|FG000|NOT COMPLETED|Overall Study||0
10690738|NCT02488109|11855082|FG000|STARTED|Treatment in Hospital||60
10690739|NCT02488109|11855083|FG001|STARTED|Treatment in Hospital||56
10690740|NCT02488109|11855082|FG000|Received Treatment|Treatment in Hospital||60
10690741|NCT02488109|11855083|FG001|Received Treatment|Treatment in Hospital||51
10690742|NCT02488109|11855082|FG000|Included in mITT Analysis|Treatment in Hospital||60
10690743|NCT02488109|11855083|FG001|Included in mITT Analysis|Treatment in Hospital||51
10690744|NCT02488109|11855082|FG000|COMPLETED|Treatment in Hospital||60
10690745|NCT02488109|11855083|FG001|COMPLETED|Treatment in Hospital||51
10690746|NCT02488109|11855082|FG000|NOT COMPLETED|Treatment in Hospital||0
10690747|NCT02488109|11855083|FG001|NOT COMPLETED|Treatment in Hospital||5
10690748|NCT02488109|11855082|FG000|STARTED|12-month Follow-Up||60
10690749|NCT02488109|11855083|FG001|STARTED|12-month Follow-Up||51
10690750|NCT02488109|11855082|FG000|Included in mITT Analysis|12-month Follow-Up||60
10690751|NCT02488109|11855083|FG001|Included in mITT Analysis|12-month Follow-Up||51
10690752|NCT02488109|11855082|FG000|COMPLETED|12-month Follow-Up||56
10690753|NCT02488109|11855083|FG001|COMPLETED|12-month Follow-Up||44
10690754|NCT02488109|11855082|FG000|NOT COMPLETED|12-month Follow-Up||4
10690755|NCT02488109|11855083|FG001|NOT COMPLETED|12-month Follow-Up||7
10690756|NCT02488239|11855091|FG000|STARTED|Overall Study||64
10690757|NCT02488239|11855091|FG000|COMPLETED|Overall Study||54
10690758|NCT02488239|11855091|FG000|NOT COMPLETED|Overall Study||10
10690759|NCT02488317|11855098|FG000|STARTED|Overall Study||117
10690760|NCT02488317|11855099|FG001|STARTED|Overall Study||117
10690761|NCT02488317|11855098|FG000|COMPLETED|Overall Study||63
10690762|NCT02488317|11855099|FG001|COMPLETED|Overall Study||70
10690763|NCT02488317|11855098|FG000|NOT COMPLETED|Overall Study||54
10690764|NCT02488317|11855099|FG001|NOT COMPLETED|Overall Study||47
10690765|NCT02488330|11855109|FG000|STARTED|Overall Study||12
10690766|NCT02488330|11855109|FG000|COMPLETED|Overall Study||0
10800279|NCT04709484|11961230|FG000|STARTED|Overall Study||34
10800280|NCT04709484|11961231|FG001|STARTED|Overall Study||32
10800281|NCT04709484|11961230|FG000|COMPLETED|Overall Study||34
10800282|NCT04709484|11961231|FG001|COMPLETED|Overall Study||32
10800283|NCT04709484|11961230|FG000|NOT COMPLETED|Overall Study||0
10800284|NCT04709484|11961231|FG001|NOT COMPLETED|Overall Study||0
10800285|NCT04727749|11961239|FG000|STARTED|Overall Study||107
10800286|NCT04727749|11961240|FG001|STARTED|Overall Study||104
10800287|NCT04727749|11961239|FG000|COMPLETED|Overall Study||97
10800288|NCT04727749|11961240|FG001|COMPLETED|Overall Study||101
10800289|NCT04727749|11961239|FG000|NOT COMPLETED|Overall Study||10
10800290|NCT04727749|11961240|FG001|NOT COMPLETED|Overall Study||3
10800291|NCT04777214|11961250|FG000|STARTED|Initial Randomization||5
10800292|NCT04777214|11961251|FG001|STARTED|Initial Randomization||5
10800293|NCT04777214|11961250|FG000|COMPLETED|Initial Randomization||5
10800294|NCT04777214|11961251|FG001|COMPLETED|Initial Randomization||5
10800295|NCT04777214|11961250|FG000|NOT COMPLETED|Initial Randomization||0
10800296|NCT04777214|11961251|FG001|NOT COMPLETED|Initial Randomization||0
10800297|NCT04777214|11961250|FG000|STARTED|Sham Crossover to Active TMS Arm||0
10800298|NCT04777214|11961251|FG001|STARTED|Sham Crossover to Active TMS Arm||5
10800299|NCT04777214|11961250|FG000|COMPLETED|Sham Crossover to Active TMS Arm||0
10800300|NCT04777214|11961251|FG001|COMPLETED|Sham Crossover to Active TMS Arm||5
10800301|NCT04777214|11961250|FG000|NOT COMPLETED|Sham Crossover to Active TMS Arm||0
10800302|NCT04777214|11961251|FG001|NOT COMPLETED|Sham Crossover to Active TMS Arm||0
10800303|NCT04854707|11961262|FG000|STARTED|Overall Study||2625
10800304|NCT04854707|11961263|FG001|STARTED|Overall Study||2183
10800305|NCT04854707|11961264|FG002|STARTED|Overall Study||676
10800306|NCT04854707|11961262|FG000|COMPLETED|Overall Study||2547
10800307|NCT04854707|11961263|FG001|COMPLETED|Overall Study||2124
10800308|NCT04854707|11961264|FG002|COMPLETED|Overall Study||646
10800309|NCT04854707|11961262|FG000|NOT COMPLETED|Overall Study||78
10800310|NCT04854707|11961263|FG001|NOT COMPLETED|Overall Study||59
10800311|NCT04854707|11961264|FG002|NOT COMPLETED|Overall Study||30
10800312|NCT04898166|11961278|FG000|STARTED|Overall Study||220
10800313|NCT04898166|11961279|FG001|STARTED|Overall Study||80
10800314|NCT04898166|11961278|FG000|COMPLETED|Overall Study||220
10800315|NCT04898166|11961279|FG001|COMPLETED|Overall Study||80
10800316|NCT04898166|11961278|FG000|NOT COMPLETED|Overall Study||0
10800317|NCT04898166|11961279|FG001|NOT COMPLETED|Overall Study||0
10800318|NCT04926233|11961299|FG000|STARTED|Overall Study||1280486
10800319|NCT04926233|11961300|FG001|STARTED|Overall Study||90660
10800320|NCT04926233|11961299|FG000|COMPLETED|Overall Study||1280486
10800321|NCT04926233|11961300|FG001|COMPLETED|Overall Study||90660
10800322|NCT04926233|11961299|FG000|NOT COMPLETED|Overall Study||0
10800323|NCT04926233|11961300|FG001|NOT COMPLETED|Overall Study||0
10800324|NCT04943159|11961352|FG000|STARTED|Overall Study||3
10800325|NCT04943159|11961352|FG000|COMPLETED|Overall Study||3
10800326|NCT04943159|11961352|FG000|NOT COMPLETED|Overall Study||0
10800327|NCT04947436|11961359|FG000|STARTED|Overall Study||7
10800328|NCT04947436|11961360|FG001|STARTED|Overall Study||10
10800329|NCT04947436|11961361|FG002|STARTED|Overall Study||11
10800330|NCT04947436|11961359|FG000|COMPLETED|Overall Study||3
10800331|NCT04947436|11961360|FG001|COMPLETED|Overall Study||2
10800332|NCT04947436|11961361|FG002|COMPLETED|Overall Study||5
10800333|NCT04947436|11961359|FG000|NOT COMPLETED|Overall Study||4
10800334|NCT04947436|11961360|FG001|NOT COMPLETED|Overall Study||8
10800335|NCT04947436|11961361|FG002|NOT COMPLETED|Overall Study||6
10800336|NCT05002972|11961369|FG000|STARTED|Overall Study||63
10800337|NCT05002972|11961369|FG000|COMPLETED|Overall Study||61
10800338|NCT05002972|11961369|FG000|NOT COMPLETED|Overall Study||2
10800339|NCT05002985|11961373|FG000|STARTED|Overall Study||49
10690767|NCT02488330|11855109|FG000|NOT COMPLETED|Overall Study||12
10690768|NCT02488681|11855113|FG000|STARTED|Overall Study|Patients with Micra implant attempt|276
10690769|NCT02488681|11855113|FG000|COMPLETED|Overall Study|Patients successfully implanted with Micra|269
10800340|NCT05002985|11961373|FG000|COMPLETED|Overall Study||48
10690770|NCT02488681|11855113|FG000|NOT COMPLETED|Overall Study||7
10690771|NCT02488824|11855119|FG000|STARTED|Overall Study||21
10690772|NCT02488824|11855120|FG001|STARTED|Overall Study||20
10690773|NCT02488824|11855119|FG000|COMPLETED|Overall Study||20
10690774|NCT02488824|11855120|FG001|COMPLETED|Overall Study||19
10690775|NCT02488824|11855119|FG000|NOT COMPLETED|Overall Study||1
10690776|NCT02488824|11855120|FG001|NOT COMPLETED|Overall Study||1
10690777|NCT02488915|11855126|FG000|STARTED|Overall Study||228
10690778|NCT02488915|11855126|FG000|COMPLETED|Overall Study||202
10690779|NCT02488915|11855126|FG000|NOT COMPLETED|Overall Study||26
10690780|NCT02488980|11855133|FG000|STARTED|Overall Study||104
10690781|NCT02488980|11855134|FG001|STARTED|Overall Study||101
10690782|NCT02488980|11855135|FG002|STARTED|Overall Study||101
10690783|NCT02488980|11855133|FG000|COMPLETED|Overall Study||102
10690784|NCT02488980|11855134|FG001|COMPLETED|Overall Study||99
10690785|NCT02488980|11855135|FG002|COMPLETED|Overall Study||99
10690786|NCT02488980|11855133|FG000|NOT COMPLETED|Overall Study||2
10690787|NCT02488980|11855134|FG001|NOT COMPLETED|Overall Study||2
10690788|NCT02488980|11855135|FG002|NOT COMPLETED|Overall Study||2
10690789|NCT02489045|11855143|FG000|STARTED|Overall Study||178
10690790|NCT02489045|11855143|FG000|COMPLETED|Overall Study||125
10690791|NCT02489045|11855143|FG000|NOT COMPLETED|Overall Study||53
10690792|NCT02489045|11855143|FG000|STARTED|Follow-up|"Only subjects with portal hypertension in overall study were eligible to progress to follow-up"|21
10690793|NCT02489045|11855143|FG000|COMPLETED|Follow-up||11
10690794|NCT02489045|11855143|FG000|NOT COMPLETED|Follow-up||10
10690795|NCT02489110|11855149|FG000|STARTED|Overall Study||75
10690796|NCT02489110|11855150|FG001|STARTED|Overall Study||75
10690797|NCT02489110|11855149|FG000|COMPLETED|Overall Study||48
10690798|NCT02489110|11855150|FG001|COMPLETED|Overall Study||50
10690799|NCT02489110|11855149|FG000|NOT COMPLETED|Overall Study||27
10690800|NCT02489110|11855150|FG001|NOT COMPLETED|Overall Study||25
10690801|NCT02489123|11855156|FG000|STARTED|Overall Study||8
10690802|NCT02489123|11855156|FG000|COMPLETED|Overall Study||8
10690803|NCT02489123|11855156|FG000|NOT COMPLETED|Overall Study||0
10690804|NCT02489227|11855163|FG000|STARTED|Overall Study||274
10690805|NCT02489227|11855164|FG001|STARTED|Overall Study||135
10690806|NCT02489227|11855165|FG002|STARTED|Overall Study||136
10690807|NCT02489227|11855163|FG000|COMPLETED|Overall Study||220
10690808|NCT02489227|11855164|FG001|COMPLETED|Overall Study||101
10690809|NCT02489227|11855165|FG002|COMPLETED|Overall Study||117
10690810|NCT02489227|11855163|FG000|NOT COMPLETED|Overall Study||54
10690811|NCT02489227|11855164|FG001|NOT COMPLETED|Overall Study||34
10690812|NCT02489227|11855165|FG002|NOT COMPLETED|Overall Study||19
10690813|NCT02489279|11855177|FG000|STARTED|Overall Study||44
10690814|NCT02489279|11855178|FG001|STARTED|Overall Study||41
10690815|NCT02489279|11855177|FG000|COMPLETED|Overall Study||32
10690816|NCT02489279|11855178|FG001|COMPLETED|Overall Study||31
10690817|NCT02489279|11855177|FG000|NOT COMPLETED|Overall Study||12
10690818|NCT02489279|11855178|FG001|NOT COMPLETED|Overall Study||10
10690819|NCT02489344|11855184|FG000|STARTED|ACT13739 (Initial Study): 26 Weeks||11
10690820|NCT02489344|11855184|FG000|COMPLETED|ACT13739 (Initial Study): 26 Weeks||9
10690821|NCT02489344|11855184|FG000|NOT COMPLETED|ACT13739 (Initial Study): 26 Weeks||2
10690822|NCT02489344|11855184|FG000|STARTED|LTS14116 (Extension Study): 31 Months||8
10690823|NCT02489344|11855184|FG000|COMPLETED|LTS14116 (Extension Study): 31 Months||5
10690824|NCT02489344|11855184|FG000|NOT COMPLETED|LTS14116 (Extension Study): 31 Months||3
10690825|NCT02489357|11855188|FG000|STARTED|Overall Study||12
10690826|NCT02489357|11855188|FG000|COMPLETED|Overall Study||12
10690827|NCT02489357|11855188|FG000|NOT COMPLETED|Overall Study||0
10690828|NCT02489500|11855194|FG000|STARTED|Overall Study||2
10690829|NCT02489500|11855195|FG001|STARTED|Overall Study||1
10690830|NCT02489500|11855194|FG000|COMPLETED|Overall Study||1
10690831|NCT02489500|11855195|FG001|COMPLETED|Overall Study||0
10690832|NCT02489500|11855194|FG000|NOT COMPLETED|Overall Study||1
10690833|NCT02489500|11855195|FG001|NOT COMPLETED|Overall Study||1
10690834|NCT02489630|11855203|FG000|STARTED|Overall Study||53
10690835|NCT02489630|11855204|FG001|STARTED|Overall Study||63
10690836|NCT02489630|11855203|FG000|COMPLETED|Overall Study||51
10690837|NCT02489630|11855204|FG001|COMPLETED|Overall Study||61
10690838|NCT02489630|11855203|FG000|NOT COMPLETED|Overall Study||2
10690839|NCT02489630|11855204|FG001|NOT COMPLETED|Overall Study||2
10690840|NCT02489734|11855212|FG000|STARTED|Overall Study||56
10800341|NCT05002985|11961373|FG000|NOT COMPLETED|Overall Study||1
10800342|NCT04512482|11961379|FG000|STARTED|First Intervention (1 Day)||24
10800343|NCT04512482|11961380|FG001|STARTED|First Intervention (1 Day)||21
10800344|NCT04512482|11961379|FG000|Baseline Plaque Assessment|First Intervention (1 Day)||24
10800345|NCT04512482|11961380|FG001|Baseline Plaque Assessment|First Intervention (1 Day)||21
10800346|NCT04512482|11961379|FG000|Baseline Photographs|First Intervention (1 Day)||24
10800347|NCT04512482|11961380|FG001|Baseline Photographs|First Intervention (1 Day)||21
10690841|NCT02489734|11855213|FG001|STARTED|Overall Study||53
10690842|NCT02489734|11855212|FG000|COMPLETED|Overall Study||39
10690843|NCT02489734|11855213|FG001|COMPLETED|Overall Study||53
10690844|NCT02489734|11855212|FG000|NOT COMPLETED|Overall Study||17
10690845|NCT02489734|11855213|FG001|NOT COMPLETED|Overall Study||0
10800348|NCT04512482|11961379|FG000|Received Rinse Intervention|First Intervention (1 Day)||24
10800349|NCT04512482|11961380|FG001|Received Rinse Intervention|First Intervention (1 Day)||21
10690846|NCT02489773|11855221|FG000|STARTED|Overall Study||98
10690847|NCT02489773|11855222|FG001|STARTED|Overall Study||52
10690848|NCT02489773|11855221|FG000|COMPLETED|Overall Study||91
10690849|NCT02489773|11855222|FG001|COMPLETED|Overall Study||50
10690850|NCT02489773|11855221|FG000|NOT COMPLETED|Overall Study||7
10690851|NCT02489773|11855222|FG001|NOT COMPLETED|Overall Study||2
10690852|NCT02489799|11855230|FG000|STARTED|Overall Study||45
10690853|NCT02489799|11855231|FG001|STARTED|Overall Study||47
10690854|NCT02489799|11855230|FG000|Presurgical Consent Visit (V2)|Overall Study||40
10690855|NCT02489799|11855231|FG001|Presurgical Consent Visit (V2)|Overall Study||39
10690856|NCT02489799|11855230|FG000|Postsurgical One Week Visit (V3)|Overall Study||40
10690857|NCT02489799|11855231|FG001|Postsurgical One Week Visit (V3)|Overall Study||39
10690858|NCT02489799|11855230|FG000|COMPLETED|Overall Study||36
10690859|NCT02489799|11855231|FG001|COMPLETED|Overall Study||38
10690860|NCT02489799|11855230|FG000|NOT COMPLETED|Overall Study||9
10690861|NCT02489799|11855231|FG001|NOT COMPLETED|Overall Study||9
10690862|NCT02489968|11855239|FG000|STARTED|Open-label Treatment Period||439
10690863|NCT02489968|11855240|FG001|STARTED|Open-label Treatment Period|1 subject did not receive treatment and hence excluded. Started represents treated numbers.|440
10690864|NCT02489968|11855241|FG002|STARTED|Open-label Treatment Period||0
10690865|NCT02489968|11855242|FG003|STARTED|Open-label Treatment Period||0
10690866|NCT02489968|11855243|FG004|STARTED|Open-label Treatment Period||0
10690867|NCT02489968|11855244|FG005|STARTED|Open-label Treatment Period||0
10690868|NCT02489968|11855239|FG000|COMPLETED|Open-label Treatment Period||215
10690869|NCT02489968|11855240|FG001|COMPLETED|Open-label Treatment Period||232
10690870|NCT02489968|11855241|FG002|COMPLETED|Open-label Treatment Period||0
10690871|NCT02489968|11855242|FG003|COMPLETED|Open-label Treatment Period||0
10690872|NCT02489968|11855243|FG004|COMPLETED|Open-label Treatment Period||0
10690873|NCT02489968|11855244|FG005|COMPLETED|Open-label Treatment Period||0
10690874|NCT02489968|11855239|FG000|NOT COMPLETED|Open-label Treatment Period||224
10690875|NCT02489968|11855240|FG001|NOT COMPLETED|Open-label Treatment Period||208
10690876|NCT02489968|11855241|FG002|NOT COMPLETED|Open-label Treatment Period||0
10690877|NCT02489968|11855242|FG003|NOT COMPLETED|Open-label Treatment Period||0
10690878|NCT02489968|11855243|FG004|NOT COMPLETED|Open-label Treatment Period||0
10690879|NCT02489968|11855244|FG005|NOT COMPLETED|Open-label Treatment Period||0
10690880|NCT02489968|11855239|FG000|STARTED|Double-blind Treatment Period||0
10690881|NCT02489968|11855240|FG001|STARTED|Double-blind Treatment Period||0
10690882|NCT02489968|11855241|FG002|STARTED|Double-blind Treatment Period||107
10690883|NCT02489968|11855242|FG003|STARTED|Double-blind Treatment Period||108
10690884|NCT02489968|11855243|FG004|STARTED|Double-blind Treatment Period||116
10690885|NCT02489968|11855244|FG005|STARTED|Double-blind Treatment Period||116
10690886|NCT02489968|11855239|FG000|COMPLETED|Double-blind Treatment Period||0
10690887|NCT02489968|11855240|FG001|COMPLETED|Double-blind Treatment Period||0
10690888|NCT02489968|11855241|FG002|COMPLETED|Double-blind Treatment Period||105
10690889|NCT02489968|11855242|FG003|COMPLETED|Double-blind Treatment Period||100
10690890|NCT02489968|11855243|FG004|COMPLETED|Double-blind Treatment Period||110
10690891|NCT02489968|11855244|FG005|COMPLETED|Double-blind Treatment Period||108
10690892|NCT02489968|11855239|FG000|NOT COMPLETED|Double-blind Treatment Period||0
10690893|NCT02489968|11855240|FG001|NOT COMPLETED|Double-blind Treatment Period||0
10690894|NCT02489968|11855241|FG002|NOT COMPLETED|Double-blind Treatment Period||2
10690895|NCT02489968|11855242|FG003|NOT COMPLETED|Double-blind Treatment Period||8
10690896|NCT02489968|11855243|FG004|NOT COMPLETED|Double-blind Treatment Period||6
10690897|NCT02489968|11855244|FG005|NOT COMPLETED|Double-blind Treatment Period||8
10690898|NCT02489981|11855256|FG000|STARTED|Overall Study||340
10690899|NCT02489981|11855256|FG000|COMPLETED|Overall Study||213
10690900|NCT02489981|11855256|FG000|NOT COMPLETED|Overall Study||127
10690901|NCT02490293|11855262|FG000|STARTED|Overall Study||96
10690902|NCT02490293|11855263|FG001|STARTED|Overall Study||102
10690903|NCT02490293|11855262|FG000|COMPLETED|Overall Study||94
10690904|NCT02490293|11855263|FG001|COMPLETED|Overall Study||99
10800350|NCT04512482|11961379|FG000|Post-rinse Photographs|First Intervention (1 Day)||24
10800351|NCT04512482|11961380|FG001|Post-rinse Photographs|First Intervention (1 Day)||21
10800352|NCT04512482|11961379|FG000|Toothbrush Utilization|First Intervention (1 Day)||24
10800353|NCT04512482|11961380|FG001|Toothbrush Utilization|First Intervention (1 Day)||21
10800354|NCT04512482|11961379|FG000|Post-toothbrush Photographs|First Intervention (1 Day)||24
10800355|NCT04512482|11961380|FG001|Post-toothbrush Photographs|First Intervention (1 Day)||21
10800356|NCT04512482|11961379|FG000|Waterpik Utilization|First Intervention (1 Day)||24
10800357|NCT04512482|11961380|FG001|Waterpik Utilization|First Intervention (1 Day)||21
10800358|NCT04512482|11961379|FG000|Post-Waterpik Photographs|First Intervention (1 Day)||24
10800359|NCT04512482|11961380|FG001|Post-Waterpik Photographs|First Intervention (1 Day)||21
10800360|NCT04512482|11961379|FG000|COMPLETED|First Intervention (1 Day)||24
10800361|NCT04512482|11961380|FG001|COMPLETED|First Intervention (1 Day)||21
10800362|NCT04512482|11961379|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10800363|NCT04512482|11961380|FG001|NOT COMPLETED|First Intervention (1 Day)||0
10800364|NCT04512482|11961379|FG000|STARTED|Washout (1 Week)||24
10800365|NCT04512482|11961380|FG001|STARTED|Washout (1 Week)||21
10800366|NCT04512482|11961379|FG000|COMPLETED|Washout (1 Week)||24
10800367|NCT04512482|11961380|FG001|COMPLETED|Washout (1 Week)||21
10800368|NCT04512482|11961379|FG000|NOT COMPLETED|Washout (1 Week)||0
10800369|NCT04512482|11961380|FG001|NOT COMPLETED|Washout (1 Week)||0
10800370|NCT04512482|11961379|FG000|STARTED|Second Intervention (1 Day)||24
10800371|NCT04512482|11961380|FG001|STARTED|Second Intervention (1 Day)||21
10690905|NCT02490293|11855262|FG000|NOT COMPLETED|Overall Study||2
10800372|NCT04512482|11961379|FG000|Baseline Plaque Assessment|Second Intervention (1 Day)||22
10690906|NCT02490293|11855263|FG001|NOT COMPLETED|Overall Study||3
10690907|NCT02490371|11855271|FG000|STARTED|Overall Study||12
10690908|NCT02490371|11855272|FG001|STARTED|Overall Study||12
10690909|NCT02490371|11855271|FG000|COMPLETED|Overall Study||11
10690910|NCT02490371|11855272|FG001|COMPLETED|Overall Study||11
10690911|NCT02490371|11855271|FG000|NOT COMPLETED|Overall Study||1
10690912|NCT02490371|11855272|FG001|NOT COMPLETED|Overall Study||1
10690913|NCT02490475|11855282|FG000|STARTED|Period 1: First 6 Cycles||6
10690914|NCT02490475|11855283|FG001|STARTED|Period 1: First 6 Cycles||2
10690915|NCT02490475|11855284|FG002|STARTED|Period 1: First 6 Cycles||6
10690916|NCT02490475|11855285|FG003|STARTED|Period 1: First 6 Cycles||5
10800373|NCT04512482|11961380|FG001|Baseline Plaque Assessment|Second Intervention (1 Day)||20
10800374|NCT04512482|11961379|FG000|Baseline Photographs|Second Intervention (1 Day)||22
10800375|NCT04512482|11961380|FG001|Baseline Photographs|Second Intervention (1 Day)||20
10800376|NCT04512482|11961379|FG000|Received Intervention|Second Intervention (1 Day)||22
10800377|NCT04512482|11961380|FG001|Received Intervention|Second Intervention (1 Day)||20
10690917|NCT02490475|11855282|FG000|COMPLETED|Period 1: First 6 Cycles||0
10690918|NCT02490475|11855283|FG001|COMPLETED|Period 1: First 6 Cycles||0
10690919|NCT02490475|11855284|FG002|COMPLETED|Period 1: First 6 Cycles||0
10690920|NCT02490475|11855285|FG003|COMPLETED|Period 1: First 6 Cycles||0
10690921|NCT02490475|11855282|FG000|NOT COMPLETED|Period 1: First 6 Cycles||6
10690922|NCT02490475|11855283|FG001|NOT COMPLETED|Period 1: First 6 Cycles||2
10690923|NCT02490475|11855284|FG002|NOT COMPLETED|Period 1: First 6 Cycles||6
10690924|NCT02490475|11855285|FG003|NOT COMPLETED|Period 1: First 6 Cycles||5
10690925|NCT02490475|11855282|FG000|STARTED|Period 2: Extension Phase||1
10690926|NCT02490475|11855283|FG001|STARTED|Period 2: Extension Phase||0
10690927|NCT02490475|11855284|FG002|STARTED|Period 2: Extension Phase||3
10690928|NCT02490475|11855285|FG003|STARTED|Period 2: Extension Phase||1
10690929|NCT02490475|11855282|FG000|COMPLETED|Period 2: Extension Phase||0
10690930|NCT02490475|11855283|FG001|COMPLETED|Period 2: Extension Phase||0
10690931|NCT02490475|11855284|FG002|COMPLETED|Period 2: Extension Phase||0
10690932|NCT02490475|11855285|FG003|COMPLETED|Period 2: Extension Phase||0
10690933|NCT02490475|11855282|FG000|NOT COMPLETED|Period 2: Extension Phase||1
10690934|NCT02490475|11855283|FG001|NOT COMPLETED|Period 2: Extension Phase||0
10690935|NCT02490475|11855284|FG002|NOT COMPLETED|Period 2: Extension Phase||3
10690936|NCT02490475|11855285|FG003|NOT COMPLETED|Period 2: Extension Phase||1
10690937|NCT02490631|11855308|FG000|STARTED|Overall Study||79
10690938|NCT02490631|11855309|FG001|STARTED|Overall Study||78
10690939|NCT02490631|11855308|FG000|COMPLETED|Overall Study||76
10690940|NCT02490631|11855309|FG001|COMPLETED|Overall Study||75
10690941|NCT02490631|11855308|FG000|NOT COMPLETED|Overall Study||3
10690942|NCT02490631|11855309|FG001|NOT COMPLETED|Overall Study||3
10690943|NCT02490670|11855317|FG000|STARTED|Period 1 (19 Days)||14
10690944|NCT02490670|11855318|FG001|STARTED|Period 1 (19 Days)||14
10690945|NCT02490670|11855317|FG000|COMPLETED|Period 1 (19 Days)||14
10690946|NCT02490670|11855318|FG001|COMPLETED|Period 1 (19 Days)||14
10690947|NCT02490670|11855317|FG000|NOT COMPLETED|Period 1 (19 Days)||0
10690948|NCT02490670|11855318|FG001|NOT COMPLETED|Period 1 (19 Days)||0
10690949|NCT02490670|11855317|FG000|STARTED|Washout Period (7 Days)||14
10690950|NCT02490670|11855318|FG001|STARTED|Washout Period (7 Days)||14
10690951|NCT02490670|11855317|FG000|COMPLETED|Washout Period (7 Days)||14
10690952|NCT02490670|11855318|FG001|COMPLETED|Washout Period (7 Days)||14
10690953|NCT02490670|11855317|FG000|NOT COMPLETED|Washout Period (7 Days)||0
10690954|NCT02490670|11855318|FG001|NOT COMPLETED|Washout Period (7 Days)||0
10690955|NCT02490670|11855317|FG000|STARTED|Period 2 (19 Days)||14
10690956|NCT02490670|11855318|FG001|STARTED|Period 2 (19 Days)||14
10690957|NCT02490670|11855317|FG000|COMPLETED|Period 2 (19 Days)||14
10690958|NCT02490670|11855318|FG001|COMPLETED|Period 2 (19 Days)||14
10690959|NCT02490670|11855317|FG000|NOT COMPLETED|Period 2 (19 Days)||0
10690960|NCT02490670|11855318|FG001|NOT COMPLETED|Period 2 (19 Days)||0
10690961|NCT02490878|11855326|FG000|STARTED|Overall Study||10
10690962|NCT02490878|11855327|FG001|STARTED|Overall Study||9
10690963|NCT02490878|11855326|FG000|Eligible Participants|Overall Study||10
10690964|NCT02490878|11855327|FG001|Eligible Participants|Overall Study||8
10690965|NCT02490878|11855326|FG000|COMPLETED|Overall Study||10
10690966|NCT02490878|11855327|FG001|COMPLETED|Overall Study||6
10690967|NCT02490878|11855326|FG000|NOT COMPLETED|Overall Study||0
10690968|NCT02490878|11855327|FG001|NOT COMPLETED|Overall Study||3
10690969|NCT02491073|11855335|FG000|STARTED|Overall Study||37
10690970|NCT02491073|11855336|FG001|STARTED|Overall Study||34
10690971|NCT02491073|11855335|FG000|COMPLETED|Overall Study||36
10690972|NCT02491073|11855336|FG001|COMPLETED|Overall Study||34
10690973|NCT02491073|11855335|FG000|NOT COMPLETED|Overall Study||1
10690974|NCT02491073|11855336|FG001|NOT COMPLETED|Overall Study||0
10690975|NCT02491359|11855358|FG000|STARTED|Overall Study||20
10690976|NCT02491359|11855358|FG000|COMPLETED|Overall Study||4
10690977|NCT02491359|11855358|FG000|NOT COMPLETED|Overall Study||16
10690978|NCT02491437|11855366|FG000|STARTED|Overall Study||520
10690979|NCT02491437|11855367|FG001|STARTED|Overall Study||514
10690980|NCT02491437|11855366|FG000|Safety Sample|Overall Study||518
10690981|NCT02491437|11855367|FG001|Safety Sample|Overall Study||512
10690982|NCT02491437|11855366|FG000|Full Analysis Sample|Overall Study||494
10800378|NCT04512482|11961379|FG000|Post-rinse Photographs|Second Intervention (1 Day)||22
10690983|NCT02491437|11855367|FG001|Full Analysis Sample|Overall Study||489
10690984|NCT02491437|11855366|FG000|COMPLETED|Overall Study||168
10690985|NCT02491437|11855367|FG001|COMPLETED|Overall Study||157
10690986|NCT02491437|11855366|FG000|NOT COMPLETED|Overall Study||352
10690987|NCT02491437|11855367|FG001|NOT COMPLETED|Overall Study||357
10690988|NCT02491463|11855379|FG000|STARTED|Overall Study||7
10690989|NCT02491463|11855380|FG001|STARTED|Overall Study||31
10690990|NCT02491463|11855381|FG002|STARTED|Overall Study||19
10690991|NCT02491463|11855382|FG003|STARTED|Overall Study||15
10690992|NCT02491463|11855379|FG000|COMPLETED|Overall Study||5
10690993|NCT02491463|11855380|FG001|COMPLETED|Overall Study||21
10690994|NCT02491463|11855381|FG002|COMPLETED|Overall Study||15
10690995|NCT02491463|11855382|FG003|COMPLETED|Overall Study||14
10690996|NCT02491463|11855379|FG000|NOT COMPLETED|Overall Study||2
10690997|NCT02491463|11855380|FG001|NOT COMPLETED|Overall Study||10
10690998|NCT02491463|11855381|FG002|NOT COMPLETED|Overall Study||4
10690999|NCT02491463|11855382|FG003|NOT COMPLETED|Overall Study||1
10691000|NCT02491671|11855394|FG000|STARTED|Overall Study||129
10691001|NCT02491671|11855395|FG001|STARTED|Overall Study||131
10691002|NCT02491671|11855394|FG000|COMPLETED|Overall Study||118
10691003|NCT02491671|11855395|FG001|COMPLETED|Overall Study||118
10691004|NCT02491671|11855394|FG000|NOT COMPLETED|Overall Study||11
10691005|NCT02491671|11855395|FG001|NOT COMPLETED|Overall Study||13
10691006|NCT02491684|11855403|FG000|STARTED|Pre-treatment Phase||61
10691007|NCT02491684|11855404|FG001|STARTED|Pre-treatment Phase||60
10691008|NCT02491684|11855403|FG000|COMPLETED|Pre-treatment Phase||61
10691009|NCT02491684|11855404|FG001|COMPLETED|Pre-treatment Phase||60
10691010|NCT02491684|11855403|FG000|NOT COMPLETED|Pre-treatment Phase||0
10691011|NCT02491684|11855404|FG001|NOT COMPLETED|Pre-treatment Phase||0
10800379|NCT04512482|11961380|FG001|Post-rinse Photographs|Second Intervention (1 Day)||20
10800380|NCT04512482|11961379|FG000|Toothbrush Utilization|Second Intervention (1 Day)||22
10800381|NCT04512482|11961380|FG001|Toothbrush Utilization|Second Intervention (1 Day)||20
10800382|NCT04512482|11961379|FG000|Post-toothbrush Photographs|Second Intervention (1 Day)||22
10800383|NCT04512482|11961380|FG001|Post-toothbrush Photographs|Second Intervention (1 Day)||20
10691012|NCT02491684|11855403|FG000|STARTED|Treatment Phase||61
10691013|NCT02491684|11855404|FG001|STARTED|Treatment Phase||60
10691014|NCT02491684|11855403|FG000|COMPLETED|Treatment Phase||58
10691015|NCT02491684|11855404|FG001|COMPLETED|Treatment Phase||57
10691016|NCT02491684|11855403|FG000|NOT COMPLETED|Treatment Phase||3
10691017|NCT02491684|11855404|FG001|NOT COMPLETED|Treatment Phase||3
10691018|NCT02491788|11855412|FG000|STARTED|Overall Study||8
10691019|NCT02491788|11855413|FG001|STARTED|Overall Study||11
10691020|NCT02491788|11855412|FG000|COMPLETED|Overall Study||8
10691021|NCT02491788|11855413|FG001|COMPLETED|Overall Study||11
10691022|NCT02491788|11855412|FG000|NOT COMPLETED|Overall Study||0
10691023|NCT02491788|11855413|FG001|NOT COMPLETED|Overall Study||0
10691024|NCT02491892|11855421|FG000|STARTED|Overall Study||41
10691025|NCT02491892|11855422|FG001|STARTED|Overall Study||38
10691026|NCT02491892|11855421|FG000|Treated|Overall Study||41
10691027|NCT02491892|11855422|FG001|Treated|Overall Study|One participant was randomized but died before receiving study medication.|37
10691028|NCT02491892|11855421|FG000|COMPLETED|Overall Study||0
10691029|NCT02491892|11855422|FG001|COMPLETED|Overall Study||0
10691030|NCT02491892|11855421|FG000|NOT COMPLETED|Overall Study||41
10691031|NCT02491892|11855422|FG001|NOT COMPLETED|Overall Study||38
10691032|NCT02491944|11855428|FG000|STARTED|Overall Study||10
10691033|NCT02491944|11855428|FG000|COMPLETED|Overall Study||10
10691034|NCT02491944|11855428|FG000|NOT COMPLETED|Overall Study||0
10691035|NCT02492100|11855432|FG000|STARTED|Overall Study||47
10691036|NCT02492100|11855432|FG000|COMPLETED|Overall Study||46
10691037|NCT02492100|11855432|FG000|NOT COMPLETED|Overall Study||1
10691038|NCT02492451|11855440|FG000|STARTED|Overall Study||40
10691039|NCT02492451|11855441|FG001|STARTED|Overall Study||39
10691040|NCT02492451|11855442|FG002|STARTED|Overall Study||39
10691041|NCT02492451|11855440|FG000|COMPLETED|Overall Study||40
10691042|NCT02492451|11855441|FG001|COMPLETED|Overall Study||39
10691043|NCT02492451|11855442|FG002|COMPLETED|Overall Study||39
10691044|NCT02492451|11855440|FG000|NOT COMPLETED|Overall Study||0
10691045|NCT02492451|11855441|FG001|NOT COMPLETED|Overall Study||0
10691046|NCT02492451|11855442|FG002|NOT COMPLETED|Overall Study||0
10691047|NCT02492750|11855453|FG000|STARTED|Overall Study||4
10691048|NCT02492750|11855454|FG001|STARTED|Overall Study||4
10691049|NCT02492750|11855455|FG002|STARTED|Overall Study||6
10691050|NCT02492750|11855453|FG000|COMPLETED|Overall Study||4
10691051|NCT02492750|11855454|FG001|COMPLETED|Overall Study||4
10691052|NCT02492750|11855455|FG002|COMPLETED|Overall Study||6
10691053|NCT02492750|11855453|FG000|NOT COMPLETED|Overall Study||0
10691054|NCT02492750|11855454|FG001|NOT COMPLETED|Overall Study||0
10691055|NCT02492750|11855455|FG002|NOT COMPLETED|Overall Study||0
10713291|NCT02677844|11878803|FG005|NOT COMPLETED|Period 4 (DDI)||0
10713292|NCT02677844|11878804|FG006|NOT COMPLETED|Period 4 (DDI)||0
10713293|NCT02677844|11878798|FG000|STARTED|Period 5||0
10713294|NCT02677844|11878799|FG001|STARTED|Period 5||0
10713295|NCT02677844|11878800|FG002|STARTED|Period 5||0
10713296|NCT02677844|11878801|FG003|STARTED|Period 5||0
10713297|NCT02677844|11878802|FG004|STARTED|Period 5||7
10713298|NCT02677844|11878803|FG005|STARTED|Period 5||4
10713299|NCT02677844|11878804|FG006|STARTED|Period 5||4
10713300|NCT02677844|11878798|FG000|COMPLETED|Period 5||0
10713301|NCT02677844|11878799|FG001|COMPLETED|Period 5||0
10713302|NCT02677844|11878800|FG002|COMPLETED|Period 5||0
10713303|NCT02677844|11878801|FG003|COMPLETED|Period 5||0
10713304|NCT02677844|11878802|FG004|COMPLETED|Period 5||7
10713305|NCT02677844|11878803|FG005|COMPLETED|Period 5||4
10713306|NCT02677844|11878804|FG006|COMPLETED|Period 5||4
10713307|NCT02677844|11878798|FG000|NOT COMPLETED|Period 5||0
10713308|NCT02677844|11878799|FG001|NOT COMPLETED|Period 5||0
10691056|NCT02492763|11855467|FG000|STARTED|Overall Study||46
10691057|NCT02492763|11855468|FG001|STARTED|Overall Study||44
10691058|NCT02492763|11855469|FG002|STARTED|Overall Study||43
10691059|NCT02492763|11855470|FG003|STARTED|Overall Study||43
10691060|NCT02492763|11855467|FG000|Treated|Overall Study||46
10691061|NCT02492763|11855468|FG001|Treated|Overall Study||44
10691062|NCT02492763|11855469|FG002|Treated|Overall Study||43
10691063|NCT02492763|11855470|FG003|Treated|Overall Study||42
10691064|NCT02492763|11855467|FG000|COMPLETED|Overall Study||30
10691065|NCT02492763|11855468|FG001|COMPLETED|Overall Study||29
10691066|NCT02492763|11855469|FG002|COMPLETED|Overall Study||33
10691067|NCT02492763|11855470|FG003|COMPLETED|Overall Study||30
10691068|NCT02492763|11855467|FG000|NOT COMPLETED|Overall Study||16
10691069|NCT02492763|11855468|FG001|NOT COMPLETED|Overall Study||15
10691070|NCT02492763|11855469|FG002|NOT COMPLETED|Overall Study||10
10691071|NCT02492763|11855470|FG003|NOT COMPLETED|Overall Study||13
10691072|NCT02492802|11855480|FG000|STARTED|Overall Study||64
10691073|NCT02492802|11855480|FG000|COMPLETED|Overall Study||64
10691074|NCT02492802|11855480|FG000|NOT COMPLETED|Overall Study||0
10691075|NCT02492841|11855487|FG000|STARTED|Overall Study||56
10691076|NCT02492841|11855488|FG001|STARTED|Overall Study||53
10691077|NCT02492841|11855489|FG002|STARTED|Overall Study||60
10691078|NCT02492841|11855487|FG000|COMPLETED|Overall Study||22
10691079|NCT02492841|11855488|FG001|COMPLETED|Overall Study||22
10691080|NCT02492841|11855489|FG002|COMPLETED|Overall Study||25
10691081|NCT02492841|11855487|FG000|NOT COMPLETED|Overall Study||34
10691082|NCT02492841|11855488|FG001|NOT COMPLETED|Overall Study||31
10691083|NCT02492841|11855489|FG002|NOT COMPLETED|Overall Study||35
10691084|NCT02492854|11855502|FG000|STARTED|Overall Study||5
10691085|NCT02492854|11855503|FG001|STARTED|Overall Study||3
10691086|NCT02492854|11855502|FG000|COMPLETED|Overall Study||5
10691087|NCT02492854|11855503|FG001|COMPLETED|Overall Study||3
10691088|NCT02492854|11855502|FG000|NOT COMPLETED|Overall Study||0
10691089|NCT02492854|11855503|FG001|NOT COMPLETED|Overall Study||0
10691090|NCT02492880|11855509|FG000|STARTED|Overall Study||15
10691091|NCT02492880|11855509|FG000|COMPLETED|Overall Study||13
10691092|NCT02492880|11855509|FG000|NOT COMPLETED|Overall Study||2
10691093|NCT02492958|11855517|FG000|STARTED|Overall Study||34
10691094|NCT02492958|11855518|FG001|STARTED|Overall Study||34
10691095|NCT02492958|11855519|FG002|STARTED|Overall Study||34
10691096|NCT02492958|11855520|FG003|STARTED|Overall Study||34
10691097|NCT02492958|11855517|FG000|COMPLETED|Overall Study||33
10691098|NCT02492958|11855518|FG001|COMPLETED|Overall Study||34
10691099|NCT02492958|11855519|FG002|COMPLETED|Overall Study||32
10691100|NCT02492958|11855520|FG003|COMPLETED|Overall Study||34
10691101|NCT02492958|11855517|FG000|NOT COMPLETED|Overall Study||1
10691102|NCT02492958|11855518|FG001|NOT COMPLETED|Overall Study||0
10691103|NCT02492958|11855519|FG002|NOT COMPLETED|Overall Study||2
10691104|NCT02492958|11855520|FG003|NOT COMPLETED|Overall Study||0
10691105|NCT02492984|11855532|FG000|STARTED|Overall Study||73
10691106|NCT02492984|11855533|FG001|STARTED|Overall Study||14
10691107|NCT02492984|11855532|FG000|COMPLETED|Overall Study||70
10691108|NCT02492984|11855533|FG001|COMPLETED|Overall Study||14
10691109|NCT02492984|11855532|FG000|NOT COMPLETED|Overall Study||3
10691110|NCT02492984|11855533|FG001|NOT COMPLETED|Overall Study||0
10691111|NCT02492997|11855544|FG000|STARTED|Overall Study||21
10691112|NCT02492997|11855545|FG001|STARTED|Overall Study||21
10691113|NCT02492997|11855544|FG000|COMPLETED|Overall Study||19
10691114|NCT02492997|11855545|FG001|COMPLETED|Overall Study||20
10691115|NCT02492997|11855544|FG000|NOT COMPLETED|Overall Study||2
10691116|NCT02492997|11855545|FG001|NOT COMPLETED|Overall Study||1
10691117|NCT02493036|11855554|FG000|STARTED|Overall Study||17
10691118|NCT02493036|11855555|FG001|STARTED|Overall Study||20
10691119|NCT02493036|11855556|FG002|STARTED|Overall Study||17
10691120|NCT02493036|11855554|FG000|COMPLETED|Overall Study||16
10691121|NCT02493036|11855555|FG001|COMPLETED|Overall Study||18
10691122|NCT02493036|11855556|FG002|COMPLETED|Overall Study||15
10691123|NCT02493036|11855554|FG000|NOT COMPLETED|Overall Study||1
10691124|NCT02493036|11855555|FG001|NOT COMPLETED|Overall Study||2
10691125|NCT02493036|11855556|FG002|NOT COMPLETED|Overall Study||2
10691126|NCT02493062|11855564|FG000|STARTED|Overall Study||35
10691127|NCT02493062|11855564|FG000|COMPLETED|Overall Study||23
10691128|NCT02493062|11855564|FG000|NOT COMPLETED|Overall Study||12
10691129|NCT02493088|11855568|FG000|STARTED|Overall Study||11
10691130|NCT02493088|11855568|FG000|COMPLETED|Overall Study||11
10691131|NCT02493088|11855568|FG000|NOT COMPLETED|Overall Study||0
10691132|NCT02493127|11855574|FG000|STARTED|Overall Study||61
10691133|NCT02493127|11855575|FG001|STARTED|Overall Study||61
10691134|NCT02493127|11855574|FG000|COMPLETED|Overall Study||60
10691135|NCT02493127|11855575|FG001|COMPLETED|Overall Study||60
10691136|NCT02493127|11855574|FG000|NOT COMPLETED|Overall Study||1
10691137|NCT02493127|11855575|FG001|NOT COMPLETED|Overall Study||1
10691138|NCT02493257|11855585|FG000|STARTED|Overall Study||11
10691139|NCT02493257|11855586|FG001|STARTED|Overall Study||11
10691140|NCT02493257|11855585|FG000|4 Week Follow up|Overall Study||11
10691141|NCT02493257|11855586|FG001|4 Week Follow up|Overall Study||11
10691142|NCT02493257|11855585|FG000|12 Week Follow up|Overall Study||10
10691143|NCT02493257|11855586|FG001|12 Week Follow up|Overall Study||10
10691144|NCT02493257|11855585|FG000|COMPLETED|Overall Study||10
10691145|NCT02493257|11855586|FG001|COMPLETED|Overall Study||10
10691146|NCT02493257|11855585|FG000|NOT COMPLETED|Overall Study||1
10691147|NCT02493257|11855586|FG001|NOT COMPLETED|Overall Study||1
10691148|NCT02493361|11855592|FG000|STARTED|Overall Study||24
10691149|NCT02493361|11855592|FG000|Week 24 Assessment|Overall Study||21
10691150|NCT02493361|11855592|FG000|COMPLETED|Overall Study||21
10691151|NCT02493361|11855592|FG000|NOT COMPLETED|Overall Study||3
10691152|NCT02493452|11855599|FG000|STARTED|Overall Study||379
10691153|NCT02493452|11855600|FG001|STARTED|Overall Study||377
10691154|NCT02493452|11855601|FG002|STARTED|Overall Study||379
10691155|NCT02493452|11855599|FG000|COMPLETED|Overall Study||329
10691156|NCT02493452|11855600|FG001|COMPLETED|Overall Study||328
10691157|NCT02493452|11855601|FG002|COMPLETED|Overall Study||325
10691158|NCT02493452|11855599|FG000|NOT COMPLETED|Overall Study||50
10691159|NCT02493452|11855600|FG001|NOT COMPLETED|Overall Study||49
10691160|NCT02493452|11855601|FG002|NOT COMPLETED|Overall Study||54
10691161|NCT02493517|11855611|FG000|STARTED|Overall Study||64
10691162|NCT02493517|11855612|FG001|STARTED|Overall Study||64
10691163|NCT02493517|11855611|FG000|COMPLETED|Overall Study||62
10691164|NCT02493517|11855612|FG001|COMPLETED|Overall Study||57
10691165|NCT02493517|11855611|FG000|NOT COMPLETED|Overall Study||2
10691166|NCT02493517|11855612|FG001|NOT COMPLETED|Overall Study||7
10691167|NCT02493608|11855622|FG000|STARTED|Overall Study||48
10691168|NCT02493608|11855623|FG001|STARTED|Overall Study||48
10691169|NCT02493608|11855622|FG000|COMPLETED|Overall Study||48
10691170|NCT02493608|11855623|FG001|COMPLETED|Overall Study||48
10691171|NCT02493608|11855622|FG000|NOT COMPLETED|Overall Study||0
10691172|NCT02493608|11855623|FG001|NOT COMPLETED|Overall Study||0
10691173|NCT02493621|11855631|FG000|STARTED|Overall Study||58
10691174|NCT02493621|11855632|FG001|STARTED|Overall Study||58
10691175|NCT02493621|11855631|FG000|COMPLETED|Overall Study||58
10691176|NCT02493621|11855632|FG001|COMPLETED|Overall Study||58
10691177|NCT02493621|11855631|FG000|NOT COMPLETED|Overall Study||0
10691178|NCT02493621|11855632|FG001|NOT COMPLETED|Overall Study||0
10691179|NCT02493712|11855641|FG000|STARTED|Overall Study||16
10691180|NCT02493712|11855642|FG001|STARTED|Overall Study||18
10691181|NCT02493712|11855643|FG002|STARTED|Overall Study||17
10691182|NCT02493712|11855641|FG000|COMPLETED|Overall Study||14
10691183|NCT02493712|11855642|FG001|COMPLETED|Overall Study||12
10691184|NCT02493712|11855643|FG002|COMPLETED|Overall Study||11
10691185|NCT02493712|11855641|FG000|NOT COMPLETED|Overall Study||2
10691186|NCT02493712|11855642|FG001|NOT COMPLETED|Overall Study||6
10691187|NCT02493712|11855643|FG002|NOT COMPLETED|Overall Study||6
10691188|NCT02493764|11855653|FG000|STARTED|Overall Study||268
10691189|NCT02493764|11855654|FG001|STARTED|Overall Study||269
10691190|NCT02493764|11855653|FG000|COMPLETED|Overall Study||185
10691191|NCT02493764|11855654|FG001|COMPLETED|Overall Study||187
10691192|NCT02493764|11855653|FG000|NOT COMPLETED|Overall Study||83
10691193|NCT02493764|11855654|FG001|NOT COMPLETED|Overall Study||82
10691194|NCT02493777|11855662|FG000|STARTED|Overall Study||65
10691195|NCT02493777|11855663|FG001|STARTED|Overall Study||54
10691196|NCT02493777|11855662|FG000|COMPLETED|Overall Study||65
10691197|NCT02493777|11855663|FG001|COMPLETED|Overall Study||53
10691198|NCT02493777|11855662|FG000|NOT COMPLETED|Overall Study||0
10691199|NCT02493777|11855663|FG001|NOT COMPLETED|Overall Study||1
10691200|NCT02493855|11855672|FG000|STARTED|Overall Study||21
10691201|NCT02493855|11855673|FG001|STARTED|Overall Study||19
10691202|NCT02493855|11855674|FG002|STARTED|Overall Study||6
10691203|NCT02493855|11855672|FG000|COMPLETED|Overall Study||19
10691204|NCT02493855|11855673|FG001|COMPLETED|Overall Study||18
10691205|NCT02493855|11855674|FG002|COMPLETED|Overall Study||6
10691206|NCT02493855|11855672|FG000|NOT COMPLETED|Overall Study||2
10691207|NCT02493855|11855673|FG001|NOT COMPLETED|Overall Study||1
10691208|NCT02493855|11855674|FG002|NOT COMPLETED|Overall Study||0
10691209|NCT02493868|11855682|FG000|STARTED|Induction Phase: DE Participants||437
10691210|NCT02493868|11855683|FG001|STARTED|Induction Phase: DE Participants||0
10691211|NCT02493868|11855682|FG000|COMPLETED|Induction Phase: DE Participants|Participants who completed and met predefined response criteria continued to OP phase.|273
10691212|NCT02493868|11855683|FG001|COMPLETED|Induction Phase: DE Participants||0
10691213|NCT02493868|11855682|FG000|NOT COMPLETED|Induction Phase: DE Participants||164
10691214|NCT02493868|11855683|FG001|NOT COMPLETED|Induction Phase: DE Participants||0
10691215|NCT02493868|11855682|FG000|STARTED|Optimization Phase: DE+TE Participants|Total participants: direct-entry (273) + esketamine-treated transferred-entry participants (182).|455
10691216|NCT02493868|11855683|FG001|STARTED|Optimization Phase: DE+TE Participants|Placebo treated transferred-entry participant.|86
10691217|NCT02493868|11855682|FG000|COMPLETED|Optimization Phase: DE+TE Participants|Participants who completed and met predefined remission/response criteria randomized to MA phase|297
10691218|NCT02493868|11855683|FG001|COMPLETED|Optimization Phase: DE+TE Participants|Participants who completed and met predefined remission/response criteria continued to MA phase.|54
10691219|NCT02493868|11855682|FG000|NOT COMPLETED|Optimization Phase: DE+TE Participants||158
10691220|NCT02493868|11855683|FG001|NOT COMPLETED|Optimization Phase: DE+TE Participants||32
10691221|NCT02493868|11855682|FG000|STARTED|Maintenance Phase: DE+TE Participants|152 participants randomized from intranasal esketamine arm after OP phase: DE (90) + TE (62)|152
10691222|NCT02493868|11855683|FG001|STARTED|Maintenance Phase: DE+TE Participants|145 participants randomized from intranasal esketamine arm after OP phase+54 continued from OP phase|199
10691223|NCT02493868|11855682|FG000|Stable Remitters|Maintenance Phase: DE+TE Participants||90
10691224|NCT02493868|11855683|FG001|Stable Remitters|Maintenance Phase: DE+TE Participants||86
10691225|NCT02493868|11855682|FG000|Stable Responders|Maintenance Phase: DE+TE Participants||62
10691226|NCT02493868|11855683|FG001|Stable Responders|Maintenance Phase: DE+TE Participants||59
10691227|NCT02493868|11855682|FG000|COMPLETED|Maintenance Phase: DE+TE Participants||139
10691228|NCT02493868|11855683|FG001|COMPLETED|Maintenance Phase: DE+TE Participants||177
10691229|NCT02493868|11855682|FG000|NOT COMPLETED|Maintenance Phase: DE+TE Participants||13
10691230|NCT02493868|11855683|FG001|NOT COMPLETED|Maintenance Phase: DE+TE Participants||22
10691231|NCT02493868|11855682|FG000|STARTED|Follow-up Phase||481
10691232|NCT02493868|11855683|FG001|STARTED|Follow-up Phase||64
10691233|NCT02493868|11855682|FG000|COMPLETED|Follow-up Phase||470
10691234|NCT02493868|11855683|FG001|COMPLETED|Follow-up Phase||62
10691235|NCT02493868|11855682|FG000|NOT COMPLETED|Follow-up Phase||11
10691236|NCT02493868|11855683|FG001|NOT COMPLETED|Follow-up Phase||2
10691255|NCT02494076|11855710|FG000|STARTED|Overall Study||26
10691256|NCT02494076|11855711|FG001|STARTED|Overall Study||26
10691257|NCT02494076|11855710|FG000|COMPLETED|Overall Study||26
10691258|NCT02494076|11855711|FG001|COMPLETED|Overall Study||26
10691259|NCT02494076|11855710|FG000|NOT COMPLETED|Overall Study||0
10691260|NCT02494076|11855711|FG001|NOT COMPLETED|Overall Study||0
10691261|NCT02494102|11855719|FG000|STARTED|Overall Study||42
10691262|NCT02494102|11855720|FG001|STARTED|Overall Study||47
10691263|NCT02494102|11855719|FG000|COMPLETED|Overall Study||42
10691264|NCT02494102|11855720|FG001|COMPLETED|Overall Study||47
10691265|NCT02494102|11855719|FG000|NOT COMPLETED|Overall Study||0
10691266|NCT02494102|11855720|FG001|NOT COMPLETED|Overall Study||0
10691267|NCT02494180|11855728|FG000|STARTED|Overall Study||85
10691268|NCT02494180|11855729|FG001|STARTED|Overall Study||85
10691269|NCT02494180|11855728|FG000|COMPLETED|Overall Study||85
10691270|NCT02494180|11855729|FG001|COMPLETED|Overall Study||85
10691271|NCT02494180|11855728|FG000|NOT COMPLETED|Overall Study||0
10691272|NCT02494180|11855729|FG001|NOT COMPLETED|Overall Study||0
10691273|NCT02494297|11855735|FG000|STARTED|Overall Study||1597
10691274|NCT02494297|11855735|FG000|COMPLETED|Overall Study|As there was no Follow-Up in this study, participation equals completion|1597
10691275|NCT02494297|11855735|FG000|NOT COMPLETED|Overall Study||0
10691276|NCT02494323|11855739|FG000|STARTED|Overall Study||70
10691277|NCT02494323|11855739|FG000|COMPLETED|Overall Study||70
10691278|NCT02494323|11855739|FG000|NOT COMPLETED|Overall Study||0
10691279|NCT02494336|11855745|FG000|STARTED|Overall Study||24
10691280|NCT02494336|11855746|FG001|STARTED|Overall Study||24
10691281|NCT02494336|11855745|FG000|COMPLETED|Overall Study||24
10691282|NCT02494336|11855746|FG001|COMPLETED|Overall Study||24
10691283|NCT02494336|11855745|FG000|NOT COMPLETED|Overall Study||0
10691284|NCT02494336|11855746|FG001|NOT COMPLETED|Overall Study||0
10691285|NCT02494401|11855754|FG000|STARTED|Overall Study||134
10691286|NCT02494401|11855755|FG001|STARTED|Overall Study||133
10691287|NCT02494401|11855754|FG000|Week 16|Overall Study||123
10691288|NCT02494401|11855755|FG001|Week 16|Overall Study||124
10691289|NCT02494401|11855754|FG000|6 Month Follow up|Overall Study||109
10691290|NCT02494401|11855755|FG001|6 Month Follow up|Overall Study||106
10691291|NCT02494401|11855754|FG000|COMPLETED|Overall Study||109
10691292|NCT02494401|11855755|FG001|COMPLETED|Overall Study||106
10691293|NCT02494401|11855754|FG000|NOT COMPLETED|Overall Study||25
10691294|NCT02494401|11855755|FG001|NOT COMPLETED|Overall Study||27
10691295|NCT02494440|11855761|FG000|STARTED|Overall Study||90
10691296|NCT02494440|11855761|FG000|COMPLETED|Overall Study||90
10691297|NCT02494440|11855761|FG000|NOT COMPLETED|Overall Study||0
10691298|NCT02494518|11855768|FG000|STARTED|Overall Study||11
10691299|NCT02494518|11855769|FG001|STARTED|Overall Study||12
10691300|NCT02494518|11855770|FG002|STARTED|Overall Study||11
10691301|NCT02494518|11855768|FG000|COMPLETED|Overall Study||10
10691302|NCT02494518|11855769|FG001|COMPLETED|Overall Study||10
10691303|NCT02494518|11855770|FG002|COMPLETED|Overall Study||8
10691304|NCT02494518|11855768|FG000|NOT COMPLETED|Overall Study||1
10691305|NCT02494518|11855769|FG001|NOT COMPLETED|Overall Study||2
10691306|NCT02494518|11855770|FG002|NOT COMPLETED|Overall Study||3
10800384|NCT04512482|11961379|FG000|Waterpik Utilization|Second Intervention (1 Day)||22
10800385|NCT04512482|11961380|FG001|Waterpik Utilization|Second Intervention (1 Day)||20
10800386|NCT04512482|11961379|FG000|Post-Waterpik Photographs|Second Intervention (1 Day)||22
10800387|NCT04512482|11961380|FG001|Post-Waterpik Photographs|Second Intervention (1 Day)||20
10800388|NCT04512482|11961379|FG000|COMPLETED|Second Intervention (1 Day)||22
10800389|NCT04512482|11961380|FG001|COMPLETED|Second Intervention (1 Day)||20
10800390|NCT04512482|11961379|FG000|NOT COMPLETED|Second Intervention (1 Day)||2
10800391|NCT04512482|11961380|FG001|NOT COMPLETED|Second Intervention (1 Day)||1
10800392|NCT04499599|11961389|FG000|STARTED|Overall Study||35
10800393|NCT04499599|11961390|FG001|STARTED|Overall Study||35
10800394|NCT04499599|11961391|FG002|STARTED|Overall Study||35
10800395|NCT04499599|11961389|FG000|COMPLETED|Overall Study||35
10691319|NCT02494596|11855791|FG000|STARTED|Overall Study||5
10691320|NCT02494596|11855792|FG001|STARTED|Overall Study||7
10691321|NCT02494596|11855793|FG002|STARTED|Overall Study||7
10691322|NCT02494596|11855791|FG000|COMPLETED|Overall Study||2
10691323|NCT02494596|11855792|FG001|COMPLETED|Overall Study||2
10691324|NCT02494596|11855793|FG002|COMPLETED|Overall Study||6
10691325|NCT02494596|11855791|FG000|NOT COMPLETED|Overall Study||3
10691326|NCT02494596|11855792|FG001|NOT COMPLETED|Overall Study||5
10691327|NCT02494596|11855793|FG002|NOT COMPLETED|Overall Study||1
10691328|NCT02494713|11855804|FG000|STARTED|Overall Study||4
10691329|NCT02494713|11855804|FG000|COMPLETED|Overall Study||4
10691330|NCT02494713|11855804|FG000|NOT COMPLETED|Overall Study||0
10691331|NCT02494778|11855808|FG000|STARTED|Overall Study||248
10691332|NCT02494778|11855808|FG000|COMPLETED|Overall Study||27
10691333|NCT02494778|11855808|FG000|NOT COMPLETED|Overall Study||221
10691334|NCT02494817|11855814|FG000|STARTED|Overall Study|representing 81 couples|162
10691335|NCT02494817|11855815|FG001|STARTED|Overall Study|representing 68 couples|136
10691336|NCT02494817|11855814|FG000|3 Month Assessment|Overall Study|represents 59 couples and 7 partnered men|125
10691337|NCT02494817|11855815|FG001|3 Month Assessment|Overall Study|represents 44 couples and 4 partnered men|92
10691338|NCT02494817|11855814|FG000|6 Month Assessment|Overall Study|represents 52 couples and 11 partnered men|115
10691339|NCT02494817|11855815|FG001|6 Month Assessment|Overall Study|represents 45 couples and 8 partnered men|98
10691340|NCT02494817|11855814|FG000|COMPLETED|Overall Study|49 couples and 9 partnered men completed all 3 assessments (baseline, 3- and 6-month)|107
10691427|NCT02495623|11855912|FG002|STARTED|Overall Study||28
10691341|NCT02494817|11855815|FG001|COMPLETED|Overall Study|41 couples and 5 partnered men completed all 3 assessments (baseline, 3- and 6-month)|87
10691342|NCT02494817|11855814|FG000|NOT COMPLETED|Overall Study||55
10691343|NCT02494817|11855815|FG001|NOT COMPLETED|Overall Study||49
10691344|NCT02495025|11855823|FG000|STARTED|Overall Study||77
10691345|NCT02495025|11855824|FG001|STARTED|Overall Study||75
10691346|NCT02495025|11855823|FG000|COMPLETED|Overall Study||51
10691347|NCT02495025|11855824|FG001|COMPLETED|Overall Study||61
10691348|NCT02495025|11855823|FG000|NOT COMPLETED|Overall Study||26
10691349|NCT02495025|11855824|FG001|NOT COMPLETED|Overall Study||14
10691350|NCT02495038|11855833|FG000|STARTED|Overall Study||27
10691351|NCT02495038|11855834|FG001|STARTED|Overall Study||27
10691352|NCT02495038|11855835|FG002|STARTED|Overall Study||27
10691353|NCT02495038|11855833|FG000|COMPLETED|Overall Study||27
10691354|NCT02495038|11855834|FG001|COMPLETED|Overall Study||27
10691355|NCT02495038|11855835|FG002|COMPLETED|Overall Study||27
10691356|NCT02495038|11855833|FG000|NOT COMPLETED|Overall Study||0
10691357|NCT02495038|11855834|FG001|NOT COMPLETED|Overall Study||0
10691358|NCT02495038|11855835|FG002|NOT COMPLETED|Overall Study||0
10691359|NCT02495103|11855845|FG000|STARTED|Overall Study||3
10691360|NCT02495103|11855846|FG001|STARTED|Overall Study||4
10691361|NCT02495103|11855845|FG000|COMPLETED|Overall Study||3
10691362|NCT02495103|11855846|FG001|COMPLETED|Overall Study||4
10691363|NCT02495103|11855845|FG000|NOT COMPLETED|Overall Study||0
10691364|NCT02495103|11855846|FG001|NOT COMPLETED|Overall Study||0
10691365|NCT02495168|11855857|FG000|STARTED|Overall Study||504
10691366|NCT02495168|11855858|FG001|STARTED|Overall Study||516
10691367|NCT02495168|11855859|FG002|STARTED|Overall Study||127
10691368|NCT02495168|11855857|FG000|Safety Population|Overall Study||501
10691369|NCT02495168|11855858|FG001|Safety Population|Overall Study||514
10691370|NCT02495168|11855859|FG002|Safety Population|Overall Study||126
10691371|NCT02495168|11855857|FG000|Modified Intent-to-Treat Population|Overall Study||468
10691372|NCT02495168|11855858|FG001|Modified Intent-to-Treat Population|Overall Study||478
10691373|NCT02495168|11855859|FG002|Modified Intent-to-Treat Population|Overall Study||111
10691374|NCT02495168|11855857|FG000|Day1 Per-protocol Set (D1PPS) Population|Overall Study||437
10691375|NCT02495168|11855858|FG001|Day1 Per-protocol Set (D1PPS) Population|Overall Study||437
10691376|NCT02495168|11855859|FG002|Day1 Per-protocol Set (D1PPS) Population|Overall Study||99
10691377|NCT02495168|11855857|FG000|Day 42 (D42PPS) Population|Overall Study||382
10691378|NCT02495168|11855858|FG001|Day 42 (D42PPS) Population|Overall Study||383
10691379|NCT02495168|11855859|FG002|Day 42 (D42PPS) Population|Overall Study||88
10691380|NCT02495168|11855857|FG000|COMPLETED|Overall Study||466
10691381|NCT02495168|11855858|FG001|COMPLETED|Overall Study||462
10691382|NCT02495168|11855859|FG002|COMPLETED|Overall Study||110
10691383|NCT02495168|11855857|FG000|NOT COMPLETED|Overall Study||38
10691384|NCT02495168|11855858|FG001|NOT COMPLETED|Overall Study||54
10691385|NCT02495168|11855859|FG002|NOT COMPLETED|Overall Study||17
10691386|NCT02495233|11855869|FG000|STARTED|Overall Study||3
10691387|NCT02495233|11855870|FG001|STARTED|Overall Study||7
10691388|NCT02495233|11855869|FG000|COMPLETED|Overall Study||3
10691389|NCT02495233|11855870|FG001|COMPLETED|Overall Study||6
10691390|NCT02495233|11855869|FG000|NOT COMPLETED|Overall Study||0
10691391|NCT02495233|11855870|FG001|NOT COMPLETED|Overall Study||1
10691392|NCT02495259|11855879|FG000|STARTED|Overall Study||7
10691393|NCT02495259|11855880|FG001|STARTED|Overall Study||4
10691394|NCT02495259|11855881|FG002|STARTED|Overall Study||8
10691395|NCT02495259|11855879|FG000|COMPLETED|Overall Study||7
10691396|NCT02495259|11855880|FG001|COMPLETED|Overall Study||3
10691397|NCT02495259|11855881|FG002|COMPLETED|Overall Study||8
10691398|NCT02495259|11855879|FG000|NOT COMPLETED|Overall Study||0
10691399|NCT02495259|11855880|FG001|NOT COMPLETED|Overall Study||1
10691400|NCT02495259|11855881|FG002|NOT COMPLETED|Overall Study||0
10691401|NCT02495389|11855889|FG000|STARTED|Overall Study||84
10691402|NCT02495389|11855889|FG000|COMPLETED|Overall Study||44
10691403|NCT02495389|11855889|FG000|NOT COMPLETED|Overall Study||40
10691404|NCT02495454|11855893|FG000|STARTED|Overall Study||34
10691405|NCT02495454|11855893|FG000|COMPLETED|Overall Study|One case excluded for violation of inclusion criteria (transformed lymphoma)|33
10691406|NCT02495454|11855893|FG000|NOT COMPLETED|Overall Study||1
10691407|NCT02495467|11855900|FG000|STARTED|First Intervention (4 Weeks)||114
10691408|NCT02495467|11855901|FG001|STARTED|First Intervention (4 Weeks)||118
10691409|NCT02495467|11855900|FG000|COMPLETED|First Intervention (4 Weeks)||114
10691410|NCT02495467|11855901|FG001|COMPLETED|First Intervention (4 Weeks)|One subject completed visits in treatment Period 1 but never used treatment|118
10691411|NCT02495467|11855900|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
10691412|NCT02495467|11855901|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
10691413|NCT02495467|11855900|FG000|STARTED|Washout (1 Week)||114
10691414|NCT02495467|11855901|FG001|STARTED|Washout (1 Week)||118
10691415|NCT02495467|11855900|FG000|COMPLETED|Washout (1 Week)||112
10691416|NCT02495467|11855901|FG001|COMPLETED|Washout (1 Week)||116
10691417|NCT02495467|11855900|FG000|NOT COMPLETED|Washout (1 Week)||2
10691418|NCT02495467|11855901|FG001|NOT COMPLETED|Washout (1 Week)||2
10691419|NCT02495467|11855900|FG000|STARTED|Second Intervention (4 Weeks)||112
10691420|NCT02495467|11855901|FG001|STARTED|Second Intervention (4 Weeks)||116
10691421|NCT02495467|11855900|FG000|COMPLETED|Second Intervention (4 Weeks)||112
10691422|NCT02495467|11855901|FG001|COMPLETED|Second Intervention (4 Weeks)||113
10691423|NCT02495467|11855900|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
10691424|NCT02495467|11855901|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||3
10691425|NCT02495623|11855910|FG000|STARTED|Overall Study||25
10691426|NCT02495623|11855911|FG001|STARTED|Overall Study||26
10691428|NCT02495623|11855910|FG000|Dosed|Overall Study||22
10691429|NCT02495623|11855911|FG001|Dosed|Overall Study||19
10691430|NCT02495623|11855912|FG002|Dosed|Overall Study||22
10691431|NCT02495623|11855910|FG000|COMPLETED|Overall Study||20
10691432|NCT02495623|11855911|FG001|COMPLETED|Overall Study||17
10691433|NCT02495623|11855912|FG002|COMPLETED|Overall Study||20
10691434|NCT02495623|11855910|FG000|NOT COMPLETED|Overall Study||5
10691435|NCT02495623|11855911|FG001|NOT COMPLETED|Overall Study||9
10691436|NCT02495623|11855912|FG002|NOT COMPLETED|Overall Study||8
10691437|NCT02495779|11855920|FG000|STARTED|Overall Study||54
10691438|NCT02495779|11855920|FG000|COMPLETED|Overall Study||48
10691439|NCT02495779|11855920|FG000|NOT COMPLETED|Overall Study||6
10691440|NCT02495831|11855924|FG000|STARTED|First Intervention||13
10691441|NCT02495831|11855925|FG001|STARTED|First Intervention||10
10691442|NCT02495831|11855924|FG000|COMPLETED|First Intervention||13
10691443|NCT02495831|11855925|FG001|COMPLETED|First Intervention||10
10691444|NCT02495831|11855924|FG000|NOT COMPLETED|First Intervention||0
10691445|NCT02495831|11855925|FG001|NOT COMPLETED|First Intervention||0
10691446|NCT02495831|11855924|FG000|STARTED|Second Intervention|One participant withdrew at the end of period 1|12
10691447|NCT02495831|11855925|FG001|STARTED|Second Intervention||10
10691448|NCT02495831|11855924|FG000|COMPLETED|Second Intervention||12
10691449|NCT02495831|11855925|FG001|COMPLETED|Second Intervention||10
10691450|NCT02495831|11855924|FG000|NOT COMPLETED|Second Intervention||0
10691451|NCT02495831|11855925|FG001|NOT COMPLETED|Second Intervention||0
10691452|NCT02495844|11855933|FG000|STARTED|Overall Study||27
10691453|NCT02495844|11855934|FG001|STARTED|Overall Study||28
10691454|NCT02495844|11855933|FG000|COMPLETED|Overall Study||26
10691455|NCT02495844|11855934|FG001|COMPLETED|Overall Study||24
10691456|NCT02495844|11855933|FG000|NOT COMPLETED|Overall Study||1
10691457|NCT02495844|11855934|FG001|NOT COMPLETED|Overall Study||4
10691458|NCT02495857|11855945|FG000|STARTED|Overall Study||200
10691459|NCT02495857|11855946|FG001|STARTED|Overall Study||200
10691460|NCT02495857|11855947|FG002|STARTED|Overall Study||199
10691461|NCT02495857|11855945|FG000|COMPLETED|Overall Study||178
10691462|NCT02495857|11855946|FG001|COMPLETED|Overall Study||184
10691463|NCT02495857|11855947|FG002|COMPLETED|Overall Study||181
10691464|NCT02495857|11855945|FG000|NOT COMPLETED|Overall Study||22
10691465|NCT02495857|11855946|FG001|NOT COMPLETED|Overall Study||16
10691466|NCT02495857|11855947|FG002|NOT COMPLETED|Overall Study||18
10691467|NCT02495883|11855957|FG000|STARTED|Overall Study||32
10691468|NCT02495883|11855958|FG001|STARTED|Overall Study||24
10691469|NCT02495883|11855957|FG000|COMPLETED|Overall Study||31
10691470|NCT02495883|11855958|FG001|COMPLETED|Overall Study||24
10691471|NCT02495883|11855957|FG000|NOT COMPLETED|Overall Study||1
10691472|NCT02495883|11855958|FG001|NOT COMPLETED|Overall Study||0
10691473|NCT02495948|11855963|FG000|STARTED|Period 1, First 30 Days of Wear||83
10691474|NCT02495948|11855964|FG001|STARTED|Period 1, First 30 Days of Wear||84
10691475|NCT02495948|11855963|FG000|COMPLETED|Period 1, First 30 Days of Wear||83
10691476|NCT02495948|11855964|FG001|COMPLETED|Period 1, First 30 Days of Wear||83
10691477|NCT02495948|11855963|FG000|NOT COMPLETED|Period 1, First 30 Days of Wear||0
10691478|NCT02495948|11855964|FG001|NOT COMPLETED|Period 1, First 30 Days of Wear||1
10691479|NCT02495948|11855963|FG000|STARTED|Period 2, Second 30 Days of Wear||83
10691480|NCT02495948|11855964|FG001|STARTED|Period 2, Second 30 Days of Wear||83
10691481|NCT02495948|11855963|FG000|COMPLETED|Period 2, Second 30 Days of Wear||82
10691482|NCT02495948|11855964|FG001|COMPLETED|Period 2, Second 30 Days of Wear||82
10691483|NCT02495948|11855963|FG000|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
10691484|NCT02495948|11855964|FG001|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
10691485|NCT02496000|11855974|FG000|STARTED|Overall Study||64
10691486|NCT02496000|11855975|FG001|STARTED|Overall Study||61
10691487|NCT02496000|11855976|FG002|STARTED|Overall Study||63
10691488|NCT02496000|11855974|FG000|COMPLETED|Overall Study||62
10691489|NCT02496000|11855975|FG001|COMPLETED|Overall Study||56
10691490|NCT02496000|11855976|FG002|COMPLETED|Overall Study||61
10691491|NCT02496000|11855974|FG000|NOT COMPLETED|Overall Study||2
10691492|NCT02496000|11855975|FG001|NOT COMPLETED|Overall Study||5
10691493|NCT02496000|11855976|FG002|NOT COMPLETED|Overall Study||2
10691494|NCT02496091|11855985|FG000|STARTED|Overall Study||144
10691495|NCT02496091|11855985|FG000|COMPLETED|Overall Study||142
10691496|NCT02496091|11855985|FG000|NOT COMPLETED|Overall Study||2
10691497|NCT02496221|11855990|FG000|STARTED|Treatment Period 1 - 4 Days||10
10691498|NCT02496221|11855991|FG001|STARTED|Treatment Period 1 - 4 Days||10
10691499|NCT02496221|11855990|FG000|COMPLETED|Treatment Period 1 - 4 Days||10
10691500|NCT02496221|11855991|FG001|COMPLETED|Treatment Period 1 - 4 Days||10
10691501|NCT02496221|11855990|FG000|NOT COMPLETED|Treatment Period 1 - 4 Days||0
10691502|NCT02496221|11855991|FG001|NOT COMPLETED|Treatment Period 1 - 4 Days||0
10691503|NCT02496221|11855990|FG000|STARTED|Treatment Period 2 - 4 Days||10
10691504|NCT02496221|11855991|FG001|STARTED|Treatment Period 2 - 4 Days||10
10691505|NCT02496221|11855990|FG000|COMPLETED|Treatment Period 2 - 4 Days||8
10691506|NCT02496221|11855991|FG001|COMPLETED|Treatment Period 2 - 4 Days||9
10691507|NCT02496221|11855990|FG000|NOT COMPLETED|Treatment Period 2 - 4 Days||2
10691508|NCT02496221|11855991|FG001|NOT COMPLETED|Treatment Period 2 - 4 Days||1
10691509|NCT02496533|11856001|FG000|STARTED|Overall Study||105
10691510|NCT02496533|11856002|FG001|STARTED|Overall Study||112
10691511|NCT02496533|11856001|FG000|COMPLETED|Overall Study||102
10691512|NCT02496533|11856002|FG001|COMPLETED|Overall Study||106
10691513|NCT02496533|11856001|FG000|NOT COMPLETED|Overall Study||3
10691514|NCT02496533|11856002|FG001|NOT COMPLETED|Overall Study||6
10691515|NCT02496702|11856010|FG000|STARTED|Overall Study||30
10691516|NCT02496702|11856011|FG001|STARTED|Overall Study||30
10691517|NCT02496702|11856010|FG000|Received Allocated Intervention|Overall Study||21
10691518|NCT02496702|11856011|FG001|Received Allocated Intervention|Overall Study||0
10691519|NCT02496702|11856010|FG000|Did Not Receive Allocated Intervention|Overall Study||9
10691520|NCT02496702|11856011|FG001|Did Not Receive Allocated Intervention|Overall Study||0
10691521|NCT02496702|11856010|FG000|COMPLETED|Overall Study||22
10691522|NCT02496702|11856011|FG001|COMPLETED|Overall Study||22
10691523|NCT02496702|11856010|FG000|NOT COMPLETED|Overall Study||8
10691524|NCT02496702|11856011|FG001|NOT COMPLETED|Overall Study||8
10691525|NCT02496767|11856021|FG000|STARTED|Open-label Lead-in Phase||744
10691526|NCT02496767|11856022|FG001|STARTED|Open-label Lead-in Phase||0
10691527|NCT02496767|11856023|FG002|STARTED|Open-label Lead-in Phase||0
10691528|NCT02496767|11856024|FG003|STARTED|Open-label Lead-in Phase||0
10691529|NCT02496767|11856025|FG004|STARTED|Open-label Lead-in Phase||0
10691530|NCT02496767|11856026|FG005|STARTED|Open-label Lead-in Phase||0
10691531|NCT02496767|11856027|FG006|STARTED|Open-label Lead-in Phase||0
10691532|NCT02496767|11856028|FG007|STARTED|Open-label Lead-in Phase||0
10691533|NCT02496767|11856021|FG000|COMPLETED|Open-label Lead-in Phase||565
10691534|NCT02496767|11856022|FG001|COMPLETED|Open-label Lead-in Phase||0
10691535|NCT02496767|11856023|FG002|COMPLETED|Open-label Lead-in Phase||0
10691536|NCT02496767|11856024|FG003|COMPLETED|Open-label Lead-in Phase||0
10691537|NCT02496767|11856025|FG004|COMPLETED|Open-label Lead-in Phase||0
10691538|NCT02496767|11856026|FG005|COMPLETED|Open-label Lead-in Phase||0
10691539|NCT02496767|11856027|FG006|COMPLETED|Open-label Lead-in Phase||0
10691540|NCT02496767|11856028|FG007|COMPLETED|Open-label Lead-in Phase||0
10691541|NCT02496767|11856021|FG000|NOT COMPLETED|Open-label Lead-in Phase||179
10691542|NCT02496767|11856022|FG001|NOT COMPLETED|Open-label Lead-in Phase||0
10691543|NCT02496767|11856023|FG002|NOT COMPLETED|Open-label Lead-in Phase||0
10691544|NCT02496767|11856024|FG003|NOT COMPLETED|Open-label Lead-in Phase||0
10691545|NCT02496767|11856025|FG004|NOT COMPLETED|Open-label Lead-in Phase||0
10691546|NCT02496767|11856026|FG005|NOT COMPLETED|Open-label Lead-in Phase||0
10691547|NCT02496767|11856027|FG006|NOT COMPLETED|Open-label Lead-in Phase||0
10691548|NCT02496767|11856028|FG007|NOT COMPLETED|Open-label Lead-in Phase||0
10691549|NCT02496767|11856021|FG000|STARTED|Double-blind, Placebo-controlled Phase||0
10691550|NCT02496767|11856022|FG001|STARTED|Double-blind, Placebo-controlled Phase||188
10691551|NCT02496767|11856023|FG002|STARTED|Double-blind, Placebo-controlled Phase||126
10691552|NCT02496767|11856024|FG003|STARTED|Double-blind, Placebo-controlled Phase||126
10691553|NCT02496767|11856025|FG004|STARTED|Double-blind, Placebo-controlled Phase||125
10691554|NCT02496767|11856026|FG005|STARTED|Double-blind, Placebo-controlled Phase||0
10691555|NCT02496767|11856027|FG006|STARTED|Double-blind, Placebo-controlled Phase||0
10691556|NCT02496767|11856028|FG007|STARTED|Double-blind, Placebo-controlled Phase||0
10691557|NCT02496767|11856021|FG000|COMPLETED|Double-blind, Placebo-controlled Phase||0
10691558|NCT02496767|11856022|FG001|COMPLETED|Double-blind, Placebo-controlled Phase||132
10691559|NCT02496767|11856023|FG002|COMPLETED|Double-blind, Placebo-controlled Phase||80
10691560|NCT02496767|11856024|FG003|COMPLETED|Double-blind, Placebo-controlled Phase||65
10691561|NCT02496767|11856025|FG004|COMPLETED|Double-blind, Placebo-controlled Phase||59
10691562|NCT02496767|11856026|FG005|COMPLETED|Double-blind, Placebo-controlled Phase||0
10691563|NCT02496767|11856027|FG006|COMPLETED|Double-blind, Placebo-controlled Phase||0
10691564|NCT02496767|11856028|FG007|COMPLETED|Double-blind, Placebo-controlled Phase||0
10691565|NCT02496767|11856021|FG000|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
10691566|NCT02496767|11856022|FG001|NOT COMPLETED|Double-blind, Placebo-controlled Phase||56
10691567|NCT02496767|11856023|FG002|NOT COMPLETED|Double-blind, Placebo-controlled Phase||46
10691568|NCT02496767|11856024|FG003|NOT COMPLETED|Double-blind, Placebo-controlled Phase||61
10691569|NCT02496767|11856025|FG004|NOT COMPLETED|Double-blind, Placebo-controlled Phase||66
10691570|NCT02496767|11856026|FG005|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
10691571|NCT02496767|11856027|FG006|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
10691572|NCT02496767|11856028|FG007|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
10691573|NCT02496767|11856021|FG000|STARTED|Double-blind, Withdrawal Phase||0
10691574|NCT02496767|11856022|FG001|STARTED|Double-blind, Withdrawal Phase||0
10691575|NCT02496767|11856023|FG002|STARTED|Double-blind, Withdrawal Phase||0
10691576|NCT02496767|11856024|FG003|STARTED|Double-blind, Withdrawal Phase||0
10691577|NCT02496767|11856025|FG004|STARTED|Double-blind, Withdrawal Phase||0
10691578|NCT02496767|11856026|FG005|STARTED|Double-blind, Withdrawal Phase||132
10691579|NCT02496767|11856027|FG006|STARTED|Double-blind, Withdrawal Phase||103
10691580|NCT02496767|11856028|FG007|STARTED|Double-blind, Withdrawal Phase||101
10691581|NCT02496767|11856021|FG000|COMPLETED|Double-blind, Withdrawal Phase||0
10691582|NCT02496767|11856022|FG001|COMPLETED|Double-blind, Withdrawal Phase||0
10691583|NCT02496767|11856023|FG002|COMPLETED|Double-blind, Withdrawal Phase||0
10691584|NCT02496767|11856024|FG003|COMPLETED|Double-blind, Withdrawal Phase||0
10691585|NCT02496767|11856025|FG004|COMPLETED|Double-blind, Withdrawal Phase||0
10691586|NCT02496767|11856026|FG005|COMPLETED|Double-blind, Withdrawal Phase||126
10691587|NCT02496767|11856027|FG006|COMPLETED|Double-blind, Withdrawal Phase||99
10691588|NCT02496767|11856028|FG007|COMPLETED|Double-blind, Withdrawal Phase||96
10691589|NCT02496767|11856021|FG000|NOT COMPLETED|Double-blind, Withdrawal Phase||0
10691590|NCT02496767|11856022|FG001|NOT COMPLETED|Double-blind, Withdrawal Phase||0
10691591|NCT02496767|11856023|FG002|NOT COMPLETED|Double-blind, Withdrawal Phase||0
10691592|NCT02496767|11856024|FG003|NOT COMPLETED|Double-blind, Withdrawal Phase||0
10691593|NCT02496767|11856025|FG004|NOT COMPLETED|Double-blind, Withdrawal Phase||0
10691594|NCT02496767|11856026|FG005|NOT COMPLETED|Double-blind, Withdrawal Phase||6
10691595|NCT02496767|11856027|FG006|NOT COMPLETED|Double-blind, Withdrawal Phase||4
10691596|NCT02496767|11856028|FG007|NOT COMPLETED|Double-blind, Withdrawal Phase||5
10691597|NCT02496884|11856046|FG000|STARTED|Overall Study||17
10691598|NCT02496884|11856047|FG001|STARTED|Overall Study||34
10691599|NCT02496884|11856048|FG002|STARTED|Overall Study||1
10691600|NCT02496884|11856049|FG003|STARTED|Overall Study||4
10691601|NCT02496884|11856046|FG000|Safety Analysis Set|Overall Study||17
10691602|NCT02496884|11856047|FG001|Safety Analysis Set|Overall Study||34
10691603|NCT02496884|11856048|FG002|Safety Analysis Set|Overall Study||1
10691604|NCT02496884|11856049|FG003|Safety Analysis Set|Overall Study||4
10691605|NCT02496884|11856046|FG000|Modified Intent to Treat Set (mITT)|Overall Study||17
10691606|NCT02496884|11856047|FG001|Modified Intent to Treat Set (mITT)|Overall Study||34
10691607|NCT02496884|11856048|FG002|Modified Intent to Treat Set (mITT)|Overall Study||1
10691608|NCT02496884|11856049|FG003|Modified Intent to Treat Set (mITT)|Overall Study||4
10691609|NCT02496884|11856046|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||0
10691610|NCT02496884|11856047|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||33
10691611|NCT02496884|11856048|FG002|Pharmacokinetic (PK) Analysis Set|Overall Study||0
10691612|NCT02496884|11856049|FG003|Pharmacokinetic (PK) Analysis Set|Overall Study||4
10691613|NCT02496884|11856046|FG000|Completed Treatment Per Protocol|Overall Study||16
10691614|NCT02496884|11856047|FG001|Completed Treatment Per Protocol|Overall Study||27
10691615|NCT02496884|11856048|FG002|Completed Treatment Per Protocol|Overall Study||1
10691616|NCT02496884|11856049|FG003|Completed Treatment Per Protocol|Overall Study||3
10691617|NCT02496884|11856046|FG000|COMPLETED|Overall Study||15
10691618|NCT02496884|11856047|FG001|COMPLETED|Overall Study||31
10691619|NCT02496884|11856048|FG002|COMPLETED|Overall Study||1
10691620|NCT02496884|11856049|FG003|COMPLETED|Overall Study||4
10691621|NCT02496884|11856046|FG000|NOT COMPLETED|Overall Study||2
10691622|NCT02496884|11856047|FG001|NOT COMPLETED|Overall Study||3
10691623|NCT02496884|11856048|FG002|NOT COMPLETED|Overall Study||0
10691624|NCT02496884|11856049|FG003|NOT COMPLETED|Overall Study||0
10691625|NCT02497001|11856063|FG000|STARTED|Overall Study||640
10691626|NCT02497001|11856064|FG001|STARTED|Overall Study||627
10691627|NCT02497001|11856065|FG002|STARTED|Overall Study||316
10691628|NCT02497001|11856066|FG003|STARTED|Overall Study||319
10691629|NCT02497001|11856063|FG000|COMPLETED|Overall Study||566
10691630|NCT02497001|11856064|FG001|COMPLETED|Overall Study||524
10691631|NCT02497001|11856065|FG002|COMPLETED|Overall Study||266
10691632|NCT02497001|11856066|FG003|COMPLETED|Overall Study||278
10691633|NCT02497001|11856063|FG000|NOT COMPLETED|Overall Study||74
10691634|NCT02497001|11856064|FG001|NOT COMPLETED|Overall Study||103
10691635|NCT02497001|11856065|FG002|NOT COMPLETED|Overall Study||50
10691636|NCT02497001|11856066|FG003|NOT COMPLETED|Overall Study||41
10691637|NCT02497040|11856082|FG000|STARTED|Overall Study||30
10691638|NCT02497040|11856083|FG001|STARTED|Overall Study||30
10691639|NCT02497040|11856084|FG002|STARTED|Overall Study||30
10691640|NCT02497040|11856082|FG000|COMPLETED|Overall Study||30
10691641|NCT02497040|11856083|FG001|COMPLETED|Overall Study||30
10691642|NCT02497040|11856084|FG002|COMPLETED|Overall Study||30
10691643|NCT02497040|11856082|FG000|NOT COMPLETED|Overall Study||0
10691644|NCT02497040|11856083|FG001|NOT COMPLETED|Overall Study||0
10691645|NCT02497040|11856084|FG002|NOT COMPLETED|Overall Study||0
10691646|NCT02497235|11856097|FG000|STARTED|Overall Study||2
10691647|NCT02497235|11856098|FG001|STARTED|Overall Study||2
10691648|NCT02497235|11856099|FG002|STARTED|Overall Study||2
10691649|NCT02497235|11856100|FG003|STARTED|Overall Study||2
10691650|NCT02497235|11856101|FG004|STARTED|Overall Study||3
10691651|NCT02497235|11856097|FG000|COMPLETED|Overall Study||2
10691652|NCT02497235|11856098|FG001|COMPLETED|Overall Study||2
10691653|NCT02497235|11856099|FG002|COMPLETED|Overall Study||2
10691654|NCT02497235|11856100|FG003|COMPLETED|Overall Study||2
10691655|NCT02497235|11856101|FG004|COMPLETED|Overall Study||3
10691656|NCT02497235|11856097|FG000|NOT COMPLETED|Overall Study||0
10691657|NCT02497235|11856098|FG001|NOT COMPLETED|Overall Study||0
10691658|NCT02497235|11856099|FG002|NOT COMPLETED|Overall Study||0
10691659|NCT02497235|11856100|FG003|NOT COMPLETED|Overall Study||0
10691660|NCT02497235|11856101|FG004|NOT COMPLETED|Overall Study||0
10691661|NCT02497287|11856116|FG000|STARTED|Induction Phase (4 Weeks)|Included DE participants (691) and non-responders from TRD3005 (88).|779
10691662|NCT02497287|11856116|FG000|COMPLETED|Induction Phase (4 Weeks)||580
10691663|NCT02497287|11856116|FG000|NOT COMPLETED|Induction Phase (4 Weeks)||199
10691664|NCT02497287|11856116|FG000|STARTED|Optimization/Maintenance (48 Weeks)|Included who completed IND phase (580) + responders from TRD3005 (23).|603
10691665|NCT02497287|11856116|FG000|COMPLETED|Optimization/Maintenance (48 Weeks)||150
10691666|NCT02497287|11856116|FG000|NOT COMPLETED|Optimization/Maintenance (48 Weeks)||453
10800396|NCT04499599|11961390|FG001|COMPLETED|Overall Study||35
10800397|NCT04499599|11961391|FG002|COMPLETED|Overall Study||35
10800398|NCT04499599|11961389|FG000|NOT COMPLETED|Overall Study||0
10800399|NCT04499599|11961390|FG001|NOT COMPLETED|Overall Study||0
10800400|NCT04499599|11961391|FG002|NOT COMPLETED|Overall Study||0
10800401|NCT04525157|11961399|FG000|STARTED|Overall Study||18
10800402|NCT04525157|11961399|FG000|COMPLETED|Overall Study||15
10800403|NCT04525157|11961399|FG000|NOT COMPLETED|Overall Study||3
10800404|NCT04523831|11961405|FG000|STARTED|Overall Study||200
10800405|NCT04523831|11961406|FG001|STARTED|Overall Study||200
10800406|NCT04523831|11961405|FG000|COMPLETED|Overall Study||183
10800407|NCT04523831|11961406|FG001|COMPLETED|Overall Study||180
10800408|NCT04523831|11961405|FG000|NOT COMPLETED|Overall Study||17
10800409|NCT04523831|11961406|FG001|NOT COMPLETED|Overall Study||20
10800410|NCT04521777|11961415|FG000|STARTED|Overall Study||24
10800411|NCT04521777|11961415|FG000|COMPLETED|Overall Study||20
10800412|NCT04521777|11961415|FG000|NOT COMPLETED|Overall Study||4
10800413|NCT04512703|11961421|FG000|STARTED|Within 7 Days From Start of Device Wear||6
10800414|NCT04512703|11961422|FG001|STARTED|Within 7 Days From Start of Device Wear||45
10800415|NCT04512703|11961421|FG000|Wore Front Position|Within 7 Days From Start of Device Wear||6
10800416|NCT04512703|11961422|FG001|Wore Front Position|Within 7 Days From Start of Device Wear||45
10800417|NCT04512703|11961421|FG000|Wore Side Position|Within 7 Days From Start of Device Wear||6
10800418|NCT04512703|11961422|FG001|Wore Side Position|Within 7 Days From Start of Device Wear||45
10800419|NCT04512703|11961421|FG000|COMPLETED|Within 7 Days From Start of Device Wear||6
10800420|NCT04512703|11961422|FG001|COMPLETED|Within 7 Days From Start of Device Wear||45
10800421|NCT04512703|11961421|FG000|NOT COMPLETED|Within 7 Days From Start of Device Wear||0
10800422|NCT04512703|11961422|FG001|NOT COMPLETED|Within 7 Days From Start of Device Wear||0
10800423|NCT04512703|11961421|FG000|STARTED|Between 7th and 90th Day of Device Wear||6
10800424|NCT04512703|11961422|FG001|STARTED|Between 7th and 90th Day of Device Wear||45
10800425|NCT04512703|11961421|FG000|Wore Side Position Device|Between 7th and 90th Day of Device Wear||3
10800426|NCT04512703|11961422|FG001|Wore Side Position Device|Between 7th and 90th Day of Device Wear||23
10800427|NCT04512703|11961421|FG000|Wore Front Position Device|Between 7th and 90th Day of Device Wear||3
10800428|NCT04512703|11961422|FG001|Wore Front Position Device|Between 7th and 90th Day of Device Wear||22
10800429|NCT04512703|11961421|FG000|COMPLETED|Between 7th and 90th Day of Device Wear||6
10800430|NCT04512703|11961422|FG001|COMPLETED|Between 7th and 90th Day of Device Wear||45
10800431|NCT04512703|11961421|FG000|NOT COMPLETED|Between 7th and 90th Day of Device Wear||0
10800432|NCT04512703|11961422|FG001|NOT COMPLETED|Between 7th and 90th Day of Device Wear||0
10800433|NCT04511520|11961434|FG000|STARTED|Overall Study||24
10800434|NCT04511520|11961435|FG001|STARTED|Overall Study||24
10800435|NCT04511520|11961436|FG002|STARTED|Overall Study||24
10800436|NCT04511520|11961434|FG000|COMPLETED|Overall Study||24
10800437|NCT04511520|11961435|FG001|COMPLETED|Overall Study||24
10800438|NCT04511520|11961436|FG002|COMPLETED|Overall Study||24
10800439|NCT04511520|11961434|FG000|NOT COMPLETED|Overall Study||0
10800440|NCT04511520|11961435|FG001|NOT COMPLETED|Overall Study||0
10800441|NCT04511520|11961436|FG002|NOT COMPLETED|Overall Study||0
10800442|NCT04507776|11961445|FG000|STARTED|Overall Study||763
10800443|NCT04507776|11961445|FG000|COMPLETED|Overall Study||562
10800444|NCT04507776|11961445|FG000|NOT COMPLETED|Overall Study||201
10800445|NCT04502979|11961456|FG000|STARTED|Overall Study||37
10800446|NCT04502979|11961457|FG001|STARTED|Overall Study||34
10800447|NCT04502979|11961456|FG000|COMPLETED|Overall Study||34
10800448|NCT04502979|11961457|FG001|COMPLETED|Overall Study||30
10800449|NCT04502979|11961456|FG000|NOT COMPLETED|Overall Study||3
10800450|NCT04502979|11961457|FG001|NOT COMPLETED|Overall Study||4
10800451|NCT04502056|11961465|FG000|STARTED|Overall Study||2046
10800452|NCT04502056|11961466|FG001|STARTED|Overall Study||2044
10800453|NCT04502056|11961467|FG002|STARTED|Overall Study||2045
10800454|NCT04502056|11961468|FG003|STARTED|Overall Study||2046
10691667|NCT02497287|11856116|FG000|STARTED|Follow-up Phase (4 Week)|Included non-responders (IND phase) or discontinued treatment phase or completed OP/MA phase.|357
10691668|NCT02497287|11856116|FG000|COMPLETED|Follow-up Phase (4 Week)||326
10691669|NCT02497287|11856116|FG000|NOT COMPLETED|Follow-up Phase (4 Week)||31
10691670|NCT02497391|11856122|FG000|STARTED|Period 1 (14 Days)||16
10691671|NCT02497391|11856123|FG001|STARTED|Period 1 (14 Days)||15
10691672|NCT02497391|11856124|FG002|STARTED|Period 1 (14 Days)||16
10691673|NCT02497391|11856125|FG003|STARTED|Period 1 (14 Days)||16
10691674|NCT02497391|11856126|FG004|STARTED|Period 1 (14 Days)||16
10800455|NCT04502056|11961469|FG004|STARTED|Overall Study||2044
10800456|NCT04502056|11961470|FG005|STARTED|Overall Study||2052
10691675|NCT02497391|11856127|FG005|STARTED|Period 1 (14 Days)||16
10691676|NCT02497391|11856122|FG000|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
10691677|NCT02497391|11856123|FG001|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||15
10691678|NCT02497391|11856124|FG002|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
10691679|NCT02497391|11856125|FG003|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
10691680|NCT02497391|11856126|FG004|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
10691681|NCT02497391|11856127|FG005|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
10691682|NCT02497391|11856122|FG000|COMPLETED|Period 1 (14 Days)||16
10691683|NCT02497391|11856123|FG001|COMPLETED|Period 1 (14 Days)||15
10691684|NCT02497391|11856124|FG002|COMPLETED|Period 1 (14 Days)||16
10691685|NCT02497391|11856125|FG003|COMPLETED|Period 1 (14 Days)||16
10691686|NCT02497391|11856126|FG004|COMPLETED|Period 1 (14 Days)||16
10691687|NCT02497391|11856127|FG005|COMPLETED|Period 1 (14 Days)||16
10691688|NCT02497391|11856122|FG000|NOT COMPLETED|Period 1 (14 Days)||0
10691689|NCT02497391|11856123|FG001|NOT COMPLETED|Period 1 (14 Days)||0
10691690|NCT02497391|11856124|FG002|NOT COMPLETED|Period 1 (14 Days)||0
10691691|NCT02497391|11856125|FG003|NOT COMPLETED|Period 1 (14 Days)||0
10691692|NCT02497391|11856126|FG004|NOT COMPLETED|Period 1 (14 Days)||0
10691693|NCT02497391|11856127|FG005|NOT COMPLETED|Period 1 (14 Days)||0
10691694|NCT02497391|11856122|FG000|STARTED|Period 2 (14 Days)||16
10691695|NCT02497391|11856123|FG001|STARTED|Period 2 (14 Days)||15
10691696|NCT02497391|11856124|FG002|STARTED|Period 2 (14 Days)||16
10800457|NCT04502056|11961471|FG006|STARTED|Overall Study||2046
10800458|NCT04502056|11961472|FG007|STARTED|Overall Study||2043
10800459|NCT04502056|11961473|FG008|STARTED|Overall Study||1026
10800460|NCT04502056|11961474|FG009|STARTED|Overall Study||1025
10800461|NCT04502056|11961475|FG010|STARTED|Overall Study||1023
10800462|NCT04502056|11961476|FG011|STARTED|Overall Study||1020
10691697|NCT02497391|11856125|FG003|STARTED|Period 2 (14 Days)||16
10691698|NCT02497391|11856126|FG004|STARTED|Period 2 (14 Days)||16
10691699|NCT02497391|11856127|FG005|STARTED|Period 2 (14 Days)||16
10800463|NCT04502056|11961465|FG000|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1859
10800464|NCT04502056|11961466|FG001|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1881
10800465|NCT04502056|11961467|FG002|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1879
10800466|NCT04502056|11961468|FG003|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1886
10800467|NCT04502056|11961469|FG004|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1846
10800468|NCT04502056|11961470|FG005|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1877
10800469|NCT04502056|11961471|FG006|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1888
10800470|NCT04502056|11961472|FG007|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1883
10800471|NCT04502056|11961473|FG008|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||947
10800472|NCT04502056|11961474|FG009|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||942
10800473|NCT04502056|11961475|FG010|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||946
10800474|NCT04502056|11961476|FG011|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||928
10800475|NCT04502056|11961465|FG000|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1799
10800476|NCT04502056|11961466|FG001|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1828
10800477|NCT04502056|11961467|FG002|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1830
10800478|NCT04502056|11961468|FG003|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1835
10800479|NCT04502056|11961469|FG004|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1792
10800480|NCT04502056|11961470|FG005|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1820
10800481|NCT04502056|11961471|FG006|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1821
10800482|NCT04502056|11961472|FG007|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1844
10800483|NCT04502056|11961473|FG008|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||914
10800484|NCT04502056|11961474|FG009|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||912
10800485|NCT04502056|11961475|FG010|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||928
10800486|NCT04502056|11961476|FG011|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||900
10800487|NCT04502056|11961465|FG000|Completed the Follow-up Survey|Overall Study||608
10800488|NCT04502056|11961466|FG001|Completed the Follow-up Survey|Overall Study||607
10800489|NCT04502056|11961467|FG002|Completed the Follow-up Survey|Overall Study||591
10800490|NCT04502056|11961468|FG003|Completed the Follow-up Survey|Overall Study||601
10810986|NCT03783130|11972701|FG001|STARTED|Overall Study||3
10691700|NCT02497391|11856122|FG000|COMPLETED|Period 2 (14 Days)||12
10691701|NCT02497391|11856123|FG001|COMPLETED|Period 2 (14 Days)||14
10691702|NCT02497391|11856124|FG002|COMPLETED|Period 2 (14 Days)||13
10691703|NCT02497391|11856125|FG003|COMPLETED|Period 2 (14 Days)||13
10691704|NCT02497391|11856126|FG004|COMPLETED|Period 2 (14 Days)||14
10691705|NCT02497391|11856127|FG005|COMPLETED|Period 2 (14 Days)||13
10691706|NCT02497391|11856122|FG000|NOT COMPLETED|Period 2 (14 Days)||4
10691707|NCT02497391|11856123|FG001|NOT COMPLETED|Period 2 (14 Days)||1
10800491|NCT04502056|11961469|FG004|Completed the Follow-up Survey|Overall Study||631
10800492|NCT04502056|11961470|FG005|Completed the Follow-up Survey|Overall Study||598
10691708|NCT02497391|11856124|FG002|NOT COMPLETED|Period 2 (14 Days)||3
10691709|NCT02497391|11856125|FG003|NOT COMPLETED|Period 2 (14 Days)||3
10691710|NCT02497391|11856126|FG004|NOT COMPLETED|Period 2 (14 Days)||2
10691711|NCT02497391|11856127|FG005|NOT COMPLETED|Period 2 (14 Days)||3
10691712|NCT02497391|11856122|FG000|STARTED|Period 3 (14 Days)||12
10691713|NCT02497391|11856123|FG001|STARTED|Period 3 (14 Days)||14
10691714|NCT02497391|11856124|FG002|STARTED|Period 3 (14 Days)||13
10691715|NCT02497391|11856125|FG003|STARTED|Period 3 (14 Days)||13
10691716|NCT02497391|11856126|FG004|STARTED|Period 3 (14 Days)||14
10691717|NCT02497391|11856127|FG005|STARTED|Period 3 (14 Days)||13
10691718|NCT02497391|11856122|FG000|COMPLETED|Period 3 (14 Days)||12
10691719|NCT02497391|11856123|FG001|COMPLETED|Period 3 (14 Days)||13
10691720|NCT02497391|11856124|FG002|COMPLETED|Period 3 (14 Days)||12
10691721|NCT02497391|11856125|FG003|COMPLETED|Period 3 (14 Days)||13
10691722|NCT02497391|11856126|FG004|COMPLETED|Period 3 (14 Days)||13
10691723|NCT02497391|11856127|FG005|COMPLETED|Period 3 (14 Days)||13
10691724|NCT02497391|11856122|FG000|NOT COMPLETED|Period 3 (14 Days)||0
10691725|NCT02497391|11856123|FG001|NOT COMPLETED|Period 3 (14 Days)||1
10691726|NCT02497391|11856124|FG002|NOT COMPLETED|Period 3 (14 Days)||1
10691727|NCT02497391|11856125|FG003|NOT COMPLETED|Period 3 (14 Days)||0
10691728|NCT02497391|11856126|FG004|NOT COMPLETED|Period 3 (14 Days)||1
10691729|NCT02497391|11856127|FG005|NOT COMPLETED|Period 3 (14 Days)||0
10691730|NCT02497404|11856135|FG000|STARTED|Overall Study||40
10691731|NCT02497404|11856135|FG000|COMPLETED|Overall Study||39
10691732|NCT02497404|11856135|FG000|NOT COMPLETED|Overall Study||1
10691733|NCT02497469|11856141|FG000|STARTED|Overall Study||386
10691734|NCT02497469|11856142|FG001|STARTED|Overall Study||385
10691735|NCT02497469|11856141|FG000|Safety Analysis Set|Overall Study||386
10691736|NCT02497469|11856142|FG001|Safety Analysis Set|Overall Study||383
10691737|NCT02497469|11856141|FG000|COMPLETED|Overall Study||217
10691738|NCT02497469|11856142|FG001|COMPLETED|Overall Study||270
10691739|NCT02497469|11856141|FG000|NOT COMPLETED|Overall Study||169
10691740|NCT02497469|11856142|FG001|NOT COMPLETED|Overall Study||115
10691741|NCT02497755|11856150|FG000|STARTED|Overall Study||18
10691742|NCT02497755|11856151|FG001|STARTED|Overall Study||1
10691743|NCT02497755|11856150|FG000|COMPLETED|Overall Study||17
10691744|NCT02497755|11856151|FG001|COMPLETED|Overall Study||1
10800493|NCT04502056|11961471|FG006|Completed the Follow-up Survey|Overall Study||607
10800494|NCT04502056|11961472|FG007|Completed the Follow-up Survey|Overall Study||607
10800495|NCT04502056|11961473|FG008|Completed the Follow-up Survey|Overall Study||301
10800496|NCT04502056|11961474|FG009|Completed the Follow-up Survey|Overall Study||313
10800497|NCT04502056|11961475|FG010|Completed the Follow-up Survey|Overall Study||291
10800498|NCT04502056|11961476|FG011|Completed the Follow-up Survey|Overall Study||316
10800499|NCT04502056|11961465|FG000|COMPLETED|Overall Study||604
10800500|NCT04502056|11961466|FG001|COMPLETED|Overall Study||602
10800501|NCT04502056|11961467|FG002|COMPLETED|Overall Study||586
10800502|NCT04502056|11961468|FG003|COMPLETED|Overall Study||597
10800503|NCT04502056|11961469|FG004|COMPLETED|Overall Study||626
10800504|NCT04502056|11961470|FG005|COMPLETED|Overall Study||596
10800505|NCT04502056|11961471|FG006|COMPLETED|Overall Study||605
10800506|NCT04502056|11961472|FG007|COMPLETED|Overall Study||603
10800507|NCT04502056|11961473|FG008|COMPLETED|Overall Study||298
10800508|NCT04502056|11961474|FG009|COMPLETED|Overall Study||311
10800509|NCT04502056|11961475|FG010|COMPLETED|Overall Study||288
10800510|NCT04502056|11961476|FG011|COMPLETED|Overall Study||614
10800511|NCT04502056|11961465|FG000|NOT COMPLETED|Overall Study||1442
10800512|NCT04502056|11961466|FG001|NOT COMPLETED|Overall Study||1442
10800513|NCT04502056|11961467|FG002|NOT COMPLETED|Overall Study||1459
10800514|NCT04502056|11961468|FG003|NOT COMPLETED|Overall Study||1449
10800515|NCT04502056|11961469|FG004|NOT COMPLETED|Overall Study||1418
10800516|NCT04502056|11961470|FG005|NOT COMPLETED|Overall Study||1456
10800517|NCT04502056|11961471|FG006|NOT COMPLETED|Overall Study||1441
10800518|NCT04502056|11961472|FG007|NOT COMPLETED|Overall Study||1440
10800519|NCT04502056|11961473|FG008|NOT COMPLETED|Overall Study||728
10800520|NCT04502056|11961474|FG009|NOT COMPLETED|Overall Study||714
10800521|NCT04502056|11961475|FG010|NOT COMPLETED|Overall Study||735
10800522|NCT04502056|11961476|FG011|NOT COMPLETED|Overall Study||406
10800523|NCT04498403|11961500|FG000|STARTED|Overall Study||30
10800524|NCT04498403|11961501|FG001|STARTED|Overall Study||10
10800525|NCT04498403|11961500|FG000|Completed Follow up|Overall Study||30
10800526|NCT04498403|11961501|FG001|Completed Follow up|Overall Study||10
10800527|NCT04498403|11961500|FG000|COMPLETED|Overall Study||0
10800528|NCT04498403|11961501|FG001|COMPLETED|Overall Study||0
10800529|NCT04498403|11961500|FG000|NOT COMPLETED|Overall Study||30
10691745|NCT02497755|11856150|FG000|NOT COMPLETED|Overall Study||1
10691746|NCT02497755|11856151|FG001|NOT COMPLETED|Overall Study||0
10691747|NCT02497781|11856160|FG000|STARTED|Overall Study||68
10691748|NCT02497781|11856161|FG001|STARTED|Overall Study||29
10691749|NCT02497781|11856160|FG000|Treated|Overall Study||67
10691750|NCT02497781|11856161|FG001|Treated|Overall Study||28
10691751|NCT02497781|11856160|FG000|COMPLETED|Overall Study||64
10691752|NCT02497781|11856161|FG001|COMPLETED|Overall Study||26
10800530|NCT04498403|11961501|FG001|NOT COMPLETED|Overall Study||10
10800531|NCT04495374|11961509|FG000|STARTED|Overall Study||30
10800532|NCT04495374|11961510|FG001|STARTED|Overall Study||28
10800533|NCT04495374|11961509|FG000|COMPLETED|Overall Study||28
10800534|NCT04495374|11961510|FG001|COMPLETED|Overall Study||27
10800535|NCT04495374|11961509|FG000|NOT COMPLETED|Overall Study||2
10691753|NCT02497781|11856160|FG000|NOT COMPLETED|Overall Study||4
10691754|NCT02497781|11856161|FG001|NOT COMPLETED|Overall Study||3
10691755|NCT02497937|11856167|FG000|STARTED|Period 1 (Up to 7 Days)||6
10691756|NCT02497937|11856168|FG001|STARTED|Period 1 (Up to 7 Days)||5
10691757|NCT02497937|11856167|FG000|COMPLETED|Period 1 (Up to 7 Days)||6
10691758|NCT02497937|11856168|FG001|COMPLETED|Period 1 (Up to 7 Days)||5
10691759|NCT02497937|11856167|FG000|NOT COMPLETED|Period 1 (Up to 7 Days)||0
10691760|NCT02497937|11856168|FG001|NOT COMPLETED|Period 1 (Up to 7 Days)||0
10691761|NCT02497937|11856167|FG000|STARTED|Washout Period (Up to 14 Days)||6
10691762|NCT02497937|11856168|FG001|STARTED|Washout Period (Up to 14 Days)||5
10691763|NCT02497937|11856167|FG000|COMPLETED|Washout Period (Up to 14 Days)||6
10691764|NCT02497937|11856168|FG001|COMPLETED|Washout Period (Up to 14 Days)||5
10691765|NCT02497937|11856167|FG000|NOT COMPLETED|Washout Period (Up to 14 Days)||0
10691766|NCT02497937|11856168|FG001|NOT COMPLETED|Washout Period (Up to 14 Days)||0
10691767|NCT02497937|11856167|FG000|STARTED|Period 2 (Up to 7 Days)||6
10691768|NCT02497937|11856168|FG001|STARTED|Period 2 (Up to 7 Days)||5
10691769|NCT02497937|11856167|FG000|COMPLETED|Period 2 (Up to 7 Days)||6
10691770|NCT02497937|11856168|FG001|COMPLETED|Period 2 (Up to 7 Days)||5
10691771|NCT02497937|11856167|FG000|NOT COMPLETED|Period 2 (Up to 7 Days)||0
10691772|NCT02497937|11856168|FG001|NOT COMPLETED|Period 2 (Up to 7 Days)||0
10691773|NCT02497976|11856177|FG000|STARTED|Overall Study||28
10691774|NCT02497976|11856178|FG001|STARTED|Overall Study||14
10691775|NCT02497976|11856177|FG000|COMPLETED|Overall Study||26
10691776|NCT02497976|11856178|FG001|COMPLETED|Overall Study||13
10691777|NCT02497976|11856177|FG000|NOT COMPLETED|Overall Study||2
10691778|NCT02497976|11856178|FG001|NOT COMPLETED|Overall Study||1
10691779|NCT02498067|11856184|FG000|STARTED|Overall Study||104
10691780|NCT02498067|11856184|FG000|COMPLETED|Overall Study||71
10691781|NCT02498067|11856184|FG000|NOT COMPLETED|Overall Study||33
10691782|NCT02498236|11856198|FG000|STARTED|Overall Study||6
10691783|NCT02498236|11856199|FG001|STARTED|Overall Study||6
10691784|NCT02498236|11856200|FG002|STARTED|Overall Study||6
10800536|NCT04495374|11961510|FG001|NOT COMPLETED|Overall Study||1
10800537|NCT04495712|11961518|FG000|STARTED|Overall Study||44
10800538|NCT04495712|11961519|FG001|STARTED|Overall Study||46
10800539|NCT04495712|11961518|FG000|COMPLETED|Overall Study||44
10800540|NCT04495712|11961519|FG001|COMPLETED|Overall Study||46
10800541|NCT04495712|11961518|FG000|NOT COMPLETED|Overall Study||0
10800542|NCT04495712|11961519|FG001|NOT COMPLETED|Overall Study||0
10800543|NCT04492397|11961525|FG000|STARTED|First Intervention||17
10800544|NCT04492397|11961526|FG001|STARTED|First Intervention||18
10800545|NCT04492397|11961525|FG000|COMPLETED|First Intervention||17
10800546|NCT04492397|11961526|FG001|COMPLETED|First Intervention||18
10800547|NCT04492397|11961525|FG000|NOT COMPLETED|First Intervention||0
10800548|NCT04492397|11961526|FG001|NOT COMPLETED|First Intervention||0
10800549|NCT04492397|11961525|FG000|STARTED|Second Intervention||17
10800550|NCT04492397|11961526|FG001|STARTED|Second Intervention||18
10800551|NCT04492397|11961525|FG000|COMPLETED|Second Intervention||17
10800552|NCT04492397|11961526|FG001|COMPLETED|Second Intervention||18
10800553|NCT04492397|11961525|FG000|NOT COMPLETED|Second Intervention||0
10800554|NCT04492397|11961526|FG001|NOT COMPLETED|Second Intervention||0
10800555|NCT04491994|11961534|FG000|STARTED|Overall Study||180
10800556|NCT04491994|11961535|FG001|STARTED|Overall Study||360
10800557|NCT04491994|11961534|FG000|COMPLETED|Overall Study||151
10800558|NCT04491994|11961535|FG001|COMPLETED|Overall Study||349
10800559|NCT04491994|11961534|FG000|NOT COMPLETED|Overall Study||29
10800560|NCT04491994|11961535|FG001|NOT COMPLETED|Overall Study||11
10800561|NCT04491240|11961544|FG000|STARTED|Overall Study||10
10800562|NCT04491240|11961545|FG001|STARTED|Overall Study||10
10800563|NCT04491240|11961546|FG002|STARTED|Overall Study||10
10800564|NCT04491240|11961544|FG000|COMPLETED|Overall Study||10
10800565|NCT04491240|11961545|FG001|COMPLETED|Overall Study||10
10800566|NCT04491240|11961546|FG002|COMPLETED|Overall Study||10
10800567|NCT04491240|11961544|FG000|NOT COMPLETED|Overall Study||0
10800568|NCT04491240|11961545|FG001|NOT COMPLETED|Overall Study||0
10800569|NCT04491240|11961546|FG002|NOT COMPLETED|Overall Study||0
10800570|NCT04490863|11961554|FG000|STARTED|Overall Study||26
10800571|NCT04490863|11961554|FG000|COMPLETED|Overall Study||26
10800572|NCT04490863|11961554|FG000|NOT COMPLETED|Overall Study||0
10800577|NCT04490239|11961562|FG000|STARTED|1000 U Acute (One Dose, Day 1)||6
10800578|NCT04490239|11961562|FG000|COMPLETED|1000 U Acute (One Dose, Day 1)||6
10800579|NCT04490239|11961562|FG000|NOT COMPLETED|1000 U Acute (One Dose, Day 1)||0
10800580|NCT04490239|11961562|FG000|STARTED|2000 U Acute (One Dose, Day 3)||6
10800581|NCT04490239|11961562|FG000|COMPLETED|2000 U Acute (One Dose, Day 3)||6
10800582|NCT04490239|11961562|FG000|NOT COMPLETED|2000 U Acute (One Dose, Day 3)||0
10800583|NCT04490239|11961562|FG000|STARTED|2000 U Chronic (Daily, 14 Days)||6
10800584|NCT04490239|11961562|FG000|COMPLETED|2000 U Chronic (Daily, 14 Days)||6
10800585|NCT04490239|11961562|FG000|NOT COMPLETED|2000 U Chronic (Daily, 14 Days)||0
10691785|NCT02498236|11856201|FG003|STARTED|Overall Study||6
10691786|NCT02498236|11856202|FG004|STARTED|Overall Study||7
10691787|NCT02498236|11856203|FG005|STARTED|Overall Study||6
10800586|NCT04486235|11961568|FG000|STARTED|Overall Study||32
10691788|NCT02498236|11856204|FG006|STARTED|Overall Study||7
10800587|NCT04486235|11961569|FG001|STARTED|Overall Study||30
10800588|NCT04486235|11961568|FG000|Analysis|Overall Study||30
10691789|NCT02498236|11856205|FG007|STARTED|Overall Study||7
10691790|NCT02498236|11856198|FG000|Randomized|Overall Study||6
10691791|NCT02498236|11856199|FG001|Randomized|Overall Study||6
10691792|NCT02498236|11856200|FG002|Randomized|Overall Study||6
10691793|NCT02498236|11856201|FG003|Randomized|Overall Study||6
10691794|NCT02498236|11856202|FG004|Randomized|Overall Study||7
10691795|NCT02498236|11856203|FG005|Randomized|Overall Study||6
10691796|NCT02498236|11856204|FG006|Randomized|Overall Study||7
10691797|NCT02498236|11856205|FG007|Randomized|Overall Study||7
10691798|NCT02498236|11856198|FG000|COMPLETED|Overall Study||5
10691799|NCT02498236|11856199|FG001|COMPLETED|Overall Study||6
10691800|NCT02498236|11856200|FG002|COMPLETED|Overall Study||6
10691801|NCT02498236|11856201|FG003|COMPLETED|Overall Study||6
10691802|NCT02498236|11856202|FG004|COMPLETED|Overall Study||6
10691803|NCT02498236|11856203|FG005|COMPLETED|Overall Study||6
10691804|NCT02498236|11856204|FG006|COMPLETED|Overall Study||6
10691805|NCT02498236|11856205|FG007|COMPLETED|Overall Study||6
10691806|NCT02498236|11856198|FG000|NOT COMPLETED|Overall Study||1
10691807|NCT02498236|11856199|FG001|NOT COMPLETED|Overall Study||0
10691808|NCT02498236|11856200|FG002|NOT COMPLETED|Overall Study||0
10691809|NCT02498236|11856201|FG003|NOT COMPLETED|Overall Study||0
10691810|NCT02498236|11856202|FG004|NOT COMPLETED|Overall Study||1
10691811|NCT02498236|11856203|FG005|NOT COMPLETED|Overall Study||0
10691812|NCT02498236|11856204|FG006|NOT COMPLETED|Overall Study||1
10691813|NCT02498236|11856205|FG007|NOT COMPLETED|Overall Study||1
10691814|NCT02498418|11856229|FG000|STARTED|Overall Study||247
10691815|NCT02498418|11856230|FG001|STARTED|Overall Study||248
10691816|NCT02498418|11856231|FG002|STARTED|Overall Study||244
10691817|NCT02498418|11856229|FG000|Safety Population|Overall Study||246
10691818|NCT02498418|11856230|FG001|Safety Population|Overall Study||247
10691819|NCT02498418|11856231|FG002|Safety Population|Overall Study||244
10691820|NCT02498418|11856229|FG000|Modified Intent-to-treat Population|Overall Study||183
10691821|NCT02498418|11856230|FG001|Modified Intent-to-treat Population|Overall Study||186
10691822|NCT02498418|11856231|FG002|Modified Intent-to-treat Population|Overall Study||180
10691823|NCT02498418|11856229|FG000|Per-protocol Analysis Set|Overall Study||182
10691824|NCT02498418|11856230|FG001|Per-protocol Analysis Set|Overall Study||181
10691825|NCT02498418|11856231|FG002|Per-protocol Analysis Set|Overall Study||176
10691826|NCT02498418|11856229|FG000|COMPLETED|Overall Study||245
10691827|NCT02498418|11856230|FG001|COMPLETED|Overall Study||246
10691828|NCT02498418|11856231|FG002|COMPLETED|Overall Study||238
10691829|NCT02498418|11856229|FG000|NOT COMPLETED|Overall Study||2
10691830|NCT02498418|11856230|FG001|NOT COMPLETED|Overall Study||2
10691831|NCT02498418|11856231|FG002|NOT COMPLETED|Overall Study||6
10691832|NCT02498483|11856241|FG000|STARTED|Overall Study||6
10691833|NCT02498483|11856242|FG001|STARTED|Overall Study||5
10691834|NCT02498483|11856241|FG000|COMPLETED|Overall Study||6
10691835|NCT02498483|11856242|FG001|COMPLETED|Overall Study||5
10691836|NCT02498483|11856241|FG000|NOT COMPLETED|Overall Study||0
10691837|NCT02498483|11856242|FG001|NOT COMPLETED|Overall Study||0
10691838|NCT02498522|11856250|FG000|STARTED|Overall Study||85
10691839|NCT02498522|11856251|FG001|STARTED|Overall Study||85
10691840|NCT02498522|11856250|FG000|COMPLETED|Overall Study||83
10691841|NCT02498522|11856251|FG001|COMPLETED|Overall Study||83
10691842|NCT02498522|11856250|FG000|NOT COMPLETED|Overall Study||2
10691843|NCT02498522|11856251|FG001|NOT COMPLETED|Overall Study||2
10691844|NCT02498652|11856259|FG000|STARTED|Overall Study||20
10691845|NCT02498652|11856260|FG001|STARTED|Overall Study||21
10691846|NCT02498652|11856259|FG000|COMPLETED|Overall Study||20
10691847|NCT02498652|11856260|FG001|COMPLETED|Overall Study|One subject was withdrawn due to noncompliance/protocol violation|20
10800589|NCT04486235|11961569|FG001|Analysis|Overall Study||30
10800590|NCT04486235|11961568|FG000|COMPLETED|Overall Study||30
10800591|NCT04486235|11961569|FG001|COMPLETED|Overall Study||30
10800592|NCT04486235|11961568|FG000|NOT COMPLETED|Overall Study||2
10800593|NCT04486235|11961569|FG001|NOT COMPLETED|Overall Study||0
10800594|NCT04483011|11961578|FG000|STARTED|Intervention Period 1 (8 Days)||9
10800595|NCT04483011|11961579|FG001|STARTED|Intervention Period 1 (8 Days)||9
10800596|NCT04483011|11961578|FG000|COMPLETED|Intervention Period 1 (8 Days)||9
10800597|NCT04483011|11961579|FG001|COMPLETED|Intervention Period 1 (8 Days)||9
10800598|NCT04483011|11961578|FG000|NOT COMPLETED|Intervention Period 1 (8 Days)||0
10800599|NCT04483011|11961579|FG001|NOT COMPLETED|Intervention Period 1 (8 Days)||0
10800600|NCT04483011|11961578|FG000|STARTED|Washout (7 Days)||9
10800601|NCT04483011|11961579|FG001|STARTED|Washout (7 Days)||9
10800602|NCT04483011|11961578|FG000|COMPLETED|Washout (7 Days)||9
10800603|NCT04483011|11961579|FG001|COMPLETED|Washout (7 Days)||8
10691848|NCT02498652|11856259|FG000|NOT COMPLETED|Overall Study||0
10691849|NCT02498652|11856260|FG001|NOT COMPLETED|Overall Study||1
10691850|NCT02498678|11856286|FG000|STARTED|Overall Study||25
10691851|NCT02498678|11856287|FG001|STARTED|Overall Study||25
10800604|NCT04483011|11961578|FG000|NOT COMPLETED|Washout (7 Days)||0
10691852|NCT02498678|11856286|FG000|COMPLETED|Overall Study||25
10691853|NCT02498678|11856287|FG001|COMPLETED|Overall Study||23
10691854|NCT02498678|11856286|FG000|NOT COMPLETED|Overall Study||0
10691855|NCT02498678|11856287|FG001|NOT COMPLETED|Overall Study||2
10691856|NCT02498769|11856295|FG000|STARTED|Overall Study||63
10691857|NCT02498769|11856296|FG001|STARTED|Overall Study||67
10691858|NCT02498769|11856295|FG000|COMPLETED|Overall Study||63
10691859|NCT02498769|11856296|FG001|COMPLETED|Overall Study||67
10691860|NCT02498769|11856295|FG000|NOT COMPLETED|Overall Study||0
10800605|NCT04483011|11961579|FG001|NOT COMPLETED|Washout (7 Days)||1
10800606|NCT04483011|11961578|FG000|STARTED|Intervention Period 2 (8 Days)||9
10691861|NCT02498769|11856296|FG001|NOT COMPLETED|Overall Study||0
10691862|NCT02498821|11856304|FG000|STARTED|Overall Study||63
10691863|NCT02498821|11856305|FG001|STARTED|Overall Study||65
10691864|NCT02498821|11856304|FG000|COMPLETED|Overall Study||60
10691865|NCT02498821|11856305|FG001|COMPLETED|Overall Study||60
10691866|NCT02498821|11856304|FG000|NOT COMPLETED|Overall Study||3
10691867|NCT02498821|11856305|FG001|NOT COMPLETED|Overall Study||5
10691868|NCT02498834|11856313|FG000|STARTED|Overall Study||185
10691869|NCT02498834|11856314|FG001|STARTED|Overall Study||174
10691870|NCT02498834|11856313|FG000|COMPLETED|Overall Study||175
10691871|NCT02498834|11856314|FG001|COMPLETED|Overall Study||164
10691872|NCT02498834|11856313|FG000|NOT COMPLETED|Overall Study||10
10691873|NCT02498834|11856314|FG001|NOT COMPLETED|Overall Study||10
10691874|NCT02499029|11856322|FG000|STARTED|Overall Study||18
10691875|NCT02499029|11856323|FG001|STARTED|Overall Study||17
10691876|NCT02499029|11856322|FG000|COMPLETED|Overall Study||13
10691877|NCT02499029|11856323|FG001|COMPLETED|Overall Study||14
10691878|NCT02499029|11856322|FG000|NOT COMPLETED|Overall Study||5
10691879|NCT02499029|11856323|FG001|NOT COMPLETED|Overall Study||3
10691880|NCT02499081|11856329|FG000|STARTED|Overall Study||20
10691881|NCT02499081|11856329|FG000|COMPLETED|Overall Study||1
10691882|NCT02499081|11856329|FG000|NOT COMPLETED|Overall Study||19
10800607|NCT04483011|11961579|FG001|STARTED|Intervention Period 2 (8 Days)||8
10800608|NCT04483011|11961578|FG000|COMPLETED|Intervention Period 2 (8 Days)||9
10800609|NCT04483011|11961579|FG001|COMPLETED|Intervention Period 2 (8 Days)||8
10800610|NCT04483011|11961578|FG000|NOT COMPLETED|Intervention Period 2 (8 Days)||0
10800611|NCT04483011|11961579|FG001|NOT COMPLETED|Intervention Period 2 (8 Days)||0
10800612|NCT04475588|11961589|FG000|STARTED|Overall Study|Stated in protocol apriori, patient not completing 1st infusion were not evaluable & were replaced.|22
10800613|NCT04475588|11961590|FG001|STARTED|Overall Study||10
10800614|NCT04475588|11961589|FG000|COMPLETED|Overall Study||20
10800615|NCT04475588|11961590|FG001|COMPLETED|Overall Study||10
10691894|NCT02499159|11856348|FG000|STARTED|Randomization||50
10691895|NCT02499159|11856349|FG001|STARTED|Randomization||50
10691896|NCT02499159|11856348|FG000|COMPLETED|Randomization||49
10691897|NCT02499159|11856349|FG001|COMPLETED|Randomization||49
10691898|NCT02499159|11856348|FG000|NOT COMPLETED|Randomization||1
10691899|NCT02499159|11856349|FG001|NOT COMPLETED|Randomization||1
10691900|NCT02499159|11856348|FG000|STARTED|30-Day Follow-Up Phone Call||49
10691901|NCT02499159|11856349|FG001|STARTED|30-Day Follow-Up Phone Call||49
10691902|NCT02499159|11856348|FG000|COMPLETED|30-Day Follow-Up Phone Call||42
10691903|NCT02499159|11856349|FG001|COMPLETED|30-Day Follow-Up Phone Call||47
10691904|NCT02499159|11856348|FG000|NOT COMPLETED|30-Day Follow-Up Phone Call||7
10691905|NCT02499159|11856349|FG001|NOT COMPLETED|30-Day Follow-Up Phone Call||2
10691906|NCT02499172|11856359|FG000|STARTED|Overall Study||900
10691907|NCT02499172|11856360|FG001|STARTED|Overall Study||899
10691908|NCT02499172|11856361|FG002|STARTED|Overall Study||523
10691909|NCT02499172|11856362|FG003|STARTED|Overall Study||436
10691910|NCT02499172|11856359|FG000|COMPLETED|Overall Study||835
10691911|NCT02499172|11856360|FG001|COMPLETED|Overall Study||835
10691912|NCT02499172|11856361|FG002|COMPLETED|Overall Study||0
10691913|NCT02499172|11856362|FG003|COMPLETED|Overall Study||0
10691914|NCT02499172|11856359|FG000|NOT COMPLETED|Overall Study||65
10691915|NCT02499172|11856360|FG001|NOT COMPLETED|Overall Study||64
10691916|NCT02499172|11856361|FG002|NOT COMPLETED|Overall Study||523
10691917|NCT02499172|11856362|FG003|NOT COMPLETED|Overall Study||436
10691918|NCT02499263|11856372|FG000|STARTED|Overall Study||146
10691919|NCT02499263|11856372|FG000|COMPLETED|Overall Study||84
10691920|NCT02499263|11856372|FG000|NOT COMPLETED|Overall Study||62
10691921|NCT02499380|11856376|FG000|STARTED|Overall Study||20
10691922|NCT02499380|11856376|FG000|COMPLETED|Overall Study||17
10691923|NCT02499380|11856376|FG000|NOT COMPLETED|Overall Study||3
10691924|NCT02499406|11856380|FG000|STARTED|Overall Study||17
10691925|NCT02499406|11856380|FG000|COMPLETED|Overall Study||13
10691926|NCT02499406|11856380|FG000|NOT COMPLETED|Overall Study||4
10713309|NCT02677844|11878800|FG002|NOT COMPLETED|Period 5||0
10713310|NCT02677844|11878801|FG003|NOT COMPLETED|Period 5||0
10713311|NCT02677844|11878802|FG004|NOT COMPLETED|Period 5||0
10713312|NCT02677844|11878803|FG005|NOT COMPLETED|Period 5||0
10713313|NCT02677844|11878804|FG006|NOT COMPLETED|Period 5||0
10713314|NCT02677844|11878798|FG000|STARTED|Period 6||0
10713315|NCT02677844|11878799|FG001|STARTED|Period 6||0
10713316|NCT02677844|11878800|FG002|STARTED|Period 6||0
10713317|NCT02677844|11878801|FG003|STARTED|Period 6||0
10713318|NCT02677844|11878802|FG004|STARTED|Period 6||7
10713319|NCT02677844|11878803|FG005|STARTED|Period 6||4
10713320|NCT02677844|11878804|FG006|STARTED|Period 6||4
10713321|NCT02677844|11878798|FG000|COMPLETED|Period 6||0
10713322|NCT02677844|11878799|FG001|COMPLETED|Period 6||0
10713323|NCT02677844|11878800|FG002|COMPLETED|Period 6||0
10713324|NCT02677844|11878801|FG003|COMPLETED|Period 6||0
10713325|NCT02677844|11878802|FG004|COMPLETED|Period 6||7
10713326|NCT02677844|11878803|FG005|COMPLETED|Period 6||4
10713327|NCT02677844|11878804|FG006|COMPLETED|Period 6||4
10713328|NCT02677844|11878798|FG000|NOT COMPLETED|Period 6||0
10713329|NCT02677844|11878799|FG001|NOT COMPLETED|Period 6||0
10713330|NCT02677844|11878800|FG002|NOT COMPLETED|Period 6||0
10713331|NCT02677844|11878801|FG003|NOT COMPLETED|Period 6||0
10713332|NCT02677844|11878802|FG004|NOT COMPLETED|Period 6||0
10713333|NCT02677844|11878803|FG005|NOT COMPLETED|Period 6||0
10713334|NCT02677844|11878804|FG006|NOT COMPLETED|Period 6||0
10713335|NCT02677844|11878798|FG000|STARTED|Period 7||0
10713336|NCT02677844|11878799|FG001|STARTED|Period 7||0
10691927|NCT02499497|11856388|FG000|STARTED|Overall Study||36
10691928|NCT02499497|11856389|FG001|STARTED|Overall Study||28
10691929|NCT02499497|11856390|FG002|STARTED|Overall Study||36
10691930|NCT02499497|11856391|FG003|STARTED|Overall Study||14
10691931|NCT02499497|11856388|FG000|COMPLETED|Overall Study||32
10691932|NCT02499497|11856389|FG001|COMPLETED|Overall Study||22
10691933|NCT02499497|11856390|FG002|COMPLETED|Overall Study||35
10691934|NCT02499497|11856391|FG003|COMPLETED|Overall Study||13
10691935|NCT02499497|11856388|FG000|NOT COMPLETED|Overall Study||4
10691936|NCT02499497|11856389|FG001|NOT COMPLETED|Overall Study||6
10691937|NCT02499497|11856390|FG002|NOT COMPLETED|Overall Study||1
10691938|NCT02499497|11856391|FG003|NOT COMPLETED|Overall Study||1
10691939|NCT02499575|11856403|FG000|STARTED|Overall Study||1
10691940|NCT02499575|11856404|FG001|STARTED|Overall Study||1
10691941|NCT02499575|11856403|FG000|COMPLETED|Overall Study||1
10691942|NCT02499575|11856404|FG001|COMPLETED|Overall Study||0
10691943|NCT02499575|11856403|FG000|NOT COMPLETED|Overall Study||0
10691944|NCT02499575|11856404|FG001|NOT COMPLETED|Overall Study||1
10691945|NCT02499692|11856410|FG000|STARTED|Overall Study||103
10691946|NCT02499692|11856410|FG000|COMPLETED|Overall Study||103
10691947|NCT02499692|11856410|FG000|NOT COMPLETED|Overall Study||0
10691948|NCT02499770|11856416|FG000|STARTED|Overall Study||19
10691949|NCT02499770|11856417|FG001|STARTED|Overall Study||77
10691950|NCT02499770|11856416|FG000|COMPLETED|Overall Study||0
10691951|NCT02499770|11856417|FG001|COMPLETED|Overall Study||0
10691952|NCT02499770|11856416|FG000|NOT COMPLETED|Overall Study||19
10691953|NCT02499770|11856417|FG001|NOT COMPLETED|Overall Study||77
10691954|NCT02499783|11856431|FG000|STARTED|DB Period/Placebo-Controlled: Weeks 0-4||102
10691955|NCT02499783|11856432|FG001|STARTED|DB Period/Placebo-Controlled: Weeks 0-4||103
10691956|NCT02499783|11856433|FG002|STARTED|DB Period/Placebo-Controlled: Weeks 0-4||0
10691957|NCT02499783|11856431|FG000|COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||98
10691958|NCT02499783|11856432|FG001|COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||98
10691959|NCT02499783|11856433|FG002|COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||0
10691960|NCT02499783|11856431|FG000|NOT COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||4
10691961|NCT02499783|11856432|FG001|NOT COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||5
10691962|NCT02499783|11856433|FG002|NOT COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||0
10691963|NCT02499783|11856431|FG000|STARTED|DB Period: Weeks 0-8||102
10800616|NCT04475588|11961589|FG000|NOT COMPLETED|Overall Study||2
10800617|NCT04475588|11961590|FG001|NOT COMPLETED|Overall Study||0
10800618|NCT04474496|11961597|FG000|STARTED|Overall Study||120
10800619|NCT04474496|11961597|FG000|COMPLETED|Overall Study|120 individuals were deemed eligible based on inclusion criteria, completed at least 10 survey items, and were included in the final analytical sample|120
10800620|NCT04474496|11961597|FG000|NOT COMPLETED|Overall Study||0
10800621|NCT04448210|11961603|FG000|STARTED|Overall Study||22
10800622|NCT04448210|11961604|FG001|STARTED|Overall Study||20
10800623|NCT04448210|11961603|FG000|COMPLETED|Overall Study||22
10691964|NCT02499783|11856432|FG001|STARTED|DB Period: Weeks 0-8||103
10691965|NCT02499783|11856433|FG002|STARTED|DB Period: Weeks 0-8||0
10691966|NCT02499783|11856431|FG000|COMPLETED|DB Period: Weeks 0-8||92
10691967|NCT02499783|11856432|FG001|COMPLETED|DB Period: Weeks 0-8||96
10691968|NCT02499783|11856433|FG002|COMPLETED|DB Period: Weeks 0-8||0
10691969|NCT02499783|11856431|FG000|NOT COMPLETED|DB Period: Weeks 0-8||10
10691970|NCT02499783|11856432|FG001|NOT COMPLETED|DB Period: Weeks 0-8||7
10691971|NCT02499783|11856433|FG002|NOT COMPLETED|DB Period: Weeks 0-8||0
10691972|NCT02499783|11856431|FG000|STARTED|Open Label Period: Weeks 8 to 26||0
10691973|NCT02499783|11856432|FG001|STARTED|Open Label Period: Weeks 8 to 26||0
10691974|NCT02499783|11856433|FG002|STARTED|Open Label Period: Weeks 8 to 26||188
10800624|NCT04448210|11961604|FG001|COMPLETED|Overall Study||20
10800625|NCT04448210|11961603|FG000|NOT COMPLETED|Overall Study||0
10800626|NCT04448210|11961604|FG001|NOT COMPLETED|Overall Study||0
10800627|NCT04474405|11961616|FG000|STARTED|Overall Study||4
10800628|NCT04474405|11961617|FG001|STARTED|Overall Study||3
10800629|NCT04474405|11961618|FG002|STARTED|Overall Study||5
10800630|NCT04474405|11961619|FG003|STARTED|Overall Study||4
10800631|NCT04474405|11961620|FG004|STARTED|Overall Study||13
10800632|NCT04474405|11961621|FG005|STARTED|Overall Study||7
10800633|NCT04474405|11961616|FG000|Flortaucipir PET Scan|Overall Study||4
10800634|NCT04474405|11961617|FG001|Flortaucipir PET Scan|Overall Study||3
10800635|NCT04474405|11961618|FG002|Flortaucipir PET Scan|Overall Study||4
10800636|NCT04474405|11961619|FG003|Flortaucipir PET Scan|Overall Study||4
10800637|NCT04474405|11961620|FG004|Flortaucipir PET Scan|Overall Study||9
10800638|NCT04474405|11961621|FG005|Flortaucipir PET Scan|Overall Study||0
10800639|NCT04474405|11961616|FG000|Florbetapir PET Scan|Overall Study||4
10800640|NCT04474405|11961617|FG001|Florbetapir PET Scan|Overall Study||3
10800641|NCT04474405|11961618|FG002|Florbetapir PET Scan|Overall Study||0
10800642|NCT04474405|11961619|FG003|Florbetapir PET Scan|Overall Study||4
10800643|NCT04474405|11961620|FG004|Florbetapir PET Scan|Overall Study||0
10691975|NCT02499783|11856431|FG000|COMPLETED|Open Label Period: Weeks 8 to 26||0
10691976|NCT02499783|11856432|FG001|COMPLETED|Open Label Period: Weeks 8 to 26||0
10691977|NCT02499783|11856433|FG002|COMPLETED|Open Label Period: Weeks 8 to 26||159
10691978|NCT02499783|11856431|FG000|NOT COMPLETED|Open Label Period: Weeks 8 to 26||0
10691979|NCT02499783|11856432|FG001|NOT COMPLETED|Open Label Period: Weeks 8 to 26||0
10691980|NCT02499783|11856433|FG002|NOT COMPLETED|Open Label Period: Weeks 8 to 26||29
10800644|NCT04474405|11961621|FG005|Florbetapir PET Scan|Overall Study||4
10800645|NCT04474405|11961616|FG000|COMPLETED|Overall Study||4
10691984|NCT02500043|11856449|FG000|STARTED|Overall Study||337
10691985|NCT02500043|11856450|FG001|STARTED|Overall Study||170
10691986|NCT02500043|11856449|FG000|As-Treated (AT) Population|Overall Study||335
10691987|NCT02500043|11856450|FG001|As-Treated (AT) Population|Overall Study||168
10691988|NCT02500043|11856449|FG000|COMPLETED|Overall Study||0
10691989|NCT02500043|11856450|FG001|COMPLETED|Overall Study||0
10691990|NCT02500043|11856449|FG000|NOT COMPLETED|Overall Study||337
10691991|NCT02500043|11856450|FG001|NOT COMPLETED|Overall Study||170
10691992|NCT02500056|11856458|FG000|STARTED|Overall Study||70
10691993|NCT02500056|11856459|FG001|STARTED|Overall Study||73
10691994|NCT02500056|11856458|FG000|COMPLETED|Overall Study||63
10691995|NCT02500056|11856459|FG001|COMPLETED|Overall Study||65
10691996|NCT02500056|11856458|FG000|NOT COMPLETED|Overall Study||7
10691997|NCT02500056|11856459|FG001|NOT COMPLETED|Overall Study||8
10691998|NCT02500368|11856465|FG000|STARTED|First Intervention (1 Week)||20
10691999|NCT02500368|11856466|FG001|STARTED|First Intervention (1 Week)||20
10692000|NCT02500368|11856465|FG000|COMPLETED|First Intervention (1 Week)||20
10692001|NCT02500368|11856466|FG001|COMPLETED|First Intervention (1 Week)||20
10692002|NCT02500368|11856465|FG000|NOT COMPLETED|First Intervention (1 Week)||0
10692003|NCT02500368|11856466|FG001|NOT COMPLETED|First Intervention (1 Week)||0
10692004|NCT02500368|11856465|FG000|STARTED|Second Intervention (1 Week)||20
10692005|NCT02500368|11856466|FG001|STARTED|Second Intervention (1 Week)||20
10692006|NCT02500368|11856465|FG000|COMPLETED|Second Intervention (1 Week)||20
10692007|NCT02500368|11856466|FG001|COMPLETED|Second Intervention (1 Week)||20
10692008|NCT02500368|11856465|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
10692009|NCT02500368|11856466|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
10713337|NCT02677844|11878800|FG002|STARTED|Period 7||0
10713338|NCT02677844|11878801|FG003|STARTED|Period 7||0
10713339|NCT02677844|11878802|FG004|STARTED|Period 7||7
10713340|NCT02677844|11878803|FG005|STARTED|Period 7||4
10713341|NCT02677844|11878804|FG006|STARTED|Period 7||4
10713342|NCT02677844|11878798|FG000|COMPLETED|Period 7||0
10713343|NCT02677844|11878799|FG001|COMPLETED|Period 7||0
10713344|NCT02677844|11878800|FG002|COMPLETED|Period 7||0
10713345|NCT02677844|11878801|FG003|COMPLETED|Period 7||0
10713346|NCT02677844|11878802|FG004|COMPLETED|Period 7||7
10713347|NCT02677844|11878803|FG005|COMPLETED|Period 7||4
10713348|NCT02677844|11878804|FG006|COMPLETED|Period 7||4
10713349|NCT02677844|11878798|FG000|NOT COMPLETED|Period 7||0
10713350|NCT02677844|11878799|FG001|NOT COMPLETED|Period 7||0
10713351|NCT02677844|11878800|FG002|NOT COMPLETED|Period 7||0
10713352|NCT02677844|11878801|FG003|NOT COMPLETED|Period 7||0
10713353|NCT02677844|11878802|FG004|NOT COMPLETED|Period 7||0
10713354|NCT02677844|11878803|FG005|NOT COMPLETED|Period 7||0
10713355|NCT02677844|11878804|FG006|NOT COMPLETED|Period 7||0
10713356|NCT02678000|11878828|FG000|STARTED|PART 1||7
10713357|NCT02678000|11878829|FG001|STARTED|PART 1||4
10713358|NCT02678000|11878830|FG002|STARTED|PART 1||0
10713359|NCT02678000|11878831|FG003|STARTED|PART 1||0
10713360|NCT02678000|11878832|FG004|STARTED|PART 1||0
10713361|NCT02678000|11878828|FG000|COMPLETED|PART 1||7
10713362|NCT02678000|11878829|FG001|COMPLETED|PART 1||4
10713363|NCT02678000|11878830|FG002|COMPLETED|PART 1||0
10713364|NCT02678000|11878831|FG003|COMPLETED|PART 1||0
10713365|NCT02678000|11878832|FG004|COMPLETED|PART 1||0
10713366|NCT02678000|11878828|FG000|NOT COMPLETED|PART 1||0
10713367|NCT02678000|11878829|FG001|NOT COMPLETED|PART 1||0
10713368|NCT02678000|11878830|FG002|NOT COMPLETED|PART 1||0
10713369|NCT02678000|11878831|FG003|NOT COMPLETED|PART 1||0
10713370|NCT02678000|11878832|FG004|NOT COMPLETED|PART 1||0
10713371|NCT02678000|11878828|FG000|STARTED|PART 2||0
10713372|NCT02678000|11878829|FG001|STARTED|PART 2||0
10713373|NCT02678000|11878830|FG002|STARTED|PART 2||28
10713374|NCT02678000|11878831|FG003|STARTED|PART 2||27
10713375|NCT02678000|11878832|FG004|STARTED|PART 2||18
10713376|NCT02678000|11878828|FG000|COMPLETED|PART 2||0
10713377|NCT02678000|11878829|FG001|COMPLETED|PART 2||0
10713378|NCT02678000|11878830|FG002|COMPLETED|PART 2||25
10713379|NCT02678000|11878831|FG003|COMPLETED|PART 2||26
10713380|NCT02678000|11878832|FG004|COMPLETED|PART 2||18
10713381|NCT02678000|11878828|FG000|NOT COMPLETED|PART 2||0
10713382|NCT02678000|11878829|FG001|NOT COMPLETED|PART 2||0
10713383|NCT02678000|11878830|FG002|NOT COMPLETED|PART 2||3
10713384|NCT02678000|11878831|FG003|NOT COMPLETED|PART 2||1
10713385|NCT02678000|11878832|FG004|NOT COMPLETED|PART 2||0
10713386|NCT02678039|11878859|FG000|STARTED|Overall Study||53
10713387|NCT02678039|11878860|FG001|STARTED|Overall Study||47
10713388|NCT02678039|11878859|FG000|COMPLETED|Overall Study||53
10713389|NCT02678039|11878860|FG001|COMPLETED|Overall Study||47
10713390|NCT02678039|11878859|FG000|NOT COMPLETED|Overall Study||0
10713391|NCT02678039|11878860|FG001|NOT COMPLETED|Overall Study||0
10713392|NCT02678247|11878868|FG000|STARTED|First Intervention (7 Weeks)||15
10713393|NCT02678247|11878869|FG001|STARTED|First Intervention (7 Weeks)||15
10713394|NCT02678247|11878868|FG000|COMPLETED|First Intervention (7 Weeks)||13
10713395|NCT02678247|11878869|FG001|COMPLETED|First Intervention (7 Weeks)||11
10713396|NCT02678247|11878868|FG000|NOT COMPLETED|First Intervention (7 Weeks)||2
10713397|NCT02678247|11878869|FG001|NOT COMPLETED|First Intervention (7 Weeks)||4
10713398|NCT02678247|11878868|FG000|STARTED|Second Intervention (7 Weeks)|One subject crossed over despite not completing all data collection time points for the preceding socket.|14
10713399|NCT02678247|11878869|FG001|STARTED|Second Intervention (7 Weeks)||11
10713400|NCT02678247|11878868|FG000|COMPLETED|Second Intervention (7 Weeks)||10
10713401|NCT02678247|11878869|FG001|COMPLETED|Second Intervention (7 Weeks)||9
10713402|NCT02678247|11878868|FG000|NOT COMPLETED|Second Intervention (7 Weeks)||4
10692010|NCT02500537|11856474|FG000|STARTED|Overall Study||60
10692011|NCT02500537|11856475|FG001|STARTED|Overall Study||40
10692012|NCT02500537|11856474|FG000|COMPLETED|Overall Study||57
10692013|NCT02500537|11856475|FG001|COMPLETED|Overall Study||39
10692014|NCT02500537|11856474|FG000|NOT COMPLETED|Overall Study||3
10692015|NCT02500537|11856475|FG001|NOT COMPLETED|Overall Study||1
10692016|NCT02500550|11856482|FG000|STARTED|Overall Study||15
10692017|NCT02500550|11856482|FG000|COMPLETED|Overall Study||8
10692018|NCT02500550|11856482|FG000|NOT COMPLETED|Overall Study||7
10692019|NCT02500602|11856488|FG000|STARTED|Treatment Phase||74
10692020|NCT02500602|11856489|FG001|STARTED|Treatment Phase||70
10692021|NCT02500602|11856488|FG000|COMPLETED|Treatment Phase||68
10692022|NCT02500602|11856489|FG001|COMPLETED|Treatment Phase||69
10692023|NCT02500602|11856488|FG000|NOT COMPLETED|Treatment Phase||6
10692024|NCT02500602|11856489|FG001|NOT COMPLETED|Treatment Phase||1
10692025|NCT02500602|11856488|FG000|STARTED|Follow Up Phase||68
10692026|NCT02500602|11856489|FG001|STARTED|Follow Up Phase||69
10692027|NCT02500602|11856488|FG000|COMPLETED|Follow Up Phase||53
10692028|NCT02500602|11856489|FG001|COMPLETED|Follow Up Phase||47
10692029|NCT02500602|11856488|FG000|NOT COMPLETED|Follow Up Phase||15
10692030|NCT02500602|11856489|FG001|NOT COMPLETED|Follow Up Phase||22
10692031|NCT02500628|11856499|FG000|STARTED|Overall Study||38
10692032|NCT02500628|11856500|FG001|STARTED|Overall Study||23
10692033|NCT02500628|11856499|FG000|COMPLETED|Overall Study||38
10692034|NCT02500628|11856500|FG001|COMPLETED|Overall Study||23
10800646|NCT04474405|11961617|FG001|COMPLETED|Overall Study||3
10800647|NCT04474405|11961618|FG002|COMPLETED|Overall Study||4
10800648|NCT04474405|11961619|FG003|COMPLETED|Overall Study||4
10800649|NCT04474405|11961620|FG004|COMPLETED|Overall Study||9
10800650|NCT04474405|11961621|FG005|COMPLETED|Overall Study||7
10800651|NCT04474405|11961616|FG000|NOT COMPLETED|Overall Study||0
10800652|NCT04474405|11961617|FG001|NOT COMPLETED|Overall Study||0
10800653|NCT04474405|11961618|FG002|NOT COMPLETED|Overall Study||1
10800654|NCT04474405|11961619|FG003|NOT COMPLETED|Overall Study||0
10800655|NCT04474405|11961620|FG004|NOT COMPLETED|Overall Study||4
10800656|NCT04474405|11961621|FG005|NOT COMPLETED|Overall Study||0
10800657|NCT04470375|11961635|FG000|STARTED|Overall Study||20
10800658|NCT04470375|11961635|FG000|COMPLETED|Overall Study||20
10800659|NCT04470375|11961635|FG000|NOT COMPLETED|Overall Study||0
10800660|NCT04468347|11961643|FG000|STARTED|Overall Study||6
10800661|NCT04468347|11961644|FG001|STARTED|Overall Study||11
10800662|NCT04468347|11961645|FG002|STARTED|Overall Study||47
10800663|NCT04468347|11961646|FG003|STARTED|Overall Study||25
10800664|NCT04468347|11961643|FG000|Baseline Flortacuipir PET Scan|Overall Study||5
10800665|NCT04468347|11961644|FG001|Baseline Flortacuipir PET Scan|Overall Study||11
10800666|NCT04468347|11961645|FG002|Baseline Flortacuipir PET Scan|Overall Study||45
10800667|NCT04468347|11961646|FG003|Baseline Flortacuipir PET Scan|Overall Study||25
10800668|NCT04468347|11961643|FG000|COMPLETED|Overall Study||4
10800669|NCT04468347|11961644|FG001|COMPLETED|Overall Study||10
10800670|NCT04468347|11961645|FG002|COMPLETED|Overall Study||41
10800671|NCT04468347|11961646|FG003|COMPLETED|Overall Study||21
10800672|NCT04468347|11961643|FG000|NOT COMPLETED|Overall Study||2
10800673|NCT04468347|11961644|FG001|NOT COMPLETED|Overall Study||1
10800674|NCT04468347|11961645|FG002|NOT COMPLETED|Overall Study||6
10800675|NCT04468347|11961646|FG003|NOT COMPLETED|Overall Study||4
10800676|NCT04467424|11961662|FG000|STARTED|Overall Study||100
10800677|NCT04467424|11961663|FG001|STARTED|Overall Study||100
10800678|NCT04467424|11961662|FG000|COMPLETED|Overall Study||100
10800679|NCT04467424|11961663|FG001|COMPLETED|Overall Study||100
10800680|NCT04467424|11961662|FG000|NOT COMPLETED|Overall Study||0
10800681|NCT04467424|11961663|FG001|NOT COMPLETED|Overall Study||0
10800682|NCT04465422|11961671|FG000|STARTED|Overall Study||17
10800683|NCT04465422|11961672|FG001|STARTED|Overall Study||16
10800684|NCT04465422|11961671|FG000|COMPLETED|Overall Study||17
10800685|NCT04465422|11961672|FG001|COMPLETED|Overall Study||14
10800686|NCT04465422|11961671|FG000|NOT COMPLETED|Overall Study||0
10800687|NCT04465422|11961672|FG001|NOT COMPLETED|Overall Study||2
10800688|NCT04463004|11961682|FG000|STARTED|Overall Study||1
10800689|NCT04463004|11961683|FG001|STARTED|Overall Study||1
10692035|NCT02500628|11856499|FG000|NOT COMPLETED|Overall Study||0
10692036|NCT02500628|11856500|FG001|NOT COMPLETED|Overall Study||0
10692037|NCT02500641|11856510|FG000|STARTED|Overall Study||98
10692038|NCT02500641|11856511|FG001|STARTED|Overall Study||98
10692039|NCT02500641|11856510|FG000|COMPLETED|Overall Study||88
10692040|NCT02500641|11856511|FG001|COMPLETED|Overall Study||86
10692041|NCT02500641|11856510|FG000|NOT COMPLETED|Overall Study||10
10692042|NCT02500641|11856511|FG001|NOT COMPLETED|Overall Study||12
10800690|NCT04463004|11961682|FG000|COMPLETED|Overall Study||1
10800691|NCT04463004|11961683|FG001|COMPLETED|Overall Study||1
10800692|NCT04463004|11961682|FG000|NOT COMPLETED|Overall Study||0
10692043|NCT02500706|11856520|FG000|STARTED|Overall Study||342
10692044|NCT02500706|11856521|FG001|STARTED|Overall Study||341
10692045|NCT02500706|11856522|FG002|STARTED|Overall Study||342
10692046|NCT02500706|11856520|FG000|Exposed|Overall Study||342
10692047|NCT02500706|11856521|FG001|Exposed|Overall Study||341
10692048|NCT02500706|11856522|FG002|Exposed|Overall Study||342
10692049|NCT02500706|11856520|FG000|COMPLETED|Overall Study||338
10692050|NCT02500706|11856521|FG001|COMPLETED|Overall Study||334
10692051|NCT02500706|11856522|FG002|COMPLETED|Overall Study||335
10692052|NCT02500706|11856520|FG000|NOT COMPLETED|Overall Study||4
10692053|NCT02500706|11856521|FG001|NOT COMPLETED|Overall Study||7
10692054|NCT02500706|11856522|FG002|NOT COMPLETED|Overall Study||7
10692055|NCT02500719|11856532|FG000|STARTED|Overall Study||14
10692056|NCT02500719|11856533|FG001|STARTED|Overall Study||16
10692057|NCT02500719|11856532|FG000|COMPLETED|Overall Study||11
10692058|NCT02500719|11856533|FG001|COMPLETED|Overall Study||9
10692059|NCT02500719|11856532|FG000|NOT COMPLETED|Overall Study||3
10692060|NCT02500719|11856533|FG001|NOT COMPLETED|Overall Study||7
10692061|NCT02500732|11856541|FG000|STARTED|Overall Study||27
10692062|NCT02500732|11856542|FG001|STARTED|Overall Study||30
10692063|NCT02500732|11856541|FG000|COMPLETED|Overall Study||27
10692064|NCT02500732|11856542|FG001|COMPLETED|Overall Study|Not true event in 1 participant (pseudosyncope)|29
10692065|NCT02500732|11856541|FG000|NOT COMPLETED|Overall Study||0
10692066|NCT02500732|11856542|FG001|NOT COMPLETED|Overall Study||1
10692067|NCT02500758|11856550|FG000|STARTED|First Intervention (2 Minutes)||15
10692068|NCT02500758|11856551|FG001|STARTED|First Intervention (2 Minutes)||15
10692069|NCT02500758|11856550|FG000|COMPLETED|First Intervention (2 Minutes)||15
10692070|NCT02500758|11856551|FG001|COMPLETED|First Intervention (2 Minutes)||14
10692071|NCT02500758|11856550|FG000|NOT COMPLETED|First Intervention (2 Minutes)||0
10692072|NCT02500758|11856551|FG001|NOT COMPLETED|First Intervention (2 Minutes)||1
10692073|NCT02500758|11856550|FG000|STARTED|Washout (1 Week)||15
10692074|NCT02500758|11856551|FG001|STARTED|Washout (1 Week)||14
10692075|NCT02500758|11856550|FG000|COMPLETED|Washout (1 Week)||13
10692076|NCT02500758|11856551|FG001|COMPLETED|Washout (1 Week)||12
10692077|NCT02500758|11856550|FG000|NOT COMPLETED|Washout (1 Week)||2
10692078|NCT02500758|11856551|FG001|NOT COMPLETED|Washout (1 Week)||2
10692079|NCT02500758|11856550|FG000|STARTED|Second Intervention (2 Minutes)||13
10692080|NCT02500758|11856551|FG001|STARTED|Second Intervention (2 Minutes)||12
10692081|NCT02500758|11856550|FG000|COMPLETED|Second Intervention (2 Minutes)||10
10692082|NCT02500758|11856551|FG001|COMPLETED|Second Intervention (2 Minutes)||10
10692083|NCT02500758|11856550|FG000|NOT COMPLETED|Second Intervention (2 Minutes)||3
10692084|NCT02500758|11856551|FG001|NOT COMPLETED|Second Intervention (2 Minutes)||2
10692085|NCT02500836|11856561|FG000|STARTED|Overall Study||259
10692086|NCT02500836|11856562|FG001|STARTED|Overall Study||259
10692087|NCT02500836|11856563|FG002|STARTED|Overall Study||128
10692088|NCT02500836|11856561|FG000|COMPLETED|Overall Study||256
10692089|NCT02500836|11856562|FG001|COMPLETED|Overall Study||254
10692090|NCT02500836|11856563|FG002|COMPLETED|Overall Study||127
10692091|NCT02500836|11856561|FG000|NOT COMPLETED|Overall Study||3
10692092|NCT02500836|11856562|FG001|NOT COMPLETED|Overall Study||5
10692093|NCT02500836|11856563|FG002|NOT COMPLETED|Overall Study||1
10692094|NCT02500979|11856573|FG000|STARTED|Period 1||16
10692095|NCT02500979|11856574|FG001|STARTED|Period 1||17
10692096|NCT02500979|11856573|FG000|COMPLETED|Period 1||12
10692097|NCT02500979|11856574|FG001|COMPLETED|Period 1||16
10692098|NCT02500979|11856573|FG000|NOT COMPLETED|Period 1||4
10692099|NCT02500979|11856574|FG001|NOT COMPLETED|Period 1||1
10692100|NCT02500979|11856573|FG000|STARTED|Period 2||12
10692101|NCT02500979|11856574|FG001|STARTED|Period 2||16
10692102|NCT02500979|11856573|FG000|COMPLETED|Period 2||11
10692103|NCT02500979|11856574|FG001|COMPLETED|Period 2||16
10692104|NCT02500979|11856573|FG000|NOT COMPLETED|Period 2||1
10692105|NCT02500979|11856574|FG001|NOT COMPLETED|Period 2||0
10692106|NCT02501135|11856580|FG000|STARTED|Overall Study||281
10692107|NCT02501135|11856580|FG000|COMPLETED|Overall Study||281
10692108|NCT02501135|11856580|FG000|NOT COMPLETED|Overall Study||0
10692109|NCT02501161|11856592|FG000|STARTED|Overall Study||506
10692110|NCT02501161|11856593|FG001|STARTED|Overall Study||506
10692111|NCT02501161|11856592|FG000|Exposed|Overall Study||506
10692112|NCT02501161|11856593|FG001|Exposed|Overall Study||504
10692113|NCT02501161|11856592|FG000|COMPLETED|Overall Study||484
10692114|NCT02501161|11856593|FG001|COMPLETED|Overall Study||481
10692115|NCT02501161|11856592|FG000|NOT COMPLETED|Overall Study||22
10692116|NCT02501161|11856593|FG001|NOT COMPLETED|Overall Study||25
10692117|NCT02501265|11856603|FG000|STARTED|Overall Study||63
10692118|NCT02501265|11856604|FG001|STARTED|Overall Study||30
10692119|NCT02501265|11856605|FG002|STARTED|Overall Study||64
10692120|NCT02501265|11856606|FG003|STARTED|Overall Study||31
10692121|NCT02501265|11856603|FG000|COMPLETED|Overall Study||46
10692122|NCT02501265|11856604|FG001|COMPLETED|Overall Study||21
10692123|NCT02501265|11856605|FG002|COMPLETED|Overall Study||46
10692124|NCT02501265|11856606|FG003|COMPLETED|Overall Study||23
10692125|NCT02501265|11856603|FG000|NOT COMPLETED|Overall Study||17
10692126|NCT02501265|11856604|FG001|NOT COMPLETED|Overall Study||9
10692127|NCT02501265|11856605|FG002|NOT COMPLETED|Overall Study||18
10692128|NCT02501265|11856606|FG003|NOT COMPLETED|Overall Study||8
10692129|NCT02501473|11856623|FG000|STARTED|Overall Study||3
10692130|NCT02501473|11856624|FG001|STARTED|Overall Study||3
10692131|NCT02501473|11856625|FG002|STARTED|Overall Study||13
10692132|NCT02501473|11856626|FG003|STARTED|Overall Study||14
10692133|NCT02501473|11856627|FG004|STARTED|Overall Study||4
10692134|NCT02501473|11856628|FG005|STARTED|Overall Study||14
10692135|NCT02501473|11856629|FG006|STARTED|Overall Study||1
10692136|NCT02501473|11856630|FG007|STARTED|Overall Study||0
10692137|NCT02501473|11856623|FG000|Treated|Overall Study||3
10692138|NCT02501473|11856624|FG001|Treated|Overall Study||3
10692139|NCT02501473|11856625|FG002|Treated|Overall Study||13
10692140|NCT02501473|11856626|FG003|Treated|Overall Study||13
10692141|NCT02501473|11856627|FG004|Treated|Overall Study||4
10692142|NCT02501473|11856628|FG005|Treated|Overall Study||14
10692143|NCT02501473|11856629|FG006|Treated|Overall Study||1
10692144|NCT02501473|11856630|FG007|Treated|Overall Study||0
10692145|NCT02501473|11856623|FG000|COMPLETED|Overall Study||0
10692146|NCT02501473|11856624|FG001|COMPLETED|Overall Study||0
10692147|NCT02501473|11856625|FG002|COMPLETED|Overall Study||0
10692148|NCT02501473|11856626|FG003|COMPLETED|Overall Study||0
10692149|NCT02501473|11856627|FG004|COMPLETED|Overall Study||0
10692150|NCT02501473|11856628|FG005|COMPLETED|Overall Study||0
10692151|NCT02501473|11856629|FG006|COMPLETED|Overall Study||0
10692152|NCT02501473|11856630|FG007|COMPLETED|Overall Study||0
10692153|NCT02501473|11856623|FG000|NOT COMPLETED|Overall Study||3
10692154|NCT02501473|11856624|FG001|NOT COMPLETED|Overall Study||3
10692155|NCT02501473|11856625|FG002|NOT COMPLETED|Overall Study||13
10692156|NCT02501473|11856626|FG003|NOT COMPLETED|Overall Study||14
10692157|NCT02501473|11856627|FG004|NOT COMPLETED|Overall Study||4
10692158|NCT02501473|11856628|FG005|NOT COMPLETED|Overall Study||14
10692159|NCT02501473|11856629|FG006|NOT COMPLETED|Overall Study||1
10692160|NCT02501473|11856630|FG007|NOT COMPLETED|Overall Study||0
10692161|NCT02501538|11856646|FG000|STARTED|Overall Study||23
10692162|NCT02501538|11856646|FG000|COMPLETED|Overall Study||20
10692163|NCT02501538|11856646|FG000|NOT COMPLETED|Overall Study||3
10692164|NCT02501590|11856655|FG000|STARTED|Overall Study||13
10692165|NCT02501590|11856656|FG001|STARTED|Overall Study||35
10692166|NCT02501590|11856655|FG000|COMPLETED|Overall Study||13
10692167|NCT02501590|11856656|FG001|COMPLETED|Overall Study||35
10692168|NCT02501590|11856655|FG000|NOT COMPLETED|Overall Study||0
10692169|NCT02501590|11856656|FG001|NOT COMPLETED|Overall Study||0
10692170|NCT02501629|11856664|FG000|STARTED|Overall Study||89
10692171|NCT02501629|11856665|FG001|STARTED|Overall Study||88
10692172|NCT02501629|11856664|FG000|COMPLETED|Overall Study||84
10692173|NCT02501629|11856665|FG001|COMPLETED|Overall Study||81
10692174|NCT02501629|11856664|FG000|NOT COMPLETED|Overall Study||5
10692175|NCT02501629|11856665|FG001|NOT COMPLETED|Overall Study||7
10692176|NCT02501642|11856673|FG000|STARTED|Overall Study|Start of study: 10.1.2014|238
10692177|NCT02501642|11856674|FG001|STARTED|Overall Study|Start of study: 10.1.2014|241
10692178|NCT02501642|11856673|FG000|COMPLETED|Overall Study|Study ended 9.30.2018|231
10692179|NCT02501642|11856674|FG001|COMPLETED|Overall Study|Study ended 9.30.2018|230
10692180|NCT02501642|11856673|FG000|NOT COMPLETED|Overall Study||7
10692181|NCT02501642|11856674|FG001|NOT COMPLETED|Overall Study||11
10692182|NCT02501811|11856684|FG000|STARTED|Overall Study||33
10692183|NCT02501811|11856685|FG001|STARTED|Overall Study||29
10692184|NCT02501811|11856686|FG002|STARTED|Overall Study||31
10692185|NCT02501811|11856687|FG003|STARTED|Overall Study||32
10692186|NCT02501811|11856684|FG000|COMPLETED|Overall Study|includes 1 participant who completed final study visit but died within 30 days after final visit.|29
10692187|NCT02501811|11856685|FG001|COMPLETED|Overall Study||23
10692188|NCT02501811|11856686|FG002|COMPLETED|Overall Study||25
10692189|NCT02501811|11856687|FG003|COMPLETED|Overall Study|includes 1 participant who completed final study visit but died within 30 days after final visit.|25
10692190|NCT02501811|11856684|FG000|NOT COMPLETED|Overall Study||4
10692191|NCT02501811|11856685|FG001|NOT COMPLETED|Overall Study||6
10692192|NCT02501811|11856686|FG002|NOT COMPLETED|Overall Study||6
10692193|NCT02501811|11856687|FG003|NOT COMPLETED|Overall Study||7
10692194|NCT02501902|11856705|FG000|STARTED|Overall Study||3
10692195|NCT02501902|11856706|FG001|STARTED|Overall Study||7
10692196|NCT02501902|11856707|FG002|STARTED|Overall Study||4
10692197|NCT02501902|11856708|FG003|STARTED|Overall Study||11
10692198|NCT02501902|11856709|FG004|STARTED|Overall Study||11
10692199|NCT02501902|11856710|FG005|STARTED|Overall Study||11
10692200|NCT02501902|11856711|FG006|STARTED|Overall Study||9
10692201|NCT02501902|11856712|FG007|STARTED|Overall Study||20
10692202|NCT02501902|11856705|FG000|COMPLETED|Overall Study||0
10692203|NCT02501902|11856706|FG001|COMPLETED|Overall Study||0
10692204|NCT02501902|11856707|FG002|COMPLETED|Overall Study||0
10692205|NCT02501902|11856708|FG003|COMPLETED|Overall Study||0
10692206|NCT02501902|11856709|FG004|COMPLETED|Overall Study||0
10692207|NCT02501902|11856710|FG005|COMPLETED|Overall Study||0
10692208|NCT02501902|11856711|FG006|COMPLETED|Overall Study||0
10692209|NCT02501902|11856712|FG007|COMPLETED|Overall Study||0
10692210|NCT02501902|11856705|FG000|NOT COMPLETED|Overall Study||3
10692211|NCT02501902|11856706|FG001|NOT COMPLETED|Overall Study||7
10692212|NCT02501902|11856707|FG002|NOT COMPLETED|Overall Study||4
10692213|NCT02501902|11856708|FG003|NOT COMPLETED|Overall Study||11
10692214|NCT02501902|11856709|FG004|NOT COMPLETED|Overall Study||11
10692215|NCT02501902|11856710|FG005|NOT COMPLETED|Overall Study||11
10692216|NCT02501902|11856711|FG006|NOT COMPLETED|Overall Study||9
10692217|NCT02501902|11856712|FG007|NOT COMPLETED|Overall Study||20
10692218|NCT02501928|11856738|FG000|STARTED|Overall Study|No participant was assigned to this arm, in this LTE study.|0
10692219|NCT02501928|11856739|FG001|STARTED|Overall Study||2
10692220|NCT02501928|11856740|FG002|STARTED|Overall Study|No participant was assigned to this arm, in this LTE study.|0
10692221|NCT02501928|11856741|FG003|STARTED|Overall Study|No participant was assigned to this arm, in this LTE study.|0
10692222|NCT02501928|11856742|FG004|STARTED|Overall Study||7
10692223|NCT02501928|11856743|FG005|STARTED|Overall Study||3
10692224|NCT02501928|11856738|FG000|COMPLETED|Overall Study||0
10692225|NCT02501928|11856739|FG001|COMPLETED|Overall Study||2
10692226|NCT02501928|11856740|FG002|COMPLETED|Overall Study||0
10692227|NCT02501928|11856741|FG003|COMPLETED|Overall Study||0
10692228|NCT02501928|11856742|FG004|COMPLETED|Overall Study||6
10692229|NCT02501928|11856743|FG005|COMPLETED|Overall Study||3
10692230|NCT02501928|11856738|FG000|NOT COMPLETED|Overall Study||0
10692231|NCT02501928|11856739|FG001|NOT COMPLETED|Overall Study||0
10692232|NCT02501928|11856740|FG002|NOT COMPLETED|Overall Study||0
10692233|NCT02501928|11856741|FG003|NOT COMPLETED|Overall Study||0
10692234|NCT02501928|11856742|FG004|NOT COMPLETED|Overall Study||1
10692235|NCT02501928|11856743|FG005|NOT COMPLETED|Overall Study||0
10692236|NCT02502019|11856760|FG000|STARTED|Overall Study||27
10692237|NCT02502019|11856760|FG000|COMPLETED|Overall Study||27
10692238|NCT02502019|11856760|FG000|NOT COMPLETED|Overall Study||0
10692239|NCT02502097|11856768|FG000|STARTED|Period 1||4
10692240|NCT02502097|11856769|FG001|STARTED|Period 1||3
10692241|NCT02502097|11856770|FG002|STARTED|Period 1||22
10692242|NCT02502097|11856771|FG003|STARTED|Period 1||22
10692243|NCT02502097|11856768|FG000|COMPLETED|Period 1||4
10692244|NCT02502097|11856769|FG001|COMPLETED|Period 1||3
10692245|NCT02502097|11856770|FG002|COMPLETED|Period 1||21
10692246|NCT02502097|11856771|FG003|COMPLETED|Period 1||22
10692247|NCT02502097|11856768|FG000|NOT COMPLETED|Period 1||0
10692248|NCT02502097|11856769|FG001|NOT COMPLETED|Period 1||0
10692249|NCT02502097|11856770|FG002|NOT COMPLETED|Period 1||1
10692250|NCT02502097|11856771|FG003|NOT COMPLETED|Period 1||0
10692251|NCT02502097|11856768|FG000|STARTED|Wash Out Period||4
10692252|NCT02502097|11856769|FG001|STARTED|Wash Out Period||3
10692253|NCT02502097|11856770|FG002|STARTED|Wash Out Period||21
10692254|NCT02502097|11856771|FG003|STARTED|Wash Out Period||22
10692255|NCT02502097|11856768|FG000|COMPLETED|Wash Out Period||4
10692256|NCT02502097|11856769|FG001|COMPLETED|Wash Out Period||2
10692257|NCT02502097|11856770|FG002|COMPLETED|Wash Out Period||20
10692258|NCT02502097|11856771|FG003|COMPLETED|Wash Out Period||21
10692259|NCT02502097|11856768|FG000|NOT COMPLETED|Wash Out Period||0
10692260|NCT02502097|11856769|FG001|NOT COMPLETED|Wash Out Period||1
10692261|NCT02502097|11856770|FG002|NOT COMPLETED|Wash Out Period||1
10692262|NCT02502097|11856771|FG003|NOT COMPLETED|Wash Out Period||1
10692263|NCT02502097|11856768|FG000|STARTED|Period 2||4
10692264|NCT02502097|11856769|FG001|STARTED|Period 2||2
10692265|NCT02502097|11856770|FG002|STARTED|Period 2||20
10692266|NCT02502097|11856771|FG003|STARTED|Period 2||21
10692267|NCT02502097|11856768|FG000|COMPLETED|Period 2||4
10692268|NCT02502097|11856769|FG001|COMPLETED|Period 2||2
10692269|NCT02502097|11856770|FG002|COMPLETED|Period 2||19
10692270|NCT02502097|11856771|FG003|COMPLETED|Period 2||21
10692271|NCT02502097|11856768|FG000|NOT COMPLETED|Period 2||0
10692272|NCT02502097|11856769|FG001|NOT COMPLETED|Period 2||0
10692273|NCT02502097|11856770|FG002|NOT COMPLETED|Period 2||1
10692274|NCT02502097|11856771|FG003|NOT COMPLETED|Period 2||0
10692275|NCT02502149|11856778|FG000|STARTED|PK1 Assessment Period||24
10692276|NCT02502149|11856779|FG001|STARTED|PK1 Assessment Period||0
10692277|NCT02502149|11856780|FG002|STARTED|PK1 Assessment Period||0
10692278|NCT02502149|11856781|FG003|STARTED|PK1 Assessment Period||0
10692279|NCT02502149|11856782|FG004|STARTED|PK1 Assessment Period||0
10692280|NCT02502149|11856778|FG000|COMPLETED|PK1 Assessment Period||24
10692281|NCT02502149|11856779|FG001|COMPLETED|PK1 Assessment Period||0
10692282|NCT02502149|11856780|FG002|COMPLETED|PK1 Assessment Period||0
10692283|NCT02502149|11856781|FG003|COMPLETED|PK1 Assessment Period||0
10692284|NCT02502149|11856782|FG004|COMPLETED|PK1 Assessment Period||0
10692285|NCT02502149|11856778|FG000|NOT COMPLETED|PK1 Assessment Period||0
10692286|NCT02502149|11856779|FG001|NOT COMPLETED|PK1 Assessment Period||0
10692287|NCT02502149|11856780|FG002|NOT COMPLETED|PK1 Assessment Period||0
10692288|NCT02502149|11856781|FG003|NOT COMPLETED|PK1 Assessment Period||0
10692289|NCT02502149|11856782|FG004|NOT COMPLETED|PK1 Assessment Period||0
10692290|NCT02502149|11856778|FG000|STARTED|Intermediate||24
10692291|NCT02502149|11856779|FG001|STARTED|Intermediate||0
10692292|NCT02502149|11856780|FG002|STARTED|Intermediate||0
10692293|NCT02502149|11856781|FG003|STARTED|Intermediate||0
10692294|NCT02502149|11856782|FG004|STARTED|Intermediate||0
10692295|NCT02502149|11856778|FG000|COMPLETED|Intermediate||23
10692296|NCT02502149|11856779|FG001|COMPLETED|Intermediate||0
10692297|NCT02502149|11856780|FG002|COMPLETED|Intermediate||0
10692298|NCT02502149|11856781|FG003|COMPLETED|Intermediate||0
10692299|NCT02502149|11856782|FG004|COMPLETED|Intermediate||0
10692300|NCT02502149|11856778|FG000|NOT COMPLETED|Intermediate||1
10692301|NCT02502149|11856779|FG001|NOT COMPLETED|Intermediate||0
10692302|NCT02502149|11856780|FG002|NOT COMPLETED|Intermediate||0
10692303|NCT02502149|11856781|FG003|NOT COMPLETED|Intermediate||0
10692304|NCT02502149|11856782|FG004|NOT COMPLETED|Intermediate||0
10692305|NCT02502149|11856778|FG000|STARTED|PK2 Assessment Period||0
10692306|NCT02502149|11856779|FG001|STARTED|PK2 Assessment Period||11
10692307|NCT02502149|11856780|FG002|STARTED|PK2 Assessment Period||12
10692308|NCT02502149|11856781|FG003|STARTED|PK2 Assessment Period||0
10692309|NCT02502149|11856782|FG004|STARTED|PK2 Assessment Period||0
10692310|NCT02502149|11856778|FG000|COMPLETED|PK2 Assessment Period||0
10692311|NCT02502149|11856779|FG001|COMPLETED|PK2 Assessment Period||11
10692312|NCT02502149|11856780|FG002|COMPLETED|PK2 Assessment Period||12
10692313|NCT02502149|11856781|FG003|COMPLETED|PK2 Assessment Period||0
10692314|NCT02502149|11856782|FG004|COMPLETED|PK2 Assessment Period||0
10692315|NCT02502149|11856778|FG000|NOT COMPLETED|PK2 Assessment Period||0
10692316|NCT02502149|11856779|FG001|NOT COMPLETED|PK2 Assessment Period||0
10692317|NCT02502149|11856780|FG002|NOT COMPLETED|PK2 Assessment Period||0
10692318|NCT02502149|11856781|FG003|NOT COMPLETED|PK2 Assessment Period||0
10692319|NCT02502149|11856782|FG004|NOT COMPLETED|PK2 Assessment Period||0
10692320|NCT02502149|11856778|FG000|STARTED|Treatment Period||0
10692321|NCT02502149|11856779|FG001|STARTED|Treatment Period||0
10692322|NCT02502149|11856780|FG002|STARTED|Treatment Period||0
10692323|NCT02502149|11856781|FG003|STARTED|Treatment Period||11
10692324|NCT02502149|11856782|FG004|STARTED|Treatment Period||12
10692325|NCT02502149|11856778|FG000|COMPLETED|Treatment Period||0
10692326|NCT02502149|11856779|FG001|COMPLETED|Treatment Period||0
10692327|NCT02502149|11856780|FG002|COMPLETED|Treatment Period||0
10692328|NCT02502149|11856781|FG003|COMPLETED|Treatment Period||11
10692329|NCT02502149|11856782|FG004|COMPLETED|Treatment Period||12
10692330|NCT02502149|11856778|FG000|NOT COMPLETED|Treatment Period||0
10692331|NCT02502149|11856779|FG001|NOT COMPLETED|Treatment Period||0
10692332|NCT02502149|11856780|FG002|NOT COMPLETED|Treatment Period||0
10692333|NCT02502149|11856781|FG003|NOT COMPLETED|Treatment Period||0
10692334|NCT02502149|11856782|FG004|NOT COMPLETED|Treatment Period||0
10692335|NCT02502461|11856801|FG000|STARTED|Overall Study||46
10692336|NCT02502461|11856802|FG001|STARTED|Overall Study||44
10692337|NCT02502461|11856801|FG000|COMPLETED|Overall Study||46
10692338|NCT02502461|11856802|FG001|COMPLETED|Overall Study||44
10692339|NCT02502461|11856801|FG000|NOT COMPLETED|Overall Study||0
10692340|NCT02502461|11856802|FG001|NOT COMPLETED|Overall Study||0
10692341|NCT02502487|11856811|FG000|STARTED|Overall Study||86
10692342|NCT02502487|11856812|FG001|STARTED|Overall Study||86
10692343|NCT02502487|11856813|FG002|STARTED|Overall Study||86
10692344|NCT02502487|11856811|FG000|COMPLETED|Overall Study||86
10692345|NCT02502487|11856812|FG001|COMPLETED|Overall Study||86
10692346|NCT02502487|11856813|FG002|COMPLETED|Overall Study||86
10692347|NCT02502487|11856811|FG000|NOT COMPLETED|Overall Study||0
10692348|NCT02502487|11856812|FG001|NOT COMPLETED|Overall Study||0
10692349|NCT02502487|11856813|FG002|NOT COMPLETED|Overall Study||0
10692350|NCT02502526|11856824|FG000|STARTED|Overall Study||62
10692351|NCT02502526|11856825|FG001|STARTED|Overall Study||59
10692352|NCT02502526|11856826|FG002|STARTED|Overall Study||61
10692353|NCT02502526|11856824|FG000|Intent-to-Treat (ITT)|Overall Study||57
10692354|NCT02502526|11856825|FG001|Intent-to-Treat (ITT)|Overall Study||57
10692355|NCT02502526|11856826|FG002|Intent-to-Treat (ITT)|Overall Study||59
10692356|NCT02502526|11856824|FG000|COMPLETED|Overall Study||56
10692357|NCT02502526|11856825|FG001|COMPLETED|Overall Study||55
10692358|NCT02502526|11856826|FG002|COMPLETED|Overall Study||55
10692359|NCT02502526|11856824|FG000|NOT COMPLETED|Overall Study||6
10800693|NCT04463004|11961683|FG001|NOT COMPLETED|Overall Study||0
10692360|NCT02502526|11856825|FG001|NOT COMPLETED|Overall Study||4
10692361|NCT02502526|11856826|FG002|NOT COMPLETED|Overall Study||6
10692362|NCT02502734|11856835|FG000|STARTED|Double-blind Treatment Period 1||30
10692363|NCT02502734|11856836|FG001|STARTED|Double-blind Treatment Period 1||30
10692364|NCT02502734|11856835|FG000|COMPLETED|Double-blind Treatment Period 1||29
10692365|NCT02502734|11856836|FG001|COMPLETED|Double-blind Treatment Period 1||30
10692366|NCT02502734|11856835|FG000|NOT COMPLETED|Double-blind Treatment Period 1||1
10692367|NCT02502734|11856836|FG001|NOT COMPLETED|Double-blind Treatment Period 1||0
10692368|NCT02502734|11856835|FG000|STARTED|Washout Period||29
10692369|NCT02502734|11856836|FG001|STARTED|Washout Period||30
10692370|NCT02502734|11856835|FG000|COMPLETED|Washout Period||28
10692371|NCT02502734|11856836|FG001|COMPLETED|Washout Period||30
10692372|NCT02502734|11856835|FG000|NOT COMPLETED|Washout Period||1
10692373|NCT02502734|11856836|FG001|NOT COMPLETED|Washout Period||0
10692374|NCT02502734|11856835|FG000|STARTED|Double-blind Treatment Period 2||28
10692375|NCT02502734|11856836|FG001|STARTED|Double-blind Treatment Period 2||30
10692376|NCT02502734|11856835|FG000|COMPLETED|Double-blind Treatment Period 2||28
10692377|NCT02502734|11856836|FG001|COMPLETED|Double-blind Treatment Period 2||30
10692378|NCT02502734|11856835|FG000|NOT COMPLETED|Double-blind Treatment Period 2||0
10692379|NCT02502734|11856836|FG001|NOT COMPLETED|Double-blind Treatment Period 2||0
10692380|NCT02502864|11856844|FG000|STARTED|Overall Study||9
10692381|NCT02502864|11856844|FG000|COMPLETED|Overall Study||8
10692382|NCT02502864|11856844|FG000|NOT COMPLETED|Overall Study||1
10800694|NCT04448561|11961691|FG000|STARTED|Overall Study||16
10692383|NCT02503085|11856848|FG000|STARTED|Period 1||7
10692384|NCT02503085|11856849|FG001|STARTED|Period 1||7
10692385|NCT02503085|11856850|FG002|STARTED|Period 1||7
10692386|NCT02503085|11856851|FG003|STARTED|Period 1||7
10692387|NCT02503085|11856848|FG000|COMPLETED|Period 1||7
10692388|NCT02503085|11856849|FG001|COMPLETED|Period 1||7
10692389|NCT02503085|11856850|FG002|COMPLETED|Period 1||7
10692390|NCT02503085|11856851|FG003|COMPLETED|Period 1||7
10692391|NCT02503085|11856848|FG000|NOT COMPLETED|Period 1||0
10692392|NCT02503085|11856849|FG001|NOT COMPLETED|Period 1||0
10692393|NCT02503085|11856850|FG002|NOT COMPLETED|Period 1||0
10692394|NCT02503085|11856851|FG003|NOT COMPLETED|Period 1||0
10692395|NCT02503085|11856848|FG000|STARTED|Period 1: Washout (3 to 7 Days)||7
10692396|NCT02503085|11856849|FG001|STARTED|Period 1: Washout (3 to 7 Days)||7
10692397|NCT02503085|11856850|FG002|STARTED|Period 1: Washout (3 to 7 Days)||7
10692398|NCT02503085|11856851|FG003|STARTED|Period 1: Washout (3 to 7 Days)||7
10692399|NCT02503085|11856848|FG000|COMPLETED|Period 1: Washout (3 to 7 Days)||7
10692400|NCT02503085|11856849|FG001|COMPLETED|Period 1: Washout (3 to 7 Days)||7
10692401|NCT02503085|11856850|FG002|COMPLETED|Period 1: Washout (3 to 7 Days)||7
10692402|NCT02503085|11856851|FG003|COMPLETED|Period 1: Washout (3 to 7 Days)||7
10692403|NCT02503085|11856848|FG000|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
10692404|NCT02503085|11856849|FG001|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
10692405|NCT02503085|11856850|FG002|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
10692406|NCT02503085|11856851|FG003|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
10692407|NCT02503085|11856848|FG000|STARTED|Period 2||7
10692408|NCT02503085|11856849|FG001|STARTED|Period 2||7
10692409|NCT02503085|11856850|FG002|STARTED|Period 2||7
10692410|NCT02503085|11856851|FG003|STARTED|Period 2||7
10692411|NCT02503085|11856848|FG000|COMPLETED|Period 2||7
10692412|NCT02503085|11856849|FG001|COMPLETED|Period 2||7
10692413|NCT02503085|11856850|FG002|COMPLETED|Period 2||7
10692414|NCT02503085|11856851|FG003|COMPLETED|Period 2||7
10692415|NCT02503085|11856848|FG000|NOT COMPLETED|Period 2||0
10692416|NCT02503085|11856849|FG001|NOT COMPLETED|Period 2||0
10692417|NCT02503085|11856850|FG002|NOT COMPLETED|Period 2||0
10692418|NCT02503085|11856851|FG003|NOT COMPLETED|Period 2||0
10692419|NCT02503085|11856848|FG000|STARTED|Period 2: Washout (3 to 7 Days)||7
10692420|NCT02503085|11856849|FG001|STARTED|Period 2: Washout (3 to 7 Days)||7
10692421|NCT02503085|11856850|FG002|STARTED|Period 2: Washout (3 to 7 Days)||7
10692422|NCT02503085|11856851|FG003|STARTED|Period 2: Washout (3 to 7 Days)||7
10692423|NCT02503085|11856848|FG000|COMPLETED|Period 2: Washout (3 to 7 Days)||6
10692424|NCT02503085|11856849|FG001|COMPLETED|Period 2: Washout (3 to 7 Days)||7
10692425|NCT02503085|11856850|FG002|COMPLETED|Period 2: Washout (3 to 7 Days)||6
10692426|NCT02503085|11856851|FG003|COMPLETED|Period 2: Washout (3 to 7 Days)||7
10692427|NCT02503085|11856848|FG000|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||1
10692428|NCT02503085|11856849|FG001|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
10692429|NCT02503085|11856850|FG002|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||1
10692430|NCT02503085|11856851|FG003|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
10692431|NCT02503085|11856848|FG000|STARTED|Period 3||6
10692432|NCT02503085|11856849|FG001|STARTED|Period 3||7
10692433|NCT02503085|11856850|FG002|STARTED|Period 3||6
10692434|NCT02503085|11856851|FG003|STARTED|Period 3||7
10692435|NCT02503085|11856848|FG000|COMPLETED|Period 3||6
10692436|NCT02503085|11856849|FG001|COMPLETED|Period 3||7
10692437|NCT02503085|11856850|FG002|COMPLETED|Period 3||6
10692438|NCT02503085|11856851|FG003|COMPLETED|Period 3||7
10692439|NCT02503085|11856848|FG000|NOT COMPLETED|Period 3||0
10692440|NCT02503085|11856849|FG001|NOT COMPLETED|Period 3||0
10692441|NCT02503085|11856850|FG002|NOT COMPLETED|Period 3||0
10692442|NCT02503085|11856851|FG003|NOT COMPLETED|Period 3||0
10692443|NCT02503085|11856848|FG000|STARTED|Period 3: Washout (3 to 7 Days)||6
10692444|NCT02503085|11856849|FG001|STARTED|Period 3: Washout (3 to 7 Days)||7
10692445|NCT02503085|11856850|FG002|STARTED|Period 3: Washout (3 to 7 Days)||6
10692446|NCT02503085|11856851|FG003|STARTED|Period 3: Washout (3 to 7 Days)||7
10692447|NCT02503085|11856848|FG000|COMPLETED|Period 3: Washout (3 to 7 Days)||6
10692448|NCT02503085|11856849|FG001|COMPLETED|Period 3: Washout (3 to 7 Days)||7
10692449|NCT02503085|11856850|FG002|COMPLETED|Period 3: Washout (3 to 7 Days)||6
10692450|NCT02503085|11856851|FG003|COMPLETED|Period 3: Washout (3 to 7 Days)||7
10692451|NCT02503085|11856848|FG000|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
10692452|NCT02503085|11856849|FG001|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
10692453|NCT02503085|11856850|FG002|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
10692454|NCT02503085|11856851|FG003|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
10692455|NCT02503085|11856848|FG000|STARTED|Period 4||6
10692456|NCT02503085|11856849|FG001|STARTED|Period 4||7
10692457|NCT02503085|11856850|FG002|STARTED|Period 4||6
10692458|NCT02503085|11856851|FG003|STARTED|Period 4||7
10692459|NCT02503085|11856848|FG000|COMPLETED|Period 4||6
10692460|NCT02503085|11856849|FG001|COMPLETED|Period 4||7
10692461|NCT02503085|11856850|FG002|COMPLETED|Period 4||6
10692462|NCT02503085|11856851|FG003|COMPLETED|Period 4||7
10692463|NCT02503085|11856848|FG000|NOT COMPLETED|Period 4||0
10692464|NCT02503085|11856849|FG001|NOT COMPLETED|Period 4||0
10692465|NCT02503085|11856850|FG002|NOT COMPLETED|Period 4||0
10692466|NCT02503085|11856851|FG003|NOT COMPLETED|Period 4||0
10692467|NCT02503202|11856863|FG000|STARTED|Base Study: Up to Month 6||266
10692468|NCT02503202|11856864|FG001|STARTED|Base Study: Up to Month 6||265
10692469|NCT02503202|11856865|FG002|STARTED|Base Study: Up to Month 6||267
10692470|NCT02503202|11856866|FG003|STARTED|Base Study: Up to Month 6||266
10692471|NCT02503202|11856867|FG004|STARTED|Base Study: Up to Month 6||133
10692472|NCT02503202|11856863|FG000|Vaccinated|Base Study: Up to Month 6||266
10692473|NCT02503202|11856864|FG001|Vaccinated|Base Study: Up to Month 6||265
10692474|NCT02503202|11856865|FG002|Vaccinated|Base Study: Up to Month 6||266
10692475|NCT02503202|11856866|FG003|Vaccinated|Base Study: Up to Month 6||264
10692476|NCT02503202|11856867|FG004|Vaccinated|Base Study: Up to Month 6||133
10692477|NCT02503202|11856863|FG000|COMPLETED|Base Study: Up to Month 6||248
10692478|NCT02503202|11856864|FG001|COMPLETED|Base Study: Up to Month 6||253
10692479|NCT02503202|11856865|FG002|COMPLETED|Base Study: Up to Month 6||252
10692480|NCT02503202|11856866|FG003|COMPLETED|Base Study: Up to Month 6||255
10692481|NCT02503202|11856867|FG004|COMPLETED|Base Study: Up to Month 6||130
10692482|NCT02503202|11856863|FG000|NOT COMPLETED|Base Study: Up to Month 6||18
10692483|NCT02503202|11856864|FG001|NOT COMPLETED|Base Study: Up to Month 6||12
10692484|NCT02503202|11856865|FG002|NOT COMPLETED|Base Study: Up to Month 6||15
10692485|NCT02503202|11856866|FG003|NOT COMPLETED|Base Study: Up to Month 6||11
10692486|NCT02503202|11856867|FG004|NOT COMPLETED|Base Study: Up to Month 6||3
10692487|NCT02503202|11856863|FG000|STARTED|Extension: Month 6 to 24||119
10692488|NCT02503202|11856864|FG001|STARTED|Extension: Month 6 to 24||130
10692489|NCT02503202|11856865|FG002|STARTED|Extension: Month 6 to 24||112
10692490|NCT02503202|11856866|FG003|STARTED|Extension: Month 6 to 24||137
10692491|NCT02503202|11856867|FG004|STARTED|Extension: Month 6 to 24||68
10692492|NCT02503202|11856863|FG000|COMPLETED|Extension: Month 6 to 24||108
10692493|NCT02503202|11856864|FG001|COMPLETED|Extension: Month 6 to 24||114
10692494|NCT02503202|11856865|FG002|COMPLETED|Extension: Month 6 to 24||103
10692495|NCT02503202|11856866|FG003|COMPLETED|Extension: Month 6 to 24||119
10692496|NCT02503202|11856867|FG004|COMPLETED|Extension: Month 6 to 24||67
10692497|NCT02503202|11856863|FG000|NOT COMPLETED|Extension: Month 6 to 24||11
10692498|NCT02503202|11856864|FG001|NOT COMPLETED|Extension: Month 6 to 24||16
10692499|NCT02503202|11856865|FG002|NOT COMPLETED|Extension: Month 6 to 24||9
10692500|NCT02503202|11856866|FG003|NOT COMPLETED|Extension: Month 6 to 24||18
10692501|NCT02503202|11856867|FG004|NOT COMPLETED|Extension: Month 6 to 24||1
10692502|NCT02503215|11856879|FG000|STARTED|Overall Study||17
10692503|NCT02503215|11856879|FG000|COMPLETED|Overall Study||14
10692504|NCT02503215|11856879|FG000|NOT COMPLETED|Overall Study||3
10692505|NCT02503254|11856885|FG000|STARTED|Overall Study||41
10692506|NCT02503254|11856886|FG001|STARTED|Overall Study||39
10692507|NCT02503254|11856885|FG000|COMPLETED|Overall Study||41
10692508|NCT02503254|11856886|FG001|COMPLETED|Overall Study||39
10692509|NCT02503254|11856885|FG000|NOT COMPLETED|Overall Study||0
10692510|NCT02503254|11856886|FG001|NOT COMPLETED|Overall Study||0
10692511|NCT02503332|11856896|FG000|STARTED|Overall Study||86
10692512|NCT02503332|11856897|FG001|STARTED|Overall Study||79
10692513|NCT02503332|11856898|FG002|STARTED|Overall Study||41
10692514|NCT02503332|11856899|FG003|STARTED|Overall Study||40
10692515|NCT02503332|11856896|FG000|COMPLETED|Overall Study||52
10692516|NCT02503332|11856897|FG001|COMPLETED|Overall Study||60
10692517|NCT02503332|11856898|FG002|COMPLETED|Overall Study||33
10692518|NCT02503332|11856899|FG003|COMPLETED|Overall Study||36
10692519|NCT02503332|11856896|FG000|NOT COMPLETED|Overall Study||34
10692520|NCT02503332|11856897|FG001|NOT COMPLETED|Overall Study||19
10692521|NCT02503332|11856898|FG002|NOT COMPLETED|Overall Study||8
10692522|NCT02503332|11856899|FG003|NOT COMPLETED|Overall Study||4
10692523|NCT02503410|11856915|FG000|STARTED|Overall Study||4
10692524|NCT02503410|11856916|FG001|STARTED|Overall Study||3
10692525|NCT02503410|11856915|FG000|COMPLETED|Overall Study||4
10692526|NCT02503410|11856916|FG001|COMPLETED|Overall Study||3
10692527|NCT02503410|11856915|FG000|NOT COMPLETED|Overall Study||0
10692528|NCT02503410|11856916|FG001|NOT COMPLETED|Overall Study||0
10318906|NCT00218335|11453166|FG000|STARTED|Overall Study||114
10318907|NCT00218335|11453167|FG001|STARTED|Overall Study||113
10318908|NCT00218335|11453168|FG002|STARTED|Overall Study||373
10318909|NCT00218335|11453169|FG003|STARTED|Overall Study||424
10318910|NCT00218335|11453166|FG000|6 Month Follow-up|Overall Study||103
10318911|NCT00218335|11453167|FG001|6 Month Follow-up|Overall Study||99
10318912|NCT00218335|11453168|FG002|6 Month Follow-up|Overall Study||219
10318913|NCT00218335|11453169|FG003|6 Month Follow-up|Overall Study||301
10318914|NCT00218335|11453166|FG000|12 Month Follow-up|Overall Study||95
10800695|NCT04448561|11961692|FG001|STARTED|Overall Study||8
10800696|NCT04448561|11961691|FG000|COMPLETED|Overall Study||15
10800697|NCT04448561|11961692|FG001|COMPLETED|Overall Study||8
10800698|NCT04448561|11961691|FG000|NOT COMPLETED|Overall Study||1
10800699|NCT04448561|11961692|FG001|NOT COMPLETED|Overall Study||0
10800700|NCT04462731|11961708|FG000|STARTED|Overall Study||97
10800701|NCT04462731|11961709|FG001|STARTED|Overall Study||97
10800702|NCT04462731|11961708|FG000|COMPLETED|Overall Study||41
10800703|NCT04462731|11961709|FG001|COMPLETED|Overall Study||51
10800704|NCT04462731|11961708|FG000|NOT COMPLETED|Overall Study||56
10800705|NCT04462731|11961709|FG001|NOT COMPLETED|Overall Study||46
10800706|NCT04459585|11961715|FG000|STARTED|Period 1 (Day 1 to Day 5)||20
10800707|NCT04459585|11961715|FG000|COMPLETED|Period 1 (Day 1 to Day 5)||20
10800708|NCT04459585|11961715|FG000|NOT COMPLETED|Period 1 (Day 1 to Day 5)||0
10800709|NCT04459585|11961715|FG000|STARTED|Period 2 (Day 5 to Day 12)||20
10800710|NCT04459585|11961715|FG000|COMPLETED|Period 2 (Day 5 to Day 12)||20
10800711|NCT04459585|11961715|FG000|NOT COMPLETED|Period 2 (Day 5 to Day 12)||0
10800712|NCT04458818|11961722|FG000|STARTED|Overall Study|May 01 2020|39
10800713|NCT04458818|11961722|FG000|COMPLETED|Overall Study|Jan 30 2021|39
10800714|NCT04458818|11961722|FG000|NOT COMPLETED|Overall Study||0
10800715|NCT04456634|11961728|FG000|STARTED|Overall Study||6
10318915|NCT00218335|11453167|FG001|12 Month Follow-up|Overall Study||102
10318916|NCT00218335|11453168|FG002|12 Month Follow-up|Overall Study||244
10318917|NCT00218335|11453169|FG003|12 Month Follow-up|Overall Study||303
10692529|NCT02503501|11856929|FG000|STARTED|Overall Study||19
10800716|NCT04456634|11961729|FG001|STARTED|Overall Study||2
10800717|NCT04456634|11961728|FG000|COMPLETED|Overall Study||5
10800718|NCT04456634|11961729|FG001|COMPLETED|Overall Study||2
10800719|NCT04456634|11961728|FG000|NOT COMPLETED|Overall Study||1
10800720|NCT04456634|11961729|FG001|NOT COMPLETED|Overall Study||0
10800721|NCT04454138|11961737|FG000|STARTED|Overall Study||65
10800722|NCT04454138|11961738|FG001|STARTED|Overall Study||77
10800723|NCT04454138|11961737|FG000|COMPLETED|Overall Study||65
10800724|NCT04454138|11961738|FG001|COMPLETED|Overall Study||77
10800725|NCT04454138|11961737|FG000|NOT COMPLETED|Overall Study||0
10800726|NCT04454138|11961738|FG001|NOT COMPLETED|Overall Study||0
10800727|NCT04452435|11961746|FG000|STARTED|Screening||51
10800728|NCT04452435|11961747|FG001|STARTED|Screening||55
10692530|NCT02503501|11856930|FG001|STARTED|Overall Study||16
10800729|NCT04452435|11961746|FG000|COMPLETED|Screening||51
10800730|NCT04452435|11961747|FG001|COMPLETED|Screening||55
10800731|NCT04452435|11961746|FG000|NOT COMPLETED|Screening||0
10800732|NCT04452435|11961747|FG001|NOT COMPLETED|Screening||0
10318918|NCT00218335|11453166|FG000|18 Month Follow-up|Overall Study||101
10318919|NCT00218335|11453167|FG001|18 Month Follow-up|Overall Study||108
10318920|NCT00218335|11453168|FG002|18 Month Follow-up|Overall Study||296
10318921|NCT00218335|11453169|FG003|18 Month Follow-up|Overall Study||368
10318922|NCT00218335|11453166|FG000|COMPLETED|Overall Study||108
10692531|NCT02503501|11856929|FG000|COMPLETED|Overall Study||18
10692532|NCT02503501|11856930|FG001|COMPLETED|Overall Study||13
10692533|NCT02503501|11856929|FG000|NOT COMPLETED|Overall Study||1
10692534|NCT02503501|11856930|FG001|NOT COMPLETED|Overall Study||3
10692535|NCT02503540|11856936|FG000|STARTED|Overall Study||31
10692536|NCT02503540|11856936|FG000|COMPLETED|Overall Study||28
10692537|NCT02503540|11856936|FG000|NOT COMPLETED|Overall Study||3
10692538|NCT02503735|11856940|FG000|STARTED|Overall Study||10
10692539|NCT02503735|11856940|FG000|SVR 12 (12week Post Treatment RNA Neg)|Overall Study||8
10692540|NCT02503735|11856940|FG000|COMPLETED|Overall Study||10
10692541|NCT02503735|11856940|FG000|NOT COMPLETED|Overall Study||0
10692542|NCT02503787|11856950|FG000|STARTED|Enrollment||64
10692543|NCT02503787|11856950|FG000|COMPLETED|Enrollment||44
10800733|NCT04452435|11961746|FG000|STARTED|Treatment Period||51
10800734|NCT04452435|11961747|FG001|STARTED|Treatment Period||55
10800735|NCT04452435|11961746|FG000|COMPLETED|Treatment Period||45
10800736|NCT04452435|11961747|FG001|COMPLETED|Treatment Period||43
10800737|NCT04452435|11961746|FG000|NOT COMPLETED|Treatment Period||6
10800738|NCT04452435|11961747|FG001|NOT COMPLETED|Treatment Period||12
10800739|NCT04452435|11961746|FG000|STARTED|Follow-up||45
10800740|NCT04452435|11961747|FG001|STARTED|Follow-up||43
10692544|NCT02503787|11856950|FG000|NOT COMPLETED|Enrollment||20
10692545|NCT02503787|11856950|FG000|STARTED|Device Trial (HD Programming Trial)||44
10692546|NCT02503787|11856950|FG000|COMPLETED|Device Trial (HD Programming Trial)||37
10692547|NCT02503787|11856950|FG000|NOT COMPLETED|Device Trial (HD Programming Trial)||7
10692548|NCT02503787|11856950|FG000|STARTED|Successful Trial (≥50% Pain Relief)||37
10692549|NCT02503787|11856950|FG000|COMPLETED|Successful Trial (≥50% Pain Relief)||32
10692550|NCT02503787|11856950|FG000|NOT COMPLETED|Successful Trial (≥50% Pain Relief)||5
10692551|NCT02503787|11856950|FG000|STARTED|Implant to 3 Month Endpoint||32
10692552|NCT02503787|11856950|FG000|COMPLETED|Implant to 3 Month Endpoint||29
10692553|NCT02503787|11856950|FG000|NOT COMPLETED|Implant to 3 Month Endpoint||3
10692554|NCT02503852|11856958|FG000|STARTED|Overall Study||16
10692555|NCT02503852|11856959|FG001|STARTED|Overall Study||22
10692556|NCT02503852|11856960|FG002|STARTED|Overall Study||24
10692557|NCT02503852|11856961|FG003|STARTED|Overall Study||9
10692558|NCT02503852|11856958|FG000|COMPLETED|Overall Study||12
10692559|NCT02503852|11856959|FG001|COMPLETED|Overall Study||19
10692560|NCT02503852|11856960|FG002|COMPLETED|Overall Study||21
10692561|NCT02503852|11856961|FG003|COMPLETED|Overall Study||8
10800741|NCT04452435|11961746|FG000|COMPLETED|Follow-up||45
10800742|NCT04452435|11961747|FG001|COMPLETED|Follow-up||42
10800743|NCT04452435|11961746|FG000|NOT COMPLETED|Follow-up||0
10800744|NCT04452435|11961747|FG001|NOT COMPLETED|Follow-up||1
10800745|NCT04451707|11961754|FG000|STARTED|Overall Study||67
10800746|NCT04451707|11961754|FG000|COMPLETED|Overall Study||67
10800747|NCT04451707|11961754|FG000|NOT COMPLETED|Overall Study||0
10800748|NCT04449263|11961758|FG000|STARTED|First Intervention||29
10800749|NCT04449263|11961759|FG001|STARTED|First Intervention||30
10800750|NCT04449263|11961758|FG000|COMPLETED|First Intervention||29
10800751|NCT04449263|11961759|FG001|COMPLETED|First Intervention||30
10800752|NCT04449263|11961758|FG000|NOT COMPLETED|First Intervention||0
10800753|NCT04449263|11961759|FG001|NOT COMPLETED|First Intervention||0
10800754|NCT04449263|11961758|FG000|STARTED|Second Intervention||29
10800755|NCT04449263|11961759|FG001|STARTED|Second Intervention||30
10800756|NCT04449263|11961758|FG000|COMPLETED|Second Intervention||29
10800757|NCT04449263|11961759|FG001|COMPLETED|Second Intervention||30
10800758|NCT04449263|11961758|FG000|NOT COMPLETED|Second Intervention||0
10800759|NCT04449263|11961759|FG001|NOT COMPLETED|Second Intervention||0
10800760|NCT04449263|11961758|FG000|STARTED|Third Intervention||29
10800761|NCT04449263|11961759|FG001|STARTED|Third Intervention||30
10800762|NCT04449263|11961758|FG000|COMPLETED|Third Intervention||29
10800763|NCT04449263|11961759|FG001|COMPLETED|Third Intervention||30
10800764|NCT04449263|11961758|FG000|NOT COMPLETED|Third Intervention||0
10800765|NCT04449263|11961759|FG001|NOT COMPLETED|Third Intervention||0
10800766|NCT04450381|11961767|FG000|STARTED|Overall Study||131
10692562|NCT02503852|11856958|FG000|NOT COMPLETED|Overall Study||4
10692563|NCT02503852|11856959|FG001|NOT COMPLETED|Overall Study||3
10692564|NCT02503852|11856960|FG002|NOT COMPLETED|Overall Study||3
10800767|NCT04450381|11961767|FG000|COMPLETED|Overall Study||125
10800768|NCT04450381|11961767|FG000|NOT COMPLETED|Overall Study||6
10800769|NCT04449341|11961773|FG000|STARTED|Overall Study||31
10800770|NCT04449341|11961774|FG001|STARTED|Overall Study||28
10800771|NCT04449341|11961773|FG000|COMPLETED|Overall Study||30
10800772|NCT04449341|11961774|FG001|COMPLETED|Overall Study||28
10800773|NCT04449341|11961773|FG000|NOT COMPLETED|Overall Study||1
10692565|NCT02503852|11856961|FG003|NOT COMPLETED|Overall Study||1
10692566|NCT02503865|11856974|FG000|STARTED|Overall Study||70
10692567|NCT02503865|11856975|FG001|STARTED|Overall Study||269
10692568|NCT02503865|11856976|FG002|STARTED|Overall Study||66
10692569|NCT02503865|11856974|FG000|COMPLETED|Overall Study||65
10692570|NCT02503865|11856975|FG001|COMPLETED|Overall Study||222
10800774|NCT04449341|11961774|FG001|NOT COMPLETED|Overall Study||0
10800775|NCT04441255|11961782|FG000|STARTED|Period 1 (1 Day)||7
10800776|NCT04441255|11961783|FG001|STARTED|Period 1 (1 Day)||7
10800777|NCT04441255|11961782|FG000|COMPLETED|Period 1 (1 Day)||7
10692571|NCT02503865|11856976|FG002|COMPLETED|Overall Study||64
10692572|NCT02503865|11856974|FG000|NOT COMPLETED|Overall Study||5
10692573|NCT02503865|11856975|FG001|NOT COMPLETED|Overall Study||47
10692574|NCT02503865|11856976|FG002|NOT COMPLETED|Overall Study||2
10692575|NCT02503982|11856985|FG000|STARTED|Overall Study||13
10692576|NCT02503982|11856985|FG000|COMPLETED|Overall Study||13
10692577|NCT02503982|11856985|FG000|NOT COMPLETED|Overall Study||0
10692578|NCT02504073|11856989|FG000|STARTED|Overall Study||54
10692579|NCT02504073|11856989|FG000|COMPLETED|Overall Study||54
10692580|NCT02504073|11856989|FG000|NOT COMPLETED|Overall Study||0
10692581|NCT02504216|11856996|FG000|STARTED|Overall Study||3286
10692582|NCT02504216|11856997|FG001|STARTED|Overall Study||3278
10692583|NCT02504216|11856996|FG000|Received Treatment|Overall Study||3256
10692584|NCT02504216|11856997|FG001|Received Treatment|Overall Study||3248
10692585|NCT02504216|11856996|FG000|COMPLETED|Overall Study||3275
10692586|NCT02504216|11856997|FG001|COMPLETED|Overall Study||3263
10692587|NCT02504216|11856996|FG000|NOT COMPLETED|Overall Study||11
10692588|NCT02504216|11856997|FG001|NOT COMPLETED|Overall Study||15
10692589|NCT02504268|11857006|FG000|STARTED|Overall Study||451
10692590|NCT02504268|11857007|FG001|STARTED|Overall Study||301
10692591|NCT02504268|11857008|FG002|STARTED|Overall Study||242
10692592|NCT02504268|11857009|FG003|STARTED|Overall Study||0
10692593|NCT02504268|11857010|FG004|STARTED|Overall Study||0
10692594|NCT02504268|11857011|FG005|STARTED|Overall Study||0
10692595|NCT02504268|11857012|FG006|STARTED|Overall Study||0
10692596|NCT02504268|11857013|FG007|STARTED|Overall Study||0
10318923|NCT00218335|11453167|FG001|COMPLETED|Overall Study||110
10318924|NCT00218335|11453168|FG002|COMPLETED|Overall Study||319
10318925|NCT00218335|11453169|FG003|COMPLETED|Overall Study||388
10800778|NCT04441255|11961783|FG001|COMPLETED|Period 1 (1 Day)||7
10800779|NCT04441255|11961782|FG000|NOT COMPLETED|Period 1 (1 Day)||0
10800780|NCT04441255|11961783|FG001|NOT COMPLETED|Period 1 (1 Day)||0
10800781|NCT04441255|11961782|FG000|STARTED|Washout Period (10 Days)||7
10800782|NCT04441255|11961783|FG001|STARTED|Washout Period (10 Days)||7
10800783|NCT04441255|11961782|FG000|COMPLETED|Washout Period (10 Days)||7
10800784|NCT04441255|11961783|FG001|COMPLETED|Washout Period (10 Days)||7
10692597|NCT02504268|11857014|FG008|STARTED|Overall Study||0
10692598|NCT02504268|11857006|FG000|Induction to Open Label|Overall Study||289
10692599|NCT02504268|11857007|FG001|Induction to Open Label|Overall Study||196
10692600|NCT02504268|11857008|FG002|Induction to Open Label|Overall Study||147
10692601|NCT02504268|11857009|FG003|Induction to Open Label|Overall Study||0
10692602|NCT02504268|11857010|FG004|Induction to Open Label|Overall Study||0
10692603|NCT02504268|11857011|FG005|Induction to Open Label|Overall Study||0
10800785|NCT04441255|11961782|FG000|NOT COMPLETED|Washout Period (10 Days)||0
10800786|NCT04441255|11961783|FG001|NOT COMPLETED|Washout Period (10 Days)||0
10800787|NCT04441255|11961782|FG000|STARTED|Period 2 (1 Day)||7
10800788|NCT04441255|11961783|FG001|STARTED|Period 2 (1 Day)||7
10692604|NCT02504268|11857012|FG006|Induction to Open Label|Overall Study||0
10692605|NCT02504268|11857013|FG007|Induction to Open Label|Overall Study||0
10692606|NCT02504268|11857014|FG008|Induction to Open Label|Overall Study||0
10692607|NCT02504268|11857006|FG000|Early Escaped to Open Label|Overall Study||10
10692608|NCT02504268|11857007|FG001|Early Escaped to Open Label|Overall Study||21
10692609|NCT02504268|11857008|FG002|Early Escaped to Open Label|Overall Study||8
10692610|NCT02504268|11857009|FG003|Early Escaped to Open Label|Overall Study||0
10692611|NCT02504268|11857010|FG004|Early Escaped to Open Label|Overall Study||0
10692612|NCT02504268|11857011|FG005|Early Escaped to Open Label|Overall Study||0
10692613|NCT02504268|11857012|FG006|Early Escaped to Open Label|Overall Study||0
10692614|NCT02504268|11857013|FG007|Early Escaped to Open Label|Overall Study||0
10692615|NCT02504268|11857014|FG008|Early Escaped to Open Label|Overall Study||0
10692616|NCT02504268|11857006|FG000|Induction to De-Escalation|Overall Study||94
10692617|NCT02504268|11857007|FG001|Induction to De-Escalation|Overall Study||37
10692618|NCT02504268|11857008|FG002|Induction to De-Escalation|Overall Study||53
10692619|NCT02504268|11857009|FG003|Induction to De-Escalation|Overall Study||0
10692620|NCT02504268|11857010|FG004|Induction to De-Escalation|Overall Study||0
10692621|NCT02504268|11857011|FG005|Induction to De-Escalation|Overall Study||0
10692622|NCT02504268|11857012|FG006|Induction to De-Escalation|Overall Study||0
10692623|NCT02504268|11857013|FG007|Induction to De-Escalation|Overall Study||0
10692624|NCT02504268|11857014|FG008|Induction to De-Escalation|Overall Study||0
10692625|NCT02504268|11857006|FG000|Randomized in De-Escalation Period|Overall Study||0
10692626|NCT02504268|11857007|FG001|Randomized in De-Escalation Period|Overall Study||0
10692627|NCT02504268|11857008|FG002|Randomized in De-Escalation Period|Overall Study||0
10692628|NCT02504268|11857009|FG003|Randomized in De-Escalation Period|Overall Study||50
10692629|NCT02504268|11857010|FG004|Randomized in De-Escalation Period|Overall Study||50
10692630|NCT02504268|11857011|FG005|Randomized in De-Escalation Period|Overall Study||47
10692631|NCT02504268|11857012|FG006|Randomized in De-Escalation Period|Overall Study||37
10692632|NCT02504268|11857013|FG007|Randomized in De-Escalation Period|Overall Study||0
10692633|NCT02504268|11857014|FG008|Randomized in De-Escalation Period|Overall Study||0
10692634|NCT02504268|11857006|FG000|De-Escalation to Open Label Extension|Overall Study||0
10692635|NCT02504268|11857007|FG001|De-Escalation to Open Label Extension|Overall Study||0
10692636|NCT02504268|11857008|FG002|De-Escalation to Open Label Extension|Overall Study||0
10692637|NCT02504268|11857009|FG003|De-Escalation to Open Label Extension|Overall Study||36
10692638|NCT02504268|11857010|FG004|De-Escalation to Open Label Extension|Overall Study||30
10692639|NCT02504268|11857011|FG005|De-Escalation to Open Label Extension|Overall Study||32
10692640|NCT02504268|11857012|FG006|De-Escalation to Open Label Extension|Overall Study||22
10692641|NCT02504268|11857013|FG007|De-Escalation to Open Label Extension|Overall Study||0
10692642|NCT02504268|11857014|FG008|De-Escalation to Open Label Extension|Overall Study||0
10692643|NCT02504268|11857006|FG000|Early Escaped De-Escalation to Open Label Period|Overall Study||0
10692644|NCT02504268|11857007|FG001|Early Escaped De-Escalation to Open Label Period|Overall Study||0
10692645|NCT02504268|11857008|FG002|Early Escaped De-Escalation to Open Label Period|Overall Study||0
10692646|NCT02504268|11857009|FG003|Early Escaped De-Escalation to Open Label Period|Overall Study||2
10692647|NCT02504268|11857010|FG004|Early Escaped De-Escalation to Open Label Period|Overall Study||5
10692648|NCT02504268|11857011|FG005|Early Escaped De-Escalation to Open Label Period|Overall Study||4
10692649|NCT02504268|11857012|FG006|Early Escaped De-Escalation to Open Label Period|Overall Study||3
10692650|NCT02504268|11857013|FG007|Early Escaped De-Escalation to Open Label Period|Overall Study||0
10692651|NCT02504268|11857014|FG008|Early Escaped De-Escalation to Open Label Period|Overall Study||0
10692652|NCT02504268|11857006|FG000|Open Label and Open Label Extension Period|Overall Study||0
10692653|NCT02504268|11857007|FG001|Open Label and Open Label Extension Period|Overall Study||0
10692654|NCT02504268|11857008|FG002|Open Label and Open Label Extension Period|Overall Study||0
10692655|NCT02504268|11857009|FG003|Open Label and Open Label Extension Period|Overall Study||0
10692656|NCT02504268|11857010|FG004|Open Label and Open Label Extension Period|Overall Study||0
10692657|NCT02504268|11857011|FG005|Open Label and Open Label Extension Period|Overall Study||0
10692658|NCT02504268|11857012|FG006|Open Label and Open Label Extension Period|Overall Study||0
10692659|NCT02504268|11857013|FG007|Open Label and Open Label Extension Period|Overall Study||685
10692660|NCT02504268|11857014|FG008|Open Label and Open Label Extension Period|Overall Study||120
10692661|NCT02504268|11857006|FG000|COMPLETED|Overall Study||388
10692662|NCT02504268|11857007|FG001|COMPLETED|Overall Study||233
10692663|NCT02504268|11857008|FG002|COMPLETED|Overall Study||201
10692664|NCT02504268|11857009|FG003|COMPLETED|Overall Study||0
10692665|NCT02504268|11857010|FG004|COMPLETED|Overall Study||0
10692666|NCT02504268|11857011|FG005|COMPLETED|Overall Study||0
10692667|NCT02504268|11857012|FG006|COMPLETED|Overall Study||0
10692668|NCT02504268|11857013|FG007|COMPLETED|Overall Study||0
10692669|NCT02504268|11857014|FG008|COMPLETED|Overall Study||0
10692670|NCT02504268|11857006|FG000|NOT COMPLETED|Overall Study||63
10692671|NCT02504268|11857007|FG001|NOT COMPLETED|Overall Study||68
10692672|NCT02504268|11857008|FG002|NOT COMPLETED|Overall Study||41
10692673|NCT02504268|11857009|FG003|NOT COMPLETED|Overall Study||0
10692674|NCT02504268|11857010|FG004|NOT COMPLETED|Overall Study||0
10692675|NCT02504268|11857011|FG005|NOT COMPLETED|Overall Study||0
10692676|NCT02504268|11857012|FG006|NOT COMPLETED|Overall Study||0
10692677|NCT02504268|11857013|FG007|NOT COMPLETED|Overall Study||0
10692678|NCT02504268|11857014|FG008|NOT COMPLETED|Overall Study||0
10692679|NCT02504294|11857036|FG000|STARTED|Overall Study||212
10692680|NCT02504294|11857037|FG001|STARTED|Overall Study||206
10692681|NCT02504294|11857036|FG000|COMPLETED|Overall Study||156
10692682|NCT02504294|11857037|FG001|COMPLETED|Overall Study||158
10692683|NCT02504294|11857036|FG000|NOT COMPLETED|Overall Study||56
10692684|NCT02504294|11857037|FG001|NOT COMPLETED|Overall Study||48
10692685|NCT02504320|11857047|FG000|STARTED|Treatment Period 1||19
10692686|NCT02504320|11857048|FG001|STARTED|Treatment Period 1||19
10692687|NCT02504320|11857049|FG002|STARTED|Treatment Period 1||20
10692688|NCT02504320|11857050|FG003|STARTED|Treatment Period 1||20
10692689|NCT02504320|11857047|FG000|COMPLETED|Treatment Period 1||19
10692690|NCT02504320|11857048|FG001|COMPLETED|Treatment Period 1||19
10692691|NCT02504320|11857049|FG002|COMPLETED|Treatment Period 1||19
10692692|NCT02504320|11857050|FG003|COMPLETED|Treatment Period 1||20
10692693|NCT02504320|11857047|FG000|NOT COMPLETED|Treatment Period 1||0
10692694|NCT02504320|11857048|FG001|NOT COMPLETED|Treatment Period 1||0
10692695|NCT02504320|11857049|FG002|NOT COMPLETED|Treatment Period 1||1
10692696|NCT02504320|11857050|FG003|NOT COMPLETED|Treatment Period 1||0
10692697|NCT02504320|11857047|FG000|STARTED|Treatment Period 2||19
10692698|NCT02504320|11857048|FG001|STARTED|Treatment Period 2||19
10692699|NCT02504320|11857049|FG002|STARTED|Treatment Period 2||19
10692700|NCT02504320|11857050|FG003|STARTED|Treatment Period 2||20
10692701|NCT02504320|11857047|FG000|COMPLETED|Treatment Period 2||19
10692702|NCT02504320|11857048|FG001|COMPLETED|Treatment Period 2||18
10692703|NCT02504320|11857049|FG002|COMPLETED|Treatment Period 2||19
10692704|NCT02504320|11857050|FG003|COMPLETED|Treatment Period 2||20
10692705|NCT02504320|11857047|FG000|NOT COMPLETED|Treatment Period 2||0
10692706|NCT02504320|11857048|FG001|NOT COMPLETED|Treatment Period 2||1
10692707|NCT02504320|11857049|FG002|NOT COMPLETED|Treatment Period 2||0
10692708|NCT02504320|11857050|FG003|NOT COMPLETED|Treatment Period 2||0
10692709|NCT02504320|11857047|FG000|STARTED|Treatment Period 3||19
10692710|NCT02504320|11857048|FG001|STARTED|Treatment Period 3||18
10692711|NCT02504320|11857049|FG002|STARTED|Treatment Period 3||19
10692712|NCT02504320|11857050|FG003|STARTED|Treatment Period 3||20
10692713|NCT02504320|11857047|FG000|COMPLETED|Treatment Period 3||19
10692714|NCT02504320|11857048|FG001|COMPLETED|Treatment Period 3||18
10692715|NCT02504320|11857049|FG002|COMPLETED|Treatment Period 3||18
10692716|NCT02504320|11857050|FG003|COMPLETED|Treatment Period 3||19
10692717|NCT02504320|11857047|FG000|NOT COMPLETED|Treatment Period 3||0
10692718|NCT02504320|11857048|FG001|NOT COMPLETED|Treatment Period 3||0
10692719|NCT02504320|11857049|FG002|NOT COMPLETED|Treatment Period 3||1
10692720|NCT02504320|11857050|FG003|NOT COMPLETED|Treatment Period 3||1
10692721|NCT02504320|11857047|FG000|STARTED|Treatment Period 4||19
10692722|NCT02504320|11857048|FG001|STARTED|Treatment Period 4||18
10692723|NCT02504320|11857049|FG002|STARTED|Treatment Period 4||18
10692724|NCT02504320|11857050|FG003|STARTED|Treatment Period 4||19
10692725|NCT02504320|11857047|FG000|COMPLETED|Treatment Period 4||19
10692726|NCT02504320|11857048|FG001|COMPLETED|Treatment Period 4||18
10692727|NCT02504320|11857049|FG002|COMPLETED|Treatment Period 4||18
10692728|NCT02504320|11857050|FG003|COMPLETED|Treatment Period 4||19
10692729|NCT02504320|11857047|FG000|NOT COMPLETED|Treatment Period 4||0
10692730|NCT02504320|11857048|FG001|NOT COMPLETED|Treatment Period 4||0
10692731|NCT02504320|11857049|FG002|NOT COMPLETED|Treatment Period 4||0
10692732|NCT02504320|11857050|FG003|NOT COMPLETED|Treatment Period 4||0
10692733|NCT02504424|11857060|FG000|STARTED|Overall Study||50
10692734|NCT02504424|11857060|FG000|COMPLETED|Overall Study||48
10692735|NCT02504424|11857060|FG000|NOT COMPLETED|Overall Study||2
10692736|NCT02504502|11857067|FG000|STARTED|Routine Care vs. Enhanced Report||24
10692737|NCT02504502|11857068|FG001|STARTED|Routine Care vs. Enhanced Report||28
10692738|NCT02504502|11857067|FG000|COMPLETED|Routine Care vs. Enhanced Report||20
10692739|NCT02504502|11857068|FG001|COMPLETED|Routine Care vs. Enhanced Report||21
10692740|NCT02504502|11857067|FG000|NOT COMPLETED|Routine Care vs. Enhanced Report||4
10692741|NCT02504502|11857068|FG001|NOT COMPLETED|Routine Care vs. Enhanced Report||7
10692742|NCT02504502|11857067|FG000|STARTED|Crossover to Enhanced Report||20
10692743|NCT02504502|11857068|FG001|STARTED|Crossover to Enhanced Report|The enhanced report arm was completed in first period and does not carry forward to period 2.|0
10692744|NCT02504502|11857067|FG000|COMPLETED|Crossover to Enhanced Report||15
10692745|NCT02504502|11857068|FG001|COMPLETED|Crossover to Enhanced Report|the enhanced report arm was completed in first period and does not carry forward to period 2|0
10692746|NCT02504502|11857067|FG000|NOT COMPLETED|Crossover to Enhanced Report||5
10692747|NCT02504502|11857068|FG001|NOT COMPLETED|Crossover to Enhanced Report||0
10692748|NCT02504541|11857074|FG000|STARTED|Overall Study||133
10692749|NCT02504541|11857074|FG000|COMPLETED|Overall Study||113
10692750|NCT02504541|11857074|FG000|NOT COMPLETED|Overall Study||20
10692751|NCT02504554|11857080|FG000|STARTED|Overall Study|1 participant was switched from the oral group to the rectal group due to nausea/vomiting.|12
10692752|NCT02504554|11857081|FG001|STARTED|Overall Study||6
10692753|NCT02504554|11857080|FG000|COMPLETED|Overall Study||12
10692754|NCT02504554|11857081|FG001|COMPLETED|Overall Study||6
10692755|NCT02504554|11857080|FG000|NOT COMPLETED|Overall Study||0
10692756|NCT02504554|11857081|FG001|NOT COMPLETED|Overall Study||0
10692757|NCT02504619|11857087|FG000|STARTED|Overall Study||1
10692758|NCT02504619|11857087|FG000|COMPLETED|Overall Study||1
10692759|NCT02504619|11857087|FG000|NOT COMPLETED|Overall Study||0
10692760|NCT02504645|11857094|FG000|STARTED|Overall Study||101
10692761|NCT02504645|11857095|FG001|STARTED|Overall Study||101
10692762|NCT02504645|11857094|FG000|COMPLETED|Overall Study||77
10692763|NCT02504645|11857095|FG001|COMPLETED|Overall Study||76
10692764|NCT02504645|11857094|FG000|NOT COMPLETED|Overall Study||24
10692765|NCT02504645|11857095|FG001|NOT COMPLETED|Overall Study||25
10692766|NCT02504671|11857107|FG000|STARTED|Overall Study||37
10692767|NCT02504671|11857108|FG001|STARTED|Overall Study||37
10692768|NCT02504671|11857109|FG002|STARTED|Overall Study||37
10692769|NCT02504671|11857110|FG003|STARTED|Overall Study||37
10692770|NCT02504671|11857111|FG004|STARTED|Overall Study||37
10692771|NCT02504671|11857112|FG005|STARTED|Overall Study||37
10692772|NCT02504671|11857107|FG000|COMPLETED|Overall Study||25
10692773|NCT02504671|11857108|FG001|COMPLETED|Overall Study||23
10692774|NCT02504671|11857109|FG002|COMPLETED|Overall Study||27
10692775|NCT02504671|11857110|FG003|COMPLETED|Overall Study||27
10692776|NCT02504671|11857111|FG004|COMPLETED|Overall Study||25
10692777|NCT02504671|11857112|FG005|COMPLETED|Overall Study||23
10692778|NCT02504671|11857107|FG000|NOT COMPLETED|Overall Study||12
10692779|NCT02504671|11857108|FG001|NOT COMPLETED|Overall Study||14
10692780|NCT02504671|11857109|FG002|NOT COMPLETED|Overall Study||10
10692781|NCT02504671|11857110|FG003|NOT COMPLETED|Overall Study||10
10692782|NCT02504671|11857111|FG004|NOT COMPLETED|Overall Study||12
10692783|NCT02504671|11857112|FG005|NOT COMPLETED|Overall Study||14
10692784|NCT02504723|11857128|FG000|STARTED|Overall Study||60
10692785|NCT02504723|11857129|FG001|STARTED|Overall Study||61
10692786|NCT02504723|11857128|FG000|COMPLETED|Overall Study||60
10692787|NCT02504723|11857129|FG001|COMPLETED|Overall Study||61
10692788|NCT02504723|11857128|FG000|NOT COMPLETED|Overall Study||0
10692789|NCT02504723|11857129|FG001|NOT COMPLETED|Overall Study||0
10692790|NCT02504775|11857135|FG000|STARTED|Period 1||14
10692791|NCT02504775|11857136|FG001|STARTED|Period 1||14
10692792|NCT02504775|11857135|FG000|COMPLETED|Period 1||14
10692793|NCT02504775|11857136|FG001|COMPLETED|Period 1||14
10692794|NCT02504775|11857135|FG000|NOT COMPLETED|Period 1||0
10692795|NCT02504775|11857136|FG001|NOT COMPLETED|Period 1||0
10692796|NCT02504775|11857135|FG000|STARTED|Washout||14
10692797|NCT02504775|11857136|FG001|STARTED|Washout||14
10692798|NCT02504775|11857135|FG000|COMPLETED|Washout||14
10692799|NCT02504775|11857136|FG001|COMPLETED|Washout||14
10692800|NCT02504775|11857135|FG000|NOT COMPLETED|Washout||0
10692801|NCT02504775|11857136|FG001|NOT COMPLETED|Washout||0
10692802|NCT02504775|11857135|FG000|STARTED|Period 2||14
10692803|NCT02504775|11857136|FG001|STARTED|Period 2||14
10692804|NCT02504775|11857135|FG000|COMPLETED|Period 2||14
10692805|NCT02504775|11857136|FG001|COMPLETED|Period 2||14
10692806|NCT02504775|11857135|FG000|NOT COMPLETED|Period 2||0
10692807|NCT02504775|11857136|FG001|NOT COMPLETED|Period 2||0
10692808|NCT02504827|11857144|FG000|STARTED|Overall Study||12
10692809|NCT02504827|11857144|FG000|COMPLETED|Overall Study||11
10692810|NCT02504827|11857144|FG000|NOT COMPLETED|Overall Study||1
10692811|NCT02504892|11857148|FG000|STARTED|Overall Study||3
10800789|NCT04441255|11961782|FG000|COMPLETED|Period 2 (1 Day)||7
10800790|NCT04441255|11961783|FG001|COMPLETED|Period 2 (1 Day)||7
10800791|NCT04441255|11961782|FG000|NOT COMPLETED|Period 2 (1 Day)||0
10800792|NCT04441255|11961783|FG001|NOT COMPLETED|Period 2 (1 Day)||0
10800793|NCT04439214|11961789|FG000|STARTED|Overall Study||47
10692812|NCT02504892|11857148|FG000|COMPLETED|Overall Study||1
10692813|NCT02504892|11857148|FG000|NOT COMPLETED|Overall Study||2
10692814|NCT02504931|11857154|FG000|STARTED|Overall Study||26
10692815|NCT02504931|11857155|FG001|STARTED|Overall Study||23
10692816|NCT02504931|11857154|FG000|COMPLETED|Overall Study||14
10692817|NCT02504931|11857155|FG001|COMPLETED|Overall Study||13
10692818|NCT02504931|11857154|FG000|NOT COMPLETED|Overall Study||12
10692819|NCT02504931|11857155|FG001|NOT COMPLETED|Overall Study||10
10692820|NCT02505217|11857163|FG000|STARTED|Overall Study||105
10692821|NCT02505217|11857164|FG001|STARTED|Overall Study||95
10692822|NCT02505217|11857163|FG000|COMPLETED|Overall Study||104
10692823|NCT02505217|11857164|FG001|COMPLETED|Overall Study||93
10692824|NCT02505217|11857163|FG000|NOT COMPLETED|Overall Study||1
10692825|NCT02505217|11857164|FG001|NOT COMPLETED|Overall Study||2
10692826|NCT02505269|11857170|FG000|STARTED|Overall Study||34
10692827|NCT02505269|11857170|FG000|COMPLETED|Overall Study||34
10692828|NCT02505269|11857170|FG000|NOT COMPLETED|Overall Study||0
10692829|NCT02505334|11857176|FG000|STARTED|Main Treatment Period||233
10692830|NCT02505334|11857177|FG001|STARTED|Main Treatment Period||233
10692831|NCT02505334|11857176|FG000|COMPLETED|Main Treatment Period||218
10692832|NCT02505334|11857177|FG001|COMPLETED|Main Treatment Period||194
10692833|NCT02505334|11857176|FG000|NOT COMPLETED|Main Treatment Period||15
10692834|NCT02505334|11857177|FG001|NOT COMPLETED|Main Treatment Period||39
10692835|NCT02505334|11857176|FG000|STARTED|Extension Treatment Period|6 subjects withdrew from the trial after the main period and prior to entering the extension period|212
10692836|NCT02505334|11857177|FG001|STARTED|Extension Treatment Period|This treatment arm is not considered for this period as the subjects were treated for 26 weeks|0
10692837|NCT02505334|11857176|FG000|COMPLETED|Extension Treatment Period||194
10692838|NCT02505334|11857177|FG001|COMPLETED|Extension Treatment Period||0
10692839|NCT02505334|11857176|FG000|NOT COMPLETED|Extension Treatment Period||18
10800794|NCT04439214|11961789|FG000|Eligible|Overall Study||42
10692840|NCT02505334|11857177|FG001|NOT COMPLETED|Extension Treatment Period||0
10692841|NCT02505542|11857183|FG000|STARTED|Part A: Open-Label Period||736
10692842|NCT02505542|11857184|FG001|STARTED|Part A: Open-Label Period||0
10692843|NCT02505542|11857185|FG002|STARTED|Part A: Open-Label Period||0
10692844|NCT02505542|11857186|FG003|STARTED|Part A: Open-Label Period||0
10692845|NCT02505542|11857183|FG000|COMPLETED|Part A: Open-Label Period||659
10692846|NCT02505542|11857184|FG001|COMPLETED|Part A: Open-Label Period||0
10800795|NCT04439214|11961789|FG000|Treated|Overall Study||47
10800796|NCT04439214|11961789|FG000|Treated and Reported Adverse Event Data|Overall Study|One patient experienced disease progression in cycle 1 and an AE form was not submitted.|46
10800797|NCT04439214|11961789|FG000|Eligible and Treated|Overall Study||42
10800798|NCT04439214|11961789|FG000|COMPLETED|Overall Study||0
10800799|NCT04439214|11961789|FG000|NOT COMPLETED|Overall Study||47
10692847|NCT02505542|11857185|FG002|COMPLETED|Part A: Open-Label Period||0
10692848|NCT02505542|11857186|FG003|COMPLETED|Part A: Open-Label Period||0
10692849|NCT02505542|11857183|FG000|NOT COMPLETED|Part A: Open-Label Period||77
10692850|NCT02505542|11857184|FG001|NOT COMPLETED|Part A: Open-Label Period||0
10692851|NCT02505542|11857185|FG002|NOT COMPLETED|Part A: Open-Label Period||0
10692852|NCT02505542|11857186|FG003|NOT COMPLETED|Part A: Open-Label Period||0
10692853|NCT02505542|11857183|FG000|STARTED|Completed Part A, Did Not Enter Part B||659
10692854|NCT02505542|11857184|FG001|STARTED|Completed Part A, Did Not Enter Part B||0
10692855|NCT02505542|11857185|FG002|STARTED|Completed Part A, Did Not Enter Part B||0
10692856|NCT02505542|11857186|FG003|STARTED|Completed Part A, Did Not Enter Part B||0
10692857|NCT02505542|11857183|FG000|COMPLETED|Completed Part A, Did Not Enter Part B||313
10692858|NCT02505542|11857184|FG001|COMPLETED|Completed Part A, Did Not Enter Part B||0
10692859|NCT02505542|11857185|FG002|COMPLETED|Completed Part A, Did Not Enter Part B||0
10692860|NCT02505542|11857186|FG003|COMPLETED|Completed Part A, Did Not Enter Part B||0
10692861|NCT02505542|11857183|FG000|NOT COMPLETED|Completed Part A, Did Not Enter Part B||346
10692862|NCT02505542|11857184|FG001|NOT COMPLETED|Completed Part A, Did Not Enter Part B||0
10692863|NCT02505542|11857185|FG002|NOT COMPLETED|Completed Part A, Did Not Enter Part B||0
10692864|NCT02505542|11857186|FG003|NOT COMPLETED|Completed Part A, Did Not Enter Part B||0
10692865|NCT02505542|11857183|FG000|STARTED|Part B: Double-Blind Period||0
10692866|NCT02505542|11857184|FG001|STARTED|Part B: Double-Blind Period||104
10692867|NCT02505542|11857185|FG002|STARTED|Part B: Double-Blind Period||104
10692868|NCT02505542|11857186|FG003|STARTED|Part B: Double-Blind Period||105
10692869|NCT02505542|11857183|FG000|Started Escape Period|Part B: Double-Blind Period||0
10692870|NCT02505542|11857184|FG001|Started Escape Period|Part B: Double-Blind Period||73
10692871|NCT02505542|11857185|FG002|Started Escape Period|Part B: Double-Blind Period||7
10692872|NCT02505542|11857186|FG003|Started Escape Period|Part B: Double-Blind Period||15
10692873|NCT02505542|11857183|FG000|COMPLETED|Part B: Double-Blind Period||0
10692874|NCT02505542|11857184|FG001|COMPLETED|Part B: Double-Blind Period||92
10692875|NCT02505542|11857185|FG002|COMPLETED|Part B: Double-Blind Period||95
10692876|NCT02505542|11857186|FG003|COMPLETED|Part B: Double-Blind Period||98
10692877|NCT02505542|11857183|FG000|NOT COMPLETED|Part B: Double-Blind Period||0
10692878|NCT02505542|11857184|FG001|NOT COMPLETED|Part B: Double-Blind Period||12
10692879|NCT02505542|11857185|FG002|NOT COMPLETED|Part B: Double-Blind Period||9
10692880|NCT02505542|11857186|FG003|NOT COMPLETED|Part B: Double-Blind Period||7
10692881|NCT02505867|11857214|FG000|STARTED|Overall Study||6
10692882|NCT02505867|11857215|FG001|STARTED|Overall Study||6
10692883|NCT02505867|11857214|FG000|COMPLETED|Overall Study||0
10692884|NCT02505867|11857215|FG001|COMPLETED|Overall Study||0
10692885|NCT02505867|11857214|FG000|NOT COMPLETED|Overall Study||6
10692886|NCT02505867|11857215|FG001|NOT COMPLETED|Overall Study||6
10692887|NCT02505919|11857223|FG000|STARTED|Treatment||117
10692888|NCT02505919|11857224|FG001|STARTED|Treatment||67
10692889|NCT02505919|11857223|FG000|COMPLETED|Treatment||116
10692890|NCT02505919|11857224|FG001|COMPLETED|Treatment||65
10692891|NCT02505919|11857223|FG000|NOT COMPLETED|Treatment||1
10692892|NCT02505919|11857224|FG001|NOT COMPLETED|Treatment||2
10692893|NCT02505919|11857223|FG000|STARTED|1 Week Follow-Up||116
10692894|NCT02505919|11857224|FG001|STARTED|1 Week Follow-Up||65
10692895|NCT02505919|11857223|FG000|COMPLETED|1 Week Follow-Up||116
10692896|NCT02505919|11857224|FG001|COMPLETED|1 Week Follow-Up||65
10692897|NCT02505919|11857223|FG000|NOT COMPLETED|1 Week Follow-Up||0
10692898|NCT02505919|11857224|FG001|NOT COMPLETED|1 Week Follow-Up||0
10692899|NCT02505919|11857223|FG000|STARTED|1 Month Follow-Up||116
10692900|NCT02505919|11857224|FG001|STARTED|1 Month Follow-Up||65
10692901|NCT02505919|11857223|FG000|COMPLETED|1 Month Follow-Up||116
10692902|NCT02505919|11857224|FG001|COMPLETED|1 Month Follow-Up||65
10692903|NCT02505919|11857223|FG000|NOT COMPLETED|1 Month Follow-Up||0
10692904|NCT02505919|11857224|FG001|NOT COMPLETED|1 Month Follow-Up||0
10692905|NCT02505919|11857223|FG000|STARTED|3 Months Follow-Up||116
10692906|NCT02505919|11857224|FG001|STARTED|3 Months Follow-Up||65
10692907|NCT02505919|11857223|FG000|COMPLETED|3 Months Follow-Up||116
10692908|NCT02505919|11857224|FG001|COMPLETED|3 Months Follow-Up||65
10692909|NCT02505919|11857223|FG000|NOT COMPLETED|3 Months Follow-Up||0
10692910|NCT02505919|11857224|FG001|NOT COMPLETED|3 Months Follow-Up||0
10692911|NCT02505919|11857223|FG000|STARTED|6 Months Follow-Up||116
10692912|NCT02505919|11857224|FG001|STARTED|6 Months Follow-Up||65
10692913|NCT02505919|11857223|FG000|COMPLETED|6 Months Follow-Up||116
10692914|NCT02505919|11857224|FG001|COMPLETED|6 Months Follow-Up||63
10692915|NCT02505919|11857223|FG000|NOT COMPLETED|6 Months Follow-Up||0
10692916|NCT02505919|11857224|FG001|NOT COMPLETED|6 Months Follow-Up||2
10692917|NCT02505919|11857223|FG000|STARTED|12 Months Follow-Up||116
10692918|NCT02505919|11857224|FG001|STARTED|12 Months Follow-Up||63
10692919|NCT02505919|11857223|FG000|COMPLETED|12 Months Follow-Up||115
10692920|NCT02505919|11857224|FG001|COMPLETED|12 Months Follow-Up||61
10692921|NCT02505919|11857223|FG000|NOT COMPLETED|12 Months Follow-Up||1
10692922|NCT02505919|11857224|FG001|NOT COMPLETED|12 Months Follow-Up||2
10692923|NCT02505919|11857223|FG000|STARTED|24 Months Follow-Up||115
10692924|NCT02505919|11857224|FG001|STARTED|24 Months Follow-Up||61
10692925|NCT02505919|11857223|FG000|COMPLETED|24 Months Follow-Up||112
10692926|NCT02505919|11857224|FG001|COMPLETED|24 Months Follow-Up||60
10692927|NCT02505919|11857223|FG000|NOT COMPLETED|24 Months Follow-Up||3
10692928|NCT02505919|11857224|FG001|NOT COMPLETED|24 Months Follow-Up||1
10692929|NCT02505919|11857223|FG000|STARTED|36 Months Follow-Up||112
10692930|NCT02505919|11857224|FG001|STARTED|36 Months Follow-Up||60
10692931|NCT02505919|11857223|FG000|COMPLETED|36 Months Follow-Up||97
10692932|NCT02505919|11857224|FG001|COMPLETED|36 Months Follow-Up||55
10692933|NCT02505919|11857223|FG000|NOT COMPLETED|36 Months Follow-Up||15
10692934|NCT02505919|11857224|FG001|NOT COMPLETED|36 Months Follow-Up||5
10692935|NCT02505945|11857232|FG000|STARTED|Overall Study||102
10692936|NCT02505945|11857233|FG001|STARTED|Overall Study||50
10692937|NCT02505945|11857232|FG000|COMPLETED|Overall Study||80
10692938|NCT02505945|11857233|FG001|COMPLETED|Overall Study||46
10692939|NCT02505945|11857232|FG000|NOT COMPLETED|Overall Study||22
10692940|NCT02505945|11857233|FG001|NOT COMPLETED|Overall Study||4
10692941|NCT02506036|11857241|FG000|STARTED|First Intervention (4-6 Weeks)||3
10692942|NCT02506036|11857242|FG001|STARTED|First Intervention (4-6 Weeks)||3
10692943|NCT02506036|11857241|FG000|COMPLETED|First Intervention (4-6 Weeks)||2
10692944|NCT02506036|11857242|FG001|COMPLETED|First Intervention (4-6 Weeks)||1
10692945|NCT02506036|11857241|FG000|NOT COMPLETED|First Intervention (4-6 Weeks)||1
10692946|NCT02506036|11857242|FG001|NOT COMPLETED|First Intervention (4-6 Weeks)||2
10692947|NCT02506036|11857241|FG000|STARTED|Washout (1-2 Weeks)||2
10692948|NCT02506036|11857242|FG001|STARTED|Washout (1-2 Weeks)||1
10692949|NCT02506036|11857241|FG000|COMPLETED|Washout (1-2 Weeks)||2
10692950|NCT02506036|11857242|FG001|COMPLETED|Washout (1-2 Weeks)||1
10692951|NCT02506036|11857241|FG000|NOT COMPLETED|Washout (1-2 Weeks)||0
10692952|NCT02506036|11857242|FG001|NOT COMPLETED|Washout (1-2 Weeks)||0
10692953|NCT02506036|11857241|FG000|STARTED|Second Intervention (4-6 Weeks)||2
10692954|NCT02506036|11857242|FG001|STARTED|Second Intervention (4-6 Weeks)||1
10692955|NCT02506036|11857241|FG000|COMPLETED|Second Intervention (4-6 Weeks)||2
10692956|NCT02506036|11857242|FG001|COMPLETED|Second Intervention (4-6 Weeks)||1
10692957|NCT02506036|11857241|FG000|NOT COMPLETED|Second Intervention (4-6 Weeks)||0
10692958|NCT02506036|11857242|FG001|NOT COMPLETED|Second Intervention (4-6 Weeks)||0
10692959|NCT02506114|11857251|FG000|STARTED|Overall Study||5
10692960|NCT02506114|11857252|FG001|STARTED|Overall Study||4
10692961|NCT02506114|11857253|FG002|STARTED|Overall Study||6
10692962|NCT02506114|11857251|FG000|COMPLETED|Overall Study||5
10692963|NCT02506114|11857252|FG001|COMPLETED|Overall Study||4
10692964|NCT02506114|11857253|FG002|COMPLETED|Overall Study||6
10692965|NCT02506114|11857251|FG000|NOT COMPLETED|Overall Study||0
10692966|NCT02506114|11857252|FG001|NOT COMPLETED|Overall Study||0
10692967|NCT02506114|11857253|FG002|NOT COMPLETED|Overall Study||0
10692968|NCT02506257|11857265|FG000|STARTED|Overall Study||26
10692969|NCT02506257|11857266|FG001|STARTED|Overall Study||28
10692970|NCT02506257|11857267|FG002|STARTED|Overall Study||27
10692971|NCT02506257|11857268|FG003|STARTED|Overall Study||9
10692972|NCT02506257|11857265|FG000|COMPLETED|Overall Study||26
10692973|NCT02506257|11857266|FG001|COMPLETED|Overall Study||26
10692974|NCT02506257|11857267|FG002|COMPLETED|Overall Study||23
10692975|NCT02506257|11857268|FG003|COMPLETED|Overall Study||9
10692976|NCT02506257|11857265|FG000|NOT COMPLETED|Overall Study||0
10692977|NCT02506257|11857266|FG001|NOT COMPLETED|Overall Study||2
10692978|NCT02506257|11857267|FG002|NOT COMPLETED|Overall Study||4
10692979|NCT02506257|11857268|FG003|NOT COMPLETED|Overall Study||0
10692980|NCT02506309|11857280|FG000|STARTED|Overall Study||84
10692981|NCT02506309|11857281|FG001|STARTED|Overall Study||84
10692982|NCT02506309|11857280|FG000|COMPLETED|Overall Study||66
10692983|NCT02506309|11857281|FG001|COMPLETED|Overall Study||64
10692984|NCT02506309|11857280|FG000|NOT COMPLETED|Overall Study||18
10692985|NCT02506309|11857281|FG001|NOT COMPLETED|Overall Study||20
10692986|NCT02506634|11857295|FG000|STARTED|Overall Study||374
10692987|NCT02506634|11857295|FG000|Participants Who Were Diagnosed as GERD|Overall Study||154
10692988|NCT02506634|11857295|FG000|Participants Who Received PPI Treatment|Overall Study||357
10692989|NCT02506634|11857295|FG000|Participants Who Finished GERDQ|Overall Study||342
10692990|NCT02506634|11857295|FG000|COMPLETED|Overall Study||357
10692991|NCT02506634|11857295|FG000|NOT COMPLETED|Overall Study||17
10692992|NCT02506660|11857335|FG000|STARTED|Overall Study||64
10692993|NCT02506660|11857336|FG001|STARTED|Overall Study||64
10692994|NCT02506660|11857335|FG000|COMPLETED|Overall Study||62
10692995|NCT02506660|11857336|FG001|COMPLETED|Overall Study||63
10692996|NCT02506660|11857335|FG000|NOT COMPLETED|Overall Study||2
10692997|NCT02506660|11857336|FG001|NOT COMPLETED|Overall Study||1
10692998|NCT02506673|11857344|FG000|STARTED|Overall Study||13
10692999|NCT02506673|11857345|FG001|STARTED|Overall Study||13
10693000|NCT02506673|11857344|FG000|COMPLETED|Overall Study||13
10693001|NCT02506673|11857345|FG001|COMPLETED|Overall Study||13
10693002|NCT02506673|11857344|FG000|NOT COMPLETED|Overall Study||0
10693003|NCT02506673|11857345|FG001|NOT COMPLETED|Overall Study||0
10693004|NCT02506816|11857351|FG000|STARTED|Overall Study||36
10693005|NCT02506816|11857351|FG000|Samples Availability|Overall Study|31 of 36 patients had valid samples for analysis of biomarkers (primary and secondary analysis)|31
10693006|NCT02506816|11857351|FG000|COMPLETED|Overall Study||33
10693007|NCT02506816|11857351|FG000|NOT COMPLETED|Overall Study||3
10693008|NCT02506868|11857357|FG000|STARTED|Main Period of Study (24 Weeks)||98
10693009|NCT02506868|11857358|FG001|STARTED|Main Period of Study (24 Weeks)||98
10693010|NCT02506868|11857357|FG000|mITT Population|Main Period of Study (24 Weeks)||98
10693011|NCT02506868|11857358|FG001|mITT Population|Main Period of Study (24 Weeks)|One patient from Aranesp group was excluded prior to the first administration|97
10693012|NCT02506868|11857357|FG000|Per Protocol Population|Main Period of Study (24 Weeks)||86
10693013|NCT02506868|11857358|FG001|Per Protocol Population|Main Period of Study (24 Weeks)||90
10693014|NCT02506868|11857357|FG000|COMPLETED|Main Period of Study (24 Weeks)||86
10693015|NCT02506868|11857358|FG001|COMPLETED|Main Period of Study (24 Weeks)||90
10693016|NCT02506868|11857357|FG000|NOT COMPLETED|Main Period of Study (24 Weeks)||12
10693017|NCT02506868|11857358|FG001|NOT COMPLETED|Main Period of Study (24 Weeks)||8
10800800|NCT04439240|11961793|FG000|STARTED|Overall Study||52
10800801|NCT04439240|11961793|FG000|Started Protocol Therapy|Overall Study||50
10800802|NCT04439240|11961793|FG000|Eligible|Overall Study||49
10800803|NCT04439240|11961793|FG000|Eligible and Started Protocol Therapy|Overall Study||48
10693018|NCT02506868|11857357|FG000|STARTED|Additional Period of Study (Until 52W)||86
10693019|NCT02506868|11857358|FG001|STARTED|Additional Period of Study (Until 52W)||90
10693020|NCT02506868|11857357|FG000|COMPLETED|Additional Period of Study (Until 52W)||83
10693021|NCT02506868|11857358|FG001|COMPLETED|Additional Period of Study (Until 52W)||85
10693022|NCT02506868|11857357|FG000|NOT COMPLETED|Additional Period of Study (Until 52W)||3
10693023|NCT02506868|11857358|FG001|NOT COMPLETED|Additional Period of Study (Until 52W)||5
10693024|NCT02506881|11857372|FG000|STARTED|First Intervention (Day 1)||13
10693025|NCT02506881|11857373|FG001|STARTED|First Intervention (Day 1)||12
10693026|NCT02506881|11857374|FG002|STARTED|First Intervention (Day 1)||25
10693027|NCT02506881|11857375|FG003|STARTED|First Intervention (Day 1)||24
10693028|NCT02506881|11857372|FG000|COMPLETED|First Intervention (Day 1)||12
10693029|NCT02506881|11857373|FG001|COMPLETED|First Intervention (Day 1)||12
10693030|NCT02506881|11857374|FG002|COMPLETED|First Intervention (Day 1)||12
10693031|NCT02506881|11857375|FG003|COMPLETED|First Intervention (Day 1)||12
10693032|NCT02506881|11857372|FG000|NOT COMPLETED|First Intervention (Day 1)||1
10693033|NCT02506881|11857373|FG001|NOT COMPLETED|First Intervention (Day 1)||0
10693034|NCT02506881|11857374|FG002|NOT COMPLETED|First Intervention (Day 1)||13
10693035|NCT02506881|11857375|FG003|NOT COMPLETED|First Intervention (Day 1)||12
10693036|NCT02506881|11857372|FG000|STARTED|Washout (at Least 25 Days)||12
10693037|NCT02506881|11857373|FG001|STARTED|Washout (at Least 25 Days)||12
10693038|NCT02506881|11857374|FG002|STARTED|Washout (at Least 25 Days)||12
10693039|NCT02506881|11857375|FG003|STARTED|Washout (at Least 25 Days)||12
10693040|NCT02506881|11857372|FG000|COMPLETED|Washout (at Least 25 Days)||12
10693041|NCT02506881|11857373|FG001|COMPLETED|Washout (at Least 25 Days)||12
10693042|NCT02506881|11857374|FG002|COMPLETED|Washout (at Least 25 Days)||12
10693043|NCT02506881|11857375|FG003|COMPLETED|Washout (at Least 25 Days)||12
10693044|NCT02506881|11857372|FG000|NOT COMPLETED|Washout (at Least 25 Days)||0
10693045|NCT02506881|11857373|FG001|NOT COMPLETED|Washout (at Least 25 Days)||0
10693046|NCT02506881|11857374|FG002|NOT COMPLETED|Washout (at Least 25 Days)||0
10693047|NCT02506881|11857375|FG003|NOT COMPLETED|Washout (at Least 25 Days)||0
10693048|NCT02506881|11857372|FG000|STARTED|Second Intervention (Day 1)||12
10693049|NCT02506881|11857373|FG001|STARTED|Second Intervention (Day 1)||12
10693050|NCT02506881|11857374|FG002|STARTED|Second Intervention (Day 1)||12
10693051|NCT02506881|11857375|FG003|STARTED|Second Intervention (Day 1)||12
10693052|NCT02506881|11857372|FG000|COMPLETED|Second Intervention (Day 1)||12
10693053|NCT02506881|11857373|FG001|COMPLETED|Second Intervention (Day 1)||12
10693054|NCT02506881|11857374|FG002|COMPLETED|Second Intervention (Day 1)||12
10693055|NCT02506881|11857375|FG003|COMPLETED|Second Intervention (Day 1)||12
10693056|NCT02506881|11857372|FG000|NOT COMPLETED|Second Intervention (Day 1)||0
10693057|NCT02506881|11857373|FG001|NOT COMPLETED|Second Intervention (Day 1)||0
10693058|NCT02506881|11857374|FG002|NOT COMPLETED|Second Intervention (Day 1)||0
10693059|NCT02506881|11857375|FG003|NOT COMPLETED|Second Intervention (Day 1)||0
10693060|NCT02507011|11857395|FG000|STARTED|First Intervention||1
10693061|NCT02507011|11857396|FG001|STARTED|First Intervention||1
10693062|NCT02507011|11857395|FG000|COMPLETED|First Intervention||1
10693063|NCT02507011|11857396|FG001|COMPLETED|First Intervention||1
10693064|NCT02507011|11857395|FG000|NOT COMPLETED|First Intervention||0
10693065|NCT02507011|11857396|FG001|NOT COMPLETED|First Intervention||0
10693066|NCT02507011|11857395|FG000|STARTED|Second Intervention||1
10693067|NCT02507011|11857396|FG001|STARTED|Second Intervention||1
10693068|NCT02507011|11857395|FG000|COMPLETED|Second Intervention||1
10800804|NCT04439240|11961793|FG000|Reported Adverse Events Data|Overall Study||49
10800805|NCT04439240|11961793|FG000|COMPLETED|Overall Study||0
10800806|NCT04439240|11961793|FG000|NOT COMPLETED|Overall Study||52
10800807|NCT04438785|11961799|FG000|STARTED|Overall Study||20
10800808|NCT04438785|11961800|FG001|STARTED|Overall Study||20
10800809|NCT04438785|11961799|FG000|COMPLETED|Overall Study||18
10800810|NCT04438785|11961800|FG001|COMPLETED|Overall Study||10
10800811|NCT04438785|11961799|FG000|NOT COMPLETED|Overall Study||2
10800812|NCT04438785|11961800|FG001|NOT COMPLETED|Overall Study||10
10800813|NCT04431908|11961808|FG000|STARTED|Overall Study||1042
10800814|NCT04431908|11961809|FG001|STARTED|Overall Study||278
10800815|NCT04431908|11961808|FG000|COMPLETED|Overall Study||1042
10800816|NCT04431908|11961809|FG001|COMPLETED|Overall Study||278
10800817|NCT04431908|11961808|FG000|NOT COMPLETED|Overall Study||0
10800818|NCT04431908|11961809|FG001|NOT COMPLETED|Overall Study||0
10800819|NCT04413929|11961816|FG000|STARTED|Overall Study||8411
10800820|NCT04413929|11961816|FG000|COMPLETED|Overall Study||8411
10800821|NCT04413929|11961816|FG000|NOT COMPLETED|Overall Study||0
10800822|NCT04430634|11961829|FG000|STARTED|Overall Study||5
10800823|NCT04430634|11961830|FG001|STARTED|Overall Study||5
10800824|NCT04430634|11961831|FG002|STARTED|Overall Study||5
10800825|NCT04430634|11961832|FG003|STARTED|Overall Study||5
10800826|NCT04430634|11961833|FG004|STARTED|Overall Study||5
10693069|NCT02507011|11857396|FG001|COMPLETED|Second Intervention||1
10800827|NCT04430634|11961834|FG005|STARTED|Overall Study||5
10800828|NCT04430634|11961835|FG006|STARTED|Overall Study||5
10800829|NCT04430634|11961836|FG007|STARTED|Overall Study||5
10800830|NCT04430634|11961829|FG000|COMPLETED|Overall Study||5
10800831|NCT04430634|11961830|FG001|COMPLETED|Overall Study||5
10693070|NCT02507011|11857395|FG000|NOT COMPLETED|Second Intervention||0
10693071|NCT02507011|11857396|FG001|NOT COMPLETED|Second Intervention||0
10693072|NCT02507219|11857402|FG000|STARTED|Overall Study||5
10693073|NCT02507219|11857403|FG001|STARTED|Overall Study||4
10693074|NCT02507219|11857404|FG002|STARTED|Overall Study||3
10693075|NCT02507219|11857405|FG003|STARTED|Overall Study||3
10800832|NCT04430634|11961831|FG002|COMPLETED|Overall Study||5
10800833|NCT04430634|11961832|FG003|COMPLETED|Overall Study||4
10800834|NCT04430634|11961833|FG004|COMPLETED|Overall Study||5
10800835|NCT04430634|11961834|FG005|COMPLETED|Overall Study||5
10800836|NCT04430634|11961835|FG006|COMPLETED|Overall Study||4
10800837|NCT04430634|11961836|FG007|COMPLETED|Overall Study||5
10800838|NCT04430634|11961829|FG000|NOT COMPLETED|Overall Study||0
10800839|NCT04430634|11961830|FG001|NOT COMPLETED|Overall Study||0
10800840|NCT04430634|11961831|FG002|NOT COMPLETED|Overall Study||0
10800841|NCT04430634|11961832|FG003|NOT COMPLETED|Overall Study||1
10693076|NCT02507219|11857406|FG004|STARTED|Overall Study||4
10693077|NCT02507219|11857407|FG005|STARTED|Overall Study||3
10693078|NCT02507219|11857402|FG000|COMPLETED|Overall Study||4
10693079|NCT02507219|11857403|FG001|COMPLETED|Overall Study||4
10693080|NCT02507219|11857404|FG002|COMPLETED|Overall Study||3
10693081|NCT02507219|11857405|FG003|COMPLETED|Overall Study||3
10693082|NCT02507219|11857406|FG004|COMPLETED|Overall Study||3
10693083|NCT02507219|11857407|FG005|COMPLETED|Overall Study||3
10693084|NCT02507219|11857402|FG000|NOT COMPLETED|Overall Study||1
10693085|NCT02507219|11857403|FG001|NOT COMPLETED|Overall Study||0
10693086|NCT02507219|11857404|FG002|NOT COMPLETED|Overall Study||0
10693087|NCT02507219|11857405|FG003|NOT COMPLETED|Overall Study||0
10693088|NCT02507219|11857406|FG004|NOT COMPLETED|Overall Study||1
10693089|NCT02507219|11857407|FG005|NOT COMPLETED|Overall Study||0
10693090|NCT02507297|11857417|FG000|STARTED|Overall Study||16
10693091|NCT02507297|11857418|FG001|STARTED|Overall Study||13
10693092|NCT02507297|11857417|FG000|COMPLETED|Overall Study||15
10693093|NCT02507297|11857418|FG001|COMPLETED|Overall Study||12
10693094|NCT02507297|11857417|FG000|NOT COMPLETED|Overall Study||1
10693095|NCT02507297|11857418|FG001|NOT COMPLETED|Overall Study||1
10693096|NCT02507349|11857426|FG000|STARTED|Overall Study||1232
10693097|NCT02507349|11857427|FG001|STARTED|Overall Study||1211
10693098|NCT02507349|11857426|FG000|COMPLETED|Overall Study||1045
10693099|NCT02507349|11857427|FG001|COMPLETED|Overall Study||1050
10693100|NCT02507349|11857426|FG000|NOT COMPLETED|Overall Study||187
10693101|NCT02507349|11857427|FG001|NOT COMPLETED|Overall Study||161
10693102|NCT02507375|11857435|FG000|STARTED|Overall Study||6
10693103|NCT02507375|11857436|FG001|STARTED|Overall Study|Two patients in cohort 2 did not begin treatment in Cycle 1 so were not included in the analysis set|9
10693104|NCT02507375|11857435|FG000|Cycle 1|Overall Study||6
10693105|NCT02507375|11857436|FG001|Cycle 1|Overall Study||9
10693106|NCT02507375|11857435|FG000|Received Pertuzumab|Overall Study||6
10693107|NCT02507375|11857436|FG001|Received Pertuzumab|Overall Study||6
10693108|NCT02507375|11857435|FG000|Cycle 2|Overall Study||5
10693109|NCT02507375|11857436|FG001|Cycle 2|Overall Study||5
10800842|NCT04430634|11961833|FG004|NOT COMPLETED|Overall Study||0
10800843|NCT04430634|11961834|FG005|NOT COMPLETED|Overall Study||0
10800844|NCT04430634|11961835|FG006|NOT COMPLETED|Overall Study||1
10800845|NCT04430634|11961836|FG007|NOT COMPLETED|Overall Study||0
10800846|NCT04429932|11961863|FG000|STARTED|Overall Study||4
10800847|NCT04429932|11961864|FG001|STARTED|Overall Study||5
10800848|NCT04429932|11961865|FG002|STARTED|Overall Study||5
10800849|NCT04429932|11961866|FG003|STARTED|Overall Study||5
10800850|NCT04429932|11961867|FG004|STARTED|Overall Study||5
10800851|NCT04429932|11961868|FG005|STARTED|Overall Study||5
10800852|NCT04429932|11961869|FG006|STARTED|Overall Study||5
10800853|NCT04429932|11961870|FG007|STARTED|Overall Study||5
10800854|NCT04429932|11961863|FG000|COMPLETED|Overall Study||3
10800855|NCT04429932|11961864|FG001|COMPLETED|Overall Study||5
10800856|NCT04429932|11961865|FG002|COMPLETED|Overall Study||5
10800857|NCT04429932|11961866|FG003|COMPLETED|Overall Study||2
10800858|NCT04429932|11961867|FG004|COMPLETED|Overall Study||5
10800859|NCT04429932|11961868|FG005|COMPLETED|Overall Study||5
10800860|NCT04429932|11961869|FG006|COMPLETED|Overall Study||5
10800861|NCT04429932|11961870|FG007|COMPLETED|Overall Study||5
10800862|NCT04429932|11961863|FG000|NOT COMPLETED|Overall Study||1
10800863|NCT04429932|11961864|FG001|NOT COMPLETED|Overall Study||0
10800864|NCT04429932|11961865|FG002|NOT COMPLETED|Overall Study||0
10693110|NCT02507375|11857435|FG000|Cycle 3|Overall Study||4
10693111|NCT02507375|11857436|FG001|Cycle 3|Overall Study||5
10693112|NCT02507375|11857435|FG000|Cycle 4|Overall Study||4
10693113|NCT02507375|11857436|FG001|Cycle 4|Overall Study||2
10693114|NCT02507375|11857435|FG000|Cycle 5|Overall Study||3
10800865|NCT04429932|11961866|FG003|NOT COMPLETED|Overall Study||3
10800866|NCT04429932|11961867|FG004|NOT COMPLETED|Overall Study||0
10800867|NCT04429932|11961868|FG005|NOT COMPLETED|Overall Study||0
10800868|NCT04429932|11961869|FG006|NOT COMPLETED|Overall Study||0
10800869|NCT04429932|11961870|FG007|NOT COMPLETED|Overall Study||0
10800870|NCT04428502|11961889|FG000|STARTED|Overall Study||127
10800871|NCT04428502|11961889|FG000|COMPLETED|Overall Study||113
10800872|NCT04428502|11961889|FG000|NOT COMPLETED|Overall Study||14
10800873|NCT04428424|11961894|FG000|STARTED|Overall Study||1493
10800874|NCT04428424|11961894|FG000|COMPLETED|Overall Study||1246
10800875|NCT04428424|11961894|FG000|NOT COMPLETED|Overall Study||247
10800876|NCT04428359|11961900|FG000|STARTED|Overall Study||33
10800877|NCT04428359|11961901|FG001|STARTED|Overall Study||33
10800878|NCT04428359|11961900|FG000|COMPLETED|Overall Study||31
10693115|NCT02507375|11857436|FG001|Cycle 5|Overall Study||1
10693116|NCT02507375|11857435|FG000|Cycle 6|Overall Study||3
10693117|NCT02507375|11857436|FG001|Cycle 6|Overall Study||1
10693118|NCT02507375|11857435|FG000|Extension Period|Overall Study||2
10693119|NCT02507375|11857436|FG001|Extension Period|Overall Study||1
10693120|NCT02507375|11857435|FG000|COMPLETED|Overall Study||2
10693121|NCT02507375|11857436|FG001|COMPLETED|Overall Study||1
10693122|NCT02507375|11857435|FG000|NOT COMPLETED|Overall Study||4
10693123|NCT02507375|11857436|FG001|NOT COMPLETED|Overall Study||8
10693124|NCT02507388|11857448|FG000|STARTED|Overall Study||25
10693125|NCT02507388|11857449|FG001|STARTED|Overall Study||25
10693126|NCT02507388|11857448|FG000|COMPLETED|Overall Study||25
10693127|NCT02507388|11857449|FG001|COMPLETED|Overall Study||25
10693128|NCT02507388|11857448|FG000|NOT COMPLETED|Overall Study||0
10693129|NCT02507388|11857449|FG001|NOT COMPLETED|Overall Study||0
10693130|NCT02507752|11857456|FG000|STARTED|Overall Study||72
10693131|NCT02507752|11857456|FG000|COMPLETED|Overall Study||55
10693132|NCT02507752|11857456|FG000|NOT COMPLETED|Overall Study||17
10693133|NCT02508077|11857460|FG000|STARTED|Overall Study||1
10693134|NCT02508077|11857460|FG000|COMPLETED|Overall Study||1
10693135|NCT02508077|11857460|FG000|NOT COMPLETED|Overall Study||0
10693136|NCT02508103|11857466|FG000|STARTED|Overall Study||5
10693137|NCT02508103|11857467|FG001|STARTED|Overall Study||5
10693138|NCT02508103|11857466|FG000|COMPLETED|Overall Study||5
10693139|NCT02508103|11857467|FG001|COMPLETED|Overall Study||5
10693140|NCT02508103|11857466|FG000|NOT COMPLETED|Overall Study||0
10693141|NCT02508103|11857467|FG001|NOT COMPLETED|Overall Study||0
10693142|NCT02508116|11857475|FG000|STARTED|Overall Study||252
10693143|NCT02508116|11857476|FG001|STARTED|Overall Study||257
10693144|NCT02508116|11857475|FG000|Received Intervention as Randomized|Overall Study||249
10693145|NCT02508116|11857476|FG001|Received Intervention as Randomized|Overall Study||255
10693146|NCT02508116|11857475|FG000|COMPLETED|Overall Study||244
10693147|NCT02508116|11857476|FG001|COMPLETED|Overall Study||250
10693148|NCT02508116|11857475|FG000|NOT COMPLETED|Overall Study||8
10693149|NCT02508116|11857476|FG001|NOT COMPLETED|Overall Study||7
10693150|NCT02508194|11857484|FG000|STARTED|Overall Study||949
10693151|NCT02508194|11857485|FG001|STARTED|Overall Study||951
10800879|NCT04428359|11961901|FG001|COMPLETED|Overall Study||30
10800880|NCT04428359|11961900|FG000|NOT COMPLETED|Overall Study||2
10800881|NCT04428359|11961901|FG001|NOT COMPLETED|Overall Study||3
10800882|NCT04410159|11961911|FG000|STARTED|Overall Study||5
10800883|NCT04410159|11961912|FG001|STARTED|Overall Study||5
10800884|NCT04410159|11961913|FG002|STARTED|Overall Study||5
10800885|NCT04410159|11961914|FG003|STARTED|Overall Study||5
10800886|NCT04410159|11961911|FG000|COMPLETED|Overall Study||5
10800887|NCT04410159|11961912|FG001|COMPLETED|Overall Study||5
10800888|NCT04410159|11961913|FG002|COMPLETED|Overall Study||5
10800889|NCT04410159|11961914|FG003|COMPLETED|Overall Study||5
10800890|NCT04410159|11961911|FG000|NOT COMPLETED|Overall Study||0
10800891|NCT04410159|11961912|FG001|NOT COMPLETED|Overall Study||0
10800892|NCT04410159|11961913|FG002|NOT COMPLETED|Overall Study||0
10800893|NCT04410159|11961914|FG003|NOT COMPLETED|Overall Study||0
10800894|NCT04425850|11961926|FG000|STARTED|Overall Study|Standard prophylactic measures and PPE + iota carrageenan (nasal and buccal) and ivermectin (buccal)|131
10800895|NCT04425850|11961927|FG001|STARTED|Overall Study|Standard prophylactic measures and PPE only|98
10800896|NCT04425850|11961926|FG000|COMPLETED|Overall Study||131
10800897|NCT04425850|11961927|FG001|COMPLETED|Overall Study||98
10800898|NCT04425850|11961926|FG000|NOT COMPLETED|Overall Study||0
10800899|NCT04425850|11961927|FG001|NOT COMPLETED|Overall Study||0
10800900|NCT04425863|11961938|FG000|STARTED|Overall Study||135
10800901|NCT04425863|11961939|FG001|STARTED|Overall Study||12
10800902|NCT04425863|11961940|FG002|STARTED|Overall Study||20
10800903|NCT04425863|11961938|FG000|COMPLETED|Overall Study||135
10800904|NCT04425863|11961939|FG001|COMPLETED|Overall Study||12
10800905|NCT04425863|11961940|FG002|COMPLETED|Overall Study||19
10800906|NCT04425863|11961938|FG000|NOT COMPLETED|Overall Study||0
10800907|NCT04425863|11961939|FG001|NOT COMPLETED|Overall Study||0
10800908|NCT04425863|11961940|FG002|NOT COMPLETED|Overall Study||1
10693152|NCT02508194|11857484|FG000|COMPLETED|Overall Study||897
10693153|NCT02508194|11857485|FG001|COMPLETED|Overall Study||907
10693154|NCT02508194|11857484|FG000|NOT COMPLETED|Overall Study||52
10693155|NCT02508194|11857485|FG001|NOT COMPLETED|Overall Study||44
10693156|NCT02508207|11857493|FG000|STARTED|Overall Study||7
10693157|NCT02508207|11857494|FG001|STARTED|Overall Study||27
10693158|NCT02508207|11857493|FG000|COMPLETED|Overall Study||7
10693159|NCT02508207|11857494|FG001|COMPLETED|Overall Study||27
10693160|NCT02508207|11857493|FG000|NOT COMPLETED|Overall Study||0
10693161|NCT02508207|11857494|FG001|NOT COMPLETED|Overall Study||0
10693162|NCT02508259|11857502|FG000|STARTED|Overall Study||5
10810987|NCT03783130|11972702|FG002|STARTED|Overall Study||5
10810988|NCT03783130|11972703|FG003|STARTED|Overall Study||5
10810989|NCT03783130|11972700|FG000|Received All Product Administrations|Overall Study||3
10810990|NCT03783130|11972701|FG001|Received All Product Administrations|Overall Study||3
10810991|NCT03783130|11972702|FG002|Received All Product Administrations|Overall Study||5
10810992|NCT03783130|11972703|FG003|Received All Product Administrations|Overall Study||5
10810993|NCT03783130|11972700|FG000|COMPLETED|Overall Study||3
10693163|NCT02508259|11857503|FG001|STARTED|Overall Study||5
10693164|NCT02508259|11857502|FG000|COMPLETED|Overall Study||5
10693165|NCT02508259|11857503|FG001|COMPLETED|Overall Study||5
10693166|NCT02508259|11857502|FG000|NOT COMPLETED|Overall Study||0
10693167|NCT02508259|11857503|FG001|NOT COMPLETED|Overall Study||0
10693168|NCT02508389|11857512|FG000|STARTED|Overall Study||73
10693169|NCT02508389|11857513|FG001|STARTED|Overall Study||76
10693170|NCT02508389|11857514|FG002|STARTED|Overall Study||74
10693171|NCT02508389|11857512|FG000|COMPLETED|Overall Study||45
10693172|NCT02508389|11857513|FG001|COMPLETED|Overall Study||45
10693173|NCT02508389|11857514|FG002|COMPLETED|Overall Study||42
10693174|NCT02508389|11857512|FG000|NOT COMPLETED|Overall Study||28
10693175|NCT02508389|11857513|FG001|NOT COMPLETED|Overall Study||31
10693176|NCT02508389|11857514|FG002|NOT COMPLETED|Overall Study||32
10693177|NCT02508428|11857524|FG000|STARTED|Overall Study||114
10693178|NCT02508428|11857525|FG001|STARTED|Overall Study||111
10693179|NCT02508428|11857524|FG000|COMPLETED|Overall Study||62
10693180|NCT02508428|11857525|FG001|COMPLETED|Overall Study||44
10693181|NCT02508428|11857524|FG000|NOT COMPLETED|Overall Study||52
10693182|NCT02508428|11857525|FG001|NOT COMPLETED|Overall Study||67
10693183|NCT02508480|11857533|FG000|STARTED|Overall Study||95
10693184|NCT02508480|11857534|FG001|STARTED|Overall Study||97
10693185|NCT02508480|11857533|FG000|Post-Treatment Assessment|Overall Study||87
10693186|NCT02508480|11857534|FG001|Post-Treatment Assessment|Overall Study||89
10693187|NCT02508480|11857533|FG000|Three Month Follow-up|Overall Study||84
10800909|NCT04425746|11961962|FG000|STARTED|Overall Study||9
10800910|NCT04425746|11961963|FG001|STARTED|Overall Study||7
10800911|NCT04425746|11961962|FG000|COMPLETED|Overall Study||9
10800912|NCT04425746|11961963|FG001|COMPLETED|Overall Study||6
10800913|NCT04425746|11961962|FG000|NOT COMPLETED|Overall Study||0
10800914|NCT04425746|11961963|FG001|NOT COMPLETED|Overall Study||1
10800915|NCT04422561|11961973|FG000|STARTED|Overall Study||228
10800916|NCT04422561|11961974|FG001|STARTED|Overall Study||112
10800917|NCT04422561|11961973|FG000|COMPLETED|Overall Study||203
10800918|NCT04422561|11961974|FG001|COMPLETED|Overall Study||101
10800919|NCT04422561|11961973|FG000|NOT COMPLETED|Overall Study||25
10800920|NCT04422561|11961974|FG001|NOT COMPLETED|Overall Study||11
10800921|NCT04421404|11961982|FG000|STARTED|Overall Study||16
10800922|NCT04421404|11961983|FG001|STARTED|Overall Study||18
10800923|NCT04421404|11961982|FG000|COMPLETED|Overall Study||16
10800924|NCT04421404|11961983|FG001|COMPLETED|Overall Study||18
10800925|NCT04421404|11961982|FG000|NOT COMPLETED|Overall Study||0
10800926|NCT04421404|11961983|FG001|NOT COMPLETED|Overall Study||0
10800927|NCT04419311|11961991|FG000|STARTED|Overall Study||33
10800928|NCT04419311|11961992|FG001|STARTED|Overall Study||33
10693188|NCT02508480|11857534|FG001|Three Month Follow-up|Overall Study||86
10693189|NCT02508480|11857533|FG000|Six-Month Follow-Up|Overall Study||84
10693190|NCT02508480|11857534|FG001|Six-Month Follow-Up|Overall Study||86
10693191|NCT02508480|11857533|FG000|COMPLETED|Overall Study||90
10693192|NCT02508480|11857534|FG001|COMPLETED|Overall Study||93
10693193|NCT02508480|11857533|FG000|NOT COMPLETED|Overall Study||5
10693194|NCT02508480|11857534|FG001|NOT COMPLETED|Overall Study||4
10693195|NCT02508636|11857540|FG000|STARTED|Overall Study||11
10693196|NCT02508636|11857540|FG000|COMPLETED|Overall Study||11
10693197|NCT02508636|11857540|FG000|NOT COMPLETED|Overall Study||0
10693198|NCT02508649|11857548|FG000|STARTED|Overall Study||283
10693199|NCT02508649|11857549|FG001|STARTED|Overall Study||197
10693200|NCT02508649|11857550|FG002|STARTED|Overall Study||189
10693201|NCT02508649|11857551|FG003|STARTED|Overall Study||199
10693202|NCT02508649|11857548|FG000|Dosed|Overall Study||266
10693203|NCT02508649|11857549|FG001|Dosed|Overall Study||191
10693204|NCT02508649|11857550|FG002|Dosed|Overall Study||177
10693205|NCT02508649|11857551|FG003|Dosed|Overall Study||194
10800929|NCT04419311|11961991|FG000|COMPLETED|Overall Study||32
10800930|NCT04419311|11961992|FG001|COMPLETED|Overall Study||33
10800931|NCT04419311|11961991|FG000|NOT COMPLETED|Overall Study||1
10800932|NCT04419311|11961992|FG001|NOT COMPLETED|Overall Study||0
10693206|NCT02508649|11857548|FG000|COMPLETED|Overall Study||265
10693207|NCT02508649|11857549|FG001|COMPLETED|Overall Study||184
10693208|NCT02508649|11857550|FG002|COMPLETED|Overall Study||174
10693209|NCT02508649|11857551|FG003|COMPLETED|Overall Study||189
10693210|NCT02508649|11857548|FG000|NOT COMPLETED|Overall Study||18
10800933|NCT04415489|11962002|FG000|STARTED|Overall Study||50
10800934|NCT04415489|11962003|FG001|STARTED|Overall Study||50
10800935|NCT04415489|11962002|FG000|COMPLETED|Overall Study||50
10800936|NCT04415489|11962003|FG001|COMPLETED|Overall Study||50
10800937|NCT04415489|11962002|FG000|NOT COMPLETED|Overall Study||0
10800938|NCT04415489|11962003|FG001|NOT COMPLETED|Overall Study||0
10800939|NCT04411667|11962012|FG000|STARTED|Overall Study||17
10800940|NCT04411667|11962013|FG001|STARTED|Overall Study||17
10800941|NCT04411667|11962012|FG000|COMPLETED|Overall Study||16
10800942|NCT04411667|11962013|FG001|COMPLETED|Overall Study||17
10800943|NCT04411667|11962012|FG000|NOT COMPLETED|Overall Study||1
10693211|NCT02508649|11857549|FG001|NOT COMPLETED|Overall Study||13
10693212|NCT02508649|11857550|FG002|NOT COMPLETED|Overall Study||15
10693213|NCT02508649|11857551|FG003|NOT COMPLETED|Overall Study||10
10693214|NCT02508701|11857568|FG000|STARTED|Overall Study||9
10693215|NCT02508701|11857569|FG001|STARTED|Overall Study||6
10693216|NCT02508701|11857570|FG002|STARTED|Overall Study||5
10693217|NCT02508701|11857571|FG003|STARTED|Overall Study||4
10693218|NCT02508701|11857568|FG000|COMPLETED|Overall Study||0
10693219|NCT02508701|11857569|FG001|COMPLETED|Overall Study||1
10693220|NCT02508701|11857570|FG002|COMPLETED|Overall Study||0
10693221|NCT02508701|11857571|FG003|COMPLETED|Overall Study||1
10693222|NCT02508701|11857568|FG000|NOT COMPLETED|Overall Study||9
10693223|NCT02508701|11857569|FG001|NOT COMPLETED|Overall Study||5
10693224|NCT02508701|11857570|FG002|NOT COMPLETED|Overall Study||5
10693225|NCT02508701|11857571|FG003|NOT COMPLETED|Overall Study||3
10693226|NCT02508935|11857585|FG000|STARTED|Overall Study||23
10693227|NCT02508935|11857585|FG000|COMPLETED|Overall Study||0
10693228|NCT02508935|11857585|FG000|NOT COMPLETED|Overall Study||23
10693229|NCT02509026|11857591|FG000|STARTED|Induction Period (24 Weeks)||210
10693230|NCT02509026|11857591|FG000|Treated|Induction Period (24 Weeks)||209
10693231|NCT02509026|11857591|FG000|COMPLETED|Induction Period (24 Weeks)||188
10693232|NCT02509026|11857591|FG000|NOT COMPLETED|Induction Period (24 Weeks)||22
10693233|NCT02509026|11857591|FG000|STARTED|Withdrawal Period (40 Weeks)|Participants who completed Period 1 and achieved ASDAS-CRP<1.3 were eligible to enter into Period 2|119
10693234|NCT02509026|11857591|FG000|COMPLETED|Withdrawal Period (40 Weeks)||112
10693235|NCT02509026|11857591|FG000|NOT COMPLETED|Withdrawal Period (40 Weeks)||7
10693236|NCT02509026|11857591|FG000|STARTED|Retreatment Period (12 Weeks)|Participants who completed Period 2 and achieved ASDAS-ESR>=2.1 were eligible to enter into Period 3|88
10693237|NCT02509026|11857591|FG000|Treated|Retreatment Period (12 Weeks)||87
10693238|NCT02509026|11857591|FG000|COMPLETED|Retreatment Period (12 Weeks)||84
10693239|NCT02509026|11857591|FG000|NOT COMPLETED|Retreatment Period (12 Weeks)||4
10693240|NCT02509065|11857600|FG000|STARTED|Overall Study||1
10693241|NCT02509065|11857601|FG001|STARTED|Overall Study||1
10693242|NCT02509065|11857602|FG002|STARTED|Overall Study||2
10693243|NCT02509065|11857603|FG003|STARTED|Overall Study||1
10693244|NCT02509065|11857604|FG004|STARTED|Overall Study||1
10693245|NCT02509065|11857605|FG005|STARTED|Overall Study||1
10693246|NCT02509065|11857606|FG006|STARTED|Overall Study||1
10693247|NCT02509065|11857607|FG007|STARTED|Overall Study||1
10693248|NCT02509065|11857608|FG008|STARTED|Overall Study||1
10693249|NCT02509065|11857609|FG009|STARTED|Overall Study||1
10693250|NCT02509065|11857610|FG010|STARTED|Overall Study||1
10693251|NCT02509065|11857611|FG011|STARTED|Overall Study||1
10693252|NCT02509065|11857612|FG012|STARTED|Overall Study||1
10693253|NCT02509065|11857613|FG013|STARTED|Overall Study||1
10693254|NCT02509065|11857614|FG014|STARTED|Overall Study||1
10693255|NCT02509065|11857615|FG015|STARTED|Overall Study||1
10693256|NCT02509065|11857616|FG016|STARTED|Overall Study||1
10693257|NCT02509065|11857617|FG017|STARTED|Overall Study||1
10693258|NCT02509065|11857618|FG018|STARTED|Overall Study||1
10693259|NCT02509065|11857619|FG019|STARTED|Overall Study||1
10693260|NCT02509065|11857620|FG020|STARTED|Overall Study||1
10693261|NCT02509065|11857621|FG021|STARTED|Overall Study||1
10693262|NCT02509065|11857622|FG022|STARTED|Overall Study||1
10693263|NCT02509065|11857600|FG000|COMPLETED|Overall Study||1
10693264|NCT02509065|11857601|FG001|COMPLETED|Overall Study||1
10693265|NCT02509065|11857602|FG002|COMPLETED|Overall Study||2
10693266|NCT02509065|11857603|FG003|COMPLETED|Overall Study||1
10693267|NCT02509065|11857604|FG004|COMPLETED|Overall Study||1
10800944|NCT04411667|11962013|FG001|NOT COMPLETED|Overall Study||0
10800945|NCT04409886|11962019|FG000|STARTED|Overall Study||1
10800946|NCT04409886|11962019|FG000|COMPLETED|Overall Study||1
10800947|NCT04409886|11962019|FG000|NOT COMPLETED|Overall Study||0
10800948|NCT04407507|11962025|FG000|STARTED|Overall Study||33
10800949|NCT04407507|11962026|FG001|STARTED|Overall Study||33
10800950|NCT04407507|11962025|FG000|COMPLETED|Overall Study||33
10800951|NCT04407507|11962026|FG001|COMPLETED|Overall Study||32
10800952|NCT04407507|11962025|FG000|NOT COMPLETED|Overall Study||0
10800953|NCT04407507|11962026|FG001|NOT COMPLETED|Overall Study||1
10800954|NCT04406194|11962034|FG000|STARTED|Period 1||15
10800955|NCT04406194|11962035|FG001|STARTED|Period 1||15
10800956|NCT04406194|11962034|FG000|COMPLETED|Period 1||15
10800957|NCT04406194|11962035|FG001|COMPLETED|Period 1||14
10800958|NCT04406194|11962034|FG000|NOT COMPLETED|Period 1||0
10800959|NCT04406194|11962035|FG001|NOT COMPLETED|Period 1||1
10800960|NCT04406194|11962034|FG000|STARTED|Period 2||15
10800961|NCT04406194|11962035|FG001|STARTED|Period 2||14
10800962|NCT04406194|11962034|FG000|COMPLETED|Period 2||15
10800963|NCT04406194|11962035|FG001|COMPLETED|Period 2||14
10800964|NCT04406194|11962034|FG000|NOT COMPLETED|Period 2||0
10800965|NCT04406194|11962035|FG001|NOT COMPLETED|Period 2||0
10800966|NCT04404907|11962046|FG000|STARTED|Overall Study||442
10693268|NCT02509065|11857605|FG005|COMPLETED|Overall Study||1
10693269|NCT02509065|11857606|FG006|COMPLETED|Overall Study||1
10693270|NCT02509065|11857607|FG007|COMPLETED|Overall Study||1
10693271|NCT02509065|11857608|FG008|COMPLETED|Overall Study||1
10693272|NCT02509065|11857609|FG009|COMPLETED|Overall Study||1
10693273|NCT02509065|11857610|FG010|COMPLETED|Overall Study||1
10693274|NCT02509065|11857611|FG011|COMPLETED|Overall Study||1
10693275|NCT02509065|11857612|FG012|COMPLETED|Overall Study||1
10693276|NCT02509065|11857613|FG013|COMPLETED|Overall Study||1
10693277|NCT02509065|11857614|FG014|COMPLETED|Overall Study||1
10693278|NCT02509065|11857615|FG015|COMPLETED|Overall Study||1
10693279|NCT02509065|11857616|FG016|COMPLETED|Overall Study||1
10693280|NCT02509065|11857617|FG017|COMPLETED|Overall Study||1
10693281|NCT02509065|11857618|FG018|COMPLETED|Overall Study||1
10693282|NCT02509065|11857619|FG019|COMPLETED|Overall Study||1
10800967|NCT04404907|11962047|FG001|STARTED|Overall Study||95
10800968|NCT04404907|11962046|FG000|Occasional Tan|Overall Study||0
10800969|NCT04404907|11962047|FG001|Occasional Tan|Overall Study||88
10800970|NCT04404907|11962046|FG000|Frequent Tan|Overall Study||0
10800971|NCT04404907|11962047|FG001|Frequent Tan|Overall Study||7
10693283|NCT02509065|11857620|FG020|COMPLETED|Overall Study||1
10693284|NCT02509065|11857621|FG021|COMPLETED|Overall Study||1
10693285|NCT02509065|11857622|FG022|COMPLETED|Overall Study||1
10693286|NCT02509065|11857600|FG000|NOT COMPLETED|Overall Study||0
10693287|NCT02509065|11857601|FG001|NOT COMPLETED|Overall Study||0
10800972|NCT04404907|11962046|FG000|COMPLETED|Overall Study||442
10693288|NCT02509065|11857602|FG002|NOT COMPLETED|Overall Study||0
10693289|NCT02509065|11857603|FG003|NOT COMPLETED|Overall Study||0
10693290|NCT02509065|11857604|FG004|NOT COMPLETED|Overall Study||0
10693291|NCT02509065|11857605|FG005|NOT COMPLETED|Overall Study||0
10693292|NCT02509065|11857606|FG006|NOT COMPLETED|Overall Study||0
10693293|NCT02509065|11857607|FG007|NOT COMPLETED|Overall Study||0
10693294|NCT02509065|11857608|FG008|NOT COMPLETED|Overall Study||0
10693295|NCT02509065|11857609|FG009|NOT COMPLETED|Overall Study||0
10693296|NCT02509065|11857610|FG010|NOT COMPLETED|Overall Study||0
10800973|NCT04404907|11962047|FG001|COMPLETED|Overall Study||95
10800974|NCT04404907|11962046|FG000|NOT COMPLETED|Overall Study||0
10800975|NCT04404907|11962047|FG001|NOT COMPLETED|Overall Study||0
10800982|NCT04403399|11962066|FG000|STARTED|Period 1||18
10800983|NCT04403399|11962067|FG001|STARTED|Period 1||16
10800984|NCT04403399|11962066|FG000|COMPLETED|Period 1||18
10800985|NCT04403399|11962067|FG001|COMPLETED|Period 1||16
10800986|NCT04403399|11962066|FG000|NOT COMPLETED|Period 1||0
10800987|NCT04403399|11962067|FG001|NOT COMPLETED|Period 1||0
10800988|NCT04403399|11962066|FG000|STARTED|Period 2||18
10800989|NCT04403399|11962067|FG001|STARTED|Period 2||16
10800990|NCT04403399|11962066|FG000|COMPLETED|Period 2||18
10800991|NCT04403399|11962067|FG001|COMPLETED|Period 2||15
10800992|NCT04403399|11962066|FG000|NOT COMPLETED|Period 2||0
10800993|NCT04403399|11962067|FG001|NOT COMPLETED|Period 2||1
10800994|NCT04402970|11962075|FG000|STARTED|Overall Study||10
10800995|NCT04402970|11962076|FG001|STARTED|Overall Study||20
10800996|NCT04402970|11962075|FG000|COMPLETED|Overall Study||10
10800997|NCT04402970|11962076|FG001|COMPLETED|Overall Study||20
10800998|NCT04402970|11962075|FG000|NOT COMPLETED|Overall Study||0
10800999|NCT04402970|11962076|FG001|NOT COMPLETED|Overall Study||0
10801000|NCT04403113|11962084|FG000|STARTED|Overall Study||20
10801001|NCT04403113|11962085|FG001|STARTED|Overall Study||20
10801002|NCT04403113|11962084|FG000|COMPLETED|Overall Study||20
10801003|NCT04403113|11962085|FG001|COMPLETED|Overall Study||20
10801004|NCT04403113|11962084|FG000|NOT COMPLETED|Overall Study||0
10801005|NCT04403113|11962085|FG001|NOT COMPLETED|Overall Study||0
10801006|NCT04401202|11962097|FG000|STARTED|Overall Study||92
10801007|NCT04401202|11962098|FG001|STARTED|Overall Study||91
10801008|NCT04401202|11962097|FG000|COMPLETED|Overall Study||86
10801009|NCT04401202|11962098|FG001|COMPLETED|Overall Study||87
10801010|NCT04401202|11962097|FG000|NOT COMPLETED|Overall Study||6
10801011|NCT04401202|11962098|FG001|NOT COMPLETED|Overall Study||4
10801012|NCT04400682|11962107|FG000|STARTED|Period 1||15
10801013|NCT04400682|11962108|FG001|STARTED|Period 1||15
10801014|NCT04400682|11962107|FG000|COMPLETED|Period 1||14
10801015|NCT04400682|11962108|FG001|COMPLETED|Period 1||11
10801016|NCT04400682|11962107|FG000|NOT COMPLETED|Period 1||1
10801017|NCT04400682|11962108|FG001|NOT COMPLETED|Period 1||4
10801018|NCT04400682|11962107|FG000|STARTED|Period 2||14
10801019|NCT04400682|11962108|FG001|STARTED|Period 2||11
10801020|NCT04400682|11962107|FG000|COMPLETED|Period 2||14
10801021|NCT04400682|11962108|FG001|COMPLETED|Period 2||11
10801022|NCT04400682|11962107|FG000|NOT COMPLETED|Period 2||0
10801023|NCT04400682|11962108|FG001|NOT COMPLETED|Period 2||0
10801024|NCT04399161|11962117|FG000|STARTED|Overall Study||20
10801025|NCT04399161|11962118|FG001|STARTED|Overall Study||20
10801026|NCT04399161|11962119|FG002|STARTED|Overall Study||20
10801027|NCT04399161|11962117|FG000|COMPLETED|Overall Study||18
10801028|NCT04399161|11962118|FG001|COMPLETED|Overall Study||18
10801029|NCT04399161|11962119|FG002|COMPLETED|Overall Study||18
10801030|NCT04399161|11962117|FG000|NOT COMPLETED|Overall Study||2
10801031|NCT04399161|11962118|FG001|NOT COMPLETED|Overall Study||2
10801032|NCT04399161|11962119|FG002|NOT COMPLETED|Overall Study||2
10693297|NCT02509065|11857611|FG011|NOT COMPLETED|Overall Study||0
10693298|NCT02509065|11857612|FG012|NOT COMPLETED|Overall Study||0
10693299|NCT02509065|11857613|FG013|NOT COMPLETED|Overall Study||0
10693300|NCT02509065|11857614|FG014|NOT COMPLETED|Overall Study||0
10693301|NCT02509065|11857615|FG015|NOT COMPLETED|Overall Study||0
10801033|NCT04399980|11962129|FG000|STARTED|Overall Study||21
10801034|NCT04399980|11962130|FG001|STARTED|Overall Study||19
10801035|NCT04399980|11962129|FG000|COMPLETED|Overall Study||21
10801036|NCT04399980|11962130|FG001|COMPLETED|Overall Study||19
10801037|NCT04399980|11962129|FG000|NOT COMPLETED|Overall Study||0
10801038|NCT04399980|11962130|FG001|NOT COMPLETED|Overall Study||0
10801039|NCT04399122|11962138|FG000|STARTED|Overall Study||100
10801040|NCT04399122|11962139|FG001|STARTED|Overall Study||100
10801041|NCT04399122|11962138|FG000|COMPLETED|Overall Study||97
10801042|NCT04399122|11962139|FG001|COMPLETED|Overall Study||100
10693302|NCT02509065|11857616|FG016|NOT COMPLETED|Overall Study||0
10693303|NCT02509065|11857617|FG017|NOT COMPLETED|Overall Study||0
10693304|NCT02509065|11857618|FG018|NOT COMPLETED|Overall Study||0
10801043|NCT04399122|11962138|FG000|NOT COMPLETED|Overall Study||3
10801044|NCT04399122|11962139|FG001|NOT COMPLETED|Overall Study||0
10693305|NCT02509065|11857619|FG019|NOT COMPLETED|Overall Study||0
10693306|NCT02509065|11857620|FG020|NOT COMPLETED|Overall Study||0
10693307|NCT02509065|11857621|FG021|NOT COMPLETED|Overall Study||0
10801045|NCT04397445|11962145|FG000|STARTED|Overall Study||5
10801046|NCT04397445|11962146|FG001|STARTED|Overall Study||5
10801047|NCT04397445|11962147|FG002|STARTED|Overall Study||4
10801048|NCT04397445|11962148|FG003|STARTED|Overall Study||4
10801049|NCT04397445|11962145|FG000|COMPLETED|Overall Study||4
10801050|NCT04397445|11962146|FG001|COMPLETED|Overall Study||5
10693308|NCT02509065|11857622|FG022|NOT COMPLETED|Overall Study||0
10693309|NCT02509078|11857640|FG000|STARTED|Overall Study||502
10693310|NCT02509078|11857641|FG001|STARTED|Overall Study||506
10693311|NCT02509078|11857640|FG000|COMPLETED|Overall Study||501
10693312|NCT02509078|11857641|FG001|COMPLETED|Overall Study||505
10693313|NCT02509078|11857640|FG000|NOT COMPLETED|Overall Study||1
10693314|NCT02509078|11857641|FG001|NOT COMPLETED|Overall Study||1
10713403|NCT02678247|11878869|FG001|NOT COMPLETED|Second Intervention (7 Weeks)||2
10713404|NCT02678286|11878882|FG000|STARTED|Treatment Phase (48 Hours Post-Dose 1)||110
10713405|NCT02678286|11878883|FG001|STARTED|Treatment Phase (48 Hours Post-Dose 1)||109
10801051|NCT04397445|11962147|FG002|COMPLETED|Overall Study||4
10801052|NCT04397445|11962148|FG003|COMPLETED|Overall Study||4
10801053|NCT04397445|11962145|FG000|NOT COMPLETED|Overall Study||1
10801054|NCT04397445|11962146|FG001|NOT COMPLETED|Overall Study||0
10801055|NCT04397445|11962147|FG002|NOT COMPLETED|Overall Study||0
10801056|NCT04397445|11962148|FG003|NOT COMPLETED|Overall Study||0
10801057|NCT04397094|11962165|FG000|STARTED|Overall Study||30
10801058|NCT04397094|11962166|FG001|STARTED|Overall Study||30
10801059|NCT04397094|11962165|FG000|COMPLETED|Overall Study||30
10801060|NCT04397094|11962166|FG001|COMPLETED|Overall Study||30
10801061|NCT04397094|11962165|FG000|NOT COMPLETED|Overall Study||0
10801062|NCT04397094|11962166|FG001|NOT COMPLETED|Overall Study||0
10801063|NCT04396639|11962174|FG000|STARTED|Overall Study||50
10801064|NCT04396639|11962174|FG000|Completed Follow up|Overall Study||48
10801065|NCT04396639|11962174|FG000|COMPLETED|Overall Study||48
10801066|NCT04396639|11962174|FG000|NOT COMPLETED|Overall Study||2
10801067|NCT04396665|11962180|FG000|STARTED|Overall Study||134
10801068|NCT04396665|11962181|FG001|STARTED|Overall Study||90
10801069|NCT04396665|11962180|FG000|COMPLETED|Overall Study||99
10801070|NCT04396665|11962181|FG001|COMPLETED|Overall Study||83
10801071|NCT04396665|11962180|FG000|NOT COMPLETED|Overall Study||35
10801072|NCT04396665|11962181|FG001|NOT COMPLETED|Overall Study||7
10801073|NCT04393493|11962193|FG000|STARTED|Follow up||40
10801074|NCT04393493|11962194|FG001|STARTED|Follow up||40
10801075|NCT04393493|11962193|FG000|COMPLETED|Follow up||40
10801076|NCT04393493|11962194|FG001|COMPLETED|Follow up||40
10801077|NCT04393493|11962193|FG000|NOT COMPLETED|Follow up||0
10801078|NCT04393493|11962194|FG001|NOT COMPLETED|Follow up||0
10801079|NCT04393493|11962193|FG000|STARTED|First 4 Days of Intervention||40
10801080|NCT04393493|11962194|FG001|STARTED|First 4 Days of Intervention||40
10801081|NCT04393493|11962193|FG000|COMPLETED|First 4 Days of Intervention||35
10801082|NCT04393493|11962194|FG001|COMPLETED|First 4 Days of Intervention||33
10801083|NCT04393493|11962193|FG000|NOT COMPLETED|First 4 Days of Intervention||5
10801084|NCT04393493|11962194|FG001|NOT COMPLETED|First 4 Days of Intervention||7
10801085|NCT04392362|11962204|FG000|STARTED|Overall Study||23
10801086|NCT04392362|11962205|FG001|STARTED|Overall Study||7
10801087|NCT04392362|11962204|FG000|COMPLETED|Overall Study||23
10801088|NCT04392362|11962205|FG001|COMPLETED|Overall Study||7
10801089|NCT04392362|11962204|FG000|NOT COMPLETED|Overall Study||0
10801090|NCT04392362|11962205|FG001|NOT COMPLETED|Overall Study||0
10801091|NCT04392141|11962213|FG000|STARTED|Overall Study||60
10801092|NCT04392141|11962214|FG001|STARTED|Overall Study||60
10801093|NCT04392141|11962213|FG000|COMPLETED|Overall Study||60
10801094|NCT04392141|11962214|FG001|COMPLETED|Overall Study||60
10801095|NCT04392141|11962213|FG000|NOT COMPLETED|Overall Study||0
10801096|NCT04392141|11962214|FG001|NOT COMPLETED|Overall Study||0
10801097|NCT04392219|11962238|FG000|STARTED|Overall Study||16
10801098|NCT04392219|11962239|FG001|STARTED|Overall Study||6
10801099|NCT04392219|11962240|FG002|STARTED|Overall Study||6
10801100|NCT04392219|11962241|FG003|STARTED|Overall Study||6
10801101|NCT04392219|11962242|FG004|STARTED|Overall Study||6
10801102|NCT04392219|11962243|FG005|STARTED|Overall Study||6
10801103|NCT04392219|11962244|FG006|STARTED|Overall Study||6
10801104|NCT04392219|11962245|FG007|STARTED|Overall Study||6
10801105|NCT04392219|11962246|FG008|STARTED|Overall Study||6
10801106|NCT04392219|11962247|FG009|STARTED|Overall Study||10
10713406|NCT02678286|11878882|FG000|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||108
10713407|NCT02678286|11878883|FG001|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||107
10801107|NCT04392219|11962248|FG010|STARTED|Overall Study||14
10801108|NCT04392219|11962249|FG011|STARTED|Overall Study||6
10801109|NCT04392219|11962250|FG012|STARTED|Overall Study||6
10713408|NCT02678286|11878882|FG000|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||2
10713409|NCT02678286|11878883|FG001|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||2
10713410|NCT02678286|11878882|FG000|STARTED|Study Overall (28 Day Follow-Up)||110
10713411|NCT02678286|11878883|FG001|STARTED|Study Overall (28 Day Follow-Up)||109
10801110|NCT04392219|11962251|FG013|STARTED|Overall Study||6
10801111|NCT04392219|11962252|FG014|STARTED|Overall Study||6
10801112|NCT04392219|11962253|FG015|STARTED|Overall Study||6
10801113|NCT04392219|11962254|FG016|STARTED|Overall Study||6
10801114|NCT04392219|11962255|FG017|STARTED|Overall Study||6
10801115|NCT04392219|11962238|FG000|COMPLETED|Overall Study||16
10801116|NCT04392219|11962239|FG001|COMPLETED|Overall Study||6
10693315|NCT02509117|11857659|FG000|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
10693316|NCT02509117|11857660|FG001|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
10693317|NCT02509117|11857661|FG002|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
10693318|NCT02509117|11857662|FG003|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
10693319|NCT02509117|11857663|FG004|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
10693320|NCT02509117|11857664|FG005|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
10693321|NCT02509117|11857665|FG006|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
10693322|NCT02509117|11857666|FG007|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
10693323|NCT02509117|11857667|FG008|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||4
10693324|NCT02509117|11857668|FG009|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||10
10693325|NCT02509117|11857659|FG000|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2
10693326|NCT02509117|11857660|FG001|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||1
10693327|NCT02509117|11857661|FG002|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2
10693328|NCT02509117|11857662|FG003|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2
10801117|NCT04392219|11962240|FG002|COMPLETED|Overall Study||6
10801118|NCT04392219|11962241|FG003|COMPLETED|Overall Study||6
10801119|NCT04392219|11962242|FG004|COMPLETED|Overall Study||6
10801120|NCT04392219|11962243|FG005|COMPLETED|Overall Study||6
10801121|NCT04392219|11962244|FG006|COMPLETED|Overall Study||6
10801122|NCT04392219|11962245|FG007|COMPLETED|Overall Study||6
10801123|NCT04392219|11962246|FG008|COMPLETED|Overall Study||6
10801124|NCT04392219|11962247|FG009|COMPLETED|Overall Study||10
10801125|NCT04392219|11962248|FG010|COMPLETED|Overall Study||14
10801126|NCT04392219|11962249|FG011|COMPLETED|Overall Study||6
10801127|NCT04392219|11962250|FG012|COMPLETED|Overall Study||6
10801128|NCT04392219|11962251|FG013|COMPLETED|Overall Study||6
10801129|NCT04392219|11962252|FG014|COMPLETED|Overall Study||6
10801130|NCT04392219|11962253|FG015|COMPLETED|Overall Study||6
10801131|NCT04392219|11962254|FG016|COMPLETED|Overall Study||6
10801132|NCT04392219|11962255|FG017|COMPLETED|Overall Study||6
10801133|NCT04392219|11962238|FG000|NOT COMPLETED|Overall Study||0
10801134|NCT04392219|11962239|FG001|NOT COMPLETED|Overall Study||0
10801135|NCT04392219|11962240|FG002|NOT COMPLETED|Overall Study||0
10801136|NCT04392219|11962241|FG003|NOT COMPLETED|Overall Study||0
10801137|NCT04392219|11962242|FG004|NOT COMPLETED|Overall Study||0
10801138|NCT04392219|11962243|FG005|NOT COMPLETED|Overall Study||0
10801139|NCT04392219|11962244|FG006|NOT COMPLETED|Overall Study||0
10801140|NCT04392219|11962245|FG007|NOT COMPLETED|Overall Study||0
10801141|NCT04392219|11962246|FG008|NOT COMPLETED|Overall Study||0
10801142|NCT04392219|11962247|FG009|NOT COMPLETED|Overall Study||0
10801143|NCT04392219|11962248|FG010|NOT COMPLETED|Overall Study||0
10801144|NCT04392219|11962249|FG011|NOT COMPLETED|Overall Study||0
10801145|NCT04392219|11962250|FG012|NOT COMPLETED|Overall Study||0
10801146|NCT04392219|11962251|FG013|NOT COMPLETED|Overall Study||0
10801147|NCT04392219|11962252|FG014|NOT COMPLETED|Overall Study||0
10801148|NCT04392219|11962253|FG015|NOT COMPLETED|Overall Study||0
10801149|NCT04392219|11962254|FG016|NOT COMPLETED|Overall Study||0
10801150|NCT04392219|11962255|FG017|NOT COMPLETED|Overall Study||0
10801151|NCT04391842|11962293|FG000|STARTED|Overall Study||34
10801152|NCT04391842|11962293|FG000|COMPLETED|Overall Study||32
10801153|NCT04391842|11962293|FG000|NOT COMPLETED|Overall Study||2
10801154|NCT04390022|11962299|FG000|STARTED|Overall Study||12
10801155|NCT04390022|11962300|FG001|STARTED|Overall Study||12
10801156|NCT04390022|11962299|FG000|COMPLETED|Overall Study||12
10801157|NCT04390022|11962300|FG001|COMPLETED|Overall Study||12
10801158|NCT04390022|11962299|FG000|NOT COMPLETED|Overall Study||0
10801159|NCT04390022|11962300|FG001|NOT COMPLETED|Overall Study||0
10801160|NCT04386902|11962306|FG000|STARTED|Overall Study||60
10801161|NCT04386902|11962306|FG000|COMPLETED|Overall Study||50
10801162|NCT04386902|11962306|FG000|NOT COMPLETED|Overall Study||10
10801163|NCT04385238|11962312|FG000|STARTED|Overall Study||5712
10801164|NCT04385238|11962313|FG001|STARTED|Overall Study||1182
10801165|NCT04385238|11962312|FG000|COMPLETED|Overall Study||5712
10801166|NCT04385238|11962313|FG001|COMPLETED|Overall Study||1182
10801167|NCT04385238|11962312|FG000|NOT COMPLETED|Overall Study||0
10801168|NCT04385238|11962313|FG001|NOT COMPLETED|Overall Study||0
10801169|NCT04384523|11962325|FG000|STARTED|Overall Study||10
10801170|NCT04384523|11962326|FG001|STARTED|Overall Study||6
10801171|NCT04384523|11962327|FG002|STARTED|Overall Study||6
10801172|NCT04384523|11962328|FG003|STARTED|Overall Study||6
10801173|NCT04384523|11962329|FG004|STARTED|Overall Study||7
10801174|NCT04384523|11962330|FG005|STARTED|Overall Study||6
10801175|NCT04384523|11962325|FG000|COMPLETED|Overall Study||9
10801176|NCT04384523|11962326|FG001|COMPLETED|Overall Study||5
10801177|NCT04384523|11962327|FG002|COMPLETED|Overall Study||6
10801178|NCT04384523|11962328|FG003|COMPLETED|Overall Study||6
10693329|NCT02509117|11857663|FG004|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
10693330|NCT02509117|11857664|FG005|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
10693331|NCT02509117|11857665|FG006|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
10801179|NCT04384523|11962329|FG004|COMPLETED|Overall Study||7
10801180|NCT04384523|11962330|FG005|COMPLETED|Overall Study||5
10801181|NCT04384523|11962325|FG000|NOT COMPLETED|Overall Study||1
10801182|NCT04384523|11962326|FG001|NOT COMPLETED|Overall Study||1
10801183|NCT04384523|11962327|FG002|NOT COMPLETED|Overall Study||0
10801184|NCT04384523|11962328|FG003|NOT COMPLETED|Overall Study||0
10801185|NCT04384523|11962329|FG004|NOT COMPLETED|Overall Study||0
10801186|NCT04384523|11962330|FG005|NOT COMPLETED|Overall Study||1
10801187|NCT04383665|11962350|FG000|STARTED|Overall Study||2
10801188|NCT04383665|11962351|FG001|STARTED|Overall Study||2
10693332|NCT02509117|11857666|FG007|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
10693333|NCT02509117|11857667|FG008|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||4
10693334|NCT02509117|11857668|FG009|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||10
10693335|NCT02509117|11857659|FG000|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
10693336|NCT02509117|11857660|FG001|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||1
10693337|NCT02509117|11857661|FG002|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
10693338|NCT02509117|11857662|FG003|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
10693339|NCT02509117|11857663|FG004|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
10693340|NCT02509117|11857664|FG005|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
10693341|NCT02509117|11857665|FG006|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
10693342|NCT02509117|11857666|FG007|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
10693343|NCT02509117|11857667|FG008|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||4
10693344|NCT02509117|11857668|FG009|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
10693345|NCT02509117|11857659|FG000|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
10693346|NCT02509117|11857660|FG001|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||1
10693347|NCT02509117|11857661|FG002|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
10693348|NCT02509117|11857662|FG003|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
10693349|NCT02509117|11857663|FG004|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
10693350|NCT02509117|11857664|FG005|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
10801189|NCT04383665|11962352|FG002|STARTED|Overall Study||2
10801190|NCT04383665|11962353|FG003|STARTED|Overall Study||2
10801191|NCT04383665|11962354|FG004|STARTED|Overall Study||2
10801192|NCT04383665|11962355|FG005|STARTED|Overall Study||2
10801193|NCT04383665|11962350|FG000|COMPLETED|Overall Study||2
10801194|NCT04383665|11962351|FG001|COMPLETED|Overall Study||2
10801195|NCT04383665|11962352|FG002|COMPLETED|Overall Study||2
10801196|NCT04383665|11962353|FG003|COMPLETED|Overall Study||2
10801197|NCT04383665|11962354|FG004|COMPLETED|Overall Study||2
10801198|NCT04383665|11962355|FG005|COMPLETED|Overall Study||2
10801199|NCT04383665|11962350|FG000|NOT COMPLETED|Overall Study||0
10801200|NCT04383665|11962351|FG001|NOT COMPLETED|Overall Study||0
10801201|NCT04383665|11962352|FG002|NOT COMPLETED|Overall Study||0
10801202|NCT04383665|11962353|FG003|NOT COMPLETED|Overall Study||0
10801203|NCT04383665|11962354|FG004|NOT COMPLETED|Overall Study||0
10801204|NCT04383665|11962355|FG005|NOT COMPLETED|Overall Study||0
10801205|NCT04383132|11962365|FG000|STARTED|Overall Study||173
10801206|NCT04383132|11962366|FG001|STARTED|Overall Study||173
10801207|NCT04383132|11962365|FG000|COMPLETED|Overall Study||173
10801208|NCT04383132|11962366|FG001|COMPLETED|Overall Study||173
10801209|NCT04383132|11962365|FG000|NOT COMPLETED|Overall Study||0
10801210|NCT04383132|11962366|FG001|NOT COMPLETED|Overall Study||0
10801223|NCT04381481|11962399|FG000|STARTED|Overall Study||200
10801224|NCT04381481|11962400|FG001|STARTED|Overall Study||205
10801225|NCT04381481|11962401|FG002|STARTED|Overall Study||199
10801226|NCT04381481|11962402|FG003|STARTED|Overall Study||197
10801227|NCT04381481|11962403|FG004|STARTED|Overall Study||199
10801228|NCT04381481|11962404|FG005|STARTED|Overall Study||195
10801229|NCT04381481|11962405|FG006|STARTED|Overall Study||194
10801230|NCT04381481|11962406|FG007|STARTED|Overall Study||193
10801231|NCT04381481|11962407|FG008|STARTED|Overall Study||214
10801232|NCT04381481|11962408|FG009|STARTED|Overall Study||198
10801233|NCT04381481|11962409|FG010|STARTED|Overall Study||192
10801234|NCT04381481|11962410|FG011|STARTED|Overall Study||188
10801235|NCT04381481|11962399|FG000|COMPLETED|Overall Study||185
10801236|NCT04381481|11962400|FG001|COMPLETED|Overall Study||190
10801237|NCT04381481|11962401|FG002|COMPLETED|Overall Study||190
10801238|NCT04381481|11962402|FG003|COMPLETED|Overall Study||183
10801239|NCT04381481|11962403|FG004|COMPLETED|Overall Study||191
10801240|NCT04381481|11962404|FG005|COMPLETED|Overall Study||180
10801241|NCT04381481|11962405|FG006|COMPLETED|Overall Study||184
10801242|NCT04381481|11962406|FG007|COMPLETED|Overall Study||177
10801243|NCT04381481|11962407|FG008|COMPLETED|Overall Study||195
10801244|NCT04381481|11962408|FG009|COMPLETED|Overall Study||188
10801245|NCT04381481|11962409|FG010|COMPLETED|Overall Study||183
10801246|NCT04381481|11962410|FG011|COMPLETED|Overall Study||173
10693351|NCT02509117|11857665|FG006|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
10801247|NCT04381481|11962399|FG000|NOT COMPLETED|Overall Study||15
10801248|NCT04381481|11962400|FG001|NOT COMPLETED|Overall Study||15
10801249|NCT04381481|11962401|FG002|NOT COMPLETED|Overall Study||9
10801250|NCT04381481|11962402|FG003|NOT COMPLETED|Overall Study||14
10801251|NCT04381481|11962403|FG004|NOT COMPLETED|Overall Study||8
10801252|NCT04381481|11962404|FG005|NOT COMPLETED|Overall Study||15
10801253|NCT04381481|11962405|FG006|NOT COMPLETED|Overall Study||10
10801254|NCT04381481|11962406|FG007|NOT COMPLETED|Overall Study||16
10693352|NCT02509117|11857666|FG007|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
10693353|NCT02509117|11857667|FG008|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
10693354|NCT02509117|11857668|FG009|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
10693355|NCT02509117|11857659|FG000|STARTED|Washout Period 1 (Part A: 7 Days)||2
10693356|NCT02509117|11857660|FG001|STARTED|Washout Period 1 (Part A: 7 Days)||1
10693357|NCT02509117|11857661|FG002|STARTED|Washout Period 1 (Part A: 7 Days)||2
10693358|NCT02509117|11857662|FG003|STARTED|Washout Period 1 (Part A: 7 Days)||2
10693359|NCT02509117|11857663|FG004|STARTED|Washout Period 1 (Part A: 7 Days)||0
10693360|NCT02509117|11857664|FG005|STARTED|Washout Period 1 (Part A: 7 Days)||0
10693361|NCT02509117|11857665|FG006|STARTED|Washout Period 1 (Part A: 7 Days)||0
10693362|NCT02509117|11857666|FG007|STARTED|Washout Period 1 (Part A: 7 Days)||0
10693363|NCT02509117|11857667|FG008|STARTED|Washout Period 1 (Part A: 7 Days)||0
10693364|NCT02509117|11857668|FG009|STARTED|Washout Period 1 (Part A: 7 Days)||0
10693365|NCT02509117|11857659|FG000|COMPLETED|Washout Period 1 (Part A: 7 Days)||2
10693366|NCT02509117|11857660|FG001|COMPLETED|Washout Period 1 (Part A: 7 Days)||1
10693367|NCT02509117|11857661|FG002|COMPLETED|Washout Period 1 (Part A: 7 Days)||2
10693368|NCT02509117|11857662|FG003|COMPLETED|Washout Period 1 (Part A: 7 Days)||2
10693369|NCT02509117|11857663|FG004|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
10693370|NCT02509117|11857664|FG005|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
10693371|NCT02509117|11857665|FG006|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
10801255|NCT04381481|11962407|FG008|NOT COMPLETED|Overall Study||19
10801256|NCT04381481|11962408|FG009|NOT COMPLETED|Overall Study||10
10801257|NCT04381481|11962409|FG010|NOT COMPLETED|Overall Study||9
10801258|NCT04381481|11962410|FG011|NOT COMPLETED|Overall Study||15
10801259|NCT04380688|11962438|FG000|STARTED|Overall Study||31
10801260|NCT04380688|11962439|FG001|STARTED|Overall Study||31
10801261|NCT04380688|11962438|FG000|COMPLETED|Overall Study||24
10801262|NCT04380688|11962439|FG001|COMPLETED|Overall Study||22
10801263|NCT04380688|11962438|FG000|NOT COMPLETED|Overall Study||7
10801264|NCT04380688|11962439|FG001|NOT COMPLETED|Overall Study||9
10801265|NCT04376060|11962445|FG000|STARTED|Overall Study||15
10801266|NCT04376060|11962445|FG000|COMPLETED|Overall Study||14
10801267|NCT04376060|11962445|FG000|NOT COMPLETED|Overall Study||1
10801268|NCT04374500|11962449|FG000|STARTED|Overall Study||10
10801269|NCT04374500|11962450|FG001|STARTED|Overall Study||10
10801270|NCT04374500|11962451|FG002|STARTED|Overall Study||83
10801271|NCT04374500|11962449|FG000|COMPLETED|Overall Study||10
10801272|NCT04374500|11962450|FG001|COMPLETED|Overall Study||10
10801273|NCT04374500|11962451|FG002|COMPLETED|Overall Study||83
10801274|NCT04374500|11962449|FG000|NOT COMPLETED|Overall Study||0
10801275|NCT04374500|11962450|FG001|NOT COMPLETED|Overall Study||0
10801276|NCT04374500|11962451|FG002|NOT COMPLETED|Overall Study||0
10801277|NCT04372186|11962464|FG000|STARTED|Overall Study||249
10801278|NCT04372186|11962465|FG001|STARTED|Overall Study||128
10801279|NCT04372186|11962464|FG000|COMPLETED|Overall Study||225
10801280|NCT04372186|11962465|FG001|COMPLETED|Overall Study||115
10801281|NCT04372186|11962464|FG000|NOT COMPLETED|Overall Study||24
10801282|NCT04372186|11962465|FG001|NOT COMPLETED|Overall Study||13
10801283|NCT04371419|11962473|FG000|STARTED|Overall Study||784
10801284|NCT04371419|11962474|FG001|STARTED|Overall Study||791
10801285|NCT04371419|11962475|FG002|STARTED|Overall Study||780
10801286|NCT04371419|11962476|FG003|STARTED|Overall Study||778
10801287|NCT04371419|11962477|FG004|STARTED|Overall Study||777
10801288|NCT04371419|11962478|FG005|STARTED|Overall Study||788
10801289|NCT04371419|11962479|FG006|STARTED|Overall Study||783
10801290|NCT04371419|11962480|FG007|STARTED|Overall Study||788
10801291|NCT04371419|11962481|FG008|STARTED|Overall Study||779
10801292|NCT04371419|11962482|FG009|STARTED|Overall Study||780
10801293|NCT04371419|11962483|FG010|STARTED|Overall Study||782
10801294|NCT04371419|11962484|FG011|STARTED|Overall Study||790
10801295|NCT04371419|11962485|FG012|STARTED|Overall Study||779
10801296|NCT04371419|11962486|FG013|STARTED|Overall Study||786
10801297|NCT04371419|11962487|FG014|STARTED|Overall Study||781
10801298|NCT04371419|11962488|FG015|STARTED|Overall Study||781
10801299|NCT04371419|11962489|FG016|STARTED|Overall Study||1617
10801300|NCT04371419|11962473|FG000|Completed the Knowledge Questions|Overall Study||663
10801301|NCT04371419|11962474|FG001|Completed the Knowledge Questions|Overall Study||669
10801302|NCT04371419|11962475|FG002|Completed the Knowledge Questions|Overall Study||673
10801303|NCT04371419|11962476|FG003|Completed the Knowledge Questions|Overall Study||664
10801304|NCT04371419|11962477|FG004|Completed the Knowledge Questions|Overall Study||666
10801305|NCT04371419|11962478|FG005|Completed the Knowledge Questions|Overall Study||683
10801306|NCT04371419|11962479|FG006|Completed the Knowledge Questions|Overall Study||664
10801307|NCT04371419|11962480|FG007|Completed the Knowledge Questions|Overall Study||679
10801308|NCT04371419|11962481|FG008|Completed the Knowledge Questions|Overall Study||670
10801309|NCT04371419|11962482|FG009|Completed the Knowledge Questions|Overall Study||655
10801310|NCT04371419|11962483|FG010|Completed the Knowledge Questions|Overall Study||656
10801311|NCT04371419|11962484|FG011|Completed the Knowledge Questions|Overall Study||692
10801312|NCT04371419|11962485|FG012|Completed the Knowledge Questions|Overall Study||664
10801313|NCT04371419|11962486|FG013|Completed the Knowledge Questions|Overall Study||687
10801314|NCT04371419|11962487|FG014|Completed the Knowledge Questions|Overall Study||652
10801315|NCT04371419|11962488|FG015|Completed the Knowledge Questions|Overall Study||652
10801316|NCT04371419|11962489|FG016|Completed the Knowledge Questions|Overall Study||1526
10693372|NCT02509117|11857666|FG007|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
10713910|NCT02683577|11879468|FG002|NOT COMPLETED|Overall Study||0
10801317|NCT04371419|11962473|FG000|COMPLETED|Overall Study||641
10801318|NCT04371419|11962474|FG001|COMPLETED|Overall Study||636
10801319|NCT04371419|11962475|FG002|COMPLETED|Overall Study||639
10801320|NCT04371419|11962476|FG003|COMPLETED|Overall Study||631
10801321|NCT04371419|11962477|FG004|COMPLETED|Overall Study||644
10801322|NCT04371419|11962478|FG005|COMPLETED|Overall Study||654
10801323|NCT04371419|11962479|FG006|COMPLETED|Overall Study||639
10801324|NCT04371419|11962480|FG007|COMPLETED|Overall Study||658
10801325|NCT04371419|11962481|FG008|COMPLETED|Overall Study||649
10801326|NCT04371419|11962482|FG009|COMPLETED|Overall Study||621
10801327|NCT04371419|11962483|FG010|COMPLETED|Overall Study||626
10801328|NCT04371419|11962484|FG011|COMPLETED|Overall Study||662
10801329|NCT04371419|11962485|FG012|COMPLETED|Overall Study||633
10801330|NCT04371419|11962486|FG013|COMPLETED|Overall Study||660
10801331|NCT04371419|11962487|FG014|COMPLETED|Overall Study||626
10801332|NCT04371419|11962488|FG015|COMPLETED|Overall Study||625
10801333|NCT04371419|11962489|FG016|COMPLETED|Overall Study||1450
10801334|NCT04371419|11962473|FG000|NOT COMPLETED|Overall Study||143
10801335|NCT04371419|11962474|FG001|NOT COMPLETED|Overall Study||155
10801336|NCT04371419|11962475|FG002|NOT COMPLETED|Overall Study||141
10801337|NCT04371419|11962476|FG003|NOT COMPLETED|Overall Study||147
10801338|NCT04371419|11962477|FG004|NOT COMPLETED|Overall Study||133
10801339|NCT04371419|11962478|FG005|NOT COMPLETED|Overall Study||134
10801340|NCT04371419|11962479|FG006|NOT COMPLETED|Overall Study||144
10801341|NCT04371419|11962480|FG007|NOT COMPLETED|Overall Study||130
10801342|NCT04371419|11962481|FG008|NOT COMPLETED|Overall Study||130
10801343|NCT04371419|11962482|FG009|NOT COMPLETED|Overall Study||159
10801344|NCT04371419|11962483|FG010|NOT COMPLETED|Overall Study||156
10801345|NCT04371419|11962484|FG011|NOT COMPLETED|Overall Study||128
10801346|NCT04371419|11962485|FG012|NOT COMPLETED|Overall Study||146
10801347|NCT04371419|11962486|FG013|NOT COMPLETED|Overall Study||126
10801348|NCT04371419|11962487|FG014|NOT COMPLETED|Overall Study||155
10801349|NCT04371419|11962488|FG015|NOT COMPLETED|Overall Study||156
10801350|NCT04371419|11962489|FG016|NOT COMPLETED|Overall Study||167
10801351|NCT04370834|11962520|FG000|STARTED|Overall Study||1
10801352|NCT04370834|11962520|FG000|COMPLETED|Overall Study||1
10801353|NCT04370834|11962520|FG000|NOT COMPLETED|Overall Study||0
10801354|NCT04370548|11962532|FG000|STARTED|Overall Study||204
10801355|NCT04370548|11962533|FG001|STARTED|Overall Study||103
10801356|NCT04370548|11962532|FG000|COMPLETED|Overall Study||190
10801357|NCT04370548|11962533|FG001|COMPLETED|Overall Study||100
10801358|NCT04370548|11962532|FG000|NOT COMPLETED|Overall Study||14
10801359|NCT04370548|11962533|FG001|NOT COMPLETED|Overall Study||3
10801360|NCT04370028|11962539|FG000|STARTED|Overall Study||2583
10801361|NCT04370028|11962539|FG000|COMPLETED|Overall Study||1876
10801362|NCT04370028|11962539|FG000|NOT COMPLETED|Overall Study||707
10801369|NCT04366583|11962561|FG000|STARTED|Overall Study||82
10801370|NCT04366583|11962562|FG001|STARTED|Overall Study||84
10801371|NCT04366583|11962561|FG000|COMPLETED|Overall Study||82
10801372|NCT04366583|11962562|FG001|COMPLETED|Overall Study||84
10801373|NCT04366583|11962561|FG000|NOT COMPLETED|Overall Study||0
10801374|NCT04366583|11962562|FG001|NOT COMPLETED|Overall Study||0
10801375|NCT04365699|11962571|FG000|STARTED|Overall Study||10
10801376|NCT04365699|11962572|FG001|STARTED|Overall Study||16
10801377|NCT04365699|11962573|FG002|STARTED|Overall Study||55
10801378|NCT04365699|11962571|FG000|COMPLETED|Overall Study||8
10801379|NCT04365699|11962572|FG001|COMPLETED|Overall Study||11
10801380|NCT04365699|11962573|FG002|COMPLETED|Overall Study||40
10801381|NCT04365699|11962571|FG000|NOT COMPLETED|Overall Study||2
10801382|NCT04365699|11962572|FG001|NOT COMPLETED|Overall Study||5
10801383|NCT04365699|11962573|FG002|NOT COMPLETED|Overall Study||15
10801384|NCT04365153|11962584|FG000|STARTED|Overall Study||15
10801385|NCT04365153|11962585|FG001|STARTED|Overall Study||14
10801386|NCT04365153|11962586|FG002|STARTED|Overall Study||16
10801387|NCT04365153|11962584|FG000|COMPLETED|Overall Study||15
10801388|NCT04365153|11962585|FG001|COMPLETED|Overall Study||14
10801389|NCT04365153|11962586|FG002|COMPLETED|Overall Study||16
10801390|NCT04365153|11962584|FG000|NOT COMPLETED|Overall Study||0
10801391|NCT04365153|11962585|FG001|NOT COMPLETED|Overall Study||0
10801392|NCT04365153|11962586|FG002|NOT COMPLETED|Overall Study||0
10801393|NCT04363879|11962597|FG000|STARTED|Overall Study||78
10801394|NCT04363879|11962598|FG001|STARTED|Overall Study||92
10801395|NCT04363879|11962597|FG000|COMPLETED|Overall Study||78
10801396|NCT04363879|11962598|FG001|COMPLETED|Overall Study||92
10801397|NCT04363879|11962597|FG000|NOT COMPLETED|Overall Study||0
10801398|NCT04363879|11962598|FG001|NOT COMPLETED|Overall Study||0
10801399|NCT04362137|11962606|FG000|STARTED|Overall Study||287
10801400|NCT04362137|11962607|FG001|STARTED|Overall Study||145
10801401|NCT04362137|11962606|FG000|Safety Set|Overall Study||281
10801402|NCT04362137|11962607|FG001|Safety Set|Overall Study||143
10801403|NCT04362137|11962606|FG000|COMPLETED|Overall Study||269
10801404|NCT04362137|11962607|FG001|COMPLETED|Overall Study||139
10801405|NCT04362137|11962606|FG000|NOT COMPLETED|Overall Study||18
10801406|NCT04362137|11962607|FG001|NOT COMPLETED|Overall Study||6
10801407|NCT04359771|11962615|FG000|STARTED|Overall Study|Right eye of every participant was assigned to the diode MPL group|15
10801408|NCT04359771|11962616|FG001|STARTED|Overall Study|Left eye of every participant was assigned to the diode MPL group|15
10810994|NCT03783130|11972701|FG001|COMPLETED|Overall Study||3
10693373|NCT02509117|11857667|FG008|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
10693374|NCT02509117|11857668|FG009|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
10693375|NCT02509117|11857659|FG000|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
10693376|NCT02509117|11857660|FG001|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
10693377|NCT02509117|11857661|FG002|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
10693378|NCT02509117|11857662|FG003|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
10693379|NCT02509117|11857663|FG004|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
10693380|NCT02509117|11857664|FG005|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
10693381|NCT02509117|11857665|FG006|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
10693382|NCT02509117|11857666|FG007|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
10693383|NCT02509117|11857667|FG008|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
10693384|NCT02509117|11857668|FG009|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
10693385|NCT02509117|11857659|FG000|STARTED|Period 2 -Part A: 4 Days||2
10693386|NCT02509117|11857660|FG001|STARTED|Period 2 -Part A: 4 Days|1 participant was added in intervention period 2|2
10693387|NCT02509117|11857661|FG002|STARTED|Period 2 -Part A: 4 Days||2
10693388|NCT02509117|11857662|FG003|STARTED|Period 2 -Part A: 4 Days||2
10693389|NCT02509117|11857663|FG004|STARTED|Period 2 -Part A: 4 Days||0
10693390|NCT02509117|11857664|FG005|STARTED|Period 2 -Part A: 4 Days||0
10693391|NCT02509117|11857665|FG006|STARTED|Period 2 -Part A: 4 Days||0
10693392|NCT02509117|11857666|FG007|STARTED|Period 2 -Part A: 4 Days||0
10693393|NCT02509117|11857667|FG008|STARTED|Period 2 -Part A: 4 Days||0
10693394|NCT02509117|11857668|FG009|STARTED|Period 2 -Part A: 4 Days||0
10693395|NCT02509117|11857659|FG000|Treated|Period 2 -Part A: 4 Days||2
10693396|NCT02509117|11857660|FG001|Treated|Period 2 -Part A: 4 Days||2
10693397|NCT02509117|11857661|FG002|Treated|Period 2 -Part A: 4 Days||2
10693398|NCT02509117|11857662|FG003|Treated|Period 2 -Part A: 4 Days||2
10693399|NCT02509117|11857663|FG004|Treated|Period 2 -Part A: 4 Days||0
10693400|NCT02509117|11857664|FG005|Treated|Period 2 -Part A: 4 Days||0
10693401|NCT02509117|11857665|FG006|Treated|Period 2 -Part A: 4 Days||0
10693402|NCT02509117|11857666|FG007|Treated|Period 2 -Part A: 4 Days||0
10693403|NCT02509117|11857667|FG008|Treated|Period 2 -Part A: 4 Days||0
10693404|NCT02509117|11857668|FG009|Treated|Period 2 -Part A: 4 Days||0
10693405|NCT02509117|11857659|FG000|COMPLETED|Period 2 -Part A: 4 Days||2
10693406|NCT02509117|11857660|FG001|COMPLETED|Period 2 -Part A: 4 Days||2
10693407|NCT02509117|11857661|FG002|COMPLETED|Period 2 -Part A: 4 Days||2
10693408|NCT02509117|11857662|FG003|COMPLETED|Period 2 -Part A: 4 Days||2
10693409|NCT02509117|11857663|FG004|COMPLETED|Period 2 -Part A: 4 Days||0
10693410|NCT02509117|11857664|FG005|COMPLETED|Period 2 -Part A: 4 Days||0
10693411|NCT02509117|11857665|FG006|COMPLETED|Period 2 -Part A: 4 Days||0
10693412|NCT02509117|11857666|FG007|COMPLETED|Period 2 -Part A: 4 Days||0
10693413|NCT02509117|11857667|FG008|COMPLETED|Period 2 -Part A: 4 Days||0
10693414|NCT02509117|11857668|FG009|COMPLETED|Period 2 -Part A: 4 Days||0
10693415|NCT02509117|11857659|FG000|NOT COMPLETED|Period 2 -Part A: 4 Days||0
10693416|NCT02509117|11857660|FG001|NOT COMPLETED|Period 2 -Part A: 4 Days||0
10693417|NCT02509117|11857661|FG002|NOT COMPLETED|Period 2 -Part A: 4 Days||0
10693418|NCT02509117|11857662|FG003|NOT COMPLETED|Period 2 -Part A: 4 Days||0
10693419|NCT02509117|11857663|FG004|NOT COMPLETED|Period 2 -Part A: 4 Days||0
10693420|NCT02509117|11857664|FG005|NOT COMPLETED|Period 2 -Part A: 4 Days||0
10693421|NCT02509117|11857665|FG006|NOT COMPLETED|Period 2 -Part A: 4 Days||0
10693422|NCT02509117|11857666|FG007|NOT COMPLETED|Period 2 -Part A: 4 Days||0
10693423|NCT02509117|11857667|FG008|NOT COMPLETED|Period 2 -Part A: 4 Days||0
10693424|NCT02509117|11857668|FG009|NOT COMPLETED|Period 2 -Part A: 4 Days||0
10693425|NCT02509117|11857659|FG000|STARTED|Washout Period 2 (Part A: 7 Days)||2
10693426|NCT02509117|11857660|FG001|STARTED|Washout Period 2 (Part A: 7 Days)||2
10693427|NCT02509117|11857661|FG002|STARTED|Washout Period 2 (Part A: 7 Days)||2
10693428|NCT02509117|11857662|FG003|STARTED|Washout Period 2 (Part A: 7 Days)||2
10693429|NCT02509117|11857663|FG004|STARTED|Washout Period 2 (Part A: 7 Days)||0
10693430|NCT02509117|11857664|FG005|STARTED|Washout Period 2 (Part A: 7 Days)||0
10693431|NCT02509117|11857665|FG006|STARTED|Washout Period 2 (Part A: 7 Days)||0
10693432|NCT02509117|11857666|FG007|STARTED|Washout Period 2 (Part A: 7 Days)||0
10693433|NCT02509117|11857667|FG008|STARTED|Washout Period 2 (Part A: 7 Days)||0
10693434|NCT02509117|11857668|FG009|STARTED|Washout Period 2 (Part A: 7 Days)||0
10693435|NCT02509117|11857659|FG000|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
10693436|NCT02509117|11857660|FG001|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
10693437|NCT02509117|11857661|FG002|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
10693438|NCT02509117|11857662|FG003|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
10693439|NCT02509117|11857663|FG004|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
10693440|NCT02509117|11857664|FG005|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
10693441|NCT02509117|11857665|FG006|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
10693442|NCT02509117|11857666|FG007|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
10693443|NCT02509117|11857667|FG008|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
10693444|NCT02509117|11857668|FG009|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
10693445|NCT02509117|11857659|FG000|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
10693446|NCT02509117|11857660|FG001|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
10693447|NCT02509117|11857661|FG002|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
10693448|NCT02509117|11857662|FG003|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
10693449|NCT02509117|11857663|FG004|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
10693450|NCT02509117|11857664|FG005|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
10693451|NCT02509117|11857665|FG006|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
10693452|NCT02509117|11857666|FG007|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
10693453|NCT02509117|11857667|FG008|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
10693454|NCT02509117|11857668|FG009|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
10693455|NCT02509117|11857659|FG000|STARTED|Period 3 -Part A: 4 Days||2
10693456|NCT02509117|11857660|FG001|STARTED|Period 3 -Part A: 4 Days||2
10693457|NCT02509117|11857661|FG002|STARTED|Period 3 -Part A: 4 Days||2
10693458|NCT02509117|11857662|FG003|STARTED|Period 3 -Part A: 4 Days||2
10693459|NCT02509117|11857663|FG004|STARTED|Period 3 -Part A: 4 Days||0
10693460|NCT02509117|11857664|FG005|STARTED|Period 3 -Part A: 4 Days||0
10693461|NCT02509117|11857665|FG006|STARTED|Period 3 -Part A: 4 Days||0
10693462|NCT02509117|11857666|FG007|STARTED|Period 3 -Part A: 4 Days||0
10693463|NCT02509117|11857667|FG008|STARTED|Period 3 -Part A: 4 Days||0
10693464|NCT02509117|11857668|FG009|STARTED|Period 3 -Part A: 4 Days||0
10693465|NCT02509117|11857659|FG000|COMPLETED|Period 3 -Part A: 4 Days||2
10693466|NCT02509117|11857660|FG001|COMPLETED|Period 3 -Part A: 4 Days||2
10693467|NCT02509117|11857661|FG002|COMPLETED|Period 3 -Part A: 4 Days||2
10693468|NCT02509117|11857662|FG003|COMPLETED|Period 3 -Part A: 4 Days||2
10693469|NCT02509117|11857663|FG004|COMPLETED|Period 3 -Part A: 4 Days||0
10693470|NCT02509117|11857664|FG005|COMPLETED|Period 3 -Part A: 4 Days||0
10693471|NCT02509117|11857665|FG006|COMPLETED|Period 3 -Part A: 4 Days||0
10693472|NCT02509117|11857666|FG007|COMPLETED|Period 3 -Part A: 4 Days||0
10693473|NCT02509117|11857667|FG008|COMPLETED|Period 3 -Part A: 4 Days||0
10693474|NCT02509117|11857668|FG009|COMPLETED|Period 3 -Part A: 4 Days||0
10693475|NCT02509117|11857659|FG000|NOT COMPLETED|Period 3 -Part A: 4 Days||0
10693476|NCT02509117|11857660|FG001|NOT COMPLETED|Period 3 -Part A: 4 Days||0
10693477|NCT02509117|11857661|FG002|NOT COMPLETED|Period 3 -Part A: 4 Days||0
10693478|NCT02509117|11857662|FG003|NOT COMPLETED|Period 3 -Part A: 4 Days||0
10693479|NCT02509117|11857663|FG004|NOT COMPLETED|Period 3 -Part A: 4 Days||0
10693480|NCT02509117|11857664|FG005|NOT COMPLETED|Period 3 -Part A: 4 Days||0
10693481|NCT02509117|11857665|FG006|NOT COMPLETED|Period 3 -Part A: 4 Days||0
10693482|NCT02509117|11857666|FG007|NOT COMPLETED|Period 3 -Part A: 4 Days||0
10693483|NCT02509117|11857667|FG008|NOT COMPLETED|Period 3 -Part A: 4 Days||0
10693484|NCT02509117|11857668|FG009|NOT COMPLETED|Period 3 -Part A: 4 Days||0
10693485|NCT02509117|11857659|FG000|STARTED|Washout Period 3 (Part A: 7 Days)||2
10693486|NCT02509117|11857660|FG001|STARTED|Washout Period 3 (Part A: 7 Days)||2
10693487|NCT02509117|11857661|FG002|STARTED|Washout Period 3 (Part A: 7 Days)||2
10693488|NCT02509117|11857662|FG003|STARTED|Washout Period 3 (Part A: 7 Days)||2
10693489|NCT02509117|11857663|FG004|STARTED|Washout Period 3 (Part A: 7 Days)||0
10693490|NCT02509117|11857664|FG005|STARTED|Washout Period 3 (Part A: 7 Days)||0
10693491|NCT02509117|11857665|FG006|STARTED|Washout Period 3 (Part A: 7 Days)||0
10693492|NCT02509117|11857666|FG007|STARTED|Washout Period 3 (Part A: 7 Days)||0
10693493|NCT02509117|11857667|FG008|STARTED|Washout Period 3 (Part A: 7 Days)||0
10693494|NCT02509117|11857668|FG009|STARTED|Washout Period 3 (Part A: 7 Days)||0
10693495|NCT02509117|11857659|FG000|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
10693496|NCT02509117|11857660|FG001|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
10693497|NCT02509117|11857661|FG002|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
10693498|NCT02509117|11857662|FG003|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
10693499|NCT02509117|11857663|FG004|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
10693500|NCT02509117|11857664|FG005|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
10693501|NCT02509117|11857665|FG006|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
10693502|NCT02509117|11857666|FG007|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
10693503|NCT02509117|11857667|FG008|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
10693504|NCT02509117|11857668|FG009|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
10693505|NCT02509117|11857659|FG000|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
10693506|NCT02509117|11857660|FG001|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
10693507|NCT02509117|11857661|FG002|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
10693508|NCT02509117|11857662|FG003|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
10693509|NCT02509117|11857663|FG004|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
10693510|NCT02509117|11857664|FG005|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
10693511|NCT02509117|11857665|FG006|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
10693512|NCT02509117|11857666|FG007|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
10693513|NCT02509117|11857667|FG008|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
10693514|NCT02509117|11857668|FG009|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
10693515|NCT02509117|11857659|FG000|STARTED|Period 4 -Part A: 4 Days||2
10801409|NCT04359771|11962615|FG000|COMPLETED|Overall Study|The right eye of each participant was assigned to the diode MPL group|13
10801410|NCT04359771|11962616|FG001|COMPLETED|Overall Study|The left eye of every participant was assigned to the diode MPL group|13
10801411|NCT04359771|11962615|FG000|NOT COMPLETED|Overall Study||2
10801412|NCT04359771|11962616|FG001|NOT COMPLETED|Overall Study||2
10801413|NCT04358991|11962622|FG000|STARTED|Overall Study||20
10801414|NCT04358991|11962622|FG000|COMPLETED|Overall Study||20
10801415|NCT04358991|11962622|FG000|NOT COMPLETED|Overall Study||0
10801416|NCT04358081|11962629|FG000|STARTED|Treatment Phase of Study||7
10801417|NCT04358081|11962630|FG001|STARTED|Treatment Phase of Study||7
10801418|NCT04358081|11962631|FG002|STARTED|Treatment Phase of Study||5
10801419|NCT04358081|11962629|FG000|COMPLETED|Treatment Phase of Study||3
10693516|NCT02509117|11857660|FG001|STARTED|Period 4 -Part A: 4 Days||2
10693517|NCT02509117|11857661|FG002|STARTED|Period 4 -Part A: 4 Days||2
10693518|NCT02509117|11857662|FG003|STARTED|Period 4 -Part A: 4 Days||2
10693519|NCT02509117|11857663|FG004|STARTED|Period 4 -Part A: 4 Days||0
10693520|NCT02509117|11857664|FG005|STARTED|Period 4 -Part A: 4 Days||0
10693521|NCT02509117|11857665|FG006|STARTED|Period 4 -Part A: 4 Days||0
10693522|NCT02509117|11857666|FG007|STARTED|Period 4 -Part A: 4 Days||0
10693523|NCT02509117|11857667|FG008|STARTED|Period 4 -Part A: 4 Days||0
10693524|NCT02509117|11857668|FG009|STARTED|Period 4 -Part A: 4 Days||0
10693525|NCT02509117|11857659|FG000|COMPLETED|Period 4 -Part A: 4 Days||2
10693526|NCT02509117|11857660|FG001|COMPLETED|Period 4 -Part A: 4 Days||2
10693527|NCT02509117|11857661|FG002|COMPLETED|Period 4 -Part A: 4 Days||2
10693528|NCT02509117|11857662|FG003|COMPLETED|Period 4 -Part A: 4 Days||2
10693529|NCT02509117|11857663|FG004|COMPLETED|Period 4 -Part A: 4 Days||0
10693530|NCT02509117|11857664|FG005|COMPLETED|Period 4 -Part A: 4 Days||0
10693531|NCT02509117|11857665|FG006|COMPLETED|Period 4 -Part A: 4 Days||0
10693532|NCT02509117|11857666|FG007|COMPLETED|Period 4 -Part A: 4 Days||0
10693533|NCT02509117|11857667|FG008|COMPLETED|Period 4 -Part A: 4 Days||0
10693534|NCT02509117|11857668|FG009|COMPLETED|Period 4 -Part A: 4 Days||0
10693535|NCT02509117|11857659|FG000|NOT COMPLETED|Period 4 -Part A: 4 Days||0
10693536|NCT02509117|11857660|FG001|NOT COMPLETED|Period 4 -Part A: 4 Days||0
10693537|NCT02509117|11857661|FG002|NOT COMPLETED|Period 4 -Part A: 4 Days||0
10693538|NCT02509117|11857662|FG003|NOT COMPLETED|Period 4 -Part A: 4 Days||0
10693539|NCT02509117|11857663|FG004|NOT COMPLETED|Period 4 -Part A: 4 Days||0
10693540|NCT02509117|11857664|FG005|NOT COMPLETED|Period 4 -Part A: 4 Days||0
10693541|NCT02509117|11857665|FG006|NOT COMPLETED|Period 4 -Part A: 4 Days||0
10693542|NCT02509117|11857666|FG007|NOT COMPLETED|Period 4 -Part A: 4 Days||0
10693543|NCT02509117|11857667|FG008|NOT COMPLETED|Period 4 -Part A: 4 Days||0
10693544|NCT02509117|11857668|FG009|NOT COMPLETED|Period 4 -Part A: 4 Days||0
10693545|NCT02509156|11857708|FG000|STARTED|Open-Label Lead-In Phase||6
10693546|NCT02509156|11857709|FG001|STARTED|Open-Label Lead-In Phase||0
10693547|NCT02509156|11857708|FG000|COMPLETED|Open-Label Lead-In Phase||6
10693548|NCT02509156|11857709|FG001|COMPLETED|Open-Label Lead-In Phase||0
10693549|NCT02509156|11857708|FG000|NOT COMPLETED|Open-Label Lead-In Phase||0
10693550|NCT02509156|11857709|FG001|NOT COMPLETED|Open-Label Lead-In Phase||0
10693551|NCT02509156|11857708|FG000|STARTED|Randomized Phase|Includes randomized participants only|14
10693552|NCT02509156|11857709|FG001|STARTED|Randomized Phase||17
10693553|NCT02509156|11857708|FG000|COMPLETED|Randomized Phase||12
10693554|NCT02509156|11857709|FG001|COMPLETED|Randomized Phase||16
10693555|NCT02509156|11857708|FG000|NOT COMPLETED|Randomized Phase||2
10693556|NCT02509156|11857709|FG001|NOT COMPLETED|Randomized Phase||1
10693557|NCT02509481|11857717|FG000|STARTED|Overall Study||1265
10693558|NCT02509481|11857718|FG001|STARTED|Overall Study||1447
10693559|NCT02509481|11857717|FG000|COMPLETED|Overall Study||1265
10693560|NCT02509481|11857718|FG001|COMPLETED|Overall Study||1447
10693561|NCT02509481|11857717|FG000|NOT COMPLETED|Overall Study||0
10693562|NCT02509481|11857718|FG001|NOT COMPLETED|Overall Study||0
10693563|NCT02509585|11857724|FG000|STARTED|Overall Study||18
10693564|NCT02509585|11857724|FG000|COMPLETED|Overall Study||18
10693565|NCT02509585|11857724|FG000|NOT COMPLETED|Overall Study||0
10693566|NCT02509624|11857733|FG000|STARTED|Overall Study||10
10693567|NCT02509624|11857734|FG001|STARTED|Overall Study||10
10693568|NCT02509624|11857735|FG002|STARTED|Overall Study||10
10693569|NCT02509624|11857736|FG003|STARTED|Overall Study||22
10693570|NCT02509624|11857733|FG000|COMPLETED|Overall Study||10
10693571|NCT02509624|11857734|FG001|COMPLETED|Overall Study||10
10693572|NCT02509624|11857735|FG002|COMPLETED|Overall Study||10
10693573|NCT02509624|11857736|FG003|COMPLETED|Overall Study||22
10693574|NCT02509624|11857733|FG000|NOT COMPLETED|Overall Study||0
10693575|NCT02509624|11857734|FG001|NOT COMPLETED|Overall Study||0
10693576|NCT02509624|11857735|FG002|NOT COMPLETED|Overall Study||0
10693577|NCT02509624|11857736|FG003|NOT COMPLETED|Overall Study||0
10693578|NCT02509767|11857751|FG000|STARTED|Overall Study||201
10693579|NCT02509767|11857752|FG001|STARTED|Overall Study||200
10693580|NCT02509767|11857751|FG000|COMPLETED|Overall Study||157
10693581|NCT02509767|11857752|FG001|COMPLETED|Overall Study||159
10693582|NCT02509767|11857751|FG000|NOT COMPLETED|Overall Study||44
10693583|NCT02509767|11857752|FG001|NOT COMPLETED|Overall Study||41
10693584|NCT02509936|11857763|FG000|STARTED|Overall Study||163
10693585|NCT02509936|11857764|FG001|STARTED|Overall Study||161
10693586|NCT02509936|11857763|FG000|COMPLETED|Overall Study||151
10693587|NCT02509936|11857764|FG001|COMPLETED|Overall Study||145
10693588|NCT02509936|11857763|FG000|NOT COMPLETED|Overall Study||12
10693589|NCT02509936|11857764|FG001|NOT COMPLETED|Overall Study||16
10693590|NCT02510001|11857778|FG000|STARTED|Overall Study||6
10693591|NCT02510001|11857779|FG001|STARTED|Overall Study||5
10693592|NCT02510001|11857780|FG002|STARTED|Overall Study||6
10693593|NCT02510001|11857781|FG003|STARTED|Overall Study||8
10693594|NCT02510001|11857782|FG004|STARTED|Overall Study||8
10693595|NCT02510001|11857783|FG005|STARTED|Overall Study||7
10693596|NCT02510001|11857784|FG006|STARTED|Overall Study||5
10693597|NCT02510001|11857785|FG007|STARTED|Overall Study||37
10693598|NCT02510001|11857778|FG000|COMPLETED|Overall Study||6
10693599|NCT02510001|11857779|FG001|COMPLETED|Overall Study||5
10693600|NCT02510001|11857780|FG002|COMPLETED|Overall Study||6
10693601|NCT02510001|11857781|FG003|COMPLETED|Overall Study||6
10693602|NCT02510001|11857782|FG004|COMPLETED|Overall Study||4
10693603|NCT02510001|11857783|FG005|COMPLETED|Overall Study||5
10693604|NCT02510001|11857784|FG006|COMPLETED|Overall Study||3
10693605|NCT02510001|11857785|FG007|COMPLETED|Overall Study||30
10693606|NCT02510001|11857778|FG000|NOT COMPLETED|Overall Study||0
10693607|NCT02510001|11857779|FG001|NOT COMPLETED|Overall Study||0
10693608|NCT02510001|11857780|FG002|NOT COMPLETED|Overall Study||0
10693609|NCT02510001|11857781|FG003|NOT COMPLETED|Overall Study||2
10693610|NCT02510001|11857782|FG004|NOT COMPLETED|Overall Study||4
10693611|NCT02510001|11857783|FG005|NOT COMPLETED|Overall Study||2
10693612|NCT02510001|11857784|FG006|NOT COMPLETED|Overall Study||2
10693613|NCT02510001|11857785|FG007|NOT COMPLETED|Overall Study||7
10693614|NCT02510014|11857823|FG000|STARTED|Run-In Period (Days -14 to Day -1)||508
10693615|NCT02510014|11857824|FG001|STARTED|Run-In Period (Days -14 to Day -1)||267
10693616|NCT02510014|11857823|FG000|COMPLETED|Run-In Period (Days -14 to Day -1)||412
10693617|NCT02510014|11857824|FG001|COMPLETED|Run-In Period (Days -14 to Day -1)||257
10693618|NCT02510014|11857823|FG000|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||96
10693619|NCT02510014|11857824|FG001|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||10
10693620|NCT02510014|11857823|FG000|STARTED|Treatment Period||412
10693621|NCT02510014|11857824|FG001|STARTED|Treatment Period||257
10693622|NCT02510014|11857823|FG000|COMPLETED|Treatment Period||206
10693623|NCT02510014|11857824|FG001|COMPLETED|Treatment Period||200
10693624|NCT02510014|11857823|FG000|NOT COMPLETED|Treatment Period||206
10693625|NCT02510014|11857824|FG001|NOT COMPLETED|Treatment Period||57
10693626|NCT02510144|11857832|FG000|STARTED|Overall Study||39
10693627|NCT02510144|11857833|FG001|STARTED|Overall Study||41
10693628|NCT02510144|11857832|FG000|COMPLETED|Overall Study||39
10693629|NCT02510144|11857833|FG001|COMPLETED|Overall Study||41
10693630|NCT02510144|11857832|FG000|NOT COMPLETED|Overall Study||0
10693631|NCT02510144|11857833|FG001|NOT COMPLETED|Overall Study||0
10693632|NCT02510664|11857842|FG000|STARTED|Overall Study||84
10693633|NCT02510664|11857843|FG001|STARTED|Overall Study||84
10693634|NCT02510664|11857844|FG002|STARTED|Overall Study||4
10693635|NCT02510664|11857842|FG000|COMPLETED|Overall Study||64
10693636|NCT02510664|11857843|FG001|COMPLETED|Overall Study||64
10693637|NCT02510664|11857844|FG002|COMPLETED|Overall Study||4
10693638|NCT02510664|11857842|FG000|NOT COMPLETED|Overall Study||20
10693639|NCT02510664|11857843|FG001|NOT COMPLETED|Overall Study||20
10693640|NCT02510664|11857844|FG002|NOT COMPLETED|Overall Study||0
10693641|NCT02510794|11857861|FG000|STARTED|Overall Study||59
10693642|NCT02510794|11857862|FG001|STARTED|Overall Study||62
10693643|NCT02510794|11857863|FG002|STARTED|Overall Study||63
10693644|NCT02510794|11857864|FG003|STARTED|Overall Study||41
10693645|NCT02510794|11857861|FG000|COMPLETED|Overall Study||51
10693646|NCT02510794|11857862|FG001|COMPLETED|Overall Study||56
10693647|NCT02510794|11857863|FG002|COMPLETED|Overall Study||56
10693648|NCT02510794|11857864|FG003|COMPLETED|Overall Study||36
10693649|NCT02510794|11857861|FG000|NOT COMPLETED|Overall Study||8
10693650|NCT02510794|11857862|FG001|NOT COMPLETED|Overall Study||6
10693651|NCT02510794|11857863|FG002|NOT COMPLETED|Overall Study||7
10693652|NCT02510794|11857864|FG003|NOT COMPLETED|Overall Study||5
10693653|NCT02510820|11857876|FG000|STARTED|First Intervention (4 Weeks)||21
10693654|NCT02510820|11857877|FG001|STARTED|First Intervention (4 Weeks)||27
10693655|NCT02510820|11857876|FG000|COMPLETED|First Intervention (4 Weeks)||21
10693656|NCT02510820|11857877|FG001|COMPLETED|First Intervention (4 Weeks)||26
10693657|NCT02510820|11857876|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
10693658|NCT02510820|11857877|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1
10693659|NCT02510820|11857876|FG000|STARTED|Washout (1 Week)||21
10693660|NCT02510820|11857877|FG001|STARTED|Washout (1 Week)||26
10693661|NCT02510820|11857876|FG000|COMPLETED|Washout (1 Week)||21
10693662|NCT02510820|11857877|FG001|COMPLETED|Washout (1 Week)||26
10693663|NCT02510820|11857876|FG000|NOT COMPLETED|Washout (1 Week)||0
10693664|NCT02510820|11857877|FG001|NOT COMPLETED|Washout (1 Week)||0
10693665|NCT02510820|11857876|FG000|STARTED|Second Intervention (4 Weeks)||21
10693666|NCT02510820|11857877|FG001|STARTED|Second Intervention (4 Weeks)||26
10693667|NCT02510820|11857876|FG000|COMPLETED|Second Intervention (4 Weeks)||20
10693668|NCT02510820|11857877|FG001|COMPLETED|Second Intervention (4 Weeks)||26
10693669|NCT02510820|11857876|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1
10693670|NCT02510820|11857877|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
10693671|NCT02511184|11857886|FG000|STARTED|Overall Study||2
10693672|NCT02511184|11857887|FG001|STARTED|Overall Study||7
10693673|NCT02511184|11857886|FG000|COMPLETED|Overall Study||0
10693674|NCT02511184|11857887|FG001|COMPLETED|Overall Study||0
10693675|NCT02511184|11857886|FG000|NOT COMPLETED|Overall Study||2
10693676|NCT02511184|11857887|FG001|NOT COMPLETED|Overall Study||7
10693677|NCT02511236|11857896|FG000|STARTED|Overall Study||165
10693678|NCT02511236|11857897|FG001|STARTED|Overall Study||191
10693679|NCT02511236|11857896|FG000|COMPLETED|Overall Study||125
10693680|NCT02511236|11857897|FG001|COMPLETED|Overall Study||146
10693681|NCT02511236|11857896|FG000|NOT COMPLETED|Overall Study||40
10693682|NCT02511236|11857897|FG001|NOT COMPLETED|Overall Study||45
10693683|NCT02511379|11857903|FG000|STARTED|Overall Study||14
10693684|NCT02511379|11857903|FG000|COMPLETED|Overall Study||14
10693685|NCT02511379|11857903|FG000|NOT COMPLETED|Overall Study||0
10693686|NCT02511431|11857913|FG000|STARTED|Treatment||4
10693687|NCT02511431|11857914|FG001|STARTED|Treatment||4
10693688|NCT02511431|11857915|FG002|STARTED|Treatment||4
10693689|NCT02511431|11857916|FG003|STARTED|Treatment||3
10693690|NCT02511431|11857917|FG004|STARTED|Treatment||3
10693691|NCT02511431|11857918|FG005|STARTED|Treatment||3
10693692|NCT02511431|11857913|FG000|COMPLETED|Treatment||4
10693693|NCT02511431|11857914|FG001|COMPLETED|Treatment||4
10693694|NCT02511431|11857915|FG002|COMPLETED|Treatment||3
10693695|NCT02511431|11857916|FG003|COMPLETED|Treatment||3
10693696|NCT02511431|11857917|FG004|COMPLETED|Treatment||3
10693697|NCT02511431|11857918|FG005|COMPLETED|Treatment||2
10693698|NCT02511431|11857913|FG000|NOT COMPLETED|Treatment||0
10693699|NCT02511431|11857914|FG001|NOT COMPLETED|Treatment||0
10693700|NCT02511431|11857915|FG002|NOT COMPLETED|Treatment||1
10693701|NCT02511431|11857916|FG003|NOT COMPLETED|Treatment||0
10693702|NCT02511431|11857917|FG004|NOT COMPLETED|Treatment||0
10693703|NCT02511431|11857918|FG005|NOT COMPLETED|Treatment||1
10693704|NCT02511431|11857913|FG000|STARTED|Post-treatment Follow-up||4
10693705|NCT02511431|11857914|FG001|STARTED|Post-treatment Follow-up||4
10693706|NCT02511431|11857915|FG002|STARTED|Post-treatment Follow-up||3
10693707|NCT02511431|11857916|FG003|STARTED|Post-treatment Follow-up||3
10693708|NCT02511431|11857917|FG004|STARTED|Post-treatment Follow-up||3
10693709|NCT02511431|11857918|FG005|STARTED|Post-treatment Follow-up||2
10693710|NCT02511431|11857913|FG000|COMPLETED|Post-treatment Follow-up||4
10693711|NCT02511431|11857914|FG001|COMPLETED|Post-treatment Follow-up||4
10693712|NCT02511431|11857915|FG002|COMPLETED|Post-treatment Follow-up||3
10693713|NCT02511431|11857916|FG003|COMPLETED|Post-treatment Follow-up||3
10693714|NCT02511431|11857917|FG004|COMPLETED|Post-treatment Follow-up||3
10693715|NCT02511431|11857918|FG005|COMPLETED|Post-treatment Follow-up||2
10693716|NCT02511431|11857913|FG000|NOT COMPLETED|Post-treatment Follow-up||0
10693717|NCT02511431|11857914|FG001|NOT COMPLETED|Post-treatment Follow-up||0
10693718|NCT02511431|11857915|FG002|NOT COMPLETED|Post-treatment Follow-up||0
10693719|NCT02511431|11857916|FG003|NOT COMPLETED|Post-treatment Follow-up||0
10693720|NCT02511431|11857917|FG004|NOT COMPLETED|Post-treatment Follow-up||0
10693721|NCT02511431|11857918|FG005|NOT COMPLETED|Post-treatment Follow-up||0
10693722|NCT02511535|11857936|FG000|STARTED|Overall Study||49
10693723|NCT02511535|11857937|FG001|STARTED|Overall Study||21
10693724|NCT02511535|11857938|FG002|STARTED|Overall Study||49
10693725|NCT02511535|11857936|FG000|COMPLETED|Overall Study||49
10693726|NCT02511535|11857937|FG001|COMPLETED|Overall Study||21
10693727|NCT02511535|11857938|FG002|COMPLETED|Overall Study||49
10693728|NCT02511535|11857936|FG000|NOT COMPLETED|Overall Study||0
10693729|NCT02511535|11857937|FG001|NOT COMPLETED|Overall Study||0
10693730|NCT02511535|11857938|FG002|NOT COMPLETED|Overall Study||0
10693731|NCT02511561|11857949|FG000|STARTED|Overall Study||25
10693732|NCT02511561|11857950|FG001|STARTED|Overall Study||25
10693733|NCT02511561|11857951|FG002|STARTED|Overall Study||25
10693734|NCT02511561|11857949|FG000|COMPLETED|Overall Study||25
10693735|NCT02511561|11857950|FG001|COMPLETED|Overall Study||25
10693736|NCT02511561|11857951|FG002|COMPLETED|Overall Study||25
10693737|NCT02511561|11857949|FG000|NOT COMPLETED|Overall Study||0
10693738|NCT02511561|11857950|FG001|NOT COMPLETED|Overall Study||0
10693739|NCT02511561|11857951|FG002|NOT COMPLETED|Overall Study||0
10693740|NCT02511587|11857962|FG000|STARTED|Overall Study||58
10693741|NCT02511587|11857963|FG001|STARTED|Overall Study||58
10693742|NCT02511587|11857962|FG000|COMPLETED|Overall Study||58
10693743|NCT02511587|11857963|FG001|COMPLETED|Overall Study||58
10693744|NCT02511587|11857962|FG000|NOT COMPLETED|Overall Study||0
10693745|NCT02511587|11857963|FG001|NOT COMPLETED|Overall Study||0
10693746|NCT02511678|11857969|FG000|STARTED|Overall Study||73
10693747|NCT02511678|11857969|FG000|Intent-to-Treat (ITT) Population|Overall Study|Participants for whom cryoablation via Galil Medical cryoablation system was attempted or performed.|66
10693748|NCT02511678|11857969|FG000|Participants Discontinued Pre-Treatment|Overall Study||7
10693749|NCT02511678|11857969|FG000|Safety Population|Overall Study|Participants for whom received the complete study cryoablation procedure.|65
10693750|NCT02511678|11857969|FG000|COMPLETED|Overall Study||37
10693751|NCT02511678|11857969|FG000|NOT COMPLETED|Overall Study||36
10693752|NCT02511717|11857976|FG000|STARTED|Overall Study||10
10693753|NCT02511717|11857977|FG001|STARTED|Overall Study||10
10693754|NCT02511717|11857976|FG000|COMPLETED|Overall Study||8
10693755|NCT02511717|11857977|FG001|COMPLETED|Overall Study||10
10693756|NCT02511717|11857976|FG000|NOT COMPLETED|Overall Study||2
10693757|NCT02511717|11857977|FG001|NOT COMPLETED|Overall Study||0
10693758|NCT02511730|11857983|FG000|STARTED|First Reading Session||50
10693759|NCT02511730|11857984|FG001|STARTED|First Reading Session||50
10693760|NCT02511730|11857983|FG000|COMPLETED|First Reading Session||50
10693761|NCT02511730|11857984|FG001|COMPLETED|First Reading Session||50
10693762|NCT02511730|11857983|FG000|NOT COMPLETED|First Reading Session||0
10693763|NCT02511730|11857984|FG001|NOT COMPLETED|First Reading Session||0
10693764|NCT02511730|11857983|FG000|STARTED|4 Week Memory Washout Period||50
10693765|NCT02511730|11857984|FG001|STARTED|4 Week Memory Washout Period||50
10693766|NCT02511730|11857983|FG000|COMPLETED|4 Week Memory Washout Period||50
10693767|NCT02511730|11857984|FG001|COMPLETED|4 Week Memory Washout Period||50
10693768|NCT02511730|11857983|FG000|NOT COMPLETED|4 Week Memory Washout Period||0
10693769|NCT02511730|11857984|FG001|NOT COMPLETED|4 Week Memory Washout Period||0
10693770|NCT02511730|11857983|FG000|STARTED|Session Reading Session||50
10693771|NCT02511730|11857984|FG001|STARTED|Session Reading Session||50
10693772|NCT02511730|11857983|FG000|COMPLETED|Session Reading Session||50
10693773|NCT02511730|11857984|FG001|COMPLETED|Session Reading Session||50
10693774|NCT02511730|11857983|FG000|NOT COMPLETED|Session Reading Session||0
10693775|NCT02511730|11857984|FG001|NOT COMPLETED|Session Reading Session||0
10693776|NCT02511782|11857993|FG000|STARTED|Overall Study||51
10693777|NCT02511782|11857994|FG001|STARTED|Overall Study||2
10693778|NCT02511782|11857995|FG002|STARTED|Overall Study||10
10693779|NCT02511782|11857993|FG000|COMPLETED|Overall Study||50
10693780|NCT02511782|11857994|FG001|COMPLETED|Overall Study||2
10693781|NCT02511782|11857995|FG002|COMPLETED|Overall Study||10
10693782|NCT02511782|11857993|FG000|NOT COMPLETED|Overall Study||1
10693783|NCT02511782|11857994|FG001|NOT COMPLETED|Overall Study||0
10693784|NCT02511782|11857995|FG002|NOT COMPLETED|Overall Study||0
10693785|NCT02512042|11858005|FG000|STARTED|Overall Study||495
10693786|NCT02512042|11858006|FG001|STARTED|Overall Study||478
10693787|NCT02512042|11858005|FG000|COMPLETED|Overall Study||472
10693788|NCT02512042|11858006|FG001|COMPLETED|Overall Study||453
10693789|NCT02512042|11858005|FG000|NOT COMPLETED|Overall Study||23
10693790|NCT02512042|11858006|FG001|NOT COMPLETED|Overall Study||25
10693791|NCT02512068|11858014|FG000|STARTED|Overall Study||55
10693792|NCT02512068|11858015|FG001|STARTED|Overall Study||52
10693793|NCT02512068|11858014|FG000|COMPLETED|Overall Study||43
10693794|NCT02512068|11858015|FG001|COMPLETED|Overall Study||39
10693795|NCT02512068|11858014|FG000|NOT COMPLETED|Overall Study||12
10693796|NCT02512068|11858015|FG001|NOT COMPLETED|Overall Study||13
10693797|NCT02512094|11858021|FG000|STARTED|Overall Study||53
10693798|NCT02512094|11858021|FG000|COMPLETED|Overall Study||53
10693799|NCT02512094|11858021|FG000|NOT COMPLETED|Overall Study||0
10693800|NCT02512224|11858027|FG000|STARTED|Overall Study||2912
10693801|NCT02512224|11858028|FG001|STARTED|Overall Study||2912
10693802|NCT02512224|11858027|FG000|COMPLETED|Overall Study||2912
10693803|NCT02512224|11858028|FG001|COMPLETED|Overall Study||2912
10693804|NCT02512224|11858027|FG000|NOT COMPLETED|Overall Study||0
10693805|NCT02512224|11858028|FG001|NOT COMPLETED|Overall Study||0
10693806|NCT02512276|11858036|FG000|STARTED|Overall Study||2038
10693807|NCT02512276|11858037|FG001|STARTED|Overall Study||2040
10693808|NCT02512276|11858036|FG000|COMPLETED|Overall Study||2030
10693809|NCT02512276|11858037|FG001|COMPLETED|Overall Study||2029
10693810|NCT02512276|11858036|FG000|NOT COMPLETED|Overall Study||8
10693811|NCT02512276|11858037|FG001|NOT COMPLETED|Overall Study||11
10693812|NCT02512302|11858043|FG000|STARTED|Period 1||3
10693813|NCT02512302|11858044|FG001|STARTED|Period 1||3
10693814|NCT02512302|11858045|FG002|STARTED|Period 1||4
10693815|NCT02512302|11858046|FG003|STARTED|Period 1||3
10693816|NCT02512302|11858047|FG004|STARTED|Period 1||3
10693817|NCT02512302|11858048|FG005|STARTED|Period 1||3
10693818|NCT02512302|11858049|FG006|STARTED|Period 1||2
10693819|NCT02512302|11858050|FG007|STARTED|Period 1||3
10693820|NCT02512302|11858051|FG008|STARTED|Period 1||3
10693821|NCT02512302|11858052|FG009|STARTED|Period 1||3
10693822|NCT02512302|11858043|FG000|COMPLETED|Period 1||3
10693823|NCT02512302|11858044|FG001|COMPLETED|Period 1||2
10693824|NCT02512302|11858045|FG002|COMPLETED|Period 1||4
10693825|NCT02512302|11858046|FG003|COMPLETED|Period 1||3
10693826|NCT02512302|11858047|FG004|COMPLETED|Period 1||3
10693827|NCT02512302|11858048|FG005|COMPLETED|Period 1||3
10693828|NCT02512302|11858049|FG006|COMPLETED|Period 1||2
10693829|NCT02512302|11858050|FG007|COMPLETED|Period 1||3
10693830|NCT02512302|11858051|FG008|COMPLETED|Period 1||3
10693831|NCT02512302|11858052|FG009|COMPLETED|Period 1||3
10693832|NCT02512302|11858043|FG000|NOT COMPLETED|Period 1||0
10693833|NCT02512302|11858044|FG001|NOT COMPLETED|Period 1||1
10693834|NCT02512302|11858045|FG002|NOT COMPLETED|Period 1||0
10693835|NCT02512302|11858046|FG003|NOT COMPLETED|Period 1||0
10693836|NCT02512302|11858047|FG004|NOT COMPLETED|Period 1||0
10693837|NCT02512302|11858048|FG005|NOT COMPLETED|Period 1||0
10693838|NCT02512302|11858049|FG006|NOT COMPLETED|Period 1||0
10693839|NCT02512302|11858050|FG007|NOT COMPLETED|Period 1||0
10693840|NCT02512302|11858051|FG008|NOT COMPLETED|Period 1||0
10693841|NCT02512302|11858052|FG009|NOT COMPLETED|Period 1||0
10693842|NCT02512302|11858043|FG000|STARTED|Period 2||3
10693843|NCT02512302|11858044|FG001|STARTED|Period 2||2
10693844|NCT02512302|11858045|FG002|STARTED|Period 2||4
10693845|NCT02512302|11858046|FG003|STARTED|Period 2||3
10693846|NCT02512302|11858047|FG004|STARTED|Period 2||3
10693847|NCT02512302|11858048|FG005|STARTED|Period 2||3
10693848|NCT02512302|11858049|FG006|STARTED|Period 2||2
10693849|NCT02512302|11858050|FG007|STARTED|Period 2||3
10693850|NCT02512302|11858051|FG008|STARTED|Period 2||3
10693851|NCT02512302|11858052|FG009|STARTED|Period 2||3
10693852|NCT02512302|11858043|FG000|COMPLETED|Period 2||3
10693853|NCT02512302|11858044|FG001|COMPLETED|Period 2||2
10693854|NCT02512302|11858045|FG002|COMPLETED|Period 2||4
10693855|NCT02512302|11858046|FG003|COMPLETED|Period 2||3
10693856|NCT02512302|11858047|FG004|COMPLETED|Period 2||3
10693857|NCT02512302|11858048|FG005|COMPLETED|Period 2||3
10693858|NCT02512302|11858049|FG006|COMPLETED|Period 2||2
10693859|NCT02512302|11858050|FG007|COMPLETED|Period 2||3
10693860|NCT02512302|11858051|FG008|COMPLETED|Period 2||3
10693861|NCT02512302|11858052|FG009|COMPLETED|Period 2||2
10693862|NCT02512302|11858043|FG000|NOT COMPLETED|Period 2||0
10693863|NCT02512302|11858044|FG001|NOT COMPLETED|Period 2||0
10693864|NCT02512302|11858045|FG002|NOT COMPLETED|Period 2||0
10693865|NCT02512302|11858046|FG003|NOT COMPLETED|Period 2||0
10693866|NCT02512302|11858047|FG004|NOT COMPLETED|Period 2||0
10693867|NCT02512302|11858048|FG005|NOT COMPLETED|Period 2||0
10693868|NCT02512302|11858049|FG006|NOT COMPLETED|Period 2||0
10693869|NCT02512302|11858050|FG007|NOT COMPLETED|Period 2||0
10693870|NCT02512302|11858051|FG008|NOT COMPLETED|Period 2||0
10693871|NCT02512302|11858052|FG009|NOT COMPLETED|Period 2||1
10693872|NCT02512302|11858043|FG000|STARTED|Period 3||3
10693873|NCT02512302|11858044|FG001|STARTED|Period 3||2
10693874|NCT02512302|11858045|FG002|STARTED|Period 3||4
10693875|NCT02512302|11858046|FG003|STARTED|Period 3||3
10693876|NCT02512302|11858047|FG004|STARTED|Period 3||3
10693877|NCT02512302|11858048|FG005|STARTED|Period 3||3
10693878|NCT02512302|11858049|FG006|STARTED|Period 3||2
10693879|NCT02512302|11858050|FG007|STARTED|Period 3||3
10693880|NCT02512302|11858051|FG008|STARTED|Period 3||3
10693881|NCT02512302|11858052|FG009|STARTED|Period 3||2
10693882|NCT02512302|11858043|FG000|COMPLETED|Period 3||3
10693883|NCT02512302|11858044|FG001|COMPLETED|Period 3||2
10693884|NCT02512302|11858045|FG002|COMPLETED|Period 3||3
10693885|NCT02512302|11858046|FG003|COMPLETED|Period 3||3
10693886|NCT02512302|11858047|FG004|COMPLETED|Period 3||3
10693887|NCT02512302|11858048|FG005|COMPLETED|Period 3||3
10693888|NCT02512302|11858049|FG006|COMPLETED|Period 3||2
10693889|NCT02512302|11858050|FG007|COMPLETED|Period 3||3
10693890|NCT02512302|11858051|FG008|COMPLETED|Period 3||3
10693891|NCT02512302|11858052|FG009|COMPLETED|Period 3||2
10693892|NCT02512302|11858043|FG000|NOT COMPLETED|Period 3||0
10693893|NCT02512302|11858044|FG001|NOT COMPLETED|Period 3||0
10693894|NCT02512302|11858045|FG002|NOT COMPLETED|Period 3||1
10693895|NCT02512302|11858046|FG003|NOT COMPLETED|Period 3||0
10693896|NCT02512302|11858047|FG004|NOT COMPLETED|Period 3||0
10693897|NCT02512302|11858048|FG005|NOT COMPLETED|Period 3||0
10693898|NCT02512302|11858049|FG006|NOT COMPLETED|Period 3||0
10693899|NCT02512302|11858050|FG007|NOT COMPLETED|Period 3||0
10693900|NCT02512302|11858051|FG008|NOT COMPLETED|Period 3||0
10693901|NCT02512302|11858052|FG009|NOT COMPLETED|Period 3||0
10693902|NCT02512302|11858043|FG000|STARTED|Period 4||3
10693903|NCT02512302|11858044|FG001|STARTED|Period 4||2
10693904|NCT02512302|11858045|FG002|STARTED|Period 4||3
10693905|NCT02512302|11858046|FG003|STARTED|Period 4||3
10693906|NCT02512302|11858047|FG004|STARTED|Period 4||3
10693907|NCT02512302|11858048|FG005|STARTED|Period 4||3
10693908|NCT02512302|11858049|FG006|STARTED|Period 4||2
10693909|NCT02512302|11858050|FG007|STARTED|Period 4||3
10693910|NCT02512302|11858051|FG008|STARTED|Period 4||3
10693911|NCT02512302|11858052|FG009|STARTED|Period 4||2
10693912|NCT02512302|11858043|FG000|COMPLETED|Period 4||3
10693913|NCT02512302|11858044|FG001|COMPLETED|Period 4||2
10693914|NCT02512302|11858045|FG002|COMPLETED|Period 4||3
10693915|NCT02512302|11858046|FG003|COMPLETED|Period 4||3
10693916|NCT02512302|11858047|FG004|COMPLETED|Period 4||3
10693917|NCT02512302|11858048|FG005|COMPLETED|Period 4||3
10693918|NCT02512302|11858049|FG006|COMPLETED|Period 4||1
10693919|NCT02512302|11858050|FG007|COMPLETED|Period 4||3
10693920|NCT02512302|11858051|FG008|COMPLETED|Period 4||3
10693921|NCT02512302|11858052|FG009|COMPLETED|Period 4||2
10693922|NCT02512302|11858043|FG000|NOT COMPLETED|Period 4||0
10693923|NCT02512302|11858044|FG001|NOT COMPLETED|Period 4||0
10693924|NCT02512302|11858045|FG002|NOT COMPLETED|Period 4||0
10693925|NCT02512302|11858046|FG003|NOT COMPLETED|Period 4||0
10693926|NCT02512302|11858047|FG004|NOT COMPLETED|Period 4||0
10693927|NCT02512302|11858048|FG005|NOT COMPLETED|Period 4||0
10693928|NCT02512302|11858049|FG006|NOT COMPLETED|Period 4||1
10693929|NCT02512302|11858050|FG007|NOT COMPLETED|Period 4||0
10693930|NCT02512302|11858051|FG008|NOT COMPLETED|Period 4||0
10693931|NCT02512302|11858052|FG009|NOT COMPLETED|Period 4||0
10693932|NCT02512302|11858043|FG000|STARTED|Period 5||3
10693933|NCT02512302|11858044|FG001|STARTED|Period 5||2
10693934|NCT02512302|11858045|FG002|STARTED|Period 5||3
10693935|NCT02512302|11858046|FG003|STARTED|Period 5||3
10693936|NCT02512302|11858047|FG004|STARTED|Period 5||3
10693937|NCT02512302|11858048|FG005|STARTED|Period 5||3
10693938|NCT02512302|11858049|FG006|STARTED|Period 5||1
10693939|NCT02512302|11858050|FG007|STARTED|Period 5||3
10693940|NCT02512302|11858051|FG008|STARTED|Period 5||3
10693941|NCT02512302|11858052|FG009|STARTED|Period 5||2
10693942|NCT02512302|11858043|FG000|COMPLETED|Period 5||3
10693943|NCT02512302|11858044|FG001|COMPLETED|Period 5||2
10693944|NCT02512302|11858045|FG002|COMPLETED|Period 5||3
10693945|NCT02512302|11858046|FG003|COMPLETED|Period 5||3
10693946|NCT02512302|11858047|FG004|COMPLETED|Period 5||3
10693947|NCT02512302|11858048|FG005|COMPLETED|Period 5||3
10693948|NCT02512302|11858049|FG006|COMPLETED|Period 5||1
10693949|NCT02512302|11858050|FG007|COMPLETED|Period 5||3
10693950|NCT02512302|11858051|FG008|COMPLETED|Period 5||3
10693951|NCT02512302|11858052|FG009|COMPLETED|Period 5||2
10693952|NCT02512302|11858043|FG000|NOT COMPLETED|Period 5||0
10693953|NCT02512302|11858044|FG001|NOT COMPLETED|Period 5||0
10693954|NCT02512302|11858045|FG002|NOT COMPLETED|Period 5||0
10693955|NCT02512302|11858046|FG003|NOT COMPLETED|Period 5||0
10693956|NCT02512302|11858047|FG004|NOT COMPLETED|Period 5||0
10693957|NCT02512302|11858048|FG005|NOT COMPLETED|Period 5||0
10693958|NCT02512302|11858049|FG006|NOT COMPLETED|Period 5||0
10693959|NCT02512302|11858050|FG007|NOT COMPLETED|Period 5||0
10693960|NCT02512302|11858051|FG008|NOT COMPLETED|Period 5||0
10693961|NCT02512302|11858052|FG009|NOT COMPLETED|Period 5||0
10693962|NCT02512393|11858067|FG000|STARTED|Overall Study||21
10693963|NCT02512393|11858068|FG001|STARTED|Overall Study||20
10693964|NCT02512393|11858067|FG000|COMPLETED|Overall Study||20
10693965|NCT02512393|11858068|FG001|COMPLETED|Overall Study||20
10693966|NCT02512393|11858067|FG000|NOT COMPLETED|Overall Study||1
10693967|NCT02512393|11858068|FG001|NOT COMPLETED|Overall Study||0
10693968|NCT02512419|11858076|FG000|STARTED|Overall Study||24
10693969|NCT02512419|11858077|FG001|STARTED|Overall Study||24
10693970|NCT02512419|11858076|FG000|COMPLETED|Overall Study|2 participants became ineligible after enrolling therefore were not included in analysis.|22
10693971|NCT02512419|11858077|FG001|COMPLETED|Overall Study||24
10693972|NCT02512419|11858076|FG000|NOT COMPLETED|Overall Study||2
10693973|NCT02512419|11858077|FG001|NOT COMPLETED|Overall Study||0
10693974|NCT02512575|11858093|FG000|STARTED|Overall Study||6
10693975|NCT02512575|11858094|FG001|STARTED|Overall Study||6
10693976|NCT02512575|11858095|FG002|STARTED|Overall Study||6
10693977|NCT02512575|11858096|FG003|STARTED|Overall Study||6
10693978|NCT02512575|11858097|FG004|STARTED|Overall Study||6
10693979|NCT02512575|11858098|FG005|STARTED|Overall Study||6
10693980|NCT02512575|11858099|FG006|STARTED|Overall Study||6
10693981|NCT02512575|11858100|FG007|STARTED|Overall Study||6
10693982|NCT02512575|11858101|FG008|STARTED|Overall Study||6
10693983|NCT02512575|11858102|FG009|STARTED|Overall Study||18
10693984|NCT02512575|11858093|FG000|COMPLETED|Overall Study||6
10693985|NCT02512575|11858094|FG001|COMPLETED|Overall Study||6
10693986|NCT02512575|11858095|FG002|COMPLETED|Overall Study||6
10693987|NCT02512575|11858096|FG003|COMPLETED|Overall Study||6
10693988|NCT02512575|11858097|FG004|COMPLETED|Overall Study||6
10693989|NCT02512575|11858098|FG005|COMPLETED|Overall Study||6
10693990|NCT02512575|11858099|FG006|COMPLETED|Overall Study||6
10693991|NCT02512575|11858100|FG007|COMPLETED|Overall Study||6
10693992|NCT02512575|11858101|FG008|COMPLETED|Overall Study||6
10693993|NCT02512575|11858102|FG009|COMPLETED|Overall Study||18
10693994|NCT02512575|11858093|FG000|NOT COMPLETED|Overall Study||0
10693995|NCT02512575|11858094|FG001|NOT COMPLETED|Overall Study||0
10693996|NCT02512575|11858095|FG002|NOT COMPLETED|Overall Study||0
10693997|NCT02512575|11858096|FG003|NOT COMPLETED|Overall Study||0
10693998|NCT02512575|11858097|FG004|NOT COMPLETED|Overall Study||0
10693999|NCT02512575|11858098|FG005|NOT COMPLETED|Overall Study||0
10694000|NCT02512575|11858099|FG006|NOT COMPLETED|Overall Study||0
10694001|NCT02512575|11858100|FG007|NOT COMPLETED|Overall Study||0
10694002|NCT02512575|11858101|FG008|NOT COMPLETED|Overall Study||0
10694003|NCT02512575|11858102|FG009|NOT COMPLETED|Overall Study||0
10694004|NCT02512679|11858124|FG000|STARTED|Overall Study||20
10694005|NCT02512679|11858125|FG001|STARTED|Overall Study||0
10694006|NCT02512679|11858124|FG000|COMPLETED|Overall Study||20
10694007|NCT02512679|11858125|FG001|COMPLETED|Overall Study||0
10694008|NCT02512679|11858124|FG000|NOT COMPLETED|Overall Study||0
10694009|NCT02512679|11858125|FG001|NOT COMPLETED|Overall Study||0
10694010|NCT02512783|11858131|FG000|STARTED|Overall Study||96
10694011|NCT02512783|11858132|FG001|STARTED|Overall Study||75
10694012|NCT02512783|11858131|FG000|COMPLETED|Overall Study||96
10694013|NCT02512783|11858132|FG001|COMPLETED|Overall Study||75
10694014|NCT02512783|11858131|FG000|NOT COMPLETED|Overall Study||0
10694015|NCT02512783|11858132|FG001|NOT COMPLETED|Overall Study||0
10694016|NCT02512809|11858141|FG000|STARTED|Overall Study||25
10694017|NCT02512809|11858141|FG000|COMPLETED|Overall Study||25
10694018|NCT02512809|11858141|FG000|NOT COMPLETED|Overall Study||0
10694019|NCT02512861|11858147|FG000|STARTED|Overall Study||44
10694020|NCT02512861|11858148|FG001|STARTED|Overall Study||49
10694021|NCT02512861|11858147|FG000|COMPLETED|Overall Study||38
10694022|NCT02512861|11858148|FG001|COMPLETED|Overall Study||40
10694023|NCT02512861|11858147|FG000|NOT COMPLETED|Overall Study||6
10694024|NCT02512861|11858148|FG001|NOT COMPLETED|Overall Study||9
10694025|NCT02512874|11858154|FG000|STARTED|Overall Study||65
10694026|NCT02512874|11858154|FG000|COMPLETED|Overall Study||63
10694027|NCT02512874|11858154|FG000|NOT COMPLETED|Overall Study||2
10694028|NCT02512900|11858160|FG000|STARTED|Overall Study||11
10694029|NCT02512900|11858161|FG001|STARTED|Overall Study||10
10694030|NCT02512900|11858160|FG000|COMPLETED|Overall Study||11
10694031|NCT02512900|11858161|FG001|COMPLETED|Overall Study||10
10694032|NCT02512900|11858160|FG000|NOT COMPLETED|Overall Study||0
10694033|NCT02512900|11858161|FG001|NOT COMPLETED|Overall Study||0
10694034|NCT02512965|11858170|FG000|STARTED|Overall Study||115
10694035|NCT02512965|11858171|FG001|STARTED|Overall Study||114
10694036|NCT02512965|11858170|FG000|COMPLETED|Overall Study||115
10694037|NCT02512965|11858171|FG001|COMPLETED|Overall Study|4 patients did not receive any dose of the assigned treatment.|110
10694038|NCT02512965|11858170|FG000|NOT COMPLETED|Overall Study||0
10694039|NCT02512965|11858171|FG001|NOT COMPLETED|Overall Study||4
10694040|NCT02513095|11858179|FG000|STARTED|Overall Study||17
10694041|NCT02513095|11858180|FG001|STARTED|Overall Study||17
10694042|NCT02513095|11858179|FG000|Treatment Phase - Up to 120 Minutes|Overall Study||17
10694043|NCT02513095|11858180|FG001|Treatment Phase - Up to 120 Minutes|Overall Study||17
10694044|NCT02513095|11858179|FG000|COMPLETED|Overall Study||17
10694045|NCT02513095|11858180|FG001|COMPLETED|Overall Study||17
10694046|NCT02513095|11858179|FG000|NOT COMPLETED|Overall Study||0
10694047|NCT02513095|11858180|FG001|NOT COMPLETED|Overall Study||0
10694048|NCT02513121|11858188|FG000|STARTED|Overall Study||20
10694049|NCT02513121|11858189|FG001|STARTED|Overall Study||20
10694050|NCT02513121|11858188|FG000|COMPLETED|Overall Study||20
10694051|NCT02513121|11858189|FG001|COMPLETED|Overall Study||20
10694052|NCT02513121|11858188|FG000|NOT COMPLETED|Overall Study||0
10694053|NCT02513121|11858189|FG001|NOT COMPLETED|Overall Study||0
10694054|NCT02513160|11858201|FG000|STARTED|Run-In Period (Days -14 to Day -1)|Enrolled|713
10694055|NCT02513160|11858202|FG001|STARTED|Run-In Period (Days -14 to Day -1)||0
10694056|NCT02513160|11858203|FG002|STARTED|Run-In Period (Days -14 to Day -1)||0
10694057|NCT02513160|11858204|FG003|STARTED|Run-In Period (Days -14 to Day -1)||0
10694058|NCT02513160|11858201|FG000|COMPLETED|Run-In Period (Days -14 to Day -1)||425
10694059|NCT02513160|11858202|FG001|COMPLETED|Run-In Period (Days -14 to Day -1)||0
10694060|NCT02513160|11858203|FG002|COMPLETED|Run-In Period (Days -14 to Day -1)||0
10694061|NCT02513160|11858204|FG003|COMPLETED|Run-In Period (Days -14 to Day -1)||0
10694062|NCT02513160|11858201|FG000|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||288
10694063|NCT02513160|11858202|FG001|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
10694064|NCT02513160|11858203|FG002|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
10694065|NCT02513160|11858204|FG003|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
10694066|NCT02513160|11858201|FG000|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|107
10694067|NCT02513160|11858202|FG001|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|108
10694068|NCT02513160|11858203|FG002|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|105
10694069|NCT02513160|11858204|FG003|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|105
10694070|NCT02513160|11858201|FG000|COMPLETED|Treatment Period (Day 0 to Week 6)||101
10694071|NCT02513160|11858202|FG001|COMPLETED|Treatment Period (Day 0 to Week 6)||104
10694072|NCT02513160|11858203|FG002|COMPLETED|Treatment Period (Day 0 to Week 6)||104
10694073|NCT02513160|11858204|FG003|COMPLETED|Treatment Period (Day 0 to Week 6)||103
10694074|NCT02513160|11858201|FG000|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||6
10694075|NCT02513160|11858202|FG001|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||4
10694076|NCT02513160|11858203|FG002|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||1
10694077|NCT02513160|11858204|FG003|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||2
10694078|NCT02513212|11858217|FG000|STARTED|Overall Study||12
10694079|NCT02513212|11858218|FG001|STARTED|Overall Study||12
10694080|NCT02513212|11858217|FG000|COMPLETED|Overall Study||11
10694081|NCT02513212|11858218|FG001|COMPLETED|Overall Study||12
10694082|NCT02513212|11858217|FG000|NOT COMPLETED|Overall Study||1
10694083|NCT02513212|11858218|FG001|NOT COMPLETED|Overall Study||0
10694084|NCT02513446|11858226|FG000|STARTED|Period 1||8
10694085|NCT02513446|11858227|FG001|STARTED|Period 1||8
10694086|NCT02513446|11858226|FG000|COMPLETED|Period 1||8
10694087|NCT02513446|11858227|FG001|COMPLETED|Period 1||8
10694088|NCT02513446|11858226|FG000|NOT COMPLETED|Period 1||0
10694089|NCT02513446|11858227|FG001|NOT COMPLETED|Period 1||0
10694090|NCT02513446|11858226|FG000|STARTED|Washout Period of 10 Days||8
10694091|NCT02513446|11858227|FG001|STARTED|Washout Period of 10 Days||8
10694092|NCT02513446|11858226|FG000|COMPLETED|Washout Period of 10 Days||8
10694093|NCT02513446|11858227|FG001|COMPLETED|Washout Period of 10 Days||8
10694094|NCT02513446|11858226|FG000|NOT COMPLETED|Washout Period of 10 Days||0
10694095|NCT02513446|11858227|FG001|NOT COMPLETED|Washout Period of 10 Days||0
10694096|NCT02513446|11858226|FG000|STARTED|Period 2||8
10694097|NCT02513446|11858227|FG001|STARTED|Period 2||8
10694098|NCT02513446|11858226|FG000|COMPLETED|Period 2||8
10694099|NCT02513446|11858227|FG001|COMPLETED|Period 2||8
10694100|NCT02513446|11858226|FG000|NOT COMPLETED|Period 2||0
10694101|NCT02513446|11858227|FG001|NOT COMPLETED|Period 2||0
10694102|NCT02513459|11858234|FG000|STARTED|Overall Study||65
10694103|NCT02513459|11858234|FG000|COMPLETED|Overall Study||44
10694104|NCT02513459|11858234|FG000|NOT COMPLETED|Overall Study||21
10694105|NCT02513498|11858243|FG000|STARTED|Overall Study||50
10694106|NCT02513498|11858243|FG000|COMPLETED|Overall Study||26
10694107|NCT02513498|11858243|FG000|NOT COMPLETED|Overall Study||24
10694108|NCT02513550|11858255|FG000|STARTED|Double Blind Treatment Period||310
10694109|NCT02513550|11858256|FG001|STARTED|Double Blind Treatment Period||306
10694110|NCT02513550|11858257|FG002|STARTED|Double Blind Treatment Period||611
10694111|NCT02513550|11858258|FG003|STARTED|Double Blind Treatment Period||9
10694112|NCT02513550|11858259|FG004|STARTED|Double Blind Treatment Period||5
10694113|NCT02513550|11858260|FG005|STARTED|Double Blind Treatment Period||16
10694114|NCT02513550|11858255|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment Period||310
10694115|NCT02513550|11858256|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment Period||306
10694116|NCT02513550|11858257|FG002|Received at Least One Dose of Study Drug|Double Blind Treatment Period||609
10694117|NCT02513550|11858258|FG003|Received at Least One Dose of Study Drug|Double Blind Treatment Period||9
10694118|NCT02513550|11858259|FG004|Received at Least One Dose of Study Drug|Double Blind Treatment Period||5
10694119|NCT02513550|11858260|FG005|Received at Least One Dose of Study Drug|Double Blind Treatment Period||16
10694120|NCT02513550|11858255|FG000|COMPLETED|Double Blind Treatment Period||274
10694121|NCT02513550|11858256|FG001|COMPLETED|Double Blind Treatment Period||268
10694122|NCT02513550|11858257|FG002|COMPLETED|Double Blind Treatment Period||537
10694123|NCT02513550|11858258|FG003|COMPLETED|Double Blind Treatment Period||9
10694124|NCT02513550|11858259|FG004|COMPLETED|Double Blind Treatment Period||4
10694125|NCT02513550|11858260|FG005|COMPLETED|Double Blind Treatment Period||15
10694126|NCT02513550|11858255|FG000|NOT COMPLETED|Double Blind Treatment Period||36
10694127|NCT02513550|11858256|FG001|NOT COMPLETED|Double Blind Treatment Period||38
10694128|NCT02513550|11858257|FG002|NOT COMPLETED|Double Blind Treatment Period||74
10694129|NCT02513550|11858258|FG003|NOT COMPLETED|Double Blind Treatment Period||0
10694130|NCT02513550|11858259|FG004|NOT COMPLETED|Double Blind Treatment Period||1
10694131|NCT02513550|11858260|FG005|NOT COMPLETED|Double Blind Treatment Period||1
10694132|NCT02513550|11858255|FG000|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|285
10694133|NCT02513550|11858256|FG001|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|283
10694134|NCT02513550|11858257|FG002|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|559
10694135|NCT02513550|11858258|FG003|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|9
10694136|NCT02513550|11858259|FG004|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|4
10694137|NCT02513550|11858260|FG005|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|15
10694138|NCT02513550|11858255|FG000|COMPLETED|Post-Treatment Follow-up Period||254
10801420|NCT04358081|11962630|FG001|COMPLETED|Treatment Phase of Study||6
10801421|NCT04358081|11962631|FG002|COMPLETED|Treatment Phase of Study||2
10694139|NCT02513550|11858256|FG001|COMPLETED|Post-Treatment Follow-up Period||244
10694140|NCT02513550|11858257|FG002|COMPLETED|Post-Treatment Follow-up Period||496
10694141|NCT02513550|11858258|FG003|COMPLETED|Post-Treatment Follow-up Period||9
10694142|NCT02513550|11858259|FG004|COMPLETED|Post-Treatment Follow-up Period||4
10694143|NCT02513550|11858260|FG005|COMPLETED|Post-Treatment Follow-up Period||15
10694144|NCT02513550|11858255|FG000|NOT COMPLETED|Post-Treatment Follow-up Period||31
10694145|NCT02513550|11858256|FG001|NOT COMPLETED|Post-Treatment Follow-up Period||39
10694146|NCT02513550|11858257|FG002|NOT COMPLETED|Post-Treatment Follow-up Period||63
10694147|NCT02513550|11858258|FG003|NOT COMPLETED|Post-Treatment Follow-up Period||0
10694148|NCT02513550|11858259|FG004|NOT COMPLETED|Post-Treatment Follow-up Period||0
10694149|NCT02513550|11858260|FG005|NOT COMPLETED|Post-Treatment Follow-up Period||0
10694150|NCT02513641|11858282|FG000|STARTED|Overall Study||8
10694151|NCT02513641|11858282|FG000|COMPLETED|Overall Study||8
10694152|NCT02513641|11858282|FG000|NOT COMPLETED|Overall Study||0
10694153|NCT02513719|11858286|FG000|STARTED|At 8 Months Clinical Follow-up||312
10694154|NCT02513719|11858286|FG000|COMPLETED|At 8 Months Clinical Follow-up||312
10694155|NCT02513719|11858286|FG000|NOT COMPLETED|At 8 Months Clinical Follow-up||0
10694156|NCT02513719|11858286|FG000|STARTED|At 1 Year Clinical Follow-up||312
10694157|NCT02513719|11858286|FG000|COMPLETED|At 1 Year Clinical Follow-up||305
10694158|NCT02513719|11858286|FG000|NOT COMPLETED|At 1 Year Clinical Follow-up||7
10694159|NCT02513719|11858286|FG000|STARTED|At 2 Years Clinical Follow-up||305
10694160|NCT02513719|11858286|FG000|COMPLETED|At 2 Years Clinical Follow-up||300
10694161|NCT02513719|11858286|FG000|NOT COMPLETED|At 2 Years Clinical Follow-up||5
10694162|NCT02513719|11858286|FG000|STARTED|At 3 Years Clinical Follow-up||300
10694163|NCT02513719|11858286|FG000|COMPLETED|At 3 Years Clinical Follow-up||289
10694164|NCT02513719|11858286|FG000|NOT COMPLETED|At 3 Years Clinical Follow-up||11
10694165|NCT02513719|11858286|FG000|STARTED|At 4 Years Clinical Follow-up||289
10694166|NCT02513719|11858286|FG000|COMPLETED|At 4 Years Clinical Follow-up||273
10694167|NCT02513719|11858286|FG000|NOT COMPLETED|At 4 Years Clinical Follow-up||16
10694168|NCT02513719|11858286|FG000|STARTED|At 5 Years Clinical Follow-up||273
10694169|NCT02513719|11858286|FG000|COMPLETED|At 5 Years Clinical Follow-up||254
10694170|NCT02513719|11858286|FG000|NOT COMPLETED|At 5 Years Clinical Follow-up||19
10694171|NCT02513732|11858290|FG000|STARTED|Overall Study||100
10694172|NCT02513732|11858290|FG000|COMPLETED|Overall Study||78
10694173|NCT02513732|11858290|FG000|NOT COMPLETED|Overall Study||22
10694174|NCT02513745|11858296|FG000|STARTED|Overall Study||42
10694175|NCT02513745|11858297|FG001|STARTED|Overall Study||42
10694176|NCT02513745|11858296|FG000|COMPLETED|Overall Study||39
10694177|NCT02513745|11858297|FG001|COMPLETED|Overall Study||39
10694178|NCT02513745|11858296|FG000|NOT COMPLETED|Overall Study||3
10694179|NCT02513745|11858297|FG001|NOT COMPLETED|Overall Study||3
10694180|NCT02513771|11858305|FG000|STARTED|Overall Study||45
10694181|NCT02513771|11858306|FG001|STARTED|Overall Study||45
10694182|NCT02513771|11858305|FG000|COMPLETED|Overall Study||43
10694183|NCT02513771|11858306|FG001|COMPLETED|Overall Study||44
10694184|NCT02513771|11858305|FG000|NOT COMPLETED|Overall Study||2
10694185|NCT02513771|11858306|FG001|NOT COMPLETED|Overall Study||1
10694186|NCT02513823|11858312|FG000|STARTED|Overall Study||27
10694187|NCT02513823|11858312|FG000|COMPLETED|Overall Study||22
10694188|NCT02513823|11858312|FG000|NOT COMPLETED|Overall Study||5
10694189|NCT02513940|11858316|FG000|STARTED|Overall Study|This was a crossover study, with a total n=14. All 14 subjects completed each phase of the study|2
10694190|NCT02513940|11858317|FG001|STARTED|Overall Study||3
10694191|NCT02513940|11858318|FG002|STARTED|Overall Study||2
10694192|NCT02513940|11858319|FG003|STARTED|Overall Study||2
10694193|NCT02513940|11858320|FG004|STARTED|Overall Study||2
10694194|NCT02513940|11858321|FG005|STARTED|Overall Study||3
10694195|NCT02513940|11858316|FG000|COMPLETED|Overall Study||2
10694196|NCT02513940|11858317|FG001|COMPLETED|Overall Study||3
10694197|NCT02513940|11858318|FG002|COMPLETED|Overall Study||2
10694198|NCT02513940|11858319|FG003|COMPLETED|Overall Study||2
10694199|NCT02513940|11858320|FG004|COMPLETED|Overall Study||2
10694200|NCT02513940|11858321|FG005|COMPLETED|Overall Study||3
10694201|NCT02513940|11858316|FG000|NOT COMPLETED|Overall Study||0
10694202|NCT02513940|11858317|FG001|NOT COMPLETED|Overall Study||0
10694203|NCT02513940|11858318|FG002|NOT COMPLETED|Overall Study||0
10694204|NCT02513940|11858319|FG003|NOT COMPLETED|Overall Study||0
10694205|NCT02513940|11858320|FG004|NOT COMPLETED|Overall Study||0
10694206|NCT02513940|11858321|FG005|NOT COMPLETED|Overall Study||0
10694207|NCT02514044|11858331|FG000|STARTED|Dexedrine+tDCS+Speech Therapy (1 Day)||10
10694208|NCT02514044|11858331|FG000|COMPLETED|Dexedrine+tDCS+Speech Therapy (1 Day)||10
10694209|NCT02514044|11858331|FG000|NOT COMPLETED|Dexedrine+tDCS+Speech Therapy (1 Day)||0
10694210|NCT02514044|11858331|FG000|STARTED|Washout (1 Week)||10
10694211|NCT02514044|11858331|FG000|COMPLETED|Washout (1 Week)||10
10694212|NCT02514044|11858331|FG000|NOT COMPLETED|Washout (1 Week)||0
10694213|NCT02514044|11858331|FG000|STARTED|Placebo+tDCS+Speech Therapy (1 Day)||10
10694214|NCT02514044|11858331|FG000|COMPLETED|Placebo+tDCS+Speech Therapy (1 Day)||10
10694215|NCT02514044|11858331|FG000|NOT COMPLETED|Placebo+tDCS+Speech Therapy (1 Day)||0
10694216|NCT02514070|11858341|FG000|STARTED|Weeks 0 to Week 6||19
10694217|NCT02514070|11858342|FG001|STARTED|Weeks 0 to Week 6||20
10694218|NCT02514070|11858341|FG000|COMPLETED|Weeks 0 to Week 6||17
10694219|NCT02514070|11858342|FG001|COMPLETED|Weeks 0 to Week 6||16
10694220|NCT02514070|11858341|FG000|NOT COMPLETED|Weeks 0 to Week 6||2
10694221|NCT02514070|11858342|FG001|NOT COMPLETED|Weeks 0 to Week 6||4
10694222|NCT02514070|11858341|FG000|STARTED|Week 6 to Week 14 - Washout Period||17
10694223|NCT02514070|11858342|FG001|STARTED|Week 6 to Week 14 - Washout Period||16
10694224|NCT02514070|11858341|FG000|COMPLETED|Week 6 to Week 14 - Washout Period||17
10694225|NCT02514070|11858342|FG001|COMPLETED|Week 6 to Week 14 - Washout Period||16
10694226|NCT02514070|11858341|FG000|NOT COMPLETED|Week 6 to Week 14 - Washout Period||0
10694227|NCT02514070|11858342|FG001|NOT COMPLETED|Week 6 to Week 14 - Washout Period||0
10694228|NCT02514070|11858341|FG000|STARTED|Week 14 to Week 20||17
10694229|NCT02514070|11858342|FG001|STARTED|Week 14 to Week 20||16
10694230|NCT02514070|11858341|FG000|COMPLETED|Week 14 to Week 20||16
10694231|NCT02514070|11858342|FG001|COMPLETED|Week 14 to Week 20||14
10694232|NCT02514070|11858341|FG000|NOT COMPLETED|Week 14 to Week 20||1
10694233|NCT02514070|11858342|FG001|NOT COMPLETED|Week 14 to Week 20||2
10694234|NCT02514122|11858354|FG000|STARTED|Overall Study||32
10694235|NCT02514122|11858355|FG001|STARTED|Overall Study||29
10694236|NCT02514122|11858354|FG000|COMPLETED|Overall Study|one participant dropped out for religious reasons; one for needle phobia|30
10694237|NCT02514122|11858355|FG001|COMPLETED|Overall Study||29
10694238|NCT02514122|11858354|FG000|NOT COMPLETED|Overall Study||2
10694239|NCT02514122|11858355|FG001|NOT COMPLETED|Overall Study||0
10694240|NCT02514174|11858361|FG000|STARTED|Overall Study||25
10694241|NCT02514174|11858361|FG000|COMPLETED|Overall Study||0
10694242|NCT02514174|11858361|FG000|NOT COMPLETED|Overall Study||25
10694243|NCT02514473|11858367|FG000|STARTED|Overall Study||101
10694244|NCT02514473|11858368|FG001|STARTED|Overall Study||103
10694245|NCT02514473|11858367|FG000|COMPLETED|Overall Study||98
10694246|NCT02514473|11858368|FG001|COMPLETED|Overall Study||98
10694247|NCT02514473|11858367|FG000|NOT COMPLETED|Overall Study||3
10694248|NCT02514473|11858368|FG001|NOT COMPLETED|Overall Study||5
10694249|NCT02514551|11858377|FG000|STARTED|Overall Study||123
10694250|NCT02514551|11858378|FG001|STARTED|Overall Study||122
10694251|NCT02514551|11858377|FG000|Received at Least One Dose of Study Drug|Overall Study||123
10694252|NCT02514551|11858378|FG001|Received at Least One Dose of Study Drug|Overall Study||120
10694253|NCT02514551|11858377|FG000|COMPLETED|Overall Study||123
10694254|NCT02514551|11858378|FG001|COMPLETED|Overall Study||119
10694255|NCT02514551|11858377|FG000|NOT COMPLETED|Overall Study||0
10694256|NCT02514551|11858378|FG001|NOT COMPLETED|Overall Study||3
10694257|NCT02514577|11858387|FG000|STARTED|Overall Study||143
10694258|NCT02514577|11858388|FG001|STARTED|Overall Study||74
10694259|NCT02514577|11858387|FG000|Intent-to-Treat (ITT) Population|Overall Study||143
10694260|NCT02514577|11858388|FG001|Intent-to-Treat (ITT) Population|Overall Study||74
10694261|NCT02514577|11858387|FG000|Safety Population|Overall Study||142
10694262|NCT02514577|11858388|FG001|Safety Population|Overall Study||72
10694263|NCT02514577|11858387|FG000|COMPLETED|Overall Study||129
10694264|NCT02514577|11858388|FG001|COMPLETED|Overall Study||61
10694265|NCT02514577|11858387|FG000|NOT COMPLETED|Overall Study||14
10694266|NCT02514577|11858388|FG001|NOT COMPLETED|Overall Study||13
10694267|NCT02514746|11858396|FG000|STARTED|Overall Study||437
10694268|NCT02514746|11858397|FG001|STARTED|Overall Study||124
10694269|NCT02514746|11858396|FG000|Valid Serology 3 Years Post Primary Dose|Overall Study||437
10694270|NCT02514746|11858397|FG001|Valid Serology 3 Years Post Primary Dose|Overall Study||123
10694271|NCT02514746|11858396|FG000|Valid Serology 4 Years Post Primary Dose|Overall Study||424
10694272|NCT02514746|11858397|FG001|Valid Serology 4 Years Post Primary Dose|Overall Study||109
10694273|NCT02514746|11858396|FG000|Received CD-JEV Booster Vaccine|Overall Study||424
10694274|NCT02514746|11858397|FG001|Received CD-JEV Booster Vaccine|Overall Study||109
10694275|NCT02514746|11858396|FG000|COMPLETED|Overall Study||415
10694276|NCT02514746|11858397|FG001|COMPLETED|Overall Study||109
10694277|NCT02514746|11858396|FG000|NOT COMPLETED|Overall Study||22
10694278|NCT02514746|11858397|FG001|NOT COMPLETED|Overall Study||15
10694279|NCT02514772|11858407|FG000|STARTED|Overall Study||53
10694280|NCT02514772|11858408|FG001|STARTED|Overall Study||54
10694281|NCT02514772|11858407|FG000|COMPLETED|Overall Study||50
10694282|NCT02514772|11858408|FG001|COMPLETED|Overall Study||52
10694283|NCT02514772|11858407|FG000|NOT COMPLETED|Overall Study||3
10694284|NCT02514772|11858408|FG001|NOT COMPLETED|Overall Study||2
10694285|NCT02514824|11858418|FG000|STARTED|Overall Study||4
10694286|NCT02514824|11858419|FG001|STARTED|Overall Study||5
10694287|NCT02514824|11858420|FG002|STARTED|Overall Study||0
10694288|NCT02514824|11858421|FG003|STARTED|Overall Study||0
10694289|NCT02514824|11858418|FG000|Evaluable for Dose-limiting Toxicity|Overall Study||3
10694290|NCT02514824|11858419|FG001|Evaluable for Dose-limiting Toxicity|Overall Study||5
10694291|NCT02514824|11858420|FG002|Evaluable for Dose-limiting Toxicity|Overall Study||0
10694292|NCT02514824|11858421|FG003|Evaluable for Dose-limiting Toxicity|Overall Study||0
10694293|NCT02514824|11858418|FG000|COMPLETED|Overall Study||3
10694294|NCT02514824|11858419|FG001|COMPLETED|Overall Study||4
10694295|NCT02514824|11858420|FG002|COMPLETED|Overall Study||0
10694296|NCT02514824|11858421|FG003|COMPLETED|Overall Study||0
10694297|NCT02514824|11858418|FG000|NOT COMPLETED|Overall Study||1
10694298|NCT02514824|11858419|FG001|NOT COMPLETED|Overall Study||1
10694299|NCT02514824|11858420|FG002|NOT COMPLETED|Overall Study||0
10694300|NCT02514824|11858421|FG003|NOT COMPLETED|Overall Study||0
10694301|NCT02514889|11858430|FG000|STARTED|Randomization/Allocation to Condition||131
10694302|NCT02514889|11858431|FG001|STARTED|Randomization/Allocation to Condition||130
10694303|NCT02514889|11858430|FG000|COMPLETED|Randomization/Allocation to Condition||111
10694304|NCT02514889|11858431|FG001|COMPLETED|Randomization/Allocation to Condition||106
10694305|NCT02514889|11858430|FG000|NOT COMPLETED|Randomization/Allocation to Condition||20
10694306|NCT02514889|11858431|FG001|NOT COMPLETED|Randomization/Allocation to Condition||24
10694307|NCT02514889|11858430|FG000|STARTED|Intervention Participation||111
10694308|NCT02514889|11858431|FG001|STARTED|Intervention Participation||106
10694309|NCT02514889|11858430|FG000|COMPLETED|Intervention Participation||102
10694310|NCT02514889|11858431|FG001|COMPLETED|Intervention Participation||98
10694311|NCT02514889|11858430|FG000|NOT COMPLETED|Intervention Participation||9
10694312|NCT02514889|11858431|FG001|NOT COMPLETED|Intervention Participation||8
10694313|NCT02514889|11858430|FG000|STARTED|Follow-up Assessment Participation||102
10694314|NCT02514889|11858431|FG001|STARTED|Follow-up Assessment Participation||98
10694315|NCT02514889|11858430|FG000|COMPLETED|Follow-up Assessment Participation||92
10694316|NCT02514889|11858431|FG001|COMPLETED|Follow-up Assessment Participation||86
10694317|NCT02514889|11858430|FG000|NOT COMPLETED|Follow-up Assessment Participation||10
10694318|NCT02514889|11858431|FG001|NOT COMPLETED|Follow-up Assessment Participation||12
10694319|NCT02515045|11858439|FG000|STARTED|Overall Study||29
10694320|NCT02515045|11858440|FG001|STARTED|Overall Study||30
10694321|NCT02515045|11858441|FG002|STARTED|Overall Study||59
10694322|NCT02515045|11858439|FG000|COMPLETED|Overall Study||29
10694323|NCT02515045|11858440|FG001|COMPLETED|Overall Study||26
10694324|NCT02515045|11858441|FG002|COMPLETED|Overall Study||55
10694325|NCT02515045|11858439|FG000|NOT COMPLETED|Overall Study||0
10694326|NCT02515045|11858440|FG001|NOT COMPLETED|Overall Study||4
10694327|NCT02515045|11858441|FG002|NOT COMPLETED|Overall Study||4
10694328|NCT02515058|11858451|FG000|STARTED|Overall Study||21
10694329|NCT02515058|11858452|FG001|STARTED|Overall Study||22
10694330|NCT02515058|11858451|FG000|COMPLETED|Overall Study||18
10694331|NCT02515058|11858452|FG001|COMPLETED|Overall Study||20
10694332|NCT02515058|11858451|FG000|NOT COMPLETED|Overall Study||3
10694333|NCT02515058|11858452|FG001|NOT COMPLETED|Overall Study||2
10694334|NCT02515097|11858460|FG000|STARTED|Overall Study||142
10694335|NCT02515097|11858461|FG001|STARTED|Overall Study||71
10694336|NCT02515097|11858460|FG000|Intent-to-Treat (ITT) Population|Overall Study||142
10694337|NCT02515097|11858461|FG001|Intent-to-Treat (ITT) Population|Overall Study||71
10694338|NCT02515097|11858460|FG000|Safety Population|Overall Study||142
10694339|NCT02515097|11858461|FG001|Safety Population|Overall Study||70
10694340|NCT02515097|11858460|FG000|COMPLETED|Overall Study||135
10694341|NCT02515097|11858461|FG001|COMPLETED|Overall Study||65
10694342|NCT02515097|11858460|FG000|NOT COMPLETED|Overall Study||7
10694343|NCT02515097|11858461|FG001|NOT COMPLETED|Overall Study||6
10694344|NCT02515253|11858469|FG000|STARTED|Overall Study||17
10694345|NCT02515253|11858470|FG001|STARTED|Overall Study||16
10694346|NCT02515253|11858469|FG000|COMPLETED|Overall Study||10
10694347|NCT02515253|11858470|FG001|COMPLETED|Overall Study||8
10694348|NCT02515253|11858469|FG000|NOT COMPLETED|Overall Study||7
10694349|NCT02515253|11858470|FG001|NOT COMPLETED|Overall Study||8
10694350|NCT02515279|11858476|FG000|STARTED|Overall Study||463
10694351|NCT02515279|11858476|FG000|COMPLETED|Overall Study||359
10694352|NCT02515279|11858476|FG000|NOT COMPLETED|Overall Study||104
10694353|NCT02515305|11858483|FG000|STARTED|Overall Study||385
10694354|NCT02515305|11858484|FG001|STARTED|Overall Study||378
10694355|NCT02515305|11858485|FG002|STARTED|Overall Study||127
10694356|NCT02515305|11858483|FG000|COMPLETED|Overall Study||356
10694357|NCT02515305|11858484|FG001|COMPLETED|Overall Study||343
10694358|NCT02515305|11858485|FG002|COMPLETED|Overall Study||113
10694359|NCT02515305|11858483|FG000|NOT COMPLETED|Overall Study||29
10694360|NCT02515305|11858484|FG001|NOT COMPLETED|Overall Study||35
10694361|NCT02515305|11858485|FG002|NOT COMPLETED|Overall Study||14
10694362|NCT02515331|11858496|FG000|STARTED|Overall Study||17
10694363|NCT02515331|11858497|FG001|STARTED|Overall Study||15
10694364|NCT02515331|11858498|FG002|STARTED|Overall Study||32
10694365|NCT02515331|11858496|FG000|Primary Pharmacodynamic Analysis Set|Overall Study||15
10694366|NCT02515331|11858497|FG001|Primary Pharmacodynamic Analysis Set|Overall Study||14
10694367|NCT02515331|11858498|FG002|Primary Pharmacodynamic Analysis Set|Overall Study||29
10694368|NCT02515331|11858496|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||17
10694369|NCT02515331|11858497|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||15
10694370|NCT02515331|11858498|FG002|Pharmacokinetic (PK) Analysis Set|Overall Study||0
10694371|NCT02515331|11858496|FG000|COMPLETED|Overall Study||15
10694372|NCT02515331|11858497|FG001|COMPLETED|Overall Study||15
10694373|NCT02515331|11858498|FG002|COMPLETED|Overall Study||28
10694374|NCT02515331|11858496|FG000|NOT COMPLETED|Overall Study||2
10694375|NCT02515331|11858497|FG001|NOT COMPLETED|Overall Study||0
10694376|NCT02515331|11858498|FG002|NOT COMPLETED|Overall Study||4
10694377|NCT02515630|11858508|FG000|STARTED|Overall Study||41
10694378|NCT02515630|11858508|FG000|COMPLETED|Overall Study||25
10694379|NCT02515630|11858508|FG000|NOT COMPLETED|Overall Study||16
10694380|NCT02515656|11858517|FG000|STARTED|Overall Study||326
10694381|NCT02515656|11858518|FG001|STARTED|Overall Study||332
10694382|NCT02515656|11858517|FG000|Full Analysis Set (FAS)|Overall Study||302
10694383|NCT02515656|11858518|FG001|Full Analysis Set (FAS)|Overall Study||309
10694384|NCT02515656|11858517|FG000|Per Protocol Set (PPS)|Overall Study||277
10694385|NCT02515656|11858518|FG001|Per Protocol Set (PPS)|Overall Study||275
10694386|NCT02515656|11858517|FG000|Safety Population|Overall Study||325
10801422|NCT04358081|11962629|FG000|NOT COMPLETED|Treatment Phase of Study||4
10801423|NCT04358081|11962630|FG001|NOT COMPLETED|Treatment Phase of Study||1
10801424|NCT04358081|11962631|FG002|NOT COMPLETED|Treatment Phase of Study||3
10801425|NCT04358081|11962629|FG000|STARTED|Study Completion Phase||7
10801426|NCT04358081|11962630|FG001|STARTED|Study Completion Phase||7
10801427|NCT04358081|11962631|FG002|STARTED|Study Completion Phase||5
10801428|NCT04358081|11962629|FG000|COMPLETED|Study Completion Phase||6
10801429|NCT04358081|11962630|FG001|COMPLETED|Study Completion Phase||7
10318926|NCT00218335|11453166|FG000|NOT COMPLETED|Overall Study||6
10694387|NCT02515656|11858518|FG001|Safety Population|Overall Study||328
10694388|NCT02515656|11858517|FG000|COMPLETED|Overall Study||270
10694389|NCT02515656|11858518|FG001|COMPLETED|Overall Study||261
10694390|NCT02515656|11858517|FG000|NOT COMPLETED|Overall Study||56
10694391|NCT02515656|11858518|FG001|NOT COMPLETED|Overall Study||71
10694392|NCT02515669|11858528|FG000|STARTED|24 Week Double-Blind Phase||11
10694393|NCT02515669|11858529|FG001|STARTED|24 Week Double-Blind Phase||7
10694394|NCT02515669|11858530|FG002|STARTED|24 Week Double-Blind Phase||6
10694395|NCT02515669|11858531|FG003|STARTED|24 Week Double-Blind Phase||19
10694396|NCT02515669|11858528|FG000|COMPLETED|24 Week Double-Blind Phase||11
10694397|NCT02515669|11858529|FG001|COMPLETED|24 Week Double-Blind Phase||7
10694398|NCT02515669|11858530|FG002|COMPLETED|24 Week Double-Blind Phase||6
10694399|NCT02515669|11858531|FG003|COMPLETED|24 Week Double-Blind Phase||19
10694400|NCT02515669|11858528|FG000|NOT COMPLETED|24 Week Double-Blind Phase||0
10694401|NCT02515669|11858529|FG001|NOT COMPLETED|24 Week Double-Blind Phase||0
10694402|NCT02515669|11858530|FG002|NOT COMPLETED|24 Week Double-Blind Phase||0
10694403|NCT02515669|11858531|FG003|NOT COMPLETED|24 Week Double-Blind Phase||0
10694404|NCT02515669|11858528|FG000|STARTED|228 Week Open-Label Phase|Double-blind (DB) placebo participants switched to RO7239361 (RO) for the open label phase.|0
10694405|NCT02515669|11858529|FG001|STARTED|228 Week Open-Label Phase|2 DB placebo participants switched to the Panel 1 RO cohort for the open-label phase.|9
10694406|NCT02515669|11858530|FG002|STARTED|228 Week Open-Label Phase|2 DB placebo participants switched to the Panel 2 RO cohort for the open-label phase.|8
10694407|NCT02515669|11858531|FG003|STARTED|228 Week Open-Label Phase|7 DB placebo participants switched to the Panel 3/Expansion RO cohort for the open-label phase.|26
10694408|NCT02515669|11858528|FG000|COMPLETED|228 Week Open-Label Phase||0
10694409|NCT02515669|11858529|FG001|COMPLETED|228 Week Open-Label Phase||0
10694410|NCT02515669|11858530|FG002|COMPLETED|228 Week Open-Label Phase||0
10694411|NCT02515669|11858531|FG003|COMPLETED|228 Week Open-Label Phase||0
10694412|NCT02515669|11858528|FG000|NOT COMPLETED|228 Week Open-Label Phase||0
10694413|NCT02515669|11858529|FG001|NOT COMPLETED|228 Week Open-Label Phase||9
10694414|NCT02515669|11858530|FG002|NOT COMPLETED|228 Week Open-Label Phase||8
10694415|NCT02515669|11858531|FG003|NOT COMPLETED|228 Week Open-Label Phase||26
10694416|NCT02515825|11858563|FG000|STARTED|Overall Study||70
10694417|NCT02515825|11858564|FG001|STARTED|Overall Study||31
10694418|NCT02515825|11858563|FG000|COMPLETED|Overall Study||70
10694419|NCT02515825|11858564|FG001|COMPLETED|Overall Study||31
10694420|NCT02515825|11858563|FG000|NOT COMPLETED|Overall Study||0
10694421|NCT02515825|11858564|FG001|NOT COMPLETED|Overall Study||0
10694422|NCT02515890|11858576|FG000|STARTED|Overall Study||7
10694423|NCT02515890|11858577|FG001|STARTED|Overall Study||4
10694424|NCT02515890|11858578|FG002|STARTED|Overall Study||5
10694425|NCT02515890|11858579|FG003|STARTED|Overall Study||8
10694426|NCT02515890|11858580|FG004|STARTED|Overall Study||8
10694427|NCT02515890|11858576|FG000|COMPLETED|Overall Study||7
10694428|NCT02515890|11858577|FG001|COMPLETED|Overall Study||4
10694429|NCT02515890|11858578|FG002|COMPLETED|Overall Study||5
10694430|NCT02515890|11858579|FG003|COMPLETED|Overall Study||8
10318927|NCT00218335|11453167|FG001|NOT COMPLETED|Overall Study||3
10694431|NCT02515890|11858580|FG004|COMPLETED|Overall Study||8
10694432|NCT02515890|11858576|FG000|NOT COMPLETED|Overall Study||0
10694433|NCT02515890|11858577|FG001|NOT COMPLETED|Overall Study||0
10801430|NCT04358081|11962631|FG002|COMPLETED|Study Completion Phase||3
10694434|NCT02515890|11858578|FG002|NOT COMPLETED|Overall Study||0
10694435|NCT02515890|11858579|FG003|NOT COMPLETED|Overall Study||0
10694436|NCT02515890|11858580|FG004|NOT COMPLETED|Overall Study||0
10694437|NCT02515942|11858594|FG000|STARTED|Overall Study||36
10694438|NCT02515942|11858595|FG001|STARTED|Overall Study||39
10694439|NCT02515942|11858596|FG002|STARTED|Overall Study||39
10694440|NCT02515942|11858594|FG000|Safety Analysis Set|Overall Study||36
10694441|NCT02515942|11858595|FG001|Safety Analysis Set|Overall Study||39
10694442|NCT02515942|11858596|FG002|Safety Analysis Set|Overall Study||39
10694443|NCT02515942|11858594|FG000|Full Analysis Set (FAS)|Overall Study||35
10694444|NCT02515942|11858595|FG001|Full Analysis Set (FAS)|Overall Study||37
10694445|NCT02515942|11858596|FG002|Full Analysis Set (FAS)|Overall Study||38
10694446|NCT02515942|11858594|FG000|Per Protocol Analysis Set (PPS)|Overall Study||30
10694447|NCT02515942|11858595|FG001|Per Protocol Analysis Set (PPS)|Overall Study||35
10694448|NCT02515942|11858596|FG002|Per Protocol Analysis Set (PPS)|Overall Study||34
10694449|NCT02515942|11858594|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study||36
10694450|NCT02515942|11858595|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study||39
10694451|NCT02515942|11858596|FG002|Pharmacokinetics (PK) Analysis Set|Overall Study||0
10694452|NCT02515942|11858594|FG000|Completed Day 85|Overall Study||35
10694453|NCT02515942|11858595|FG001|Completed Day 85|Overall Study||38
10694454|NCT02515942|11858596|FG002|Completed Day 85|Overall Study||37
10694455|NCT02515942|11858594|FG000|Completed Day 169|Overall Study||32
10694456|NCT02515942|11858595|FG001|Completed Day 169|Overall Study||37
10694457|NCT02515942|11858596|FG002|Completed Day 169|Overall Study||37
10694458|NCT02515942|11858594|FG000|Completed Day 253|Overall Study|One subject missed Day 253 visit|29
10694459|NCT02515942|11858595|FG001|Completed Day 253|Overall Study||37
10694460|NCT02515942|11858596|FG002|Completed Day 253|Overall Study||36
10694461|NCT02515942|11858594|FG000|Completed Day 337|Overall Study||30
10694462|NCT02515942|11858595|FG001|Completed Day 337|Overall Study||36
10694463|NCT02515942|11858596|FG002|Completed Day 337|Overall Study||35
10694464|NCT02515942|11858594|FG000|COMPLETED|Overall Study||29
10694465|NCT02515942|11858595|FG001|COMPLETED|Overall Study||36
10694466|NCT02515942|11858596|FG002|COMPLETED|Overall Study||35
10694467|NCT02515942|11858594|FG000|NOT COMPLETED|Overall Study||7
10694468|NCT02515942|11858595|FG001|NOT COMPLETED|Overall Study||3
10694469|NCT02515942|11858596|FG002|NOT COMPLETED|Overall Study||4
10694470|NCT02515994|11858608|FG000|STARTED|Overall Study||109
10694471|NCT02515994|11858609|FG001|STARTED|Overall Study||112
10694472|NCT02515994|11858608|FG000|COMPLETED|Overall Study||99
10694473|NCT02515994|11858609|FG001|COMPLETED|Overall Study||105
10694474|NCT02515994|11858608|FG000|NOT COMPLETED|Overall Study||10
10694475|NCT02515994|11858609|FG001|NOT COMPLETED|Overall Study||7
10694476|NCT02516046|11858615|FG000|STARTED|Overall Study|Total number of subjects scanned|156
10694477|NCT02516046|11858615|FG000|Died While on Study|Overall Study||73
10694478|NCT02516046|11858615|FG000|Valid Autopsy Results and PET Scan|Overall Study|includes 3 front-runners|67
10694479|NCT02516046|11858615|FG000|COMPLETED|Overall Study|Completed = included in autopsy cohort|64
10694480|NCT02516046|11858615|FG000|NOT COMPLETED|Overall Study||92
10694481|NCT02516098|11858631|FG000|STARTED|Period 1||28
10694482|NCT02516098|11858632|FG001|STARTED|Period 1||28
10694483|NCT02516098|11858631|FG000|COMPLETED|Period 1||27
10694484|NCT02516098|11858632|FG001|COMPLETED|Period 1||28
10694485|NCT02516098|11858631|FG000|NOT COMPLETED|Period 1||1
10694486|NCT02516098|11858632|FG001|NOT COMPLETED|Period 1||0
10694487|NCT02516098|11858631|FG000|STARTED|Washout After Period 1||27
10694488|NCT02516098|11858632|FG001|STARTED|Washout After Period 1||28
10694489|NCT02516098|11858631|FG000|COMPLETED|Washout After Period 1||27
10694490|NCT02516098|11858632|FG001|COMPLETED|Washout After Period 1||27
10694491|NCT02516098|11858631|FG000|NOT COMPLETED|Washout After Period 1||0
10694492|NCT02516098|11858632|FG001|NOT COMPLETED|Washout After Period 1||1
10694493|NCT02516098|11858631|FG000|STARTED|Period 2||27
10694494|NCT02516098|11858632|FG001|STARTED|Period 2||27
10694495|NCT02516098|11858631|FG000|COMPLETED|Period 2||27
10694496|NCT02516098|11858632|FG001|COMPLETED|Period 2||26
10694497|NCT02516098|11858631|FG000|NOT COMPLETED|Period 2||0
10694498|NCT02516098|11858632|FG001|NOT COMPLETED|Period 2||1
10694499|NCT02516098|11858631|FG000|STARTED|Washout After Period 2||27
10694500|NCT02516098|11858632|FG001|STARTED|Washout After Period 2||26
10694501|NCT02516098|11858631|FG000|COMPLETED|Washout After Period 2||27
10694502|NCT02516098|11858632|FG001|COMPLETED|Washout After Period 2||26
10694503|NCT02516098|11858631|FG000|NOT COMPLETED|Washout After Period 2||0
10694504|NCT02516098|11858632|FG001|NOT COMPLETED|Washout After Period 2||0
10694505|NCT02516150|11858638|FG000|STARTED|Overall Study||15
10694506|NCT02516150|11858638|FG000|COMPLETED|Overall Study||15
10694507|NCT02516150|11858638|FG000|NOT COMPLETED|Overall Study||0
10694508|NCT02516163|11858644|FG000|STARTED|Overall Study||52
10694509|NCT02516163|11858644|FG000|COMPLETED|Overall Study||24
10694510|NCT02516163|11858644|FG000|NOT COMPLETED|Overall Study||28
10694511|NCT02516202|11858651|FG000|STARTED|Overall Study||102
10694512|NCT02516202|11858652|FG001|STARTED|Overall Study||100
10694513|NCT02516202|11858653|FG002|STARTED|Overall Study||100
10694514|NCT02516202|11858651|FG000|COMPLETED|Overall Study||100
10694515|NCT02516202|11858652|FG001|COMPLETED|Overall Study||99
10694516|NCT02516202|11858653|FG002|COMPLETED|Overall Study||97
10694517|NCT02516202|11858651|FG000|NOT COMPLETED|Overall Study||2
10694518|NCT02516202|11858652|FG001|NOT COMPLETED|Overall Study||1
10694519|NCT02516202|11858653|FG002|NOT COMPLETED|Overall Study||3
10694520|NCT02516306|11858663|FG000|STARTED|Period 1: Day 1 - 7||50
10694521|NCT02516306|11858664|FG001|STARTED|Period 1: Day 1 - 7||25
10694522|NCT02516306|11858663|FG000|COMPLETED|Period 1: Day 1 - 7||50
10694523|NCT02516306|11858664|FG001|COMPLETED|Period 1: Day 1 - 7||25
10694524|NCT02516306|11858663|FG000|NOT COMPLETED|Period 1: Day 1 - 7||0
10694525|NCT02516306|11858664|FG001|NOT COMPLETED|Period 1: Day 1 - 7||0
10694526|NCT02516306|11858663|FG000|STARTED|Period 2: Day 8 - 91||50
10694527|NCT02516306|11858664|FG001|STARTED|Period 2: Day 8 - 91||25
10694528|NCT02516306|11858663|FG000|COMPLETED|Period 2: Day 8 - 91||49
10694529|NCT02516306|11858664|FG001|COMPLETED|Period 2: Day 8 - 91||23
10694530|NCT02516306|11858663|FG000|NOT COMPLETED|Period 2: Day 8 - 91||1
10694531|NCT02516306|11858664|FG001|NOT COMPLETED|Period 2: Day 8 - 91||2
10694532|NCT02516332|11858673|FG000|STARTED|Overall Study||52
10694533|NCT02516332|11858674|FG001|STARTED|Overall Study||53
10694534|NCT02516332|11858675|FG002|STARTED|Overall Study||23
10694535|NCT02516332|11858673|FG000|COMPLETED|Overall Study||50
10694536|NCT02516332|11858674|FG001|COMPLETED|Overall Study||52
10694537|NCT02516332|11858675|FG002|COMPLETED|Overall Study||21
10694538|NCT02516332|11858673|FG000|NOT COMPLETED|Overall Study||2
10694539|NCT02516332|11858674|FG001|NOT COMPLETED|Overall Study||1
10694540|NCT02516332|11858675|FG002|NOT COMPLETED|Overall Study||2
10694541|NCT02516410|11858685|FG000|STARTED|Overall Study||85
10694542|NCT02516410|11858686|FG001|STARTED|Overall Study||83
10694543|NCT02516410|11858685|FG000|COMPLETED|Overall Study||85
10694544|NCT02516410|11858686|FG001|COMPLETED|Overall Study||81
10694545|NCT02516410|11858685|FG000|NOT COMPLETED|Overall Study||0
10694546|NCT02516410|11858686|FG001|NOT COMPLETED|Overall Study||2
10694547|NCT02516579|11858693|FG000|STARTED|Overall Study||1906
10694548|NCT02516579|11858693|FG000|COMPLETED|Overall Study||1906
10694549|NCT02516579|11858693|FG000|NOT COMPLETED|Overall Study||0
10694550|NCT02516592|11858699|FG000|STARTED|Overall Study||251
10694551|NCT02516592|11858700|FG001|STARTED|Overall Study||251
10694552|NCT02516592|11858699|FG000|Full Analysis Set|Overall Study||248
10694553|NCT02516592|11858700|FG001|Full Analysis Set|Overall Study||250
10694554|NCT02516592|11858699|FG000|COMPLETED|Overall Study||235
10694555|NCT02516592|11858700|FG001|COMPLETED|Overall Study||238
10694556|NCT02516592|11858699|FG000|NOT COMPLETED|Overall Study||16
10694557|NCT02516592|11858700|FG001|NOT COMPLETED|Overall Study||13
10694558|NCT02516605|11858711|FG000|STARTED|Overall Study||11
10694559|NCT02516605|11858712|FG001|STARTED|Overall Study||9
10694560|NCT02516605|11858713|FG002|STARTED|Overall Study||12
10694561|NCT02516605|11858714|FG003|STARTED|Overall Study||8
10694562|NCT02516605|11858715|FG004|STARTED|Overall Study||21
10694563|NCT02516605|11858711|FG000|COMPLETED|Overall Study||11
10694564|NCT02516605|11858712|FG001|COMPLETED|Overall Study||9
10694565|NCT02516605|11858713|FG002|COMPLETED|Overall Study||12
10694566|NCT02516605|11858714|FG003|COMPLETED|Overall Study||7
10694567|NCT02516605|11858715|FG004|COMPLETED|Overall Study||20
10694568|NCT02516605|11858711|FG000|NOT COMPLETED|Overall Study||0
10694569|NCT02516605|11858712|FG001|NOT COMPLETED|Overall Study||0
10694570|NCT02516605|11858713|FG002|NOT COMPLETED|Overall Study||0
10694571|NCT02516605|11858714|FG003|NOT COMPLETED|Overall Study||1
10694572|NCT02516605|11858715|FG004|NOT COMPLETED|Overall Study||1
10694573|NCT02516982|11858735|FG000|STARTED|Overall Study||305
10694574|NCT02516982|11858736|FG001|STARTED|Overall Study||292
10694575|NCT02516982|11858737|FG002|STARTED|Overall Study||174
10694576|NCT02516982|11858738|FG003|STARTED|Overall Study||175
10694577|NCT02516982|11858735|FG000|COMPLETED|Overall Study||273
10694578|NCT02516982|11858736|FG001|COMPLETED|Overall Study||257
10694579|NCT02516982|11858737|FG002|COMPLETED|Overall Study||126
10694580|NCT02516982|11858738|FG003|COMPLETED|Overall Study||125
10694581|NCT02516982|11858735|FG000|NOT COMPLETED|Overall Study||32
10694582|NCT02516982|11858736|FG001|NOT COMPLETED|Overall Study||35
10694583|NCT02516982|11858737|FG002|NOT COMPLETED|Overall Study||48
10694584|NCT02516982|11858738|FG003|NOT COMPLETED|Overall Study||50
10694585|NCT02517021|11858750|FG000|STARTED|Overall Study||203
10694586|NCT02517021|11858751|FG001|STARTED|Overall Study||202
10694587|NCT02517021|11858750|FG000|COMPLETED|Overall Study||120
10694588|NCT02517021|11858751|FG001|COMPLETED|Overall Study||117
10694589|NCT02517021|11858750|FG000|NOT COMPLETED|Overall Study||83
10694590|NCT02517021|11858751|FG001|NOT COMPLETED|Overall Study||85
10694591|NCT02517047|11858757|FG000|STARTED|Overall Study||26
10694592|NCT02517047|11858757|FG000|COMPLETED|Overall Study||24
10694593|NCT02517047|11858757|FG000|NOT COMPLETED|Overall Study||2
10694594|NCT02517268|11858764|FG000|STARTED|Overall Study||40
10694595|NCT02517268|11858765|FG001|STARTED|Overall Study||37
10694596|NCT02517268|11858764|FG000|COMPLETED|Overall Study||39
10694597|NCT02517268|11858765|FG001|COMPLETED|Overall Study||37
10694598|NCT02517268|11858764|FG000|NOT COMPLETED|Overall Study||1
10694599|NCT02517268|11858765|FG001|NOT COMPLETED|Overall Study||0
10694600|NCT02517463|11858773|FG000|STARTED|Overall Study||369
10694601|NCT02517463|11858774|FG001|STARTED|Overall Study||331
10694602|NCT02517463|11858773|FG000|COMPLETED|Overall Study||364
10694603|NCT02517463|11858774|FG001|COMPLETED|Overall Study||329
10801431|NCT04358081|11962629|FG000|NOT COMPLETED|Study Completion Phase||1
10801432|NCT04358081|11962630|FG001|NOT COMPLETED|Study Completion Phase||0
10801433|NCT04358081|11962631|FG002|NOT COMPLETED|Study Completion Phase||2
10694604|NCT02517463|11858773|FG000|NOT COMPLETED|Overall Study||5
10694605|NCT02517463|11858774|FG001|NOT COMPLETED|Overall Study||2
10694606|NCT02517515|11858782|FG000|STARTED|Overall Study||325
10694607|NCT02517515|11858783|FG001|STARTED|Overall Study||325
10694608|NCT02517515|11858782|FG000|COMPLETED|Overall Study||323
10694609|NCT02517515|11858783|FG001|COMPLETED|Overall Study||323
10694610|NCT02517515|11858782|FG000|NOT COMPLETED|Overall Study||2
10694611|NCT02517515|11858783|FG001|NOT COMPLETED|Overall Study||2
10694612|NCT02517528|11858790|FG000|STARTED|Overall Study||104
10694613|NCT02517528|11858790|FG000|COMPLETED|Overall Study||103
10694614|NCT02517528|11858790|FG000|NOT COMPLETED|Overall Study||1
10694615|NCT02517541|11858794|FG000|STARTED|Baseline Period (Own Product)||74
10694616|NCT02517541|11858794|FG000|COMPLETED|Baseline Period (Own Product)||73
10694617|NCT02517541|11858794|FG000|NOT COMPLETED|Baseline Period (Own Product)||1
10694618|NCT02517541|11858794|FG000|STARTED|Test Period (SenSura Mio Convex Soft)||73
10694619|NCT02517541|11858794|FG000|COMPLETED|Test Period (SenSura Mio Convex Soft)||61
10694620|NCT02517541|11858794|FG000|NOT COMPLETED|Test Period (SenSura Mio Convex Soft)||12
10694621|NCT02517567|11858800|FG000|STARTED|First Exposure (8 Hours)||6
10694622|NCT02517567|11858801|FG001|STARTED|First Exposure (8 Hours)||8
10694623|NCT02517567|11858802|FG002|STARTED|First Exposure (8 Hours)||7
10694624|NCT02517567|11858803|FG003|STARTED|First Exposure (8 Hours)||8
10694625|NCT02517567|11858800|FG000|COMPLETED|First Exposure (8 Hours)||6
10694626|NCT02517567|11858801|FG001|COMPLETED|First Exposure (8 Hours)||8
10694627|NCT02517567|11858802|FG002|COMPLETED|First Exposure (8 Hours)||7
10694628|NCT02517567|11858803|FG003|COMPLETED|First Exposure (8 Hours)||8
10694629|NCT02517567|11858800|FG000|NOT COMPLETED|First Exposure (8 Hours)||0
10694630|NCT02517567|11858801|FG001|NOT COMPLETED|First Exposure (8 Hours)||0
10694631|NCT02517567|11858802|FG002|NOT COMPLETED|First Exposure (8 Hours)||0
10694632|NCT02517567|11858803|FG003|NOT COMPLETED|First Exposure (8 Hours)||0
10694633|NCT02517567|11858800|FG000|STARTED|Second Exposure (8 Hours)||6
10694634|NCT02517567|11858801|FG001|STARTED|Second Exposure (8 Hours)||8
10694635|NCT02517567|11858802|FG002|STARTED|Second Exposure (8 Hours)||7
10694636|NCT02517567|11858803|FG003|STARTED|Second Exposure (8 Hours)||8
10694637|NCT02517567|11858800|FG000|COMPLETED|Second Exposure (8 Hours)||6
10694638|NCT02517567|11858801|FG001|COMPLETED|Second Exposure (8 Hours)||8
10694639|NCT02517567|11858802|FG002|COMPLETED|Second Exposure (8 Hours)||7
10694640|NCT02517567|11858803|FG003|COMPLETED|Second Exposure (8 Hours)||8
10694641|NCT02517567|11858800|FG000|NOT COMPLETED|Second Exposure (8 Hours)||0
10694642|NCT02517567|11858801|FG001|NOT COMPLETED|Second Exposure (8 Hours)||0
10694643|NCT02517567|11858802|FG002|NOT COMPLETED|Second Exposure (8 Hours)||0
10694644|NCT02517567|11858803|FG003|NOT COMPLETED|Second Exposure (8 Hours)||0
10694645|NCT02517567|11858800|FG000|STARTED|Third Exposure (8 Hours)||6
10694646|NCT02517567|11858801|FG001|STARTED|Third Exposure (8 Hours)||8
10694647|NCT02517567|11858802|FG002|STARTED|Third Exposure (8 Hours)||7
10694648|NCT02517567|11858803|FG003|STARTED|Third Exposure (8 Hours)||8
10694649|NCT02517567|11858800|FG000|COMPLETED|Third Exposure (8 Hours)||6
10694650|NCT02517567|11858801|FG001|COMPLETED|Third Exposure (8 Hours)||8
10694651|NCT02517567|11858802|FG002|COMPLETED|Third Exposure (8 Hours)||7
10694652|NCT02517567|11858803|FG003|COMPLETED|Third Exposure (8 Hours)||8
10694653|NCT02517567|11858800|FG000|NOT COMPLETED|Third Exposure (8 Hours)||0
10694654|NCT02517567|11858801|FG001|NOT COMPLETED|Third Exposure (8 Hours)||0
10694655|NCT02517567|11858802|FG002|NOT COMPLETED|Third Exposure (8 Hours)||0
10694656|NCT02517567|11858803|FG003|NOT COMPLETED|Third Exposure (8 Hours)||0
10694657|NCT02517567|11858800|FG000|STARTED|Fourth Exposure (8 Hours)||6
10694658|NCT02517567|11858801|FG001|STARTED|Fourth Exposure (8 Hours)||8
10694659|NCT02517567|11858802|FG002|STARTED|Fourth Exposure (8 Hours)|One subject discontinued between Period 3 and Period 4 (withdrawal by subject)|6
10694660|NCT02517567|11858803|FG003|STARTED|Fourth Exposure (8 Hours)||8
10694661|NCT02517567|11858800|FG000|COMPLETED|Fourth Exposure (8 Hours)||6
10694662|NCT02517567|11858801|FG001|COMPLETED|Fourth Exposure (8 Hours)||8
10694663|NCT02517567|11858802|FG002|COMPLETED|Fourth Exposure (8 Hours)||6
10694664|NCT02517567|11858803|FG003|COMPLETED|Fourth Exposure (8 Hours)||8
10694665|NCT02517567|11858800|FG000|NOT COMPLETED|Fourth Exposure (8 Hours)||0
10694666|NCT02517567|11858801|FG001|NOT COMPLETED|Fourth Exposure (8 Hours)||0
10694667|NCT02517567|11858802|FG002|NOT COMPLETED|Fourth Exposure (8 Hours)||0
10694668|NCT02517567|11858803|FG003|NOT COMPLETED|Fourth Exposure (8 Hours)||0
10713412|NCT02678286|11878882|FG000|COMPLETED|Study Overall (28 Day Follow-Up)||104
10713413|NCT02678286|11878883|FG001|COMPLETED|Study Overall (28 Day Follow-Up)||105
10713414|NCT02678286|11878882|FG000|NOT COMPLETED|Study Overall (28 Day Follow-Up)||6
10713415|NCT02678286|11878883|FG001|NOT COMPLETED|Study Overall (28 Day Follow-Up)||4
10713416|NCT02678390|11878891|FG000|STARTED|Control (5 Days)||10
10694669|NCT02517580|11858812|FG000|STARTED|Overall Study||60
10694670|NCT02517580|11858812|FG000|COMPLETED|Overall Study||56
10694671|NCT02517580|11858812|FG000|NOT COMPLETED|Overall Study||4
10694672|NCT02517658|11858819|FG000|STARTED|Overall Study||33
10694673|NCT02517658|11858820|FG001|STARTED|Overall Study||33
10694674|NCT02517658|11858821|FG002|STARTED|Overall Study||33
10694675|NCT02517658|11858819|FG000|COMPLETED|Overall Study||33
10694676|NCT02517658|11858820|FG001|COMPLETED|Overall Study||33
10694677|NCT02517658|11858821|FG002|COMPLETED|Overall Study||33
10694678|NCT02517658|11858819|FG000|NOT COMPLETED|Overall Study||0
10694679|NCT02517658|11858820|FG001|NOT COMPLETED|Overall Study||0
10694680|NCT02517658|11858821|FG002|NOT COMPLETED|Overall Study||0
10694681|NCT02517866|11858829|FG000|STARTED|Overall Study||289
10694682|NCT02517866|11858830|FG001|STARTED|Overall Study||90
10694683|NCT02517866|11858831|FG002|STARTED|Overall Study||1
10694684|NCT02517866|11858829|FG000|COMPLETED|Overall Study||269
10694685|NCT02517866|11858830|FG001|COMPLETED|Overall Study||84
10694686|NCT02517866|11858831|FG002|COMPLETED|Overall Study||1
10694687|NCT02517866|11858829|FG000|NOT COMPLETED|Overall Study||20
10694688|NCT02517866|11858830|FG001|NOT COMPLETED|Overall Study||6
10694689|NCT02517866|11858831|FG002|NOT COMPLETED|Overall Study||0
10694690|NCT02517905|11858843|FG000|STARTED|Overall Study||107
10694691|NCT02517905|11858844|FG001|STARTED|Overall Study||59
10694692|NCT02517905|11858843|FG000|COMPLETED|Overall Study||97
10694693|NCT02517905|11858844|FG001|COMPLETED|Overall Study||57
10694694|NCT02517905|11858843|FG000|NOT COMPLETED|Overall Study||10
10694695|NCT02517905|11858844|FG001|NOT COMPLETED|Overall Study||2
10694696|NCT02517996|11858852|FG000|STARTED|Overall Study||8
10694697|NCT02517996|11858853|FG001|STARTED|Overall Study||9
10694698|NCT02517996|11858852|FG000|COMPLETED|Overall Study||8
10694699|NCT02517996|11858853|FG001|COMPLETED|Overall Study||9
10694700|NCT02517996|11858852|FG000|NOT COMPLETED|Overall Study||0
10694701|NCT02517996|11858853|FG001|NOT COMPLETED|Overall Study||0
10694702|NCT02518048|11858859|FG000|STARTED|Overall Study||35
10694703|NCT02518048|11858859|FG000|COMPLETED|Overall Study||34
10694704|NCT02518048|11858859|FG000|NOT COMPLETED|Overall Study||1
10694705|NCT02518113|11858868|FG000|STARTED|Overall Study||6
10694706|NCT02518113|11858869|FG001|STARTED|Overall Study||12
10694707|NCT02518113|11858870|FG002|STARTED|Overall Study||15
10694708|NCT02518113|11858871|FG003|STARTED|Overall Study||3
10694709|NCT02518113|11858868|FG000|COMPLETED|Overall Study||3
10694710|NCT02518113|11858869|FG001|COMPLETED|Overall Study||7
10694711|NCT02518113|11858870|FG002|COMPLETED|Overall Study||11
10694712|NCT02518113|11858871|FG003|COMPLETED|Overall Study||3
10694713|NCT02518113|11858868|FG000|NOT COMPLETED|Overall Study||3
10694714|NCT02518113|11858869|FG001|NOT COMPLETED|Overall Study||5
10694715|NCT02518113|11858870|FG002|NOT COMPLETED|Overall Study||4
10694716|NCT02518113|11858871|FG003|NOT COMPLETED|Overall Study||0
10694717|NCT02518191|11858886|FG000|STARTED|Overall Study||171
10694718|NCT02518191|11858887|FG001|STARTED|Overall Study||174
10694719|NCT02518191|11858886|FG000|COMPLETED|Overall Study||165
10694720|NCT02518191|11858887|FG001|COMPLETED|Overall Study||165
10694721|NCT02518191|11858886|FG000|NOT COMPLETED|Overall Study||6
10694722|NCT02518191|11858887|FG001|NOT COMPLETED|Overall Study||9
10694723|NCT02518230|11858897|FG000|STARTED|Overall Study||11
10694724|NCT02518230|11858898|FG001|STARTED|Overall Study||11
10694725|NCT02518230|11858897|FG000|COMPLETED|Overall Study||11
10694726|NCT02518230|11858898|FG001|COMPLETED|Overall Study||11
10694727|NCT02518230|11858897|FG000|NOT COMPLETED|Overall Study||0
10694728|NCT02518230|11858898|FG001|NOT COMPLETED|Overall Study||0
10694729|NCT02518464|11858905|FG000|STARTED|Overall Study||40
10694730|NCT02518464|11858905|FG000|COMPLETED|Overall Study||38
10694731|NCT02518464|11858905|FG000|NOT COMPLETED|Overall Study||2
10694732|NCT02518490|11858909|FG000|STARTED|Overall Study||18
10694733|NCT02518490|11858910|FG001|STARTED|Overall Study||18
10694734|NCT02518490|11858909|FG000|COMPLETED|Overall Study||17
10694735|NCT02518490|11858910|FG001|COMPLETED|Overall Study||17
10694736|NCT02518490|11858909|FG000|NOT COMPLETED|Overall Study||1
10694737|NCT02518490|11858910|FG001|NOT COMPLETED|Overall Study||1
10694738|NCT02518620|11858919|FG000|STARTED|Overall Study||257
10694739|NCT02518620|11858920|FG001|STARTED|Overall Study||149
10694740|NCT02518620|11858919|FG000|COMPLETED|Overall Study||205
10694741|NCT02518620|11858920|FG001|COMPLETED|Overall Study||123
10694742|NCT02518620|11858919|FG000|NOT COMPLETED|Overall Study||52
10694743|NCT02518620|11858920|FG001|NOT COMPLETED|Overall Study||26
10694744|NCT02518685|11858930|FG000|STARTED|Overall Study||213
10694745|NCT02518685|11858931|FG001|STARTED|Overall Study||89
10694746|NCT02518685|11858930|FG000|Safety Cohort|Overall Study|Randomized to and successfully received TPS (171) + Open-Label TPS-treated Subjects (32)|203
10694747|NCT02518685|11858931|FG001|Safety Cohort|Overall Study||89
10694748|NCT02518685|11858930|FG000|Randomized Cohort|Overall Study||181
10694749|NCT02518685|11858931|FG001|Randomized Cohort|Overall Study||89
10694750|NCT02518685|11858930|FG000|Enrolled|Overall Study|Includes 171 Successful device deployments, 10 unsuccessful delivery attempts and 32 Open-Label|213
10694751|NCT02518685|11858931|FG001|Enrolled|Overall Study||89
10694752|NCT02518685|11858930|FG000|Per Protocol Analysis|Overall Study|Three TPS-treated subjects were inadvertently unblinded, excluding them from efficacy analyses.|168
10694753|NCT02518685|11858931|FG001|Per Protocol Analysis|Overall Study||89
10694754|NCT02518685|11858930|FG000|COMPLETED|Overall Study|Randomized Completers (139) plus Open-Label Completers (25)|164
10694755|NCT02518685|11858931|FG001|COMPLETED|Overall Study||79
10694756|NCT02518685|11858930|FG000|NOT COMPLETED|Overall Study||49
10694757|NCT02518685|11858931|FG001|NOT COMPLETED|Overall Study||10
10694758|NCT02518919|11858941|FG000|STARTED|Overall Study||21
10694759|NCT02518919|11858942|FG001|STARTED|Overall Study||21
10694760|NCT02518919|11858943|FG002|STARTED|Overall Study||21
10694761|NCT02518919|11858941|FG000|COMPLETED|Overall Study||20
10694762|NCT02518919|11858942|FG001|COMPLETED|Overall Study||20
10694763|NCT02518919|11858943|FG002|COMPLETED|Overall Study||19
10694764|NCT02518919|11858941|FG000|NOT COMPLETED|Overall Study||1
10694765|NCT02518919|11858942|FG001|NOT COMPLETED|Overall Study||1
10694766|NCT02518919|11858943|FG002|NOT COMPLETED|Overall Study||2
10694767|NCT02518971|11858953|FG000|STARTED|Overall Study||87
10694768|NCT02518971|11858954|FG001|STARTED|Overall Study||87
10694769|NCT02518971|11858953|FG000|COMPLETED|Overall Study||64
10694770|NCT02518971|11858954|FG001|COMPLETED|Overall Study||67
10694771|NCT02518971|11858953|FG000|NOT COMPLETED|Overall Study||23
10694772|NCT02518971|11858954|FG001|NOT COMPLETED|Overall Study||20
10694773|NCT02518997|11858961|FG000|STARTED|Overall Study||18
10694774|NCT02518997|11858961|FG000|COMPLETED|Overall Study||18
10694775|NCT02518997|11858961|FG000|NOT COMPLETED|Overall Study||0
10694776|NCT02519023|11858970|FG000|STARTED|Overall Study||49
10694777|NCT02519023|11858971|FG001|STARTED|Overall Study||38
10694778|NCT02519023|11858970|FG000|COMPLETED|Overall Study||31
10694779|NCT02519023|11858971|FG001|COMPLETED|Overall Study||31
10694780|NCT02519023|11858970|FG000|NOT COMPLETED|Overall Study||18
10694781|NCT02519023|11858971|FG001|NOT COMPLETED|Overall Study||7
10694782|NCT02519036|11858983|FG000|STARTED|Overall Study||12
10694783|NCT02519036|11858984|FG001|STARTED|Overall Study||3
10694784|NCT02519036|11858985|FG002|STARTED|Overall Study||6
10694785|NCT02519036|11858986|FG003|STARTED|Overall Study||6
10694786|NCT02519036|11858987|FG004|STARTED|Overall Study||9
10694787|NCT02519036|11858988|FG005|STARTED|Overall Study||10
10694788|NCT02519036|11858983|FG000|COMPLETED|Overall Study||12
10694789|NCT02519036|11858984|FG001|COMPLETED|Overall Study||3
10694790|NCT02519036|11858985|FG002|COMPLETED|Overall Study||6
10694791|NCT02519036|11858986|FG003|COMPLETED|Overall Study||6
10694792|NCT02519036|11858987|FG004|COMPLETED|Overall Study||9
10694793|NCT02519036|11858988|FG005|COMPLETED|Overall Study||10
10694794|NCT02519036|11858983|FG000|NOT COMPLETED|Overall Study||0
10694795|NCT02519036|11858984|FG001|NOT COMPLETED|Overall Study||0
10694796|NCT02519036|11858985|FG002|NOT COMPLETED|Overall Study||0
10694797|NCT02519036|11858986|FG003|NOT COMPLETED|Overall Study||0
10694798|NCT02519036|11858987|FG004|NOT COMPLETED|Overall Study||0
10694799|NCT02519036|11858988|FG005|NOT COMPLETED|Overall Study||0
10694800|NCT02519231|11859009|FG000|STARTED|Overall Study||14
10694801|NCT02519231|11859010|FG001|STARTED|Overall Study||14
10694802|NCT02519231|11859009|FG000|COMPLETED|Overall Study|One was lost to follow up and never took the treatment. another never turned in bleeding diary.|12
10694803|NCT02519231|11859010|FG001|COMPLETED|Overall Study|Six participants never turned in their bleeding diaries.|8
10694804|NCT02519231|11859009|FG000|NOT COMPLETED|Overall Study||2
10694805|NCT02519231|11859010|FG001|NOT COMPLETED|Overall Study||6
10694806|NCT02519244|11859018|FG000|STARTED|Overall Study||10
10694807|NCT02519244|11859018|FG000|COMPLETED|Overall Study||10
10694808|NCT02519244|11859018|FG000|NOT COMPLETED|Overall Study||0
10694809|NCT02519387|11859022|FG000|STARTED|Overall Study||78
10694810|NCT02519387|11859022|FG000|COMPLETED|Overall Study||56
10694811|NCT02519387|11859022|FG000|NOT COMPLETED|Overall Study||22
10694812|NCT02519491|11859028|FG000|STARTED|Overall Study||219
10694813|NCT02519491|11859029|FG001|STARTED|Overall Study||219
10694814|NCT02519491|11859028|FG000|COMPLETED|Overall Study||219
10694815|NCT02519491|11859029|FG001|COMPLETED|Overall Study||219
10694816|NCT02519491|11859028|FG000|NOT COMPLETED|Overall Study||0
10694817|NCT02519491|11859029|FG001|NOT COMPLETED|Overall Study||0
10694818|NCT02519504|11859037|FG000|STARTED|Overall Study||319
10694819|NCT02519504|11859038|FG001|STARTED|Overall Study||247
10694820|NCT02519504|11859037|FG000|Attended Direct Testing|Overall Study||212
10694821|NCT02519504|11859038|FG001|Attended Direct Testing|Overall Study||149
10694822|NCT02519504|11859037|FG000|COMPLETED|Overall Study||206
10694823|NCT02519504|11859038|FG001|COMPLETED|Overall Study||144
10694824|NCT02519504|11859037|FG000|NOT COMPLETED|Overall Study||113
10694825|NCT02519504|11859038|FG001|NOT COMPLETED|Overall Study||103
10694826|NCT02519595|11859047|FG000|STARTED|Overall Study||58
10694827|NCT02519595|11859048|FG001|STARTED|Overall Study||57
10694828|NCT02519595|11859049|FG002|STARTED|Overall Study||56
10694829|NCT02519595|11859047|FG000|COMPLETED|Overall Study||50
10694830|NCT02519595|11859048|FG001|COMPLETED|Overall Study||35
10694831|NCT02519595|11859049|FG002|COMPLETED|Overall Study||40
10694832|NCT02519595|11859047|FG000|NOT COMPLETED|Overall Study||8
10694833|NCT02519595|11859048|FG001|NOT COMPLETED|Overall Study||22
10694834|NCT02519595|11859049|FG002|NOT COMPLETED|Overall Study||16
10694835|NCT02519621|11859060|FG000|STARTED|Overall Study||30
10694836|NCT02519621|11859061|FG001|STARTED|Overall Study||30
10694837|NCT02519621|11859062|FG002|STARTED|Overall Study||30
10694838|NCT02519621|11859060|FG000|COMPLETED|Overall Study||30
10694839|NCT02519621|11859061|FG001|COMPLETED|Overall Study||30
10694840|NCT02519621|11859062|FG002|COMPLETED|Overall Study||30
10694841|NCT02519621|11859060|FG000|NOT COMPLETED|Overall Study||0
10694842|NCT02519621|11859061|FG001|NOT COMPLETED|Overall Study||0
10694843|NCT02519621|11859062|FG002|NOT COMPLETED|Overall Study||0
10694844|NCT02519842|11859072|FG000|STARTED|Base Study: Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6.|38
10694845|NCT02519842|11859073|FG001|STARTED|Base Study: Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6.|37
10694846|NCT02519842|11859074|FG002|STARTED|Base Study: Cycle 1||0
10694847|NCT02519842|11859072|FG000|Treated|Base Study: Cycle 1||37
10694848|NCT02519842|11859073|FG001|Treated|Base Study: Cycle 1||34
10694849|NCT02519842|11859074|FG002|Treated|Base Study: Cycle 1||0
10694850|NCT02519842|11859072|FG000|COMPLETED|Base Study: Cycle 1||36
10694851|NCT02519842|11859073|FG001|COMPLETED|Base Study: Cycle 1||34
10694852|NCT02519842|11859074|FG002|COMPLETED|Base Study: Cycle 1||0
10694853|NCT02519842|11859072|FG000|NOT COMPLETED|Base Study: Cycle 1||2
10694854|NCT02519842|11859073|FG001|NOT COMPLETED|Base Study: Cycle 1||3
10694855|NCT02519842|11859074|FG002|NOT COMPLETED|Base Study: Cycle 1||0
10694856|NCT02519842|11859072|FG000|STARTED|Optional Extension: Cycles 2-6|27 participants from this arm in Cycle 1 entered optional Cycles 2-6|0
10694857|NCT02519842|11859073|FG001|STARTED|Optional Extension: Cycles 2-6|28 participants from this arm in Cycle 1 entered optional Cycles 2-6|0
10694858|NCT02519842|11859074|FG002|STARTED|Optional Extension: Cycles 2-6|Enrollment in Cycles 2-6 was optional.|55
10694859|NCT02519842|11859072|FG000|Treated|Optional Extension: Cycles 2-6||0
10694860|NCT02519842|11859073|FG001|Treated|Optional Extension: Cycles 2-6||0
10694861|NCT02519842|11859074|FG002|Treated|Optional Extension: Cycles 2-6||55
10694862|NCT02519842|11859072|FG000|COMPLETED|Optional Extension: Cycles 2-6||0
10694863|NCT02519842|11859073|FG001|COMPLETED|Optional Extension: Cycles 2-6||0
10694864|NCT02519842|11859074|FG002|COMPLETED|Optional Extension: Cycles 2-6||26
10694865|NCT02519842|11859072|FG000|NOT COMPLETED|Optional Extension: Cycles 2-6||0
10694866|NCT02519842|11859073|FG001|NOT COMPLETED|Optional Extension: Cycles 2-6||0
10694867|NCT02519842|11859074|FG002|NOT COMPLETED|Optional Extension: Cycles 2-6||29
10694868|NCT02519855|11859084|FG000|STARTED|Overall Study|Participants are included as treated|441
10694869|NCT02519855|11859085|FG001|STARTED|Overall Study|Participants are included as treated|441
10694870|NCT02519855|11859084|FG000|Vaccinated on Day 1|Overall Study||440
10694871|NCT02519855|11859085|FG001|Vaccinated on Day 1|Overall Study||441
10694872|NCT02519855|11859084|FG000|Vaccinated at Week 4|Overall Study||432
10694873|NCT02519855|11859085|FG001|Vaccinated at Week 4|Overall Study||424
10694874|NCT02519855|11859084|FG000|COMPLETED|Overall Study||438
10694875|NCT02519855|11859085|FG001|COMPLETED|Overall Study||437
10694876|NCT02519855|11859084|FG000|NOT COMPLETED|Overall Study||3
10694877|NCT02519855|11859085|FG001|NOT COMPLETED|Overall Study||4
10694878|NCT02520089|11859093|FG000|STARTED|Overall Study||12
10694879|NCT02520089|11859094|FG001|STARTED|Overall Study||11
10694880|NCT02520089|11859093|FG000|COMPLETED|Overall Study||9
10694881|NCT02520089|11859094|FG001|COMPLETED|Overall Study||7
10694882|NCT02520089|11859093|FG000|NOT COMPLETED|Overall Study||3
10694883|NCT02520089|11859094|FG001|NOT COMPLETED|Overall Study||4
10694884|NCT02520284|11859103|FG000|STARTED|Blinded Induction Phase: Up to Week 8||54
10694885|NCT02520284|11859104|FG001|STARTED|Blinded Induction Phase: Up to Week 8||56
10694886|NCT02520284|11859105|FG002|STARTED|Blinded Induction Phase: Up to Week 8||55
10694887|NCT02520284|11859103|FG000|COMPLETED|Blinded Induction Phase: Up to Week 8||52
10694888|NCT02520284|11859104|FG001|COMPLETED|Blinded Induction Phase: Up to Week 8|1 Participant completed Blinded Induction Phase but did not continue further in study.|52
10694889|NCT02520284|11859105|FG002|COMPLETED|Blinded Induction Phase: Up to Week 8|1 Participant completed Blinded Induction Phase but did not continue further in study.|53
10694890|NCT02520284|11859103|FG000|NOT COMPLETED|Blinded Induction Phase: Up to Week 8||2
10694891|NCT02520284|11859104|FG001|NOT COMPLETED|Blinded Induction Phase: Up to Week 8||4
10694892|NCT02520284|11859105|FG002|NOT COMPLETED|Blinded Induction Phase: Up to Week 8||2
10694893|NCT02520284|11859103|FG000|STARTED|Blinded Maintenance Phase: Up to Week 51|Participants achieving EBS remission and/or MCS response continued in Blinded Maintenance Phase.|20
10694894|NCT02520284|11859104|FG001|STARTED|Blinded Maintenance Phase: Up to Week 51|Participants achieving EBS remission and/or MCS response continued in Blinded Maintenance Phase.|16
10694895|NCT02520284|11859105|FG002|STARTED|Blinded Maintenance Phase: Up to Week 51|Participants achieving EBS remission and/or MCS response continued in Blinded Maintenance Phase.|18
10694896|NCT02520284|11859103|FG000|COMPLETED|Blinded Maintenance Phase: Up to Week 51||0
10694897|NCT02520284|11859104|FG001|COMPLETED|Blinded Maintenance Phase: Up to Week 51||0
10694898|NCT02520284|11859105|FG002|COMPLETED|Blinded Maintenance Phase: Up to Week 51||0
10694899|NCT02520284|11859103|FG000|NOT COMPLETED|Blinded Maintenance Phase: Up to Week 51||20
10694900|NCT02520284|11859104|FG001|NOT COMPLETED|Blinded Maintenance Phase: Up to Week 51||16
10694901|NCT02520284|11859105|FG002|NOT COMPLETED|Blinded Maintenance Phase: Up to Week 51||18
10694975|NCT02521376|11859194|FG002|STARTED|Overall Study||10
10694902|NCT02520284|11859103|FG000|STARTED|Open-Label MaintenancePhase: Upto Week51|Participants achieving neither EBS remission nor MCS response entered Open-Label Maintenance Phase.|32
10694903|NCT02520284|11859104|FG001|STARTED|Open-Label MaintenancePhase: Upto Week51|Participants achieving neither EBS remission nor MCS response entered Open-Label Maintenance Phase.|35
10694904|NCT02520284|11859105|FG002|STARTED|Open-Label MaintenancePhase: Upto Week51|Participants achieving neither EBS remission nor MCS response entered Open-Label Maintenance Phase.|34
10694905|NCT02520284|11859103|FG000|COMPLETED|Open-Label MaintenancePhase: Upto Week51||0
10694906|NCT02520284|11859104|FG001|COMPLETED|Open-Label MaintenancePhase: Upto Week51||0
10694907|NCT02520284|11859105|FG002|COMPLETED|Open-Label MaintenancePhase: Upto Week51||0
10694908|NCT02520284|11859103|FG000|NOT COMPLETED|Open-Label MaintenancePhase: Upto Week51||32
10694909|NCT02520284|11859104|FG001|NOT COMPLETED|Open-Label MaintenancePhase: Upto Week51||35
10694910|NCT02520284|11859105|FG002|NOT COMPLETED|Open-Label MaintenancePhase: Upto Week51||34
10694911|NCT02520310|11859119|FG000|STARTED|At 30 Days Clinical Follow-up||30
10694912|NCT02520310|11859119|FG000|COMPLETED|At 30 Days Clinical Follow-up||30
10694913|NCT02520310|11859119|FG000|NOT COMPLETED|At 30 Days Clinical Follow-up||0
10694914|NCT02520310|11859119|FG000|STARTED|At 6 Months Clinical Follow-up||30
10694915|NCT02520310|11859119|FG000|COMPLETED|At 6 Months Clinical Follow-up||29
10694916|NCT02520310|11859119|FG000|NOT COMPLETED|At 6 Months Clinical Follow-up||1
10694917|NCT02520310|11859119|FG000|STARTED|At 1 Year Clinical Follow-up||29
10694918|NCT02520310|11859119|FG000|COMPLETED|At 1 Year Clinical Follow-up||28
10694919|NCT02520310|11859119|FG000|NOT COMPLETED|At 1 Year Clinical Follow-up||1
10694920|NCT02520310|11859119|FG000|STARTED|At 2 Year Clinical Follow-up||28
10694921|NCT02520310|11859119|FG000|COMPLETED|At 2 Year Clinical Follow-up||28
10694922|NCT02520310|11859119|FG000|NOT COMPLETED|At 2 Year Clinical Follow-up||0
10694923|NCT02520310|11859119|FG000|STARTED|AT 3 Year Clinical Follow-up||28
10694924|NCT02520310|11859119|FG000|COMPLETED|AT 3 Year Clinical Follow-up||24
10694925|NCT02520310|11859119|FG000|NOT COMPLETED|AT 3 Year Clinical Follow-up||4
10694926|NCT02520310|11859119|FG000|STARTED|AT 4 Year Clinical Follow-up||24
10694927|NCT02520310|11859119|FG000|COMPLETED|AT 4 Year Clinical Follow-up||22
10694928|NCT02520310|11859119|FG000|NOT COMPLETED|AT 4 Year Clinical Follow-up||2
10694929|NCT02520388|11859127|FG000|STARTED|Overall Study||82
10694930|NCT02520388|11859128|FG001|STARTED|Overall Study||81
10694931|NCT02520388|11859127|FG000|Treated|Overall Study||81
10694932|NCT02520388|11859128|FG001|Treated|Overall Study||80
10694933|NCT02520388|11859127|FG000|COMPLETED|Overall Study||73
10694934|NCT02520388|11859128|FG001|COMPLETED|Overall Study||65
10694935|NCT02520388|11859127|FG000|NOT COMPLETED|Overall Study||9
10694936|NCT02520388|11859128|FG001|NOT COMPLETED|Overall Study||16
10694937|NCT02520414|11859134|FG000|STARTED|Overall Study||10
10694938|NCT02520414|11859134|FG000|COMPLETED|Overall Study||10
10694939|NCT02520414|11859134|FG000|NOT COMPLETED|Overall Study||0
10694940|NCT02520518|11859142|FG000|STARTED|Overall Study||3
10694941|NCT02520518|11859143|FG001|STARTED|Overall Study||1
10694942|NCT02520518|11859144|FG002|STARTED|Overall Study||3
10694943|NCT02520518|11859145|FG003|STARTED|Overall Study||2
10694944|NCT02520518|11859142|FG000|COMPLETED|Overall Study||3
10694945|NCT02520518|11859143|FG001|COMPLETED|Overall Study||1
10694946|NCT02520518|11859144|FG002|COMPLETED|Overall Study||1
10694947|NCT02520518|11859145|FG003|COMPLETED|Overall Study||1
10694948|NCT02520518|11859142|FG000|NOT COMPLETED|Overall Study||0
10694949|NCT02520518|11859143|FG001|NOT COMPLETED|Overall Study||0
10694950|NCT02520518|11859144|FG002|NOT COMPLETED|Overall Study||2
10694951|NCT02520518|11859145|FG003|NOT COMPLETED|Overall Study||1
10694952|NCT02520531|11859159|FG000|STARTED|Overall Study||42
10694953|NCT02520531|11859160|FG001|STARTED|Overall Study||42
10694954|NCT02520531|11859159|FG000|COMPLETED|Overall Study||36
10694955|NCT02520531|11859160|FG001|COMPLETED|Overall Study||36
10694956|NCT02520531|11859159|FG000|NOT COMPLETED|Overall Study||6
10694957|NCT02520531|11859160|FG001|NOT COMPLETED|Overall Study||6
10694958|NCT02521181|11859169|FG000|STARTED|Overall Study||52
10694959|NCT02521181|11859170|FG001|STARTED|Overall Study||90
10694960|NCT02521181|11859171|FG002|STARTED|Overall Study||52
10694961|NCT02521181|11859169|FG000|COMPLETED|Overall Study|All patients included in primary analysis|52
10694962|NCT02521181|11859170|FG001|COMPLETED|Overall Study|All patients included in primary analysis|90
10694963|NCT02521181|11859171|FG002|COMPLETED|Overall Study|All patients included in primary analysis|52
10694964|NCT02521181|11859169|FG000|NOT COMPLETED|Overall Study||0
10694965|NCT02521181|11859170|FG001|NOT COMPLETED|Overall Study||0
10694966|NCT02521181|11859171|FG002|NOT COMPLETED|Overall Study||0
10694967|NCT02521259|11859181|FG000|STARTED|Overall Study||35
10694968|NCT02521259|11859182|FG001|STARTED|Overall Study||33
10694969|NCT02521259|11859181|FG000|COMPLETED|Overall Study||34
10694970|NCT02521259|11859182|FG001|COMPLETED|Overall Study||28
10694971|NCT02521259|11859181|FG000|NOT COMPLETED|Overall Study||1
10694972|NCT02521259|11859182|FG001|NOT COMPLETED|Overall Study||5
10318928|NCT00218335|11453168|FG002|NOT COMPLETED|Overall Study||54
10318929|NCT00218335|11453169|FG003|NOT COMPLETED|Overall Study||36
10318930|NCT00218387|11453184|FG000|STARTED|Overall Study||40
10318931|NCT00218387|11453185|FG001|STARTED|Overall Study||43
10318932|NCT00218387|11453186|FG002|STARTED|Overall Study||40
10318933|NCT00218387|11453184|FG000|COMPLETED|Overall Study||25
10318934|NCT00218387|11453185|FG001|COMPLETED|Overall Study||25
10318935|NCT00218387|11453186|FG002|COMPLETED|Overall Study||17
10318936|NCT00218387|11453184|FG000|NOT COMPLETED|Overall Study||15
10318937|NCT00218387|11453185|FG001|NOT COMPLETED|Overall Study||18
10694973|NCT02521376|11859192|FG000|STARTED|Overall Study||8
10694974|NCT02521376|11859193|FG001|STARTED|Overall Study||18
10318938|NCT00218387|11453186|FG002|NOT COMPLETED|Overall Study||23
10318939|NCT00218426|11453197|FG000|STARTED|Overall Study||102
10694976|NCT02521376|11859195|FG003|STARTED|Overall Study||20
10694977|NCT02521376|11859192|FG000|COMPLETED|Overall Study||7
10694978|NCT02521376|11859193|FG001|COMPLETED|Overall Study||18
10694979|NCT02521376|11859194|FG002|COMPLETED|Overall Study||10
10694980|NCT02521376|11859195|FG003|COMPLETED|Overall Study||20
10694981|NCT02521376|11859192|FG000|NOT COMPLETED|Overall Study||1
10694982|NCT02521376|11859193|FG001|NOT COMPLETED|Overall Study||0
10694983|NCT02521376|11859194|FG002|NOT COMPLETED|Overall Study||0
10694984|NCT02521376|11859195|FG003|NOT COMPLETED|Overall Study||0
10694985|NCT02521766|11859215|FG000|STARTED|Overall Study||49
10694986|NCT02521766|11859216|FG001|STARTED|Overall Study||65
10694987|NCT02521766|11859215|FG000|Per Protocol|Overall Study||47
10694988|NCT02521766|11859216|FG001|Per Protocol|Overall Study||65
10694989|NCT02521766|11859215|FG000|COMPLETED|Overall Study||44
10694990|NCT02521766|11859216|FG001|COMPLETED|Overall Study||62
10694991|NCT02521766|11859215|FG000|NOT COMPLETED|Overall Study||5
10694992|NCT02521766|11859216|FG001|NOT COMPLETED|Overall Study||3
10694993|NCT02521792|11859233|FG000|STARTED|Overall Study||6
10694994|NCT02521792|11859233|FG000|Received Treatment|Overall Study||4
10694995|NCT02521792|11859233|FG000|COMPLETED|Overall Study||0
10694996|NCT02521792|11859233|FG000|NOT COMPLETED|Overall Study||6
10694997|NCT02521870|11859245|FG000|STARTED|Phase 1: Dose Escalation||6
10694998|NCT02521870|11859246|FG001|STARTED|Phase 1: Dose Escalation||5
10694999|NCT02521870|11859247|FG002|STARTED|Phase 1: Dose Escalation||5
10695000|NCT02521870|11859248|FG003|STARTED|Phase 1: Dose Escalation||6
10695001|NCT02521870|11859249|FG004|STARTED|Phase 1: Dose Escalation||0
10695002|NCT02521870|11859250|FG005|STARTED|Phase 1: Dose Escalation||0
10695003|NCT02521870|11859251|FG006|STARTED|Phase 1: Dose Escalation||0
10695004|NCT02521870|11859252|FG007|STARTED|Phase 1: Dose Escalation||0
10695005|NCT02521870|11859253|FG008|STARTED|Phase 1: Dose Escalation||0
10695006|NCT02521870|11859254|FG009|STARTED|Phase 1: Dose Escalation||0
10695007|NCT02521870|11859255|FG010|STARTED|Phase 1: Dose Escalation||0
10695008|NCT02521870|11859256|FG011|STARTED|Phase 1: Dose Escalation||0
10695009|NCT02521870|11859245|FG000|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||3
10695010|NCT02521870|11859246|FG001|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||3
10695011|NCT02521870|11859247|FG002|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
10695012|NCT02521870|11859248|FG003|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||1
10695013|NCT02521870|11859249|FG004|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
10695014|NCT02521870|11859250|FG005|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
10695015|NCT02521870|11859251|FG006|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
10695016|NCT02521870|11859252|FG007|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
10695017|NCT02521870|11859253|FG008|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
10695018|NCT02521870|11859254|FG009|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
10695019|NCT02521870|11859255|FG010|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
10695020|NCT02521870|11859256|FG011|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
10695021|NCT02521870|11859245|FG000|COMPLETED|Phase 1: Dose Escalation||1
10695022|NCT02521870|11859246|FG001|COMPLETED|Phase 1: Dose Escalation||1
10695023|NCT02521870|11859247|FG002|COMPLETED|Phase 1: Dose Escalation||1
10695024|NCT02521870|11859248|FG003|COMPLETED|Phase 1: Dose Escalation||0
10695025|NCT02521870|11859249|FG004|COMPLETED|Phase 1: Dose Escalation||0
10695026|NCT02521870|11859250|FG005|COMPLETED|Phase 1: Dose Escalation||0
10695027|NCT02521870|11859251|FG006|COMPLETED|Phase 1: Dose Escalation||0
10695028|NCT02521870|11859252|FG007|COMPLETED|Phase 1: Dose Escalation||0
10695029|NCT02521870|11859253|FG008|COMPLETED|Phase 1: Dose Escalation||0
10695030|NCT02521870|11859254|FG009|COMPLETED|Phase 1: Dose Escalation||0
10695031|NCT02521870|11859255|FG010|COMPLETED|Phase 1: Dose Escalation||0
10695032|NCT02521870|11859256|FG011|COMPLETED|Phase 1: Dose Escalation||0
10695033|NCT02521870|11859245|FG000|NOT COMPLETED|Phase 1: Dose Escalation||5
10695034|NCT02521870|11859246|FG001|NOT COMPLETED|Phase 1: Dose Escalation||4
10695035|NCT02521870|11859247|FG002|NOT COMPLETED|Phase 1: Dose Escalation||4
10695036|NCT02521870|11859248|FG003|NOT COMPLETED|Phase 1: Dose Escalation||6
10695037|NCT02521870|11859249|FG004|NOT COMPLETED|Phase 1: Dose Escalation||0
10695038|NCT02521870|11859250|FG005|NOT COMPLETED|Phase 1: Dose Escalation||0
10695039|NCT02521870|11859251|FG006|NOT COMPLETED|Phase 1: Dose Escalation||0
10695040|NCT02521870|11859252|FG007|NOT COMPLETED|Phase 1: Dose Escalation||0
10695041|NCT02521870|11859253|FG008|NOT COMPLETED|Phase 1: Dose Escalation||0
10695042|NCT02521870|11859254|FG009|NOT COMPLETED|Phase 1: Dose Escalation||0
10695043|NCT02521870|11859255|FG010|NOT COMPLETED|Phase 1: Dose Escalation||0
10695044|NCT02521870|11859256|FG011|NOT COMPLETED|Phase 1: Dose Escalation||0
10695045|NCT02521870|11859245|FG000|STARTED|Phase 2: Dose Expansion||0
10695046|NCT02521870|11859246|FG001|STARTED|Phase 2: Dose Expansion||0
10695047|NCT02521870|11859247|FG002|STARTED|Phase 2: Dose Expansion||0
10695048|NCT02521870|11859248|FG003|STARTED|Phase 2: Dose Expansion||0
10695049|NCT02521870|11859249|FG004|STARTED|Phase 2: Dose Expansion||57
10695050|NCT02521870|11859250|FG005|STARTED|Phase 2: Dose Expansion||25
10695051|NCT02521870|11859251|FG006|STARTED|Phase 2: Dose Expansion||23
10695052|NCT02521870|11859252|FG007|STARTED|Phase 2: Dose Expansion||9
10695053|NCT02521870|11859253|FG008|STARTED|Phase 2: Dose Expansion||24
10695054|NCT02521870|11859254|FG009|STARTED|Phase 2: Dose Expansion||28
10695055|NCT02521870|11859255|FG010|STARTED|Phase 2: Dose Expansion||23
10695056|NCT02521870|11859256|FG011|STARTED|Phase 2: Dose Expansion||30
10695057|NCT02521870|11859245|FG000|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||0
10695058|NCT02521870|11859246|FG001|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||0
10695059|NCT02521870|11859247|FG002|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||0
10695060|NCT02521870|11859248|FG003|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||0
10695061|NCT02521870|11859249|FG004|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||25
10695062|NCT02521870|11859250|FG005|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||7
10695063|NCT02521870|11859251|FG006|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||3
10695064|NCT02521870|11859252|FG007|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||2
10695065|NCT02521870|11859253|FG008|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||9
10695066|NCT02521870|11859254|FG009|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||5
10695067|NCT02521870|11859255|FG010|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||1
10695068|NCT02521870|11859256|FG011|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||11
10695069|NCT02521870|11859245|FG000|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
10695070|NCT02521870|11859246|FG001|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
10695071|NCT02521870|11859247|FG002|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
10695072|NCT02521870|11859248|FG003|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
10695073|NCT02521870|11859249|FG004|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||7
10695074|NCT02521870|11859250|FG005|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||1
10695075|NCT02521870|11859251|FG006|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
10695076|NCT02521870|11859252|FG007|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
10695077|NCT02521870|11859253|FG008|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
10695078|NCT02521870|11859254|FG009|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
10695079|NCT02521870|11859255|FG010|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
10695080|NCT02521870|11859256|FG011|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
10695081|NCT02521870|11859245|FG000|COMPLETED|Phase 2: Dose Expansion||0
10695082|NCT02521870|11859246|FG001|COMPLETED|Phase 2: Dose Expansion||0
10695083|NCT02521870|11859247|FG002|COMPLETED|Phase 2: Dose Expansion||0
10695084|NCT02521870|11859248|FG003|COMPLETED|Phase 2: Dose Expansion||0
10695085|NCT02521870|11859249|FG004|COMPLETED|Phase 2: Dose Expansion||5
10695086|NCT02521870|11859250|FG005|COMPLETED|Phase 2: Dose Expansion||0
10695087|NCT02521870|11859251|FG006|COMPLETED|Phase 2: Dose Expansion||0
10695088|NCT02521870|11859252|FG007|COMPLETED|Phase 2: Dose Expansion||0
10695089|NCT02521870|11859253|FG008|COMPLETED|Phase 2: Dose Expansion|4 participants completed pembrolizumab treatment (up to 35 cycles).|2
10695090|NCT02521870|11859254|FG009|COMPLETED|Phase 2: Dose Expansion||0
10695091|NCT02521870|11859255|FG010|COMPLETED|Phase 2: Dose Expansion||0
10695092|NCT02521870|11859256|FG011|COMPLETED|Phase 2: Dose Expansion||0
10695093|NCT02521870|11859245|FG000|NOT COMPLETED|Phase 2: Dose Expansion||0
10695094|NCT02521870|11859246|FG001|NOT COMPLETED|Phase 2: Dose Expansion||0
10695095|NCT02521870|11859247|FG002|NOT COMPLETED|Phase 2: Dose Expansion||0
10695096|NCT02521870|11859248|FG003|NOT COMPLETED|Phase 2: Dose Expansion||0
10695097|NCT02521870|11859249|FG004|NOT COMPLETED|Phase 2: Dose Expansion||52
10695098|NCT02521870|11859250|FG005|NOT COMPLETED|Phase 2: Dose Expansion||25
10695099|NCT02521870|11859251|FG006|NOT COMPLETED|Phase 2: Dose Expansion||23
10695100|NCT02521870|11859252|FG007|NOT COMPLETED|Phase 2: Dose Expansion||9
10695101|NCT02521870|11859253|FG008|NOT COMPLETED|Phase 2: Dose Expansion||22
10695102|NCT02521870|11859254|FG009|NOT COMPLETED|Phase 2: Dose Expansion||28
10695103|NCT02521870|11859255|FG010|NOT COMPLETED|Phase 2: Dose Expansion||23
10695104|NCT02521870|11859256|FG011|NOT COMPLETED|Phase 2: Dose Expansion||30
10695105|NCT02521948|11859286|FG000|STARTED|Overall Study||50
10695106|NCT02521948|11859286|FG000|COMPLETED|Overall Study||37
10695107|NCT02521948|11859286|FG000|NOT COMPLETED|Overall Study||13
10695108|NCT02521974|11859295|FG000|STARTED|Overall Study||50
10695109|NCT02521974|11859296|FG001|STARTED|Overall Study||114
10695110|NCT02521974|11859295|FG000|COMPLETED|Overall Study||47
10695111|NCT02521974|11859296|FG001|COMPLETED|Overall Study||110
10695112|NCT02521974|11859295|FG000|NOT COMPLETED|Overall Study||3
10695113|NCT02521974|11859296|FG001|NOT COMPLETED|Overall Study||4
10695114|NCT02522104|11859306|FG000|STARTED|Overall Study||13
10695115|NCT02522104|11859307|FG001|STARTED|Overall Study||15
10695116|NCT02522104|11859308|FG002|STARTED|Overall Study||12
10695117|NCT02522104|11859306|FG000|COMPLETED|Overall Study||10
10695118|NCT02522104|11859307|FG001|COMPLETED|Overall Study||12
10695119|NCT02522104|11859308|FG002|COMPLETED|Overall Study||5
10695120|NCT02522104|11859306|FG000|NOT COMPLETED|Overall Study||3
10695121|NCT02522104|11859307|FG001|NOT COMPLETED|Overall Study||3
10695122|NCT02522104|11859308|FG002|NOT COMPLETED|Overall Study||7
10695123|NCT02522286|11859323|FG000|STARTED|Overall Study||78
10695124|NCT02522286|11859324|FG001|STARTED|Overall Study||75
10695125|NCT02522286|11859325|FG002|STARTED|Overall Study||75
10695126|NCT02522286|11859326|FG003|STARTED|Overall Study||78
10695127|NCT02522286|11859323|FG000|COMPLETED|Overall Study||75
10695128|NCT02522286|11859324|FG001|COMPLETED|Overall Study||75
10695129|NCT02522286|11859325|FG002|COMPLETED|Overall Study||75
10695130|NCT02522286|11859326|FG003|COMPLETED|Overall Study||75
10695131|NCT02522286|11859323|FG000|NOT COMPLETED|Overall Study||3
10695132|NCT02522286|11859324|FG001|NOT COMPLETED|Overall Study||0
10695133|NCT02522286|11859325|FG002|NOT COMPLETED|Overall Study||0
10695134|NCT02522286|11859326|FG003|NOT COMPLETED|Overall Study||3
10695135|NCT02522299|11859338|FG000|STARTED|Overall Study||22
10695136|NCT02522299|11859339|FG001|STARTED|Overall Study||22
10695137|NCT02522299|11859338|FG000|COMPLETED|Overall Study||18
10695138|NCT02522299|11859339|FG001|COMPLETED|Overall Study||21
10695139|NCT02522299|11859338|FG000|NOT COMPLETED|Overall Study||4
10695140|NCT02522299|11859339|FG001|NOT COMPLETED|Overall Study||1
10695141|NCT02522325|11859359|FG000|STARTED|Overall Study||15
10695142|NCT02522325|11859360|FG001|STARTED|Overall Study||15
10695143|NCT02522325|11859359|FG000|COMPLETED|Overall Study||15
10695144|NCT02522325|11859360|FG001|COMPLETED|Overall Study||14
10695145|NCT02522325|11859359|FG000|NOT COMPLETED|Overall Study||0
10695146|NCT02522325|11859360|FG001|NOT COMPLETED|Overall Study||1
10695147|NCT02522377|11859368|FG000|STARTED|Overall Study||7
10695148|NCT02522377|11859369|FG001|STARTED|Overall Study||5
10695149|NCT02522377|11859368|FG000|COMPLETED|Overall Study||3
10695150|NCT02522377|11859369|FG001|COMPLETED|Overall Study||5
10695151|NCT02522377|11859368|FG000|NOT COMPLETED|Overall Study||4
10695152|NCT02522377|11859369|FG001|NOT COMPLETED|Overall Study||0
10801434|NCT04356937|11962643|FG000|STARTED|Randomization (Safety Population)||161
10801435|NCT04356937|11962644|FG001|STARTED|Randomization (Safety Population)||82
10801436|NCT04356937|11962643|FG000|COMPLETED|Randomization (Safety Population)||161
10801437|NCT04356937|11962644|FG001|COMPLETED|Randomization (Safety Population)||82
10801438|NCT04356937|11962643|FG000|NOT COMPLETED|Randomization (Safety Population)||0
10801439|NCT04356937|11962644|FG001|NOT COMPLETED|Randomization (Safety Population)||0
10695153|NCT02522403|11859377|FG000|STARTED|Overall Study||17
10695154|NCT02522403|11859378|FG001|STARTED|Overall Study||19
10695155|NCT02522403|11859377|FG000|COMPLETED|Overall Study||13
10695156|NCT02522403|11859378|FG001|COMPLETED|Overall Study||13
10695157|NCT02522403|11859377|FG000|NOT COMPLETED|Overall Study||4
10695158|NCT02522403|11859378|FG001|NOT COMPLETED|Overall Study||6
10695159|NCT02522442|11859386|FG000|STARTED|Overall Study||26
10695160|NCT02522442|11859387|FG001|STARTED|Overall Study||22
10695161|NCT02522442|11859386|FG000|COMPLETED|Overall Study||26
10695162|NCT02522442|11859387|FG001|COMPLETED|Overall Study||22
10695163|NCT02522442|11859386|FG000|NOT COMPLETED|Overall Study||0
10695164|NCT02522442|11859387|FG001|NOT COMPLETED|Overall Study||0
10695165|NCT02522481|11859393|FG000|STARTED|Overall Study||175
10695166|NCT02522481|11859393|FG000|COMPLETED|Overall Study||172
10695167|NCT02522481|11859393|FG000|NOT COMPLETED|Overall Study||3
10695178|NCT02522624|11859415|FG000|STARTED|Overall Study||165
10695179|NCT02522624|11859416|FG001|STARTED|Overall Study||163
10695180|NCT02522624|11859415|FG000|COMPLETED|Overall Study|Discontinued intervention due to technical failure (n=1)|164
10695181|NCT02522624|11859416|FG001|COMPLETED|Overall Study||163
10695182|NCT02522624|11859415|FG000|NOT COMPLETED|Overall Study||1
10695183|NCT02522624|11859416|FG001|NOT COMPLETED|Overall Study||0
10695184|NCT02522728|11859424|FG000|STARTED|Overall Study||28
10695185|NCT02522728|11859425|FG001|STARTED|Overall Study||30
10695186|NCT02522728|11859424|FG000|COMPLETED|Overall Study||16
10695187|NCT02522728|11859425|FG001|COMPLETED|Overall Study||19
10695188|NCT02522728|11859424|FG000|NOT COMPLETED|Overall Study||12
10695189|NCT02522728|11859425|FG001|NOT COMPLETED|Overall Study||11
10695190|NCT02522767|11859433|FG000|STARTED|Double-blind||114
10695191|NCT02522767|11859434|FG001|STARTED|Double-blind||114
10695192|NCT02522767|11859433|FG000|COMPLETED|Double-blind||103
10695193|NCT02522767|11859434|FG001|COMPLETED|Double-blind||90
10695194|NCT02522767|11859433|FG000|NOT COMPLETED|Double-blind||11
10695195|NCT02522767|11859434|FG001|NOT COMPLETED|Double-blind||24
10695196|NCT02522767|11859433|FG000|STARTED|Open-label|Subjects provided their consent to receive additional 8 weeks open-label treatment with mesalamine.|88
10695197|NCT02522767|11859434|FG001|STARTED|Open-label|Subjects provided their consent to receive additional 8 weeks open-label treatment with mesalamine.|82
10695198|NCT02522767|11859433|FG000|COMPLETED|Open-label||83
10695199|NCT02522767|11859434|FG001|COMPLETED|Open-label||75
10695200|NCT02522767|11859433|FG000|NOT COMPLETED|Open-label||5
10695201|NCT02522767|11859434|FG001|NOT COMPLETED|Open-label||7
10695202|NCT02522780|11859444|FG000|STARTED|Overall Study||138
10695203|NCT02522780|11859445|FG001|STARTED|Overall Study||138
10695204|NCT02522780|11859444|FG000|Treated|Overall Study||137
10695205|NCT02522780|11859445|FG001|Treated|Overall Study||135
10695206|NCT02522780|11859444|FG000|Intention-to-treat (ITT) Population|Overall Study||136
10695207|NCT02522780|11859445|FG001|Intention-to-treat (ITT) Population|Overall Study||136
10695208|NCT02522780|11859444|FG000|COMPLETED|Overall Study||121
10695209|NCT02522780|11859445|FG001|COMPLETED|Overall Study||111
10695210|NCT02522780|11859444|FG000|NOT COMPLETED|Overall Study||17
10695211|NCT02522780|11859445|FG001|NOT COMPLETED|Overall Study||27
10695218|NCT02522884|11859461|FG000|STARTED|Overall Study|Intent to Treat (ITT) population.|213
10695219|NCT02522884|11859461|FG000|COMPLETED|Overall Study|Completed 12-month follow-up.|195
10695220|NCT02522884|11859461|FG000|NOT COMPLETED|Overall Study||18
10695221|NCT02523196|11859465|FG000|STARTED|Overall Study||20
10695222|NCT02523196|11859465|FG000|Received HVPG|Overall Study||20
10695223|NCT02523196|11859465|FG000|Received HQ Shunt|Overall Study||20
10695224|NCT02523196|11859465|FG000|COMPLETED|Overall Study||20
10695225|NCT02523196|11859465|FG000|NOT COMPLETED|Overall Study||0
10695226|NCT02523235|11859476|FG000|STARTED|Overall Study||56
10695227|NCT02523235|11859477|FG001|STARTED|Overall Study||58
10695228|NCT02523235|11859476|FG000|COMPLETED|Overall Study||56
10695229|NCT02523235|11859477|FG001|COMPLETED|Overall Study||58
10695230|NCT02523235|11859476|FG000|NOT COMPLETED|Overall Study||0
10695231|NCT02523235|11859477|FG001|NOT COMPLETED|Overall Study||0
10695232|NCT02523586|11859484|FG000|STARTED|Overall Study||14
10695233|NCT02523586|11859484|FG000|COMPLETED|Overall Study||10
10695234|NCT02523586|11859484|FG000|NOT COMPLETED|Overall Study||4
10695235|NCT02523599|11859497|FG000|STARTED|Overall Study||204
10695236|NCT02523599|11859498|FG001|STARTED|Overall Study||101
10695237|NCT02523599|11859497|FG000|Randomized But Not Treated|Overall Study||1
10695238|NCT02523599|11859498|FG001|Randomized But Not Treated|Overall Study||0
10695239|NCT02523599|11859497|FG000|COMPLETED|Overall Study||196
10695240|NCT02523599|11859498|FG001|COMPLETED|Overall Study||100
10695241|NCT02523599|11859497|FG000|NOT COMPLETED|Overall Study||8
10695242|NCT02523599|11859498|FG001|NOT COMPLETED|Overall Study||1
10695243|NCT02523690|11859506|FG000|STARTED|Overall Study||3
10695244|NCT02523690|11859507|FG001|STARTED|Overall Study||2
10695245|NCT02523690|11859506|FG000|COMPLETED|Overall Study||3
10695246|NCT02523690|11859507|FG001|COMPLETED|Overall Study||2
10695247|NCT02523690|11859506|FG000|NOT COMPLETED|Overall Study||0
10695248|NCT02523690|11859507|FG001|NOT COMPLETED|Overall Study||0
10695249|NCT02523924|11859513|FG000|STARTED|Overall Study||31
10695250|NCT02523924|11859513|FG000|COMPLETED|Overall Study||31
10695251|NCT02523924|11859513|FG000|NOT COMPLETED|Overall Study||0
10695252|NCT02524054|11859519|FG000|STARTED|Overall Study||7
10695253|NCT02524054|11859520|FG001|STARTED|Overall Study||9
10695254|NCT02524054|11859521|FG002|STARTED|Overall Study||8
10695255|NCT02524054|11859519|FG000|COMPLETED|Overall Study||7
10695256|NCT02524054|11859520|FG001|COMPLETED|Overall Study||9
10695257|NCT02524054|11859521|FG002|COMPLETED|Overall Study||8
10695258|NCT02524054|11859519|FG000|NOT COMPLETED|Overall Study||0
10695259|NCT02524054|11859520|FG001|NOT COMPLETED|Overall Study||0
10695260|NCT02524054|11859521|FG002|NOT COMPLETED|Overall Study||0
10695261|NCT02524106|11859533|FG000|STARTED|Overall Study||6
10695262|NCT02524106|11859534|FG001|STARTED|Overall Study||5
10695263|NCT02524106|11859533|FG000|COMPLETED|Overall Study||6
10695264|NCT02524106|11859534|FG001|COMPLETED|Overall Study||5
10695265|NCT02524106|11859533|FG000|NOT COMPLETED|Overall Study||0
10695266|NCT02524106|11859534|FG001|NOT COMPLETED|Overall Study||0
10695267|NCT02524119|11859540|FG000|STARTED|Overall Study||5
10695268|NCT02524119|11859540|FG000|COMPLETED|Overall Study||5
10695269|NCT02524119|11859540|FG000|NOT COMPLETED|Overall Study||0
10695270|NCT02524145|11859547|FG000|STARTED|Overall Study||15
10695271|NCT02524145|11859548|FG001|STARTED|Overall Study||15
10695272|NCT02524145|11859549|FG002|STARTED|Overall Study||10
10695273|NCT02524145|11859547|FG000|COMPLETED|Overall Study||13
10695274|NCT02524145|11859548|FG001|COMPLETED|Overall Study||13
10695275|NCT02524145|11859549|FG002|COMPLETED|Overall Study||7
10695276|NCT02524145|11859547|FG000|NOT COMPLETED|Overall Study||2
10695277|NCT02524145|11859548|FG001|NOT COMPLETED|Overall Study||2
10695278|NCT02524145|11859549|FG002|NOT COMPLETED|Overall Study||3
10695279|NCT02524158|11859559|FG000|STARTED|12-weeks Assessment||76
10695280|NCT02524158|11859560|FG001|STARTED|12-weeks Assessment||76
10695281|NCT02524158|11859559|FG000|COMPLETED|12-weeks Assessment||57
10695282|NCT02524158|11859560|FG001|COMPLETED|12-weeks Assessment||63
10695283|NCT02524158|11859559|FG000|NOT COMPLETED|12-weeks Assessment||19
10695284|NCT02524158|11859560|FG001|NOT COMPLETED|12-weeks Assessment||13
10695285|NCT02524158|11859559|FG000|STARTED|6-month Assessment||76
10695286|NCT02524158|11859560|FG001|STARTED|6-month Assessment||76
10695287|NCT02524158|11859559|FG000|COMPLETED|6-month Assessment||54
10695288|NCT02524158|11859560|FG001|COMPLETED|6-month Assessment||55
10695289|NCT02524158|11859559|FG000|NOT COMPLETED|6-month Assessment||22
10695290|NCT02524158|11859560|FG001|NOT COMPLETED|6-month Assessment||21
10695291|NCT02524418|11859569|FG000|STARTED|Overall Study||88
10695292|NCT02524418|11859569|FG000|COMPLETED|Overall Study||75
10695293|NCT02524418|11859569|FG000|NOT COMPLETED|Overall Study||13
10695294|NCT02524561|11859579|FG000|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS|168
10695295|NCT02524561|11859580|FG001|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS|162
10695296|NCT02524561|11859581|FG002|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS.|187
10695297|NCT02524561|11859579|FG000|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||137
10695298|NCT02524561|11859580|FG001|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||133
10695299|NCT02524561|11859581|FG002|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||151
10695300|NCT02524561|11859579|FG000|COMPLETED|Baseline: Pre-randomization Mammogram||168
10695301|NCT02524561|11859580|FG001|COMPLETED|Baseline: Pre-randomization Mammogram||162
10695302|NCT02524561|11859581|FG002|COMPLETED|Baseline: Pre-randomization Mammogram||187
10695303|NCT02524561|11859579|FG000|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
10695304|NCT02524561|11859580|FG001|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
10695305|NCT02524561|11859581|FG002|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
10695306|NCT02524561|11859579|FG000|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|168
10695307|NCT02524561|11859580|FG001|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|162
10695308|NCT02524561|11859581|FG002|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|187
10695309|NCT02524561|11859579|FG000|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post-randomization mammogram|136
10695310|NCT02524561|11859580|FG001|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post randomization mammogram|123
10695311|NCT02524561|11859581|FG002|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post randomization mammogram|148
10695312|NCT02524561|11859579|FG000|COMPLETED|Year 1: Post Randomization Mammograms||168
10695313|NCT02524561|11859580|FG001|COMPLETED|Year 1: Post Randomization Mammograms||162
10695314|NCT02524561|11859581|FG002|COMPLETED|Year 1: Post Randomization Mammograms||187
10695315|NCT02524561|11859579|FG000|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
10695316|NCT02524561|11859580|FG001|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
10695317|NCT02524561|11859581|FG002|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
10695318|NCT02524561|11859579|FG000|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|168
10695319|NCT02524561|11859580|FG001|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|162
10695320|NCT02524561|11859581|FG002|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|187
10695321|NCT02524561|11859579|FG000|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||143
10695322|NCT02524561|11859580|FG001|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||139
10695323|NCT02524561|11859581|FG002|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||151
10695324|NCT02524561|11859579|FG000|COMPLETED|Final: Year 3 or 4 Post-randomization||168
10695325|NCT02524561|11859580|FG001|COMPLETED|Final: Year 3 or 4 Post-randomization||162
10695326|NCT02524561|11859581|FG002|COMPLETED|Final: Year 3 or 4 Post-randomization||187
10695327|NCT02524561|11859579|FG000|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
10695328|NCT02524561|11859580|FG001|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
10695329|NCT02524561|11859581|FG002|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
10695330|NCT02524665|11859589|FG000|STARTED|Overall Study||20
10695331|NCT02524665|11859589|FG000|COMPLETED|Overall Study||19
10695332|NCT02524665|11859589|FG000|NOT COMPLETED|Overall Study||1
10695333|NCT02524730|11859594|FG000|STARTED|Overall Study||205
10695334|NCT02524730|11859594|FG000|COMPLETED|Overall Study||159
10695335|NCT02524730|11859594|FG000|NOT COMPLETED|Overall Study||46
10695336|NCT02524769|11859598|FG000|STARTED|Overall Study||27
10695337|NCT02524769|11859598|FG000|COMPLETED|Overall Study||17
10695338|NCT02524769|11859598|FG000|NOT COMPLETED|Overall Study||10
10695339|NCT02524847|11859602|FG000|STARTED|Overall Study||29
10695340|NCT02524847|11859602|FG000|Completed Treatment Up to Week 12|Overall Study||14
10695341|NCT02524847|11859602|FG000|Started Second Line Treatment|Overall Study||5
10695342|NCT02524847|11859602|FG000|COMPLETED|Overall Study||15
10695343|NCT02524847|11859602|FG000|NOT COMPLETED|Overall Study||14
10695344|NCT02524977|11859609|FG000|STARTED|Overall Study||738
10695345|NCT02524977|11859610|FG001|STARTED|Overall Study||846
10695346|NCT02524977|11859609|FG000|COMPLETED|Overall Study||692
10695347|NCT02524977|11859610|FG001|COMPLETED|Overall Study||801
10695348|NCT02524977|11859609|FG000|NOT COMPLETED|Overall Study||46
10695349|NCT02524977|11859610|FG001|NOT COMPLETED|Overall Study||45
10695350|NCT02525055|11859624|FG000|STARTED|Overall Study||6
10695351|NCT02525055|11859625|FG001|STARTED|Overall Study||6
10695352|NCT02525055|11859626|FG002|STARTED|Overall Study||6
10695353|NCT02525055|11859627|FG003|STARTED|Overall Study||6
10695354|NCT02525055|11859628|FG004|STARTED|Overall Study||6
10695355|NCT02525055|11859629|FG005|STARTED|Overall Study||16
10695356|NCT02525055|11859624|FG000|COMPLETED|Overall Study||6
10695357|NCT02525055|11859625|FG001|COMPLETED|Overall Study||6
10695358|NCT02525055|11859626|FG002|COMPLETED|Overall Study||6
10695359|NCT02525055|11859627|FG003|COMPLETED|Overall Study||6
10695360|NCT02525055|11859628|FG004|COMPLETED|Overall Study||6
10695361|NCT02525055|11859629|FG005|COMPLETED|Overall Study||16
10695362|NCT02525055|11859624|FG000|NOT COMPLETED|Overall Study||0
10695363|NCT02525055|11859625|FG001|NOT COMPLETED|Overall Study||0
10695364|NCT02525055|11859626|FG002|NOT COMPLETED|Overall Study||0
10695365|NCT02525055|11859627|FG003|NOT COMPLETED|Overall Study||0
10695366|NCT02525055|11859628|FG004|NOT COMPLETED|Overall Study||0
10695367|NCT02525055|11859629|FG005|NOT COMPLETED|Overall Study||0
10695368|NCT02525094|11859645|FG000|STARTED|Overall Study||57
10695369|NCT02525094|11859646|FG001|STARTED|Overall Study||56
10695370|NCT02525094|11859645|FG000|Treated|Overall Study||56
10695371|NCT02525094|11859646|FG001|Treated|Overall Study||55
10695372|NCT02525094|11859645|FG000|COMPLETED|Overall Study||49
10695373|NCT02525094|11859646|FG001|COMPLETED|Overall Study||48
10695374|NCT02525094|11859645|FG000|NOT COMPLETED|Overall Study||8
10695375|NCT02525094|11859646|FG001|NOT COMPLETED|Overall Study||8
10695376|NCT02525133|11859655|FG000|STARTED|Overall Study||213
10695377|NCT02525133|11859656|FG001|STARTED|Overall Study||106
10695378|NCT02525133|11859655|FG000|Randomized But Not Treated|Overall Study||4
10695379|NCT02525133|11859656|FG001|Randomized But Not Treated|Overall Study||0
10695380|NCT02525133|11859655|FG000|COMPLETED|Overall Study||203
10695381|NCT02525133|11859656|FG001|COMPLETED|Overall Study||103
10695382|NCT02525133|11859655|FG000|NOT COMPLETED|Overall Study||10
10695383|NCT02525133|11859656|FG001|NOT COMPLETED|Overall Study||3
10695384|NCT02525263|11859662|FG000|STARTED|Overall Study|The single patient in this trial was enrolled on 18 July 2016.|1
10695385|NCT02525263|11859662|FG000|COMPLETED|Overall Study|The trial was completed when the patient reached the specified endpoint of starting hemodialysis.|1
10695386|NCT02525263|11859662|FG000|NOT COMPLETED|Overall Study||0
10695387|NCT02525471|11859668|FG000|STARTED|Overall Study||24
10695388|NCT02525471|11859668|FG000|Randomized/Treated|Overall Study||16
10695389|NCT02525471|11859668|FG000|COMPLETED|Overall Study||13
10695390|NCT02525471|11859668|FG000|NOT COMPLETED|Overall Study||11
10695391|NCT02525523|11859675|FG000|STARTED|Overall Study||69
10695392|NCT02525523|11859676|FG001|STARTED|Overall Study||69
10695393|NCT02525523|11859675|FG000|COMPLETED|Overall Study||46
10695394|NCT02525523|11859676|FG001|COMPLETED|Overall Study||44
10695395|NCT02525523|11859675|FG000|NOT COMPLETED|Overall Study||23
10695396|NCT02525523|11859676|FG001|NOT COMPLETED|Overall Study||25
10695397|NCT02525536|11859685|FG000|STARTED|Overall Study||6
10695398|NCT02525536|11859686|FG001|STARTED|Overall Study||6
10695399|NCT02525536|11859687|FG002|STARTED|Overall Study||6
10695400|NCT02525536|11859685|FG000|COMPLETED|Overall Study||6
10695401|NCT02525536|11859686|FG001|COMPLETED|Overall Study||6
10695402|NCT02525536|11859687|FG002|COMPLETED|Overall Study||6
10695403|NCT02525536|11859685|FG000|NOT COMPLETED|Overall Study||0
10695404|NCT02525536|11859686|FG001|NOT COMPLETED|Overall Study||0
10695405|NCT02525536|11859687|FG002|NOT COMPLETED|Overall Study||0
10695406|NCT02525549|11859698|FG000|STARTED|Overall Study||365
10695407|NCT02525549|11859699|FG001|STARTED|Overall Study||360
10695408|NCT02525549|11859700|FG002|STARTED|Overall Study||178
10695409|NCT02525549|11859698|FG000|COMPLETED|Overall Study||330
10695410|NCT02525549|11859699|FG001|COMPLETED|Overall Study||307
10695411|NCT02525549|11859700|FG002|COMPLETED|Overall Study||159
10695412|NCT02525549|11859698|FG000|NOT COMPLETED|Overall Study||35
10695413|NCT02525549|11859699|FG001|NOT COMPLETED|Overall Study||53
10695414|NCT02525549|11859700|FG002|NOT COMPLETED|Overall Study||19
10695415|NCT02525575|11859708|FG000|STARTED|Overall Study||37
10695416|NCT02525575|11859708|FG000|COMPLETED|Overall Study||22
10695417|NCT02525575|11859708|FG000|NOT COMPLETED|Overall Study||15
10695418|NCT02525588|11859714|FG000|STARTED|Overall Study||48
10695419|NCT02525588|11859715|FG001|STARTED|Overall Study||48
10695420|NCT02525588|11859714|FG000|COMPLETED|Overall Study||42
10695421|NCT02525588|11859715|FG001|COMPLETED|Overall Study||45
10695422|NCT02525588|11859714|FG000|NOT COMPLETED|Overall Study||6
10695423|NCT02525588|11859715|FG001|NOT COMPLETED|Overall Study||3
10695424|NCT02525627|11859723|FG000|STARTED|Overall Study||16
10695425|NCT02525627|11859724|FG001|STARTED|Overall Study||18
10695426|NCT02525627|11859723|FG000|COMPLETED|Overall Study||2
10695427|NCT02525627|11859724|FG001|COMPLETED|Overall Study||5
10695428|NCT02525627|11859723|FG000|NOT COMPLETED|Overall Study||14
10695429|NCT02525627|11859724|FG001|NOT COMPLETED|Overall Study||13
10695430|NCT02525653|11859730|FG000|STARTED|Overall Study||40
10695431|NCT02525653|11859730|FG000|COMPLETED|Overall Study||40
10695432|NCT02525653|11859730|FG000|NOT COMPLETED|Overall Study||0
10695433|NCT02525718|11859736|FG000|STARTED|Overall Study||23
10695434|NCT02525718|11859737|FG001|STARTED|Overall Study||24
10695435|NCT02525718|11859736|FG000|COMPLETED|Overall Study||22
10695436|NCT02525718|11859737|FG001|COMPLETED|Overall Study||23
10695437|NCT02525718|11859736|FG000|NOT COMPLETED|Overall Study||1
10695438|NCT02525718|11859737|FG001|NOT COMPLETED|Overall Study||1
10695439|NCT02525744|11859743|FG000|STARTED|Period 1||6
10695440|NCT02525744|11859744|FG001|STARTED|Period 1||6
10695441|NCT02525744|11859745|FG002|STARTED|Period 1||6
10695442|NCT02525744|11859746|FG003|STARTED|Period 1||6
10695443|NCT02525744|11859743|FG000|Received at Least 1 Dose of Study Drug|Period 1||6
10695444|NCT02525744|11859744|FG001|Received at Least 1 Dose of Study Drug|Period 1||6
10695445|NCT02525744|11859745|FG002|Received at Least 1 Dose of Study Drug|Period 1||5
10695446|NCT02525744|11859746|FG003|Received at Least 1 Dose of Study Drug|Period 1||6
10695447|NCT02525744|11859743|FG000|COMPLETED|Period 1||6
10695448|NCT02525744|11859744|FG001|COMPLETED|Period 1||6
10695449|NCT02525744|11859745|FG002|COMPLETED|Period 1||5
10695450|NCT02525744|11859746|FG003|COMPLETED|Period 1||6
10695451|NCT02525744|11859743|FG000|NOT COMPLETED|Period 1||0
10695452|NCT02525744|11859744|FG001|NOT COMPLETED|Period 1||0
10695453|NCT02525744|11859745|FG002|NOT COMPLETED|Period 1||1
10695454|NCT02525744|11859746|FG003|NOT COMPLETED|Period 1||0
10695455|NCT02525744|11859743|FG000|STARTED|Period 2||6
10695456|NCT02525744|11859744|FG001|STARTED|Period 2||6
10695457|NCT02525744|11859745|FG002|STARTED|Period 2||5
10695458|NCT02525744|11859746|FG003|STARTED|Period 2||6
10695459|NCT02525744|11859743|FG000|Received at Least 1 Dose of Study Drug|Period 2||6
10695460|NCT02525744|11859744|FG001|Received at Least 1 Dose of Study Drug|Period 2||6
10695461|NCT02525744|11859745|FG002|Received at Least 1 Dose of Study Drug|Period 2||5
10695462|NCT02525744|11859746|FG003|Received at Least 1 Dose of Study Drug|Period 2||6
10695463|NCT02525744|11859743|FG000|COMPLETED|Period 2||6
10695464|NCT02525744|11859744|FG001|COMPLETED|Period 2||6
10695465|NCT02525744|11859745|FG002|COMPLETED|Period 2||5
10695466|NCT02525744|11859746|FG003|COMPLETED|Period 2||6
10695467|NCT02525744|11859743|FG000|NOT COMPLETED|Period 2||0
10695468|NCT02525744|11859744|FG001|NOT COMPLETED|Period 2||0
10695469|NCT02525744|11859745|FG002|NOT COMPLETED|Period 2||0
10695470|NCT02525744|11859746|FG003|NOT COMPLETED|Period 2||0
10695471|NCT02525744|11859743|FG000|STARTED|Period 3||6
10695472|NCT02525744|11859744|FG001|STARTED|Period 3||6
10695473|NCT02525744|11859745|FG002|STARTED|Period 3||5
10695474|NCT02525744|11859746|FG003|STARTED|Period 3||6
10695475|NCT02525744|11859743|FG000|Received at Least 1 Dose of Study Drug|Period 3||6
10695476|NCT02525744|11859744|FG001|Received at Least 1 Dose of Study Drug|Period 3||6
10695477|NCT02525744|11859745|FG002|Received at Least 1 Dose of Study Drug|Period 3||5
10695478|NCT02525744|11859746|FG003|Received at Least 1 Dose of Study Drug|Period 3||6
10695479|NCT02525744|11859743|FG000|COMPLETED|Period 3||6
10695480|NCT02525744|11859744|FG001|COMPLETED|Period 3||5
10695481|NCT02525744|11859745|FG002|COMPLETED|Period 3||5
10695482|NCT02525744|11859746|FG003|COMPLETED|Period 3||6
10695483|NCT02525744|11859743|FG000|NOT COMPLETED|Period 3||0
10695484|NCT02525744|11859744|FG001|NOT COMPLETED|Period 3||1
10695485|NCT02525744|11859745|FG002|NOT COMPLETED|Period 3||0
10695486|NCT02525744|11859746|FG003|NOT COMPLETED|Period 3||0
10695487|NCT02525744|11859743|FG000|STARTED|Period 4||6
10695488|NCT02525744|11859744|FG001|STARTED|Period 4||5
10695489|NCT02525744|11859745|FG002|STARTED|Period 4||5
10695490|NCT02525744|11859746|FG003|STARTED|Period 4||6
10695491|NCT02525744|11859743|FG000|Received at Least 1 Dose of Study Drug|Period 4||6
10695492|NCT02525744|11859744|FG001|Received at Least 1 Dose of Study Drug|Period 4||5
10695493|NCT02525744|11859745|FG002|Received at Least 1 Dose of Study Drug|Period 4||5
10695494|NCT02525744|11859746|FG003|Received at Least 1 Dose of Study Drug|Period 4||6
10695495|NCT02525744|11859743|FG000|COMPLETED|Period 4||5
10695496|NCT02525744|11859744|FG001|COMPLETED|Period 4||5
10695497|NCT02525744|11859745|FG002|COMPLETED|Period 4||5
10695498|NCT02525744|11859746|FG003|COMPLETED|Period 4||6
10695499|NCT02525744|11859743|FG000|NOT COMPLETED|Period 4||1
10695500|NCT02525744|11859744|FG001|NOT COMPLETED|Period 4||0
10695501|NCT02525744|11859745|FG002|NOT COMPLETED|Period 4||0
10695502|NCT02525744|11859746|FG003|NOT COMPLETED|Period 4||0
10695503|NCT02525744|11859743|FG000|STARTED|Period 5||5
10695504|NCT02525744|11859744|FG001|STARTED|Period 5||5
10695505|NCT02525744|11859745|FG002|STARTED|Period 5||5
10695506|NCT02525744|11859746|FG003|STARTED|Period 5||6
10695507|NCT02525744|11859743|FG000|Received at Least 1 Dose of Study Drug|Period 5||4
10695508|NCT02525744|11859744|FG001|Received at Least 1 Dose of Study Drug|Period 5||5
10695509|NCT02525744|11859745|FG002|Received at Least 1 Dose of Study Drug|Period 5||5
10695510|NCT02525744|11859746|FG003|Received at Least 1 Dose of Study Drug|Period 5||6
10695511|NCT02525744|11859743|FG000|COMPLETED|Period 5||4
10695512|NCT02525744|11859744|FG001|COMPLETED|Period 5||5
10695513|NCT02525744|11859745|FG002|COMPLETED|Period 5||5
10695514|NCT02525744|11859746|FG003|COMPLETED|Period 5||6
10695515|NCT02525744|11859743|FG000|NOT COMPLETED|Period 5||1
10695516|NCT02525744|11859744|FG001|NOT COMPLETED|Period 5||0
10695517|NCT02525744|11859745|FG002|NOT COMPLETED|Period 5||0
10695518|NCT02525744|11859746|FG003|NOT COMPLETED|Period 5||0
10695519|NCT02525861|11859758|FG000|STARTED|Overall Study||18
10695520|NCT02525861|11859759|FG001|STARTED|Overall Study||16
10695521|NCT02525861|11859758|FG000|COMPLETED|Overall Study||17
10695522|NCT02525861|11859759|FG001|COMPLETED|Overall Study||14
10695523|NCT02525861|11859758|FG000|NOT COMPLETED|Overall Study||1
10695524|NCT02525861|11859759|FG001|NOT COMPLETED|Overall Study||2
10695525|NCT02525874|11859767|FG000|STARTED|Overall Study||218
10695526|NCT02525874|11859767|FG000|COMPLETED|Overall Study||158
10695527|NCT02525874|11859767|FG000|NOT COMPLETED|Overall Study||60
10695528|NCT02526160|11859773|FG000|STARTED|Double-Blind (Placebo-Controlled) Period||66
10695529|NCT02526160|11859774|FG001|STARTED|Double-Blind (Placebo-Controlled) Period||68
10695530|NCT02526160|11859773|FG000|COMPLETED|Double-Blind (Placebo-Controlled) Period||66
10695531|NCT02526160|11859774|FG001|COMPLETED|Double-Blind (Placebo-Controlled) Period||67
10695532|NCT02526160|11859773|FG000|NOT COMPLETED|Double-Blind (Placebo-Controlled) Period||0
10695533|NCT02526160|11859774|FG001|NOT COMPLETED|Double-Blind (Placebo-Controlled) Period||1
10695534|NCT02526160|11859773|FG000|STARTED|Open-label Treatment Continuation Period||66
10695535|NCT02526160|11859774|FG001|STARTED|Open-label Treatment Continuation Period||67
10695536|NCT02526160|11859773|FG000|COMPLETED|Open-label Treatment Continuation Period||63
10695537|NCT02526160|11859774|FG001|COMPLETED|Open-label Treatment Continuation Period||63
10695538|NCT02526160|11859773|FG000|NOT COMPLETED|Open-label Treatment Continuation Period||3
10695539|NCT02526160|11859774|FG001|NOT COMPLETED|Open-label Treatment Continuation Period||4
10695540|NCT02526160|11859773|FG000|STARTED|Open-Label Treatment Extension Period I||63
10695541|NCT02526160|11859774|FG001|STARTED|Open-Label Treatment Extension Period I||63
10695542|NCT02526160|11859773|FG000|COMPLETED|Open-Label Treatment Extension Period I||60
10695543|NCT02526160|11859774|FG001|COMPLETED|Open-Label Treatment Extension Period I||59
10695544|NCT02526160|11859773|FG000|NOT COMPLETED|Open-Label Treatment Extension Period I||3
10695545|NCT02526160|11859774|FG001|NOT COMPLETED|Open-Label Treatment Extension Period I||4
10695546|NCT02526160|11859773|FG000|STARTED|Open-Label Treatment Extension Period II||52
10695547|NCT02526160|11859774|FG001|STARTED|Open-Label Treatment Extension Period II||49
10695548|NCT02526160|11859773|FG000|COMPLETED|Open-Label Treatment Extension Period II||51
10695549|NCT02526160|11859774|FG001|COMPLETED|Open-Label Treatment Extension Period II||49
10695550|NCT02526160|11859773|FG000|NOT COMPLETED|Open-Label Treatment Extension Period II||1
10695551|NCT02526160|11859774|FG001|NOT COMPLETED|Open-Label Treatment Extension Period II||0
10695552|NCT02526212|11859787|FG000|STARTED|Overall Study||10
10695553|NCT02526212|11859788|FG001|STARTED|Overall Study||8
10695554|NCT02526212|11859787|FG000|COMPLETED|Overall Study||8
10695555|NCT02526212|11859788|FG001|COMPLETED|Overall Study||7
10695556|NCT02526212|11859787|FG000|NOT COMPLETED|Overall Study||2
10695557|NCT02526212|11859788|FG001|NOT COMPLETED|Overall Study||1
10695558|NCT02526277|11859798|FG000|STARTED|Overall Study||8
10695559|NCT02526277|11859799|FG001|STARTED|Overall Study||6
10695560|NCT02526277|11859800|FG002|STARTED|Overall Study||7
10695561|NCT02526277|11859801|FG003|STARTED|Overall Study||7
10695562|NCT02526277|11859798|FG000|COMPLETED|Overall Study||8
10695563|NCT02526277|11859799|FG001|COMPLETED|Overall Study||6
10695564|NCT02526277|11859800|FG002|COMPLETED|Overall Study||7
10695565|NCT02526277|11859801|FG003|COMPLETED|Overall Study||7
10695566|NCT02526277|11859798|FG000|NOT COMPLETED|Overall Study||0
10695567|NCT02526277|11859799|FG001|NOT COMPLETED|Overall Study||0
10695568|NCT02526277|11859800|FG002|NOT COMPLETED|Overall Study||0
10695569|NCT02526277|11859801|FG003|NOT COMPLETED|Overall Study||0
10695570|NCT02526290|11859814|FG000|STARTED|Overall Study||97
10695571|NCT02526290|11859814|FG000|COMPLETED|Overall Study||89
10695572|NCT02526290|11859814|FG000|NOT COMPLETED|Overall Study||8
10695573|NCT02526524|11859824|FG000|STARTED|Overall Study||94
10695574|NCT02526524|11859825|FG001|STARTED|Overall Study||95
10695575|NCT02526524|11859826|FG002|STARTED|Overall Study||96
10695576|NCT02526524|11859827|FG003|STARTED|Overall Study||96
10695577|NCT02526524|11859828|FG004|STARTED|Overall Study||96
10695578|NCT02526524|11859829|FG005|STARTED|Overall Study||94
10695579|NCT02526524|11859824|FG000|COMPLETED|Overall Study||82
10695580|NCT02526524|11859825|FG001|COMPLETED|Overall Study||86
10695581|NCT02526524|11859826|FG002|COMPLETED|Overall Study||70
10695582|NCT02526524|11859827|FG003|COMPLETED|Overall Study||89
10695583|NCT02526524|11859828|FG004|COMPLETED|Overall Study||72
10695584|NCT02526524|11859829|FG005|COMPLETED|Overall Study||73
10695585|NCT02526524|11859824|FG000|NOT COMPLETED|Overall Study||12
10695586|NCT02526524|11859825|FG001|NOT COMPLETED|Overall Study||9
10695587|NCT02526524|11859826|FG002|NOT COMPLETED|Overall Study||26
10695588|NCT02526524|11859827|FG003|NOT COMPLETED|Overall Study||7
10695589|NCT02526524|11859828|FG004|NOT COMPLETED|Overall Study||24
10695590|NCT02526524|11859829|FG005|NOT COMPLETED|Overall Study||21
10695591|NCT02526550|11859843|FG000|STARTED|Overall Study||50
10695592|NCT02526550|11859843|FG000|COMPLETED|Overall Study||49
10695593|NCT02526550|11859843|FG000|NOT COMPLETED|Overall Study||1
10695594|NCT02526654|11859849|FG000|STARTED|Overall Study||79
10695595|NCT02526654|11859850|FG001|STARTED|Overall Study||36
10695596|NCT02526654|11859849|FG000|COMPLETED|Overall Study||79
10695597|NCT02526654|11859850|FG001|COMPLETED|Overall Study||36
10695598|NCT02526654|11859849|FG000|NOT COMPLETED|Overall Study||0
10695599|NCT02526654|11859850|FG001|NOT COMPLETED|Overall Study||0
10695600|NCT02526667|11859859|FG000|STARTED|Abdomen||284
10695601|NCT02526667|11859860|FG001|STARTED|Abdomen||56
10695602|NCT02526667|11859861|FG002|STARTED|Abdomen||281
10695603|NCT02526667|11859859|FG000|COMPLETED|Abdomen||284
10695604|NCT02526667|11859860|FG001|COMPLETED|Abdomen||56
10695605|NCT02526667|11859861|FG002|COMPLETED|Abdomen||281
10695606|NCT02526667|11859859|FG000|NOT COMPLETED|Abdomen||0
10695607|NCT02526667|11859860|FG001|NOT COMPLETED|Abdomen||0
10695608|NCT02526667|11859861|FG002|NOT COMPLETED|Abdomen||0
10695609|NCT02526667|11859859|FG000|STARTED|Groin||290
10695610|NCT02526667|11859860|FG001|STARTED|Groin||56
10695611|NCT02526667|11859861|FG002|STARTED|Groin||294
10695612|NCT02526667|11859859|FG000|COMPLETED|Groin||290
10695613|NCT02526667|11859860|FG001|COMPLETED|Groin||56
10695614|NCT02526667|11859861|FG002|COMPLETED|Groin||294
10695615|NCT02526667|11859859|FG000|NOT COMPLETED|Groin||0
10695616|NCT02526667|11859860|FG001|NOT COMPLETED|Groin||0
10695617|NCT02526667|11859861|FG002|NOT COMPLETED|Groin||0
10695618|NCT02526680|11859875|FG000|STARTED|Overall Study||27
10695619|NCT02526680|11859875|FG000|COMPLETED|Overall Study||27
10695620|NCT02526680|11859875|FG000|NOT COMPLETED|Overall Study||0
10713417|NCT02678390|11878892|FG001|STARTED|Control (5 Days)||10
10713418|NCT02678390|11878891|FG000|COMPLETED|Control (5 Days)||10
10713419|NCT02678390|11878892|FG001|COMPLETED|Control (5 Days)||10
10713420|NCT02678390|11878891|FG000|NOT COMPLETED|Control (5 Days)||0
10713421|NCT02678390|11878892|FG001|NOT COMPLETED|Control (5 Days)||0
10713422|NCT02678390|11878891|FG000|STARTED|MCT (5 Days)||10
10713423|NCT02678390|11878892|FG001|STARTED|MCT (5 Days)||10
10713424|NCT02678390|11878891|FG000|COMPLETED|MCT (5 Days)||10
10713425|NCT02678390|11878892|FG001|COMPLETED|MCT (5 Days)||10
10713426|NCT02678390|11878891|FG000|NOT COMPLETED|MCT (5 Days)||0
10713427|NCT02678390|11878892|FG001|NOT COMPLETED|MCT (5 Days)||0
10713428|NCT02678390|11878891|FG000|STARTED|AE (1 Day)||10
10713429|NCT02678390|11878892|FG001|STARTED|AE (1 Day)||10
10713430|NCT02678390|11878891|FG000|COMPLETED|AE (1 Day)||10
10713431|NCT02678390|11878892|FG001|COMPLETED|AE (1 Day)||9
10713432|NCT02678390|11878891|FG000|NOT COMPLETED|AE (1 Day)||0
10713433|NCT02678390|11878892|FG001|NOT COMPLETED|AE (1 Day)||1
10713434|NCT02678390|11878891|FG000|STARTED|MCT + AE (5 Days)||10
10713435|NCT02678390|11878892|FG001|STARTED|MCT + AE (5 Days)||9
10713436|NCT02678390|11878891|FG000|COMPLETED|MCT + AE (5 Days)||10
10713437|NCT02678390|11878892|FG001|COMPLETED|MCT + AE (5 Days)||9
10713438|NCT02678390|11878891|FG000|NOT COMPLETED|MCT + AE (5 Days)||0
10713439|NCT02678390|11878892|FG001|NOT COMPLETED|MCT + AE (5 Days)||0
10713440|NCT02678416|11878900|FG000|STARTED|Part 1||12
10713441|NCT02678416|11878900|FG000|Safety Population|Part 1||12
10713442|NCT02678416|11878900|FG000|Modified Intent to Treat (mITT)|Part 1||12
10713443|NCT02678416|11878900|FG000|Per Protocol Population|Part 1||8
10713444|NCT02678416|11878900|FG000|COMPLETED|Part 1||11
10713445|NCT02678416|11878900|FG000|NOT COMPLETED|Part 1||1
10713446|NCT02678416|11878900|FG000|STARTED|Part 2|Part 2 enrolled all new participants|67
10713447|NCT02678416|11878900|FG000|Treated (Safety Population)|Part 2||66
10713448|NCT02678416|11878900|FG000|Modified Intent to Treat Population|Part 2||66
10713449|NCT02678416|11878900|FG000|Pharmacokinetic Population|Part 2||65
10713450|NCT02678416|11878900|FG000|Per Protocol Population|Part 2||64
10713451|NCT02678416|11878900|FG000|COMPLETED|Part 2||64
10713452|NCT02678416|11878900|FG000|NOT COMPLETED|Part 2||3
10713453|NCT02678442|11878920|FG000|STARTED|First Intervention||25
10713454|NCT02678442|11878921|FG001|STARTED|First Intervention||25
10713455|NCT02678442|11878920|FG000|COMPLETED|First Intervention||25
10713456|NCT02678442|11878921|FG001|COMPLETED|First Intervention||25
10713457|NCT02678442|11878920|FG000|NOT COMPLETED|First Intervention||0
10713458|NCT02678442|11878921|FG001|NOT COMPLETED|First Intervention||0
10713459|NCT02678442|11878920|FG000|STARTED|Second Intervention||25
10713460|NCT02678442|11878921|FG001|STARTED|Second Intervention||25
10713461|NCT02678442|11878920|FG000|COMPLETED|Second Intervention||23
10713462|NCT02678442|11878921|FG001|COMPLETED|Second Intervention||23
10713463|NCT02678442|11878920|FG000|NOT COMPLETED|Second Intervention||2
10713464|NCT02678442|11878921|FG001|NOT COMPLETED|Second Intervention||2
10713465|NCT02678676|11878929|FG000|STARTED|Overall Study||1820
10713466|NCT02678676|11878930|FG001|STARTED|Overall Study||1779
10713467|NCT02678676|11878929|FG000|COMPLETED|Overall Study||932
10713468|NCT02678676|11878930|FG001|COMPLETED|Overall Study||907
10695621|NCT02526693|11859882|FG000|STARTED|Overall Study||53
10695622|NCT02526693|11859883|FG001|STARTED|Overall Study||51
10695623|NCT02526693|11859882|FG000|COMPLETED|Overall Study||50
10695624|NCT02526693|11859883|FG001|COMPLETED|Overall Study||50
10695625|NCT02526693|11859882|FG000|NOT COMPLETED|Overall Study||3
10695626|NCT02526693|11859883|FG001|NOT COMPLETED|Overall Study||1
10695627|NCT02527148|11859895|FG000|STARTED|Overall Study||50
10695628|NCT02527148|11859896|FG001|STARTED|Overall Study||50
10695629|NCT02527148|11859895|FG000|COMPLETED|Overall Study||49
10695630|NCT02527148|11859896|FG001|COMPLETED|Overall Study||50
10695631|NCT02527148|11859895|FG000|NOT COMPLETED|Overall Study||1
10695632|NCT02527148|11859896|FG001|NOT COMPLETED|Overall Study||0
10695633|NCT02527161|11859904|FG000|STARTED|Overall Study|All results are reported by knee throughout record. Participant=knee.|205
10695634|NCT02527161|11859904|FG000|COMPLETED|Overall Study|Completed/Not completed counts are for knees at the 5 year outcome interval.|73
10695635|NCT02527161|11859904|FG000|NOT COMPLETED|Overall Study||132
10695636|NCT02527265|11859911|FG000|STARTED|Overall Study||15
10695637|NCT02527265|11859912|FG001|STARTED|Overall Study||15
10695638|NCT02527265|11859911|FG000|COMPLETED|Overall Study||13
10695639|NCT02527265|11859912|FG001|COMPLETED|Overall Study||11
10695640|NCT02527265|11859911|FG000|NOT COMPLETED|Overall Study||2
10695641|NCT02527265|11859912|FG001|NOT COMPLETED|Overall Study||4
10695642|NCT02527343|11859920|FG000|STARTED|RT Period: Weeks 1 to 52||19
10695643|NCT02527343|11859921|FG001|STARTED|RT Period: Weeks 1 to 52||21
10695644|NCT02527343|11859922|FG002|STARTED|RT Period: Weeks 1 to 52||0
10695645|NCT02527343|11859923|FG003|STARTED|RT Period: Weeks 1 to 52||0
10695646|NCT02527343|11859924|FG004|STARTED|RT Period: Weeks 1 to 52||0
10695647|NCT02527343|11859925|FG005|STARTED|RT Period: Weeks 1 to 52||0
10695648|NCT02527343|11859920|FG000|COMPLETED|RT Period: Weeks 1 to 52||13
10695649|NCT02527343|11859921|FG001|COMPLETED|RT Period: Weeks 1 to 52||14
10695650|NCT02527343|11859922|FG002|COMPLETED|RT Period: Weeks 1 to 52||0
10695651|NCT02527343|11859923|FG003|COMPLETED|RT Period: Weeks 1 to 52||0
10695652|NCT02527343|11859924|FG004|COMPLETED|RT Period: Weeks 1 to 52||0
10695653|NCT02527343|11859925|FG005|COMPLETED|RT Period: Weeks 1 to 52||0
10695654|NCT02527343|11859920|FG000|NOT COMPLETED|RT Period: Weeks 1 to 52||6
10695655|NCT02527343|11859921|FG001|NOT COMPLETED|RT Period: Weeks 1 to 52||7
10695656|NCT02527343|11859922|FG002|NOT COMPLETED|RT Period: Weeks 1 to 52||0
10695657|NCT02527343|11859923|FG003|NOT COMPLETED|RT Period: Weeks 1 to 52||0
10695658|NCT02527343|11859924|FG004|NOT COMPLETED|RT Period: Weeks 1 to 52||0
10695659|NCT02527343|11859925|FG005|NOT COMPLETED|RT Period: Weeks 1 to 52||0
10695660|NCT02527343|11859920|FG000|STARTED|RT Post Treatment Follow-up: Weeks 54-65||0
10695661|NCT02527343|11859921|FG001|STARTED|RT Post Treatment Follow-up: Weeks 54-65||0
10695662|NCT02527343|11859922|FG002|STARTED|RT Post Treatment Follow-up: Weeks 54-65|Only those participants who were entered in the 13-week post-treatment follow-up period after the randomized treatment period.|7
10695663|NCT02527343|11859923|FG003|STARTED|RT Post Treatment Follow-up: Weeks 54-65|Only those participants who were entered in the 13-week post-treatment follow-up period after the randomized treatment period.|9
10695664|NCT02527343|11859924|FG004|STARTED|RT Post Treatment Follow-up: Weeks 54-65||0
10695665|NCT02527343|11859925|FG005|STARTED|RT Post Treatment Follow-up: Weeks 54-65||0
10695666|NCT02527343|11859920|FG000|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
10695667|NCT02527343|11859921|FG001|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
10695668|NCT02527343|11859922|FG002|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||6
10695669|NCT02527343|11859923|FG003|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||7
10695670|NCT02527343|11859924|FG004|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
10695671|NCT02527343|11859925|FG005|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
10695672|NCT02527343|11859920|FG000|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
10695673|NCT02527343|11859921|FG001|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
10695674|NCT02527343|11859922|FG002|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||1
10695675|NCT02527343|11859923|FG003|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||2
10695676|NCT02527343|11859924|FG004|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
10695677|NCT02527343|11859925|FG005|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
10695678|NCT02527343|11859920|FG000|STARTED|OLE Period-Year 1: Week 53 to 104||0
10695679|NCT02527343|11859921|FG001|STARTED|OLE Period-Year 1: Week 53 to 104||0
10695680|NCT02527343|11859922|FG002|STARTED|OLE Period-Year 1: Week 53 to 104||0
10695681|NCT02527343|11859923|FG003|STARTED|OLE Period-Year 1: Week 53 to 104||0
10695682|NCT02527343|11859924|FG004|STARTED|OLE Period-Year 1: Week 53 to 104|Only those participants who were entered the in the OLE period (first OLE period) after the randomized treatment period.|12
10695683|NCT02527343|11859925|FG005|STARTED|OLE Period-Year 1: Week 53 to 104|Only those participants who were entered the in the OLE period (first OLE period) after the randomized treatment period.|12
10695684|NCT02527343|11859920|FG000|COMPLETED|OLE Period-Year 1: Week 53 to 104||0
10695685|NCT02527343|11859921|FG001|COMPLETED|OLE Period-Year 1: Week 53 to 104||0
10695686|NCT02527343|11859922|FG002|COMPLETED|OLE Period-Year 1: Week 53 to 104||0
10695687|NCT02527343|11859923|FG003|COMPLETED|OLE Period-Year 1: Week 53 to 104||0
10695688|NCT02527343|11859924|FG004|COMPLETED|OLE Period-Year 1: Week 53 to 104||1
10695689|NCT02527343|11859925|FG005|COMPLETED|OLE Period-Year 1: Week 53 to 104||3
10695690|NCT02527343|11859920|FG000|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||0
10695691|NCT02527343|11859921|FG001|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||0
10695692|NCT02527343|11859922|FG002|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||0
10695693|NCT02527343|11859923|FG003|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||0
10695694|NCT02527343|11859924|FG004|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||11
10695695|NCT02527343|11859925|FG005|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||9
10695696|NCT02527343|11859920|FG000|STARTED|OLE Period-Year 2: Week 105 to 156||0
10695697|NCT02527343|11859921|FG001|STARTED|OLE Period-Year 2: Week 105 to 156||0
10695698|NCT02527343|11859922|FG002|STARTED|OLE Period-Year 2: Week 105 to 156||0
10695699|NCT02527343|11859923|FG003|STARTED|OLE Period-Year 2: Week 105 to 156||0
10695700|NCT02527343|11859924|FG004|STARTED|OLE Period-Year 2: Week 105 to 156|Only those participants who were continuing the dosing for up to an additional 52 weeks in the second OLE period.|1
10695701|NCT02527343|11859925|FG005|STARTED|OLE Period-Year 2: Week 105 to 156|Only those participants who were continuing the dosing for up to an additional 52 weeks in the second OLE period.|2
10695702|NCT02527343|11859920|FG000|COMPLETED|OLE Period-Year 2: Week 105 to 156||0
10695703|NCT02527343|11859921|FG001|COMPLETED|OLE Period-Year 2: Week 105 to 156||0
10695704|NCT02527343|11859922|FG002|COMPLETED|OLE Period-Year 2: Week 105 to 156||0
10695705|NCT02527343|11859923|FG003|COMPLETED|OLE Period-Year 2: Week 105 to 156||0
10695706|NCT02527343|11859924|FG004|COMPLETED|OLE Period-Year 2: Week 105 to 156||0
10695707|NCT02527343|11859925|FG005|COMPLETED|OLE Period-Year 2: Week 105 to 156||0
10695708|NCT02527343|11859920|FG000|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||0
10695709|NCT02527343|11859921|FG001|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||0
10695710|NCT02527343|11859922|FG002|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||0
10695711|NCT02527343|11859923|FG003|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||0
10695712|NCT02527343|11859924|FG004|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||1
10695713|NCT02527343|11859925|FG005|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||2
10695714|NCT02527343|11859920|FG000|STARTED|PT Follow-up: Weeks 104 to 169||0
10695715|NCT02527343|11859921|FG001|STARTED|PT Follow-up: Weeks 104 to 169||0
10695716|NCT02527343|11859922|FG002|STARTED|PT Follow-up: Weeks 104 to 169||0
10695717|NCT02527343|11859923|FG003|STARTED|PT Follow-up: Weeks 104 to 169||0
10695718|NCT02527343|11859924|FG004|STARTED|PT Follow-up: Weeks 104 to 169|Participants who were entered in the post-treatment follow-up after the OLE Period.|12
10695719|NCT02527343|11859925|FG005|STARTED|PT Follow-up: Weeks 104 to 169|Participants who were entered in the post-treatment follow-up after the OLE Period.|12
10695720|NCT02527343|11859920|FG000|COMPLETED|PT Follow-up: Weeks 104 to 169||0
10695721|NCT02527343|11859921|FG001|COMPLETED|PT Follow-up: Weeks 104 to 169||0
10695722|NCT02527343|11859922|FG002|COMPLETED|PT Follow-up: Weeks 104 to 169||0
10695723|NCT02527343|11859923|FG003|COMPLETED|PT Follow-up: Weeks 104 to 169||0
10695724|NCT02527343|11859924|FG004|COMPLETED|PT Follow-up: Weeks 104 to 169||11
10695725|NCT02527343|11859925|FG005|COMPLETED|PT Follow-up: Weeks 104 to 169||11
10695726|NCT02527343|11859920|FG000|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||0
10695727|NCT02527343|11859921|FG001|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||0
10695728|NCT02527343|11859922|FG002|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||0
10695729|NCT02527343|11859923|FG003|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||0
10695730|NCT02527343|11859924|FG004|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||1
10695731|NCT02527343|11859925|FG005|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||1
10695732|NCT02527421|11859942|FG000|STARTED|Overall Study||2
10695733|NCT02527421|11859943|FG001|STARTED|Overall Study||1
10695734|NCT02527421|11859942|FG000|COMPLETED|Overall Study||1
10695735|NCT02527421|11859943|FG001|COMPLETED|Overall Study||1
10695736|NCT02527421|11859942|FG000|NOT COMPLETED|Overall Study||1
10695737|NCT02527421|11859943|FG001|NOT COMPLETED|Overall Study||0
10695738|NCT02527512|11859951|FG000|STARTED|Overall Study||85
10695739|NCT02527512|11859952|FG001|STARTED|Overall Study||82
10695740|NCT02527512|11859951|FG000|COMPLETED|Overall Study||77
10695741|NCT02527512|11859952|FG001|COMPLETED|Overall Study||76
10695742|NCT02527512|11859951|FG000|NOT COMPLETED|Overall Study||8
10695743|NCT02527512|11859952|FG001|NOT COMPLETED|Overall Study||6
10695744|NCT02527694|11859964|FG000|STARTED|Overall Study||20
10695745|NCT02527694|11859965|FG001|STARTED|Overall Study||29
10695746|NCT02527694|11859964|FG000|COMPLETED|Overall Study||10
10695747|NCT02527694|11859965|FG001|COMPLETED|Overall Study||21
10695748|NCT02527694|11859964|FG000|NOT COMPLETED|Overall Study||10
10695749|NCT02527694|11859965|FG001|NOT COMPLETED|Overall Study||8
10695750|NCT02528188|11859976|FG000|STARTED|Overall Study||1008
10695751|NCT02528188|11859977|FG001|STARTED|Overall Study||1005
10695752|NCT02528188|11859978|FG002|STARTED|Overall Study||1008
10695753|NCT02528188|11859976|FG000|Treated|Overall Study||1002
10695754|NCT02528188|11859977|FG001|Treated|Overall Study||998
10695755|NCT02528188|11859978|FG002|Treated|Overall Study||996
10695756|NCT02528188|11859976|FG000|COMPLETED|Overall Study||741
10695757|NCT02528188|11859977|FG001|COMPLETED|Overall Study||729
10695758|NCT02528188|11859978|FG002|COMPLETED|Overall Study||757
10695759|NCT02528188|11859976|FG000|NOT COMPLETED|Overall Study||267
10695760|NCT02528188|11859977|FG001|NOT COMPLETED|Overall Study||276
10695761|NCT02528188|11859978|FG002|NOT COMPLETED|Overall Study||251
10695762|NCT02528214|11859988|FG000|STARTED|Overall Study||107
10695763|NCT02528214|11859989|FG001|STARTED|Overall Study||103
10695764|NCT02528214|11859988|FG000|Treated|Overall Study||107
10695765|NCT02528214|11859989|FG001|Treated|Overall Study||103
10695766|NCT02528214|11859988|FG000|COMPLETED|Overall Study||107
10695767|NCT02528214|11859989|FG001|COMPLETED|Overall Study||100
10695768|NCT02528214|11859988|FG000|NOT COMPLETED|Overall Study||0
10695769|NCT02528214|11859989|FG001|NOT COMPLETED|Overall Study||3
10695770|NCT02528253|11860001|FG000|STARTED|Overall Study||205
10695771|NCT02528253|11860002|FG001|STARTED|Overall Study||204
10695772|NCT02528253|11860003|FG002|STARTED|Overall Study||407
10695773|NCT02528253|11860004|FG003|STARTED|Overall Study||407
10695774|NCT02528253|11860005|FG004|STARTED|Overall Study||602
10695775|NCT02528253|11860001|FG000|Intent to Treat Population|Overall Study||202
10695776|NCT02528253|11860002|FG001|Intent to Treat Population|Overall Study||204
10695777|NCT02528253|11860003|FG002|Intent to Treat Population|Overall Study||407
10695778|NCT02528253|11860004|FG003|Intent to Treat Population|Overall Study||407
10695779|NCT02528253|11860005|FG004|Intent to Treat Population|Overall Study|3 participants randomized to placebo arm received tramadol during the course of study|605
10695780|NCT02528253|11860001|FG000|Treated at Week 16|Overall Study||99
10695781|NCT02528253|11860002|FG001|Treated at Week 16|Overall Study||95
10695782|NCT02528253|11860003|FG002|Treated at Week 16|Overall Study||236
10695783|NCT02528253|11860004|FG003|Treated at Week 16|Overall Study||242
10695784|NCT02528253|11860005|FG004|Treated at Week 16|Overall Study||307
10695785|NCT02528253|11860001|FG000|COMPLETED|Overall Study||130
10695786|NCT02528253|11860002|FG001|COMPLETED|Overall Study||134
10695787|NCT02528253|11860003|FG002|COMPLETED|Overall Study||267
10695788|NCT02528253|11860004|FG003|COMPLETED|Overall Study||271
10695789|NCT02528253|11860005|FG004|COMPLETED|Overall Study||379
10695790|NCT02528253|11860001|FG000|NOT COMPLETED|Overall Study||75
10695791|NCT02528253|11860002|FG001|NOT COMPLETED|Overall Study||70
10695792|NCT02528253|11860003|FG002|NOT COMPLETED|Overall Study||140
10695793|NCT02528253|11860004|FG003|NOT COMPLETED|Overall Study||136
10695794|NCT02528253|11860005|FG004|NOT COMPLETED|Overall Study||223
10695795|NCT02528305|11860036|FG000|STARTED|Overall Study||12
10695796|NCT02528305|11860036|FG000|End of Control Period Assessment|Overall Study||11
10695797|NCT02528305|11860036|FG000|End of Intervention Period Assessment|Overall Study||9
10695798|NCT02528305|11860036|FG000|COMPLETED|Overall Study||9
10695799|NCT02528305|11860036|FG000|NOT COMPLETED|Overall Study||3
10695800|NCT02528318|11860047|FG000|STARTED|Overall Study||8
10695801|NCT02528318|11860048|FG001|STARTED|Overall Study||8
10695802|NCT02528318|11860049|FG002|STARTED|Overall Study||8
10695803|NCT02528318|11860050|FG003|STARTED|Overall Study|Study was terminated prior to initiation of this intervention|0
10695804|NCT02528318|11860051|FG004|STARTED|Overall Study||24
10695805|NCT02528318|11860047|FG000|COMPLETED|Overall Study||8
10695806|NCT02528318|11860048|FG001|COMPLETED|Overall Study||8
10695807|NCT02528318|11860049|FG002|COMPLETED|Overall Study||8
10695808|NCT02528318|11860050|FG003|COMPLETED|Overall Study||0
10695809|NCT02528318|11860051|FG004|COMPLETED|Overall Study||24
10695810|NCT02528318|11860047|FG000|NOT COMPLETED|Overall Study||0
10695811|NCT02528318|11860048|FG001|NOT COMPLETED|Overall Study||0
10695812|NCT02528318|11860049|FG002|NOT COMPLETED|Overall Study||0
10695813|NCT02528318|11860050|FG003|NOT COMPLETED|Overall Study||0
10695814|NCT02528318|11860051|FG004|NOT COMPLETED|Overall Study||0
10695815|NCT02528331|11860063|FG000|STARTED|Overall Study||2
10695816|NCT02528331|11860063|FG000|COMPLETED|Overall Study||0
10695817|NCT02528331|11860063|FG000|NOT COMPLETED|Overall Study||2
10695818|NCT02528357|11860086|FG000|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||1
10695819|NCT02528357|11860087|FG001|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||1
10695820|NCT02528357|11860088|FG002|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||8
10695821|NCT02528357|11860089|FG003|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||10
10695822|NCT02528357|11860090|FG004|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||10
10695823|NCT02528357|11860091|FG005|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||4
10695824|NCT02528357|11860092|FG006|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||7
10695825|NCT02528357|11860093|FG007|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||4
10695826|NCT02528357|11860094|FG008|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10695827|NCT02528357|11860095|FG009|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10695828|NCT02528357|11860096|FG010|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10695829|NCT02528357|11860097|FG011|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10695830|NCT02528357|11860098|FG012|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10695831|NCT02528357|11860099|FG013|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10695832|NCT02528357|11860100|FG014|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10695833|NCT02528357|11860101|FG015|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10695834|NCT02528357|11860102|FG016|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10695835|NCT02528357|11860103|FG017|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10695836|NCT02528357|11860104|FG018|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10695837|NCT02528357|11860086|FG000|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||1
10695838|NCT02528357|11860087|FG001|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10695839|NCT02528357|11860088|FG002|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||6
10695840|NCT02528357|11860089|FG003|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||9
10695841|NCT02528357|11860090|FG004|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||6
10695842|NCT02528357|11860091|FG005|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2
10695843|NCT02528357|11860092|FG006|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||5
10695844|NCT02528357|11860093|FG007|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2
10695845|NCT02528357|11860094|FG008|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10695846|NCT02528357|11860095|FG009|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10695847|NCT02528357|11860096|FG010|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10695848|NCT02528357|11860097|FG011|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10695849|NCT02528357|11860098|FG012|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10695850|NCT02528357|11860099|FG013|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10695851|NCT02528357|11860100|FG014|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10695852|NCT02528357|11860101|FG015|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10695853|NCT02528357|11860102|FG016|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10695854|NCT02528357|11860103|FG017|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10695855|NCT02528357|11860104|FG018|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10695856|NCT02528357|11860086|FG000|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10695857|NCT02528357|11860087|FG001|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||1
10695858|NCT02528357|11860088|FG002|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2
10695859|NCT02528357|11860089|FG003|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||1
10695860|NCT02528357|11860090|FG004|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||4
10695861|NCT02528357|11860091|FG005|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2
10695862|NCT02528357|11860092|FG006|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2
10695863|NCT02528357|11860093|FG007|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2
10695864|NCT02528357|11860094|FG008|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10695865|NCT02528357|11860095|FG009|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10695866|NCT02528357|11860096|FG010|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10695867|NCT02528357|11860097|FG011|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10695868|NCT02528357|11860098|FG012|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10695869|NCT02528357|11860099|FG013|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10695870|NCT02528357|11860100|FG014|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10695871|NCT02528357|11860101|FG015|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10695872|NCT02528357|11860102|FG016|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10695873|NCT02528357|11860103|FG017|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10695874|NCT02528357|11860104|FG018|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
10695875|NCT02528357|11860086|FG000|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10695876|NCT02528357|11860087|FG001|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10695877|NCT02528357|11860088|FG002|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10695878|NCT02528357|11860089|FG003|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10695879|NCT02528357|11860090|FG004|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10695880|NCT02528357|11860091|FG005|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10695881|NCT02528357|11860092|FG006|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10695882|NCT02528357|11860093|FG007|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10695883|NCT02528357|11860094|FG008|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||5
10695884|NCT02528357|11860095|FG009|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||5
10695885|NCT02528357|11860096|FG010|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||10
10695886|NCT02528357|11860097|FG011|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||12
10695887|NCT02528357|11860098|FG012|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||14
10695888|NCT02528357|11860099|FG013|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||12
10695889|NCT02528357|11860100|FG014|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||12
10695890|NCT02528357|11860101|FG015|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||4
10695891|NCT02528357|11860102|FG016|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10695892|NCT02528357|11860103|FG017|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10695893|NCT02528357|11860104|FG018|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10695894|NCT02528357|11860086|FG000|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10695895|NCT02528357|11860087|FG001|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10695896|NCT02528357|11860088|FG002|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10695897|NCT02528357|11860089|FG003|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10695898|NCT02528357|11860090|FG004|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10695899|NCT02528357|11860091|FG005|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10695900|NCT02528357|11860092|FG006|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10695901|NCT02528357|11860093|FG007|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10695902|NCT02528357|11860094|FG008|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||4
10695903|NCT02528357|11860095|FG009|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||4
10695904|NCT02528357|11860096|FG010|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||7
10695905|NCT02528357|11860097|FG011|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||9
10695906|NCT02528357|11860098|FG012|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||9
10695907|NCT02528357|11860099|FG013|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||6
10695908|NCT02528357|11860100|FG014|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||5
10695909|NCT02528357|11860101|FG015|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||4
10695910|NCT02528357|11860102|FG016|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10695911|NCT02528357|11860103|FG017|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10695912|NCT02528357|11860104|FG018|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10695913|NCT02528357|11860086|FG000|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10695914|NCT02528357|11860087|FG001|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10695915|NCT02528357|11860088|FG002|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10695916|NCT02528357|11860089|FG003|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10695917|NCT02528357|11860090|FG004|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10695918|NCT02528357|11860091|FG005|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10695919|NCT02528357|11860092|FG006|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10695920|NCT02528357|11860093|FG007|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10695921|NCT02528357|11860094|FG008|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||1
10695922|NCT02528357|11860095|FG009|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||1
10695923|NCT02528357|11860096|FG010|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||3
10695924|NCT02528357|11860097|FG011|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||3
10695925|NCT02528357|11860098|FG012|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||5
10695926|NCT02528357|11860099|FG013|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||6
10695927|NCT02528357|11860100|FG014|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||7
10695928|NCT02528357|11860101|FG015|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10695929|NCT02528357|11860102|FG016|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10695930|NCT02528357|11860103|FG017|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10695931|NCT02528357|11860104|FG018|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
10695932|NCT02528357|11860086|FG000|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10695933|NCT02528357|11860087|FG001|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10695934|NCT02528357|11860088|FG002|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10695935|NCT02528357|11860089|FG003|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10695936|NCT02528357|11860090|FG004|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10695937|NCT02528357|11860091|FG005|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10695938|NCT02528357|11860092|FG006|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10695939|NCT02528357|11860093|FG007|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10695940|NCT02528357|11860094|FG008|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10695941|NCT02528357|11860095|FG009|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10695942|NCT02528357|11860096|FG010|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10695943|NCT02528357|11860097|FG011|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10695944|NCT02528357|11860098|FG012|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10695945|NCT02528357|11860099|FG013|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10695946|NCT02528357|11860100|FG014|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10695947|NCT02528357|11860101|FG015|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10695948|NCT02528357|11860102|FG016|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||9
10695949|NCT02528357|11860103|FG017|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||8
10695950|NCT02528357|11860104|FG018|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||5
10695951|NCT02528357|11860086|FG000|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10695952|NCT02528357|11860087|FG001|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10695953|NCT02528357|11860088|FG002|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10695954|NCT02528357|11860089|FG003|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10695955|NCT02528357|11860090|FG004|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10695956|NCT02528357|11860091|FG005|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10695957|NCT02528357|11860092|FG006|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10695958|NCT02528357|11860093|FG007|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10695959|NCT02528357|11860094|FG008|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10695960|NCT02528357|11860095|FG009|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10695961|NCT02528357|11860096|FG010|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10695962|NCT02528357|11860097|FG011|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10695963|NCT02528357|11860098|FG012|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10695964|NCT02528357|11860099|FG013|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10695965|NCT02528357|11860100|FG014|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10695966|NCT02528357|11860101|FG015|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10695967|NCT02528357|11860102|FG016|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||6
10695968|NCT02528357|11860103|FG017|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||4
10695969|NCT02528357|11860104|FG018|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||2
10695970|NCT02528357|11860086|FG000|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10695971|NCT02528357|11860087|FG001|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10695972|NCT02528357|11860088|FG002|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10695973|NCT02528357|11860089|FG003|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10695974|NCT02528357|11860090|FG004|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10695975|NCT02528357|11860091|FG005|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10695976|NCT02528357|11860092|FG006|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10695977|NCT02528357|11860093|FG007|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10695978|NCT02528357|11860094|FG008|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10695979|NCT02528357|11860095|FG009|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10695980|NCT02528357|11860096|FG010|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10695981|NCT02528357|11860097|FG011|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10695982|NCT02528357|11860098|FG012|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10695983|NCT02528357|11860099|FG013|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10695984|NCT02528357|11860100|FG014|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10695985|NCT02528357|11860101|FG015|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
10695986|NCT02528357|11860102|FG016|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||3
10695987|NCT02528357|11860103|FG017|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||4
10695988|NCT02528357|11860104|FG018|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||3
10695989|NCT02528370|11860146|FG000|STARTED|Overall Study||119
10695990|NCT02528370|11860147|FG001|STARTED|Overall Study||78
10695991|NCT02528370|11860146|FG000|COMPLETED|Overall Study||102
10695992|NCT02528370|11860147|FG001|COMPLETED|Overall Study||77
10695993|NCT02528370|11860146|FG000|NOT COMPLETED|Overall Study||17
10695994|NCT02528370|11860147|FG001|NOT COMPLETED|Overall Study||1
10695995|NCT02528409|11860155|FG000|STARTED|Overall Study||40
10695996|NCT02528409|11860156|FG001|STARTED|Overall Study||40
10695997|NCT02528409|11860155|FG000|COMPLETED|Overall Study||18
10695998|NCT02528409|11860156|FG001|COMPLETED|Overall Study||24
10695999|NCT02528409|11860155|FG000|NOT COMPLETED|Overall Study||22
10696000|NCT02528409|11860156|FG001|NOT COMPLETED|Overall Study||16
10696001|NCT02528721|11860164|FG000|STARTED|Overall Study||203
10696002|NCT02528721|11860165|FG001|STARTED|Overall Study||79
10696003|NCT02528721|11860164|FG000|COMPLETED|Overall Study||196
10696004|NCT02528721|11860165|FG001|COMPLETED|Overall Study||76
10696005|NCT02528721|11860164|FG000|NOT COMPLETED|Overall Study||7
10696006|NCT02528721|11860165|FG001|NOT COMPLETED|Overall Study||3
10696007|NCT02528786|11860171|FG000|STARTED|Overall Study||8
10696008|NCT02528786|11860171|FG000|COMPLETED|Overall Study||8
10696009|NCT02528786|11860171|FG000|NOT COMPLETED|Overall Study||0
10696010|NCT02528942|11860175|FG000|STARTED|Overall Study||101
10696011|NCT02528942|11860175|FG000|COMPLETED|Overall Study||67
10696012|NCT02528942|11860175|FG000|NOT COMPLETED|Overall Study||34
10696013|NCT02529072|11860181|FG000|STARTED|Overall Study||3
10696014|NCT02529072|11860182|FG001|STARTED|Overall Study||3
10696015|NCT02529072|11860181|FG000|COMPLETED|Overall Study||3
10696016|NCT02529072|11860182|FG001|COMPLETED|Overall Study||3
10696017|NCT02529072|11860181|FG000|NOT COMPLETED|Overall Study||0
10696018|NCT02529072|11860182|FG001|NOT COMPLETED|Overall Study||0
10696019|NCT02529137|11860188|FG000|STARTED|Overall Study||2000
10696020|NCT02529137|11860188|FG000|COMPLETED|Overall Study||1992
10696021|NCT02529137|11860188|FG000|NOT COMPLETED|Overall Study||8
10696022|NCT02529488|11860193|FG000|STARTED|Overall Study||149
10696023|NCT02529488|11860193|FG000|COMPLETED|Overall Study||145
10696024|NCT02529488|11860193|FG000|NOT COMPLETED|Overall Study||4
10696025|NCT02529553|11860210|FG000|STARTED|Overall Study||1
10696026|NCT02529553|11860211|FG001|STARTED|Overall Study||1
10696027|NCT02529553|11860212|FG002|STARTED|Overall Study||1
10696028|NCT02529553|11860213|FG003|STARTED|Overall Study||3
10696029|NCT02529553|11860214|FG004|STARTED|Overall Study||3
10696030|NCT02529553|11860215|FG005|STARTED|Overall Study||4
10696031|NCT02529553|11860216|FG006|STARTED|Overall Study||3
10696032|NCT02529553|11860217|FG007|STARTED|Overall Study||6
10696033|NCT02529553|11860218|FG008|STARTED|Overall Study||3
10696034|NCT02529553|11860210|FG000|COMPLETED|Overall Study||0
10696035|NCT02529553|11860211|FG001|COMPLETED|Overall Study||0
10696036|NCT02529553|11860212|FG002|COMPLETED|Overall Study||0
10696037|NCT02529553|11860213|FG003|COMPLETED|Overall Study||0
10696038|NCT02529553|11860214|FG004|COMPLETED|Overall Study||0
10696039|NCT02529553|11860215|FG005|COMPLETED|Overall Study||0
10696040|NCT02529553|11860216|FG006|COMPLETED|Overall Study||0
10696041|NCT02529553|11860217|FG007|COMPLETED|Overall Study||0
10696042|NCT02529553|11860218|FG008|COMPLETED|Overall Study||0
10696043|NCT02529553|11860210|FG000|NOT COMPLETED|Overall Study||1
10696044|NCT02529553|11860211|FG001|NOT COMPLETED|Overall Study||1
10696045|NCT02529553|11860212|FG002|NOT COMPLETED|Overall Study||1
10696046|NCT02529553|11860213|FG003|NOT COMPLETED|Overall Study||3
10696047|NCT02529553|11860214|FG004|NOT COMPLETED|Overall Study||3
10696048|NCT02529553|11860215|FG005|NOT COMPLETED|Overall Study||4
10696049|NCT02529553|11860216|FG006|NOT COMPLETED|Overall Study||3
10696050|NCT02529553|11860217|FG007|NOT COMPLETED|Overall Study||6
10696051|NCT02529553|11860218|FG008|NOT COMPLETED|Overall Study||3
10696052|NCT02529995|11860241|FG000|STARTED|Part A||15
10696053|NCT02529995|11860242|FG001|STARTED|Part A||16
10696054|NCT02529995|11860241|FG000|COMPLETED|Part A|'Completed' means 'Completed the Study', i.e. zero patient completed the study in part A.|0
10696055|NCT02529995|11860242|FG001|COMPLETED|Part A|'Completed' means 'Completed the Study', i.e. zero patient completed the study in part A.|0
10696056|NCT02529995|11860241|FG000|NOT COMPLETED|Part A||15
10696057|NCT02529995|11860242|FG001|NOT COMPLETED|Part A||16
10696058|NCT02529995|11860241|FG000|STARTED|Part B||15
10696059|NCT02529995|11860242|FG001|STARTED|Part B||16
10696060|NCT02529995|11860241|FG000|COMPLETED|Part B||9
10696061|NCT02529995|11860242|FG001|COMPLETED|Part B||4
10696062|NCT02529995|11860241|FG000|NOT COMPLETED|Part B||6
10696063|NCT02529995|11860242|FG001|NOT COMPLETED|Part B||12
10696064|NCT02530125|11860248|FG000|STARTED|Completed Treatment||4
10696065|NCT02530125|11860248|FG000|COMPLETED|Completed Treatment||3
10696066|NCT02530125|11860248|FG000|NOT COMPLETED|Completed Treatment||1
10696067|NCT02530125|11860248|FG000|STARTED|Followed for Survival for 2 Years||3
10696068|NCT02530125|11860248|FG000|COMPLETED|Followed for Survival for 2 Years||0
10696069|NCT02530125|11860248|FG000|NOT COMPLETED|Followed for Survival for 2 Years||3
10696070|NCT02530151|11860254|FG000|STARTED|Overall Study||37
10696071|NCT02530151|11860255|FG001|STARTED|Overall Study||33
10696072|NCT02530151|11860254|FG000|COMPLETED|Overall Study||16
10696073|NCT02530151|11860255|FG001|COMPLETED|Overall Study||17
10696074|NCT02530151|11860254|FG000|NOT COMPLETED|Overall Study||21
10696075|NCT02530151|11860255|FG001|NOT COMPLETED|Overall Study||16
10696076|NCT02530242|11860263|FG000|STARTED|Overall Study||16
10696077|NCT02530242|11860264|FG001|STARTED|Overall Study||16
10696078|NCT02530242|11860263|FG000|COMPLETED|Overall Study||16
10696079|NCT02530242|11860264|FG001|COMPLETED|Overall Study||15
10696080|NCT02530242|11860263|FG000|NOT COMPLETED|Overall Study||0
10696081|NCT02530242|11860264|FG001|NOT COMPLETED|Overall Study||1
10696082|NCT02530281|11860272|FG000|STARTED|Overall Study||229
10696083|NCT02530281|11860273|FG001|STARTED|Overall Study||115
10696084|NCT02530281|11860272|FG000|COMPLETED|Overall Study||208
10696085|NCT02530281|11860273|FG001|COMPLETED|Overall Study||112
10696086|NCT02530281|11860272|FG000|NOT COMPLETED|Overall Study||21
10696087|NCT02530281|11860273|FG001|NOT COMPLETED|Overall Study||3
10696088|NCT02530294|11860283|FG000|STARTED|Overall Study||234
10696089|NCT02530294|11860284|FG001|STARTED|Overall Study||119
10696090|NCT02530294|11860283|FG000|COMPLETED|Overall Study||218
10696091|NCT02530294|11860284|FG001|COMPLETED|Overall Study||113
10696092|NCT02530294|11860283|FG000|NOT COMPLETED|Overall Study||16
10696093|NCT02530294|11860284|FG001|NOT COMPLETED|Overall Study||6
10696094|NCT02530385|11860292|FG000|STARTED|Overall Study||12
10696095|NCT02530385|11860293|FG001|STARTED|Overall Study||12
10696096|NCT02530385|11860292|FG000|COMPLETED|Overall Study||12
10696097|NCT02530385|11860293|FG001|COMPLETED|Overall Study||11
10696098|NCT02530385|11860292|FG000|NOT COMPLETED|Overall Study||0
10696099|NCT02530385|11860293|FG001|NOT COMPLETED|Overall Study||1
10696100|NCT02530450|11860301|FG000|STARTED|Overall Study||16
10696101|NCT02530450|11860302|FG001|STARTED|Overall Study||14
10696102|NCT02530450|11860301|FG000|COMPLETED|Overall Study||10
10696103|NCT02530450|11860302|FG001|COMPLETED|Overall Study||9
10696104|NCT02530450|11860301|FG000|NOT COMPLETED|Overall Study||6
10696105|NCT02530450|11860302|FG001|NOT COMPLETED|Overall Study||5
10696106|NCT02530476|11860312|FG000|STARTED|Overall Study||4
10696107|NCT02530476|11860313|FG001|STARTED|Overall Study||3
10696108|NCT02530476|11860314|FG002|STARTED|Overall Study||7
10696109|NCT02530476|11860315|FG003|STARTED|Overall Study||3
10696110|NCT02530476|11860312|FG000|COMPLETED|Overall Study||4
10696111|NCT02530476|11860313|FG001|COMPLETED|Overall Study||3
10696112|NCT02530476|11860314|FG002|COMPLETED|Overall Study||7
10696113|NCT02530476|11860315|FG003|COMPLETED|Overall Study||3
10696114|NCT02530476|11860312|FG000|NOT COMPLETED|Overall Study||0
10696115|NCT02530476|11860313|FG001|NOT COMPLETED|Overall Study||0
10696116|NCT02530476|11860314|FG002|NOT COMPLETED|Overall Study||0
10696117|NCT02530476|11860315|FG003|NOT COMPLETED|Overall Study||0
10696118|NCT02530515|11860328|FG000|STARTED|Overall Study||0
10696119|NCT02530515|11860329|FG001|STARTED|Overall Study||0
10696120|NCT02530515|11860330|FG002|STARTED|Overall Study||8
10696121|NCT02530515|11860328|FG000|COMPLETED|Overall Study||0
10696122|NCT02530515|11860329|FG001|COMPLETED|Overall Study||0
10696123|NCT02530515|11860330|FG002|COMPLETED|Overall Study||8
10696124|NCT02530515|11860328|FG000|NOT COMPLETED|Overall Study||0
10696125|NCT02530515|11860329|FG001|NOT COMPLETED|Overall Study||0
10696126|NCT02530515|11860330|FG002|NOT COMPLETED|Overall Study||0
10696127|NCT02530528|11860338|FG000|STARTED|Overall Study||13
10696128|NCT02530528|11860339|FG001|STARTED|Overall Study||13
10696129|NCT02530528|11860340|FG002|STARTED|Overall Study||14
10696130|NCT02530528|11860341|FG003|STARTED|Overall Study||14
10696131|NCT02530528|11860342|FG004|STARTED|Overall Study||13
10696132|NCT02530528|11860343|FG005|STARTED|Overall Study||13
10696133|NCT02530528|11860344|FG006|STARTED|Overall Study||14
10696134|NCT02530528|11860345|FG007|STARTED|Overall Study||14
10696135|NCT02530528|11860338|FG000|COMPLETED|Overall Study|13 participants received CHG Cloth|12
10696136|NCT02530528|11860339|FG001|COMPLETED|Overall Study||12
10696137|NCT02530528|11860340|FG002|COMPLETED|Overall Study|14 participants received CHG cloth|12
10696138|NCT02530528|11860341|FG003|COMPLETED|Overall Study||12
10696139|NCT02530528|11860342|FG004|COMPLETED|Overall Study|13 participants received CHG cloth|12
10696140|NCT02530528|11860343|FG005|COMPLETED|Overall Study||12
10696141|NCT02530528|11860344|FG006|COMPLETED|Overall Study|14 participants received comparator CHG.|12
10696142|NCT02530528|11860345|FG007|COMPLETED|Overall Study||12
10696143|NCT02530528|11860338|FG000|NOT COMPLETED|Overall Study||1
10696144|NCT02530528|11860339|FG001|NOT COMPLETED|Overall Study||1
10696145|NCT02530528|11860340|FG002|NOT COMPLETED|Overall Study||2
10696146|NCT02530528|11860341|FG003|NOT COMPLETED|Overall Study||2
10696147|NCT02530528|11860342|FG004|NOT COMPLETED|Overall Study||1
10696148|NCT02530528|11860343|FG005|NOT COMPLETED|Overall Study||1
10696149|NCT02530528|11860344|FG006|NOT COMPLETED|Overall Study||2
10696150|NCT02530528|11860345|FG007|NOT COMPLETED|Overall Study||2
10696151|NCT02530541|11860359|FG000|STARTED|Overall Study||21
10696152|NCT02530541|11860360|FG001|STARTED|Overall Study||23
10696153|NCT02530541|11860361|FG002|STARTED|Overall Study||22
10696154|NCT02530541|11860362|FG003|STARTED|Overall Study||21
10696155|NCT02530541|11860363|FG004|STARTED|Overall Study||20
10696156|NCT02530541|11860364|FG005|STARTED|Overall Study||19
10696157|NCT02530541|11860359|FG000|COMPLETED|Overall Study||14
10696158|NCT02530541|11860360|FG001|COMPLETED|Overall Study||15
10696159|NCT02530541|11860361|FG002|COMPLETED|Overall Study||14
10696160|NCT02530541|11860362|FG003|COMPLETED|Overall Study||15
10696161|NCT02530541|11860363|FG004|COMPLETED|Overall Study||15
10696162|NCT02530541|11860364|FG005|COMPLETED|Overall Study||14
10696163|NCT02530541|11860359|FG000|NOT COMPLETED|Overall Study||7
10696164|NCT02530541|11860360|FG001|NOT COMPLETED|Overall Study||8
10696165|NCT02530541|11860361|FG002|NOT COMPLETED|Overall Study||8
10696166|NCT02530541|11860362|FG003|NOT COMPLETED|Overall Study||6
10696167|NCT02530541|11860363|FG004|NOT COMPLETED|Overall Study||5
10696168|NCT02530541|11860364|FG005|NOT COMPLETED|Overall Study||5
10696169|NCT02530554|11860373|FG000|STARTED|Overall Study||12
10696170|NCT02530554|11860374|FG001|STARTED|Overall Study||14
10696171|NCT02530554|11860375|FG002|STARTED|Overall Study||12
10696172|NCT02530554|11860376|FG003|STARTED|Overall Study||14
10696173|NCT02530554|11860373|FG000|COMPLETED|Overall Study||12
10696174|NCT02530554|11860374|FG001|COMPLETED|Overall Study||14
10696175|NCT02530554|11860375|FG002|COMPLETED|Overall Study||12
10696176|NCT02530554|11860376|FG003|COMPLETED|Overall Study||14
10696177|NCT02530554|11860373|FG000|NOT COMPLETED|Overall Study||0
10696178|NCT02530554|11860374|FG001|NOT COMPLETED|Overall Study||0
10696179|NCT02530554|11860375|FG002|NOT COMPLETED|Overall Study||0
10696180|NCT02530554|11860376|FG003|NOT COMPLETED|Overall Study||0
10696181|NCT02530619|11860383|FG000|STARTED|Registered for Study||26
10696182|NCT02530619|11860383|FG000|Registered|Registered for Study||26
10696183|NCT02530619|11860383|FG000|Received 1st Dose of Alisertib|Registered for Study||24
10696184|NCT02530619|11860383|FG000|COMPLETED|Registered for Study||24
10696185|NCT02530619|11860383|FG000|NOT COMPLETED|Registered for Study||2
10696186|NCT02530619|11860383|FG000|STARTED|Completed 1st Cycle of Treatment||24
10696187|NCT02530619|11860383|FG000|COMPLETED|Completed 1st Cycle of Treatment||24
10696188|NCT02530619|11860383|FG000|NOT COMPLETED|Completed 1st Cycle of Treatment||0
10696189|NCT02530619|11860383|FG000|STARTED|Continued Treatment Cycles 2 Through 6||24
10696190|NCT02530619|11860383|FG000|COMPLETED|Continued Treatment Cycles 2 Through 6||14
10696191|NCT02530619|11860383|FG000|NOT COMPLETED|Continued Treatment Cycles 2 Through 6||10
10696192|NCT02530619|11860383|FG000|STARTED|Continued Treatment Cycle 7+||14
10696193|NCT02530619|11860383|FG000|COMPLETED|Continued Treatment Cycle 7+||14
10696194|NCT02530619|11860383|FG000|NOT COMPLETED|Continued Treatment Cycle 7+||0
10696195|NCT02530619|11860383|FG000|STARTED|Follow-up Period (6 Months)|Patients who received at least one dose of study drug go into follow-up.|21
10696196|NCT02530619|11860383|FG000|COMPLETED|Follow-up Period (6 Months)||10
10696197|NCT02530619|11860383|FG000|NOT COMPLETED|Follow-up Period (6 Months)||11
10696198|NCT02530671|11860389|FG000|STARTED|Overall Study||55
10696199|NCT02530671|11860390|FG001|STARTED|Overall Study||55
10696200|NCT02530671|11860389|FG000|COMPLETED|Overall Study||52
10696201|NCT02530671|11860390|FG001|COMPLETED|Overall Study||55
10696202|NCT02530671|11860389|FG000|NOT COMPLETED|Overall Study||3
10696203|NCT02530671|11860390|FG001|NOT COMPLETED|Overall Study||0
10696204|NCT02530905|11860398|FG000|STARTED|Double-Blind Period (12 Weeks)||4
10696205|NCT02530905|11860399|FG001|STARTED|Double-Blind Period (12 Weeks)||8
10696206|NCT02530905|11860400|FG002|STARTED|Double-Blind Period (12 Weeks)||0
10696207|NCT02530905|11860398|FG000|Received 4 mg/kg|Double-Blind Period (12 Weeks)||0
10696208|NCT02530905|11860399|FG001|Received 4 mg/kg|Double-Blind Period (12 Weeks)||8
10696209|NCT02530905|11860400|FG002|Received 4 mg/kg|Double-Blind Period (12 Weeks)||0
10696210|NCT02530905|11860398|FG000|Received 10 mg/kg|Double-Blind Period (12 Weeks)||0
10696211|NCT02530905|11860399|FG001|Received 10 mg/kg|Double-Blind Period (12 Weeks)||8
10696212|NCT02530905|11860400|FG002|Received 10 mg/kg|Double-Blind Period (12 Weeks)||0
10696213|NCT02530905|11860398|FG000|Received 20 mg/kg|Double-Blind Period (12 Weeks)||0
10696214|NCT02530905|11860399|FG001|Received 20 mg/kg|Double-Blind Period (12 Weeks)||8
10696215|NCT02530905|11860400|FG002|Received 20 mg/kg|Double-Blind Period (12 Weeks)||0
10696216|NCT02530905|11860398|FG000|Received 30 mg/kg|Double-Blind Period (12 Weeks)||0
10696217|NCT02530905|11860399|FG001|Received 30 mg/kg|Double-Blind Period (12 Weeks)||8
10696218|NCT02530905|11860400|FG002|Received 30 mg/kg|Double-Blind Period (12 Weeks)||0
10696219|NCT02530905|11860398|FG000|COMPLETED|Double-Blind Period (12 Weeks)||4
10696220|NCT02530905|11860399|FG001|COMPLETED|Double-Blind Period (12 Weeks)||8
10696221|NCT02530905|11860400|FG002|COMPLETED|Double-Blind Period (12 Weeks)||0
10696222|NCT02530905|11860398|FG000|NOT COMPLETED|Double-Blind Period (12 Weeks)||0
10696223|NCT02530905|11860399|FG001|NOT COMPLETED|Double-Blind Period (12 Weeks)||0
10696224|NCT02530905|11860400|FG002|NOT COMPLETED|Double-Blind Period (12 Weeks)||0
10696225|NCT02530905|11860398|FG000|STARTED|Open Label Extension Period (132 Weeks)||0
10696226|NCT02530905|11860399|FG001|STARTED|Open Label Extension Period (132 Weeks)||0
10696227|NCT02530905|11860400|FG002|STARTED|Open Label Extension Period (132 Weeks)|All participants from the double-blind period amenable to exon 45 skipping were enrolled to open-label extension period.|12
10696228|NCT02530905|11860398|FG000|COMPLETED|Open Label Extension Period (132 Weeks)||0
10696229|NCT02530905|11860399|FG001|COMPLETED|Open Label Extension Period (132 Weeks)||0
10696230|NCT02530905|11860400|FG002|COMPLETED|Open Label Extension Period (132 Weeks)||11
10696231|NCT02530905|11860398|FG000|NOT COMPLETED|Open Label Extension Period (132 Weeks)||0
10696232|NCT02530905|11860399|FG001|NOT COMPLETED|Open Label Extension Period (132 Weeks)||0
10696233|NCT02530905|11860400|FG002|NOT COMPLETED|Open Label Extension Period (132 Weeks)||1
10696234|NCT02530970|11860422|FG000|STARTED|Overall Study||1025
10696235|NCT02530970|11860422|FG000|COMPLETED|Overall Study||891
10696236|NCT02530970|11860422|FG000|NOT COMPLETED|Overall Study||134
10696237|NCT02530996|11860426|FG000|STARTED|First Intervention||6
10696238|NCT02530996|11860427|FG001|STARTED|First Intervention||6
10696239|NCT02530996|11860426|FG000|COMPLETED|First Intervention||6
10696240|NCT02530996|11860427|FG001|COMPLETED|First Intervention||6
10696241|NCT02530996|11860426|FG000|NOT COMPLETED|First Intervention||0
10696242|NCT02530996|11860427|FG001|NOT COMPLETED|First Intervention||0
10696243|NCT02530996|11860426|FG000|STARTED|Washout (5 Days)||6
10696244|NCT02530996|11860427|FG001|STARTED|Washout (5 Days)||6
10696245|NCT02530996|11860426|FG000|COMPLETED|Washout (5 Days)||6
10696246|NCT02530996|11860427|FG001|COMPLETED|Washout (5 Days)||6
10696247|NCT02530996|11860426|FG000|NOT COMPLETED|Washout (5 Days)||0
10696248|NCT02530996|11860427|FG001|NOT COMPLETED|Washout (5 Days)||0
10696249|NCT02530996|11860426|FG000|STARTED|Second Intervention||6
10696250|NCT02530996|11860427|FG001|STARTED|Second Intervention||6
10696251|NCT02530996|11860426|FG000|COMPLETED|Second Intervention||6
10696252|NCT02530996|11860427|FG001|COMPLETED|Second Intervention||6
10696253|NCT02530996|11860426|FG000|NOT COMPLETED|Second Intervention||0
10696254|NCT02530996|11860427|FG001|NOT COMPLETED|Second Intervention||0
10696255|NCT02531022|11860439|FG000|STARTED|Overall Study||55
10696256|NCT02531022|11860440|FG001|STARTED|Overall Study||50
10696257|NCT02531022|11860439|FG000|COMPLETED|Overall Study||55
10696258|NCT02531022|11860440|FG001|COMPLETED|Overall Study||48
10696259|NCT02531022|11860439|FG000|NOT COMPLETED|Overall Study||0
10696260|NCT02531022|11860440|FG001|NOT COMPLETED|Overall Study||2
10696261|NCT02531035|11860448|FG000|STARTED|Overall Study||705
10696262|NCT02531035|11860449|FG001|STARTED|Overall Study||700
10696263|NCT02531035|11860448|FG000|Treated|Overall Study||703
10696264|NCT02531035|11860449|FG001|Treated|Overall Study||699
10696265|NCT02531035|11860448|FG000|COMPLETED|Overall Study||624
10696266|NCT02531035|11860449|FG001|COMPLETED|Overall Study||605
10696267|NCT02531035|11860448|FG000|NOT COMPLETED|Overall Study||81
10696268|NCT02531035|11860449|FG001|NOT COMPLETED|Overall Study||95
10696269|NCT02531113|11860455|FG000|STARTED|Induction Period: Week 0 to 12||69
10696270|NCT02531113|11860455|FG000|COMPLETED|Induction Period: Week 0 to 12||58
10696271|NCT02531113|11860455|FG000|NOT COMPLETED|Induction Period: Week 0 to 12||11
10696272|NCT02531113|11860455|FG000|STARTED|Extension Period: Week 12 up to Week 160|6 participants completed induction; did not advance to extension due to lack efficacy.|52
10696273|NCT02531113|11860455|FG000|COMPLETED|Extension Period: Week 12 up to Week 160||14
10696274|NCT02531113|11860455|FG000|NOT COMPLETED|Extension Period: Week 12 up to Week 160||38
10696275|NCT02531321|11860461|FG000|STARTED|Overall Study||7
10696276|NCT02531321|11860462|FG001|STARTED|Overall Study||10
10696277|NCT02531321|11860461|FG000|COMPLETED|Overall Study||5
10696278|NCT02531321|11860462|FG001|COMPLETED|Overall Study||10
10696279|NCT02531321|11860461|FG000|NOT COMPLETED|Overall Study||2
10696280|NCT02531321|11860462|FG001|NOT COMPLETED|Overall Study||0
10696281|NCT02531373|11860477|FG000|STARTED|Overall Study||20
10696282|NCT02531373|11860478|FG001|STARTED|Overall Study||20
10696283|NCT02531373|11860479|FG002|STARTED|Overall Study||20
10696284|NCT02531373|11860480|FG003|STARTED|Overall Study||20
10696285|NCT02531373|11860481|FG004|STARTED|Overall Study||51
10696286|NCT02531373|11860482|FG005|STARTED|Overall Study||51
10696287|NCT02531373|11860483|FG006|STARTED|Overall Study||52
10696288|NCT02531373|11860484|FG007|STARTED|Overall Study||52
10696289|NCT02531373|11860485|FG008|STARTED|Overall Study||52
10696290|NCT02531373|11860477|FG000|Vaccination 1|Overall Study||20
10696291|NCT02531373|11860478|FG001|Vaccination 1|Overall Study||20
10696292|NCT02531373|11860479|FG002|Vaccination 1|Overall Study||20
10696293|NCT02531373|11860480|FG003|Vaccination 1|Overall Study||20
10696294|NCT02531373|11860481|FG004|Vaccination 1|Overall Study||50
10696295|NCT02531373|11860482|FG005|Vaccination 1|Overall Study||50
10696296|NCT02531373|11860483|FG006|Vaccination 1|Overall Study||52
10696297|NCT02531373|11860484|FG007|Vaccination 1|Overall Study||52
10696298|NCT02531373|11860485|FG008|Vaccination 1|Overall Study||52
10696299|NCT02531373|11860477|FG000|Vaccination 2|Overall Study||0
10696300|NCT02531373|11860478|FG001|Vaccination 2|Overall Study||0
10696301|NCT02531373|11860479|FG002|Vaccination 2|Overall Study||0
10696302|NCT02531373|11860480|FG003|Vaccination 2|Overall Study||0
10696303|NCT02531373|11860481|FG004|Vaccination 2|Overall Study||49
10696304|NCT02531373|11860482|FG005|Vaccination 2|Overall Study||48
10696305|NCT02531373|11860483|FG006|Vaccination 2|Overall Study||50
10696306|NCT02531373|11860484|FG007|Vaccination 2|Overall Study||51
10696307|NCT02531373|11860485|FG008|Vaccination 2|Overall Study||51
10696308|NCT02531373|11860477|FG000|Vaccination 3|Overall Study||0
10696309|NCT02531373|11860478|FG001|Vaccination 3|Overall Study||0
10696310|NCT02531373|11860479|FG002|Vaccination 3|Overall Study||0
10696311|NCT02531373|11860480|FG003|Vaccination 3|Overall Study||0
10696312|NCT02531373|11860481|FG004|Vaccination 3|Overall Study||48
10696313|NCT02531373|11860482|FG005|Vaccination 3|Overall Study||47
10696314|NCT02531373|11860483|FG006|Vaccination 3|Overall Study||49
10696315|NCT02531373|11860484|FG007|Vaccination 3|Overall Study||51
10696316|NCT02531373|11860485|FG008|Vaccination 3|Overall Study||49
10696317|NCT02531373|11860477|FG000|Vaccination 4|Overall Study||0
10696318|NCT02531373|11860478|FG001|Vaccination 4|Overall Study||0
10696319|NCT02531373|11860479|FG002|Vaccination 4|Overall Study||0
10696320|NCT02531373|11860480|FG003|Vaccination 4|Overall Study||0
10696321|NCT02531373|11860481|FG004|Vaccination 4|Overall Study||44
10696322|NCT02531373|11860482|FG005|Vaccination 4|Overall Study||43
10696323|NCT02531373|11860483|FG006|Vaccination 4|Overall Study||43
10696324|NCT02531373|11860484|FG007|Vaccination 4|Overall Study||43
10696325|NCT02531373|11860485|FG008|Vaccination 4|Overall Study||43
10696326|NCT02531373|11860477|FG000|COMPLETED|Overall Study||20
10696327|NCT02531373|11860478|FG001|COMPLETED|Overall Study||20
10696328|NCT02531373|11860479|FG002|COMPLETED|Overall Study||20
10696329|NCT02531373|11860480|FG003|COMPLETED|Overall Study||20
10696330|NCT02531373|11860481|FG004|COMPLETED|Overall Study||43
10696331|NCT02531373|11860482|FG005|COMPLETED|Overall Study||42
10696332|NCT02531373|11860483|FG006|COMPLETED|Overall Study||41
10696333|NCT02531373|11860484|FG007|COMPLETED|Overall Study||43
10696334|NCT02531373|11860485|FG008|COMPLETED|Overall Study||43
10696335|NCT02531373|11860477|FG000|NOT COMPLETED|Overall Study||0
10696336|NCT02531373|11860478|FG001|NOT COMPLETED|Overall Study||0
10696337|NCT02531373|11860479|FG002|NOT COMPLETED|Overall Study||0
10696338|NCT02531373|11860480|FG003|NOT COMPLETED|Overall Study||0
10696339|NCT02531373|11860481|FG004|NOT COMPLETED|Overall Study||8
10696340|NCT02531373|11860482|FG005|NOT COMPLETED|Overall Study||9
10696341|NCT02531373|11860483|FG006|NOT COMPLETED|Overall Study||11
10696342|NCT02531373|11860484|FG007|NOT COMPLETED|Overall Study||9
10696343|NCT02531373|11860485|FG008|NOT COMPLETED|Overall Study||9
10696344|NCT02531438|11860508|FG000|STARTED|Overall Study||386
10696345|NCT02531438|11860509|FG001|STARTED|Overall Study||388
10696346|NCT02531438|11860508|FG000|COMPLETED|Overall Study||356
10696347|NCT02531438|11860509|FG001|COMPLETED|Overall Study||362
10696348|NCT02531438|11860508|FG000|NOT COMPLETED|Overall Study||30
10696349|NCT02531438|11860509|FG001|NOT COMPLETED|Overall Study||26
10696350|NCT02531633|11860520|FG000|STARTED|Part A (52 Weeks)||42
10696351|NCT02531633|11860521|FG001|STARTED|Part A (52 Weeks)||39
10696352|NCT02531633|11860522|FG002|STARTED|Part A (52 Weeks)||26
10696353|NCT02531633|11860523|FG003|STARTED|Part A (52 Weeks)||27
10696354|NCT02531633|11860524|FG004|STARTED|Part A (52 Weeks)||27
10696355|NCT02531633|11860525|FG005|STARTED|Part A (52 Weeks)||0
10696356|NCT02531633|11860526|FG006|STARTED|Part A (52 Weeks)||0
10455389|NCT01001520|11603460|FG001|STARTED|Medication Period 2||16
10455390|NCT01001520|11603459|FG000|COMPLETED|Medication Period 2||16
10455391|NCT01001520|11603460|FG001|COMPLETED|Medication Period 2||13
10455392|NCT01001520|11603459|FG000|NOT COMPLETED|Medication Period 2||0
10455393|NCT01001520|11603460|FG001|NOT COMPLETED|Medication Period 2||3
10455394|NCT01001546|11603471|FG000|STARTED|Overall Study||206
10455395|NCT01001546|11603472|FG001|STARTED|Overall Study||207
10455396|NCT01001546|11603471|FG000|COMPLETED|Overall Study||206
10696357|NCT02531633|11860527|FG007|STARTED|Part A (52 Weeks)||0
10696358|NCT02531633|11860528|FG008|STARTED|Part A (52 Weeks)||0
10696359|NCT02531633|11860529|FG009|STARTED|Part A (52 Weeks)||0
10696360|NCT02531633|11860520|FG000|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||1
10696361|NCT02531633|11860521|FG001|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
10696362|NCT02531633|11860522|FG002|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||1
10696363|NCT02531633|11860523|FG003|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
10696364|NCT02531633|11860524|FG004|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
10696365|NCT02531633|11860525|FG005|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
10696366|NCT02531633|11860526|FG006|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
10696367|NCT02531633|11860527|FG007|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
10696368|NCT02531633|11860528|FG008|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
10696369|NCT02531633|11860529|FG009|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
10696370|NCT02531633|11860520|FG000|COMPLETED|Part A (52 Weeks)||8
10696371|NCT02531633|11860521|FG001|COMPLETED|Part A (52 Weeks)||5
10696372|NCT02531633|11860522|FG002|COMPLETED|Part A (52 Weeks)||4
10696373|NCT02531633|11860523|FG003|COMPLETED|Part A (52 Weeks)||5
10696374|NCT02531633|11860524|FG004|COMPLETED|Part A (52 Weeks)||4
10696375|NCT02531633|11860525|FG005|COMPLETED|Part A (52 Weeks)||0
10696376|NCT02531633|11860526|FG006|COMPLETED|Part A (52 Weeks)||0
10696377|NCT02531633|11860527|FG007|COMPLETED|Part A (52 Weeks)||0
10696378|NCT02531633|11860528|FG008|COMPLETED|Part A (52 Weeks)||0
10696379|NCT02531633|11860529|FG009|COMPLETED|Part A (52 Weeks)||0
10696380|NCT02531633|11860520|FG000|NOT COMPLETED|Part A (52 Weeks)||34
10696381|NCT02531633|11860521|FG001|NOT COMPLETED|Part A (52 Weeks)||34
10696382|NCT02531633|11860522|FG002|NOT COMPLETED|Part A (52 Weeks)||22
10696383|NCT02531633|11860523|FG003|NOT COMPLETED|Part A (52 Weeks)||22
10696384|NCT02531633|11860524|FG004|NOT COMPLETED|Part A (52 Weeks)||23
10696385|NCT02531633|11860525|FG005|NOT COMPLETED|Part A (52 Weeks)||0
10696386|NCT02531633|11860526|FG006|NOT COMPLETED|Part A (52 Weeks)||0
10696387|NCT02531633|11860527|FG007|NOT COMPLETED|Part A (52 Weeks)||0
10696388|NCT02531633|11860528|FG008|NOT COMPLETED|Part A (52 Weeks)||0
10696389|NCT02531633|11860529|FG009|NOT COMPLETED|Part A (52 Weeks)||0
10696390|NCT02531633|11860520|FG000|STARTED|Part B (104 Weeks)||0
10696391|NCT02531633|11860521|FG001|STARTED|Part B (104 Weeks)||0
10696392|NCT02531633|11860522|FG002|STARTED|Part B (104 Weeks)||0
10696393|NCT02531633|11860523|FG003|STARTED|Part B (104 Weeks)||0
10696394|NCT02531633|11860524|FG004|STARTED|Part B (104 Weeks)||0
10696395|NCT02531633|11860525|FG005|STARTED|Part B (104 Weeks)||8
10696396|NCT02531633|11860526|FG006|STARTED|Part B (104 Weeks)||5
10696397|NCT02531633|11860527|FG007|STARTED|Part B (104 Weeks)||4
10696398|NCT02531633|11860528|FG008|STARTED|Part B (104 Weeks)||5
10696399|NCT02531633|11860529|FG009|STARTED|Part B (104 Weeks)||4
10696400|NCT02531633|11860520|FG000|COMPLETED|Part B (104 Weeks)||0
10696401|NCT02531633|11860521|FG001|COMPLETED|Part B (104 Weeks)||0
10696402|NCT02531633|11860522|FG002|COMPLETED|Part B (104 Weeks)||0
10696403|NCT02531633|11860523|FG003|COMPLETED|Part B (104 Weeks)||0
10696404|NCT02531633|11860524|FG004|COMPLETED|Part B (104 Weeks)||0
10696405|NCT02531633|11860525|FG005|COMPLETED|Part B (104 Weeks)||0
10696406|NCT02531633|11860526|FG006|COMPLETED|Part B (104 Weeks)||0
10696407|NCT02531633|11860527|FG007|COMPLETED|Part B (104 Weeks)||0
10696408|NCT02531633|11860528|FG008|COMPLETED|Part B (104 Weeks)||0
10696409|NCT02531633|11860529|FG009|COMPLETED|Part B (104 Weeks)||0
10696410|NCT02531633|11860520|FG000|NOT COMPLETED|Part B (104 Weeks)||0
10696411|NCT02531633|11860521|FG001|NOT COMPLETED|Part B (104 Weeks)||0
10696412|NCT02531633|11860522|FG002|NOT COMPLETED|Part B (104 Weeks)||0
10696413|NCT02531633|11860523|FG003|NOT COMPLETED|Part B (104 Weeks)||0
10696414|NCT02531633|11860524|FG004|NOT COMPLETED|Part B (104 Weeks)||0
10696415|NCT02531633|11860525|FG005|NOT COMPLETED|Part B (104 Weeks)||8
10696416|NCT02531633|11860526|FG006|NOT COMPLETED|Part B (104 Weeks)||5
10696417|NCT02531633|11860527|FG007|NOT COMPLETED|Part B (104 Weeks)||4
10455397|NCT01001546|11603472|FG001|COMPLETED|Overall Study||207
10455398|NCT01001546|11603471|FG000|NOT COMPLETED|Overall Study||0
10455399|NCT01001546|11603472|FG001|NOT COMPLETED|Overall Study||0
10455400|NCT01001559|11603480|FG000|STARTED|Overall Study||95
10696418|NCT02531633|11860528|FG008|NOT COMPLETED|Part B (104 Weeks)||5
10696419|NCT02531633|11860529|FG009|NOT COMPLETED|Part B (104 Weeks)||4
10696420|NCT02531646|11860572|FG000|STARTED|Overall Study||37
10696421|NCT02531646|11860573|FG001|STARTED|Overall Study||18
10696422|NCT02531646|11860574|FG002|STARTED|Overall Study||11
10696423|NCT02531646|11860572|FG000|COMPLETED|Overall Study||32
10696424|NCT02531646|11860573|FG001|COMPLETED|Overall Study||17
10696425|NCT02531646|11860574|FG002|COMPLETED|Overall Study||11
10696426|NCT02531646|11860572|FG000|NOT COMPLETED|Overall Study||5
10696427|NCT02531646|11860573|FG001|NOT COMPLETED|Overall Study||1
10696428|NCT02531646|11860574|FG002|NOT COMPLETED|Overall Study||0
10696429|NCT02531698|11860584|FG000|STARTED|Overall Study||294
10696430|NCT02531698|11860585|FG001|STARTED|Overall Study||106
10696431|NCT02531698|11860584|FG000|COMPLETED|Overall Study||283
10696432|NCT02531698|11860585|FG001|COMPLETED|Overall Study||104
10696433|NCT02531698|11860584|FG000|NOT COMPLETED|Overall Study||11
10696434|NCT02531698|11860585|FG001|NOT COMPLETED|Overall Study||2
10696435|NCT02531802|11860621|FG000|STARTED|Received Vaccination 1||15
10696436|NCT02531802|11860622|FG001|STARTED|Received Vaccination 1||15
10696437|NCT02531802|11860623|FG002|STARTED|Received Vaccination 1||15
10696438|NCT02531802|11860624|FG003|STARTED|Received Vaccination 1||15
10696439|NCT02531802|11860625|FG004|STARTED|Received Vaccination 1||15
10696440|NCT02531802|11860626|FG005|STARTED|Received Vaccination 1||3
10696441|NCT02531802|11860627|FG006|STARTED|Received Vaccination 1||15
10696442|NCT02531802|11860628|FG007|STARTED|Received Vaccination 1||15
10696443|NCT02531802|11860629|FG008|STARTED|Received Vaccination 1||15
10696444|NCT02531802|11860630|FG009|STARTED|Received Vaccination 1||52
10696445|NCT02531802|11860631|FG010|STARTED|Received Vaccination 1||15
10696446|NCT02531802|11860632|FG011|STARTED|Received Vaccination 1||15
10696447|NCT02531802|11860633|FG012|STARTED|Received Vaccination 1||15
10696448|NCT02531802|11860634|FG013|STARTED|Received Vaccination 1||15
10696449|NCT02531802|11860635|FG014|STARTED|Received Vaccination 1||40
10696450|NCT02531802|11860636|FG015|STARTED|Received Vaccination 1||30
10696451|NCT02531802|11860637|FG016|STARTED|Received Vaccination 1||30
10696452|NCT02531802|11860638|FG017|STARTED|Received Vaccination 1||30
10696453|NCT02531802|11860639|FG018|STARTED|Received Vaccination 1||30
10696454|NCT02531802|11860640|FG019|STARTED|Received Vaccination 1||30
10696455|NCT02531802|11860641|FG020|STARTED|Received Vaccination 1||50
10696456|NCT02531802|11860621|FG000|COMPLETED|Received Vaccination 1||15
10696457|NCT02531802|11860622|FG001|COMPLETED|Received Vaccination 1||15
10696458|NCT02531802|11860623|FG002|COMPLETED|Received Vaccination 1||15
10696459|NCT02531802|11860624|FG003|COMPLETED|Received Vaccination 1||15
10696460|NCT02531802|11860625|FG004|COMPLETED|Received Vaccination 1||15
10696461|NCT02531802|11860626|FG005|COMPLETED|Received Vaccination 1||3
10696462|NCT02531802|11860627|FG006|COMPLETED|Received Vaccination 1||15
10696463|NCT02531802|11860628|FG007|COMPLETED|Received Vaccination 1||15
10696464|NCT02531802|11860629|FG008|COMPLETED|Received Vaccination 1||15
10696465|NCT02531802|11860630|FG009|COMPLETED|Received Vaccination 1||52
10696466|NCT02531802|11860631|FG010|COMPLETED|Received Vaccination 1||15
10696467|NCT02531802|11860632|FG011|COMPLETED|Received Vaccination 1||15
10696468|NCT02531802|11860633|FG012|COMPLETED|Received Vaccination 1||15
10696469|NCT02531802|11860634|FG013|COMPLETED|Received Vaccination 1||15
10696470|NCT02531802|11860635|FG014|COMPLETED|Received Vaccination 1||40
10696471|NCT02531802|11860636|FG015|COMPLETED|Received Vaccination 1||30
10696472|NCT02531802|11860637|FG016|COMPLETED|Received Vaccination 1||30
10696473|NCT02531802|11860638|FG017|COMPLETED|Received Vaccination 1||30
10696474|NCT02531802|11860639|FG018|COMPLETED|Received Vaccination 1||30
10696475|NCT02531802|11860640|FG019|COMPLETED|Received Vaccination 1||30
10696476|NCT02531802|11860641|FG020|COMPLETED|Received Vaccination 1||50
10696477|NCT02531802|11860621|FG000|NOT COMPLETED|Received Vaccination 1||0
10696478|NCT02531802|11860622|FG001|NOT COMPLETED|Received Vaccination 1||0
10696479|NCT02531802|11860623|FG002|NOT COMPLETED|Received Vaccination 1||0
10696480|NCT02531802|11860624|FG003|NOT COMPLETED|Received Vaccination 1||0
10696481|NCT02531802|11860625|FG004|NOT COMPLETED|Received Vaccination 1||0
10696482|NCT02531802|11860626|FG005|NOT COMPLETED|Received Vaccination 1||0
10696483|NCT02531802|11860627|FG006|NOT COMPLETED|Received Vaccination 1||0
10696484|NCT02531802|11860628|FG007|NOT COMPLETED|Received Vaccination 1||0
10696485|NCT02531802|11860629|FG008|NOT COMPLETED|Received Vaccination 1||0
10696486|NCT02531802|11860630|FG009|NOT COMPLETED|Received Vaccination 1||0
10696487|NCT02531802|11860631|FG010|NOT COMPLETED|Received Vaccination 1||0
10696488|NCT02531802|11860632|FG011|NOT COMPLETED|Received Vaccination 1||0
10696489|NCT02531802|11860633|FG012|NOT COMPLETED|Received Vaccination 1||0
10696490|NCT02531802|11860634|FG013|NOT COMPLETED|Received Vaccination 1||0
10696491|NCT02531802|11860635|FG014|NOT COMPLETED|Received Vaccination 1||0
10696492|NCT02531802|11860636|FG015|NOT COMPLETED|Received Vaccination 1||0
10696493|NCT02531802|11860637|FG016|NOT COMPLETED|Received Vaccination 1||0
10696494|NCT02531802|11860638|FG017|NOT COMPLETED|Received Vaccination 1||0
10696495|NCT02531802|11860639|FG018|NOT COMPLETED|Received Vaccination 1||0
10696496|NCT02531802|11860640|FG019|NOT COMPLETED|Received Vaccination 1||0
10696497|NCT02531802|11860641|FG020|NOT COMPLETED|Received Vaccination 1||0
10696498|NCT02531802|11860621|FG000|STARTED|Received Vaccination 2||15
10696499|NCT02531802|11860622|FG001|STARTED|Received Vaccination 2||15
10696500|NCT02531802|11860623|FG002|STARTED|Received Vaccination 2||15
10696501|NCT02531802|11860624|FG003|STARTED|Received Vaccination 2||15
10696502|NCT02531802|11860625|FG004|STARTED|Received Vaccination 2||15
10696503|NCT02531802|11860626|FG005|STARTED|Received Vaccination 2||3
10696504|NCT02531802|11860627|FG006|STARTED|Received Vaccination 2||15
10696505|NCT02531802|11860628|FG007|STARTED|Received Vaccination 2||15
10696506|NCT02531802|11860629|FG008|STARTED|Received Vaccination 2||15
10696507|NCT02531802|11860630|FG009|STARTED|Received Vaccination 2||52
10696508|NCT02531802|11860631|FG010|STARTED|Received Vaccination 2||15
10696509|NCT02531802|11860632|FG011|STARTED|Received Vaccination 2||15
10696510|NCT02531802|11860633|FG012|STARTED|Received Vaccination 2||15
10696511|NCT02531802|11860634|FG013|STARTED|Received Vaccination 2||15
10696512|NCT02531802|11860635|FG014|STARTED|Received Vaccination 2||40
10696513|NCT02531802|11860636|FG015|STARTED|Received Vaccination 2||30
10696514|NCT02531802|11860637|FG016|STARTED|Received Vaccination 2||30
10696515|NCT02531802|11860638|FG017|STARTED|Received Vaccination 2||30
10696516|NCT02531802|11860639|FG018|STARTED|Received Vaccination 2||30
10696517|NCT02531802|11860640|FG019|STARTED|Received Vaccination 2||30
10696518|NCT02531802|11860641|FG020|STARTED|Received Vaccination 2||50
10696519|NCT02531802|11860621|FG000|COMPLETED|Received Vaccination 2||15
10696520|NCT02531802|11860622|FG001|COMPLETED|Received Vaccination 2||15
10696521|NCT02531802|11860623|FG002|COMPLETED|Received Vaccination 2||14
10696522|NCT02531802|11860624|FG003|COMPLETED|Received Vaccination 2||15
10696523|NCT02531802|11860625|FG004|COMPLETED|Received Vaccination 2||15
10696524|NCT02531802|11860626|FG005|COMPLETED|Received Vaccination 2||0
10696525|NCT02531802|11860627|FG006|COMPLETED|Received Vaccination 2||15
10696526|NCT02531802|11860628|FG007|COMPLETED|Received Vaccination 2||15
10696527|NCT02531802|11860629|FG008|COMPLETED|Received Vaccination 2||15
10696528|NCT02531802|11860630|FG009|COMPLETED|Received Vaccination 2||49
10696529|NCT02531802|11860631|FG010|COMPLETED|Received Vaccination 2||13
10696530|NCT02531802|11860632|FG011|COMPLETED|Received Vaccination 2||15
10696531|NCT02531802|11860633|FG012|COMPLETED|Received Vaccination 2||13
10696532|NCT02531802|11860634|FG013|COMPLETED|Received Vaccination 2||13
10696533|NCT02531802|11860635|FG014|COMPLETED|Received Vaccination 2||39
10696534|NCT02531802|11860636|FG015|COMPLETED|Received Vaccination 2||30
10696535|NCT02531802|11860637|FG016|COMPLETED|Received Vaccination 2||30
10696536|NCT02531802|11860638|FG017|COMPLETED|Received Vaccination 2||26
10696537|NCT02531802|11860639|FG018|COMPLETED|Received Vaccination 2||27
10696538|NCT02531802|11860640|FG019|COMPLETED|Received Vaccination 2||29
10696539|NCT02531802|11860641|FG020|COMPLETED|Received Vaccination 2||49
10696540|NCT02531802|11860621|FG000|NOT COMPLETED|Received Vaccination 2||0
10696541|NCT02531802|11860622|FG001|NOT COMPLETED|Received Vaccination 2||0
10696542|NCT02531802|11860623|FG002|NOT COMPLETED|Received Vaccination 2||1
10696543|NCT02531802|11860624|FG003|NOT COMPLETED|Received Vaccination 2||0
10696544|NCT02531802|11860625|FG004|NOT COMPLETED|Received Vaccination 2||0
10696545|NCT02531802|11860626|FG005|NOT COMPLETED|Received Vaccination 2||3
10696546|NCT02531802|11860627|FG006|NOT COMPLETED|Received Vaccination 2||0
10696547|NCT02531802|11860628|FG007|NOT COMPLETED|Received Vaccination 2||0
10696548|NCT02531802|11860629|FG008|NOT COMPLETED|Received Vaccination 2||0
10696549|NCT02531802|11860630|FG009|NOT COMPLETED|Received Vaccination 2||3
10696550|NCT02531802|11860631|FG010|NOT COMPLETED|Received Vaccination 2||2
10696551|NCT02531802|11860632|FG011|NOT COMPLETED|Received Vaccination 2||0
10696552|NCT02531802|11860633|FG012|NOT COMPLETED|Received Vaccination 2||2
10696553|NCT02531802|11860634|FG013|NOT COMPLETED|Received Vaccination 2||2
10696554|NCT02531802|11860635|FG014|NOT COMPLETED|Received Vaccination 2||1
10696555|NCT02531802|11860636|FG015|NOT COMPLETED|Received Vaccination 2||0
10696556|NCT02531802|11860637|FG016|NOT COMPLETED|Received Vaccination 2||0
10696557|NCT02531802|11860638|FG017|NOT COMPLETED|Received Vaccination 2||4
10696558|NCT02531802|11860639|FG018|NOT COMPLETED|Received Vaccination 2||3
10696559|NCT02531802|11860640|FG019|NOT COMPLETED|Received Vaccination 2||1
10696560|NCT02531802|11860641|FG020|NOT COMPLETED|Received Vaccination 2||1
10696561|NCT02531867|11860714|FG000|STARTED|Overall Study||13
10696562|NCT02531867|11860714|FG000|COMPLETED|Overall Study||13
10696563|NCT02531867|11860714|FG000|NOT COMPLETED|Overall Study||0
10696564|NCT02531971|11860720|FG000|STARTED|Overall Study||11
10696565|NCT02531971|11860721|FG001|STARTED|Overall Study||13
10696566|NCT02531971|11860720|FG000|COMPLETED|Overall Study||11
10696567|NCT02531971|11860721|FG001|COMPLETED|Overall Study||13
10696568|NCT02531971|11860720|FG000|NOT COMPLETED|Overall Study||0
10696569|NCT02531971|11860721|FG001|NOT COMPLETED|Overall Study||0
10696570|NCT02532010|11860730|FG000|STARTED|Overall Study||9
10696571|NCT02532010|11860731|FG001|STARTED|Overall Study||4
10696572|NCT02532010|11860730|FG000|COMPLETED|Overall Study||0
10696573|NCT02532010|11860731|FG001|COMPLETED|Overall Study||0
10696574|NCT02532010|11860730|FG000|NOT COMPLETED|Overall Study||9
10696575|NCT02532010|11860731|FG001|NOT COMPLETED|Overall Study||4
10696576|NCT02532036|11860737|FG000|STARTED|Overall Study||2
10696577|NCT02532036|11860738|FG001|STARTED|Overall Study||0
10696578|NCT02532036|11860737|FG000|COMPLETED|Overall Study||2
10696579|NCT02532036|11860738|FG001|COMPLETED|Overall Study||0
10696580|NCT02532036|11860737|FG000|NOT COMPLETED|Overall Study||0
10696581|NCT02532036|11860738|FG001|NOT COMPLETED|Overall Study||0
10696582|NCT02532179|11860742|FG000|STARTED|Overall Study||12
10696583|NCT02532179|11860742|FG000|COMPLETED|Overall Study||9
10696584|NCT02532179|11860742|FG000|NOT COMPLETED|Overall Study||3
10696585|NCT02532283|11860748|FG000|STARTED|Overall Study||64
10696586|NCT02532283|11860749|FG001|STARTED|Overall Study||35
10696587|NCT02532283|11860748|FG000|Full Analysis Set|Overall Study||63
10696588|NCT02532283|11860749|FG001|Full Analysis Set|Overall Study||32
10696589|NCT02532283|11860748|FG000|COMPLETED|Overall Study||55
10696590|NCT02532283|11860749|FG001|COMPLETED|Overall Study||30
10696591|NCT02532283|11860748|FG000|NOT COMPLETED|Overall Study||9
10696592|NCT02532283|11860749|FG001|NOT COMPLETED|Overall Study||5
10696593|NCT02532374|11860757|FG000|STARTED|Overall Study||16
10696594|NCT02532374|11860757|FG000|Nicorette Inhalator (Visit 3)|Overall Study||15
10696595|NCT02532374|11860757|FG000|P3L 50 μg/Puff (Visit 4)|Overall Study||15
10696596|NCT02532374|11860757|FG000|P3L 80 μg/Puff (Visit 5)|Overall Study||14
10696597|NCT02532374|11860757|FG000|P3L150 μg/Puff (Visit 6)|Overall Study||14
10696598|NCT02532374|11860757|FG000|COMPLETED|Overall Study||14
10696599|NCT02532374|11860757|FG000|NOT COMPLETED|Overall Study||2
10696600|NCT02532465|11860771|FG000|STARTED|Overall Study||25
10696601|NCT02532465|11860772|FG001|STARTED|Overall Study||25
10696602|NCT02532465|11860771|FG000|COMPLETED|Overall Study||24
10696603|NCT02532465|11860772|FG001|COMPLETED|Overall Study||24
10696604|NCT02532465|11860771|FG000|NOT COMPLETED|Overall Study||1
10696605|NCT02532465|11860772|FG001|NOT COMPLETED|Overall Study||1
10696606|NCT02532517|11860778|FG000|STARTED|Overall Study||45
10696607|NCT02532517|11860778|FG000|mITT Analysis Set|Overall Study||44
10696608|NCT02532517|11860778|FG000|COMPLETED|Overall Study||28
10696609|NCT02532517|11860778|FG000|NOT COMPLETED|Overall Study||17
10696610|NCT02532543|11860786|FG000|STARTED|Overall Study||3
10696611|NCT02532543|11860787|FG001|STARTED|Overall Study||4
10696612|NCT02532543|11860788|FG002|STARTED|Overall Study||5
10696613|NCT02532543|11860789|FG003|STARTED|Overall Study||4
10696614|NCT02532543|11860786|FG000|COMPLETED|Overall Study||3
10696615|NCT02532543|11860787|FG001|COMPLETED|Overall Study||4
10696616|NCT02532543|11860788|FG002|COMPLETED|Overall Study||4
10696617|NCT02532543|11860789|FG003|COMPLETED|Overall Study||4
10696618|NCT02532543|11860786|FG000|NOT COMPLETED|Overall Study||0
10696619|NCT02532543|11860787|FG001|NOT COMPLETED|Overall Study||0
10696620|NCT02532543|11860788|FG002|NOT COMPLETED|Overall Study||1
10696621|NCT02532543|11860789|FG003|NOT COMPLETED|Overall Study||0
10696622|NCT02532556|11860799|FG000|STARTED|Overall Study||12
10696623|NCT02532556|11860799|FG000|COMPLETED|Overall Study||12
10696624|NCT02532556|11860799|FG000|NOT COMPLETED|Overall Study||0
10696625|NCT02532647|11860812|FG000|STARTED|Overall Study||32
10696626|NCT02532647|11860813|FG001|STARTED|Overall Study||16
10696627|NCT02532647|11860814|FG002|STARTED|Overall Study||31
10696628|NCT02532647|11860812|FG000|Safety Population|Overall Study||31
10696629|NCT02532647|11860813|FG001|Safety Population|Overall Study||16
10696630|NCT02532647|11860814|FG002|Safety Population|Overall Study||30
10696631|NCT02532647|11860812|FG000|COMPLETED|Overall Study||31
10696632|NCT02532647|11860813|FG001|COMPLETED|Overall Study||16
10696633|NCT02532647|11860814|FG002|COMPLETED|Overall Study||30
10696634|NCT02532647|11860812|FG000|NOT COMPLETED|Overall Study||1
10696635|NCT02532647|11860813|FG001|NOT COMPLETED|Overall Study||0
10696636|NCT02532647|11860814|FG002|NOT COMPLETED|Overall Study||1
10696637|NCT02532764|11860832|FG000|STARTED|Single Ascending Dose (SAD) Cohorts||6
10696638|NCT02532764|11860833|FG001|STARTED|Single Ascending Dose (SAD) Cohorts||6
10696639|NCT02532764|11860834|FG002|STARTED|Single Ascending Dose (SAD) Cohorts||9
10696640|NCT02532764|11860835|FG003|STARTED|Single Ascending Dose (SAD) Cohorts||6
10696641|NCT02532764|11860836|FG004|STARTED|Single Ascending Dose (SAD) Cohorts||9
10696642|NCT02532764|11860837|FG005|STARTED|Single Ascending Dose (SAD) Cohorts||0
10696643|NCT02532764|11860838|FG006|STARTED|Single Ascending Dose (SAD) Cohorts||0
10696644|NCT02532764|11860839|FG007|STARTED|Single Ascending Dose (SAD) Cohorts||0
10696645|NCT02532764|11860840|FG008|STARTED|Single Ascending Dose (SAD) Cohorts||0
10696646|NCT02532764|11860841|FG009|STARTED|Single Ascending Dose (SAD) Cohorts||0
10696647|NCT02532764|11860832|FG000|COMPLETED|Single Ascending Dose (SAD) Cohorts||6
10696648|NCT02532764|11860833|FG001|COMPLETED|Single Ascending Dose (SAD) Cohorts||6
10696649|NCT02532764|11860834|FG002|COMPLETED|Single Ascending Dose (SAD) Cohorts||9
10696650|NCT02532764|11860835|FG003|COMPLETED|Single Ascending Dose (SAD) Cohorts||6
10696651|NCT02532764|11860836|FG004|COMPLETED|Single Ascending Dose (SAD) Cohorts||9
10696652|NCT02532764|11860837|FG005|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
10696653|NCT02532764|11860838|FG006|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
10696654|NCT02532764|11860839|FG007|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
10696655|NCT02532764|11860840|FG008|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
10696656|NCT02532764|11860841|FG009|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
10696657|NCT02532764|11860832|FG000|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
10696658|NCT02532764|11860833|FG001|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
10696659|NCT02532764|11860834|FG002|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
10696660|NCT02532764|11860835|FG003|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
10696661|NCT02532764|11860836|FG004|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
10696662|NCT02532764|11860837|FG005|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
10696663|NCT02532764|11860838|FG006|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
10696664|NCT02532764|11860839|FG007|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
10696665|NCT02532764|11860840|FG008|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
10696666|NCT02532764|11860841|FG009|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
10696667|NCT02532764|11860832|FG000|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
10696668|NCT02532764|11860833|FG001|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
10696669|NCT02532764|11860834|FG002|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
10696670|NCT02532764|11860835|FG003|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
10696671|NCT02532764|11860836|FG004|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
10696672|NCT02532764|11860837|FG005|STARTED|Multiple Ascending Dose (MAD) Cohorst||6
10696673|NCT02532764|11860838|FG006|STARTED|Multiple Ascending Dose (MAD) Cohorst||6
10696674|NCT02532764|11860839|FG007|STARTED|Multiple Ascending Dose (MAD) Cohorst||7
10696675|NCT02532764|11860840|FG008|STARTED|Multiple Ascending Dose (MAD) Cohorst||6
10696676|NCT02532764|11860841|FG009|STARTED|Multiple Ascending Dose (MAD) Cohorst||9
10696677|NCT02532764|11860832|FG000|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
10696678|NCT02532764|11860833|FG001|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
10696679|NCT02532764|11860834|FG002|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
10696680|NCT02532764|11860835|FG003|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
10696681|NCT02532764|11860836|FG004|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
10696682|NCT02532764|11860837|FG005|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||6
10696683|NCT02532764|11860838|FG006|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||6
10696684|NCT02532764|11860839|FG007|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||6
10696685|NCT02532764|11860840|FG008|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||5
10696686|NCT02532764|11860841|FG009|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||8
10696687|NCT02532764|11860832|FG000|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
10696688|NCT02532764|11860833|FG001|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
10696689|NCT02532764|11860834|FG002|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
10696690|NCT02532764|11860835|FG003|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
10696691|NCT02532764|11860836|FG004|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
10696692|NCT02532764|11860837|FG005|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
10696693|NCT02532764|11860838|FG006|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
10696694|NCT02532764|11860839|FG007|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||1
10696695|NCT02532764|11860840|FG008|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||1
10696696|NCT02532764|11860841|FG009|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||1
10696697|NCT02532855|11860870|FG000|STARTED|Overall Study||307
10696698|NCT02532855|11860871|FG001|STARTED|Overall Study||307
10696699|NCT02532855|11860870|FG000|Treated|Overall Study||307
10696700|NCT02532855|11860871|FG001|Treated|Overall Study|One participant had a protocol violation, was randomized but did not take study medication.|306
10696701|NCT02532855|11860870|FG000|COMPLETED|Overall Study||299
10696702|NCT02532855|11860871|FG001|COMPLETED|Overall Study||296
10696703|NCT02532855|11860870|FG000|NOT COMPLETED|Overall Study||8
10696704|NCT02532855|11860871|FG001|NOT COMPLETED|Overall Study||11
10696705|NCT02532933|11860879|FG000|STARTED|Overall Study||22
10696706|NCT02532933|11860880|FG001|STARTED|Overall Study||22
10696707|NCT02532933|11860879|FG000|COMPLETED|Overall Study||16
10696708|NCT02532933|11860880|FG001|COMPLETED|Overall Study||16
10696709|NCT02532933|11860879|FG000|NOT COMPLETED|Overall Study||6
10696710|NCT02532933|11860880|FG001|NOT COMPLETED|Overall Study||6
10696711|NCT02532972|11860886|FG000|STARTED|Overall Study||11
10696712|NCT02532972|11860886|FG000|COMPLETED|Overall Study||10
10696713|NCT02532972|11860886|FG000|NOT COMPLETED|Overall Study||1
10696714|NCT02532998|11860890|FG000|STARTED|Overall Study||23
10696715|NCT02532998|11860890|FG000|COMPLETED|Overall Study||23
10696716|NCT02532998|11860890|FG000|NOT COMPLETED|Overall Study||0
10696717|NCT02533063|11860906|FG000|STARTED|Intervention 1 (8 Weeks)||16
10696718|NCT02533063|11860907|FG001|STARTED|Intervention 1 (8 Weeks)||16
10696719|NCT02533063|11860906|FG000|COMPLETED|Intervention 1 (8 Weeks)||14
10696720|NCT02533063|11860907|FG001|COMPLETED|Intervention 1 (8 Weeks)||11
10696721|NCT02533063|11860906|FG000|NOT COMPLETED|Intervention 1 (8 Weeks)||2
10696722|NCT02533063|11860907|FG001|NOT COMPLETED|Intervention 1 (8 Weeks)||5
10696723|NCT02533063|11860906|FG000|STARTED|Washout (4 Weeks)||14
10696724|NCT02533063|11860907|FG001|STARTED|Washout (4 Weeks)||11
10696725|NCT02533063|11860906|FG000|COMPLETED|Washout (4 Weeks)||14
10696726|NCT02533063|11860907|FG001|COMPLETED|Washout (4 Weeks)||11
10696727|NCT02533063|11860906|FG000|NOT COMPLETED|Washout (4 Weeks)||0
10696728|NCT02533063|11860907|FG001|NOT COMPLETED|Washout (4 Weeks)||0
10696729|NCT02533063|11860906|FG000|STARTED|Intervention 2 (8 Weeks)||14
10696730|NCT02533063|11860907|FG001|STARTED|Intervention 2 (8 Weeks)||11
10696731|NCT02533063|11860906|FG000|COMPLETED|Intervention 2 (8 Weeks)||14
10696732|NCT02533063|11860907|FG001|COMPLETED|Intervention 2 (8 Weeks)||11
10696733|NCT02533063|11860906|FG000|NOT COMPLETED|Intervention 2 (8 Weeks)||0
10696734|NCT02533063|11860907|FG001|NOT COMPLETED|Intervention 2 (8 Weeks)||0
10696735|NCT02533089|11860916|FG000|STARTED|Overall Study||605
10696736|NCT02533089|11860917|FG001|STARTED|Overall Study||548
10696737|NCT02533089|11860916|FG000|COMPLETED|Overall Study|4 HC accrued no eligable patients 11 HC no patients with outcome data 241 cases missing outcome|364
10696738|NCT02533089|11860917|FG001|COMPLETED|Overall Study|6 HC accrued no eligible patients 8 HC no patients with outcome data 114 cases missing outcome|434
10696739|NCT02533089|11860916|FG000|NOT COMPLETED|Overall Study||241
10696740|NCT02533089|11860917|FG001|NOT COMPLETED|Overall Study||114
10696741|NCT02533167|11860923|FG000|STARTED|Overall Study||70
10696742|NCT02533167|11860923|FG000|COMPLETED|Overall Study||55
10696743|NCT02533167|11860923|FG000|NOT COMPLETED|Overall Study||15
10696750|NCT02533258|11860936|FG000|STARTED|Overall Study||13
10696751|NCT02533258|11860936|FG000|COMPLETED|Overall Study||5
10696752|NCT02533258|11860936|FG000|NOT COMPLETED|Overall Study||8
10696753|NCT02533375|11860940|FG000|STARTED|Overall Study||10
10696754|NCT02533375|11860940|FG000|COMPLETED|Overall Study||5
10696755|NCT02533375|11860940|FG000|NOT COMPLETED|Overall Study||5
10696756|NCT02533401|11860944|FG000|STARTED|Overall Study||34
10696757|NCT02533401|11860944|FG000|COMPLETED|Overall Study||23
10696758|NCT02533401|11860944|FG000|NOT COMPLETED|Overall Study||11
10696759|NCT02533427|11860948|FG000|STARTED|Overall Study||15
10696760|NCT02533427|11860948|FG000|COMPLETED|Overall Study||15
10696761|NCT02533427|11860948|FG000|NOT COMPLETED|Overall Study||0
10696762|NCT02533453|11860955|FG000|STARTED|Overall Study||110
10696763|NCT02533453|11860955|FG000|COMPLETED|Overall Study||101
10696764|NCT02533453|11860955|FG000|NOT COMPLETED|Overall Study||9
10696765|NCT02533466|11860961|FG000|STARTED|Overall Study||16
10696766|NCT02533466|11860962|FG001|STARTED|Overall Study||14
10696767|NCT02533466|11860961|FG000|COMPLETED|Overall Study||16
10696768|NCT02533466|11860962|FG001|COMPLETED|Overall Study||14
10696769|NCT02533466|11860961|FG000|NOT COMPLETED|Overall Study||0
10696770|NCT02533466|11860962|FG001|NOT COMPLETED|Overall Study||0
10696771|NCT02533505|11860970|FG000|STARTED|Overall Study||26
10696772|NCT02533505|11860971|FG001|STARTED|Overall Study||25
10696773|NCT02533505|11860970|FG000|COMPLETED|Overall Study||23
10696774|NCT02533505|11860971|FG001|COMPLETED|Overall Study||24
10696775|NCT02533505|11860970|FG000|NOT COMPLETED|Overall Study||3
10696776|NCT02533505|11860971|FG001|NOT COMPLETED|Overall Study||1
10696777|NCT02533570|11860980|FG000|STARTED|Overall Study||4
10696778|NCT02533570|11860981|FG001|STARTED|Overall Study||8
10696779|NCT02533570|11860982|FG002|STARTED|Overall Study||8
10696780|NCT02533570|11860980|FG000|COMPLETED|Overall Study||4
10696781|NCT02533570|11860981|FG001|COMPLETED|Overall Study||7
10696782|NCT02533570|11860982|FG002|COMPLETED|Overall Study||7
10696783|NCT02533570|11860980|FG000|NOT COMPLETED|Overall Study||0
10696784|NCT02533570|11860981|FG001|NOT COMPLETED|Overall Study||1
10696785|NCT02533570|11860982|FG002|NOT COMPLETED|Overall Study||1
10696786|NCT02533674|11860998|FG000|STARTED|Dose Level I||5
10696787|NCT02533674|11860999|FG001|STARTED|Dose Level I||0
10696788|NCT02533674|11861000|FG002|STARTED|Dose Level I||0
10696789|NCT02533674|11861001|FG003|STARTED|Dose Level I||0
10696790|NCT02533674|11861002|FG004|STARTED|Dose Level I||0
10696791|NCT02533674|11861003|FG005|STARTED|Dose Level I||0
10696792|NCT02533674|11861004|FG006|STARTED|Dose Level I||0
10696793|NCT02533674|11861005|FG007|STARTED|Dose Level I||0
10696794|NCT02533674|11860998|FG000|COMPLETED|Dose Level I||0
10696795|NCT02533674|11860999|FG001|COMPLETED|Dose Level I||0
10696796|NCT02533674|11861000|FG002|COMPLETED|Dose Level I||0
10696797|NCT02533674|11861001|FG003|COMPLETED|Dose Level I||0
10696798|NCT02533674|11861002|FG004|COMPLETED|Dose Level I||0
10696799|NCT02533674|11861003|FG005|COMPLETED|Dose Level I||0
10696800|NCT02533674|11861004|FG006|COMPLETED|Dose Level I||0
10696801|NCT02533674|11861005|FG007|COMPLETED|Dose Level I||0
10696802|NCT02533674|11860998|FG000|NOT COMPLETED|Dose Level I||5
10696803|NCT02533674|11860999|FG001|NOT COMPLETED|Dose Level I||0
10696804|NCT02533674|11861000|FG002|NOT COMPLETED|Dose Level I||0
10696805|NCT02533674|11861001|FG003|NOT COMPLETED|Dose Level I||0
10696806|NCT02533674|11861002|FG004|NOT COMPLETED|Dose Level I||0
10696807|NCT02533674|11861003|FG005|NOT COMPLETED|Dose Level I||0
10696808|NCT02533674|11861004|FG006|NOT COMPLETED|Dose Level I||0
10696809|NCT02533674|11861005|FG007|NOT COMPLETED|Dose Level I||0
10696810|NCT02533674|11860998|FG000|STARTED|Dose Level II||0
10696811|NCT02533674|11860999|FG001|STARTED|Dose Level II||7
10696812|NCT02533674|11861000|FG002|STARTED|Dose Level II||0
10696813|NCT02533674|11861001|FG003|STARTED|Dose Level II||0
10696814|NCT02533674|11861002|FG004|STARTED|Dose Level II||0
10696815|NCT02533674|11861003|FG005|STARTED|Dose Level II||0
10696816|NCT02533674|11861004|FG006|STARTED|Dose Level II||0
10696817|NCT02533674|11861005|FG007|STARTED|Dose Level II||0
10696818|NCT02533674|11860998|FG000|COMPLETED|Dose Level II||0
10696819|NCT02533674|11860999|FG001|COMPLETED|Dose Level II||0
10696820|NCT02533674|11861000|FG002|COMPLETED|Dose Level II||0
10696821|NCT02533674|11861001|FG003|COMPLETED|Dose Level II||0
10696822|NCT02533674|11861002|FG004|COMPLETED|Dose Level II||0
10696823|NCT02533674|11861003|FG005|COMPLETED|Dose Level II||0
10696824|NCT02533674|11861004|FG006|COMPLETED|Dose Level II||0
10696825|NCT02533674|11861005|FG007|COMPLETED|Dose Level II||0
10696826|NCT02533674|11860998|FG000|NOT COMPLETED|Dose Level II||0
10696827|NCT02533674|11860999|FG001|NOT COMPLETED|Dose Level II||7
10696828|NCT02533674|11861000|FG002|NOT COMPLETED|Dose Level II||0
10696829|NCT02533674|11861001|FG003|NOT COMPLETED|Dose Level II||0
10696830|NCT02533674|11861002|FG004|NOT COMPLETED|Dose Level II||0
10696831|NCT02533674|11861003|FG005|NOT COMPLETED|Dose Level II||0
10696832|NCT02533674|11861004|FG006|NOT COMPLETED|Dose Level II||0
10696833|NCT02533674|11861005|FG007|NOT COMPLETED|Dose Level II||0
10696834|NCT02533674|11860998|FG000|STARTED|Dose Level III||0
10696835|NCT02533674|11860999|FG001|STARTED|Dose Level III||0
10696836|NCT02533674|11861000|FG002|STARTED|Dose Level III||4
10696837|NCT02533674|11861001|FG003|STARTED|Dose Level III||0
10696838|NCT02533674|11861002|FG004|STARTED|Dose Level III||0
10696839|NCT02533674|11861003|FG005|STARTED|Dose Level III||0
10696840|NCT02533674|11861004|FG006|STARTED|Dose Level III||0
10696841|NCT02533674|11861005|FG007|STARTED|Dose Level III||0
10696842|NCT02533674|11860998|FG000|COMPLETED|Dose Level III||0
10696843|NCT02533674|11860999|FG001|COMPLETED|Dose Level III||0
10696844|NCT02533674|11861000|FG002|COMPLETED|Dose Level III||0
10696845|NCT02533674|11861001|FG003|COMPLETED|Dose Level III||0
10696846|NCT02533674|11861002|FG004|COMPLETED|Dose Level III||0
10696847|NCT02533674|11861003|FG005|COMPLETED|Dose Level III||0
10696848|NCT02533674|11861004|FG006|COMPLETED|Dose Level III||0
10696849|NCT02533674|11861005|FG007|COMPLETED|Dose Level III||0
10696850|NCT02533674|11860998|FG000|NOT COMPLETED|Dose Level III||0
10696851|NCT02533674|11860999|FG001|NOT COMPLETED|Dose Level III||0
10696852|NCT02533674|11861000|FG002|NOT COMPLETED|Dose Level III||4
10696853|NCT02533674|11861001|FG003|NOT COMPLETED|Dose Level III||0
10696854|NCT02533674|11861002|FG004|NOT COMPLETED|Dose Level III||0
10696855|NCT02533674|11861003|FG005|NOT COMPLETED|Dose Level III||0
10696856|NCT02533674|11861004|FG006|NOT COMPLETED|Dose Level III||0
10696857|NCT02533674|11861005|FG007|NOT COMPLETED|Dose Level III||0
10696858|NCT02533674|11860998|FG000|STARTED|Dose Level IV||0
10696859|NCT02533674|11860999|FG001|STARTED|Dose Level IV||0
10696860|NCT02533674|11861000|FG002|STARTED|Dose Level IV||0
10696861|NCT02533674|11861001|FG003|STARTED|Dose Level IV||5
10696862|NCT02533674|11861002|FG004|STARTED|Dose Level IV||0
10696863|NCT02533674|11861003|FG005|STARTED|Dose Level IV||0
10696864|NCT02533674|11861004|FG006|STARTED|Dose Level IV||0
10696865|NCT02533674|11861005|FG007|STARTED|Dose Level IV||0
10696866|NCT02533674|11860998|FG000|COMPLETED|Dose Level IV||0
10696867|NCT02533674|11860999|FG001|COMPLETED|Dose Level IV||0
10696868|NCT02533674|11861000|FG002|COMPLETED|Dose Level IV||0
10696869|NCT02533674|11861001|FG003|COMPLETED|Dose Level IV||0
10696870|NCT02533674|11861002|FG004|COMPLETED|Dose Level IV||0
10696871|NCT02533674|11861003|FG005|COMPLETED|Dose Level IV||0
10696872|NCT02533674|11861004|FG006|COMPLETED|Dose Level IV||0
10696873|NCT02533674|11861005|FG007|COMPLETED|Dose Level IV||0
10696874|NCT02533674|11860998|FG000|NOT COMPLETED|Dose Level IV||0
10696875|NCT02533674|11860999|FG001|NOT COMPLETED|Dose Level IV||0
10696876|NCT02533674|11861000|FG002|NOT COMPLETED|Dose Level IV||0
10696877|NCT02533674|11861001|FG003|NOT COMPLETED|Dose Level IV||5
10696878|NCT02533674|11861002|FG004|NOT COMPLETED|Dose Level IV||0
10696879|NCT02533674|11861003|FG005|NOT COMPLETED|Dose Level IV||0
10696880|NCT02533674|11861004|FG006|NOT COMPLETED|Dose Level IV||0
10696881|NCT02533674|11861005|FG007|NOT COMPLETED|Dose Level IV||0
10696882|NCT02533674|11860998|FG000|STARTED|Dose Level V||0
10696883|NCT02533674|11860999|FG001|STARTED|Dose Level V||0
10696884|NCT02533674|11861000|FG002|STARTED|Dose Level V||0
10696885|NCT02533674|11861001|FG003|STARTED|Dose Level V||0
10696886|NCT02533674|11861002|FG004|STARTED|Dose Level V||5
10696887|NCT02533674|11861003|FG005|STARTED|Dose Level V||0
10696888|NCT02533674|11861004|FG006|STARTED|Dose Level V||0
10696889|NCT02533674|11861005|FG007|STARTED|Dose Level V||0
10696890|NCT02533674|11860998|FG000|COMPLETED|Dose Level V||0
10696891|NCT02533674|11860999|FG001|COMPLETED|Dose Level V||0
10696892|NCT02533674|11861000|FG002|COMPLETED|Dose Level V||0
10696893|NCT02533674|11861001|FG003|COMPLETED|Dose Level V||0
10696894|NCT02533674|11861002|FG004|COMPLETED|Dose Level V||0
10696895|NCT02533674|11861003|FG005|COMPLETED|Dose Level V||0
10696896|NCT02533674|11861004|FG006|COMPLETED|Dose Level V||0
10696897|NCT02533674|11861005|FG007|COMPLETED|Dose Level V||0
10696898|NCT02533674|11860998|FG000|NOT COMPLETED|Dose Level V||0
10696899|NCT02533674|11860999|FG001|NOT COMPLETED|Dose Level V||0
10696900|NCT02533674|11861000|FG002|NOT COMPLETED|Dose Level V||0
10696901|NCT02533674|11861001|FG003|NOT COMPLETED|Dose Level V||0
10696902|NCT02533674|11861002|FG004|NOT COMPLETED|Dose Level V||5
10696903|NCT02533674|11861003|FG005|NOT COMPLETED|Dose Level V||0
10696904|NCT02533674|11861004|FG006|NOT COMPLETED|Dose Level V||0
10696905|NCT02533674|11861005|FG007|NOT COMPLETED|Dose Level V||0
10696906|NCT02533674|11860998|FG000|STARTED|Dose Level VI||0
10696907|NCT02533674|11860999|FG001|STARTED|Dose Level VI||0
10696908|NCT02533674|11861000|FG002|STARTED|Dose Level VI||0
10696909|NCT02533674|11861001|FG003|STARTED|Dose Level VI||0
10696910|NCT02533674|11861002|FG004|STARTED|Dose Level VI||0
10696911|NCT02533674|11861003|FG005|STARTED|Dose Level VI||9
10696912|NCT02533674|11861004|FG006|STARTED|Dose Level VI||0
10696913|NCT02533674|11861005|FG007|STARTED|Dose Level VI||0
10696914|NCT02533674|11860998|FG000|COMPLETED|Dose Level VI||0
10696915|NCT02533674|11860999|FG001|COMPLETED|Dose Level VI||0
10696916|NCT02533674|11861000|FG002|COMPLETED|Dose Level VI||0
10696917|NCT02533674|11861001|FG003|COMPLETED|Dose Level VI||0
10696918|NCT02533674|11861002|FG004|COMPLETED|Dose Level VI||0
10696919|NCT02533674|11861003|FG005|COMPLETED|Dose Level VI||0
10696920|NCT02533674|11861004|FG006|COMPLETED|Dose Level VI||0
10696921|NCT02533674|11861005|FG007|COMPLETED|Dose Level VI||0
10696922|NCT02533674|11860998|FG000|NOT COMPLETED|Dose Level VI||0
10696923|NCT02533674|11860999|FG001|NOT COMPLETED|Dose Level VI||0
10696924|NCT02533674|11861000|FG002|NOT COMPLETED|Dose Level VI||0
10696925|NCT02533674|11861001|FG003|NOT COMPLETED|Dose Level VI||0
10696926|NCT02533674|11861002|FG004|NOT COMPLETED|Dose Level VI||0
10696927|NCT02533674|11861003|FG005|NOT COMPLETED|Dose Level VI||9
10696928|NCT02533674|11861004|FG006|NOT COMPLETED|Dose Level VI||0
10696929|NCT02533674|11861005|FG007|NOT COMPLETED|Dose Level VI||0
10696930|NCT02533674|11860998|FG000|STARTED|Dose Level VII||0
10696931|NCT02533674|11860999|FG001|STARTED|Dose Level VII||0
10696932|NCT02533674|11861000|FG002|STARTED|Dose Level VII||0
10696933|NCT02533674|11861001|FG003|STARTED|Dose Level VII||0
10696934|NCT02533674|11861002|FG004|STARTED|Dose Level VII||0
10696935|NCT02533674|11861003|FG005|STARTED|Dose Level VII||0
10696936|NCT02533674|11861004|FG006|STARTED|Dose Level VII||16
10696937|NCT02533674|11861005|FG007|STARTED|Dose Level VII||0
10696938|NCT02533674|11860998|FG000|COMPLETED|Dose Level VII||0
10696939|NCT02533674|11860999|FG001|COMPLETED|Dose Level VII||0
10696940|NCT02533674|11861000|FG002|COMPLETED|Dose Level VII||0
10696941|NCT02533674|11861001|FG003|COMPLETED|Dose Level VII||0
10696942|NCT02533674|11861002|FG004|COMPLETED|Dose Level VII||0
10696943|NCT02533674|11861003|FG005|COMPLETED|Dose Level VII||0
10696944|NCT02533674|11861004|FG006|COMPLETED|Dose Level VII||0
10696945|NCT02533674|11861005|FG007|COMPLETED|Dose Level VII||0
10696946|NCT02533674|11860998|FG000|NOT COMPLETED|Dose Level VII||0
10696947|NCT02533674|11860999|FG001|NOT COMPLETED|Dose Level VII||0
10696948|NCT02533674|11861000|FG002|NOT COMPLETED|Dose Level VII||0
10696949|NCT02533674|11861001|FG003|NOT COMPLETED|Dose Level VII||0
10696950|NCT02533674|11861002|FG004|NOT COMPLETED|Dose Level VII||0
10696951|NCT02533674|11861003|FG005|NOT COMPLETED|Dose Level VII||0
10696952|NCT02533674|11861004|FG006|NOT COMPLETED|Dose Level VII||16
10696953|NCT02533674|11861005|FG007|NOT COMPLETED|Dose Level VII||0
10696954|NCT02533674|11860998|FG000|STARTED|Dose Level VIII||0
10696955|NCT02533674|11860999|FG001|STARTED|Dose Level VIII||0
10696956|NCT02533674|11861000|FG002|STARTED|Dose Level VIII||0
10696957|NCT02533674|11861001|FG003|STARTED|Dose Level VIII||0
10696958|NCT02533674|11861002|FG004|STARTED|Dose Level VIII||0
10696959|NCT02533674|11861003|FG005|STARTED|Dose Level VIII||0
10696960|NCT02533674|11861004|FG006|STARTED|Dose Level VIII||0
10696961|NCT02533674|11861005|FG007|STARTED|Dose Level VIII||6
10696962|NCT02533674|11860998|FG000|COMPLETED|Dose Level VIII||0
10696963|NCT02533674|11860999|FG001|COMPLETED|Dose Level VIII||0
10696964|NCT02533674|11861000|FG002|COMPLETED|Dose Level VIII||0
10696965|NCT02533674|11861001|FG003|COMPLETED|Dose Level VIII||0
10696966|NCT02533674|11861002|FG004|COMPLETED|Dose Level VIII||0
10696967|NCT02533674|11861003|FG005|COMPLETED|Dose Level VIII||0
10696968|NCT02533674|11861004|FG006|COMPLETED|Dose Level VIII||0
10696969|NCT02533674|11861005|FG007|COMPLETED|Dose Level VIII||0
10696970|NCT02533674|11860998|FG000|NOT COMPLETED|Dose Level VIII||0
10696971|NCT02533674|11860999|FG001|NOT COMPLETED|Dose Level VIII||0
10696972|NCT02533674|11861000|FG002|NOT COMPLETED|Dose Level VIII||0
10696973|NCT02533674|11861001|FG003|NOT COMPLETED|Dose Level VIII||0
10696974|NCT02533674|11861002|FG004|NOT COMPLETED|Dose Level VIII||0
10696975|NCT02533674|11861003|FG005|NOT COMPLETED|Dose Level VIII||0
10696976|NCT02533674|11861004|FG006|NOT COMPLETED|Dose Level VIII||0
10696977|NCT02533674|11861005|FG007|NOT COMPLETED|Dose Level VIII||6
10696978|NCT02533726|11861025|FG000|STARTED|Initial Allocation||659
10696979|NCT02533726|11861026|FG001|STARTED|Initial Allocation||653
10696980|NCT02533726|11861025|FG000|COMPLETED|Initial Allocation||659
10696981|NCT02533726|11861026|FG001|COMPLETED|Initial Allocation||653
10696982|NCT02533726|11861025|FG000|NOT COMPLETED|Initial Allocation||0
10696983|NCT02533726|11861026|FG001|NOT COMPLETED|Initial Allocation||0
10696984|NCT02533726|11861025|FG000|STARTED|Treatment|54 participants allocated to Standard Care actually received Optimal Turning|709
10696985|NCT02533726|11861026|FG001|STARTED|Treatment|4 participants allocated to Optimal Turning actually received Standard Care|603
10696986|NCT02533726|11861025|FG000|Per Protocol Population|Treatment||671
10696987|NCT02533726|11861026|FG001|Per Protocol Population|Treatment||555
10696988|NCT02533726|11861025|FG000|COMPLETED|Treatment||709
10696989|NCT02533726|11861026|FG001|COMPLETED|Treatment||603
10696990|NCT02533726|11861025|FG000|NOT COMPLETED|Treatment||0
10696991|NCT02533726|11861026|FG001|NOT COMPLETED|Treatment||0
10696992|NCT02533921|11861034|FG000|STARTED|Overall Study||104
10696993|NCT02533921|11861035|FG001|STARTED|Overall Study||106
10696994|NCT02533921|11861034|FG000|COMPLETED|Overall Study||88
10696995|NCT02533921|11861035|FG001|COMPLETED|Overall Study||95
10696996|NCT02533921|11861034|FG000|NOT COMPLETED|Overall Study||16
10696997|NCT02533921|11861035|FG001|NOT COMPLETED|Overall Study||11
10696998|NCT02533934|11861043|FG000|STARTED|Overall Study||42
10696999|NCT02533934|11861044|FG001|STARTED|Overall Study||26
10697000|NCT02533934|11861043|FG000|COMPLETED|Overall Study||42
10697001|NCT02533934|11861044|FG001|COMPLETED|Overall Study||26
10697002|NCT02533934|11861043|FG000|NOT COMPLETED|Overall Study||0
10697003|NCT02533934|11861044|FG001|NOT COMPLETED|Overall Study||0
10697004|NCT02533999|11861052|FG000|STARTED|Overall Study||38
10697005|NCT02533999|11861053|FG001|STARTED|Overall Study||37
10697006|NCT02533999|11861052|FG000|COMPLETED|Overall Study||32
10697007|NCT02533999|11861053|FG001|COMPLETED|Overall Study||30
10697008|NCT02533999|11861052|FG000|NOT COMPLETED|Overall Study||6
10697009|NCT02533999|11861053|FG001|NOT COMPLETED|Overall Study||7
10697010|NCT02534129|11861059|FG000|STARTED|Overall Study||13
10697011|NCT02534129|11861060|FG001|STARTED|Overall Study||13
10697012|NCT02534129|11861059|FG000|COMPLETED|Overall Study||13
10697013|NCT02534129|11861060|FG001|COMPLETED|Overall Study||13
10697014|NCT02534129|11861059|FG000|NOT COMPLETED|Overall Study||0
10697015|NCT02534129|11861060|FG001|NOT COMPLETED|Overall Study||0
10697016|NCT02534285|11861068|FG000|STARTED|Overall Study||50
10697017|NCT02534285|11861069|FG001|STARTED|Overall Study||50
10697018|NCT02534285|11861068|FG000|COMPLETED|Overall Study||50
10697019|NCT02534285|11861069|FG001|COMPLETED|Overall Study||50
10697020|NCT02534285|11861068|FG000|NOT COMPLETED|Overall Study||0
10697021|NCT02534285|11861069|FG001|NOT COMPLETED|Overall Study||0
10697022|NCT02534324|11861077|FG000|STARTED|Overall Study||98
10697023|NCT02534324|11861078|FG001|STARTED|Overall Study||48
10697024|NCT02534324|11861077|FG000|COMPLETED|Overall Study||73
10697025|NCT02534324|11861078|FG001|COMPLETED|Overall Study||40
10697026|NCT02534324|11861077|FG000|NOT COMPLETED|Overall Study||25
10697027|NCT02534324|11861078|FG001|NOT COMPLETED|Overall Study||8
10697028|NCT02534350|11861086|FG000|STARTED|Overall Study||41
10697029|NCT02534350|11861087|FG001|STARTED|Overall Study||20
10697030|NCT02534350|11861086|FG000|COMPLETED|Overall Study||37
10697031|NCT02534350|11861087|FG001|COMPLETED|Overall Study||20
10697032|NCT02534350|11861086|FG000|NOT COMPLETED|Overall Study||4
10697033|NCT02534350|11861087|FG001|NOT COMPLETED|Overall Study||0
10697034|NCT02534493|11861093|FG000|STARTED|Overall Study||13
10697035|NCT02534493|11861093|FG000|COMPLETED|Overall Study||11
10697036|NCT02534493|11861093|FG000|NOT COMPLETED|Overall Study||2
10697037|NCT02534883|11861101|FG000|STARTED|Overall Study||8
10697038|NCT02534883|11861102|FG001|STARTED|Overall Study||3
10697039|NCT02534883|11861101|FG000|COMPLETED|Overall Study||0
10697040|NCT02534883|11861102|FG001|COMPLETED|Overall Study||0
10697041|NCT02534883|11861101|FG000|NOT COMPLETED|Overall Study||8
10697042|NCT02534883|11861102|FG001|NOT COMPLETED|Overall Study||3
10697043|NCT02534896|11861111|FG000|STARTED|Overall Study||49
10697044|NCT02534896|11861112|FG001|STARTED|Overall Study||52
10697045|NCT02534896|11861113|FG002|STARTED|Overall Study||49
10697046|NCT02534896|11861111|FG000|COMPLETED|Overall Study||45
10697047|NCT02534896|11861112|FG001|COMPLETED|Overall Study||51
10697048|NCT02534896|11861113|FG002|COMPLETED|Overall Study||48
10697049|NCT02534896|11861111|FG000|NOT COMPLETED|Overall Study||4
10697050|NCT02534896|11861112|FG001|NOT COMPLETED|Overall Study||1
10697051|NCT02534896|11861113|FG002|NOT COMPLETED|Overall Study||1
10697052|NCT02534935|11861124|FG000|STARTED|Stage 1: 24 Months||44
10697053|NCT02534935|11861125|FG001|STARTED|Stage 1: 24 Months||220
10697054|NCT02534935|11861126|FG002|STARTED|Stage 1: 24 Months||132
10697055|NCT02534935|11861124|FG000|COMPLETED|Stage 1: 24 Months||44
10697056|NCT02534935|11861125|FG001|COMPLETED|Stage 1: 24 Months||210
10697057|NCT02534935|11861126|FG002|COMPLETED|Stage 1: 24 Months||127
10697058|NCT02534935|11861124|FG000|NOT COMPLETED|Stage 1: 24 Months||0
10697059|NCT02534935|11861125|FG001|NOT COMPLETED|Stage 1: 24 Months||10
10697060|NCT02534935|11861126|FG002|NOT COMPLETED|Stage 1: 24 Months||5
10697061|NCT02534935|11861124|FG000|STARTED|Stage 2: 8 Months|Participants entered into Stage 2.|40
10697062|NCT02534935|11861125|FG001|STARTED|Stage 2: 8 Months|Participants who received all 3 doses and entered Stage 2.|174
10697063|NCT02534935|11861126|FG002|STARTED|Stage 2: 8 Months|Participants of HAV/Saline were not eligible for Stage 2.|0
10697064|NCT02534935|11861124|FG000|COMPLETED|Stage 2: 8 Months||40
10697065|NCT02534935|11861125|FG001|COMPLETED|Stage 2: 8 Months||170
10697066|NCT02534935|11861126|FG002|COMPLETED|Stage 2: 8 Months||0
10697067|NCT02534935|11861124|FG000|NOT COMPLETED|Stage 2: 8 Months||0
10697068|NCT02534935|11861125|FG001|NOT COMPLETED|Stage 2: 8 Months||4
10697069|NCT02534935|11861126|FG002|NOT COMPLETED|Stage 2: 8 Months||0
10697070|NCT02534935|11861124|FG000|STARTED|Stage 2: Booster Phase (6 Months)|Participants were not eligible for Booster vaccination in Stage 2.|0
10697071|NCT02534935|11861125|FG001|STARTED|Stage 2: Booster Phase (6 Months)|Participants who received 3 doses of bivalent rLP2086 in Stage 1 and gave consent for booster vaccination.|148
10697072|NCT02534935|11861126|FG002|STARTED|Stage 2: Booster Phase (6 Months)|Participants of HAV/Saline were not eligible for Stage 2.|0
10697073|NCT02534935|11861124|FG000|COMPLETED|Stage 2: Booster Phase (6 Months)||0
10697074|NCT02534935|11861125|FG001|COMPLETED|Stage 2: Booster Phase (6 Months)||147
10697075|NCT02534935|11861126|FG002|COMPLETED|Stage 2: Booster Phase (6 Months)||0
10697076|NCT02534935|11861124|FG000|NOT COMPLETED|Stage 2: Booster Phase (6 Months)||0
10697077|NCT02534935|11861125|FG001|NOT COMPLETED|Stage 2: Booster Phase (6 Months)||1
10697078|NCT02534935|11861126|FG002|NOT COMPLETED|Stage 2: Booster Phase (6 Months)||0
10697079|NCT02535000|11861154|FG000|STARTED|Overall Study||30
10697080|NCT02535000|11861155|FG001|STARTED|Overall Study||30
10697081|NCT02535000|11861154|FG000|COMPLETED|Overall Study||29
10697082|NCT02535000|11861155|FG001|COMPLETED|Overall Study||28
10697083|NCT02535000|11861154|FG000|NOT COMPLETED|Overall Study||1
10697084|NCT02535000|11861155|FG001|NOT COMPLETED|Overall Study||2
10697085|NCT02535026|11861161|FG000|STARTED|Overall Study||580
10697086|NCT02535026|11861161|FG000|COMPLETED|Overall Study||580
10697087|NCT02535026|11861161|FG000|NOT COMPLETED|Overall Study||0
10697088|NCT02535364|11861175|FG000|STARTED|Part A Screening Through Leukapheresis||82
10697089|NCT02535364|11861175|FG000|COMPLETED|Part A Screening Through Leukapheresis||57
10697090|NCT02535364|11861175|FG000|NOT COMPLETED|Part A Screening Through Leukapheresis||25
10697091|NCT02535364|11861175|FG000|STARTED|Part B Screening||57
10697092|NCT02535364|11861175|FG000|COMPLETED|Part B Screening||40
10697093|NCT02535364|11861175|FG000|NOT COMPLETED|Part B Screening||17
10697094|NCT02535364|11861175|FG000|STARTED|Study Treatment||40
10697095|NCT02535364|11861175|FG000|COMPLETED|Study Treatment||38
10697096|NCT02535364|11861175|FG000|NOT COMPLETED|Study Treatment||2
10697097|NCT02535364|11861175|FG000|STARTED|12-Month Follow-up Period||38
10697098|NCT02535364|11861175|FG000|COMPLETED|12-Month Follow-up Period||3
10697099|NCT02535364|11861175|FG000|NOT COMPLETED|12-Month Follow-up Period||35
10697100|NCT02535416|11861188|FG000|STARTED|Overall Study||4
10697101|NCT02535416|11861189|FG001|STARTED|Overall Study||2
10697102|NCT02535416|11861190|FG002|STARTED|Overall Study||4
10697103|NCT02535416|11861191|FG003|STARTED|Overall Study||4
10697104|NCT02535416|11861192|FG004|STARTED|Overall Study||4
10697105|NCT02535416|11861193|FG005|STARTED|Overall Study||4
10697106|NCT02535416|11861194|FG006|STARTED|Overall Study||6
10697107|NCT02535416|11861195|FG007|STARTED|Overall Study||6
10697108|NCT02535416|11861196|FG008|STARTED|Overall Study||6
10697109|NCT02535416|11861188|FG000|COMPLETED|Overall Study||3
10697110|NCT02535416|11861189|FG001|COMPLETED|Overall Study||2
10697111|NCT02535416|11861190|FG002|COMPLETED|Overall Study||4
10697112|NCT02535416|11861191|FG003|COMPLETED|Overall Study||4
10697113|NCT02535416|11861192|FG004|COMPLETED|Overall Study||4
10697114|NCT02535416|11861193|FG005|COMPLETED|Overall Study||4
10697115|NCT02535416|11861194|FG006|COMPLETED|Overall Study||6
10697116|NCT02535416|11861195|FG007|COMPLETED|Overall Study||6
10697117|NCT02535416|11861196|FG008|COMPLETED|Overall Study||6
10697118|NCT02535416|11861188|FG000|NOT COMPLETED|Overall Study||1
10697119|NCT02535416|11861189|FG001|NOT COMPLETED|Overall Study||0
10697120|NCT02535416|11861190|FG002|NOT COMPLETED|Overall Study||0
10697121|NCT02535416|11861191|FG003|NOT COMPLETED|Overall Study||0
10697122|NCT02535416|11861192|FG004|NOT COMPLETED|Overall Study||0
10697123|NCT02535416|11861193|FG005|NOT COMPLETED|Overall Study||0
10697124|NCT02535416|11861194|FG006|NOT COMPLETED|Overall Study||0
10697125|NCT02535416|11861195|FG007|NOT COMPLETED|Overall Study||0
10697126|NCT02535416|11861196|FG008|NOT COMPLETED|Overall Study||0
10697127|NCT02535481|11861222|FG000|STARTED|Overall Study||22
10697128|NCT02535481|11861223|FG001|STARTED|Overall Study||22
10697129|NCT02535481|11861222|FG000|COMPLETED|Overall Study||22
10697130|NCT02535481|11861223|FG001|COMPLETED|Overall Study||22
10697131|NCT02535481|11861222|FG000|NOT COMPLETED|Overall Study||0
10697132|NCT02535481|11861223|FG001|NOT COMPLETED|Overall Study||0
10697133|NCT02535572|11861231|FG000|STARTED|Overall Study||21
10697134|NCT02535572|11861232|FG001|STARTED|Overall Study||20
10697135|NCT02535572|11861231|FG000|COMPLETED|Overall Study||17
10697136|NCT02535572|11861232|FG001|COMPLETED|Overall Study||17
10697137|NCT02535572|11861231|FG000|NOT COMPLETED|Overall Study||4
10697138|NCT02535572|11861232|FG001|NOT COMPLETED|Overall Study||3
10713469|NCT02678676|11878929|FG000|NOT COMPLETED|Overall Study||888
10713470|NCT02678676|11878930|FG001|NOT COMPLETED|Overall Study||872
10713471|NCT02678923|11878938|FG000|STARTED|Overall Study||59
10713472|NCT02678923|11878939|FG001|STARTED|Overall Study||67
10713473|NCT02678923|11878938|FG000|Received at Least 1 Dose of Study Drug|Overall Study||58
10713474|NCT02678923|11878939|FG001|Received at Least 1 Dose of Study Drug|Overall Study||64
10713475|NCT02678923|11878938|FG000|mITT Population|Overall Study||52
10713476|NCT02678923|11878939|FG001|mITT Population|Overall Study||61
10713477|NCT02678923|11878938|FG000|COMPLETED|Overall Study||53
10713478|NCT02678923|11878939|FG001|COMPLETED|Overall Study||62
10713479|NCT02678923|11878938|FG000|NOT COMPLETED|Overall Study||6
10713480|NCT02678923|11878939|FG001|NOT COMPLETED|Overall Study||5
10713481|NCT02679079|11878948|FG000|STARTED|Overall Study||33
10713482|NCT02679079|11878949|FG001|STARTED|Overall Study||32
10713483|NCT02679079|11878950|FG002|STARTED|Overall Study||33
10713484|NCT02679079|11878948|FG000|ITT Analysis Set|Overall Study||31
10713485|NCT02679079|11878949|FG001|ITT Analysis Set|Overall Study||32
10713486|NCT02679079|11878950|FG002|ITT Analysis Set|Overall Study||32
10713487|NCT02679079|11878948|FG000|COMPLETED|Overall Study||29
10713488|NCT02679079|11878949|FG001|COMPLETED|Overall Study||30
10713489|NCT02679079|11878950|FG002|COMPLETED|Overall Study||31
10713490|NCT02679079|11878948|FG000|NOT COMPLETED|Overall Study||4
10713491|NCT02679079|11878949|FG001|NOT COMPLETED|Overall Study||2
10713492|NCT02679079|11878950|FG002|NOT COMPLETED|Overall Study||2
10713493|NCT02679222|11878958|FG000|STARTED|Overall Study||10
10713494|NCT02679222|11878958|FG000|COMPLETED|Overall Study||9
10713495|NCT02679222|11878958|FG000|NOT COMPLETED|Overall Study||1
10713496|NCT02679235|11878970|FG000|STARTED|Overall Study||15
10713497|NCT02679235|11878970|FG000|COMPLETED|Overall Study||11
10713498|NCT02679235|11878970|FG000|NOT COMPLETED|Overall Study||4
10713499|NCT02679274|11878976|FG000|STARTED|Overall Study||2
10713500|NCT02679274|11878977|FG001|STARTED|Overall Study||1
10713501|NCT02679274|11878976|FG000|COMPLETED|Overall Study||1
10713502|NCT02679274|11878977|FG001|COMPLETED|Overall Study||1
10713503|NCT02679274|11878976|FG000|NOT COMPLETED|Overall Study||1
10713504|NCT02679274|11878977|FG001|NOT COMPLETED|Overall Study||0
10713505|NCT02679287|11878985|FG000|STARTED|Period 1: Randomization-Study Session 1||47
10713506|NCT02679287|11878986|FG001|STARTED|Period 1: Randomization-Study Session 1||46
10713507|NCT02679287|11878985|FG000|COMPLETED|Period 1: Randomization-Study Session 1||43
10713508|NCT02679287|11878986|FG001|COMPLETED|Period 1: Randomization-Study Session 1||40
10713509|NCT02679287|11878985|FG000|NOT COMPLETED|Period 1: Randomization-Study Session 1||4
10713510|NCT02679287|11878986|FG001|NOT COMPLETED|Period 1: Randomization-Study Session 1||6
10713511|NCT02679287|11878985|FG000|STARTED|Period 2||43
10713512|NCT02679287|11878986|FG001|STARTED|Period 2||40
10713513|NCT02679287|11878985|FG000|COMPLETED|Period 2||40
10713514|NCT02679287|11878986|FG001|COMPLETED|Period 2||40
10713515|NCT02679287|11878985|FG000|NOT COMPLETED|Period 2||3
10713516|NCT02679287|11878986|FG001|NOT COMPLETED|Period 2||0
10713517|NCT02679287|11878985|FG000|STARTED|Period 3||40
10713518|NCT02679287|11878986|FG001|STARTED|Period 3||40
10713519|NCT02679287|11878985|FG000|COMPLETED|Period 3||40
10801440|NCT04356937|11962643|FG000|STARTED|Treatment (mITT Population)||161
10801441|NCT04356937|11962644|FG001|STARTED|Treatment (mITT Population)||82
10801442|NCT04356937|11962643|FG000|COMPLETED|Treatment (mITT Population)||161
10801443|NCT04356937|11962644|FG001|COMPLETED|Treatment (mITT Population)||81
10801444|NCT04356937|11962643|FG000|NOT COMPLETED|Treatment (mITT Population)||0
10801445|NCT04356937|11962644|FG001|NOT COMPLETED|Treatment (mITT Population)||1
10713520|NCT02679287|11878986|FG001|COMPLETED|Period 3||39
10713521|NCT02679287|11878985|FG000|NOT COMPLETED|Period 3||0
10713522|NCT02679287|11878986|FG001|NOT COMPLETED|Period 3||1
10713523|NCT02679287|11878985|FG000|STARTED|Phase 4||40
10713524|NCT02679287|11878986|FG001|STARTED|Phase 4||39
10713525|NCT02679287|11878985|FG000|COMPLETED|Phase 4||40
10713526|NCT02679287|11878986|FG001|COMPLETED|Phase 4||39
10713527|NCT02679287|11878985|FG000|NOT COMPLETED|Phase 4||0
10713528|NCT02679287|11878986|FG001|NOT COMPLETED|Phase 4||0
10713529|NCT02679469|11878998|FG000|STARTED|Overall Study||7
10713530|NCT02679469|11878998|FG000|COMPLETED|Overall Study||7
10713531|NCT02679469|11878998|FG000|NOT COMPLETED|Overall Study||0
10713532|NCT02679573|11879004|FG000|STARTED|Overall Study||431
10713533|NCT02679573|11879005|FG001|STARTED|Overall Study||428
10713534|NCT02679573|11879004|FG000|COMPLETED|Overall Study||394
10713535|NCT02679573|11879005|FG001|COMPLETED|Overall Study||389
10713536|NCT02679573|11879004|FG000|NOT COMPLETED|Overall Study||37
10713537|NCT02679573|11879005|FG001|NOT COMPLETED|Overall Study||39
10713538|NCT02679690|11879011|FG000|STARTED|Overall Study||10
10713539|NCT02679690|11879011|FG000|COMPLETED|Overall Study||9
10697139|NCT02535611|11861241|FG000|STARTED|Overall Study||27
10697140|NCT02535611|11861242|FG001|STARTED|Overall Study||20
10697141|NCT02535611|11861241|FG000|COMPLETED|Overall Study||27
10697142|NCT02535611|11861242|FG001|COMPLETED|Overall Study||20
10697143|NCT02535611|11861241|FG000|NOT COMPLETED|Overall Study||0
10697144|NCT02535611|11861242|FG001|NOT COMPLETED|Overall Study||0
10697145|NCT02535715|11861248|FG000|STARTED|Overall Study||4
10697146|NCT02535715|11861249|FG001|STARTED|Overall Study||4
10697147|NCT02535715|11861250|FG002|STARTED|Overall Study||3
10697148|NCT02535715|11861248|FG000|COMPLETED|Overall Study||4
10697149|NCT02535715|11861249|FG001|COMPLETED|Overall Study||4
10697150|NCT02535715|11861250|FG002|COMPLETED|Overall Study||2
10697151|NCT02535715|11861248|FG000|NOT COMPLETED|Overall Study||0
10697152|NCT02535715|11861249|FG001|NOT COMPLETED|Overall Study||0
10697153|NCT02535715|11861250|FG002|NOT COMPLETED|Overall Study||1
10697154|NCT02535741|11861261|FG000|STARTED|Overall Study||168
10697155|NCT02535741|11861261|FG000|COMPLETED|Overall Study|Completed cases at 2 years follow-up|136
10697156|NCT02535741|11861261|FG000|NOT COMPLETED|Overall Study||32
10697157|NCT02535806|11861266|FG000|STARTED|Overall Study||2
10697158|NCT02535806|11861266|FG000|COMPLETED|Overall Study||2
10697159|NCT02535806|11861266|FG000|NOT COMPLETED|Overall Study||0
10697160|NCT02535949|11861273|FG000|STARTED|Overall Study||50
10697161|NCT02535949|11861274|FG001|STARTED|Overall Study||50
10697162|NCT02535949|11861275|FG002|STARTED|Overall Study||50
10697163|NCT02535949|11861273|FG000|COMPLETED|Overall Study||49
10697164|NCT02535949|11861274|FG001|COMPLETED|Overall Study||50
10697165|NCT02535949|11861275|FG002|COMPLETED|Overall Study||50
10697166|NCT02535949|11861273|FG000|NOT COMPLETED|Overall Study||1
10697167|NCT02535949|11861274|FG001|NOT COMPLETED|Overall Study||0
10697168|NCT02535949|11861275|FG002|NOT COMPLETED|Overall Study||0
10697169|NCT02536040|11861286|FG000|STARTED|Overall Study||30
10697170|NCT02536040|11861287|FG001|STARTED|Overall Study||36
10697171|NCT02536040|11861286|FG000|COMPLETED|Overall Study||29
10697172|NCT02536040|11861287|FG001|COMPLETED|Overall Study||35
10697173|NCT02536040|11861286|FG000|NOT COMPLETED|Overall Study||1
10697174|NCT02536040|11861287|FG001|NOT COMPLETED|Overall Study||1
10697175|NCT02536105|11861293|FG000|STARTED|Concerta Open Label||80
10697176|NCT02536105|11861293|FG000|Completion of Phase|Concerta Open Label||76
10697177|NCT02536105|11861293|FG000|COMPLETED|Concerta Open Label||72
10697178|NCT02536105|11861293|FG000|NOT COMPLETED|Concerta Open Label||8
10697179|NCT02536105|11861293|FG000|STARTED|Placebo||74
10697180|NCT02536105|11861293|FG000|Completion of Placebo Day|Placebo||74
10697181|NCT02536105|11861293|FG000|COMPLETED|Placebo||72
10697182|NCT02536105|11861293|FG000|NOT COMPLETED|Placebo||2
10697183|NCT02536105|11861293|FG000|STARTED|Methylphenidate HCl ER Tablet 1||72
10697184|NCT02536105|11861293|FG000|Completion of MPH HCl ER Tab 1 Day|Methylphenidate HCl ER Tablet 1||72
10697185|NCT02536105|11861293|FG000|COMPLETED|Methylphenidate HCl ER Tablet 1||72
10697186|NCT02536105|11861293|FG000|NOT COMPLETED|Methylphenidate HCl ER Tablet 1||0
10697187|NCT02536105|11861293|FG000|STARTED|Methylphenidate HCl ER Tablet 2||73
10697188|NCT02536105|11861293|FG000|Completion of MPH HCl ER Tablet 2 Phase|Methylphenidate HCl ER Tablet 2||73
10697189|NCT02536105|11861293|FG000|COMPLETED|Methylphenidate HCl ER Tablet 2||72
10697190|NCT02536105|11861293|FG000|NOT COMPLETED|Methylphenidate HCl ER Tablet 2||1
10697191|NCT02536105|11861293|FG000|STARTED|Methylphenidate HCl ER Suspension||74
10697192|NCT02536105|11861293|FG000|Completion of MPH HCl ER Susp Phase|Methylphenidate HCl ER Suspension||74
10697193|NCT02536105|11861293|FG000|COMPLETED|Methylphenidate HCl ER Suspension||72
10697194|NCT02536105|11861293|FG000|NOT COMPLETED|Methylphenidate HCl ER Suspension||2
10697195|NCT02536196|11861306|FG000|STARTED|Overall Study||262
10697196|NCT02536196|11861307|FG001|STARTED|Overall Study||121
10697197|NCT02536196|11861308|FG002|STARTED|Overall Study||95
10697198|NCT02536196|11861306|FG000|COMPLETED|Overall Study||233
10697199|NCT02536196|11861307|FG001|COMPLETED|Overall Study||107
10697200|NCT02536196|11861308|FG002|COMPLETED|Overall Study||95
10697201|NCT02536196|11861306|FG000|NOT COMPLETED|Overall Study||29
10697202|NCT02536196|11861307|FG001|NOT COMPLETED|Overall Study||14
10697203|NCT02536196|11861308|FG002|NOT COMPLETED|Overall Study||0
10697204|NCT02536248|11861317|FG000|STARTED|First Intervention (6 Weeks)||10
10697205|NCT02536248|11861318|FG001|STARTED|First Intervention (6 Weeks)||10
10697206|NCT02536248|11861317|FG000|COMPLETED|First Intervention (6 Weeks)||10
10697207|NCT02536248|11861318|FG001|COMPLETED|First Intervention (6 Weeks)||10
10697208|NCT02536248|11861317|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
10697209|NCT02536248|11861318|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
10697210|NCT02536248|11861317|FG000|STARTED|Wash-out (14 Days)||10
10697211|NCT02536248|11861318|FG001|STARTED|Wash-out (14 Days)||10
10697212|NCT02536248|11861317|FG000|COMPLETED|Wash-out (14 Days)||10
10697213|NCT02536248|11861318|FG001|COMPLETED|Wash-out (14 Days)||10
10697214|NCT02536248|11861317|FG000|NOT COMPLETED|Wash-out (14 Days)||0
10697215|NCT02536248|11861318|FG001|NOT COMPLETED|Wash-out (14 Days)||0
10697216|NCT02536248|11861317|FG000|STARTED|Second Intervention (6 Weeks)||10
10697217|NCT02536248|11861318|FG001|STARTED|Second Intervention (6 Weeks)||10
10697218|NCT02536248|11861317|FG000|COMPLETED|Second Intervention (6 Weeks)||10
10697219|NCT02536248|11861318|FG001|COMPLETED|Second Intervention (6 Weeks)||10
10697220|NCT02536248|11861317|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
10697221|NCT02536248|11861318|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
10697222|NCT02536313|11861326|FG000|STARTED|Overall Study||24
10697223|NCT02536313|11861327|FG001|STARTED|Overall Study||25
10697224|NCT02536313|11861326|FG000|COMPLETED|Overall Study||24
10697225|NCT02536313|11861327|FG001|COMPLETED|Overall Study||24
10697226|NCT02536313|11861326|FG000|NOT COMPLETED|Overall Study||0
10697227|NCT02536313|11861327|FG001|NOT COMPLETED|Overall Study||1
10697228|NCT02536378|11861337|FG000|STARTED|Overall Study||632
10697229|NCT02536378|11861338|FG001|STARTED|Overall Study||60
10697230|NCT02536378|11861337|FG000|COMPLETED|Overall Study||625
10697231|NCT02536378|11861338|FG001|COMPLETED|Overall Study||53
10697232|NCT02536378|11861337|FG000|NOT COMPLETED|Overall Study||7
10697233|NCT02536378|11861338|FG001|NOT COMPLETED|Overall Study||7
10697234|NCT02536404|11861348|FG000|STARTED|Overall Study||112
10697235|NCT02536404|11861349|FG001|STARTED|Overall Study||6
10697236|NCT02536404|11861348|FG000|COMPLETED|Overall Study||92
10697237|NCT02536404|11861349|FG001|COMPLETED|Overall Study||5
10697238|NCT02536404|11861348|FG000|NOT COMPLETED|Overall Study||20
10697239|NCT02536404|11861349|FG001|NOT COMPLETED|Overall Study||1
10697240|NCT02536508|11861358|FG000|STARTED|Overall Study||194
10697241|NCT02536508|11861359|FG001|STARTED|Overall Study||174
10697242|NCT02536508|11861360|FG002|STARTED|Overall Study||88
10697243|NCT02536508|11861358|FG000|COMPLETED|Overall Study||142
10697244|NCT02536508|11861359|FG001|COMPLETED|Overall Study||130
10697245|NCT02536508|11861360|FG002|COMPLETED|Overall Study||65
10697246|NCT02536508|11861358|FG000|NOT COMPLETED|Overall Study||52
10697247|NCT02536508|11861359|FG001|NOT COMPLETED|Overall Study||44
10697248|NCT02536508|11861360|FG002|NOT COMPLETED|Overall Study||23
10697249|NCT02536664|11861370|FG000|STARTED|Overall Study||312
10697250|NCT02536664|11861371|FG001|STARTED|Overall Study||177
10697251|NCT02536664|11861370|FG000|COMPLETED|Overall Study||205
10697252|NCT02536664|11861371|FG001|COMPLETED|Overall Study||97
10697253|NCT02536664|11861370|FG000|NOT COMPLETED|Overall Study||107
10697254|NCT02536664|11861371|FG001|NOT COMPLETED|Overall Study||80
10697255|NCT02536781|11861379|FG000|STARTED|Overall Study||36
10697256|NCT02536781|11861380|FG001|STARTED|Overall Study||34
10697257|NCT02536781|11861379|FG000|COMPLETED|Overall Study||34
10697258|NCT02536781|11861380|FG001|COMPLETED|Overall Study||34
10697259|NCT02536781|11861379|FG000|NOT COMPLETED|Overall Study||2
10697260|NCT02536781|11861380|FG001|NOT COMPLETED|Overall Study||0
10697261|NCT02536833|11861390|FG000|STARTED|Overall Study||112
10697262|NCT02536833|11861391|FG001|STARTED|Overall Study||117
10697263|NCT02536833|11861392|FG002|STARTED|Overall Study||110
10697264|NCT02536833|11861393|FG003|STARTED|Overall Study||116
10697265|NCT02536833|11861390|FG000|COMPLETED|Overall Study||103
10697266|NCT02536833|11861391|FG001|COMPLETED|Overall Study||107
10697267|NCT02536833|11861392|FG002|COMPLETED|Overall Study||95
10697268|NCT02536833|11861393|FG003|COMPLETED|Overall Study||97
10697269|NCT02536833|11861390|FG000|NOT COMPLETED|Overall Study||9
10697270|NCT02536833|11861391|FG001|NOT COMPLETED|Overall Study||10
10697271|NCT02536833|11861392|FG002|NOT COMPLETED|Overall Study||15
10697272|NCT02536833|11861393|FG003|NOT COMPLETED|Overall Study||19
10697273|NCT02536846|11861404|FG000|STARTED|Overall Study||10
10697274|NCT02536846|11861404|FG000|COMPLETED|Overall Study||9
10697275|NCT02536846|11861404|FG000|NOT COMPLETED|Overall Study||1
10697276|NCT02536963|11861409|FG000|STARTED|Overall Study||318
10697277|NCT02536963|11861409|FG000|COMPLETED|Overall Study||300
10697278|NCT02536963|11861409|FG000|NOT COMPLETED|Overall Study||18
10697279|NCT02536976|11861415|FG000|STARTED|Overall Study|2 weeks single blind placebo run-in|3
10697280|NCT02536976|11861416|FG001|STARTED|Overall Study|2 weeks single blind placebo run-in. 1 participant terminated due to unrelated failing health|2
10697281|NCT02536976|11861415|FG000|Randomization|Overall Study|2 weeks double blind mirabegron|3
10697282|NCT02536976|11861416|FG001|Randomization|Overall Study|2 weeks double blind placebo matching mirabegron|1
10697283|NCT02536976|11861415|FG000|Dose Escalation and Maintenance|Overall Study|10 weeks double blind mirabegron|3
10697284|NCT02536976|11861416|FG001|Dose Escalation and Maintenance|Overall Study|10 weeks double blind placebo matching mirabegron|1
10697285|NCT02536976|11861415|FG000|Washout|Overall Study||3
10697286|NCT02536976|11861416|FG001|Washout|Overall Study||1
10697287|NCT02536976|11861415|FG000|COMPLETED|Overall Study||3
10697288|NCT02536976|11861416|FG001|COMPLETED|Overall Study||1
10697289|NCT02536976|11861415|FG000|NOT COMPLETED|Overall Study||0
10697290|NCT02536976|11861416|FG001|NOT COMPLETED|Overall Study||1
10697291|NCT02537015|11861424|FG000|STARTED|Overall Study||81
10697292|NCT02537015|11861424|FG000|COMPLETED|Overall Study||75
10697293|NCT02537015|11861424|FG000|NOT COMPLETED|Overall Study||6
10697294|NCT02537431|11861428|FG000|STARTED|Open-Label Period (Week 0 to Week 48)|Screened and received at least 1 dose of study drug.|14
10697295|NCT02537431|11861428|FG000|COMPLETED|Open-Label Period (Week 0 to Week 48)|Completed Open-Label Period (Week 0 - Week 48)|13
10697296|NCT02537431|11861428|FG000|NOT COMPLETED|Open-Label Period (Week 0 to Week 48)||1
10697297|NCT02537431|11861428|FG000|STARTED|Treatment Extension Period I||13
10697298|NCT02537431|11861428|FG000|COMPLETED|Treatment Extension Period I||13
10697299|NCT02537431|11861428|FG000|NOT COMPLETED|Treatment Extension Period I||0
10697300|NCT02537431|11861428|FG000|STARTED|Treatment Extension Period II|5 participants completing Treatment Extension Period I did not enter Treatment Extension Period II|8
10697301|NCT02537431|11861428|FG000|COMPLETED|Treatment Extension Period II||8
10697302|NCT02537431|11861428|FG000|NOT COMPLETED|Treatment Extension Period II||0
10697303|NCT02537444|11861434|FG000|STARTED|Overall Study||39
10697304|NCT02537444|11861435|FG001|STARTED|Overall Study||39
10697305|NCT02537444|11861434|FG000|Enrolled|Overall Study||39
10697306|NCT02537444|11861435|FG001|Enrolled|Overall Study||39
10697307|NCT02537444|11861434|FG000|Received Study Medication|Overall Study||38
10697308|NCT02537444|11861435|FG001|Received Study Medication|Overall Study||39
10697309|NCT02537444|11861434|FG000|Discontinued Study|Overall Study||39
10697310|NCT02537444|11861435|FG001|Discontinued Study|Overall Study||39
10697311|NCT02537444|11861434|FG000|COMPLETED|Overall Study||0
10697312|NCT02537444|11861435|FG001|COMPLETED|Overall Study||0
10697313|NCT02537444|11861434|FG000|NOT COMPLETED|Overall Study||39
10697314|NCT02537444|11861435|FG001|NOT COMPLETED|Overall Study||39
10697315|NCT02537522|11861441|FG000|STARTED|Phase I - Contralateral||34
10697316|NCT02537522|11861442|FG001|STARTED|Phase I - Contralateral||37
10697317|NCT02537522|11861443|FG002|STARTED|Phase I - Contralateral||0
10697318|NCT02537522|11861444|FG003|STARTED|Phase I - Contralateral||0
10697319|NCT02537522|11861441|FG000|COMPLETED|Phase I - Contralateral||19
10697320|NCT02537522|11861442|FG001|COMPLETED|Phase I - Contralateral||27
10697321|NCT02537522|11861443|FG002|COMPLETED|Phase I - Contralateral||0
10697322|NCT02537522|11861444|FG003|COMPLETED|Phase I - Contralateral||0
10697323|NCT02537522|11861441|FG000|NOT COMPLETED|Phase I - Contralateral||15
10697324|NCT02537522|11861442|FG001|NOT COMPLETED|Phase I - Contralateral||10
10697325|NCT02537522|11861443|FG002|NOT COMPLETED|Phase I - Contralateral||0
10697326|NCT02537522|11861444|FG003|NOT COMPLETED|Phase I - Contralateral||0
10697327|NCT02537522|11861441|FG000|STARTED|Phase II - Period 1 Bilateral||0
10697328|NCT02537522|11861442|FG001|STARTED|Phase II - Period 1 Bilateral||0
10697329|NCT02537522|11861443|FG002|STARTED|Phase II - Period 1 Bilateral||23
10697330|NCT02537522|11861444|FG003|STARTED|Phase II - Period 1 Bilateral||23
10697331|NCT02537522|11861441|FG000|COMPLETED|Phase II - Period 1 Bilateral||0
10697332|NCT02537522|11861442|FG001|COMPLETED|Phase II - Period 1 Bilateral||0
10697333|NCT02537522|11861443|FG002|COMPLETED|Phase II - Period 1 Bilateral||23
10697334|NCT02537522|11861444|FG003|COMPLETED|Phase II - Period 1 Bilateral||22
10697335|NCT02537522|11861441|FG000|NOT COMPLETED|Phase II - Period 1 Bilateral||0
10697336|NCT02537522|11861442|FG001|NOT COMPLETED|Phase II - Period 1 Bilateral||0
10697337|NCT02537522|11861443|FG002|NOT COMPLETED|Phase II - Period 1 Bilateral||0
10697338|NCT02537522|11861444|FG003|NOT COMPLETED|Phase II - Period 1 Bilateral||1
10697339|NCT02537522|11861441|FG000|STARTED|Phase II - Period 2 Bilateral||0
10697340|NCT02537522|11861442|FG001|STARTED|Phase II - Period 2 Bilateral||0
10697341|NCT02537522|11861443|FG002|STARTED|Phase II - Period 2 Bilateral||23
10697342|NCT02537522|11861444|FG003|STARTED|Phase II - Period 2 Bilateral||22
10697343|NCT02537522|11861441|FG000|COMPLETED|Phase II - Period 2 Bilateral||0
10697344|NCT02537522|11861442|FG001|COMPLETED|Phase II - Period 2 Bilateral||0
10697345|NCT02537522|11861443|FG002|COMPLETED|Phase II - Period 2 Bilateral||23
10697346|NCT02537522|11861444|FG003|COMPLETED|Phase II - Period 2 Bilateral||22
10697347|NCT02537522|11861441|FG000|NOT COMPLETED|Phase II - Period 2 Bilateral||0
10697348|NCT02537522|11861442|FG001|NOT COMPLETED|Phase II - Period 2 Bilateral||0
10697349|NCT02537522|11861443|FG002|NOT COMPLETED|Phase II - Period 2 Bilateral||0
10697350|NCT02537522|11861444|FG003|NOT COMPLETED|Phase II - Period 2 Bilateral||0
10697351|NCT02537574|11861453|FG000|STARTED|Overall Study||126
10697352|NCT02537574|11861454|FG001|STARTED|Overall Study||126
10697353|NCT02537574|11861455|FG002|STARTED|Overall Study||126
10697354|NCT02537574|11861453|FG000|COMPLETED|Overall Study||27
10697355|NCT02537574|11861454|FG001|COMPLETED|Overall Study||23
10697356|NCT02537574|11861455|FG002|COMPLETED|Overall Study||18
10697357|NCT02537574|11861453|FG000|NOT COMPLETED|Overall Study||99
10697358|NCT02537574|11861454|FG001|NOT COMPLETED|Overall Study||103
10697359|NCT02537574|11861455|FG002|NOT COMPLETED|Overall Study||108
10697360|NCT02537717|11861463|FG000|STARTED|Overall Study||17
10697361|NCT02537717|11861463|FG000|COMPLETED|Overall Study||17
10697362|NCT02537717|11861463|FG000|NOT COMPLETED|Overall Study||0
10697363|NCT02537730|11861470|FG000|STARTED|First Intervention (7 Days)||17
10697364|NCT02537730|11861471|FG001|STARTED|First Intervention (7 Days)||16
10697365|NCT02537730|11861470|FG000|COMPLETED|First Intervention (7 Days)||17
10697366|NCT02537730|11861471|FG001|COMPLETED|First Intervention (7 Days)||16
10697367|NCT02537730|11861470|FG000|NOT COMPLETED|First Intervention (7 Days)||0
10697368|NCT02537730|11861471|FG001|NOT COMPLETED|First Intervention (7 Days)||0
10697369|NCT02537730|11861470|FG000|STARTED|Second Intervention (7 Days)||17
10697370|NCT02537730|11861471|FG001|STARTED|Second Intervention (7 Days)||16
10697371|NCT02537730|11861470|FG000|COMPLETED|Second Intervention (7 Days)||17
10697372|NCT02537730|11861471|FG001|COMPLETED|Second Intervention (7 Days)||16
10697373|NCT02537730|11861470|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
10697374|NCT02537730|11861471|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
10697375|NCT02537873|11861479|FG000|STARTED|Overall Study||17
10697376|NCT02537873|11861480|FG001|STARTED|Overall Study||8
10697377|NCT02537873|11861479|FG000|COMPLETED|Overall Study||9
10697378|NCT02537873|11861480|FG001|COMPLETED|Overall Study||4
10697379|NCT02537873|11861479|FG000|NOT COMPLETED|Overall Study||8
10697380|NCT02537873|11861480|FG001|NOT COMPLETED|Overall Study||4
10697381|NCT02537951|11861487|FG000|STARTED|Overall Study||10
10697382|NCT02537951|11861487|FG000|COMPLETED|Overall Study||10
10697383|NCT02537951|11861487|FG000|NOT COMPLETED|Overall Study||0
10697384|NCT02538016|11861495|FG000|STARTED|Overall Study||4
10697385|NCT02538016|11861495|FG000|COMPLETED|Overall Study||4
10697386|NCT02538016|11861495|FG000|NOT COMPLETED|Overall Study||0
10697387|NCT02538029|11861502|FG000|STARTED|Overall Study||24
10697388|NCT02538029|11861503|FG001|STARTED|Overall Study||10
10697389|NCT02538029|11861504|FG002|STARTED|Overall Study||11
10697390|NCT02538029|11861502|FG000|COMPLETED|Overall Study||23
10697391|NCT02538029|11861503|FG001|COMPLETED|Overall Study||10
10697392|NCT02538029|11861504|FG002|COMPLETED|Overall Study||10
10697393|NCT02538029|11861502|FG000|NOT COMPLETED|Overall Study||1
10697394|NCT02538029|11861503|FG001|NOT COMPLETED|Overall Study||0
10697395|NCT02538029|11861504|FG002|NOT COMPLETED|Overall Study||1
10697396|NCT02538042|11861516|FG000|STARTED|Overall Study||17
10697397|NCT02538042|11861517|FG001|STARTED|Overall Study||17
10697398|NCT02538042|11861516|FG000|Completed All MCE Sessions|Overall Study||15
10697399|NCT02538042|11861517|FG001|Completed All MCE Sessions|Overall Study||15
10697400|NCT02538042|11861516|FG000|Attended Post-Quit Visit|Overall Study||15
10697401|NCT02538042|11861517|FG001|Attended Post-Quit Visit|Overall Study||14
10697402|NCT02538042|11861516|FG000|Completed All Post-Quit Visits|Overall Study||12
10697403|NCT02538042|11861517|FG001|Completed All Post-Quit Visits|Overall Study||12
10697404|NCT02538042|11861516|FG000|COMPLETED|Overall Study||6
10697405|NCT02538042|11861517|FG001|COMPLETED|Overall Study||6
10697406|NCT02538042|11861516|FG000|NOT COMPLETED|Overall Study||11
10697407|NCT02538042|11861517|FG001|NOT COMPLETED|Overall Study||11
10697408|NCT02538094|11861525|FG000|STARTED|Intervention 1 (5 Days Per Participant)||2
10697409|NCT02538094|11861526|FG001|STARTED|Intervention 1 (5 Days Per Participant)||5
10697410|NCT02538094|11861525|FG000|COMPLETED|Intervention 1 (5 Days Per Participant)||2
10697411|NCT02538094|11861526|FG001|COMPLETED|Intervention 1 (5 Days Per Participant)||4
10697412|NCT02538094|11861525|FG000|NOT COMPLETED|Intervention 1 (5 Days Per Participant)||0
10697413|NCT02538094|11861526|FG001|NOT COMPLETED|Intervention 1 (5 Days Per Participant)||1
10697414|NCT02538094|11861525|FG000|STARTED|Washout (4 Weeks)||2
10697415|NCT02538094|11861526|FG001|STARTED|Washout (4 Weeks)||4
10697416|NCT02538094|11861525|FG000|COMPLETED|Washout (4 Weeks)||2
10697417|NCT02538094|11861526|FG001|COMPLETED|Washout (4 Weeks)||3
10697418|NCT02538094|11861525|FG000|NOT COMPLETED|Washout (4 Weeks)||0
10697419|NCT02538094|11861526|FG001|NOT COMPLETED|Washout (4 Weeks)||1
10697420|NCT02538094|11861525|FG000|STARTED|Intervention 2 (5 Days Per Participant)||2
10697421|NCT02538094|11861526|FG001|STARTED|Intervention 2 (5 Days Per Participant)||3
10697422|NCT02538094|11861525|FG000|COMPLETED|Intervention 2 (5 Days Per Participant)||2
10697423|NCT02538094|11861526|FG001|COMPLETED|Intervention 2 (5 Days Per Participant)||3
10697424|NCT02538094|11861525|FG000|NOT COMPLETED|Intervention 2 (5 Days Per Participant)||0
10697425|NCT02538094|11861526|FG001|NOT COMPLETED|Intervention 2 (5 Days Per Participant)||0
10697426|NCT02538107|11861532|FG000|STARTED|Overall Study||290
10697427|NCT02538107|11861532|FG000|COMPLETED|Overall Study||180
10697428|NCT02538107|11861532|FG000|NOT COMPLETED|Overall Study||110
10697429|NCT02538341|11861548|FG000|STARTED|Overall Study||310
10697430|NCT02538341|11861549|FG001|STARTED|Overall Study||307
10697431|NCT02538341|11861548|FG000|Week 6 (Primary Outcome)|Overall Study||303
10697432|NCT02538341|11861549|FG001|Week 6 (Primary Outcome)|Overall Study||299
10697433|NCT02538341|11861548|FG000|Month 6 (Safety Outcome)|Overall Study||276
10697434|NCT02538341|11861549|FG001|Month 6 (Safety Outcome)|Overall Study||260
10697435|NCT02538341|11861548|FG000|1 Year Visit|Overall Study||254
10697436|NCT02538341|11861549|FG001|1 Year Visit|Overall Study||0
10697437|NCT02538341|11861548|FG000|COMPLETED|Overall Study||254
10697438|NCT02538341|11861549|FG001|COMPLETED|Overall Study||260
10697439|NCT02538341|11861548|FG000|NOT COMPLETED|Overall Study||56
10697440|NCT02538341|11861549|FG001|NOT COMPLETED|Overall Study||47
10697441|NCT02538354|11861557|FG000|STARTED|Overall Study||40
10697442|NCT02538354|11861558|FG001|STARTED|Overall Study||30
10697443|NCT02538354|11861557|FG000|COMPLETED|Overall Study||40
10697444|NCT02538354|11861558|FG001|COMPLETED|Overall Study||30
10697445|NCT02538354|11861557|FG000|NOT COMPLETED|Overall Study||0
10697446|NCT02538354|11861558|FG001|NOT COMPLETED|Overall Study||0
10697447|NCT02538419|11861566|FG000|STARTED|Overall Study||20
10697448|NCT02538419|11861567|FG001|STARTED|Overall Study||20
10697449|NCT02538419|11861566|FG000|COMPLETED|Overall Study||20
10697450|NCT02538419|11861567|FG001|COMPLETED|Overall Study||20
10697451|NCT02538419|11861566|FG000|NOT COMPLETED|Overall Study||0
10697452|NCT02538419|11861567|FG001|NOT COMPLETED|Overall Study||0
10697453|NCT02538471|11861573|FG000|STARTED|Overall Study||3
10697454|NCT02538471|11861573|FG000|COMPLETED|Overall Study||1
10697455|NCT02538471|11861573|FG000|NOT COMPLETED|Overall Study||2
10697456|NCT02538523|11861579|FG000|STARTED|Overall Study||29
10697457|NCT02538523|11861580|FG001|STARTED|Overall Study||29
10697458|NCT02538523|11861579|FG000|COMPLETED|Overall Study||29
10697459|NCT02538523|11861580|FG001|COMPLETED|Overall Study||29
10697460|NCT02538523|11861579|FG000|NOT COMPLETED|Overall Study||0
10697461|NCT02538523|11861580|FG001|NOT COMPLETED|Overall Study||0
10697462|NCT02538614|11861586|FG000|STARTED|Overall Study||2
10697463|NCT02538614|11861586|FG000|COMPLETED|Overall Study||0
10697464|NCT02538614|11861586|FG000|NOT COMPLETED|Overall Study||2
10697465|NCT02538679|11861595|FG000|STARTED|Overall Study||24
10697466|NCT02538679|11861596|FG001|STARTED|Overall Study||54
10697467|NCT02538679|11861597|FG002|STARTED|Overall Study||49
10697468|NCT02538679|11861595|FG000|COMPLETED|Overall Study||21
10697469|NCT02538679|11861596|FG001|COMPLETED|Overall Study||45
10697470|NCT02538679|11861597|FG002|COMPLETED|Overall Study||41
10697471|NCT02538679|11861595|FG000|NOT COMPLETED|Overall Study||3
10697472|NCT02538679|11861596|FG001|NOT COMPLETED|Overall Study||9
10697473|NCT02538679|11861597|FG002|NOT COMPLETED|Overall Study||8
10697474|NCT02538783|11861607|FG000|STARTED|Overall Study||130
10697475|NCT02538783|11861608|FG001|STARTED|Overall Study||129
10697476|NCT02538783|11861607|FG000|COMPLETED|Overall Study||130
10697477|NCT02538783|11861608|FG001|COMPLETED|Overall Study||128
10697478|NCT02538783|11861607|FG000|NOT COMPLETED|Overall Study||0
10697479|NCT02538783|11861608|FG001|NOT COMPLETED|Overall Study||1
10697480|NCT02538900|11861617|FG000|STARTED|Overall Study||116
10697481|NCT02538900|11861618|FG001|STARTED|Overall Study||124
10697482|NCT02538900|11861619|FG002|STARTED|Overall Study||65
10697483|NCT02538900|11861617|FG000|COMPLETED|Overall Study||96
10697484|NCT02538900|11861618|FG001|COMPLETED|Overall Study||106
10697485|NCT02538900|11861619|FG002|COMPLETED|Overall Study||48
10697486|NCT02538900|11861617|FG000|NOT COMPLETED|Overall Study||20
10697487|NCT02538900|11861618|FG001|NOT COMPLETED|Overall Study||18
10697488|NCT02538900|11861619|FG002|NOT COMPLETED|Overall Study||17
10697489|NCT02538965|11861627|FG000|STARTED|Treatment Period||17
10697490|NCT02538965|11861627|FG000|COMPLETED|Treatment Period||0
10697491|NCT02538965|11861627|FG000|NOT COMPLETED|Treatment Period||17
10697492|NCT02538965|11861627|FG000|STARTED|Follow-Up Period||17
10697493|NCT02538965|11861627|FG000|COMPLETED|Follow-Up Period||0
10697494|NCT02538965|11861627|FG000|NOT COMPLETED|Follow-Up Period||17
10697495|NCT02539108|11861633|FG000|STARTED|Overall Study||30
10697496|NCT02539108|11861634|FG001|STARTED|Overall Study||30
10697497|NCT02539108|11861633|FG000|COMPLETED|Overall Study||30
10697498|NCT02539108|11861634|FG001|COMPLETED|Overall Study||30
10697499|NCT02539108|11861633|FG000|NOT COMPLETED|Overall Study||0
10697500|NCT02539108|11861634|FG001|NOT COMPLETED|Overall Study||0
10697501|NCT02539134|11861646|FG000|STARTED|Overall Study||10
10697502|NCT02539134|11861647|FG001|STARTED|Overall Study||6
10697503|NCT02539134|11861648|FG002|STARTED|Overall Study||6
10697504|NCT02539134|11861649|FG003|STARTED|Overall Study||6
10697505|NCT02539134|11861650|FG004|STARTED|Overall Study||6
10697506|NCT02539134|11861651|FG005|STARTED|Overall Study||6
10697507|NCT02539134|11861646|FG000|COMPLETED|Overall Study||9
10697508|NCT02539134|11861647|FG001|COMPLETED|Overall Study||6
10697509|NCT02539134|11861648|FG002|COMPLETED|Overall Study||6
10697510|NCT02539134|11861649|FG003|COMPLETED|Overall Study||6
10697511|NCT02539134|11861650|FG004|COMPLETED|Overall Study||6
10697512|NCT02539134|11861651|FG005|COMPLETED|Overall Study||6
10697513|NCT02539134|11861646|FG000|NOT COMPLETED|Overall Study||1
10697514|NCT02539134|11861647|FG001|NOT COMPLETED|Overall Study||0
10697515|NCT02539134|11861648|FG002|NOT COMPLETED|Overall Study||0
10697516|NCT02539134|11861649|FG003|NOT COMPLETED|Overall Study||0
10697517|NCT02539134|11861650|FG004|NOT COMPLETED|Overall Study||0
10697518|NCT02539134|11861651|FG005|NOT COMPLETED|Overall Study||0
10697519|NCT02539342|11861672|FG000|STARTED|Overall Study||1
10697520|NCT02539342|11861673|FG001|STARTED|Overall Study||0
10697521|NCT02539342|11861672|FG000|COMPLETED|Overall Study||1
10697522|NCT02539342|11861673|FG001|COMPLETED|Overall Study||0
10697523|NCT02539342|11861672|FG000|NOT COMPLETED|Overall Study||0
10697524|NCT02539342|11861673|FG001|NOT COMPLETED|Overall Study||0
10697525|NCT02539368|11861684|FG000|STARTED|Overall Study||1522
10697526|NCT02539368|11861685|FG001|STARTED|Overall Study||494
10697527|NCT02539368|11861686|FG002|STARTED|Overall Study||358
10697528|NCT02539368|11861687|FG003|STARTED|Overall Study||67
10697529|NCT02539368|11861688|FG004|STARTED|Overall Study||102
10697530|NCT02539368|11861684|FG000|COMPLETED|Overall Study||1117
10697531|NCT02539368|11861685|FG001|COMPLETED|Overall Study||393
10697532|NCT02539368|11861686|FG002|COMPLETED|Overall Study||291
10697533|NCT02539368|11861687|FG003|COMPLETED|Overall Study||60
10697534|NCT02539368|11861688|FG004|COMPLETED|Overall Study||88
10697535|NCT02539368|11861684|FG000|NOT COMPLETED|Overall Study||405
10697536|NCT02539368|11861685|FG001|NOT COMPLETED|Overall Study||101
10697537|NCT02539368|11861686|FG002|NOT COMPLETED|Overall Study||67
10697538|NCT02539368|11861687|FG003|NOT COMPLETED|Overall Study||7
10697539|NCT02539368|11861688|FG004|NOT COMPLETED|Overall Study||14
10697540|NCT02539459|11861703|FG000|STARTED|Overall Study||20
10697541|NCT02539459|11861703|FG000|COMPLETED|Overall Study||18
10697542|NCT02539459|11861703|FG000|NOT COMPLETED|Overall Study||2
10697543|NCT02539511|11861709|FG000|STARTED|Overall Study||23
10697544|NCT02539511|11861710|FG001|STARTED|Overall Study||17
10697545|NCT02539511|11861709|FG000|COMPLETED|Overall Study||17
10697546|NCT02539511|11861710|FG001|COMPLETED|Overall Study||17
10697547|NCT02539511|11861709|FG000|NOT COMPLETED|Overall Study||6
10697548|NCT02539511|11861710|FG001|NOT COMPLETED|Overall Study||0
10697549|NCT02539654|11861716|FG000|STARTED|Overall Study||14
10697550|NCT02539654|11861716|FG000|COMPLETED|Overall Study||14
10697551|NCT02539654|11861716|FG000|NOT COMPLETED|Overall Study||0
10697552|NCT02539797|11861721|FG000|STARTED|Overall Study||12
10697553|NCT02539797|11861722|FG001|STARTED|Overall Study||13
10697554|NCT02539797|11861723|FG002|STARTED|Overall Study||13
10697555|NCT02539797|11861721|FG000|COMPLETED|Overall Study||12
10697556|NCT02539797|11861722|FG001|COMPLETED|Overall Study||12
10697557|NCT02539797|11861723|FG002|COMPLETED|Overall Study||13
10697558|NCT02539797|11861721|FG000|NOT COMPLETED|Overall Study||0
10697559|NCT02539797|11861722|FG001|NOT COMPLETED|Overall Study||1
10697560|NCT02539797|11861723|FG002|NOT COMPLETED|Overall Study||0
10697561|NCT02539992|11861734|FG000|STARTED|Overall Study||15
10697562|NCT02539992|11861735|FG001|STARTED|Overall Study||11
10697563|NCT02539992|11861736|FG002|STARTED|Overall Study||18
10697564|NCT02539992|11861734|FG000|COMPLETED|Overall Study||15
10697565|NCT02539992|11861735|FG001|COMPLETED|Overall Study||7
10697566|NCT02539992|11861736|FG002|COMPLETED|Overall Study||14
10697567|NCT02539992|11861734|FG000|NOT COMPLETED|Overall Study||0
10697568|NCT02539992|11861735|FG001|NOT COMPLETED|Overall Study||4
10697569|NCT02539992|11861736|FG002|NOT COMPLETED|Overall Study||4
10697570|NCT02540083|11861746|FG000|STARTED|Overall Study||94
10697571|NCT02540083|11861746|FG000|COMPLETED|Overall Study||78
10697572|NCT02540083|11861746|FG000|NOT COMPLETED|Overall Study||16
10697573|NCT02540161|11861754|FG000|STARTED|Overall Study||20
10697574|NCT02540161|11861755|FG001|STARTED|Overall Study||7
10697575|NCT02540161|11861756|FG002|STARTED|Overall Study||5
10697576|NCT02540161|11861757|FG003|STARTED|Overall Study||7
10697577|NCT02540161|11861754|FG000|COMPLETED|Overall Study||20
10697578|NCT02540161|11861755|FG001|COMPLETED|Overall Study||7
10697579|NCT02540161|11861756|FG002|COMPLETED|Overall Study||5
10697580|NCT02540161|11861757|FG003|COMPLETED|Overall Study||7
10697581|NCT02540161|11861754|FG000|NOT COMPLETED|Overall Study||0
10697582|NCT02540161|11861755|FG001|NOT COMPLETED|Overall Study||0
10697583|NCT02540161|11861756|FG002|NOT COMPLETED|Overall Study||0
10697584|NCT02540161|11861757|FG003|NOT COMPLETED|Overall Study||0
10697585|NCT02540213|11861767|FG000|STARTED|Overall Study||240
10697586|NCT02540213|11861767|FG000|COMPLETED|Overall Study||201
10697587|NCT02540213|11861767|FG000|NOT COMPLETED|Overall Study||39
10697588|NCT02540226|11861773|FG000|STARTED|Overall Study||33
10697589|NCT02540226|11861774|FG001|STARTED|Overall Study||33
10697590|NCT02540226|11861773|FG000|COMPLETED|Overall Study||31
10697591|NCT02540226|11861774|FG001|COMPLETED|Overall Study||32
10697592|NCT02540226|11861773|FG000|NOT COMPLETED|Overall Study||2
10697593|NCT02540226|11861774|FG001|NOT COMPLETED|Overall Study||1
10697594|NCT02540265|11861783|FG000|STARTED|Overall Study||20
10697595|NCT02540265|11861784|FG001|STARTED|Overall Study||20
10697596|NCT02540265|11861785|FG002|STARTED|Overall Study||19
10697597|NCT02540265|11861783|FG000|Treatment Completion|Overall Study||20
10697598|NCT02540265|11861784|FG001|Treatment Completion|Overall Study||19
10697599|NCT02540265|11861785|FG002|Treatment Completion|Overall Study||18
10697600|NCT02540265|11861783|FG000|COMPLETED|Overall Study||20
10697601|NCT02540265|11861784|FG001|COMPLETED|Overall Study||20
10697602|NCT02540265|11861785|FG002|COMPLETED|Overall Study||18
10697603|NCT02540265|11861783|FG000|NOT COMPLETED|Overall Study||0
10697604|NCT02540265|11861784|FG001|NOT COMPLETED|Overall Study||0
10697605|NCT02540265|11861785|FG002|NOT COMPLETED|Overall Study||1
10697606|NCT02540291|11861797|FG000|STARTED|Overall Study||8
10697607|NCT02540291|11861798|FG001|STARTED|Overall Study||8
10697608|NCT02540291|11861799|FG002|STARTED|Overall Study||7
10697609|NCT02540291|11861800|FG003|STARTED|Overall Study||7
10697610|NCT02540291|11861797|FG000|COMPLETED|Overall Study||0
10697611|NCT02540291|11861798|FG001|COMPLETED|Overall Study||0
10697612|NCT02540291|11861799|FG002|COMPLETED|Overall Study||0
10697613|NCT02540291|11861800|FG003|COMPLETED|Overall Study||0
10697614|NCT02540291|11861797|FG000|NOT COMPLETED|Overall Study||8
10697615|NCT02540291|11861798|FG001|NOT COMPLETED|Overall Study||8
10697616|NCT02540291|11861799|FG002|NOT COMPLETED|Overall Study||7
10697617|NCT02540291|11861800|FG003|NOT COMPLETED|Overall Study||7
10697618|NCT02540356|11861814|FG000|STARTED|Overall Study||1
10697619|NCT02540356|11861815|FG001|STARTED|Overall Study||0
10697620|NCT02540356|11861814|FG000|COMPLETED|Overall Study||0
10697621|NCT02540356|11861815|FG001|COMPLETED|Overall Study||0
10697622|NCT02540356|11861814|FG000|NOT COMPLETED|Overall Study||1
10697623|NCT02540356|11861815|FG001|NOT COMPLETED|Overall Study||0
10697624|NCT02540447|11861822|FG000|STARTED|Overall Study||40
10697625|NCT02540447|11861823|FG001|STARTED|Overall Study||40
10697626|NCT02540447|11861822|FG000|COMPLETED|Overall Study||40
10697627|NCT02540447|11861823|FG001|COMPLETED|Overall Study||40
10697628|NCT02540447|11861822|FG000|NOT COMPLETED|Overall Study||0
10697629|NCT02540447|11861823|FG001|NOT COMPLETED|Overall Study||0
10697630|NCT02540538|11861832|FG000|STARTED|Overall Study||12
10697631|NCT02540538|11861833|FG001|STARTED|Overall Study||12
10697632|NCT02540538|11861834|FG002|STARTED|Overall Study||10
10697633|NCT02540538|11861832|FG000|COMPLETED|Overall Study||12
10697634|NCT02540538|11861833|FG001|COMPLETED|Overall Study||11
10697635|NCT02540538|11861834|FG002|COMPLETED|Overall Study||10
10697636|NCT02540538|11861832|FG000|NOT COMPLETED|Overall Study||0
10697637|NCT02540538|11861833|FG001|NOT COMPLETED|Overall Study||1
10697638|NCT02540538|11861834|FG002|NOT COMPLETED|Overall Study||0
10697639|NCT02540629|11861844|FG000|STARTED|Overall Study||6201
10697640|NCT02540629|11861845|FG001|STARTED|Overall Study||6469
10697641|NCT02540629|11861844|FG000|COMPLETED|Overall Study||6201
10697642|NCT02540629|11861845|FG001|COMPLETED|Overall Study||6469
10697643|NCT02540629|11861844|FG000|NOT COMPLETED|Overall Study||0
10697644|NCT02540629|11861845|FG001|NOT COMPLETED|Overall Study||0
10697645|NCT02540668|11861852|FG000|STARTED|Period 1 - Warfarin Single Dose||15
10697646|NCT02540668|11861853|FG001|STARTED|Period 1 - Warfarin Single Dose||0
10697647|NCT02540668|11861852|FG000|Received at Least One Dose of Study Drug|Period 1 - Warfarin Single Dose||15
10697648|NCT02540668|11861853|FG001|Received at Least One Dose of Study Drug|Period 1 - Warfarin Single Dose||0
10697649|NCT02540668|11861852|FG000|COMPLETED|Period 1 - Warfarin Single Dose||15
10697650|NCT02540668|11861853|FG001|COMPLETED|Period 1 - Warfarin Single Dose||0
10697651|NCT02540668|11861852|FG000|NOT COMPLETED|Period 1 - Warfarin Single Dose||0
10697652|NCT02540668|11861853|FG001|NOT COMPLETED|Period 1 - Warfarin Single Dose||0
10697653|NCT02540668|11861852|FG000|STARTED|Period 2 - LY3314814 and Warfarin|Warfarin was administered alone only in Period 1.|0
10697654|NCT02540668|11861853|FG001|STARTED|Period 2 - LY3314814 and Warfarin|Warfarin was co-administered with LY3314814 only in Period 2.|15
10697655|NCT02540668|11861852|FG000|COMPLETED|Period 2 - LY3314814 and Warfarin||0
10697656|NCT02540668|11861853|FG001|COMPLETED|Period 2 - LY3314814 and Warfarin||14
10697657|NCT02540668|11861852|FG000|NOT COMPLETED|Period 2 - LY3314814 and Warfarin||0
10697658|NCT02540668|11861853|FG001|NOT COMPLETED|Period 2 - LY3314814 and Warfarin||1
10697659|NCT02540772|11861862|FG000|STARTED|Overall Study||10
10697660|NCT02540772|11861863|FG001|STARTED|Overall Study||10
10697661|NCT02540772|11861862|FG000|COMPLETED|Overall Study||10
10697662|NCT02540772|11861863|FG001|COMPLETED|Overall Study||10
10697663|NCT02540772|11861862|FG000|NOT COMPLETED|Overall Study||0
10697664|NCT02540772|11861863|FG001|NOT COMPLETED|Overall Study||0
10697665|NCT02540850|11861872|FG000|STARTED|Overall Study||360
10697666|NCT02540850|11861873|FG001|STARTED|Overall Study||396
10697667|NCT02540850|11861874|FG002|STARTED|Overall Study||444
10697668|NCT02540850|11861872|FG000|COMPLETED|Overall Study||291
10697669|NCT02540850|11861873|FG001|COMPLETED|Overall Study||330
10697670|NCT02540850|11861874|FG002|COMPLETED|Overall Study||410
10697671|NCT02540850|11861872|FG000|NOT COMPLETED|Overall Study||69
10697672|NCT02540850|11861873|FG001|NOT COMPLETED|Overall Study||66
10697673|NCT02540850|11861874|FG002|NOT COMPLETED|Overall Study||34
10697674|NCT02540954|11861884|FG000|STARTED|Overall Study||168
10697675|NCT02540954|11861885|FG001|STARTED|Overall Study||168
10697676|NCT02540954|11861884|FG000|Treated|Overall Study||167
10697677|NCT02540954|11861885|FG001|Treated|Overall Study||168
10697678|NCT02540954|11861884|FG000|Post-baseline BCVA Assessment|Overall Study|FAS|165
10697679|NCT02540954|11861885|FG001|Post-baseline BCVA Assessment|Overall Study|FAS|167
10697680|NCT02540954|11861884|FG000|COMPLETED|Overall Study|Completed treatment|149
10697681|NCT02540954|11861885|FG001|COMPLETED|Overall Study|Completed treatment|154
10697682|NCT02540954|11861884|FG000|NOT COMPLETED|Overall Study||19
10697683|NCT02540954|11861885|FG001|NOT COMPLETED|Overall Study||14
10697684|NCT02540993|11861893|FG000|STARTED|Overall Study||2866
10697685|NCT02540993|11861894|FG001|STARTED|Overall Study||2868
10697686|NCT02540993|11861893|FG000|Included in FAS|Overall Study||2833
10697687|NCT02540993|11861894|FG001|Included in FAS|Overall Study||2841
10697688|NCT02540993|11861893|FG000|Treated|Overall Study||2827
10697689|NCT02540993|11861894|FG001|Treated|Overall Study||2831
10697690|NCT02540993|11861893|FG000|COMPLETED|Overall Study||2824
10697691|NCT02540993|11861894|FG001|COMPLETED|Overall Study||2832
10697692|NCT02540993|11861893|FG000|NOT COMPLETED|Overall Study||42
10697693|NCT02540993|11861894|FG001|NOT COMPLETED|Overall Study||36
10697694|NCT02541409|11861902|FG000|STARTED|Overall Study||25
10697695|NCT02541409|11861903|FG001|STARTED|Overall Study||25
10801446|NCT04355663|11962653|FG000|STARTED|Overall Study||42
10801447|NCT04355663|11962654|FG001|STARTED|Overall Study||29
10801448|NCT04355663|11962655|FG002|STARTED|Overall Study||21
10801449|NCT04355663|11962653|FG000|COMPLETED|Overall Study||40
10801450|NCT04355663|11962654|FG001|COMPLETED|Overall Study||14
10801451|NCT04355663|11962655|FG002|COMPLETED|Overall Study||17
10697696|NCT02541409|11861902|FG000|COMPLETED|Overall Study||22
10697697|NCT02541409|11861903|FG001|COMPLETED|Overall Study||22
10697698|NCT02541409|11861902|FG000|NOT COMPLETED|Overall Study||3
10697699|NCT02541409|11861903|FG001|NOT COMPLETED|Overall Study||3
10697700|NCT02541422|11861909|FG000|STARTED|First Intervention||23
10697701|NCT02541422|11861910|FG001|STARTED|First Intervention||26
10697702|NCT02541422|11861909|FG000|COMPLETED|First Intervention||23
10697703|NCT02541422|11861910|FG001|COMPLETED|First Intervention||26
10697704|NCT02541422|11861909|FG000|NOT COMPLETED|First Intervention||0
10697705|NCT02541422|11861910|FG001|NOT COMPLETED|First Intervention||0
10697706|NCT02541422|11861909|FG000|STARTED|Second Intervention||23
10697707|NCT02541422|11861910|FG001|STARTED|Second Intervention||26
10697708|NCT02541422|11861909|FG000|COMPLETED|Second Intervention||23
10697709|NCT02541422|11861910|FG001|COMPLETED|Second Intervention||26
10697710|NCT02541422|11861909|FG000|NOT COMPLETED|Second Intervention||0
10697711|NCT02541422|11861910|FG001|NOT COMPLETED|Second Intervention||0
10697712|NCT02541565|11861916|FG000|STARTED|Overall Study||30
10697713|NCT02541565|11861916|FG000|COMPLETED|Overall Study||27
10697714|NCT02541565|11861916|FG000|NOT COMPLETED|Overall Study||3
10697715|NCT02541604|11861932|FG000|STARTED|Overall Study||11
10697716|NCT02541604|11861933|FG001|STARTED|Overall Study||9
10697717|NCT02541604|11861934|FG002|STARTED|Overall Study||11
10697718|NCT02541604|11861935|FG003|STARTED|Overall Study||3
10697719|NCT02541604|11861936|FG004|STARTED|Overall Study||10
10697720|NCT02541604|11861937|FG005|STARTED|Overall Study||10
10697721|NCT02541604|11861938|FG006|STARTED|Overall Study||10
10697722|NCT02541604|11861939|FG007|STARTED|Overall Study||10
10697723|NCT02541604|11861940|FG008|STARTED|Overall Study||4
10697724|NCT02541604|11861941|FG009|STARTED|Overall Study||4
10697725|NCT02541604|11861942|FG010|STARTED|Overall Study||2
10697726|NCT02541604|11861943|FG011|STARTED|Overall Study||3
10697727|NCT02541604|11861932|FG000|COMPLETED|Overall Study||0
10697728|NCT02541604|11861933|FG001|COMPLETED|Overall Study||0
10697729|NCT02541604|11861934|FG002|COMPLETED|Overall Study||0
10697730|NCT02541604|11861935|FG003|COMPLETED|Overall Study||0
10697731|NCT02541604|11861936|FG004|COMPLETED|Overall Study||0
10697732|NCT02541604|11861937|FG005|COMPLETED|Overall Study||0
10801452|NCT04355663|11962653|FG000|NOT COMPLETED|Overall Study||2
10697733|NCT02541604|11861938|FG006|COMPLETED|Overall Study||0
10697734|NCT02541604|11861939|FG007|COMPLETED|Overall Study||0
10697735|NCT02541604|11861940|FG008|COMPLETED|Overall Study||0
10697736|NCT02541604|11861941|FG009|COMPLETED|Overall Study||0
10697737|NCT02541604|11861942|FG010|COMPLETED|Overall Study||0
10697738|NCT02541604|11861943|FG011|COMPLETED|Overall Study||0
10697739|NCT02541604|11861932|FG000|NOT COMPLETED|Overall Study||11
10697740|NCT02541604|11861933|FG001|NOT COMPLETED|Overall Study||9
10697741|NCT02541604|11861934|FG002|NOT COMPLETED|Overall Study||11
10697742|NCT02541604|11861935|FG003|NOT COMPLETED|Overall Study||3
10697743|NCT02541604|11861936|FG004|NOT COMPLETED|Overall Study||10
10697744|NCT02541604|11861937|FG005|NOT COMPLETED|Overall Study||10
10697745|NCT02541604|11861938|FG006|NOT COMPLETED|Overall Study||10
10697746|NCT02541604|11861939|FG007|NOT COMPLETED|Overall Study||10
10697747|NCT02541604|11861940|FG008|NOT COMPLETED|Overall Study||4
10697748|NCT02541604|11861941|FG009|NOT COMPLETED|Overall Study||4
10697749|NCT02541604|11861942|FG010|NOT COMPLETED|Overall Study||2
10697750|NCT02541604|11861943|FG011|NOT COMPLETED|Overall Study||3
10697751|NCT02541669|11861997|FG000|STARTED|Open Label Treatment Period||8
10697752|NCT02541669|11861998|FG001|STARTED|Open Label Treatment Period||8
10697753|NCT02541669|11861999|FG002|STARTED|Open Label Treatment Period||0
10697754|NCT02541669|11862000|FG003|STARTED|Open Label Treatment Period||0
10697755|NCT02541669|11862001|FG004|STARTED|Open Label Treatment Period||0
10697756|NCT02541669|11861997|FG000|COMPLETED|Open Label Treatment Period||8
10697757|NCT02541669|11861998|FG001|COMPLETED|Open Label Treatment Period||8
10697758|NCT02541669|11861999|FG002|COMPLETED|Open Label Treatment Period||0
10697759|NCT02541669|11862000|FG003|COMPLETED|Open Label Treatment Period||0
10697760|NCT02541669|11862001|FG004|COMPLETED|Open Label Treatment Period||0
10697761|NCT02541669|11861997|FG000|NOT COMPLETED|Open Label Treatment Period||0
10697762|NCT02541669|11861998|FG001|NOT COMPLETED|Open Label Treatment Period||0
10697763|NCT02541669|11861999|FG002|NOT COMPLETED|Open Label Treatment Period||0
10697764|NCT02541669|11862000|FG003|NOT COMPLETED|Open Label Treatment Period||0
10697765|NCT02541669|11862001|FG004|NOT COMPLETED|Open Label Treatment Period||0
10697766|NCT02541669|11861997|FG000|STARTED|Double-Blinded Treatment Period||0
10697767|NCT02541669|11861998|FG001|STARTED|Double-Blinded Treatment Period||0
10697768|NCT02541669|11861999|FG002|STARTED|Double-Blinded Treatment Period||16
10697769|NCT02541669|11862000|FG003|STARTED|Double-Blinded Treatment Period||16
10697770|NCT02541669|11862001|FG004|STARTED|Double-Blinded Treatment Period||16
10697771|NCT02541669|11861997|FG000|COMPLETED|Double-Blinded Treatment Period||0
10697772|NCT02541669|11861998|FG001|COMPLETED|Double-Blinded Treatment Period||0
10697773|NCT02541669|11861999|FG002|COMPLETED|Double-Blinded Treatment Period||15
10697774|NCT02541669|11862000|FG003|COMPLETED|Double-Blinded Treatment Period||16
10697775|NCT02541669|11862001|FG004|COMPLETED|Double-Blinded Treatment Period||15
10697776|NCT02541669|11861997|FG000|NOT COMPLETED|Double-Blinded Treatment Period||0
10697777|NCT02541669|11861998|FG001|NOT COMPLETED|Double-Blinded Treatment Period||0
10697778|NCT02541669|11861999|FG002|NOT COMPLETED|Double-Blinded Treatment Period||1
10697779|NCT02541669|11862000|FG003|NOT COMPLETED|Double-Blinded Treatment Period||0
10697780|NCT02541669|11862001|FG004|NOT COMPLETED|Double-Blinded Treatment Period||1
10697781|NCT02541812|11862014|FG000|STARTED|Overall Study||10
10697782|NCT02541812|11862015|FG001|STARTED|Overall Study||10
10697783|NCT02541812|11862014|FG000|COMPLETED|Overall Study||10
10697784|NCT02541812|11862015|FG001|COMPLETED|Overall Study||10
10697785|NCT02541812|11862014|FG000|NOT COMPLETED|Overall Study||0
10697786|NCT02541812|11862015|FG001|NOT COMPLETED|Overall Study||0
10697787|NCT02541864|11862024|FG000|STARTED|Overall Study||164
10697788|NCT02541864|11862025|FG001|STARTED|Overall Study||166
10697789|NCT02541864|11862024|FG000|COMPLETED|Overall Study||164
10697790|NCT02541864|11862025|FG001|COMPLETED|Overall Study||166
10697791|NCT02541864|11862024|FG000|NOT COMPLETED|Overall Study||0
10697792|NCT02541864|11862025|FG001|NOT COMPLETED|Overall Study||0
10697793|NCT02541903|11862031|FG000|STARTED|Overall Study||8
10697794|NCT02541903|11862031|FG000|COMPLETED|Overall Study||7
10697795|NCT02541903|11862031|FG000|NOT COMPLETED|Overall Study||1
10697796|NCT02541942|11862035|FG000|STARTED|Overall Study||19
10697797|NCT02541942|11862035|FG000|COMPLETED|Overall Study||19
10697798|NCT02541942|11862035|FG000|NOT COMPLETED|Overall Study||0
10697799|NCT02542046|11862042|FG000|STARTED|Overall Study||300
10697800|NCT02542046|11862043|FG001|STARTED|Overall Study||300
10697801|NCT02542046|11862044|FG002|STARTED|Overall Study||300
10697802|NCT02542046|11862042|FG000|COMPLETED|Overall Study||300
10697803|NCT02542046|11862043|FG001|COMPLETED|Overall Study||300
10697804|NCT02542046|11862044|FG002|COMPLETED|Overall Study||300
10697805|NCT02542046|11862042|FG000|NOT COMPLETED|Overall Study||0
10697806|NCT02542046|11862043|FG001|NOT COMPLETED|Overall Study||0
10697807|NCT02542046|11862044|FG002|NOT COMPLETED|Overall Study||0
10697808|NCT02542072|11862054|FG000|STARTED|First Intervention (1 Month)||44
10697809|NCT02542072|11862055|FG001|STARTED|First Intervention (1 Month)||46
10697810|NCT02542072|11862054|FG000|COMPLETED|First Intervention (1 Month)||39
10697811|NCT02542072|11862055|FG001|COMPLETED|First Intervention (1 Month)||43
10697812|NCT02542072|11862054|FG000|NOT COMPLETED|First Intervention (1 Month)||5
10697813|NCT02542072|11862055|FG001|NOT COMPLETED|First Intervention (1 Month)||3
10697814|NCT02542072|11862054|FG000|STARTED|Second Intervention (1 Month)||39
10697815|NCT02542072|11862055|FG001|STARTED|Second Intervention (1 Month)||43
10697816|NCT02542072|11862054|FG000|COMPLETED|Second Intervention (1 Month)||37
10697817|NCT02542072|11862055|FG001|COMPLETED|Second Intervention (1 Month)||43
10697818|NCT02542072|11862054|FG000|NOT COMPLETED|Second Intervention (1 Month)||2
10697819|NCT02542072|11862055|FG001|NOT COMPLETED|Second Intervention (1 Month)||0
10697820|NCT02542150|11862083|FG000|STARTED|Overall Study||12
10697821|NCT02542150|11862084|FG001|STARTED|Overall Study||12
10697822|NCT02542150|11862083|FG000|Completed Placebo|Overall Study||12
10697823|NCT02542150|11862084|FG001|Completed Placebo|Overall Study||12
10697824|NCT02542150|11862083|FG000|Started Intervention|Overall Study||12
10697825|NCT02542150|11862084|FG001|Started Intervention|Overall Study||12
10697826|NCT02542150|11862083|FG000|COMPLETED|Overall Study||12
10697827|NCT02542150|11862084|FG001|COMPLETED|Overall Study||12
10697828|NCT02542150|11862083|FG000|NOT COMPLETED|Overall Study||0
10697829|NCT02542150|11862084|FG001|NOT COMPLETED|Overall Study||0
10697830|NCT02542280|11862096|FG000|STARTED|Overall Study||174
10697831|NCT02542280|11862097|FG001|STARTED|Overall Study||175
10697832|NCT02542280|11862096|FG000|COMPLETED|Overall Study||162
10697833|NCT02542280|11862097|FG001|COMPLETED|Overall Study||167
10697834|NCT02542280|11862096|FG000|NOT COMPLETED|Overall Study||12
10697835|NCT02542280|11862097|FG001|NOT COMPLETED|Overall Study||8
10697836|NCT02542410|11862105|FG000|STARTED|Overall Study||5
10697837|NCT02542410|11862106|FG001|STARTED|Overall Study||5
10697838|NCT02542410|11862105|FG000|COMPLETED|Overall Study||3
10697839|NCT02542410|11862106|FG001|COMPLETED|Overall Study||4
10697840|NCT02542410|11862105|FG000|NOT COMPLETED|Overall Study||2
10697841|NCT02542410|11862106|FG001|NOT COMPLETED|Overall Study||1
10697842|NCT02542462|11862116|FG000|STARTED|Overall Study||25
10697843|NCT02542462|11862117|FG001|STARTED|Overall Study||25
10697844|NCT02542462|11862118|FG002|STARTED|Overall Study||25
10697845|NCT02542462|11862119|FG003|STARTED|Overall Study||26
10801453|NCT04355663|11962654|FG001|NOT COMPLETED|Overall Study||15
10801454|NCT04355663|11962655|FG002|NOT COMPLETED|Overall Study||4
10801455|NCT04354870|11962665|FG000|STARTED|Overall Study||83
10697846|NCT02542462|11862116|FG000|COMPLETED|Overall Study||25
10697847|NCT02542462|11862117|FG001|COMPLETED|Overall Study||25
10697848|NCT02542462|11862118|FG002|COMPLETED|Overall Study||25
10697849|NCT02542462|11862119|FG003|COMPLETED|Overall Study||25
10697850|NCT02542462|11862116|FG000|NOT COMPLETED|Overall Study||0
10697851|NCT02542462|11862117|FG001|NOT COMPLETED|Overall Study||0
10697852|NCT02542462|11862118|FG002|NOT COMPLETED|Overall Study||0
10697853|NCT02542462|11862119|FG003|NOT COMPLETED|Overall Study||1
10697854|NCT02542605|11862130|FG000|STARTED|Part A: PACAP-38 Dose Selection Phase||12
10697855|NCT02542605|11862131|FG001|STARTED|Part A: PACAP-38 Dose Selection Phase||0
10697856|NCT02542605|11862132|FG002|STARTED|Part A: PACAP-38 Dose Selection Phase||0
10697857|NCT02542605|11862130|FG000|Received PACAP-38|Part A: PACAP-38 Dose Selection Phase||12
10697858|NCT02542605|11862131|FG001|Received PACAP-38|Part A: PACAP-38 Dose Selection Phase||0
10697859|NCT02542605|11862132|FG002|Received PACAP-38|Part A: PACAP-38 Dose Selection Phase||0
10697860|NCT02542605|11862130|FG000|Proceeded to Part B Randomization Phase|Part A: PACAP-38 Dose Selection Phase||2
10697861|NCT02542605|11862131|FG001|Proceeded to Part B Randomization Phase|Part A: PACAP-38 Dose Selection Phase||0
10697862|NCT02542605|11862132|FG002|Proceeded to Part B Randomization Phase|Part A: PACAP-38 Dose Selection Phase||0
10697863|NCT02542605|11862130|FG000|COMPLETED|Part A: PACAP-38 Dose Selection Phase||12
10697864|NCT02542605|11862131|FG001|COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
10697865|NCT02542605|11862132|FG002|COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
10697866|NCT02542605|11862130|FG000|NOT COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
10697867|NCT02542605|11862131|FG001|NOT COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
10697868|NCT02542605|11862132|FG002|NOT COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
10697869|NCT02542605|11862130|FG000|STARTED|Part B: Challenge Phase||23
10697870|NCT02542605|11862131|FG001|STARTED|Part B: Challenge Phase||0
10697871|NCT02542605|11862132|FG002|STARTED|Part B: Challenge Phase||0
10697872|NCT02542605|11862130|FG000|Received PACAP-38|Part B: Challenge Phase||23
10697873|NCT02542605|11862131|FG001|Received PACAP-38|Part B: Challenge Phase||0
10697874|NCT02542605|11862132|FG002|Received PACAP-38|Part B: Challenge Phase||0
10697875|NCT02542605|11862130|FG000|Proceeded to Randomization Phase|Part B: Challenge Phase||15
10697876|NCT02542605|11862131|FG001|Proceeded to Randomization Phase|Part B: Challenge Phase||0
10697877|NCT02542605|11862132|FG002|Proceeded to Randomization Phase|Part B: Challenge Phase||0
10697878|NCT02542605|11862130|FG000|COMPLETED|Part B: Challenge Phase||22
10697879|NCT02542605|11862131|FG001|COMPLETED|Part B: Challenge Phase||0
10697880|NCT02542605|11862132|FG002|COMPLETED|Part B: Challenge Phase||0
10697881|NCT02542605|11862130|FG000|NOT COMPLETED|Part B: Challenge Phase||1
10697882|NCT02542605|11862131|FG001|NOT COMPLETED|Part B: Challenge Phase||0
10697883|NCT02542605|11862132|FG002|NOT COMPLETED|Part B: Challenge Phase||0
10697884|NCT02542605|11862130|FG000|STARTED|Part B: Randomization Phase||0
10697885|NCT02542605|11862131|FG001|STARTED|Part B: Randomization Phase||9
10697886|NCT02542605|11862132|FG002|STARTED|Part B: Randomization Phase||8
10697887|NCT02542605|11862130|FG000|Not PACAP-38 naïve Participants|Part B: Randomization Phase||0
10697888|NCT02542605|11862131|FG001|Not PACAP-38 naïve Participants|Part B: Randomization Phase||2
10697889|NCT02542605|11862132|FG002|Not PACAP-38 naïve Participants|Part B: Randomization Phase||0
10697890|NCT02542605|11862130|FG000|PACAP-38 naïve Participants|Part B: Randomization Phase||0
10801456|NCT04354870|11962666|FG001|STARTED|Overall Study||47
10801457|NCT04354870|11962665|FG000|COMPLETED|Overall Study||35
10801458|NCT04354870|11962666|FG001|COMPLETED|Overall Study||14
10801459|NCT04354870|11962665|FG000|NOT COMPLETED|Overall Study||48
10801460|NCT04354870|11962666|FG001|NOT COMPLETED|Overall Study||33
10801461|NCT04350307|11962674|FG000|STARTED|Overall Study||84
10801462|NCT04350307|11962675|FG001|STARTED|Overall Study||78
10801463|NCT04350307|11962674|FG000|COMPLETED|Overall Study||84
10801464|NCT04350307|11962675|FG001|COMPLETED|Overall Study||78
10801465|NCT04350307|11962674|FG000|NOT COMPLETED|Overall Study||0
10801466|NCT04350307|11962675|FG001|NOT COMPLETED|Overall Study||0
10801467|NCT04352660|11962683|FG000|STARTED|Overall Study||50
10801468|NCT04352660|11962684|FG001|STARTED|Overall Study||50
10801469|NCT04352660|11962683|FG000|COMPLETED|Overall Study||36
10801470|NCT04352660|11962684|FG001|COMPLETED|Overall Study||40
10801471|NCT04352660|11962683|FG000|NOT COMPLETED|Overall Study||14
10801472|NCT04352660|11962684|FG001|NOT COMPLETED|Overall Study||10
10697891|NCT02542605|11862131|FG001|PACAP-38 naïve Participants|Part B: Randomization Phase||7
10801473|NCT04350788|11962692|FG000|STARTED|Overall Study||62
10801474|NCT04350788|11962693|FG001|STARTED|Overall Study||62
10801475|NCT04350788|11962692|FG000|COMPLETED|Overall Study||50
10801476|NCT04350788|11962693|FG001|COMPLETED|Overall Study||56
10801477|NCT04350788|11962692|FG000|NOT COMPLETED|Overall Study||12
10697892|NCT02542605|11862132|FG002|PACAP-38 naïve Participants|Part B: Randomization Phase||8
10697893|NCT02542605|11862130|FG000|Received Placebo/Erenumab|Part B: Randomization Phase||0
10697894|NCT02542605|11862131|FG001|Received Placebo/Erenumab|Part B: Randomization Phase||9
10697895|NCT02542605|11862132|FG002|Received Placebo/Erenumab|Part B: Randomization Phase||7
10697896|NCT02542605|11862130|FG000|COMPLETED|Part B: Randomization Phase||0
10697897|NCT02542605|11862131|FG001|COMPLETED|Part B: Randomization Phase||9
10697898|NCT02542605|11862132|FG002|COMPLETED|Part B: Randomization Phase||7
10697899|NCT02542605|11862130|FG000|NOT COMPLETED|Part B: Randomization Phase||0
10697900|NCT02542605|11862131|FG001|NOT COMPLETED|Part B: Randomization Phase||0
10697901|NCT02542605|11862132|FG002|NOT COMPLETED|Part B: Randomization Phase||1
10697902|NCT02542631|11862143|FG000|STARTED|Overall Study||139
10697903|NCT02542631|11862144|FG001|STARTED|Overall Study||139
10697904|NCT02542631|11862143|FG000|COMPLETED|Overall Study||108
10697905|NCT02542631|11862144|FG001|COMPLETED|Overall Study||108
10697906|NCT02542631|11862143|FG000|NOT COMPLETED|Overall Study||31
10697907|NCT02542631|11862144|FG001|NOT COMPLETED|Overall Study||31
10697908|NCT02542761|11862150|FG000|STARTED|Acclimation Period 1||5
10697909|NCT02542761|11862151|FG001|STARTED|Acclimation Period 1||5
10697910|NCT02542761|11862150|FG000|COMPLETED|Acclimation Period 1||5
10697911|NCT02542761|11862151|FG001|COMPLETED|Acclimation Period 1||5
10697912|NCT02542761|11862150|FG000|NOT COMPLETED|Acclimation Period 1||0
10697913|NCT02542761|11862151|FG001|NOT COMPLETED|Acclimation Period 1||0
10697914|NCT02542761|11862150|FG000|STARTED|First Intervention||5
10697915|NCT02542761|11862151|FG001|STARTED|First Intervention||5
10697916|NCT02542761|11862150|FG000|COMPLETED|First Intervention||5
10697917|NCT02542761|11862151|FG001|COMPLETED|First Intervention||5
10697918|NCT02542761|11862150|FG000|NOT COMPLETED|First Intervention||0
10697919|NCT02542761|11862151|FG001|NOT COMPLETED|First Intervention||0
10697920|NCT02542761|11862150|FG000|STARTED|Acclimation Period 2||5
10697921|NCT02542761|11862151|FG001|STARTED|Acclimation Period 2||5
10697922|NCT02542761|11862150|FG000|COMPLETED|Acclimation Period 2||5
10697923|NCT02542761|11862151|FG001|COMPLETED|Acclimation Period 2||5
10697924|NCT02542761|11862150|FG000|NOT COMPLETED|Acclimation Period 2||0
10697925|NCT02542761|11862151|FG001|NOT COMPLETED|Acclimation Period 2||0
10697926|NCT02542761|11862150|FG000|STARTED|Second Intervention||5
10697927|NCT02542761|11862151|FG001|STARTED|Second Intervention||5
10697928|NCT02542761|11862150|FG000|COMPLETED|Second Intervention||5
10697929|NCT02542761|11862151|FG001|COMPLETED|Second Intervention||5
10697930|NCT02542761|11862150|FG000|NOT COMPLETED|Second Intervention||0
10697931|NCT02542761|11862151|FG001|NOT COMPLETED|Second Intervention||0
10697932|NCT02542865|11862159|FG000|STARTED|Overall Study||462
10697933|NCT02542865|11862160|FG001|STARTED|Overall Study||462
10697934|NCT02542865|11862159|FG000|Treated|Overall Study||460
10697935|NCT02542865|11862160|FG001|Treated|Overall Study||462
10697936|NCT02542865|11862159|FG000|COMPLETED|Overall Study||445
10697937|NCT02542865|11862160|FG001|COMPLETED|Overall Study||462
10697938|NCT02542865|11862159|FG000|NOT COMPLETED|Overall Study||17
10697939|NCT02542865|11862160|FG001|NOT COMPLETED|Overall Study||0
10697940|NCT02542943|11862169|FG000|STARTED|Overall Study||79
10697941|NCT02542943|11862170|FG001|STARTED|Overall Study||80
10697942|NCT02542943|11862171|FG002|STARTED|Overall Study||81
10697943|NCT02542943|11862169|FG000|COMPLETED|Overall Study||78
10697944|NCT02542943|11862170|FG001|COMPLETED|Overall Study||79
10697945|NCT02542943|11862171|FG002|COMPLETED|Overall Study||81
10697946|NCT02542943|11862169|FG000|NOT COMPLETED|Overall Study||1
10697947|NCT02542943|11862170|FG001|NOT COMPLETED|Overall Study||1
10697948|NCT02542943|11862171|FG002|NOT COMPLETED|Overall Study||0
10697949|NCT02543203|11862182|FG000|STARTED|Overall Study||13
10697950|NCT02543203|11862183|FG001|STARTED|Overall Study||15
10697951|NCT02543203|11862182|FG000|COMPLETED|Overall Study||7
10697952|NCT02543203|11862183|FG001|COMPLETED|Overall Study||10
10697953|NCT02543203|11862182|FG000|NOT COMPLETED|Overall Study||6
10697954|NCT02543203|11862183|FG001|NOT COMPLETED|Overall Study||5
10697955|NCT02543294|11862197|FG000|STARTED|Overall Study||20
10697956|NCT02543294|11862197|FG000|COMPLETED|Overall Study||8
10697957|NCT02543294|11862197|FG000|NOT COMPLETED|Overall Study||12
10697958|NCT02543346|11862202|FG000|STARTED|First Priming Visit||26
10697959|NCT02543346|11862203|FG001|STARTED|First Priming Visit||25
10697960|NCT02543346|11862204|FG002|STARTED|First Priming Visit||24
10697961|NCT02543346|11862205|FG003|STARTED|First Priming Visit||23
10697962|NCT02543346|11862202|FG000|COMPLETED|First Priming Visit||26
10697963|NCT02543346|11862203|FG001|COMPLETED|First Priming Visit||25
10697964|NCT02543346|11862204|FG002|COMPLETED|First Priming Visit||24
10697965|NCT02543346|11862205|FG003|COMPLETED|First Priming Visit||23
10697966|NCT02543346|11862202|FG000|NOT COMPLETED|First Priming Visit||0
10697967|NCT02543346|11862203|FG001|NOT COMPLETED|First Priming Visit||0
10697968|NCT02543346|11862204|FG002|NOT COMPLETED|First Priming Visit||0
10697969|NCT02543346|11862205|FG003|NOT COMPLETED|First Priming Visit||0
10697970|NCT02543346|11862202|FG000|STARTED|First Treatment Visit||26
10697971|NCT02543346|11862203|FG001|STARTED|First Treatment Visit||25
10697972|NCT02543346|11862204|FG002|STARTED|First Treatment Visit||24
10697973|NCT02543346|11862205|FG003|STARTED|First Treatment Visit||23
10697974|NCT02543346|11862202|FG000|COMPLETED|First Treatment Visit||26
10697975|NCT02543346|11862203|FG001|COMPLETED|First Treatment Visit||25
10697976|NCT02543346|11862204|FG002|COMPLETED|First Treatment Visit||24
10697977|NCT02543346|11862205|FG003|COMPLETED|First Treatment Visit||23
10697978|NCT02543346|11862202|FG000|NOT COMPLETED|First Treatment Visit||0
10697979|NCT02543346|11862203|FG001|NOT COMPLETED|First Treatment Visit||0
10697980|NCT02543346|11862204|FG002|NOT COMPLETED|First Treatment Visit||0
10697981|NCT02543346|11862205|FG003|NOT COMPLETED|First Treatment Visit||0
10697982|NCT02543346|11862202|FG000|STARTED|Washout (at Least 14 Days)||26
10697983|NCT02543346|11862203|FG001|STARTED|Washout (at Least 14 Days)||25
10697984|NCT02543346|11862204|FG002|STARTED|Washout (at Least 14 Days)||24
10697985|NCT02543346|11862205|FG003|STARTED|Washout (at Least 14 Days)||23
10697986|NCT02543346|11862202|FG000|COMPLETED|Washout (at Least 14 Days)||26
10697987|NCT02543346|11862203|FG001|COMPLETED|Washout (at Least 14 Days)||25
10697988|NCT02543346|11862204|FG002|COMPLETED|Washout (at Least 14 Days)||24
10697989|NCT02543346|11862205|FG003|COMPLETED|Washout (at Least 14 Days)||23
10697990|NCT02543346|11862202|FG000|NOT COMPLETED|Washout (at Least 14 Days)||0
10697991|NCT02543346|11862203|FG001|NOT COMPLETED|Washout (at Least 14 Days)||0
10697992|NCT02543346|11862204|FG002|NOT COMPLETED|Washout (at Least 14 Days)||0
10697993|NCT02543346|11862205|FG003|NOT COMPLETED|Washout (at Least 14 Days)||0
10697994|NCT02543346|11862202|FG000|STARTED|Second Priming Visit||26
10697995|NCT02543346|11862203|FG001|STARTED|Second Priming Visit||25
10697996|NCT02543346|11862204|FG002|STARTED|Second Priming Visit||24
10697997|NCT02543346|11862205|FG003|STARTED|Second Priming Visit||23
10697998|NCT02543346|11862202|FG000|COMPLETED|Second Priming Visit||25
10697999|NCT02543346|11862203|FG001|COMPLETED|Second Priming Visit||23
10698000|NCT02543346|11862204|FG002|COMPLETED|Second Priming Visit||22
10698001|NCT02543346|11862205|FG003|COMPLETED|Second Priming Visit||21
10698002|NCT02543346|11862202|FG000|NOT COMPLETED|Second Priming Visit||1
10698003|NCT02543346|11862203|FG001|NOT COMPLETED|Second Priming Visit||2
10698004|NCT02543346|11862204|FG002|NOT COMPLETED|Second Priming Visit||2
10698005|NCT02543346|11862205|FG003|NOT COMPLETED|Second Priming Visit||2
10698006|NCT02543346|11862202|FG000|STARTED|Second Treatment Visit||25
10698007|NCT02543346|11862203|FG001|STARTED|Second Treatment Visit||23
10698008|NCT02543346|11862204|FG002|STARTED|Second Treatment Visit||22
10698009|NCT02543346|11862205|FG003|STARTED|Second Treatment Visit||21
10698010|NCT02543346|11862202|FG000|COMPLETED|Second Treatment Visit||25
10698011|NCT02543346|11862203|FG001|COMPLETED|Second Treatment Visit||23
10698012|NCT02543346|11862204|FG002|COMPLETED|Second Treatment Visit||22
10698013|NCT02543346|11862205|FG003|COMPLETED|Second Treatment Visit||21
10698014|NCT02543346|11862202|FG000|NOT COMPLETED|Second Treatment Visit||0
10698015|NCT02543346|11862203|FG001|NOT COMPLETED|Second Treatment Visit||0
10698016|NCT02543346|11862204|FG002|NOT COMPLETED|Second Treatment Visit||0
10698017|NCT02543346|11862205|FG003|NOT COMPLETED|Second Treatment Visit||0
10698018|NCT02543398|11862217|FG000|STARTED|Overall Study||20
10698019|NCT02543398|11862218|FG001|STARTED|Overall Study||20
10698020|NCT02543398|11862217|FG000|COMPLETED|Overall Study||20
10698021|NCT02543398|11862218|FG001|COMPLETED|Overall Study||20
10698022|NCT02543398|11862217|FG000|NOT COMPLETED|Overall Study||0
10698023|NCT02543398|11862218|FG001|NOT COMPLETED|Overall Study||0
10698024|NCT02543437|11862224|FG000|STARTED|Overall Study||117
10698025|NCT02543437|11862224|FG000|COMPLETED|Overall Study||117
10698026|NCT02543437|11862224|FG000|NOT COMPLETED|Overall Study||0
10698027|NCT02543528|11862228|FG000|STARTED|Adaptation Period||0
10698028|NCT02543528|11862229|FG001|STARTED|Adaptation Period||0
10698029|NCT02543528|11862230|FG002|STARTED|Adaptation Period||0
10698030|NCT02543528|11862231|FG003|STARTED|Adaptation Period||0
10698031|NCT02543528|11862232|FG004|STARTED|Adaptation Period||168
10698032|NCT02543528|11862228|FG000|COMPLETED|Adaptation Period||0
10698033|NCT02543528|11862229|FG001|COMPLETED|Adaptation Period||0
10698034|NCT02543528|11862230|FG002|COMPLETED|Adaptation Period||0
10698035|NCT02543528|11862231|FG003|COMPLETED|Adaptation Period||0
10698036|NCT02543528|11862232|FG004|COMPLETED|Adaptation Period||142
10698037|NCT02543528|11862228|FG000|NOT COMPLETED|Adaptation Period||0
10698038|NCT02543528|11862229|FG001|NOT COMPLETED|Adaptation Period||0
10698039|NCT02543528|11862230|FG002|NOT COMPLETED|Adaptation Period||0
10698040|NCT02543528|11862231|FG003|NOT COMPLETED|Adaptation Period||0
10698041|NCT02543528|11862232|FG004|NOT COMPLETED|Adaptation Period||26
10698042|NCT02543528|11862228|FG000|STARTED|Extended Wear Period||36
10698043|NCT02543528|11862229|FG001|STARTED|Extended Wear Period||35
10698044|NCT02543528|11862230|FG002|STARTED|Extended Wear Period||36
10698045|NCT02543528|11862231|FG003|STARTED|Extended Wear Period||35
10698046|NCT02543528|11862232|FG004|STARTED|Extended Wear Period||0
10698047|NCT02543528|11862228|FG000|COMPLETED|Extended Wear Period||8
10698048|NCT02543528|11862229|FG001|COMPLETED|Extended Wear Period||14
10698049|NCT02543528|11862230|FG002|COMPLETED|Extended Wear Period||13
10698050|NCT02543528|11862231|FG003|COMPLETED|Extended Wear Period||23
10698051|NCT02543528|11862232|FG004|COMPLETED|Extended Wear Period||0
10698052|NCT02543528|11862228|FG000|NOT COMPLETED|Extended Wear Period||28
10698053|NCT02543528|11862229|FG001|NOT COMPLETED|Extended Wear Period||21
10698054|NCT02543528|11862230|FG002|NOT COMPLETED|Extended Wear Period||23
10698055|NCT02543528|11862231|FG003|NOT COMPLETED|Extended Wear Period||12
10698056|NCT02543528|11862232|FG004|NOT COMPLETED|Extended Wear Period||0
10698057|NCT02543554|11862248|FG000|STARTED|Overall Study||1192
10698058|NCT02543554|11862249|FG001|STARTED|Overall Study||513
10698059|NCT02543554|11862248|FG000|COMPLETED|Overall Study||1192
10698060|NCT02543554|11862249|FG001|COMPLETED|Overall Study||513
10698061|NCT02543554|11862248|FG000|NOT COMPLETED|Overall Study||0
10698062|NCT02543554|11862249|FG001|NOT COMPLETED|Overall Study||0
10698063|NCT02543658|11862257|FG000|STARTED|Overall Study||40
10698064|NCT02543658|11862258|FG001|STARTED|Overall Study||40
10698065|NCT02543658|11862257|FG000|COMPLETED|Overall Study||40
10698066|NCT02543658|11862258|FG001|COMPLETED|Overall Study||36
10698067|NCT02543658|11862257|FG000|NOT COMPLETED|Overall Study||0
10698068|NCT02543658|11862258|FG001|NOT COMPLETED|Overall Study||4
10698069|NCT02543723|11862267|FG000|STARTED|Overall Study||65
10698070|NCT02543723|11862268|FG001|STARTED|Overall Study||63
10698071|NCT02543723|11862267|FG000|COMPLETED|Overall Study||65
10698072|NCT02543723|11862268|FG001|COMPLETED|Overall Study||63
10698073|NCT02543723|11862267|FG000|NOT COMPLETED|Overall Study||0
10698074|NCT02543723|11862268|FG001|NOT COMPLETED|Overall Study||0
10698075|NCT02543801|11862280|FG000|STARTED|Overall Study||61
10698076|NCT02543801|11862281|FG001|STARTED|Overall Study||60
10698077|NCT02543801|11862282|FG002|STARTED|Overall Study||59
10698078|NCT02543801|11862283|FG003|STARTED|Overall Study||59
10698079|NCT02543801|11862280|FG000|COMPLETED|Overall Study||60
10698080|NCT02543801|11862281|FG001|COMPLETED|Overall Study||58
10698081|NCT02543801|11862282|FG002|COMPLETED|Overall Study||59
10698082|NCT02543801|11862283|FG003|COMPLETED|Overall Study||59
10698083|NCT02543801|11862280|FG000|NOT COMPLETED|Overall Study||1
10698084|NCT02543801|11862281|FG001|NOT COMPLETED|Overall Study||2
10698085|NCT02543801|11862282|FG002|NOT COMPLETED|Overall Study||0
10698086|NCT02543801|11862283|FG003|NOT COMPLETED|Overall Study||0
10698087|NCT02543840|11862295|FG000|STARTED|Overall Study|This is a quasi-experimental design, not a RCT. 1050 veterans did 1436 interviews at 3 time points.|1050
10698088|NCT02543840|11862296|FG001|STARTED|Overall Study||62
10698089|NCT02543840|11862295|FG000|0 Month Timepoint (t0)|Overall Study||593
10698090|NCT02543840|11862296|FG001|0 Month Timepoint (t0)|Overall Study||40
10698091|NCT02543840|11862295|FG000|6 Month Timepoint (t6)|Overall Study|593 participants started at 0 months; 188 repeated and 66 participants added at 6 months timepoint.|66
10698092|NCT02543840|11862296|FG001|6 Month Timepoint (t6)|Overall Study||0
10698093|NCT02543840|11862295|FG000|12 Month Timepoint (t12)|Overall Study|91 continued from 0 months (t0), 16 from 6 months (t6), 91 from t0 & t6; 391 added at 12 months.|391
10698094|NCT02543840|11862296|FG001|12 Month Timepoint (t12)|Overall Study|22 new providers completed at 12 months; 21 completed at both 0 and 12 months. 19 completed only T0.|22
10698095|NCT02543840|11862295|FG000|COMPLETED|Overall Study||1050
10698096|NCT02543840|11862296|FG001|COMPLETED|Overall Study||62
10698097|NCT02543840|11862295|FG000|NOT COMPLETED|Overall Study||0
10698098|NCT02543840|11862296|FG001|NOT COMPLETED|Overall Study||0
10698099|NCT02543892|11862311|FG000|STARTED|Received Vaccination 1||12
10698100|NCT02543892|11862312|FG001|STARTED|Received Vaccination 1||12
10698101|NCT02543892|11862313|FG002|STARTED|Received Vaccination 1||12
10698102|NCT02543892|11862314|FG003|STARTED|Received Vaccination 1||12
10698103|NCT02543892|11862315|FG004|STARTED|Received Vaccination 1||50
10698104|NCT02543892|11862316|FG005|STARTED|Received Vaccination 1||50
10698105|NCT02543892|11862317|FG006|STARTED|Received Vaccination 1||50
10698106|NCT02543892|11862318|FG007|STARTED|Received Vaccination 1||50
10698107|NCT02543892|11862311|FG000|COMPLETED|Received Vaccination 1||12
10698108|NCT02543892|11862312|FG001|COMPLETED|Received Vaccination 1||12
10698109|NCT02543892|11862313|FG002|COMPLETED|Received Vaccination 1||12
10698110|NCT02543892|11862314|FG003|COMPLETED|Received Vaccination 1||12
10698111|NCT02543892|11862315|FG004|COMPLETED|Received Vaccination 1||50
10698112|NCT02543892|11862316|FG005|COMPLETED|Received Vaccination 1||50
10698113|NCT02543892|11862317|FG006|COMPLETED|Received Vaccination 1||50
10698114|NCT02543892|11862318|FG007|COMPLETED|Received Vaccination 1||50
10698115|NCT02543892|11862311|FG000|NOT COMPLETED|Received Vaccination 1||0
10698116|NCT02543892|11862312|FG001|NOT COMPLETED|Received Vaccination 1||0
10698117|NCT02543892|11862313|FG002|NOT COMPLETED|Received Vaccination 1||0
10698118|NCT02543892|11862314|FG003|NOT COMPLETED|Received Vaccination 1||0
10698119|NCT02543892|11862315|FG004|NOT COMPLETED|Received Vaccination 1||0
10698120|NCT02543892|11862316|FG005|NOT COMPLETED|Received Vaccination 1||0
10698121|NCT02543892|11862317|FG006|NOT COMPLETED|Received Vaccination 1||0
10698122|NCT02543892|11862318|FG007|NOT COMPLETED|Received Vaccination 1||0
10698123|NCT02543892|11862311|FG000|STARTED|Received Vaccination 2||12
10698124|NCT02543892|11862312|FG001|STARTED|Received Vaccination 2||12
10698125|NCT02543892|11862313|FG002|STARTED|Received Vaccination 2||12
10698126|NCT02543892|11862314|FG003|STARTED|Received Vaccination 2||12
10698127|NCT02543892|11862315|FG004|STARTED|Received Vaccination 2||50
10698128|NCT02543892|11862316|FG005|STARTED|Received Vaccination 2||50
10698129|NCT02543892|11862317|FG006|STARTED|Received Vaccination 2||50
10698130|NCT02543892|11862318|FG007|STARTED|Received Vaccination 2||50
10698131|NCT02543892|11862311|FG000|COMPLETED|Received Vaccination 2||11
10698132|NCT02543892|11862312|FG001|COMPLETED|Received Vaccination 2||11
10698133|NCT02543892|11862313|FG002|COMPLETED|Received Vaccination 2||12
10698134|NCT02543892|11862314|FG003|COMPLETED|Received Vaccination 2||12
10698135|NCT02543892|11862315|FG004|COMPLETED|Received Vaccination 2||50
10698136|NCT02543892|11862316|FG005|COMPLETED|Received Vaccination 2||49
10698137|NCT02543892|11862317|FG006|COMPLETED|Received Vaccination 2||50
10698138|NCT02543892|11862318|FG007|COMPLETED|Received Vaccination 2||49
10698139|NCT02543892|11862311|FG000|NOT COMPLETED|Received Vaccination 2||1
10698140|NCT02543892|11862312|FG001|NOT COMPLETED|Received Vaccination 2||1
10698141|NCT02543892|11862313|FG002|NOT COMPLETED|Received Vaccination 2||0
10698142|NCT02543892|11862314|FG003|NOT COMPLETED|Received Vaccination 2||0
10698143|NCT02543892|11862315|FG004|NOT COMPLETED|Received Vaccination 2||0
10698144|NCT02543892|11862316|FG005|NOT COMPLETED|Received Vaccination 2||1
10698145|NCT02543892|11862317|FG006|NOT COMPLETED|Received Vaccination 2||0
10698146|NCT02543892|11862318|FG007|NOT COMPLETED|Received Vaccination 2||1
10698147|NCT02543892|11862311|FG000|STARTED|Had Immunology Data||11
10698148|NCT02543892|11862312|FG001|STARTED|Had Immunology Data||11
10698149|NCT02543892|11862313|FG002|STARTED|Had Immunology Data||12
10698150|NCT02543892|11862314|FG003|STARTED|Had Immunology Data||12
10698151|NCT02543892|11862315|FG004|STARTED|Had Immunology Data||50
10698152|NCT02543892|11862316|FG005|STARTED|Had Immunology Data||49
10698153|NCT02543892|11862317|FG006|STARTED|Had Immunology Data||50
10698154|NCT02543892|11862318|FG007|STARTED|Had Immunology Data||49
10698155|NCT02543892|11862311|FG000|COMPLETED|Had Immunology Data||11
10698156|NCT02543892|11862312|FG001|COMPLETED|Had Immunology Data||11
10698157|NCT02543892|11862313|FG002|COMPLETED|Had Immunology Data||12
10698158|NCT02543892|11862314|FG003|COMPLETED|Had Immunology Data||12
10698159|NCT02543892|11862315|FG004|COMPLETED|Had Immunology Data||50
10698160|NCT02543892|11862316|FG005|COMPLETED|Had Immunology Data||49
10698161|NCT02543892|11862317|FG006|COMPLETED|Had Immunology Data|Subject received both vaccinations and attended last visit, but withdrew consent afterwards.|49
10698162|NCT02543892|11862318|FG007|COMPLETED|Had Immunology Data||49
10698163|NCT02543892|11862311|FG000|NOT COMPLETED|Had Immunology Data||0
10698164|NCT02543892|11862312|FG001|NOT COMPLETED|Had Immunology Data||0
10698165|NCT02543892|11862313|FG002|NOT COMPLETED|Had Immunology Data||0
10698166|NCT02543892|11862314|FG003|NOT COMPLETED|Had Immunology Data||0
10698167|NCT02543892|11862315|FG004|NOT COMPLETED|Had Immunology Data||0
10698168|NCT02543892|11862316|FG005|NOT COMPLETED|Had Immunology Data||0
10698169|NCT02543892|11862317|FG006|NOT COMPLETED|Had Immunology Data||1
10698170|NCT02543892|11862318|FG007|NOT COMPLETED|Had Immunology Data||0
10698171|NCT02543918|11862343|FG000|STARTED|Overall Study||41
10698172|NCT02543918|11862344|FG001|STARTED|Overall Study||43
10698173|NCT02543918|11862343|FG000|Received at Least 1 Dose of Study Drug|Overall Study||41
10698174|NCT02543918|11862344|FG001|Received at Least 1 Dose of Study Drug|Overall Study||42
10698175|NCT02543918|11862343|FG000|COMPLETED|Overall Study||38
10698176|NCT02543918|11862344|FG001|COMPLETED|Overall Study||39
10698177|NCT02543918|11862343|FG000|NOT COMPLETED|Overall Study||3
10698178|NCT02543918|11862344|FG001|NOT COMPLETED|Overall Study||4
10713540|NCT02679690|11879011|FG000|NOT COMPLETED|Overall Study||1
10713541|NCT02679729|11879026|FG000|STARTED|Overall Study||6
10713542|NCT02679729|11879027|FG001|STARTED|Overall Study||7
10713543|NCT02679729|11879028|FG002|STARTED|Overall Study||6
10713544|NCT02679729|11879029|FG003|STARTED|Overall Study||6
10713545|NCT02679729|11879030|FG004|STARTED|Overall Study||6
10801478|NCT04350788|11962693|FG001|NOT COMPLETED|Overall Study||6
10801479|NCT04349917|11962706|FG000|STARTED|First Intervention (2-4 Hours)||19
10801480|NCT04349917|11962707|FG001|STARTED|First Intervention (2-4 Hours)||18
10801481|NCT04349917|11962706|FG000|Received Intervention|First Intervention (2-4 Hours)||19
10801482|NCT04349917|11962707|FG001|Received Intervention|First Intervention (2-4 Hours)||17
10801483|NCT04349917|11962706|FG000|COMPLETED|First Intervention (2-4 Hours)||19
10713546|NCT02679729|11879031|FG005|STARTED|Overall Study||6
10713547|NCT02679729|11879032|FG006|STARTED|Overall Study||6
10713548|NCT02679729|11879033|FG007|STARTED|Overall Study||14
10713549|NCT02679729|11879034|FG008|STARTED|Overall Study||6
10713550|NCT02679729|11879026|FG000|COMPLETED|Overall Study||6
10713551|NCT02679729|11879027|FG001|COMPLETED|Overall Study||5
10318940|NCT00218426|11453198|FG001|STARTED|Overall Study||102
10318941|NCT00218426|11453199|FG002|STARTED|Overall Study||102
10318942|NCT00218426|11453197|FG000|COMPLETED|Overall Study||54
10318943|NCT00218426|11453198|FG001|COMPLETED|Overall Study||16
10318944|NCT00218426|11453199|FG002|COMPLETED|Overall Study||11
10713552|NCT02679729|11879028|FG002|COMPLETED|Overall Study||6
10713553|NCT02679729|11879029|FG003|COMPLETED|Overall Study||6
10713554|NCT02679729|11879030|FG004|COMPLETED|Overall Study||5
10713555|NCT02679729|11879031|FG005|COMPLETED|Overall Study||6
10713556|NCT02679729|11879032|FG006|COMPLETED|Overall Study||5
10713557|NCT02679729|11879033|FG007|COMPLETED|Overall Study||14
10713558|NCT02679729|11879034|FG008|COMPLETED|Overall Study||6
10713559|NCT02679729|11879026|FG000|NOT COMPLETED|Overall Study||0
10713560|NCT02679729|11879027|FG001|NOT COMPLETED|Overall Study||2
10713561|NCT02679729|11879028|FG002|NOT COMPLETED|Overall Study||0
10713562|NCT02679729|11879029|FG003|NOT COMPLETED|Overall Study||0
10713563|NCT02679729|11879030|FG004|NOT COMPLETED|Overall Study||1
10713564|NCT02679729|11879031|FG005|NOT COMPLETED|Overall Study||0
10713565|NCT02679729|11879032|FG006|NOT COMPLETED|Overall Study||1
10713566|NCT02679729|11879033|FG007|NOT COMPLETED|Overall Study||0
10801484|NCT04349917|11962707|FG001|COMPLETED|First Intervention (2-4 Hours)||16
10801485|NCT04349917|11962706|FG000|NOT COMPLETED|First Intervention (2-4 Hours)||0
10801486|NCT04349917|11962707|FG001|NOT COMPLETED|First Intervention (2-4 Hours)||2
10713567|NCT02679729|11879034|FG008|NOT COMPLETED|Overall Study||0
10801487|NCT04349917|11962706|FG000|STARTED|Washout Period (4-20 Days)||19
10318945|NCT00218426|11453197|FG000|NOT COMPLETED|Overall Study||48
10713574|NCT02679807|11879080|FG000|STARTED|Overall Study||165
10713575|NCT02679807|11879081|FG001|STARTED|Overall Study||169
10713576|NCT02679807|11879080|FG000|COMPLETED|Overall Study||143
10713577|NCT02679807|11879081|FG001|COMPLETED|Overall Study||153
10713578|NCT02679807|11879080|FG000|NOT COMPLETED|Overall Study||22
10713579|NCT02679807|11879081|FG001|NOT COMPLETED|Overall Study||16
10698179|NCT02544113|11862352|FG000|STARTED|Overall Study||55
10698180|NCT02544113|11862353|FG001|STARTED|Overall Study||55
10698181|NCT02544113|11862352|FG000|COMPLETED|Overall Study||52
10698182|NCT02544113|11862353|FG001|COMPLETED|Overall Study||51
10698183|NCT02544113|11862352|FG000|NOT COMPLETED|Overall Study||3
10698184|NCT02544113|11862353|FG001|NOT COMPLETED|Overall Study||4
10698185|NCT02544152|11862361|FG000|STARTED|Overall Study||34
10698186|NCT02544152|11862362|FG001|STARTED|Overall Study||37
10698187|NCT02544152|11862361|FG000|Modified Intent to Treat (mITT)|Overall Study||34
10698188|NCT02544152|11862362|FG001|Modified Intent to Treat (mITT)|Overall Study||37
10698189|NCT02544152|11862361|FG000|Safety Analysis Set (SAS)|Overall Study||34
10698190|NCT02544152|11862362|FG001|Safety Analysis Set (SAS)|Overall Study||37
10698191|NCT02544152|11862361|FG000|COMPLETED|Overall Study||33
10698192|NCT02544152|11862362|FG001|COMPLETED|Overall Study||30
10698193|NCT02544152|11862361|FG000|NOT COMPLETED|Overall Study||1
10698194|NCT02544152|11862362|FG001|NOT COMPLETED|Overall Study||7
10698195|NCT02544217|11862374|FG000|STARTED|Overall Study||7
10698196|NCT02544217|11862375|FG001|STARTED|Overall Study||7
10698197|NCT02544217|11862376|FG002|STARTED|Overall Study||4
10698198|NCT02544217|11862377|FG003|STARTED|Overall Study||4
10698199|NCT02544217|11862378|FG004|STARTED|Overall Study||4
10698200|NCT02544217|11862379|FG005|STARTED|Overall Study||6
10698201|NCT02544217|11862374|FG000|COMPLETED|Overall Study||6
10698202|NCT02544217|11862375|FG001|COMPLETED|Overall Study|Two subjects prematurely withdrew from the study for non-medical reasons and were replaced.|6
10698203|NCT02544217|11862376|FG002|COMPLETED|Overall Study||4
10698204|NCT02544217|11862377|FG003|COMPLETED|Overall Study||4
10698205|NCT02544217|11862378|FG004|COMPLETED|Overall Study||4
10698206|NCT02544217|11862379|FG005|COMPLETED|Overall Study||6
10698207|NCT02544217|11862374|FG000|NOT COMPLETED|Overall Study||1
10698208|NCT02544217|11862375|FG001|NOT COMPLETED|Overall Study||1
10698209|NCT02544217|11862376|FG002|NOT COMPLETED|Overall Study||0
10698210|NCT02544217|11862377|FG003|NOT COMPLETED|Overall Study||0
10698211|NCT02544217|11862378|FG004|NOT COMPLETED|Overall Study||0
10698212|NCT02544217|11862379|FG005|NOT COMPLETED|Overall Study||0
10698213|NCT02544321|11862448|FG000|STARTED|Overall Study||43
10698214|NCT02544321|11862449|FG001|STARTED|Overall Study||43
10698215|NCT02544321|11862448|FG000|Completed First Treatment|Overall Study||43
10698216|NCT02544321|11862449|FG001|Completed First Treatment|Overall Study||41
10698217|NCT02544321|11862448|FG000|Completed Washout|Overall Study||43
10698218|NCT02544321|11862449|FG001|Completed Washout|Overall Study||41
10698219|NCT02544321|11862448|FG000|Started Second Treatment|Overall Study||42
10698220|NCT02544321|11862449|FG001|Started Second Treatment|Overall Study||40
10698221|NCT02544321|11862448|FG000|COMPLETED|Overall Study||41
10698222|NCT02544321|11862449|FG001|COMPLETED|Overall Study||39
10698223|NCT02544321|11862448|FG000|NOT COMPLETED|Overall Study||2
10698224|NCT02544321|11862449|FG001|NOT COMPLETED|Overall Study||4
10698225|NCT02544451|11862467|FG000|STARTED|Treatment Period 1 (96 Weeks)||143
10698226|NCT02544451|11862468|FG001|STARTED|Treatment Period 1 (96 Weeks)||96
10698227|NCT02544451|11862469|FG002|STARTED|Treatment Period 1 (96 Weeks)||6
10698228|NCT02544451|11862470|FG003|STARTED|Treatment Period 1 (96 Weeks)||0
10698229|NCT02544451|11862467|FG000|COMPLETED|Treatment Period 1 (96 Weeks)||129
10698230|NCT02544451|11862468|FG001|COMPLETED|Treatment Period 1 (96 Weeks)||84
10698231|NCT02544451|11862469|FG002|COMPLETED|Treatment Period 1 (96 Weeks)||5
10698232|NCT02544451|11862470|FG003|COMPLETED|Treatment Period 1 (96 Weeks)||0
10698233|NCT02544451|11862467|FG000|NOT COMPLETED|Treatment Period 1 (96 Weeks)||14
10698234|NCT02544451|11862468|FG001|NOT COMPLETED|Treatment Period 1 (96 Weeks)||12
10698235|NCT02544451|11862469|FG002|NOT COMPLETED|Treatment Period 1 (96 Weeks)||1
10698236|NCT02544451|11862470|FG003|NOT COMPLETED|Treatment Period 1 (96 Weeks)||0
10698237|NCT02544451|11862467|FG000|STARTED|Treatment Period 2 (168 Weeks)||0
10698238|NCT02544451|11862468|FG001|STARTED|Treatment Period 2 (168 Weeks)||0
10698239|NCT02544451|11862469|FG002|STARTED|Treatment Period 2 (168 Weeks)||0
10698240|NCT02544451|11862470|FG003|STARTED|Treatment Period 2 (168 Weeks)||10
10698241|NCT02544451|11862467|FG000|COMPLETED|Treatment Period 2 (168 Weeks)||0
10698242|NCT02544451|11862468|FG001|COMPLETED|Treatment Period 2 (168 Weeks)||0
10698243|NCT02544451|11862469|FG002|COMPLETED|Treatment Period 2 (168 Weeks)||0
10698244|NCT02544451|11862470|FG003|COMPLETED|Treatment Period 2 (168 Weeks)||0
10698245|NCT02544451|11862467|FG000|NOT COMPLETED|Treatment Period 2 (168 Weeks)||0
10698246|NCT02544451|11862468|FG001|NOT COMPLETED|Treatment Period 2 (168 Weeks)||0
10698247|NCT02544451|11862469|FG002|NOT COMPLETED|Treatment Period 2 (168 Weeks)||0
10698248|NCT02544451|11862470|FG003|NOT COMPLETED|Treatment Period 2 (168 Weeks)||10
10698249|NCT02544607|11862488|FG000|STARTED|Overall Study||16
10698250|NCT02544607|11862488|FG000|COMPLETED|Overall Study||16
10698251|NCT02544607|11862488|FG000|NOT COMPLETED|Overall Study||0
10698252|NCT02544633|11862497|FG000|STARTED|Treatment Period||28
10698253|NCT02544633|11862498|FG001|STARTED|Treatment Period||20
10698254|NCT02544633|11862499|FG002|STARTED|Treatment Period||8
10698255|NCT02544633|11862500|FG003|STARTED|Treatment Period||12
10698256|NCT02544633|11862497|FG000|COMPLETED|Treatment Period||0
10698257|NCT02544633|11862498|FG001|COMPLETED|Treatment Period||0
10698258|NCT02544633|11862499|FG002|COMPLETED|Treatment Period||0
10698259|NCT02544633|11862500|FG003|COMPLETED|Treatment Period||0
10698260|NCT02544633|11862497|FG000|NOT COMPLETED|Treatment Period||28
10698261|NCT02544633|11862498|FG001|NOT COMPLETED|Treatment Period||20
10698262|NCT02544633|11862499|FG002|NOT COMPLETED|Treatment Period||8
10698263|NCT02544633|11862500|FG003|NOT COMPLETED|Treatment Period||12
10698264|NCT02544633|11862497|FG000|STARTED|Survival Follow-up Period||28
10698265|NCT02544633|11862498|FG001|STARTED|Survival Follow-up Period||19
10698266|NCT02544633|11862499|FG002|STARTED|Survival Follow-up Period||7
10698267|NCT02544633|11862500|FG003|STARTED|Survival Follow-up Period||12
10698268|NCT02544633|11862497|FG000|COMPLETED|Survival Follow-up Period||0
10698269|NCT02544633|11862498|FG001|COMPLETED|Survival Follow-up Period||0
10698270|NCT02544633|11862499|FG002|COMPLETED|Survival Follow-up Period||0
10698271|NCT02544633|11862500|FG003|COMPLETED|Survival Follow-up Period||0
10698272|NCT02544633|11862497|FG000|NOT COMPLETED|Survival Follow-up Period||28
10698273|NCT02544633|11862498|FG001|NOT COMPLETED|Survival Follow-up Period||19
10698274|NCT02544633|11862499|FG002|NOT COMPLETED|Survival Follow-up Period||7
10698275|NCT02544633|11862500|FG003|NOT COMPLETED|Survival Follow-up Period||12
10698285|NCT02544984|11862537|FG000|STARTED|Overall Study||30
10801488|NCT04349917|11962707|FG001|STARTED|Washout Period (4-20 Days)||16
10801489|NCT04349917|11962706|FG000|COMPLETED|Washout Period (4-20 Days)||19
10801490|NCT04349917|11962707|FG001|COMPLETED|Washout Period (4-20 Days)||16
10801491|NCT04349917|11962706|FG000|NOT COMPLETED|Washout Period (4-20 Days)||0
10801492|NCT04349917|11962707|FG001|NOT COMPLETED|Washout Period (4-20 Days)||0
10801493|NCT04349917|11962706|FG000|STARTED|Second Intervention (2-4 Hours)||19
10801494|NCT04349917|11962707|FG001|STARTED|Second Intervention (2-4 Hours)||16
10801495|NCT04349917|11962706|FG000|Received Intervention|Second Intervention (2-4 Hours)||19
10801496|NCT04349917|11962707|FG001|Received Intervention|Second Intervention (2-4 Hours)||16
10801497|NCT04349917|11962706|FG000|COMPLETED|Second Intervention (2-4 Hours)||19
10801498|NCT04349917|11962707|FG001|COMPLETED|Second Intervention (2-4 Hours)||16
10801499|NCT04349917|11962706|FG000|NOT COMPLETED|Second Intervention (2-4 Hours)||0
10801500|NCT04349917|11962707|FG001|NOT COMPLETED|Second Intervention (2-4 Hours)||0
10801501|NCT04348851|11962718|FG000|STARTED|Post-Test 1||13
10801502|NCT04348851|11962719|FG001|STARTED|Post-Test 1||13
10801503|NCT04348851|11962720|FG002|STARTED|Post-Test 1||13
10698286|NCT02544984|11862538|FG001|STARTED|Overall Study||30
10698287|NCT02544984|11862537|FG000|COMPLETED|Overall Study||28
10698288|NCT02544984|11862538|FG001|COMPLETED|Overall Study||28
10698289|NCT02544984|11862537|FG000|NOT COMPLETED|Overall Study||2
10698290|NCT02544984|11862538|FG001|NOT COMPLETED|Overall Study||2
10698291|NCT02545075|11862546|FG000|STARTED|Randomization||122
10698292|NCT02545075|11862547|FG001|STARTED|Randomization||60
10698293|NCT02545075|11862546|FG000|COMPLETED|Randomization||122
10698294|NCT02545075|11862547|FG001|COMPLETED|Randomization||53
10698295|NCT02545075|11862546|FG000|NOT COMPLETED|Randomization||0
10698296|NCT02545075|11862547|FG001|NOT COMPLETED|Randomization||7
10698297|NCT02545075|11862546|FG000|STARTED|Treatment||122
10698298|NCT02545075|11862547|FG001|STARTED|Treatment||53
10698299|NCT02545075|11862546|FG000|COMPLETED|Treatment||0
10698300|NCT02545075|11862547|FG001|COMPLETED|Treatment||0
10698301|NCT02545075|11862546|FG000|NOT COMPLETED|Treatment||122
10698302|NCT02545075|11862547|FG001|NOT COMPLETED|Treatment||53
10698303|NCT02545101|11862553|FG000|STARTED|Overall Study||100
10698304|NCT02545101|11862553|FG000|COMPLETED|Overall Study||100
10698305|NCT02545101|11862553|FG000|NOT COMPLETED|Overall Study||0
10698306|NCT02545270|11862560|FG000|STARTED|Overall Study||6
10698307|NCT02545270|11862561|FG001|STARTED|Overall Study||5
10698308|NCT02545270|11862562|FG002|STARTED|Overall Study||5
10698309|NCT02545270|11862560|FG000|COMPLETED|Overall Study||6
10698310|NCT02545270|11862561|FG001|COMPLETED|Overall Study||4
10698311|NCT02545270|11862562|FG002|COMPLETED|Overall Study||3
10698312|NCT02545270|11862560|FG000|NOT COMPLETED|Overall Study||0
10698313|NCT02545270|11862561|FG001|NOT COMPLETED|Overall Study||1
10698314|NCT02545270|11862562|FG002|NOT COMPLETED|Overall Study||2
10698315|NCT02545322|11862571|FG000|STARTED|Overall Study||18
10698316|NCT02545322|11862571|FG000|COMPLETED|Overall Study||15
10698317|NCT02545322|11862571|FG000|NOT COMPLETED|Overall Study||3
10698318|NCT02545504|11862577|FG000|STARTED|Overall Study||218
10698319|NCT02545504|11862578|FG001|STARTED|Overall Study||214
10698320|NCT02545504|11862577|FG000|COMPLETED|Overall Study||0
10698321|NCT02545504|11862578|FG001|COMPLETED|Overall Study||0
10698322|NCT02545504|11862577|FG000|NOT COMPLETED|Overall Study||218
10698323|NCT02545504|11862578|FG001|NOT COMPLETED|Overall Study||214
10698324|NCT02545543|11862590|FG000|STARTED|Overall Study||1709
10698325|NCT02545543|11862591|FG001|STARTED|Overall Study||569
10698326|NCT02545543|11862590|FG000|COMPLETED|Overall Study||1628
10698327|NCT02545543|11862591|FG001|COMPLETED|Overall Study||535
10698328|NCT02545543|11862590|FG000|NOT COMPLETED|Overall Study||81
10698329|NCT02545543|11862591|FG001|NOT COMPLETED|Overall Study||34
10801504|NCT04348851|11962721|FG003|STARTED|Post-Test 1||14
10801505|NCT04348851|11962718|FG000|COMPLETED|Post-Test 1||13
10801506|NCT04348851|11962719|FG001|COMPLETED|Post-Test 1||11
10698336|NCT02545907|11862611|FG000|STARTED|Overall Study||3
10801507|NCT04348851|11962720|FG002|COMPLETED|Post-Test 1||13
10801508|NCT04348851|11962721|FG003|COMPLETED|Post-Test 1||14
10698337|NCT02545907|11862612|FG001|STARTED|Overall Study||3
10698338|NCT02545907|11862613|FG002|STARTED|Overall Study||4
10698339|NCT02545907|11862611|FG000|COMPLETED|Overall Study||3
10698340|NCT02545907|11862612|FG001|COMPLETED|Overall Study||3
10698341|NCT02545907|11862613|FG002|COMPLETED|Overall Study||4
10698342|NCT02545907|11862611|FG000|NOT COMPLETED|Overall Study||0
10698343|NCT02545907|11862612|FG001|NOT COMPLETED|Overall Study||0
10698344|NCT02545907|11862613|FG002|NOT COMPLETED|Overall Study||0
10698345|NCT02545933|11862625|FG000|STARTED|Overall Study||44
10698346|NCT02545933|11862626|FG001|STARTED|Overall Study||43
10698347|NCT02545933|11862627|FG002|STARTED|Overall Study||43
10698348|NCT02545933|11862625|FG000|COMPLETED|Overall Study||38
10698349|NCT02545933|11862626|FG001|COMPLETED|Overall Study||40
10698350|NCT02545933|11862627|FG002|COMPLETED|Overall Study||39
10698351|NCT02545933|11862625|FG000|NOT COMPLETED|Overall Study||6
10698352|NCT02545933|11862626|FG001|NOT COMPLETED|Overall Study||3
10698353|NCT02545933|11862627|FG002|NOT COMPLETED|Overall Study||4
10698354|NCT02546193|11862637|FG000|STARTED|Overall Study||10
10698355|NCT02546193|11862638|FG001|STARTED|Overall Study||10
10698356|NCT02546193|11862639|FG002|STARTED|Overall Study|Enrolled independently (Prospective study). Not counted in Outpatient Foley Catheter Arm.|2
10698357|NCT02546193|11862640|FG003|STARTED|Overall Study||0
10698358|NCT02546193|11862637|FG000|COMPLETED|Overall Study||4
10698359|NCT02546193|11862638|FG001|COMPLETED|Overall Study||4
10698360|NCT02546193|11862639|FG002|COMPLETED|Overall Study||0
10698361|NCT02546193|11862640|FG003|COMPLETED|Overall Study||0
10698362|NCT02546193|11862637|FG000|NOT COMPLETED|Overall Study||6
10698363|NCT02546193|11862638|FG001|NOT COMPLETED|Overall Study||6
10698364|NCT02546193|11862639|FG002|NOT COMPLETED|Overall Study||2
10698365|NCT02546193|11862640|FG003|NOT COMPLETED|Overall Study||0
10698366|NCT02546323|11862648|FG000|STARTED|Overall Study||272
10698367|NCT02546323|11862649|FG001|STARTED|Overall Study||271
10698368|NCT02546323|11862648|FG000|Received Treatment|Overall Study||272
10698369|NCT02546323|11862649|FG001|Received Treatment|Overall Study||268
10698370|NCT02546323|11862648|FG000|COMPLETED|Overall Study||212
10698371|NCT02546323|11862649|FG001|COMPLETED|Overall Study||205
10698372|NCT02546323|11862648|FG000|NOT COMPLETED|Overall Study||60
10698373|NCT02546323|11862649|FG001|NOT COMPLETED|Overall Study||66
10698374|NCT02546362|11862655|FG000|STARTED|4-week Treatment Period||50
10698375|NCT02546362|11862655|FG000|COMPLETED|4-week Treatment Period||47
10698376|NCT02546362|11862655|FG000|NOT COMPLETED|4-week Treatment Period||3
10698377|NCT02546362|11862655|FG000|STARTED|12-week Treatment Period||47
10698378|NCT02546362|11862655|FG000|COMPLETED|12-week Treatment Period||38
10698379|NCT02546362|11862655|FG000|NOT COMPLETED|12-week Treatment Period||9
10698380|NCT02546375|11862659|FG000|STARTED|Overall Study||87
10698381|NCT02546375|11862659|FG000|COMPLETED|Overall Study||87
10698382|NCT02546375|11862659|FG000|NOT COMPLETED|Overall Study||0
10698383|NCT02546388|11862665|FG000|STARTED|Overall Study||4
10698384|NCT02546388|11862666|FG001|STARTED|Overall Study||13
10698385|NCT02546388|11862665|FG000|COMPLETED|Overall Study||4
10698386|NCT02546388|11862666|FG001|COMPLETED|Overall Study||13
10698387|NCT02546388|11862665|FG000|NOT COMPLETED|Overall Study||0
10698388|NCT02546388|11862666|FG001|NOT COMPLETED|Overall Study||0
10698389|NCT02546544|11862673|FG000|STARTED|Overall Study||16
10698390|NCT02546544|11862673|FG000|Received Allocated Intervention|Overall Study||16
10698391|NCT02546544|11862673|FG000|COMPLETED|Overall Study||0
10698392|NCT02546544|11862673|FG000|NOT COMPLETED|Overall Study||16
10698393|NCT02546570|11862679|FG000|STARTED|Overall Study||9
10698394|NCT02546570|11862680|FG001|STARTED|Overall Study||2
10698395|NCT02546570|11862679|FG000|Crossover Order: Oxytocin, Placebo|Overall Study||6
10698396|NCT02546570|11862680|FG001|Crossover Order: Oxytocin, Placebo|Overall Study||2
10698397|NCT02546570|11862679|FG000|Crossover Order: Placebo, Oxytocin|Overall Study||3
10698398|NCT02546570|11862680|FG001|Crossover Order: Placebo, Oxytocin|Overall Study||0
10698399|NCT02546570|11862679|FG000|COMPLETED|Overall Study||9
10698400|NCT02546570|11862680|FG001|COMPLETED|Overall Study||2
10698401|NCT02546570|11862679|FG000|NOT COMPLETED|Overall Study||0
10801509|NCT04348851|11962718|FG000|NOT COMPLETED|Post-Test 1||0
10801510|NCT04348851|11962719|FG001|NOT COMPLETED|Post-Test 1||2
10801511|NCT04348851|11962720|FG002|NOT COMPLETED|Post-Test 1||0
10455401|NCT01001559|11603481|FG001|STARTED|Overall Study||147
10455402|NCT01001559|11603480|FG000|COMPLETED|Overall Study||95
10801512|NCT04348851|11962721|FG003|NOT COMPLETED|Post-Test 1||0
10801513|NCT04348851|11962718|FG000|STARTED|Post-Test 2||13
10801514|NCT04348851|11962719|FG001|STARTED|Post-Test 2||11
10801515|NCT04348851|11962720|FG002|STARTED|Post-Test 2||13
10801516|NCT04348851|11962721|FG003|STARTED|Post-Test 2||14
10455403|NCT01001559|11603481|FG001|COMPLETED|Overall Study||147
10455404|NCT01001559|11603480|FG000|NOT COMPLETED|Overall Study||0
10455405|NCT01001559|11603481|FG001|NOT COMPLETED|Overall Study||0
10455406|NCT01001572|11603489|FG000|STARTED|Single-Blind Valsartan 160 mg||932
10455407|NCT01001572|11603490|FG001|STARTED|Single-Blind Valsartan 160 mg|Participants did not enroll into this arm during single blind period.|0
10455408|NCT01001572|11603491|FG002|STARTED|Single-Blind Valsartan 160 mg|Participants did not enroll into this arm during single blind period.|0
10455409|NCT01001572|11603489|FG000|COMPLETED|Single-Blind Valsartan 160 mg||654
10455410|NCT01001572|11603490|FG001|COMPLETED|Single-Blind Valsartan 160 mg||0
10455411|NCT01001572|11603491|FG002|COMPLETED|Single-Blind Valsartan 160 mg||0
10455412|NCT01001572|11603489|FG000|NOT COMPLETED|Single-Blind Valsartan 160 mg||278
10455413|NCT01001572|11603490|FG001|NOT COMPLETED|Single-Blind Valsartan 160 mg||0
10455414|NCT01001572|11603491|FG002|NOT COMPLETED|Single-Blind Valsartan 160 mg||0
10698402|NCT02546570|11862680|FG001|NOT COMPLETED|Overall Study||0
10698403|NCT02546609|11862693|FG000|STARTED|Overall Study||24
10698404|NCT02546609|11862694|FG001|STARTED|Overall Study||35
10698405|NCT02546609|11862695|FG002|STARTED|Overall Study||32
10698406|NCT02546609|11862693|FG000|COMPLETED|Overall Study||22
10698407|NCT02546609|11862694|FG001|COMPLETED|Overall Study||24
10698408|NCT02546609|11862695|FG002|COMPLETED|Overall Study||25
10698409|NCT02546609|11862693|FG000|NOT COMPLETED|Overall Study||2
10698410|NCT02546609|11862694|FG001|NOT COMPLETED|Overall Study||11
10698411|NCT02546609|11862695|FG002|NOT COMPLETED|Overall Study||7
10698412|NCT02546765|11862707|FG000|STARTED|Overall Study||31
10698413|NCT02546765|11862708|FG001|STARTED|Overall Study||30
10698414|NCT02546765|11862709|FG002|STARTED|Overall Study||30
10698415|NCT02546765|11862710|FG003|STARTED|Overall Study||30
10698416|NCT02546765|11862707|FG000|COMPLETED|Overall Study||31
10698417|NCT02546765|11862708|FG001|COMPLETED|Overall Study|29 Received study drug; 1 withdrew before surgery and after randomization|29
10698418|NCT02546765|11862709|FG002|COMPLETED|Overall Study||30
10698419|NCT02546765|11862710|FG003|COMPLETED|Overall Study||30
10698420|NCT02546765|11862707|FG000|NOT COMPLETED|Overall Study||0
10698421|NCT02546765|11862708|FG001|NOT COMPLETED|Overall Study||1
10698422|NCT02546765|11862709|FG002|NOT COMPLETED|Overall Study||0
10698423|NCT02546765|11862710|FG003|NOT COMPLETED|Overall Study||0
10698424|NCT02546856|11862733|FG000|STARTED|4 Months Evaluation||164
10698425|NCT02546856|11862734|FG001|STARTED|4 Months Evaluation||156
10698426|NCT02546856|11862733|FG000|COMPLETED|4 Months Evaluation||144
10698427|NCT02546856|11862734|FG001|COMPLETED|4 Months Evaluation||145
10698428|NCT02546856|11862733|FG000|NOT COMPLETED|4 Months Evaluation||20
10698429|NCT02546856|11862734|FG001|NOT COMPLETED|4 Months Evaluation||11
10698430|NCT02546856|11862733|FG000|STARTED|6 Months Evaluation||144
10698431|NCT02546856|11862734|FG001|STARTED|6 Months Evaluation||145
10698432|NCT02546856|11862733|FG000|COMPLETED|6 Months Evaluation||136
10698433|NCT02546856|11862734|FG001|COMPLETED|6 Months Evaluation||138
10698434|NCT02546856|11862733|FG000|NOT COMPLETED|6 Months Evaluation||8
10698435|NCT02546856|11862734|FG001|NOT COMPLETED|6 Months Evaluation||7
10698436|NCT02547012|11862754|FG000|STARTED|Overall Study||24
10698437|NCT02547012|11862755|FG001|STARTED|Overall Study||27
10698438|NCT02547012|11862754|FG000|COMPLETED|Overall Study||24
10698439|NCT02547012|11862755|FG001|COMPLETED|Overall Study||27
10698440|NCT02547012|11862754|FG000|NOT COMPLETED|Overall Study||0
10698441|NCT02547012|11862755|FG001|NOT COMPLETED|Overall Study||0
10698442|NCT02547038|11862763|FG000|STARTED|Overall Study||176
10698443|NCT02547038|11862764|FG001|STARTED|Overall Study||176
10698444|NCT02547038|11862763|FG000|COMPLETED|Overall Study||173
10698445|NCT02547038|11862764|FG001|COMPLETED|Overall Study||174
10698446|NCT02547038|11862763|FG000|NOT COMPLETED|Overall Study||3
10698447|NCT02547038|11862764|FG001|NOT COMPLETED|Overall Study||2
10698448|NCT02547064|11862772|FG000|STARTED|Overall Study||81
10698449|NCT02547064|11862773|FG001|STARTED|Overall Study||81
10698450|NCT02547064|11862772|FG000|COMPLETED|Overall Study||78
10698451|NCT02547064|11862773|FG001|COMPLETED|Overall Study||79
10698452|NCT02547064|11862772|FG000|NOT COMPLETED|Overall Study||3
10698453|NCT02547064|11862773|FG001|NOT COMPLETED|Overall Study||2
10698454|NCT02547220|11862781|FG000|STARTED|Overall Study||19
10698455|NCT02547220|11862782|FG001|STARTED|Overall Study||20
10698456|NCT02547220|11862781|FG000|COMPLETED|Overall Study||0
10698457|NCT02547220|11862782|FG001|COMPLETED|Overall Study||0
10698458|NCT02547220|11862781|FG000|NOT COMPLETED|Overall Study||19
10698459|NCT02547220|11862782|FG001|NOT COMPLETED|Overall Study||20
10698460|NCT02547233|11862790|FG000|STARTED|3-day Treatment and 8-week Follow-up||205
10318946|NCT00218426|11453198|FG001|NOT COMPLETED|Overall Study||86
10318947|NCT00218426|11453199|FG002|NOT COMPLETED|Overall Study||91
10801517|NCT04348851|11962718|FG000|COMPLETED|Post-Test 2||13
10801518|NCT04348851|11962719|FG001|COMPLETED|Post-Test 2||10
10801519|NCT04348851|11962720|FG002|COMPLETED|Post-Test 2||13
10801520|NCT04348851|11962721|FG003|COMPLETED|Post-Test 2||13
10801521|NCT04348851|11962718|FG000|NOT COMPLETED|Post-Test 2||0
10801522|NCT04348851|11962719|FG001|NOT COMPLETED|Post-Test 2||1
10801523|NCT04348851|11962720|FG002|NOT COMPLETED|Post-Test 2||0
10801524|NCT04348851|11962721|FG003|NOT COMPLETED|Post-Test 2||1
10801525|NCT04348357|11962733|FG000|STARTED|Overall Study||25
10801526|NCT04348357|11962734|FG001|STARTED|Overall Study||28
10318948|NCT00218439|11453212|FG000|STARTED|First Intervention (4 Weeks)||58
10318949|NCT00218439|11453213|FG001|STARTED|First Intervention (4 Weeks)||47
10801527|NCT04348357|11962733|FG000|COMPLETED|Overall Study||25
10801528|NCT04348357|11962734|FG001|COMPLETED|Overall Study||16
10318950|NCT00218439|11453212|FG000|COMPLETED|First Intervention (4 Weeks)||40
10318951|NCT00218439|11453213|FG001|COMPLETED|First Intervention (4 Weeks)||35
10318952|NCT00218439|11453212|FG000|NOT COMPLETED|First Intervention (4 Weeks)||18
10698461|NCT02547233|11862791|FG001|STARTED|3-day Treatment and 8-week Follow-up||102
10698462|NCT02547233|11862790|FG000|Treated|3-day Treatment and 8-week Follow-up||205
10698463|NCT02547233|11862791|FG001|Treated|3-day Treatment and 8-week Follow-up||100
10698464|NCT02547233|11862790|FG000|COMPLETED|3-day Treatment and 8-week Follow-up||203
10713911|NCT02683668|11879478|FG000|STARTED|Period 1||44
10801529|NCT04348357|11962733|FG000|NOT COMPLETED|Overall Study||0
10801530|NCT04348357|11962734|FG001|NOT COMPLETED|Overall Study||12
10801531|NCT04346199|11962742|FG000|STARTED|Overall Study||89
10698465|NCT02547233|11862791|FG001|COMPLETED|3-day Treatment and 8-week Follow-up||92
10698466|NCT02547233|11862790|FG000|NOT COMPLETED|3-day Treatment and 8-week Follow-up||2
10698467|NCT02547233|11862791|FG001|NOT COMPLETED|3-day Treatment and 8-week Follow-up||10
10698468|NCT02547233|11862790|FG000|STARTED|12-month Follow-up||199
10698469|NCT02547233|11862791|FG001|STARTED|12-month Follow-up||84
10698470|NCT02547233|11862790|FG000|COMPLETED|12-month Follow-up||185
10698471|NCT02547233|11862791|FG001|COMPLETED|12-month Follow-up||67
10698472|NCT02547233|11862790|FG000|NOT COMPLETED|12-month Follow-up||14
10698473|NCT02547233|11862791|FG001|NOT COMPLETED|12-month Follow-up||17
10698474|NCT02547363|11862801|FG000|STARTED|3-day Treatment and 8-week Follow-up||211
10698475|NCT02547363|11862802|FG001|STARTED|3-day Treatment and 8-week Follow-up||105
10698476|NCT02547363|11862801|FG000|Treated|3-day Treatment and 8-week Follow-up||209
10698477|NCT02547363|11862802|FG001|Treated|3-day Treatment and 8-week Follow-up||104
10698478|NCT02547363|11862801|FG000|COMPLETED|3-day Treatment and 8-week Follow-up||207
10698479|NCT02547363|11862802|FG001|COMPLETED|3-day Treatment and 8-week Follow-up||94
10698480|NCT02547363|11862801|FG000|NOT COMPLETED|3-day Treatment and 8-week Follow-up||4
10698481|NCT02547363|11862802|FG001|NOT COMPLETED|3-day Treatment and 8-week Follow-up||11
10698482|NCT02547363|11862801|FG000|STARTED|12-month Follow-up||204
10698483|NCT02547363|11862802|FG001|STARTED|12-month Follow-up||86
10698484|NCT02547363|11862801|FG000|COMPLETED|12-month Follow-up||194
10698485|NCT02547363|11862802|FG001|COMPLETED|12-month Follow-up||81
10698486|NCT02547363|11862801|FG000|NOT COMPLETED|12-month Follow-up||10
10698487|NCT02547363|11862802|FG001|NOT COMPLETED|12-month Follow-up||5
10698488|NCT02547428|11862812|FG000|STARTED|Period 1- Treatment Sequence 1 (3 Weeks)||42
10698489|NCT02547428|11862813|FG001|STARTED|Period 1- Treatment Sequence 1 (3 Weeks)||43
10698490|NCT02547428|11862812|FG000|Received at Least 1 Dose of Study Drug|Period 1- Treatment Sequence 1 (3 Weeks)||42
10698491|NCT02547428|11862813|FG001|Received at Least 1 Dose of Study Drug|Period 1- Treatment Sequence 1 (3 Weeks)||43
10698492|NCT02547428|11862812|FG000|COMPLETED|Period 1- Treatment Sequence 1 (3 Weeks)||31
10698493|NCT02547428|11862813|FG001|COMPLETED|Period 1- Treatment Sequence 1 (3 Weeks)||37
10698494|NCT02547428|11862812|FG000|NOT COMPLETED|Period 1- Treatment Sequence 1 (3 Weeks)||11
10698495|NCT02547428|11862813|FG001|NOT COMPLETED|Period 1- Treatment Sequence 1 (3 Weeks)||6
10698496|NCT02547428|11862812|FG000|STARTED|Period 2- Treatment Sequence 2 (3 Weeks)||31
10698497|NCT02547428|11862813|FG001|STARTED|Period 2- Treatment Sequence 2 (3 Weeks)||37
10698498|NCT02547428|11862812|FG000|COMPLETED|Period 2- Treatment Sequence 2 (3 Weeks)||30
10698499|NCT02547428|11862813|FG001|COMPLETED|Period 2- Treatment Sequence 2 (3 Weeks)||30
10698500|NCT02547428|11862812|FG000|NOT COMPLETED|Period 2- Treatment Sequence 2 (3 Weeks)||1
10698501|NCT02547428|11862813|FG001|NOT COMPLETED|Period 2- Treatment Sequence 2 (3 Weeks)||7
10698502|NCT02547454|11862826|FG000|STARTED|Overall Study||393
10698503|NCT02547454|11862826|FG000|COMPLETED|Overall Study||221
10698504|NCT02547454|11862826|FG000|NOT COMPLETED|Overall Study||172
10698505|NCT02547623|11862832|FG000|STARTED|Overall Study||126
10698506|NCT02547623|11862833|FG001|STARTED|Overall Study||55
10698507|NCT02547623|11862832|FG000|COMPLETED|Overall Study||122
10698508|NCT02547623|11862833|FG001|COMPLETED|Overall Study||52
10698509|NCT02547623|11862832|FG000|NOT COMPLETED|Overall Study||4
10698510|NCT02547623|11862833|FG001|NOT COMPLETED|Overall Study||3
10698511|NCT02547649|11862842|FG000|STARTED|Overall Study||231
10698512|NCT02547649|11862843|FG001|STARTED|Overall Study||231
10698513|NCT02547649|11862844|FG002|STARTED|Overall Study||228
10698514|NCT02547649|11862842|FG000|Vaccinated|Overall Study||231
10698515|NCT02547649|11862843|FG001|Vaccinated|Overall Study||231
10698516|NCT02547649|11862844|FG002|Vaccinated|Overall Study||227
10698517|NCT02547649|11862842|FG000|COMPLETED|Overall Study||228
10698518|NCT02547649|11862843|FG001|COMPLETED|Overall Study||226
10698519|NCT02547649|11862844|FG002|COMPLETED|Overall Study||224
10698520|NCT02547649|11862842|FG000|NOT COMPLETED|Overall Study||3
10698521|NCT02547649|11862843|FG001|NOT COMPLETED|Overall Study||5
10698522|NCT02547649|11862844|FG002|NOT COMPLETED|Overall Study||4
10698523|NCT02547714|11862852|FG000|STARTED|Overall Study||34
10698524|NCT02547714|11862852|FG000|COMPLETED|Overall Study||34
10698525|NCT02547714|11862852|FG000|NOT COMPLETED|Overall Study||0
10698526|NCT02547766|11862857|FG000|STARTED|Overall Study||10
10698527|NCT02547766|11862857|FG000|COMPLETED|Overall Study||9
10698528|NCT02547766|11862857|FG000|NOT COMPLETED|Overall Study||1
10698529|NCT02547779|11862863|FG000|STARTED|Overall Study||5214
10698530|NCT02547779|11862864|FG001|STARTED|Overall Study||5207
10698531|NCT02547779|11862863|FG000|COMPLETED|Overall Study||5214
10698532|NCT02547779|11862864|FG001|COMPLETED|Overall Study||5207
10698533|NCT02547779|11862863|FG000|NOT COMPLETED|Overall Study||0
10698534|NCT02547779|11862864|FG001|NOT COMPLETED|Overall Study||0
10698535|NCT02547922|11862873|FG000|STARTED|Overall Study||46
10698536|NCT02547922|11862874|FG001|STARTED|Overall Study||52
10698537|NCT02547922|11862875|FG002|STARTED|Overall Study||49
10698538|NCT02547922|11862873|FG000|FAS (Full Analysis Set)|Overall Study||45
10698539|NCT02547922|11862874|FG001|FAS (Full Analysis Set)|Overall Study||51
10698540|NCT02547922|11862875|FG002|FAS (Full Analysis Set)|Overall Study||49
10698541|NCT02547922|11862873|FG000|COMPLETED|Overall Study||18
10698542|NCT02547922|11862874|FG001|COMPLETED|Overall Study||28
10698543|NCT02547922|11862875|FG002|COMPLETED|Overall Study||20
10698544|NCT02547922|11862873|FG000|NOT COMPLETED|Overall Study||28
10698545|NCT02547922|11862874|FG001|NOT COMPLETED|Overall Study||24
10698546|NCT02547922|11862875|FG002|NOT COMPLETED|Overall Study||29
10698547|NCT02547935|11862892|FG000|STARTED|Overall Study||155
10698548|NCT02547935|11862893|FG001|STARTED|Overall Study||145
10698549|NCT02547935|11862894|FG002|STARTED|Overall Study||148
10698550|NCT02547935|11862892|FG000|Received Treatment|Overall Study||152
10698551|NCT02547935|11862893|FG001|Received Treatment|Overall Study||145
10698552|NCT02547935|11862894|FG002|Received Treatment|Overall Study||148
10698553|NCT02547935|11862892|FG000|Full Analysis Set|Overall Study||152
10698554|NCT02547935|11862893|FG001|Full Analysis Set|Overall Study||144
10698555|NCT02547935|11862894|FG002|Full Analysis Set|Overall Study||148
10698556|NCT02547935|11862892|FG000|Safety Analysis Set|Overall Study||152
10698557|NCT02547935|11862893|FG001|Safety Analysis Set|Overall Study||145
10698558|NCT02547935|11862894|FG002|Safety Analysis Set|Overall Study||148
10698559|NCT02547935|11862892|FG000|COMPLETED|Overall Study||150
10698560|NCT02547935|11862893|FG001|COMPLETED|Overall Study||137
10698561|NCT02547935|11862894|FG002|COMPLETED|Overall Study||143
10698562|NCT02547935|11862892|FG000|NOT COMPLETED|Overall Study||5
10698563|NCT02547935|11862893|FG001|NOT COMPLETED|Overall Study||8
10698564|NCT02547935|11862894|FG002|NOT COMPLETED|Overall Study||5
10698565|NCT02547974|11862908|FG000|STARTED|Overall Study||15
10698566|NCT02547974|11862909|FG001|STARTED|Overall Study||31
10698567|NCT02547974|11862910|FG002|STARTED|Overall Study||30
10698568|NCT02547974|11862911|FG003|STARTED|Overall Study||44
10698569|NCT02547974|11862908|FG000|COMPLETED|Overall Study||14
10698570|NCT02547974|11862909|FG001|COMPLETED|Overall Study||31
10698571|NCT02547974|11862910|FG002|COMPLETED|Overall Study||30
10698572|NCT02547974|11862911|FG003|COMPLETED|Overall Study||44
10698573|NCT02547974|11862908|FG000|NOT COMPLETED|Overall Study||1
10698574|NCT02547974|11862909|FG001|NOT COMPLETED|Overall Study||0
10698575|NCT02547974|11862910|FG002|NOT COMPLETED|Overall Study||0
10698576|NCT02547974|11862911|FG003|NOT COMPLETED|Overall Study||0
10698577|NCT02547987|11862924|FG000|STARTED|Overall Study||25
10698578|NCT02547987|11862924|FG000|COMPLETED|Overall Study||22
10698579|NCT02547987|11862924|FG000|NOT COMPLETED|Overall Study||3
10698580|NCT02548078|11862930|FG000|STARTED|Overall Study||300
10698581|NCT02548078|11862931|FG001|STARTED|Overall Study||300
10698582|NCT02548078|11862930|FG000|COMPLETED|Overall Study||295
10698583|NCT02548078|11862931|FG001|COMPLETED|Overall Study||294
10698584|NCT02548078|11862930|FG000|NOT COMPLETED|Overall Study||5
10698585|NCT02548078|11862931|FG001|NOT COMPLETED|Overall Study||6
10698586|NCT02548156|11862944|FG000|STARTED|Period 1||5
10698587|NCT02548156|11862945|FG001|STARTED|Period 1||5
10698588|NCT02548156|11862946|FG002|STARTED|Period 1||4
10698589|NCT02548156|11862947|FG003|STARTED|Period 1||5
10698590|NCT02548156|11862948|FG004|STARTED|Period 1||5
10698591|NCT02548156|11862949|FG005|STARTED|Period 1||5
10698592|NCT02548156|11862944|FG000|COMPLETED|Period 1||5
10698593|NCT02548156|11862945|FG001|COMPLETED|Period 1||5
10698594|NCT02548156|11862946|FG002|COMPLETED|Period 1||4
10698595|NCT02548156|11862947|FG003|COMPLETED|Period 1||5
10698596|NCT02548156|11862948|FG004|COMPLETED|Period 1||5
10698597|NCT02548156|11862949|FG005|COMPLETED|Period 1||5
10698598|NCT02548156|11862944|FG000|NOT COMPLETED|Period 1||0
10698599|NCT02548156|11862945|FG001|NOT COMPLETED|Period 1||0
10698600|NCT02548156|11862946|FG002|NOT COMPLETED|Period 1||0
10698601|NCT02548156|11862947|FG003|NOT COMPLETED|Period 1||0
10698602|NCT02548156|11862948|FG004|NOT COMPLETED|Period 1||0
10698603|NCT02548156|11862949|FG005|NOT COMPLETED|Period 1||0
10698604|NCT02548156|11862944|FG000|STARTED|Washout Period 1||5
10698605|NCT02548156|11862945|FG001|STARTED|Washout Period 1||5
10698606|NCT02548156|11862946|FG002|STARTED|Washout Period 1||4
10698607|NCT02548156|11862947|FG003|STARTED|Washout Period 1||5
10698608|NCT02548156|11862948|FG004|STARTED|Washout Period 1||5
10698609|NCT02548156|11862949|FG005|STARTED|Washout Period 1||5
10698610|NCT02548156|11862944|FG000|COMPLETED|Washout Period 1||5
10698611|NCT02548156|11862945|FG001|COMPLETED|Washout Period 1||5
10698612|NCT02548156|11862946|FG002|COMPLETED|Washout Period 1||4
10698613|NCT02548156|11862947|FG003|COMPLETED|Washout Period 1||5
10698614|NCT02548156|11862948|FG004|COMPLETED|Washout Period 1||4
10698615|NCT02548156|11862949|FG005|COMPLETED|Washout Period 1||5
10698616|NCT02548156|11862944|FG000|NOT COMPLETED|Washout Period 1||0
10698617|NCT02548156|11862945|FG001|NOT COMPLETED|Washout Period 1||0
10698618|NCT02548156|11862946|FG002|NOT COMPLETED|Washout Period 1||0
10698619|NCT02548156|11862947|FG003|NOT COMPLETED|Washout Period 1||0
10698620|NCT02548156|11862948|FG004|NOT COMPLETED|Washout Period 1||1
10698621|NCT02548156|11862949|FG005|NOT COMPLETED|Washout Period 1||0
10698622|NCT02548156|11862944|FG000|STARTED|Period 2||5
10698623|NCT02548156|11862945|FG001|STARTED|Period 2||5
10698624|NCT02548156|11862946|FG002|STARTED|Period 2||4
10698625|NCT02548156|11862947|FG003|STARTED|Period 2||5
10698626|NCT02548156|11862948|FG004|STARTED|Period 2||4
10698627|NCT02548156|11862949|FG005|STARTED|Period 2||5
10698628|NCT02548156|11862944|FG000|COMPLETED|Period 2||5
10698629|NCT02548156|11862945|FG001|COMPLETED|Period 2||5
10698630|NCT02548156|11862946|FG002|COMPLETED|Period 2||4
10698631|NCT02548156|11862947|FG003|COMPLETED|Period 2||5
10698632|NCT02548156|11862948|FG004|COMPLETED|Period 2||4
10698633|NCT02548156|11862949|FG005|COMPLETED|Period 2||5
10698634|NCT02548156|11862944|FG000|NOT COMPLETED|Period 2||0
10698635|NCT02548156|11862945|FG001|NOT COMPLETED|Period 2||0
10698636|NCT02548156|11862946|FG002|NOT COMPLETED|Period 2||0
10698637|NCT02548156|11862947|FG003|NOT COMPLETED|Period 2||0
10698638|NCT02548156|11862948|FG004|NOT COMPLETED|Period 2||0
10698639|NCT02548156|11862949|FG005|NOT COMPLETED|Period 2||0
10698640|NCT02548156|11862944|FG000|STARTED|Washout Period 2||5
10698641|NCT02548156|11862945|FG001|STARTED|Washout Period 2||5
10698642|NCT02548156|11862946|FG002|STARTED|Washout Period 2||4
10698643|NCT02548156|11862947|FG003|STARTED|Washout Period 2||5
10698644|NCT02548156|11862948|FG004|STARTED|Washout Period 2||4
10698645|NCT02548156|11862949|FG005|STARTED|Washout Period 2||5
10698646|NCT02548156|11862944|FG000|COMPLETED|Washout Period 2||5
10698647|NCT02548156|11862945|FG001|COMPLETED|Washout Period 2||5
10698648|NCT02548156|11862946|FG002|COMPLETED|Washout Period 2||4
10698649|NCT02548156|11862947|FG003|COMPLETED|Washout Period 2||5
10698650|NCT02548156|11862948|FG004|COMPLETED|Washout Period 2||4
10698651|NCT02548156|11862949|FG005|COMPLETED|Washout Period 2||5
10698652|NCT02548156|11862944|FG000|NOT COMPLETED|Washout Period 2||0
10801532|NCT04346199|11962743|FG001|STARTED|Overall Study||88
10801533|NCT04346199|11962742|FG000|COMPLETED|Overall Study||74
10801534|NCT04346199|11962743|FG001|COMPLETED|Overall Study||77
10801535|NCT04346199|11962742|FG000|NOT COMPLETED|Overall Study||15
10801536|NCT04346199|11962743|FG001|NOT COMPLETED|Overall Study||11
10801537|NCT04345653|11962749|FG000|STARTED|Overall Study||48
10698653|NCT02548156|11862945|FG001|NOT COMPLETED|Washout Period 2||0
10698654|NCT02548156|11862946|FG002|NOT COMPLETED|Washout Period 2||0
10698655|NCT02548156|11862947|FG003|NOT COMPLETED|Washout Period 2||0
10698656|NCT02548156|11862948|FG004|NOT COMPLETED|Washout Period 2||0
10318953|NCT00218439|11453213|FG001|NOT COMPLETED|First Intervention (4 Weeks)||12
10318954|NCT00218439|11453212|FG000|STARTED|Second Intervention (4 Weeks)||40
10318955|NCT00218439|11453213|FG001|STARTED|Second Intervention (4 Weeks)||35
10698657|NCT02548156|11862949|FG005|NOT COMPLETED|Washout Period 2||0
10698658|NCT02548156|11862944|FG000|STARTED|Period 3||5
10698659|NCT02548156|11862945|FG001|STARTED|Period 3||5
10698660|NCT02548156|11862946|FG002|STARTED|Period 3||4
10698661|NCT02548156|11862947|FG003|STARTED|Period 3||5
10698662|NCT02548156|11862948|FG004|STARTED|Period 3||4
10698663|NCT02548156|11862949|FG005|STARTED|Period 3||5
10698664|NCT02548156|11862944|FG000|COMPLETED|Period 3||5
10698665|NCT02548156|11862945|FG001|COMPLETED|Period 3||5
10698666|NCT02548156|11862946|FG002|COMPLETED|Period 3||4
10698667|NCT02548156|11862947|FG003|COMPLETED|Period 3||5
10698668|NCT02548156|11862948|FG004|COMPLETED|Period 3||4
10698669|NCT02548156|11862949|FG005|COMPLETED|Period 3||5
10698670|NCT02548156|11862944|FG000|NOT COMPLETED|Period 3||0
10698671|NCT02548156|11862945|FG001|NOT COMPLETED|Period 3||0
10698672|NCT02548156|11862946|FG002|NOT COMPLETED|Period 3||0
10698673|NCT02548156|11862947|FG003|NOT COMPLETED|Period 3||0
10698674|NCT02548156|11862948|FG004|NOT COMPLETED|Period 3||0
10698675|NCT02548156|11862949|FG005|NOT COMPLETED|Period 3||0
10698676|NCT02548312|11862965|FG000|STARTED|Overall Study||133
10698677|NCT02548312|11862966|FG001|STARTED|Overall Study||133
10698678|NCT02548312|11862967|FG002|STARTED|Overall Study||134
10698679|NCT02548312|11862968|FG003|STARTED|Overall Study||133
10698680|NCT02548312|11862969|FG004|STARTED|Overall Study||133
10698681|NCT02548312|11862970|FG005|STARTED|Overall Study||133
10698682|NCT02548312|11862971|FG006|STARTED|Overall Study||133
10698683|NCT02548312|11862972|FG007|STARTED|Overall Study||133
10698684|NCT02548312|11862965|FG000|COMPLETED|Overall Study||100
10698685|NCT02548312|11862966|FG001|COMPLETED|Overall Study||90
10698686|NCT02548312|11862967|FG002|COMPLETED|Overall Study||96
10698687|NCT02548312|11862968|FG003|COMPLETED|Overall Study||87
10698688|NCT02548312|11862969|FG004|COMPLETED|Overall Study||99
10698689|NCT02548312|11862970|FG005|COMPLETED|Overall Study||93
10698690|NCT02548312|11862971|FG006|COMPLETED|Overall Study||93
10698691|NCT02548312|11862972|FG007|COMPLETED|Overall Study||91
10698692|NCT02548312|11862965|FG000|NOT COMPLETED|Overall Study||33
10698693|NCT02548312|11862966|FG001|NOT COMPLETED|Overall Study||43
10698694|NCT02548312|11862967|FG002|NOT COMPLETED|Overall Study||38
10698695|NCT02548312|11862968|FG003|NOT COMPLETED|Overall Study||46
10698696|NCT02548312|11862969|FG004|NOT COMPLETED|Overall Study||34
10698697|NCT02548312|11862970|FG005|NOT COMPLETED|Overall Study||40
10698698|NCT02548312|11862971|FG006|NOT COMPLETED|Overall Study||40
10698699|NCT02548312|11862972|FG007|NOT COMPLETED|Overall Study||42
10698700|NCT02548455|11862990|FG000|STARTED|Overall Study|A total of 499 subjects were enrolled at 31 investigational sites.|499
10698701|NCT02548455|11862990|FG000|Completed Pre-Discharge|Overall Study||484
10698702|NCT02548455|11862990|FG000|Completed 6-Month Follow-up|Overall Study||259
10698703|NCT02548455|11862990|FG000|Completed 12-Month Follow-up|Overall Study|Study completed prior to all subjects reaching the 6- and 12-month visits.|61
10698704|NCT02548455|11862990|FG000|COMPLETED|Overall Study|Completed 6-Month Follow-up|259
10698705|NCT02548455|11862990|FG000|NOT COMPLETED|Overall Study||240
10698706|NCT02548585|11863001|FG000|STARTED|Overall Study||45
10698707|NCT02548585|11863002|FG001|STARTED|Overall Study||6
10698708|NCT02548585|11863003|FG002|STARTED|Overall Study||6
10801538|NCT04345653|11962749|FG000|COMPLETED|Overall Study||46
10801539|NCT04345653|11962749|FG000|NOT COMPLETED|Overall Study||2
10801540|NCT04343261|11962754|FG000|STARTED|Overall Study||48
10801541|NCT04343261|11962754|FG000|COMPLETED|Overall Study||40
10801542|NCT04343261|11962754|FG000|NOT COMPLETED|Overall Study||8
10801543|NCT04343222|11962761|FG000|STARTED|Overall Study||16
10801544|NCT04343222|11962762|FG001|STARTED|Overall Study||15
10698709|NCT02548585|11863004|FG003|STARTED|Overall Study||7
10698710|NCT02548585|11863005|FG004|STARTED|Overall Study||25
10698711|NCT02548585|11863006|FG005|STARTED|Overall Study||12
10698712|NCT02548585|11863007|FG006|STARTED|Overall Study||12
10698713|NCT02548585|11863001|FG000|Treated|Overall Study||45
10698714|NCT02548585|11863002|FG001|Treated|Overall Study||6
10698715|NCT02548585|11863003|FG002|Treated|Overall Study||6
10698716|NCT02548585|11863004|FG003|Treated|Overall Study||7
10698717|NCT02548585|11863005|FG004|Treated|Overall Study||25
10698718|NCT02548585|11863006|FG005|Treated|Overall Study||11
10698719|NCT02548585|11863007|FG006|Treated|Overall Study||12
10698720|NCT02548585|11863001|FG000|COMPLETED|Overall Study||43
10698721|NCT02548585|11863002|FG001|COMPLETED|Overall Study||6
10698722|NCT02548585|11863003|FG002|COMPLETED|Overall Study||6
10698723|NCT02548585|11863004|FG003|COMPLETED|Overall Study||5
10698724|NCT02548585|11863005|FG004|COMPLETED|Overall Study||22
10698725|NCT02548585|11863006|FG005|COMPLETED|Overall Study||10
10698726|NCT02548585|11863007|FG006|COMPLETED|Overall Study||11
10698727|NCT02548585|11863001|FG000|NOT COMPLETED|Overall Study||2
10698728|NCT02548585|11863002|FG001|NOT COMPLETED|Overall Study||0
10698729|NCT02548585|11863003|FG002|NOT COMPLETED|Overall Study||0
10801545|NCT04343222|11962763|FG002|STARTED|Overall Study||15
10801546|NCT04343222|11962761|FG000|COMPLETED|Overall Study||16
10801547|NCT04343222|11962762|FG001|COMPLETED|Overall Study||15
10801548|NCT04343222|11962763|FG002|COMPLETED|Overall Study||15
10801549|NCT04343222|11962761|FG000|NOT COMPLETED|Overall Study||0
10801550|NCT04343222|11962762|FG001|NOT COMPLETED|Overall Study||0
10801551|NCT04343222|11962763|FG002|NOT COMPLETED|Overall Study||0
10801552|NCT04343092|11962771|FG000|STARTED|Overall Study||16
10698730|NCT02548585|11863004|FG003|NOT COMPLETED|Overall Study||2
10698731|NCT02548585|11863005|FG004|NOT COMPLETED|Overall Study||3
10698732|NCT02548585|11863006|FG005|NOT COMPLETED|Overall Study||2
10698733|NCT02548585|11863007|FG006|NOT COMPLETED|Overall Study||1
10698734|NCT02548650|11863050|FG000|STARTED|Triple Therapy||30
10698735|NCT02548650|11863051|FG001|STARTED|Triple Therapy||36
10698736|NCT02548650|11863050|FG000|COMPLETED|Triple Therapy||29
10698737|NCT02548650|11863051|FG001|COMPLETED|Triple Therapy||32
10698738|NCT02548650|11863050|FG000|NOT COMPLETED|Triple Therapy||1
10698739|NCT02548650|11863051|FG001|NOT COMPLETED|Triple Therapy||4
10698740|NCT02548650|11863050|FG000|STARTED|Double Therapy||29
10698741|NCT02548650|11863051|FG001|STARTED|Double Therapy||32
10698742|NCT02548650|11863050|FG000|COMPLETED|Double Therapy||28
10698743|NCT02548650|11863051|FG001|COMPLETED|Double Therapy||30
10698744|NCT02548650|11863050|FG000|NOT COMPLETED|Double Therapy||1
10698745|NCT02548650|11863051|FG001|NOT COMPLETED|Double Therapy||2
10698746|NCT02548728|11863059|FG000|STARTED|Overall Study||6
10698747|NCT02548728|11863060|FG001|STARTED|Overall Study||6
10698748|NCT02548728|11863059|FG000|COMPLETED|Overall Study||6
10698749|NCT02548728|11863060|FG001|COMPLETED|Overall Study||6
10698750|NCT02548728|11863059|FG000|NOT COMPLETED|Overall Study||0
10698751|NCT02548728|11863060|FG001|NOT COMPLETED|Overall Study||0
10698752|NCT02548845|11863066|FG000|STARTED|Overall Study||70
10698753|NCT02548845|11863066|FG000|COMPLETED|Overall Study||70
10698754|NCT02548845|11863066|FG000|NOT COMPLETED|Overall Study||0
10698755|NCT02548910|11863076|FG000|STARTED|Overall Study||31
10698756|NCT02548910|11863077|FG001|STARTED|Overall Study||31
10698757|NCT02548910|11863076|FG000|COMPLETED|Overall Study||31
10698758|NCT02548910|11863077|FG001|COMPLETED|Overall Study||31
10698759|NCT02548910|11863076|FG000|NOT COMPLETED|Overall Study||0
10698760|NCT02548910|11863077|FG001|NOT COMPLETED|Overall Study||0
10698761|NCT02548949|11863084|FG000|STARTED|Overall Study||700
10698762|NCT02548949|11863084|FG000|COMPLETED|Overall Study||700
10698763|NCT02548949|11863084|FG000|NOT COMPLETED|Overall Study||0
10698764|NCT02548962|11863090|FG000|STARTED|Overall Study||8
10698765|NCT02548962|11863091|FG001|STARTED|Overall Study||3
10698766|NCT02548962|11863090|FG000|COMPLETED|Overall Study||7
10698767|NCT02548962|11863091|FG001|COMPLETED|Overall Study||3
10698768|NCT02548962|11863090|FG000|NOT COMPLETED|Overall Study||1
10698769|NCT02548962|11863091|FG001|NOT COMPLETED|Overall Study||0
10698770|NCT02549014|11863101|FG000|STARTED|Overall Study||8
10698771|NCT02549014|11863102|FG001|STARTED|Overall Study||8
10698772|NCT02549014|11863101|FG000|COMPLETED|Overall Study||8
10698773|NCT02549014|11863102|FG001|COMPLETED|Overall Study||8
10698774|NCT02549014|11863101|FG000|NOT COMPLETED|Overall Study||0
10698775|NCT02549014|11863102|FG001|NOT COMPLETED|Overall Study||0
10698776|NCT02549027|11863126|FG000|STARTED|Period 1 - MK-1064 or Placebo||5
10698777|NCT02549027|11863127|FG001|STARTED|Period 1 - MK-1064 or Placebo||5
10698778|NCT02549027|11863128|FG002|STARTED|Period 1 - MK-1064 or Placebo||5
10801553|NCT04343092|11962771|FG000|COMPLETED|Overall Study||16
10801554|NCT04343092|11962771|FG000|NOT COMPLETED|Overall Study||0
10801555|NCT04342663|11962777|FG000|STARTED|Overall Study||80
10801556|NCT04342663|11962778|FG001|STARTED|Overall Study||72
10801557|NCT04342663|11962777|FG000|COMPLETED|Overall Study||62
10698779|NCT02549027|11863129|FG003|STARTED|Period 1 - MK-1064 or Placebo||5
10698780|NCT02549027|11863130|FG004|STARTED|Period 1 - MK-1064 or Placebo||0
10698781|NCT02549027|11863131|FG005|STARTED|Period 1 - MK-1064 or Placebo||0
10698782|NCT02549027|11863126|FG000|COMPLETED|Period 1 - MK-1064 or Placebo||5
10698783|NCT02549027|11863127|FG001|COMPLETED|Period 1 - MK-1064 or Placebo||5
10698784|NCT02549027|11863128|FG002|COMPLETED|Period 1 - MK-1064 or Placebo||5
10698785|NCT02549027|11863129|FG003|COMPLETED|Period 1 - MK-1064 or Placebo||5
10698786|NCT02549027|11863130|FG004|COMPLETED|Period 1 - MK-1064 or Placebo||0
10698787|NCT02549027|11863131|FG005|COMPLETED|Period 1 - MK-1064 or Placebo||0
10698788|NCT02549027|11863126|FG000|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
10801558|NCT04342663|11962778|FG001|COMPLETED|Overall Study||53
10698789|NCT02549027|11863127|FG001|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
10698790|NCT02549027|11863128|FG002|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
10698791|NCT02549027|11863129|FG003|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
10698792|NCT02549027|11863130|FG004|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
10698793|NCT02549027|11863131|FG005|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
10801559|NCT04342663|11962777|FG000|NOT COMPLETED|Overall Study||18
10698794|NCT02549027|11863126|FG000|STARTED|Washout After Period 1||5
10698795|NCT02549027|11863127|FG001|STARTED|Washout After Period 1||5
10698796|NCT02549027|11863128|FG002|STARTED|Washout After Period 1||5
10698797|NCT02549027|11863129|FG003|STARTED|Washout After Period 1||5
10698798|NCT02549027|11863130|FG004|STARTED|Washout After Period 1||0
10698799|NCT02549027|11863131|FG005|STARTED|Washout After Period 1||0
10698800|NCT02549027|11863126|FG000|COMPLETED|Washout After Period 1||5
10698801|NCT02549027|11863127|FG001|COMPLETED|Washout After Period 1||5
10698802|NCT02549027|11863128|FG002|COMPLETED|Washout After Period 1||5
10698803|NCT02549027|11863129|FG003|COMPLETED|Washout After Period 1||5
10698804|NCT02549027|11863130|FG004|COMPLETED|Washout After Period 1||0
10698805|NCT02549027|11863131|FG005|COMPLETED|Washout After Period 1||0
10698806|NCT02549027|11863126|FG000|NOT COMPLETED|Washout After Period 1||0
10698807|NCT02549027|11863127|FG001|NOT COMPLETED|Washout After Period 1||0
10698808|NCT02549027|11863128|FG002|NOT COMPLETED|Washout After Period 1||0
10698809|NCT02549027|11863129|FG003|NOT COMPLETED|Washout After Period 1||0
10698810|NCT02549027|11863130|FG004|NOT COMPLETED|Washout After Period 1||0
10698811|NCT02549027|11863131|FG005|NOT COMPLETED|Washout After Period 1||0
10698812|NCT02549027|11863126|FG000|STARTED|Period 2 - MK-1064 or Placebo||5
10698813|NCT02549027|11863127|FG001|STARTED|Period 2 - MK-1064 or Placebo||5
10698814|NCT02549027|11863128|FG002|STARTED|Period 2 - MK-1064 or Placebo||5
10698815|NCT02549027|11863129|FG003|STARTED|Period 2 - MK-1064 or Placebo||5
10698816|NCT02549027|11863130|FG004|STARTED|Period 2 - MK-1064 or Placebo||0
10698817|NCT02549027|11863131|FG005|STARTED|Period 2 - MK-1064 or Placebo||0
10698818|NCT02549027|11863126|FG000|COMPLETED|Period 2 - MK-1064 or Placebo||5
10698819|NCT02549027|11863127|FG001|COMPLETED|Period 2 - MK-1064 or Placebo||5
10698820|NCT02549027|11863128|FG002|COMPLETED|Period 2 - MK-1064 or Placebo||5
10698821|NCT02549027|11863129|FG003|COMPLETED|Period 2 - MK-1064 or Placebo||5
10698822|NCT02549027|11863130|FG004|COMPLETED|Period 2 - MK-1064 or Placebo||0
10698823|NCT02549027|11863131|FG005|COMPLETED|Period 2 - MK-1064 or Placebo||0
10698824|NCT02549027|11863126|FG000|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
10698825|NCT02549027|11863127|FG001|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
10698826|NCT02549027|11863128|FG002|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
10698827|NCT02549027|11863129|FG003|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
10698828|NCT02549027|11863130|FG004|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
10698829|NCT02549027|11863131|FG005|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
10698830|NCT02549027|11863126|FG000|STARTED|Washout After Period 2||5
10698831|NCT02549027|11863127|FG001|STARTED|Washout After Period 2||5
10698832|NCT02549027|11863128|FG002|STARTED|Washout After Period 2||5
10698833|NCT02549027|11863129|FG003|STARTED|Washout After Period 2||5
10698834|NCT02549027|11863130|FG004|STARTED|Washout After Period 2||0
10698835|NCT02549027|11863131|FG005|STARTED|Washout After Period 2||0
10698836|NCT02549027|11863126|FG000|COMPLETED|Washout After Period 2||5
10698837|NCT02549027|11863127|FG001|COMPLETED|Washout After Period 2||5
10698838|NCT02549027|11863128|FG002|COMPLETED|Washout After Period 2||5
10698839|NCT02549027|11863129|FG003|COMPLETED|Washout After Period 2||5
10698840|NCT02549027|11863130|FG004|COMPLETED|Washout After Period 2||0
10698841|NCT02549027|11863131|FG005|COMPLETED|Washout After Period 2||0
10698842|NCT02549027|11863126|FG000|NOT COMPLETED|Washout After Period 2||0
10698843|NCT02549027|11863127|FG001|NOT COMPLETED|Washout After Period 2||0
10698844|NCT02549027|11863128|FG002|NOT COMPLETED|Washout After Period 2||0
10698845|NCT02549027|11863129|FG003|NOT COMPLETED|Washout After Period 2||0
10698846|NCT02549027|11863130|FG004|NOT COMPLETED|Washout After Period 2||0
10698847|NCT02549027|11863131|FG005|NOT COMPLETED|Washout After Period 2||0
10698848|NCT02549027|11863126|FG000|STARTED|Period 3 - MK-1064 or Placebo||5
10698849|NCT02549027|11863127|FG001|STARTED|Period 3 - MK-1064 or Placebo||5
10698850|NCT02549027|11863128|FG002|STARTED|Period 3 - MK-1064 or Placebo||5
10698851|NCT02549027|11863129|FG003|STARTED|Period 3 - MK-1064 or Placebo||5
10698852|NCT02549027|11863130|FG004|STARTED|Period 3 - MK-1064 or Placebo||0
10698853|NCT02549027|11863131|FG005|STARTED|Period 3 - MK-1064 or Placebo||0
10698854|NCT02549027|11863126|FG000|COMPLETED|Period 3 - MK-1064 or Placebo||5
10698855|NCT02549027|11863127|FG001|COMPLETED|Period 3 - MK-1064 or Placebo||5
10698856|NCT02549027|11863128|FG002|COMPLETED|Period 3 - MK-1064 or Placebo||5
10698857|NCT02549027|11863129|FG003|COMPLETED|Period 3 - MK-1064 or Placebo||5
10698858|NCT02549027|11863130|FG004|COMPLETED|Period 3 - MK-1064 or Placebo||0
10698859|NCT02549027|11863131|FG005|COMPLETED|Period 3 - MK-1064 or Placebo||0
10698860|NCT02549027|11863126|FG000|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
10698861|NCT02549027|11863127|FG001|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
10698862|NCT02549027|11863128|FG002|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
10698863|NCT02549027|11863129|FG003|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
10698864|NCT02549027|11863130|FG004|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
10698865|NCT02549027|11863131|FG005|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
10698866|NCT02549027|11863126|FG000|STARTED|Washout After Period 3||5
10698867|NCT02549027|11863127|FG001|STARTED|Washout After Period 3||5
10698868|NCT02549027|11863128|FG002|STARTED|Washout After Period 3||5
10698869|NCT02549027|11863129|FG003|STARTED|Washout After Period 3||5
10698870|NCT02549027|11863130|FG004|STARTED|Washout After Period 3||0
10698871|NCT02549027|11863131|FG005|STARTED|Washout After Period 3||0
10698872|NCT02549027|11863126|FG000|COMPLETED|Washout After Period 3||5
10698873|NCT02549027|11863127|FG001|COMPLETED|Washout After Period 3||5
10698874|NCT02549027|11863128|FG002|COMPLETED|Washout After Period 3||5
10698875|NCT02549027|11863129|FG003|COMPLETED|Washout After Period 3||5
10698876|NCT02549027|11863130|FG004|COMPLETED|Washout After Period 3||0
10698877|NCT02549027|11863131|FG005|COMPLETED|Washout After Period 3||0
10698878|NCT02549027|11863126|FG000|NOT COMPLETED|Washout After Period 3||0
10698879|NCT02549027|11863127|FG001|NOT COMPLETED|Washout After Period 3||0
10698880|NCT02549027|11863128|FG002|NOT COMPLETED|Washout After Period 3||0
10698881|NCT02549027|11863129|FG003|NOT COMPLETED|Washout After Period 3||0
10698882|NCT02549027|11863130|FG004|NOT COMPLETED|Washout After Period 3||0
10698883|NCT02549027|11863131|FG005|NOT COMPLETED|Washout After Period 3||0
10698884|NCT02549027|11863126|FG000|STARTED|Period 4 - MK-1064 or Placebo||5
10698885|NCT02549027|11863127|FG001|STARTED|Period 4 - MK-1064 or Placebo||5
10698886|NCT02549027|11863128|FG002|STARTED|Period 4 - MK-1064 or Placebo||5
10698887|NCT02549027|11863129|FG003|STARTED|Period 4 - MK-1064 or Placebo||5
10698888|NCT02549027|11863130|FG004|STARTED|Period 4 - MK-1064 or Placebo||0
10698889|NCT02549027|11863131|FG005|STARTED|Period 4 - MK-1064 or Placebo||0
10698890|NCT02549027|11863126|FG000|COMPLETED|Period 4 - MK-1064 or Placebo||5
10698891|NCT02549027|11863127|FG001|COMPLETED|Period 4 - MK-1064 or Placebo||5
10698892|NCT02549027|11863128|FG002|COMPLETED|Period 4 - MK-1064 or Placebo||5
10698893|NCT02549027|11863129|FG003|COMPLETED|Period 4 - MK-1064 or Placebo||5
10698894|NCT02549027|11863130|FG004|COMPLETED|Period 4 - MK-1064 or Placebo||0
10698895|NCT02549027|11863131|FG005|COMPLETED|Period 4 - MK-1064 or Placebo||0
10698896|NCT02549027|11863126|FG000|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
10698897|NCT02549027|11863127|FG001|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
10698898|NCT02549027|11863128|FG002|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
10698899|NCT02549027|11863129|FG003|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
10698900|NCT02549027|11863130|FG004|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
10698901|NCT02549027|11863131|FG005|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
10698902|NCT02549027|11863126|FG000|STARTED|Washout After Period 4||5
10698903|NCT02549027|11863127|FG001|STARTED|Washout After Period 4||5
10698904|NCT02549027|11863128|FG002|STARTED|Washout After Period 4||5
10698905|NCT02549027|11863129|FG003|STARTED|Washout After Period 4||5
10698906|NCT02549027|11863130|FG004|STARTED|Washout After Period 4||0
10698907|NCT02549027|11863131|FG005|STARTED|Washout After Period 4||0
10698908|NCT02549027|11863126|FG000|COMPLETED|Washout After Period 4||5
10698909|NCT02549027|11863127|FG001|COMPLETED|Washout After Period 4||4
10698910|NCT02549027|11863128|FG002|COMPLETED|Washout After Period 4||4
10698911|NCT02549027|11863129|FG003|COMPLETED|Washout After Period 4||4
10698912|NCT02549027|11863130|FG004|COMPLETED|Washout After Period 4||0
10698913|NCT02549027|11863131|FG005|COMPLETED|Washout After Period 4||0
10698914|NCT02549027|11863126|FG000|NOT COMPLETED|Washout After Period 4||0
10698915|NCT02549027|11863127|FG001|NOT COMPLETED|Washout After Period 4||1
10698916|NCT02549027|11863128|FG002|NOT COMPLETED|Washout After Period 4||1
10698917|NCT02549027|11863129|FG003|NOT COMPLETED|Washout After Period 4||1
10698918|NCT02549027|11863130|FG004|NOT COMPLETED|Washout After Period 4||0
10698919|NCT02549027|11863131|FG005|NOT COMPLETED|Washout After Period 4||0
10698920|NCT02549027|11863126|FG000|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg/Placebo (Period 5) arms|0
10698921|NCT02549027|11863127|FG001|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
10698922|NCT02549027|11863128|FG002|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
10698923|NCT02549027|11863129|FG003|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
10698924|NCT02549027|11863130|FG004|STARTED|Period 5 - MK-6096 or Placebo|Participants entering Period 5 were previously in MK-1064/Placebo (Period 1-4) arms|16
10698925|NCT02549027|11863131|FG005|STARTED|Period 5 - MK-6096 or Placebo|Participants entering Period 5 were previously in MK-1064/Placebo (Period 1-4) arms|1
10698926|NCT02549027|11863126|FG000|COMPLETED|Period 5 - MK-6096 or Placebo||0
10698927|NCT02549027|11863127|FG001|COMPLETED|Period 5 - MK-6096 or Placebo||0
10698928|NCT02549027|11863128|FG002|COMPLETED|Period 5 - MK-6096 or Placebo||0
10698929|NCT02549027|11863129|FG003|COMPLETED|Period 5 - MK-6096 or Placebo||0
10698930|NCT02549027|11863130|FG004|COMPLETED|Period 5 - MK-6096 or Placebo|The 2 participants who did not complete Period 5 did not receive study drug in Period 5|14
10698931|NCT02549027|11863131|FG005|COMPLETED|Period 5 - MK-6096 or Placebo||1
10698932|NCT02549027|11863126|FG000|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
10698933|NCT02549027|11863127|FG001|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
10698934|NCT02549027|11863128|FG002|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
10698935|NCT02549027|11863129|FG003|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
10698936|NCT02549027|11863130|FG004|NOT COMPLETED|Period 5 - MK-6096 or Placebo||2
10698937|NCT02549027|11863131|FG005|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
10698938|NCT02549040|11863146|FG000|STARTED|Period 1||16
10698939|NCT02549040|11863146|FG000|COMPLETED|Period 1||16
10698940|NCT02549040|11863146|FG000|NOT COMPLETED|Period 1||0
10698941|NCT02549040|11863146|FG000|STARTED|Period 2||16
10698942|NCT02549040|11863146|FG000|COMPLETED|Period 2||16
10698943|NCT02549040|11863146|FG000|NOT COMPLETED|Period 2||0
10698944|NCT02549040|11863146|FG000|STARTED|Period 3||16
10698945|NCT02549040|11863146|FG000|COMPLETED|Period 3||16
10698946|NCT02549040|11863146|FG000|NOT COMPLETED|Period 3||0
10698947|NCT02549040|11863146|FG000|STARTED|Period 4||16
10698948|NCT02549040|11863146|FG000|COMPLETED|Period 4||16
10801560|NCT04342663|11962778|FG001|NOT COMPLETED|Overall Study||19
10801561|NCT04342897|11962786|FG000|STARTED|Overall Study||47
10801562|NCT04342897|11962787|FG001|STARTED|Overall Study||48
10801563|NCT04342897|11962786|FG000|Received at Least One Dose of Study Drug|Overall Study||47
10698949|NCT02549040|11863146|FG000|NOT COMPLETED|Period 4||0
10698950|NCT02549040|11863146|FG000|STARTED|Period 5||16
10698951|NCT02549040|11863146|FG000|COMPLETED|Period 5||16
10698952|NCT02549040|11863146|FG000|NOT COMPLETED|Period 5||0
10698953|NCT02549196|11863162|FG000|STARTED|Overall Study||8
10698954|NCT02549196|11863163|FG001|STARTED|Overall Study||1
10698955|NCT02549196|11863164|FG002|STARTED|Overall Study||6
10698956|NCT02549196|11863165|FG003|STARTED|Overall Study||13
10698957|NCT02549196|11863162|FG000|COMPLETED|Overall Study||7
10698958|NCT02549196|11863163|FG001|COMPLETED|Overall Study||1
10698959|NCT02549196|11863164|FG002|COMPLETED|Overall Study||5
10698960|NCT02549196|11863165|FG003|COMPLETED|Overall Study||12
10698961|NCT02549196|11863162|FG000|NOT COMPLETED|Overall Study||1
10698962|NCT02549196|11863163|FG001|NOT COMPLETED|Overall Study||0
10698963|NCT02549196|11863164|FG002|NOT COMPLETED|Overall Study||1
10698964|NCT02549196|11863165|FG003|NOT COMPLETED|Overall Study||1
10698965|NCT02549287|11863177|FG000|STARTED|Overall Study||193
10698966|NCT02549287|11863178|FG001|STARTED|Overall Study||96
10698967|NCT02549287|11863177|FG000|COMPLETED|Overall Study||113
10698968|NCT02549287|11863178|FG001|COMPLETED|Overall Study||64
10698969|NCT02549287|11863177|FG000|NOT COMPLETED|Overall Study||80
10698970|NCT02549287|11863178|FG001|NOT COMPLETED|Overall Study||32
10698971|NCT02549339|11863186|FG000|STARTED|3-day Treatment and 8-week Follow-up||205
10698972|NCT02549339|11863187|FG001|STARTED|3-day Treatment and 8-week Follow-up||104
10698973|NCT02549339|11863186|FG000|Treated|3-day Treatment and 8-week Follow-up||202
10698974|NCT02549339|11863187|FG001|Treated|3-day Treatment and 8-week Follow-up||104
10698975|NCT02549339|11863186|FG000|COMPLETED|3-day Treatment and 8-week Follow-up||201
10698976|NCT02549339|11863187|FG001|COMPLETED|3-day Treatment and 8-week Follow-up||99
10698977|NCT02549339|11863186|FG000|NOT COMPLETED|3-day Treatment and 8-week Follow-up||4
10698978|NCT02549339|11863187|FG001|NOT COMPLETED|3-day Treatment and 8-week Follow-up||5
10698979|NCT02549339|11863186|FG000|STARTED|12-month Follow-up||201
10698980|NCT02549339|11863187|FG001|STARTED|12-month Follow-up||98
10698981|NCT02549339|11863186|FG000|COMPLETED|12-month Follow-up||192
10698982|NCT02549339|11863187|FG001|COMPLETED|12-month Follow-up||87
10698983|NCT02549339|11863186|FG000|NOT COMPLETED|12-month Follow-up||9
10698984|NCT02549339|11863187|FG001|NOT COMPLETED|12-month Follow-up||11
10698985|NCT02549352|11863197|FG000|STARTED|3-day Treatment and 8-week Follow-up||209
10698986|NCT02549352|11863198|FG001|STARTED|3-day Treatment and 8-week Follow-up||102
10698987|NCT02549352|11863197|FG000|Treated|3-day Treatment and 8-week Follow-up||209
10698988|NCT02549352|11863198|FG001|Treated|3-day Treatment and 8-week Follow-up|1 participant was included in 0.037% in the safety analysis set as they received both IMPs in error|101
10698989|NCT02549352|11863197|FG000|COMPLETED|3-day Treatment and 8-week Follow-up||207
10698990|NCT02549352|11863198|FG001|COMPLETED|3-day Treatment and 8-week Follow-up||96
10698991|NCT02549352|11863197|FG000|NOT COMPLETED|3-day Treatment and 8-week Follow-up||2
10698992|NCT02549352|11863198|FG001|NOT COMPLETED|3-day Treatment and 8-week Follow-up||6
10698993|NCT02549352|11863197|FG000|STARTED|12-month Follow-up||207
10698994|NCT02549352|11863198|FG001|STARTED|12-month Follow-up||93
10698995|NCT02549352|11863197|FG000|COMPLETED|12-month Follow-up||199
10698996|NCT02549352|11863198|FG001|COMPLETED|12-month Follow-up||81
10698997|NCT02549352|11863197|FG000|NOT COMPLETED|12-month Follow-up||8
10698998|NCT02549352|11863198|FG001|NOT COMPLETED|12-month Follow-up||12
10698999|NCT02549365|11863208|FG000|STARTED|Overall Study||164
10699000|NCT02549365|11863209|FG001|STARTED|Overall Study||112
10699001|NCT02549365|11863208|FG000|COMPLETED|Overall Study||164
10699002|NCT02549365|11863209|FG001|COMPLETED|Overall Study||112
10699003|NCT02549365|11863208|FG000|NOT COMPLETED|Overall Study||0
10699004|NCT02549365|11863209|FG001|NOT COMPLETED|Overall Study||0
10699005|NCT02549508|11863217|FG000|STARTED|Overall Study||47
10699006|NCT02549508|11863218|FG001|STARTED|Overall Study||38
10699007|NCT02549508|11863217|FG000|COMPLETED|Overall Study||33
10699008|NCT02549508|11863218|FG001|COMPLETED|Overall Study||21
10699009|NCT02549508|11863217|FG000|NOT COMPLETED|Overall Study||14
10699010|NCT02549508|11863218|FG001|NOT COMPLETED|Overall Study||17
10699011|NCT02549573|11863228|FG000|STARTED|Overall Study||6
10699012|NCT02549573|11863229|FG001|STARTED|Overall Study||7
10699013|NCT02549573|11863228|FG000|COMPLETED|Overall Study||6
10699014|NCT02549573|11863229|FG001|COMPLETED|Overall Study||4
10699015|NCT02549573|11863228|FG000|NOT COMPLETED|Overall Study||0
10699016|NCT02549573|11863229|FG001|NOT COMPLETED|Overall Study||3
10699017|NCT02549859|11863235|FG000|STARTED|Visit 1||11
10699018|NCT02549859|11863235|FG000|COMPLETED|Visit 1||11
10699019|NCT02549859|11863235|FG000|NOT COMPLETED|Visit 1||0
10699020|NCT02549859|11863235|FG000|STARTED|Long-term 60 Hz DBS||11
10699021|NCT02549859|11863235|FG000|COMPLETED|Long-term 60 Hz DBS||10
10699022|NCT02549859|11863235|FG000|NOT COMPLETED|Long-term 60 Hz DBS||1
10699023|NCT02549859|11863235|FG000|STARTED|Visit 2||10
10699024|NCT02549859|11863235|FG000|COMPLETED|Visit 2||10
10699025|NCT02549859|11863235|FG000|NOT COMPLETED|Visit 2||0
10699026|NCT02550106|11863243|FG000|STARTED|Overall Study||136
10699027|NCT02550106|11863243|FG000|COMPLETED|Overall Study||124
10699028|NCT02550106|11863243|FG000|NOT COMPLETED|Overall Study||12
10699029|NCT02550132|11863249|FG000|STARTED|Overall Study||25
10699030|NCT02550132|11863249|FG000|COMPLETED|Overall Study||25
10699031|NCT02550132|11863249|FG000|NOT COMPLETED|Overall Study||0
10699032|NCT02550210|11863253|FG000|STARTED|Overall Study||23
10699033|NCT02550210|11863253|FG000|COMPLETED|Overall Study||19
10699034|NCT02550210|11863253|FG000|NOT COMPLETED|Overall Study||4
10699035|NCT02550743|11863261|FG000|STARTED|Overall Study||3
10699036|NCT02550743|11863262|FG001|STARTED|Overall Study||3
10699037|NCT02550743|11863263|FG002|STARTED|Overall Study||1
10699038|NCT02550743|11863264|FG003|STARTED|Overall Study||0
10699039|NCT02550743|11863261|FG000|COMPLETED|Overall Study||3
10699040|NCT02550743|11863262|FG001|COMPLETED|Overall Study||3
10699041|NCT02550743|11863263|FG002|COMPLETED|Overall Study||1
10699042|NCT02550743|11863264|FG003|COMPLETED|Overall Study||0
10699043|NCT02550743|11863261|FG000|NOT COMPLETED|Overall Study||0
10699044|NCT02550743|11863262|FG001|NOT COMPLETED|Overall Study||0
10699045|NCT02550743|11863263|FG002|NOT COMPLETED|Overall Study||0
10699046|NCT02550743|11863264|FG003|NOT COMPLETED|Overall Study||0
10699047|NCT02550795|11863278|FG000|STARTED|Overall Study||50
10699048|NCT02550795|11863279|FG001|STARTED|Overall Study||50
10699049|NCT02550795|11863280|FG002|STARTED|Overall Study||50
10699050|NCT02550795|11863278|FG000|COMPLETED|Overall Study||50
10699051|NCT02550795|11863279|FG001|COMPLETED|Overall Study||49
10699052|NCT02550795|11863280|FG002|COMPLETED|Overall Study||50
10699053|NCT02550795|11863278|FG000|NOT COMPLETED|Overall Study||0
10699054|NCT02550795|11863279|FG001|NOT COMPLETED|Overall Study||1
10699055|NCT02550795|11863280|FG002|NOT COMPLETED|Overall Study||0
10699056|NCT02550938|11863292|FG000|STARTED|Overall Study||44
10699057|NCT02550938|11863293|FG001|STARTED|Overall Study||85
10699058|NCT02550938|11863294|FG002|STARTED|Overall Study||43
10699059|NCT02550938|11863295|FG003|STARTED|Overall Study||81
10699060|NCT02550938|11863292|FG000|COMPLETED|Overall Study||36
10699061|NCT02550938|11863293|FG001|COMPLETED|Overall Study||78
10699062|NCT02550938|11863294|FG002|COMPLETED|Overall Study||31
10699063|NCT02550938|11863295|FG003|COMPLETED|Overall Study||70
10699064|NCT02550938|11863292|FG000|NOT COMPLETED|Overall Study||8
10699065|NCT02550938|11863293|FG001|NOT COMPLETED|Overall Study||7
10699066|NCT02550938|11863294|FG002|NOT COMPLETED|Overall Study||12
10699067|NCT02550938|11863295|FG003|NOT COMPLETED|Overall Study||11
10699068|NCT02551055|11863312|FG000|STARTED|Overall Study||4
10699069|NCT02551055|11863313|FG001|STARTED|Overall Study||6
10699070|NCT02551055|11863314|FG002|STARTED|Overall Study||3
10699071|NCT02551055|11863315|FG003|STARTED|Overall Study||6
10699072|NCT02551055|11863316|FG004|STARTED|Overall Study||7
10699073|NCT02551055|11863317|FG005|STARTED|Overall Study||2
10699074|NCT02551055|11863318|FG006|STARTED|Overall Study||4
10699075|NCT02551055|11863319|FG007|STARTED|Overall Study||0
10699076|NCT02551055|11863312|FG000|COMPLETED|Overall Study||0
10699077|NCT02551055|11863313|FG001|COMPLETED|Overall Study||0
10699078|NCT02551055|11863314|FG002|COMPLETED|Overall Study||1
10699079|NCT02551055|11863315|FG003|COMPLETED|Overall Study||1
10699080|NCT02551055|11863316|FG004|COMPLETED|Overall Study||0
10699081|NCT02551055|11863317|FG005|COMPLETED|Overall Study||1
10699082|NCT02551055|11863318|FG006|COMPLETED|Overall Study||1
10699083|NCT02551055|11863319|FG007|COMPLETED|Overall Study||0
10699084|NCT02551055|11863312|FG000|NOT COMPLETED|Overall Study||4
10699085|NCT02551055|11863313|FG001|NOT COMPLETED|Overall Study||6
10699086|NCT02551055|11863314|FG002|NOT COMPLETED|Overall Study||2
10699087|NCT02551055|11863315|FG003|NOT COMPLETED|Overall Study||5
10699088|NCT02551055|11863316|FG004|NOT COMPLETED|Overall Study||7
10699089|NCT02551055|11863317|FG005|NOT COMPLETED|Overall Study||1
10699090|NCT02551055|11863318|FG006|NOT COMPLETED|Overall Study||3
10699091|NCT02551055|11863319|FG007|NOT COMPLETED|Overall Study||0
10699092|NCT02551094|11863339|FG000|STARTED|Overall Study||2366
10699093|NCT02551094|11863340|FG001|STARTED|Overall Study||2379
10699094|NCT02551094|11863339|FG000|COMPLETED|Overall Study||2226
10801564|NCT04342897|11962787|FG001|Received at Least One Dose of Study Drug|Overall Study||48
10801565|NCT04342897|11962786|FG000|COMPLETED|Overall Study||33
10801566|NCT04342897|11962787|FG001|COMPLETED|Overall Study||36
10801567|NCT04342897|11962786|FG000|NOT COMPLETED|Overall Study||14
10801568|NCT04342897|11962787|FG001|NOT COMPLETED|Overall Study||12
10801569|NCT04342130|11962793|FG000|STARTED|Overall Study||10
10801570|NCT04342130|11962793|FG000|COMPLETED|Overall Study||10
10801571|NCT04342130|11962793|FG000|NOT COMPLETED|Overall Study||0
10801572|NCT04340557|11962799|FG000|STARTED|Overall Study||16
10801573|NCT04340557|11962800|FG001|STARTED|Overall Study||15
10699095|NCT02551094|11863340|FG001|COMPLETED|Overall Study||2232
10699096|NCT02551094|11863339|FG000|NOT COMPLETED|Overall Study||140
10699097|NCT02551094|11863340|FG001|NOT COMPLETED|Overall Study||147
10699098|NCT02551159|11863349|FG000|STARTED|Overall Study||413
10699099|NCT02551159|11863350|FG001|STARTED|Overall Study||204
10699100|NCT02551159|11863351|FG002|STARTED|Overall Study||206
10699101|NCT02551159|11863349|FG000|Full Analysis Set|Overall Study||413
10699102|NCT02551159|11863350|FG001|Full Analysis Set|Overall Study||204
10699103|NCT02551159|11863351|FG002|Full Analysis Set|Overall Study||206
10699104|NCT02551159|11863349|FG000|Safety Analysis Set|Overall Study||408
10699105|NCT02551159|11863350|FG001|Safety Analysis Set|Overall Study||202
10801574|NCT04340557|11962799|FG000|COMPLETED|Overall Study||15
10801575|NCT04340557|11962800|FG001|COMPLETED|Overall Study||13
10801576|NCT04340557|11962799|FG000|NOT COMPLETED|Overall Study||1
10699106|NCT02551159|11863351|FG002|Safety Analysis Set|Overall Study||196
10699107|NCT02551159|11863349|FG000|PD-L1 TC/IC High Subgroup Analysis Set|Overall Study||190
10699108|NCT02551159|11863350|FG001|PD-L1 TC/IC High Subgroup Analysis Set|Overall Study||99
10699109|NCT02551159|11863351|FG002|PD-L1 TC/IC High Subgroup Analysis Set|Overall Study||94
10699110|NCT02551159|11863349|FG000|COMPLETED|Overall Study||0
10699111|NCT02551159|11863350|FG001|COMPLETED|Overall Study||0
10699112|NCT02551159|11863351|FG002|COMPLETED|Overall Study||0
10699113|NCT02551159|11863349|FG000|NOT COMPLETED|Overall Study||413
10699114|NCT02551159|11863350|FG001|NOT COMPLETED|Overall Study||204
10801577|NCT04340557|11962800|FG001|NOT COMPLETED|Overall Study||2
10699115|NCT02551159|11863351|FG002|NOT COMPLETED|Overall Study||206
10699116|NCT02551224|11863359|FG000|STARTED|First Intervention||50
10699117|NCT02551224|11863360|FG001|STARTED|First Intervention||50
10699118|NCT02551224|11863359|FG000|COMPLETED|First Intervention||50
10699119|NCT02551224|11863360|FG001|COMPLETED|First Intervention||50
10699120|NCT02551224|11863359|FG000|NOT COMPLETED|First Intervention||0
10699121|NCT02551224|11863360|FG001|NOT COMPLETED|First Intervention||0
10699122|NCT02551224|11863359|FG000|STARTED|Second Intervention (5 Min After First )||50
10699123|NCT02551224|11863360|FG001|STARTED|Second Intervention (5 Min After First )||50
10699124|NCT02551224|11863359|FG000|COMPLETED|Second Intervention (5 Min After First )||50
10699125|NCT02551224|11863360|FG001|COMPLETED|Second Intervention (5 Min After First )||50
10699126|NCT02551224|11863359|FG000|NOT COMPLETED|Second Intervention (5 Min After First )||0
10699127|NCT02551224|11863360|FG001|NOT COMPLETED|Second Intervention (5 Min After First )||0
10699128|NCT02551432|11863366|FG000|STARTED|Overall Study||26
10699129|NCT02551432|11863366|FG000|COMPLETED|Overall Study||26
10699130|NCT02551432|11863366|FG000|NOT COMPLETED|Overall Study||0
10699131|NCT02551653|11863372|FG000|STARTED|Overall Study||5
10699132|NCT02551653|11863373|FG001|STARTED|Overall Study||5
10699133|NCT02551653|11863372|FG000|COMPLETED|Overall Study||5
10699134|NCT02551653|11863373|FG001|COMPLETED|Overall Study||5
10699135|NCT02551653|11863372|FG000|NOT COMPLETED|Overall Study||0
10699136|NCT02551653|11863373|FG001|NOT COMPLETED|Overall Study||0
10699137|NCT02551666|11863381|FG000|STARTED|Overall Study||16
10699138|NCT02551666|11863382|FG001|STARTED|Overall Study||19
10699139|NCT02551666|11863381|FG000|COMPLETED|Overall Study||15
10699140|NCT02551666|11863382|FG001|COMPLETED|Overall Study||16
10699141|NCT02551666|11863381|FG000|NOT COMPLETED|Overall Study||1
10699142|NCT02551666|11863382|FG001|NOT COMPLETED|Overall Study||3
10699143|NCT02551692|11863391|FG000|STARTED|Overall Study||31
10699144|NCT02551692|11863392|FG001|STARTED|Overall Study||27
10699145|NCT02551692|11863393|FG002|STARTED|Overall Study||30
10699146|NCT02551692|11863391|FG000|COMPLETED|Overall Study||30
10699147|NCT02551692|11863392|FG001|COMPLETED|Overall Study||26
10699148|NCT02551692|11863393|FG002|COMPLETED|Overall Study||25
10699149|NCT02551692|11863391|FG000|NOT COMPLETED|Overall Study||1
10699150|NCT02551692|11863392|FG001|NOT COMPLETED|Overall Study||1
10699151|NCT02551692|11863393|FG002|NOT COMPLETED|Overall Study||5
10699152|NCT02551731|11863401|FG000|STARTED|Overall Study||9
10699153|NCT02551731|11863401|FG000|COMPLETED|Overall Study||7
10699154|NCT02551731|11863401|FG000|NOT COMPLETED|Overall Study||2
10699155|NCT02551744|11863407|FG000|STARTED|Overall Study||50
10699156|NCT02551744|11863408|FG001|STARTED|Overall Study||51
10699157|NCT02551744|11863407|FG000|COMPLETED|Overall Study||50
10699158|NCT02551744|11863408|FG001|COMPLETED|Overall Study||51
10699159|NCT02551744|11863407|FG000|NOT COMPLETED|Overall Study||0
10699160|NCT02551744|11863408|FG001|NOT COMPLETED|Overall Study||0
10699161|NCT02551757|11863416|FG000|STARTED|Overall Study||20
10699162|NCT02551757|11863417|FG001|STARTED|Overall Study||20
10699163|NCT02551757|11863416|FG000|COMPLETED|Overall Study||13
10699164|NCT02551757|11863417|FG001|COMPLETED|Overall Study||17
10699165|NCT02551757|11863416|FG000|NOT COMPLETED|Overall Study||7
10699166|NCT02551757|11863417|FG001|NOT COMPLETED|Overall Study||3
10699167|NCT02551770|11863427|FG000|STARTED|Overall Study||51
10699168|NCT02551770|11863428|FG001|STARTED|Overall Study||51
10699169|NCT02551770|11863427|FG000|COMPLETED|Overall Study||48
10699170|NCT02551770|11863428|FG001|COMPLETED|Overall Study||48
10699171|NCT02551770|11863427|FG000|NOT COMPLETED|Overall Study||3
10699172|NCT02551770|11863428|FG001|NOT COMPLETED|Overall Study||3
10699173|NCT02551809|11863436|FG000|STARTED|Overall Study||14
10699174|NCT02551809|11863437|FG001|STARTED|Overall Study||15
10699175|NCT02551809|11863438|FG002|STARTED|Overall Study||14
10699176|NCT02551809|11863436|FG000|COMPLETED|Overall Study||14
10699177|NCT02551809|11863437|FG001|COMPLETED|Overall Study||14
10699178|NCT02551809|11863438|FG002|COMPLETED|Overall Study||13
10699179|NCT02551809|11863436|FG000|NOT COMPLETED|Overall Study||0
10699180|NCT02551809|11863437|FG001|NOT COMPLETED|Overall Study||1
10699181|NCT02551809|11863438|FG002|NOT COMPLETED|Overall Study||1
10699182|NCT02551822|11863448|FG000|STARTED|Overall Study||11
10699183|NCT02551822|11863449|FG001|STARTED|Overall Study||12
10699184|NCT02551822|11863448|FG000|COMPLETED|Overall Study||9
10699185|NCT02551822|11863449|FG001|COMPLETED|Overall Study||10
10699186|NCT02551822|11863448|FG000|NOT COMPLETED|Overall Study||2
10699187|NCT02551822|11863449|FG001|NOT COMPLETED|Overall Study||2
10699188|NCT02551874|11863457|FG000|STARTED|Overall Study||324
10699189|NCT02551874|11863458|FG001|STARTED|Overall Study||326
10699190|NCT02551874|11863457|FG000|Received Treatment in Short-term Study|Overall Study||324
10699191|NCT02551874|11863458|FG001|Received Treatment in Short-term Study|Overall Study||319
10699192|NCT02551874|11863457|FG000|Entered Long-term Study|Overall Study||306
10699193|NCT02551874|11863458|FG001|Entered Long-term Study|Overall Study||294
10699194|NCT02551874|11863457|FG000|Received Treatment in Long-term Study|Overall Study||295
10699195|NCT02551874|11863458|FG001|Received Treatment in Long-term Study|Overall Study||284
10699196|NCT02551874|11863457|FG000|COMPLETED|Overall Study||296
10699197|NCT02551874|11863458|FG001|COMPLETED|Overall Study||287
10699198|NCT02551874|11863457|FG000|NOT COMPLETED|Overall Study||28
10699199|NCT02551874|11863458|FG001|NOT COMPLETED|Overall Study||39
10699200|NCT02551887|11863467|FG000|STARTED|Overall Study||301
10699201|NCT02551887|11863468|FG001|STARTED|Overall Study||124
10699202|NCT02551887|11863469|FG002|STARTED|Overall Study||222
10699203|NCT02551887|11863467|FG000|COMPLETED|Overall Study||301
10699204|NCT02551887|11863468|FG001|COMPLETED|Overall Study||124
10699205|NCT02551887|11863469|FG002|COMPLETED|Overall Study||222
10699206|NCT02551887|11863467|FG000|NOT COMPLETED|Overall Study||0
10699207|NCT02551887|11863468|FG001|NOT COMPLETED|Overall Study||0
10699208|NCT02551887|11863469|FG002|NOT COMPLETED|Overall Study||0
10699209|NCT02552121|11863485|FG000|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||3
10699210|NCT02552121|11863486|FG001|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
10699211|NCT02552121|11863487|FG002|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
10699212|NCT02552121|11863488|FG003|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
10699213|NCT02552121|11863489|FG004|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
10699214|NCT02552121|11863490|FG005|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
10699215|NCT02552121|11863491|FG006|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
10699216|NCT02552121|11863492|FG007|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
10699217|NCT02552121|11863485|FG000|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
10699218|NCT02552121|11863486|FG001|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
10699219|NCT02552121|11863487|FG002|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
10699220|NCT02552121|11863488|FG003|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
10699221|NCT02552121|11863489|FG004|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
10699222|NCT02552121|11863490|FG005|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
10699223|NCT02552121|11863491|FG006|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
10699224|NCT02552121|11863492|FG007|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
10699225|NCT02552121|11863485|FG000|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||3
10699226|NCT02552121|11863486|FG001|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
10699227|NCT02552121|11863487|FG002|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
10699228|NCT02552121|11863488|FG003|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
10699229|NCT02552121|11863489|FG004|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
10699230|NCT02552121|11863490|FG005|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
10699231|NCT02552121|11863491|FG006|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
10699232|NCT02552121|11863492|FG007|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
10699233|NCT02552121|11863485|FG000|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
10699234|NCT02552121|11863486|FG001|STARTED|Part 1: Dose Level 2 (Week 17-48)||6
10699235|NCT02552121|11863487|FG002|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
10699236|NCT02552121|11863488|FG003|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
10699237|NCT02552121|11863489|FG004|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
10699238|NCT02552121|11863490|FG005|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
10699239|NCT02552121|11863491|FG006|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
10699240|NCT02552121|11863492|FG007|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
10699241|NCT02552121|11863485|FG000|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
10699242|NCT02552121|11863486|FG001|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
10699243|NCT02552121|11863487|FG002|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
10699244|NCT02552121|11863488|FG003|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
10699245|NCT02552121|11863489|FG004|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
10699246|NCT02552121|11863490|FG005|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
10699247|NCT02552121|11863491|FG006|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
10699248|NCT02552121|11863492|FG007|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
10699249|NCT02552121|11863485|FG000|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
10699250|NCT02552121|11863486|FG001|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||6
10699251|NCT02552121|11863487|FG002|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
10699252|NCT02552121|11863488|FG003|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
10699253|NCT02552121|11863489|FG004|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
10699254|NCT02552121|11863490|FG005|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
10699255|NCT02552121|11863491|FG006|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
10699256|NCT02552121|11863492|FG007|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
10699257|NCT02552121|11863485|FG000|STARTED|Part 2: Cohort Expansion||0
10699258|NCT02552121|11863486|FG001|STARTED|Part 2: Cohort Expansion||0
10699259|NCT02552121|11863487|FG002|STARTED|Part 2: Cohort Expansion||11
10699260|NCT02552121|11863488|FG003|STARTED|Part 2: Cohort Expansion||3
10699261|NCT02552121|11863489|FG004|STARTED|Part 2: Cohort Expansion||1
10699262|NCT02552121|11863490|FG005|STARTED|Part 2: Cohort Expansion||5
10699263|NCT02552121|11863491|FG006|STARTED|Part 2: Cohort Expansion||1
10801578|NCT04339972|11962808|FG000|STARTED|Overall Study||15
10801579|NCT04339972|11962809|FG001|STARTED|Overall Study||14
10801580|NCT04339972|11962808|FG000|COMPLETED|Overall Study||10
10801581|NCT04339972|11962809|FG001|COMPLETED|Overall Study||9
10801582|NCT04339972|11962808|FG000|NOT COMPLETED|Overall Study||5
10801583|NCT04339972|11962809|FG001|NOT COMPLETED|Overall Study||5
10801584|NCT04339296|11962817|FG000|STARTED|Overall Study||24
10801585|NCT04339296|11962818|FG001|STARTED|Overall Study||26
10801586|NCT04339296|11962817|FG000|Completed Baseline|Overall Study||23
10801587|NCT04339296|11962818|FG001|Completed Baseline|Overall Study||25
10801588|NCT04339296|11962817|FG000|Received Allocated Intervention|Overall Study||21
10801589|NCT04339296|11962818|FG001|Received Allocated Intervention|Overall Study||24
10801590|NCT04339296|11962817|FG000|COMPLETED|Overall Study||16
10801591|NCT04339296|11962818|FG001|COMPLETED|Overall Study||17
10801592|NCT04339296|11962817|FG000|NOT COMPLETED|Overall Study||8
10801593|NCT04339296|11962818|FG001|NOT COMPLETED|Overall Study||9
10801594|NCT04338009|11962826|FG000|STARTED|Overall Study||77
10801595|NCT04338009|11962827|FG001|STARTED|Overall Study||75
10699264|NCT02552121|11863492|FG007|STARTED|Part 2: Cohort Expansion||3
10699265|NCT02552121|11863485|FG000|COMPLETED|Part 2: Cohort Expansion||0
10699266|NCT02552121|11863486|FG001|COMPLETED|Part 2: Cohort Expansion||0
10699267|NCT02552121|11863487|FG002|COMPLETED|Part 2: Cohort Expansion||0
10699268|NCT02552121|11863488|FG003|COMPLETED|Part 2: Cohort Expansion||0
10699269|NCT02552121|11863489|FG004|COMPLETED|Part 2: Cohort Expansion||0
10699270|NCT02552121|11863490|FG005|COMPLETED|Part 2: Cohort Expansion||1
10699271|NCT02552121|11863491|FG006|COMPLETED|Part 2: Cohort Expansion||0
10699272|NCT02552121|11863492|FG007|COMPLETED|Part 2: Cohort Expansion||0
10699273|NCT02552121|11863485|FG000|NOT COMPLETED|Part 2: Cohort Expansion||0
10699274|NCT02552121|11863486|FG001|NOT COMPLETED|Part 2: Cohort Expansion||0
10699275|NCT02552121|11863487|FG002|NOT COMPLETED|Part 2: Cohort Expansion||11
10699276|NCT02552121|11863488|FG003|NOT COMPLETED|Part 2: Cohort Expansion||3
10699277|NCT02552121|11863489|FG004|NOT COMPLETED|Part 2: Cohort Expansion||1
10699278|NCT02552121|11863490|FG005|NOT COMPLETED|Part 2: Cohort Expansion||4
10699279|NCT02552121|11863491|FG006|NOT COMPLETED|Part 2: Cohort Expansion||1
10699280|NCT02552121|11863492|FG007|NOT COMPLETED|Part 2: Cohort Expansion||3
10699281|NCT02552147|11863524|FG000|STARTED|First Intervention (7 Days)||4
10699282|NCT02552147|11863525|FG001|STARTED|First Intervention (7 Days)||4
10699283|NCT02552147|11863524|FG000|COMPLETED|First Intervention (7 Days)||3
10699284|NCT02552147|11863525|FG001|COMPLETED|First Intervention (7 Days)||4
10699285|NCT02552147|11863524|FG000|NOT COMPLETED|First Intervention (7 Days)||1
10699286|NCT02552147|11863525|FG001|NOT COMPLETED|First Intervention (7 Days)||0
10699287|NCT02552147|11863524|FG000|STARTED|Washout (7 Days)||3
10699288|NCT02552147|11863525|FG001|STARTED|Washout (7 Days)||4
10699289|NCT02552147|11863524|FG000|COMPLETED|Washout (7 Days)||3
10699290|NCT02552147|11863525|FG001|COMPLETED|Washout (7 Days)||4
10699291|NCT02552147|11863524|FG000|NOT COMPLETED|Washout (7 Days)||0
10699292|NCT02552147|11863525|FG001|NOT COMPLETED|Washout (7 Days)||0
10699293|NCT02552147|11863524|FG000|STARTED|Second Intervention (7 Days)||3
10699294|NCT02552147|11863525|FG001|STARTED|Second Intervention (7 Days)||4
10699295|NCT02552147|11863524|FG000|COMPLETED|Second Intervention (7 Days)||1
10699296|NCT02552147|11863525|FG001|COMPLETED|Second Intervention (7 Days)||4
10699297|NCT02552147|11863524|FG000|NOT COMPLETED|Second Intervention (7 Days)||2
10699298|NCT02552147|11863525|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
10699299|NCT02552225|11863533|FG000|STARTED|Overall Study||3
10699300|NCT02552225|11863534|FG001|STARTED|Overall Study||3
10699301|NCT02552225|11863533|FG000|COMPLETED|Overall Study||2
10699302|NCT02552225|11863534|FG001|COMPLETED|Overall Study||3
10699303|NCT02552225|11863533|FG000|NOT COMPLETED|Overall Study||1
10699304|NCT02552225|11863534|FG001|NOT COMPLETED|Overall Study||0
10699305|NCT02552238|11863540|FG000|STARTED|Overall Study||174
10699306|NCT02552238|11863540|FG000|COMPLETED|Overall Study|Of the 174 subjects enrolled in the study, 2 withdrew consent prior to administration of investigational product and 2 discontinued due to post-dose adverse event. Therefore, 170 subjects completed the study.|170
10699307|NCT02552238|11863540|FG000|NOT COMPLETED|Overall Study||4
10699308|NCT02552303|11863555|FG000|STARTED|Allocation||10
10699309|NCT02552303|11863556|FG001|STARTED|Allocation||10
10699310|NCT02552303|11863557|FG002|STARTED|Allocation||8
10699311|NCT02552303|11863558|FG003|STARTED|Allocation||11
10699312|NCT02552303|11863555|FG000|COMPLETED|Allocation||7
10699313|NCT02552303|11863556|FG001|COMPLETED|Allocation||8
10699314|NCT02552303|11863557|FG002|COMPLETED|Allocation||7
10699315|NCT02552303|11863558|FG003|COMPLETED|Allocation||10
10699316|NCT02552303|11863555|FG000|NOT COMPLETED|Allocation||3
10699317|NCT02552303|11863556|FG001|NOT COMPLETED|Allocation||2
10699318|NCT02552303|11863557|FG002|NOT COMPLETED|Allocation||1
10699319|NCT02552303|11863558|FG003|NOT COMPLETED|Allocation||1
10699320|NCT02552303|11863555|FG000|STARTED|Follow-Up||7
10699321|NCT02552303|11863556|FG001|STARTED|Follow-Up||8
10699322|NCT02552303|11863557|FG002|STARTED|Follow-Up||7
10699323|NCT02552303|11863558|FG003|STARTED|Follow-Up||10
10699324|NCT02552303|11863555|FG000|COMPLETED|Follow-Up||7
10699325|NCT02552303|11863556|FG001|COMPLETED|Follow-Up||6
10801596|NCT04338009|11962826|FG000|COMPLETED|Overall Study||77
10801597|NCT04338009|11962827|FG001|COMPLETED|Overall Study||75
10801598|NCT04338009|11962826|FG000|NOT COMPLETED|Overall Study||0
10801599|NCT04338009|11962827|FG001|NOT COMPLETED|Overall Study||0
10801600|NCT04338074|11962835|FG000|STARTED|Overall Study||3
10801601|NCT04338074|11962836|FG001|STARTED|Overall Study||2
10801602|NCT04338074|11962835|FG000|COMPLETED|Overall Study||3
10801603|NCT04338074|11962836|FG001|COMPLETED|Overall Study||2
10801604|NCT04338074|11962835|FG000|NOT COMPLETED|Overall Study||0
10801605|NCT04338074|11962836|FG001|NOT COMPLETED|Overall Study||0
10801606|NCT04337138|11962842|FG000|STARTED|Overall Study||32
10801607|NCT04337138|11962842|FG000|COMPLETED|Overall Study||32
10801608|NCT04337138|11962842|FG000|NOT COMPLETED|Overall Study||0
10801609|NCT04336475|11962848|FG000|STARTED|Overall Study||30
10801610|NCT04336475|11962849|FG001|STARTED|Overall Study||30
10801611|NCT04336475|11962848|FG000|COMPLETED|Overall Study||28
10801612|NCT04336475|11962849|FG001|COMPLETED|Overall Study||28
10801613|NCT04336475|11962848|FG000|NOT COMPLETED|Overall Study||2
10801614|NCT04336475|11962849|FG001|NOT COMPLETED|Overall Study||2
10699326|NCT02552303|11863557|FG002|COMPLETED|Follow-Up||6
10801615|NCT04335929|11962855|FG000|STARTED|Overall Study||32
10801616|NCT04335929|11962855|FG000|COMPLETED|Overall Study||22
10801617|NCT04335929|11962855|FG000|NOT COMPLETED|Overall Study||10
10801618|NCT04335812|11962861|FG000|STARTED|Overall Study||63
10699327|NCT02552303|11863558|FG003|COMPLETED|Follow-Up||10
10699328|NCT02552303|11863555|FG000|NOT COMPLETED|Follow-Up||0
10699329|NCT02552303|11863556|FG001|NOT COMPLETED|Follow-Up||2
10699330|NCT02552303|11863557|FG002|NOT COMPLETED|Follow-Up||1
10699331|NCT02552303|11863558|FG003|NOT COMPLETED|Follow-Up||0
10699332|NCT02552316|11863568|FG000|STARTED|Overall Study||34
10699333|NCT02552316|11863568|FG000|COMPLETED|Overall Study||32
10699334|NCT02552316|11863568|FG000|NOT COMPLETED|Overall Study||2
10699335|NCT02552355|11863620|FG000|STARTED|Overall Study||14
10699336|NCT02552355|11863621|FG001|STARTED|Overall Study||13
10699337|NCT02552355|11863622|FG002|STARTED|Overall Study||14
10699338|NCT02552355|11863623|FG003|STARTED|Overall Study||15
10699339|NCT02552355|11863620|FG000|COMPLETED|Overall Study||14
10699340|NCT02552355|11863621|FG001|COMPLETED|Overall Study||11
10699341|NCT02552355|11863622|FG002|COMPLETED|Overall Study||12
10699342|NCT02552355|11863623|FG003|COMPLETED|Overall Study||14
10699343|NCT02552355|11863620|FG000|NOT COMPLETED|Overall Study||0
10699344|NCT02552355|11863621|FG001|NOT COMPLETED|Overall Study||2
10699345|NCT02552355|11863622|FG002|NOT COMPLETED|Overall Study||2
10699346|NCT02552355|11863623|FG003|NOT COMPLETED|Overall Study||1
10699347|NCT02552368|11863633|FG000|STARTED|Overall Study||23
10699348|NCT02552368|11863633|FG000|COMPLETED|Overall Study||10
10699349|NCT02552368|11863633|FG000|NOT COMPLETED|Overall Study||13
10699350|NCT02552732|11863638|FG000|STARTED|Overall Study||29
10699351|NCT02552732|11863638|FG000|Used Device|Overall Study||23
10699352|NCT02552732|11863638|FG000|Completed Week 1|Overall Study||21
10699353|NCT02552732|11863638|FG000|Completed Week 2|Overall Study||20
10699354|NCT02552732|11863638|FG000|Completed Week 3|Overall Study||19
10699355|NCT02552732|11863638|FG000|Completed Week 4|Overall Study||19
10699356|NCT02552732|11863638|FG000|Completed Day 1 and Day 31 Spirometry|Overall Study||12
10699357|NCT02552732|11863638|FG000|COMPLETED|Overall Study||19
10699358|NCT02552732|11863638|FG000|NOT COMPLETED|Overall Study||10
10699359|NCT02552810|11863645|FG000|STARTED|Overall Study||15
10699360|NCT02552810|11863646|FG001|STARTED|Overall Study||15
10699361|NCT02552810|11863645|FG000|COMPLETED|Overall Study||15
10699362|NCT02552810|11863646|FG001|COMPLETED|Overall Study||15
10699363|NCT02552810|11863645|FG000|NOT COMPLETED|Overall Study||0
10699364|NCT02552810|11863646|FG001|NOT COMPLETED|Overall Study||0
10699365|NCT02552888|11863654|FG000|STARTED|Overall Study|35 participants were enrolled.|35
10699366|NCT02552888|11863655|FG001|STARTED|Overall Study|35 participants were enrolled.|35
10699367|NCT02552888|11863654|FG000|COMPLETED|Overall Study|34 participants completed the study.|34
10699368|NCT02552888|11863655|FG001|COMPLETED|Overall Study|34 participants completed the study|34
10699369|NCT02552888|11863654|FG000|NOT COMPLETED|Overall Study||1
10699370|NCT02552888|11863655|FG001|NOT COMPLETED|Overall Study||1
10713580|NCT02679911|11879087|FG000|STARTED|Overall Study|Intra-individual study|20
10713581|NCT02679911|11879087|FG000|COMPLETED|Overall Study||20
10713582|NCT02679911|11879087|FG000|NOT COMPLETED|Overall Study||0
10713583|NCT02679976|11879092|FG000|STARTED|Overall Study||30
10713584|NCT02679976|11879092|FG000|Hyperopes|Overall Study||16
10713585|NCT02679976|11879092|FG000|Myopes|Overall Study||14
10713586|NCT02679976|11879092|FG000|COMPLETED|Overall Study||30
10713587|NCT02679976|11879092|FG000|NOT COMPLETED|Overall Study||0
10713588|NCT02680002|11879103|FG000|STARTED|Overall Study||71
10713589|NCT02680002|11879104|FG001|STARTED|Overall Study||70
10713590|NCT02680002|11879105|FG002|STARTED|Overall Study||70
10713591|NCT02680002|11879106|FG003|STARTED|Overall Study||71
10713592|NCT02680002|11879107|FG004|STARTED|Overall Study||70
10713593|NCT02680002|11879108|FG005|STARTED|Overall Study||70
10713594|NCT02680002|11879103|FG000|Day 0 (Dose 1)|Overall Study||70
10713595|NCT02680002|11879104|FG001|Day 0 (Dose 1)|Overall Study||70
10713596|NCT02680002|11879105|FG002|Day 0 (Dose 1)|Overall Study||70
10713597|NCT02680002|11879106|FG003|Day 0 (Dose 1)|Overall Study||71
10713598|NCT02680002|11879107|FG004|Day 0 (Dose 1)|Overall Study||70
10713599|NCT02680002|11879108|FG005|Day 0 (Dose 1)|Overall Study||68
10713600|NCT02680002|11879103|FG000|Day 21 (Dose 2)|Overall Study||63
10713601|NCT02680002|11879104|FG001|Day 21 (Dose 2)|Overall Study||68
10713602|NCT02680002|11879105|FG002|Day 21 (Dose 2)|Overall Study||65
10713603|NCT02680002|11879106|FG003|Day 21 (Dose 2)|Overall Study||69
10713604|NCT02680002|11879107|FG004|Day 21 (Dose 2)|Overall Study||65
10713605|NCT02680002|11879108|FG005|Day 21 (Dose 2)|Overall Study||63
10713606|NCT02680002|11879103|FG000|Day 201|Overall Study||58
10713607|NCT02680002|11879104|FG001|Day 201|Overall Study||66
10801619|NCT04335812|11962862|FG001|STARTED|Overall Study||63
10801620|NCT04335812|11962861|FG000|COMPLETED|Overall Study||28
10801621|NCT04335812|11962862|FG001|COMPLETED|Overall Study||30
10801622|NCT04335812|11962861|FG000|NOT COMPLETED|Overall Study||35
10713608|NCT02680002|11879105|FG002|Day 201|Overall Study||60
10713609|NCT02680002|11879106|FG003|Day 201|Overall Study||67
10713610|NCT02680002|11879107|FG004|Day 201|Overall Study||59
10713611|NCT02680002|11879108|FG005|Day 201|Overall Study||61
10713612|NCT02680002|11879103|FG000|COMPLETED|Overall Study||58
10801623|NCT04335812|11962862|FG001|NOT COMPLETED|Overall Study||33
10713613|NCT02680002|11879104|FG001|COMPLETED|Overall Study||66
10713614|NCT02680002|11879105|FG002|COMPLETED|Overall Study||60
10713615|NCT02680002|11879106|FG003|COMPLETED|Overall Study||67
10713616|NCT02680002|11879107|FG004|COMPLETED|Overall Study||59
10713617|NCT02680002|11879108|FG005|COMPLETED|Overall Study||61
10713618|NCT02680002|11879103|FG000|NOT COMPLETED|Overall Study||13
10713619|NCT02680002|11879104|FG001|NOT COMPLETED|Overall Study||4
10713620|NCT02680002|11879105|FG002|NOT COMPLETED|Overall Study||10
10713621|NCT02680002|11879106|FG003|NOT COMPLETED|Overall Study||4
10713622|NCT02680002|11879107|FG004|NOT COMPLETED|Overall Study||11
10713623|NCT02680002|11879108|FG005|NOT COMPLETED|Overall Study||9
10699371|NCT02552966|11863665|FG000|STARTED|Overall Study||20
10699372|NCT02552966|11863665|FG000|COMPLETED|Overall Study||15
10699373|NCT02552966|11863665|FG000|NOT COMPLETED|Overall Study||5
10699374|NCT02553135|11863669|FG000|STARTED|Overall Study||6
10699375|NCT02553135|11863669|FG000|COMPLETED|Overall Study||6
10699376|NCT02553135|11863669|FG000|NOT COMPLETED|Overall Study||0
10699377|NCT02553317|11863675|FG000|STARTED|Overall Treatment Period + Follow-up||72
10699378|NCT02553317|11863676|FG001|STARTED|Overall Treatment Period + Follow-up||73
10699379|NCT02553317|11863675|FG000|Received Study Drug|Overall Treatment Period + Follow-up||71
10699380|NCT02553317|11863676|FG001|Received Study Drug|Overall Treatment Period + Follow-up||73
10699381|NCT02553317|11863675|FG000|COMPLETED|Overall Treatment Period + Follow-up||58
10699382|NCT02553317|11863676|FG001|COMPLETED|Overall Treatment Period + Follow-up||50
10699383|NCT02553317|11863675|FG000|NOT COMPLETED|Overall Treatment Period + Follow-up||14
10699384|NCT02553317|11863676|FG001|NOT COMPLETED|Overall Treatment Period + Follow-up||23
10699385|NCT02553317|11863675|FG000|STARTED|Double-blind (DB) Treatment Period|One patient withdrew consent prior to first dosing and did not start the DB treatment period.|71
10699386|NCT02553317|11863676|FG001|STARTED|Double-blind (DB) Treatment Period||73
10699387|NCT02553317|11863675|FG000|COMPLETED|Double-blind (DB) Treatment Period||68
10699388|NCT02553317|11863676|FG001|COMPLETED|Double-blind (DB) Treatment Period||65
10699389|NCT02553317|11863675|FG000|NOT COMPLETED|Double-blind (DB) Treatment Period||3
10699390|NCT02553317|11863676|FG001|NOT COMPLETED|Double-blind (DB) Treatment Period||8
10699391|NCT02553317|11863675|FG000|STARTED|Open-label (OL) Treatment Period|2 patients on caplacizumab had a recurrence of TTP during the DB period and started OL treatment.|2
10699392|NCT02553317|11863676|FG001|STARTED|Open-label (OL) Treatment Period|26 patients on placebo had a recurrence of TTP during the DB period and started OL treatment.|26
10699393|NCT02553317|11863675|FG000|COMPLETED|Open-label (OL) Treatment Period||2
10699394|NCT02553317|11863676|FG001|COMPLETED|Open-label (OL) Treatment Period||22
10699395|NCT02553317|11863675|FG000|NOT COMPLETED|Open-label (OL) Treatment Period||0
10699396|NCT02553317|11863676|FG001|NOT COMPLETED|Open-label (OL) Treatment Period||4
10699397|NCT02553330|11863686|FG000|STARTED|Overall Study||12
10699398|NCT02553330|11863687|FG001|STARTED|Overall Study||39
10699399|NCT02553330|11863688|FG002|STARTED|Overall Study||39
10699400|NCT02553330|11863686|FG000|COMPLETED|Overall Study||7
10699401|NCT02553330|11863687|FG001|COMPLETED|Overall Study||0
10699402|NCT02553330|11863688|FG002|COMPLETED|Overall Study||2
10699403|NCT02553330|11863686|FG000|NOT COMPLETED|Overall Study||5
10699404|NCT02553330|11863687|FG001|NOT COMPLETED|Overall Study||39
10699405|NCT02553330|11863688|FG002|NOT COMPLETED|Overall Study||37
10699406|NCT02553395|11863699|FG000|STARTED|First Intervention||12
10699407|NCT02553395|11863700|FG001|STARTED|First Intervention||18
10699408|NCT02553395|11863699|FG000|COMPLETED|First Intervention||12
10699409|NCT02553395|11863700|FG001|COMPLETED|First Intervention||18
10699410|NCT02553395|11863699|FG000|NOT COMPLETED|First Intervention||0
10699411|NCT02553395|11863700|FG001|NOT COMPLETED|First Intervention||0
10699412|NCT02553395|11863699|FG000|STARTED|Second Intervention||12
10699413|NCT02553395|11863700|FG001|STARTED|Second Intervention||18
10699414|NCT02553395|11863699|FG000|COMPLETED|Second Intervention||12
10699415|NCT02553395|11863700|FG001|COMPLETED|Second Intervention||18
10699416|NCT02553395|11863699|FG000|NOT COMPLETED|Second Intervention||0
10699417|NCT02553395|11863700|FG001|NOT COMPLETED|Second Intervention||0
10699418|NCT02553421|11863709|FG000|STARTED|Overall Study||185
10699419|NCT02553421|11863710|FG001|STARTED|Overall Study||58
10699420|NCT02553421|11863709|FG000|COMPLETED|Overall Study||156
10699421|NCT02553421|11863710|FG001|COMPLETED|Overall Study||57
10699422|NCT02553421|11863709|FG000|NOT COMPLETED|Overall Study||29
10699423|NCT02553421|11863710|FG001|NOT COMPLETED|Overall Study||1
10699424|NCT02553499|11863731|FG000|STARTED|Overall Study||2
10699425|NCT02553499|11863732|FG001|STARTED|Overall Study||2
10699426|NCT02553499|11863733|FG002|STARTED|Overall Study||2
10699427|NCT02553499|11863734|FG003|STARTED|Overall Study||2
10699428|NCT02553499|11863735|FG004|STARTED|Overall Study||3
10699429|NCT02553499|11863736|FG005|STARTED|Overall Study||3
10699430|NCT02553499|11863737|FG006|STARTED|Overall Study||3
10699431|NCT02553499|11863738|FG007|STARTED|Overall Study||3
10699432|NCT02553499|11863739|FG008|STARTED|Overall Study||3
10699433|NCT02553499|11863740|FG009|STARTED|Overall Study||3
10699434|NCT02553499|11863741|FG010|STARTED|Overall Study||3
10699435|NCT02553499|11863742|FG011|STARTED|Overall Study||3
10699436|NCT02553499|11863743|FG012|STARTED|Overall Study||3
10699437|NCT02553499|11863744|FG013|STARTED|Overall Study||2
10699438|NCT02553499|11863731|FG000|COMPLETED|Overall Study||0
10699439|NCT02553499|11863732|FG001|COMPLETED|Overall Study||0
10699440|NCT02553499|11863733|FG002|COMPLETED|Overall Study||0
10699441|NCT02553499|11863734|FG003|COMPLETED|Overall Study||0
10699442|NCT02553499|11863735|FG004|COMPLETED|Overall Study||0
10699443|NCT02553499|11863736|FG005|COMPLETED|Overall Study||0
10699444|NCT02553499|11863737|FG006|COMPLETED|Overall Study||0
10699445|NCT02553499|11863738|FG007|COMPLETED|Overall Study||0
10699446|NCT02553499|11863739|FG008|COMPLETED|Overall Study||0
10699447|NCT02553499|11863740|FG009|COMPLETED|Overall Study||0
10699448|NCT02553499|11863741|FG010|COMPLETED|Overall Study||0
10699449|NCT02553499|11863742|FG011|COMPLETED|Overall Study||0
10699450|NCT02553499|11863743|FG012|COMPLETED|Overall Study||0
10699451|NCT02553499|11863744|FG013|COMPLETED|Overall Study||0
10699452|NCT02553499|11863731|FG000|NOT COMPLETED|Overall Study||2
10699453|NCT02553499|11863732|FG001|NOT COMPLETED|Overall Study||2
10699454|NCT02553499|11863733|FG002|NOT COMPLETED|Overall Study||2
10699455|NCT02553499|11863734|FG003|NOT COMPLETED|Overall Study||2
10699456|NCT02553499|11863735|FG004|NOT COMPLETED|Overall Study||3
10699457|NCT02553499|11863736|FG005|NOT COMPLETED|Overall Study||3
10699458|NCT02553499|11863737|FG006|NOT COMPLETED|Overall Study||3
10699459|NCT02553499|11863738|FG007|NOT COMPLETED|Overall Study||3
10699460|NCT02553499|11863739|FG008|NOT COMPLETED|Overall Study||3
10699461|NCT02553499|11863740|FG009|NOT COMPLETED|Overall Study||3
10699462|NCT02553499|11863741|FG010|NOT COMPLETED|Overall Study||3
10699463|NCT02553499|11863742|FG011|NOT COMPLETED|Overall Study||3
10699464|NCT02553499|11863743|FG012|NOT COMPLETED|Overall Study||3
10699465|NCT02553499|11863744|FG013|NOT COMPLETED|Overall Study||2
10699466|NCT02553512|11863775|FG000|STARTED|Overall Study||167
10699467|NCT02553512|11863775|FG000|COMPLETED|Overall Study||144
10699468|NCT02553512|11863775|FG000|NOT COMPLETED|Overall Study||23
10699469|NCT02553538|11863781|FG000|STARTED|Overall Study||792
10699470|NCT02553538|11863782|FG001|STARTED|Overall Study||820
10699471|NCT02553538|11863781|FG000|COMPLETED|Overall Study||605
10699472|NCT02553538|11863782|FG001|COMPLETED|Overall Study||764
10699473|NCT02553538|11863781|FG000|NOT COMPLETED|Overall Study||187
10699474|NCT02553538|11863782|FG001|NOT COMPLETED|Overall Study||56
10699475|NCT02553629|11863790|FG000|STARTED|Overall Study||53
10699476|NCT02553629|11863791|FG001|STARTED|Overall Study||56
10699477|NCT02553629|11863790|FG000|COMPLETED|Overall Study||50
10699478|NCT02553629|11863791|FG001|COMPLETED|Overall Study||50
10699479|NCT02553629|11863790|FG000|NOT COMPLETED|Overall Study||3
10699480|NCT02553629|11863791|FG001|NOT COMPLETED|Overall Study||6
10699481|NCT02553746|11863799|FG000|STARTED|Overall Study||80
10699482|NCT02553746|11863800|FG001|STARTED|Overall Study||66
10699483|NCT02553746|11863799|FG000|COMPLETED|Overall Study||77
10699484|NCT02553746|11863800|FG001|COMPLETED|Overall Study||64
10699485|NCT02553746|11863799|FG000|NOT COMPLETED|Overall Study||3
10699486|NCT02553746|11863800|FG001|NOT COMPLETED|Overall Study||2
10699487|NCT02553772|11863808|FG000|STARTED|Overall Study||120
10699488|NCT02553772|11863809|FG001|STARTED|Overall Study||122
10699489|NCT02553772|11863808|FG000|COMPLETED|Overall Study||114
10699490|NCT02553772|11863809|FG001|COMPLETED|Overall Study||116
10699491|NCT02553772|11863808|FG000|NOT COMPLETED|Overall Study||6
10699492|NCT02553772|11863809|FG001|NOT COMPLETED|Overall Study||6
10699493|NCT02553798|11863815|FG000|STARTED|Overall Study||564
10699494|NCT02553798|11863815|FG000|COMPLETED|Overall Study||226
10699495|NCT02553798|11863815|FG000|NOT COMPLETED|Overall Study||338
10699496|NCT02553928|11863821|FG000|STARTED|Overall Study||30
10699497|NCT02553928|11863822|FG001|STARTED|Overall Study||32
10699498|NCT02553928|11863821|FG000|COMPLETED|Overall Study||28
10699499|NCT02553928|11863822|FG001|COMPLETED|Overall Study||29
10699500|NCT02553928|11863821|FG000|NOT COMPLETED|Overall Study||2
10699501|NCT02553928|11863822|FG001|NOT COMPLETED|Overall Study||3
10699502|NCT02554019|11863832|FG000|STARTED|Overall Study||12
10699503|NCT02554019|11863833|FG001|STARTED|Overall Study||12
10699504|NCT02554019|11863834|FG002|STARTED|Overall Study||12
10699505|NCT02554019|11863832|FG000|COMPLETED|Overall Study||10
10699506|NCT02554019|11863833|FG001|COMPLETED|Overall Study||12
10699507|NCT02554019|11863834|FG002|COMPLETED|Overall Study||10
10699508|NCT02554019|11863832|FG000|NOT COMPLETED|Overall Study||2
10699509|NCT02554019|11863833|FG001|NOT COMPLETED|Overall Study||0
10699510|NCT02554019|11863834|FG002|NOT COMPLETED|Overall Study||2
10699511|NCT02554279|11863844|FG000|STARTED|Overall Study||311
10699512|NCT02554279|11863845|FG001|STARTED|Overall Study||309
10699513|NCT02554279|11863844|FG000|Treated|Overall Study||310
10699514|NCT02554279|11863845|FG001|Treated|Overall Study||309
10699515|NCT02554279|11863844|FG000|Completed Day 6 of Stimulation|Overall Study||308
10699516|NCT02554279|11863845|FG001|Completed Day 6 of Stimulation|Overall Study||309
10699517|NCT02554279|11863844|FG000|Received Trigger|Overall Study||293
10699518|NCT02554279|11863845|FG001|Received Trigger|Overall Study||307
10699519|NCT02554279|11863844|FG000|Completed Oocyte Retrieval|Overall Study||292
10699520|NCT02554279|11863845|FG001|Completed Oocyte Retrieval|Overall Study||306
10699521|NCT02554279|11863844|FG000|Completed Fresh Blastocyst Transfer|Overall Study||201
10699522|NCT02554279|11863845|FG001|Completed Fresh Blastocyst Transfer|Overall Study||191
10699523|NCT02554279|11863844|FG000|COMPLETED|Overall Study||279
10699524|NCT02554279|11863845|FG001|COMPLETED|Overall Study||291
10699525|NCT02554279|11863844|FG000|NOT COMPLETED|Overall Study||32
10699526|NCT02554279|11863845|FG001|NOT COMPLETED|Overall Study||18
10699527|NCT02554435|11863860|FG000|STARTED|Overall Study||20
10699528|NCT02554435|11863861|FG001|STARTED|Overall Study||20
10699529|NCT02554435|11863860|FG000|COMPLETED|Overall Study||14
10699530|NCT02554435|11863861|FG001|COMPLETED|Overall Study||19
10699531|NCT02554435|11863860|FG000|NOT COMPLETED|Overall Study||6
10699532|NCT02554435|11863861|FG001|NOT COMPLETED|Overall Study||1
10699533|NCT02554513|11863868|FG000|STARTED|First Treatment Phase (7 Weeks)||3
10699534|NCT02554513|11863869|FG001|STARTED|First Treatment Phase (7 Weeks)||3
10699535|NCT02554513|11863868|FG000|COMPLETED|First Treatment Phase (7 Weeks)||3
10699536|NCT02554513|11863869|FG001|COMPLETED|First Treatment Phase (7 Weeks)||2
10699537|NCT02554513|11863868|FG000|NOT COMPLETED|First Treatment Phase (7 Weeks)||0
10699538|NCT02554513|11863869|FG001|NOT COMPLETED|First Treatment Phase (7 Weeks)||1
10699539|NCT02554513|11863868|FG000|STARTED|Washout (2 Weeks)||3
10699540|NCT02554513|11863869|FG001|STARTED|Washout (2 Weeks)||2
10699541|NCT02554513|11863868|FG000|COMPLETED|Washout (2 Weeks)||3
10699542|NCT02554513|11863869|FG001|COMPLETED|Washout (2 Weeks)||2
10699543|NCT02554513|11863868|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10699544|NCT02554513|11863869|FG001|NOT COMPLETED|Washout (2 Weeks)||0
10699545|NCT02554513|11863868|FG000|STARTED|Second Treatment Phase (7 Weeks)||3
10699546|NCT02554513|11863869|FG001|STARTED|Second Treatment Phase (7 Weeks)||2
10699547|NCT02554513|11863868|FG000|COMPLETED|Second Treatment Phase (7 Weeks)||3
10699548|NCT02554513|11863869|FG001|COMPLETED|Second Treatment Phase (7 Weeks)||2
10699549|NCT02554513|11863868|FG000|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0
10699550|NCT02554513|11863869|FG001|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0
10699551|NCT02554656|11863881|FG000|STARTED|Overall Study||89
10699552|NCT02554656|11863881|FG000|COMPLETED|Overall Study||86
10699553|NCT02554656|11863881|FG000|NOT COMPLETED|Overall Study||3
10699554|NCT02554682|11863895|FG000|STARTED|Overall Study||40
10699555|NCT02554682|11863896|FG001|STARTED|Overall Study||40
10699556|NCT02554682|11863897|FG002|STARTED|Overall Study||40
10699557|NCT02554682|11863898|FG003|STARTED|Overall Study||40
10699558|NCT02554682|11863899|FG004|STARTED|Overall Study||40
10699559|NCT02554682|11863900|FG005|STARTED|Overall Study||40
10699560|NCT02554682|11863901|FG006|STARTED|Overall Study||28
10699561|NCT02554682|11863902|FG007|STARTED|Overall Study||28
10699562|NCT02554682|11863903|FG008|STARTED|Overall Study||26
10699563|NCT02554682|11863904|FG009|STARTED|Overall Study||26
10699564|NCT02554682|11863895|FG000|COMPLETED|Overall Study||25
10699565|NCT02554682|11863896|FG001|COMPLETED|Overall Study||28
10699566|NCT02554682|11863897|FG002|COMPLETED|Overall Study||36
10699567|NCT02554682|11863898|FG003|COMPLETED|Overall Study||37
10699568|NCT02554682|11863899|FG004|COMPLETED|Overall Study||38
10699569|NCT02554682|11863900|FG005|COMPLETED|Overall Study||39
10699570|NCT02554682|11863901|FG006|COMPLETED|Overall Study||22
10699571|NCT02554682|11863902|FG007|COMPLETED|Overall Study||22
10699572|NCT02554682|11863903|FG008|COMPLETED|Overall Study||24
10699573|NCT02554682|11863904|FG009|COMPLETED|Overall Study||24
10699574|NCT02554682|11863895|FG000|NOT COMPLETED|Overall Study||15
10699575|NCT02554682|11863896|FG001|NOT COMPLETED|Overall Study||12
10699576|NCT02554682|11863897|FG002|NOT COMPLETED|Overall Study||4
10699577|NCT02554682|11863898|FG003|NOT COMPLETED|Overall Study||3
10699578|NCT02554682|11863899|FG004|NOT COMPLETED|Overall Study||2
10699579|NCT02554682|11863900|FG005|NOT COMPLETED|Overall Study||1
10699580|NCT02554682|11863901|FG006|NOT COMPLETED|Overall Study||6
10699581|NCT02554682|11863902|FG007|NOT COMPLETED|Overall Study||6
10699582|NCT02554682|11863903|FG008|NOT COMPLETED|Overall Study||2
10699583|NCT02554682|11863904|FG009|NOT COMPLETED|Overall Study||2
10699584|NCT02554721|11863934|FG000|STARTED|Overall Study||20
10699585|NCT02554721|11863935|FG001|STARTED|Overall Study||19
10699586|NCT02554721|11863936|FG002|STARTED|Overall Study||19
10699587|NCT02554721|11863937|FG003|STARTED|Overall Study||17
10699588|NCT02554721|11863938|FG004|STARTED|Overall Study||2
10699589|NCT02554721|11863934|FG000|COMPLETED|Overall Study||19
10699590|NCT02554721|11863935|FG001|COMPLETED|Overall Study||19
10699591|NCT02554721|11863936|FG002|COMPLETED|Overall Study||19
10699592|NCT02554721|11863937|FG003|COMPLETED|Overall Study||17
10699593|NCT02554721|11863938|FG004|COMPLETED|Overall Study||0
10699594|NCT02554721|11863934|FG000|NOT COMPLETED|Overall Study||1
10699595|NCT02554721|11863935|FG001|NOT COMPLETED|Overall Study||0
10699596|NCT02554721|11863936|FG002|NOT COMPLETED|Overall Study||0
10699597|NCT02554721|11863937|FG003|NOT COMPLETED|Overall Study||0
10699598|NCT02554721|11863938|FG004|NOT COMPLETED|Overall Study||2
10699599|NCT02554760|11863947|FG000|STARTED|Overall Study||9
10699600|NCT02554760|11863948|FG001|STARTED|Overall Study||10
10699601|NCT02554760|11863947|FG000|COMPLETED|Overall Study||9
10699602|NCT02554760|11863948|FG001|COMPLETED|Overall Study||10
10699603|NCT02554760|11863947|FG000|NOT COMPLETED|Overall Study||0
10699604|NCT02554760|11863948|FG001|NOT COMPLETED|Overall Study||0
10699605|NCT02554786|11863962|FG000|STARTED|Overall Study||445
10699606|NCT02554786|11863963|FG001|STARTED|Overall Study||439
10699607|NCT02554786|11863964|FG002|STARTED|Overall Study||442
10699608|NCT02554786|11863965|FG003|STARTED|Overall Study||444
10699609|NCT02554786|11863966|FG004|STARTED|Overall Study||446
10699610|NCT02554786|11863962|FG000|COMPLETED|Overall Study||410
10699611|NCT02554786|11863963|FG001|COMPLETED|Overall Study||413
10699612|NCT02554786|11863964|FG002|COMPLETED|Overall Study||412
10699613|NCT02554786|11863965|FG003|COMPLETED|Overall Study||403
10699614|NCT02554786|11863966|FG004|COMPLETED|Overall Study||416
10699615|NCT02554786|11863962|FG000|NOT COMPLETED|Overall Study||35
10699616|NCT02554786|11863963|FG001|NOT COMPLETED|Overall Study||26
10699617|NCT02554786|11863964|FG002|NOT COMPLETED|Overall Study||30
10699618|NCT02554786|11863965|FG003|NOT COMPLETED|Overall Study||41
10699619|NCT02554786|11863966|FG004|NOT COMPLETED|Overall Study||30
10699620|NCT02554799|11863984|FG000|STARTED|Overall Study||9
10699621|NCT02554799|11863985|FG001|STARTED|Overall Study||9
10699622|NCT02554799|11863984|FG000|COMPLETED|Overall Study||9
10699623|NCT02554799|11863985|FG001|COMPLETED|Overall Study||9
10699624|NCT02554799|11863984|FG000|NOT COMPLETED|Overall Study||0
10699625|NCT02554799|11863985|FG001|NOT COMPLETED|Overall Study||0
10699626|NCT02554877|11863995|FG000|STARTED|Overall Study||51
10699627|NCT02554877|11863996|FG001|STARTED|Overall Study||51
10699628|NCT02554877|11863997|FG002|STARTED|Overall Study||52
10699629|NCT02554877|11863998|FG003|STARTED|Overall Study||52
10699630|NCT02554877|11863995|FG000|COMPLETED|Overall Study||39
10699631|NCT02554877|11863996|FG001|COMPLETED|Overall Study||44
10699632|NCT02554877|11863997|FG002|COMPLETED|Overall Study||46
10699633|NCT02554877|11863998|FG003|COMPLETED|Overall Study||45
10699634|NCT02554877|11863995|FG000|NOT COMPLETED|Overall Study||12
10699635|NCT02554877|11863996|FG001|NOT COMPLETED|Overall Study||7
10699636|NCT02554877|11863997|FG002|NOT COMPLETED|Overall Study||6
10699637|NCT02554877|11863998|FG003|NOT COMPLETED|Overall Study||7
10699638|NCT02554890|11864010|FG000|STARTED|Double-blind||444
10699639|NCT02554890|11864011|FG001|STARTED|Double-blind||443
10699640|NCT02554890|11864010|FG000|Treated Patients|Double-blind||436
10699641|NCT02554890|11864011|FG001|Treated Patients|Double-blind||439
10699642|NCT02554890|11864010|FG000|COMPLETED|Double-blind||348
10699643|NCT02554890|11864011|FG001|COMPLETED|Double-blind||352
10699644|NCT02554890|11864010|FG000|NOT COMPLETED|Double-blind||96
10699645|NCT02554890|11864011|FG001|NOT COMPLETED|Double-blind||91
10699646|NCT02554890|11864010|FG000|STARTED|Open-label||0
10699647|NCT02554890|11864011|FG001|STARTED|Open-label||887
10699648|NCT02554890|11864010|FG000|COMPLETED|Open-label||0
10699649|NCT02554890|11864011|FG001|COMPLETED|Open-label||835
10699650|NCT02554890|11864010|FG000|NOT COMPLETED|Open-label||0
10699651|NCT02554890|11864011|FG001|NOT COMPLETED|Open-label||52
10699652|NCT02554903|11864021|FG000|STARTED|Overall Study||28
10699653|NCT02554903|11864022|FG001|STARTED|Overall Study||29
10699654|NCT02554903|11864021|FG000|COMPLETED|Overall Study||24
10699655|NCT02554903|11864022|FG001|COMPLETED|Overall Study||24
10699656|NCT02554903|11864021|FG000|NOT COMPLETED|Overall Study||4
10699657|NCT02554903|11864022|FG001|NOT COMPLETED|Overall Study||5
10699658|NCT02554929|11864031|FG000|STARTED|Overall Study||46
10699659|NCT02554929|11864032|FG001|STARTED|Overall Study||44
10699660|NCT02554929|11864031|FG000|Per Protocol Received Intervention|Overall Study||44
10699661|NCT02554929|11864032|FG001|Per Protocol Received Intervention|Overall Study||36
10699662|NCT02554929|11864031|FG000|Per Protocol Post-Intervention|Overall Study||42
10699663|NCT02554929|11864032|FG001|Per Protocol Post-Intervention|Overall Study||36
10699664|NCT02554929|11864031|FG000|Per Protocol 6 Month Follow-up|Overall Study||40
10699665|NCT02554929|11864032|FG001|Per Protocol 6 Month Follow-up|Overall Study||32
10699666|NCT02554929|11864031|FG000|COMPLETED|Overall Study||40
10699667|NCT02554929|11864032|FG001|COMPLETED|Overall Study||32
10699668|NCT02554929|11864031|FG000|NOT COMPLETED|Overall Study||6
10699669|NCT02554929|11864032|FG001|NOT COMPLETED|Overall Study||12
10699670|NCT02554981|11864038|FG000|STARTED|Overall Study||51
10699671|NCT02554981|11864038|FG000|COMPLETED|Overall Study||46
10699672|NCT02554981|11864038|FG000|NOT COMPLETED|Overall Study||5
10699673|NCT02555098|11864042|FG000|STARTED|First Intervention||12
10699674|NCT02555098|11864043|FG001|STARTED|First Intervention||11
10699675|NCT02555098|11864042|FG000|COMPLETED|First Intervention||12
10699676|NCT02555098|11864043|FG001|COMPLETED|First Intervention||11
10699677|NCT02555098|11864042|FG000|NOT COMPLETED|First Intervention||0
10699678|NCT02555098|11864043|FG001|NOT COMPLETED|First Intervention||0
10699679|NCT02555098|11864042|FG000|STARTED|Second Intervention||12
10699680|NCT02555098|11864043|FG001|STARTED|Second Intervention||11
10699681|NCT02555098|11864042|FG000|COMPLETED|Second Intervention||12
10699682|NCT02555098|11864043|FG001|COMPLETED|Second Intervention||11
10699683|NCT02555098|11864042|FG000|NOT COMPLETED|Second Intervention||0
10699684|NCT02555098|11864043|FG001|NOT COMPLETED|Second Intervention||0
10699685|NCT02555215|11864053|FG000|STARTED|Overall Study||20
10699686|NCT02555215|11864053|FG000|COMPLETED|Overall Study||17
10699687|NCT02555215|11864053|FG000|NOT COMPLETED|Overall Study||3
10699688|NCT02555228|11864059|FG000|STARTED|Overall Study|20th August 2015|27
10699689|NCT02555228|11864060|FG001|STARTED|Overall Study|14th August 2015|27
10699690|NCT02555228|11864059|FG000|COMPLETED|Overall Study|19th November 2015|27
10699691|NCT02555228|11864060|FG001|COMPLETED|Overall Study|29th October 2015|27
10699692|NCT02555228|11864059|FG000|NOT COMPLETED|Overall Study||0
10699693|NCT02555228|11864060|FG001|NOT COMPLETED|Overall Study||0
10699694|NCT02555306|11864070|FG000|STARTED|Overall Study||3
10699695|NCT02555306|11864071|FG001|STARTED|Overall Study||3
10699696|NCT02555306|11864072|FG002|STARTED|Overall Study||3
10699697|NCT02555306|11864073|FG003|STARTED|Overall Study||3
10699698|NCT02555306|11864070|FG000|COMPLETED|Overall Study||3
10699699|NCT02555306|11864071|FG001|COMPLETED|Overall Study||3
10699700|NCT02555306|11864072|FG002|COMPLETED|Overall Study||3
10699701|NCT02555306|11864073|FG003|COMPLETED|Overall Study||3
10699702|NCT02555306|11864070|FG000|NOT COMPLETED|Overall Study||0
10699703|NCT02555306|11864071|FG001|NOT COMPLETED|Overall Study||0
10699704|NCT02555306|11864072|FG002|NOT COMPLETED|Overall Study||0
10699705|NCT02555306|11864073|FG003|NOT COMPLETED|Overall Study||0
10699706|NCT02555371|11864083|FG000|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||306
10699707|NCT02555371|11864084|FG001|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
10699708|NCT02555371|11864085|FG002|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
10699709|NCT02555371|11864086|FG003|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
10699710|NCT02555371|11864087|FG004|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
10699711|NCT02555371|11864083|FG000|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||295
10699712|NCT02555371|11864084|FG001|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
10699713|NCT02555371|11864085|FG002|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
10699714|NCT02555371|11864086|FG003|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
10699715|NCT02555371|11864087|FG004|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
10699716|NCT02555371|11864083|FG000|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||11
10699717|NCT02555371|11864084|FG001|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
10699718|NCT02555371|11864085|FG002|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
10699719|NCT02555371|11864086|FG003|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
10699720|NCT02555371|11864087|FG004|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
10699721|NCT02555371|11864083|FG000|STARTED|Part C (DB Period: Up to 52W)||0
10699722|NCT02555371|11864084|FG001|STARTED|Part C (DB Period: Up to 52W)||151
10699723|NCT02555371|11864085|FG002|STARTED|Part C (DB Period: Up to 52W)||144
10801624|NCT04335136|11962870|FG000|STARTED|Overall Study||91
10801625|NCT04335136|11962871|FG001|STARTED|Overall Study||90
10801626|NCT04335136|11962870|FG000|Treated|Overall Study||88
10801627|NCT04335136|11962871|FG001|Treated|Overall Study||90
10801628|NCT04335136|11962870|FG000|COMPLETED|Overall Study||77
10801629|NCT04335136|11962871|FG001|COMPLETED|Overall Study||83
10801630|NCT04335136|11962870|FG000|NOT COMPLETED|Overall Study||14
10699724|NCT02555371|11864086|FG003|STARTED|Part C (DB Period: Up to 52W)||0
10699725|NCT02555371|11864087|FG004|STARTED|Part C (DB Period: Up to 52W)||0
10699726|NCT02555371|11864083|FG000|COMPLETED|Part C (DB Period: Up to 52W)||0
10699727|NCT02555371|11864084|FG001|COMPLETED|Part C (DB Period: Up to 52W)||62
10699728|NCT02555371|11864085|FG002|COMPLETED|Part C (DB Period: Up to 52W)||96
10699729|NCT02555371|11864086|FG003|COMPLETED|Part C (DB Period: Up to 52W)||0
10699730|NCT02555371|11864087|FG004|COMPLETED|Part C (DB Period: Up to 52W)||0
10699731|NCT02555371|11864083|FG000|NOT COMPLETED|Part C (DB Period: Up to 52W)||0
10699732|NCT02555371|11864084|FG001|NOT COMPLETED|Part C (DB Period: Up to 52W)||89
10699733|NCT02555371|11864085|FG002|NOT COMPLETED|Part C (DB Period: Up to 52W)||48
10699734|NCT02555371|11864086|FG003|NOT COMPLETED|Part C (DB Period: Up to 52W)||0
10699735|NCT02555371|11864087|FG004|NOT COMPLETED|Part C (DB Period: Up to 52W)||0
10699736|NCT02555371|11864083|FG000|STARTED|PartD(OL: 52W Post-randomization PartC)||0
10699737|NCT02555371|11864084|FG001|STARTED|PartD(OL: 52W Post-randomization PartC)||0
10699738|NCT02555371|11864085|FG002|STARTED|PartD(OL: 52W Post-randomization PartC)||0
10699739|NCT02555371|11864086|FG003|STARTED|PartD(OL: 52W Post-randomization PartC)||84
10699740|NCT02555371|11864087|FG004|STARTED|PartD(OL: 52W Post-randomization PartC)||45
10699741|NCT02555371|11864083|FG000|COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
10699742|NCT02555371|11864084|FG001|COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
10699743|NCT02555371|11864085|FG002|COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
10699744|NCT02555371|11864086|FG003|COMPLETED|PartD(OL: 52W Post-randomization PartC)||80
10699745|NCT02555371|11864087|FG004|COMPLETED|PartD(OL: 52W Post-randomization PartC)||42
10699746|NCT02555371|11864083|FG000|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
10699747|NCT02555371|11864084|FG001|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
10699748|NCT02555371|11864085|FG002|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
10699749|NCT02555371|11864086|FG003|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||4
10699750|NCT02555371|11864087|FG004|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||3
10699751|NCT02555449|11864096|FG000|STARTED|Overall Study||6
10699752|NCT02555449|11864096|FG000|COMPLETED|Overall Study||6
10699753|NCT02555449|11864096|FG000|NOT COMPLETED|Overall Study||0
10699754|NCT02555618|11864102|FG000|STARTED|Overall Study||200
10699755|NCT02555618|11864103|FG001|STARTED|Overall Study||200
10699756|NCT02555618|11864102|FG000|COMPLETED|Overall Study||199
10699757|NCT02555618|11864103|FG001|COMPLETED|Overall Study||200
10699758|NCT02555618|11864102|FG000|NOT COMPLETED|Overall Study||1
10699759|NCT02555618|11864103|FG001|NOT COMPLETED|Overall Study||0
10699760|NCT02555631|11864109|FG000|STARTED|Overall Study||29
10699761|NCT02555631|11864109|FG000|COMPLETED|Overall Study||25
10699762|NCT02555631|11864109|FG000|NOT COMPLETED|Overall Study||4
10699763|NCT02555683|11864116|FG000|STARTED|Overall Study||301
10699764|NCT02555683|11864117|FG001|STARTED|Overall Study||295
10699765|NCT02555683|11864118|FG002|STARTED|Overall Study||298
10699766|NCT02555683|11864116|FG000|FAS/SAF: High Eosinophil Subpopulation|Overall Study||200
10699767|NCT02555683|11864117|FG001|FAS/SAF: High Eosinophil Subpopulation|Overall Study||201
10699768|NCT02555683|11864118|FG002|FAS/SAF: High Eosinophil Subpopulation|Overall Study||201
10699769|NCT02555683|11864116|FG000|FAS/SAF: Overall Population|Overall Study||299
10699770|NCT02555683|11864117|FG001|FAS/SAF: Overall Population|Overall Study||293
10699771|NCT02555683|11864118|FG002|FAS/SAF: Overall Population|Overall Study||298
10801631|NCT04335136|11962871|FG001|NOT COMPLETED|Overall Study||7
10699772|NCT02555683|11864116|FG000|COMPLETED|Overall Study||282
10699773|NCT02555683|11864117|FG001|COMPLETED|Overall Study||278
10699774|NCT02555683|11864118|FG002|COMPLETED|Overall Study||269
10699775|NCT02555683|11864116|FG000|NOT COMPLETED|Overall Study||19
10699776|NCT02555683|11864117|FG001|NOT COMPLETED|Overall Study||17
10699777|NCT02555683|11864118|FG002|NOT COMPLETED|Overall Study||29
10699778|NCT02555722|11864128|FG000|STARTED|Lens Dispensed||60
10699779|NCT02555722|11864129|FG001|STARTED|Lens Dispensed||30
10699780|NCT02555722|11864128|FG000|COMPLETED|Lens Dispensed||60
10699781|NCT02555722|11864129|FG001|COMPLETED|Lens Dispensed||30
10699782|NCT02555722|11864128|FG000|NOT COMPLETED|Lens Dispensed||0
10699783|NCT02555722|11864129|FG001|NOT COMPLETED|Lens Dispensed||0
10699784|NCT02555722|11864128|FG000|STARTED|Week 1||60
10699785|NCT02555722|11864129|FG001|STARTED|Week 1||30
10699786|NCT02555722|11864128|FG000|COMPLETED|Week 1||60
10699787|NCT02555722|11864129|FG001|COMPLETED|Week 1||30
10699788|NCT02555722|11864128|FG000|NOT COMPLETED|Week 1||0
10699789|NCT02555722|11864129|FG001|NOT COMPLETED|Week 1||0
10699790|NCT02555722|11864128|FG000|STARTED|Week 2||60
10801632|NCT04335552|11962881|FG000|STARTED|Overall Study||2
10801633|NCT04335552|11962882|FG001|STARTED|Overall Study||4
10801634|NCT04335552|11962883|FG002|STARTED|Overall Study||3
10801635|NCT04335552|11962884|FG003|STARTED|Overall Study||2
10699791|NCT02555722|11864129|FG001|STARTED|Week 2||30
10801636|NCT04335552|11962881|FG000|COMPLETED|Overall Study||1
10699792|NCT02555722|11864128|FG000|COMPLETED|Week 2||59
10699793|NCT02555722|11864129|FG001|COMPLETED|Week 2||29
10699794|NCT02555722|11864128|FG000|NOT COMPLETED|Week 2||1
10699795|NCT02555722|11864129|FG001|NOT COMPLETED|Week 2||1
10699796|NCT02555722|11864128|FG000|STARTED|Month 1||59
10801637|NCT04335552|11962882|FG001|COMPLETED|Overall Study||4
10699797|NCT02555722|11864129|FG001|STARTED|Month 1||29
10699798|NCT02555722|11864128|FG000|COMPLETED|Month 1||58
10699799|NCT02555722|11864129|FG001|COMPLETED|Month 1||29
10699800|NCT02555722|11864128|FG000|NOT COMPLETED|Month 1||1
10699801|NCT02555722|11864129|FG001|NOT COMPLETED|Month 1||0
10699802|NCT02555722|11864128|FG000|STARTED|Month 2||58
10699803|NCT02555722|11864129|FG001|STARTED|Month 2||29
10699804|NCT02555722|11864128|FG000|COMPLETED|Month 2||54
10699805|NCT02555722|11864129|FG001|COMPLETED|Month 2||29
10699806|NCT02555722|11864128|FG000|NOT COMPLETED|Month 2||4
10699807|NCT02555722|11864129|FG001|NOT COMPLETED|Month 2||0
10699808|NCT02555722|11864128|FG000|STARTED|Month 3||54
10699809|NCT02555722|11864129|FG001|STARTED|Month 3||29
10699810|NCT02555722|11864128|FG000|COMPLETED|Month 3||54
10699811|NCT02555722|11864129|FG001|COMPLETED|Month 3||29
10699812|NCT02555722|11864128|FG000|NOT COMPLETED|Month 3||0
10699813|NCT02555722|11864129|FG001|NOT COMPLETED|Month 3||0
10699814|NCT02555878|11864160|FG000|STARTED|Overall Study||421
10699815|NCT02555878|11864161|FG001|STARTED|Overall Study||420
10699816|NCT02555878|11864160|FG000|Treated|Overall Study||404
10699817|NCT02555878|11864161|FG001|Treated|Overall Study||405
10699818|NCT02555878|11864160|FG000|COMPLETED|Overall Study||255
10699819|NCT02555878|11864161|FG001|COMPLETED|Overall Study||270
10699820|NCT02555878|11864160|FG000|NOT COMPLETED|Overall Study||166
10699821|NCT02555878|11864161|FG001|NOT COMPLETED|Overall Study||150
10699822|NCT02555930|11864167|FG000|STARTED|Overall Study||148
10699823|NCT02555930|11864167|FG000|COMPLETED|Overall Study||148
10699824|NCT02555930|11864167|FG000|NOT COMPLETED|Overall Study||0
10699825|NCT02556112|11864175|FG000|STARTED|Overall Study||40
10699826|NCT02556112|11864176|FG001|STARTED|Overall Study||40
10699827|NCT02556112|11864177|FG002|STARTED|Overall Study||42
10699828|NCT02556112|11864175|FG000|COMPLETED|Overall Study||30
10699829|NCT02556112|11864176|FG001|COMPLETED|Overall Study||23
10699830|NCT02556112|11864177|FG002|COMPLETED|Overall Study||30
10699831|NCT02556112|11864175|FG000|NOT COMPLETED|Overall Study||10
10699832|NCT02556112|11864176|FG001|NOT COMPLETED|Overall Study||17
10699833|NCT02556112|11864177|FG002|NOT COMPLETED|Overall Study||12
10699834|NCT02556138|11864186|FG000|STARTED|Overall Study||8
10699835|NCT02556138|11864186|FG000|COMPLETED|Overall Study|One patient withdrew from the study due to intolerance of the balloon after 1 month.|7
10699836|NCT02556138|11864186|FG000|NOT COMPLETED|Overall Study||1
10699837|NCT02556177|11864192|FG000|STARTED|Overall Study||325
10699838|NCT02556177|11864193|FG001|STARTED|Overall Study||152
10699839|NCT02556177|11864192|FG000|COMPLETED|Overall Study||42
10699840|NCT02556177|11864193|FG001|COMPLETED|Overall Study||91
10699841|NCT02556177|11864192|FG000|NOT COMPLETED|Overall Study||283
10699842|NCT02556177|11864193|FG001|NOT COMPLETED|Overall Study||61
10699843|NCT02556203|11864201|FG000|STARTED|Overall Study||826
10699844|NCT02556203|11864202|FG001|STARTED|Overall Study||818
10699845|NCT02556203|11864201|FG000|Received Treatment|Overall Study||801
10699846|NCT02556203|11864202|FG001|Received Treatment|Overall Study||807
10699847|NCT02556203|11864201|FG000|COMPLETED|Overall Study||799
10699848|NCT02556203|11864202|FG001|COMPLETED|Overall Study||792
10699849|NCT02556203|11864201|FG000|NOT COMPLETED|Overall Study||27
10699850|NCT02556203|11864202|FG001|NOT COMPLETED|Overall Study||26
10699851|NCT02556255|11864208|FG000|STARTED|Overall Study||50
10699852|NCT02556255|11864208|FG000|COMPLETED|Overall Study||46
10699853|NCT02556255|11864208|FG000|NOT COMPLETED|Overall Study||4
10699854|NCT02556307|11864212|FG000|STARTED|Overall Study||270
10699855|NCT02556307|11864212|FG000|Treated|Overall Study||268
10699856|NCT02556307|11864212|FG000|COMPLETED|Overall Study||217
10699857|NCT02556307|11864212|FG000|NOT COMPLETED|Overall Study||53
10699858|NCT02556333|11864216|FG000|STARTED|Overall Study||1
10699859|NCT02556333|11864216|FG000|COMPLETED|Overall Study||1
10699860|NCT02556333|11864216|FG000|NOT COMPLETED|Overall Study||0
10699861|NCT02556554|11864223|FG000|STARTED|Overall Study||8
10699862|NCT02556554|11864224|FG001|STARTED|Overall Study||14
10699863|NCT02556554|11864225|FG002|STARTED|Overall Study||19
10699864|NCT02556554|11864226|FG003|STARTED|Overall Study||12
10801638|NCT04335552|11962883|FG002|COMPLETED|Overall Study||3
10801639|NCT04335552|11962884|FG003|COMPLETED|Overall Study||2
10801640|NCT04335552|11962881|FG000|NOT COMPLETED|Overall Study||1
10801641|NCT04335552|11962882|FG001|NOT COMPLETED|Overall Study||0
10801642|NCT04335552|11962883|FG002|NOT COMPLETED|Overall Study||0
10801643|NCT04335552|11962884|FG003|NOT COMPLETED|Overall Study||0
10801644|NCT04334876|11962894|FG000|STARTED|Overall Study||571
10801645|NCT04334876|11962894|FG000|COMPLETED|Overall Study||500
10801646|NCT04334876|11962894|FG000|NOT COMPLETED|Overall Study||71
10801647|NCT04334681|11962900|FG000|STARTED|Overall Study||135
10699865|NCT02556554|11864227|FG004|STARTED|Overall Study||14
10699866|NCT02556554|11864223|FG000|COMPLETED|Overall Study||8
10699867|NCT02556554|11864224|FG001|COMPLETED|Overall Study||13
10699868|NCT02556554|11864225|FG002|COMPLETED|Overall Study||15
10699869|NCT02556554|11864226|FG003|COMPLETED|Overall Study||12
10699870|NCT02556554|11864227|FG004|COMPLETED|Overall Study||14
10699871|NCT02556554|11864223|FG000|NOT COMPLETED|Overall Study||0
10801648|NCT04334681|11962901|FG001|STARTED|Overall Study||143
10699872|NCT02556554|11864224|FG001|NOT COMPLETED|Overall Study||1
10699873|NCT02556554|11864225|FG002|NOT COMPLETED|Overall Study||4
10699874|NCT02556554|11864226|FG003|NOT COMPLETED|Overall Study||0
10699875|NCT02556554|11864227|FG004|NOT COMPLETED|Overall Study||0
10699876|NCT02556632|11864241|FG000|STARTED|Overall Study||64
10699877|NCT02556632|11864242|FG001|STARTED|Overall Study||65
10699878|NCT02556632|11864243|FG002|STARTED|Overall Study||62
10699879|NCT02556632|11864241|FG000|COMPLETED|Overall Study||59
10699880|NCT02556632|11864242|FG001|COMPLETED|Overall Study||59
10699881|NCT02556632|11864243|FG002|COMPLETED|Overall Study||53
10699882|NCT02556632|11864241|FG000|NOT COMPLETED|Overall Study||5
10699883|NCT02556632|11864242|FG001|NOT COMPLETED|Overall Study||6
10699884|NCT02556632|11864243|FG002|NOT COMPLETED|Overall Study||9
10699885|NCT02556775|11864255|FG000|STARTED|Overall Study||7
10699886|NCT02556775|11864256|FG001|STARTED|Overall Study||2
10699887|NCT02556775|11864257|FG002|STARTED|Overall Study||5
10699888|NCT02556775|11864258|FG003|STARTED|Overall Study||2
10699889|NCT02556775|11864255|FG000|COMPLETED|Overall Study||5
10699890|NCT02556775|11864256|FG001|COMPLETED|Overall Study||2
10699891|NCT02556775|11864257|FG002|COMPLETED|Overall Study||4
10699892|NCT02556775|11864258|FG003|COMPLETED|Overall Study||2
10699893|NCT02556775|11864255|FG000|NOT COMPLETED|Overall Study||2
10699894|NCT02556775|11864256|FG001|NOT COMPLETED|Overall Study||0
10699895|NCT02556775|11864257|FG002|NOT COMPLETED|Overall Study||1
10699896|NCT02556775|11864258|FG003|NOT COMPLETED|Overall Study||0
10699897|NCT02556788|11864272|FG000|STARTED|Overall Study||602
10699898|NCT02556788|11864273|FG001|STARTED|Overall Study||610
10699899|NCT02556788|11864272|FG000|COMPLETED|Overall Study||558
10801649|NCT04334681|11962900|FG000|COMPLETED|Overall Study||135
10801650|NCT04334681|11962901|FG001|COMPLETED|Overall Study||143
10801651|NCT04334681|11962900|FG000|NOT COMPLETED|Overall Study||0
10801652|NCT04334681|11962901|FG001|NOT COMPLETED|Overall Study||0
10801653|NCT04333225|11962911|FG000|STARTED|Overall Study||101
10699900|NCT02556788|11864273|FG001|COMPLETED|Overall Study||573
10699901|NCT02556788|11864272|FG000|NOT COMPLETED|Overall Study||44
10699902|NCT02556788|11864273|FG001|NOT COMPLETED|Overall Study||37
10699903|NCT02556801|11864283|FG000|STARTED|Overall Study||42
10699904|NCT02556801|11864284|FG001|STARTED|Overall Study||42
10699905|NCT02556801|11864285|FG002|STARTED|Overall Study||42
10699906|NCT02556801|11864286|FG003|STARTED|Overall Study||42
10699907|NCT02556801|11864283|FG000|COMPLETED|Overall Study||40
10699908|NCT02556801|11864284|FG001|COMPLETED|Overall Study||35
10699909|NCT02556801|11864285|FG002|COMPLETED|Overall Study||38
10699910|NCT02556801|11864286|FG003|COMPLETED|Overall Study||37
10699911|NCT02556801|11864283|FG000|NOT COMPLETED|Overall Study||2
10699912|NCT02556801|11864284|FG001|NOT COMPLETED|Overall Study||7
10699913|NCT02556801|11864285|FG002|NOT COMPLETED|Overall Study||4
10699914|NCT02556801|11864286|FG003|NOT COMPLETED|Overall Study||5
10699915|NCT02556918|11864298|FG000|STARTED|Overall Study||100
10699916|NCT02556918|11864299|FG001|STARTED|Overall Study||101
10699917|NCT02556918|11864298|FG000|COMPLETED|Overall Study||91
10699918|NCT02556918|11864299|FG001|COMPLETED|Overall Study||91
10699919|NCT02556918|11864298|FG000|NOT COMPLETED|Overall Study||9
10699920|NCT02556918|11864299|FG001|NOT COMPLETED|Overall Study||10
10699921|NCT02557035|11864308|FG000|STARTED|Overall Study||225
10699922|NCT02557035|11864309|FG001|STARTED|Overall Study||215
10699923|NCT02557035|11864308|FG000|COMPLETED|Overall Study||218
10699924|NCT02557035|11864309|FG001|COMPLETED|Overall Study||206
10699925|NCT02557035|11864308|FG000|NOT COMPLETED|Overall Study||7
10699926|NCT02557035|11864309|FG001|NOT COMPLETED|Overall Study||9
10699927|NCT02557100|11864318|FG000|STARTED|Single Blind Treatment Period||40
10699928|NCT02557100|11864319|FG001|STARTED|Single Blind Treatment Period||40
10699929|NCT02557100|11864320|FG002|STARTED|Single Blind Treatment Period||0
10699930|NCT02557100|11864318|FG000|COMPLETED|Single Blind Treatment Period||40
10699931|NCT02557100|11864319|FG001|COMPLETED|Single Blind Treatment Period||36
10699932|NCT02557100|11864320|FG002|COMPLETED|Single Blind Treatment Period||0
10699933|NCT02557100|11864318|FG000|NOT COMPLETED|Single Blind Treatment Period||0
10699934|NCT02557100|11864319|FG001|NOT COMPLETED|Single Blind Treatment Period||4
10699935|NCT02557100|11864320|FG002|NOT COMPLETED|Single Blind Treatment Period||0
10699936|NCT02557100|11864318|FG000|STARTED|Transition to Open Label||40
10699937|NCT02557100|11864319|FG001|STARTED|Transition to Open Label||36
10699938|NCT02557100|11864320|FG002|STARTED|Transition to Open Label||0
10699939|NCT02557100|11864318|FG000|COMPLETED|Transition to Open Label||0
10699940|NCT02557100|11864319|FG001|COMPLETED|Transition to Open Label||0
10699941|NCT02557100|11864320|FG002|COMPLETED|Transition to Open Label||0
10699942|NCT02557100|11864318|FG000|NOT COMPLETED|Transition to Open Label||40
10699943|NCT02557100|11864319|FG001|NOT COMPLETED|Transition to Open Label||36
10699944|NCT02557100|11864320|FG002|NOT COMPLETED|Transition to Open Label||0
10699945|NCT02557100|11864318|FG000|STARTED|Cumulative Abatacept Period||0
10699946|NCT02557100|11864319|FG001|STARTED|Cumulative Abatacept Period||0
10699947|NCT02557100|11864320|FG002|STARTED|Cumulative Abatacept Period||76
10699948|NCT02557100|11864318|FG000|COMPLETED|Cumulative Abatacept Period||0
10699949|NCT02557100|11864319|FG001|COMPLETED|Cumulative Abatacept Period||0
10699950|NCT02557100|11864320|FG002|COMPLETED|Cumulative Abatacept Period||72
10699951|NCT02557100|11864318|FG000|NOT COMPLETED|Cumulative Abatacept Period||0
10699952|NCT02557100|11864319|FG001|NOT COMPLETED|Cumulative Abatacept Period||0
10699953|NCT02557100|11864320|FG002|NOT COMPLETED|Cumulative Abatacept Period||4
10699954|NCT02557178|11864330|FG000|STARTED|Overall Study||72
10699955|NCT02557178|11864331|FG001|STARTED|Overall Study||74
10801654|NCT04333225|11962912|FG001|STARTED|Overall Study||120
10801655|NCT04333225|11962911|FG000|COMPLETED|Overall Study||98
10699956|NCT02557178|11864330|FG000|COMPLETED|Overall Study||56
10699957|NCT02557178|11864331|FG001|COMPLETED|Overall Study||63
10699958|NCT02557178|11864330|FG000|NOT COMPLETED|Overall Study||16
10699959|NCT02557178|11864331|FG001|NOT COMPLETED|Overall Study||11
10699960|NCT02557399|11864339|FG000|STARTED|Overall Study||172
10699961|NCT02557399|11864340|FG001|STARTED|Overall Study||177
10801656|NCT04333225|11962912|FG001|COMPLETED|Overall Study||115
10801657|NCT04333225|11962911|FG000|NOT COMPLETED|Overall Study||3
10801658|NCT04333225|11962912|FG001|NOT COMPLETED|Overall Study||5
10801659|NCT04333199|11962921|FG000|STARTED|Evaluated Patients||1669
10801660|NCT04333199|11962922|FG001|STARTED|Evaluated Patients||1672
10801661|NCT04333199|11962923|FG002|STARTED|Evaluated Patients||1671
10801662|NCT04333199|11962921|FG000|COMPLETED|Evaluated Patients||1669
10801663|NCT04333199|11962922|FG001|COMPLETED|Evaluated Patients||1671
10801664|NCT04333199|11962923|FG002|COMPLETED|Evaluated Patients||1669
10801665|NCT04333199|11962921|FG000|NOT COMPLETED|Evaluated Patients||0
10801666|NCT04333199|11962922|FG001|NOT COMPLETED|Evaluated Patients||1
10699962|NCT02557399|11864339|FG000|COMPLETED|Overall Study||165
10699963|NCT02557399|11864340|FG001|COMPLETED|Overall Study||169
10699964|NCT02557399|11864339|FG000|NOT COMPLETED|Overall Study||7
10699965|NCT02557399|11864340|FG001|NOT COMPLETED|Overall Study||8
10699966|NCT02557516|11864353|FG000|STARTED|Overall Study||3
10699967|NCT02557516|11864354|FG001|STARTED|Overall Study||6
10699968|NCT02557516|11864355|FG002|STARTED|Overall Study||4
10699969|NCT02557516|11864356|FG003|STARTED|Overall Study||9
10699970|NCT02557516|11864353|FG000|COMPLETED|Overall Study||2
10699971|NCT02557516|11864354|FG001|COMPLETED|Overall Study||1
10699972|NCT02557516|11864355|FG002|COMPLETED|Overall Study||0
10699973|NCT02557516|11864356|FG003|COMPLETED|Overall Study||0
10699974|NCT02557516|11864353|FG000|NOT COMPLETED|Overall Study||1
10699975|NCT02557516|11864354|FG001|NOT COMPLETED|Overall Study||5
10699976|NCT02557516|11864355|FG002|NOT COMPLETED|Overall Study||4
10699977|NCT02557516|11864356|FG003|NOT COMPLETED|Overall Study||9
10699978|NCT02557555|11864375|FG000|STARTED|Overall Study||100
10699979|NCT02557555|11864375|FG000|COMPLETED|Overall Study||100
10699980|NCT02557555|11864375|FG000|NOT COMPLETED|Overall Study||0
10699981|NCT02557646|11864380|FG000|STARTED|Overall Study||693
10699982|NCT02557646|11864380|FG000|COMPLETED|Overall Study||417
10699983|NCT02557646|11864380|FG000|NOT COMPLETED|Overall Study||276
10699984|NCT02557698|11864386|FG000|STARTED|Overall Study||30
10699985|NCT02557698|11864387|FG001|STARTED|Overall Study||30
10699986|NCT02557698|11864386|FG000|COMPLETED|Overall Study||30
10699987|NCT02557698|11864387|FG001|COMPLETED|Overall Study||30
10699988|NCT02557698|11864386|FG000|NOT COMPLETED|Overall Study||0
10699989|NCT02557698|11864387|FG001|NOT COMPLETED|Overall Study||0
10699990|NCT02558231|11864395|FG000|STARTED|Overall Study||123
10699991|NCT02558231|11864396|FG001|STARTED|Overall Study||124
10699992|NCT02558231|11864395|FG000|Treated|Overall Study||123
10699993|NCT02558231|11864396|FG001|Treated|Overall Study||123
10699994|NCT02558231|11864395|FG000|COMPLETED|Overall Study||98
10699995|NCT02558231|11864396|FG001|COMPLETED|Overall Study||98
10699996|NCT02558231|11864395|FG000|NOT COMPLETED|Overall Study||25
10699997|NCT02558231|11864396|FG001|NOT COMPLETED|Overall Study||26
10699998|NCT02558296|11864404|FG000|STARTED|Completed the Study Through Week 24||1133
10699999|NCT02558296|11864405|FG001|STARTED|Completed the Study Through Week 24||567
10700000|NCT02558296|11864404|FG000|COMPLETED|Completed the Study Through Week 24||1089
10700001|NCT02558296|11864405|FG001|COMPLETED|Completed the Study Through Week 24||542
10700002|NCT02558296|11864404|FG000|NOT COMPLETED|Completed the Study Through Week 24||44
10700003|NCT02558296|11864405|FG001|NOT COMPLETED|Completed the Study Through Week 24||25
10700004|NCT02558296|11864404|FG000|STARTED|Completed the Study||1133
10700005|NCT02558296|11864405|FG001|STARTED|Completed the Study||567
10700006|NCT02558296|11864404|FG000|COMPLETED|Completed the Study||987
10700007|NCT02558296|11864405|FG001|COMPLETED|Completed the Study||482
10700008|NCT02558296|11864404|FG000|NOT COMPLETED|Completed the Study||146
10801667|NCT04333199|11962923|FG002|NOT COMPLETED|Evaluated Patients||2
10801668|NCT04333199|11962921|FG000|STARTED|Emailed Patients|Patients in this group were not emailed|0
10801669|NCT04333199|11962922|FG001|STARTED|Emailed Patients||1671
10801670|NCT04333199|11962923|FG002|STARTED|Emailed Patients||1669
10801671|NCT04333199|11962921|FG000|Valid Email Address|Emailed Patients|Patients in this group were not emailed|0
10801672|NCT04333199|11962922|FG001|Valid Email Address|Emailed Patients||1495
10801673|NCT04333199|11962923|FG002|Valid Email Address|Emailed Patients||1441
10801674|NCT04333199|11962921|FG000|COMPLETED|Emailed Patients|Patients in this group were not emailed|0
10801675|NCT04333199|11962922|FG001|COMPLETED|Emailed Patients||1399
10801676|NCT04333199|11962923|FG002|COMPLETED|Emailed Patients||1351
10801677|NCT04333199|11962921|FG000|NOT COMPLETED|Emailed Patients||0
10700009|NCT02558296|11864405|FG001|NOT COMPLETED|Completed the Study||85
10700010|NCT02558374|11864417|FG000|STARTED|Overall Study||351
10700011|NCT02558374|11864418|FG001|STARTED|Overall Study||357
10700012|NCT02558374|11864417|FG000|COMPLETED|Overall Study||243
10700013|NCT02558374|11864418|FG001|COMPLETED|Overall Study||314
10700014|NCT02558374|11864417|FG000|NOT COMPLETED|Overall Study||108
10700015|NCT02558374|11864418|FG001|NOT COMPLETED|Overall Study||43
10700016|NCT02558400|11864427|FG000|STARTED|Overall Study||238
10700017|NCT02558400|11864428|FG001|STARTED|Overall Study||244
10700018|NCT02558400|11864429|FG002|STARTED|Overall Study||236
10700019|NCT02558400|11864427|FG000|COMPLETED|Overall Study||159
10700020|NCT02558400|11864428|FG001|COMPLETED|Overall Study||148
10801678|NCT04333199|11962922|FG001|NOT COMPLETED|Emailed Patients||272
10801679|NCT04333199|11962923|FG002|NOT COMPLETED|Emailed Patients||318
10801680|NCT04332991|11962934|FG000|STARTED|Overall Study||242
10801681|NCT04332991|11962935|FG001|STARTED|Overall Study||237
10801682|NCT04332991|11962934|FG000|COMPLETED|Overall Study||242
10801683|NCT04332991|11962935|FG001|COMPLETED|Overall Study||237
10801684|NCT04332991|11962934|FG000|NOT COMPLETED|Overall Study||0
10700021|NCT02558400|11864429|FG002|COMPLETED|Overall Study||203
10700022|NCT02558400|11864427|FG000|NOT COMPLETED|Overall Study||79
10700023|NCT02558400|11864428|FG001|NOT COMPLETED|Overall Study||96
10700024|NCT02558400|11864429|FG002|NOT COMPLETED|Overall Study||33
10700025|NCT02558790|11864440|FG000|STARTED|Overall Study|20 subjects signed consent to participate in the study. 15 subjects began taking L-TAMS.|20
10700026|NCT02558790|11864440|FG000|Treated|Overall Study||15
10700027|NCT02558790|11864440|FG000|COMPLETED|Overall Study||13
10700028|NCT02558790|11864440|FG000|NOT COMPLETED|Overall Study||7
10700029|NCT02558829|11864448|FG000|STARTED|Overall Study||21
10700030|NCT02558829|11864449|FG001|STARTED|Overall Study||21
10700031|NCT02558829|11864450|FG002|STARTED|Overall Study||24
10700032|NCT02558829|11864451|FG003|STARTED|Overall Study||18
10700033|NCT02558829|11864452|FG004|STARTED|Overall Study||18
10700034|NCT02558829|11864453|FG005|STARTED|Overall Study||26
10700035|NCT02558829|11864454|FG006|STARTED|Overall Study||18
10700036|NCT02558829|11864455|FG007|STARTED|Overall Study||11
10700037|NCT02558829|11864448|FG000|COMPLETED|Overall Study||20
10700038|NCT02558829|11864449|FG001|COMPLETED|Overall Study||18
10700039|NCT02558829|11864450|FG002|COMPLETED|Overall Study||21
10700040|NCT02558829|11864451|FG003|COMPLETED|Overall Study||16
10700041|NCT02558829|11864452|FG004|COMPLETED|Overall Study||16
10700042|NCT02558829|11864453|FG005|COMPLETED|Overall Study||24
10700043|NCT02558829|11864454|FG006|COMPLETED|Overall Study||17
10700044|NCT02558829|11864455|FG007|COMPLETED|Overall Study||8
10700045|NCT02558829|11864448|FG000|NOT COMPLETED|Overall Study||1
10700046|NCT02558829|11864449|FG001|NOT COMPLETED|Overall Study||3
10700047|NCT02558829|11864450|FG002|NOT COMPLETED|Overall Study||3
10700048|NCT02558829|11864451|FG003|NOT COMPLETED|Overall Study||2
10700049|NCT02558829|11864452|FG004|NOT COMPLETED|Overall Study||2
10700050|NCT02558829|11864453|FG005|NOT COMPLETED|Overall Study||2
10700051|NCT02558829|11864454|FG006|NOT COMPLETED|Overall Study||1
10700052|NCT02558829|11864455|FG007|NOT COMPLETED|Overall Study||3
10700053|NCT02558894|11864479|FG000|STARTED|Overall Study||32
10700054|NCT02558894|11864480|FG001|STARTED|Overall Study||33
10700055|NCT02558894|11864479|FG000|Patients Who Received IP|Overall Study||32
10700056|NCT02558894|11864480|FG001|Patients Who Received IP|Overall Study||32
10700057|NCT02558894|11864479|FG000|COMPLETED|Overall Study||0
10700058|NCT02558894|11864480|FG001|COMPLETED|Overall Study||0
10700059|NCT02558894|11864479|FG000|NOT COMPLETED|Overall Study||32
10700060|NCT02558894|11864480|FG001|NOT COMPLETED|Overall Study||33
10700061|NCT02559115|11864486|FG000|STARTED|Overall Study||19
10700062|NCT02559115|11864486|FG000|COMPLETED|Overall Study||16
10700063|NCT02559115|11864486|FG000|NOT COMPLETED|Overall Study||3
10700064|NCT02559206|11864498|FG000|STARTED|Overall Study||66
10700065|NCT02559206|11864499|FG001|STARTED|Overall Study||66
10700066|NCT02559206|11864500|FG002|STARTED|Overall Study||67
10700067|NCT02559206|11864501|FG003|STARTED|Overall Study||67
10700068|NCT02559206|11864502|FG004|STARTED|Overall Study||67
10700069|NCT02559206|11864503|FG005|STARTED|Overall Study||67
10700070|NCT02559206|11864504|FG006|STARTED|Overall Study||66
10700071|NCT02559206|11864505|FG007|STARTED|Overall Study||66
10700072|NCT02559206|11864498|FG000|COMPLETED|Overall Study||58
10700073|NCT02559206|11864499|FG001|COMPLETED|Overall Study||54
10700074|NCT02559206|11864500|FG002|COMPLETED|Overall Study||58
10700075|NCT02559206|11864501|FG003|COMPLETED|Overall Study||53
10700076|NCT02559206|11864502|FG004|COMPLETED|Overall Study||55
10700077|NCT02559206|11864503|FG005|COMPLETED|Overall Study||53
10700078|NCT02559206|11864504|FG006|COMPLETED|Overall Study||60
10700079|NCT02559206|11864505|FG007|COMPLETED|Overall Study||57
10700080|NCT02559206|11864498|FG000|NOT COMPLETED|Overall Study||8
10700081|NCT02559206|11864499|FG001|NOT COMPLETED|Overall Study||12
10700082|NCT02559206|11864500|FG002|NOT COMPLETED|Overall Study||9
10700083|NCT02559206|11864501|FG003|NOT COMPLETED|Overall Study||14
10700084|NCT02559206|11864502|FG004|NOT COMPLETED|Overall Study||12
10700085|NCT02559206|11864503|FG005|NOT COMPLETED|Overall Study||14
10700086|NCT02559206|11864504|FG006|NOT COMPLETED|Overall Study||6
10700087|NCT02559206|11864505|FG007|NOT COMPLETED|Overall Study||9
10700088|NCT02559310|11864525|FG000|STARTED|Overall Study||276
10700089|NCT02559310|11864526|FG001|STARTED|Overall Study||275
10700090|NCT02559310|11864525|FG000|COMPLETED|Overall Study||249
10700091|NCT02559310|11864526|FG001|COMPLETED|Overall Study||256
10700092|NCT02559310|11864525|FG000|NOT COMPLETED|Overall Study||27
10700093|NCT02559310|11864526|FG001|NOT COMPLETED|Overall Study||19
10700094|NCT02559414|11864535|FG000|STARTED|Overall Study||11
10700095|NCT02559414|11864536|FG001|STARTED|Overall Study||22
10700096|NCT02559414|11864537|FG002|STARTED|Overall Study||22
10700097|NCT02559414|11864535|FG000|COMPLETED|Overall Study||10
10700098|NCT02559414|11864536|FG001|COMPLETED|Overall Study||20
10700099|NCT02559414|11864537|FG002|COMPLETED|Overall Study||20
10700100|NCT02559414|11864535|FG000|NOT COMPLETED|Overall Study||1
10700101|NCT02559414|11864536|FG001|NOT COMPLETED|Overall Study||2
10700102|NCT02559414|11864537|FG002|NOT COMPLETED|Overall Study||2
10700103|NCT02559505|11864562|FG000|STARTED|Overall Study||49
10700104|NCT02559505|11864563|FG001|STARTED|Overall Study||84
10700105|NCT02559505|11864562|FG000|COMPLETED|Overall Study||22
10700106|NCT02559505|11864563|FG001|COMPLETED|Overall Study||62
10700107|NCT02559505|11864562|FG000|NOT COMPLETED|Overall Study||27
10700108|NCT02559505|11864563|FG001|NOT COMPLETED|Overall Study||22
10700109|NCT02559570|11864586|FG000|STARTED|Overall Study||41
10700110|NCT02559570|11864587|FG001|STARTED|Overall Study||36
10700111|NCT02559570|11864588|FG002|STARTED|Overall Study||41
10700112|NCT02559570|11864589|FG003|STARTED|Overall Study||39
10700113|NCT02559570|11864590|FG004|STARTED|Overall Study||16
10700114|NCT02559570|11864586|FG000|COMPLETED|Overall Study||39
10700115|NCT02559570|11864587|FG001|COMPLETED|Overall Study||34
10700116|NCT02559570|11864588|FG002|COMPLETED|Overall Study||39
10700117|NCT02559570|11864589|FG003|COMPLETED|Overall Study||36
10700118|NCT02559570|11864590|FG004|COMPLETED|Overall Study||14
10700119|NCT02559570|11864586|FG000|NOT COMPLETED|Overall Study||2
10700120|NCT02559570|11864587|FG001|NOT COMPLETED|Overall Study||2
10700121|NCT02559570|11864588|FG002|NOT COMPLETED|Overall Study||2
10700122|NCT02559570|11864589|FG003|NOT COMPLETED|Overall Study||3
10700123|NCT02559570|11864590|FG004|NOT COMPLETED|Overall Study||2
10700124|NCT02559622|11864605|FG000|STARTED|Overall Study||48
10700125|NCT02559622|11864606|FG001|STARTED|Overall Study||54
10700126|NCT02559622|11864607|FG002|STARTED|Overall Study||26
10700127|NCT02559622|11864608|FG003|STARTED|Overall Study||23
10700128|NCT02559622|11864605|FG000|COMPLETED|Overall Study||47
10700129|NCT02559622|11864606|FG001|COMPLETED|Overall Study||49
10700130|NCT02559622|11864607|FG002|COMPLETED|Overall Study||24
10700131|NCT02559622|11864608|FG003|COMPLETED|Overall Study||20
10700132|NCT02559622|11864605|FG000|NOT COMPLETED|Overall Study||1
10700133|NCT02559622|11864606|FG001|NOT COMPLETED|Overall Study||5
10700134|NCT02559622|11864607|FG002|NOT COMPLETED|Overall Study||2
10700135|NCT02559622|11864608|FG003|NOT COMPLETED|Overall Study||3
10700139|NCT02559713|11864626|FG000|STARTED|Overall Study||11
10700140|NCT02559713|11864626|FG000|Safety Set|Overall Study||11
10700141|NCT02559713|11864626|FG000|Pharmacokinetic Set|Overall Study||11
10700142|NCT02559713|11864626|FG000|COMPLETED|Overall Study||10
10700143|NCT02559713|11864626|FG000|NOT COMPLETED|Overall Study||1
10700144|NCT02559817|11864635|FG000|STARTED|Treatment Period||19
10700145|NCT02559817|11864636|FG001|STARTED|Treatment Period||29
10700146|NCT02559817|11864637|FG002|STARTED|Treatment Period||21
10700147|NCT02559817|11864638|FG003|STARTED|Treatment Period||24
10700148|NCT02559817|11864639|FG004|STARTED|Treatment Period||8
10700149|NCT02559817|11864635|FG000|COMPLETED|Treatment Period||18
10700150|NCT02559817|11864636|FG001|COMPLETED|Treatment Period||27
10700151|NCT02559817|11864637|FG002|COMPLETED|Treatment Period||19
10700152|NCT02559817|11864638|FG003|COMPLETED|Treatment Period||22
10700153|NCT02559817|11864639|FG004|COMPLETED|Treatment Period||8
10700154|NCT02559817|11864635|FG000|NOT COMPLETED|Treatment Period||1
10700155|NCT02559817|11864636|FG001|NOT COMPLETED|Treatment Period||2
10700156|NCT02559817|11864637|FG002|NOT COMPLETED|Treatment Period||2
10700157|NCT02559817|11864638|FG003|NOT COMPLETED|Treatment Period||2
10700158|NCT02559817|11864639|FG004|NOT COMPLETED|Treatment Period||0
10700159|NCT02559817|11864635|FG000|STARTED|Post-treatment Period||18
10700160|NCT02559817|11864636|FG001|STARTED|Post-treatment Period||27
10700161|NCT02559817|11864637|FG002|STARTED|Post-treatment Period|1 participant who did not complete the first period, entered and completed the Post-treatment Period|20
10700162|NCT02559817|11864638|FG003|STARTED|Post-treatment Period||22
10700163|NCT02559817|11864639|FG004|STARTED|Post-treatment Period||8
10700164|NCT02559817|11864635|FG000|COMPLETED|Post-treatment Period||18
10700165|NCT02559817|11864636|FG001|COMPLETED|Post-treatment Period||27
10700166|NCT02559817|11864637|FG002|COMPLETED|Post-treatment Period||20
10700167|NCT02559817|11864638|FG003|COMPLETED|Post-treatment Period||22
10700168|NCT02559817|11864639|FG004|COMPLETED|Post-treatment Period||8
10700169|NCT02559817|11864635|FG000|NOT COMPLETED|Post-treatment Period||0
10700170|NCT02559817|11864636|FG001|NOT COMPLETED|Post-treatment Period||0
10700171|NCT02559817|11864637|FG002|NOT COMPLETED|Post-treatment Period||0
10700172|NCT02559817|11864638|FG003|NOT COMPLETED|Post-treatment Period||0
10700173|NCT02559817|11864639|FG004|NOT COMPLETED|Post-treatment Period||0
10700174|NCT02559895|11864655|FG000|STARTED|Overall Study||224
10700175|NCT02559895|11864656|FG001|STARTED|Overall Study||225
10700176|NCT02559895|11864657|FG002|STARTED|Overall Study||224
10700177|NCT02559895|11864658|FG003|STARTED|Overall Study||225
10700178|NCT02559895|11864655|FG000|Participants Treated|Overall Study||222
10700179|NCT02559895|11864656|FG001|Participants Treated|Overall Study||221
10700180|NCT02559895|11864657|FG002|Participants Treated|Overall Study||223
10700181|NCT02559895|11864658|FG003|Participants Treated|Overall Study||222
10700182|NCT02559895|11864655|FG000|COMPLETED|Overall Study||169
10700183|NCT02559895|11864656|FG001|COMPLETED|Overall Study||172
10700184|NCT02559895|11864657|FG002|COMPLETED|Overall Study||170
10700185|NCT02559895|11864658|FG003|COMPLETED|Overall Study||165
10700186|NCT02559895|11864655|FG000|NOT COMPLETED|Overall Study||55
10700187|NCT02559895|11864656|FG001|NOT COMPLETED|Overall Study||53
10700188|NCT02559895|11864657|FG002|NOT COMPLETED|Overall Study||54
10700189|NCT02559895|11864658|FG003|NOT COMPLETED|Overall Study||60
10700190|NCT02560012|11864668|FG000|STARTED|Overall Study||3
10700191|NCT02560012|11864668|FG000|COMPLETED|Overall Study||1
10700192|NCT02560012|11864668|FG000|NOT COMPLETED|Overall Study||2
10700193|NCT02560025|11864672|FG000|STARTED|Overall Study||42
10700194|NCT02560025|11864672|FG000|COMPLETED|Overall Study||39
10700195|NCT02560025|11864672|FG000|NOT COMPLETED|Overall Study||3
10700196|NCT02560038|11864676|FG000|STARTED|Overall Study||3
10700197|NCT02560038|11864676|FG000|COMPLETED|Overall Study||1
10700198|NCT02560038|11864676|FG000|NOT COMPLETED|Overall Study||2
10700199|NCT02560051|11864683|FG000|STARTED|Overall Study||6
10700200|NCT02560051|11864684|FG001|STARTED|Overall Study||8
10700201|NCT02560051|11864685|FG002|STARTED|Overall Study||5
10700202|NCT02560051|11864683|FG000|COMPLETED|Overall Study||3
10700203|NCT02560051|11864684|FG001|COMPLETED|Overall Study||4
10700204|NCT02560051|11864685|FG002|COMPLETED|Overall Study||4
10700205|NCT02560051|11864683|FG000|NOT COMPLETED|Overall Study||3
10700206|NCT02560051|11864684|FG001|NOT COMPLETED|Overall Study||4
10700207|NCT02560051|11864685|FG002|NOT COMPLETED|Overall Study||1
10700208|NCT02560324|11864695|FG000|STARTED|Period 1 (2 Weeks)||35
10700209|NCT02560324|11864696|FG001|STARTED|Period 1 (2 Weeks)||34
10700210|NCT02560324|11864695|FG000|COMPLETED|Period 1 (2 Weeks)||23
10700211|NCT02560324|11864696|FG001|COMPLETED|Period 1 (2 Weeks)||25
10700212|NCT02560324|11864695|FG000|NOT COMPLETED|Period 1 (2 Weeks)||12
10700213|NCT02560324|11864696|FG001|NOT COMPLETED|Period 1 (2 Weeks)||9
10700214|NCT02560324|11864695|FG000|STARTED|Washout (2 Weeks)||23
10700215|NCT02560324|11864696|FG001|STARTED|Washout (2 Weeks)||25
10700216|NCT02560324|11864695|FG000|COMPLETED|Washout (2 Weeks)||23
10700217|NCT02560324|11864696|FG001|COMPLETED|Washout (2 Weeks)||23
10700218|NCT02560324|11864695|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10700219|NCT02560324|11864696|FG001|NOT COMPLETED|Washout (2 Weeks)||2
10700220|NCT02560324|11864695|FG000|STARTED|Period 2 (2 Weeks)||23
10700221|NCT02560324|11864696|FG001|STARTED|Period 2 (2 Weeks)||23
10700222|NCT02560324|11864695|FG000|COMPLETED|Period 2 (2 Weeks)||22
10700223|NCT02560324|11864696|FG001|COMPLETED|Period 2 (2 Weeks)||21
10700224|NCT02560324|11864695|FG000|NOT COMPLETED|Period 2 (2 Weeks)||1
10700225|NCT02560324|11864696|FG001|NOT COMPLETED|Period 2 (2 Weeks)||2
10700226|NCT02560389|11864709|FG000|STARTED|Overall Study||34
10700227|NCT02560389|11864710|FG001|STARTED|Overall Study||28
10700228|NCT02560389|11864711|FG002|STARTED|Overall Study||29
10700229|NCT02560389|11864709|FG000|COMPLETED|Overall Study||33
10700230|NCT02560389|11864710|FG001|COMPLETED|Overall Study||25
10700231|NCT02560389|11864711|FG002|COMPLETED|Overall Study||27
10700232|NCT02560389|11864709|FG000|NOT COMPLETED|Overall Study||1
10700233|NCT02560389|11864710|FG001|NOT COMPLETED|Overall Study||3
10700234|NCT02560389|11864711|FG002|NOT COMPLETED|Overall Study||2
10700235|NCT02560493|11864721|FG000|STARTED|Overall Study||23
10700236|NCT02560493|11864722|FG001|STARTED|Overall Study||23
10700237|NCT02560493|11864721|FG000|COMPLETED|Overall Study||22
10700238|NCT02560493|11864722|FG001|COMPLETED|Overall Study||23
10700239|NCT02560493|11864721|FG000|NOT COMPLETED|Overall Study||1
10700240|NCT02560493|11864722|FG001|NOT COMPLETED|Overall Study||0
10700241|NCT02560558|11864730|FG000|STARTED|Overall Study||84
10700242|NCT02560558|11864731|FG001|STARTED|Overall Study||82
10700243|NCT02560558|11864730|FG000|COMPLETED|Overall Study||77
10700244|NCT02560558|11864731|FG001|COMPLETED|Overall Study||76
10700245|NCT02560558|11864730|FG000|NOT COMPLETED|Overall Study||7
10700246|NCT02560558|11864731|FG001|NOT COMPLETED|Overall Study||6
10700247|NCT02560584|11864737|FG000|STARTED|Overall Study||304
10700248|NCT02560584|11864737|FG000|COMPLETED|Overall Study||304
10700249|NCT02560584|11864737|FG000|NOT COMPLETED|Overall Study||0
10700250|NCT02560701|11864745|FG000|STARTED|Overall Study||8060
10700251|NCT02560701|11864746|FG001|STARTED|Overall Study||89242
10801685|NCT04332991|11962935|FG001|NOT COMPLETED|Overall Study||0
10801686|NCT04332614|11962947|FG000|STARTED|~1 Week After Study Launch||2350
10801687|NCT04332614|11962948|FG001|STARTED|~1 Week After Study Launch||2350
10801688|NCT04332614|11962949|FG002|STARTED|~1 Week After Study Launch||2350
10801689|NCT04332614|11962950|FG003|STARTED|~1 Week After Study Launch||2350
10801690|NCT04332614|11962951|FG004|STARTED|~1 Week After Study Launch||2350
10801691|NCT04332614|11962952|FG005|STARTED|~1 Week After Study Launch||2349
10801692|NCT04332614|11962947|FG000|Data in EHR|~1 Week After Study Launch||2245
10801693|NCT04332614|11962948|FG001|Data in EHR|~1 Week After Study Launch||2273
10801694|NCT04332614|11962949|FG002|Data in EHR|~1 Week After Study Launch||2251
10801695|NCT04332614|11962950|FG003|Data in EHR|~1 Week After Study Launch||2254
10801696|NCT04332614|11962951|FG004|Data in EHR|~1 Week After Study Launch||2251
10801697|NCT04332614|11962952|FG005|Data in EHR|~1 Week After Study Launch||2249
10801698|NCT04332614|11962947|FG000|COMPLETED|~1 Week After Study Launch||2117
10801699|NCT04332614|11962948|FG001|COMPLETED|~1 Week After Study Launch||2129
10801700|NCT04332614|11962949|FG002|COMPLETED|~1 Week After Study Launch||2124
10801701|NCT04332614|11962950|FG003|COMPLETED|~1 Week After Study Launch||2131
10801702|NCT04332614|11962951|FG004|COMPLETED|~1 Week After Study Launch||2127
10801703|NCT04332614|11962952|FG005|COMPLETED|~1 Week After Study Launch||2115
10801704|NCT04332614|11962947|FG000|NOT COMPLETED|~1 Week After Study Launch||233
10700252|NCT02560701|11864745|FG000|Carve Out|Overall Study||8060
10700253|NCT02560701|11864746|FG001|Carve Out|Overall Study||88729
10700254|NCT02560701|11864745|FG000|Restrict to Patients Between 12 and 64|Overall Study||7598
10700255|NCT02560701|11864746|FG001|Restrict to Patients Between 12 and 64|Overall Study||82367
10700256|NCT02560701|11864745|FG000|Bipolar Diagnosis Time Constraints|Overall Study||3533
10801705|NCT04332614|11962948|FG001|NOT COMPLETED|~1 Week After Study Launch||221
10801706|NCT04332614|11962949|FG002|NOT COMPLETED|~1 Week After Study Launch||226
10801707|NCT04332614|11962950|FG003|NOT COMPLETED|~1 Week After Study Launch||219
10801708|NCT04332614|11962951|FG004|NOT COMPLETED|~1 Week After Study Launch||223
10801709|NCT04332614|11962952|FG005|NOT COMPLETED|~1 Week After Study Launch||234
10801710|NCT04332614|11962947|FG000|STARTED|~1 Month After Study Launch||2117
10700257|NCT02560701|11864746|FG001|Bipolar Diagnosis Time Constraints|Overall Study||39427
10700258|NCT02560701|11864745|FG000|Matched Cohort|Overall Study||3517
10700259|NCT02560701|11864746|FG001|Matched Cohort|Overall Study||37776
10700260|NCT02560701|11864745|FG000|COMPLETED|Overall Study||3517
10700261|NCT02560701|11864746|FG001|COMPLETED|Overall Study||37776
10700262|NCT02560701|11864745|FG000|NOT COMPLETED|Overall Study||4543
10700263|NCT02560701|11864746|FG001|NOT COMPLETED|Overall Study||51466
10700264|NCT02560753|11864756|FG000|STARTED|Overall Study||9
10700265|NCT02560753|11864757|FG001|STARTED|Overall Study||9
10700266|NCT02560753|11864758|FG002|STARTED|Overall Study||10
10700267|NCT02560753|11864759|FG003|STARTED|Overall Study||8
10700268|NCT02560753|11864756|FG000|COMPLETED|Overall Study||8
10700269|NCT02560753|11864757|FG001|COMPLETED|Overall Study||9
10700270|NCT02560753|11864758|FG002|COMPLETED|Overall Study||9
10700271|NCT02560753|11864759|FG003|COMPLETED|Overall Study||8
10700272|NCT02560753|11864756|FG000|NOT COMPLETED|Overall Study||1
10700273|NCT02560753|11864757|FG001|NOT COMPLETED|Overall Study||0
10700274|NCT02560753|11864758|FG002|NOT COMPLETED|Overall Study||1
10700275|NCT02560753|11864759|FG003|NOT COMPLETED|Overall Study||0
10700276|NCT02560779|11864771|FG000|STARTED|Overall Study||14
10700277|NCT02560779|11864772|FG001|STARTED|Overall Study||13
10700278|NCT02560779|11864771|FG000|COMPLETED|Overall Study||14
10700279|NCT02560779|11864772|FG001|COMPLETED|Overall Study||13
10700280|NCT02560779|11864771|FG000|NOT COMPLETED|Overall Study||0
10700281|NCT02560779|11864772|FG001|NOT COMPLETED|Overall Study||0
10700282|NCT02560922|11864780|FG000|STARTED|Overall Study||124
10700283|NCT02560922|11864781|FG001|STARTED|Overall Study||124
10700284|NCT02560922|11864780|FG000|COMPLETED|Overall Study||98
10700285|NCT02560922|11864781|FG001|COMPLETED|Overall Study||112
10700286|NCT02560922|11864780|FG000|NOT COMPLETED|Overall Study||26
10700287|NCT02560922|11864781|FG001|NOT COMPLETED|Overall Study||12
10700288|NCT02561000|11864790|FG000|STARTED|Overall Study||34
10700289|NCT02561000|11864791|FG001|STARTED|Overall Study||35
10700290|NCT02561000|11864792|FG002|STARTED|Overall Study||31
10700291|NCT02561000|11864790|FG000|Safety Population|Overall Study|Includes 1 additional patient who was assigned PZ-128 0.3 mg/kg but received placebo in error (evaluated as placebo for primary safety outcome and adverse events).|35
10700292|NCT02561000|11864791|FG001|Safety Population|Overall Study|Excludes 4 patients who did not receive the study drug as allocated: 1 patient received placebo in error and was evaluated as placebo for primary safety outcome and adverse events; 2 patients withdrew full consent immediately after randomization prior to receiving any study drug; and 1 patient had an adverse event shortly after randomization prior to receiving any study drug.|31
10700293|NCT02561000|11864792|FG002|Safety Population|Overall Study||31
10801711|NCT04332614|11962948|FG001|STARTED|~1 Month After Study Launch||2129
10801712|NCT04332614|11962949|FG002|STARTED|~1 Month After Study Launch||2124
10801713|NCT04332614|11962950|FG003|STARTED|~1 Month After Study Launch||2131
10801714|NCT04332614|11962951|FG004|STARTED|~1 Month After Study Launch||2127
10801715|NCT04332614|11962952|FG005|STARTED|~1 Month After Study Launch||2115
10801716|NCT04332614|11962947|FG000|COMPLETED|~1 Month After Study Launch||2095
10801717|NCT04332614|11962948|FG001|COMPLETED|~1 Month After Study Launch||2107
10801718|NCT04332614|11962949|FG002|COMPLETED|~1 Month After Study Launch||2094
10801719|NCT04332614|11962950|FG003|COMPLETED|~1 Month After Study Launch||2107
10801720|NCT04332614|11962951|FG004|COMPLETED|~1 Month After Study Launch||2107
10801721|NCT04332614|11962952|FG005|COMPLETED|~1 Month After Study Launch||2096
10801722|NCT04332614|11962947|FG000|NOT COMPLETED|~1 Month After Study Launch||22
10801723|NCT04332614|11962948|FG001|NOT COMPLETED|~1 Month After Study Launch||22
10801724|NCT04332614|11962949|FG002|NOT COMPLETED|~1 Month After Study Launch||30
10801725|NCT04332614|11962950|FG003|NOT COMPLETED|~1 Month After Study Launch||24
10801726|NCT04332614|11962951|FG004|NOT COMPLETED|~1 Month After Study Launch||20
10801727|NCT04332614|11962952|FG005|NOT COMPLETED|~1 Month After Study Launch||19
10801728|NCT04322968|11962971|FG000|STARTED|Overall Study||11
10801729|NCT04322968|11962972|FG001|STARTED|Overall Study||10
10801730|NCT04322968|11962973|FG002|STARTED|Overall Study||10
10801731|NCT04322968|11962974|FG003|STARTED|Overall Study||10
10801732|NCT04322968|11962971|FG000|COMPLETED|Overall Study||10
10801733|NCT04322968|11962972|FG001|COMPLETED|Overall Study||9
10801734|NCT04322968|11962973|FG002|COMPLETED|Overall Study||10
10801735|NCT04322968|11962974|FG003|COMPLETED|Overall Study||10
10801736|NCT04322968|11962971|FG000|NOT COMPLETED|Overall Study||1
10801737|NCT04322968|11962972|FG001|NOT COMPLETED|Overall Study||1
10700294|NCT02561000|11864790|FG000|Intent-to-Treat (ITT) Population at 30 Days|Overall Study||34
10700295|NCT02561000|11864791|FG001|Intent-to-Treat (ITT) Population at 30 Days|Overall Study|Excludes 2 patients who withdrew full consent immediately after randomization.|33
10700296|NCT02561000|11864792|FG002|Intent-to-Treat (ITT) Population at 30 Days|Overall Study||31
10700297|NCT02561000|11864790|FG000|Intent-to-Treat (ITT) Population at 90 Days|Overall Study|Excludes 1 patient who withdrew consent for follow-up 21 days after study drug dosing.|33
10700298|NCT02561000|11864791|FG001|Intent-to-Treat (ITT) Population at 90 Days|Overall Study|Excludes 4 patients: 2 patients withdrew full consent immediately after randomization; 1 patient followed only for 30 day ITT outcome (did not receive any study drug due to adverse event post randomization); and 1 patient withdrew consent for follow-up 7 days after study drug dosing.|31
10700299|NCT02561000|11864792|FG002|Intent-to-Treat (ITT) Population at 90 Days|Overall Study||31
10801738|NCT04322968|11962973|FG002|NOT COMPLETED|Overall Study||0
10801739|NCT04322968|11962974|FG003|NOT COMPLETED|Overall Study||0
10801740|NCT04332081|11962986|FG000|STARTED|Overall Study||20
10801741|NCT04332081|11962987|FG001|STARTED|Overall Study||60
10801742|NCT04332081|11962986|FG000|COMPLETED|Overall Study||20
10801743|NCT04332081|11962987|FG001|COMPLETED|Overall Study||60
10801744|NCT04332081|11962986|FG000|NOT COMPLETED|Overall Study||0
10801745|NCT04332081|11962987|FG001|NOT COMPLETED|Overall Study||0
10801746|NCT04332107|11962995|FG000|STARTED|Day 3||171
10801747|NCT04332107|11962996|FG001|STARTED|Day 3||92
10801748|NCT04332107|11962995|FG000|COMPLETED|Day 3||145
10801749|NCT04332107|11962996|FG001|COMPLETED|Day 3||72
10801750|NCT04332107|11962995|FG000|NOT COMPLETED|Day 3||26
10801751|NCT04332107|11962996|FG001|NOT COMPLETED|Day 3||20
10810995|NCT03783130|11972702|FG002|COMPLETED|Overall Study||5
10700300|NCT02561000|11864790|FG000|COMPLETED|Overall Study||32
10700301|NCT02561000|11864791|FG001|COMPLETED|Overall Study||31
10700302|NCT02561000|11864792|FG002|COMPLETED|Overall Study||31
10700303|NCT02561000|11864790|FG000|NOT COMPLETED|Overall Study||2
10700304|NCT02561000|11864791|FG001|NOT COMPLETED|Overall Study||4
10700305|NCT02561000|11864792|FG002|NOT COMPLETED|Overall Study||0
10700306|NCT02561078|11864802|FG000|STARTED|Overall Study||209
10700307|NCT02561078|11864803|FG001|STARTED|Overall Study||211
10700308|NCT02561078|11864802|FG000|Received at Least 1 Dose of Study Drug|Overall Study||208
10700309|NCT02561078|11864803|FG001|Received at Least 1 Dose of Study Drug|Overall Study||210
10700310|NCT02561078|11864802|FG000|COMPLETED|Overall Study||179
10700311|NCT02561078|11864803|FG001|COMPLETED|Overall Study||186
10700312|NCT02561078|11864802|FG000|NOT COMPLETED|Overall Study||30
10700313|NCT02561078|11864803|FG001|NOT COMPLETED|Overall Study||25
10700314|NCT02561130|11864811|FG000|STARTED|Overall Study||77
10700315|NCT02561130|11864812|FG001|STARTED|Overall Study||77
10700316|NCT02561130|11864811|FG000|COMPLETED|Overall Study||76
10700317|NCT02561130|11864812|FG001|COMPLETED|Overall Study||76
10700318|NCT02561130|11864811|FG000|NOT COMPLETED|Overall Study||1
10700319|NCT02561130|11864812|FG001|NOT COMPLETED|Overall Study||1
10700320|NCT02561156|11864831|FG000|STARTED|Part 1||12
10700321|NCT02561156|11864832|FG001|STARTED|Part 1||6
10700322|NCT02561156|11864833|FG002|STARTED|Part 1||6
10700323|NCT02561156|11864834|FG003|STARTED|Part 1||6
10700324|NCT02561156|11864835|FG004|STARTED|Part 1||6
10700325|NCT02561156|11864836|FG005|STARTED|Part 1||6
10700326|NCT02561156|11864837|FG006|STARTED|Part 1||6
10700327|NCT02561156|11864838|FG007|STARTED|Part 1||0
10700328|NCT02561156|11864839|FG008|STARTED|Part 1||0
10700329|NCT02561156|11864840|FG009|STARTED|Part 1||0
10700330|NCT02561156|11864841|FG010|STARTED|Part 1||0
10700331|NCT02561156|11864842|FG011|STARTED|Part 1||0
10700332|NCT02561156|11864843|FG012|STARTED|Part 1||0
10700333|NCT02561156|11864831|FG000|COMPLETED|Part 1||12
10700334|NCT02561156|11864832|FG001|COMPLETED|Part 1||6
10700335|NCT02561156|11864833|FG002|COMPLETED|Part 1||6
10700336|NCT02561156|11864834|FG003|COMPLETED|Part 1||6
10700337|NCT02561156|11864835|FG004|COMPLETED|Part 1||6
10700338|NCT02561156|11864836|FG005|COMPLETED|Part 1||6
10700339|NCT02561156|11864837|FG006|COMPLETED|Part 1||6
10700340|NCT02561156|11864838|FG007|COMPLETED|Part 1||0
10700341|NCT02561156|11864839|FG008|COMPLETED|Part 1||0
10700342|NCT02561156|11864840|FG009|COMPLETED|Part 1||0
10700343|NCT02561156|11864841|FG010|COMPLETED|Part 1||0
10700344|NCT02561156|11864842|FG011|COMPLETED|Part 1||0
10700345|NCT02561156|11864843|FG012|COMPLETED|Part 1||0
10700346|NCT02561156|11864831|FG000|NOT COMPLETED|Part 1||0
10700347|NCT02561156|11864832|FG001|NOT COMPLETED|Part 1||0
10700348|NCT02561156|11864833|FG002|NOT COMPLETED|Part 1||0
10700349|NCT02561156|11864834|FG003|NOT COMPLETED|Part 1||0
10700350|NCT02561156|11864835|FG004|NOT COMPLETED|Part 1||0
10700351|NCT02561156|11864836|FG005|NOT COMPLETED|Part 1||0
10700352|NCT02561156|11864837|FG006|NOT COMPLETED|Part 1||0
10700353|NCT02561156|11864838|FG007|NOT COMPLETED|Part 1||0
10700354|NCT02561156|11864839|FG008|NOT COMPLETED|Part 1||0
10700355|NCT02561156|11864840|FG009|NOT COMPLETED|Part 1||0
10700356|NCT02561156|11864841|FG010|NOT COMPLETED|Part 1||0
10700357|NCT02561156|11864842|FG011|NOT COMPLETED|Part 1||0
10700358|NCT02561156|11864843|FG012|NOT COMPLETED|Part 1||0
10700359|NCT02561156|11864831|FG000|STARTED|Part 2||0
10700360|NCT02561156|11864832|FG001|STARTED|Part 2||0
10700361|NCT02561156|11864833|FG002|STARTED|Part 2||0
10700362|NCT02561156|11864834|FG003|STARTED|Part 2||0
10700363|NCT02561156|11864835|FG004|STARTED|Part 2||0
10700364|NCT02561156|11864836|FG005|STARTED|Part 2||0
10700365|NCT02561156|11864837|FG006|STARTED|Part 2||0
10700366|NCT02561156|11864838|FG007|STARTED|Part 2||10
10700367|NCT02561156|11864839|FG008|STARTED|Part 2||6
10700368|NCT02561156|11864840|FG009|STARTED|Part 2||6
10700369|NCT02561156|11864841|FG010|STARTED|Part 2||6
10700370|NCT02561156|11864842|FG011|STARTED|Part 2||6
10700371|NCT02561156|11864843|FG012|STARTED|Part 2||6
10801752|NCT04332107|11962995|FG000|STARTED|Day 14|Those who had missing measurements at Day 3 but were not completely lost-to-followup were allowed to continue with the trial.|148
10801753|NCT04332107|11962996|FG001|STARTED|Day 14|Those who had missing measurements at Day 3 but were not completely lost-to-followup were allowed to continue with the trial.|78
10801754|NCT04332107|11962995|FG000|COMPLETED|Day 14||131
10801755|NCT04332107|11962996|FG001|COMPLETED|Day 14||70
10700372|NCT02561156|11864831|FG000|COMPLETED|Part 2||0
10700373|NCT02561156|11864832|FG001|COMPLETED|Part 2||0
10700374|NCT02561156|11864833|FG002|COMPLETED|Part 2||0
10700375|NCT02561156|11864834|FG003|COMPLETED|Part 2||0
10700376|NCT02561156|11864835|FG004|COMPLETED|Part 2||0
10700377|NCT02561156|11864836|FG005|COMPLETED|Part 2||0
10700378|NCT02561156|11864837|FG006|COMPLETED|Part 2||0
10700379|NCT02561156|11864838|FG007|COMPLETED|Part 2||10
10700380|NCT02561156|11864839|FG008|COMPLETED|Part 2||6
10700381|NCT02561156|11864840|FG009|COMPLETED|Part 2||6
10700382|NCT02561156|11864841|FG010|COMPLETED|Part 2||6
10700383|NCT02561156|11864842|FG011|COMPLETED|Part 2||5
10700384|NCT02561156|11864843|FG012|COMPLETED|Part 2||6
10700385|NCT02561156|11864831|FG000|NOT COMPLETED|Part 2||0
10700386|NCT02561156|11864832|FG001|NOT COMPLETED|Part 2||0
10700387|NCT02561156|11864833|FG002|NOT COMPLETED|Part 2||0
10700388|NCT02561156|11864834|FG003|NOT COMPLETED|Part 2||0
10700389|NCT02561156|11864835|FG004|NOT COMPLETED|Part 2||0
10700390|NCT02561156|11864836|FG005|NOT COMPLETED|Part 2||0
10700391|NCT02561156|11864837|FG006|NOT COMPLETED|Part 2||0
10700392|NCT02561156|11864838|FG007|NOT COMPLETED|Part 2||0
10700393|NCT02561156|11864839|FG008|NOT COMPLETED|Part 2||0
10700394|NCT02561156|11864840|FG009|NOT COMPLETED|Part 2||0
10700395|NCT02561156|11864841|FG010|NOT COMPLETED|Part 2||0
10700396|NCT02561156|11864842|FG011|NOT COMPLETED|Part 2||1
10700397|NCT02561156|11864843|FG012|NOT COMPLETED|Part 2||0
10700398|NCT02561195|11864893|FG000|STARTED|Vaccination 1 to 3||183
10700399|NCT02561195|11864894|FG001|STARTED|Vaccination 1 to 3||184
10700400|NCT02561195|11864895|FG002|STARTED|Vaccination 1 to 3||61
10700401|NCT02561195|11864896|FG003|STARTED|Vaccination 1 to 3||183
10700402|NCT02561195|11864897|FG004|STARTED|Vaccination 1 to 3||183
10700403|NCT02561195|11864898|FG005|STARTED|Vaccination 1 to 3||61
10700404|NCT02561195|11864899|FG006|STARTED|Vaccination 1 to 3||0
10700405|NCT02561195|11864900|FG007|STARTED|Vaccination 1 to 3||0
10700406|NCT02561195|11864901|FG008|STARTED|Vaccination 1 to 3||0
10700407|NCT02561195|11864902|FG009|STARTED|Vaccination 1 to 3||0
10700408|NCT02561195|11864903|FG010|STARTED|Vaccination 1 to 3||0
10700409|NCT02561195|11864904|FG011|STARTED|Vaccination 1 to 3||0
10700410|NCT02561195|11864905|FG012|STARTED|Vaccination 1 to 3||0
10700411|NCT02561195|11864906|FG013|STARTED|Vaccination 1 to 3||0
10700412|NCT02561195|11864893|FG000|Treated|Vaccination 1 to 3||182
10700413|NCT02561195|11864894|FG001|Treated|Vaccination 1 to 3||184
10700414|NCT02561195|11864895|FG002|Treated|Vaccination 1 to 3||61
10700415|NCT02561195|11864896|FG003|Treated|Vaccination 1 to 3||183
10700416|NCT02561195|11864897|FG004|Treated|Vaccination 1 to 3||183
10700417|NCT02561195|11864898|FG005|Treated|Vaccination 1 to 3||61
10700418|NCT02561195|11864899|FG006|Treated|Vaccination 1 to 3||0
10700419|NCT02561195|11864900|FG007|Treated|Vaccination 1 to 3||0
10700420|NCT02561195|11864901|FG008|Treated|Vaccination 1 to 3||0
10700421|NCT02561195|11864902|FG009|Treated|Vaccination 1 to 3||0
10700422|NCT02561195|11864903|FG010|Treated|Vaccination 1 to 3||0
10700423|NCT02561195|11864904|FG011|Treated|Vaccination 1 to 3||0
10700424|NCT02561195|11864905|FG012|Treated|Vaccination 1 to 3||0
10700425|NCT02561195|11864906|FG013|Treated|Vaccination 1 to 3||0
10700426|NCT02561195|11864893|FG000|COMPLETED|Vaccination 1 to 3||160
10700427|NCT02561195|11864894|FG001|COMPLETED|Vaccination 1 to 3||162
10700428|NCT02561195|11864895|FG002|COMPLETED|Vaccination 1 to 3||55
10700429|NCT02561195|11864896|FG003|COMPLETED|Vaccination 1 to 3||157
10700430|NCT02561195|11864897|FG004|COMPLETED|Vaccination 1 to 3||155
10700431|NCT02561195|11864898|FG005|COMPLETED|Vaccination 1 to 3||51
10700432|NCT02561195|11864899|FG006|COMPLETED|Vaccination 1 to 3||0
10700433|NCT02561195|11864900|FG007|COMPLETED|Vaccination 1 to 3||0
10700434|NCT02561195|11864901|FG008|COMPLETED|Vaccination 1 to 3||0
10700435|NCT02561195|11864902|FG009|COMPLETED|Vaccination 1 to 3||0
10700436|NCT02561195|11864903|FG010|COMPLETED|Vaccination 1 to 3||0
10700437|NCT02561195|11864904|FG011|COMPLETED|Vaccination 1 to 3||0
10700438|NCT02561195|11864905|FG012|COMPLETED|Vaccination 1 to 3||0
10700439|NCT02561195|11864906|FG013|COMPLETED|Vaccination 1 to 3||0
10700440|NCT02561195|11864893|FG000|NOT COMPLETED|Vaccination 1 to 3||23
10700441|NCT02561195|11864894|FG001|NOT COMPLETED|Vaccination 1 to 3||22
10801756|NCT04332107|11962995|FG000|NOT COMPLETED|Day 14||17
10801757|NCT04332107|11962996|FG001|NOT COMPLETED|Day 14||8
10801758|NCT04332107|11962995|FG000|STARTED|Day 21|Those who had missing measurements at Day 14 but were not completely lost-to-followup were allowed to continue with the trial.|135
10801759|NCT04332107|11962996|FG001|STARTED|Day 21|Those who had missing measurements at Day 14 but were not completely lost-to-followup were allowed to continue with the trial.|74
10801760|NCT04332107|11962995|FG000|COMPLETED|Day 21||125
10801761|NCT04332107|11962996|FG001|COMPLETED|Day 21||72
10801762|NCT04332107|11962995|FG000|NOT COMPLETED|Day 21||10
10801763|NCT04332107|11962996|FG001|NOT COMPLETED|Day 21||2
10801764|NCT04323592|11963004|FG000|STARTED|Overall Study||83
10801765|NCT04323592|11963005|FG001|STARTED|Overall Study||90
10801766|NCT04323592|11963004|FG000|COMPLETED|Overall Study||83
10801767|NCT04323592|11963005|FG001|COMPLETED|Overall Study||90
10801768|NCT04323592|11963004|FG000|NOT COMPLETED|Overall Study||0
10801769|NCT04323592|11963005|FG001|NOT COMPLETED|Overall Study||0
10801770|NCT04326842|11963013|FG000|STARTED|Overall Study||40
10801771|NCT04326842|11963014|FG001|STARTED|Overall Study||89
10801772|NCT04326842|11963013|FG000|COMPLETED|Overall Study||31
10801773|NCT04326842|11963014|FG001|COMPLETED|Overall Study||31
10801774|NCT04326842|11963013|FG000|NOT COMPLETED|Overall Study||9
10801775|NCT04326842|11963014|FG001|NOT COMPLETED|Overall Study||58
10801776|NCT04325542|11963020|FG000|STARTED|Overall Study|one participant withdraw consent during the study|743
10801777|NCT04325542|11963020|FG000|COMPLETED|Overall Study||742
10700442|NCT02561195|11864895|FG002|NOT COMPLETED|Vaccination 1 to 3||6
10700443|NCT02561195|11864896|FG003|NOT COMPLETED|Vaccination 1 to 3||26
10700444|NCT02561195|11864897|FG004|NOT COMPLETED|Vaccination 1 to 3||28
10700445|NCT02561195|11864898|FG005|NOT COMPLETED|Vaccination 1 to 3||10
10700446|NCT02561195|11864899|FG006|NOT COMPLETED|Vaccination 1 to 3||0
10700447|NCT02561195|11864900|FG007|NOT COMPLETED|Vaccination 1 to 3||0
10801778|NCT04325542|11963020|FG000|NOT COMPLETED|Overall Study||1
10801779|NCT04329923|11963030|FG000|STARTED|Overall Study||17
10801780|NCT04329923|11963031|FG001|STARTED|Overall Study||17
10801781|NCT04329923|11963032|FG002|STARTED|Overall Study||4
10801782|NCT04329923|11963033|FG003|STARTED|Overall Study||3
10801783|NCT04329923|11963034|FG004|STARTED|Overall Study||66
10801784|NCT04329923|11963035|FG005|STARTED|Overall Study||66
10801785|NCT04329923|11963030|FG000|COMPLETED|Overall Study||16
10801786|NCT04329923|11963031|FG001|COMPLETED|Overall Study||13
10801787|NCT04329923|11963032|FG002|COMPLETED|Overall Study||3
10801788|NCT04329923|11963033|FG003|COMPLETED|Overall Study||2
10700448|NCT02561195|11864901|FG008|NOT COMPLETED|Vaccination 1 to 3||0
10700449|NCT02561195|11864902|FG009|NOT COMPLETED|Vaccination 1 to 3||0
10700450|NCT02561195|11864903|FG010|NOT COMPLETED|Vaccination 1 to 3||0
10700451|NCT02561195|11864904|FG011|NOT COMPLETED|Vaccination 1 to 3||0
10700452|NCT02561195|11864905|FG012|NOT COMPLETED|Vaccination 1 to 3||0
10700453|NCT02561195|11864906|FG013|NOT COMPLETED|Vaccination 1 to 3||0
10700454|NCT02561195|11864893|FG000|STARTED|Extension Stage (Vaccination 4)||0
10700455|NCT02561195|11864894|FG001|STARTED|Extension Stage (Vaccination 4)||0
10700456|NCT02561195|11864895|FG002|STARTED|Extension Stage (Vaccination 4)||0
10700457|NCT02561195|11864896|FG003|STARTED|Extension Stage (Vaccination 4)||0
10700458|NCT02561195|11864897|FG004|STARTED|Extension Stage (Vaccination 4)||0
10700459|NCT02561195|11864898|FG005|STARTED|Extension Stage (Vaccination 4)||0
10700460|NCT02561195|11864899|FG006|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|16
10700461|NCT02561195|11864900|FG007|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|18
10700462|NCT02561195|11864901|FG008|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|24
10700463|NCT02561195|11864902|FG009|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|22
10700464|NCT02561195|11864903|FG010|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|51
10700465|NCT02561195|11864904|FG011|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|52
10700466|NCT02561195|11864905|FG012|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|58
10700467|NCT02561195|11864906|FG013|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|59
10700468|NCT02561195|11864893|FG000|COMPLETED|Extension Stage (Vaccination 4)||0
10700469|NCT02561195|11864894|FG001|COMPLETED|Extension Stage (Vaccination 4)||0
10700470|NCT02561195|11864895|FG002|COMPLETED|Extension Stage (Vaccination 4)||0
10700471|NCT02561195|11864896|FG003|COMPLETED|Extension Stage (Vaccination 4)||0
10700472|NCT02561195|11864897|FG004|COMPLETED|Extension Stage (Vaccination 4)||0
10700473|NCT02561195|11864898|FG005|COMPLETED|Extension Stage (Vaccination 4)||0
10700474|NCT02561195|11864899|FG006|COMPLETED|Extension Stage (Vaccination 4)||14
10700475|NCT02561195|11864900|FG007|COMPLETED|Extension Stage (Vaccination 4)||17
10700476|NCT02561195|11864901|FG008|COMPLETED|Extension Stage (Vaccination 4)||21
10700477|NCT02561195|11864902|FG009|COMPLETED|Extension Stage (Vaccination 4)||20
10700478|NCT02561195|11864903|FG010|COMPLETED|Extension Stage (Vaccination 4)||43
10700479|NCT02561195|11864904|FG011|COMPLETED|Extension Stage (Vaccination 4)||45
10700480|NCT02561195|11864905|FG012|COMPLETED|Extension Stage (Vaccination 4)||51
10700481|NCT02561195|11864906|FG013|COMPLETED|Extension Stage (Vaccination 4)||54
10700482|NCT02561195|11864893|FG000|NOT COMPLETED|Extension Stage (Vaccination 4)||0
10700483|NCT02561195|11864894|FG001|NOT COMPLETED|Extension Stage (Vaccination 4)||0
10700484|NCT02561195|11864895|FG002|NOT COMPLETED|Extension Stage (Vaccination 4)||0
10700485|NCT02561195|11864896|FG003|NOT COMPLETED|Extension Stage (Vaccination 4)||0
10700486|NCT02561195|11864897|FG004|NOT COMPLETED|Extension Stage (Vaccination 4)||0
10700487|NCT02561195|11864898|FG005|NOT COMPLETED|Extension Stage (Vaccination 4)||0
10700488|NCT02561195|11864899|FG006|NOT COMPLETED|Extension Stage (Vaccination 4)||2
10700489|NCT02561195|11864900|FG007|NOT COMPLETED|Extension Stage (Vaccination 4)||1
10700490|NCT02561195|11864901|FG008|NOT COMPLETED|Extension Stage (Vaccination 4)||3
10700491|NCT02561195|11864902|FG009|NOT COMPLETED|Extension Stage (Vaccination 4)||2
10700492|NCT02561195|11864903|FG010|NOT COMPLETED|Extension Stage (Vaccination 4)||8
10700493|NCT02561195|11864904|FG011|NOT COMPLETED|Extension Stage (Vaccination 4)||7
10700494|NCT02561195|11864905|FG012|NOT COMPLETED|Extension Stage (Vaccination 4)||7
10801789|NCT04329923|11963034|FG004|COMPLETED|Overall Study||64
10801790|NCT04329923|11963035|FG005|COMPLETED|Overall Study||61
10801791|NCT04329923|11963030|FG000|NOT COMPLETED|Overall Study||1
10801792|NCT04329923|11963031|FG001|NOT COMPLETED|Overall Study||4
10801793|NCT04329923|11963032|FG002|NOT COMPLETED|Overall Study||1
10801794|NCT04329923|11963033|FG003|NOT COMPLETED|Overall Study||1
10801795|NCT04329923|11963034|FG004|NOT COMPLETED|Overall Study||2
10801796|NCT04329923|11963035|FG005|NOT COMPLETED|Overall Study||5
10801797|NCT04328467|11963052|FG000|STARTED|Overall Study||494
10801798|NCT04328467|11963053|FG001|STARTED|Overall Study||495
10801799|NCT04328467|11963054|FG002|STARTED|Overall Study||494
10801800|NCT04328467|11963052|FG000|COMPLETED|Overall Study||490
10801801|NCT04328467|11963053|FG001|COMPLETED|Overall Study||493
10801802|NCT04328467|11963054|FG002|COMPLETED|Overall Study||493
10801803|NCT04328467|11963052|FG000|NOT COMPLETED|Overall Study||4
10801804|NCT04328467|11963053|FG001|NOT COMPLETED|Overall Study||2
10801805|NCT04328467|11963054|FG002|NOT COMPLETED|Overall Study||1
10801806|NCT04322526|11963064|FG000|STARTED|First Intervention (1 Day)||13
10801807|NCT04322526|11963065|FG001|STARTED|First Intervention (1 Day)||12
10801808|NCT04322526|11963064|FG000|COMPLETED|First Intervention (1 Day)||12
10801809|NCT04322526|11963065|FG001|COMPLETED|First Intervention (1 Day)||11
10801810|NCT04322526|11963064|FG000|NOT COMPLETED|First Intervention (1 Day)||1
10801811|NCT04322526|11963065|FG001|NOT COMPLETED|First Intervention (1 Day)||1
10801812|NCT04322526|11963064|FG000|STARTED|Washout (1 Week)||12
10801813|NCT04322526|11963065|FG001|STARTED|Washout (1 Week)||11
10801814|NCT04322526|11963064|FG000|COMPLETED|Washout (1 Week)||11
10801815|NCT04322526|11963065|FG001|COMPLETED|Washout (1 Week)||9
10801816|NCT04322526|11963064|FG000|NOT COMPLETED|Washout (1 Week)||1
10700495|NCT02561195|11864906|FG013|NOT COMPLETED|Extension Stage (Vaccination 4)||5
10700508|NCT02561247|11864947|FG000|STARTED|Overall Study||23
10700509|NCT02561247|11864947|FG000|COMPLETED|Overall Study||17
10700510|NCT02561247|11864947|FG000|NOT COMPLETED|Overall Study||6
10713624|NCT02680041|11879125|FG000|STARTED|Overall Study||221
10713625|NCT02680041|11879125|FG000|Received 18F-fluciclovine|Overall Study||213
10713626|NCT02680041|11879125|FG000|COMPLETED|Overall Study||211
10713627|NCT02680041|11879125|FG000|NOT COMPLETED|Overall Study||10
10713628|NCT02680054|11879130|FG000|STARTED|Overall Study||38
10713629|NCT02680054|11879130|FG000|COMPLETED|Overall Study||27
10713630|NCT02680054|11879130|FG000|NOT COMPLETED|Overall Study||11
10713631|NCT02680145|11879139|FG000|STARTED|Overall Study||58
10713632|NCT02680145|11879139|FG000|COMPLETED|Overall Study||47
10713633|NCT02680145|11879139|FG000|NOT COMPLETED|Overall Study||11
10713634|NCT02680158|11879143|FG000|STARTED|Overall Study||8
10713635|NCT02680158|11879144|FG001|STARTED|Overall Study||8
10713636|NCT02680158|11879145|FG002|STARTED|Overall Study||8
10713637|NCT02680158|11879146|FG003|STARTED|Overall Study||8
10713638|NCT02680158|11879147|FG004|STARTED|Overall Study||8
10713639|NCT02680158|11879148|FG005|STARTED|Overall Study||8
10713640|NCT02680158|11879143|FG000|COMPLETED|Overall Study||8
10713641|NCT02680158|11879144|FG001|COMPLETED|Overall Study||8
10713642|NCT02680158|11879145|FG002|COMPLETED|Overall Study||8
10713643|NCT02680158|11879146|FG003|COMPLETED|Overall Study||8
10713644|NCT02680158|11879147|FG004|COMPLETED|Overall Study||8
10713645|NCT02680158|11879148|FG005|COMPLETED|Overall Study||8
10713646|NCT02680158|11879143|FG000|NOT COMPLETED|Overall Study||0
10713647|NCT02680158|11879144|FG001|NOT COMPLETED|Overall Study||0
10713648|NCT02680158|11879145|FG002|NOT COMPLETED|Overall Study||0
10713649|NCT02680158|11879146|FG003|NOT COMPLETED|Overall Study||0
10713650|NCT02680158|11879147|FG004|NOT COMPLETED|Overall Study||0
10713651|NCT02680158|11879148|FG005|NOT COMPLETED|Overall Study||0
10713652|NCT02680301|11879158|FG000|STARTED|Overall Study||22
10713653|NCT02680301|11879159|FG001|STARTED|Overall Study||18
10713654|NCT02680301|11879158|FG000|COMPLETED|Overall Study||22
10713655|NCT02680301|11879159|FG001|COMPLETED|Overall Study||17
10713656|NCT02680301|11879158|FG000|NOT COMPLETED|Overall Study||0
10713657|NCT02680301|11879159|FG001|NOT COMPLETED|Overall Study||1
10713664|NCT02680457|11879175|FG000|STARTED|Initial Intervention||6
10713665|NCT02680457|11879176|FG001|STARTED|Initial Intervention||6
10713666|NCT02680457|11879175|FG000|COMPLETED|Initial Intervention||6
10713667|NCT02680457|11879176|FG001|COMPLETED|Initial Intervention||6
10713668|NCT02680457|11879175|FG000|NOT COMPLETED|Initial Intervention||0
10713669|NCT02680457|11879176|FG001|NOT COMPLETED|Initial Intervention||0
10713670|NCT02680457|11879175|FG000|STARTED|Washout Period||6
10713671|NCT02680457|11879176|FG001|STARTED|Washout Period||6
10713672|NCT02680457|11879175|FG000|COMPLETED|Washout Period||6
10713673|NCT02680457|11879176|FG001|COMPLETED|Washout Period||6
10713674|NCT02680457|11879175|FG000|NOT COMPLETED|Washout Period||0
10713675|NCT02680457|11879176|FG001|NOT COMPLETED|Washout Period||0
10713676|NCT02680457|11879175|FG000|STARTED|Cross-over Intervention||6
10713677|NCT02680457|11879176|FG001|STARTED|Cross-over Intervention||6
10713678|NCT02680457|11879175|FG000|COMPLETED|Cross-over Intervention||6
10713679|NCT02680457|11879176|FG001|COMPLETED|Cross-over Intervention||6
10713680|NCT02680457|11879175|FG000|NOT COMPLETED|Cross-over Intervention||0
10713681|NCT02680457|11879176|FG001|NOT COMPLETED|Cross-over Intervention||0
10713682|NCT02680639|11879182|FG000|STARTED|Screening Period||10
10713683|NCT02680639|11879183|FG001|STARTED|Screening Period||0
10713684|NCT02680639|11879184|FG002|STARTED|Screening Period||0
10713685|NCT02680639|11879182|FG000|COMPLETED|Screening Period||3
10713686|NCT02680639|11879183|FG001|COMPLETED|Screening Period||0
10713687|NCT02680639|11879184|FG002|COMPLETED|Screening Period||0
10713688|NCT02680639|11879182|FG000|NOT COMPLETED|Screening Period||7
10713689|NCT02680639|11879183|FG001|NOT COMPLETED|Screening Period||0
10713690|NCT02680639|11879184|FG002|NOT COMPLETED|Screening Period||0
10713691|NCT02680639|11879182|FG000|STARTED|High Frequency Oscillation (HFO) Therapy||0
10713692|NCT02680639|11879183|FG001|STARTED|High Frequency Oscillation (HFO) Therapy||2
10713693|NCT02680639|11879184|FG002|STARTED|High Frequency Oscillation (HFO) Therapy||1
10713694|NCT02680639|11879182|FG000|COMPLETED|High Frequency Oscillation (HFO) Therapy||0
10713695|NCT02680639|11879183|FG001|COMPLETED|High Frequency Oscillation (HFO) Therapy||2
10713696|NCT02680639|11879184|FG002|COMPLETED|High Frequency Oscillation (HFO) Therapy||1
10713697|NCT02680639|11879182|FG000|NOT COMPLETED|High Frequency Oscillation (HFO) Therapy||0
10700511|NCT02561273|11864953|FG000|STARTED|Overall Study||40
10700512|NCT02561273|11864954|FG001|STARTED|Overall Study||4
10700513|NCT02561273|11864953|FG000|COMPLETED|Overall Study||39
10700514|NCT02561273|11864954|FG001|COMPLETED|Overall Study||4
10700515|NCT02561273|11864953|FG000|NOT COMPLETED|Overall Study||1
10700516|NCT02561273|11864954|FG001|NOT COMPLETED|Overall Study||0
10700517|NCT02561338|11864967|FG000|STARTED|Overall Study||53
10700518|NCT02561338|11864968|FG001|STARTED|Overall Study||50
10700519|NCT02561338|11864969|FG002|STARTED|Overall Study||51
10700520|NCT02561338|11864970|FG003|STARTED|Overall Study||51
10700521|NCT02561338|11864971|FG004|STARTED|Overall Study||53
10700522|NCT02561338|11864967|FG000|COMPLETED|Overall Study||45
10700523|NCT02561338|11864968|FG001|COMPLETED|Overall Study||44
10700524|NCT02561338|11864969|FG002|COMPLETED|Overall Study||42
10700525|NCT02561338|11864970|FG003|COMPLETED|Overall Study||46
10700526|NCT02561338|11864971|FG004|COMPLETED|Overall Study||51
10700527|NCT02561338|11864967|FG000|NOT COMPLETED|Overall Study||8
10700528|NCT02561338|11864968|FG001|NOT COMPLETED|Overall Study||6
10700529|NCT02561338|11864969|FG002|NOT COMPLETED|Overall Study||9
10700530|NCT02561338|11864970|FG003|NOT COMPLETED|Overall Study||5
10700531|NCT02561338|11864971|FG004|NOT COMPLETED|Overall Study||2
10700532|NCT02561455|11864989|FG000|STARTED|Overall Study||2
10700533|NCT02561455|11864990|FG001|STARTED|Overall Study||3
10700534|NCT02561455|11864991|FG002|STARTED|Overall Study||3
10700535|NCT02561455|11864992|FG003|STARTED|Overall Study||1
10700536|NCT02561455|11864989|FG000|COMPLETED|Overall Study||0
10700537|NCT02561455|11864990|FG001|COMPLETED|Overall Study||1
10700538|NCT02561455|11864991|FG002|COMPLETED|Overall Study||0
10700539|NCT02561455|11864992|FG003|COMPLETED|Overall Study||0
10700540|NCT02561455|11864989|FG000|NOT COMPLETED|Overall Study||2
10700541|NCT02561455|11864990|FG001|NOT COMPLETED|Overall Study||2
10700542|NCT02561455|11864991|FG002|NOT COMPLETED|Overall Study||3
10700543|NCT02561455|11864992|FG003|NOT COMPLETED|Overall Study||1
10700544|NCT02561481|11865004|FG000|STARTED|Pilot Trial||10
10700545|NCT02561481|11865005|FG001|STARTED|Pilot Trial||0
10700546|NCT02561481|11865004|FG000|COMPLETED|Pilot Trial||10
10700547|NCT02561481|11865005|FG001|COMPLETED|Pilot Trial||0
10700548|NCT02561481|11865004|FG000|NOT COMPLETED|Pilot Trial||0
10700549|NCT02561481|11865005|FG001|NOT COMPLETED|Pilot Trial||0
10700550|NCT02561481|11865004|FG000|STARTED|Main Trial - Double Blind Phase||25
10700551|NCT02561481|11865005|FG001|STARTED|Main Trial - Double Blind Phase||25
10700552|NCT02561481|11865004|FG000|COMPLETED|Main Trial - Double Blind Phase||22
10700553|NCT02561481|11865005|FG001|COMPLETED|Main Trial - Double Blind Phase||23
10700554|NCT02561481|11865004|FG000|NOT COMPLETED|Main Trial - Double Blind Phase||3
10700555|NCT02561481|11865005|FG001|NOT COMPLETED|Main Trial - Double Blind Phase||2
10700556|NCT02561481|11865004|FG000|STARTED|Main Trial - Open Label Phase||45
10700557|NCT02561481|11865005|FG001|STARTED|Main Trial - Open Label Phase||0
10700558|NCT02561481|11865004|FG000|COMPLETED|Main Trial - Open Label Phase||32
10700559|NCT02561481|11865005|FG001|COMPLETED|Main Trial - Open Label Phase||0
10700560|NCT02561481|11865004|FG000|NOT COMPLETED|Main Trial - Open Label Phase||13
10700561|NCT02561481|11865005|FG001|NOT COMPLETED|Main Trial - Open Label Phase||0
10700562|NCT02561572|11865016|FG000|STARTED|Overall Study||64
10700563|NCT02561572|11865017|FG001|STARTED|Overall Study||64
10700564|NCT02561572|11865016|FG000|COMPLETED|Overall Study||62
10700565|NCT02561572|11865017|FG001|COMPLETED|Overall Study||62
10700566|NCT02561572|11865016|FG000|NOT COMPLETED|Overall Study||2
10801817|NCT04322526|11963065|FG001|NOT COMPLETED|Washout (1 Week)||2
10801818|NCT04322526|11963064|FG000|STARTED|Second Intervention (1day)||11
10801819|NCT04322526|11963065|FG001|STARTED|Second Intervention (1day)||9
10801820|NCT04322526|11963064|FG000|COMPLETED|Second Intervention (1day)||11
10801821|NCT04322526|11963065|FG001|COMPLETED|Second Intervention (1day)||9
10801822|NCT04322526|11963064|FG000|NOT COMPLETED|Second Intervention (1day)||0
10801823|NCT04322526|11963065|FG001|NOT COMPLETED|Second Intervention (1day)||0
10801824|NCT04322500|11963073|FG000|STARTED|Overall Study||13
10801825|NCT04322500|11963074|FG001|STARTED|Overall Study||13
10801826|NCT04322500|11963073|FG000|COMPLETED|Overall Study||13
10700567|NCT02561572|11865017|FG001|NOT COMPLETED|Overall Study||2
10700568|NCT02561585|11865025|FG000|STARTED|Overall Study||20
10700569|NCT02561585|11865026|FG001|STARTED|Overall Study||11
10801827|NCT04322500|11963074|FG001|COMPLETED|Overall Study||13
10700570|NCT02561585|11865025|FG000|COMPLETED|Overall Study||17
10700571|NCT02561585|11865026|FG001|COMPLETED|Overall Study||6
10700572|NCT02561585|11865025|FG000|NOT COMPLETED|Overall Study||3
10700573|NCT02561585|11865026|FG001|NOT COMPLETED|Overall Study||5
10801828|NCT04322500|11963073|FG000|NOT COMPLETED|Overall Study||0
10801829|NCT04322500|11963074|FG001|NOT COMPLETED|Overall Study||0
10700574|NCT02561702|11865036|FG000|STARTED|First Intervention||2
10700575|NCT02561702|11865037|FG001|STARTED|First Intervention||2
10700576|NCT02561702|11865036|FG000|COMPLETED|First Intervention||2
10700577|NCT02561702|11865037|FG001|COMPLETED|First Intervention||2
10700578|NCT02561702|11865036|FG000|NOT COMPLETED|First Intervention||0
10700579|NCT02561702|11865037|FG001|NOT COMPLETED|First Intervention||0
10700580|NCT02561702|11865036|FG000|STARTED|Washout||2
10700581|NCT02561702|11865037|FG001|STARTED|Washout||2
10700582|NCT02561702|11865036|FG000|COMPLETED|Washout||2
10700583|NCT02561702|11865037|FG001|COMPLETED|Washout||2
10700584|NCT02561702|11865036|FG000|NOT COMPLETED|Washout||0
10700585|NCT02561702|11865037|FG001|NOT COMPLETED|Washout||0
10700586|NCT02561702|11865036|FG000|STARTED|Second Intervention||2
10700587|NCT02561702|11865037|FG001|STARTED|Second Intervention||2
10700588|NCT02561702|11865036|FG000|COMPLETED|Second Intervention||2
10700589|NCT02561702|11865037|FG001|COMPLETED|Second Intervention||2
10700590|NCT02561702|11865036|FG000|NOT COMPLETED|Second Intervention||0
10700591|NCT02561702|11865037|FG001|NOT COMPLETED|Second Intervention||0
10700592|NCT02561806|11865045|FG000|STARTED|Induction Period||166
10700593|NCT02561806|11865046|FG001|STARTED|Induction Period||136
10700594|NCT02561806|11865045|FG000|Received At Least One Dose of Study Drug|Induction Period||166
10700595|NCT02561806|11865046|FG001|Received At Least One Dose of Study Drug|Induction Period||135
10700596|NCT02561806|11865045|FG000|COMPLETED|Induction Period||164
10700597|NCT02561806|11865046|FG001|COMPLETED|Induction Period||131
10700598|NCT02561806|11865045|FG000|NOT COMPLETED|Induction Period||2
10700599|NCT02561806|11865046|FG001|NOT COMPLETED|Induction Period||5
10700600|NCT02561806|11865045|FG000|STARTED|Maintenance Period||164
10700601|NCT02561806|11865046|FG001|STARTED|Maintenance Period||131
10700602|NCT02561806|11865045|FG000|COMPLETED|Maintenance Period||151
10700603|NCT02561806|11865046|FG001|COMPLETED|Maintenance Period||123
10700604|NCT02561806|11865045|FG000|NOT COMPLETED|Maintenance Period||13
10801830|NCT04322682|11963082|FG000|STARTED|Overall Study||2235
10801831|NCT04322682|11963083|FG001|STARTED|Overall Study||2253
10801832|NCT04322682|11963082|FG000|COMPLETED|Overall Study||2192
10801833|NCT04322682|11963083|FG001|COMPLETED|Overall Study||2189
10801834|NCT04322682|11963082|FG000|NOT COMPLETED|Overall Study||43
10801835|NCT04322682|11963083|FG001|NOT COMPLETED|Overall Study||64
10801836|NCT04321980|11963091|FG000|STARTED|Overall Study||4
10801837|NCT04321980|11963092|FG001|STARTED|Overall Study||4
10801838|NCT04321980|11963091|FG000|COMPLETED|Overall Study||4
10801839|NCT04321980|11963092|FG001|COMPLETED|Overall Study||4
10801840|NCT04321980|11963091|FG000|NOT COMPLETED|Overall Study||0
10801841|NCT04321980|11963092|FG001|NOT COMPLETED|Overall Study||0
10801842|NCT04322396|11963100|FG000|STARTED|Overall Study||56
10801843|NCT04322396|11963101|FG001|STARTED|Overall Study||61
10801844|NCT04322396|11963100|FG000|COMPLETED|Overall Study||56
10801845|NCT04322396|11963101|FG001|COMPLETED|Overall Study||61
10801846|NCT04322396|11963100|FG000|NOT COMPLETED|Overall Study||0
10801847|NCT04322396|11963101|FG001|NOT COMPLETED|Overall Study||0
10810996|NCT03783130|11972703|FG003|COMPLETED|Overall Study||5
10810997|NCT03783130|11972700|FG000|NOT COMPLETED|Overall Study||0
10810998|NCT03783130|11972701|FG001|NOT COMPLETED|Overall Study||0
10810999|NCT03783130|11972702|FG002|NOT COMPLETED|Overall Study||0
10811000|NCT03783130|11972703|FG003|NOT COMPLETED|Overall Study||0
10811001|NCT03776175|11972718|FG000|STARTED|Treatment Period (42 Days)||14
10811002|NCT03776175|11972719|FG001|STARTED|Treatment Period (42 Days)||29
10811003|NCT03776175|11972720|FG002|STARTED|Treatment Period (42 Days)||28
10811004|NCT03776175|11972721|FG003|STARTED|Treatment Period (42 Days)||28
10811005|NCT03776175|11972718|FG000|Treated|Treatment Period (42 Days)||14
10811006|NCT03776175|11972719|FG001|Treated|Treatment Period (42 Days)||29
10811007|NCT03776175|11972720|FG002|Treated|Treatment Period (42 Days)||28
10811008|NCT03776175|11972721|FG003|Treated|Treatment Period (42 Days)||28
10811009|NCT03776175|11972718|FG000|COMPLETED|Treatment Period (42 Days)||13
10811010|NCT03776175|11972719|FG001|COMPLETED|Treatment Period (42 Days)||22
10811011|NCT03776175|11972720|FG002|COMPLETED|Treatment Period (42 Days)||24
10811012|NCT03776175|11972721|FG003|COMPLETED|Treatment Period (42 Days)||26
10811013|NCT03776175|11972718|FG000|NOT COMPLETED|Treatment Period (42 Days)||1
10811014|NCT03776175|11972719|FG001|NOT COMPLETED|Treatment Period (42 Days)||7
10811015|NCT03776175|11972720|FG002|NOT COMPLETED|Treatment Period (42 Days)||4
10811016|NCT03776175|11972721|FG003|NOT COMPLETED|Treatment Period (42 Days)||2
10811017|NCT03776175|11972718|FG000|STARTED|Follow-Up Period (35 Days)||13
10811018|NCT03776175|11972719|FG001|STARTED|Follow-Up Period (35 Days)||22
10811019|NCT03776175|11972720|FG002|STARTED|Follow-Up Period (35 Days)||24
10811020|NCT03776175|11972721|FG003|STARTED|Follow-Up Period (35 Days)||26
10811021|NCT03776175|11972718|FG000|COMPLETED|Follow-Up Period (35 Days)||13
10811022|NCT03776175|11972719|FG001|COMPLETED|Follow-Up Period (35 Days)||22
10811023|NCT03776175|11972720|FG002|COMPLETED|Follow-Up Period (35 Days)||24
10811024|NCT03776175|11972721|FG003|COMPLETED|Follow-Up Period (35 Days)||24
10811025|NCT03776175|11972718|FG000|NOT COMPLETED|Follow-Up Period (35 Days)||0
10811026|NCT03776175|11972719|FG001|NOT COMPLETED|Follow-Up Period (35 Days)||0
10700605|NCT02561806|11865046|FG001|NOT COMPLETED|Maintenance Period||8
10700606|NCT02561806|11865045|FG000|STARTED|Post-Treatment Follow-up|Participants who discontinued previous periods had option to enter post treatment follow-up period.|157
10700607|NCT02561806|11865046|FG001|STARTED|Post-Treatment Follow-up|Participants who discontinued previous periods had option to enter post treatment follow-up period.|60
10811027|NCT03776175|11972720|FG002|NOT COMPLETED|Follow-Up Period (35 Days)||0
10811028|NCT03776175|11972721|FG003|NOT COMPLETED|Follow-Up Period (35 Days)||2
10700608|NCT02561806|11865045|FG000|COMPLETED|Post-Treatment Follow-up||155
10700609|NCT02561806|11865046|FG001|COMPLETED|Post-Treatment Follow-up||59
10700610|NCT02561806|11865045|FG000|NOT COMPLETED|Post-Treatment Follow-up||2
10700611|NCT02561806|11865046|FG001|NOT COMPLETED|Post-Treatment Follow-up||1
10700612|NCT02561832|11865069|FG000|STARTED|Overall Study||8
10700613|NCT02561832|11865070|FG001|STARTED|Overall Study||7
10700614|NCT02561832|11865069|FG000|INFORMED CONSENT OBTAINED|Overall Study||8
10700615|NCT02561832|11865070|FG001|INFORMED CONSENT OBTAINED|Overall Study||7
10700616|NCT02561832|11865069|FG000|COMPLETED|Overall Study||1
10700617|NCT02561832|11865070|FG001|COMPLETED|Overall Study||3
10700618|NCT02561832|11865069|FG000|NOT COMPLETED|Overall Study||7
10700619|NCT02561832|11865070|FG001|NOT COMPLETED|Overall Study||4
10700620|NCT02561897|11865078|FG000|STARTED|Overall Study||2
10700621|NCT02561897|11865079|FG001|STARTED|Overall Study||3
10700622|NCT02561897|11865078|FG000|COMPLETED|Overall Study||2
10700623|NCT02561897|11865079|FG001|COMPLETED|Overall Study||3
10700624|NCT02561897|11865078|FG000|NOT COMPLETED|Overall Study||0
10700625|NCT02561897|11865079|FG001|NOT COMPLETED|Overall Study||0
10700626|NCT02562066|11865089|FG000|STARTED|Overall Study||8
10700627|NCT02562066|11865090|FG001|STARTED|Overall Study||8
10700628|NCT02562066|11865091|FG002|STARTED|Overall Study||4
10700629|NCT02562066|11865089|FG000|COMPLETED|Overall Study||7
10700630|NCT02562066|11865090|FG001|COMPLETED|Overall Study||7
10700631|NCT02562066|11865091|FG002|COMPLETED|Overall Study||0
10700632|NCT02562066|11865089|FG000|NOT COMPLETED|Overall Study||1
10700633|NCT02562066|11865090|FG001|NOT COMPLETED|Overall Study||1
10700634|NCT02562066|11865091|FG002|NOT COMPLETED|Overall Study||4
10700635|NCT02562482|11865099|FG000|STARTED|Overall Study||201
10700636|NCT02562482|11865100|FG001|STARTED|Overall Study||199
10700637|NCT02562482|11865099|FG000|Received 1st Injection|Overall Study||197
10700638|NCT02562482|11865100|FG001|Received 1st Injection|Overall Study||199
10700639|NCT02562482|11865099|FG000|Received 2nd Injection|Overall Study||192
10700640|NCT02562482|11865100|FG001|Received 2nd Injection|Overall Study||192
10700641|NCT02562482|11865099|FG000|COMPLETED|Overall Study||180
10700642|NCT02562482|11865100|FG001|COMPLETED|Overall Study||183
10700643|NCT02562482|11865099|FG000|NOT COMPLETED|Overall Study||21
10700644|NCT02562482|11865100|FG001|NOT COMPLETED|Overall Study||16
10700645|NCT02562521|11865108|FG000|STARTED|Overall Study||18
10700646|NCT02562521|11865109|FG001|STARTED|Overall Study||7
10700647|NCT02562521|11865108|FG000|COMPLETED|Overall Study||18
10700648|NCT02562521|11865109|FG001|COMPLETED|Overall Study||7
10700649|NCT02562521|11865108|FG000|NOT COMPLETED|Overall Study||0
10700650|NCT02562521|11865109|FG001|NOT COMPLETED|Overall Study||0
10700651|NCT02562755|11865117|FG000|STARTED|Overall Study||234
10700652|NCT02562755|11865118|FG001|STARTED|Overall Study||225
10700653|NCT02562755|11865117|FG000|Safety Population|Overall Study||218
10700654|NCT02562755|11865118|FG001|Safety Population|Overall Study||217
10700655|NCT02562755|11865117|FG000|COMPLETED|Overall Study||161
10700656|NCT02562755|11865118|FG001|COMPLETED|Overall Study||153
10700657|NCT02562755|11865117|FG000|NOT COMPLETED|Overall Study||73
10700658|NCT02562755|11865118|FG001|NOT COMPLETED|Overall Study||72
10700659|NCT02562898|11865126|FG000|STARTED|Overall Study||10
10700660|NCT02562898|11865127|FG001|STARTED|Overall Study||8
10700661|NCT02562898|11865126|FG000|COMPLETED|Overall Study||10
10700662|NCT02562898|11865127|FG001|COMPLETED|Overall Study||8
10700663|NCT02562898|11865126|FG000|NOT COMPLETED|Overall Study||0
10700664|NCT02562898|11865127|FG001|NOT COMPLETED|Overall Study||0
10700665|NCT02562924|11865136|FG000|STARTED|Overall Study||13
10700666|NCT02562924|11865137|FG001|STARTED|Overall Study||12
10700667|NCT02562924|11865138|FG002|STARTED|Overall Study||12
10700668|NCT02562924|11865136|FG000|COMPLETED|Overall Study||12
10700669|NCT02562924|11865137|FG001|COMPLETED|Overall Study||1
10700670|NCT02562924|11865138|FG002|COMPLETED|Overall Study||8
10700671|NCT02562924|11865136|FG000|NOT COMPLETED|Overall Study||1
10700672|NCT02562924|11865137|FG001|NOT COMPLETED|Overall Study||11
10700673|NCT02562924|11865138|FG002|NOT COMPLETED|Overall Study||4
10700674|NCT02562989|11865152|FG000|STARTED|Overall Study||3
10700675|NCT02562989|11865153|FG001|STARTED|Overall Study||4
10700676|NCT02562989|11865154|FG002|STARTED|Overall Study||6
10700677|NCT02562989|11865152|FG000|COMPLETED|Overall Study||3
10700678|NCT02562989|11865153|FG001|COMPLETED|Overall Study||4
10700679|NCT02562989|11865154|FG002|COMPLETED|Overall Study||6
10700680|NCT02562989|11865152|FG000|NOT COMPLETED|Overall Study||0
10700681|NCT02562989|11865153|FG001|NOT COMPLETED|Overall Study||0
10700682|NCT02562989|11865154|FG002|NOT COMPLETED|Overall Study||0
10700683|NCT02563067|11865165|FG000|STARTED|Overall Study||296
10700684|NCT02563067|11865166|FG001|STARTED|Overall Study||294
10700685|NCT02563067|11865167|FG002|STARTED|Overall Study||287
10700686|NCT02563067|11865165|FG000|FAS/SAF: High Eosinophils Subpopulation|Overall Study||198
10700687|NCT02563067|11865166|FG001|FAS/SAF: High Eosinophils Subpopulation|Overall Study||196
10700688|NCT02563067|11865167|FG002|FAS/SAF: High Eosinophils Subpopulation|Overall Study||193
10700689|NCT02563067|11865165|FG000|FAS/SAF: Overall Population|Overall Study||296
10700690|NCT02563067|11865166|FG001|FAS/SAF: Overall Population|Overall Study||293
10700691|NCT02563067|11865167|FG002|FAS/SAF: Overall Population|Overall Study||287
10700692|NCT02563067|11865165|FG000|COMPLETED|Overall Study||277
10318956|NCT00218439|11453212|FG000|COMPLETED|Second Intervention (4 Weeks)||33
10318957|NCT00218439|11453213|FG001|COMPLETED|Second Intervention (4 Weeks)||30
10318958|NCT00218439|11453212|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||7
10700693|NCT02563067|11865166|FG001|COMPLETED|Overall Study||268
10700694|NCT02563067|11865167|FG002|COMPLETED|Overall Study||267
10700695|NCT02563067|11865165|FG000|NOT COMPLETED|Overall Study||19
10700696|NCT02563067|11865166|FG001|NOT COMPLETED|Overall Study||26
10700697|NCT02563067|11865167|FG002|NOT COMPLETED|Overall Study||20
10700698|NCT02563093|11865179|FG000|STARTED|Overall Study||52
10700699|NCT02563093|11865180|FG001|STARTED|Overall Study||52
10700700|NCT02563093|11865181|FG002|STARTED|Overall Study||53
10700701|NCT02563093|11865182|FG003|STARTED|Overall Study||51
10700702|NCT02563093|11865179|FG000|COMPLETED|Overall Study||52
10700703|NCT02563093|11865180|FG001|COMPLETED|Overall Study||52
10700704|NCT02563093|11865181|FG002|COMPLETED|Overall Study||53
10700705|NCT02563093|11865182|FG003|COMPLETED|Overall Study||51
10700706|NCT02563093|11865179|FG000|NOT COMPLETED|Overall Study||0
10700707|NCT02563093|11865180|FG001|NOT COMPLETED|Overall Study||0
10700708|NCT02563093|11865181|FG002|NOT COMPLETED|Overall Study||0
10700709|NCT02563093|11865182|FG003|NOT COMPLETED|Overall Study||0
10700710|NCT02563106|11865195|FG000|STARTED|Overall Study||206
10700711|NCT02563106|11865196|FG001|STARTED|Overall Study||207
10700712|NCT02563106|11865195|FG000|COMPLETED|Overall Study||172
10700713|NCT02563106|11865196|FG001|COMPLETED|Overall Study||178
10700714|NCT02563106|11865195|FG000|NOT COMPLETED|Overall Study||34
10700715|NCT02563106|11865196|FG001|NOT COMPLETED|Overall Study||29
10700716|NCT02563496|11865207|FG000|STARTED|Overall Study|No participants were enrolled since they didn't meet inclusion/exclusion criteria.|0
10700717|NCT02563496|11865208|FG001|STARTED|Overall Study||14
10700718|NCT02563496|11865209|FG002|STARTED|Overall Study||5
10700719|NCT02563496|11865210|FG003|STARTED|Overall Study||22
10700720|NCT02563496|11865211|FG004|STARTED|Overall Study||19
10700721|NCT02563496|11865207|FG000|COMPLETED|Overall Study||0
10700722|NCT02563496|11865208|FG001|COMPLETED|Overall Study||14
10700723|NCT02563496|11865209|FG002|COMPLETED|Overall Study||5
10700724|NCT02563496|11865210|FG003|COMPLETED|Overall Study||22
10700725|NCT02563496|11865211|FG004|COMPLETED|Overall Study||19
10700726|NCT02563496|11865207|FG000|NOT COMPLETED|Overall Study||0
10700727|NCT02563496|11865208|FG001|NOT COMPLETED|Overall Study||0
10700728|NCT02563496|11865209|FG002|NOT COMPLETED|Overall Study||0
10700729|NCT02563496|11865210|FG003|NOT COMPLETED|Overall Study||0
10700730|NCT02563496|11865211|FG004|NOT COMPLETED|Overall Study||0
10700731|NCT02563548|11865225|FG000|STARTED|Dose Escalation (Up to 46 Weeks)||3
10700732|NCT02563548|11865226|FG001|STARTED|Dose Escalation (Up to 46 Weeks)||2
10700733|NCT02563548|11865227|FG002|STARTED|Dose Escalation (Up to 46 Weeks)||7
10700734|NCT02563548|11865228|FG003|STARTED|Dose Escalation (Up to 46 Weeks)||2
10700735|NCT02563548|11865229|FG004|STARTED|Dose Escalation (Up to 46 Weeks)||0
10700736|NCT02563548|11865230|FG005|STARTED|Dose Escalation (Up to 46 Weeks)||0
10700737|NCT02563548|11865225|FG000|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||3
10700738|NCT02563548|11865226|FG001|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||2
10700739|NCT02563548|11865227|FG002|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||7
10700740|NCT02563548|11865228|FG003|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||2
10700741|NCT02563548|11865229|FG004|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||0
10700742|NCT02563548|11865230|FG005|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||0
10700743|NCT02563548|11865225|FG000|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
10700744|NCT02563548|11865226|FG001|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
10700745|NCT02563548|11865227|FG002|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
10700746|NCT02563548|11865228|FG003|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
10700747|NCT02563548|11865229|FG004|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
10700748|NCT02563548|11865230|FG005|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
10700749|NCT02563548|11865225|FG000|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||3
10700750|NCT02563548|11865226|FG001|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||2
10700751|NCT02563548|11865227|FG002|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||7
10700752|NCT02563548|11865228|FG003|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||2
10700753|NCT02563548|11865229|FG004|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||0
10801848|NCT04320823|11963109|FG000|STARTED|Overall Study||1717
10801849|NCT04320823|11963110|FG001|STARTED|Overall Study||1726
10801850|NCT04320823|11963109|FG000|COMPLETED|Overall Study|Includes 47 donors who withdrew from the study after one or more donations.|1717
10801851|NCT04320823|11963110|FG001|COMPLETED|Overall Study|Includes 38 donors who withdrew from the study after one or more donations.|1726
10801852|NCT04320823|11963109|FG000|NOT COMPLETED|Overall Study||0
10801853|NCT04320823|11963110|FG001|NOT COMPLETED|Overall Study||0
10801854|NCT04320615|11963134|FG000|STARTED|Overall Study||144
10801855|NCT04320615|11963135|FG001|STARTED|Overall Study||294
10801856|NCT04320615|11963134|FG000|COMPLETED|Overall Study||96
10801857|NCT04320615|11963135|FG001|COMPLETED|Overall Study||190
10801858|NCT04320615|11963134|FG000|NOT COMPLETED|Overall Study||48
10801859|NCT04320615|11963135|FG001|NOT COMPLETED|Overall Study||104
10801860|NCT04318535|11963145|FG000|STARTED|Treatment Period 1 (Day -1 to Day 5)||12
10801861|NCT04318535|11963146|FG001|STARTED|Treatment Period 1 (Day -1 to Day 5)||12
10801862|NCT04318535|11963147|FG002|STARTED|Treatment Period 1 (Day -1 to Day 5)||12
10801863|NCT04318535|11963145|FG000|COMPLETED|Treatment Period 1 (Day -1 to Day 5)||12
10801864|NCT04318535|11963146|FG001|COMPLETED|Treatment Period 1 (Day -1 to Day 5)||12
10801865|NCT04318535|11963147|FG002|COMPLETED|Treatment Period 1 (Day -1 to Day 5)||12
10700754|NCT02563548|11865230|FG005|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||0
10700755|NCT02563548|11865225|FG000|STARTED|Dose Expansion (Up to 60 Weeks)||0
10700756|NCT02563548|11865226|FG001|STARTED|Dose Expansion (Up to 60 Weeks)||0
10801866|NCT04318535|11963145|FG000|NOT COMPLETED|Treatment Period 1 (Day -1 to Day 5)||0
10700757|NCT02563548|11865227|FG002|STARTED|Dose Expansion (Up to 60 Weeks)||0
10700758|NCT02563548|11865228|FG003|STARTED|Dose Expansion (Up to 60 Weeks)||0
10700759|NCT02563548|11865229|FG004|STARTED|Dose Expansion (Up to 60 Weeks)||25
10700760|NCT02563548|11865230|FG005|STARTED|Dose Expansion (Up to 60 Weeks)||17
10700761|NCT02563548|11865225|FG000|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
10700762|NCT02563548|11865226|FG001|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
10700763|NCT02563548|11865227|FG002|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
10700764|NCT02563548|11865228|FG003|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
10700765|NCT02563548|11865229|FG004|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||24
10700766|NCT02563548|11865230|FG005|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||17
10700767|NCT02563548|11865225|FG000|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
10700768|NCT02563548|11865226|FG001|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
10700769|NCT02563548|11865227|FG002|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
10700770|NCT02563548|11865228|FG003|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
10700771|NCT02563548|11865229|FG004|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
10700772|NCT02563548|11865230|FG005|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
10700773|NCT02563548|11865225|FG000|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
10700774|NCT02563548|11865226|FG001|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
10700775|NCT02563548|11865227|FG002|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
10700776|NCT02563548|11865228|FG003|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
10700777|NCT02563548|11865229|FG004|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||25
10700778|NCT02563548|11865230|FG005|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||17
10700779|NCT02563561|11865253|FG000|STARTED|Overall Study||19
10700780|NCT02563561|11865254|FG001|STARTED|Overall Study||23
10700781|NCT02563561|11865255|FG002|STARTED|Overall Study||20
10700782|NCT02563561|11865253|FG000|Safety Population|Overall Study||19
10700783|NCT02563561|11865254|FG001|Safety Population|Overall Study||21
10700784|NCT02563561|11865255|FG002|Safety Population|Overall Study||17
10700785|NCT02563561|11865253|FG000|COMPLETED|Overall Study||1
10700786|NCT02563561|11865254|FG001|COMPLETED|Overall Study||2
10700787|NCT02563561|11865255|FG002|COMPLETED|Overall Study||3
10700788|NCT02563561|11865253|FG000|NOT COMPLETED|Overall Study||18
10700789|NCT02563561|11865254|FG001|NOT COMPLETED|Overall Study||21
10700790|NCT02563561|11865255|FG002|NOT COMPLETED|Overall Study||17
10700791|NCT02563808|11865265|FG000|STARTED|Overall Study||96
10700792|NCT02563808|11865266|FG001|STARTED|Overall Study|A total of 5 participants enrolled were not included in final data due to data collection error|88
10700793|NCT02563808|11865265|FG000|COMPLETED|Overall Study||96
10700794|NCT02563808|11865266|FG001|COMPLETED|Overall Study||88
10700795|NCT02563808|11865265|FG000|NOT COMPLETED|Overall Study||0
10700796|NCT02563808|11865266|FG001|NOT COMPLETED|Overall Study||0
10700797|NCT02563834|11865274|FG000|STARTED|Control (Saline) Infusion (*Day 1)||10
10700798|NCT02563834|11865275|FG001|STARTED|Control (Saline) Infusion (*Day 1)||8
10700799|NCT02563834|11865274|FG000|COMPLETED|Control (Saline) Infusion (*Day 1)||10
10700800|NCT02563834|11865275|FG001|COMPLETED|Control (Saline) Infusion (*Day 1)||8
10700801|NCT02563834|11865274|FG000|NOT COMPLETED|Control (Saline) Infusion (*Day 1)||0
10700802|NCT02563834|11865275|FG001|NOT COMPLETED|Control (Saline) Infusion (*Day 1)||0
10700803|NCT02563834|11865274|FG000|STARTED|Insulin Infusion (*Day 2)||10
10700804|NCT02563834|11865275|FG001|STARTED|Insulin Infusion (*Day 2)||8
10700805|NCT02563834|11865274|FG000|COMPLETED|Insulin Infusion (*Day 2)||10
10700806|NCT02563834|11865275|FG001|COMPLETED|Insulin Infusion (*Day 2)||8
10700807|NCT02563834|11865274|FG000|NOT COMPLETED|Insulin Infusion (*Day 2)||0
10700808|NCT02563834|11865275|FG001|NOT COMPLETED|Insulin Infusion (*Day 2)||0
10700809|NCT02563860|11865283|FG000|STARTED|Overall Study||20
10700810|NCT02563860|11865283|FG000|COMPLETED|Overall Study||19
10700811|NCT02563860|11865283|FG000|NOT COMPLETED|Overall Study||1
10700812|NCT02563899|11865291|FG000|STARTED|Overall Study||18
10700813|NCT02563899|11865292|FG001|STARTED|Overall Study||5
10700814|NCT02563899|11865293|FG002|STARTED|Overall Study||10
10700815|NCT02563899|11865294|FG003|STARTED|Overall Study||6
10700816|NCT02563899|11865291|FG000|COMPLETED|Overall Study||17
10801867|NCT04318535|11963146|FG001|NOT COMPLETED|Treatment Period 1 (Day -1 to Day 5)||0
10801868|NCT04318535|11963147|FG002|NOT COMPLETED|Treatment Period 1 (Day -1 to Day 5)||0
10801869|NCT04318535|11963145|FG000|STARTED|Period1washout(Atleast 7 Days Post-dose)||12
10801870|NCT04318535|11963146|FG001|STARTED|Period1washout(Atleast 7 Days Post-dose)||12
10801871|NCT04318535|11963147|FG002|STARTED|Period1washout(Atleast 7 Days Post-dose)||12
10801872|NCT04318535|11963145|FG000|COMPLETED|Period1washout(Atleast 7 Days Post-dose)||12
10801873|NCT04318535|11963146|FG001|COMPLETED|Period1washout(Atleast 7 Days Post-dose)||12
10801874|NCT04318535|11963147|FG002|COMPLETED|Period1washout(Atleast 7 Days Post-dose)||12
10801875|NCT04318535|11963145|FG000|NOT COMPLETED|Period1washout(Atleast 7 Days Post-dose)||0
10801876|NCT04318535|11963146|FG001|NOT COMPLETED|Period1washout(Atleast 7 Days Post-dose)||0
10801877|NCT04318535|11963147|FG002|NOT COMPLETED|Period1washout(Atleast 7 Days Post-dose)||0
10801878|NCT04318535|11963145|FG000|STARTED|Treatment Period 2 (Day 7 to Day 12)||12
10801879|NCT04318535|11963146|FG001|STARTED|Treatment Period 2 (Day 7 to Day 12)||12
10801880|NCT04318535|11963147|FG002|STARTED|Treatment Period 2 (Day 7 to Day 12)||12
10801881|NCT04318535|11963145|FG000|COMPLETED|Treatment Period 2 (Day 7 to Day 12)||12
10801882|NCT04318535|11963146|FG001|COMPLETED|Treatment Period 2 (Day 7 to Day 12)||12
10801883|NCT04318535|11963147|FG002|COMPLETED|Treatment Period 2 (Day 7 to Day 12)||12
10801884|NCT04318535|11963145|FG000|NOT COMPLETED|Treatment Period 2 (Day 7 to Day 12)||0
10700817|NCT02563899|11865292|FG001|COMPLETED|Overall Study||5
10700818|NCT02563899|11865293|FG002|COMPLETED|Overall Study||9
10700819|NCT02563899|11865294|FG003|COMPLETED|Overall Study||6
10700820|NCT02563899|11865291|FG000|NOT COMPLETED|Overall Study||1
10700821|NCT02563899|11865292|FG001|NOT COMPLETED|Overall Study||0
10700822|NCT02563899|11865293|FG002|NOT COMPLETED|Overall Study||1
10700823|NCT02563899|11865294|FG003|NOT COMPLETED|Overall Study||0
10700824|NCT02563990|11865307|FG000|STARTED|Overall Study||12
10700825|NCT02563990|11865308|FG001|STARTED|Overall Study||14
10700826|NCT02563990|11865307|FG000|COMPLETED|Overall Study||12
10700827|NCT02563990|11865308|FG001|COMPLETED|Overall Study||14
10700828|NCT02563990|11865307|FG000|NOT COMPLETED|Overall Study||0
10700829|NCT02563990|11865308|FG001|NOT COMPLETED|Overall Study||0
10700830|NCT02564016|11865318|FG000|STARTED|Overall Study||22
10700831|NCT02564016|11865319|FG001|STARTED|Overall Study||14
10700832|NCT02564016|11865318|FG000|COMPLETED|Overall Study||4
10700833|NCT02564016|11865319|FG001|COMPLETED|Overall Study||4
10700834|NCT02564016|11865318|FG000|NOT COMPLETED|Overall Study||18
10700835|NCT02564016|11865319|FG001|NOT COMPLETED|Overall Study||10
10700836|NCT02564029|11865325|FG000|STARTED|Overall Study||7
10700837|NCT02564029|11865325|FG000|COMPLETED|Overall Study||7
10700838|NCT02564029|11865325|FG000|NOT COMPLETED|Overall Study||0
10700839|NCT02564042|11865342|FG000|STARTED|Overall Study||38
10700840|NCT02564042|11865343|FG001|STARTED|Overall Study||38
10700841|NCT02564042|11865344|FG002|STARTED|Overall Study||38
10801885|NCT04318535|11963146|FG001|NOT COMPLETED|Treatment Period 2 (Day 7 to Day 12)||0
10801886|NCT04318535|11963147|FG002|NOT COMPLETED|Treatment Period 2 (Day 7 to Day 12)||0
10801887|NCT04318535|11963145|FG000|STARTED|Period2washout(Atleast 7 Days Post-dose)||12
10801888|NCT04318535|11963146|FG001|STARTED|Period2washout(Atleast 7 Days Post-dose)||12
10801889|NCT04318535|11963147|FG002|STARTED|Period2washout(Atleast 7 Days Post-dose)||12
10801890|NCT04318535|11963145|FG000|COMPLETED|Period2washout(Atleast 7 Days Post-dose)||12
10801891|NCT04318535|11963146|FG001|COMPLETED|Period2washout(Atleast 7 Days Post-dose)||11
10801892|NCT04318535|11963147|FG002|COMPLETED|Period2washout(Atleast 7 Days Post-dose)||12
10801893|NCT04318535|11963145|FG000|NOT COMPLETED|Period2washout(Atleast 7 Days Post-dose)||0
10801894|NCT04318535|11963146|FG001|NOT COMPLETED|Period2washout(Atleast 7 Days Post-dose)||1
10801895|NCT04318535|11963147|FG002|NOT COMPLETED|Period2washout(Atleast 7 Days Post-dose)||0
10801896|NCT04318535|11963145|FG000|STARTED|Treatment Period 3 (Day 17 to Day 22)||12
10801897|NCT04318535|11963146|FG001|STARTED|Treatment Period 3 (Day 17 to Day 22)||11
10801898|NCT04318535|11963147|FG002|STARTED|Treatment Period 3 (Day 17 to Day 22)||12
10801899|NCT04318535|11963145|FG000|COMPLETED|Treatment Period 3 (Day 17 to Day 22)||12
10801900|NCT04318535|11963146|FG001|COMPLETED|Treatment Period 3 (Day 17 to Day 22)||11
10801901|NCT04318535|11963147|FG002|COMPLETED|Treatment Period 3 (Day 17 to Day 22)||12
10801902|NCT04318535|11963145|FG000|NOT COMPLETED|Treatment Period 3 (Day 17 to Day 22)||0
10801903|NCT04318535|11963146|FG001|NOT COMPLETED|Treatment Period 3 (Day 17 to Day 22)||0
10801904|NCT04318535|11963147|FG002|NOT COMPLETED|Treatment Period 3 (Day 17 to Day 22)||0
10801905|NCT04316260|11963158|FG000|STARTED|Overall Study||34
10801906|NCT04316260|11963159|FG001|STARTED|Overall Study||17
10801907|NCT04316260|11963158|FG000|COMPLETED|Overall Study||34
10801908|NCT04316260|11963159|FG001|COMPLETED|Overall Study||17
10801909|NCT04316260|11963158|FG000|NOT COMPLETED|Overall Study||0
10801910|NCT04316260|11963159|FG001|NOT COMPLETED|Overall Study||0
10801911|NCT04314037|11963168|FG000|STARTED|Treatment Period 1||18
10801912|NCT04314037|11963169|FG001|STARTED|Treatment Period 1||18
10801913|NCT04314037|11963168|FG000|COMPLETED|Treatment Period 1||18
10801914|NCT04314037|11963169|FG001|COMPLETED|Treatment Period 1||18
10801915|NCT04314037|11963168|FG000|NOT COMPLETED|Treatment Period 1||0
10801916|NCT04314037|11963169|FG001|NOT COMPLETED|Treatment Period 1||0
10801917|NCT04314037|11963168|FG000|STARTED|Treatment Period 2||18
10801918|NCT04314037|11963169|FG001|STARTED|Treatment Period 2||18
10801919|NCT04314037|11963168|FG000|COMPLETED|Treatment Period 2||17
10801920|NCT04314037|11963169|FG001|COMPLETED|Treatment Period 2||18
10801921|NCT04314037|11963168|FG000|NOT COMPLETED|Treatment Period 2||1
10801922|NCT04314037|11963169|FG001|NOT COMPLETED|Treatment Period 2||0
10801923|NCT04314037|11963168|FG000|STARTED|Treatment Period 3||17
10801924|NCT04314037|11963169|FG001|STARTED|Treatment Period 3||18
10801925|NCT04314037|11963168|FG000|COMPLETED|Treatment Period 3||16
10801926|NCT04314037|11963169|FG001|COMPLETED|Treatment Period 3||17
10801927|NCT04314037|11963168|FG000|NOT COMPLETED|Treatment Period 3||1
10801928|NCT04314037|11963169|FG001|NOT COMPLETED|Treatment Period 3||1
10801929|NCT04314037|11963168|FG000|STARTED|Treatment Period 4||16
10801930|NCT04314037|11963169|FG001|STARTED|Treatment Period 4||17
10801931|NCT04314037|11963168|FG000|COMPLETED|Treatment Period 4||16
10801932|NCT04314037|11963169|FG001|COMPLETED|Treatment Period 4||17
10801933|NCT04314037|11963168|FG000|NOT COMPLETED|Treatment Period 4||0
10700842|NCT02564042|11865345|FG003|STARTED|Overall Study||38
10700843|NCT02564042|11865346|FG004|STARTED|Overall Study||37
10700844|NCT02564042|11865347|FG005|STARTED|Overall Study||38
10700845|NCT02564042|11865342|FG000|COMPLETED|Overall Study||27
10700846|NCT02564042|11865343|FG001|COMPLETED|Overall Study||30
10700847|NCT02564042|11865344|FG002|COMPLETED|Overall Study||32
10700848|NCT02564042|11865345|FG003|COMPLETED|Overall Study||35
10700849|NCT02564042|11865346|FG004|COMPLETED|Overall Study||26
10700850|NCT02564042|11865347|FG005|COMPLETED|Overall Study||24
10700851|NCT02564042|11865342|FG000|NOT COMPLETED|Overall Study||11
10700852|NCT02564042|11865343|FG001|NOT COMPLETED|Overall Study||8
10801934|NCT04314037|11963169|FG001|NOT COMPLETED|Treatment Period 4||0
10700853|NCT02564042|11865344|FG002|NOT COMPLETED|Overall Study||6
10700854|NCT02564042|11865345|FG003|NOT COMPLETED|Overall Study||3
10700855|NCT02564042|11865346|FG004|NOT COMPLETED|Overall Study||11
10700856|NCT02564042|11865347|FG005|NOT COMPLETED|Overall Study||14
10700857|NCT02564055|11865367|FG000|STARTED|Overall Study||40
10700858|NCT02564055|11865368|FG001|STARTED|Overall Study||41
10700859|NCT02564055|11865369|FG002|STARTED|Overall Study||43
10700860|NCT02564055|11865370|FG003|STARTED|Overall Study||41
10700861|NCT02564055|11865371|FG004|STARTED|Overall Study||42
10700862|NCT02564055|11865372|FG005|STARTED|Overall Study||40
10700863|NCT02564055|11865367|FG000|COMPLETED|Overall Study||34
10700864|NCT02564055|11865368|FG001|COMPLETED|Overall Study||36
10700865|NCT02564055|11865369|FG002|COMPLETED|Overall Study||31
10700866|NCT02564055|11865370|FG003|COMPLETED|Overall Study||35
10700867|NCT02564055|11865371|FG004|COMPLETED|Overall Study||27
10700868|NCT02564055|11865372|FG005|COMPLETED|Overall Study||28
10700869|NCT02564055|11865367|FG000|NOT COMPLETED|Overall Study||6
10700870|NCT02564055|11865368|FG001|NOT COMPLETED|Overall Study||5
10700871|NCT02564055|11865369|FG002|NOT COMPLETED|Overall Study||12
10700872|NCT02564055|11865370|FG003|NOT COMPLETED|Overall Study||6
10700873|NCT02564055|11865371|FG004|NOT COMPLETED|Overall Study||15
10700874|NCT02564055|11865372|FG005|NOT COMPLETED|Overall Study||12
10700875|NCT02564120|11865391|FG000|STARTED|Overall Study||1556
10700876|NCT02564120|11865391|FG000|COMPLETED|Overall Study||1110
10700877|NCT02564120|11865391|FG000|NOT COMPLETED|Overall Study||446
10700878|NCT02564198|11865408|FG000|STARTED|Overall Study||8
10700879|NCT02564198|11865409|FG001|STARTED|Overall Study||15
10700880|NCT02564198|11865410|FG002|STARTED|Overall Study||6
10700881|NCT02564198|11865408|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
10700882|NCT02564198|11865409|FG001|Received at Least 1 Dose of Study Drug|Overall Study||15
10700883|NCT02564198|11865410|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
10700884|NCT02564198|11865408|FG000|COMPLETED|Overall Study||6
10700885|NCT02564198|11865409|FG001|COMPLETED|Overall Study||10
10700886|NCT02564198|11865410|FG002|COMPLETED|Overall Study||6
10700887|NCT02564198|11865408|FG000|NOT COMPLETED|Overall Study||2
10700888|NCT02564198|11865409|FG001|NOT COMPLETED|Overall Study||5
10700889|NCT02564198|11865410|FG002|NOT COMPLETED|Overall Study||0
10700890|NCT02564211|11865420|FG000|STARTED|Overall Study||77
10700891|NCT02564211|11865420|FG000|COMPLETED|Overall Study||73
10700892|NCT02564211|11865420|FG000|NOT COMPLETED|Overall Study||4
10700893|NCT02564354|11865426|FG000|STARTED|Overall Study||10
10700894|NCT02564354|11865427|FG001|STARTED|Overall Study||8
10801935|NCT04315298|11963200|FG000|STARTED|Overall Study||90
10801936|NCT04315298|11963201|FG001|STARTED|Overall Study||187
10801937|NCT04315298|11963202|FG002|STARTED|Overall Study||180
10801938|NCT04315298|11963203|FG003|STARTED|Overall Study||170
10801939|NCT04315298|11963204|FG004|STARTED|Overall Study||242
10801940|NCT04315298|11963205|FG005|STARTED|Overall Study||338
10700895|NCT02564354|11865426|FG000|COMPLETED|Overall Study||10
10700896|NCT02564354|11865427|FG001|COMPLETED|Overall Study||8
10700897|NCT02564354|11865426|FG000|NOT COMPLETED|Overall Study||0
10700898|NCT02564354|11865427|FG001|NOT COMPLETED|Overall Study||0
10700899|NCT02564432|11865433|FG000|STARTED|Overall Study||10
10700900|NCT02564432|11865433|FG000|COMPLETED|Overall Study|1 patient suffered periprosthetic fracture at 8 months; 1 failed to osseointegrate|8
10700901|NCT02564432|11865433|FG000|NOT COMPLETED|Overall Study||2
10700902|NCT02564471|11865443|FG000|STARTED|Overall Study||25
10700903|NCT02564471|11865444|FG001|STARTED|Overall Study||26
10700904|NCT02564471|11865445|FG002|STARTED|Overall Study||27
10700905|NCT02564471|11865446|FG003|STARTED|Overall Study||25
10801941|NCT04315298|11963206|FG006|STARTED|Overall Study||70
10801942|NCT04315298|11963207|FG007|STARTED|Overall Study||140
10801943|NCT04315298|11963208|FG008|STARTED|Overall Study||137
10801944|NCT04315298|11963209|FG009|STARTED|Overall Study||46
10801945|NCT04315298|11963210|FG010|STARTED|Overall Study||95
10801946|NCT04315298|11963211|FG011|STARTED|Overall Study||92
10801947|NCT04315298|11963212|FG012|STARTED|Overall Study||8
10801948|NCT04315298|11963213|FG013|STARTED|Overall Study||12
10801949|NCT04315298|11963214|FG014|STARTED|Overall Study||15
10801950|NCT04315298|11963215|FG015|STARTED|Overall Study||15
10801951|NCT04315298|11963216|FG016|STARTED|Overall Study||16
10801952|NCT04315298|11963217|FG017|STARTED|Overall Study||6
10801953|NCT04315298|11963218|FG018|STARTED|Overall Study||2
10801954|NCT04315298|11963200|FG000|COMPLETED|Overall Study||61
10801955|NCT04315298|11963201|FG001|COMPLETED|Overall Study||117
10801956|NCT04315298|11963202|FG002|COMPLETED|Overall Study||125
10801957|NCT04315298|11963203|FG003|COMPLETED|Overall Study||101
10801958|NCT04315298|11963204|FG004|COMPLETED|Overall Study||157
10801959|NCT04315298|11963205|FG005|COMPLETED|Overall Study||209
10801960|NCT04315298|11963206|FG006|COMPLETED|Overall Study||52
10801961|NCT04315298|11963207|FG007|COMPLETED|Overall Study||111
10700906|NCT02564471|11865443|FG000|COMPLETED|Overall Study||22
10700907|NCT02564471|11865444|FG001|COMPLETED|Overall Study||23
10700908|NCT02564471|11865445|FG002|COMPLETED|Overall Study||24
10700909|NCT02564471|11865446|FG003|COMPLETED|Overall Study||25
10700910|NCT02564471|11865443|FG000|NOT COMPLETED|Overall Study||3
10700911|NCT02564471|11865444|FG001|NOT COMPLETED|Overall Study||3
10700912|NCT02564471|11865445|FG002|NOT COMPLETED|Overall Study||3
10700913|NCT02564471|11865446|FG003|NOT COMPLETED|Overall Study||0
10700914|NCT02564497|11865458|FG000|STARTED|Overall Study||74
10700915|NCT02564497|11865459|FG001|STARTED|Overall Study||72
10801962|NCT04315298|11963208|FG008|COMPLETED|Overall Study||101
10801963|NCT04315298|11963209|FG009|COMPLETED|Overall Study||29
10700916|NCT02564497|11865458|FG000|COMPLETED|Overall Study||74
10700917|NCT02564497|11865459|FG001|COMPLETED|Overall Study||72
10700918|NCT02564497|11865458|FG000|NOT COMPLETED|Overall Study||0
10700919|NCT02564497|11865459|FG001|NOT COMPLETED|Overall Study||0
10700920|NCT02564718|11865467|FG000|STARTED|Overall Study||5
10700921|NCT02564718|11865468|FG001|STARTED|Overall Study||5
10700922|NCT02564718|11865467|FG000|COMPLETED|Overall Study||5
10700923|NCT02564718|11865468|FG001|COMPLETED|Overall Study||4
10700924|NCT02564718|11865467|FG000|NOT COMPLETED|Overall Study||0
10700925|NCT02564718|11865468|FG001|NOT COMPLETED|Overall Study||1
10700926|NCT02564887|11865476|FG000|STARTED|Overall Study||16
10700927|NCT02564887|11865477|FG001|STARTED|Overall Study||10
10700928|NCT02564887|11865476|FG000|COMPLETED|Overall Study||10
10801964|NCT04315298|11963210|FG010|COMPLETED|Overall Study||53
10801965|NCT04315298|11963211|FG011|COMPLETED|Overall Study||51
10801966|NCT04315298|11963212|FG012|COMPLETED|Overall Study||5
10801967|NCT04315298|11963213|FG013|COMPLETED|Overall Study||8
10801968|NCT04315298|11963214|FG014|COMPLETED|Overall Study||9
10801969|NCT04315298|11963215|FG015|COMPLETED|Overall Study||9
10700929|NCT02564887|11865477|FG001|COMPLETED|Overall Study||10
10700930|NCT02564887|11865476|FG000|NOT COMPLETED|Overall Study||6
10700931|NCT02564887|11865477|FG001|NOT COMPLETED|Overall Study||0
10700932|NCT02564926|11865487|FG000|STARTED|Overall Study||60
10700933|NCT02564926|11865488|FG001|STARTED|Overall Study||61
10700934|NCT02564926|11865487|FG000|COMPLETED|Overall Study||52
10700935|NCT02564926|11865488|FG001|COMPLETED|Overall Study||54
10700936|NCT02564926|11865487|FG000|NOT COMPLETED|Overall Study||8
10700937|NCT02564926|11865488|FG001|NOT COMPLETED|Overall Study||7
10801970|NCT04315298|11963216|FG016|COMPLETED|Overall Study||13
10801971|NCT04315298|11963217|FG017|COMPLETED|Overall Study||5
10801972|NCT04315298|11963218|FG018|COMPLETED|Overall Study||2
10801973|NCT04315298|11963200|FG000|NOT COMPLETED|Overall Study||29
10801974|NCT04315298|11963201|FG001|NOT COMPLETED|Overall Study||70
10801975|NCT04315298|11963202|FG002|NOT COMPLETED|Overall Study||55
10801976|NCT04315298|11963203|FG003|NOT COMPLETED|Overall Study||69
10801977|NCT04315298|11963204|FG004|NOT COMPLETED|Overall Study||85
10801978|NCT04315298|11963205|FG005|NOT COMPLETED|Overall Study||129
10801979|NCT04315298|11963206|FG006|NOT COMPLETED|Overall Study||18
10801980|NCT04315298|11963207|FG007|NOT COMPLETED|Overall Study||29
10801981|NCT04315298|11963208|FG008|NOT COMPLETED|Overall Study||36
10801982|NCT04315298|11963209|FG009|NOT COMPLETED|Overall Study||17
10801983|NCT04315298|11963210|FG010|NOT COMPLETED|Overall Study||42
10801984|NCT04315298|11963211|FG011|NOT COMPLETED|Overall Study||41
10801985|NCT04315298|11963212|FG012|NOT COMPLETED|Overall Study||3
10801986|NCT04315298|11963213|FG013|NOT COMPLETED|Overall Study||4
10801987|NCT04315298|11963214|FG014|NOT COMPLETED|Overall Study||6
10801988|NCT04315298|11963215|FG015|NOT COMPLETED|Overall Study||6
10801989|NCT04315298|11963216|FG016|NOT COMPLETED|Overall Study||3
10801990|NCT04315298|11963217|FG017|NOT COMPLETED|Overall Study||1
10801991|NCT04315298|11963218|FG018|NOT COMPLETED|Overall Study||0
10801992|NCT04313647|11963290|FG000|STARTED|Overall Study||3
10801993|NCT04313647|11963291|FG001|STARTED|Overall Study||3
10801994|NCT04313647|11963292|FG002|STARTED|Overall Study||6
10801995|NCT04313647|11963293|FG003|STARTED|Overall Study||6
10801996|NCT04313647|11963294|FG004|STARTED|Overall Study||6
10801997|NCT04313647|11963290|FG000|COMPLETED|Overall Study||3
10801998|NCT04313647|11963291|FG001|COMPLETED|Overall Study||3
10801999|NCT04313647|11963292|FG002|COMPLETED|Overall Study||6
10802000|NCT04313647|11963293|FG003|COMPLETED|Overall Study||6
10802001|NCT04313647|11963294|FG004|COMPLETED|Overall Study||6
10802002|NCT04313647|11963290|FG000|NOT COMPLETED|Overall Study||0
10802003|NCT04313647|11963291|FG001|NOT COMPLETED|Overall Study||0
10802004|NCT04313647|11963292|FG002|NOT COMPLETED|Overall Study||0
10802005|NCT04313647|11963293|FG003|NOT COMPLETED|Overall Study||0
10802006|NCT04313647|11963294|FG004|NOT COMPLETED|Overall Study||0
10802007|NCT04310085|11963313|FG000|STARTED|Overall Study||8
10318959|NCT00218439|11453213|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||5
10318960|NCT00218465|11453229|FG000|STARTED|Overall Study||50
10318961|NCT00218465|11453230|FG001|STARTED|Overall Study||48
10318962|NCT00218465|11453229|FG000|COMPLETED|Overall Study||33
10318963|NCT00218465|11453230|FG001|COMPLETED|Overall Study||30
10318964|NCT00218465|11453229|FG000|NOT COMPLETED|Overall Study||17
10318965|NCT00218465|11453230|FG001|NOT COMPLETED|Overall Study||18
10318966|NCT00218491|11453239|FG000|STARTED|Overall Study||40
10318967|NCT00218491|11453240|FG001|STARTED|Overall Study||33
10318968|NCT00218491|11453241|FG002|STARTED|Overall Study||38
10318969|NCT00218491|11453239|FG000|COMPLETED|Overall Study||40
10318970|NCT00218491|11453240|FG001|COMPLETED|Overall Study||33
10318971|NCT00218491|11453241|FG002|COMPLETED|Overall Study||38
10318972|NCT00218491|11453239|FG000|NOT COMPLETED|Overall Study||0
10318973|NCT00218491|11453240|FG001|NOT COMPLETED|Overall Study||0
10318974|NCT00218491|11453241|FG002|NOT COMPLETED|Overall Study||0
10802008|NCT04310085|11963314|FG001|STARTED|Overall Study||8
10318975|NCT00218543|11453249|FG000|STARTED|Overall Study||20
10700953|NCT02565147|11865509|FG000|STARTED|Overall Study||38
10700954|NCT02565147|11865510|FG001|STARTED|Overall Study||40
10700955|NCT02565147|11865509|FG000|Received Study Drug|Overall Study||38
10700956|NCT02565147|11865510|FG001|Received Study Drug|Overall Study||40
10700957|NCT02565147|11865509|FG000|Per-Protocol Population|Overall Study||28
10700958|NCT02565147|11865510|FG001|Per-Protocol Population|Overall Study||36
10700959|NCT02565147|11865509|FG000|COMPLETED|Overall Study||32
10700960|NCT02565147|11865510|FG001|COMPLETED|Overall Study||37
10700961|NCT02565147|11865509|FG000|NOT COMPLETED|Overall Study||6
10700962|NCT02565147|11865510|FG001|NOT COMPLETED|Overall Study||3
10700963|NCT02565186|11865518|FG000|STARTED|Overall Study||1046
10700964|NCT02565186|11865519|FG001|STARTED|Overall Study||1125
10700965|NCT02565186|11865518|FG000|Received at Least One Dose of Study Drug|Overall Study||991
10700966|NCT02565186|11865519|FG001|Received at Least One Dose of Study Drug|Overall Study||1039
10700967|NCT02565186|11865518|FG000|COMPLETED|Overall Study||466
10318976|NCT00218543|11453249|FG000|COMPLETED|Overall Study|13 reached the maintenance dose phase of treatment; 9 completed at least six weeks of treatment.|5
10318977|NCT00218543|11453249|FG000|NOT COMPLETED|Overall Study||15
10318978|NCT00218634|11453255|FG000|STARTED|Overall Study||44
10318979|NCT00218634|11453256|FG001|STARTED|Overall Study||45
10318980|NCT00218634|11453255|FG000|COMPLETED|Overall Study||36
10318981|NCT00218634|11453256|FG001|COMPLETED|Overall Study||30
10318982|NCT00218634|11453255|FG000|NOT COMPLETED|Overall Study||8
10318983|NCT00218634|11453256|FG001|NOT COMPLETED|Overall Study||15
10318984|NCT00219141|11453268|FG000|STARTED|Overall Study||154
10318985|NCT00219141|11453269|FG001|STARTED|Overall Study||152
10318986|NCT00219141|11453270|FG002|STARTED|Overall Study||154
10318987|NCT00219141|11453268|FG000|COMPLETED|Overall Study||140
10318988|NCT00219141|11453269|FG001|COMPLETED|Overall Study||131
10318989|NCT00219141|11453270|FG002|COMPLETED|Overall Study||142
10318990|NCT00219141|11453268|FG000|NOT COMPLETED|Overall Study||14
10318991|NCT00219141|11453269|FG001|NOT COMPLETED|Overall Study||21
10318992|NCT00219141|11453270|FG002|NOT COMPLETED|Overall Study||12
10318993|NCT00219284|11453280|FG000|STARTED|Treatment Phase - 16 Weeks||180
10318994|NCT00219284|11453281|FG001|STARTED|Treatment Phase - 16 Weeks||179
10318995|NCT00219284|11453280|FG000|COMPLETED|Treatment Phase - 16 Weeks||136
10318996|NCT00219284|11453281|FG001|COMPLETED|Treatment Phase - 16 Weeks||128
10318997|NCT00219284|11453280|FG000|NOT COMPLETED|Treatment Phase - 16 Weeks||44
10318998|NCT00219284|11453281|FG001|NOT COMPLETED|Treatment Phase - 16 Weeks||51
10318999|NCT00219284|11453280|FG000|STARTED|Extension Phase - 8 Weeks|Not all subjects who completed the treatment phase chose to enter this optional extension phase.|114
10802009|NCT04310085|11963313|FG000|COMPLETED|Overall Study||8
10802010|NCT04310085|11963314|FG001|COMPLETED|Overall Study||8
10802011|NCT04310085|11963313|FG000|NOT COMPLETED|Overall Study||0
10802012|NCT04310085|11963314|FG001|NOT COMPLETED|Overall Study||0
10802013|NCT04309617|11963320|FG000|STARTED|Overall Study||618
10802014|NCT04309617|11963320|FG000|Modified High Risk of Recurrence|Overall Study||136
10802015|NCT04309617|11963320|FG000|COMPLETED|Overall Study||618
10802016|NCT04309617|11963320|FG000|NOT COMPLETED|Overall Study||0
10802017|NCT04308239|11963328|FG000|STARTED|Pre-intervention Evaluation (1 Week)||20
10802018|NCT04308239|11963329|FG001|STARTED|Pre-intervention Evaluation (1 Week)||14
10802019|NCT04308239|11963328|FG000|COMPLETED|Pre-intervention Evaluation (1 Week)|No withdrawals. These participants just missed this evaluation but stayed in study.|17
10802020|NCT04308239|11963329|FG001|COMPLETED|Pre-intervention Evaluation (1 Week)|No withdrawals. These participants just missed this evaluation but stayed in study.|11
10802021|NCT04308239|11963328|FG000|NOT COMPLETED|Pre-intervention Evaluation (1 Week)||3
10802022|NCT04308239|11963329|FG001|NOT COMPLETED|Pre-intervention Evaluation (1 Week)||3
10802023|NCT04308239|11963328|FG000|STARTED|Intervention (2 Weeks)||20
10802024|NCT04308239|11963329|FG001|STARTED|Intervention (2 Weeks)||14
10802025|NCT04308239|11963328|FG000|COMPLETED|Intervention (2 Weeks)||20
10802026|NCT04308239|11963329|FG001|COMPLETED|Intervention (2 Weeks)||14
10802027|NCT04308239|11963328|FG000|NOT COMPLETED|Intervention (2 Weeks)||0
10802028|NCT04308239|11963329|FG001|NOT COMPLETED|Intervention (2 Weeks)||0
10700968|NCT02565186|11865519|FG001|COMPLETED|Overall Study||504
10700969|NCT02565186|11865518|FG000|NOT COMPLETED|Overall Study||580
10802029|NCT04308239|11963328|FG000|STARTED|Post-intervention Evaluation (1 Week)||20
10802030|NCT04308239|11963329|FG001|STARTED|Post-intervention Evaluation (1 Week)||14
10802031|NCT04308239|11963328|FG000|COMPLETED|Post-intervention Evaluation (1 Week)||19
10802032|NCT04308239|11963329|FG001|COMPLETED|Post-intervention Evaluation (1 Week)||10
10802033|NCT04308239|11963328|FG000|NOT COMPLETED|Post-intervention Evaluation (1 Week)||1
10802034|NCT04308239|11963329|FG001|NOT COMPLETED|Post-intervention Evaluation (1 Week)||4
10319000|NCT00219284|11453281|FG001|STARTED|Extension Phase - 8 Weeks|Not all subjects who completed the treatment phase chose to enter this optional extension phase.|106
10700970|NCT02565186|11865519|FG001|NOT COMPLETED|Overall Study||621
10700971|NCT02565381|11865528|FG000|STARTED|Overall Study||25
10700972|NCT02565381|11865529|FG001|STARTED|Overall Study||25
10700973|NCT02565381|11865530|FG002|STARTED|Overall Study||25
10700974|NCT02565381|11865528|FG000|COMPLETED|Overall Study||24
10700975|NCT02565381|11865529|FG001|COMPLETED|Overall Study||25
10700976|NCT02565381|11865530|FG002|COMPLETED|Overall Study||24
10700977|NCT02565381|11865528|FG000|NOT COMPLETED|Overall Study||1
10802035|NCT04308668|11963341|FG000|STARTED|Overall Study||658
10802036|NCT04308668|11963342|FG001|STARTED|Overall Study||654
10802037|NCT04308668|11963341|FG000|COMPLETED|Overall Study||622
10700978|NCT02565381|11865529|FG001|NOT COMPLETED|Overall Study||0
10700979|NCT02565381|11865530|FG002|NOT COMPLETED|Overall Study||1
10700980|NCT02565485|11865540|FG000|STARTED|Overall Study||139
10700981|NCT02565485|11865541|FG001|STARTED|Overall Study||137
10700982|NCT02565485|11865540|FG000|COMPLETED|Overall Study||139
10700983|NCT02565485|11865541|FG001|COMPLETED|Overall Study||137
10700984|NCT02565485|11865540|FG000|NOT COMPLETED|Overall Study||0
10700985|NCT02565485|11865541|FG001|NOT COMPLETED|Overall Study||0
10700986|NCT02565511|11865551|FG000|STARTED|Overall Study||42
10700987|NCT02565511|11865552|FG001|STARTED|Overall Study||23
10700988|NCT02565511|11865553|FG002|STARTED|Overall Study||251
10700989|NCT02565511|11865554|FG003|STARTED|Overall Study||164
10700990|NCT02565511|11865551|FG000|3 Patients Were Mis-randomized|Overall Study||0
10700991|NCT02565511|11865552|FG001|3 Patients Were Mis-randomized|Overall Study||0
10700992|NCT02565511|11865553|FG002|3 Patients Were Mis-randomized|Overall Study||2
10700993|NCT02565511|11865554|FG003|3 Patients Were Mis-randomized|Overall Study||1
10700994|NCT02565511|11865551|FG000|COMPLETED|Overall Study||0
10700995|NCT02565511|11865552|FG001|COMPLETED|Overall Study||0
10700996|NCT02565511|11865553|FG002|COMPLETED|Overall Study||0
10802038|NCT04308668|11963342|FG001|COMPLETED|Overall Study||612
10802039|NCT04308668|11963341|FG000|NOT COMPLETED|Overall Study||36
10802040|NCT04308668|11963342|FG001|NOT COMPLETED|Overall Study||42
10802041|NCT04307940|11963351|FG000|STARTED|Overall Study||90
10802042|NCT04307940|11963352|FG001|STARTED|Overall Study||87
10802043|NCT04307940|11963353|FG002|STARTED|Overall Study||44
10802044|NCT04307940|11963351|FG000|COMPLETED|Overall Study||85
10802045|NCT04307940|11963352|FG001|COMPLETED|Overall Study||84
10802046|NCT04307940|11963353|FG002|COMPLETED|Overall Study||42
10802047|NCT04307940|11963351|FG000|NOT COMPLETED|Overall Study||5
10802048|NCT04307940|11963352|FG001|NOT COMPLETED|Overall Study||3
10802049|NCT04307940|11963353|FG002|NOT COMPLETED|Overall Study||2
10802050|NCT04302545|11963363|FG000|STARTED|Overall Study||107
10802051|NCT04302545|11963364|FG001|STARTED|Overall Study||107
10802052|NCT04302545|11963363|FG000|COMPLETED|Overall Study||104
10802053|NCT04302545|11963364|FG001|COMPLETED|Overall Study||103
10802054|NCT04302545|11963363|FG000|NOT COMPLETED|Overall Study||3
10802055|NCT04302545|11963364|FG001|NOT COMPLETED|Overall Study||4
10319001|NCT00219284|11453280|FG000|COMPLETED|Extension Phase - 8 Weeks||112
10319002|NCT00219284|11453281|FG001|COMPLETED|Extension Phase - 8 Weeks||99
10319003|NCT00219284|11453280|FG000|NOT COMPLETED|Extension Phase - 8 Weeks||2
10319004|NCT00219284|11453281|FG001|NOT COMPLETED|Extension Phase - 8 Weeks||7
10700997|NCT02565511|11865554|FG003|COMPLETED|Overall Study||0
10802056|NCT04297631|11963381|FG000|STARTED|Overall Study||20
10802057|NCT04297631|11963381|FG000|COMPLETED|Overall Study||20
10802058|NCT04297631|11963381|FG000|NOT COMPLETED|Overall Study||0
10802059|NCT04297241|11963386|FG000|STARTED|Overall Study||20
10802060|NCT04297241|11963386|FG000|COMPLETED|Overall Study||15
10802061|NCT04297241|11963386|FG000|NOT COMPLETED|Overall Study||5
10802062|NCT04296448|11963402|FG000|STARTED|Overall Study||98
10802063|NCT04296448|11963403|FG001|STARTED|Overall Study||99
10802064|NCT04296448|11963402|FG000|COMPLETED|Overall Study||98
10802065|NCT04296448|11963403|FG001|COMPLETED|Overall Study||99
10802066|NCT04296448|11963402|FG000|NOT COMPLETED|Overall Study||0
10802067|NCT04296448|11963403|FG001|NOT COMPLETED|Overall Study||0
10802068|NCT04296227|11963409|FG000|STARTED|Overall Study||85
10802069|NCT04296227|11963409|FG000|COMPLETED|Overall Study||85
10802070|NCT04296227|11963409|FG000|NOT COMPLETED|Overall Study||0
10802071|NCT04295356|11963415|FG000|STARTED|Overall Study||93
10802072|NCT04295356|11963416|FG001|STARTED|Overall Study||87
10802073|NCT04295356|11963415|FG000|COMPLETED|Overall Study||92
10802074|NCT04295356|11963416|FG001|COMPLETED|Overall Study||83
10802075|NCT04295356|11963415|FG000|NOT COMPLETED|Overall Study||1
10802076|NCT04295356|11963416|FG001|NOT COMPLETED|Overall Study||4
10802077|NCT04292639|11963422|FG000|STARTED|Overall Study||20
10802078|NCT04292639|11963422|FG000|COMPLETED|Overall Study||20
10802079|NCT04292639|11963422|FG000|NOT COMPLETED|Overall Study||0
10802080|NCT04292535|11963440|FG000|STARTED|Overall Study||8
10802081|NCT04292535|11963441|FG001|STARTED|Overall Study||8
10802082|NCT04292535|11963442|FG002|STARTED|Overall Study||9
10802083|NCT04292535|11963443|FG003|STARTED|Overall Study||8
10802084|NCT04292535|11963444|FG004|STARTED|Overall Study||8
10802085|NCT04292535|11963445|FG005|STARTED|Overall Study||9
10802086|NCT04292535|11963446|FG006|STARTED|Overall Study||8
10802087|NCT04292535|11963447|FG007|STARTED|Overall Study||10
10802088|NCT04292535|11963448|FG008|STARTED|Overall Study||8
10802089|NCT04292535|11963449|FG009|STARTED|Overall Study||8
10802090|NCT04292535|11963450|FG010|STARTED|Overall Study||7
10802091|NCT04292535|11963451|FG011|STARTED|Overall Study||7
10802092|NCT04292535|11963452|FG012|STARTED|Overall Study||9
10802093|NCT04292535|11963453|FG013|STARTED|Overall Study||9
10802094|NCT04292535|11963440|FG000|COMPLETED|Overall Study||8
10802095|NCT04292535|11963441|FG001|COMPLETED|Overall Study||8
10802096|NCT04292535|11963442|FG002|COMPLETED|Overall Study||9
10700998|NCT02565511|11865551|FG000|NOT COMPLETED|Overall Study||42
10700999|NCT02565511|11865552|FG001|NOT COMPLETED|Overall Study||23
10701000|NCT02565511|11865553|FG002|NOT COMPLETED|Overall Study||251
10701001|NCT02565511|11865554|FG003|NOT COMPLETED|Overall Study||164
10802097|NCT04292535|11963443|FG003|COMPLETED|Overall Study||8
10802098|NCT04292535|11963444|FG004|COMPLETED|Overall Study||8
10802099|NCT04292535|11963445|FG005|COMPLETED|Overall Study||9
10802100|NCT04292535|11963446|FG006|COMPLETED|Overall Study||8
10802101|NCT04292535|11963447|FG007|COMPLETED|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL (n = 1)|8
10802102|NCT04292535|11963448|FG008|COMPLETED|Overall Study||8
10802103|NCT04292535|11963449|FG009|COMPLETED|Overall Study||8
10802104|NCT04292535|11963450|FG010|COMPLETED|Overall Study||7
10802105|NCT04292535|11963451|FG011|COMPLETED|Overall Study||6
10802106|NCT04292535|11963452|FG012|COMPLETED|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL (n = 1)|8
10802107|NCT04292535|11963453|FG013|COMPLETED|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL (n = 1) Condition stopped due to Report of Dizziness (n = 1)|7
10802108|NCT04292535|11963440|FG000|NOT COMPLETED|Overall Study||0
10802109|NCT04292535|11963441|FG001|NOT COMPLETED|Overall Study||0
10802110|NCT04292535|11963442|FG002|NOT COMPLETED|Overall Study||0
10802111|NCT04292535|11963443|FG003|NOT COMPLETED|Overall Study||0
10455415|NCT01001572|11603489|FG000|STARTED|Double-Blind Treatment Phase|This arm is only used for single blind period. So, no enrollment during double blind period.|0
10455416|NCT01001572|11603490|FG001|STARTED|Double-Blind Treatment Phase||329
10455417|NCT01001572|11603491|FG002|STARTED|Double-Blind Treatment Phase||325
10455418|NCT01001572|11603489|FG000|Full Analysis Set (FAS)|Double-Blind Treatment Phase||0
10455419|NCT01001572|11603490|FG001|Full Analysis Set (FAS)|Double-Blind Treatment Phase|One patient was excluded from full analysis set for having no post-baseline efficacy assessment.|328
10455420|NCT01001572|11603491|FG002|Full Analysis Set (FAS)|Double-Blind Treatment Phase|Two patients were excluded from full analysis set for having no post-baseline efficacy assessment.|323
10455421|NCT01001572|11603489|FG000|COMPLETED|Double-Blind Treatment Phase||0
10455422|NCT01001572|11603490|FG001|COMPLETED|Double-Blind Treatment Phase||319
10455423|NCT01001572|11603491|FG002|COMPLETED|Double-Blind Treatment Phase||306
10455424|NCT01001572|11603489|FG000|NOT COMPLETED|Double-Blind Treatment Phase||0
10455425|NCT01001572|11603490|FG001|NOT COMPLETED|Double-Blind Treatment Phase||10
10455426|NCT01001572|11603491|FG002|NOT COMPLETED|Double-Blind Treatment Phase||19
10455427|NCT01001598|11603497|FG000|STARTED|Overall Study||5
10455428|NCT01001598|11603497|FG000|COMPLETED|Overall Study|3 completed study (2 FA and 1 DC) in 2011|3
10455429|NCT01001598|11603497|FG000|NOT COMPLETED|Overall Study||2
10455430|NCT01001702|11603501|FG000|STARTED|Overall Study||85
10455431|NCT01001702|11603501|FG000|COMPLETED|Overall Study||13
10455432|NCT01001702|11603501|FG000|NOT COMPLETED|Overall Study||72
10455433|NCT01001767|11603507|FG000|STARTED|Overall Study||18
10455434|NCT01001767|11603508|FG001|STARTED|Overall Study||17
10455435|NCT01001767|11603507|FG000|COMPLETED|Overall Study||14
10455436|NCT01001767|11603508|FG001|COMPLETED|Overall Study||17
10455437|NCT01001767|11603507|FG000|NOT COMPLETED|Overall Study||4
10455438|NCT01001767|11603508|FG001|NOT COMPLETED|Overall Study||0
10455439|NCT01001806|11603517|FG000|STARTED|Overall Study||42
10455440|NCT01001806|11603518|FG001|STARTED|Overall Study||42
10455441|NCT01001806|11603519|FG002|STARTED|Overall Study||42
10455442|NCT01001806|11603517|FG000|COMPLETED|Overall Study||42
10455443|NCT01001806|11603518|FG001|COMPLETED|Overall Study||41
10455444|NCT01001806|11603519|FG002|COMPLETED|Overall Study||38
10455445|NCT01001806|11603517|FG000|NOT COMPLETED|Overall Study||0
10455446|NCT01001806|11603518|FG001|NOT COMPLETED|Overall Study||1
10455447|NCT01001806|11603519|FG002|NOT COMPLETED|Overall Study||4
10455448|NCT01001832|11603529|FG000|STARTED|Short-term Period||59
10455449|NCT01001832|11603530|FG001|STARTED|Short-term Period||59
10455450|NCT01001832|11603529|FG000|COMPLETED|Short-term Period||57
10455451|NCT01001832|11603530|FG001|COMPLETED|Short-term Period||56
10455452|NCT01001832|11603529|FG000|NOT COMPLETED|Short-term Period||2
10455453|NCT01001832|11603530|FG001|NOT COMPLETED|Short-term Period||3
10455454|NCT01001832|11603529|FG000|STARTED|Long-term Period|1 participant completed the short term period but discontinued before start of the Long-term Period.|56
10455455|NCT01001832|11603530|FG001|STARTED|Long-term Period||56
10455456|NCT01001832|11603529|FG000|COMPLETED|Long-term Period||52
10802112|NCT04292535|11963444|FG004|NOT COMPLETED|Overall Study||0
10802113|NCT04292535|11963445|FG005|NOT COMPLETED|Overall Study||0
10802114|NCT04292535|11963446|FG006|NOT COMPLETED|Overall Study||0
10802115|NCT04292535|11963447|FG007|NOT COMPLETED|Overall Study||2
10802116|NCT04292535|11963448|FG008|NOT COMPLETED|Overall Study||0
10802117|NCT04292535|11963449|FG009|NOT COMPLETED|Overall Study||0
10802118|NCT04292535|11963450|FG010|NOT COMPLETED|Overall Study||0
10802119|NCT04292535|11963451|FG011|NOT COMPLETED|Overall Study||1
10802120|NCT04292535|11963452|FG012|NOT COMPLETED|Overall Study||1
10802121|NCT04292535|11963453|FG013|NOT COMPLETED|Overall Study||2
10455457|NCT01001832|11603530|FG001|COMPLETED|Long-term Period||51
10455458|NCT01001832|11603529|FG000|NOT COMPLETED|Long-term Period||4
10455459|NCT01001832|11603530|FG001|NOT COMPLETED|Long-term Period||5
10455460|NCT01001832|11603529|FG000|STARTED|Follow-up Period||52
10455461|NCT01001832|11603530|FG001|STARTED|Follow-up Period||51
10455462|NCT01001832|11603529|FG000|COMPLETED|Follow-up Period||34
10455463|NCT01001832|11603530|FG001|COMPLETED|Follow-up Period||30
10455464|NCT01001832|11603529|FG000|NOT COMPLETED|Follow-up Period||18
10455465|NCT01001832|11603530|FG001|NOT COMPLETED|Follow-up Period||21
10526092|NCT01380093|11678037|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
10526093|NCT01380093|11678038|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
10802122|NCT04292171|11963485|FG000|STARTED|Overall Study||109
10802123|NCT04292171|11963486|FG001|STARTED|Overall Study||110
10802124|NCT04292171|11963485|FG000|COMPLETED|Overall Study||107
10802125|NCT04292171|11963486|FG001|COMPLETED|Overall Study||109
10455466|NCT01001910|11603539|FG000|STARTED|Overall Study|We screened and started 28 patients in the study. However only 22 patients were evaluable for outcome, because 6 patients did not receive adequate number of cycles of treatment for analysis. While we could not evaluate these 6 patients for their outcome, their treatment-cycles were included in the safe analysis.|28
10455467|NCT01001910|11603539|FG000|COMPLETED|Overall Study|6 patients did not receive 3 cycles required for evaluation of response as per protocol s7.1.1|22
10455468|NCT01001910|11603539|FG000|NOT COMPLETED|Overall Study||6
10455469|NCT01001975|11603545|FG000|STARTED|Overall Study||5
10455470|NCT01001975|11603546|FG001|STARTED|Overall Study||5
10455471|NCT01001975|11603545|FG000|COMPLETED|Overall Study||5
10455472|NCT01001975|11603546|FG001|COMPLETED|Overall Study||5
10455473|NCT01001975|11603545|FG000|NOT COMPLETED|Overall Study||0
10455474|NCT01001975|11603546|FG001|NOT COMPLETED|Overall Study||0
10455475|NCT01001988|11603552|FG000|STARTED|Overall Study||596
10455476|NCT01001988|11603552|FG000|COMPLETED|Overall Study||479
10455477|NCT01001988|11603552|FG000|NOT COMPLETED|Overall Study||117
10455478|NCT01002105|11603558|FG000|STARTED|Overall Study||32
10455479|NCT01002105|11603559|FG001|STARTED|Overall Study||32
10455480|NCT01002105|11603558|FG000|COMPLETED|Overall Study||13
10455481|NCT01002105|11603559|FG001|COMPLETED|Overall Study||11
10455482|NCT01002105|11603558|FG000|NOT COMPLETED|Overall Study||19
10455483|NCT01002105|11603559|FG001|NOT COMPLETED|Overall Study||21
10455484|NCT01002118|11603568|FG000|STARTED|Overall Study||1
10455485|NCT01002118|11603568|FG000|Randomized Only Patient|Overall Study||1
10455486|NCT01002118|11603568|FG000|COMPLETED|Overall Study||1
10455487|NCT01002118|11603568|FG000|NOT COMPLETED|Overall Study||0
10455488|NCT01002287|11603574|FG000|STARTED|Overall Study||8
10455489|NCT01002287|11603575|FG001|STARTED|Overall Study||3
10455490|NCT01002287|11603574|FG000|COMPLETED|Overall Study||8
10455491|NCT01002287|11603575|FG001|COMPLETED|Overall Study||3
10455492|NCT01002287|11603574|FG000|NOT COMPLETED|Overall Study||0
10455493|NCT01002287|11603575|FG001|NOT COMPLETED|Overall Study||0
10455494|NCT01002339|11603584|FG000|STARTED|Overall Study||44
10455495|NCT01002339|11603585|FG001|STARTED|Overall Study||43
10455496|NCT01002339|11603586|FG002|STARTED|Overall Study||47
10455497|NCT01002339|11603584|FG000|COMPLETED|Overall Study||44
10455498|NCT01002339|11603585|FG001|COMPLETED|Overall Study||42
10455499|NCT01002339|11603586|FG002|COMPLETED|Overall Study||42
10455500|NCT01002339|11603584|FG000|NOT COMPLETED|Overall Study||0
10455501|NCT01002339|11603585|FG001|NOT COMPLETED|Overall Study||1
10455502|NCT01002339|11603586|FG002|NOT COMPLETED|Overall Study||5
10802126|NCT04292171|11963485|FG000|NOT COMPLETED|Overall Study||2
10802127|NCT04292171|11963486|FG001|NOT COMPLETED|Overall Study||1
10802128|NCT04292899|11963496|FG000|STARTED|Overall Study||200
10802129|NCT04292899|11963497|FG001|STARTED|Overall Study||197
10802130|NCT04292899|11963498|FG002|STARTED|Overall Study||844
10802131|NCT04292899|11963499|FG003|STARTED|Overall Study||3597
10802132|NCT04292899|11963496|FG000|COMPLETED|Overall Study||168
10802133|NCT04292899|11963497|FG001|COMPLETED|Overall Study||164
10802134|NCT04292899|11963498|FG002|COMPLETED|Overall Study||621
10802135|NCT04292899|11963499|FG003|COMPLETED|Overall Study||2952
10802136|NCT04292899|11963496|FG000|NOT COMPLETED|Overall Study||32
10802137|NCT04292899|11963497|FG001|NOT COMPLETED|Overall Study||33
10802138|NCT04292899|11963498|FG002|NOT COMPLETED|Overall Study||223
10802139|NCT04292899|11963499|FG003|NOT COMPLETED|Overall Study||645
10802140|NCT04292730|11963511|FG000|STARTED|Overall Study||199
10802141|NCT04292730|11963512|FG001|STARTED|Overall Study||197
10802142|NCT04292730|11963513|FG002|STARTED|Overall Study||200
10802143|NCT04292730|11963514|FG003|STARTED|Overall Study||517
10802144|NCT04292730|11963511|FG000|COMPLETED|Overall Study||179
10802145|NCT04292730|11963512|FG001|COMPLETED|Overall Study||176
10802146|NCT04292730|11963513|FG002|COMPLETED|Overall Study||178
10802147|NCT04292730|11963514|FG003|COMPLETED|Overall Study||437
10802148|NCT04292730|11963511|FG000|NOT COMPLETED|Overall Study||20
10802149|NCT04292730|11963512|FG001|NOT COMPLETED|Overall Study||21
10802150|NCT04292730|11963513|FG002|NOT COMPLETED|Overall Study||22
10802151|NCT04292730|11963514|FG003|NOT COMPLETED|Overall Study||80
10802152|NCT04290676|11963523|FG000|STARTED|Overall Study||527
10802153|NCT04290676|11963523|FG000|COMPLETED|Overall Study||527
10802154|NCT04290676|11963523|FG000|NOT COMPLETED|Overall Study||0
10802155|NCT04290039|11963530|FG000|STARTED|Period 1 (Visit 1; Day 1)||5
10802156|NCT04290039|11963531|FG001|STARTED|Period 1 (Visit 1; Day 1)||5
10802157|NCT04290039|11963532|FG002|STARTED|Period 1 (Visit 1; Day 1)||5
10802158|NCT04290039|11963530|FG000|COMPLETED|Period 1 (Visit 1; Day 1)||5
10455503|NCT01002456|11603596|FG000|STARTED|Overall Study||98
10455504|NCT01002456|11603597|FG001|STARTED|Overall Study||122
10455505|NCT01002456|11603596|FG000|COMPLETED|Overall Study||98
10455506|NCT01002456|11603597|FG001|COMPLETED|Overall Study||122
10455507|NCT01002456|11603596|FG000|NOT COMPLETED|Overall Study||0
10455508|NCT01002456|11603597|FG001|NOT COMPLETED|Overall Study||0
10455509|NCT01002482|11603607|FG000|STARTED|Overall Study||1351
10455510|NCT01002482|11603608|FG001|STARTED|Overall Study||1333
10455511|NCT01002482|11603607|FG000|COMPLETED|Overall Study||1336
10802159|NCT04290039|11963531|FG001|COMPLETED|Period 1 (Visit 1; Day 1)||5
10802160|NCT04290039|11963532|FG002|COMPLETED|Period 1 (Visit 1; Day 1)||5
10802161|NCT04290039|11963530|FG000|NOT COMPLETED|Period 1 (Visit 1; Day 1)||0
10802162|NCT04290039|11963531|FG001|NOT COMPLETED|Period 1 (Visit 1; Day 1)||0
10802163|NCT04290039|11963532|FG002|NOT COMPLETED|Period 1 (Visit 1; Day 1)||0
10802164|NCT04290039|11963530|FG000|STARTED|Period 2 (Visit 2; Day 8)||5
10455512|NCT01002482|11603608|FG001|COMPLETED|Overall Study||1312
10455513|NCT01002482|11603607|FG000|NOT COMPLETED|Overall Study||15
10455514|NCT01002482|11603608|FG001|NOT COMPLETED|Overall Study||21
10455515|NCT01002547|11603617|FG000|STARTED|Overall Study||32
10455516|NCT01002547|11603618|FG001|STARTED|Overall Study||36
10455517|NCT01002547|11603619|FG002|STARTED|Overall Study||37
10455518|NCT01002547|11603617|FG000|COMPLETED|Overall Study||24
10455519|NCT01002547|11603618|FG001|COMPLETED|Overall Study||33
10455520|NCT01002547|11603619|FG002|COMPLETED|Overall Study||29
10455521|NCT01002547|11603617|FG000|NOT COMPLETED|Overall Study||8
10455522|NCT01002547|11603618|FG001|NOT COMPLETED|Overall Study||3
10455523|NCT01002547|11603619|FG002|NOT COMPLETED|Overall Study||8
10455524|NCT01002573|11603629|FG000|STARTED|Overall Study||58
10455525|NCT01002573|11603630|FG001|STARTED|Overall Study||60
10455526|NCT01002573|11603629|FG000|COMPLETED|Overall Study||47
10455527|NCT01002573|11603630|FG001|COMPLETED|Overall Study||53
10455528|NCT01002573|11603629|FG000|NOT COMPLETED|Overall Study||11
10455529|NCT01002573|11603630|FG001|NOT COMPLETED|Overall Study||7
10455530|NCT01002742|11603638|FG000|STARTED|Overall Study||119
10455531|NCT01002742|11603639|FG001|STARTED|Overall Study||117
10455532|NCT01002742|11603638|FG000|COMPLETED|Overall Study||119
10455533|NCT01002742|11603639|FG001|COMPLETED|Overall Study||116
10455534|NCT01002742|11603638|FG000|NOT COMPLETED|Overall Study||0
10455535|NCT01002742|11603639|FG001|NOT COMPLETED|Overall Study||1
10455536|NCT01002755|11603645|FG000|STARTED|Overall Study||36
10455537|NCT01002755|11603645|FG000|COMPLETED|Overall Study||36
10455538|NCT01002755|11603645|FG000|NOT COMPLETED|Overall Study||0
10455539|NCT01002989|11603649|FG000|STARTED|Overall Study||98
10455540|NCT01002989|11603649|FG000|COMPLETED|Overall Study||93
10455541|NCT01002989|11603649|FG000|NOT COMPLETED|Overall Study||5
10455542|NCT01003067|11603655|FG000|STARTED|Overall Study||136
10455543|NCT01003067|11603656|FG001|STARTED|Overall Study||131
10455544|NCT01003067|11603655|FG000|COMPLETED|Overall Study||103
10455545|NCT01003067|11603656|FG001|COMPLETED|Overall Study||107
10455546|NCT01003067|11603655|FG000|NOT COMPLETED|Overall Study||33
10455547|NCT01003067|11603656|FG001|NOT COMPLETED|Overall Study||24
10455548|NCT01003080|11603664|FG000|STARTED|Overall Study||50
10455549|NCT01003080|11603665|FG001|STARTED|Overall Study||61
10455550|NCT01003080|11603664|FG000|COMPLETED|Overall Study||50
10455551|NCT01003080|11603665|FG001|COMPLETED|Overall Study||61
10455552|NCT01003080|11603664|FG000|NOT COMPLETED|Overall Study||0
10455553|NCT01003080|11603665|FG001|NOT COMPLETED|Overall Study||0
10455554|NCT01003106|11603675|FG000|STARTED|Baseline to Month 6||22
10455555|NCT01003106|11603676|FG001|STARTED|Baseline to Month 6||20
10455556|NCT01003106|11603677|FG002|STARTED|Baseline to Month 6||0
10455557|NCT01003106|11603678|FG003|STARTED|Baseline to Month 6||0
10455558|NCT01003106|11603679|FG004|STARTED|Baseline to Month 6||19
10455559|NCT01003106|11603680|FG005|STARTED|Baseline to Month 6||20
10455560|NCT01003106|11603681|FG006|STARTED|Baseline to Month 6||0
10455561|NCT01003106|11603682|FG007|STARTED|Baseline to Month 6||0
10455562|NCT01003106|11603675|FG000|COMPLETED|Baseline to Month 6||22
10455563|NCT01003106|11603676|FG001|COMPLETED|Baseline to Month 6||20
10455564|NCT01003106|11603677|FG002|COMPLETED|Baseline to Month 6||0
10455565|NCT01003106|11603678|FG003|COMPLETED|Baseline to Month 6||0
10455566|NCT01003106|11603679|FG004|COMPLETED|Baseline to Month 6||19
10455567|NCT01003106|11603680|FG005|COMPLETED|Baseline to Month 6||20
10455568|NCT01003106|11603681|FG006|COMPLETED|Baseline to Month 6||0
10455569|NCT01003106|11603682|FG007|COMPLETED|Baseline to Month 6||0
10455570|NCT01003106|11603675|FG000|NOT COMPLETED|Baseline to Month 6||0
10455571|NCT01003106|11603676|FG001|NOT COMPLETED|Baseline to Month 6||0
10455572|NCT01003106|11603677|FG002|NOT COMPLETED|Baseline to Month 6||0
10455573|NCT01003106|11603678|FG003|NOT COMPLETED|Baseline to Month 6||0
10455574|NCT01003106|11603679|FG004|NOT COMPLETED|Baseline to Month 6||0
10455575|NCT01003106|11603680|FG005|NOT COMPLETED|Baseline to Month 6||0
10455576|NCT01003106|11603681|FG006|NOT COMPLETED|Baseline to Month 6||0
10455577|NCT01003106|11603682|FG007|NOT COMPLETED|Baseline to Month 6||0
10455578|NCT01003106|11603675|FG000|STARTED|Month 6-Month 36||0
10455579|NCT01003106|11603676|FG001|STARTED|Month 6-Month 36||0
10455580|NCT01003106|11603677|FG002|STARTED|Month 6-Month 36||19
10455581|NCT01003106|11603678|FG003|STARTED|Month 6-Month 36||20
10455582|NCT01003106|11603679|FG004|STARTED|Month 6-Month 36||0
10455583|NCT01003106|11603680|FG005|STARTED|Month 6-Month 36||0
10455584|NCT01003106|11603681|FG006|STARTED|Month 6-Month 36||20
10455585|NCT01003106|11603682|FG007|STARTED|Month 6-Month 36||18
10455586|NCT01003106|11603675|FG000|COMPLETED|Month 6-Month 36||0
10455587|NCT01003106|11603676|FG001|COMPLETED|Month 6-Month 36||0
10455588|NCT01003106|11603677|FG002|COMPLETED|Month 6-Month 36||18
10455589|NCT01003106|11603678|FG003|COMPLETED|Month 6-Month 36||20
10455590|NCT01003106|11603679|FG004|COMPLETED|Month 6-Month 36||0
10455591|NCT01003106|11603680|FG005|COMPLETED|Month 6-Month 36||0
10455592|NCT01003106|11603681|FG006|COMPLETED|Month 6-Month 36||19
10455593|NCT01003106|11603682|FG007|COMPLETED|Month 6-Month 36||18
10455594|NCT01003106|11603675|FG000|NOT COMPLETED|Month 6-Month 36||0
10455595|NCT01003106|11603676|FG001|NOT COMPLETED|Month 6-Month 36||0
10455596|NCT01003106|11603677|FG002|NOT COMPLETED|Month 6-Month 36||1
10455597|NCT01003106|11603678|FG003|NOT COMPLETED|Month 6-Month 36||0
10455598|NCT01003106|11603679|FG004|NOT COMPLETED|Month 6-Month 36||0
10455599|NCT01003106|11603680|FG005|NOT COMPLETED|Month 6-Month 36||0
10455600|NCT01003106|11603681|FG006|NOT COMPLETED|Month 6-Month 36||1
10455601|NCT01003106|11603682|FG007|NOT COMPLETED|Month 6-Month 36||0
10455602|NCT01003184|11603698|FG000|STARTED|Overall Study||111
10701002|NCT02565576|11865566|FG000|STARTED|Overall Study||22
10701003|NCT02565576|11865567|FG001|STARTED|Overall Study||22
10701004|NCT02565576|11865566|FG000|COMPLETED|Overall Study||17
10701005|NCT02565576|11865567|FG001|COMPLETED|Overall Study||17
10701006|NCT02565576|11865566|FG000|NOT COMPLETED|Overall Study||5
10701007|NCT02565576|11865567|FG001|NOT COMPLETED|Overall Study||5
10701008|NCT02565615|11865578|FG000|STARTED|Overall Study||291
10701009|NCT02565615|11865579|FG001|STARTED|Overall Study||3080
10701010|NCT02565615|11865580|FG002|STARTED|Overall Study||21
10701011|NCT02565615|11865581|FG003|STARTED|Overall Study||101
10701012|NCT02565615|11865582|FG004|STARTED|Overall Study||1622
10701013|NCT02565615|11865578|FG000|Treated|Overall Study||291
10701014|NCT02565615|11865579|FG001|Treated|Overall Study||3080
10701015|NCT02565615|11865580|FG002|Treated|Overall Study||21
10701016|NCT02565615|11865581|FG003|Treated|Overall Study||101
10802165|NCT04290039|11963531|FG001|STARTED|Period 2 (Visit 2; Day 8)||5
10802166|NCT04290039|11963532|FG002|STARTED|Period 2 (Visit 2; Day 8)||5
10802167|NCT04290039|11963530|FG000|COMPLETED|Period 2 (Visit 2; Day 8)||5
10802168|NCT04290039|11963531|FG001|COMPLETED|Period 2 (Visit 2; Day 8)||5
10802169|NCT04290039|11963532|FG002|COMPLETED|Period 2 (Visit 2; Day 8)||5
10802170|NCT04290039|11963530|FG000|NOT COMPLETED|Period 2 (Visit 2; Day 8)||0
10802171|NCT04290039|11963531|FG001|NOT COMPLETED|Period 2 (Visit 2; Day 8)||0
10802172|NCT04290039|11963532|FG002|NOT COMPLETED|Period 2 (Visit 2; Day 8)||0
10802173|NCT04290039|11963530|FG000|STARTED|Period 3 (Visit 3; Day 15)||5
10802174|NCT04290039|11963531|FG001|STARTED|Period 3 (Visit 3; Day 15)||4
10802175|NCT04290039|11963532|FG002|STARTED|Period 3 (Visit 3; Day 15)||5
10802176|NCT04290039|11963530|FG000|COMPLETED|Period 3 (Visit 3; Day 15)||5
10802177|NCT04290039|11963531|FG001|COMPLETED|Period 3 (Visit 3; Day 15)||4
10802178|NCT04290039|11963532|FG002|COMPLETED|Period 3 (Visit 3; Day 15)||5
10802179|NCT04290039|11963530|FG000|NOT COMPLETED|Period 3 (Visit 3; Day 15)||0
10802180|NCT04290039|11963531|FG001|NOT COMPLETED|Period 3 (Visit 3; Day 15)||0
10802181|NCT04290039|11963532|FG002|NOT COMPLETED|Period 3 (Visit 3; Day 15)||0
10802182|NCT04289623|11963547|FG000|STARTED|Wave 1 Emails||6782
10802183|NCT04289623|11963548|FG001|STARTED|Wave 1 Emails||6764
10802184|NCT04289623|11963549|FG002|STARTED|Wave 1 Emails|Participants who did not respond to the intervention in Wave 1 were randomly assigned to this intervention or the testimonial (rank-and-file) email in Wave 2.|0
10802185|NCT04289623|11963550|FG003|STARTED|Wave 1 Emails|Participants who did not respond to the intervention in Wave 1 were randomly assigned to this intervention or the testimonial (medical expert) email in Wave 2.|0
10802186|NCT04289623|11963551|FG004|STARTED|Wave 1 Emails|A planned Wave 3 of the study was not conducted due to COVID-19-related changes in the program being offered as part of the intervention.|0
10802187|NCT04289623|11963552|FG005|STARTED|Wave 1 Emails|A planned Wave 3 of the study was not conducted due to COVID-19-related changes in the program being offered as part of the intervention.|0
10802188|NCT04289623|11963547|FG000|COMPLETED|Wave 1 Emails||6514
10802189|NCT04289623|11963548|FG001|COMPLETED|Wave 1 Emails||6507
10802190|NCT04289623|11963549|FG002|COMPLETED|Wave 1 Emails||0
10802191|NCT04289623|11963550|FG003|COMPLETED|Wave 1 Emails||0
10802192|NCT04289623|11963551|FG004|COMPLETED|Wave 1 Emails||0
10802193|NCT04289623|11963552|FG005|COMPLETED|Wave 1 Emails||0
10802194|NCT04289623|11963547|FG000|NOT COMPLETED|Wave 1 Emails||268
10802195|NCT04289623|11963548|FG001|NOT COMPLETED|Wave 1 Emails||257
10802196|NCT04289623|11963549|FG002|NOT COMPLETED|Wave 1 Emails||0
10802197|NCT04289623|11963550|FG003|NOT COMPLETED|Wave 1 Emails||0
10802198|NCT04289623|11963551|FG004|NOT COMPLETED|Wave 1 Emails||0
10802199|NCT04289623|11963552|FG005|NOT COMPLETED|Wave 1 Emails||0
10802200|NCT04289623|11963547|FG000|STARTED|Wave 2 Emails|Participants were already sent this intervention or the loss frame email in Wave 1.|0
10802201|NCT04289623|11963548|FG001|STARTED|Wave 2 Emails|Participants were already sent this intervention or the standard email in Wave 1.|0
10802202|NCT04289623|11963549|FG002|STARTED|Wave 2 Emails|Participants who did not respond to the intervention in Wave 1 were randomly assigned to these groups in Wave 2.|6099
10802203|NCT04289623|11963550|FG003|STARTED|Wave 2 Emails|Participants who did not respond to the intervention in Wave 1 were randomly assigned to these groups in Wave 2.|6117
10802204|NCT04289623|11963551|FG004|STARTED|Wave 2 Emails|A planned Wave 3 of the study was not conducted due to COVID-19-related changes in the program being offered as part of the intervention.|0
10802205|NCT04289623|11963552|FG005|STARTED|Wave 2 Emails|A planned Wave 3 of the study was not conducted due to COVID-19-related changes in the program being offered as part of the intervention.|0
10802206|NCT04289623|11963547|FG000|COMPLETED|Wave 2 Emails||0
10802207|NCT04289623|11963548|FG001|COMPLETED|Wave 2 Emails||0
10802208|NCT04289623|11963549|FG002|COMPLETED|Wave 2 Emails||6099
10802209|NCT04289623|11963550|FG003|COMPLETED|Wave 2 Emails||6117
10802210|NCT04289623|11963551|FG004|COMPLETED|Wave 2 Emails||0
10802211|NCT04289623|11963552|FG005|COMPLETED|Wave 2 Emails||0
10802212|NCT04289623|11963547|FG000|NOT COMPLETED|Wave 2 Emails||0
10802213|NCT04289623|11963548|FG001|NOT COMPLETED|Wave 2 Emails||0
10802214|NCT04289623|11963549|FG002|NOT COMPLETED|Wave 2 Emails||0
10802215|NCT04289623|11963550|FG003|NOT COMPLETED|Wave 2 Emails||0
10802216|NCT04289623|11963551|FG004|NOT COMPLETED|Wave 2 Emails||0
10802217|NCT04289623|11963552|FG005|NOT COMPLETED|Wave 2 Emails||0
10802218|NCT04276207|11963566|FG000|STARTED|Period 1||15
10701017|NCT02565615|11865582|FG004|Treated|Overall Study||1055
10701018|NCT02565615|11865578|FG000|COMPLETED|Overall Study||288
10701019|NCT02565615|11865579|FG001|COMPLETED|Overall Study||3044
10701020|NCT02565615|11865580|FG002|COMPLETED|Overall Study||21
10701021|NCT02565615|11865581|FG003|COMPLETED|Overall Study||98
10701022|NCT02565615|11865582|FG004|COMPLETED|Overall Study||21
10701023|NCT02565615|11865578|FG000|NOT COMPLETED|Overall Study||3
10701024|NCT02565615|11865579|FG001|NOT COMPLETED|Overall Study||36
10802219|NCT04276207|11963567|FG001|STARTED|Period 1||17
10802220|NCT04276207|11963566|FG000|Received at Least One Dose of Study Drug|Period 1||15
10802221|NCT04276207|11963567|FG001|Received at Least One Dose of Study Drug|Period 1||17
10802222|NCT04276207|11963566|FG000|COMPLETED|Period 1||15
10802223|NCT04276207|11963567|FG001|COMPLETED|Period 1||16
10802224|NCT04276207|11963566|FG000|NOT COMPLETED|Period 1||0
10802225|NCT04276207|11963567|FG001|NOT COMPLETED|Period 1||1
10802226|NCT04276207|11963566|FG000|STARTED|Washout (3- 14 Days)||15
10802227|NCT04276207|11963567|FG001|STARTED|Washout (3- 14 Days)||16
10802228|NCT04276207|11963566|FG000|COMPLETED|Washout (3- 14 Days)||15
10802229|NCT04276207|11963567|FG001|COMPLETED|Washout (3- 14 Days)||16
10802230|NCT04276207|11963566|FG000|NOT COMPLETED|Washout (3- 14 Days)||0
10802231|NCT04276207|11963567|FG001|NOT COMPLETED|Washout (3- 14 Days)||0
10802232|NCT04276207|11963566|FG000|STARTED|Period 2||15
10802233|NCT04276207|11963567|FG001|STARTED|Period 2||16
10802234|NCT04276207|11963566|FG000|COMPLETED|Period 2||15
10802235|NCT04276207|11963567|FG001|COMPLETED|Period 2||16
10802236|NCT04276207|11963566|FG000|NOT COMPLETED|Period 2||0
10802237|NCT04276207|11963567|FG001|NOT COMPLETED|Period 2||0
10701025|NCT02565615|11865580|FG002|NOT COMPLETED|Overall Study||0
10701026|NCT02565615|11865581|FG003|NOT COMPLETED|Overall Study||3
10802238|NCT04289714|11963576|FG000|STARTED|Overall Study||14
10802239|NCT04289714|11963577|FG001|STARTED|Overall Study||11
10802240|NCT04289714|11963578|FG002|STARTED|Overall Study||10
10802241|NCT04289714|11963576|FG000|COMPLETED|Overall Study||8
10802242|NCT04289714|11963577|FG001|COMPLETED|Overall Study||6
10802243|NCT04289714|11963578|FG002|COMPLETED|Overall Study||4
10802244|NCT04289714|11963576|FG000|NOT COMPLETED|Overall Study||6
10802245|NCT04289714|11963577|FG001|NOT COMPLETED|Overall Study||5
10802246|NCT04289714|11963578|FG002|NOT COMPLETED|Overall Study||6
10802247|NCT04288752|11963588|FG000|STARTED|Overall Study|88 Participants were randomized to the VR101 group. However, one randomized participant (AR33) was unable to place the device and was immediately terminated from the study, prior to any post-randomization data collection. Therefore, 87 participants assigned to the VR101 group entered the treatment phase.|87
10802248|NCT04288752|11963589|FG001|STARTED|Overall Study||88
10802249|NCT04288752|11963588|FG000|COMPLETED|Overall Study||81
10802250|NCT04288752|11963589|FG001|COMPLETED|Overall Study||85
10802251|NCT04288752|11963588|FG000|NOT COMPLETED|Overall Study||6
10802252|NCT04288752|11963589|FG001|NOT COMPLETED|Overall Study||3
10802253|NCT04287517|11963597|FG000|STARTED|Overall Study||19
10802254|NCT04287517|11963598|FG001|STARTED|Overall Study||19
10802255|NCT04287517|11963597|FG000|COMPLETED|Overall Study||18
10802256|NCT04287517|11963598|FG001|COMPLETED|Overall Study||18
10802257|NCT04287517|11963597|FG000|NOT COMPLETED|Overall Study||1
10802258|NCT04287517|11963598|FG001|NOT COMPLETED|Overall Study||1
10802259|NCT04287036|11963604|FG000|STARTED|Period 1||13
10802260|NCT04287036|11963605|FG001|STARTED|Period 1||12
10802261|NCT04287036|11963604|FG000|COMPLETED|Period 1||13
10802262|NCT04287036|11963605|FG001|COMPLETED|Period 1||12
10802263|NCT04287036|11963604|FG000|NOT COMPLETED|Period 1||0
10802264|NCT04287036|11963605|FG001|NOT COMPLETED|Period 1||0
10701027|NCT02565615|11865582|FG004|NOT COMPLETED|Overall Study||1601
10701028|NCT02565628|11865596|FG000|STARTED|Overall Study||10
10701029|NCT02565628|11865597|FG001|STARTED|Overall Study||9
10701030|NCT02565628|11865596|FG000|Received Treatment|Overall Study||10
10701031|NCT02565628|11865597|FG001|Received Treatment|Overall Study||9
10701032|NCT02565628|11865596|FG000|COMPLETED|Overall Study||10
10701033|NCT02565628|11865597|FG001|COMPLETED|Overall Study||9
10701034|NCT02565628|11865596|FG000|NOT COMPLETED|Overall Study||0
10701035|NCT02565628|11865597|FG001|NOT COMPLETED|Overall Study||0
10701036|NCT02565706|11865607|FG000|STARTED|Overall Study||178
10701037|NCT02565706|11865608|FG001|STARTED|Overall Study||172
10701038|NCT02565706|11865609|FG002|STARTED|Overall Study||193
10701039|NCT02565706|11865610|FG003|STARTED|Overall Study||201
10701040|NCT02565706|11865607|FG000|COMPLETED|Overall Study||101
10701041|NCT02565706|11865608|FG001|COMPLETED|Overall Study||90
10701042|NCT02565706|11865609|FG002|COMPLETED|Overall Study||104
10701043|NCT02565706|11865610|FG003|COMPLETED|Overall Study||116
10701044|NCT02565706|11865607|FG000|NOT COMPLETED|Overall Study||77
10701045|NCT02565706|11865608|FG001|NOT COMPLETED|Overall Study||82
10701046|NCT02565706|11865609|FG002|NOT COMPLETED|Overall Study||89
10701047|NCT02565706|11865610|FG003|NOT COMPLETED|Overall Study||85
10701058|NCT02565810|11865633|FG000|STARTED|Overall Study||49
10701059|NCT02565810|11865633|FG000|COMPLETED|Overall Study||48
10701060|NCT02565810|11865633|FG000|NOT COMPLETED|Overall Study||1
10701061|NCT02565901|11865645|FG000|STARTED|Overall Study||11
10701062|NCT02565901|11865646|FG001|STARTED|Overall Study||11
10802265|NCT04287036|11963604|FG000|STARTED|Period 2||13
10802266|NCT04287036|11963605|FG001|STARTED|Period 2||12
10802267|NCT04287036|11963604|FG000|COMPLETED|Period 2||13
10701063|NCT02565901|11865647|FG002|STARTED|Overall Study||6
10701064|NCT02565901|11865645|FG000|COMPLETED|Overall Study||11
10701065|NCT02565901|11865646|FG001|COMPLETED|Overall Study||11
10701066|NCT02565901|11865647|FG002|COMPLETED|Overall Study||6
10701067|NCT02565901|11865645|FG000|NOT COMPLETED|Overall Study||0
10701068|NCT02565901|11865646|FG001|NOT COMPLETED|Overall Study||0
10701069|NCT02565901|11865647|FG002|NOT COMPLETED|Overall Study||0
10701070|NCT02566005|11865658|FG000|STARTED|Overall Study||100
10701071|NCT02566005|11865659|FG001|STARTED|Overall Study||100
10701072|NCT02566005|11865658|FG000|COMPLETED|Overall Study||92
10701073|NCT02566005|11865659|FG001|COMPLETED|Overall Study||94
10701074|NCT02566005|11865658|FG000|NOT COMPLETED|Overall Study||8
10701075|NCT02566005|11865659|FG001|NOT COMPLETED|Overall Study||6
10701076|NCT02566031|11865667|FG000|STARTED|Overall Study||189
10701077|NCT02566031|11865668|FG001|STARTED|Overall Study||190
10701078|NCT02566031|11865667|FG000|COMPLETED|Overall Study||169
10701079|NCT02566031|11865668|FG001|COMPLETED|Overall Study||178
10701080|NCT02566031|11865667|FG000|NOT COMPLETED|Overall Study||20
10701081|NCT02566031|11865668|FG001|NOT COMPLETED|Overall Study||12
10701082|NCT02566044|11865678|FG000|STARTED|Overall Study||6
10701083|NCT02566044|11865679|FG001|STARTED|Overall Study||6
10701084|NCT02566044|11865680|FG002|STARTED|Overall Study||4
10701085|NCT02566044|11865678|FG000|COMPLETED|Overall Study||6
10701086|NCT02566044|11865679|FG001|COMPLETED|Overall Study||6
10701087|NCT02566044|11865680|FG002|COMPLETED|Overall Study||4
10701088|NCT02566044|11865678|FG000|NOT COMPLETED|Overall Study||0
10701089|NCT02566044|11865679|FG001|NOT COMPLETED|Overall Study||0
10701090|NCT02566044|11865680|FG002|NOT COMPLETED|Overall Study||0
10701091|NCT02566083|11865695|FG000|STARTED|Overall Study||214
10701092|NCT02566083|11865696|FG001|STARTED|Overall Study||151
10701093|NCT02566083|11865695|FG000|COMPLETED|Overall Study||198
10701094|NCT02566083|11865696|FG001|COMPLETED|Overall Study||141
10701095|NCT02566083|11865695|FG000|NOT COMPLETED|Overall Study||16
10701096|NCT02566083|11865696|FG001|NOT COMPLETED|Overall Study||10
10701097|NCT02566109|11865702|FG000|STARTED|Overall Study||6
10701098|NCT02566109|11865702|FG000|COMPLETED|Overall Study||5
10701099|NCT02566109|11865702|FG000|NOT COMPLETED|Overall Study||1
10701100|NCT02566135|11865708|FG000|STARTED|Overall Study||29
10701101|NCT02566135|11865709|FG001|STARTED|Overall Study||29
10701102|NCT02566135|11865708|FG000|COMPLETED|Overall Study||29
10701103|NCT02566135|11865709|FG001|COMPLETED|Overall Study||29
10701104|NCT02566135|11865708|FG000|NOT COMPLETED|Overall Study||0
10701105|NCT02566135|11865709|FG001|NOT COMPLETED|Overall Study||0
10701106|NCT02566239|11865717|FG000|STARTED|Overall Study||43
10701107|NCT02566239|11865718|FG001|STARTED|Overall Study||48
10802268|NCT04287036|11963605|FG001|COMPLETED|Period 2||12
10802269|NCT04287036|11963604|FG000|NOT COMPLETED|Period 2||0
10802270|NCT04287036|11963605|FG001|NOT COMPLETED|Period 2||0
10802271|NCT04285411|11963611|FG000|STARTED|Overall Study||10
10802272|NCT04285411|11963611|FG000|COMPLETED|Overall Study||10
10802273|NCT04285411|11963611|FG000|NOT COMPLETED|Overall Study||0
10802274|NCT04284930|11963619|FG000|STARTED|Overall Study||8
10802275|NCT04284930|11963620|FG001|STARTED|Overall Study||5
10802276|NCT04284930|11963621|FG002|STARTED|Overall Study||8
10802277|NCT04284930|11963619|FG000|COMPLETED|Overall Study||8
10802278|NCT04284930|11963620|FG001|COMPLETED|Overall Study||5
10802279|NCT04284930|11963621|FG002|COMPLETED|Overall Study||8
10802280|NCT04284930|11963619|FG000|NOT COMPLETED|Overall Study||0
10802281|NCT04284930|11963620|FG001|NOT COMPLETED|Overall Study||0
10802282|NCT04284930|11963621|FG002|NOT COMPLETED|Overall Study||0
10802283|NCT04283773|11963632|FG000|STARTED|Overall Study||22
10802284|NCT04283773|11963633|FG001|STARTED|Overall Study||20
10802285|NCT04283773|11963634|FG002|STARTED|Overall Study||20
10802286|NCT04283773|11963632|FG000|COMPLETED|Overall Study||22
10802287|NCT04283773|11963633|FG001|COMPLETED|Overall Study||20
10802288|NCT04283773|11963634|FG002|COMPLETED|Overall Study||20
10802289|NCT04283773|11963632|FG000|NOT COMPLETED|Overall Study||0
10802290|NCT04283773|11963633|FG001|NOT COMPLETED|Overall Study||0
10802291|NCT04283773|11963634|FG002|NOT COMPLETED|Overall Study||0
10802292|NCT04281901|11963646|FG000|STARTED|Overall Study||12
10802293|NCT04281901|11963647|FG001|STARTED|Overall Study||12
10802294|NCT04281901|11963646|FG000|2. Check-up|Overall Study||11
10802295|NCT04281901|11963647|FG001|2. Check-up|Overall Study||11
10802296|NCT04281901|11963646|FG000|3. Check-up|Overall Study||11
10802297|NCT04281901|11963647|FG001|3. Check-up|Overall Study||11
10802298|NCT04281901|11963646|FG000|COMPLETED|Overall Study||11
10802299|NCT04281901|11963647|FG001|COMPLETED|Overall Study||11
10802300|NCT04281901|11963646|FG000|NOT COMPLETED|Overall Study||1
10802301|NCT04281901|11963647|FG001|NOT COMPLETED|Overall Study||1
10802302|NCT04280653|11963653|FG000|STARTED|Overall Study||15
10802303|NCT04280653|11963653|FG000|COMPLETED|Overall Study||15
10802304|NCT04280653|11963653|FG000|NOT COMPLETED|Overall Study||0
10701108|NCT02566239|11865717|FG000|COMPLETED|Overall Study||39
10701109|NCT02566239|11865718|FG001|COMPLETED|Overall Study||44
10701110|NCT02566239|11865717|FG000|NOT COMPLETED|Overall Study||4
10701111|NCT02566239|11865718|FG001|NOT COMPLETED|Overall Study||4
10701112|NCT02566265|11865726|FG000|STARTED|Overall Study||81
10701113|NCT02566265|11865727|FG001|STARTED|Overall Study||41
10701114|NCT02566265|11865726|FG000|Day 7 (+/- 2 Days) (Optional)|Overall Study||19
10701115|NCT02566265|11865727|FG001|Day 7 (+/- 2 Days) (Optional)|Overall Study||12
10701116|NCT02566265|11865726|FG000|Day of Second Vaccine|Overall Study||74
10701117|NCT02566265|11865727|FG001|Day of Second Vaccine|Overall Study||41
10802305|NCT04277936|11963657|FG000|STARTED|Overall Study||1
10701118|NCT02566265|11865726|FG000|30 Days Following 2nd Vaccine|Overall Study||72
10701119|NCT02566265|11865727|FG001|30 Days Following 2nd Vaccine|Overall Study||35
10701120|NCT02566265|11865726|FG000|End of Study Visit (Optional)|Overall Study||38
10701121|NCT02566265|11865727|FG001|End of Study Visit (Optional)|Overall Study||18
10701122|NCT02566265|11865726|FG000|COMPLETED|Overall Study||72
10701123|NCT02566265|11865727|FG001|COMPLETED|Overall Study||35
10701124|NCT02566265|11865726|FG000|NOT COMPLETED|Overall Study||9
10701125|NCT02566265|11865727|FG001|NOT COMPLETED|Overall Study||6
10701126|NCT02566317|11865735|FG000|STARTED|Overall Study||276
10701127|NCT02566317|11865736|FG001|STARTED|Overall Study||354
10701128|NCT02566317|11865735|FG000|COMPLETED|Overall Study||247
10701129|NCT02566317|11865736|FG001|COMPLETED|Overall Study||292
10701130|NCT02566317|11865735|FG000|NOT COMPLETED|Overall Study||29
10701131|NCT02566317|11865736|FG001|NOT COMPLETED|Overall Study||62
10701132|NCT02566369|11865744|FG000|STARTED|Overall Study||612
10701133|NCT02566369|11865745|FG001|STARTED|Overall Study||596
10701134|NCT02566369|11865744|FG000|COMPLETED|Overall Study||540
10701135|NCT02566369|11865745|FG001|COMPLETED|Overall Study||535
10701136|NCT02566369|11865744|FG000|NOT COMPLETED|Overall Study||72
10701137|NCT02566369|11865745|FG001|NOT COMPLETED|Overall Study||61
10701138|NCT02566525|11865753|FG000|STARTED|Overall Study|FPI - CytoSorb Patient 15 Jan 2016|23
10701139|NCT02566525|11865754|FG001|STARTED|Overall Study|FPI - Control Patient 8 Dec 2015|23
10701140|NCT02566525|11865753|FG000|COMPLETED|Overall Study|LPI - CytoSorb Patient 19 Aug 2016|20
10701141|NCT02566525|11865754|FG001|COMPLETED|Overall Study|LPI - Control 16 Aug 2016|18
10701142|NCT02566525|11865753|FG000|NOT COMPLETED|Overall Study||3
10701143|NCT02566525|11865754|FG001|NOT COMPLETED|Overall Study||5
10701144|NCT02566577|11865764|FG000|STARTED|Overall Study||9
10701145|NCT02566577|11865765|FG001|STARTED|Overall Study||6
10701146|NCT02566577|11865764|FG000|COMPLETED|Overall Study||6
10701147|NCT02566577|11865765|FG001|COMPLETED|Overall Study||4
10701148|NCT02566577|11865764|FG000|NOT COMPLETED|Overall Study||3
10701149|NCT02566577|11865765|FG001|NOT COMPLETED|Overall Study||2
10701150|NCT02566590|11865775|FG000|STARTED|Overall Study||10
10701151|NCT02566590|11865776|FG001|STARTED|Overall Study||10
10701152|NCT02566590|11865775|FG000|COMPLETED|Overall Study||10
10701153|NCT02566590|11865776|FG001|COMPLETED|Overall Study||10
10701154|NCT02566590|11865775|FG000|NOT COMPLETED|Overall Study||0
10701155|NCT02566590|11865776|FG001|NOT COMPLETED|Overall Study||0
10701156|NCT02566759|11865799|FG000|STARTED|All Parts||12
10701157|NCT02566759|11865800|FG001|STARTED|All Parts||6
10802306|NCT04277936|11963657|FG000|COMPLETED|Overall Study||1
10802307|NCT04277936|11963657|FG000|NOT COMPLETED|Overall Study||0
10802308|NCT04275336|11963664|FG000|STARTED|Overall Study||120
10802309|NCT04275336|11963665|FG001|STARTED|Overall Study||118
10802310|NCT04275336|11963666|FG002|STARTED|Overall Study||116
10802311|NCT04275336|11963664|FG000|COMPLETED|Overall Study||103
10802312|NCT04275336|11963665|FG001|COMPLETED|Overall Study||96
10802313|NCT04275336|11963666|FG002|COMPLETED|Overall Study||100
10802314|NCT04275336|11963664|FG000|NOT COMPLETED|Overall Study||17
10802315|NCT04275336|11963665|FG001|NOT COMPLETED|Overall Study||22
10802316|NCT04275336|11963666|FG002|NOT COMPLETED|Overall Study||16
10802317|NCT04272775|11963679|FG000|STARTED|Overall Study||7
10802318|NCT04272775|11963680|FG001|STARTED|Overall Study||7
10802319|NCT04272775|11963679|FG000|COMPLETED|Overall Study||0
10802320|NCT04272775|11963680|FG001|COMPLETED|Overall Study||0
10802321|NCT04272775|11963679|FG000|NOT COMPLETED|Overall Study||7
10802322|NCT04272775|11963680|FG001|NOT COMPLETED|Overall Study||7
10802323|NCT04271020|11963686|FG000|STARTED|Overall Study||12
10802324|NCT04271020|11963686|FG000|COMPLETED|Overall Study||12
10802325|NCT04271020|11963686|FG000|NOT COMPLETED|Overall Study||0
10802326|NCT04274075|11963696|FG000|STARTED|Overall Study||3
10802327|NCT04274075|11963697|FG001|STARTED|Overall Study||3
10802328|NCT04274075|11963698|FG002|STARTED|Overall Study||3
10802329|NCT04274075|11963699|FG003|STARTED|Overall Study||3
10802330|NCT04274075|11963700|FG004|STARTED|Overall Study||3
10802331|NCT04274075|11963701|FG005|STARTED|Overall Study||3
10802332|NCT04274075|11963696|FG000|Completed Treatment Period 1 (9 Days)|Overall Study||3
10802333|NCT04274075|11963697|FG001|Completed Treatment Period 1 (9 Days)|Overall Study||3
10802334|NCT04274075|11963698|FG002|Completed Treatment Period 1 (9 Days)|Overall Study||3
10802335|NCT04274075|11963699|FG003|Completed Treatment Period 1 (9 Days)|Overall Study||3
10802336|NCT04274075|11963700|FG004|Completed Treatment Period 1 (9 Days)|Overall Study||3
10802337|NCT04274075|11963701|FG005|Completed Treatment Period 1 (9 Days)|Overall Study||3
10802338|NCT04274075|11963696|FG000|Completed Treatment Period 2 (9 Days)|Overall Study||3
10802339|NCT04274075|11963697|FG001|Completed Treatment Period 2 (9 Days)|Overall Study||3
10802340|NCT04274075|11963698|FG002|Completed Treatment Period 2 (9 Days)|Overall Study||3
10802341|NCT04274075|11963699|FG003|Completed Treatment Period 2 (9 Days)|Overall Study||3
10802342|NCT04274075|11963700|FG004|Completed Treatment Period 2 (9 Days)|Overall Study||3
10802343|NCT04274075|11963701|FG005|Completed Treatment Period 2 (9 Days)|Overall Study||3
10802344|NCT04274075|11963696|FG000|Completed Treatment Period 3 (9 Days)|Overall Study||3
10701158|NCT02566759|11865801|FG002|STARTED|All Parts||6
10701159|NCT02566759|11865802|FG003|STARTED|All Parts||6
10701160|NCT02566759|11865803|FG004|STARTED|All Parts||6
10701161|NCT02566759|11865804|FG005|STARTED|All Parts||6
10701162|NCT02566759|11865805|FG006|STARTED|All Parts||6
10701163|NCT02566759|11865806|FG007|STARTED|All Parts||8
10701164|NCT02566759|11865807|FG008|STARTED|All Parts||6
10701165|NCT02566759|11865808|FG009|STARTED|All Parts||6
10701166|NCT02566759|11865809|FG010|STARTED|All Parts||6
10701167|NCT02566759|11865810|FG011|STARTED|All Parts||6
10701168|NCT02566759|11865811|FG012|STARTED|All Parts||1
10701169|NCT02566759|11865812|FG013|STARTED|All Parts||5
10701170|NCT02566759|11865813|FG014|STARTED|All Parts||8
10701171|NCT02566759|11865814|FG015|STARTED|All Parts||8
10701172|NCT02566759|11865815|FG016|STARTED|All Parts||8
10701173|NCT02566759|11865799|FG000|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|12
10701174|NCT02566759|11865800|FG001|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|5
10802345|NCT04274075|11963697|FG001|Completed Treatment Period 3 (9 Days)|Overall Study||3
10802346|NCT04274075|11963698|FG002|Completed Treatment Period 3 (9 Days)|Overall Study||3
10802347|NCT04274075|11963699|FG003|Completed Treatment Period 3 (9 Days)|Overall Study||3
10802348|NCT04274075|11963700|FG004|Completed Treatment Period 3 (9 Days)|Overall Study||3
10802349|NCT04274075|11963701|FG005|Completed Treatment Period 3 (9 Days)|Overall Study||3
10802350|NCT04274075|11963696|FG000|Completed Follow-up Visit|Overall Study||3
10802351|NCT04274075|11963697|FG001|Completed Follow-up Visit|Overall Study||3
10802352|NCT04274075|11963698|FG002|Completed Follow-up Visit|Overall Study||3
10802353|NCT04274075|11963699|FG003|Completed Follow-up Visit|Overall Study||3
10802354|NCT04274075|11963700|FG004|Completed Follow-up Visit|Overall Study||3
10802355|NCT04274075|11963701|FG005|Completed Follow-up Visit|Overall Study||3
10802356|NCT04274075|11963696|FG000|COMPLETED|Overall Study||3
10802357|NCT04274075|11963697|FG001|COMPLETED|Overall Study||3
10802358|NCT04274075|11963698|FG002|COMPLETED|Overall Study||3
10802359|NCT04274075|11963699|FG003|COMPLETED|Overall Study||3
10802360|NCT04274075|11963700|FG004|COMPLETED|Overall Study||3
10802361|NCT04274075|11963701|FG005|COMPLETED|Overall Study||3
10802362|NCT04274075|11963696|FG000|NOT COMPLETED|Overall Study||0
10802363|NCT04274075|11963697|FG001|NOT COMPLETED|Overall Study||0
10802364|NCT04274075|11963698|FG002|NOT COMPLETED|Overall Study||0
10802365|NCT04274075|11963699|FG003|NOT COMPLETED|Overall Study||0
10802366|NCT04274075|11963700|FG004|NOT COMPLETED|Overall Study||0
10802367|NCT04274075|11963701|FG005|NOT COMPLETED|Overall Study||0
10802368|NCT04271605|11963712|FG000|STARTED|Overall Study|Baseline questionnaire and examination were done after enrollment.|5
10802369|NCT04271605|11963712|FG000|COMPLETED|Overall Study||0
10802370|NCT04271605|11963712|FG000|NOT COMPLETED|Overall Study||5
10802371|NCT04271761|11963716|FG000|STARTED|Overall Study||14
10802372|NCT04271761|11963716|FG000|COMPLETED|Overall Study||14
10802373|NCT04271761|11963716|FG000|NOT COMPLETED|Overall Study||0
10802374|NCT04268316|11963723|FG000|STARTED|Overall Study||5
10802375|NCT04268316|11963724|FG001|STARTED|Overall Study||4
10802376|NCT04268316|11963725|FG002|STARTED|Overall Study||4
10802377|NCT04268316|11963723|FG000|COMPLETED|Overall Study||3
10802378|NCT04268316|11963724|FG001|COMPLETED|Overall Study||3
10802379|NCT04268316|11963725|FG002|COMPLETED|Overall Study||4
10802380|NCT04268316|11963723|FG000|NOT COMPLETED|Overall Study||2
10802381|NCT04268316|11963724|FG001|NOT COMPLETED|Overall Study||1
10802382|NCT04268316|11963725|FG002|NOT COMPLETED|Overall Study||0
10802383|NCT04269629|11963733|FG000|STARTED|Overall Study|1425 patients were included in the study (=Visit 1)|1425
10802384|NCT04269629|11963733|FG000|Number of Patients Who Performed VIT|Overall Study|Visit 2 was performed with 1342 patients|1342
10802385|NCT04269629|11963733|FG000|COMPLETED|Overall Study|Visit 3 was performed with 1186 patients|1186
10802386|NCT04269629|11963733|FG000|NOT COMPLETED|Overall Study||239
10802387|NCT04267575|11963741|FG000|STARTED|Overall Study||20
10802388|NCT04267575|11963741|FG000|COMPLETED|Overall Study||20
10802389|NCT04267575|11963741|FG000|NOT COMPLETED|Overall Study||0
10802390|NCT04267770|11963747|FG000|STARTED|Overall Study||9
10802391|NCT04267770|11963748|FG001|STARTED|Overall Study||8
10802392|NCT04267770|11963747|FG000|COMPLETED|Overall Study||9
10802393|NCT04267770|11963748|FG001|COMPLETED|Overall Study||8
10802394|NCT04267770|11963747|FG000|NOT COMPLETED|Overall Study||0
10802395|NCT04267770|11963748|FG001|NOT COMPLETED|Overall Study||0
10802396|NCT04266925|11963756|FG000|STARTED|1 Referee Game (~1 Hour)||23
10802397|NCT04266925|11963757|FG001|STARTED|1 Referee Game (~1 Hour)||26
10802398|NCT04266925|11963756|FG000|COMPLETED|1 Referee Game (~1 Hour)||23
10802399|NCT04266925|11963757|FG001|COMPLETED|1 Referee Game (~1 Hour)||26
10802400|NCT04266925|11963756|FG000|NOT COMPLETED|1 Referee Game (~1 Hour)||0
10802401|NCT04266925|11963757|FG001|NOT COMPLETED|1 Referee Game (~1 Hour)||0
10802402|NCT04266925|11963756|FG000|STARTED|3 Referee Game (~1 Hour)||23
10802403|NCT04266925|11963757|FG001|STARTED|3 Referee Game (~1 Hour)||26
10802404|NCT04266925|11963756|FG000|COMPLETED|3 Referee Game (~1 Hour)||23
10802405|NCT04266925|11963757|FG001|COMPLETED|3 Referee Game (~1 Hour)||26
10802406|NCT04266925|11963756|FG000|NOT COMPLETED|3 Referee Game (~1 Hour)||0
10802407|NCT04266925|11963757|FG001|NOT COMPLETED|3 Referee Game (~1 Hour)||0
10802408|NCT04263142|11963768|FG000|STARTED|Part 1 Period 1 (Day 1)||9
10802409|NCT04263142|11963769|FG001|STARTED|Part 1 Period 1 (Day 1)||9
10802410|NCT04263142|11963770|FG002|STARTED|Part 1 Period 1 (Day 1)||0
10802411|NCT04263142|11963771|FG003|STARTED|Part 1 Period 1 (Day 1)||0
10802412|NCT04263142|11963772|FG004|STARTED|Part 1 Period 1 (Day 1)||0
10802413|NCT04263142|11963768|FG000|COMPLETED|Part 1 Period 1 (Day 1)||9
10802414|NCT04263142|11963769|FG001|COMPLETED|Part 1 Period 1 (Day 1)||9
10802415|NCT04263142|11963770|FG002|COMPLETED|Part 1 Period 1 (Day 1)||0
10802416|NCT04263142|11963771|FG003|COMPLETED|Part 1 Period 1 (Day 1)||0
10701175|NCT02566759|11865801|FG002|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
10802417|NCT04263142|11963772|FG004|COMPLETED|Part 1 Period 1 (Day 1)||0
10802418|NCT04263142|11963768|FG000|NOT COMPLETED|Part 1 Period 1 (Day 1)||0
10701176|NCT02566759|11865802|FG003|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
10701177|NCT02566759|11865803|FG004|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
10701178|NCT02566759|11865804|FG005|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
10701179|NCT02566759|11865805|FG006|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
10802419|NCT04263142|11963769|FG001|NOT COMPLETED|Part 1 Period 1 (Day 1)||0
10802420|NCT04263142|11963770|FG002|NOT COMPLETED|Part 1 Period 1 (Day 1)||0
10802421|NCT04263142|11963771|FG003|NOT COMPLETED|Part 1 Period 1 (Day 1)||0
10802422|NCT04263142|11963772|FG004|NOT COMPLETED|Part 1 Period 1 (Day 1)||0
10802423|NCT04263142|11963768|FG000|STARTED|Part 1 Period 2 (Up to Day 5)||9
10802424|NCT04263142|11963769|FG001|STARTED|Part 1 Period 2 (Up to Day 5)||9
10802425|NCT04263142|11963770|FG002|STARTED|Part 1 Period 2 (Up to Day 5)||0
10802426|NCT04263142|11963771|FG003|STARTED|Part 1 Period 2 (Up to Day 5)||0
10802427|NCT04263142|11963772|FG004|STARTED|Part 1 Period 2 (Up to Day 5)||0
10802428|NCT04263142|11963768|FG000|COMPLETED|Part 1 Period 2 (Up to Day 5)||9
10802429|NCT04263142|11963769|FG001|COMPLETED|Part 1 Period 2 (Up to Day 5)||9
10802430|NCT04263142|11963770|FG002|COMPLETED|Part 1 Period 2 (Up to Day 5)||0
10802431|NCT04263142|11963771|FG003|COMPLETED|Part 1 Period 2 (Up to Day 5)||0
10802432|NCT04263142|11963772|FG004|COMPLETED|Part 1 Period 2 (Up to Day 5)||0
10802433|NCT04263142|11963768|FG000|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0
10802434|NCT04263142|11963769|FG001|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0
10802435|NCT04263142|11963770|FG002|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0
10802436|NCT04263142|11963771|FG003|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0
10802437|NCT04263142|11963772|FG004|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0
10802438|NCT04263142|11963768|FG000|STARTED|Part 2 Period 1 (Day 1)||0
10802439|NCT04263142|11963769|FG001|STARTED|Part 2 Period 1 (Day 1)||0
10802440|NCT04263142|11963770|FG002|STARTED|Part 2 Period 1 (Day 1)||7
10802441|NCT04263142|11963771|FG003|STARTED|Part 2 Period 1 (Day 1)||7
10802442|NCT04263142|11963772|FG004|STARTED|Part 2 Period 1 (Day 1)||7
10802443|NCT04263142|11963768|FG000|COMPLETED|Part 2 Period 1 (Day 1)||0
10802444|NCT04263142|11963769|FG001|COMPLETED|Part 2 Period 1 (Day 1)||0
10802445|NCT04263142|11963770|FG002|COMPLETED|Part 2 Period 1 (Day 1)||7
10802446|NCT04263142|11963771|FG003|COMPLETED|Part 2 Period 1 (Day 1)||7
10802447|NCT04263142|11963772|FG004|COMPLETED|Part 2 Period 1 (Day 1)||6
10802448|NCT04263142|11963768|FG000|NOT COMPLETED|Part 2 Period 1 (Day 1)||0
10802449|NCT04263142|11963769|FG001|NOT COMPLETED|Part 2 Period 1 (Day 1)||0
10802450|NCT04263142|11963770|FG002|NOT COMPLETED|Part 2 Period 1 (Day 1)||0
10802451|NCT04263142|11963771|FG003|NOT COMPLETED|Part 2 Period 1 (Day 1)||0
10701180|NCT02566759|11865806|FG007|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|8
10701181|NCT02566759|11865807|FG008|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
10701182|NCT02566759|11865808|FG009|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
10701183|NCT02566759|11865809|FG010|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
10701184|NCT02566759|11865810|FG011|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
10701185|NCT02566759|11865811|FG012|COMPLETED|All Parts||0
10701186|NCT02566759|11865812|FG013|COMPLETED|All Parts||0
10701187|NCT02566759|11865813|FG014|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
10701188|NCT02566759|11865814|FG015|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
10701189|NCT02566759|11865815|FG016|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
10701190|NCT02566759|11865799|FG000|NOT COMPLETED|All Parts||0
10701191|NCT02566759|11865800|FG001|NOT COMPLETED|All Parts||1
10701192|NCT02566759|11865801|FG002|NOT COMPLETED|All Parts||0
10701193|NCT02566759|11865802|FG003|NOT COMPLETED|All Parts||0
10701194|NCT02566759|11865803|FG004|NOT COMPLETED|All Parts||0
10701195|NCT02566759|11865804|FG005|NOT COMPLETED|All Parts||0
10701196|NCT02566759|11865805|FG006|NOT COMPLETED|All Parts||0
10701197|NCT02566759|11865806|FG007|NOT COMPLETED|All Parts||0
10701198|NCT02566759|11865807|FG008|NOT COMPLETED|All Parts||0
10701199|NCT02566759|11865808|FG009|NOT COMPLETED|All Parts||0
10701200|NCT02566759|11865809|FG010|NOT COMPLETED|All Parts||0
10701201|NCT02566759|11865810|FG011|NOT COMPLETED|All Parts||0
10701202|NCT02566759|11865811|FG012|NOT COMPLETED|All Parts||1
10701203|NCT02566759|11865812|FG013|NOT COMPLETED|All Parts||5
10701204|NCT02566759|11865813|FG014|NOT COMPLETED|All Parts||0
10701205|NCT02566759|11865814|FG015|NOT COMPLETED|All Parts||0
10701206|NCT02566759|11865815|FG016|NOT COMPLETED|All Parts||0
10701207|NCT02566759|11865799|FG000|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10701208|NCT02566759|11865800|FG001|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10701209|NCT02566759|11865801|FG002|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10701210|NCT02566759|11865802|FG003|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10701211|NCT02566759|11865803|FG004|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10701212|NCT02566759|11865804|FG005|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10802452|NCT04263142|11963772|FG004|NOT COMPLETED|Part 2 Period 1 (Day 1)||1
10802453|NCT04263142|11963768|FG000|STARTED|Part 2 Period 2 (Day 1)||0
10802454|NCT04263142|11963769|FG001|STARTED|Part 2 Period 2 (Day 1)||0
10802455|NCT04263142|11963770|FG002|STARTED|Part 2 Period 2 (Day 1)||7
10802456|NCT04263142|11963771|FG003|STARTED|Part 2 Period 2 (Day 1)||7
10701213|NCT02566759|11865805|FG006|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10802457|NCT04263142|11963772|FG004|STARTED|Part 2 Period 2 (Day 1)||6
10802458|NCT04263142|11963768|FG000|COMPLETED|Part 2 Period 2 (Day 1)||0
10802459|NCT04263142|11963769|FG001|COMPLETED|Part 2 Period 2 (Day 1)||0
10802460|NCT04263142|11963770|FG002|COMPLETED|Part 2 Period 2 (Day 1)||7
10802461|NCT04263142|11963771|FG003|COMPLETED|Part 2 Period 2 (Day 1)||7
10802462|NCT04263142|11963772|FG004|COMPLETED|Part 2 Period 2 (Day 1)||5
10802463|NCT04263142|11963768|FG000|NOT COMPLETED|Part 2 Period 2 (Day 1)||0
10802464|NCT04263142|11963769|FG001|NOT COMPLETED|Part 2 Period 2 (Day 1)||0
10802465|NCT04263142|11963770|FG002|NOT COMPLETED|Part 2 Period 2 (Day 1)||0
10802466|NCT04263142|11963771|FG003|NOT COMPLETED|Part 2 Period 2 (Day 1)||0
10802467|NCT04263142|11963772|FG004|NOT COMPLETED|Part 2 Period 2 (Day 1)||1
10802468|NCT04263142|11963768|FG000|STARTED|Part 2 Period 3 (Up to Day 5)||0
10802469|NCT04263142|11963769|FG001|STARTED|Part 2 Period 3 (Up to Day 5)||0
10802470|NCT04263142|11963770|FG002|STARTED|Part 2 Period 3 (Up to Day 5)||7
10802471|NCT04263142|11963771|FG003|STARTED|Part 2 Period 3 (Up to Day 5)||7
10802472|NCT04263142|11963772|FG004|STARTED|Part 2 Period 3 (Up to Day 5)||5
10802473|NCT04263142|11963768|FG000|COMPLETED|Part 2 Period 3 (Up to Day 5)||0
10802474|NCT04263142|11963769|FG001|COMPLETED|Part 2 Period 3 (Up to Day 5)||0
10802475|NCT04263142|11963770|FG002|COMPLETED|Part 2 Period 3 (Up to Day 5)||7
10802476|NCT04263142|11963771|FG003|COMPLETED|Part 2 Period 3 (Up to Day 5)||7
10802477|NCT04263142|11963772|FG004|COMPLETED|Part 2 Period 3 (Up to Day 5)||5
10802478|NCT04263142|11963768|FG000|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0
10802479|NCT04263142|11963769|FG001|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0
10802480|NCT04263142|11963770|FG002|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0
10802481|NCT04263142|11963771|FG003|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0
10802482|NCT04263142|11963772|FG004|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0
10802483|NCT04256785|11963787|FG000|STARTED|Overall Study||54
10802484|NCT04256785|11963788|FG001|STARTED|Overall Study||56
10802485|NCT04256785|11963787|FG000|COMPLETED|Overall Study||26
10802486|NCT04256785|11963788|FG001|COMPLETED|Overall Study||31
10802487|NCT04256785|11963787|FG000|NOT COMPLETED|Overall Study||28
10802488|NCT04256785|11963788|FG001|NOT COMPLETED|Overall Study||25
10802489|NCT04252092|11963798|FG000|STARTED|Overall Study||15
10802490|NCT04252092|11963799|FG001|STARTED|Overall Study||15
10802491|NCT04252092|11963798|FG000|COMPLETED|Overall Study||15
10802492|NCT04252092|11963799|FG001|COMPLETED|Overall Study||15
10802493|NCT04252092|11963798|FG000|NOT COMPLETED|Overall Study||0
10802494|NCT04252092|11963799|FG001|NOT COMPLETED|Overall Study||0
10802495|NCT04250987|11963805|FG000|STARTED|Overall Study||12
10802496|NCT04250987|11963805|FG000|COMPLETED|Overall Study||12
10802497|NCT04250987|11963805|FG000|NOT COMPLETED|Overall Study||0
10802498|NCT04249336|11963813|FG000|STARTED|Overall Study||35
10802499|NCT04249336|11963814|FG001|STARTED|Overall Study||35
10802500|NCT04249336|11963815|FG002|STARTED|Overall Study||35
10802501|NCT04249336|11963816|FG003|STARTED|Overall Study||35
10802502|NCT04249336|11963813|FG000|Per Protocol Population Day 3|Overall Study||32
10802503|NCT04249336|11963814|FG001|Per Protocol Population Day 3|Overall Study||32
10802504|NCT04249336|11963815|FG002|Per Protocol Population Day 3|Overall Study||32
10802505|NCT04249336|11963816|FG003|Per Protocol Population Day 3|Overall Study||32
10802506|NCT04249336|11963813|FG000|Per Protocol Population Week 4|Overall Study||33
10802507|NCT04249336|11963814|FG001|Per Protocol Population Week 4|Overall Study||35
10802508|NCT04249336|11963815|FG002|Per Protocol Population Week 4|Overall Study||33
10802509|NCT04249336|11963816|FG003|Per Protocol Population Week 4|Overall Study||34
10802510|NCT04249336|11963813|FG000|COMPLETED|Overall Study||32
10802511|NCT04249336|11963814|FG001|COMPLETED|Overall Study||32
10802512|NCT04249336|11963815|FG002|COMPLETED|Overall Study||32
10802513|NCT04249336|11963816|FG003|COMPLETED|Overall Study||32
10701214|NCT02566759|11865806|FG007|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10701215|NCT02566759|11865807|FG008|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10701216|NCT02566759|11865808|FG009|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10701217|NCT02566759|11865809|FG010|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10701218|NCT02566759|11865810|FG011|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10701219|NCT02566759|11865811|FG012|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10701220|NCT02566759|11865812|FG013|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10701221|NCT02566759|11865813|FG014|STARTED|Washout Crossover Period (Part 4:5 Days)||8
10701222|NCT02566759|11865814|FG015|STARTED|Washout Crossover Period (Part 4:5 Days)||8
10701223|NCT02566759|11865815|FG016|STARTED|Washout Crossover Period (Part 4:5 Days)||8
10701224|NCT02566759|11865799|FG000|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701225|NCT02566759|11865800|FG001|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701226|NCT02566759|11865801|FG002|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701227|NCT02566759|11865802|FG003|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701228|NCT02566759|11865803|FG004|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701229|NCT02566759|11865804|FG005|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10802514|NCT04249336|11963813|FG000|NOT COMPLETED|Overall Study||3
10802515|NCT04249336|11963814|FG001|NOT COMPLETED|Overall Study||3
10802516|NCT04249336|11963815|FG002|NOT COMPLETED|Overall Study||3
10802517|NCT04249336|11963816|FG003|NOT COMPLETED|Overall Study||3
10802518|NCT04247581|11963828|FG000|STARTED|Overall Study||241
10802519|NCT04247581|11963829|FG001|STARTED|Overall Study||305
10802520|NCT04247581|11963828|FG000|COMPLETED|Overall Study||241
10802521|NCT04247581|11963829|FG001|COMPLETED|Overall Study||293
10701230|NCT02566759|11865805|FG006|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701231|NCT02566759|11865806|FG007|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701232|NCT02566759|11865807|FG008|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701233|NCT02566759|11865808|FG009|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701234|NCT02566759|11865809|FG010|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701235|NCT02566759|11865810|FG011|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701236|NCT02566759|11865811|FG012|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701237|NCT02566759|11865812|FG013|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10802522|NCT04247581|11963828|FG000|NOT COMPLETED|Overall Study||0
10802523|NCT04247581|11963829|FG001|NOT COMPLETED|Overall Study||12
10802524|NCT04247061|11963835|FG000|STARTED|Overall Study|13 Subjects completed the required pre-dental appointment study activities and were scheduled to attend the dental clinic|13
10802525|NCT04247061|11963835|FG000|COMPLETED|Overall Study||4
10802526|NCT04247061|11963835|FG000|NOT COMPLETED|Overall Study||9
10802527|NCT04245202|11963841|FG000|STARTED|Overall Study|After getting consent.|48
10802528|NCT04245202|11963842|FG001|STARTED|Overall Study|After getting consent|39
10802529|NCT04245202|11963841|FG000|COMPLETED|Overall Study||38
10802530|NCT04245202|11963842|FG001|COMPLETED|Overall Study||38
10802531|NCT04245202|11963841|FG000|NOT COMPLETED|Overall Study||10
10802532|NCT04245202|11963842|FG001|NOT COMPLETED|Overall Study||1
10802533|NCT04243369|11963849|FG000|STARTED|Overall Study||30
10802534|NCT04243369|11963849|FG000|COMPLETED|Overall Study||30
10802535|NCT04243369|11963849|FG000|NOT COMPLETED|Overall Study||0
10802536|NCT04241146|11963855|FG000|STARTED|Overall Study||24
10802537|NCT04241146|11963856|FG001|STARTED|Overall Study||28
10802538|NCT04241146|11963855|FG000|COMPLETED|Overall Study||24
10802539|NCT04241146|11963856|FG001|COMPLETED|Overall Study||28
10802540|NCT04241146|11963855|FG000|NOT COMPLETED|Overall Study||0
10802541|NCT04241146|11963856|FG001|NOT COMPLETED|Overall Study||0
10802542|NCT04240678|11963864|FG000|STARTED|Overall Study||4141
10802543|NCT04240678|11963865|FG001|STARTED|Overall Study||4158
10802544|NCT04240678|11963864|FG000|COMPLETED|Overall Study||4141
10802545|NCT04240678|11963865|FG001|COMPLETED|Overall Study||4158
10802546|NCT04240678|11963864|FG000|NOT COMPLETED|Overall Study||0
10802547|NCT04240678|11963865|FG001|NOT COMPLETED|Overall Study||0
10802548|NCT04238650|11963873|FG000|STARTED|Overall Study||24
10802549|NCT04238650|11963874|FG001|STARTED|Overall Study|One subject was enrolled and randomized to EU Avastin® but the subject was not dosed (subject withdrawal before study drug administration)|25
10802550|NCT04238650|11963873|FG000|COMPLETED|Overall Study||24
10802551|NCT04238650|11963874|FG001|COMPLETED|Overall Study||24
10802552|NCT04238650|11963873|FG000|NOT COMPLETED|Overall Study||0
10802553|NCT04238650|11963874|FG001|NOT COMPLETED|Overall Study||1
10802554|NCT04238663|11963883|FG000|STARTED|Overall Study||38
10802555|NCT04238663|11963884|FG001|STARTED|Overall Study||38
10802556|NCT04238663|11963885|FG002|STARTED|Overall Study||38
10701238|NCT02566759|11865813|FG014|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
10701239|NCT02566759|11865814|FG015|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
10802557|NCT04238663|11963883|FG000|COMPLETED|Overall Study||38
10701240|NCT02566759|11865815|FG016|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
10701241|NCT02566759|11865799|FG000|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701242|NCT02566759|11865800|FG001|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701243|NCT02566759|11865801|FG002|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701244|NCT02566759|11865802|FG003|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701245|NCT02566759|11865803|FG004|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701246|NCT02566759|11865804|FG005|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701247|NCT02566759|11865805|FG006|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701248|NCT02566759|11865806|FG007|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701249|NCT02566759|11865807|FG008|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701250|NCT02566759|11865808|FG009|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701251|NCT02566759|11865809|FG010|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701252|NCT02566759|11865810|FG011|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701253|NCT02566759|11865811|FG012|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701254|NCT02566759|11865812|FG013|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701255|NCT02566759|11865813|FG014|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701256|NCT02566759|11865814|FG015|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701257|NCT02566759|11865815|FG016|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701258|NCT02566759|11865799|FG000|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10701259|NCT02566759|11865800|FG001|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10701260|NCT02566759|11865801|FG002|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10701261|NCT02566759|11865802|FG003|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10701262|NCT02566759|11865803|FG004|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10701263|NCT02566759|11865804|FG005|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10701264|NCT02566759|11865805|FG006|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10701265|NCT02566759|11865806|FG007|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10701266|NCT02566759|11865807|FG008|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10701267|NCT02566759|11865808|FG009|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10701268|NCT02566759|11865809|FG010|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10701269|NCT02566759|11865810|FG011|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10701270|NCT02566759|11865811|FG012|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10701271|NCT02566759|11865812|FG013|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10701272|NCT02566759|11865813|FG014|STARTED|Crossover Treatment (Part 4: 1 Day)||8
10701273|NCT02566759|11865814|FG015|STARTED|Crossover Treatment (Part 4: 1 Day)||8
10701274|NCT02566759|11865815|FG016|STARTED|Crossover Treatment (Part 4: 1 Day)||8
10701275|NCT02566759|11865799|FG000|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701276|NCT02566759|11865800|FG001|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701277|NCT02566759|11865801|FG002|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701278|NCT02566759|11865802|FG003|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701279|NCT02566759|11865803|FG004|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701280|NCT02566759|11865804|FG005|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701281|NCT02566759|11865805|FG006|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701282|NCT02566759|11865806|FG007|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701283|NCT02566759|11865807|FG008|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701284|NCT02566759|11865808|FG009|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701285|NCT02566759|11865809|FG010|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701286|NCT02566759|11865810|FG011|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701287|NCT02566759|11865811|FG012|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701288|NCT02566759|11865812|FG013|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701289|NCT02566759|11865813|FG014|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
10701290|NCT02566759|11865814|FG015|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
10701291|NCT02566759|11865815|FG016|COMPLETED|Crossover Treatment (Part 4: 1 Day)||7
10701292|NCT02566759|11865799|FG000|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701293|NCT02566759|11865800|FG001|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701294|NCT02566759|11865801|FG002|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701295|NCT02566759|11865802|FG003|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701296|NCT02566759|11865803|FG004|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701297|NCT02566759|11865804|FG005|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701298|NCT02566759|11865805|FG006|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701299|NCT02566759|11865806|FG007|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701300|NCT02566759|11865807|FG008|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701301|NCT02566759|11865808|FG009|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701302|NCT02566759|11865809|FG010|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701303|NCT02566759|11865810|FG011|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701304|NCT02566759|11865811|FG012|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701305|NCT02566759|11865812|FG013|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701306|NCT02566759|11865813|FG014|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701307|NCT02566759|11865814|FG015|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701308|NCT02566759|11865815|FG016|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||1
10701309|NCT02566759|11865799|FG000|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10701310|NCT02566759|11865800|FG001|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10701311|NCT02566759|11865801|FG002|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10701312|NCT02566759|11865802|FG003|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10701313|NCT02566759|11865803|FG004|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10701314|NCT02566759|11865804|FG005|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10701315|NCT02566759|11865805|FG006|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10701316|NCT02566759|11865806|FG007|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10701317|NCT02566759|11865807|FG008|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10701318|NCT02566759|11865808|FG009|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10701319|NCT02566759|11865809|FG010|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10701320|NCT02566759|11865810|FG011|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10701321|NCT02566759|11865811|FG012|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10701322|NCT02566759|11865812|FG013|STARTED|Washout Crossover Period (Part 4:5 Days)||0
10701323|NCT02566759|11865813|FG014|STARTED|Washout Crossover Period (Part 4:5 Days)||8
10701324|NCT02566759|11865814|FG015|STARTED|Washout Crossover Period (Part 4:5 Days)||8
10701325|NCT02566759|11865815|FG016|STARTED|Washout Crossover Period (Part 4:5 Days)||7
10701326|NCT02566759|11865799|FG000|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701327|NCT02566759|11865800|FG001|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701328|NCT02566759|11865801|FG002|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701329|NCT02566759|11865802|FG003|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10802558|NCT04238663|11963884|FG001|COMPLETED|Overall Study||37
10802559|NCT04238663|11963885|FG002|COMPLETED|Overall Study||38
10802560|NCT04238663|11963883|FG000|NOT COMPLETED|Overall Study||0
10802561|NCT04238663|11963884|FG001|NOT COMPLETED|Overall Study||1
10802562|NCT04238663|11963885|FG002|NOT COMPLETED|Overall Study||0
10802563|NCT04235582|11963896|FG000|STARTED|Overall Study||12
10802564|NCT04235582|11963897|FG001|STARTED|Overall Study||13
10802565|NCT04235582|11963898|FG002|STARTED|Overall Study||11
10802566|NCT04235582|11963896|FG000|COMPLETED|Overall Study||12
10802567|NCT04235582|11963897|FG001|COMPLETED|Overall Study||12
10802568|NCT04235582|11963898|FG002|COMPLETED|Overall Study||8
10802569|NCT04235582|11963896|FG000|NOT COMPLETED|Overall Study||0
10802570|NCT04235582|11963897|FG001|NOT COMPLETED|Overall Study||1
10802571|NCT04235582|11963898|FG002|NOT COMPLETED|Overall Study||3
10802572|NCT04203225|11963908|FG000|STARTED|Overall Study||21
10802573|NCT04203225|11963909|FG001|STARTED|Overall Study||27
10802574|NCT04203225|11963908|FG000|COMPLETED|Overall Study||21
10802575|NCT04203225|11963909|FG001|COMPLETED|Overall Study||27
10802576|NCT04203225|11963908|FG000|NOT COMPLETED|Overall Study||0
10802577|NCT04203225|11963909|FG001|NOT COMPLETED|Overall Study||0
10802578|NCT04234672|11963915|FG000|STARTED|Treatment Period 1 (Day 1)||6
10802579|NCT04234672|11963915|FG000|COMPLETED|Treatment Period 1 (Day 1)||6
10802580|NCT04234672|11963915|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10802581|NCT04234672|11963915|FG000|STARTED|Washout Period (Day 2 to 8)||6
10802582|NCT04234672|11963915|FG000|COMPLETED|Washout Period (Day 2 to 8)||6
10802583|NCT04234672|11963915|FG000|NOT COMPLETED|Washout Period (Day 2 to 8)||0
10802584|NCT04234672|11963915|FG000|STARTED|Treatment Period 2(Day9[Day1of Period2])||6
10802585|NCT04234672|11963915|FG000|COMPLETED|Treatment Period 2(Day9[Day1of Period2])||6
10802586|NCT04234672|11963915|FG000|NOT COMPLETED|Treatment Period 2(Day9[Day1of Period2])||0
10802587|NCT04223635|11963928|FG000|STARTED|Overall Study||8
10802588|NCT04223635|11963929|FG001|STARTED|Overall Study||8
10802589|NCT04223635|11963928|FG000|COMPLETED|Overall Study||8
10802590|NCT04223635|11963929|FG001|COMPLETED|Overall Study||8
10802591|NCT04223635|11963928|FG000|NOT COMPLETED|Overall Study||0
10802592|NCT04223635|11963929|FG001|NOT COMPLETED|Overall Study||0
10802593|NCT04214951|11963937|FG000|STARTED|Overall Study||50
10802594|NCT04214951|11963938|FG001|STARTED|Overall Study||50
10802595|NCT04214951|11963937|FG000|COMPLETED|Overall Study||10
10802596|NCT04214951|11963938|FG001|COMPLETED|Overall Study||10
10802597|NCT04214951|11963937|FG000|NOT COMPLETED|Overall Study||40
10802598|NCT04214951|11963938|FG001|NOT COMPLETED|Overall Study||40
10802599|NCT04234425|11963944|FG000|STARTED|Overall Study||18
10802600|NCT04234425|11963944|FG000|Midpoint-Week 4|Overall Study||18
10802601|NCT04234425|11963944|FG000|COMPLETED|Overall Study||18
10802602|NCT04234425|11963944|FG000|NOT COMPLETED|Overall Study||0
10802603|NCT04232137|11963952|FG000|STARTED|Overall Study||254
10802604|NCT04232137|11963953|FG001|STARTED|Overall Study||185
10802605|NCT04232137|11963952|FG000|COMPLETED|Overall Study||254
10802606|NCT04232137|11963953|FG001|COMPLETED|Overall Study||185
10802607|NCT04232137|11963952|FG000|NOT COMPLETED|Overall Study||0
10802608|NCT04232137|11963953|FG001|NOT COMPLETED|Overall Study||0
10802609|NCT04222699|11963959|FG000|STARTED|Overall Study||28
10802610|NCT04222699|11963959|FG000|COMPLETED|Overall Study||26
10802611|NCT04222699|11963959|FG000|NOT COMPLETED|Overall Study||2
10802612|NCT04208698|11963968|FG000|STARTED|Overall Study||2
10802613|NCT04208698|11963969|FG001|STARTED|Overall Study||0
10802614|NCT04208698|11963970|FG002|STARTED|Overall Study||0
10802615|NCT04208698|11963971|FG003|STARTED|Overall Study||0
10802616|NCT04208698|11963972|FG004|STARTED|Overall Study||0
10802617|NCT04208698|11963968|FG000|COMPLETED|Overall Study||0
10802618|NCT04208698|11963969|FG001|COMPLETED|Overall Study||0
10701330|NCT02566759|11865803|FG004|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701331|NCT02566759|11865804|FG005|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701332|NCT02566759|11865805|FG006|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701333|NCT02566759|11865806|FG007|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701334|NCT02566759|11865807|FG008|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701335|NCT02566759|11865808|FG009|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701336|NCT02566759|11865809|FG010|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701337|NCT02566759|11865810|FG011|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10802619|NCT04208698|11963970|FG002|COMPLETED|Overall Study||0
10802620|NCT04208698|11963971|FG003|COMPLETED|Overall Study||0
10802621|NCT04208698|11963972|FG004|COMPLETED|Overall Study||0
10802622|NCT04208698|11963968|FG000|NOT COMPLETED|Overall Study||2
10802623|NCT04208698|11963969|FG001|NOT COMPLETED|Overall Study||0
10802624|NCT04208698|11963970|FG002|NOT COMPLETED|Overall Study||0
10802625|NCT04208698|11963971|FG003|NOT COMPLETED|Overall Study||0
10802626|NCT04208698|11963972|FG004|NOT COMPLETED|Overall Study||0
10802627|NCT04206293|11963982|FG000|STARTED|Overall Study||11
10802628|NCT04206293|11963982|FG000|COMPLETED|Overall Study||10
10802629|NCT04206293|11963982|FG000|NOT COMPLETED|Overall Study||1
10802630|NCT04228302|11963993|FG000|STARTED|Overall Study||6
10802631|NCT04228302|11963994|FG001|STARTED|Overall Study||6
10802632|NCT04228302|11963995|FG002|STARTED|Overall Study||6
10802633|NCT04228302|11963996|FG003|STARTED|Overall Study||6
10802634|NCT04228302|11963997|FG004|STARTED|Overall Study||6
10802635|NCT04228302|11963998|FG005|STARTED|Overall Study||10
10802636|NCT04228302|11963993|FG000|COMPLETED|Overall Study||6
10802637|NCT04228302|11963994|FG001|COMPLETED|Overall Study||6
10802638|NCT04228302|11963995|FG002|COMPLETED|Overall Study||6
10802639|NCT04228302|11963996|FG003|COMPLETED|Overall Study||6
10802640|NCT04228302|11963997|FG004|COMPLETED|Overall Study||5
10802641|NCT04228302|11963998|FG005|COMPLETED|Overall Study||10
10802642|NCT04228302|11963993|FG000|NOT COMPLETED|Overall Study||0
10802643|NCT04228302|11963994|FG001|NOT COMPLETED|Overall Study||0
10802644|NCT04228302|11963995|FG002|NOT COMPLETED|Overall Study||0
10802645|NCT04228302|11963996|FG003|NOT COMPLETED|Overall Study||0
10802646|NCT04228302|11963997|FG004|NOT COMPLETED|Overall Study||1
10802647|NCT04228302|11963998|FG005|NOT COMPLETED|Overall Study||0
10802648|NCT04227119|11964012|FG000|STARTED|Overall Study||11
10802649|NCT04227119|11964012|FG000|COMPLETED|Overall Study||11
10802650|NCT04227119|11964012|FG000|NOT COMPLETED|Overall Study||0
10802651|NCT04224753|11964018|FG000|STARTED|Overall Study||51
10802652|NCT04224753|11964018|FG000|COMPLETED|Overall Study||51
10802653|NCT04224753|11964018|FG000|NOT COMPLETED|Overall Study||0
10802654|NCT04218799|11964022|FG000|STARTED|Overall Study||7
10802655|NCT04218799|11964022|FG000|COMPLETED|Overall Study||7
10802656|NCT04218799|11964022|FG000|NOT COMPLETED|Overall Study||0
10802657|NCT04204057|11964026|FG000|STARTED|Overall Study||21
10802658|NCT04204057|11964026|FG000|COMPLETED|Overall Study||21
10802659|NCT04204057|11964026|FG000|NOT COMPLETED|Overall Study||0
10802660|NCT04195594|11964030|FG000|STARTED|Overall Study||14
10802661|NCT04195594|11964030|FG000|COMPLETED|Overall Study||11
10802662|NCT04195594|11964030|FG000|NOT COMPLETED|Overall Study||3
10802663|NCT04223687|11964036|FG000|STARTED|Overall Study||163
10802664|NCT04223687|11964037|FG001|STARTED|Overall Study||163
10802665|NCT04223687|11964036|FG000|COMPLETED|Overall Study||162
10802666|NCT04223687|11964037|FG001|COMPLETED|Overall Study||163
10802667|NCT04223687|11964036|FG000|NOT COMPLETED|Overall Study||1
10802668|NCT04223687|11964037|FG001|NOT COMPLETED|Overall Study||0
10802669|NCT04223232|11964043|FG000|STARTED|Overall Study||6
10802670|NCT04223232|11964043|FG000|COMPLETED|Overall Study||5
10802671|NCT04223232|11964043|FG000|NOT COMPLETED|Overall Study||1
10802672|NCT04189224|11964047|FG000|STARTED|Period 1||23
10802673|NCT04189224|11964048|FG001|STARTED|Period 1||21
10802674|NCT04189224|11964047|FG000|COMPLETED|Period 1||23
10802675|NCT04189224|11964048|FG001|COMPLETED|Period 1||21
10802676|NCT04189224|11964047|FG000|NOT COMPLETED|Period 1||0
10802677|NCT04189224|11964048|FG001|NOT COMPLETED|Period 1||0
10802678|NCT04189224|11964047|FG000|STARTED|Period 2||23
10701338|NCT02566759|11865811|FG012|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701339|NCT02566759|11865812|FG013|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701340|NCT02566759|11865813|FG014|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
10701341|NCT02566759|11865814|FG015|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
10701342|NCT02566759|11865815|FG016|COMPLETED|Washout Crossover Period (Part 4:5 Days)||7
10701343|NCT02566759|11865799|FG000|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701344|NCT02566759|11865800|FG001|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10802679|NCT04189224|11964048|FG001|STARTED|Period 2||21
10802680|NCT04189224|11964047|FG000|COMPLETED|Period 2||23
10802681|NCT04189224|11964048|FG001|COMPLETED|Period 2||20
10802682|NCT04189224|11964047|FG000|NOT COMPLETED|Period 2||0
10802683|NCT04189224|11964048|FG001|NOT COMPLETED|Period 2||1
10802684|NCT04214600|11964056|FG000|STARTED|Overall Study||50
10802685|NCT04214600|11964057|FG001|STARTED|Overall Study||50
10802686|NCT04214600|11964056|FG000|COMPLETED|Overall Study||41
10802687|NCT04214600|11964057|FG001|COMPLETED|Overall Study||36
10802688|NCT04214600|11964056|FG000|NOT COMPLETED|Overall Study||9
10802689|NCT04214600|11964057|FG001|NOT COMPLETED|Overall Study||14
10802690|NCT04202497|11964064|FG000|STARTED|Baseline Scan (Day-1)||7
10802691|NCT04202497|11964065|FG001|STARTED|Baseline Scan (Day-1)||0
10802692|NCT04202497|11964066|FG002|STARTED|Baseline Scan (Day-1)||0
10701345|NCT02566759|11865801|FG002|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701346|NCT02566759|11865802|FG003|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701347|NCT02566759|11865803|FG004|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701348|NCT02566759|11865804|FG005|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701349|NCT02566759|11865805|FG006|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701350|NCT02566759|11865806|FG007|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10802693|NCT04202497|11964067|FG003|STARTED|Baseline Scan (Day-1)||0
10802694|NCT04202497|11964064|FG000|COMPLETED|Baseline Scan (Day-1)||6
10802695|NCT04202497|11964065|FG001|COMPLETED|Baseline Scan (Day-1)||0
10802696|NCT04202497|11964066|FG002|COMPLETED|Baseline Scan (Day-1)||0
10802697|NCT04202497|11964067|FG003|COMPLETED|Baseline Scan (Day-1)||0
10802698|NCT04202497|11964064|FG000|NOT COMPLETED|Baseline Scan (Day-1)||1
10802699|NCT04202497|11964065|FG001|NOT COMPLETED|Baseline Scan (Day-1)||0
10802700|NCT04202497|11964066|FG002|NOT COMPLETED|Baseline Scan (Day-1)||0
10802701|NCT04202497|11964067|FG003|NOT COMPLETED|Baseline Scan (Day-1)||0
10802702|NCT04202497|11964064|FG000|STARTED|Treatment Period (Day 1 Through Day 2-3)||0
10802703|NCT04202497|11964065|FG001|STARTED|Treatment Period (Day 1 Through Day 2-3)|Eligible participants from Baseline Period who received 10 mCi of [18F]MNI-1054 on Day -1.|2
10802704|NCT04202497|11964066|FG002|STARTED|Treatment Period (Day 1 Through Day 2-3)|Eligible participants from Baseline Period who received 10 mCi of [18F]MNI-1054 on Day -1.|2
10802705|NCT04202497|11964067|FG003|STARTED|Treatment Period (Day 1 Through Day 2-3)|Eligible participants from Baseline Period who received 10 mCi of [18F]MNI-1054 on Day -1.|2
10802706|NCT04202497|11964064|FG000|COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0
10802707|NCT04202497|11964065|FG001|COMPLETED|Treatment Period (Day 1 Through Day 2-3)||2
10802708|NCT04202497|11964066|FG002|COMPLETED|Treatment Period (Day 1 Through Day 2-3)||2
10802709|NCT04202497|11964067|FG003|COMPLETED|Treatment Period (Day 1 Through Day 2-3)||2
10802710|NCT04202497|11964064|FG000|NOT COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0
10802711|NCT04202497|11964065|FG001|NOT COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0
10802712|NCT04202497|11964066|FG002|NOT COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0
10802713|NCT04202497|11964067|FG003|NOT COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0
10802714|NCT04214080|11964083|FG000|STARTED|Overall Study||20
10802715|NCT04214080|11964084|FG001|STARTED|Overall Study||20
10802716|NCT04214080|11964083|FG000|COMPLETED|Overall Study||20
10802717|NCT04214080|11964084|FG001|COMPLETED|Overall Study||20
10802718|NCT04214080|11964083|FG000|NOT COMPLETED|Overall Study||0
10802719|NCT04214080|11964084|FG001|NOT COMPLETED|Overall Study||0
10802720|NCT04209530|11964094|FG000|STARTED|Overall Study||4
10802721|NCT04209530|11964095|FG001|STARTED|Overall Study||3
10802722|NCT04209530|11964094|FG000|COMPLETED|Overall Study||0
10802723|NCT04209530|11964095|FG001|COMPLETED|Overall Study||0
10802724|NCT04209530|11964094|FG000|NOT COMPLETED|Overall Study||4
10802725|NCT04209530|11964095|FG001|NOT COMPLETED|Overall Study||3
10802726|NCT04209335|11964101|FG000|STARTED|Overall Study||48
10802727|NCT04209335|11964101|FG000|COMPLETED|Overall Study||48
10802728|NCT04209335|11964101|FG000|NOT COMPLETED|Overall Study||0
10802729|NCT04207333|11964108|FG000|STARTED|First Intervention (Single 1-Day Visit)||3
10802730|NCT04207333|11964109|FG001|STARTED|First Intervention (Single 1-Day Visit)||3
10802731|NCT04207333|11964108|FG000|COMPLETED|First Intervention (Single 1-Day Visit)||3
10802732|NCT04207333|11964109|FG001|COMPLETED|First Intervention (Single 1-Day Visit)||3
10802733|NCT04207333|11964108|FG000|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0
10802734|NCT04207333|11964109|FG001|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0
10802735|NCT04207333|11964108|FG000|STARTED|Washout (2-7 Days)||3
10802736|NCT04207333|11964109|FG001|STARTED|Washout (2-7 Days)||3
10802737|NCT04207333|11964108|FG000|COMPLETED|Washout (2-7 Days)||3
10802738|NCT04207333|11964109|FG001|COMPLETED|Washout (2-7 Days)||3
10802739|NCT04207333|11964108|FG000|NOT COMPLETED|Washout (2-7 Days)||0
10802740|NCT04207333|11964109|FG001|NOT COMPLETED|Washout (2-7 Days)||0
10802741|NCT04207333|11964108|FG000|STARTED|Second Intervention (Single 1-Day Visit)||3
10802742|NCT04207333|11964109|FG001|STARTED|Second Intervention (Single 1-Day Visit)||3
10802743|NCT04207333|11964108|FG000|COMPLETED|Second Intervention (Single 1-Day Visit)||3
10802744|NCT04207333|11964109|FG001|COMPLETED|Second Intervention (Single 1-Day Visit)||3
10802745|NCT04207333|11964108|FG000|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0
10802746|NCT04207333|11964109|FG001|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0
10802747|NCT04207840|11964115|FG000|STARTED|Treatment Period 1||9
10802748|NCT04207840|11964116|FG001|STARTED|Treatment Period 1||10
10802749|NCT04207840|11964117|FG002|STARTED|Treatment Period 1||9
10802750|NCT04207840|11964115|FG000|COMPLETED|Treatment Period 1||9
10802751|NCT04207840|11964116|FG001|COMPLETED|Treatment Period 1||10
10802752|NCT04207840|11964117|FG002|COMPLETED|Treatment Period 1||9
10802753|NCT04207840|11964115|FG000|NOT COMPLETED|Treatment Period 1||0
10802754|NCT04207840|11964116|FG001|NOT COMPLETED|Treatment Period 1||0
10802755|NCT04207840|11964117|FG002|NOT COMPLETED|Treatment Period 1||0
10802756|NCT04207840|11964115|FG000|STARTED|Washout Period 1 (2-7 Days)||9
10802757|NCT04207840|11964116|FG001|STARTED|Washout Period 1 (2-7 Days)||10
10802758|NCT04207840|11964117|FG002|STARTED|Washout Period 1 (2-7 Days)||9
10802759|NCT04207840|11964115|FG000|COMPLETED|Washout Period 1 (2-7 Days)||9
10802760|NCT04207840|11964116|FG001|COMPLETED|Washout Period 1 (2-7 Days)||10
10802761|NCT04207840|11964117|FG002|COMPLETED|Washout Period 1 (2-7 Days)||8
10701351|NCT02566759|11865807|FG008|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10713912|NCT02683668|11879479|FG001|STARTED|Period 1||0
10802762|NCT04207840|11964115|FG000|NOT COMPLETED|Washout Period 1 (2-7 Days)||0
10802763|NCT04207840|11964116|FG001|NOT COMPLETED|Washout Period 1 (2-7 Days)||0
10802764|NCT04207840|11964117|FG002|NOT COMPLETED|Washout Period 1 (2-7 Days)||1
10802765|NCT04207840|11964115|FG000|STARTED|Treatment Period 2||9
10802766|NCT04207840|11964116|FG001|STARTED|Treatment Period 2||10
10802767|NCT04207840|11964117|FG002|STARTED|Treatment Period 2||8
10802768|NCT04207840|11964115|FG000|COMPLETED|Treatment Period 2||9
10802769|NCT04207840|11964116|FG001|COMPLETED|Treatment Period 2||10
10802770|NCT04207840|11964117|FG002|COMPLETED|Treatment Period 2||8
10802771|NCT04207840|11964115|FG000|NOT COMPLETED|Treatment Period 2||0
10802772|NCT04207840|11964116|FG001|NOT COMPLETED|Treatment Period 2||0
10802773|NCT04207840|11964117|FG002|NOT COMPLETED|Treatment Period 2||0
10802774|NCT04207840|11964115|FG000|STARTED|Washout Period 2 (2-7 Days)||9
10802775|NCT04207840|11964116|FG001|STARTED|Washout Period 2 (2-7 Days)||10
10802776|NCT04207840|11964117|FG002|STARTED|Washout Period 2 (2-7 Days)||8
10802777|NCT04207840|11964115|FG000|COMPLETED|Washout Period 2 (2-7 Days)||9
10802778|NCT04207840|11964116|FG001|COMPLETED|Washout Period 2 (2-7 Days)||10
10802779|NCT04207840|11964117|FG002|COMPLETED|Washout Period 2 (2-7 Days)||7
10802780|NCT04207840|11964115|FG000|NOT COMPLETED|Washout Period 2 (2-7 Days)||0
10802781|NCT04207840|11964116|FG001|NOT COMPLETED|Washout Period 2 (2-7 Days)||0
10802782|NCT04207840|11964117|FG002|NOT COMPLETED|Washout Period 2 (2-7 Days)||1
10802783|NCT04207840|11964115|FG000|STARTED|Treatment Period 3||9
10802784|NCT04207840|11964116|FG001|STARTED|Treatment Period 3||10
10802785|NCT04207840|11964117|FG002|STARTED|Treatment Period 3||7
10802786|NCT04207840|11964115|FG000|COMPLETED|Treatment Period 3||9
10802787|NCT04207840|11964116|FG001|COMPLETED|Treatment Period 3||10
10802788|NCT04207840|11964117|FG002|COMPLETED|Treatment Period 3||7
10802789|NCT04207840|11964115|FG000|NOT COMPLETED|Treatment Period 3||0
10802790|NCT04207840|11964116|FG001|NOT COMPLETED|Treatment Period 3||0
10802791|NCT04207840|11964117|FG002|NOT COMPLETED|Treatment Period 3||0
10802792|NCT04206800|11964127|FG000|STARTED|Overall Study||4
10802793|NCT04206800|11964128|FG001|STARTED|Overall Study||1
10802794|NCT04206800|11964127|FG000|COMPLETED|Overall Study||4
10802795|NCT04206800|11964128|FG001|COMPLETED|Overall Study||1
10802796|NCT04206800|11964127|FG000|NOT COMPLETED|Overall Study||0
10802797|NCT04206800|11964128|FG001|NOT COMPLETED|Overall Study||0
10802798|NCT04205669|11964136|FG000|STARTED|Overall Study||47
10802799|NCT04205669|11964137|FG001|STARTED|Overall Study||57
10802800|NCT04205669|11964136|FG000|COMPLETED|Overall Study||34
10802801|NCT04205669|11964137|FG001|COMPLETED|Overall Study||45
10802802|NCT04205669|11964136|FG000|NOT COMPLETED|Overall Study||13
10802803|NCT04205669|11964137|FG001|NOT COMPLETED|Overall Study||12
10802804|NCT04198948|11964145|FG000|STARTED|First Period||7
10802805|NCT04198948|11964146|FG001|STARTED|First Period||8
10802806|NCT04198948|11964145|FG000|COMPLETED|First Period||7
10802807|NCT04198948|11964146|FG001|COMPLETED|First Period||8
10802808|NCT04198948|11964145|FG000|NOT COMPLETED|First Period||0
10802809|NCT04198948|11964146|FG001|NOT COMPLETED|First Period||0
10802810|NCT04198948|11964145|FG000|STARTED|Wash-out (10 Days)||7
10802811|NCT04198948|11964146|FG001|STARTED|Wash-out (10 Days)||8
10802812|NCT04198948|11964145|FG000|COMPLETED|Wash-out (10 Days)||7
10802813|NCT04198948|11964146|FG001|COMPLETED|Wash-out (10 Days)||8
10802814|NCT04198948|11964145|FG000|NOT COMPLETED|Wash-out (10 Days)||0
10802815|NCT04198948|11964146|FG001|NOT COMPLETED|Wash-out (10 Days)||0
10802816|NCT04198948|11964145|FG000|STARTED|Second Period||7
10802817|NCT04198948|11964146|FG001|STARTED|Second Period||8
10802818|NCT04198948|11964145|FG000|COMPLETED|Second Period||7
10802819|NCT04198948|11964146|FG001|COMPLETED|Second Period||7
10802820|NCT04198948|11964145|FG000|NOT COMPLETED|Second Period||0
10802821|NCT04198948|11964146|FG001|NOT COMPLETED|Second Period||1
10802822|NCT04206384|11964152|FG000|STARTED|Overall Study||52
10802823|NCT04206384|11964152|FG000|COMPLETED|Overall Study||42
10802824|NCT04206384|11964152|FG000|NOT COMPLETED|Overall Study||10
10802825|NCT04204200|11964159|FG000|STARTED|Overall Study||22
10802826|NCT04204200|11964160|FG001|STARTED|Overall Study||22
10802827|NCT04204200|11964161|FG002|STARTED|Overall Study||22
10802828|NCT04204200|11964159|FG000|COMPLETED|Overall Study||22
10802829|NCT04204200|11964160|FG001|COMPLETED|Overall Study||22
10802830|NCT04204200|11964161|FG002|COMPLETED|Overall Study||22
10802831|NCT04204200|11964159|FG000|NOT COMPLETED|Overall Study||0
10802832|NCT04204200|11964160|FG001|NOT COMPLETED|Overall Study||0
10802833|NCT04204200|11964161|FG002|NOT COMPLETED|Overall Study||0
10802834|NCT04196907|11964169|FG000|STARTED|Overall Study||20
10802835|NCT04196907|11964169|FG000|COMPLETED|Overall Study||20
10802836|NCT04196907|11964169|FG000|NOT COMPLETED|Overall Study||0
10802837|NCT04195893|11964173|FG000|STARTED|First Intervention||27
10802838|NCT04195893|11964174|FG001|STARTED|First Intervention||29
10802839|NCT04195893|11964173|FG000|COMPLETED|First Intervention||27
10802840|NCT04195893|11964174|FG001|COMPLETED|First Intervention||29
10802841|NCT04195893|11964173|FG000|NOT COMPLETED|First Intervention||0
10802842|NCT04195893|11964174|FG001|NOT COMPLETED|First Intervention||0
10802843|NCT04195893|11964173|FG000|STARTED|Second Intervention||27
10802844|NCT04195893|11964174|FG001|STARTED|Second Intervention||29
10802845|NCT04195893|11964173|FG000|COMPLETED|Second Intervention||26
10802846|NCT04195893|11964174|FG001|COMPLETED|Second Intervention||29
10802847|NCT04195893|11964173|FG000|NOT COMPLETED|Second Intervention||1
10802848|NCT04195893|11964174|FG001|NOT COMPLETED|Second Intervention||0
10802849|NCT04195880|11964182|FG000|STARTED|Overall Study||3205
10802850|NCT04195880|11964183|FG001|STARTED|Overall Study||3338
10802851|NCT04195880|11964182|FG000|COMPLETED|Overall Study||3205
10802852|NCT04195880|11964183|FG001|COMPLETED|Overall Study||3338
10802853|NCT04195880|11964182|FG000|NOT COMPLETED|Overall Study||0
10802854|NCT04195880|11964183|FG001|NOT COMPLETED|Overall Study||0
10802855|NCT04195581|11964189|FG000|STARTED|Comfilcon A With All in One Light||28
10802856|NCT04195581|11964189|FG000|COMPLETED|Comfilcon A With All in One Light||24
10802857|NCT04195581|11964189|FG000|NOT COMPLETED|Comfilcon A With All in One Light||4
10802858|NCT04195581|11964189|FG000|STARTED|Comfilcon A With Hy-Care||30
10802859|NCT04195581|11964189|FG000|COMPLETED|Comfilcon A With Hy-Care||25
10802860|NCT04195581|11964189|FG000|NOT COMPLETED|Comfilcon A With Hy-Care||5
10802861|NCT04195581|11964189|FG000|STARTED|Comfilcon A With Refine One Step||25
10802862|NCT04195581|11964189|FG000|COMPLETED|Comfilcon A With Refine One Step||24
10802863|NCT04195581|11964189|FG000|NOT COMPLETED|Comfilcon A With Refine One Step||1
10802864|NCT04195581|11964189|FG000|STARTED|Fanfilcon A With All in One Light||28
10802865|NCT04195581|11964189|FG000|COMPLETED|Fanfilcon A With All in One Light||27
10802866|NCT04195581|11964189|FG000|NOT COMPLETED|Fanfilcon A With All in One Light||1
10802867|NCT04195581|11964189|FG000|STARTED|Fanfilcon A With Hy-Care||28
10802868|NCT04195581|11964189|FG000|COMPLETED|Fanfilcon A With Hy-Care||25
10802869|NCT04195581|11964189|FG000|NOT COMPLETED|Fanfilcon A With Hy-Care||3
10802870|NCT04195581|11964189|FG000|STARTED|Fanfilcon A With Refine One Step||29
10802871|NCT04195581|11964189|FG000|COMPLETED|Fanfilcon A With Refine One Step||27
10802872|NCT04195581|11964189|FG000|NOT COMPLETED|Fanfilcon A With Refine One Step||2
10802873|NCT04194151|11964213|FG000|STARTED|Overall Study||32
10802874|NCT04194151|11964214|FG001|STARTED|Overall Study||32
10802875|NCT04194151|11964215|FG002|STARTED|Overall Study||32
10802876|NCT04194151|11964216|FG003|STARTED|Overall Study||32
10802877|NCT04194151|11964217|FG004|STARTED|Overall Study||32
10802878|NCT04194151|11964218|FG005|STARTED|Overall Study||32
10802879|NCT04194151|11964213|FG000|COMPLETED|Overall Study||31
10802880|NCT04194151|11964214|FG001|COMPLETED|Overall Study||30
10802881|NCT04194151|11964215|FG002|COMPLETED|Overall Study||31
10802882|NCT04194151|11964216|FG003|COMPLETED|Overall Study||31
10802883|NCT04194151|11964217|FG004|COMPLETED|Overall Study||32
10802884|NCT04194151|11964218|FG005|COMPLETED|Overall Study||31
10802885|NCT04194151|11964213|FG000|NOT COMPLETED|Overall Study||1
10802886|NCT04194151|11964214|FG001|NOT COMPLETED|Overall Study||2
10802887|NCT04194151|11964215|FG002|NOT COMPLETED|Overall Study||1
10802888|NCT04194151|11964216|FG003|NOT COMPLETED|Overall Study||1
10802889|NCT04194151|11964217|FG004|NOT COMPLETED|Overall Study||0
10802890|NCT04194151|11964218|FG005|NOT COMPLETED|Overall Study||1
10802891|NCT04194008|11964232|FG000|STARTED|Baseline (Run-in) Phase||126
10802892|NCT04194008|11964232|FG000|COMPLETED|Baseline (Run-in) Phase||99
10802893|NCT04194008|11964232|FG000|NOT COMPLETED|Baseline (Run-in) Phase||27
10802894|NCT04194008|11964232|FG000|STARTED|Treatment Phase With Nerivio||99
10802895|NCT04194008|11964232|FG000|COMPLETED|Treatment Phase With Nerivio||91
10802896|NCT04194008|11964232|FG000|NOT COMPLETED|Treatment Phase With Nerivio||8
10802897|NCT04191668|11964236|FG000|STARTED|Overall Study||106
10802898|NCT04191668|11964236|FG000|COMPLETED|Overall Study||106
10802899|NCT04191668|11964236|FG000|NOT COMPLETED|Overall Study||0
10802900|NCT04189081|11964243|FG000|STARTED|Overall Study||46
10802901|NCT04189081|11964244|FG001|STARTED|Overall Study||45
10802902|NCT04189081|11964245|FG002|STARTED|Overall Study||46
10802903|NCT04189081|11964243|FG000|COMPLETED|Overall Study||45
10802904|NCT04189081|11964244|FG001|COMPLETED|Overall Study||45
10802905|NCT04189081|11964245|FG002|COMPLETED|Overall Study||45
10802906|NCT04189081|11964243|FG000|NOT COMPLETED|Overall Study||1
10802907|NCT04189081|11964244|FG001|NOT COMPLETED|Overall Study||0
10802908|NCT04189081|11964245|FG002|NOT COMPLETED|Overall Study||1
10811029|NCT03771963|11972731|FG000|STARTED|Overall Study||200
10811030|NCT03771963|11972731|FG000|COMPLETED|Overall Study||168
10811031|NCT03771963|11972731|FG000|NOT COMPLETED|Overall Study||32
10811032|NCT03771352|11972735|FG000|STARTED|Overall Study||55
10701352|NCT02566759|11865808|FG009|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701353|NCT02566759|11865809|FG010|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701354|NCT02566759|11865810|FG011|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701355|NCT02566759|11865811|FG012|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701356|NCT02566759|11865812|FG013|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701357|NCT02566759|11865813|FG014|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701358|NCT02566759|11865814|FG015|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10701359|NCT02566759|11865815|FG016|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
10811033|NCT03771352|11972735|FG000|COMPLETED|Overall Study|The fellow eye of one subject was not implanted per the discretion of the investigator.|51
10811034|NCT03771352|11972735|FG000|NOT COMPLETED|Overall Study||4
10811035|NCT03773796|11972739|FG000|STARTED|Overall Study||22
10811036|NCT03773796|11972739|FG000|COMPLETED|Overall Study||19
10811037|NCT03773796|11972739|FG000|NOT COMPLETED|Overall Study||3
10811038|NCT03782233|11972745|FG000|STARTED|Overall Study||50
10811039|NCT03782233|11972746|FG001|STARTED|Overall Study||33
10811040|NCT03782233|11972745|FG000|COMPLETED|Overall Study||46
10811041|NCT03782233|11972746|FG001|COMPLETED|Overall Study||31
10811042|NCT03782233|11972745|FG000|NOT COMPLETED|Overall Study||4
10811043|NCT03782233|11972746|FG001|NOT COMPLETED|Overall Study||2
10811044|NCT03781375|11972756|FG000|STARTED|Double-blind Phase||12
10811045|NCT03781375|11972757|FG001|STARTED|Double-blind Phase||13
10701360|NCT02566759|11865799|FG000|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10701361|NCT02566759|11865800|FG001|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10701362|NCT02566759|11865801|FG002|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10802909|NCT04186780|11964255|FG000|STARTED|Overall Study||36
10802910|NCT04186780|11964256|FG001|STARTED|Overall Study||32
10802911|NCT04186780|11964255|FG000|COMPLETED|Overall Study||22
10802912|NCT04186780|11964256|FG001|COMPLETED|Overall Study||25
10802913|NCT04186780|11964255|FG000|NOT COMPLETED|Overall Study||14
10802914|NCT04186780|11964256|FG001|NOT COMPLETED|Overall Study||7
10802915|NCT04186806|11964266|FG000|STARTED|Period 1: 7 Days||20
10802916|NCT04186806|11964267|FG001|STARTED|Period 1: 7 Days||20
10802917|NCT04186806|11964266|FG000|COMPLETED|Period 1: 7 Days||19
10802918|NCT04186806|11964267|FG001|COMPLETED|Period 1: 7 Days||20
10802919|NCT04186806|11964266|FG000|NOT COMPLETED|Period 1: 7 Days||1
10802920|NCT04186806|11964267|FG001|NOT COMPLETED|Period 1: 7 Days||0
10802921|NCT04186806|11964266|FG000|STARTED|Washout Period: at Least 2 Days||19
10802922|NCT04186806|11964267|FG001|STARTED|Washout Period: at Least 2 Days||20
10802923|NCT04186806|11964266|FG000|COMPLETED|Washout Period: at Least 2 Days||19
10802924|NCT04186806|11964267|FG001|COMPLETED|Washout Period: at Least 2 Days||20
10802925|NCT04186806|11964266|FG000|NOT COMPLETED|Washout Period: at Least 2 Days||0
10802926|NCT04186806|11964267|FG001|NOT COMPLETED|Washout Period: at Least 2 Days||0
10802927|NCT04186806|11964266|FG000|STARTED|Period 2: 7 Days||19
10802928|NCT04186806|11964267|FG001|STARTED|Period 2: 7 Days||20
10319005|NCT00219349|11453287|FG000|STARTED|Cognitive Behavioral Therapy Phase||25
10802929|NCT04186806|11964266|FG000|COMPLETED|Period 2: 7 Days||19
10802930|NCT04186806|11964267|FG001|COMPLETED|Period 2: 7 Days||20
10802931|NCT04186806|11964266|FG000|NOT COMPLETED|Period 2: 7 Days||0
10802932|NCT04186806|11964267|FG001|NOT COMPLETED|Period 2: 7 Days||0
10802933|NCT04186481|11964274|FG000|STARTED|Overall Study||32
10802934|NCT04186481|11964274|FG000|Completed 6 Month Visit|Overall Study||31
10802935|NCT04186481|11964274|FG000|Completed 12 Month Visit|Overall Study||4
10802936|NCT04186481|11964274|FG000|COMPLETED|Overall Study||32
10802937|NCT04186481|11964274|FG000|NOT COMPLETED|Overall Study||0
10802938|NCT04184999|11964280|FG000|STARTED|Overall Study||40
10802939|NCT04184999|11964281|FG001|STARTED|Overall Study||40
10802940|NCT04184999|11964280|FG000|3 Week Tear Film Osmolarity Testing|Overall Study||40
10802941|NCT04184999|11964281|FG001|3 Week Tear Film Osmolarity Testing|Overall Study||40
10802942|NCT04184999|11964280|FG000|COMPLETED|Overall Study||40
10802943|NCT04184999|11964281|FG001|COMPLETED|Overall Study||40
10802944|NCT04184999|11964280|FG000|NOT COMPLETED|Overall Study||0
10802945|NCT04184999|11964281|FG001|NOT COMPLETED|Overall Study||0
10802946|NCT04184271|11964287|FG000|STARTED|Overall Study||16
10802947|NCT04184271|11964287|FG000|COMPLETED|Overall Study||16
10802948|NCT04184271|11964287|FG000|NOT COMPLETED|Overall Study||0
10802949|NCT04183231|11964291|FG000|STARTED|Overall Study||16
10802950|NCT04183231|11964291|FG000|COMPLETED|Overall Study||16
10802951|NCT04183231|11964291|FG000|NOT COMPLETED|Overall Study||0
10802952|NCT04182958|11964295|FG000|STARTED|Overall Study||8
10802953|NCT04182958|11964295|FG000|COMPLETED|Overall Study||8
10802954|NCT04182958|11964295|FG000|NOT COMPLETED|Overall Study||0
10802955|NCT04179838|11964301|FG000|STARTED|First Intervention (1 Day)||13
10802956|NCT04179838|11964302|FG001|STARTED|First Intervention (1 Day)||16
10802957|NCT04179838|11964301|FG000|COMPLETED|First Intervention (1 Day)||13
10802958|NCT04179838|11964302|FG001|COMPLETED|First Intervention (1 Day)||13
10802959|NCT04179838|11964301|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10802960|NCT04179838|11964302|FG001|NOT COMPLETED|First Intervention (1 Day)||3
10802961|NCT04179838|11964301|FG000|STARTED|Washout (4 Weeks)||13
10802962|NCT04179838|11964302|FG001|STARTED|Washout (4 Weeks)||13
10802963|NCT04179838|11964301|FG000|COMPLETED|Washout (4 Weeks)||13
10802964|NCT04179838|11964302|FG001|COMPLETED|Washout (4 Weeks)||13
10802965|NCT04179838|11964301|FG000|NOT COMPLETED|Washout (4 Weeks)||0
10802966|NCT04179838|11964302|FG001|NOT COMPLETED|Washout (4 Weeks)||0
10802967|NCT04179838|11964301|FG000|STARTED|Second Intervention (1 Day)||13
10802968|NCT04179838|11964302|FG001|STARTED|Second Intervention (1 Day)||13
10802969|NCT04179838|11964301|FG000|COMPLETED|Second Intervention (1 Day)||13
10802970|NCT04179838|11964302|FG001|COMPLETED|Second Intervention (1 Day)||12
10802971|NCT04179838|11964301|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10802972|NCT04179838|11964302|FG001|NOT COMPLETED|Second Intervention (1 Day)||1
10802973|NCT04179461|11964308|FG000|STARTED|Overall Study||21
10802974|NCT04179461|11964308|FG000|COMPLETED|Overall Study||17
10802975|NCT04179461|11964308|FG000|NOT COMPLETED|Overall Study||4
10802976|NCT04179474|11964314|FG000|STARTED|Treatment Period 1 (First Intervention)||20
10802977|NCT04179474|11964315|FG001|STARTED|Treatment Period 1 (First Intervention)||20
10802978|NCT04179474|11964314|FG000|COMPLETED|Treatment Period 1 (First Intervention)||20
10802979|NCT04179474|11964315|FG001|COMPLETED|Treatment Period 1 (First Intervention)||20
10802980|NCT04179474|11964314|FG000|NOT COMPLETED|Treatment Period 1 (First Intervention)||0
10319006|NCT00219349|11453287|FG000|COMPLETED|Cognitive Behavioral Therapy Phase||15
10802981|NCT04179474|11964315|FG001|NOT COMPLETED|Treatment Period 1 (First Intervention)||0
10802982|NCT04179474|11964314|FG000|STARTED|Treatment Period 2 (Second Intervention)|1 participant did not receive Intervention B.|19
10802983|NCT04179474|11964315|FG001|STARTED|Treatment Period 2 (Second Intervention)||20
10802984|NCT04179474|11964314|FG000|COMPLETED|Treatment Period 2 (Second Intervention)||19
10802985|NCT04179474|11964315|FG001|COMPLETED|Treatment Period 2 (Second Intervention)||20
10802986|NCT04179474|11964314|FG000|NOT COMPLETED|Treatment Period 2 (Second Intervention)||0
10802987|NCT04179474|11964315|FG001|NOT COMPLETED|Treatment Period 2 (Second Intervention)||0
10802988|NCT04179474|11964314|FG000|STARTED|Treatment Period 3 (Third Intervention)||19
10802989|NCT04179474|11964315|FG001|STARTED|Treatment Period 3 (Third Intervention)|1 participant did not receive Intervention D.|19
10802990|NCT04179474|11964314|FG000|COMPLETED|Treatment Period 3 (Third Intervention)||19
10802991|NCT04179474|11964315|FG001|COMPLETED|Treatment Period 3 (Third Intervention)||19
10802992|NCT04179474|11964314|FG000|NOT COMPLETED|Treatment Period 3 (Third Intervention)||0
10802993|NCT04179474|11964315|FG001|NOT COMPLETED|Treatment Period 3 (Third Intervention)||0
10802994|NCT04178590|11964336|FG000|STARTED|Overall Study||32
10802995|NCT04178590|11964336|FG000|COMPLETED|Overall Study||30
10802996|NCT04178590|11964336|FG000|NOT COMPLETED|Overall Study||2
10802997|NCT04177862|11964364|FG000|STARTED|Overall Study||35
10802998|NCT04177862|11964365|FG001|STARTED|Overall Study||40
10802999|NCT04177862|11964364|FG000|COMPLETED|Overall Study||33
10803000|NCT04177862|11964365|FG001|COMPLETED|Overall Study||33
10803001|NCT04177862|11964364|FG000|NOT COMPLETED|Overall Study||2
10803002|NCT04177862|11964365|FG001|NOT COMPLETED|Overall Study||7
10803003|NCT04176406|11964372|FG000|STARTED|Overall Study||0
10803004|NCT04176406|11964373|FG001|STARTED|Overall Study||0
10803005|NCT04176406|11964374|FG002|STARTED|Overall Study||0
10803006|NCT04176406|11964375|FG003|STARTED|Overall Study||0
10803007|NCT04176406|11964372|FG000|COMPLETED|Overall Study||0
10803008|NCT04176406|11964373|FG001|COMPLETED|Overall Study||0
10803009|NCT04176406|11964374|FG002|COMPLETED|Overall Study||0
10803010|NCT04176406|11964375|FG003|COMPLETED|Overall Study||0
10803011|NCT04176406|11964372|FG000|NOT COMPLETED|Overall Study||0
10803012|NCT04176406|11964373|FG001|NOT COMPLETED|Overall Study||0
10803013|NCT04176406|11964374|FG002|NOT COMPLETED|Overall Study||0
10803014|NCT04176406|11964375|FG003|NOT COMPLETED|Overall Study||0
10803015|NCT04175262|11964386|FG000|STARTED|Overall Study||102
10803016|NCT04175262|11964386|FG000|COMPLETED|Overall Study||102
10803017|NCT04175262|11964386|FG000|NOT COMPLETED|Overall Study||0
10803018|NCT04171102|11964393|FG000|STARTED|Overall Study||4
10803019|NCT04171102|11964394|FG001|STARTED|Overall Study||5
10803020|NCT04171102|11964395|FG002|STARTED|Overall Study||6
10803021|NCT04171102|11964393|FG000|COMPLETED|Overall Study||4
10803022|NCT04171102|11964394|FG001|COMPLETED|Overall Study||5
10803023|NCT04171102|11964395|FG002|COMPLETED|Overall Study||6
10803024|NCT04171102|11964393|FG000|NOT COMPLETED|Overall Study||0
10803025|NCT04171102|11964394|FG001|NOT COMPLETED|Overall Study||0
10803026|NCT04171102|11964395|FG002|NOT COMPLETED|Overall Study||0
10803027|NCT04174638|11964405|FG000|STARTED|Overall Study||32
10803028|NCT04174638|11964406|FG001|STARTED|Overall Study||28
10803029|NCT04174638|11964405|FG000|COMPLETED|Overall Study||32
10803030|NCT04174638|11964406|FG001|COMPLETED|Overall Study||28
10803031|NCT04174638|11964405|FG000|NOT COMPLETED|Overall Study||0
10803032|NCT04174638|11964406|FG001|NOT COMPLETED|Overall Study||0
10803033|NCT04174313|11964417|FG000|STARTED|Overall Study||15
10803034|NCT04174313|11964418|FG001|STARTED|Overall Study||50
10803035|NCT04174313|11964417|FG000|COMPLETED|Overall Study||15
10803036|NCT04174313|11964418|FG001|COMPLETED|Overall Study||50
10803037|NCT04174313|11964417|FG000|NOT COMPLETED|Overall Study||0
10803038|NCT04174313|11964418|FG001|NOT COMPLETED|Overall Study||0
10803039|NCT04173429|11964430|FG000|STARTED|Overall Study||32
10803040|NCT04173429|11964431|FG001|STARTED|Overall Study||32
10803041|NCT04173429|11964430|FG000|Completed the Nadroparin Calcium Therapy and Received Warfarin|Overall Study||32
10803042|NCT04173429|11964431|FG001|Completed the Nadroparin Calcium Therapy and Received Warfarin|Overall Study||0
10803043|NCT04173429|11964430|FG000|COMPLETED|Overall Study||30
10803044|NCT04173429|11964431|FG001|COMPLETED|Overall Study||30
10803045|NCT04173429|11964430|FG000|NOT COMPLETED|Overall Study||2
10803046|NCT04173429|11964431|FG001|NOT COMPLETED|Overall Study||2
10803047|NCT04173741|11964440|FG000|STARTED|Overall Study||23
10803048|NCT04173741|11964441|FG001|STARTED|Overall Study||23
10803049|NCT04173741|11964440|FG000|COMPLETED|Overall Study||22
10803050|NCT04173741|11964441|FG001|COMPLETED|Overall Study||22
10803051|NCT04173741|11964440|FG000|NOT COMPLETED|Overall Study||1
10803052|NCT04173741|11964441|FG001|NOT COMPLETED|Overall Study||1
10803053|NCT04169061|11964447|FG000|STARTED|Overall Study||36
10803054|NCT04169061|11964447|FG000|Safety Population|Overall Study||36
10803055|NCT04169061|11964447|FG000|Modified Intent to Treat (mITT) Population|Overall Study||34
10803056|NCT04169061|11964447|FG000|COMPLETED|Overall Study||31
10803057|NCT04169061|11964447|FG000|NOT COMPLETED|Overall Study||5
10803058|NCT04157738|11964453|FG000|STARTED|Overall Study||12
10803059|NCT04157738|11964454|FG001|STARTED|Overall Study||12
10803060|NCT04157738|11964453|FG000|COMPLETED|Overall Study||11
10803061|NCT04157738|11964454|FG001|COMPLETED|Overall Study||10
10803062|NCT04157738|11964453|FG000|NOT COMPLETED|Overall Study||1
10803063|NCT04157738|11964454|FG001|NOT COMPLETED|Overall Study||2
10803064|NCT04156646|11964462|FG000|STARTED|Treatment Period 1 (6 Days)||8
10803065|NCT04156646|11964463|FG001|STARTED|Treatment Period 1 (6 Days)||8
10803066|NCT04156646|11964462|FG000|COMPLETED|Treatment Period 1 (6 Days)||8
10803067|NCT04156646|11964463|FG001|COMPLETED|Treatment Period 1 (6 Days)||8
10803068|NCT04156646|11964462|FG000|NOT COMPLETED|Treatment Period 1 (6 Days)||0
10803069|NCT04156646|11964463|FG001|NOT COMPLETED|Treatment Period 1 (6 Days)||0
10803070|NCT04156646|11964462|FG000|STARTED|Wash-out Period (12- to 21-days)||8
10803071|NCT04156646|11964463|FG001|STARTED|Wash-out Period (12- to 21-days)||8
10803072|NCT04156646|11964462|FG000|COMPLETED|Wash-out Period (12- to 21-days)||8
10803073|NCT04156646|11964463|FG001|COMPLETED|Wash-out Period (12- to 21-days)||8
10803074|NCT04156646|11964462|FG000|NOT COMPLETED|Wash-out Period (12- to 21-days)||0
10803075|NCT04156646|11964463|FG001|NOT COMPLETED|Wash-out Period (12- to 21-days)||0
10803076|NCT04156646|11964462|FG000|STARTED|Treatment Period 2 (6 Days)||8
10803077|NCT04156646|11964463|FG001|STARTED|Treatment Period 2 (6 Days)||8
10803078|NCT04156646|11964462|FG000|COMPLETED|Treatment Period 2 (6 Days)||8
10803079|NCT04156646|11964463|FG001|COMPLETED|Treatment Period 2 (6 Days)||8
10803080|NCT04156646|11964462|FG000|NOT COMPLETED|Treatment Period 2 (6 Days)||0
10803081|NCT04156646|11964463|FG001|NOT COMPLETED|Treatment Period 2 (6 Days)||0
10803082|NCT04156646|11964462|FG000|STARTED|Wash-out Period (12- to 21-days)||8
10803083|NCT04156646|11964463|FG001|STARTED|Wash-out Period (12- to 21-days)||8
10803084|NCT04156646|11964462|FG000|COMPLETED|Wash-out Period (12- to 21-days)||8
10803085|NCT04156646|11964463|FG001|COMPLETED|Wash-out Period (12- to 21-days)||8
10803086|NCT04156646|11964462|FG000|NOT COMPLETED|Wash-out Period (12- to 21-days)||0
10803087|NCT04156646|11964463|FG001|NOT COMPLETED|Wash-out Period (12- to 21-days)||0
10803088|NCT04156646|11964462|FG000|STARTED|Treatment Period 3 (6 Days)||8
10803089|NCT04156646|11964463|FG001|STARTED|Treatment Period 3 (6 Days)||8
10803090|NCT04156646|11964462|FG000|COMPLETED|Treatment Period 3 (6 Days)||8
10803091|NCT04156646|11964463|FG001|COMPLETED|Treatment Period 3 (6 Days)||7
10803092|NCT04156646|11964462|FG000|NOT COMPLETED|Treatment Period 3 (6 Days)||0
10803093|NCT04156646|11964463|FG001|NOT COMPLETED|Treatment Period 3 (6 Days)||1
10803094|NCT04170686|11964474|FG000|STARTED|Screening||74
10803095|NCT04170686|11964475|FG001|STARTED|Screening||72
10803096|NCT04170686|11964474|FG000|COMPLETED|Screening||62
10803097|NCT04170686|11964475|FG001|COMPLETED|Screening||59
10803098|NCT04170686|11964474|FG000|NOT COMPLETED|Screening||12
10803099|NCT04170686|11964475|FG001|NOT COMPLETED|Screening||13
10803100|NCT04170686|11964474|FG000|STARTED|Randomization and Treatment||62
10803101|NCT04170686|11964475|FG001|STARTED|Randomization and Treatment||59
10803102|NCT04170686|11964474|FG000|COMPLETED|Randomization and Treatment||36
10803103|NCT04170686|11964475|FG001|COMPLETED|Randomization and Treatment||44
10803104|NCT04170686|11964474|FG000|NOT COMPLETED|Randomization and Treatment||26
10803105|NCT04170686|11964475|FG001|NOT COMPLETED|Randomization and Treatment||15
10803106|NCT04169113|11964483|FG000|STARTED|Overall Study||52
10803107|NCT04169113|11964484|FG001|STARTED|Overall Study||59
10803108|NCT04169113|11964483|FG000|COMPLETED|Overall Study||47
10803109|NCT04169113|11964484|FG001|COMPLETED|Overall Study||53
10803110|NCT04169113|11964483|FG000|NOT COMPLETED|Overall Study||5
10803111|NCT04169113|11964484|FG001|NOT COMPLETED|Overall Study||6
10803112|NCT04160975|11964496|FG000|STARTED|Overall Study||479
10803113|NCT04160975|11964497|FG001|STARTED|Overall Study||496
10803114|NCT04160975|11964498|FG002|STARTED|Overall Study||478
10803115|NCT04160975|11964499|FG003|STARTED|Overall Study||485
10803116|NCT04160975|11964500|FG004|STARTED|Overall Study||649
10803117|NCT04160975|11964501|FG005|STARTED|Overall Study||658
10803118|NCT04160975|11964496|FG000|COMPLETED|Overall Study||415
10803119|NCT04160975|11964497|FG001|COMPLETED|Overall Study||430
10803120|NCT04160975|11964498|FG002|COMPLETED|Overall Study||417
10803121|NCT04160975|11964499|FG003|COMPLETED|Overall Study||410
10803122|NCT04160975|11964500|FG004|COMPLETED|Overall Study||614
10803123|NCT04160975|11964501|FG005|COMPLETED|Overall Study||607
10803124|NCT04160975|11964496|FG000|NOT COMPLETED|Overall Study||64
10803125|NCT04160975|11964497|FG001|NOT COMPLETED|Overall Study||66
10803126|NCT04160975|11964498|FG002|NOT COMPLETED|Overall Study||61
10803127|NCT04160975|11964499|FG003|NOT COMPLETED|Overall Study||75
10803128|NCT04160975|11964500|FG004|NOT COMPLETED|Overall Study||35
10803129|NCT04160975|11964501|FG005|NOT COMPLETED|Overall Study||51
10803130|NCT04153409|11964516|FG000|STARTED|Overall Study||10
10803131|NCT04153409|11964517|FG001|STARTED|Overall Study||11
10803132|NCT04153409|11964516|FG000|COMPLETED|Overall Study||8
10803133|NCT04153409|11964517|FG001|COMPLETED|Overall Study||9
10803134|NCT04153409|11964516|FG000|NOT COMPLETED|Overall Study||2
10803135|NCT04153409|11964517|FG001|NOT COMPLETED|Overall Study||2
10803136|NCT04167189|11964523|FG000|STARTED|Overall Study||28
10803137|NCT04167189|11964523|FG000|COMPLETED|Overall Study||28
10803138|NCT04167189|11964523|FG000|NOT COMPLETED|Overall Study||0
10803139|NCT04162795|11964527|FG000|STARTED|Overall Study||468
10803140|NCT04162795|11964527|FG000|COMPLETED|Overall Study||442
10803141|NCT04162795|11964527|FG000|NOT COMPLETED|Overall Study||26
10803142|NCT04161807|11964531|FG000|STARTED|Overall Study||42
10803143|NCT04161807|11964531|FG000|COMPLETED|Overall Study||38
10803144|NCT04161807|11964531|FG000|NOT COMPLETED|Overall Study||4
10803145|NCT04161144|11964537|FG000|STARTED|Overall Study||12
10803146|NCT04161144|11964538|FG001|STARTED|Overall Study||10
10803147|NCT04161144|11964537|FG000|COMPLETED|Overall Study||11
10803148|NCT04161144|11964538|FG001|COMPLETED|Overall Study||9
10803149|NCT04161144|11964537|FG000|NOT COMPLETED|Overall Study||1
10803150|NCT04161144|11964538|FG001|NOT COMPLETED|Overall Study||1
10803151|NCT04161079|11964544|FG000|STARTED|Clinical Investigation 2010-040||12
10803152|NCT04161079|11964544|FG000|COMPLETED|Clinical Investigation 2010-040||11
10803153|NCT04161079|11964544|FG000|NOT COMPLETED|Clinical Investigation 2010-040||1
10803154|NCT04161079|11964544|FG000|STARTED|2010-040FU5 >5 Years Follow-up|Of 11 subjects 3 refused to participate and 1 died.|7
10803155|NCT04161079|11964544|FG000|COMPLETED|2010-040FU5 >5 Years Follow-up|Timepoint distribution for individual patients ranged approximately 6-8 yrs after MAR implantation.|7
10803156|NCT04161079|11964544|FG000|NOT COMPLETED|2010-040FU5 >5 Years Follow-up||0
10803157|NCT04158466|11964554|FG000|STARTED|Overall Study||124
10803158|NCT04158466|11964555|FG001|STARTED|Overall Study||127
10803159|NCT04158466|11964554|FG000|COMPLETED|Overall Study||121
10803160|NCT04158466|11964555|FG001|COMPLETED|Overall Study||126
10803161|NCT04158466|11964554|FG000|NOT COMPLETED|Overall Study||3
10803162|NCT04158466|11964555|FG001|NOT COMPLETED|Overall Study||1
10803163|NCT04152083|11964563|FG000|STARTED|Overall Study||241
10803164|NCT04152083|11964564|FG001|STARTED|Overall Study||244
10803165|NCT04152083|11964563|FG000|Received at Least 1 Dose of Study Drug|Overall Study||238
10803166|NCT04152083|11964564|FG001|Received at Least 1 Dose of Study Drug|Overall Study||242
10803167|NCT04152083|11964563|FG000|COMPLETED|Overall Study||235
10803168|NCT04152083|11964564|FG001|COMPLETED|Overall Study||241
10803169|NCT04152083|11964563|FG000|NOT COMPLETED|Overall Study||6
10803170|NCT04152083|11964564|FG001|NOT COMPLETED|Overall Study||3
10803171|NCT04155567|11964570|FG000|STARTED|Overall Study||10
10803172|NCT04155567|11964570|FG000|COMPLETED|Overall Study||10
10803173|NCT04155567|11964570|FG000|NOT COMPLETED|Overall Study||0
10803174|NCT04155047|11964576|FG000|STARTED|Overall Study||11
10803175|NCT04155047|11964577|FG001|STARTED|Overall Study||11
10803176|NCT04155047|11964576|FG000|COMPLETED|Overall Study||9
10803177|NCT04155047|11964577|FG001|COMPLETED|Overall Study||11
10803178|NCT04155047|11964576|FG000|NOT COMPLETED|Overall Study||2
10803179|NCT04155047|11964577|FG001|NOT COMPLETED|Overall Study||0
10803180|NCT04152642|11964583|FG000|STARTED|Overall Study||22
10803181|NCT04152642|11964583|FG000|C (Water/Negative) Control|Overall Study||20
10803182|NCT04152642|11964583|FG000|A (Marketed Rinse)|Overall Study||19
10803183|NCT04152642|11964583|FG000|B (Experimental Rinse)|Overall Study||19
10803184|NCT04152642|11964583|FG000|COMPLETED|Overall Study||15
10803185|NCT04152642|11964583|FG000|NOT COMPLETED|Overall Study||7
10803186|NCT04150861|11964594|FG000|STARTED|Overall Study||8
10803187|NCT04150861|11964595|FG001|STARTED|Overall Study||8
10803188|NCT04150861|11964596|FG002|STARTED|Overall Study||8
10803189|NCT04150861|11964594|FG000|COMPLETED|Overall Study||8
10803190|NCT04150861|11964595|FG001|COMPLETED|Overall Study||8
10803191|NCT04150861|11964596|FG002|COMPLETED|Overall Study||8
10803192|NCT04150861|11964594|FG000|NOT COMPLETED|Overall Study||0
10803193|NCT04150861|11964595|FG001|NOT COMPLETED|Overall Study||0
10803194|NCT04150861|11964596|FG002|NOT COMPLETED|Overall Study||0
10803195|NCT04150250|11964606|FG000|STARTED|Overall Study||23
10803196|NCT04150250|11964607|FG001|STARTED|Overall Study||24
10803197|NCT04150250|11964606|FG000|COMPLETED|Overall Study||23
10803198|NCT04150250|11964607|FG001|COMPLETED|Overall Study||22
10803199|NCT04150250|11964606|FG000|NOT COMPLETED|Overall Study||0
10803200|NCT04150250|11964607|FG001|NOT COMPLETED|Overall Study||2
10803201|NCT04149925|11964615|FG000|STARTED|Overall Study||30
10803202|NCT04149925|11964616|FG001|STARTED|Overall Study||30
10803203|NCT04149925|11964615|FG000|COMPLETED|Overall Study||30
10803204|NCT04149925|11964616|FG001|COMPLETED|Overall Study||30
10803205|NCT04149925|11964615|FG000|NOT COMPLETED|Overall Study||0
10803206|NCT04149925|11964616|FG001|NOT COMPLETED|Overall Study||0
10803207|NCT04150224|11964628|FG000|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
10803208|NCT04150224|11964629|FG001|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
10803209|NCT04150224|11964630|FG002|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
10803210|NCT04150224|11964631|FG003|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
10803211|NCT04150224|11964632|FG004|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
10803212|NCT04150224|11964633|FG005|STARTED|Overall Study|Period 2: Multple Dosing|10
10803213|NCT04150224|11964628|FG000|COMPLETED|Overall Study||10
10803214|NCT04150224|11964629|FG001|COMPLETED|Overall Study||10
10803215|NCT04150224|11964630|FG002|COMPLETED|Overall Study||10
10803216|NCT04150224|11964631|FG003|COMPLETED|Overall Study||10
10803217|NCT04150224|11964632|FG004|COMPLETED|Overall Study||10
10803218|NCT04150224|11964633|FG005|COMPLETED|Overall Study|Period 2: Multple Dosing|10
10803219|NCT04150224|11964628|FG000|NOT COMPLETED|Overall Study||0
10803220|NCT04150224|11964629|FG001|NOT COMPLETED|Overall Study||0
10803221|NCT04150224|11964630|FG002|NOT COMPLETED|Overall Study||0
10803222|NCT04150224|11964631|FG003|NOT COMPLETED|Overall Study||0
10803223|NCT04150224|11964632|FG004|NOT COMPLETED|Overall Study||0
10803224|NCT04150224|11964633|FG005|NOT COMPLETED|Overall Study||0
10803225|NCT04149405|11964660|FG000|STARTED|Overall Study||12
10803226|NCT04149405|11964661|FG001|STARTED|Overall Study||10
10803227|NCT04149405|11964662|FG002|STARTED|Overall Study||11
10803228|NCT04149405|11964663|FG003|STARTED|Overall Study||10
10803229|NCT04149405|11964660|FG000|COMPLETED|Overall Study||12
10803230|NCT04149405|11964661|FG001|COMPLETED|Overall Study||10
10803231|NCT04149405|11964662|FG002|COMPLETED|Overall Study||11
10803232|NCT04149405|11964663|FG003|COMPLETED|Overall Study||10
10803233|NCT04149405|11964660|FG000|NOT COMPLETED|Overall Study||0
10803234|NCT04149405|11964661|FG001|NOT COMPLETED|Overall Study||0
10803235|NCT04149405|11964662|FG002|NOT COMPLETED|Overall Study||0
10803236|NCT04149405|11964663|FG003|NOT COMPLETED|Overall Study||0
10803237|NCT04144088|11964682|FG000|STARTED|Overall Study||20
10803238|NCT04144088|11964683|FG001|STARTED|Overall Study||20
10803239|NCT04144088|11964684|FG002|STARTED|Overall Study||20
10803240|NCT04144088|11964682|FG000|COMPLETED|Overall Study||14
10803241|NCT04144088|11964683|FG001|COMPLETED|Overall Study||15
10803242|NCT04144088|11964684|FG002|COMPLETED|Overall Study||13
10803243|NCT04144088|11964682|FG000|NOT COMPLETED|Overall Study||6
10803244|NCT04144088|11964683|FG001|NOT COMPLETED|Overall Study||5
10803245|NCT04144088|11964684|FG002|NOT COMPLETED|Overall Study||7
10803246|NCT04149353|11964692|FG000|STARTED|Overall Study|The study was terminated for low recruitment before this subject's second imaging scan was due.|1
10803247|NCT04149353|11964692|FG000|COMPLETED|Overall Study||0
10803248|NCT04149353|11964692|FG000|NOT COMPLETED|Overall Study||1
10803249|NCT04137783|11964700|FG000|STARTED|Overall Study||7
10803250|NCT04137783|11964701|FG001|STARTED|Overall Study||10
10803251|NCT04137783|11964702|FG002|STARTED|Overall Study||22
10803252|NCT04137783|11964700|FG000|COMPLETED|Overall Study||7
10803253|NCT04137783|11964701|FG001|COMPLETED|Overall Study||10
10803254|NCT04137783|11964702|FG002|COMPLETED|Overall Study||22
10803255|NCT04137783|11964700|FG000|NOT COMPLETED|Overall Study||0
10803256|NCT04137783|11964701|FG001|NOT COMPLETED|Overall Study||0
10803257|NCT04137783|11964702|FG002|NOT COMPLETED|Overall Study||0
10803258|NCT04136444|11964712|FG000|STARTED|Overall Study||3
10803259|NCT04136444|11964713|FG001|STARTED|Overall Study||9
10803260|NCT04136444|11964712|FG000|COMPLETED|Overall Study|The cohort was not completely recruited, as the study was stopped/terminated due to COVID-19.|3
10803261|NCT04136444|11964713|FG001|COMPLETED|Overall Study||8
10803262|NCT04136444|11964712|FG000|NOT COMPLETED|Overall Study||0
10803263|NCT04136444|11964713|FG001|NOT COMPLETED|Overall Study||1
10803264|NCT04124536|11964730|FG000|STARTED|Overall Study||58
10803265|NCT04124536|11964731|FG001|STARTED|Overall Study||58
10803266|NCT04124536|11964732|FG002|STARTED|Overall Study||105
10803267|NCT04124536|11964733|FG003|STARTED|Overall Study||105
10803268|NCT04124536|11964734|FG004|STARTED|Overall Study||15
10803269|NCT04124536|11964730|FG000|COMPLETED|Overall Study||47
10803270|NCT04124536|11964731|FG001|COMPLETED|Overall Study||53
10803271|NCT04124536|11964732|FG002|COMPLETED|Overall Study||102
10803272|NCT04124536|11964733|FG003|COMPLETED|Overall Study||98
10803273|NCT04124536|11964734|FG004|COMPLETED|Overall Study||15
10803274|NCT04124536|11964730|FG000|NOT COMPLETED|Overall Study||11
10803275|NCT04124536|11964731|FG001|NOT COMPLETED|Overall Study||5
10803276|NCT04124536|11964732|FG002|NOT COMPLETED|Overall Study||3
10803277|NCT04124536|11964733|FG003|NOT COMPLETED|Overall Study||7
10803278|NCT04124536|11964734|FG004|NOT COMPLETED|Overall Study||0
10803279|NCT04147611|11964747|FG000|STARTED|Overall Study||9
10803280|NCT04147611|11964748|FG001|STARTED|Overall Study||13
10803281|NCT04147611|11964747|FG000|COMPLETED|Overall Study||9
10803282|NCT04147611|11964748|FG001|COMPLETED|Overall Study||12
10803283|NCT04147611|11964747|FG000|NOT COMPLETED|Overall Study||0
10803284|NCT04147611|11964748|FG001|NOT COMPLETED|Overall Study||1
10803285|NCT04147442|11964754|FG000|STARTED|Overall Study||20
10803286|NCT04147442|11964754|FG000|COMPLETED|Overall Study||20
10803287|NCT04147442|11964754|FG000|NOT COMPLETED|Overall Study||0
10803288|NCT04147455|11964768|FG000|STARTED|Overall Study||397
10803289|NCT04147455|11964769|FG001|STARTED|Overall Study||396
10803290|NCT04147455|11964768|FG000|COMPLETED|Overall Study||375
10803291|NCT04147455|11964769|FG001|COMPLETED|Overall Study||364
10803292|NCT04147455|11964768|FG000|NOT COMPLETED|Overall Study||22
10803293|NCT04147455|11964769|FG001|NOT COMPLETED|Overall Study||32
10803294|NCT04146272|11964779|FG000|STARTED|First Intervention||11
10803295|NCT04146272|11964780|FG001|STARTED|First Intervention||11
10803296|NCT04146272|11964781|FG002|STARTED|First Intervention||6
10803297|NCT04146272|11964782|FG003|STARTED|First Intervention||5
10803298|NCT04146272|11964779|FG000|COMPLETED|First Intervention||11
10803299|NCT04146272|11964780|FG001|COMPLETED|First Intervention||11
10803300|NCT04146272|11964781|FG002|COMPLETED|First Intervention||6
10803301|NCT04146272|11964782|FG003|COMPLETED|First Intervention||5
10803302|NCT04146272|11964779|FG000|NOT COMPLETED|First Intervention||0
10803303|NCT04146272|11964780|FG001|NOT COMPLETED|First Intervention||0
10803304|NCT04146272|11964781|FG002|NOT COMPLETED|First Intervention||0
10803305|NCT04146272|11964782|FG003|NOT COMPLETED|First Intervention||0
10803306|NCT04146272|11964779|FG000|STARTED|Second Intervention||11
10803307|NCT04146272|11964780|FG001|STARTED|Second Intervention||11
10803308|NCT04146272|11964781|FG002|STARTED|Second Intervention||6
10803309|NCT04146272|11964782|FG003|STARTED|Second Intervention||5
10803310|NCT04146272|11964779|FG000|COMPLETED|Second Intervention||11
10803311|NCT04146272|11964780|FG001|COMPLETED|Second Intervention||11
10803312|NCT04146272|11964781|FG002|COMPLETED|Second Intervention||6
10803313|NCT04146272|11964782|FG003|COMPLETED|Second Intervention||5
10803314|NCT04146272|11964779|FG000|NOT COMPLETED|Second Intervention||0
10803315|NCT04146272|11964780|FG001|NOT COMPLETED|Second Intervention||0
10803316|NCT04146272|11964781|FG002|NOT COMPLETED|Second Intervention||0
10803317|NCT04146272|11964782|FG003|NOT COMPLETED|Second Intervention||0
10803318|NCT04143945|11964801|FG000|STARTED|Treatment Period 1 (Day 1)||26
10803319|NCT04143945|11964802|FG001|STARTED|Treatment Period 1 (Day 1)||26
10803320|NCT04143945|11964803|FG002|STARTED|Treatment Period 1 (Day 1)||26
10803321|NCT04143945|11964804|FG003|STARTED|Treatment Period 1 (Day 1)||26
10803322|NCT04143945|11964801|FG000|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
10803323|NCT04143945|11964802|FG001|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
10803324|NCT04143945|11964803|FG002|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
10803325|NCT04143945|11964804|FG003|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
10803326|NCT04143945|11964801|FG000|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
10803327|NCT04143945|11964802|FG001|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
10803328|NCT04143945|11964803|FG002|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
10803329|NCT04143945|11964804|FG003|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
10803330|NCT04143945|11964801|FG000|Per Protocol Set|Treatment Period 1 (Day 1)||26
10803331|NCT04143945|11964802|FG001|Per Protocol Set|Treatment Period 1 (Day 1)||26
10803332|NCT04143945|11964803|FG002|Per Protocol Set|Treatment Period 1 (Day 1)||26
10803333|NCT04143945|11964804|FG003|Per Protocol Set|Treatment Period 1 (Day 1)||26
10803334|NCT04143945|11964801|FG000|COMPLETED|Treatment Period 1 (Day 1)||26
10803335|NCT04143945|11964802|FG001|COMPLETED|Treatment Period 1 (Day 1)||26
10803336|NCT04143945|11964803|FG002|COMPLETED|Treatment Period 1 (Day 1)||26
10803337|NCT04143945|11964804|FG003|COMPLETED|Treatment Period 1 (Day 1)||26
10803338|NCT04143945|11964801|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10803339|NCT04143945|11964802|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10803340|NCT04143945|11964803|FG002|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10803341|NCT04143945|11964804|FG003|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10803342|NCT04143945|11964801|FG000|STARTED|Treatment Period 2 (Day 1)||26
10803343|NCT04143945|11964802|FG001|STARTED|Treatment Period 2 (Day 1)||26
10803344|NCT04143945|11964803|FG002|STARTED|Treatment Period 2 (Day 1)||26
10803345|NCT04143945|11964804|FG003|STARTED|Treatment Period 2 (Day 1)||26
10803346|NCT04143945|11964801|FG000|COMPLETED|Treatment Period 2 (Day 1)||26
10803347|NCT04143945|11964802|FG001|COMPLETED|Treatment Period 2 (Day 1)||26
10803348|NCT04143945|11964803|FG002|COMPLETED|Treatment Period 2 (Day 1)||26
10803349|NCT04143945|11964804|FG003|COMPLETED|Treatment Period 2 (Day 1)||26
10803350|NCT04143945|11964801|FG000|NOT COMPLETED|Treatment Period 2 (Day 1)||0
10803351|NCT04143945|11964802|FG001|NOT COMPLETED|Treatment Period 2 (Day 1)||0
10803352|NCT04143945|11964803|FG002|NOT COMPLETED|Treatment Period 2 (Day 1)||0
10803353|NCT04143945|11964804|FG003|NOT COMPLETED|Treatment Period 2 (Day 1)||0
10803354|NCT04143373|11964809|FG000|STARTED|Overall Study||20
10803355|NCT04143373|11964810|FG001|STARTED|Overall Study||20
10803356|NCT04143373|11964809|FG000|COMPLETED|Overall Study||20
10803357|NCT04143373|11964810|FG001|COMPLETED|Overall Study||20
10803358|NCT04143373|11964809|FG000|NOT COMPLETED|Overall Study||0
10803359|NCT04143373|11964810|FG001|NOT COMPLETED|Overall Study||0
10803360|NCT04142216|11964817|FG000|STARTED|Overall Study||28
10803361|NCT04142216|11964818|FG001|STARTED|Overall Study||28
10803362|NCT04142216|11964817|FG000|COMPLETED|Overall Study||22
10803363|NCT04142216|11964818|FG001|COMPLETED|Overall Study||22
10803364|NCT04142216|11964817|FG000|NOT COMPLETED|Overall Study||6
10803365|NCT04142216|11964818|FG001|NOT COMPLETED|Overall Study||6
10803366|NCT04141930|11964824|FG000|STARTED|Overall Study||302
10803367|NCT04141930|11964825|FG001|STARTED|Overall Study|The 179 individuals that were not eligible to receive the study drug, participated in an observation portion of the study where all study procedures were the same excluding telehealth visit and an antiviral delivery.|179
10803368|NCT04141930|11964824|FG000|COMPLETED|Overall Study||302
10803369|NCT04141930|11964825|FG001|COMPLETED|Overall Study||179
10803370|NCT04141930|11964824|FG000|NOT COMPLETED|Overall Study||0
10803371|NCT04141930|11964825|FG001|NOT COMPLETED|Overall Study||0
10803372|NCT04142450|11964829|FG000|STARTED|Overall Study||50
10803373|NCT04142450|11964829|FG000|Safety Population|Overall Study||49
10803374|NCT04142450|11964829|FG000|COMPLETED|Overall Study||48
10803375|NCT04142450|11964829|FG000|NOT COMPLETED|Overall Study||2
10803376|NCT04140890|11964835|FG000|STARTED|Overall Study||9
10803377|NCT04140890|11964836|FG001|STARTED|Overall Study||12
10803378|NCT04140890|11964835|FG000|COMPLETED|Overall Study||9
10803379|NCT04140890|11964836|FG001|COMPLETED|Overall Study||11
10803380|NCT04140890|11964835|FG000|NOT COMPLETED|Overall Study||0
10803381|NCT04140890|11964836|FG001|NOT COMPLETED|Overall Study||1
10803382|NCT04139018|11964847|FG000|STARTED|Overall Study||14
10803383|NCT04139018|11964848|FG001|STARTED|Overall Study||13
10803384|NCT04139018|11964847|FG000|COMPLETED|Overall Study||11
10803385|NCT04139018|11964848|FG001|COMPLETED|Overall Study||12
10803386|NCT04139018|11964847|FG000|NOT COMPLETED|Overall Study||3
10803387|NCT04139018|11964848|FG001|NOT COMPLETED|Overall Study||1
10803388|NCT04138810|11964856|FG000|STARTED|Overall Study||27
10803389|NCT04138810|11964857|FG001|STARTED|Overall Study||27
10803390|NCT04138810|11964856|FG000|COMPLETED|Overall Study||26
10803391|NCT04138810|11964857|FG001|COMPLETED|Overall Study||26
10803392|NCT04138810|11964856|FG000|NOT COMPLETED|Overall Study||1
10803393|NCT04138810|11964857|FG001|NOT COMPLETED|Overall Study||1
10803394|NCT04131556|11964863|FG000|STARTED|Overall Study||20
10803395|NCT04131556|11964863|FG000|COMPLETED|Overall Study||18
10803396|NCT04131556|11964863|FG000|NOT COMPLETED|Overall Study||2
10803397|NCT04126174|11964870|FG000|STARTED|Overall Study||41
10803398|NCT04126174|11964871|FG001|STARTED|Overall Study||41
10803399|NCT04126174|11964870|FG000|COMPLETED|Overall Study||38
10803400|NCT04126174|11964871|FG001|COMPLETED|Overall Study||38
10803401|NCT04126174|11964870|FG000|NOT COMPLETED|Overall Study||3
10803402|NCT04126174|11964871|FG001|NOT COMPLETED|Overall Study||3
10803403|NCT04134429|11964877|FG000|STARTED|Overall Study||20
10803404|NCT04134429|11964877|FG000|COMPLETED|Overall Study||19
10803405|NCT04134429|11964877|FG000|NOT COMPLETED|Overall Study||1
10803406|NCT04130425|11964881|FG000|STARTED|Overall Study||30
10803407|NCT04130425|11964881|FG000|COMPLETED|Overall Study||30
10803408|NCT04130425|11964881|FG000|NOT COMPLETED|Overall Study||0
10803409|NCT04138498|11964896|FG000|STARTED|Overall Study||11
10803410|NCT04138498|11964897|FG001|STARTED|Overall Study||10
10803411|NCT04138498|11964898|FG002|STARTED|Overall Study||12
10803412|NCT04138498|11964899|FG003|STARTED|Overall Study||12
10803413|NCT04138498|11964896|FG000|COMPLETED|Overall Study||10
10803414|NCT04138498|11964897|FG001|COMPLETED|Overall Study||10
10803415|NCT04138498|11964898|FG002|COMPLETED|Overall Study||10
10803416|NCT04138498|11964899|FG003|COMPLETED|Overall Study||9
10803417|NCT04138498|11964896|FG000|NOT COMPLETED|Overall Study||1
10803418|NCT04138498|11964897|FG001|NOT COMPLETED|Overall Study||0
10803419|NCT04138498|11964898|FG002|NOT COMPLETED|Overall Study||2
10803420|NCT04138498|11964899|FG003|NOT COMPLETED|Overall Study||3
10803421|NCT04138043|11964915|FG000|STARTED|Overall Study||2
10803422|NCT04138043|11964916|FG001|STARTED|Overall Study||7
10803423|NCT04138043|11964915|FG000|COMPLETED|Overall Study||2
10803424|NCT04138043|11964916|FG001|COMPLETED|Overall Study||6
10803425|NCT04138043|11964915|FG000|NOT COMPLETED|Overall Study||0
10803426|NCT04138043|11964916|FG001|NOT COMPLETED|Overall Study||1
10803427|NCT04137627|11964925|FG000|STARTED|Overall Study||25
10803428|NCT04137627|11964926|FG001|STARTED|Overall Study||25
10803429|NCT04137627|11964925|FG000|COMPLETED|Overall Study||13
10803430|NCT04137627|11964926|FG001|COMPLETED|Overall Study||12
10803431|NCT04137627|11964925|FG000|NOT COMPLETED|Overall Study||12
10803432|NCT04137627|11964926|FG001|NOT COMPLETED|Overall Study||13
10803433|NCT04136145|11964934|FG000|STARTED|Overall Study||12
10803434|NCT04136145|11964935|FG001|STARTED|Overall Study||24
10803435|NCT04136145|11964934|FG000|COMPLETED|Overall Study||12
10803436|NCT04136145|11964935|FG001|COMPLETED|Overall Study||24
10803437|NCT04136145|11964934|FG000|NOT COMPLETED|Overall Study||0
10803438|NCT04136145|11964935|FG001|NOT COMPLETED|Overall Study||0
10803439|NCT04132336|11964949|FG000|STARTED|Overall Study||32
10803440|NCT04132336|11964950|FG001|STARTED|Overall Study||32
10803441|NCT04132336|11964951|FG002|STARTED|Overall Study||32
10803442|NCT04132336|11964952|FG003|STARTED|Overall Study||32
10803443|NCT04132336|11964953|FG004|STARTED|Overall Study||32
10803444|NCT04132336|11964954|FG005|STARTED|Overall Study||16
10803445|NCT04132336|11964955|FG006|STARTED|Overall Study||17
10803446|NCT04132336|11964949|FG000|COMPLETED|Overall Study||32
10803447|NCT04132336|11964950|FG001|COMPLETED|Overall Study||31
10803448|NCT04132336|11964951|FG002|COMPLETED|Overall Study||32
10803449|NCT04132336|11964952|FG003|COMPLETED|Overall Study||32
10803450|NCT04132336|11964953|FG004|COMPLETED|Overall Study||32
10803451|NCT04132336|11964954|FG005|COMPLETED|Overall Study||16
10803452|NCT04132336|11964955|FG006|COMPLETED|Overall Study||17
10803453|NCT04132336|11964949|FG000|NOT COMPLETED|Overall Study||0
10803454|NCT04132336|11964950|FG001|NOT COMPLETED|Overall Study||1
10803455|NCT04132336|11964951|FG002|NOT COMPLETED|Overall Study||0
10803456|NCT04132336|11964952|FG003|NOT COMPLETED|Overall Study||0
10803457|NCT04132336|11964953|FG004|NOT COMPLETED|Overall Study||0
10803458|NCT04132336|11964954|FG005|NOT COMPLETED|Overall Study||0
10803459|NCT04132336|11964955|FG006|NOT COMPLETED|Overall Study||0
10803460|NCT04131517|11964973|FG000|STARTED|Overall Study||7
10803461|NCT04131517|11964974|FG001|STARTED|Overall Study||7
10803462|NCT04131517|11964973|FG000|COMPLETED|Overall Study||7
10803463|NCT04131517|11964974|FG001|COMPLETED|Overall Study||7
10803464|NCT04131517|11964973|FG000|NOT COMPLETED|Overall Study||0
10803465|NCT04131517|11964974|FG001|NOT COMPLETED|Overall Study||0
10803466|NCT04128293|11964995|FG000|STARTED|Treatment Period 1 (1 Day)||4
10803467|NCT04128293|11964996|FG001|STARTED|Treatment Period 1 (1 Day)||4
10803468|NCT04128293|11964997|FG002|STARTED|Treatment Period 1 (1 Day)||4
10803469|NCT04128293|11964998|FG003|STARTED|Treatment Period 1 (1 Day)||4
10803470|NCT04128293|11964995|FG000|COMPLETED|Treatment Period 1 (1 Day)||4
10803471|NCT04128293|11964996|FG001|COMPLETED|Treatment Period 1 (1 Day)||4
10803472|NCT04128293|11964997|FG002|COMPLETED|Treatment Period 1 (1 Day)||4
10803473|NCT04128293|11964998|FG003|COMPLETED|Treatment Period 1 (1 Day)||4
10803474|NCT04128293|11964995|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0
10803475|NCT04128293|11964996|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0
10803476|NCT04128293|11964997|FG002|NOT COMPLETED|Treatment Period 1 (1 Day)||0
10803477|NCT04128293|11964998|FG003|NOT COMPLETED|Treatment Period 1 (1 Day)||0
10803478|NCT04128293|11964995|FG000|STARTED|Washout Period 1 (Up to 7 Days)||4
10803479|NCT04128293|11964996|FG001|STARTED|Washout Period 1 (Up to 7 Days)||4
10803480|NCT04128293|11964997|FG002|STARTED|Washout Period 1 (Up to 7 Days)||4
10803481|NCT04128293|11964998|FG003|STARTED|Washout Period 1 (Up to 7 Days)||4
10803482|NCT04128293|11964995|FG000|COMPLETED|Washout Period 1 (Up to 7 Days)||4
10803483|NCT04128293|11964996|FG001|COMPLETED|Washout Period 1 (Up to 7 Days)||4
10803484|NCT04128293|11964997|FG002|COMPLETED|Washout Period 1 (Up to 7 Days)||4
10803485|NCT04128293|11964998|FG003|COMPLETED|Washout Period 1 (Up to 7 Days)||4
10803486|NCT04128293|11964995|FG000|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0
10803487|NCT04128293|11964996|FG001|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0
10803488|NCT04128293|11964997|FG002|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0
10803489|NCT04128293|11964998|FG003|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0
10803490|NCT04128293|11964995|FG000|STARTED|Treatment Period 2 (1 Day)||4
10803491|NCT04128293|11964996|FG001|STARTED|Treatment Period 2 (1 Day)||4
10803492|NCT04128293|11964997|FG002|STARTED|Treatment Period 2 (1 Day)||4
10803493|NCT04128293|11964998|FG003|STARTED|Treatment Period 2 (1 Day)||4
10803494|NCT04128293|11964995|FG000|COMPLETED|Treatment Period 2 (1 Day)||4
10803495|NCT04128293|11964996|FG001|COMPLETED|Treatment Period 2 (1 Day)||4
10803496|NCT04128293|11964997|FG002|COMPLETED|Treatment Period 2 (1 Day)||4
10803497|NCT04128293|11964998|FG003|COMPLETED|Treatment Period 2 (1 Day)||4
10803498|NCT04128293|11964995|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0
10803499|NCT04128293|11964996|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0
10803500|NCT04128293|11964997|FG002|NOT COMPLETED|Treatment Period 2 (1 Day)||0
10803501|NCT04128293|11964998|FG003|NOT COMPLETED|Treatment Period 2 (1 Day)||0
10803502|NCT04128293|11964995|FG000|STARTED|Washout Period 2 (Up to 7 Days)||4
10803503|NCT04128293|11964996|FG001|STARTED|Washout Period 2 (Up to 7 Days)||4
10803504|NCT04128293|11964997|FG002|STARTED|Washout Period 2 (Up to 7 Days)||4
10803505|NCT04128293|11964998|FG003|STARTED|Washout Period 2 (Up to 7 Days)||4
10803506|NCT04128293|11964995|FG000|COMPLETED|Washout Period 2 (Up to 7 Days)||0
10803507|NCT04128293|11964996|FG001|COMPLETED|Washout Period 2 (Up to 7 Days)||0
10803508|NCT04128293|11964997|FG002|COMPLETED|Washout Period 2 (Up to 7 Days)||0
10803509|NCT04128293|11964998|FG003|COMPLETED|Washout Period 2 (Up to 7 Days)||0
10803510|NCT04128293|11964995|FG000|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4
10803511|NCT04128293|11964996|FG001|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4
10803512|NCT04128293|11964997|FG002|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4
10803513|NCT04128293|11964998|FG003|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4
10803514|NCT04128293|11964995|FG000|STARTED|Treatment Period 3 (1 Day)||0
10803515|NCT04128293|11964996|FG001|STARTED|Treatment Period 3 (1 Day)||0
10803516|NCT04128293|11964997|FG002|STARTED|Treatment Period 3 (1 Day)||0
10803517|NCT04128293|11964998|FG003|STARTED|Treatment Period 3 (1 Day)||0
10803518|NCT04128293|11964995|FG000|COMPLETED|Treatment Period 3 (1 Day)||0
10803519|NCT04128293|11964996|FG001|COMPLETED|Treatment Period 3 (1 Day)||0
10803520|NCT04128293|11964997|FG002|COMPLETED|Treatment Period 3 (1 Day)||0
10803521|NCT04128293|11964998|FG003|COMPLETED|Treatment Period 3 (1 Day)||0
10803522|NCT04128293|11964995|FG000|NOT COMPLETED|Treatment Period 3 (1 Day)||0
10803523|NCT04128293|11964996|FG001|NOT COMPLETED|Treatment Period 3 (1 Day)||0
10803524|NCT04128293|11964997|FG002|NOT COMPLETED|Treatment Period 3 (1 Day)||0
10803525|NCT04128293|11964998|FG003|NOT COMPLETED|Treatment Period 3 (1 Day)||0
10803526|NCT04128293|11964995|FG000|STARTED|Washout Period 3 (Up to 7 Days)||0
10803527|NCT04128293|11964996|FG001|STARTED|Washout Period 3 (Up to 7 Days)||0
10803528|NCT04128293|11964997|FG002|STARTED|Washout Period 3 (Up to 7 Days)||0
10803529|NCT04128293|11964998|FG003|STARTED|Washout Period 3 (Up to 7 Days)||0
10803530|NCT04128293|11964995|FG000|COMPLETED|Washout Period 3 (Up to 7 Days)||0
10803531|NCT04128293|11964996|FG001|COMPLETED|Washout Period 3 (Up to 7 Days)||0
10803532|NCT04128293|11964997|FG002|COMPLETED|Washout Period 3 (Up to 7 Days)||0
10803533|NCT04128293|11964998|FG003|COMPLETED|Washout Period 3 (Up to 7 Days)||0
10803534|NCT04128293|11964995|FG000|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0
10803535|NCT04128293|11964996|FG001|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0
10803536|NCT04128293|11964997|FG002|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0
10803537|NCT04128293|11964998|FG003|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0
10803538|NCT04128293|11964995|FG000|STARTED|Treatment Period 4 (1 Day)||0
10803539|NCT04128293|11964996|FG001|STARTED|Treatment Period 4 (1 Day)||0
10803540|NCT04128293|11964997|FG002|STARTED|Treatment Period 4 (1 Day)||0
10803541|NCT04128293|11964998|FG003|STARTED|Treatment Period 4 (1 Day)||0
10803542|NCT04128293|11964995|FG000|COMPLETED|Treatment Period 4 (1 Day)||0
10803543|NCT04128293|11964996|FG001|COMPLETED|Treatment Period 4 (1 Day)||0
10803544|NCT04128293|11964997|FG002|COMPLETED|Treatment Period 4 (1 Day)||0
10803545|NCT04128293|11964998|FG003|COMPLETED|Treatment Period 4 (1 Day)||0
10803546|NCT04128293|11964995|FG000|NOT COMPLETED|Treatment Period 4 (1 Day)||0
10803547|NCT04128293|11964996|FG001|NOT COMPLETED|Treatment Period 4 (1 Day)||0
10803548|NCT04128293|11964997|FG002|NOT COMPLETED|Treatment Period 4 (1 Day)||0
10803549|NCT04128293|11964998|FG003|NOT COMPLETED|Treatment Period 4 (1 Day)||0
10803550|NCT04126343|11965019|FG000|STARTED|Overall Study||9
10803551|NCT04126343|11965020|FG001|STARTED|Overall Study||9
10803552|NCT04126343|11965021|FG002|STARTED|Overall Study||9
10803553|NCT04126343|11965022|FG003|STARTED|Overall Study||9
10803554|NCT04126343|11965023|FG004|STARTED|Overall Study||9
10803555|NCT04126343|11965024|FG005|STARTED|Overall Study||9
10701363|NCT02566759|11865802|FG003|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10701364|NCT02566759|11865803|FG004|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10701365|NCT02566759|11865804|FG005|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10803556|NCT04126343|11965019|FG000|Completed Padsevonil Period|Overall Study||9
10803557|NCT04126343|11965020|FG001|Completed Padsevonil Period|Overall Study||9
10803558|NCT04126343|11965021|FG002|Completed Padsevonil Period|Overall Study||9
10803559|NCT04126343|11965022|FG003|Completed Padsevonil Period|Overall Study||7
10803560|NCT04126343|11965023|FG004|Completed Padsevonil Period|Overall Study||9
10803561|NCT04126343|11965024|FG005|Completed Padsevonil Period|Overall Study||8
10803562|NCT04126343|11965019|FG000|Completed Placebo Period|Overall Study||9
10803563|NCT04126343|11965020|FG001|Completed Placebo Period|Overall Study||7
10803564|NCT04126343|11965021|FG002|Completed Placebo Period|Overall Study||9
10803565|NCT04126343|11965022|FG003|Completed Placebo Period|Overall Study||9
10803566|NCT04126343|11965023|FG004|Completed Placebo Period|Overall Study||7
10803567|NCT04126343|11965024|FG005|Completed Placebo Period|Overall Study||9
10803568|NCT04126343|11965019|FG000|Completed Moxifloxacin Period|Overall Study||8
10803569|NCT04126343|11965020|FG001|Completed Moxifloxacin Period|Overall Study||9
10803570|NCT04126343|11965021|FG002|Completed Moxifloxacin Period|Overall Study||7
10803571|NCT04126343|11965022|FG003|Completed Moxifloxacin Period|Overall Study||9
10803572|NCT04126343|11965023|FG004|Completed Moxifloxacin Period|Overall Study||9
10803573|NCT04126343|11965024|FG005|Completed Moxifloxacin Period|Overall Study||9
10803574|NCT04126343|11965019|FG000|COMPLETED|Overall Study||6
10803575|NCT04126343|11965020|FG001|COMPLETED|Overall Study||5
10803576|NCT04126343|11965021|FG002|COMPLETED|Overall Study||6
10803577|NCT04126343|11965022|FG003|COMPLETED|Overall Study||5
10803578|NCT04126343|11965023|FG004|COMPLETED|Overall Study||6
10803579|NCT04126343|11965024|FG005|COMPLETED|Overall Study||5
10803580|NCT04126343|11965019|FG000|NOT COMPLETED|Overall Study||3
10455603|NCT01003184|11603699|FG001|STARTED|Overall Study||111
10455604|NCT01003184|11603698|FG000|Full Analysis Set (FAS)|Overall Study||111
10701366|NCT02566759|11865805|FG006|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10803581|NCT04126343|11965020|FG001|NOT COMPLETED|Overall Study||4
10803582|NCT04126343|11965021|FG002|NOT COMPLETED|Overall Study||3
10803583|NCT04126343|11965022|FG003|NOT COMPLETED|Overall Study||4
10803584|NCT04126343|11965023|FG004|NOT COMPLETED|Overall Study||3
10803585|NCT04126343|11965024|FG005|NOT COMPLETED|Overall Study||4
10803586|NCT04126187|11965039|FG000|STARTED|Overall Study||30
10803587|NCT04126187|11965039|FG000|COMPLETED|Overall Study||30
10803588|NCT04126187|11965039|FG000|NOT COMPLETED|Overall Study||0
10803589|NCT04124952|11965043|FG000|STARTED|Overall Study||30
10803590|NCT04124952|11965043|FG000|COMPLETED|Overall Study||29
10803591|NCT04124952|11965043|FG000|NOT COMPLETED|Overall Study||1
10803592|NCT04123665|11965049|FG000|STARTED|Overall Study||50
10803593|NCT04123665|11965050|FG001|STARTED|Overall Study||48
10803594|NCT04123665|11965049|FG000|COMPLETED|Overall Study||42
10803595|NCT04123665|11965050|FG001|COMPLETED|Overall Study||48
10803596|NCT04123665|11965049|FG000|NOT COMPLETED|Overall Study||8
10803597|NCT04123665|11965050|FG001|NOT COMPLETED|Overall Study||0
10803598|NCT04122534|11965056|FG000|STARTED|Overall Study||48
10803599|NCT04122534|11965056|FG000|COMPLETED|Overall Study||44
10803600|NCT04122534|11965056|FG000|NOT COMPLETED|Overall Study||4
10803601|NCT04121078|11965062|FG000|STARTED|Study Period 1 (1 Day)||6
10803602|NCT04121078|11965063|FG001|STARTED|Study Period 1 (1 Day)||6
10803603|NCT04121078|11965062|FG000|COMPLETED|Study Period 1 (1 Day)||6
10803604|NCT04121078|11965063|FG001|COMPLETED|Study Period 1 (1 Day)||6
10803605|NCT04121078|11965062|FG000|NOT COMPLETED|Study Period 1 (1 Day)||0
10803606|NCT04121078|11965063|FG001|NOT COMPLETED|Study Period 1 (1 Day)||0
10803607|NCT04121078|11965062|FG000|STARTED|Washout Period (at Least 7 Days)||6
10803608|NCT04121078|11965063|FG001|STARTED|Washout Period (at Least 7 Days)||6
10803609|NCT04121078|11965062|FG000|COMPLETED|Washout Period (at Least 7 Days)||6
10803610|NCT04121078|11965063|FG001|COMPLETED|Washout Period (at Least 7 Days)||6
10803611|NCT04121078|11965062|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
10803612|NCT04121078|11965063|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
10803613|NCT04121078|11965062|FG000|STARTED|Study Period 2 (1 Day)||6
10803614|NCT04121078|11965063|FG001|STARTED|Study Period 2 (1 Day)||6
10803615|NCT04121078|11965062|FG000|COMPLETED|Study Period 2 (1 Day)||6
10803616|NCT04121078|11965063|FG001|COMPLETED|Study Period 2 (1 Day)||6
10701367|NCT02566759|11865806|FG007|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10701368|NCT02566759|11865807|FG008|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10701369|NCT02566759|11865808|FG009|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10701370|NCT02566759|11865809|FG010|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10701371|NCT02566759|11865810|FG011|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10701372|NCT02566759|11865811|FG012|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10701373|NCT02566759|11865812|FG013|STARTED|Crossover Treatment (Part 4: 1 Day)||0
10701374|NCT02566759|11865813|FG014|STARTED|Crossover Treatment (Part 4: 1 Day)||8
10701375|NCT02566759|11865814|FG015|STARTED|Crossover Treatment (Part 4: 1 Day)||8
10701376|NCT02566759|11865815|FG016|STARTED|Crossover Treatment (Part 4: 1 Day)||7
10701377|NCT02566759|11865799|FG000|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10803617|NCT04121078|11965062|FG000|NOT COMPLETED|Study Period 2 (1 Day)||0
10803618|NCT04121078|11965063|FG001|NOT COMPLETED|Study Period 2 (1 Day)||0
10803619|NCT04117607|11965072|FG000|STARTED|Overall Study||3
10803620|NCT04117607|11965073|FG001|STARTED|Overall Study||7
10811046|NCT03781375|11972756|FG000|Received Study Drug|Double-blind Phase||12
10803621|NCT04117607|11965074|FG002|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
10803622|NCT04117607|11965075|FG003|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
10803623|NCT04117607|11965076|FG004|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
10803624|NCT04117607|11965077|FG005|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
10803625|NCT04117607|11965078|FG006|STARTED|Overall Study||4
10803626|NCT04117607|11965079|FG007|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
10803627|NCT04117607|11965080|FG008|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
10803628|NCT04117607|11965081|FG009|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
10803629|NCT04117607|11965082|FG010|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
10803630|NCT04117607|11965083|FG011|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
10803631|NCT04117607|11965084|FG012|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
10803632|NCT04117607|11965085|FG013|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
10803633|NCT04117607|11965072|FG000|Received Study Product|Overall Study||3
10803634|NCT04117607|11965073|FG001|Received Study Product|Overall Study||6
10803635|NCT04117607|11965074|FG002|Received Study Product|Overall Study||0
10803636|NCT04117607|11965075|FG003|Received Study Product|Overall Study||0
10803637|NCT04117607|11965076|FG004|Received Study Product|Overall Study||0
10803638|NCT04117607|11965077|FG005|Received Study Product|Overall Study||0
10803639|NCT04117607|11965078|FG006|Received Study Product|Overall Study||3
10803640|NCT04117607|11965079|FG007|Received Study Product|Overall Study||0
10803641|NCT04117607|11965080|FG008|Received Study Product|Overall Study||0
10803642|NCT04117607|11965081|FG009|Received Study Product|Overall Study||0
10803643|NCT04117607|11965082|FG010|Received Study Product|Overall Study||0
10803644|NCT04117607|11965083|FG011|Received Study Product|Overall Study||0
10803645|NCT04117607|11965084|FG012|Received Study Product|Overall Study||0
10803646|NCT04117607|11965085|FG013|Received Study Product|Overall Study||0
10803647|NCT04117607|11965072|FG000|Completed All PK Blood Draws|Overall Study||0
10803648|NCT04117607|11965073|FG001|Completed All PK Blood Draws|Overall Study||6
10803649|NCT04117607|11965074|FG002|Completed All PK Blood Draws|Overall Study||0
10803650|NCT04117607|11965075|FG003|Completed All PK Blood Draws|Overall Study||0
10803651|NCT04117607|11965076|FG004|Completed All PK Blood Draws|Overall Study||0
10803652|NCT04117607|11965077|FG005|Completed All PK Blood Draws|Overall Study||0
10803653|NCT04117607|11965078|FG006|Completed All PK Blood Draws|Overall Study||1
10803654|NCT04117607|11965079|FG007|Completed All PK Blood Draws|Overall Study||0
10803655|NCT04117607|11965080|FG008|Completed All PK Blood Draws|Overall Study||0
10803656|NCT04117607|11965081|FG009|Completed All PK Blood Draws|Overall Study||0
10803657|NCT04117607|11965082|FG010|Completed All PK Blood Draws|Overall Study||0
10803658|NCT04117607|11965083|FG011|Completed All PK Blood Draws|Overall Study||0
10803659|NCT04117607|11965084|FG012|Completed All PK Blood Draws|Overall Study||0
10803660|NCT04117607|11965085|FG013|Completed All PK Blood Draws|Overall Study||0
10803661|NCT04117607|11965072|FG000|COMPLETED|Overall Study||3
10803662|NCT04117607|11965073|FG001|COMPLETED|Overall Study||6
10803663|NCT04117607|11965074|FG002|COMPLETED|Overall Study||0
10803664|NCT04117607|11965075|FG003|COMPLETED|Overall Study||0
10803665|NCT04117607|11965076|FG004|COMPLETED|Overall Study||0
10803666|NCT04117607|11965077|FG005|COMPLETED|Overall Study||0
10803667|NCT04117607|11965078|FG006|COMPLETED|Overall Study||3
10803668|NCT04117607|11965079|FG007|COMPLETED|Overall Study||0
10803669|NCT04117607|11965080|FG008|COMPLETED|Overall Study||0
10803670|NCT04117607|11965081|FG009|COMPLETED|Overall Study||0
10803671|NCT04117607|11965082|FG010|COMPLETED|Overall Study||0
10803672|NCT04117607|11965083|FG011|COMPLETED|Overall Study||0
10803673|NCT04117607|11965084|FG012|COMPLETED|Overall Study||0
10803674|NCT04117607|11965085|FG013|COMPLETED|Overall Study||0
10803675|NCT04117607|11965072|FG000|NOT COMPLETED|Overall Study||0
10803676|NCT04117607|11965073|FG001|NOT COMPLETED|Overall Study||1
10803677|NCT04117607|11965074|FG002|NOT COMPLETED|Overall Study||0
10701378|NCT02566759|11865800|FG001|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701379|NCT02566759|11865801|FG002|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701380|NCT02566759|11865802|FG003|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701381|NCT02566759|11865803|FG004|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701382|NCT02566759|11865804|FG005|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701383|NCT02566759|11865805|FG006|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701384|NCT02566759|11865806|FG007|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701385|NCT02566759|11865807|FG008|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701386|NCT02566759|11865808|FG009|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701387|NCT02566759|11865809|FG010|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701388|NCT02566759|11865810|FG011|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701389|NCT02566759|11865811|FG012|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701390|NCT02566759|11865812|FG013|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701391|NCT02566759|11865813|FG014|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
10701392|NCT02566759|11865814|FG015|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
10803678|NCT04117607|11965075|FG003|NOT COMPLETED|Overall Study||0
10319007|NCT00219349|11453287|FG000|NOT COMPLETED|Cognitive Behavioral Therapy Phase||10
10319008|NCT00219349|11453287|FG000|STARTED|Escitalopram Phase|7 responders to CBT were ineligible to start and 1 declined, leaving 7 who started escitalopram|7
10319009|NCT00219349|11453287|FG000|COMPLETED|Escitalopram Phase||4
10319010|NCT00219349|11453287|FG000|NOT COMPLETED|Escitalopram Phase||3
10319011|NCT00219544|11453291|FG000|STARTED|Single Blind Treatment Period||256
10319012|NCT00219544|11453292|FG001|STARTED|Single Blind Treatment Period||0
10319013|NCT00219544|11453291|FG000|COMPLETED|Single Blind Treatment Period||234
10319014|NCT00219544|11453292|FG001|COMPLETED|Single Blind Treatment Period||0
10319015|NCT00219544|11453291|FG000|NOT COMPLETED|Single Blind Treatment Period||22
10319016|NCT00219544|11453292|FG001|NOT COMPLETED|Single Blind Treatment Period||0
10319017|NCT00219544|11453291|FG000|STARTED|Double Blind Treatment Period||80
10319018|NCT00219544|11453292|FG001|STARTED|Double Blind Treatment Period||77
10319019|NCT00219544|11453291|FG000|COMPLETED|Double Blind Treatment Period||80
10319020|NCT00219544|11453292|FG001|COMPLETED|Double Blind Treatment Period||77
10319021|NCT00219544|11453291|FG000|NOT COMPLETED|Double Blind Treatment Period||0
10319022|NCT00219544|11453292|FG001|NOT COMPLETED|Double Blind Treatment Period||0
10319023|NCT00219557|11453303|FG000|STARTED|Phase 1||8
10319024|NCT00219557|11453304|FG001|STARTED|Phase 1||0
10319025|NCT00219557|11453305|FG002|STARTED|Phase 1||0
10319026|NCT00219557|11453303|FG000|COMPLETED|Phase 1||1
10319027|NCT00219557|11453304|FG001|COMPLETED|Phase 1||0
10319028|NCT00219557|11453305|FG002|COMPLETED|Phase 1||0
10319029|NCT00219557|11453303|FG000|NOT COMPLETED|Phase 1||7
10319030|NCT00219557|11453304|FG001|NOT COMPLETED|Phase 1||0
10319031|NCT00219557|11453305|FG002|NOT COMPLETED|Phase 1||0
10319032|NCT00219557|11453303|FG000|STARTED|Phase 2||0
10319033|NCT00219557|11453304|FG001|STARTED|Phase 2||69
10319034|NCT00219557|11453305|FG002|STARTED|Phase 2||34
10319035|NCT00219557|11453303|FG000|Treated|Phase 2||0
10319036|NCT00219557|11453304|FG001|Treated|Phase 2||68
10319037|NCT00219557|11453305|FG002|Treated|Phase 2||31
10319038|NCT00219557|11453303|FG000|COMPLETED|Phase 2||0
10319039|NCT00219557|11453304|FG001|COMPLETED|Phase 2||0
10319040|NCT00219557|11453305|FG002|COMPLETED|Phase 2||1
10319041|NCT00219557|11453303|FG000|NOT COMPLETED|Phase 2||0
10319042|NCT00219557|11453304|FG001|NOT COMPLETED|Phase 2||69
10319043|NCT00219557|11453305|FG002|NOT COMPLETED|Phase 2||33
10319044|NCT00220636|11453314|FG000|STARTED|Overall Study||15
10319045|NCT00220636|11453314|FG000|COMPLETED|Overall Study||11
10319046|NCT00220636|11453314|FG000|NOT COMPLETED|Overall Study||4
10319047|NCT00220701|11453321|FG000|STARTED|Overall Study||17
10319048|NCT00220701|11453322|FG001|STARTED|Overall Study||17
10319049|NCT00220701|11453321|FG000|COMPLETED|Overall Study||12
10319050|NCT00220701|11453322|FG001|COMPLETED|Overall Study||13
10319051|NCT00220701|11453321|FG000|NOT COMPLETED|Overall Study||5
10319052|NCT00220701|11453322|FG001|NOT COMPLETED|Overall Study||4
10319053|NCT00220727|11453330|FG000|STARTED|First Infusion (Week 0)||4
10319054|NCT00220727|11453331|FG001|STARTED|First Infusion (Week 0)||4
10319055|NCT00220727|11453330|FG000|COMPLETED|First Infusion (Week 0)||4
10319056|NCT00220727|11453331|FG001|COMPLETED|First Infusion (Week 0)||4
10319057|NCT00220727|11453330|FG000|NOT COMPLETED|First Infusion (Week 0)||0
10319058|NCT00220727|11453331|FG001|NOT COMPLETED|First Infusion (Week 0)||0
10319059|NCT00220727|11453330|FG000|STARTED|Second Infusion (Week <6)||4
10319060|NCT00220727|11453331|FG001|STARTED|Second Infusion (Week <6)||4
10319061|NCT00220727|11453330|FG000|COMPLETED|Second Infusion (Week <6)||3
10319062|NCT00220727|11453331|FG001|COMPLETED|Second Infusion (Week <6)||4
10319063|NCT00220727|11453330|FG000|NOT COMPLETED|Second Infusion (Week <6)||1
10319064|NCT00220727|11453331|FG001|NOT COMPLETED|Second Infusion (Week <6)||0
10319065|NCT00220740|11453341|FG000|STARTED|Efficacy Period||59
10319066|NCT00220740|11453342|FG001|STARTED|Efficacy Period||58
10319067|NCT00220740|11453341|FG000|COMPLETED|Efficacy Period||33
10319068|NCT00220740|11453342|FG001|COMPLETED|Efficacy Period||12
10319069|NCT00220740|11453341|FG000|NOT COMPLETED|Efficacy Period||26
10319070|NCT00220740|11453342|FG001|NOT COMPLETED|Efficacy Period||46
10701393|NCT02566759|11865815|FG016|COMPLETED|Crossover Treatment (Part 4: 1 Day)||7
10701394|NCT02566759|11865799|FG000|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701395|NCT02566759|11865800|FG001|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701396|NCT02566759|11865801|FG002|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701397|NCT02566759|11865802|FG003|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701398|NCT02566759|11865803|FG004|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701399|NCT02566759|11865804|FG005|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10319071|NCT00220740|11453341|FG000|STARTED|Rescue Treatment|Only the subjects who failed the treatment in the Efficacy period entered the Rescue period.|45
10319072|NCT00220740|11453342|FG001|STARTED|Rescue Treatment|Only the subjects who failed the treatment in the Efficacy period entered the Rescue period.|23
10319073|NCT00220740|11453341|FG000|COMPLETED|Rescue Treatment||26
10319074|NCT00220740|11453342|FG001|COMPLETED|Rescue Treatment||5
10319075|NCT00220740|11453341|FG000|NOT COMPLETED|Rescue Treatment||19
10319076|NCT00220740|11453342|FG001|NOT COMPLETED|Rescue Treatment||18
10319077|NCT00220740|11453341|FG000|STARTED|Withdrawal Period|The subjects who were success in Efficacy or Rescue Period were re-randomized to Withdrawal period.|43
10319078|NCT00220740|11453342|FG001|STARTED|Withdrawal Period|The subjects who were success in Efficacy or Rescue Period were re-randomized to Withdrawal period.|31
10319079|NCT00220740|11453341|FG000|COMPLETED|Withdrawal Period||37
10319080|NCT00220740|11453342|FG001|COMPLETED|Withdrawal Period||16
10319081|NCT00220740|11453341|FG000|NOT COMPLETED|Withdrawal Period||6
10319082|NCT00220740|11453342|FG001|NOT COMPLETED|Withdrawal Period||15
10319083|NCT00220779|11453353|FG000|STARTED|Overall Study||45
10319084|NCT00220779|11453354|FG001|STARTED|Overall Study||42
10319085|NCT00220779|11453355|FG002|STARTED|Overall Study||41
10319086|NCT00220779|11453353|FG000|COMPLETED|Overall Study||38
10319087|NCT00220779|11453354|FG001|COMPLETED|Overall Study||38
10319088|NCT00220779|11453355|FG002|COMPLETED|Overall Study||37
10319089|NCT00220779|11453353|FG000|NOT COMPLETED|Overall Study||7
10319090|NCT00220779|11453354|FG001|NOT COMPLETED|Overall Study||4
10319091|NCT00220779|11453355|FG002|NOT COMPLETED|Overall Study||4
10319092|NCT00220805|11453365|FG000|STARTED|Overall Study||30
10319093|NCT00220805|11453366|FG001|STARTED|Overall Study||27
10319094|NCT00220805|11453365|FG000|COMPLETED|Overall Study||22
10319095|NCT00220805|11453366|FG001|COMPLETED|Overall Study||16
10319096|NCT00220805|11453365|FG000|NOT COMPLETED|Overall Study||8
10319097|NCT00220805|11453366|FG001|NOT COMPLETED|Overall Study||11
10319098|NCT00220961|11453374|FG000|STARTED|Overall Study||299
10319099|NCT00220961|11453375|FG001|STARTED|Overall Study||303
10319100|NCT00220961|11453374|FG000|COMPLETED|Overall Study||228
10319101|NCT00220961|11453375|FG001|COMPLETED|Overall Study||213
10319102|NCT00220961|11453374|FG000|NOT COMPLETED|Overall Study||71
10319103|NCT00220961|11453375|FG001|NOT COMPLETED|Overall Study||90
10319104|NCT00221104|11453383|FG000|STARTED|Overall Study||793
10319105|NCT00221104|11453384|FG001|STARTED|Overall Study||785
10319106|NCT00221104|11453383|FG000|COMPLETED|Overall Study||710
10319107|NCT00221104|11453384|FG001|COMPLETED|Overall Study||709
10319108|NCT00221104|11453383|FG000|NOT COMPLETED|Overall Study||83
10319109|NCT00221104|11453384|FG001|NOT COMPLETED|Overall Study||76
10319110|NCT00221117|11453394|FG000|STARTED|Overall Study||12
10319111|NCT00221117|11453395|FG001|STARTED|Overall Study|One participant dropped out of the study after signing consent but prior to baseline assessments.|9
10319112|NCT00221117|11453394|FG000|COMPLETED|Overall Study||12
10319113|NCT00221117|11453395|FG001|COMPLETED|Overall Study||9
10319114|NCT00221117|11453394|FG000|NOT COMPLETED|Overall Study||0
10319115|NCT00221117|11453395|FG001|NOT COMPLETED|Overall Study||0
10319116|NCT00221195|11453405|FG000|STARTED|Therapy 1 (Months 1-6)||17
10319117|NCT00221195|11453406|FG001|STARTED|Therapy 1 (Months 1-6)||17
10319118|NCT00221195|11453405|FG000|COMPLETED|Therapy 1 (Months 1-6)||14
10319119|NCT00221195|11453406|FG001|COMPLETED|Therapy 1 (Months 1-6)||15
10319120|NCT00221195|11453405|FG000|NOT COMPLETED|Therapy 1 (Months 1-6)||3
10319121|NCT00221195|11453406|FG001|NOT COMPLETED|Therapy 1 (Months 1-6)||2
10319122|NCT00221195|11453405|FG000|STARTED|Washout Period (Months 7-9)||14
10319123|NCT00221195|11453406|FG001|STARTED|Washout Period (Months 7-9)||15
10319124|NCT00221195|11453405|FG000|COMPLETED|Washout Period (Months 7-9)||14
10319125|NCT00221195|11453406|FG001|COMPLETED|Washout Period (Months 7-9)||14
10319126|NCT00221195|11453405|FG000|NOT COMPLETED|Washout Period (Months 7-9)||0
10319127|NCT00221195|11453406|FG001|NOT COMPLETED|Washout Period (Months 7-9)||1
10319128|NCT00221195|11453405|FG000|STARTED|Therapy 2 (Months 10-15)||14
10319129|NCT00221195|11453406|FG001|STARTED|Therapy 2 (Months 10-15)||14
10319130|NCT00221195|11453405|FG000|COMPLETED|Therapy 2 (Months 10-15)||12
10319131|NCT00221195|11453406|FG001|COMPLETED|Therapy 2 (Months 10-15)||14
10319132|NCT00221195|11453405|FG000|NOT COMPLETED|Therapy 2 (Months 10-15)||2
10319133|NCT00221195|11453406|FG001|NOT COMPLETED|Therapy 2 (Months 10-15)||0
10319134|NCT00221299|11453416|FG000|STARTED|Overall Study||11
10319135|NCT00221299|11453417|FG001|STARTED|Overall Study||13
10319136|NCT00221299|11453418|FG002|STARTED|Overall Study||14
10319137|NCT00221299|11453419|FG003|STARTED|Overall Study||11
10319138|NCT00221299|11453416|FG000|COMPLETED|Overall Study||10
10319139|NCT00221299|11453417|FG001|COMPLETED|Overall Study||11
10319140|NCT00221299|11453418|FG002|COMPLETED|Overall Study||14
10319141|NCT00221299|11453419|FG003|COMPLETED|Overall Study||10
10319142|NCT00221299|11453416|FG000|NOT COMPLETED|Overall Study||1
10319143|NCT00221299|11453417|FG001|NOT COMPLETED|Overall Study||2
10319144|NCT00221299|11453418|FG002|NOT COMPLETED|Overall Study||0
10319145|NCT00221299|11453419|FG003|NOT COMPLETED|Overall Study||1
10319146|NCT00221338|11453429|FG000|STARTED|Overall Study||374
10319147|NCT00221338|11453430|FG001|STARTED|Overall Study||376
10319148|NCT00221338|11453429|FG000|COMPLETED|Overall Study||350
10319149|NCT00221338|11453430|FG001|COMPLETED|Overall Study||347
10319150|NCT00221338|11453429|FG000|NOT COMPLETED|Overall Study||24
10319151|NCT00221338|11453430|FG001|NOT COMPLETED|Overall Study||29
10319152|NCT00221403|11453439|FG000|STARTED|Overall Study||18
10319153|NCT00221403|11453440|FG001|STARTED|Overall Study||21
10319154|NCT00221403|11453441|FG002|STARTED|Overall Study||7
10319155|NCT00221403|11453439|FG000|COMPLETED|Overall Study||16
10319156|NCT00221403|11453440|FG001|COMPLETED|Overall Study||16
10319157|NCT00221403|11453441|FG002|COMPLETED|Overall Study||7
10319158|NCT00221403|11453439|FG000|NOT COMPLETED|Overall Study||2
10319159|NCT00221403|11453440|FG001|NOT COMPLETED|Overall Study||5
10319160|NCT00221403|11453441|FG002|NOT COMPLETED|Overall Study||0
10319161|NCT00222105|11453449|FG000|STARTED|Overall Study||25
10319162|NCT00222105|11453449|FG000|COMPLETED|Overall Study||11
10319163|NCT00222105|11453449|FG000|NOT COMPLETED|Overall Study||14
10319164|NCT00222131|11453455|FG000|STARTED|Overall Study||38
10319165|NCT00222131|11453456|FG001|STARTED|Overall Study||35
10319166|NCT00222131|11453455|FG000|COMPLETED|Overall Study||38
10319167|NCT00222131|11453456|FG001|COMPLETED|Overall Study||35
10319168|NCT00222131|11453455|FG000|NOT COMPLETED|Overall Study||0
10319169|NCT00222131|11453456|FG001|NOT COMPLETED|Overall Study||0
10319170|NCT00222729|11453462|FG000|STARTED|Overall Study||40
10319171|NCT00222729|11453462|FG000|COMPLETED|Overall Study||37
10319172|NCT00222729|11453462|FG000|NOT COMPLETED|Overall Study||3
10319173|NCT00223080|11453468|FG000|STARTED|Overall Study||8197
10319174|NCT00223080|11453469|FG001|STARTED|Overall Study||8198
10319175|NCT00223080|11453468|FG000|COMPLETED|Overall Study||7401
10319176|NCT00223080|11453469|FG001|COMPLETED|Overall Study||7401
10319177|NCT00223080|11453468|FG000|NOT COMPLETED|Overall Study||796
10319178|NCT00223080|11453469|FG001|NOT COMPLETED|Overall Study||797
10319179|NCT00223236|11453477|FG000|STARTED|Overall Study|23 completed baseline assessment but 16 completed at least one treatment visit.|16
10319180|NCT00223236|11453478|FG001|STARTED|Overall Study|21 completed baseline assessment but 18 completed at least one treatment visit.|18
10319181|NCT00223236|11453477|FG000|COMPLETED|Overall Study|9 completed 12 week trial.|9
10319182|NCT00223236|11453478|FG001|COMPLETED|Overall Study|4 completed 12 week trial.|4
10319183|NCT00223236|11453477|FG000|NOT COMPLETED|Overall Study||7
10319184|NCT00223236|11453478|FG001|NOT COMPLETED|Overall Study||14
10319185|NCT00223262|11453486|FG000|STARTED|Overall Study||16
10319186|NCT00223262|11453487|FG001|STARTED|Overall Study||12
10319187|NCT00223262|11453486|FG000|COMPLETED|Overall Study||8
10319188|NCT00223262|11453487|FG001|COMPLETED|Overall Study||11
10319189|NCT00223262|11453486|FG000|NOT COMPLETED|Overall Study||8
10319190|NCT00223262|11453487|FG001|NOT COMPLETED|Overall Study||1
10319191|NCT00223496|11453493|FG000|STARTED|Overall Study|32 people consented, 19 were baselined|32
10319192|NCT00223496|11453493|FG000|COMPLETED|Overall Study||10
10319193|NCT00223496|11453493|FG000|NOT COMPLETED|Overall Study||22
10319194|NCT00223652|11453499|FG000|STARTED|T-CBT 12 Weeks, TAU 20 Weeks||41
10319195|NCT00223652|11453500|FG001|STARTED|T-CBT 12 Weeks, TAU 20 Weeks||44
10319196|NCT00223652|11453499|FG000|COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||40
10319197|NCT00223652|11453500|FG001|COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||41
10319198|NCT00223652|11453499|FG000|NOT COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||1
10319199|NCT00223652|11453500|FG001|NOT COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||3
10319200|NCT00223652|11453499|FG000|STARTED|T-CBT 20 Weeks, TAU 20 Weeks||40
10319201|NCT00223652|11453500|FG001|STARTED|T-CBT 20 Weeks, TAU 20 Weeks||41
10319202|NCT00223652|11453499|FG000|COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||40
10319203|NCT00223652|11453500|FG001|COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||41
10319204|NCT00223652|11453499|FG000|NOT COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||0
10319205|NCT00223652|11453500|FG001|NOT COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||0
10319206|NCT00223652|11453499|FG000|STARTED|T-CBT and TAU 6 Month Follow-up||40
10701400|NCT02566759|11865805|FG006|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701401|NCT02566759|11865806|FG007|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701402|NCT02566759|11865807|FG008|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10319207|NCT00223652|11453500|FG001|STARTED|T-CBT and TAU 6 Month Follow-up||41
10319208|NCT00223652|11453499|FG000|COMPLETED|T-CBT and TAU 6 Month Follow-up||39
10319209|NCT00223652|11453500|FG001|COMPLETED|T-CBT and TAU 6 Month Follow-up||37
10319210|NCT00223652|11453499|FG000|NOT COMPLETED|T-CBT and TAU 6 Month Follow-up||1
10319211|NCT00223652|11453500|FG001|NOT COMPLETED|T-CBT and TAU 6 Month Follow-up||4
10319212|NCT00223665|11453507|FG000|STARTED|Overall Study||102
10319213|NCT00223665|11453507|FG000|COMPLETED|Overall Study||102
10319214|NCT00223665|11453507|FG000|NOT COMPLETED|Overall Study||0
10319215|NCT00223678|11453514|FG000|STARTED|Overall Study||13
10319216|NCT00223678|11453515|FG001|STARTED|Overall Study||7
10319217|NCT00223678|11453514|FG000|COMPLETED|Overall Study||13
10319218|NCT00223678|11453515|FG001|COMPLETED|Overall Study||7
10319219|NCT00223678|11453514|FG000|NOT COMPLETED|Overall Study||0
10319220|NCT00223678|11453515|FG001|NOT COMPLETED|Overall Study||0
10319221|NCT00223704|11453524|FG000|STARTED|Overall Study||38
10319222|NCT00223704|11453525|FG001|STARTED|Overall Study||37
10319223|NCT00223704|11453526|FG002|STARTED|Overall Study||40
10319224|NCT00223704|11453524|FG000|COMPLETED|Overall Study||38
10319225|NCT00223704|11453525|FG001|COMPLETED|Overall Study||37
10319226|NCT00223704|11453526|FG002|COMPLETED|Overall Study||40
10319227|NCT00223704|11453524|FG000|NOT COMPLETED|Overall Study||0
10319228|NCT00223704|11453525|FG001|NOT COMPLETED|Overall Study||0
10319229|NCT00223704|11453526|FG002|NOT COMPLETED|Overall Study||0
10319230|NCT00223795|11453534|FG000|STARTED|First Intervention - Eight Weeks||26
10319231|NCT00223795|11453535|FG001|STARTED|First Intervention - Eight Weeks||27
10319232|NCT00223795|11453534|FG000|COMPLETED|First Intervention - Eight Weeks||19
10319233|NCT00223795|11453535|FG001|COMPLETED|First Intervention - Eight Weeks||18
10319234|NCT00223795|11453534|FG000|NOT COMPLETED|First Intervention - Eight Weeks||7
10319235|NCT00223795|11453535|FG001|NOT COMPLETED|First Intervention - Eight Weeks||9
10319236|NCT00223795|11453534|FG000|STARTED|Second Intervention - All Use Canes 4 mo||19
10701403|NCT02566759|11865808|FG009|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701404|NCT02566759|11865809|FG010|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701405|NCT02566759|11865810|FG011|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10319237|NCT00223795|11453535|FG001|STARTED|Second Intervention - All Use Canes 4 mo||18
10319238|NCT00223795|11453534|FG000|COMPLETED|Second Intervention - All Use Canes 4 mo||18
10319239|NCT00223795|11453535|FG001|COMPLETED|Second Intervention - All Use Canes 4 mo||17
10319240|NCT00223795|11453534|FG000|NOT COMPLETED|Second Intervention - All Use Canes 4 mo||1
10319241|NCT00223795|11453535|FG001|NOT COMPLETED|Second Intervention - All Use Canes 4 mo||1
10319242|NCT00223808|11453545|FG000|STARTED|Overall Study||22
10319243|NCT00223808|11453546|FG001|STARTED|Overall Study||22
10319244|NCT00223808|11453547|FG002|STARTED|Overall Study||23
10319245|NCT00223808|11453545|FG000|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|19
10701406|NCT02566759|11865811|FG012|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701407|NCT02566759|11865812|FG013|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701408|NCT02566759|11865813|FG014|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10319246|NCT00223808|11453546|FG001|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|17
10319247|NCT00223808|11453547|FG002|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|18
10319248|NCT00223808|11453545|FG000|NOT COMPLETED|Overall Study||3
10319249|NCT00223808|11453546|FG001|NOT COMPLETED|Overall Study||5
10319250|NCT00223808|11453547|FG002|NOT COMPLETED|Overall Study||5
10319251|NCT00223821|11453557|FG000|STARTED|Overall Study||32
10319252|NCT00223821|11453558|FG001|STARTED|Overall Study||32
10319253|NCT00223821|11453557|FG000|Completed Therapy|Overall Study||31
10319254|NCT00223821|11453558|FG001|Completed Therapy|Overall Study||28
10319255|NCT00223821|11453557|FG000|Completed Post-treatment Assessment|Overall Study||31
10319256|NCT00223821|11453558|FG001|Completed Post-treatment Assessment|Overall Study||27
10319257|NCT00223821|11453557|FG000|Completed 6-month Follow-up|Overall Study||28
10319258|NCT00223821|11453558|FG001|Completed 6-month Follow-up|Overall Study||25
10319259|NCT00223821|11453557|FG000|COMPLETED|Overall Study||28
10319260|NCT00223821|11453558|FG001|COMPLETED|Overall Study||22
10319261|NCT00223821|11453557|FG000|NOT COMPLETED|Overall Study||4
10319262|NCT00223821|11453558|FG001|NOT COMPLETED|Overall Study||10
10319263|NCT00223977|11453567|FG000|STARTED|Overall Study||46
10319264|NCT00223977|11453568|FG001|STARTED|Overall Study||58
10319265|NCT00223977|11453569|FG002|STARTED|Overall Study||42
10319266|NCT00223977|11453567|FG000|COMPLETED|Overall Study||37
10319267|NCT00223977|11453568|FG001|COMPLETED|Overall Study||47
10319268|NCT00223977|11453569|FG002|COMPLETED|Overall Study||39
10319269|NCT00223977|11453567|FG000|NOT COMPLETED|Overall Study||9
10319270|NCT00223977|11453568|FG001|NOT COMPLETED|Overall Study||11
10319271|NCT00223977|11453569|FG002|NOT COMPLETED|Overall Study||3
10319272|NCT00223990|11453579|FG000|STARTED|Overall Study||200
10319273|NCT00223990|11453580|FG001|STARTED|Overall Study||200
10319274|NCT00223990|11453579|FG000|COMPLETED|Overall Study||193
10319275|NCT00223990|11453580|FG001|COMPLETED|Overall Study||191
10319276|NCT00223990|11453579|FG000|NOT COMPLETED|Overall Study||7
10319277|NCT00223990|11453580|FG001|NOT COMPLETED|Overall Study||9
10319278|NCT00224016|11453588|FG000|STARTED|Titration Period||39
10319279|NCT00224016|11453589|FG001|STARTED|Titration Period||16
10319280|NCT00224016|11453588|FG000|COMPLETED|Titration Period||38
10319281|NCT00224016|11453589|FG001|COMPLETED|Titration Period||15
10319282|NCT00224016|11453588|FG000|NOT COMPLETED|Titration Period||1
10319283|NCT00224016|11453589|FG001|NOT COMPLETED|Titration Period||1
10319284|NCT00224016|11453588|FG000|STARTED|Maintenance Period||38
10319285|NCT00224016|11453589|FG001|STARTED|Maintenance Period||15
10319286|NCT00224016|11453588|FG000|COMPLETED|Maintenance Period||36
10319287|NCT00224016|11453589|FG001|COMPLETED|Maintenance Period||14
10319288|NCT00224016|11453588|FG000|NOT COMPLETED|Maintenance Period||2
10319289|NCT00224016|11453589|FG001|NOT COMPLETED|Maintenance Period||1
10319290|NCT00224016|11453588|FG000|STARTED|Follow-Up Period||35
10319291|NCT00224016|11453589|FG001|STARTED|Follow-Up Period|This group of subjects did not proceed to follow-up period.|0
10319292|NCT00224016|11453588|FG000|COMPLETED|Follow-Up Period||35
10319293|NCT00224016|11453589|FG001|COMPLETED|Follow-Up Period||0
10319294|NCT00224016|11453588|FG000|NOT COMPLETED|Follow-Up Period||0
10319295|NCT00224016|11453589|FG001|NOT COMPLETED|Follow-Up Period||0
10319296|NCT00224029|11453595|FG000|STARTED|Overall Study||24
10319297|NCT00224029|11453595|FG000|COMPLETED|Overall Study||18
10319298|NCT00224029|11453595|FG000|NOT COMPLETED|Overall Study||6
10319299|NCT00224042|11453601|FG000|STARTED|Overall Study||26
10319300|NCT00224042|11453602|FG001|STARTED|Overall Study||26
10319301|NCT00224042|11453601|FG000|COMPLETED|Overall Study||20
10319302|NCT00224042|11453602|FG001|COMPLETED|Overall Study||20
10319303|NCT00224042|11453601|FG000|NOT COMPLETED|Overall Study||6
10319304|NCT00224042|11453602|FG001|NOT COMPLETED|Overall Study||6
10319305|NCT00224055|11453610|FG000|STARTED|Overall Study||44
10319306|NCT00224055|11453611|FG001|STARTED|Overall Study||45
10319307|NCT00224055|11453610|FG000|COMPLETED|Overall Study||29
10319308|NCT00224055|11453611|FG001|COMPLETED|Overall Study||31
10319309|NCT00224055|11453610|FG000|NOT COMPLETED|Overall Study||15
10319310|NCT00224055|11453611|FG001|NOT COMPLETED|Overall Study||14
10319311|NCT00224107|11453619|FG000|STARTED|Overall Study||233
10319312|NCT00224107|11453620|FG001|STARTED|Overall Study||228
10319313|NCT00224107|11453619|FG000|COMPLETED|Overall Study||202
10319314|NCT00224107|11453620|FG001|COMPLETED|Overall Study||214
10701409|NCT02566759|11865814|FG015|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701410|NCT02566759|11865815|FG016|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
10701411|NCT02566785|11865876|FG000|STARTED|Overall Study||15
10319315|NCT00224107|11453619|FG000|NOT COMPLETED|Overall Study||31
10319316|NCT00224107|11453620|FG001|NOT COMPLETED|Overall Study||14
10319317|NCT00224120|11453628|FG000|STARTED|Overall Study||233
10319318|NCT00224120|11453629|FG001|STARTED|Overall Study||229
10319319|NCT00224120|11453628|FG000|COMPLETED|Overall Study||211
10319320|NCT00224120|11453629|FG001|COMPLETED|Overall Study||205
10319321|NCT00224120|11453628|FG000|NOT COMPLETED|Overall Study||22
10319322|NCT00224120|11453629|FG001|NOT COMPLETED|Overall Study||24
10319323|NCT00224133|11453635|FG000|STARTED|Overall Study||661
10319324|NCT00224133|11453635|FG000|COMPLETED|Overall Study||435
10319325|NCT00224133|11453635|FG000|NOT COMPLETED|Overall Study||226
10319326|NCT00224289|11453639|FG000|STARTED|Overall Study||17
10701412|NCT02566785|11865877|FG001|STARTED|Overall Study||18
10319327|NCT00224289|11453639|FG000|COMPLETED|Overall Study||17
10319328|NCT00224289|11453639|FG000|NOT COMPLETED|Overall Study||0
10319329|NCT00224484|11453646|FG000|STARTED|Overall Study||2977
10319330|NCT00224484|11453647|FG001|STARTED|Overall Study||1491
10319331|NCT00224484|11453648|FG002|STARTED|Overall Study||1487
10319332|NCT00224484|11453646|FG000|COMPLETED|Overall Study||2831
10319333|NCT00224484|11453647|FG001|COMPLETED|Overall Study||1426
10319334|NCT00224484|11453648|FG002|COMPLETED|Overall Study||1425
10319335|NCT00224484|11453646|FG000|NOT COMPLETED|Overall Study||146
10319336|NCT00224484|11453647|FG001|NOT COMPLETED|Overall Study||65
10319337|NCT00224484|11453648|FG002|NOT COMPLETED|Overall Study||62
10319338|NCT00224770|11453662|FG000|STARTED|Overall Study||42
10319339|NCT00224770|11453663|FG001|STARTED|Overall Study||54
10319340|NCT00224770|11453664|FG002|STARTED|Overall Study||14
10319341|NCT00224770|11453662|FG000|COMPLETED|Overall Study||38
10319342|NCT00224770|11453663|FG001|COMPLETED|Overall Study||52
10319343|NCT00224770|11453664|FG002|COMPLETED|Overall Study||14
10319344|NCT00224770|11453662|FG000|NOT COMPLETED|Overall Study||4
10319345|NCT00224770|11453663|FG001|NOT COMPLETED|Overall Study||2
10319346|NCT00224770|11453664|FG002|NOT COMPLETED|Overall Study||0
10319347|NCT00224874|11453677|FG000|STARTED|Overall Study||46
10319348|NCT00224874|11453678|FG001|STARTED|Overall Study||45
10319349|NCT00224874|11453679|FG002|STARTED|Overall Study||47
10319350|NCT00224874|11453680|FG003|STARTED|Overall Study||42
10319351|NCT00224874|11453677|FG000|COMPLETED|Overall Study||46
10319352|NCT00224874|11453678|FG001|COMPLETED|Overall Study||45
10319353|NCT00224874|11453679|FG002|COMPLETED|Overall Study||46
10319354|NCT00224874|11453680|FG003|COMPLETED|Overall Study||42
10319355|NCT00224874|11453677|FG000|NOT COMPLETED|Overall Study||0
10319356|NCT00224874|11453678|FG001|NOT COMPLETED|Overall Study||0
10319357|NCT00224874|11453679|FG002|NOT COMPLETED|Overall Study||1
10319358|NCT00224874|11453680|FG003|NOT COMPLETED|Overall Study||0
10319359|NCT00224887|11453692|FG000|STARTED|Overall Study||154
10319360|NCT00224887|11453693|FG001|STARTED|Overall Study||153
10319361|NCT00224887|11453692|FG000|COMPLETED|Overall Study||148
10319362|NCT00224887|11453693|FG001|COMPLETED|Overall Study||147
10319363|NCT00224887|11453692|FG000|NOT COMPLETED|Overall Study||6
10319364|NCT00224887|11453693|FG001|NOT COMPLETED|Overall Study||6
10319365|NCT00224952|11453702|FG000|STARTED|Overall Study||53
10319366|NCT00224952|11453703|FG001|STARTED|Overall Study||87
10319367|NCT00224952|11453704|FG002|STARTED|Overall Study||134
10319368|NCT00224952|11453702|FG000|COMPLETED|Overall Study||53
10319369|NCT00224952|11453703|FG001|COMPLETED|Overall Study||87
10319370|NCT00224952|11453704|FG002|COMPLETED|Overall Study||134
10319371|NCT00224952|11453702|FG000|NOT COMPLETED|Overall Study||0
10319372|NCT00224952|11453703|FG001|NOT COMPLETED|Overall Study||0
10319373|NCT00224952|11453704|FG002|NOT COMPLETED|Overall Study||0
10319374|NCT00225017|11453715|FG000|STARTED|Overall Study||26
10319375|NCT00225017|11453716|FG001|STARTED|Overall Study||24
10319376|NCT00225017|11453715|FG000|COMPLETED|Overall Study||26
10319377|NCT00225017|11453716|FG001|COMPLETED|Overall Study|1 subject did not complete week 24 assessments|23
10319378|NCT00225017|11453715|FG000|NOT COMPLETED|Overall Study||0
10319379|NCT00225017|11453716|FG001|NOT COMPLETED|Overall Study||1
10319380|NCT00225147|11453726|FG000|STARTED|Double-blind Phase||13
10319381|NCT00225147|11453727|FG001|STARTED|Double-blind Phase||12
10319382|NCT00225147|11453728|FG002|STARTED|Double-blind Phase||13
10319383|NCT00225147|11453729|FG003|STARTED|Double-blind Phase||0
10319384|NCT00225147|11453726|FG000|COMPLETED|Double-blind Phase||13
10319385|NCT00225147|11453727|FG001|COMPLETED|Double-blind Phase||12
10319386|NCT00225147|11453728|FG002|COMPLETED|Double-blind Phase||13
10319387|NCT00225147|11453729|FG003|COMPLETED|Double-blind Phase||0
10319388|NCT00225147|11453726|FG000|NOT COMPLETED|Double-blind Phase||0
10319389|NCT00225147|11453727|FG001|NOT COMPLETED|Double-blind Phase||0
10319390|NCT00225147|11453728|FG002|NOT COMPLETED|Double-blind Phase||0
10319391|NCT00225147|11453729|FG003|NOT COMPLETED|Double-blind Phase||0
10319392|NCT00225147|11453726|FG000|STARTED|Open-label Phase||0
10319393|NCT00225147|11453727|FG001|STARTED|Open-label Phase||0
10319394|NCT00225147|11453728|FG002|STARTED|Open-label Phase||0
10319395|NCT00225147|11453729|FG003|STARTED|Open-label Phase||62
10319396|NCT00225147|11453726|FG000|COMPLETED|Open-label Phase||0
10701413|NCT02566785|11865876|FG000|COMPLETED|Overall Study||14
10701414|NCT02566785|11865877|FG001|COMPLETED|Overall Study||15
10701415|NCT02566785|11865876|FG000|NOT COMPLETED|Overall Study||1
10319397|NCT00225147|11453727|FG001|COMPLETED|Open-label Phase||0
10319398|NCT00225147|11453728|FG002|COMPLETED|Open-label Phase||0
10319399|NCT00225147|11453729|FG003|COMPLETED|Open-label Phase||52
10319400|NCT00225147|11453726|FG000|NOT COMPLETED|Open-label Phase||0
10319401|NCT00225147|11453727|FG001|NOT COMPLETED|Open-label Phase||0
10319402|NCT00225147|11453728|FG002|NOT COMPLETED|Open-label Phase||0
10319403|NCT00225147|11453729|FG003|NOT COMPLETED|Open-label Phase||10
10319404|NCT00225212|11453741|FG000|STARTED|Overall Study||35
10319405|NCT00225212|11453741|FG000|COMPLETED|Overall Study||29
10319406|NCT00225212|11453741|FG000|NOT COMPLETED|Overall Study||6
10319407|NCT00225251|11453747|FG000|STARTED|Overall Study||11
10319408|NCT00225251|11453748|FG001|STARTED|Overall Study||7
10319409|NCT00225251|11453747|FG000|COMPLETED|Overall Study||10
10319410|NCT00225251|11453748|FG001|COMPLETED|Overall Study||6
10319411|NCT00225251|11453747|FG000|NOT COMPLETED|Overall Study||1
10319412|NCT00225251|11453748|FG001|NOT COMPLETED|Overall Study||1
10319413|NCT00225277|11453756|FG000|STARTED|Overall Study|274 subjects randomized, but four subjects did not receive drug.|274
10701416|NCT02566785|11865877|FG001|NOT COMPLETED|Overall Study||3
10319414|NCT00225277|11453757|FG001|STARTED|Overall Study|Mean treatment durations were 56.3 weeks (glimepiride) and 56.5 weeks (pioglitazone).|273
10319415|NCT00225277|11453756|FG000|COMPLETED|Overall Study||177
10319416|NCT00225277|11453757|FG001|COMPLETED|Overall Study||178
10319417|NCT00225277|11453756|FG000|NOT COMPLETED|Overall Study||97
10319418|NCT00225277|11453757|FG001|NOT COMPLETED|Overall Study||95
10319419|NCT00225420|11453763|FG000|STARTED|Overall Study||9
10319420|NCT00225420|11453764|FG001|STARTED|Overall Study||6
10319421|NCT00225420|11453765|FG002|STARTED|Overall Study||3
10319422|NCT00225420|11453763|FG000|COMPLETED|Overall Study||9
10319423|NCT00225420|11453764|FG001|COMPLETED|Overall Study||6
10319424|NCT00225420|11453765|FG002|COMPLETED|Overall Study||3
10319425|NCT00225420|11453763|FG000|NOT COMPLETED|Overall Study||0
10319426|NCT00225420|11453764|FG001|NOT COMPLETED|Overall Study||0
10319427|NCT00225420|11453765|FG002|NOT COMPLETED|Overall Study||0
10319428|NCT00225498|11453772|FG000|STARTED|Overall Study||10
10319429|NCT00225498|11453772|FG000|COMPLETED|Overall Study|The only analyses with adequate statistical power were of the 10 ziprasidone nonresponders.|10
10319430|NCT00225498|11453772|FG000|NOT COMPLETED|Overall Study||0
10701417|NCT02566889|11865885|FG000|STARTED|Overall Study||45
10701418|NCT02566889|11865886|FG001|STARTED|Overall Study||8
10701419|NCT02566889|11865885|FG000|Cross-over to Dose Escalation Group|Overall Study||1
10701420|NCT02566889|11865886|FG001|Cross-over to Dose Escalation Group|Overall Study||0
10701421|NCT02566889|11865885|FG000|COMPLETED|Overall Study||32
10701422|NCT02566889|11865886|FG001|COMPLETED|Overall Study||3
10701423|NCT02566889|11865885|FG000|NOT COMPLETED|Overall Study||13
10701424|NCT02566889|11865886|FG001|NOT COMPLETED|Overall Study||5
10701425|NCT02566902|11865893|FG000|STARTED|Overall Study||60
10701426|NCT02566902|11865894|FG001|STARTED|Overall Study||58
10701427|NCT02566902|11865893|FG000|COMPLETED|Overall Study||58
10701428|NCT02566902|11865894|FG001|COMPLETED|Overall Study||57
10701429|NCT02566902|11865893|FG000|NOT COMPLETED|Overall Study||2
10701430|NCT02566902|11865894|FG001|NOT COMPLETED|Overall Study||1
10701431|NCT02566993|11865902|FG000|STARTED|Overall Study||307
10319431|NCT00225732|11453778|FG000|STARTED|Overall Study||153
10319432|NCT00225732|11453779|FG001|STARTED|Overall Study||166
10319433|NCT00225732|11453778|FG000|COMPLETED|Overall Study||153
10319434|NCT00225732|11453779|FG001|COMPLETED|Overall Study||166
10319435|NCT00225732|11453778|FG000|NOT COMPLETED|Overall Study||0
10319436|NCT00225732|11453779|FG001|NOT COMPLETED|Overall Study||0
10319437|NCT00225758|11453785|FG000|STARTED|Overall Study||27
10319438|NCT00225758|11453785|FG000|COMPLETED|Overall Study||23
10319439|NCT00225758|11453785|FG000|NOT COMPLETED|Overall Study||4
10319440|NCT00225784|11453791|FG000|STARTED|Overall Study||37
10319441|NCT00225784|11453791|FG000|COMPLETED|Overall Study||33
10319442|NCT00225784|11453791|FG000|NOT COMPLETED|Overall Study||4
10319443|NCT00226239|11453798|FG000|STARTED|TPE, Induction Therapy||39
10319444|NCT00226239|11453798|FG000|COMPLETED|TPE, Induction Therapy||37
10319445|NCT00226239|11453798|FG000|NOT COMPLETED|TPE, Induction Therapy||2
10319446|NCT00226239|11453798|FG000|STARTED|XPE, Definitive Therapy||37
10319447|NCT00226239|11453798|FG000|COMPLETED|XPE, Definitive Therapy||33
10319448|NCT00226239|11453798|FG000|NOT COMPLETED|XPE, Definitive Therapy||4
10319449|NCT00226239|11453798|FG000|STARTED|Maintenance Cetuximab||31
10319450|NCT00226239|11453798|FG000|COMPLETED|Maintenance Cetuximab||17
10319451|NCT00226239|11453798|FG000|NOT COMPLETED|Maintenance Cetuximab||14
10319452|NCT00226499|11453806|FG000|STARTED|Overall Study||2489
10319453|NCT00226499|11453807|FG001|STARTED|Overall Study||2487
10319454|NCT00226499|11453808|FG002|STARTED|Overall Study||827
10319455|NCT00226499|11453806|FG000|COMPLETED|Overall Study||1415
10319456|NCT00226499|11453807|FG001|COMPLETED|Overall Study||1415
10319457|NCT00226499|11453808|FG002|COMPLETED|Overall Study||468
10319458|NCT00226499|11453806|FG000|NOT COMPLETED|Overall Study||1074
10319459|NCT00226499|11453807|FG001|NOT COMPLETED|Overall Study||1072
10319460|NCT00226499|11453808|FG002|NOT COMPLETED|Overall Study||359
10319461|NCT00226577|11453818|FG000|STARTED|Overall Study||52
10319462|NCT00226577|11453818|FG000|COMPLETED|Overall Study||52
10319463|NCT00226577|11453818|FG000|NOT COMPLETED|Overall Study||0
10319464|NCT00226590|11453822|FG000|STARTED|Overall Study||39
10319465|NCT00226590|11453822|FG000|COMPLETED|Overall Study||39
10319466|NCT00226590|11453822|FG000|NOT COMPLETED|Overall Study||0
10701432|NCT02566993|11865903|FG001|STARTED|Overall Study||306
10701433|NCT02566993|11865902|FG000|COMPLETED|Overall Study||0
10701434|NCT02566993|11865903|FG001|COMPLETED|Overall Study||0
10319467|NCT00226655|11453827|FG000|STARTED|Overall Study||112
10319468|NCT00226655|11453827|FG000|COMPLETED|Overall Study||33
10319469|NCT00226655|11453827|FG000|NOT COMPLETED|Overall Study||79
10319470|NCT00226811|11453831|FG000|STARTED|Overall Study||78
10319471|NCT00226811|11453831|FG000|COMPLETED|Overall Study||2
10319472|NCT00226811|11453831|FG000|NOT COMPLETED|Overall Study||76
10319473|NCT00226941|11453839|FG000|STARTED|Overall Study||6
10319474|NCT00226941|11453840|FG001|STARTED|Overall Study||6
10319475|NCT00226941|11453841|FG002|STARTED|Overall Study||4
10319476|NCT00226941|11453842|FG003|STARTED|Overall Study||7
10319477|NCT00226941|11453839|FG000|COMPLETED|Overall Study||6
10319478|NCT00226941|11453840|FG001|COMPLETED|Overall Study||6
10319479|NCT00226941|11453841|FG002|COMPLETED|Overall Study||4
10319480|NCT00226941|11453842|FG003|COMPLETED|Overall Study||5
10319481|NCT00226941|11453839|FG000|NOT COMPLETED|Overall Study||0
10701435|NCT02566993|11865902|FG000|NOT COMPLETED|Overall Study||307
10701436|NCT02566993|11865903|FG001|NOT COMPLETED|Overall Study||306
10701437|NCT02567188|11865911|FG000|STARTED|Overall Study||144
10701438|NCT02567188|11865911|FG000|COMPLETED|Overall Study||109
10319482|NCT00226941|11453840|FG001|NOT COMPLETED|Overall Study||0
10319483|NCT00226941|11453841|FG002|NOT COMPLETED|Overall Study||0
10319484|NCT00226941|11453842|FG003|NOT COMPLETED|Overall Study||2
10319485|NCT00227019|11453858|FG000|STARTED|Overall Study||16
10319486|NCT00227019|11453858|FG000|COMPLETED|Overall Study||16
10319487|NCT00227019|11453858|FG000|NOT COMPLETED|Overall Study||0
10319488|NCT00227266|11453866|FG000|STARTED|Overall Study||31
10319489|NCT00227266|11453867|FG001|STARTED|Overall Study||30
10319490|NCT00227266|11453868|FG002|STARTED|Overall Study||33
10319491|NCT00227266|11453866|FG000|COMPLETED|Overall Study||30
10319492|NCT00227266|11453867|FG001|COMPLETED|Overall Study||30
10319493|NCT00227266|11453868|FG002|COMPLETED|Overall Study||29
10319494|NCT00227266|11453866|FG000|NOT COMPLETED|Overall Study||1
10319495|NCT00227266|11453867|FG001|NOT COMPLETED|Overall Study||0
10319496|NCT00227266|11453868|FG002|NOT COMPLETED|Overall Study||4
10319497|NCT00227305|11453879|FG000|STARTED|Overall Study|enrolled|381
10319498|NCT00227305|11453879|FG000|Drug Received|Overall Study|safety population|380
10319499|NCT00227305|11453879|FG000|COMPLETED|Overall Study|Completed 26 weeks|237
10319500|NCT00227305|11453879|FG000|NOT COMPLETED|Overall Study||144
10319501|NCT00227344|11453885|FG000|STARTED|Overall Study||87
10319502|NCT00227344|11453886|FG001|STARTED|Overall Study||42
10319503|NCT00227344|11453885|FG000|COMPLETED|Overall Study||75
10319504|NCT00227344|11453886|FG001|COMPLETED|Overall Study||37
10319505|NCT00227344|11453885|FG000|NOT COMPLETED|Overall Study||12
10319506|NCT00227344|11453886|FG001|NOT COMPLETED|Overall Study||5
10319507|NCT00227370|11453894|FG000|STARTED|Overall Study|Placebo Group|66
10319508|NCT00227370|11453895|FG001|STARTED|Overall Study|Treatment Group|70
10319509|NCT00227370|11453894|FG000|COMPLETED|Overall Study||45
10319510|NCT00227370|11453895|FG001|COMPLETED|Overall Study||46
10319511|NCT00227370|11453894|FG000|NOT COMPLETED|Overall Study||21
10319512|NCT00227370|11453895|FG001|NOT COMPLETED|Overall Study||24
10319513|NCT00227539|11453901|FG000|STARTED|Overall Study||25
10319514|NCT00227539|11453901|FG000|COMPLETED|Overall Study||24
10319515|NCT00227539|11453901|FG000|NOT COMPLETED|Overall Study||1
10319516|NCT00227591|11453905|FG000|STARTED|Overall Study|48 pts registered to the study|48
10319517|NCT00227591|11453905|FG000|Began Treatment|Overall Study||47
10319518|NCT00227591|11453905|FG000|COMPLETED|Overall Study||47
10319519|NCT00227591|11453905|FG000|NOT COMPLETED|Overall Study||1
10319520|NCT00227617|11453909|FG000|STARTED|Stage 1||22
10319521|NCT00227617|11453910|FG001|STARTED|Stage 1||12
10319522|NCT00227617|11453911|FG002|STARTED|Stage 1||2
10319523|NCT00227617|11453909|FG000|COMPLETED|Stage 1||22
10319524|NCT00227617|11453910|FG001|COMPLETED|Stage 1||12
10319525|NCT00227617|11453911|FG002|COMPLETED|Stage 1||2
10319526|NCT00227617|11453909|FG000|NOT COMPLETED|Stage 1||0
10319527|NCT00227617|11453910|FG001|NOT COMPLETED|Stage 1||0
10701439|NCT02567188|11865911|FG000|NOT COMPLETED|Overall Study||35
10701440|NCT02567227|11865918|FG000|STARTED|9 Weeks||192
10319528|NCT00227617|11453911|FG002|NOT COMPLETED|Stage 1||0
10319529|NCT00227617|11453909|FG000|STARTED|Stage 2||0
10319530|NCT00227617|11453910|FG001|STARTED|Stage 2||0
10319531|NCT00227617|11453911|FG002|STARTED|Stage 2||0
10319532|NCT00227617|11453909|FG000|COMPLETED|Stage 2||0
10319533|NCT00227617|11453910|FG001|COMPLETED|Stage 2||0
10319534|NCT00227617|11453911|FG002|COMPLETED|Stage 2||0
10319535|NCT00227617|11453909|FG000|NOT COMPLETED|Stage 2||0
10319536|NCT00227617|11453910|FG001|NOT COMPLETED|Stage 2||0
10319537|NCT00227617|11453911|FG002|NOT COMPLETED|Stage 2||0
10319538|NCT00227721|11453923|FG000|STARTED|Overall Study||30
10319539|NCT00227721|11453923|FG000|COMPLETED|Overall Study||29
10319540|NCT00227721|11453923|FG000|NOT COMPLETED|Overall Study||1
10319541|NCT00227760|11453927|FG000|STARTED|Overall Study||44
10319542|NCT00227760|11453927|FG000|COMPLETED|Overall Study||44
10319543|NCT00227760|11453927|FG000|NOT COMPLETED|Overall Study||0
10319544|NCT00227877|11453935|FG000|STARTED|Pre-visit Assessment||1075
10319545|NCT00227877|11453936|FG001|STARTED|Pre-visit Assessment||1031
10319546|NCT00227877|11453937|FG002|STARTED|Pre-visit Assessment||297
10319547|NCT00227877|11453938|FG003|STARTED|Pre-visit Assessment||292
10319548|NCT00227877|11453935|FG000|COMPLETED|Pre-visit Assessment|Final analysis sample|1068
10319549|NCT00227877|11453936|FG001|COMPLETED|Pre-visit Assessment|Final analysis sample|1028
10319550|NCT00227877|11453937|FG002|COMPLETED|Pre-visit Assessment|Final analysis sample|297
10319551|NCT00227877|11453938|FG003|COMPLETED|Pre-visit Assessment|Final analysis sample|292
10319552|NCT00227877|11453935|FG000|NOT COMPLETED|Pre-visit Assessment||7
10701441|NCT02567227|11865919|FG001|STARTED|9 Weeks||191
10319553|NCT00227877|11453936|FG001|NOT COMPLETED|Pre-visit Assessment||3
10319554|NCT00227877|11453937|FG002|NOT COMPLETED|Pre-visit Assessment||0
10319555|NCT00227877|11453938|FG003|NOT COMPLETED|Pre-visit Assessment||0
10319556|NCT00227877|11453935|FG000|STARTED|Post-visit Checklist||1068
10319557|NCT00227877|11453936|FG001|STARTED|Post-visit Checklist||1028
10319558|NCT00227877|11453937|FG002|STARTED|Post-visit Checklist||297
10319559|NCT00227877|11453938|FG003|STARTED|Post-visit Checklist||292
10319560|NCT00227877|11453935|FG000|COMPLETED|Post-visit Checklist||1044
10319561|NCT00227877|11453936|FG001|COMPLETED|Post-visit Checklist||1015
10319562|NCT00227877|11453937|FG002|COMPLETED|Post-visit Checklist||296
10319563|NCT00227877|11453938|FG003|COMPLETED|Post-visit Checklist||292
10319564|NCT00227877|11453935|FG000|NOT COMPLETED|Post-visit Checklist||24
10319565|NCT00227877|11453936|FG001|NOT COMPLETED|Post-visit Checklist||13
10319566|NCT00227877|11453937|FG002|NOT COMPLETED|Post-visit Checklist||1
10319567|NCT00227877|11453938|FG003|NOT COMPLETED|Post-visit Checklist||0
10319568|NCT00227877|11453935|FG000|STARTED|3-months Follow-up||1068
10319569|NCT00227877|11453936|FG001|STARTED|3-months Follow-up||1028
10319570|NCT00227877|11453937|FG002|STARTED|3-months Follow-up||297
10319571|NCT00227877|11453938|FG003|STARTED|3-months Follow-up||292
10319572|NCT00227877|11453935|FG000|COMPLETED|3-months Follow-up||755
10319573|NCT00227877|11453936|FG001|COMPLETED|3-months Follow-up||761
10319574|NCT00227877|11453937|FG002|COMPLETED|3-months Follow-up||245
10319575|NCT00227877|11453938|FG003|COMPLETED|3-months Follow-up||271
10319576|NCT00227877|11453935|FG000|NOT COMPLETED|3-months Follow-up||313
10319577|NCT00227877|11453936|FG001|NOT COMPLETED|3-months Follow-up||267
10319578|NCT00227877|11453937|FG002|NOT COMPLETED|3-months Follow-up||52
10319579|NCT00227877|11453938|FG003|NOT COMPLETED|3-months Follow-up||21
10319580|NCT00227877|11453935|FG000|STARTED|12-months Follow-up||1068
10319581|NCT00227877|11453936|FG001|STARTED|12-months Follow-up||1028
10319582|NCT00227877|11453937|FG002|STARTED|12-months Follow-up||297
10319583|NCT00227877|11453938|FG003|STARTED|12-months Follow-up||292
10319584|NCT00227877|11453935|FG000|COMPLETED|12-months Follow-up||758
10319585|NCT00227877|11453936|FG001|COMPLETED|12-months Follow-up||765
10319586|NCT00227877|11453937|FG002|COMPLETED|12-months Follow-up||266
10319587|NCT00227877|11453938|FG003|COMPLETED|12-months Follow-up||266
10319588|NCT00227877|11453935|FG000|NOT COMPLETED|12-months Follow-up||310
10319589|NCT00227877|11453936|FG001|NOT COMPLETED|12-months Follow-up||263
10319590|NCT00227877|11453937|FG002|NOT COMPLETED|12-months Follow-up||31
10319591|NCT00227877|11453938|FG003|NOT COMPLETED|12-months Follow-up||26
10319592|NCT00227903|11453952|FG000|STARTED|Overall Study||91
10319593|NCT00227903|11453953|FG001|STARTED|Overall Study||92
10319594|NCT00227903|11453952|FG000|Received ≥ 1 Follow-up Assessment|Overall Study|1 participant did not receive any treatment sessions.|86
10319595|NCT00227903|11453953|FG001|Received ≥ 1 Follow-up Assessment|Overall Study|4 participants did not receive any treatment sessions.|82
10319596|NCT00227903|11453952|FG000|COMPLETED|Overall Study|Participants with at least 1 follow-up assessment were analyzed|86
10319597|NCT00227903|11453953|FG001|COMPLETED|Overall Study|Participants with at least 1 follow-up assessment were analyzed|82
10319598|NCT00227903|11453952|FG000|NOT COMPLETED|Overall Study||5
10319599|NCT00227903|11453953|FG001|NOT COMPLETED|Overall Study||10
10319600|NCT00227994|11453961|FG000|STARTED|Overall Study||20
10319601|NCT00227994|11453962|FG001|STARTED|Overall Study||20
10319602|NCT00227994|11453961|FG000|COMPLETED|Overall Study||13
10319603|NCT00227994|11453962|FG001|COMPLETED|Overall Study||13
10319604|NCT00227994|11453961|FG000|NOT COMPLETED|Overall Study||7
10319605|NCT00227994|11453962|FG001|NOT COMPLETED|Overall Study||7
10319606|NCT00228384|11453970|FG000|STARTED|Overall Study||72
10319607|NCT00228384|11453971|FG001|STARTED|Overall Study||76
10319608|NCT00228384|11453970|FG000|Baseline|Overall Study||72
10319609|NCT00228384|11453971|FG001|Baseline|Overall Study||76
10319610|NCT00228384|11453970|FG000|30-Day Follow-up (Safety Outcome)|Overall Study||69
10319611|NCT00228384|11453971|FG001|30-Day Follow-up (Safety Outcome)|Overall Study||72
10319612|NCT00228384|11453970|FG000|Three Year Follow-up (Final)|Overall Study||43
10319613|NCT00228384|11453971|FG001|Three Year Follow-up (Final)|Overall Study||47
10319614|NCT00228384|11453970|FG000|COMPLETED|Overall Study||43
10319615|NCT00228384|11453971|FG001|COMPLETED|Overall Study||47
10319616|NCT00228384|11453970|FG000|NOT COMPLETED|Overall Study||29
10319617|NCT00228384|11453971|FG001|NOT COMPLETED|Overall Study||29
10319618|NCT00228423|11453979|FG000|STARTED|Overall Study||56
10319619|NCT00228423|11453980|FG001|STARTED|Overall Study||57
10319620|NCT00228423|11453979|FG000|COMPLETED|Overall Study||46
10319621|NCT00228423|11453980|FG001|COMPLETED|Overall Study||45
10319622|NCT00228423|11453979|FG000|NOT COMPLETED|Overall Study||10
10319623|NCT00228423|11453980|FG001|NOT COMPLETED|Overall Study||12
10319624|NCT00228553|11453986|FG000|STARTED|Overall Study||743
10319625|NCT00228553|11453986|FG000|COMPLETED|Overall Study||313
10455605|NCT01003184|11603699|FG001|Full Analysis Set (FAS)|Overall Study||105
10455606|NCT01003184|11603698|FG000|COMPLETED|Overall Study||92
10455607|NCT01003184|11603699|FG001|COMPLETED|Overall Study||99
10455608|NCT01003184|11603698|FG000|NOT COMPLETED|Overall Study||19
10455609|NCT01003184|11603699|FG001|NOT COMPLETED|Overall Study||12
10455610|NCT01003210|11603707|FG000|STARTED|Overall Study||105
10455611|NCT01003210|11603708|FG001|STARTED|Overall Study||105
10455612|NCT01003210|11603707|FG000|COMPLETED|Overall Study||104
10455613|NCT01003210|11603708|FG001|COMPLETED|Overall Study||102
10455614|NCT01003210|11603707|FG000|NOT COMPLETED|Overall Study||1
10455615|NCT01003210|11603708|FG001|NOT COMPLETED|Overall Study||3
10455616|NCT01003249|11603714|FG000|STARTED|First Intervention (4 Weeks)||7
10455617|NCT01003249|11603715|FG001|STARTED|First Intervention (4 Weeks)||5
10455618|NCT01003249|11603714|FG000|Received Intervention|First Intervention (4 Weeks)||7
10455619|NCT01003249|11603715|FG001|Received Intervention|First Intervention (4 Weeks)||5
10455620|NCT01003249|11603714|FG000|COMPLETED|First Intervention (4 Weeks)||5
10319626|NCT00228553|11453986|FG000|NOT COMPLETED|Overall Study||430
10319627|NCT00228566|11453990|FG000|STARTED|Overall Study||247
10319628|NCT00228566|11453990|FG000|COMPLETED|Overall Study||176
10319629|NCT00228566|11453990|FG000|NOT COMPLETED|Overall Study||71
10319630|NCT00228813|11453994|FG000|STARTED|Overall Study||8
10319631|NCT00228813|11453994|FG000|COMPLETED|Overall Study||4
10319632|NCT00228813|11453994|FG000|NOT COMPLETED|Overall Study||4
10319633|NCT00228917|11454006|FG000|STARTED|Overall Study||193
10319634|NCT00228917|11454007|FG001|STARTED|Overall Study||96
10319635|NCT00228917|11454008|FG002|STARTED|Overall Study||65
10319636|NCT00228917|11454009|FG003|STARTED|Overall Study||33
10319637|NCT00228917|11454010|FG004|STARTED|Overall Study||205
10455621|NCT01003249|11603715|FG001|COMPLETED|First Intervention (4 Weeks)||3
10319638|NCT00228917|11454011|FG005|STARTED|Overall Study||104
10319639|NCT00228917|11454012|FG006|STARTED|Overall Study||69
10319640|NCT00228917|11454013|FG007|STARTED|Overall Study||33
10319641|NCT00228917|11454006|FG000|COMPLETED|Overall Study||193
10319642|NCT00228917|11454007|FG001|COMPLETED|Overall Study||96
10319643|NCT00228917|11454008|FG002|COMPLETED|Overall Study||65
10701442|NCT02567227|11865918|FG000|COMPLETED|9 Weeks||158
10319644|NCT00228917|11454009|FG003|COMPLETED|Overall Study||33
10319645|NCT00228917|11454010|FG004|COMPLETED|Overall Study||205
10319646|NCT00228917|11454011|FG005|COMPLETED|Overall Study||102
10319647|NCT00228917|11454012|FG006|COMPLETED|Overall Study||69
10319648|NCT00228917|11454013|FG007|COMPLETED|Overall Study||33
10319649|NCT00228917|11454006|FG000|NOT COMPLETED|Overall Study||0
10319650|NCT00228917|11454007|FG001|NOT COMPLETED|Overall Study||0
10319651|NCT00228917|11454008|FG002|NOT COMPLETED|Overall Study||0
10319652|NCT00228917|11454009|FG003|NOT COMPLETED|Overall Study||0
10319653|NCT00228917|11454010|FG004|NOT COMPLETED|Overall Study||0
10319654|NCT00228917|11454011|FG005|NOT COMPLETED|Overall Study||2
10319655|NCT00228917|11454012|FG006|NOT COMPLETED|Overall Study||0
10319656|NCT00228917|11454013|FG007|NOT COMPLETED|Overall Study||0
10319657|NCT00228943|11454027|FG000|STARTED|Week 1||28
10319658|NCT00228943|11454027|FG000|COMPLETED|Week 1||28
10319659|NCT00228943|11454027|FG000|NOT COMPLETED|Week 1||0
10319660|NCT00228943|11454027|FG000|STARTED|Week 2||28
10319661|NCT00228943|11454027|FG000|COMPLETED|Week 2||27
10455622|NCT01003249|11603714|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2
10455623|NCT01003249|11603715|FG001|NOT COMPLETED|First Intervention (4 Weeks)||2
10455624|NCT01003249|11603714|FG000|STARTED|Washout (3 Weeks)||4
10455625|NCT01003249|11603715|FG001|STARTED|Washout (3 Weeks)||3
10455626|NCT01003249|11603714|FG000|COMPLETED|Washout (3 Weeks)||4
10455627|NCT01003249|11603715|FG001|COMPLETED|Washout (3 Weeks)||3
10455628|NCT01003249|11603714|FG000|NOT COMPLETED|Washout (3 Weeks)||0
10455629|NCT01003249|11603715|FG001|NOT COMPLETED|Washout (3 Weeks)||0
10455630|NCT01003249|11603714|FG000|STARTED|Second Intervention (4 Weeks)||4
10455631|NCT01003249|11603715|FG001|STARTED|Second Intervention (4 Weeks)||3
10455632|NCT01003249|11603714|FG000|COMPLETED|Second Intervention (4 Weeks)||3
10455633|NCT01003249|11603715|FG001|COMPLETED|Second Intervention (4 Weeks)||2
10455634|NCT01003249|11603714|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1
10455635|NCT01003249|11603715|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1
10455636|NCT01003275|11603727|FG000|STARTED|Overall Study||11
10455637|NCT01003275|11603728|FG001|STARTED|Overall Study||11
10455638|NCT01003275|11603727|FG000|COMPLETED|Overall Study||10
10455639|NCT01003275|11603728|FG001|COMPLETED|Overall Study||11
10455640|NCT01003275|11603727|FG000|NOT COMPLETED|Overall Study||1
10455641|NCT01003275|11603728|FG001|NOT COMPLETED|Overall Study||0
10455642|NCT01003288|11603736|FG000|STARTED|Overall Study||255
10455643|NCT01003288|11603736|FG000|COMPLETED|Overall Study||255
10455644|NCT01003288|11603736|FG000|NOT COMPLETED|Overall Study||0
10455645|NCT01003301|11603743|FG000|STARTED|Overall Study||10
10455646|NCT01003301|11603744|FG001|STARTED|Overall Study||9
10455647|NCT01003301|11603743|FG000|COMPLETED|Overall Study||10
10455648|NCT01003301|11603744|FG001|COMPLETED|Overall Study||9
10455649|NCT01003301|11603743|FG000|NOT COMPLETED|Overall Study||0
10455650|NCT01003301|11603744|FG001|NOT COMPLETED|Overall Study||0
10455651|NCT01003418|11603752|FG000|STARTED|Overall Study||5
10455652|NCT01003418|11603753|FG001|STARTED|Overall Study||3
10455653|NCT01003418|11603752|FG000|COMPLETED|Overall Study||5
10455654|NCT01003418|11603753|FG001|COMPLETED|Overall Study||3
10455655|NCT01003418|11603752|FG000|NOT COMPLETED|Overall Study||0
10455656|NCT01003418|11603753|FG001|NOT COMPLETED|Overall Study||0
10455657|NCT01003639|11603761|FG000|STARTED|Overall Study||86
10455658|NCT01003639|11603762|FG001|STARTED|Overall Study||79
10455659|NCT01003639|11603761|FG000|COMPLETED|Overall Study||69
10455660|NCT01003639|11603762|FG001|COMPLETED|Overall Study||57
10455661|NCT01003639|11603761|FG000|NOT COMPLETED|Overall Study||17
10455662|NCT01003639|11603762|FG001|NOT COMPLETED|Overall Study||22
10455663|NCT01003769|11603768|FG000|STARTED|Overall Study||5
10455664|NCT01003769|11603768|FG000|COMPLETED|Overall Study||5
10701443|NCT02567227|11865919|FG001|COMPLETED|9 Weeks||167
10701444|NCT02567227|11865918|FG000|NOT COMPLETED|9 Weeks||34
10701445|NCT02567227|11865919|FG001|NOT COMPLETED|9 Weeks||24
10701446|NCT02567227|11865918|FG000|STARTED|6 Month||158
10701447|NCT02567227|11865919|FG001|STARTED|6 Month||167
10319662|NCT00228943|11454027|FG000|NOT COMPLETED|Week 2||1
10319663|NCT00229203|11454035|FG000|STARTED|Overall Study||32
10319664|NCT00229203|11454036|FG001|STARTED|Overall Study||19
10319665|NCT00229203|11454035|FG000|COMPLETED|Overall Study||0
10319666|NCT00229203|11454036|FG001|COMPLETED|Overall Study||0
10319667|NCT00229203|11454035|FG000|NOT COMPLETED|Overall Study||32
10319668|NCT00229203|11454036|FG001|NOT COMPLETED|Overall Study||19
10319669|NCT00229619|11454042|FG000|STARTED|Overall Study||11
10455665|NCT01003769|11603768|FG000|NOT COMPLETED|Overall Study||0
10455666|NCT01003886|11603772|FG000|STARTED|Overall Study||989
10455667|NCT01003886|11603772|FG000|COMPLETED|Overall Study||759
10455668|NCT01003886|11603772|FG000|NOT COMPLETED|Overall Study||230
10455669|NCT01003899|11603776|FG000|STARTED|Overall Study|enrolled|47
10455670|NCT01003899|11603776|FG000|COMPLETED|Overall Study||0
10455671|NCT01003899|11603776|FG000|NOT COMPLETED|Overall Study||47
10455672|NCT01003938|11603780|FG000|STARTED|Overall Study||6
10455673|NCT01003938|11603780|FG000|COMPLETED|Overall Study||6
10455674|NCT01003938|11603780|FG000|NOT COMPLETED|Overall Study||0
10455675|NCT01003990|11603787|FG000|STARTED|Overall Study||459
10701448|NCT02567227|11865918|FG000|COMPLETED|6 Month||113
10701449|NCT02567227|11865919|FG001|COMPLETED|6 Month||127
10319670|NCT00229619|11454042|FG000|COMPLETED|Overall Study||11
10319671|NCT00229619|11454042|FG000|NOT COMPLETED|Overall Study||0
10701450|NCT02567227|11865918|FG000|NOT COMPLETED|6 Month||45
10701451|NCT02567227|11865919|FG001|NOT COMPLETED|6 Month||40
10701452|NCT02567227|11865918|FG000|STARTED|12 Months||113
10701453|NCT02567227|11865919|FG001|STARTED|12 Months||127
10701454|NCT02567227|11865918|FG000|COMPLETED|12 Months||82
10701455|NCT02567227|11865919|FG001|COMPLETED|12 Months||93
10701456|NCT02567227|11865918|FG000|NOT COMPLETED|12 Months||31
10701457|NCT02567227|11865919|FG001|NOT COMPLETED|12 Months||34
10701458|NCT02567266|11865928|FG000|STARTED|Overall Study||68
10701459|NCT02567266|11865929|FG001|STARTED|Overall Study||60
10319672|NCT00229658|11454050|FG000|STARTED|Overall Study||766
10319673|NCT00229658|11454051|FG001|STARTED|Overall Study||531
10319674|NCT00229658|11454050|FG000|COMPLETED|Overall Study||541
10319675|NCT00229658|11454051|FG001|COMPLETED|Overall Study||364
10319676|NCT00229658|11454050|FG000|NOT COMPLETED|Overall Study||225
10319677|NCT00229658|11454051|FG001|NOT COMPLETED|Overall Study||167
10319678|NCT00229723|11454064|FG000|STARTED|Concomitant Phase|Received randomized treatment|60
10319679|NCT00229723|11454065|FG001|STARTED|Concomitant Phase|Received randomized treatment|24
10319680|NCT00229723|11454066|FG002|STARTED|Concomitant Phase|Received randomized treatment|31
10319681|NCT00229723|11454067|FG003|STARTED|Concomitant Phase|Received randomized treatment|31
10319682|NCT00229723|11454068|FG004|STARTED|Concomitant Phase|Received randomized treatment|24
10319683|NCT00229723|11454069|FG005|STARTED|Concomitant Phase|Received randomized treatment|34
10319684|NCT00229723|11454070|FG006|STARTED|Concomitant Phase|Received randomized treatment|22
10319685|NCT00229723|11454064|FG000|COMPLETED|Concomitant Phase||50
10319686|NCT00229723|11454065|FG001|COMPLETED|Concomitant Phase||19
10319687|NCT00229723|11454066|FG002|COMPLETED|Concomitant Phase||25
10319688|NCT00229723|11454067|FG003|COMPLETED|Concomitant Phase||26
10319689|NCT00229723|11454068|FG004|COMPLETED|Concomitant Phase||22
10319690|NCT00229723|11454069|FG005|COMPLETED|Concomitant Phase||31
10319691|NCT00229723|11454070|FG006|COMPLETED|Concomitant Phase||19
10319692|NCT00229723|11454064|FG000|NOT COMPLETED|Concomitant Phase||10
10319693|NCT00229723|11454065|FG001|NOT COMPLETED|Concomitant Phase||5
10319694|NCT00229723|11454066|FG002|NOT COMPLETED|Concomitant Phase||6
10319695|NCT00229723|11454067|FG003|NOT COMPLETED|Concomitant Phase||5
10319696|NCT00229723|11454068|FG004|NOT COMPLETED|Concomitant Phase||2
10319697|NCT00229723|11454069|FG005|NOT COMPLETED|Concomitant Phase||3
10319698|NCT00229723|11454070|FG006|NOT COMPLETED|Concomitant Phase||3
10319699|NCT00229723|11454064|FG000|STARTED|Maintenance Phase||50
10319700|NCT00229723|11454065|FG001|STARTED|Maintenance Phase||19
10319701|NCT00229723|11454066|FG002|STARTED|Maintenance Phase||25
10319702|NCT00229723|11454067|FG003|STARTED|Maintenance Phase||26
10319703|NCT00229723|11454068|FG004|STARTED|Maintenance Phase||22
10319704|NCT00229723|11454069|FG005|STARTED|Maintenance Phase||31
10319705|NCT00229723|11454070|FG006|STARTED|Maintenance Phase||19
10319706|NCT00229723|11454064|FG000|COMPLETED|Maintenance Phase|Completed study on randomized treatment|25
10319707|NCT00229723|11454065|FG001|COMPLETED|Maintenance Phase|Completed study on randomized treatment|5
10319708|NCT00229723|11454066|FG002|COMPLETED|Maintenance Phase|Completed study on randomized treatment|16
10319709|NCT00229723|11454067|FG003|COMPLETED|Maintenance Phase|Completed study on randomized treatment|9
10319710|NCT00229723|11454068|FG004|COMPLETED|Maintenance Phase|Completed study on randomized treatment|7
10319711|NCT00229723|11454069|FG005|COMPLETED|Maintenance Phase|Completed study on randomized treatment|12
10319712|NCT00229723|11454070|FG006|COMPLETED|Maintenance Phase|Completed study on randomized treatment|9
10319713|NCT00229723|11454064|FG000|NOT COMPLETED|Maintenance Phase||25
10319714|NCT00229723|11454065|FG001|NOT COMPLETED|Maintenance Phase||14
10319715|NCT00229723|11454066|FG002|NOT COMPLETED|Maintenance Phase||9
10319716|NCT00229723|11454067|FG003|NOT COMPLETED|Maintenance Phase||17
10319717|NCT00229723|11454068|FG004|NOT COMPLETED|Maintenance Phase||15
10319718|NCT00229723|11454069|FG005|NOT COMPLETED|Maintenance Phase||19
10319719|NCT00229723|11454070|FG006|NOT COMPLETED|Maintenance Phase||10
10319720|NCT00229957|11454088|FG000|STARTED|Overall Study||152
10319721|NCT00229957|11454089|FG001|STARTED|Overall Study||151
10319722|NCT00229957|11454088|FG000|COMPLETED|Overall Study||132
10319723|NCT00229957|11454089|FG001|COMPLETED|Overall Study||139
10319724|NCT00229957|11454088|FG000|NOT COMPLETED|Overall Study||20
10319725|NCT00229957|11454089|FG001|NOT COMPLETED|Overall Study||12
10319726|NCT00230009|11454097|FG000|STARTED|Single Session Intervention/Control||50
10319727|NCT00230009|11454098|FG001|STARTED|Single Session Intervention/Control||50
10319728|NCT00230009|11454097|FG000|COMPLETED|Single Session Intervention/Control||50
10701460|NCT02567266|11865930|FG002|STARTED|Overall Study||68
10319729|NCT00230009|11454098|FG001|COMPLETED|Single Session Intervention/Control||50
10319730|NCT00230009|11454097|FG000|NOT COMPLETED|Single Session Intervention/Control||0
10319731|NCT00230009|11454098|FG001|NOT COMPLETED|Single Session Intervention/Control||0
10319732|NCT00230009|11454097|FG000|STARTED|Follow-up||50
10319733|NCT00230009|11454098|FG001|STARTED|Follow-up||50
10319734|NCT00230009|11454097|FG000|COMPLETED|Follow-up||19
10319735|NCT00230009|11454098|FG001|COMPLETED|Follow-up||24
10319736|NCT00230009|11454097|FG000|NOT COMPLETED|Follow-up||31
10319737|NCT00230009|11454098|FG001|NOT COMPLETED|Follow-up||26
10319738|NCT00230022|11454106|FG000|STARTED|Overall Study||15
10319739|NCT00230022|11454107|FG001|STARTED|Overall Study||15
10319740|NCT00230022|11454106|FG000|COMPLETED|Overall Study||15
10701461|NCT02567266|11865928|FG000|Midpoint (8 Weeks)|Overall Study||54
10701462|NCT02567266|11865929|FG001|Midpoint (8 Weeks)|Overall Study||52
10701463|NCT02567266|11865930|FG002|Midpoint (8 Weeks)|Overall Study||55
10319741|NCT00230022|11454107|FG001|COMPLETED|Overall Study||15
10319742|NCT00230022|11454106|FG000|NOT COMPLETED|Overall Study||0
10319743|NCT00230022|11454107|FG001|NOT COMPLETED|Overall Study||0
10319744|NCT00230048|11454115|FG000|STARTED|Overall Study||52
10319745|NCT00230048|11454116|FG001|STARTED|Overall Study||55
10319746|NCT00230048|11454115|FG000|Completed Intervention/Control Session|Overall Study||52
10319747|NCT00230048|11454116|FG001|Completed Intervention/Control Session|Overall Study||55
10319748|NCT00230048|11454115|FG000|COMPLETED|Overall Study||39
10319749|NCT00230048|11454116|FG001|COMPLETED|Overall Study||37
10319750|NCT00230048|11454115|FG000|NOT COMPLETED|Overall Study||13
10319751|NCT00230048|11454116|FG001|NOT COMPLETED|Overall Study||18
10455676|NCT01003990|11603788|FG001|STARTED|Overall Study||154
10455677|NCT01003990|11603789|FG002|STARTED|Overall Study||96
10455678|NCT01003990|11603787|FG000|COMPLETED|Overall Study||367
10455679|NCT01003990|11603788|FG001|COMPLETED|Overall Study||103
10455680|NCT01003990|11603789|FG002|COMPLETED|Overall Study||53
10455681|NCT01003990|11603787|FG000|NOT COMPLETED|Overall Study||92
10455682|NCT01003990|11603788|FG001|NOT COMPLETED|Overall Study||51
10455683|NCT01003990|11603789|FG002|NOT COMPLETED|Overall Study||43
10455684|NCT01004003|11603806|FG000|STARTED|Overall Study||6
10455685|NCT01004003|11603807|FG001|STARTED|Overall Study||3
10455686|NCT01004003|11603808|FG002|STARTED|Overall Study||4
10455687|NCT01004003|11603809|FG003|STARTED|Overall Study||3
10455688|NCT01004003|11603810|FG004|STARTED|Overall Study||4
10455689|NCT01004003|11603811|FG005|STARTED|Overall Study||4
10455690|NCT01004003|11603812|FG006|STARTED|Overall Study||8
10455691|NCT01004003|11603813|FG007|STARTED|Overall Study||62
10455692|NCT01004003|11603814|FG008|STARTED|Overall Study||31
10455693|NCT01004003|11603806|FG000|COMPLETED|Overall Study||0
10455694|NCT01004003|11603807|FG001|COMPLETED|Overall Study||0
10455695|NCT01004003|11603808|FG002|COMPLETED|Overall Study||0
10455696|NCT01004003|11603809|FG003|COMPLETED|Overall Study||0
10455697|NCT01004003|11603810|FG004|COMPLETED|Overall Study||0
10455698|NCT01004003|11603811|FG005|COMPLETED|Overall Study||0
10455699|NCT01004003|11603812|FG006|COMPLETED|Overall Study||0
10455700|NCT01004003|11603813|FG007|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 July 2014).|2
10455701|NCT01004003|11603814|FG008|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 July 2014).|1
10455702|NCT01004003|11603806|FG000|NOT COMPLETED|Overall Study||6
10455703|NCT01004003|11603807|FG001|NOT COMPLETED|Overall Study||3
10455704|NCT01004003|11603808|FG002|NOT COMPLETED|Overall Study||4
10455705|NCT01004003|11603809|FG003|NOT COMPLETED|Overall Study||3
10455706|NCT01004003|11603810|FG004|NOT COMPLETED|Overall Study||4
10455707|NCT01004003|11603811|FG005|NOT COMPLETED|Overall Study||4
10455708|NCT01004003|11603812|FG006|NOT COMPLETED|Overall Study||8
10455709|NCT01004003|11603813|FG007|NOT COMPLETED|Overall Study||60
10455710|NCT01004003|11603814|FG008|NOT COMPLETED|Overall Study||30
10455711|NCT01004042|11603838|FG000|STARTED|Overall Study||25
10455712|NCT01004042|11603839|FG001|STARTED|Overall Study||25
10455713|NCT01004042|11603838|FG000|COMPLETED|Overall Study||21
10455714|NCT01004042|11603839|FG001|COMPLETED|Overall Study||25
10455715|NCT01004042|11603838|FG000|NOT COMPLETED|Overall Study||4
10455716|NCT01004042|11603839|FG001|NOT COMPLETED|Overall Study||0
10455717|NCT01004107|11603847|FG000|STARTED|Overall Study||76
10455718|NCT01004107|11603848|FG001|STARTED|Overall Study||25
10455719|NCT01004107|11603847|FG000|COMPLETED|Overall Study||75
10455720|NCT01004107|11603848|FG001|COMPLETED|Overall Study||23
10455721|NCT01004107|11603847|FG000|NOT COMPLETED|Overall Study||1
10455722|NCT01004107|11603848|FG001|NOT COMPLETED|Overall Study||2
10455723|NCT01004146|11603875|FG000|STARTED|Overall Study||25
10455724|NCT01004146|11603876|FG001|STARTED|Overall Study||25
10455725|NCT01004146|11603875|FG000|Have Incentive Spirometry Data|Overall Study||21
10455726|NCT01004146|11603876|FG001|Have Incentive Spirometry Data|Overall Study||20
10455727|NCT01004146|11603875|FG000|COMPLETED|Overall Study||21
10455728|NCT01004146|11603876|FG001|COMPLETED|Overall Study||20
10455729|NCT01004146|11603875|FG000|NOT COMPLETED|Overall Study||4
10455730|NCT01004146|11603876|FG001|NOT COMPLETED|Overall Study||5
10455731|NCT01004159|11603882|FG000|STARTED|Overall Study||20
10455732|NCT01004159|11603882|FG000|COMPLETED|Overall Study||0
10455733|NCT01004159|11603882|FG000|NOT COMPLETED|Overall Study||20
10455734|NCT01004172|11603886|FG000|STARTED|Overall Study||38
10455735|NCT01004172|11603886|FG000|COMPLETED|Overall Study||0
10455736|NCT01004172|11603886|FG000|NOT COMPLETED|Overall Study||38
10455737|NCT01004185|11603893|FG000|STARTED|Overall Study||19
10455738|NCT01004185|11603894|FG001|STARTED|Overall Study||20
10338427|NCT00369655|11475291|FG000|STARTED|Overall Study||21
10338428|NCT00369655|11475291|FG000|COMPLETED|Overall Study||19
10338429|NCT00369655|11475291|FG000|NOT COMPLETED|Overall Study||2
10338430|NCT00369668|11475298|FG000|STARTED|Overall Study|Original number of participants to be recruited for each group.|10
10455739|NCT01004185|11603893|FG000|COMPLETED|Overall Study||10
10455740|NCT01004185|11603894|FG001|COMPLETED|Overall Study||11
10455741|NCT01004185|11603893|FG000|NOT COMPLETED|Overall Study||9
10455742|NCT01004185|11603894|FG001|NOT COMPLETED|Overall Study||9
10455743|NCT01004250|11603900|FG000|STARTED|Induction Therapy Period||109
10455744|NCT01004250|11603900|FG000|Received at Least One Dose of Study Drug|Induction Therapy Period||109
10455745|NCT01004250|11603900|FG000|Death (Any Cause) or Disease Progression|Induction Therapy Period|Participants (pts) with death or disease progression considered to have completed phase.|21
10455746|NCT01004250|11603900|FG000|COMPLETED|Induction Therapy Period||94
10455747|NCT01004250|11603900|FG000|NOT COMPLETED|Induction Therapy Period||15
10548397|NCT01519284|11702195|FG003|COMPLETED|Overall Study||16
10319752|NCT00230100|11454126|FG000|STARTED|Overall Study||29
10319753|NCT00230100|11454127|FG001|STARTED|Overall Study||17
10319754|NCT00230100|11454126|FG000|COMPLETED|Overall Study||29
10319755|NCT00230100|11454127|FG001|COMPLETED|Overall Study||17
10319756|NCT00230100|11454126|FG000|NOT COMPLETED|Overall Study||0
10319757|NCT00230100|11454127|FG001|NOT COMPLETED|Overall Study||0
10319758|NCT00230126|11454135|FG000|STARTED|Overall Study||30
10319759|NCT00230126|11454136|FG001|STARTED|Overall Study||28
10319760|NCT00230126|11454135|FG000|COMPLETED|Overall Study||28
10319761|NCT00230126|11454136|FG001|COMPLETED|Overall Study||27
10319762|NCT00230126|11454135|FG000|NOT COMPLETED|Overall Study||2
10319763|NCT00230126|11454136|FG001|NOT COMPLETED|Overall Study||1
10319764|NCT00230178|11454147|FG000|STARTED|Overall Study|Intent-to-treat (ITT)population: randomized patients|94
10319765|NCT00230178|11454148|FG001|STARTED|Overall Study||93
10319766|NCT00230178|11454149|FG002|STARTED|Overall Study||93
10319767|NCT00230178|11454147|FG000|Treated|Overall Study|Modified ITT population: ITT patients with at least 1 dose of study drug|92
10701464|NCT02567266|11865928|FG000|Post (16 Weeks)|Overall Study||49
10701465|NCT02567266|11865929|FG001|Post (16 Weeks)|Overall Study||43
10701466|NCT02567266|11865930|FG002|Post (16 Weeks)|Overall Study||53
10701467|NCT02567266|11865928|FG000|Follow-up (28 Weeks)|Overall Study||45
10319768|NCT00230178|11454148|FG001|Treated|Overall Study||92
10319769|NCT00230178|11454149|FG002|Treated|Overall Study||91
10319770|NCT00230178|11454147|FG000|COMPLETED|Overall Study||90
10319771|NCT00230178|11454148|FG001|COMPLETED|Overall Study||86
10319772|NCT00230178|11454149|FG002|COMPLETED|Overall Study||86
10319773|NCT00230178|11454147|FG000|NOT COMPLETED|Overall Study||4
10319774|NCT00230178|11454148|FG001|NOT COMPLETED|Overall Study||7
10319775|NCT00230178|11454149|FG002|NOT COMPLETED|Overall Study||7
10319776|NCT00230282|11454157|FG000|STARTED|Fludarabine + Cyclophosphamide||25
10319777|NCT00230282|11454157|FG000|COMPLETED|Fludarabine + Cyclophosphamide||17
10319778|NCT00230282|11454157|FG000|NOT COMPLETED|Fludarabine + Cyclophosphamide||8
10319779|NCT00230282|11454157|FG000|STARTED|Maintanence Therapy With Alemtuzumab||17
10319780|NCT00230282|11454157|FG000|COMPLETED|Maintanence Therapy With Alemtuzumab||17
10319781|NCT00230282|11454157|FG000|NOT COMPLETED|Maintanence Therapy With Alemtuzumab||0
10319782|NCT00230737|11454164|FG000|STARTED|Overall Study||9
10319783|NCT00230737|11454165|FG001|STARTED|Overall Study||10
10319784|NCT00230737|11454166|FG002|STARTED|Overall Study||8
10319785|NCT00230737|11454164|FG000|COMPLETED|Overall Study||9
10319786|NCT00230737|11454165|FG001|COMPLETED|Overall Study||10
10319787|NCT00230737|11454166|FG002|COMPLETED|Overall Study||8
10319788|NCT00230737|11454164|FG000|NOT COMPLETED|Overall Study||0
10319789|NCT00230737|11454165|FG001|NOT COMPLETED|Overall Study||0
10319790|NCT00230737|11454166|FG002|NOT COMPLETED|Overall Study||0
10319791|NCT00230802|11454176|FG000|STARTED|Overall Study||25
10319792|NCT00230802|11454177|FG001|STARTED|Overall Study||23
10319793|NCT00230802|11454176|FG000|COMPLETED|Overall Study||25
10319794|NCT00230802|11454177|FG001|COMPLETED|Overall Study||23
10319795|NCT00230802|11454176|FG000|NOT COMPLETED|Overall Study||0
10319796|NCT00230802|11454177|FG001|NOT COMPLETED|Overall Study||0
10319797|NCT00230971|11454187|FG000|STARTED|Randomization||235
10319798|NCT00230971|11454188|FG001|STARTED|Randomization||238
10319799|NCT00230971|11454187|FG000|COMPLETED|Randomization||232
10319800|NCT00230971|11454188|FG001|COMPLETED|Randomization||235
10319801|NCT00230971|11454187|FG000|NOT COMPLETED|Randomization||3
10319802|NCT00230971|11454188|FG001|NOT COMPLETED|Randomization||3
10319803|NCT00230971|11454187|FG000|STARTED|Baseline Participants||232
10319804|NCT00230971|11454188|FG001|STARTED|Baseline Participants||235
10319805|NCT00230971|11454187|FG000|COMPLETED|Baseline Participants||210
10319806|NCT00230971|11454188|FG001|COMPLETED|Baseline Participants||216
10319807|NCT00230971|11454187|FG000|NOT COMPLETED|Baseline Participants||22
10319808|NCT00230971|11454188|FG001|NOT COMPLETED|Baseline Participants||19
10319809|NCT00231062|11454194|FG000|STARTED|Overall Study||115
10319810|NCT00231062|11454194|FG000|COMPLETED|Overall Study||109
10319811|NCT00231062|11454194|FG000|NOT COMPLETED|Overall Study||6
10319812|NCT00231114|11454200|FG000|STARTED|Randomized||196
10319813|NCT00231114|11454201|FG001|STARTED|Randomized||101
10319814|NCT00231114|11454200|FG000|COMPLETED|Randomized||190
10319815|NCT00231114|11454201|FG001|COMPLETED|Randomized||98
10319816|NCT00231114|11454200|FG000|NOT COMPLETED|Randomized||6
10319817|NCT00231114|11454201|FG001|NOT COMPLETED|Randomized||3
10319818|NCT00231114|11454200|FG000|STARTED|Treatment Period||190
10319819|NCT00231114|11454201|FG001|STARTED|Treatment Period||98
10319820|NCT00231114|11454200|FG000|COMPLETED|Treatment Period||189
10319821|NCT00231114|11454201|FG001|COMPLETED|Treatment Period||98
10319822|NCT00231114|11454200|FG000|NOT COMPLETED|Treatment Period||1
10319823|NCT00231114|11454201|FG001|NOT COMPLETED|Treatment Period||0
10319824|NCT00231114|11454200|FG000|STARTED|Post-Treatment Period||189
10319825|NCT00231114|11454201|FG001|STARTED|Post-Treatment Period||98
10319826|NCT00231114|11454200|FG000|COMPLETED|Post-Treatment Period||181
10319827|NCT00231114|11454201|FG001|COMPLETED|Post-Treatment Period||97
10319828|NCT00231114|11454200|FG000|NOT COMPLETED|Post-Treatment Period||8
10319829|NCT00231114|11454201|FG001|NOT COMPLETED|Post-Treatment Period||1
10319830|NCT00231179|11454211|FG000|STARTED|Overall Study||152
10319831|NCT00231179|11454212|FG001|STARTED|Overall Study||150
10319832|NCT00231179|11454211|FG000|COMPLETED|Overall Study|128 (95%) in intervention group completed the five year follow-up visit.|128
10319833|NCT00231179|11454212|FG001|COMPLETED|Overall Study|126 (93%) in the control group completed the five year follow-up visit.|126
10319834|NCT00231179|11454211|FG000|NOT COMPLETED|Overall Study||24
10319835|NCT00231179|11454212|FG001|NOT COMPLETED|Overall Study||24
10319836|NCT00231283|11454218|FG000|STARTED|Overall Study||100
10319837|NCT00231283|11454218|FG000|COMPLETED|Overall Study||95
10319838|NCT00231283|11454218|FG000|NOT COMPLETED|Overall Study||5
10319839|NCT00231309|11454222|FG000|STARTED|Overall Study||10
10319840|NCT00231309|11454222|FG000|COMPLETED|Overall Study||10
10319841|NCT00231309|11454222|FG000|NOT COMPLETED|Overall Study||0
10319842|NCT00231413|11454234|FG000|STARTED|Overall Study||88
10319843|NCT00231413|11454235|FG001|STARTED|Overall Study||50
10319844|NCT00231413|11454236|FG002|STARTED|Overall Study||49
10319845|NCT00231413|11454237|FG003|STARTED|Overall Study||48
10319846|NCT00231413|11454238|FG004|STARTED|Overall Study||48
10319847|NCT00231413|11454239|FG005|STARTED|Overall Study||50
10319848|NCT00231413|11454240|FG006|STARTED|Overall Study||50
10319849|NCT00231413|11454234|FG000|COMPLETED|Overall Study||80
10319850|NCT00231413|11454235|FG001|COMPLETED|Overall Study||45
10319851|NCT00231413|11454236|FG002|COMPLETED|Overall Study||42
10319852|NCT00231413|11454237|FG003|COMPLETED|Overall Study||45
10319853|NCT00231413|11454238|FG004|COMPLETED|Overall Study||45
10319854|NCT00231413|11454239|FG005|COMPLETED|Overall Study||45
10319855|NCT00231413|11454240|FG006|COMPLETED|Overall Study||46
10319856|NCT00231413|11454234|FG000|NOT COMPLETED|Overall Study||8
10319857|NCT00231413|11454235|FG001|NOT COMPLETED|Overall Study||5
10319858|NCT00231413|11454236|FG002|NOT COMPLETED|Overall Study||7
10319859|NCT00231413|11454237|FG003|NOT COMPLETED|Overall Study||3
10319860|NCT00231413|11454238|FG004|NOT COMPLETED|Overall Study||3
10319861|NCT00231413|11454239|FG005|NOT COMPLETED|Overall Study||5
10319862|NCT00231413|11454240|FG006|NOT COMPLETED|Overall Study||4
10319863|NCT00231465|11454256|FG000|STARTED|Overall Study||44
10319864|NCT00231465|11454256|FG000|COMPLETED|Overall Study||42
10319865|NCT00231465|11454256|FG000|NOT COMPLETED|Overall Study||2
10319866|NCT00231478|11454262|FG000|STARTED|Overall Study||87
10319867|NCT00231478|11454263|FG001|STARTED|Overall Study||84
10319868|NCT00231478|11454262|FG000|COMPLETED|Overall Study||79
10319869|NCT00231478|11454263|FG001|COMPLETED|Overall Study||78
10319870|NCT00231478|11454262|FG000|NOT COMPLETED|Overall Study||8
10319871|NCT00231478|11454263|FG001|NOT COMPLETED|Overall Study||6
10455748|NCT01004250|11603900|FG000|STARTED|Maintenance Therapy Period|Did not enter Maint: 21 pts due to death or disease progression; 1 pts had performance status 2.|72
10455749|NCT01004250|11603900|FG000|Death (Any Cause) or Disease Progression|Maintenance Therapy Period|Pts with death or disease progression considered to have completed phase.|46
10455750|NCT01004250|11603900|FG000|COMPLETED|Maintenance Therapy Period||46
10455751|NCT01004250|11603900|FG000|NOT COMPLETED|Maintenance Therapy Period||26
10455752|NCT01004250|11603900|FG000|STARTED|Follow-Up (FU) Period|Did not enter FU:Death-4pts Ind,1pts Maint; Pt Withdrew-1 pts Ind,1pts Maint; Lost to FU-1 pts Maint|101
10455753|NCT01004250|11603900|FG000|COMPLETED|Follow-Up (FU) Period||100
10455754|NCT01004250|11603900|FG000|NOT COMPLETED|Follow-Up (FU) Period||1
10455755|NCT01004354|11603908|FG000|STARTED|Overall Study||12
10455756|NCT01004354|11603908|FG000|COMPLETED|Overall Study||12
10701468|NCT02567266|11865929|FG001|Follow-up (28 Weeks)|Overall Study||45
10701469|NCT02567266|11865930|FG002|Follow-up (28 Weeks)|Overall Study||52
10701470|NCT02567266|11865928|FG000|COMPLETED|Overall Study||45
10701471|NCT02567266|11865929|FG001|COMPLETED|Overall Study||45
10701472|NCT02567266|11865930|FG002|COMPLETED|Overall Study||52
10701473|NCT02567266|11865928|FG000|NOT COMPLETED|Overall Study||23
10319872|NCT00231777|11454271|FG000|STARTED|Overall Study||170
10319873|NCT00231777|11454272|FG001|STARTED|Overall Study||46
10319874|NCT00231777|11454271|FG000|COMPLETED|Overall Study||164
10319875|NCT00231777|11454272|FG001|COMPLETED|Overall Study||44
10319876|NCT00231777|11454271|FG000|NOT COMPLETED|Overall Study||6
10319877|NCT00231777|11454272|FG001|NOT COMPLETED|Overall Study||2
10319878|NCT00231816|11454280|FG000|STARTED|Overall Study||382
10319879|NCT00231816|11454281|FG001|STARTED|Overall Study||381
10319880|NCT00231816|11454280|FG000|Vaccinated at Visit 1|Overall Study||382
10319881|NCT00231816|11454281|FG001|Vaccinated at Visit 1|Overall Study|One participant was randomized but not vaccinated|380
10319882|NCT00231816|11454280|FG000|Vaccinated at Visit 2|Overall Study||369
10319883|NCT00231816|11454281|FG001|Vaccinated at Visit 2|Overall Study||371
10319884|NCT00231816|11454280|FG000|COMPLETED|Overall Study|Participant received required vaccines and returned completed vaccination report cards at Visits 2&3|366
10319885|NCT00231816|11454281|FG001|COMPLETED|Overall Study|Participant received required vaccines and returned completed vaccination report cards at Visits 2&3|369
10319886|NCT00231816|11454280|FG000|NOT COMPLETED|Overall Study||16
10319887|NCT00231816|11454281|FG001|NOT COMPLETED|Overall Study||12
10319888|NCT00231842|11454288|FG000|STARTED|Overall Study||30
10319889|NCT00231842|11454288|FG000|Initiated Therapy|Overall Study||27
10701474|NCT02567266|11865929|FG001|NOT COMPLETED|Overall Study||15
10701475|NCT02567266|11865930|FG002|NOT COMPLETED|Overall Study||16
10319890|NCT00231842|11454288|FG000|Completed First 3 Cycles|Overall Study||27
10319891|NCT00231842|11454288|FG000|Completed Prescribed RT|Overall Study||27
10319892|NCT00231842|11454288|FG000|Completed Full Prescribed Therapy|Overall Study||19
10319893|NCT00231842|11454288|FG000|COMPLETED|Overall Study||19
10319894|NCT00231842|11454288|FG000|NOT COMPLETED|Overall Study||11
10319895|NCT00231868|11454293|FG000|STARTED|Overall Study||81
10319896|NCT00231868|11454293|FG000|COMPLETED|Overall Study||65
10319897|NCT00231868|11454293|FG000|NOT COMPLETED|Overall Study||16
10319898|NCT00231894|11454299|FG000|STARTED|Overall Study||31
10319899|NCT00231894|11454300|FG001|STARTED|Overall Study||25
10319900|NCT00231894|11454299|FG000|COMPLETED|Overall Study||30
10319901|NCT00231894|11454300|FG001|COMPLETED|Overall Study||24
10319902|NCT00231894|11454299|FG000|NOT COMPLETED|Overall Study||1
10319903|NCT00231894|11454300|FG001|NOT COMPLETED|Overall Study||1
10319904|NCT00232180|11454314|FG000|STARTED|Double-blind (DB) Phase|Three participants in each arm were enrolled after data cut-off.|1367
10319905|NCT00232180|11454315|FG001|STARTED|Double-blind (DB) Phase|Three participants in each arm were enrolled after data cut-off.|1376
10319906|NCT00232180|11454316|FG002|STARTED|Double-blind (DB) Phase||0
10319907|NCT00232180|11454314|FG000|Treated|Double-blind (DB) Phase||1364
10319908|NCT00232180|11454315|FG001|Treated|Double-blind (DB) Phase||1372
10319909|NCT00232180|11454316|FG002|Treated|Double-blind (DB) Phase||0
10319910|NCT00232180|11454314|FG000|COMPLETED|Double-blind (DB) Phase||826
10319911|NCT00232180|11454315|FG001|COMPLETED|Double-blind (DB) Phase||771
10319912|NCT00232180|11454316|FG002|COMPLETED|Double-blind (DB) Phase||0
10319913|NCT00232180|11454314|FG000|NOT COMPLETED|Double-blind (DB) Phase||541
10319914|NCT00232180|11454315|FG001|NOT COMPLETED|Double-blind (DB) Phase||605
10319915|NCT00232180|11454316|FG002|NOT COMPLETED|Double-blind (DB) Phase||0
10319916|NCT00232180|11454314|FG000|STARTED|Open Label Phase||0
10319917|NCT00232180|11454315|FG001|STARTED|Open Label Phase||0
10319918|NCT00232180|11454316|FG002|STARTED|Open Label Phase||1246
10319919|NCT00232180|11454314|FG000|Treated|Open Label Phase||0
10319920|NCT00232180|11454315|FG001|Treated|Open Label Phase||0
10319921|NCT00232180|11454316|FG002|Treated|Open Label Phase||1245
10319922|NCT00232180|11454314|FG000|COMPLETED|Open Label Phase||0
10319923|NCT00232180|11454315|FG001|COMPLETED|Open Label Phase||0
10319924|NCT00232180|11454316|FG002|COMPLETED|Open Label Phase||1098
10319925|NCT00232180|11454314|FG000|NOT COMPLETED|Open Label Phase||0
10319926|NCT00232180|11454315|FG001|NOT COMPLETED|Open Label Phase||0
10319927|NCT00232180|11454316|FG002|NOT COMPLETED|Open Label Phase||148
10319928|NCT00232479|11454325|FG000|STARTED|Overall Study||44
10319929|NCT00232479|11454325|FG000|COMPLETED|Overall Study||44
10319930|NCT00232479|11454325|FG000|NOT COMPLETED|Overall Study||0
10319931|NCT00232505|11454332|FG000|STARTED|Overall Study||31
10319932|NCT00232505|11454333|FG001|STARTED|Overall Study||71
10319933|NCT00232505|11454332|FG000|Not Evaluable|Overall Study||0
10319934|NCT00232505|11454333|FG001|Not Evaluable|Overall Study||6
10319935|NCT00232505|11454332|FG000|Early Progressors|Overall Study||2
10319936|NCT00232505|11454333|FG001|Early Progressors|Overall Study||5
10319937|NCT00232505|11454332|FG000|Off Protocol|Overall Study||5
10319938|NCT00232505|11454333|FG001|Off Protocol|Overall Study||0
10319939|NCT00232505|11454332|FG000|COMPLETED|Overall Study||26
10319940|NCT00232505|11454333|FG001|COMPLETED|Overall Study||60
10319941|NCT00232505|11454332|FG000|NOT COMPLETED|Overall Study||5
10319942|NCT00232505|11454333|FG001|NOT COMPLETED|Overall Study||11
10319943|NCT00232544|11454345|FG000|STARTED|Overall Study||124
10319944|NCT00232544|11454346|FG001|STARTED|Overall Study||126
10319945|NCT00232544|11454345|FG000|COMPLETED|Overall Study||104
10319946|NCT00232544|11454346|FG001|COMPLETED|Overall Study||111
10319947|NCT00232544|11454345|FG000|NOT COMPLETED|Overall Study||20
10319948|NCT00232544|11454346|FG001|NOT COMPLETED|Overall Study||15
10319949|NCT00232557|11454354|FG000|STARTED|Overall Study||71
10319950|NCT00232557|11454355|FG001|STARTED|Overall Study||65
10319951|NCT00232557|11454354|FG000|COMPLETED|Overall Study||68
10319952|NCT00232557|11454355|FG001|COMPLETED|Overall Study||60
10319953|NCT00232557|11454354|FG000|NOT COMPLETED|Overall Study||3
10319954|NCT00232557|11454355|FG001|NOT COMPLETED|Overall Study||5
10319955|NCT00232583|11454363|FG000|STARTED|Overall Study||29
10319956|NCT00232583|11454364|FG001|STARTED|Overall Study||29
10319957|NCT00232583|11454363|FG000|COMPLETED|Overall Study||19
10319958|NCT00232583|11454364|FG001|COMPLETED|Overall Study||16
10319959|NCT00232583|11454363|FG000|NOT COMPLETED|Overall Study||10
10319960|NCT00232583|11454364|FG001|NOT COMPLETED|Overall Study||13
10319961|NCT00232596|11454376|FG000|STARTED|6-Week Titration Phase||152
10319962|NCT00232596|11454377|FG001|STARTED|6-Week Titration Phase||154
10319963|NCT00232596|11454376|FG000|COMPLETED|6-Week Titration Phase||138
10319964|NCT00232596|11454377|FG001|COMPLETED|6-Week Titration Phase||125
10319965|NCT00232596|11454376|FG000|NOT COMPLETED|6-Week Titration Phase||14
10319966|NCT00232596|11454377|FG001|NOT COMPLETED|6-Week Titration Phase||29
10319967|NCT00232596|11454376|FG000|STARTED|12-Week Maintenance Phase||138
10319968|NCT00232596|11454377|FG001|STARTED|12-Week Maintenance Phase||125
10319969|NCT00232596|11454376|FG000|COMPLETED|12-Week Maintenance Phase|"One participant withdrew after being considered a completer and is listed as an early withdraw."|126
10319970|NCT00232596|11454377|FG001|COMPLETED|12-Week Maintenance Phase||97
10319971|NCT00232596|11454376|FG000|NOT COMPLETED|12-Week Maintenance Phase||12
10319972|NCT00232596|11454377|FG001|NOT COMPLETED|12-Week Maintenance Phase||28
10319973|NCT00232739|11454395|FG000|STARTED|Overall Study||100
10319974|NCT00232739|11454395|FG000|COMPLETED|Overall Study||91
10319975|NCT00232739|11454395|FG000|NOT COMPLETED|Overall Study||9
10319976|NCT00233064|11454401|FG000|STARTED|Overall Study||211
10319977|NCT00233064|11454402|FG001|STARTED|Overall Study||202
10319978|NCT00233064|11454401|FG000|COMPLETED|Overall Study||197
10319979|NCT00233064|11454402|FG001|COMPLETED|Overall Study||190
10319980|NCT00233064|11454401|FG000|NOT COMPLETED|Overall Study||14
10319981|NCT00233064|11454402|FG001|NOT COMPLETED|Overall Study||12
10319982|NCT00233103|11454411|FG000|STARTED|Overall Study||27
10319983|NCT00233103|11454412|FG001|STARTED|Overall Study||25
10455757|NCT01004354|11603908|FG000|NOT COMPLETED|Overall Study||0
10319984|NCT00233103|11454411|FG000|COMPLETED|Overall Study||22
10319985|NCT00233103|11454412|FG001|COMPLETED|Overall Study||19
10319986|NCT00233103|11454411|FG000|NOT COMPLETED|Overall Study||5
10455758|NCT01004393|11603912|FG000|STARTED|Overall Study||12
10455759|NCT01004393|11603912|FG000|COMPLETED|Overall Study||12
10319987|NCT00233103|11454412|FG001|NOT COMPLETED|Overall Study||6
10319988|NCT00233324|11454422|FG000|STARTED|Main Study||318
10319989|NCT00233324|11454423|FG001|STARTED|Main Study||335
10319990|NCT00233324|11454424|FG002|STARTED|Main Study||336
10319991|NCT00233324|11454425|FG003|STARTED|Main Study||327
10319992|NCT00233324|11454422|FG000|COMPLETED|Main Study||250
10319993|NCT00233324|11454423|FG001|COMPLETED|Main Study||275
10319994|NCT00233324|11454424|FG002|COMPLETED|Main Study||274
10319995|NCT00233324|11454425|FG003|COMPLETED|Main Study||280
10319996|NCT00233324|11454422|FG000|NOT COMPLETED|Main Study||68
10319997|NCT00233324|11454423|FG001|NOT COMPLETED|Main Study||60
10319998|NCT00233324|11454424|FG002|NOT COMPLETED|Main Study||62
10319999|NCT00233324|11454425|FG003|NOT COMPLETED|Main Study||47
10320000|NCT00233324|11454422|FG000|STARTED|Follow up at 18-22 Months Corrected Age||250
10320001|NCT00233324|11454423|FG001|STARTED|Follow up at 18-22 Months Corrected Age||275
10320002|NCT00233324|11454424|FG002|STARTED|Follow up at 18-22 Months Corrected Age||274
10320003|NCT00233324|11454425|FG003|STARTED|Follow up at 18-22 Months Corrected Age||280
10320004|NCT00233324|11454422|FG000|COMPLETED|Follow up at 18-22 Months Corrected Age||237
10320005|NCT00233324|11454423|FG001|COMPLETED|Follow up at 18-22 Months Corrected Age||261
10320006|NCT00233324|11454424|FG002|COMPLETED|Follow up at 18-22 Months Corrected Age||256
10320007|NCT00233324|11454425|FG003|COMPLETED|Follow up at 18-22 Months Corrected Age||269
10320008|NCT00233324|11454422|FG000|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||13
10320009|NCT00233324|11454423|FG001|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||14
10320010|NCT00233324|11454424|FG002|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||18
10320011|NCT00233324|11454425|FG003|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||11
10320012|NCT00233363|11454444|FG000|STARTED|Overall Study||53
10320013|NCT00233363|11454445|FG001|STARTED|Overall Study||51
10320014|NCT00233363|11454444|FG000|COMPLETED|Overall Study||50
10320015|NCT00233363|11454445|FG001|COMPLETED|Overall Study||46
10320016|NCT00233363|11454444|FG000|NOT COMPLETED|Overall Study||3
10320017|NCT00233363|11454445|FG001|NOT COMPLETED|Overall Study||5
10320018|NCT00233389|11454453|FG000|STARTED|Overall Study||154
10320019|NCT00233389|11454454|FG001|STARTED|Overall Study||147
10320020|NCT00233389|11454453|FG000|COMPLETED|Overall Study||136
10320021|NCT00233389|11454454|FG001|COMPLETED|Overall Study||131
10320022|NCT00233389|11454453|FG000|NOT COMPLETED|Overall Study||18
10320023|NCT00233389|11454454|FG001|NOT COMPLETED|Overall Study||16
10320024|NCT00233402|11454462|FG000|STARTED|Overall Study||384
10320025|NCT00233402|11454463|FG001|STARTED|Overall Study||395
10320026|NCT00233402|11454462|FG000|COMPLETED|Overall Study||280
10320027|NCT00233402|11454463|FG001|COMPLETED|Overall Study||271
10320028|NCT00233402|11454462|FG000|NOT COMPLETED|Overall Study||104
10320029|NCT00233402|11454463|FG001|NOT COMPLETED|Overall Study||124
10320030|NCT00233454|11454471|FG000|STARTED|Overall Study||26
10320031|NCT00233454|11454471|FG000|2 Months (for Response Rate)|Overall Study||26
10320032|NCT00233454|11454471|FG000|COMPLETED|Overall Study||20
10320033|NCT00233454|11454471|FG000|NOT COMPLETED|Overall Study||6
10320034|NCT00233480|11454477|FG000|STARTED|Overall Study||14
10320035|NCT00233480|11454478|FG001|STARTED|Overall Study||13
10320036|NCT00233480|11454477|FG000|COMPLETED|Overall Study||14
10320037|NCT00233480|11454478|FG001|COMPLETED|Overall Study||12
10320038|NCT00233480|11454477|FG000|NOT COMPLETED|Overall Study||0
10320039|NCT00233480|11454478|FG001|NOT COMPLETED|Overall Study||1
10320040|NCT00233519|11454488|FG000|STARTED|Overall Study||7
10320041|NCT00233519|11454489|FG001|STARTED|Overall Study||10
10320042|NCT00233519|11454488|FG000|COMPLETED|Overall Study||6
10320043|NCT00233519|11454489|FG001|COMPLETED|Overall Study||9
10320044|NCT00233519|11454488|FG000|NOT COMPLETED|Overall Study||1
10320045|NCT00233519|11454489|FG001|NOT COMPLETED|Overall Study||1
10320046|NCT00233948|11454497|FG000|STARTED|Overall Study||4
10320047|NCT00233948|11454498|FG001|STARTED|Overall Study||3
10320048|NCT00233948|11454499|FG002|STARTED|Overall Study||3
10320049|NCT00233948|11454500|FG003|STARTED|Overall Study||3
10320050|NCT00233948|11454501|FG004|STARTED|Overall Study||4
10320051|NCT00233948|11454502|FG005|STARTED|Overall Study||12
10320052|NCT00233948|11454497|FG000|COMPLETED|Overall Study||3
10320053|NCT00233948|11454498|FG001|COMPLETED|Overall Study||3
10320054|NCT00233948|11454499|FG002|COMPLETED|Overall Study||3
10320055|NCT00233948|11454500|FG003|COMPLETED|Overall Study||3
10320056|NCT00233948|11454501|FG004|COMPLETED|Overall Study||4
10320057|NCT00233948|11454502|FG005|COMPLETED|Overall Study||12
10320058|NCT00233948|11454497|FG000|NOT COMPLETED|Overall Study||1
10320059|NCT00233948|11454498|FG001|NOT COMPLETED|Overall Study||0
10320060|NCT00233948|11454499|FG002|NOT COMPLETED|Overall Study||0
10320061|NCT00233948|11454500|FG003|NOT COMPLETED|Overall Study||0
10320062|NCT00233948|11454501|FG004|NOT COMPLETED|Overall Study||0
10320063|NCT00233948|11454502|FG005|NOT COMPLETED|Overall Study||0
10320064|NCT00233987|11454517|FG000|STARTED|Overall Study||98
10320065|NCT00233987|11454517|FG000|Eligible|Overall Study||94
10320066|NCT00233987|11454517|FG000|Eligible and Treated|Overall Study||92
10320067|NCT00233987|11454517|FG000|COMPLETED|Overall Study||83
10320068|NCT00233987|11454517|FG000|NOT COMPLETED|Overall Study||15
10320069|NCT00234039|11454521|FG000|STARTED|Overall Study||58
10320070|NCT00234039|11454521|FG000|Eligible|Overall Study||49
10320071|NCT00234039|11454521|FG000|Eligible and Began Protocol Therapy|Overall Study||47
10320072|NCT00234039|11454521|FG000|COMPLETED|Overall Study||8
10320073|NCT00234039|11454521|FG000|NOT COMPLETED|Overall Study||50
10320074|NCT00234052|11454525|FG000|STARTED|Treatment||51
10320075|NCT00234052|11454525|FG000|Started Treatment|Treatment||50
10320076|NCT00234052|11454525|FG000|Completed 6 Cycles|Treatment||33
10320077|NCT00234052|11454525|FG000|Went Into Maintenance Phase|Treatment||30
10320078|NCT00234052|11454525|FG000|COMPLETED|Treatment||30
10320079|NCT00234052|11454525|FG000|NOT COMPLETED|Treatment||21
10320080|NCT00234052|11454525|FG000|STARTED|Follow-up for 5 Years|All patients that are treated on study go into the follow up period.|50
10320081|NCT00234052|11454525|FG000|COMPLETED|Follow-up for 5 Years||1
10320082|NCT00234052|11454525|FG000|NOT COMPLETED|Follow-up for 5 Years||49
10320083|NCT00234065|11454531|FG000|STARTED|Overall Study||1356
10320084|NCT00234065|11454532|FG001|STARTED|Overall Study||1360
10320085|NCT00234065|11454531|FG000|COMPLETED|Overall Study||881
10320086|NCT00234065|11454532|FG001|COMPLETED|Overall Study||1004
10320087|NCT00234065|11454531|FG000|NOT COMPLETED|Overall Study||475
10320088|NCT00234065|11454532|FG001|NOT COMPLETED|Overall Study||356
10320089|NCT00234078|11454542|FG000|STARTED|Overall Study||72
10320090|NCT00234078|11454543|FG001|STARTED|Overall Study||72
10320091|NCT00234078|11454544|FG002|STARTED|Overall Study||74
10320092|NCT00234078|11454545|FG003|STARTED|Overall Study||72
10320093|NCT00234078|11454542|FG000|COMPLETED|Overall Study||66
10320094|NCT00234078|11454543|FG001|COMPLETED|Overall Study||63
10320095|NCT00234078|11454544|FG002|COMPLETED|Overall Study||64
10320096|NCT00234078|11454545|FG003|COMPLETED|Overall Study||68
10320097|NCT00234078|11454542|FG000|NOT COMPLETED|Overall Study||6
10320098|NCT00234078|11454543|FG001|NOT COMPLETED|Overall Study||9
10320099|NCT00234078|11454544|FG002|NOT COMPLETED|Overall Study||10
10320100|NCT00234078|11454545|FG003|NOT COMPLETED|Overall Study||4
10320101|NCT00234104|11454559|FG000|STARTED|Overall Study||30
10320102|NCT00234104|11454560|FG001|STARTED|Overall Study||29
10320103|NCT00234104|11454561|FG002|STARTED|Overall Study||34
10320104|NCT00234104|11454562|FG003|STARTED|Overall Study||29
10320105|NCT00234104|11454559|FG000|COMPLETED|Overall Study||26
10320106|NCT00234104|11454560|FG001|COMPLETED|Overall Study||28
10320107|NCT00234104|11454561|FG002|COMPLETED|Overall Study||29
10320108|NCT00234104|11454562|FG003|COMPLETED|Overall Study||21
10320109|NCT00234104|11454559|FG000|NOT COMPLETED|Overall Study||4
10320110|NCT00234104|11454560|FG001|NOT COMPLETED|Overall Study||1
10320111|NCT00234104|11454561|FG002|NOT COMPLETED|Overall Study||5
10320112|NCT00234104|11454562|FG003|NOT COMPLETED|Overall Study||8
10320113|NCT00234286|11454572|FG000|STARTED|Overall Study|We reviewed eletronic health records for 6066 deceased individuals within 6 VA Hospitals|6066
10320114|NCT00234286|11454572|FG000|COMPLETED|Overall Study|We reviewed eletronic health records for 6066 deceased individuals within 6 VA Hospitals|6066
10320115|NCT00234286|11454572|FG000|NOT COMPLETED|Overall Study||0
10320116|NCT00234494|11454605|FG000|STARTED|Overall Study||45
10320117|NCT00234494|11454605|FG000|COMPLETED|Overall Study||43
10320118|NCT00234494|11454605|FG000|NOT COMPLETED|Overall Study||2
10320119|NCT00234533|11454609|FG000|STARTED|Overall Study||251
10320120|NCT00234533|11454609|FG000|COMPLETED|Overall Study||240
10320121|NCT00234533|11454609|FG000|NOT COMPLETED|Overall Study||11
10320122|NCT00234832|11454616|FG000|STARTED|Overall Study|Subjects completed the 6-week Lead-in Period and were dispensed randomized study drug.|4906
10320123|NCT00234832|11454617|FG001|STARTED|Overall Study|Subjects completed the 6-week Lead-in Period and were dispensed randomized study drug.|4898
10320124|NCT00234832|11454616|FG000|COMPLETED|Overall Study|Subjects completed the Randomization Phase.|3890
10320125|NCT00234832|11454617|FG001|COMPLETED|Overall Study|Subjects completed the Randomization Phase.|3902
10320126|NCT00234832|11454616|FG000|NOT COMPLETED|Overall Study||1016
10320127|NCT00234832|11454617|FG001|NOT COMPLETED|Overall Study||996
10320128|NCT00234884|11454630|FG000|STARTED|Overall Study||3435
10320129|NCT00234884|11454630|FG000|COMPLETED|Overall Study||1805
10320130|NCT00234884|11454630|FG000|NOT COMPLETED|Overall Study||1630
10320131|NCT00235391|11454640|FG000|STARTED|Overall Study||97
10320132|NCT00235391|11454641|FG001|STARTED|Overall Study||200
10320133|NCT00235391|11454642|FG002|STARTED|Overall Study||172
10320134|NCT00235391|11454643|FG003|STARTED|Overall Study||1164
10320135|NCT00235391|11454644|FG004|STARTED|Overall Study||43
10320136|NCT00235391|11454645|FG005|STARTED|Overall Study||7
10320137|NCT00235391|11454640|FG000|Deferasirox Treatment|Overall Study||97
10320138|NCT00235391|11454641|FG001|Deferasirox Treatment|Overall Study||200
10320139|NCT00235391|11454642|FG002|Deferasirox Treatment|Overall Study||172
10320140|NCT00235391|11454643|FG003|Deferasirox Treatment|Overall Study||1164
10320141|NCT00235391|11454644|FG004|Deferasirox Treatment|Overall Study||43
10320142|NCT00235391|11454645|FG005|Deferasirox Treatment|Overall Study||7
10320143|NCT00235391|11454640|FG000|COMPLETED|Overall Study||85
10320144|NCT00235391|11454641|FG001|COMPLETED|Overall Study||182
10320145|NCT00235391|11454642|FG002|COMPLETED|Overall Study||148
10320146|NCT00235391|11454643|FG003|COMPLETED|Overall Study||944
10320147|NCT00235391|11454644|FG004|COMPLETED|Overall Study||31
10320148|NCT00235391|11454645|FG005|COMPLETED|Overall Study||3
10320149|NCT00235391|11454640|FG000|NOT COMPLETED|Overall Study||12
10320150|NCT00235391|11454641|FG001|NOT COMPLETED|Overall Study||18
10320151|NCT00235391|11454642|FG002|NOT COMPLETED|Overall Study||24
10320152|NCT00235391|11454643|FG003|NOT COMPLETED|Overall Study||220
10320153|NCT00235391|11454644|FG004|NOT COMPLETED|Overall Study||12
10320154|NCT00235391|11454645|FG005|NOT COMPLETED|Overall Study||4
10320155|NCT00235443|11454660|FG000|STARTED|Overall Study||11
10320156|NCT00235443|11454661|FG001|STARTED|Overall Study||57
10320157|NCT00235443|11454662|FG002|STARTED|Overall Study||85
10320158|NCT00235443|11454663|FG003|STARTED|Overall Study||205
10320159|NCT00235443|11454664|FG004|STARTED|Overall Study||39
10320160|NCT00235443|11454665|FG005|STARTED|Overall Study||54
10320161|NCT00235443|11454660|FG000|COMPLETED|Overall Study||3
10320162|NCT00235443|11454661|FG001|COMPLETED|Overall Study||19
10320163|NCT00235443|11454662|FG002|COMPLETED|Overall Study||23
10320164|NCT00235443|11454663|FG003|COMPLETED|Overall Study||108
10320165|NCT00235443|11454664|FG004|COMPLETED|Overall Study||9
10320166|NCT00235443|11454665|FG005|COMPLETED|Overall Study||9
10320167|NCT00235443|11454660|FG000|NOT COMPLETED|Overall Study||8
10320168|NCT00235443|11454661|FG001|NOT COMPLETED|Overall Study||38
10320169|NCT00235443|11454662|FG002|NOT COMPLETED|Overall Study||62
10320170|NCT00235443|11454663|FG003|NOT COMPLETED|Overall Study||97
10320171|NCT00235443|11454664|FG004|NOT COMPLETED|Overall Study||30
10320172|NCT00235443|11454665|FG005|NOT COMPLETED|Overall Study||45
10320173|NCT00235456|11454683|FG000|STARTED|Overall Study||150
10320174|NCT00235456|11454684|FG001|STARTED|Overall Study||150
10320175|NCT00235456|11454683|FG000|COMPLETED|Overall Study||148
10320176|NCT00235456|11454684|FG001|COMPLETED|Overall Study||143
10320177|NCT00235456|11454683|FG000|NOT COMPLETED|Overall Study||2
10320178|NCT00235456|11454684|FG001|NOT COMPLETED|Overall Study||7
10320179|NCT00235495|11454692|FG000|STARTED|Overall Study||422
10320180|NCT00235495|11454693|FG001|STARTED|Overall Study||419
10320181|NCT00235495|11454692|FG000|COMPLETED|Overall Study||354
10320182|NCT00235495|11454693|FG001|COMPLETED|Overall Study||351
10320183|NCT00235495|11454692|FG000|NOT COMPLETED|Overall Study||68
10320184|NCT00235495|11454693|FG001|NOT COMPLETED|Overall Study||68
10701476|NCT02567552|11865940|FG000|STARTED|Overall Study||12
10701477|NCT02567552|11865941|FG001|STARTED|Overall Study||12
10320185|NCT00235547|11454701|FG000|STARTED|2 Month Follow-up Survey||154
10320186|NCT00235547|11454702|FG001|STARTED|2 Month Follow-up Survey||144
10320187|NCT00235547|11454701|FG000|COMPLETED|2 Month Follow-up Survey||108
10320188|NCT00235547|11454702|FG001|COMPLETED|2 Month Follow-up Survey||104
10320189|NCT00235547|11454701|FG000|NOT COMPLETED|2 Month Follow-up Survey||46
10320190|NCT00235547|11454702|FG001|NOT COMPLETED|2 Month Follow-up Survey||40
10320191|NCT00235547|11454701|FG000|STARTED|6 Month Follow-up Survey||154
10320192|NCT00235547|11454702|FG001|STARTED|6 Month Follow-up Survey||144
10320193|NCT00235547|11454701|FG000|COMPLETED|6 Month Follow-up Survey||83
10320194|NCT00235547|11454702|FG001|COMPLETED|6 Month Follow-up Survey||76
10320195|NCT00235547|11454701|FG000|NOT COMPLETED|6 Month Follow-up Survey||71
10320196|NCT00235547|11454702|FG001|NOT COMPLETED|6 Month Follow-up Survey||68
10320197|NCT00235573|11454708|FG000|STARTED|Overall Study|35 subjects screened; 14 not eligible; 21 started and completed study|21
10320198|NCT00235573|11454708|FG000|COMPLETED|Overall Study||21
10320199|NCT00235573|11454708|FG000|NOT COMPLETED|Overall Study||0
10320200|NCT00235716|11454716|FG000|STARTED|Overall Study||152
10320201|NCT00235716|11454717|FG001|STARTED|Overall Study||155
10320202|NCT00235716|11454718|FG002|STARTED|Overall Study||154
10320203|NCT00235716|11454719|FG003|STARTED|Overall Study||152
10320204|NCT00235716|11454716|FG000|COMPLETED|Overall Study||90
10320205|NCT00235716|11454717|FG001|COMPLETED|Overall Study||88
10320206|NCT00235716|11454718|FG002|COMPLETED|Overall Study||89
10320207|NCT00235716|11454719|FG003|COMPLETED|Overall Study||90
10320208|NCT00235716|11454716|FG000|NOT COMPLETED|Overall Study||62
10320209|NCT00235716|11454717|FG001|NOT COMPLETED|Overall Study||67
10320210|NCT00235716|11454718|FG002|NOT COMPLETED|Overall Study||65
10320211|NCT00235716|11454719|FG003|NOT COMPLETED|Overall Study||62
10320212|NCT00235755|11454732|FG000|STARTED|4-Week Titration Phase||179
10320213|NCT00235755|11454733|FG001|STARTED|4-Week Titration Phase||181
10320214|NCT00235755|11454734|FG002|STARTED|4-Week Titration Phase||179
10320215|NCT00235755|11454732|FG000|COMPLETED|4-Week Titration Phase||168
10320216|NCT00235755|11454733|FG001|COMPLETED|4-Week Titration Phase||162
10320217|NCT00235755|11454734|FG002|COMPLETED|4-Week Titration Phase||153
10320218|NCT00235755|11454732|FG000|NOT COMPLETED|4-Week Titration Phase||11
10320219|NCT00235755|11454733|FG001|NOT COMPLETED|4-Week Titration Phase||19
10320220|NCT00235755|11454734|FG002|NOT COMPLETED|4-Week Titration Phase||26
10320221|NCT00235755|11454732|FG000|STARTED|12-Week Maintenance Phase||168
10320222|NCT00235755|11454733|FG001|STARTED|12-Week Maintenance Phase||162
10320223|NCT00235755|11454734|FG002|STARTED|12-Week Maintenance Phase||153
10320224|NCT00235755|11454732|FG000|COMPLETED|12-Week Maintenance Phase||152
10320225|NCT00235755|11454733|FG001|COMPLETED|12-Week Maintenance Phase||135
10320226|NCT00235755|11454734|FG002|COMPLETED|12-Week Maintenance Phase||122
10320227|NCT00235755|11454732|FG000|NOT COMPLETED|12-Week Maintenance Phase||16
10320228|NCT00235755|11454733|FG001|NOT COMPLETED|12-Week Maintenance Phase||27
10320229|NCT00235755|11454734|FG002|NOT COMPLETED|12-Week Maintenance Phase||31
10320230|NCT00235833|11454757|FG000|STARTED|Overall Study||25
10320231|NCT00235833|11454757|FG000|COMPLETED|Overall Study||9
10320232|NCT00235833|11454757|FG000|NOT COMPLETED|Overall Study||16
10320233|NCT00235872|11454761|FG000|STARTED|Overall Study||309
10320234|NCT00235872|11454761|FG000|COMPLETED|Overall Study||162
10320235|NCT00235872|11454761|FG000|NOT COMPLETED|Overall Study||147
10320236|NCT00235989|11454769|FG000|STARTED|Core Treatment Period (CT)||0
10320237|NCT00235989|11454770|FG001|STARTED|Core Treatment Period (CT)||0
10701478|NCT02567552|11865940|FG000|COMPLETED|Overall Study||12
10701479|NCT02567552|11865941|FG001|COMPLETED|Overall Study|dropout by pain in the puncture site|11
10320238|NCT00235989|11454771|FG002|STARTED|Core Treatment Period (CT)||0
10320239|NCT00235989|11454772|FG003|STARTED|Core Treatment Period (CT)||0
10320240|NCT00235989|11454773|FG004|STARTED|Core Treatment Period (CT)||36
10320241|NCT00235989|11454774|FG005|STARTED|Core Treatment Period (CT)||27
10320242|NCT00235989|11454769|FG000|COMPLETED|Core Treatment Period (CT)||0
10320243|NCT00235989|11454770|FG001|COMPLETED|Core Treatment Period (CT)||0
10320244|NCT00235989|11454771|FG002|COMPLETED|Core Treatment Period (CT)||0
10320245|NCT00235989|11454772|FG003|COMPLETED|Core Treatment Period (CT)||0
10701480|NCT02567552|11865940|FG000|NOT COMPLETED|Overall Study||0
10701481|NCT02567552|11865941|FG001|NOT COMPLETED|Overall Study||1
10701482|NCT02567656|11865953|FG000|STARTED|Overall Study||4
10320246|NCT00235989|11454773|FG004|COMPLETED|Core Treatment Period (CT)||36
10320247|NCT00235989|11454774|FG005|COMPLETED|Core Treatment Period (CT)||25
10320248|NCT00235989|11454769|FG000|NOT COMPLETED|Core Treatment Period (CT)||0
10320249|NCT00235989|11454770|FG001|NOT COMPLETED|Core Treatment Period (CT)||0
10320250|NCT00235989|11454771|FG002|NOT COMPLETED|Core Treatment Period (CT)||0
10320251|NCT00235989|11454772|FG003|NOT COMPLETED|Core Treatment Period (CT)||0
10320252|NCT00235989|11454773|FG004|NOT COMPLETED|Core Treatment Period (CT)||0
10320253|NCT00235989|11454774|FG005|NOT COMPLETED|Core Treatment Period (CT)||2
10320254|NCT00235989|11454769|FG000|STARTED|Extension Treatment Period (ET)||16
10320255|NCT00235989|11454770|FG001|STARTED|Extension Treatment Period (ET)||6
10320256|NCT00235989|11454771|FG002|STARTED|Extension Treatment Period (ET)||19
10320257|NCT00235989|11454772|FG003|STARTED|Extension Treatment Period (ET)||20
10320258|NCT00235989|11454773|FG004|STARTED|Extension Treatment Period (ET)||0
10320259|NCT00235989|11454774|FG005|STARTED|Extension Treatment Period (ET)||0
10320260|NCT00235989|11454769|FG000|COMPLETED|Extension Treatment Period (ET)||8
10320261|NCT00235989|11454770|FG001|COMPLETED|Extension Treatment Period (ET)||2
10320262|NCT00235989|11454771|FG002|COMPLETED|Extension Treatment Period (ET)||14
10320263|NCT00235989|11454772|FG003|COMPLETED|Extension Treatment Period (ET)||14
10320264|NCT00235989|11454773|FG004|COMPLETED|Extension Treatment Period (ET)||0
10320265|NCT00235989|11454774|FG005|COMPLETED|Extension Treatment Period (ET)||0
10320266|NCT00235989|11454769|FG000|NOT COMPLETED|Extension Treatment Period (ET)||8
10320267|NCT00235989|11454770|FG001|NOT COMPLETED|Extension Treatment Period (ET)||4
10320268|NCT00235989|11454771|FG002|NOT COMPLETED|Extension Treatment Period (ET)||5
10803679|NCT04117607|11965076|FG004|NOT COMPLETED|Overall Study||0
10320269|NCT00235989|11454772|FG003|NOT COMPLETED|Extension Treatment Period (ET)||6
10320270|NCT00235989|11454773|FG004|NOT COMPLETED|Extension Treatment Period (ET)||0
10320271|NCT00235989|11454774|FG005|NOT COMPLETED|Extension Treatment Period (ET)||0
10320272|NCT00236080|11454789|FG000|STARTED|Overall Study||29
10320273|NCT00236080|11454790|FG001|STARTED|Overall Study||28
10320274|NCT00236080|11454791|FG002|STARTED|Overall Study||27
10320275|NCT00236080|11454792|FG003|STARTED|Overall Study||25
10320276|NCT00236080|11454793|FG004|STARTED|Overall Study||27
10320277|NCT00236080|11454789|FG000|COMPLETED|Overall Study||27
10320278|NCT00236080|11454790|FG001|COMPLETED|Overall Study||27
10320279|NCT00236080|11454791|FG002|COMPLETED|Overall Study||22
10320280|NCT00236080|11454792|FG003|COMPLETED|Overall Study||23
10320281|NCT00236080|11454793|FG004|COMPLETED|Overall Study||26
10320282|NCT00236080|11454789|FG000|NOT COMPLETED|Overall Study||2
10320283|NCT00236080|11454790|FG001|NOT COMPLETED|Overall Study||1
10320284|NCT00236080|11454791|FG002|NOT COMPLETED|Overall Study||5
10320285|NCT00236080|11454792|FG003|NOT COMPLETED|Overall Study||2
10320286|NCT00236080|11454793|FG004|NOT COMPLETED|Overall Study||1
10320287|NCT00236184|11454807|FG000|STARTED|Overall Study||310
10320288|NCT00236184|11454808|FG001|STARTED|Overall Study||319
10320289|NCT00236184|11454807|FG000|COMPLETED|Overall Study||292
10320290|NCT00236184|11454808|FG001|COMPLETED|Overall Study||308
10320291|NCT00236184|11454807|FG000|NOT COMPLETED|Overall Study||18
10320292|NCT00236184|11454808|FG001|NOT COMPLETED|Overall Study||11
10320293|NCT00236197|11454816|FG000|STARTED|Overall Study||312
10320294|NCT00236197|11454817|FG001|STARTED|Overall Study||307
10320295|NCT00236197|11454816|FG000|COMPLETED|Overall Study||307
10320296|NCT00236197|11454817|FG001|COMPLETED|Overall Study||293
10320297|NCT00236197|11454816|FG000|NOT COMPLETED|Overall Study||5
10320298|NCT00236197|11454817|FG001|NOT COMPLETED|Overall Study||14
10320299|NCT00236899|11454827|FG000|STARTED|Overall Study||60
10320300|NCT00236899|11454828|FG001|STARTED|Overall Study||64
10320301|NCT00236899|11454829|FG002|STARTED|Overall Study||58
10320302|NCT00236899|11454830|FG003|STARTED|Overall Study||59
10320303|NCT00236899|11454827|FG000|COMPLETED|Overall Study||18
10320304|NCT00236899|11454828|FG001|COMPLETED|Overall Study||24
10320305|NCT00236899|11454829|FG002|COMPLETED|Overall Study||14
10320306|NCT00236899|11454830|FG003|COMPLETED|Overall Study||19
10320307|NCT00236899|11454827|FG000|NOT COMPLETED|Overall Study||42
10320308|NCT00236899|11454828|FG001|NOT COMPLETED|Overall Study||40
10320309|NCT00236899|11454829|FG002|NOT COMPLETED|Overall Study||44
10320310|NCT00236899|11454830|FG003|NOT COMPLETED|Overall Study||40
10320311|NCT00236938|11454849|FG000|STARTED|Overall Study||75
10320312|NCT00236938|11454850|FG001|STARTED|Overall Study||46
10320313|NCT00236938|11454849|FG000|COMPLETED|Overall Study||62
10320314|NCT00236938|11454850|FG001|COMPLETED|Overall Study||26
10320315|NCT00236938|11454849|FG000|NOT COMPLETED|Overall Study||13
10320316|NCT00236938|11454850|FG001|NOT COMPLETED|Overall Study||20
10320317|NCT00236951|11454860|FG000|STARTED|Overall Study||59
10320318|NCT00236951|11454861|FG001|STARTED|Overall Study||77
10320319|NCT00236951|11454862|FG002|STARTED|Overall Study||40
10320320|NCT00236951|11454863|FG003|STARTED|Overall Study||48
10320321|NCT00236951|11454860|FG000|COMPLETED|Overall Study||33
10320322|NCT00236951|11454861|FG001|COMPLETED|Overall Study||46
10320323|NCT00236951|11454862|FG002|COMPLETED|Overall Study||21
10320324|NCT00236951|11454863|FG003|COMPLETED|Overall Study||17
10320325|NCT00236951|11454860|FG000|NOT COMPLETED|Overall Study||26
10320326|NCT00236951|11454861|FG001|NOT COMPLETED|Overall Study||31
10320327|NCT00236951|11454862|FG002|NOT COMPLETED|Overall Study||19
10320328|NCT00236951|11454863|FG003|NOT COMPLETED|Overall Study||31
10701483|NCT02567656|11865954|FG001|STARTED|Overall Study||4
10803680|NCT04117607|11965077|FG005|NOT COMPLETED|Overall Study||0
10320329|NCT00236977|11454875|FG000|STARTED|Overall Study||91
10320330|NCT00236977|11454876|FG001|STARTED|Overall Study||91
10320331|NCT00236977|11454875|FG000|COMPLETED|Overall Study||70
10320332|NCT00236977|11454876|FG001|COMPLETED|Overall Study||72
10320333|NCT00236977|11454875|FG000|NOT COMPLETED|Overall Study||21
10320334|NCT00236977|11454876|FG001|NOT COMPLETED|Overall Study||19
10320335|NCT00237042|11454885|FG000|STARTED|Treatment||60
10320336|NCT00237042|11454886|FG001|STARTED|Treatment||57
10320337|NCT00237042|11454887|FG002|STARTED|Treatment||74
10320338|NCT00237042|11454885|FG000|COMPLETED|Treatment||54
10320339|NCT00237042|11454886|FG001|COMPLETED|Treatment||50
10320340|NCT00237042|11454887|FG002|COMPLETED|Treatment||36
10320341|NCT00237042|11454885|FG000|NOT COMPLETED|Treatment||6
10320342|NCT00237042|11454886|FG001|NOT COMPLETED|Treatment||7
10320343|NCT00237042|11454887|FG002|NOT COMPLETED|Treatment||38
10320344|NCT00237042|11454885|FG000|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|59
10320345|NCT00237042|11454886|FG001|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|55
10320346|NCT00237042|11454887|FG002|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|57
10320347|NCT00237042|11454885|FG000|COMPLETED|Short Term (6 Month) Follow up||50
10320348|NCT00237042|11454886|FG001|COMPLETED|Short Term (6 Month) Follow up||47
10320349|NCT00237042|11454887|FG002|COMPLETED|Short Term (6 Month) Follow up||46
10320350|NCT00237042|11454885|FG000|NOT COMPLETED|Short Term (6 Month) Follow up||9
10320351|NCT00237042|11454886|FG001|NOT COMPLETED|Short Term (6 Month) Follow up||8
10320352|NCT00237042|11454887|FG002|NOT COMPLETED|Short Term (6 Month) Follow up||11
10320353|NCT00237042|11454885|FG000|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|59
10320354|NCT00237042|11454886|FG001|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|55
10320355|NCT00237042|11454887|FG002|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|57
10320356|NCT00237042|11454885|FG000|COMPLETED|Long Term (12 Month) Follow up||48
10320357|NCT00237042|11454886|FG001|COMPLETED|Long Term (12 Month) Follow up||46
10320358|NCT00237042|11454887|FG002|COMPLETED|Long Term (12 Month) Follow up||48
10320359|NCT00237042|11454885|FG000|NOT COMPLETED|Long Term (12 Month) Follow up||11
10320360|NCT00237042|11454886|FG001|NOT COMPLETED|Long Term (12 Month) Follow up||9
10320361|NCT00237042|11454887|FG002|NOT COMPLETED|Long Term (12 Month) Follow up||9
10320362|NCT00237185|11454897|FG000|STARTED|Core||74
10320363|NCT00237185|11454898|FG001|STARTED|Core||74
10320364|NCT00237185|11454897|FG000|Treated Participants|Core||73
10320365|NCT00237185|11454898|FG001|Treated Participants|Core||74
10320366|NCT00237185|11454897|FG000|COMPLETED|Core||30
10320367|NCT00237185|11454898|FG001|COMPLETED|Core||37
10320368|NCT00237185|11454897|FG000|NOT COMPLETED|Core||44
10320369|NCT00237185|11454898|FG001|NOT COMPLETED|Core||37
10320370|NCT00237185|11454897|FG000|STARTED|Extension|A portion of the participants, who completed the core, entered the extension.|24
10320371|NCT00237185|11454898|FG001|STARTED|Extension|A portion of the participants, who completed the core, entered the extension.|32
10320372|NCT00237185|11454897|FG000|COMPLETED|Extension||8
10320373|NCT00237185|11454898|FG001|COMPLETED|Extension||13
10320374|NCT00237185|11454897|FG000|NOT COMPLETED|Extension||16
10320375|NCT00237185|11454898|FG001|NOT COMPLETED|Extension||19
10320376|NCT00237458|11454904|FG000|STARTED|Overall Study||7
10320377|NCT00237458|11454904|FG000|COMPLETED|Overall Study||4
10320378|NCT00237458|11454904|FG000|NOT COMPLETED|Overall Study||3
10320379|NCT00237666|11454908|FG000|STARTED|Overall Study||30
10320380|NCT00237666|11454908|FG000|COMPLETED|Overall Study||24
10320381|NCT00237666|11454908|FG000|NOT COMPLETED|Overall Study||6
10320382|NCT00237692|11454916|FG000|STARTED|Overall Study||147
10320383|NCT00237692|11454917|FG001|STARTED|Overall Study||148
10701484|NCT02567656|11865955|FG002|STARTED|Overall Study||5
10701485|NCT02567656|11865956|FG003|STARTED|Overall Study||6
10701486|NCT02567656|11865957|FG004|STARTED|Overall Study||19
10803681|NCT04117607|11965078|FG006|NOT COMPLETED|Overall Study||1
10803682|NCT04117607|11965079|FG007|NOT COMPLETED|Overall Study||0
10803683|NCT04117607|11965080|FG008|NOT COMPLETED|Overall Study||0
10455760|NCT01004393|11603912|FG000|NOT COMPLETED|Overall Study||0
10803684|NCT04117607|11965081|FG009|NOT COMPLETED|Overall Study||0
10320384|NCT00237692|11454918|FG002|STARTED|Overall Study||149
10320385|NCT00237692|11454919|FG003|STARTED|Overall Study||147
10455761|NCT01004406|11603918|FG000|STARTED|Overall Study||21
10455762|NCT01004406|11603919|FG001|STARTED|Overall Study||10
10455763|NCT01004406|11603918|FG000|COMPLETED|Overall Study||18
10701487|NCT02567656|11865958|FG005|STARTED|Overall Study||20
10701488|NCT02567656|11865953|FG000|COMPLETED|Overall Study||3
10701489|NCT02567656|11865954|FG001|COMPLETED|Overall Study||3
10701490|NCT02567656|11865955|FG002|COMPLETED|Overall Study||3
10701491|NCT02567656|11865956|FG003|COMPLETED|Overall Study||6
10701492|NCT02567656|11865957|FG004|COMPLETED|Overall Study||19
10701493|NCT02567656|11865958|FG005|COMPLETED|Overall Study||20
10320386|NCT00237692|11454916|FG000|6 Month f/u|Overall Study||132
10320387|NCT00237692|11454917|FG001|6 Month f/u|Overall Study||134
10320388|NCT00237692|11454918|FG002|6 Month f/u|Overall Study||135
10320389|NCT00237692|11454919|FG003|6 Month f/u|Overall Study||134
10320390|NCT00237692|11454916|FG000|12 Month f/u|Overall Study||137
10320391|NCT00237692|11454917|FG001|12 Month f/u|Overall Study||127
10320392|NCT00237692|11454918|FG002|12 Month f/u|Overall Study||132
10320393|NCT00237692|11454919|FG003|12 Month f/u|Overall Study||127
10701494|NCT02567656|11865953|FG000|NOT COMPLETED|Overall Study||1
10701495|NCT02567656|11865954|FG001|NOT COMPLETED|Overall Study||1
10320394|NCT00237692|11454916|FG000|18 Month f/u|Overall Study||124
10320395|NCT00237692|11454917|FG001|18 Month f/u|Overall Study||131
10320396|NCT00237692|11454918|FG002|18 Month f/u|Overall Study||126
10320397|NCT00237692|11454919|FG003|18 Month f/u|Overall Study||122
10320398|NCT00237692|11454916|FG000|COMPLETED|Overall Study||129
10320399|NCT00237692|11454917|FG001|COMPLETED|Overall Study||134
10320400|NCT00237692|11454918|FG002|COMPLETED|Overall Study||127
10320401|NCT00237692|11454919|FG003|COMPLETED|Overall Study||128
10320402|NCT00237692|11454916|FG000|NOT COMPLETED|Overall Study||18
10320403|NCT00237692|11454917|FG001|NOT COMPLETED|Overall Study||14
10320404|NCT00237692|11454918|FG002|NOT COMPLETED|Overall Study||22
10320405|NCT00237692|11454919|FG003|NOT COMPLETED|Overall Study||19
10320406|NCT00237718|11454931|FG000|STARTED|Overall Study||160
10320407|NCT00237718|11454932|FG001|STARTED|Overall Study||165
10320408|NCT00237718|11454931|FG000|COMPLETED|Overall Study||114
10320409|NCT00237718|11454932|FG001|COMPLETED|Overall Study||124
10320410|NCT00237718|11454931|FG000|NOT COMPLETED|Overall Study||46
10320411|NCT00237718|11454932|FG001|NOT COMPLETED|Overall Study||41
10320412|NCT00237744|11454941|FG000|STARTED|Overall Study||11
10320413|NCT00237744|11454942|FG001|STARTED|Overall Study||11
10320414|NCT00237744|11454943|FG002|STARTED|Overall Study||18
10320415|NCT00237744|11454941|FG000|COMPLETED|Overall Study||8
10320416|NCT00237744|11454942|FG001|COMPLETED|Overall Study||10
10320417|NCT00237744|11454943|FG002|COMPLETED|Overall Study||18
10320418|NCT00237744|11454941|FG000|NOT COMPLETED|Overall Study||3
10320419|NCT00237744|11454942|FG001|NOT COMPLETED|Overall Study||1
10320420|NCT00237744|11454943|FG002|NOT COMPLETED|Overall Study||0
10320421|NCT00237770|11454956|FG000|STARTED|Overall Study||9
10320422|NCT00237770|11454957|FG001|STARTED|Overall Study||7
10320423|NCT00237770|11454956|FG000|COMPLETED|Overall Study||9
10320424|NCT00237770|11454957|FG001|COMPLETED|Overall Study||7
10320425|NCT00237770|11454956|FG000|NOT COMPLETED|Overall Study||0
10320426|NCT00237770|11454957|FG001|NOT COMPLETED|Overall Study||0
10320427|NCT00237796|11454969|FG000|STARTED|Overall Study||41
10320428|NCT00237796|11454970|FG001|STARTED|Overall Study||38
10320429|NCT00237796|11454969|FG000|COMPLETED|Overall Study||31
10320430|NCT00237796|11454970|FG001|COMPLETED|Overall Study||33
10320431|NCT00237796|11454969|FG000|NOT COMPLETED|Overall Study||10
10320432|NCT00237796|11454970|FG001|NOT COMPLETED|Overall Study||5
10320433|NCT00237809|11454981|FG000|STARTED|Overall Study||27
10320434|NCT00237809|11454982|FG001|STARTED|Overall Study||27
10320435|NCT00237809|11454983|FG002|STARTED|Overall Study||24
10320436|NCT00237809|11454984|FG003|STARTED|Overall Study||26
10320437|NCT00237809|11454981|FG000|COMPLETED|Overall Study||16
10320438|NCT00237809|11454982|FG001|COMPLETED|Overall Study||17
10320439|NCT00237809|11454983|FG002|COMPLETED|Overall Study||15
10320440|NCT00237809|11454984|FG003|COMPLETED|Overall Study||17
10320441|NCT00237809|11454981|FG000|NOT COMPLETED|Overall Study||11
10320442|NCT00237809|11454982|FG001|NOT COMPLETED|Overall Study||10
10320443|NCT00237809|11454983|FG002|NOT COMPLETED|Overall Study||9
10320444|NCT00237809|11454984|FG003|NOT COMPLETED|Overall Study||9
10320445|NCT00238108|11454996|FG000|STARTED|Overall Study||8
10320446|NCT00238108|11454997|FG001|STARTED|Overall Study||8
10320447|NCT00238108|11454996|FG000|COMPLETED|Overall Study||8
10701496|NCT02567656|11865955|FG002|NOT COMPLETED|Overall Study||2
10701497|NCT02567656|11865956|FG003|NOT COMPLETED|Overall Study||0
10701498|NCT02567656|11865957|FG004|NOT COMPLETED|Overall Study||0
10701499|NCT02567656|11865958|FG005|NOT COMPLETED|Overall Study||0
10701500|NCT02567708|11865972|FG000|STARTED|Treatment Period 1 (Up to 4 Weeks)||24
10320448|NCT00238108|11454997|FG001|COMPLETED|Overall Study||8
10320449|NCT00238108|11454996|FG000|NOT COMPLETED|Overall Study||0
10320450|NCT00238108|11454997|FG001|NOT COMPLETED|Overall Study||0
10320451|NCT00238121|11455005|FG000|STARTED|Overall Study||40
10320452|NCT00238121|11455006|FG001|STARTED|Overall Study||16
10320453|NCT00238121|11455005|FG000|COMPLETED|Overall Study||37
10320454|NCT00238121|11455006|FG001|COMPLETED|Overall Study||14
10320455|NCT00238121|11455005|FG000|NOT COMPLETED|Overall Study||3
10320456|NCT00238121|11455006|FG001|NOT COMPLETED|Overall Study||2
10320457|NCT00238238|11455014|FG000|STARTED|Overall Study||3
10320458|NCT00238238|11455015|FG001|STARTED|Overall Study||48
10320459|NCT00238238|11455016|FG002|STARTED|Overall Study||46
10320460|NCT00238238|11455014|FG000|COMPLETED|Overall Study||3
10320461|NCT00238238|11455015|FG001|COMPLETED|Overall Study||45
10320462|NCT00238238|11455016|FG002|COMPLETED|Overall Study||46
10320463|NCT00238238|11455014|FG000|NOT COMPLETED|Overall Study||0
10320464|NCT00238238|11455015|FG001|NOT COMPLETED|Overall Study||3
10320465|NCT00238238|11455016|FG002|NOT COMPLETED|Overall Study||0
10320466|NCT00238264|11455024|FG000|STARTED|Overall Study||92
10320467|NCT00238264|11455024|FG000|COMPLETED|Overall Study||56
10320468|NCT00238264|11455024|FG000|NOT COMPLETED|Overall Study||36
10320469|NCT00238303|11455031|FG000|STARTED|Overall Study||68
10320470|NCT00238303|11455032|FG001|STARTED|Overall Study||15
10320471|NCT00238303|11455033|FG002|STARTED|Overall Study||20
10320472|NCT00238303|11455031|FG000|COMPLETED|Overall Study||53
10320473|NCT00238303|11455032|FG001|COMPLETED|Overall Study||13
10320474|NCT00238303|11455033|FG002|COMPLETED|Overall Study||11
10320475|NCT00238303|11455031|FG000|NOT COMPLETED|Overall Study||15
10320476|NCT00238303|11455032|FG001|NOT COMPLETED|Overall Study||2
10320477|NCT00238303|11455033|FG002|NOT COMPLETED|Overall Study||9
10320478|NCT00238355|11455042|FG000|STARTED|Overall Study||13
10320479|NCT00238355|11455042|FG000|COMPLETED|Overall Study||10
10320480|NCT00238355|11455042|FG000|NOT COMPLETED|Overall Study||3
10713913|NCT02683668|11879480|FG002|STARTED|Period 1||0
10320481|NCT00238433|11455046|FG000|STARTED|Overall Study||37
10320482|NCT00238433|11455046|FG000|COMPLETED|Overall Study||34
10320483|NCT00238433|11455046|FG000|NOT COMPLETED|Overall Study||3
10320484|NCT00238615|11455051|FG000|STARTED|Overall Study||13
10320485|NCT00238615|11455051|FG000|COMPLETED|Overall Study||13
10320486|NCT00238615|11455051|FG000|NOT COMPLETED|Overall Study||0
10320487|NCT00239005|11455059|FG000|STARTED|Overall Study||69
10320488|NCT00239005|11455060|FG001|STARTED|Overall Study||65
10320489|NCT00239005|11455059|FG000|Intention-to-treat Population (ITT)|Overall Study||68
10320490|NCT00239005|11455060|FG001|Intention-to-treat Population (ITT)|Overall Study||61
10320491|NCT00239005|11455059|FG000|COMPLETED|Overall Study||57
10320492|NCT00239005|11455060|FG001|COMPLETED|Overall Study||53
10320493|NCT00239005|11455059|FG000|NOT COMPLETED|Overall Study||12
10320494|NCT00239005|11455060|FG001|NOT COMPLETED|Overall Study||12
10701501|NCT02567708|11865973|FG001|STARTED|Treatment Period 1 (Up to 4 Weeks)||26
10701502|NCT02567708|11865972|FG000|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||22
10701503|NCT02567708|11865973|FG001|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||23
10701504|NCT02567708|11865972|FG000|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||2
10320495|NCT00239226|11455070|FG000|STARTED|Overall Study||30
10320496|NCT00239226|11455071|FG001|STARTED|Overall Study||18
10320497|NCT00239226|11455072|FG002|STARTED|Overall Study||37
10320498|NCT00239226|11455073|FG003|STARTED|Overall Study||17
10320499|NCT00239226|11455070|FG000|COMPLETED|Overall Study||29
10701505|NCT02567708|11865973|FG001|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||3
10701506|NCT02567708|11865972|FG000|STARTED|Washout Period (Up to 4 Weeks)||22
10701507|NCT02567708|11865973|FG001|STARTED|Washout Period (Up to 4 Weeks)||23
10701508|NCT02567708|11865972|FG000|COMPLETED|Washout Period (Up to 4 Weeks)||22
10701509|NCT02567708|11865973|FG001|COMPLETED|Washout Period (Up to 4 Weeks)||23
10701510|NCT02567708|11865972|FG000|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
10320500|NCT00239226|11455071|FG001|COMPLETED|Overall Study||18
10320501|NCT00239226|11455072|FG002|COMPLETED|Overall Study||36
10320502|NCT00239226|11455073|FG003|COMPLETED|Overall Study||14
10320503|NCT00239226|11455070|FG000|NOT COMPLETED|Overall Study||1
10320504|NCT00239226|11455071|FG001|NOT COMPLETED|Overall Study||0
10320505|NCT00239226|11455072|FG002|NOT COMPLETED|Overall Study||1
10320506|NCT00239226|11455073|FG003|NOT COMPLETED|Overall Study||3
10320507|NCT00239356|11455085|FG000|STARTED|Overall Study||97
10320508|NCT00239356|11455086|FG001|STARTED|Overall Study||20
10320509|NCT00239356|11455085|FG000|COMPLETED|Overall Study||58
10320510|NCT00239356|11455086|FG001|COMPLETED|Overall Study||11
10320511|NCT00239356|11455085|FG000|NOT COMPLETED|Overall Study||39
10320512|NCT00239356|11455086|FG001|NOT COMPLETED|Overall Study||9
10320513|NCT00239577|11455096|FG000|STARTED|Primary Phase||22
10320514|NCT00239577|11455097|FG001|STARTED|Primary Phase||22
10320515|NCT00239577|11455098|FG002|STARTED|Primary Phase||21
10320516|NCT00239577|11455099|FG003|STARTED|Primary Phase||21
10320517|NCT00239577|11455096|FG000|COMPLETED|Primary Phase||17
10320518|NCT00239577|11455097|FG001|COMPLETED|Primary Phase||19
10320519|NCT00239577|11455098|FG002|COMPLETED|Primary Phase||18
10320520|NCT00239577|11455099|FG003|COMPLETED|Primary Phase||21
10320521|NCT00239577|11455096|FG000|NOT COMPLETED|Primary Phase||5
10320522|NCT00239577|11455097|FG001|NOT COMPLETED|Primary Phase||3
10320523|NCT00239577|11455098|FG002|NOT COMPLETED|Primary Phase||3
10320524|NCT00239577|11455099|FG003|NOT COMPLETED|Primary Phase||0
10320525|NCT00239577|11455096|FG000|STARTED|Booster Phase|The subjects belonging to this group did not receive a booster dose of Dengue vaccine.|0
10320526|NCT00239577|11455097|FG001|STARTED|Booster Phase||9
10320527|NCT00239577|11455098|FG002|STARTED|Booster Phase||12
10320528|NCT00239577|11455099|FG003|STARTED|Booster Phase|The subjects belonging to this group did not receive an additional dose of Placebo.|0
10320529|NCT00239577|11455096|FG000|COMPLETED|Booster Phase|The subjects belonging to this group did not receive a booster dose of Dengue vaccine.|0
10320530|NCT00239577|11455097|FG001|COMPLETED|Booster Phase||9
10320531|NCT00239577|11455098|FG002|COMPLETED|Booster Phase||12
10320532|NCT00239577|11455099|FG003|COMPLETED|Booster Phase|The subjects belonging to this group did not receive an additional dose of Placebo.|0
10320533|NCT00239577|11455096|FG000|NOT COMPLETED|Booster Phase||0
10701511|NCT02567708|11865973|FG001|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
10701512|NCT02567708|11865972|FG000|STARTED|Treatment Period 2 (Up to 4 Weeks)||22
10701513|NCT02567708|11865973|FG001|STARTED|Treatment Period 2 (Up to 4 Weeks)||23
10701514|NCT02567708|11865972|FG000|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||22
10701515|NCT02567708|11865973|FG001|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||20
10701516|NCT02567708|11865972|FG000|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0
10701517|NCT02567708|11865973|FG001|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||3
10701518|NCT02567968|11865980|FG000|STARTED|First Intervention||4
10320534|NCT00239577|11455097|FG001|NOT COMPLETED|Booster Phase||0
10320535|NCT00239577|11455098|FG002|NOT COMPLETED|Booster Phase||0
10320536|NCT00239577|11455099|FG003|NOT COMPLETED|Booster Phase||0
10320537|NCT00239590|11455111|FG000|STARTED|Randomized||14
10701519|NCT02567968|11865981|FG001|STARTED|First Intervention||4
10320538|NCT00239590|11455112|FG001|STARTED|Randomized||14
10320539|NCT00239590|11455111|FG000|COMPLETED|Randomized||14
10320540|NCT00239590|11455112|FG001|COMPLETED|Randomized||12
10320541|NCT00239590|11455111|FG000|NOT COMPLETED|Randomized||0
10320542|NCT00239590|11455112|FG001|NOT COMPLETED|Randomized||2
10320543|NCT00239590|11455111|FG000|STARTED|Started Intervention After Randomization||14
10320544|NCT00239590|11455112|FG001|STARTED|Started Intervention After Randomization||12
10338431|NCT00369668|11475299|FG001|STARTED|Overall Study||10
10320545|NCT00239590|11455111|FG000|COMPLETED|Started Intervention After Randomization||14
10320546|NCT00239590|11455112|FG001|COMPLETED|Started Intervention After Randomization||12
10320547|NCT00239590|11455111|FG000|NOT COMPLETED|Started Intervention After Randomization||0
10320548|NCT00239590|11455112|FG001|NOT COMPLETED|Started Intervention After Randomization||0
10320549|NCT00239590|11455111|FG000|STARTED|Completed Study Protocol||14
10320550|NCT00239590|11455112|FG001|STARTED|Completed Study Protocol||12
10320551|NCT00239590|11455111|FG000|COMPLETED|Completed Study Protocol||13
10320552|NCT00239590|11455112|FG001|COMPLETED|Completed Study Protocol||10
10320553|NCT00239590|11455111|FG000|NOT COMPLETED|Completed Study Protocol||1
10320554|NCT00239590|11455112|FG001|NOT COMPLETED|Completed Study Protocol||2
10803685|NCT04117607|11965082|FG010|NOT COMPLETED|Overall Study||0
10320555|NCT00239642|11455123|FG000|STARTED|Overall Study||49
10320556|NCT00239642|11455124|FG001|STARTED|Overall Study||47
10320557|NCT00239642|11455125|FG002|STARTED|Overall Study||49
10320558|NCT00239642|11455123|FG000|COMPLETED|Overall Study||47
10320559|NCT00239642|11455124|FG001|COMPLETED|Overall Study||47
10320560|NCT00239642|11455125|FG002|COMPLETED|Overall Study||47
10320561|NCT00239642|11455123|FG000|NOT COMPLETED|Overall Study||2
10320562|NCT00239642|11455124|FG001|NOT COMPLETED|Overall Study||0
10320563|NCT00239642|11455125|FG002|NOT COMPLETED|Overall Study||2
10320564|NCT00239681|11455135|FG000|STARTED|Overall Study||8901
10320565|NCT00239681|11455136|FG001|STARTED|Overall Study||8901
10320566|NCT00239681|11455135|FG000|Randomized and Treated (Safety Pop)|Overall Study||8869
10320567|NCT00239681|11455136|FG001|Randomized and Treated (Safety Pop)|Overall Study||8864
10320568|NCT00239681|11455135|FG000|COMPLETED|Overall Study||8208
10320569|NCT00239681|11455136|FG001|COMPLETED|Overall Study||8186
10803686|NCT04117607|11965083|FG011|NOT COMPLETED|Overall Study||0
10803687|NCT04117607|11965084|FG012|NOT COMPLETED|Overall Study||0
10803688|NCT04117607|11965085|FG013|NOT COMPLETED|Overall Study||0
10803689|NCT04116684|11965103|FG000|STARTED|Overall Study||3
10803690|NCT04116684|11965104|FG001|STARTED|Overall Study||1
10803691|NCT04116684|11965103|FG000|COMPLETED|Overall Study||1
10803692|NCT04116684|11965104|FG001|COMPLETED|Overall Study||1
10803693|NCT04116684|11965103|FG000|NOT COMPLETED|Overall Study||2
10803694|NCT04116684|11965104|FG001|NOT COMPLETED|Overall Study||0
10803695|NCT04096365|11965110|FG000|STARTED|Overall Study||12
10803696|NCT04096365|11965110|FG000|COMPLETED|Overall Study||11
10803697|NCT04096365|11965110|FG000|NOT COMPLETED|Overall Study||1
10320570|NCT00239681|11455135|FG000|NOT COMPLETED|Overall Study||693
10320571|NCT00239681|11455136|FG001|NOT COMPLETED|Overall Study||715
10320572|NCT00239733|11455142|FG000|STARTED|Overall Study||6
10320573|NCT00239733|11455142|FG000|COMPLETED|Overall Study||6
10320574|NCT00239733|11455142|FG000|NOT COMPLETED|Overall Study||0
10320575|NCT00239837|11455148|FG000|STARTED|Overall Study||48
10320576|NCT00239837|11455149|FG001|STARTED|Overall Study||52
10320577|NCT00239837|11455148|FG000|6 Months|Overall Study||48
10320578|NCT00239837|11455149|FG001|6 Months|Overall Study||50
10320579|NCT00239837|11455148|FG000|COMPLETED|Overall Study|3-year follow-up|45
10320580|NCT00239837|11455149|FG001|COMPLETED|Overall Study|3-year follow-up|45
10320581|NCT00239837|11455148|FG000|NOT COMPLETED|Overall Study||3
10320582|NCT00239837|11455149|FG001|NOT COMPLETED|Overall Study||7
10320583|NCT00239928|11455157|FG000|STARTED|Overall Study||61
10320584|NCT00239928|11455157|FG000|COMPLETED|Overall Study||51
10320585|NCT00239928|11455157|FG000|NOT COMPLETED|Overall Study||10
10320586|NCT00240071|11455161|FG000|STARTED|Overall Study||30
10320587|NCT00240071|11455161|FG000|COMPLETED|Overall Study|3 patients withdrew consent after 29, 5 and 3 1/2 months on study.|27
10320588|NCT00240071|11455161|FG000|NOT COMPLETED|Overall Study||3
10320589|NCT00240097|11455166|FG000|STARTED|Part I||30
10320590|NCT00240097|11455166|FG000|COMPLETED|Part I||26
10320591|NCT00240097|11455166|FG000|NOT COMPLETED|Part I||4
10320592|NCT00240097|11455166|FG000|STARTED|Part II||26
10320593|NCT00240097|11455166|FG000|COMPLETED|Part II||3
10320594|NCT00240097|11455166|FG000|NOT COMPLETED|Part II||23
10320595|NCT00240110|11455176|FG000|STARTED|Overall Study||13
10320596|NCT00240110|11455177|FG001|STARTED|Overall Study||13
10320597|NCT00240110|11455176|FG000|COMPLETED|Overall Study||7
10320598|NCT00240110|11455177|FG001|COMPLETED|Overall Study||6
10320599|NCT00240110|11455176|FG000|NOT COMPLETED|Overall Study||6
10320600|NCT00240110|11455177|FG001|NOT COMPLETED|Overall Study||7
10320601|NCT00240162|11455185|FG000|STARTED|Overall Study||21
10320602|NCT00240162|11455185|FG000|COMPLETED|Overall Study||21
10803698|NCT04080297|11965116|FG000|STARTED|Overall Study||10
10803699|NCT04080297|11965117|FG001|STARTED|Overall Study||11
10320603|NCT00240162|11455185|FG000|NOT COMPLETED|Overall Study||0
10803700|NCT04080297|11965116|FG000|COMPLETED|Overall Study||8
10803701|NCT04080297|11965117|FG001|COMPLETED|Overall Study||8
10803702|NCT04080297|11965116|FG000|NOT COMPLETED|Overall Study||2
10320604|NCT00240331|11455191|FG000|STARTED|Overall Study|Two patients were incorrectly randomised and not included in the analyses.|1389
10320605|NCT00240331|11455192|FG001|STARTED|Overall Study|One patient was incorrectly randomised and not included in the analyses|1384
10320606|NCT00240331|11455191|FG000|COMPLETED|Overall Study|Vital status was obtained for all randomised patients at the end of the study|1263
10320607|NCT00240331|11455192|FG001|COMPLETED|Overall Study|Vital status was obtained for all randomised patients at the end of the study|1250
10320608|NCT00240331|11455191|FG000|NOT COMPLETED|Overall Study||126
10320609|NCT00240331|11455192|FG001|NOT COMPLETED|Overall Study||134
10338432|NCT00369668|11475300|FG002|STARTED|Overall Study||10
10338433|NCT00369668|11475298|FG000|COMPLETED|Overall Study||6
10338434|NCT00369668|11475299|FG001|COMPLETED|Overall Study||5
10803703|NCT04080297|11965117|FG001|NOT COMPLETED|Overall Study||3
10320610|NCT00240487|11455200|FG000|STARTED|Overall Study||24
10320611|NCT00240487|11455201|FG001|STARTED|Overall Study||28
10320612|NCT00240487|11455200|FG000|COMPLETED|Overall Study||24
10320613|NCT00240487|11455201|FG001|COMPLETED|Overall Study||28
10320614|NCT00240487|11455200|FG000|NOT COMPLETED|Overall Study||0
10320615|NCT00240487|11455201|FG001|NOT COMPLETED|Overall Study||0
10320616|NCT00240526|11455211|FG000|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|19
10320617|NCT00240526|11455212|FG001|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|19
10320618|NCT00240526|11455213|FG002|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|14
10320619|NCT00240526|11455214|FG003|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|21
10320620|NCT00240526|11455211|FG000|COMPLETED|Year 15||19
10320621|NCT00240526|11455212|FG001|COMPLETED|Year 15||19
10320622|NCT00240526|11455213|FG002|COMPLETED|Year 15||14
10320623|NCT00240526|11455214|FG003|COMPLETED|Year 15||21
10320624|NCT00240526|11455211|FG000|NOT COMPLETED|Year 15||0
10320625|NCT00240526|11455212|FG001|NOT COMPLETED|Year 15||0
10320626|NCT00240526|11455213|FG002|NOT COMPLETED|Year 15||0
10320627|NCT00240526|11455214|FG003|NOT COMPLETED|Year 15||0
10320628|NCT00240526|11455211|FG000|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|17
10320629|NCT00240526|11455212|FG001|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|19
10320630|NCT00240526|11455213|FG002|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|16
10320631|NCT00240526|11455214|FG003|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|22
10320632|NCT00240526|11455211|FG000|COMPLETED|Year 16||17
10320633|NCT00240526|11455212|FG001|COMPLETED|Year 16||19
10320634|NCT00240526|11455213|FG002|COMPLETED|Year 16||16
10320635|NCT00240526|11455214|FG003|COMPLETED|Year 16||22
10320636|NCT00240526|11455211|FG000|NOT COMPLETED|Year 16||0
10320637|NCT00240526|11455212|FG001|NOT COMPLETED|Year 16||0
10320638|NCT00240526|11455213|FG002|NOT COMPLETED|Year 16||0
10320639|NCT00240526|11455214|FG003|NOT COMPLETED|Year 16||0
10320640|NCT00240526|11455211|FG000|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|19
10320641|NCT00240526|11455212|FG001|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|17
10320642|NCT00240526|11455213|FG002|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|13
10320643|NCT00240526|11455214|FG003|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|20
10320644|NCT00240526|11455211|FG000|COMPLETED|Year 17||19
10320645|NCT00240526|11455212|FG001|COMPLETED|Year 17||17
10320646|NCT00240526|11455213|FG002|COMPLETED|Year 17||13
10320647|NCT00240526|11455214|FG003|COMPLETED|Year 17||20
10320648|NCT00240526|11455211|FG000|NOT COMPLETED|Year 17||0
10320649|NCT00240526|11455212|FG001|NOT COMPLETED|Year 17||0
10320650|NCT00240526|11455213|FG002|NOT COMPLETED|Year 17||0
10320651|NCT00240526|11455214|FG003|NOT COMPLETED|Year 17||0
10320652|NCT00240526|11455211|FG000|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|16
10320653|NCT00240526|11455212|FG001|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|17
10320654|NCT00240526|11455213|FG002|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|14
10320655|NCT00240526|11455214|FG003|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|20
10320656|NCT00240526|11455211|FG000|COMPLETED|Year 18||16
10320657|NCT00240526|11455212|FG001|COMPLETED|Year 18||17
10320658|NCT00240526|11455213|FG002|COMPLETED|Year 18||14
10320659|NCT00240526|11455214|FG003|COMPLETED|Year 18||20
10320660|NCT00240526|11455211|FG000|NOT COMPLETED|Year 18||0
10320661|NCT00240526|11455212|FG001|NOT COMPLETED|Year 18||0
10320662|NCT00240526|11455213|FG002|NOT COMPLETED|Year 18||0
10320663|NCT00240526|11455214|FG003|NOT COMPLETED|Year 18||0
10320664|NCT00240526|11455211|FG000|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|17
10701529|NCT02567968|11865981|FG001|NOT COMPLETED|Washout (2 Weeks)||0
10320665|NCT00240526|11455212|FG001|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|16
10320666|NCT00240526|11455213|FG002|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|12
10320667|NCT00240526|11455214|FG003|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|18
10320668|NCT00240526|11455211|FG000|COMPLETED|Year 19||17
10320669|NCT00240526|11455212|FG001|COMPLETED|Year 19||16
10320670|NCT00240526|11455213|FG002|COMPLETED|Year 19||12
10320671|NCT00240526|11455214|FG003|COMPLETED|Year 19||18
10320672|NCT00240526|11455211|FG000|NOT COMPLETED|Year 19||0
10320673|NCT00240526|11455212|FG001|NOT COMPLETED|Year 19||0
10320674|NCT00240526|11455213|FG002|NOT COMPLETED|Year 19||0
10320675|NCT00240526|11455214|FG003|NOT COMPLETED|Year 19||0
10320676|NCT00240526|11455211|FG000|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|19
10320677|NCT00240526|11455212|FG001|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|17
10320678|NCT00240526|11455213|FG002|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|13
10320679|NCT00240526|11455214|FG003|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|20
10320680|NCT00240526|11455211|FG000|COMPLETED|Year 20||19
10320681|NCT00240526|11455212|FG001|COMPLETED|Year 20||17
10320682|NCT00240526|11455213|FG002|COMPLETED|Year 20||13
10320683|NCT00240526|11455214|FG003|COMPLETED|Year 20||20
10320684|NCT00240526|11455211|FG000|NOT COMPLETED|Year 20||0
10320685|NCT00240526|11455212|FG001|NOT COMPLETED|Year 20||0
10320686|NCT00240526|11455213|FG002|NOT COMPLETED|Year 20||0
10320687|NCT00240526|11455214|FG003|NOT COMPLETED|Year 20||0
10320688|NCT00240539|11455232|FG000|STARTED|Overall Study||2
10320689|NCT00240539|11455233|FG001|STARTED|Overall Study||2
10320690|NCT00240539|11455234|FG002|STARTED|Overall Study||31
10320691|NCT00240539|11455235|FG003|STARTED|Overall Study||1
10320692|NCT00240539|11455232|FG000|COMPLETED|Overall Study||2
10320693|NCT00240539|11455233|FG001|COMPLETED|Overall Study||2
10320694|NCT00240539|11455234|FG002|COMPLETED|Overall Study||31
10455764|NCT01004406|11603919|FG001|COMPLETED|Overall Study||10
10455765|NCT01004406|11603918|FG000|NOT COMPLETED|Overall Study||3
10455766|NCT01004406|11603919|FG001|NOT COMPLETED|Overall Study||0
10455767|NCT01004432|11603925|FG000|STARTED|Open-label (OL) Period (Week 0 - 16)||433
10574630|NCT01679314|11729889|FG001|COMPLETED|Overall Study||28
10574631|NCT01679314|11729888|FG000|NOT COMPLETED|Overall Study||2
10574632|NCT01679314|11729889|FG001|NOT COMPLETED|Overall Study||0
10574633|NCT01679405|11729901|FG000|STARTED|Overall Study||3
10701520|NCT02567968|11865980|FG000|COMPLETED|First Intervention||4
10701521|NCT02567968|11865981|FG001|COMPLETED|First Intervention||4
10701522|NCT02567968|11865980|FG000|NOT COMPLETED|First Intervention||0
10701523|NCT02567968|11865981|FG001|NOT COMPLETED|First Intervention||0
10701524|NCT02567968|11865980|FG000|STARTED|Washout (2 Weeks)||4
10455768|NCT01004432|11603926|FG001|STARTED|Open-label (OL) Period (Week 0 - 16)||0
10455769|NCT01004432|11603927|FG002|STARTED|Open-label (OL) Period (Week 0 - 16)||0
10455770|NCT01004432|11603928|FG003|STARTED|Open-label (OL) Period (Week 0 - 16)||0
10455771|NCT01004432|11603929|FG004|STARTED|Open-label (OL) Period (Week 0 - 16)||0
10455772|NCT01004432|11603925|FG000|COMPLETED|Open-label (OL) Period (Week 0 - 16)|1 Participant died after completing open-label period. Discontinuation was noted as adverse event.|350
10455773|NCT01004432|11603926|FG001|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
10455774|NCT01004432|11603927|FG002|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
10455775|NCT01004432|11603928|FG003|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
10455776|NCT01004432|11603929|FG004|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
10455777|NCT01004432|11603925|FG000|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||83
10455778|NCT01004432|11603926|FG001|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
10455779|NCT01004432|11603927|FG002|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
10455780|NCT01004432|11603928|FG003|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
10455781|NCT01004432|11603929|FG004|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
10455782|NCT01004432|11603925|FG000|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||0
10455783|NCT01004432|11603926|FG001|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||75
10455784|NCT01004432|11603927|FG002|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||91
10455785|NCT01004432|11603928|FG003|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||184
10455786|NCT01004432|11603929|FG004|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||0
10455787|NCT01004432|11603925|FG000|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
10455788|NCT01004432|11603926|FG001|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||65
10455789|NCT01004432|11603927|FG002|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||54
10455790|NCT01004432|11603928|FG003|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||126
10455791|NCT01004432|11603929|FG004|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
10455792|NCT01004432|11603925|FG000|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
10455793|NCT01004432|11603926|FG001|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||10
10455794|NCT01004432|11603927|FG002|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||37
10455795|NCT01004432|11603928|FG003|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||58
10455796|NCT01004432|11603929|FG004|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
10455797|NCT01004432|11603925|FG000|STARTED|OL Study Extension (Week 52 - 76)||0
10701525|NCT02567968|11865981|FG001|STARTED|Washout (2 Weeks)||4
10320695|NCT00240539|11455235|FG003|COMPLETED|Overall Study||1
10320696|NCT00240539|11455232|FG000|NOT COMPLETED|Overall Study||0
10320697|NCT00240539|11455233|FG001|NOT COMPLETED|Overall Study||0
10701526|NCT02567968|11865980|FG000|COMPLETED|Washout (2 Weeks)||4
10701527|NCT02567968|11865981|FG001|COMPLETED|Washout (2 Weeks)||4
10701528|NCT02567968|11865980|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10701530|NCT02567968|11865980|FG000|STARTED|Second Intervention||4
10701531|NCT02567968|11865981|FG001|STARTED|Second Intervention||4
10701532|NCT02567968|11865980|FG000|COMPLETED|Second Intervention||4
10701533|NCT02567968|11865981|FG001|COMPLETED|Second Intervention||4
10701534|NCT02567968|11865980|FG000|NOT COMPLETED|Second Intervention||0
10701535|NCT02567968|11865981|FG001|NOT COMPLETED|Second Intervention||0
10701536|NCT02568046|11865989|FG000|STARTED|Overall Study||5
10701537|NCT02568046|11865990|FG001|STARTED|Overall Study||5
10701538|NCT02568046|11865989|FG000|COMPLETED|Overall Study||0
10701539|NCT02568046|11865990|FG001|COMPLETED|Overall Study||2
10701540|NCT02568046|11865989|FG000|NOT COMPLETED|Overall Study||5
10803704|NCT04115358|11965126|FG000|STARTED|Overall Study||34
10803705|NCT04115358|11965127|FG001|STARTED|Overall Study||33
10803706|NCT04115358|11965128|FG002|STARTED|Overall Study||34
10803707|NCT04115358|11965126|FG000|COMPLETED|Overall Study|34 participants 48 teeth for clinical assessment, 28 participants 35 teeth for radiographic assessment.|34
10803708|NCT04115358|11965127|FG001|COMPLETED|Overall Study|33 participants 40 teeth for clinical assessment, 26 participants 32 teeth for radiographic assessment.|33
10803709|NCT04115358|11965128|FG002|COMPLETED|Overall Study|34 participants 38 teeth for clinical assessment, 26 participants 31 teeth for radiographic assessment.|33
10803710|NCT04115358|11965126|FG000|NOT COMPLETED|Overall Study||0
10803711|NCT04115358|11965127|FG001|NOT COMPLETED|Overall Study||0
10803712|NCT04115358|11965128|FG002|NOT COMPLETED|Overall Study||1
10320698|NCT00240539|11455234|FG002|NOT COMPLETED|Overall Study||0
10320699|NCT00240539|11455235|FG003|NOT COMPLETED|Overall Study||0
10320700|NCT00240981|11455247|FG000|STARTED|Overall Study||106
10320701|NCT00240981|11455248|FG001|STARTED|Overall Study||103
10320702|NCT00240981|11455247|FG000|Intent to Treat Sample|Overall Study||82
10320703|NCT00240981|11455248|FG001|Intent to Treat Sample|Overall Study||83
10320704|NCT00240981|11455247|FG000|COMPLETED|Overall Study||68
10320705|NCT00240981|11455248|FG001|COMPLETED|Overall Study||70
10320706|NCT00240981|11455247|FG000|NOT COMPLETED|Overall Study||38
10320707|NCT00240981|11455248|FG001|NOT COMPLETED|Overall Study||33
10320708|NCT00240994|11455255|FG000|STARTED|Overall Study||35
10320709|NCT00240994|11455255|FG000|COMPLETED|Overall Study||32
10320710|NCT00240994|11455255|FG000|NOT COMPLETED|Overall Study||3
10320711|NCT00241176|11455259|FG000|STARTED|Overall Study||11
10320712|NCT00241176|11455259|FG000|COMPLETED|Overall Study||11
10803713|NCT04114058|11965139|FG000|STARTED|Overall Study||20
10803714|NCT04114058|11965140|FG001|STARTED|Overall Study||17
10803715|NCT04114058|11965139|FG000|COMPLETED|Overall Study||20
10803716|NCT04114058|11965140|FG001|COMPLETED|Overall Study||17
10803717|NCT04114058|11965139|FG000|NOT COMPLETED|Overall Study||0
10803718|NCT04114058|11965140|FG001|NOT COMPLETED|Overall Study||0
10803719|NCT04113785|11965146|FG000|STARTED|Overall Study||21
10320713|NCT00241176|11455259|FG000|NOT COMPLETED|Overall Study||0
10320714|NCT00241280|11455266|FG000|STARTED|Overall Study||247
10320715|NCT00241280|11455267|FG001|STARTED|Overall Study||254
10320716|NCT00241280|11455266|FG000|COMPLETED|Overall Study||199
10320717|NCT00241280|11455267|FG001|COMPLETED|Overall Study||186
10320718|NCT00241280|11455266|FG000|NOT COMPLETED|Overall Study||48
10320719|NCT00241280|11455267|FG001|NOT COMPLETED|Overall Study||68
10320720|NCT00241358|11455277|FG000|STARTED|Overall Study||25
10320721|NCT00241358|11455278|FG001|STARTED|Overall Study||46
10320722|NCT00241358|11455279|FG002|STARTED|Overall Study||21
10320723|NCT00241358|11455277|FG000|COMPLETED|Overall Study||25
10320724|NCT00241358|11455278|FG001|COMPLETED|Overall Study||45
10320725|NCT00241358|11455279|FG002|COMPLETED|Overall Study||20
10455798|NCT01004432|11603926|FG001|STARTED|OL Study Extension (Week 52 - 76)||0
10455799|NCT01004432|11603927|FG002|STARTED|OL Study Extension (Week 52 - 76)||0
10455800|NCT01004432|11603928|FG003|STARTED|OL Study Extension (Week 52 - 76)||0
10455801|NCT01004432|11603929|FG004|STARTED|OL Study Extension (Week 52 - 76)||212
10455802|NCT01004432|11603925|FG000|COMPLETED|OL Study Extension (Week 52 - 76)||0
10455803|NCT01004432|11603926|FG001|COMPLETED|OL Study Extension (Week 52 - 76)||0
10455804|NCT01004432|11603927|FG002|COMPLETED|OL Study Extension (Week 52 - 76)||0
10455805|NCT01004432|11603928|FG003|COMPLETED|OL Study Extension (Week 52 - 76)||0
10455806|NCT01004432|11603929|FG004|COMPLETED|OL Study Extension (Week 52 - 76)||194
10455807|NCT01004432|11603925|FG000|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
10548398|NCT01519284|11702196|FG004|COMPLETED|Overall Study||16
10548399|NCT01519284|11702192|FG000|NOT COMPLETED|Overall Study||0
10548400|NCT01519284|11702193|FG001|NOT COMPLETED|Overall Study||0
10320726|NCT00241358|11455277|FG000|NOT COMPLETED|Overall Study||0
10320727|NCT00241358|11455278|FG001|NOT COMPLETED|Overall Study||1
10320728|NCT00241358|11455279|FG002|NOT COMPLETED|Overall Study||1
10548401|NCT01519284|11702194|FG002|NOT COMPLETED|Overall Study||2
10548402|NCT01519284|11702195|FG003|NOT COMPLETED|Overall Study||0
10548403|NCT01519284|11702196|FG004|NOT COMPLETED|Overall Study||0
10548404|NCT01519323|11702208|FG000|STARTED|Overall Study||3
10548405|NCT01519323|11702209|FG001|STARTED|Overall Study||3
10548406|NCT01519323|11702208|FG000|COMPLETED|Overall Study||0
10548407|NCT01519323|11702209|FG001|COMPLETED|Overall Study||0
10548408|NCT01519323|11702208|FG000|NOT COMPLETED|Overall Study||3
10548409|NCT01519323|11702209|FG001|NOT COMPLETED|Overall Study||3
10548410|NCT01519414|11702217|FG000|STARTED|Pre Cross-over||52
10548411|NCT01519414|11702218|FG001|STARTED|Pre Cross-over||26
10320729|NCT00241631|11455288|FG000|STARTED|Run in (2 Weeks)||25
10320730|NCT00241631|11455289|FG001|STARTED|Run in (2 Weeks)||24
10320731|NCT00241631|11455288|FG000|COMPLETED|Run in (2 Weeks)||22
10320732|NCT00241631|11455289|FG001|COMPLETED|Run in (2 Weeks)||21
10320733|NCT00241631|11455288|FG000|NOT COMPLETED|Run in (2 Weeks)||3
10320734|NCT00241631|11455289|FG001|NOT COMPLETED|Run in (2 Weeks)||3
10320735|NCT00241631|11455288|FG000|STARTED|Phase 1 (4 Weeks)||22
10320736|NCT00241631|11455289|FG001|STARTED|Phase 1 (4 Weeks)||21
10320737|NCT00241631|11455288|FG000|COMPLETED|Phase 1 (4 Weeks)||14
10320738|NCT00241631|11455289|FG001|COMPLETED|Phase 1 (4 Weeks)||16
10320739|NCT00241631|11455288|FG000|NOT COMPLETED|Phase 1 (4 Weeks)||8
10320740|NCT00241631|11455289|FG001|NOT COMPLETED|Phase 1 (4 Weeks)||5
10320741|NCT00241631|11455288|FG000|STARTED|Wash Out (2 Weeks)||14
10320742|NCT00241631|11455289|FG001|STARTED|Wash Out (2 Weeks)||16
10320743|NCT00241631|11455288|FG000|COMPLETED|Wash Out (2 Weeks)||14
10320744|NCT00241631|11455289|FG001|COMPLETED|Wash Out (2 Weeks)||16
10320745|NCT00241631|11455288|FG000|NOT COMPLETED|Wash Out (2 Weeks)||0
10320746|NCT00241631|11455289|FG001|NOT COMPLETED|Wash Out (2 Weeks)||0
10320747|NCT00241631|11455288|FG000|STARTED|Phase 2 (4 Weeks)||14
10320748|NCT00241631|11455289|FG001|STARTED|Phase 2 (4 Weeks)||16
10320749|NCT00241631|11455288|FG000|COMPLETED|Phase 2 (4 Weeks)||14
10320750|NCT00241631|11455289|FG001|COMPLETED|Phase 2 (4 Weeks)||16
10320751|NCT00241631|11455288|FG000|NOT COMPLETED|Phase 2 (4 Weeks)||0
10320752|NCT00241631|11455289|FG001|NOT COMPLETED|Phase 2 (4 Weeks)||0
10320753|NCT00241644|11455299|FG000|STARTED|First Efficacy Period (Year 1)||1647
10320754|NCT00241644|11455300|FG001|STARTED|First Efficacy Period (Year 1)||1651
10320755|NCT00241644|11455301|FG002|STARTED|First Efficacy Period (Year 1)||1641
10320756|NCT00241644|11455302|FG003|STARTED|First Efficacy Period (Year 1)||3298
10320757|NCT00241644|11455299|FG000|COMPLETED|First Efficacy Period (Year 1)||1420
10320758|NCT00241644|11455300|FG001|COMPLETED|First Efficacy Period (Year 1)||1383
10320759|NCT00241644|11455301|FG002|COMPLETED|First Efficacy Period (Year 1)||1392
10320760|NCT00241644|11455302|FG003|COMPLETED|First Efficacy Period (Year 1)||2803
10320761|NCT00241644|11455299|FG000|NOT COMPLETED|First Efficacy Period (Year 1)||227
10320762|NCT00241644|11455300|FG001|NOT COMPLETED|First Efficacy Period (Year 1)||268
10320763|NCT00241644|11455301|FG002|NOT COMPLETED|First Efficacy Period (Year 1)||249
10320764|NCT00241644|11455302|FG003|NOT COMPLETED|First Efficacy Period (Year 1)||495
10320765|NCT00241644|11455299|FG000|STARTED|Second Efficacy Period (Year 2)||771
10320766|NCT00241644|11455300|FG001|STARTED|Second Efficacy Period (Year 2)||754
10320767|NCT00241644|11455301|FG002|STARTED|Second Efficacy Period (Year 2)||746
10320768|NCT00241644|11455302|FG003|STARTED|Second Efficacy Period (Year 2)||1525
10320769|NCT00241644|11455299|FG000|COMPLETED|Second Efficacy Period (Year 2)||710
10320770|NCT00241644|11455300|FG001|COMPLETED|Second Efficacy Period (Year 2)||697
10320771|NCT00241644|11455301|FG002|COMPLETED|Second Efficacy Period (Year 2)||682
10320772|NCT00241644|11455302|FG003|COMPLETED|Second Efficacy Period (Year 2)||1407
10320773|NCT00241644|11455299|FG000|NOT COMPLETED|Second Efficacy Period (Year 2)||61
10320774|NCT00241644|11455300|FG001|NOT COMPLETED|Second Efficacy Period (Year 2)||57
10320775|NCT00241644|11455301|FG002|NOT COMPLETED|Second Efficacy Period (Year 2)||64
10320776|NCT00241644|11455302|FG003|NOT COMPLETED|Second Efficacy Period (Year 2)||118
10320777|NCT00241839|11455314|FG000|STARTED|Overall Study||71
10320778|NCT00241839|11455315|FG001|STARTED|Overall Study||71
10320779|NCT00241839|11455314|FG000|COMPLETED|Overall Study|N=52 represents number with both baseline and 8-10 week data. N<52 implies missing data.|52
10320780|NCT00241839|11455315|FG001|COMPLETED|Overall Study|N=53 represents number with both baseline and 8-10 week data. N<53 implies missing data.|53
10320781|NCT00241839|11455314|FG000|NOT COMPLETED|Overall Study||19
10320782|NCT00241839|11455315|FG001|NOT COMPLETED|Overall Study||18
10320783|NCT00241904|11455323|FG000|STARTED|Overall Study||261
10320784|NCT00241904|11455324|FG001|STARTED|Overall Study||264
10320785|NCT00241904|11455323|FG000|COMPLETED|Overall Study||227
10320786|NCT00241904|11455324|FG001|COMPLETED|Overall Study||240
10320787|NCT00241904|11455323|FG000|NOT COMPLETED|Overall Study||34
10320788|NCT00241904|11455324|FG001|NOT COMPLETED|Overall Study||24
10320789|NCT00241969|11455333|FG000|STARTED|Overall Study||36
10320790|NCT00241969|11455334|FG001|STARTED|Overall Study||42
10320791|NCT00241969|11455333|FG000|COMPLETED|Overall Study||36
10320792|NCT00241969|11455334|FG001|COMPLETED|Overall Study||42
10320793|NCT00241969|11455333|FG000|NOT COMPLETED|Overall Study||0
10320794|NCT00241969|11455334|FG001|NOT COMPLETED|Overall Study||0
10320795|NCT00242216|11455342|FG000|STARTED|Overall Study||39
10320796|NCT00242216|11455343|FG001|STARTED|Overall Study||37
10320797|NCT00242216|11455342|FG000|COMPLETED|Overall Study||21
10320798|NCT00242216|11455343|FG001|COMPLETED|Overall Study||15
10320799|NCT00242216|11455342|FG000|NOT COMPLETED|Overall Study||18
10320800|NCT00242216|11455343|FG001|NOT COMPLETED|Overall Study||22
10320801|NCT00242385|11455349|FG000|STARTED|Period 1||14
10320802|NCT00242385|11455350|FG001|STARTED|Period 1||11
10320803|NCT00242385|11455349|FG000|COMPLETED|Period 1||14
10320804|NCT00242385|11455350|FG001|COMPLETED|Period 1||11
10320805|NCT00242385|11455349|FG000|NOT COMPLETED|Period 1||0
10320806|NCT00242385|11455350|FG001|NOT COMPLETED|Period 1||0
10320807|NCT00242385|11455349|FG000|STARTED|Period 2||14
10320808|NCT00242385|11455350|FG001|STARTED|Period 2||11
10320809|NCT00242385|11455349|FG000|COMPLETED|Period 2||14
10320810|NCT00242385|11455350|FG001|COMPLETED|Period 2||11
10320811|NCT00242385|11455349|FG000|NOT COMPLETED|Period 2||0
10320812|NCT00242385|11455350|FG001|NOT COMPLETED|Period 2||0
10320813|NCT00242502|11455356|FG000|STARTED|Overall Study||59
10320814|NCT00242502|11455356|FG000|COMPLETED|Overall Study||59
10320815|NCT00242502|11455356|FG000|NOT COMPLETED|Overall Study||0
10320816|NCT00242567|11455362|FG000|STARTED|Overall Study||259
10320817|NCT00242567|11455363|FG001|STARTED|Overall Study||263
10320818|NCT00242567|11455362|FG000|Received at Least 1 Dose of Study Drug|Overall Study||259
10320819|NCT00242567|11455363|FG001|Received at Least 1 Dose of Study Drug|Overall Study||72
10320820|NCT00242567|11455362|FG000|Never Received Study Drug|Overall Study||0
10320821|NCT00242567|11455363|FG001|Never Received Study Drug|Overall Study||191
10320822|NCT00242567|11455362|FG000|COMPLETED|Overall Study||93
10320823|NCT00242567|11455363|FG001|COMPLETED|Overall Study||123
10320824|NCT00242567|11455362|FG000|NOT COMPLETED|Overall Study||166
10320825|NCT00242567|11455363|FG001|NOT COMPLETED|Overall Study||140
10320826|NCT00242580|11455374|FG000|STARTED|Overall Study||32
10320827|NCT00242580|11455375|FG001|STARTED|Overall Study||41
10320828|NCT00242580|11455376|FG002|STARTED|Overall Study||38
10320829|NCT00242580|11455374|FG000|COMPLETED|Overall Study|"Completed indicates 12 month data."|22
10320830|NCT00242580|11455375|FG001|COMPLETED|Overall Study||29
10320831|NCT00242580|11455376|FG002|COMPLETED|Overall Study||24
10320832|NCT00242580|11455374|FG000|NOT COMPLETED|Overall Study||10
10320833|NCT00242580|11455375|FG001|NOT COMPLETED|Overall Study||12
10320834|NCT00242580|11455376|FG002|NOT COMPLETED|Overall Study||14
10320835|NCT00242619|11455386|FG000|STARTED|Overall Study||8
10320836|NCT00242619|11455387|FG001|STARTED|Overall Study||4
10320837|NCT00242619|11455386|FG000|COMPLETED|Overall Study||8
10320838|NCT00242619|11455387|FG001|COMPLETED|Overall Study||4
10320839|NCT00242619|11455386|FG000|NOT COMPLETED|Overall Study||0
10320840|NCT00242619|11455387|FG001|NOT COMPLETED|Overall Study||0
10320841|NCT00242632|11455397|FG000|STARTED|Overall Study||11
10320842|NCT00242632|11455398|FG001|STARTED|Overall Study||11
10320843|NCT00242632|11455397|FG000|COMPLETED|Overall Study||11
10320844|NCT00242632|11455398|FG001|COMPLETED|Overall Study||11
10320845|NCT00242632|11455397|FG000|NOT COMPLETED|Overall Study||0
10320846|NCT00242632|11455398|FG001|NOT COMPLETED|Overall Study||0
10320847|NCT00242658|11455405|FG000|STARTED|Overall Study||187
10320848|NCT00242658|11455406|FG001|STARTED|Overall Study||207
10320849|NCT00242658|11455405|FG000|COMPLETED|Overall Study||165
10320850|NCT00242658|11455406|FG001|COMPLETED|Overall Study||188
10320851|NCT00242658|11455405|FG000|NOT COMPLETED|Overall Study||22
10320852|NCT00242658|11455406|FG001|NOT COMPLETED|Overall Study||19
10320853|NCT00242684|11455412|FG000|STARTED|Overall Study||446
10320854|NCT00242684|11455412|FG000|COMPLETED|Overall Study||446
10320855|NCT00242684|11455412|FG000|NOT COMPLETED|Overall Study||0
10320856|NCT00242710|11455420|FG000|STARTED|Core Study (up to Year 1)||373
10320857|NCT00242710|11455421|FG001|STARTED|Core Study (up to Year 1)||353
10320858|NCT00242710|11455422|FG002|STARTED|Core Study (up to Year 1)||183
10320859|NCT00242710|11455423|FG003|STARTED|Core Study (up to Year 1)||174
10320860|NCT00242710|11455420|FG000|Treated|Core Study (up to Year 1)||361
10320861|NCT00242710|11455421|FG001|Treated|Core Study (up to Year 1)||349
10320862|NCT00242710|11455422|FG002|Treated|Core Study (up to Year 1)||179
10320863|NCT00242710|11455423|FG003|Treated|Core Study (up to Year 1)||172
10320864|NCT00242710|11455420|FG000|COMPLETED|Core Study (up to Year 1)||287
10320865|NCT00242710|11455421|FG001|COMPLETED|Core Study (up to Year 1)||289
10320866|NCT00242710|11455422|FG002|COMPLETED|Core Study (up to Year 1)||132
10320867|NCT00242710|11455423|FG003|COMPLETED|Core Study (up to Year 1)||143
10320868|NCT00242710|11455420|FG000|NOT COMPLETED|Core Study (up to Year 1)||86
10320869|NCT00242710|11455421|FG001|NOT COMPLETED|Core Study (up to Year 1)||64
10320870|NCT00242710|11455422|FG002|NOT COMPLETED|Core Study (up to Year 1)||51
10320871|NCT00242710|11455423|FG003|NOT COMPLETED|Core Study (up to Year 1)||31
10320872|NCT00242710|11455420|FG000|STARTED|Period Between Core Study and Extension||287
10320873|NCT00242710|11455421|FG001|STARTED|Period Between Core Study and Extension||289
10320874|NCT00242710|11455422|FG002|STARTED|Period Between Core Study and Extension||132
10320875|NCT00242710|11455423|FG003|STARTED|Period Between Core Study and Extension||143
10320876|NCT00242710|11455420|FG000|COMPLETED|Period Between Core Study and Extension||168
10320877|NCT00242710|11455421|FG001|COMPLETED|Period Between Core Study and Extension||177
10320878|NCT00242710|11455422|FG002|COMPLETED|Period Between Core Study and Extension||84
10320879|NCT00242710|11455423|FG003|COMPLETED|Period Between Core Study and Extension||94
10320880|NCT00242710|11455420|FG000|NOT COMPLETED|Period Between Core Study and Extension||119
10320881|NCT00242710|11455421|FG001|NOT COMPLETED|Period Between Core Study and Extension||112
10320882|NCT00242710|11455422|FG002|NOT COMPLETED|Period Between Core Study and Extension||48
10320883|NCT00242710|11455423|FG003|NOT COMPLETED|Period Between Core Study and Extension||49
10320884|NCT00242710|11455420|FG000|STARTED|Study Extension (up to Year 2)||168
10320885|NCT00242710|11455421|FG001|STARTED|Study Extension (up to Year 2)||177
10320886|NCT00242710|11455422|FG002|STARTED|Study Extension (up to Year 2)||84
10320887|NCT00242710|11455423|FG003|STARTED|Study Extension (up to Year 2)||94
10320888|NCT00242710|11455420|FG000|COMPLETED|Study Extension (up to Year 2)||141
10320889|NCT00242710|11455421|FG001|COMPLETED|Study Extension (up to Year 2)||148
10320890|NCT00242710|11455422|FG002|COMPLETED|Study Extension (up to Year 2)||69
10320891|NCT00242710|11455423|FG003|COMPLETED|Study Extension (up to Year 2)||84
10320892|NCT00242710|11455420|FG000|NOT COMPLETED|Study Extension (up to Year 2)||27
10320893|NCT00242710|11455421|FG001|NOT COMPLETED|Study Extension (up to Year 2)||29
10320894|NCT00242710|11455422|FG002|NOT COMPLETED|Study Extension (up to Year 2)||15
10320895|NCT00242710|11455423|FG003|NOT COMPLETED|Study Extension (up to Year 2)||10
10320896|NCT00243022|11455435|FG000|STARTED|Overall Study||7
10320897|NCT00243022|11455436|FG001|STARTED|Overall Study||5
10320898|NCT00243022|11455435|FG000|COMPLETED|Overall Study||5
10320899|NCT00243022|11455436|FG001|COMPLETED|Overall Study||4
10320900|NCT00243022|11455435|FG000|NOT COMPLETED|Overall Study||2
10320901|NCT00243022|11455436|FG001|NOT COMPLETED|Overall Study||1
10320902|NCT00243061|11455443|FG000|STARTED|Overall Study||24
10320903|NCT00243061|11455443|FG000|COMPLETED|Overall Study||24
10320904|NCT00243061|11455443|FG000|NOT COMPLETED|Overall Study||0
10320905|NCT00243074|11455448|FG000|STARTED|Overall Study||54
10320906|NCT00243074|11455448|FG000|COMPLETED|Overall Study||0
10320907|NCT00243074|11455448|FG000|NOT COMPLETED|Overall Study||54
10320908|NCT00243152|11455453|FG000|STARTED|Overall Study||3
10320909|NCT00243152|11455454|FG001|STARTED|Overall Study||3
10320910|NCT00243152|11455453|FG000|Scan 1: Drug or Placebo|Overall Study||3
10320911|NCT00243152|11455454|FG001|Scan 1: Drug or Placebo|Overall Study||3
10320912|NCT00243152|11455453|FG000|Scan 2: Placebo or Drug|Overall Study||3
10320913|NCT00243152|11455454|FG001|Scan 2: Placebo or Drug|Overall Study||3
10320914|NCT00243152|11455453|FG000|COMPLETED|Overall Study||3
10320915|NCT00243152|11455454|FG001|COMPLETED|Overall Study||3
10320916|NCT00243152|11455453|FG000|NOT COMPLETED|Overall Study||0
10320917|NCT00243152|11455454|FG001|NOT COMPLETED|Overall Study||0
10320918|NCT00243191|11455461|FG000|STARTED|Overall Study||18
10320919|NCT00243191|11455461|FG000|COMPLETED|Overall Study||18
10455808|NCT01004432|11603926|FG001|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
10455809|NCT01004432|11603927|FG002|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
10455810|NCT01004432|11603928|FG003|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
10803720|NCT04113785|11965146|FG000|COMPLETED|Overall Study||21
10803721|NCT04113785|11965146|FG000|NOT COMPLETED|Overall Study||0
10803722|NCT04113694|11965152|FG000|STARTED|Overall Study||259
10803723|NCT04113694|11965152|FG000|COMPLETED|Overall Study||248
10803724|NCT04113694|11965152|FG000|NOT COMPLETED|Overall Study||11
10803725|NCT04112160|11965161|FG000|STARTED|Overall Study||63
10803726|NCT04112160|11965162|FG001|STARTED|Overall Study||62
10803727|NCT04112160|11965161|FG000|COMPLETED|Overall Study||62
10803728|NCT04112160|11965162|FG001|COMPLETED|Overall Study||62
10803729|NCT04112160|11965161|FG000|NOT COMPLETED|Overall Study||1
10803730|NCT04112160|11965162|FG001|NOT COMPLETED|Overall Study||0
10803731|NCT04112069|11965168|FG000|STARTED|Overall Study||10
10803732|NCT04112069|11965169|FG001|STARTED|Overall Study||10
10803733|NCT04112069|11965168|FG000|COMPLETED|Overall Study||10
10803734|NCT04112069|11965169|FG001|COMPLETED|Overall Study||10
10803735|NCT04112069|11965168|FG000|NOT COMPLETED|Overall Study||0
10803736|NCT04112069|11965169|FG001|NOT COMPLETED|Overall Study||0
10803737|NCT04109703|11965177|FG000|STARTED|Overall Study||49
10803738|NCT04109703|11965178|FG001|STARTED|Overall Study||51
10803739|NCT04109703|11965177|FG000|COMPLETED|Overall Study||49
10803740|NCT04109703|11965178|FG001|COMPLETED|Overall Study||51
10701541|NCT02568046|11865990|FG001|NOT COMPLETED|Overall Study||3
10701542|NCT02568072|11865996|FG000|STARTED|Overall Study||120
10701543|NCT02568072|11865996|FG000|COMPLETED|Overall Study||68
10701544|NCT02568072|11865996|FG000|NOT COMPLETED|Overall Study||52
10803741|NCT04109703|11965177|FG000|NOT COMPLETED|Overall Study||0
10803742|NCT04109703|11965178|FG001|NOT COMPLETED|Overall Study||0
10803743|NCT04109443|11965188|FG000|STARTED|Overall Study||77
10803744|NCT04109443|11965189|FG001|STARTED|Overall Study||77
10803745|NCT04109443|11965188|FG000|COMPLETED|Overall Study||67
10803746|NCT04109443|11965189|FG001|COMPLETED|Overall Study||65
10803747|NCT04109443|11965188|FG000|NOT COMPLETED|Overall Study||10
10803748|NCT04109443|11965189|FG001|NOT COMPLETED|Overall Study||12
10803749|NCT04107493|11965198|FG000|STARTED|First Intervention (1 Hour)||16
10455811|NCT01004432|11603929|FG004|NOT COMPLETED|OL Study Extension (Week 52 - 76)||18
10455812|NCT01004614|11603947|FG000|STARTED|First Intervention||12
10455813|NCT01004614|11603948|FG001|STARTED|First Intervention||12
10455814|NCT01004614|11603949|FG002|STARTED|First Intervention||12
10455815|NCT01004614|11603950|FG003|STARTED|First Intervention||12
10455816|NCT01004614|11603947|FG000|COMPLETED|First Intervention||12
10455817|NCT01004614|11603948|FG001|COMPLETED|First Intervention||12
10455818|NCT01004614|11603949|FG002|COMPLETED|First Intervention||12
10455819|NCT01004614|11603950|FG003|COMPLETED|First Intervention||12
10455820|NCT01004614|11603947|FG000|NOT COMPLETED|First Intervention||0
10455821|NCT01004614|11603948|FG001|NOT COMPLETED|First Intervention||0
10455822|NCT01004614|11603949|FG002|NOT COMPLETED|First Intervention||0
10455823|NCT01004614|11603950|FG003|NOT COMPLETED|First Intervention||0
10455824|NCT01004614|11603947|FG000|STARTED|Washout||12
10455825|NCT01004614|11603948|FG001|STARTED|Washout||12
10455826|NCT01004614|11603949|FG002|STARTED|Washout||12
10455827|NCT01004614|11603950|FG003|STARTED|Washout||12
10455828|NCT01004614|11603947|FG000|COMPLETED|Washout||12
10455829|NCT01004614|11603948|FG001|COMPLETED|Washout||11
10455830|NCT01004614|11603949|FG002|COMPLETED|Washout||12
10455831|NCT01004614|11603950|FG003|COMPLETED|Washout||12
10455832|NCT01004614|11603947|FG000|NOT COMPLETED|Washout||0
10455833|NCT01004614|11603948|FG001|NOT COMPLETED|Washout||1
10455834|NCT01004614|11603949|FG002|NOT COMPLETED|Washout||0
10455835|NCT01004614|11603950|FG003|NOT COMPLETED|Washout||0
10455836|NCT01004614|11603947|FG000|STARTED|Second Intervention||12
10455837|NCT01004614|11603948|FG001|STARTED|Second Intervention||11
10455838|NCT01004614|11603949|FG002|STARTED|Second Intervention||12
10455839|NCT01004614|11603950|FG003|STARTED|Second Intervention||12
10455840|NCT01004614|11603947|FG000|COMPLETED|Second Intervention||12
10455841|NCT01004614|11603948|FG001|COMPLETED|Second Intervention||11
10701545|NCT02568254|11866001|FG000|STARTED|Period 1||13
10701546|NCT02568254|11866002|FG001|STARTED|Period 1||12
10701547|NCT02568254|11866003|FG002|STARTED|Period 1||13
10701548|NCT02568254|11866004|FG003|STARTED|Period 1||12
10701549|NCT02568254|11866005|FG004|STARTED|Period 1||12
10701550|NCT02568254|11866006|FG005|STARTED|Period 1||12
10701551|NCT02568254|11866001|FG000|COMPLETED|Period 1||13
10701552|NCT02568254|11866002|FG001|COMPLETED|Period 1||12
10701553|NCT02568254|11866003|FG002|COMPLETED|Period 1||13
10701554|NCT02568254|11866004|FG003|COMPLETED|Period 1||12
10701555|NCT02568254|11866005|FG004|COMPLETED|Period 1||12
10701556|NCT02568254|11866006|FG005|COMPLETED|Period 1||12
10803750|NCT04107493|11965199|FG001|STARTED|First Intervention (1 Hour)||17
10803751|NCT04107493|11965198|FG000|COMPLETED|First Intervention (1 Hour)||16
10455842|NCT01004614|11603949|FG002|COMPLETED|Second Intervention||12
10455843|NCT01004614|11603950|FG003|COMPLETED|Second Intervention||12
10455844|NCT01004614|11603947|FG000|NOT COMPLETED|Second Intervention||0
10455845|NCT01004614|11603948|FG001|NOT COMPLETED|Second Intervention||0
10455846|NCT01004614|11603949|FG002|NOT COMPLETED|Second Intervention||0
10455847|NCT01004614|11603950|FG003|NOT COMPLETED|Second Intervention||0
10701557|NCT02568254|11866001|FG000|NOT COMPLETED|Period 1||0
10701558|NCT02568254|11866002|FG001|NOT COMPLETED|Period 1||0
10701559|NCT02568254|11866003|FG002|NOT COMPLETED|Period 1||0
10803752|NCT04107493|11965199|FG001|COMPLETED|First Intervention (1 Hour)||17
10320920|NCT00243191|11455461|FG000|NOT COMPLETED|Overall Study||0
10320921|NCT00243230|11455468|FG000|STARTED|Double-Blind Period||39
10320922|NCT00243230|11455469|FG001|STARTED|Double-Blind Period||40
10320923|NCT00243230|11455470|FG002|STARTED|Double-Blind Period||37
10320924|NCT00243230|11455471|FG003|STARTED|Double-Blind Period||0
10320925|NCT00243230|11455468|FG000|Treated|Double-Blind Period||39
10701560|NCT02568254|11866004|FG003|NOT COMPLETED|Period 1||0
10701561|NCT02568254|11866005|FG004|NOT COMPLETED|Period 1||0
10701562|NCT02568254|11866006|FG005|NOT COMPLETED|Period 1||0
10701563|NCT02568254|11866001|FG000|STARTED|Period 2||13
10320926|NCT00243230|11455469|FG001|Treated|Double-Blind Period||40
10320927|NCT00243230|11455470|FG002|Treated|Double-Blind Period||35
10320928|NCT00243230|11455471|FG003|Treated|Double-Blind Period||0
10320929|NCT00243230|11455468|FG000|COMPLETED|Double-Blind Period||33
10320930|NCT00243230|11455469|FG001|COMPLETED|Double-Blind Period||35
10320931|NCT00243230|11455470|FG002|COMPLETED|Double-Blind Period||18
10320932|NCT00243230|11455471|FG003|COMPLETED|Double-Blind Period||0
10320933|NCT00243230|11455468|FG000|NOT COMPLETED|Double-Blind Period||6
10320934|NCT00243230|11455469|FG001|NOT COMPLETED|Double-Blind Period||5
10320935|NCT00243230|11455470|FG002|NOT COMPLETED|Double-Blind Period||19
10320936|NCT00243230|11455471|FG003|NOT COMPLETED|Double-Blind Period||0
10320937|NCT00243230|11455468|FG000|STARTED|Open Label Period||0
10320938|NCT00243230|11455469|FG001|STARTED|Open Label Period||0
10320939|NCT00243230|11455470|FG002|STARTED|Open Label Period||0
10320940|NCT00243230|11455471|FG003|STARTED|Open Label Period||85
10320941|NCT00243230|11455468|FG000|COMPLETED|Open Label Period||0
10320942|NCT00243230|11455469|FG001|COMPLETED|Open Label Period||0
10320943|NCT00243230|11455470|FG002|COMPLETED|Open Label Period||0
10320944|NCT00243230|11455471|FG003|COMPLETED|Open Label Period||0
10320945|NCT00243230|11455468|FG000|NOT COMPLETED|Open Label Period||0
10320946|NCT00243230|11455469|FG001|NOT COMPLETED|Open Label Period||0
10320947|NCT00243230|11455470|FG002|NOT COMPLETED|Open Label Period||0
10320948|NCT00243230|11455471|FG003|NOT COMPLETED|Open Label Period||85
10320949|NCT00243243|11455483|FG000|STARTED|Overall Study||10
10320950|NCT00243243|11455484|FG001|STARTED|Overall Study||10
10320951|NCT00243243|11455483|FG000|COMPLETED|Overall Study||10
10320952|NCT00243243|11455484|FG001|COMPLETED|Overall Study||10
10320953|NCT00243243|11455483|FG000|NOT COMPLETED|Overall Study||0
10320954|NCT00243243|11455484|FG001|NOT COMPLETED|Overall Study||0
10320955|NCT00243269|11455494|FG000|STARTED|Overall Study||31
10320956|NCT00243269|11455495|FG001|STARTED|Overall Study||11
10320957|NCT00243269|11455496|FG002|STARTED|Overall Study||12
10320958|NCT00243269|11455497|FG003|STARTED|Overall Study||29
10320959|NCT00243269|11455494|FG000|COMPLETED|Overall Study||28
10320960|NCT00243269|11455495|FG001|COMPLETED|Overall Study||10
10320961|NCT00243269|11455496|FG002|COMPLETED|Overall Study||11
10320962|NCT00243269|11455497|FG003|COMPLETED|Overall Study||25
10320963|NCT00243269|11455494|FG000|NOT COMPLETED|Overall Study||3
10320964|NCT00243269|11455495|FG001|NOT COMPLETED|Overall Study||1
10320965|NCT00243269|11455496|FG002|NOT COMPLETED|Overall Study||1
10320966|NCT00243269|11455497|FG003|NOT COMPLETED|Overall Study||4
10320967|NCT00243347|11455507|FG000|STARTED|Overall Study|Treated|19
10320968|NCT00243347|11455507|FG000|COMPLETED|Overall Study|Completed study|0
10320969|NCT00243347|11455507|FG000|NOT COMPLETED|Overall Study||19
10320970|NCT00243386|11455511|FG000|STARTED|On-Demand Regimen (Study Part 1)||73
10320971|NCT00243386|11455512|FG001|STARTED|On-Demand Regimen (Study Part 1)|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
10320972|NCT00243386|11455513|FG002|STARTED|On-Demand Regimen (Study Part 1)|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
10320973|NCT00243386|11455511|FG000|COMPLETED|On-Demand Regimen (Study Part 1)||69
10320974|NCT00243386|11455512|FG001|COMPLETED|On-Demand Regimen (Study Part 1)||0
10320975|NCT00243386|11455513|FG002|COMPLETED|On-Demand Regimen (Study Part 1)||0
10320976|NCT00243386|11455511|FG000|NOT COMPLETED|On-Demand Regimen (Study Part 1)||4
10320977|NCT00243386|11455512|FG001|NOT COMPLETED|On-Demand Regimen (Study Part 1)||0
10320978|NCT00243386|11455513|FG002|NOT COMPLETED|On-Demand Regimen (Study Part 1)||0
10320979|NCT00243386|11455511|FG000|STARTED|End of Part 1, But Prior to Prophylaxis||69
10320980|NCT00243386|11455512|FG001|STARTED|End of Part 1, But Prior to Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
10320981|NCT00243386|11455513|FG002|STARTED|End of Part 1, But Prior to Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
10320982|NCT00243386|11455511|FG000|COMPLETED|End of Part 1, But Prior to Prophylaxis||66
10701564|NCT02568254|11866002|FG001|STARTED|Period 2||12
10320983|NCT00243386|11455512|FG001|COMPLETED|End of Part 1, But Prior to Prophylaxis||0
10320984|NCT00243386|11455513|FG002|COMPLETED|End of Part 1, But Prior to Prophylaxis||0
10320985|NCT00243386|11455511|FG000|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||3
10320986|NCT00243386|11455512|FG001|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||0
10320987|NCT00243386|11455513|FG002|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||0
10320988|NCT00243386|11455511|FG000|STARTED|PK-Driven or Standard Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
10320989|NCT00243386|11455512|FG001|STARTED|PK-Driven or Standard Prophylaxis||34
10320990|NCT00243386|11455513|FG002|STARTED|PK-Driven or Standard Prophylaxis||32
10320991|NCT00243386|11455511|FG000|COMPLETED|PK-Driven or Standard Prophylaxis||0
10320992|NCT00243386|11455512|FG001|COMPLETED|PK-Driven or Standard Prophylaxis||31
10701565|NCT02568254|11866003|FG002|STARTED|Period 2||13
10701566|NCT02568254|11866004|FG003|STARTED|Period 2||12
10701567|NCT02568254|11866005|FG004|STARTED|Period 2||12
10320993|NCT00243386|11455513|FG002|COMPLETED|PK-Driven or Standard Prophylaxis||32
10320994|NCT00243386|11455511|FG000|NOT COMPLETED|PK-Driven or Standard Prophylaxis||0
10320995|NCT00243386|11455512|FG001|NOT COMPLETED|PK-Driven or Standard Prophylaxis||3
10320996|NCT00243386|11455513|FG002|NOT COMPLETED|PK-Driven or Standard Prophylaxis||0
10320997|NCT00243412|11455551|FG000|STARTED|Overall Study|Intent to treat|21
10320998|NCT00243412|11455552|FG001|STARTED|Overall Study|Intent to treat|21
10320999|NCT00243412|11455551|FG000|Safety Evaluable|Overall Study||21
10321000|NCT00243412|11455552|FG001|Safety Evaluable|Overall Study||20
10321001|NCT00243412|11455551|FG000|COMPLETED|Overall Study|Completed Week 104|11
10803753|NCT04107493|11965198|FG000|NOT COMPLETED|First Intervention (1 Hour)||0
10803754|NCT04107493|11965199|FG001|NOT COMPLETED|First Intervention (1 Hour)||0
10803755|NCT04107493|11965198|FG000|STARTED|Washout (One Hour)||16
10321002|NCT00243412|11455552|FG001|COMPLETED|Overall Study|Completed Week 104|10
10321003|NCT00243412|11455551|FG000|NOT COMPLETED|Overall Study||10
10321004|NCT00243412|11455552|FG001|NOT COMPLETED|Overall Study||11
10803756|NCT04107493|11965199|FG001|STARTED|Washout (One Hour)||17
10803757|NCT04107493|11965198|FG000|COMPLETED|Washout (One Hour)||16
10803758|NCT04107493|11965199|FG001|COMPLETED|Washout (One Hour)||17
10803759|NCT04107493|11965198|FG000|NOT COMPLETED|Washout (One Hour)||0
10803760|NCT04107493|11965199|FG001|NOT COMPLETED|Washout (One Hour)||0
10803761|NCT04107493|11965198|FG000|STARTED|Second Intervention||16
10321005|NCT00243503|11455558|FG000|STARTED|Overall Study|3 participants discontinued and only took Trastuzumab.|60
10321006|NCT00243503|11455558|FG000|COMPLETED|Overall Study||2
10321007|NCT00243503|11455558|FG000|NOT COMPLETED|Overall Study||58
10321008|NCT00243659|11455565|FG000|STARTED|Overall Study||22
10321009|NCT00243659|11455566|FG001|STARTED|Overall Study||8
10321010|NCT00243659|11455565|FG000|COMPLETED|Overall Study||20
10321011|NCT00243659|11455566|FG001|COMPLETED|Overall Study||5
10321012|NCT00243659|11455565|FG000|NOT COMPLETED|Overall Study||2
10321013|NCT00243659|11455566|FG001|NOT COMPLETED|Overall Study||3
10321014|NCT00243841|11455575|FG000|STARTED|Overall Study||3
10321015|NCT00243841|11455576|FG001|STARTED|Overall Study||6
10321016|NCT00243841|11455577|FG002|STARTED|Overall Study||5
10321017|NCT00243841|11455578|FG003|STARTED|Overall Study||3
10321018|NCT00243841|11455579|FG004|STARTED|Overall Study||39
10321019|NCT00243841|11455580|FG005|STARTED|Overall Study||21
10321020|NCT00243841|11455575|FG000|COMPLETED|Overall Study||3
10321021|NCT00243841|11455576|FG001|COMPLETED|Overall Study||6
10321022|NCT00243841|11455577|FG002|COMPLETED|Overall Study||4
10321023|NCT00243841|11455578|FG003|COMPLETED|Overall Study||3
10321024|NCT00243841|11455579|FG004|COMPLETED|Overall Study||39
10321025|NCT00243841|11455580|FG005|COMPLETED|Overall Study||19
10321026|NCT00243841|11455575|FG000|NOT COMPLETED|Overall Study||0
10321027|NCT00243841|11455576|FG001|NOT COMPLETED|Overall Study||0
10321028|NCT00243841|11455577|FG002|NOT COMPLETED|Overall Study||1
10321029|NCT00243841|11455578|FG003|NOT COMPLETED|Overall Study||0
10321030|NCT00243841|11455579|FG004|NOT COMPLETED|Overall Study||0
10321031|NCT00243841|11455580|FG005|NOT COMPLETED|Overall Study||2
10321032|NCT00243919|11455599|FG000|STARTED|Overall Study||139
10321033|NCT00243919|11455600|FG001|STARTED|Overall Study||143
10321034|NCT00243919|11455601|FG002|STARTED|Overall Study||126
10321035|NCT00243919|11455599|FG000|COMPLETED|Overall Study||122
10321036|NCT00243919|11455600|FG001|COMPLETED|Overall Study||125
10321037|NCT00243919|11455601|FG002|COMPLETED|Overall Study||115
10321038|NCT00243919|11455599|FG000|NOT COMPLETED|Overall Study||17
10321039|NCT00243919|11455600|FG001|NOT COMPLETED|Overall Study||18
10321040|NCT00243919|11455601|FG002|NOT COMPLETED|Overall Study||11
10321041|NCT00243932|11455612|FG000|STARTED|Stage 1: Dose Selection||35
10321042|NCT00243932|11455613|FG001|STARTED|Stage 1: Dose Selection||35
10321043|NCT00243932|11455614|FG002|STARTED|Stage 1: Dose Selection||35
10321044|NCT00243932|11455612|FG000|COMPLETED|Stage 1: Dose Selection||33
10321045|NCT00243932|11455613|FG001|COMPLETED|Stage 1: Dose Selection||35
10321046|NCT00243932|11455614|FG002|COMPLETED|Stage 1: Dose Selection||35
10321047|NCT00243932|11455612|FG000|NOT COMPLETED|Stage 1: Dose Selection||2
10321048|NCT00243932|11455613|FG001|NOT COMPLETED|Stage 1: Dose Selection||0
10321049|NCT00243932|11455614|FG002|NOT COMPLETED|Stage 1: Dose Selection||0
10321050|NCT00243932|11455612|FG000|STARTED|Stage 2: Efficacy|40 newly randomized pts. Efficacy analysis included Stage 1 + Stage 2 patients|40
10321051|NCT00243932|11455613|FG001|STARTED|Stage 2: Efficacy|40 newly randomized pts. Efficacy analysis included Stage 1 + Stage 2 patients|40
10321052|NCT00243932|11455614|FG002|STARTED|Stage 2: Efficacy|No new pts. randomized because selection procedure in Stage 1 selected the 2,700 mg dose.|0
10321053|NCT00243932|11455612|FG000|COMPLETED|Stage 2: Efficacy||40
10321054|NCT00243932|11455613|FG001|COMPLETED|Stage 2: Efficacy||40
10321055|NCT00243932|11455614|FG002|COMPLETED|Stage 2: Efficacy||0
10321056|NCT00243932|11455612|FG000|NOT COMPLETED|Stage 2: Efficacy||0
10321057|NCT00243932|11455613|FG001|NOT COMPLETED|Stage 2: Efficacy||0
10321058|NCT00243932|11455614|FG002|NOT COMPLETED|Stage 2: Efficacy||0
10321059|NCT00244101|11455625|FG000|STARTED|Overall Study||209
10321060|NCT00244101|11455626|FG001|STARTED|Overall Study||223
10321061|NCT00244101|11455627|FG002|STARTED|Overall Study||216
10321062|NCT00244101|11455625|FG000|COMPLETED|Overall Study||209
10321063|NCT00244101|11455626|FG001|COMPLETED|Overall Study||223
10321064|NCT00244101|11455627|FG002|COMPLETED|Overall Study||216
10321065|NCT00244101|11455625|FG000|NOT COMPLETED|Overall Study||0
10321066|NCT00244101|11455626|FG001|NOT COMPLETED|Overall Study||0
10321067|NCT00244101|11455627|FG002|NOT COMPLETED|Overall Study||0
10321068|NCT00244140|11455637|FG000|STARTED|Overall Study||412
10321069|NCT00244140|11455638|FG001|STARTED|Overall Study||22
10321070|NCT00244140|11455637|FG000|COMPLETED|Overall Study||412
10321071|NCT00244140|11455638|FG001|COMPLETED|Overall Study||22
10321072|NCT00244140|11455637|FG000|NOT COMPLETED|Overall Study||0
10321073|NCT00244140|11455638|FG001|NOT COMPLETED|Overall Study||0
10321074|NCT00244374|11455644|FG000|STARTED|Pre-Randomization Cross-sectional Study||546
10321075|NCT00244374|11455645|FG001|STARTED|Pre-Randomization Cross-sectional Study||0
10321076|NCT00244374|11455646|FG002|STARTED|Pre-Randomization Cross-sectional Study||0
10321077|NCT00244374|11455647|FG003|STARTED|Pre-Randomization Cross-sectional Study||0
10321078|NCT00244374|11455648|FG004|STARTED|Pre-Randomization Cross-sectional Study||0
10321079|NCT00244374|11455644|FG000|COMPLETED|Pre-Randomization Cross-sectional Study||409
10321080|NCT00244374|11455645|FG001|COMPLETED|Pre-Randomization Cross-sectional Study||0
10321081|NCT00244374|11455646|FG002|COMPLETED|Pre-Randomization Cross-sectional Study||0
10321082|NCT00244374|11455647|FG003|COMPLETED|Pre-Randomization Cross-sectional Study||0
10321083|NCT00244374|11455648|FG004|COMPLETED|Pre-Randomization Cross-sectional Study||0
10321084|NCT00244374|11455644|FG000|NOT COMPLETED|Pre-Randomization Cross-sectional Study||137
10321085|NCT00244374|11455645|FG001|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
10321086|NCT00244374|11455646|FG002|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
10321087|NCT00244374|11455647|FG003|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
10321088|NCT00244374|11455648|FG004|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
10321089|NCT00244374|11455644|FG000|STARTED|Evaluation for Vaccine Adherence Cohort|440 study participants enrolled prior to 3/31/2007 were evaluated for vaccine adherence cohort|440
10321090|NCT00244374|11455645|FG001|STARTED|Evaluation for Vaccine Adherence Cohort||0
10321091|NCT00244374|11455646|FG002|STARTED|Evaluation for Vaccine Adherence Cohort||0
10321092|NCT00244374|11455647|FG003|STARTED|Evaluation for Vaccine Adherence Cohort||0
10321093|NCT00244374|11455648|FG004|STARTED|Evaluation for Vaccine Adherence Cohort||0
10321094|NCT00244374|11455644|FG000|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||217
10321095|NCT00244374|11455645|FG001|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
10321096|NCT00244374|11455646|FG002|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
10321097|NCT00244374|11455647|FG003|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
10321098|NCT00244374|11455648|FG004|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
10321099|NCT00244374|11455644|FG000|COMPLETED|Evaluation for Vaccine Adherence Cohort||167
10321100|NCT00244374|11455645|FG001|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
10321101|NCT00244374|11455646|FG002|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
10321102|NCT00244374|11455647|FG003|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
10321103|NCT00244374|11455648|FG004|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
10321104|NCT00244374|11455644|FG000|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||273
10321105|NCT00244374|11455645|FG001|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
10321106|NCT00244374|11455646|FG002|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
10321107|NCT00244374|11455647|FG003|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
10321108|NCT00244374|11455648|FG004|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
10321109|NCT00244374|11455644|FG000|STARTED|Vaccine Adherence Cohort|Eligible and willing cross-sectional study participants progressed to adherence cohort randomization|0
10321110|NCT00244374|11455645|FG001|STARTED|Vaccine Adherence Cohort||47
10321111|NCT00244374|11455646|FG002|STARTED|Vaccine Adherence Cohort||43
10321112|NCT00244374|11455647|FG003|STARTED|Vaccine Adherence Cohort||36
10321113|NCT00244374|11455648|FG004|STARTED|Vaccine Adherence Cohort||41
10321114|NCT00244374|11455644|FG000|COMPLETED|Vaccine Adherence Cohort||0
10321115|NCT00244374|11455645|FG001|COMPLETED|Vaccine Adherence Cohort||47
10321116|NCT00244374|11455646|FG002|COMPLETED|Vaccine Adherence Cohort||43
10321117|NCT00244374|11455647|FG003|COMPLETED|Vaccine Adherence Cohort||36
10321118|NCT00244374|11455648|FG004|COMPLETED|Vaccine Adherence Cohort||41
10321119|NCT00244374|11455644|FG000|NOT COMPLETED|Vaccine Adherence Cohort||0
10321120|NCT00244374|11455645|FG001|NOT COMPLETED|Vaccine Adherence Cohort||0
10321121|NCT00244374|11455646|FG002|NOT COMPLETED|Vaccine Adherence Cohort||0
10321122|NCT00244374|11455647|FG003|NOT COMPLETED|Vaccine Adherence Cohort||0
10321123|NCT00244374|11455648|FG004|NOT COMPLETED|Vaccine Adherence Cohort||0
10321124|NCT00244621|11455667|FG000|STARTED|Double-blind Treatment Period||29
10321125|NCT00244621|11455668|FG001|STARTED|Double-blind Treatment Period||32
10321126|NCT00244621|11455669|FG002|STARTED|Double-blind Treatment Period||32
10321127|NCT00244621|11455667|FG000|COMPLETED|Double-blind Treatment Period||27
10321128|NCT00244621|11455668|FG001|COMPLETED|Double-blind Treatment Period||29
10321129|NCT00244621|11455669|FG002|COMPLETED|Double-blind Treatment Period||30
10321130|NCT00244621|11455667|FG000|NOT COMPLETED|Double-blind Treatment Period||2
10321131|NCT00244621|11455668|FG001|NOT COMPLETED|Double-blind Treatment Period||3
10321132|NCT00244621|11455669|FG002|NOT COMPLETED|Double-blind Treatment Period||2
10321133|NCT00244621|11455667|FG000|STARTED|Open-label Treatment Period|One participant discontinued study due to Adverse Event after completing the double-blind period.|26
10321134|NCT00244621|11455668|FG001|STARTED|Open-label Treatment Period||29
10321135|NCT00244621|11455669|FG002|STARTED|Open-label Treatment Period||30
10321136|NCT00244621|11455667|FG000|COMPLETED|Open-label Treatment Period||25
10321137|NCT00244621|11455668|FG001|COMPLETED|Open-label Treatment Period||28
10321138|NCT00244621|11455669|FG002|COMPLETED|Open-label Treatment Period||28
10321139|NCT00244621|11455667|FG000|NOT COMPLETED|Open-label Treatment Period||1
10321140|NCT00244621|11455668|FG001|NOT COMPLETED|Open-label Treatment Period||1
10321141|NCT00244621|11455669|FG002|NOT COMPLETED|Open-label Treatment Period||2
10321142|NCT00244712|11455679|FG000|STARTED|Overall Study||343
10321143|NCT00244712|11455680|FG001|STARTED|Overall Study||345
10321144|NCT00244712|11455679|FG000|COMPLETED|Overall Study||234
10321145|NCT00244712|11455680|FG001|COMPLETED|Overall Study||221
10321146|NCT00244712|11455679|FG000|NOT COMPLETED|Overall Study||109
10321147|NCT00244712|11455680|FG001|NOT COMPLETED|Overall Study||124
10321148|NCT00244725|11455690|FG000|STARTED|Overall Study||237
10321149|NCT00244725|11455691|FG001|STARTED|Overall Study||245
10321150|NCT00244725|11455692|FG002|STARTED|Overall Study||239
10321151|NCT00244725|11455693|FG003|STARTED|Overall Study||237
10321152|NCT00244725|11455690|FG000|COMPLETED|Overall Study||214
10701568|NCT02568254|11866006|FG005|STARTED|Period 2||12
10701569|NCT02568254|11866001|FG000|COMPLETED|Period 2||13
10701570|NCT02568254|11866002|FG001|COMPLETED|Period 2||12
10701571|NCT02568254|11866003|FG002|COMPLETED|Period 2||12
10701572|NCT02568254|11866004|FG003|COMPLETED|Period 2||12
10701573|NCT02568254|11866005|FG004|COMPLETED|Period 2||12
10701574|NCT02568254|11866006|FG005|COMPLETED|Period 2||12
10701575|NCT02568254|11866001|FG000|NOT COMPLETED|Period 2||0
10701576|NCT02568254|11866002|FG001|NOT COMPLETED|Period 2||0
10321153|NCT00244725|11455691|FG001|COMPLETED|Overall Study||226
10321154|NCT00244725|11455692|FG002|COMPLETED|Overall Study||215
10701577|NCT02568254|11866003|FG002|NOT COMPLETED|Period 2||1
10701578|NCT02568254|11866004|FG003|NOT COMPLETED|Period 2||0
10701579|NCT02568254|11866005|FG004|NOT COMPLETED|Period 2||0
10321155|NCT00244725|11455693|FG003|COMPLETED|Overall Study||216
10321156|NCT00244725|11455690|FG000|NOT COMPLETED|Overall Study||23
10321157|NCT00244725|11455691|FG001|NOT COMPLETED|Overall Study||19
10321158|NCT00244725|11455692|FG002|NOT COMPLETED|Overall Study||24
10321159|NCT00244725|11455693|FG003|NOT COMPLETED|Overall Study||21
10321160|NCT00244751|11455706|FG000|STARTED|Overall Study||88
10321161|NCT00244751|11455707|FG001|STARTED|Overall Study||89
10321162|NCT00244751|11455708|FG002|STARTED|Overall Study||88
10321163|NCT00244751|11455706|FG000|COMPLETED|Overall Study||72
10321164|NCT00244751|11455707|FG001|COMPLETED|Overall Study||74
10321165|NCT00244751|11455708|FG002|COMPLETED|Overall Study||78
10321166|NCT00244751|11455706|FG000|NOT COMPLETED|Overall Study||16
10321167|NCT00244751|11455707|FG001|NOT COMPLETED|Overall Study||15
10321168|NCT00244751|11455708|FG002|NOT COMPLETED|Overall Study||10
10321169|NCT00244764|11455725|FG000|STARTED|Overall Study||225
10321170|NCT00244764|11455725|FG000|COMPLETED|Overall Study||129
10321171|NCT00244764|11455725|FG000|NOT COMPLETED|Overall Study||96
10321172|NCT00244855|11455732|FG000|STARTED|Overall Study||7
10321173|NCT00244855|11455733|FG001|STARTED|Overall Study||25
10321174|NCT00244855|11455732|FG000|COMPLETED|Overall Study||7
10321175|NCT00244855|11455733|FG001|COMPLETED|Overall Study||24
10321176|NCT00244855|11455732|FG000|NOT COMPLETED|Overall Study||0
10321177|NCT00244855|11455733|FG001|NOT COMPLETED|Overall Study||1
10321178|NCT00244881|11455741|FG000|STARTED|Overall Study||26
10321179|NCT00244881|11455741|FG000|COMPLETED|Overall Study||23
10321180|NCT00244881|11455741|FG000|NOT COMPLETED|Overall Study||3
10321181|NCT00244933|11455745|FG000|STARTED|Overall Study||19
10321182|NCT00244933|11455745|FG000|COMPLETED|Overall Study||17
10321183|NCT00244933|11455745|FG000|NOT COMPLETED|Overall Study||2
10321184|NCT00244985|11455749|FG000|STARTED|Overall Study||42
10321185|NCT00244985|11455749|FG000|COMPLETED|Overall Study||42
10321186|NCT00244985|11455749|FG000|NOT COMPLETED|Overall Study||0
10321187|NCT00245011|11455753|FG000|STARTED|Overall Study||11
10321188|NCT00245011|11455753|FG000|COMPLETED|Overall Study|Subject had disease progression prior to completing study.|10
10321189|NCT00245011|11455753|FG000|NOT COMPLETED|Overall Study||1
10321190|NCT00245037|11455757|FG000|STARTED|Overall Study||147
10321191|NCT00245037|11455757|FG000|COMPLETED|Overall Study|17 participants died from infectious complications.|130
10321192|NCT00245037|11455757|FG000|NOT COMPLETED|Overall Study||17
10321193|NCT00245050|11455763|FG000|STARTED|Overall Study||18
10321194|NCT00245050|11455764|FG001|STARTED|Overall Study||16
10321195|NCT00245050|11455763|FG000|COMPLETED|Overall Study||15
10321196|NCT00245050|11455764|FG001|COMPLETED|Overall Study||14
10321197|NCT00245050|11455763|FG000|NOT COMPLETED|Overall Study||3
10321198|NCT00245050|11455764|FG001|NOT COMPLETED|Overall Study||2
10321199|NCT00245063|11455772|FG000|STARTED|Overall Study||12
10321200|NCT00245063|11455773|FG001|STARTED|Overall Study||13
10321201|NCT00245063|11455772|FG000|COMPLETED|Overall Study||5
10321202|NCT00245063|11455773|FG001|COMPLETED|Overall Study||8
10321203|NCT00245063|11455772|FG000|NOT COMPLETED|Overall Study||7
10321204|NCT00245063|11455773|FG001|NOT COMPLETED|Overall Study||5
10321205|NCT00245102|11455785|FG000|STARTED|Overall Study||44
10321206|NCT00245102|11455786|FG001|STARTED|Overall Study||16
10321207|NCT00245102|11455787|FG002|STARTED|Overall Study||46
10321208|NCT00245102|11455788|FG003|STARTED|Overall Study||13
10321209|NCT00245102|11455789|FG004|STARTED|Overall Study||5
10321210|NCT00245102|11455790|FG005|STARTED|Overall Study||23
10321211|NCT00245102|11455785|FG000|COMPLETED|Overall Study||37
10321212|NCT00245102|11455786|FG001|COMPLETED|Overall Study||12
10321213|NCT00245102|11455787|FG002|COMPLETED|Overall Study||39
10321214|NCT00245102|11455788|FG003|COMPLETED|Overall Study||10
10321215|NCT00245102|11455789|FG004|COMPLETED|Overall Study||5
10321216|NCT00245102|11455790|FG005|COMPLETED|Overall Study||19
10321217|NCT00245102|11455785|FG000|NOT COMPLETED|Overall Study||7
10321218|NCT00245102|11455786|FG001|NOT COMPLETED|Overall Study||4
10321219|NCT00245102|11455787|FG002|NOT COMPLETED|Overall Study||7
10321220|NCT00245102|11455788|FG003|NOT COMPLETED|Overall Study||3
10701580|NCT02568254|11866006|FG005|NOT COMPLETED|Period 2||0
10701581|NCT02568254|11866001|FG000|STARTED|Period 3||13
10321221|NCT00245102|11455789|FG004|NOT COMPLETED|Overall Study||0
10321222|NCT00245102|11455790|FG005|NOT COMPLETED|Overall Study||4
10321223|NCT00245219|11455807|FG000|STARTED|Overall Study||91
10321224|NCT00245219|11455808|FG001|STARTED|Overall Study||94
10321225|NCT00245219|11455809|FG002|STARTED|Overall Study||60
10321226|NCT00245219|11455807|FG000|COMPLETED|Overall Study||85
10321227|NCT00245219|11455808|FG001|COMPLETED|Overall Study||88
10321228|NCT00245219|11455809|FG002|COMPLETED|Overall Study||58
10321229|NCT00245219|11455807|FG000|NOT COMPLETED|Overall Study||6
10321230|NCT00245219|11455808|FG001|NOT COMPLETED|Overall Study||6
10321231|NCT00245219|11455809|FG002|NOT COMPLETED|Overall Study||2
10321232|NCT00245466|11455820|FG000|STARTED|Overall Study||43
10321233|NCT00245466|11455821|FG001|STARTED|Overall Study||46
10321234|NCT00245466|11455822|FG002|STARTED|Overall Study||40
10321235|NCT00245466|11455820|FG000|Started FE200486 CS02A|Overall Study||32
10321236|NCT00245466|11455821|FG001|Started FE200486 CS02A|Overall Study||30
10321237|NCT00245466|11455822|FG002|Started FE200486 CS02A|Overall Study||26
10701582|NCT02568254|11866002|FG001|STARTED|Period 3||12
10321238|NCT00245466|11455820|FG000|COMPLETED|Overall Study|Defined as those participants ongoing when the extension study was terminated|7
10321239|NCT00245466|11455821|FG001|COMPLETED|Overall Study||2
10321240|NCT00245466|11455822|FG002|COMPLETED|Overall Study||3
10321241|NCT00245466|11455820|FG000|NOT COMPLETED|Overall Study||36
10701583|NCT02568254|11866003|FG002|STARTED|Period 3||12
10321242|NCT00245466|11455821|FG001|NOT COMPLETED|Overall Study||44
10321243|NCT00245466|11455822|FG002|NOT COMPLETED|Overall Study||37
10321244|NCT00245518|11455832|FG000|STARTED|Overall Study||17
10321245|NCT00245518|11455833|FG001|STARTED|Overall Study||16
10321246|NCT00245518|11455832|FG000|COMPLETED|Overall Study||17
10321247|NCT00245518|11455833|FG001|COMPLETED|Overall Study||16
10321248|NCT00245518|11455832|FG000|NOT COMPLETED|Overall Study||0
10321249|NCT00245518|11455833|FG001|NOT COMPLETED|Overall Study||0
10321250|NCT00245557|11455841|FG000|STARTED|Overall Study||17
10321251|NCT00245557|11455842|FG001|STARTED|Overall Study||26
10321252|NCT00245557|11455841|FG000|COMPLETED|Overall Study||11
10321253|NCT00245557|11455842|FG001|COMPLETED|Overall Study||10
10321254|NCT00245557|11455841|FG000|NOT COMPLETED|Overall Study||6
10321255|NCT00245557|11455842|FG001|NOT COMPLETED|Overall Study||16
10321256|NCT00245583|11455851|FG000|STARTED|Overall Study||20
10321257|NCT00245583|11455852|FG001|STARTED|Overall Study||22
10321258|NCT00245583|11455851|FG000|COMPLETED|Overall Study||14
10321259|NCT00245583|11455852|FG001|COMPLETED|Overall Study||13
10321260|NCT00245583|11455851|FG000|NOT COMPLETED|Overall Study||6
10321261|NCT00245583|11455852|FG001|NOT COMPLETED|Overall Study||9
10321262|NCT00245635|11455860|FG000|STARTED|Overall Study||25
10803762|NCT04107493|11965199|FG001|STARTED|Second Intervention||17
10803763|NCT04107493|11965198|FG000|COMPLETED|Second Intervention||16
10803764|NCT04107493|11965199|FG001|COMPLETED|Second Intervention||17
10803765|NCT04107493|11965198|FG000|NOT COMPLETED|Second Intervention||0
10803766|NCT04107493|11965199|FG001|NOT COMPLETED|Second Intervention||0
10803767|NCT04106817|11965208|FG000|STARTED|Overall Study||12
10321263|NCT00245635|11455861|FG001|STARTED|Overall Study||18
10321264|NCT00245635|11455860|FG000|COMPLETED|Overall Study||25
10321265|NCT00245635|11455861|FG001|COMPLETED|Overall Study||18
10321266|NCT00245635|11455860|FG000|NOT COMPLETED|Overall Study||0
10321267|NCT00245635|11455861|FG001|NOT COMPLETED|Overall Study||0
10321268|NCT00245765|11455870|FG000|STARTED|Overall Study||59
10321269|NCT00245765|11455871|FG001|STARTED|Overall Study||59
10321270|NCT00245765|11455872|FG002|STARTED|Overall Study||58
10321271|NCT00245765|11455870|FG000|Safety Population|Overall Study|One subject in the Placebo (PBO) group received one injection of CDP870 200 mg on one occasion.|58
10321272|NCT00245765|11455871|FG001|Safety Population|Overall Study|For safety analysis, the PBO group subj. who received CDP870 was considered to be in the 200mg group|60
10321273|NCT00245765|11455872|FG002|Safety Population|Overall Study|One subject in the 400 mg group was randomized by mistake but did not receive study medication.|57
10321274|NCT00245765|11455870|FG000|COMPLETED|Overall Study||27
10321275|NCT00245765|11455871|FG001|COMPLETED|Overall Study||45
10321276|NCT00245765|11455872|FG002|COMPLETED|Overall Study||50
10321277|NCT00245765|11455870|FG000|NOT COMPLETED|Overall Study||32
10321278|NCT00245765|11455871|FG001|NOT COMPLETED|Overall Study||14
10321279|NCT00245765|11455872|FG002|NOT COMPLETED|Overall Study||8
10321280|NCT00245856|11455880|FG000|STARTED|Period One||28
10321281|NCT00245856|11455881|FG001|STARTED|Period One||0
10321282|NCT00245856|11455880|FG000|COMPLETED|Period One||28
10321283|NCT00245856|11455881|FG001|COMPLETED|Period One||0
10321284|NCT00245856|11455880|FG000|NOT COMPLETED|Period One||0
10321285|NCT00245856|11455881|FG001|NOT COMPLETED|Period One||0
10321286|NCT00245856|11455880|FG000|STARTED|Period Two||0
10321287|NCT00245856|11455881|FG001|STARTED|Period Two||39
10321288|NCT00245856|11455880|FG000|COMPLETED|Period Two||0
10321289|NCT00245856|11455881|FG001|COMPLETED|Period Two||38
10321290|NCT00245856|11455880|FG000|NOT COMPLETED|Period Two||0
10321291|NCT00245856|11455881|FG001|NOT COMPLETED|Period Two||1
10321292|NCT00246012|11455897|FG000|STARTED|Overall Study||3
10321293|NCT00246012|11455898|FG001|STARTED|Overall Study||3
10321294|NCT00246012|11455899|FG002|STARTED|Overall Study||3
10321295|NCT00246012|11455900|FG003|STARTED|Overall Study||3
10321296|NCT00246012|11455901|FG004|STARTED|Overall Study||3
10321297|NCT00246012|11455902|FG005|STARTED|Overall Study||32
10321298|NCT00246012|11455903|FG006|STARTED|Overall Study||32
10321299|NCT00246012|11455904|FG007|STARTED|Overall Study||33
10321300|NCT00246012|11455905|FG008|STARTED|Overall Study||32
10321301|NCT00246012|11455897|FG000|Treated|Overall Study||3
10321302|NCT00246012|11455898|FG001|Treated|Overall Study||3
10321303|NCT00246012|11455899|FG002|Treated|Overall Study||3
10321304|NCT00246012|11455900|FG003|Treated|Overall Study||3
10321305|NCT00246012|11455901|FG004|Treated|Overall Study||3
10321306|NCT00246012|11455902|FG005|Treated|Overall Study||31
10321307|NCT00246012|11455903|FG006|Treated|Overall Study||31
10321308|NCT00246012|11455904|FG007|Treated|Overall Study||33
10321309|NCT00246012|11455905|FG008|Treated|Overall Study||32
10321310|NCT00246012|11455897|FG000|COMPLETED|Overall Study||0
10321311|NCT00246012|11455898|FG001|COMPLETED|Overall Study||2
10321312|NCT00246012|11455899|FG002|COMPLETED|Overall Study||1
10321313|NCT00246012|11455900|FG003|COMPLETED|Overall Study||0
10321314|NCT00246012|11455901|FG004|COMPLETED|Overall Study||0
10321315|NCT00246012|11455902|FG005|COMPLETED|Overall Study||4
10803768|NCT04106817|11965209|FG001|STARTED|Overall Study||11
10803769|NCT04106817|11965210|FG002|STARTED|Overall Study||12
10803770|NCT04106817|11965208|FG000|COMPLETED|Overall Study||11
10803771|NCT04106817|11965209|FG001|COMPLETED|Overall Study||11
10803772|NCT04106817|11965210|FG002|COMPLETED|Overall Study||12
10803773|NCT04106817|11965208|FG000|NOT COMPLETED|Overall Study||1
10321316|NCT00246012|11455903|FG006|COMPLETED|Overall Study||1
10321317|NCT00246012|11455904|FG007|COMPLETED|Overall Study||5
10321318|NCT00246012|11455905|FG008|COMPLETED|Overall Study||4
10321319|NCT00246012|11455897|FG000|NOT COMPLETED|Overall Study||3
10803774|NCT04106817|11965209|FG001|NOT COMPLETED|Overall Study||0
10321320|NCT00246012|11455898|FG001|NOT COMPLETED|Overall Study||1
10321321|NCT00246012|11455899|FG002|NOT COMPLETED|Overall Study||2
10321322|NCT00246012|11455900|FG003|NOT COMPLETED|Overall Study||3
10321323|NCT00246012|11455901|FG004|NOT COMPLETED|Overall Study||3
10321324|NCT00246012|11455902|FG005|NOT COMPLETED|Overall Study||28
10321325|NCT00246012|11455903|FG006|NOT COMPLETED|Overall Study||31
10321326|NCT00246012|11455904|FG007|NOT COMPLETED|Overall Study||28
10321327|NCT00246012|11455905|FG008|NOT COMPLETED|Overall Study||28
10321328|NCT00246025|11455931|FG000|STARTED|Overall Study||124
10321329|NCT00246025|11455932|FG001|STARTED|Overall Study||133
10321330|NCT00246025|11455933|FG002|STARTED|Overall Study||126
10321331|NCT00246025|11455934|FG003|STARTED|Overall Study||129
10321332|NCT00246025|11455931|FG000|COMPLETED|Overall Study||114
10321333|NCT00246025|11455932|FG001|COMPLETED|Overall Study||124
10321334|NCT00246025|11455933|FG002|COMPLETED|Overall Study||116
10321335|NCT00246025|11455934|FG003|COMPLETED|Overall Study||116
10321336|NCT00246025|11455931|FG000|NOT COMPLETED|Overall Study||10
10321337|NCT00246025|11455932|FG001|NOT COMPLETED|Overall Study||9
10321338|NCT00246025|11455933|FG002|NOT COMPLETED|Overall Study||10
10321339|NCT00246025|11455934|FG003|NOT COMPLETED|Overall Study||13
10321340|NCT00246090|11455944|FG000|STARTED|Overall Study||298
10321341|NCT00246090|11455944|FG000|COMPLETED|Overall Study||3
10321342|NCT00246090|11455944|FG000|NOT COMPLETED|Overall Study||295
10321343|NCT00246129|11455950|FG000|STARTED|Overall Study||82
10321344|NCT00246129|11455951|FG001|STARTED|Overall Study||41
10321345|NCT00246129|11455950|FG000|COMPLETED|Overall Study||75
10321346|NCT00246129|11455951|FG001|COMPLETED|Overall Study||39
10321347|NCT00246129|11455950|FG000|NOT COMPLETED|Overall Study||7
10321348|NCT00246129|11455951|FG001|NOT COMPLETED|Overall Study||2
10321349|NCT00246259|11455962|FG000|STARTED|Overall Study||44
10321350|NCT00246259|11455963|FG001|STARTED|Overall Study||41
10321351|NCT00246259|11455962|FG000|Eligible for Intent-to-treat (ITT)|Overall Study||42
10321352|NCT00246259|11455963|FG001|Eligible for Intent-to-treat (ITT)|Overall Study||35
10321353|NCT00246259|11455962|FG000|COMPLETED|Overall Study||16
10321354|NCT00246259|11455963|FG001|COMPLETED|Overall Study||15
10321355|NCT00246259|11455962|FG000|NOT COMPLETED|Overall Study||28
10321356|NCT00246259|11455963|FG001|NOT COMPLETED|Overall Study||26
10321357|NCT00246324|11455969|FG000|STARTED|Overall Study||16
10321358|NCT00246324|11455969|FG000|COMPLETED|Overall Study||15
10321359|NCT00246324|11455969|FG000|NOT COMPLETED|Overall Study||1
10321360|NCT00246337|11455982|FG000|STARTED|Overall Study||147
10321361|NCT00246337|11455983|FG001|STARTED|Overall Study||16
10321362|NCT00246337|11455984|FG002|STARTED|Overall Study||18
10321363|NCT00246337|11455985|FG003|STARTED|Overall Study||17
10321364|NCT00246337|11455986|FG004|STARTED|Overall Study||16
10321365|NCT00246337|11455987|FG005|STARTED|Overall Study||54
10321366|NCT00246337|11455988|FG006|STARTED|Overall Study||54
10321367|NCT00246337|11455989|FG007|STARTED|Overall Study||53
10321368|NCT00246337|11455990|FG008|STARTED|Overall Study||45
10321369|NCT00246337|11455982|FG000|Completed Period (Initial Dose)|Overall Study||46
10321370|NCT00246337|11455983|FG001|Completed Period (Initial Dose)|Overall Study||4
10321371|NCT00246337|11455984|FG002|Completed Period (Initial Dose)|Overall Study||9
10321372|NCT00246337|11455985|FG003|Completed Period (Initial Dose)|Overall Study||5
10321373|NCT00246337|11455986|FG004|Completed Period (Initial Dose)|Overall Study||8
10321374|NCT00246337|11455987|FG005|Completed Period (Initial Dose)|Overall Study||29
10321375|NCT00246337|11455988|FG006|Completed Period (Initial Dose)|Overall Study||29
10321376|NCT00246337|11455989|FG007|Completed Period (Initial Dose)|Overall Study||27
10321377|NCT00246337|11455990|FG008|Completed Period (Initial Dose)|Overall Study||19
10321378|NCT00246337|11455982|FG000|Completed Period (Both Doses)|Overall Study||69
10321379|NCT00246337|11455983|FG001|Completed Period (Both Doses)|Overall Study||10
10803775|NCT04106817|11965210|FG002|NOT COMPLETED|Overall Study||0
10803776|NCT04105972|11965220|FG000|STARTED|Overall Study||88
10803777|NCT04105972|11965221|FG001|STARTED|Overall Study||87
10803778|NCT04105972|11965220|FG000|COMPLETED|Overall Study||86
10803779|NCT04105972|11965221|FG001|COMPLETED|Overall Study||86
10803780|NCT04105972|11965220|FG000|NOT COMPLETED|Overall Study||2
10803781|NCT04105972|11965221|FG001|NOT COMPLETED|Overall Study||1
10803782|NCT04105218|11965229|FG000|STARTED|Overall Study||6
10803783|NCT04105218|11965230|FG001|STARTED|Overall Study||6
10803784|NCT04105218|11965229|FG000|Completed First Condition|Overall Study||0
10803785|NCT04105218|11965230|FG001|Completed First Condition|Overall Study||1
10803786|NCT04105218|11965229|FG000|Completed Second Condition|Overall Study||0
10803787|NCT04105218|11965230|FG001|Completed Second Condition|Overall Study||0
10803788|NCT04105218|11965229|FG000|COMPLETED|Overall Study||0
10321380|NCT00246337|11455984|FG002|Completed Period (Both Doses)|Overall Study||6
10321381|NCT00246337|11455985|FG003|Completed Period (Both Doses)|Overall Study||11
10321382|NCT00246337|11455986|FG004|Completed Period (Both Doses)|Overall Study||4
10321383|NCT00246337|11455987|FG005|Completed Period (Both Doses)|Overall Study||10
10321384|NCT00246337|11455988|FG006|Completed Period (Both Doses)|Overall Study||16
10321385|NCT00246337|11455989|FG007|Completed Period (Both Doses)|Overall Study||13
10321386|NCT00246337|11455990|FG008|Completed Period (Both Doses)|Overall Study||15
10321387|NCT00246337|11455982|FG000|COMPLETED|Overall Study||115
10321388|NCT00246337|11455983|FG001|COMPLETED|Overall Study||14
10321389|NCT00246337|11455984|FG002|COMPLETED|Overall Study||15
10321390|NCT00246337|11455985|FG003|COMPLETED|Overall Study||16
10321391|NCT00246337|11455986|FG004|COMPLETED|Overall Study||12
10321392|NCT00246337|11455987|FG005|COMPLETED|Overall Study||39
10321393|NCT00246337|11455988|FG006|COMPLETED|Overall Study||45
10321394|NCT00246337|11455989|FG007|COMPLETED|Overall Study||40
10321395|NCT00246337|11455990|FG008|COMPLETED|Overall Study||34
10321396|NCT00246337|11455982|FG000|NOT COMPLETED|Overall Study||32
10321397|NCT00246337|11455983|FG001|NOT COMPLETED|Overall Study||2
10321398|NCT00246337|11455984|FG002|NOT COMPLETED|Overall Study||3
10321399|NCT00246337|11455985|FG003|NOT COMPLETED|Overall Study||1
10321400|NCT00246337|11455986|FG004|NOT COMPLETED|Overall Study||4
10321401|NCT00246337|11455987|FG005|NOT COMPLETED|Overall Study||15
10321402|NCT00246337|11455988|FG006|NOT COMPLETED|Overall Study||9
10321403|NCT00246337|11455989|FG007|NOT COMPLETED|Overall Study||13
10321404|NCT00246337|11455990|FG008|NOT COMPLETED|Overall Study||11
10321405|NCT00246376|11456015|FG000|STARTED|Overall Study||41
10321406|NCT00246376|11456016|FG001|STARTED|Overall Study||43
10321407|NCT00246376|11456017|FG002|STARTED|Overall Study||45
10321408|NCT00246376|11456018|FG003|STARTED|Overall Study||47
10321409|NCT00246376|11456019|FG004|STARTED|Overall Study||45
10321410|NCT00246376|11456015|FG000|After Dietary run-in at Two Weeks|Overall Study||30
10321411|NCT00246376|11456016|FG001|After Dietary run-in at Two Weeks|Overall Study||38
10321412|NCT00246376|11456017|FG002|After Dietary run-in at Two Weeks|Overall Study||41
10321413|NCT00246376|11456018|FG003|After Dietary run-in at Two Weeks|Overall Study||40
10321414|NCT00246376|11456019|FG004|After Dietary run-in at Two Weeks|Overall Study||42
10321415|NCT00246376|11456015|FG000|COMPLETED|Overall Study||26
10321416|NCT00246376|11456016|FG001|COMPLETED|Overall Study||24
10321417|NCT00246376|11456017|FG002|COMPLETED|Overall Study||29
10321418|NCT00246376|11456018|FG003|COMPLETED|Overall Study||21
10321419|NCT00246376|11456019|FG004|COMPLETED|Overall Study||28
10321420|NCT00246376|11456015|FG000|NOT COMPLETED|Overall Study||15
10321421|NCT00246376|11456016|FG001|NOT COMPLETED|Overall Study||19
10321422|NCT00246376|11456017|FG002|NOT COMPLETED|Overall Study||16
10321423|NCT00246376|11456018|FG003|NOT COMPLETED|Overall Study||26
10321424|NCT00246376|11456019|FG004|NOT COMPLETED|Overall Study||17
10321425|NCT00246441|11456039|FG000|STARTED|Overall Study||20
10321426|NCT00246441|11456040|FG001|STARTED|Overall Study||22
10321427|NCT00246441|11456039|FG000|COMPLETED|Overall Study||19
10321428|NCT00246441|11456040|FG001|COMPLETED|Overall Study||22
10321429|NCT00246441|11456039|FG000|NOT COMPLETED|Overall Study||1
10321430|NCT00246441|11456040|FG001|NOT COMPLETED|Overall Study||0
10321431|NCT00246519|11456048|FG000|STARTED|Overall Study||442
10321432|NCT00246519|11456049|FG001|STARTED|Overall Study||446
10321433|NCT00246519|11456048|FG000|COMPLETED|Overall Study||386
10321434|NCT00246519|11456049|FG001|COMPLETED|Overall Study||382
10321435|NCT00246519|11456048|FG000|NOT COMPLETED|Overall Study||56
10321436|NCT00246519|11456049|FG001|NOT COMPLETED|Overall Study||64
10321437|NCT00246571|11456057|FG000|STARTED|Overall Study||113
10321438|NCT00246571|11456058|FG001|STARTED|Overall Study||104
10321439|NCT00246571|11456057|FG000|Randomized But Not Treated|Overall Study||3
10321440|NCT00246571|11456058|FG001|Randomized But Not Treated|Overall Study||1
10321441|NCT00246571|11456057|FG000|COMPLETED|Overall Study||0
10321442|NCT00246571|11456058|FG001|COMPLETED|Overall Study||0
10321443|NCT00246571|11456057|FG000|NOT COMPLETED|Overall Study||113
10321444|NCT00246571|11456058|FG001|NOT COMPLETED|Overall Study||104
10321445|NCT00246740|11456066|FG000|STARTED|Initial Enrollment||28
10321446|NCT00246740|11456067|FG001|STARTED|Initial Enrollment||28
10321447|NCT00246740|11456066|FG000|COMPLETED|Initial Enrollment||22
10321448|NCT00246740|11456067|FG001|COMPLETED|Initial Enrollment||20
10321449|NCT00246740|11456066|FG000|NOT COMPLETED|Initial Enrollment||6
10321450|NCT00246740|11456067|FG001|NOT COMPLETED|Initial Enrollment||8
10321451|NCT00246740|11456066|FG000|STARTED|Experimental Phase||22
10321452|NCT00246740|11456067|FG001|STARTED|Experimental Phase||20
10321453|NCT00246740|11456066|FG000|COMPLETED|Experimental Phase||22
10321454|NCT00246740|11456067|FG001|COMPLETED|Experimental Phase||20
10321455|NCT00246740|11456066|FG000|NOT COMPLETED|Experimental Phase||0
10321456|NCT00246740|11456067|FG001|NOT COMPLETED|Experimental Phase||0
10321457|NCT00246753|11456073|FG000|STARTED|Overall Study||29
10321458|NCT00246753|11456073|FG000|COMPLETED|Overall Study||21
10321459|NCT00246753|11456073|FG000|NOT COMPLETED|Overall Study||8
10321460|NCT00246805|11456079|FG000|STARTED|Phase 1||34
10321461|NCT00246805|11456080|FG001|STARTED|Phase 1||33
10455848|NCT01004705|11603960|FG000|STARTED|Run-In||44
10455849|NCT01004705|11603961|FG001|STARTED|Run-In||0
10455850|NCT01004705|11603962|FG002|STARTED|Run-In||0
10321462|NCT00246805|11456079|FG000|COMPLETED|Phase 1||33
10455851|NCT01004705|11603960|FG000|COMPLETED|Run-In||36
10321463|NCT00246805|11456080|FG001|COMPLETED|Phase 1||33
10321464|NCT00246805|11456079|FG000|NOT COMPLETED|Phase 1||1
10321465|NCT00246805|11456080|FG001|NOT COMPLETED|Phase 1||0
10321466|NCT00246805|11456079|FG000|STARTED|Phase 2||33
10321467|NCT00246805|11456080|FG001|STARTED|Phase 2||33
10455852|NCT01004705|11603961|FG001|COMPLETED|Run-In||0
10321468|NCT00246805|11456079|FG000|COMPLETED|Phase 2||33
10321469|NCT00246805|11456080|FG001|COMPLETED|Phase 2||33
10321470|NCT00246805|11456079|FG000|NOT COMPLETED|Phase 2||0
10321471|NCT00246805|11456080|FG001|NOT COMPLETED|Phase 2||0
10321472|NCT00247273|11456088|FG000|STARTED|Overall Study||644
10321473|NCT00247273|11456089|FG001|STARTED|Overall Study||650
10321474|NCT00247273|11456088|FG000|Intent to Treat Population|Overall Study|Two subjects not included as they did not take any study medication.|642
10321475|NCT00247273|11456089|FG001|Intent to Treat Population|Overall Study||650
10321476|NCT00247273|11456088|FG000|COMPLETED|Overall Study||498
10455853|NCT01004705|11603962|FG002|COMPLETED|Run-In||0
10455854|NCT01004705|11603960|FG000|NOT COMPLETED|Run-In||8
10455855|NCT01004705|11603961|FG001|NOT COMPLETED|Run-In||0
10455856|NCT01004705|11603962|FG002|NOT COMPLETED|Run-In||0
10455857|NCT01004705|11603960|FG000|STARTED|Period 1 (12 Weeks)||0
10455858|NCT01004705|11603961|FG001|STARTED|Period 1 (12 Weeks)||18
10455859|NCT01004705|11603962|FG002|STARTED|Period 1 (12 Weeks)||18
10455860|NCT01004705|11603960|FG000|COMPLETED|Period 1 (12 Weeks)||0
10455861|NCT01004705|11603961|FG001|COMPLETED|Period 1 (12 Weeks)||13
10455862|NCT01004705|11603962|FG002|COMPLETED|Period 1 (12 Weeks)||13
10455863|NCT01004705|11603960|FG000|NOT COMPLETED|Period 1 (12 Weeks)||0
10455864|NCT01004705|11603961|FG001|NOT COMPLETED|Period 1 (12 Weeks)||5
10455865|NCT01004705|11603962|FG002|NOT COMPLETED|Period 1 (12 Weeks)||5
10455866|NCT01004705|11603960|FG000|STARTED|Washout Period (6 Weeks)||0
10455867|NCT01004705|11603961|FG001|STARTED|Washout Period (6 Weeks)||13
10455868|NCT01004705|11603962|FG002|STARTED|Washout Period (6 Weeks)||13
10455869|NCT01004705|11603960|FG000|COMPLETED|Washout Period (6 Weeks)||0
10455870|NCT01004705|11603961|FG001|COMPLETED|Washout Period (6 Weeks)||13
10455871|NCT01004705|11603962|FG002|COMPLETED|Washout Period (6 Weeks)||13
10455872|NCT01004705|11603960|FG000|NOT COMPLETED|Washout Period (6 Weeks)||0
10455873|NCT01004705|11603961|FG001|NOT COMPLETED|Washout Period (6 Weeks)||0
10455874|NCT01004705|11603962|FG002|NOT COMPLETED|Washout Period (6 Weeks)||0
10455875|NCT01004705|11603960|FG000|STARTED|Period 2 (12 Weeks)||0
10455876|NCT01004705|11603961|FG001|STARTED|Period 2 (12 Weeks)||13
10455877|NCT01004705|11603962|FG002|STARTED|Period 2 (12 Weeks)||13
10455878|NCT01004705|11603960|FG000|COMPLETED|Period 2 (12 Weeks)||0
10455879|NCT01004705|11603961|FG001|COMPLETED|Period 2 (12 Weeks)||13
10455880|NCT01004705|11603962|FG002|COMPLETED|Period 2 (12 Weeks)||9
10455881|NCT01004705|11603960|FG000|NOT COMPLETED|Period 2 (12 Weeks)||0
10455882|NCT01004705|11603961|FG001|NOT COMPLETED|Period 2 (12 Weeks)||0
10455883|NCT01004705|11603962|FG002|NOT COMPLETED|Period 2 (12 Weeks)||4
10455884|NCT01004718|11603969|FG000|STARTED|Overall Study||10
10455885|NCT01004718|11603969|FG000|COMPLETED|Overall Study||10
10455886|NCT01004718|11603969|FG000|NOT COMPLETED|Overall Study||0
10455887|NCT01004744|11603974|FG000|STARTED|Overall Study||10
10455888|NCT01004744|11603974|FG000|COMPLETED|Overall Study||10
10455889|NCT01004744|11603974|FG000|NOT COMPLETED|Overall Study||0
10526094|NCT01380093|11678039|FG007|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
10526095|NCT01380093|11678040|FG008|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
10526096|NCT01380093|11678032|FG000|STARTED|Treatment Phase: First Intervention||0
10526097|NCT01380093|11678033|FG001|STARTED|Treatment Phase: First Intervention||0
10526098|NCT01380093|11678034|FG002|STARTED|Treatment Phase: First Intervention||0
10526099|NCT01380093|11678035|FG003|STARTED|Treatment Phase: First Intervention||6
10526100|NCT01380093|11678036|FG004|STARTED|Treatment Phase: First Intervention||6
10526101|NCT01380093|11678037|FG005|STARTED|Treatment Phase: First Intervention||6
10526102|NCT01380093|11678038|FG006|STARTED|Treatment Phase: First Intervention||6
10526103|NCT01380093|11678039|FG007|STARTED|Treatment Phase: First Intervention||6
10526104|NCT01380093|11678040|FG008|STARTED|Treatment Phase: First Intervention||6
10526105|NCT01380093|11678032|FG000|COMPLETED|Treatment Phase: First Intervention||0
10526106|NCT01380093|11678033|FG001|COMPLETED|Treatment Phase: First Intervention||0
10526107|NCT01380093|11678034|FG002|COMPLETED|Treatment Phase: First Intervention||0
10526108|NCT01380093|11678035|FG003|COMPLETED|Treatment Phase: First Intervention||6
10526109|NCT01380093|11678036|FG004|COMPLETED|Treatment Phase: First Intervention||6
10526110|NCT01380093|11678037|FG005|COMPLETED|Treatment Phase: First Intervention||6
10526111|NCT01380093|11678038|FG006|COMPLETED|Treatment Phase: First Intervention||6
10526112|NCT01380093|11678039|FG007|COMPLETED|Treatment Phase: First Intervention||6
10526113|NCT01380093|11678040|FG008|COMPLETED|Treatment Phase: First Intervention||6
10526114|NCT01380093|11678032|FG000|NOT COMPLETED|Treatment Phase: First Intervention||0
10526115|NCT01380093|11678033|FG001|NOT COMPLETED|Treatment Phase: First Intervention||0
10321477|NCT00247273|11456089|FG001|COMPLETED|Overall Study||513
10321478|NCT00247273|11456088|FG000|NOT COMPLETED|Overall Study||146
10321479|NCT00247273|11456089|FG001|NOT COMPLETED|Overall Study||137
10321480|NCT00247377|11456097|FG000|STARTED|Overall Study||111
10321481|NCT00247377|11456098|FG001|STARTED|Overall Study||86
10526116|NCT01380093|11678034|FG002|NOT COMPLETED|Treatment Phase: First Intervention||0
10526117|NCT01380093|11678035|FG003|NOT COMPLETED|Treatment Phase: First Intervention||0
10526118|NCT01380093|11678036|FG004|NOT COMPLETED|Treatment Phase: First Intervention||0
10526119|NCT01380093|11678037|FG005|NOT COMPLETED|Treatment Phase: First Intervention||0
10526120|NCT01380093|11678038|FG006|NOT COMPLETED|Treatment Phase: First Intervention||0
10526121|NCT01380093|11678039|FG007|NOT COMPLETED|Treatment Phase: First Intervention||0
10526122|NCT01380093|11678040|FG008|NOT COMPLETED|Treatment Phase: First Intervention||0
10526123|NCT01380093|11678032|FG000|STARTED|Treatment Phase: Washout Period||0
10526124|NCT01380093|11678033|FG001|STARTED|Treatment Phase: Washout Period||0
10526125|NCT01380093|11678034|FG002|STARTED|Treatment Phase: Washout Period||0
10321482|NCT00247377|11456097|FG000|COMPLETED|Overall Study||111
10321483|NCT00247377|11456098|FG001|COMPLETED|Overall Study||86
10321484|NCT00247377|11456097|FG000|NOT COMPLETED|Overall Study||0
10321485|NCT00247377|11456098|FG001|NOT COMPLETED|Overall Study||0
10321486|NCT00247416|11456106|FG000|STARTED|Overall Study||26
10321487|NCT00247416|11456107|FG001|STARTED|Overall Study||33
10321488|NCT00247416|11456106|FG000|COMPLETED|Overall Study||25
10321489|NCT00247416|11456107|FG001|COMPLETED|Overall Study||31
10701584|NCT02568254|11866004|FG003|STARTED|Period 3||12
10701585|NCT02568254|11866005|FG004|STARTED|Period 3||12
10701586|NCT02568254|11866006|FG005|STARTED|Period 3||12
10701587|NCT02568254|11866001|FG000|COMPLETED|Period 3||13
10701588|NCT02568254|11866002|FG001|COMPLETED|Period 3||12
10701589|NCT02568254|11866003|FG002|COMPLETED|Period 3||12
10321490|NCT00247416|11456106|FG000|NOT COMPLETED|Overall Study||1
10321491|NCT00247416|11456107|FG001|NOT COMPLETED|Overall Study||2
10321492|NCT00247611|11456117|FG000|STARTED|Baselined|Participants randomized|304
10321493|NCT00247611|11456118|FG001|STARTED|Baselined|Participants randomized|290
10321494|NCT00247611|11456117|FG000|COMPLETED|Baselined|Randomized participants who completed at least 2 adherence assessments/sessions|287
10321495|NCT00247611|11456118|FG001|COMPLETED|Baselined|Randomized participants who completed at least 2 adherence assessments/sessions|277
10321496|NCT00247611|11456117|FG000|NOT COMPLETED|Baselined||17
10321497|NCT00247611|11456118|FG001|NOT COMPLETED|Baselined||13
10321498|NCT00247611|11456117|FG000|STARTED|Intention to Treat Sample|Participants randomized|304
10321499|NCT00247611|11456118|FG001|STARTED|Intention to Treat Sample|Participants randomized|290
10321500|NCT00247611|11456117|FG000|COMPLETED|Intention to Treat Sample|Randomized participants who completed at least 2 adherence assessments/sessions|287
10321501|NCT00247611|11456118|FG001|COMPLETED|Intention to Treat Sample|Randomized participants who completed at least 2 adherence assessments/sessions|277
10321502|NCT00247611|11456117|FG000|NOT COMPLETED|Intention to Treat Sample||17
10321503|NCT00247611|11456118|FG001|NOT COMPLETED|Intention to Treat Sample||13
10321504|NCT00247611|11456117|FG000|STARTED|On Protocol Sample|ITT sample participants|287
10321505|NCT00247611|11456118|FG001|STARTED|On Protocol Sample|ITT sample participants|277
10321506|NCT00247611|11456117|FG000|COMPLETED|On Protocol Sample|Participants with no interruptions in ART receipt and completing 6 or more LifeWindows assessments|176
10321507|NCT00247611|11456118|FG001|COMPLETED|On Protocol Sample|Participants with no interruptions in ART receipt and completing 6 or more LifeWindows assessments|152
10321508|NCT00247611|11456117|FG000|NOT COMPLETED|On Protocol Sample||111
10321509|NCT00247611|11456118|FG001|NOT COMPLETED|On Protocol Sample||125
10321510|NCT00247624|11456132|FG000|STARTED|Overall Study||30
10321511|NCT00247624|11456133|FG001|STARTED|Overall Study||30
10321512|NCT00247624|11456132|FG000|COMPLETED|Overall Study||25
10321513|NCT00247624|11456133|FG001|COMPLETED|Overall Study||26
10321514|NCT00247624|11456132|FG000|NOT COMPLETED|Overall Study||5
10321515|NCT00247624|11456133|FG001|NOT COMPLETED|Overall Study||4
10321516|NCT00247676|11456139|FG000|STARTED|Overall Study||37
10321517|NCT00247676|11456139|FG000|COMPLETED|Overall Study||1
10321518|NCT00247676|11456139|FG000|NOT COMPLETED|Overall Study||36
10321519|NCT00247962|11456145|FG000|STARTED|Overall Study||379
10321520|NCT00247962|11456146|FG001|STARTED|Overall Study||187
10321521|NCT00247962|11456145|FG000|COMPLETED|Overall Study||353
10321522|NCT00247962|11456146|FG001|COMPLETED|Overall Study||168
10321523|NCT00247962|11456145|FG000|NOT COMPLETED|Overall Study||26
10321524|NCT00247962|11456146|FG001|NOT COMPLETED|Overall Study||19
10321525|NCT00248040|11456155|FG000|STARTED|Overall Study||25
10321526|NCT00248040|11456156|FG001|STARTED|Overall Study||23
10321527|NCT00248040|11456157|FG002|STARTED|Overall Study||26
10321528|NCT00248040|11456155|FG000|COMPLETED|Overall Study||22
10321529|NCT00248040|11456156|FG001|COMPLETED|Overall Study||22
10321530|NCT00248040|11456157|FG002|COMPLETED|Overall Study||22
10321531|NCT00248040|11456155|FG000|NOT COMPLETED|Overall Study||3
10321532|NCT00248040|11456156|FG001|NOT COMPLETED|Overall Study||1
10321533|NCT00248040|11456157|FG002|NOT COMPLETED|Overall Study||4
10321534|NCT00248170|11456168|FG000|STARTED|Overall Study||2078
10321535|NCT00248170|11456169|FG001|STARTED|Overall Study||2094
10321536|NCT00248170|11456168|FG000|Intent-to-treat (ITT)|Overall Study||2061
10321537|NCT00248170|11456169|FG001|Intent-to-treat (ITT)|Overall Study||2075
10321538|NCT00248170|11456168|FG000|Safety Set|Overall Study||2049
10321539|NCT00248170|11456169|FG001|Safety Set|Overall Study||2062
10321540|NCT00248170|11456168|FG000|COMPLETED|Overall Study||1317
10321541|NCT00248170|11456169|FG001|COMPLETED|Overall Study||1286
10321542|NCT00248170|11456168|FG000|NOT COMPLETED|Overall Study||761
10321543|NCT00248170|11456169|FG001|NOT COMPLETED|Overall Study||808
10321544|NCT00248495|11456175|FG000|STARTED|Overall Study||38
10321545|NCT00248495|11456175|FG000|COMPLETED|Overall Study||37
10321546|NCT00248495|11456175|FG000|NOT COMPLETED|Overall Study||1
10321547|NCT00248534|11456179|FG000|STARTED|Overall Study||16
10321548|NCT00248534|11456179|FG000|COMPLETED|Overall Study||16
10321549|NCT00248534|11456179|FG000|NOT COMPLETED|Overall Study||0
10321550|NCT00248547|11456185|FG000|STARTED|Overall Study||20
10321551|NCT00248547|11456186|FG001|STARTED|Overall Study||20
10321552|NCT00248547|11456185|FG000|COMPLETED|Overall Study||20
10701590|NCT02568254|11866004|FG003|COMPLETED|Period 3||12
10321553|NCT00248547|11456186|FG001|COMPLETED|Overall Study||20
10321554|NCT00248547|11456185|FG000|NOT COMPLETED|Overall Study||0
10321555|NCT00248547|11456186|FG001|NOT COMPLETED|Overall Study||0
10321556|NCT00248560|11456192|FG000|STARTED|Overall Study||36
10321557|NCT00248560|11456192|FG000|COMPLETED|Overall Study||36
10701591|NCT02568254|11866005|FG004|COMPLETED|Period 3||11
10701592|NCT02568254|11866006|FG005|COMPLETED|Period 3||12
10321558|NCT00248560|11456192|FG000|NOT COMPLETED|Overall Study||0
10321559|NCT00248612|11456201|FG000|STARTED|Overall Study||24
10321560|NCT00248612|11456202|FG001|STARTED|Overall Study||21
10321561|NCT00248612|11456203|FG002|STARTED|Overall Study||14
10321562|NCT00248612|11456204|FG003|STARTED|Overall Study||22
10321563|NCT00248612|11456201|FG000|COMPLETED|Overall Study||24
10321564|NCT00248612|11456202|FG001|COMPLETED|Overall Study||21
10321565|NCT00248612|11456203|FG002|COMPLETED|Overall Study||14
10321566|NCT00248612|11456204|FG003|COMPLETED|Overall Study||22
10321567|NCT00248612|11456201|FG000|NOT COMPLETED|Overall Study||0
10321568|NCT00248612|11456202|FG001|NOT COMPLETED|Overall Study||0
10321569|NCT00248612|11456203|FG002|NOT COMPLETED|Overall Study||0
10321570|NCT00248612|11456204|FG003|NOT COMPLETED|Overall Study||0
10321571|NCT00248625|11456218|FG000|STARTED|Overall Study||92
10321572|NCT00248625|11456219|FG001|STARTED|Overall Study||92
10321573|NCT00248625|11456218|FG000|COMPLETED|Overall Study||92
10321574|NCT00248625|11456219|FG001|COMPLETED|Overall Study||90
10321575|NCT00248625|11456218|FG000|NOT COMPLETED|Overall Study||0
10321576|NCT00248625|11456219|FG001|NOT COMPLETED|Overall Study||2
10321577|NCT00248638|11456227|FG000|STARTED|Overall Study||75
10321578|NCT00248638|11456228|FG001|STARTED|Overall Study||75
10321579|NCT00248638|11456227|FG000|COMPLETED|Overall Study||75
10321580|NCT00248638|11456228|FG001|COMPLETED|Overall Study||75
10321581|NCT00248638|11456227|FG000|NOT COMPLETED|Overall Study||0
10321582|NCT00248638|11456228|FG001|NOT COMPLETED|Overall Study||0
10321583|NCT00248651|11456239|FG000|STARTED|Overall Study||97
10321584|NCT00248651|11456240|FG001|STARTED|Overall Study||98
10321585|NCT00248651|11456241|FG002|STARTED|Overall Study||97
10321586|NCT00248651|11456239|FG000|Completed 12 Weeks of Treatment|Overall Study||78
10321587|NCT00248651|11456240|FG001|Completed 12 Weeks of Treatment|Overall Study||66
10321588|NCT00248651|11456241|FG002|Completed 12 Weeks of Treatment|Overall Study||75
10321589|NCT00248651|11456239|FG000|COMPLETED|Overall Study||69
10321590|NCT00248651|11456240|FG001|COMPLETED|Overall Study||58
10321591|NCT00248651|11456241|FG002|COMPLETED|Overall Study||65
10321592|NCT00248651|11456239|FG000|NOT COMPLETED|Overall Study||28
10321593|NCT00248651|11456240|FG001|NOT COMPLETED|Overall Study||40
10321594|NCT00248651|11456241|FG002|NOT COMPLETED|Overall Study||32
10321595|NCT00248781|11456251|FG000|STARTED|Overall Study||52
10321596|NCT00248781|11456252|FG001|STARTED|Overall Study||51
10321597|NCT00248781|11456251|FG000|COMPLETED|Overall Study||42
10321598|NCT00248781|11456252|FG001|COMPLETED|Overall Study||47
10321599|NCT00248781|11456251|FG000|NOT COMPLETED|Overall Study||10
10321600|NCT00248781|11456252|FG001|NOT COMPLETED|Overall Study||4
10321601|NCT00248794|11456261|FG000|STARTED|Overall Study||25
10321602|NCT00248794|11456262|FG001|STARTED|Overall Study||24
10321603|NCT00248794|11456263|FG002|STARTED|Overall Study||10
10321604|NCT00248794|11456261|FG000|COMPLETED|Overall Study||19
10321605|NCT00248794|11456262|FG001|COMPLETED|Overall Study||16
10321606|NCT00248794|11456263|FG002|COMPLETED|Overall Study||7
10321607|NCT00248794|11456261|FG000|NOT COMPLETED|Overall Study||6
10321608|NCT00248794|11456262|FG001|NOT COMPLETED|Overall Study||8
10321609|NCT00248794|11456263|FG002|NOT COMPLETED|Overall Study||3
10321610|NCT00248807|11456279|FG000|STARTED|Overall Study||19
10321611|NCT00248807|11456280|FG001|STARTED|Overall Study||11
10321612|NCT00248807|11456279|FG000|COMPLETED|Overall Study||19
10321613|NCT00248807|11456280|FG001|COMPLETED|Overall Study||11
10321614|NCT00248807|11456279|FG000|NOT COMPLETED|Overall Study||0
10321615|NCT00248807|11456280|FG001|NOT COMPLETED|Overall Study||0
10321616|NCT00248833|11456295|FG000|STARTED|Overall Study||12
10321617|NCT00248833|11456296|FG001|STARTED|Overall Study||11
10321618|NCT00248833|11456297|FG002|STARTED|Overall Study||11
10321619|NCT00248833|11456295|FG000|COMPLETED|Overall Study||9
10321620|NCT00248833|11456296|FG001|COMPLETED|Overall Study||8
10321621|NCT00248833|11456297|FG002|COMPLETED|Overall Study||9
10321622|NCT00248833|11456295|FG000|NOT COMPLETED|Overall Study||3
10321623|NCT00248833|11456296|FG001|NOT COMPLETED|Overall Study||3
10321624|NCT00248833|11456297|FG002|NOT COMPLETED|Overall Study||2
10321625|NCT00249002|11456307|FG000|STARTED|Overall Study||9
10321626|NCT00249002|11456307|FG000|COMPLETED|Overall Study||2
10701593|NCT02568254|11866001|FG000|NOT COMPLETED|Period 3||0
10701594|NCT02568254|11866002|FG001|NOT COMPLETED|Period 3||0
10701595|NCT02568254|11866003|FG002|NOT COMPLETED|Period 3||0
10701596|NCT02568254|11866004|FG003|NOT COMPLETED|Period 3||0
10321627|NCT00249002|11456307|FG000|NOT COMPLETED|Overall Study||7
10338435|NCT00369668|11475300|FG002|COMPLETED|Overall Study||3
10338436|NCT00369668|11475298|FG000|NOT COMPLETED|Overall Study||4
10338437|NCT00369668|11475299|FG001|NOT COMPLETED|Overall Study||5
10338438|NCT00369668|11475300|FG002|NOT COMPLETED|Overall Study||7
10338439|NCT00369681|11475311|FG000|STARTED|Overall Study||50
10338440|NCT00369681|11475311|FG000|COMPLETED|Overall Study||49
10338441|NCT00369681|11475311|FG000|NOT COMPLETED|Overall Study||1
10338442|NCT00369707|11475315|FG000|STARTED|Induction Part A (1 Cycle -35 Days)||42
10338443|NCT00369707|11475315|FG000|COMPLETED|Induction Part A (1 Cycle -35 Days)||42
10338444|NCT00369707|11475315|FG000|NOT COMPLETED|Induction Part A (1 Cycle -35 Days)||0
10338445|NCT00369707|11475315|FG000|STARTED|Induction Part B (2 Cycles)||42
10701597|NCT02568254|11866005|FG004|NOT COMPLETED|Period 3||1
10338446|NCT00369707|11475315|FG000|COMPLETED|Induction Part B (2 Cycles)||35
10338447|NCT00369707|11475315|FG000|NOT COMPLETED|Induction Part B (2 Cycles)||7
10338448|NCT00369707|11475315|FG000|STARTED|Maintenance Period (up to 4 Cycles)||35
10701598|NCT02568254|11866006|FG005|NOT COMPLETED|Period 3||0
10701599|NCT02568345|11866014|FG000|STARTED|Overall Study||31
10321628|NCT00249249|11456315|FG000|STARTED|Overall Study||321
10321629|NCT00249249|11456316|FG001|STARTED|Overall Study||103
10321630|NCT00249249|11456317|FG002|STARTED|Overall Study||303
10321631|NCT00249249|11456318|FG003|STARTED|Overall Study||103
10321632|NCT00249249|11456315|FG000|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|316
10321633|NCT00249249|11456316|FG001|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|102
10321634|NCT00249249|11456317|FG002|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|300
10321635|NCT00249249|11456318|FG003|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|103
10321636|NCT00249249|11456315|FG000|COMPLETED|Overall Study||301
10321637|NCT00249249|11456316|FG001|COMPLETED|Overall Study||98
10321638|NCT00249249|11456317|FG002|COMPLETED|Overall Study||288
10321639|NCT00249249|11456318|FG003|COMPLETED|Overall Study||100
10321640|NCT00249249|11456315|FG000|NOT COMPLETED|Overall Study||20
10321641|NCT00249249|11456316|FG001|NOT COMPLETED|Overall Study||5
10321642|NCT00249249|11456317|FG002|NOT COMPLETED|Overall Study||15
10321643|NCT00249249|11456318|FG003|NOT COMPLETED|Overall Study||3
10321644|NCT00249288|11456330|FG000|STARTED|Overall Study||19
10321645|NCT00249288|11456331|FG001|STARTED|Overall Study||19
10321646|NCT00249288|11456330|FG000|Initiated Treatment|Overall Study||17
10321647|NCT00249288|11456331|FG001|Initiated Treatment|Overall Study||15
10321648|NCT00249288|11456330|FG000|COMPLETED|Overall Study||14
10321649|NCT00249288|11456331|FG001|COMPLETED|Overall Study||14
10321650|NCT00249288|11456330|FG000|NOT COMPLETED|Overall Study||5
10321651|NCT00249288|11456331|FG001|NOT COMPLETED|Overall Study||5
10321652|NCT00249379|11456347|FG000|STARTED|Overall Study||14
10321653|NCT00249379|11456348|FG001|STARTED|Overall Study||12
10321654|NCT00249379|11456347|FG000|COMPLETED|Overall Study||6
10321655|NCT00249379|11456348|FG001|COMPLETED|Overall Study||4
10321656|NCT00249379|11456347|FG000|NOT COMPLETED|Overall Study||8
10321657|NCT00249379|11456348|FG001|NOT COMPLETED|Overall Study||8
10321658|NCT00249444|11456356|FG000|STARTED|Overall Study||42
10321659|NCT00249444|11456357|FG001|STARTED|Overall Study||44
10321660|NCT00249444|11456356|FG000|COMPLETED|Overall Study||30
10321661|NCT00249444|11456357|FG001|COMPLETED|Overall Study||29
10321662|NCT00249444|11456356|FG000|NOT COMPLETED|Overall Study||12
10321663|NCT00249444|11456357|FG001|NOT COMPLETED|Overall Study||15
10321664|NCT00249470|11456365|FG000|STARTED|Overall Study||28
10321665|NCT00249470|11456366|FG001|STARTED|Overall Study||28
10321666|NCT00249470|11456365|FG000|COMPLETED|Overall Study||28
10321667|NCT00249470|11456366|FG001|COMPLETED|Overall Study||28
10321668|NCT00249470|11456365|FG000|NOT COMPLETED|Overall Study||0
10321669|NCT00249470|11456366|FG001|NOT COMPLETED|Overall Study||0
10321670|NCT00249496|11456374|FG000|STARTED|Overall Study||24
10321671|NCT00249496|11456375|FG001|STARTED|Overall Study||27
10321672|NCT00249496|11456374|FG000|COMPLETED|Overall Study||24
10321673|NCT00249496|11456375|FG001|COMPLETED|Overall Study||26
10321674|NCT00249496|11456374|FG000|NOT COMPLETED|Overall Study||0
10321675|NCT00249496|11456375|FG001|NOT COMPLETED|Overall Study||1
10321676|NCT00249613|11456385|FG000|STARTED|Baseline||152
10321677|NCT00249613|11456386|FG001|STARTED|Baseline||139
10321678|NCT00249613|11456385|FG000|COMPLETED|Baseline||152
10321679|NCT00249613|11456386|FG001|COMPLETED|Baseline||139
10321680|NCT00249613|11456385|FG000|NOT COMPLETED|Baseline||0
10321681|NCT00249613|11456386|FG001|NOT COMPLETED|Baseline||0
10321682|NCT00249613|11456385|FG000|STARTED|12 Month Follow-up||152
10321683|NCT00249613|11456386|FG001|STARTED|12 Month Follow-up||139
10321684|NCT00249613|11456385|FG000|COMPLETED|12 Month Follow-up||135
10321685|NCT00249613|11456386|FG001|COMPLETED|12 Month Follow-up||124
10321686|NCT00249613|11456385|FG000|NOT COMPLETED|12 Month Follow-up||17
10321687|NCT00249613|11456386|FG001|NOT COMPLETED|12 Month Follow-up||15
10321688|NCT00249769|11456398|FG000|STARTED|Overall Study||100
10321689|NCT00249769|11456399|FG001|STARTED|Overall Study||250
10321690|NCT00249769|11456400|FG002|STARTED|Overall Study||250
10321691|NCT00249769|11456398|FG000|Received LJEV|Overall Study||100
10321692|NCT00249769|11456399|FG001|Received LJEV|Overall Study||236
10321693|NCT00249769|11456400|FG002|Received LJEV|Overall Study||224
10321694|NCT00249769|11456398|FG000|Received Measles Vaccine|Overall Study||97
10321695|NCT00249769|11456399|FG001|Received Measles Vaccine|Overall Study||236
10321696|NCT00249769|11456400|FG002|Received Measles Vaccine|Overall Study||235
10321697|NCT00249769|11456398|FG000|COMPLETED|Overall Study||98
10321698|NCT00249769|11456399|FG001|COMPLETED|Overall Study||235
10321699|NCT00249769|11456400|FG002|COMPLETED|Overall Study||222
10321700|NCT00249769|11456398|FG000|NOT COMPLETED|Overall Study||2
10321701|NCT00249769|11456399|FG001|NOT COMPLETED|Overall Study||15
10321702|NCT00249769|11456400|FG002|NOT COMPLETED|Overall Study||28
10321703|NCT00249795|11456410|FG000|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|4518
10321704|NCT00249795|11456411|FG001|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|4498
10321705|NCT00249795|11456410|FG000|COMPLETED|Overall Study|started and completed study drug|3124
10321706|NCT00249795|11456411|FG001|COMPLETED|Overall Study|started and completed study drug|3108
10321707|NCT00249795|11456410|FG000|NOT COMPLETED|Overall Study||1394
10321708|NCT00249795|11456411|FG001|NOT COMPLETED|Overall Study||1390
10321709|NCT00249808|11456417|FG000|STARTED|Overall Study||1266
10321710|NCT00249808|11456417|FG000|COMPLETED|Overall Study||1084
10321711|NCT00249808|11456417|FG000|NOT COMPLETED|Overall Study||182
10321712|NCT00249821|11456423|FG000|STARTED|Overall Study||10
10321713|NCT00249821|11456424|FG001|STARTED|Overall Study||12
10321714|NCT00249821|11456423|FG000|COMPLETED|Overall Study||10
10321715|NCT00249821|11456424|FG001|COMPLETED|Overall Study||11
10321716|NCT00249821|11456423|FG000|NOT COMPLETED|Overall Study||0
10321717|NCT00249821|11456424|FG001|NOT COMPLETED|Overall Study||1
10321718|NCT00249834|11456438|FG000|STARTED|Overall Study||1
10321719|NCT00249834|11456439|FG001|STARTED|Overall Study||48
10321720|NCT00249834|11456440|FG002|STARTED|Overall Study||45
10321721|NCT00249834|11456441|FG003|STARTED|Overall Study||34
10321722|NCT00249834|11456442|FG004|STARTED|Overall Study||24
10321723|NCT00249834|11456443|FG005|STARTED|Overall Study||10
10321724|NCT00249834|11456444|FG006|STARTED|Overall Study||2
10321725|NCT00249834|11456445|FG007|STARTED|Overall Study||2
10321726|NCT00249834|11456438|FG000|COMPLETED|Overall Study||0
10321727|NCT00249834|11456439|FG001|COMPLETED|Overall Study||29
10321728|NCT00249834|11456440|FG002|COMPLETED|Overall Study||31
10321729|NCT00249834|11456441|FG003|COMPLETED|Overall Study||26
10321730|NCT00249834|11456442|FG004|COMPLETED|Overall Study||19
10321731|NCT00249834|11456443|FG005|COMPLETED|Overall Study||8
10321732|NCT00249834|11456444|FG006|COMPLETED|Overall Study||1
10321733|NCT00249834|11456445|FG007|COMPLETED|Overall Study||2
10321734|NCT00249834|11456438|FG000|NOT COMPLETED|Overall Study||1
10321735|NCT00249834|11456439|FG001|NOT COMPLETED|Overall Study||19
10321736|NCT00249834|11456440|FG002|NOT COMPLETED|Overall Study||14
10321737|NCT00249834|11456441|FG003|NOT COMPLETED|Overall Study||8
10321738|NCT00249834|11456442|FG004|NOT COMPLETED|Overall Study||5
10321739|NCT00249834|11456443|FG005|NOT COMPLETED|Overall Study||2
10321740|NCT00249834|11456444|FG006|NOT COMPLETED|Overall Study||1
10701600|NCT02568345|11866014|FG000|Treated at 2.2 mg/kg|Overall Study|patients: 6th, 20th, 26th|3
10701601|NCT02568345|11866014|FG000|Treated at 2.4 mg/kg|Overall Study|Patients: 1st-5th; 7th; 11th-15th; 21st-25th; 27th-31st|25
10701602|NCT02568345|11866014|FG000|Treated at 2.6 mg/kg|Overall Study|Patients: 8th-10th|3
10701603|NCT02568345|11866014|FG000|COMPLETED|Overall Study||31
10701604|NCT02568345|11866014|FG000|NOT COMPLETED|Overall Study||0
10701605|NCT02568384|11866018|FG000|STARTED|Overall Study||45
10701606|NCT02568384|11866018|FG000|COMPLETED|Overall Study||43
10701607|NCT02568384|11866018|FG000|NOT COMPLETED|Overall Study||2
10701608|NCT02568397|11866022|FG000|STARTED|Period 1||60
10321741|NCT00249834|11456445|FG007|NOT COMPLETED|Overall Study||0
10321742|NCT00249873|11456459|FG000|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|3772
10321743|NCT00249873|11456460|FG001|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|3782
10321744|NCT00249873|11456459|FG000|COMPLETED|Overall Study|started and completed study drug|2442
10321745|NCT00249873|11456460|FG001|COMPLETED|Overall Study|started and completed study drug|2528
10321746|NCT00249873|11456459|FG000|NOT COMPLETED|Overall Study||1330
10701609|NCT02568397|11866023|FG001|STARTED|Period 1||0
10321747|NCT00249873|11456460|FG001|NOT COMPLETED|Overall Study||1254
10321748|NCT00250276|11456470|FG000|STARTED|Overall Study||199
10321749|NCT00250276|11456471|FG001|STARTED|Overall Study||198
10321750|NCT00250276|11456472|FG002|STARTED|Overall Study||201
10321751|NCT00250276|11456473|FG003|STARTED|Overall Study||200
10321752|NCT00250276|11456470|FG000|COMPLETED|Overall Study||182
10321753|NCT00250276|11456471|FG001|COMPLETED|Overall Study||177
10321754|NCT00250276|11456472|FG002|COMPLETED|Overall Study||182
10321755|NCT00250276|11456473|FG003|COMPLETED|Overall Study||181
10321756|NCT00250276|11456470|FG000|NOT COMPLETED|Overall Study||17
10321757|NCT00250276|11456471|FG001|NOT COMPLETED|Overall Study||21
10321758|NCT00250276|11456472|FG002|NOT COMPLETED|Overall Study||19
10321759|NCT00250276|11456473|FG003|NOT COMPLETED|Overall Study||19
10321760|NCT00250432|11456490|FG000|STARTED|Overall Study||104
10321761|NCT00250432|11456491|FG001|STARTED|Overall Study||100
10321762|NCT00250432|11456490|FG000|COMPLETED|Overall Study||59
10321763|NCT00250432|11456491|FG001|COMPLETED|Overall Study||53
10321764|NCT00250432|11456490|FG000|NOT COMPLETED|Overall Study||45
10321765|NCT00250432|11456491|FG001|NOT COMPLETED|Overall Study||47
10321766|NCT00250484|11456499|FG000|STARTED|Overall Study||9
10321767|NCT00250484|11456500|FG001|STARTED|Overall Study||8
10321768|NCT00250484|11456499|FG000|COMPLETED|Overall Study||9
10321769|NCT00250484|11456500|FG001|COMPLETED|Overall Study||8
10321770|NCT00250484|11456499|FG000|NOT COMPLETED|Overall Study||0
10321771|NCT00250484|11456500|FG001|NOT COMPLETED|Overall Study||0
10321772|NCT00250497|11456508|FG000|STARTED|Overall Study||182
10701610|NCT02568397|11866022|FG000|Received at Least 1 Dose of Study Drug|Period 1||60
10321773|NCT00250497|11456509|FG001|STARTED|Overall Study||174
10321774|NCT00250497|11456508|FG000|COMPLETED|Overall Study||177
10321775|NCT00250497|11456509|FG001|COMPLETED|Overall Study||159
10321776|NCT00250497|11456508|FG000|NOT COMPLETED|Overall Study||5
10321777|NCT00250497|11456509|FG001|NOT COMPLETED|Overall Study||15
10321778|NCT00250588|11456518|FG000|STARTED|Overall Study||81
10321779|NCT00250588|11456519|FG001|STARTED|Overall Study||84
10321780|NCT00250588|11456520|FG002|STARTED|Overall Study||87
10321781|NCT00250588|11456518|FG000|COMPLETED|Overall Study||72
10321782|NCT00250588|11456519|FG001|COMPLETED|Overall Study||65
10321783|NCT00250588|11456520|FG002|COMPLETED|Overall Study||74
10321784|NCT00250588|11456518|FG000|NOT COMPLETED|Overall Study||9
10321785|NCT00250588|11456519|FG001|NOT COMPLETED|Overall Study||19
10321786|NCT00250588|11456520|FG002|NOT COMPLETED|Overall Study||13
10321787|NCT00250679|11456531|FG000|STARTED|Overall Study||147
10321788|NCT00250679|11456532|FG001|STARTED|Overall Study||149
10321789|NCT00250679|11456533|FG002|STARTED|Overall Study||147
10701611|NCT02568397|11866023|FG001|Received at Least 1 Dose of Study Drug|Period 1||0
10701612|NCT02568397|11866022|FG000|COMPLETED|Period 1||60
10321790|NCT00250679|11456531|FG000|COMPLETED|Overall Study||108
10321791|NCT00250679|11456532|FG001|COMPLETED|Overall Study||100
10321792|NCT00250679|11456533|FG002|COMPLETED|Overall Study||103
10701613|NCT02568397|11866023|FG001|COMPLETED|Period 1||0
10701614|NCT02568397|11866022|FG000|NOT COMPLETED|Period 1||0
10701615|NCT02568397|11866023|FG001|NOT COMPLETED|Period 1||0
10701616|NCT02568397|11866022|FG000|STARTED|Period 2|A single oral dose of 150 mg dabigatran etexilate was administered on Day 1 of Period 1.|0
10713698|NCT02680639|11879183|FG001|NOT COMPLETED|High Frequency Oscillation (HFO) Therapy||0
10321793|NCT00250679|11456531|FG000|NOT COMPLETED|Overall Study||39
10321794|NCT00250679|11456532|FG001|NOT COMPLETED|Overall Study||49
10321795|NCT00250679|11456533|FG002|NOT COMPLETED|Overall Study||44
10321796|NCT00250705|11456541|FG000|STARTED|Overall Study||12
10321797|NCT00250705|11456541|FG000|COMPLETED|Overall Study||10
10321798|NCT00250705|11456541|FG000|NOT COMPLETED|Overall Study||2
10321799|NCT00250835|11456547|FG000|STARTED|Overall Study||38
10321800|NCT00250835|11456547|FG000|COMPLETED|Overall Study||37
10321801|NCT00250835|11456547|FG000|NOT COMPLETED|Overall Study||1
10321802|NCT00250926|11456551|FG000|STARTED|Overall Study||23
10321803|NCT00250926|11456551|FG000|COMPLETED|Overall Study||23
10321804|NCT00250926|11456551|FG000|NOT COMPLETED|Overall Study||0
10321805|NCT00251004|11456559|FG000|STARTED|Overall Study||277
10321806|NCT00251004|11456560|FG001|STARTED|Overall Study||279
10321807|NCT00251004|11456561|FG002|STARTED|Overall Study||277
10321808|NCT00251004|11456559|FG000|12 Month Analysis|Overall Study|Under 12 month analysis under group 1, 179 Completed study medication.|241
10321809|NCT00251004|11456560|FG001|12 Month Analysis|Overall Study|Under 12 month analysis under group 2, 175 Completed study medication.|249
10321810|NCT00251004|11456561|FG002|12 Month Analysis|Overall Study|Under 12 month analysis under group 3, 200 Completed study medication.|253
10321811|NCT00251004|11456559|FG000|24 Month Analysis|Overall Study|Under 24 month analysis under group 1, 167 Completed study medication.|232
10321812|NCT00251004|11456560|FG001|24 Month Analysis|Overall Study|Under 24 month analysis under group 2, 161 Completed study medication.|238
10321813|NCT00251004|11456561|FG002|24 Month Analysis|Overall Study|Under 24 month analysis under group 3, 185 Completed study medication.|246
10321814|NCT00251004|11456559|FG000|COMPLETED|Overall Study||232
10321815|NCT00251004|11456560|FG001|COMPLETED|Overall Study||238
10321816|NCT00251004|11456561|FG002|COMPLETED|Overall Study||246
10321817|NCT00251004|11456559|FG000|NOT COMPLETED|Overall Study||45
10321818|NCT00251004|11456560|FG001|NOT COMPLETED|Overall Study||41
10321819|NCT00251004|11456561|FG002|NOT COMPLETED|Overall Study||31
10321820|NCT00251225|11456569|FG000|STARTED|Overall Study||49
10321821|NCT00251225|11456569|FG000|COMPLETED|Overall Study||49
10321822|NCT00251225|11456569|FG000|NOT COMPLETED|Overall Study||0
10321823|NCT00251238|11456575|FG000|STARTED|Overall Study||21
10321824|NCT00251238|11456576|FG001|STARTED|Overall Study||20
10321825|NCT00251238|11456575|FG000|COMPLETED|Overall Study||21
10321826|NCT00251238|11456576|FG001|COMPLETED|Overall Study||20
10321827|NCT00251238|11456575|FG000|NOT COMPLETED|Overall Study||0
10321828|NCT00251238|11456576|FG001|NOT COMPLETED|Overall Study||0
10321829|NCT00251303|11456584|FG000|STARTED|Overall Study|78 subjects signed any consent. 60 started drug (30 riluzole & 30 placebo).|30
10321830|NCT00251303|11456585|FG001|STARTED|Overall Study||30
10321831|NCT00251303|11456584|FG000|COMPLETED|Overall Study||22
10321832|NCT00251303|11456585|FG001|COMPLETED|Overall Study||29
10321833|NCT00251303|11456584|FG000|NOT COMPLETED|Overall Study||8
10321834|NCT00251303|11456585|FG001|NOT COMPLETED|Overall Study||1
10321835|NCT00251316|11456595|FG000|STARTED|Overall Study||17
10321836|NCT00251316|11456596|FG001|STARTED|Overall Study||17
10321837|NCT00251316|11456595|FG000|COMPLETED|Overall Study||15
10321838|NCT00251316|11456596|FG001|COMPLETED|Overall Study||14
10321839|NCT00251316|11456595|FG000|NOT COMPLETED|Overall Study||2
10321840|NCT00251316|11456596|FG001|NOT COMPLETED|Overall Study||3
10321841|NCT00251589|11456606|FG000|STARTED|Overall Study|4 of the 16 patients participated in Phase I and II portions. 12 participated in Phase II only.|16
10321842|NCT00251589|11456607|FG001|STARTED|Overall Study||3
10321843|NCT00251589|11456608|FG002|STARTED|Overall Study||2
10321844|NCT00251589|11456609|FG003|STARTED|Overall Study||2
10321845|NCT00251589|11456606|FG000|COMPLETED|Overall Study||1
10321846|NCT00251589|11456607|FG001|COMPLETED|Overall Study||0
10321847|NCT00251589|11456608|FG002|COMPLETED|Overall Study||0
10321848|NCT00251589|11456609|FG003|COMPLETED|Overall Study||0
10321849|NCT00251589|11456606|FG000|NOT COMPLETED|Overall Study||15
10321850|NCT00251589|11456607|FG001|NOT COMPLETED|Overall Study||3
10321851|NCT00251589|11456608|FG002|NOT COMPLETED|Overall Study||2
10321852|NCT00251589|11456609|FG003|NOT COMPLETED|Overall Study||2
10321853|NCT00251641|11456621|FG000|STARTED|Overall Study||653
10321854|NCT00251641|11456622|FG001|STARTED|Overall Study||215
10321855|NCT00251641|11456621|FG000|COMPLETED|Overall Study||541
10321856|NCT00251641|11456622|FG001|COMPLETED|Overall Study||127
10321857|NCT00251641|11456621|FG000|NOT COMPLETED|Overall Study||112
10321858|NCT00251641|11456622|FG001|NOT COMPLETED|Overall Study||88
10321859|NCT00251693|11456633|FG000|STARTED|Overall Study||680
10321860|NCT00251693|11456634|FG001|STARTED|Overall Study||668
10321861|NCT00251693|11456635|FG002|STARTED|Overall Study||690
10321862|NCT00251693|11456633|FG000|COMPLETED|Overall Study||629
10321863|NCT00251693|11456634|FG001|COMPLETED|Overall Study||624
10321864|NCT00251693|11456635|FG002|COMPLETED|Overall Study||644
10321865|NCT00251693|11456633|FG000|NOT COMPLETED|Overall Study||51
10321866|NCT00251693|11456634|FG001|NOT COMPLETED|Overall Study||44
10321867|NCT00251693|11456635|FG002|NOT COMPLETED|Overall Study||46
10321868|NCT00251719|11456646|FG000|STARTED|Overall Study||694
10321869|NCT00251719|11456647|FG001|STARTED|Overall Study||687
10321870|NCT00251719|11456648|FG002|STARTED|Overall Study||673
10321871|NCT00251719|11456646|FG000|COMPLETED|Overall Study||641
10321872|NCT00251719|11456647|FG001|COMPLETED|Overall Study||642
10321873|NCT00251719|11456648|FG002|COMPLETED|Overall Study||643
10321874|NCT00251719|11456646|FG000|NOT COMPLETED|Overall Study||53
10321875|NCT00251719|11456647|FG001|NOT COMPLETED|Overall Study||45
10321876|NCT00251719|11456648|FG002|NOT COMPLETED|Overall Study||30
10321877|NCT00251745|11456659|FG000|STARTED|Overall Study||292
10321878|NCT00251745|11456660|FG001|STARTED|Overall Study||312
10321879|NCT00251745|11456661|FG002|STARTED|Overall Study||304
10321880|NCT00251745|11456659|FG000|COMPLETED|Overall Study||264
10321881|NCT00251745|11456660|FG001|COMPLETED|Overall Study||285
10321882|NCT00251745|11456661|FG002|COMPLETED|Overall Study||277
10321883|NCT00251745|11456659|FG000|NOT COMPLETED|Overall Study||28
10321884|NCT00251745|11456660|FG001|NOT COMPLETED|Overall Study||27
10321885|NCT00251745|11456661|FG002|NOT COMPLETED|Overall Study||27
10321886|NCT00251758|11456672|FG000|STARTED|Overall Study||292
10321887|NCT00251758|11456673|FG001|STARTED|Overall Study||312
10321888|NCT00251758|11456674|FG002|STARTED|Overall Study||304
10321889|NCT00251758|11456672|FG000|COMPLETED|Overall Study||264
10321890|NCT00251758|11456673|FG001|COMPLETED|Overall Study||285
10321891|NCT00251758|11456674|FG002|COMPLETED|Overall Study||277
10321892|NCT00251758|11456672|FG000|NOT COMPLETED|Overall Study||28
10321893|NCT00251758|11456673|FG001|NOT COMPLETED|Overall Study||27
10321894|NCT00251758|11456674|FG002|NOT COMPLETED|Overall Study||27
10321895|NCT00251862|11456685|FG000|STARTED|Overall Study||280
10321896|NCT00251862|11456686|FG001|STARTED|Overall Study||269
10321897|NCT00251862|11456687|FG002|STARTED|Overall Study||276
10321898|NCT00251862|11456685|FG000|COMPLETED|Overall Study||280
10321899|NCT00251862|11456686|FG001|COMPLETED|Overall Study||269
10321900|NCT00251862|11456687|FG002|COMPLETED|Overall Study||276
10321901|NCT00251862|11456685|FG000|NOT COMPLETED|Overall Study||0
10321902|NCT00251862|11456686|FG001|NOT COMPLETED|Overall Study||0
10321903|NCT00251862|11456687|FG002|NOT COMPLETED|Overall Study||0
10321904|NCT00251927|11456697|FG000|STARTED|Overall Study|Randomised|288
10321905|NCT00251927|11456698|FG001|STARTED|Overall Study|Randomised|266
10321906|NCT00251927|11456697|FG000|COMPLETED|Overall Study|Completed 5 year visit|180
10321907|NCT00251927|11456698|FG001|COMPLETED|Overall Study|Completed 5 year visit|192
10321908|NCT00251927|11456697|FG000|NOT COMPLETED|Overall Study||108
10321909|NCT00251927|11456698|FG001|NOT COMPLETED|Overall Study||74
10321910|NCT00251979|11456707|FG000|STARTED|Overall Study|ITT population|375
10455890|NCT01004770|11603983|FG000|STARTED|Overall Study||10
10455891|NCT01004770|11603984|FG001|STARTED|Overall Study||10
10455892|NCT01004770|11603985|FG002|STARTED|Overall Study||10
10455893|NCT01004770|11603986|FG003|STARTED|Overall Study||10
10455894|NCT01004770|11603987|FG004|STARTED|Overall Study||10
10455895|NCT01004770|11603983|FG000|COMPLETED|Overall Study||10
10455896|NCT01004770|11603984|FG001|COMPLETED|Overall Study||10
10455897|NCT01004770|11603985|FG002|COMPLETED|Overall Study||10
10455898|NCT01004770|11603986|FG003|COMPLETED|Overall Study||10
10455899|NCT01004770|11603987|FG004|COMPLETED|Overall Study||10
10455900|NCT01004770|11603983|FG000|NOT COMPLETED|Overall Study||0
10455901|NCT01004770|11603984|FG001|NOT COMPLETED|Overall Study||0
10455902|NCT01004770|11603985|FG002|NOT COMPLETED|Overall Study||0
10455903|NCT01004770|11603986|FG003|NOT COMPLETED|Overall Study||0
10455904|NCT01004770|11603987|FG004|NOT COMPLETED|Overall Study||0
10455905|NCT01004822|11604007|FG000|STARTED|Overall Study||3
10455906|NCT01004822|11604008|FG001|STARTED|Overall Study||3
10455907|NCT01004822|11604009|FG002|STARTED|Overall Study||4
10455908|NCT01004822|11604010|FG003|STARTED|Overall Study||4
10455909|NCT01004822|11604011|FG004|STARTED|Overall Study||4
10455910|NCT01004822|11604012|FG005|STARTED|Overall Study||4
10455911|NCT01004822|11604013|FG006|STARTED|Overall Study||4
10455912|NCT01004822|11604014|FG007|STARTED|Overall Study||5
10455913|NCT01004822|11604007|FG000|Treated|Overall Study||3
10455914|NCT01004822|11604008|FG001|Treated|Overall Study||3
10455915|NCT01004822|11604009|FG002|Treated|Overall Study||3
10455916|NCT01004822|11604010|FG003|Treated|Overall Study||4
10455917|NCT01004822|11604011|FG004|Treated|Overall Study||4
10455918|NCT01004822|11604012|FG005|Treated|Overall Study||4
10455919|NCT01004822|11604013|FG006|Treated|Overall Study||4
10455920|NCT01004822|11604014|FG007|Treated|Overall Study||5
10455921|NCT01004822|11604007|FG000|COMPLETED|Overall Study||0
10455922|NCT01004822|11604008|FG001|COMPLETED|Overall Study||0
10455923|NCT01004822|11604009|FG002|COMPLETED|Overall Study||0
10455924|NCT01004822|11604010|FG003|COMPLETED|Overall Study||0
10455925|NCT01004822|11604011|FG004|COMPLETED|Overall Study||0
10455926|NCT01004822|11604012|FG005|COMPLETED|Overall Study||0
10455927|NCT01004822|11604013|FG006|COMPLETED|Overall Study||0
10321911|NCT00251979|11456708|FG001|STARTED|Overall Study|ITT population|389
10321912|NCT00251979|11456707|FG000|COMPLETED|Overall Study||337
10321913|NCT00251979|11456708|FG001|COMPLETED|Overall Study||349
10321914|NCT00251979|11456707|FG000|NOT COMPLETED|Overall Study||38
10321915|NCT00251979|11456708|FG001|NOT COMPLETED|Overall Study||40
10321916|NCT00252057|11456716|FG000|STARTED|Overall Study||373
10321917|NCT00252057|11456717|FG001|STARTED|Overall Study||376
10455928|NCT01004822|11604014|FG007|COMPLETED|Overall Study||0
10455929|NCT01004822|11604007|FG000|NOT COMPLETED|Overall Study||3
10455930|NCT01004822|11604008|FG001|NOT COMPLETED|Overall Study||3
10455931|NCT01004822|11604009|FG002|NOT COMPLETED|Overall Study||4
10455932|NCT01004822|11604010|FG003|NOT COMPLETED|Overall Study||4
10455933|NCT01004822|11604011|FG004|NOT COMPLETED|Overall Study||4
10455934|NCT01004822|11604012|FG005|NOT COMPLETED|Overall Study||4
10321918|NCT00252057|11456716|FG000|COMPLETED|Overall Study||370
10321919|NCT00252057|11456717|FG001|COMPLETED|Overall Study||368
10321920|NCT00252057|11456716|FG000|NOT COMPLETED|Overall Study||3
10321921|NCT00252057|11456717|FG001|NOT COMPLETED|Overall Study||8
10321922|NCT00252187|11456725|FG000|STARTED|Overall Study||24
10321923|NCT00252187|11456726|FG001|STARTED|Overall Study||21
10321924|NCT00252187|11456725|FG000|COMPLETED|Overall Study||20
10321925|NCT00252187|11456726|FG001|COMPLETED|Overall Study||20
10321926|NCT00252187|11456725|FG000|NOT COMPLETED|Overall Study||4
10321927|NCT00252187|11456726|FG001|NOT COMPLETED|Overall Study||1
10321928|NCT00252239|11456736|FG000|STARTED|Overall Study||31
10321929|NCT00252239|11456737|FG001|STARTED|Overall Study||31
10321930|NCT00252239|11456738|FG002|STARTED|Overall Study||19
10321931|NCT00252239|11456739|FG003|STARTED|Overall Study||31
10321932|NCT00252239|11456736|FG000|COMPLETED|Overall Study||30
10321933|NCT00252239|11456737|FG001|COMPLETED|Overall Study||31
10321934|NCT00252239|11456738|FG002|COMPLETED|Overall Study||17
10321935|NCT00252239|11456739|FG003|COMPLETED|Overall Study||30
10321936|NCT00252239|11456736|FG000|NOT COMPLETED|Overall Study||1
10321937|NCT00252239|11456737|FG001|NOT COMPLETED|Overall Study||0
10321938|NCT00252239|11456738|FG002|NOT COMPLETED|Overall Study||2
10321939|NCT00252239|11456739|FG003|NOT COMPLETED|Overall Study||1
10321940|NCT00252382|11456749|FG000|STARTED|Overall Study||31
10321941|NCT00252382|11456749|FG000|COMPLETED|Overall Study||5
10321942|NCT00252382|11456749|FG000|NOT COMPLETED|Overall Study||26
10321943|NCT00252499|11456756|FG000|STARTED|Overall Study||5
10321944|NCT00252499|11456757|FG001|STARTED|Overall Study||2
10321945|NCT00252499|11456758|FG002|STARTED|Overall Study||6
10321946|NCT00252499|11456756|FG000|COMPLETED|Overall Study||4
10321947|NCT00252499|11456757|FG001|COMPLETED|Overall Study||2
10321948|NCT00252499|11456758|FG002|COMPLETED|Overall Study||6
10321949|NCT00252499|11456756|FG000|NOT COMPLETED|Overall Study||1
10321950|NCT00252499|11456757|FG001|NOT COMPLETED|Overall Study||0
10321951|NCT00252499|11456758|FG002|NOT COMPLETED|Overall Study||0
10321952|NCT00252512|11456768|FG000|STARTED|Intervention||165
10803789|NCT04105218|11965230|FG001|COMPLETED|Overall Study||0
10803790|NCT04105218|11965229|FG000|NOT COMPLETED|Overall Study||6
10803791|NCT04105218|11965230|FG001|NOT COMPLETED|Overall Study||6
10321953|NCT00252512|11456769|FG001|STARTED|Intervention||165
10321954|NCT00252512|11456768|FG000|COMPLETED|Intervention||136
10321955|NCT00252512|11456769|FG001|COMPLETED|Intervention||134
10321956|NCT00252512|11456768|FG000|NOT COMPLETED|Intervention||29
10321957|NCT00252512|11456769|FG001|NOT COMPLETED|Intervention||31
10321958|NCT00252512|11456768|FG000|STARTED|Six Month Follow up||136
10321959|NCT00252512|11456769|FG001|STARTED|Six Month Follow up||134
10321960|NCT00252512|11456768|FG000|COMPLETED|Six Month Follow up||132
10321961|NCT00252512|11456769|FG001|COMPLETED|Six Month Follow up||122
10321962|NCT00252512|11456768|FG000|NOT COMPLETED|Six Month Follow up||4
10321963|NCT00252512|11456769|FG001|NOT COMPLETED|Six Month Follow up||12
10321964|NCT00252512|11456768|FG000|STARTED|12 Month Follow up||132
10321965|NCT00252512|11456769|FG001|STARTED|12 Month Follow up||122
10321966|NCT00252512|11456768|FG000|COMPLETED|12 Month Follow up||123
10321967|NCT00252512|11456769|FG001|COMPLETED|12 Month Follow up||121
10321968|NCT00252512|11456768|FG000|NOT COMPLETED|12 Month Follow up||9
10321969|NCT00252512|11456769|FG001|NOT COMPLETED|12 Month Follow up||1
10321970|NCT00252538|11456775|FG000|STARTED|Overall Study||19
10321971|NCT00252538|11456776|FG001|STARTED|Overall Study||114
10321972|NCT00252538|11456775|FG000|COMPLETED|Overall Study||19
10321973|NCT00252538|11456776|FG001|COMPLETED|Overall Study||114
10321974|NCT00252538|11456775|FG000|NOT COMPLETED|Overall Study||0
10321975|NCT00252538|11456776|FG001|NOT COMPLETED|Overall Study||0
10321976|NCT00252564|11456783|FG000|STARTED|Overall Study|From randomization|124
10321977|NCT00252564|11456784|FG001|STARTED|Overall Study|From randomization|123
10321978|NCT00252564|11456783|FG000|COMPLETED|Overall Study|Received 6+ cycles OR had response (RECIST criteria, CR or PR)|85
10321979|NCT00252564|11456784|FG001|COMPLETED|Overall Study|Received 6+ cycles OR had response (RECIST criteria, CR or PR)|79
10321980|NCT00252564|11456783|FG000|NOT COMPLETED|Overall Study||39
10321981|NCT00252564|11456784|FG001|NOT COMPLETED|Overall Study||44
10321982|NCT00252577|11456790|FG000|STARTED|Overall Study||130
10321983|NCT00252577|11456790|FG000|COMPLETED|Overall Study||110
10321984|NCT00252577|11456790|FG000|NOT COMPLETED|Overall Study||20
10321985|NCT00252590|11456797|FG000|STARTED|Overall Study||35
10321986|NCT00252590|11456798|FG001|STARTED|Overall Study||30
10321987|NCT00252590|11456799|FG002|STARTED|Overall Study||34
10321988|NCT00252590|11456797|FG000|COMPLETED|Overall Study||33
10321989|NCT00252590|11456798|FG001|COMPLETED|Overall Study||28
10321990|NCT00252590|11456799|FG002|COMPLETED|Overall Study||31
10321991|NCT00252590|11456797|FG000|NOT COMPLETED|Overall Study||2
10321992|NCT00252590|11456798|FG001|NOT COMPLETED|Overall Study||2
10803792|NCT04102956|11965238|FG000|STARTED|Overall Study||42
10803793|NCT04102956|11965239|FG001|STARTED|Overall Study||38
10321993|NCT00252590|11456799|FG002|NOT COMPLETED|Overall Study||3
10321994|NCT00252629|11456810|FG000|STARTED|Overall Study||9
10321995|NCT00252629|11456811|FG001|STARTED|Overall Study||9
10321996|NCT00252629|11456812|FG002|STARTED|Overall Study|We used data from the 18 veterans with GWS in addition to the 11 control|11
10321997|NCT00252629|11456810|FG000|COMPLETED|Overall Study|One participant assigned to therapeutic CPAP was excluded from the trial before starting treatment.|8
10321998|NCT00252629|11456811|FG001|COMPLETED|Overall Study||9
10321999|NCT00252629|11456812|FG002|COMPLETED|Overall Study|We used data from the 18 veterans with GWS in addition to the 11 control|11
10803794|NCT04102956|11965238|FG000|COMPLETED|Overall Study||42
10322000|NCT00252629|11456810|FG000|NOT COMPLETED|Overall Study||1
10322001|NCT00252629|11456811|FG001|NOT COMPLETED|Overall Study||0
10322002|NCT00252629|11456812|FG002|NOT COMPLETED|Overall Study||0
10322003|NCT00252694|11456827|FG000|STARTED|Overall Study||951
10322004|NCT00252694|11456828|FG001|STARTED|Overall Study||954
10322005|NCT00252694|11456827|FG000|COMPLETED|Overall Study||807
10322006|NCT00252694|11456828|FG001|COMPLETED|Overall Study||800
10322007|NCT00252694|11456827|FG000|NOT COMPLETED|Overall Study||144
10322008|NCT00252694|11456828|FG001|NOT COMPLETED|Overall Study||154
10322009|NCT00252720|11456836|FG000|STARTED|Overall Study||951
10322010|NCT00252720|11456837|FG001|STARTED|Overall Study||954
10322011|NCT00252720|11456836|FG000|COMPLETED|Overall Study||819
10322012|NCT00252720|11456837|FG001|COMPLETED|Overall Study||789
10322013|NCT00252720|11456836|FG000|NOT COMPLETED|Overall Study||132
10322014|NCT00252720|11456837|FG001|NOT COMPLETED|Overall Study||165
10322015|NCT00252733|11456845|FG000|STARTED|Overall Study||711
10322016|NCT00252733|11456846|FG001|STARTED|Overall Study||710
10322017|NCT00252733|11456845|FG000|COMPLETED|Overall Study||605
10322018|NCT00252733|11456846|FG001|COMPLETED|Overall Study||618
10322019|NCT00252733|11456845|FG000|NOT COMPLETED|Overall Study||106
10322020|NCT00252733|11456846|FG001|NOT COMPLETED|Overall Study||92
10322021|NCT00252967|11456854|FG000|STARTED|Overall Study||31
10322022|NCT00252967|11456855|FG001|STARTED|Overall Study||33
10322023|NCT00252967|11456854|FG000|COMPLETED|Overall Study||31
10322024|NCT00252967|11456855|FG001|COMPLETED|Overall Study||33
10322025|NCT00252967|11456854|FG000|NOT COMPLETED|Overall Study||0
10322026|NCT00252967|11456855|FG001|NOT COMPLETED|Overall Study||0
10322027|NCT00253019|11456864|FG000|STARTED|Overall Study||111
10322028|NCT00253019|11456865|FG001|STARTED|Overall Study||109
10322029|NCT00253019|11456866|FG002|STARTED|Overall Study||101
10322030|NCT00253019|11456864|FG000|COMPLETED|Overall Study||82
10322031|NCT00253019|11456865|FG001|COMPLETED|Overall Study||78
10322032|NCT00253019|11456866|FG002|COMPLETED|Overall Study||83
10322033|NCT00253019|11456864|FG000|NOT COMPLETED|Overall Study||29
10322034|NCT00253019|11456865|FG001|NOT COMPLETED|Overall Study||31
10322035|NCT00253019|11456866|FG002|NOT COMPLETED|Overall Study||18
10322036|NCT00253370|11456874|FG000|STARTED|Overall Study||44
10322037|NCT00253370|11456874|FG000|COMPLETED|Overall Study||1
10322038|NCT00253370|11456874|FG000|NOT COMPLETED|Overall Study||43
10322039|NCT00253435|11456881|FG000|STARTED|Overall Study|Total number is 42|42
10322040|NCT00253435|11456882|FG001|STARTED|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|8
10322041|NCT00253435|11456881|FG000|1st Interim Analysis|Overall Study|First interim analysis: need 2+ responses in first 15 patients. Goal met study continued.|15
10322042|NCT00253435|11456882|FG001|1st Interim Analysis|Overall Study|Only interim analysis: need 1+ response in first 10 patients.|8
10322043|NCT00253435|11456881|FG000|2nd Interim Analysis|Overall Study|Second interim analysis: need 3+ responses in first 25 patients. Goal met study continued.|10
10322044|NCT00253435|11456882|FG001|2nd Interim Analysis|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|0
10322045|NCT00253435|11456881|FG000|3rd Interim Analysis|Overall Study|Third interim analysis: need 4+ responses in first 35 patients. Goal met study continued.|10
10322046|NCT00253435|11456882|FG001|3rd Interim Analysis|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|0
10322047|NCT00253435|11456881|FG000|COMPLETED|Overall Study|Forty-two evaluable poor risk patients enrolled.|42
10322048|NCT00253435|11456882|FG001|COMPLETED|Overall Study|Eight evaluable patients enrolled.|8
10322049|NCT00253435|11456881|FG000|NOT COMPLETED|Overall Study||0
10322050|NCT00253435|11456882|FG001|NOT COMPLETED|Overall Study||0
10322051|NCT00253448|11456888|FG000|STARTED|Overall Study||35
10322052|NCT00253448|11456888|FG000|COMPLETED|Overall Study||34
10322053|NCT00253448|11456888|FG000|NOT COMPLETED|Overall Study||1
10322054|NCT00253513|11456892|FG000|STARTED|Overall Study||60
10322055|NCT00253513|11456892|FG000|COMPLETED|Overall Study||60
10322056|NCT00253513|11456892|FG000|NOT COMPLETED|Overall Study||0
10322057|NCT00253630|11456896|FG000|STARTED|Overall Study||37
10322058|NCT00253630|11456896|FG000|COMPLETED|Overall Study||35
10322059|NCT00253630|11456896|FG000|NOT COMPLETED|Overall Study||2
10322060|NCT00253643|11456904|FG000|STARTED|Overall Study||14
10322061|NCT00253643|11456905|FG001|STARTED|Overall Study||15
10322062|NCT00253643|11456906|FG002|STARTED|Overall Study||29
10322063|NCT00253643|11456907|FG003|STARTED|Overall Study||31
10322064|NCT00253643|11456904|FG000|COMPLETED|Overall Study||14
10322065|NCT00253643|11456905|FG001|COMPLETED|Overall Study||15
10322066|NCT00253643|11456906|FG002|COMPLETED|Overall Study||28
10322067|NCT00253643|11456907|FG003|COMPLETED|Overall Study||28
10322068|NCT00253643|11456904|FG000|NOT COMPLETED|Overall Study||0
10322069|NCT00253643|11456905|FG001|NOT COMPLETED|Overall Study||0
10322070|NCT00253643|11456906|FG002|NOT COMPLETED|Overall Study||1
10322071|NCT00253643|11456907|FG003|NOT COMPLETED|Overall Study||3
10322072|NCT00253708|11456920|FG000|STARTED|Overall Study||20
10322073|NCT00253708|11456921|FG001|STARTED|Overall Study||10
10322074|NCT00253708|11456922|FG002|STARTED|Overall Study||9
10322075|NCT00253708|11456920|FG000|COMPLETED|Overall Study||20
10322076|NCT00253708|11456921|FG001|COMPLETED|Overall Study||10
10322077|NCT00253708|11456922|FG002|COMPLETED|Overall Study||8
10322078|NCT00253708|11456920|FG000|NOT COMPLETED|Overall Study||0
10322079|NCT00253708|11456921|FG001|NOT COMPLETED|Overall Study||0
10322080|NCT00253708|11456922|FG002|NOT COMPLETED|Overall Study||1
10322081|NCT00253747|11456932|FG000|STARTED|Overall Study||127
10322082|NCT00253747|11456933|FG001|STARTED|Overall Study||128
10322083|NCT00253747|11456932|FG000|COMPLETED|Overall Study||103
10322084|NCT00253747|11456933|FG001|COMPLETED|Overall Study||101
10322085|NCT00253747|11456932|FG000|NOT COMPLETED|Overall Study||24
10322086|NCT00253747|11456933|FG001|NOT COMPLETED|Overall Study||27
10322087|NCT00253890|11456951|FG000|STARTED|Overall Study||69
10322088|NCT00253890|11456952|FG001|STARTED|Overall Study||68
10322089|NCT00253890|11456951|FG000|COMPLETED|Overall Study||62
10322090|NCT00253890|11456952|FG001|COMPLETED|Overall Study||61
10322091|NCT00253890|11456951|FG000|NOT COMPLETED|Overall Study||7
10322092|NCT00253890|11456952|FG001|NOT COMPLETED|Overall Study||7
10322093|NCT00254072|11456960|FG000|STARTED|Overall Study||180
10322094|NCT00254072|11456961|FG001|STARTED|Overall Study||175
10322095|NCT00254072|11456960|FG000|COMPLETED|Overall Study||180
10322096|NCT00254072|11456961|FG001|COMPLETED|Overall Study||175
10322097|NCT00254072|11456960|FG000|NOT COMPLETED|Overall Study||0
10322098|NCT00254072|11456961|FG001|NOT COMPLETED|Overall Study||0
10322099|NCT00254163|11456969|FG000|STARTED|Overall Study||92
10322100|NCT00254163|11456970|FG001|STARTED|Overall Study||92
10322101|NCT00254163|11456969|FG000|COMPLETED|Overall Study||47
10322102|NCT00254163|11456970|FG001|COMPLETED|Overall Study||46
10322103|NCT00254163|11456969|FG000|NOT COMPLETED|Overall Study||45
10322104|NCT00254163|11456970|FG001|NOT COMPLETED|Overall Study||46
10322105|NCT00254293|11456982|FG000|STARTED|Short Term (12 Week) Randomized Dosing||7
10322106|NCT00254293|11456983|FG001|STARTED|Short Term (12 Week) Randomized Dosing||4
10322107|NCT00254293|11456984|FG002|STARTED|Short Term (12 Week) Randomized Dosing||29
10322108|NCT00254293|11456985|FG003|STARTED|Short Term (12 Week) Randomized Dosing||6
10322109|NCT00254293|11456986|FG004|STARTED|Short Term (12 Week) Randomized Dosing||5
10322110|NCT00254293|11456987|FG005|STARTED|Short Term (12 Week) Randomized Dosing|2, 2, 9, 2, and 2 were randomized to placebo in body weight Groups 1, 2, 3, 4, 5, respectively.|17
10322111|NCT00254293|11456988|FG006|STARTED|Short Term (12 Week) Randomized Dosing||0
10322112|NCT00254293|11456982|FG000|COMPLETED|Short Term (12 Week) Randomized Dosing||7
10322113|NCT00254293|11456983|FG001|COMPLETED|Short Term (12 Week) Randomized Dosing||3
10322114|NCT00254293|11456984|FG002|COMPLETED|Short Term (12 Week) Randomized Dosing||26
10322115|NCT00254293|11456985|FG003|COMPLETED|Short Term (12 Week) Randomized Dosing||5
10322116|NCT00254293|11456986|FG004|COMPLETED|Short Term (12 Week) Randomized Dosing||5
10322117|NCT00254293|11456987|FG005|COMPLETED|Short Term (12 Week) Randomized Dosing||17
10322118|NCT00254293|11456988|FG006|COMPLETED|Short Term (12 Week) Randomized Dosing||0
10322119|NCT00254293|11456982|FG000|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
10322120|NCT00254293|11456983|FG001|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||1
10322121|NCT00254293|11456984|FG002|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||3
10322122|NCT00254293|11456985|FG003|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||1
10322123|NCT00254293|11456986|FG004|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
10322124|NCT00254293|11456987|FG005|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
10322125|NCT00254293|11456988|FG006|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
10322126|NCT00254293|11456982|FG000|STARTED|LTE Open Label Variable SC Dosing|Participants who received ST placebo rolled over to 75mg SC dose group (by body weight, <60kg).|11
10322127|NCT00254293|11456983|FG001|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to 125mg dose group summarized as one group (body weight <60 to >100 kg).|0
10322128|NCT00254293|11456984|FG002|STARTED|LTE Open Label Variable SC Dosing|Variable SC dose group: 125 mg Weekly, body weight <60 to >100kg (Groups 2, 3, 4 in ST Period).|42
10322129|NCT00254293|11456985|FG003|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to 125mg dose group summarized as one group (body weight <60 to >100 kg).|0
10322130|NCT00254293|11456986|FG004|STARTED|LTE Open Label Variable SC Dosing|Participants who received ST placebo rolled over to variable SC dose group (by body weight, >100kg).|10
10322131|NCT00254293|11456987|FG005|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to a variable SC dose group of 75, 125 or 200 mg Weekly by body weight.|0
10322132|NCT00254293|11456988|FG006|STARTED|LTE Open Label Variable SC Dosing|Participant rolled over from LTE (Variable Dose Period) to LTE (Fixed Dose Period).|0
10322133|NCT00254293|11456982|FG000|COMPLETED|LTE Open Label Variable SC Dosing||8
10322134|NCT00254293|11456983|FG001|COMPLETED|LTE Open Label Variable SC Dosing||0
10322135|NCT00254293|11456984|FG002|COMPLETED|LTE Open Label Variable SC Dosing||32
10322136|NCT00254293|11456985|FG003|COMPLETED|LTE Open Label Variable SC Dosing||0
10322137|NCT00254293|11456986|FG004|COMPLETED|LTE Open Label Variable SC Dosing||8
10322138|NCT00254293|11456987|FG005|COMPLETED|LTE Open Label Variable SC Dosing||0
10322139|NCT00254293|11456988|FG006|COMPLETED|LTE Open Label Variable SC Dosing||0
10322140|NCT00254293|11456982|FG000|NOT COMPLETED|LTE Open Label Variable SC Dosing||3
10322141|NCT00254293|11456983|FG001|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
10322142|NCT00254293|11456984|FG002|NOT COMPLETED|LTE Open Label Variable SC Dosing||10
10322143|NCT00254293|11456985|FG003|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
10322144|NCT00254293|11456986|FG004|NOT COMPLETED|LTE Open Label Variable SC Dosing||2
10322145|NCT00254293|11456987|FG005|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
10322146|NCT00254293|11456988|FG006|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
10322147|NCT00254293|11456982|FG000|STARTED|LTE Open Label Fixed Dosing||0
10322148|NCT00254293|11456983|FG001|STARTED|LTE Open Label Fixed Dosing||0
10322149|NCT00254293|11456984|FG002|STARTED|LTE Open Label Fixed Dosing||0
10322150|NCT00254293|11456985|FG003|STARTED|LTE Open Label Fixed Dosing||0
10322151|NCT00254293|11456986|FG004|STARTED|LTE Open Label Fixed Dosing||0
10322152|NCT00254293|11456987|FG005|STARTED|LTE Open Label Fixed Dosing||0
10322153|NCT00254293|11456988|FG006|STARTED|LTE Open Label Fixed Dosing||48
10322154|NCT00254293|11456982|FG000|COMPLETED|LTE Open Label Fixed Dosing||0
10322155|NCT00254293|11456983|FG001|COMPLETED|LTE Open Label Fixed Dosing||0
10322156|NCT00254293|11456984|FG002|COMPLETED|LTE Open Label Fixed Dosing||0
10322157|NCT00254293|11456985|FG003|COMPLETED|LTE Open Label Fixed Dosing||0
10322158|NCT00254293|11456986|FG004|COMPLETED|LTE Open Label Fixed Dosing||0
10322159|NCT00254293|11456987|FG005|COMPLETED|LTE Open Label Fixed Dosing||0
10322160|NCT00254293|11456988|FG006|COMPLETED|LTE Open Label Fixed Dosing||35
10322161|NCT00254293|11456982|FG000|NOT COMPLETED|LTE Open Label Fixed Dosing||0
10322162|NCT00254293|11456983|FG001|NOT COMPLETED|LTE Open Label Fixed Dosing||0
10322163|NCT00254293|11456984|FG002|NOT COMPLETED|LTE Open Label Fixed Dosing||0
10803795|NCT04102956|11965239|FG001|COMPLETED|Overall Study||38
10803796|NCT04102956|11965238|FG000|NOT COMPLETED|Overall Study||0
10803797|NCT04102956|11965239|FG001|NOT COMPLETED|Overall Study||0
10803798|NCT04102540|11965245|FG000|STARTED|Overall Study||32
10803799|NCT04102540|11965245|FG000|COMPLETED|Overall Study||24
10803800|NCT04102540|11965245|FG000|NOT COMPLETED|Overall Study||8
10803801|NCT04102345|11965251|FG000|STARTED|Overall Study||26
10803802|NCT04102345|11965252|FG001|STARTED|Overall Study||32
10803803|NCT04102345|11965251|FG000|COMPLETED|Overall Study||25
10322164|NCT00254293|11456985|FG003|NOT COMPLETED|LTE Open Label Fixed Dosing||0
10322165|NCT00254293|11456986|FG004|NOT COMPLETED|LTE Open Label Fixed Dosing||0
10322166|NCT00254293|11456987|FG005|NOT COMPLETED|LTE Open Label Fixed Dosing||0
10322167|NCT00254293|11456988|FG006|NOT COMPLETED|LTE Open Label Fixed Dosing||13
10322168|NCT00254397|11457035|FG000|STARTED|Overall Study||10
10322169|NCT00254397|11457036|FG001|STARTED|Overall Study||6
10322170|NCT00254397|11457037|FG002|STARTED|Overall Study||37
10322171|NCT00254397|11457038|FG003|STARTED|Overall Study||45
10322172|NCT00254397|11457035|FG000|COMPLETED|Overall Study||4
10322173|NCT00254397|11457036|FG001|COMPLETED|Overall Study||5
10322174|NCT00254397|11457037|FG002|COMPLETED|Overall Study||18
10322175|NCT00254397|11457038|FG003|COMPLETED|Overall Study||20
10322176|NCT00254397|11457035|FG000|NOT COMPLETED|Overall Study||6
10322177|NCT00254397|11457036|FG001|NOT COMPLETED|Overall Study||1
10322178|NCT00254397|11457037|FG002|NOT COMPLETED|Overall Study||19
10322179|NCT00254397|11457038|FG003|NOT COMPLETED|Overall Study||25
10322180|NCT00254410|11457047|FG000|STARTED|Overall Study||30
10322181|NCT00254410|11457047|FG000|COMPLETED|Overall Study||30
10322182|NCT00254410|11457047|FG000|NOT COMPLETED|Overall Study||0
10322183|NCT00254462|11457053|FG000|STARTED|Overall Study||44
10322184|NCT00254462|11457054|FG001|STARTED|Overall Study||49
10322185|NCT00254462|11457053|FG000|COMPLETED|Overall Study||36
10322186|NCT00254462|11457054|FG001|COMPLETED|Overall Study||39
10322187|NCT00254462|11457053|FG000|NOT COMPLETED|Overall Study||8
10322188|NCT00254462|11457054|FG001|NOT COMPLETED|Overall Study||10
10322189|NCT00254488|11457064|FG000|STARTED|Overall Study||112
10322190|NCT00254488|11457065|FG001|STARTED|Overall Study||112
10322191|NCT00254488|11457064|FG000|COMPLETED|Overall Study||55
10322192|NCT00254488|11457065|FG001|COMPLETED|Overall Study||63
10322193|NCT00254488|11457064|FG000|NOT COMPLETED|Overall Study||57
10322194|NCT00254488|11457065|FG001|NOT COMPLETED|Overall Study||49
10322195|NCT00254501|11457073|FG000|STARTED|Overall Study||32
10322196|NCT00254501|11457074|FG001|STARTED|Overall Study||37
10322197|NCT00254501|11457073|FG000|COMPLETED|Overall Study||31
10322198|NCT00254501|11457074|FG001|COMPLETED|Overall Study||36
10322199|NCT00254501|11457073|FG000|NOT COMPLETED|Overall Study||1
10322200|NCT00254501|11457074|FG001|NOT COMPLETED|Overall Study||1
10322201|NCT00254540|11457084|FG000|STARTED|Overall Study|All 25 subjects enrolled were included in Intent-To Treat population.|25
10322202|NCT00254540|11457085|FG001|STARTED|Overall Study|All 26 subjects enrolled were included in Intent-To Treat population.|26
10322203|NCT00254540|11457084|FG000|COMPLETED|Overall Study||6
10322204|NCT00254540|11457085|FG001|COMPLETED|Overall Study||4
10322205|NCT00254540|11457084|FG000|NOT COMPLETED|Overall Study||19
10322206|NCT00254540|11457085|FG001|NOT COMPLETED|Overall Study||22
10322207|NCT00254566|11457094|FG000|STARTED|Overall Study||198
10322208|NCT00254566|11457095|FG001|STARTED|Overall Study||198
10322209|NCT00254566|11457094|FG000|COMPLETED|Overall Study||167
10322210|NCT00254566|11457095|FG001|COMPLETED|Overall Study||172
10803804|NCT04102345|11965252|FG001|COMPLETED|Overall Study||32
10803805|NCT04102345|11965251|FG000|NOT COMPLETED|Overall Study||1
10803806|NCT04102345|11965252|FG001|NOT COMPLETED|Overall Study||0
10803807|NCT04092907|11965260|FG000|STARTED|Overall Study||50
10322211|NCT00254566|11457094|FG000|NOT COMPLETED|Overall Study||31
10322212|NCT00254566|11457095|FG001|NOT COMPLETED|Overall Study||26
10322213|NCT00254592|11457101|FG000|STARTED|Overall Study||43
10322214|NCT00254592|11457101|FG000|COMPLETED|Overall Study||41
10322215|NCT00254592|11457101|FG000|NOT COMPLETED|Overall Study||2
10322216|NCT00254982|11457107|FG000|STARTED|Overall Study||297
10322217|NCT00254982|11457108|FG001|STARTED|Overall Study||296
10322218|NCT00254982|11457107|FG000|COMPLETED|Overall Study||261
10322219|NCT00254982|11457108|FG001|COMPLETED|Overall Study||265
10322220|NCT00254982|11457107|FG000|NOT COMPLETED|Overall Study||36
10322221|NCT00254982|11457108|FG001|NOT COMPLETED|Overall Study||31
10322222|NCT00254995|11457116|FG000|STARTED|Overall Study||31561
10322223|NCT00254995|11457117|FG001|STARTED|Overall Study||31065
10322224|NCT00254995|11457116|FG000|COMPLETED|Overall Study||31561
10322225|NCT00254995|11457117|FG001|COMPLETED|Overall Study||31065
10322226|NCT00254995|11457116|FG000|NOT COMPLETED|Overall Study||0
10322227|NCT00254995|11457117|FG001|NOT COMPLETED|Overall Study||0
10322228|NCT00255008|11457129|FG000|STARTED|Overall Study||45
10322229|NCT00255008|11457130|FG001|STARTED|Overall Study||9
10322230|NCT00255008|11457131|FG002|STARTED|Overall Study||33
10322231|NCT00255008|11457132|FG003|STARTED|Overall Study||34
10338449|NCT00369707|11475315|FG000|COMPLETED|Maintenance Period (up to 4 Cycles)||27
10803808|NCT04092907|11965261|FG001|STARTED|Overall Study||50
10322232|NCT00255008|11457129|FG000|COMPLETED|Overall Study|The study was terminated early and as a result only 42 patients completed the study.|13
10322233|NCT00255008|11457130|FG001|COMPLETED|Overall Study||0
10322234|NCT00255008|11457131|FG002|COMPLETED|Overall Study||17
10322235|NCT00255008|11457132|FG003|COMPLETED|Overall Study||12
10322236|NCT00255008|11457129|FG000|NOT COMPLETED|Overall Study||32
10322237|NCT00255008|11457130|FG001|NOT COMPLETED|Overall Study||9
10322238|NCT00255008|11457131|FG002|NOT COMPLETED|Overall Study||16
10322239|NCT00255008|11457132|FG003|NOT COMPLETED|Overall Study||22
10322240|NCT00255034|11457144|FG000|STARTED|Overall Study||79
10322241|NCT00255034|11457145|FG001|STARTED|Overall Study||64
10322242|NCT00255034|11457144|FG000|COMPLETED|Overall Study||64
10322243|NCT00255034|11457145|FG001|COMPLETED|Overall Study||26
10322244|NCT00255034|11457144|FG000|NOT COMPLETED|Overall Study||15
10322245|NCT00255034|11457145|FG001|NOT COMPLETED|Overall Study||38
10322246|NCT00255047|11457155|FG000|STARTED|Overall Study||538
10322247|NCT00255047|11457156|FG001|STARTED|Overall Study||535
10322248|NCT00255047|11457157|FG002|STARTED|Overall Study||546
10322249|NCT00255047|11457158|FG003|STARTED|Overall Study||548
10322250|NCT00255047|11457155|FG000|COMPLETED|Overall Study||490
10322251|NCT00255047|11457156|FG001|COMPLETED|Overall Study||487
10322252|NCT00255047|11457157|FG002|COMPLETED|Overall Study||496
10322253|NCT00255047|11457158|FG003|COMPLETED|Overall Study||502
10322254|NCT00255047|11457155|FG000|NOT COMPLETED|Overall Study||48
10322255|NCT00255047|11457156|FG001|NOT COMPLETED|Overall Study||48
10322256|NCT00255047|11457157|FG002|NOT COMPLETED|Overall Study||50
10322257|NCT00255047|11457158|FG003|NOT COMPLETED|Overall Study||46
10322258|NCT00255086|11457170|FG000|STARTED|Overall Study||9
10322259|NCT00255086|11457171|FG001|STARTED|Overall Study||8
10322260|NCT00255086|11457170|FG000|COMPLETED|Overall Study||7
10322261|NCT00255086|11457171|FG001|COMPLETED|Overall Study||6
10322262|NCT00255086|11457170|FG000|NOT COMPLETED|Overall Study||2
10322263|NCT00255086|11457171|FG001|NOT COMPLETED|Overall Study||2
10322264|NCT00255125|11457180|FG000|STARTED|Overall Study||42
10322265|NCT00255125|11457181|FG001|STARTED|Overall Study||44
10322266|NCT00255125|11457180|FG000|COMPLETED|Overall Study||42
10322267|NCT00255125|11457181|FG001|COMPLETED|Overall Study||44
10322268|NCT00255125|11457180|FG000|NOT COMPLETED|Overall Study||0
10322269|NCT00255125|11457181|FG001|NOT COMPLETED|Overall Study||0
10322270|NCT00255151|11457192|FG000|STARTED|Overall Study||140
10322271|NCT00255151|11457193|FG001|STARTED|Overall Study||159
10322272|NCT00255151|11457194|FG002|STARTED|Overall Study||152
10322273|NCT00255151|11457192|FG000|COMPLETED|Overall Study||17
10322274|NCT00255151|11457193|FG001|COMPLETED|Overall Study||110
10322275|NCT00255151|11457194|FG002|COMPLETED|Overall Study||103
10322276|NCT00255151|11457192|FG000|NOT COMPLETED|Overall Study||123
10322277|NCT00255151|11457193|FG001|NOT COMPLETED|Overall Study||49
10322278|NCT00255151|11457194|FG002|NOT COMPLETED|Overall Study||49
10322279|NCT00255164|11457205|FG000|STARTED|Overall Study||140
10322280|NCT00255164|11457206|FG001|STARTED|Overall Study||159
10322281|NCT00255164|11457207|FG002|STARTED|Overall Study||152
10322282|NCT00255164|11457205|FG000|COMPLETED|Overall Study||17
10322283|NCT00255164|11457206|FG001|COMPLETED|Overall Study||110
10322284|NCT00255164|11457207|FG002|COMPLETED|Overall Study||103
10322285|NCT00255164|11457205|FG000|NOT COMPLETED|Overall Study||123
10322286|NCT00255164|11457206|FG001|NOT COMPLETED|Overall Study||49
10322287|NCT00255164|11457207|FG002|NOT COMPLETED|Overall Study||49
10322288|NCT00255177|11457219|FG000|STARTED|Overall Study||11
10322289|NCT00255177|11457220|FG001|STARTED|Overall Study||14
10322290|NCT00255177|11457221|FG002|STARTED|Overall Study||13
10322291|NCT00255177|11457222|FG003|STARTED|Overall Study||6
10322292|NCT00255177|11457219|FG000|COMPLETED|Overall Study||9
10322293|NCT00255177|11457220|FG001|COMPLETED|Overall Study||13
10322294|NCT00255177|11457221|FG002|COMPLETED|Overall Study||12
10322295|NCT00255177|11457222|FG003|COMPLETED|Overall Study||4
10322296|NCT00255177|11457219|FG000|NOT COMPLETED|Overall Study||2
10322297|NCT00255177|11457220|FG001|NOT COMPLETED|Overall Study||1
10701617|NCT02568397|11866023|FG001|STARTED|Period 2|Daily doses of 50 mg LY3314814 were administered daily on Days 3 to 21 of Period 2.|60
10803809|NCT04092907|11965260|FG000|COMPLETED|Overall Study||48
10803810|NCT04092907|11965261|FG001|COMPLETED|Overall Study||50
10322298|NCT00255177|11457221|FG002|NOT COMPLETED|Overall Study||1
10701618|NCT02568397|11866022|FG000|COMPLETED|Period 2||0
10701619|NCT02568397|11866023|FG001|COMPLETED|Period 2||58
10701620|NCT02568397|11866022|FG000|NOT COMPLETED|Period 2||0
10701621|NCT02568397|11866023|FG001|NOT COMPLETED|Period 2||2
10701622|NCT02568475|11866040|FG000|STARTED|Overall Study||97
10701623|NCT02568475|11866041|FG001|STARTED|Overall Study||95
10701624|NCT02568475|11866040|FG000|Post-test|Overall Study||85
10322299|NCT00255177|11457222|FG003|NOT COMPLETED|Overall Study||2
10803811|NCT04092907|11965260|FG000|NOT COMPLETED|Overall Study||2
10322300|NCT00255190|11457234|FG000|STARTED|Overall Study||153
10322301|NCT00255190|11457235|FG001|STARTED|Overall Study||438
10322302|NCT00255190|11457234|FG000|COMPLETED|Overall Study||103
10322303|NCT00255190|11457235|FG001|COMPLETED|Overall Study||281
10322304|NCT00255190|11457234|FG000|NOT COMPLETED|Overall Study||50
10322305|NCT00255190|11457235|FG001|NOT COMPLETED|Overall Study||157
10322306|NCT00255346|11457246|FG000|STARTED|Overall Study||10
10322307|NCT00255346|11457247|FG001|STARTED|Overall Study||6
10322308|NCT00255346|11457248|FG002|STARTED|Overall Study||8
10322309|NCT00255346|11457249|FG003|STARTED|Overall Study||11
10322310|NCT00255346|11457250|FG004|STARTED|Overall Study||33
10701625|NCT02568475|11866041|FG001|Post-test|Overall Study||82
10701626|NCT02568475|11866040|FG000|COMPLETED|Overall Study||46
10322311|NCT00255346|11457246|FG000|COMPLETED|Overall Study||9
10322312|NCT00255346|11457247|FG001|COMPLETED|Overall Study||6
10322313|NCT00255346|11457248|FG002|COMPLETED|Overall Study||8
10322314|NCT00255346|11457249|FG003|COMPLETED|Overall Study||11
10322315|NCT00255346|11457250|FG004|COMPLETED|Overall Study||33
10322316|NCT00255346|11457246|FG000|NOT COMPLETED|Overall Study||1
10322317|NCT00255346|11457247|FG001|NOT COMPLETED|Overall Study||0
10322318|NCT00255346|11457248|FG002|NOT COMPLETED|Overall Study||0
10322319|NCT00255346|11457249|FG003|NOT COMPLETED|Overall Study||0
10322320|NCT00255346|11457250|FG004|NOT COMPLETED|Overall Study||0
10322321|NCT00255684|11457258|FG000|STARTED|Overall Study||16
10322322|NCT00255684|11457258|FG000|COMPLETED|Overall Study||16
10322323|NCT00255684|11457258|FG000|NOT COMPLETED|Overall Study||0
10322324|NCT00255723|11457264|FG000|STARTED|Overall Study||56
10322325|NCT00255723|11457265|FG001|STARTED|Overall Study||41
10322326|NCT00255723|11457264|FG000|COMPLETED|Overall Study||54
10322327|NCT00255723|11457265|FG001|COMPLETED|Overall Study||39
10322328|NCT00255723|11457264|FG000|NOT COMPLETED|Overall Study||2
10322329|NCT00255723|11457265|FG001|NOT COMPLETED|Overall Study||2
10322330|NCT00255801|11457271|FG000|STARTED|Overall Study||37
10322331|NCT00255801|11457271|FG000|COMPLETED|Overall Study||37
10322332|NCT00255801|11457271|FG000|NOT COMPLETED|Overall Study||0
10322333|NCT00255840|11457277|FG000|STARTED|Overall Study||408
10322334|NCT00255840|11457278|FG001|STARTED|Overall Study||404
10322335|NCT00255840|11457277|FG000|COMPLETED|Overall Study||345
10322336|NCT00255840|11457278|FG001|COMPLETED|Overall Study||334
10322337|NCT00255840|11457277|FG000|NOT COMPLETED|Overall Study||63
10322338|NCT00255840|11457278|FG001|NOT COMPLETED|Overall Study||70
10322339|NCT00255944|11457286|FG000|STARTED|Overall Study||1311
10322340|NCT00255944|11457287|FG001|STARTED|Overall Study||1311
10322341|NCT00255944|11457286|FG000|COMPLETED|Overall Study||514
10322342|NCT00255944|11457287|FG001|COMPLETED|Overall Study||477
10322343|NCT00255944|11457286|FG000|NOT COMPLETED|Overall Study||797
10322344|NCT00255944|11457287|FG001|NOT COMPLETED|Overall Study||834
10322345|NCT00255970|11457295|FG000|STARTED|Overall Study||21
10322346|NCT00255970|11457296|FG001|STARTED|Overall Study||19
10322347|NCT00255970|11457295|FG000|Screening Visit|Overall Study||21
10322348|NCT00255970|11457296|FG001|Screening Visit|Overall Study||19
10322349|NCT00255970|11457295|FG000|Final Visit Week 24|Overall Study||21
10322350|NCT00255970|11457296|FG001|Final Visit Week 24|Overall Study||19
10322351|NCT00255970|11457295|FG000|COMPLETED|Overall Study||21
10322352|NCT00255970|11457296|FG001|COMPLETED|Overall Study||19
10322353|NCT00255970|11457295|FG000|NOT COMPLETED|Overall Study||0
10322354|NCT00255970|11457296|FG001|NOT COMPLETED|Overall Study||0
10322355|NCT00256126|11457304|FG000|STARTED|Overall Study||149
10322356|NCT00256126|11457305|FG001|STARTED|Overall Study||169
10322357|NCT00256126|11457304|FG000|COMPLETED|Overall Study||147
10322358|NCT00256126|11457305|FG001|COMPLETED|Overall Study||167
10322359|NCT00256126|11457304|FG000|NOT COMPLETED|Overall Study||2
10322360|NCT00256126|11457305|FG001|NOT COMPLETED|Overall Study||2
10322361|NCT00256204|11457315|FG000|STARTED|Overall Study||298
10322362|NCT00256204|11457316|FG001|STARTED|Overall Study||288
10322363|NCT00256204|11457317|FG002|STARTED|Overall Study||295
10322364|NCT00256204|11457318|FG003|STARTED|Overall Study||293
10322365|NCT00256204|11457315|FG000|COMPLETED|Overall Study||231
10322366|NCT00256204|11457316|FG001|COMPLETED|Overall Study||238
10322367|NCT00256204|11457317|FG002|COMPLETED|Overall Study||241
10322368|NCT00256204|11457318|FG003|COMPLETED|Overall Study||244
10322369|NCT00256204|11457315|FG000|NOT COMPLETED|Overall Study||67
10322370|NCT00256204|11457316|FG001|NOT COMPLETED|Overall Study||50
10322371|NCT00256204|11457317|FG002|NOT COMPLETED|Overall Study||54
10322372|NCT00256204|11457318|FG003|NOT COMPLETED|Overall Study||49
10322373|NCT00256217|11457331|FG000|STARTED|Overall Study||42
10322374|NCT00256217|11457331|FG000|COMPLETED|Overall Study||34
10322375|NCT00256217|11457331|FG000|NOT COMPLETED|Overall Study||8
10322376|NCT00256243|11457335|FG000|STARTED|Overall Study||48
10322377|NCT00256243|11457335|FG000|COMPLETED|Overall Study||38
10322378|NCT00256243|11457335|FG000|NOT COMPLETED|Overall Study||10
10322379|NCT00256282|11457340|FG000|STARTED|Overall Study||52
10322380|NCT00256282|11457340|FG000|COMPLETED|Overall Study||36
10322381|NCT00256282|11457340|FG000|NOT COMPLETED|Overall Study||16
10322382|NCT00256308|11457344|FG000|STARTED|Overall Study||6
10322383|NCT00256308|11457344|FG000|COMPLETED|Overall Study||4
10322384|NCT00256308|11457344|FG000|NOT COMPLETED|Overall Study||2
10322385|NCT00256451|11457348|FG000|STARTED|Session1||10
10322386|NCT00256451|11457349|FG001|STARTED|Session1||11
10322387|NCT00256451|11457350|FG002|STARTED|Session1||11
10322388|NCT00256451|11457351|FG003|STARTED|Session1||11
10322389|NCT00256451|11457348|FG000|COMPLETED|Session1||10
10322390|NCT00256451|11457349|FG001|COMPLETED|Session1||11
10322391|NCT00256451|11457350|FG002|COMPLETED|Session1||11
10322392|NCT00256451|11457351|FG003|COMPLETED|Session1||11
10322393|NCT00256451|11457348|FG000|NOT COMPLETED|Session1||0
10322394|NCT00256451|11457349|FG001|NOT COMPLETED|Session1||0
10322395|NCT00256451|11457350|FG002|NOT COMPLETED|Session1||0
10322396|NCT00256451|11457351|FG003|NOT COMPLETED|Session1||0
10322397|NCT00256451|11457348|FG000|STARTED|Session2||9
10322398|NCT00256451|11457349|FG001|STARTED|Session2||11
10322399|NCT00256451|11457350|FG002|STARTED|Session2||10
10322400|NCT00256451|11457351|FG003|STARTED|Session2||10
10322401|NCT00256451|11457348|FG000|COMPLETED|Session2||9
10322402|NCT00256451|11457349|FG001|COMPLETED|Session2||11
10322403|NCT00256451|11457350|FG002|COMPLETED|Session2||10
10322404|NCT00256451|11457351|FG003|COMPLETED|Session2||10
10322405|NCT00256451|11457348|FG000|NOT COMPLETED|Session2||0
10322406|NCT00256451|11457349|FG001|NOT COMPLETED|Session2||0
10322407|NCT00256451|11457350|FG002|NOT COMPLETED|Session2||0
10322408|NCT00256451|11457351|FG003|NOT COMPLETED|Session2||0
10322409|NCT00256451|11457348|FG000|STARTED|Session3||9
10322410|NCT00256451|11457349|FG001|STARTED|Session3||9
10322411|NCT00256451|11457350|FG002|STARTED|Session3||10
10322412|NCT00256451|11457351|FG003|STARTED|Session3||9
10322413|NCT00256451|11457348|FG000|COMPLETED|Session3||9
10322414|NCT00256451|11457349|FG001|COMPLETED|Session3||9
10322415|NCT00256451|11457350|FG002|COMPLETED|Session3||10
10322416|NCT00256451|11457351|FG003|COMPLETED|Session3||9
10322417|NCT00256451|11457348|FG000|NOT COMPLETED|Session3||0
10701627|NCT02568475|11866041|FG001|COMPLETED|Overall Study||52
10701628|NCT02568475|11866040|FG000|NOT COMPLETED|Overall Study||51
10701629|NCT02568475|11866041|FG001|NOT COMPLETED|Overall Study||43
10322418|NCT00256451|11457349|FG001|NOT COMPLETED|Session3||0
10322419|NCT00256451|11457350|FG002|NOT COMPLETED|Session3||0
10322420|NCT00256451|11457351|FG003|NOT COMPLETED|Session3||0
10322421|NCT00256451|11457348|FG000|STARTED|Session4||9
10322422|NCT00256451|11457349|FG001|STARTED|Session4||8
10322423|NCT00256451|11457350|FG002|STARTED|Session4||10
10322424|NCT00256451|11457351|FG003|STARTED|Session4||8
10322425|NCT00256451|11457348|FG000|COMPLETED|Session4||9
10322426|NCT00256451|11457349|FG001|COMPLETED|Session4||8
10322427|NCT00256451|11457350|FG002|COMPLETED|Session4||10
10322428|NCT00256451|11457351|FG003|COMPLETED|Session4||8
10322429|NCT00256451|11457348|FG000|NOT COMPLETED|Session4||0
10322430|NCT00256451|11457349|FG001|NOT COMPLETED|Session4||0
10322431|NCT00256451|11457350|FG002|NOT COMPLETED|Session4||0
10322432|NCT00256451|11457351|FG003|NOT COMPLETED|Session4||0
10322433|NCT00256698|11457363|FG000|STARTED|Overall Study||258
10322434|NCT00256698|11457364|FG001|STARTED|Overall Study||256
10322435|NCT00256698|11457363|FG000|COMPLETED|Overall Study||91
10322436|NCT00256698|11457364|FG001|COMPLETED|Overall Study||84
10322437|NCT00256698|11457363|FG000|NOT COMPLETED|Overall Study||167
10322438|NCT00256698|11457364|FG001|NOT COMPLETED|Overall Study||172
10322439|NCT00256724|11457372|FG000|STARTED|Overall Study||23
10322440|NCT00256724|11457373|FG001|STARTED|Overall Study||24
10322441|NCT00256724|11457372|FG000|COMPLETED|Overall Study||18
10322442|NCT00256724|11457373|FG001|COMPLETED|Overall Study||16
10322443|NCT00256724|11457372|FG000|NOT COMPLETED|Overall Study||5
10322444|NCT00256724|11457373|FG001|NOT COMPLETED|Overall Study||8
10322445|NCT00256750|11457382|FG000|STARTED|Transplanted Pre-Treatment||221
10322446|NCT00256750|11457383|FG001|STARTED|Transplanted Pre-Treatment||226
10322447|NCT00256750|11457384|FG002|STARTED|Transplanted Pre-Treatment||219
10322448|NCT00256750|11457382|FG000|COMPLETED|Transplanted Pre-Treatment||215
10322449|NCT00256750|11457383|FG001|COMPLETED|Transplanted Pre-Treatment||226
10322450|NCT00256750|11457384|FG002|COMPLETED|Transplanted Pre-Treatment||219
10322451|NCT00256750|11457382|FG000|NOT COMPLETED|Transplanted Pre-Treatment||6
10322452|NCT00256750|11457383|FG001|NOT COMPLETED|Transplanted Pre-Treatment||0
10322453|NCT00256750|11457384|FG002|NOT COMPLETED|Transplanted Pre-Treatment||0
10322454|NCT00256750|11457382|FG000|STARTED|Post-Transplant Treated (12 Months)||215
10322455|NCT00256750|11457383|FG001|STARTED|Post-Transplant Treated (12 Months)||226
10322456|NCT00256750|11457384|FG002|STARTED|Post-Transplant Treated (12 Months)||219
10322457|NCT00256750|11457382|FG000|COMPLETED|Post-Transplant Treated (12 Months)||174
10322458|NCT00256750|11457383|FG001|COMPLETED|Post-Transplant Treated (12 Months)||183
10322459|NCT00256750|11457384|FG002|COMPLETED|Post-Transplant Treated (12 Months)||173
10322460|NCT00256750|11457382|FG000|NOT COMPLETED|Post-Transplant Treated (12 Months)||41
10322461|NCT00256750|11457383|FG001|NOT COMPLETED|Post-Transplant Treated (12 Months)||43
10322462|NCT00256750|11457384|FG002|NOT COMPLETED|Post-Transplant Treated (12 Months)||46
10322463|NCT00256750|11457382|FG000|STARTED|Post-Transplant Treated (24 Months)||174
10322464|NCT00256750|11457383|FG001|STARTED|Post-Transplant Treated (24 Months)||183
10322465|NCT00256750|11457384|FG002|STARTED|Post-Transplant Treated (24 Months)||173
10322466|NCT00256750|11457382|FG000|COMPLETED|Post-Transplant Treated (24 Months)||153
10322467|NCT00256750|11457383|FG001|COMPLETED|Post-Transplant Treated (24 Months)||176
10322468|NCT00256750|11457384|FG002|COMPLETED|Post-Transplant Treated (24 Months)||164
10322469|NCT00256750|11457382|FG000|NOT COMPLETED|Post-Transplant Treated (24 Months)||21
10322470|NCT00256750|11457383|FG001|NOT COMPLETED|Post-Transplant Treated (24 Months)||7
10322471|NCT00256750|11457384|FG002|NOT COMPLETED|Post-Transplant Treated (24 Months)||9
10322472|NCT00256750|11457382|FG000|STARTED|Post-Transplant Treated (36 Months)||153
10322473|NCT00256750|11457383|FG001|STARTED|Post-Transplant Treated (36 Months)||176
10322474|NCT00256750|11457384|FG002|STARTED|Post-Transplant Treated (36 Months)||164
10322475|NCT00256750|11457382|FG000|COMPLETED|Post-Transplant Treated (36 Months)||143
10322476|NCT00256750|11457383|FG001|COMPLETED|Post-Transplant Treated (36 Months)||170
10322477|NCT00256750|11457384|FG002|COMPLETED|Post-Transplant Treated (36 Months)||158
10322478|NCT00256750|11457382|FG000|NOT COMPLETED|Post-Transplant Treated (36 Months)||10
10322479|NCT00256750|11457383|FG001|NOT COMPLETED|Post-Transplant Treated (36 Months)||6
10322480|NCT00256750|11457384|FG002|NOT COMPLETED|Post-Transplant Treated (36 Months)||6
10322481|NCT00256750|11457382|FG000|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 eligible to enroll in LTE; 2 ineligible, 5 withdrew or refused|136
10322482|NCT00256750|11457383|FG001|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 were eligible to enroll in LTE; 4 withdrew or refused.|166
10322483|NCT00256750|11457384|FG002|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 were eligible to enroll in LTE; 3 withdrew or refused.|155
10701630|NCT02568644|11866049|FG000|STARTED|Overall Study||30
10701631|NCT02568644|11866050|FG001|STARTED|Overall Study||30
10322484|NCT00256750|11457382|FG000|COMPLETED|Long Term Extension (LTE; 84 Months)||89
10322485|NCT00256750|11457383|FG001|COMPLETED|Long Term Extension (LTE; 84 Months)||136
10322486|NCT00256750|11457384|FG002|COMPLETED|Long Term Extension (LTE; 84 Months)||127
10322487|NCT00256750|11457382|FG000|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||47
10322488|NCT00256750|11457383|FG001|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||30
10322489|NCT00256750|11457384|FG002|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||28
10338450|NCT00369707|11475315|FG000|NOT COMPLETED|Maintenance Period (up to 4 Cycles)||8
10338451|NCT00369707|11475315|FG000|STARTED|Follow up for 2 Years After Treatment||41
10338452|NCT00369707|11475315|FG000|COMPLETED|Follow up for 2 Years After Treatment||38
10338453|NCT00369707|11475315|FG000|NOT COMPLETED|Follow up for 2 Years After Treatment||3
10338454|NCT00369746|11475321|FG000|STARTED|Overall Study||138
10338455|NCT00369746|11475322|FG001|STARTED|Overall Study||536
10338456|NCT00369746|11475321|FG000|COMPLETED|Overall Study||138
10338457|NCT00369746|11475322|FG001|COMPLETED|Overall Study||536
10338458|NCT00369746|11475321|FG000|NOT COMPLETED|Overall Study||0
10338459|NCT00369746|11475322|FG001|NOT COMPLETED|Overall Study||0
10338460|NCT00369785|11475330|FG000|STARTED|Overall Study||99
10338461|NCT00369785|11475331|FG001|STARTED|Overall Study||99
10338462|NCT00369785|11475330|FG000|COMPLETED|Overall Study||72
10338463|NCT00369785|11475331|FG001|COMPLETED|Overall Study||74
10338464|NCT00369785|11475330|FG000|NOT COMPLETED|Overall Study||27
10338465|NCT00369785|11475331|FG001|NOT COMPLETED|Overall Study||25
10338466|NCT00369824|11475343|FG000|STARTED|Overall Study||212
10338467|NCT00369824|11475344|FG001|STARTED|Overall Study||214
10338468|NCT00369824|11475345|FG002|STARTED|Overall Study||214
10338469|NCT00369824|11475346|FG003|STARTED|Overall Study||214
10338470|NCT00369824|11475347|FG004|STARTED|Overall Study||214
10338471|NCT00369824|11475348|FG005|STARTED|Overall Study||215
10338472|NCT00369824|11475343|FG000|COMPLETED|Overall Study||197
10338473|NCT00369824|11475344|FG001|COMPLETED|Overall Study||195
10338474|NCT00369824|11475345|FG002|COMPLETED|Overall Study||202
10338475|NCT00369824|11475346|FG003|COMPLETED|Overall Study||199
10338476|NCT00369824|11475347|FG004|COMPLETED|Overall Study||196
10338477|NCT00369824|11475348|FG005|COMPLETED|Overall Study||204
10338478|NCT00369824|11475343|FG000|NOT COMPLETED|Overall Study||15
10338479|NCT00369824|11475344|FG001|NOT COMPLETED|Overall Study||19
10338480|NCT00369824|11475345|FG002|NOT COMPLETED|Overall Study||12
10338481|NCT00369824|11475346|FG003|NOT COMPLETED|Overall Study||15
10338482|NCT00369824|11475347|FG004|NOT COMPLETED|Overall Study||18
10338483|NCT00369824|11475348|FG005|NOT COMPLETED|Overall Study||11
10338484|NCT00369915|11475364|FG000|STARTED|Overall Study||10
10338485|NCT00369915|11475365|FG001|STARTED|Overall Study||7
10338486|NCT00369915|11475364|FG000|COMPLETED|Overall Study||4
10338487|NCT00369915|11475365|FG001|COMPLETED|Overall Study||4
10338488|NCT00369915|11475364|FG000|NOT COMPLETED|Overall Study||6
10338489|NCT00369915|11475365|FG001|NOT COMPLETED|Overall Study||3
10338490|NCT00369928|11475374|FG000|STARTED|Overall Study||85
10338491|NCT00369928|11475375|FG001|STARTED|Overall Study||85
10338492|NCT00369928|11475376|FG002|STARTED|Overall Study||86
10338493|NCT00369928|11475374|FG000|COMPLETED|Overall Study||77
10338494|NCT00369928|11475375|FG001|COMPLETED|Overall Study||69
10338495|NCT00369928|11475376|FG002|COMPLETED|Overall Study||66
10338496|NCT00369928|11475374|FG000|NOT COMPLETED|Overall Study||8
10338497|NCT00369928|11475375|FG001|NOT COMPLETED|Overall Study||16
10338498|NCT00369928|11475376|FG002|NOT COMPLETED|Overall Study||20
10338499|NCT00369941|11475386|FG000|STARTED|Overall Study||282
10338500|NCT00369941|11475387|FG001|STARTED|Overall Study||284
10338501|NCT00369941|11475386|FG000|Treated|Overall Study||281
10338502|NCT00369941|11475387|FG001|Treated|Overall Study||282
10338503|NCT00369941|11475386|FG000|COMPLETED|Overall Study||210
10338504|NCT00369941|11475387|FG001|COMPLETED|Overall Study||184
10338505|NCT00369941|11475386|FG000|NOT COMPLETED|Overall Study||72
10338506|NCT00369941|11475387|FG001|NOT COMPLETED|Overall Study||100
10338507|NCT00369967|11475396|FG000|STARTED|Overall Study||31
10338508|NCT00369967|11475397|FG001|STARTED|Overall Study||17
10338509|NCT00369967|11475396|FG000|COMPLETED|Overall Study||8
10338510|NCT00369967|11475397|FG001|COMPLETED|Overall Study||5
10338511|NCT00369967|11475396|FG000|NOT COMPLETED|Overall Study||23
10338512|NCT00369967|11475397|FG001|NOT COMPLETED|Overall Study||12
10338513|NCT00370032|11475409|FG000|STARTED|Treatment Period 1|Safety Population - all subjects who took at least one dose of study medication.|24
10322529|NCT00256867|11457445|FG007|COMPLETED|Overall Study||36
10338514|NCT00370032|11475410|FG001|STARTED|Treatment Period 1|Safety Population - all subjects who took at least one dose of study medication.|25
10338515|NCT00370032|11475409|FG000|COMPLETED|Treatment Period 1||24
10338516|NCT00370032|11475410|FG001|COMPLETED|Treatment Period 1||24
10338517|NCT00370032|11475409|FG000|NOT COMPLETED|Treatment Period 1||0
10338518|NCT00370032|11475410|FG001|NOT COMPLETED|Treatment Period 1||1
10338519|NCT00370032|11475409|FG000|STARTED|Washout Period||24
10338520|NCT00370032|11475410|FG001|STARTED|Washout Period||24
10338521|NCT00370032|11475409|FG000|COMPLETED|Washout Period||23
10338522|NCT00370032|11475410|FG001|COMPLETED|Washout Period||22
10338523|NCT00370032|11475409|FG000|NOT COMPLETED|Washout Period||1
10338524|NCT00370032|11475410|FG001|NOT COMPLETED|Washout Period||2
10338525|NCT00370032|11475409|FG000|STARTED|Treatment Period 2||23
10338526|NCT00370032|11475410|FG001|STARTED|Treatment Period 2||22
10338527|NCT00370032|11475409|FG000|COMPLETED|Treatment Period 2||23
10338528|NCT00370032|11475410|FG001|COMPLETED|Treatment Period 2||22
10338529|NCT00370032|11475409|FG000|NOT COMPLETED|Treatment Period 2||0
10338530|NCT00370032|11475410|FG001|NOT COMPLETED|Treatment Period 2||0
10338531|NCT00370032|11475409|FG000|STARTED|Follow-up Period||23
10701632|NCT02568644|11866049|FG000|COMPLETED|Overall Study||30
10701633|NCT02568644|11866050|FG001|COMPLETED|Overall Study||30
10701634|NCT02568644|11866049|FG000|NOT COMPLETED|Overall Study||0
10322490|NCT00256776|11457395|FG000|STARTED|Overall Study||135
10322491|NCT00256776|11457396|FG001|STARTED|Overall Study||134
10322492|NCT00256776|11457395|FG000|COMPLETED|Overall Study||52
10322493|NCT00256776|11457396|FG001|COMPLETED|Overall Study||54
10322494|NCT00256776|11457395|FG000|NOT COMPLETED|Overall Study||83
10322495|NCT00256776|11457396|FG001|NOT COMPLETED|Overall Study||80
10322496|NCT00256854|11457410|FG000|STARTED|Overall Study||26
10322497|NCT00256854|11457411|FG001|STARTED|Overall Study||26
10322498|NCT00256854|11457412|FG002|STARTED|Overall Study||26
10322499|NCT00256854|11457413|FG003|STARTED|Overall Study||27
10322500|NCT00256854|11457414|FG004|STARTED|Overall Study||16
10322501|NCT00256854|11457415|FG005|STARTED|Overall Study||14
10322502|NCT00256854|11457410|FG000|COMPLETED|Overall Study||23
10322503|NCT00256854|11457411|FG001|COMPLETED|Overall Study||22
10322504|NCT00256854|11457412|FG002|COMPLETED|Overall Study||23
10322505|NCT00256854|11457413|FG003|COMPLETED|Overall Study||24
10322506|NCT00256854|11457414|FG004|COMPLETED|Overall Study||15
10322507|NCT00256854|11457415|FG005|COMPLETED|Overall Study||13
10322508|NCT00256854|11457410|FG000|NOT COMPLETED|Overall Study||3
10322509|NCT00256854|11457411|FG001|NOT COMPLETED|Overall Study||4
10322510|NCT00256854|11457412|FG002|NOT COMPLETED|Overall Study||3
10322511|NCT00256854|11457413|FG003|NOT COMPLETED|Overall Study||3
10322512|NCT00256854|11457414|FG004|NOT COMPLETED|Overall Study||1
10455935|NCT01004822|11604013|FG006|NOT COMPLETED|Overall Study||4
10455936|NCT01004822|11604014|FG007|NOT COMPLETED|Overall Study||5
10455937|NCT01004848|11604036|FG000|STARTED|Overall Study||210
10455938|NCT01004848|11604037|FG001|STARTED|Overall Study||192
10455939|NCT01004848|11604036|FG000|COMPLETED|Overall Study||155
10455940|NCT01004848|11604037|FG001|COMPLETED|Overall Study||147
10455941|NCT01004848|11604036|FG000|NOT COMPLETED|Overall Study||55
10455942|NCT01004848|11604037|FG001|NOT COMPLETED|Overall Study||45
10455943|NCT01004939|11604045|FG000|STARTED|Overall Study||120
10455944|NCT01004939|11604045|FG000|COMPLETED|Overall Study||120
10455945|NCT01004939|11604045|FG000|NOT COMPLETED|Overall Study||0
10455946|NCT01004991|11604051|FG000|STARTED|Overall Study||12
10455947|NCT01004991|11604051|FG000|COMPLETED|Overall Study||12
10455948|NCT01004991|11604051|FG000|NOT COMPLETED|Overall Study||0
10455949|NCT01005251|11604060|FG000|STARTED|Overall Study||134
10455950|NCT01005251|11604061|FG001|STARTED|Overall Study||125
10455951|NCT01005251|11604062|FG002|STARTED|Overall Study||136
10455952|NCT01005251|11604063|FG003|STARTED|Overall Study||126
10455953|NCT01005251|11604064|FG004|STARTED|Overall Study||140
10455954|NCT01005251|11604060|FG000|COMPLETED|Overall Study||121
10455955|NCT01005251|11604061|FG001|COMPLETED|Overall Study||109
10455956|NCT01005251|11604062|FG002|COMPLETED|Overall Study||114
10455957|NCT01005251|11604063|FG003|COMPLETED|Overall Study||114
10455958|NCT01005251|11604064|FG004|COMPLETED|Overall Study||122
10455959|NCT01005251|11604060|FG000|NOT COMPLETED|Overall Study||13
10455960|NCT01005251|11604061|FG001|NOT COMPLETED|Overall Study||16
10455961|NCT01005251|11604062|FG002|NOT COMPLETED|Overall Study||22
10455962|NCT01005251|11604063|FG003|NOT COMPLETED|Overall Study||12
10455963|NCT01005251|11604064|FG004|NOT COMPLETED|Overall Study||18
10455964|NCT01005290|11604076|FG000|STARTED|Run-In||52
10455965|NCT01005290|11604077|FG001|STARTED|Run-In||0
10455966|NCT01005290|11604078|FG002|STARTED|Run-In||0
10455967|NCT01005290|11604076|FG000|COMPLETED|Run-In||38
10322513|NCT00256854|11457415|FG005|NOT COMPLETED|Overall Study||1
10322514|NCT00256867|11457438|FG000|STARTED|Overall Study||47
10322515|NCT00256867|11457439|FG001|STARTED|Overall Study||44
10322516|NCT00256867|11457440|FG002|STARTED|Overall Study||45
10322517|NCT00256867|11457441|FG003|STARTED|Overall Study||46
10322518|NCT00256867|11457442|FG004|STARTED|Overall Study||48
10322519|NCT00256867|11457443|FG005|STARTED|Overall Study||46
10322520|NCT00256867|11457444|FG006|STARTED|Overall Study||46
10322521|NCT00256867|11457445|FG007|STARTED|Overall Study||47
10322522|NCT00256867|11457438|FG000|COMPLETED|Overall Study||45
10322523|NCT00256867|11457439|FG001|COMPLETED|Overall Study||39
10322524|NCT00256867|11457440|FG002|COMPLETED|Overall Study||40
10322525|NCT00256867|11457441|FG003|COMPLETED|Overall Study||40
10322526|NCT00256867|11457442|FG004|COMPLETED|Overall Study||41
10322527|NCT00256867|11457443|FG005|COMPLETED|Overall Study||40
10322528|NCT00256867|11457444|FG006|COMPLETED|Overall Study||41
10322530|NCT00256867|11457438|FG000|NOT COMPLETED|Overall Study||2
10322531|NCT00256867|11457439|FG001|NOT COMPLETED|Overall Study||5
10322532|NCT00256867|11457440|FG002|NOT COMPLETED|Overall Study||5
10455968|NCT01005290|11604077|FG001|COMPLETED|Run-In||0
10455969|NCT01005290|11604078|FG002|COMPLETED|Run-In||0
10455970|NCT01005290|11604076|FG000|NOT COMPLETED|Run-In||14
10455971|NCT01005290|11604077|FG001|NOT COMPLETED|Run-In||0
10701635|NCT02568644|11866050|FG001|NOT COMPLETED|Overall Study||0
10701636|NCT02568683|11866060|FG000|STARTED|Overall Study||6
10322533|NCT00256867|11457441|FG003|NOT COMPLETED|Overall Study||6
10322534|NCT00256867|11457442|FG004|NOT COMPLETED|Overall Study||7
10322535|NCT00256867|11457443|FG005|NOT COMPLETED|Overall Study||6
10322536|NCT00256867|11457444|FG006|NOT COMPLETED|Overall Study||5
10322537|NCT00256867|11457445|FG007|NOT COMPLETED|Overall Study||11
10322538|NCT00256984|11457468|FG000|STARTED|Overall Study||75
10322539|NCT00256984|11457468|FG000|COMPLETED|Overall Study||59
10322540|NCT00256984|11457468|FG000|NOT COMPLETED|Overall Study||16
10455972|NCT01005290|11604078|FG002|NOT COMPLETED|Run-In||0
10322541|NCT00256997|11457474|FG000|STARTED|Overall Study||81
10322542|NCT00256997|11457475|FG001|STARTED|Overall Study||86
10322543|NCT00256997|11457474|FG000|Treated|Overall Study||79
10322544|NCT00256997|11457475|FG001|Treated|Overall Study||86
10322545|NCT00256997|11457474|FG000|COMPLETED|Overall Study||33
10322546|NCT00256997|11457475|FG001|COMPLETED|Overall Study||31
10322547|NCT00256997|11457474|FG000|NOT COMPLETED|Overall Study||48
10322548|NCT00256997|11457475|FG001|NOT COMPLETED|Overall Study||55
10322549|NCT00257010|11457482|FG000|STARTED|Overall Study||447
10322550|NCT00257010|11457482|FG000|COMPLETED|Overall Study||319
10322551|NCT00257010|11457482|FG000|NOT COMPLETED|Overall Study||128
10322552|NCT00257166|11457488|FG000|STARTED|Overall Study||150
10322553|NCT00257166|11457489|FG001|STARTED|Overall Study||88
10322554|NCT00257166|11457488|FG000|Treated|Overall Study||149
10322555|NCT00257166|11457489|FG001|Treated|Overall Study||88
10322556|NCT00257166|11457488|FG000|COMPLETED|Overall Study||97
10322557|NCT00257166|11457489|FG001|COMPLETED|Overall Study||51
10322558|NCT00257166|11457488|FG000|NOT COMPLETED|Overall Study||53
10322559|NCT00257166|11457489|FG001|NOT COMPLETED|Overall Study||37
10322560|NCT00257192|11457497|FG000|STARTED|Overall Study||193
10322561|NCT00257192|11457498|FG001|STARTED|Overall Study|Includes 1 subject randomized but not treated|91
10322562|NCT00257192|11457497|FG000|Received Study Treatment|Overall Study||193
10322563|NCT00257192|11457498|FG001|Received Study Treatment|Overall Study||90
10322564|NCT00257192|11457497|FG000|COMPLETED|Overall Study||135
10322565|NCT00257192|11457498|FG001|COMPLETED|Overall Study||52
10322566|NCT00257192|11457497|FG000|NOT COMPLETED|Overall Study||58
10322567|NCT00257192|11457498|FG001|NOT COMPLETED|Overall Study||39
10322568|NCT00257309|11457506|FG000|STARTED|Overall Study||134
10322569|NCT00257309|11457507|FG001|STARTED|Overall Study||132
10322570|NCT00257309|11457506|FG000|COMPLETED|Overall Study||132
10322571|NCT00257309|11457507|FG001|COMPLETED|Overall Study||130
10322572|NCT00257309|11457506|FG000|NOT COMPLETED|Overall Study||2
10322573|NCT00257309|11457507|FG001|NOT COMPLETED|Overall Study||2
10322574|NCT00257322|11457513|FG000|STARTED|Overall Study|20 subjects accrued.|20
10322575|NCT00257322|11457513|FG000|COMPLETED|Overall Study|4 subjects withdrew from this study.|16
10322576|NCT00257322|11457513|FG000|NOT COMPLETED|Overall Study||4
10322577|NCT00257556|11457519|FG000|STARTED|Overall Study||38
10322578|NCT00257556|11457520|FG001|STARTED|Overall Study||42
10322579|NCT00257556|11457519|FG000|All Patients Treated Population|Overall Study|Also the safety population. One randomized patient did not receive study medication.|37
10322580|NCT00257556|11457520|FG001|All Patients Treated Population|Overall Study|Also the safety population. Three randomized patients did not receive study medication.|39
10322581|NCT00257556|11457519|FG000|COMPLETED|Overall Study||24
10322582|NCT00257556|11457520|FG001|COMPLETED|Overall Study||32
10322583|NCT00257556|11457519|FG000|NOT COMPLETED|Overall Study||14
10322584|NCT00257556|11457520|FG001|NOT COMPLETED|Overall Study||10
10322585|NCT00257608|11457528|FG000|STARTED|Chemotherapy Phase||1145
10322586|NCT00257608|11457529|FG001|STARTED|Chemotherapy Phase||0
10322587|NCT00257608|11457530|FG002|STARTED|Chemotherapy Phase||0
10322588|NCT00257608|11457528|FG000|COMPLETED|Chemotherapy Phase||769
10322589|NCT00257608|11457529|FG001|COMPLETED|Chemotherapy Phase||0
10322590|NCT00257608|11457530|FG002|COMPLETED|Chemotherapy Phase||0
10322591|NCT00257608|11457528|FG000|NOT COMPLETED|Chemotherapy Phase||376
10322592|NCT00257608|11457529|FG001|NOT COMPLETED|Chemotherapy Phase||0
10322593|NCT00257608|11457530|FG002|NOT COMPLETED|Chemotherapy Phase||0
10322594|NCT00257608|11457528|FG000|STARTED|Post Chemotherapy Phase||0
10322595|NCT00257608|11457529|FG001|STARTED|Post Chemotherapy Phase||373
10322596|NCT00257608|11457530|FG002|STARTED|Post Chemotherapy Phase||370
10322597|NCT00257608|11457528|FG000|COMPLETED|Post Chemotherapy Phase||0
10322598|NCT00257608|11457529|FG001|COMPLETED|Post Chemotherapy Phase||109
10455973|NCT01005290|11604076|FG000|STARTED|Period 1 (5 Weeks)||0
10455974|NCT01005290|11604077|FG001|STARTED|Period 1 (5 Weeks)||20
10322599|NCT00257608|11457530|FG002|COMPLETED|Post Chemotherapy Phase||126
10322600|NCT00257608|11457528|FG000|NOT COMPLETED|Post Chemotherapy Phase||0
10322601|NCT00257608|11457529|FG001|NOT COMPLETED|Post Chemotherapy Phase||264
10322602|NCT00257608|11457530|FG002|NOT COMPLETED|Post Chemotherapy Phase||244
10322609|NCT00257686|11457558|FG000|STARTED|Overall Study||209
10322610|NCT00257686|11457559|FG001|STARTED|Overall Study||108
10322611|NCT00257686|11457560|FG002|STARTED|Overall Study||226
10322612|NCT00257686|11457561|FG003|STARTED|Overall Study||99
10322613|NCT00257686|11457562|FG004|STARTED|Overall Study||216
10322614|NCT00257686|11457563|FG005|STARTED|Overall Study||104
10322615|NCT00257686|11457558|FG000|Safety Population|Overall Study|Subjects who received at least one dose of study medication|207
10322616|NCT00257686|11457559|FG001|Safety Population|Overall Study|Subjects who received at least one dose of study medication|103
10322617|NCT00257686|11457560|FG002|Safety Population|Overall Study|Subjects who received at least one dose of study medication|224
10322618|NCT00257686|11457561|FG003|Safety Population|Overall Study|Subjects who received at least one dose of study medication|96
10322619|NCT00257686|11457562|FG004|Safety Population|Overall Study|Subjects who received at least one dose of study medication|210
10322620|NCT00257686|11457563|FG005|Safety Population|Overall Study|Subjects who received at least one dose of study medication|102
10322621|NCT00257686|11457558|FG000|COMPLETED|Overall Study||188
10322622|NCT00257686|11457559|FG001|COMPLETED|Overall Study||89
10322623|NCT00257686|11457560|FG002|COMPLETED|Overall Study||208
10322624|NCT00257686|11457561|FG003|COMPLETED|Overall Study||88
10322625|NCT00257686|11457562|FG004|COMPLETED|Overall Study||194
10322626|NCT00257686|11457563|FG005|COMPLETED|Overall Study||95
10322627|NCT00257686|11457558|FG000|NOT COMPLETED|Overall Study||21
10322628|NCT00257686|11457559|FG001|NOT COMPLETED|Overall Study||19
10322629|NCT00257686|11457560|FG002|NOT COMPLETED|Overall Study||18
10322630|NCT00257686|11457561|FG003|NOT COMPLETED|Overall Study||11
10322631|NCT00257686|11457562|FG004|NOT COMPLETED|Overall Study||22
10322632|NCT00257686|11457563|FG005|NOT COMPLETED|Overall Study||9
10322633|NCT00257725|11457577|FG000|STARTED|Overall Study||11
10322634|NCT00257725|11457577|FG000|COMPLETED|Overall Study||8
10322635|NCT00257725|11457577|FG000|NOT COMPLETED|Overall Study||3
10322636|NCT00257894|11457584|FG000|STARTED|Overall Study||21
10322637|NCT00257894|11457585|FG001|STARTED|Overall Study||20
10322638|NCT00257894|11457584|FG000|COMPLETED|Overall Study||17
10322639|NCT00257894|11457585|FG001|COMPLETED|Overall Study||15
10322640|NCT00257894|11457584|FG000|NOT COMPLETED|Overall Study||4
10322641|NCT00257894|11457585|FG001|NOT COMPLETED|Overall Study||5
10322642|NCT00257920|11457593|FG000|STARTED|Period: First Intervention||21
10322643|NCT00257920|11457594|FG001|STARTED|Period: First Intervention||20
10322644|NCT00257920|11457593|FG000|COMPLETED|Period: First Intervention||21
10322645|NCT00257920|11457594|FG001|COMPLETED|Period: First Intervention||20
10322646|NCT00257920|11457593|FG000|NOT COMPLETED|Period: First Intervention||0
10322647|NCT00257920|11457594|FG001|NOT COMPLETED|Period: First Intervention||0
10322648|NCT00257920|11457593|FG000|STARTED|Period: Washout Period of Two Weeks||21
10322649|NCT00257920|11457594|FG001|STARTED|Period: Washout Period of Two Weeks||20
10322650|NCT00257920|11457593|FG000|COMPLETED|Period: Washout Period of Two Weeks||21
10322651|NCT00257920|11457594|FG001|COMPLETED|Period: Washout Period of Two Weeks||19
10322652|NCT00257920|11457593|FG000|NOT COMPLETED|Period: Washout Period of Two Weeks||0
10322653|NCT00257920|11457594|FG001|NOT COMPLETED|Period: Washout Period of Two Weeks||1
10322654|NCT00257920|11457593|FG000|STARTED|Period: Second Intervention||21
10322655|NCT00257920|11457594|FG001|STARTED|Period: Second Intervention||19
10322656|NCT00257920|11457593|FG000|COMPLETED|Period: Second Intervention||19
10322657|NCT00257920|11457594|FG001|COMPLETED|Period: Second Intervention||18
10322658|NCT00257920|11457593|FG000|NOT COMPLETED|Period: Second Intervention||2
10322659|NCT00257920|11457594|FG001|NOT COMPLETED|Period: Second Intervention||1
10322660|NCT00257933|11457603|FG000|STARTED|Overall Study||74
10455975|NCT01005290|11604078|FG002|STARTED|Period 1 (5 Weeks)||18
10455976|NCT01005290|11604076|FG000|COMPLETED|Period 1 (5 Weeks)||0
10455977|NCT01005290|11604077|FG001|COMPLETED|Period 1 (5 Weeks)||13
10455978|NCT01005290|11604078|FG002|COMPLETED|Period 1 (5 Weeks)||9
10455979|NCT01005290|11604076|FG000|NOT COMPLETED|Period 1 (5 Weeks)||0
10803812|NCT04092907|11965261|FG001|NOT COMPLETED|Overall Study||0
10803813|NCT04089982|11965269|FG000|STARTED|Overall Study||6
10803814|NCT04089982|11965270|FG001|STARTED|Overall Study||5
10803815|NCT04089982|11965269|FG000|COMPLETED|Overall Study||6
10455980|NCT01005290|11604077|FG001|NOT COMPLETED|Period 1 (5 Weeks)||7
10455981|NCT01005290|11604078|FG002|NOT COMPLETED|Period 1 (5 Weeks)||9
10455982|NCT01005290|11604076|FG000|STARTED|Washout Period (2 Weeks)||0
10455983|NCT01005290|11604077|FG001|STARTED|Washout Period (2 Weeks)||13
10455984|NCT01005290|11604078|FG002|STARTED|Washout Period (2 Weeks)||9
10803816|NCT04089982|11965270|FG001|COMPLETED|Overall Study||5
10322661|NCT00257933|11457604|FG001|STARTED|Overall Study||78
10322662|NCT00257933|11457603|FG000|COMPLETED|Overall Study||74
10322663|NCT00257933|11457604|FG001|COMPLETED|Overall Study||78
10322664|NCT00257933|11457603|FG000|NOT COMPLETED|Overall Study||0
10322665|NCT00257933|11457604|FG001|NOT COMPLETED|Overall Study||0
10322666|NCT00258011|11457610|FG000|STARTED|Overall Study||3
10322667|NCT00258011|11457610|FG000|COMPLETED|Overall Study||3
10322668|NCT00258011|11457610|FG000|NOT COMPLETED|Overall Study||0
10322669|NCT00258128|11457616|FG000|STARTED|Overall Study||8
10322670|NCT00258128|11457617|FG001|STARTED|Overall Study||9
10322671|NCT00258128|11457616|FG000|COMPLETED|Overall Study||8
10322672|NCT00258128|11457617|FG001|COMPLETED|Overall Study||9
10322673|NCT00258128|11457616|FG000|NOT COMPLETED|Overall Study||0
10322674|NCT00258128|11457617|FG001|NOT COMPLETED|Overall Study||0
10322675|NCT00258154|11457627|FG000|STARTED|Overall Study|Healthy infants who started in the RotaTeq™ concomitantly with INFANRIX™ hexa group.|201
10322676|NCT00258154|11457628|FG001|STARTED|Overall Study|Healthy infants who started in the Placebo concomitantly with INFANRIX™ hexa group.|202
10455985|NCT01005290|11604076|FG000|COMPLETED|Washout Period (2 Weeks)||0
10322677|NCT00258154|11457627|FG000|Vaccinated at Visit 1|Overall Study||201
10322678|NCT00258154|11457628|FG001|Vaccinated at Visit 1|Overall Study||202
10322679|NCT00258154|11457627|FG000|Vaccinated at Visit 2|Overall Study||198
10322680|NCT00258154|11457628|FG001|Vaccinated at Visit 2|Overall Study||198
10322681|NCT00258154|11457627|FG000|Vaccinated at Visit 3|Overall Study||195
10322682|NCT00258154|11457628|FG001|Vaccinated at Visit 3|Overall Study||197
10322683|NCT00258154|11457627|FG000|COMPLETED|Overall Study|Subjects who completed the study.|192
10322684|NCT00258154|11457628|FG001|COMPLETED|Overall Study|Subjects who completed the study.|195
10322685|NCT00258154|11457627|FG000|NOT COMPLETED|Overall Study||9
10322686|NCT00258154|11457628|FG001|NOT COMPLETED|Overall Study||7
10322687|NCT00258180|11457634|FG000|STARTED|Overall Study||2
10322688|NCT00258180|11457634|FG000|COMPLETED|Overall Study||2
10322689|NCT00258180|11457634|FG000|NOT COMPLETED|Overall Study||0
10322690|NCT00258206|11457639|FG000|STARTED|Overall Study||21
10322691|NCT00258206|11457639|FG000|COMPLETED|Overall Study||21
10322692|NCT00258206|11457639|FG000|NOT COMPLETED|Overall Study||0
10322693|NCT00258310|11457643|FG000|STARTED|Overall Study||35
10322694|NCT00258310|11457643|FG000|COMPLETED|Overall Study||35
10322695|NCT00258310|11457643|FG000|NOT COMPLETED|Overall Study||0
10322696|NCT00258349|11457647|FG000|STARTED|Overall Study||16
10322697|NCT00258349|11457647|FG000|HER2-positive by Central Review|Overall Study||10
10322698|NCT00258349|11457647|FG000|COMPLETED|Overall Study||16
10322699|NCT00258349|11457647|FG000|NOT COMPLETED|Overall Study||0
10322700|NCT00258362|11457653|FG000|STARTED|Overall Study||41
10322701|NCT00258362|11457653|FG000|COMPLETED|Overall Study||41
10322702|NCT00258362|11457653|FG000|NOT COMPLETED|Overall Study||0
10322703|NCT00258440|11457661|FG000|STARTED|Overall Study||1
10322704|NCT00258440|11457662|FG001|STARTED|Overall Study||0
10322705|NCT00258440|11457663|FG002|STARTED|Overall Study||6
10322706|NCT00258440|11457661|FG000|COMPLETED|Overall Study||1
10322707|NCT00258440|11457662|FG001|COMPLETED|Overall Study||0
10322708|NCT00258440|11457663|FG002|COMPLETED|Overall Study||5
10322709|NCT00258440|11457661|FG000|NOT COMPLETED|Overall Study||0
10322710|NCT00258440|11457662|FG001|NOT COMPLETED|Overall Study||0
10322711|NCT00258440|11457663|FG002|NOT COMPLETED|Overall Study||1
10322712|NCT00258674|11457674|FG000|STARTED|Overall Study||597
10322713|NCT00258674|11457675|FG001|STARTED|Overall Study||811
10322714|NCT00258674|11457676|FG002|STARTED|Overall Study||602
10322715|NCT00258674|11457674|FG000|COMPLETED|Overall Study||565
10322716|NCT00258674|11457675|FG001|COMPLETED|Overall Study||758
10322717|NCT00258674|11457676|FG002|COMPLETED|Overall Study||568
10322718|NCT00258674|11457674|FG000|NOT COMPLETED|Overall Study||32
10322719|NCT00258674|11457675|FG001|NOT COMPLETED|Overall Study||53
10322720|NCT00258674|11457676|FG002|NOT COMPLETED|Overall Study||34
10322721|NCT00258817|11457686|FG000|STARTED|Overall Study||15
10322722|NCT00258817|11457687|FG001|STARTED|Overall Study||15
10322723|NCT00258817|11457686|FG000|COMPLETED|Overall Study||15
10322724|NCT00258817|11457687|FG001|COMPLETED|Overall Study||15
10322725|NCT00258817|11457686|FG000|NOT COMPLETED|Overall Study||0
10322726|NCT00258817|11457687|FG001|NOT COMPLETED|Overall Study||0
10322727|NCT00258830|11457695|FG000|STARTED|Overall Study||60
10322728|NCT00258830|11457696|FG001|STARTED|Overall Study||60
10322729|NCT00258830|11457695|FG000|COMPLETED|Overall Study||60
10322730|NCT00258830|11457696|FG001|COMPLETED|Overall Study||60
10322731|NCT00258830|11457695|FG000|NOT COMPLETED|Overall Study||0
10322732|NCT00258830|11457696|FG001|NOT COMPLETED|Overall Study||0
10322733|NCT00258856|11457706|FG000|STARTED|Overall Study||59
10322734|NCT00258856|11457707|FG001|STARTED|Overall Study||58
10322735|NCT00258856|11457708|FG002|STARTED|Overall Study||58
10322736|NCT00258856|11457709|FG003|STARTED|Overall Study||59
10322737|NCT00258856|11457706|FG000|COMPLETED|Overall Study||56
10322738|NCT00258856|11457707|FG001|COMPLETED|Overall Study||58
10322739|NCT00258856|11457708|FG002|COMPLETED|Overall Study||56
10322740|NCT00258856|11457709|FG003|COMPLETED|Overall Study||58
10322741|NCT00258856|11457706|FG000|NOT COMPLETED|Overall Study||3
10322742|NCT00258856|11457707|FG001|NOT COMPLETED|Overall Study||0
10322743|NCT00258856|11457708|FG002|NOT COMPLETED|Overall Study||2
10322744|NCT00258856|11457709|FG003|NOT COMPLETED|Overall Study||1
10322745|NCT00258882|11457721|FG000|STARTED|Adacel Recipients Historic Cohort Method||124139
10322746|NCT00258882|11457722|FG001|STARTED|Adacel Recipients Historic Cohort Method||203154
10322747|NCT00258882|11457721|FG000|COMPLETED|Adacel Recipients Historic Cohort Method||124139
10322748|NCT00258882|11457722|FG001|COMPLETED|Adacel Recipients Historic Cohort Method||203154
10322749|NCT00258882|11457721|FG000|NOT COMPLETED|Adacel Recipients Historic Cohort Method||0
10322750|NCT00258882|11457722|FG001|NOT COMPLETED|Adacel Recipients Historic Cohort Method||0
10322751|NCT00258882|11457721|FG000|STARTED|Adacel Recipients-Risk Interval Method||124139
10322752|NCT00258882|11457722|FG001|STARTED|Adacel Recipients-Risk Interval Method|Study participants served as their own controls for this analysis|0
10322753|NCT00258882|11457721|FG000|COMPLETED|Adacel Recipients-Risk Interval Method||124139
10322754|NCT00258882|11457722|FG001|COMPLETED|Adacel Recipients-Risk Interval Method||0
10322755|NCT00258882|11457721|FG000|NOT COMPLETED|Adacel Recipients-Risk Interval Method||0
10322756|NCT00258882|11457722|FG001|NOT COMPLETED|Adacel Recipients-Risk Interval Method||0
10322757|NCT00258882|11457721|FG000|STARTED|Pregnancy Surveillance|Adacel recipients who were pregnant at the time of vaccination or within 28 days thereafter.|225
10322758|NCT00258882|11457722|FG001|STARTED|Pregnancy Surveillance|Non-vaccinated age-matched subjects with first positive pregnancy test in the same month (± 1 month)|675
10322759|NCT00258882|11457721|FG000|COMPLETED|Pregnancy Surveillance||225
10322760|NCT00258882|11457722|FG001|COMPLETED|Pregnancy Surveillance||675
10322761|NCT00258882|11457721|FG000|NOT COMPLETED|Pregnancy Surveillance||0
10322762|NCT00258882|11457722|FG001|NOT COMPLETED|Pregnancy Surveillance||0
10322763|NCT00258895|11457732|FG000|STARTED|Overall Study||487
10322764|NCT00258895|11457733|FG001|STARTED|Overall Study||162
10322765|NCT00258895|11457732|FG000|COMPLETED|Overall Study||477
10322766|NCT00258895|11457733|FG001|COMPLETED|Overall Study||159
10322767|NCT00258895|11457732|FG000|NOT COMPLETED|Overall Study||10
10322768|NCT00258895|11457733|FG001|NOT COMPLETED|Overall Study||3
10322769|NCT00258908|11457739|FG000|STARTED|Overall Study|3 participants were not vaccinated and were not included in the final analysis and in this report.|112
10322770|NCT00258908|11457739|FG000|COMPLETED|Overall Study||112
10322771|NCT00258908|11457739|FG000|NOT COMPLETED|Overall Study||0
10322772|NCT00258960|11457743|FG000|STARTED|Overall Study|49 patients included but 1 is not considered due to not receive any treatment and died before start|49
10322773|NCT00258960|11457743|FG000|COMPLETED|Overall Study||32
10322774|NCT00258960|11457743|FG000|NOT COMPLETED|Overall Study||17
10322775|NCT00259012|11457749|FG000|STARTED|Overall Study||33
10322776|NCT00259012|11457750|FG001|STARTED|Overall Study||34
10322777|NCT00259012|11457749|FG000|COMPLETED|Overall Study||31
10322778|NCT00259012|11457750|FG001|COMPLETED|Overall Study||30
10322779|NCT00259012|11457749|FG000|NOT COMPLETED|Overall Study||2
10322780|NCT00259012|11457750|FG001|NOT COMPLETED|Overall Study||4
10322781|NCT00259090|11457759|FG000|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|35
10322782|NCT00259090|11457760|FG001|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|31
10322783|NCT00259090|11457761|FG002|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|37
10322784|NCT00259090|11457759|FG000|COMPLETED|Overall Study||35
10322785|NCT00259090|11457760|FG001|COMPLETED|Overall Study||31
10322786|NCT00259090|11457761|FG002|COMPLETED|Overall Study||37
10322787|NCT00259090|11457759|FG000|NOT COMPLETED|Overall Study||0
10322788|NCT00259090|11457760|FG001|NOT COMPLETED|Overall Study||0
10322789|NCT00259090|11457761|FG002|NOT COMPLETED|Overall Study||0
10322790|NCT00259272|11457773|FG000|STARTED|Overall Study||36
10322791|NCT00259272|11457774|FG001|STARTED|Overall Study||31
10322792|NCT00259272|11457775|FG002|STARTED|Overall Study||26
10322793|NCT00259272|11457776|FG003|STARTED|Overall Study||48
10322794|NCT00259272|11457773|FG000|COMPLETED|Overall Study||21
10322795|NCT00259272|11457774|FG001|COMPLETED|Overall Study||24
10322796|NCT00259272|11457775|FG002|COMPLETED|Overall Study||21
10322797|NCT00259272|11457776|FG003|COMPLETED|Overall Study||27
10322798|NCT00259272|11457773|FG000|NOT COMPLETED|Overall Study||15
10322799|NCT00259272|11457774|FG001|NOT COMPLETED|Overall Study||7
10322800|NCT00259272|11457775|FG002|NOT COMPLETED|Overall Study||5
10322801|NCT00259272|11457776|FG003|NOT COMPLETED|Overall Study||21
10322802|NCT00259285|11457791|FG000|STARTED|Overall Study||10
10322803|NCT00259285|11457791|FG000|COMPLETED|Overall Study||10
10322804|NCT00259285|11457791|FG000|NOT COMPLETED|Overall Study||0
10322805|NCT00259298|11457795|FG000|STARTED|Overall Study||12
10322806|NCT00259298|11457795|FG000|Received at Least 1 Dose of Study Drug|Overall Study||10
10322807|NCT00259298|11457795|FG000|COMPLETED|Overall Study||9
10322808|NCT00259298|11457795|FG000|NOT COMPLETED|Overall Study||3
10322809|NCT00259610|11457803|FG000|STARTED|Overall Study||244
10322810|NCT00259610|11457804|FG001|STARTED|Overall Study||132
10322811|NCT00259610|11457805|FG002|STARTED|Overall Study||255
10322812|NCT00259610|11457806|FG003|STARTED|Overall Study||124
10322813|NCT00259610|11457803|FG000|COMPLETED|Overall Study||168
10322814|NCT00259610|11457804|FG001|COMPLETED|Overall Study||86
10322815|NCT00259610|11457805|FG002|COMPLETED|Overall Study||182
10322816|NCT00259610|11457806|FG003|COMPLETED|Overall Study||81
10322817|NCT00259610|11457803|FG000|NOT COMPLETED|Overall Study||76
10322818|NCT00259610|11457804|FG001|NOT COMPLETED|Overall Study||46
10322819|NCT00259610|11457805|FG002|NOT COMPLETED|Overall Study||73
10322820|NCT00259610|11457806|FG003|NOT COMPLETED|Overall Study||43
10322821|NCT00259649|11457816|FG000|STARTED|Overall Study||71
10322822|NCT00259649|11457816|FG000|COMPLETED|Overall Study||61
10322823|NCT00259649|11457816|FG000|NOT COMPLETED|Overall Study||10
10322824|NCT00259740|11457822|FG000|STARTED|Overall Study||43
10322825|NCT00259740|11457823|FG001|STARTED|Overall Study||53
10322826|NCT00259740|11457822|FG000|Received Study Medication|Overall Study||42
10322827|NCT00259740|11457823|FG001|Received Study Medication|Overall Study||53
10322828|NCT00259740|11457822|FG000|COMPLETED|Overall Study||0
10322829|NCT00259740|11457823|FG001|COMPLETED|Overall Study||0
10322830|NCT00259740|11457822|FG000|NOT COMPLETED|Overall Study||43
10322831|NCT00259740|11457823|FG001|NOT COMPLETED|Overall Study||53
10322832|NCT00259857|11457831|FG000|STARTED|12 Months Treatment||11
10322833|NCT00259857|11457832|FG001|STARTED|12 Months Treatment||11
10322834|NCT00259857|11457831|FG000|COMPLETED|12 Months Treatment||10
10322835|NCT00259857|11457832|FG001|COMPLETED|12 Months Treatment||9
10322836|NCT00259857|11457831|FG000|NOT COMPLETED|12 Months Treatment||1
10322837|NCT00259857|11457832|FG001|NOT COMPLETED|12 Months Treatment||2
10322838|NCT00259857|11457831|FG000|STARTED|24 Months Treatment||10
10322839|NCT00259857|11457832|FG001|STARTED|24 Months Treatment||9
10322840|NCT00259857|11457831|FG000|COMPLETED|24 Months Treatment||10
10322841|NCT00259857|11457832|FG001|COMPLETED|24 Months Treatment||6
10322842|NCT00259857|11457831|FG000|NOT COMPLETED|24 Months Treatment||0
10322843|NCT00259857|11457832|FG001|NOT COMPLETED|24 Months Treatment||3
10322844|NCT00260065|11457838|FG000|STARTED|Overall Study||99
10322845|NCT00260065|11457838|FG000|COMPLETED|Overall Study||6
10322846|NCT00260065|11457838|FG000|NOT COMPLETED|Overall Study||93
10322847|NCT00260195|11457844|FG000|STARTED|Overall Study||39
10322848|NCT00260195|11457845|FG001|STARTED|Overall Study||37
10322849|NCT00260195|11457844|FG000|COMPLETED|Overall Study||39
10322850|NCT00260195|11457845|FG001|COMPLETED|Overall Study||37
10322851|NCT00260195|11457844|FG000|NOT COMPLETED|Overall Study||0
10322852|NCT00260195|11457845|FG001|NOT COMPLETED|Overall Study||0
10322853|NCT00260208|11457854|FG000|STARTED|Overall Study|"Started indicates safety population."|184
10322854|NCT00260208|11457855|FG001|STARTED|Overall Study||172
10322855|NCT00260208|11457854|FG000|Intent to Treat (ITT) Population|Overall Study||182
10322856|NCT00260208|11457855|FG001|Intent to Treat (ITT) Population|Overall Study||169
10322857|NCT00260208|11457854|FG000|Modified ITT|Overall Study||101
10322858|NCT00260208|11457855|FG001|Modified ITT|Overall Study||96
10322859|NCT00260208|11457854|FG000|COMPLETED|Overall Study||137
10322860|NCT00260208|11457855|FG001|COMPLETED|Overall Study||138
10322861|NCT00260208|11457854|FG000|NOT COMPLETED|Overall Study||47
10322862|NCT00260208|11457855|FG001|NOT COMPLETED|Overall Study||34
10322863|NCT00260429|11457863|FG000|STARTED|Overall Study||23
10322864|NCT00260429|11457864|FG001|STARTED|Overall Study||12
10322865|NCT00260429|11457863|FG000|COMPLETED|Overall Study||21
10322866|NCT00260429|11457864|FG001|COMPLETED|Overall Study||12
10322867|NCT00260429|11457863|FG000|NOT COMPLETED|Overall Study||2
10322868|NCT00260429|11457864|FG001|NOT COMPLETED|Overall Study||0
10322869|NCT00260533|11457872|FG000|STARTED|Overall Study||14
10322870|NCT00260533|11457873|FG001|STARTED|Overall Study||13
10322871|NCT00260533|11457872|FG000|COMPLETED|Overall Study||11
10322872|NCT00260533|11457873|FG001|COMPLETED|Overall Study||10
10322873|NCT00260533|11457872|FG000|NOT COMPLETED|Overall Study||3
10322874|NCT00260533|11457873|FG001|NOT COMPLETED|Overall Study||3
10322875|NCT00260689|11457882|FG000|STARTED|Overall Study||60
10322876|NCT00260689|11457883|FG001|STARTED|Overall Study||60
10322877|NCT00260689|11457884|FG002|STARTED|Overall Study||16
10322878|NCT00260689|11457882|FG000|COMPLETED|Overall Study||19
10322879|NCT00260689|11457883|FG001|COMPLETED|Overall Study||11
10322880|NCT00260689|11457884|FG002|COMPLETED|Overall Study||1
10322881|NCT00260689|11457882|FG000|NOT COMPLETED|Overall Study||41
10322882|NCT00260689|11457883|FG001|NOT COMPLETED|Overall Study||49
10322883|NCT00260689|11457884|FG002|NOT COMPLETED|Overall Study||15
10322884|NCT00260832|11457894|FG000|STARTED|Overall Study||243
10322885|NCT00260832|11457895|FG001|STARTED|Overall Study||242
10322886|NCT00260832|11457894|FG000|COMPLETED|Overall Study|At study completion, these subjects chose to remain on treatment|15
10322887|NCT00260832|11457895|FG001|COMPLETED|Overall Study|At study completion, these subjects chose to remain on treatment|31
10322888|NCT00260832|11457894|FG000|NOT COMPLETED|Overall Study||228
10322889|NCT00260832|11457895|FG001|NOT COMPLETED|Overall Study||211
10322890|NCT00260962|11457903|FG000|STARTED|Overall Study||18
10322891|NCT00260962|11457904|FG001|STARTED|Overall Study||16
10322892|NCT00260962|11457903|FG000|COMPLETED|Overall Study||14
10322893|NCT00260962|11457904|FG001|COMPLETED|Overall Study||14
10322894|NCT00260962|11457903|FG000|NOT COMPLETED|Overall Study||4
10322895|NCT00260962|11457904|FG001|NOT COMPLETED|Overall Study||2
10322896|NCT00261040|11457912|FG000|STARTED|Overall Study||20
10322897|NCT00261040|11457913|FG001|STARTED|Overall Study||20
10322898|NCT00261040|11457912|FG000|COMPLETED|Overall Study||19
10322899|NCT00261040|11457913|FG001|COMPLETED|Overall Study||20
10322900|NCT00261040|11457912|FG000|NOT COMPLETED|Overall Study||1
10322901|NCT00261040|11457913|FG001|NOT COMPLETED|Overall Study||0
10322902|NCT00261443|11457921|FG000|STARTED|1: Confirmation of Partial Nonresponse||1270
10322903|NCT00261443|11457922|FG001|STARTED|1: Confirmation of Partial Nonresponse||0
10322904|NCT00261443|11457923|FG002|STARTED|1: Confirmation of Partial Nonresponse||0
10322905|NCT00261443|11457921|FG000|COMPLETED|1: Confirmation of Partial Nonresponse||686
10322906|NCT00261443|11457922|FG001|COMPLETED|1: Confirmation of Partial Nonresponse||0
10322907|NCT00261443|11457923|FG002|COMPLETED|1: Confirmation of Partial Nonresponse||0
10322908|NCT00261443|11457921|FG000|NOT COMPLETED|1: Confirmation of Partial Nonresponse||584
10322909|NCT00261443|11457922|FG001|NOT COMPLETED|1: Confirmation of Partial Nonresponse||0
10322910|NCT00261443|11457923|FG002|NOT COMPLETED|1: Confirmation of Partial Nonresponse||0
10322911|NCT00261443|11457921|FG000|STARTED|2: Stability & Maintenance of Stability||686
10322912|NCT00261443|11457922|FG001|STARTED|2: Stability & Maintenance of Stability||0
10322913|NCT00261443|11457923|FG002|STARTED|2: Stability & Maintenance of Stability||0
10322914|NCT00261443|11457921|FG000|COMPLETED|2: Stability & Maintenance of Stability||346
10322915|NCT00261443|11457922|FG001|COMPLETED|2: Stability & Maintenance of Stability||0
10322916|NCT00261443|11457923|FG002|COMPLETED|2: Stability & Maintenance of Stability||0
10322917|NCT00261443|11457921|FG000|NOT COMPLETED|2: Stability & Maintenance of Stability||340
10322918|NCT00261443|11457922|FG001|NOT COMPLETED|2: Stability & Maintenance of Stability||0
10322919|NCT00261443|11457923|FG002|NOT COMPLETED|2: Stability & Maintenance of Stability||0
10322920|NCT00261443|11457921|FG000|STARTED|3: Assessment of Relapse||0
10322921|NCT00261443|11457922|FG001|STARTED|3: Assessment of Relapse||169
10322922|NCT00261443|11457923|FG002|STARTED|3: Assessment of Relapse||168
10322923|NCT00261443|11457921|FG000|COMPLETED|3: Assessment of Relapse||0
10322924|NCT00261443|11457922|FG001|COMPLETED|3: Assessment of Relapse||89
10322925|NCT00261443|11457923|FG002|COMPLETED|3: Assessment of Relapse||103
10322926|NCT00261443|11457921|FG000|NOT COMPLETED|3: Assessment of Relapse||0
10322927|NCT00261443|11457922|FG001|NOT COMPLETED|3: Assessment of Relapse||80
10322928|NCT00261443|11457923|FG002|NOT COMPLETED|3: Assessment of Relapse||65
10322929|NCT00261443|11457921|FG000|STARTED|4: Extension Phase||0
10322930|NCT00261443|11457922|FG001|STARTED|4: Extension Phase||19
10322931|NCT00261443|11457923|FG002|STARTED|4: Extension Phase||23
10322932|NCT00261443|11457921|FG000|COMPLETED|4: Extension Phase||0
10322933|NCT00261443|11457922|FG001|COMPLETED|4: Extension Phase||16
10322934|NCT00261443|11457923|FG002|COMPLETED|4: Extension Phase||21
10322935|NCT00261443|11457921|FG000|NOT COMPLETED|4: Extension Phase||0
10322936|NCT00261443|11457922|FG001|NOT COMPLETED|4: Extension Phase||3
10322937|NCT00261443|11457923|FG002|NOT COMPLETED|4: Extension Phase||2
10322938|NCT00261495|11457936|FG000|STARTED|Titration Phase (Weeks 0 to 4)||254
10322939|NCT00261495|11457937|FG001|STARTED|Titration Phase (Weeks 0 to 4)||250
10322940|NCT00261495|11457936|FG000|COMPLETED|Titration Phase (Weeks 0 to 4)||206
10322941|NCT00261495|11457937|FG001|COMPLETED|Titration Phase (Weeks 0 to 4)||185
10322942|NCT00261495|11457936|FG000|NOT COMPLETED|Titration Phase (Weeks 0 to 4)||48
10322943|NCT00261495|11457937|FG001|NOT COMPLETED|Titration Phase (Weeks 0 to 4)||65
10322944|NCT00261495|11457936|FG000|STARTED|Maintenance Phase (Weeks 4 to 24)||206
10322945|NCT00261495|11457937|FG001|STARTED|Maintenance Phase (Weeks 4 to 24)||185
10322946|NCT00261495|11457936|FG000|COMPLETED|Maintenance Phase (Weeks 4 to 24)||140
10322947|NCT00261495|11457937|FG001|COMPLETED|Maintenance Phase (Weeks 4 to 24)||137
10322948|NCT00261495|11457936|FG000|NOT COMPLETED|Maintenance Phase (Weeks 4 to 24)||66
10322949|NCT00261495|11457937|FG001|NOT COMPLETED|Maintenance Phase (Weeks 4 to 24)||48
10322950|NCT00261495|11457936|FG000|STARTED|Extension Phase (Weeks 24 to 52)|Number started is different to number completed maintenance phase owing to drop outs (80 subjects).|60
10322951|NCT00261495|11457937|FG001|STARTED|Extension Phase (Weeks 24 to 52)|Number started is different to number completed maintenance phase owing to drop outs (85 subjects).|52
10322952|NCT00261495|11457936|FG000|COMPLETED|Extension Phase (Weeks 24 to 52)||50
10322953|NCT00261495|11457937|FG001|COMPLETED|Extension Phase (Weeks 24 to 52)||47
10322954|NCT00261495|11457936|FG000|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||10
10322955|NCT00261495|11457937|FG001|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
10322956|NCT00261716|11457945|FG000|STARTED|Overall Study||17
10322957|NCT00261716|11457946|FG001|STARTED|Overall Study||21
10322958|NCT00261716|11457945|FG000|COMPLETED|Overall Study||11
10322959|NCT00261716|11457946|FG001|COMPLETED|Overall Study||11
10322960|NCT00261716|11457945|FG000|NOT COMPLETED|Overall Study||6
10322961|NCT00261716|11457946|FG001|NOT COMPLETED|Overall Study||10
10455986|NCT01005290|11604077|FG001|COMPLETED|Washout Period (2 Weeks)||13
10455987|NCT01005290|11604078|FG002|COMPLETED|Washout Period (2 Weeks)||9
10455988|NCT01005290|11604076|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
10322962|NCT00261833|11457958|FG000|STARTED|Overall Study||93
10322963|NCT00261833|11457959|FG001|STARTED|Overall Study||87
10322964|NCT00261833|11457958|FG000|COMPLETED|Overall Study||84
10322965|NCT00261833|11457959|FG001|COMPLETED|Overall Study||69
10322966|NCT00261833|11457958|FG000|NOT COMPLETED|Overall Study||9
10322967|NCT00261833|11457959|FG001|NOT COMPLETED|Overall Study||18
10322968|NCT00261846|11457975|FG000|STARTED|Period 1: Part 1 (Dose Escalation)||3
10322969|NCT00261846|11457976|FG001|STARTED|Period 1: Part 1 (Dose Escalation)||3
10322970|NCT00261846|11457977|FG002|STARTED|Period 1: Part 1 (Dose Escalation)||12
10322971|NCT00261846|11457978|FG003|STARTED|Period 1: Part 1 (Dose Escalation)||0
10322972|NCT00261846|11457979|FG004|STARTED|Period 1: Part 1 (Dose Escalation)||0
10322973|NCT00261846|11457980|FG005|STARTED|Period 1: Part 1 (Dose Escalation)||0
10322974|NCT00261846|11457981|FG006|STARTED|Period 1: Part 1 (Dose Escalation)||0
10322975|NCT00261846|11457982|FG007|STARTED|Period 1: Part 1 (Dose Escalation)||0
10322976|NCT00261846|11457983|FG008|STARTED|Period 1: Part 1 (Dose Escalation)||0
10322977|NCT00261846|11457984|FG009|STARTED|Period 1: Part 1 (Dose Escalation)||0
10322978|NCT00261846|11457985|FG010|STARTED|Period 1: Part 1 (Dose Escalation)||0
10322979|NCT00261846|11457986|FG011|STARTED|Period 1: Part 1 (Dose Escalation)||0
10322980|NCT00261846|11457975|FG000|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
10322981|NCT00261846|11457976|FG001|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
10322982|NCT00261846|11457977|FG002|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
10322983|NCT00261846|11457978|FG003|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
10322984|NCT00261846|11457979|FG004|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
10322985|NCT00261846|11457980|FG005|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
10322986|NCT00261846|11457981|FG006|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
10322987|NCT00261846|11457982|FG007|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
10322988|NCT00261846|11457983|FG008|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
10322989|NCT00261846|11457984|FG009|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
10322990|NCT00261846|11457985|FG010|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
10322991|NCT00261846|11457986|FG011|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
10322992|NCT00261846|11457975|FG000|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||3
10322993|NCT00261846|11457976|FG001|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||3
10322994|NCT00261846|11457977|FG002|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||12
10322995|NCT00261846|11457978|FG003|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
10322996|NCT00261846|11457979|FG004|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
10322997|NCT00261846|11457980|FG005|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
10322998|NCT00261846|11457981|FG006|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
10322999|NCT00261846|11457982|FG007|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
10323000|NCT00261846|11457983|FG008|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
10323001|NCT00261846|11457984|FG009|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
10323002|NCT00261846|11457985|FG010|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
10323003|NCT00261846|11457986|FG011|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
10323004|NCT00261846|11457975|FG000|STARTED|Period 2: Part 2 (Efficacy)||0
10323005|NCT00261846|11457976|FG001|STARTED|Period 2: Part 2 (Efficacy)||0
10323006|NCT00261846|11457977|FG002|STARTED|Period 2: Part 2 (Efficacy)||0
10323007|NCT00261846|11457978|FG003|STARTED|Period 2: Part 2 (Efficacy)|17 participants from Part 1 (Bosutinib 400mg, 500mg, 600mg cohort) continued in Part 2 of the study.|195
10323008|NCT00261846|11457979|FG004|STARTED|Period 2: Part 2 (Efficacy)||89
10323009|NCT00261846|11457980|FG005|STARTED|Period 2: Part 2 (Efficacy)||5
10323010|NCT00261846|11457981|FG006|STARTED|Period 2: Part 2 (Efficacy)||38
10323011|NCT00261846|11457982|FG007|STARTED|Period 2: Part 2 (Efficacy)||50
10323012|NCT00261846|11457983|FG008|STARTED|Period 2: Part 2 (Efficacy)||26
10323013|NCT00261846|11457984|FG009|STARTED|Period 2: Part 2 (Efficacy)|1 participant from Part 1 (Bosutinib 600mg cohort) continued in Part 2 of the study.|79
10323014|NCT00261846|11457985|FG010|STARTED|Period 2: Part 2 (Efficacy)||64
10323015|NCT00261846|11457986|FG011|STARTED|Period 2: Part 2 (Efficacy)||24
10323016|NCT00261846|11457975|FG000|COMPLETED|Period 2: Part 2 (Efficacy)||0
10323017|NCT00261846|11457976|FG001|COMPLETED|Period 2: Part 2 (Efficacy)||0
10323018|NCT00261846|11457977|FG002|COMPLETED|Period 2: Part 2 (Efficacy)||0
10323019|NCT00261846|11457978|FG003|COMPLETED|Period 2: Part 2 (Efficacy)||60
10323020|NCT00261846|11457979|FG004|COMPLETED|Period 2: Part 2 (Efficacy)||39
10323021|NCT00261846|11457980|FG005|COMPLETED|Period 2: Part 2 (Efficacy)||3
10323022|NCT00261846|11457981|FG006|COMPLETED|Period 2: Part 2 (Efficacy)||16
10323023|NCT00261846|11457982|FG007|COMPLETED|Period 2: Part 2 (Efficacy)||21
10323024|NCT00261846|11457983|FG008|COMPLETED|Period 2: Part 2 (Efficacy)||12
10323025|NCT00261846|11457984|FG009|COMPLETED|Period 2: Part 2 (Efficacy)||30
10323026|NCT00261846|11457985|FG010|COMPLETED|Period 2: Part 2 (Efficacy)||15
10323027|NCT00261846|11457986|FG011|COMPLETED|Period 2: Part 2 (Efficacy)||1
10323028|NCT00261846|11457975|FG000|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
10323029|NCT00261846|11457976|FG001|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
10323030|NCT00261846|11457977|FG002|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
10323031|NCT00261846|11457978|FG003|NOT COMPLETED|Period 2: Part 2 (Efficacy)||135
10323032|NCT00261846|11457979|FG004|NOT COMPLETED|Period 2: Part 2 (Efficacy)||50
10323033|NCT00261846|11457980|FG005|NOT COMPLETED|Period 2: Part 2 (Efficacy)||2
10323034|NCT00261846|11457981|FG006|NOT COMPLETED|Period 2: Part 2 (Efficacy)||22
10323035|NCT00261846|11457982|FG007|NOT COMPLETED|Period 2: Part 2 (Efficacy)||29
10323036|NCT00261846|11457983|FG008|NOT COMPLETED|Period 2: Part 2 (Efficacy)||14
10323037|NCT00261846|11457984|FG009|NOT COMPLETED|Period 2: Part 2 (Efficacy)||49
10323038|NCT00261846|11457985|FG010|NOT COMPLETED|Period 2: Part 2 (Efficacy)||49
10323039|NCT00261846|11457986|FG011|NOT COMPLETED|Period 2: Part 2 (Efficacy)||23
10323040|NCT00261950|11458025|FG000|STARTED|Overall Study||110
10323041|NCT00261950|11458025|FG000|COMPLETED|Overall Study||84
10323042|NCT00261950|11458025|FG000|NOT COMPLETED|Overall Study||26
10323043|NCT00262002|11458036|FG000|STARTED|Overall Study||90
10323044|NCT00262002|11458037|FG001|STARTED|Overall Study||90
10323045|NCT00262002|11458038|FG002|STARTED|Overall Study||45
10323046|NCT00262002|11458039|FG003|STARTED|Overall Study||98
10323047|NCT00262002|11458040|FG004|STARTED|Overall Study||98
10323048|NCT00262002|11458041|FG005|STARTED|Overall Study||90
10323049|NCT00262002|11458042|FG006|STARTED|Overall Study||90
10323050|NCT00262002|11458036|FG000|COMPLETED|Overall Study||79
10323051|NCT00262002|11458037|FG001|COMPLETED|Overall Study||84
10323052|NCT00262002|11458038|FG002|COMPLETED|Overall Study||45
10323053|NCT00262002|11458039|FG003|COMPLETED|Overall Study||93
10323054|NCT00262002|11458040|FG004|COMPLETED|Overall Study||91
10323055|NCT00262002|11458041|FG005|COMPLETED|Overall Study||83
10323056|NCT00262002|11458042|FG006|COMPLETED|Overall Study||84
10323057|NCT00262002|11458036|FG000|NOT COMPLETED|Overall Study||11
10323058|NCT00262002|11458037|FG001|NOT COMPLETED|Overall Study||6
10323059|NCT00262002|11458038|FG002|NOT COMPLETED|Overall Study||0
10323060|NCT00262002|11458039|FG003|NOT COMPLETED|Overall Study||5
10323061|NCT00262002|11458040|FG004|NOT COMPLETED|Overall Study||7
10323062|NCT00262002|11458041|FG005|NOT COMPLETED|Overall Study||7
10323063|NCT00262002|11458042|FG006|NOT COMPLETED|Overall Study||6
10323064|NCT00262028|11458116|FG000|STARTED|Overall Study||152
10323065|NCT00262028|11458117|FG001|STARTED|Overall Study||153
10323066|NCT00262028|11458118|FG002|STARTED|Overall Study||157
10323067|NCT00262028|11458119|FG003|STARTED|Overall Study||157
10323068|NCT00262028|11458120|FG004|STARTED|Overall Study||74
10323069|NCT00262028|11458121|FG005|STARTED|Overall Study||73
10323070|NCT00262028|11458122|FG006|STARTED|Overall Study||71
10323071|NCT00262028|11458123|FG007|STARTED|Overall Study||73
10323072|NCT00262028|11458124|FG008|STARTED|Overall Study||100
10323073|NCT00262028|11458116|FG000|COMPLETED|Overall Study||128
10323074|NCT00262028|11458117|FG001|COMPLETED|Overall Study||126
10323075|NCT00262028|11458118|FG002|COMPLETED|Overall Study||137
10323076|NCT00262028|11458119|FG003|COMPLETED|Overall Study||134
10323077|NCT00262028|11458120|FG004|COMPLETED|Overall Study||62
10323078|NCT00262028|11458121|FG005|COMPLETED|Overall Study||60
10323079|NCT00262028|11458122|FG006|COMPLETED|Overall Study||59
10323080|NCT00262028|11458123|FG007|COMPLETED|Overall Study||55
10323081|NCT00262028|11458124|FG008|COMPLETED|Overall Study||81
10323082|NCT00262028|11458116|FG000|NOT COMPLETED|Overall Study||24
10323083|NCT00262028|11458117|FG001|NOT COMPLETED|Overall Study||27
10323084|NCT00262028|11458118|FG002|NOT COMPLETED|Overall Study||20
10323085|NCT00262028|11458119|FG003|NOT COMPLETED|Overall Study||23
10323086|NCT00262028|11458120|FG004|NOT COMPLETED|Overall Study||12
10323087|NCT00262028|11458121|FG005|NOT COMPLETED|Overall Study||13
10323088|NCT00262028|11458122|FG006|NOT COMPLETED|Overall Study||12
10323089|NCT00262028|11458123|FG007|NOT COMPLETED|Overall Study||18
10323090|NCT00262028|11458124|FG008|NOT COMPLETED|Overall Study||19
10323091|NCT00262041|11458170|FG000|STARTED|Overall Study||164
10323092|NCT00262041|11458171|FG001|STARTED|Overall Study||151
10803817|NCT04089982|11965269|FG000|NOT COMPLETED|Overall Study||0
10803818|NCT04089982|11965270|FG001|NOT COMPLETED|Overall Study||0
10803819|NCT04086433|11965278|FG000|STARTED|Overall Study||17
10803820|NCT04086433|11965279|FG001|STARTED|Overall Study||18
10803821|NCT04086433|11965278|FG000|COMPLETED|Overall Study||17
10803822|NCT04086433|11965279|FG001|COMPLETED|Overall Study||18
10803823|NCT04086433|11965278|FG000|NOT COMPLETED|Overall Study||0
10803824|NCT04086433|11965279|FG001|NOT COMPLETED|Overall Study||0
10803825|NCT04086407|11965285|FG000|STARTED|Overall Study||8
10323093|NCT00262041|11458172|FG002|STARTED|Overall Study||209
10323094|NCT00262041|11458170|FG000|COMPLETED|Overall Study||162
10323095|NCT00262041|11458171|FG001|COMPLETED|Overall Study||147
10323096|NCT00262041|11458172|FG002|COMPLETED|Overall Study||203
10323097|NCT00262041|11458170|FG000|NOT COMPLETED|Overall Study||2
10323098|NCT00262041|11458171|FG001|NOT COMPLETED|Overall Study||4
10323099|NCT00262041|11458172|FG002|NOT COMPLETED|Overall Study||6
10323100|NCT00262067|11458190|FG000|STARTED|Overall Study||415
10323101|NCT00262067|11458191|FG001|STARTED|Overall Study||207
10803826|NCT04086407|11965285|FG000|COMPLETED|Overall Study||8
10803827|NCT04086407|11965285|FG000|NOT COMPLETED|Overall Study||0
10803828|NCT04099277|11965292|FG000|STARTED|Overall Study||2
10323102|NCT00262067|11458192|FG002|STARTED|Overall Study||409
10323103|NCT00262067|11458193|FG003|STARTED|Overall Study||206
10323104|NCT00262067|11458190|FG000|COMPLETED|Overall Study||196
10323105|NCT00262067|11458191|FG001|COMPLETED|Overall Study||107
10323106|NCT00262067|11458192|FG002|COMPLETED|Overall Study||193
10323107|NCT00262067|11458193|FG003|COMPLETED|Overall Study||93
10323108|NCT00262067|11458190|FG000|NOT COMPLETED|Overall Study||219
10323109|NCT00262067|11458191|FG001|NOT COMPLETED|Overall Study||100
10323110|NCT00262067|11458192|FG002|NOT COMPLETED|Overall Study||216
10323111|NCT00262067|11458193|FG003|NOT COMPLETED|Overall Study||113
10323112|NCT00262080|11458206|FG000|STARTED|Double Blind Treatment Period|One patient was randomized to receive ecallantide but was treated with placebo.|36
10323113|NCT00262080|11458207|FG001|STARTED|Double Blind Treatment Period|One patient was randomized to receive placebo but was treated with ecallantide.|36
10323114|NCT00262080|11458208|FG002|STARTED|Double Blind Treatment Period||0
10323115|NCT00262080|11458206|FG000|COMPLETED|Double Blind Treatment Period||35
10323116|NCT00262080|11458207|FG001|COMPLETED|Double Blind Treatment Period||36
10323117|NCT00262080|11458208|FG002|COMPLETED|Double Blind Treatment Period||0
10323118|NCT00262080|11458206|FG000|NOT COMPLETED|Double Blind Treatment Period||1
10323119|NCT00262080|11458207|FG001|NOT COMPLETED|Double Blind Treatment Period||0
10323120|NCT00262080|11458208|FG002|NOT COMPLETED|Double Blind Treatment Period||0
10323121|NCT00262080|11458206|FG000|STARTED|Repeat Dose Treatment Period|Not all patients treated in the double-blind part came for treatment in the repeat-dose part.|22
10323122|NCT00262080|11458207|FG001|STARTED|Repeat Dose Treatment Period|Not all patients treated in the double-blind part came for treatment in the repeat-dose part.|26
10323123|NCT00262080|11458208|FG002|STARTED|Repeat Dose Treatment Period|This arm represents new patients, not treated in the double-blind part of the study.|19
10323124|NCT00262080|11458206|FG000|COMPLETED|Repeat Dose Treatment Period|Some patients participated in only the double-blind or the open label phase.|18
10323125|NCT00262080|11458207|FG001|COMPLETED|Repeat Dose Treatment Period||25
10323126|NCT00262080|11458208|FG002|COMPLETED|Repeat Dose Treatment Period||14
10323127|NCT00262080|11458206|FG000|NOT COMPLETED|Repeat Dose Treatment Period||4
10323128|NCT00262080|11458207|FG001|NOT COMPLETED|Repeat Dose Treatment Period||1
10323129|NCT00262080|11458208|FG002|NOT COMPLETED|Repeat Dose Treatment Period||5
10323130|NCT00262119|11458219|FG000|STARTED|Overall Study||385
10323131|NCT00262119|11458220|FG001|STARTED|Overall Study||398
10323132|NCT00262119|11458221|FG002|STARTED|Overall Study||383
10323133|NCT00262119|11458219|FG000|COMPLETED|Overall Study||327
10323134|NCT00262119|11458220|FG001|COMPLETED|Overall Study||328
10323135|NCT00262119|11458221|FG002|COMPLETED|Overall Study||325
10323136|NCT00262119|11458219|FG000|NOT COMPLETED|Overall Study||58
10323137|NCT00262119|11458220|FG001|NOT COMPLETED|Overall Study||70
10323138|NCT00262119|11458221|FG002|NOT COMPLETED|Overall Study||58
10323139|NCT00262223|11458231|FG000|STARTED|Treatment Phase||32
10323140|NCT00262223|11458232|FG001|STARTED|Treatment Phase||37
10323141|NCT00262223|11458231|FG000|COMPLETED|Treatment Phase||28
10323142|NCT00262223|11458232|FG001|COMPLETED|Treatment Phase||29
10323143|NCT00262223|11458231|FG000|NOT COMPLETED|Treatment Phase||4
10323144|NCT00262223|11458232|FG001|NOT COMPLETED|Treatment Phase||8
10323145|NCT00262223|11458231|FG000|STARTED|1-week Post-treatment Follow-up||28
10323146|NCT00262223|11458232|FG001|STARTED|1-week Post-treatment Follow-up||29
10323147|NCT00262223|11458231|FG000|COMPLETED|1-week Post-treatment Follow-up||24
10323148|NCT00262223|11458232|FG001|COMPLETED|1-week Post-treatment Follow-up||25
10323149|NCT00262223|11458231|FG000|NOT COMPLETED|1-week Post-treatment Follow-up||4
10323150|NCT00262223|11458232|FG001|NOT COMPLETED|1-week Post-treatment Follow-up||4
10323151|NCT00262223|11458231|FG000|STARTED|6-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|28
10323152|NCT00262223|11458232|FG001|STARTED|6-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|29
10803829|NCT04099277|11965292|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2
10803830|NCT04099277|11965292|FG000|COMPLETED|Overall Study||0
10803831|NCT04099277|11965292|FG000|NOT COMPLETED|Overall Study||2
10803832|NCT04098809|11965298|FG000|STARTED|Overall Study||27
10803833|NCT04098809|11965299|FG001|STARTED|Overall Study||25
10803834|NCT04098809|11965298|FG000|COMPLETED|Overall Study||24
10323153|NCT00262223|11458231|FG000|COMPLETED|6-month Post-treatment Follow-up||22
10323154|NCT00262223|11458232|FG001|COMPLETED|6-month Post-treatment Follow-up||28
10323155|NCT00262223|11458231|FG000|NOT COMPLETED|6-month Post-treatment Follow-up||6
10323156|NCT00262223|11458232|FG001|NOT COMPLETED|6-month Post-treatment Follow-up||1
10323157|NCT00262223|11458231|FG000|STARTED|12-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|28
10323158|NCT00262223|11458232|FG001|STARTED|12-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|29
10323159|NCT00262223|11458231|FG000|COMPLETED|12-month Post-treatment Follow-up||21
10323160|NCT00262223|11458232|FG001|COMPLETED|12-month Post-treatment Follow-up||22
10323161|NCT00262223|11458231|FG000|NOT COMPLETED|12-month Post-treatment Follow-up||7
10323162|NCT00262223|11458232|FG001|NOT COMPLETED|12-month Post-treatment Follow-up||7
10323163|NCT00262301|11458242|FG000|STARTED|Double-blind Phase||16
10323164|NCT00262301|11458243|FG001|STARTED|Double-blind Phase||16
10323165|NCT00262301|11458244|FG002|STARTED|Double-blind Phase||0
10323166|NCT00262301|11458242|FG000|COMPLETED|Double-blind Phase||15
10323167|NCT00262301|11458243|FG001|COMPLETED|Double-blind Phase||15
10323168|NCT00262301|11458244|FG002|COMPLETED|Double-blind Phase||0
10323169|NCT00262301|11458242|FG000|NOT COMPLETED|Double-blind Phase||1
10323170|NCT00262301|11458243|FG001|NOT COMPLETED|Double-blind Phase||1
10323171|NCT00262301|11458244|FG002|NOT COMPLETED|Double-blind Phase||0
10323172|NCT00262301|11458242|FG000|STARTED|Open-label Phase||0
10323173|NCT00262301|11458243|FG001|STARTED|Open-label Phase||0
10323174|NCT00262301|11458244|FG002|STARTED|Open-label Phase|"14/57 patients crossed over from the double-blind phase (7/14 were treated with 100 U/kg rhC1INH)"|57
10323175|NCT00262301|11458242|FG000|COMPLETED|Open-label Phase||0
10323176|NCT00262301|11458243|FG001|COMPLETED|Open-label Phase||0
10323177|NCT00262301|11458244|FG002|COMPLETED|Open-label Phase||57
10323178|NCT00262301|11458242|FG000|NOT COMPLETED|Open-label Phase||0
10323179|NCT00262301|11458243|FG001|NOT COMPLETED|Open-label Phase||0
10323180|NCT00262301|11458244|FG002|NOT COMPLETED|Open-label Phase||0
10323181|NCT00262314|11458252|FG000|STARTED|Overall Study|Patients with validated data who received at least 1 dose of Novantrone®|509
10323182|NCT00262314|11458252|FG000|COMPLETED|Overall Study|Patients in the study for 5 years +/-3 months are considered to have completed the 5-year study|172
10323183|NCT00262314|11458252|FG000|NOT COMPLETED|Overall Study||337
10323184|NCT00262509|11458258|FG000|STARTED|Overall Study||8
10323185|NCT00262509|11458259|FG001|STARTED|Overall Study||9
10323186|NCT00262509|11458258|FG000|COMPLETED|Overall Study||8
10323187|NCT00262509|11458259|FG001|COMPLETED|Overall Study||9
10323188|NCT00262509|11458258|FG000|NOT COMPLETED|Overall Study||0
10323189|NCT00262509|11458259|FG001|NOT COMPLETED|Overall Study||0
10323190|NCT00262522|11458269|FG000|STARTED|Study Start Through 8 Weeks||167
10323191|NCT00262522|11458270|FG001|STARTED|Study Start Through 8 Weeks||166
10323192|NCT00262522|11458271|FG002|STARTED|Study Start Through 8 Weeks||166
10323193|NCT00262522|11458272|FG003|STARTED|Study Start Through 8 Weeks||165
10323194|NCT00262522|11458269|FG000|COMPLETED|Study Start Through 8 Weeks||163
10323195|NCT00262522|11458270|FG001|COMPLETED|Study Start Through 8 Weeks||161
10323196|NCT00262522|11458271|FG002|COMPLETED|Study Start Through 8 Weeks||155
10323197|NCT00262522|11458272|FG003|COMPLETED|Study Start Through 8 Weeks||160
10323198|NCT00262522|11458269|FG000|NOT COMPLETED|Study Start Through 8 Weeks||4
10323199|NCT00262522|11458270|FG001|NOT COMPLETED|Study Start Through 8 Weeks||5
10323200|NCT00262522|11458271|FG002|NOT COMPLETED|Study Start Through 8 Weeks||11
10323201|NCT00262522|11458272|FG003|NOT COMPLETED|Study Start Through 8 Weeks||5
10323202|NCT00262522|11458269|FG000|STARTED|Study Start Through 48 Weeks|Number of subjects who started the study, not the number who completed the first 8 weeks.|333
10323203|NCT00262522|11458270|FG001|STARTED|Study Start Through 48 Weeks|After Week 8, these subjects received the tablet formulation once daily through the end of study.|0
10323204|NCT00262522|11458271|FG002|STARTED|Study Start Through 48 Weeks|Number of subjects who started the study, not the number who completed the first 8 weeks.|331
10323205|NCT00262522|11458272|FG003|STARTED|Study Start Through 48 Weeks|After Week 8, these subjects received the tablet formulation twice daily through the end of study.|0
10323206|NCT00262522|11458269|FG000|COMPLETED|Study Start Through 48 Weeks||284
10323207|NCT00262522|11458270|FG001|COMPLETED|Study Start Through 48 Weeks||0
10323208|NCT00262522|11458271|FG002|COMPLETED|Study Start Through 48 Weeks||276
10323209|NCT00262522|11458272|FG003|COMPLETED|Study Start Through 48 Weeks||0
10323210|NCT00262522|11458269|FG000|NOT COMPLETED|Study Start Through 48 Weeks||49
10323211|NCT00262522|11458270|FG001|NOT COMPLETED|Study Start Through 48 Weeks||0
10323212|NCT00262522|11458271|FG002|NOT COMPLETED|Study Start Through 48 Weeks||55
10323213|NCT00262522|11458272|FG003|NOT COMPLETED|Study Start Through 48 Weeks||0
10323214|NCT00262522|11458269|FG000|STARTED|Study Start Through 96 Weeks|Number of subjects who started the study, not the number who completed the first 48 weeks.|333
10323215|NCT00262522|11458270|FG001|STARTED|Study Start Through 96 Weeks|After Week 8, these subjects received the tablet formulation once daily through the end of study.|0
10323216|NCT00262522|11458271|FG002|STARTED|Study Start Through 96 Weeks|Number of subjects who started the study, not the number who completed the first 48 weeks.|331
10323217|NCT00262522|11458272|FG003|STARTED|Study Start Through 96 Weeks|After Week 8, these subjects received the tablet formulation twice daily through the end of study.|0
10323218|NCT00262522|11458269|FG000|COMPLETED|Study Start Through 96 Weeks||256
10323219|NCT00262522|11458270|FG001|COMPLETED|Study Start Through 96 Weeks||0
10323220|NCT00262522|11458271|FG002|COMPLETED|Study Start Through 96 Weeks||254
10323221|NCT00262522|11458272|FG003|COMPLETED|Study Start Through 96 Weeks||0
10323222|NCT00262522|11458269|FG000|NOT COMPLETED|Study Start Through 96 Weeks||77
10323223|NCT00262522|11458270|FG001|NOT COMPLETED|Study Start Through 96 Weeks||0
10323224|NCT00262522|11458271|FG002|NOT COMPLETED|Study Start Through 96 Weeks||77
10323225|NCT00262522|11458272|FG003|NOT COMPLETED|Study Start Through 96 Weeks||0
10323226|NCT00262600|11458283|FG000|STARTED|Overall Study||6015
10323227|NCT00262600|11458284|FG001|STARTED|Overall Study||6076
10323228|NCT00262600|11458285|FG002|STARTED|Overall Study||6022
10323229|NCT00262600|11458283|FG000|COMPLETED|Overall Study||5780
10323230|NCT00262600|11458284|FG001|COMPLETED|Overall Study||5824
10323231|NCT00262600|11458285|FG002|COMPLETED|Overall Study||5756
10323232|NCT00262600|11458283|FG000|NOT COMPLETED|Overall Study||235
10323233|NCT00262600|11458284|FG001|NOT COMPLETED|Overall Study||252
10323234|NCT00262600|11458285|FG002|NOT COMPLETED|Overall Study||266
10323235|NCT00262639|11458297|FG000|STARTED|Overall Study||18
10323236|NCT00262639|11458298|FG001|STARTED|Overall Study||26
10323237|NCT00262639|11458299|FG002|STARTED|Overall Study||9
10323238|NCT00262639|11458300|FG003|STARTED|Overall Study||7
10323239|NCT00262639|11458297|FG000|COMPLETED|Overall Study||18
10323240|NCT00262639|11458298|FG001|COMPLETED|Overall Study||26
10323241|NCT00262639|11458299|FG002|COMPLETED|Overall Study||9
10323242|NCT00262639|11458300|FG003|COMPLETED|Overall Study||7
10323243|NCT00262639|11458297|FG000|NOT COMPLETED|Overall Study||0
10323244|NCT00262639|11458298|FG001|NOT COMPLETED|Overall Study||0
10323245|NCT00262639|11458299|FG002|NOT COMPLETED|Overall Study||0
10323246|NCT00262639|11458300|FG003|NOT COMPLETED|Overall Study||0
10323247|NCT00262730|11458310|FG000|STARTED|Overall Study||97
10323248|NCT00262730|11458310|FG000|COMPLETED|Overall Study||97
10323249|NCT00262730|11458310|FG000|NOT COMPLETED|Overall Study||0
10323250|NCT00262743|11458316|FG000|STARTED|Overall Study||27
10323251|NCT00262743|11458317|FG001|STARTED|Overall Study||42
10323252|NCT00262743|11458316|FG000|COMPLETED|Overall Study||27
10323253|NCT00262743|11458317|FG001|COMPLETED|Overall Study||30
10323254|NCT00262743|11458316|FG000|NOT COMPLETED|Overall Study||0
10323255|NCT00262743|11458317|FG001|NOT COMPLETED|Overall Study||12
10323256|NCT00262821|11458323|FG000|STARTED|Overall Study||198
10323257|NCT00262821|11458324|FG001|STARTED|Overall Study||204
10323258|NCT00262821|11458323|FG000|COMPLETED|Overall Study||194
10323259|NCT00262821|11458324|FG001|COMPLETED|Overall Study||185
10323260|NCT00262821|11458323|FG000|NOT COMPLETED|Overall Study||4
10323261|NCT00262821|11458324|FG001|NOT COMPLETED|Overall Study||19
10323262|NCT00262834|11458332|FG000|STARTED|Overall Study||25
10323263|NCT00262834|11458333|FG001|STARTED|Overall Study||29
10323264|NCT00262834|11458332|FG000|COMPLETED|Overall Study||24
10323265|NCT00262834|11458333|FG001|COMPLETED|Overall Study||25
10323266|NCT00262834|11458332|FG000|NOT COMPLETED|Overall Study||1
10323267|NCT00262834|11458333|FG001|NOT COMPLETED|Overall Study||4
10323268|NCT00262847|11458342|FG000|STARTED|Overall Study|Total enrolled and included in efficacy analysis|625
10323269|NCT00262847|11458343|FG001|STARTED|Overall Study|Total enrolled and included in efficacy analysis|625
10323270|NCT00262847|11458344|FG002|STARTED|Overall Study|Total enrolled and included in efficacy analysis|623
10323271|NCT00262847|11458342|FG000|COMPLETED|Overall Study||107
10323272|NCT00262847|11458343|FG001|COMPLETED|Overall Study||112
10323273|NCT00262847|11458344|FG002|COMPLETED|Overall Study||227
10323274|NCT00262847|11458342|FG000|NOT COMPLETED|Overall Study||518
10323275|NCT00262847|11458343|FG001|NOT COMPLETED|Overall Study||513
10323276|NCT00262847|11458344|FG002|NOT COMPLETED|Overall Study||396
10323277|NCT00262860|11458355|FG000|STARTED|Overall Study||18
10323278|NCT00262860|11458355|FG000|COMPLETED|Overall Study||16
10323279|NCT00262860|11458355|FG000|NOT COMPLETED|Overall Study||2
10323280|NCT00262873|11458359|FG000|STARTED|Overall Study||8
10323281|NCT00262873|11458359|FG000|COMPLETED|Overall Study||0
10323282|NCT00262873|11458359|FG000|NOT COMPLETED|Overall Study||8
10323283|NCT00262925|11458363|FG000|STARTED|Overall Study|7 patients were enrolled to step 1, and 5 patients were enrolled to step 2|12
10323284|NCT00262925|11458363|FG000|COMPLETED|Overall Study||1
10323285|NCT00262925|11458363|FG000|NOT COMPLETED|Overall Study||11
10323286|NCT00262951|11458369|FG000|STARTED|Overall Study||23
10323287|NCT00262951|11458369|FG000|COMPLETED|Overall Study||7
10323288|NCT00262951|11458369|FG000|NOT COMPLETED|Overall Study||16
10323289|NCT00262964|11458375|FG000|STARTED|Overall Study||11
10323290|NCT00262964|11458376|FG001|STARTED|Overall Study||11
10323291|NCT00262964|11458377|FG002|STARTED|Overall Study||17
10323292|NCT00262964|11458378|FG003|STARTED|Overall Study||12
10323293|NCT00262964|11458375|FG000|COMPLETED|Overall Study||11
10323294|NCT00262964|11458376|FG001|COMPLETED|Overall Study||11
10323295|NCT00262964|11458377|FG002|COMPLETED|Overall Study||17
10323296|NCT00262964|11458378|FG003|COMPLETED|Overall Study||12
10323297|NCT00262964|11458375|FG000|NOT COMPLETED|Overall Study||0
10323298|NCT00262964|11458376|FG001|NOT COMPLETED|Overall Study||0
10323299|NCT00262964|11458377|FG002|NOT COMPLETED|Overall Study||0
10323300|NCT00262964|11458378|FG003|NOT COMPLETED|Overall Study||0
10323301|NCT00263211|11458402|FG000|STARTED|Overall Study||24
10323302|NCT00263211|11458403|FG001|STARTED|Overall Study||24
10323303|NCT00263211|11458402|FG000|COMPLETED|Overall Study||19
10323304|NCT00263211|11458403|FG001|COMPLETED|Overall Study||23
10323305|NCT00263211|11458402|FG000|NOT COMPLETED|Overall Study||5
10323306|NCT00263211|11458403|FG001|NOT COMPLETED|Overall Study||1
10323307|NCT00263328|11458415|FG000|STARTED|Overall Study||18
10323308|NCT00263328|11458416|FG001|STARTED|Overall Study||14
10323309|NCT00263328|11458417|FG002|STARTED|Overall Study||13
10323310|NCT00263328|11458415|FG000|COMPLETED|Overall Study||10
10323311|NCT00263328|11458416|FG001|COMPLETED|Overall Study||12
10323312|NCT00263328|11458417|FG002|COMPLETED|Overall Study||6
10323313|NCT00263328|11458415|FG000|NOT COMPLETED|Overall Study||8
10323314|NCT00263328|11458416|FG001|NOT COMPLETED|Overall Study||2
10323315|NCT00263328|11458417|FG002|NOT COMPLETED|Overall Study||7
10323316|NCT00263562|11458429|FG000|STARTED|Overall Study||9
10323317|NCT00263562|11458430|FG001|STARTED|Overall Study||9
10323318|NCT00263562|11458429|FG000|COMPLETED|Overall Study||6
10323319|NCT00263562|11458430|FG001|COMPLETED|Overall Study||9
10323320|NCT00263562|11458429|FG000|NOT COMPLETED|Overall Study||3
10323321|NCT00263562|11458430|FG001|NOT COMPLETED|Overall Study||0
10323322|NCT00263575|11458438|FG000|STARTED|Titration Period||139
10323323|NCT00263575|11458438|FG000|COMPLETED|Titration Period||96
10323324|NCT00263575|11458438|FG000|NOT COMPLETED|Titration Period||43
10323325|NCT00263575|11458438|FG000|STARTED|Maintence Period||96
10323326|NCT00263575|11458438|FG000|COMPLETED|Maintence Period||19
10323327|NCT00263575|11458438|FG000|NOT COMPLETED|Maintence Period||77
10323328|NCT00263588|11458446|FG000|STARTED|Overall Study||95
10323329|NCT00263588|11458447|FG001|STARTED|Overall Study||147
10323330|NCT00263588|11458446|FG000|COMPLETED|Overall Study||14
10323331|NCT00263588|11458447|FG001|COMPLETED|Overall Study||15
10323332|NCT00263588|11458446|FG000|NOT COMPLETED|Overall Study||81
10323333|NCT00263588|11458447|FG001|NOT COMPLETED|Overall Study||132
10323334|NCT00263666|11458456|FG000|STARTED|Overall Study||50
10323335|NCT00263666|11458457|FG001|STARTED|Overall Study||50
10323336|NCT00263666|11458456|FG000|COMPLETED|Overall Study||43
10323337|NCT00263666|11458457|FG001|COMPLETED|Overall Study||39
10323338|NCT00263666|11458456|FG000|NOT COMPLETED|Overall Study||7
10323339|NCT00263666|11458457|FG001|NOT COMPLETED|Overall Study||11
10323340|NCT00263757|11458465|FG000|STARTED|Overall Study||12
10323341|NCT00263757|11458466|FG001|STARTED|Overall Study||13
10323342|NCT00263757|11458465|FG000|COMPLETED|Overall Study||4
10323343|NCT00263757|11458466|FG001|COMPLETED|Overall Study||5
10323344|NCT00263757|11458465|FG000|NOT COMPLETED|Overall Study||8
10323345|NCT00263757|11458466|FG001|NOT COMPLETED|Overall Study||8
10323346|NCT00263887|11458474|FG000|STARTED|Overall Study||38
10323347|NCT00263887|11458475|FG001|STARTED|Overall Study||39
10323348|NCT00263887|11458474|FG000|COMPLETED|Overall Study||35
10323349|NCT00263887|11458475|FG001|COMPLETED|Overall Study||32
10323350|NCT00263887|11458474|FG000|NOT COMPLETED|Overall Study||3
10323351|NCT00263887|11458475|FG001|NOT COMPLETED|Overall Study||7
10323352|NCT00264004|11458485|FG000|STARTED|Overall Study|Randomised|30
10323353|NCT00264004|11458486|FG001|STARTED|Overall Study|Randomised|32
10323354|NCT00264004|11458487|FG002|STARTED|Overall Study|Randomised|30
10323355|NCT00264004|11458488|FG003|STARTED|Overall Study|Randomised|34
10323356|NCT00264004|11458485|FG000|COMPLETED|Overall Study|Completed 12 weeks treatment|13
10323357|NCT00264004|11458486|FG001|COMPLETED|Overall Study|Completed 12 weeks treatment|21
10323358|NCT00264004|11458487|FG002|COMPLETED|Overall Study|Completed 12 weeks treatment|16
10323359|NCT00264004|11458488|FG003|COMPLETED|Overall Study|Completed 12 weeks treatment|19
10323360|NCT00264004|11458485|FG000|NOT COMPLETED|Overall Study||17
10323361|NCT00264004|11458486|FG001|NOT COMPLETED|Overall Study||11
10323362|NCT00264004|11458487|FG002|NOT COMPLETED|Overall Study||14
10323363|NCT00264004|11458488|FG003|NOT COMPLETED|Overall Study||15
10323364|NCT00264238|11458498|FG000|STARTED|Overall Study||15
10323365|NCT00264238|11458498|FG000|COMPLETED|Overall Study||14
10323366|NCT00264238|11458498|FG000|NOT COMPLETED|Overall Study||1
10323367|NCT00264290|11458506|FG000|STARTED|Intervention (8 Weeks)||16
10323368|NCT00264290|11458507|FG001|STARTED|Intervention (8 Weeks)||14
10323369|NCT00264290|11458506|FG000|COMPLETED|Intervention (8 Weeks)||15
10323370|NCT00264290|11458507|FG001|COMPLETED|Intervention (8 Weeks)||14
10323371|NCT00264290|11458506|FG000|NOT COMPLETED|Intervention (8 Weeks)||1
10323372|NCT00264290|11458507|FG001|NOT COMPLETED|Intervention (8 Weeks)||0
10323373|NCT00264290|11458506|FG000|STARTED|Observation (4 Weeks)||15
10323374|NCT00264290|11458507|FG001|STARTED|Observation (4 Weeks)||14
10323375|NCT00264290|11458506|FG000|COMPLETED|Observation (4 Weeks)||15
10323376|NCT00264290|11458507|FG001|COMPLETED|Observation (4 Weeks)||14
10323377|NCT00264290|11458506|FG000|NOT COMPLETED|Observation (4 Weeks)||0
10323378|NCT00264290|11458507|FG001|NOT COMPLETED|Observation (4 Weeks)||0
10323379|NCT00264303|11458519|FG000|STARTED|Overall Study||438
10323380|NCT00264303|11458520|FG001|STARTED|Overall Study||448
10323381|NCT00264303|11458519|FG000|COMPLETED|Overall Study||413
10323382|NCT00264303|11458520|FG001|COMPLETED|Overall Study||419
10323383|NCT00264303|11458519|FG000|NOT COMPLETED|Overall Study||25
10323384|NCT00264303|11458520|FG001|NOT COMPLETED|Overall Study||29
10323385|NCT00264381|11458528|FG000|STARTED|Overall Study||35
10323386|NCT00264381|11458529|FG001|STARTED|Overall Study||37
10323387|NCT00264381|11458528|FG000|COMPLETED|Overall Study||35
10323388|NCT00264381|11458529|FG001|COMPLETED|Overall Study||37
10323389|NCT00264381|11458528|FG000|NOT COMPLETED|Overall Study||0
10323390|NCT00264381|11458529|FG001|NOT COMPLETED|Overall Study||0
10323391|NCT00264498|11458537|FG000|STARTED|Randomized Treatment||17
10323392|NCT00264498|11458538|FG001|STARTED|Randomized Treatment||18
10323393|NCT00264498|11458537|FG000|COMPLETED|Randomized Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
10323394|NCT00264498|11458538|FG001|COMPLETED|Randomized Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
10323395|NCT00264498|11458537|FG000|NOT COMPLETED|Randomized Treatment||17
10323396|NCT00264498|11458538|FG001|NOT COMPLETED|Randomized Treatment||18
10323397|NCT00264498|11458537|FG000|STARTED|Crossover Treatment||6
10323398|NCT00264498|11458538|FG001|STARTED|Crossover Treatment||9
10338532|NCT00370032|11475410|FG001|STARTED|Follow-up Period||22
10323399|NCT00264498|11458537|FG000|COMPLETED|Crossover Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
10323400|NCT00264498|11458538|FG001|COMPLETED|Crossover Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
10323401|NCT00264498|11458537|FG000|NOT COMPLETED|Crossover Treatment||6
10323402|NCT00264498|11458538|FG001|NOT COMPLETED|Crossover Treatment||9
10323403|NCT00264537|11458548|FG000|STARTED|Overall Study||160
10323404|NCT00264537|11458549|FG001|STARTED|Overall Study||159
10323405|NCT00264537|11458550|FG002|STARTED|Overall Study||159
10323406|NCT00264537|11458551|FG003|STARTED|Overall Study||159
10323407|NCT00264537|11458548|FG000|COMPLETED|Overall Study||110
10323408|NCT00264537|11458549|FG001|COMPLETED|Overall Study||101
10323409|NCT00264537|11458550|FG002|COMPLETED|Overall Study||109
10323410|NCT00264537|11458551|FG003|COMPLETED|Overall Study||99
10323411|NCT00264537|11458548|FG000|NOT COMPLETED|Overall Study||50
10323412|NCT00264537|11458549|FG001|NOT COMPLETED|Overall Study||58
10323413|NCT00264537|11458550|FG002|NOT COMPLETED|Overall Study||50
10323414|NCT00264537|11458551|FG003|NOT COMPLETED|Overall Study||60
10323415|NCT00264550|11458567|FG000|STARTED|Overall Study||133
10323416|NCT00264550|11458568|FG001|STARTED|Overall Study||133
10323417|NCT00264550|11458569|FG002|STARTED|Overall Study||89
10323418|NCT00264550|11458570|FG003|STARTED|Overall Study||89
10323419|NCT00264550|11458567|FG000|COMPLETED|Overall Study||90
10323420|NCT00264550|11458568|FG001|COMPLETED|Overall Study||92
10323421|NCT00264550|11458569|FG002|COMPLETED|Overall Study||72
10323422|NCT00264550|11458570|FG003|COMPLETED|Overall Study||59
10323423|NCT00264550|11458567|FG000|NOT COMPLETED|Overall Study||43
10323424|NCT00264550|11458568|FG001|NOT COMPLETED|Overall Study||41
10323425|NCT00264550|11458569|FG002|NOT COMPLETED|Overall Study||17
10323426|NCT00264550|11458570|FG003|NOT COMPLETED|Overall Study||30
10323427|NCT00264576|11458582|FG000|STARTED|Overall Study||308
10323428|NCT00264576|11458583|FG001|STARTED|Overall Study||305
10323429|NCT00264576|11458582|FG000|COMPLETED|Overall Study||307
10323430|NCT00264576|11458583|FG001|COMPLETED|Overall Study||304
10323431|NCT00264576|11458582|FG000|NOT COMPLETED|Overall Study||1
10323432|NCT00264576|11458583|FG001|NOT COMPLETED|Overall Study||1
10323433|NCT00264641|11458592|FG000|STARTED|Overall Study||10
10323434|NCT00264641|11458593|FG001|STARTED|Overall Study||10
10323435|NCT00264641|11458592|FG000|Initiation of the Study|Overall Study||10
10323436|NCT00264641|11458593|FG001|Initiation of the Study|Overall Study||10
10323437|NCT00264641|11458592|FG000|COMPLETED|Overall Study||10
10323438|NCT00264641|11458593|FG001|COMPLETED|Overall Study||10
10323439|NCT00264641|11458592|FG000|NOT COMPLETED|Overall Study||0
10323440|NCT00264641|11458593|FG001|NOT COMPLETED|Overall Study||0
10338533|NCT00370032|11475409|FG000|COMPLETED|Follow-up Period||22
10338534|NCT00370032|11475410|FG001|COMPLETED|Follow-up Period||22
10338535|NCT00370032|11475409|FG000|NOT COMPLETED|Follow-up Period||1
10338536|NCT00370032|11475410|FG001|NOT COMPLETED|Follow-up Period||0
10338537|NCT00370071|11475425|FG000|STARTED|Overall Study||39
10338538|NCT00370071|11475425|FG000|COMPLETED|Overall Study||37
10338539|NCT00370071|11475425|FG000|NOT COMPLETED|Overall Study||2
10338540|NCT00370149|11475431|FG000|STARTED|Overall Study||165
10338541|NCT00370149|11475432|FG001|STARTED|Overall Study||161
10338542|NCT00370149|11475431|FG000|COMPLETED|Overall Study||146
10338543|NCT00370149|11475432|FG001|COMPLETED|Overall Study||142
10338544|NCT00370149|11475431|FG000|NOT COMPLETED|Overall Study||19
10338545|NCT00370149|11475432|FG001|NOT COMPLETED|Overall Study||19
10338546|NCT00370292|11475443|FG000|STARTED|Overall Study||19
10338547|NCT00370292|11475443|FG000|COMPLETED|Overall Study||6
10338548|NCT00370292|11475443|FG000|NOT COMPLETED|Overall Study||13
10339224|NCT00371566|11476130|FG001|STARTED|Follow Up Phase||65
10339225|NCT00371566|11476129|FG000|COMPLETED|Follow Up Phase||28
10339226|NCT00371566|11476130|FG001|COMPLETED|Follow Up Phase||58
10339227|NCT00371566|11476129|FG000|NOT COMPLETED|Follow Up Phase||3
10339228|NCT00371566|11476130|FG001|NOT COMPLETED|Follow Up Phase||7
10339229|NCT00371631|11476136|FG000|STARTED|Overall Study||13
10339230|NCT00371631|11476136|FG000|COMPLETED|Overall Study||13
10339231|NCT00371631|11476136|FG000|NOT COMPLETED|Overall Study||0
10339232|NCT00371644|11476142|FG000|STARTED|Overall Study||72
10339233|NCT00371644|11476143|FG001|STARTED|Overall Study||57
10339234|NCT00371644|11476142|FG000|COMPLETED|Overall Study||44
10339235|NCT00371644|11476143|FG001|COMPLETED|Overall Study||44
10339236|NCT00371644|11476142|FG000|NOT COMPLETED|Overall Study||28
10339237|NCT00371644|11476143|FG001|NOT COMPLETED|Overall Study||13
10339238|NCT00371683|11476151|FG000|STARTED|DB Treatment Period-Randomized Patients||1599
10339239|NCT00371683|11476152|FG001|STARTED|DB Treatment Period-Randomized Patients||1596
10339240|NCT00371683|11476151|FG000|COMPLETED|DB Treatment Period-Randomized Patients||1509
10339241|NCT00371683|11476152|FG001|COMPLETED|DB Treatment Period-Randomized Patients||1489
10339242|NCT00371683|11476151|FG000|NOT COMPLETED|DB Treatment Period-Randomized Patients||90
10339243|NCT00371683|11476152|FG001|NOT COMPLETED|DB Treatment Period-Randomized Patients||107
10339244|NCT00371683|11476151|FG000|STARTED|Follow-Up Period - Randomized Patients||1553
10339245|NCT00371683|11476152|FG001|STARTED|Follow-Up Period - Randomized Patients||1533
10339246|NCT00371683|11476151|FG000|COMPLETED|Follow-Up Period - Randomized Patients||1492
10339247|NCT00371683|11476152|FG001|COMPLETED|Follow-Up Period - Randomized Patients||1461
10339248|NCT00371683|11476151|FG000|NOT COMPLETED|Follow-Up Period - Randomized Patients||61
10339249|NCT00371683|11476152|FG001|NOT COMPLETED|Follow-Up Period - Randomized Patients||72
10339250|NCT00371761|11476170|FG000|STARTED|Overall Study||13
10339251|NCT00371761|11476171|FG001|STARTED|Overall Study||12
10339252|NCT00371761|11476170|FG000|COMPLETED|Overall Study||5
10323441|NCT00264797|11458600|FG000|STARTED|Overall Study||151
10323442|NCT00264797|11458601|FG001|STARTED|Overall Study||152
10323443|NCT00264797|11458600|FG000|COMPLETED|Overall Study||118
10323444|NCT00264797|11458601|FG001|COMPLETED|Overall Study||109
10323445|NCT00264797|11458600|FG000|NOT COMPLETED|Overall Study||33
10323446|NCT00264797|11458601|FG001|NOT COMPLETED|Overall Study||43
10323447|NCT00264810|11458609|FG000|STARTED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|120
10323448|NCT00264810|11458610|FG001|STARTED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|120
10323449|NCT00264810|11458609|FG000|COMPLETED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|97
10323450|NCT00264810|11458610|FG001|COMPLETED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|94
10323451|NCT00264810|11458609|FG000|NOT COMPLETED|Baseline||23
10323452|NCT00264810|11458610|FG001|NOT COMPLETED|Baseline||26
10323453|NCT00264810|11458609|FG000|STARTED|Post-Operative Stabilization Period|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|97
10323454|NCT00264810|11458610|FG001|STARTED|Post-Operative Stabilization Period|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|94
10323455|NCT00264810|11458609|FG000|COMPLETED|Post-Operative Stabilization Period||97
10323456|NCT00264810|11458610|FG001|COMPLETED|Post-Operative Stabilization Period||94
10323457|NCT00264810|11458609|FG000|NOT COMPLETED|Post-Operative Stabilization Period||0
10323458|NCT00264810|11458610|FG001|NOT COMPLETED|Post-Operative Stabilization Period||0
10323459|NCT00264810|11458609|FG000|STARTED|Stimulation Optimization Period||97
10323460|NCT00264810|11458610|FG001|STARTED|Stimulation Optimization Period||94
10323461|NCT00264810|11458609|FG000|COMPLETED|Stimulation Optimization Period||96
10323462|NCT00264810|11458610|FG001|COMPLETED|Stimulation Optimization Period||93
10323463|NCT00264810|11458609|FG000|NOT COMPLETED|Stimulation Optimization Period||1
10323464|NCT00264810|11458610|FG001|NOT COMPLETED|Stimulation Optimization Period||1
10323465|NCT00264810|11458609|FG000|STARTED|Blinded Evaluation Period||96
10323466|NCT00264810|11458610|FG001|STARTED|Blinded Evaluation Period||93
10323467|NCT00264810|11458609|FG000|COMPLETED|Blinded Evaluation Period||95
10323468|NCT00264810|11458610|FG001|COMPLETED|Blinded Evaluation Period||92
10323469|NCT00264810|11458609|FG000|NOT COMPLETED|Blinded Evaluation Period||1
10323470|NCT00264810|11458610|FG001|NOT COMPLETED|Blinded Evaluation Period||1
10323471|NCT00264810|11458609|FG000|STARTED|Open Label Evaluation Period||95
10323472|NCT00264810|11458610|FG001|STARTED|Open Label Evaluation Period||92
10323473|NCT00264810|11458609|FG000|1-year Post-implant|Open Label Evaluation Period||92
10323474|NCT00264810|11458610|FG001|1-year Post-implant|Open Label Evaluation Period||90
10323475|NCT00264810|11458609|FG000|COMPLETED|Open Label Evaluation Period||89
10323476|NCT00264810|11458610|FG001|COMPLETED|Open Label Evaluation Period||86
10323477|NCT00264810|11458609|FG000|NOT COMPLETED|Open Label Evaluation Period||6
10323478|NCT00264810|11458610|FG001|NOT COMPLETED|Open Label Evaluation Period||6
10323479|NCT00264849|11458620|FG000|STARTED|Overall Study||275
10323480|NCT00264849|11458621|FG001|STARTED|Overall Study||131
10323481|NCT00264849|11458620|FG000|COMPLETED|Overall Study||253
10323482|NCT00264849|11458621|FG001|COMPLETED|Overall Study||106
10323483|NCT00264849|11458620|FG000|NOT COMPLETED|Overall Study||22
10323484|NCT00264849|11458621|FG001|NOT COMPLETED|Overall Study||25
10323485|NCT00264875|11458627|FG000|STARTED|Overall Study||220
10323486|NCT00264875|11458627|FG000|COMPLETED|Overall Study||190
10323487|NCT00264875|11458627|FG000|NOT COMPLETED|Overall Study||30
10323488|NCT00265083|11458634|FG000|STARTED|Overall Study||78
10323489|NCT00265083|11458635|FG001|STARTED|Overall Study|One patient did not receive study agent.|138
10323490|NCT00265083|11458636|FG002|STARTED|Overall Study||140
10323491|NCT00265083|11458634|FG000|COMPLETED|Overall Study||61
10803835|NCT04098809|11965299|FG001|COMPLETED|Overall Study||21
10803836|NCT04098809|11965298|FG000|NOT COMPLETED|Overall Study||3
10803837|NCT04098809|11965299|FG001|NOT COMPLETED|Overall Study||4
10811047|NCT03781375|11972757|FG001|Received Study Drug|Double-blind Phase||13
10811048|NCT03781375|11972756|FG000|COMPLETED|Double-blind Phase||5
10811049|NCT03781375|11972757|FG001|COMPLETED|Double-blind Phase||7
10811050|NCT03781375|11972756|FG000|NOT COMPLETED|Double-blind Phase||7
10811051|NCT03781375|11972757|FG001|NOT COMPLETED|Double-blind Phase||6
10811052|NCT03781375|11972756|FG000|STARTED|Open-label Phase||11
10323492|NCT00265083|11458635|FG001|COMPLETED|Overall Study|One patient did not receive study agent.|96
10323493|NCT00265083|11458636|FG002|COMPLETED|Overall Study||98
10323494|NCT00265083|11458634|FG000|NOT COMPLETED|Overall Study||17
10323495|NCT00265083|11458635|FG001|NOT COMPLETED|Overall Study||42
10323496|NCT00265083|11458636|FG002|NOT COMPLETED|Overall Study||42
10323497|NCT00265096|11458648|FG000|STARTED|Overall Study||113
10323498|NCT00265096|11458649|FG001|STARTED|Overall Study||146
10323499|NCT00265096|11458650|FG002|STARTED|Overall Study||146
10323500|NCT00265096|11458648|FG000|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|77
10323501|NCT00265096|11458649|FG001|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|95
10323502|NCT00265096|11458650|FG002|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|107
10323503|NCT00265096|11458648|FG000|NOT COMPLETED|Overall Study||36
10323504|NCT00265096|11458649|FG001|NOT COMPLETED|Overall Study||51
10811053|NCT03781375|11972757|FG001|STARTED|Open-label Phase||9
10811054|NCT03781375|11972756|FG000|Received Study Drug|Open-label Phase||10
10811055|NCT03781375|11972757|FG001|Received Study Drug|Open-label Phase||9
10811056|NCT03781375|11972756|FG000|COMPLETED|Open-label Phase||8
10323505|NCT00265096|11458650|FG002|NOT COMPLETED|Overall Study||39
10323506|NCT00265109|11458660|FG000|STARTED|Overall Study||17
10323507|NCT00265109|11458660|FG000|COMPLETED|Overall Study||11
10323508|NCT00265109|11458660|FG000|NOT COMPLETED|Overall Study||6
10323509|NCT00265122|11458671|FG000|STARTED|Intervention Period 1 (Weeks 0 to 8):||26
10323510|NCT00265122|11458672|FG001|STARTED|Intervention Period 1 (Weeks 0 to 8):||25
10323511|NCT00265122|11458673|FG002|STARTED|Intervention Period 1 (Weeks 0 to 8):||27
10323512|NCT00265122|11458674|FG003|STARTED|Intervention Period 1 (Weeks 0 to 8):||26
10323513|NCT00265122|11458675|FG004|STARTED|Intervention Period 1 (Weeks 0 to 8):||14
10323514|NCT00265122|11458676|FG005|STARTED|Intervention Period 1 (Weeks 0 to 8):||13
10323515|NCT00265122|11458671|FG000|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||24
10323516|NCT00265122|11458672|FG001|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||23
10323517|NCT00265122|11458673|FG002|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||22
10323518|NCT00265122|11458674|FG003|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||24
10323519|NCT00265122|11458675|FG004|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||13
10323520|NCT00265122|11458676|FG005|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||13
10323521|NCT00265122|11458671|FG000|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
10323522|NCT00265122|11458672|FG001|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
10323523|NCT00265122|11458673|FG002|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||5
10323524|NCT00265122|11458674|FG003|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
10323525|NCT00265122|11458675|FG004|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||1
10323526|NCT00265122|11458676|FG005|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||0
10323527|NCT00265122|11458671|FG000|STARTED|Intervention Period 2 (Weeks 8 to 28):||24
10323528|NCT00265122|11458672|FG001|STARTED|Intervention Period 2 (Weeks 8 to 28):||23
10323529|NCT00265122|11458673|FG002|STARTED|Intervention Period 2 (Weeks 8 to 28):||22
10323530|NCT00265122|11458674|FG003|STARTED|Intervention Period 2 (Weeks 8 to 28):||24
10323531|NCT00265122|11458675|FG004|STARTED|Intervention Period 2 (Weeks 8 to 28):||13
10323532|NCT00265122|11458676|FG005|STARTED|Intervention Period 2 (Weeks 8 to 28):||13
10323533|NCT00265122|11458671|FG000|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||17
10323534|NCT00265122|11458672|FG001|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||22
10323535|NCT00265122|11458673|FG002|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||18
10323536|NCT00265122|11458674|FG003|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||20
10323537|NCT00265122|11458675|FG004|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||8
10323538|NCT00265122|11458676|FG005|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||12
10323539|NCT00265122|11458671|FG000|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||7
10323540|NCT00265122|11458672|FG001|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||1
10323541|NCT00265122|11458673|FG002|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||4
10323542|NCT00265122|11458674|FG003|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||4
10323543|NCT00265122|11458675|FG004|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||5
10323544|NCT00265122|11458676|FG005|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||1
10323545|NCT00265148|11458697|FG000|STARTED|Overall Study||40
10323546|NCT00265148|11458698|FG001|STARTED|Overall Study||40
10323547|NCT00265148|11458697|FG000|COMPLETED|Overall Study||31
10323548|NCT00265148|11458698|FG001|COMPLETED|Overall Study||31
10323549|NCT00265148|11458697|FG000|NOT COMPLETED|Overall Study||9
10323550|NCT00265148|11458698|FG001|NOT COMPLETED|Overall Study||9
10323551|NCT00265200|11458705|FG000|STARTED|Overall Study||28
10323552|NCT00265200|11458705|FG000|COMPLETED|Overall Study||24
10323553|NCT00265200|11458705|FG000|NOT COMPLETED|Overall Study||4
10323554|NCT00265239|11458711|FG000|STARTED|Overall Study||52
10323555|NCT00265239|11458712|FG001|STARTED|Overall Study||52
10323556|NCT00265239|11458711|FG000|COMPLETED|Overall Study||50
10323557|NCT00265239|11458712|FG001|COMPLETED|Overall Study||51
10323558|NCT00265239|11458711|FG000|NOT COMPLETED|Overall Study||2
10323559|NCT00265239|11458712|FG001|NOT COMPLETED|Overall Study||1
10323560|NCT00265317|11458722|FG000|STARTED|Lead-In||13
10323561|NCT00265317|11458723|FG001|STARTED|Lead-In||17
10323562|NCT00265317|11458724|FG002|STARTED|Lead-In||0
10323563|NCT00265317|11458725|FG003|STARTED|Lead-In||0
10323564|NCT00265317|11458722|FG000|COMPLETED|Lead-In||1
10323565|NCT00265317|11458723|FG001|COMPLETED|Lead-In||0
10323566|NCT00265317|11458724|FG002|COMPLETED|Lead-In||0
10323567|NCT00265317|11458725|FG003|COMPLETED|Lead-In||0
10323568|NCT00265317|11458722|FG000|NOT COMPLETED|Lead-In||12
10323569|NCT00265317|11458723|FG001|NOT COMPLETED|Lead-In||17
10323570|NCT00265317|11458724|FG002|NOT COMPLETED|Lead-In||0
10323571|NCT00265317|11458725|FG003|NOT COMPLETED|Lead-In||0
10323572|NCT00265317|11458722|FG000|STARTED|Phase 2||0
10323573|NCT00265317|11458723|FG001|STARTED|Phase 2||0
10323574|NCT00265317|11458724|FG002|STARTED|Phase 2||65
10323575|NCT00265317|11458725|FG003|STARTED|Phase 2||67
10323576|NCT00265317|11458722|FG000|COMPLETED|Phase 2||0
10323577|NCT00265317|11458723|FG001|COMPLETED|Phase 2||0
10323578|NCT00265317|11458724|FG002|COMPLETED|Phase 2||1
10323579|NCT00265317|11458725|FG003|COMPLETED|Phase 2||2
10323580|NCT00265317|11458722|FG000|NOT COMPLETED|Phase 2||0
10323581|NCT00265317|11458723|FG001|NOT COMPLETED|Phase 2||0
10323582|NCT00265317|11458724|FG002|NOT COMPLETED|Phase 2||64
10323583|NCT00265317|11458725|FG003|NOT COMPLETED|Phase 2||65
10323584|NCT00265330|11458744|FG000|STARTED|Overall Study||162
10323585|NCT00265330|11458744|FG000|COMPLETED|Overall Study||67
10323586|NCT00265330|11458744|FG000|NOT COMPLETED|Overall Study||95
10323587|NCT00265382|11458748|FG000|STARTED|Overall Study||221
10323588|NCT00265382|11458748|FG000|COMPLETED|Overall Study||76
10323589|NCT00265382|11458748|FG000|NOT COMPLETED|Overall Study||145
10323590|NCT00265395|11458754|FG000|STARTED|Overall Study||86
10323591|NCT00265395|11458755|FG001|STARTED|Overall Study||73
10323592|NCT00265395|11458754|FG000|COMPLETED|Overall Study||78
10323593|NCT00265395|11458755|FG001|COMPLETED|Overall Study||56
10323594|NCT00265395|11458754|FG000|NOT COMPLETED|Overall Study||8
10323595|NCT00265395|11458755|FG001|NOT COMPLETED|Overall Study||17
10323596|NCT00265473|11458760|FG000|STARTED|Overall Study||5
10323597|NCT00265473|11458760|FG000|COMPLETED|Overall Study||5
10323598|NCT00265473|11458760|FG000|NOT COMPLETED|Overall Study||0
10803838|NCT04098575|11965308|FG000|STARTED|Overall Study||505
10803839|NCT04098575|11965309|FG001|STARTED|Overall Study||2961
10803840|NCT04098575|11965310|FG002|STARTED|Overall Study||6105
10803841|NCT04098575|11965308|FG000|COMPLETED|Overall Study||505
10323599|NCT00265512|11458767|FG000|STARTED|Overall Study||213
10323600|NCT00265512|11458768|FG001|STARTED|Overall Study||454
10323601|NCT00265512|11458767|FG000|COMPLETED|Overall Study||168
10323602|NCT00265512|11458768|FG001|COMPLETED|Overall Study||359
10323603|NCT00265512|11458767|FG000|NOT COMPLETED|Overall Study||45
10323604|NCT00265512|11458768|FG001|NOT COMPLETED|Overall Study||95
10323605|NCT00265538|11458776|FG000|STARTED|Overall Study||196
10323606|NCT00265538|11458777|FG001|STARTED|Overall Study||170
10323607|NCT00265538|11458778|FG002|STARTED|Overall Study||182
10323608|NCT00265538|11458779|FG003|STARTED|Overall Study||286
10323609|NCT00265538|11458776|FG000|COMPLETED|Overall Study||186
10323610|NCT00265538|11458777|FG001|COMPLETED|Overall Study||161
10323611|NCT00265538|11458778|FG002|COMPLETED|Overall Study||171
10323612|NCT00265538|11458779|FG003|COMPLETED|Overall Study||267
10323613|NCT00265538|11458776|FG000|NOT COMPLETED|Overall Study||10
10323614|NCT00265538|11458777|FG001|NOT COMPLETED|Overall Study||9
10323615|NCT00265538|11458778|FG002|NOT COMPLETED|Overall Study||11
10323616|NCT00265538|11458779|FG003|NOT COMPLETED|Overall Study||19
10323617|NCT00265564|11458793|FG000|STARTED|Overall Study||59
10323618|NCT00265564|11458794|FG001|STARTED|Overall Study||58
10323619|NCT00265564|11458793|FG000|COMPLETED|Overall Study||49
10323620|NCT00265564|11458794|FG001|COMPLETED|Overall Study||49
10323621|NCT00265564|11458793|FG000|NOT COMPLETED|Overall Study||10
10323622|NCT00265564|11458794|FG001|NOT COMPLETED|Overall Study||9
10323623|NCT00265616|11458802|FG000|STARTED|Overall Study||14
10323624|NCT00265616|11458803|FG001|STARTED|Overall Study||9
10323625|NCT00265616|11458802|FG000|COMPLETED|Overall Study||14
10323626|NCT00265616|11458803|FG001|COMPLETED|Overall Study||9
10323627|NCT00265616|11458802|FG000|NOT COMPLETED|Overall Study||0
10323628|NCT00265616|11458803|FG001|NOT COMPLETED|Overall Study||0
10323629|NCT00265759|11458815|FG000|STARTED|Overall Study||124
10323630|NCT00265759|11458816|FG001|STARTED|Overall Study||128
10323631|NCT00265759|11458817|FG002|STARTED|Overall Study||125
10323632|NCT00265759|11458818|FG003|STARTED|Overall Study||245
10323633|NCT00265759|11458815|FG000|COMPLETED|Overall Study||124
10323634|NCT00265759|11458816|FG001|COMPLETED|Overall Study||127
10323635|NCT00265759|11458817|FG002|COMPLETED|Overall Study||123
10323636|NCT00265759|11458818|FG003|COMPLETED|Overall Study||236
10455989|NCT01005290|11604077|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0
10455990|NCT01005290|11604078|FG002|NOT COMPLETED|Washout Period (2 Weeks)||0
10455991|NCT01005290|11604076|FG000|STARTED|Period 2 (5 Weeks)||0
10455992|NCT01005290|11604077|FG001|STARTED|Period 2 (5 Weeks)||13
10455993|NCT01005290|11604078|FG002|STARTED|Period 2 (5 Weeks)||9
10455994|NCT01005290|11604076|FG000|COMPLETED|Period 2 (5 Weeks)||0
10455995|NCT01005290|11604077|FG001|COMPLETED|Period 2 (5 Weeks)||13
10455996|NCT01005290|11604078|FG002|COMPLETED|Period 2 (5 Weeks)||7
10455997|NCT01005290|11604076|FG000|NOT COMPLETED|Period 2 (5 Weeks)||0
10455998|NCT01005290|11604077|FG001|NOT COMPLETED|Period 2 (5 Weeks)||0
10455999|NCT01005290|11604078|FG002|NOT COMPLETED|Period 2 (5 Weeks)||2
10456000|NCT01005316|11604088|FG000|STARTED|Overall Study||50
10456001|NCT01005316|11604089|FG001|STARTED|Overall Study||97
10456002|NCT01005316|11604090|FG002|STARTED|Overall Study||16
10456003|NCT01005316|11604091|FG003|STARTED|Overall Study||127
10456004|NCT01005316|11604088|FG000|COMPLETED|Overall Study||0
10456005|NCT01005316|11604089|FG001|COMPLETED|Overall Study||21
10456006|NCT01005316|11604090|FG002|COMPLETED|Overall Study||5
10456007|NCT01005316|11604091|FG003|COMPLETED|Overall Study||19
10456008|NCT01005316|11604088|FG000|NOT COMPLETED|Overall Study||50
10803842|NCT04098575|11965309|FG001|COMPLETED|Overall Study||2961
10803843|NCT04098575|11965310|FG002|COMPLETED|Overall Study||6105
10323637|NCT00265759|11458815|FG000|NOT COMPLETED|Overall Study||0
10323638|NCT00265759|11458816|FG001|NOT COMPLETED|Overall Study||1
10323639|NCT00265759|11458817|FG002|NOT COMPLETED|Overall Study||2
10323640|NCT00265759|11458818|FG003|NOT COMPLETED|Overall Study||9
10323641|NCT00265785|11458829|FG000|STARTED|Overall Study||27
10323642|NCT00265785|11458829|FG000|Eligible|Overall Study||26
10456009|NCT01005316|11604089|FG001|NOT COMPLETED|Overall Study||76
10803844|NCT04098575|11965308|FG000|NOT COMPLETED|Overall Study||0
10803845|NCT04098575|11965309|FG001|NOT COMPLETED|Overall Study||0
10323643|NCT00265785|11458829|FG000|Eligible and Began Protocol Treatment|Overall Study||24
10323644|NCT00265785|11458829|FG000|COMPLETED|Overall Study||0
10323645|NCT00265785|11458829|FG000|NOT COMPLETED|Overall Study||27
10323646|NCT00265850|11458836|FG000|STARTED|Overall Study||899
10323647|NCT00265850|11458837|FG001|STARTED|Overall Study||902
10323648|NCT00265850|11458838|FG002|STARTED|Overall Study||533
10323649|NCT00265850|11458836|FG000|COMPLETED|Overall Study||899
10323650|NCT00265850|11458837|FG001|COMPLETED|Overall Study||902
10323651|NCT00265850|11458838|FG002|COMPLETED|Overall Study||533
10323652|NCT00265850|11458836|FG000|NOT COMPLETED|Overall Study||0
10456010|NCT01005316|11604090|FG002|NOT COMPLETED|Overall Study||11
10803846|NCT04098575|11965310|FG002|NOT COMPLETED|Overall Study||0
10803847|NCT04098458|11965318|FG000|STARTED|Overall Study||18
10803848|NCT04098458|11965318|FG000|COMPLETED|Overall Study||14
10803849|NCT04098458|11965318|FG000|NOT COMPLETED|Overall Study||4
10803850|NCT04095286|11965323|FG000|STARTED|Period 1 (4 Days) + Washout (7days)||4
10803851|NCT04095286|11965324|FG001|STARTED|Period 1 (4 Days) + Washout (7days)||5
10803852|NCT04095286|11965325|FG002|STARTED|Period 1 (4 Days) + Washout (7days)||5
10803853|NCT04095286|11965326|FG003|STARTED|Period 1 (4 Days) + Washout (7days)||5
10803854|NCT04095286|11965327|FG004|STARTED|Period 1 (4 Days) + Washout (7days)||5
10803855|NCT04095286|11965328|FG005|STARTED|Period 1 (4 Days) + Washout (7days)||5
10803856|NCT04095286|11965323|FG000|COMPLETED|Period 1 (4 Days) + Washout (7days)||3
10323653|NCT00265850|11458837|FG001|NOT COMPLETED|Overall Study||0
10323654|NCT00265850|11458838|FG002|NOT COMPLETED|Overall Study||0
10323655|NCT00265889|11458845|FG000|STARTED|Overall Study||42
10323656|NCT00265889|11458845|FG000|Cycle 1: 1st Regimen/Transplant|Overall Study||37
10323657|NCT00265889|11458845|FG000|Cycle 2: 2nd Regimen/Transplant|Overall Study||37
10323658|NCT00265889|11458845|FG000|COMPLETED|Overall Study||37
10323659|NCT00265889|11458845|FG000|NOT COMPLETED|Overall Study||5
10323660|NCT00265980|11458849|FG000|STARTED|Overall Study||22
10323661|NCT00265980|11458849|FG000|Weight Initial|Overall Study||22
10323662|NCT00265980|11458849|FG000|Weight -10% Placebo|Overall Study||22
10323663|NCT00265980|11458849|FG000|Weight -10% Leptin|Overall Study||22
10323664|NCT00265980|11458849|FG000|COMPLETED|Overall Study||22
10323665|NCT00265980|11458849|FG000|NOT COMPLETED|Overall Study||0
10323666|NCT00266032|11458856|FG000|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|691
10323667|NCT00266032|11458857|FG001|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|236
10456011|NCT01005316|11604091|FG003|NOT COMPLETED|Overall Study||108
10456012|NCT01005329|11604102|FG000|STARTED|Overall Study||34
10456013|NCT01005329|11604102|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|30
10456014|NCT01005329|11604102|FG000|NOT COMPLETED|Overall Study||4
10456015|NCT01005355|11604110|FG000|STARTED|Overall Study||3
10456016|NCT01005355|11604111|FG001|STARTED|Overall Study||6
10456017|NCT01005355|11604112|FG002|STARTED|Overall Study||6
10456018|NCT01005355|11604110|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
10456019|NCT01005355|11604111|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
10456020|NCT01005355|11604112|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
10456021|NCT01005355|11604110|FG000|COMPLETED|Overall Study||3
10456022|NCT01005355|11604111|FG001|COMPLETED|Overall Study||6
10456023|NCT01005355|11604112|FG002|COMPLETED|Overall Study||6
10456024|NCT01005355|11604110|FG000|NOT COMPLETED|Overall Study||0
10456025|NCT01005355|11604111|FG001|NOT COMPLETED|Overall Study||0
10456026|NCT01005355|11604112|FG002|NOT COMPLETED|Overall Study||0
10456027|NCT01005407|11604125|FG000|STARTED|Overall Study||1969
10456028|NCT01005407|11604126|FG001|STARTED|Overall Study||483
10456029|NCT01005407|11604125|FG000|COMPLETED|Overall Study||1818
10456030|NCT01005407|11604126|FG001|COMPLETED|Overall Study||451
10456031|NCT01005407|11604125|FG000|NOT COMPLETED|Overall Study||151
10456032|NCT01005407|11604126|FG001|NOT COMPLETED|Overall Study||32
10456033|NCT01005459|11604134|FG000|STARTED|Overall Study||23
10456034|NCT01005459|11604135|FG001|STARTED|Overall Study||23
10456035|NCT01005459|11604134|FG000|COMPLETED|Overall Study||23
10456036|NCT01005459|11604135|FG001|COMPLETED|Overall Study||23
10456037|NCT01005459|11604134|FG000|NOT COMPLETED|Overall Study||0
10456038|NCT01005459|11604135|FG001|NOT COMPLETED|Overall Study||0
10456039|NCT01005576|11604141|FG000|STARTED|Overall Study||21
10456040|NCT01005576|11604141|FG000|COMPLETED|Overall Study|All participants completed the conditioning regimen and received their stem cell transplant|21
10456041|NCT01005576|11604141|FG000|NOT COMPLETED|Overall Study||0
10456042|NCT01005602|11604147|FG000|STARTED|Overall Study||66
10456043|NCT01005602|11604148|FG001|STARTED|Overall Study||66
10456044|NCT01005602|11604147|FG000|COMPLETED|Overall Study|One patient completed the trial but was excluded from data analyses due to unreliable clinical data.|65
10456045|NCT01005602|11604148|FG001|COMPLETED|Overall Study||66
10456046|NCT01005602|11604147|FG000|NOT COMPLETED|Overall Study||1
10456047|NCT01005602|11604148|FG001|NOT COMPLETED|Overall Study||0
10456048|NCT01005680|11604163|FG000|STARTED|Overall Study||126
10456049|NCT01005680|11604164|FG001|STARTED|Overall Study||130
10456050|NCT01005680|11604163|FG000|Received at Least 1 Dose of Study Drug|Overall Study||125
10456051|NCT01005680|11604164|FG001|Received at Least 1 Dose of Study Drug|Overall Study||127
10456052|NCT01005680|11604163|FG000|COMPLETED|Overall Study||120
10456053|NCT01005680|11604164|FG001|COMPLETED|Overall Study||119
10456054|NCT01005680|11604163|FG000|NOT COMPLETED|Overall Study||6
10803857|NCT04095286|11965324|FG001|COMPLETED|Period 1 (4 Days) + Washout (7days)||4
10803858|NCT04095286|11965325|FG002|COMPLETED|Period 1 (4 Days) + Washout (7days)||4
10323668|NCT00266032|11458858|FG002|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|239
10323669|NCT00266032|11458856|FG000|Patients Treated|Treatment||684
10323670|NCT00266032|11458857|FG001|Patients Treated|Treatment||221
10323671|NCT00266032|11458858|FG002|Patients Treated|Treatment||229
10323672|NCT00266032|11458856|FG000|Patients Treated and in FAS|Treatment|FAS|642
10323673|NCT00266032|11458857|FG001|Patients Treated and in FAS|Treatment|FAS|209
10323674|NCT00266032|11458858|FG002|Patients Treated and in FAS|Treatment|FAS|216
10323675|NCT00266032|11458856|FG000|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|580
10323676|NCT00266032|11458857|FG001|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|172
10803859|NCT04095286|11965326|FG003|COMPLETED|Period 1 (4 Days) + Washout (7days)||5
10803860|NCT04095286|11965327|FG004|COMPLETED|Period 1 (4 Days) + Washout (7days)||5
10803861|NCT04095286|11965328|FG005|COMPLETED|Period 1 (4 Days) + Washout (7days)||5
10803862|NCT04095286|11965323|FG000|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||1
10803863|NCT04095286|11965324|FG001|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||1
10323677|NCT00266032|11458858|FG002|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|192
10323678|NCT00266032|11458856|FG000|NOT COMPLETED|Treatment||111
10323679|NCT00266032|11458857|FG001|NOT COMPLETED|Treatment||64
10323680|NCT00266032|11458858|FG002|NOT COMPLETED|Treatment||47
10323681|NCT00266032|11458856|FG000|STARTED|Open-label Safety Extension|treatment for subjects of all 3 treatment groups in 2nd period, except for 28 in subgroups|489
10323682|NCT00266032|11458857|FG001|STARTED|Open-label Safety Extension|7 subjects continued their treatment in second period (safety extension)|129
10323683|NCT00266032|11458858|FG002|STARTED|Open-label Safety Extension|21 subjects continued their treatment in second period (safety extension)|165
10323684|NCT00266032|11458856|FG000|COMPLETED|Open-label Safety Extension||448
10323685|NCT00266032|11458857|FG001|COMPLETED|Open-label Safety Extension||115
10323686|NCT00266032|11458858|FG002|COMPLETED|Open-label Safety Extension||140
10323687|NCT00266032|11458856|FG000|NOT COMPLETED|Open-label Safety Extension||41
10323688|NCT00266032|11458857|FG001|NOT COMPLETED|Open-label Safety Extension||14
10323689|NCT00266032|11458858|FG002|NOT COMPLETED|Open-label Safety Extension||25
10323690|NCT00266110|11458866|FG000|STARTED|Overall Study||17
10323691|NCT00266110|11458866|FG000|COMPLETED|Overall Study||10
10323692|NCT00266110|11458866|FG000|NOT COMPLETED|Overall Study||7
10323693|NCT00266227|11458873|FG000|STARTED|Initial Treatment||0
10323694|NCT00266227|11458874|FG001|STARTED|Initial Treatment||0
10323695|NCT00266227|11458875|FG002|STARTED|Initial Treatment||559
10323696|NCT00266227|11458873|FG000|COMPLETED|Initial Treatment||0
10323697|NCT00266227|11458874|FG001|COMPLETED|Initial Treatment||0
10323698|NCT00266227|11458875|FG002|COMPLETED|Initial Treatment||482
10323699|NCT00266227|11458873|FG000|NOT COMPLETED|Initial Treatment||0
10323700|NCT00266227|11458874|FG001|NOT COMPLETED|Initial Treatment||0
10323701|NCT00266227|11458875|FG002|NOT COMPLETED|Initial Treatment||77
10323702|NCT00266227|11458873|FG000|STARTED|Retreatment: Up to Week 48||318
10323703|NCT00266227|11458874|FG001|STARTED|Retreatment: Up to Week 48||157
10323704|NCT00266227|11458875|FG002|STARTED|Retreatment: Up to Week 48||0
10323705|NCT00266227|11458873|FG000|COMPLETED|Retreatment: Up to Week 48||291
10323706|NCT00266227|11458874|FG001|COMPLETED|Retreatment: Up to Week 48||134
10323707|NCT00266227|11458875|FG002|COMPLETED|Retreatment: Up to Week 48||0
10323708|NCT00266227|11458873|FG000|NOT COMPLETED|Retreatment: Up to Week 48||27
10323709|NCT00266227|11458874|FG001|NOT COMPLETED|Retreatment: Up to Week 48||23
10323710|NCT00266227|11458875|FG002|NOT COMPLETED|Retreatment: Up to Week 48||0
10323711|NCT00266227|11458873|FG000|STARTED|Retreatment: Week 48 to Week 72||291
10323712|NCT00266227|11458874|FG001|STARTED|Retreatment: Week 48 to Week 72||134
10323713|NCT00266227|11458875|FG002|STARTED|Retreatment: Week 48 to Week 72||0
10323714|NCT00266227|11458873|FG000|COMPLETED|Retreatment: Week 48 to Week 72||227
10323715|NCT00266227|11458874|FG001|COMPLETED|Retreatment: Week 48 to Week 72||92
10323716|NCT00266227|11458875|FG002|COMPLETED|Retreatment: Week 48 to Week 72||0
10323717|NCT00266227|11458873|FG000|NOT COMPLETED|Retreatment: Week 48 to Week 72||64
10323718|NCT00266227|11458874|FG001|NOT COMPLETED|Retreatment: Week 48 to Week 72||42
10323719|NCT00266227|11458875|FG002|NOT COMPLETED|Retreatment: Week 48 to Week 72||0
10323720|NCT00266279|11458884|FG000|STARTED|Overall Study||17
10323721|NCT00266279|11458884|FG000|COMPLETED|Overall Study||15
10323722|NCT00266279|11458884|FG000|NOT COMPLETED|Overall Study||2
10323723|NCT00266409|11458893|FG000|STARTED|Overall Study||137
10323724|NCT00266409|11458894|FG001|STARTED|Overall Study||138
10323725|NCT00266409|11458895|FG002|STARTED|Overall Study||72
10323726|NCT00266409|11458896|FG003|STARTED|Overall Study||71
10323727|NCT00266409|11458893|FG000|COMPLETED|Overall Study||92
10323728|NCT00266409|11458894|FG001|COMPLETED|Overall Study||92
10323729|NCT00266409|11458895|FG002|COMPLETED|Overall Study||55
10323730|NCT00266409|11458896|FG003|COMPLETED|Overall Study||49
10323731|NCT00266409|11458893|FG000|NOT COMPLETED|Overall Study||45
10323732|NCT00266409|11458894|FG001|NOT COMPLETED|Overall Study||46
10323733|NCT00266409|11458895|FG002|NOT COMPLETED|Overall Study||17
10323734|NCT00266409|11458896|FG003|NOT COMPLETED|Overall Study||22
10323735|NCT00266630|11458908|FG000|STARTED|Overall Study||100
10323736|NCT00266630|11458909|FG001|STARTED|Overall Study||39
10323737|NCT00266630|11458908|FG000|COMPLETED|Overall Study||58
10323738|NCT00266630|11458909|FG001|COMPLETED|Overall Study||11
10323739|NCT00266630|11458908|FG000|NOT COMPLETED|Overall Study||42
10323740|NCT00266630|11458909|FG001|NOT COMPLETED|Overall Study||28
10323741|NCT00266656|11458919|FG000|STARTED|Overall Study||36
10803864|NCT04095286|11965325|FG002|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||1
10803865|NCT04095286|11965326|FG003|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||0
10323742|NCT00266656|11458920|FG001|STARTED|Overall Study||33
10323743|NCT00266656|11458919|FG000|COMPLETED|Overall Study||22
10323744|NCT00266656|11458920|FG001|COMPLETED|Overall Study||20
10323745|NCT00266656|11458919|FG000|NOT COMPLETED|Overall Study||14
10323746|NCT00266656|11458920|FG001|NOT COMPLETED|Overall Study||13
10323747|NCT00266695|11458926|FG000|STARTED|Overall Study||203
10323748|NCT00266695|11458926|FG000|COMPLETED|Overall Study||174
10323749|NCT00266695|11458926|FG000|NOT COMPLETED|Overall Study||29
10323750|NCT00266708|11458932|FG000|STARTED|Overall Study||20
10323751|NCT00266708|11458933|FG001|STARTED|Overall Study||22
10811057|NCT03781375|11972757|FG001|COMPLETED|Open-label Phase||6
10323752|NCT00266708|11458932|FG000|COMPLETED|Overall Study||16
10323753|NCT00266708|11458933|FG001|COMPLETED|Overall Study||13
10323754|NCT00266708|11458932|FG000|NOT COMPLETED|Overall Study||4
10323755|NCT00266708|11458933|FG001|NOT COMPLETED|Overall Study||9
10323756|NCT00266799|11458941|FG000|STARTED|Overall Study||98
10323757|NCT00266799|11458942|FG001|STARTED|Overall Study||102
10323758|NCT00266799|11458941|FG000|COMPLETED|Overall Study||62
10323759|NCT00266799|11458942|FG001|COMPLETED|Overall Study||68
10323760|NCT00266799|11458941|FG000|NOT COMPLETED|Overall Study||36
10323761|NCT00266799|11458942|FG001|NOT COMPLETED|Overall Study||34
10323762|NCT00266812|11458950|FG000|STARTED|Overall Study||22
10323763|NCT00266812|11458951|FG001|STARTED|Overall Study||13
10323764|NCT00266812|11458950|FG000|COMPLETED|Overall Study||1
10323765|NCT00266812|11458951|FG001|COMPLETED|Overall Study||2
10323766|NCT00266812|11458950|FG000|NOT COMPLETED|Overall Study||21
10323767|NCT00266812|11458951|FG001|NOT COMPLETED|Overall Study||11
10323768|NCT00266825|11458959|FG000|STARTED|Enrolled and Allocated Intervention||172
10323769|NCT00266825|11458960|FG001|STARTED|Enrolled and Allocated Intervention||178
10323770|NCT00266825|11458959|FG000|COMPLETED|Enrolled and Allocated Intervention||172
10323771|NCT00266825|11458960|FG001|COMPLETED|Enrolled and Allocated Intervention||178
10323772|NCT00266825|11458959|FG000|NOT COMPLETED|Enrolled and Allocated Intervention||0
10323773|NCT00266825|11458960|FG001|NOT COMPLETED|Enrolled and Allocated Intervention||0
10323774|NCT00266825|11458959|FG000|STARTED|Completed Follow-Up||172
10323775|NCT00266825|11458960|FG001|STARTED|Completed Follow-Up||178
10323776|NCT00266825|11458959|FG000|COMPLETED|Completed Follow-Up||147
10323777|NCT00266825|11458960|FG001|COMPLETED|Completed Follow-Up||154
10323778|NCT00266825|11458959|FG000|NOT COMPLETED|Completed Follow-Up||25
10323779|NCT00266825|11458960|FG001|NOT COMPLETED|Completed Follow-Up||24
10323780|NCT00266851|11458971|FG000|STARTED|Overall Study||37
10323781|NCT00266851|11458972|FG001|STARTED|Overall Study||38
10323782|NCT00266851|11458973|FG002|STARTED|Overall Study||22
10323783|NCT00266851|11458971|FG000|Completed 3 Month Follow up|Overall Study||26
10323784|NCT00266851|11458972|FG001|Completed 3 Month Follow up|Overall Study||22
10323785|NCT00266851|11458973|FG002|Completed 3 Month Follow up|Overall Study||15
10323786|NCT00266851|11458971|FG000|Completed 6 Month Follow up|Overall Study||27
10323787|NCT00266851|11458972|FG001|Completed 6 Month Follow up|Overall Study||22
10323788|NCT00266851|11458973|FG002|Completed 6 Month Follow up|Overall Study||17
10323789|NCT00266851|11458971|FG000|Completed 9 Month Follow up|Overall Study||22
10323790|NCT00266851|11458972|FG001|Completed 9 Month Follow up|Overall Study||23
10323791|NCT00266851|11458973|FG002|Completed 9 Month Follow up|Overall Study||15
10323792|NCT00266851|11458971|FG000|Completed 12 Month Follow up|Overall Study||25
10323793|NCT00266851|11458972|FG001|Completed 12 Month Follow up|Overall Study||19
10323794|NCT00266851|11458973|FG002|Completed 12 Month Follow up|Overall Study||13
10323795|NCT00266851|11458971|FG000|COMPLETED|Overall Study||37
10323796|NCT00266851|11458972|FG001|COMPLETED|Overall Study||38
10323797|NCT00266851|11458973|FG002|COMPLETED|Overall Study||22
10323798|NCT00266851|11458971|FG000|NOT COMPLETED|Overall Study||0
10323799|NCT00266851|11458972|FG001|NOT COMPLETED|Overall Study||0
10323800|NCT00266851|11458973|FG002|NOT COMPLETED|Overall Study||0
10323801|NCT00266864|11458987|FG000|STARTED|Overall Study||18
10323802|NCT00266864|11458988|FG001|STARTED|Overall Study||13
10323803|NCT00266864|11458987|FG000|COMPLETED|Overall Study||13
10323804|NCT00266864|11458988|FG001|COMPLETED|Overall Study||11
10323805|NCT00266864|11458987|FG000|NOT COMPLETED|Overall Study||5
10323806|NCT00266864|11458988|FG001|NOT COMPLETED|Overall Study||2
10323807|NCT00266877|11458997|FG000|STARTED|Overall Study||91
10323808|NCT00266877|11458998|FG001|STARTED|Overall Study||48
10323809|NCT00266877|11458999|FG002|STARTED|Overall Study||28
10323810|NCT00266877|11458997|FG000|COMPLETED|Overall Study||0
10323811|NCT00266877|11458998|FG001|COMPLETED|Overall Study||0
10323812|NCT00266877|11458999|FG002|COMPLETED|Overall Study||0
10323813|NCT00266877|11458997|FG000|NOT COMPLETED|Overall Study||91
10323814|NCT00266877|11458998|FG001|NOT COMPLETED|Overall Study||48
10323815|NCT00266877|11458999|FG002|NOT COMPLETED|Overall Study||28
10323816|NCT00267007|11459009|FG000|STARTED|Overall Study|2 additional patients were randomized but never received study medication and no data were collected|19
10323817|NCT00267007|11459010|FG001|STARTED|Overall Study||11
10323818|NCT00267007|11459009|FG000|COMPLETED|Overall Study||11
10323819|NCT00267007|11459010|FG001|COMPLETED|Overall Study||10
10323820|NCT00267007|11459009|FG000|NOT COMPLETED|Overall Study||8
10323821|NCT00267007|11459010|FG001|NOT COMPLETED|Overall Study||1
10323822|NCT00267020|11459018|FG000|STARTED|Overall Study||86
10701637|NCT02568683|11866061|FG001|STARTED|Overall Study||4
10701638|NCT02568683|11866060|FG000|COMPLETED|Overall Study||0
10701639|NCT02568683|11866061|FG001|COMPLETED|Overall Study||0
10323823|NCT00267020|11459019|FG001|STARTED|Overall Study||44
10323824|NCT00267020|11459018|FG000|Received at Least 1 Dose|Overall Study||82
10323825|NCT00267020|11459019|FG001|Received at Least 1 Dose|Overall Study||39
10323826|NCT00267020|11459018|FG000|Per-Protocol Population|Overall Study|With: cancer of the pancreas;no other chemotherapy;disease at baseline;received 1 dose of study drug|81
10323827|NCT00267020|11459019|FG001|Per-Protocol Population|Overall Study|With: cancer of the pancreas;no other chemotherapy;disease at baseline;received 1 dose of study drug|38
10323828|NCT00267020|11459018|FG000|COMPLETED|Overall Study||0
10323829|NCT00267020|11459019|FG001|COMPLETED|Overall Study||1
10323830|NCT00267020|11459018|FG000|NOT COMPLETED|Overall Study||86
10323831|NCT00267020|11459019|FG001|NOT COMPLETED|Overall Study||43
10323832|NCT00267046|11459027|FG000|STARTED|Overall Study||32
10323833|NCT00267046|11459028|FG001|STARTED|Overall Study||16
10701640|NCT02568683|11866060|FG000|NOT COMPLETED|Overall Study||6
10323834|NCT00267046|11459027|FG000|COMPLETED|Overall Study||20
10323835|NCT00267046|11459028|FG001|COMPLETED|Overall Study||5
10323836|NCT00267046|11459027|FG000|NOT COMPLETED|Overall Study||12
10323837|NCT00267046|11459028|FG001|NOT COMPLETED|Overall Study||11
10323838|NCT00267059|11459034|FG000|STARTED|Overall Study||44
10323839|NCT00267059|11459034|FG000|COMPLETED|Overall Study||44
10323840|NCT00267059|11459034|FG000|NOT COMPLETED|Overall Study||0
10323841|NCT00267085|11459038|FG000|STARTED|Overall Study||10
10323842|NCT00267085|11459038|FG000|COMPLETED|Overall Study||10
10323843|NCT00267085|11459038|FG000|NOT COMPLETED|Overall Study||0
10323844|NCT00267098|11459050|FG000|STARTED|Overall Study||109
10323845|NCT00267098|11459051|FG001|STARTED|Overall Study||51
10323846|NCT00267098|11459052|FG002|STARTED|Overall Study||243
10323847|NCT00267098|11459053|FG003|STARTED|Overall Study||241
10323848|NCT00267098|11459054|FG004|STARTED|Overall Study||47
10323849|NCT00267098|11459055|FG005|STARTED|Overall Study||106
10323850|NCT00267098|11459056|FG006|STARTED|Overall Study||101
10323851|NCT00267098|11459057|FG007|STARTED|Overall Study||20
10803866|NCT04095286|11965327|FG004|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||0
10803867|NCT04095286|11965328|FG005|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||0
10803868|NCT04095286|11965323|FG000|STARTED|Period 2 (4 Days) + Washout (7days)||3
10323852|NCT00267098|11459050|FG000|COMPLETED|Overall Study||0
10323853|NCT00267098|11459051|FG001|COMPLETED|Overall Study||0
10323854|NCT00267098|11459052|FG002|COMPLETED|Overall Study||149
10323855|NCT00267098|11459053|FG003|COMPLETED|Overall Study||135
10323856|NCT00267098|11459054|FG004|COMPLETED|Overall Study||10
10323857|NCT00267098|11459055|FG005|COMPLETED|Overall Study||66
10323858|NCT00267098|11459056|FG006|COMPLETED|Overall Study||55
10323859|NCT00267098|11459057|FG007|COMPLETED|Overall Study||5
10323860|NCT00267098|11459050|FG000|NOT COMPLETED|Overall Study||109
10323861|NCT00267098|11459051|FG001|NOT COMPLETED|Overall Study||51
10323862|NCT00267098|11459052|FG002|NOT COMPLETED|Overall Study||94
10323863|NCT00267098|11459053|FG003|NOT COMPLETED|Overall Study||106
10323864|NCT00267098|11459054|FG004|NOT COMPLETED|Overall Study||37
10323865|NCT00267098|11459055|FG005|NOT COMPLETED|Overall Study||40
10323866|NCT00267098|11459056|FG006|NOT COMPLETED|Overall Study||46
10323867|NCT00267098|11459057|FG007|NOT COMPLETED|Overall Study||15
10323868|NCT00267111|11459082|FG000|STARTED|Overall Study||55
10323869|NCT00267111|11459083|FG001|STARTED|Overall Study||55
10323870|NCT00267111|11459082|FG000|COMPLETED|Overall Study||55
10323871|NCT00267111|11459083|FG001|COMPLETED|Overall Study||55
10323872|NCT00267111|11459082|FG000|NOT COMPLETED|Overall Study||0
10323873|NCT00267111|11459083|FG001|NOT COMPLETED|Overall Study||0
10323874|NCT00267150|11459090|FG000|STARTED|Overall Study||31
10323875|NCT00267150|11459090|FG000|COMPLETED|Overall Study||30
10323876|NCT00267150|11459090|FG000|NOT COMPLETED|Overall Study||1
10323877|NCT00267189|11459096|FG000|STARTED|Overall Study|Intention to treat (ITT) population.|72
10323878|NCT00267189|11459097|FG001|STARTED|Overall Study||73
10323879|NCT00267189|11459096|FG000|Completed Study Medication|Overall Study||54
10323880|NCT00267189|11459097|FG001|Completed Study Medication|Overall Study||72
10323881|NCT00267189|11459096|FG000|COMPLETED|Overall Study|"Completed indicates completed study."|67
10803869|NCT04095286|11965324|FG001|STARTED|Period 2 (4 Days) + Washout (7days)||4
10803870|NCT04095286|11965325|FG002|STARTED|Period 2 (4 Days) + Washout (7days)||4
10323882|NCT00267189|11459097|FG001|COMPLETED|Overall Study||72
10323883|NCT00267189|11459096|FG000|NOT COMPLETED|Overall Study||5
10323884|NCT00267189|11459097|FG001|NOT COMPLETED|Overall Study||1
10323885|NCT00267202|11459105|FG000|STARTED|Overall Study||136
10323886|NCT00267202|11459106|FG001|STARTED|Overall Study||139
10323887|NCT00267202|11459105|FG000|COMPLETED|Overall Study||83
10323888|NCT00267202|11459106|FG001|COMPLETED|Overall Study||105
10323889|NCT00267202|11459105|FG000|NOT COMPLETED|Overall Study||53
10323890|NCT00267202|11459106|FG001|NOT COMPLETED|Overall Study||34
10323891|NCT00267293|11459116|FG000|STARTED|Overall Study||20
10323892|NCT00267293|11459117|FG001|STARTED|Overall Study||20
10323893|NCT00267293|11459118|FG002|STARTED|Overall Study||20
10323894|NCT00267293|11459116|FG000|COMPLETED|Overall Study||20
10323895|NCT00267293|11459117|FG001|COMPLETED|Overall Study||20
10323896|NCT00267293|11459118|FG002|COMPLETED|Overall Study||20
10323897|NCT00267293|11459116|FG000|NOT COMPLETED|Overall Study||0
10323898|NCT00267293|11459117|FG001|NOT COMPLETED|Overall Study||0
10323899|NCT00267293|11459118|FG002|NOT COMPLETED|Overall Study||0
10323900|NCT00267488|11459126|FG000|STARTED|Overall Study||37
10323901|NCT00267488|11459126|FG000|COMPLETED|Overall Study||26
10323902|NCT00267488|11459126|FG000|NOT COMPLETED|Overall Study||11
10803871|NCT04095286|11965326|FG003|STARTED|Period 2 (4 Days) + Washout (7days)||5
10803872|NCT04095286|11965327|FG004|STARTED|Period 2 (4 Days) + Washout (7days)||5
10323903|NCT00267631|11459132|FG000|STARTED|Overall Study||2361
10323904|NCT00267631|11459133|FG001|STARTED|Overall Study||3031
10323905|NCT00267631|11459132|FG000|COMPLETED|Overall Study||2361
10323906|NCT00267631|11459133|FG001|COMPLETED|Overall Study||3031
10323907|NCT00267631|11459132|FG000|NOT COMPLETED|Overall Study||0
10323908|NCT00267631|11459133|FG001|NOT COMPLETED|Overall Study||0
10323909|NCT00267644|11459141|FG000|STARTED|Overall Study||13
10323910|NCT00267644|11459142|FG001|STARTED|Overall Study||63
10323911|NCT00267644|11459141|FG000|COMPLETED|Overall Study||13
10323912|NCT00267644|11459142|FG001|COMPLETED|Overall Study||63
10323913|NCT00267644|11459141|FG000|NOT COMPLETED|Overall Study||0
10323914|NCT00267644|11459142|FG001|NOT COMPLETED|Overall Study||0
10323915|NCT00267670|11459152|FG000|STARTED|Overall Study||19
10323916|NCT00267670|11459153|FG001|STARTED|Overall Study||7
10323917|NCT00267670|11459152|FG000|COMPLETED|Overall Study||15
10323918|NCT00267670|11459153|FG001|COMPLETED|Overall Study||7
10323919|NCT00267670|11459152|FG000|NOT COMPLETED|Overall Study||4
10323920|NCT00267670|11459153|FG001|NOT COMPLETED|Overall Study||0
10323921|NCT00267696|11459160|FG000|STARTED|Overall Study||45
10323922|NCT00267696|11459160|FG000|COMPLETED|Overall Study||45
10323923|NCT00267696|11459160|FG000|NOT COMPLETED|Overall Study||0
10323924|NCT00267748|11459167|FG000|STARTED|Non-randomized Period||25
10323925|NCT00267748|11459168|FG001|STARTED|Non-randomized Period||0
10323926|NCT00267748|11459169|FG002|STARTED|Non-randomized Period||0
10323927|NCT00267748|11459167|FG000|COMPLETED|Non-randomized Period||2
10323928|NCT00267748|11459168|FG001|COMPLETED|Non-randomized Period||0
10323929|NCT00267748|11459169|FG002|COMPLETED|Non-randomized Period||0
10323930|NCT00267748|11459167|FG000|NOT COMPLETED|Non-randomized Period||23
10323931|NCT00267748|11459168|FG001|NOT COMPLETED|Non-randomized Period||0
10323932|NCT00267748|11459169|FG002|NOT COMPLETED|Non-randomized Period||0
10323933|NCT00267748|11459167|FG000|STARTED|Randomized Period||0
10323934|NCT00267748|11459168|FG001|STARTED|Randomized Period||146
10323935|NCT00267748|11459169|FG002|STARTED|Randomized Period||146
10323936|NCT00267748|11459167|FG000|Treated|Randomized Period||0
10323937|NCT00267748|11459168|FG001|Treated|Randomized Period||146
10323938|NCT00267748|11459169|FG002|Treated|Randomized Period||143
10323939|NCT00267748|11459167|FG000|COMPLETED|Randomized Period||0
10323940|NCT00267748|11459168|FG001|COMPLETED|Randomized Period||19
10323941|NCT00267748|11459169|FG002|COMPLETED|Randomized Period||14
10323942|NCT00267748|11459167|FG000|NOT COMPLETED|Randomized Period||0
10323943|NCT00267748|11459168|FG001|NOT COMPLETED|Randomized Period||127
10323944|NCT00267748|11459169|FG002|NOT COMPLETED|Randomized Period||132
10323945|NCT00267774|11459178|FG000|STARTED|Overall Study||509
10323946|NCT00267774|11459179|FG001|STARTED|Overall Study||496
10323947|NCT00267774|11459178|FG000|COMPLETED|Overall Study||509
10323948|NCT00267774|11459179|FG001|COMPLETED|Overall Study||496
10323949|NCT00267774|11459178|FG000|NOT COMPLETED|Overall Study||0
10323950|NCT00267774|11459179|FG001|NOT COMPLETED|Overall Study||0
10323951|NCT00267865|11459185|FG000|STARTED|Induction Treatment||12
10323952|NCT00267865|11459185|FG000|COMPLETED|Induction Treatment||9
10323953|NCT00267865|11459185|FG000|NOT COMPLETED|Induction Treatment||3
10323954|NCT00267865|11459185|FG000|STARTED|Consolidation Treatment||5
10323955|NCT00267865|11459185|FG000|COMPLETED|Consolidation Treatment||5
10323956|NCT00267865|11459185|FG000|NOT COMPLETED|Consolidation Treatment||0
10323957|NCT00267956|11459191|FG000|STARTED|Controlled Period||70
10323958|NCT00267956|11459192|FG001|STARTED|Controlled Period||76
10323959|NCT00267956|11459193|FG002|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
10323960|NCT00267956|11459194|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
10323961|NCT00267956|11459191|FG000|COMPLETED|Controlled Period||57
10323962|NCT00267956|11459192|FG001|COMPLETED|Controlled Period||72
10323963|NCT00267956|11459193|FG002|COMPLETED|Controlled Period||0
10323964|NCT00267956|11459194|FG003|COMPLETED|Controlled Period||0
10323965|NCT00267956|11459191|FG000|NOT COMPLETED|Controlled Period||13
10323966|NCT00267956|11459192|FG001|NOT COMPLETED|Controlled Period||4
10323967|NCT00267956|11459193|FG002|NOT COMPLETED|Controlled Period||0
10323968|NCT00267956|11459194|FG003|NOT COMPLETED|Controlled Period||0
10323969|NCT00267956|11459191|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
10323970|NCT00267956|11459192|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
10323971|NCT00267956|11459193|FG002|STARTED|After Controlled Period||57
10323972|NCT00267956|11459194|FG003|STARTED|After Controlled Period||72
10323973|NCT00267956|11459191|FG000|COMPLETED|After Controlled Period||0
10323974|NCT00267956|11459192|FG001|COMPLETED|After Controlled Period||0
10323975|NCT00267956|11459193|FG002|COMPLETED|After Controlled Period||52
10323976|NCT00267956|11459194|FG003|COMPLETED|After Controlled Period||70
10323977|NCT00267956|11459191|FG000|NOT COMPLETED|After Controlled Period||0
10323978|NCT00267956|11459192|FG001|NOT COMPLETED|After Controlled Period||0
10323979|NCT00267956|11459193|FG002|NOT COMPLETED|After Controlled Period||5
10323980|NCT00267956|11459194|FG003|NOT COMPLETED|After Controlled Period||2
10323981|NCT00267969|11459205|FG000|STARTED|Controlled Period|Number of patients randomized|255
10323982|NCT00267969|11459206|FG001|STARTED|Controlled Period|Number of patients randomized|255
10323983|NCT00267969|11459207|FG002|STARTED|Controlled Period|Number of patients randomized|256
10323984|NCT00267969|11459208|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
10323985|NCT00267969|11459209|FG004|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
10323986|NCT00267969|11459210|FG005|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
10323987|NCT00267969|11459211|FG006|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
10323988|NCT00267969|11459205|FG000|COMPLETED|Controlled Period||243
10323989|NCT00267969|11459206|FG001|COMPLETED|Controlled Period||254
10323990|NCT00267969|11459207|FG002|COMPLETED|Controlled Period||245
10323991|NCT00267969|11459208|FG003|COMPLETED|Controlled Period||0
10323992|NCT00267969|11459209|FG004|COMPLETED|Controlled Period||0
10323993|NCT00267969|11459210|FG005|COMPLETED|Controlled Period||0
10323994|NCT00267969|11459211|FG006|COMPLETED|Controlled Period||0
10323995|NCT00267969|11459205|FG000|NOT COMPLETED|Controlled Period||12
10323996|NCT00267969|11459206|FG001|NOT COMPLETED|Controlled Period||1
10323997|NCT00267969|11459207|FG002|NOT COMPLETED|Controlled Period||11
10323998|NCT00267969|11459208|FG003|NOT COMPLETED|Controlled Period||0
10323999|NCT00267969|11459209|FG004|NOT COMPLETED|Controlled Period||0
10324000|NCT00267969|11459210|FG005|NOT COMPLETED|Controlled Period||0
10324001|NCT00267969|11459211|FG006|NOT COMPLETED|Controlled Period||0
10324002|NCT00267969|11459205|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
10324003|NCT00267969|11459206|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
10324004|NCT00267969|11459207|FG002|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
10324005|NCT00267969|11459208|FG003|STARTED|After Controlled Period||123
10324006|NCT00267969|11459209|FG004|STARTED|After Controlled Period||120
10324007|NCT00267969|11459210|FG005|STARTED|After Controlled Period||254
10324008|NCT00267969|11459211|FG006|STARTED|After Controlled Period||245
10324009|NCT00267969|11459205|FG000|COMPLETED|After Controlled Period||0
10324010|NCT00267969|11459206|FG001|COMPLETED|After Controlled Period||0
10324011|NCT00267969|11459207|FG002|COMPLETED|After Controlled Period||0
10324012|NCT00267969|11459208|FG003|COMPLETED|After Controlled Period||87
10324013|NCT00267969|11459209|FG004|COMPLETED|After Controlled Period||85
10324014|NCT00267969|11459210|FG005|COMPLETED|After Controlled Period||172
10324015|NCT00267969|11459211|FG006|COMPLETED|After Controlled Period||173
10324016|NCT00267969|11459205|FG000|NOT COMPLETED|After Controlled Period||0
10324017|NCT00267969|11459206|FG001|NOT COMPLETED|After Controlled Period||0
10324018|NCT00267969|11459207|FG002|NOT COMPLETED|After Controlled Period||0
10324019|NCT00267969|11459208|FG003|NOT COMPLETED|After Controlled Period||36
10324020|NCT00267969|11459209|FG004|NOT COMPLETED|After Controlled Period||35
10324021|NCT00267969|11459210|FG005|NOT COMPLETED|After Controlled Period||82
10324022|NCT00267969|11459211|FG006|NOT COMPLETED|After Controlled Period||72
10324023|NCT00268203|11459229|FG000|STARTED|Overall Study||765
10324024|NCT00268203|11459229|FG000|Completed 2 Years of Follow-up|Overall Study||62
10324025|NCT00268203|11459229|FG000|COMPLETED|Overall Study|These participants completed 10 years of follow-up.|118
10324026|NCT00268203|11459229|FG000|NOT COMPLETED|Overall Study||647
10324027|NCT00268242|11459233|FG000|STARTED|Overall Study||24
10324028|NCT00268242|11459233|FG000|COMPLETED|Overall Study||23
10324029|NCT00268242|11459233|FG000|NOT COMPLETED|Overall Study||1
10324030|NCT00268346|11459239|FG000|STARTED|Overall Study||18
10324031|NCT00268346|11459240|FG001|STARTED|Overall Study||40
10324032|NCT00268346|11459239|FG000|Started Treatment|Overall Study||18
10324033|NCT00268346|11459240|FG001|Started Treatment|Overall Study||40
10324034|NCT00268346|11459239|FG000|COMPLETED|Overall Study||18
10324035|NCT00268346|11459240|FG001|COMPLETED|Overall Study||37
10324036|NCT00268346|11459239|FG000|NOT COMPLETED|Overall Study||0
10324037|NCT00268346|11459240|FG001|NOT COMPLETED|Overall Study||3
10324038|NCT00268437|11459246|FG000|STARTED|Overall Study||27
10324039|NCT00268437|11459246|FG000|COMPLETED|Overall Study||26
10324040|NCT00268437|11459246|FG000|NOT COMPLETED|Overall Study||1
10324041|NCT00268762|11459251|FG000|STARTED|Overall Study||65
10324042|NCT00268762|11459251|FG000|COMPLETED|Overall Study||65
10324043|NCT00268762|11459251|FG000|NOT COMPLETED|Overall Study||0
10324044|NCT00268892|11459258|FG000|STARTED|Overall Study||90
10324045|NCT00268892|11459259|FG001|STARTED|Overall Study||95
10324046|NCT00268892|11459260|FG002|STARTED|Overall Study||93
10324047|NCT00268892|11459258|FG000|Switched to Higher Dose|Overall Study||59
10324048|NCT00268892|11459259|FG001|Switched to Higher Dose|Overall Study||68
10324049|NCT00268892|11459260|FG002|Switched to Higher Dose|Overall Study||76
10324050|NCT00268892|11459258|FG000|COMPLETED|Overall Study||51
10324051|NCT00268892|11459259|FG001|COMPLETED|Overall Study||53
10324052|NCT00268892|11459260|FG002|COMPLETED|Overall Study||54
10324053|NCT00268892|11459258|FG000|NOT COMPLETED|Overall Study||39
10324054|NCT00268892|11459259|FG001|NOT COMPLETED|Overall Study||42
10324055|NCT00268892|11459260|FG002|NOT COMPLETED|Overall Study||39
10324056|NCT00268905|11459271|FG000|STARTED|Overall Study||43
10324057|NCT00268905|11459272|FG001|STARTED|Overall Study||9
10324058|NCT00268905|11459273|FG002|STARTED|Overall Study||12
10324059|NCT00268905|11459271|FG000|COMPLETED|Overall Study||0
10324060|NCT00268905|11459272|FG001|COMPLETED|Overall Study||0
10324061|NCT00268905|11459273|FG002|COMPLETED|Overall Study||0
10324062|NCT00268905|11459271|FG000|NOT COMPLETED|Overall Study||43
10324063|NCT00268905|11459272|FG001|NOT COMPLETED|Overall Study||9
10324064|NCT00268905|11459273|FG002|NOT COMPLETED|Overall Study||12
10324065|NCT00268983|11459283|FG000|STARTED|Overall Study||6
10324066|NCT00268983|11459284|FG001|STARTED|Overall Study||8
10324067|NCT00268983|11459283|FG000|COMPLETED|Overall Study||3
10324068|NCT00268983|11459284|FG001|COMPLETED|Overall Study||8
10324069|NCT00268983|11459283|FG000|NOT COMPLETED|Overall Study||3
10324070|NCT00268983|11459284|FG001|NOT COMPLETED|Overall Study||0
10324071|NCT00268996|11459292|FG000|STARTED|Overall Study||151
10324072|NCT00268996|11459293|FG001|STARTED|Overall Study||172
10324073|NCT00268996|11459292|FG000|COMPLETED|Overall Study||130
10324074|NCT00268996|11459293|FG001|COMPLETED|Overall Study||152
10324075|NCT00268996|11459292|FG000|NOT COMPLETED|Overall Study||21
10324076|NCT00268996|11459293|FG001|NOT COMPLETED|Overall Study||20
10324077|NCT00269087|11459301|FG000|STARTED|Overall Study||122
10324078|NCT00269087|11459301|FG000|COMPLETED|Overall Study||88
10324079|NCT00269087|11459301|FG000|NOT COMPLETED|Overall Study||34
10324080|NCT00269113|11459307|FG000|STARTED|Overall Study||177
10324081|NCT00269113|11459308|FG001|STARTED|Overall Study||183
10324082|NCT00269113|11459307|FG000|COMPLETED|Overall Study||103
10324083|NCT00269113|11459308|FG001|COMPLETED|Overall Study||146
10324084|NCT00269113|11459307|FG000|NOT COMPLETED|Overall Study||74
10324085|NCT00269113|11459308|FG001|NOT COMPLETED|Overall Study||37
10324086|NCT00269152|11459316|FG000|STARTED|Overall Study|One participant in Pemetrexed+Carboplatin actually received Pemetrexed+Cisplatin|63
10324087|NCT00269152|11459317|FG001|STARTED|Overall Study|4 were randomized without receiving any study drug.|59
10324088|NCT00269152|11459316|FG000|COMPLETED|Overall Study||45
10324089|NCT00269152|11459317|FG001|COMPLETED|Overall Study||49
10324090|NCT00269152|11459316|FG000|NOT COMPLETED|Overall Study||18
10324091|NCT00269152|11459317|FG001|NOT COMPLETED|Overall Study||10
10324092|NCT00269399|11459325|FG000|STARTED|Overall Study||119
10324093|NCT00269399|11459326|FG001|STARTED|Overall Study||118
10324094|NCT00269399|11459325|FG000|COMPLETED|Overall Study||78
10324095|NCT00269399|11459326|FG001|COMPLETED|Overall Study||91
10324096|NCT00269399|11459325|FG000|NOT COMPLETED|Overall Study||41
10324097|NCT00269399|11459326|FG001|NOT COMPLETED|Overall Study||27
10324098|NCT00269477|11459336|FG000|STARTED|Overall Study||9
10324099|NCT00269477|11459337|FG001|STARTED|Overall Study||18
10324100|NCT00269477|11459338|FG002|STARTED|Overall Study||58
10324101|NCT00269477|11459339|FG003|STARTED|Overall Study||60
10324102|NCT00269477|11459336|FG000|COMPLETED|Overall Study||4
10324103|NCT00269477|11459337|FG001|COMPLETED|Overall Study||12
10324104|NCT00269477|11459338|FG002|COMPLETED|Overall Study||57
10324105|NCT00269477|11459339|FG003|COMPLETED|Overall Study||60
10324106|NCT00269477|11459336|FG000|NOT COMPLETED|Overall Study||5
10324107|NCT00269477|11459337|FG001|NOT COMPLETED|Overall Study||6
10324108|NCT00269477|11459338|FG002|NOT COMPLETED|Overall Study||1
10324109|NCT00269477|11459339|FG003|NOT COMPLETED|Overall Study||0
10324110|NCT00269633|11459351|FG000|STARTED|Overall Study||4
10324111|NCT00269633|11459352|FG001|STARTED|Overall Study||5
10324112|NCT00269633|11459351|FG000|COMPLETED|Overall Study||3
10324113|NCT00269633|11459352|FG001|COMPLETED|Overall Study||5
10324114|NCT00269633|11459351|FG000|NOT COMPLETED|Overall Study||1
10324115|NCT00269633|11459352|FG001|NOT COMPLETED|Overall Study||0
10324116|NCT00269919|11459358|FG000|STARTED|Overall Study||40
10324117|NCT00269919|11459358|FG000|Treated|Overall Study||39
10324118|NCT00269919|11459358|FG000|COMPLETED|Overall Study||13
10324119|NCT00269919|11459358|FG000|NOT COMPLETED|Overall Study||27
10324120|NCT00270205|11459367|FG000|STARTED|Overall Study||6
10324121|NCT00270205|11459368|FG001|STARTED|Overall Study|7 participants enrolled. One never started study vaccination and was excluded from all analyses.|6
10324122|NCT00270205|11459369|FG002|STARTED|Overall Study||6
10324123|NCT00270205|11459370|FG003|STARTED|Overall Study||7
10324124|NCT00270205|11459367|FG000|COMPLETED|Overall Study||5
10324125|NCT00270205|11459368|FG001|COMPLETED|Overall Study||6
10324126|NCT00270205|11459369|FG002|COMPLETED|Overall Study||6
10324127|NCT00270205|11459370|FG003|COMPLETED|Overall Study||6
10324128|NCT00270205|11459367|FG000|NOT COMPLETED|Overall Study||1
10324129|NCT00270205|11459368|FG001|NOT COMPLETED|Overall Study||0
10324130|NCT00270205|11459369|FG002|NOT COMPLETED|Overall Study||0
10324131|NCT00270205|11459370|FG003|NOT COMPLETED|Overall Study||1
10324132|NCT00270231|11459380|FG000|STARTED|First Intervention||32
10324133|NCT00270231|11459381|FG001|STARTED|First Intervention||32
10324134|NCT00270231|11459380|FG000|COMPLETED|First Intervention||31
10324135|NCT00270231|11459381|FG001|COMPLETED|First Intervention||31
10324136|NCT00270231|11459380|FG000|NOT COMPLETED|First Intervention||1
10324137|NCT00270231|11459381|FG001|NOT COMPLETED|First Intervention||1
10324138|NCT00270231|11459380|FG000|STARTED|Washout Period||31
10324139|NCT00270231|11459381|FG001|STARTED|Washout Period||31
10324140|NCT00270231|11459380|FG000|COMPLETED|Washout Period||30
10324141|NCT00270231|11459381|FG001|COMPLETED|Washout Period||31
10324142|NCT00270231|11459380|FG000|NOT COMPLETED|Washout Period||1
10324143|NCT00270231|11459381|FG001|NOT COMPLETED|Washout Period||0
10324144|NCT00270231|11459380|FG000|STARTED|Second Intervention||30
10324145|NCT00270231|11459381|FG001|STARTED|Second Intervention||31
10324146|NCT00270231|11459380|FG000|COMPLETED|Second Intervention||30
10324147|NCT00270231|11459381|FG001|COMPLETED|Second Intervention||30
10324148|NCT00270231|11459380|FG000|NOT COMPLETED|Second Intervention||0
10324149|NCT00270231|11459381|FG001|NOT COMPLETED|Second Intervention||1
10324150|NCT00270257|11459389|FG000|STARTED|Overall Study||623
10324151|NCT00270257|11459390|FG001|STARTED|Overall Study|1 excluded from analysis (enrollment date exceeded eligibility window by 13 days)|628
10324152|NCT00270257|11459389|FG000|Week 8|Overall Study||510
10324153|NCT00270257|11459390|FG001|Week 8|Overall Study||443
10324154|NCT00270257|11459389|FG000|Week 26|Overall Study||460
10324155|NCT00270257|11459390|FG001|Week 26|Overall Study||440
10324156|NCT00270257|11459389|FG000|Week 52|Overall Study||362
10324157|NCT00270257|11459390|FG001|Week 52|Overall Study||340
10324158|NCT00270257|11459389|FG000|Week 78|Overall Study||283
10324159|NCT00270257|11459390|FG001|Week 78|Overall Study||285
10324160|NCT00270257|11459389|FG000|Visit 104|Overall Study||211
10324161|NCT00270257|11459390|FG001|Visit 104|Overall Study||204
10324162|NCT00270257|11459389|FG000|COMPLETED|Overall Study||211
10324163|NCT00270257|11459390|FG001|COMPLETED|Overall Study||204
10324164|NCT00270257|11459389|FG000|NOT COMPLETED|Overall Study||412
10324165|NCT00270257|11459390|FG001|NOT COMPLETED|Overall Study||424
10324166|NCT00270296|11459401|FG000|STARTED|Overall Study||285
10324167|NCT00270296|11459402|FG001|STARTED|Overall Study||275
10324168|NCT00270296|11459403|FG002|STARTED|Overall Study||170
10324169|NCT00270296|11459401|FG000|COMPLETED|Overall Study||186
10324170|NCT00270296|11459402|FG001|COMPLETED|Overall Study||185
10324171|NCT00270296|11459403|FG002|COMPLETED|Overall Study||109
10324172|NCT00270296|11459401|FG000|NOT COMPLETED|Overall Study||99
10324173|NCT00270296|11459402|FG001|NOT COMPLETED|Overall Study||90
10324174|NCT00270296|11459403|FG002|NOT COMPLETED|Overall Study||61
10324175|NCT00270634|11459415|FG000|STARTED|Overall Study||87
10324176|NCT00270634|11459416|FG001|STARTED|Overall Study||77
10324177|NCT00270634|11459417|FG002|STARTED|Overall Study||84
10324178|NCT00270634|11459418|FG003|STARTED|Overall Study||86
10324179|NCT00270634|11459415|FG000|COMPLETED|Overall Study||70
10324180|NCT00270634|11459416|FG001|COMPLETED|Overall Study||64
10324181|NCT00270634|11459417|FG002|COMPLETED|Overall Study||62
10324182|NCT00270634|11459418|FG003|COMPLETED|Overall Study||81
10324183|NCT00270634|11459415|FG000|NOT COMPLETED|Overall Study||17
10324184|NCT00270634|11459416|FG001|NOT COMPLETED|Overall Study||13
10324185|NCT00270634|11459417|FG002|NOT COMPLETED|Overall Study||22
10324186|NCT00270634|11459418|FG003|NOT COMPLETED|Overall Study||5
10324187|NCT00270790|11459432|FG000|STARTED|Overall Study||21
10324188|NCT00270790|11459432|FG000|COMPLETED|Overall Study||16
10324189|NCT00270790|11459432|FG000|NOT COMPLETED|Overall Study||5
10324190|NCT00270842|11459439|FG000|STARTED|Overall Study||33
10324191|NCT00270842|11459440|FG001|STARTED|Overall Study||34
10324192|NCT00270842|11459441|FG002|STARTED|Overall Study||34
10324193|NCT00270842|11459439|FG000|COMPLETED|Overall Study||18
10324194|NCT00270842|11459440|FG001|COMPLETED|Overall Study||18
10324195|NCT00270842|11459441|FG002|COMPLETED|Overall Study||18
10324196|NCT00270842|11459439|FG000|NOT COMPLETED|Overall Study||15
10324197|NCT00270842|11459440|FG001|NOT COMPLETED|Overall Study||16
10324198|NCT00270842|11459441|FG002|NOT COMPLETED|Overall Study||16
10324199|NCT00270855|11459451|FG000|STARTED|Overall Study||15
10324200|NCT00270855|11459452|FG001|STARTED|Overall Study||14
10324201|NCT00270855|11459451|FG000|COMPLETED|Overall Study||7
10324202|NCT00270855|11459452|FG001|COMPLETED|Overall Study||6
10324203|NCT00270855|11459451|FG000|NOT COMPLETED|Overall Study||8
10324204|NCT00270855|11459452|FG001|NOT COMPLETED|Overall Study||8
10324205|NCT00270894|11459460|FG000|STARTED|Overall Study||30
10324206|NCT00270894|11459460|FG000|COMPLETED|Overall Study||28
10324207|NCT00270894|11459460|FG000|NOT COMPLETED|Overall Study||2
10324208|NCT00270998|11459467|FG000|STARTED|3 Month Follow-up||149
10324209|NCT00270998|11459468|FG001|STARTED|3 Month Follow-up||146
10324210|NCT00270998|11459469|FG002|STARTED|3 Month Follow-up|1 participant randomized to combined found ineligible at first treatment visit, removed from study.|150
10324211|NCT00270998|11459467|FG000|COMPLETED|3 Month Follow-up||110
10324212|NCT00270998|11459468|FG001|COMPLETED|3 Month Follow-up||124
10324213|NCT00270998|11459469|FG002|COMPLETED|3 Month Follow-up||132
10324214|NCT00270998|11459467|FG000|NOT COMPLETED|3 Month Follow-up||39
10324215|NCT00270998|11459468|FG001|NOT COMPLETED|3 Month Follow-up||22
10324216|NCT00270998|11459469|FG002|NOT COMPLETED|3 Month Follow-up||18
10324217|NCT00270998|11459467|FG000|STARTED|12 Month Follow-up||110
10324218|NCT00270998|11459468|FG001|STARTED|12 Month Follow-up||124
10324219|NCT00270998|11459469|FG002|STARTED|12 Month Follow-up||132
10324220|NCT00270998|11459467|FG000|COMPLETED|12 Month Follow-up||96
10324221|NCT00270998|11459468|FG001|COMPLETED|12 Month Follow-up||99
10324222|NCT00270998|11459469|FG002|COMPLETED|12 Month Follow-up||111
10324223|NCT00270998|11459467|FG000|NOT COMPLETED|12 Month Follow-up||14
10324224|NCT00270998|11459468|FG001|NOT COMPLETED|12 Month Follow-up||25
10324225|NCT00270998|11459469|FG002|NOT COMPLETED|12 Month Follow-up||21
10324226|NCT00271024|11459483|FG000|STARTED|Overall Study||80
10324227|NCT00271024|11459484|FG001|STARTED|Overall Study||77
10324228|NCT00271024|11459485|FG002|STARTED|Overall Study||88
10324229|NCT00271024|11459486|FG003|STARTED|Overall Study||88
10324230|NCT00271024|11459483|FG000|Received Study Treatment|Overall Study|n=4 did not start treatment (3 lost interest, 1 unknown)|76
10324231|NCT00271024|11459484|FG001|Received Study Treatment|Overall Study|n=6 did not start treatment (1 diff treat. desired, 3 lost interest, 1 began psych meds, 1 unknown)|71
10324232|NCT00271024|11459485|FG002|Received Study Treatment|Overall Study|n=3 did not start treatment (2 lost interest, 1 unknown)|85
10324233|NCT00271024|11459486|FG003|Received Study Treatment|Overall Study|n=5 did not start treatment (2 health problems, 1 wanted diff. treatment method, 2 lost interest)|83
10324234|NCT00271024|11459483|FG000|COMPLETED|Overall Study|Discontinued: 1 smoking related, 1 reaction to tablet, 6 time commitment, 2 other, 8 unspecified|58
10324235|NCT00271024|11459484|FG001|COMPLETED|Overall Study|Discontinued: 5 smoking related, 3 reaction to tablet, 2 time commitment, 1 other, 9 unspecified|51
10324236|NCT00271024|11459485|FG002|COMPLETED|Overall Study|Discontinued: 5 smoking related, 4 reaction to tablet, 4 time commitment, 3 other, 4 unspecified|65
10324237|NCT00271024|11459486|FG003|COMPLETED|Overall Study|Discontinued: 9 smoking related, 2 reaction to tablet, 4 time commitment, 1 other, 3 unspecified|64
10324238|NCT00271024|11459483|FG000|NOT COMPLETED|Overall Study||22
10324239|NCT00271024|11459484|FG001|NOT COMPLETED|Overall Study||26
10324240|NCT00271024|11459485|FG002|NOT COMPLETED|Overall Study||23
10324241|NCT00271024|11459486|FG003|NOT COMPLETED|Overall Study||24
10324242|NCT00271154|11459498|FG000|STARTED|Overall Study||191
10324243|NCT00271154|11459499|FG001|STARTED|Overall Study||419
10324244|NCT00271154|11459498|FG000|COMPLETED|Overall Study||191
10324245|NCT00271154|11459499|FG001|COMPLETED|Overall Study||419
10324246|NCT00271154|11459498|FG000|NOT COMPLETED|Overall Study||0
10324247|NCT00271154|11459499|FG001|NOT COMPLETED|Overall Study||0
10324248|NCT00271219|11459508|FG000|STARTED|Overall Study||89
10324249|NCT00271219|11459509|FG001|STARTED|Overall Study||86
10324250|NCT00271219|11459508|FG000|COMPLETED|Overall Study||73
10324251|NCT00271219|11459509|FG001|COMPLETED|Overall Study||58
10324252|NCT00271219|11459508|FG000|NOT COMPLETED|Overall Study||16
10324253|NCT00271219|11459509|FG001|NOT COMPLETED|Overall Study||28
10324254|NCT00271375|11459522|FG000|STARTED|Overall Study||114
10324255|NCT00271375|11459523|FG001|STARTED|Overall Study||83
10324256|NCT00271375|11459524|FG002|STARTED|Overall Study||57
10324257|NCT00271375|11459522|FG000|COMPLETED|Overall Study||114
10324258|NCT00271375|11459523|FG001|COMPLETED|Overall Study||83
10324259|NCT00271375|11459524|FG002|COMPLETED|Overall Study||57
10324260|NCT00271375|11459522|FG000|NOT COMPLETED|Overall Study||0
10324261|NCT00271375|11459523|FG001|NOT COMPLETED|Overall Study||0
10324262|NCT00271375|11459524|FG002|NOT COMPLETED|Overall Study||0
10324263|NCT00271505|11459533|FG000|STARTED|Overall Study||43
10324264|NCT00271505|11459533|FG000|COMPLETED|Overall Study||38
10324265|NCT00271505|11459533|FG000|NOT COMPLETED|Overall Study||5
10324266|NCT00271570|11459540|FG000|STARTED|Overall Study||12
10324267|NCT00271570|11459541|FG001|STARTED|Overall Study||12
10324268|NCT00271570|11459540|FG000|COMPLETED|Overall Study||12
10324269|NCT00271570|11459541|FG001|COMPLETED|Overall Study||12
10324270|NCT00271570|11459540|FG000|NOT COMPLETED|Overall Study||0
10324271|NCT00271570|11459541|FG001|NOT COMPLETED|Overall Study||0
10324272|NCT00271596|11459549|FG000|STARTED|Overall Study||17
10324273|NCT00271596|11459550|FG001|STARTED|Overall Study||16
10324274|NCT00271596|11459549|FG000|COMPLETED|Overall Study||16
10324275|NCT00271596|11459550|FG001|COMPLETED|Overall Study||15
10324276|NCT00271596|11459549|FG000|NOT COMPLETED|Overall Study||1
10324277|NCT00271596|11459550|FG001|NOT COMPLETED|Overall Study||1
10324278|NCT00271609|11459558|FG000|STARTED|Overall Study||56
10324279|NCT00271609|11459559|FG001|STARTED|Overall Study||32
10324280|NCT00271609|11459558|FG000|COMPLETED|Overall Study||43
10324281|NCT00271609|11459559|FG001|COMPLETED|Overall Study||29
10324282|NCT00271609|11459558|FG000|NOT COMPLETED|Overall Study||13
10324283|NCT00271609|11459559|FG001|NOT COMPLETED|Overall Study||3
10324284|NCT00271739|11459567|FG000|STARTED|Overall Study||844
10324285|NCT00271739|11459568|FG001|STARTED|Overall Study||821
10324286|NCT00271739|11459567|FG000|COMPLETED|Overall Study||729
10324287|NCT00271739|11459568|FG001|COMPLETED|Overall Study||716
10324288|NCT00271739|11459567|FG000|NOT COMPLETED|Overall Study||115
10324289|NCT00271739|11459568|FG001|NOT COMPLETED|Overall Study||105
10324290|NCT00271856|11459576|FG000|STARTED|Overall Study||89
10324291|NCT00271856|11459577|FG001|STARTED|Overall Study||88
10324292|NCT00271856|11459576|FG000|COMPLETED|Overall Study||78
10324293|NCT00271856|11459577|FG001|COMPLETED|Overall Study||70
10324294|NCT00271856|11459576|FG000|NOT COMPLETED|Overall Study||11
10324295|NCT00271856|11459577|FG001|NOT COMPLETED|Overall Study||18
10324296|NCT00272038|11459583|FG000|STARTED|Overall Study||29
10324297|NCT00272038|11459583|FG000|COMPLETED|Overall Study||22
10324298|NCT00272038|11459583|FG000|NOT COMPLETED|Overall Study||7
10324299|NCT00272168|11459590|FG000|STARTED|Overall Study||47
10324300|NCT00272168|11459591|FG001|STARTED|Overall Study||41
10324301|NCT00272168|11459590|FG000|COMPLETED|Overall Study||37
10324302|NCT00272168|11459591|FG001|COMPLETED|Overall Study||31
10324303|NCT00272168|11459590|FG000|NOT COMPLETED|Overall Study||10
10324304|NCT00272168|11459591|FG001|NOT COMPLETED|Overall Study||10
10324305|NCT00272311|11459602|FG000|STARTED|Overall Study||14
10324306|NCT00272311|11459603|FG001|STARTED|Overall Study||14
10324307|NCT00272311|11459604|FG002|STARTED|Overall Study||14
10324308|NCT00272311|11459605|FG003|STARTED|Overall Study||14
10324309|NCT00272311|11459606|FG004|STARTED|Overall Study||14
10324310|NCT00272311|11459602|FG000|COMPLETED|Overall Study||14
10324311|NCT00272311|11459603|FG001|COMPLETED|Overall Study||14
10324312|NCT00272311|11459604|FG002|COMPLETED|Overall Study||14
10324313|NCT00272311|11459605|FG003|COMPLETED|Overall Study||14
10324314|NCT00272311|11459606|FG004|COMPLETED|Overall Study||14
10324315|NCT00272311|11459602|FG000|NOT COMPLETED|Overall Study||0
10324316|NCT00272311|11459603|FG001|NOT COMPLETED|Overall Study||0
10324317|NCT00272311|11459604|FG002|NOT COMPLETED|Overall Study||0
10324318|NCT00272311|11459605|FG003|NOT COMPLETED|Overall Study||0
10324319|NCT00272311|11459606|FG004|NOT COMPLETED|Overall Study||0
10338549|NCT04876274|11475456|FG000|STARTED|Overall Study||91
10338550|NCT04876274|11475457|FG001|STARTED|Overall Study||90
10338551|NCT04876274|11475456|FG000|COMPLETED|Overall Study||82
10338552|NCT04876274|11475457|FG001|COMPLETED|Overall Study||78
10338553|NCT04876274|11475456|FG000|NOT COMPLETED|Overall Study||9
10338554|NCT04876274|11475457|FG001|NOT COMPLETED|Overall Study||12
10338555|NCT04656691|11475463|FG000|STARTED|Overall Study||139
10338556|NCT04656691|11475463|FG000|COMPLETED|Overall Study||138
10338557|NCT04656691|11475463|FG000|NOT COMPLETED|Overall Study||1
10338558|NCT04615299|11475469|FG000|STARTED|Overall Study||36
10338559|NCT04615299|11475470|FG001|STARTED|Overall Study||36
10338560|NCT04615299|11475469|FG000|COMPLETED|Overall Study||36
10338561|NCT04615299|11475470|FG001|COMPLETED|Overall Study||36
10338562|NCT04615299|11475469|FG000|NOT COMPLETED|Overall Study||0
10338563|NCT04615299|11475470|FG001|NOT COMPLETED|Overall Study||0
10338564|NCT04555096|11475478|FG000|STARTED|Overall Study||9
10338565|NCT04555096|11475479|FG001|STARTED|Overall Study||7
10338566|NCT04555096|11475478|FG000|COMPLETED|Overall Study||4
10338567|NCT04555096|11475479|FG001|COMPLETED|Overall Study||2
10338568|NCT04555096|11475478|FG000|NOT COMPLETED|Overall Study||5
10338569|NCT04555096|11475479|FG001|NOT COMPLETED|Overall Study||5
10338570|NCT04150341|11475485|FG000|STARTED|Overall Study||4
10338571|NCT04150341|11475486|FG001|STARTED|Overall Study||4
10338572|NCT04150341|11475487|FG002|STARTED|Overall Study||4
10338573|NCT04150341|11475488|FG003|STARTED|Overall Study||4
10338574|NCT04150341|11475489|FG004|STARTED|Overall Study||4
10338575|NCT04150341|11475490|FG005|STARTED|Overall Study||4
10338576|NCT04150341|11475485|FG000|COMPLETED|Overall Study||4
10338577|NCT04150341|11475486|FG001|COMPLETED|Overall Study||4
10338578|NCT04150341|11475487|FG002|COMPLETED|Overall Study||3
10324320|NCT00272337|11459623|FG000|STARTED|Overall Study||8
10324321|NCT00272337|11459624|FG001|STARTED|Overall Study||7
10324322|NCT00272337|11459625|FG002|STARTED|Overall Study||7
10324323|NCT00272337|11459626|FG003|STARTED|Overall Study||7
10324324|NCT00272337|11459627|FG004|STARTED|Overall Study||8
10324325|NCT00272337|11459623|FG000|COMPLETED|Overall Study||8
10324326|NCT00272337|11459624|FG001|COMPLETED|Overall Study||7
10324327|NCT00272337|11459625|FG002|COMPLETED|Overall Study||7
10324328|NCT00272337|11459626|FG003|COMPLETED|Overall Study||7
10324329|NCT00272337|11459627|FG004|COMPLETED|Overall Study||8
10324330|NCT00272337|11459623|FG000|NOT COMPLETED|Overall Study||0
10324331|NCT00272337|11459624|FG001|NOT COMPLETED|Overall Study||0
10324332|NCT00272337|11459625|FG002|NOT COMPLETED|Overall Study||0
10324333|NCT00272337|11459626|FG003|NOT COMPLETED|Overall Study||0
10324334|NCT00272337|11459627|FG004|NOT COMPLETED|Overall Study||0
10324335|NCT00272779|11459641|FG000|STARTED|Baseline Through Week 48|Number of participants randomized to ATV|440
10324336|NCT00272779|11459642|FG001|STARTED|Baseline Through Week 48|Number of participants randomized to LPV|443
10324337|NCT00272779|11459641|FG000|RECEIVED ANY TREATMENT|Baseline Through Week 48|1 participant randomized to LPV received ATV instead (treatment error)|441
10324338|NCT00272779|11459642|FG001|RECEIVED ANY TREATMENT|Baseline Through Week 48|3 participants received ATV instead of LPV (treatment error), 3 participants never treated with LPV|437
10324339|NCT00272779|11459641|FG000|TREATED AS RANDOMIZED|Baseline Through Week 48||438
10324340|NCT00272779|11459642|FG001|TREATED AS RANDOMIZED|Baseline Through Week 48||440
10324341|NCT00272779|11459641|FG000|Discontinued Before Week 48|Baseline Through Week 48||39
10324342|NCT00272779|11459642|FG001|Discontinued Before Week 48|Baseline Through Week 48||58
10324343|NCT00272779|11459641|FG000|Discontinued on or After Week 48|Baseline Through Week 48||14
10324344|NCT00272779|11459642|FG001|Discontinued on or After Week 48|Baseline Through Week 48||14
10324345|NCT00272779|11459641|FG000|STILL ON TREATMENT|Baseline Through Week 48||385
10324346|NCT00272779|11459642|FG001|STILL ON TREATMENT|Baseline Through Week 48||368
10324347|NCT00272779|11459641|FG000|COMPLETED|Baseline Through Week 48||0
10324348|NCT00272779|11459642|FG001|COMPLETED|Baseline Through Week 48||0
10324349|NCT00272779|11459641|FG000|NOT COMPLETED|Baseline Through Week 48||440
10324350|NCT00272779|11459642|FG001|NOT COMPLETED|Baseline Through Week 48||443
10324351|NCT00272779|11459641|FG000|STARTED|Baseline Through Week 96|Number randomized to ATV|440
10324352|NCT00272779|11459642|FG001|STARTED|Baseline Through Week 96|Number randomized to LPV|443
10324353|NCT00272779|11459641|FG000|RECEIVED ANY TREATMENT|Baseline Through Week 96|1 participant randomized to LPV received ATV instead (treatment error)|441
10324354|NCT00272779|11459642|FG001|RECEIVED ANY TREATMENT|Baseline Through Week 96|3 participants received ATV instead of LPV (treatment error) and 3 participants never treated|437
10324355|NCT00272779|11459641|FG000|COMPLETED|Baseline Through Week 96||301
10324356|NCT00272779|11459642|FG001|COMPLETED|Baseline Through Week 96||307
10324357|NCT00272779|11459641|FG000|NOT COMPLETED|Baseline Through Week 96||139
10324358|NCT00272779|11459642|FG001|NOT COMPLETED|Baseline Through Week 96||136
10324359|NCT00272792|11459651|FG000|STARTED|Part 1: Responsiveness||90
10324360|NCT00272792|11459652|FG001|STARTED|Part 1: Responsiveness||0
10324361|NCT00272792|11459651|FG000|COMPLETED|Part 1: Responsiveness||89
10324362|NCT00272792|11459652|FG001|COMPLETED|Part 1: Responsiveness||0
10324363|NCT00272792|11459651|FG000|NOT COMPLETED|Part 1: Responsiveness||1
10324364|NCT00272792|11459652|FG001|NOT COMPLETED|Part 1: Responsiveness||0
10324365|NCT00272792|11459651|FG000|STARTED|Part 2: Blinded, Placebo Control Period||33
10324366|NCT00272792|11459652|FG001|STARTED|Part 2: Blinded, Placebo Control Period||12
10324367|NCT00272792|11459651|FG000|COMPLETED|Part 2: Blinded, Placebo Control Period||32
10324368|NCT00272792|11459652|FG001|COMPLETED|Part 2: Blinded, Placebo Control Period||9
10324369|NCT00272792|11459651|FG000|NOT COMPLETED|Part 2: Blinded, Placebo Control Period||1
10324370|NCT00272792|11459652|FG001|NOT COMPLETED|Part 2: Blinded, Placebo Control Period||3
10324371|NCT00272844|11459658|FG000|STARTED|Overall Study||23
10324372|NCT00272844|11459658|FG000|COMPLETED|Overall Study||18
10324373|NCT00272844|11459658|FG000|NOT COMPLETED|Overall Study||5
10324374|NCT00272961|11459667|FG000|STARTED|Placebo Run-in Phase: Up to Week 2||60
10324375|NCT00272961|11459668|FG001|STARTED|Placebo Run-in Phase: Up to Week 2||0
10324376|NCT00272961|11459669|FG002|STARTED|Placebo Run-in Phase: Up to Week 2||0
10324377|NCT00272961|11459670|FG003|STARTED|Placebo Run-in Phase: Up to Week 2||0
10324378|NCT00272961|11459671|FG004|STARTED|Placebo Run-in Phase: Up to Week 2||0
10324379|NCT00272961|11459667|FG000|COMPLETED|Placebo Run-in Phase: Up to Week 2||49
10324380|NCT00272961|11459668|FG001|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
10324381|NCT00272961|11459669|FG002|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
10324382|NCT00272961|11459670|FG003|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
10324383|NCT00272961|11459671|FG004|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
10324384|NCT00272961|11459667|FG000|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||11
10324385|NCT00272961|11459668|FG001|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
10324386|NCT00272961|11459669|FG002|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
10324387|NCT00272961|11459670|FG003|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
10324388|NCT00272961|11459671|FG004|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
10324389|NCT00272961|11459667|FG000|STARTED|Treatment Phase: Week 3 Up to Week 12||10
10324390|NCT00272961|11459668|FG001|STARTED|Treatment Phase: Week 3 Up to Week 12||8
10324391|NCT00272961|11459669|FG002|STARTED|Treatment Phase: Week 3 Up to Week 12||11
10324392|NCT00272961|11459670|FG003|STARTED|Treatment Phase: Week 3 Up to Week 12||10
10324393|NCT00272961|11459671|FG004|STARTED|Treatment Phase: Week 3 Up to Week 12||10
10324394|NCT00272961|11459667|FG000|COMPLETED|Treatment Phase: Week 3 Up to Week 12||8
10324395|NCT00272961|11459668|FG001|COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
10324396|NCT00272961|11459669|FG002|COMPLETED|Treatment Phase: Week 3 Up to Week 12||7
10324397|NCT00272961|11459670|FG003|COMPLETED|Treatment Phase: Week 3 Up to Week 12||7
10324398|NCT00272961|11459671|FG004|COMPLETED|Treatment Phase: Week 3 Up to Week 12||6
10324399|NCT00272961|11459667|FG000|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||2
10324400|NCT00272961|11459668|FG001|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
10324401|NCT00272961|11459669|FG002|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
10324402|NCT00272961|11459670|FG003|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||3
10324403|NCT00272961|11459671|FG004|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
10324404|NCT00272987|11459686|FG000|STARTED|Overall Study||29
10324405|NCT00272987|11459687|FG001|STARTED|Overall Study||14
10324406|NCT00272987|11459688|FG002|STARTED|Overall Study||20
10324407|NCT00272987|11459686|FG000|COMPLETED|Overall Study||20
10324408|NCT00272987|11459687|FG001|COMPLETED|Overall Study||10
10324409|NCT00272987|11459688|FG002|COMPLETED|Overall Study||9
10324410|NCT00272987|11459686|FG000|NOT COMPLETED|Overall Study||9
10324411|NCT00272987|11459687|FG001|NOT COMPLETED|Overall Study||4
10324412|NCT00272987|11459688|FG002|NOT COMPLETED|Overall Study||11
10324413|NCT00273052|11459698|FG000|STARTED|Overall Study||290
10324414|NCT00273052|11459699|FG001|STARTED|Overall Study||278
10324415|NCT00273052|11459698|FG000|COMPLETED|Overall Study||221
10324416|NCT00273052|11459699|FG001|COMPLETED|Overall Study||190
10324417|NCT00273052|11459698|FG000|NOT COMPLETED|Overall Study||69
10324418|NCT00273052|11459699|FG001|NOT COMPLETED|Overall Study||88
10324419|NCT00273182|11459705|FG000|STARTED|Overall Study||1999
10324420|NCT00273182|11459705|FG000|COMPLETED|Overall Study||1014
10324421|NCT00273182|11459705|FG000|NOT COMPLETED|Overall Study||985
10324422|NCT00273364|11459712|FG000|STARTED|Overall Study||55
10324423|NCT00273364|11459713|FG001|STARTED|Overall Study||55
10324424|NCT00273364|11459712|FG000|COMPLETED|Overall Study||55
10324425|NCT00273364|11459713|FG001|COMPLETED|Overall Study||55
10324426|NCT00273364|11459712|FG000|NOT COMPLETED|Overall Study||0
10324427|NCT00273364|11459713|FG001|NOT COMPLETED|Overall Study||0
10324428|NCT00273754|11459721|FG000|STARTED|Overall Study||36
10324429|NCT00273754|11459722|FG001|STARTED|Overall Study||36
10324430|NCT00273754|11459721|FG000|COMPLETED|Overall Study||36
10324431|NCT00273754|11459722|FG001|COMPLETED|Overall Study||36
10324432|NCT00273754|11459721|FG000|NOT COMPLETED|Overall Study||0
10324433|NCT00273754|11459722|FG001|NOT COMPLETED|Overall Study||0
10324434|NCT00273793|11459734|FG000|STARTED|Overall Study||36
10324435|NCT00273793|11459735|FG001|STARTED|Overall Study||38
10324436|NCT00273793|11459736|FG002|STARTED|Overall Study||18
10324437|NCT00273793|11459737|FG003|STARTED|Overall Study||60
10324438|NCT00273793|11459738|FG004|STARTED|Overall Study||58
10324439|NCT00273793|11459739|FG005|STARTED|Overall Study||29
10324440|NCT00273793|11459734|FG000|COMPLETED|Overall Study||36
10324441|NCT00273793|11459735|FG001|COMPLETED|Overall Study||38
10324442|NCT00273793|11459736|FG002|COMPLETED|Overall Study||18
10324443|NCT00273793|11459737|FG003|COMPLETED|Overall Study||60
10324444|NCT00273793|11459738|FG004|COMPLETED|Overall Study||58
10324445|NCT00273793|11459739|FG005|COMPLETED|Overall Study||29
10324446|NCT00273793|11459734|FG000|NOT COMPLETED|Overall Study||0
10324447|NCT00273793|11459735|FG001|NOT COMPLETED|Overall Study||0
10324448|NCT00273793|11459736|FG002|NOT COMPLETED|Overall Study||0
10324449|NCT00273793|11459737|FG003|NOT COMPLETED|Overall Study||0
10324450|NCT00273793|11459738|FG004|NOT COMPLETED|Overall Study||0
10324451|NCT00273793|11459739|FG005|NOT COMPLETED|Overall Study||0
10324452|NCT00273858|11459753|FG000|STARTED|Overall Study||880
10324453|NCT00273858|11459753|FG000|COMPLETED|Overall Study||343
10324454|NCT00273858|11459753|FG000|NOT COMPLETED|Overall Study||537
10324455|NCT00273910|11459763|FG000|STARTED|Overall Study||19
10324456|NCT00273910|11459764|FG001|STARTED|Overall Study||19
10324457|NCT00273910|11459765|FG002|STARTED|Overall Study||18
10324458|NCT00273910|11459766|FG003|STARTED|Overall Study||19
10324459|NCT00273910|11459767|FG004|STARTED|Overall Study||15
10324460|NCT00273910|11459768|FG005|STARTED|Overall Study||14
10324461|NCT00273910|11459763|FG000|COMPLETED|Overall Study||19
10324462|NCT00273910|11459764|FG001|COMPLETED|Overall Study||19
10324463|NCT00273910|11459765|FG002|COMPLETED|Overall Study||18
10324464|NCT00273910|11459766|FG003|COMPLETED|Overall Study||19
10324465|NCT00273910|11459767|FG004|COMPLETED|Overall Study||15
10324466|NCT00273910|11459768|FG005|COMPLETED|Overall Study||14
10324467|NCT00273910|11459763|FG000|NOT COMPLETED|Overall Study||0
10324468|NCT00273910|11459764|FG001|NOT COMPLETED|Overall Study||0
10324469|NCT00273910|11459765|FG002|NOT COMPLETED|Overall Study||0
10324470|NCT00273910|11459766|FG003|NOT COMPLETED|Overall Study||0
10324471|NCT00273910|11459767|FG004|NOT COMPLETED|Overall Study||0
10324472|NCT00273910|11459768|FG005|NOT COMPLETED|Overall Study||0
10324473|NCT00274261|11459784|FG000|STARTED|Overall Study||932
10324474|NCT00274261|11459785|FG001|STARTED|Overall Study||633
10324475|NCT00274261|11459784|FG000|COMPLETED|Overall Study||443
10324476|NCT00274261|11459785|FG001|COMPLETED|Overall Study||296
10324477|NCT00274261|11459784|FG000|NOT COMPLETED|Overall Study||489
10324478|NCT00274261|11459785|FG001|NOT COMPLETED|Overall Study||337
10324479|NCT00274287|11459793|FG000|STARTED|Overall Study||15
10324480|NCT00274287|11459793|FG000|COMPLETED|Overall Study||13
10324481|NCT00274287|11459793|FG000|NOT COMPLETED|Overall Study||2
10324482|NCT00274456|11459802|FG000|STARTED|Overall Study||76
10324483|NCT00274456|11459803|FG001|STARTED|Overall Study||76
10324484|NCT00274456|11459804|FG002|STARTED|Overall Study||74
10324485|NCT00274456|11459805|FG003|STARTED|Overall Study||74
10324486|NCT00274456|11459802|FG000|At Least One Response Assessment|Overall Study||73
10324487|NCT00274456|11459803|FG001|At Least One Response Assessment|Overall Study||76
10324488|NCT00274456|11459804|FG002|At Least One Response Assessment|Overall Study||73
10324489|NCT00274456|11459805|FG003|At Least One Response Assessment|Overall Study||70
10324490|NCT00274456|11459802|FG000|COMPLETED|Overall Study|Treatment completed upon progressive disease|39
10324491|NCT00274456|11459803|FG001|COMPLETED|Overall Study|Treatment completed upon progressive disease|49
10324492|NCT00274456|11459804|FG002|COMPLETED|Overall Study|Treatment completed upon progressive disease|39
10324493|NCT00274456|11459805|FG003|COMPLETED|Overall Study|Treatment completed upon progressive disease|29
10324494|NCT00274456|11459802|FG000|NOT COMPLETED|Overall Study||37
10324495|NCT00274456|11459803|FG001|NOT COMPLETED|Overall Study||27
10324496|NCT00274456|11459804|FG002|NOT COMPLETED|Overall Study||35
10324497|NCT00274456|11459805|FG003|NOT COMPLETED|Overall Study||45
10324498|NCT00274469|11459817|FG000|STARTED|Overall Study|Number of patients randomized|102
10324499|NCT00274469|11459818|FG001|STARTED|Overall Study|Number of patients randomized|103
10324500|NCT00274469|11459817|FG000|COMPLETED|Overall Study|Number of patients ongoing study treatment at data cut-off|23
10324501|NCT00274469|11459818|FG001|COMPLETED|Overall Study|Number of patients ongoing study treatment at data cut-off|10
10324502|NCT00274469|11459817|FG000|NOT COMPLETED|Overall Study||79
10324503|NCT00274469|11459818|FG001|NOT COMPLETED|Overall Study||93
10324504|NCT00274625|11459826|FG000|STARTED|Overall Study||199
10324505|NCT00274625|11459827|FG001|STARTED|Overall Study||203
10324506|NCT00274625|11459826|FG000|COMPLETED|Overall Study||139
10324507|NCT00274625|11459827|FG001|COMPLETED|Overall Study||141
10324508|NCT00274625|11459826|FG000|NOT COMPLETED|Overall Study||60
10324509|NCT00274625|11459827|FG001|NOT COMPLETED|Overall Study||62
10324510|NCT00274651|11459835|FG000|STARTED|Overall Study||29
10324511|NCT00274651|11459836|FG001|STARTED|Overall Study||24
10324512|NCT00274651|11459835|FG000|COMPLETED|Overall Study||1
10324513|NCT00274651|11459836|FG001|COMPLETED|Overall Study||4
10324514|NCT00274651|11459835|FG000|NOT COMPLETED|Overall Study||28
10324515|NCT00274651|11459836|FG001|NOT COMPLETED|Overall Study||20
10324516|NCT00274716|11459849|FG000|STARTED|Phase A||54
10324517|NCT00274716|11459850|FG001|STARTED|Phase A||54
10324518|NCT00274716|11459851|FG002|STARTED|Phase A||52
10324519|NCT00274716|11459852|FG003|STARTED|Phase A||51
10324520|NCT00274716|11459853|FG004|STARTED|Phase A||19
10324521|NCT00274716|11459854|FG005|STARTED|Phase A||19
10324522|NCT00274716|11459849|FG000|COMPLETED|Phase A||43
10324523|NCT00274716|11459850|FG001|COMPLETED|Phase A||44
10324524|NCT00274716|11459851|FG002|COMPLETED|Phase A||44
10324525|NCT00274716|11459852|FG003|COMPLETED|Phase A||42
10324526|NCT00274716|11459853|FG004|COMPLETED|Phase A||16
10324527|NCT00274716|11459854|FG005|COMPLETED|Phase A||15
10324528|NCT00274716|11459849|FG000|NOT COMPLETED|Phase A||11
10324529|NCT00274716|11459850|FG001|NOT COMPLETED|Phase A||10
10324530|NCT00274716|11459851|FG002|NOT COMPLETED|Phase A||8
10324531|NCT00274716|11459852|FG003|NOT COMPLETED|Phase A||9
10324532|NCT00274716|11459853|FG004|NOT COMPLETED|Phase A||3
10324533|NCT00274716|11459854|FG005|NOT COMPLETED|Phase A||4
10324534|NCT00274716|11459849|FG000|STARTED|Phase B||43
10324535|NCT00274716|11459850|FG001|STARTED|Phase B||44
10324536|NCT00274716|11459851|FG002|STARTED|Phase B||44
10324537|NCT00274716|11459852|FG003|STARTED|Phase B||42
10324538|NCT00274716|11459853|FG004|STARTED|Phase B||16
10324539|NCT00274716|11459854|FG005|STARTED|Phase B||15
10324540|NCT00274716|11459849|FG000|COMPLETED|Phase B||42
10324541|NCT00274716|11459850|FG001|COMPLETED|Phase B||40
10324542|NCT00274716|11459851|FG002|COMPLETED|Phase B||41
10324543|NCT00274716|11459852|FG003|COMPLETED|Phase B||41
10324544|NCT00274716|11459853|FG004|COMPLETED|Phase B||16
10324545|NCT00274716|11459854|FG005|COMPLETED|Phase B||14
10324546|NCT00274716|11459849|FG000|NOT COMPLETED|Phase B||1
10324547|NCT00274716|11459850|FG001|NOT COMPLETED|Phase B||4
10324548|NCT00274716|11459851|FG002|NOT COMPLETED|Phase B||3
10324549|NCT00274716|11459852|FG003|NOT COMPLETED|Phase B||1
10324550|NCT00274716|11459853|FG004|NOT COMPLETED|Phase B||0
10324551|NCT00274716|11459854|FG005|NOT COMPLETED|Phase B||1
10324552|NCT00274742|11459878|FG000|STARTED|Overall Study||12
10324553|NCT00274742|11459879|FG001|STARTED|Overall Study||13
10324554|NCT00274742|11459880|FG002|STARTED|Overall Study||6
10324555|NCT00274742|11459881|FG003|STARTED|Overall Study||9
10324556|NCT00274742|11459882|FG004|STARTED|Overall Study||32
10324557|NCT00274742|11459883|FG005|STARTED|Overall Study||4
10324558|NCT00274742|11459878|FG000|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|12
10324559|NCT00274742|11459879|FG001|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|5
10324560|NCT00274742|11459880|FG002|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|4
10324561|NCT00274742|11459881|FG003|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|4
10324562|NCT00274742|11459882|FG004|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|16
10324563|NCT00274742|11459883|FG005|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|1
10324564|NCT00274742|11459878|FG000|NOT COMPLETED|Overall Study||0
10324565|NCT00274742|11459879|FG001|NOT COMPLETED|Overall Study||8
10324566|NCT00274742|11459880|FG002|NOT COMPLETED|Overall Study||2
10324567|NCT00274742|11459881|FG003|NOT COMPLETED|Overall Study||5
10324568|NCT00274742|11459882|FG004|NOT COMPLETED|Overall Study||16
10324569|NCT00274742|11459883|FG005|NOT COMPLETED|Overall Study||3
10324570|NCT00274768|11459903|FG000|STARTED|Overall Study||26
10324571|NCT00274768|11459903|FG000|COMPLETED|Overall Study||26
10324572|NCT00274768|11459903|FG000|NOT COMPLETED|Overall Study||0
10324573|NCT00274781|11459907|FG000|STARTED|Overall Study||30
10324574|NCT00274781|11459907|FG000|COMPLETED|Overall Study||30
10324575|NCT00274781|11459907|FG000|NOT COMPLETED|Overall Study||0
10324576|NCT00274846|11459912|FG000|STARTED|Overall Study||21
10324577|NCT00274846|11459912|FG000|COMPLETED|Overall Study|Evaluable patients - received adequate natural killer (NK) cells|20
10324578|NCT00274846|11459912|FG000|NOT COMPLETED|Overall Study||1
10324579|NCT00274924|11459920|FG000|STARTED|Step 1 (R-CHOP X 3 Cycles)||17
10324580|NCT00274924|11459921|FG001|STARTED|Step 1 (R-CHOP X 3 Cycles)||77
10324581|NCT00274924|11459922|FG002|STARTED|Step 1 (R-CHOP X 3 Cycles)||6
10324582|NCT00274924|11459920|FG000|Treated|Step 1 (R-CHOP X 3 Cycles)||17
10324583|NCT00274924|11459921|FG001|Treated|Step 1 (R-CHOP X 3 Cycles)||77
10324584|NCT00274924|11459922|FG002|Treated|Step 1 (R-CHOP X 3 Cycles)||5
10701641|NCT02568683|11866061|FG001|NOT COMPLETED|Overall Study||4
10701642|NCT02568852|11866069|FG000|STARTED|Overall Study||25
10701643|NCT02568852|11866070|FG001|STARTED|Overall Study||25
10701644|NCT02568852|11866069|FG000|COMPLETED|Overall Study||25
10701645|NCT02568852|11866070|FG001|COMPLETED|Overall Study||25
10701646|NCT02568852|11866069|FG000|NOT COMPLETED|Overall Study||0
10324585|NCT00274924|11459920|FG000|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||13
10324586|NCT00274924|11459921|FG001|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||63
10324587|NCT00274924|11459922|FG002|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||4
10324588|NCT00274924|11459920|FG000|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||13
10324589|NCT00274924|11459921|FG001|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||63
10324590|NCT00274924|11459922|FG002|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||0
10324591|NCT00274924|11459920|FG000|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||4
10324592|NCT00274924|11459921|FG001|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||14
10324593|NCT00274924|11459922|FG002|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||6
10324594|NCT00274924|11459920|FG000|STARTED|Step 2 (Tx Based on Mid-treatment PET)|All patients who started step 2 therapy were included regardless of eligibility.|17
10324595|NCT00274924|11459921|FG001|STARTED|Step 2 (Tx Based on Mid-treatment PET)|One patient withdrew from the study after step 1 treatment.|76
10324596|NCT00274924|11459922|FG002|STARTED|Step 2 (Tx Based on Mid-treatment PET)||0
10324597|NCT00274924|11459920|FG000|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||13
10324598|NCT00274924|11459921|FG001|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||61
10324599|NCT00274924|11459922|FG002|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||0
10324600|NCT00274924|11459920|FG000|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||10
10324601|NCT00274924|11459921|FG001|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||58
10324602|NCT00274924|11459922|FG002|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||0
10324603|NCT00274924|11459920|FG000|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||7
10324604|NCT00274924|11459921|FG001|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||18
10456055|NCT01005680|11604164|FG001|NOT COMPLETED|Overall Study||11
10456056|NCT01005706|11604173|FG000|STARTED|Overall Study||23
10456057|NCT01005706|11604174|FG001|STARTED|Overall Study||17
10456058|NCT01005706|11604173|FG000|COMPLETED|Overall Study||23
10456059|NCT01005706|11604174|FG001|COMPLETED|Overall Study||17
10456060|NCT01005706|11604173|FG000|NOT COMPLETED|Overall Study||0
10456061|NCT01005706|11604174|FG001|NOT COMPLETED|Overall Study||0
10456062|NCT01005719|11604180|FG000|STARTED|Period 1||10
10456063|NCT01005719|11604181|FG001|STARTED|Period 1||10
10324605|NCT00274924|11459922|FG002|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||0
10803873|NCT04095286|11965328|FG005|STARTED|Period 2 (4 Days) + Washout (7days)||5
10803874|NCT04095286|11965323|FG000|COMPLETED|Period 2 (4 Days) + Washout (7days)||3
10803875|NCT04095286|11965324|FG001|COMPLETED|Period 2 (4 Days) + Washout (7days)||4
10456064|NCT01005719|11604182|FG002|STARTED|Period 1||10
10701647|NCT02568852|11866070|FG001|NOT COMPLETED|Overall Study||0
10701648|NCT02569086|11866076|FG000|STARTED|Overall Study||22
10701649|NCT02569086|11866076|FG000|COMPLETED|Overall Study||22
10324609|NCT00275002|11459935|FG000|STARTED|Overall Study||25
10324610|NCT00275002|11459936|FG001|STARTED|Overall Study||16
10324611|NCT00275002|11459935|FG000|COMPLETED|Overall Study||3
10324612|NCT00275002|11459936|FG001|COMPLETED|Overall Study||0
10324613|NCT00275002|11459935|FG000|NOT COMPLETED|Overall Study||22
10324614|NCT00275002|11459936|FG001|NOT COMPLETED|Overall Study||16
10324615|NCT00275028|11459942|FG000|STARTED|Overall Study||47
10324616|NCT00275028|11459942|FG000|COMPLETED|Overall Study|Participants are treated until one of the below milestones is reached. Completion is N/A.|0
10324617|NCT00275028|11459942|FG000|NOT COMPLETED|Overall Study||47
10324618|NCT00275262|11459948|FG000|STARTED|Overall Study||12
10324619|NCT00275262|11459949|FG001|STARTED|Overall Study||13
10324620|NCT00275262|11459948|FG000|COMPLETED|Overall Study|Patients who completed the entire 12 month study period|6
10324621|NCT00275262|11459949|FG001|COMPLETED|Overall Study|Patients who completed the entire 12 month study period|4
10324622|NCT00275262|11459948|FG000|NOT COMPLETED|Overall Study||6
10324623|NCT00275262|11459949|FG001|NOT COMPLETED|Overall Study||9
10324624|NCT00275275|11459958|FG000|STARTED|Overall Study||20
10324625|NCT00275275|11459959|FG001|STARTED|Overall Study||20
10324626|NCT00275275|11459960|FG002|STARTED|Overall Study|One participant was removed after enrollment and before any data was collected for him.|21
10324627|NCT00275275|11459958|FG000|COMPLETED|Overall Study||14
10324628|NCT00275275|11459959|FG001|COMPLETED|Overall Study||18
10324629|NCT00275275|11459960|FG002|COMPLETED|Overall Study||15
10324630|NCT00275275|11459958|FG000|NOT COMPLETED|Overall Study||6
10803876|NCT04095286|11965325|FG002|COMPLETED|Period 2 (4 Days) + Washout (7days)||2
10803877|NCT04095286|11965326|FG003|COMPLETED|Period 2 (4 Days) + Washout (7days)||5
10803878|NCT04095286|11965327|FG004|COMPLETED|Period 2 (4 Days) + Washout (7days)||4
10803879|NCT04095286|11965328|FG005|COMPLETED|Period 2 (4 Days) + Washout (7days)||5
10803880|NCT04095286|11965323|FG000|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0
10324631|NCT00275275|11459959|FG001|NOT COMPLETED|Overall Study||2
10324632|NCT00275275|11459960|FG002|NOT COMPLETED|Overall Study||6
10324633|NCT00275301|11459968|FG000|STARTED|Overall Study||19
10324634|NCT00275301|11459968|FG000|COMPLETED|Overall Study||14
10324635|NCT00275301|11459968|FG000|NOT COMPLETED|Overall Study||5
10324636|NCT00275392|11459974|FG000|STARTED|Overall Study||20
10324637|NCT00275392|11459975|FG001|STARTED|Overall Study||19
10324638|NCT00275392|11459974|FG000|COMPLETED|Overall Study||20
10324639|NCT00275392|11459975|FG001|COMPLETED|Overall Study||17
10324640|NCT00275392|11459974|FG000|NOT COMPLETED|Overall Study||0
10456065|NCT01005719|11604183|FG003|STARTED|Period 1||11
10456066|NCT01005719|11604184|FG004|STARTED|Period 1||11
10456067|NCT01005719|11604185|FG005|STARTED|Period 1||11
10456068|NCT01005719|11604180|FG000|COMPLETED|Period 1||10
10456069|NCT01005719|11604181|FG001|COMPLETED|Period 1||10
10456070|NCT01005719|11604182|FG002|COMPLETED|Period 1||10
10456071|NCT01005719|11604183|FG003|COMPLETED|Period 1||10
10456072|NCT01005719|11604184|FG004|COMPLETED|Period 1||11
10456073|NCT01005719|11604185|FG005|COMPLETED|Period 1||10
10456074|NCT01005719|11604180|FG000|NOT COMPLETED|Period 1||0
10456075|NCT01005719|11604181|FG001|NOT COMPLETED|Period 1||0
10456076|NCT01005719|11604182|FG002|NOT COMPLETED|Period 1||0
10456077|NCT01005719|11604183|FG003|NOT COMPLETED|Period 1||1
10456078|NCT01005719|11604184|FG004|NOT COMPLETED|Period 1||0
10456079|NCT01005719|11604185|FG005|NOT COMPLETED|Period 1||1
10456080|NCT01005719|11604180|FG000|STARTED|Period 2||10
10456081|NCT01005719|11604181|FG001|STARTED|Period 2||10
10456082|NCT01005719|11604182|FG002|STARTED|Period 2||10
10456083|NCT01005719|11604183|FG003|STARTED|Period 2||10
10456084|NCT01005719|11604184|FG004|STARTED|Period 2||11
10456085|NCT01005719|11604185|FG005|STARTED|Period 2||10
10456086|NCT01005719|11604180|FG000|COMPLETED|Period 2||10
10456087|NCT01005719|11604181|FG001|COMPLETED|Period 2||10
10456088|NCT01005719|11604182|FG002|COMPLETED|Period 2||10
10456089|NCT01005719|11604183|FG003|COMPLETED|Period 2||10
10456090|NCT01005719|11604184|FG004|COMPLETED|Period 2||10
10456091|NCT01005719|11604185|FG005|COMPLETED|Period 2||9
10456092|NCT01005719|11604180|FG000|NOT COMPLETED|Period 2||0
10456093|NCT01005719|11604181|FG001|NOT COMPLETED|Period 2||0
10456094|NCT01005719|11604182|FG002|NOT COMPLETED|Period 2||0
10456095|NCT01005719|11604183|FG003|NOT COMPLETED|Period 2||0
10456096|NCT01005719|11604184|FG004|NOT COMPLETED|Period 2||1
10456097|NCT01005719|11604185|FG005|NOT COMPLETED|Period 2||1
10456098|NCT01005719|11604180|FG000|STARTED|Period 3||10
10456099|NCT01005719|11604181|FG001|STARTED|Period 3||10
10456100|NCT01005719|11604182|FG002|STARTED|Period 3||10
10456101|NCT01005719|11604183|FG003|STARTED|Period 3||10
10456102|NCT01005719|11604184|FG004|STARTED|Period 3||10
10456103|NCT01005719|11604185|FG005|STARTED|Period 3||9
10803881|NCT04095286|11965324|FG001|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0
10324641|NCT00275392|11459975|FG001|NOT COMPLETED|Overall Study||2
10456104|NCT01005719|11604180|FG000|COMPLETED|Period 3||10
10456105|NCT01005719|11604181|FG001|COMPLETED|Period 3||10
10456106|NCT01005719|11604182|FG002|COMPLETED|Period 3||10
10324642|NCT00275509|11459983|FG000|STARTED|Overall Study||30
10324643|NCT00275509|11459984|FG001|STARTED|Overall Study||26
10324644|NCT00275509|11459983|FG000|COMPLETED|Overall Study||30
10456107|NCT01005719|11604183|FG003|COMPLETED|Period 3||10
10456108|NCT01005719|11604184|FG004|COMPLETED|Period 3||10
10456109|NCT01005719|11604185|FG005|COMPLETED|Period 3||9
10456110|NCT01005719|11604180|FG000|NOT COMPLETED|Period 3||0
10456111|NCT01005719|11604181|FG001|NOT COMPLETED|Period 3||0
10456112|NCT01005719|11604182|FG002|NOT COMPLETED|Period 3||0
10456113|NCT01005719|11604183|FG003|NOT COMPLETED|Period 3||0
10456114|NCT01005719|11604184|FG004|NOT COMPLETED|Period 3||0
10324645|NCT00275509|11459984|FG001|COMPLETED|Overall Study||25
10324646|NCT00275509|11459983|FG000|NOT COMPLETED|Overall Study||0
10324647|NCT00275509|11459984|FG001|NOT COMPLETED|Overall Study||1
10324648|NCT00275561|11459992|FG000|STARTED|Overall Study||21
10324649|NCT00275561|11459993|FG001|STARTED|Overall Study||21
10324650|NCT00275561|11459992|FG000|COMPLETED|Overall Study||19
10324651|NCT00275561|11459993|FG001|COMPLETED|Overall Study||15
10324652|NCT00275561|11459992|FG000|NOT COMPLETED|Overall Study||2
10324653|NCT00275561|11459993|FG001|NOT COMPLETED|Overall Study||6
10324654|NCT00275821|11460002|FG000|STARTED|Overall Study||120
10324655|NCT00275821|11460003|FG001|STARTED|Overall Study||118
10324656|NCT00275821|11460004|FG002|STARTED|Overall Study||115
10324657|NCT00275821|11460002|FG000|COMPLETED|Overall Study||106
10324658|NCT00275821|11460003|FG001|COMPLETED|Overall Study||95
10324659|NCT00275821|11460004|FG002|COMPLETED|Overall Study||103
10324660|NCT00275821|11460002|FG000|NOT COMPLETED|Overall Study||14
10324661|NCT00275821|11460003|FG001|NOT COMPLETED|Overall Study||23
10324662|NCT00275821|11460004|FG002|NOT COMPLETED|Overall Study||12
10324663|NCT00275834|11460015|FG000|STARTED|Overall Study||74
10324664|NCT00275834|11460016|FG001|STARTED|Overall Study||76
10324665|NCT00275834|11460017|FG002|STARTED|Overall Study||75
10324666|NCT00275834|11460015|FG000|Completed Study While on Study Drug|Overall Study||54
10324667|NCT00275834|11460016|FG001|Completed Study While on Study Drug|Overall Study||51
10324668|NCT00275834|11460017|FG002|Completed Study While on Study Drug|Overall Study||62
10324669|NCT00275834|11460015|FG000|COMPLETED|Overall Study||71
10324670|NCT00275834|11460016|FG001|COMPLETED|Overall Study||73
10324671|NCT00275834|11460017|FG002|COMPLETED|Overall Study||74
10324672|NCT00275834|11460015|FG000|NOT COMPLETED|Overall Study||3
10324673|NCT00275834|11460016|FG001|NOT COMPLETED|Overall Study||3
10324674|NCT00275834|11460017|FG002|NOT COMPLETED|Overall Study||1
10324675|NCT00276094|11460030|FG000|STARTED|Overall Study||282
10324676|NCT00276094|11460031|FG001|STARTED|Overall Study||276
10324677|NCT00276094|11460032|FG002|STARTED|Overall Study||268
10324678|NCT00276094|11460030|FG000|COMPLETED|Overall Study||225
10324679|NCT00276094|11460031|FG001|COMPLETED|Overall Study||234
10324680|NCT00276094|11460032|FG002|COMPLETED|Overall Study||230
10324681|NCT00276094|11460030|FG000|NOT COMPLETED|Overall Study||57
10324682|NCT00276094|11460031|FG001|NOT COMPLETED|Overall Study||42
10324683|NCT00276094|11460032|FG002|NOT COMPLETED|Overall Study||38
10324684|NCT00276159|11460040|FG000|STARTED|Overall Study||6
10324685|NCT00276159|11460040|FG000|COMPLETED|Overall Study||0
10324686|NCT00276159|11460040|FG000|NOT COMPLETED|Overall Study||6
10324687|NCT00276250|11460047|FG000|STARTED|Overall Study||4
10324688|NCT00276250|11460048|FG001|STARTED|Overall Study||1
10324689|NCT00276250|11460049|FG002|STARTED|Overall Study||0
10324690|NCT00276250|11460047|FG000|COMPLETED|Overall Study||4
10324691|NCT00276250|11460048|FG001|COMPLETED|Overall Study||1
10324692|NCT00276250|11460049|FG002|COMPLETED|Overall Study||0
10324693|NCT00276250|11460047|FG000|NOT COMPLETED|Overall Study||0
10324694|NCT00276250|11460048|FG001|NOT COMPLETED|Overall Study||0
10324695|NCT00276250|11460049|FG002|NOT COMPLETED|Overall Study||0
10324696|NCT00276380|11460059|FG000|STARTED|Overall Study||102
10324697|NCT00276380|11460060|FG001|STARTED|Overall Study||102
10324698|NCT00276380|11460059|FG000|COMPLETED|Overall Study||88
10324699|NCT00276380|11460060|FG001|COMPLETED|Overall Study||88
10324700|NCT00276380|11460059|FG000|NOT COMPLETED|Overall Study||14
10324701|NCT00276380|11460060|FG001|NOT COMPLETED|Overall Study||14
10324702|NCT00276406|11460069|FG000|STARTED|Overall Study||16
10324703|NCT00276406|11460070|FG001|STARTED|Overall Study||14
10324704|NCT00276406|11460069|FG000|COMPLETED|Overall Study|14 of 16 subjects tolerated 360mg daily, while 2 of 16 tolerated 180mg daily.|16
10324705|NCT00276406|11460070|FG001|COMPLETED|Overall Study||14
10324706|NCT00276406|11460069|FG000|NOT COMPLETED|Overall Study||0
10324707|NCT00276406|11460070|FG001|NOT COMPLETED|Overall Study||0
10324708|NCT00276549|11460076|FG000|STARTED|Overall Study||35
10324709|NCT00276549|11460076|FG000|COMPLETED|Overall Study||35
10324710|NCT00276549|11460076|FG000|NOT COMPLETED|Overall Study||0
10324711|NCT00276614|11460080|FG000|STARTED|Overall Study||4
10324712|NCT00276614|11460080|FG000|COMPLETED|Overall Study||1
10324713|NCT00276614|11460080|FG000|NOT COMPLETED|Overall Study||3
10324714|NCT00276744|11460084|FG000|STARTED|PART A||240
10324715|NCT00276744|11460084|FG000|COMPLETED|PART A||142
10324716|NCT00276744|11460084|FG000|NOT COMPLETED|PART A||98
10324717|NCT00276744|11460084|FG000|STARTED|PART B|This study was terminated before participants could reach this stage of the study.|0
10324718|NCT00276744|11460084|FG000|COMPLETED|PART B||0
10324719|NCT00276744|11460084|FG000|NOT COMPLETED|PART B||0
10324720|NCT00276861|11460088|FG000|STARTED|Overall Study||10
10324721|NCT00276861|11460088|FG000|COMPLETED|Overall Study||10
10324722|NCT00276861|11460088|FG000|NOT COMPLETED|Overall Study||0
10324723|NCT00277095|11460093|FG000|STARTED|Overall Study|Anatomy of 1 patient did not allow ProACT to be implanted, hence only 123 patients were implanted.|124
10324724|NCT00277095|11460093|FG000|COMPLETED|Overall Study|Details of patients who did not complete study are given below.|103
10324725|NCT00277095|11460093|FG000|NOT COMPLETED|Overall Study||21
10324726|NCT00277212|11460097|FG000|STARTED|Phase 1 - Single-Blind Treatment||787
10324727|NCT00277212|11460098|FG001|STARTED|Phase 1 - Single-Blind Treatment||0
10324728|NCT00277212|11460099|FG002|STARTED|Phase 1 - Single-Blind Treatment||0
10324729|NCT00277212|11460097|FG000|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||787
10324730|NCT00277212|11460098|FG001|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||0
10324731|NCT00277212|11460099|FG002|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||0
10324732|NCT00277212|11460097|FG000|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||756
10324733|NCT00277212|11460098|FG001|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||0
10324734|NCT00277212|11460099|FG002|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||0
10324735|NCT00277212|11460097|FG000|COMPLETED|Phase 1 - Single-Blind Treatment||352
10324736|NCT00277212|11460098|FG001|COMPLETED|Phase 1 - Single-Blind Treatment||0
10324737|NCT00277212|11460099|FG002|COMPLETED|Phase 1 - Single-Blind Treatment||0
10324738|NCT00277212|11460097|FG000|NOT COMPLETED|Phase 1 - Single-Blind Treatment||435
10324739|NCT00277212|11460098|FG001|NOT COMPLETED|Phase 1 - Single-Blind Treatment||0
10324740|NCT00277212|11460099|FG002|NOT COMPLETED|Phase 1 - Single-Blind Treatment||0
10324741|NCT00277212|11460097|FG000|STARTED|Phase 2 - Double-Blind Treatment||0
10324742|NCT00277212|11460098|FG001|STARTED|Phase 2 - Double-Blind Treatment||173
10324743|NCT00277212|11460099|FG002|STARTED|Phase 2 - Double-Blind Treatment|1 participant did not want to continue in the study for personal reasons, and did not enter Phase 2.|178
10324744|NCT00277212|11460097|FG000|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||0
10324745|NCT00277212|11460098|FG001|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||165
10324746|NCT00277212|11460099|FG002|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||176
10324747|NCT00277212|11460097|FG000|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||0
10324748|NCT00277212|11460098|FG001|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||164
10324749|NCT00277212|11460099|FG002|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||174
10324750|NCT00277212|11460097|FG000|COMPLETED|Phase 2 - Double-Blind Treatment||0
10324751|NCT00277212|11460098|FG001|COMPLETED|Phase 2 - Double-Blind Treatment||53
10324752|NCT00277212|11460099|FG002|COMPLETED|Phase 2 - Double-Blind Treatment||65
10324753|NCT00277212|11460097|FG000|NOT COMPLETED|Phase 2 - Double-Blind Treatment||0
10324754|NCT00277212|11460098|FG001|NOT COMPLETED|Phase 2 - Double-Blind Treatment||120
10324755|NCT00277212|11460099|FG002|NOT COMPLETED|Phase 2 - Double-Blind Treatment||113
10324756|NCT00277355|11460109|FG000|STARTED|Overall Study||87
10324757|NCT00277355|11460110|FG001|STARTED|Overall Study||27
10324758|NCT00277355|11460109|FG000|COMPLETED|Overall Study||73
10324759|NCT00277355|11460110|FG001|COMPLETED|Overall Study||22
10324760|NCT00277355|11460109|FG000|NOT COMPLETED|Overall Study||14
10324761|NCT00277355|11460110|FG001|NOT COMPLETED|Overall Study||5
10324762|NCT00277394|11460119|FG000|STARTED|Overall Study||269
10324763|NCT00277394|11460120|FG001|STARTED|Overall Study||270
10324764|NCT00277394|11460119|FG000|COMPLETED|Overall Study||232
10324765|NCT00277394|11460120|FG001|COMPLETED|Overall Study||246
10324766|NCT00277394|11460119|FG000|NOT COMPLETED|Overall Study||37
10324767|NCT00277394|11460120|FG001|NOT COMPLETED|Overall Study||24
10324768|NCT00277446|11460126|FG000|STARTED|Overall Study||13
10324769|NCT00277446|11460126|FG000|COMPLETED|Overall Study||13
10324770|NCT00277446|11460126|FG000|NOT COMPLETED|Overall Study||0
10324771|NCT00277524|11460130|FG000|STARTED|Overall Study||621
10324772|NCT00277524|11460131|FG001|STARTED|Overall Study||324
10324773|NCT00277524|11460132|FG002|STARTED|Overall Study||1088
10324774|NCT00277524|11460133|FG003|STARTED|Overall Study||850
10324775|NCT00277524|11460130|FG000|COMPLETED|Overall Study||621
10324776|NCT00277524|11460131|FG001|COMPLETED|Overall Study||324
10324777|NCT00277524|11460132|FG002|COMPLETED|Overall Study||1088
10324778|NCT00277524|11460133|FG003|COMPLETED|Overall Study||850
10324779|NCT00277524|11460130|FG000|NOT COMPLETED|Overall Study||0
10324780|NCT00277524|11460131|FG001|NOT COMPLETED|Overall Study||0
10324781|NCT00277524|11460132|FG002|NOT COMPLETED|Overall Study||0
10324782|NCT00277524|11460133|FG003|NOT COMPLETED|Overall Study||0
10324783|NCT00278109|11460151|FG000|STARTED|Overall Study||25
10324784|NCT00278109|11460151|FG000|Completed 3 Cycles of Chemotherapy|Overall Study||25
10324785|NCT00278109|11460151|FG000|COMPLETED|Overall Study||21
10324786|NCT00278109|11460151|FG000|NOT COMPLETED|Overall Study||4
10324787|NCT00278148|11460155|FG000|STARTED|Phase I - Dose Escalation||4
10324788|NCT00278148|11460156|FG001|STARTED|Phase I - Dose Escalation||2
10324789|NCT00278148|11460157|FG002|STARTED|Phase I - Dose Escalation||3
10324790|NCT00278148|11460155|FG000|COMPLETED|Phase I - Dose Escalation||4
10324791|NCT00278148|11460156|FG001|COMPLETED|Phase I - Dose Escalation||2
10324792|NCT00278148|11460157|FG002|COMPLETED|Phase I - Dose Escalation||3
10324793|NCT00278148|11460155|FG000|NOT COMPLETED|Phase I - Dose Escalation||0
10324794|NCT00278148|11460156|FG001|NOT COMPLETED|Phase I - Dose Escalation||0
10324795|NCT00278148|11460157|FG002|NOT COMPLETED|Phase I - Dose Escalation||0
10324796|NCT00278148|11460155|FG000|STARTED|Phase II - Expansion Phase||0
10324797|NCT00278148|11460156|FG001|STARTED|Phase II - Expansion Phase||0
10324798|NCT00278148|11460157|FG002|STARTED|Phase II - Expansion Phase|Includes the 3 participants from phase I|26
10324799|NCT00278148|11460155|FG000|COMPLETED|Phase II - Expansion Phase||0
10324800|NCT00278148|11460156|FG001|COMPLETED|Phase II - Expansion Phase||0
10324801|NCT00278148|11460157|FG002|COMPLETED|Phase II - Expansion Phase||20
10324802|NCT00278148|11460155|FG000|NOT COMPLETED|Phase II - Expansion Phase||0
10324803|NCT00278148|11460156|FG001|NOT COMPLETED|Phase II - Expansion Phase||0
10324804|NCT00278148|11460157|FG002|NOT COMPLETED|Phase II - Expansion Phase||6
10324805|NCT00278161|11460164|FG000|STARTED|Overall Study||81
10324806|NCT00278161|11460164|FG000|COMPLETED|Overall Study||70
10324807|NCT00278161|11460164|FG000|NOT COMPLETED|Overall Study||11
10324808|NCT00278200|11460170|FG000|STARTED|Overall Study||2
10324809|NCT00278200|11460171|FG001|STARTED|Overall Study||12
10324810|NCT00278200|11460170|FG000|COMPLETED|Overall Study||1
10324811|NCT00278200|11460171|FG001|COMPLETED|Overall Study||8
10324812|NCT00278200|11460170|FG000|NOT COMPLETED|Overall Study||1
10324813|NCT00278200|11460171|FG001|NOT COMPLETED|Overall Study||4
10324814|NCT00278395|11460177|FG000|STARTED|Overall Study||14
10324815|NCT00278395|11460177|FG000|COMPLETED|Overall Study||11
10324816|NCT00278395|11460177|FG000|NOT COMPLETED|Overall Study||3
10324817|NCT00278473|11460186|FG000|STARTED|Overall Study||45
10324818|NCT00278473|11460187|FG001|STARTED|Overall Study||43
10324819|NCT00278473|11460186|FG000|COMPLETED|Overall Study||41
10324820|NCT00278473|11460187|FG001|COMPLETED|Overall Study||40
10324821|NCT00278473|11460186|FG000|NOT COMPLETED|Overall Study||4
10701650|NCT02569086|11866076|FG000|NOT COMPLETED|Overall Study||0
10701651|NCT02569112|11866080|FG000|STARTED|Overall Study||10
10701652|NCT02569112|11866081|FG001|STARTED|Overall Study||10
10701653|NCT02569112|11866080|FG000|COMPLETED|Overall Study||10
10701654|NCT02569112|11866081|FG001|COMPLETED|Overall Study|Each subject received multipolar RF with varipulse technology to only one side of their body.|10
10701655|NCT02569112|11866080|FG000|NOT COMPLETED|Overall Study||0
10701656|NCT02569112|11866081|FG001|NOT COMPLETED|Overall Study||0
10701657|NCT02569398|11866089|FG000|STARTED|Overall Study||185
10324822|NCT00278473|11460187|FG001|NOT COMPLETED|Overall Study||3
10324823|NCT00278512|11460195|FG000|STARTED|Overall Study||7
10324824|NCT00278512|11460196|FG001|STARTED|Overall Study||0
10324825|NCT00278512|11460195|FG000|COMPLETED|Overall Study||6
10324826|NCT00278512|11460196|FG001|COMPLETED|Overall Study||0
10324827|NCT00278512|11460195|FG000|NOT COMPLETED|Overall Study||1
10324828|NCT00278512|11460196|FG001|NOT COMPLETED|Overall Study||0
10324829|NCT00278525|11460204|FG000|STARTED|Overall Study||9
10324830|NCT00278525|11460205|FG001|STARTED|Overall Study||10
10324831|NCT00278525|11460204|FG000|COMPLETED|Overall Study|7 participants crossed to HSCT arm in accordance with the protocol|9
10324832|NCT00278525|11460205|FG001|COMPLETED|Overall Study|7 participant crossed over to the HSCT arm and underwent HSCT, in accordance with the protocol.|10
10324833|NCT00278525|11460204|FG000|NOT COMPLETED|Overall Study||0
10324834|NCT00278525|11460205|FG001|NOT COMPLETED|Overall Study||0
10324835|NCT00278538|11460211|FG000|STARTED|Overall Study||32
10324836|NCT00278538|11460211|FG000|COMPLETED|Overall Study||30
10324837|NCT00278538|11460211|FG000|NOT COMPLETED|Overall Study||2
10324838|NCT00278564|11460215|FG000|STARTED|Overall Study||7
10324839|NCT00278564|11460215|FG000|COMPLETED|Overall Study||3
10324840|NCT00278564|11460215|FG000|NOT COMPLETED|Overall Study||4
10324841|NCT00278629|11460219|FG000|STARTED|Overall Study||80
10324842|NCT00278629|11460219|FG000|COMPLETED|Overall Study||66
10324843|NCT00278629|11460219|FG000|NOT COMPLETED|Overall Study||14
10324844|NCT00278655|11460224|FG000|STARTED|Overall Study||21
10324845|NCT00278655|11460224|FG000|COMPLETED|Overall Study||21
10324846|NCT00278655|11460224|FG000|NOT COMPLETED|Overall Study||0
10324847|NCT00278863|11460231|FG000|STARTED|Overall Study||49
10324848|NCT00278863|11460232|FG001|STARTED|Overall Study||47
10324849|NCT00278863|11460231|FG000|COMPLETED|Overall Study||44
10324850|NCT00278863|11460232|FG001|COMPLETED|Overall Study||45
10324851|NCT00278863|11460231|FG000|NOT COMPLETED|Overall Study||5
10324852|NCT00278863|11460232|FG001|NOT COMPLETED|Overall Study||2
10324853|NCT00278876|11460238|FG000|STARTED|Overall Study||47
10324854|NCT00278876|11460238|FG000|COMPLETED|Overall Study||38
10324855|NCT00278876|11460238|FG000|NOT COMPLETED|Overall Study||9
10324856|NCT00278889|11460245|FG000|STARTED|Overall Study|Randomised|73
10324857|NCT00278889|11460246|FG001|STARTED|Overall Study|Randomised|74
10324858|NCT00278889|11460247|FG002|STARTED|Overall Study|Randomised|68
10324859|NCT00278889|11460245|FG000|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|16
10324860|NCT00278889|11460246|FG001|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|20
10324861|NCT00278889|11460247|FG002|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|19
10324862|NCT00278889|11460245|FG000|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|48
10324863|NCT00278889|11460246|FG001|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|47
10324864|NCT00278889|11460247|FG002|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|48
10324865|NCT00278889|11460245|FG000|NOT COMPLETED|Overall Study||25
10324866|NCT00278889|11460246|FG001|NOT COMPLETED|Overall Study||27
10324867|NCT00278889|11460247|FG002|NOT COMPLETED|Overall Study||20
10324868|NCT00278954|11460255|FG000|STARTED|Overall Study||50
10324869|NCT00278954|11460255|FG000|COMPLETED|Overall Study||45
10324870|NCT00278954|11460255|FG000|NOT COMPLETED|Overall Study||5
10324871|NCT00278993|11460259|FG000|STARTED|Overall Study||108
10324872|NCT00278993|11460259|FG000|COMPLETED|Overall Study||1
10324873|NCT00278993|11460259|FG000|NOT COMPLETED|Overall Study||107
10324874|NCT00279201|11460265|FG000|STARTED|Initiation||1046
10324875|NCT00279201|11460266|FG001|STARTED|Initiation||1045
10324876|NCT00279201|11460267|FG002|STARTED|Initiation||0
10324877|NCT00279201|11460268|FG003|STARTED|Initiation||0
10324878|NCT00279201|11460269|FG004|STARTED|Initiation||0
10324879|NCT00279201|11460270|FG005|STARTED|Initiation||0
10324880|NCT00279201|11460265|FG000|COMPLETED|Initiation||918
10324881|NCT00279201|11460266|FG001|COMPLETED|Initiation||900
10324882|NCT00279201|11460267|FG002|COMPLETED|Initiation||0
10324883|NCT00279201|11460268|FG003|COMPLETED|Initiation||0
10324884|NCT00279201|11460269|FG004|COMPLETED|Initiation||0
10324885|NCT00279201|11460270|FG005|COMPLETED|Initiation||0
10324886|NCT00279201|11460265|FG000|NOT COMPLETED|Initiation||128
10324887|NCT00279201|11460266|FG001|NOT COMPLETED|Initiation||145
10324888|NCT00279201|11460267|FG002|NOT COMPLETED|Initiation||0
10324889|NCT00279201|11460268|FG003|NOT COMPLETED|Initiation||0
10324890|NCT00279201|11460269|FG004|NOT COMPLETED|Initiation||0
10324891|NCT00279201|11460270|FG005|NOT COMPLETED|Initiation||0
10338579|NCT04150341|11475488|FG003|COMPLETED|Overall Study||4
10701658|NCT02569398|11866090|FG001|STARTED|Overall Study||189
10324892|NCT00279201|11460265|FG000|STARTED|Maintenance|100 left the study after initiation. 399 had HbA1c>7% and enrolled in intensification addendum.|419
10324893|NCT00279201|11460266|FG001|STARTED|Maintenance|82 left the study after initiation. 345 had HbA1c>7% and enrolled in intensification addendum.|473
10324894|NCT00279201|11460267|FG002|STARTED|Maintenance||0
10324895|NCT00279201|11460268|FG003|STARTED|Maintenance||0
10324896|NCT00279201|11460269|FG004|STARTED|Maintenance||0
10324897|NCT00279201|11460270|FG005|STARTED|Maintenance||0
10324898|NCT00279201|11460265|FG000|COMPLETED|Maintenance||188
10324899|NCT00279201|11460266|FG001|COMPLETED|Maintenance||239
10324900|NCT00279201|11460267|FG002|COMPLETED|Maintenance||0
10324901|NCT00279201|11460268|FG003|COMPLETED|Maintenance||0
10324902|NCT00279201|11460269|FG004|COMPLETED|Maintenance||0
10324903|NCT00279201|11460270|FG005|COMPLETED|Maintenance||0
10324904|NCT00279201|11460265|FG000|NOT COMPLETED|Maintenance||231
10324905|NCT00279201|11460266|FG001|NOT COMPLETED|Maintenance||234
10324906|NCT00279201|11460267|FG002|NOT COMPLETED|Maintenance||0
10324907|NCT00279201|11460268|FG003|NOT COMPLETED|Maintenance||0
10324908|NCT00279201|11460269|FG004|NOT COMPLETED|Maintenance||0
10324909|NCT00279201|11460270|FG005|NOT COMPLETED|Maintenance||0
10324910|NCT00279201|11460265|FG000|STARTED|Intensification Addendum||0
10324911|NCT00279201|11460266|FG001|STARTED|Intensification Addendum||0
10324912|NCT00279201|11460267|FG002|STARTED|Intensification Addendum||174
10324913|NCT00279201|11460268|FG003|STARTED|Intensification Addendum||200
10324914|NCT00279201|11460269|FG004|STARTED|Intensification Addendum||171
10324915|NCT00279201|11460270|FG005|STARTED|Intensification Addendum||199
10324916|NCT00279201|11460265|FG000|COMPLETED|Intensification Addendum||0
10324917|NCT00279201|11460266|FG001|COMPLETED|Intensification Addendum||0
10324918|NCT00279201|11460267|FG002|COMPLETED|Intensification Addendum||151
10324919|NCT00279201|11460268|FG003|COMPLETED|Intensification Addendum||172
10324920|NCT00279201|11460269|FG004|COMPLETED|Intensification Addendum||142
10324921|NCT00279201|11460270|FG005|COMPLETED|Intensification Addendum||162
10324922|NCT00279201|11460265|FG000|NOT COMPLETED|Intensification Addendum||0
10324923|NCT00279201|11460266|FG001|NOT COMPLETED|Intensification Addendum||0
10324924|NCT00279201|11460267|FG002|NOT COMPLETED|Intensification Addendum||23
10324925|NCT00279201|11460268|FG003|NOT COMPLETED|Intensification Addendum||28
10324926|NCT00279201|11460269|FG004|NOT COMPLETED|Intensification Addendum||29
10324927|NCT00279201|11460270|FG005|NOT COMPLETED|Intensification Addendum||37
10324928|NCT00279214|11460305|FG000|STARTED|Overall Study||22
10324929|NCT00279214|11460306|FG001|STARTED|Overall Study||21
10324930|NCT00279214|11460305|FG000|COMPLETED|Overall Study|Completed means the number of per-protocol patients in the study|19
10324931|NCT00279214|11460306|FG001|COMPLETED|Overall Study|Completed means the number of per-protocol patients in the study|19
10324932|NCT00279214|11460305|FG000|NOT COMPLETED|Overall Study||3
10324933|NCT00279214|11460306|FG001|NOT COMPLETED|Overall Study||2
10324934|NCT00279305|11460314|FG000|STARTED|Overall Study||57
10324935|NCT00279305|11460315|FG001|STARTED|Overall Study||30
10324936|NCT00279305|11460314|FG000|COMPLETED|Overall Study||49
10324937|NCT00279305|11460315|FG001|COMPLETED|Overall Study||29
10324938|NCT00279305|11460314|FG000|NOT COMPLETED|Overall Study||8
10324939|NCT00279305|11460315|FG001|NOT COMPLETED|Overall Study||1
10324940|NCT00279500|11460321|FG000|STARTED|Overall Study|6 patients treated|6
10324941|NCT00279500|11460321|FG000|COMPLETED|Overall Study|6 patients treated|6
10324942|NCT00279500|11460321|FG000|NOT COMPLETED|Overall Study||0
10324943|NCT00279591|11460327|FG000|STARTED|Overall Study||48
10324944|NCT00279591|11460328|FG001|STARTED|Overall Study||46
10324945|NCT00279591|11460327|FG000|COMPLETED|Overall Study||48
10324946|NCT00279591|11460328|FG001|COMPLETED|Overall Study||46
10324947|NCT00279591|11460327|FG000|NOT COMPLETED|Overall Study||0
10324948|NCT00279591|11460328|FG001|NOT COMPLETED|Overall Study||0
10324949|NCT00279708|11460338|FG000|STARTED|Overall Study|"Started meaning randomized"|27
10324950|NCT00279708|11460339|FG001|STARTED|Overall Study||28
10324951|NCT00279708|11460338|FG000|COMPLETED|Overall Study||24
10324952|NCT00279708|11460339|FG001|COMPLETED|Overall Study||24
10324953|NCT00279708|11460338|FG000|NOT COMPLETED|Overall Study||3
10324954|NCT00279708|11460339|FG001|NOT COMPLETED|Overall Study||4
10324955|NCT00279812|11460351|FG000|STARTED|Overall Study||21
10324956|NCT00279812|11460352|FG001|STARTED|Overall Study||26
10324957|NCT00279812|11460353|FG002|STARTED|Overall Study||24
10324958|NCT00279812|11460354|FG003|STARTED|Overall Study||23
10324959|NCT00279812|11460355|FG004|STARTED|Overall Study||20
10324960|NCT00279812|11460356|FG005|STARTED|Overall Study||19
10803882|NCT04095286|11965325|FG002|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||2
10803883|NCT04095286|11965326|FG003|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0
10803884|NCT04095286|11965327|FG004|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||1
10324961|NCT00279812|11460351|FG000|COMPLETED|Overall Study||20
10324962|NCT00279812|11460352|FG001|COMPLETED|Overall Study||20
10324963|NCT00279812|11460353|FG002|COMPLETED|Overall Study||21
10324964|NCT00279812|11460354|FG003|COMPLETED|Overall Study||23
10324965|NCT00279812|11460355|FG004|COMPLETED|Overall Study||17
10324966|NCT00279812|11460356|FG005|COMPLETED|Overall Study||18
10324967|NCT00279812|11460351|FG000|NOT COMPLETED|Overall Study||1
10324968|NCT00279812|11460352|FG001|NOT COMPLETED|Overall Study||6
10324969|NCT00279812|11460353|FG002|NOT COMPLETED|Overall Study||3
10324970|NCT00279812|11460354|FG003|NOT COMPLETED|Overall Study||0
10324971|NCT00279812|11460355|FG004|NOT COMPLETED|Overall Study||3
10324972|NCT00279812|11460356|FG005|NOT COMPLETED|Overall Study||1
10324973|NCT00279916|11460372|FG000|STARTED|Overall Study||45
10324974|NCT00279916|11460373|FG001|STARTED|Overall Study||46
10324975|NCT00279916|11460372|FG000|COMPLETED|Overall Study||38
10324976|NCT00279916|11460373|FG001|COMPLETED|Overall Study||41
10324977|NCT00279916|11460372|FG000|NOT COMPLETED|Overall Study||7
10324978|NCT00279916|11460373|FG001|NOT COMPLETED|Overall Study||5
10324979|NCT00279955|11460382|FG000|STARTED|Overall Study||157
10324980|NCT00279955|11460383|FG001|STARTED|Overall Study||486
10324981|NCT00279955|11460384|FG002|STARTED|Overall Study||358
10324982|NCT00279955|11460382|FG000|COMPLETED|Overall Study||157
10324983|NCT00279955|11460383|FG001|COMPLETED|Overall Study||486
10324984|NCT00279955|11460384|FG002|COMPLETED|Overall Study|They are still counted as completes, though they are never used for the analyses of objectives.|358
10324985|NCT00279955|11460382|FG000|NOT COMPLETED|Overall Study||0
10324986|NCT00279955|11460383|FG001|NOT COMPLETED|Overall Study||0
10324987|NCT00279955|11460384|FG002|NOT COMPLETED|Overall Study||0
10324988|NCT00280059|11460393|FG000|STARTED|Efficacy Assessment Phase||330
10324989|NCT00280059|11460394|FG001|STARTED|Efficacy Assessment Phase||330
10324990|NCT00280059|11460393|FG000|COMPLETED|Efficacy Assessment Phase|Week 56: up to end of efficacy assessment phase (excluding extension phase).|236
10324991|NCT00280059|11460394|FG001|COMPLETED|Efficacy Assessment Phase|Week 56: up to end of efficacy assessment phase (excluding extension phase).|250
10324992|NCT00280059|11460393|FG000|NOT COMPLETED|Efficacy Assessment Phase||94
10324993|NCT00280059|11460394|FG001|NOT COMPLETED|Efficacy Assessment Phase||80
10324994|NCT00280059|11460393|FG000|STARTED|Extension Phase|Optional phase; number entered was less than the number who completed the efficacy assessment phase.|194
10324995|NCT00280059|11460394|FG001|STARTED|Extension Phase|Optional phase; number entered was less than the number who completed the efficacy assessment phase.|215
10324996|NCT00280059|11460393|FG000|COMPLETED|Extension Phase||145
10324997|NCT00280059|11460394|FG001|COMPLETED|Extension Phase||177
10324998|NCT00280059|11460393|FG000|NOT COMPLETED|Extension Phase||49
10324999|NCT00280059|11460394|FG001|NOT COMPLETED|Extension Phase||38
10325000|NCT00280150|11460412|FG000|STARTED|Overall Study||5
10325001|NCT00280150|11460413|FG001|STARTED|Overall Study||5
10325002|NCT00280150|11460414|FG002|STARTED|Overall Study||6
10325003|NCT00280150|11460415|FG003|STARTED|Overall Study||30
10325004|NCT00280150|11460412|FG000|Cohort Induction|Overall Study||5
10325005|NCT00280150|11460413|FG001|Cohort Induction|Overall Study||5
10325006|NCT00280150|11460414|FG002|Cohort Induction|Overall Study||6
10325007|NCT00280150|11460415|FG003|Cohort Induction|Overall Study||30
10325008|NCT00280150|11460412|FG000|Consolidation Therapy|Overall Study||2
10325009|NCT00280150|11460413|FG001|Consolidation Therapy|Overall Study||5
10325010|NCT00280150|11460414|FG002|Consolidation Therapy|Overall Study||3
10325011|NCT00280150|11460415|FG003|Consolidation Therapy|Overall Study|Phase II participants did not receive consolidation therapy.|0
10325012|NCT00280150|11460412|FG000|COMPLETED|Overall Study||2
10325013|NCT00280150|11460413|FG001|COMPLETED|Overall Study||4
10325014|NCT00280150|11460414|FG002|COMPLETED|Overall Study||1
10325015|NCT00280150|11460415|FG003|COMPLETED|Overall Study||20
10325016|NCT00280150|11460412|FG000|NOT COMPLETED|Overall Study||3
10325017|NCT00280150|11460413|FG001|NOT COMPLETED|Overall Study||1
10325018|NCT00280150|11460414|FG002|NOT COMPLETED|Overall Study||5
10325019|NCT00280150|11460415|FG003|NOT COMPLETED|Overall Study||10
10325020|NCT00280241|11460426|FG000|STARTED|Overall Study||65
10325021|NCT00280241|11460426|FG000|COMPLETED|Overall Study||55
10325022|NCT00280241|11460426|FG000|NOT COMPLETED|Overall Study||10
10325023|NCT00280293|11460432|FG000|STARTED|Overall Study||55
10325024|NCT00280293|11460433|FG001|STARTED|Overall Study||57
10325025|NCT00280293|11460432|FG000|COMPLETED|Overall Study||29
10325026|NCT00280293|11460433|FG001|COMPLETED|Overall Study||34
10325027|NCT00280293|11460432|FG000|NOT COMPLETED|Overall Study||26
10325028|NCT00280293|11460433|FG001|NOT COMPLETED|Overall Study||23
10325029|NCT00280384|11460447|FG000|STARTED|Overall Study||6
10325030|NCT00280384|11460448|FG001|STARTED|Overall Study||6
10325031|NCT00280384|11460449|FG002|STARTED|Overall Study||6
10325032|NCT00280384|11460450|FG003|STARTED|Overall Study||6
10325033|NCT00280384|11460451|FG004|STARTED|Overall Study||6
10325034|NCT00280384|11460452|FG005|STARTED|Overall Study||6
10325035|NCT00280384|11460453|FG006|STARTED|Overall Study||6
10325036|NCT00280384|11460454|FG007|STARTED|Overall Study||6
10325037|NCT00280384|11460447|FG000|COMPLETED|Overall Study||6
10325038|NCT00280384|11460448|FG001|COMPLETED|Overall Study||6
10325039|NCT00280384|11460449|FG002|COMPLETED|Overall Study||6
10325040|NCT00280384|11460450|FG003|COMPLETED|Overall Study||6
10325041|NCT00280384|11460451|FG004|COMPLETED|Overall Study||6
10325042|NCT00280384|11460452|FG005|COMPLETED|Overall Study||6
10325043|NCT00280384|11460453|FG006|COMPLETED|Overall Study||6
10325044|NCT00280384|11460454|FG007|COMPLETED|Overall Study||6
10325045|NCT00280384|11460447|FG000|NOT COMPLETED|Overall Study||0
10325046|NCT00280384|11460448|FG001|NOT COMPLETED|Overall Study||0
10325047|NCT00280384|11460449|FG002|NOT COMPLETED|Overall Study||0
10325048|NCT00280384|11460450|FG003|NOT COMPLETED|Overall Study||0
10325049|NCT00280384|11460451|FG004|NOT COMPLETED|Overall Study||0
10325050|NCT00280384|11460452|FG005|NOT COMPLETED|Overall Study||0
10325051|NCT00280384|11460453|FG006|NOT COMPLETED|Overall Study||0
10325052|NCT00280384|11460454|FG007|NOT COMPLETED|Overall Study||0
10325053|NCT00280397|11460472|FG000|STARTED|Overall Study||27
10325054|NCT00280397|11460472|FG000|COMPLETED|Overall Study||26
10325055|NCT00280397|11460472|FG000|NOT COMPLETED|Overall Study||1
10325056|NCT00280566|11460480|FG000|STARTED|Period 1 Open Label Ziprasidone|1 subject inappropriately randomized into 2 different sites. Data from this subject was excluded.|584
10325057|NCT00280566|11460481|FG001|STARTED|Period 1 Open Label Ziprasidone||0
10325058|NCT00280566|11460482|FG002|STARTED|Period 1 Open Label Ziprasidone||0
10803885|NCT04095286|11965328|FG005|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0
10803886|NCT04095286|11965323|FG000|STARTED|Period 3 (4 Days) + Follow up (14 Days)||3
10803887|NCT04095286|11965324|FG001|STARTED|Period 3 (4 Days) + Follow up (14 Days)||4
10803888|NCT04095286|11965325|FG002|STARTED|Period 3 (4 Days) + Follow up (14 Days)||2
10803889|NCT04095286|11965326|FG003|STARTED|Period 3 (4 Days) + Follow up (14 Days)||5
10803890|NCT04095286|11965327|FG004|STARTED|Period 3 (4 Days) + Follow up (14 Days)||4
10803891|NCT04095286|11965328|FG005|STARTED|Period 3 (4 Days) + Follow up (14 Days)||5
10803892|NCT04095286|11965323|FG000|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||3
10803893|NCT04095286|11965324|FG001|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||4
10803894|NCT04095286|11965325|FG002|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||2
10803895|NCT04095286|11965326|FG003|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||5
10803896|NCT04095286|11965327|FG004|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||4
10803897|NCT04095286|11965328|FG005|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||5
10803898|NCT04095286|11965323|FG000|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
10803899|NCT04095286|11965324|FG001|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
10803900|NCT04095286|11965325|FG002|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
10803901|NCT04095286|11965326|FG003|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
10803902|NCT04095286|11965327|FG004|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
10803903|NCT04095286|11965328|FG005|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
10803904|NCT04094883|11965336|FG000|STARTED|Overall Study||11
10803905|NCT04094883|11965336|FG000|COMPLETED|Overall Study||10
10803906|NCT04094883|11965336|FG000|NOT COMPLETED|Overall Study||1
10803907|NCT04091659|11965342|FG000|STARTED|Overall Study||40
10803908|NCT04091659|11965343|FG001|STARTED|Overall Study||58
10803909|NCT04091659|11965342|FG000|COMPLETED|Overall Study||37
10803910|NCT04091659|11965343|FG001|COMPLETED|Overall Study||57
10803911|NCT04091659|11965342|FG000|NOT COMPLETED|Overall Study||3
10803912|NCT04091659|11965343|FG001|NOT COMPLETED|Overall Study||1
10803913|NCT04091061|11965353|FG000|STARTED|Overall Study||6
10803914|NCT04091061|11965354|FG001|STARTED|Overall Study||6
10803915|NCT04091061|11965355|FG002|STARTED|Overall Study||6
10803916|NCT04091061|11965356|FG003|STARTED|Overall Study||6
10803917|NCT04091061|11965353|FG000|COMPLETED|Overall Study||6
10803918|NCT04091061|11965354|FG001|COMPLETED|Overall Study||6
10803919|NCT04091061|11965355|FG002|COMPLETED|Overall Study||6
10803920|NCT04091061|11965356|FG003|COMPLETED|Overall Study||6
10803921|NCT04091061|11965353|FG000|NOT COMPLETED|Overall Study||0
10803922|NCT04091061|11965354|FG001|NOT COMPLETED|Overall Study||0
10803923|NCT04091061|11965355|FG002|NOT COMPLETED|Overall Study||0
10803924|NCT04091061|11965356|FG003|NOT COMPLETED|Overall Study||0
10803925|NCT04090242|11965368|FG000|STARTED|Overall Study||28
10803926|NCT04090242|11965369|FG001|STARTED|Overall Study||30
10803927|NCT04090242|11965368|FG000|COMPLETED|Overall Study||27
10803928|NCT04090242|11965369|FG001|COMPLETED|Overall Study||30
10803929|NCT04090242|11965368|FG000|NOT COMPLETED|Overall Study||1
10803930|NCT04090242|11965369|FG001|NOT COMPLETED|Overall Study||0
10803931|NCT04089761|11965376|FG000|STARTED|"Run In Phase"||60
10803932|NCT04089761|11965376|FG000|COMPLETED|"Run In Phase"||45
10803933|NCT04089761|11965376|FG000|NOT COMPLETED|"Run In Phase"||15
10803934|NCT04089761|11965376|FG000|STARTED|"Treatment Phase"||45
10803935|NCT04089761|11965376|FG000|COMPLETED|"Treatment Phase"||39
10803936|NCT04089761|11965376|FG000|NOT COMPLETED|"Treatment Phase"||6
10803937|NCT04089761|11965376|FG000|STARTED|"Follow Up Phase (Optional)"|"Due to the COVID-19 pandemic, Only 27 participants were able to continue to the folllow Up phase"|27
10803938|NCT04089761|11965376|FG000|COMPLETED|"Follow Up Phase (Optional)"||27
10803939|NCT04089761|11965376|FG000|NOT COMPLETED|"Follow Up Phase (Optional)"||0
10803940|NCT04079803|11965383|FG000|STARTED|Overall Study||22
10803941|NCT04079803|11965384|FG001|STARTED|Overall Study||21
10803942|NCT04079803|11965385|FG002|STARTED|Overall Study||21
10803943|NCT04079803|11965383|FG000|COMPLETED|Overall Study||22
10803944|NCT04079803|11965384|FG001|COMPLETED|Overall Study||21
10803945|NCT04079803|11965385|FG002|COMPLETED|Overall Study||20
10803946|NCT04079803|11965383|FG000|NOT COMPLETED|Overall Study||0
10803947|NCT04079803|11965384|FG001|NOT COMPLETED|Overall Study||0
10803948|NCT04079803|11965385|FG002|NOT COMPLETED|Overall Study||1
10803949|NCT04086576|11965409|FG000|STARTED|Overall Study||10
10803950|NCT04086576|11965410|FG001|STARTED|Overall Study||10
10803951|NCT04086576|11965409|FG000|COMPLETED|Overall Study||10
10803952|NCT04086576|11965410|FG001|COMPLETED|Overall Study||10
10803953|NCT04086576|11965409|FG000|NOT COMPLETED|Overall Study||0
10803954|NCT04086576|11965410|FG001|NOT COMPLETED|Overall Study||0
10803955|NCT04086641|11965428|FG000|STARTED|Foot 1 (Two Week Utilization)||2
10803956|NCT04086641|11965429|FG001|STARTED|Foot 1 (Two Week Utilization)||3
10803957|NCT04086641|11965428|FG000|COMPLETED|Foot 1 (Two Week Utilization)||1
10803958|NCT04086641|11965429|FG001|COMPLETED|Foot 1 (Two Week Utilization)||1
10803959|NCT04086641|11965428|FG000|NOT COMPLETED|Foot 1 (Two Week Utilization)||1
10803960|NCT04086641|11965429|FG001|NOT COMPLETED|Foot 1 (Two Week Utilization)||2
10803961|NCT04086641|11965428|FG000|STARTED|Foot 2 (Two Week Utilization)||1
10803962|NCT04086641|11965429|FG001|STARTED|Foot 2 (Two Week Utilization)||1
10803963|NCT04086641|11965428|FG000|COMPLETED|Foot 2 (Two Week Utilization)||1
10803964|NCT04086641|11965429|FG001|COMPLETED|Foot 2 (Two Week Utilization)||1
10803965|NCT04086641|11965428|FG000|NOT COMPLETED|Foot 2 (Two Week Utilization)||0
10803966|NCT04086641|11965429|FG001|NOT COMPLETED|Foot 2 (Two Week Utilization)||0
10325059|NCT00280566|11460480|FG000|COMPLETED|Period 1 Open Label Ziprasidone|Subject excluded as described above is counted as 2; enrolled in 2 sites (2 identification numbers)|241
10325060|NCT00280566|11460481|FG001|COMPLETED|Period 1 Open Label Ziprasidone||0
10325061|NCT00280566|11460482|FG002|COMPLETED|Period 1 Open Label Ziprasidone||0
10325062|NCT00280566|11460480|FG000|NOT COMPLETED|Period 1 Open Label Ziprasidone||343
10325063|NCT00280566|11460481|FG001|NOT COMPLETED|Period 1 Open Label Ziprasidone||0
10325064|NCT00280566|11460482|FG002|NOT COMPLETED|Period 1 Open Label Ziprasidone||0
10325065|NCT00280566|11460480|FG000|STARTED|Period 2 Double Blind|1 subject in Period 1 did not want to be randomized into Period 2|0
10325066|NCT00280566|11460481|FG001|STARTED|Period 2 Double Blind||127
10325067|NCT00280566|11460482|FG002|STARTED|Period 2 Double Blind||111
10325068|NCT00280566|11460480|FG000|COMPLETED|Period 2 Double Blind||0
10325069|NCT00280566|11460481|FG001|COMPLETED|Period 2 Double Blind||84
10325070|NCT00280566|11460482|FG002|COMPLETED|Period 2 Double Blind||54
10325071|NCT00280566|11460480|FG000|NOT COMPLETED|Period 2 Double Blind||0
10325072|NCT00280566|11460481|FG001|NOT COMPLETED|Period 2 Double Blind||43
10325073|NCT00280566|11460482|FG002|NOT COMPLETED|Period 2 Double Blind||57
10325074|NCT00280683|11460491|FG000|STARTED|Overall Study||10
10325075|NCT00280683|11460492|FG001|STARTED|Overall Study||10
10325076|NCT00280683|11460491|FG000|COMPLETED|Overall Study|Reasons for subjects discontinuing included inability to adhere to the schedule or adverse event.|8
10325077|NCT00280683|11460492|FG001|COMPLETED|Overall Study||7
10325078|NCT00280683|11460491|FG000|NOT COMPLETED|Overall Study||2
10325079|NCT00280683|11460492|FG001|NOT COMPLETED|Overall Study||3
10325080|NCT00280735|11460500|FG000|STARTED|Overall Study||75
10325081|NCT00280735|11460500|FG000|Received Treatment|Overall Study||72
10325082|NCT00280735|11460500|FG000|Received Adequate Exposure|Overall Study||57
10325083|NCT00280735|11460500|FG000|COMPLETED|Overall Study||57
10325084|NCT00280735|11460500|FG000|NOT COMPLETED|Overall Study||18
10325085|NCT00280748|11460508|FG000|STARTED|Overall Study||10
10325086|NCT00280748|11460508|FG000|COMPLETED|Overall Study||6
10325087|NCT00280748|11460508|FG000|NOT COMPLETED|Overall Study||4
10325088|NCT00280826|11460512|FG000|STARTED|Overall Study||6
10325089|NCT00280826|11460512|FG000|COMPLETED|Overall Study||6
10325090|NCT00280826|11460512|FG000|NOT COMPLETED|Overall Study||0
10325091|NCT00280904|11460516|FG000|STARTED|Overall Study||433
10325092|NCT00280904|11460516|FG000|COMPLETED|Overall Study||433
10325093|NCT00280904|11460516|FG000|NOT COMPLETED|Overall Study||0
10325094|NCT00280917|11460525|FG000|STARTED|Overall Study||65
10325095|NCT00280917|11460526|FG001|STARTED|Overall Study||63
10325096|NCT00280917|11460527|FG002|STARTED|Overall Study||63
10325097|NCT00280917|11460528|FG003|STARTED|Overall Study||63
10325098|NCT00280917|11460525|FG000|COMPLETED|Overall Study||63
10325099|NCT00280917|11460526|FG001|COMPLETED|Overall Study||57
10325100|NCT00280917|11460527|FG002|COMPLETED|Overall Study||57
10325101|NCT00280917|11460528|FG003|COMPLETED|Overall Study||61
10325102|NCT00280917|11460525|FG000|NOT COMPLETED|Overall Study||2
10325103|NCT00280917|11460526|FG001|NOT COMPLETED|Overall Study||6
10325104|NCT00280917|11460527|FG002|NOT COMPLETED|Overall Study||6
10325105|NCT00280917|11460528|FG003|NOT COMPLETED|Overall Study||2
10325106|NCT00281021|11460538|FG000|STARTED|Overall Study||26
10325107|NCT00281021|11460538|FG000|COMPLETED|Overall Study||24
10325108|NCT00281021|11460538|FG000|NOT COMPLETED|Overall Study||2
10325109|NCT00281099|11460544|FG000|STARTED|Overall Study||513
10325110|NCT00281099|11460545|FG001|STARTED|Overall Study||518
10325111|NCT00281099|11460544|FG000|COMPLETED|Overall Study||308
10325112|NCT00281099|11460545|FG001|COMPLETED|Overall Study||296
10325113|NCT00281099|11460544|FG000|NOT COMPLETED|Overall Study||205
10325114|NCT00281099|11460545|FG001|NOT COMPLETED|Overall Study||222
10325115|NCT00281463|11460552|FG000|STARTED|Overall Study||45
10325116|NCT00281463|11460552|FG000|COMPLETED|Overall Study||45
10325117|NCT00281463|11460552|FG000|NOT COMPLETED|Overall Study||0
10325118|NCT00281528|11460559|FG000|STARTED|Overall Study||75
10325119|NCT00281528|11460560|FG001|STARTED|Overall Study||54
10325120|NCT00281528|11460561|FG002|STARTED|Overall Study||79
10325121|NCT00281528|11460559|FG000|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
10325122|NCT00281528|11460560|FG001|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
10325123|NCT00281528|11460561|FG002|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
10325124|NCT00281528|11460559|FG000|NOT COMPLETED|Overall Study||75
10325125|NCT00281528|11460560|FG001|NOT COMPLETED|Overall Study||54
10325126|NCT00281528|11460561|FG002|NOT COMPLETED|Overall Study||79
10325127|NCT00281580|11460585|FG000|STARTED|Overall Study||46
10803973|NCT04085289|11965447|FG000|STARTED|Overall Study||6
10325128|NCT00281580|11460586|FG001|STARTED|Overall Study||42
10325129|NCT00281580|11460587|FG002|STARTED|Overall Study||130
10325130|NCT00281580|11460588|FG003|STARTED|Overall Study||135
10325131|NCT00281580|11460589|FG004|STARTED|Overall Study||44
10325132|NCT00281580|11460590|FG005|STARTED|Overall Study||46
10325133|NCT00281580|11460591|FG006|STARTED|Overall Study||44
10325134|NCT00281580|11460592|FG007|STARTED|Overall Study||47
10325135|NCT00281580|11460593|FG008|STARTED|Overall Study||143
10325136|NCT00281580|11460594|FG009|STARTED|Overall Study||129
10325137|NCT00281580|11460595|FG010|STARTED|Overall Study||48
10325138|NCT00281580|11460596|FG011|STARTED|Overall Study||146
10325139|NCT00281580|11460597|FG012|STARTED|Overall Study||142
10325140|NCT00281580|11460598|FG013|STARTED|Overall Study||50
10325141|NCT00281580|11460599|FG014|STARTED|Overall Study||140
10325142|NCT00281580|11460600|FG015|STARTED|Overall Study||129
10325143|NCT00281580|11460585|FG000|COMPLETED|Overall Study||39
10325144|NCT00281580|11460586|FG001|COMPLETED|Overall Study||41
10325145|NCT00281580|11460587|FG002|COMPLETED|Overall Study||125
10325146|NCT00281580|11460588|FG003|COMPLETED|Overall Study||118
10325147|NCT00281580|11460589|FG004|COMPLETED|Overall Study||40
10325148|NCT00281580|11460590|FG005|COMPLETED|Overall Study||43
10325149|NCT00281580|11460591|FG006|COMPLETED|Overall Study||39
10325150|NCT00281580|11460592|FG007|COMPLETED|Overall Study||46
10325151|NCT00281580|11460593|FG008|COMPLETED|Overall Study||135
10325152|NCT00281580|11460594|FG009|COMPLETED|Overall Study||117
10325153|NCT00281580|11460595|FG010|COMPLETED|Overall Study||44
10325154|NCT00281580|11460596|FG011|COMPLETED|Overall Study||136
10325155|NCT00281580|11460597|FG012|COMPLETED|Overall Study||129
10325156|NCT00281580|11460598|FG013|COMPLETED|Overall Study||43
10325157|NCT00281580|11460599|FG014|COMPLETED|Overall Study||133
10325158|NCT00281580|11460600|FG015|COMPLETED|Overall Study||116
10325159|NCT00281580|11460585|FG000|NOT COMPLETED|Overall Study||7
10325160|NCT00281580|11460586|FG001|NOT COMPLETED|Overall Study||1
10325161|NCT00281580|11460587|FG002|NOT COMPLETED|Overall Study||5
10325162|NCT00281580|11460588|FG003|NOT COMPLETED|Overall Study||17
10325163|NCT00281580|11460589|FG004|NOT COMPLETED|Overall Study||4
10325164|NCT00281580|11460590|FG005|NOT COMPLETED|Overall Study||3
10325165|NCT00281580|11460591|FG006|NOT COMPLETED|Overall Study||5
10325166|NCT00281580|11460592|FG007|NOT COMPLETED|Overall Study||1
10325167|NCT00281580|11460593|FG008|NOT COMPLETED|Overall Study||8
10325168|NCT00281580|11460594|FG009|NOT COMPLETED|Overall Study||12
10325169|NCT00281580|11460595|FG010|NOT COMPLETED|Overall Study||4
10325170|NCT00281580|11460596|FG011|NOT COMPLETED|Overall Study||10
10325171|NCT00281580|11460597|FG012|NOT COMPLETED|Overall Study||13
10325172|NCT00281580|11460598|FG013|NOT COMPLETED|Overall Study||7
10325173|NCT00281580|11460599|FG014|NOT COMPLETED|Overall Study||7
10325174|NCT00281580|11460600|FG015|NOT COMPLETED|Overall Study||13
10325175|NCT00281632|11460669|FG000|STARTED|Overall Study||36
10803974|NCT04085289|11965448|FG001|STARTED|Overall Study||12
10803975|NCT04085289|11965449|FG002|STARTED|Overall Study||12
10803976|NCT04085289|11965447|FG000|Received at Least One Dose of Study Drug|Overall Study||6
10803977|NCT04085289|11965448|FG001|Received at Least One Dose of Study Drug|Overall Study||12
10803978|NCT04085289|11965449|FG002|Received at Least One Dose of Study Drug|Overall Study||12
10803979|NCT04085289|11965447|FG000|COMPLETED|Overall Study||6
10803980|NCT04085289|11965448|FG001|COMPLETED|Overall Study||12
10803981|NCT04085289|11965449|FG002|COMPLETED|Overall Study||11
10803982|NCT04085289|11965447|FG000|NOT COMPLETED|Overall Study||0
10803983|NCT04085289|11965448|FG001|NOT COMPLETED|Overall Study||0
10803984|NCT04085289|11965449|FG002|NOT COMPLETED|Overall Study||1
10803985|NCT04084015|11965456|FG000|STARTED|Overall Study||2
10803986|NCT04084015|11965456|FG000|COMPLETED|Overall Study||2
10803987|NCT04084015|11965456|FG000|NOT COMPLETED|Overall Study||0
10803988|NCT04082663|11965460|FG000|STARTED|Overall Study||20
10803989|NCT04082663|11965460|FG000|COMPLETED|Overall Study||13
10803990|NCT04082663|11965460|FG000|NOT COMPLETED|Overall Study||7
10803991|NCT04084028|11965468|FG000|STARTED|Overall Study||18
10803992|NCT04084028|11965469|FG001|STARTED|Overall Study||16
10803993|NCT04084028|11965470|FG002|STARTED|Overall Study||9
10803994|NCT04084028|11965471|FG003|STARTED|Overall Study||10
10803995|NCT04084028|11965468|FG000|COMPLETED|Overall Study||18
10803996|NCT04084028|11965469|FG001|COMPLETED|Overall Study||16
10803997|NCT04084028|11965470|FG002|COMPLETED|Overall Study||9
10803998|NCT04084028|11965471|FG003|COMPLETED|Overall Study||10
10803999|NCT04084028|11965468|FG000|NOT COMPLETED|Overall Study||0
10804000|NCT04084028|11965469|FG001|NOT COMPLETED|Overall Study||0
10804001|NCT04084028|11965470|FG002|NOT COMPLETED|Overall Study||0
10804002|NCT04084028|11965471|FG003|NOT COMPLETED|Overall Study||0
10804003|NCT04082819|11965486|FG000|STARTED|Overall Study||37
10804004|NCT04082819|11965487|FG001|STARTED|Overall Study||54
10804005|NCT04082819|11965488|FG002|STARTED|Overall Study||3
10804006|NCT04082819|11965486|FG000|COMPLETED|Overall Study||37
10804007|NCT04082819|11965487|FG001|COMPLETED|Overall Study||54
10804008|NCT04082819|11965488|FG002|COMPLETED|Overall Study||3
10804009|NCT04082819|11965486|FG000|NOT COMPLETED|Overall Study||0
10804010|NCT04082819|11965487|FG001|NOT COMPLETED|Overall Study||0
10804011|NCT04082819|11965488|FG002|NOT COMPLETED|Overall Study||0
10804012|NCT04081961|11965502|FG000|STARTED|Overall Study||9
10804013|NCT04081961|11965503|FG001|STARTED|Overall Study||9
10804014|NCT04081961|11965504|FG002|STARTED|Overall Study||9
10325176|NCT00281632|11460669|FG000|COMPLETED|Overall Study|Three participants were ongoing in the study at the time of the data cut-off (30 Apr 2008).|0
10325177|NCT00281632|11460669|FG000|NOT COMPLETED|Overall Study||36
10325178|NCT00281671|11460681|FG000|STARTED|Overall Study||5
10804015|NCT04081961|11965502|FG000|COMPLETED|Overall Study||9
10325179|NCT00281671|11460682|FG001|STARTED|Overall Study||4
10325180|NCT00281671|11460681|FG000|COMPLETED|Overall Study||5
10325181|NCT00281671|11460682|FG001|COMPLETED|Overall Study||4
10325182|NCT00281671|11460681|FG000|NOT COMPLETED|Overall Study||0
10325183|NCT00281671|11460682|FG001|NOT COMPLETED|Overall Study||0
10325184|NCT00281684|11460695|FG000|STARTED|Overall Study||37
10804016|NCT04081961|11965503|FG001|COMPLETED|Overall Study||9
10804017|NCT04081961|11965504|FG002|COMPLETED|Overall Study||9
10804018|NCT04081961|11965502|FG000|NOT COMPLETED|Overall Study||0
10325185|NCT00281684|11460696|FG001|STARTED|Overall Study||36
10325186|NCT00281684|11460697|FG002|STARTED|Overall Study||34
10325187|NCT00281684|11460698|FG003|STARTED|Overall Study||38
10325188|NCT00281684|11460695|FG000|COMPLETED|Overall Study||36
10325189|NCT00281684|11460696|FG001|COMPLETED|Overall Study||36
10325190|NCT00281684|11460697|FG002|COMPLETED|Overall Study||33
10325191|NCT00281684|11460698|FG003|COMPLETED|Overall Study||38
10325192|NCT00281684|11460695|FG000|NOT COMPLETED|Overall Study||1
10325193|NCT00281684|11460696|FG001|NOT COMPLETED|Overall Study||0
10325194|NCT00281684|11460697|FG002|NOT COMPLETED|Overall Study||1
10325195|NCT00281684|11460698|FG003|NOT COMPLETED|Overall Study||0
10325196|NCT00281697|11460712|FG000|STARTED|Overall Study||459
10325197|NCT00281697|11460713|FG001|STARTED|Overall Study||225
10325198|NCT00281697|11460712|FG000|COMPLETED|Overall Study||58
10325199|NCT00281697|11460713|FG001|COMPLETED|Overall Study||28
10325200|NCT00281697|11460712|FG000|NOT COMPLETED|Overall Study||401
10325201|NCT00281697|11460713|FG001|NOT COMPLETED|Overall Study||197
10325202|NCT00281827|11460719|FG000|STARTED|Overall Study||22
10325203|NCT00281827|11460719|FG000|COMPLETED|Overall Study|All patients received 3 cycles of therapy; 2 did not receive all 3 thalidomide cycles|22
10325204|NCT00281827|11460719|FG000|NOT COMPLETED|Overall Study||0
10338580|NCT04150341|11475489|FG004|COMPLETED|Overall Study||3
10338581|NCT04150341|11475490|FG005|COMPLETED|Overall Study||4
10338582|NCT04150341|11475485|FG000|NOT COMPLETED|Overall Study||0
10338583|NCT04150341|11475486|FG001|NOT COMPLETED|Overall Study||0
10338584|NCT04150341|11475487|FG002|NOT COMPLETED|Overall Study||1
10338585|NCT04150341|11475488|FG003|NOT COMPLETED|Overall Study||0
10338586|NCT04150341|11475489|FG004|NOT COMPLETED|Overall Study||1
10338587|NCT04150341|11475490|FG005|NOT COMPLETED|Overall Study||0
10338588|NCT04115839|11475503|FG000|STARTED|Main Study (Up to 16 Weeks)||36
10338589|NCT04115839|11475504|FG001|STARTED|Main Study (Up to 16 Weeks)||34
10338590|NCT04115839|11475505|FG002|STARTED|Main Study (Up to 16 Weeks)||36
10338591|NCT04115839|11475506|FG003|STARTED|Main Study (Up to 16 Weeks)||0
10338592|NCT04115839|11475507|FG004|STARTED|Main Study (Up to 16 Weeks)||0
10338593|NCT04115839|11475508|FG005|STARTED|Main Study (Up to 16 Weeks)||0
10338594|NCT04115839|11475509|FG006|STARTED|Main Study (Up to 16 Weeks)||0
10338595|NCT04115839|11475503|FG000|COMPLETED|Main Study (Up to 16 Weeks)||18
10338596|NCT04115839|11475504|FG001|COMPLETED|Main Study (Up to 16 Weeks)||20
10338597|NCT04115839|11475505|FG002|COMPLETED|Main Study (Up to 16 Weeks)||18
10338598|NCT04115839|11475506|FG003|COMPLETED|Main Study (Up to 16 Weeks)||0
10338599|NCT04115839|11475507|FG004|COMPLETED|Main Study (Up to 16 Weeks)||0
10338600|NCT04115839|11475508|FG005|COMPLETED|Main Study (Up to 16 Weeks)||0
10338601|NCT04115839|11475509|FG006|COMPLETED|Main Study (Up to 16 Weeks)||0
10338602|NCT04115839|11475503|FG000|NOT COMPLETED|Main Study (Up to 16 Weeks)||18
10338603|NCT04115839|11475504|FG001|NOT COMPLETED|Main Study (Up to 16 Weeks)||14
10338604|NCT04115839|11475505|FG002|NOT COMPLETED|Main Study (Up to 16 Weeks)||18
10338605|NCT04115839|11475506|FG003|NOT COMPLETED|Main Study (Up to 16 Weeks)||0
10338606|NCT04115839|11475507|FG004|NOT COMPLETED|Main Study (Up to 16 Weeks)||0
10338607|NCT04115839|11475508|FG005|NOT COMPLETED|Main Study (Up to 16 Weeks)||0
10338608|NCT04115839|11475509|FG006|NOT COMPLETED|Main Study (Up to 16 Weeks)||0
10338609|NCT04115839|11475503|FG000|STARTED|LTE Phase (After Week 16 to Week 63)|Participants who completed main study were randomised in LTE phase to receive filgotinib 200 mg or 100 mg.|0
10338610|NCT04115839|11475504|FG001|STARTED|LTE Phase (After Week 16 to Week 63)|Participants who completed main study were randomised in LTE phase to receive filgotinib 200 mg or 100 mg.|0
10338611|NCT04115839|11475505|FG002|STARTED|LTE Phase (After Week 16 to Week 63)|18 participants who completed main study did not enter LTE phase.|0
10338612|NCT04115839|11475506|FG003|STARTED|LTE Phase (After Week 16 to Week 63)|Participants who completed main study were randomised in LTE phase to receive filgotinib 200 mg or 100 mg.|18
10338613|NCT04115839|11475507|FG004|STARTED|LTE Phase (After Week 16 to Week 63)|Participants who completed main study were randomised in LTE phase to receive filgotinib 200 mg or 100 mg.|20
10338614|NCT04115839|11475508|FG005|STARTED|LTE Phase (After Week 16 to Week 63)|10 participants who received placebo and completed main study were randomised in LTE phase to receive filgotinib 200 mg.|10
10338615|NCT04115839|11475509|FG006|STARTED|LTE Phase (After Week 16 to Week 63)|8 participants who received placebo and completed main study were randomised in LTE phase to receive filgotinib 100 mg.|8
10338616|NCT04115839|11475503|FG000|COMPLETED|LTE Phase (After Week 16 to Week 63)||0
10338617|NCT04115839|11475504|FG001|COMPLETED|LTE Phase (After Week 16 to Week 63)||0
10338618|NCT04115839|11475505|FG002|COMPLETED|LTE Phase (After Week 16 to Week 63)||0
10804019|NCT04081961|11965503|FG001|NOT COMPLETED|Overall Study||0
10804020|NCT04081961|11965504|FG002|NOT COMPLETED|Overall Study||0
10804021|NCT04081610|11965514|FG000|STARTED|Overall Study||16
10804022|NCT04081610|11965515|FG001|STARTED|Overall Study||18
10804023|NCT04081610|11965514|FG000|COMPLETED|Overall Study||16
10804024|NCT04081610|11965515|FG001|COMPLETED|Overall Study||18
10804025|NCT04081610|11965514|FG000|NOT COMPLETED|Overall Study||0
10804026|NCT04081610|11965515|FG001|NOT COMPLETED|Overall Study||0
10804027|NCT04081324|11965525|FG000|STARTED|Overall Study||6
10804028|NCT04081324|11965526|FG001|STARTED|Overall Study||10
10804029|NCT04081324|11965527|FG002|STARTED|Overall Study||10
10804030|NCT04081324|11965528|FG003|STARTED|Overall Study||10
10804031|NCT04081324|11965525|FG000|Received At Least One Dose of Study Drug|Overall Study||6
10804032|NCT04081324|11965526|FG001|Received At Least One Dose of Study Drug|Overall Study||10
10804033|NCT04081324|11965527|FG002|Received At Least One Dose of Study Drug|Overall Study||10
10804034|NCT04081324|11965528|FG003|Received At Least One Dose of Study Drug|Overall Study||10
10804035|NCT04081324|11965525|FG000|COMPLETED|Overall Study||6
10325205|NCT00281840|11460725|FG000|STARTED|Overall Study||30
10325206|NCT00281840|11460725|FG000|COMPLETED|Overall Study||5
10325207|NCT00281840|11460725|FG000|NOT COMPLETED|Overall Study||25
10325208|NCT00281918|11460732|FG000|STARTED|Overall Study|Informed consent unavailable for 2 patients at time of analysis; intent-to-treat population was 407.|409
10325209|NCT00281918|11460733|FG001|STARTED|Overall Study|Informed consent unavailable for 5 patients at time of analysis; intent-to-treat population was 403.|408
10325210|NCT00281918|11460732|FG000|Safety Population; Received Study Drug|Overall Study||398
10325211|NCT00281918|11460733|FG001|Safety Population; Received Study Drug|Overall Study||402
10325212|NCT00281918|11460732|FG000|COMPLETED|Overall Study|Completed all 6 cycles of study medication.|267
10325213|NCT00281918|11460733|FG001|COMPLETED|Overall Study|Completed all 6 cycles of study medication.|300
10325214|NCT00281918|11460732|FG000|NOT COMPLETED|Overall Study||142
10325215|NCT00281918|11460733|FG001|NOT COMPLETED|Overall Study||108
10325216|NCT00281957|11460741|FG000|STARTED|Overall Study||67
10325217|NCT00281957|11460742|FG001|STARTED|Overall Study||42
10325218|NCT00281957|11460741|FG000|Eligible|Overall Study||66
10325219|NCT00281957|11460742|FG001|Eligible|Overall Study||40
10325220|NCT00281957|11460741|FG000|Eligible and Received Treatment|Overall Study||63
10325221|NCT00281957|11460742|FG001|Eligible and Received Treatment|Overall Study||39
10325222|NCT00281957|11460741|FG000|COMPLETED|Overall Study||0
10325223|NCT00281957|11460742|FG001|COMPLETED|Overall Study||0
10325224|NCT00281957|11460741|FG000|NOT COMPLETED|Overall Study||67
10325225|NCT00281957|11460742|FG001|NOT COMPLETED|Overall Study||42
10325226|NCT00282048|11460750|FG000|STARTED|Overall Study||62
10325227|NCT00282048|11460750|FG000|COMPLETED|Overall Study||0
10325228|NCT00282048|11460750|FG000|NOT COMPLETED|Overall Study||62
10325229|NCT00282087|11460754|FG000|STARTED|Overall Study||47
10325230|NCT00282087|11460754|FG000|COMPLETED|Overall Study|One patient died during cycle 1 of treatment because of infectious complications of AIDS.|46
10325231|NCT00282087|11460754|FG000|NOT COMPLETED|Overall Study||1
10325232|NCT00282113|11460762|FG000|STARTED|Overall Study||31
10325233|NCT00282113|11460763|FG001|STARTED|Overall Study||30
10325234|NCT00282113|11460764|FG002|STARTED|Overall Study||29
10325235|NCT00282113|11460762|FG000|COMPLETED|Overall Study||30
10325236|NCT00282113|11460763|FG001|COMPLETED|Overall Study||30
10325237|NCT00282113|11460764|FG002|COMPLETED|Overall Study||29
10325238|NCT00282113|11460762|FG000|NOT COMPLETED|Overall Study||1
10325239|NCT00282113|11460763|FG001|NOT COMPLETED|Overall Study||0
10325240|NCT00282113|11460764|FG002|NOT COMPLETED|Overall Study||0
10325241|NCT00282152|11460774|FG000|STARTED|Overall Study||15
10325242|NCT00282152|11460775|FG001|STARTED|Overall Study||15
10325243|NCT00282152|11460774|FG000|COMPLETED|Overall Study||14
10325244|NCT00282152|11460775|FG001|COMPLETED|Overall Study||15
10325245|NCT00282152|11460774|FG000|NOT COMPLETED|Overall Study||1
10325246|NCT00282152|11460775|FG001|NOT COMPLETED|Overall Study||0
10325247|NCT00282243|11460782|FG000|STARTED|Pharmacokinetic Treatment Period||70
10325248|NCT00282243|11460782|FG000|Received Tacrolimus|Pharmacokinetic Treatment Period||70
10325249|NCT00282243|11460782|FG000|Received Tacrolimus MR|Pharmacokinetic Treatment Period||69
10325250|NCT00282243|11460782|FG000|COMPLETED|Pharmacokinetic Treatment Period||65
10325251|NCT00282243|11460782|FG000|NOT COMPLETED|Pharmacokinetic Treatment Period||5
10325252|NCT00282243|11460782|FG000|STARTED|Extension Treatment Period||65
10325253|NCT00282243|11460782|FG000|COMPLETED|Extension Treatment Period||43
10325254|NCT00282243|11460782|FG000|NOT COMPLETED|Extension Treatment Period||22
10325255|NCT00282256|11460786|FG000|STARTED|Pharmacokinetic Treatment Period||19
10325256|NCT00282256|11460786|FG000|Received Tacrolimus|Pharmacokinetic Treatment Period||19
10325257|NCT00282256|11460786|FG000|Received Tacrolimus MR|Pharmacokinetic Treatment Period||18
10325258|NCT00282256|11460786|FG000|COMPLETED|Pharmacokinetic Treatment Period||18
10325259|NCT00282256|11460786|FG000|NOT COMPLETED|Pharmacokinetic Treatment Period||1
10325260|NCT00282256|11460786|FG000|STARTED|Extension Treatment Period||18
10325261|NCT00282256|11460786|FG000|COMPLETED|Extension Treatment Period||16
10325262|NCT00282256|11460786|FG000|NOT COMPLETED|Extension Treatment Period||2
10325263|NCT00282282|11460790|FG000|STARTED|Overall Study|31 patients enrolled but 2 patients did not go through with transplant|29
10325264|NCT00282282|11460790|FG000|COMPLETED|Overall Study||29
10325265|NCT00282282|11460790|FG000|NOT COMPLETED|Overall Study||0
10325266|NCT00282295|11460798|FG000|STARTED|Overall Study||446
10325267|NCT00282295|11460799|FG001|STARTED|Overall Study||446
10325268|NCT00282295|11460800|FG002|STARTED|Overall Study||449
10325269|NCT00282295|11460798|FG000|COMPLETED|Overall Study||443
10325270|NCT00282295|11460799|FG001|COMPLETED|Overall Study||429
10325271|NCT00282295|11460800|FG002|COMPLETED|Overall Study||441
10325272|NCT00282295|11460798|FG000|NOT COMPLETED|Overall Study||3
10325273|NCT00282295|11460799|FG001|NOT COMPLETED|Overall Study||17
10325274|NCT00282295|11460800|FG002|NOT COMPLETED|Overall Study||8
10325275|NCT00282308|11460815|FG000|STARTED|Treatment Period||69
10325276|NCT00282308|11460816|FG001|STARTED|Treatment Period||34
10325277|NCT00282308|11460817|FG002|STARTED|Treatment Period|Participant Flow is reported separately for the treatment groups for this Period.|0
10325278|NCT00282308|11460815|FG000|COMPLETED|Treatment Period||65
10325279|NCT00282308|11460816|FG001|COMPLETED|Treatment Period||28
10325280|NCT00282308|11460817|FG002|COMPLETED|Treatment Period||0
10325281|NCT00282308|11460815|FG000|NOT COMPLETED|Treatment Period||4
10325282|NCT00282308|11460816|FG001|NOT COMPLETED|Treatment Period||6
10325283|NCT00282308|11460817|FG002|NOT COMPLETED|Treatment Period||0
10325284|NCT00282308|11460815|FG000|STARTED|Optional Extension Re-treatment Period|Participant Flow is reported for the combined treatment groups for this Period.|0
10325285|NCT00282308|11460816|FG001|STARTED|Optional Extension Re-treatment Period|Participant Flow is reported for the combined treatment groups for this Period.|0
10325286|NCT00282308|11460817|FG002|STARTED|Optional Extension Re-treatment Period|Not all patients who completed the Treatment Period entered this Optional Re-treatment Period.|78
10325287|NCT00282308|11460815|FG000|COMPLETED|Optional Extension Re-treatment Period||0
10325288|NCT00282308|11460816|FG001|COMPLETED|Optional Extension Re-treatment Period||0
10325289|NCT00282308|11460817|FG002|COMPLETED|Optional Extension Re-treatment Period||72
10325290|NCT00282308|11460815|FG000|NOT COMPLETED|Optional Extension Re-treatment Period||0
10325291|NCT00282308|11460816|FG001|NOT COMPLETED|Optional Extension Re-treatment Period||0
10325292|NCT00282308|11460817|FG002|NOT COMPLETED|Optional Extension Re-treatment Period||6
10325293|NCT00282308|11460815|FG000|STARTED|Safety Follow-up Period|Participant Flow is reported for the combined treatment groups for this Period.|0
10325294|NCT00282308|11460816|FG001|STARTED|Safety Follow-up Period|Participant Flow is reported for the combined treatment groups for this Period.|0
10325295|NCT00282308|11460817|FG002|STARTED|Safety Follow-up Period|Some patients entered this Safety Follow-up Period directly from the Treatment Period.|100
10325296|NCT00282308|11460815|FG000|COMPLETED|Safety Follow-up Period||0
10325297|NCT00282308|11460816|FG001|COMPLETED|Safety Follow-up Period||0
10325298|NCT00282308|11460817|FG002|COMPLETED|Safety Follow-up Period||81
10325299|NCT00282308|11460815|FG000|NOT COMPLETED|Safety Follow-up Period||0
10325300|NCT00282308|11460816|FG001|NOT COMPLETED|Safety Follow-up Period||0
10325301|NCT00282308|11460817|FG002|NOT COMPLETED|Safety Follow-up Period||19
10325302|NCT00282334|11460829|FG000|STARTED|Overall Study||113
10325303|NCT00282334|11460830|FG001|STARTED|Overall Study||123
10325304|NCT00282334|11460829|FG000|COMPLETED|Overall Study||105
10325305|NCT00282334|11460830|FG001|COMPLETED|Overall Study||118
10325306|NCT00282334|11460829|FG000|NOT COMPLETED|Overall Study||8
10325307|NCT00282334|11460830|FG001|NOT COMPLETED|Overall Study||5
10325308|NCT00282347|11460838|FG000|STARTED|Treatment Period||72
10325309|NCT00282347|11460839|FG001|STARTED|Treatment Period||72
10325310|NCT00282347|11460838|FG000|COMPLETED|Treatment Period||67
10325311|NCT00282347|11460839|FG001|COMPLETED|Treatment Period||63
10325312|NCT00282347|11460838|FG000|NOT COMPLETED|Treatment Period||5
10325313|NCT00282347|11460839|FG001|NOT COMPLETED|Treatment Period||9
10325314|NCT00282347|11460838|FG000|STARTED|Safety Follow-up Period||67
10325315|NCT00282347|11460839|FG001|STARTED|Safety Follow-up Period||63
10325316|NCT00282347|11460838|FG000|COMPLETED|Safety Follow-up Period||64
10325317|NCT00282347|11460839|FG001|COMPLETED|Safety Follow-up Period||57
10325318|NCT00282347|11460838|FG000|NOT COMPLETED|Safety Follow-up Period||3
10325319|NCT00282347|11460839|FG001|NOT COMPLETED|Safety Follow-up Period||6
10325320|NCT00282347|11460838|FG000|STARTED|B Cell Follow-up Period||20
10325321|NCT00282347|11460839|FG001|STARTED|B Cell Follow-up Period||4
10325322|NCT00282347|11460838|FG000|COMPLETED|B Cell Follow-up Period||15
10325323|NCT00282347|11460839|FG001|COMPLETED|B Cell Follow-up Period||4
10325324|NCT00282347|11460838|FG000|NOT COMPLETED|B Cell Follow-up Period||5
10325325|NCT00282347|11460839|FG001|NOT COMPLETED|B Cell Follow-up Period||0
10325326|NCT00282412|11460847|FG000|STARTED|Overall Study||4
10325327|NCT00282412|11460847|FG000|COMPLETED|Overall Study|Two late deaths non-treatment related. One from pulmonary embolism and one from late leukemia.|2
10325328|NCT00282412|11460847|FG000|NOT COMPLETED|Overall Study||2
10325329|NCT00282438|11460853|FG000|STARTED|Overall Study||1
10325330|NCT00282438|11460854|FG001|STARTED|Overall Study||1
10325331|NCT00282438|11460853|FG000|COMPLETED|Overall Study||0
10325332|NCT00282438|11460854|FG001|COMPLETED|Overall Study||0
10325333|NCT00282438|11460853|FG000|NOT COMPLETED|Overall Study||1
10325334|NCT00282438|11460854|FG001|NOT COMPLETED|Overall Study||1
10325335|NCT00282464|11460862|FG000|STARTED|Overall Study||185
10325336|NCT00282464|11460863|FG001|STARTED|Overall Study||196
10325337|NCT00282464|11460862|FG000|COMPLETED|Overall Study||112
10325338|NCT00282464|11460863|FG001|COMPLETED|Overall Study||134
10325339|NCT00282464|11460862|FG000|NOT COMPLETED|Overall Study||73
10325340|NCT00282464|11460863|FG001|NOT COMPLETED|Overall Study||62
10325341|NCT00282568|11460869|FG000|STARTED|Pharmacokinetic Treatment Period||70
10325342|NCT00282568|11460869|FG000|Received Tacrolimus|Pharmacokinetic Treatment Period||68
10325343|NCT00282568|11460869|FG000|Received Tacrolimus MR|Pharmacokinetic Treatment Period||67
10325344|NCT00282568|11460869|FG000|COMPLETED|Pharmacokinetic Treatment Period||67
10325345|NCT00282568|11460869|FG000|NOT COMPLETED|Pharmacokinetic Treatment Period||3
10325346|NCT00282568|11460869|FG000|STARTED|Extended Treatment Period|One patient who completed the PK period did not enter the extended treatment period.|66
10325347|NCT00282568|11460869|FG000|COMPLETED|Extended Treatment Period||42
10325348|NCT00282568|11460869|FG000|NOT COMPLETED|Extended Treatment Period||24
10325349|NCT00282672|11460877|FG000|STARTED|1 Year||22
10325350|NCT00282672|11460878|FG001|STARTED|1 Year||42
10325351|NCT00282672|11460879|FG002|STARTED|1 Year||21
10325352|NCT00282672|11460880|FG003|STARTED|1 Year||42
10325353|NCT00282672|11460877|FG000|COMPLETED|1 Year||19
10325354|NCT00282672|11460878|FG001|COMPLETED|1 Year||40
10325355|NCT00282672|11460879|FG002|COMPLETED|1 Year||20
10325356|NCT00282672|11460880|FG003|COMPLETED|1 Year||38
10325357|NCT00282672|11460877|FG000|NOT COMPLETED|1 Year||3
10325358|NCT00282672|11460878|FG001|NOT COMPLETED|1 Year||2
10325359|NCT00282672|11460879|FG002|NOT COMPLETED|1 Year||1
10325360|NCT00282672|11460880|FG003|NOT COMPLETED|1 Year||4
10325361|NCT00282672|11460877|FG000|STARTED|2 Year: Sham Crossed Over to RFA|19 crossed over to RFA treatment|19
10325362|NCT00282672|11460878|FG001|STARTED|2 Year: Sham Crossed Over to RFA||40
10325363|NCT00282672|11460879|FG002|STARTED|2 Year: Sham Crossed Over to RFA|16 Crossed over to RFA treatment|16
10325364|NCT00282672|11460880|FG003|STARTED|2 Year: Sham Crossed Over to RFA||38
10325365|NCT00282672|11460877|FG000|COMPLETED|2 Year: Sham Crossed Over to RFA||16
10325366|NCT00282672|11460878|FG001|COMPLETED|2 Year: Sham Crossed Over to RFA||39
10325367|NCT00282672|11460879|FG002|COMPLETED|2 Year: Sham Crossed Over to RFA||15
10325368|NCT00282672|11460880|FG003|COMPLETED|2 Year: Sham Crossed Over to RFA||36
10325369|NCT00282672|11460877|FG000|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||3
10325370|NCT00282672|11460878|FG001|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||1
10325371|NCT00282672|11460879|FG002|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||1
10325372|NCT00282672|11460880|FG003|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||2
10325373|NCT00282672|11460877|FG000|STARTED|5 Year: Follow up|1 withdrew|15
10325374|NCT00282672|11460878|FG001|STARTED|5 Year: Follow up|7 withdrew|32
10325375|NCT00282672|11460879|FG002|STARTED|5 Year: Follow up|3 withdrew|12
10325376|NCT00282672|11460880|FG003|STARTED|5 Year: Follow up|11 withdrew|25
10325377|NCT00282672|11460877|FG000|COMPLETED|5 Year: Follow up||14
10325378|NCT00282672|11460878|FG001|COMPLETED|5 Year: Follow up||27
10325379|NCT00282672|11460879|FG002|COMPLETED|5 Year: Follow up||12
10325380|NCT00282672|11460880|FG003|COMPLETED|5 Year: Follow up||20
10325381|NCT00282672|11460877|FG000|NOT COMPLETED|5 Year: Follow up||1
10325382|NCT00282672|11460878|FG001|NOT COMPLETED|5 Year: Follow up||5
10325383|NCT00282672|11460879|FG002|NOT COMPLETED|5 Year: Follow up||0
10325384|NCT00282672|11460880|FG003|NOT COMPLETED|5 Year: Follow up||5
10325385|NCT00282815|11460916|FG000|STARTED|Overall Study||15
10325386|NCT00282815|11460917|FG001|STARTED|Overall Study||17
10325387|NCT00282815|11460916|FG000|COMPLETED|Overall Study||8
10325388|NCT00282815|11460917|FG001|COMPLETED|Overall Study||11
10325389|NCT00282815|11460916|FG000|NOT COMPLETED|Overall Study||7
10325390|NCT00282815|11460917|FG001|NOT COMPLETED|Overall Study||6
10325391|NCT00282828|11460929|FG000|STARTED|Overall Study||63
10325392|NCT00282828|11460930|FG001|STARTED|Overall Study||59
10325393|NCT00282828|11460931|FG002|STARTED|Overall Study||59
10325394|NCT00282828|11460929|FG000|COMPLETED|Overall Study||57
10325395|NCT00282828|11460930|FG001|COMPLETED|Overall Study||47
10325396|NCT00282828|11460931|FG002|COMPLETED|Overall Study||50
10325397|NCT00282828|11460929|FG000|NOT COMPLETED|Overall Study||6
10325398|NCT00282828|11460930|FG001|NOT COMPLETED|Overall Study||12
10325399|NCT00282828|11460931|FG002|NOT COMPLETED|Overall Study||9
10325400|NCT00282841|11460939|FG000|STARTED|Overall Study|Anticipated recruitment 400; stopped due to funding and poor recruitment.|61
10325401|NCT00282841|11460939|FG000|COMPLETED|Overall Study||61
10325402|NCT00282841|11460939|FG000|NOT COMPLETED|Overall Study||0
10325403|NCT00282919|11460944|FG000|STARTED|Overall Study||110
10325404|NCT00282919|11460944|FG000|COMPLETED|Overall Study||103
10325405|NCT00282919|11460944|FG000|NOT COMPLETED|Overall Study||7
10325406|NCT00282971|11460950|FG000|STARTED|Overall Study||180
10325407|NCT00282971|11460951|FG001|STARTED|Overall Study||171
10325408|NCT00282971|11460950|FG000|COMPLETED|Overall Study||146
10325409|NCT00282971|11460951|FG001|COMPLETED|Overall Study||149
10325410|NCT00282971|11460950|FG000|NOT COMPLETED|Overall Study||34
10325411|NCT00282971|11460951|FG001|NOT COMPLETED|Overall Study||22
10325412|NCT00282984|11460959|FG000|STARTED|Overall Study||353
10325413|NCT00282984|11460960|FG001|STARTED|Overall Study||350
10325414|NCT00282984|11460959|FG000|COMPLETED|Overall Study||302
10325415|NCT00282984|11460960|FG001|COMPLETED|Overall Study||289
10325416|NCT00282984|11460959|FG000|NOT COMPLETED|Overall Study||51
10325417|NCT00282984|11460960|FG001|NOT COMPLETED|Overall Study||61
10325418|NCT00283049|11460969|FG000|STARTED|Overall Study|2 randomized patients did not receive study drug and were not included in the safety population|128
10325419|NCT00283049|11460970|FG001|STARTED|Overall Study|1 randomized patient did not receive study drug and was not included in the safety population|128
10325420|NCT00283049|11460971|FG002|STARTED|Overall Study|1 randomized patient did not receive study drug and was not included in the safety population|130
10325421|NCT00283049|11460969|FG000|COMPLETED|Overall Study||70
10325422|NCT00283049|11460970|FG001|COMPLETED|Overall Study||83
10325423|NCT00283049|11460971|FG002|COMPLETED|Overall Study||76
10325424|NCT00283049|11460969|FG000|NOT COMPLETED|Overall Study||58
10325425|NCT00283049|11460970|FG001|NOT COMPLETED|Overall Study||45
10325426|NCT00283049|11460971|FG002|NOT COMPLETED|Overall Study||54
10325427|NCT00283062|11460983|FG000|STARTED|Overall Study||55
10325428|NCT00283062|11460984|FG001|STARTED|Overall Study||55
10325429|NCT00283062|11460985|FG002|STARTED|Overall Study||56
10325430|NCT00283062|11460986|FG003|STARTED|Overall Study||62
10325431|NCT00283062|11460983|FG000|ADMINISTERED STUDY TREATMENT|Overall Study||50
10325432|NCT00283062|11460984|FG001|ADMINISTERED STUDY TREATMENT|Overall Study||51
10325433|NCT00283062|11460985|FG002|ADMINISTERED STUDY TREATMENT|Overall Study||20
10325434|NCT00283062|11460986|FG003|ADMINISTERED STUDY TREATMENT|Overall Study||17
10325435|NCT00283062|11460983|FG000|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||44
10325436|NCT00283062|11460984|FG001|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||48
10325437|NCT00283062|11460985|FG002|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||15
10325438|NCT00283062|11460986|FG003|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||13
10325439|NCT00283062|11460983|FG000|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study||43
10325440|NCT00283062|11460984|FG001|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study|Not applicable, since participants in this arm did not receive chemotherapy.|0
10325441|NCT00283062|11460985|FG002|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study||15
10325442|NCT00283062|11460986|FG003|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study|Not applicable, since participants in this arm did not receive chemotherapy.|0
10325443|NCT00283062|11460983|FG000|COMPLETED|Overall Study||43
10325444|NCT00283062|11460984|FG001|COMPLETED|Overall Study||48
10325445|NCT00283062|11460985|FG002|COMPLETED|Overall Study||15
10325446|NCT00283062|11460986|FG003|COMPLETED|Overall Study||13
10325447|NCT00283062|11460983|FG000|NOT COMPLETED|Overall Study||12
10325448|NCT00283062|11460984|FG001|NOT COMPLETED|Overall Study||7
10325449|NCT00283062|11460985|FG002|NOT COMPLETED|Overall Study||41
10325450|NCT00283062|11460986|FG003|NOT COMPLETED|Overall Study||49
10325451|NCT00283075|11460996|FG000|STARTED|Overall Study||25
10325452|NCT00283075|11460997|FG001|STARTED|Overall Study||6
10325453|NCT00283075|11460996|FG000|COMPLETED|Overall Study||25
10325454|NCT00283075|11460997|FG001|COMPLETED|Overall Study||6
10325455|NCT00283075|11460996|FG000|NOT COMPLETED|Overall Study||0
10325456|NCT00283075|11460997|FG001|NOT COMPLETED|Overall Study||0
10325457|NCT00283244|11461011|FG000|STARTED|Overall Study||44
10325458|NCT00283244|11461012|FG001|STARTED|Overall Study||51
10325459|NCT00283244|11461013|FG002|STARTED|Overall Study||51
10325460|NCT00283244|11461011|FG000|COMPLETED|Overall Study|19 patients went on to receive second line Erlotinib|26
10325461|NCT00283244|11461012|FG001|COMPLETED|Overall Study|Patients treated until progression or unacceptable toxicity; 12 patients received 2nd line therapy|0
10325462|NCT00283244|11461013|FG002|COMPLETED|Overall Study|Patients treated until progression or unacceptable toxicity; 9 patients received 2nd line therapy|0
10325463|NCT00283244|11461011|FG000|NOT COMPLETED|Overall Study||18
10325464|NCT00283244|11461012|FG001|NOT COMPLETED|Overall Study||51
10325465|NCT00283244|11461013|FG002|NOT COMPLETED|Overall Study||51
10325466|NCT00283283|11461026|FG000|STARTED|Overall Study||274
10325467|NCT00283283|11461027|FG001|STARTED|Overall Study||284
10325468|NCT00283283|11461028|FG002|STARTED|Overall Study||280
10325469|NCT00283283|11461029|FG003|STARTED|Overall Study||276
10325470|NCT00283283|11461026|FG000|COMPLETED|Overall Study||274
10325471|NCT00283283|11461027|FG001|COMPLETED|Overall Study||284
10325472|NCT00283283|11461028|FG002|COMPLETED|Overall Study||280
10325473|NCT00283283|11461029|FG003|COMPLETED|Overall Study||276
10325474|NCT00283283|11461026|FG000|NOT COMPLETED|Overall Study||0
10325475|NCT00283283|11461027|FG001|NOT COMPLETED|Overall Study||0
10325476|NCT00283283|11461028|FG002|NOT COMPLETED|Overall Study||0
10325477|NCT00283283|11461029|FG003|NOT COMPLETED|Overall Study||0
10325478|NCT00283296|11461044|FG000|STARTED|Overall Study||14
10325479|NCT00283296|11461044|FG000|COMPLETED|Overall Study|Completed in-lab and in-home trial.|9
10325480|NCT00283296|11461044|FG000|NOT COMPLETED|Overall Study||5
10325481|NCT00283387|11461049|FG000|STARTED|First Intervention||6
10325482|NCT00283387|11461050|FG001|STARTED|First Intervention||7
10325483|NCT00283387|11461049|FG000|COMPLETED|First Intervention||5
10325484|NCT00283387|11461050|FG001|COMPLETED|First Intervention||5
10325485|NCT00283387|11461049|FG000|NOT COMPLETED|First Intervention||1
10325486|NCT00283387|11461050|FG001|NOT COMPLETED|First Intervention||2
10456115|NCT01005719|11604185|FG005|NOT COMPLETED|Period 3||0
10456116|NCT01005732|11604194|FG000|STARTED|Overall Study||54
10456117|NCT01005732|11604194|FG000|COMPLETED|Overall Study||43
10456118|NCT01005732|11604194|FG000|NOT COMPLETED|Overall Study||11
10456119|NCT01005810|11604204|FG000|STARTED|Overall Study||58
10456120|NCT01005810|11604205|FG001|STARTED|Overall Study||58
10456121|NCT01005810|11604204|FG000|COMPLETED|Overall Study||37
10456122|NCT01005810|11604205|FG001|COMPLETED|Overall Study||33
10456123|NCT01005810|11604204|FG000|NOT COMPLETED|Overall Study||21
10456124|NCT01005810|11604205|FG001|NOT COMPLETED|Overall Study||25
10325487|NCT00283387|11461049|FG000|STARTED|Washout Period of 2 Months||5
10325488|NCT00283387|11461050|FG001|STARTED|Washout Period of 2 Months||5
10325489|NCT00283387|11461049|FG000|COMPLETED|Washout Period of 2 Months||5
10325490|NCT00283387|11461050|FG001|COMPLETED|Washout Period of 2 Months||5
10325491|NCT00283387|11461049|FG000|NOT COMPLETED|Washout Period of 2 Months||0
10325492|NCT00283387|11461050|FG001|NOT COMPLETED|Washout Period of 2 Months||0
10325493|NCT00283387|11461049|FG000|STARTED|Second Intervention||5
10325494|NCT00283387|11461050|FG001|STARTED|Second Intervention||5
10325495|NCT00283387|11461049|FG000|COMPLETED|Second Intervention||5
10325496|NCT00283387|11461050|FG001|COMPLETED|Second Intervention||5
10325497|NCT00283387|11461049|FG000|NOT COMPLETED|Second Intervention||0
10325498|NCT00283387|11461050|FG001|NOT COMPLETED|Second Intervention||0
10325499|NCT00283400|11461060|FG000|STARTED|Overall Study||20
10325500|NCT00283400|11461061|FG001|STARTED|Overall Study||20
10325501|NCT00283400|11461062|FG002|STARTED|Overall Study||7
10325502|NCT00283400|11461063|FG003|STARTED|Overall Study||0
10325503|NCT00283400|11461060|FG000|COMPLETED|Overall Study||18
10325504|NCT00283400|11461061|FG001|COMPLETED|Overall Study||19
10325505|NCT00283400|11461062|FG002|COMPLETED|Overall Study||6
10325506|NCT00283400|11461063|FG003|COMPLETED|Overall Study||0
10325507|NCT00283400|11461060|FG000|NOT COMPLETED|Overall Study||2
10325508|NCT00283400|11461061|FG001|NOT COMPLETED|Overall Study||1
10325509|NCT00283400|11461062|FG002|NOT COMPLETED|Overall Study||1
10325510|NCT00283400|11461063|FG003|NOT COMPLETED|Overall Study||0
10325511|NCT00283439|11461077|FG000|STARTED|Overall Study||8
10325512|NCT00283439|11461078|FG001|STARTED|Overall Study||11
10325513|NCT00283439|11461079|FG002|STARTED|Overall Study||11
10325514|NCT00283439|11461080|FG003|STARTED|Overall Study||9
10325515|NCT00283439|11461077|FG000|COMPLETED|Overall Study||0
10325516|NCT00283439|11461078|FG001|COMPLETED|Overall Study||0
10325517|NCT00283439|11461079|FG002|COMPLETED|Overall Study||0
10325518|NCT00283439|11461080|FG003|COMPLETED|Overall Study||0
10325519|NCT00283439|11461077|FG000|NOT COMPLETED|Overall Study||8
10325520|NCT00283439|11461078|FG001|NOT COMPLETED|Overall Study||11
10325521|NCT00283439|11461079|FG002|NOT COMPLETED|Overall Study||11
10325522|NCT00283439|11461080|FG003|NOT COMPLETED|Overall Study||9
10456125|NCT01005875|11604211|FG000|STARTED|Overall Study||5
10325523|NCT00283504|11461092|FG000|STARTED|Overall Study||7
10325524|NCT00283504|11461093|FG001|STARTED|Overall Study||6
10325525|NCT00283504|11461092|FG000|COMPLETED|Overall Study||7
10325526|NCT00283504|11461093|FG001|COMPLETED|Overall Study||6
10325527|NCT00283504|11461092|FG000|NOT COMPLETED|Overall Study||0
10325528|NCT00283504|11461093|FG001|NOT COMPLETED|Overall Study||0
10325529|NCT00283595|11461103|FG000|STARTED|Overall Study||10
10325530|NCT00283595|11461104|FG001|STARTED|Overall Study||11
10325531|NCT00283595|11461103|FG000|COMPLETED|Overall Study||9
10325532|NCT00283595|11461104|FG001|COMPLETED|Overall Study||9
10325533|NCT00283595|11461103|FG000|NOT COMPLETED|Overall Study||1
10325534|NCT00283595|11461104|FG001|NOT COMPLETED|Overall Study||2
10325535|NCT00283686|11461114|FG000|STARTED|Overall Study||140
10325536|NCT00283686|11461115|FG001|STARTED|Overall Study||133
10325537|NCT00283686|11461116|FG002|STARTED|Overall Study||144
10325538|NCT00283686|11461117|FG003|STARTED|Overall Study||141
10325539|NCT00283686|11461114|FG000|COMPLETED|Overall Study||111
10325540|NCT00283686|11461115|FG001|COMPLETED|Overall Study||92
10325541|NCT00283686|11461116|FG002|COMPLETED|Overall Study||111
10325542|NCT00283686|11461117|FG003|COMPLETED|Overall Study||109
10325543|NCT00283686|11461114|FG000|NOT COMPLETED|Overall Study||29
10325544|NCT00283686|11461115|FG001|NOT COMPLETED|Overall Study||41
10325545|NCT00283686|11461116|FG002|NOT COMPLETED|Overall Study||33
10325546|NCT00283686|11461117|FG003|NOT COMPLETED|Overall Study||32
10325547|NCT00283712|11461129|FG000|STARTED|Overall Study||10
10325548|NCT00283712|11461130|FG001|STARTED|Overall Study||10
10325549|NCT00283712|11461129|FG000|Intent-to-treat Sample|Overall Study||10
10325550|NCT00283712|11461130|FG001|Intent-to-treat Sample|Overall Study||10
10325551|NCT00283712|11461129|FG000|Safety Sample|Overall Study||10
10325552|NCT00283712|11461130|FG001|Safety Sample|Overall Study||10
10325553|NCT00283712|11461129|FG000|Per-Protocol Sample|Overall Study||6
10325554|NCT00283712|11461130|FG001|Per-Protocol Sample|Overall Study||7
10325555|NCT00283712|11461129|FG000|COMPLETED|Overall Study||10
10325556|NCT00283712|11461130|FG001|COMPLETED|Overall Study|One subject in placebo arm died prior to study completion.|9
10325557|NCT00283712|11461129|FG000|NOT COMPLETED|Overall Study||0
10325558|NCT00283712|11461130|FG001|NOT COMPLETED|Overall Study||1
10325559|NCT00283803|11461136|FG000|STARTED|Overall Study||32
10325560|NCT00283803|11461136|FG000|COMPLETED|Overall Study||19
10325561|NCT00283803|11461136|FG000|NOT COMPLETED|Overall Study||13
10456126|NCT01005875|11604211|FG000|COMPLETED|Overall Study||2
10456127|NCT01005875|11604211|FG000|NOT COMPLETED|Overall Study||3
10456128|NCT01005888|11604219|FG000|STARTED|First Intervention||12
10456129|NCT01005888|11604220|FG001|STARTED|First Intervention||12
10456130|NCT01005888|11604219|FG000|COMPLETED|First Intervention||11
10456131|NCT01005888|11604220|FG001|COMPLETED|First Intervention||11
10456132|NCT01005888|11604219|FG000|NOT COMPLETED|First Intervention||1
10456133|NCT01005888|11604220|FG001|NOT COMPLETED|First Intervention||1
10456134|NCT01005888|11604219|FG000|STARTED|Second Intervention||11
10456135|NCT01005888|11604220|FG001|STARTED|Second Intervention||11
10456136|NCT01005888|11604219|FG000|COMPLETED|Second Intervention||10
10456137|NCT01005888|11604220|FG001|COMPLETED|Second Intervention||10
10456138|NCT01005888|11604219|FG000|NOT COMPLETED|Second Intervention||1
10456139|NCT01005888|11604220|FG001|NOT COMPLETED|Second Intervention||1
10456140|NCT01005901|11604228|FG000|STARTED|Overall Study||552
10456141|NCT01005901|11604229|FG001|STARTED|Overall Study||270
10456142|NCT01005901|11604228|FG000|Safety Population|Overall Study||550
10456143|NCT01005901|11604229|FG001|Safety Population|Overall Study||267
10456144|NCT01005901|11604228|FG000|Full Analysis Set|Overall Study||534
10456145|NCT01005901|11604229|FG001|Full Analysis Set|Overall Study||260
10456146|NCT01005901|11604228|FG000|COMPLETED|Overall Study||450
10456147|NCT01005901|11604229|FG001|COMPLETED|Overall Study||212
10456148|NCT01005901|11604228|FG000|NOT COMPLETED|Overall Study||102
10456149|NCT01005901|11604229|FG001|NOT COMPLETED|Overall Study||58
10456150|NCT01005966|11604235|FG000|STARTED|Treatment Period 1 (14 Days)||13
10456151|NCT01005966|11604236|FG001|STARTED|Treatment Period 1 (14 Days)||13
10456152|NCT01005966|11604237|FG002|STARTED|Treatment Period 1 (14 Days)||13
10456153|NCT01005966|11604238|FG003|STARTED|Treatment Period 1 (14 Days)||13
10456154|NCT01005966|11604239|FG004|STARTED|Treatment Period 1 (14 Days)||13
10456155|NCT01005966|11604235|FG000|COMPLETED|Treatment Period 1 (14 Days)||11
10456156|NCT01005966|11604236|FG001|COMPLETED|Treatment Period 1 (14 Days)||13
10456157|NCT01005966|11604237|FG002|COMPLETED|Treatment Period 1 (14 Days)||12
10456158|NCT01005966|11604238|FG003|COMPLETED|Treatment Period 1 (14 Days)||13
10456159|NCT01005966|11604239|FG004|COMPLETED|Treatment Period 1 (14 Days)||13
10456160|NCT01005966|11604235|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||2
10456161|NCT01005966|11604236|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||0
10456162|NCT01005966|11604237|FG002|NOT COMPLETED|Treatment Period 1 (14 Days)||1
10456163|NCT01005966|11604238|FG003|NOT COMPLETED|Treatment Period 1 (14 Days)||0
10456164|NCT01005966|11604239|FG004|NOT COMPLETED|Treatment Period 1 (14 Days)||0
10456165|NCT01005966|11604235|FG000|STARTED|Washout Period 1 (4 Days)||11
10456166|NCT01005966|11604236|FG001|STARTED|Washout Period 1 (4 Days)||13
10456167|NCT01005966|11604237|FG002|STARTED|Washout Period 1 (4 Days)||12
10456168|NCT01005966|11604238|FG003|STARTED|Washout Period 1 (4 Days)||13
10456169|NCT01005966|11604239|FG004|STARTED|Washout Period 1 (4 Days)||13
10456170|NCT01005966|11604235|FG000|COMPLETED|Washout Period 1 (4 Days)||11
10456171|NCT01005966|11604236|FG001|COMPLETED|Washout Period 1 (4 Days)||13
10325562|NCT00283816|11461142|FG000|STARTED|Overall Study||18
10325563|NCT00283816|11461143|FG001|STARTED|Overall Study||18
10325564|NCT00283816|11461142|FG000|COMPLETED|Overall Study||16
10325565|NCT00283816|11461143|FG001|COMPLETED|Overall Study||16
10325566|NCT00283816|11461142|FG000|NOT COMPLETED|Overall Study||2
10325567|NCT00283816|11461143|FG001|NOT COMPLETED|Overall Study||2
10325568|NCT00283842|11461156|FG000|STARTED|Overall Study||63
10325569|NCT00283842|11461157|FG001|STARTED|Overall Study||87
10325570|NCT00283842|11461158|FG002|STARTED|Overall Study||99
10325571|NCT00283842|11461159|FG003|STARTED|Overall Study||69
10325572|NCT00283842|11461160|FG004|STARTED|Overall Study||90
10325573|NCT00283842|11461156|FG000|COMPLETED|Overall Study||51
10325574|NCT00283842|11461157|FG001|COMPLETED|Overall Study||69
10325575|NCT00283842|11461158|FG002|COMPLETED|Overall Study||68
10325576|NCT00283842|11461159|FG003|COMPLETED|Overall Study||42
10325577|NCT00283842|11461160|FG004|COMPLETED|Overall Study||75
10325578|NCT00283842|11461156|FG000|NOT COMPLETED|Overall Study||12
10325579|NCT00283842|11461157|FG001|NOT COMPLETED|Overall Study||18
10325580|NCT00283842|11461158|FG002|NOT COMPLETED|Overall Study||31
10325581|NCT00283842|11461159|FG003|NOT COMPLETED|Overall Study||27
10325582|NCT00283842|11461160|FG004|NOT COMPLETED|Overall Study||15
10325583|NCT00283933|11461172|FG000|STARTED|Treatment Period||5
10701659|NCT02569398|11866091|FG002|STARTED|Overall Study||183
10701660|NCT02569398|11866089|FG000|COMPLETED|Overall Study||0
10701661|NCT02569398|11866090|FG001|COMPLETED|Overall Study||0
10701662|NCT02569398|11866091|FG002|COMPLETED|Overall Study||0
10701663|NCT02569398|11866089|FG000|NOT COMPLETED|Overall Study||185
10701664|NCT02569398|11866090|FG001|NOT COMPLETED|Overall Study||189
10701665|NCT02569398|11866091|FG002|NOT COMPLETED|Overall Study||183
10701666|NCT02569411|11866101|FG000|STARTED|Overall Study||65
10701667|NCT02569411|11866102|FG001|STARTED|Overall Study||64
10701668|NCT02569411|11866101|FG000|COMPLETED|Overall Study||0
10325584|NCT00283933|11461172|FG000|Safety Population|Treatment Period||5
10325585|NCT00283933|11461172|FG000|Pharmacodynamic (PD) Population|Treatment Period||5
10325586|NCT00283933|11461172|FG000|COMPLETED|Treatment Period||5
10325587|NCT00283933|11461172|FG000|NOT COMPLETED|Treatment Period||0
10325588|NCT00283933|11461172|FG000|STARTED|Extension Period||5
10325589|NCT00283933|11461172|FG000|COMPLETED|Extension Period||5
10325590|NCT00283933|11461172|FG000|NOT COMPLETED|Extension Period||0
10325591|NCT00284050|11461179|FG000|STARTED|Overall Study||51
10325592|NCT00284050|11461180|FG001|STARTED|Overall Study||51
10325593|NCT00284050|11461181|FG002|STARTED|Overall Study||49
10325594|NCT00284050|11461179|FG000|COMPLETED|Overall Study||46
10325595|NCT00284050|11461180|FG001|COMPLETED|Overall Study||46
10325596|NCT00284050|11461181|FG002|COMPLETED|Overall Study||40
10325597|NCT00284050|11461179|FG000|NOT COMPLETED|Overall Study||5
10325598|NCT00284050|11461180|FG001|NOT COMPLETED|Overall Study||5
10325599|NCT00284050|11461181|FG002|NOT COMPLETED|Overall Study||9
10325600|NCT00284089|11461193|FG000|STARTED|Single Dose Phase||6
10325601|NCT00284089|11461194|FG001|STARTED|Single Dose Phase||6
10325602|NCT00284089|11461195|FG002|STARTED|Single Dose Phase|Group B patients did not participate in the Single Dose Phase of the study.|0
10325603|NCT00284089|11461196|FG003|STARTED|Single Dose Phase|Group B patients did not participate in the Single Dose Phase of the study.|0
10325604|NCT00284089|11461193|FG000|COMPLETED|Single Dose Phase||6
10325605|NCT00284089|11461194|FG001|COMPLETED|Single Dose Phase||6
10325606|NCT00284089|11461195|FG002|COMPLETED|Single Dose Phase||0
10325607|NCT00284089|11461196|FG003|COMPLETED|Single Dose Phase||0
10325608|NCT00284089|11461193|FG000|NOT COMPLETED|Single Dose Phase||0
10325609|NCT00284089|11461194|FG001|NOT COMPLETED|Single Dose Phase||0
10325610|NCT00284089|11461195|FG002|NOT COMPLETED|Single Dose Phase||0
10325611|NCT00284089|11461196|FG003|NOT COMPLETED|Single Dose Phase||0
10325612|NCT00284089|11461193|FG000|STARTED|Multiple Dose Phase|1 subject chose to receive other treatment & discontinued before starting the multiple dose phase.|5
10325613|NCT00284089|11461194|FG001|STARTED|Multiple Dose Phase||6
10701669|NCT02569411|11866102|FG001|COMPLETED|Overall Study||0
10701670|NCT02569411|11866101|FG000|NOT COMPLETED|Overall Study||65
10701671|NCT02569411|11866102|FG001|NOT COMPLETED|Overall Study||64
10804036|NCT04081324|11965526|FG001|COMPLETED|Overall Study||10
10804037|NCT04081324|11965527|FG002|COMPLETED|Overall Study||10
10325614|NCT00284089|11461195|FG002|STARTED|Multiple Dose Phase||35
10325615|NCT00284089|11461196|FG003|STARTED|Multiple Dose Phase||41
10325616|NCT00284089|11461193|FG000|COMPLETED|Multiple Dose Phase||4
10325617|NCT00284089|11461194|FG001|COMPLETED|Multiple Dose Phase||6
10325618|NCT00284089|11461195|FG002|COMPLETED|Multiple Dose Phase||31
10325619|NCT00284089|11461196|FG003|COMPLETED|Multiple Dose Phase||37
10325620|NCT00284089|11461193|FG000|NOT COMPLETED|Multiple Dose Phase||1
10325621|NCT00284089|11461194|FG001|NOT COMPLETED|Multiple Dose Phase||0
10325622|NCT00284089|11461195|FG002|NOT COMPLETED|Multiple Dose Phase||4
10325623|NCT00284089|11461196|FG003|NOT COMPLETED|Multiple Dose Phase||4
10325624|NCT00284089|11461193|FG000|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|3
10701672|NCT02569437|11866110|FG000|STARTED|Overall Study||24
10701673|NCT02569437|11866111|FG001|STARTED|Overall Study||25
10804038|NCT04081324|11965528|FG003|COMPLETED|Overall Study||10
10325625|NCT00284089|11461194|FG001|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|6
10325626|NCT00284089|11461195|FG002|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|28
10338619|NCT04115839|11475506|FG003|COMPLETED|LTE Phase (After Week 16 to Week 63)||0
10701674|NCT02569437|11866110|FG000|COMPLETED|Overall Study||12
10701675|NCT02569437|11866111|FG001|COMPLETED|Overall Study||11
10701676|NCT02569437|11866110|FG000|NOT COMPLETED|Overall Study||12
10804039|NCT04081324|11965525|FG000|NOT COMPLETED|Overall Study||0
10325627|NCT00284089|11461196|FG003|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|33
10325628|NCT00284089|11461193|FG000|COMPLETED|Extension Phase||1
10325629|NCT00284089|11461194|FG001|COMPLETED|Extension Phase||6
10325630|NCT00284089|11461195|FG002|COMPLETED|Extension Phase||22
10325631|NCT00284089|11461196|FG003|COMPLETED|Extension Phase||21
10325632|NCT00284089|11461193|FG000|NOT COMPLETED|Extension Phase||2
10325633|NCT00284089|11461194|FG001|NOT COMPLETED|Extension Phase||0
10325634|NCT00284089|11461195|FG002|NOT COMPLETED|Extension Phase||6
10325635|NCT00284089|11461196|FG003|NOT COMPLETED|Extension Phase||12
10701677|NCT02569437|11866111|FG001|NOT COMPLETED|Overall Study||14
10701678|NCT02569541|11866117|FG000|STARTED|Overall Study||30
10701679|NCT02569541|11866117|FG000|COMPLETED|Overall Study||9
10701680|NCT02569541|11866117|FG000|NOT COMPLETED|Overall Study||21
10701681|NCT02569632|11866121|FG000|STARTED|Overall Study||18
10701682|NCT02569632|11866121|FG000|COMPLETED|Overall Study||17
10701683|NCT02569632|11866121|FG000|NOT COMPLETED|Overall Study||1
10325636|NCT00284141|11461206|FG000|STARTED|Overall Study||98
10325637|NCT00284141|11461206|FG000|TREATED|Overall Study|Participants received at least part of one dose of Aflibercept.|96
10325638|NCT00284141|11461206|FG000|ONGOING TREATMENT|Overall Study|Participants were still on study treatment at the clinical database cut-off date.|2
10325639|NCT00284141|11461206|FG000|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were still ongoing treatment.|0
10325640|NCT00284141|11461206|FG000|NOT COMPLETED|Overall Study||98
10325641|NCT00284154|11461212|FG000|STARTED|Overall Study||51
10325642|NCT00284154|11461212|FG000|COMPLETED|Overall Study||9
10325643|NCT00284154|11461212|FG000|NOT COMPLETED|Overall Study||42
10325644|NCT00284180|11461218|FG000|STARTED|Overall Study||11
10325645|NCT00284180|11461219|FG001|STARTED|Overall Study||21
10325646|NCT00284180|11461218|FG000|COMPLETED|Overall Study||11
10325647|NCT00284180|11461219|FG001|COMPLETED|Overall Study||17
10325648|NCT00284180|11461218|FG000|NOT COMPLETED|Overall Study||0
10325649|NCT00284180|11461219|FG001|NOT COMPLETED|Overall Study||4
10325650|NCT00284518|11461229|FG000|STARTED|Overall Study||97
10325651|NCT00284518|11461230|FG001|STARTED|Overall Study||94
10325652|NCT00284518|11461231|FG002|STARTED|Overall Study||95
10325653|NCT00284518|11461232|FG003|STARTED|Overall Study||94
10325654|NCT00284518|11461229|FG000|COMPLETED|Overall Study||71
10325655|NCT00284518|11461230|FG001|COMPLETED|Overall Study||66
10325656|NCT00284518|11461231|FG002|COMPLETED|Overall Study||67
10325657|NCT00284518|11461232|FG003|COMPLETED|Overall Study||61
10325658|NCT00284518|11461229|FG000|NOT COMPLETED|Overall Study||26
10325659|NCT00284518|11461230|FG001|NOT COMPLETED|Overall Study||28
10325660|NCT00284518|11461231|FG002|NOT COMPLETED|Overall Study||28
10325661|NCT00284518|11461232|FG003|NOT COMPLETED|Overall Study||33
10325662|NCT00284557|11461244|FG000|STARTED|Overall Study||67
10325663|NCT00284557|11461245|FG001|STARTED|Overall Study||63
10325664|NCT00284557|11461244|FG000|COMPLETED|Overall Study||58
10325665|NCT00284557|11461245|FG001|COMPLETED|Overall Study||50
10325666|NCT00284557|11461244|FG000|NOT COMPLETED|Overall Study||9
10325667|NCT00284557|11461245|FG001|NOT COMPLETED|Overall Study||13
10325668|NCT00284739|11461253|FG000|STARTED|Overall Study||11
10325669|NCT00284739|11461254|FG001|STARTED|Overall Study||9
10325670|NCT00284739|11461253|FG000|COMPLETED|Overall Study||11
10325671|NCT00284739|11461254|FG001|COMPLETED|Overall Study||9
10325672|NCT00284739|11461253|FG000|NOT COMPLETED|Overall Study||0
10325673|NCT00284739|11461254|FG001|NOT COMPLETED|Overall Study||0
10325674|NCT00284934|11461262|FG000|STARTED|Overall Study||48
10325675|NCT00284934|11461263|FG001|STARTED|Overall Study||46
10325676|NCT00284934|11461262|FG000|Intent-to-treat Population (ITT)|Overall Study||47
10325677|NCT00284934|11461263|FG001|Intent-to-treat Population (ITT)|Overall Study||45
10325678|NCT00284934|11461262|FG000|COMPLETED|Overall Study||44
10325679|NCT00284934|11461263|FG001|COMPLETED|Overall Study||43
10325680|NCT00284934|11461262|FG000|NOT COMPLETED|Overall Study||4
10325681|NCT00284934|11461263|FG001|NOT COMPLETED|Overall Study||3
10325682|NCT00285012|11461271|FG000|STARTED|Assigned to Study Treatment (Tx)||250
10325683|NCT00285012|11461272|FG001|STARTED|Assigned to Study Treatment (Tx)||254
10325684|NCT00285012|11461271|FG000|COMPLETED|Assigned to Study Treatment (Tx)||248
10325685|NCT00285012|11461272|FG001|COMPLETED|Assigned to Study Treatment (Tx)||251
10325686|NCT00285012|11461271|FG000|NOT COMPLETED|Assigned to Study Treatment (Tx)||2
10325687|NCT00285012|11461272|FG001|NOT COMPLETED|Assigned to Study Treatment (Tx)||3
10325688|NCT00285012|11461271|FG000|STARTED|Received Study Tx||248
10325689|NCT00285012|11461272|FG001|STARTED|Received Study Tx||251
10325690|NCT00285012|11461271|FG000|Completed Tx (May Continue in Study)|Received Study Tx|After treatment completion at Wk 12, subjects may continue in nontreatment follow-up phase|207
10325691|NCT00285012|11461272|FG001|Completed Tx (May Continue in Study)|Received Study Tx|After treatment completion at Wk 12, subjects may continue in nontreatment follow-up phase|193
10325692|NCT00285012|11461271|FG000|Discontinued Tx (May Continue in Study)|Received Study Tx|Discontinued Tx=12 Adverse Event (AE); 10 Lost to follow up; 13 subject withdrawal; 6 other, unknown|41
10325693|NCT00285012|11461272|FG001|Discontinued Tx (May Continue in Study)|Received Study Tx|Discontinued Tx=14 AE;3 Lack of efficacy;10 Lost to follow up;25 subject withdrawal;6 other, unknown|58
10325694|NCT00285012|11461271|FG000|COMPLETED|Received Study Tx|Completed study through nontreatment follow-up phase Week 13 to Week 52|176
10325695|NCT00285012|11461272|FG001|COMPLETED|Received Study Tx|Completed study through nontreatment follow-up phase Week 13 to Week 52|157
10701684|NCT02569658|11866127|FG000|STARTED|Overall Study||53
10701685|NCT02569658|11866128|FG001|STARTED|Overall Study||57
10701686|NCT02569658|11866127|FG000|COMPLETED|Overall Study||52
10701687|NCT02569658|11866128|FG001|COMPLETED|Overall Study||56
10325696|NCT00285012|11461271|FG000|NOT COMPLETED|Received Study Tx||72
10325697|NCT00285012|11461272|FG001|NOT COMPLETED|Received Study Tx||94
10325698|NCT00285207|11461280|FG000|STARTED|Overall Study||70
10325699|NCT00285207|11461281|FG001|STARTED|Overall Study||77
10325700|NCT00285207|11461280|FG000|Treated|Overall Study||63
10325701|NCT00285207|11461281|FG001|Treated|Overall Study||75
10325702|NCT00285207|11461280|FG000|COMPLETED|Overall Study||61
10325703|NCT00285207|11461281|FG001|COMPLETED|Overall Study||71
10325704|NCT00285207|11461280|FG000|NOT COMPLETED|Overall Study||9
10325705|NCT00285207|11461281|FG001|NOT COMPLETED|Overall Study||6
10325706|NCT00285246|11461287|FG000|STARTED|Overall Study||838
10325707|NCT00285246|11461287|FG000|COMPLETED|Overall Study|Number of participants who were eligible and completed at least one phase of data collection|790
10325708|NCT00285246|11461287|FG000|NOT COMPLETED|Overall Study||48
10325709|NCT00285467|11461293|FG000|STARTED|Overall Study||25
10325710|NCT00285467|11461294|FG001|STARTED|Overall Study||22
10325711|NCT00285467|11461293|FG000|COMPLETED|Overall Study||25
10325712|NCT00285467|11461294|FG001|COMPLETED|Overall Study||22
10325713|NCT00285467|11461293|FG000|NOT COMPLETED|Overall Study||0
10325714|NCT00285467|11461294|FG001|NOT COMPLETED|Overall Study||0
10325715|NCT00285584|11461302|FG000|STARTED|Enrollment (Month 0)||20
10325716|NCT00285584|11461303|FG001|STARTED|Enrollment (Month 0)||21
10325717|NCT00285584|11461302|FG000|COMPLETED|Enrollment (Month 0)||20
10325718|NCT00285584|11461303|FG001|COMPLETED|Enrollment (Month 0)||21
10325719|NCT00285584|11461302|FG000|NOT COMPLETED|Enrollment (Month 0)||0
10325720|NCT00285584|11461303|FG001|NOT COMPLETED|Enrollment (Month 0)||0
10325721|NCT00285584|11461302|FG000|STARTED|Month 3||20
10325722|NCT00285584|11461303|FG001|STARTED|Month 3||21
10325723|NCT00285584|11461302|FG000|COMPLETED|Month 3||16
10325724|NCT00285584|11461303|FG001|COMPLETED|Month 3||18
10325725|NCT00285584|11461302|FG000|NOT COMPLETED|Month 3||4
10325726|NCT00285584|11461303|FG001|NOT COMPLETED|Month 3||3
10325727|NCT00285584|11461302|FG000|STARTED|Month 6||16
10325728|NCT00285584|11461303|FG001|STARTED|Month 6||18
10325729|NCT00285584|11461302|FG000|COMPLETED|Month 6||16
10325730|NCT00285584|11461303|FG001|COMPLETED|Month 6||17
10325731|NCT00285584|11461302|FG000|NOT COMPLETED|Month 6||0
10325732|NCT00285584|11461303|FG001|NOT COMPLETED|Month 6||1
10325733|NCT00285584|11461302|FG000|STARTED|Month 9||16
10325734|NCT00285584|11461303|FG001|STARTED|Month 9||17
10325735|NCT00285584|11461302|FG000|COMPLETED|Month 9||15
10325736|NCT00285584|11461303|FG001|COMPLETED|Month 9||14
10325737|NCT00285584|11461302|FG000|NOT COMPLETED|Month 9||1
10325738|NCT00285584|11461303|FG001|NOT COMPLETED|Month 9||3
10325739|NCT00285649|11461316|FG000|STARTED|Overall Study||72
10325740|NCT00285649|11461317|FG001|STARTED|Overall Study||72
10325741|NCT00285649|11461318|FG002|STARTED|Overall Study||48
10325742|NCT00285649|11461316|FG000|COMPLETED|Overall Study||63
10325743|NCT00285649|11461317|FG001|COMPLETED|Overall Study||66
10325744|NCT00285649|11461318|FG002|COMPLETED|Overall Study||42
10325745|NCT00285649|11461316|FG000|NOT COMPLETED|Overall Study||9
10325746|NCT00285649|11461317|FG001|NOT COMPLETED|Overall Study||6
10325747|NCT00285649|11461318|FG002|NOT COMPLETED|Overall Study||6
10325748|NCT00285779|11461328|FG000|STARTED|Placebo-controlled Period (wk 1-12)||14
10325749|NCT00285779|11461329|FG001|STARTED|Placebo-controlled Period (wk 1-12)||13
10325750|NCT00285779|11461328|FG000|COMPLETED|Placebo-controlled Period (wk 1-12)||11
10325751|NCT00285779|11461329|FG001|COMPLETED|Placebo-controlled Period (wk 1-12)||12
10325752|NCT00285779|11461328|FG000|NOT COMPLETED|Placebo-controlled Period (wk 1-12)||3
10325753|NCT00285779|11461329|FG001|NOT COMPLETED|Placebo-controlled Period (wk 1-12)||1
10325754|NCT00285779|11461328|FG000|STARTED|Open Label Period (wk 12-24)||11
10325755|NCT00285779|11461329|FG001|STARTED|Open Label Period (wk 12-24)||12
10325756|NCT00285779|11461328|FG000|COMPLETED|Open Label Period (wk 12-24)||9
10325757|NCT00285779|11461329|FG001|COMPLETED|Open Label Period (wk 12-24)||10
10325758|NCT00285779|11461328|FG000|NOT COMPLETED|Open Label Period (wk 12-24)||2
10325759|NCT00285779|11461329|FG001|NOT COMPLETED|Open Label Period (wk 12-24)||2
10325760|NCT00285779|11461328|FG000|STARTED|Follow-up Period (wk 24-32)||9
10325761|NCT00285779|11461329|FG001|STARTED|Follow-up Period (wk 24-32)||10
10325762|NCT00285779|11461328|FG000|COMPLETED|Follow-up Period (wk 24-32)||8
10325763|NCT00285779|11461329|FG001|COMPLETED|Follow-up Period (wk 24-32)||10
10325764|NCT00285779|11461328|FG000|NOT COMPLETED|Follow-up Period (wk 24-32)||1
10325765|NCT00285779|11461329|FG001|NOT COMPLETED|Follow-up Period (wk 24-32)||0
10325766|NCT00285818|11461337|FG000|STARTED|Overall Study||6
10325767|NCT00285818|11461338|FG001|STARTED|Overall Study||5
10325768|NCT00285818|11461337|FG000|COMPLETED|Overall Study||2
10325769|NCT00285818|11461338|FG001|COMPLETED|Overall Study||3
10325770|NCT00285818|11461337|FG000|NOT COMPLETED|Overall Study||4
10325771|NCT00285818|11461338|FG001|NOT COMPLETED|Overall Study||2
10325772|NCT00285857|11461344|FG000|STARTED|Overall Study||30
10325773|NCT00285857|11461344|FG000|COMPLETED|Overall Study||26
10325774|NCT00285857|11461344|FG000|NOT COMPLETED|Overall Study||4
10325775|NCT00286078|11461355|FG000|STARTED|Overall Study||72
10325776|NCT00286078|11461356|FG001|STARTED|Overall Study||68
10325777|NCT00286078|11461355|FG000|12 Weeks|Overall Study||63
10325778|NCT00286078|11461356|FG001|12 Weeks|Overall Study||62
10325779|NCT00286078|11461355|FG000|COMPLETED|Overall Study||40
10325780|NCT00286078|11461356|FG001|COMPLETED|Overall Study||34
10325781|NCT00286078|11461355|FG000|NOT COMPLETED|Overall Study||32
10325782|NCT00286078|11461356|FG001|NOT COMPLETED|Overall Study||34
10325783|NCT00286091|11461364|FG000|STARTED|Double-blind Treatment Phase||716
10325784|NCT00286091|11461365|FG001|STARTED|Double-blind Treatment Phase||716
10325785|NCT00286091|11461364|FG000|Received Treatment|Double-blind Treatment Phase|4 participants received ≥ 1 dose of denosumab in error|709
10325786|NCT00286091|11461365|FG001|Received Treatment|Double-blind Treatment Phase||716
10325787|NCT00286091|11461364|FG000|On Study at Primary Data Analysis Cutoff|Double-blind Treatment Phase|Primary analysis cut-off date was 30 July 2010|164
10325788|NCT00286091|11461365|FG001|On Study at Primary Data Analysis Cutoff|Double-blind Treatment Phase|Primary analysis cut-off date was 30 July 2010|174
10325789|NCT00286091|11461364|FG000|COMPLETED|Double-blind Treatment Phase|On study through blinded treatment cutoff date of 09 January 2011|132
10325790|NCT00286091|11461365|FG001|COMPLETED|Double-blind Treatment Phase|On study through blinded treatment cutoff date of 09 January 2011|123
10325791|NCT00286091|11461364|FG000|NOT COMPLETED|Double-blind Treatment Phase||584
10325792|NCT00286091|11461365|FG001|NOT COMPLETED|Double-blind Treatment Phase||593
10325793|NCT00286091|11461364|FG000|STARTED|Open-label Treatment Phase|Participants in the Czech Republic and UK are reported separately (Study 20080585; NCT01824342)|110
10325794|NCT00286091|11461365|FG001|STARTED|Open-label Treatment Phase|Participants in the Czech Republic and UK are reported separately (Study 20080585; NCT01824342)|104
10325795|NCT00286091|11461364|FG000|Received Treatment|Open-label Treatment Phase||109
10325796|NCT00286091|11461365|FG001|Received Treatment|Open-label Treatment Phase||101
10325797|NCT00286091|11461364|FG000|COMPLETED|Open-label Treatment Phase|Completed 3 years of open-label treatment|33
10325798|NCT00286091|11461365|FG001|COMPLETED|Open-label Treatment Phase|Completed 3 years of open-label treatment|33
10325799|NCT00286091|11461364|FG000|NOT COMPLETED|Open-label Treatment Phase||77
10325800|NCT00286091|11461365|FG001|NOT COMPLETED|Open-label Treatment Phase||71
10325801|NCT00286156|11461376|FG000|STARTED|Overall Study||10
10325802|NCT00286156|11461377|FG001|STARTED|Overall Study||10
10325803|NCT00286156|11461378|FG002|STARTED|Overall Study||10
10325804|NCT00286156|11461376|FG000|COMPLETED|Overall Study||8
10325805|NCT00286156|11461377|FG001|COMPLETED|Overall Study||9
10325806|NCT00286156|11461378|FG002|COMPLETED|Overall Study||9
10325807|NCT00286156|11461376|FG000|NOT COMPLETED|Overall Study||2
10325808|NCT00286156|11461377|FG001|NOT COMPLETED|Overall Study||1
10325809|NCT00286156|11461378|FG002|NOT COMPLETED|Overall Study||1
10325810|NCT00286182|11461388|FG000|STARTED|Overall Study||28
10325811|NCT00286182|11461389|FG001|STARTED|Overall Study||28
10325812|NCT00286182|11461388|FG000|COMPLETED|Overall Study||23
10325813|NCT00286182|11461389|FG001|COMPLETED|Overall Study||25
10325814|NCT00286182|11461388|FG000|NOT COMPLETED|Overall Study||5
10325815|NCT00286182|11461389|FG001|NOT COMPLETED|Overall Study||3
10325816|NCT00286221|11461399|FG000|STARTED|Overall Study||39
10325817|NCT00286221|11461400|FG001|STARTED|Overall Study||40
10325818|NCT00286221|11461401|FG002|STARTED|Overall Study||40
10325819|NCT00286221|11461402|FG003|STARTED|Overall Study||40
10325820|NCT00286221|11461399|FG000|COMPLETED|Overall Study||29
10325821|NCT00286221|11461400|FG001|COMPLETED|Overall Study||35
10325822|NCT00286221|11461401|FG002|COMPLETED|Overall Study||31
10325823|NCT00286221|11461402|FG003|COMPLETED|Overall Study||34
10325824|NCT00286221|11461399|FG000|NOT COMPLETED|Overall Study||10
10325825|NCT00286221|11461400|FG001|NOT COMPLETED|Overall Study||5
10325826|NCT00286221|11461401|FG002|NOT COMPLETED|Overall Study||9
10325827|NCT00286221|11461402|FG003|NOT COMPLETED|Overall Study||6
10325828|NCT00286234|11461416|FG000|STARTED|Overall Study||17
10325829|NCT00286234|11461417|FG001|STARTED|Overall Study||17
10325830|NCT00286234|11461418|FG002|STARTED|Overall Study||17
10325831|NCT00286234|11461419|FG003|STARTED|Overall Study||17
10325832|NCT00286234|11461416|FG000|COMPLETED|Overall Study||15
10325833|NCT00286234|11461417|FG001|COMPLETED|Overall Study||15
10325834|NCT00286234|11461418|FG002|COMPLETED|Overall Study||17
10325835|NCT00286234|11461419|FG003|COMPLETED|Overall Study||13
10325836|NCT00286234|11461416|FG000|NOT COMPLETED|Overall Study||2
10325837|NCT00286234|11461417|FG001|NOT COMPLETED|Overall Study||2
10804040|NCT04081324|11965526|FG001|NOT COMPLETED|Overall Study||0
10804041|NCT04081324|11965527|FG002|NOT COMPLETED|Overall Study||0
10804042|NCT04081324|11965528|FG003|NOT COMPLETED|Overall Study||0
10804043|NCT04079790|11965541|FG000|STARTED|Part 1, Period 1(Day 1 to Day 4)||14
10804044|NCT04079790|11965542|FG001|STARTED|Part 1, Period 1(Day 1 to Day 4)||2
10804045|NCT04079790|11965543|FG002|STARTED|Part 1, Period 1(Day 1 to Day 4)||0
10804046|NCT04079790|11965544|FG003|STARTED|Part 1, Period 1(Day 1 to Day 4)||0
10804047|NCT04079790|11965541|FG000|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||13
10804048|NCT04079790|11965542|FG001|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||2
10804049|NCT04079790|11965543|FG002|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
10804050|NCT04079790|11965544|FG003|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
10804051|NCT04079790|11965541|FG000|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||1
10804052|NCT04079790|11965542|FG001|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
10804053|NCT04079790|11965543|FG002|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
10804054|NCT04079790|11965544|FG003|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
10804055|NCT04079790|11965541|FG000|STARTED|Part 1, Period 2 (Day 5 to Day 8)||13
10804056|NCT04079790|11965542|FG001|STARTED|Part 1, Period 2 (Day 5 to Day 8)||2
10804057|NCT04079790|11965543|FG002|STARTED|Part 1, Period 2 (Day 5 to Day 8)||0
10804058|NCT04079790|11965544|FG003|STARTED|Part 1, Period 2 (Day 5 to Day 8)||0
10811058|NCT03781375|11972756|FG000|NOT COMPLETED|Open-label Phase||3
10325838|NCT00286234|11461418|FG002|NOT COMPLETED|Overall Study||0
10325839|NCT00286234|11461419|FG003|NOT COMPLETED|Overall Study||4
10325840|NCT00286325|11461429|FG000|STARTED|Overall Study||8
10325841|NCT00286325|11461429|FG000|COMPLETED|Overall Study||8
10325842|NCT00286325|11461429|FG000|NOT COMPLETED|Overall Study||0
10325843|NCT00286429|11461436|FG000|STARTED|Overall Study||130
10325844|NCT00286429|11461437|FG001|STARTED|Overall Study||131
10325845|NCT00286429|11461438|FG002|STARTED|Overall Study||129
10325846|NCT00286429|11461436|FG000|COMPLETED|Overall Study||55
10325847|NCT00286429|11461437|FG001|COMPLETED|Overall Study||83
10325848|NCT00286429|11461438|FG002|COMPLETED|Overall Study||77
10325849|NCT00286429|11461436|FG000|NOT COMPLETED|Overall Study||75
10325850|NCT00286429|11461437|FG001|NOT COMPLETED|Overall Study||48
10325851|NCT00286429|11461438|FG002|NOT COMPLETED|Overall Study||52
10325852|NCT00286442|11461449|FG000|STARTED|Overall Study||213
10325853|NCT00286442|11461450|FG001|STARTED|Overall Study||210
10325854|NCT00286442|11461451|FG002|STARTED|Overall Study||104
10325855|NCT00286442|11461449|FG000|COMPLETED|Overall Study||176
10325856|NCT00286442|11461450|FG001|COMPLETED|Overall Study||165
10325857|NCT00286442|11461451|FG002|COMPLETED|Overall Study||72
10325858|NCT00286442|11461449|FG000|NOT COMPLETED|Overall Study||37
10325859|NCT00286442|11461450|FG001|NOT COMPLETED|Overall Study||45
10325860|NCT00286442|11461451|FG002|NOT COMPLETED|Overall Study||32
10325861|NCT00286455|11461462|FG000|STARTED|Overall Study||65
10325862|NCT00286455|11461463|FG001|STARTED|Overall Study||133
10325863|NCT00286455|11461464|FG002|STARTED|Overall Study||131
10325864|NCT00286455|11461462|FG000|COMPLETED|Overall Study||40
10325865|NCT00286455|11461463|FG001|COMPLETED|Overall Study||105
10325866|NCT00286455|11461464|FG002|COMPLETED|Overall Study||107
10325867|NCT00286455|11461462|FG000|NOT COMPLETED|Overall Study||25
10325868|NCT00286455|11461463|FG001|NOT COMPLETED|Overall Study||28
10325869|NCT00286455|11461464|FG002|NOT COMPLETED|Overall Study||24
10325870|NCT00286468|11461475|FG000|STARTED|Overall Study||99
10325871|NCT00286468|11461476|FG001|STARTED|Overall Study||203
10325872|NCT00286468|11461477|FG002|STARTED|Overall Study||198
10325873|NCT00286468|11461475|FG000|COMPLETED|Overall Study||62
10325874|NCT00286468|11461476|FG001|COMPLETED|Overall Study||153
10325875|NCT00286468|11461477|FG002|COMPLETED|Overall Study||148
10325876|NCT00286468|11461475|FG000|NOT COMPLETED|Overall Study||37
10325877|NCT00286468|11461476|FG001|NOT COMPLETED|Overall Study||50
10325878|NCT00286468|11461477|FG002|NOT COMPLETED|Overall Study||50
10325879|NCT00286494|11461488|FG000|STARTED|Overall Study||97
10325880|NCT00286494|11461489|FG001|STARTED|Overall Study||197
10325881|NCT00286494|11461490|FG002|STARTED|Overall Study||199
10325882|NCT00286494|11461488|FG000|COMPLETED|Overall Study||71
10325883|NCT00286494|11461489|FG001|COMPLETED|Overall Study||153
10325884|NCT00286494|11461490|FG002|COMPLETED|Overall Study||160
10325885|NCT00286494|11461488|FG000|NOT COMPLETED|Overall Study||26
10325886|NCT00286494|11461489|FG001|NOT COMPLETED|Overall Study||44
10325887|NCT00286494|11461490|FG002|NOT COMPLETED|Overall Study||39
10325888|NCT00286728|11461500|FG000|STARTED|Overall Study||142
10325889|NCT00286728|11461501|FG001|STARTED|Overall Study||145
10325890|NCT00286728|11461500|FG000|COMPLETED|Overall Study||106
10325891|NCT00286728|11461501|FG001|COMPLETED|Overall Study||116
10325892|NCT00286728|11461500|FG000|NOT COMPLETED|Overall Study||36
10325893|NCT00286728|11461501|FG001|NOT COMPLETED|Overall Study||29
10325894|NCT00286741|11461509|FG000|STARTED|Overall Study||133
10325895|NCT00286741|11461510|FG001|STARTED|Overall Study||106
10325896|NCT00286741|11461509|FG000|COMPLETED|Overall Study||122
10325897|NCT00286741|11461510|FG001|COMPLETED|Overall Study||89
10325898|NCT00286741|11461509|FG000|NOT COMPLETED|Overall Study||11
10325899|NCT00286741|11461510|FG001|NOT COMPLETED|Overall Study||17
10325900|NCT00286754|11461522|FG000|STARTED|Overall Study||176
10325901|NCT00286754|11461523|FG001|STARTED|Overall Study||177
10325902|NCT00286754|11461524|FG002|STARTED|Overall Study||180
10325903|NCT00286754|11461522|FG000|COMPLETED|Overall Study||156
10325904|NCT00286754|11461523|FG001|COMPLETED|Overall Study||159
10325905|NCT00286754|11461524|FG002|COMPLETED|Overall Study||170
10325906|NCT00286754|11461522|FG000|NOT COMPLETED|Overall Study||20
10325907|NCT00286754|11461523|FG001|NOT COMPLETED|Overall Study||18
10325908|NCT00286754|11461524|FG002|NOT COMPLETED|Overall Study||10
10325909|NCT00286949|11461538|FG000|STARTED|Overall Study||12
10325910|NCT00286949|11461538|FG000|COMPLETED|Overall Study||12
10325911|NCT00286949|11461538|FG000|NOT COMPLETED|Overall Study||0
10325912|NCT00287053|11461546|FG000|STARTED|Overall Study||30
10325913|NCT00287053|11461547|FG001|STARTED|Overall Study||27
10325914|NCT00287053|11461546|FG000|COMPLETED|Overall Study||26
10325915|NCT00287053|11461547|FG001|COMPLETED|Overall Study||26
10325916|NCT00287053|11461546|FG000|NOT COMPLETED|Overall Study||4
10325917|NCT00287053|11461547|FG001|NOT COMPLETED|Overall Study||1
10325918|NCT00287079|11461555|FG000|STARTED|Overall Study||32
10325919|NCT00287079|11461556|FG001|STARTED|Overall Study||3
10325920|NCT00287079|11461555|FG000|COMPLETED|Overall Study||10
10325921|NCT00287079|11461556|FG001|COMPLETED|Overall Study||2
10325922|NCT00287079|11461555|FG000|NOT COMPLETED|Overall Study||22
10325923|NCT00287079|11461556|FG001|NOT COMPLETED|Overall Study||1
10325924|NCT00287118|11461562|FG000|STARTED|Overall Study||189
10325925|NCT00287118|11461562|FG000|COMPLETED|Overall Study||137
10325926|NCT00287118|11461562|FG000|NOT COMPLETED|Overall Study||52
10325927|NCT00287222|11461566|FG000|STARTED|Overall Study||21
10325928|NCT00287222|11461566|FG000|COMPLETED|Overall Study||21
10325929|NCT00287222|11461566|FG000|NOT COMPLETED|Overall Study||0
10325930|NCT00287287|11461570|FG000|STARTED|Overall Study||25
10325931|NCT00287287|11461570|FG000|COMPLETED|Overall Study||25
10325932|NCT00287287|11461570|FG000|NOT COMPLETED|Overall Study||0
10325933|NCT00287339|11461576|FG000|STARTED|Overall Study||22
10325934|NCT00287339|11461577|FG001|STARTED|Overall Study||18
10325935|NCT00287339|11461576|FG000|COMPLETED|Overall Study||22
10325936|NCT00287339|11461577|FG001|COMPLETED|Overall Study||18
10325937|NCT00287339|11461576|FG000|NOT COMPLETED|Overall Study||0
10325938|NCT00287339|11461577|FG001|NOT COMPLETED|Overall Study||0
10325939|NCT00287365|11461583|FG000|STARTED|Overall Study||25
10325940|NCT00287365|11461583|FG000|COMPLETED|Overall Study||12
10325941|NCT00287365|11461583|FG000|NOT COMPLETED|Overall Study||13
10325942|NCT00287469|11461590|FG000|STARTED|Overall Study||1000
10325943|NCT00287469|11461591|FG001|STARTED|Overall Study||1000
10325944|NCT00287469|11461590|FG000|COMPLETED|Overall Study||780
10325945|NCT00287469|11461591|FG001|COMPLETED|Overall Study||786
10325946|NCT00287469|11461590|FG000|NOT COMPLETED|Overall Study||220
10325947|NCT00287469|11461591|FG001|NOT COMPLETED|Overall Study||214
10325948|NCT00287586|11461601|FG000|STARTED|Overall Study||156
10325949|NCT00287586|11461602|FG001|STARTED|Overall Study||152
10325950|NCT00287586|11461601|FG000|Intent-to-treat: Received Study Drug|Overall Study||155
10325951|NCT00287586|11461602|FG001|Intent-to-treat: Received Study Drug|Overall Study||151
10325952|NCT00287586|11461601|FG000|COMPLETED|Overall Study||111
10325953|NCT00287586|11461602|FG001|COMPLETED|Overall Study||100
10325954|NCT00287586|11461601|FG000|NOT COMPLETED|Overall Study||45
10325955|NCT00287586|11461602|FG001|NOT COMPLETED|Overall Study||52
10325956|NCT00287690|11461610|FG000|STARTED|Overall Study||33
10325957|NCT00287690|11461611|FG001|STARTED|Overall Study||38
10325958|NCT00287690|11461610|FG000|COMPLETED|Overall Study||13
10325959|NCT00287690|11461611|FG001|COMPLETED|Overall Study||12
10325960|NCT00287690|11461610|FG000|NOT COMPLETED|Overall Study||20
10325961|NCT00287690|11461611|FG001|NOT COMPLETED|Overall Study||26
10325962|NCT00287716|11461620|FG000|STARTED|Overall Study||174
10325963|NCT00287716|11461621|FG001|STARTED|Overall Study||87
10325964|NCT00287716|11461622|FG002|STARTED|Overall Study||174
10325965|NCT00287716|11461620|FG000|COMPLETED|Overall Study||136
10325966|NCT00287716|11461621|FG001|COMPLETED|Overall Study||70
10325967|NCT00287716|11461622|FG002|COMPLETED|Overall Study||143
10325968|NCT00287716|11461620|FG000|NOT COMPLETED|Overall Study||38
10325969|NCT00287716|11461621|FG001|NOT COMPLETED|Overall Study||17
10325970|NCT00287716|11461622|FG002|NOT COMPLETED|Overall Study||31
10325971|NCT00287729|11461632|FG000|STARTED|Overall Study||171
10325972|NCT00287729|11461633|FG001|STARTED|Overall Study||173
10325973|NCT00287729|11461632|FG000|COMPLETED|Overall Study||137
10325974|NCT00287729|11461633|FG001|COMPLETED|Overall Study||142
10804059|NCT04079790|11965541|FG000|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||13
10804060|NCT04079790|11965542|FG001|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||2
10804061|NCT04079790|11965543|FG002|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
10804062|NCT04079790|11965544|FG003|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
10804063|NCT04079790|11965541|FG000|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
10804064|NCT04079790|11965542|FG001|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
10804065|NCT04079790|11965543|FG002|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
10804066|NCT04079790|11965544|FG003|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
10804067|NCT04079790|11965541|FG000|STARTED|Part 1, Period 3 (Day 9 to Day 11)||13
10804068|NCT04079790|11965542|FG001|STARTED|Part 1, Period 3 (Day 9 to Day 11)||2
10804069|NCT04079790|11965543|FG002|STARTED|Part 1, Period 3 (Day 9 to Day 11)||0
10804070|NCT04079790|11965544|FG003|STARTED|Part 1, Period 3 (Day 9 to Day 11)||0
10804071|NCT04079790|11965541|FG000|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||13
10804072|NCT04079790|11965542|FG001|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||2
10804073|NCT04079790|11965543|FG002|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
10804074|NCT04079790|11965544|FG003|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
10804075|NCT04079790|11965541|FG000|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
10804076|NCT04079790|11965542|FG001|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
10325975|NCT00287729|11461632|FG000|NOT COMPLETED|Overall Study||34
10325976|NCT00287729|11461633|FG001|NOT COMPLETED|Overall Study||31
10325977|NCT00287872|11461639|FG000|STARTED|Overall Study||30
10325978|NCT00287872|11461639|FG000|COMPLETED|Overall Study||30
10325979|NCT00287872|11461639|FG000|NOT COMPLETED|Overall Study||0
10325980|NCT00287989|11461647|FG000|STARTED|Overall Study||28
10804077|NCT04079790|11965543|FG002|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
10804078|NCT04079790|11965544|FG003|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
10804079|NCT04079790|11965541|FG000|STARTED|Part 2, Period 1 (Day 1 to Day 3)||0
10804080|NCT04079790|11965542|FG001|STARTED|Part 2, Period 1 (Day 1 to Day 3)||0
10804081|NCT04079790|11965543|FG002|STARTED|Part 2, Period 1 (Day 1 to Day 3)||15
10804082|NCT04079790|11965544|FG003|STARTED|Part 2, Period 1 (Day 1 to Day 3)||3
10804083|NCT04079790|11965541|FG000|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
10804084|NCT04079790|11965542|FG001|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
10804085|NCT04079790|11965543|FG002|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||12
10804086|NCT04079790|11965544|FG003|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||3
10804087|NCT04079790|11965541|FG000|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
10804088|NCT04079790|11965542|FG001|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
10325981|NCT00287989|11461648|FG001|STARTED|Overall Study||29
10325982|NCT00287989|11461649|FG002|STARTED|Overall Study||29
10325983|NCT00287989|11461647|FG000|COMPLETED|Overall Study||28
10325984|NCT00287989|11461648|FG001|COMPLETED|Overall Study||29
10325985|NCT00287989|11461649|FG002|COMPLETED|Overall Study||29
10325986|NCT00287989|11461647|FG000|NOT COMPLETED|Overall Study||0
10325987|NCT00287989|11461648|FG001|NOT COMPLETED|Overall Study||0
10325988|NCT00287989|11461649|FG002|NOT COMPLETED|Overall Study||0
10325989|NCT00288015|11461657|FG000|STARTED|Registered to Study||32
10325990|NCT00288015|11461657|FG000|COMPLETED|Registered to Study||32
10325991|NCT00288015|11461657|FG000|NOT COMPLETED|Registered to Study||0
10325992|NCT00288015|11461657|FG000|STARTED|Bevacizumab Treatment Cycles 1-2||32
10325993|NCT00288015|11461657|FG000|COMPLETED|Bevacizumab Treatment Cycles 1-2||30
10325994|NCT00288015|11461657|FG000|NOT COMPLETED|Bevacizumab Treatment Cycles 1-2||2
10325995|NCT00288015|11461657|FG000|STARTED|First Response Assessment||30
10325996|NCT00288015|11461657|FG000|COMPLETED|First Response Assessment||26
10325997|NCT00288015|11461657|FG000|NOT COMPLETED|First Response Assessment||4
10325998|NCT00288015|11461657|FG000|STARTED|Continued Bevacizumab Cycle 3+||26
10325999|NCT00288015|11461657|FG000|COMPLETED|Continued Bevacizumab Cycle 3+||19
10326000|NCT00288015|11461657|FG000|NOT COMPLETED|Continued Bevacizumab Cycle 3+||7
10326001|NCT00288015|11461657|FG000|STARTED|Follow up for Survival x 2 Years||29
10326002|NCT00288015|11461657|FG000|COMPLETED|Follow up for Survival x 2 Years||3
10326003|NCT00288015|11461657|FG000|NOT COMPLETED|Follow up for Survival x 2 Years||26
10326004|NCT00288054|11461661|FG000|STARTED|Overall Study||24
10326005|NCT00288054|11461661|FG000|COMPLETED|Overall Study||0
10326006|NCT00288054|11461661|FG000|NOT COMPLETED|Overall Study||24
10326007|NCT00288067|11461667|FG000|STARTED|Overall Study||32
10326008|NCT00288067|11461667|FG000|COMPLETED|Overall Study||32
10326009|NCT00288067|11461667|FG000|NOT COMPLETED|Overall Study||0
10326010|NCT00288366|11461675|FG000|STARTED|Overall Study||23
10326011|NCT00288366|11461676|FG001|STARTED|Overall Study||26
10326012|NCT00288366|11461675|FG000|COMPLETED|Overall Study||23
10326013|NCT00288366|11461676|FG001|COMPLETED|Overall Study||26
10326014|NCT00288366|11461675|FG000|NOT COMPLETED|Overall Study||0
10326015|NCT00288366|11461676|FG001|NOT COMPLETED|Overall Study||0
10326028|NCT00288574|11461688|FG000|STARTED|Overall Study||49
10326029|NCT00288574|11461689|FG001|STARTED|Overall Study||44
10326030|NCT00288574|11461688|FG000|COMPLETED|Overall Study||49
10326031|NCT00288574|11461689|FG001|COMPLETED|Overall Study||44
10326032|NCT00288574|11461688|FG000|NOT COMPLETED|Overall Study||0
10326033|NCT00288574|11461689|FG001|NOT COMPLETED|Overall Study||0
10326034|NCT00288587|11461700|FG000|STARTED|Overall Study||19
10326035|NCT00288587|11461701|FG001|STARTED|Overall Study||17
10326036|NCT00288587|11461700|FG000|COMPLETED|Overall Study||14
10326037|NCT00288587|11461701|FG001|COMPLETED|Overall Study||7
10326038|NCT00288587|11461700|FG000|NOT COMPLETED|Overall Study||5
10326039|NCT00288587|11461701|FG001|NOT COMPLETED|Overall Study||10
10326040|NCT00288600|11461709|FG000|STARTED|Overall Study||46
10326041|NCT00288600|11461710|FG001|STARTED|Overall Study||46
10326042|NCT00288600|11461709|FG000|COMPLETED|Overall Study||46
10326043|NCT00288600|11461710|FG001|COMPLETED|Overall Study||46
10326044|NCT00288600|11461709|FG000|NOT COMPLETED|Overall Study||0
10326045|NCT00288600|11461710|FG001|NOT COMPLETED|Overall Study||0
10326046|NCT00288626|11461716|FG000|STARTED|Overall Study||24
10326047|NCT00288626|11461716|FG000|COMPLETED|Overall Study||17
10326048|NCT00288626|11461716|FG000|NOT COMPLETED|Overall Study||7
10326049|NCT00288639|11461722|FG000|STARTED|Overall Study||98
10326050|NCT00288639|11461722|FG000|COMPLETED|Overall Study||86
10326051|NCT00288639|11461722|FG000|NOT COMPLETED|Overall Study||12
10338620|NCT04115839|11475507|FG004|COMPLETED|LTE Phase (After Week 16 to Week 63)||0
10338621|NCT04115839|11475508|FG005|COMPLETED|LTE Phase (After Week 16 to Week 63)||0
10338622|NCT04115839|11475509|FG006|COMPLETED|LTE Phase (After Week 16 to Week 63)||0
10338623|NCT04115839|11475503|FG000|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||0
10338624|NCT04115839|11475504|FG001|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||0
10338625|NCT04115839|11475505|FG002|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||0
10338626|NCT04115839|11475506|FG003|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||18
10338627|NCT04115839|11475507|FG004|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||20
10338628|NCT04115839|11475508|FG005|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||10
10804089|NCT04079790|11965543|FG002|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||3
10804090|NCT04079790|11965544|FG003|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
10804091|NCT04079790|11965541|FG000|STARTED|Part 2, Period 2 (Day 1 to Day 3)||0
10338629|NCT04115839|11475509|FG006|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||8
10338630|NCT04078126|11475534|FG000|STARTED|Period 1||18
10338631|NCT04078126|11475535|FG001|STARTED|Period 1||17
10338632|NCT04078126|11475534|FG000|COMPLETED|Period 1||18
10338633|NCT04078126|11475535|FG001|COMPLETED|Period 1||17
10338634|NCT04078126|11475534|FG000|NOT COMPLETED|Period 1||0
10338635|NCT04078126|11475535|FG001|NOT COMPLETED|Period 1||0
10338636|NCT04078126|11475534|FG000|STARTED|Washout||18
10338637|NCT04078126|11475535|FG001|STARTED|Washout||17
10338638|NCT04078126|11475534|FG000|COMPLETED|Washout||18
10338639|NCT04078126|11475535|FG001|COMPLETED|Washout||15
10338640|NCT04078126|11475534|FG000|NOT COMPLETED|Washout||0
10338641|NCT04078126|11475535|FG001|NOT COMPLETED|Washout||2
10338642|NCT04078126|11475534|FG000|STARTED|Period 2||18
10338643|NCT04078126|11475535|FG001|STARTED|Period 2||15
10326052|NCT00288704|11461729|FG000|STARTED|Part A, Double Blind, Weeks 1-6||24
10326053|NCT00288704|11461730|FG001|STARTED|Part A, Double Blind, Weeks 1-6||23
10326054|NCT00288704|11461731|FG002|STARTED|Part A, Double Blind, Weeks 1-6|Subjects enrolled into the open-label phase do not complete this part of the study.|0
10326055|NCT00288704|11461729|FG000|COMPLETED|Part A, Double Blind, Weeks 1-6||24
10326056|NCT00288704|11461730|FG001|COMPLETED|Part A, Double Blind, Weeks 1-6||22
10326057|NCT00288704|11461731|FG002|COMPLETED|Part A, Double Blind, Weeks 1-6||0
10326058|NCT00288704|11461729|FG000|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||0
10326059|NCT00288704|11461730|FG001|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||1
10326060|NCT00288704|11461731|FG002|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||0
10326061|NCT00288704|11461729|FG000|STARTED|Part B, Randomized Withdrawal, Wks 15-24|1 subject discontinued during weeks 6-14 due to non-compliance with study drug dosing procedures.|23
10326062|NCT00288704|11461730|FG001|STARTED|Part B, Randomized Withdrawal, Wks 15-24||22
10326063|NCT00288704|11461731|FG002|STARTED|Part B, Randomized Withdrawal, Wks 15-24||0
10326064|NCT00288704|11461729|FG000|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||23
10326065|NCT00288704|11461730|FG001|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||21
10326066|NCT00288704|11461731|FG002|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
10326067|NCT00288704|11461729|FG000|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
10326068|NCT00288704|11461730|FG001|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||1
10326069|NCT00288704|11461731|FG002|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
10326070|NCT00288704|11461729|FG000|STARTED|Open-Label Extension (OLE) Weeks 24-117|After week 24, all subjects are treated with Open label rilonacept.|0
10326071|NCT00288704|11461730|FG001|STARTED|Open-Label Extension (OLE) Weeks 24-117||0
10326072|NCT00288704|11461731|FG002|STARTED|Open-Label Extension (OLE) Weeks 24-117||101
10326073|NCT00288704|11461729|FG000|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
10326074|NCT00288704|11461730|FG001|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
10326075|NCT00288704|11461731|FG002|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||81
10326076|NCT00288704|11461729|FG000|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
10326077|NCT00288704|11461730|FG001|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
10326078|NCT00288704|11461731|FG002|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||20
10326079|NCT00288860|11461740|FG000|STARTED|Overall Study||412
10326080|NCT00288860|11461741|FG001|STARTED|Overall Study||425
10326081|NCT00288860|11461740|FG000|Completed Intake Survey|Overall Study||408
10326082|NCT00288860|11461741|FG001|Completed Intake Survey|Overall Study||417
10326083|NCT00288860|11461740|FG000|Completed 4 Month fu Survey|Overall Study||275
10326084|NCT00288860|11461741|FG001|Completed 4 Month fu Survey|Overall Study||299
10326085|NCT00288860|11461740|FG000|Completed 12 Month fu Survey|Overall Study||257
10326086|NCT00288860|11461741|FG001|Completed 12 Month fu Survey|Overall Study||281
10326087|NCT00288860|11461740|FG000|COMPLETED|Overall Study|310 completed either 4 or 12 month survey. Used all with intake (n = 408) in intent-to-treat.|310
10326088|NCT00288860|11461741|FG001|COMPLETED|Overall Study|328 completed 4 or 12 month survey. Used all with intake (n=417) in intent to treat.|328
10326089|NCT00288860|11461740|FG000|NOT COMPLETED|Overall Study||102
10326090|NCT00288860|11461741|FG001|NOT COMPLETED|Overall Study||97
10326091|NCT00288886|11461752|FG000|STARTED|Overall Study||91
10326092|NCT00288886|11461753|FG001|STARTED|Overall Study||92
10326093|NCT00288886|11461752|FG000|3-month Follow Up|Overall Study||82
10326094|NCT00288886|11461753|FG001|3-month Follow Up|Overall Study||85
10326095|NCT00288886|11461752|FG000|6-month Follow Up|Overall Study||85
10326096|NCT00288886|11461753|FG001|6-month Follow Up|Overall Study||84
10326097|NCT00288886|11461752|FG000|12-month Follow Up|Overall Study||80
10326098|NCT00288886|11461753|FG001|12-month Follow Up|Overall Study||81
10326099|NCT00288886|11461752|FG000|COMPLETED|Overall Study||80
10326100|NCT00288886|11461753|FG001|COMPLETED|Overall Study||81
10326101|NCT00288886|11461752|FG000|NOT COMPLETED|Overall Study||11
10326102|NCT00288886|11461753|FG001|NOT COMPLETED|Overall Study||11
10326103|NCT00288912|11461762|FG000|STARTED|Overall Study||175
10326104|NCT00288912|11461763|FG001|STARTED|Overall Study||174
10326105|NCT00288912|11461764|FG002|STARTED|Overall Study||174
10326106|NCT00288912|11461762|FG000|COMPLETED|Overall Study||158
10326107|NCT00288912|11461763|FG001|COMPLETED|Overall Study||157
10326108|NCT00288912|11461764|FG002|COMPLETED|Overall Study||146
10804092|NCT04079790|11965542|FG001|STARTED|Part 2, Period 2 (Day 1 to Day 3)||0
10804093|NCT04079790|11965543|FG002|STARTED|Part 2, Period 2 (Day 1 to Day 3)||12
10804094|NCT04079790|11965544|FG003|STARTED|Part 2, Period 2 (Day 1 to Day 3)||3
10804095|NCT04079790|11965541|FG000|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
10804096|NCT04079790|11965542|FG001|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
10804097|NCT04079790|11965543|FG002|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||12
10804098|NCT04079790|11965544|FG003|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||3
10804099|NCT04079790|11965541|FG000|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
10804100|NCT04079790|11965542|FG001|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
10804101|NCT04079790|11965543|FG002|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
10326109|NCT00288912|11461762|FG000|NOT COMPLETED|Overall Study||17
10326110|NCT00288912|11461763|FG001|NOT COMPLETED|Overall Study||17
10326111|NCT00288912|11461764|FG002|NOT COMPLETED|Overall Study||28
10326112|NCT00289016|11461772|FG000|STARTED|Overall Study||50
10326113|NCT00289016|11461772|FG000|COMPLETED|Overall Study||13
10326114|NCT00289016|11461772|FG000|NOT COMPLETED|Overall Study||37
10804102|NCT04079790|11965544|FG003|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
10804103|NCT04079127|11965570|FG000|STARTED|Overall Study|hips (in 141 patients)|150
10326121|NCT00289107|11461787|FG000|STARTED|Overall Study||77
10326122|NCT00289107|11461788|FG001|STARTED|Overall Study||72
10326123|NCT00289107|11461787|FG000|COMPLETED|Overall Study||24
10326124|NCT00289107|11461788|FG001|COMPLETED|Overall Study||28
10326125|NCT00289107|11461787|FG000|NOT COMPLETED|Overall Study||53
10326126|NCT00289107|11461788|FG001|NOT COMPLETED|Overall Study||44
10326127|NCT00289120|11461794|FG000|STARTED|Overall Study||13
10326128|NCT00289120|11461794|FG000|COMPLETED|Overall Study||13
10326129|NCT00289120|11461794|FG000|NOT COMPLETED|Overall Study||0
10326130|NCT00289133|11461804|FG000|STARTED|Overall Study||461
10326131|NCT00289133|11461805|FG001|STARTED|Overall Study||477
10326132|NCT00289133|11461804|FG000|COMPLETED|Overall Study||189
10326133|NCT00289133|11461805|FG001|COMPLETED|Overall Study||179
10326134|NCT00289133|11461804|FG000|NOT COMPLETED|Overall Study||272
10326135|NCT00289133|11461805|FG001|NOT COMPLETED|Overall Study||298
10326136|NCT00289185|11461817|FG000|STARTED|Overall Study||170
10326137|NCT00289185|11461818|FG001|STARTED|Overall Study||170
10326138|NCT00289185|11461817|FG000|COMPLETED|Overall Study||142
10326139|NCT00289185|11461818|FG001|COMPLETED|Overall Study||144
10326140|NCT00289185|11461817|FG000|NOT COMPLETED|Overall Study||28
10326141|NCT00289185|11461818|FG001|NOT COMPLETED|Overall Study||26
10326142|NCT00289198|11461827|FG000|STARTED|Overall Study||151
10326143|NCT00289198|11461828|FG001|STARTED|Overall Study||151
10326144|NCT00289198|11461827|FG000|COMPLETED|Overall Study||120
10326145|NCT00289198|11461828|FG001|COMPLETED|Overall Study||121
10326146|NCT00289198|11461827|FG000|NOT COMPLETED|Overall Study||31
10326147|NCT00289198|11461828|FG001|NOT COMPLETED|Overall Study||30
10326148|NCT00289211|11461838|FG000|STARTED|Overall Study||36
10326149|NCT00289211|11461839|FG001|STARTED|Overall Study||35
10326150|NCT00289211|11461840|FG002|STARTED|Overall Study||12
10326151|NCT00289211|11461838|FG000|COMPLETED|Overall Study||36
10326152|NCT00289211|11461839|FG001|COMPLETED|Overall Study||34
10326153|NCT00289211|11461840|FG002|COMPLETED|Overall Study||2
10326154|NCT00289211|11461838|FG000|NOT COMPLETED|Overall Study||0
10326155|NCT00289211|11461839|FG001|NOT COMPLETED|Overall Study||1
10326156|NCT00289211|11461840|FG002|NOT COMPLETED|Overall Study||10
10326157|NCT00289276|11461848|FG000|STARTED|First Part of FAST Study (Pivotal)|11 patients were re-consented under version 7 of the CIP, but are included in Pivotal results only|47
10326158|NCT00289276|11461849|FG001|STARTED|First Part of FAST Study (Pivotal)||0
10326159|NCT00289276|11461848|FG000|COMPLETED|First Part of FAST Study (Pivotal)||47
10326160|NCT00289276|11461849|FG001|COMPLETED|First Part of FAST Study (Pivotal)||0
10326161|NCT00289276|11461848|FG000|NOT COMPLETED|First Part of FAST Study (Pivotal)||0
10326162|NCT00289276|11461849|FG001|NOT COMPLETED|First Part of FAST Study (Pivotal)||0
10326163|NCT00289276|11461848|FG000|STARTED|Second Part of FAST Study (Expansion)||0
10326164|NCT00289276|11461849|FG001|STARTED|Second Part of FAST Study (Expansion)||109
10326165|NCT00289276|11461848|FG000|COMPLETED|Second Part of FAST Study (Expansion)||0
10326166|NCT00289276|11461849|FG001|COMPLETED|Second Part of FAST Study (Expansion)||106
10326167|NCT00289276|11461848|FG000|NOT COMPLETED|Second Part of FAST Study (Expansion)||0
10326168|NCT00289276|11461849|FG001|NOT COMPLETED|Second Part of FAST Study (Expansion)||3
10326169|NCT00289289|11461858|FG000|STARTED|Overall Study||132
10326170|NCT00289289|11461859|FG001|STARTED|Overall Study||124
10326171|NCT00289289|11461860|FG002|STARTED|Overall Study||144
10326172|NCT00289289|11461858|FG000|COMPLETED|Overall Study||113
10326173|NCT00289289|11461859|FG001|COMPLETED|Overall Study||114
10326174|NCT00289289|11461860|FG002|COMPLETED|Overall Study||95
10326175|NCT00289289|11461858|FG000|NOT COMPLETED|Overall Study||19
10326176|NCT00289289|11461859|FG001|NOT COMPLETED|Overall Study||10
10326177|NCT00289289|11461860|FG002|NOT COMPLETED|Overall Study||49
10326178|NCT00289315|11461870|FG000|STARTED|Overall Study||713
10326179|NCT00289315|11461871|FG001|STARTED|Overall Study||760
10326180|NCT00289315|11461872|FG002|STARTED|Overall Study||587
10326181|NCT00289315|11461870|FG000|COMPLETED|Overall Study||612
10326182|NCT00289315|11461871|FG001|COMPLETED|Overall Study||638
10326183|NCT00289315|11461872|FG002|COMPLETED|Overall Study||447
10326184|NCT00289315|11461870|FG000|NOT COMPLETED|Overall Study||101
10326185|NCT00289315|11461871|FG001|NOT COMPLETED|Overall Study||122
10326186|NCT00289315|11461872|FG002|NOT COMPLETED|Overall Study||140
10326187|NCT00289341|11461882|FG000|STARTED|Overall Study||12
10326188|NCT00289341|11461883|FG001|STARTED|Overall Study||12
10326189|NCT00289341|11461882|FG000|COMPLETED|Overall Study||12
10326190|NCT00289341|11461883|FG001|COMPLETED|Overall Study||12
10326191|NCT00289341|11461882|FG000|NOT COMPLETED|Overall Study||0
10326192|NCT00289341|11461883|FG001|NOT COMPLETED|Overall Study||0
10326193|NCT00289458|11461896|FG000|STARTED|Overall Study||25
10326194|NCT00289458|11461897|FG001|STARTED|Overall Study||26
10326195|NCT00289458|11461898|FG002|STARTED|Overall Study||28
10326196|NCT00289458|11461896|FG000|COMPLETED|Overall Study||19
10326197|NCT00289458|11461897|FG001|COMPLETED|Overall Study||20
10326198|NCT00289458|11461898|FG002|COMPLETED|Overall Study||22
10326199|NCT00289458|11461896|FG000|NOT COMPLETED|Overall Study||6
10326200|NCT00289458|11461897|FG001|NOT COMPLETED|Overall Study||6
10326201|NCT00289458|11461898|FG002|NOT COMPLETED|Overall Study||6
10326202|NCT00289471|11461906|FG000|STARTED|Overall Study||630
10326203|NCT00289471|11461906|FG000|COMPLETED|Overall Study||630
10326204|NCT00289471|11461906|FG000|NOT COMPLETED|Overall Study||0
10326205|NCT00289536|11461910|FG000|STARTED|Period 1||9
10326206|NCT00289536|11461911|FG001|STARTED|Period 1||8
10326207|NCT00289536|11461912|FG002|STARTED|Period 1||9
10326208|NCT00289536|11461910|FG000|COMPLETED|Period 1||9
10326209|NCT00289536|11461911|FG001|COMPLETED|Period 1||8
10326210|NCT00289536|11461912|FG002|COMPLETED|Period 1||9
10326211|NCT00289536|11461910|FG000|NOT COMPLETED|Period 1||0
10326212|NCT00289536|11461911|FG001|NOT COMPLETED|Period 1||0
10804104|NCT04079127|11965570|FG000|COMPLETED|Overall Study|89 hips have completed the study, and all 10 year data of 81 were available for analysis.|89
10804105|NCT04079127|11965570|FG000|NOT COMPLETED|Overall Study||61
10804106|NCT04076787|11965577|FG000|STARTED|Overall Study||318
10326213|NCT00289536|11461912|FG002|NOT COMPLETED|Period 1||0
10326214|NCT00289536|11461910|FG000|STARTED|Period 2|5 participants received Medium Dose and 5 participants received High Dose in Period 1|10
10326215|NCT00289536|11461911|FG001|STARTED|Period 2|5 participants received Low Dose and 4 participants received High Dose in Period 1|9
10326216|NCT00289536|11461912|FG002|STARTED|Period 2|4 participants received Low Dose and 3 participants received Medium Dose in Period 1|7
10326217|NCT00289536|11461910|FG000|COMPLETED|Period 2||10
10326218|NCT00289536|11461911|FG001|COMPLETED|Period 2||9
10326219|NCT00289536|11461912|FG002|COMPLETED|Period 2||7
10326220|NCT00289536|11461910|FG000|NOT COMPLETED|Period 2||0
10326221|NCT00289536|11461911|FG001|NOT COMPLETED|Period 2||0
10326222|NCT00289536|11461912|FG002|NOT COMPLETED|Period 2||0
10326223|NCT00289536|11461910|FG000|STARTED|Period 3|3 participants received Medium Dose and 4 participants received High Dose in Period 2|7
10326224|NCT00289536|11461911|FG001|STARTED|Period 3|5 participants received Low Dose and 4 participants received High Dose in Period 2|9
10326225|NCT00289536|11461912|FG002|STARTED|Period 3|5 participants received Low Dose and 5 participants received Medium Dose in Period 2|10
10326226|NCT00289536|11461910|FG000|COMPLETED|Period 3||7
10326227|NCT00289536|11461911|FG001|COMPLETED|Period 3||9
10326228|NCT00289536|11461912|FG002|COMPLETED|Period 3||9
10326229|NCT00289536|11461910|FG000|NOT COMPLETED|Period 3||0
10326230|NCT00289536|11461911|FG001|NOT COMPLETED|Period 3||0
10326231|NCT00289536|11461912|FG002|NOT COMPLETED|Period 3||1
10326232|NCT00289653|11461918|FG000|STARTED|Overall Study||23
10326233|NCT00289653|11461918|FG000|COMPLETED|Overall Study||12
10326234|NCT00289653|11461918|FG000|NOT COMPLETED|Overall Study||11
10326235|NCT00289718|11461923|FG000|STARTED|Overall Study||51
10326236|NCT00289718|11461923|FG000|COMPLETED|Overall Study||51
10326237|NCT00289718|11461923|FG000|NOT COMPLETED|Overall Study||0
10326238|NCT00289731|11461935|FG000|STARTED|Overall Study||199
10326239|NCT00289731|11461936|FG001|STARTED|Overall Study||200
10326240|NCT00289731|11461937|FG002|STARTED|Overall Study||197
10326241|NCT00289731|11461935|FG000|COMPLETED|Overall Study||197
10326242|NCT00289731|11461936|FG001|COMPLETED|Overall Study||198
10326243|NCT00289731|11461937|FG002|COMPLETED|Overall Study||195
10326244|NCT00289731|11461935|FG000|NOT COMPLETED|Overall Study||2
10326245|NCT00289731|11461936|FG001|NOT COMPLETED|Overall Study||2
10326246|NCT00289731|11461937|FG002|NOT COMPLETED|Overall Study||2
10326247|NCT00289744|11461947|FG000|STARTED|Year 6 Long-term Follow-up|Number of subjects who come back at Year 6 blood sampling time-point|178
10326248|NCT00289744|11461948|FG001|STARTED|Year 6 Long-term Follow-up||0
10326249|NCT00289744|11461949|FG002|STARTED|Year 6 Long-term Follow-up||0
10326250|NCT00289744|11461947|FG000|COMPLETED|Year 6 Long-term Follow-up||178
10804107|NCT04076787|11965578|FG001|STARTED|Overall Study||1031
10804108|NCT04076787|11965579|FG002|STARTED|Overall Study||420
10804109|NCT04076787|11965577|FG000|COMPLETED|Overall Study||318
10804110|NCT04076787|11965578|FG001|COMPLETED|Overall Study||1031
10804111|NCT04076787|11965579|FG002|COMPLETED|Overall Study||420
10804112|NCT04076787|11965577|FG000|NOT COMPLETED|Overall Study||0
10804113|NCT04076787|11965578|FG001|NOT COMPLETED|Overall Study||0
10804114|NCT04076787|11965579|FG002|NOT COMPLETED|Overall Study||0
10804115|NCT04075812|11965587|FG000|STARTED|Overall Study||2
10804116|NCT04075812|11965587|FG000|COMPLETED|Overall Study||2
10804117|NCT04075812|11965587|FG000|NOT COMPLETED|Overall Study||0
10804118|NCT04075409|11965594|FG000|STARTED|Overall Study||13
10804119|NCT04075409|11965595|FG001|STARTED|Overall Study||13
10804120|NCT04075409|11965596|FG002|STARTED|Overall Study||13
10804121|NCT04075409|11965594|FG000|COMPLETED|Overall Study||13
10804122|NCT04075409|11965595|FG001|COMPLETED|Overall Study||13
10804123|NCT04075409|11965596|FG002|COMPLETED|Overall Study||13
10804124|NCT04075409|11965594|FG000|NOT COMPLETED|Overall Study||0
10804125|NCT04075409|11965595|FG001|NOT COMPLETED|Overall Study||0
10804126|NCT04075409|11965596|FG002|NOT COMPLETED|Overall Study||0
10804127|NCT04074941|11965617|FG000|STARTED|Overall Study||11
10804128|NCT04074941|11965618|FG001|STARTED|Overall Study||9
10804129|NCT04074941|11965617|FG000|COMPLETED|Overall Study||11
10804130|NCT04074941|11965618|FG001|COMPLETED|Overall Study||9
10326251|NCT00289744|11461948|FG001|COMPLETED|Year 6 Long-term Follow-up||0
10326252|NCT00289744|11461949|FG002|COMPLETED|Year 6 Long-term Follow-up||0
10326253|NCT00289744|11461947|FG000|NOT COMPLETED|Year 6 Long-term Follow-up||0
10326254|NCT00289744|11461948|FG001|NOT COMPLETED|Year 6 Long-term Follow-up||0
10326255|NCT00289744|11461949|FG002|NOT COMPLETED|Year 6 Long-term Follow-up||0
10326256|NCT00289744|11461947|FG000|STARTED|Year 7 Long-term Follow-up|Subjects who came back at Year 7 blood sampling time-point|175
10804131|NCT04074941|11965617|FG000|NOT COMPLETED|Overall Study||0
10804132|NCT04074941|11965618|FG001|NOT COMPLETED|Overall Study||0
10804133|NCT04073823|11965626|FG000|STARTED|Overall Study||1
10804134|NCT04073823|11965627|FG001|STARTED|Overall Study||1
10804135|NCT04073823|11965626|FG000|COMPLETED|Overall Study||1
10804136|NCT04073823|11965627|FG001|COMPLETED|Overall Study||1
10804137|NCT04073823|11965626|FG000|NOT COMPLETED|Overall Study||0
10326257|NCT00289744|11461948|FG001|STARTED|Year 7 Long-term Follow-up||0
10326258|NCT00289744|11461949|FG002|STARTED|Year 7 Long-term Follow-up||0
10326259|NCT00289744|11461947|FG000|COMPLETED|Year 7 Long-term Follow-up||175
10326260|NCT00289744|11461948|FG001|COMPLETED|Year 7 Long-term Follow-up||0
10326261|NCT00289744|11461949|FG002|COMPLETED|Year 7 Long-term Follow-up||0
10326262|NCT00289744|11461947|FG000|NOT COMPLETED|Year 7 Long-term Follow-up||0
10326263|NCT00289744|11461948|FG001|NOT COMPLETED|Year 7 Long-term Follow-up||0
10326264|NCT00289744|11461949|FG002|NOT COMPLETED|Year 7 Long-term Follow-up||0
10326265|NCT00289744|11461947|FG000|STARTED|Year 8 Long-term Follow-up|Subjects who came back at Year 8 blood sampling time-point|174
10326266|NCT00289744|11461948|FG001|STARTED|Year 8 Long-term Follow-up||0
10326267|NCT00289744|11461949|FG002|STARTED|Year 8 Long-term Follow-up||0
10326268|NCT00289744|11461947|FG000|COMPLETED|Year 8 Long-term Follow-up||174
10326269|NCT00289744|11461948|FG001|COMPLETED|Year 8 Long-term Follow-up||0
10326270|NCT00289744|11461949|FG002|COMPLETED|Year 8 Long-term Follow-up||0
10326271|NCT00289744|11461947|FG000|NOT COMPLETED|Year 8 Long-term Follow-up||0
10326272|NCT00289744|11461948|FG001|NOT COMPLETED|Year 8 Long-term Follow-up||0
10326273|NCT00289744|11461949|FG002|NOT COMPLETED|Year 8 Long-term Follow-up||0
10326274|NCT00289744|11461947|FG000|STARTED|Year 9 Long-term Follow-up|Subjects who came back at Year 9 blood sampling time-point|173
10326275|NCT00289744|11461948|FG001|STARTED|Year 9 Long-term Follow-up||0
10326276|NCT00289744|11461949|FG002|STARTED|Year 9 Long-term Follow-up||0
10326277|NCT00289744|11461947|FG000|COMPLETED|Year 9 Long-term Follow-up||173
10326278|NCT00289744|11461948|FG001|COMPLETED|Year 9 Long-term Follow-up||0
10326279|NCT00289744|11461949|FG002|COMPLETED|Year 9 Long-term Follow-up||0
10326280|NCT00289744|11461947|FG000|NOT COMPLETED|Year 9 Long-term Follow-up||0
10326281|NCT00289744|11461948|FG001|NOT COMPLETED|Year 9 Long-term Follow-up||0
10326282|NCT00289744|11461949|FG002|NOT COMPLETED|Year 9 Long-term Follow-up||0
10326283|NCT00289744|11461947|FG000|STARTED|Year 10 Long-term Follow-up|Subjects who came back at Year 10 blood sampling time-point|171
10326284|NCT00289744|11461948|FG001|STARTED|Year 10 Long-term Follow-up||0
10326285|NCT00289744|11461949|FG002|STARTED|Year 10 Long-term Follow-up||0
10326286|NCT00289744|11461947|FG000|COMPLETED|Year 10 Long-term Follow-up||171
10326287|NCT00289744|11461948|FG001|COMPLETED|Year 10 Long-term Follow-up||0
10326288|NCT00289744|11461949|FG002|COMPLETED|Year 10 Long-term Follow-up||0
10326289|NCT00289744|11461947|FG000|NOT COMPLETED|Year 10 Long-term Follow-up||0
10326290|NCT00289744|11461948|FG001|NOT COMPLETED|Year 10 Long-term Follow-up||0
10326291|NCT00289744|11461949|FG002|NOT COMPLETED|Year 10 Long-term Follow-up||0
10326292|NCT00289744|11461947|FG000|STARTED|Additional Dose Phase||0
10326293|NCT00289744|11461948|FG001|STARTED|Additional Dose Phase||19
10804138|NCT04073823|11965627|FG001|NOT COMPLETED|Overall Study||0
10804139|NCT04073407|11965635|FG000|STARTED|Part 1||6
10804140|NCT04073407|11965636|FG001|STARTED|Part 1||3
10804141|NCT04073407|11965635|FG000|COMPLETED|Part 1||1
10804142|NCT04073407|11965636|FG001|COMPLETED|Part 1||2
10804143|NCT04073407|11965635|FG000|NOT COMPLETED|Part 1||5
10804144|NCT04073407|11965636|FG001|NOT COMPLETED|Part 1||1
10804145|NCT04073407|11965635|FG000|STARTED|Part 2|Following Part 1, all subjects (including those randomly assigned to the placebo arm in Part 1) were given the option to continue in Part 2 to receive the study food product twice daily for an additional 12 weeks. If the subject chose to not take part in Part 2, the subject underwent a safety follow-up visit approximately 2 weeks after Week13 (Visit 6).|0
10326294|NCT00289744|11461949|FG002|STARTED|Additional Dose Phase||6
10326295|NCT00289744|11461947|FG000|COMPLETED|Additional Dose Phase||0
10326296|NCT00289744|11461948|FG001|COMPLETED|Additional Dose Phase||19
10326297|NCT00289744|11461949|FG002|COMPLETED|Additional Dose Phase||6
10326298|NCT00289744|11461947|FG000|NOT COMPLETED|Additional Dose Phase||0
10326299|NCT00289744|11461948|FG001|NOT COMPLETED|Additional Dose Phase||0
10326300|NCT00289744|11461949|FG002|NOT COMPLETED|Additional Dose Phase||0
10326301|NCT00289757|11461957|FG000|STARTED|Overall Study||78
10326302|NCT00289757|11461957|FG000|COMPLETED|Overall Study||78
10326303|NCT00289757|11461957|FG000|NOT COMPLETED|Overall Study||0
10326304|NCT00289770|11461961|FG000|STARTED|Year 11||37
10326305|NCT00289770|11461961|FG000|COMPLETED|Year 11||37
10326306|NCT00289770|11461961|FG000|NOT COMPLETED|Year 11||0
10326307|NCT00289770|11461961|FG000|STARTED|Year 12||40
10326308|NCT00289770|11461961|FG000|COMPLETED|Year 12||40
10326309|NCT00289770|11461961|FG000|NOT COMPLETED|Year 12||0
10326310|NCT00289770|11461961|FG000|STARTED|Year 13||37
10326311|NCT00289770|11461961|FG000|COMPLETED|Year 13||37
10326312|NCT00289770|11461961|FG000|NOT COMPLETED|Year 13||0
10326313|NCT00289770|11461961|FG000|STARTED|Year 14||43
10326314|NCT00289770|11461961|FG000|COMPLETED|Year 14||43
10326315|NCT00289770|11461961|FG000|NOT COMPLETED|Year 14||0
10326316|NCT00289770|11461961|FG000|STARTED|Year 15||50
10326317|NCT00289770|11461961|FG000|COMPLETED|Year 15||49
10326318|NCT00289770|11461961|FG000|NOT COMPLETED|Year 15||1
10326319|NCT00289783|11461967|FG000|STARTED|Primary Phase||3136
10326320|NCT00289783|11461968|FG001|STARTED|Primary Phase||1044
10326321|NCT00289783|11461967|FG000|COMPLETED|Primary Phase||2888
10811059|NCT03781375|11972757|FG001|NOT COMPLETED|Open-label Phase||3
10811060|NCT03781336|11972766|FG000|STARTED|Overall Study||45
10811061|NCT03781336|11972767|FG001|STARTED|Overall Study||37
10811220|NCT03769896|11972941|FG001|STARTED|Double-blind Treatment Phase||19
10326322|NCT00289783|11461968|FG001|COMPLETED|Primary Phase||961
10326323|NCT00289783|11461967|FG000|NOT COMPLETED|Primary Phase||248
10326324|NCT00289783|11461968|FG001|NOT COMPLETED|Primary Phase||83
10326325|NCT00289783|11461967|FG000|STARTED|Fourth Dose Phase||2769
10326326|NCT00289783|11461968|FG001|STARTED|Fourth Dose Phase||923
10326327|NCT00289783|11461967|FG000|COMPLETED|Fourth Dose Phase||2682
10326328|NCT00289783|11461968|FG001|COMPLETED|Fourth Dose Phase||899
10326329|NCT00289783|11461967|FG000|NOT COMPLETED|Fourth Dose Phase||87
10326330|NCT00289783|11461968|FG001|NOT COMPLETED|Fourth Dose Phase||24
10326331|NCT00289848|11461984|FG000|STARTED|Overall Study||352
10326332|NCT00289848|11461985|FG001|STARTED|Overall Study||178
10326333|NCT00289848|11461984|FG000|COMPLETED|Overall Study||306
10326334|NCT00289848|11461985|FG001|COMPLETED|Overall Study||133
10701688|NCT02569658|11866127|FG000|NOT COMPLETED|Overall Study||1
10701689|NCT02569658|11866128|FG001|NOT COMPLETED|Overall Study||1
10701690|NCT02569710|11866144|FG000|STARTED|Overall Study||20
10701691|NCT02569710|11866145|FG001|STARTED|Overall Study||25
10804146|NCT04073407|11965636|FG001|STARTED|Part 2|Following Part 1, all subjects (including those randomly assigned to the placebo arm in Part 1) were given the option to continue in Part 2 to receive the study food product twice daily for an additional 12 weeks. If the subject chose to not take part in Part 2, the subject underwent a safety follow-up visit approximately 2 weeks after Week13 (Visit 6).|1
10804147|NCT04073407|11965635|FG000|COMPLETED|Part 2||0
10326335|NCT00289848|11461984|FG000|NOT COMPLETED|Overall Study||46
10326336|NCT00289848|11461985|FG001|NOT COMPLETED|Overall Study||45
10326337|NCT00289900|11461997|FG000|STARTED|Overall Study||297
10326338|NCT00289900|11461998|FG001|STARTED|Overall Study||436
10326339|NCT00289900|11461999|FG002|STARTED|Overall Study||298
10326340|NCT00289900|11462000|FG003|STARTED|Overall Study||439
10326341|NCT00289900|11462001|FG004|STARTED|Overall Study||437
10326342|NCT00289900|11462002|FG005|STARTED|Overall Study||433
10326343|NCT00289900|11461997|FG000|Treated|Overall Study||297
10326344|NCT00289900|11461998|FG001|Treated|Overall Study||435
10326345|NCT00289900|11461999|FG002|Treated|Overall Study||298
10326346|NCT00289900|11462000|FG003|Treated|Overall Study||439
10326347|NCT00289900|11462001|FG004|Treated|Overall Study||437
10326348|NCT00289900|11462002|FG005|Treated|Overall Study||433
10326349|NCT00289900|11461997|FG000|COMPLETED|Overall Study||229
10326350|NCT00289900|11461998|FG001|COMPLETED|Overall Study||316
10326351|NCT00289900|11461999|FG002|COMPLETED|Overall Study||265
10326352|NCT00289900|11462000|FG003|COMPLETED|Overall Study||380
10326353|NCT00289900|11462001|FG004|COMPLETED|Overall Study||392
10326354|NCT00289900|11462002|FG005|COMPLETED|Overall Study||372
10326355|NCT00289900|11461997|FG000|NOT COMPLETED|Overall Study||68
10326356|NCT00289900|11461998|FG001|NOT COMPLETED|Overall Study||120
10326357|NCT00289900|11461999|FG002|NOT COMPLETED|Overall Study||33
10804148|NCT04073407|11965636|FG001|COMPLETED|Part 2||0
10804149|NCT04073407|11965635|FG000|NOT COMPLETED|Part 2||0
10804150|NCT04073407|11965636|FG001|NOT COMPLETED|Part 2||1
10804151|NCT04073368|11965646|FG000|STARTED|Overall Study||32
10804152|NCT04073368|11965647|FG001|STARTED|Overall Study||26
10804153|NCT04073368|11965648|FG002|STARTED|Overall Study||29
10804154|NCT04073368|11965649|FG003|STARTED|Overall Study||15
10804155|NCT04073368|11965646|FG000|COMPLETED|Overall Study||20
10804156|NCT04073368|11965647|FG001|COMPLETED|Overall Study||18
10804157|NCT04073368|11965648|FG002|COMPLETED|Overall Study||26
10804158|NCT04073368|11965649|FG003|COMPLETED|Overall Study||13
10804159|NCT04073368|11965646|FG000|NOT COMPLETED|Overall Study||12
10804160|NCT04073368|11965647|FG001|NOT COMPLETED|Overall Study||8
10804161|NCT04073368|11965648|FG002|NOT COMPLETED|Overall Study||3
10804162|NCT04073368|11965649|FG003|NOT COMPLETED|Overall Study||2
10326358|NCT00289900|11462000|FG003|NOT COMPLETED|Overall Study||59
10326359|NCT00289900|11462001|FG004|NOT COMPLETED|Overall Study||45
10326360|NCT00289900|11462002|FG005|NOT COMPLETED|Overall Study||61
10326361|NCT00289913|11462024|FG000|STARTED|Visit 1 (Stage I and Stage II)||155
10326362|NCT00289913|11462025|FG001|STARTED|Visit 1 (Stage I and Stage II)||151
10326363|NCT00289913|11462026|FG002|STARTED|Visit 1 (Stage I and Stage II)||159
10326364|NCT00289913|11462027|FG003|STARTED|Visit 1 (Stage I and Stage II)||152
10326365|NCT00289913|11462028|FG004|STARTED|Visit 1 (Stage I and Stage II)|Participants were enrolled during Stage II.|654
10701692|NCT02569710|11866146|FG002|STARTED|Overall Study||20
10701693|NCT02569710|11866147|FG003|STARTED|Overall Study||20
10701694|NCT02569710|11866148|FG004|STARTED|Overall Study||8
10701695|NCT02569710|11866149|FG005|STARTED|Overall Study||5
10701696|NCT02569710|11866150|FG006|STARTED|Overall Study||14
10701697|NCT02569710|11866151|FG007|STARTED|Overall Study||30
10701698|NCT02569710|11866152|FG008|STARTED|Overall Study||15
10701699|NCT02569710|11866153|FG009|STARTED|Overall Study||4
10701700|NCT02569710|11866144|FG000|COMPLETED|Overall Study||19
10701701|NCT02569710|11866145|FG001|COMPLETED|Overall Study||25
10326366|NCT00289913|11462024|FG000|COMPLETED|Visit 1 (Stage I and Stage II)||146
10456172|NCT01005966|11604237|FG002|COMPLETED|Washout Period 1 (4 Days)||12
10456173|NCT01005966|11604238|FG003|COMPLETED|Washout Period 1 (4 Days)||12
10456174|NCT01005966|11604239|FG004|COMPLETED|Washout Period 1 (4 Days)||13
10326367|NCT00289913|11462025|FG001|COMPLETED|Visit 1 (Stage I and Stage II)||135
10701702|NCT02569710|11866146|FG002|COMPLETED|Overall Study||20
10701703|NCT02569710|11866147|FG003|COMPLETED|Overall Study||20
10701704|NCT02569710|11866148|FG004|COMPLETED|Overall Study||7
10326368|NCT00289913|11462026|FG002|COMPLETED|Visit 1 (Stage I and Stage II)||150
10326369|NCT00289913|11462027|FG003|COMPLETED|Visit 1 (Stage I and Stage II)||141
10326370|NCT00289913|11462028|FG004|COMPLETED|Visit 1 (Stage I and Stage II)||645
10701705|NCT02569710|11866149|FG005|COMPLETED|Overall Study||4
10456175|NCT01005966|11604235|FG000|NOT COMPLETED|Washout Period 1 (4 Days)||0
10456176|NCT01005966|11604236|FG001|NOT COMPLETED|Washout Period 1 (4 Days)||0
10456177|NCT01005966|11604237|FG002|NOT COMPLETED|Washout Period 1 (4 Days)||0
10456178|NCT01005966|11604238|FG003|NOT COMPLETED|Washout Period 1 (4 Days)||1
10456179|NCT01005966|11604239|FG004|NOT COMPLETED|Washout Period 1 (4 Days)||0
10456180|NCT01005966|11604235|FG000|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
10456181|NCT01005966|11604236|FG001|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
10701706|NCT02569710|11866150|FG006|COMPLETED|Overall Study||12
10701707|NCT02569710|11866151|FG007|COMPLETED|Overall Study||30
10326371|NCT00289913|11462024|FG000|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
10326372|NCT00289913|11462025|FG001|NOT COMPLETED|Visit 1 (Stage I and Stage II)||16
10326373|NCT00289913|11462026|FG002|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
10701708|NCT02569710|11866152|FG008|COMPLETED|Overall Study||14
10701709|NCT02569710|11866153|FG009|COMPLETED|Overall Study||4
10701710|NCT02569710|11866144|FG000|NOT COMPLETED|Overall Study||1
10701711|NCT02569710|11866145|FG001|NOT COMPLETED|Overall Study||0
10701712|NCT02569710|11866146|FG002|NOT COMPLETED|Overall Study||0
10701713|NCT02569710|11866147|FG003|NOT COMPLETED|Overall Study||0
10326374|NCT00289913|11462027|FG003|NOT COMPLETED|Visit 1 (Stage I and Stage II)||11
10326375|NCT00289913|11462028|FG004|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
10326376|NCT00289913|11462024|FG000|STARTED|Visit 2 (Stage I and Stage II)||146
10326377|NCT00289913|11462025|FG001|STARTED|Visit 2 (Stage I and Stage II)||135
10326378|NCT00289913|11462026|FG002|STARTED|Visit 2 (Stage I and Stage II)||150
10326379|NCT00289913|11462027|FG003|STARTED|Visit 2 (Stage I and Stage II)||141
10326380|NCT00289913|11462028|FG004|STARTED|Visit 2 (Stage I and Stage II)|No vaccine administered at Visit 2 (Stage II), therefore there was no safety F/U period.|645
10326381|NCT00289913|11462024|FG000|COMPLETED|Visit 2 (Stage I and Stage II)||131
10326382|NCT00289913|11462025|FG001|COMPLETED|Visit 2 (Stage I and Stage II)||114
10326383|NCT00289913|11462026|FG002|COMPLETED|Visit 2 (Stage I and Stage II)||140
10326384|NCT00289913|11462027|FG003|COMPLETED|Visit 2 (Stage I and Stage II)||135
10326385|NCT00289913|11462028|FG004|COMPLETED|Visit 2 (Stage I and Stage II)||605
10804169|NCT04072237|11965664|FG000|STARTED|Stage I: MarzAA 18 µg/kg IV||11
10804170|NCT04072237|11965664|FG000|COMPLETED|Stage I: MarzAA 18 µg/kg IV||10
10804171|NCT04072237|11965664|FG000|NOT COMPLETED|Stage I: MarzAA 18 µg/kg IV||1
10804172|NCT04072237|11965664|FG000|STARTED|Stage 2: MarzAA 30 µg/kg SC||8
10804173|NCT04072237|11965664|FG000|COMPLETED|Stage 2: MarzAA 30 µg/kg SC||8
10804174|NCT04072237|11965664|FG000|NOT COMPLETED|Stage 2: MarzAA 30 µg/kg SC||0
10804175|NCT04072237|11965664|FG000|STARTED|Stage 3: MarzAA 45 µg/kg SC||8
10804176|NCT04072237|11965664|FG000|COMPLETED|Stage 3: MarzAA 45 µg/kg SC||8
10804177|NCT04072237|11965664|FG000|NOT COMPLETED|Stage 3: MarzAA 45 µg/kg SC||0
10804178|NCT04072237|11965664|FG000|STARTED|Stage 4: MarzAA 60 µg/kg SC||8
10804179|NCT04072237|11965664|FG000|COMPLETED|Stage 4: MarzAA 60 µg/kg SC||8
10804180|NCT04072237|11965664|FG000|NOT COMPLETED|Stage 4: MarzAA 60 µg/kg SC||0
10804181|NCT04072237|11965664|FG000|STARTED|Stage 5: MarzAA 2 x 30 ug/kg SC||8
10804182|NCT04072237|11965664|FG000|COMPLETED|Stage 5: MarzAA 2 x 30 ug/kg SC||8
10804183|NCT04072237|11965664|FG000|NOT COMPLETED|Stage 5: MarzAA 2 x 30 ug/kg SC||0
10804184|NCT04072237|11965664|FG000|STARTED|Stage 6: MarzAA 90 µg/kg SC||8
10804185|NCT04072237|11965664|FG000|COMPLETED|Stage 6: MarzAA 90 µg/kg SC||8
10326386|NCT00289913|11462024|FG000|NOT COMPLETED|Visit 2 (Stage I and Stage II)||15
10804187|NCT04072237|11965664|FG000|STARTED|Stage 7: MarzAA 120 µg/kg SC||8
10326387|NCT00289913|11462025|FG001|NOT COMPLETED|Visit 2 (Stage I and Stage II)||21
10326388|NCT00289913|11462026|FG002|NOT COMPLETED|Visit 2 (Stage I and Stage II)||10
10326389|NCT00289913|11462027|FG003|NOT COMPLETED|Visit 2 (Stage I and Stage II)||6
10326390|NCT00289913|11462028|FG004|NOT COMPLETED|Visit 2 (Stage I and Stage II)||40
10326391|NCT00289913|11462024|FG000|STARTED|Visit 3 (Stage I and Stage II)||131
10326392|NCT00289913|11462025|FG001|STARTED|Visit 3 (Stage I and Stage II)||114
10326393|NCT00289913|11462026|FG002|STARTED|Visit 3 (Stage I and Stage II)||140
10326394|NCT00289913|11462027|FG003|STARTED|Visit 3 (Stage I and Stage II)||135
10326395|NCT00289913|11462028|FG004|STARTED|Visit 3 (Stage I and Stage II)||605
10326396|NCT00289913|11462024|FG000|COMPLETED|Visit 3 (Stage I and Stage II)||122
10326397|NCT00289913|11462025|FG001|COMPLETED|Visit 3 (Stage I and Stage II)||106
10326398|NCT00289913|11462026|FG002|COMPLETED|Visit 3 (Stage I and Stage II)||138
10326399|NCT00289913|11462027|FG003|COMPLETED|Visit 3 (Stage I and Stage II)||131
10326400|NCT00289913|11462028|FG004|COMPLETED|Visit 3 (Stage I and Stage II)||597
10326401|NCT00289913|11462024|FG000|NOT COMPLETED|Visit 3 (Stage I and Stage II)||9
10326402|NCT00289913|11462025|FG001|NOT COMPLETED|Visit 3 (Stage I and Stage II)||8
10326403|NCT00289913|11462026|FG002|NOT COMPLETED|Visit 3 (Stage I and Stage II)||2
10326404|NCT00289913|11462027|FG003|NOT COMPLETED|Visit 3 (Stage I and Stage II)||4
10326405|NCT00289913|11462028|FG004|NOT COMPLETED|Visit 3 (Stage I and Stage II)||8
10326406|NCT00289913|11462024|FG000|STARTED|Visit 4 (Stage I and Stage II)||122
10326407|NCT00289913|11462025|FG001|STARTED|Visit 4 (Stage I and Stage II)||106
10701714|NCT02569710|11866148|FG004|NOT COMPLETED|Overall Study||1
10326408|NCT00289913|11462026|FG002|STARTED|Visit 4 (Stage I and Stage II)||138
10326409|NCT00289913|11462027|FG003|STARTED|Visit 4 (Stage I and Stage II)||131
10326410|NCT00289913|11462028|FG004|STARTED|Visit 4 (Stage I and Stage II)||597
10326411|NCT00289913|11462024|FG000|COMPLETED|Visit 4 (Stage I and Stage II)||122
10326412|NCT00289913|11462025|FG001|COMPLETED|Visit 4 (Stage I and Stage II)||106
10701715|NCT02569710|11866149|FG005|NOT COMPLETED|Overall Study||1
10701716|NCT02569710|11866150|FG006|NOT COMPLETED|Overall Study||2
10326413|NCT00289913|11462026|FG002|COMPLETED|Visit 4 (Stage I and Stage II)||138
10326414|NCT00289913|11462027|FG003|COMPLETED|Visit 4 (Stage I and Stage II)||131
10326415|NCT00289913|11462028|FG004|COMPLETED|Visit 4 (Stage I and Stage II)||597
10326416|NCT00289913|11462024|FG000|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
10326417|NCT00289913|11462025|FG001|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
10326418|NCT00289913|11462026|FG002|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
10326419|NCT00289913|11462027|FG003|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
10326420|NCT00289913|11462028|FG004|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
10326421|NCT00289978|11462046|FG000|STARTED|Overall Study||429
10326422|NCT00289978|11462047|FG001|STARTED|Overall Study||425
10326423|NCT00289978|11462048|FG002|STARTED|Overall Study||418
10326424|NCT00289978|11462046|FG000|COMPLETED|Overall Study|296 completed on study drug, 35 completed off study drug.|332
10326425|NCT00289978|11462047|FG001|COMPLETED|Overall Study|345 completed on study drug, 24 completed off study drug.|369
10326426|NCT00289978|11462048|FG002|COMPLETED|Overall Study|303 completed on study drug, 29 completed off study drug.|332
10326427|NCT00289978|11462046|FG000|NOT COMPLETED|Overall Study||97
10326428|NCT00289978|11462047|FG001|NOT COMPLETED|Overall Study||56
10326429|NCT00289978|11462048|FG002|NOT COMPLETED|Overall Study||86
10326430|NCT00289991|11462058|FG000|STARTED|Overall Study||234
10326431|NCT00289991|11462059|FG001|STARTED|Overall Study||255
10326432|NCT00289991|11462058|FG000|COMPLETED|Overall Study||176
10326433|NCT00289991|11462059|FG001|COMPLETED|Overall Study||175
10326434|NCT00289991|11462058|FG000|NOT COMPLETED|Overall Study||58
10326435|NCT00289991|11462059|FG001|NOT COMPLETED|Overall Study||80
10326436|NCT00290147|11462067|FG000|STARTED|Overall Study||10
10326437|NCT00290147|11462068|FG001|STARTED|Overall Study||12
10326438|NCT00290147|11462067|FG000|COMPLETED|Overall Study||10
10326439|NCT00290147|11462068|FG001|COMPLETED|Overall Study||12
10326440|NCT00290147|11462067|FG000|NOT COMPLETED|Overall Study||0
10326441|NCT00290147|11462068|FG001|NOT COMPLETED|Overall Study||0
10326442|NCT00290186|11462076|FG000|STARTED|Overall Study||25
10326443|NCT00290186|11462077|FG001|STARTED|Overall Study||24
10326444|NCT00290186|11462076|FG000|Completed Baseline Assessments|Overall Study||25
10326445|NCT00290186|11462077|FG001|Completed Baseline Assessments|Overall Study||24
10326446|NCT00290186|11462076|FG000|Completed 8 Weeks of Treatment|Overall Study||24
10326447|NCT00290186|11462077|FG001|Completed 8 Weeks of Treatment|Overall Study||22
10326448|NCT00290186|11462076|FG000|Completed Post-treatment Assessments|Overall Study||24
10326449|NCT00290186|11462077|FG001|Completed Post-treatment Assessments|Overall Study||22
10326450|NCT00290186|11462076|FG000|Completed 3-month Followup Assessments|Overall Study||20
10326451|NCT00290186|11462077|FG001|Completed 3-month Followup Assessments|Overall Study||21
10326452|NCT00290186|11462076|FG000|Completed 6-month Followup Assessments|Overall Study||20
10326453|NCT00290186|11462077|FG001|Completed 6-month Followup Assessments|Overall Study||19
10326454|NCT00290186|11462076|FG000|COMPLETED|Overall Study||20
10326455|NCT00290186|11462077|FG001|COMPLETED|Overall Study||19
10326456|NCT00290186|11462076|FG000|NOT COMPLETED|Overall Study||5
10326457|NCT00290186|11462077|FG001|NOT COMPLETED|Overall Study||5
10326458|NCT00290199|11462087|FG000|STARTED|Overall Study||87
10326459|NCT00290199|11462088|FG001|STARTED|Overall Study||82
10326460|NCT00290199|11462087|FG000|COMPLETED|Overall Study||87
10326461|NCT00290199|11462088|FG001|COMPLETED|Overall Study||82
10326462|NCT00290199|11462087|FG000|NOT COMPLETED|Overall Study||0
10326463|NCT00290199|11462088|FG001|NOT COMPLETED|Overall Study||0
10326464|NCT00290238|11462098|FG000|STARTED|Overall Study||57
10804186|NCT04072237|11965664|FG000|NOT COMPLETED|Stage 6: MarzAA 90 µg/kg SC||0
10326465|NCT00290238|11462099|FG001|STARTED|Overall Study|One subject had an invalid birth date and was excluded from the Age Categorical counts.|65
10326466|NCT00290238|11462098|FG000|COMPLETED|Overall Study||15
10326467|NCT00290238|11462099|FG001|COMPLETED|Overall Study||24
10326468|NCT00290238|11462098|FG000|NOT COMPLETED|Overall Study||42
10326469|NCT00290238|11462099|FG001|NOT COMPLETED|Overall Study||41
10326470|NCT00290290|11462107|FG000|STARTED|Overall Study||440
10326471|NCT00290290|11462108|FG001|STARTED|Overall Study||409
10326472|NCT00290290|11462107|FG000|COMPLETED|Overall Study||422
10326473|NCT00290290|11462108|FG001|COMPLETED|Overall Study||391
10326474|NCT00290290|11462107|FG000|NOT COMPLETED|Overall Study||18
10326475|NCT00290290|11462108|FG001|NOT COMPLETED|Overall Study||18
10326476|NCT00290329|11462117|FG000|STARTED|Overall Study||102
10326477|NCT00290329|11462118|FG001|STARTED|Overall Study||86
10326478|NCT00290329|11462119|FG002|STARTED|Overall Study||61
10326479|NCT00290329|11462117|FG000|COMPLETED|Overall Study||102
10326480|NCT00290329|11462118|FG001|COMPLETED|Overall Study||86
10326481|NCT00290329|11462119|FG002|COMPLETED|Overall Study||61
10326482|NCT00290329|11462117|FG000|NOT COMPLETED|Overall Study||0
10326483|NCT00290329|11462118|FG001|NOT COMPLETED|Overall Study||0
10326484|NCT00290329|11462119|FG002|NOT COMPLETED|Overall Study||0
10326485|NCT00290342|11462131|FG000|STARTED|Overall Study||224
10326486|NCT00290342|11462132|FG001|STARTED|Overall Study||228
10326487|NCT00290342|11462131|FG000|COMPLETED|Overall Study||217
10326488|NCT00290342|11462132|FG001|COMPLETED|Overall Study||223
10326489|NCT00290342|11462131|FG000|NOT COMPLETED|Overall Study||7
10326490|NCT00290342|11462132|FG001|NOT COMPLETED|Overall Study||5
10326491|NCT00290355|11462140|FG000|STARTED|Overall Study||122
10326492|NCT00290355|11462141|FG001|STARTED|Overall Study||60
10326493|NCT00290355|11462140|FG000|COMPLETED|Overall Study||105
10326494|NCT00290355|11462141|FG001|COMPLETED|Overall Study||55
10326495|NCT00290355|11462140|FG000|NOT COMPLETED|Overall Study||17
10326496|NCT00290355|11462141|FG001|NOT COMPLETED|Overall Study||5
10326497|NCT00290433|11462147|FG000|STARTED|Overall Study||53
10326498|NCT00290433|11462147|FG000|COMPLETED|Overall Study||17
10326499|NCT00290433|11462147|FG000|NOT COMPLETED|Overall Study||36
10456182|NCT01005966|11604237|FG002|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|12
10456183|NCT01005966|11604238|FG003|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|12
10456184|NCT01005966|11604239|FG004|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|11
10456185|NCT01005966|11604235|FG000|COMPLETED|Treatment Period 2 (14 Days)||13
10456186|NCT01005966|11604236|FG001|COMPLETED|Treatment Period 2 (14 Days)||12
10456187|NCT01005966|11604237|FG002|COMPLETED|Treatment Period 2 (14 Days)||10
10456188|NCT01005966|11604238|FG003|COMPLETED|Treatment Period 2 (14 Days)||11
10456189|NCT01005966|11604239|FG004|COMPLETED|Treatment Period 2 (14 Days)||11
10456190|NCT01005966|11604235|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||0
10456191|NCT01005966|11604236|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||1
10456192|NCT01005966|11604237|FG002|NOT COMPLETED|Treatment Period 2 (14 Days)||2
10456193|NCT01005966|11604238|FG003|NOT COMPLETED|Treatment Period 2 (14 Days)||1
10456194|NCT01005966|11604239|FG004|NOT COMPLETED|Treatment Period 2 (14 Days)||0
10456195|NCT01005966|11604235|FG000|STARTED|Washout Period 2 (4 Days)||13
10456196|NCT01005966|11604236|FG001|STARTED|Washout Period 2 (4 Days)||12
10456197|NCT01005966|11604237|FG002|STARTED|Washout Period 2 (4 Days)||10
10456198|NCT01005966|11604238|FG003|STARTED|Washout Period 2 (4 Days)||11
10456199|NCT01005966|11604239|FG004|STARTED|Washout Period 2 (4 Days)||11
10456200|NCT01005966|11604235|FG000|COMPLETED|Washout Period 2 (4 Days)||13
10456201|NCT01005966|11604236|FG001|COMPLETED|Washout Period 2 (4 Days)||12
10456202|NCT01005966|11604237|FG002|COMPLETED|Washout Period 2 (4 Days)||10
10456203|NCT01005966|11604238|FG003|COMPLETED|Washout Period 2 (4 Days)||11
10456204|NCT01005966|11604239|FG004|COMPLETED|Washout Period 2 (4 Days)||11
10456205|NCT01005966|11604235|FG000|NOT COMPLETED|Washout Period 2 (4 Days)||0
10456206|NCT01005966|11604236|FG001|NOT COMPLETED|Washout Period 2 (4 Days)||0
10456207|NCT01005966|11604237|FG002|NOT COMPLETED|Washout Period 2 (4 Days)||0
10456208|NCT01005966|11604238|FG003|NOT COMPLETED|Washout Period 2 (4 Days)||0
10456209|NCT01005966|11604239|FG004|NOT COMPLETED|Washout Period 2 (4 Days)||0
10456210|NCT01005966|11604235|FG000|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
10456211|NCT01005966|11604236|FG001|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|8
10456212|NCT01005966|11604237|FG002|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
10456213|NCT01005966|11604238|FG003|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|13
10456214|NCT01005966|11604239|FG004|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
10456215|NCT01005966|11604235|FG000|COMPLETED|Treatment Period 3 (14 Days)||12
10456216|NCT01005966|11604236|FG001|COMPLETED|Treatment Period 3 (14 Days)||7
10456217|NCT01005966|11604237|FG002|COMPLETED|Treatment Period 3 (14 Days)||12
10456218|NCT01005966|11604238|FG003|COMPLETED|Treatment Period 3 (14 Days)||13
10456219|NCT01005966|11604239|FG004|COMPLETED|Treatment Period 3 (14 Days)||11
10456220|NCT01005966|11604235|FG000|NOT COMPLETED|Treatment Period 3 (14 Days)||0
10456221|NCT01005966|11604236|FG001|NOT COMPLETED|Treatment Period 3 (14 Days)||1
10456222|NCT01005966|11604237|FG002|NOT COMPLETED|Treatment Period 3 (14 Days)||0
10456223|NCT01005966|11604238|FG003|NOT COMPLETED|Treatment Period 3 (14 Days)||0
10804188|NCT04072237|11965664|FG000|COMPLETED|Stage 7: MarzAA 120 µg/kg SC||8
10804189|NCT04072237|11965664|FG000|NOT COMPLETED|Stage 7: MarzAA 120 µg/kg SC||0
10804190|NCT04072237|11965664|FG000|STARTED|Stage 8: MarzAA 2 x 60 µg/kg Q3H SC||8
10804191|NCT04072237|11965664|FG000|COMPLETED|Stage 8: MarzAA 2 x 60 µg/kg Q3H SC||8
10804192|NCT04072237|11965664|FG000|NOT COMPLETED|Stage 8: MarzAA 2 x 60 µg/kg Q3H SC||0
10804193|NCT04072237|11965664|FG000|STARTED|Stage 9: MarzAA 3 x 60 µg/kg Q3H SC||8
10804194|NCT04072237|11965664|FG000|COMPLETED|Stage 9: MarzAA 3 x 60 µg/kg Q3H SC||8
10804195|NCT04072237|11965664|FG000|NOT COMPLETED|Stage 9: MarzAA 3 x 60 µg/kg Q3H SC||0
10804196|NCT04063371|11965694|FG000|STARTED|Overall Study||100
10804197|NCT04063371|11965695|FG001|STARTED|Overall Study||100
10804198|NCT04063371|11965696|FG002|STARTED|Overall Study||100
10804199|NCT04063371|11965694|FG000|COMPLETED|Overall Study||100
10804200|NCT04063371|11965695|FG001|COMPLETED|Overall Study||100
10326500|NCT00290472|11462154|FG000|STARTED|Overall Study||32
10326501|NCT00290472|11462155|FG001|STARTED|Overall Study||39
10326502|NCT00290472|11462156|FG002|STARTED|Overall Study||18
10326503|NCT00290472|11462154|FG000|COMPLETED|Overall Study||32
10326504|NCT00290472|11462155|FG001|COMPLETED|Overall Study||39
10326505|NCT00290472|11462156|FG002|COMPLETED|Overall Study||18
10326506|NCT00290472|11462154|FG000|NOT COMPLETED|Overall Study||0
10326507|NCT00290472|11462155|FG001|NOT COMPLETED|Overall Study||0
10326508|NCT00290472|11462156|FG002|NOT COMPLETED|Overall Study||0
10326509|NCT00290498|11462164|FG000|STARTED|Overall Study||49
10326510|NCT00290498|11462165|FG001|STARTED|Overall Study||10
10326511|NCT00290498|11462164|FG000|COMPLETED|Overall Study||41
10326512|NCT00290498|11462165|FG001|COMPLETED|Overall Study||10
10326513|NCT00290498|11462164|FG000|NOT COMPLETED|Overall Study||8
10326514|NCT00290498|11462165|FG001|NOT COMPLETED|Overall Study||0
10326515|NCT00290537|11462172|FG000|STARTED|Overall Study||4
10326516|NCT00290537|11462173|FG001|STARTED|Overall Study||0
10326517|NCT00290537|11462172|FG000|COMPLETED|Overall Study||4
10326518|NCT00290537|11462173|FG001|COMPLETED|Overall Study||0
10326519|NCT00290537|11462172|FG000|NOT COMPLETED|Overall Study||0
10326520|NCT00290537|11462173|FG001|NOT COMPLETED|Overall Study||0
10326521|NCT00290589|11462180|FG000|STARTED|Overall Study||39
10326522|NCT00290589|11462181|FG001|STARTED|Overall Study||43
10326523|NCT00290589|11462180|FG000|COMPLETED|Overall Study||37
10326524|NCT00290589|11462181|FG001|COMPLETED|Overall Study||41
10326525|NCT00290589|11462180|FG000|NOT COMPLETED|Overall Study||2
10326526|NCT00290589|11462181|FG001|NOT COMPLETED|Overall Study||2
10326527|NCT00290615|11462187|FG000|STARTED|Overall Study||30
10326528|NCT00290615|11462187|FG000|COMPLETED|Overall Study||30
10326529|NCT00290615|11462187|FG000|NOT COMPLETED|Overall Study||0
10326530|NCT00290654|11462191|FG000|STARTED|Overall Study||41
10326531|NCT00290654|11462191|FG000|COMPLETED|Overall Study||41
10326532|NCT00290654|11462191|FG000|NOT COMPLETED|Overall Study||0
10326533|NCT00290693|11462195|FG000|STARTED|Overall Study||45
10326534|NCT00290693|11462195|FG000|COMPLETED|Overall Study||43
10326535|NCT00290693|11462195|FG000|NOT COMPLETED|Overall Study||2
10326536|NCT00290706|11462204|FG000|STARTED|Overall Study||5
10326537|NCT00290706|11462205|FG001|STARTED|Overall Study||6
10326538|NCT00290706|11462206|FG002|STARTED|Overall Study||7
10326539|NCT00290706|11462207|FG003|STARTED|Overall Study||14
10326540|NCT00290706|11462204|FG000|Attempted1st Cycle|Overall Study||5
10326541|NCT00290706|11462205|FG001|Attempted1st Cycle|Overall Study||6
10326542|NCT00290706|11462206|FG002|Attempted1st Cycle|Overall Study||7
10326543|NCT00290706|11462207|FG003|Attempted1st Cycle|Overall Study||14
10804201|NCT04063371|11965696|FG002|COMPLETED|Overall Study||100
10804202|NCT04063371|11965694|FG000|NOT COMPLETED|Overall Study||0
10804203|NCT04063371|11965695|FG001|NOT COMPLETED|Overall Study||0
10804204|NCT04063371|11965696|FG002|NOT COMPLETED|Overall Study||0
10804205|NCT04042324|11965706|FG000|STARTED|UFH and Triferic Admixture (Day 1)||12
10804206|NCT04042324|11965707|FG001|STARTED|UFH and Triferic Admixture (Day 1)||0
10804207|NCT04042324|11965708|FG002|STARTED|UFH and Triferic Admixture (Day 1)||0
10804208|NCT04042324|11965706|FG000|COMPLETED|UFH and Triferic Admixture (Day 1)||12
10804209|NCT04042324|11965707|FG001|COMPLETED|UFH and Triferic Admixture (Day 1)||0
10804210|NCT04042324|11965708|FG002|COMPLETED|UFH and Triferic Admixture (Day 1)||0
10804211|NCT04042324|11965706|FG000|NOT COMPLETED|UFH and Triferic Admixture (Day 1)||0
10804212|NCT04042324|11965707|FG001|NOT COMPLETED|UFH and Triferic Admixture (Day 1)||0
10804213|NCT04042324|11965708|FG002|NOT COMPLETED|UFH and Triferic Admixture (Day 1)||0
10804214|NCT04042324|11965706|FG000|STARTED|Triferic Post-dialyzer (Day 3)||0
10804215|NCT04042324|11965707|FG001|STARTED|Triferic Post-dialyzer (Day 3)||12
10804216|NCT04042324|11965708|FG002|STARTED|Triferic Post-dialyzer (Day 3)||0
10804217|NCT04042324|11965706|FG000|COMPLETED|Triferic Post-dialyzer (Day 3)||0
10804218|NCT04042324|11965707|FG001|COMPLETED|Triferic Post-dialyzer (Day 3)||12
10804219|NCT04042324|11965708|FG002|COMPLETED|Triferic Post-dialyzer (Day 3)||0
10804220|NCT04042324|11965706|FG000|NOT COMPLETED|Triferic Post-dialyzer (Day 3)||0
10804221|NCT04042324|11965707|FG001|NOT COMPLETED|Triferic Post-dialyzer (Day 3)||0
10804222|NCT04042324|11965708|FG002|NOT COMPLETED|Triferic Post-dialyzer (Day 3)||0
10804223|NCT04042324|11965706|FG000|STARTED|Triferic Pre-dialyzer (Day 5)||0
10804224|NCT04042324|11965707|FG001|STARTED|Triferic Pre-dialyzer (Day 5)||0
10804225|NCT04042324|11965708|FG002|STARTED|Triferic Pre-dialyzer (Day 5)||12
10804226|NCT04042324|11965706|FG000|COMPLETED|Triferic Pre-dialyzer (Day 5)||0
10804227|NCT04042324|11965707|FG001|COMPLETED|Triferic Pre-dialyzer (Day 5)||0
10804228|NCT04042324|11965708|FG002|COMPLETED|Triferic Pre-dialyzer (Day 5)||12
10804229|NCT04042324|11965706|FG000|NOT COMPLETED|Triferic Pre-dialyzer (Day 5)||0
10804230|NCT04042324|11965707|FG001|NOT COMPLETED|Triferic Pre-dialyzer (Day 5)||0
10804231|NCT04042324|11965708|FG002|NOT COMPLETED|Triferic Pre-dialyzer (Day 5)||0
10804232|NCT04071392|11965720|FG000|STARTED|Overall Study||12
10804233|NCT04071392|11965721|FG001|STARTED|Overall Study||12
10804234|NCT04071392|11965720|FG000|COMPLETED|Overall Study||10
10804235|NCT04071392|11965721|FG001|COMPLETED|Overall Study||10
10804236|NCT04071392|11965720|FG000|NOT COMPLETED|Overall Study||2
10804237|NCT04071392|11965721|FG001|NOT COMPLETED|Overall Study||2
10804238|NCT04071301|11965727|FG000|STARTED|Overall Study||15
10804239|NCT04071301|11965727|FG000|COMPLETED|Overall Study||8
10804240|NCT04071301|11965727|FG000|NOT COMPLETED|Overall Study||7
10804241|NCT04071158|11965736|FG000|STARTED|Overall Study||143
10804242|NCT04071158|11965737|FG001|STARTED|Overall Study||143
10326544|NCT00290706|11462204|FG000|Reached 1st Response/Cycle 3|Overall Study||0
10326545|NCT00290706|11462205|FG001|Reached 1st Response/Cycle 3|Overall Study||0
10326546|NCT00290706|11462206|FG002|Reached 1st Response/Cycle 3|Overall Study||1
10326547|NCT00290706|11462207|FG003|Reached 1st Response/Cycle 3|Overall Study||2
10326548|NCT00290706|11462204|FG000|COMPLETED|Overall Study||0
10326549|NCT00290706|11462205|FG001|COMPLETED|Overall Study||0
10326550|NCT00290706|11462206|FG002|COMPLETED|Overall Study||1
10326551|NCT00290706|11462207|FG003|COMPLETED|Overall Study||2
10326552|NCT00290706|11462204|FG000|NOT COMPLETED|Overall Study||5
10804243|NCT04071158|11965738|FG002|STARTED|Overall Study||143
10804244|NCT04071158|11965739|FG003|STARTED|Overall Study||143
10804245|NCT04071158|11965740|FG004|STARTED|Overall Study||141
10804246|NCT04071158|11965736|FG000|Treated|Overall Study||141
10804247|NCT04071158|11965737|FG001|Treated|Overall Study||141
10804248|NCT04071158|11965738|FG002|Treated|Overall Study||143
10326553|NCT00290706|11462205|FG001|NOT COMPLETED|Overall Study||6
10326554|NCT00290706|11462206|FG002|NOT COMPLETED|Overall Study||6
10326555|NCT00290706|11462207|FG003|NOT COMPLETED|Overall Study||12
10326556|NCT00290732|11462220|FG000|STARTED|Overall Study||3
10326557|NCT00290732|11462221|FG001|STARTED|Overall Study||4
10326558|NCT00290732|11462222|FG002|STARTED|Overall Study||4
10326559|NCT00290732|11462223|FG003|STARTED|Overall Study||6
10326560|NCT00290732|11462224|FG004|STARTED|Overall Study||3
10326561|NCT00290732|11462220|FG000|COMPLETED|Overall Study||3
10326562|NCT00290732|11462221|FG001|COMPLETED|Overall Study||3
10326563|NCT00290732|11462222|FG002|COMPLETED|Overall Study||3
10326564|NCT00290732|11462223|FG003|COMPLETED|Overall Study||6
10326565|NCT00290732|11462224|FG004|COMPLETED|Overall Study||3
10326566|NCT00290732|11462220|FG000|NOT COMPLETED|Overall Study||0
10326567|NCT00290732|11462221|FG001|NOT COMPLETED|Overall Study||1
10326568|NCT00290732|11462222|FG002|NOT COMPLETED|Overall Study||1
10326569|NCT00290732|11462223|FG003|NOT COMPLETED|Overall Study||0
10326570|NCT00290732|11462224|FG004|NOT COMPLETED|Overall Study||0
10326571|NCT00290745|11462237|FG000|STARTED|Overall Study||79
10326572|NCT00290745|11462237|FG000|COMPLETED|Overall Study||67
10326573|NCT00290745|11462237|FG000|NOT COMPLETED|Overall Study||12
10326574|NCT00290771|11462243|FG000|STARTED|Overall Study||131
10326575|NCT00290771|11462244|FG001|STARTED|Overall Study||100
10326576|NCT00290771|11462243|FG000|COMPLETED|Overall Study||4
10326577|NCT00290771|11462244|FG001|COMPLETED|Overall Study||3
10326578|NCT00290771|11462243|FG000|NOT COMPLETED|Overall Study||127
10326579|NCT00290771|11462244|FG001|NOT COMPLETED|Overall Study||97
10326580|NCT00290810|11462251|FG000|STARTED|Overall Study||12
10326581|NCT00290810|11462251|FG000|COMPLETED|Overall Study||12
10326582|NCT00290810|11462251|FG000|NOT COMPLETED|Overall Study||0
10326583|NCT00290888|11462257|FG000|STARTED|Overall Study||41
10326584|NCT00290888|11462258|FG001|STARTED|Overall Study||45
10326585|NCT00290888|11462257|FG000|COMPLETED|Overall Study||38
10326586|NCT00290888|11462258|FG001|COMPLETED|Overall Study||44
10326587|NCT00290888|11462257|FG000|NOT COMPLETED|Overall Study||3
10326588|NCT00290888|11462258|FG001|NOT COMPLETED|Overall Study||1
10326589|NCT00291018|11462268|FG000|STARTED|Overall Study|Enrolled and Treated. 111 PDC subjects were Enrolled but only 103 were Treated.|103
10326590|NCT00291018|11462269|FG001|STARTED|Overall Study|Enrolled and Treated. 117 ACDF subjects were Enrolled but only 106 were Treated.|106
10326591|NCT00291018|11462270|FG002|STARTED|Overall Study|Enrolled and Treated. 140 PDC-CA subjects were Enrolled but only 136 were Treated.|136
10326592|NCT00291018|11462268|FG000|Evaluated at 24 Months|Overall Study||99
10326593|NCT00291018|11462269|FG001|Evaluated at 24 Months|Overall Study||92
10326594|NCT00291018|11462270|FG002|Evaluated at 24 Months|Overall Study||105
10326595|NCT00291018|11462268|FG000|COMPLETED|Overall Study|Evaluated at 84 Months|78
10326596|NCT00291018|11462269|FG001|COMPLETED|Overall Study|Evaluated at 84 Months|64
10326597|NCT00291018|11462270|FG002|COMPLETED|Overall Study|Evaluated at 84 Months|93
10326598|NCT00291018|11462268|FG000|NOT COMPLETED|Overall Study||25
10326599|NCT00291018|11462269|FG001|NOT COMPLETED|Overall Study||42
10326600|NCT00291018|11462270|FG002|NOT COMPLETED|Overall Study||43
10326601|NCT00291135|11462281|FG000|STARTED|Overall Study||42
10326602|NCT00291135|11462281|FG000|COMPLETED|Overall Study||42
10326603|NCT00291135|11462281|FG000|NOT COMPLETED|Overall Study||0
10326604|NCT00291161|11462289|FG000|STARTED|Overall Study||316
10326605|NCT00291161|11462290|FG001|STARTED|Overall Study||192
10326606|NCT00291161|11462291|FG002|STARTED|Overall Study||299
10326607|NCT00291161|11462292|FG003|STARTED|Overall Study||187
10326608|NCT00291161|11462289|FG000|COMPLETED|Overall Study||235
10326609|NCT00291161|11462290|FG001|COMPLETED|Overall Study||134
10701717|NCT02569710|11866151|FG007|NOT COMPLETED|Overall Study||0
10701718|NCT02569710|11866152|FG008|NOT COMPLETED|Overall Study||1
10701719|NCT02569710|11866153|FG009|NOT COMPLETED|Overall Study||0
10713699|NCT02680639|11879184|FG002|NOT COMPLETED|High Frequency Oscillation (HFO) Therapy||0
10713700|NCT02680665|11879194|FG000|STARTED|Overall Study||120
10713701|NCT02680665|11879194|FG000|COMPLETED|Overall Study||115
10713702|NCT02680665|11879194|FG000|NOT COMPLETED|Overall Study||5
10713703|NCT02680756|11879200|FG000|STARTED|Overall Study||125
10713704|NCT02680756|11879201|FG001|STARTED|Overall Study||125
10713705|NCT02680756|11879200|FG000|Received Treatment|Overall Study||127
10713706|NCT02680756|11879201|FG001|Received Treatment|Overall Study||120
10713707|NCT02680756|11879200|FG000|COMPLETED|Overall Study||93
10713708|NCT02680756|11879201|FG001|COMPLETED|Overall Study||106
10713709|NCT02680756|11879200|FG000|NOT COMPLETED|Overall Study||32
10713710|NCT02680756|11879201|FG001|NOT COMPLETED|Overall Study||19
10713711|NCT02680834|11879209|FG000|STARTED|Overall Study||26
10713712|NCT02680834|11879210|FG001|STARTED|Overall Study||30
10326610|NCT00291161|11462291|FG002|COMPLETED|Overall Study||206
10326611|NCT00291161|11462292|FG003|COMPLETED|Overall Study||122
10326612|NCT00291161|11462289|FG000|NOT COMPLETED|Overall Study||81
10326613|NCT00291161|11462290|FG001|NOT COMPLETED|Overall Study||58
10326614|NCT00291161|11462291|FG002|NOT COMPLETED|Overall Study||93
10326615|NCT00291161|11462292|FG003|NOT COMPLETED|Overall Study||65
10326616|NCT00291187|11462304|FG000|STARTED|Overall Study||103
10326617|NCT00291187|11462305|FG001|STARTED|Overall Study||100
10326618|NCT00291187|11462306|FG002|STARTED|Overall Study||103
10326619|NCT00291187|11462307|FG003|STARTED|Overall Study||106
10326620|NCT00291187|11462304|FG000|COMPLETED|Overall Study||103
10326621|NCT00291187|11462305|FG001|COMPLETED|Overall Study||100
10713713|NCT02680834|11879209|FG000|COMPLETED|Overall Study||15
10713714|NCT02680834|11879210|FG001|COMPLETED|Overall Study||27
10713715|NCT02680834|11879209|FG000|NOT COMPLETED|Overall Study||11
10713716|NCT02680834|11879210|FG001|NOT COMPLETED|Overall Study||3
10713717|NCT02680847|11879219|FG000|STARTED|Overall Study||16
10326622|NCT00291187|11462306|FG002|COMPLETED|Overall Study||102
10326623|NCT00291187|11462307|FG003|COMPLETED|Overall Study||106
10326624|NCT00291187|11462304|FG000|NOT COMPLETED|Overall Study||0
10326625|NCT00291187|11462305|FG001|NOT COMPLETED|Overall Study||0
10326626|NCT00291187|11462306|FG002|NOT COMPLETED|Overall Study||1
10326627|NCT00291187|11462307|FG003|NOT COMPLETED|Overall Study||0
10326628|NCT00291226|11462323|FG000|STARTED|Overall Study||4
10326629|NCT00291226|11462324|FG001|STARTED|Overall Study||4
10326630|NCT00291226|11462323|FG000|COMPLETED|Overall Study||3
10326631|NCT00291226|11462324|FG001|COMPLETED|Overall Study||3
10326632|NCT00291226|11462323|FG000|NOT COMPLETED|Overall Study||1
10326633|NCT00291226|11462324|FG001|NOT COMPLETED|Overall Study||1
10326634|NCT00291317|11462330|FG000|STARTED|Overall Study||6
10326635|NCT00291317|11462330|FG000|COMPLETED|Overall Study||6
10326636|NCT00291317|11462330|FG000|NOT COMPLETED|Overall Study||0
10326637|NCT00291330|11462337|FG000|STARTED|Overall Study|Started Treatment|1273
10326638|NCT00291330|11462338|FG001|STARTED|Overall Study|Started Treatment|1266
10326639|NCT00291330|11462337|FG000|COMPLETED|Overall Study|Completed planned observation time|1172
10326640|NCT00291330|11462338|FG001|COMPLETED|Overall Study|Completed planned observation time|1169
10326641|NCT00291330|11462337|FG000|NOT COMPLETED|Overall Study||101
10326642|NCT00291330|11462338|FG001|NOT COMPLETED|Overall Study||97
10326643|NCT00291343|11462346|FG000|STARTED|Overall Study||203
10326644|NCT00291343|11462347|FG001|STARTED|Overall Study||93
10326645|NCT00291343|11462346|FG000|COMPLETED|Overall Study||203
10326646|NCT00291343|11462347|FG001|COMPLETED|Overall Study||93
10326647|NCT00291343|11462346|FG000|NOT COMPLETED|Overall Study||0
10326648|NCT00291343|11462347|FG001|NOT COMPLETED|Overall Study||0
10326649|NCT00291447|11462357|FG000|STARTED|Overall Study||2
10326650|NCT00291447|11462358|FG001|STARTED|Overall Study||2
10326651|NCT00291447|11462359|FG002|STARTED|Overall Study||2
10326652|NCT00291447|11462360|FG003|STARTED|Overall Study||2
10326653|NCT00291447|11462357|FG000|COMPLETED|Overall Study||2
10326654|NCT00291447|11462358|FG001|COMPLETED|Overall Study||2
10326655|NCT00291447|11462359|FG002|COMPLETED|Overall Study||2
10326656|NCT00291447|11462360|FG003|COMPLETED|Overall Study||2
10326657|NCT00291447|11462357|FG000|NOT COMPLETED|Overall Study||0
10326658|NCT00291447|11462358|FG001|NOT COMPLETED|Overall Study||0
10326659|NCT00291447|11462359|FG002|NOT COMPLETED|Overall Study||0
10326660|NCT00291447|11462360|FG003|NOT COMPLETED|Overall Study||0
10326661|NCT00291499|11462373|FG000|STARTED|Overall Study||81
10326662|NCT00291499|11462374|FG001|STARTED|Overall Study||82
10326663|NCT00291499|11462373|FG000|Intention to Treat (ITT)|Overall Study||80
10326664|NCT00291499|11462374|FG001|Intention to Treat (ITT)|Overall Study||82
10326665|NCT00291499|11462373|FG000|Per Protocol (PP)|Overall Study||72
10326666|NCT00291499|11462374|FG001|Per Protocol (PP)|Overall Study||67
10326667|NCT00291499|11462373|FG000|Safety Population|Overall Study||81
10326668|NCT00291499|11462374|FG001|Safety Population|Overall Study||82
10326669|NCT00291499|11462373|FG000|COMPLETED|Overall Study||72
10326670|NCT00291499|11462374|FG001|COMPLETED|Overall Study||67
10326671|NCT00291499|11462373|FG000|NOT COMPLETED|Overall Study||9
10326672|NCT00291499|11462374|FG001|NOT COMPLETED|Overall Study||15
10326673|NCT00291551|11462380|FG000|STARTED|Overall Study||39
10326674|NCT00291551|11462380|FG000|COMPLETED|Overall Study||26
10326675|NCT00291551|11462380|FG000|NOT COMPLETED|Overall Study||13
10326676|NCT00291577|11462385|FG000|STARTED|Overall Study||22
10326677|NCT00291577|11462385|FG000|COMPLETED|Overall Study|Subject End of Study=Completed; not per protocol reason. PI reason=withdrawn during active treatment|1
10326678|NCT00291577|11462385|FG000|NOT COMPLETED|Overall Study||21
10326679|NCT00291642|11462394|FG000|STARTED|Overall Study||78
10326680|NCT00291642|11462395|FG001|STARTED|Overall Study||116
10326681|NCT00291642|11462396|FG002|STARTED|Overall Study||119
10326682|NCT00291642|11462397|FG003|STARTED|Overall Study||119
10326683|NCT00291642|11462398|FG004|STARTED|Overall Study||119
10326684|NCT00291642|11462394|FG000|COMPLETED|Overall Study||76
10326685|NCT00291642|11462395|FG001|COMPLETED|Overall Study||116
10326686|NCT00291642|11462396|FG002|COMPLETED|Overall Study||117
10326687|NCT00291642|11462397|FG003|COMPLETED|Overall Study||119
10326688|NCT00291642|11462398|FG004|COMPLETED|Overall Study||118
10326689|NCT00291642|11462394|FG000|NOT COMPLETED|Overall Study||2
10326690|NCT00291642|11462395|FG001|NOT COMPLETED|Overall Study||0
10326691|NCT00291642|11462396|FG002|NOT COMPLETED|Overall Study||2
10326692|NCT00291642|11462397|FG003|NOT COMPLETED|Overall Study||0
10326693|NCT00291642|11462398|FG004|NOT COMPLETED|Overall Study||1
10326694|NCT00291655|11462410|FG000|STARTED|Overall Study||130
10326695|NCT00291655|11462410|FG000|COMPLETED|Overall Study||115
10326696|NCT00291655|11462410|FG000|NOT COMPLETED|Overall Study||15
10326697|NCT00291668|11462417|FG000|STARTED|Overall Study||32
10326698|NCT00291668|11462418|FG001|STARTED|Overall Study||30
10326699|NCT00291668|11462419|FG002|STARTED|Overall Study||32
10326700|NCT00291668|11462417|FG000|COMPLETED|Overall Study||28
10326701|NCT00291668|11462418|FG001|COMPLETED|Overall Study||29
10326702|NCT00291668|11462419|FG002|COMPLETED|Overall Study||31
10326703|NCT00291668|11462417|FG000|NOT COMPLETED|Overall Study||4
10326704|NCT00291668|11462418|FG001|NOT COMPLETED|Overall Study||1
10326705|NCT00291668|11462419|FG002|NOT COMPLETED|Overall Study||1
10326706|NCT00291694|11462429|FG000|STARTED|Overall Study||24
10326707|NCT00291694|11462430|FG001|STARTED|Overall Study||48
10326708|NCT00291694|11462429|FG000|COMPLETED|Overall Study||21
10326709|NCT00291694|11462430|FG001|COMPLETED|Overall Study||43
10326710|NCT00291694|11462429|FG000|NOT COMPLETED|Overall Study||3
10326711|NCT00291694|11462430|FG001|NOT COMPLETED|Overall Study||5
10326712|NCT00291876|11462438|FG000|STARTED|Month 138||107
10326713|NCT00291876|11462438|FG000|COMPLETED|Month 138||107
10326714|NCT00291876|11462438|FG000|NOT COMPLETED|Month 138||0
10326715|NCT00291876|11462438|FG000|STARTED|Month 150||117
10326716|NCT00291876|11462438|FG000|COMPLETED|Month 150||117
10326717|NCT00291876|11462438|FG000|NOT COMPLETED|Month 150||0
10326718|NCT00291876|11462438|FG000|STARTED|Month 162||127
10326719|NCT00291876|11462438|FG000|COMPLETED|Month 162||127
10326720|NCT00291876|11462438|FG000|NOT COMPLETED|Month 162||0
10326721|NCT00291876|11462438|FG000|STARTED|Month 174||127
10326722|NCT00291876|11462438|FG000|COMPLETED|Month 174||127
10326723|NCT00291876|11462438|FG000|NOT COMPLETED|Month 174||0
10326724|NCT00291876|11462438|FG000|STARTED|Month 186||129
10326725|NCT00291876|11462438|FG000|COMPLETED|Month 186||129
10326726|NCT00291876|11462438|FG000|NOT COMPLETED|Month 186||0
10326727|NCT00291876|11462438|FG000|STARTED|Month 198||135
10326728|NCT00291876|11462438|FG000|COMPLETED|Month 198||135
10326729|NCT00291876|11462438|FG000|NOT COMPLETED|Month 198||0
10326730|NCT00291876|11462438|FG000|STARTED|Month 210||124
10326731|NCT00291876|11462438|FG000|COMPLETED|Month 210||124
10326732|NCT00291876|11462438|FG000|NOT COMPLETED|Month 210||0
10326733|NCT00291876|11462438|FG000|STARTED|Month 222||114
10326734|NCT00291876|11462438|FG000|COMPLETED|Month 222||114
10326735|NCT00291876|11462438|FG000|NOT COMPLETED|Month 222||0
10326736|NCT00291876|11462438|FG000|STARTED|Month 234||110
10326737|NCT00291876|11462438|FG000|COMPLETED|Month 234||110
10326738|NCT00291876|11462438|FG000|NOT COMPLETED|Month 234||0
10326739|NCT00291876|11462438|FG000|STARTED|Month 246||116
10326740|NCT00291876|11462438|FG000|COMPLETED|Month 246||116
10326741|NCT00291876|11462438|FG000|NOT COMPLETED|Month 246||0
10326742|NCT00292045|11462442|FG000|STARTED|Core Study (Through Week 13)||15
10326743|NCT00292045|11462442|FG000|COMPLETED|Core Study (Through Week 13)||13
10326744|NCT00292045|11462442|FG000|NOT COMPLETED|Core Study (Through Week 13)||2
10326745|NCT00292045|11462442|FG000|STARTED|Extended Treatment Beyond Week 13||10
10326746|NCT00292045|11462442|FG000|COMPLETED|Extended Treatment Beyond Week 13||10
10326747|NCT00292045|11462442|FG000|NOT COMPLETED|Extended Treatment Beyond Week 13||0
10326748|NCT00292162|11462448|FG000|STARTED|Overall Study||19
10326749|NCT00292162|11462449|FG001|STARTED|Overall Study||22
10326750|NCT00292162|11462448|FG000|COMPLETED|Overall Study||18
10326751|NCT00292162|11462449|FG001|COMPLETED|Overall Study||20
10326752|NCT00292162|11462448|FG000|NOT COMPLETED|Overall Study||1
10326753|NCT00292162|11462449|FG001|NOT COMPLETED|Overall Study||2
10326754|NCT00292188|11462457|FG000|STARTED|Single-Blind||368
10326755|NCT00292188|11462458|FG001|STARTED|Single-Blind||0
10326756|NCT00292188|11462459|FG002|STARTED|Single-Blind||0
10326757|NCT00292188|11462457|FG000|Received Treatment|Single-Blind||367
10326758|NCT00292188|11462458|FG001|Received Treatment|Single-Blind||0
10326759|NCT00292188|11462459|FG002|Received Treatment|Single-Blind||0
10326760|NCT00292188|11462457|FG000|COMPLETED|Single-Blind||254
10326761|NCT00292188|11462458|FG001|COMPLETED|Single-Blind||0
10326762|NCT00292188|11462459|FG002|COMPLETED|Single-Blind||0
10326763|NCT00292188|11462457|FG000|NOT COMPLETED|Single-Blind||114
10326764|NCT00292188|11462458|FG001|NOT COMPLETED|Single-Blind||0
10326765|NCT00292188|11462459|FG002|NOT COMPLETED|Single-Blind||0
10326766|NCT00292188|11462457|FG000|STARTED|Double-Blind||0
10326767|NCT00292188|11462458|FG001|STARTED|Double-Blind||127
10326768|NCT00292188|11462459|FG002|STARTED|Double-Blind||127
10326769|NCT00292188|11462457|FG000|COMPLETED|Double-Blind||0
10326770|NCT00292188|11462458|FG001|COMPLETED|Double-Blind||96
10326771|NCT00292188|11462459|FG002|COMPLETED|Double-Blind||98
10326772|NCT00292188|11462457|FG000|NOT COMPLETED|Double-Blind||0
10326773|NCT00292188|11462458|FG001|NOT COMPLETED|Double-Blind||31
10326774|NCT00292188|11462459|FG002|NOT COMPLETED|Double-Blind||29
10326775|NCT00292227|11462468|FG000|STARTED|Patch Period||66
10326776|NCT00292227|11462469|FG001|STARTED|Patch Period||31
10326777|NCT00292227|11462470|FG002|STARTED|Patch Period||33
10326778|NCT00292227|11462468|FG000|COMPLETED|Patch Period||65
10326779|NCT00292227|11462469|FG001|COMPLETED|Patch Period||31
10326780|NCT00292227|11462470|FG002|COMPLETED|Patch Period||30
10326781|NCT00292227|11462468|FG000|NOT COMPLETED|Patch Period||1
10326782|NCT00292227|11462469|FG001|NOT COMPLETED|Patch Period||0
10326783|NCT00292227|11462470|FG002|NOT COMPLETED|Patch Period||3
10326784|NCT00292227|11462468|FG000|STARTED|Cross-over Period 1 (Day 32)||65
10326785|NCT00292227|11462469|FG001|STARTED|Cross-over Period 1 (Day 32)||31
10326786|NCT00292227|11462470|FG002|STARTED|Cross-over Period 1 (Day 32)||30
10326787|NCT00292227|11462468|FG000|COMPLETED|Cross-over Period 1 (Day 32)||65
10326788|NCT00292227|11462469|FG001|COMPLETED|Cross-over Period 1 (Day 32)||31
10326789|NCT00292227|11462470|FG002|COMPLETED|Cross-over Period 1 (Day 32)||30
10326790|NCT00292227|11462468|FG000|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
10326791|NCT00292227|11462469|FG001|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
10326792|NCT00292227|11462470|FG002|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
10326793|NCT00292227|11462468|FG000|STARTED|Cross-over Period 2 (Day 39)||65
10326794|NCT00292227|11462469|FG001|STARTED|Cross-over Period 2 (Day 39)||31
10326795|NCT00292227|11462470|FG002|STARTED|Cross-over Period 2 (Day 39)||30
10326796|NCT00292227|11462468|FG000|COMPLETED|Cross-over Period 2 (Day 39)||65
10326797|NCT00292227|11462469|FG001|COMPLETED|Cross-over Period 2 (Day 39)||31
10326798|NCT00292227|11462470|FG002|COMPLETED|Cross-over Period 2 (Day 39)||30
10326799|NCT00292227|11462468|FG000|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
10326800|NCT00292227|11462469|FG001|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
10326801|NCT00292227|11462470|FG002|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
10326802|NCT00292318|11462480|FG000|STARTED|Overall Study||4
10326803|NCT00292318|11462481|FG001|STARTED|Overall Study||3
10326804|NCT00292318|11462480|FG000|COMPLETED|Overall Study||2
10456224|NCT01005966|11604239|FG004|NOT COMPLETED|Treatment Period 3 (14 Days)||1
10456225|NCT01005966|11604235|FG000|STARTED|Washout Period 3 ( 4 Days)||12
10456226|NCT01005966|11604236|FG001|STARTED|Washout Period 3 ( 4 Days)||7
10456227|NCT01005966|11604237|FG002|STARTED|Washout Period 3 ( 4 Days)||12
10456228|NCT01005966|11604238|FG003|STARTED|Washout Period 3 ( 4 Days)||13
10456229|NCT01005966|11604239|FG004|STARTED|Washout Period 3 ( 4 Days)||11
10456230|NCT01005966|11604235|FG000|COMPLETED|Washout Period 3 ( 4 Days)||12
10456231|NCT01005966|11604236|FG001|COMPLETED|Washout Period 3 ( 4 Days)||7
10456232|NCT01005966|11604237|FG002|COMPLETED|Washout Period 3 ( 4 Days)||12
10456233|NCT01005966|11604238|FG003|COMPLETED|Washout Period 3 ( 4 Days)||13
10456234|NCT01005966|11604239|FG004|COMPLETED|Washout Period 3 ( 4 Days)||11
10456235|NCT01005966|11604235|FG000|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
10456236|NCT01005966|11604236|FG001|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
10456237|NCT01005966|11604237|FG002|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
10456238|NCT01005966|11604238|FG003|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
10456239|NCT01005966|11604239|FG004|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
10456240|NCT01005966|11604235|FG000|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
10456241|NCT01005966|11604236|FG001|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
10456242|NCT01005966|11604237|FG002|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
10456243|NCT01005966|11604238|FG003|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
10456244|NCT01005966|11604239|FG004|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|13
10456245|NCT01005966|11604235|FG000|COMPLETED|Treatment Period 4 (14 Days)||10
10456246|NCT01005966|11604236|FG001|COMPLETED|Treatment Period 4 (14 Days)||10
10456247|NCT01005966|11604237|FG002|COMPLETED|Treatment Period 4 (14 Days)||11
10456248|NCT01005966|11604238|FG003|COMPLETED|Treatment Period 4 (14 Days)||10
10456249|NCT01005966|11604239|FG004|COMPLETED|Treatment Period 4 (14 Days)||12
10456250|NCT01005966|11604235|FG000|NOT COMPLETED|Treatment Period 4 (14 Days)||0
10456251|NCT01005966|11604236|FG001|NOT COMPLETED|Treatment Period 4 (14 Days)||1
10456252|NCT01005966|11604237|FG002|NOT COMPLETED|Treatment Period 4 (14 Days)||0
10456253|NCT01005966|11604238|FG003|NOT COMPLETED|Treatment Period 4 (14 Days)||0
10456254|NCT01005966|11604239|FG004|NOT COMPLETED|Treatment Period 4 (14 Days)||1
10456255|NCT01005966|11604235|FG000|STARTED|Washout Period 4 (4 Days)||10
10456256|NCT01005966|11604236|FG001|STARTED|Washout Period 4 (4 Days)||10
10456257|NCT01005966|11604237|FG002|STARTED|Washout Period 4 (4 Days)||11
10456258|NCT01005966|11604238|FG003|STARTED|Washout Period 4 (4 Days)||10
10456259|NCT01005966|11604239|FG004|STARTED|Washout Period 4 (4 Days)||12
10456260|NCT01005966|11604235|FG000|COMPLETED|Washout Period 4 (4 Days)||10
10456261|NCT01005966|11604236|FG001|COMPLETED|Washout Period 4 (4 Days)||10
10456262|NCT01005966|11604237|FG002|COMPLETED|Washout Period 4 (4 Days)||11
10456263|NCT01005966|11604238|FG003|COMPLETED|Washout Period 4 (4 Days)||10
10456264|NCT01005966|11604239|FG004|COMPLETED|Washout Period 4 (4 Days)||12
10456265|NCT01005966|11604235|FG000|NOT COMPLETED|Washout Period 4 (4 Days)||0
10456266|NCT01005966|11604236|FG001|NOT COMPLETED|Washout Period 4 (4 Days)||0
10456267|NCT01005966|11604237|FG002|NOT COMPLETED|Washout Period 4 (4 Days)||0
10456268|NCT01005966|11604238|FG003|NOT COMPLETED|Washout Period 4 (4 Days)||0
10456269|NCT01005966|11604239|FG004|NOT COMPLETED|Washout Period 4 (4 Days)||0
10456270|NCT01005966|11604235|FG000|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|9
10456271|NCT01005966|11604236|FG001|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|12
10456272|NCT01005966|11604237|FG002|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|11
10456273|NCT01005966|11604238|FG003|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|11
10456274|NCT01005966|11604239|FG004|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|10
10456275|NCT01005966|11604235|FG000|COMPLETED|Treatment Period 5 (14 Days)||9
10456276|NCT01005966|11604236|FG001|COMPLETED|Treatment Period 5 (14 Days)||12
10701720|NCT02569723|11866186|FG000|STARTED|Overall Study||6
10701721|NCT02569723|11866186|FG000|COMPLETED|Overall Study||6
10701722|NCT02569723|11866186|FG000|NOT COMPLETED|Overall Study||0
10701723|NCT02569801|11866192|FG000|STARTED|Overall Study||36
10326805|NCT00292318|11462481|FG001|COMPLETED|Overall Study||2
10326806|NCT00292318|11462480|FG000|NOT COMPLETED|Overall Study||2
10326807|NCT00292318|11462481|FG001|NOT COMPLETED|Overall Study||1
10326808|NCT00292370|11462490|FG000|STARTED|Phase I - Open-Label Paroxetine (OLP)||124
10326809|NCT00292370|11462491|FG001|STARTED|Phase I - Open-Label Paroxetine (OLP)||0
10326810|NCT00292370|11462492|FG002|STARTED|Phase I - Open-Label Paroxetine (OLP)||0
10326811|NCT00292370|11462490|FG000|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||78
10326812|NCT00292370|11462491|FG001|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
10326813|NCT00292370|11462492|FG002|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
10326814|NCT00292370|11462490|FG000|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||46
10326815|NCT00292370|11462491|FG001|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
10326816|NCT00292370|11462492|FG002|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
10338644|NCT04078126|11475534|FG000|COMPLETED|Period 2||17
10326817|NCT00292370|11462490|FG000|STARTED|Phase II: OLP + DB Quetiapine or Placebo|"78 Completed Ph I~28 Excluded Ph II:~20 responded~7 declined~1 medical~50 to Arm 2 & 3"|0
10326818|NCT00292370|11462491|FG001|STARTED|Phase II: OLP + DB Quetiapine or Placebo|25 out of 50 in Arm I PhI, eligible for Ph II|25
10326819|NCT00292370|11462492|FG002|STARTED|Phase II: OLP + DB Quetiapine or Placebo|25 out of 50 in Arm I PhI, eligible for Ph II|25
10326820|NCT00292370|11462490|FG000|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||0
10326821|NCT00292370|11462491|FG001|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||21
10326822|NCT00292370|11462492|FG002|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||18
10326823|NCT00292370|11462490|FG000|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||0
10326824|NCT00292370|11462491|FG001|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||4
10326825|NCT00292370|11462492|FG002|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||7
10326826|NCT00292461|11462501|FG000|STARTED|Overall Study||34
10326827|NCT00292461|11462502|FG001|STARTED|Overall Study||30
10326828|NCT00292461|11462501|FG000|COMPLETED|Overall Study||24
10326829|NCT00292461|11462502|FG001|COMPLETED|Overall Study||24
10326830|NCT00292461|11462501|FG000|NOT COMPLETED|Overall Study||10
10326831|NCT00292461|11462502|FG001|NOT COMPLETED|Overall Study||6
10326832|NCT00292591|11462511|FG000|STARTED|Overall Study||166
10326833|NCT00292591|11462512|FG001|STARTED|Overall Study||167
10326834|NCT00292591|11462513|FG002|STARTED|Overall Study||168
10326835|NCT00292591|11462511|FG000|COMPLETED|Overall Study||102
10326836|NCT00292591|11462512|FG001|COMPLETED|Overall Study||111
10326837|NCT00292591|11462513|FG002|COMPLETED|Overall Study||110
10326838|NCT00292591|11462511|FG000|NOT COMPLETED|Overall Study||64
10326839|NCT00292591|11462512|FG001|NOT COMPLETED|Overall Study||56
10326840|NCT00292591|11462513|FG002|NOT COMPLETED|Overall Study||58
10326841|NCT00292942|11462525|FG000|STARTED|Overall Study||6
10326842|NCT00292942|11462526|FG001|STARTED|Overall Study||6
10326843|NCT00292942|11462527|FG002|STARTED|Overall Study||7
10326844|NCT00292942|11462528|FG003|STARTED|Overall Study||7
10326845|NCT00292942|11462525|FG000|COMPLETED|Overall Study||6
10326846|NCT00292942|11462526|FG001|COMPLETED|Overall Study||6
10326847|NCT00292942|11462527|FG002|COMPLETED|Overall Study||6
10326848|NCT00292942|11462528|FG003|COMPLETED|Overall Study||6
10326849|NCT00292942|11462525|FG000|NOT COMPLETED|Overall Study||0
10326850|NCT00292942|11462526|FG001|NOT COMPLETED|Overall Study||0
10326851|NCT00292942|11462527|FG002|NOT COMPLETED|Overall Study||1
10326852|NCT00292942|11462528|FG003|NOT COMPLETED|Overall Study||1
10326853|NCT00292981|11462541|FG000|STARTED|Overall Study||57
10326854|NCT00292981|11462541|FG000|COMPLETED|Overall Study||18
10804249|NCT04071158|11965739|FG003|Treated|Overall Study||143
10804250|NCT04071158|11965740|FG004|Treated|Overall Study||141
10804251|NCT04071158|11965736|FG000|Safety Population|Overall Study||141
10804252|NCT04071158|11965737|FG001|Safety Population|Overall Study||141
10804253|NCT04071158|11965738|FG002|Safety Population|Overall Study|1 participant randomized to this arm received RSV vaccine 240 mcg with aluminum hydroxide withTdap|142
10804254|NCT04071158|11965739|FG003|Safety Population|Overall Study|1 participant of this arm actually received RSV vaccine 240 mcg with aluminum hydroxide with Tdap|144
10804255|NCT04071158|11965740|FG004|Safety Population|Overall Study||141
10804256|NCT04071158|11965736|FG000|COMPLETED|Overall Study||140
10804257|NCT04071158|11965737|FG001|COMPLETED|Overall Study||139
10804258|NCT04071158|11965738|FG002|COMPLETED|Overall Study||140
10804259|NCT04071158|11965739|FG003|COMPLETED|Overall Study||140
10804260|NCT04071158|11965740|FG004|COMPLETED|Overall Study||136
10804261|NCT04071158|11965736|FG000|NOT COMPLETED|Overall Study||3
10804262|NCT04071158|11965737|FG001|NOT COMPLETED|Overall Study||4
10804263|NCT04071158|11965738|FG002|NOT COMPLETED|Overall Study||3
10804264|NCT04071158|11965739|FG003|NOT COMPLETED|Overall Study||3
10804265|NCT04071158|11965740|FG004|NOT COMPLETED|Overall Study||5
10804266|NCT04070287|11965763|FG000|STARTED|Overall Study||114
10804267|NCT04070287|11965764|FG001|STARTED|Overall Study||86
10804268|NCT04070287|11965765|FG002|STARTED|Overall Study||81
10804269|NCT04070287|11965766|FG003|STARTED|Overall Study||11
10326855|NCT00292981|11462541|FG000|NOT COMPLETED|Overall Study||39
10326856|NCT00293020|11462545|FG000|STARTED|Overall Study||244
10326857|NCT00293020|11462545|FG000|COMPLETED|Overall Study||82
10326858|NCT00293020|11462545|FG000|NOT COMPLETED|Overall Study||162
10326859|NCT00293033|11462549|FG000|STARTED|Open-label Titration Period|152 subjects enrolled; 151 subjects received at least one dose of study drug|151
10326860|NCT00293033|11462549|FG000|COMPLETED|Open-label Titration Period||82
10326861|NCT00293033|11462549|FG000|NOT COMPLETED|Open-label Titration Period||69
10326862|NCT00293033|11462549|FG000|STARTED|Double-blind Treatment Period|82 randomized; 1 didn't take double-blind drug; 1 didn't report a pain assessment within 30 minutes|82
10326863|NCT00293033|11462549|FG000|COMPLETED|Double-blind Treatment Period||70
10326864|NCT00293033|11462549|FG000|NOT COMPLETED|Double-blind Treatment Period||12
10326865|NCT00293059|11462559|FG000|STARTED|Overall Study||120
10326866|NCT00293059|11462560|FG001|STARTED|Overall Study||70
10326867|NCT00293059|11462559|FG000|Subjects Received Treatment|Overall Study||119
10326868|NCT00293059|11462560|FG001|Subjects Received Treatment|Overall Study||66
10326869|NCT00293059|11462559|FG000|Cycle 1/Treatment Day 28|Overall Study||115
10326870|NCT00293059|11462560|FG001|Cycle 1/Treatment Day 28|Overall Study||64
10326871|NCT00293059|11462559|FG000|Cycle 3/Treatment Day 84|Overall Study||100
10326872|NCT00293059|11462560|FG001|Cycle 3/Treatment Day 84|Overall Study||55
10326873|NCT00293059|11462559|FG000|Cycle 7/Treatment Day 196|Overall Study|Includes participants that prematurely discontinued and may not be counted in earlier visits.|113
10804270|NCT04070287|11965767|FG004|STARTED|Overall Study||96
10804271|NCT04070287|11965763|FG000|COMPLETED|Overall Study||103
10804272|NCT04070287|11965764|FG001|COMPLETED|Overall Study||44
10326874|NCT00293059|11462560|FG001|Cycle 7/Treatment Day 196|Overall Study|Includes participants that prematurely discontinued and may not be counted in earlier visits.|62
10326875|NCT00293059|11462559|FG000|COMPLETED|Overall Study||85
10326876|NCT00293059|11462560|FG001|COMPLETED|Overall Study||51
10326877|NCT00293059|11462559|FG000|NOT COMPLETED|Overall Study||35
10326878|NCT00293059|11462560|FG001|NOT COMPLETED|Overall Study||19
10326879|NCT00293202|11462568|FG000|STARTED|Overall Study||5
10326880|NCT00293202|11462569|FG001|STARTED|Overall Study||5
10326881|NCT00293202|11462568|FG000|COMPLETED|Overall Study||2
10326882|NCT00293202|11462569|FG001|COMPLETED|Overall Study||3
10326883|NCT00293202|11462568|FG000|NOT COMPLETED|Overall Study||3
10326884|NCT00293202|11462569|FG001|NOT COMPLETED|Overall Study||2
10326885|NCT00293215|11462581|FG000|STARTED|Overall Study||6
10326886|NCT00293215|11462582|FG001|STARTED|Overall Study||3
10326887|NCT00293215|11462581|FG000|COMPLETED|Overall Study||1
10326888|NCT00293215|11462582|FG001|COMPLETED|Overall Study||0
10326889|NCT00293215|11462581|FG000|NOT COMPLETED|Overall Study||5
10326890|NCT00293215|11462582|FG001|NOT COMPLETED|Overall Study||3
10326891|NCT00293241|11462590|FG000|STARTED|Overall Study||299
10326892|NCT00293241|11462591|FG001|STARTED|Overall Study||306
10326893|NCT00293241|11462590|FG000|COMPLETED|Overall Study||263
10326894|NCT00293241|11462591|FG001|COMPLETED|Overall Study||265
10326895|NCT00293241|11462590|FG000|NOT COMPLETED|Overall Study||36
10326896|NCT00293241|11462591|FG001|NOT COMPLETED|Overall Study||41
10326897|NCT00293254|11462602|FG000|STARTED|Primary Study - Double-Blind Week 0-48||232
10326898|NCT00293254|11462603|FG001|STARTED|Primary Study - Double-Blind Week 0-48||119
10326899|NCT00293254|11462602|FG000|Treated|Primary Study - Double-Blind Week 0-48||230
10326900|NCT00293254|11462603|FG001|Treated|Primary Study - Double-Blind Week 0-48||119
10326901|NCT00293254|11462602|FG000|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the Open-Label Post-Virologic Failure (OLPVF) Phase|177
10326902|NCT00293254|11462603|FG001|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the OLPVF phase|55
10326903|NCT00293254|11462602|FG000|COMPLETED|Primary Study - Double-Blind Week 0-48||177
10326904|NCT00293254|11462603|FG001|COMPLETED|Primary Study - Double-Blind Week 0-48||55
10326905|NCT00293254|11462602|FG000|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||55
10326906|NCT00293254|11462603|FG001|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||64
10326907|NCT00293254|11462602|FG000|STARTED|Extension - Double-Blind Week 49-156||177
10326908|NCT00293254|11462603|FG001|STARTED|Extension - Double-Blind Week 49-156|1 of 55 participants who completed Week 48 did not enter the extension study.|54
10326909|NCT00293254|11462602|FG000|COMPLETED|Extension - Double-Blind Week 49-156||120
10326910|NCT00293254|11462603|FG001|COMPLETED|Extension - Double-Blind Week 49-156||25
10326911|NCT00293254|11462602|FG000|NOT COMPLETED|Extension - Double-Blind Week 49-156||57
10326912|NCT00293254|11462603|FG001|NOT COMPLETED|Extension - Double-Blind Week 49-156||29
10326913|NCT00293254|11462602|FG000|STARTED|Extension - Open-Label Week 157-240||120
10326914|NCT00293254|11462603|FG001|STARTED|Extension - Open-Label Week 157-240|6 of 25 participants who completed the double-blind phase did not enter this open-label phase.|19
10326915|NCT00293254|11462602|FG000|COMPLETED|Extension - Open-Label Week 157-240||110
10326916|NCT00293254|11462603|FG001|COMPLETED|Extension - Open-Label Week 157-240||18
10326917|NCT00293254|11462602|FG000|NOT COMPLETED|Extension - Open-Label Week 157-240||10
10326918|NCT00293254|11462603|FG001|NOT COMPLETED|Extension - Open-Label Week 157-240||1
10326919|NCT00293254|11462602|FG000|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|50
10326920|NCT00293254|11462603|FG001|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|64
10326921|NCT00293254|11462602|FG000|COMPLETED|Open-Label Post Virologic Failure Phase||19
10326922|NCT00293254|11462603|FG001|COMPLETED|Open-Label Post Virologic Failure Phase||37
10326923|NCT00293254|11462602|FG000|NOT COMPLETED|Open-Label Post Virologic Failure Phase||31
10326924|NCT00293254|11462603|FG001|NOT COMPLETED|Open-Label Post Virologic Failure Phase||27
10326925|NCT00293267|11462613|FG000|STARTED|Primary Study - Double-Blind Week 0-48||234
10326926|NCT00293267|11462614|FG001|STARTED|Primary Study - Double-Blind Week 0-48||118
10326927|NCT00293267|11462613|FG000|Treated|Primary Study - Double-Blind Week 0-48||232
10326928|NCT00293267|11462614|FG001|Treated|Primary Study - Double-Blind Week 0-48||118
10326929|NCT00293267|11462613|FG000|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the open-label post virological failure (OLPVF) phase|193
10326930|NCT00293267|11462614|FG001|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48||50
10326931|NCT00293267|11462613|FG000|COMPLETED|Primary Study - Double-Blind Week 0-48||193
10326932|NCT00293267|11462614|FG001|COMPLETED|Primary Study - Double-Blind Week 0-48||50
10326933|NCT00293267|11462613|FG000|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||41
10326934|NCT00293267|11462614|FG001|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||68
10326935|NCT00293267|11462613|FG000|STARTED|Extension - Double-Blind Week 49-156|2 participants who completed Week 48 did not enter the extension study|191
10326936|NCT00293267|11462614|FG001|STARTED|Extension - Double-Blind Week 49-156||50
10326937|NCT00293267|11462613|FG000|COMPLETED|Extension - Double-Blind Week 49-156||139
10326938|NCT00293267|11462614|FG001|COMPLETED|Extension - Double-Blind Week 49-156||35
10326939|NCT00293267|11462613|FG000|NOT COMPLETED|Extension - Double-Blind Week 49-156||52
10326940|NCT00293267|11462614|FG001|NOT COMPLETED|Extension - Double-Blind Week 49-156||15
10326941|NCT00293267|11462613|FG000|STARTED|Extension - Open-Label Week 157-240|8 of 139 participants who completed the double-blind phase did not enter this open-label phase|131
10326942|NCT00293267|11462614|FG001|STARTED|Extension - Open-Label Week 157-240|7 of 35 participants who completed the double-blind phase did not enter this open-label phase|28
10326943|NCT00293267|11462613|FG000|COMPLETED|Extension - Open-Label Week 157-240||111
10326944|NCT00293267|11462614|FG001|COMPLETED|Extension - Open-Label Week 157-240||26
10326945|NCT00293267|11462613|FG000|NOT COMPLETED|Extension - Open-Label Week 157-240||20
10326946|NCT00293267|11462614|FG001|NOT COMPLETED|Extension - Open-Label Week 157-240||2
10326947|NCT00293267|11462613|FG000|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|48
10326948|NCT00293267|11462614|FG001|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|66
10326949|NCT00293267|11462613|FG000|COMPLETED|Open-Label Post Virologic Failure Phase||15
10326950|NCT00293267|11462614|FG001|COMPLETED|Open-Label Post Virologic Failure Phase||29
10326951|NCT00293267|11462613|FG000|NOT COMPLETED|Open-Label Post Virologic Failure Phase||33
10326952|NCT00293267|11462614|FG001|NOT COMPLETED|Open-Label Post Virologic Failure Phase||37
10326953|NCT00293293|11462624|FG000|STARTED|Overall Study||20
10326954|NCT00293293|11462625|FG001|STARTED|Overall Study||23
10326955|NCT00293293|11462624|FG000|COMPLETED|Overall Study||18
10326956|NCT00293293|11462625|FG001|COMPLETED|Overall Study||21
10326957|NCT00293293|11462624|FG000|NOT COMPLETED|Overall Study||2
10326958|NCT00293293|11462625|FG001|NOT COMPLETED|Overall Study||2
10326959|NCT00293384|11462632|FG000|STARTED|Overall Study||40
10326960|NCT00293384|11462632|FG000|COMPLETED|Overall Study||35
10326961|NCT00293384|11462632|FG000|NOT COMPLETED|Overall Study||5
10326962|NCT00293397|11462636|FG000|STARTED|Overall Study||20
10326963|NCT00293397|11462636|FG000|Received First DEB-TACE|Overall Study|1 patient death after baseline inclusion screening and before first treatment|19
10326964|NCT00293397|11462636|FG000|COMPLETED|Overall Study|1 patient death within 30 days post-TACE - not attributed to TACE procedure|18
10326965|NCT00293397|11462636|FG000|NOT COMPLETED|Overall Study||2
10326966|NCT00293423|11462643|FG000|STARTED|Surgical Resection||28
10326967|NCT00293423|11462644|FG001|STARTED|Surgical Resection||68
10326968|NCT00293423|11462643|FG000|COMPLETED|Surgical Resection||12
10326969|NCT00293423|11462644|FG001|COMPLETED|Surgical Resection||41
10326970|NCT00293423|11462643|FG000|NOT COMPLETED|Surgical Resection||16
10326971|NCT00293423|11462644|FG001|NOT COMPLETED|Surgical Resection||27
10326972|NCT00293423|11462643|FG000|STARTED|Vaccination Treatment Period||12
10326973|NCT00293423|11462644|FG001|STARTED|Vaccination Treatment Period||41
10326974|NCT00293423|11462643|FG000|COMPLETED|Vaccination Treatment Period||12
10326975|NCT00293423|11462644|FG001|COMPLETED|Vaccination Treatment Period||38
10326976|NCT00293423|11462643|FG000|NOT COMPLETED|Vaccination Treatment Period||0
10326977|NCT00293423|11462644|FG001|NOT COMPLETED|Vaccination Treatment Period||3
10326978|NCT00293462|11462653|FG000|STARTED|Overall Study||31
10326979|NCT00293462|11462654|FG001|STARTED|Overall Study||29
10326980|NCT00293462|11462655|FG002|STARTED|Overall Study||31
10326981|NCT00293462|11462653|FG000|COMPLETED|Overall Study||24
10326982|NCT00293462|11462654|FG001|COMPLETED|Overall Study||21
10326983|NCT00293462|11462655|FG002|COMPLETED|Overall Study||19
10326984|NCT00293462|11462653|FG000|NOT COMPLETED|Overall Study||7
10326985|NCT00293462|11462654|FG001|NOT COMPLETED|Overall Study||8
10326986|NCT00293462|11462655|FG002|NOT COMPLETED|Overall Study||12
10326987|NCT00293540|11462665|FG000|STARTED|Overall Study||122
10326988|NCT00293540|11462666|FG001|STARTED|Overall Study||127
10326989|NCT00293540|11462665|FG000|COMPLETED|Overall Study||115
10326990|NCT00293540|11462666|FG001|COMPLETED|Overall Study||119
10326991|NCT00293540|11462665|FG000|NOT COMPLETED|Overall Study||7
10326992|NCT00293540|11462666|FG001|NOT COMPLETED|Overall Study||8
10326993|NCT00293579|11462672|FG000|STARTED|Overall Study||5
10326994|NCT00293579|11462672|FG000|COMPLETED|Overall Study||4
10326995|NCT00293579|11462672|FG000|NOT COMPLETED|Overall Study||1
10326996|NCT00293709|11462677|FG000|STARTED|Overall Study||149
10326997|NCT00293709|11462677|FG000|COMPLETED|Overall Study||102
10326998|NCT00293709|11462677|FG000|NOT COMPLETED|Overall Study||47
10326999|NCT00293722|11462681|FG000|STARTED|Overall Study||1291
10327000|NCT00293722|11462681|FG000|COMPLETED|Overall Study||864
10327001|NCT00293722|11462681|FG000|NOT COMPLETED|Overall Study||427
10327002|NCT00293813|11462688|FG000|STARTED|Overall Study||82
10327003|NCT00293813|11462689|FG001|STARTED|Overall Study||83
10327004|NCT00293813|11462690|FG002|STARTED|Overall Study||82
10327005|NCT00293813|11462688|FG000|COMPLETED|Overall Study||69
10327006|NCT00293813|11462689|FG001|COMPLETED|Overall Study||74
10327007|NCT00293813|11462690|FG002|COMPLETED|Overall Study||74
10327008|NCT00293813|11462688|FG000|NOT COMPLETED|Overall Study||13
10327009|NCT00293813|11462689|FG001|NOT COMPLETED|Overall Study||9
10327010|NCT00293813|11462690|FG002|NOT COMPLETED|Overall Study||8
10327011|NCT00294047|11462700|FG000|STARTED|Month 48||2881
10327012|NCT00294047|11462701|FG001|STARTED|Month 48||2871
10327013|NCT00294047|11462700|FG000|Participated up to Month 48|Month 48||2305
10804273|NCT04070287|11965765|FG002|COMPLETED|Overall Study||75
10804274|NCT04070287|11965766|FG003|COMPLETED|Overall Study||7
10804275|NCT04070287|11965767|FG004|COMPLETED|Overall Study||95
10804276|NCT04070287|11965763|FG000|NOT COMPLETED|Overall Study||11
10804277|NCT04070287|11965764|FG001|NOT COMPLETED|Overall Study||42
10804278|NCT04070287|11965765|FG002|NOT COMPLETED|Overall Study||6
10804279|NCT04070287|11965766|FG003|NOT COMPLETED|Overall Study||4
10804280|NCT04070287|11965767|FG004|NOT COMPLETED|Overall Study||1
10804281|NCT04069715|11965781|FG000|STARTED|Overall Study||47
10804282|NCT04069715|11965782|FG001|STARTED|Overall Study||48
10804283|NCT04069715|11965781|FG000|COMPLETED|Overall Study||42
10804284|NCT04069715|11965782|FG001|COMPLETED|Overall Study||43
10804285|NCT04069715|11965781|FG000|NOT COMPLETED|Overall Study||5
10804286|NCT04069715|11965782|FG001|NOT COMPLETED|Overall Study||5
10804287|NCT04050722|11965790|FG000|STARTED|Overall Study||65
10804288|NCT04050722|11965791|FG001|STARTED|Overall Study||65
10804289|NCT04050722|11965790|FG000|COMPLETED|Overall Study||64
10804290|NCT04050722|11965791|FG001|COMPLETED|Overall Study||65
10327014|NCT00294047|11462701|FG001|Participated up to Month 48|Month 48||2281
10327015|NCT00294047|11462700|FG000|COMPLETED|Month 48||2456
10327016|NCT00294047|11462701|FG001|COMPLETED|Month 48||2438
10327017|NCT00294047|11462700|FG000|NOT COMPLETED|Month 48||425
10327018|NCT00294047|11462701|FG001|NOT COMPLETED|Month 48||433
10327019|NCT00294047|11462700|FG000|STARTED|Month 84||2877
10327020|NCT00294047|11462701|FG001|STARTED|Month 84||2870
10327021|NCT00294047|11462700|FG000|COMPLETED|Month 84|The number of subjects who remained up to Month 48 in the Cervarix Group = 2146|1904
10327022|NCT00294047|11462701|FG001|COMPLETED|Month 84|The number of subjects who remained up to Month 48 in the Aluminium Hydroxide Group = 2116|1881
10327023|NCT00294047|11462700|FG000|NOT COMPLETED|Month 84||973
10327024|NCT00294047|11462701|FG001|NOT COMPLETED|Month 84||989
10804291|NCT04050722|11965790|FG000|NOT COMPLETED|Overall Study||1
10804292|NCT04050722|11965791|FG001|NOT COMPLETED|Overall Study||0
10804293|NCT04069221|11965799|FG000|STARTED|Overall Study||8
10804294|NCT04069221|11965800|FG001|STARTED|Overall Study||6
10804295|NCT04069221|11965801|FG002|STARTED|Overall Study||6
10327025|NCT00294060|11462708|FG000|STARTED|Overall Study||2013
10327026|NCT00294060|11462708|FG000|COMPLETED|Overall Study||840
10327027|NCT00294060|11462708|FG000|NOT COMPLETED|Overall Study||1173
10338645|NCT04078126|11475535|FG001|COMPLETED|Period 2||14
10338646|NCT04078126|11475534|FG000|NOT COMPLETED|Period 2||1
10338647|NCT04078126|11475535|FG001|NOT COMPLETED|Period 2||1
10338648|NCT03825341|11475543|FG000|STARTED|Overall Study||0
10338649|NCT03825341|11475544|FG001|STARTED|Overall Study||1
10338650|NCT03825341|11475543|FG000|COMPLETED|Overall Study||0
10338651|NCT03825341|11475544|FG001|COMPLETED|Overall Study||0
10338652|NCT03825341|11475543|FG000|NOT COMPLETED|Overall Study||0
10338653|NCT03825341|11475544|FG001|NOT COMPLETED|Overall Study||1
10339253|NCT00371761|11476171|FG001|COMPLETED|Overall Study||2
10339254|NCT00371761|11476170|FG000|NOT COMPLETED|Overall Study||8
10339255|NCT00371761|11476171|FG001|NOT COMPLETED|Overall Study||10
10339256|NCT00371787|11476179|FG000|STARTED|Overall Study||26
10339257|NCT00371787|11476180|FG001|STARTED|Overall Study||12
10339258|NCT00371787|11476179|FG000|COMPLETED|Overall Study||23
10339259|NCT00371787|11476180|FG001|COMPLETED|Overall Study||11
10339260|NCT00371787|11476179|FG000|NOT COMPLETED|Overall Study||3
10339261|NCT00371787|11476180|FG001|NOT COMPLETED|Overall Study||1
10339262|NCT00371826|11476189|FG000|STARTED|Core Phase (12 Months)|"Started indicates patients in Randomized, Intent to treat (ITT) and Safety set."|49
10339263|NCT00371826|11476190|FG001|STARTED|Core Phase (12 Months)||47
10339264|NCT00371826|11476191|FG002|STARTED|Core Phase (12 Months)||30
10339265|NCT00371826|11476189|FG000|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||46
10804296|NCT04069221|11965802|FG003|STARTED|Overall Study||6
10804297|NCT04069221|11965799|FG000|COMPLETED|Overall Study||8
10804298|NCT04069221|11965800|FG001|COMPLETED|Overall Study||6
10804299|NCT04069221|11965801|FG002|COMPLETED|Overall Study||6
10804300|NCT04069221|11965802|FG003|COMPLETED|Overall Study||6
10804301|NCT04069221|11965799|FG000|NOT COMPLETED|Overall Study||0
10804302|NCT04069221|11965800|FG001|NOT COMPLETED|Overall Study||0
10804303|NCT04069221|11965801|FG002|NOT COMPLETED|Overall Study||0
10804304|NCT04069221|11965802|FG003|NOT COMPLETED|Overall Study||0
10804305|NCT04067141|11965812|FG000|STARTED|First Intervention||35
10804306|NCT04067141|11965813|FG001|STARTED|First Intervention||35
10804307|NCT04067141|11965812|FG000|COMPLETED|First Intervention||35
10804308|NCT04067141|11965813|FG001|COMPLETED|First Intervention||34
10804309|NCT04067141|11965812|FG000|NOT COMPLETED|First Intervention||0
10804310|NCT04067141|11965813|FG001|NOT COMPLETED|First Intervention||1
10804357|NCT04066426|11965851|FG002|NOT COMPLETED|Overall Study||8
10804311|NCT04067141|11965812|FG000|STARTED|Second Intervention|Unacceptable lens fit at dispense. One withdrawal by subject.|34
10804312|NCT04067141|11965813|FG001|STARTED|Second Intervention|Unacceptable lens fit at dispense. One withdrawal by subject|33
10804313|NCT04067141|11965812|FG000|COMPLETED|Second Intervention||34
10804314|NCT04067141|11965813|FG001|COMPLETED|Second Intervention||31
10804315|NCT04067141|11965812|FG000|NOT COMPLETED|Second Intervention||0
10804316|NCT04067141|11965813|FG001|NOT COMPLETED|Second Intervention||2
10804317|NCT04049578|11965819|FG000|STARTED|Overall Study||2
10804318|NCT04049578|11965819|FG000|COMPLETED|Overall Study||1
10804319|NCT04049578|11965819|FG000|NOT COMPLETED|Overall Study||1
10804320|NCT04067401|11965825|FG000|STARTED|Overall Study||748
10804321|NCT04067401|11965826|FG001|STARTED|Overall Study||737
10804322|NCT04067401|11965825|FG000|Baseline Survey Completion|Overall Study||746
10804323|NCT04067401|11965826|FG001|Baseline Survey Completion|Overall Study||735
10804324|NCT04067401|11965825|FG000|1 Month Survey Completion|Overall Study||697
10804325|NCT04067401|11965826|FG001|1 Month Survey Completion|Overall Study||694
10804326|NCT04067401|11965825|FG000|6 Month Survey Completion|Overall Study||629
10804327|NCT04067401|11965826|FG001|6 Month Survey Completion|Overall Study||618
10804328|NCT04067401|11965825|FG000|COMPLETED|Overall Study||740
10804329|NCT04067401|11965826|FG001|COMPLETED|Overall Study||737
10804330|NCT04067401|11965825|FG000|NOT COMPLETED|Overall Study||8
10804331|NCT04067401|11965826|FG001|NOT COMPLETED|Overall Study||0
10804332|NCT04067050|11965834|FG000|STARTED|One Month||32
10804333|NCT04067050|11965835|FG001|STARTED|One Month||29
10804334|NCT04067050|11965834|FG000|COMPLETED|One Month||28
10804335|NCT04067050|11965835|FG001|COMPLETED|One Month||29
10804336|NCT04067050|11965834|FG000|NOT COMPLETED|One Month||4
10804337|NCT04067050|11965835|FG001|NOT COMPLETED|One Month||0
10804338|NCT04067050|11965834|FG000|STARTED|Two Month|6 subjects discontinued after 1 month visit. 22 Subjects continued the study.|22
10804339|NCT04067050|11965835|FG001|STARTED|Two Month||29
10804340|NCT04067050|11965834|FG000|COMPLETED|Two Month||20
10804341|NCT04067050|11965835|FG001|COMPLETED|Two Month||29
10804342|NCT04067050|11965834|FG000|NOT COMPLETED|Two Month||2
10804343|NCT04067050|11965835|FG001|NOT COMPLETED|Two Month||0
10804344|NCT04066647|11965841|FG000|STARTED|Overall Study||7
10804345|NCT04066647|11965841|FG000|COMPLETED|Overall Study||7
10804346|NCT04066647|11965841|FG000|NOT COMPLETED|Overall Study||0
10804347|NCT04066426|11965849|FG000|STARTED|Overall Study||50
10804348|NCT04066426|11965850|FG001|STARTED|Overall Study||50
10804349|NCT04066426|11965851|FG002|STARTED|Overall Study||50
10339266|NCT00371826|11476190|FG001|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||44
10804350|NCT04066426|11965852|FG003|STARTED|Overall Study||50
10804351|NCT04066426|11965849|FG000|COMPLETED|Overall Study||40
10339267|NCT00371826|11476191|FG002|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||20
10339268|NCT00371826|11476189|FG000|Modified Intent to Treat (mITT)|Core Phase (12 Months)||27
10339269|NCT00371826|11476190|FG001|Modified Intent to Treat (mITT)|Core Phase (12 Months)||39
10804352|NCT04066426|11965850|FG001|COMPLETED|Overall Study||40
10804353|NCT04066426|11965851|FG002|COMPLETED|Overall Study||42
10327028|NCT00294398|11462714|FG000|STARTED|Overall Study||78
10327029|NCT00294398|11462715|FG001|STARTED|Overall Study||74
10327030|NCT00294398|11462714|FG000|COMPLETED|Overall Study||57
10327031|NCT00294398|11462715|FG001|COMPLETED|Overall Study||48
10327032|NCT00294398|11462714|FG000|NOT COMPLETED|Overall Study||21
10327033|NCT00294398|11462715|FG001|NOT COMPLETED|Overall Study||26
10327034|NCT00294515|11462723|FG000|STARTED|Overall Study|Randomized|166
10327035|NCT00294515|11462724|FG001|STARTED|Overall Study|Randomized|160
10327036|NCT00294515|11462723|FG000|COMPLETED|Overall Study||132
10327037|NCT00294515|11462724|FG001|COMPLETED|Overall Study||132
10327038|NCT00294515|11462723|FG000|NOT COMPLETED|Overall Study||34
10327039|NCT00294515|11462724|FG001|NOT COMPLETED|Overall Study||28
10327040|NCT00294554|11462732|FG000|STARTED|Overall Study||10
10327041|NCT00294554|11462733|FG001|STARTED|Overall Study||10
10327042|NCT00294554|11462732|FG000|COMPLETED|Overall Study||10
10327043|NCT00294554|11462733|FG001|COMPLETED|Overall Study|"1 S withdrew @ 20 wks for lack perceived benefit~1 S withdrawn @ 13 wks b/o extreme agitation"|8
10327044|NCT00294554|11462732|FG000|NOT COMPLETED|Overall Study||0
10327045|NCT00294554|11462733|FG001|NOT COMPLETED|Overall Study||2
10327046|NCT00294632|11462741|FG000|STARTED|Phase I Dose Escalation Period||14
10327047|NCT00294632|11462742|FG001|STARTED|Phase I Dose Escalation Period||0
10327048|NCT00294632|11462741|FG000|Cohort 1: 10 mg|Phase I Dose Escalation Period||3
10327049|NCT00294632|11462742|FG001|Cohort 1: 10 mg|Phase I Dose Escalation Period||0
10327050|NCT00294632|11462741|FG000|Cohort 2: 15 mg|Phase I Dose Escalation Period||3
10327051|NCT00294632|11462742|FG001|Cohort 2: 15 mg|Phase I Dose Escalation Period||0
10327052|NCT00294632|11462741|FG000|Cohort 3: 20 mg|Phase I Dose Escalation Period||6
10327053|NCT00294632|11462742|FG001|Cohort 3: 20 mg|Phase I Dose Escalation Period||0
10327054|NCT00294632|11462741|FG000|Cohort 4: 25 mg|Phase I Dose Escalation Period||2
10327055|NCT00294632|11462742|FG001|Cohort 4: 25 mg|Phase I Dose Escalation Period||0
10327056|NCT00294632|11462741|FG000|COMPLETED|Phase I Dose Escalation Period||14
10327057|NCT00294632|11462742|FG001|COMPLETED|Phase I Dose Escalation Period||0
10327058|NCT00294632|11462741|FG000|NOT COMPLETED|Phase I Dose Escalation Period||0
10327059|NCT00294632|11462742|FG001|NOT COMPLETED|Phase I Dose Escalation Period||0
10327060|NCT00294632|11462741|FG000|STARTED|Phase II: 20 mg Lenalidomide||6
10327061|NCT00294632|11462742|FG001|STARTED|Phase II: 20 mg Lenalidomide||38
10327062|NCT00294632|11462741|FG000|COMPLETED|Phase II: 20 mg Lenalidomide||6
10804354|NCT04066426|11965852|FG003|COMPLETED|Overall Study||47
10804355|NCT04066426|11965849|FG000|NOT COMPLETED|Overall Study||10
10804356|NCT04066426|11965850|FG001|NOT COMPLETED|Overall Study||10
10804358|NCT04066426|11965852|FG003|NOT COMPLETED|Overall Study||3
10804359|NCT04061694|11965864|FG000|STARTED|Overall Study||21
10456277|NCT01005966|11604237|FG002|COMPLETED|Treatment Period 5 (14 Days)||11
10456278|NCT01005966|11604238|FG003|COMPLETED|Treatment Period 5 (14 Days)||11
10456279|NCT01005966|11604239|FG004|COMPLETED|Treatment Period 5 (14 Days)||10
10804360|NCT04061694|11965865|FG001|STARTED|Overall Study||25
10804361|NCT04061694|11965864|FG000|COMPLETED|Overall Study||19
10804362|NCT04061694|11965865|FG001|COMPLETED|Overall Study||25
10804363|NCT04061694|11965864|FG000|NOT COMPLETED|Overall Study||2
10804364|NCT04061694|11965865|FG001|NOT COMPLETED|Overall Study||0
10804365|NCT04060654|11965871|FG000|STARTED|Overall Study||17
10804366|NCT04060654|11965871|FG000|COMPLETED|Overall Study||11
10804367|NCT04060654|11965871|FG000|NOT COMPLETED|Overall Study||6
10804368|NCT04059250|11965875|FG000|STARTED|Overall Study||25
10804369|NCT04059250|11965876|FG001|STARTED|Overall Study||25
10804370|NCT04059250|11965875|FG000|COMPLETED|Overall Study||25
10804371|NCT04059250|11965876|FG001|COMPLETED|Overall Study||25
10804372|NCT04059250|11965875|FG000|NOT COMPLETED|Overall Study||0
10804373|NCT04059250|11965876|FG001|NOT COMPLETED|Overall Study||0
10804374|NCT04058353|11965884|FG000|STARTED|Overall Study||126
10804375|NCT04058353|11965885|FG001|STARTED|Overall Study||132
10804376|NCT04058353|11965884|FG000|COMPLETED|Overall Study||122
10804377|NCT04058353|11965885|FG001|COMPLETED|Overall Study||131
10804378|NCT04058353|11965884|FG000|NOT COMPLETED|Overall Study||4
10804379|NCT04058353|11965885|FG001|NOT COMPLETED|Overall Study||1
10804380|NCT04057248|11965892|FG000|STARTED|Overall Study||14
10804381|NCT04057248|11965892|FG000|COMPLETED|Overall Study||12
10804382|NCT04057248|11965892|FG000|NOT COMPLETED|Overall Study||2
10804383|NCT04055519|11965896|FG000|STARTED|First Wear Period (30 Days)||16
10804384|NCT04055519|11965897|FG001|STARTED|First Wear Period (30 Days)||20
10804385|NCT04055519|11965896|FG000|COMPLETED|First Wear Period (30 Days)||16
10804386|NCT04055519|11965897|FG001|COMPLETED|First Wear Period (30 Days)||20
10804387|NCT04055519|11965896|FG000|NOT COMPLETED|First Wear Period (30 Days)||0
10804388|NCT04055519|11965897|FG001|NOT COMPLETED|First Wear Period (30 Days)||0
10804389|NCT04055519|11965896|FG000|STARTED|Second Wear Period (30 Days)||16
10804390|NCT04055519|11965897|FG001|STARTED|Second Wear Period (30 Days)||20
10804391|NCT04055519|11965896|FG000|COMPLETED|Second Wear Period (30 Days)||16
10804392|NCT04055519|11965897|FG001|COMPLETED|Second Wear Period (30 Days)||20
10804393|NCT04055519|11965896|FG000|NOT COMPLETED|Second Wear Period (30 Days)||0
10804394|NCT04055519|11965897|FG001|NOT COMPLETED|Second Wear Period (30 Days)||0
10804395|NCT04055675|11965908|FG000|STARTED|Overall Study||96
10804396|NCT04055675|11965909|FG001|STARTED|Overall Study||104
10804397|NCT04055675|11965908|FG000|COMPLETED|Overall Study||96
10804398|NCT04055675|11965909|FG001|COMPLETED|Overall Study||104
10804399|NCT04055675|11965908|FG000|NOT COMPLETED|Overall Study||0
10804400|NCT04055675|11965909|FG001|NOT COMPLETED|Overall Study||0
10804401|NCT04054765|11965917|FG000|STARTED|Baseline||155
10327063|NCT00294632|11462742|FG001|COMPLETED|Phase II: 20 mg Lenalidomide||38
10327064|NCT00294632|11462741|FG000|NOT COMPLETED|Phase II: 20 mg Lenalidomide||0
10327065|NCT00294632|11462742|FG001|NOT COMPLETED|Phase II: 20 mg Lenalidomide||0
10327066|NCT00294645|11462751|FG000|STARTED|Overall Study||295
10327067|NCT00294645|11462752|FG001|STARTED|Overall Study||602
10327068|NCT00294645|11462751|FG000|COMPLETED|Overall Study||247
10327069|NCT00294645|11462752|FG001|COMPLETED|Overall Study||510
10327070|NCT00294645|11462751|FG000|NOT COMPLETED|Overall Study||48
10327071|NCT00294645|11462752|FG001|NOT COMPLETED|Overall Study||92
10327072|NCT00294658|11462760|FG000|STARTED|Overall Study||66
10327073|NCT00294658|11462761|FG001|STARTED|Overall Study||60
10327074|NCT00294658|11462760|FG000|COMPLETED|Overall Study||60
10327075|NCT00294658|11462761|FG001|COMPLETED|Overall Study||51
10327076|NCT00294658|11462760|FG000|NOT COMPLETED|Overall Study||6
10327077|NCT00294658|11462761|FG001|NOT COMPLETED|Overall Study||9
10327078|NCT00294671|11462769|FG000|STARTED|Overall Study||64
10327079|NCT00294671|11462770|FG001|STARTED|Overall Study||66
10327080|NCT00294671|11462769|FG000|COMPLETED|Overall Study||37
10327081|NCT00294671|11462770|FG001|COMPLETED|Overall Study||26
10327082|NCT00294671|11462769|FG000|NOT COMPLETED|Overall Study||27
10327083|NCT00294671|11462770|FG001|NOT COMPLETED|Overall Study||40
10327084|NCT00294684|11462778|FG000|STARTED|Overall Study||70
10327085|NCT00294684|11462779|FG001|STARTED|Overall Study||70
10327086|NCT00294684|11462778|FG000|COMPLETED|Overall Study||65
10327087|NCT00294684|11462779|FG001|COMPLETED|Overall Study||62
10327088|NCT00294684|11462778|FG000|NOT COMPLETED|Overall Study||5
10327089|NCT00294684|11462779|FG001|NOT COMPLETED|Overall Study||8
10327090|NCT00294723|11462788|FG000|STARTED|Double-Blind Period 52 Weeks|Randomised|247
10327091|NCT00294723|11462789|FG001|STARTED|Double-Blind Period 52 Weeks|Randomised|251
10327092|NCT00294723|11462790|FG002|STARTED|Double-Blind Period 52 Weeks|Randomised|248
10327093|NCT00294723|11462788|FG000|Exposed to Study Drug|Double-Blind Period 52 Weeks|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|246
10327094|NCT00294723|11462789|FG001|Exposed to Study Drug|Double-Blind Period 52 Weeks||251
10327095|NCT00294723|11462790|FG002|Exposed to Study Drug|Double-Blind Period 52 Weeks||248
10327096|NCT00294723|11462788|FG000|COMPLETED|Double-Blind Period 52 Weeks||173
10327097|NCT00294723|11462789|FG001|COMPLETED|Double-Blind Period 52 Weeks||162
10327098|NCT00294723|11462790|FG002|COMPLETED|Double-Blind Period 52 Weeks||152
10327099|NCT00294723|11462788|FG000|NOT COMPLETED|Double-Blind Period 52 Weeks||74
10327100|NCT00294723|11462789|FG001|NOT COMPLETED|Double-Blind Period 52 Weeks||89
10327101|NCT00294723|11462790|FG002|NOT COMPLETED|Double-Blind Period 52 Weeks||96
10804402|NCT04054765|11965918|FG001|STARTED|Baseline||132
10804403|NCT04054765|11965917|FG000|COMPLETED|Baseline||150
10804404|NCT04054765|11965918|FG001|COMPLETED|Baseline||129
10804405|NCT04054765|11965917|FG000|NOT COMPLETED|Baseline||5
10804406|NCT04054765|11965918|FG001|NOT COMPLETED|Baseline||3
10804407|NCT04054765|11965917|FG000|STARTED|Post-Gameplay / 1-week Follow up||150
10804408|NCT04054765|11965918|FG001|STARTED|Post-Gameplay / 1-week Follow up||129
10804409|NCT04054765|11965917|FG000|COMPLETED|Post-Gameplay / 1-week Follow up||142
10804410|NCT04054765|11965918|FG001|COMPLETED|Post-Gameplay / 1-week Follow up||126
10804411|NCT04054765|11965917|FG000|NOT COMPLETED|Post-Gameplay / 1-week Follow up||8
10804412|NCT04054765|11965918|FG001|NOT COMPLETED|Post-Gameplay / 1-week Follow up||3
10804413|NCT04054765|11965917|FG000|STARTED|3-month Follow up||142
10804414|NCT04054765|11965918|FG001|STARTED|3-month Follow up||126
10804415|NCT04054765|11965917|FG000|COMPLETED|3-month Follow up||142
10804416|NCT04054765|11965918|FG001|COMPLETED|3-month Follow up||123
10804417|NCT04054765|11965917|FG000|NOT COMPLETED|3-month Follow up||0
10804418|NCT04054765|11965918|FG001|NOT COMPLETED|3-month Follow up||3
10804419|NCT04054765|11965917|FG000|STARTED|6-month Follow up||142
10804420|NCT04054765|11965918|FG001|STARTED|6-month Follow up||123
10804421|NCT04054765|11965917|FG000|COMPLETED|6-month Follow up||110
10804422|NCT04054765|11965918|FG001|COMPLETED|6-month Follow up||91
10804423|NCT04054765|11965917|FG000|NOT COMPLETED|6-month Follow up||32
10804424|NCT04054765|11965918|FG001|NOT COMPLETED|6-month Follow up||32
10804425|NCT04054011|11965924|FG000|STARTED|Overall Study||15
10804426|NCT04054011|11965924|FG000|COMPLETED|Overall Study||12
10804427|NCT04054011|11965924|FG000|NOT COMPLETED|Overall Study||3
10804428|NCT04059094|11965935|FG000|STARTED|Overall Study||18
10804429|NCT04059094|11965936|FG001|STARTED|Overall Study||6
10804430|NCT04059094|11965937|FG002|STARTED|Overall Study||5
10804431|NCT04059094|11965938|FG003|STARTED|Overall Study||5
10804432|NCT04059094|11965939|FG004|STARTED|Overall Study||18
10804433|NCT04059094|11965935|FG000|COMPLETED|Overall Study||18
10804434|NCT04059094|11965936|FG001|COMPLETED|Overall Study||4
10804435|NCT04059094|11965937|FG002|COMPLETED|Overall Study||5
10327102|NCT00294723|11462788|FG000|STARTED|Open-Label Extension 52 Weeks|19 subjects did not continue into the extension period|154
10327103|NCT00294723|11462789|FG001|STARTED|Open-Label Extension 52 Weeks|13 subjects did not continue into the extension period|149
10327104|NCT00294723|11462790|FG002|STARTED|Open-Label Extension 52 Weeks|15 subjects did not continue into the extension period|137
10804436|NCT04059094|11965938|FG003|COMPLETED|Overall Study||5
10804437|NCT04059094|11965939|FG004|COMPLETED|Overall Study||17
10804438|NCT04059094|11965935|FG000|NOT COMPLETED|Overall Study||0
10804439|NCT04059094|11965936|FG001|NOT COMPLETED|Overall Study||2
10804440|NCT04059094|11965937|FG002|NOT COMPLETED|Overall Study||0
10804441|NCT04059094|11965938|FG003|NOT COMPLETED|Overall Study||0
10804442|NCT04059094|11965939|FG004|NOT COMPLETED|Overall Study||1
10804443|NCT04051684|11965957|FG000|STARTED|Overall Study||12
10804444|NCT04051684|11965958|FG001|STARTED|Overall Study||11
10327105|NCT00294723|11462788|FG000|COMPLETED|Open-Label Extension 52 Weeks||114
10327106|NCT00294723|11462789|FG001|COMPLETED|Open-Label Extension 52 Weeks||110
10327107|NCT00294723|11462790|FG002|COMPLETED|Open-Label Extension 52 Weeks||97
10327108|NCT00294723|11462788|FG000|NOT COMPLETED|Open-Label Extension 52 Weeks||40
10327109|NCT00294723|11462789|FG001|NOT COMPLETED|Open-Label Extension 52 Weeks||39
10327110|NCT00294723|11462790|FG002|NOT COMPLETED|Open-Label Extension 52 Weeks||40
10327111|NCT00294723|11462788|FG000|STARTED|Additional Open-Label Extension 91 Weeks|52 subjects did not continue into the extension period|62
10327112|NCT00294723|11462789|FG001|STARTED|Additional Open-Label Extension 91 Weeks|57 subjects did not continue into the extension period|53
10327113|NCT00294723|11462790|FG002|STARTED|Additional Open-Label Extension 91 Weeks|69 subjects did not continue into the extension period|28
10327114|NCT00294723|11462788|FG000|COMPLETED|Additional Open-Label Extension 91 Weeks||34
10327115|NCT00294723|11462789|FG001|COMPLETED|Additional Open-Label Extension 91 Weeks||32
10327116|NCT00294723|11462790|FG002|COMPLETED|Additional Open-Label Extension 91 Weeks||8
10327117|NCT00294723|11462788|FG000|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||28
10327118|NCT00294723|11462789|FG001|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||21
10327119|NCT00294723|11462790|FG002|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||20
10327120|NCT00294762|11462803|FG000|STARTED|Overall Study||72
10327121|NCT00294762|11462804|FG001|STARTED|Overall Study||71
10327122|NCT00294762|11462803|FG000|COMPLETED|Overall Study||69
10327123|NCT00294762|11462804|FG001|COMPLETED|Overall Study||68
10327124|NCT00294762|11462803|FG000|NOT COMPLETED|Overall Study||3
10327125|NCT00294762|11462804|FG001|NOT COMPLETED|Overall Study||3
10327126|NCT00295009|11462816|FG000|STARTED|Overall Study||93
10327127|NCT00295009|11462817|FG001|STARTED|Overall Study||183
10327128|NCT00295009|11462818|FG002|STARTED|Overall Study||51
10327129|NCT00295009|11462819|FG003|STARTED|Overall Study||82
10327130|NCT00295009|11462820|FG004|STARTED|Overall Study||174
10327131|NCT00295009|11462821|FG005|STARTED|Overall Study||269
10327132|NCT00295009|11462816|FG000|Treated|Overall Study||80
10327133|NCT00295009|11462817|FG001|Treated|Overall Study||162
10327134|NCT00295009|11462818|FG002|Treated|Overall Study||50
10327135|NCT00295009|11462819|FG003|Treated|Overall Study||72
10327136|NCT00295009|11462820|FG004|Treated|Overall Study||165
10327137|NCT00295009|11462821|FG005|Treated|Overall Study||259
10327138|NCT00295009|11462816|FG000|Completed 24 Month Analysis|Overall Study||71
10327139|NCT00295009|11462817|FG001|Completed 24 Month Analysis|Overall Study||148
10327140|NCT00295009|11462818|FG002|Completed 24 Month Analysis|Overall Study||45
10327141|NCT00295009|11462819|FG003|Completed 24 Month Analysis|Overall Study||60
10327142|NCT00295009|11462820|FG004|Completed 24 Month Analysis|Overall Study||133
10327143|NCT00295009|11462821|FG005|Completed 24 Month Analysis|Overall Study||198
10327144|NCT00295009|11462816|FG000|COMPLETED|Overall Study|Completed 60 month visit|52
10327145|NCT00295009|11462817|FG001|COMPLETED|Overall Study|Completed 60 month visit|134
10327146|NCT00295009|11462818|FG002|COMPLETED|Overall Study|Completed 60 month visit|39
10327147|NCT00295009|11462819|FG003|COMPLETED|Overall Study|Completed 60 month visit|57
10327148|NCT00295009|11462820|FG004|COMPLETED|Overall Study|Completed 60 month visit|116
10327149|NCT00295009|11462821|FG005|COMPLETED|Overall Study|Continued Access patients were only followed out to 24 months|0
10327150|NCT00295009|11462816|FG000|NOT COMPLETED|Overall Study||41
10327151|NCT00295009|11462817|FG001|NOT COMPLETED|Overall Study||49
10327152|NCT00295009|11462818|FG002|NOT COMPLETED|Overall Study||12
10327153|NCT00295009|11462819|FG003|NOT COMPLETED|Overall Study||25
10327154|NCT00295009|11462820|FG004|NOT COMPLETED|Overall Study||58
10327155|NCT00295009|11462821|FG005|NOT COMPLETED|Overall Study||269
10327156|NCT00295022|11462838|FG000|STARTED|Overall Study||105
10327157|NCT00295022|11462839|FG001|STARTED|Overall Study||157
10327158|NCT00295022|11462840|FG002|STARTED|Overall Study||156
10327159|NCT00295022|11462838|FG000|COMPLETED|Overall Study||104
10327160|NCT00295022|11462839|FG001|COMPLETED|Overall Study||156
10327161|NCT00295022|11462840|FG002|COMPLETED|Overall Study||151
10327162|NCT00295022|11462838|FG000|NOT COMPLETED|Overall Study||1
10327163|NCT00295022|11462839|FG001|NOT COMPLETED|Overall Study||1
10327164|NCT00295022|11462840|FG002|NOT COMPLETED|Overall Study||5
10327165|NCT00295061|11462852|FG000|STARTED|Overall Study||12
10327166|NCT00295061|11462853|FG001|STARTED|Overall Study||12
10327167|NCT00295061|11462852|FG000|COMPLETED|Overall Study||12
10327168|NCT00295061|11462853|FG001|COMPLETED|Overall Study||12
10327169|NCT00295061|11462852|FG000|NOT COMPLETED|Overall Study||0
10327170|NCT00295061|11462853|FG001|NOT COMPLETED|Overall Study||0
10327171|NCT00295503|11462859|FG000|STARTED|Overall Study||53
10327172|NCT00295503|11462859|FG000|COMPLETED|Overall Study||53
10327173|NCT00295503|11462859|FG000|NOT COMPLETED|Overall Study||0
10327174|NCT00295620|11462866|FG000|STARTED|Overall Study||1732
10327175|NCT00295620|11462867|FG001|STARTED|Overall Study||1738
10327176|NCT00295620|11462866|FG000|Safety Analysis Set|Overall Study||1705
10327177|NCT00295620|11462867|FG001|Safety Analysis Set|Overall Study||1710
10327178|NCT00295620|11462866|FG000|COMPLETED|Overall Study||860
10327179|NCT00295620|11462867|FG001|COMPLETED|Overall Study||842
10327180|NCT00295620|11462866|FG000|NOT COMPLETED|Overall Study||872
10327181|NCT00295620|11462867|FG001|NOT COMPLETED|Overall Study||896
10327182|NCT00295633|11462876|FG000|STARTED|Overall Study||195
10327183|NCT00295633|11462877|FG001|STARTED|Overall Study||186
10327184|NCT00295633|11462878|FG002|STARTED|Overall Study||184
10327185|NCT00295633|11462876|FG000|Completed Study Without Being Rescued|Overall Study||88
10327186|NCT00295633|11462877|FG001|Completed Study Without Being Rescued|Overall Study||82
10327187|NCT00295633|11462878|FG002|Completed Study Without Being Rescued|Overall Study||51
10327188|NCT00295633|11462876|FG000|COMPLETED|Overall Study||133
10327189|NCT00295633|11462877|FG001|COMPLETED|Overall Study||119
10327190|NCT00295633|11462878|FG002|COMPLETED|Overall Study||108
10327191|NCT00295633|11462876|FG000|NOT COMPLETED|Overall Study||62
10327192|NCT00295633|11462877|FG001|NOT COMPLETED|Overall Study||67
10327193|NCT00295633|11462878|FG002|NOT COMPLETED|Overall Study||76
10327194|NCT00295750|11462889|FG000|STARTED|Overall Study|randomized|206
10327195|NCT00295750|11462890|FG001|STARTED|Overall Study|randomized|210
10327196|NCT00295750|11462891|FG002|STARTED|Overall Study|randomized|204
10327197|NCT00295750|11462889|FG000|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|202
10327198|NCT00295750|11462890|FG001|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|207
10327199|NCT00295750|11462891|FG002|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|201
10327200|NCT00295750|11462889|FG000|COMPLETED|Overall Study||163
10327201|NCT00295750|11462890|FG001|COMPLETED|Overall Study||169
10327202|NCT00295750|11462891|FG002|COMPLETED|Overall Study||172
10327203|NCT00295750|11462889|FG000|NOT COMPLETED|Overall Study||43
10327204|NCT00295750|11462890|FG001|NOT COMPLETED|Overall Study||41
10327205|NCT00295750|11462891|FG002|NOT COMPLETED|Overall Study||32
10327206|NCT00295854|11462902|FG000|STARTED|Overall Study||95
10327207|NCT00295854|11462903|FG001|STARTED|Overall Study||108
10327208|NCT00295854|11462904|FG002|STARTED|Overall Study||102
10327209|NCT00295854|11462902|FG000|Safety Population (N=304)|Overall Study||95
10327210|NCT00295854|11462903|FG001|Safety Population (N=304)|Overall Study||108
10327211|NCT00295854|11462904|FG002|Safety Population (N=304)|Overall Study||101
10327212|NCT00295854|11462902|FG000|ITT Population (N=296)|Overall Study||92
10327213|NCT00295854|11462903|FG001|ITT Population (N=296)|Overall Study||105
10327214|NCT00295854|11462904|FG002|ITT Population (N=296)|Overall Study||99
10327215|NCT00295854|11462902|FG000|COMPLETED|Overall Study||77
10327216|NCT00295854|11462903|FG001|COMPLETED|Overall Study||87
10327217|NCT00295854|11462904|FG002|COMPLETED|Overall Study||87
10327218|NCT00295854|11462902|FG000|NOT COMPLETED|Overall Study||18
10327219|NCT00295854|11462903|FG001|NOT COMPLETED|Overall Study||21
10327220|NCT00295854|11462904|FG002|NOT COMPLETED|Overall Study||15
10327221|NCT00295867|11462912|FG000|STARTED|Overall Study||45
10327222|NCT00295867|11462912|FG000|COMPLETED|Overall Study||34
10327223|NCT00295867|11462912|FG000|NOT COMPLETED|Overall Study||11
10327224|NCT00295880|11462916|FG000|STARTED|Overall Study||12
10327225|NCT00295880|11462916|FG000|COMPLETED|Overall Study||10
10327226|NCT00295880|11462916|FG000|NOT COMPLETED|Overall Study||2
10327227|NCT00295932|11462931|FG000|STARTED|Overall Study||4
10327228|NCT00295932|11462932|FG001|STARTED|Overall Study||6
10327229|NCT00295932|11462933|FG002|STARTED|Overall Study||3
10327230|NCT00295932|11462934|FG003|STARTED|Overall Study||4
10327231|NCT00295932|11462935|FG004|STARTED|Overall Study||2
10327232|NCT00295932|11462936|FG005|STARTED|Overall Study||18
10327233|NCT00295932|11462937|FG006|STARTED|Overall Study||3
10327234|NCT00295932|11462938|FG007|STARTED|Overall Study||4
10327235|NCT00295932|11462939|FG008|STARTED|Overall Study||10
10327236|NCT00295932|11462940|FG009|STARTED|Overall Study||12
10327237|NCT00295932|11462941|FG010|STARTED|Overall Study||13
10327238|NCT00295932|11462931|FG000|COMPLETED|Overall Study||4
10327239|NCT00295932|11462932|FG001|COMPLETED|Overall Study||6
10327240|NCT00295932|11462933|FG002|COMPLETED|Overall Study||3
10327241|NCT00295932|11462934|FG003|COMPLETED|Overall Study||4
10327242|NCT00295932|11462935|FG004|COMPLETED|Overall Study||2
10327243|NCT00295932|11462936|FG005|COMPLETED|Overall Study||18
10327244|NCT00295932|11462937|FG006|COMPLETED|Overall Study||3
10327245|NCT00295932|11462938|FG007|COMPLETED|Overall Study||4
10327246|NCT00295932|11462939|FG008|COMPLETED|Overall Study||10
10327247|NCT00295932|11462940|FG009|COMPLETED|Overall Study||12
10327248|NCT00295932|11462941|FG010|COMPLETED|Overall Study||12
10327249|NCT00295932|11462931|FG000|NOT COMPLETED|Overall Study||0
10327250|NCT00295932|11462932|FG001|NOT COMPLETED|Overall Study||0
10327251|NCT00295932|11462933|FG002|NOT COMPLETED|Overall Study||0
10327252|NCT00295932|11462934|FG003|NOT COMPLETED|Overall Study||0
10327253|NCT00295932|11462935|FG004|NOT COMPLETED|Overall Study||0
10804445|NCT04051684|11965957|FG000|COMPLETED|Overall Study||12
10804446|NCT04051684|11965958|FG001|COMPLETED|Overall Study||11
10804447|NCT04051684|11965957|FG000|NOT COMPLETED|Overall Study||0
10804448|NCT04051684|11965958|FG001|NOT COMPLETED|Overall Study||0
10804449|NCT04046341|11965964|FG000|STARTED|Overall Study||15
10804450|NCT04046341|11965964|FG000|COMPLETED|Overall Study||12
10804451|NCT04046341|11965964|FG000|NOT COMPLETED|Overall Study||3
10327254|NCT00295932|11462936|FG005|NOT COMPLETED|Overall Study||0
10327255|NCT00295932|11462937|FG006|NOT COMPLETED|Overall Study||0
10327256|NCT00295932|11462938|FG007|NOT COMPLETED|Overall Study||0
10327257|NCT00295932|11462939|FG008|NOT COMPLETED|Overall Study||0
10327258|NCT00295932|11462940|FG009|NOT COMPLETED|Overall Study||0
10327259|NCT00295932|11462941|FG010|NOT COMPLETED|Overall Study||1
10327260|NCT00296036|11462969|FG000|STARTED|Overall Study||19
10327261|NCT00296036|11462970|FG001|STARTED|Overall Study||18
10327262|NCT00296036|11462971|FG002|STARTED|Overall Study||18
10327263|NCT00296036|11462972|FG003|STARTED|Overall Study||17
10327264|NCT00296036|11462973|FG004|STARTED|Overall Study||33
10327265|NCT00296036|11462974|FG005|STARTED|Overall Study||32
10327266|NCT00296036|11462969|FG000|COMPLETED|Overall Study||18
10327267|NCT00296036|11462970|FG001|COMPLETED|Overall Study||18
10327268|NCT00296036|11462971|FG002|COMPLETED|Overall Study||16
10327269|NCT00296036|11462972|FG003|COMPLETED|Overall Study||16
10804452|NCT04045964|11965970|FG000|STARTED|Overall Study||16
10804453|NCT04045964|11965971|FG001|STARTED|Overall Study||16
10327270|NCT00296036|11462973|FG004|COMPLETED|Overall Study||31
10327271|NCT00296036|11462974|FG005|COMPLETED|Overall Study||28
10327272|NCT00296036|11462969|FG000|NOT COMPLETED|Overall Study||1
10327273|NCT00296036|11462970|FG001|NOT COMPLETED|Overall Study||0
10327274|NCT00296036|11462971|FG002|NOT COMPLETED|Overall Study||2
10327275|NCT00296036|11462972|FG003|NOT COMPLETED|Overall Study||1
10327276|NCT00296036|11462973|FG004|NOT COMPLETED|Overall Study||2
10327277|NCT00296036|11462974|FG005|NOT COMPLETED|Overall Study||4
10327278|NCT00296140|11462993|FG000|STARTED|Overall Study||33
10327279|NCT00296140|11462994|FG001|STARTED|Overall Study||33
10327280|NCT00296140|11462993|FG000|COMPLETED|Overall Study||30
10327281|NCT00296140|11462994|FG001|COMPLETED|Overall Study||33
10327282|NCT00296140|11462993|FG000|NOT COMPLETED|Overall Study||3
10327283|NCT00296140|11462994|FG001|NOT COMPLETED|Overall Study||0
10327284|NCT00296192|11463005|FG000|STARTED|Overall Study||17
10327285|NCT00296192|11463006|FG001|STARTED|Overall Study||16
10327286|NCT00296192|11463007|FG002|STARTED|Overall Study||16
10327287|NCT00296192|11463008|FG003|STARTED|Overall Study||17
10327288|NCT00296192|11463009|FG004|STARTED|Overall Study||16
10327289|NCT00296192|11463005|FG000|COMPLETED|Overall Study||17
10327290|NCT00296192|11463006|FG001|COMPLETED|Overall Study||16
10327291|NCT00296192|11463007|FG002|COMPLETED|Overall Study||16
10327292|NCT00296192|11463008|FG003|COMPLETED|Overall Study||17
10327293|NCT00296192|11463009|FG004|COMPLETED|Overall Study||16
10327294|NCT00296192|11463005|FG000|NOT COMPLETED|Overall Study||0
10327295|NCT00296192|11463006|FG001|NOT COMPLETED|Overall Study||0
10327296|NCT00296192|11463007|FG002|NOT COMPLETED|Overall Study||0
10327297|NCT00296192|11463008|FG003|NOT COMPLETED|Overall Study||0
10327298|NCT00296192|11463009|FG004|NOT COMPLETED|Overall Study||0
10327299|NCT00296231|11463021|FG000|STARTED|Overall Study||14
10327300|NCT00296231|11463021|FG000|COMPLETED|Overall Study||14
10327301|NCT00296231|11463021|FG000|NOT COMPLETED|Overall Study||0
10327302|NCT00296244|11463027|FG000|STARTED|Overall Study||20
10327303|NCT00296244|11463028|FG001|STARTED|Overall Study||20
10327304|NCT00296244|11463027|FG000|COMPLETED|Overall Study||20
10327305|NCT00296244|11463028|FG001|COMPLETED|Overall Study||19
10327306|NCT00296244|11463027|FG000|NOT COMPLETED|Overall Study||0
10327307|NCT00296244|11463028|FG001|NOT COMPLETED|Overall Study||1
10327308|NCT00296296|11463041|FG000|STARTED|Overall Study||11
10327309|NCT00296296|11463042|FG001|STARTED|Overall Study||18
10327310|NCT00296296|11463041|FG000|COMPLETED|Overall Study||9
10327311|NCT00296296|11463042|FG001|COMPLETED|Overall Study||5
10804454|NCT04045964|11965970|FG000|Intervention Visit(s)|Overall Study||15
10804455|NCT04045964|11965971|FG001|Intervention Visit(s)|Overall Study||16
10804456|NCT04045964|11965970|FG000|Follow up Visit 1|Overall Study||15
10804457|NCT04045964|11965971|FG001|Follow up Visit 1|Overall Study||15
10804458|NCT04045964|11965970|FG000|Follow up Visit 2|Overall Study||15
10804459|NCT04045964|11965971|FG001|Follow up Visit 2|Overall Study||15
10804460|NCT04045964|11965970|FG000|COMPLETED|Overall Study||15
10804461|NCT04045964|11965971|FG001|COMPLETED|Overall Study||15
10804462|NCT04045964|11965970|FG000|NOT COMPLETED|Overall Study||1
10804463|NCT04045964|11965971|FG001|NOT COMPLETED|Overall Study||1
10804464|NCT04043416|11965979|FG000|STARTED|Campaign 1||14
10804465|NCT04043416|11965980|FG001|STARTED|Campaign 1||14
10804466|NCT04043416|11965979|FG000|COMPLETED|Campaign 1||14
10804467|NCT04043416|11965980|FG001|COMPLETED|Campaign 1||14
10804468|NCT04043416|11965979|FG000|NOT COMPLETED|Campaign 1||0
10804469|NCT04043416|11965980|FG001|NOT COMPLETED|Campaign 1||0
10804470|NCT04043416|11965979|FG000|STARTED|Washout||14
10804471|NCT04043416|11965980|FG001|STARTED|Washout||14
10804472|NCT04043416|11965979|FG000|COMPLETED|Washout||14
10804473|NCT04043416|11965980|FG001|COMPLETED|Washout||13
10804474|NCT04043416|11965979|FG000|NOT COMPLETED|Washout||0
10804475|NCT04043416|11965980|FG001|NOT COMPLETED|Washout||1
10804476|NCT04043416|11965979|FG000|STARTED|Campaign 2||14
10804477|NCT04043416|11965980|FG001|STARTED|Campaign 2||13
10804478|NCT04043416|11965979|FG000|COMPLETED|Campaign 2||14
10804479|NCT04043416|11965980|FG001|COMPLETED|Campaign 2||13
10804480|NCT04043416|11965979|FG000|NOT COMPLETED|Campaign 2||0
10804481|NCT04043416|11965980|FG001|NOT COMPLETED|Campaign 2||0
10804482|NCT04057768|11965989|FG000|STARTED|Overall Study||10
10804483|NCT04057768|11965989|FG000|COMPLETED|Overall Study||10
10804484|NCT04057768|11965989|FG000|NOT COMPLETED|Overall Study||0
10804485|NCT04052542|11966005|FG000|STARTED|Overall Study||116
10804486|NCT04052542|11966006|FG001|STARTED|Overall Study||28
10804487|NCT04052542|11966007|FG002|STARTED|Overall Study||146
10456280|NCT01005966|11604235|FG000|NOT COMPLETED|Treatment Period 5 (14 Days)||0
10804488|NCT04052542|11966008|FG003|STARTED|Overall Study||188
10327312|NCT00296296|11463041|FG000|NOT COMPLETED|Overall Study||2
10327313|NCT00296296|11463042|FG001|NOT COMPLETED|Overall Study||13
10327314|NCT00296322|11463050|FG000|STARTED|Overall Study||258
10327315|NCT00296322|11463051|FG001|STARTED|Overall Study||263
10327316|NCT00296322|11463050|FG000|COMPLETED|Overall Study||237
10804489|NCT04052542|11966009|FG004|STARTED|Overall Study||24
10804490|NCT04052542|11966010|FG005|STARTED|Overall Study||183
10804491|NCT04052542|11966011|FG006|STARTED|Overall Study||275
10327317|NCT00296322|11463051|FG001|COMPLETED|Overall Study||184
10327318|NCT00296322|11463050|FG000|NOT COMPLETED|Overall Study||21
10327319|NCT00296322|11463051|FG001|NOT COMPLETED|Overall Study||79
10327320|NCT00296335|11463059|FG000|STARTED|Overall Study||424
10327321|NCT00296335|11463060|FG001|STARTED|Overall Study||431
10804492|NCT04052542|11966012|FG007|STARTED|Overall Study||27
10804493|NCT04052542|11966013|FG008|STARTED|Overall Study||276
10804494|NCT04052542|11966014|FG009|STARTED|Overall Study||22
10327322|NCT00296335|11463059|FG000|COMPLETED|Overall Study||394
10327323|NCT00296335|11463060|FG001|COMPLETED|Overall Study||309
10327324|NCT00296335|11463059|FG000|NOT COMPLETED|Overall Study||30
10327325|NCT00296335|11463060|FG001|NOT COMPLETED|Overall Study||122
10327326|NCT00296374|11463071|FG000|STARTED|Overall Study||118
10327327|NCT00296374|11463072|FG001|STARTED|Overall Study||124
10327328|NCT00296374|11463073|FG002|STARTED|Overall Study||111
10327329|NCT00296374|11463071|FG000|COMPLETED|Overall Study||93
10327330|NCT00296374|11463072|FG001|COMPLETED|Overall Study||101
10327331|NCT00296374|11463073|FG002|COMPLETED|Overall Study||82
10327332|NCT00296374|11463071|FG000|NOT COMPLETED|Overall Study||25
10327333|NCT00296374|11463072|FG001|NOT COMPLETED|Overall Study||23
10327334|NCT00296374|11463073|FG002|NOT COMPLETED|Overall Study||29
10327335|NCT00296400|11463090|FG000|STARTED|Overall Study||70
10327336|NCT00296400|11463091|FG001|STARTED|Overall Study||87
10327337|NCT00296400|11463092|FG002|STARTED|Overall Study||80
10327338|NCT00296400|11463090|FG000|COMPLETED|Overall Study||53
10327339|NCT00296400|11463091|FG001|COMPLETED|Overall Study||69
10327340|NCT00296400|11463092|FG002|COMPLETED|Overall Study||67
10327341|NCT00296400|11463090|FG000|NOT COMPLETED|Overall Study||17
10327342|NCT00296400|11463091|FG001|NOT COMPLETED|Overall Study||18
10327343|NCT00296400|11463092|FG002|NOT COMPLETED|Overall Study||13
10327344|NCT00296491|11463107|FG000|STARTED|Overall Study|Please note: Outcome Measures generally conducts analysis of 2 of the 4 Arms at a time.|182
10327345|NCT00296491|11463108|FG001|STARTED|Overall Study||182
10327346|NCT00296491|11463109|FG002|STARTED|Overall Study||180
10327347|NCT00296491|11463110|FG003|STARTED|Overall Study||181
10327348|NCT00296491|11463107|FG000|COMPLETED|Overall Study||140
10327349|NCT00296491|11463108|FG001|COMPLETED|Overall Study||129
10327350|NCT00296491|11463109|FG002|COMPLETED|Overall Study||137
10327351|NCT00296491|11463110|FG003|COMPLETED|Overall Study||138
10327352|NCT00296491|11463107|FG000|NOT COMPLETED|Overall Study||42
10327353|NCT00296491|11463108|FG001|NOT COMPLETED|Overall Study||53
10327354|NCT00296491|11463109|FG002|NOT COMPLETED|Overall Study||43
10327355|NCT00296491|11463110|FG003|NOT COMPLETED|Overall Study||43
10327356|NCT00296504|11463135|FG000|STARTED|Interim Analysis||119
10327357|NCT00296504|11463136|FG001|STARTED|Interim Analysis||18
10327358|NCT00296504|11463137|FG002|STARTED|Interim Analysis||221
10327359|NCT00296504|11463138|FG003|STARTED|Interim Analysis||54
10327360|NCT00296504|11463139|FG004|STARTED|Interim Analysis||73
10327361|NCT00296504|11463140|FG005|STARTED|Interim Analysis||78
10327362|NCT00296504|11463141|FG006|STARTED|Interim Analysis||104
10327363|NCT00296504|11463142|FG007|STARTED|Interim Analysis||86
10327364|NCT00296504|11463143|FG008|STARTED|Interim Analysis||0
10327365|NCT00296504|11463135|FG000|Ongoing|Interim Analysis||32
10327366|NCT00296504|11463136|FG001|Ongoing|Interim Analysis||12
10327367|NCT00296504|11463137|FG002|Ongoing|Interim Analysis||16
10327368|NCT00296504|11463138|FG003|Ongoing|Interim Analysis||22
10327369|NCT00296504|11463139|FG004|Ongoing|Interim Analysis||0
10327370|NCT00296504|11463140|FG005|Ongoing|Interim Analysis||0
10327371|NCT00296504|11463141|FG006|Ongoing|Interim Analysis||30
10327372|NCT00296504|11463142|FG007|Ongoing|Interim Analysis||1
10327373|NCT00296504|11463143|FG008|Ongoing|Interim Analysis||0
10327374|NCT00296504|11463135|FG000|COMPLETED|Interim Analysis||43
10327375|NCT00296504|11463136|FG001|COMPLETED|Interim Analysis||0
10327376|NCT00296504|11463137|FG002|COMPLETED|Interim Analysis||116
10327377|NCT00296504|11463138|FG003|COMPLETED|Interim Analysis||11
10327378|NCT00296504|11463139|FG004|COMPLETED|Interim Analysis||36
10327379|NCT00296504|11463140|FG005|COMPLETED|Interim Analysis||41
10327380|NCT00296504|11463141|FG006|COMPLETED|Interim Analysis||30
10327381|NCT00296504|11463142|FG007|COMPLETED|Interim Analysis||37
10327382|NCT00296504|11463143|FG008|COMPLETED|Interim Analysis||0
10327383|NCT00296504|11463135|FG000|NOT COMPLETED|Interim Analysis||76
10327384|NCT00296504|11463136|FG001|NOT COMPLETED|Interim Analysis||18
10327385|NCT00296504|11463137|FG002|NOT COMPLETED|Interim Analysis||105
10327386|NCT00296504|11463138|FG003|NOT COMPLETED|Interim Analysis||43
10327387|NCT00296504|11463139|FG004|NOT COMPLETED|Interim Analysis||37
10327388|NCT00296504|11463140|FG005|NOT COMPLETED|Interim Analysis||37
10327389|NCT00296504|11463141|FG006|NOT COMPLETED|Interim Analysis||74
10327390|NCT00296504|11463142|FG007|NOT COMPLETED|Interim Analysis||49
10327391|NCT00296504|11463143|FG008|NOT COMPLETED|Interim Analysis||0
10327392|NCT00296504|11463135|FG000|STARTED|Final Analysis||0
10327393|NCT00296504|11463136|FG001|STARTED|Final Analysis||0
10327394|NCT00296504|11463137|FG002|STARTED|Final Analysis||0
10327395|NCT00296504|11463138|FG003|STARTED|Final Analysis||0
10327396|NCT00296504|11463139|FG004|STARTED|Final Analysis||0
10327397|NCT00296504|11463140|FG005|STARTED|Final Analysis||0
10327398|NCT00296504|11463141|FG006|STARTED|Final Analysis||0
10327399|NCT00296504|11463142|FG007|STARTED|Final Analysis||0
10327400|NCT00296504|11463143|FG008|STARTED|Final Analysis|Continued in study; commercial supplies of FPV were unavailable locally at end of Interim Analysis.|111
10327401|NCT00296504|11463135|FG000|COMPLETED|Final Analysis||0
10327402|NCT00296504|11463136|FG001|COMPLETED|Final Analysis||0
10327403|NCT00296504|11463137|FG002|COMPLETED|Final Analysis||0
10327404|NCT00296504|11463138|FG003|COMPLETED|Final Analysis||0
10327405|NCT00296504|11463139|FG004|COMPLETED|Final Analysis||0
10327406|NCT00296504|11463140|FG005|COMPLETED|Final Analysis||0
10327407|NCT00296504|11463141|FG006|COMPLETED|Final Analysis||0
10327408|NCT00296504|11463142|FG007|COMPLETED|Final Analysis||0
10327409|NCT00296504|11463143|FG008|COMPLETED|Final Analysis||90
10327410|NCT00296504|11463135|FG000|NOT COMPLETED|Final Analysis||0
10327411|NCT00296504|11463136|FG001|NOT COMPLETED|Final Analysis||0
10327412|NCT00296504|11463137|FG002|NOT COMPLETED|Final Analysis||0
10327413|NCT00296504|11463138|FG003|NOT COMPLETED|Final Analysis||0
10327414|NCT00296504|11463139|FG004|NOT COMPLETED|Final Analysis||0
10327415|NCT00296504|11463140|FG005|NOT COMPLETED|Final Analysis||0
10327416|NCT00296504|11463141|FG006|NOT COMPLETED|Final Analysis||0
10327417|NCT00296504|11463142|FG007|NOT COMPLETED|Final Analysis||0
10327418|NCT00296504|11463143|FG008|NOT COMPLETED|Final Analysis||21
10327419|NCT00296517|11463170|FG000|STARTED|Dose Level 1 - Week 1||159
10327420|NCT00296517|11463171|FG001|STARTED|Dose Level 1 - Week 1||166
10327421|NCT00296517|11463170|FG000|COMPLETED|Dose Level 1 - Week 1||159
10327422|NCT00296517|11463171|FG001|COMPLETED|Dose Level 1 - Week 1||166
10327423|NCT00296517|11463170|FG000|NOT COMPLETED|Dose Level 1 - Week 1||0
10327424|NCT00296517|11463171|FG001|NOT COMPLETED|Dose Level 1 - Week 1||0
10327425|NCT00296517|11463170|FG000|STARTED|Dose Level 2 - Week 2||159
10327426|NCT00296517|11463171|FG001|STARTED|Dose Level 2 - Week 2||166
10327427|NCT00296517|11463170|FG000|COMPLETED|Dose Level 2 - Week 2||157
10327428|NCT00296517|11463171|FG001|COMPLETED|Dose Level 2 - Week 2||161
10327429|NCT00296517|11463170|FG000|NOT COMPLETED|Dose Level 2 - Week 2||2
10327430|NCT00296517|11463171|FG001|NOT COMPLETED|Dose Level 2 - Week 2||5
10327431|NCT00296517|11463170|FG000|STARTED|Dose Level 3 - Weeks 3-12||157
10327432|NCT00296517|11463171|FG001|STARTED|Dose Level 3 - Weeks 3-12||161
10327433|NCT00296517|11463170|FG000|COMPLETED|Dose Level 3 - Weeks 3-12||112
10327434|NCT00296517|11463171|FG001|COMPLETED|Dose Level 3 - Weeks 3-12||99
10327435|NCT00296517|11463170|FG000|NOT COMPLETED|Dose Level 3 - Weeks 3-12||45
10327436|NCT00296517|11463171|FG001|NOT COMPLETED|Dose Level 3 - Weeks 3-12||62
10327437|NCT00296647|11463182|FG000|STARTED|Overall Study||282
10327438|NCT00296647|11463183|FG001|STARTED|Overall Study||261
10327439|NCT00296647|11463184|FG002|STARTED|Overall Study||256
10327440|NCT00296647|11463185|FG003|STARTED|Overall Study||279
10327441|NCT00296647|11463186|FG004|STARTED|Overall Study||268
10327442|NCT00296647|11463182|FG000|COMPLETED|Overall Study||250
10327443|NCT00296647|11463183|FG001|COMPLETED|Overall Study||233
10327444|NCT00296647|11463184|FG002|COMPLETED|Overall Study||222
10327445|NCT00296647|11463185|FG003|COMPLETED|Overall Study||262
10327446|NCT00296647|11463186|FG004|COMPLETED|Overall Study||248
10327447|NCT00296647|11463182|FG000|NOT COMPLETED|Overall Study||32
10327448|NCT00296647|11463183|FG001|NOT COMPLETED|Overall Study||28
10327449|NCT00296647|11463184|FG002|NOT COMPLETED|Overall Study||34
10327450|NCT00296647|11463185|FG003|NOT COMPLETED|Overall Study||17
10327451|NCT00296647|11463186|FG004|NOT COMPLETED|Overall Study||20
10327452|NCT00296725|11463198|FG000|STARTED|Phase 1: Fluoxetine (1-12 Weeks)||17
10327453|NCT00296725|11463198|FG000|COMPLETED|Phase 1: Fluoxetine (1-12 Weeks)||12
10327454|NCT00296725|11463198|FG000|NOT COMPLETED|Phase 1: Fluoxetine (1-12 Weeks)||5
10327455|NCT00296725|11463198|FG000|STARTED|Phase 2: Imipramine (1-6 Weeks)||8
10327456|NCT00296725|11463198|FG000|COMPLETED|Phase 2: Imipramine (1-6 Weeks)||7
10327457|NCT00296725|11463198|FG000|NOT COMPLETED|Phase 2: Imipramine (1-6 Weeks)||1
10327458|NCT00296816|11463206|FG000|STARTED|Overall Study||132
10327459|NCT00296816|11463206|FG000|COMPLETED|Overall Study|Completed study treatment for a minimum of three years|58
10327460|NCT00296816|11463206|FG000|NOT COMPLETED|Overall Study||74
10327461|NCT00297037|11463212|FG000|STARTED|Overall Study||10
10327462|NCT00297037|11463213|FG001|STARTED|Overall Study||11
10327463|NCT00297037|11463212|FG000|COMPLETED|Overall Study||8
10804495|NCT04052542|11966015|FG010|STARTED|Overall Study||31
10804496|NCT04052542|11966016|FG011|STARTED|Overall Study||12
10804497|NCT04052542|11966005|FG000|COMPLETED|Overall Study||116
10804498|NCT04052542|11966006|FG001|COMPLETED|Overall Study||28
10804499|NCT04052542|11966007|FG002|COMPLETED|Overall Study||146
10804500|NCT04052542|11966008|FG003|COMPLETED|Overall Study||188
10804501|NCT04052542|11966009|FG004|COMPLETED|Overall Study||24
10804502|NCT04052542|11966010|FG005|COMPLETED|Overall Study||183
10804503|NCT04052542|11966011|FG006|COMPLETED|Overall Study||275
10804504|NCT04052542|11966012|FG007|COMPLETED|Overall Study||27
10804505|NCT04052542|11966013|FG008|COMPLETED|Overall Study||276
10804506|NCT04052542|11966014|FG009|COMPLETED|Overall Study||22
10804507|NCT04052542|11966015|FG010|COMPLETED|Overall Study||31
10804508|NCT04052542|11966016|FG011|COMPLETED|Overall Study||12
10804509|NCT04052542|11966005|FG000|NOT COMPLETED|Overall Study||0
10804510|NCT04052542|11966006|FG001|NOT COMPLETED|Overall Study||0
10804511|NCT04052542|11966007|FG002|NOT COMPLETED|Overall Study||0
10804512|NCT04052542|11966008|FG003|NOT COMPLETED|Overall Study||0
10804513|NCT04052542|11966009|FG004|NOT COMPLETED|Overall Study||0
10804514|NCT04052542|11966010|FG005|NOT COMPLETED|Overall Study||0
10804515|NCT04052542|11966011|FG006|NOT COMPLETED|Overall Study||0
10804516|NCT04052542|11966012|FG007|NOT COMPLETED|Overall Study||0
10327464|NCT00297037|11463213|FG001|COMPLETED|Overall Study||11
10327465|NCT00297037|11463212|FG000|NOT COMPLETED|Overall Study||2
10804517|NCT04052542|11966013|FG008|NOT COMPLETED|Overall Study||0
10804518|NCT04052542|11966014|FG009|NOT COMPLETED|Overall Study||0
10804519|NCT04052542|11966015|FG010|NOT COMPLETED|Overall Study||0
10804520|NCT04052542|11966016|FG011|NOT COMPLETED|Overall Study||0
10804521|NCT04054193|11966042|FG000|STARTED|Cycle 1||103
10804522|NCT04054193|11966042|FG000|Treated (≥1 Dose)|Cycle 1||100
10327466|NCT00297037|11463213|FG001|NOT COMPLETED|Overall Study||0
10327467|NCT00297102|11463223|FG000|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|765
10327468|NCT00297102|11463224|FG001|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|758
10327469|NCT00297102|11463223|FG000|COMPLETED|Overall Study||502
10327470|NCT00297102|11463224|FG001|COMPLETED|Overall Study||525
10327471|NCT00297102|11463223|FG000|NOT COMPLETED|Overall Study||263
10327472|NCT00297102|11463224|FG001|NOT COMPLETED|Overall Study||233
10327473|NCT00297115|11463232|FG000|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|772
10327474|NCT00297115|11463233|FG001|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|796
10327475|NCT00297115|11463232|FG000|COMPLETED|Overall Study||527
10327476|NCT00297115|11463233|FG001|COMPLETED|Overall Study||550
10804523|NCT04054193|11966042|FG000|COMPLETED|Cycle 1||98
10804524|NCT04054193|11966042|FG000|NOT COMPLETED|Cycle 1||5
10804525|NCT04054193|11966042|FG000|STARTED|Cycles 2-3|Participation in Cycles 2-3 was optional after completing Cycle 1.|69
10574634|NCT01679405|11729902|FG001|STARTED|Overall Study||6
10804526|NCT04054193|11966042|FG000|COMPLETED|Cycles 2-3||48
10804527|NCT04054193|11966042|FG000|NOT COMPLETED|Cycles 2-3||21
10804528|NCT04050618|11966049|FG000|STARTED|First Intervention||58
10804529|NCT04050618|11966050|FG001|STARTED|First Intervention||56
10804530|NCT04050618|11966049|FG000|COMPLETED|First Intervention||56
10804531|NCT04050618|11966050|FG001|COMPLETED|First Intervention||56
10804532|NCT04050618|11966049|FG000|NOT COMPLETED|First Intervention||2
10804533|NCT04050618|11966050|FG001|NOT COMPLETED|First Intervention||0
10804534|NCT04050618|11966049|FG000|STARTED|Second Intervention||56
10804535|NCT04050618|11966050|FG001|STARTED|Second Intervention||56
10804536|NCT04050618|11966049|FG000|COMPLETED|Second Intervention||55
10804537|NCT04050618|11966050|FG001|COMPLETED|Second Intervention||56
10804538|NCT04050618|11966049|FG000|NOT COMPLETED|Second Intervention||1
10804539|NCT04050618|11966050|FG001|NOT COMPLETED|Second Intervention||0
10804540|NCT04053465|11966063|FG000|STARTED|Overall Study||22
10804541|NCT04053465|11966064|FG001|STARTED|Overall Study||12
10804542|NCT04053465|11966063|FG000|COMPLETED|Overall Study||18
10804543|NCT04053465|11966064|FG001|COMPLETED|Overall Study||8
10804544|NCT04053465|11966063|FG000|NOT COMPLETED|Overall Study||4
10804545|NCT04053465|11966064|FG001|NOT COMPLETED|Overall Study||4
10804546|NCT04053270|11966072|FG000|STARTED|Overall Study||49
10804547|NCT04053270|11966073|FG001|STARTED|Overall Study||51
10804548|NCT04053270|11966072|FG000|COMPLETED|Overall Study||47
10804549|NCT04053270|11966073|FG001|COMPLETED|Overall Study||46
10804550|NCT04053270|11966072|FG000|NOT COMPLETED|Overall Study||2
10804551|NCT04053270|11966073|FG001|NOT COMPLETED|Overall Study||5
10804552|NCT04049552|11966083|FG000|STARTED|Overall Study||4
10804553|NCT04049552|11966083|FG000|COMPLETED|Overall Study||3
10804554|NCT04049552|11966083|FG000|NOT COMPLETED|Overall Study||1
10804555|NCT04053023|11966091|FG000|STARTED|Part A: Period 1 (Day 1 to Day 19)||19
10804556|NCT04053023|11966092|FG001|STARTED|Part A: Period 1 (Day 1 to Day 19)||0
10804557|NCT04053023|11966091|FG000|COMPLETED|Part A: Period 1 (Day 1 to Day 19)||19
10804558|NCT04053023|11966092|FG001|COMPLETED|Part A: Period 1 (Day 1 to Day 19)||0
10804559|NCT04053023|11966091|FG000|NOT COMPLETED|Part A: Period 1 (Day 1 to Day 19)||0
10804560|NCT04053023|11966092|FG001|NOT COMPLETED|Part A: Period 1 (Day 1 to Day 19)||0
10804561|NCT04053023|11966091|FG000|STARTED|Part A: Period 2 (Day 20 to Day 38)||19
10804562|NCT04053023|11966092|FG001|STARTED|Part A: Period 2 (Day 20 to Day 38)||0
10804563|NCT04053023|11966091|FG000|COMPLETED|Part A: Period 2 (Day 20 to Day 38)||18
10804564|NCT04053023|11966092|FG001|COMPLETED|Part A: Period 2 (Day 20 to Day 38)||0
10804565|NCT04053023|11966091|FG000|NOT COMPLETED|Part A: Period 2 (Day 20 to Day 38)||1
10804566|NCT04053023|11966092|FG001|NOT COMPLETED|Part A: Period 2 (Day 20 to Day 38)||0
10804567|NCT04053023|11966091|FG000|STARTED|Part B: Period 1 (Day 1 to Day 19)||0
10804568|NCT04053023|11966092|FG001|STARTED|Part B: Period 1 (Day 1 to Day 19)||0
10804569|NCT04053023|11966091|FG000|COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0
10804570|NCT04053023|11966092|FG001|COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0
10804571|NCT04053023|11966091|FG000|NOT COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0
10804572|NCT04053023|11966092|FG001|NOT COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0
10804573|NCT04053023|11966091|FG000|STARTED|Part B: Period 2 (Day 20 to Day 38)||0
10804574|NCT04053023|11966092|FG001|STARTED|Part B: Period 2 (Day 20 to Day 38)||0
10804575|NCT04053023|11966091|FG000|COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0
10804576|NCT04053023|11966092|FG001|COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0
10804577|NCT04053023|11966091|FG000|NOT COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0
10804578|NCT04053023|11966092|FG001|NOT COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0
10804579|NCT04051710|11966105|FG000|STARTED|Overall Study||620
10804580|NCT04051710|11966106|FG001|STARTED|Overall Study||620
10804581|NCT04051710|11966107|FG002|STARTED|Overall Study||310
10574635|NCT01679405|11729901|FG000|COMPLETED|Overall Study||1
10574636|NCT01679405|11729902|FG001|COMPLETED|Overall Study||1
10574637|NCT01679405|11729901|FG000|NOT COMPLETED|Overall Study||2
10574638|NCT01679405|11729902|FG001|NOT COMPLETED|Overall Study||5
10574639|NCT01679600|11729910|FG000|STARTED|Overall Study||7
10804582|NCT04051710|11966105|FG000|COMPLETED|Overall Study||616
10804583|NCT04051710|11966106|FG001|COMPLETED|Overall Study||612
10804584|NCT04051710|11966107|FG002|COMPLETED|Overall Study||306
10574640|NCT01679600|11729911|FG001|STARTED|Overall Study||7
10804585|NCT04051710|11966105|FG000|NOT COMPLETED|Overall Study||4
10804586|NCT04051710|11966106|FG001|NOT COMPLETED|Overall Study||8
10804587|NCT04051710|11966107|FG002|NOT COMPLETED|Overall Study||4
10804588|NCT04050865|11966117|FG000|STARTED|Overall Study||48
10804589|NCT04050865|11966118|FG001|STARTED|Overall Study||48
10327477|NCT00297115|11463232|FG000|NOT COMPLETED|Overall Study||245
10804590|NCT04050865|11966117|FG000|COMPLETED|Overall Study||44
10804591|NCT04050865|11966118|FG001|COMPLETED|Overall Study||43
10804592|NCT04050865|11966117|FG000|NOT COMPLETED|Overall Study||4
10804593|NCT04050865|11966118|FG001|NOT COMPLETED|Overall Study||5
10804594|NCT04050605|11966124|FG000|STARTED|Overall Study||40
10804595|NCT04050605|11966124|FG000|COMPLETED|Overall Study||40
10804596|NCT04050605|11966124|FG000|NOT COMPLETED|Overall Study||0
10804597|NCT04050371|11966136|FG000|STARTED|Overall Study||24
10804598|NCT04050371|11966137|FG001|STARTED|Overall Study||24
10804599|NCT04050371|11966136|FG000|COMPLETED|Overall Study||23
10804600|NCT04050371|11966137|FG001|COMPLETED|Overall Study||24
10804601|NCT04050371|11966136|FG000|NOT COMPLETED|Overall Study||1
10804602|NCT04050371|11966137|FG001|NOT COMPLETED|Overall Study||0
10804603|NCT04048460|11966143|FG000|STARTED|Overall Study||10
10804604|NCT04048460|11966143|FG000|COMPLETED|Overall Study||10
10804605|NCT04048460|11966143|FG000|NOT COMPLETED|Overall Study||0
10804606|NCT04048681|11966147|FG000|STARTED|Overall Study||1
10804607|NCT04048681|11966148|FG001|STARTED|Overall Study||1
10804608|NCT04048681|11966149|FG002|STARTED|Overall Study||1
10804609|NCT04048681|11966150|FG003|STARTED|Overall Study||1
10804610|NCT04048681|11966151|FG004|STARTED|Overall Study||1
10804611|NCT04048681|11966147|FG000|COMPLETED|Overall Study||1
10804612|NCT04048681|11966148|FG001|COMPLETED|Overall Study||1
10804613|NCT04048681|11966149|FG002|COMPLETED|Overall Study||1
10804614|NCT04048681|11966150|FG003|COMPLETED|Overall Study||0
10804615|NCT04048681|11966151|FG004|COMPLETED|Overall Study||1
10804616|NCT04048681|11966147|FG000|NOT COMPLETED|Overall Study||0
10804617|NCT04048681|11966148|FG001|NOT COMPLETED|Overall Study||0
10804618|NCT04048681|11966149|FG002|NOT COMPLETED|Overall Study||0
10804619|NCT04048681|11966150|FG003|NOT COMPLETED|Overall Study||1
10804620|NCT04048681|11966151|FG004|NOT COMPLETED|Overall Study||0
10804621|NCT04046250|11966161|FG000|STARTED|Overall Study||11
10804622|NCT04046250|11966162|FG001|STARTED|Overall Study||11
10804623|NCT04046250|11966161|FG000|COMPLETED|Overall Study|Four Methotrexate + TK-112690 Treatments|8
10804624|NCT04046250|11966162|FG001|COMPLETED|Overall Study|Four Methotrexate + TK-12260 Placebo Treatments|7
10804625|NCT04046250|11966161|FG000|NOT COMPLETED|Overall Study||3
10804626|NCT04046250|11966162|FG001|NOT COMPLETED|Overall Study||4
10804627|NCT04047342|11966170|FG000|STARTED|Overall Study||409
10804628|NCT04047342|11966171|FG001|STARTED|Overall Study||415
10804629|NCT04047342|11966170|FG000|COMPLETED|Overall Study||409
10804630|NCT04047342|11966171|FG001|COMPLETED|Overall Study||415
10804631|NCT04047342|11966170|FG000|NOT COMPLETED|Overall Study||0
10804632|NCT04047342|11966171|FG001|NOT COMPLETED|Overall Study||0
10804633|NCT04044352|11966177|FG000|STARTED|Overall Study||76
10804634|NCT04044352|11966177|FG000|COMPLETED|Overall Study||65
10804635|NCT04044352|11966177|FG000|NOT COMPLETED|Overall Study||11
10804636|NCT04043728|11966185|FG000|STARTED|Overall Study||6
10804637|NCT04043728|11966186|FG001|STARTED|Overall Study||6
10804638|NCT04043728|11966187|FG002|STARTED|Overall Study||6
10804639|NCT04043728|11966185|FG000|COMPLETED|Overall Study||5
10804640|NCT04043728|11966186|FG001|COMPLETED|Overall Study||4
10804641|NCT04043728|11966187|FG002|COMPLETED|Overall Study||6
10804642|NCT04043728|11966185|FG000|NOT COMPLETED|Overall Study||1
10804643|NCT04043728|11966186|FG001|NOT COMPLETED|Overall Study||2
10804644|NCT04043728|11966187|FG002|NOT COMPLETED|Overall Study||0
10804645|NCT04041453|11966199|FG000|STARTED|Overall Study||38
10804646|NCT04041453|11966200|FG001|STARTED|Overall Study||57
10804647|NCT04041453|11966201|FG002|STARTED|Overall Study||23
10804648|NCT04041453|11966202|FG003|STARTED|Overall Study||58
10804649|NCT04041453|11966199|FG000|Safety Population|Overall Study||38
10804650|NCT04041453|11966200|FG001|Safety Population|Overall Study||56
10804651|NCT04041453|11966201|FG002|Safety Population|Overall Study||23
10804652|NCT04041453|11966202|FG003|Safety Population|Overall Study||58
10804653|NCT04041453|11966199|FG000|COMPLETED|Overall Study||24
10804654|NCT04041453|11966200|FG001|COMPLETED|Overall Study||35
10804655|NCT04041453|11966201|FG002|COMPLETED|Overall Study||18
10804656|NCT04041453|11966202|FG003|COMPLETED|Overall Study||40
10804657|NCT04041453|11966199|FG000|NOT COMPLETED|Overall Study||14
10804658|NCT04041453|11966200|FG001|NOT COMPLETED|Overall Study||22
10804659|NCT04041453|11966201|FG002|NOT COMPLETED|Overall Study||5
10804660|NCT04041453|11966202|FG003|NOT COMPLETED|Overall Study||18
10804661|NCT04041414|11966216|FG000|STARTED|Overall Study||27
10804662|NCT04041414|11966217|FG001|STARTED|Overall Study||20
10804663|NCT04041414|11966216|FG000|COMPLETED|Overall Study||26
10804664|NCT04041414|11966217|FG001|COMPLETED|Overall Study||18
10804665|NCT04041414|11966216|FG000|NOT COMPLETED|Overall Study||1
10804666|NCT04041414|11966217|FG001|NOT COMPLETED|Overall Study||2
10804667|NCT04041219|11966226|FG000|STARTED|Overall Study||10
10804668|NCT04041219|11966226|FG000|COMPLETED|Overall Study||10
10804669|NCT04041219|11966226|FG000|NOT COMPLETED|Overall Study||0
10804670|NCT04041700|11966230|FG000|STARTED|Overall Study||29
10804671|NCT04041700|11966230|FG000|COMPLETED|Overall Study||27
10804672|NCT04041700|11966230|FG000|NOT COMPLETED|Overall Study||2
10804673|NCT04039867|11966234|FG000|STARTED|Overall Study||17
10804674|NCT04039867|11966234|FG000|COMPLETED|Overall Study||17
10804675|NCT04039867|11966234|FG000|NOT COMPLETED|Overall Study||0
10804676|NCT04039412|11966241|FG000|STARTED|Overall Study||110
10804677|NCT04039412|11966242|FG001|STARTED|Overall Study||110
10804678|NCT04039412|11966243|FG002|STARTED|Overall Study||110
10804679|NCT04039412|11966241|FG000|COMPLETED|Overall Study||109
10327478|NCT00297115|11463233|FG001|NOT COMPLETED|Overall Study||246
10327479|NCT00297167|11463239|FG000|STARTED|First Double-blind Intervention Period||17
10327480|NCT00297167|11463240|FG001|STARTED|First Double-blind Intervention Period||16
10327481|NCT00297167|11463241|FG002|STARTED|First Double-blind Intervention Period||0
10804680|NCT04039412|11966242|FG001|COMPLETED|Overall Study||107
10804681|NCT04039412|11966243|FG002|COMPLETED|Overall Study||108
10804682|NCT04039412|11966241|FG000|NOT COMPLETED|Overall Study||1
10804683|NCT04039412|11966242|FG001|NOT COMPLETED|Overall Study||3
10804684|NCT04039412|11966243|FG002|NOT COMPLETED|Overall Study||2
10804685|NCT04035161|11966254|FG000|STARTED|Overall Study||1121
10804686|NCT04035161|11966254|FG000|Treated With Investigational Product|Overall Study||609
10804687|NCT04035161|11966254|FG000|Treated With Reference Standard|Overall Study||419
10804688|NCT04035161|11966254|FG000|Treated With Active Control|Overall Study||609
10804689|NCT04035161|11966254|FG000|Treated With Negative Control|Overall Study||605
10804690|NCT04035161|11966254|FG000|COMPLETED|Overall Study||1121
10804691|NCT04035161|11966254|FG000|NOT COMPLETED|Overall Study||0
10804692|NCT04029519|11966264|FG000|STARTED|Overall Study||84
10804693|NCT04029519|11966264|FG000|COMPLETED|Overall Study||79
10804694|NCT04029519|11966264|FG000|NOT COMPLETED|Overall Study||5
10804695|NCT04039919|11966273|FG000|STARTED|Treatment Period 1||7
10804696|NCT04039919|11966274|FG001|STARTED|Treatment Period 1||6
10804697|NCT04039919|11966275|FG002|STARTED|Treatment Period 1||5
10804698|NCT04039919|11966276|FG003|STARTED|Treatment Period 1||6
10804699|NCT04039919|11966277|FG004|STARTED|Treatment Period 1||16
10804700|NCT04039919|11966273|FG000|COMPLETED|Treatment Period 1||6
10804701|NCT04039919|11966274|FG001|COMPLETED|Treatment Period 1||6
10804702|NCT04039919|11966275|FG002|COMPLETED|Treatment Period 1||5
10804703|NCT04039919|11966276|FG003|COMPLETED|Treatment Period 1||6
10804704|NCT04039919|11966277|FG004|COMPLETED|Treatment Period 1||0
10804705|NCT04039919|11966273|FG000|NOT COMPLETED|Treatment Period 1||1
10804706|NCT04039919|11966274|FG001|NOT COMPLETED|Treatment Period 1||0
10804707|NCT04039919|11966275|FG002|NOT COMPLETED|Treatment Period 1||0
10804708|NCT04039919|11966276|FG003|NOT COMPLETED|Treatment Period 1||0
10804709|NCT04039919|11966277|FG004|NOT COMPLETED|Treatment Period 1||16
10804710|NCT04039919|11966273|FG000|STARTED|Treatment Period 2||6
10804711|NCT04039919|11966274|FG001|STARTED|Treatment Period 2||6
10804712|NCT04039919|11966275|FG002|STARTED|Treatment Period 2||5
10804713|NCT04039919|11966276|FG003|STARTED|Treatment Period 2||6
10804714|NCT04039919|11966277|FG004|STARTED|Treatment Period 2||0
10804715|NCT04039919|11966273|FG000|COMPLETED|Treatment Period 2||6
10804716|NCT04039919|11966274|FG001|COMPLETED|Treatment Period 2||6
10804717|NCT04039919|11966275|FG002|COMPLETED|Treatment Period 2||5
10804718|NCT04039919|11966276|FG003|COMPLETED|Treatment Period 2||6
10804719|NCT04039919|11966277|FG004|COMPLETED|Treatment Period 2||0
10804720|NCT04039919|11966273|FG000|NOT COMPLETED|Treatment Period 2||0
10804721|NCT04039919|11966274|FG001|NOT COMPLETED|Treatment Period 2||0
10804722|NCT04039919|11966275|FG002|NOT COMPLETED|Treatment Period 2||0
10804723|NCT04039919|11966276|FG003|NOT COMPLETED|Treatment Period 2||0
10804724|NCT04039919|11966277|FG004|NOT COMPLETED|Treatment Period 2||0
10804725|NCT04039919|11966273|FG000|STARTED|Treatment Period 3||6
10804726|NCT04039919|11966274|FG001|STARTED|Treatment Period 3||6
10804727|NCT04039919|11966275|FG002|STARTED|Treatment Period 3||5
10804728|NCT04039919|11966276|FG003|STARTED|Treatment Period 3||6
10804729|NCT04039919|11966277|FG004|STARTED|Treatment Period 3||0
10804730|NCT04039919|11966273|FG000|COMPLETED|Treatment Period 3||6
10804731|NCT04039919|11966274|FG001|COMPLETED|Treatment Period 3||6
10804732|NCT04039919|11966275|FG002|COMPLETED|Treatment Period 3||5
10804733|NCT04039919|11966276|FG003|COMPLETED|Treatment Period 3||6
10804734|NCT04039919|11966277|FG004|COMPLETED|Treatment Period 3||0
10804735|NCT04039919|11966273|FG000|NOT COMPLETED|Treatment Period 3||0
10804736|NCT04039919|11966274|FG001|NOT COMPLETED|Treatment Period 3||0
10804737|NCT04039919|11966275|FG002|NOT COMPLETED|Treatment Period 3||0
10804738|NCT04039919|11966276|FG003|NOT COMPLETED|Treatment Period 3||0
10804739|NCT04039919|11966277|FG004|NOT COMPLETED|Treatment Period 3||0
10804740|NCT04039919|11966273|FG000|STARTED|Treatment Period 4||6
10804741|NCT04039919|11966274|FG001|STARTED|Treatment Period 4||6
10804742|NCT04039919|11966275|FG002|STARTED|Treatment Period 4||5
10804743|NCT04039919|11966276|FG003|STARTED|Treatment Period 4||6
10804744|NCT04039919|11966277|FG004|STARTED|Treatment Period 4||0
10804745|NCT04039919|11966273|FG000|COMPLETED|Treatment Period 4||6
10804746|NCT04039919|11966274|FG001|COMPLETED|Treatment Period 4||6
10804747|NCT04039919|11966275|FG002|COMPLETED|Treatment Period 4||5
10804748|NCT04039919|11966276|FG003|COMPLETED|Treatment Period 4||6
10804749|NCT04039919|11966277|FG004|COMPLETED|Treatment Period 4||0
10804750|NCT04039919|11966273|FG000|NOT COMPLETED|Treatment Period 4||0
10804751|NCT04039919|11966274|FG001|NOT COMPLETED|Treatment Period 4||0
10804752|NCT04039919|11966275|FG002|NOT COMPLETED|Treatment Period 4||0
10804753|NCT04039919|11966276|FG003|NOT COMPLETED|Treatment Period 4||0
10804754|NCT04039919|11966277|FG004|NOT COMPLETED|Treatment Period 4||0
10804755|NCT04039919|11966273|FG000|STARTED|Treatment Period 5||6
10804756|NCT04039919|11966274|FG001|STARTED|Treatment Period 5||6
10804757|NCT04039919|11966275|FG002|STARTED|Treatment Period 5||5
10804758|NCT04039919|11966276|FG003|STARTED|Treatment Period 5||6
10804759|NCT04039919|11966277|FG004|STARTED|Treatment Period 5||0
10804760|NCT04039919|11966273|FG000|COMPLETED|Treatment Period 5||5
10804761|NCT04039919|11966274|FG001|COMPLETED|Treatment Period 5||6
10804762|NCT04039919|11966275|FG002|COMPLETED|Treatment Period 5||5
10327482|NCT00297167|11463239|FG000|COMPLETED|First Double-blind Intervention Period||17
10804763|NCT04039919|11966276|FG003|COMPLETED|Treatment Period 5||6
10804764|NCT04039919|11966277|FG004|COMPLETED|Treatment Period 5||0
10804765|NCT04039919|11966273|FG000|NOT COMPLETED|Treatment Period 5||1
10804766|NCT04039919|11966274|FG001|NOT COMPLETED|Treatment Period 5||0
10804767|NCT04039919|11966275|FG002|NOT COMPLETED|Treatment Period 5||0
10804768|NCT04039919|11966276|FG003|NOT COMPLETED|Treatment Period 5||0
10804769|NCT04039919|11966277|FG004|NOT COMPLETED|Treatment Period 5||0
10804770|NCT04039919|11966273|FG000|STARTED|Treatment Period 6||5
10804771|NCT04039919|11966274|FG001|STARTED|Treatment Period 6||6
10804772|NCT04039919|11966275|FG002|STARTED|Treatment Period 6||5
10804773|NCT04039919|11966276|FG003|STARTED|Treatment Period 6||6
10804774|NCT04039919|11966277|FG004|STARTED|Treatment Period 6||0
10804775|NCT04039919|11966273|FG000|COMPLETED|Treatment Period 6||5
10804776|NCT04039919|11966274|FG001|COMPLETED|Treatment Period 6||6
10804777|NCT04039919|11966275|FG002|COMPLETED|Treatment Period 6||5
10804778|NCT04039919|11966276|FG003|COMPLETED|Treatment Period 6||6
10804779|NCT04039919|11966277|FG004|COMPLETED|Treatment Period 6||0
10804780|NCT04039919|11966273|FG000|NOT COMPLETED|Treatment Period 6||0
10804781|NCT04039919|11966274|FG001|NOT COMPLETED|Treatment Period 6||0
10804782|NCT04039919|11966275|FG002|NOT COMPLETED|Treatment Period 6||0
10804783|NCT04039919|11966276|FG003|NOT COMPLETED|Treatment Period 6||0
10804784|NCT04039919|11966277|FG004|NOT COMPLETED|Treatment Period 6||0
10804785|NCT04037969|11966313|FG000|STARTED|Overall Study||10
10804786|NCT04037969|11966314|FG001|STARTED|Overall Study||10
10804787|NCT04037969|11966313|FG000|COMPLETED|Overall Study||10
10804788|NCT04037969|11966314|FG001|COMPLETED|Overall Study||10
10804789|NCT04037969|11966313|FG000|NOT COMPLETED|Overall Study||0
10804790|NCT04037969|11966314|FG001|NOT COMPLETED|Overall Study||0
10804791|NCT04037865|11966319|FG000|STARTED|Overall Study||8
10804792|NCT04037865|11966319|FG000|COMPLETED|Overall Study||8
10804793|NCT04037865|11966319|FG000|NOT COMPLETED|Overall Study||0
10804794|NCT04037748|11966326|FG000|STARTED|Treatment Period 1||36
10804795|NCT04037748|11966327|FG001|STARTED|Treatment Period 1||36
10804796|NCT04037748|11966326|FG000|COMPLETED|Treatment Period 1||28
10804797|NCT04037748|11966327|FG001|COMPLETED|Treatment Period 1||30
10804798|NCT04037748|11966326|FG000|NOT COMPLETED|Treatment Period 1||8
10804799|NCT04037748|11966327|FG001|NOT COMPLETED|Treatment Period 1||6
10804800|NCT04037748|11966326|FG000|STARTED|Treatment Period 2||28
10804801|NCT04037748|11966327|FG001|STARTED|Treatment Period 2||30
10804802|NCT04037748|11966326|FG000|COMPLETED|Treatment Period 2||26
10804803|NCT04037748|11966327|FG001|COMPLETED|Treatment Period 2||29
10804804|NCT04037748|11966326|FG000|NOT COMPLETED|Treatment Period 2||2
10804805|NCT04037748|11966327|FG001|NOT COMPLETED|Treatment Period 2||1
10804806|NCT04036838|11966333|FG000|STARTED|Overall Study||415
10804807|NCT04036838|11966333|FG000|COMPLETED|Overall Study||324
10804808|NCT04036838|11966333|FG000|NOT COMPLETED|Overall Study||91
10804809|NCT04034121|11966337|FG000|STARTED|European Cohort|The European Cohort enrolled 30 patients|30
10804810|NCT04034121|11966337|FG000|COMPLETED|European Cohort||30
10804811|NCT04034121|11966337|FG000|NOT COMPLETED|European Cohort||0
10804812|NCT04034121|11966337|FG000|STARTED|Brazil Cohort|The Brazil Cohort enrolled 20 patients|20
10804813|NCT04034121|11966337|FG000|COMPLETED|Brazil Cohort||20
10804814|NCT04034121|11966337|FG000|NOT COMPLETED|Brazil Cohort||0
10804815|NCT04027686|11966344|FG000|STARTED|Overall Study||17
10804816|NCT04027686|11966345|FG001|STARTED|Overall Study||6
10804817|NCT04027686|11966344|FG000|COMPLETED|Overall Study||15
10804818|NCT04027686|11966345|FG001|COMPLETED|Overall Study||5
10804819|NCT04027686|11966344|FG000|NOT COMPLETED|Overall Study||2
10804820|NCT04027686|11966345|FG001|NOT COMPLETED|Overall Study||1
10804821|NCT04022694|11966357|FG000|STARTED|Overall Study||167
10804822|NCT04022694|11966358|FG001|STARTED|Overall Study||145
10804823|NCT04022694|11966359|FG002|STARTED|Overall Study|This was a cross-sectional study, so participants at baseline -- were not the same as exposure.|143
10804824|NCT04022694|11966360|FG003|STARTED|Overall Study|This was a cross-sectional study, so participants at baseline -- were not the same as exposure.|173
10804825|NCT04022694|11966357|FG000|COMPLETED|Overall Study||167
10804826|NCT04022694|11966358|FG001|COMPLETED|Overall Study||145
10804827|NCT04022694|11966359|FG002|COMPLETED|Overall Study||143
10804828|NCT04022694|11966360|FG003|COMPLETED|Overall Study||173
10804829|NCT04022694|11966357|FG000|NOT COMPLETED|Overall Study||0
10804830|NCT04022694|11966358|FG001|NOT COMPLETED|Overall Study||0
10804831|NCT04022694|11966359|FG002|NOT COMPLETED|Overall Study||0
10804832|NCT04022694|11966360|FG003|NOT COMPLETED|Overall Study||0
10804833|NCT04036110|11966375|FG000|STARTED|Overall Study||12
10804834|NCT04036110|11966376|FG001|STARTED|Overall Study||12
10804835|NCT04036110|11966377|FG002|STARTED|Overall Study||12
10804836|NCT04036110|11966375|FG000|COMPLETED|Overall Study||5
10804837|NCT04036110|11966376|FG001|COMPLETED|Overall Study||5
10804838|NCT04036110|11966377|FG002|COMPLETED|Overall Study||10
10804839|NCT04036110|11966375|FG000|NOT COMPLETED|Overall Study||7
10804840|NCT04036110|11966376|FG001|NOT COMPLETED|Overall Study||7
10804841|NCT04036110|11966377|FG002|NOT COMPLETED|Overall Study||2
10804842|NCT04035694|11966387|FG000|STARTED|Overall Study||374
10804843|NCT04035694|11966388|FG001|STARTED|Overall Study||216
10804844|NCT04035694|11966387|FG000|COMPLETED|Overall Study||374
10804845|NCT04035694|11966388|FG001|COMPLETED|Overall Study||216
10804846|NCT04035694|11966387|FG000|NOT COMPLETED|Overall Study||0
10804847|NCT04035694|11966388|FG001|NOT COMPLETED|Overall Study||0
10804848|NCT04035577|11966394|FG000|STARTED|Overall Study|One participant withdrew after signing the consent but before initiating any study activities.|21
10804849|NCT04035577|11966394|FG000|COMPLETED|Overall Study||19
10327483|NCT00297167|11463240|FG001|COMPLETED|First Double-blind Intervention Period||16
10327484|NCT00297167|11463241|FG002|COMPLETED|First Double-blind Intervention Period||0
10327485|NCT00297167|11463239|FG000|NOT COMPLETED|First Double-blind Intervention Period||0
10327486|NCT00297167|11463240|FG001|NOT COMPLETED|First Double-blind Intervention Period||0
10327487|NCT00297167|11463241|FG002|NOT COMPLETED|First Double-blind Intervention Period||0
10327488|NCT00297167|11463239|FG000|STARTED|Open-label Dose Normalization Period 1||0
10327489|NCT00297167|11463240|FG001|STARTED|Open-label Dose Normalization Period 1||0
10327490|NCT00297167|11463241|FG002|STARTED|Open-label Dose Normalization Period 1||33
10327491|NCT00297167|11463239|FG000|COMPLETED|Open-label Dose Normalization Period 1||0
10327492|NCT00297167|11463240|FG001|COMPLETED|Open-label Dose Normalization Period 1||0
10327493|NCT00297167|11463241|FG002|COMPLETED|Open-label Dose Normalization Period 1||32
10327494|NCT00297167|11463239|FG000|NOT COMPLETED|Open-label Dose Normalization Period 1||0
10327495|NCT00297167|11463240|FG001|NOT COMPLETED|Open-label Dose Normalization Period 1||0
10327496|NCT00297167|11463241|FG002|NOT COMPLETED|Open-label Dose Normalization Period 1||1
10327497|NCT00297167|11463239|FG000|STARTED|Second Double-blind Intervention Period||17
10327498|NCT00297167|11463240|FG001|STARTED|Second Double-blind Intervention Period||15
10327499|NCT00297167|11463241|FG002|STARTED|Second Double-blind Intervention Period||0
10327500|NCT00297167|11463239|FG000|COMPLETED|Second Double-blind Intervention Period||16
10327501|NCT00297167|11463240|FG001|COMPLETED|Second Double-blind Intervention Period||15
10327502|NCT00297167|11463241|FG002|COMPLETED|Second Double-blind Intervention Period||0
10327503|NCT00297167|11463239|FG000|NOT COMPLETED|Second Double-blind Intervention Period||1
10327504|NCT00297167|11463240|FG001|NOT COMPLETED|Second Double-blind Intervention Period||0
10327505|NCT00297167|11463241|FG002|NOT COMPLETED|Second Double-blind Intervention Period||0
10327506|NCT00297167|11463239|FG000|STARTED|Open-label Dose Normalization Period 2||0
10327507|NCT00297167|11463240|FG001|STARTED|Open-label Dose Normalization Period 2||0
10327508|NCT00297167|11463241|FG002|STARTED|Open-label Dose Normalization Period 2||31
10327509|NCT00297167|11463239|FG000|COMPLETED|Open-label Dose Normalization Period 2||0
10327510|NCT00297167|11463240|FG001|COMPLETED|Open-label Dose Normalization Period 2||0
10327511|NCT00297167|11463241|FG002|COMPLETED|Open-label Dose Normalization Period 2||31
10327512|NCT00297167|11463239|FG000|NOT COMPLETED|Open-label Dose Normalization Period 2||0
10327513|NCT00297167|11463240|FG001|NOT COMPLETED|Open-label Dose Normalization Period 2||0
10327514|NCT00297167|11463241|FG002|NOT COMPLETED|Open-label Dose Normalization Period 2||0
10327515|NCT00297232|11463248|FG000|STARTED|Overall Study||1094
10327516|NCT00297232|11463248|FG000|COMPLETED|Overall Study||489
10327517|NCT00297232|11463248|FG000|NOT COMPLETED|Overall Study||605
10327518|NCT00297258|11463252|FG000|STARTED|Overall Study||142
10327519|NCT00297258|11463252|FG000|COMPLETED|Overall Study||0
10327520|NCT00297258|11463252|FG000|NOT COMPLETED|Overall Study||142
10327521|NCT00297427|11463261|FG000|STARTED|Phase 1: Initial Intervention|Intention-to-treat analysis; all randomized subjects were included in analysis|64
10327522|NCT00297427|11463262|FG001|STARTED|Phase 1: Initial Intervention|Intention-to-treat analysis; all randomized subjects were included in analysis|63
10327523|NCT00297427|11463261|FG000|COMPLETED|Phase 1: Initial Intervention||56
10327524|NCT00297427|11463262|FG001|COMPLETED|Phase 1: Initial Intervention||54
10327525|NCT00297427|11463261|FG000|NOT COMPLETED|Phase 1: Initial Intervention||8
10327526|NCT00297427|11463262|FG001|NOT COMPLETED|Phase 1: Initial Intervention||9
10327527|NCT00297427|11463261|FG000|STARTED|Phase 2: Optional Crossover for Sham||54
10327528|NCT00297427|11463262|FG001|STARTED|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
10327529|NCT00297427|11463261|FG000|Crossed Over to True Acupuncture|Phase 2: Optional Crossover for Sham|54 subjects completed the sham acupuncture & were offered the opportunity to cross-over; 12 declined|42
10327530|NCT00297427|11463262|FG001|Crossed Over to True Acupuncture|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
10327531|NCT00297427|11463261|FG000|COMPLETED|Phase 2: Optional Crossover for Sham||38
10327532|NCT00297427|11463262|FG001|COMPLETED|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
10327533|NCT00297427|11463261|FG000|NOT COMPLETED|Phase 2: Optional Crossover for Sham||16
10327534|NCT00297427|11463262|FG001|NOT COMPLETED|Phase 2: Optional Crossover for Sham||0
10327535|NCT00297427|11463261|FG000|STARTED|Phase 3: Follow-up Post-True Acupuncture||94
10327536|NCT00297427|11463262|FG001|STARTED|Phase 3: Follow-up Post-True Acupuncture|Only subjects who received true acupuncture initially or after cross-over entered follow-up|0
10327537|NCT00297427|11463261|FG000|COMPLETED|Phase 3: Follow-up Post-True Acupuncture|Subjects who completed=/>1 follow-up visits and were evaluated for booster acupuncture|60
10327538|NCT00297427|11463262|FG001|COMPLETED|Phase 3: Follow-up Post-True Acupuncture|Only subjects who received true acupuncture initially or after cross-over entered follow-up|0
10327539|NCT00297427|11463261|FG000|NOT COMPLETED|Phase 3: Follow-up Post-True Acupuncture||34
10327540|NCT00297427|11463262|FG001|NOT COMPLETED|Phase 3: Follow-up Post-True Acupuncture||0
10327541|NCT00297479|11463279|FG000|STARTED|Overall Study||103
10327542|NCT00297479|11463280|FG001|STARTED|Overall Study||155
10327543|NCT00297479|11463281|FG002|STARTED|Overall Study||154
10327544|NCT00297479|11463279|FG000|4-Week Follow Up|Overall Study||78
10327545|NCT00297479|11463280|FG001|4-Week Follow Up|Overall Study||132
10327546|NCT00297479|11463281|FG002|4-Week Follow Up|Overall Study||128
10327547|NCT00297479|11463279|FG000|26- Week Follow Up|Overall Study||66
10327548|NCT00297479|11463280|FG001|26- Week Follow Up|Overall Study||101
10327549|NCT00297479|11463281|FG002|26- Week Follow Up|Overall Study||103
10327550|NCT00297479|11463279|FG000|COMPLETED|Overall Study||66
10327551|NCT00297479|11463280|FG001|COMPLETED|Overall Study||101
10327552|NCT00297479|11463281|FG002|COMPLETED|Overall Study||103
10327553|NCT00297479|11463279|FG000|NOT COMPLETED|Overall Study||37
10327554|NCT00297479|11463280|FG001|NOT COMPLETED|Overall Study||54
10327555|NCT00297479|11463281|FG002|NOT COMPLETED|Overall Study||51
10327556|NCT00297492|11463292|FG000|STARTED|Set Quit Date||297
10327557|NCT00297492|11463293|FG001|STARTED|Set Quit Date||299
10804850|NCT04035577|11966394|FG000|NOT COMPLETED|Overall Study||2
10804851|NCT04035564|11966402|FG000|STARTED|Overall Study||27
10804852|NCT04035564|11966403|FG001|STARTED|Overall Study||25
10804853|NCT04035564|11966402|FG000|COMPLETED|Overall Study||23
10804854|NCT04035564|11966403|FG001|COMPLETED|Overall Study||19
10804855|NCT04035564|11966402|FG000|NOT COMPLETED|Overall Study||4
10804856|NCT04035564|11966403|FG001|NOT COMPLETED|Overall Study||6
10804857|NCT04032977|11966411|FG000|STARTED|Overall Study||80
10804858|NCT04032977|11966412|FG001|STARTED|Overall Study||78
10804859|NCT04032977|11966411|FG000|COMPLETED|Overall Study||71
10804860|NCT04032977|11966412|FG001|COMPLETED|Overall Study||70
10804861|NCT04032977|11966411|FG000|NOT COMPLETED|Overall Study||9
10804862|NCT04032977|11966412|FG001|NOT COMPLETED|Overall Study||8
10804863|NCT04032652|11966420|FG000|STARTED|Overall Study||1
10804864|NCT04032652|11966421|FG001|STARTED|Overall Study||1
10804865|NCT04032652|11966420|FG000|COMPLETED|Overall Study||0
10804866|NCT04032652|11966421|FG001|COMPLETED|Overall Study||0
10804867|NCT04032652|11966420|FG000|NOT COMPLETED|Overall Study||1
10804868|NCT04032652|11966421|FG001|NOT COMPLETED|Overall Study||1
10811062|NCT03781336|11972766|FG000|COMPLETED|Overall Study|All participants were included in the analysis (Intent to treat)|43
10811063|NCT03781336|11972767|FG001|COMPLETED|Overall Study|All participants were included in the analysis (Intent to treat)|35
10811064|NCT03781336|11972766|FG000|NOT COMPLETED|Overall Study||2
10811065|NCT03781336|11972767|FG001|NOT COMPLETED|Overall Study||2
10811066|NCT03780400|11972773|FG000|STARTED|Overall Study||60
10811067|NCT03780400|11972773|FG000|COMPLETED|Overall Study||53
10811068|NCT03780400|11972773|FG000|NOT COMPLETED|Overall Study||7
10811069|NCT03779997|11972779|FG000|STARTED|Overall Study||39
10811070|NCT03779997|11972780|FG001|STARTED|Overall Study||39
10811071|NCT03779997|11972779|FG000|Completed at Least One Visit|Overall Study||39
10811072|NCT03779997|11972780|FG001|Completed at Least One Visit|Overall Study||39
10811073|NCT03779997|11972779|FG000|COMPLETED|Overall Study||39
10811074|NCT03779997|11972780|FG001|COMPLETED|Overall Study||39
10811075|NCT03779997|11972779|FG000|NOT COMPLETED|Overall Study||0
10811076|NCT03779997|11972780|FG001|NOT COMPLETED|Overall Study||0
10811077|NCT03779503|11972786|FG000|STARTED|First Intervention||28
10811078|NCT03779503|11972787|FG001|STARTED|First Intervention||27
10811079|NCT03779503|11972786|FG000|COMPLETED|First Intervention||27
10811080|NCT03779503|11972787|FG001|COMPLETED|First Intervention||26
10811081|NCT03779503|11972786|FG000|NOT COMPLETED|First Intervention||1
10811082|NCT03779503|11972787|FG001|NOT COMPLETED|First Intervention||1
10811083|NCT03779503|11972786|FG000|STARTED|Second Intervention||27
10811084|NCT03779503|11972787|FG001|STARTED|Second Intervention||26
10811085|NCT03779503|11972786|FG000|COMPLETED|Second Intervention||27
10811086|NCT03779503|11972787|FG001|COMPLETED|Second Intervention||26
10811087|NCT03779503|11972786|FG000|NOT COMPLETED|Second Intervention||0
10811088|NCT03779503|11972787|FG001|NOT COMPLETED|Second Intervention||0
10811089|NCT03780010|11972795|FG000|STARTED|Overall Study||3
10811090|NCT03780010|11972796|FG001|STARTED|Overall Study||12
10811091|NCT03780010|11972795|FG000|COMPLETED|Overall Study||3
10811092|NCT03780010|11972796|FG001|COMPLETED|Overall Study||12
10811093|NCT03780010|11972795|FG000|NOT COMPLETED|Overall Study||0
10811094|NCT03780010|11972796|FG001|NOT COMPLETED|Overall Study||0
10811095|NCT03778190|11972813|FG000|STARTED|Overall Study||10
10811096|NCT03778190|11972813|FG000|COMPLETED|Overall Study||10
10811097|NCT03778190|11972813|FG000|NOT COMPLETED|Overall Study||0
10811098|NCT03777059|11972821|FG000|STARTED|DB Treatment Period (Up to Week 12)||223
10811099|NCT03777059|11972822|FG001|STARTED|DB Treatment Period (Up to Week 12)||222
10811100|NCT03777059|11972823|FG002|STARTED|DB Treatment Period (Up to Week 12)||230
10811101|NCT03777059|11972824|FG003|STARTED|DB Treatment Period (Up to Week 12)||235
10811102|NCT03777059|11972821|FG000|Treated: Safety Population|DB Treatment Period (Up to Week 12)||222
10811103|NCT03777059|11972822|FG001|Treated: Safety Population|DB Treatment Period (Up to Week 12)||221
10811104|NCT03777059|11972823|FG002|Treated: Safety Population|DB Treatment Period (Up to Week 12)||228
10811105|NCT03777059|11972824|FG003|Treated: Safety Population|DB Treatment Period (Up to Week 12)||231
10811106|NCT03777059|11972821|FG000|COMPLETED|DB Treatment Period (Up to Week 12)||201
10811107|NCT03777059|11972822|FG001|COMPLETED|DB Treatment Period (Up to Week 12)||193
10811108|NCT03777059|11972823|FG002|COMPLETED|DB Treatment Period (Up to Week 12)||207
10811109|NCT03777059|11972824|FG003|COMPLETED|DB Treatment Period (Up to Week 12)||204
10811110|NCT03777059|11972821|FG000|NOT COMPLETED|DB Treatment Period (Up to Week 12)||22
10811111|NCT03777059|11972822|FG001|NOT COMPLETED|DB Treatment Period (Up to Week 12)||29
10811112|NCT03777059|11972823|FG002|NOT COMPLETED|DB Treatment Period (Up to Week 12)||23
10811113|NCT03777059|11972824|FG003|NOT COMPLETED|DB Treatment Period (Up to Week 12)||31
10811114|NCT03777059|11972821|FG000|STARTED|Follow-Up Period (Weeks 12 to 16)||46
10811115|NCT03777059|11972822|FG001|STARTED|Follow-Up Period (Weeks 12 to 16)||54
10811116|NCT03777059|11972823|FG002|STARTED|Follow-Up Period (Weeks 12 to 16)||38
10811117|NCT03777059|11972824|FG003|STARTED|Follow-Up Period (Weeks 12 to 16)||45
10811118|NCT03777059|11972821|FG000|COMPLETED|Follow-Up Period (Weeks 12 to 16)||41
10811221|NCT03769896|11972940|FG000|COMPLETED|Double-blind Treatment Phase||19
10327558|NCT00297492|11463294|FG002|STARTED|Set Quit Date||150
10327559|NCT00297492|11463292|FG000|COMPLETED|Set Quit Date||290
10327560|NCT00297492|11463293|FG001|COMPLETED|Set Quit Date||286
10804869|NCT04024501|11966427|FG000|STARTED|Overall Study||25
10804870|NCT04024501|11966427|FG000|COMPLETED|Overall Study||25
10804871|NCT04024501|11966427|FG000|NOT COMPLETED|Overall Study||0
10804872|NCT04032613|11966441|FG000|STARTED|Overall Study||21
10804873|NCT04032613|11966442|FG001|STARTED|Overall Study||25
10804874|NCT04032613|11966441|FG000|COMPLETED|Overall Study||16
10804875|NCT04032613|11966442|FG001|COMPLETED|Overall Study||23
10804876|NCT04032613|11966441|FG000|NOT COMPLETED|Overall Study||5
10804877|NCT04032613|11966442|FG001|NOT COMPLETED|Overall Study||2
10804878|NCT04032171|11966450|FG000|STARTED|Overall Study||1
10804879|NCT04032171|11966451|FG001|STARTED|Overall Study||0
10804880|NCT04032171|11966450|FG000|COMPLETED|Overall Study||0
10804881|NCT04032171|11966451|FG001|COMPLETED|Overall Study||0
10804882|NCT04032171|11966450|FG000|NOT COMPLETED|Overall Study||1
10804883|NCT04032171|11966451|FG001|NOT COMPLETED|Overall Study||0
10804884|NCT04032158|11966459|FG000|STARTED|Overall Study||2
10804885|NCT04032158|11966460|FG001|STARTED|Overall Study||1
10804886|NCT04032158|11966459|FG000|COMPLETED|Overall Study||0
10804887|NCT04032158|11966460|FG001|COMPLETED|Overall Study||0
10804888|NCT04032158|11966459|FG000|NOT COMPLETED|Overall Study||2
10804889|NCT04032158|11966460|FG001|NOT COMPLETED|Overall Study||1
10804890|NCT04031404|11966466|FG000|STARTED|Baseline||10
10804891|NCT04031404|11966467|FG001|STARTED|Baseline||13
10804892|NCT04031404|11966466|FG000|COMPLETED|Baseline||8
10804893|NCT04031404|11966467|FG001|COMPLETED|Baseline||8
10804894|NCT04031404|11966466|FG000|NOT COMPLETED|Baseline||2
10804895|NCT04031404|11966467|FG001|NOT COMPLETED|Baseline||5
10804896|NCT04031404|11966466|FG000|STARTED|Pre-randomization||8
10804897|NCT04031404|11966467|FG001|STARTED|Pre-randomization||8
10804898|NCT04031404|11966466|FG000|COMPLETED|Pre-randomization||6
10804899|NCT04031404|11966467|FG001|COMPLETED|Pre-randomization||5
10804900|NCT04031404|11966466|FG000|NOT COMPLETED|Pre-randomization||2
10804901|NCT04031404|11966467|FG001|NOT COMPLETED|Pre-randomization||3
10804902|NCT04031404|11966466|FG000|STARTED|First Drink Visit||6
10804903|NCT04031404|11966467|FG001|STARTED|First Drink Visit||5
10804904|NCT04031404|11966466|FG000|COMPLETED|First Drink Visit||6
10804905|NCT04031404|11966467|FG001|COMPLETED|First Drink Visit||5
10804906|NCT04031404|11966466|FG000|NOT COMPLETED|First Drink Visit||0
10804907|NCT04031404|11966467|FG001|NOT COMPLETED|First Drink Visit||0
10804908|NCT04031404|11966466|FG000|STARTED|Washout (5 Day Min)||6
10804909|NCT04031404|11966467|FG001|STARTED|Washout (5 Day Min)||5
10804910|NCT04031404|11966466|FG000|COMPLETED|Washout (5 Day Min)||5
10804911|NCT04031404|11966467|FG001|COMPLETED|Washout (5 Day Min)||5
10804912|NCT04031404|11966466|FG000|NOT COMPLETED|Washout (5 Day Min)||1
10804913|NCT04031404|11966467|FG001|NOT COMPLETED|Washout (5 Day Min)||0
10804914|NCT04031404|11966466|FG000|STARTED|Second Drink Visit||5
10804915|NCT04031404|11966467|FG001|STARTED|Second Drink Visit||5
10804916|NCT04031404|11966466|FG000|COMPLETED|Second Drink Visit||5
10804917|NCT04031404|11966467|FG001|COMPLETED|Second Drink Visit||5
10804918|NCT04031404|11966466|FG000|NOT COMPLETED|Second Drink Visit||0
10804919|NCT04031404|11966467|FG001|NOT COMPLETED|Second Drink Visit||0
10804920|NCT04031885|11966483|FG000|STARTED|Overall Study||1
10804921|NCT04031885|11966484|FG001|STARTED|Overall Study||3
10804922|NCT04031885|11966483|FG000|Received Any Quantity of Study Treatment|Overall Study||1
10804923|NCT04031885|11966484|FG001|Received Any Quantity of Study Treatment|Overall Study||1
10804924|NCT04031885|11966483|FG000|COMPLETED|Overall Study||1
10804925|NCT04031885|11966484|FG001|COMPLETED|Overall Study||3
10804926|NCT04031885|11966483|FG000|NOT COMPLETED|Overall Study||0
10804927|NCT04031885|11966484|FG001|NOT COMPLETED|Overall Study||0
10804928|NCT04018924|11966490|FG000|STARTED|Overall Study|The total number of participants is 90 and the patient is control of themselves.|90
10804929|NCT04018924|11966490|FG000|Standard Of Care Intervention|Overall Study||90
10804930|NCT04018924|11966490|FG000|EmoLED Intervention|Overall Study||90
10804931|NCT04018924|11966490|FG000|COMPLETED|Overall Study||84
10804932|NCT04018924|11966490|FG000|NOT COMPLETED|Overall Study||6
10804933|NCT04015440|11966496|FG000|STARTED|Overall Study||117
10804934|NCT04015440|11966497|FG001|STARTED|Overall Study||112
10804935|NCT04015440|11966496|FG000|COMPLETED|Overall Study||109
10804936|NCT04015440|11966497|FG001|COMPLETED|Overall Study||108
10804937|NCT04015440|11966496|FG000|NOT COMPLETED|Overall Study||8
10804938|NCT04015440|11966497|FG001|NOT COMPLETED|Overall Study||4
10804939|NCT04030104|11966503|FG000|STARTED|Overall Study||480
10804940|NCT04030104|11966503|FG000|COMPLETED|Overall Study||480
10804941|NCT04030104|11966503|FG000|NOT COMPLETED|Overall Study||0
10804942|NCT04029961|11966512|FG000|STARTED|Overall Study||13
10804943|NCT04029961|11966513|FG001|STARTED|Overall Study||13
10804944|NCT04029961|11966512|FG000|COMPLETED|Overall Study||12
10804945|NCT04029961|11966513|FG001|COMPLETED|Overall Study||12
10804946|NCT04029961|11966512|FG000|NOT COMPLETED|Overall Study||1
10804947|NCT04029961|11966513|FG001|NOT COMPLETED|Overall Study||1
10804948|NCT04025684|11966523|FG000|STARTED|Overall Study||20
10804949|NCT04025684|11966524|FG001|STARTED|Overall Study||19
10327561|NCT00297492|11463294|FG002|COMPLETED|Set Quit Date||145
10804950|NCT04025684|11966525|FG002|STARTED|Overall Study||20
10804951|NCT04025684|11966526|FG003|STARTED|Overall Study||21
10804952|NCT04025684|11966523|FG000|COMPLETED|Overall Study||18
10804953|NCT04025684|11966524|FG001|COMPLETED|Overall Study||15
10804954|NCT04025684|11966525|FG002|COMPLETED|Overall Study||20
10804955|NCT04025684|11966526|FG003|COMPLETED|Overall Study||20
10804956|NCT04025684|11966523|FG000|NOT COMPLETED|Overall Study||2
10804957|NCT04025684|11966524|FG001|NOT COMPLETED|Overall Study||4
10327562|NCT00297492|11463292|FG000|NOT COMPLETED|Set Quit Date||7
10804958|NCT04025684|11966525|FG002|NOT COMPLETED|Overall Study||0
10804959|NCT04025684|11966526|FG003|NOT COMPLETED|Overall Study||1
10804960|NCT04019054|11966538|FG000|STARTED|Overall Study||11
10804961|NCT04019054|11966539|FG001|STARTED|Overall Study||11
10804962|NCT04019054|11966538|FG000|COMPLETED|Overall Study||8
10804963|NCT04019054|11966539|FG001|COMPLETED|Overall Study||9
10804964|NCT04019054|11966538|FG000|NOT COMPLETED|Overall Study||3
10804965|NCT04019054|11966539|FG001|NOT COMPLETED|Overall Study||2
10804966|NCT04029545|11966548|FG000|STARTED|Overall Study||2
10804967|NCT04029545|11966549|FG001|STARTED|Overall Study||1
10804968|NCT04029545|11966550|FG002|STARTED|Overall Study||2
10804969|NCT04029545|11966548|FG000|COMPLETED|Overall Study||2
10804970|NCT04029545|11966549|FG001|COMPLETED|Overall Study||1
10804971|NCT04029545|11966550|FG002|COMPLETED|Overall Study||2
10804972|NCT04029545|11966548|FG000|NOT COMPLETED|Overall Study||0
10804973|NCT04029545|11966549|FG001|NOT COMPLETED|Overall Study||0
10804974|NCT04029545|11966550|FG002|NOT COMPLETED|Overall Study||0
10804975|NCT04029584|11966558|FG000|STARTED|Uninduced Study 1st Intervention (1 Day)||4
10804976|NCT04029584|11966559|FG001|STARTED|Uninduced Study 1st Intervention (1 Day)||6
10804977|NCT04029584|11966558|FG000|COMPLETED|Uninduced Study 1st Intervention (1 Day)||4
10804978|NCT04029584|11966559|FG001|COMPLETED|Uninduced Study 1st Intervention (1 Day)||6
10804979|NCT04029584|11966558|FG000|NOT COMPLETED|Uninduced Study 1st Intervention (1 Day)||0
10804980|NCT04029584|11966559|FG001|NOT COMPLETED|Uninduced Study 1st Intervention (1 Day)||0
10804981|NCT04029584|11966558|FG000|STARTED|Uninduced Washout (1 Day)||4
10804982|NCT04029584|11966559|FG001|STARTED|Uninduced Washout (1 Day)||6
10804983|NCT04029584|11966558|FG000|COMPLETED|Uninduced Washout (1 Day)||4
10804984|NCT04029584|11966559|FG001|COMPLETED|Uninduced Washout (1 Day)||6
10804985|NCT04029584|11966558|FG000|NOT COMPLETED|Uninduced Washout (1 Day)||0
10804986|NCT04029584|11966559|FG001|NOT COMPLETED|Uninduced Washout (1 Day)||0
10804987|NCT04029584|11966558|FG000|STARTED|Uninduced Study 2nd Intervention (1 Day)||4
10804988|NCT04029584|11966559|FG001|STARTED|Uninduced Study 2nd Intervention (1 Day)||6
10804989|NCT04029584|11966558|FG000|COMPLETED|Uninduced Study 2nd Intervention (1 Day)||4
10804990|NCT04029584|11966559|FG001|COMPLETED|Uninduced Study 2nd Intervention (1 Day)||6
10804991|NCT04029584|11966558|FG000|NOT COMPLETED|Uninduced Study 2nd Intervention (1 Day)||0
10804992|NCT04029584|11966559|FG001|NOT COMPLETED|Uninduced Study 2nd Intervention (1 Day)||0
10804993|NCT04029584|11966558|FG000|STARTED|Washout Between (>1 Week)||4
10804994|NCT04029584|11966559|FG001|STARTED|Washout Between (>1 Week)||6
10804995|NCT04029584|11966558|FG000|COMPLETED|Washout Between (>1 Week)||4
10804996|NCT04029584|11966559|FG001|COMPLETED|Washout Between (>1 Week)||6
10804997|NCT04029584|11966558|FG000|NOT COMPLETED|Washout Between (>1 Week)||0
10804998|NCT04029584|11966559|FG001|NOT COMPLETED|Washout Between (>1 Week)||0
10804999|NCT04029584|11966558|FG000|STARTED|Induced Study 1st Intervention (1 Day)||2
10805000|NCT04029584|11966559|FG001|STARTED|Induced Study 1st Intervention (1 Day)||8
10805001|NCT04029584|11966558|FG000|COMPLETED|Induced Study 1st Intervention (1 Day)||2
10805002|NCT04029584|11966559|FG001|COMPLETED|Induced Study 1st Intervention (1 Day)||8
10805003|NCT04029584|11966558|FG000|NOT COMPLETED|Induced Study 1st Intervention (1 Day)||0
10805004|NCT04029584|11966559|FG001|NOT COMPLETED|Induced Study 1st Intervention (1 Day)||0
10805005|NCT04029584|11966558|FG000|STARTED|Induced Washout (1 Day)||2
10805006|NCT04029584|11966559|FG001|STARTED|Induced Washout (1 Day)||8
10805007|NCT04029584|11966558|FG000|COMPLETED|Induced Washout (1 Day)||2
10805008|NCT04029584|11966559|FG001|COMPLETED|Induced Washout (1 Day)||8
10805009|NCT04029584|11966558|FG000|NOT COMPLETED|Induced Washout (1 Day)||0
10805010|NCT04029584|11966559|FG001|NOT COMPLETED|Induced Washout (1 Day)||0
10805011|NCT04029584|11966558|FG000|STARTED|Induced Study 2nd Intervention (1 Day)||2
10805012|NCT04029584|11966559|FG001|STARTED|Induced Study 2nd Intervention (1 Day)||8
10805013|NCT04029584|11966558|FG000|COMPLETED|Induced Study 2nd Intervention (1 Day)||2
10805014|NCT04029584|11966559|FG001|COMPLETED|Induced Study 2nd Intervention (1 Day)||8
10805015|NCT04029584|11966558|FG000|NOT COMPLETED|Induced Study 2nd Intervention (1 Day)||0
10805016|NCT04029584|11966559|FG001|NOT COMPLETED|Induced Study 2nd Intervention (1 Day)||0
10805017|NCT04029311|11966571|FG000|STARTED|Overall Study||15
10805018|NCT04029311|11966572|FG001|STARTED|Overall Study||13
10805019|NCT04029311|11966571|FG000|COMPLETED|Overall Study||12
10805020|NCT04029311|11966572|FG001|COMPLETED|Overall Study||13
10805021|NCT04029311|11966571|FG000|NOT COMPLETED|Overall Study||3
10805022|NCT04029311|11966572|FG001|NOT COMPLETED|Overall Study||0
10805023|NCT04028960|11966580|FG000|STARTED|Overall Study||2
10805024|NCT04028960|11966581|FG001|STARTED|Overall Study||2
10805025|NCT04028960|11966580|FG000|COMPLETED|Overall Study||2
10805026|NCT04028960|11966581|FG001|COMPLETED|Overall Study||2
10805027|NCT04028960|11966580|FG000|NOT COMPLETED|Overall Study||0
10805028|NCT04028960|11966581|FG001|NOT COMPLETED|Overall Study||0
10805029|NCT04026399|11966589|FG000|STARTED|Overall Study||6
10805030|NCT04026399|11966590|FG001|STARTED|Overall Study||6
10805031|NCT04026399|11966589|FG000|COMPLETED|Overall Study||1
10805032|NCT04026399|11966590|FG001|COMPLETED|Overall Study||3
10805033|NCT04026399|11966589|FG000|NOT COMPLETED|Overall Study||5
10805034|NCT04026399|11966590|FG001|NOT COMPLETED|Overall Study||3
10805035|NCT04023578|11966596|FG000|STARTED|Overall Study||15
10805036|NCT04023578|11966596|FG000|COMPLETED|Overall Study||13
10805037|NCT04023578|11966596|FG000|NOT COMPLETED|Overall Study||2
10805038|NCT04023695|11966603|FG000|STARTED|Overall Study||57
10805039|NCT04023695|11966604|FG001|STARTED|Overall Study||53
10805040|NCT04023695|11966603|FG000|COMPLETED|Overall Study||57
10805041|NCT04023695|11966604|FG001|COMPLETED|Overall Study||53
10805042|NCT04023695|11966603|FG000|NOT COMPLETED|Overall Study||0
10805043|NCT04023695|11966604|FG001|NOT COMPLETED|Overall Study||0
10805044|NCT04018664|11966618|FG000|STARTED|Overall Study||14
10805045|NCT04018664|11966619|FG001|STARTED|Overall Study||6
10805046|NCT04018664|11966620|FG002|STARTED|Overall Study||6
10805047|NCT04018664|11966621|FG003|STARTED|Overall Study||6
10805048|NCT04018664|11966622|FG004|STARTED|Overall Study||6
10805049|NCT04018664|11966623|FG005|STARTED|Overall Study||6
10805050|NCT04018664|11966624|FG006|STARTED|Overall Study||6
10805051|NCT04018664|11966625|FG007|STARTED|Overall Study||6
10805052|NCT04018664|11966618|FG000|COMPLETED|Overall Study||14
10805053|NCT04018664|11966619|FG001|COMPLETED|Overall Study||6
10805054|NCT04018664|11966620|FG002|COMPLETED|Overall Study||6
10574641|NCT01679600|11729910|FG000|COMPLETED|Overall Study||7
10805055|NCT04018664|11966621|FG003|COMPLETED|Overall Study||6
10805056|NCT04018664|11966622|FG004|COMPLETED|Overall Study||6
10805057|NCT04018664|11966623|FG005|COMPLETED|Overall Study||6
10805058|NCT04018664|11966624|FG006|COMPLETED|Overall Study||6
10805059|NCT04018664|11966625|FG007|COMPLETED|Overall Study||6
10805060|NCT04018664|11966618|FG000|NOT COMPLETED|Overall Study||0
10805061|NCT04018664|11966619|FG001|NOT COMPLETED|Overall Study||0
10805062|NCT04018664|11966620|FG002|NOT COMPLETED|Overall Study||0
10805063|NCT04018664|11966621|FG003|NOT COMPLETED|Overall Study||0
10805064|NCT04018664|11966622|FG004|NOT COMPLETED|Overall Study||0
10805065|NCT04018664|11966623|FG005|NOT COMPLETED|Overall Study||0
10805066|NCT04018664|11966624|FG006|NOT COMPLETED|Overall Study||0
10805067|NCT04018664|11966625|FG007|NOT COMPLETED|Overall Study||0
10805068|NCT04016259|11966645|FG000|STARTED|Overall Study||15
10805069|NCT04016259|11966646|FG001|STARTED|Overall Study||15
10805070|NCT04016259|11966645|FG000|COMPLETED|Overall Study||15
10805071|NCT04016259|11966646|FG001|COMPLETED|Overall Study||15
10805072|NCT04016259|11966645|FG000|NOT COMPLETED|Overall Study||0
10805073|NCT04016259|11966646|FG001|NOT COMPLETED|Overall Study||0
10805074|NCT04016077|11966654|FG000|STARTED|Overall Study||10
10805075|NCT04016077|11966655|FG001|STARTED|Overall Study||8
10805076|NCT04016077|11966654|FG000|COMPLETED|Overall Study||10
10805077|NCT04016077|11966655|FG001|COMPLETED|Overall Study||8
10805078|NCT04016077|11966654|FG000|NOT COMPLETED|Overall Study||0
10805079|NCT04016077|11966655|FG001|NOT COMPLETED|Overall Study||0
10805080|NCT04027803|11966663|FG000|STARTED|Overall Study||39
10805081|NCT04027803|11966664|FG001|STARTED|Overall Study||39
10805082|NCT04027803|11966663|FG000|COMPLETED|Overall Study||39
10805083|NCT04027803|11966664|FG001|COMPLETED|Overall Study||39
10805084|NCT04027803|11966663|FG000|NOT COMPLETED|Overall Study||0
10805085|NCT04027803|11966664|FG001|NOT COMPLETED|Overall Study||0
10805086|NCT04016311|11966672|FG000|STARTED|Overall Study||18
10805087|NCT04016311|11966673|FG001|STARTED|Overall Study||20
10805088|NCT04016311|11966672|FG000|COMPLETED|Overall Study||17
10805089|NCT04016311|11966673|FG001|COMPLETED|Overall Study||20
10805090|NCT04016311|11966672|FG000|NOT COMPLETED|Overall Study||1
10805091|NCT04016311|11966673|FG001|NOT COMPLETED|Overall Study||0
10574642|NCT01679600|11729911|FG001|COMPLETED|Overall Study||7
10327563|NCT00297492|11463293|FG001|NOT COMPLETED|Set Quit Date||13
10327564|NCT00297492|11463294|FG002|NOT COMPLETED|Set Quit Date||5
10327565|NCT00297492|11463292|FG000|STARTED|6 Month Follow-up||290
10327566|NCT00297492|11463293|FG001|STARTED|6 Month Follow-up||286
10327567|NCT00297492|11463294|FG002|STARTED|6 Month Follow-up||145
10327568|NCT00297492|11463292|FG000|COMPLETED|6 Month Follow-up||227
10327569|NCT00297492|11463293|FG001|COMPLETED|6 Month Follow-up||237
10327570|NCT00297492|11463294|FG002|COMPLETED|6 Month Follow-up||118
10327571|NCT00297492|11463292|FG000|NOT COMPLETED|6 Month Follow-up||63
10327572|NCT00297492|11463293|FG001|NOT COMPLETED|6 Month Follow-up||49
10327573|NCT00297492|11463294|FG002|NOT COMPLETED|6 Month Follow-up||27
10327574|NCT00297596|11463302|FG000|STARTED|Overall Study||25
10327575|NCT00297596|11463302|FG000|COMPLETED|Overall Study||25
10327576|NCT00297596|11463302|FG000|NOT COMPLETED|Overall Study||0
10327577|NCT00297648|11463306|FG000|STARTED|Overall Study||89
10327578|NCT00297648|11463306|FG000|COMPLETED|Overall Study||53
10327579|NCT00297648|11463306|FG000|NOT COMPLETED|Overall Study||36
10327580|NCT00297778|11463312|FG000|STARTED|Overall Study||152
10327581|NCT00297778|11463313|FG001|STARTED|Overall Study||144
10327582|NCT00297778|11463312|FG000|COMPLETED|Overall Study||133
10327583|NCT00297778|11463313|FG001|COMPLETED|Overall Study||124
10327584|NCT00297778|11463312|FG000|NOT COMPLETED|Overall Study||19
10327585|NCT00297778|11463313|FG001|NOT COMPLETED|Overall Study||20
10327586|NCT00297830|11463322|FG000|STARTED|Baseline||41
10327587|NCT00297830|11463323|FG001|STARTED|Baseline||43
10327588|NCT00297830|11463324|FG002|STARTED|Baseline||27
10327589|NCT00297830|11463322|FG000|COMPLETED|Baseline||41
10327590|NCT00297830|11463323|FG001|COMPLETED|Baseline||43
10327591|NCT00297830|11463324|FG002|COMPLETED|Baseline||27
10327592|NCT00297830|11463322|FG000|NOT COMPLETED|Baseline||0
10456281|NCT01005966|11604236|FG001|NOT COMPLETED|Treatment Period 5 (14 Days)||0
10456282|NCT01005966|11604237|FG002|NOT COMPLETED|Treatment Period 5 (14 Days)||0
10456283|NCT01005966|11604238|FG003|NOT COMPLETED|Treatment Period 5 (14 Days)||0
10456284|NCT01005966|11604239|FG004|NOT COMPLETED|Treatment Period 5 (14 Days)||0
10456285|NCT01006122|11604256|FG000|STARTED|First Double-blind Intervention Period||47
10456286|NCT01006122|11604257|FG001|STARTED|First Double-blind Intervention Period||48
10456287|NCT01006122|11604256|FG000|COMPLETED|First Double-blind Intervention Period||31
10456288|NCT01006122|11604257|FG001|COMPLETED|First Double-blind Intervention Period||31
10456289|NCT01006122|11604256|FG000|NOT COMPLETED|First Double-blind Intervention Period||16
10456290|NCT01006122|11604257|FG001|NOT COMPLETED|First Double-blind Intervention Period||17
10456291|NCT01006122|11604256|FG000|STARTED|Wash-out Period (at Least 7 Days)||31
10456292|NCT01006122|11604257|FG001|STARTED|Wash-out Period (at Least 7 Days)||31
10456293|NCT01006122|11604256|FG000|COMPLETED|Wash-out Period (at Least 7 Days)||31
10456294|NCT01006122|11604257|FG001|COMPLETED|Wash-out Period (at Least 7 Days)||31
10456295|NCT01006122|11604256|FG000|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
10456296|NCT01006122|11604257|FG001|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
10456297|NCT01006122|11604256|FG000|STARTED|Second Double-blind Intervention Period||31
10456298|NCT01006122|11604257|FG001|STARTED|Second Double-blind Intervention Period||31
10456299|NCT01006122|11604256|FG000|COMPLETED|Second Double-blind Intervention Period||29
10456300|NCT01006122|11604257|FG001|COMPLETED|Second Double-blind Intervention Period||24
10456301|NCT01006122|11604256|FG000|NOT COMPLETED|Second Double-blind Intervention Period||2
10456302|NCT01006122|11604257|FG001|NOT COMPLETED|Second Double-blind Intervention Period||7
10456303|NCT01006135|11604263|FG000|STARTED|Overall Study||4852
10456304|NCT01006135|11604263|FG000|COMPLETED|Overall Study||4712
10456305|NCT01006135|11604263|FG000|NOT COMPLETED|Overall Study||140
10456306|NCT01006252|11604269|FG000|STARTED|Overall Study||168
10456307|NCT01006252|11604270|FG001|STARTED|Overall Study||168
10456308|NCT01006252|11604269|FG000|Received Treatment|Overall Study||164
10456309|NCT01006252|11604270|FG001|Received Treatment|Overall Study||161
10456310|NCT01006252|11604269|FG000|COMPLETED|Overall Study||168
10327593|NCT00297830|11463323|FG001|NOT COMPLETED|Baseline||0
10327594|NCT00297830|11463324|FG002|NOT COMPLETED|Baseline||0
10327595|NCT00297830|11463322|FG000|STARTED|6 Month Visit||41
10327596|NCT00297830|11463323|FG001|STARTED|6 Month Visit||43
10327597|NCT00297830|11463324|FG002|STARTED|6 Month Visit||27
10327598|NCT00297830|11463322|FG000|COMPLETED|6 Month Visit||38
10327599|NCT00297830|11463323|FG001|COMPLETED|6 Month Visit||41
10327600|NCT00297830|11463324|FG002|COMPLETED|6 Month Visit||24
10327601|NCT00297830|11463322|FG000|NOT COMPLETED|6 Month Visit||3
10327602|NCT00297830|11463323|FG001|NOT COMPLETED|6 Month Visit||2
10327603|NCT00297830|11463324|FG002|NOT COMPLETED|6 Month Visit||3
10327604|NCT00297830|11463322|FG000|STARTED|12 Month Visit||38
10327605|NCT00297830|11463323|FG001|STARTED|12 Month Visit||41
10327606|NCT00297830|11463324|FG002|STARTED|12 Month Visit||24
10327607|NCT00297830|11463322|FG000|COMPLETED|12 Month Visit||37
10327608|NCT00297830|11463323|FG001|COMPLETED|12 Month Visit||35
10327609|NCT00297830|11463324|FG002|COMPLETED|12 Month Visit||24
10327610|NCT00297830|11463322|FG000|NOT COMPLETED|12 Month Visit||1
10327611|NCT00297830|11463323|FG001|NOT COMPLETED|12 Month Visit||6
10327612|NCT00297830|11463324|FG002|NOT COMPLETED|12 Month Visit||0
10327613|NCT00297882|11463334|FG000|STARTED|Day 14||204
10327614|NCT00297882|11463335|FG001|STARTED|Day 14||612
10327615|NCT00297882|11463334|FG000|COMPLETED|Day 14||192
10327616|NCT00297882|11463335|FG001|COMPLETED|Day 14||563
10327617|NCT00297882|11463334|FG000|NOT COMPLETED|Day 14||12
10327618|NCT00297882|11463335|FG001|NOT COMPLETED|Day 14||49
10327619|NCT00297882|11463334|FG000|STARTED|Day 28||192
10327620|NCT00297882|11463335|FG001|STARTED|Day 28||563
10327621|NCT00297882|11463334|FG000|COMPLETED|Day 28||176
10327622|NCT00297882|11463335|FG001|COMPLETED|Day 28||540
10327623|NCT00297882|11463334|FG000|NOT COMPLETED|Day 28||16
10327624|NCT00297882|11463335|FG001|NOT COMPLETED|Day 28||23
10327625|NCT00298038|11463345|FG000|STARTED|Overall Study||140
10701724|NCT02569801|11866193|FG001|STARTED|Overall Study||35
10327626|NCT00298038|11463346|FG001|STARTED|Overall Study||159
10327627|NCT00298038|11463345|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||140
10327628|NCT00298038|11463346|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||159
10327629|NCT00298038|11463345|FG000|COMPLETED|Overall Study||88
10327630|NCT00298038|11463346|FG001|COMPLETED|Overall Study||66
10327631|NCT00298038|11463345|FG000|NOT COMPLETED|Overall Study||52
10327632|NCT00298038|11463346|FG001|NOT COMPLETED|Overall Study||93
10327633|NCT00298090|11463352|FG000|STARTED|Overall Study||47
10327634|NCT00298090|11463352|FG000|COMPLETED|Overall Study|Eighteen subjects were not included in final analysis due to incomplete data sets|29
10327635|NCT00298090|11463352|FG000|NOT COMPLETED|Overall Study||18
10327636|NCT00298155|11463359|FG000|STARTED|Overall Study||12
10327637|NCT00298155|11463360|FG001|STARTED|Overall Study||10
10327638|NCT00298155|11463361|FG002|STARTED|Overall Study||13
10327639|NCT00298155|11463359|FG000|COMPLETED|Overall Study||12
10327640|NCT00298155|11463360|FG001|COMPLETED|Overall Study||10
10327641|NCT00298155|11463361|FG002|COMPLETED|Overall Study||13
10327642|NCT00298155|11463359|FG000|NOT COMPLETED|Overall Study||0
10327643|NCT00298155|11463360|FG001|NOT COMPLETED|Overall Study||0
10327644|NCT00298155|11463361|FG002|NOT COMPLETED|Overall Study||0
10327645|NCT00298233|11463371|FG000|STARTED|Overall Study||39
10327646|NCT00298233|11463372|FG001|STARTED|Overall Study||41
10327647|NCT00298233|11463373|FG002|STARTED|Overall Study||122
10327648|NCT00298233|11463374|FG003|STARTED|Overall Study||124
10327649|NCT00298233|11463371|FG000|COMPLETED|Overall Study||39
10327650|NCT00298233|11463372|FG001|COMPLETED|Overall Study||41
10327651|NCT00298233|11463373|FG002|COMPLETED|Overall Study||122
10327652|NCT00298233|11463374|FG003|COMPLETED|Overall Study||124
10327653|NCT00298233|11463371|FG000|NOT COMPLETED|Overall Study||0
10327654|NCT00298233|11463372|FG001|NOT COMPLETED|Overall Study||0
10327655|NCT00298233|11463373|FG002|NOT COMPLETED|Overall Study||0
10327656|NCT00298233|11463374|FG003|NOT COMPLETED|Overall Study||0
10327657|NCT00298272|11463382|FG000|STARTED|Double-blind Phase|enrolled and randomized (2:1 scheme)|36
10327658|NCT00298272|11463383|FG001|STARTED|Double-blind Phase||18
10327659|NCT00298272|11463382|FG000|Safety Population|Double-blind Phase|received treatment|33
10327660|NCT00298272|11463383|FG001|Safety Population|Double-blind Phase||18
10327661|NCT00298272|11463382|FG000|Completed to Week 24|Double-blind Phase|received full course of rituximab therapy|31
10327662|NCT00298272|11463383|FG001|Completed to Week 24|Double-blind Phase|received full course of placebo therapy|18
10327663|NCT00298272|11463382|FG000|Completed to Week 56|Double-blind Phase||8
10327664|NCT00298272|11463383|FG001|Completed to Week 56|Double-blind Phase||3
10327665|NCT00298272|11463382|FG000|COMPLETED|Double-blind Phase||28
10327666|NCT00298272|11463383|FG001|COMPLETED|Double-blind Phase||18
10327667|NCT00298272|11463382|FG000|NOT COMPLETED|Double-blind Phase||8
10327668|NCT00298272|11463383|FG001|NOT COMPLETED|Double-blind Phase||0
10327669|NCT00298272|11463382|FG000|STARTED|Open Label Retreatment Phase||22
10327670|NCT00298272|11463383|FG001|STARTED|Open Label Retreatment Phase||16
10327671|NCT00298272|11463382|FG000|Completed to Week 24|Open Label Retreatment Phase|received full course of open-label rituximab therapy|22
10327672|NCT00298272|11463383|FG001|Completed to Week 24|Open Label Retreatment Phase|received full course of open-label rituximab therapy|15
10327673|NCT00298272|11463382|FG000|Completed to Week 56|Open Label Retreatment Phase||13
10327674|NCT00298272|11463383|FG001|Completed to Week 56|Open Label Retreatment Phase||12
10327675|NCT00298272|11463382|FG000|COMPLETED|Open Label Retreatment Phase||13
10327676|NCT00298272|11463383|FG001|COMPLETED|Open Label Retreatment Phase||12
10327677|NCT00298272|11463382|FG000|NOT COMPLETED|Open Label Retreatment Phase||9
10327678|NCT00298272|11463383|FG001|NOT COMPLETED|Open Label Retreatment Phase||4
10327679|NCT00298272|11463382|FG000|STARTED|Safety Follow-up Phase||22
10327680|NCT00298272|11463383|FG001|STARTED|Safety Follow-up Phase||17
10327681|NCT00298272|11463382|FG000|COMPLETED|Safety Follow-up Phase||18
10327682|NCT00298272|11463383|FG001|COMPLETED|Safety Follow-up Phase||13
10327683|NCT00298272|11463382|FG000|NOT COMPLETED|Safety Follow-up Phase||4
10327684|NCT00298272|11463383|FG001|NOT COMPLETED|Safety Follow-up Phase||4
10327685|NCT00298363|11463395|FG000|STARTED|Overall Study||45
10327686|NCT00298363|11463396|FG001|STARTED|Overall Study||45
10327687|NCT00298363|11463397|FG002|STARTED|Overall Study||22
10327688|NCT00298363|11463395|FG000|COMPLETED|Overall Study|22 completed while taking DB TDF; 6 completed following switch from DB TDF to OL FTC/TDF.|28
10327689|NCT00298363|11463396|FG001|COMPLETED|Overall Study|34 completed while taking DB FTC/TDF; 3 completed following switch from DB TDF to OL FTC/TDF.|37
10327690|NCT00298363|11463397|FG002|COMPLETED|Overall Study|13 completed while taking DB ETV; 3 completed following switch from DB ETV to OL FTC/TDF.|16
10327691|NCT00298363|11463395|FG000|NOT COMPLETED|Overall Study||17
10327692|NCT00298363|11463396|FG001|NOT COMPLETED|Overall Study||8
10327693|NCT00298363|11463397|FG002|NOT COMPLETED|Overall Study||6
10327694|NCT00298389|11463414|FG000|STARTED|Overall Study||20
10327695|NCT00298389|11463415|FG001|STARTED|Overall Study||17
10327696|NCT00298389|11463416|FG002|STARTED|Overall Study||19
10327697|NCT00298389|11463414|FG000|COMPLETED|Overall Study||20
10327698|NCT00298389|11463415|FG001|COMPLETED|Overall Study||17
10327699|NCT00298389|11463416|FG002|COMPLETED|Overall Study||19
10327700|NCT00298389|11463414|FG000|NOT COMPLETED|Overall Study||0
10327701|NCT00298389|11463415|FG001|NOT COMPLETED|Overall Study||0
10327702|NCT00298389|11463416|FG002|NOT COMPLETED|Overall Study||0
10327703|NCT00298558|11463428|FG000|STARTED|Baseline||711
10327704|NCT00298558|11463429|FG001|STARTED|Baseline||705
10327705|NCT00298558|11463430|FG002|STARTED|Baseline||712
10327706|NCT00298558|11463431|FG003|STARTED|Baseline||704
10327707|NCT00298558|11463428|FG000|COMPLETED|Baseline||711
10327708|NCT00298558|11463429|FG001|COMPLETED|Baseline||705
10327709|NCT00298558|11463430|FG002|COMPLETED|Baseline||712
10327710|NCT00298558|11463431|FG003|COMPLETED|Baseline||704
10327711|NCT00298558|11463428|FG000|NOT COMPLETED|Baseline||0
10327712|NCT00298558|11463429|FG001|NOT COMPLETED|Baseline||0
10327713|NCT00298558|11463430|FG002|NOT COMPLETED|Baseline||0
10327714|NCT00298558|11463431|FG003|NOT COMPLETED|Baseline||0
10327715|NCT00298558|11463428|FG000|STARTED|Intervention||711
10327716|NCT00298558|11463429|FG001|STARTED|Intervention||705
10327717|NCT00298558|11463430|FG002|STARTED|Intervention||712
10327718|NCT00298558|11463431|FG003|STARTED|Intervention||704
10327719|NCT00298558|11463428|FG000|COMPLETED|Intervention||620
10327720|NCT00298558|11463429|FG001|COMPLETED|Intervention||627
10327721|NCT00298558|11463430|FG002|COMPLETED|Intervention||637
10327722|NCT00298558|11463431|FG003|COMPLETED|Intervention||285
10327723|NCT00298558|11463428|FG000|NOT COMPLETED|Intervention||91
10327724|NCT00298558|11463429|FG001|NOT COMPLETED|Intervention||78
10327725|NCT00298558|11463430|FG002|NOT COMPLETED|Intervention||75
10327726|NCT00298558|11463431|FG003|NOT COMPLETED|Intervention||419
10327727|NCT00298558|11463428|FG000|STARTED|Immediate Post Test||711
10327728|NCT00298558|11463429|FG001|STARTED|Immediate Post Test||705
10327729|NCT00298558|11463430|FG002|STARTED|Immediate Post Test||712
10327730|NCT00298558|11463431|FG003|STARTED|Immediate Post Test||704
10327731|NCT00298558|11463428|FG000|COMPLETED|Immediate Post Test||640
10701725|NCT02569801|11866192|FG000|Received Treatment|Overall Study||35
10701726|NCT02569801|11866193|FG001|Received Treatment|Overall Study||35
10701727|NCT02569801|11866192|FG000|COMPLETED|Overall Study||0
10701728|NCT02569801|11866193|FG001|COMPLETED|Overall Study||0
10701729|NCT02569801|11866192|FG000|NOT COMPLETED|Overall Study||36
10701730|NCT02569801|11866193|FG001|NOT COMPLETED|Overall Study||35
10701731|NCT02569853|11866201|FG000|STARTED|Overall Study||131
10327732|NCT00298558|11463429|FG001|COMPLETED|Immediate Post Test||629
10327733|NCT00298558|11463430|FG002|COMPLETED|Immediate Post Test||653
10327734|NCT00298558|11463431|FG003|COMPLETED|Immediate Post Test||639
10327735|NCT00298558|11463428|FG000|NOT COMPLETED|Immediate Post Test||71
10327736|NCT00298558|11463429|FG001|NOT COMPLETED|Immediate Post Test||76
10327737|NCT00298558|11463430|FG002|NOT COMPLETED|Immediate Post Test||59
10327738|NCT00298558|11463431|FG003|NOT COMPLETED|Immediate Post Test||65
10327739|NCT00298558|11463428|FG000|STARTED|Booster||372
10327740|NCT00298558|11463429|FG001|STARTED|Booster||371
10327741|NCT00298558|11463430|FG002|STARTED|Booster||370
10327742|NCT00298558|11463431|FG003|STARTED|Booster||0
10327743|NCT00298558|11463428|FG000|COMPLETED|Booster||283
10327744|NCT00298558|11463429|FG001|COMPLETED|Booster||301
10327745|NCT00298558|11463430|FG002|COMPLETED|Booster||295
10327746|NCT00298558|11463431|FG003|COMPLETED|Booster||0
10327747|NCT00298558|11463428|FG000|NOT COMPLETED|Booster||89
10327748|NCT00298558|11463429|FG001|NOT COMPLETED|Booster||70
10327749|NCT00298558|11463430|FG002|NOT COMPLETED|Booster||75
10327750|NCT00298558|11463431|FG003|NOT COMPLETED|Booster||0
10327751|NCT00298558|11463428|FG000|STARTED|1st Annual (A1)||640
10327752|NCT00298558|11463429|FG001|STARTED|1st Annual (A1)||629
10327753|NCT00298558|11463430|FG002|STARTED|1st Annual (A1)||653
10327754|NCT00298558|11463431|FG003|STARTED|1st Annual (A1)||639
10327755|NCT00298558|11463428|FG000|COMPLETED|1st Annual (A1)||585
10327756|NCT00298558|11463429|FG001|COMPLETED|1st Annual (A1)||566
10327757|NCT00298558|11463430|FG002|COMPLETED|1st Annual (A1)||601
10327758|NCT00298558|11463431|FG003|COMPLETED|1st Annual (A1)||584
10327759|NCT00298558|11463428|FG000|NOT COMPLETED|1st Annual (A1)||55
10327760|NCT00298558|11463429|FG001|NOT COMPLETED|1st Annual (A1)||63
10327761|NCT00298558|11463430|FG002|NOT COMPLETED|1st Annual (A1)||52
10327762|NCT00298558|11463431|FG003|NOT COMPLETED|1st Annual (A1)||55
10327763|NCT00298558|11463428|FG000|STARTED|2nd Annual (A2)||585
10327764|NCT00298558|11463429|FG001|STARTED|2nd Annual (A2)||566
10327765|NCT00298558|11463430|FG002|STARTED|2nd Annual (A2)||601
10327766|NCT00298558|11463431|FG003|STARTED|2nd Annual (A2)||584
10327767|NCT00298558|11463428|FG000|COMPLETED|2nd Annual (A2)||563
10327768|NCT00298558|11463429|FG001|COMPLETED|2nd Annual (A2)||555
10327769|NCT00298558|11463430|FG002|COMPLETED|2nd Annual (A2)||574
10327770|NCT00298558|11463431|FG003|COMPLETED|2nd Annual (A2)||552
10327771|NCT00298558|11463428|FG000|NOT COMPLETED|2nd Annual (A2)||22
10327772|NCT00298558|11463429|FG001|NOT COMPLETED|2nd Annual (A2)||11
10327773|NCT00298558|11463430|FG002|NOT COMPLETED|2nd Annual (A2)||27
10327774|NCT00298558|11463431|FG003|NOT COMPLETED|2nd Annual (A2)||32
10327775|NCT00298558|11463428|FG000|STARTED|3rd Annual Booster||372
10327776|NCT00298558|11463429|FG001|STARTED|3rd Annual Booster||371
10327777|NCT00298558|11463430|FG002|STARTED|3rd Annual Booster||370
10327778|NCT00298558|11463431|FG003|STARTED|3rd Annual Booster||0
10327779|NCT00298558|11463428|FG000|COMPLETED|3rd Annual Booster||250
10327780|NCT00298558|11463429|FG001|COMPLETED|3rd Annual Booster||243
10327781|NCT00298558|11463430|FG002|COMPLETED|3rd Annual Booster||230
10327782|NCT00298558|11463431|FG003|COMPLETED|3rd Annual Booster||0
10327783|NCT00298558|11463428|FG000|NOT COMPLETED|3rd Annual Booster||122
10327784|NCT00298558|11463429|FG001|NOT COMPLETED|3rd Annual Booster||128
10327785|NCT00298558|11463430|FG002|NOT COMPLETED|3rd Annual Booster||140
10327786|NCT00298558|11463431|FG003|NOT COMPLETED|3rd Annual Booster||0
10327787|NCT00298558|11463428|FG000|STARTED|3rd Annual (A3) and 5th Annual (A5)||563
10701732|NCT02569853|11866202|FG001|STARTED|Overall Study||137
10701733|NCT02569853|11866201|FG000|COMPLETED|Overall Study||111
10327788|NCT00298558|11463429|FG001|STARTED|3rd Annual (A3) and 5th Annual (A5)||555
10327789|NCT00298558|11463430|FG002|STARTED|3rd Annual (A3) and 5th Annual (A5)||574
10327790|NCT00298558|11463431|FG003|STARTED|3rd Annual (A3) and 5th Annual (A5)||552
10327791|NCT00298558|11463428|FG000|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||472
10327792|NCT00298558|11463429|FG001|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||469
10327793|NCT00298558|11463430|FG002|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||490
10327794|NCT00298558|11463431|FG003|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||448
10327795|NCT00298558|11463428|FG000|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||91
10327796|NCT00298558|11463429|FG001|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||86
10327797|NCT00298558|11463430|FG002|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||84
10327798|NCT00298558|11463431|FG003|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||104
10327799|NCT00298558|11463428|FG000|STARTED|10th Annual (A10)||472
10327800|NCT00298558|11463429|FG001|STARTED|10th Annual (A10)||469
10327801|NCT00298558|11463430|FG002|STARTED|10th Annual (A10)||490
10327802|NCT00298558|11463431|FG003|STARTED|10th Annual (A10)||448
10327803|NCT00298558|11463428|FG000|COMPLETED|10th Annual (A10)||300
10327804|NCT00298558|11463429|FG001|COMPLETED|10th Annual (A10)||316
10327805|NCT00298558|11463430|FG002|COMPLETED|10th Annual (A10)||319
10327806|NCT00298558|11463431|FG003|COMPLETED|10th Annual (A10)||285
10327807|NCT00298558|11463428|FG000|NOT COMPLETED|10th Annual (A10)||172
10327808|NCT00298558|11463429|FG001|NOT COMPLETED|10th Annual (A10)||153
10327809|NCT00298558|11463430|FG002|NOT COMPLETED|10th Annual (A10)||171
10327810|NCT00298558|11463431|FG003|NOT COMPLETED|10th Annual (A10)||163
10327811|NCT00298610|11463441|FG000|STARTED|Overall Study||30
10327812|NCT00298610|11463441|FG000|COMPLETED|Overall Study||30
10327813|NCT00298610|11463441|FG000|NOT COMPLETED|Overall Study||0
10327814|NCT00298766|11463445|FG000|STARTED|Overall Study||70
10327815|NCT00298766|11463445|FG000|COMPLETED|Overall Study||24
10327816|NCT00298766|11463445|FG000|NOT COMPLETED|Overall Study||46
10327817|NCT00298831|11463449|FG000|STARTED|Overall Study||224
10327818|NCT00298831|11463449|FG000|Treated|Overall Study||197
10327819|NCT00298831|11463449|FG000|COMPLETED|Overall Study||192
10327820|NCT00298831|11463449|FG000|NOT COMPLETED|Overall Study||32
10327821|NCT00298896|11463453|FG000|STARTED|Overall Study||55
10327822|NCT00298896|11463453|FG000|COMPLETED|Overall Study||5
10327823|NCT00298896|11463453|FG000|NOT COMPLETED|Overall Study||50
10327824|NCT00299000|11463459|FG000|STARTED|Overall Study||2
10327825|NCT00299000|11463460|FG001|STARTED|Overall Study||2
10327826|NCT00299000|11463459|FG000|COMPLETED|Overall Study||2
10327827|NCT00299000|11463460|FG001|COMPLETED|Overall Study||2
10327828|NCT00299000|11463459|FG000|NOT COMPLETED|Overall Study||0
10327829|NCT00299000|11463460|FG001|NOT COMPLETED|Overall Study||0
10327830|NCT00299104|11463469|FG000|STARTED|Treatment Period||251
10327831|NCT00299104|11463470|FG001|STARTED|Treatment Period||252
10327832|NCT00299104|11463471|FG002|STARTED|Treatment Period||252
10327833|NCT00299104|11463469|FG000|Safety/ITT: Received Study Drug|Treatment Period||249
10327834|NCT00299104|11463470|FG001|Safety/ITT: Received Study Drug|Treatment Period||249
10327835|NCT00299104|11463471|FG002|Safety/ITT: Received Study Drug|Treatment Period||250
10327836|NCT00299104|11463469|FG000|Completed Week 24|Treatment Period||227
10456311|NCT01006252|11604270|FG001|COMPLETED|Overall Study||168
10456312|NCT01006252|11604269|FG000|NOT COMPLETED|Overall Study||0
10456313|NCT01006252|11604270|FG001|NOT COMPLETED|Overall Study||0
10456314|NCT01006291|11604283|FG000|STARTED|Overall Study||229
10456315|NCT01006291|11604284|FG001|STARTED|Overall Study||228
10456316|NCT01006291|11604285|FG002|STARTED|Overall Study||230
10456317|NCT01006291|11604283|FG000|Exposed|Overall Study|1 subject withdrew before exposure to drug. 2 subjects randomised to IDeg OD received IDeg OD FF|230
10456318|NCT01006291|11604284|FG001|Exposed|Overall Study|2 subjects received IDeg OD FF|226
10456319|NCT01006291|11604285|FG002|Exposed|Overall Study|1 subject withdrew prior to exposure to trial drug|229
10456320|NCT01006291|11604283|FG000|COMPLETED|Overall Study||203
10456321|NCT01006291|11604284|FG001|COMPLETED|Overall Study||204
10456322|NCT01006291|11604285|FG002|COMPLETED|Overall Study||203
10456323|NCT01006291|11604283|FG000|NOT COMPLETED|Overall Study||26
10456324|NCT01006291|11604284|FG001|NOT COMPLETED|Overall Study||24
10456325|NCT01006291|11604285|FG002|NOT COMPLETED|Overall Study||27
10456326|NCT01006356|11604293|FG000|STARTED|Overall Study||141
10456327|NCT01006356|11604293|FG000|COMPLETED|Overall Study||99
10456328|NCT01006356|11604293|FG000|NOT COMPLETED|Overall Study||42
10456329|NCT01006369|11604299|FG000|STARTED|Overall Study||13
10456330|NCT01006369|11604300|FG001|STARTED|Overall Study||25
10456331|NCT01006369|11604299|FG000|COMPLETED|Overall Study||1
10456332|NCT01006369|11604300|FG001|COMPLETED|Overall Study||0
10456333|NCT01006369|11604299|FG000|NOT COMPLETED|Overall Study||12
10456334|NCT01006369|11604300|FG001|NOT COMPLETED|Overall Study||25
10456335|NCT01006538|11604307|FG000|STARTED|Overall Study||244
10456336|NCT01006538|11604308|FG001|STARTED|Overall Study||119
10456337|NCT01006538|11604307|FG000|COMPLETED|Overall Study||233
10456338|NCT01006538|11604308|FG001|COMPLETED|Overall Study||115
10327837|NCT00299104|11463470|FG001|Completed Week 24|Treatment Period||240
10327838|NCT00299104|11463471|FG002|Completed Week 24|Treatment Period||241
10327839|NCT00299104|11463469|FG000|Completed Week 52|Treatment Period||213
10327840|NCT00299104|11463470|FG001|Completed Week 52|Treatment Period||227
10327841|NCT00299104|11463471|FG002|Completed Week 52|Treatment Period||232
10456339|NCT01006538|11604307|FG000|NOT COMPLETED|Overall Study||11
10327842|NCT00299104|11463469|FG000|Completed Week 104|Treatment Period||178
10327843|NCT00299104|11463470|FG001|Completed Week 104|Treatment Period||213
10327844|NCT00299104|11463471|FG002|Completed Week 104|Treatment Period||216
10327845|NCT00299104|11463469|FG000|COMPLETED|Treatment Period|Completed Week 152|62
10327846|NCT00299104|11463470|FG001|COMPLETED|Treatment Period||77
10327847|NCT00299104|11463471|FG002|COMPLETED|Treatment Period||80
10327848|NCT00299104|11463469|FG000|NOT COMPLETED|Treatment Period||189
10327849|NCT00299104|11463470|FG001|NOT COMPLETED|Treatment Period||175
10327850|NCT00299104|11463471|FG002|NOT COMPLETED|Treatment Period||172
10327851|NCT00299104|11463469|FG000|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|184
10327852|NCT00299104|11463470|FG001|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|212
10327853|NCT00299104|11463471|FG002|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|213
10327854|NCT00299104|11463469|FG000|COMPLETED|Safety Follow-Up (SFU) Period||129
10327855|NCT00299104|11463470|FG001|COMPLETED|Safety Follow-Up (SFU) Period||171
10327856|NCT00299104|11463471|FG002|COMPLETED|Safety Follow-Up (SFU) Period||176
10327857|NCT00299104|11463469|FG000|NOT COMPLETED|Safety Follow-Up (SFU) Period||55
10327858|NCT00299104|11463470|FG001|NOT COMPLETED|Safety Follow-Up (SFU) Period||41
10327859|NCT00299104|11463471|FG002|NOT COMPLETED|Safety Follow-Up (SFU) Period||37
10327860|NCT00299104|11463469|FG000|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|34
10327861|NCT00299104|11463470|FG001|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|40
10327862|NCT00299104|11463471|FG002|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|51
10327863|NCT00299104|11463469|FG000|COMPLETED|Extended Safety Follow-Up (ESFU) Period||29
10327864|NCT00299104|11463470|FG001|COMPLETED|Extended Safety Follow-Up (ESFU) Period||31
10327865|NCT00299104|11463471|FG002|COMPLETED|Extended Safety Follow-Up (ESFU) Period||39
10327866|NCT00299104|11463469|FG000|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||5
10327867|NCT00299104|11463470|FG001|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||9
10327868|NCT00299104|11463471|FG002|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||12
10327869|NCT00299130|11463482|FG000|STARTED|Treatment Period (up to 5 Years)||172
10327870|NCT00299130|11463483|FG001|STARTED|Treatment Period (up to 5 Years)||168
10327871|NCT00299130|11463484|FG002|STARTED|Treatment Period (up to 5 Years)||171
10327872|NCT00299130|11463482|FG000|Treated|Treatment Period (up to 5 Years)|155 participants in placebo arm switched to active therapy (rituximab 2 x 0.5g) between Weeks 16-48.|172
10327873|NCT00299130|11463483|FG001|Treated|Treatment Period (up to 5 Years)||167
10327874|NCT00299130|11463484|FG002|Treated|Treatment Period (up to 5 Years)||170
10327875|NCT00299130|11463482|FG000|Completed 24 Weeks|Treatment Period (up to 5 Years)||159
10327876|NCT00299130|11463483|FG001|Completed 24 Weeks|Treatment Period (up to 5 Years)||162
10327877|NCT00299130|11463484|FG002|Completed 24 Weeks|Treatment Period (up to 5 Years)||166
10327878|NCT00299130|11463482|FG000|Completed 48 Weeks|Treatment Period (up to 5 Years)||155
10327879|NCT00299130|11463483|FG001|Completed 48 Weeks|Treatment Period (up to 5 Years)||157
10327880|NCT00299130|11463484|FG002|Completed 48 Weeks|Treatment Period (up to 5 Years)||158
10327881|NCT00299130|11463482|FG000|Completed 144 Weeks|Treatment Period (up to 5 Years)||133
10327882|NCT00299130|11463483|FG001|Completed 144 Weeks|Treatment Period (up to 5 Years)||138
10327883|NCT00299130|11463484|FG002|Completed 144 Weeks|Treatment Period (up to 5 Years)||132
10327884|NCT00299130|11463482|FG000|COMPLETED|Treatment Period (up to 5 Years)||119
10327885|NCT00299130|11463483|FG001|COMPLETED|Treatment Period (up to 5 Years)||125
10327886|NCT00299130|11463484|FG002|COMPLETED|Treatment Period (up to 5 Years)||121
10327887|NCT00299130|11463482|FG000|NOT COMPLETED|Treatment Period (up to 5 Years)||53
10327888|NCT00299130|11463483|FG001|NOT COMPLETED|Treatment Period (up to 5 Years)||43
10327889|NCT00299130|11463484|FG002|NOT COMPLETED|Treatment Period (up to 5 Years)||50
10327890|NCT00299130|11463482|FG000|STARTED|Safety Follow-up (SFU) (48 Weeks)||167
10327891|NCT00299130|11463483|FG001|STARTED|Safety Follow-up (SFU) (48 Weeks)||165
10327892|NCT00299130|11463484|FG002|STARTED|Safety Follow-up (SFU) (48 Weeks)||168
10327893|NCT00299130|11463482|FG000|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||122
10327894|NCT00299130|11463483|FG001|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||120
10327895|NCT00299130|11463484|FG002|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||123
10327896|NCT00299130|11463482|FG000|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
10327897|NCT00299130|11463483|FG001|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
10327898|NCT00299130|11463484|FG002|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
10327899|NCT00299130|11463482|FG000|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||0
10327900|NCT00299130|11463483|FG001|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||82
10327901|NCT00299130|11463484|FG002|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||44
10327902|NCT00299130|11463482|FG000|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||0
10327903|NCT00299130|11463483|FG001|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||74
10327904|NCT00299130|11463484|FG002|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||38
10327905|NCT00299130|11463482|FG000|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||0
10327906|NCT00299130|11463483|FG001|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||8
10327907|NCT00299130|11463484|FG002|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||6
10327908|NCT00299156|11463502|FG000|STARTED|Period 1 (Non-Randomized)||32
10327909|NCT00299156|11463503|FG001|STARTED|Period 1 (Non-Randomized)||0
10327910|NCT00299156|11463504|FG002|STARTED|Period 1 (Non-Randomized)||0
10327911|NCT00299156|11463502|FG000|COMPLETED|Period 1 (Non-Randomized)||32
10327912|NCT00299156|11463503|FG001|COMPLETED|Period 1 (Non-Randomized)||0
10327913|NCT00299156|11463504|FG002|COMPLETED|Period 1 (Non-Randomized)||0
10327914|NCT00299156|11463502|FG000|NOT COMPLETED|Period 1 (Non-Randomized)||0
10327915|NCT00299156|11463503|FG001|NOT COMPLETED|Period 1 (Non-Randomized)||0
10327916|NCT00299156|11463504|FG002|NOT COMPLETED|Period 1 (Non-Randomized)||0
10327917|NCT00299156|11463502|FG000|STARTED|Period 2 (Randomized)||0
10327918|NCT00299156|11463503|FG001|STARTED|Period 2 (Randomized)||17
10327919|NCT00299156|11463504|FG002|STARTED|Period 2 (Randomized)||16
10327920|NCT00299156|11463502|FG000|COMPLETED|Period 2 (Randomized)||0
10327921|NCT00299156|11463503|FG001|COMPLETED|Period 2 (Randomized)||16
10327922|NCT00299156|11463504|FG002|COMPLETED|Period 2 (Randomized)||16
10327923|NCT00299156|11463502|FG000|NOT COMPLETED|Period 2 (Randomized)||0
10327924|NCT00299156|11463503|FG001|NOT COMPLETED|Period 2 (Randomized)||1
10327925|NCT00299156|11463504|FG002|NOT COMPLETED|Period 2 (Randomized)||0
10327926|NCT00299182|11463519|FG000|STARTED|Overall Study||6
10327927|NCT00299182|11463520|FG001|STARTED|Overall Study||4
10327928|NCT00299182|11463521|FG002|STARTED|Overall Study||6
10327929|NCT00299182|11463522|FG003|STARTED|Overall Study||14
10327930|NCT00299182|11463523|FG004|STARTED|Overall Study||8
10327931|NCT00299182|11463524|FG005|STARTED|Overall Study||7
10327932|NCT00299182|11463525|FG006|STARTED|Overall Study||5
10327933|NCT00299182|11463519|FG000|COMPLETED|Overall Study||6
10327934|NCT00299182|11463520|FG001|COMPLETED|Overall Study||4
10327935|NCT00299182|11463521|FG002|COMPLETED|Overall Study||4
10327936|NCT00299182|11463522|FG003|COMPLETED|Overall Study||14
10327937|NCT00299182|11463523|FG004|COMPLETED|Overall Study||5
10327938|NCT00299182|11463524|FG005|COMPLETED|Overall Study||4
10327939|NCT00299182|11463525|FG006|COMPLETED|Overall Study||4
10327940|NCT00299182|11463519|FG000|NOT COMPLETED|Overall Study||0
10327941|NCT00299182|11463520|FG001|NOT COMPLETED|Overall Study||0
10327942|NCT00299182|11463521|FG002|NOT COMPLETED|Overall Study||2
10327943|NCT00299182|11463522|FG003|NOT COMPLETED|Overall Study||0
10327944|NCT00299182|11463523|FG004|NOT COMPLETED|Overall Study||3
10327945|NCT00299182|11463524|FG005|NOT COMPLETED|Overall Study||3
10327946|NCT00299182|11463525|FG006|NOT COMPLETED|Overall Study||1
10327947|NCT00299221|11463545|FG000|STARTED|Overall Study||79
10327948|NCT00299221|11463546|FG001|STARTED|Overall Study||71
10327949|NCT00299221|11463545|FG000|COMPLETED|Overall Study||79
10327950|NCT00299221|11463546|FG001|COMPLETED|Overall Study||71
10327951|NCT00299221|11463545|FG000|NOT COMPLETED|Overall Study||0
10327952|NCT00299221|11463546|FG001|NOT COMPLETED|Overall Study||0
10327953|NCT00299416|11463552|FG000|STARTED|Overall Study||30
10327954|NCT00299416|11463552|FG000|COMPLETED|Overall Study||30
10327955|NCT00299416|11463552|FG000|NOT COMPLETED|Overall Study||0
10327956|NCT00299494|11463562|FG000|STARTED|Overall Study||5
10327957|NCT00299494|11463563|FG001|STARTED|Overall Study||3
10327958|NCT00299494|11463564|FG002|STARTED|Overall Study||7
10327959|NCT00299494|11463565|FG003|STARTED|Overall Study||34
10327960|NCT00299494|11463566|FG004|STARTED|Overall Study|1 participant received rituximab only, and did not receive inotuzumab ozogamicin|40
10327961|NCT00299494|11463567|FG005|STARTED|Overall Study||30
10327962|NCT00299494|11463562|FG000|COMPLETED|Overall Study||2
10327963|NCT00299494|11463563|FG001|COMPLETED|Overall Study||2
10327964|NCT00299494|11463564|FG002|COMPLETED|Overall Study||3
10327965|NCT00299494|11463565|FG003|COMPLETED|Overall Study||24
10327966|NCT00299494|11463566|FG004|COMPLETED|Overall Study||13
10327967|NCT00299494|11463567|FG005|COMPLETED|Overall Study||4
10327968|NCT00299494|11463562|FG000|NOT COMPLETED|Overall Study||3
10327969|NCT00299494|11463563|FG001|NOT COMPLETED|Overall Study||1
10327970|NCT00299494|11463564|FG002|NOT COMPLETED|Overall Study||4
10327971|NCT00299494|11463565|FG003|NOT COMPLETED|Overall Study||10
10327972|NCT00299494|11463566|FG004|NOT COMPLETED|Overall Study||27
10327973|NCT00299494|11463567|FG005|NOT COMPLETED|Overall Study||26
10327974|NCT00299546|11463595|FG000|STARTED|Overall Study||155
10327975|NCT00299546|11463596|FG001|STARTED|Overall Study||153
10327976|NCT00299546|11463597|FG002|STARTED|Overall Study||153
10327977|NCT00299546|11463595|FG000|COMPLETED|Overall Study||55
10327978|NCT00299546|11463596|FG001|COMPLETED|Overall Study||61
10327979|NCT00299546|11463597|FG002|COMPLETED|Overall Study||67
10327980|NCT00299546|11463595|FG000|NOT COMPLETED|Overall Study||100
10574643|NCT01679600|11729910|FG000|NOT COMPLETED|Overall Study||0
10574644|NCT01679600|11729911|FG001|NOT COMPLETED|Overall Study||0
10574645|NCT01679613|11729917|FG000|STARTED|Overall Study||4
10574646|NCT01679613|11729918|FG001|STARTED|Overall Study||4
10574647|NCT01679613|11729919|FG002|STARTED|Overall Study||13
10574648|NCT01679613|11729920|FG003|STARTED|Overall Study||13
10327981|NCT00299546|11463596|FG001|NOT COMPLETED|Overall Study||92
10327982|NCT00299546|11463597|FG002|NOT COMPLETED|Overall Study||86
10327983|NCT00299689|11463606|FG000|STARTED|Overall Study||69
10327984|NCT00299689|11463606|FG000|COMPLETED|Overall Study||69
10327985|NCT00299689|11463606|FG000|NOT COMPLETED|Overall Study||0
10327986|NCT00299702|11463612|FG000|STARTED|Overall Study||179
10327987|NCT00299702|11463613|FG001|STARTED|Overall Study||176
10327988|NCT00299702|11463612|FG000|COMPLETED|Overall Study||126
10327989|NCT00299702|11463613|FG001|COMPLETED|Overall Study||126
10327990|NCT00299702|11463612|FG000|NOT COMPLETED|Overall Study||53
10327991|NCT00299702|11463613|FG001|NOT COMPLETED|Overall Study||50
10327992|NCT00299741|11463619|FG000|STARTED|Overall Study||36
10327993|NCT00299741|11463619|FG000|COMPLETED|Overall Study||36
10327994|NCT00299741|11463619|FG000|NOT COMPLETED|Overall Study||0
10574649|NCT01679613|11729917|FG000|Received Nintedanib (Pilot)|Overall Study||4
10327995|NCT00299975|11463626|FG000|STARTED|Overall Study||32
10327996|NCT00299975|11463627|FG001|STARTED|Overall Study||32
10327997|NCT00299975|11463628|FG002|STARTED|Overall Study||33
10327998|NCT00299975|11463626|FG000|Received Allocated Intervention|Overall Study||32
10327999|NCT00299975|11463627|FG001|Received Allocated Intervention|Overall Study||32
10328000|NCT00299975|11463628|FG002|Received Allocated Intervention|Overall Study||32
10328001|NCT00299975|11463626|FG000|COMPLETED|Overall Study||29
10328002|NCT00299975|11463627|FG001|COMPLETED|Overall Study||31
10328003|NCT00299975|11463628|FG002|COMPLETED|Overall Study||25
10328004|NCT00299975|11463626|FG000|NOT COMPLETED|Overall Study||3
10328005|NCT00299975|11463627|FG001|NOT COMPLETED|Overall Study||1
10328006|NCT00299975|11463628|FG002|NOT COMPLETED|Overall Study||8
10328007|NCT00299988|11463638|FG000|STARTED|Overall Study||16
10328008|NCT00299988|11463639|FG001|STARTED|Overall Study||8
10328009|NCT00299988|11463638|FG000|COMPLETED|Overall Study||16
10328010|NCT00299988|11463639|FG001|COMPLETED|Overall Study||8
10328011|NCT00299988|11463638|FG000|NOT COMPLETED|Overall Study||0
10328012|NCT00299988|11463639|FG001|NOT COMPLETED|Overall Study||0
10328013|NCT00300053|11463649|FG000|STARTED|Overall Study|started = randomized and treated/injected|55
10328014|NCT00300053|11463650|FG001|STARTED|Overall Study|started = randomized and treated/injected|56
10328015|NCT00300053|11463651|FG002|STARTED|Overall Study|started = randomized and treated/injected|56
10328016|NCT00300053|11463649|FG000|3-Month Evaluation|Overall Study||55
10328017|NCT00300053|11463650|FG001|3-Month Evaluation|Overall Study||56
10328018|NCT00300053|11463651|FG002|3-Month Evaluation|Overall Study||54
10328019|NCT00300053|11463649|FG000|6-Month Evaluation|Overall Study||54
10328020|NCT00300053|11463650|FG001|6-Month Evaluation|Overall Study||55
10328021|NCT00300053|11463651|FG002|6-Month Evaluation|Overall Study||53
10328022|NCT00300053|11463649|FG000|COMPLETED|Overall Study||53
10328023|NCT00300053|11463650|FG001|COMPLETED|Overall Study||53
10328024|NCT00300053|11463651|FG002|COMPLETED|Overall Study||50
10328025|NCT00300053|11463649|FG000|NOT COMPLETED|Overall Study||2
10328026|NCT00300053|11463650|FG001|NOT COMPLETED|Overall Study||3
10328027|NCT00300053|11463651|FG002|NOT COMPLETED|Overall Study||6
10328028|NCT00300235|11463665|FG000|STARTED|Overall Study||208
10328029|NCT00300235|11463666|FG001|STARTED|Overall Study||240
10328030|NCT00300235|11463667|FG002|STARTED|Overall Study||398
10328031|NCT00300235|11463668|FG003|STARTED|Overall Study||362
10328032|NCT00300235|11463669|FG004|STARTED|Overall Study||251
10328033|NCT00300235|11463665|FG000|COMPLETED|Overall Study||208
10328034|NCT00300235|11463666|FG001|COMPLETED|Overall Study||240
10328035|NCT00300235|11463667|FG002|COMPLETED|Overall Study||398
10328036|NCT00300235|11463668|FG003|COMPLETED|Overall Study||362
10328037|NCT00300235|11463669|FG004|COMPLETED|Overall Study||251
10328038|NCT00300235|11463665|FG000|NOT COMPLETED|Overall Study||0
10328039|NCT00300235|11463666|FG001|NOT COMPLETED|Overall Study||0
10328040|NCT00300235|11463667|FG002|NOT COMPLETED|Overall Study||0
10328041|NCT00300235|11463668|FG003|NOT COMPLETED|Overall Study||0
10328042|NCT00300235|11463669|FG004|NOT COMPLETED|Overall Study||0
10328043|NCT00300274|11463684|FG000|STARTED|Overall Study||282
10328044|NCT00300274|11463685|FG001|STARTED|Overall Study||168
10328045|NCT00300274|11463686|FG002|STARTED|Overall Study||271
10328046|NCT00300274|11463684|FG000|Completed 12 Month|Overall Study||250
10328047|NCT00300274|11463685|FG001|Completed 12 Month|Overall Study||149
10328048|NCT00300274|11463686|FG002|Completed 12 Month|Overall Study||248
10328049|NCT00300274|11463684|FG000|COMPLETED|Overall Study||236
10328050|NCT00300274|11463685|FG001|COMPLETED|Overall Study||141
10328051|NCT00300274|11463686|FG002|COMPLETED|Overall Study||226
10328052|NCT00300274|11463684|FG000|NOT COMPLETED|Overall Study||46
10328053|NCT00300274|11463685|FG001|NOT COMPLETED|Overall Study||27
10328054|NCT00300274|11463686|FG002|NOT COMPLETED|Overall Study||45
10328055|NCT00300365|11463696|FG000|STARTED|Overall Study||38
10328056|NCT00300365|11463697|FG001|STARTED|Overall Study||40
10328057|NCT00300365|11463696|FG000|COMPLETED|Overall Study||34
10328058|NCT00300365|11463697|FG001|COMPLETED|Overall Study||38
10328059|NCT00300365|11463696|FG000|NOT COMPLETED|Overall Study||4
10328060|NCT00300365|11463697|FG001|NOT COMPLETED|Overall Study||2
10328061|NCT00300391|11463705|FG000|STARTED|Overall Study||16
10328062|NCT00300391|11463706|FG001|STARTED|Overall Study||14
10328063|NCT00300391|11463705|FG000|COMPLETED|Overall Study||16
10328064|NCT00300391|11463706|FG001|COMPLETED|Overall Study||14
10328065|NCT00300391|11463705|FG000|NOT COMPLETED|Overall Study||0
10328066|NCT00300391|11463706|FG001|NOT COMPLETED|Overall Study||0
10328067|NCT00300430|11463716|FG000|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|1186
10328068|NCT00300430|11463717|FG001|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|514
10328069|NCT00300430|11463718|FG002|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|501
10328070|NCT00300430|11463716|FG000|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|819
10328071|NCT00300430|11463717|FG001|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|345
10328072|NCT00300430|11463718|FG002|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|350
10328073|NCT00300430|11463716|FG000|NOT COMPLETED|Overall Study||367
10328074|NCT00300430|11463717|FG001|NOT COMPLETED|Overall Study||169
10328075|NCT00300430|11463718|FG002|NOT COMPLETED|Overall Study||151
10328076|NCT00300456|11463732|FG000|STARTED|Overall Study|"For all arms, started means treated."|119
10328077|NCT00300456|11463733|FG001|STARTED|Overall Study||118
10328078|NCT00300456|11463734|FG002|STARTED|Overall Study||119
10328079|NCT00300456|11463735|FG003|STARTED|Overall Study||119
10328080|NCT00300456|11463736|FG004|STARTED|Overall Study||116
10328081|NCT00300456|11463737|FG005|STARTED|Overall Study||59
10328082|NCT00300456|11463732|FG000|COMPLETED|Overall Study||103
10328083|NCT00300456|11463733|FG001|COMPLETED|Overall Study||102
10328084|NCT00300456|11463734|FG002|COMPLETED|Overall Study||98
10328085|NCT00300456|11463735|FG003|COMPLETED|Overall Study||105
10328086|NCT00300456|11463736|FG004|COMPLETED|Overall Study||99
10328087|NCT00300456|11463737|FG005|COMPLETED|Overall Study||48
10328088|NCT00300456|11463732|FG000|NOT COMPLETED|Overall Study||16
10328089|NCT00300456|11463733|FG001|NOT COMPLETED|Overall Study||16
10328090|NCT00300456|11463734|FG002|NOT COMPLETED|Overall Study||21
10328091|NCT00300456|11463735|FG003|NOT COMPLETED|Overall Study||14
10328092|NCT00300456|11463736|FG004|NOT COMPLETED|Overall Study||17
10328093|NCT00300456|11463737|FG005|NOT COMPLETED|Overall Study||11
10328094|NCT00300469|11463757|FG000|STARTED|Overall Study|"For all arms, started means treated."|110
10328095|NCT00300469|11463758|FG001|STARTED|Overall Study||110
10328096|NCT00300469|11463759|FG002|STARTED|Overall Study||112
10328097|NCT00300469|11463760|FG003|STARTED|Overall Study||113
10328098|NCT00300469|11463761|FG004|STARTED|Overall Study||109
10328099|NCT00300469|11463762|FG005|STARTED|Overall Study||55
10328100|NCT00300469|11463757|FG000|COMPLETED|Overall Study||89
10328101|NCT00300469|11463758|FG001|COMPLETED|Overall Study||89
10328102|NCT00300469|11463759|FG002|COMPLETED|Overall Study||95
10328103|NCT00300469|11463760|FG003|COMPLETED|Overall Study||104
10328104|NCT00300469|11463761|FG004|COMPLETED|Overall Study||95
10328105|NCT00300469|11463762|FG005|COMPLETED|Overall Study||46
10328106|NCT00300469|11463757|FG000|NOT COMPLETED|Overall Study||21
10328107|NCT00300469|11463758|FG001|NOT COMPLETED|Overall Study||21
10328108|NCT00300469|11463759|FG002|NOT COMPLETED|Overall Study||17
10328109|NCT00300469|11463760|FG003|NOT COMPLETED|Overall Study||9
10328110|NCT00300469|11463761|FG004|NOT COMPLETED|Overall Study||14
10328111|NCT00300469|11463762|FG005|NOT COMPLETED|Overall Study||9
10328112|NCT00300482|11463782|FG000|STARTED|Overall Study|"For all arms, started means treated."|261
10328113|NCT00300482|11463783|FG001|STARTED|Overall Study||261
10328114|NCT00300482|11463784|FG002|STARTED|Overall Study||259
10328115|NCT00300482|11463785|FG003|STARTED|Overall Study||261
10328116|NCT00300482|11463786|FG004|STARTED|Overall Study||266
10328117|NCT00300482|11463787|FG005|STARTED|Overall Study||131
10328118|NCT00300482|11463782|FG000|COMPLETED|Overall Study||220
10328119|NCT00300482|11463783|FG001|COMPLETED|Overall Study||220
10328120|NCT00300482|11463784|FG002|COMPLETED|Overall Study||208
10328121|NCT00300482|11463785|FG003|COMPLETED|Overall Study||237
10328122|NCT00300482|11463786|FG004|COMPLETED|Overall Study||243
10328123|NCT00300482|11463787|FG005|COMPLETED|Overall Study||115
10328124|NCT00300482|11463782|FG000|NOT COMPLETED|Overall Study||41
10328125|NCT00300482|11463783|FG001|NOT COMPLETED|Overall Study||41
10328126|NCT00300482|11463784|FG002|NOT COMPLETED|Overall Study||51
10328127|NCT00300482|11463785|FG003|NOT COMPLETED|Overall Study||24
10328128|NCT00300482|11463786|FG004|NOT COMPLETED|Overall Study||23
10328129|NCT00300482|11463787|FG005|NOT COMPLETED|Overall Study||16
10328130|NCT00300495|11463803|FG000|STARTED|Overall Study||10
10328131|NCT00300495|11463804|FG001|STARTED|Overall Study||9
10328132|NCT00300495|11463803|FG000|COMPLETED|Overall Study||6
10328133|NCT00300495|11463804|FG001|COMPLETED|Overall Study||8
10328134|NCT00300495|11463803|FG000|NOT COMPLETED|Overall Study||4
10328135|NCT00300495|11463804|FG001|NOT COMPLETED|Overall Study||1
10328136|NCT00300677|11463810|FG000|STARTED|Overall Study||12
10328137|NCT00300677|11463810|FG000|COMPLETED|Overall Study||12
10328138|NCT00300677|11463810|FG000|NOT COMPLETED|Overall Study||0
10328139|NCT00300742|11463814|FG000|STARTED|Overall Study||5
10328140|NCT00300742|11463814|FG000|COMPLETED|Overall Study||3
10328141|NCT00300742|11463814|FG000|NOT COMPLETED|Overall Study||2
10328142|NCT00300755|11463822|FG000|STARTED|Overall Study||18
10328143|NCT00300755|11463823|FG001|STARTED|Overall Study||21
10328144|NCT00300755|11463824|FG002|STARTED|Overall Study||21
10328145|NCT00300755|11463822|FG000|COMPLETED|Overall Study||17
10328146|NCT00300755|11463823|FG001|COMPLETED|Overall Study||17
10328147|NCT00300755|11463824|FG002|COMPLETED|Overall Study||19
10328148|NCT00300755|11463822|FG000|NOT COMPLETED|Overall Study||1
10456340|NCT01006538|11604308|FG001|NOT COMPLETED|Overall Study||4
10456341|NCT01006590|11604316|FG000|STARTED|Overall Study|Randomised and treated|147
10456342|NCT01006590|11604317|FG001|STARTED|Overall Study|Randomised and treated|139
10456343|NCT01006590|11604316|FG000|COMPLETED|Overall Study|Completed 24 weeks of treatment|119
10456344|NCT01006590|11604317|FG001|COMPLETED|Overall Study|Completed 24 weeks of treatment|107
10456345|NCT01006590|11604316|FG000|NOT COMPLETED|Overall Study||28
10456346|NCT01006590|11604317|FG001|NOT COMPLETED|Overall Study||32
10456347|NCT01006603|11604325|FG000|STARTED|Overall Study|Completed lead-in period and were randomised|360
10456348|NCT01006603|11604326|FG001|STARTED|Overall Study|Completed lead-in period and were randomised|360
10456349|NCT01006603|11604325|FG000|COMPLETED|Overall Study||289
10456350|NCT01006603|11604326|FG001|COMPLETED|Overall Study||285
10328149|NCT00300755|11463823|FG001|NOT COMPLETED|Overall Study||4
10328150|NCT00300755|11463824|FG002|NOT COMPLETED|Overall Study||2
10328151|NCT00300781|11463834|FG000|STARTED|Overall Study||66
10328152|NCT00300781|11463835|FG001|STARTED|Overall Study||70
10328153|NCT00300781|11463834|FG000|COMPLETED|Overall Study||3
10328154|NCT00300781|11463835|FG001|COMPLETED|Overall Study||8
10328155|NCT00300781|11463834|FG000|NOT COMPLETED|Overall Study||63
10328156|NCT00300781|11463835|FG001|NOT COMPLETED|Overall Study||62
10328157|NCT00300885|11463843|FG000|STARTED|Treatment||464
10328158|NCT00300885|11463844|FG001|STARTED|Treatment|ongoing in double -blind treatment at data cut-off|462
10328159|NCT00300885|11463843|FG000|Received Treatment|Treatment||463
10328160|NCT00300885|11463844|FG001|Received Treatment|Treatment||459
10328161|NCT00300885|11463843|FG000|COMPLETED|Treatment||91
10328162|NCT00300885|11463844|FG001|COMPLETED|Treatment||88
10328163|NCT00300885|11463843|FG000|NOT COMPLETED|Treatment||373
10328164|NCT00300885|11463844|FG001|NOT COMPLETED|Treatment||374
10328165|NCT00300885|11463843|FG000|STARTED|Follow-up|Subjects entered Follow-up period after termination of Treatment period due to any reason.|354
10328166|NCT00300885|11463844|FG001|STARTED|Follow-up|Subjects entered Follow-up period after termination of Treatment period due to any reason.|369
10328167|NCT00300885|11463843|FG000|COMPLETED|Follow-up|Subjects still in Follow up period at data cut-off date.|176
10328168|NCT00300885|11463844|FG001|COMPLETED|Follow-up|Subjects still in Follow up period at data cut-off date.|174
10328169|NCT00300885|11463843|FG000|NOT COMPLETED|Follow-up||178
10328170|NCT00300885|11463844|FG001|NOT COMPLETED|Follow-up||195
10328171|NCT00301028|11463850|FG000|STARTED|Overall Study||47
10328172|NCT00301028|11463850|FG000|COMPLETED|Overall Study||47
10328173|NCT00301028|11463850|FG000|NOT COMPLETED|Overall Study||0
10328174|NCT00301067|11463854|FG000|STARTED|Completed DLT Period/1st Cycle||4
10328175|NCT00301067|11463855|FG001|STARTED|Completed DLT Period/1st Cycle||3
10328176|NCT00301067|11463856|FG002|STARTED|Completed DLT Period/1st Cycle||3
10328177|NCT00301067|11463857|FG003|STARTED|Completed DLT Period/1st Cycle|Patients did not participate in the DLT portion of the trial, they completed 1st cycle of treatment.|10
10328178|NCT00301067|11463854|FG000|COMPLETED|Completed DLT Period/1st Cycle||3
10328179|NCT00301067|11463855|FG001|COMPLETED|Completed DLT Period/1st Cycle||3
10328180|NCT00301067|11463856|FG002|COMPLETED|Completed DLT Period/1st Cycle||3
10328181|NCT00301067|11463857|FG003|COMPLETED|Completed DLT Period/1st Cycle||9
10328182|NCT00301067|11463854|FG000|NOT COMPLETED|Completed DLT Period/1st Cycle||1
10328183|NCT00301067|11463855|FG001|NOT COMPLETED|Completed DLT Period/1st Cycle||0
10328184|NCT00301067|11463856|FG002|NOT COMPLETED|Completed DLT Period/1st Cycle||0
10328185|NCT00301067|11463857|FG003|NOT COMPLETED|Completed DLT Period/1st Cycle||1
10328186|NCT00301067|11463854|FG000|STARTED|Reached 1st Response/2 Cycles||3
10328187|NCT00301067|11463855|FG001|STARTED|Reached 1st Response/2 Cycles||3
10328188|NCT00301067|11463856|FG002|STARTED|Reached 1st Response/2 Cycles||3
10328189|NCT00301067|11463857|FG003|STARTED|Reached 1st Response/2 Cycles||9
10328190|NCT00301067|11463854|FG000|COMPLETED|Reached 1st Response/2 Cycles||1
10328191|NCT00301067|11463855|FG001|COMPLETED|Reached 1st Response/2 Cycles||2
10328192|NCT00301067|11463856|FG002|COMPLETED|Reached 1st Response/2 Cycles||2
10328193|NCT00301067|11463857|FG003|COMPLETED|Reached 1st Response/2 Cycles||7
10328194|NCT00301067|11463854|FG000|NOT COMPLETED|Reached 1st Response/2 Cycles||2
10328195|NCT00301067|11463855|FG001|NOT COMPLETED|Reached 1st Response/2 Cycles||1
10328196|NCT00301067|11463856|FG002|NOT COMPLETED|Reached 1st Response/2 Cycles||1
10328197|NCT00301067|11463857|FG003|NOT COMPLETED|Reached 1st Response/2 Cycles||2
10328198|NCT00301067|11463854|FG000|STARTED|Completed 4 Cycles of Treatment||1
10328199|NCT00301067|11463855|FG001|STARTED|Completed 4 Cycles of Treatment||2
10328200|NCT00301067|11463856|FG002|STARTED|Completed 4 Cycles of Treatment||2
10328201|NCT00301067|11463857|FG003|STARTED|Completed 4 Cycles of Treatment||7
10328202|NCT00301067|11463854|FG000|COMPLETED|Completed 4 Cycles of Treatment||0
10328203|NCT00301067|11463855|FG001|COMPLETED|Completed 4 Cycles of Treatment||1
10328204|NCT00301067|11463856|FG002|COMPLETED|Completed 4 Cycles of Treatment||0
10328205|NCT00301067|11463857|FG003|COMPLETED|Completed 4 Cycles of Treatment||2
10328206|NCT00301067|11463854|FG000|NOT COMPLETED|Completed 4 Cycles of Treatment||1
10328207|NCT00301067|11463855|FG001|NOT COMPLETED|Completed 4 Cycles of Treatment||1
10328208|NCT00301067|11463856|FG002|NOT COMPLETED|Completed 4 Cycles of Treatment||2
10328209|NCT00301067|11463857|FG003|NOT COMPLETED|Completed 4 Cycles of Treatment||5
10328210|NCT00301067|11463854|FG000|STARTED|Completed 12 Cycles of Treatment||0
10328211|NCT00301067|11463855|FG001|STARTED|Completed 12 Cycles of Treatment||1
10328212|NCT00301067|11463856|FG002|STARTED|Completed 12 Cycles of Treatment||0
10328213|NCT00301067|11463857|FG003|STARTED|Completed 12 Cycles of Treatment||2
10328214|NCT00301067|11463854|FG000|COMPLETED|Completed 12 Cycles of Treatment||0
10328215|NCT00301067|11463855|FG001|COMPLETED|Completed 12 Cycles of Treatment||0
10328216|NCT00301067|11463856|FG002|COMPLETED|Completed 12 Cycles of Treatment||0
10328217|NCT00301067|11463857|FG003|COMPLETED|Completed 12 Cycles of Treatment||0
10328218|NCT00301067|11463854|FG000|NOT COMPLETED|Completed 12 Cycles of Treatment||0
10328219|NCT00301067|11463855|FG001|NOT COMPLETED|Completed 12 Cycles of Treatment||1
10328220|NCT00301067|11463856|FG002|NOT COMPLETED|Completed 12 Cycles of Treatment||0
10328221|NCT00301067|11463857|FG003|NOT COMPLETED|Completed 12 Cycles of Treatment||2
10328222|NCT00301067|11463854|FG000|STARTED|Follow up Until Death||4
10328223|NCT00301067|11463855|FG001|STARTED|Follow up Until Death||3
10328224|NCT00301067|11463856|FG002|STARTED|Follow up Until Death||3
10328225|NCT00301067|11463857|FG003|STARTED|Follow up Until Death||3
10328226|NCT00301067|11463854|FG000|COMPLETED|Follow up Until Death||3
10328227|NCT00301067|11463855|FG001|COMPLETED|Follow up Until Death||3
10328228|NCT00301067|11463856|FG002|COMPLETED|Follow up Until Death||3
10328229|NCT00301067|11463857|FG003|COMPLETED|Follow up Until Death||2
10328230|NCT00301067|11463854|FG000|NOT COMPLETED|Follow up Until Death||1
10328231|NCT00301067|11463855|FG001|NOT COMPLETED|Follow up Until Death||0
10328232|NCT00301067|11463856|FG002|NOT COMPLETED|Follow up Until Death||0
10328233|NCT00301067|11463857|FG003|NOT COMPLETED|Follow up Until Death||1
10328234|NCT00301366|11463868|FG000|STARTED|Overall Study||38
10328235|NCT00301366|11463868|FG000|COMPLETED|Overall Study||37
10328236|NCT00301366|11463868|FG000|NOT COMPLETED|Overall Study||1
10328237|NCT00301418|11463872|FG000|STARTED|Overall Study||11
10328238|NCT00301418|11463872|FG000|COMPLETED|Overall Study||11
10328239|NCT00301418|11463872|FG000|NOT COMPLETED|Overall Study||0
10328240|NCT00301756|11463876|FG000|STARTED|Overall Study||32
10328241|NCT00301756|11463876|FG000|COMPLETED|Overall Study||32
10328242|NCT00301756|11463876|FG000|NOT COMPLETED|Overall Study||0
10328243|NCT00301808|11463882|FG000|STARTED|Overall Study||29
10328244|NCT00301808|11463882|FG000|COMPLETED|Overall Study||17
10328245|NCT00301808|11463882|FG000|NOT COMPLETED|Overall Study||12
10328246|NCT00301821|11463886|FG000|STARTED|Overall Study||107
10328247|NCT00301821|11463886|FG000|COMPLETED|Overall Study||81
10328248|NCT00301821|11463886|FG000|NOT COMPLETED|Overall Study||26
10328249|NCT00301834|11463890|FG000|STARTED|Overall Study||35
10328250|NCT00301834|11463890|FG000|COMPLETED|Overall Study||34
10328251|NCT00301834|11463890|FG000|NOT COMPLETED|Overall Study||1
10338654|NCT03751631|11475552|FG000|STARTED|Overall Study||10
10338655|NCT03751631|11475553|FG001|STARTED|Overall Study||11
10338656|NCT03751631|11475554|FG002|STARTED|Overall Study||11
10338657|NCT03751631|11475555|FG003|STARTED|Overall Study||11
10338658|NCT03751631|11475556|FG004|STARTED|Overall Study||10
10338659|NCT03751631|11475557|FG005|STARTED|Overall Study||11
10338660|NCT03751631|11475552|FG000|Received 1st Drug in Sequence|Overall Study||10
10338661|NCT03751631|11475553|FG001|Received 1st Drug in Sequence|Overall Study||11
10338662|NCT03751631|11475554|FG002|Received 1st Drug in Sequence|Overall Study||11
10338663|NCT03751631|11475555|FG003|Received 1st Drug in Sequence|Overall Study||11
10338664|NCT03751631|11475556|FG004|Received 1st Drug in Sequence|Overall Study||10
10338665|NCT03751631|11475557|FG005|Received 1st Drug in Sequence|Overall Study||11
10338666|NCT03751631|11475552|FG000|Received 2nd Drug in Sequence|Overall Study||10
10338667|NCT03751631|11475553|FG001|Received 2nd Drug in Sequence|Overall Study||11
10338668|NCT03751631|11475554|FG002|Received 2nd Drug in Sequence|Overall Study||10
10338669|NCT03751631|11475555|FG003|Received 2nd Drug in Sequence|Overall Study||10
10338670|NCT03751631|11475556|FG004|Received 2nd Drug in Sequence|Overall Study||10
10338671|NCT03751631|11475557|FG005|Received 2nd Drug in Sequence|Overall Study||11
10338672|NCT03751631|11475552|FG000|Received 3rd Drug in Sequence|Overall Study||10
10338673|NCT03751631|11475553|FG001|Received 3rd Drug in Sequence|Overall Study||11
10338674|NCT03751631|11475554|FG002|Received 3rd Drug in Sequence|Overall Study||10
10338675|NCT03751631|11475555|FG003|Received 3rd Drug in Sequence|Overall Study||10
10338676|NCT03751631|11475556|FG004|Received 3rd Drug in Sequence|Overall Study||10
10338677|NCT03751631|11475557|FG005|Received 3rd Drug in Sequence|Overall Study||11
10338678|NCT03751631|11475552|FG000|COMPLETED|Overall Study||10
10338679|NCT03751631|11475553|FG001|COMPLETED|Overall Study||11
10338680|NCT03751631|11475554|FG002|COMPLETED|Overall Study||10
10338681|NCT03751631|11475555|FG003|COMPLETED|Overall Study||10
10338682|NCT03751631|11475556|FG004|COMPLETED|Overall Study||10
10338683|NCT03751631|11475557|FG005|COMPLETED|Overall Study||11
10338684|NCT03751631|11475552|FG000|NOT COMPLETED|Overall Study||0
10338685|NCT03751631|11475553|FG001|NOT COMPLETED|Overall Study||0
10338686|NCT03751631|11475554|FG002|NOT COMPLETED|Overall Study||1
10338687|NCT03751631|11475555|FG003|NOT COMPLETED|Overall Study||1
10338688|NCT03751631|11475556|FG004|NOT COMPLETED|Overall Study||0
10338689|NCT03751631|11475557|FG005|NOT COMPLETED|Overall Study||0
10338690|NCT03751098|11475568|FG000|STARTED|Overall Study||37
10338691|NCT03751098|11475569|FG001|STARTED|Overall Study||33
10338692|NCT03751098|11475568|FG000|COMPLETED|Overall Study||37
10338693|NCT03751098|11475569|FG001|COMPLETED|Overall Study||32
10338694|NCT03751098|11475568|FG000|NOT COMPLETED|Overall Study||0
10338695|NCT03751098|11475569|FG001|NOT COMPLETED|Overall Study||1
10338696|NCT03673345|11475585|FG000|STARTED|Overall Study||5
10338697|NCT03673345|11475586|FG001|STARTED|Overall Study||3
10338698|NCT03673345|11475587|FG002|STARTED|Overall Study||57
10338699|NCT03673345|11475588|FG003|STARTED|Overall Study||12
10338700|NCT03673345|11475589|FG004|STARTED|Overall Study||21
10338701|NCT03673345|11475590|FG005|STARTED|Overall Study||7
10338702|NCT03673345|11475591|FG006|STARTED|Overall Study||20
10338703|NCT03673345|11475592|FG007|STARTED|Overall Study||0
10338704|NCT03673345|11475585|FG000|COMPLETED|Overall Study||3
10338705|NCT03673345|11475586|FG001|COMPLETED|Overall Study||3
10338706|NCT03673345|11475587|FG002|COMPLETED|Overall Study||48
10338707|NCT03673345|11475588|FG003|COMPLETED|Overall Study||7
10338708|NCT03673345|11475589|FG004|COMPLETED|Overall Study||19
10338709|NCT03673345|11475590|FG005|COMPLETED|Overall Study||6
10338710|NCT03673345|11475591|FG006|COMPLETED|Overall Study||20
10338711|NCT03673345|11475592|FG007|COMPLETED|Overall Study||0
10338712|NCT03673345|11475585|FG000|NOT COMPLETED|Overall Study||2
10338713|NCT03673345|11475586|FG001|NOT COMPLETED|Overall Study||0
10338714|NCT03673345|11475587|FG002|NOT COMPLETED|Overall Study||9
10338715|NCT03673345|11475588|FG003|NOT COMPLETED|Overall Study||5
10338716|NCT03673345|11475589|FG004|NOT COMPLETED|Overall Study||2
10338717|NCT03673345|11475590|FG005|NOT COMPLETED|Overall Study||1
10338718|NCT03673345|11475591|FG006|NOT COMPLETED|Overall Study||0
10338719|NCT03673345|11475592|FG007|NOT COMPLETED|Overall Study||0
10338720|NCT03418675|11475612|FG000|STARTED|Overall Study||40
10338721|NCT03418675|11475613|FG001|STARTED|Overall Study||40
10328252|NCT00301873|11463897|FG000|STARTED|Overall Study||59
10328253|NCT00301873|11463897|FG000|COMPLETED|Overall Study||59
10328254|NCT00301873|11463897|FG000|NOT COMPLETED|Overall Study||0
10328255|NCT00301964|11463901|FG000|STARTED|Overall Study||56
10328256|NCT00301964|11463901|FG000|COMPLETED|Overall Study|Total number of eligible and evaluable participants|52
10328257|NCT00301964|11463901|FG000|NOT COMPLETED|Overall Study||4
10328258|NCT00302003|11463911|FG000|STARTED|Overall Study||287
10328259|NCT00302003|11463911|FG000|COMPLETED|Overall Study||207
10328260|NCT00302003|11463911|FG000|NOT COMPLETED|Overall Study||80
10328261|NCT00302042|11463917|FG000|STARTED|Overall Study||46
10328262|NCT00302042|11463918|FG001|STARTED|Overall Study||46
10328263|NCT00302042|11463917|FG000|COMPLETED|Overall Study||39
10328264|NCT00302042|11463918|FG001|COMPLETED|Overall Study||38
10328265|NCT00302042|11463917|FG000|NOT COMPLETED|Overall Study||7
10328266|NCT00302042|11463918|FG001|NOT COMPLETED|Overall Study||8
10328267|NCT00302055|11463926|FG000|STARTED|Overall Study||23
10328268|NCT00302055|11463927|FG001|STARTED|Overall Study||49
10328269|NCT00302055|11463926|FG000|COMPLETED|Overall Study||14
10328270|NCT00302055|11463927|FG001|COMPLETED|Overall Study||36
10328271|NCT00302055|11463926|FG000|NOT COMPLETED|Overall Study||9
10328272|NCT00302055|11463927|FG001|NOT COMPLETED|Overall Study||13
10328273|NCT00302068|11463936|FG000|STARTED|Overall Study||37
10328274|NCT00302068|11463937|FG001|STARTED|Overall Study||40
10328275|NCT00302068|11463938|FG002|STARTED|Overall Study||24
10328276|NCT00302068|11463936|FG000|COMPLETED|Overall Study||36
10328277|NCT00302068|11463937|FG001|COMPLETED|Overall Study||36
10328278|NCT00302068|11463938|FG002|COMPLETED|Overall Study||23
10328279|NCT00302068|11463936|FG000|NOT COMPLETED|Overall Study||1
10328280|NCT00302068|11463937|FG001|NOT COMPLETED|Overall Study||4
10328281|NCT00302068|11463938|FG002|NOT COMPLETED|Overall Study||1
10328282|NCT00302081|11463950|FG000|STARTED|Overall Study||237
10328283|NCT00302081|11463951|FG001|STARTED|Overall Study||229
10328284|NCT00302081|11463952|FG002|STARTED|Overall Study||230
10328285|NCT00302081|11463950|FG000|COMPLETED|Overall Study||181
10328286|NCT00302081|11463951|FG001|COMPLETED|Overall Study||186
10328287|NCT00302081|11463952|FG002|COMPLETED|Overall Study||178
10328288|NCT00302081|11463950|FG000|NOT COMPLETED|Overall Study||56
10328289|NCT00302081|11463951|FG001|NOT COMPLETED|Overall Study||43
10328290|NCT00302081|11463952|FG002|NOT COMPLETED|Overall Study||52
10328291|NCT00302107|11463962|FG000|STARTED|Overall Study||39
10328292|NCT00302107|11463963|FG001|STARTED|Overall Study||39
10328293|NCT00302107|11463962|FG000|COMPLETED|Overall Study||31
10328294|NCT00302107|11463963|FG001|COMPLETED|Overall Study||30
10328295|NCT00302107|11463962|FG000|NOT COMPLETED|Overall Study||8
10328296|NCT00302107|11463963|FG001|NOT COMPLETED|Overall Study||9
10328297|NCT00302133|11463971|FG000|STARTED|Overall Study||9
10328298|NCT00302133|11463972|FG001|STARTED|Overall Study||9
10328299|NCT00302133|11463971|FG000|COMPLETED|Overall Study||5
10328300|NCT00302133|11463972|FG001|COMPLETED|Overall Study||5
10328301|NCT00302133|11463971|FG000|NOT COMPLETED|Overall Study||4
10328302|NCT00302133|11463972|FG001|NOT COMPLETED|Overall Study||4
10328303|NCT00302159|11463978|FG000|STARTED|Overall Study||43
10328304|NCT00302159|11463978|FG000|COMPLETED|Overall Study||41
10328305|NCT00302159|11463978|FG000|NOT COMPLETED|Overall Study||2
10328306|NCT00302211|11463986|FG000|STARTED|Double Blind Period (New Patients)|These subjects had the option to continue with the same dose of iloprost during the OL period|26
10328378|NCT00302848|11464068|FG000|NOT COMPLETED|Overall Study||401
10328379|NCT00302848|11464069|FG001|NOT COMPLETED|Overall Study||419
10328307|NCT00302211|11463987|FG001|STARTED|Double Blind Period (New Patients)|These subjects had the option to continue with the same dose of iloprost during the OL period|27
10328308|NCT00302211|11463988|FG002|STARTED|Double Blind Period (New Patients)|These subjects could receive either iloprost 4x/day or 6x/day in the OL period|14
10701734|NCT02569853|11866202|FG001|COMPLETED|Overall Study||123
10701735|NCT02569853|11866201|FG000|NOT COMPLETED|Overall Study||20
10328309|NCT00302211|11463989|FG003|STARTED|Double Blind Period (New Patients)||0
10328310|NCT00302211|11463990|FG004|STARTED|Double Blind Period (New Patients)||0
10328311|NCT00302211|11463986|FG000|COMPLETED|Double Blind Period (New Patients)||23
10328312|NCT00302211|11463987|FG001|COMPLETED|Double Blind Period (New Patients)||25
10328313|NCT00302211|11463988|FG002|COMPLETED|Double Blind Period (New Patients)||10
10328314|NCT00302211|11463989|FG003|COMPLETED|Double Blind Period (New Patients)||0
10456351|NCT01006603|11604325|FG000|NOT COMPLETED|Overall Study||71
10456352|NCT01006603|11604326|FG001|NOT COMPLETED|Overall Study||75
10456353|NCT01006616|11604336|FG000|STARTED|Period 1 (6 Months)||152
10328315|NCT00302211|11463990|FG004|COMPLETED|Double Blind Period (New Patients)||0
10328316|NCT00302211|11463986|FG000|NOT COMPLETED|Double Blind Period (New Patients)||3
10328317|NCT00302211|11463987|FG001|NOT COMPLETED|Double Blind Period (New Patients)||2
10328318|NCT00302211|11463988|FG002|NOT COMPLETED|Double Blind Period (New Patients)||4
10328319|NCT00302211|11463989|FG003|NOT COMPLETED|Double Blind Period (New Patients)||0
10328320|NCT00302211|11463990|FG004|NOT COMPLETED|Double Blind Period (New Patients)||0
10328321|NCT00302211|11463986|FG000|STARTED|Open Label-Patients From Double-Blind||0
10456354|NCT01006616|11604337|FG001|STARTED|Period 1 (6 Months)||156
10701736|NCT02569853|11866202|FG001|NOT COMPLETED|Overall Study||14
10328322|NCT00302211|11463987|FG001|STARTED|Open Label-Patients From Double-Blind||0
10328323|NCT00302211|11463988|FG002|STARTED|Open Label-Patients From Double-Blind||0
10328324|NCT00302211|11463989|FG003|STARTED|Open Label-Patients From Double-Blind|21 patients (pts) in 6x/day DB phase & 5 patients in placebo 6x/day DB phase enrolled in OL 6x/day|26
10328325|NCT00302211|11463990|FG004|STARTED|Open Label-Patients From Double-Blind|26 pts in 4x/day + placebo 2x/day DB phase & 6 pts in placebo 6x/day DB phase enrolled in OL 4x/day|32
10328326|NCT00302211|11463986|FG000|COMPLETED|Open Label-Patients From Double-Blind||0
10328327|NCT00302211|11463987|FG001|COMPLETED|Open Label-Patients From Double-Blind||0
10328328|NCT00302211|11463988|FG002|COMPLETED|Open Label-Patients From Double-Blind||0
10328329|NCT00302211|11463989|FG003|COMPLETED|Open Label-Patients From Double-Blind||18
10328330|NCT00302211|11463990|FG004|COMPLETED|Open Label-Patients From Double-Blind||24
10328331|NCT00302211|11463986|FG000|NOT COMPLETED|Open Label-Patients From Double-Blind||0
10328332|NCT00302211|11463987|FG001|NOT COMPLETED|Open Label-Patients From Double-Blind||0
10328333|NCT00302211|11463988|FG002|NOT COMPLETED|Open Label-Patients From Double-Blind||0
10328334|NCT00302211|11463989|FG003|NOT COMPLETED|Open Label-Patients From Double-Blind||8
10328335|NCT00302211|11463990|FG004|NOT COMPLETED|Open Label-Patients From Double-Blind||8
10328336|NCT00302328|11464005|FG000|STARTED|Overall Study||25
10328337|NCT00302328|11464006|FG001|STARTED|Overall Study||35
10328338|NCT00302328|11464007|FG002|STARTED|Overall Study||18
10328339|NCT00302328|11464005|FG000|COMPLETED|Overall Study||25
10328340|NCT00302328|11464006|FG001|COMPLETED|Overall Study|developed cancer during the study|34
10328341|NCT00302328|11464007|FG002|COMPLETED|Overall Study||18
10328342|NCT00302328|11464005|FG000|NOT COMPLETED|Overall Study||0
10328343|NCT00302328|11464006|FG001|NOT COMPLETED|Overall Study||1
10328344|NCT00302328|11464007|FG002|NOT COMPLETED|Overall Study||0
10328345|NCT00302458|11464018|FG000|STARTED|Overall Study||29
10328346|NCT00302458|11464018|FG000|COMPLETED|Overall Study||26
10328347|NCT00302458|11464018|FG000|NOT COMPLETED|Overall Study||3
10328348|NCT00302718|11464030|FG000|STARTED|Overall Study||20
10328349|NCT00302718|11464031|FG001|STARTED|Overall Study||21
10328350|NCT00302718|11464032|FG002|STARTED|Overall Study||21
10328351|NCT00302718|11464033|FG003|STARTED|Overall Study||21
10328352|NCT00302718|11464030|FG000|COMPLETED|Overall Study||19
10328353|NCT00302718|11464031|FG001|COMPLETED|Overall Study||20
10328354|NCT00302718|11464032|FG002|COMPLETED|Overall Study||19
10328355|NCT00302718|11464033|FG003|COMPLETED|Overall Study||19
10328356|NCT00302718|11464030|FG000|NOT COMPLETED|Overall Study||1
10328357|NCT00302718|11464031|FG001|NOT COMPLETED|Overall Study||1
10328358|NCT00302718|11464032|FG002|NOT COMPLETED|Overall Study||2
10328359|NCT00302718|11464033|FG003|NOT COMPLETED|Overall Study||2
10328360|NCT00302731|11464052|FG000|STARTED|Overall Study||6
10328361|NCT00302731|11464053|FG001|STARTED|Overall Study||6
10328362|NCT00302731|11464054|FG002|STARTED|Overall Study||5
10328363|NCT00302731|11464055|FG003|STARTED|Overall Study||4
10328364|NCT00302731|11464052|FG000|COMPLETED|Overall Study||2
10328365|NCT00302731|11464053|FG001|COMPLETED|Overall Study||1
10328366|NCT00302731|11464054|FG002|COMPLETED|Overall Study||2
10328367|NCT00302731|11464055|FG003|COMPLETED|Overall Study||4
10328368|NCT00302731|11464052|FG000|NOT COMPLETED|Overall Study||4
10328369|NCT00302731|11464053|FG001|NOT COMPLETED|Overall Study||5
10328370|NCT00302731|11464054|FG002|NOT COMPLETED|Overall Study||3
10328371|NCT00302731|11464055|FG003|NOT COMPLETED|Overall Study||0
10328372|NCT00302848|11464068|FG000|STARTED|Overall Study||16534
10328373|NCT00302848|11464069|FG001|STARTED|Overall Study||15428
10328374|NCT00302848|11464070|FG002|STARTED|Overall Study||26341
10328375|NCT00302848|11464068|FG000|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|16133
10328376|NCT00302848|11464069|FG001|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|15009
10328377|NCT00302848|11464070|FG002|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|25762
10328380|NCT00302848|11464070|FG002|NOT COMPLETED|Overall Study||579
10328391|NCT00303069|11464090|FG000|STARTED|Overall Study||31
10328392|NCT00303069|11464091|FG001|STARTED|Overall Study||28
10328393|NCT00303069|11464092|FG002|STARTED|Overall Study||34
10701737|NCT02569892|11866210|FG000|STARTED|Overall Study||10
10701738|NCT02569892|11866211|FG001|STARTED|Overall Study||9
10701739|NCT02569892|11866210|FG000|COMPLETED|Overall Study||10
10328394|NCT00303069|11464093|FG003|STARTED|Overall Study||31
10328395|NCT00303069|11464090|FG000|COMPLETED|Overall Study||29
10328396|NCT00303069|11464091|FG001|COMPLETED|Overall Study||28
10701740|NCT02569892|11866211|FG001|COMPLETED|Overall Study||8
10328397|NCT00303069|11464092|FG002|COMPLETED|Overall Study||33
10328398|NCT00303069|11464093|FG003|COMPLETED|Overall Study||29
10328399|NCT00303069|11464090|FG000|NOT COMPLETED|Overall Study||2
10328400|NCT00303069|11464091|FG001|NOT COMPLETED|Overall Study||0
10328401|NCT00303069|11464092|FG002|NOT COMPLETED|Overall Study||1
10328402|NCT00303069|11464093|FG003|NOT COMPLETED|Overall Study||2
10328403|NCT00303108|11464106|FG000|STARTED|Overall Study||43
10328404|NCT00303108|11464107|FG001|STARTED|Overall Study||46
10328405|NCT00303108|11464108|FG002|STARTED|Overall Study||47
10701741|NCT02569892|11866210|FG000|NOT COMPLETED|Overall Study||0
10328406|NCT00303108|11464106|FG000|COMPLETED|Overall Study||31
10328407|NCT00303108|11464107|FG001|COMPLETED|Overall Study||37
10328408|NCT00303108|11464108|FG002|COMPLETED|Overall Study||31
10328409|NCT00303108|11464106|FG000|NOT COMPLETED|Overall Study||12
10328410|NCT00303108|11464107|FG001|NOT COMPLETED|Overall Study||9
10328411|NCT00303108|11464108|FG002|NOT COMPLETED|Overall Study||16
10328412|NCT00303186|11464115|FG000|STARTED|Overall Study||107
10328413|NCT00303186|11464115|FG000|COMPLETED|Overall Study||55
10328414|NCT00303186|11464115|FG000|NOT COMPLETED|Overall Study||52
10328415|NCT00303316|11464121|FG000|STARTED|Overall Study||232
10328416|NCT00303316|11464122|FG001|STARTED|Overall Study||226
10328417|NCT00303316|11464121|FG000|COMPLETED|Overall Study||230
10328418|NCT00303316|11464122|FG001|COMPLETED|Overall Study||223
10328419|NCT00303316|11464121|FG000|NOT COMPLETED|Overall Study||2
10328420|NCT00303316|11464122|FG001|NOT COMPLETED|Overall Study||3
10328421|NCT00303329|11464130|FG000|STARTED|Overall Study||85
10328422|NCT00303329|11464131|FG001|STARTED|Overall Study||99
10328423|NCT00303329|11464130|FG000|COMPLETED|Overall Study||50
10328424|NCT00303329|11464131|FG001|COMPLETED|Overall Study||37
10328425|NCT00303329|11464130|FG000|NOT COMPLETED|Overall Study||35
10328426|NCT00303329|11464131|FG001|NOT COMPLETED|Overall Study||62
10328427|NCT00303446|11464139|FG000|STARTED|Overall Study||25
10328428|NCT00303446|11464140|FG001|STARTED|Overall Study||25
10328429|NCT00303446|11464139|FG000|COMPLETED|Overall Study||23
10328430|NCT00303446|11464140|FG001|COMPLETED|Overall Study||21
10328431|NCT00303446|11464139|FG000|NOT COMPLETED|Overall Study||2
10328432|NCT00303446|11464140|FG001|NOT COMPLETED|Overall Study||4
10328433|NCT00303459|11464148|FG000|STARTED|Overall Study||159
10328434|NCT00303459|11464149|FG001|STARTED|Overall Study|One subject randomized to placebo did not receive study treatment|175
10328435|NCT00303459|11464148|FG000|COMPLETED|Overall Study||76
10328436|NCT00303459|11464149|FG001|COMPLETED|Overall Study||86
10328437|NCT00303459|11464148|FG000|NOT COMPLETED|Overall Study||83
10328438|NCT00303459|11464149|FG001|NOT COMPLETED|Overall Study||89
10328439|NCT00303472|11464163|FG000|STARTED|Treatment Period||6
10328440|NCT00303472|11464164|FG001|STARTED|Treatment Period||11
10328441|NCT00303472|11464165|FG002|STARTED|Treatment Period||11
10328442|NCT00303472|11464166|FG003|STARTED|Treatment Period||16
10328443|NCT00303472|11464167|FG004|STARTED|Treatment Period||11
10328444|NCT00303472|11464168|FG005|STARTED|Treatment Period||12
10328445|NCT00303472|11464169|FG006|STARTED|Treatment Period||5
10328446|NCT00303472|11464163|FG000|COMPLETED|Treatment Period||6
10328447|NCT00303472|11464164|FG001|COMPLETED|Treatment Period||11
10328448|NCT00303472|11464165|FG002|COMPLETED|Treatment Period||11
10328449|NCT00303472|11464166|FG003|COMPLETED|Treatment Period||14
10328450|NCT00303472|11464167|FG004|COMPLETED|Treatment Period||8
10328451|NCT00303472|11464168|FG005|COMPLETED|Treatment Period||11
10328452|NCT00303472|11464169|FG006|COMPLETED|Treatment Period||3
10328453|NCT00303472|11464163|FG000|NOT COMPLETED|Treatment Period||0
10328454|NCT00303472|11464164|FG001|NOT COMPLETED|Treatment Period||0
10328455|NCT00303472|11464165|FG002|NOT COMPLETED|Treatment Period||0
10328456|NCT00303472|11464166|FG003|NOT COMPLETED|Treatment Period||2
10328457|NCT00303472|11464167|FG004|NOT COMPLETED|Treatment Period||3
10328458|NCT00303472|11464168|FG005|NOT COMPLETED|Treatment Period||1
10328459|NCT00303472|11464169|FG006|NOT COMPLETED|Treatment Period||2
10328460|NCT00303472|11464163|FG000|STARTED|Treatment Extension (Optional)||6
10328461|NCT00303472|11464164|FG001|STARTED|Treatment Extension (Optional)||11
10328462|NCT00303472|11464165|FG002|STARTED|Treatment Extension (Optional)||11
10328463|NCT00303472|11464166|FG003|STARTED|Treatment Extension (Optional)||13
10328464|NCT00303472|11464167|FG004|STARTED|Treatment Extension (Optional)||5
10328465|NCT00303472|11464168|FG005|STARTED|Treatment Extension (Optional)||5
10328466|NCT00303472|11464169|FG006|STARTED|Treatment Extension (Optional)||1
10328467|NCT00303472|11464163|FG000|COMPLETED|Treatment Extension (Optional)||1
10328468|NCT00303472|11464164|FG001|COMPLETED|Treatment Extension (Optional)||5
10328469|NCT00303472|11464165|FG002|COMPLETED|Treatment Extension (Optional)||2
10328470|NCT00303472|11464166|FG003|COMPLETED|Treatment Extension (Optional)||5
10328471|NCT00303472|11464167|FG004|COMPLETED|Treatment Extension (Optional)||1
10328472|NCT00303472|11464168|FG005|COMPLETED|Treatment Extension (Optional)||4
10328473|NCT00303472|11464169|FG006|COMPLETED|Treatment Extension (Optional)||1
10328474|NCT00303472|11464163|FG000|NOT COMPLETED|Treatment Extension (Optional)||5
10328475|NCT00303472|11464164|FG001|NOT COMPLETED|Treatment Extension (Optional)||6
10328476|NCT00303472|11464165|FG002|NOT COMPLETED|Treatment Extension (Optional)||9
10328477|NCT00303472|11464166|FG003|NOT COMPLETED|Treatment Extension (Optional)||8
10328478|NCT00303472|11464167|FG004|NOT COMPLETED|Treatment Extension (Optional)||4
10328479|NCT00303472|11464168|FG005|NOT COMPLETED|Treatment Extension (Optional)||1
10328480|NCT00303472|11464169|FG006|NOT COMPLETED|Treatment Extension (Optional)||0
10328481|NCT00303485|11464187|FG000|STARTED|Overall Study||49
10328482|NCT00303485|11464188|FG001|STARTED|Overall Study||17
10328483|NCT00303485|11464187|FG000|COMPLETED|Overall Study||48
10328484|NCT00303485|11464188|FG001|COMPLETED|Overall Study||15
10328485|NCT00303485|11464187|FG000|NOT COMPLETED|Overall Study||1
10328486|NCT00303485|11464188|FG001|NOT COMPLETED|Overall Study||2
10328487|NCT00303511|11464194|FG000|STARTED|Overall Study||10
10328488|NCT00303511|11464194|FG000|COMPLETED|Overall Study||10
10328489|NCT00303511|11464194|FG000|NOT COMPLETED|Overall Study||0
10328490|NCT00303602|11464200|FG000|STARTED|Overall Study||84
10328491|NCT00303602|11464201|FG001|STARTED|Overall Study||65
10328492|NCT00303602|11464200|FG000|COMPLETED|Overall Study||65
10328493|NCT00303602|11464201|FG001|COMPLETED|Overall Study||50
10328494|NCT00303602|11464200|FG000|NOT COMPLETED|Overall Study||19
10328495|NCT00303602|11464201|FG001|NOT COMPLETED|Overall Study||15
10328496|NCT00303628|11464209|FG000|STARTED|Overall Study||176
10328497|NCT00303628|11464210|FG001|STARTED|Overall Study||179
10328498|NCT00303628|11464209|FG000|Eligible|Overall Study||171
10328499|NCT00303628|11464210|FG001|Eligible|Overall Study||177
10328500|NCT00303628|11464209|FG000|Treated|Overall Study||173
10328501|NCT00303628|11464210|FG001|Treated|Overall Study||174
10328502|NCT00303628|11464209|FG000|COMPLETED|Overall Study||126
10328503|NCT00303628|11464210|FG001|COMPLETED|Overall Study||106
10328504|NCT00303628|11464209|FG000|NOT COMPLETED|Overall Study||50
10328505|NCT00303628|11464210|FG001|NOT COMPLETED|Overall Study||73
10328506|NCT00303667|11464218|FG000|STARTED|Overall Study||8
10328507|NCT00303667|11464219|FG001|STARTED|Overall Study||39
10328508|NCT00303667|11464218|FG000|COMPLETED|Overall Study||8
10328509|NCT00303667|11464219|FG001|COMPLETED|Overall Study|Completed = remained alive and on study through Day 0 (day of transplant)|35
10328510|NCT00303667|11464218|FG000|NOT COMPLETED|Overall Study||0
10328511|NCT00303667|11464219|FG001|NOT COMPLETED|Overall Study||4
10328512|NCT00303719|11464227|FG000|STARTED|Overall Study||13
10328513|NCT00303719|11464228|FG001|STARTED|Overall Study||329
10328514|NCT00303719|11464227|FG000|COMPLETED|Overall Study||13
10328515|NCT00303719|11464228|FG001|COMPLETED|Overall Study||292
10328516|NCT00303719|11464227|FG000|NOT COMPLETED|Overall Study||0
10328517|NCT00303719|11464228|FG001|NOT COMPLETED|Overall Study||37
10328518|NCT00303823|11464237|FG000|STARTED|Overall Study||50
10328519|NCT00303823|11464238|FG001|STARTED|Overall Study||48
10328520|NCT00303823|11464237|FG000|COMPLETED|Overall Study||35
10328521|NCT00303823|11464238|FG001|COMPLETED|Overall Study||38
10328522|NCT00303823|11464237|FG000|NOT COMPLETED|Overall Study||15
10328523|NCT00303823|11464238|FG001|NOT COMPLETED|Overall Study||10
10328524|NCT00303862|11464244|FG000|STARTED|Overall Study||10
10328525|NCT00303862|11464244|FG000|COMPLETED|Overall Study||10
10328526|NCT00303862|11464244|FG000|NOT COMPLETED|Overall Study||0
10328527|NCT00303901|11464248|FG000|STARTED|Overall Study||40
10328528|NCT00303901|11464248|FG000|COMPLETED|Overall Study||40
10328529|NCT00303901|11464248|FG000|NOT COMPLETED|Overall Study||0
10328530|NCT00303953|11464252|FG000|STARTED|Overall Study||22
10328531|NCT00303953|11464252|FG000|Eligible|Overall Study||21
10328532|NCT00303953|11464252|FG000|Eligible and Treated|Overall Study||20
10328533|NCT00303953|11464252|FG000|COMPLETED|Overall Study||3
10328534|NCT00303953|11464252|FG000|NOT COMPLETED|Overall Study||19
10328535|NCT00303966|11464256|FG000|STARTED|Overall Study||5
10328536|NCT00303966|11464256|FG000|COMPLETED|Overall Study||5
10328537|NCT00303966|11464256|FG000|NOT COMPLETED|Overall Study||0
10328538|NCT00303979|11464263|FG000|STARTED|Overall Study|at baseline|15177
10328539|NCT00303979|11464264|FG001|STARTED|Overall Study|at 6 months|9992
10328540|NCT00303979|11464265|FG002|STARTED|Overall Study|at 18 months|9641
10328541|NCT00303979|11464263|FG000|COMPLETED|Overall Study|at 24 Months|7605
10328542|NCT00303979|11464264|FG001|COMPLETED|Overall Study|at 6 months|9992
10328543|NCT00303979|11464265|FG002|COMPLETED|Overall Study|at 18 months|9641
10328544|NCT00303979|11464263|FG000|NOT COMPLETED|Overall Study||7572
10328545|NCT00303979|11464264|FG001|NOT COMPLETED|Overall Study||0
10328546|NCT00303979|11464265|FG002|NOT COMPLETED|Overall Study||0
10328547|NCT00304031|11464285|FG000|STARTED|Concomitant RT+TMZ (Pre-randomization)|All participants registered to concomitant treatment; randomized after completing this treatment.|1125
10328548|NCT00304031|11464286|FG001|STARTED|Concomitant RT+TMZ (Pre-randomization)|Participants were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
10328615|NCT00304187|11464331|FG000|NOT COMPLETED|Overall Study||2
10328549|NCT00304031|11464287|FG002|STARTED|Concomitant RT+TMZ (Pre-randomization)|Participants were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
10328550|NCT00304031|11464285|FG000|Eligible Pre-randomization Population|Concomitant RT+TMZ (Pre-randomization)||1125
10328551|NCT00304031|11464286|FG001|Eligible Pre-randomization Population|Concomitant RT+TMZ (Pre-randomization)||0
10328552|NCT00304031|11464287|FG002|Eligible Pre-randomization Population|Concomitant RT+TMZ (Pre-randomization)||0
10328553|NCT00304031|11464285|FG000|Eligible Pre-randomization Follow-up|Concomitant RT+TMZ (Pre-randomization)||1120
10328554|NCT00304031|11464286|FG001|Eligible Pre-randomization Follow-up|Concomitant RT+TMZ (Pre-randomization)||0
10328555|NCT00304031|11464287|FG002|Eligible Pre-randomization Follow-up|Concomitant RT+TMZ (Pre-randomization)||0
10328556|NCT00304031|11464285|FG000|COMPLETED|Concomitant RT+TMZ (Pre-randomization)|These participants completed concomitant treatment and met requirements for randomization.|833
10328557|NCT00304031|11464286|FG001|COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0
10328558|NCT00304031|11464287|FG002|COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0
10328559|NCT00304031|11464285|FG000|NOT COMPLETED|Concomitant RT+TMZ (Pre-randomization)||292
10328560|NCT00304031|11464286|FG001|NOT COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0
10328561|NCT00304031|11464287|FG002|NOT COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0
10328562|NCT00304031|11464285|FG000|STARTED|Randomization to Adjuvant TMZ Arm||0
10328563|NCT00304031|11464286|FG001|STARTED|Randomization to Adjuvant TMZ Arm||411
10701742|NCT02569892|11866211|FG001|NOT COMPLETED|Overall Study||1
10701743|NCT02569996|11866217|FG000|STARTED|Overall Study||124
10328564|NCT00304031|11464287|FG002|STARTED|Randomization to Adjuvant TMZ Arm||422
10328565|NCT00304031|11464285|FG000|Eligible Population|Randomization to Adjuvant TMZ Arm||0
10328566|NCT00304031|11464286|FG001|Eligible Population|Randomization to Adjuvant TMZ Arm||411
10328567|NCT00304031|11464287|FG002|Eligible Population|Randomization to Adjuvant TMZ Arm||420
10328568|NCT00304031|11464285|FG000|Unmethylated MGMT Population|Randomization to Adjuvant TMZ Arm||0
10328569|NCT00304031|11464286|FG001|Unmethylated MGMT Population|Randomization to Adjuvant TMZ Arm||254
10701744|NCT02569996|11866217|FG000|COMPLETED|Overall Study||69
10701745|NCT02569996|11866217|FG000|NOT COMPLETED|Overall Study||55
10701746|NCT02570022|11866223|FG000|STARTED|Overall Study||26
10701747|NCT02570022|11866224|FG001|STARTED|Overall Study||31
10701748|NCT02570022|11866223|FG000|COMPLETED|Overall Study||26
10701749|NCT02570022|11866224|FG001|COMPLETED|Overall Study||31
10328570|NCT00304031|11464287|FG002|Unmethylated MGMT Population|Randomization to Adjuvant TMZ Arm||262
10328571|NCT00304031|11464285|FG000|Methylated MGMT Population|Randomization to Adjuvant TMZ Arm||0
10328572|NCT00304031|11464286|FG001|Methylated MGMT Population|Randomization to Adjuvant TMZ Arm||122
10328573|NCT00304031|11464287|FG002|Methylated MGMT Population|Randomization to Adjuvant TMZ Arm||122
10328574|NCT00304031|11464285|FG000|Quality of Life Population|Randomization to Adjuvant TMZ Arm||0
10328575|NCT00304031|11464286|FG001|Quality of Life Population|Randomization to Adjuvant TMZ Arm||96
10328576|NCT00304031|11464287|FG002|Quality of Life Population|Randomization to Adjuvant TMZ Arm||95
10328577|NCT00304031|11464285|FG000|COMPLETED|Randomization to Adjuvant TMZ Arm||0
10328578|NCT00304031|11464286|FG001|COMPLETED|Randomization to Adjuvant TMZ Arm|Randomized participants contributing data to results are considered to have completed the study.|411
10328579|NCT00304031|11464287|FG002|COMPLETED|Randomization to Adjuvant TMZ Arm|Randomized participants contributing data to results are considered to have completed the study.|420
10328580|NCT00304031|11464285|FG000|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||0
10328581|NCT00304031|11464286|FG001|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||0
10328582|NCT00304031|11464287|FG002|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||2
10328583|NCT00304083|11464304|FG000|STARTED|Overall Study||34
10328584|NCT00304083|11464305|FG001|STARTED|Overall Study||14
10328585|NCT00304083|11464304|FG000|Completed 4 Cycles|Overall Study||22
10328586|NCT00304083|11464305|FG001|Completed 4 Cycles|Overall Study||7
10328587|NCT00304083|11464304|FG000|Patients Treated With Surgery|Overall Study||7
10328588|NCT00304083|11464305|FG001|Patients Treated With Surgery|Overall Study||3
10328589|NCT00304083|11464304|FG000|Patients Treated With Surgery and RT|Overall Study||5
10328590|NCT00304083|11464305|FG001|Patients Treated With Surgery and RT|Overall Study||1
10328591|NCT00304083|11464304|FG000|Patients Treated With RT Only|Overall Study||4
10328592|NCT00304083|11464305|FG001|Patients Treated With RT Only|Overall Study||2
10328593|NCT00304083|11464304|FG000|Patients Had Neither RT or Surgery|Overall Study||6
10328594|NCT00304083|11464305|FG001|Patients Had Neither RT or Surgery|Overall Study||1
10328595|NCT00304083|11464304|FG000|COMPLETED|Overall Study||12
10328596|NCT00304083|11464305|FG001|COMPLETED|Overall Study||6
10328597|NCT00304083|11464304|FG000|NOT COMPLETED|Overall Study||22
10328598|NCT00304083|11464305|FG001|NOT COMPLETED|Overall Study||8
10328599|NCT00304096|11464313|FG000|STARTED|Overall Study||6
10328600|NCT00304096|11464314|FG001|STARTED|Overall Study||5
10328601|NCT00304096|11464313|FG000|COMPLETED|Overall Study||6
10328602|NCT00304096|11464314|FG001|COMPLETED|Overall Study|6 patients enrolled, 1 not treated|5
10328603|NCT00304096|11464313|FG000|NOT COMPLETED|Overall Study||0
10328604|NCT00304096|11464314|FG001|NOT COMPLETED|Overall Study||0
10328605|NCT00304161|11464322|FG000|STARTED|Overall Study||28
10328606|NCT00304161|11464323|FG001|STARTED|Overall Study||27
10328607|NCT00304161|11464322|FG000|COMPLETED|Overall Study||22
10328608|NCT00304161|11464323|FG001|COMPLETED|Overall Study||21
10328609|NCT00304161|11464322|FG000|NOT COMPLETED|Overall Study||6
10328610|NCT00304161|11464323|FG001|NOT COMPLETED|Overall Study||6
10328611|NCT00304187|11464331|FG000|STARTED|Overall Study||15
10328612|NCT00304187|11464332|FG001|STARTED|Overall Study||14
10328613|NCT00304187|11464331|FG000|COMPLETED|Overall Study||13
10328614|NCT00304187|11464332|FG001|COMPLETED|Overall Study||13
10328616|NCT00304187|11464332|FG001|NOT COMPLETED|Overall Study||1
10328617|NCT00304265|11464342|FG000|STARTED|Overall Study||117
10328618|NCT00304265|11464343|FG001|STARTED|Overall Study||98
10328619|NCT00304265|11464342|FG000|COMPLETED|Overall Study||117
10328620|NCT00304265|11464343|FG001|COMPLETED|Overall Study||98
10328621|NCT00304265|11464342|FG000|NOT COMPLETED|Overall Study||0
10328622|NCT00304265|11464343|FG001|NOT COMPLETED|Overall Study||0
10328623|NCT00304278|11464349|FG000|STARTED|Overall Study||21
10701750|NCT02570022|11866223|FG000|NOT COMPLETED|Overall Study||0
10328624|NCT00304278|11464349|FG000|COMPLETED|Overall Study||19
10328625|NCT00304278|11464349|FG000|NOT COMPLETED|Overall Study||2
10328626|NCT00304356|11464353|FG000|STARTED|Nitazoxanide||27
10328627|NCT00304356|11464353|FG000|COMPLETED|Nitazoxanide||22
10328628|NCT00304356|11464353|FG000|NOT COMPLETED|Nitazoxanide||5
10328629|NCT00304356|11464353|FG000|STARTED|Nitazoxanide||27
10328630|NCT00304356|11464353|FG000|COMPLETED|Nitazoxanide||22
10328631|NCT00304356|11464353|FG000|NOT COMPLETED|Nitazoxanide||5
10328632|NCT00304512|11464360|FG000|STARTED|Treatment Period||2
10328633|NCT00304512|11464361|FG001|STARTED|Treatment Period||4
10328634|NCT00304512|11464362|FG002|STARTED|Treatment Period||3
10328635|NCT00304512|11464360|FG000|Safety Population|Treatment Period||2
10328636|NCT00304512|11464361|FG001|Safety Population|Treatment Period||4
10328637|NCT00304512|11464362|FG002|Safety Population|Treatment Period||3
10328638|NCT00304512|11464360|FG000|Pharmacokinetic (PK) Population|Treatment Period||2
10328639|NCT00304512|11464361|FG001|Pharmacokinetic (PK) Population|Treatment Period||4
10328640|NCT00304512|11464362|FG002|Pharmacokinetic (PK) Population|Treatment Period||3
10328641|NCT00304512|11464360|FG000|Pharmacodynamic (PD) Population|Treatment Period||2
10701751|NCT02570022|11866224|FG001|NOT COMPLETED|Overall Study||0
10701752|NCT02570074|11866232|FG000|STARTED|Period 1 (First Dosing Regimen)||9
10328642|NCT00304512|11464361|FG001|Pharmacodynamic (PD) Population|Treatment Period||4
10328643|NCT00304512|11464362|FG002|Pharmacodynamic (PD) Population|Treatment Period||3
10328644|NCT00304512|11464360|FG000|COMPLETED|Treatment Period||2
10328645|NCT00304512|11464361|FG001|COMPLETED|Treatment Period||4
10328646|NCT00304512|11464362|FG002|COMPLETED|Treatment Period||3
10328647|NCT00304512|11464360|FG000|NOT COMPLETED|Treatment Period||0
10328648|NCT00304512|11464361|FG001|NOT COMPLETED|Treatment Period||0
10328649|NCT00304512|11464362|FG002|NOT COMPLETED|Treatment Period||0
10328650|NCT00304512|11464360|FG000|STARTED|Extension Period||2
10328651|NCT00304512|11464361|FG001|STARTED|Extension Period||4
10328652|NCT00304512|11464362|FG002|STARTED|Extension Period||3
10328653|NCT00304512|11464360|FG000|COMPLETED|Extension Period||2
10328654|NCT00304512|11464361|FG001|COMPLETED|Extension Period||4
10328655|NCT00304512|11464362|FG002|COMPLETED|Extension Period||3
10328656|NCT00304512|11464360|FG000|NOT COMPLETED|Extension Period||0
10328657|NCT00304512|11464361|FG001|NOT COMPLETED|Extension Period||0
10328658|NCT00304512|11464362|FG002|NOT COMPLETED|Extension Period||0
10328659|NCT00304707|11464372|FG000|STARTED|Overall Study||73
10328660|NCT00304707|11464373|FG001|STARTED|Overall Study||70
10328661|NCT00304707|11464372|FG000|COMPLETED|Overall Study||66
10328662|NCT00304707|11464373|FG001|COMPLETED|Overall Study||64
10328663|NCT00304707|11464372|FG000|NOT COMPLETED|Overall Study||7
10328664|NCT00304707|11464373|FG001|NOT COMPLETED|Overall Study||6
10328665|NCT00304746|11464381|FG000|STARTED|Overall Study||50
10328666|NCT00304746|11464382|FG001|STARTED|Overall Study||50
10328667|NCT00304746|11464381|FG000|COMPLETED|Overall Study||50
10328668|NCT00304746|11464382|FG001|COMPLETED|Overall Study||50
10328669|NCT00304746|11464381|FG000|NOT COMPLETED|Overall Study||0
10328670|NCT00304746|11464382|FG001|NOT COMPLETED|Overall Study||0
10338722|NCT03418675|11475612|FG000|Completed All Baseline Measures|Overall Study||37
10338723|NCT03418675|11475613|FG001|Completed All Baseline Measures|Overall Study||40
10338724|NCT03418675|11475612|FG000|Completed One-post Randomization Visit|Overall Study||34
10338725|NCT03418675|11475613|FG001|Completed One-post Randomization Visit|Overall Study||35
10338726|NCT03418675|11475612|FG000|COMPLETED|Overall Study||25
10338727|NCT03418675|11475613|FG001|COMPLETED|Overall Study||30
10338728|NCT03418675|11475612|FG000|NOT COMPLETED|Overall Study||15
10338729|NCT03418675|11475613|FG001|NOT COMPLETED|Overall Study||10
10338730|NCT03367910|11475619|FG000|STARTED|Overall Study||1
10338731|NCT03367910|11475619|FG000|COMPLETED|Overall Study||1
10338732|NCT03367910|11475619|FG000|NOT COMPLETED|Overall Study||0
10338733|NCT03329690|11475628|FG000|STARTED|Overall Study||126
10338734|NCT03329690|11475629|FG001|STARTED|Overall Study||55
10338735|NCT03329690|11475630|FG002|STARTED|Overall Study||7
10338736|NCT03329690|11475631|FG003|STARTED|Overall Study||21
10338737|NCT03329690|11475632|FG004|STARTED|Overall Study||24
10338738|NCT03329690|11475628|FG000|Received Treatment|Overall Study||125
10338739|NCT03329690|11475629|FG001|Received Treatment|Overall Study||55
10338740|NCT03329690|11475630|FG002|Received Treatment|Overall Study||7
10338741|NCT03329690|11475631|FG003|Received Treatment|Overall Study||20
10338742|NCT03329690|11475632|FG004|Received Treatment|Overall Study||24
10338743|NCT03329690|11475628|FG000|COMPLETED|Overall Study||0
10338744|NCT03329690|11475629|FG001|COMPLETED|Overall Study||0
10338745|NCT03329690|11475630|FG002|COMPLETED|Overall Study||0
10338746|NCT03329690|11475631|FG003|COMPLETED|Overall Study||0
10338747|NCT03329690|11475632|FG004|COMPLETED|Overall Study||0
10338748|NCT03329690|11475628|FG000|NOT COMPLETED|Overall Study||126
10338749|NCT03329690|11475629|FG001|NOT COMPLETED|Overall Study||55
10338750|NCT03329690|11475630|FG002|NOT COMPLETED|Overall Study||7
10338751|NCT03329690|11475631|FG003|NOT COMPLETED|Overall Study||21
10338752|NCT03329690|11475632|FG004|NOT COMPLETED|Overall Study||24
10338753|NCT03320564|11475650|FG000|STARTED|Overall Study||2
10338754|NCT03320564|11475650|FG000|COMPLETED|Overall Study||1
10338755|NCT03320564|11475650|FG000|NOT COMPLETED|Overall Study||1
10338756|NCT03235817|11475657|FG000|STARTED|Overall Study||13
10338757|NCT03235817|11475658|FG001|STARTED|Overall Study||13
10338758|NCT03235817|11475659|FG002|STARTED|Overall Study||13
10338759|NCT03235817|11475657|FG000|COMPLETED|Overall Study||10
10338760|NCT03235817|11475658|FG001|COMPLETED|Overall Study||12
10338761|NCT03235817|11475659|FG002|COMPLETED|Overall Study||11
10338762|NCT03235817|11475657|FG000|NOT COMPLETED|Overall Study||3
10338763|NCT03235817|11475658|FG001|NOT COMPLETED|Overall Study||1
10338764|NCT03235817|11475659|FG002|NOT COMPLETED|Overall Study||2
10338765|NCT03165955|11475668|FG000|STARTED|Screening/Baseline||31
10338766|NCT03165955|11475668|FG000|COMPLETED|Screening/Baseline||28
10338767|NCT03165955|11475668|FG000|NOT COMPLETED|Screening/Baseline||3
10338768|NCT03165955|11475668|FG000|STARTED|Treatment||28
10338769|NCT03165955|11475668|FG000|COMPLETED|Treatment||20
10338770|NCT03165955|11475668|FG000|NOT COMPLETED|Treatment||8
10338771|NCT03133793|11475676|FG000|STARTED|Overall Study||39
10338772|NCT03133793|11475677|FG001|STARTED|Overall Study||39
10338773|NCT03133793|11475678|FG002|STARTED|Overall Study||37
10338774|NCT03133793|11475679|FG003|STARTED|Overall Study||38
10338775|NCT03133793|11475676|FG000|COMPLETED|Overall Study||38
10338776|NCT03133793|11475677|FG001|COMPLETED|Overall Study||35
10338777|NCT03133793|11475678|FG002|COMPLETED|Overall Study||33
10338778|NCT03133793|11475679|FG003|COMPLETED|Overall Study||33
10338779|NCT03133793|11475676|FG000|NOT COMPLETED|Overall Study||1
10338780|NCT03133793|11475677|FG001|NOT COMPLETED|Overall Study||4
10338781|NCT03133793|11475678|FG002|NOT COMPLETED|Overall Study||4
10338782|NCT03133793|11475679|FG003|NOT COMPLETED|Overall Study||5
10339296|NCT00371839|11476203|FG001|COMPLETED|Overall Study||13
10328671|NCT04721171|11464390|FG000|STARTED|Overall Study||2
10328672|NCT04721171|11464391|FG001|STARTED|Overall Study||2
10328673|NCT04721171|11464390|FG000|COMPLETED|Overall Study||2
10328674|NCT04721171|11464391|FG001|COMPLETED|Overall Study||2
10328675|NCT04721171|11464390|FG000|NOT COMPLETED|Overall Study||0
10328676|NCT04721171|11464391|FG001|NOT COMPLETED|Overall Study||0
10328677|NCT04717323|11464401|FG000|STARTED|Overall Study||0
10328678|NCT04717323|11464402|FG001|STARTED|Overall Study||10
10328679|NCT04717323|11464401|FG000|COMPLETED|Overall Study||0
10328680|NCT04717323|11464402|FG001|COMPLETED|Overall Study||10
10328681|NCT04717323|11464401|FG000|NOT COMPLETED|Overall Study||0
10328682|NCT04717323|11464402|FG001|NOT COMPLETED|Overall Study||0
10328683|NCT04511338|11464410|FG000|STARTED|Period 1||8
10328684|NCT04511338|11464411|FG001|STARTED|Period 1||8
10328685|NCT04511338|11464410|FG000|COMPLETED|Period 1||7
10328686|NCT04511338|11464411|FG001|COMPLETED|Period 1||8
10328687|NCT04511338|11464410|FG000|NOT COMPLETED|Period 1||1
10328688|NCT04511338|11464411|FG001|NOT COMPLETED|Period 1||0
10328689|NCT04511338|11464410|FG000|STARTED|Washout|"We followed the rules in protocol (brief version in SARP sec. 3.1) to withdraw or move subjects to the next period.~Period 1:~Dialyzer with Endexo has grade 4 clotting, subjects is withdrawn from the study~CombiSet with grade 4 clotting only (not the dialyzer): subjects end Period 1, move to Washout, and then Period 2~There was a subject with CombiSet bloodline grade 4 clotting in the 50% heparin reduction HD. The subject was moved to washout period without any heparin free sessions."|8
10328690|NCT04511338|11464411|FG001|STARTED|Washout||8
10328691|NCT04511338|11464410|FG000|COMPLETED|Washout||8
10328692|NCT04511338|11464411|FG001|COMPLETED|Washout||8
10328693|NCT04511338|11464410|FG000|NOT COMPLETED|Washout||0
10328694|NCT04511338|11464411|FG001|NOT COMPLETED|Washout||0
10328695|NCT04511338|11464410|FG000|STARTED|Period 2||8
10328696|NCT04511338|11464411|FG001|STARTED|Period 2||8
10328697|NCT04511338|11464410|FG000|COMPLETED|Period 2||8
10328698|NCT04511338|11464411|FG001|COMPLETED|Period 2||5
10328699|NCT04511338|11464410|FG000|NOT COMPLETED|Period 2||0
10328700|NCT04511338|11464411|FG001|NOT COMPLETED|Period 2||3
10328704|NCT04493931|11464428|FG000|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||14
10328705|NCT04493931|11464429|FG001|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||0
10328706|NCT04493931|11464430|FG002|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||0
10328707|NCT04493931|11464431|FG003|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||0
10328708|NCT04493931|11464432|FG004|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||0
10328709|NCT04493931|11464433|FG005|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||0
10328710|NCT04493931|11464434|FG006|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||0
10328711|NCT04493931|11464428|FG000|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||13
10328712|NCT04493931|11464429|FG001|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
10328713|NCT04493931|11464430|FG002|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
10328714|NCT04493931|11464431|FG003|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
10328715|NCT04493931|11464432|FG004|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
10328716|NCT04493931|11464433|FG005|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
10328717|NCT04493931|11464434|FG006|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
10328718|NCT04493931|11464428|FG000|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||1
10328719|NCT04493931|11464429|FG001|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
10328720|NCT04493931|11464430|FG002|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
10328721|NCT04493931|11464431|FG003|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
10328722|NCT04493931|11464432|FG004|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
10328723|NCT04493931|11464433|FG005|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
10328724|NCT04493931|11464434|FG006|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
10328725|NCT04493931|11464428|FG000|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||13
10328726|NCT04493931|11464429|FG001|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
10328727|NCT04493931|11464430|FG002|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
10328728|NCT04493931|11464431|FG003|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
10328729|NCT04493931|11464432|FG004|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
10328730|NCT04493931|11464433|FG005|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
10328731|NCT04493931|11464434|FG006|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
10328732|NCT04493931|11464428|FG000|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||13
10328733|NCT04493931|11464429|FG001|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
10328734|NCT04493931|11464430|FG002|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
10328735|NCT04493931|11464431|FG003|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
10328736|NCT04493931|11464432|FG004|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
10328737|NCT04493931|11464433|FG005|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
10328738|NCT04493931|11464434|FG006|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
10328739|NCT04493931|11464428|FG000|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
10328740|NCT04493931|11464429|FG001|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
10328741|NCT04493931|11464430|FG002|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
10328742|NCT04493931|11464431|FG003|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
10328743|NCT04493931|11464432|FG004|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
10328744|NCT04493931|11464433|FG005|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
10328745|NCT04493931|11464434|FG006|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
10328746|NCT04493931|11464428|FG000|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||13
10328747|NCT04493931|11464429|FG001|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||0
10328748|NCT04493931|11464430|FG002|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||0
10328749|NCT04493931|11464431|FG003|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||0
10328750|NCT04493931|11464432|FG004|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||0
10328751|NCT04493931|11464433|FG005|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||0
10328752|NCT04493931|11464434|FG006|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||0
10328753|NCT04493931|11464428|FG000|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||13
10328754|NCT04493931|11464429|FG001|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
10328755|NCT04493931|11464430|FG002|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
10328756|NCT04493931|11464431|FG003|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
10328757|NCT04493931|11464432|FG004|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
10328758|NCT04493931|11464433|FG005|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
10328759|NCT04493931|11464434|FG006|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
10328760|NCT04493931|11464428|FG000|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
10328761|NCT04493931|11464429|FG001|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
10328762|NCT04493931|11464430|FG002|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
10328763|NCT04493931|11464431|FG003|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
10328764|NCT04493931|11464432|FG004|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
10328765|NCT04493931|11464433|FG005|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
10328766|NCT04493931|11464434|FG006|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
10328767|NCT04493931|11464428|FG000|STARTED|Cohort 1: Follow-up (Up to 7 Days)||13
10328768|NCT04493931|11464429|FG001|STARTED|Cohort 1: Follow-up (Up to 7 Days)||0
10328769|NCT04493931|11464430|FG002|STARTED|Cohort 1: Follow-up (Up to 7 Days)||0
10328770|NCT04493931|11464431|FG003|STARTED|Cohort 1: Follow-up (Up to 7 Days)||0
10328771|NCT04493931|11464432|FG004|STARTED|Cohort 1: Follow-up (Up to 7 Days)||0
10328772|NCT04493931|11464433|FG005|STARTED|Cohort 1: Follow-up (Up to 7 Days)||0
10328773|NCT04493931|11464434|FG006|STARTED|Cohort 1: Follow-up (Up to 7 Days)||0
10328774|NCT04493931|11464428|FG000|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||13
10328775|NCT04493931|11464429|FG001|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
10328776|NCT04493931|11464430|FG002|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
10328777|NCT04493931|11464431|FG003|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
10328778|NCT04493931|11464432|FG004|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
10328779|NCT04493931|11464433|FG005|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
10328780|NCT04493931|11464434|FG006|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
10328781|NCT04493931|11464428|FG000|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
10328782|NCT04493931|11464429|FG001|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
10328783|NCT04493931|11464430|FG002|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
10328784|NCT04493931|11464431|FG003|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
10328785|NCT04493931|11464432|FG004|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
10328786|NCT04493931|11464433|FG005|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
10328787|NCT04493931|11464434|FG006|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
10328788|NCT04493931|11464428|FG000|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||0
10328789|NCT04493931|11464429|FG001|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||17
10328790|NCT04493931|11464430|FG002|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||0
10328791|NCT04493931|11464431|FG003|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||0
10328792|NCT04493931|11464432|FG004|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||0
10328793|NCT04493931|11464433|FG005|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||0
10328794|NCT04493931|11464434|FG006|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||0
10328795|NCT04493931|11464428|FG000|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
10328796|NCT04493931|11464429|FG001|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||17
10328797|NCT04493931|11464430|FG002|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
10328798|NCT04493931|11464431|FG003|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
10328799|NCT04493931|11464432|FG004|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
10328800|NCT04493931|11464433|FG005|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
10328801|NCT04493931|11464434|FG006|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
10328802|NCT04493931|11464428|FG000|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
10328803|NCT04493931|11464429|FG001|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
10339297|NCT00371839|11476204|FG002|COMPLETED|Overall Study||7
10811222|NCT03769896|11972941|FG001|COMPLETED|Double-blind Treatment Phase||19
10328804|NCT04493931|11464430|FG002|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
10328805|NCT04493931|11464431|FG003|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
10328806|NCT04493931|11464432|FG004|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
10328807|NCT04493931|11464433|FG005|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
10328808|NCT04493931|11464434|FG006|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
10328809|NCT04493931|11464428|FG000|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||0
10328810|NCT04493931|11464429|FG001|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||17
10328811|NCT04493931|11464430|FG002|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||0
10328812|NCT04493931|11464431|FG003|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||0
10328813|NCT04493931|11464432|FG004|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||0
10328814|NCT04493931|11464433|FG005|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||0
10328815|NCT04493931|11464434|FG006|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||0
10328816|NCT04493931|11464428|FG000|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
10328817|NCT04493931|11464429|FG001|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||17
10328818|NCT04493931|11464430|FG002|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
10328819|NCT04493931|11464431|FG003|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
10328820|NCT04493931|11464432|FG004|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
10328821|NCT04493931|11464433|FG005|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
10328822|NCT04493931|11464434|FG006|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
10328823|NCT04493931|11464428|FG000|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
10328824|NCT04493931|11464429|FG001|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
10328825|NCT04493931|11464430|FG002|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
10328826|NCT04493931|11464431|FG003|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
10328827|NCT04493931|11464432|FG004|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
10328828|NCT04493931|11464433|FG005|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
10328829|NCT04493931|11464434|FG006|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
10328830|NCT04493931|11464428|FG000|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||0
10328831|NCT04493931|11464429|FG001|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||17
10328832|NCT04493931|11464430|FG002|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||0
10328833|NCT04493931|11464431|FG003|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||0
10328834|NCT04493931|11464432|FG004|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||0
10328835|NCT04493931|11464433|FG005|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||0
10328836|NCT04493931|11464434|FG006|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||0
10328837|NCT04493931|11464428|FG000|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
10328838|NCT04493931|11464429|FG001|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||14
10328839|NCT04493931|11464430|FG002|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
10328840|NCT04493931|11464431|FG003|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
10328841|NCT04493931|11464432|FG004|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
10328842|NCT04493931|11464433|FG005|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
10328843|NCT04493931|11464434|FG006|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
10328844|NCT04493931|11464428|FG000|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
10328845|NCT04493931|11464429|FG001|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||3
10328846|NCT04493931|11464430|FG002|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
10328847|NCT04493931|11464431|FG003|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
10328848|NCT04493931|11464432|FG004|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
10328849|NCT04493931|11464433|FG005|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
10328850|NCT04493931|11464434|FG006|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
10328851|NCT04493931|11464428|FG000|STARTED|Cohort 2: Follow-up (Up to 10 Days)||0
10328852|NCT04493931|11464429|FG001|STARTED|Cohort 2: Follow-up (Up to 10 Days)||14
10328853|NCT04493931|11464430|FG002|STARTED|Cohort 2: Follow-up (Up to 10 Days)||0
10328854|NCT04493931|11464431|FG003|STARTED|Cohort 2: Follow-up (Up to 10 Days)||0
10328855|NCT04493931|11464432|FG004|STARTED|Cohort 2: Follow-up (Up to 10 Days)||0
10328856|NCT04493931|11464433|FG005|STARTED|Cohort 2: Follow-up (Up to 10 Days)||0
10328857|NCT04493931|11464434|FG006|STARTED|Cohort 2: Follow-up (Up to 10 Days)||0
10328858|NCT04493931|11464428|FG000|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
10328859|NCT04493931|11464429|FG001|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||14
10328860|NCT04493931|11464430|FG002|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
10328861|NCT04493931|11464431|FG003|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
10328862|NCT04493931|11464432|FG004|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
10328863|NCT04493931|11464433|FG005|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
10328864|NCT04493931|11464434|FG006|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
10328865|NCT04493931|11464428|FG000|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
10328866|NCT04493931|11464429|FG001|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
10328867|NCT04493931|11464430|FG002|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
10328868|NCT04493931|11464431|FG003|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
10328869|NCT04493931|11464432|FG004|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
10328870|NCT04493931|11464433|FG005|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
10328871|NCT04493931|11464434|FG006|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
10328872|NCT04493931|11464428|FG000|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||0
10328873|NCT04493931|11464429|FG001|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||0
10328874|NCT04493931|11464430|FG002|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||10
10328875|NCT04493931|11464431|FG003|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||9
10328876|NCT04493931|11464432|FG004|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||0
10328877|NCT04493931|11464433|FG005|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||0
10328878|NCT04493931|11464434|FG006|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||0
10328879|NCT04493931|11464428|FG000|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
10328880|NCT04493931|11464429|FG001|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
10328881|NCT04493931|11464430|FG002|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||9
10328882|NCT04493931|11464431|FG003|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||9
10328883|NCT04493931|11464432|FG004|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
10328884|NCT04493931|11464433|FG005|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
10328885|NCT04493931|11464434|FG006|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
10328886|NCT04493931|11464428|FG000|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
10328887|NCT04493931|11464429|FG001|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
10328888|NCT04493931|11464430|FG002|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||1
10328889|NCT04493931|11464431|FG003|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
10328890|NCT04493931|11464432|FG004|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
10328891|NCT04493931|11464433|FG005|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
10328892|NCT04493931|11464434|FG006|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
10328893|NCT04493931|11464428|FG000|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||0
10328894|NCT04493931|11464429|FG001|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||0
10328895|NCT04493931|11464430|FG002|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||9
10328896|NCT04493931|11464431|FG003|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||9
10328897|NCT04493931|11464432|FG004|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||0
10328898|NCT04493931|11464433|FG005|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||0
10328899|NCT04493931|11464434|FG006|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||0
10328900|NCT04493931|11464428|FG000|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
10328901|NCT04493931|11464429|FG001|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
10328902|NCT04493931|11464430|FG002|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||9
10328903|NCT04493931|11464431|FG003|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||9
10328904|NCT04493931|11464432|FG004|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
10328905|NCT04493931|11464433|FG005|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
10328906|NCT04493931|11464434|FG006|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
10328907|NCT04493931|11464428|FG000|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
10328908|NCT04493931|11464429|FG001|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
10328909|NCT04493931|11464430|FG002|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
10328910|NCT04493931|11464431|FG003|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
10574650|NCT01679613|11729918|FG001|Received Nintedanib (Pilot)|Overall Study||3
10574651|NCT01679613|11729919|FG002|Received Nintedanib (Pilot)|Overall Study||0
10574652|NCT01679613|11729920|FG003|Received Nintedanib (Pilot)|Overall Study||0
10456355|NCT01006616|11604338|FG002|STARTED|Period 1 (6 Months)||153
10456356|NCT01006616|11604339|FG003|STARTED|Period 1 (6 Months)||155
10456357|NCT01006616|11604336|FG000|Treated|Period 1 (6 Months)||152
10456358|NCT01006616|11604337|FG001|Treated|Period 1 (6 Months)||156
10456359|NCT01006616|11604338|FG002|Treated|Period 1 (6 Months)||152
10456360|NCT01006616|11604339|FG003|Treated|Period 1 (6 Months)||154
10456361|NCT01006616|11604336|FG000|COMPLETED|Period 1 (6 Months)||126
10456362|NCT01006616|11604337|FG001|COMPLETED|Period 1 (6 Months)||102
10456363|NCT01006616|11604338|FG002|COMPLETED|Period 1 (6 Months)||102
10456364|NCT01006616|11604339|FG003|COMPLETED|Period 1 (6 Months)||128
10456365|NCT01006616|11604336|FG000|NOT COMPLETED|Period 1 (6 Months)||26
10456366|NCT01006616|11604337|FG001|NOT COMPLETED|Period 1 (6 Months)||54
10456367|NCT01006616|11604338|FG002|NOT COMPLETED|Period 1 (6 Months)||51
10456368|NCT01006616|11604339|FG003|NOT COMPLETED|Period 1 (6 Months)||27
10328952|NCT04493931|11464431|FG003|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
10456369|NCT01006616|11604336|FG000|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|75
10456370|NCT01006616|11604337|FG001|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|63
10456371|NCT01006616|11604338|FG002|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|55
10456372|NCT01006616|11604339|FG003|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|82
10456373|NCT01006616|11604336|FG000|Treated|Period 2 (18 Months)||75
10456374|NCT01006616|11604337|FG001|Treated|Period 2 (18 Months)||63
10456375|NCT01006616|11604338|FG002|Treated|Period 2 (18 Months)||55
10456376|NCT01006616|11604339|FG003|Treated|Period 2 (18 Months)||82
10456377|NCT01006616|11604336|FG000|COMPLETED|Period 2 (18 Months)||0
10456378|NCT01006616|11604337|FG001|COMPLETED|Period 2 (18 Months)||0
10456379|NCT01006616|11604338|FG002|COMPLETED|Period 2 (18 Months)||0
10456380|NCT01006616|11604339|FG003|COMPLETED|Period 2 (18 Months)||0
10456381|NCT01006616|11604336|FG000|NOT COMPLETED|Period 2 (18 Months)||75
10456382|NCT01006616|11604337|FG001|NOT COMPLETED|Period 2 (18 Months)||63
10456383|NCT01006616|11604338|FG002|NOT COMPLETED|Period 2 (18 Months)||55
10574653|NCT01679613|11729917|FG000|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||4
10651408|NCT02175758|11811577|FG005|NOT COMPLETED|Treatment Phase||0
10328911|NCT04493931|11464432|FG004|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
10328912|NCT04493931|11464433|FG005|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
10328913|NCT04493931|11464434|FG006|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
10328914|NCT04493931|11464428|FG000|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||0
10328915|NCT04493931|11464429|FG001|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||0
10328916|NCT04493931|11464430|FG002|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||9
10328917|NCT04493931|11464431|FG003|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||9
10328918|NCT04493931|11464432|FG004|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||0
10328919|NCT04493931|11464433|FG005|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||0
10328920|NCT04493931|11464434|FG006|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||0
10328921|NCT04493931|11464428|FG000|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
10328922|NCT04493931|11464429|FG001|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
10328923|NCT04493931|11464430|FG002|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||9
10328924|NCT04493931|11464431|FG003|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||9
10328925|NCT04493931|11464432|FG004|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
10328926|NCT04493931|11464433|FG005|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
10328927|NCT04493931|11464434|FG006|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
10328928|NCT04493931|11464428|FG000|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
10328929|NCT04493931|11464429|FG001|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
10328930|NCT04493931|11464430|FG002|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
10328931|NCT04493931|11464431|FG003|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
10328932|NCT04493931|11464432|FG004|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
10328933|NCT04493931|11464433|FG005|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
10328934|NCT04493931|11464434|FG006|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
10328935|NCT04493931|11464428|FG000|STARTED|Cohort 3: Follow-up (Up to 10 Days)||0
10456384|NCT01006616|11604339|FG003|NOT COMPLETED|Period 2 (18 Months)||82
10456385|NCT01006629|11604349|FG000|STARTED|Overall Study||100
10456386|NCT01006629|11604349|FG000|COMPLETED|Overall Study||94
10456387|NCT01006629|11604349|FG000|NOT COMPLETED|Overall Study||6
10456388|NCT01006655|11604355|FG000|STARTED|First Intervention||11
10456389|NCT01006655|11604356|FG001|STARTED|First Intervention||10
10328936|NCT04493931|11464429|FG001|STARTED|Cohort 3: Follow-up (Up to 10 Days)||0
10328937|NCT04493931|11464430|FG002|STARTED|Cohort 3: Follow-up (Up to 10 Days)||9
10328938|NCT04493931|11464431|FG003|STARTED|Cohort 3: Follow-up (Up to 10 Days)||9
10328939|NCT04493931|11464432|FG004|STARTED|Cohort 3: Follow-up (Up to 10 Days)||0
10328940|NCT04493931|11464433|FG005|STARTED|Cohort 3: Follow-up (Up to 10 Days)||0
10328941|NCT04493931|11464434|FG006|STARTED|Cohort 3: Follow-up (Up to 10 Days)||0
10328942|NCT04493931|11464428|FG000|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
10328943|NCT04493931|11464429|FG001|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
10328944|NCT04493931|11464430|FG002|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||9
10328945|NCT04493931|11464431|FG003|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||9
10328946|NCT04493931|11464432|FG004|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
10328947|NCT04493931|11464433|FG005|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
10328948|NCT04493931|11464434|FG006|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
10328949|NCT04493931|11464428|FG000|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
10328950|NCT04493931|11464429|FG001|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
10328951|NCT04493931|11464430|FG002|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
10456426|NCT01006707|11604364|FG002|STARTED|Study Session 3||6
10328953|NCT04493931|11464432|FG004|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
10328954|NCT04493931|11464433|FG005|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
10328955|NCT04493931|11464434|FG006|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
10328956|NCT04493931|11464428|FG000|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||0
10328957|NCT04493931|11464429|FG001|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||0
10328958|NCT04493931|11464430|FG002|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||0
10456390|NCT01006655|11604355|FG000|COMPLETED|First Intervention||11
10456391|NCT01006655|11604356|FG001|COMPLETED|First Intervention||10
10456392|NCT01006655|11604355|FG000|NOT COMPLETED|First Intervention||0
10456393|NCT01006655|11604356|FG001|NOT COMPLETED|First Intervention||0
10456394|NCT01006655|11604355|FG000|STARTED|Washout Period of 2 Weeks||11
10456395|NCT01006655|11604356|FG001|STARTED|Washout Period of 2 Weeks||10
10456396|NCT01006655|11604355|FG000|COMPLETED|Washout Period of 2 Weeks||11
10456397|NCT01006655|11604356|FG001|COMPLETED|Washout Period of 2 Weeks||10
10456398|NCT01006655|11604355|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
10456399|NCT01006655|11604356|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
10456400|NCT01006655|11604355|FG000|STARTED|Second Intervention||11
10456401|NCT01006655|11604356|FG001|STARTED|Second Intervention||10
10456402|NCT01006655|11604355|FG000|COMPLETED|Second Intervention||11
10456403|NCT01006655|11604356|FG001|COMPLETED|Second Intervention||10
10456404|NCT01006655|11604355|FG000|NOT COMPLETED|Second Intervention||0
10456405|NCT01006655|11604356|FG001|NOT COMPLETED|Second Intervention||0
10456406|NCT01006707|11604362|FG000|STARTED|Study Session 1||15
10456407|NCT01006707|11604363|FG001|STARTED|Study Session 1||0
10456408|NCT01006707|11604364|FG002|STARTED|Study Session 1||0
10328959|NCT04493931|11464431|FG003|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||0
10328960|NCT04493931|11464432|FG004|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||6
10328961|NCT04493931|11464433|FG005|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||5
10328962|NCT04493931|11464434|FG006|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||3
10328963|NCT04493931|11464428|FG000|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
10328964|NCT04493931|11464429|FG001|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
10328965|NCT04493931|11464430|FG002|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
10328966|NCT04493931|11464431|FG003|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
10328967|NCT04493931|11464432|FG004|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||6
10328968|NCT04493931|11464433|FG005|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||5
10328969|NCT04493931|11464434|FG006|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||3
10328970|NCT04493931|11464428|FG000|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
10328971|NCT04493931|11464429|FG001|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
10328972|NCT04493931|11464430|FG002|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
10328973|NCT04493931|11464431|FG003|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
10328974|NCT04493931|11464432|FG004|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
10328975|NCT04493931|11464433|FG005|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
10328976|NCT04493931|11464434|FG006|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
10328977|NCT04493931|11464428|FG000|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||0
10328978|NCT04493931|11464429|FG001|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||0
10328979|NCT04493931|11464430|FG002|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||0
10328980|NCT04493931|11464431|FG003|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||0
10328981|NCT04493931|11464432|FG004|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||6
10328982|NCT04493931|11464433|FG005|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||5
10328983|NCT04493931|11464434|FG006|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||3
10328984|NCT04493931|11464428|FG000|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
10328985|NCT04493931|11464429|FG001|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
10328986|NCT04493931|11464430|FG002|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
10328987|NCT04493931|11464431|FG003|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
10328988|NCT04493931|11464432|FG004|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||6
10328989|NCT04493931|11464433|FG005|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||5
10328990|NCT04493931|11464434|FG006|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||3
10328991|NCT04493931|11464428|FG000|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
10328992|NCT04493931|11464429|FG001|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
10328993|NCT04493931|11464430|FG002|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
10328994|NCT04493931|11464431|FG003|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
10328995|NCT04493931|11464432|FG004|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
10701753|NCT02570074|11866233|FG001|STARTED|Period 1 (First Dosing Regimen)||10
10701754|NCT02570074|11866232|FG000|COMPLETED|Period 1 (First Dosing Regimen)||9
10701755|NCT02570074|11866233|FG001|COMPLETED|Period 1 (First Dosing Regimen)||10
10701756|NCT02570074|11866232|FG000|NOT COMPLETED|Period 1 (First Dosing Regimen)||0
10701757|NCT02570074|11866233|FG001|NOT COMPLETED|Period 1 (First Dosing Regimen)||0
10701758|NCT02570074|11866232|FG000|STARTED|Period 2 (Second Dosing Regimen)||9
10328996|NCT04493931|11464433|FG005|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
10328997|NCT04493931|11464434|FG006|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
10328998|NCT04493931|11464428|FG000|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||0
10328999|NCT04493931|11464429|FG001|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||0
10329000|NCT04493931|11464430|FG002|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||0
10329001|NCT04493931|11464431|FG003|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||0
10329002|NCT04493931|11464432|FG004|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||6
10329003|NCT04493931|11464433|FG005|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||5
10329004|NCT04493931|11464434|FG006|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||3
10329005|NCT04493931|11464428|FG000|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
10701759|NCT02570074|11866233|FG001|STARTED|Period 2 (Second Dosing Regimen)||10
10701760|NCT02570074|11866232|FG000|COMPLETED|Period 2 (Second Dosing Regimen)||8
10701761|NCT02570074|11866233|FG001|COMPLETED|Period 2 (Second Dosing Regimen)||10
10701762|NCT02570074|11866232|FG000|NOT COMPLETED|Period 2 (Second Dosing Regimen)||1
10701763|NCT02570074|11866233|FG001|NOT COMPLETED|Period 2 (Second Dosing Regimen)||0
10701764|NCT02570126|11866253|FG000|STARTED|Overall Study||615
10701765|NCT02570126|11866254|FG001|STARTED|Overall Study||616
10701766|NCT02570126|11866253|FG000|COMPLETED|Overall Study||609
10701767|NCT02570126|11866254|FG001|COMPLETED|Overall Study||607
10701768|NCT02570126|11866253|FG000|NOT COMPLETED|Overall Study||6
10701769|NCT02570126|11866254|FG001|NOT COMPLETED|Overall Study||9
10701770|NCT02570139|11866262|FG000|STARTED|Overall Study|24 subjects were treated w/ Cavilon Advanced Skin Protectant. Study terminated due to low enrollment|24
10701771|NCT02570139|11866263|FG001|STARTED|Overall Study|21 subjects treated with SensiCare Protective Barrier|21
10701772|NCT02570139|11866262|FG000|COMPLETED|Overall Study||24
10701773|NCT02570139|11866263|FG001|COMPLETED|Overall Study||21
10701774|NCT02570139|11866262|FG000|NOT COMPLETED|Overall Study||0
10701775|NCT02570139|11866263|FG001|NOT COMPLETED|Overall Study||0
10701776|NCT02570152|11866269|FG000|STARTED|Overall Study||2004
10701777|NCT02570152|11866269|FG000|COMPLETED|Overall Study||1989
10701778|NCT02570152|11866269|FG000|NOT COMPLETED|Overall Study||15
10701779|NCT02570165|11866280|FG000|STARTED|Overall Study||46
10701780|NCT02570165|11866281|FG001|STARTED|Overall Study||46
10329006|NCT04493931|11464429|FG001|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
10329007|NCT04493931|11464430|FG002|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
10329008|NCT04493931|11464431|FG003|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
10329009|NCT04493931|11464432|FG004|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||6
10329010|NCT04493931|11464433|FG005|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||5
10329011|NCT04493931|11464434|FG006|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||3
10329012|NCT04493931|11464428|FG000|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
10329013|NCT04493931|11464429|FG001|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
10329014|NCT04493931|11464430|FG002|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
10329015|NCT04493931|11464431|FG003|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
10329016|NCT04493931|11464432|FG004|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
10329017|NCT04493931|11464433|FG005|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
10329018|NCT04493931|11464434|FG006|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
10329019|NCT04493931|11464428|FG000|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||0
10329020|NCT04493931|11464429|FG001|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||0
10329021|NCT04493931|11464430|FG002|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||0
10329022|NCT04493931|11464431|FG003|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||0
10329023|NCT04493931|11464432|FG004|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||6
10329024|NCT04493931|11464433|FG005|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||5
10329025|NCT04493931|11464434|FG006|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||3
10329026|NCT04493931|11464428|FG000|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
10329027|NCT04493931|11464429|FG001|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
10329028|NCT04493931|11464430|FG002|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
10329029|NCT04493931|11464431|FG003|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
10329030|NCT04493931|11464432|FG004|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||6
10329031|NCT04493931|11464433|FG005|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||5
10329032|NCT04493931|11464434|FG006|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||3
10329033|NCT04493931|11464428|FG000|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
10329034|NCT04493931|11464429|FG001|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
10329035|NCT04493931|11464430|FG002|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
10329036|NCT04493931|11464431|FG003|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
10329037|NCT04493931|11464432|FG004|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
10456409|NCT01006707|11604362|FG000|COMPLETED|Study Session 1||10
10456410|NCT01006707|11604363|FG001|COMPLETED|Study Session 1||0
10456411|NCT01006707|11604364|FG002|COMPLETED|Study Session 1||0
10456412|NCT01006707|11604362|FG000|NOT COMPLETED|Study Session 1||5
10456413|NCT01006707|11604363|FG001|NOT COMPLETED|Study Session 1||0
10456414|NCT01006707|11604364|FG002|NOT COMPLETED|Study Session 1||0
10456415|NCT01006707|11604362|FG000|STARTED|Study Session 2||0
10456416|NCT01006707|11604363|FG001|STARTED|Study Session 2||4
10456417|NCT01006707|11604364|FG002|STARTED|Study Session 2||6
10456418|NCT01006707|11604362|FG000|COMPLETED|Study Session 2||0
10456419|NCT01006707|11604363|FG001|COMPLETED|Study Session 2||4
10456420|NCT01006707|11604364|FG002|COMPLETED|Study Session 2||6
10456421|NCT01006707|11604362|FG000|NOT COMPLETED|Study Session 2||0
10456422|NCT01006707|11604363|FG001|NOT COMPLETED|Study Session 2||0
10456423|NCT01006707|11604364|FG002|NOT COMPLETED|Study Session 2||0
10456424|NCT01006707|11604362|FG000|STARTED|Study Session 3||0
10456425|NCT01006707|11604363|FG001|STARTED|Study Session 3||4
10456427|NCT01006707|11604362|FG000|COMPLETED|Study Session 3||0
10456428|NCT01006707|11604363|FG001|COMPLETED|Study Session 3||4
10456429|NCT01006707|11604364|FG002|COMPLETED|Study Session 3||6
10456430|NCT01006707|11604362|FG000|NOT COMPLETED|Study Session 3||0
10456431|NCT01006707|11604363|FG001|NOT COMPLETED|Study Session 3||0
10456432|NCT01006707|11604364|FG002|NOT COMPLETED|Study Session 3||0
10456433|NCT01006889|11604372|FG000|STARTED|Overall Study||20
10456434|NCT01006889|11604372|FG000|COMPLETED|Overall Study||17
10456435|NCT01006889|11604372|FG000|NOT COMPLETED|Overall Study||3
10456436|NCT01006967|11604379|FG000|STARTED|Overall Study||253
10456437|NCT01006967|11604380|FG001|STARTED|Overall Study||253
10456438|NCT01006967|11604379|FG000|Received Treatment|Overall Study||245
10456439|NCT01006967|11604380|FG001|Received Treatment|Overall Study||245
10456440|NCT01006967|11604379|FG000|3 Month Follow-up|Overall Study||212
10456441|NCT01006967|11604380|FG001|3 Month Follow-up|Overall Study||210
10456442|NCT01006967|11604379|FG000|COMPLETED|Overall Study||187
10456443|NCT01006967|11604380|FG001|COMPLETED|Overall Study||190
10456444|NCT01006967|11604379|FG000|NOT COMPLETED|Overall Study||66
10456445|NCT01006967|11604380|FG001|NOT COMPLETED|Overall Study||63
10456446|NCT01006980|11604390|FG000|STARTED|Vemurafenib and Dacarbazine||337
10456447|NCT01006980|11604391|FG001|STARTED|Vemurafenib and Dacarbazine||338
10456448|NCT01006980|11604390|FG000|Treated|Vemurafenib and Dacarbazine||336
10456449|NCT01006980|11604391|FG001|Treated|Vemurafenib and Dacarbazine||293
10456450|NCT01006980|11604390|FG000|COMPLETED|Vemurafenib and Dacarbazine||0
10456451|NCT01006980|11604391|FG001|COMPLETED|Vemurafenib and Dacarbazine||0
10456452|NCT01006980|11604390|FG000|NOT COMPLETED|Vemurafenib and Dacarbazine||337
10456453|NCT01006980|11604391|FG001|NOT COMPLETED|Vemurafenib and Dacarbazine||338
10456454|NCT01006980|11604390|FG000|STARTED|Crossover: Dacarbazine to Vemurafenib||0
10456455|NCT01006980|11604391|FG001|STARTED|Crossover: Dacarbazine to Vemurafenib|Participants who crossed over from dacarbazine to vemurafenib treatment.|84
10456456|NCT01006980|11604390|FG000|COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
10456457|NCT01006980|11604391|FG001|COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
10456458|NCT01006980|11604390|FG000|NOT COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
10456459|NCT01006980|11604391|FG001|NOT COMPLETED|Crossover: Dacarbazine to Vemurafenib||84
10456460|NCT01007032|11604402|FG000|STARTED|Overall Study||4
10456461|NCT01007032|11604403|FG001|STARTED|Overall Study||7
10456462|NCT01007032|11604404|FG002|STARTED|Overall Study||3
10456463|NCT01007032|11604405|FG003|STARTED|Overall Study||7
10456464|NCT01007032|11604402|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
10456465|NCT01007032|11604403|FG001|Received at Least 1 Dose of Study Drug|Overall Study||7
10456466|NCT01007032|11604404|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
10456467|NCT01007032|11604405|FG003|Received at Least 1 Dose of Study Drug|Overall Study||7
10456468|NCT01007032|11604402|FG000|COMPLETED|Overall Study||4
10456469|NCT01007032|11604403|FG001|COMPLETED|Overall Study||6
10456470|NCT01007032|11604404|FG002|COMPLETED|Overall Study||2
10456471|NCT01007032|11604405|FG003|COMPLETED|Overall Study||6
10456472|NCT01007032|11604402|FG000|NOT COMPLETED|Overall Study||0
10456473|NCT01007032|11604403|FG001|NOT COMPLETED|Overall Study||1
10456474|NCT01007032|11604404|FG002|NOT COMPLETED|Overall Study||1
10456475|NCT01007032|11604405|FG003|NOT COMPLETED|Overall Study||1
10456476|NCT01007071|11604422|FG000|STARTED|Overall Study||6
10456477|NCT01007071|11604423|FG001|STARTED|Overall Study||5
10456478|NCT01007071|11604422|FG000|COMPLETED|Overall Study||6
10456479|NCT01007071|11604423|FG001|COMPLETED|Overall Study||5
10456480|NCT01007071|11604422|FG000|NOT COMPLETED|Overall Study||0
10456481|NCT01007071|11604423|FG001|NOT COMPLETED|Overall Study||0
10456482|NCT01007110|11604432|FG000|STARTED|Allocation||32
10456483|NCT01007110|11604433|FG001|STARTED|Allocation||35
10456484|NCT01007110|11604432|FG000|COMPLETED|Allocation||25
10456485|NCT01007110|11604433|FG001|COMPLETED|Allocation||27
10456486|NCT01007110|11604432|FG000|NOT COMPLETED|Allocation||7
10456487|NCT01007110|11604433|FG001|NOT COMPLETED|Allocation||8
10456488|NCT01007110|11604432|FG000|STARTED|Follow-Up at 24 Weeks||25
10701781|NCT02570165|11866282|FG002|STARTED|Overall Study||46
10701782|NCT02570165|11866283|FG003|STARTED|Overall Study||45
10456489|NCT01007110|11604433|FG001|STARTED|Follow-Up at 24 Weeks||27
10456490|NCT01007110|11604432|FG000|COMPLETED|Follow-Up at 24 Weeks||25
10456491|NCT01007110|11604433|FG001|COMPLETED|Follow-Up at 24 Weeks||23
10456492|NCT01007110|11604432|FG000|NOT COMPLETED|Follow-Up at 24 Weeks||0
10456493|NCT01007110|11604433|FG001|NOT COMPLETED|Follow-Up at 24 Weeks||4
10456494|NCT01007110|11604432|FG000|STARTED|Follow-Up at 32 Weeks||25
10456495|NCT01007110|11604433|FG001|STARTED|Follow-Up at 32 Weeks||23
10456496|NCT01007110|11604432|FG000|COMPLETED|Follow-Up at 32 Weeks||24
10456497|NCT01007110|11604433|FG001|COMPLETED|Follow-Up at 32 Weeks||22
10456498|NCT01007110|11604432|FG000|NOT COMPLETED|Follow-Up at 32 Weeks||1
10456499|NCT01007110|11604433|FG001|NOT COMPLETED|Follow-Up at 32 Weeks||1
10456500|NCT01007110|11604432|FG000|STARTED|Follow-Up at 36 Weeks||24
10456501|NCT01007110|11604433|FG001|STARTED|Follow-Up at 36 Weeks||22
10456502|NCT01007110|11604432|FG000|COMPLETED|Follow-Up at 36 Weeks||24
10456503|NCT01007110|11604433|FG001|COMPLETED|Follow-Up at 36 Weeks||20
10456504|NCT01007110|11604432|FG000|NOT COMPLETED|Follow-Up at 36 Weeks||0
10456505|NCT01007110|11604433|FG001|NOT COMPLETED|Follow-Up at 36 Weeks||2
10456506|NCT01007110|11604432|FG000|STARTED|Neonatal Behavioral Assessment Scale (NB||24
10456507|NCT01007110|11604433|FG001|STARTED|Neonatal Behavioral Assessment Scale (NB||20
10456508|NCT01007110|11604432|FG000|COMPLETED|Neonatal Behavioral Assessment Scale (NB||12
10456509|NCT01007110|11604433|FG001|COMPLETED|Neonatal Behavioral Assessment Scale (NB||15
10329114|NCT03999554|11464495|FG002|COMPLETED|Overall Study||28
10456510|NCT01007110|11604432|FG000|NOT COMPLETED|Neonatal Behavioral Assessment Scale (NB||12
10456511|NCT01007110|11604433|FG001|NOT COMPLETED|Neonatal Behavioral Assessment Scale (NB||5
10456512|NCT01007123|11604444|FG000|STARTED|Overall Study||48
10456513|NCT01007123|11604445|FG001|STARTED|Overall Study||47
10456514|NCT01007123|11604446|FG002|STARTED|Overall Study||48
10456515|NCT01007123|11604447|FG003|STARTED|Overall Study||47
10329038|NCT04493931|11464433|FG005|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
10701783|NCT02570165|11866284|FG004|STARTED|Overall Study||47
10701784|NCT02570165|11866285|FG005|STARTED|Overall Study||46
10701785|NCT02570165|11866286|FG006|STARTED|Overall Study||47
10701786|NCT02570165|11866280|FG000|COMPLETED|Overall Study||44
10701787|NCT02570165|11866281|FG001|COMPLETED|Overall Study||43
10701788|NCT02570165|11866282|FG002|COMPLETED|Overall Study||41
10329039|NCT04493931|11464434|FG006|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
10329040|NCT04493931|11464428|FG000|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||0
10329041|NCT04493931|11464429|FG001|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||0
10329042|NCT04493931|11464430|FG002|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||0
10329043|NCT04493931|11464431|FG003|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||0
10701789|NCT02570165|11866283|FG003|COMPLETED|Overall Study||40
10701790|NCT02570165|11866284|FG004|COMPLETED|Overall Study||41
10701791|NCT02570165|11866285|FG005|COMPLETED|Overall Study||44
10329044|NCT04493931|11464432|FG004|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||6
10329045|NCT04493931|11464433|FG005|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||5
10329046|NCT04493931|11464434|FG006|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||3
10329047|NCT04493931|11464428|FG000|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
10329048|NCT04493931|11464429|FG001|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
10329049|NCT04493931|11464430|FG002|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
10329050|NCT04493931|11464431|FG003|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
10329051|NCT04493931|11464432|FG004|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||6
10329052|NCT04493931|11464433|FG005|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||5
10329053|NCT04493931|11464434|FG006|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||3
10329054|NCT04493931|11464428|FG000|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
10329055|NCT04493931|11464429|FG001|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
10329056|NCT04493931|11464430|FG002|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
10329057|NCT04493931|11464431|FG003|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
10329058|NCT04493931|11464432|FG004|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
10329059|NCT04493931|11464433|FG005|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
10329060|NCT04493931|11464434|FG006|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
10329061|NCT04493931|11464428|FG000|STARTED|Cohort 4: Follow-up (Up to 7 Days)||0
10329062|NCT04493931|11464429|FG001|STARTED|Cohort 4: Follow-up (Up to 7 Days)||0
10329063|NCT04493931|11464430|FG002|STARTED|Cohort 4: Follow-up (Up to 7 Days)||0
10329064|NCT04493931|11464431|FG003|STARTED|Cohort 4: Follow-up (Up to 7 Days)||0
10329065|NCT04493931|11464432|FG004|STARTED|Cohort 4: Follow-up (Up to 7 Days)||6
10329066|NCT04493931|11464433|FG005|STARTED|Cohort 4: Follow-up (Up to 7 Days)||5
10329067|NCT04493931|11464434|FG006|STARTED|Cohort 4: Follow-up (Up to 7 Days)||3
10329068|NCT04493931|11464428|FG000|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
10329069|NCT04493931|11464429|FG001|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
10329070|NCT04493931|11464430|FG002|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
10329071|NCT04493931|11464431|FG003|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
10329072|NCT04493931|11464432|FG004|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||6
10329073|NCT04493931|11464433|FG005|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||5
10329074|NCT04493931|11464434|FG006|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||3
10329075|NCT04493931|11464428|FG000|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
10329076|NCT04493931|11464429|FG001|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
10329077|NCT04493931|11464430|FG002|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
10329078|NCT04493931|11464431|FG003|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
10329079|NCT04493931|11464432|FG004|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
10329080|NCT04493931|11464433|FG005|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
10329081|NCT04493931|11464434|FG006|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
10329092|NCT04262947|11464471|FG000|STARTED|Overall Study||13
10329093|NCT04262947|11464472|FG001|STARTED|Overall Study||13
10329094|NCT04262947|11464473|FG002|STARTED|Overall Study||12
10329095|NCT04262947|11464471|FG000|COMPLETED|Overall Study||13
10329096|NCT04262947|11464472|FG001|COMPLETED|Overall Study||13
10329097|NCT04262947|11464473|FG002|COMPLETED|Overall Study||12
10329098|NCT04262947|11464471|FG000|NOT COMPLETED|Overall Study||0
10329099|NCT04262947|11464472|FG001|NOT COMPLETED|Overall Study||0
10329100|NCT04262947|11464473|FG002|NOT COMPLETED|Overall Study||0
10329101|NCT04177680|11464481|FG000|STARTED|Overall Study||49
10329102|NCT04177680|11464482|FG001|STARTED|Overall Study||51
10329103|NCT04177680|11464481|FG000|COMPLETED|Overall Study||47
10329104|NCT04177680|11464482|FG001|COMPLETED|Overall Study||48
10329105|NCT04177680|11464481|FG000|NOT COMPLETED|Overall Study||2
10329106|NCT04177680|11464482|FG001|NOT COMPLETED|Overall Study||3
10329107|NCT03999554|11464493|FG000|STARTED|Overall Study||42
10329108|NCT03999554|11464494|FG001|STARTED|Overall Study||41
10329109|NCT03999554|11464495|FG002|STARTED|Overall Study||40
10329110|NCT03999554|11464496|FG003|STARTED|Overall Study||42
10329111|NCT03999554|11464497|FG004|STARTED|Overall Study||41
10329112|NCT03999554|11464493|FG000|COMPLETED|Overall Study||36
10329113|NCT03999554|11464494|FG001|COMPLETED|Overall Study||34
10329115|NCT03999554|11464496|FG003|COMPLETED|Overall Study||35
10329116|NCT03999554|11464497|FG004|COMPLETED|Overall Study||32
10329117|NCT03999554|11464493|FG000|NOT COMPLETED|Overall Study||6
10329118|NCT03999554|11464494|FG001|NOT COMPLETED|Overall Study||7
10329119|NCT03999554|11464495|FG002|NOT COMPLETED|Overall Study||12
10329120|NCT03999554|11464496|FG003|NOT COMPLETED|Overall Study||7
10329121|NCT03999554|11464497|FG004|NOT COMPLETED|Overall Study||9
10338783|NCT03103542|11475693|FG000|STARTED|Overall Study|18 - screened 16 - enrolled|16
10338784|NCT03103542|11475693|FG000|COMPLETED|Overall Study||9
10338785|NCT03103542|11475693|FG000|NOT COMPLETED|Overall Study||7
10338786|NCT03086317|11475700|FG000|STARTED|Overall Study||10
10338787|NCT03086317|11475701|FG001|STARTED|Overall Study||8
10338788|NCT03086317|11475700|FG000|COMPLETED|Overall Study||10
10338789|NCT03086317|11475701|FG001|COMPLETED|Overall Study||8
10338790|NCT03086317|11475700|FG000|NOT COMPLETED|Overall Study||0
10338791|NCT03086317|11475701|FG001|NOT COMPLETED|Overall Study||0
10338792|NCT02676765|11475709|FG000|STARTED|Overall Study||10
10338793|NCT02676765|11475710|FG001|STARTED|Overall Study||10
10338794|NCT02676765|11475709|FG000|COMPLETED|Overall Study||10
10338795|NCT02676765|11475710|FG001|COMPLETED|Overall Study||9
10338796|NCT02676765|11475709|FG000|NOT COMPLETED|Overall Study||0
10338797|NCT02676765|11475710|FG001|NOT COMPLETED|Overall Study||1
10338798|NCT02539563|11475718|FG000|STARTED|Overall Study||45
10338799|NCT02539563|11475719|FG001|STARTED|Overall Study||56
10338800|NCT02539563|11475718|FG000|COMPLETED|Overall Study||39
10338801|NCT02539563|11475719|FG001|COMPLETED|Overall Study||42
10338802|NCT02539563|11475718|FG000|NOT COMPLETED|Overall Study||6
10338803|NCT02539563|11475719|FG001|NOT COMPLETED|Overall Study||14
10338804|NCT02422446|11475727|FG000|STARTED|Overall Study||1
10338805|NCT02422446|11475728|FG001|STARTED|Overall Study||1
10338806|NCT02422446|11475727|FG000|COMPLETED|Overall Study||1
10338807|NCT02422446|11475728|FG001|COMPLETED|Overall Study||1
10338808|NCT02422446|11475727|FG000|NOT COMPLETED|Overall Study||0
10338809|NCT02422446|11475728|FG001|NOT COMPLETED|Overall Study||0
10338810|NCT02362451|11475736|FG000|STARTED|Overall Study||6
10338811|NCT02362451|11475737|FG001|STARTED|Overall Study||1
10338812|NCT02362451|11475736|FG000|COMPLETED|Overall Study||2
10338813|NCT02362451|11475737|FG001|COMPLETED|Overall Study||0
10338814|NCT02362451|11475736|FG000|NOT COMPLETED|Overall Study||4
10338815|NCT02362451|11475737|FG001|NOT COMPLETED|Overall Study||1
10338824|NCT02271230|11475756|FG000|STARTED|Overall Study||6463
10338825|NCT02271230|11475757|FG001|STARTED|Overall Study||6464
10338826|NCT02271230|11475758|FG002|STARTED|Overall Study||6470
10338827|NCT02271230|11475759|FG003|STARTED|Overall Study||6474
10338828|NCT02271230|11475756|FG000|COMPLETED|Overall Study||6463
10338829|NCT02271230|11475757|FG001|COMPLETED|Overall Study||6464
10338830|NCT02271230|11475758|FG002|COMPLETED|Overall Study||6470
10338831|NCT02271230|11475759|FG003|COMPLETED|Overall Study||6474
10338832|NCT02271230|11475756|FG000|NOT COMPLETED|Overall Study||0
10338833|NCT02271230|11475757|FG001|NOT COMPLETED|Overall Study||0
10338834|NCT02271230|11475758|FG002|NOT COMPLETED|Overall Study||0
10338835|NCT02271230|11475759|FG003|NOT COMPLETED|Overall Study||0
10339270|NCT00371826|11476191|FG002|Modified Intent to Treat (mITT)|Core Phase (12 Months)||6
10339271|NCT00371826|11476189|FG000|COMPLETED|Core Phase (12 Months)|"Completed means patients were still on study medication by month 12."|25
10339272|NCT00371826|11476190|FG001|COMPLETED|Core Phase (12 Months)||39
10339273|NCT00371826|11476191|FG002|COMPLETED|Core Phase (12 Months)||6
10339274|NCT00371826|11476189|FG000|NOT COMPLETED|Core Phase (12 Months)||24
10339275|NCT00371826|11476190|FG001|NOT COMPLETED|Core Phase (12 Months)||8
10339276|NCT00371826|11476191|FG002|NOT COMPLETED|Core Phase (12 Months)||24
10339277|NCT00371826|11476189|FG000|STARTED|Extension Phase (24 Months)|2 patients who completed 12 month core did not wish to continue in extension.|23
10339278|NCT00371826|11476190|FG001|STARTED|Extension Phase (24 Months)||39
10339279|NCT00371826|11476191|FG002|STARTED|Extension Phase (24 Months)|One patient completed core, did not wish to continue to extension.|5
10339280|NCT00371826|11476189|FG000|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)||23
10339281|NCT00371826|11476190|FG001|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)||39
10339282|NCT00371826|11476191|FG002|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)|One patient entered extension, was withdrawn (no efficacy data in extension) due to DMC suggestion|4
10339283|NCT00371826|11476189|FG000|Safety Set|Extension Phase (24 Months)|One patient randomized to this arm, was treated with the control regimen (CNI+MPA+Steroid)|22
10339284|NCT00371826|11476190|FG001|Safety Set|Extension Phase (24 Months)|One patient mis-randomised to 1st arm but treated in this arm, evaluated for safety in this arm.|40
10339285|NCT00371826|11476191|FG002|Safety Set|Extension Phase (24 Months)|Patient withdrawn as per DMC suggestion had no efficacy data, but was included in safety set.|5
10339286|NCT00371826|11476189|FG000|COMPLETED|Extension Phase (24 Months)||18
10339287|NCT00371826|11476190|FG001|COMPLETED|Extension Phase (24 Months)||29
10339288|NCT00371826|11476191|FG002|COMPLETED|Extension Phase (24 Months)||3
10339289|NCT00371826|11476189|FG000|NOT COMPLETED|Extension Phase (24 Months)||5
10339290|NCT00371826|11476190|FG001|NOT COMPLETED|Extension Phase (24 Months)||10
10339291|NCT00371826|11476191|FG002|NOT COMPLETED|Extension Phase (24 Months)||2
10339292|NCT00371839|11476202|FG000|STARTED|Overall Study||49
10339293|NCT00371839|11476203|FG001|STARTED|Overall Study||20
10339294|NCT00371839|11476204|FG002|STARTED|Overall Study||9
10339295|NCT00371839|11476202|FG000|COMPLETED|Overall Study||32
10329122|NCT03651622|11464513|FG000|STARTED|Diet Period 1 (Randomization 1)||23
10329123|NCT03651622|11464514|FG001|STARTED|Diet Period 1 (Randomization 1)||24
10329124|NCT03651622|11464515|FG002|STARTED|Diet Period 1 (Randomization 1)||21
10329125|NCT03651622|11464513|FG000|COMPLETED|Diet Period 1 (Randomization 1)||19
10329126|NCT03651622|11464514|FG001|COMPLETED|Diet Period 1 (Randomization 1)||17
10329127|NCT03651622|11464515|FG002|COMPLETED|Diet Period 1 (Randomization 1)||12
10329128|NCT03651622|11464513|FG000|NOT COMPLETED|Diet Period 1 (Randomization 1)||4
10329129|NCT03651622|11464514|FG001|NOT COMPLETED|Diet Period 1 (Randomization 1)||7
10329130|NCT03651622|11464515|FG002|NOT COMPLETED|Diet Period 1 (Randomization 1)||9
10329131|NCT03651622|11464513|FG000|STARTED|Diet Period 2 (Randomization 2)||19
10329132|NCT03651622|11464514|FG001|STARTED|Diet Period 2 (Randomization 2)||15
10329133|NCT03651622|11464515|FG002|STARTED|Diet Period 2 (Randomization 2)||14
10329134|NCT03651622|11464513|FG000|Number of Participants Rerandomized From Hypocaloric, Low Carbohydrate Diet|Diet Period 2 (Randomization 2)||0
10329135|NCT03651622|11464514|FG001|Number of Participants Rerandomized From Hypocaloric, Low Carbohydrate Diet|Diet Period 2 (Randomization 2)||5
10329136|NCT03651622|11464515|FG002|Number of Participants Rerandomized From Hypocaloric, Low Carbohydrate Diet|Diet Period 2 (Randomization 2)||5
10329137|NCT03651622|11464513|FG000|Number of Participants Rerandomized From Hypocaloric, Moderate Low Fat Diet|Diet Period 2 (Randomization 2)||5
10329138|NCT03651622|11464514|FG001|Number of Participants Rerandomized From Hypocaloric, Moderate Low Fat Diet|Diet Period 2 (Randomization 2)||0
10329139|NCT03651622|11464515|FG002|Number of Participants Rerandomized From Hypocaloric, Moderate Low Fat Diet|Diet Period 2 (Randomization 2)||6
10329140|NCT03651622|11464513|FG000|Number of Participants Rerandomized From Mediterranean, no Caloric Restriction Diet|Diet Period 2 (Randomization 2)||5
10329141|NCT03651622|11464514|FG001|Number of Participants Rerandomized From Mediterranean, no Caloric Restriction Diet|Diet Period 2 (Randomization 2)||4
10329142|NCT03651622|11464515|FG002|Number of Participants Rerandomized From Mediterranean, no Caloric Restriction Diet|Diet Period 2 (Randomization 2)||0
10329143|NCT03651622|11464513|FG000|Number of Participants Not Rerandomized|Diet Period 2 (Randomization 2)||9
10329144|NCT03651622|11464514|FG001|Number of Participants Not Rerandomized|Diet Period 2 (Randomization 2)||6
10329145|NCT03651622|11464515|FG002|Number of Participants Not Rerandomized|Diet Period 2 (Randomization 2)||3
10329146|NCT03651622|11464513|FG000|COMPLETED|Diet Period 2 (Randomization 2)||17
10329147|NCT03651622|11464514|FG001|COMPLETED|Diet Period 2 (Randomization 2)||13
10329148|NCT03651622|11464515|FG002|COMPLETED|Diet Period 2 (Randomization 2)||11
10329149|NCT03651622|11464513|FG000|NOT COMPLETED|Diet Period 2 (Randomization 2)||2
10329150|NCT03651622|11464514|FG001|NOT COMPLETED|Diet Period 2 (Randomization 2)||2
10329151|NCT03651622|11464515|FG002|NOT COMPLETED|Diet Period 2 (Randomization 2)||3
10329152|NCT03651622|11464513|FG000|STARTED|Diet Period 3 (Randomization 3)||14
10329153|NCT03651622|11464514|FG001|STARTED|Diet Period 3 (Randomization 3)||9
10329154|NCT03651622|11464515|FG002|STARTED|Diet Period 3 (Randomization 3)||18
10329155|NCT03651622|11464513|FG000|Number of Participants Rerandomized From Hypocaloric, Low Carbohydrate Diet|Diet Period 3 (Randomization 3)||0
10329156|NCT03651622|11464514|FG001|Number of Participants Rerandomized From Hypocaloric, Low Carbohydrate Diet|Diet Period 3 (Randomization 3)||2
10329157|NCT03651622|11464515|FG002|Number of Participants Rerandomized From Hypocaloric, Low Carbohydrate Diet|Diet Period 3 (Randomization 3)||10
10329158|NCT03651622|11464513|FG000|Number of Participants Rerandomized From Hypocaloric, Moderate Low Fat Diet|Diet Period 3 (Randomization 3)||4
10329159|NCT03651622|11464514|FG001|Number of Participants Rerandomized From Hypocaloric, Moderate Low Fat Diet|Diet Period 3 (Randomization 3)||0
10329160|NCT03651622|11464515|FG002|Number of Participants Rerandomized From Hypocaloric, Moderate Low Fat Diet|Diet Period 3 (Randomization 3)||6
10329161|NCT03651622|11464513|FG000|Number of Participants Rerandomized From Mediterranean|Diet Period 3 (Randomization 3)||6
10329162|NCT03651622|11464514|FG001|Number of Participants Rerandomized From Mediterranean|Diet Period 3 (Randomization 3)||4
10329163|NCT03651622|11464515|FG002|Number of Participants Rerandomized From Mediterranean|Diet Period 3 (Randomization 3)||0
10329164|NCT03651622|11464513|FG000|Number of Participants Not Rerandomized|Diet Period 3 (Randomization 3)||4
10329165|NCT03651622|11464514|FG001|Number of Participants Not Rerandomized|Diet Period 3 (Randomization 3)||3
10329166|NCT03651622|11464515|FG002|Number of Participants Not Rerandomized|Diet Period 3 (Randomization 3)||2
10329167|NCT03651622|11464513|FG000|COMPLETED|Diet Period 3 (Randomization 3)||14
10329168|NCT03651622|11464514|FG001|COMPLETED|Diet Period 3 (Randomization 3)||9
10329169|NCT03651622|11464515|FG002|COMPLETED|Diet Period 3 (Randomization 3)||17
10329170|NCT03651622|11464513|FG000|NOT COMPLETED|Diet Period 3 (Randomization 3)||0
10329171|NCT03651622|11464514|FG001|NOT COMPLETED|Diet Period 3 (Randomization 3)||0
10329172|NCT03651622|11464515|FG002|NOT COMPLETED|Diet Period 3 (Randomization 3)||1
10701792|NCT02570165|11866286|FG006|COMPLETED|Overall Study||47
10701793|NCT02570165|11866280|FG000|NOT COMPLETED|Overall Study||2
10701794|NCT02570165|11866281|FG001|NOT COMPLETED|Overall Study||3
10701795|NCT02570165|11866282|FG002|NOT COMPLETED|Overall Study||5
10701796|NCT02570165|11866283|FG003|NOT COMPLETED|Overall Study||5
10701797|NCT02570165|11866284|FG004|NOT COMPLETED|Overall Study||6
10701798|NCT02570165|11866285|FG005|NOT COMPLETED|Overall Study||2
10701799|NCT02570165|11866286|FG006|NOT COMPLETED|Overall Study||0
10701800|NCT02570295|11866304|FG000|STARTED|Overall Study||375
10701801|NCT02570295|11866305|FG001|STARTED|Overall Study||347
10701802|NCT02570295|11866304|FG000|COMPLETED|Overall Study||364
10701803|NCT02570295|11866305|FG001|COMPLETED|Overall Study||289
10701804|NCT02570295|11866304|FG000|NOT COMPLETED|Overall Study||11
10701805|NCT02570295|11866305|FG001|NOT COMPLETED|Overall Study||58
10701806|NCT02570425|11866313|FG000|STARTED|Visit 1||274
10701807|NCT02570425|11866314|FG001|STARTED|Visit 1||242
10701808|NCT02570425|11866313|FG000|COMPLETED|Visit 1||274
10701809|NCT02570425|11866314|FG001|COMPLETED|Visit 1||242
10701810|NCT02570425|11866313|FG000|NOT COMPLETED|Visit 1||0
10701811|NCT02570425|11866314|FG001|NOT COMPLETED|Visit 1||0
10701812|NCT02570425|11866313|FG000|STARTED|Visit 2|In total 18 patients who completed Visit 1, did not attend Visit 2.|251
10701813|NCT02570425|11866314|FG001|STARTED|Visit 2|In total 18 patients who completed Visit 1, did not attend Visit 2.|247
10701814|NCT02570425|11866313|FG000|COMPLETED|Visit 2||251
10701815|NCT02570425|11866314|FG001|COMPLETED|Visit 2||247
10701816|NCT02570425|11866313|FG000|NOT COMPLETED|Visit 2||0
10701817|NCT02570425|11866314|FG001|NOT COMPLETED|Visit 2||0
10701818|NCT02570425|11866313|FG000|STARTED|Visit 3|In total 38 patients who completed Visit 2, did not attend Visit 3.|229
10701819|NCT02570425|11866314|FG001|STARTED|Visit 3|In total 38 patients who completed Visit 2, did not attend Visit 3.|231
10701820|NCT02570425|11866313|FG000|COMPLETED|Visit 3||229
10701821|NCT02570425|11866314|FG001|COMPLETED|Visit 3||231
10701822|NCT02570425|11866313|FG000|NOT COMPLETED|Visit 3||0
10701823|NCT02570425|11866314|FG001|NOT COMPLETED|Visit 3||0
10701824|NCT02570711|11866325|FG000|STARTED|Overall Study||1
10701825|NCT02570711|11866326|FG001|STARTED|Overall Study||2
10701826|NCT02570711|11866325|FG000|COMPLETED|Overall Study||0
10701827|NCT02570711|11866326|FG001|COMPLETED|Overall Study||0
10701828|NCT02570711|11866325|FG000|NOT COMPLETED|Overall Study||1
10701829|NCT02570711|11866326|FG001|NOT COMPLETED|Overall Study||2
10701830|NCT02570750|11866334|FG000|STARTED|Overall Study||110
10701831|NCT02570750|11866335|FG001|STARTED|Overall Study||73
10701832|NCT02570750|11866334|FG000|COMPLETED|Overall Study||96
10701833|NCT02570750|11866335|FG001|COMPLETED|Overall Study||68
10701834|NCT02570750|11866334|FG000|NOT COMPLETED|Overall Study||14
10701835|NCT02570750|11866335|FG001|NOT COMPLETED|Overall Study||5
10701836|NCT02571049|11866341|FG000|STARTED|Screening||10
10701837|NCT02571049|11866342|FG001|STARTED|Screening||14
10701838|NCT02571049|11866341|FG000|COMPLETED|Screening||8
10701839|NCT02571049|11866342|FG001|COMPLETED|Screening||12
10701840|NCT02571049|11866341|FG000|NOT COMPLETED|Screening||2
10701841|NCT02571049|11866342|FG001|NOT COMPLETED|Screening||2
10701842|NCT02571049|11866341|FG000|STARTED|Randomization||8
10701843|NCT02571049|11866342|FG001|STARTED|Randomization||12
10701844|NCT02571049|11866341|FG000|COMPLETED|Randomization||8
10701845|NCT02571049|11866342|FG001|COMPLETED|Randomization||10
10701846|NCT02571049|11866341|FG000|NOT COMPLETED|Randomization||0
10701847|NCT02571049|11866342|FG001|NOT COMPLETED|Randomization||2
10701848|NCT02571075|11866350|FG000|STARTED|Overall Study||45
10701849|NCT02571075|11866351|FG001|STARTED|Overall Study||50
10701850|NCT02571075|11866350|FG000|COMPLETED|Overall Study||25
10701851|NCT02571075|11866351|FG001|COMPLETED|Overall Study||26
10701852|NCT02571075|11866350|FG000|NOT COMPLETED|Overall Study||20
10701853|NCT02571075|11866351|FG001|NOT COMPLETED|Overall Study||24
10701854|NCT02571153|11866360|FG000|STARTED|Overall Study||45
10701855|NCT02571153|11866361|FG001|STARTED|Overall Study||45
10701856|NCT02571153|11866362|FG002|STARTED|Overall Study||45
10701857|NCT02571153|11866360|FG000|COMPLETED|Overall Study||39
10701858|NCT02571153|11866361|FG001|COMPLETED|Overall Study||37
10701859|NCT02571153|11866362|FG002|COMPLETED|Overall Study||43
10701860|NCT02571153|11866360|FG000|NOT COMPLETED|Overall Study||6
10701861|NCT02571153|11866361|FG001|NOT COMPLETED|Overall Study||8
10701862|NCT02571153|11866362|FG002|NOT COMPLETED|Overall Study||2
10701863|NCT02571218|11866372|FG000|STARTED|Overall Study||40
10701864|NCT02571218|11866373|FG001|STARTED|Overall Study||41
10701865|NCT02571218|11866372|FG000|COMPLETED|Overall Study||40
10701866|NCT02571218|11866373|FG001|COMPLETED|Overall Study||41
10701867|NCT02571218|11866372|FG000|NOT COMPLETED|Overall Study||0
10701868|NCT02571218|11866373|FG001|NOT COMPLETED|Overall Study||0
10701869|NCT02571244|11866381|FG000|STARTED|Overall Study||44
10701870|NCT02571244|11866382|FG001|STARTED|Overall Study||22
10701871|NCT02571244|11866381|FG000|COMPLETED|Overall Study||41
10701872|NCT02571244|11866382|FG001|COMPLETED|Overall Study||21
10701873|NCT02571244|11866381|FG000|NOT COMPLETED|Overall Study||3
10456516|NCT01007123|11604444|FG000|COMPLETED|Overall Study||42
10456517|NCT01007123|11604445|FG001|COMPLETED|Overall Study||41
10456518|NCT01007123|11604446|FG002|COMPLETED|Overall Study||37
10456519|NCT01007123|11604447|FG003|COMPLETED|Overall Study||41
10456520|NCT01007123|11604444|FG000|NOT COMPLETED|Overall Study||6
10701874|NCT02571244|11866382|FG001|NOT COMPLETED|Overall Study||1
10701875|NCT02571439|11866393|FG000|STARTED|Overall Study||20
10701876|NCT02571439|11866394|FG001|STARTED|Overall Study||21
10701877|NCT02571439|11866393|FG000|COMPLETED|Overall Study||20
10701878|NCT02571439|11866394|FG001|COMPLETED|Overall Study||21
10701879|NCT02571439|11866393|FG000|NOT COMPLETED|Overall Study||0
10701880|NCT02571439|11866394|FG001|NOT COMPLETED|Overall Study||0
10701881|NCT02571452|11866402|FG000|STARTED|Overall Study Treatment||47
10701882|NCT02571452|11866403|FG001|STARTED|Overall Study Treatment||46
10701883|NCT02571452|11866402|FG000|COMPLETED|Overall Study Treatment||47
10701884|NCT02571452|11866403|FG001|COMPLETED|Overall Study Treatment||45
10701885|NCT02571452|11866402|FG000|NOT COMPLETED|Overall Study Treatment||0
10701886|NCT02571452|11866403|FG001|NOT COMPLETED|Overall Study Treatment||1
10701887|NCT02571452|11866402|FG000|STARTED|Overall Study 6-Month Follow-up||47
10701888|NCT02571452|11866403|FG001|STARTED|Overall Study 6-Month Follow-up|Participants in the PMRT arm were not invited to complete 6-Month Follow-up.|0
10701889|NCT02571452|11866402|FG000|COMPLETED|Overall Study 6-Month Follow-up||42
10701890|NCT02571452|11866403|FG001|COMPLETED|Overall Study 6-Month Follow-up||0
10701891|NCT02571452|11866402|FG000|NOT COMPLETED|Overall Study 6-Month Follow-up||5
10701892|NCT02571452|11866403|FG001|NOT COMPLETED|Overall Study 6-Month Follow-up||0
10701893|NCT02571634|11866409|FG000|STARTED|Overall Study|First subject wasn't enrolled until July related to receipt of medications from sponsor.|23
10701894|NCT02571634|11866409|FG000|COMPLETED|Overall Study|The final subject was enrolled on this date.|23
10456521|NCT01007123|11604445|FG001|NOT COMPLETED|Overall Study||6
10701895|NCT02571634|11866409|FG000|NOT COMPLETED|Overall Study||0
10329327|NCT03138096|11464570|FG000|STARTED|Overall Study||3
10329328|NCT03138096|11464571|FG001|STARTED|Overall Study||3
10701896|NCT02571777|11866419|FG000|STARTED|Overall Study||619
10701897|NCT02571777|11866420|FG001|STARTED|Overall Study||620
10701898|NCT02571777|11866421|FG002|STARTED|Overall Study||618
10701899|NCT02571777|11866422|FG003|STARTED|Overall Study||617
10329329|NCT03138096|11464572|FG002|STARTED|Overall Study||12
10329330|NCT03138096|11464573|FG003|STARTED|Overall Study||6
10329331|NCT03138096|11464574|FG004|STARTED|Overall Study|Phase 2 was not started because of unsufficient effectivity of the Pb(PfCS@UIS4) immunizations as pre-determined in the study protocol.|0
10329332|NCT03138096|11464570|FG000|COMPLETED|Overall Study||3
10329333|NCT03138096|11464571|FG001|COMPLETED|Overall Study||3
10329334|NCT03138096|11464572|FG002|COMPLETED|Overall Study||12
10329335|NCT03138096|11464573|FG003|COMPLETED|Overall Study||6
10329336|NCT03138096|11464574|FG004|COMPLETED|Overall Study||0
10329337|NCT03138096|11464570|FG000|NOT COMPLETED|Overall Study||0
10329338|NCT03138096|11464571|FG001|NOT COMPLETED|Overall Study||0
10329339|NCT03138096|11464572|FG002|NOT COMPLETED|Overall Study||0
10329340|NCT03138096|11464573|FG003|NOT COMPLETED|Overall Study||0
10329341|NCT03138096|11464574|FG004|NOT COMPLETED|Overall Study||0
10329342|NCT02678351|11464597|FG000|STARTED|Overall Study||74
10329343|NCT02678351|11464597|FG000|COMPLETED|Overall Study||73
10329344|NCT02678351|11464597|FG000|NOT COMPLETED|Overall Study||1
10329345|NCT02578732|11464601|FG000|STARTED|Overall Study||28
10329346|NCT02578732|11464601|FG000|COMPLETED|Overall Study||28
10329347|NCT02578732|11464601|FG000|NOT COMPLETED|Overall Study||0
10338836|NCT02180724|11475771|FG000|STARTED|Overall Study||92
10338837|NCT02180724|11475772|FG001|STARTED|Overall Study||14
10338838|NCT02180724|11475771|FG000|Enrolled|Overall Study||92
10338839|NCT02180724|11475772|FG001|Enrolled|Overall Study||14
10338840|NCT02180724|11475771|FG000|Received Study Medication|Overall Study||92
10338841|NCT02180724|11475772|FG001|Received Study Medication|Overall Study||14
10338842|NCT02180724|11475771|FG000|Discontinued Study|Overall Study||14
10338843|NCT02180724|11475772|FG001|Discontinued Study|Overall Study||3
10338844|NCT02180724|11475771|FG000|Discontinued Treatment|Overall Study||23
10338845|NCT02180724|11475772|FG001|Discontinued Treatment|Overall Study||7
10338846|NCT02180724|11475771|FG000|COMPLETED|Overall Study||0
10338847|NCT02180724|11475772|FG001|COMPLETED|Overall Study||0
10338848|NCT02180724|11475771|FG000|NOT COMPLETED|Overall Study||92
10338849|NCT02180724|11475772|FG001|NOT COMPLETED|Overall Study||14
10338850|NCT02038777|11475786|FG000|STARTED|Overall Study||3
10574654|NCT01679613|11729918|FG001|Received Nintedanib+Ketoconazole (Pilot)|Overall Study|One subject received only ketoconazole not nintedanib|4
10574655|NCT01679613|11729919|FG002|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||0
10574656|NCT01679613|11729920|FG003|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||0
10574657|NCT01679613|11729917|FG000|Received Nintedanib (Main)|Overall Study||0
10574658|NCT01679613|11729918|FG001|Received Nintedanib (Main)|Overall Study||0
10574659|NCT01679613|11729919|FG002|Received Nintedanib (Main)|Overall Study||13
10574660|NCT01679613|11729920|FG003|Received Nintedanib (Main)|Overall Study||11
10574661|NCT01679613|11729917|FG000|Received Nintedanib+Ketoconazole (Main)|Overall Study||0
10574662|NCT01679613|11729918|FG001|Received Nintedanib+Ketoconazole (Main)|Overall Study||0
10574663|NCT01679613|11729919|FG002|Received Nintedanib+Ketoconazole (Main)|Overall Study|Two subjects received only ketoconazole not nintedanib|13
10574664|NCT01679613|11729920|FG003|Received Nintedanib+Ketoconazole (Main)|Overall Study|Two subjects received only ketoconazole not nintedanib|13
10574665|NCT01679613|11729917|FG000|COMPLETED|Overall Study||4
10574666|NCT01679613|11729918|FG001|COMPLETED|Overall Study||3
10574667|NCT01679613|11729919|FG002|COMPLETED|Overall Study||11
10574668|NCT01679613|11729920|FG003|COMPLETED|Overall Study||11
10574669|NCT01679613|11729917|FG000|NOT COMPLETED|Overall Study||0
10574670|NCT01679613|11729918|FG001|NOT COMPLETED|Overall Study||1
10574671|NCT01679613|11729919|FG002|NOT COMPLETED|Overall Study||2
10574672|NCT01679613|11729920|FG003|NOT COMPLETED|Overall Study||2
10701900|NCT02571777|11866423|FG004|STARTED|Overall Study||618
10338851|NCT02038777|11475787|FG001|STARTED|Overall Study||5
10338852|NCT02038777|11475788|FG002|STARTED|Overall Study||6
10338853|NCT02038777|11475789|FG003|STARTED|Overall Study||6
10338854|NCT02038777|11475790|FG004|STARTED|Overall Study||6
10338855|NCT02038777|11475791|FG005|STARTED|Overall Study||6
10338856|NCT02038777|11475792|FG006|STARTED|Overall Study||1
10338857|NCT02038777|11475793|FG007|STARTED|Overall Study||15
10456522|NCT01007123|11604446|FG002|NOT COMPLETED|Overall Study||11
10456523|NCT01007123|11604447|FG003|NOT COMPLETED|Overall Study||6
10456524|NCT01007136|11604463|FG000|STARTED|Overall Study||19
10456525|NCT01007136|11604464|FG001|STARTED|Overall Study|One additional subject was excluded prior to randomization due to illicit drug use.|17
10456526|NCT01007136|11604465|FG002|STARTED|Overall Study||15
10456527|NCT01007136|11604466|FG003|STARTED|Overall Study||6
10456528|NCT01007136|11604467|FG004|STARTED|Overall Study||4
10456529|NCT01007136|11604463|FG000|COMPLETED|Overall Study||15
10456530|NCT01007136|11604464|FG001|COMPLETED|Overall Study||13
10456531|NCT01007136|11604465|FG002|COMPLETED|Overall Study||15
10456532|NCT01007136|11604466|FG003|COMPLETED|Overall Study||6
10456533|NCT01007136|11604467|FG004|COMPLETED|Overall Study||4
10456534|NCT01007136|11604463|FG000|NOT COMPLETED|Overall Study||4
10456535|NCT01007136|11604464|FG001|NOT COMPLETED|Overall Study||4
10456536|NCT01007136|11604465|FG002|NOT COMPLETED|Overall Study||0
10456537|NCT01007136|11604466|FG003|NOT COMPLETED|Overall Study||0
10456538|NCT01007136|11604467|FG004|NOT COMPLETED|Overall Study||0
10456539|NCT01007149|11604480|FG000|STARTED|Overall Study||20
10456540|NCT01007149|11604481|FG001|STARTED|Overall Study||21
10456541|NCT01007149|11604480|FG000|COMPLETED|Overall Study||20
10456542|NCT01007149|11604481|FG001|COMPLETED|Overall Study||20
10456543|NCT01007149|11604480|FG000|NOT COMPLETED|Overall Study||0
10456544|NCT01007149|11604481|FG001|NOT COMPLETED|Overall Study||1
10456545|NCT01007253|11604487|FG000|STARTED|First Intervention||6
10456546|NCT01007253|11604488|FG001|STARTED|First Intervention||5
10329366|NCT01961531|11464636|FG000|STARTED|Overall Study||40
10329367|NCT01961531|11464636|FG000|COMPLETED|Overall Study||40
10329368|NCT01961531|11464636|FG000|NOT COMPLETED|Overall Study||0
10329369|NCT01880541|11464642|FG000|STARTED|Overall Study||10
10329370|NCT01880541|11464643|FG001|STARTED|Overall Study||20
10329371|NCT01880541|11464642|FG000|COMPLETED|Overall Study||10
10329372|NCT01880541|11464643|FG001|COMPLETED|Overall Study||20
10329373|NCT01880541|11464642|FG000|NOT COMPLETED|Overall Study||0
10329374|NCT01880541|11464643|FG001|NOT COMPLETED|Overall Study||0
10701901|NCT02571777|11866419|FG000|Full Analysis Set (FAS)|Overall Study||615
10701902|NCT02571777|11866420|FG001|Full Analysis Set (FAS)|Overall Study||616
10701903|NCT02571777|11866421|FG002|Full Analysis Set (FAS)|Overall Study||611
10701904|NCT02571777|11866422|FG003|Full Analysis Set (FAS)|Overall Study||607
10329375|NCT01693692|11464652|FG000|STARTED|Overall Study||130
10329376|NCT01693692|11464653|FG001|STARTED|Overall Study||131
10456547|NCT01007253|11604489|FG002|STARTED|First Intervention||5
10456548|NCT01007253|11604490|FG003|STARTED|First Intervention||5
10456549|NCT01007253|11604487|FG000|COMPLETED|First Intervention||6
10456550|NCT01007253|11604488|FG001|COMPLETED|First Intervention||5
10456551|NCT01007253|11604489|FG002|COMPLETED|First Intervention||5
10456552|NCT01007253|11604490|FG003|COMPLETED|First Intervention||5
10456553|NCT01007253|11604487|FG000|NOT COMPLETED|First Intervention||0
10456554|NCT01007253|11604488|FG001|NOT COMPLETED|First Intervention||0
10456555|NCT01007253|11604489|FG002|NOT COMPLETED|First Intervention||0
10456556|NCT01007253|11604490|FG003|NOT COMPLETED|First Intervention||0
10456557|NCT01007253|11604487|FG000|STARTED|Washout Period (2 Weeks) # 1||6
10456558|NCT01007253|11604488|FG001|STARTED|Washout Period (2 Weeks) # 1||5
10456559|NCT01007253|11604489|FG002|STARTED|Washout Period (2 Weeks) # 1||5
10456560|NCT01007253|11604490|FG003|STARTED|Washout Period (2 Weeks) # 1||5
10456561|NCT01007253|11604487|FG000|COMPLETED|Washout Period (2 Weeks) # 1||6
10456562|NCT01007253|11604488|FG001|COMPLETED|Washout Period (2 Weeks) # 1||5
10456563|NCT01007253|11604489|FG002|COMPLETED|Washout Period (2 Weeks) # 1||5
10456564|NCT01007253|11604490|FG003|COMPLETED|Washout Period (2 Weeks) # 1||5
10456565|NCT01007253|11604487|FG000|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
10701905|NCT02571777|11866423|FG004|Full Analysis Set (FAS)|Overall Study||612
10701906|NCT02571777|11866419|FG000|Safety Set (SAF)|Overall Study||616
10329377|NCT01693692|11464654|FG002|STARTED|Overall Study||131
10329378|NCT01693692|11464652|FG000|Received Study Drug|Overall Study||128
10329379|NCT01693692|11464653|FG001|Received Study Drug|Overall Study||127
10329380|NCT01693692|11464654|FG002|Received Study Drug|Overall Study||128
10329381|NCT01693692|11464652|FG000|COMPLETED|Overall Study||100
10329382|NCT01693692|11464653|FG001|COMPLETED|Overall Study||97
10329383|NCT01693692|11464654|FG002|COMPLETED|Overall Study||95
10329384|NCT01693692|11464652|FG000|NOT COMPLETED|Overall Study||30
10329385|NCT01693692|11464653|FG001|NOT COMPLETED|Overall Study||34
10329386|NCT01693692|11464654|FG002|NOT COMPLETED|Overall Study||36
10329387|NCT01685606|11464662|FG000|STARTED|Overall Study||6
10329388|NCT01685606|11464662|FG000|COMPLETED|Overall Study||5
10456566|NCT01007253|11604488|FG001|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
10456567|NCT01007253|11604489|FG002|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
10456568|NCT01007253|11604490|FG003|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
10456569|NCT01007253|11604487|FG000|STARTED|Second Intervention||6
10456570|NCT01007253|11604488|FG001|STARTED|Second Intervention||5
10329389|NCT01685606|11464662|FG000|NOT COMPLETED|Overall Study||1
10329390|NCT01650350|11464666|FG000|STARTED|Overall Study||7
10329391|NCT01650350|11464666|FG000|COMPLETED|Overall Study||7
10329392|NCT01650350|11464666|FG000|NOT COMPLETED|Overall Study||0
10329393|NCT01650285|11464672|FG000|STARTED|Overall Study||5
10329394|NCT01650285|11464672|FG000|COMPLETED|Overall Study||4
10329395|NCT01650285|11464672|FG000|NOT COMPLETED|Overall Study||1
10329396|NCT01083771|11464676|FG000|STARTED|Overall Study||21
10329397|NCT01083771|11464676|FG000|COMPLETED|Overall Study||16
10329398|NCT01083771|11464676|FG000|NOT COMPLETED|Overall Study||5
10329399|NCT00743197|11464682|FG000|STARTED|Overall Study||1
10329400|NCT00743197|11464683|FG001|STARTED|Overall Study||2
10329401|NCT00743197|11464682|FG000|COMPLETED|Overall Study||0
10329402|NCT00743197|11464683|FG001|COMPLETED|Overall Study||0
10329403|NCT00743197|11464682|FG000|NOT COMPLETED|Overall Study||1
10329404|NCT00743197|11464683|FG001|NOT COMPLETED|Overall Study||2
10329405|NCT00304915|11464691|FG000|STARTED|Overall Study||123
10329406|NCT00304915|11464692|FG001|STARTED|Overall Study||126
10329407|NCT00304915|11464691|FG000|COMPLETED|Overall Study||105
10329408|NCT00304915|11464692|FG001|COMPLETED|Overall Study||110
10329409|NCT00304915|11464691|FG000|NOT COMPLETED|Overall Study||18
10329410|NCT00304915|11464692|FG001|NOT COMPLETED|Overall Study||16
10329411|NCT00304954|11464702|FG000|STARTED|Overall Study||4
10329412|NCT00304954|11464703|FG001|STARTED|Overall Study||3
10329413|NCT00304954|11464704|FG002|STARTED|Overall Study||3
10329414|NCT00304954|11464705|FG003|STARTED|Overall Study||3
10329415|NCT00304954|11464702|FG000|COMPLETED|Overall Study||3
10329416|NCT00304954|11464703|FG001|COMPLETED|Overall Study||3
10329417|NCT00304954|11464704|FG002|COMPLETED|Overall Study||2
10329418|NCT00304954|11464705|FG003|COMPLETED|Overall Study||3
10329419|NCT00304954|11464702|FG000|NOT COMPLETED|Overall Study||1
10329420|NCT00304954|11464703|FG001|NOT COMPLETED|Overall Study||0
10329421|NCT00304954|11464704|FG002|NOT COMPLETED|Overall Study||1
10329422|NCT00304954|11464705|FG003|NOT COMPLETED|Overall Study||0
10329423|NCT00305006|11464725|FG000|STARTED|Overall Study||22
10456571|NCT01007253|11604489|FG002|STARTED|Second Intervention||5
10456572|NCT01007253|11604490|FG003|STARTED|Second Intervention||5
10456573|NCT01007253|11604487|FG000|COMPLETED|Second Intervention||6
10456574|NCT01007253|11604488|FG001|COMPLETED|Second Intervention||5
10456575|NCT01007253|11604489|FG002|COMPLETED|Second Intervention||5
10456576|NCT01007253|11604490|FG003|COMPLETED|Second Intervention||5
10456577|NCT01007253|11604487|FG000|NOT COMPLETED|Second Intervention||0
10456578|NCT01007253|11604488|FG001|NOT COMPLETED|Second Intervention||0
10456579|NCT01007253|11604489|FG002|NOT COMPLETED|Second Intervention||0
10456580|NCT01007253|11604490|FG003|NOT COMPLETED|Second Intervention||0
10456581|NCT01007253|11604487|FG000|STARTED|Washout Period (2 Weeks) # 2||6
10456582|NCT01007253|11604488|FG001|STARTED|Washout Period (2 Weeks) # 2||5
10456583|NCT01007253|11604489|FG002|STARTED|Washout Period (2 Weeks) # 2||5
10456584|NCT01007253|11604490|FG003|STARTED|Washout Period (2 Weeks) # 2||5
10456585|NCT01007253|11604487|FG000|COMPLETED|Washout Period (2 Weeks) # 2||6
10456586|NCT01007253|11604488|FG001|COMPLETED|Washout Period (2 Weeks) # 2||5
10456587|NCT01007253|11604489|FG002|COMPLETED|Washout Period (2 Weeks) # 2||5
10456588|NCT01007253|11604490|FG003|COMPLETED|Washout Period (2 Weeks) # 2||5
10456589|NCT01007253|11604487|FG000|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
10456590|NCT01007253|11604488|FG001|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
10456591|NCT01007253|11604489|FG002|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
10456592|NCT01007253|11604490|FG003|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
10456593|NCT01007253|11604487|FG000|STARTED|Third Intervention||6
10456594|NCT01007253|11604488|FG001|STARTED|Third Intervention||5
10456595|NCT01007253|11604489|FG002|STARTED|Third Intervention||5
10456596|NCT01007253|11604490|FG003|STARTED|Third Intervention||5
10456597|NCT01007253|11604487|FG000|COMPLETED|Third Intervention||6
10456598|NCT01007253|11604488|FG001|COMPLETED|Third Intervention||5
10456599|NCT01007253|11604489|FG002|COMPLETED|Third Intervention||5
10456600|NCT01007253|11604490|FG003|COMPLETED|Third Intervention||5
10456601|NCT01007253|11604487|FG000|NOT COMPLETED|Third Intervention||0
10456602|NCT01007253|11604488|FG001|NOT COMPLETED|Third Intervention||0
10456603|NCT01007253|11604489|FG002|NOT COMPLETED|Third Intervention||0
10701907|NCT02571777|11866420|FG001|Safety Set (SAF)|Overall Study||617
10701908|NCT02571777|11866421|FG002|Safety Set (SAF)|Overall Study||613
10701909|NCT02571777|11866422|FG003|Safety Set (SAF)|Overall Study||608
10701910|NCT02571777|11866423|FG004|Safety Set (SAF)|Overall Study||618
10701911|NCT02571777|11866419|FG000|COMPLETED|Overall Study||580
10329424|NCT00305006|11464726|FG001|STARTED|Overall Study||22
10329425|NCT00305006|11464725|FG000|COMPLETED|Overall Study||21
10329426|NCT00305006|11464726|FG001|COMPLETED|Overall Study||21
10701912|NCT02571777|11866420|FG001|COMPLETED|Overall Study||582
10701913|NCT02571777|11866421|FG002|COMPLETED|Overall Study||577
10701914|NCT02571777|11866422|FG003|COMPLETED|Overall Study||580
10329427|NCT00305006|11464725|FG000|NOT COMPLETED|Overall Study||1
10329428|NCT00305006|11464726|FG001|NOT COMPLETED|Overall Study||1
10329429|NCT00305058|11464734|FG000|STARTED|Overall Study||97
10329430|NCT00305058|11464735|FG001|STARTED|Overall Study||97
10329431|NCT00305058|11464734|FG000|Inclusion/Exclusion Verification|Overall Study||96
10338858|NCT02038777|11475786|FG000|Treated (Safety Set)|Overall Study||3
10456604|NCT01007253|11604490|FG003|NOT COMPLETED|Third Intervention||0
10456605|NCT01007253|11604487|FG000|STARTED|Washout Period (2 Weeks) # 3||6
10456606|NCT01007253|11604488|FG001|STARTED|Washout Period (2 Weeks) # 3||5
10701915|NCT02571777|11866423|FG004|COMPLETED|Overall Study||582
10701916|NCT02571777|11866419|FG000|NOT COMPLETED|Overall Study||39
10701917|NCT02571777|11866420|FG001|NOT COMPLETED|Overall Study||38
10701918|NCT02571777|11866421|FG002|NOT COMPLETED|Overall Study||41
10701919|NCT02571777|11866422|FG003|NOT COMPLETED|Overall Study||37
10329432|NCT00305058|11464735|FG001|Inclusion/Exclusion Verification|Overall Study||97
10329433|NCT00305058|11464734|FG000|All Outcome Data Collected|Overall Study||93
10329434|NCT00305058|11464735|FG001|All Outcome Data Collected|Overall Study||95
10329435|NCT00305058|11464734|FG000|Data Collection Forms Filed for Analysis|Overall Study||90
10329436|NCT00305058|11464735|FG001|Data Collection Forms Filed for Analysis|Overall Study||93
10329437|NCT00305058|11464734|FG000|COMPLETED|Overall Study||90
10329438|NCT00305058|11464735|FG001|COMPLETED|Overall Study||93
10329439|NCT00305058|11464734|FG000|NOT COMPLETED|Overall Study||7
10329440|NCT00305058|11464735|FG001|NOT COMPLETED|Overall Study||4
10329441|NCT00305084|11464746|FG000|STARTED|Overall Study||3
10329442|NCT00305084|11464747|FG001|STARTED|Overall Study||3
10329443|NCT00305084|11464748|FG002|STARTED|Overall Study||3
10329444|NCT00305084|11464749|FG003|STARTED|Overall Study||3
10329445|NCT00305084|11464750|FG004|STARTED|Overall Study||3
10329446|NCT00305084|11464746|FG000|COMPLETED|Overall Study||3
10329447|NCT00305084|11464747|FG001|COMPLETED|Overall Study||3
10329448|NCT00305084|11464748|FG002|COMPLETED|Overall Study||3
10329449|NCT00305084|11464749|FG003|COMPLETED|Overall Study||3
10329450|NCT00305084|11464750|FG004|COMPLETED|Overall Study||3
10329451|NCT00305084|11464746|FG000|NOT COMPLETED|Overall Study||0
10329452|NCT00305084|11464747|FG001|NOT COMPLETED|Overall Study||0
10329453|NCT00305084|11464748|FG002|NOT COMPLETED|Overall Study||0
10329454|NCT00305084|11464749|FG003|NOT COMPLETED|Overall Study||0
10329455|NCT00305084|11464750|FG004|NOT COMPLETED|Overall Study||0
10329456|NCT00305110|11464790|FG000|STARTED|Overall Study||298
10329457|NCT00305110|11464790|FG000|All Necessary Data Collected|Overall Study||269
10329458|NCT00305110|11464790|FG000|COMPLETED|Overall Study||269
10329459|NCT00305110|11464790|FG000|NOT COMPLETED|Overall Study||29
10329460|NCT00305162|11464796|FG000|STARTED|48 Hour Follow-up Period||4435
10329461|NCT00305162|11464797|FG001|STARTED|48 Hour Follow-up Period||4447
10329462|NCT00305162|11464796|FG000|Intent-to-treat (ITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|3933
10329463|NCT00305162|11464797|FG001|Intent-to-treat (ITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|3924
10329464|NCT00305162|11464796|FG000|Intent-to-treat (ITT): STEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|482
10329465|NCT00305162|11464797|FG001|Intent-to-treat (ITT): STEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|507
10329466|NCT00305162|11464796|FG000|Modified ITT (mITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|3889
10329467|NCT00305162|11464797|FG001|Modified ITT (mITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|3865
10329468|NCT00305162|11464796|FG000|Modified ITT (mITT): STEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|446
10329469|NCT00305162|11464797|FG001|Modified ITT (mITT): STEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|447
10329470|NCT00305162|11464796|FG000|Safety Population|48 Hour Follow-up Period|Patients who received at least 1 dose of study drug, according to the actual treatment received.|4374
10329471|NCT00305162|11464797|FG001|Safety Population|48 Hour Follow-up Period|Patients who received at least 1 dose of study drug, according to the actual treatment received.|4365
10329472|NCT00305162|11464796|FG000|COMPLETED|48 Hour Follow-up Period|intent-to-treat (ITT) completers at 48 hour follow-up|4415
10329473|NCT00305162|11464797|FG001|COMPLETED|48 Hour Follow-up Period|intent-to-treat (ITT) completers at 48 hour follow-up|4431
10329474|NCT00305162|11464796|FG000|NOT COMPLETED|48 Hour Follow-up Period||20
10329475|NCT00305162|11464797|FG001|NOT COMPLETED|48 Hour Follow-up Period||16
10329476|NCT00305162|11464796|FG000|STARTED|30-day Follow-up Period||4435
10329477|NCT00305162|11464797|FG001|STARTED|30-day Follow-up Period||4447
10329478|NCT00305162|11464796|FG000|Intent-to-treat (ITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days|3902
10329479|NCT00305162|11464797|FG001|Intent-to-treat (ITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days|3883
10329480|NCT00305162|11464796|FG000|Intent-to-treat (ITT): STEMI|30-day Follow-up Period|Completed through 30-days|471
10329481|NCT00305162|11464797|FG001|Intent-to-treat (ITT): STEMI|30-day Follow-up Period|Completed through 30-days|501
10329482|NCT00305162|11464796|FG000|Modified ITT (mITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|3860
10329483|NCT00305162|11464797|FG001|Modified ITT (mITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|3827
10329484|NCT00305162|11464796|FG000|Modified ITT (mITT): STEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|438
10329485|NCT00305162|11464797|FG001|Modified ITT (mITT): STEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|444
10329486|NCT00305162|11464796|FG000|COMPLETED|30-day Follow-up Period|intent-to-treat (ITT) completers at 30-day follow-up|4373
10329487|NCT00305162|11464797|FG001|COMPLETED|30-day Follow-up Period|intent-to-treat (ITT) completers at 30-day follow-up|4384
10329488|NCT00305162|11464796|FG000|NOT COMPLETED|30-day Follow-up Period||62
10329489|NCT00305162|11464797|FG001|NOT COMPLETED|30-day Follow-up Period||63
10329490|NCT00305162|11464796|FG000|STARTED|1 Year Follow-up Period||4435
10329491|NCT00305162|11464797|FG001|STARTED|1 Year Follow-up Period||4447
10329492|NCT00305162|11464796|FG000|Intent-to-treat (ITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year|3900
10701920|NCT02571777|11866423|FG004|NOT COMPLETED|Overall Study||36
10329493|NCT00305162|11464797|FG001|Intent-to-treat (ITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year|3878
10329494|NCT00305162|11464796|FG000|Intent-to-treat (ITT): STEMI|1 Year Follow-up Period|Completed through 1 year|480
10329576|NCT00305695|11464896|FG001|COMPLETED|Overall Study||52
10329495|NCT00305162|11464797|FG001|Intent-to-treat (ITT): STEMI|1 Year Follow-up Period|Completed through 1 year|504
10329496|NCT00305162|11464796|FG000|Modified ITT (mITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|3851
10329497|NCT00305162|11464797|FG001|Modified ITT (mITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|3818
10329498|NCT00305162|11464796|FG000|Modified ITT (mITT): STEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|446
10329499|NCT00305162|11464797|FG001|Modified ITT (mITT): STEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|444
10329500|NCT00305162|11464796|FG000|COMPLETED|1 Year Follow-up Period|intent-to-treat (ITT) completers at 1-year follow-up|4380
10329501|NCT00305162|11464797|FG001|COMPLETED|1 Year Follow-up Period|intent-to-treat (ITT) completers at 1-year follow-up|4382
10329502|NCT00305162|11464796|FG000|NOT COMPLETED|1 Year Follow-up Period||55
10329503|NCT00305162|11464797|FG001|NOT COMPLETED|1 Year Follow-up Period||65
10329504|NCT00305227|11464806|FG000|STARTED|Overall Study||50
10329505|NCT00305227|11464807|FG001|STARTED|Overall Study||50
10329506|NCT00305227|11464806|FG000|COMPLETED|Overall Study|with at least 8 weeks of observation|43
10329507|NCT00305227|11464807|FG001|COMPLETED|Overall Study|with at least 8 weeks of observation|44
10329508|NCT00305227|11464806|FG000|NOT COMPLETED|Overall Study||7
10329509|NCT00305227|11464807|FG001|NOT COMPLETED|Overall Study||6
10329510|NCT00305253|11464815|FG000|STARTED|Overall Study||432
10329511|NCT00305253|11464816|FG001|STARTED|Overall Study||559
10329512|NCT00305253|11464815|FG000|COMPLETED|Overall Study||432
10329513|NCT00305253|11464816|FG001|COMPLETED|Overall Study||558
10329514|NCT00305253|11464815|FG000|NOT COMPLETED|Overall Study||0
10329515|NCT00305253|11464816|FG001|NOT COMPLETED|Overall Study||1
10329516|NCT00305448|11464825|FG000|STARTED|Overall Study||45
10329517|NCT00305448|11464826|FG001|STARTED|Overall Study||51
10329518|NCT00305448|11464827|FG002|STARTED|Overall Study||47
10329519|NCT00305448|11464825|FG000|COMPLETED|Overall Study||14
10329520|NCT00305448|11464826|FG001|COMPLETED|Overall Study||17
10329521|NCT00305448|11464827|FG002|COMPLETED|Overall Study||14
10329522|NCT00305448|11464825|FG000|NOT COMPLETED|Overall Study||31
10329523|NCT00305448|11464826|FG001|NOT COMPLETED|Overall Study||34
10329524|NCT00305448|11464827|FG002|NOT COMPLETED|Overall Study||33
10329525|NCT00305565|11464839|FG000|STARTED|Overall Study (Safety Population)||111
10329526|NCT00305565|11464840|FG001|STARTED|Overall Study (Safety Population)||107
10329527|NCT00305565|11464841|FG002|STARTED|Overall Study (Safety Population)||113
10329528|NCT00305565|11464839|FG000|COMPLETED|Overall Study (Safety Population)||97
10329529|NCT00305565|11464840|FG001|COMPLETED|Overall Study (Safety Population)||95
10329530|NCT00305565|11464841|FG002|COMPLETED|Overall Study (Safety Population)||106
10329531|NCT00305565|11464839|FG000|NOT COMPLETED|Overall Study (Safety Population)||14
10329532|NCT00305565|11464840|FG001|NOT COMPLETED|Overall Study (Safety Population)||12
10329533|NCT00305565|11464841|FG002|NOT COMPLETED|Overall Study (Safety Population)||7
10329534|NCT00305565|11464839|FG000|STARTED|Overall Study (ITT Population)||102
10329535|NCT00305565|11464840|FG001|STARTED|Overall Study (ITT Population)||101
10329536|NCT00305565|11464841|FG002|STARTED|Overall Study (ITT Population)||107
10329537|NCT00305565|11464839|FG000|COMPLETED|Overall Study (ITT Population)||89
10329538|NCT00305565|11464840|FG001|COMPLETED|Overall Study (ITT Population)||90
10329539|NCT00305565|11464841|FG002|COMPLETED|Overall Study (ITT Population)||102
10329540|NCT00305565|11464839|FG000|NOT COMPLETED|Overall Study (ITT Population)||13
10329541|NCT00305565|11464840|FG001|NOT COMPLETED|Overall Study (ITT Population)||11
10329542|NCT00305565|11464841|FG002|NOT COMPLETED|Overall Study (ITT Population)||5
10329543|NCT00305578|11464852|FG000|STARTED|Overall Study||15
10329544|NCT00305578|11464853|FG001|STARTED|Overall Study||14
10329545|NCT00305578|11464852|FG000|COMPLETED|Overall Study||12
10329546|NCT00305578|11464853|FG001|COMPLETED|Overall Study||12
10329547|NCT00305578|11464852|FG000|NOT COMPLETED|Overall Study||3
10329548|NCT00305578|11464853|FG001|NOT COMPLETED|Overall Study||2
10329549|NCT00305604|11464861|FG000|STARTED|Overall Study||102
10329550|NCT00305604|11464862|FG001|STARTED|Overall Study||104
10329551|NCT00305604|11464861|FG000|COMPLETED|Overall Study||70
10329552|NCT00305604|11464862|FG001|COMPLETED|Overall Study||57
10329553|NCT00305604|11464861|FG000|NOT COMPLETED|Overall Study||32
10329554|NCT00305604|11464862|FG001|NOT COMPLETED|Overall Study||47
10329555|NCT00305682|11464874|FG000|STARTED|Overall Study||98
10329556|NCT00305682|11464875|FG001|STARTED|Overall Study||71
10329557|NCT00305682|11464876|FG002|STARTED|Overall Study||7
10329558|NCT00305682|11464877|FG003|STARTED|Overall Study||34
10329559|NCT00305682|11464878|FG004|STARTED|Overall Study||39
10329560|NCT00305682|11464879|FG005|STARTED|Overall Study||35
10329561|NCT00305682|11464874|FG000|COMPLETED|Overall Study||98
10329562|NCT00305682|11464875|FG001|COMPLETED|Overall Study||71
10329563|NCT00305682|11464876|FG002|COMPLETED|Overall Study||7
10329564|NCT00305682|11464877|FG003|COMPLETED|Overall Study||34
10329565|NCT00305682|11464878|FG004|COMPLETED|Overall Study||39
10329566|NCT00305682|11464879|FG005|COMPLETED|Overall Study||35
10329567|NCT00305682|11464874|FG000|NOT COMPLETED|Overall Study||0
10329568|NCT00305682|11464875|FG001|NOT COMPLETED|Overall Study||0
10329569|NCT00305682|11464876|FG002|NOT COMPLETED|Overall Study||0
10329570|NCT00305682|11464877|FG003|NOT COMPLETED|Overall Study||0
10329571|NCT00305682|11464878|FG004|NOT COMPLETED|Overall Study||0
10329572|NCT00305682|11464879|FG005|NOT COMPLETED|Overall Study||0
10329573|NCT00305695|11464895|FG000|STARTED|Overall Study||81
10329574|NCT00305695|11464896|FG001|STARTED|Overall Study||79
10329575|NCT00305695|11464895|FG000|COMPLETED|Overall Study||40
10329577|NCT00305695|11464895|FG000|NOT COMPLETED|Overall Study||41
10329578|NCT00305695|11464896|FG001|NOT COMPLETED|Overall Study||27
10329579|NCT00305760|11464902|FG000|STARTED|Overall Study||60
10329580|NCT00305760|11464902|FG000|COMPLETED|Overall Study||13
10329581|NCT00305760|11464902|FG000|NOT COMPLETED|Overall Study||47
10329582|NCT00305773|11464908|FG000|STARTED|Overall Study||15
10329583|NCT00305773|11464909|FG001|STARTED|Overall Study||22
10329584|NCT00305773|11464908|FG000|COMPLETED|Overall Study||1
10329585|NCT00305773|11464909|FG001|COMPLETED|Overall Study||4
10329586|NCT00305773|11464908|FG000|NOT COMPLETED|Overall Study||14
10329587|NCT00305773|11464909|FG001|NOT COMPLETED|Overall Study||18
10329588|NCT00305864|11464919|FG000|STARTED|Overall Study||7
10329589|NCT00305864|11464920|FG001|STARTED|Overall Study||10
10329590|NCT00305864|11464921|FG002|STARTED|Overall Study||7
10329591|NCT00305864|11464922|FG003|STARTED|Overall Study||94
10329592|NCT00305864|11464919|FG000|COMPLETED|Overall Study||7
10329593|NCT00305864|11464920|FG001|COMPLETED|Overall Study||9
10701921|NCT02571972|11866435|FG000|STARTED|Overall Study|2 patients signed consent but withdrew from the study prior to using dorzolamide-timolol drops.|14
10701922|NCT02571972|11866435|FG000|COMPLETED|Overall Study||10
10701923|NCT02571972|11866435|FG000|NOT COMPLETED|Overall Study||4
10701924|NCT02572076|11866439|FG000|STARTED|Overall Study||10
10701925|NCT02572076|11866439|FG000|COMPLETED|Overall Study||9
10701926|NCT02572076|11866439|FG000|NOT COMPLETED|Overall Study||1
10329594|NCT00305864|11464921|FG002|COMPLETED|Overall Study||6
10329595|NCT00305864|11464922|FG003|COMPLETED|Overall Study||81
10329596|NCT00305864|11464919|FG000|NOT COMPLETED|Overall Study||0
10329597|NCT00305864|11464920|FG001|NOT COMPLETED|Overall Study||1
10329598|NCT00305864|11464921|FG002|NOT COMPLETED|Overall Study||1
10329599|NCT00305864|11464922|FG003|NOT COMPLETED|Overall Study||13
10329600|NCT00305877|11464934|FG000|STARTED|Overall Study||69
10329601|NCT00305877|11464935|FG001|STARTED|Overall Study||68
10329602|NCT00305877|11464934|FG000|Treated|Overall Study||67
10329603|NCT00305877|11464935|FG001|Treated|Overall Study||63
10329604|NCT00305877|11464934|FG000|Eligible|Overall Study||66
10329605|NCT00305877|11464935|FG001|Eligible|Overall Study||66
10329606|NCT00305877|11464934|FG000|Included in Efficacy Analysis|Overall Study||65
10329607|NCT00305877|11464935|FG001|Included in Efficacy Analysis|Overall Study||62
10329608|NCT00305877|11464934|FG000|COMPLETED|Overall Study||45
10329609|NCT00305877|11464935|FG001|COMPLETED|Overall Study||34
10329610|NCT00305877|11464934|FG000|NOT COMPLETED|Overall Study||24
10329611|NCT00305877|11464935|FG001|NOT COMPLETED|Overall Study||34
10329612|NCT00305942|11464941|FG000|STARTED|Overall Study||61
10329613|NCT00305942|11464941|FG000|COMPLETED|Overall Study||23
10329614|NCT00305942|11464941|FG000|NOT COMPLETED|Overall Study||38
10329615|NCT00306163|11464947|FG000|STARTED|Overall Study||19
10329616|NCT00306163|11464948|FG001|STARTED|Overall Study||18
10329617|NCT00306163|11464947|FG000|COMPLETED|Overall Study||19
10329618|NCT00306163|11464948|FG001|COMPLETED|Overall Study||18
10329619|NCT00306163|11464947|FG000|NOT COMPLETED|Overall Study||0
10329620|NCT00306163|11464948|FG001|NOT COMPLETED|Overall Study||0
10329621|NCT00306189|11464958|FG000|STARTED|Overall Study||57
10329622|NCT00306189|11464959|FG001|STARTED|Overall Study||56
10329623|NCT00306189|11464960|FG002|STARTED|Overall Study||56
10329624|NCT00306189|11464961|FG003|STARTED|Overall Study||57
10329625|NCT00306189|11464958|FG000|COMPLETED|Overall Study||48
10329626|NCT00306189|11464959|FG001|COMPLETED|Overall Study||50
10329627|NCT00306189|11464960|FG002|COMPLETED|Overall Study||45
10329628|NCT00306189|11464961|FG003|COMPLETED|Overall Study||52
10701927|NCT02572167|11866446|FG000|STARTED|Overall Study||6
10701928|NCT02572167|11866447|FG001|STARTED|Overall Study||56
10701929|NCT02572167|11866448|FG002|STARTED|Overall Study||31
10701930|NCT02572167|11866446|FG000|COMPLETED|Overall Study||0
10329629|NCT00306189|11464958|FG000|NOT COMPLETED|Overall Study||9
10329630|NCT00306189|11464959|FG001|NOT COMPLETED|Overall Study||6
10329631|NCT00306189|11464960|FG002|NOT COMPLETED|Overall Study||11
10329632|NCT00306189|11464961|FG003|NOT COMPLETED|Overall Study||5
10329633|NCT00306202|11464974|FG000|STARTED|Overall Study|Started = Treated. 18 were enrolled; 1 no longer met study criteria and was never treated|17
10329634|NCT00306202|11464975|FG001|STARTED|Overall Study|Started=Treated. 20 were enrolled;3 never treated(2 no longer met study criteria;1 withdrew consent)|17
10329635|NCT00306202|11464976|FG002|STARTED|Overall Study|Started = Treated. 25 were enrolled; 1 no longer met study criteria and was never treated|24
10329636|NCT00306202|11464974|FG000|COMPLETED|Overall Study|Completed = Off-treatment|17
10329637|NCT00306202|11464975|FG001|COMPLETED|Overall Study|Completed = Off-treatment|17
10329638|NCT00306202|11464976|FG002|COMPLETED|Overall Study|Completed = Off-treatment|24
10329639|NCT00306202|11464974|FG000|NOT COMPLETED|Overall Study||0
10329640|NCT00306202|11464975|FG001|NOT COMPLETED|Overall Study||0
10329641|NCT00306202|11464976|FG002|NOT COMPLETED|Overall Study||0
10329642|NCT00306293|11465022|FG000|STARTED|Period 1 (Day 1 to Day 60)||35
10329643|NCT00306293|11465023|FG001|STARTED|Period 1 (Day 1 to Day 60)||35
10329644|NCT00306293|11465022|FG000|COMPLETED|Period 1 (Day 1 to Day 60)||27
10329645|NCT00306293|11465023|FG001|COMPLETED|Period 1 (Day 1 to Day 60)||27
10329646|NCT00306293|11465022|FG000|NOT COMPLETED|Period 1 (Day 1 to Day 60)||8
10329647|NCT00306293|11465023|FG001|NOT COMPLETED|Period 1 (Day 1 to Day 60)||8
10701931|NCT02572167|11866447|FG001|COMPLETED|Overall Study||0
10701932|NCT02572167|11866448|FG002|COMPLETED|Overall Study||0
10701933|NCT02572167|11866446|FG000|NOT COMPLETED|Overall Study||6
10701934|NCT02572167|11866447|FG001|NOT COMPLETED|Overall Study||56
10701935|NCT02572167|11866448|FG002|NOT COMPLETED|Overall Study||31
10701936|NCT02572388|11866460|FG000|STARTED|Overall Study||11
10701937|NCT02572388|11866461|FG001|STARTED|Overall Study||4
10701938|NCT02572388|11866462|FG002|STARTED|Overall Study||10
10701939|NCT02572388|11866463|FG003|STARTED|Overall Study||6
10701940|NCT02572388|11866460|FG000|COMPLETED|Overall Study||10
10701941|NCT02572388|11866461|FG001|COMPLETED|Overall Study||3
10701942|NCT02572388|11866462|FG002|COMPLETED|Overall Study||8
10701943|NCT02572388|11866463|FG003|COMPLETED|Overall Study||4
10701944|NCT02572388|11866460|FG000|NOT COMPLETED|Overall Study||1
10701945|NCT02572388|11866461|FG001|NOT COMPLETED|Overall Study||1
10701946|NCT02572388|11866462|FG002|NOT COMPLETED|Overall Study||2
10701947|NCT02572388|11866463|FG003|NOT COMPLETED|Overall Study||2
10701948|NCT02572401|11866477|FG000|STARTED|Overall Study||97
10701949|NCT02572401|11866478|FG001|STARTED|Overall Study||98
10701950|NCT02572401|11866479|FG002|STARTED|Overall Study||98
10701951|NCT02572401|11866480|FG003|STARTED|Overall Study||98
10329648|NCT00306293|11465022|FG000|STARTED|Washout (Day 61 to Day 66)||27
10329649|NCT00306293|11465023|FG001|STARTED|Washout (Day 61 to Day 66)||27
10329650|NCT00306293|11465022|FG000|COMPLETED|Washout (Day 61 to Day 66)||27
10329651|NCT00306293|11465023|FG001|COMPLETED|Washout (Day 61 to Day 66)||27
10329652|NCT00306293|11465022|FG000|NOT COMPLETED|Washout (Day 61 to Day 66)||0
10329653|NCT00306293|11465023|FG001|NOT COMPLETED|Washout (Day 61 to Day 66)||0
10329654|NCT00306293|11465022|FG000|STARTED|Period 2 (Day 67 to Day 126 )||27
10329655|NCT00306293|11465023|FG001|STARTED|Period 2 (Day 67 to Day 126 )||27
10329656|NCT00306293|11465022|FG000|COMPLETED|Period 2 (Day 67 to Day 126 )||24
10329657|NCT00306293|11465023|FG001|COMPLETED|Period 2 (Day 67 to Day 126 )||26
10329658|NCT00306293|11465022|FG000|NOT COMPLETED|Period 2 (Day 67 to Day 126 )||3
10329659|NCT00306293|11465023|FG001|NOT COMPLETED|Period 2 (Day 67 to Day 126 )||1
10329660|NCT00306384|11465034|FG000|STARTED|Overall Study||1396
10329661|NCT00306384|11465035|FG001|STARTED|Overall Study||1399
10329662|NCT00306384|11465036|FG002|STARTED|Overall Study||528
10329663|NCT00306384|11465034|FG000|Safety Set|Overall Study|Patients who received at least one dose of study drug|1395
10329664|NCT00306384|11465035|FG001|Safety Set|Overall Study|Patients who received at least one dose of study drug|1398
10701952|NCT02572401|11866477|FG000|COMPLETED|Overall Study||92
10701953|NCT02572401|11866478|FG001|COMPLETED|Overall Study||90
10701954|NCT02572401|11866479|FG002|COMPLETED|Overall Study||89
10701955|NCT02572401|11866480|FG003|COMPLETED|Overall Study||88
10701956|NCT02572401|11866477|FG000|NOT COMPLETED|Overall Study||5
10701957|NCT02572401|11866478|FG001|NOT COMPLETED|Overall Study||8
10701958|NCT02572401|11866479|FG002|NOT COMPLETED|Overall Study||9
10701959|NCT02572401|11866480|FG003|NOT COMPLETED|Overall Study||10
10701960|NCT02572427|11866492|FG000|STARTED|Overall Study||37
10701961|NCT02572427|11866493|FG001|STARTED|Overall Study||45
10701962|NCT02572427|11866492|FG000|COMPLETED|Overall Study||31
10701963|NCT02572427|11866493|FG001|COMPLETED|Overall Study||36
10701964|NCT02572427|11866492|FG000|NOT COMPLETED|Overall Study||6
10701965|NCT02572427|11866493|FG001|NOT COMPLETED|Overall Study||9
10701966|NCT02572570|11866499|FG000|STARTED|Overall Study||27
10701967|NCT02572570|11866499|FG000|Filtek Bulk Fill Posterior|Overall Study||27
10701968|NCT02572570|11866499|FG000|Filtek Supreme Ultra|Overall Study||27
10701969|NCT02572570|11866499|FG000|1 Year Follow-Up|Overall Study||20
10701970|NCT02572570|11866499|FG000|2 Year Follow-Up|Overall Study||13
10701971|NCT02572570|11866499|FG000|3 Year Follow-Up|Overall Study||5
10701972|NCT02572570|11866499|FG000|5 Year Follow-Up|Overall Study||0
10701973|NCT02572570|11866499|FG000|COMPLETED|Overall Study||0
10701974|NCT02572570|11866499|FG000|NOT COMPLETED|Overall Study||27
10701975|NCT02572609|11866508|FG000|STARTED|Period 1: Treatment Period 1 + Washout||18
10701976|NCT02572609|11866509|FG001|STARTED|Period 1: Treatment Period 1 + Washout||18
10701977|NCT02572609|11866508|FG000|COMPLETED|Period 1: Treatment Period 1 + Washout||18
10701978|NCT02572609|11866509|FG001|COMPLETED|Period 1: Treatment Period 1 + Washout||18
10329665|NCT00306384|11465036|FG002|Safety Set|Overall Study|Patients who received at least one dose of study drug|527
10329666|NCT00306384|11465034|FG000|COMPLETED|Overall Study||854
10329667|NCT00306384|11465035|FG001|COMPLETED|Overall Study||891
10329668|NCT00306384|11465036|FG002|COMPLETED|Overall Study||251
10329669|NCT00306384|11465034|FG000|NOT COMPLETED|Overall Study||542
10329670|NCT00306384|11465035|FG001|NOT COMPLETED|Overall Study||508
10329671|NCT00306384|11465036|FG002|NOT COMPLETED|Overall Study||277
10329672|NCT00306488|11465044|FG000|STARTED|Overall Study||11
10329673|NCT00306488|11465044|FG000|COMPLETED|Overall Study||10
10329674|NCT00306488|11465044|FG000|NOT COMPLETED|Overall Study||1
10329675|NCT00306527|11465053|FG000|STARTED|Overall Study||533
10329676|NCT00306527|11465054|FG001|STARTED|Overall Study||534
10329677|NCT00306527|11465055|FG002|STARTED|Overall Study||572
10329678|NCT00306527|11465056|FG003|STARTED|Overall Study||596
10701979|NCT02572609|11866508|FG000|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
10701980|NCT02572609|11866509|FG001|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
10701981|NCT02572609|11866508|FG000|STARTED|Period 2: Treatment Period 2||18
10701982|NCT02572609|11866509|FG001|STARTED|Period 2: Treatment Period 2||18
10701983|NCT02572609|11866508|FG000|COMPLETED|Period 2: Treatment Period 2||18
10329679|NCT00306527|11465053|FG000|COMPLETED|Overall Study||527
10329680|NCT00306527|11465054|FG001|COMPLETED|Overall Study||527
10338859|NCT02038777|11475787|FG001|Treated (Safety Set)|Overall Study||4
10329681|NCT00306527|11465055|FG002|COMPLETED|Overall Study|3 of 4 deaths in the elderly subjects resulted in premature discontinuation. Refer to OM2 .|567
10329682|NCT00306527|11465056|FG003|COMPLETED|Overall Study||590
10329683|NCT00306527|11465053|FG000|NOT COMPLETED|Overall Study||6
10329684|NCT00306527|11465054|FG001|NOT COMPLETED|Overall Study||7
10329685|NCT00306527|11465055|FG002|NOT COMPLETED|Overall Study||5
10329686|NCT00306527|11465056|FG003|NOT COMPLETED|Overall Study||6
10329687|NCT00306592|11465070|FG000|STARTED|Overall Study||404
10329688|NCT00306592|11465071|FG001|STARTED|Overall Study||690
10329689|NCT00306592|11465070|FG000|Completed at 24 Weeks|Overall Study||207
10329690|NCT00306592|11465071|FG001|Completed at 24 Weeks|Overall Study||0
10329691|NCT00306592|11465070|FG000|Completed Between 24 and 48 Weeks|Overall Study||85
10329692|NCT00306592|11465071|FG001|Completed Between 24 and 48 Weeks|Overall Study||0
10329693|NCT00306592|11465070|FG000|Completed at 48 Weeks|Overall Study||81
10329694|NCT00306592|11465071|FG001|Completed at 48 Weeks|Overall Study||632
10329695|NCT00306592|11465070|FG000|Entered 101-MS-321 Extension Study|Overall Study||22
10329696|NCT00306592|11465071|FG001|Entered 101-MS-321 Extension Study|Overall Study|pertains to participants transitioning from 101-MS-322 (NCT00306592) study only|0
10329697|NCT00306592|11465070|FG000|COMPLETED|Overall Study||373
10329698|NCT00306592|11465071|FG001|COMPLETED|Overall Study||632
10329699|NCT00306592|11465070|FG000|NOT COMPLETED|Overall Study||31
10329700|NCT00306592|11465071|FG001|NOT COMPLETED|Overall Study||58
10329701|NCT00306670|11465077|FG000|STARTED|Overall Study|no patients recruited; Genentech, the study sponsor, pulled funding and discontinued the protocol|0
10329702|NCT00306670|11465078|FG001|STARTED|Overall Study|2 patients recruited; Genentech, the study sponsor, discontinued trial before treatment started|2
10329703|NCT00306670|11465077|FG000|COMPLETED|Overall Study|no patients recruited; Genentech, the study sponsor, pulled funding and discontinued the protocol|0
10329704|NCT00306670|11465078|FG001|COMPLETED|Overall Study|2 patients recruited; Genentech, the study sponsor, discontinued study before treatment initiated|0
10329705|NCT00306670|11465077|FG000|NOT COMPLETED|Overall Study||0
10329706|NCT00306670|11465078|FG001|NOT COMPLETED|Overall Study||2
10329707|NCT00306787|11465086|FG000|STARTED|Overall Study||579
10329708|NCT00306787|11465087|FG001|STARTED|Overall Study||600
10329709|NCT00306787|11465086|FG000|Received Study Drug (Safety Population)|Overall Study||371
10329710|NCT00306787|11465087|FG001|Received Study Drug (Safety Population)|Overall Study||385
10329711|NCT00306787|11465086|FG000|Intent to Treat (ITT) Population|Overall Study||370
10329712|NCT00306787|11465087|FG001|Intent to Treat (ITT) Population|Overall Study||381
10329713|NCT00306787|11465086|FG000|COMPLETED|Overall Study||345
10329714|NCT00306787|11465087|FG001|COMPLETED|Overall Study||359
10329715|NCT00306787|11465086|FG000|NOT COMPLETED|Overall Study||234
10329716|NCT00306787|11465087|FG001|NOT COMPLETED|Overall Study||241
10329717|NCT00306852|11465095|FG000|STARTED|Overall Study||105
10329718|NCT00306852|11465096|FG001|STARTED|Overall Study||107
10329719|NCT00306852|11465095|FG000|COMPLETED|Overall Study||76
10329720|NCT00306852|11465096|FG001|COMPLETED|Overall Study||69
10329721|NCT00306852|11465095|FG000|NOT COMPLETED|Overall Study||29
10329722|NCT00306852|11465096|FG001|NOT COMPLETED|Overall Study||38
10329723|NCT00306891|11465106|FG000|STARTED|Part A||23
10329724|NCT00306891|11465107|FG001|STARTED|Part A||22
10329725|NCT00306891|11465108|FG002|STARTED|Part A||0
10329726|NCT00306891|11465109|FG003|STARTED|Part A||0
10329727|NCT00306891|11465106|FG000|COMPLETED|Part A||18
10329728|NCT00306891|11465107|FG001|COMPLETED|Part A||16
10329729|NCT00306891|11465108|FG002|COMPLETED|Part A||0
10329730|NCT00306891|11465109|FG003|COMPLETED|Part A||0
10329731|NCT00306891|11465106|FG000|NOT COMPLETED|Part A||5
10329732|NCT00306891|11465107|FG001|NOT COMPLETED|Part A||6
10329733|NCT00306891|11465108|FG002|NOT COMPLETED|Part A||0
10329734|NCT00306891|11465109|FG003|NOT COMPLETED|Part A||0
10329735|NCT00306891|11465106|FG000|STARTED|Part B||0
10329736|NCT00306891|11465107|FG001|STARTED|Part B||0
10329737|NCT00306891|11465108|FG002|STARTED|Part B|In Part B: Cediranib 45 mg Fixed Dose 4 new patients were randomized|16
10329738|NCT00306891|11465109|FG003|STARTED|Part B|in Part B: Cediranib Dose Escalation 11 new patients were randomized.|31
10329739|NCT00306891|11465106|FG000|COMPLETED|Part B||0
10329740|NCT00306891|11465107|FG001|COMPLETED|Part B||0
10329741|NCT00306891|11465108|FG002|COMPLETED|Part B||5
10329742|NCT00306891|11465109|FG003|COMPLETED|Part B||14
10329743|NCT00306891|11465106|FG000|NOT COMPLETED|Part B||0
10329744|NCT00306891|11465107|FG001|NOT COMPLETED|Part B||0
10701984|NCT02572609|11866509|FG001|COMPLETED|Period 2: Treatment Period 2||18
10701985|NCT02572609|11866508|FG000|NOT COMPLETED|Period 2: Treatment Period 2||0
10329745|NCT00306891|11465108|FG002|NOT COMPLETED|Part B||11
10329746|NCT00306891|11465109|FG003|NOT COMPLETED|Part B||17
10329765|NCT00306995|11465136|FG000|STARTED|Study Part I||55
10329766|NCT00306995|11465137|FG001|STARTED|Study Part I||55
10329767|NCT00306995|11465138|FG002|STARTED|Study Part I||55
10329768|NCT00306995|11465139|FG003|STARTED|Study Part I||55
10329769|NCT00306995|11465140|FG004|STARTED|Study Part I||55
10329770|NCT00306995|11465141|FG005|STARTED|Study Part I||55
10329771|NCT00306995|11465142|FG006|STARTED|Study Part I||55
10329772|NCT00306995|11465136|FG000|COMPLETED|Study Part I||55
10329773|NCT00306995|11465137|FG001|COMPLETED|Study Part I||55
10329774|NCT00306995|11465138|FG002|COMPLETED|Study Part I||55
10329775|NCT00306995|11465139|FG003|COMPLETED|Study Part I||55
10329776|NCT00306995|11465140|FG004|COMPLETED|Study Part I||55
10329777|NCT00306995|11465141|FG005|COMPLETED|Study Part I||55
10329778|NCT00306995|11465142|FG006|COMPLETED|Study Part I||54
10329779|NCT00306995|11465136|FG000|NOT COMPLETED|Study Part I||0
10329780|NCT00306995|11465137|FG001|NOT COMPLETED|Study Part I||0
10329781|NCT00306995|11465138|FG002|NOT COMPLETED|Study Part I||0
10329782|NCT00306995|11465139|FG003|NOT COMPLETED|Study Part I||0
10329783|NCT00306995|11465140|FG004|NOT COMPLETED|Study Part I||0
10329784|NCT00306995|11465141|FG005|NOT COMPLETED|Study Part I||0
10329785|NCT00306995|11465142|FG006|NOT COMPLETED|Study Part I||1
10329786|NCT00306995|11465136|FG000|STARTED|Study Part II for Subset 1||27
10329787|NCT00306995|11465137|FG001|STARTED|Study Part II for Subset 1||26
10329788|NCT00306995|11465138|FG002|STARTED|Study Part II for Subset 1||27
10329789|NCT00306995|11465139|FG003|STARTED|Study Part II for Subset 1||27
10329790|NCT00306995|11465140|FG004|STARTED|Study Part II for Subset 1||27
10329791|NCT00306995|11465141|FG005|STARTED|Study Part II for Subset 1||26
10329792|NCT00306995|11465142|FG006|STARTED|Study Part II for Subset 1||23
10329793|NCT00306995|11465136|FG000|COMPLETED|Study Part II for Subset 1||27
10329794|NCT00306995|11465137|FG001|COMPLETED|Study Part II for Subset 1||26
10329795|NCT00306995|11465138|FG002|COMPLETED|Study Part II for Subset 1||27
10329796|NCT00306995|11465139|FG003|COMPLETED|Study Part II for Subset 1||27
10329797|NCT00306995|11465140|FG004|COMPLETED|Study Part II for Subset 1||27
10329798|NCT00306995|11465141|FG005|COMPLETED|Study Part II for Subset 1||26
10329799|NCT00306995|11465142|FG006|COMPLETED|Study Part II for Subset 1||23
10329800|NCT00306995|11465136|FG000|NOT COMPLETED|Study Part II for Subset 1||0
10329801|NCT00306995|11465137|FG001|NOT COMPLETED|Study Part II for Subset 1||0
10329802|NCT00306995|11465138|FG002|NOT COMPLETED|Study Part II for Subset 1||0
10329803|NCT00306995|11465139|FG003|NOT COMPLETED|Study Part II for Subset 1||0
10329804|NCT00306995|11465140|FG004|NOT COMPLETED|Study Part II for Subset 1||0
10329805|NCT00306995|11465141|FG005|NOT COMPLETED|Study Part II for Subset 1||0
10329806|NCT00306995|11465142|FG006|NOT COMPLETED|Study Part II for Subset 1||0
10329807|NCT00306995|11465136|FG000|STARTED|Study Part II for Subset 2||23
10329808|NCT00306995|11465137|FG001|STARTED|Study Part II for Subset 2||24
10329809|NCT00306995|11465138|FG002|STARTED|Study Part II for Subset 2||23
10329810|NCT00306995|11465139|FG003|STARTED|Study Part II for Subset 2||22
10329811|NCT00306995|11465140|FG004|STARTED|Study Part II for Subset 2||23
10329812|NCT00306995|11465141|FG005|STARTED|Study Part II for Subset 2||26
10329813|NCT00306995|11465142|FG006|STARTED|Study Part II for Subset 2||24
10329814|NCT00306995|11465136|FG000|COMPLETED|Study Part II for Subset 2||23
10329815|NCT00306995|11465137|FG001|COMPLETED|Study Part II for Subset 2||23
10329816|NCT00306995|11465138|FG002|COMPLETED|Study Part II for Subset 2||23
10329817|NCT00306995|11465139|FG003|COMPLETED|Study Part II for Subset 2||22
10329818|NCT00306995|11465140|FG004|COMPLETED|Study Part II for Subset 2||23
10329819|NCT00306995|11465141|FG005|COMPLETED|Study Part II for Subset 2||26
10329820|NCT00306995|11465142|FG006|COMPLETED|Study Part II for Subset 2||24
10329821|NCT00306995|11465136|FG000|NOT COMPLETED|Study Part II for Subset 2||0
10329822|NCT00306995|11465137|FG001|NOT COMPLETED|Study Part II for Subset 2||1
10329823|NCT00306995|11465138|FG002|NOT COMPLETED|Study Part II for Subset 2||0
10329824|NCT00306995|11465139|FG003|NOT COMPLETED|Study Part II for Subset 2||0
10329825|NCT00306995|11465140|FG004|NOT COMPLETED|Study Part II for Subset 2||0
10329826|NCT00306995|11465141|FG005|NOT COMPLETED|Study Part II for Subset 2||0
10329827|NCT00306995|11465142|FG006|NOT COMPLETED|Study Part II for Subset 2||0
10329828|NCT00307034|11465189|FG000|STARTED|Overall Study||175
10329829|NCT00307034|11465190|FG001|STARTED|Overall Study||176
10329830|NCT00307034|11465189|FG000|COMPLETED|Overall Study||173
10329831|NCT00307034|11465190|FG001|COMPLETED|Overall Study||169
10329832|NCT00307034|11465189|FG000|NOT COMPLETED|Overall Study||2
10329833|NCT00307034|11465190|FG001|NOT COMPLETED|Overall Study||7
10329834|NCT00307047|11465198|FG000|STARTED|Overall Study||2458
10329835|NCT00307047|11465199|FG001|STARTED|Overall Study||1229
10329836|NCT00307047|11465198|FG000|COMPLETED|Overall Study||2389
10329837|NCT00307047|11465199|FG001|COMPLETED|Overall Study||1180
10329838|NCT00307047|11465198|FG000|NOT COMPLETED|Overall Study||69
10329839|NCT00307047|11465199|FG001|NOT COMPLETED|Overall Study||49
10329840|NCT00307086|11465205|FG000|STARTED|Overall Study||30
10329841|NCT00307086|11465205|FG000|COMPLETED|Overall Study||25
10329842|NCT00307086|11465205|FG000|NOT COMPLETED|Overall Study||5
10329843|NCT00307125|11465211|FG000|STARTED|Screening Phase||757
10329844|NCT00307125|11465212|FG001|STARTED|Screening Phase||0
10329845|NCT00307125|11465213|FG002|STARTED|Screening Phase||0
10329846|NCT00307125|11465211|FG000|COMPLETED|Screening Phase||303
10329847|NCT00307125|11465212|FG001|COMPLETED|Screening Phase||0
10329848|NCT00307125|11465213|FG002|COMPLETED|Screening Phase||0
10329849|NCT00307125|11465211|FG000|NOT COMPLETED|Screening Phase||454
10329850|NCT00307125|11465212|FG001|NOT COMPLETED|Screening Phase||0
10329851|NCT00307125|11465213|FG002|NOT COMPLETED|Screening Phase||0
10329852|NCT00307125|11465211|FG000|STARTED|Pilot Phase||0
10329853|NCT00307125|11465212|FG001|STARTED|Pilot Phase||15
10329854|NCT00307125|11465213|FG002|STARTED|Pilot Phase||7
10329855|NCT00307125|11465211|FG000|COMPLETED|Pilot Phase||0
10329856|NCT00307125|11465212|FG001|COMPLETED|Pilot Phase|2 participants had reduced follow-up|13
10329857|NCT00307125|11465213|FG002|COMPLETED|Pilot Phase|1 participant had reduced follow-up|6
10329858|NCT00307125|11465211|FG000|NOT COMPLETED|Pilot Phase||0
10329859|NCT00307125|11465212|FG001|NOT COMPLETED|Pilot Phase||2
10329860|NCT00307125|11465213|FG002|NOT COMPLETED|Pilot Phase||1
10329861|NCT00307151|11465227|FG000|STARTED|Overall Study||82
10329862|NCT00307151|11465228|FG001|STARTED|Overall Study||82
10329863|NCT00307151|11465229|FG002|STARTED|Overall Study||147
10701986|NCT02572609|11866509|FG001|NOT COMPLETED|Period 2: Treatment Period 2||0
10701987|NCT02572752|11866518|FG000|STARTED|Period 1 Including Washout||23
10701988|NCT02572752|11866519|FG001|STARTED|Period 1 Including Washout||23
10701989|NCT02572752|11866520|FG002|STARTED|Period 1 Including Washout||24
10701990|NCT02572752|11866518|FG000|COMPLETED|Period 1 Including Washout||23
10701991|NCT02572752|11866519|FG001|COMPLETED|Period 1 Including Washout||23
10329864|NCT00307151|11465230|FG003|STARTED|Overall Study|One participant never started treatment, were not followed and not included in analysis.|140
10329903|NCT00307437|11465267|FG001|NOT COMPLETED|Controlled Period||6
10329865|NCT00307151|11465227|FG000|COMPLETED|Overall Study|Results are through date DSMB closed Cohort I to accrual (April 20, 2009)|71
10329866|NCT00307151|11465228|FG001|COMPLETED|Overall Study|Results are through date DSMB closed Cohort I to accrual (April 20, 2009)|75
10329867|NCT00307151|11465229|FG002|COMPLETED|Overall Study|Results are through date DSMB recommended Cohort II results be unblinded (October 27, 2010)|127
10329868|NCT00307151|11465230|FG003|COMPLETED|Overall Study|Results are through date DSMB recommended Cohort II results be unblinded (October 27, 2010)|129
10329869|NCT00307151|11465227|FG000|NOT COMPLETED|Overall Study||11
10329870|NCT00307151|11465228|FG001|NOT COMPLETED|Overall Study||7
10805188|NCT04027218|11966732|FG000|STARTED|Overall Study||10
10329871|NCT00307151|11465229|FG002|NOT COMPLETED|Overall Study||20
10329872|NCT00307151|11465230|FG003|NOT COMPLETED|Overall Study||11
10329873|NCT00307164|11465242|FG000|STARTED|Overall Study||83
10329874|NCT00307164|11465243|FG001|STARTED|Overall Study||82
10329875|NCT00307164|11465242|FG000|COMPLETED|Overall Study||68
10329876|NCT00307164|11465243|FG001|COMPLETED|Overall Study||68
10329877|NCT00307164|11465242|FG000|NOT COMPLETED|Overall Study||15
10329878|NCT00307164|11465243|FG001|NOT COMPLETED|Overall Study||14
10701992|NCT02572752|11866520|FG002|COMPLETED|Period 1 Including Washout||24
10701993|NCT02572752|11866518|FG000|NOT COMPLETED|Period 1 Including Washout||0
10701994|NCT02572752|11866519|FG001|NOT COMPLETED|Period 1 Including Washout||0
10701995|NCT02572752|11866520|FG002|NOT COMPLETED|Period 1 Including Washout||0
10805189|NCT04027218|11966733|FG001|STARTED|Overall Study||11
10805190|NCT04027218|11966734|FG002|STARTED|Overall Study||9
10805191|NCT04027218|11966735|FG003|STARTED|Overall Study||11
10329879|NCT00307294|11465249|FG000|STARTED|Overall Study||40
10329880|NCT00307294|11465249|FG000|COMPLETED|Overall Study||39
10329881|NCT00307294|11465249|FG000|NOT COMPLETED|Overall Study||1
10701996|NCT02572752|11866518|FG000|STARTED|Period 2 Including Washout||23
10805192|NCT04027218|11966736|FG004|STARTED|Overall Study||10
10805193|NCT04027218|11966737|FG005|STARTED|Overall Study||11
10805194|NCT04027218|11966732|FG000|COMPLETED|Overall Study||10
10805195|NCT04027218|11966733|FG001|COMPLETED|Overall Study||8
10329882|NCT00307333|11465256|FG000|STARTED|Overall Study||1511
10329883|NCT00307333|11465257|FG001|STARTED|Overall Study||1492
10329884|NCT00307333|11465256|FG000|COMPLETED|Overall Study||1500
10329885|NCT00307333|11465257|FG001|COMPLETED|Overall Study||1489
10329886|NCT00307333|11465256|FG000|NOT COMPLETED|Overall Study||11
10329887|NCT00307333|11465257|FG001|NOT COMPLETED|Overall Study||3
10701997|NCT02572752|11866519|FG001|STARTED|Period 2 Including Washout||23
10701998|NCT02572752|11866520|FG002|STARTED|Period 2 Including Washout||24
10805196|NCT04027218|11966734|FG002|COMPLETED|Overall Study||9
10329888|NCT00307437|11465266|FG000|STARTED|Controlled Period||410
10329889|NCT00307437|11465267|FG001|STARTED|Controlled Period||409
10329890|NCT00307437|11465268|FG002|STARTED|Controlled Period||411
10329891|NCT00307437|11465269|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
10329892|NCT00307437|11465270|FG004|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
10329893|NCT00307437|11465271|FG005|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
10329894|NCT00307437|11465272|FG006|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
10329895|NCT00307437|11465266|FG000|COMPLETED|Controlled Period||394
10329896|NCT00307437|11465267|FG001|COMPLETED|Controlled Period||403
10329897|NCT00307437|11465268|FG002|COMPLETED|Controlled Period||402
10329898|NCT00307437|11465269|FG003|COMPLETED|Controlled Period||0
10329899|NCT00307437|11465270|FG004|COMPLETED|Controlled Period||0
10329900|NCT00307437|11465271|FG005|COMPLETED|Controlled Period||0
10329901|NCT00307437|11465272|FG006|COMPLETED|Controlled Period||0
10329902|NCT00307437|11465266|FG000|NOT COMPLETED|Controlled Period||16
10329904|NCT00307437|11465268|FG002|NOT COMPLETED|Controlled Period||9
10329905|NCT00307437|11465269|FG003|NOT COMPLETED|Controlled Period||0
10329906|NCT00307437|11465270|FG004|NOT COMPLETED|Controlled Period||0
10329907|NCT00307437|11465271|FG005|NOT COMPLETED|Controlled Period||0
10329908|NCT00307437|11465272|FG006|NOT COMPLETED|Controlled Period||0
10329909|NCT00307437|11465266|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
10329910|NCT00307437|11465267|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
10329911|NCT00307437|11465268|FG002|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
10329912|NCT00307437|11465269|FG003|STARTED|After Controlled Period||197
10329913|NCT00307437|11465270|FG004|STARTED|After Controlled Period|2 participants from placebo group in CP did not crossover to this group after CP.|195
10329914|NCT00307437|11465271|FG005|STARTED|After Controlled Period||403
10329915|NCT00307437|11465272|FG006|STARTED|After Controlled Period||402
10329916|NCT00307437|11465266|FG000|COMPLETED|After Controlled Period||0
10329917|NCT00307437|11465267|FG001|COMPLETED|After Controlled Period||0
10329918|NCT00307437|11465268|FG002|COMPLETED|After Controlled Period||0
10329919|NCT00307437|11465269|FG003|COMPLETED|After Controlled Period||139
10329920|NCT00307437|11465270|FG004|COMPLETED|After Controlled Period||140
10329921|NCT00307437|11465271|FG005|COMPLETED|After Controlled Period||281
10329922|NCT00307437|11465272|FG006|COMPLETED|After Controlled Period||289
10329923|NCT00307437|11465266|FG000|NOT COMPLETED|After Controlled Period||0
10329924|NCT00307437|11465267|FG001|NOT COMPLETED|After Controlled Period||0
10329925|NCT00307437|11465268|FG002|NOT COMPLETED|After Controlled Period||0
10329926|NCT00307437|11465269|FG003|NOT COMPLETED|After Controlled Period||58
10329927|NCT00307437|11465270|FG004|NOT COMPLETED|After Controlled Period||55
10329928|NCT00307437|11465271|FG005|NOT COMPLETED|After Controlled Period||122
10329929|NCT00307437|11465272|FG006|NOT COMPLETED|After Controlled Period||113
10329930|NCT00307489|11465296|FG000|STARTED|Baseline Through Week 48||53
10329931|NCT00307489|11465297|FG001|STARTED|Baseline Through Week 48||52
10329932|NCT00307489|11465296|FG000|COMPLETED|Baseline Through Week 48|16 of the 52 subjects switched to open-label FTC/TDF prior to Week 48.|52
10329933|NCT00307489|11465297|FG001|COMPLETED|Baseline Through Week 48|9 of the 50 subjects switched to open-label FTC/TDF prior to Week 48.|50
10329934|NCT00307489|11465296|FG000|NOT COMPLETED|Baseline Through Week 48||1
10329935|NCT00307489|11465297|FG001|NOT COMPLETED|Baseline Through Week 48||2
10329936|NCT00307489|11465296|FG000|STARTED|Week 48 Through Week 168||52
10329937|NCT00307489|11465297|FG001|STARTED|Week 48 Through Week 168||50
10701999|NCT02572752|11866518|FG000|COMPLETED|Period 2 Including Washout||23
10702000|NCT02572752|11866519|FG001|COMPLETED|Period 2 Including Washout||23
10805197|NCT04027218|11966735|FG003|COMPLETED|Overall Study||11
10805198|NCT04027218|11966736|FG004|COMPLETED|Overall Study||10
10805199|NCT04027218|11966737|FG005|COMPLETED|Overall Study||11
10329938|NCT00307489|11465296|FG000|COMPLETED|Week 48 Through Week 168|11 of the 46 subjects switched to open-label FTC/TDF prior to Week 168.|46
10329939|NCT00307489|11465297|FG001|COMPLETED|Week 48 Through Week 168|5 of the 44 subjects switched to open-label FTC/TDF prior to Week 168.|44
10329940|NCT00307489|11465296|FG000|NOT COMPLETED|Week 48 Through Week 168||6
10329941|NCT00307489|11465297|FG001|NOT COMPLETED|Week 48 Through Week 168||6
10329942|NCT00307684|11465303|FG000|STARTED|Open Label Phase||0
10329943|NCT00307684|11465304|FG001|STARTED|Open Label Phase||0
10329944|NCT00307684|11465305|FG002|STARTED|Open Label Phase|1 screening failure|155
10329945|NCT00307684|11465303|FG000|COMPLETED|Open Label Phase||0
10329946|NCT00307684|11465304|FG001|COMPLETED|Open Label Phase||0
10329947|NCT00307684|11465305|FG002|COMPLETED|Open Label Phase||99
10329948|NCT00307684|11465303|FG000|NOT COMPLETED|Open Label Phase||0
10329949|NCT00307684|11465304|FG001|NOT COMPLETED|Open Label Phase||0
10702001|NCT02572752|11866520|FG002|COMPLETED|Period 2 Including Washout||24
10329950|NCT00307684|11465305|FG002|NOT COMPLETED|Open Label Phase||56
10329951|NCT00307684|11465303|FG000|STARTED|Double Blind Phase||23
10329952|NCT00307684|11465304|FG001|STARTED|Double Blind Phase||22
10329953|NCT00307684|11465305|FG002|STARTED|Double Blind Phase||0
10329954|NCT00307684|11465303|FG000|COMPLETED|Double Blind Phase||21
10329955|NCT00307684|11465304|FG001|COMPLETED|Double Blind Phase||17
10329956|NCT00307684|11465305|FG002|COMPLETED|Double Blind Phase||0
10329957|NCT00307684|11465303|FG000|NOT COMPLETED|Double Blind Phase||2
10329958|NCT00307684|11465304|FG001|NOT COMPLETED|Double Blind Phase||5
10329959|NCT00307684|11465305|FG002|NOT COMPLETED|Double Blind Phase||0
10329960|NCT00307736|11465313|FG000|STARTED|Overall Study||3
10329961|NCT00307736|11465314|FG001|STARTED|Overall Study||3
10329962|NCT00307736|11465315|FG002|STARTED|Overall Study||3
10329963|NCT00307736|11465316|FG003|STARTED|Overall Study||23
10329964|NCT00307736|11465313|FG000|COMPLETED|Overall Study||3
10329965|NCT00307736|11465314|FG001|COMPLETED|Overall Study||3
10329966|NCT00307736|11465315|FG002|COMPLETED|Overall Study||0
10329967|NCT00307736|11465316|FG003|COMPLETED|Overall Study||20
10329968|NCT00307736|11465313|FG000|NOT COMPLETED|Overall Study||0
10329969|NCT00307736|11465314|FG001|NOT COMPLETED|Overall Study||0
10329970|NCT00307736|11465315|FG002|NOT COMPLETED|Overall Study||3
10329971|NCT00307736|11465316|FG003|NOT COMPLETED|Overall Study||3
10329972|NCT00307801|11465329|FG000|STARTED|Overall Study||149
10329973|NCT00307801|11465330|FG001|STARTED|Overall Study||82
10329974|NCT00307801|11465329|FG000|Subjects Received Treatment|Overall Study||145
10329975|NCT00307801|11465330|FG001|Subjects Received Treatment|Overall Study||81
10805200|NCT04027218|11966732|FG000|NOT COMPLETED|Overall Study||0
10805201|NCT04027218|11966733|FG001|NOT COMPLETED|Overall Study||3
10805202|NCT04027218|11966734|FG002|NOT COMPLETED|Overall Study||0
10329976|NCT00307801|11465329|FG000|Cycle 1, Visit 5, Baseline|Overall Study||145
10329977|NCT00307801|11465330|FG001|Cycle 1, Visit 5, Baseline|Overall Study||81
10329978|NCT00307801|11465329|FG000|Cycle 3, Visit 7, Treatment Day 84|Overall Study||130
10329979|NCT00307801|11465330|FG001|Cycle 3, Visit 7, Treatment Day 84|Overall Study||71
10329980|NCT00307801|11465329|FG000|Cycle 7, Treatment Day 196|Overall Study|Includes subjects that prematurely discontinued the study and may not be counted in earlier visits.|141
10329981|NCT00307801|11465330|FG001|Cycle 7, Treatment Day 196|Overall Study|Includes subjects that prematurely discontinued the study and may not be counted in earlier visits.|77
10329982|NCT00307801|11465329|FG000|COMPLETED|Overall Study||117
10329983|NCT00307801|11465330|FG001|COMPLETED|Overall Study||65
10329984|NCT00307801|11465329|FG000|NOT COMPLETED|Overall Study||32
10329985|NCT00307801|11465330|FG001|NOT COMPLETED|Overall Study||17
10329986|NCT00307931|11465337|FG000|STARTED|Overall Study|Number of subjects who entered the study and have been treated|16
10329987|NCT00307931|11465337|FG000|COMPLETED|Overall Study|Number of subjects who completed the Week 12 visit|15
10329988|NCT00307931|11465337|FG000|NOT COMPLETED|Overall Study||1
10329989|NCT00308061|11465343|FG000|STARTED|Overall Study||20
10329990|NCT00308061|11465344|FG001|STARTED|Overall Study||20
10329991|NCT00308061|11465343|FG000|COMPLETED|Overall Study||20
10329992|NCT00308061|11465344|FG001|COMPLETED|Overall Study||20
10329993|NCT00308061|11465343|FG000|NOT COMPLETED|Overall Study||0
10329994|NCT00308061|11465344|FG001|NOT COMPLETED|Overall Study||0
10329995|NCT00308074|11465351|FG000|STARTED|Overall Study||14
10329996|NCT00308074|11465351|FG000|COMPLETED|Overall Study||13
10329997|NCT00308074|11465351|FG000|NOT COMPLETED|Overall Study||1
10329998|NCT00308087|11465357|FG000|STARTED|Overall Study||37
10329999|NCT00308087|11465358|FG001|STARTED|Overall Study||38
10805203|NCT04027218|11966735|FG003|NOT COMPLETED|Overall Study||0
10330000|NCT00308087|11465357|FG000|COMPLETED|Overall Study|Completers finished treatment and the 24 month follow-up.|1
10330001|NCT00308087|11465358|FG001|COMPLETED|Overall Study|Completers finished treatment and the 24 month follow-up.|1
10330002|NCT00308087|11465357|FG000|NOT COMPLETED|Overall Study||36
10330003|NCT00308087|11465358|FG001|NOT COMPLETED|Overall Study||37
10330004|NCT00308139|11465366|FG000|STARTED|Overall Study||152
10330005|NCT00308139|11465367|FG001|STARTED|Overall Study||151
10330006|NCT00308139|11465366|FG000|Intent to Treat (ITT)|Overall Study|Subjects who received at least one injection of lead-in exenatide 5 mcg.|148
10330007|NCT00308139|11465367|FG001|Intent to Treat (ITT)|Overall Study|Subjects who received at least one injection of lead-in exenatide 5 mcg.|147
10330008|NCT00308139|11465366|FG000|ITT in the 30-Week Assessment|Overall Study|ITT Subjects who received at least one injection of randomized dose.|148
10330009|NCT00308139|11465367|FG001|ITT in the 30-Week Assessment|Overall Study|ITT Subjects who received at least one injection of randomized dose.|145
10330010|NCT00308139|11465366|FG000|Pharmacokinetics Population|Overall Study||129
10330011|NCT00308139|11465367|FG001|Pharmacokinetics Population|Overall Study||0
10330012|NCT00308139|11465366|FG000|Evaluable Meal Tolerance Cohort|Overall Study||27
10330013|NCT00308139|11465367|FG001|Evaluable Meal Tolerance Cohort|Overall Study||24
10330014|NCT00308139|11465366|FG000|30-Week Completed|Overall Study|Subjects who completed 30 weeks of assessment|128
10330015|NCT00308139|11465367|FG001|30-Week Completed|Overall Study|Subjects who completed 30 weeks of assessment|130
10330016|NCT00308139|11465366|FG000|COMPLETED|Overall Study|Subjects who completed 364 weeks of assessment|58
10805204|NCT04027218|11966736|FG004|NOT COMPLETED|Overall Study||0
10330017|NCT00308139|11465367|FG001|COMPLETED|Overall Study|Subjects who completed 364 weeks of assessment|64
10330018|NCT00308139|11465366|FG000|NOT COMPLETED|Overall Study||94
10330019|NCT00308139|11465367|FG001|NOT COMPLETED|Overall Study||87
10330020|NCT00308230|11465396|FG000|STARTED|Overall Study||6
10330021|NCT00308230|11465397|FG001|STARTED|Overall Study||8
10330022|NCT00308230|11465398|FG002|STARTED|Overall Study||20
10330023|NCT00308230|11465396|FG000|COMPLETED|Overall Study||6
10330024|NCT00308230|11465397|FG001|COMPLETED|Overall Study||8
10330025|NCT00308230|11465398|FG002|COMPLETED|Overall Study||20
10330026|NCT00308230|11465396|FG000|NOT COMPLETED|Overall Study||0
10330027|NCT00308230|11465397|FG001|NOT COMPLETED|Overall Study||0
10330028|NCT00308230|11465398|FG002|NOT COMPLETED|Overall Study||0
10330029|NCT00308282|11465410|FG000|STARTED|Overall Study||34
10330030|NCT00308282|11465411|FG001|STARTED|Overall Study||34
10330031|NCT00308282|11465412|FG002|STARTED|Overall Study||34
10330032|NCT00308282|11465413|FG003|STARTED|Overall Study||34
10330033|NCT00308282|11465410|FG000|Received at Least One Dose of Study Drug|Overall Study||34
10330034|NCT00308282|11465411|FG001|Received at Least One Dose of Study Drug|Overall Study||34
10330035|NCT00308282|11465412|FG002|Received at Least One Dose of Study Drug|Overall Study||34
10330036|NCT00308282|11465413|FG003|Received at Least One Dose of Study Drug|Overall Study||34
10702002|NCT02572752|11866518|FG000|NOT COMPLETED|Period 2 Including Washout||0
10702003|NCT02572752|11866519|FG001|NOT COMPLETED|Period 2 Including Washout||0
10330037|NCT00308282|11465410|FG000|COMPLETED|Overall Study||31
10330038|NCT00308282|11465411|FG001|COMPLETED|Overall Study||30
10330039|NCT00308282|11465412|FG002|COMPLETED|Overall Study||33
10330040|NCT00308282|11465413|FG003|COMPLETED|Overall Study||32
10330041|NCT00308282|11465410|FG000|NOT COMPLETED|Overall Study||3
10330042|NCT00308282|11465411|FG001|NOT COMPLETED|Overall Study||4
10330043|NCT00308282|11465412|FG002|NOT COMPLETED|Overall Study||1
10330044|NCT00308282|11465413|FG003|NOT COMPLETED|Overall Study||2
10330045|NCT00308308|11465428|FG000|STARTED|Overall Study||301
10330046|NCT00308308|11465429|FG001|STARTED|Overall Study||288
10330047|NCT00308308|11465428|FG000|COMPLETED|Overall Study||198
10330048|NCT00308308|11465429|FG001|COMPLETED|Overall Study||220
10330049|NCT00308308|11465428|FG000|NOT COMPLETED|Overall Study||103
10330050|NCT00308308|11465429|FG001|NOT COMPLETED|Overall Study||68
10330051|NCT00308555|11465437|FG000|STARTED|Overall Study||13
10330052|NCT00308555|11465438|FG001|STARTED|Overall Study||11
10330053|NCT00308555|11465437|FG000|COMPLETED|Overall Study||10
10330054|NCT00308555|11465438|FG001|COMPLETED|Overall Study||11
10330055|NCT00308555|11465437|FG000|NOT COMPLETED|Overall Study||3
10330056|NCT00308555|11465438|FG001|NOT COMPLETED|Overall Study||0
10330057|NCT00308581|11465444|FG000|STARTED|Induction Phase|Not applicable in this period|0
10330058|NCT00308581|11465445|FG001|STARTED|Induction Phase|Not applicable in this period|0
10330059|NCT00308581|11465446|FG002|STARTED|Induction Phase||539
10330060|NCT00308581|11465444|FG000|COMPLETED|Induction Phase|Not applicable in this period|0
10330061|NCT00308581|11465445|FG001|COMPLETED|Induction Phase|Not applicable in this period|0
10330062|NCT00308581|11465446|FG002|COMPLETED|Induction Phase||373
10330063|NCT00308581|11465444|FG000|NOT COMPLETED|Induction Phase||0
10330064|NCT00308581|11465445|FG001|NOT COMPLETED|Induction Phase||0
10330065|NCT00308581|11465446|FG002|NOT COMPLETED|Induction Phase||166
10330066|NCT00308581|11465444|FG000|STARTED|Randomized Maintenance Phase||187
10330067|NCT00308581|11465445|FG001|STARTED|Randomized Maintenance Phase||186
10330068|NCT00308581|11465446|FG002|STARTED|Randomized Maintenance Phase||0
10330069|NCT00308581|11465444|FG000|COMPLETED|Randomized Maintenance Phase||82
10330070|NCT00308581|11465445|FG001|COMPLETED|Randomized Maintenance Phase||83
10330071|NCT00308581|11465446|FG002|COMPLETED|Randomized Maintenance Phase||0
10330072|NCT00308581|11465444|FG000|NOT COMPLETED|Randomized Maintenance Phase||105
10330073|NCT00308581|11465445|FG001|NOT COMPLETED|Randomized Maintenance Phase||103
10330074|NCT00308581|11465446|FG002|NOT COMPLETED|Randomized Maintenance Phase||0
10330075|NCT00308620|11465457|FG000|STARTED|Overall Study||3
10330076|NCT00308620|11465458|FG001|STARTED|Overall Study||4
10330077|NCT00308620|11465459|FG002|STARTED|Overall Study||6
10330078|NCT00308620|11465457|FG000|COMPLETED|Overall Study||2
10330079|NCT00308620|11465458|FG001|COMPLETED|Overall Study||3
10330080|NCT00308620|11465459|FG002|COMPLETED|Overall Study||5
10330081|NCT00308620|11465457|FG000|NOT COMPLETED|Overall Study||1
10330082|NCT00308620|11465458|FG001|NOT COMPLETED|Overall Study||1
10330083|NCT00308620|11465459|FG002|NOT COMPLETED|Overall Study||1
10330084|NCT00308711|11465470|FG000|STARTED|Overall Study||428
10330085|NCT00308711|11465471|FG001|STARTED|Overall Study||444
10330086|NCT00308711|11465472|FG002|STARTED|Overall Study||436
10330087|NCT00308711|11465470|FG000|COMPLETED|Overall Study||426
10330088|NCT00308711|11465471|FG001|COMPLETED|Overall Study||440
10330089|NCT00308711|11465472|FG002|COMPLETED|Overall Study||431
10330090|NCT00308711|11465470|FG000|NOT COMPLETED|Overall Study||2
10330091|NCT00308711|11465471|FG001|NOT COMPLETED|Overall Study||4
10330092|NCT00308711|11465472|FG002|NOT COMPLETED|Overall Study||5
10330093|NCT00308737|11465483|FG000|STARTED|Overall Study||938
10330094|NCT00308737|11465484|FG001|STARTED|Overall Study||951
10330095|NCT00308737|11465485|FG002|STARTED|Overall Study||164
10330096|NCT00308737|11465483|FG000|COMPLETED|Overall Study||475
10330097|NCT00308737|11465484|FG001|COMPLETED|Overall Study||662
10330098|NCT00308737|11465485|FG002|COMPLETED|Overall Study||127
10330099|NCT00308737|11465483|FG000|NOT COMPLETED|Overall Study||463
10330100|NCT00308737|11465484|FG001|NOT COMPLETED|Overall Study||289
10330101|NCT00308737|11465485|FG002|NOT COMPLETED|Overall Study||37
10338860|NCT02038777|11475788|FG002|Treated (Safety Set)|Overall Study||6
10338861|NCT02038777|11475789|FG003|Treated (Safety Set)|Overall Study||6
10338862|NCT02038777|11475790|FG004|Treated (Safety Set)|Overall Study||6
10338863|NCT02038777|11475791|FG005|Treated (Safety Set)|Overall Study||6
10338864|NCT02038777|11475792|FG006|Treated (Safety Set)|Overall Study||1
10338865|NCT02038777|11475793|FG007|Treated (Safety Set)|Overall Study||15
10338866|NCT02038777|11475786|FG000|COMPLETED|Overall Study||2
10330102|NCT00308750|11465496|FG000|STARTED|Overall Study||72
10330103|NCT00308750|11465497|FG001|STARTED|Overall Study||74
10330104|NCT00308750|11465498|FG002|STARTED|Overall Study||72
10330105|NCT00308750|11465496|FG000|Received at Least 1 Dose of Study Drug|Overall Study||67
10330106|NCT00308750|11465497|FG001|Received at Least 1 Dose of Study Drug|Overall Study||72
10330107|NCT00308750|11465498|FG002|Received at Least 1 Dose of Study Drug|Overall Study||70
10330108|NCT00308750|11465496|FG000|COMPLETED|Overall Study||0
10330109|NCT00308750|11465497|FG001|COMPLETED|Overall Study||34
10330110|NCT00308750|11465498|FG002|COMPLETED|Overall Study||23
10330111|NCT00308750|11465496|FG000|NOT COMPLETED|Overall Study||72
10330112|NCT00308750|11465497|FG001|NOT COMPLETED|Overall Study||40
10330113|NCT00308750|11465498|FG002|NOT COMPLETED|Overall Study||49
10330114|NCT00308997|11465509|FG000|STARTED|Overall Study||56
10330115|NCT00308997|11465510|FG001|STARTED|Overall Study||29
10330116|NCT00308997|11465509|FG000|COMPLETED|Overall Study||55
10330117|NCT00308997|11465510|FG001|COMPLETED|Overall Study||28
10330118|NCT00308997|11465509|FG000|NOT COMPLETED|Overall Study||1
10330119|NCT00308997|11465510|FG001|NOT COMPLETED|Overall Study||1
10330120|NCT00309140|11465516|FG000|STARTED|Overall Study||23
10330121|NCT00309140|11465516|FG000|Received at Least 1 Dose of Study Drug|Overall Study||23
10330122|NCT00309140|11465516|FG000|COMPLETED|Overall Study||23
10330123|NCT00309140|11465516|FG000|NOT COMPLETED|Overall Study||0
10330124|NCT00309166|11465522|FG000|STARTED|Overall Study||181
10330125|NCT00309166|11465523|FG001|STARTED|Overall Study||89
10330126|NCT00309166|11465522|FG000|COMPLETED|Overall Study||176
10330127|NCT00309166|11465523|FG001|COMPLETED|Overall Study||86
10330128|NCT00309166|11465522|FG000|NOT COMPLETED|Overall Study||5
10330129|NCT00309166|11465523|FG001|NOT COMPLETED|Overall Study||3
10330130|NCT00309244|11465531|FG000|STARTED|Overall Study||334
10330131|NCT00309244|11465532|FG001|STARTED|Overall Study||343
10330132|NCT00309244|11465531|FG000|COMPLETED|Overall Study||216
10330133|NCT00309244|11465532|FG001|COMPLETED|Overall Study||246
10330134|NCT00309244|11465531|FG000|NOT COMPLETED|Overall Study||118
10330135|NCT00309244|11465532|FG001|NOT COMPLETED|Overall Study||97
10330136|NCT00309387|11465540|FG000|STARTED|Overall Study||510
10330137|NCT00309387|11465541|FG001|STARTED|Overall Study||510
10330138|NCT00309387|11465540|FG000|COMPLETED|Overall Study||368
10330139|NCT00309387|11465541|FG001|COMPLETED|Overall Study||351
10330140|NCT00309387|11465540|FG000|NOT COMPLETED|Overall Study||142
10330141|NCT00309387|11465541|FG001|NOT COMPLETED|Overall Study||159
10330142|NCT00309452|11465550|FG000|STARTED|Overall Study||60
10330143|NCT00309452|11465551|FG001|STARTED|Overall Study||60
10330144|NCT00309452|11465550|FG000|COMPLETED|Overall Study||57
10330145|NCT00309452|11465551|FG001|COMPLETED|Overall Study||60
10330146|NCT00309452|11465550|FG000|NOT COMPLETED|Overall Study||3
10330147|NCT00309452|11465551|FG001|NOT COMPLETED|Overall Study||0
10330148|NCT00309465|11465563|FG000|STARTED|Overall Study||58
10330149|NCT00309465|11465564|FG001|STARTED|Overall Study||58
10330150|NCT00309465|11465565|FG002|STARTED|Overall Study||58
10330151|NCT00309465|11465566|FG003|STARTED|Overall Study||76
10330152|NCT00309465|11465567|FG004|STARTED|Overall Study||76
10330153|NCT00309465|11465568|FG005|STARTED|Overall Study||76
10330154|NCT00309465|11465563|FG000|COMPLETED|Overall Study||58
10330155|NCT00309465|11465564|FG001|COMPLETED|Overall Study||58
10330156|NCT00309465|11465565|FG002|COMPLETED|Overall Study||58
10330157|NCT00309465|11465566|FG003|COMPLETED|Overall Study|One subject was excluded due to eligibility error.|75
10330158|NCT00309465|11465567|FG004|COMPLETED|Overall Study||76
10330159|NCT00309465|11465568|FG005|COMPLETED|Overall Study||76
10330160|NCT00309465|11465563|FG000|NOT COMPLETED|Overall Study||0
10330161|NCT00309465|11465564|FG001|NOT COMPLETED|Overall Study||0
10330162|NCT00309465|11465565|FG002|NOT COMPLETED|Overall Study||0
10330163|NCT00309465|11465566|FG003|NOT COMPLETED|Overall Study||1
10330164|NCT00309465|11465567|FG004|NOT COMPLETED|Overall Study||0
10330165|NCT00309465|11465568|FG005|NOT COMPLETED|Overall Study||0
10456607|NCT01007253|11604489|FG002|STARTED|Washout Period (2 Weeks) # 3||5
10456608|NCT01007253|11604490|FG003|STARTED|Washout Period (2 Weeks) # 3||5
10456609|NCT01007253|11604487|FG000|COMPLETED|Washout Period (2 Weeks) # 3||5
10456610|NCT01007253|11604488|FG001|COMPLETED|Washout Period (2 Weeks) # 3||5
10456611|NCT01007253|11604489|FG002|COMPLETED|Washout Period (2 Weeks) # 3||5
10456612|NCT01007253|11604490|FG003|COMPLETED|Washout Period (2 Weeks) # 3||5
10456613|NCT01007253|11604487|FG000|NOT COMPLETED|Washout Period (2 Weeks) # 3||1
10456614|NCT01007253|11604488|FG001|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
10456615|NCT01007253|11604489|FG002|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
10456616|NCT01007253|11604490|FG003|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
10330166|NCT00309608|11465587|FG000|STARTED|Overall Study||71
10330167|NCT00309608|11465588|FG001|STARTED|Overall Study||65
10330168|NCT00309608|11465589|FG002|STARTED|Overall Study||66
10330169|NCT00309608|11465590|FG003|STARTED|Overall Study||66
10330170|NCT00309608|11465591|FG004|STARTED|Overall Study||65
10330171|NCT00309608|11465587|FG000|COMPLETED|Overall Study||57
10330172|NCT00309608|11465588|FG001|COMPLETED|Overall Study||52
10330173|NCT00309608|11465589|FG002|COMPLETED|Overall Study||56
10330174|NCT00309608|11465590|FG003|COMPLETED|Overall Study||60
10330175|NCT00309608|11465591|FG004|COMPLETED|Overall Study||61
10330176|NCT00309608|11465587|FG000|NOT COMPLETED|Overall Study||14
10330177|NCT00309608|11465588|FG001|NOT COMPLETED|Overall Study||13
10330178|NCT00309608|11465589|FG002|NOT COMPLETED|Overall Study||10
10330179|NCT00309608|11465590|FG003|NOT COMPLETED|Overall Study||6
10330180|NCT00309608|11465591|FG004|NOT COMPLETED|Overall Study||4
10330181|NCT00309738|11465605|FG000|STARTED|Overall Study||236
10330182|NCT00309738|11465606|FG001|STARTED|Overall Study||119
10330183|NCT00309738|11465605|FG000|Safety Population|Overall Study|Subjects who received at least one dose of study medication|233
10330184|NCT00309738|11465606|FG001|Safety Population|Overall Study|Subjects who received at least one dose of study medication|119
10330185|NCT00309738|11465605|FG000|COMPLETED|Overall Study||223
10330186|NCT00309738|11465606|FG001|COMPLETED|Overall Study||107
10330187|NCT00309738|11465605|FG000|NOT COMPLETED|Overall Study||13
10330188|NCT00309738|11465606|FG001|NOT COMPLETED|Overall Study||12
10330189|NCT00309751|11465614|FG000|STARTED|Overall Study||279
10330190|NCT00309751|11465615|FG001|STARTED|Overall Study||139
10330191|NCT00309751|11465614|FG000|Safety Population|Overall Study|Subjects who received at least 1 dose of study drug|275
10330192|NCT00309751|11465615|FG001|Safety Population|Overall Study|Subjects who received at least 1 dose of study drug|137
10330193|NCT00309751|11465614|FG000|COMPLETED|Overall Study||248
10574673|NCT01680016|11729929|FG000|STARTED|Overall Study||121
10574674|NCT01680016|11729930|FG001|STARTED|Overall Study||122
10574675|NCT01680016|11729931|FG002|STARTED|Overall Study||201
10574676|NCT01680016|11729932|FG003|STARTED|Overall Study||200
10574677|NCT01680016|11729929|FG000|COMPLETED|Overall Study||115
10330194|NCT00309751|11465615|FG001|COMPLETED|Overall Study||124
10330195|NCT00309751|11465614|FG000|NOT COMPLETED|Overall Study||31
10330196|NCT00309751|11465615|FG001|NOT COMPLETED|Overall Study||15
10330197|NCT00309777|11465625|FG000|STARTED|Overall Study||315
10330198|NCT00309777|11465626|FG001|STARTED|Overall Study||108
10330199|NCT00309777|11465627|FG002|STARTED|Overall Study||323
10330200|NCT00309777|11465628|FG003|STARTED|Overall Study||111
10330201|NCT00309777|11465625|FG000|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|311
10330202|NCT00309777|11465626|FG001|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|107
10330203|NCT00309777|11465627|FG002|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|320
10330204|NCT00309777|11465628|FG003|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|110
10330205|NCT00309777|11465625|FG000|COMPLETED|Overall Study||292
10330206|NCT00309777|11465626|FG001|COMPLETED|Overall Study||99
10330207|NCT00309777|11465627|FG002|COMPLETED|Overall Study||304
10330208|NCT00309777|11465628|FG003|COMPLETED|Overall Study||107
10330209|NCT00309777|11465625|FG000|NOT COMPLETED|Overall Study||23
10330210|NCT00309777|11465626|FG001|NOT COMPLETED|Overall Study||9
10330211|NCT00309777|11465627|FG002|NOT COMPLETED|Overall Study||19
10330212|NCT00309777|11465628|FG003|NOT COMPLETED|Overall Study||4
10330213|NCT00309842|11465638|FG000|STARTED|Overall Study||213
10330214|NCT00309842|11465638|FG000|COMPLETED|Overall Study||212
10330215|NCT00309842|11465638|FG000|NOT COMPLETED|Overall Study||1
10330216|NCT00309907|11465642|FG000|STARTED|Overall Study||39
10330217|NCT00309907|11465642|FG000|COMPLETED|Overall Study||19
10330218|NCT00309907|11465642|FG000|NOT COMPLETED|Overall Study||20
10330219|NCT00309946|11465647|FG000|STARTED|Overall Study||51
10330220|NCT00309946|11465647|FG000|COMPLETED|Overall Study||50
10330221|NCT00309946|11465647|FG000|NOT COMPLETED|Overall Study||1
10330222|NCT00309959|11465651|FG000|STARTED|Overall Study||37
10330223|NCT00309959|11465651|FG000|COMPLETED|Overall Study||35
10330224|NCT00309959|11465651|FG000|NOT COMPLETED|Overall Study||2
10330225|NCT00310037|11465662|FG000|STARTED|Overall Study||52
10330226|NCT00310037|11465663|FG001|STARTED|Overall Study||50
10330227|NCT00310037|11465662|FG000|COMPLETED|Overall Study||34
10330228|NCT00310037|11465663|FG001|COMPLETED|Overall Study||33
10330229|NCT00310037|11465662|FG000|NOT COMPLETED|Overall Study||18
10330230|NCT00310037|11465663|FG001|NOT COMPLETED|Overall Study||17
10330231|NCT00310050|11465669|FG000|STARTED|Overall Study||4
10330232|NCT00310050|11465669|FG000|COMPLETED|Overall Study||3
10330233|NCT00310050|11465669|FG000|NOT COMPLETED|Overall Study||1
10330234|NCT00310076|11465673|FG000|STARTED|Overall Study||29
10330235|NCT00310076|11465673|FG000|COMPLETED|Overall Study||26
10330236|NCT00310076|11465673|FG000|NOT COMPLETED|Overall Study||3
10330237|NCT00310310|11465679|FG000|STARTED|Overall Study||120
10330238|NCT00310310|11465680|FG001|STARTED|Overall Study||120
10330239|NCT00310310|11465679|FG000|COMPLETED|Overall Study||90
10330240|NCT00310310|11465680|FG001|COMPLETED|Overall Study||100
10330241|NCT00310310|11465679|FG000|NOT COMPLETED|Overall Study||30
10330242|NCT00310310|11465680|FG001|NOT COMPLETED|Overall Study||20
10330243|NCT00310362|11465689|FG000|STARTED|Overall Study||1199
10330244|NCT00310362|11465690|FG001|STARTED|Overall Study||1205
10330245|NCT00310362|11465691|FG002|STARTED|Overall Study||1206
10330246|NCT00310362|11465689|FG000|COMPLETED|Overall Study||1199
10330247|NCT00310362|11465690|FG001|COMPLETED|Overall Study||1205
10330248|NCT00310362|11465691|FG002|COMPLETED|Overall Study||1206
10330249|NCT00310362|11465689|FG000|NOT COMPLETED|Overall Study||0
10330250|NCT00310362|11465690|FG001|NOT COMPLETED|Overall Study||0
10330251|NCT00310362|11465691|FG002|NOT COMPLETED|Overall Study||0
10330252|NCT00310375|11465707|FG000|STARTED|Primary Reporting Phase||102
10330253|NCT00310375|11465708|FG001|STARTED|Primary Reporting Phase||79
10330254|NCT00310375|11465709|FG002|STARTED|Primary Reporting Phase||0
10330255|NCT00310375|11465707|FG000|COMPLETED|Primary Reporting Phase||11
10330256|NCT00310375|11465708|FG001|COMPLETED|Primary Reporting Phase||11
10330257|NCT00310375|11465709|FG002|COMPLETED|Primary Reporting Phase||0
10330258|NCT00310375|11465707|FG000|NOT COMPLETED|Primary Reporting Phase||91
10574678|NCT01680016|11729930|FG001|COMPLETED|Overall Study||114
10330259|NCT00310375|11465708|FG001|NOT COMPLETED|Primary Reporting Phase||68
10330260|NCT00310375|11465709|FG002|NOT COMPLETED|Primary Reporting Phase||0
10574679|NCT01680016|11729931|FG002|COMPLETED|Overall Study||196
10330261|NCT00310375|11465707|FG000|STARTED|Safety Follow-up Continuation Phase||0
10330262|NCT00310375|11465708|FG001|STARTED|Safety Follow-up Continuation Phase||0
10330263|NCT00310375|11465709|FG002|STARTED|Safety Follow-up Continuation Phase||19
10330264|NCT00310375|11465707|FG000|COMPLETED|Safety Follow-up Continuation Phase||0
10330265|NCT00310375|11465708|FG001|COMPLETED|Safety Follow-up Continuation Phase||0
10330266|NCT00310375|11465709|FG002|COMPLETED|Safety Follow-up Continuation Phase|Met the protocol defined stopping criteria|18
10330267|NCT00310375|11465707|FG000|NOT COMPLETED|Safety Follow-up Continuation Phase||0
10330268|NCT00310375|11465708|FG001|NOT COMPLETED|Safety Follow-up Continuation Phase||0
10330269|NCT00310375|11465709|FG002|NOT COMPLETED|Safety Follow-up Continuation Phase||1
10330270|NCT00310401|11465720|FG000|STARTED|Overall Study||260
10330271|NCT00310401|11465721|FG001|STARTED|Overall Study||246
10330272|NCT00310401|11465720|FG000|COMPLETED|Overall Study||260
10330273|NCT00310401|11465721|FG001|COMPLETED|Overall Study||246
10330274|NCT00310401|11465720|FG000|NOT COMPLETED|Overall Study||0
10330275|NCT00310401|11465721|FG001|NOT COMPLETED|Overall Study||0
10330276|NCT00310427|11465731|FG000|STARTED|Overall Study||27
10330277|NCT00310427|11465732|FG001|STARTED|Overall Study||26
10330278|NCT00310427|11465731|FG000|COMPLETED|Overall Study||25
10330279|NCT00310427|11465732|FG001|COMPLETED|Overall Study||25
10330280|NCT00310427|11465731|FG000|NOT COMPLETED|Overall Study||2
10330281|NCT00310427|11465732|FG001|NOT COMPLETED|Overall Study||1
10330282|NCT00310440|11465740|FG000|STARTED|Overall Study||165
10330283|NCT00310440|11465741|FG001|STARTED|Overall Study||154
10330284|NCT00310440|11465740|FG000|COMPLETED|Overall Study||139
10330285|NCT00310440|11465741|FG001|COMPLETED|Overall Study||141
10330286|NCT00310440|11465740|FG000|NOT COMPLETED|Overall Study||26
10330287|NCT00310440|11465741|FG001|NOT COMPLETED|Overall Study||13
10330288|NCT00310466|11465749|FG000|STARTED|Overall Study||113
10330289|NCT00310466|11465750|FG001|STARTED|Overall Study||113
10330290|NCT00310466|11465749|FG000|COMPLETED|Overall Study||95
10330291|NCT00310466|11465750|FG001|COMPLETED|Overall Study||101
10330292|NCT00310466|11465749|FG000|NOT COMPLETED|Overall Study||18
10330293|NCT00310466|11465750|FG001|NOT COMPLETED|Overall Study||12
10330294|NCT00310791|11465758|FG000|STARTED|Overall Study||40
10330295|NCT00310791|11465759|FG001|STARTED|Overall Study||40
10330296|NCT00310791|11465758|FG000|COMPLETED|Overall Study||30
10330297|NCT00310791|11465759|FG001|COMPLETED|Overall Study||30
10330298|NCT00310791|11465758|FG000|NOT COMPLETED|Overall Study||10
10330299|NCT00310791|11465759|FG001|NOT COMPLETED|Overall Study||10
10330300|NCT00310804|11465767|FG000|STARTED|Overall Study||1029
10330301|NCT00310804|11465768|FG001|STARTED|Overall Study||171
10330302|NCT00310804|11465767|FG000|COMPLETED|Overall Study||1024
10330303|NCT00310804|11465768|FG001|COMPLETED|Overall Study||171
10330304|NCT00310804|11465767|FG000|NOT COMPLETED|Overall Study||5
10330305|NCT00310804|11465768|FG001|NOT COMPLETED|Overall Study||0
10330306|NCT00310817|11465792|FG000|STARTED|Overall Study||207
10330307|NCT00310817|11465793|FG001|STARTED|Overall Study||206
10330308|NCT00310817|11465794|FG002|STARTED|Overall Study||128
10330309|NCT00310817|11465795|FG003|STARTED|Overall Study||82
10330310|NCT00310817|11465792|FG000|COMPLETED|Overall Study||196
10330311|NCT00310817|11465793|FG001|COMPLETED|Overall Study||198
10330312|NCT00310817|11465794|FG002|COMPLETED|Overall Study||120
10330313|NCT00310817|11465795|FG003|COMPLETED|Overall Study||74
10330314|NCT00310817|11465792|FG000|NOT COMPLETED|Overall Study||11
10702004|NCT02572752|11866520|FG002|NOT COMPLETED|Period 2 Including Washout||0
10702005|NCT02572752|11866518|FG000|STARTED|Period 3 Including Washout||23
10702006|NCT02572752|11866519|FG001|STARTED|Period 3 Including Washout||23
10702007|NCT02572752|11866520|FG002|STARTED|Period 3 Including Washout||24
10702008|NCT02572752|11866518|FG000|COMPLETED|Period 3 Including Washout||23
10330315|NCT00310817|11465793|FG001|NOT COMPLETED|Overall Study||8
10330316|NCT00310817|11465794|FG002|NOT COMPLETED|Overall Study||8
10330317|NCT00310817|11465795|FG003|NOT COMPLETED|Overall Study||8
10330318|NCT00310856|11465841|FG000|STARTED|Overall Study||64
10330319|NCT00310856|11465842|FG001|STARTED|Overall Study||61
10330320|NCT00310856|11465843|FG002|STARTED|Overall Study||50
10330321|NCT00310856|11465841|FG000|COMPLETED|Overall Study||59
10330322|NCT00310856|11465842|FG001|COMPLETED|Overall Study||56
10330323|NCT00310856|11465843|FG002|COMPLETED|Overall Study||42
10330324|NCT00310856|11465841|FG000|NOT COMPLETED|Overall Study||5
10330325|NCT00310856|11465842|FG001|NOT COMPLETED|Overall Study||5
10330326|NCT00310856|11465843|FG002|NOT COMPLETED|Overall Study||8
10330327|NCT00311155|11465852|FG000|STARTED|Overall Study||694
10330328|NCT00311155|11465852|FG000|COMPLETED|Overall Study|Some participants had multiple reasons for discontinuation|601
10330329|NCT00311155|11465852|FG000|NOT COMPLETED|Overall Study||93
10330330|NCT00311168|11465858|FG000|STARTED|First Intervention||66
10330331|NCT00311168|11465859|FG001|STARTED|First Intervention||68
10330332|NCT00311168|11465858|FG000|COMPLETED|First Intervention||59
10330333|NCT00311168|11465859|FG001|COMPLETED|First Intervention||62
10330334|NCT00311168|11465858|FG000|NOT COMPLETED|First Intervention||7
10330335|NCT00311168|11465859|FG001|NOT COMPLETED|First Intervention||6
10330336|NCT00311168|11465858|FG000|STARTED|Second Intervention||59
10330337|NCT00311168|11465859|FG001|STARTED|Second Intervention||62
10330338|NCT00311168|11465858|FG000|COMPLETED|Second Intervention||49
10330339|NCT00311168|11465859|FG001|COMPLETED|Second Intervention||58
10330340|NCT00311168|11465858|FG000|NOT COMPLETED|Second Intervention||10
10330341|NCT00311168|11465859|FG001|NOT COMPLETED|Second Intervention||4
10330342|NCT00311181|11465867|FG000|STARTED|Overall Study||217
10330343|NCT00311181|11465867|FG000|COMPLETED|Overall Study||121
10330344|NCT00311181|11465867|FG000|NOT COMPLETED|Overall Study||96
10330345|NCT00311246|11465871|FG000|STARTED|Overall Study||11
10330346|NCT00311246|11465871|FG000|COMPLETED|Overall Study||11
10330347|NCT00311246|11465871|FG000|NOT COMPLETED|Overall Study||0
10330348|NCT00311311|11465880|FG000|STARTED|Overall Study||37
10330349|NCT00311311|11465881|FG001|STARTED|Overall Study||35
10330350|NCT00311311|11465880|FG000|COMPLETED|Overall Study||29
10702009|NCT02572752|11866519|FG001|COMPLETED|Period 3 Including Washout||23
10330351|NCT00311311|11465881|FG001|COMPLETED|Overall Study||26
10330352|NCT00311311|11465880|FG000|NOT COMPLETED|Overall Study||8
10330353|NCT00311311|11465881|FG001|NOT COMPLETED|Overall Study||9
10330354|NCT00311363|11465890|FG000|STARTED|24-Week Single-Blind Treatment Period||327
10330355|NCT00311363|11465891|FG001|STARTED|24-Week Single-Blind Treatment Period||0
10330356|NCT00311363|11465892|FG002|STARTED|24-Week Single-Blind Treatment Period||0
10330357|NCT00311363|11465890|FG000|COMPLETED|24-Week Single-Blind Treatment Period||221
10330358|NCT00311363|11465891|FG001|COMPLETED|24-Week Single-Blind Treatment Period||0
10330359|NCT00311363|11465892|FG002|COMPLETED|24-Week Single-Blind Treatment Period||0
10330360|NCT00311363|11465890|FG000|NOT COMPLETED|24-Week Single-Blind Treatment Period||106
10330361|NCT00311363|11465891|FG001|NOT COMPLETED|24-Week Single-Blind Treatment Period||0
10330362|NCT00311363|11465892|FG002|NOT COMPLETED|24-Week Single-Blind Treatment Period||0
10330363|NCT00311363|11465890|FG000|STARTED|12-Week Double-Blind Treatment Period||0
10330364|NCT00311363|11465891|FG001|STARTED|12-Week Double-Blind Treatment Period||98
10330365|NCT00311363|11465892|FG002|STARTED|12-Week Double-Blind Treatment Period||96
10330366|NCT00311363|11465890|FG000|COMPLETED|12-Week Double-Blind Treatment Period||0
10330367|NCT00311363|11465891|FG001|COMPLETED|12-Week Double-Blind Treatment Period||84
10330368|NCT00311363|11465892|FG002|COMPLETED|12-Week Double-Blind Treatment Period||84
10330369|NCT00311363|11465890|FG000|NOT COMPLETED|12-Week Double-Blind Treatment Period||0
10330370|NCT00311363|11465891|FG001|NOT COMPLETED|12-Week Double-Blind Treatment Period||14
10330371|NCT00311363|11465892|FG002|NOT COMPLETED|12-Week Double-Blind Treatment Period||12
10330372|NCT00311376|11465905|FG000|STARTED|Treatment Cycle 1||132
10330373|NCT00311376|11465906|FG001|STARTED|Treatment Cycle 1||135
10330374|NCT00311376|11465907|FG002|STARTED|Treatment Cycle 1||149
10330375|NCT00311376|11465905|FG000|COMPLETED|Treatment Cycle 1||105
10330376|NCT00311376|11465906|FG001|COMPLETED|Treatment Cycle 1||118
10330377|NCT00311376|11465907|FG002|COMPLETED|Treatment Cycle 1||132
10330378|NCT00311376|11465905|FG000|NOT COMPLETED|Treatment Cycle 1||27
10330379|NCT00311376|11465906|FG001|NOT COMPLETED|Treatment Cycle 1||17
10330380|NCT00311376|11465907|FG002|NOT COMPLETED|Treatment Cycle 1||17
10330381|NCT00311376|11465905|FG000|STARTED|Treatment Cycle 2|69 from the 300U group + 46 from the Placebo group entered Cycle 2|115
10330382|NCT00311376|11465906|FG001|STARTED|Treatment Cycle 2|74 from the 200U group + 51 from the Placebo group entered Cycle 2|125
10330383|NCT00311376|11465907|FG002|STARTED|Treatment Cycle 2|Cycle 1 Placebo pts were randomized to receive 300U or 200U in Cycle 2|0
10330384|NCT00311376|11465905|FG000|COMPLETED|Treatment Cycle 2||106
10330385|NCT00311376|11465906|FG001|COMPLETED|Treatment Cycle 2||112
10330386|NCT00311376|11465907|FG002|COMPLETED|Treatment Cycle 2||0
10330387|NCT00311376|11465905|FG000|NOT COMPLETED|Treatment Cycle 2||9
10330388|NCT00311376|11465906|FG001|NOT COMPLETED|Treatment Cycle 2||13
10330389|NCT00311376|11465907|FG002|NOT COMPLETED|Treatment Cycle 2||0
10330390|NCT00311402|11465917|FG000|STARTED|Overall Study||655
10330391|NCT00311402|11465918|FG001|STARTED|Overall Study||639
10330392|NCT00311402|11465917|FG000|COMPLETED|Overall Study||445
10330393|NCT00311402|11465918|FG001|COMPLETED|Overall Study||462
10330394|NCT00311402|11465917|FG000|NOT COMPLETED|Overall Study||210
10330395|NCT00311402|11465918|FG001|NOT COMPLETED|Overall Study||177
10330396|NCT00311584|11465926|FG000|STARTED|Overall Study||29
10330397|NCT00311584|11465927|FG001|STARTED|Overall Study||30
10330398|NCT00311584|11465926|FG000|COMPLETED|Overall Study||9
10330399|NCT00311584|11465927|FG001|COMPLETED|Overall Study||7
10330400|NCT00311584|11465926|FG000|NOT COMPLETED|Overall Study||20
10330401|NCT00311584|11465927|FG001|NOT COMPLETED|Overall Study||23
10330402|NCT00311623|11465936|FG000|STARTED|Overall Study||10
10330403|NCT00311623|11465937|FG001|STARTED|Overall Study||20
10330404|NCT00311623|11465938|FG002|STARTED|Overall Study||2
10330405|NCT00311623|11465936|FG000|COMPLETED|Overall Study||10
10330406|NCT00311623|11465937|FG001|COMPLETED|Overall Study||20
10330407|NCT00311623|11465938|FG002|COMPLETED|Overall Study||0
10330408|NCT00311623|11465936|FG000|NOT COMPLETED|Overall Study||0
10330409|NCT00311623|11465937|FG001|NOT COMPLETED|Overall Study||0
10330410|NCT00311623|11465938|FG002|NOT COMPLETED|Overall Study||2
10330411|NCT00311766|11465949|FG000|STARTED|Overall Study||8
10330412|NCT00311766|11465950|FG001|STARTED|Overall Study||22
10330413|NCT00311766|11465949|FG000|COMPLETED|Overall Study||8
10330414|NCT00311766|11465950|FG001|COMPLETED|Overall Study||17
10330415|NCT00311766|11465949|FG000|NOT COMPLETED|Overall Study||0
10330416|NCT00311766|11465950|FG001|NOT COMPLETED|Overall Study||5
10330417|NCT00312195|11465958|FG000|STARTED|Overall Study||138
10330418|NCT00312195|11465959|FG001|STARTED|Overall Study||129
10330419|NCT00312195|11465958|FG000|COMPLETED|Overall Study||132
10330420|NCT00312195|11465959|FG001|COMPLETED|Overall Study||123
10330421|NCT00312195|11465958|FG000|NOT COMPLETED|Overall Study||6
10330422|NCT00312195|11465959|FG001|NOT COMPLETED|Overall Study||6
10330423|NCT00312208|11465969|FG000|STARTED|Overall Study|1649 patients randomized, 1634 patients treated|1649
10330424|NCT00312208|11465970|FG001|STARTED|Overall Study|1649 patients randomized 1635 patients treated|1649
10330425|NCT00312208|11465969|FG000|COMPLETED|Overall Study||1477
10330426|NCT00312208|11465970|FG001|COMPLETED|Overall Study||1526
10805205|NCT04027218|11966737|FG005|NOT COMPLETED|Overall Study||0
10805206|NCT04026750|11966749|FG000|STARTED|Overall Study||3
10805207|NCT04026750|11966750|FG001|STARTED|Overall Study||2
10805208|NCT04026750|11966749|FG000|COMPLETED|Overall Study||3
10330427|NCT00312208|11465969|FG000|NOT COMPLETED|Overall Study||172
10330428|NCT00312208|11465970|FG001|NOT COMPLETED|Overall Study||123
10330429|NCT00312221|11465979|FG000|STARTED|Open-label Run-in Period||652
10330430|NCT00312221|11465980|FG001|STARTED|Open-label Run-in Period||0
10330431|NCT00312221|11465981|FG002|STARTED|Open-label Run-in Period||0
10330432|NCT00312221|11465982|FG003|STARTED|Open-label Run-in Period||0
10330433|NCT00312221|11465979|FG000|COMPLETED|Open-label Run-in Period||418
10330434|NCT00312221|11465980|FG001|COMPLETED|Open-label Run-in Period||0
10330435|NCT00312221|11465981|FG002|COMPLETED|Open-label Run-in Period||0
10330436|NCT00312221|11465982|FG003|COMPLETED|Open-label Run-in Period||0
10330437|NCT00312221|11465979|FG000|NOT COMPLETED|Open-label Run-in Period||234
10330438|NCT00312221|11465980|FG001|NOT COMPLETED|Open-label Run-in Period||0
10330439|NCT00312221|11465981|FG002|NOT COMPLETED|Open-label Run-in Period||0
10330440|NCT00312221|11465982|FG003|NOT COMPLETED|Open-label Run-in Period||0
10330441|NCT00312221|11465979|FG000|STARTED|Double-blind Phase||0
10330442|NCT00312221|11465980|FG001|STARTED|Double-blind Phase||136
10330443|NCT00312221|11465981|FG002|STARTED|Double-blind Phase||149
10330444|NCT00312221|11465982|FG003|STARTED|Double-blind Phase||133
10330445|NCT00312221|11465979|FG000|COMPLETED|Double-blind Phase||0
10330446|NCT00312221|11465980|FG001|COMPLETED|Double-blind Phase||77
10330447|NCT00312221|11465981|FG002|COMPLETED|Double-blind Phase||77
10330448|NCT00312221|11465982|FG003|COMPLETED|Double-blind Phase||63
10330449|NCT00312221|11465979|FG000|NOT COMPLETED|Double-blind Phase||0
10330450|NCT00312221|11465980|FG001|NOT COMPLETED|Double-blind Phase||59
10330451|NCT00312221|11465981|FG002|NOT COMPLETED|Double-blind Phase||72
10330452|NCT00312221|11465982|FG003|NOT COMPLETED|Double-blind Phase||70
10330453|NCT00312338|11465993|FG000|STARTED|Overall Study||105
10330454|NCT00312338|11465994|FG001|STARTED|Overall Study||57
10330455|NCT00312338|11465993|FG000|COMPLETED|Overall Study||83
10330456|NCT00312338|11465994|FG001|COMPLETED|Overall Study||54
10330457|NCT00312338|11465993|FG000|NOT COMPLETED|Overall Study||22
10330458|NCT00312338|11465994|FG001|NOT COMPLETED|Overall Study||3
10330459|NCT00312377|11466002|FG000|STARTED|Overall Study|randomised patients|694
10330460|NCT00312377|11466003|FG001|STARTED|Overall Study|randomised patients|697
10330461|NCT00312377|11466002|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|50
10330462|NCT00312377|11466003|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|29
10330463|NCT00312377|11466002|FG000|NOT COMPLETED|Overall Study||644
10330464|NCT00312377|11466003|FG001|NOT COMPLETED|Overall Study||668
10330465|NCT00312494|11466012|FG000|STARTED|Overall Study||232
10330466|NCT00312494|11466013|FG001|STARTED|Overall Study||226
10330467|NCT00312494|11466014|FG002|STARTED|Overall Study||222
10330468|NCT00312494|11466012|FG000|Received Study Treatment|Overall Study|1 subject randomized to higher dose; received lower dose at baseline, higher dose weeks 1 and 2.|223
10330469|NCT00312494|11466013|FG001|Received Study Treatment|Overall Study||216
10330470|NCT00312494|11466014|FG002|Received Study Treatment|Overall Study||217
10330471|NCT00312494|11466012|FG000|COMPLETED|Overall Study|1 subject randomized to higher dose; received lower dose baseline and/or week 1; higher dose week 2.|161
10330472|NCT00312494|11466013|FG001|COMPLETED|Overall Study||168
10330473|NCT00312494|11466014|FG002|COMPLETED|Overall Study||179
10330474|NCT00312494|11466012|FG000|NOT COMPLETED|Overall Study||71
10330475|NCT00312494|11466013|FG001|NOT COMPLETED|Overall Study||58
10330476|NCT00312494|11466014|FG002|NOT COMPLETED|Overall Study||43
10330477|NCT00312572|11466024|FG000|STARTED|Overall Study||101
10330478|NCT00312572|11466025|FG001|STARTED|Overall Study||103
10330479|NCT00312572|11466024|FG000|COMPLETED|Overall Study||85
10330480|NCT00312572|11466025|FG001|COMPLETED|Overall Study||82
10330481|NCT00312572|11466024|FG000|NOT COMPLETED|Overall Study||16
10330482|NCT00312572|11466025|FG001|NOT COMPLETED|Overall Study||21
10330483|NCT00312663|11466036|FG000|STARTED|Immunization Phase||5
10330484|NCT00312663|11466037|FG001|STARTED|Immunization Phase||13
10330485|NCT00312663|11466038|FG002|STARTED|Immunization Phase||0
10330486|NCT00312663|11466036|FG000|COMPLETED|Immunization Phase||5
10330487|NCT00312663|11466037|FG001|COMPLETED|Immunization Phase||12
10330488|NCT00312663|11466038|FG002|COMPLETED|Immunization Phase||0
10805209|NCT04026750|11966750|FG001|COMPLETED|Overall Study||2
10805210|NCT04026750|11966749|FG000|NOT COMPLETED|Overall Study||0
10330489|NCT00312663|11466036|FG000|NOT COMPLETED|Immunization Phase||0
10330490|NCT00312663|11466037|FG001|NOT COMPLETED|Immunization Phase||1
10330491|NCT00312663|11466038|FG002|NOT COMPLETED|Immunization Phase||0
10330492|NCT00312663|11466036|FG000|STARTED|Challenge Phase|low dose subjects didn't participate in the challenge phase|0
10330493|NCT00312663|11466037|FG001|STARTED|Challenge Phase|10 subjects from the high dose group participated in the challenge phase|10
10330494|NCT00312663|11466038|FG002|STARTED|Challenge Phase|6 non-immunized subjects participated in the challenge phase|6
10330495|NCT00312663|11466036|FG000|COMPLETED|Challenge Phase||0
10330496|NCT00312663|11466037|FG001|COMPLETED|Challenge Phase||10
10330497|NCT00312663|11466038|FG002|COMPLETED|Challenge Phase||6
10330498|NCT00312663|11466036|FG000|NOT COMPLETED|Challenge Phase||0
10330499|NCT00312663|11466037|FG001|NOT COMPLETED|Challenge Phase||0
10330500|NCT00312663|11466038|FG002|NOT COMPLETED|Challenge Phase||0
10330501|NCT00312702|11466050|FG000|STARTED|Immunization Phase||5
10330502|NCT00312702|11466051|FG001|STARTED|Immunization Phase||13
10330503|NCT00312702|11466052|FG002|STARTED|Immunization Phase||0
10805211|NCT04026750|11966750|FG001|NOT COMPLETED|Overall Study||0
10330504|NCT00312702|11466050|FG000|COMPLETED|Immunization Phase||5
10330505|NCT00312702|11466051|FG001|COMPLETED|Immunization Phase||12
10330506|NCT00312702|11466052|FG002|COMPLETED|Immunization Phase||0
10330507|NCT00312702|11466050|FG000|NOT COMPLETED|Immunization Phase||0
10330508|NCT00312702|11466051|FG001|NOT COMPLETED|Immunization Phase||1
10330509|NCT00312702|11466052|FG002|NOT COMPLETED|Immunization Phase||0
10330510|NCT00312702|11466050|FG000|STARTED|Challenge Phase|low dose subjects didn't participate in the challenge phase|0
10330511|NCT00312702|11466051|FG001|STARTED|Challenge Phase|12 subjects from the high dose group participated in the challenge phase|12
10330512|NCT00312702|11466052|FG002|STARTED|Challenge Phase|1 non-immunized subjects participated in the challenge phase.|1
10330513|NCT00312702|11466050|FG000|COMPLETED|Challenge Phase||0
10330514|NCT00312702|11466051|FG001|COMPLETED|Challenge Phase||12
10330515|NCT00312702|11466052|FG002|COMPLETED|Challenge Phase||1
10330516|NCT00312702|11466050|FG000|NOT COMPLETED|Challenge Phase||0
10330517|NCT00312702|11466051|FG001|NOT COMPLETED|Challenge Phase||0
10330518|NCT00312702|11466052|FG002|NOT COMPLETED|Challenge Phase||0
10330519|NCT00312728|11466060|FG000|STARTED|Overall Study||115
10330520|NCT00312728|11466060|FG000|COMPLETED|Overall Study||5
10330521|NCT00312728|11466060|FG000|NOT COMPLETED|Overall Study||110
10330522|NCT00312845|11466066|FG000|STARTED|Overall Study||336
10330523|NCT00312845|11466067|FG001|STARTED|Overall Study||340
10330524|NCT00312845|11466066|FG000|COMPLETED|Overall Study||237
10330525|NCT00312845|11466067|FG001|COMPLETED|Overall Study||245
10330526|NCT00312845|11466066|FG000|NOT COMPLETED|Overall Study||99
10330527|NCT00312845|11466067|FG001|NOT COMPLETED|Overall Study||95
10330528|NCT00312858|11466075|FG000|STARTED|Overall Study||330
10330529|NCT00312858|11466076|FG001|STARTED|Overall Study||323
10330530|NCT00312858|11466075|FG000|Visit 1|Overall Study||330
10330531|NCT00312858|11466076|FG001|Visit 1|Overall Study||323
10330532|NCT00312858|11466075|FG000|Visit 2|Overall Study||305
10330533|NCT00312858|11466076|FG001|Visit 2|Overall Study||294
10330534|NCT00312858|11466075|FG000|Visit 3|Overall Study||273
10330535|NCT00312858|11466076|FG001|Visit 3|Overall Study||261
10330536|NCT00312858|11466075|FG000|Visit 4|Overall Study||262
10330537|NCT00312858|11466076|FG001|Visit 4|Overall Study||240
10330538|NCT00312858|11466075|FG000|COMPLETED|Overall Study||262
10330539|NCT00312858|11466076|FG001|COMPLETED|Overall Study||230
10330540|NCT00312858|11466075|FG000|NOT COMPLETED|Overall Study||68
10330541|NCT00312858|11466076|FG001|NOT COMPLETED|Overall Study||93
10330542|NCT00312884|11466084|FG000|STARTED|Overall Study||91
10330543|NCT00312884|11466085|FG001|STARTED|Overall Study||91
10330544|NCT00312884|11466084|FG000|COMPLETED|Overall Study||74
10330545|NCT00312884|11466085|FG001|COMPLETED|Overall Study||79
10330546|NCT00312884|11466084|FG000|NOT COMPLETED|Overall Study||17
10330547|NCT00312884|11466085|FG001|NOT COMPLETED|Overall Study||12
10330548|NCT00312897|11466093|FG000|STARTED|Overall Study||27
10330549|NCT00312897|11466094|FG001|STARTED|Overall Study||24
10330550|NCT00312897|11466093|FG000|COMPLETED|Overall Study||21
10330551|NCT00312897|11466094|FG001|COMPLETED|Overall Study||18
10330552|NCT00312897|11466093|FG000|NOT COMPLETED|Overall Study||6
10330553|NCT00312897|11466094|FG001|NOT COMPLETED|Overall Study||6
10330554|NCT00312923|11466102|FG000|STARTED|Overall Study||28
10330555|NCT00312923|11466103|FG001|STARTED|Overall Study||26
10330556|NCT00312923|11466102|FG000|COMPLETED|Overall Study||19
10330557|NCT00312923|11466103|FG001|COMPLETED|Overall Study||20
10330558|NCT00312923|11466102|FG000|NOT COMPLETED|Overall Study||9
10330559|NCT00312923|11466103|FG001|NOT COMPLETED|Overall Study||6
10330560|NCT00313014|11466112|FG000|STARTED|Overall Study||221
10330561|NCT00313014|11466113|FG001|STARTED|Overall Study||219
10330562|NCT00313014|11466114|FG002|STARTED|Overall Study||220
10330563|NCT00313014|11466112|FG000|COMPLETED|Overall Study||128
10330564|NCT00313014|11466113|FG001|COMPLETED|Overall Study||146
10702010|NCT02572752|11866520|FG002|COMPLETED|Period 3 Including Washout||24
10330565|NCT00313014|11466114|FG002|COMPLETED|Overall Study||159
10330566|NCT00313014|11466112|FG000|NOT COMPLETED|Overall Study||93
10330567|NCT00313014|11466113|FG001|NOT COMPLETED|Overall Study||73
10330568|NCT00313014|11466114|FG002|NOT COMPLETED|Overall Study||61
10330569|NCT00313144|11466123|FG000|STARTED|Overall Study||127
10330570|NCT00313144|11466123|FG000|COMPLETED|Overall Study||17
10330571|NCT00313144|11466123|FG000|NOT COMPLETED|Overall Study||110
10330572|NCT00313170|11466139|FG000|STARTED|Overall Study||47
10330573|NCT00313170|11466140|FG001|STARTED|Overall Study||51
10330574|NCT00313170|11466141|FG002|STARTED|Overall Study||46
10330575|NCT00313170|11466139|FG000|COMPLETED|Overall Study||11
10330576|NCT00313170|11466140|FG001|COMPLETED|Overall Study||17
10330577|NCT00313170|11466141|FG002|COMPLETED|Overall Study||14
10330578|NCT00313170|11466139|FG000|NOT COMPLETED|Overall Study||36
10330579|NCT00313170|11466140|FG001|NOT COMPLETED|Overall Study||34
10330580|NCT00313170|11466141|FG002|NOT COMPLETED|Overall Study||32
10330581|NCT00313209|11466152|FG000|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|466
10330582|NCT00313209|11466153|FG001|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|467
10330583|NCT00313209|11466152|FG000|COMPLETED|Overall Study||359
10330584|NCT00313209|11466153|FG001|COMPLETED|Overall Study||385
10330585|NCT00313209|11466152|FG000|NOT COMPLETED|Overall Study||107
10330586|NCT00313209|11466153|FG001|NOT COMPLETED|Overall Study||82
10330587|NCT00313300|11466164|FG000|STARTED|Randomized in Phase A (26 Weeks)||184
10330588|NCT00313300|11466165|FG001|STARTED|Randomized in Phase A (26 Weeks)||179
10330589|NCT00313300|11466166|FG002|STARTED|Randomized in Phase A (26 Weeks)||184
10330590|NCT00313300|11466167|FG003|STARTED|Randomized in Phase A (26 Weeks)||0
10330591|NCT00313300|11466168|FG004|STARTED|Randomized in Phase A (26 Weeks)||0
10330592|NCT00313300|11466164|FG000|COMPLETED|Randomized in Phase A (26 Weeks)||130
10330593|NCT00313300|11466165|FG001|COMPLETED|Randomized in Phase A (26 Weeks)||140
10330594|NCT00313300|11466166|FG002|COMPLETED|Randomized in Phase A (26 Weeks)||149
10330595|NCT00313300|11466167|FG003|COMPLETED|Randomized in Phase A (26 Weeks)||0
10330596|NCT00313300|11466168|FG004|COMPLETED|Randomized in Phase A (26 Weeks)||0
10330597|NCT00313300|11466164|FG000|NOT COMPLETED|Randomized in Phase A (26 Weeks)||54
10330598|NCT00313300|11466165|FG001|NOT COMPLETED|Randomized in Phase A (26 Weeks)||39
10330599|NCT00313300|11466166|FG002|NOT COMPLETED|Randomized in Phase A (26 Weeks)||35
10330600|NCT00313300|11466167|FG003|NOT COMPLETED|Randomized in Phase A (26 Weeks)||0
10330601|NCT00313300|11466168|FG004|NOT COMPLETED|Randomized in Phase A (26 Weeks)||0
10330602|NCT00313300|11466164|FG000|STARTED|Randomized in Phase B (26 Weeks)||427
10330603|NCT00313300|11466165|FG001|STARTED|Randomized in Phase B (26 Weeks)||138
10330604|NCT00313300|11466166|FG002|STARTED|Randomized in Phase B (26 Weeks)||134
10330605|NCT00313300|11466167|FG003|STARTED|Randomized in Phase B (26 Weeks)||248
10330606|NCT00313300|11466168|FG004|STARTED|Randomized in Phase B (26 Weeks)||221
10330607|NCT00313300|11466164|FG000|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||368
10330608|NCT00313300|11466165|FG001|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||120
10330609|NCT00313300|11466166|FG002|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||110
10330610|NCT00313300|11466167|FG003|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||248
10330611|NCT00313300|11466168|FG004|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||221
10330612|NCT00313300|11466164|FG000|COMPLETED|Randomized in Phase B (26 Weeks)||333
10330613|NCT00313300|11466165|FG001|COMPLETED|Randomized in Phase B (26 Weeks)||105
10330614|NCT00313300|11466166|FG002|COMPLETED|Randomized in Phase B (26 Weeks)||94
10330615|NCT00313300|11466167|FG003|COMPLETED|Randomized in Phase B (26 Weeks)||15
10330616|NCT00313300|11466168|FG004|COMPLETED|Randomized in Phase B (26 Weeks)||13
10330617|NCT00313300|11466164|FG000|NOT COMPLETED|Randomized in Phase B (26 Weeks)||94
10330618|NCT00313300|11466165|FG001|NOT COMPLETED|Randomized in Phase B (26 Weeks)||33
10330619|NCT00313300|11466166|FG002|NOT COMPLETED|Randomized in Phase B (26 Weeks)||40
10330620|NCT00313300|11466167|FG003|NOT COMPLETED|Randomized in Phase B (26 Weeks)||233
10330621|NCT00313300|11466168|FG004|NOT COMPLETED|Randomized in Phase B (26 Weeks)||208
10330622|NCT00313300|11466164|FG000|STARTED|Follow-Up(30days)-Randomized Phase A||163
10330623|NCT00313300|11466165|FG001|STARTED|Follow-Up(30days)-Randomized Phase A||162
10330624|NCT00313300|11466166|FG002|STARTED|Follow-Up(30days)-Randomized Phase A||174
10330625|NCT00313300|11466167|FG003|STARTED|Follow-Up(30days)-Randomized Phase A||0
10330626|NCT00313300|11466168|FG004|STARTED|Follow-Up(30days)-Randomized Phase A||0
10330627|NCT00313300|11466164|FG000|COMPLETED|Follow-Up(30days)-Randomized Phase A||158
10330628|NCT00313300|11466165|FG001|COMPLETED|Follow-Up(30days)-Randomized Phase A||156
10330629|NCT00313300|11466166|FG002|COMPLETED|Follow-Up(30days)-Randomized Phase A||172
10330630|NCT00313300|11466167|FG003|COMPLETED|Follow-Up(30days)-Randomized Phase A||0
10330631|NCT00313300|11466168|FG004|COMPLETED|Follow-Up(30days)-Randomized Phase A||0
10330632|NCT00313300|11466164|FG000|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||5
10330633|NCT00313300|11466165|FG001|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||6
10330634|NCT00313300|11466166|FG002|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||2
10330635|NCT00313300|11466167|FG003|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||0
10330636|NCT00313300|11466168|FG004|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||0
10330637|NCT00313300|11466164|FG000|STARTED|Follow-Up(30days)-Randomized Phase B||383
10330638|NCT00313300|11466165|FG001|STARTED|Follow-Up(30days)-Randomized Phase B||123
10330639|NCT00313300|11466166|FG002|STARTED|Follow-Up(30days)-Randomized Phase B||119
10330640|NCT00313300|11466167|FG003|STARTED|Follow-Up(30days)-Randomized Phase B||222
10330641|NCT00313300|11466168|FG004|STARTED|Follow-Up(30days)-Randomized Phase B||201
10330642|NCT00313300|11466164|FG000|COMPLETED|Follow-Up(30days)-Randomized Phase B||380
10330643|NCT00313300|11466165|FG001|COMPLETED|Follow-Up(30days)-Randomized Phase B||123
10330644|NCT00313300|11466166|FG002|COMPLETED|Follow-Up(30days)-Randomized Phase B||117
10330645|NCT00313300|11466167|FG003|COMPLETED|Follow-Up(30days)-Randomized Phase B||217
10330646|NCT00313300|11466168|FG004|COMPLETED|Follow-Up(30days)-Randomized Phase B||199
10330647|NCT00313300|11466164|FG000|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||3
10330648|NCT00313300|11466165|FG001|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||0
10330649|NCT00313300|11466166|FG002|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||2
10330650|NCT00313300|11466167|FG003|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||5
10330651|NCT00313300|11466168|FG004|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||2
10330652|NCT00313313|11466189|FG000|STARTED|Overall Study||248
10330653|NCT00313313|11466190|FG001|STARTED|Overall Study||253
10330654|NCT00313313|11466191|FG002|STARTED|Overall Study||267
10330655|NCT00313313|11466189|FG000|COMPLETED|Overall Study|61 subjects completed the study without being rescued|185
10330656|NCT00313313|11466190|FG001|COMPLETED|Overall Study|55 subjects completed the study without being rescued|187
10330657|NCT00313313|11466191|FG002|COMPLETED|Overall Study|26 subjects completed the study without being rescued|185
10330658|NCT00313313|11466189|FG000|NOT COMPLETED|Overall Study||63
10330659|NCT00313313|11466190|FG001|NOT COMPLETED|Overall Study||66
10330660|NCT00313313|11466191|FG002|NOT COMPLETED|Overall Study||82
10330661|NCT00313443|11466199|FG000|STARTED|Overall Study||30
10330662|NCT00313443|11466199|FG000|COMPLETED|Overall Study||30
10330663|NCT00313443|11466199|FG000|NOT COMPLETED|Overall Study||0
10456617|NCT01007253|11604487|FG000|STARTED|Fourth Intervention||5
10330664|NCT00313560|11466203|FG000|STARTED|Overall Study||48
10330665|NCT00313560|11466203|FG000|COMPLETED|Overall Study||48
10330666|NCT00313560|11466203|FG000|NOT COMPLETED|Overall Study||0
10330667|NCT00313586|11466215|FG000|STARTED|Overall Study||75
10330668|NCT00313586|11466216|FG001|STARTED|Overall Study||75
10330669|NCT00313586|11466217|FG002|STARTED|Overall Study||24
10330670|NCT00313586|11466218|FG003|STARTED|Overall Study||23
10330671|NCT00313586|11466215|FG000|Treated|Overall Study||74
10330672|NCT00313586|11466216|FG001|Treated|Overall Study||75
10330673|NCT00313586|11466217|FG002|Treated|Overall Study||24
10330674|NCT00313586|11466218|FG003|Treated|Overall Study||23
10330675|NCT00313586|11466215|FG000|COMPLETED|Overall Study||5
10330676|NCT00313586|11466216|FG001|COMPLETED|Overall Study||5
10330677|NCT00313586|11466217|FG002|COMPLETED|Overall Study||0
10330678|NCT00313586|11466218|FG003|COMPLETED|Overall Study||0
10330679|NCT00313586|11466215|FG000|NOT COMPLETED|Overall Study||70
10330680|NCT00313586|11466216|FG001|NOT COMPLETED|Overall Study||70
10330681|NCT00313586|11466217|FG002|NOT COMPLETED|Overall Study||24
10330682|NCT00313586|11466218|FG003|NOT COMPLETED|Overall Study||23
10330683|NCT00313612|11466228|FG000|STARTED|Overall Study||19
10330684|NCT00313612|11466229|FG001|STARTED|Overall Study||20
10330685|NCT00313612|11466228|FG000|COMPLETED|Overall Study||19
10330686|NCT00313612|11466229|FG001|COMPLETED|Overall Study||19
10330687|NCT00313612|11466228|FG000|NOT COMPLETED|Overall Study||0
10330688|NCT00313612|11466229|FG001|NOT COMPLETED|Overall Study||1
10330689|NCT00313703|11466239|FG000|STARTED|Overall Study||186
10330690|NCT00313703|11466240|FG001|STARTED|Overall Study||34
10330691|NCT00313703|11466241|FG002|STARTED|Overall Study||77
10330692|NCT00313703|11466242|FG003|STARTED|Overall Study||12
10330693|NCT00313703|11466239|FG000|COMPLETED|Overall Study|Some subjects lost to follow-up|175
10330694|NCT00313703|11466240|FG001|COMPLETED|Overall Study|Some subjects lost-to follow-up|32
10330695|NCT00313703|11466241|FG002|COMPLETED|Overall Study|Some subjects lost-to-follow-up|72
10330696|NCT00313703|11466242|FG003|COMPLETED|Overall Study|Outcomes not reported due to heterogeneity of this group|0
10330697|NCT00313703|11466239|FG000|NOT COMPLETED|Overall Study||11
10330698|NCT00313703|11466240|FG001|NOT COMPLETED|Overall Study||2
10330699|NCT00313703|11466241|FG002|NOT COMPLETED|Overall Study||5
10330700|NCT00313703|11466242|FG003|NOT COMPLETED|Overall Study||12
10330701|NCT00313716|11466258|FG000|STARTED|Overall Study||18
10330702|NCT00313716|11466259|FG001|STARTED|Overall Study||31
10330703|NCT00313716|11466260|FG002|STARTED|Overall Study||50
10330704|NCT00313716|11466261|FG003|STARTED|Overall Study||20
10330705|NCT00313716|11466262|FG004|STARTED|Overall Study||33
10330706|NCT00313716|11466263|FG005|STARTED|Overall Study||48
10330707|NCT00313716|11466258|FG000|COMPLETED|Overall Study||13
10330708|NCT00313716|11466259|FG001|COMPLETED|Overall Study||23
10330709|NCT00313716|11466260|FG002|COMPLETED|Overall Study||38
10330710|NCT00313716|11466261|FG003|COMPLETED|Overall Study||16
10330711|NCT00313716|11466262|FG004|COMPLETED|Overall Study||27
10330712|NCT00313716|11466263|FG005|COMPLETED|Overall Study||35
10330713|NCT00313716|11466258|FG000|NOT COMPLETED|Overall Study||5
10330714|NCT00313716|11466259|FG001|NOT COMPLETED|Overall Study||8
10330715|NCT00313716|11466260|FG002|NOT COMPLETED|Overall Study||12
10330716|NCT00313716|11466261|FG003|NOT COMPLETED|Overall Study||4
10456618|NCT01007253|11604488|FG001|STARTED|Fourth Intervention||5
10456619|NCT01007253|11604489|FG002|STARTED|Fourth Intervention||5
10456620|NCT01007253|11604490|FG003|STARTED|Fourth Intervention||5
10456621|NCT01007253|11604487|FG000|COMPLETED|Fourth Intervention||5
10456622|NCT01007253|11604488|FG001|COMPLETED|Fourth Intervention||5
10456623|NCT01007253|11604489|FG002|COMPLETED|Fourth Intervention||5
10456624|NCT01007253|11604490|FG003|COMPLETED|Fourth Intervention||5
10456625|NCT01007253|11604487|FG000|NOT COMPLETED|Fourth Intervention||0
10456626|NCT01007253|11604488|FG001|NOT COMPLETED|Fourth Intervention||0
10456627|NCT01007253|11604489|FG002|NOT COMPLETED|Fourth Intervention||0
10456628|NCT01007253|11604490|FG003|NOT COMPLETED|Fourth Intervention||0
10456629|NCT01007396|11604500|FG000|STARTED|Overall Study||322
10456630|NCT01007396|11604500|FG000|COMPLETED|Overall Study||275
10456631|NCT01007396|11604500|FG000|NOT COMPLETED|Overall Study||47
10456632|NCT01007435|11604508|FG000|STARTED|Overall Study||289
10456633|NCT01007435|11604509|FG001|STARTED|Overall Study||290
10456634|NCT01007435|11604510|FG002|STARTED|Overall Study||291
10456635|NCT01007435|11604511|FG003|STARTED|Overall Study||292
10456636|NCT01007435|11604508|FG000|COMPLETED|Overall Study||226
10456637|NCT01007435|11604509|FG001|COMPLETED|Overall Study||231
10456638|NCT01007435|11604510|FG002|COMPLETED|Overall Study||227
10456639|NCT01007435|11604511|FG003|COMPLETED|Overall Study||236
10456640|NCT01007435|11604508|FG000|NOT COMPLETED|Overall Study||63
10330717|NCT00313716|11466262|FG004|NOT COMPLETED|Overall Study||6
10330718|NCT00313716|11466263|FG005|NOT COMPLETED|Overall Study||13
10330719|NCT00313729|11466281|FG000|STARTED|Overall Study||120
10330720|NCT00313729|11466281|FG000|COMPLETED|Overall Study||120
10330721|NCT00313729|11466281|FG000|NOT COMPLETED|Overall Study||0
10330722|NCT00313781|11466287|FG000|STARTED|Before Crossover||102
10330723|NCT00313781|11466288|FG001|STARTED|Before Crossover||102
10330724|NCT00313781|11466289|FG002|STARTED|Before Crossover||0
10330725|NCT00313781|11466287|FG000|Treated|Before Crossover||97
10330726|NCT00313781|11466288|FG001|Treated|Before Crossover||102
10330727|NCT00313781|11466289|FG002|Treated|Before Crossover||0
10456641|NCT01007435|11604509|FG001|NOT COMPLETED|Overall Study||59
10456642|NCT01007435|11604510|FG002|NOT COMPLETED|Overall Study||64
10456643|NCT01007435|11604511|FG003|NOT COMPLETED|Overall Study||56
10456644|NCT01007448|11604523|FG000|STARTED|Overall Study||30
10330728|NCT00313781|11466287|FG000|COMPLETED|Before Crossover||27
10330729|NCT00313781|11466288|FG001|COMPLETED|Before Crossover||23
10330730|NCT00313781|11466289|FG002|COMPLETED|Before Crossover||0
10330731|NCT00313781|11466287|FG000|NOT COMPLETED|Before Crossover||75
10330732|NCT00313781|11466288|FG001|NOT COMPLETED|Before Crossover||79
10330733|NCT00313781|11466289|FG002|NOT COMPLETED|Before Crossover||0
10330734|NCT00313781|11466287|FG000|STARTED|After Crossover||0
10330735|NCT00313781|11466288|FG001|STARTED|After Crossover||0
10330736|NCT00313781|11466289|FG002|STARTED|After Crossover||37
10330737|NCT00313781|11466287|FG000|COMPLETED|After Crossover||0
10330738|NCT00313781|11466288|FG001|COMPLETED|After Crossover||0
10330739|NCT00313781|11466289|FG002|COMPLETED|After Crossover||10
10330740|NCT00313781|11466287|FG000|NOT COMPLETED|After Crossover||0
10330741|NCT00313781|11466288|FG001|NOT COMPLETED|After Crossover||0
10330742|NCT00313781|11466289|FG002|NOT COMPLETED|After Crossover||27
10330743|NCT00313820|11466300|FG000|STARTED|Assigned to Treatment||111
10330744|NCT00313820|11466301|FG001|STARTED|Assigned to Treatment||109
10330745|NCT00313820|11466300|FG000|COMPLETED|Assigned to Treatment||110
10330746|NCT00313820|11466301|FG001|COMPLETED|Assigned to Treatment||109
10330747|NCT00313820|11466300|FG000|NOT COMPLETED|Assigned to Treatment||1
10330748|NCT00313820|11466301|FG001|NOT COMPLETED|Assigned to Treatment||0
10330749|NCT00313820|11466300|FG000|STARTED|Pregabalin or Placebo Treatment Period||110
10330750|NCT00313820|11466301|FG001|STARTED|Pregabalin or Placebo Treatment Period||109
10330751|NCT00313820|11466300|FG000|COMPLETED|Pregabalin or Placebo Treatment Period||93
10330752|NCT00313820|11466301|FG001|COMPLETED|Pregabalin or Placebo Treatment Period||90
10330753|NCT00313820|11466300|FG000|NOT COMPLETED|Pregabalin or Placebo Treatment Period||17
10330754|NCT00313820|11466301|FG001|NOT COMPLETED|Pregabalin or Placebo Treatment Period||19
10330755|NCT00313846|11466309|FG000|STARTED|Overall Study||162
10330756|NCT00313846|11466310|FG001|STARTED|Overall Study|327 subjects were randomized: 1 subject was lost to follow-up (N = 326).|164
10330757|NCT00313846|11466309|FG000|COMPLETED|Overall Study||157
10330758|NCT00313846|11466310|FG001|COMPLETED|Overall Study||153
10330759|NCT00313846|11466309|FG000|NOT COMPLETED|Overall Study||5
10330760|NCT00313846|11466310|FG001|NOT COMPLETED|Overall Study||11
10330761|NCT00313911|11466319|FG000|STARTED|Overall Study|N for outcomes adjusted to include participant in Group 2 that got vaccine assigned to this group.|1422
10330762|NCT00313911|11466320|FG001|STARTED|Overall Study|A participant in this group mistakenly got Group 1 vaccine. N in outcomes adjusted accordingly.|711
10330763|NCT00313911|11466319|FG000|COMPLETED|Overall Study||1328
10330764|NCT00313911|11466320|FG001|COMPLETED|Overall Study||670
10330765|NCT00313911|11466319|FG000|NOT COMPLETED|Overall Study||94
10330766|NCT00313911|11466320|FG001|NOT COMPLETED|Overall Study||41
10330767|NCT00314106|11466328|FG000|STARTED|Overall Study||18
10330768|NCT00314106|11466329|FG001|STARTED|Overall Study||8
10330769|NCT00314106|11466328|FG000|COMPLETED|Overall Study||18
10330770|NCT00314106|11466329|FG001|COMPLETED|Overall Study||8
10330771|NCT00314106|11466328|FG000|NOT COMPLETED|Overall Study||0
10330772|NCT00314106|11466329|FG001|NOT COMPLETED|Overall Study||0
10330773|NCT00314132|11466337|FG000|STARTED|Overall Study||403
10330774|NCT00314132|11466338|FG001|STARTED|Overall Study||1601
10330775|NCT00314132|11466337|FG000|COMPLETED|Overall Study||395
10330776|NCT00314132|11466338|FG001|COMPLETED|Overall Study||1583
10330777|NCT00314132|11466337|FG000|NOT COMPLETED|Overall Study||8
10330778|NCT00314132|11466338|FG001|NOT COMPLETED|Overall Study||18
10330779|NCT00314145|11466348|FG000|STARTED|Overall Study||410
10330780|NCT00314145|11466349|FG001|STARTED|Overall Study||410
10330781|NCT00314145|11466348|FG000|COMPLETED|Overall Study||389
10330782|NCT00314145|11466349|FG001|COMPLETED|Overall Study||381
10330783|NCT00314145|11466348|FG000|NOT COMPLETED|Overall Study||21
10330784|NCT00314145|11466349|FG001|NOT COMPLETED|Overall Study||29
10330785|NCT00314236|11466358|FG000|STARTED|Overall Study||41
10330786|NCT00314236|11466359|FG001|STARTED|Overall Study||39
10330787|NCT00314236|11466358|FG000|COMPLETED|Overall Study||41
10330788|NCT00314236|11466359|FG001|COMPLETED|Overall Study||37
10330789|NCT00314236|11466358|FG000|NOT COMPLETED|Overall Study||0
10330790|NCT00314236|11466359|FG001|NOT COMPLETED|Overall Study||2
10330791|NCT00314249|11466367|FG000|STARTED|Overall Study||509
10330792|NCT00314249|11466368|FG001|STARTED|Overall Study||516
10330793|NCT00314249|11466367|FG000|COMPLETED|Overall Study||357
10330794|NCT00314249|11466368|FG001|COMPLETED|Overall Study||353
10330795|NCT00314249|11466367|FG000|NOT COMPLETED|Overall Study||152
10330796|NCT00314249|11466368|FG001|NOT COMPLETED|Overall Study||163
10330797|NCT00314262|11466374|FG000|STARTED|Overall Study||12
10330798|NCT00314262|11466374|FG000|COMPLETED|Overall Study||7
10330799|NCT00314262|11466374|FG000|NOT COMPLETED|Overall Study||5
10330800|NCT00314340|11466378|FG000|STARTED|Overall Study||12
10330801|NCT00314340|11466378|FG000|ER Morphine|Overall Study||11
10330802|NCT00314340|11466378|FG000|Hydrocodone Plus APAP|Overall Study||12
10330803|NCT00314340|11466378|FG000|Placebo|Overall Study||12
10330804|NCT00314340|11466378|FG000|COMPLETED|Overall Study||11
10330805|NCT00314340|11466378|FG000|NOT COMPLETED|Overall Study||1
10330806|NCT00314574|11466386|FG000|STARTED|Overall Study||423
10330807|NCT00314574|11466387|FG001|STARTED|Overall Study||427
10330808|NCT00314574|11466386|FG000|Received at Least One Dose of Study Drug|Overall Study||421
10330809|NCT00314574|11466387|FG001|Received at Least One Dose of Study Drug|Overall Study||427
10330810|NCT00314574|11466386|FG000|Safety Population|Overall Study|1 patient in the placebo arm received Xolair and was added to the Xolair arm for Safety analyses.|420
10330811|NCT00314574|11466387|FG001|Safety Population|Overall Study||428
10330812|NCT00314574|11466386|FG000|COMPLETED|Overall Study||329
10330813|NCT00314574|11466387|FG001|COMPLETED|Overall Study||344
10330814|NCT00314574|11466386|FG000|NOT COMPLETED|Overall Study||94
10330815|NCT00314574|11466387|FG001|NOT COMPLETED|Overall Study||83
10330816|NCT00314795|11466393|FG000|STARTED|Overall Study||22
10330817|NCT00314795|11466393|FG000|COMPLETED|Overall Study||2
10330818|NCT00314795|11466393|FG000|NOT COMPLETED|Overall Study||20
10330819|NCT00314808|11466397|FG000|STARTED|Overall Study||33
10330820|NCT00314808|11466397|FG000|COMPLETED|Overall Study|Completed 2 cycles of Dronabinol or terminated early due to treatment-related adverse events (AE)|25
10330821|NCT00314808|11466397|FG000|NOT COMPLETED|Overall Study||8
10330822|NCT00314951|11466403|FG000|STARTED|Enrollment||323
10330823|NCT00314951|11466404|FG001|STARTED|Enrollment||306
10330824|NCT00314951|11466403|FG000|COMPLETED|Enrollment|6 subjects took incorrect treatment assignment, 6 subjects didn't take drug|323
10330825|NCT00314951|11466404|FG001|COMPLETED|Enrollment|6 subjects took incorrect treatment assignment, 6 subjects didn't take drug|300
10330826|NCT00314951|11466403|FG000|NOT COMPLETED|Enrollment||0
10330827|NCT00314951|11466404|FG001|NOT COMPLETED|Enrollment||6
10330828|NCT00314951|11466403|FG000|STARTED|Treatment||323
10330829|NCT00314951|11466404|FG001|STARTED|Treatment||300
10330830|NCT00314951|11466403|FG000|COMPLETED|Treatment||307
10330831|NCT00314951|11466404|FG001|COMPLETED|Treatment||289
10330832|NCT00314951|11466403|FG000|NOT COMPLETED|Treatment||16
10330833|NCT00314951|11466404|FG001|NOT COMPLETED|Treatment||11
10330834|NCT00314951|11466403|FG000|STARTED|Follow-up||307
10330835|NCT00314951|11466404|FG001|STARTED|Follow-up||289
10330836|NCT00314951|11466403|FG000|COMPLETED|Follow-up||263
10330837|NCT00314951|11466404|FG001|COMPLETED|Follow-up||255
10330838|NCT00314951|11466403|FG000|NOT COMPLETED|Follow-up||44
10330839|NCT00314951|11466404|FG001|NOT COMPLETED|Follow-up||34
10330840|NCT00315055|11466412|FG000|STARTED|Overall Study||155
10330841|NCT00315055|11466413|FG001|STARTED|Overall Study||155
10330842|NCT00315055|11466412|FG000|COMPLETED|Overall Study||152
10330843|NCT00315055|11466413|FG001|COMPLETED|Overall Study||150
10330844|NCT00315055|11466412|FG000|NOT COMPLETED|Overall Study||3
10330845|NCT00315055|11466413|FG001|NOT COMPLETED|Overall Study||5
10330846|NCT00315120|11466426|FG000|STARTED|Overall Study||115
10330847|NCT00315120|11466427|FG001|STARTED|Overall Study||118
10330848|NCT00315120|11466428|FG002|STARTED|Overall Study||115
10330849|NCT00315120|11466429|FG003|STARTED|Overall Study||107
10330850|NCT00315120|11466426|FG000|COMPLETED|Overall Study||115
10330851|NCT00315120|11466427|FG001|COMPLETED|Overall Study||118
10330852|NCT00315120|11466428|FG002|COMPLETED|Overall Study||115
10330853|NCT00315120|11466429|FG003|COMPLETED|Overall Study||107
10330854|NCT00315120|11466426|FG000|NOT COMPLETED|Overall Study||0
10330855|NCT00315120|11466427|FG001|NOT COMPLETED|Overall Study||0
10330856|NCT00315120|11466428|FG002|NOT COMPLETED|Overall Study||0
10330857|NCT00315120|11466429|FG003|NOT COMPLETED|Overall Study||0
10330858|NCT00315146|11466445|FG000|STARTED|Overall Study||22
10330859|NCT00315146|11466446|FG001|STARTED|Overall Study||22
10330860|NCT00315146|11466447|FG002|STARTED|Overall Study||22
10330861|NCT00315146|11466448|FG003|STARTED|Overall Study||22
10330862|NCT00315146|11466445|FG000|COMPLETED|Overall Study||20
10330863|NCT00315146|11466446|FG001|COMPLETED|Overall Study||19
10330864|NCT00315146|11466447|FG002|COMPLETED|Overall Study||20
10330865|NCT00315146|11466448|FG003|COMPLETED|Overall Study||22
10330866|NCT00315146|11466445|FG000|NOT COMPLETED|Overall Study||2
10330867|NCT00315146|11466446|FG001|NOT COMPLETED|Overall Study||3
10330868|NCT00315146|11466447|FG002|NOT COMPLETED|Overall Study||2
10330869|NCT00315146|11466448|FG003|NOT COMPLETED|Overall Study||0
10330870|NCT00315302|11466466|FG000|STARTED|Overall Study||90
10330871|NCT00315302|11466467|FG001|STARTED|Overall Study||90
10330872|NCT00315302|11466468|FG002|STARTED|Overall Study||26
10330873|NCT00315302|11466469|FG003|STARTED|Overall Study||34
10330874|NCT00315302|11466466|FG000|5 Week Visit|Overall Study||85
10330875|NCT00315302|11466467|FG001|5 Week Visit|Overall Study||86
10330876|NCT00315302|11466468|FG002|5 Week Visit|Overall Study||26
10330877|NCT00315302|11466469|FG003|5 Week Visit|Overall Study||30
10330878|NCT00315302|11466466|FG000|10 Week Visit|Overall Study|Can be higher as includes subjects who may have missed the 5 week visit|86
10330879|NCT00315302|11466467|FG001|10 Week Visit|Overall Study||85
10330880|NCT00315302|11466468|FG002|10 Week Visit|Overall Study||24
10330881|NCT00315302|11466469|FG003|10 Week Visit|Overall Study||29
10330882|NCT00315302|11466466|FG000|18 Week Primary Outcome Visit|Overall Study||84
10330883|NCT00315302|11466467|FG001|18 Week Primary Outcome Visit|Overall Study|Can be higher as includes subjects who may have missed the 10 week or other visit|88
10330884|NCT00315302|11466468|FG002|18 Week Primary Outcome Visit|Overall Study||24
10330885|NCT00315302|11466469|FG003|18 Week Primary Outcome Visit|Overall Study|Can be higher as includes subjects who may have missed the 10 week or other visit|31
10330886|NCT00315302|11466466|FG000|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|16
10330887|NCT00315302|11466467|FG001|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|13
10330888|NCT00315302|11466468|FG002|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|9
10330889|NCT00315302|11466469|FG003|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|11
10330890|NCT00315302|11466466|FG000|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|84
10330891|NCT00315302|11466467|FG001|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|88
10330892|NCT00315302|11466468|FG002|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|24
10330893|NCT00315302|11466469|FG003|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|31
10330894|NCT00315302|11466466|FG000|NOT COMPLETED|Overall Study||6
10330895|NCT00315302|11466467|FG001|NOT COMPLETED|Overall Study||2
10330896|NCT00315302|11466468|FG002|NOT COMPLETED|Overall Study||2
10330897|NCT00315302|11466469|FG003|NOT COMPLETED|Overall Study||3
10330898|NCT00315328|11466483|FG000|STARTED|Overall Study|Includes subjects with moderate amblyopia only (20/40 to 20/100 at baseline)|98
10330899|NCT00315328|11466484|FG001|STARTED|Overall Study|Includes subjects with moderate amblyopia only (20/40 to 20/100 at baseline)|95
10330900|NCT00315328|11466485|FG002|STARTED|Overall Study|Includes subjects with severe amblyopia only (20/125 to 20/400 at baseline)|18
10330901|NCT00315328|11466486|FG003|STARTED|Overall Study|Includes subjects with severe amblyopia only (20/125 to 20/400 at baseline)|22
10330902|NCT00315328|11466483|FG000|5 Week Visit|Overall Study||91
10330903|NCT00315328|11466484|FG001|5 Week Visit|Overall Study||89
10330904|NCT00315328|11466485|FG002|5 Week Visit|Overall Study||17
10330905|NCT00315328|11466486|FG003|5 Week Visit|Overall Study||19
10330906|NCT00315328|11466483|FG000|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|84
10330907|NCT00315328|11466484|FG001|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|88
10330908|NCT00315328|11466485|FG002|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|13
10330909|NCT00315328|11466486|FG003|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|20
10330910|NCT00315328|11466483|FG000|NOT COMPLETED|Overall Study||14
10330911|NCT00315328|11466484|FG001|NOT COMPLETED|Overall Study||7
10330912|NCT00315328|11466485|FG002|NOT COMPLETED|Overall Study||5
10330913|NCT00315328|11466486|FG003|NOT COMPLETED|Overall Study||2
10330914|NCT00315341|11466498|FG000|STARTED|Overall Study||740
10330915|NCT00315341|11466499|FG001|STARTED|Overall Study||529
10330916|NCT00315341|11466498|FG000|COMPLETED|Overall Study||340
10330917|NCT00315341|11466499|FG001|COMPLETED|Overall Study||391
10330918|NCT00315341|11466498|FG000|NOT COMPLETED|Overall Study||400
10330919|NCT00315341|11466499|FG001|NOT COMPLETED|Overall Study||138
10330920|NCT00315445|11466508|FG000|STARTED|Overall Study||45
10330921|NCT00315445|11466509|FG001|STARTED|Overall Study||43
10330922|NCT00315445|11466510|FG002|STARTED|Overall Study||46
10330923|NCT00315445|11466508|FG000|COMPLETED|Overall Study||18
10330924|NCT00315445|11466509|FG001|COMPLETED|Overall Study||27
10330925|NCT00315445|11466510|FG002|COMPLETED|Overall Study||22
10330926|NCT00315445|11466508|FG000|NOT COMPLETED|Overall Study||27
10330927|NCT00315445|11466509|FG001|NOT COMPLETED|Overall Study||16
10330928|NCT00315445|11466510|FG002|NOT COMPLETED|Overall Study||24
10330929|NCT00315458|11466520|FG000|STARTED|Overall Study||51
10330930|NCT00315458|11466521|FG001|STARTED|Overall Study||56
10330931|NCT00315458|11466522|FG002|STARTED|Overall Study||159
10330932|NCT00315458|11466523|FG003|STARTED|Overall Study||39
10330933|NCT00315458|11466520|FG000|COMPLETED|Overall Study||48
10330934|NCT00315458|11466521|FG001|COMPLETED|Overall Study||44
10330935|NCT00315458|11466522|FG002|COMPLETED|Overall Study||107
10330936|NCT00315458|11466523|FG003|COMPLETED|Overall Study||10
10330937|NCT00315458|11466520|FG000|NOT COMPLETED|Overall Study||3
10330938|NCT00315458|11466521|FG001|NOT COMPLETED|Overall Study||12
10330939|NCT00315458|11466522|FG002|NOT COMPLETED|Overall Study||52
10330940|NCT00315458|11466523|FG003|NOT COMPLETED|Overall Study||29
10330941|NCT00315588|11466533|FG000|STARTED|Overall Study||7
10330942|NCT00315588|11466533|FG000|COMPLETED|Overall Study||7
10330943|NCT00315588|11466533|FG000|NOT COMPLETED|Overall Study||0
10330944|NCT00315614|11466539|FG000|STARTED|Overall Study||3
10330945|NCT00315614|11466539|FG000|COMPLETED|Overall Study||3
10330946|NCT00315614|11466539|FG000|NOT COMPLETED|Overall Study||0
10330947|NCT00315627|11466544|FG000|STARTED|Overall Study||3
10330948|NCT00315627|11466544|FG000|COMPLETED|Overall Study||3
10330949|NCT00315627|11466544|FG000|NOT COMPLETED|Overall Study||0
10330950|NCT00315705|11466552|FG000|STARTED|Phase 1||25
10330951|NCT00315705|11466552|FG000|COMPLETED|Phase 1|No Phase 1 participants completed the treatment period (i.e. all 8 cycles and follow-up)|0
10330952|NCT00315705|11466552|FG000|NOT COMPLETED|Phase 1||25
10330953|NCT00315705|11466552|FG000|STARTED|Phase 2|Phase 1 and phase 2 are separate populations|25
10456645|NCT01007448|11604524|FG001|STARTED|Overall Study||29
10456646|NCT01007448|11604523|FG000|Full Analysis Population|Overall Study||30
10456647|NCT01007448|11604524|FG001|Full Analysis Population|Overall Study||29
10456648|NCT01007448|11604523|FG000|Safety Population|Overall Study||30
10456649|NCT01007448|11604524|FG001|Safety Population|Overall Study||29
10456650|NCT01007448|11604523|FG000|COMPLETED|Overall Study||20
10456651|NCT01007448|11604524|FG001|COMPLETED|Overall Study||20
10456652|NCT01007448|11604523|FG000|NOT COMPLETED|Overall Study||10
10456653|NCT01007448|11604524|FG001|NOT COMPLETED|Overall Study||9
10330954|NCT00315705|11466552|FG000|COMPLETED|Phase 2|No Phase 2 participants completed the treatment period (i.e. all 8 cycles and follow-up)|0
10330955|NCT00315705|11466552|FG000|NOT COMPLETED|Phase 2||25
10330956|NCT00315731|11466569|FG000|STARTED|Overall Study||15
10330957|NCT00315731|11466569|FG000|COMPLETED|Overall Study||9
10330958|NCT00315731|11466569|FG000|NOT COMPLETED|Overall Study||6
10330959|NCT00315822|11466577|FG000|STARTED|Overall Study||198
10330960|NCT00315822|11466578|FG001|STARTED|Overall Study||202
10330961|NCT00315822|11466577|FG000|COMPLETED|Overall Study||198
10456654|NCT01007526|11604530|FG000|STARTED|Overall Study||31
10456655|NCT01007526|11604530|FG000|COMPLETED|Overall Study||31
10330962|NCT00315822|11466578|FG001|COMPLETED|Overall Study||202
10330963|NCT00315822|11466577|FG000|NOT COMPLETED|Overall Study||0
10456656|NCT01007526|11604530|FG000|NOT COMPLETED|Overall Study||0
10330964|NCT00315822|11466578|FG001|NOT COMPLETED|Overall Study||0
10330965|NCT00315939|11466586|FG000|STARTED|Admission 1 (3 Months)||59
10330966|NCT00315939|11466587|FG001|STARTED|Admission 1 (3 Months)||61
10330967|NCT00315939|11466586|FG000|COMPLETED|Admission 1 (3 Months)||56
10330968|NCT00315939|11466587|FG001|COMPLETED|Admission 1 (3 Months)||55
10330969|NCT00315939|11466586|FG000|NOT COMPLETED|Admission 1 (3 Months)||3
10330970|NCT00315939|11466587|FG001|NOT COMPLETED|Admission 1 (3 Months)||6
10330971|NCT00315939|11466586|FG000|STARTED|Admission 2 (3 Months)||56
10330972|NCT00315939|11466587|FG001|STARTED|Admission 2 (3 Months)||55
10330973|NCT00315939|11466586|FG000|COMPLETED|Admission 2 (3 Months)||52
10330974|NCT00315939|11466587|FG001|COMPLETED|Admission 2 (3 Months)||51
10330975|NCT00315939|11466586|FG000|NOT COMPLETED|Admission 2 (3 Months)||4
10330976|NCT00315939|11466587|FG001|NOT COMPLETED|Admission 2 (3 Months)||4
10330977|NCT00315939|11466586|FG000|STARTED|Admission 3 (3 Months)||52
10330978|NCT00315939|11466587|FG001|STARTED|Admission 3 (3 Months)||51
10330979|NCT00315939|11466586|FG000|COMPLETED|Admission 3 (3 Months)||48
10330980|NCT00315939|11466587|FG001|COMPLETED|Admission 3 (3 Months)||49
10330981|NCT00315939|11466586|FG000|NOT COMPLETED|Admission 3 (3 Months)||4
10330982|NCT00315939|11466587|FG001|NOT COMPLETED|Admission 3 (3 Months)||2
10330983|NCT00316004|11466595|FG000|STARTED|Overall Study||373
10330984|NCT00316004|11466596|FG001|STARTED|Overall Study||355
10330985|NCT00316004|11466597|FG002|STARTED|Overall Study||603
10330986|NCT00316004|11466595|FG000|COMPLETED|Overall Study||359
10330987|NCT00316004|11466596|FG001|COMPLETED|Overall Study||341
10330988|NCT00316004|11466597|FG002|COMPLETED|Overall Study||582
10330989|NCT00316004|11466595|FG000|NOT COMPLETED|Overall Study||14
10330990|NCT00316004|11466596|FG001|NOT COMPLETED|Overall Study||14
10330991|NCT00316004|11466597|FG002|NOT COMPLETED|Overall Study||21
10338867|NCT02038777|11475787|FG001|COMPLETED|Overall Study||1
10338868|NCT02038777|11475788|FG002|COMPLETED|Overall Study||3
10338869|NCT02038777|11475789|FG003|COMPLETED|Overall Study||2
10338870|NCT02038777|11475790|FG004|COMPLETED|Overall Study||3
10338871|NCT02038777|11475791|FG005|COMPLETED|Overall Study||2
10338872|NCT02038777|11475792|FG006|COMPLETED|Overall Study||1
10338873|NCT02038777|11475793|FG007|COMPLETED|Overall Study||5
10338874|NCT02038777|11475786|FG000|NOT COMPLETED|Overall Study||1
10338875|NCT02038777|11475787|FG001|NOT COMPLETED|Overall Study||4
10338876|NCT02038777|11475788|FG002|NOT COMPLETED|Overall Study||3
10338877|NCT02038777|11475789|FG003|NOT COMPLETED|Overall Study||4
10338878|NCT02038777|11475790|FG004|NOT COMPLETED|Overall Study||3
10338879|NCT02038777|11475791|FG005|NOT COMPLETED|Overall Study||4
10338880|NCT02038777|11475792|FG006|NOT COMPLETED|Overall Study||0
10338881|NCT02038777|11475793|FG007|NOT COMPLETED|Overall Study||10
10338882|NCT01996449|11475812|FG000|STARTED|Period 1: First Drug||6
10338883|NCT01996449|11475813|FG001|STARTED|Period 1: First Drug||8
10338884|NCT01996449|11475812|FG000|COMPLETED|Period 1: First Drug||6
10338885|NCT01996449|11475813|FG001|COMPLETED|Period 1: First Drug||8
10338886|NCT01996449|11475812|FG000|NOT COMPLETED|Period 1: First Drug||0
10338887|NCT01996449|11475813|FG001|NOT COMPLETED|Period 1: First Drug||0
10338888|NCT01996449|11475812|FG000|STARTED|Period 2: Second Drug||6
10338889|NCT01996449|11475813|FG001|STARTED|Period 2: Second Drug||8
10338890|NCT01996449|11475812|FG000|COMPLETED|Period 2: Second Drug||6
10338891|NCT01996449|11475813|FG001|COMPLETED|Period 2: Second Drug||8
10338892|NCT01996449|11475812|FG000|NOT COMPLETED|Period 2: Second Drug||0
10338893|NCT01996449|11475813|FG001|NOT COMPLETED|Period 2: Second Drug||0
10338894|NCT01927419|11475823|FG000|STARTED|Pre-Treatment Period||95
10338895|NCT01927419|11475824|FG001|STARTED|Pre-Treatment Period||47
10338896|NCT01927419|11475823|FG000|COMPLETED|Pre-Treatment Period||94
10338897|NCT01927419|11475824|FG001|COMPLETED|Pre-Treatment Period||46
10338898|NCT01927419|11475823|FG000|NOT COMPLETED|Pre-Treatment Period||1
10338899|NCT01927419|11475824|FG001|NOT COMPLETED|Pre-Treatment Period||1
10338900|NCT01927419|11475823|FG000|STARTED|Treatment Period||94
10338901|NCT01927419|11475824|FG001|STARTED|Treatment Period||46
10338902|NCT01927419|11475823|FG000|COMPLETED|Treatment Period||0
10338903|NCT01927419|11475824|FG001|COMPLETED|Treatment Period||0
10338904|NCT01927419|11475823|FG000|NOT COMPLETED|Treatment Period||94
10338905|NCT01927419|11475824|FG001|NOT COMPLETED|Treatment Period||46
10805212|NCT04026308|11966759|FG000|STARTED|Overall Study||14
10805213|NCT04026308|11966760|FG001|STARTED|Overall Study||16
10805214|NCT04026308|11966759|FG000|COMPLETED|Overall Study||14
10805215|NCT04026308|11966760|FG001|COMPLETED|Overall Study||16
10805216|NCT04026308|11966759|FG000|NOT COMPLETED|Overall Study||0
10805217|NCT04026308|11966760|FG001|NOT COMPLETED|Overall Study||0
10338912|NCT01856140|11475841|FG000|STARTED|Overall Study||6
10338913|NCT01856140|11475842|FG001|STARTED|Overall Study||6
10338914|NCT01856140|11475841|FG000|COMPLETED|Overall Study||6
10338915|NCT01856140|11475842|FG001|COMPLETED|Overall Study||6
10338916|NCT01856140|11475841|FG000|NOT COMPLETED|Overall Study||0
10338917|NCT01856140|11475842|FG001|NOT COMPLETED|Overall Study||0
10456657|NCT01007552|11604534|FG000|STARTED|Overall Study||50
10456658|NCT01007552|11604534|FG000|COMPLETED|Overall Study||49
10456659|NCT01007552|11604534|FG000|NOT COMPLETED|Overall Study||1
10456660|NCT01007591|11604540|FG000|STARTED|Overall Study||27
10456661|NCT01007591|11604541|FG001|STARTED|Overall Study||13
10456662|NCT01007591|11604540|FG000|COMPLETED|Overall Study||26
10456663|NCT01007591|11604541|FG001|COMPLETED|Overall Study||12
10330992|NCT00316017|11466608|FG000|STARTED|Overall Study|"11 of 11 not completed due to Bag Opened Not Given (BONG)"|231
10330993|NCT00316017|11466609|FG001|STARTED|Overall Study|12 of 13 not completed due to BONG; 1 not completed was a prisoner who was excluded|269
10330994|NCT00316017|11466610|FG002|STARTED|Overall Study|19 of 19 not complete due to BONG|395
10330995|NCT00316017|11466608|FG000|COMPLETED|Overall Study||220
10330996|NCT00316017|11466609|FG001|COMPLETED|Overall Study||256
10805218|NCT04023682|11966766|FG000|STARTED|Overall Study||31
10805219|NCT04023682|11966766|FG000|COMPLETED|Overall Study||25
10805220|NCT04023682|11966766|FG000|NOT COMPLETED|Overall Study||6
10805221|NCT04021771|11966776|FG000|STARTED|Overall Study||55
10805222|NCT04021771|11966777|FG001|STARTED|Overall Study||54
10805223|NCT04021771|11966776|FG000|COMPLETED|Overall Study||55
10805224|NCT04021771|11966777|FG001|COMPLETED|Overall Study||54
10805225|NCT04021771|11966776|FG000|NOT COMPLETED|Overall Study||0
10805226|NCT04021771|11966777|FG001|NOT COMPLETED|Overall Study||0
10805227|NCT04019626|11966788|FG000|STARTED|Overall Study||42
10805228|NCT04019626|11966789|FG001|STARTED|Overall Study||42
10805229|NCT04019626|11966790|FG002|STARTED|Overall Study||45
10805230|NCT04019626|11966791|FG003|STARTED|Overall Study||46
10805231|NCT04019626|11966792|FG004|STARTED|Overall Study||44
10805232|NCT04019626|11966793|FG005|STARTED|Overall Study||21
10805233|NCT04019626|11966788|FG000|COMPLETED|Overall Study||36
10805234|NCT04019626|11966789|FG001|COMPLETED|Overall Study||32
10805235|NCT04019626|11966790|FG002|COMPLETED|Overall Study||37
10330997|NCT00316017|11466610|FG002|COMPLETED|Overall Study||376
10330998|NCT00316017|11466608|FG000|NOT COMPLETED|Overall Study||11
10330999|NCT00316017|11466609|FG001|NOT COMPLETED|Overall Study||13
10331000|NCT00316017|11466610|FG002|NOT COMPLETED|Overall Study||19
10331001|NCT00316082|11466623|FG000|STARTED|Overall Study||74
10331002|NCT00316082|11466624|FG001|STARTED|Overall Study||74
10331003|NCT00316082|11466625|FG002|STARTED|Overall Study||71
10331004|NCT00316082|11466626|FG003|STARTED|Overall Study||72
10331005|NCT00316082|11466627|FG004|STARTED|Overall Study||74
10331006|NCT00316082|11466623|FG000|Completed Study Without Being Rescued|Overall Study||25
10331007|NCT00316082|11466624|FG001|Completed Study Without Being Rescued|Overall Study||35
10331008|NCT00316082|11466625|FG002|Completed Study Without Being Rescued|Overall Study||29
10331009|NCT00316082|11466626|FG003|Completed Study Without Being Rescued|Overall Study||27
10331010|NCT00316082|11466627|FG004|Completed Study Without Being Rescued|Overall Study||31
10331011|NCT00316082|11466623|FG000|COMPLETED|Overall Study||41
10331012|NCT00316082|11466624|FG001|COMPLETED|Overall Study||52
10331013|NCT00316082|11466625|FG002|COMPLETED|Overall Study||44
10331014|NCT00316082|11466626|FG003|COMPLETED|Overall Study||46
10331015|NCT00316082|11466627|FG004|COMPLETED|Overall Study||48
10331016|NCT00316082|11466623|FG000|NOT COMPLETED|Overall Study||33
10331017|NCT00316082|11466624|FG001|NOT COMPLETED|Overall Study||22
10331018|NCT00316082|11466625|FG002|NOT COMPLETED|Overall Study||27
10331019|NCT00316082|11466626|FG003|NOT COMPLETED|Overall Study||26
10331020|NCT00316082|11466627|FG004|NOT COMPLETED|Overall Study||26
10331021|NCT00316121|11466645|FG000|STARTED|Overall Study||92
10331022|NCT00316121|11466646|FG001|STARTED|Overall Study||46
10331023|NCT00316121|11466645|FG000|COMPLETED|Overall Study||70
10331024|NCT00316121|11466646|FG001|COMPLETED|Overall Study||37
10331025|NCT00316121|11466645|FG000|NOT COMPLETED|Overall Study||22
10331026|NCT00316121|11466646|FG001|NOT COMPLETED|Overall Study||9
10331027|NCT00316173|11466654|FG000|STARTED|Run-in Phase||22
10331028|NCT00316173|11466655|FG001|STARTED|Run-in Phase||0
10331029|NCT00316173|11466654|FG000|COMPLETED|Run-in Phase||15
10331030|NCT00316173|11466655|FG001|COMPLETED|Run-in Phase||0
10331031|NCT00316173|11466654|FG000|NOT COMPLETED|Run-in Phase||7
10331032|NCT00316173|11466655|FG001|NOT COMPLETED|Run-in Phase||0
10331033|NCT00316173|11466654|FG000|STARTED|Treatment Phase||0
10331034|NCT00316173|11466655|FG001|STARTED|Treatment Phase||55
10331035|NCT00316173|11466654|FG000|COMPLETED|Treatment Phase||0
10331036|NCT00316173|11466655|FG001|COMPLETED|Treatment Phase||13
10331037|NCT00316173|11466654|FG000|NOT COMPLETED|Treatment Phase||0
10331038|NCT00316173|11466655|FG001|NOT COMPLETED|Treatment Phase||42
10331039|NCT00316186|11466660|FG000|STARTED|Overall Study||33
10331040|NCT00316186|11466660|FG000|COMPLETED|Overall Study||21
10331041|NCT00316186|11466660|FG000|NOT COMPLETED|Overall Study||12
10331042|NCT00316199|11466664|FG000|STARTED|Overall Study||60
10331043|NCT00316199|11466664|FG000|COMPLETED|Overall Study||48
10331044|NCT00316199|11466664|FG000|NOT COMPLETED|Overall Study||12
10331045|NCT00316225|11466668|FG000|STARTED|Overall Study||31
10331046|NCT00316225|11466668|FG000|COMPLETED|Overall Study||6
10331047|NCT00316225|11466668|FG000|NOT COMPLETED|Overall Study||25
10331048|NCT00316264|11466675|FG000|STARTED|Overall Study||83
10331049|NCT00316264|11466676|FG001|STARTED|Overall Study||84
10331050|NCT00316264|11466677|FG002|STARTED|Overall Study||93
10331051|NCT00316264|11466675|FG000|COMPLETED|Overall Study||77
10331052|NCT00316264|11466676|FG001|COMPLETED|Overall Study||77
10331053|NCT00316264|11466677|FG002|COMPLETED|Overall Study||87
10331054|NCT00316264|11466675|FG000|NOT COMPLETED|Overall Study||6
10456664|NCT01007591|11604540|FG000|NOT COMPLETED|Overall Study||1
10456665|NCT01007591|11604541|FG001|NOT COMPLETED|Overall Study||1
10456666|NCT01007643|11604549|FG000|STARTED|Overall Study||8
10456667|NCT01007643|11604550|FG001|STARTED|Overall Study||14
10456668|NCT01007643|11604549|FG000|COMPLETED|Overall Study||8
10456669|NCT01007643|11604550|FG001|COMPLETED|Overall Study||14
10456670|NCT01007643|11604549|FG000|NOT COMPLETED|Overall Study||0
10456671|NCT01007643|11604550|FG001|NOT COMPLETED|Overall Study||0
10331055|NCT00316264|11466676|FG001|NOT COMPLETED|Overall Study||7
10331056|NCT00316264|11466677|FG002|NOT COMPLETED|Overall Study||6
10331057|NCT00316277|11466687|FG000|STARTED|Phase 1 (12 Weeks)||329
10331058|NCT00316277|11466688|FG001|STARTED|Phase 1 (12 Weeks)||324
10331059|NCT00316277|11466687|FG000|COMPLETED|Phase 1 (12 Weeks)||19
10331060|NCT00316277|11466688|FG001|COMPLETED|Phase 1 (12 Weeks)||24
10331061|NCT00316277|11466687|FG000|NOT COMPLETED|Phase 1 (12 Weeks)||310
10331062|NCT00316277|11466688|FG001|NOT COMPLETED|Phase 1 (12 Weeks)||300
10331063|NCT00316277|11466687|FG000|STARTED|Phase 2 (24 Weeks)||180
10331064|NCT00316277|11466688|FG001|STARTED|Phase 2 (24 Weeks)||180
10331065|NCT00316277|11466687|FG000|COMPLETED|Phase 2 (24 Weeks)||161
10702011|NCT02572752|11866518|FG000|NOT COMPLETED|Period 3 Including Washout||0
10702012|NCT02572752|11866519|FG001|NOT COMPLETED|Period 3 Including Washout||0
10702013|NCT02572752|11866520|FG002|NOT COMPLETED|Period 3 Including Washout||0
10331066|NCT00316277|11466688|FG001|COMPLETED|Phase 2 (24 Weeks)||161
10331067|NCT00316277|11466687|FG000|NOT COMPLETED|Phase 2 (24 Weeks)||19
10331068|NCT00316277|11466688|FG001|NOT COMPLETED|Phase 2 (24 Weeks)||19
10331069|NCT00316303|11466704|FG000|STARTED|Overall Study||118
10331070|NCT00316303|11466705|FG001|STARTED|Overall Study||118
10331071|NCT00316303|11466704|FG000|COMPLETED|Overall Study||107
10331072|NCT00316303|11466705|FG001|COMPLETED|Overall Study||102
10331073|NCT00316303|11466704|FG000|NOT COMPLETED|Overall Study||11
10331074|NCT00316303|11466705|FG001|NOT COMPLETED|Overall Study||16
10331075|NCT00316355|11466716|FG000|STARTED|Overall Study||15
10331076|NCT00316355|11466717|FG001|STARTED|Overall Study||19
10331077|NCT00316355|11466716|FG000|Started Treatment|Overall Study||12
10331078|NCT00316355|11466717|FG001|Started Treatment|Overall Study||18
10331079|NCT00316355|11466716|FG000|COMPLETED|Overall Study||10
10331080|NCT00316355|11466717|FG001|COMPLETED|Overall Study||12
10331081|NCT00316355|11466716|FG000|NOT COMPLETED|Overall Study||5
10331082|NCT00316355|11466717|FG001|NOT COMPLETED|Overall Study||7
10331083|NCT00316524|11466727|FG000|STARTED|Overall Study||183
10331084|NCT00316524|11466728|FG001|STARTED|Overall Study||181
10331085|NCT00316524|11466729|FG002|STARTED|Overall Study||181
10331086|NCT00316524|11466730|FG003|STARTED|Overall Study||200
10331087|NCT00316524|11466727|FG000|COMPLETED|Overall Study||175
10331088|NCT00316524|11466728|FG001|COMPLETED|Overall Study||173
10331089|NCT00316524|11466729|FG002|COMPLETED|Overall Study||175
10331090|NCT00316524|11466730|FG003|COMPLETED|Overall Study||200
10331091|NCT00316524|11466727|FG000|NOT COMPLETED|Overall Study||8
10331092|NCT00316524|11466728|FG001|NOT COMPLETED|Overall Study||8
10331093|NCT00316524|11466729|FG002|NOT COMPLETED|Overall Study||6
10331094|NCT00316524|11466730|FG003|NOT COMPLETED|Overall Study||0
10331095|NCT00316589|11466748|FG000|STARTED|Overall Study||88
10331096|NCT00316589|11466749|FG001|STARTED|Overall Study||352
10331097|NCT00316589|11466750|FG002|STARTED|Overall Study||9
10331098|NCT00316589|11466751|FG003|STARTED|Overall Study||132
10331099|NCT00316589|11466748|FG000|COMPLETED|Overall Study||87
10331100|NCT00316589|11466749|FG001|COMPLETED|Overall Study||328
10331101|NCT00316589|11466750|FG002|COMPLETED|Overall Study||8
10331102|NCT00316589|11466751|FG003|COMPLETED|Overall Study||127
10331103|NCT00316589|11466748|FG000|NOT COMPLETED|Overall Study||1
10331104|NCT00316589|11466749|FG001|NOT COMPLETED|Overall Study||24
10331105|NCT00316589|11466750|FG002|NOT COMPLETED|Overall Study||1
10331106|NCT00316589|11466751|FG003|NOT COMPLETED|Overall Study||5
10331107|NCT00316602|11466765|FG000|STARTED|Overall Study||282
10331108|NCT00316602|11466766|FG001|STARTED|Overall Study||350
10331109|NCT00316602|11466765|FG000|COMPLETED|Overall Study||272
10331110|NCT00316602|11466766|FG001|COMPLETED|Overall Study||325
10331111|NCT00316602|11466765|FG000|NOT COMPLETED|Overall Study||10
10331112|NCT00316602|11466766|FG001|NOT COMPLETED|Overall Study||25
10331113|NCT00316693|11466774|FG000|STARTED|Overall Study||519
10331114|NCT00316693|11466775|FG001|STARTED|Overall Study||521
10331115|NCT00316693|11466774|FG000|COMPLETED|Overall Study||442
10331116|NCT00316693|11466775|FG001|COMPLETED|Overall Study||436
10331117|NCT00316693|11466774|FG000|NOT COMPLETED|Overall Study||77
10331118|NCT00316693|11466775|FG001|NOT COMPLETED|Overall Study||85
10331119|NCT00316706|11466783|FG000|STARTED|Overall Study||626
10331120|NCT00316706|11466784|FG001|STARTED|Overall Study||619
10331121|NCT00316706|11466783|FG000|COMPLETED|Overall Study|Subjects in Cervarix group that completed the study at Month 48|588
10702014|NCT02572817|11866529|FG000|STARTED|Overall Study||91
10702015|NCT02572817|11866530|FG001|STARTED|Overall Study||47
10702016|NCT02572817|11866529|FG000|COMPLETED|Overall Study||82
10702017|NCT02572817|11866530|FG001|COMPLETED|Overall Study||41
10702018|NCT02572817|11866529|FG000|NOT COMPLETED|Overall Study||9
10702019|NCT02572817|11866530|FG001|NOT COMPLETED|Overall Study||6
10331122|NCT00316706|11466784|FG001|COMPLETED|Overall Study|Subjects in Havrix group that completed the study at Month 24|571
10331123|NCT00316706|11466783|FG000|NOT COMPLETED|Overall Study||38
10702020|NCT02573012|11866538|FG000|STARTED|Overall Study||131
10702021|NCT02573012|11866539|FG001|STARTED|Overall Study||128
10702022|NCT02573012|11866538|FG000|COMPLETED|Overall Study||116
10331124|NCT00316706|11466784|FG001|NOT COMPLETED|Overall Study||48
10702023|NCT02573012|11866539|FG001|COMPLETED|Overall Study||113
10702024|NCT02573012|11866538|FG000|NOT COMPLETED|Overall Study||15
10331125|NCT00316719|11466792|FG000|STARTED|Overall Study||52
10331126|NCT00316719|11466793|FG001|STARTED|Overall Study||53
10331127|NCT00316719|11466792|FG000|COMPLETED|Overall Study||50
10331128|NCT00316719|11466793|FG001|COMPLETED|Overall Study||47
10702025|NCT02573012|11866539|FG001|NOT COMPLETED|Overall Study||15
10702026|NCT02573155|11866547|FG000|STARTED|Treatment Period 1||16
10331129|NCT00316719|11466792|FG000|NOT COMPLETED|Overall Study||2
10331130|NCT00316719|11466793|FG001|NOT COMPLETED|Overall Study||6
10331131|NCT00316862|11466799|FG000|STARTED|Overall Study||82
10331132|NCT00316862|11466799|FG000|COMPLETED|Overall Study||82
10331133|NCT00316862|11466799|FG000|NOT COMPLETED|Overall Study||0
10331134|NCT00316914|11466805|FG000|STARTED|Overall Study||50
10331135|NCT00316914|11466806|FG001|STARTED|Overall Study||52
10331136|NCT00316914|11466805|FG000|COMPLETED|Overall Study||17
10331137|NCT00316914|11466806|FG001|COMPLETED|Overall Study||16
10331138|NCT00316914|11466805|FG000|NOT COMPLETED|Overall Study||33
10331139|NCT00316914|11466806|FG001|NOT COMPLETED|Overall Study||36
10702027|NCT02573155|11866548|FG001|STARTED|Treatment Period 1||38
10702028|NCT02573155|11866547|FG000|COMPLETED|Treatment Period 1||16
10702029|NCT02573155|11866548|FG001|COMPLETED|Treatment Period 1||38
10702030|NCT02573155|11866547|FG000|NOT COMPLETED|Treatment Period 1||0
10702031|NCT02573155|11866548|FG001|NOT COMPLETED|Treatment Period 1||0
10702032|NCT02573155|11866547|FG000|STARTED|Washout Between Treatment Period 1 and 2||16
10331140|NCT00317044|11466815|FG000|STARTED|Overall Study||320
10331141|NCT00317044|11466816|FG001|STARTED|Overall Study||313
10331142|NCT00317044|11466817|FG002|STARTED|Overall Study||328
10331143|NCT00317044|11466815|FG000|COMPLETED|Overall Study||272
10331144|NCT00317044|11466816|FG001|COMPLETED|Overall Study||273
10331145|NCT00317044|11466817|FG002|COMPLETED|Overall Study||283
10331146|NCT00317044|11466815|FG000|NOT COMPLETED|Overall Study||48
10331147|NCT00317044|11466816|FG001|NOT COMPLETED|Overall Study||40
10331148|NCT00317044|11466817|FG002|NOT COMPLETED|Overall Study||45
10331149|NCT00317109|11466827|FG000|STARTED|Overall Study||84
10331150|NCT00317109|11466828|FG001|STARTED|Overall Study||84
10331151|NCT00317109|11466827|FG000|COMPLETED|Overall Study||81
10331152|NCT00317109|11466828|FG001|COMPLETED|Overall Study||84
10331153|NCT00317109|11466827|FG000|NOT COMPLETED|Overall Study||3
10331154|NCT00317109|11466828|FG001|NOT COMPLETED|Overall Study||0
10331155|NCT00317226|11466834|FG000|STARTED|Overall Study||127
10331156|NCT00317226|11466834|FG000|COMPLETED|Overall Study||104
10331157|NCT00317226|11466834|FG000|NOT COMPLETED|Overall Study||23
10331158|NCT00317239|11466840|FG000|STARTED|Overall Study||147
10331159|NCT00317239|11466841|FG001|STARTED|Overall Study||103
10331160|NCT00317239|11466840|FG000|COMPLETED|Overall Study||134
10331161|NCT00317239|11466841|FG001|COMPLETED|Overall Study||84
10331162|NCT00317239|11466840|FG000|NOT COMPLETED|Overall Study||13
10331163|NCT00317239|11466841|FG001|NOT COMPLETED|Overall Study||19
10331164|NCT00317356|11466851|FG000|STARTED|Overall Study||11
10331165|NCT00317356|11466852|FG001|STARTED|Overall Study||11
10331166|NCT00317356|11466853|FG002|STARTED|Overall Study||10
10331167|NCT00317356|11466854|FG003|STARTED|Overall Study||11
10331168|NCT00317356|11466851|FG000|COMPLETED|Overall Study||10
10331169|NCT00317356|11466852|FG001|COMPLETED|Overall Study||9
10331170|NCT00317356|11466853|FG002|COMPLETED|Overall Study||9
10331171|NCT00317356|11466854|FG003|COMPLETED|Overall Study||8
10331172|NCT00317356|11466851|FG000|NOT COMPLETED|Overall Study||1
10331173|NCT00317356|11466852|FG001|NOT COMPLETED|Overall Study||2
10331174|NCT00317356|11466853|FG002|NOT COMPLETED|Overall Study||1
10331175|NCT00317356|11466854|FG003|NOT COMPLETED|Overall Study||3
10331176|NCT00317369|11466867|FG000|STARTED|Overall Study||10
10331177|NCT00317369|11466868|FG001|STARTED|Overall Study||9
10331178|NCT00317369|11466869|FG002|STARTED|Overall Study||10
10331179|NCT00317369|11466867|FG000|COMPLETED|Overall Study||8
10331180|NCT00317369|11466868|FG001|COMPLETED|Overall Study||7
10331181|NCT00317369|11466869|FG002|COMPLETED|Overall Study||8
10331182|NCT00317369|11466867|FG000|NOT COMPLETED|Overall Study||2
10331183|NCT00317369|11466868|FG001|NOT COMPLETED|Overall Study||2
10702033|NCT02573155|11866548|FG001|STARTED|Washout Between Treatment Period 1 and 2||38
10331184|NCT00317369|11466869|FG002|NOT COMPLETED|Overall Study||2
10331185|NCT00317473|11466883|FG000|STARTED|Overall Study||30
10331186|NCT00317473|11466884|FG001|STARTED|Overall Study||15
10331187|NCT00317473|11466885|FG002|STARTED|Overall Study||30
10331188|NCT00317473|11466886|FG003|STARTED|Overall Study||15
10331189|NCT00317473|11466887|FG004|STARTED|Overall Study||30
10331190|NCT00317473|11466888|FG005|STARTED|Overall Study||15
10331191|NCT00317473|11466883|FG000|COMPLETED|Overall Study||26
10331192|NCT00317473|11466884|FG001|COMPLETED|Overall Study||12
10331193|NCT00317473|11466885|FG002|COMPLETED|Overall Study||27
10702034|NCT02573155|11866547|FG000|COMPLETED|Washout Between Treatment Period 1 and 2||16
10702035|NCT02573155|11866548|FG001|COMPLETED|Washout Between Treatment Period 1 and 2||33
10331194|NCT00317473|11466886|FG003|COMPLETED|Overall Study||13
10331195|NCT00317473|11466887|FG004|COMPLETED|Overall Study||22
10331196|NCT00317473|11466888|FG005|COMPLETED|Overall Study||12
10331197|NCT00317473|11466883|FG000|NOT COMPLETED|Overall Study||4
10331198|NCT00317473|11466884|FG001|NOT COMPLETED|Overall Study||3
10331199|NCT00317473|11466885|FG002|NOT COMPLETED|Overall Study||3
10331200|NCT00317473|11466886|FG003|NOT COMPLETED|Overall Study||2
10331201|NCT00317473|11466887|FG004|NOT COMPLETED|Overall Study||8
10331202|NCT00317473|11466888|FG005|NOT COMPLETED|Overall Study||3
10331203|NCT00317603|11466912|FG000|STARTED|Overall Study||15
10331204|NCT00317603|11466912|FG000|Treated|Overall Study||12
10331205|NCT00317603|11466912|FG000|COMPLETED|Overall Study||12
10331206|NCT00317603|11466912|FG000|NOT COMPLETED|Overall Study||3
10331207|NCT00317642|11466918|FG000|STARTED|Overall Study||163
10331208|NCT00317642|11466919|FG001|STARTED|Overall Study||163
10331209|NCT00317642|11466918|FG000|Full Analysis Set|Overall Study|AML Centrally Confirmed|162
10331210|NCT00317642|11466919|FG001|Full Analysis Set|Overall Study|AML Centrally Confirmed|158
10331211|NCT00317642|11466918|FG000|Received >= 1 Study Drug (Safety Set)|Overall Study||161
10331212|NCT00317642|11466919|FG001|Received >= 1 Study Drug (Safety Set)|Overall Study||155
10331213|NCT00317642|11466918|FG000|COMPLETED|Overall Study|achieved remission and completed consolidation|41
10331214|NCT00317642|11466919|FG001|COMPLETED|Overall Study|achieved remission and completed consolidation|28
10331215|NCT00317642|11466918|FG000|NOT COMPLETED|Overall Study||122
10331216|NCT00317642|11466919|FG001|NOT COMPLETED|Overall Study||135
10331217|NCT00317720|11466932|FG000|STARTED|Overall Study||40
10331218|NCT00317720|11466933|FG001|STARTED|Overall Study||7
10331219|NCT00317720|11466932|FG000|COMPLETED|Overall Study||40
10331220|NCT00317720|11466933|FG001|COMPLETED|Overall Study||7
10331221|NCT00317720|11466932|FG000|NOT COMPLETED|Overall Study||0
10331222|NCT00317720|11466933|FG001|NOT COMPLETED|Overall Study||0
10331223|NCT00317941|11466939|FG000|STARTED|Overall Study||73
10331224|NCT00317941|11466940|FG001|STARTED|Overall Study||79
10331225|NCT00317941|11466941|FG002|STARTED|Overall Study||68
10331226|NCT00317941|11466939|FG000|Participants Received Treatment|Overall Study||73
10331227|NCT00317941|11466940|FG001|Participants Received Treatment|Overall Study||79
10331228|NCT00317941|11466941|FG002|Participants Received Treatment|Overall Study||68
10331229|NCT00317941|11466939|FG000|Fulfilled Requirement Safety Population|Overall Study||73
10331230|NCT00317941|11466940|FG001|Fulfilled Requirement Safety Population|Overall Study||77
10331231|NCT00317941|11466941|FG002|Fulfilled Requirement Safety Population|Overall Study||65
10331232|NCT00317941|11466939|FG000|Fulfilled Requirements PP Population|Overall Study||66
10331233|NCT00317941|11466940|FG001|Fulfilled Requirements PP Population|Overall Study||76
10331234|NCT00317941|11466941|FG002|Fulfilled Requirements PP Population|Overall Study||63
10331235|NCT00317941|11466939|FG000|COMPLETED|Overall Study||66
10331236|NCT00317941|11466940|FG001|COMPLETED|Overall Study||74
10331237|NCT00317941|11466941|FG002|COMPLETED|Overall Study||60
10331238|NCT00317941|11466939|FG000|NOT COMPLETED|Overall Study||7
10331239|NCT00317941|11466940|FG001|NOT COMPLETED|Overall Study||5
10331240|NCT00317941|11466941|FG002|NOT COMPLETED|Overall Study||8
10331241|NCT00318136|11466950|FG000|STARTED|Overall Study||47
10331242|NCT00318136|11466950|FG000|COMPLETED|Overall Study||2
10331243|NCT00318136|11466950|FG000|NOT COMPLETED|Overall Study||45
10331244|NCT00318149|11466960|FG000|STARTED|Overall Study||75
10331245|NCT00318149|11466961|FG001|STARTED|Overall Study||50
10331246|NCT00318149|11466962|FG002|STARTED|Overall Study||75
10331247|NCT00318149|11466963|FG003|STARTED|Overall Study||75
10331248|NCT00318149|11466964|FG004|STARTED|Overall Study||75
10331249|NCT00318149|11466965|FG005|STARTED|Overall Study||75
10331250|NCT00318149|11466960|FG000|COMPLETED|Overall Study||75
10331251|NCT00318149|11466961|FG001|COMPLETED|Overall Study||50
10331252|NCT00318149|11466962|FG002|COMPLETED|Overall Study||75
10331253|NCT00318149|11466963|FG003|COMPLETED|Overall Study||75
10331254|NCT00318149|11466964|FG004|COMPLETED|Overall Study||75
10331255|NCT00318149|11466965|FG005|COMPLETED|Overall Study||73
10331256|NCT00318149|11466960|FG000|NOT COMPLETED|Overall Study||0
10331257|NCT00318149|11466961|FG001|NOT COMPLETED|Overall Study||0
10331258|NCT00318149|11466962|FG002|NOT COMPLETED|Overall Study||0
10331259|NCT00318149|11466963|FG003|NOT COMPLETED|Overall Study||0
10331260|NCT00318149|11466964|FG004|NOT COMPLETED|Overall Study||0
10331261|NCT00318149|11466965|FG005|NOT COMPLETED|Overall Study||2
10331262|NCT00318292|11466983|FG000|STARTED|Overall Study||45
10331263|NCT00318292|11466984|FG001|STARTED|Overall Study||45
10331264|NCT00318292|11466983|FG000|COMPLETED|Overall Study||45
10331265|NCT00318292|11466984|FG001|COMPLETED|Overall Study||45
10331266|NCT00318292|11466983|FG000|NOT COMPLETED|Overall Study||0
10331267|NCT00318292|11466984|FG001|NOT COMPLETED|Overall Study||0
10331268|NCT00318357|11466992|FG000|STARTED|Overall Study||173
10331269|NCT00318357|11466993|FG001|STARTED|Overall Study||136
10331270|NCT00318357|11466992|FG000|COMPLETED|Overall Study||134
10331271|NCT00318357|11466993|FG001|COMPLETED|Overall Study||104
10331272|NCT00318357|11466992|FG000|NOT COMPLETED|Overall Study||39
10331273|NCT00318357|11466993|FG001|NOT COMPLETED|Overall Study||32
10331274|NCT00318370|11466999|FG000|STARTED|Period 1||28
10331275|NCT00318370|11467000|FG001|STARTED|Period 1||0
10331276|NCT00318370|11467001|FG002|STARTED|Period 1||0
10331277|NCT00318370|11466999|FG000|COMPLETED|Period 1|21 participants proceeded from Far Only to Chemo Plus Far.|21
10331278|NCT00318370|11467000|FG001|COMPLETED|Period 1||0
10331279|NCT00318370|11467001|FG002|COMPLETED|Period 1||0
10331280|NCT00318370|11466999|FG000|NOT COMPLETED|Period 1||7
10331281|NCT00318370|11467000|FG001|NOT COMPLETED|Period 1||0
10331282|NCT00318370|11467001|FG002|NOT COMPLETED|Period 1||0
10331283|NCT00318370|11466999|FG000|STARTED|Period 2||0
10331284|NCT00318370|11467000|FG001|STARTED|Period 2|26 participants enrolled directly into Chemo Plus Far plus 21 participants from Far Only.|47
10331285|NCT00318370|11467001|FG002|STARTED|Period 2||0
10331286|NCT00318370|11466999|FG000|COMPLETED|Period 2||0
10331287|NCT00318370|11467000|FG001|COMPLETED|Period 2||36
10331288|NCT00318370|11467001|FG002|COMPLETED|Period 2||0
10331289|NCT00318370|11466999|FG000|NOT COMPLETED|Period 2||0
10331290|NCT00318370|11467000|FG001|NOT COMPLETED|Period 2||11
10331291|NCT00318370|11467001|FG002|NOT COMPLETED|Period 2||0
10331292|NCT00318370|11466999|FG000|STARTED|Period 3||0
10331293|NCT00318370|11467000|FG001|STARTED|Period 3||0
10331294|NCT00318370|11467001|FG002|STARTED|Period 3||36
10331295|NCT00318370|11466999|FG000|COMPLETED|Period 3||0
10331296|NCT00318370|11467000|FG001|COMPLETED|Period 3||0
10331297|NCT00318370|11467001|FG002|COMPLETED|Period 3||3
10331298|NCT00318370|11466999|FG000|NOT COMPLETED|Period 3||0
10331299|NCT00318370|11467000|FG001|NOT COMPLETED|Period 3||0
10331300|NCT00318370|11467001|FG002|NOT COMPLETED|Period 3||33
10331301|NCT00318409|11467009|FG000|STARTED|Overall Study||20
10331302|NCT00318409|11467010|FG001|STARTED|Overall Study||10
10331303|NCT00318409|11467009|FG000|COMPLETED|Overall Study||18
10331304|NCT00318409|11467010|FG001|COMPLETED|Overall Study||9
10331305|NCT00318409|11467009|FG000|NOT COMPLETED|Overall Study||2
10331306|NCT00318409|11467010|FG001|NOT COMPLETED|Overall Study||1
10331307|NCT00318461|11467022|FG000|STARTED|Double-Blind, 6 Months|Randomised|242
10331308|NCT00318461|11467023|FG001|STARTED|Double-Blind, 6 Months|Randomised|241
10331309|NCT00318461|11467024|FG002|STARTED|Double-Blind, 6 Months|Randomised|242
10331310|NCT00318461|11467025|FG003|STARTED|Double-Blind, 6 Months|Randomised|122
10331311|NCT00318461|11467026|FG004|STARTED|Double-Blind, 6 Months|Randomised|244
10331312|NCT00318461|11467022|FG000|Exposed to Study Drug|Double-Blind, 6 Months||242
10331313|NCT00318461|11467023|FG001|Exposed to Study Drug|Double-Blind, 6 Months|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|240
10331314|NCT00318461|11467024|FG002|Exposed to Study Drug|Double-Blind, 6 Months||242
10331315|NCT00318461|11467025|FG003|Exposed to Study Drug|Double-Blind, 6 Months|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|121
10331316|NCT00318461|11467026|FG004|Exposed to Study Drug|Double-Blind, 6 Months|Subjects withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|242
10331317|NCT00318461|11467022|FG000|COMPLETED|Double-Blind, 6 Months||208
10331318|NCT00318461|11467023|FG001|COMPLETED|Double-Blind, 6 Months||197
10331319|NCT00318461|11467024|FG002|COMPLETED|Double-Blind, 6 Months||191
10331320|NCT00318461|11467025|FG003|COMPLETED|Double-Blind, 6 Months||74
10331321|NCT00318461|11467026|FG004|COMPLETED|Double-Blind, 6 Months||210
10331322|NCT00318461|11467022|FG000|NOT COMPLETED|Double-Blind, 6 Months||34
10331323|NCT00318461|11467023|FG001|NOT COMPLETED|Double-Blind, 6 Months||44
10331324|NCT00318461|11467024|FG002|NOT COMPLETED|Double-Blind, 6 Months||51
10331325|NCT00318461|11467025|FG003|NOT COMPLETED|Double-Blind, 6 Months||48
10331326|NCT00318461|11467026|FG004|NOT COMPLETED|Double-Blind, 6 Months||34
10331327|NCT00318461|11467022|FG000|STARTED|Open-Label Extension, 18 Months||208
10331328|NCT00318461|11467023|FG001|STARTED|Open-Label Extension, 18 Months||197
10331329|NCT00318461|11467024|FG002|STARTED|Open-Label Extension, 18 Months||191
10331330|NCT00318461|11467025|FG003|STARTED|Open-Label Extension, 18 Months||74
10331331|NCT00318461|11467026|FG004|STARTED|Open-Label Extension, 18 Months||210
10331332|NCT00318461|11467022|FG000|COMPLETED|Open-Label Extension, 18 Months||130
10331333|NCT00318461|11467023|FG001|COMPLETED|Open-Label Extension, 18 Months||137
10331334|NCT00318461|11467024|FG002|COMPLETED|Open-Label Extension, 18 Months||118
10331335|NCT00318461|11467025|FG003|COMPLETED|Open-Label Extension, 18 Months||31
10331336|NCT00318461|11467026|FG004|COMPLETED|Open-Label Extension, 18 Months||113
10331337|NCT00318461|11467022|FG000|NOT COMPLETED|Open-Label Extension, 18 Months||78
10331338|NCT00318461|11467023|FG001|NOT COMPLETED|Open-Label Extension, 18 Months||60
10331339|NCT00318461|11467024|FG002|NOT COMPLETED|Open-Label Extension, 18 Months||73
10331340|NCT00318461|11467025|FG003|NOT COMPLETED|Open-Label Extension, 18 Months||43
10331341|NCT00318461|11467026|FG004|NOT COMPLETED|Open-Label Extension, 18 Months||97
10331342|NCT00318474|11467040|FG000|STARTED|Overall Study||25
10331343|NCT00318474|11467041|FG001|STARTED|Overall Study||27
10331344|NCT00318474|11467040|FG000|COMPLETED|Overall Study||7
10331345|NCT00318474|11467041|FG001|COMPLETED|Overall Study||10
10331346|NCT00318474|11467040|FG000|NOT COMPLETED|Overall Study||18
10331347|NCT00318474|11467041|FG001|NOT COMPLETED|Overall Study||17
10331348|NCT00318565|11467047|FG000|STARTED|Overall Study||291
10331349|NCT00318565|11467047|FG000|COMPLETED|Overall Study||267
10331350|NCT00318565|11467047|FG000|NOT COMPLETED|Overall Study||24
10331351|NCT00318591|11467053|FG000|STARTED|Overall Study||105
10331352|NCT00318591|11467054|FG001|STARTED|Overall Study||114
10331353|NCT00318591|11467053|FG000|COMPLETED|Overall Study||45
10331354|NCT00318591|11467054|FG001|COMPLETED|Overall Study||69
10331355|NCT00318591|11467053|FG000|NOT COMPLETED|Overall Study||60
10331356|NCT00318591|11467054|FG001|NOT COMPLETED|Overall Study||45
10331357|NCT00318643|11467067|FG000|STARTED|Overall Study||3
10331358|NCT00318643|11467068|FG001|STARTED|Overall Study||3
10331359|NCT00318643|11467069|FG002|STARTED|Overall Study||6
10331360|NCT00318643|11467070|FG003|STARTED|Overall Study||3
10331361|NCT00318643|11467071|FG004|STARTED|Overall Study||12
10331362|NCT00318643|11467067|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
10331363|NCT00318643|11467068|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
10331364|NCT00318643|11467069|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
10331365|NCT00318643|11467070|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
10331366|NCT00318643|11467071|FG004|Received at Least 1 Dose of Study Drug|Overall Study||12
10331367|NCT00318643|11467067|FG000|COMPLETED|Overall Study||3
10331368|NCT00318643|11467068|FG001|COMPLETED|Overall Study||3
10331369|NCT00318643|11467069|FG002|COMPLETED|Overall Study||6
10331370|NCT00318643|11467070|FG003|COMPLETED|Overall Study||3
10331371|NCT00318643|11467071|FG004|COMPLETED|Overall Study||9
10331372|NCT00318643|11467067|FG000|NOT COMPLETED|Overall Study||0
10331373|NCT00318643|11467068|FG001|NOT COMPLETED|Overall Study||0
10331374|NCT00318643|11467069|FG002|NOT COMPLETED|Overall Study||0
10331375|NCT00318643|11467070|FG003|NOT COMPLETED|Overall Study||0
10331376|NCT00318643|11467071|FG004|NOT COMPLETED|Overall Study||3
10331377|NCT00318708|11467086|FG000|STARTED|Overall Study||47
10331378|NCT00318708|11467087|FG001|STARTED|Overall Study||45
10331379|NCT00318708|11467086|FG000|8-week Milestone|Overall Study||42
10331380|NCT00318708|11467087|FG001|8-week Milestone|Overall Study||42
10331381|NCT00318708|11467086|FG000|COMPLETED|Overall Study||39
10331382|NCT00318708|11467087|FG001|COMPLETED|Overall Study||40
10331383|NCT00318708|11467086|FG000|NOT COMPLETED|Overall Study||8
10331384|NCT00318708|11467087|FG001|NOT COMPLETED|Overall Study||5
10331385|NCT00318812|11467099|FG000|STARTED|Overall Study||18
10331386|NCT00318812|11467100|FG001|STARTED|Overall Study||22
10331387|NCT00318812|11467099|FG000|COMPLETED|Overall Study||18
10331388|NCT00318812|11467100|FG001|COMPLETED|Overall Study||22
10331389|NCT00318812|11467099|FG000|NOT COMPLETED|Overall Study||0
10331390|NCT00318812|11467100|FG001|NOT COMPLETED|Overall Study||0
10331391|NCT00318929|11467106|FG000|STARTED|Overall Study||14
10331392|NCT00318929|11467106|FG000|COMPLETED|Overall Study||14
10331393|NCT00318929|11467106|FG000|NOT COMPLETED|Overall Study||0
10331394|NCT00319020|11467112|FG000|STARTED|Overall Study||15
10331395|NCT00319020|11467113|FG001|STARTED|Overall Study||21
10331396|NCT00319020|11467112|FG000|Enrollment in FUTURE 2 (F-2)|Overall Study||13
10331397|NCT00319020|11467113|FG001|Enrollment in FUTURE 2 (F-2)|Overall Study||20
10331398|NCT00319020|11467112|FG000|COMPLETED|Overall Study||8
10331399|NCT00319020|11467113|FG001|COMPLETED|Overall Study||8
10331400|NCT00319020|11467112|FG000|NOT COMPLETED|Overall Study||7
10331401|NCT00319020|11467113|FG001|NOT COMPLETED|Overall Study||13
10331402|NCT00319046|11467121|FG000|STARTED|Overall Study|One patient was excluded from analysis as the baseline liver volume not available|42
10331403|NCT00319046|11467121|FG000|COMPLETED|Overall Study||34
10331404|NCT00319046|11467121|FG000|NOT COMPLETED|Overall Study||8
10331405|NCT00319098|11467129|FG000|STARTED|Overall Study||3802
10331406|NCT00319098|11467130|FG001|STARTED|Overall Study||1269
10331407|NCT00319098|11467129|FG000|COMPLETED|Overall Study||3667
10331408|NCT00319098|11467130|FG001|COMPLETED|Overall Study||1237
10331409|NCT00319098|11467129|FG000|NOT COMPLETED|Overall Study||135
10331410|NCT00319098|11467130|FG001|NOT COMPLETED|Overall Study||32
10331411|NCT00319111|11467140|FG000|STARTED|Overall Study|148 patients enrolled in BENEFIT OL & 3 prematurely discontinued from BENEFIT (NCT00313222)|151
10331412|NCT00319111|11467140|FG000|COMPLETED|Overall Study||104
10331413|NCT00319111|11467140|FG000|NOT COMPLETED|Overall Study||47
10331414|NCT00319254|11467144|FG000|STARTED|Overall Study||75
10331415|NCT00319254|11467144|FG000|Treated|Overall Study||73
10331416|NCT00319254|11467144|FG000|COMPLETED|Overall Study||21
10331417|NCT00319254|11467144|FG000|NOT COMPLETED|Overall Study||54
10331418|NCT00319436|11467150|FG000|STARTED|Overall Study||23
10331419|NCT00319436|11467151|FG001|STARTED|Overall Study||24
10331420|NCT00319436|11467150|FG000|COMPLETED|Overall Study||17
10702036|NCT02573155|11866547|FG000|NOT COMPLETED|Washout Between Treatment Period 1 and 2||0
10331421|NCT00319436|11467151|FG001|COMPLETED|Overall Study||17
10331422|NCT00319436|11467150|FG000|NOT COMPLETED|Overall Study||6
10331423|NCT00319436|11467151|FG001|NOT COMPLETED|Overall Study||7
10456672|NCT01007656|11604556|FG000|STARTED|Overall Study||31
10456673|NCT01007656|11604556|FG000|COMPLETED|Overall Study||31
10456674|NCT01007656|11604556|FG000|NOT COMPLETED|Overall Study||0
10456675|NCT01007812|11604560|FG000|STARTED|Period 1, One Week||25
10456676|NCT01007812|11604561|FG001|STARTED|Period 1, One Week||25
10456677|NCT01007812|11604560|FG000|COMPLETED|Period 1, One Week||24
10456678|NCT01007812|11604561|FG001|COMPLETED|Period 1, One Week||24
10456679|NCT01007812|11604560|FG000|NOT COMPLETED|Period 1, One Week||1
10456680|NCT01007812|11604561|FG001|NOT COMPLETED|Period 1, One Week||1
10456681|NCT01007812|11604560|FG000|STARTED|Period 2, One Week||24
10456682|NCT01007812|11604561|FG001|STARTED|Period 2, One Week||24
10456683|NCT01007812|11604560|FG000|COMPLETED|Period 2, One Week||24
10456684|NCT01007812|11604561|FG001|COMPLETED|Period 2, One Week||24
10456685|NCT01007812|11604560|FG000|NOT COMPLETED|Period 2, One Week||0
10456686|NCT01007812|11604561|FG001|NOT COMPLETED|Period 2, One Week||0
10456687|NCT01007838|11604571|FG000|STARTED|Overall Study||12
10456688|NCT01007838|11604572|FG001|STARTED|Overall Study||11
10456689|NCT01007838|11604573|FG002|STARTED|Overall Study||5
10456690|NCT01007838|11604574|FG003|STARTED|Overall Study||4
10456691|NCT01007838|11604571|FG000|COMPLETED|Overall Study||9
10456692|NCT01007838|11604572|FG001|COMPLETED|Overall Study||11
10456693|NCT01007838|11604573|FG002|COMPLETED|Overall Study||5
10456694|NCT01007838|11604574|FG003|COMPLETED|Overall Study||4
10456695|NCT01007838|11604571|FG000|NOT COMPLETED|Overall Study||3
10456696|NCT01007838|11604572|FG001|NOT COMPLETED|Overall Study||0
10456697|NCT01007838|11604573|FG002|NOT COMPLETED|Overall Study||0
10456698|NCT01007838|11604574|FG003|NOT COMPLETED|Overall Study||0
10456699|NCT01007916|11604584|FG000|STARTED|Period 1, 4 Weeks of Wear||23
10456700|NCT01007916|11604585|FG001|STARTED|Period 1, 4 Weeks of Wear||26
10456701|NCT01007916|11604584|FG000|COMPLETED|Period 1, 4 Weeks of Wear||22
10456702|NCT01007916|11604585|FG001|COMPLETED|Period 1, 4 Weeks of Wear||26
10456703|NCT01007916|11604584|FG000|NOT COMPLETED|Period 1, 4 Weeks of Wear||1
10456704|NCT01007916|11604585|FG001|NOT COMPLETED|Period 1, 4 Weeks of Wear||0
10456705|NCT01007916|11604584|FG000|STARTED|Period 2, 4 Weeks of Wear||22
10456706|NCT01007916|11604585|FG001|STARTED|Period 2, 4 Weeks of Wear|One participant completed Period 1 but did not start Period 2 due to failing inclusion criteria.|25
10456707|NCT01007916|11604584|FG000|COMPLETED|Period 2, 4 Weeks of Wear||21
10456708|NCT01007916|11604585|FG001|COMPLETED|Period 2, 4 Weeks of Wear||25
10456709|NCT01007916|11604584|FG000|NOT COMPLETED|Period 2, 4 Weeks of Wear||1
10456710|NCT01007916|11604585|FG001|NOT COMPLETED|Period 2, 4 Weeks of Wear||0
10456711|NCT01007942|11604593|FG000|STARTED|Overall Study||284
10456712|NCT01007942|11604594|FG001|STARTED|Overall Study||285
10456713|NCT01007942|11604593|FG000|COMPLETED|Overall Study|Pts completed= on treatment at time of DCO. Not Completed = ended treatment as per protocol.|3
10456714|NCT01007942|11604594|FG001|COMPLETED|Overall Study|Pts completed= on treatment at time of DCO. Not Completed = ended treatment as per protocol.|7
10456715|NCT01007942|11604593|FG000|NOT COMPLETED|Overall Study||281
10456716|NCT01007942|11604594|FG001|NOT COMPLETED|Overall Study||278
10456717|NCT01007994|11604606|FG000|STARTED|Overall Study||17
10456718|NCT01007994|11604607|FG001|STARTED|Overall Study||16
10456719|NCT01007994|11604606|FG000|COMPLETED|Overall Study||15
10456720|NCT01007994|11604607|FG001|COMPLETED|Overall Study||14
10456721|NCT01007994|11604606|FG000|NOT COMPLETED|Overall Study||2
10456722|NCT01007994|11604607|FG001|NOT COMPLETED|Overall Study||2
10456723|NCT01008059|11604613|FG000|STARTED|Control Sequential Alfentanil||6
10456724|NCT01008059|11604614|FG001|STARTED|Control Sequential Alfentanil||0
10456725|NCT01008059|11604615|FG002|STARTED|Control Sequential Alfentanil||0
10456726|NCT01008059|11604616|FG003|STARTED|Control Sequential Alfentanil||0
10456727|NCT01008059|11604617|FG004|STARTED|Control Sequential Alfentanil||0
10456728|NCT01008059|11604618|FG005|STARTED|Control Sequential Alfentanil||0
10702037|NCT02573155|11866548|FG001|NOT COMPLETED|Washout Between Treatment Period 1 and 2||5
10331424|NCT00319501|11467159|FG000|STARTED|Double-blind Period|Randomized participants|124
10331425|NCT00319501|11467160|FG001|STARTED|Double-blind Period|Randomized participants|110
10331426|NCT00319501|11467159|FG000|Received Treatment|Double-blind Period||82
10331427|NCT00319501|11467160|FG001|Received Treatment|Double-blind Period||81
10331428|NCT00319501|11467159|FG000|COMPLETED|Double-blind Period||81
10456729|NCT01008059|11604619|FG006|STARTED|Control Sequential Alfentanil||0
10456730|NCT01008059|11604620|FG007|STARTED|Control Sequential Alfentanil||0
10331429|NCT00319501|11467160|FG001|COMPLETED|Double-blind Period||78
10331430|NCT00319501|11467159|FG000|NOT COMPLETED|Double-blind Period||43
10331431|NCT00319501|11467160|FG001|NOT COMPLETED|Double-blind Period||32
10331432|NCT00319501|11467159|FG000|STARTED|Open-label Period|Participants who continued to meet eligibility requirements|161
10331433|NCT00319501|11467160|FG001|STARTED|Open-label Period||0
10331434|NCT00319501|11467159|FG000|Received Treatment|Open-label Period||128
10331435|NCT00319501|11467160|FG001|Received Treatment|Open-label Period||0
10331436|NCT00319501|11467159|FG000|COMPLETED|Open-label Period|Competed=continuing treatment|45
10331437|NCT00319501|11467160|FG001|COMPLETED|Open-label Period||0
10331438|NCT00319501|11467159|FG000|NOT COMPLETED|Open-label Period||116
10331439|NCT00319501|11467160|FG001|NOT COMPLETED|Open-label Period||0
10331440|NCT00319501|11467159|FG000|STARTED|Open-label Extension Period|Eligible participants who chose to continue treatment|51
10331441|NCT00319501|11467160|FG001|STARTED|Open-label Extension Period||0
10331442|NCT00319501|11467159|FG000|Received Treatment|Open-label Extension Period||33
10331443|NCT00319501|11467160|FG001|Received Treatment|Open-label Extension Period||0
10331444|NCT00319501|11467159|FG000|COMPLETED|Open-label Extension Period||0
10331445|NCT00319501|11467160|FG001|COMPLETED|Open-label Extension Period||0
10331446|NCT00319501|11467159|FG000|NOT COMPLETED|Open-label Extension Period||51
10331447|NCT00319501|11467160|FG001|NOT COMPLETED|Open-label Extension Period||0
10331448|NCT00319553|11467173|FG000|STARTED|Overall Study||323
10331449|NCT00319553|11467174|FG001|STARTED|Overall Study||321
10331450|NCT00319553|11467173|FG000|COMPLETED|Overall Study||319
10331451|NCT00319553|11467174|FG001|COMPLETED|Overall Study||317
10331452|NCT00319553|11467173|FG000|NOT COMPLETED|Overall Study||4
10331453|NCT00319553|11467174|FG001|NOT COMPLETED|Overall Study||4
10331454|NCT00319592|11467182|FG000|STARTED|Overall Study||30
10331455|NCT00319592|11467183|FG001|STARTED|Overall Study||30
10331456|NCT00319592|11467182|FG000|COMPLETED|Overall Study||29
10331457|NCT00319592|11467183|FG001|COMPLETED|Overall Study||29
10331458|NCT00319592|11467182|FG000|NOT COMPLETED|Overall Study||1
10331459|NCT00319592|11467183|FG001|NOT COMPLETED|Overall Study||1
10331460|NCT00319644|11467191|FG000|STARTED|Overall Study||21
10331461|NCT00319644|11467192|FG001|STARTED|Overall Study||16
10331462|NCT00319644|11467191|FG000|COMPLETED|Overall Study||21
10331463|NCT00319644|11467192|FG001|COMPLETED|Overall Study||16
10331464|NCT00319644|11467191|FG000|NOT COMPLETED|Overall Study||0
10331465|NCT00319644|11467192|FG001|NOT COMPLETED|Overall Study||0
10331466|NCT00319696|11467198|FG000|STARTED|Overall Study||116
10331467|NCT00319696|11467198|FG000|COMPLETED|Overall Study||56
10331468|NCT00319696|11467198|FG000|NOT COMPLETED|Overall Study||60
10331469|NCT00319735|11467208|FG000|STARTED|Overall Study||41
10331470|NCT00319735|11467208|FG000|COMPLETED|Overall Study||39
10331471|NCT00319735|11467208|FG000|NOT COMPLETED|Overall Study||2
10331472|NCT00319748|11467213|FG000|STARTED|Overall Study||13
10331473|NCT00319748|11467213|FG000|COMPLETED|Overall Study||13
10331474|NCT00319748|11467213|FG000|NOT COMPLETED|Overall Study||0
10331475|NCT00319956|11467225|FG000|STARTED|Overall Study||111
10331476|NCT00319956|11467226|FG001|STARTED|Overall Study||109
10331477|NCT00319956|11467225|FG000|COMPLETED|Overall Study||91
10331478|NCT00319956|11467226|FG001|COMPLETED|Overall Study||85
10331479|NCT00319956|11467225|FG000|NOT COMPLETED|Overall Study||20
10331480|NCT00319956|11467226|FG001|NOT COMPLETED|Overall Study||24
10331481|NCT00319982|11467234|FG000|STARTED|Overall Study||19
10331482|NCT00319982|11467235|FG001|STARTED|Overall Study||20
10331483|NCT00319982|11467234|FG000|COMPLETED|Overall Study||18
10331484|NCT00319982|11467235|FG001|COMPLETED|Overall Study||20
10331485|NCT00319982|11467234|FG000|NOT COMPLETED|Overall Study||1
10331486|NCT00319982|11467235|FG001|NOT COMPLETED|Overall Study||0
10331487|NCT00320112|11467243|FG000|STARTED|Overall Study||125
10702038|NCT02573155|11866547|FG000|STARTED|Period 2||16
10702039|NCT02573155|11866548|FG001|STARTED|Period 2||33
10702040|NCT02573155|11866547|FG000|COMPLETED|Period 2||16
10702041|NCT02573155|11866548|FG001|COMPLETED|Period 2||33
10702042|NCT02573155|11866547|FG000|NOT COMPLETED|Period 2||0
10331488|NCT00320112|11467244|FG001|STARTED|Overall Study||119
10331489|NCT00320112|11467243|FG000|COMPLETED|Overall Study||117
10331490|NCT00320112|11467244|FG001|COMPLETED|Overall Study||114
10331491|NCT00320112|11467243|FG000|NOT COMPLETED|Overall Study||8
10331492|NCT00320112|11467244|FG001|NOT COMPLETED|Overall Study||5
10331493|NCT00320190|11467258|FG000|STARTED|First 12 Months||19
10331494|NCT00320190|11467259|FG001|STARTED|First 12 Months||13
10331495|NCT00320190|11467258|FG000|COMPLETED|First 12 Months||11
10331496|NCT00320190|11467259|FG001|COMPLETED|First 12 Months||3
10331497|NCT00320190|11467258|FG000|NOT COMPLETED|First 12 Months||8
10331498|NCT00320190|11467259|FG001|NOT COMPLETED|First 12 Months||10
10331499|NCT00320190|11467258|FG000|STARTED|Long-term (12-month) Extension||11
10331500|NCT00320190|11467259|FG001|STARTED|Long-term (12-month) Extension||3
10331501|NCT00320190|11467258|FG000|COMPLETED|Long-term (12-month) Extension||2
10331502|NCT00320190|11467259|FG001|COMPLETED|Long-term (12-month) Extension||1
10331503|NCT00320190|11467258|FG000|NOT COMPLETED|Long-term (12-month) Extension||9
10331504|NCT00320190|11467259|FG001|NOT COMPLETED|Long-term (12-month) Extension||2
10331505|NCT00320216|11467270|FG000|STARTED|Overall Study||64
10331506|NCT00320216|11467271|FG001|STARTED|Overall Study|1 patient randomized but not treated was included as discontinued due to Other reason.|64
10331507|NCT00320216|11467272|FG002|STARTED|Overall Study|1 patient randomized but not treated was included as discontinued due to Other reason.|64
10331508|NCT00320216|11467273|FG003|STARTED|Overall Study||64
10702043|NCT02573155|11866548|FG001|NOT COMPLETED|Period 2||0
10702044|NCT02573155|11866547|FG000|STARTED|Washout Between Treatment Period 2 and 3||16
10331509|NCT00320216|11467274|FG004|STARTED|Overall Study||64
10331510|NCT00320216|11467270|FG000|COMPLETED|Overall Study||48
10331511|NCT00320216|11467271|FG001|COMPLETED|Overall Study||54
10331512|NCT00320216|11467272|FG002|COMPLETED|Overall Study||58
10331513|NCT00320216|11467273|FG003|COMPLETED|Overall Study||61
10331514|NCT00320216|11467274|FG004|COMPLETED|Overall Study||58
10331515|NCT00320216|11467270|FG000|NOT COMPLETED|Overall Study||16
10331516|NCT00320216|11467271|FG001|NOT COMPLETED|Overall Study||10
10331517|NCT00320216|11467272|FG002|NOT COMPLETED|Overall Study||6
10331518|NCT00320216|11467273|FG003|NOT COMPLETED|Overall Study||3
10331519|NCT00320216|11467274|FG004|NOT COMPLETED|Overall Study||6
10331520|NCT00320242|11467291|FG000|STARTED|Overall Study||16
10331521|NCT00320242|11467292|FG001|STARTED|Overall Study||16
10331522|NCT00320242|11467291|FG000|COMPLETED|Overall Study||14
10331523|NCT00320242|11467292|FG001|COMPLETED|Overall Study||12
10331524|NCT00320242|11467291|FG000|NOT COMPLETED|Overall Study||2
10331525|NCT00320242|11467292|FG001|NOT COMPLETED|Overall Study||4
10331526|NCT00320255|11467305|FG000|STARTED|Overall Study||30
10331527|NCT00320255|11467306|FG001|STARTED|Overall Study||32
10331528|NCT00320255|11467307|FG002|STARTED|Overall Study||30
10331529|NCT00320255|11467308|FG003|STARTED|Overall Study||33
10331530|NCT00320255|11467309|FG004|STARTED|Overall Study||2
10331531|NCT00320255|11467310|FG005|STARTED|Overall Study||3
10331532|NCT00320255|11467305|FG000|Received Treatment|Overall Study||29
10331533|NCT00320255|11467306|FG001|Received Treatment|Overall Study||32
10331534|NCT00320255|11467307|FG002|Received Treatment|Overall Study||29
10331535|NCT00320255|11467308|FG003|Received Treatment|Overall Study||32
10331536|NCT00320255|11467309|FG004|Received Treatment|Overall Study||2
10331537|NCT00320255|11467310|FG005|Received Treatment|Overall Study||3
10331538|NCT00320255|11467305|FG000|COMPLETED|Overall Study||19
10331539|NCT00320255|11467306|FG001|COMPLETED|Overall Study||25
10331540|NCT00320255|11467307|FG002|COMPLETED|Overall Study||24
10331541|NCT00320255|11467308|FG003|COMPLETED|Overall Study||25
10331542|NCT00320255|11467309|FG004|COMPLETED|Overall Study||2
10331543|NCT00320255|11467310|FG005|COMPLETED|Overall Study||3
10331544|NCT00320255|11467305|FG000|NOT COMPLETED|Overall Study||11
10331545|NCT00320255|11467306|FG001|NOT COMPLETED|Overall Study||7
10331546|NCT00320255|11467307|FG002|NOT COMPLETED|Overall Study||6
10331547|NCT00320255|11467308|FG003|NOT COMPLETED|Overall Study||8
10331548|NCT00320255|11467309|FG004|NOT COMPLETED|Overall Study||0
10331549|NCT00320255|11467310|FG005|NOT COMPLETED|Overall Study||0
10331550|NCT00320281|11467327|FG000|STARTED|Overall Study||10
10331551|NCT00320281|11467328|FG001|STARTED|Overall Study||9
10331552|NCT00320281|11467327|FG000|COMPLETED|Overall Study||10
10331553|NCT00320281|11467328|FG001|COMPLETED|Overall Study||9
10331554|NCT00320281|11467327|FG000|NOT COMPLETED|Overall Study||0
10331555|NCT00320281|11467328|FG001|NOT COMPLETED|Overall Study||0
10331556|NCT00320372|11467339|FG000|STARTED|Overall Study||494
10331557|NCT00320372|11467340|FG001|STARTED|Overall Study||301
10331558|NCT00320372|11467339|FG000|VNS Therapy D-23 Original|Overall Study||335
10331559|NCT00320372|11467340|FG001|VNS Therapy D-23 Original|Overall Study||0
10331560|NCT00320372|11467339|FG000|VNS Therapy D-21 (NCT00305565) Rollovers|Overall Study||159
10331561|NCT00320372|11467340|FG001|VNS Therapy D-21 (NCT00305565) Rollovers|Overall Study||0
10331562|NCT00320372|11467339|FG000|COMPLETED|Overall Study||299
10331563|NCT00320372|11467340|FG001|COMPLETED|Overall Study||138
10331564|NCT00320372|11467339|FG000|NOT COMPLETED|Overall Study||195
10331565|NCT00320372|11467340|FG001|NOT COMPLETED|Overall Study||163
10331566|NCT00320385|11467356|FG000|STARTED|Overall Study||148
10331567|NCT00320385|11467357|FG001|STARTED|Overall Study||148
10331568|NCT00320385|11467356|FG000|COMPLETED|Overall Study||130
10331569|NCT00320385|11467357|FG001|COMPLETED|Overall Study||126
10331570|NCT00320385|11467356|FG000|NOT COMPLETED|Overall Study||18
10331571|NCT00320385|11467357|FG001|NOT COMPLETED|Overall Study||22
10331572|NCT00320398|11467365|FG000|STARTED|Overall Study||58
10331573|NCT00320398|11467366|FG001|STARTED|Overall Study||56
10331574|NCT00320398|11467365|FG000|COMPLETED|Overall Study||56
10331575|NCT00320398|11467366|FG001|COMPLETED|Overall Study||52
10331576|NCT00320398|11467365|FG000|NOT COMPLETED|Overall Study||2
10331577|NCT00320398|11467366|FG001|NOT COMPLETED|Overall Study||4
10331578|NCT00320411|11467373|FG000|STARTED|Overall Study||62
10331579|NCT00320411|11467373|FG000|COMPLETED|Overall Study||58
10331580|NCT00320411|11467373|FG000|NOT COMPLETED|Overall Study||4
10331581|NCT00320424|11467377|FG000|STARTED|Overall Study||48
10331582|NCT00320424|11467377|FG000|COMPLETED|Overall Study||42
10331583|NCT00320424|11467377|FG000|NOT COMPLETED|Overall Study||6
10331584|NCT00320489|11467383|FG000|STARTED|Overall Study||264
10331585|NCT00320489|11467384|FG001|STARTED|Overall Study||260
10331586|NCT00320489|11467383|FG000|COMPLETED|Overall Study||119
10331587|NCT00320489|11467384|FG001|COMPLETED|Overall Study||124
10331588|NCT00320489|11467383|FG000|NOT COMPLETED|Overall Study||145
10331589|NCT00320489|11467384|FG001|NOT COMPLETED|Overall Study||136
10331590|NCT00320515|11467390|FG000|STARTED|Overall Study||69
10331591|NCT00320515|11467390|FG000|COMPLETED|Overall Study||20
10331592|NCT00320515|11467390|FG000|NOT COMPLETED|Overall Study||49
10331593|NCT00320528|11467397|FG000|STARTED|Study Period II||98
10331594|NCT00320528|11467398|FG001|STARTED|Study Period II||41
10331595|NCT00320528|11467399|FG002|STARTED|Study Period II||130
10331596|NCT00320528|11467397|FG000|Received at Least One Dose of Study Drug|Study Period II||97
10331597|NCT00320528|11467398|FG001|Received at Least One Dose of Study Drug|Study Period II||38
10331598|NCT00320528|11467399|FG002|Received at Least One Dose of Study Drug|Study Period II||128
10331599|NCT00320528|11467397|FG000|COMPLETED|Study Period II||87
10331600|NCT00320528|11467398|FG001|COMPLETED|Study Period II||31
10331601|NCT00320528|11467399|FG002|COMPLETED|Study Period II||108
10331602|NCT00320528|11467397|FG000|NOT COMPLETED|Study Period II||11
10331603|NCT00320528|11467398|FG001|NOT COMPLETED|Study Period II||10
10331604|NCT00320528|11467399|FG002|NOT COMPLETED|Study Period II||22
10331605|NCT00320528|11467397|FG000|STARTED|Study Period III||87
10331606|NCT00320528|11467398|FG001|STARTED|Study Period III||31
10331607|NCT00320528|11467399|FG002|STARTED|Study Period III||108
10331608|NCT00320528|11467397|FG000|COMPLETED|Study Period III||0
10331609|NCT00320528|11467398|FG001|COMPLETED|Study Period III||0
10331610|NCT00320528|11467399|FG002|COMPLETED|Study Period III||2
10331611|NCT00320528|11467397|FG000|NOT COMPLETED|Study Period III||87
10331612|NCT00320528|11467398|FG001|NOT COMPLETED|Study Period III||31
10331613|NCT00320528|11467399|FG002|NOT COMPLETED|Study Period III||106
10331614|NCT00320541|11467409|FG000|STARTED|Overall Study||94
10331615|NCT00320541|11467410|FG001|STARTED|Overall Study||93
10331616|NCT00320541|11467409|FG000|COMPLETED|Overall Study||44
10331617|NCT00320541|11467410|FG001|COMPLETED|Overall Study||36
10331618|NCT00320541|11467409|FG000|NOT COMPLETED|Overall Study||50
10331619|NCT00320541|11467410|FG001|NOT COMPLETED|Overall Study||57
10331620|NCT00320593|11467418|FG000|STARTED|Overall Study||59
10331621|NCT00320593|11467419|FG001|STARTED|Overall Study||59
10331622|NCT00320593|11467418|FG000|COMPLETED|Overall Study|Completed defined as completing the 3 year primary outcome exam|52
10331623|NCT00320593|11467419|FG001|COMPLETED|Overall Study|Completed defined as completing the 3 year primary outcome exam|58
10331624|NCT00320593|11467418|FG000|NOT COMPLETED|Overall Study||7
10331625|NCT00320593|11467419|FG001|NOT COMPLETED|Overall Study||1
10331626|NCT00320606|11467425|FG000|STARTED|Overall Study||20
10331627|NCT00320606|11467425|FG000|COMPLETED|Overall Study||17
10331628|NCT00320606|11467425|FG000|NOT COMPLETED|Overall Study||3
10331629|NCT00320671|11467432|FG000|STARTED|Overall Study||102
10331630|NCT00320671|11467433|FG001|STARTED|Overall Study||96
10331631|NCT00320671|11467432|FG000|COMPLETED|Overall Study||69
10331632|NCT00320671|11467433|FG001|COMPLETED|Overall Study||58
10331633|NCT00320671|11467432|FG000|NOT COMPLETED|Overall Study||33
10331634|NCT00320671|11467433|FG001|NOT COMPLETED|Overall Study||38
10331635|NCT00320710|11467442|FG000|STARTED|Overall Study||200
10331636|NCT00320710|11467443|FG001|STARTED|Overall Study||203
10331637|NCT00320710|11467444|FG002|STARTED|Overall Study||13
10331638|NCT00320710|11467442|FG000|Treated (Safety Set)|Overall Study||198
10331639|NCT00320710|11467443|FG001|Treated (Safety Set)|Overall Study||202
10331640|NCT00320710|11467444|FG002|Treated (Safety Set)|Overall Study||13
10331641|NCT00320710|11467442|FG000|COMPLETED|Overall Study||106
10331642|NCT00320710|11467443|FG001|COMPLETED|Overall Study||127
10331643|NCT00320710|11467444|FG002|COMPLETED|Overall Study||8
10331644|NCT00320710|11467442|FG000|NOT COMPLETED|Overall Study||94
10331645|NCT00320710|11467443|FG001|NOT COMPLETED|Overall Study||76
10331646|NCT00320710|11467444|FG002|NOT COMPLETED|Overall Study||5
10331647|NCT00320749|11467451|FG000|STARTED|Overall Study||3
10331648|NCT00320749|11467452|FG001|STARTED|Overall Study||8
10331649|NCT00320749|11467453|FG002|STARTED|Overall Study||10
10331650|NCT00320749|11467451|FG000|COMPLETED|Overall Study||3
10331651|NCT00320749|11467452|FG001|COMPLETED|Overall Study||6
10331652|NCT00320749|11467453|FG002|COMPLETED|Overall Study||1
10331653|NCT00320749|11467451|FG000|NOT COMPLETED|Overall Study||0
10331654|NCT00320749|11467452|FG001|NOT COMPLETED|Overall Study||2
10331655|NCT00320749|11467453|FG002|NOT COMPLETED|Overall Study||9
10331656|NCT00320788|11467463|FG000|STARTED|Overall Study||32
10331657|NCT00320788|11467464|FG001|STARTED|Overall Study||32
10331658|NCT00320788|11467465|FG002|STARTED|Overall Study||32
10331659|NCT00320788|11467466|FG003|STARTED|Overall Study|Participants Randomized|32
10331660|NCT00320788|11467467|FG004|STARTED|Overall Study||31
10331661|NCT00320788|11467463|FG000|Participants Received Treatment (SAF)|Overall Study||32
10331662|NCT00320788|11467464|FG001|Participants Received Treatment (SAF)|Overall Study||32
10331663|NCT00320788|11467465|FG002|Participants Received Treatment (SAF)|Overall Study|One participant in this group did not receive treatment and was not included in the SAF and FAS|31
10331664|NCT00320788|11467466|FG003|Participants Received Treatment (SAF)|Overall Study|One participant in this group did not receive treatment and was not included in the SAF and FAS|31
10331665|NCT00320788|11467467|FG004|Participants Received Treatment (SAF)|Overall Study||31
10331666|NCT00320788|11467463|FG000|COMPLETED|Overall Study||26
10331667|NCT00320788|11467464|FG001|COMPLETED|Overall Study||26
10331668|NCT00320788|11467465|FG002|COMPLETED|Overall Study||29
10331669|NCT00320788|11467466|FG003|COMPLETED|Overall Study||27
10331670|NCT00320788|11467467|FG004|COMPLETED|Overall Study||26
10331671|NCT00320788|11467463|FG000|NOT COMPLETED|Overall Study||6
10331672|NCT00320788|11467464|FG001|NOT COMPLETED|Overall Study||6
10331673|NCT00320788|11467465|FG002|NOT COMPLETED|Overall Study||3
10331674|NCT00320788|11467466|FG003|NOT COMPLETED|Overall Study||5
10331675|NCT00320788|11467467|FG004|NOT COMPLETED|Overall Study||5
10331676|NCT00320801|11467487|FG000|STARTED|Open-label Run-in Period||188
10331677|NCT00320801|11467488|FG001|STARTED|Open-label Run-in Period||0
10331678|NCT00320801|11467489|FG002|STARTED|Open-label Run-in Period||0
10331679|NCT00320801|11467490|FG003|STARTED|Open-label Run-in Period||0
10331680|NCT00320801|11467487|FG000|COMPLETED|Open-label Run-in Period||96
10331681|NCT00320801|11467488|FG001|COMPLETED|Open-label Run-in Period||0
10331682|NCT00320801|11467489|FG002|COMPLETED|Open-label Run-in Period||0
10331683|NCT00320801|11467490|FG003|COMPLETED|Open-label Run-in Period||0
10331684|NCT00320801|11467487|FG000|NOT COMPLETED|Open-label Run-in Period||92
10331685|NCT00320801|11467488|FG001|NOT COMPLETED|Open-label Run-in Period||0
10331686|NCT00320801|11467489|FG002|NOT COMPLETED|Open-label Run-in Period||0
10331687|NCT00320801|11467490|FG003|NOT COMPLETED|Open-label Run-in Period||0
10331688|NCT00320801|11467487|FG000|STARTED|Double-blind Phase||0
10331689|NCT00320801|11467488|FG001|STARTED|Double-blind Phase||47
10331690|NCT00320801|11467489|FG002|STARTED|Double-blind Phase||49
10331691|NCT00320801|11467490|FG003|STARTED|Double-blind Phase||0
10331692|NCT00320801|11467487|FG000|COMPLETED|Double-blind Phase||0
10331693|NCT00320801|11467488|FG001|COMPLETED|Double-blind Phase||36
10331694|NCT00320801|11467489|FG002|COMPLETED|Double-blind Phase||35
10574680|NCT01680016|11729932|FG003|COMPLETED|Overall Study||195
10574681|NCT01680016|11729929|FG000|NOT COMPLETED|Overall Study||6
10574682|NCT01680016|11729930|FG001|NOT COMPLETED|Overall Study||8
10574683|NCT01680016|11729931|FG002|NOT COMPLETED|Overall Study||5
10574684|NCT01680016|11729932|FG003|NOT COMPLETED|Overall Study||5
10702045|NCT02573155|11866548|FG001|STARTED|Washout Between Treatment Period 2 and 3||33
10331695|NCT00320801|11467490|FG003|COMPLETED|Double-blind Phase||0
10331696|NCT00320801|11467487|FG000|NOT COMPLETED|Double-blind Phase||0
10331697|NCT00320801|11467488|FG001|NOT COMPLETED|Double-blind Phase||11
10331698|NCT00320801|11467489|FG002|NOT COMPLETED|Double-blind Phase||14
10331699|NCT00320801|11467490|FG003|NOT COMPLETED|Double-blind Phase||0
10331700|NCT00320801|11467487|FG000|STARTED|Extension Phase||0
10331701|NCT00320801|11467488|FG001|STARTED|Extension Phase||0
10331702|NCT00320801|11467489|FG002|STARTED|Extension Phase||0
10331703|NCT00320801|11467490|FG003|STARTED|Extension Phase||55
10331704|NCT00320801|11467487|FG000|COMPLETED|Extension Phase||0
10331705|NCT00320801|11467488|FG001|COMPLETED|Extension Phase||0
10331706|NCT00320801|11467489|FG002|COMPLETED|Extension Phase||0
10331707|NCT00320801|11467490|FG003|COMPLETED|Extension Phase||7
10331708|NCT00320801|11467487|FG000|NOT COMPLETED|Extension Phase||0
10331709|NCT00320801|11467488|FG001|NOT COMPLETED|Extension Phase||0
10331710|NCT00320801|11467489|FG002|NOT COMPLETED|Extension Phase||0
10331711|NCT00320801|11467490|FG003|NOT COMPLETED|Extension Phase||48
10331712|NCT00321048|11467502|FG000|STARTED|Overall Study||28
10331713|NCT00321048|11467503|FG001|STARTED|Overall Study||29
10331714|NCT00321048|11467502|FG000|COMPLETED|Overall Study||22
10331715|NCT00321048|11467503|FG001|COMPLETED|Overall Study||21
10331716|NCT00321048|11467502|FG000|NOT COMPLETED|Overall Study||6
10331717|NCT00321048|11467503|FG001|NOT COMPLETED|Overall Study||8
10331718|NCT00321269|11467511|FG000|STARTED|Overall Study||74
10331719|NCT00321269|11467512|FG001|STARTED|Overall Study||74
10331720|NCT00321269|11467511|FG000|COMPLETED|Overall Study||66
10331721|NCT00321269|11467512|FG001|COMPLETED|Overall Study||68
10331722|NCT00321269|11467511|FG000|NOT COMPLETED|Overall Study||8
10331723|NCT00321269|11467512|FG001|NOT COMPLETED|Overall Study||6
10331724|NCT00321321|11467520|FG000|STARTED|Overall Study||12
10331725|NCT00321321|11467520|FG000|COMPLETED|Overall Study||12
10331726|NCT00321321|11467520|FG000|NOT COMPLETED|Overall Study||0
10331727|NCT00321373|11467527|FG000|STARTED|Overall Study||407
10331728|NCT00321373|11467528|FG001|STARTED|Overall Study||406
10702046|NCT02573155|11866547|FG000|COMPLETED|Washout Between Treatment Period 2 and 3||15
10702047|NCT02573155|11866548|FG001|COMPLETED|Washout Between Treatment Period 2 and 3||31
10702048|NCT02573155|11866547|FG000|NOT COMPLETED|Washout Between Treatment Period 2 and 3||1
10713718|NCT02680847|11879220|FG001|STARTED|Overall Study||9
10331729|NCT00321373|11467529|FG002|STARTED|Overall Study||407
10331730|NCT00321373|11467527|FG000|COMPLETED|Overall Study||405
10331731|NCT00321373|11467528|FG001|COMPLETED|Overall Study||406
10331732|NCT00321373|11467529|FG002|COMPLETED|Overall Study||404
10331733|NCT00321373|11467527|FG000|NOT COMPLETED|Overall Study||2
10331734|NCT00321373|11467528|FG001|NOT COMPLETED|Overall Study||0
10331735|NCT00321373|11467529|FG002|NOT COMPLETED|Overall Study||3
10331736|NCT00321464|11467539|FG000|STARTED|Overall Study||1020
10331737|NCT00321464|11467540|FG001|STARTED|Overall Study||1026
10331738|NCT00321464|11467539|FG000|Received Investigational Product|Overall Study||1014
10331739|NCT00321464|11467540|FG001|Received Investigational Product|Overall Study||1019
10331740|NCT00321464|11467539|FG000|COMPLETED|Overall Study||461
10331741|NCT00321464|11467540|FG001|COMPLETED|Overall Study||468
10331742|NCT00321464|11467539|FG000|NOT COMPLETED|Overall Study||559
10331743|NCT00321464|11467540|FG001|NOT COMPLETED|Overall Study||558
10331744|NCT00321594|11467548|FG000|STARTED|Phase I, Level 1-4||3
10331745|NCT00321594|11467549|FG001|STARTED|Phase I, Level 1-4||3
10331746|NCT00321594|11467550|FG002|STARTED|Phase I, Level 1-4||6
10331747|NCT00321594|11467551|FG003|STARTED|Phase I, Level 1-4||6
10331748|NCT00321594|11467552|FG004|STARTED|Phase I, Level 1-4||0
10331749|NCT00321594|11467548|FG000|COMPLETED|Phase I, Level 1-4||3
10331750|NCT00321594|11467549|FG001|COMPLETED|Phase I, Level 1-4||3
10331751|NCT00321594|11467550|FG002|COMPLETED|Phase I, Level 1-4||6
10331752|NCT00321594|11467551|FG003|COMPLETED|Phase I, Level 1-4||6
10331753|NCT00321594|11467552|FG004|COMPLETED|Phase I, Level 1-4||0
10331754|NCT00321594|11467548|FG000|NOT COMPLETED|Phase I, Level 1-4||0
10331755|NCT00321594|11467549|FG001|NOT COMPLETED|Phase I, Level 1-4||0
10331756|NCT00321594|11467550|FG002|NOT COMPLETED|Phase I, Level 1-4||0
10331757|NCT00321594|11467551|FG003|NOT COMPLETED|Phase I, Level 1-4||0
10331758|NCT00321594|11467552|FG004|NOT COMPLETED|Phase I, Level 1-4||0
10331759|NCT00321594|11467548|FG000|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
10331760|NCT00321594|11467549|FG001|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
10331761|NCT00321594|11467550|FG002|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
10574685|NCT01680159|11729958|FG000|STARTED|Screening Period||46
10331762|NCT00321594|11467551|FG003|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|6
10331763|NCT00321594|11467552|FG004|STARTED|Phase II, MTD Dose|last six patients in Phase I, Level 4 include in Phase II MTD Dose total number = 6 + 36 = 42|36
10331764|NCT00321594|11467548|FG000|COMPLETED|Phase II, MTD Dose||0
10331765|NCT00321594|11467549|FG001|COMPLETED|Phase II, MTD Dose||0
10331766|NCT00321594|11467550|FG002|COMPLETED|Phase II, MTD Dose||0
10331767|NCT00321594|11467551|FG003|COMPLETED|Phase II, MTD Dose||6
10331768|NCT00321594|11467552|FG004|COMPLETED|Phase II, MTD Dose||36
10331769|NCT00321594|11467548|FG000|NOT COMPLETED|Phase II, MTD Dose||0
10331770|NCT00321594|11467549|FG001|NOT COMPLETED|Phase II, MTD Dose||0
10331771|NCT00321594|11467550|FG002|NOT COMPLETED|Phase II, MTD Dose||0
10331772|NCT00321594|11467551|FG003|NOT COMPLETED|Phase II, MTD Dose||0
10331773|NCT00321594|11467552|FG004|NOT COMPLETED|Phase II, MTD Dose||0
10331774|NCT00321620|11467566|FG000|STARTED|Overall Study||951
10331775|NCT00321620|11467567|FG001|STARTED|Overall Study||950
10331776|NCT00321620|11467566|FG000|Received Investigational Product|Overall Study||946
10331777|NCT00321620|11467567|FG001|Received Investigational Product|Overall Study||942
10331778|NCT00321620|11467566|FG000|COMPLETED|Overall Study||208
10331779|NCT00321620|11467567|FG001|COMPLETED|Overall Study||228
10331780|NCT00321620|11467566|FG000|NOT COMPLETED|Overall Study||743
10331781|NCT00321620|11467567|FG001|NOT COMPLETED|Overall Study||722
10456731|NCT01008059|11604613|FG000|COMPLETED|Control Sequential Alfentanil||6
10456732|NCT01008059|11604614|FG001|COMPLETED|Control Sequential Alfentanil||0
10331782|NCT00321646|11467573|FG000|STARTED|Neoadjuvant Chemotherapy||42
10331783|NCT00321646|11467573|FG000|COMPLETED|Neoadjuvant Chemotherapy|1 pt withdrew before start of therapy, 38 completed 6 cycles neoadjuvant therapy.|38
10331784|NCT00321646|11467573|FG000|NOT COMPLETED|Neoadjuvant Chemotherapy||4
10331785|NCT00321646|11467573|FG000|STARTED|Prostatectomy||37
10331786|NCT00321646|11467573|FG000|COMPLETED|Prostatectomy||37
10331787|NCT00321646|11467573|FG000|NOT COMPLETED|Prostatectomy||0
10331788|NCT00321672|11467581|FG000|STARTED|Overall Study||165
10331789|NCT00321672|11467582|FG001|STARTED|Overall Study|One randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety.|89
10331790|NCT00321672|11467583|FG002|STARTED|Overall Study||167
10331791|NCT00321672|11467584|FG003|STARTED|Overall Study|One randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety.|73
10331792|NCT00321672|11467581|FG000|COMPLETED|Overall Study||153
10331793|NCT00321672|11467582|FG001|COMPLETED|Overall Study||81
10331794|NCT00321672|11467583|FG002|COMPLETED|Overall Study||156
10331795|NCT00321672|11467584|FG003|COMPLETED|Overall Study||71
10331796|NCT00321672|11467581|FG000|NOT COMPLETED|Overall Study||12
10331797|NCT00321672|11467582|FG001|NOT COMPLETED|Overall Study||8
10331798|NCT00321672|11467583|FG002|NOT COMPLETED|Overall Study||11
10331799|NCT00321672|11467584|FG003|NOT COMPLETED|Overall Study||2
10331800|NCT00321685|11467598|FG000|STARTED|Overall Study||57
10331801|NCT00321685|11467598|FG000|Eligible|Overall Study||55
10331802|NCT00321685|11467598|FG000|Started Protocol Therapy|Overall Study||55
10331803|NCT00321685|11467598|FG000|Eligible and Treated|Overall Study||53
10331804|NCT00321685|11467598|FG000|COMPLETED|Overall Study||18
10331805|NCT00321685|11467598|FG000|NOT COMPLETED|Overall Study||39
10331806|NCT00321711|11467607|FG000|STARTED|Part A||13
10331807|NCT00321711|11467608|FG001|STARTED|Part A||13
10331808|NCT00321711|11467609|FG002|STARTED|Part A||14
10331809|NCT00321711|11467610|FG003|STARTED|Part A||0
10331810|NCT00321711|11467611|FG004|STARTED|Part A||0
10331811|NCT00321711|11467607|FG000|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|8
10331812|NCT00321711|11467608|FG001|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|3
10331813|NCT00321711|11467609|FG002|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|3
10331814|NCT00321711|11467610|FG003|COMPLETED|Part A||0
10331815|NCT00321711|11467611|FG004|COMPLETED|Part A||0
10331816|NCT00321711|11467607|FG000|NOT COMPLETED|Part A||5
10331817|NCT00321711|11467608|FG001|NOT COMPLETED|Part A||10
10331818|NCT00321711|11467609|FG002|NOT COMPLETED|Part A||11
10331819|NCT00321711|11467610|FG003|NOT COMPLETED|Part A||0
10331820|NCT00321711|11467611|FG004|NOT COMPLETED|Part A||0
10331821|NCT00321711|11467607|FG000|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
10331822|NCT00321711|11467608|FG001|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
10331823|NCT00321711|11467609|FG002|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
10331824|NCT00321711|11467610|FG003|STARTED|Part B||14
10331825|NCT00321711|11467611|FG004|STARTED|Part B||15
10331826|NCT00321711|11467607|FG000|COMPLETED|Part B||0
10331827|NCT00321711|11467608|FG001|COMPLETED|Part B||0
10331828|NCT00321711|11467609|FG002|COMPLETED|Part B||0
10331829|NCT00321711|11467610|FG003|COMPLETED|Part B||8
10331830|NCT00321711|11467611|FG004|COMPLETED|Part B||10
10331831|NCT00321711|11467607|FG000|NOT COMPLETED|Part B||0
10331832|NCT00321711|11467608|FG001|NOT COMPLETED|Part B||0
10331833|NCT00321711|11467609|FG002|NOT COMPLETED|Part B||0
10331834|NCT00321711|11467610|FG003|NOT COMPLETED|Part B||6
10331835|NCT00321711|11467611|FG004|NOT COMPLETED|Part B||5
10331836|NCT00321737|11467626|FG000|STARTED|Overall Study||147
10331837|NCT00321737|11467627|FG001|STARTED|Overall Study||140
10331838|NCT00321737|11467628|FG002|STARTED|Overall Study||158
10331839|NCT00321737|11467626|FG000|COMPLETED|Overall Study||25
10331840|NCT00321737|11467627|FG001|COMPLETED|Overall Study||92
10331841|NCT00321737|11467628|FG002|COMPLETED|Overall Study||104
10331842|NCT00321737|11467626|FG000|NOT COMPLETED|Overall Study||122
10456733|NCT01008059|11604615|FG002|COMPLETED|Control Sequential Alfentanil||0
10331843|NCT00321737|11467627|FG001|NOT COMPLETED|Overall Study||48
10331844|NCT00321737|11467628|FG002|NOT COMPLETED|Overall Study||54
10331845|NCT00321763|11467640|FG000|STARTED|Overall Study||850
10331846|NCT00321763|11467641|FG001|STARTED|Overall Study||850
10331847|NCT00321763|11467642|FG002|STARTED|Overall Study||854
10331848|NCT00321763|11467643|FG003|STARTED|Overall Study||570
10331849|NCT00321763|11467640|FG000|COMPLETED|Overall Study||844
10331850|NCT00321763|11467641|FG001|COMPLETED|Overall Study||848
10331851|NCT00321763|11467642|FG002|COMPLETED|Overall Study||848
10331852|NCT00321763|11467643|FG003|COMPLETED|Overall Study||565
10331853|NCT00321763|11467640|FG000|NOT COMPLETED|Overall Study||6
10331854|NCT00321763|11467641|FG001|NOT COMPLETED|Overall Study||2
10331855|NCT00321763|11467642|FG002|NOT COMPLETED|Overall Study||6
10331856|NCT00321763|11467643|FG003|NOT COMPLETED|Overall Study||5
10331857|NCT00321789|11467657|FG000|STARTED|Overall Study||127
10331858|NCT00321789|11467658|FG001|STARTED|Overall Study||128
10331859|NCT00321789|11467657|FG000|COMPLETED|Overall Study||112
10331860|NCT00321789|11467658|FG001|COMPLETED|Overall Study||112
10331861|NCT00321789|11467657|FG000|NOT COMPLETED|Overall Study||15
10331862|NCT00321789|11467658|FG001|NOT COMPLETED|Overall Study||16
10331863|NCT00321828|11467664|FG000|STARTED|Overall Study||90
10331864|NCT00321828|11467664|FG000|COMPLETED|Overall Study||86
10331865|NCT00321828|11467664|FG000|NOT COMPLETED|Overall Study||4
10331866|NCT00321854|11467670|FG000|STARTED|Overall Study||261
10331867|NCT00321854|11467671|FG001|STARTED|Overall Study||274
10331868|NCT00321854|11467670|FG000|COMPLETED|Overall Study||198
10331869|NCT00321854|11467671|FG001|COMPLETED|Overall Study||192
10331870|NCT00321854|11467670|FG000|NOT COMPLETED|Overall Study||63
10331871|NCT00321854|11467671|FG001|NOT COMPLETED|Overall Study||82
10331872|NCT00321893|11467681|FG000|STARTED|Overall Study||101
10331873|NCT00321893|11467682|FG001|STARTED|Overall Study||101
10331874|NCT00321893|11467681|FG000|COMPLETED|Overall Study||77
10331875|NCT00321893|11467682|FG001|COMPLETED|Overall Study||87
10331876|NCT00321893|11467681|FG000|NOT COMPLETED|Overall Study||24
10331877|NCT00321893|11467682|FG001|NOT COMPLETED|Overall Study||14
10331878|NCT00321906|11467690|FG000|STARTED|Overall Study||94
10331879|NCT00321906|11467691|FG001|STARTED|Overall Study||87
10331880|NCT00321906|11467690|FG000|COMPLETED|Overall Study||48
10331881|NCT00321906|11467691|FG001|COMPLETED|Overall Study||31
10331882|NCT00321906|11467690|FG000|NOT COMPLETED|Overall Study||46
10331883|NCT00321906|11467691|FG001|NOT COMPLETED|Overall Study||56
10331884|NCT00321919|11467699|FG000|STARTED|Overall Study||301
10331885|NCT00321919|11467700|FG001|STARTED|Overall Study||302
10331886|NCT00321919|11467699|FG000|COMPLETED|Overall Study||226
10331887|NCT00321919|11467700|FG001|COMPLETED|Overall Study||250
10331888|NCT00321919|11467699|FG000|NOT COMPLETED|Overall Study||75
10331889|NCT00321919|11467700|FG001|NOT COMPLETED|Overall Study||52
10338924|NCT01711879|11475859|FG000|STARTED|Overall Study||3
10338925|NCT01711879|11475860|FG001|STARTED|Overall Study||4
10338926|NCT01711879|11475859|FG000|COMPLETED|Overall Study||2
10338927|NCT01711879|11475860|FG001|COMPLETED|Overall Study||4
10338928|NCT01711879|11475859|FG000|NOT COMPLETED|Overall Study||1
10338929|NCT01711879|11475860|FG001|NOT COMPLETED|Overall Study||0
10338930|NCT01697267|11475870|FG000|STARTED|Overall Study||85
10338931|NCT01697267|11475871|FG001|STARTED|Overall Study||85
10338932|NCT01697267|11475870|FG000|Month 24|Overall Study||78
10338933|NCT01697267|11475871|FG001|Month 24|Overall Study||78
10338934|NCT01697267|11475870|FG000|COMPLETED|Overall Study||71
10338935|NCT01697267|11475871|FG001|COMPLETED|Overall Study||70
10338936|NCT01697267|11475870|FG000|NOT COMPLETED|Overall Study||14
10338937|NCT01697267|11475871|FG001|NOT COMPLETED|Overall Study||15
10338938|NCT01527149|11475877|FG000|STARTED|Overall Study||37
10805236|NCT04019626|11966791|FG003|COMPLETED|Overall Study||39
10805237|NCT04019626|11966792|FG004|COMPLETED|Overall Study||38
10805238|NCT04019626|11966793|FG005|COMPLETED|Overall Study||20
10338939|NCT01527149|11475877|FG000|COMPLETED|Overall Study||35
10338940|NCT01527149|11475877|FG000|NOT COMPLETED|Overall Study||2
10338941|NCT01388920|11475884|FG000|STARTED|Overall Study||1
10338942|NCT01388920|11475885|FG001|STARTED|Overall Study||1
10338943|NCT01388920|11475886|FG002|STARTED|Overall Study||0
10338944|NCT01388920|11475884|FG000|COMPLETED|Overall Study||1
10338945|NCT01388920|11475885|FG001|COMPLETED|Overall Study||1
10338946|NCT01388920|11475886|FG002|COMPLETED|Overall Study||0
10338947|NCT01388920|11475884|FG000|NOT COMPLETED|Overall Study||0
10338948|NCT01388920|11475885|FG001|NOT COMPLETED|Overall Study||0
10338949|NCT01388920|11475886|FG002|NOT COMPLETED|Overall Study||0
10338950|NCT01164202|11475896|FG000|STARTED|Overall Study||39
10338951|NCT01164202|11475897|FG001|STARTED|Overall Study||39
10338952|NCT01164202|11475896|FG000|COMPLETED|Overall Study||38
10338953|NCT01164202|11475897|FG001|COMPLETED|Overall Study||39
10338954|NCT01164202|11475896|FG000|NOT COMPLETED|Overall Study||1
10338955|NCT01164202|11475897|FG001|NOT COMPLETED|Overall Study||0
10338956|NCT00554840|11475907|FG000|STARTED|Overall Study||4
10338957|NCT00554840|11475908|FG001|STARTED|Overall Study||5
10338958|NCT00554840|11475907|FG000|COMPLETED|Overall Study||4
10338959|NCT00554840|11475908|FG001|COMPLETED|Overall Study||4
10338960|NCT00554840|11475907|FG000|NOT COMPLETED|Overall Study||0
10338961|NCT00554840|11475908|FG001|NOT COMPLETED|Overall Study||1
10805239|NCT04019626|11966788|FG000|NOT COMPLETED|Overall Study||6
10338962|NCT00003656|11475918|FG000|STARTED|Overall Study||12
10338963|NCT00003656|11475919|FG001|STARTED|Overall Study||14
10338964|NCT00003656|11475918|FG000|COMPLETED|Overall Study||12
10338965|NCT00003656|11475919|FG001|COMPLETED|Overall Study||13
10331890|NCT00321932|11467709|FG000|STARTED|Overall Study||29
10331891|NCT00321932|11467710|FG001|STARTED|Overall Study||32
10331892|NCT00321932|11467709|FG000|COMPLETED|Overall Study||19
10331893|NCT00321932|11467710|FG001|COMPLETED|Overall Study||11
10331894|NCT00321932|11467709|FG000|NOT COMPLETED|Overall Study||10
10331895|NCT00321932|11467710|FG001|NOT COMPLETED|Overall Study||21
10331896|NCT00321971|11467719|FG000|STARTED|Overall Study|Subject recruitment began in February 2007 and ended in December 2011|36
10331897|NCT00321971|11467720|FG001|STARTED|Overall Study||37
10331898|NCT00321971|11467719|FG000|COMPLETED|Overall Study||28
10331899|NCT00321971|11467720|FG001|COMPLETED|Overall Study||26
10331900|NCT00321971|11467719|FG000|NOT COMPLETED|Overall Study||8
10331901|NCT00321971|11467720|FG001|NOT COMPLETED|Overall Study||11
10331902|NCT00321984|11467729|FG000|STARTED|Overall Study||317
10331903|NCT00321984|11467730|FG001|STARTED|Overall Study||315
10331904|NCT00321984|11467731|FG002|STARTED|Overall Study||315
10331905|NCT00321984|11467729|FG000|COMPLETED|Overall Study||290
10331906|NCT00321984|11467730|FG001|COMPLETED|Overall Study||294
10331907|NCT00321984|11467731|FG002|COMPLETED|Overall Study||289
10331908|NCT00321984|11467729|FG000|NOT COMPLETED|Overall Study||27
10331909|NCT00321984|11467730|FG001|NOT COMPLETED|Overall Study||21
10331910|NCT00321984|11467731|FG002|NOT COMPLETED|Overall Study||26
10331911|NCT00322023|11467742|FG000|STARTED|Overall Study||12
10331912|NCT00322023|11467743|FG001|STARTED|Overall Study||21
10331913|NCT00322023|11467744|FG002|STARTED|Overall Study||22
10331914|NCT00322023|11467742|FG000|COMPLETED|Overall Study||12
10331915|NCT00322023|11467743|FG001|COMPLETED|Overall Study||19
10331916|NCT00322023|11467744|FG002|COMPLETED|Overall Study||16
10331917|NCT00322023|11467742|FG000|NOT COMPLETED|Overall Study||0
10331918|NCT00322023|11467743|FG001|NOT COMPLETED|Overall Study||2
10331919|NCT00322023|11467744|FG002|NOT COMPLETED|Overall Study||6
10331920|NCT00322049|11467756|FG000|STARTED|Overall Study||4
10331921|NCT00322049|11467757|FG001|STARTED|Overall Study||10
10331922|NCT00322049|11467758|FG002|STARTED|Overall Study||20
10331923|NCT00322049|11467759|FG003|STARTED|Overall Study||17
10331924|NCT00322049|11467756|FG000|COMPLETED|Overall Study||4
10331925|NCT00322049|11467757|FG001|COMPLETED|Overall Study||9
10331926|NCT00322049|11467758|FG002|COMPLETED|Overall Study||20
10331927|NCT00322049|11467759|FG003|COMPLETED|Overall Study||16
10331928|NCT00322049|11467756|FG000|NOT COMPLETED|Overall Study||0
10331929|NCT00322049|11467757|FG001|NOT COMPLETED|Overall Study||1
10331930|NCT00322049|11467758|FG002|NOT COMPLETED|Overall Study||0
10331931|NCT00322049|11467759|FG003|NOT COMPLETED|Overall Study||1
10331932|NCT00322101|11467780|FG000|STARTED|Overall Study||14
10331933|NCT00322101|11467781|FG001|STARTED|Overall Study||11
10331934|NCT00322101|11467780|FG000|COMPLETED|Overall Study||14
10331935|NCT00322101|11467781|FG001|COMPLETED|Overall Study||11
10331936|NCT00322101|11467780|FG000|NOT COMPLETED|Overall Study||0
10331937|NCT00322101|11467781|FG001|NOT COMPLETED|Overall Study||0
10331938|NCT00322153|11467789|FG000|STARTED|Overall Study|Randomized to placebo|335
10331939|NCT00322153|11467790|FG001|STARTED|Overall Study|Randomized to Memantine ER|342
10331940|NCT00322153|11467789|FG000|SAFETY POPULATION|Overall Study|Safety population defined as all patients who took at least one dose of double-blind study drug.|335
10331941|NCT00322153|11467790|FG001|SAFETY POPULATION|Overall Study|Safety population: one patient was randomized but did not receive double-blind study drug.|341
10331942|NCT00322153|11467789|FG000|COMPLETED|Overall Study||272
10331943|NCT00322153|11467790|FG001|COMPLETED|Overall Study||273
10331944|NCT00322153|11467789|FG000|NOT COMPLETED|Overall Study||63
10331945|NCT00322153|11467790|FG001|NOT COMPLETED|Overall Study||69
10331946|NCT00322231|11467798|FG000|STARTED|Period 1||51
10331947|NCT00322231|11467799|FG001|STARTED|Period 1||50
10331948|NCT00322231|11467798|FG000|COMPLETED|Period 1||51
10331949|NCT00322231|11467799|FG001|COMPLETED|Period 1||50
10331950|NCT00322231|11467798|FG000|NOT COMPLETED|Period 1||0
10331951|NCT00322231|11467799|FG001|NOT COMPLETED|Period 1||0
10331952|NCT00322231|11467798|FG000|STARTED|Period 2||51
10331953|NCT00322231|11467799|FG001|STARTED|Period 2|One participant was lost between Period 1 and Period 2|49
10331954|NCT00322231|11467798|FG000|COMPLETED|Period 2||51
10331955|NCT00322231|11467799|FG001|COMPLETED|Period 2||49
10331956|NCT00322231|11467798|FG000|NOT COMPLETED|Period 2||0
10331957|NCT00322231|11467799|FG001|NOT COMPLETED|Period 2||0
10331958|NCT00322309|11467811|FG000|STARTED|Overall Study||11
10331959|NCT00322309|11467812|FG001|STARTED|Overall Study||13
10331960|NCT00322309|11467811|FG000|COMPLETED|Overall Study||9
10331961|NCT00322309|11467812|FG001|COMPLETED|Overall Study||9
10331962|NCT00322309|11467811|FG000|NOT COMPLETED|Overall Study||2
10331963|NCT00322309|11467812|FG001|NOT COMPLETED|Overall Study||4
10331964|NCT00322335|11467824|FG000|STARTED|Subjects 18 Months After Booster Dose||58
10331965|NCT00322335|11467825|FG001|STARTED|Subjects 18 Months After Booster Dose||123
10331966|NCT00322335|11467826|FG002|STARTED|Subjects 18 Months After Booster Dose|Subjects who received Meningitec booster outside scope study NCT00323050 eliminated from this period|3
10331967|NCT00322335|11467824|FG000|COMPLETED|Subjects 18 Months After Booster Dose||58
10331968|NCT00322335|11467825|FG001|COMPLETED|Subjects 18 Months After Booster Dose||123
10331969|NCT00322335|11467826|FG002|COMPLETED|Subjects 18 Months After Booster Dose||3
10331970|NCT00322335|11467824|FG000|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
10331971|NCT00322335|11467825|FG001|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
10331972|NCT00322335|11467826|FG002|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
10331973|NCT00322335|11467824|FG000|STARTED|Subjects 30 Months After Booster Dose||54
10331974|NCT00322335|11467825|FG001|STARTED|Subjects 30 Months After Booster Dose||119
10331975|NCT00322335|11467826|FG002|STARTED|Subjects 30 Months After Booster Dose|Subjects eliminated from previous timepoint were included again from this timepoint onwards|57
10331976|NCT00322335|11467824|FG000|COMPLETED|Subjects 30 Months After Booster Dose||54
10331977|NCT00322335|11467825|FG001|COMPLETED|Subjects 30 Months After Booster Dose||119
10331978|NCT00322335|11467826|FG002|COMPLETED|Subjects 30 Months After Booster Dose||57
10331979|NCT00322335|11467824|FG000|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
10331980|NCT00322335|11467825|FG001|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
10331981|NCT00322335|11467826|FG002|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
10331982|NCT00322335|11467824|FG000|STARTED|Subjects 42 Months After Booster Dose||51
10331983|NCT00322335|11467825|FG001|STARTED|Subjects 42 Months After Booster Dose||113
10331984|NCT00322335|11467826|FG002|STARTED|Subjects 42 Months After Booster Dose||56
10331985|NCT00322335|11467824|FG000|COMPLETED|Subjects 42 Months After Booster Dose||51
10331986|NCT00322335|11467825|FG001|COMPLETED|Subjects 42 Months After Booster Dose||113
10331987|NCT00322335|11467826|FG002|COMPLETED|Subjects 42 Months After Booster Dose||56
10331988|NCT00322335|11467824|FG000|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
10331989|NCT00322335|11467825|FG001|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
10331990|NCT00322335|11467826|FG002|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
10331991|NCT00322335|11467824|FG000|STARTED|Subjects 54 Months After Booster Dose||50
10331992|NCT00322335|11467825|FG001|STARTED|Subjects 54 Months After Booster Dose||108
10332044|NCT00322374|11467849|FG003|STARTED|First Escalation||0
10331993|NCT00322335|11467826|FG002|STARTED|Subjects 54 Months After Booster Dose||56
10331994|NCT00322335|11467824|FG000|COMPLETED|Subjects 54 Months After Booster Dose||50
10331995|NCT00322335|11467825|FG001|COMPLETED|Subjects 54 Months After Booster Dose||108
10331996|NCT00322335|11467826|FG002|COMPLETED|Subjects 54 Months After Booster Dose||56
10331997|NCT00322335|11467824|FG000|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
10331998|NCT00322335|11467825|FG001|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
10331999|NCT00322335|11467826|FG002|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
10332000|NCT00322335|11467824|FG000|STARTED|Subjects 66 Months After Booster Dose||48
10332001|NCT00322335|11467825|FG001|STARTED|Subjects 66 Months After Booster Dose||104
10332002|NCT00322335|11467826|FG002|STARTED|Subjects 66 Months After Booster Dose||53
10332003|NCT00322335|11467824|FG000|COMPLETED|Subjects 66 Months After Booster Dose||48
10332004|NCT00322335|11467825|FG001|COMPLETED|Subjects 66 Months After Booster Dose||104
10332005|NCT00322335|11467826|FG002|COMPLETED|Subjects 66 Months After Booster Dose||53
10332006|NCT00322335|11467824|FG000|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
10332007|NCT00322335|11467825|FG001|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
10332008|NCT00322335|11467826|FG002|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
10332009|NCT00322348|11467836|FG000|STARTED|Overall Study||49
10332010|NCT00322348|11467837|FG001|STARTED|Overall Study||49
10332011|NCT00322348|11467836|FG000|Received Study Treatment|Overall Study||50
10332012|NCT00322348|11467837|FG001|Received Study Treatment|Overall Study||48
10332013|NCT00322348|11467836|FG000|COMPLETED|Overall Study|Number of participants completed up to Week 96|12
10332014|NCT00322348|11467837|FG001|COMPLETED|Overall Study|Number of participants completed up to Week 96|16
10332015|NCT00322348|11467836|FG000|NOT COMPLETED|Overall Study||37
10332016|NCT00322348|11467837|FG001|NOT COMPLETED|Overall Study||33
10332017|NCT00322374|11467846|FG000|STARTED|Enrollment||0
10456734|NCT01008059|11604616|FG003|COMPLETED|Control Sequential Alfentanil||0
10456735|NCT01008059|11604617|FG004|COMPLETED|Control Sequential Alfentanil||0
10456736|NCT01008059|11604618|FG005|COMPLETED|Control Sequential Alfentanil||0
10456737|NCT01008059|11604619|FG006|COMPLETED|Control Sequential Alfentanil||0
10456738|NCT01008059|11604620|FG007|COMPLETED|Control Sequential Alfentanil||0
10456739|NCT01008059|11604613|FG000|NOT COMPLETED|Control Sequential Alfentanil||0
10456740|NCT01008059|11604614|FG001|NOT COMPLETED|Control Sequential Alfentanil||0
10456741|NCT01008059|11604615|FG002|NOT COMPLETED|Control Sequential Alfentanil||0
10456742|NCT01008059|11604616|FG003|NOT COMPLETED|Control Sequential Alfentanil||0
10456743|NCT01008059|11604617|FG004|NOT COMPLETED|Control Sequential Alfentanil||0
10456744|NCT01008059|11604618|FG005|NOT COMPLETED|Control Sequential Alfentanil||0
10456745|NCT01008059|11604619|FG006|NOT COMPLETED|Control Sequential Alfentanil||0
10456746|NCT01008059|11604620|FG007|NOT COMPLETED|Control Sequential Alfentanil||0
10456747|NCT01008059|11604613|FG000|STARTED|Rifampin Sequential Alfentanil||0
10702049|NCT02573155|11866548|FG001|NOT COMPLETED|Washout Between Treatment Period 2 and 3||2
10702050|NCT02573155|11866547|FG000|STARTED|Period 3||15
10332018|NCT00322374|11467847|FG001|STARTED|Enrollment||0
10456748|NCT01008059|11604614|FG001|STARTED|Rifampin Sequential Alfentanil||6
10456749|NCT01008059|11604615|FG002|STARTED|Rifampin Sequential Alfentanil||0
10456750|NCT01008059|11604616|FG003|STARTED|Rifampin Sequential Alfentanil||0
10456751|NCT01008059|11604617|FG004|STARTED|Rifampin Sequential Alfentanil||0
10456752|NCT01008059|11604618|FG005|STARTED|Rifampin Sequential Alfentanil||0
10456753|NCT01008059|11604619|FG006|STARTED|Rifampin Sequential Alfentanil||0
10456754|NCT01008059|11604620|FG007|STARTED|Rifampin Sequential Alfentanil||0
10456755|NCT01008059|11604613|FG000|COMPLETED|Rifampin Sequential Alfentanil||0
10456756|NCT01008059|11604614|FG001|COMPLETED|Rifampin Sequential Alfentanil||6
10456757|NCT01008059|11604615|FG002|COMPLETED|Rifampin Sequential Alfentanil||0
10456758|NCT01008059|11604616|FG003|COMPLETED|Rifampin Sequential Alfentanil||0
10456759|NCT01008059|11604617|FG004|COMPLETED|Rifampin Sequential Alfentanil||0
10456760|NCT01008059|11604618|FG005|COMPLETED|Rifampin Sequential Alfentanil||0
10456761|NCT01008059|11604619|FG006|COMPLETED|Rifampin Sequential Alfentanil||0
10456762|NCT01008059|11604620|FG007|COMPLETED|Rifampin Sequential Alfentanil||0
10702051|NCT02573155|11866548|FG001|STARTED|Period 3||31
10332019|NCT00322374|11467848|FG002|STARTED|Enrollment||0
10332020|NCT00322374|11467849|FG003|STARTED|Enrollment||42
10332021|NCT00322374|11467846|FG000|COMPLETED|Enrollment||0
10332022|NCT00322374|11467847|FG001|COMPLETED|Enrollment||0
10332023|NCT00322374|11467848|FG002|COMPLETED|Enrollment||0
10332024|NCT00322374|11467849|FG003|COMPLETED|Enrollment||42
10332025|NCT00322374|11467846|FG000|NOT COMPLETED|Enrollment||0
10332026|NCT00322374|11467847|FG001|NOT COMPLETED|Enrollment||0
10332027|NCT00322374|11467848|FG002|NOT COMPLETED|Enrollment||0
10332028|NCT00322374|11467849|FG003|NOT COMPLETED|Enrollment||0
10332029|NCT00322374|11467846|FG000|STARTED|Starting Dose||6
10332030|NCT00322374|11467847|FG001|STARTED|Starting Dose||0
10332031|NCT00322374|11467848|FG002|STARTED|Starting Dose||0
10332032|NCT00322374|11467849|FG003|STARTED|Starting Dose||0
10332033|NCT00322374|11467846|FG000|COMPLETED|Starting Dose||0
10332034|NCT00322374|11467847|FG001|COMPLETED|Starting Dose||0
10332035|NCT00322374|11467848|FG002|COMPLETED|Starting Dose||0
10332036|NCT00322374|11467849|FG003|COMPLETED|Starting Dose||0
10332037|NCT00322374|11467846|FG000|NOT COMPLETED|Starting Dose||6
10332038|NCT00322374|11467847|FG001|NOT COMPLETED|Starting Dose||0
10332039|NCT00322374|11467848|FG002|NOT COMPLETED|Starting Dose||0
10332040|NCT00322374|11467849|FG003|NOT COMPLETED|Starting Dose||0
10332041|NCT00322374|11467846|FG000|STARTED|First Escalation||0
10332042|NCT00322374|11467847|FG001|STARTED|First Escalation||30
10332043|NCT00322374|11467848|FG002|STARTED|First Escalation||0
10332045|NCT00322374|11467846|FG000|COMPLETED|First Escalation||0
10332046|NCT00322374|11467847|FG001|COMPLETED|First Escalation||0
10332047|NCT00322374|11467848|FG002|COMPLETED|First Escalation||0
10332048|NCT00322374|11467849|FG003|COMPLETED|First Escalation||0
10332049|NCT00322374|11467846|FG000|NOT COMPLETED|First Escalation||0
10332050|NCT00322374|11467847|FG001|NOT COMPLETED|First Escalation||30
10332051|NCT00322374|11467848|FG002|NOT COMPLETED|First Escalation||0
10332052|NCT00322374|11467849|FG003|NOT COMPLETED|First Escalation||0
10332053|NCT00322374|11467846|FG000|STARTED|Second Escalation||0
10332054|NCT00322374|11467847|FG001|STARTED|Second Escalation||0
10332055|NCT00322374|11467848|FG002|STARTED|Second Escalation||6
10332056|NCT00322374|11467849|FG003|STARTED|Second Escalation||0
10332057|NCT00322374|11467846|FG000|COMPLETED|Second Escalation||0
10332058|NCT00322374|11467847|FG001|COMPLETED|Second Escalation||0
10332059|NCT00322374|11467848|FG002|COMPLETED|Second Escalation||0
10332060|NCT00322374|11467849|FG003|COMPLETED|Second Escalation||0
10332061|NCT00322374|11467846|FG000|NOT COMPLETED|Second Escalation||0
10332062|NCT00322374|11467847|FG001|NOT COMPLETED|Second Escalation||0
10332063|NCT00322374|11467848|FG002|NOT COMPLETED|Second Escalation||6
10332064|NCT00322374|11467849|FG003|NOT COMPLETED|Second Escalation||0
10332065|NCT00322387|11467864|FG000|STARTED|Treatment Period|Plerixafor PM=7, Plerixafor AM=6, Low CD34+ Count/Plerixafor PM=0, and Plerixafor After Chemo=1|14
10332066|NCT00322387|11467865|FG001|STARTED|Treatment Period|Plerixafor PM=12, Plerixafor AM=9, Low CD34+ Count/Plerixafor PM=1, and Plerixafor After Chemo=4|26
10332067|NCT00322387|11467864|FG000|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|14
10332068|NCT00322387|11467865|FG001|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|25
10332069|NCT00322387|11467864|FG000|NOT COMPLETED|Treatment Period||0
10332070|NCT00322387|11467865|FG001|NOT COMPLETED|Treatment Period||1
10332071|NCT00322387|11467864|FG000|STARTED|Follow-up Period|Participants who had transplants|14
10332072|NCT00322387|11467865|FG001|STARTED|Follow-up Period|Participants who had transplants. One participant did not complete therapy but had a transplant.|26
10332073|NCT00322387|11467864|FG000|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|12
10332074|NCT00322387|11467865|FG001|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|23
10332075|NCT00322387|11467864|FG000|NOT COMPLETED|Follow-up Period||2
10332076|NCT00322387|11467865|FG001|NOT COMPLETED|Follow-up Period||3
10332077|NCT00322439|11467882|FG000|STARTED|Overall Study||2511
10332078|NCT00322439|11467882|FG000|Received at Least 1 Dose of Etanercept|Overall Study||2510
10332079|NCT00322439|11467882|FG000|COMPLETED|Overall Study||1455
10332080|NCT00322439|11467882|FG000|NOT COMPLETED|Overall Study||1056
10332081|NCT00322452|11467888|FG000|STARTED|Overall Study|Number of patients randomized|609
10332082|NCT00322452|11467889|FG001|STARTED|Overall Study|Number of patients randomized|608
10332083|NCT00322452|11467888|FG000|COMPLETED|Overall Study|Patients still in study at PFS Data Cut Off (14 April 2008), 97 remained at OS DCO (14 June 2010)|362
10332084|NCT00322452|11467889|FG001|COMPLETED|Overall Study|Patients still in study at PFS Data Cut Off (14 April 2008), 84 remained at OS DCO (14 June 2010)|332
10332085|NCT00322452|11467888|FG000|NOT COMPLETED|Overall Study||247
10332086|NCT00322452|11467889|FG001|NOT COMPLETED|Overall Study||276
10332087|NCT00322465|11467899|FG000|STARTED|Overall Study|Randomized|76
10332088|NCT00322465|11467900|FG001|STARTED|Overall Study|Randomized|73
10332089|NCT00322465|11467901|FG002|STARTED|Overall Study|Randomized|77
10332090|NCT00322465|11467902|FG003|STARTED|Overall Study|Randomized|79
10332091|NCT00322465|11467899|FG000|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|56
10332092|NCT00322465|11467900|FG001|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|49
10332093|NCT00322465|11467901|FG002|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|51
10332094|NCT00322465|11467902|FG003|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|53
10332095|NCT00322465|11467899|FG000|NOT COMPLETED|Overall Study||20
10332096|NCT00322465|11467900|FG001|NOT COMPLETED|Overall Study||24
10332097|NCT00322465|11467901|FG002|NOT COMPLETED|Overall Study||26
10332098|NCT00322465|11467902|FG003|NOT COMPLETED|Overall Study||26
10332099|NCT00322491|11467917|FG000|STARTED|Overall Study||23
10332100|NCT00322491|11467918|FG001|STARTED|Overall Study||26
10332101|NCT00322491|11467917|FG000|COMPLETED|Overall Study||21
10332102|NCT00322491|11467918|FG001|COMPLETED|Overall Study||24
10332103|NCT00322491|11467917|FG000|NOT COMPLETED|Overall Study||2
10332104|NCT00322491|11467918|FG001|NOT COMPLETED|Overall Study||2
10332105|NCT00322556|11467925|FG000|STARTED|Overall Study||55
10332106|NCT00322556|11467925|FG000|COMPLETED|Overall Study||43
10332107|NCT00322556|11467925|FG000|NOT COMPLETED|Overall Study||12
10332108|NCT00322621|11467932|FG000|STARTED|Period II - Acute Therapy Phase||216
10332109|NCT00322621|11467933|FG001|STARTED|Period II - Acute Therapy Phase||0
10332110|NCT00322621|11467934|FG002|STARTED|Period II - Acute Therapy Phase||0
10332111|NCT00322621|11467932|FG000|COMPLETED|Period II - Acute Therapy Phase||184
10332112|NCT00322621|11467933|FG001|COMPLETED|Period II - Acute Therapy Phase||0
10332113|NCT00322621|11467934|FG002|COMPLETED|Period II - Acute Therapy Phase||0
10332114|NCT00322621|11467932|FG000|NOT COMPLETED|Period II - Acute Therapy Phase||32
10332115|NCT00322621|11467933|FG001|NOT COMPLETED|Period II - Acute Therapy Phase||0
10332116|NCT00322621|11467934|FG002|NOT COMPLETED|Period II - Acute Therapy Phase||0
10332117|NCT00322621|11467932|FG000|STARTED|Period III - Maintenance / Rescue Phase||0
10332118|NCT00322621|11467933|FG001|STARTED|Period III - Maintenance / Rescue Phase||115
10332119|NCT00322621|11467934|FG002|STARTED|Period III - Maintenance / Rescue Phase||69
10332120|NCT00322621|11467932|FG000|COMPLETED|Period III - Maintenance / Rescue Phase||0
10332121|NCT00322621|11467933|FG001|COMPLETED|Period III - Maintenance / Rescue Phase||86
10332122|NCT00322621|11467934|FG002|COMPLETED|Period III - Maintenance / Rescue Phase||33
10332123|NCT00322621|11467932|FG000|NOT COMPLETED|Period III - Maintenance / Rescue Phase||0
10332124|NCT00322621|11467933|FG001|NOT COMPLETED|Period III - Maintenance / Rescue Phase||29
10332125|NCT00322621|11467934|FG002|NOT COMPLETED|Period III - Maintenance / Rescue Phase||36
10332126|NCT00322712|11467947|FG000|STARTED|Overall Study||12
10332127|NCT00322712|11467947|FG000|COMPLETED|Overall Study||11
10332128|NCT00322712|11467947|FG000|NOT COMPLETED|Overall Study||1
10332129|NCT00322777|11467953|FG000|STARTED|Overall Study||39
10332130|NCT00322777|11467954|FG001|STARTED|Overall Study||45
10332131|NCT00322777|11467953|FG000|"Data Collection at BASELINE|"|Overall Study||39
10332132|NCT00322777|11467954|FG001|"Data Collection at BASELINE|"|Overall Study||45
10332133|NCT00322777|11467953|FG000|Data Collection at Week 8|Overall Study||39
10332134|NCT00322777|11467954|FG001|Data Collection at Week 8|Overall Study||45
10332135|NCT00322777|11467953|FG000|Data Collection at Week 16|Overall Study||39
10332136|NCT00322777|11467954|FG001|Data Collection at Week 16|Overall Study||45
10332137|NCT00322777|11467953|FG000|Data Collection at Week 24|Overall Study||39
10332138|NCT00322777|11467954|FG001|Data Collection at Week 24|Overall Study||45
10332139|NCT00322777|11467953|FG000|COMPLETED|Overall Study||39
10332140|NCT00322777|11467954|FG001|COMPLETED|Overall Study||45
10332141|NCT00322777|11467953|FG000|NOT COMPLETED|Overall Study||0
10332142|NCT00322777|11467954|FG001|NOT COMPLETED|Overall Study||0
10332143|NCT00322842|11467962|FG000|STARTED|Overall Study||4
10332144|NCT00322842|11467963|FG001|STARTED|Overall Study||31
10332145|NCT00322842|11467962|FG000|COMPLETED|Overall Study|One participant discontinued (d/c) treatment early, received a transplant, and completed the study.|2
10332146|NCT00322842|11467963|FG001|COMPLETED|Overall Study|One participant d/c treatment early, received a transplant, and was lost to follow-up after 6 months|29
10332147|NCT00322842|11467962|FG000|NOT COMPLETED|Overall Study||2
10332148|NCT00322842|11467963|FG001|NOT COMPLETED|Overall Study||2
10332149|NCT00322868|11467970|FG000|STARTED|Overall Study||21
10332150|NCT00322868|11467970|FG000|COMPLETED|Overall Study||20
10332151|NCT00322868|11467970|FG000|NOT COMPLETED|Overall Study||1
10332152|NCT00322881|11467975|FG000|STARTED|Overall Study||12
10332153|NCT00322881|11467975|FG000|COMPLETED|Overall Study||7
10332154|NCT00322881|11467975|FG000|NOT COMPLETED|Overall Study||5
10332161|NCT00323115|11467988|FG000|STARTED|Vaccine Administration||11
10332162|NCT00323115|11467988|FG000|COMPLETED|Vaccine Administration||10
10332163|NCT00323115|11467988|FG000|NOT COMPLETED|Vaccine Administration||1
10332164|NCT00323115|11467988|FG000|STARTED|Adjuvant Therapy & Survival Follow-Up||10
10332165|NCT00323115|11467988|FG000|COMPLETED|Adjuvant Therapy & Survival Follow-Up||2
10332166|NCT00323115|11467988|FG000|NOT COMPLETED|Adjuvant Therapy & Survival Follow-Up||8
10332167|NCT00323193|11467999|FG000|STARTED|Overall Study||53
10332168|NCT00323193|11468000|FG001|STARTED|Overall Study||56
10332169|NCT00323193|11467999|FG000|COMPLETED|Overall Study||30
10332170|NCT00323193|11468000|FG001|COMPLETED|Overall Study||41
10332171|NCT00323193|11467999|FG000|NOT COMPLETED|Overall Study||23
10332172|NCT00323193|11468000|FG001|NOT COMPLETED|Overall Study||15
10332173|NCT00323258|11468008|FG000|STARTED|Primary Outcome (Phone Call at 6 Months)||71
10332174|NCT00323258|11468009|FG001|STARTED|Primary Outcome (Phone Call at 6 Months)||72
10332175|NCT00323258|11468008|FG000|COMPLETED|Primary Outcome (Phone Call at 6 Months)||55
10332176|NCT00323258|11468009|FG001|COMPLETED|Primary Outcome (Phone Call at 6 Months)||53
10332177|NCT00323258|11468008|FG000|NOT COMPLETED|Primary Outcome (Phone Call at 6 Months)||16
10338966|NCT00003656|11475918|FG000|NOT COMPLETED|Overall Study||0
10332178|NCT00323258|11468009|FG001|NOT COMPLETED|Primary Outcome (Phone Call at 6 Months)||19
10332179|NCT00323258|11468008|FG000|STARTED|Secondary Outcome (6 Mon Refill Records)||71
10332180|NCT00323258|11468009|FG001|STARTED|Secondary Outcome (6 Mon Refill Records)||72
10332181|NCT00323258|11468008|FG000|COMPLETED|Secondary Outcome (6 Mon Refill Records)||57
10332182|NCT00323258|11468009|FG001|COMPLETED|Secondary Outcome (6 Mon Refill Records)||58
10332183|NCT00323258|11468008|FG000|NOT COMPLETED|Secondary Outcome (6 Mon Refill Records)||14
10332184|NCT00323258|11468009|FG001|NOT COMPLETED|Secondary Outcome (6 Mon Refill Records)||14
10332185|NCT00323271|11468017|FG000|STARTED|Overall Study||13
10332186|NCT00323271|11468018|FG001|STARTED|Overall Study||12
10332187|NCT00323271|11468017|FG000|COMPLETED|Overall Study||11
10332188|NCT00323271|11468018|FG001|COMPLETED|Overall Study||9
10332189|NCT00323271|11468017|FG000|NOT COMPLETED|Overall Study||2
10332190|NCT00323271|11468018|FG001|NOT COMPLETED|Overall Study||3
10332191|NCT00323284|11468026|FG000|STARTED|12 Months Follow-up||116
10332192|NCT00323284|11468027|FG001|STARTED|12 Months Follow-up||123
10332193|NCT00323284|11468026|FG000|COMPLETED|12 Months Follow-up||111
10332194|NCT00323284|11468027|FG001|COMPLETED|12 Months Follow-up||114
10332195|NCT00323284|11468026|FG000|NOT COMPLETED|12 Months Follow-up||5
10332196|NCT00323284|11468027|FG001|NOT COMPLETED|12 Months Follow-up||9
10332197|NCT00323284|11468026|FG000|STARTED|24 Months Follow-up||116
10332198|NCT00323284|11468027|FG001|STARTED|24 Months Follow-up||123
10332199|NCT00323284|11468026|FG000|COMPLETED|24 Months Follow-up||98
10332200|NCT00323284|11468027|FG001|COMPLETED|24 Months Follow-up||101
10332201|NCT00323284|11468026|FG000|NOT COMPLETED|24 Months Follow-up||18
10332202|NCT00323284|11468027|FG001|NOT COMPLETED|24 Months Follow-up||22
10332203|NCT00323297|11468035|FG000|STARTED|Part A (Double Blind Randomized)||53
10332204|NCT00323297|11468036|FG001|STARTED|Part A (Double Blind Randomized)||50
10332205|NCT00323297|11468035|FG000|COMPLETED|Part A (Double Blind Randomized)||48
10332206|NCT00323297|11468036|FG001|COMPLETED|Part A (Double Blind Randomized)||43
10332207|NCT00323297|11468035|FG000|NOT COMPLETED|Part A (Double Blind Randomized)||5
10332208|NCT00323297|11468036|FG001|NOT COMPLETED|Part A (Double Blind Randomized)||7
10332209|NCT00323297|11468035|FG000|STARTED|Part B (Open-label)||48
10332210|NCT00323297|11468036|FG001|STARTED|Part B (Open-label)||43
10332211|NCT00323297|11468035|FG000|COMPLETED|Part B (Open-label)||39
10332212|NCT00323297|11468036|FG001|COMPLETED|Part B (Open-label)||31
10332213|NCT00323297|11468035|FG000|NOT COMPLETED|Part B (Open-label)||9
10332214|NCT00323297|11468036|FG001|NOT COMPLETED|Part B (Open-label)||12
10332215|NCT00323310|11468042|FG000|STARTED|Overall Study||92
10332216|NCT00323310|11468042|FG000|COMPLETED|Overall Study||89
10332217|NCT00323310|11468042|FG000|NOT COMPLETED|Overall Study||3
10332218|NCT00323362|11468046|FG000|STARTED|Overall Study||17
10332219|NCT00323362|11468046|FG000|COMPLETED|Overall Study||17
10332220|NCT00323362|11468046|FG000|NOT COMPLETED|Overall Study||0
10332221|NCT00323414|11468052|FG000|STARTED|Overall Study||18
10332222|NCT00323414|11468053|FG001|STARTED|Overall Study||19
10332223|NCT00323414|11468052|FG000|COMPLETED|Overall Study||18
10332224|NCT00323414|11468053|FG001|COMPLETED|Overall Study||18
10332225|NCT00323414|11468052|FG000|NOT COMPLETED|Overall Study||0
10332226|NCT00323414|11468053|FG001|NOT COMPLETED|Overall Study||1
10332227|NCT00323427|11468061|FG000|STARTED|Overall Study||69
10332228|NCT00323427|11468062|FG001|STARTED|Overall Study||66
10332229|NCT00323427|11468061|FG000|COMPLETED|Overall Study||38
10332230|NCT00323427|11468062|FG001|COMPLETED|Overall Study||43
10332231|NCT00323427|11468061|FG000|NOT COMPLETED|Overall Study||31
10332232|NCT00323427|11468062|FG001|NOT COMPLETED|Overall Study||23
10332233|NCT00323453|11468070|FG000|STARTED|Overall Study||61
10332234|NCT00323453|11468071|FG001|STARTED|Overall Study||48
10332235|NCT00323453|11468070|FG000|COMPLETED|Overall Study||61
10332236|NCT00323453|11468071|FG001|COMPLETED|Overall Study||48
10332237|NCT00323453|11468070|FG000|NOT COMPLETED|Overall Study||0
10332238|NCT00323453|11468071|FG001|NOT COMPLETED|Overall Study||0
10332239|NCT00323479|11468077|FG000|STARTED|Overall Study||114
10332240|NCT00323479|11468077|FG000|Safety Population|Overall Study|Patients who taken at least one dose of treatment|110
10332241|NCT00323479|11468077|FG000|COMPLETED|Overall Study|with at least 1 evaluation for primary efficacy endpoint|106
10332242|NCT00323479|11468077|FG000|NOT COMPLETED|Overall Study||8
10332243|NCT00323492|11468083|FG000|STARTED|Study Phase 1||47
10332244|NCT00323492|11468084|FG001|STARTED|Study Phase 1||45
10332245|NCT00323492|11468085|FG002|STARTED|Study Phase 1|Not applicable to Phase 1.|0
10332246|NCT00323492|11468083|FG000|Intent-to-Treat (ITT) Analysis Set|Study Phase 1|One subject was excluded from ITT analysis set due to protocol violation.|46
10332247|NCT00323492|11468084|FG001|Intent-to-Treat (ITT) Analysis Set|Study Phase 1||45
10332248|NCT00323492|11468085|FG002|Intent-to-Treat (ITT) Analysis Set|Study Phase 1||0
10332249|NCT00323492|11468083|FG000|COMPLETED|Study Phase 1||45
10332250|NCT00323492|11468084|FG001|COMPLETED|Study Phase 1||45
10332251|NCT00323492|11468085|FG002|COMPLETED|Study Phase 1||0
10332252|NCT00323492|11468083|FG000|NOT COMPLETED|Study Phase 1||2
10332253|NCT00323492|11468084|FG001|NOT COMPLETED|Study Phase 1||0
10332254|NCT00323492|11468085|FG002|NOT COMPLETED|Study Phase 1||0
10332255|NCT00323492|11468083|FG000|STARTED|Study Phase 2|1/45 subjects completed Phase 1 but did not start Phase 2. Week 48 ITT N=46|44
10332256|NCT00323492|11468084|FG001|STARTED|Study Phase 2|2/45 subjects completed Phase 1 but did not start Phase 2. Week 48 ITT N=20 (no switch to Truvada)|18
10332257|NCT00323492|11468085|FG002|STARTED|Study Phase 2|N=25 switched to Truvada in Phase 2.|25
10332258|NCT00323492|11468083|FG000|COMPLETED|Study Phase 2||40
10332259|NCT00323492|11468084|FG001|COMPLETED|Study Phase 2||17
10332260|NCT00323492|11468085|FG002|COMPLETED|Study Phase 2||24
10332261|NCT00323492|11468083|FG000|NOT COMPLETED|Study Phase 2||4
10332262|NCT00323492|11468084|FG001|NOT COMPLETED|Study Phase 2||1
10332263|NCT00323492|11468085|FG002|NOT COMPLETED|Study Phase 2||1
10332264|NCT00323557|11468094|FG000|STARTED|Overall Study|GM-CSF pre and post vaccine.|25
10332265|NCT00323557|11468095|FG001|STARTED|Overall Study||7
10332266|NCT00323557|11468094|FG000|COMPLETED|Overall Study||24
10332267|NCT00323557|11468095|FG001|COMPLETED|Overall Study||7
10332268|NCT00323557|11468094|FG000|NOT COMPLETED|Overall Study||1
10332269|NCT00323557|11468095|FG001|NOT COMPLETED|Overall Study||0
10332270|NCT00323609|11468104|FG000|STARTED|Overall Study||191
10332271|NCT00323609|11468105|FG001|STARTED|Overall Study||190
10332272|NCT00323609|11468106|FG002|STARTED|Overall Study||8
10332273|NCT00323609|11468107|FG003|STARTED|Overall Study||15
10332274|NCT00323609|11468104|FG000|COMPLETED|Overall Study|Revision retains subjects with follow-up data in a visit window when terminated in same visit window|100
10332275|NCT00323609|11468105|FG001|COMPLETED|Overall Study|Revision retains subjects with follow-up data in a visit window when terminated in same visit window|91
10332276|NCT00323609|11468106|FG002|COMPLETED|Overall Study||0
10332277|NCT00323609|11468107|FG003|COMPLETED|Overall Study||0
10332278|NCT00323609|11468104|FG000|NOT COMPLETED|Overall Study||91
10332279|NCT00323609|11468105|FG001|NOT COMPLETED|Overall Study||99
10332280|NCT00323609|11468106|FG002|NOT COMPLETED|Overall Study||8
10332281|NCT00323609|11468107|FG003|NOT COMPLETED|Overall Study||15
10332282|NCT00323622|11468121|FG000|STARTED|Overall Study||176
10332283|NCT00323622|11468122|FG001|STARTED|Overall Study||515
10332284|NCT00323622|11468123|FG002|STARTED|Overall Study||42
10332285|NCT00323622|11468124|FG003|STARTED|Overall Study||134
10332286|NCT00323622|11468125|FG004|STARTED|Overall Study||159
10332287|NCT00323622|11468126|FG005|STARTED|Overall Study||528
10332288|NCT00323622|11468127|FG006|STARTED|Overall Study||43
10332289|NCT00323622|11468128|FG007|STARTED|Overall Study||140
10332290|NCT00323622|11468121|FG000|COMPLETED|Overall Study||145
10332291|NCT00323622|11468122|FG001|COMPLETED|Overall Study||423
10332292|NCT00323622|11468123|FG002|COMPLETED|Overall Study||38
10332293|NCT00323622|11468124|FG003|COMPLETED|Overall Study||122
10332294|NCT00323622|11468125|FG004|COMPLETED|Overall Study||120
10332295|NCT00323622|11468126|FG005|COMPLETED|Overall Study||454
10332296|NCT00323622|11468127|FG006|COMPLETED|Overall Study||38
10332297|NCT00323622|11468128|FG007|COMPLETED|Overall Study||125
10332298|NCT00323622|11468121|FG000|NOT COMPLETED|Overall Study||31
10332299|NCT00323622|11468122|FG001|NOT COMPLETED|Overall Study||92
10332300|NCT00323622|11468123|FG002|NOT COMPLETED|Overall Study||4
10332301|NCT00323622|11468124|FG003|NOT COMPLETED|Overall Study||12
10332302|NCT00323622|11468125|FG004|NOT COMPLETED|Overall Study||39
10332303|NCT00323622|11468126|FG005|NOT COMPLETED|Overall Study||74
10332304|NCT00323622|11468127|FG006|NOT COMPLETED|Overall Study||5
10332305|NCT00323622|11468128|FG007|NOT COMPLETED|Overall Study||15
10456763|NCT01008059|11604613|FG000|NOT COMPLETED|Rifampin Sequential Alfentanil||0
10456764|NCT01008059|11604614|FG001|NOT COMPLETED|Rifampin Sequential Alfentanil||0
10456765|NCT01008059|11604615|FG002|NOT COMPLETED|Rifampin Sequential Alfentanil||0
10456766|NCT01008059|11604616|FG003|NOT COMPLETED|Rifampin Sequential Alfentanil||0
10456767|NCT01008059|11604617|FG004|NOT COMPLETED|Rifampin Sequential Alfentanil||0
10456768|NCT01008059|11604618|FG005|NOT COMPLETED|Rifampin Sequential Alfentanil||0
10456769|NCT01008059|11604619|FG006|NOT COMPLETED|Rifampin Sequential Alfentanil||0
10456770|NCT01008059|11604620|FG007|NOT COMPLETED|Rifampin Sequential Alfentanil||0
10456771|NCT01008059|11604613|FG000|STARTED|Grapefruit Juice Sequential Alfentanil||0
10456772|NCT01008059|11604614|FG001|STARTED|Grapefruit Juice Sequential Alfentanil||0
10456773|NCT01008059|11604615|FG002|STARTED|Grapefruit Juice Sequential Alfentanil||6
10456774|NCT01008059|11604616|FG003|STARTED|Grapefruit Juice Sequential Alfentanil||0
10456775|NCT01008059|11604617|FG004|STARTED|Grapefruit Juice Sequential Alfentanil||0
10456776|NCT01008059|11604618|FG005|STARTED|Grapefruit Juice Sequential Alfentanil||0
10456777|NCT01008059|11604619|FG006|STARTED|Grapefruit Juice Sequential Alfentanil||0
10456778|NCT01008059|11604620|FG007|STARTED|Grapefruit Juice Sequential Alfentanil||0
10456779|NCT01008059|11604613|FG000|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
10456780|NCT01008059|11604614|FG001|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
10456781|NCT01008059|11604615|FG002|COMPLETED|Grapefruit Juice Sequential Alfentanil||6
10456782|NCT01008059|11604616|FG003|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
10456783|NCT01008059|11604617|FG004|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
10456784|NCT01008059|11604618|FG005|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
10456785|NCT01008059|11604619|FG006|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
10456786|NCT01008059|11604620|FG007|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
10456787|NCT01008059|11604613|FG000|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
10456788|NCT01008059|11604614|FG001|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
10456789|NCT01008059|11604615|FG002|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
10456790|NCT01008059|11604616|FG003|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
10456791|NCT01008059|11604617|FG004|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
10702052|NCT02573155|11866547|FG000|COMPLETED|Period 3||15
10702053|NCT02573155|11866548|FG001|COMPLETED|Period 3||31
10702054|NCT02573155|11866547|FG000|NOT COMPLETED|Period 3||0
10702055|NCT02573155|11866548|FG001|NOT COMPLETED|Period 3||0
10713719|NCT02680847|11879221|FG002|STARTED|Overall Study||7
10332306|NCT00323739|11468154|FG000|STARTED|Overall Study||80
10332307|NCT00323739|11468154|FG000|COMPLETED|Overall Study||80
10332308|NCT00323739|11468154|FG000|NOT COMPLETED|Overall Study||0
10332309|NCT00323869|11468158|FG000|STARTED|Overall Study|Enrollment|48
10332310|NCT00323869|11468158|FG000|Treatment Initiation|Overall Study|One participant died before receiving therapy, not included in analysis|47
10332311|NCT00323869|11468158|FG000|COMPLETED|Overall Study||47
10332312|NCT00323869|11468158|FG000|NOT COMPLETED|Overall Study||1
10332313|NCT00323882|11468167|FG000|STARTED|Overall Study||8
10332314|NCT00323882|11468168|FG001|STARTED|Overall Study||6
10332315|NCT00323882|11468169|FG002|STARTED|Overall Study||16
10332316|NCT00323882|11468170|FG003|STARTED|Overall Study||7
10332317|NCT00323882|11468171|FG004|STARTED|Overall Study||34
10332318|NCT00323882|11468167|FG000|COMPLETED|Overall Study||0
10332319|NCT00323882|11468168|FG001|COMPLETED|Overall Study||0
10332320|NCT00323882|11468169|FG002|COMPLETED|Overall Study||3
10332321|NCT00323882|11468170|FG003|COMPLETED|Overall Study||0
10332322|NCT00323882|11468171|FG004|COMPLETED|Overall Study||2
10332323|NCT00323882|11468167|FG000|NOT COMPLETED|Overall Study||8
10702056|NCT02573155|11866547|FG000|STARTED|Washout Between Treatment Period 3 and 4|Part 1 comprised 3 treatment periods only|0
10702057|NCT02573155|11866548|FG001|STARTED|Washout Between Treatment Period 3 and 4||31
10702058|NCT02573155|11866547|FG000|COMPLETED|Washout Between Treatment Period 3 and 4|Part 1 comprised 3 treatment periods only|0
10702059|NCT02573155|11866548|FG001|COMPLETED|Washout Between Treatment Period 3 and 4||29
10702060|NCT02573155|11866547|FG000|NOT COMPLETED|Washout Between Treatment Period 3 and 4||0
10702061|NCT02573155|11866548|FG001|NOT COMPLETED|Washout Between Treatment Period 3 and 4||2
10702062|NCT02573155|11866547|FG000|STARTED|Period 4|Part 1 comprised 3 treatment periods only|0
10702063|NCT02573155|11866548|FG001|STARTED|Period 4||29
10702064|NCT02573155|11866547|FG000|COMPLETED|Period 4|Part 1 comprised 3 treatment periods only|0
10702065|NCT02573155|11866548|FG001|COMPLETED|Period 4||29
10332324|NCT00323882|11468168|FG001|NOT COMPLETED|Overall Study||6
10332325|NCT00323882|11468169|FG002|NOT COMPLETED|Overall Study||13
10332326|NCT00323882|11468170|FG003|NOT COMPLETED|Overall Study||7
10332327|NCT00323882|11468171|FG004|NOT COMPLETED|Overall Study||32
10332328|NCT00323960|11468195|FG000|STARTED|Overall Study||47
10332329|NCT00323960|11468196|FG001|STARTED|Overall Study||46
10332330|NCT00323960|11468197|FG002|STARTED|Overall Study||46
10332331|NCT00323960|11468195|FG000|COMPLETED|Overall Study||47
10332332|NCT00323960|11468196|FG001|COMPLETED|Overall Study||46
10332333|NCT00323960|11468197|FG002|COMPLETED|Overall Study||46
10332334|NCT00323960|11468195|FG000|NOT COMPLETED|Overall Study||0
10332335|NCT00323960|11468196|FG001|NOT COMPLETED|Overall Study||0
10332336|NCT00323960|11468197|FG002|NOT COMPLETED|Overall Study||0
10332337|NCT00324038|11468210|FG000|STARTED|Overall Study||110
10332338|NCT00324038|11468211|FG001|STARTED|Overall Study||109
10332339|NCT00324038|11468210|FG000|COMPLETED|Overall Study||61
10332340|NCT00324038|11468211|FG001|COMPLETED|Overall Study||58
10332341|NCT00324038|11468210|FG000|NOT COMPLETED|Overall Study||49
10332342|NCT00324038|11468211|FG001|NOT COMPLETED|Overall Study||51
10332343|NCT00324116|11468217|FG000|STARTED|Overall Study|subjects received treatment|81
10332344|NCT00324116|11468217|FG000|COMPLETED|Overall Study||49
10332345|NCT00324116|11468217|FG000|NOT COMPLETED|Overall Study||32
10332346|NCT00324155|11468223|FG000|STARTED|Enrolled and Randomized||250
10332347|NCT00324155|11468224|FG001|STARTED|Enrolled and Randomized||252
10332348|NCT00324155|11468223|FG000|COMPLETED|Enrolled and Randomized|3 randomized but who did not receive treatment (no longer met study criteria).|247
10332349|NCT00324155|11468224|FG001|COMPLETED|Enrolled and Randomized|1 randomized but who did not receive treatment (lost to follow-up).|251
10332350|NCT00324155|11468223|FG000|NOT COMPLETED|Enrolled and Randomized||3
10332351|NCT00324155|11468224|FG001|NOT COMPLETED|Enrolled and Randomized||1
10332352|NCT00324155|11468223|FG000|STARTED|Received Treatment in Induction Phase||247
10332353|NCT00324155|11468224|FG001|STARTED|Received Treatment in Induction Phase||251
10332354|NCT00324155|11468223|FG000|COMPLETED|Received Treatment in Induction Phase|45 participants on treatment at end of Induction Phase. Study undergoing closure.|45
10332355|NCT00324155|11468224|FG001|COMPLETED|Received Treatment in Induction Phase|54 participants on treatment at end of Induction Phase. Study undergoing closure.|54
10332356|NCT00324155|11468223|FG000|NOT COMPLETED|Received Treatment in Induction Phase||202
10332357|NCT00324155|11468224|FG001|NOT COMPLETED|Received Treatment in Induction Phase||197
10332358|NCT00324155|11468223|FG000|STARTED|Received Treatment in Maintenance Phase|2 completed Induction Phase but did not enter Maintenance Phase|43
10332359|NCT00324155|11468224|FG001|STARTED|Received Treatment in Maintenance Phase|1 completed Induction Phase but did not enter Maintenance Phase|53
10332360|NCT00324155|11468223|FG000|COMPLETED|Received Treatment in Maintenance Phase|Study is in closure at this time. 11 in Maintenance Phase not yet summarized.|11
10332361|NCT00324155|11468224|FG001|COMPLETED|Received Treatment in Maintenance Phase|Study is in closure. 6 participants in Maintenance Phase not yet summarized.|6
10332362|NCT00324155|11468223|FG000|NOT COMPLETED|Received Treatment in Maintenance Phase||32
10332363|NCT00324155|11468224|FG001|NOT COMPLETED|Received Treatment in Maintenance Phase||47
10332364|NCT00324155|11468223|FG000|STARTED|Follow-up Phase|All participants received study drug. Follow-up was performed for those leaving earlier phases.|247
10332365|NCT00324155|11468224|FG001|STARTED|Follow-up Phase|All participants received study drug. Follow-up was performed for those leaving earlier phases.|251
10332366|NCT00324155|11468223|FG000|COMPLETED|Follow-up Phase||236
10702066|NCT02573155|11866547|FG000|NOT COMPLETED|Period 4||0
10702067|NCT02573155|11866548|FG001|NOT COMPLETED|Period 4||0
10702068|NCT02573155|11866547|FG000|STARTED|Washout Between Treatment Period 4 and 5|Part 1 comprised 3 treatment periods only|0
10702069|NCT02573155|11866548|FG001|STARTED|Washout Between Treatment Period 4 and 5||29
10702070|NCT02573155|11866547|FG000|COMPLETED|Washout Between Treatment Period 4 and 5|Part 1 comprised 3 treatment periods only|0
10702071|NCT02573155|11866548|FG001|COMPLETED|Washout Between Treatment Period 4 and 5||28
10332367|NCT00324155|11468224|FG001|COMPLETED|Follow-up Phase||245
10332368|NCT00324155|11468223|FG000|NOT COMPLETED|Follow-up Phase||11
10332369|NCT00324155|11468224|FG001|NOT COMPLETED|Follow-up Phase||6
10332370|NCT00324168|11468245|FG000|STARTED|Overall Study||250
10332371|NCT00324168|11468246|FG001|STARTED|Overall Study||250
10332372|NCT00324168|11468245|FG000|COMPLETED|Overall Study||222
10332373|NCT00324168|11468246|FG001|COMPLETED|Overall Study||220
10332374|NCT00324168|11468245|FG000|NOT COMPLETED|Overall Study||28
10332375|NCT00324168|11468246|FG001|NOT COMPLETED|Overall Study||30
10332376|NCT00324233|11468254|FG000|STARTED|First Period||18
10332377|NCT00324233|11468255|FG001|STARTED|First Period||18
10332378|NCT00324233|11468254|FG000|COMPLETED|First Period||17
10332379|NCT00324233|11468255|FG001|COMPLETED|First Period||18
10332380|NCT00324233|11468254|FG000|NOT COMPLETED|First Period||1
10332381|NCT00324233|11468255|FG001|NOT COMPLETED|First Period||0
10332382|NCT00324233|11468254|FG000|STARTED|Second Period||17
10332383|NCT00324233|11468255|FG001|STARTED|Second Period||18
10332384|NCT00324233|11468254|FG000|COMPLETED|Second Period||12
10332385|NCT00324233|11468255|FG001|COMPLETED|Second Period||11
10332386|NCT00324233|11468254|FG000|NOT COMPLETED|Second Period||5
10332387|NCT00324233|11468255|FG001|NOT COMPLETED|Second Period||7
10332388|NCT00324259|11468263|FG000|STARTED|Overall Study||34
10332389|NCT00324259|11468264|FG001|STARTED|Overall Study||32
10332390|NCT00324259|11468263|FG000|COMPLETED|Overall Study||34
10332391|NCT00324259|11468264|FG001|COMPLETED|Overall Study||32
10332392|NCT00324259|11468263|FG000|NOT COMPLETED|Overall Study||0
10332393|NCT00324259|11468264|FG001|NOT COMPLETED|Overall Study||0
10332394|NCT00324272|11468275|FG000|STARTED|Overall Study||18
10332395|NCT00324272|11468276|FG001|STARTED|Overall Study||20
10332396|NCT00324272|11468277|FG002|STARTED|Overall Study||18
10332397|NCT00324272|11468278|FG003|STARTED|Overall Study||18
10332398|NCT00324272|11468275|FG000|COMPLETED|Overall Study||18
10332399|NCT00324272|11468276|FG001|COMPLETED|Overall Study||20
10332400|NCT00324272|11468277|FG002|COMPLETED|Overall Study||18
10332401|NCT00324272|11468278|FG003|COMPLETED|Overall Study||18
10332402|NCT00324272|11468275|FG000|NOT COMPLETED|Overall Study||0
10332403|NCT00324272|11468276|FG001|NOT COMPLETED|Overall Study||0
10332404|NCT00324272|11468277|FG002|NOT COMPLETED|Overall Study||0
10332405|NCT00324272|11468278|FG003|NOT COMPLETED|Overall Study||0
10332406|NCT00324350|11468290|FG000|STARTED|Overall Study||3655
10332407|NCT00324350|11468291|FG001|STARTED|Overall Study||3632
10332408|NCT00324350|11468290|FG000|Non-Vertebral Fracture Follow-Up|Overall Study||3655
10332409|NCT00324350|11468291|FG001|Non-Vertebral Fracture Follow-Up|Overall Study||3632
10332410|NCT00324350|11468290|FG000|Falls Follow-Up|Overall Study||3364
10332411|NCT00324350|11468291|FG001|Falls Follow-Up|Overall Study||3418
10332412|NCT00324350|11468290|FG000|COMPLETED|Overall Study||3655
10332413|NCT00324350|11468291|FG001|COMPLETED|Overall Study||3632
10332414|NCT00324350|11468290|FG000|NOT COMPLETED|Overall Study||0
10332415|NCT00324350|11468291|FG001|NOT COMPLETED|Overall Study||0
10332416|NCT00324415|11468298|FG000|STARTED|Overall Study||45
10332417|NCT00324415|11468298|FG000|COMPLETED|Overall Study||45
10332418|NCT00324415|11468298|FG000|NOT COMPLETED|Overall Study||0
10332419|NCT00324649|11468305|FG000|STARTED|Overall Study||39
10332420|NCT00324649|11468306|FG001|STARTED|Overall Study||41
10332421|NCT00324649|11468305|FG000|COMPLETED|Overall Study||37
10332422|NCT00324649|11468306|FG001|COMPLETED|Overall Study||36
10332423|NCT00324649|11468305|FG000|NOT COMPLETED|Overall Study||2
10332424|NCT00324649|11468306|FG001|NOT COMPLETED|Overall Study||5
10702072|NCT02573155|11866547|FG000|NOT COMPLETED|Washout Between Treatment Period 4 and 5||0
10332425|NCT00324675|11468314|FG000|STARTED|Overall Study||14
10332426|NCT00324675|11468315|FG001|STARTED|Overall Study||14
10332427|NCT00324675|11468314|FG000|COMPLETED|Overall Study||13
10332428|NCT00324675|11468315|FG001|COMPLETED|Overall Study||14
10332429|NCT00324675|11468314|FG000|NOT COMPLETED|Overall Study||1
10332430|NCT00324675|11468315|FG001|NOT COMPLETED|Overall Study||0
10332431|NCT00324701|11468323|FG000|STARTED|Overall Study||120
10332432|NCT00324701|11468324|FG001|STARTED|Overall Study||121
10332433|NCT00324701|11468323|FG000|Week 8 Assessment|Overall Study||108
10332434|NCT00324701|11468324|FG001|Week 8 Assessment|Overall Study||107
10332435|NCT00324701|11468323|FG000|COMPLETED|Overall Study||100
10332436|NCT00324701|11468324|FG001|COMPLETED|Overall Study||104
10332437|NCT00324701|11468323|FG000|NOT COMPLETED|Overall Study||20
10332438|NCT00324701|11468324|FG001|NOT COMPLETED|Overall Study||17
10332439|NCT00324740|11468330|FG000|STARTED|Overall Study||7
10332440|NCT00324740|11468331|FG001|STARTED|Overall Study||3
10332441|NCT00324740|11468332|FG002|STARTED|Overall Study||4
10332442|NCT00324740|11468330|FG000|COMPLETED|Overall Study||6
10332443|NCT00324740|11468331|FG001|COMPLETED|Overall Study||3
10332444|NCT00324740|11468332|FG002|COMPLETED|Overall Study||3
10332445|NCT00324740|11468330|FG000|NOT COMPLETED|Overall Study||1
10332446|NCT00324740|11468331|FG001|NOT COMPLETED|Overall Study||0
10332447|NCT00324740|11468332|FG002|NOT COMPLETED|Overall Study||1
10332448|NCT00324753|11468341|FG000|STARTED|Overall Study||190
10332449|NCT00324753|11468342|FG001|STARTED|Overall Study||264
10332450|NCT00324753|11468341|FG000|COMPLETED|Overall Study||190
10332451|NCT00324753|11468342|FG001|COMPLETED|Overall Study||264
10332452|NCT00324753|11468341|FG000|NOT COMPLETED|Overall Study||0
10332453|NCT00324753|11468342|FG001|NOT COMPLETED|Overall Study||0
10332454|NCT00324857|11468354|FG000|STARTED|Overall Study||167
10332455|NCT00324857|11468355|FG001|STARTED|Overall Study||168
10332456|NCT00324857|11468356|FG002|STARTED|Overall Study||165
10332457|NCT00324857|11468357|FG003|STARTED|Overall Study||163
10332458|NCT00324857|11468354|FG000|COMPLETED|Overall Study||161
10332459|NCT00324857|11468355|FG001|COMPLETED|Overall Study||162
10332460|NCT00324857|11468356|FG002|COMPLETED|Overall Study||158
10332461|NCT00324857|11468357|FG003|COMPLETED|Overall Study||158
10332462|NCT00324857|11468354|FG000|NOT COMPLETED|Overall Study||6
10332463|NCT00324857|11468355|FG001|NOT COMPLETED|Overall Study||6
10332464|NCT00324857|11468356|FG002|NOT COMPLETED|Overall Study||7
10332465|NCT00324857|11468357|FG003|NOT COMPLETED|Overall Study||5
10332466|NCT00324870|11468371|FG000|STARTED|Overall Study||37
10332467|NCT00324870|11468371|FG000|COMPLETED|Overall Study||37
10332468|NCT00324870|11468371|FG000|NOT COMPLETED|Overall Study||0
10332469|NCT00324896|11468377|FG000|STARTED|Overall Study||15
10332470|NCT00324896|11468378|FG001|STARTED|Overall Study||15
10332471|NCT00324896|11468377|FG000|COMPLETED|Overall Study||12
10332472|NCT00324896|11468378|FG001|COMPLETED|Overall Study||7
10332473|NCT00324896|11468377|FG000|NOT COMPLETED|Overall Study||3
10332474|NCT00324896|11468378|FG001|NOT COMPLETED|Overall Study||8
10332475|NCT00324961|11468384|FG000|STARTED|Overall Study||533
10332476|NCT00324961|11468384|FG000|COMPLETED|Overall Study||490
10332477|NCT00324961|11468384|FG000|NOT COMPLETED|Overall Study||43
10332478|NCT00324987|11468392|FG000|STARTED|Overall Study||6
10332479|NCT00324987|11468393|FG001|STARTED|Overall Study||6
10332480|NCT00324987|11468392|FG000|COMPLETED|Overall Study|Patients were to be treated until progression|0
10332481|NCT00324987|11468393|FG001|COMPLETED|Overall Study|Patients were to be treated until progression|0
10332482|NCT00324987|11468392|FG000|NOT COMPLETED|Overall Study||6
10332483|NCT00324987|11468393|FG001|NOT COMPLETED|Overall Study||6
10332484|NCT00325039|11468401|FG000|STARTED|Overall Study||298
10332485|NCT00325039|11468402|FG001|STARTED|Overall Study||299
10332486|NCT00325039|11468401|FG000|COMPLETED|Overall Study||280
10332487|NCT00325039|11468402|FG001|COMPLETED|Overall Study||285
10332488|NCT00325039|11468401|FG000|NOT COMPLETED|Overall Study||18
10332489|NCT00325039|11468402|FG001|NOT COMPLETED|Overall Study||14
10332490|NCT00325078|11468411|FG000|STARTED|Overall Study||8
10332491|NCT00325078|11468412|FG001|STARTED|Overall Study||7
10332492|NCT00325078|11468413|FG002|STARTED|Overall Study||25
10332493|NCT00325078|11468411|FG000|COMPLETED|Overall Study||3
10332494|NCT00325078|11468412|FG001|COMPLETED|Overall Study||2
10332495|NCT00325078|11468413|FG002|COMPLETED|Overall Study||23
10332496|NCT00325078|11468411|FG000|NOT COMPLETED|Overall Study||5
10332497|NCT00325078|11468412|FG001|NOT COMPLETED|Overall Study||5
10332498|NCT00325078|11468413|FG002|NOT COMPLETED|Overall Study||2
10332499|NCT00325130|11468424|FG000|STARTED|Overall Study||518
10332500|NCT00325130|11468425|FG001|STARTED|Overall Study||524
10805240|NCT04019626|11966789|FG001|NOT COMPLETED|Overall Study||10
10332501|NCT00325130|11468424|FG000|COMPLETED|Overall Study||499
10332502|NCT00325130|11468425|FG001|COMPLETED|Overall Study||494
10332503|NCT00325130|11468424|FG000|NOT COMPLETED|Overall Study||19
10332504|NCT00325130|11468425|FG001|NOT COMPLETED|Overall Study||30
10332505|NCT00325143|11468431|FG000|STARTED|Overall Study||702
10332506|NCT00325143|11468431|FG000|COMPLETED|Overall Study||676
10332507|NCT00325143|11468431|FG000|NOT COMPLETED|Overall Study||26
10332508|NCT00325156|11468435|FG000|STARTED|Overall Study||2590
10332509|NCT00325156|11468435|FG000|COMPLETED|Overall Study||2478
10332510|NCT00325156|11468435|FG000|NOT COMPLETED|Overall Study||112
10332511|NCT00325195|11468442|FG000|STARTED|Randomized||90
10332512|NCT00325195|11468443|FG001|STARTED|Randomized||89
10332513|NCT00325195|11468444|FG002|STARTED|Randomized||46
10332514|NCT00325195|11468442|FG000|COMPLETED|Randomized||85
10332515|NCT00325195|11468443|FG001|COMPLETED|Randomized||84
10332516|NCT00325195|11468444|FG002|COMPLETED|Randomized||43
10332517|NCT00325195|11468442|FG000|NOT COMPLETED|Randomized||5
10332518|NCT00325195|11468443|FG001|NOT COMPLETED|Randomized||5
10332519|NCT00325195|11468444|FG002|NOT COMPLETED|Randomized||3
10332520|NCT00325195|11468442|FG000|STARTED|Received Intervention: ITT Population||85
10332521|NCT00325195|11468443|FG001|STARTED|Received Intervention: ITT Population||84
10332522|NCT00325195|11468444|FG002|STARTED|Received Intervention: ITT Population||43
10332523|NCT00325195|11468442|FG000|COMPLETED|Received Intervention: ITT Population||59
10332524|NCT00325195|11468443|FG001|COMPLETED|Received Intervention: ITT Population||59
10332525|NCT00325195|11468444|FG002|COMPLETED|Received Intervention: ITT Population||39
10332526|NCT00325195|11468442|FG000|NOT COMPLETED|Received Intervention: ITT Population||26
10332527|NCT00325195|11468443|FG001|NOT COMPLETED|Received Intervention: ITT Population||25
10332528|NCT00325195|11468444|FG002|NOT COMPLETED|Received Intervention: ITT Population||4
10332529|NCT00325234|11468454|FG000|STARTED|Overall Study||69
10332530|NCT00325234|11468455|FG001|STARTED|Overall Study||66
10332531|NCT00325234|11468454|FG000|Received At Least 1 Dose of Study Drug|Overall Study||65
10332532|NCT00325234|11468455|FG001|Received At Least 1 Dose of Study Drug|Overall Study||66
10332533|NCT00325234|11468454|FG000|COMPLETED|Overall Study||0
10332534|NCT00325234|11468455|FG001|COMPLETED|Overall Study||0
10332535|NCT00325234|11468454|FG000|NOT COMPLETED|Overall Study||69
10332536|NCT00325234|11468455|FG001|NOT COMPLETED|Overall Study||66
10332537|NCT00325403|11468465|FG000|STARTED|Overall Study||116
10332538|NCT00325403|11468466|FG001|STARTED|Overall Study||233
10332539|NCT00325403|11468465|FG000|COMPLETED|Overall Study|98 subjects receiving placebo completed the study on study drug|98
10332540|NCT00325403|11468466|FG001|COMPLETED|Overall Study|182 subjects receiving oral treprostinil completed the study on study drug|182
10332541|NCT00325403|11468465|FG000|NOT COMPLETED|Overall Study||18
10332542|NCT00325403|11468466|FG001|NOT COMPLETED|Overall Study||51
10332543|NCT00325416|11468476|FG000|STARTED|Phase I: Dose Escalation||70
10805241|NCT04019626|11966790|FG002|NOT COMPLETED|Overall Study||8
10332544|NCT00325416|11468477|FG001|STARTED|Phase I: Dose Escalation||60
10332545|NCT00325416|11468476|FG000|COMPLETED|Phase I: Dose Escalation||48
10332546|NCT00325416|11468477|FG001|COMPLETED|Phase I: Dose Escalation||44
10332547|NCT00325416|11468476|FG000|NOT COMPLETED|Phase I: Dose Escalation||22
10332548|NCT00325416|11468477|FG001|NOT COMPLETED|Phase I: Dose Escalation||16
10332549|NCT00325416|11468476|FG000|STARTED|Phase II: Treatment at MTD||78
10332550|NCT00325416|11468477|FG001|STARTED|Phase II: Treatment at MTD||42
10332551|NCT00325416|11468476|FG000|Proceeded From Phase I to Phase II|Phase II: Treatment at MTD||38
10332552|NCT00325416|11468477|FG001|Proceeded From Phase I to Phase II|Phase II: Treatment at MTD||34
10702073|NCT02573155|11866548|FG001|NOT COMPLETED|Washout Between Treatment Period 4 and 5||1
10702074|NCT02573155|11866547|FG000|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
10702075|NCT02573155|11866548|FG001|STARTED|Period 5||28
10702076|NCT02573155|11866547|FG000|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
10702077|NCT02573155|11866548|FG001|COMPLETED|Period 5||28
10332553|NCT00325416|11468476|FG000|Enrolled During Phase II|Phase II: Treatment at MTD||40
10332554|NCT00325416|11468477|FG001|Enrolled During Phase II|Phase II: Treatment at MTD||8
10332555|NCT00325416|11468476|FG000|COMPLETED|Phase II: Treatment at MTD||78
10332556|NCT00325416|11468477|FG001|COMPLETED|Phase II: Treatment at MTD||40
10332557|NCT00325416|11468476|FG000|NOT COMPLETED|Phase II: Treatment at MTD||0
10332558|NCT00325416|11468477|FG001|NOT COMPLETED|Phase II: Treatment at MTD||2
10332559|NCT00325442|11468485|FG000|STARTED|Overall Study||176
10332560|NCT00325442|11468486|FG001|STARTED|Overall Study||174
10332561|NCT00325442|11468485|FG000|COMPLETED|Overall Study||167
10332562|NCT00325442|11468486|FG001|COMPLETED|Overall Study||153
10332563|NCT00325442|11468485|FG000|NOT COMPLETED|Overall Study||9
10332564|NCT00325442|11468486|FG001|NOT COMPLETED|Overall Study||21
10332565|NCT00325468|11468500|FG000|STARTED|Overall Study||23
10332566|NCT00325468|11468501|FG001|STARTED|Overall Study||17
10332567|NCT00325468|11468502|FG002|STARTED|Overall Study||14
10332568|NCT00325468|11468503|FG003|STARTED|Overall Study||124
10332569|NCT00325468|11468504|FG004|STARTED|Overall Study||22
10332570|NCT00325468|11468500|FG000|COMPLETED|Overall Study||12
10332571|NCT00325468|11468501|FG001|COMPLETED|Overall Study||12
10332572|NCT00325468|11468502|FG002|COMPLETED|Overall Study||10
10332573|NCT00325468|11468503|FG003|COMPLETED|Overall Study||90
10332574|NCT00325468|11468504|FG004|COMPLETED|Overall Study||14
10332575|NCT00325468|11468500|FG000|NOT COMPLETED|Overall Study||11
10332576|NCT00325468|11468501|FG001|NOT COMPLETED|Overall Study||5
10332577|NCT00325468|11468502|FG002|NOT COMPLETED|Overall Study||4
10332578|NCT00325468|11468503|FG003|NOT COMPLETED|Overall Study||34
10332579|NCT00325468|11468504|FG004|NOT COMPLETED|Overall Study||8
10332580|NCT00325598|11468519|FG000|STARTED|Overall Study||50
10332581|NCT00325598|11468520|FG001|STARTED|Overall Study||50
10332582|NCT00325598|11468519|FG000|COMPLETED|Overall Study||50
10332583|NCT00325598|11468520|FG001|COMPLETED|Overall Study||50
10332584|NCT00325598|11468519|FG000|NOT COMPLETED|Overall Study||0
10332585|NCT00325598|11468520|FG001|NOT COMPLETED|Overall Study||0
10332586|NCT00325754|11468530|FG000|STARTED|Overall Study||11
10332587|NCT00325754|11468531|FG001|STARTED|Overall Study||11
10332588|NCT00325754|11468530|FG000|COMPLETED|Overall Study||7
10332589|NCT00325754|11468531|FG001|COMPLETED|Overall Study||10
10332590|NCT00325754|11468530|FG000|NOT COMPLETED|Overall Study||4
10332591|NCT00325754|11468531|FG001|NOT COMPLETED|Overall Study||1
10332592|NCT00325780|11468537|FG000|STARTED|Overall Study||1355
10332593|NCT00325780|11468537|FG000|Safety Population|Overall Study|Patients who received at least one dose of study treatment in this extension study.|1353
10332594|NCT00325780|11468537|FG000|COMPLETED|Overall Study||1200
10332595|NCT00325780|11468537|FG000|NOT COMPLETED|Overall Study||155
10332596|NCT00325819|11468543|FG000|STARTED|Overall Study||185
10332597|NCT00325819|11468544|FG001|STARTED|Overall Study||189
10332598|NCT00325819|11468543|FG000|COMPLETED|Overall Study||176
10332599|NCT00325819|11468544|FG001|COMPLETED|Overall Study||176
10332600|NCT00325819|11468543|FG000|NOT COMPLETED|Overall Study||9
10332601|NCT00325819|11468544|FG001|NOT COMPLETED|Overall Study||13
10332602|NCT00325897|11468554|FG000|STARTED|Overall Study||570
10332603|NCT00325897|11468555|FG001|STARTED|Overall Study||572
10332604|NCT00325897|11468554|FG000|COMPLETED|Overall Study||558
10702078|NCT02573155|11866547|FG000|NOT COMPLETED|Period 5||0
10702079|NCT02573155|11866548|FG001|NOT COMPLETED|Period 5||0
10702080|NCT02573181|11866576|FG000|STARTED|Overall Study||127
10805242|NCT04019626|11966791|FG003|NOT COMPLETED|Overall Study||7
10332605|NCT00325897|11468555|FG001|COMPLETED|Overall Study||559
10332606|NCT00325897|11468554|FG000|NOT COMPLETED|Overall Study||12
10332607|NCT00325897|11468555|FG001|NOT COMPLETED|Overall Study||13
10332608|NCT00326001|11468566|FG000|STARTED|Overall Study||236
10332609|NCT00326001|11468567|FG001|STARTED|Overall Study||227
10332610|NCT00326001|11468566|FG000|COMPLETED|Overall Study||229
10332611|NCT00326001|11468567|FG001|COMPLETED|Overall Study||219
10332612|NCT00326001|11468566|FG000|NOT COMPLETED|Overall Study||7
10332613|NCT00326001|11468567|FG001|NOT COMPLETED|Overall Study||8
10332614|NCT00326118|11468575|FG000|STARTED|Active Phase||324
10332615|NCT00326118|11468576|FG001|STARTED|Active Phase||109
10332616|NCT00326118|11468575|FG000|COMPLETED|Active Phase||320
10332617|NCT00326118|11468576|FG001|COMPLETED|Active Phase||108
10332618|NCT00326118|11468575|FG000|NOT COMPLETED|Active Phase||4
10332619|NCT00326118|11468576|FG001|NOT COMPLETED|Active Phase||1
10332620|NCT00326118|11468575|FG000|STARTED|Year 1 Follow-up||295
10332621|NCT00326118|11468576|FG001|STARTED|Year 1 Follow-up||100
10332622|NCT00326118|11468575|FG000|COMPLETED|Year 1 Follow-up||295
10702081|NCT02573181|11866577|FG001|STARTED|Overall Study||126
10702082|NCT02573181|11866576|FG000|Vaccinated|Overall Study||127
10332623|NCT00326118|11468576|FG001|COMPLETED|Year 1 Follow-up||100
10332624|NCT00326118|11468575|FG000|NOT COMPLETED|Year 1 Follow-up||0
10332625|NCT00326118|11468576|FG001|NOT COMPLETED|Year 1 Follow-up||0
10332626|NCT00326118|11468575|FG000|STARTED|Year 2 Follow-up||270
10332627|NCT00326118|11468576|FG001|STARTED|Year 2 Follow-up||92
10332628|NCT00326118|11468575|FG000|COMPLETED|Year 2 Follow-up||270
10332629|NCT00326118|11468576|FG001|COMPLETED|Year 2 Follow-up||92
10332630|NCT00326118|11468575|FG000|NOT COMPLETED|Year 2 Follow-up||0
10332631|NCT00326118|11468576|FG001|NOT COMPLETED|Year 2 Follow-up||0
10332632|NCT00326118|11468575|FG000|STARTED|Year 3 Follow-up||256
10332633|NCT00326118|11468576|FG001|STARTED|Year 3 Follow-up||89
10332634|NCT00326118|11468575|FG000|COMPLETED|Year 3 Follow-up||256
10332635|NCT00326118|11468576|FG001|COMPLETED|Year 3 Follow-up||89
10332636|NCT00326118|11468575|FG000|NOT COMPLETED|Year 3 Follow-up||0
10332637|NCT00326118|11468576|FG001|NOT COMPLETED|Year 3 Follow-up||0
10332638|NCT00326118|11468575|FG000|STARTED|Year 4 Follow-up||228
10332639|NCT00326118|11468576|FG001|STARTED|Year 4 Follow-up||80
10332640|NCT00326118|11468575|FG000|COMPLETED|Year 4 Follow-up||228
10332641|NCT00326118|11468576|FG001|COMPLETED|Year 4 Follow-up||80
10332642|NCT00326118|11468575|FG000|NOT COMPLETED|Year 4 Follow-up||0
10332643|NCT00326118|11468576|FG001|NOT COMPLETED|Year 4 Follow-up||0
10332644|NCT00326118|11468575|FG000|STARTED|Year 5 Follow up||217
10332645|NCT00326118|11468576|FG001|STARTED|Year 5 Follow up||78
10332646|NCT00326118|11468575|FG000|COMPLETED|Year 5 Follow up||217
10332647|NCT00326118|11468576|FG001|COMPLETED|Year 5 Follow up||78
10332648|NCT00326118|11468575|FG000|NOT COMPLETED|Year 5 Follow up||0
10332649|NCT00326118|11468576|FG001|NOT COMPLETED|Year 5 Follow up||0
10332650|NCT00326170|11468583|FG000|STARTED|Overall Study||34
10332651|NCT00326170|11468583|FG000|COMPLETED|Overall Study||34
10332652|NCT00326170|11468583|FG000|NOT COMPLETED|Overall Study||0
10332653|NCT00326196|11468589|FG000|STARTED|Overall Study||101
10332654|NCT00326196|11468590|FG001|STARTED|Overall Study||97
10332655|NCT00326196|11468589|FG000|COMPLETED|Overall Study||101
10332656|NCT00326196|11468590|FG001|COMPLETED|Overall Study||97
10332657|NCT00326196|11468589|FG000|NOT COMPLETED|Overall Study||0
10332658|NCT00326196|11468590|FG001|NOT COMPLETED|Overall Study||0
10332659|NCT00326209|11468596|FG000|STARTED|Overall Study||393
10332660|NCT00326209|11468596|FG000|Safety Population|Overall Study||388
10332661|NCT00326209|11468596|FG000|COMPLETED|Overall Study||111
10332662|NCT00326209|11468596|FG000|NOT COMPLETED|Overall Study||282
10332663|NCT00326417|11468602|FG000|STARTED|Overall Study||14
10332664|NCT00326417|11468603|FG001|STARTED|Overall Study||41
10332665|NCT00326417|11468604|FG002|STARTED|Overall Study||39
10332666|NCT00326417|11468605|FG003|STARTED|Overall Study||3
10332667|NCT00326417|11468602|FG000|Phase I|Overall Study||6
10332668|NCT00326417|11468603|FG001|Phase I|Overall Study||6
10332669|NCT00326417|11468604|FG002|Phase I|Overall Study||6
10332670|NCT00326417|11468605|FG003|Phase I|Overall Study||3
10332671|NCT00326417|11468602|FG000|Phase II|Overall Study||8
10332672|NCT00326417|11468603|FG001|Phase II|Overall Study||35
10332673|NCT00326417|11468604|FG002|Phase II|Overall Study||33
10332674|NCT00326417|11468605|FG003|Phase II|Overall Study||0
10332675|NCT00326417|11468602|FG000|COMPLETED|Overall Study|Dose level was closed for excessive toxicity after 8 patients in Phase II accrued.|0
10332676|NCT00326417|11468603|FG001|COMPLETED|Overall Study||41
10332677|NCT00326417|11468604|FG002|COMPLETED|Overall Study||38
10332678|NCT00326417|11468605|FG003|COMPLETED|Overall Study|Arm was closed to accrual after 3 patients experienced graft failure.|0
10332679|NCT00326417|11468602|FG000|NOT COMPLETED|Overall Study||14
10332680|NCT00326417|11468603|FG001|NOT COMPLETED|Overall Study||0
10332681|NCT00326417|11468604|FG002|NOT COMPLETED|Overall Study||1
10332682|NCT00326417|11468605|FG003|NOT COMPLETED|Overall Study||3
10332683|NCT00326495|11468613|FG000|STARTED|Overall Study||51
10332684|NCT00326495|11468613|FG000|COMPLETED|Overall Study||46
10332685|NCT00326495|11468613|FG000|NOT COMPLETED|Overall Study||5
10332686|NCT00326599|11468621|FG000|STARTED|Overall Study||6
10332687|NCT00326599|11468622|FG001|STARTED|Overall Study||3
10332688|NCT00326599|11468623|FG002|STARTED|Overall Study||58
10332689|NCT00326599|11468624|FG003|STARTED|Overall Study||29
10332690|NCT00326599|11468621|FG000|COMPLETED|Overall Study||0
10332691|NCT00326599|11468622|FG001|COMPLETED|Overall Study||2
10332692|NCT00326599|11468623|FG002|COMPLETED|Overall Study||5
10332693|NCT00326599|11468624|FG003|COMPLETED|Overall Study||10
10332694|NCT00326599|11468621|FG000|NOT COMPLETED|Overall Study||6
10332695|NCT00326599|11468622|FG001|NOT COMPLETED|Overall Study||1
10332696|NCT00326599|11468623|FG002|NOT COMPLETED|Overall Study||53
10332697|NCT00326599|11468624|FG003|NOT COMPLETED|Overall Study||19
10332698|NCT00326612|11468635|FG000|STARTED|Overall Study||179
10332699|NCT00326612|11468636|FG001|STARTED|Overall Study||179
10332700|NCT00326612|11468635|FG000|COMPLETED|Overall Study||50
10702083|NCT02573181|11866577|FG001|Vaccinated|Overall Study||126
10332701|NCT00326612|11468636|FG001|COMPLETED|Overall Study||42
10332702|NCT00326612|11468635|FG000|NOT COMPLETED|Overall Study||129
10332703|NCT00326612|11468636|FG001|NOT COMPLETED|Overall Study||137
10332710|NCT00326716|11468657|FG000|STARTED|Pre-Natal Mothers||20
10332711|NCT00326716|11468658|FG001|STARTED|Pre-Natal Mothers||21
10332712|NCT00326716|11468659|FG002|STARTED|Pre-Natal Mothers||0
10332713|NCT00326716|11468660|FG003|STARTED|Pre-Natal Mothers||0
10332714|NCT00326716|11468657|FG000|COMPLETED|Pre-Natal Mothers|Completion was defined as completing the study.|19
10332715|NCT00326716|11468658|FG001|COMPLETED|Pre-Natal Mothers|Completion was defined as completing the study.|19
10332716|NCT00326716|11468659|FG002|COMPLETED|Pre-Natal Mothers|Completion was defined as completing all follow up visits through 6 months.|0
10332717|NCT00326716|11468660|FG003|COMPLETED|Pre-Natal Mothers|Completion was defined as completing all follow up visits through 6 months.|0
10332718|NCT00326716|11468657|FG000|NOT COMPLETED|Pre-Natal Mothers||1
10332719|NCT00326716|11468658|FG001|NOT COMPLETED|Pre-Natal Mothers||2
10332720|NCT00326716|11468659|FG002|NOT COMPLETED|Pre-Natal Mothers||0
10332721|NCT00326716|11468660|FG003|NOT COMPLETED|Pre-Natal Mothers||0
10332722|NCT00326716|11468657|FG000|STARTED|Infants||0
10332723|NCT00326716|11468658|FG001|STARTED|Infants||0
10332724|NCT00326716|11468659|FG002|STARTED|Infants|All infants were followed.|20
10332725|NCT00326716|11468660|FG003|STARTED|Infants|All infants were followed. One mother withdrew consent pre-delivery and her infant was not followed.|20
10332726|NCT00326716|11468657|FG000|COMPLETED|Infants||0
10332727|NCT00326716|11468658|FG001|COMPLETED|Infants||0
10332728|NCT00326716|11468659|FG002|COMPLETED|Infants||20
10332729|NCT00326716|11468660|FG003|COMPLETED|Infants||20
10332730|NCT00326716|11468657|FG000|NOT COMPLETED|Infants||0
10332731|NCT00326716|11468658|FG001|NOT COMPLETED|Infants||0
10332732|NCT00326716|11468659|FG002|NOT COMPLETED|Infants||0
10332733|NCT00326716|11468660|FG003|NOT COMPLETED|Infants||0
10332734|NCT00326781|11468692|FG000|STARTED|Overall Study||344
10332735|NCT00326781|11468693|FG001|STARTED|Overall Study||330
10332736|NCT00326781|11468692|FG000|COMPLETED|Overall Study||302
10332737|NCT00326781|11468693|FG001|COMPLETED|Overall Study||298
10332738|NCT00326781|11468692|FG000|NOT COMPLETED|Overall Study||42
10332739|NCT00326781|11468693|FG001|NOT COMPLETED|Overall Study||32
10332740|NCT00326872|11468699|FG000|STARTED|Overall Study||26
10332741|NCT00326872|11468699|FG000|COMPLETED|Overall Study||26
10332742|NCT00326872|11468699|FG000|NOT COMPLETED|Overall Study||0
10332743|NCT00326885|11468703|FG000|STARTED|Overall Study||32
10332744|NCT00326885|11468703|FG000|COMPLETED|Overall Study||25
10332745|NCT00326885|11468703|FG000|NOT COMPLETED|Overall Study||7
10332746|NCT00326911|11468710|FG000|STARTED|Overall Study|This number reflects all randomized patients.|30
10332747|NCT00326911|11468711|FG001|STARTED|Overall Study|This number reflects all randomized patients.|31
10332748|NCT00326911|11468710|FG000|COMPLETED|Overall Study|This number reflects all treated patients.|29
10332749|NCT00326911|11468711|FG001|COMPLETED|Overall Study|This number reflects all treated patients.|29
10332750|NCT00326911|11468710|FG000|NOT COMPLETED|Overall Study||1
10332751|NCT00326911|11468711|FG001|NOT COMPLETED|Overall Study||2
10332752|NCT00326924|11468719|FG000|STARTED|Overall Study||188
10332753|NCT00326924|11468720|FG001|STARTED|Overall Study||189
10332754|NCT00326924|11468719|FG000|COMPLETED|Overall Study||187
10332755|NCT00326924|11468720|FG001|COMPLETED|Overall Study||188
10332756|NCT00326924|11468719|FG000|NOT COMPLETED|Overall Study||1
10332757|NCT00326924|11468720|FG001|NOT COMPLETED|Overall Study||1
10332758|NCT00326950|11468726|FG000|STARTED|Overall Study||15
10332759|NCT00326950|11468726|FG000|COMPLETED|Overall Study||14
10332760|NCT00326950|11468726|FG000|NOT COMPLETED|Overall Study||1
10332761|NCT00326963|11468730|FG000|STARTED|Overall Study||140
10332762|NCT00326963|11468730|FG000|COMPLETED|Overall Study||107
10332763|NCT00326963|11468730|FG000|NOT COMPLETED|Overall Study||33
10332764|NCT00327015|11468739|FG000|STARTED|Overall Study||320
10332765|NCT00327015|11468740|FG001|STARTED|Overall Study||323
10332766|NCT00327015|11468741|FG002|STARTED|Overall Study||335
10332767|NCT00327015|11468742|FG003|STARTED|Overall Study||328
10332768|NCT00327015|11468739|FG000|Completed Study Without Being Rescued|Overall Study||179
10332769|NCT00327015|11468740|FG001|Completed Study Without Being Rescued|Overall Study||177
10332770|NCT00327015|11468741|FG002|Completed Study Without Being Rescued|Overall Study||113
10332771|NCT00327015|11468742|FG003|Completed Study Without Being Rescued|Overall Study||144
10332772|NCT00327015|11468739|FG000|COMPLETED|Overall Study||229
10332773|NCT00327015|11468740|FG001|COMPLETED|Overall Study||231
10332774|NCT00327015|11468741|FG002|COMPLETED|Overall Study||209
10332775|NCT00327015|11468742|FG003|COMPLETED|Overall Study||219
10332776|NCT00327015|11468739|FG000|NOT COMPLETED|Overall Study||91
10332777|NCT00327015|11468740|FG001|NOT COMPLETED|Overall Study||92
10332778|NCT00327015|11468741|FG002|NOT COMPLETED|Overall Study||126
10332779|NCT00327015|11468742|FG003|NOT COMPLETED|Overall Study||109
10332780|NCT00327171|11468754|FG000|STARTED|Overall Study||109
10332781|NCT00327171|11468755|FG001|STARTED|Overall Study||109
10332782|NCT00327171|11468754|FG000|COMPLETED|Overall Study|Participants received treatment until they met treatment discontinuation criteria|1
10332783|NCT00327171|11468755|FG001|COMPLETED|Overall Study|Participants received treatment until they met treatment discontinuation criteria|0
10332784|NCT00327171|11468754|FG000|NOT COMPLETED|Overall Study||108
10332785|NCT00327171|11468755|FG001|NOT COMPLETED|Overall Study||109
10338967|NCT00003656|11475919|FG001|NOT COMPLETED|Overall Study||1
10338968|NCT00370331|11475928|FG000|STARTED|Overall Study||62
10338969|NCT00370331|11475929|FG001|STARTED|Overall Study||135
10338970|NCT00370331|11475928|FG000|COMPLETED|Overall Study||55
10338971|NCT00370331|11475929|FG001|COMPLETED|Overall Study||112
10338972|NCT00370331|11475928|FG000|NOT COMPLETED|Overall Study||7
10338973|NCT00370331|11475929|FG001|NOT COMPLETED|Overall Study||23
10338974|NCT00370396|11475938|FG000|STARTED|Overall Study||737
10332786|NCT00327340|11468763|FG000|STARTED|Overall Study||23
10332787|NCT00327340|11468764|FG001|STARTED|Overall Study||46
10332788|NCT00327340|11468763|FG000|COMPLETED|Overall Study||8
10332789|NCT00327340|11468764|FG001|COMPLETED|Overall Study||16
10332790|NCT00327340|11468763|FG000|NOT COMPLETED|Overall Study||15
10332791|NCT00327340|11468764|FG001|NOT COMPLETED|Overall Study||30
10332792|NCT00327392|11468772|FG000|STARTED|Overall Study||123
10332793|NCT00327392|11468772|FG000|COMPLETED|Overall Study||123
10332794|NCT00327392|11468772|FG000|NOT COMPLETED|Overall Study||0
10332795|NCT00327444|11468778|FG000|STARTED|Double Blind Treatment (DB) Period||26
10332796|NCT00327444|11468779|FG001|STARTED|Double Blind Treatment (DB) Period||29
10332797|NCT00327444|11468778|FG000|SAFETY|Double Blind Treatment (DB) Period|Excludes one participant from the Placebo arm who received aflibercept in error in the DB period.|25
10332798|NCT00327444|11468779|FG001|SAFETY|Double Blind Treatment (DB) Period|Includes 1 from Placebo who received aflibercept in DB period|30
10332799|NCT00327444|11468778|FG000|COMPLETED|Double Blind Treatment (DB) Period||0
10332800|NCT00327444|11468779|FG001|COMPLETED|Double Blind Treatment (DB) Period||0
10332801|NCT00327444|11468778|FG000|NOT COMPLETED|Double Blind Treatment (DB) Period||26
10332802|NCT00327444|11468779|FG001|NOT COMPLETED|Double Blind Treatment (DB) Period||29
10332803|NCT00327444|11468778|FG000|STARTED|Open Label Treatment (OL) Period||11
10332804|NCT00327444|11468779|FG001|STARTED|Open Label Treatment (OL) Period||10
10332805|NCT00327444|11468778|FG000|ONGOING TREATMENT|Open Label Treatment (OL) Period||1
10332806|NCT00327444|11468779|FG001|ONGOING TREATMENT|Open Label Treatment (OL) Period||0
10332807|NCT00327444|11468778|FG000|COMPLETED|Open Label Treatment (OL) Period|All participants were treated till they met treatment discontinuation criteria|0
10332808|NCT00327444|11468779|FG001|COMPLETED|Open Label Treatment (OL) Period|All participants were treated till they met treatment discontinuation criteria|0
10332809|NCT00327444|11468778|FG000|NOT COMPLETED|Open Label Treatment (OL) Period||11
10332810|NCT00327444|11468779|FG001|NOT COMPLETED|Open Label Treatment (OL) Period||10
10332811|NCT00327470|11468789|FG000|STARTED|Overall Study||107
10332812|NCT00327470|11468790|FG001|STARTED|Overall Study||181
10332813|NCT00327470|11468789|FG000|Treated|Overall Study||107
10332814|NCT00327470|11468790|FG001|Treated|Overall Study||179
10332815|NCT00327470|11468789|FG000|COMPLETED|Overall Study||78
10332816|NCT00327470|11468790|FG001|COMPLETED|Overall Study||118
10332817|NCT00327470|11468789|FG000|NOT COMPLETED|Overall Study||29
10332818|NCT00327470|11468790|FG001|NOT COMPLETED|Overall Study||63
10332819|NCT00327717|11468798|FG000|STARTED|Overall Study||120
10332820|NCT00327717|11468799|FG001|STARTED|Overall Study||120
10332821|NCT00327717|11468798|FG000|COMPLETED|Overall Study||111
10332822|NCT00327717|11468799|FG001|COMPLETED|Overall Study||106
10332823|NCT00327717|11468798|FG000|NOT COMPLETED|Overall Study||9
10332824|NCT00327717|11468799|FG001|NOT COMPLETED|Overall Study||14
10332825|NCT00328016|11468807|FG000|STARTED|Overall Study||23
10332826|NCT00328016|11468808|FG001|STARTED|Overall Study||21
10332827|NCT00328016|11468807|FG000|COMPLETED|Overall Study||23
10332828|NCT00328016|11468808|FG001|COMPLETED|Overall Study||21
10332829|NCT00328016|11468807|FG000|NOT COMPLETED|Overall Study||0
10332830|NCT00328016|11468808|FG001|NOT COMPLETED|Overall Study||0
10332831|NCT00328042|11468817|FG000|STARTED|Overall Study||69
10332832|NCT00328042|11468818|FG001|STARTED|Overall Study||65
10332833|NCT00328042|11468817|FG000|COMPLETED|Overall Study||69
10332834|NCT00328042|11468818|FG001|COMPLETED|Overall Study||63
10332835|NCT00328042|11468817|FG000|NOT COMPLETED|Overall Study||0
10332836|NCT00328042|11468818|FG001|NOT COMPLETED|Overall Study||2
10332837|NCT00328094|11468828|FG000|STARTED|Overall Study||117
10332838|NCT00328094|11468829|FG001|STARTED|Overall Study||125
10332839|NCT00328094|11468828|FG000|COMPLETED|Overall Study|2 did not receive intervention. 1 patient refusal|114
10332840|NCT00328094|11468829|FG001|COMPLETED|Overall Study|3 did not receive interevention. 1 post induction arrest. 1 case cancelled.|122
10332841|NCT00328094|11468828|FG000|NOT COMPLETED|Overall Study||3
10332842|NCT00328094|11468829|FG001|NOT COMPLETED|Overall Study||3
10332843|NCT00328172|11468840|FG000|STARTED|Overall Study||67
10332844|NCT00328172|11468841|FG001|STARTED|Overall Study||58
10332845|NCT00328172|11468842|FG002|STARTED|Overall Study||57
10332846|NCT00328172|11468843|FG003|STARTED|Overall Study||55
10332847|NCT00328172|11468844|FG004|STARTED|Overall Study||65
10332848|NCT00328172|11468840|FG000|COMPLETED|Overall Study||45
10332849|NCT00328172|11468841|FG001|COMPLETED|Overall Study||44
10332850|NCT00328172|11468842|FG002|COMPLETED|Overall Study||47
10332851|NCT00328172|11468843|FG003|COMPLETED|Overall Study||42
10332852|NCT00328172|11468844|FG004|COMPLETED|Overall Study||60
10332853|NCT00328172|11468840|FG000|NOT COMPLETED|Overall Study||22
10332854|NCT00328172|11468841|FG001|NOT COMPLETED|Overall Study||14
10332855|NCT00328172|11468842|FG002|NOT COMPLETED|Overall Study||10
10332856|NCT00328172|11468843|FG003|NOT COMPLETED|Overall Study||13
10332857|NCT00328172|11468844|FG004|NOT COMPLETED|Overall Study||5
10332858|NCT00328198|11468856|FG000|STARTED|Treatment|16 participants escalated the dose. 70 participants started at the 30 mg target dose.|86
10332859|NCT00328198|11468856|FG000|COMPLETED|Treatment|Depending upon protocol version, completed treatment was either 12 or 18 weeks in duration.|48
10332860|NCT00328198|11468856|FG000|NOT COMPLETED|Treatment||38
10332861|NCT00328198|11468856|FG000|STARTED|Follow-up|Eight participants did not enter Follow-up|78
10332862|NCT00328198|11468856|FG000|COMPLETED|Follow-up||43
10332863|NCT00328198|11468856|FG000|NOT COMPLETED|Follow-up||35
10332864|NCT00328263|11468862|FG000|STARTED|Overall Study||216
10332865|NCT00328263|11468863|FG001|STARTED|Overall Study||221
10332866|NCT00328263|11468862|FG000|COMPLETED|Overall Study|3 deaths occured during the study. None of the deaths were causally related to the study product.|213
10332867|NCT00328263|11468863|FG001|COMPLETED|Overall Study|4 deaths occured during the study. None of the deaths were causally related to the study product.|217
10332868|NCT00328263|11468862|FG000|NOT COMPLETED|Overall Study||3
10332869|NCT00328263|11468863|FG001|NOT COMPLETED|Overall Study||4
10332870|NCT00328510|11468871|FG000|STARTED|Overall Study||42
10332871|NCT00328510|11468872|FG001|STARTED|Overall Study||41
10332872|NCT00328510|11468871|FG000|COMPLETED|Overall Study||32
10332873|NCT00328510|11468872|FG001|COMPLETED|Overall Study||37
10332874|NCT00328510|11468871|FG000|NOT COMPLETED|Overall Study||10
10332875|NCT00328510|11468872|FG001|NOT COMPLETED|Overall Study||4
10332876|NCT00328562|11468878|FG000|STARTED|Overall Study||13
10332877|NCT00328562|11468878|FG000|COMPLETED|Overall Study||12
10332878|NCT00328562|11468878|FG000|NOT COMPLETED|Overall Study||1
10332879|NCT00328614|11468888|FG000|STARTED|Overall Study||4
10332880|NCT00328614|11468889|FG001|STARTED|Overall Study||4
10332881|NCT00328614|11468890|FG002|STARTED|Overall Study||6
10332882|NCT00328614|11468891|FG003|STARTED|Overall Study||6
10332883|NCT00328614|11468892|FG004|STARTED|Overall Study||6
10332884|NCT00328614|11468893|FG005|STARTED|Overall Study||6
10332885|NCT00328614|11468888|FG000|COMPLETED|Overall Study||4
10332886|NCT00328614|11468889|FG001|COMPLETED|Overall Study||4
10332887|NCT00328614|11468890|FG002|COMPLETED|Overall Study||6
10332888|NCT00328614|11468891|FG003|COMPLETED|Overall Study||5
10332889|NCT00328614|11468892|FG004|COMPLETED|Overall Study||5
10332890|NCT00328614|11468893|FG005|COMPLETED|Overall Study||5
10332891|NCT00328614|11468888|FG000|NOT COMPLETED|Overall Study||0
10332892|NCT00328614|11468889|FG001|NOT COMPLETED|Overall Study||0
10332893|NCT00328614|11468890|FG002|NOT COMPLETED|Overall Study||0
10332894|NCT00328614|11468891|FG003|NOT COMPLETED|Overall Study||1
10332895|NCT00328614|11468892|FG004|NOT COMPLETED|Overall Study||1
10332896|NCT00328614|11468893|FG005|NOT COMPLETED|Overall Study||1
10332897|NCT00328627|11468914|FG000|STARTED|Overall Study||129
10332898|NCT00328627|11468915|FG001|STARTED|Overall Study||128
10332899|NCT00328627|11468916|FG002|STARTED|Overall Study||129
10332900|NCT00328627|11468917|FG003|STARTED|Overall Study||130
10332901|NCT00328627|11468918|FG004|STARTED|Overall Study||130
10332902|NCT00328627|11468919|FG005|STARTED|Overall Study||130
10332903|NCT00328627|11468920|FG006|STARTED|Overall Study||129
10332904|NCT00328627|11468921|FG007|STARTED|Overall Study||130
10332905|NCT00328627|11468922|FG008|STARTED|Overall Study||130
10332906|NCT00328627|11468923|FG009|STARTED|Overall Study||129
10332907|NCT00328627|11468924|FG010|STARTED|Overall Study||130
10332908|NCT00328627|11468925|FG011|STARTED|Overall Study||130
10332909|NCT00328627|11468914|FG000|Safety Set|Overall Study|All patients who took at least 1 dose of double-blind study drug.|129
10332910|NCT00328627|11468915|FG001|Safety Set|Overall Study||128
10332911|NCT00328627|11468916|FG002|Safety Set|Overall Study||129
10332912|NCT00328627|11468917|FG003|Safety Set|Overall Study||129
10332913|NCT00328627|11468918|FG004|Safety Set|Overall Study||130
10332914|NCT00328627|11468919|FG005|Safety Set|Overall Study||130
10332915|NCT00328627|11468920|FG006|Safety Set|Overall Study||129
10332916|NCT00328627|11468921|FG007|Safety Set|Overall Study||130
10332917|NCT00328627|11468922|FG008|Safety Set|Overall Study||130
10332918|NCT00328627|11468923|FG009|Safety Set|Overall Study||129
10332919|NCT00328627|11468924|FG010|Safety Set|Overall Study||130
10332920|NCT00328627|11468925|FG011|Safety Set|Overall Study||130
10332921|NCT00328627|11468914|FG000|COMPLETED|Overall Study||70
10332922|NCT00328627|11468915|FG001|COMPLETED|Overall Study||97
10332923|NCT00328627|11468916|FG002|COMPLETED|Overall Study||101
10332924|NCT00328627|11468917|FG003|COMPLETED|Overall Study||93
10332925|NCT00328627|11468918|FG004|COMPLETED|Overall Study||115
10332926|NCT00328627|11468919|FG005|COMPLETED|Overall Study||110
10332927|NCT00328627|11468920|FG006|COMPLETED|Overall Study||94
10332928|NCT00328627|11468921|FG007|COMPLETED|Overall Study||116
10332929|NCT00328627|11468922|FG008|COMPLETED|Overall Study||113
10332930|NCT00328627|11468923|FG009|COMPLETED|Overall Study||97
10332931|NCT00328627|11468924|FG010|COMPLETED|Overall Study||112
10332932|NCT00328627|11468925|FG011|COMPLETED|Overall Study||114
10332933|NCT00328627|11468914|FG000|NOT COMPLETED|Overall Study||59
10332934|NCT00328627|11468915|FG001|NOT COMPLETED|Overall Study||31
10332935|NCT00328627|11468916|FG002|NOT COMPLETED|Overall Study||28
10332936|NCT00328627|11468917|FG003|NOT COMPLETED|Overall Study||37
10332937|NCT00328627|11468918|FG004|NOT COMPLETED|Overall Study||15
10332938|NCT00328627|11468919|FG005|NOT COMPLETED|Overall Study||20
10332939|NCT00328627|11468920|FG006|NOT COMPLETED|Overall Study||35
10332940|NCT00328627|11468921|FG007|NOT COMPLETED|Overall Study||14
10332941|NCT00328627|11468922|FG008|NOT COMPLETED|Overall Study||17
10332942|NCT00328627|11468923|FG009|NOT COMPLETED|Overall Study||32
10332943|NCT00328627|11468924|FG010|NOT COMPLETED|Overall Study||18
10332944|NCT00328627|11468925|FG011|NOT COMPLETED|Overall Study||16
10332945|NCT00328770|11468959|FG000|STARTED|Overall Study||70
10332946|NCT00328770|11468959|FG000|COMPLETED|Overall Study||70
10332947|NCT00328770|11468959|FG000|NOT COMPLETED|Overall Study||0
10332948|NCT00328783|11468964|FG000|STARTED|Overall Study||112
10332949|NCT00328783|11468964|FG000|COMPLETED|Overall Study||86
10332950|NCT00328783|11468964|FG000|NOT COMPLETED|Overall Study||26
10332951|NCT00328861|11468972|FG000|STARTED|Overall Study||7
10332952|NCT00328861|11468973|FG001|STARTED|Overall Study||1
10332953|NCT00328861|11468972|FG000|COMPLETED|Overall Study||7
10332954|NCT00328861|11468973|FG001|COMPLETED|Overall Study||1
10332955|NCT00328861|11468972|FG000|NOT COMPLETED|Overall Study||0
10332956|NCT00328861|11468973|FG001|NOT COMPLETED|Overall Study||0
10332957|NCT00328926|11468982|FG000|STARTED|Overall Study||5
10332958|NCT00328926|11468983|FG001|STARTED|Overall Study||3
10332959|NCT00328926|11468984|FG002|STARTED|Overall Study||3
10332960|NCT00328926|11468982|FG000|COMPLETED|Overall Study||3
10332961|NCT00328926|11468983|FG001|COMPLETED|Overall Study||0
10332962|NCT00328926|11468984|FG002|COMPLETED|Overall Study||1
10332963|NCT00328926|11468982|FG000|NOT COMPLETED|Overall Study||2
10332964|NCT00328926|11468983|FG001|NOT COMPLETED|Overall Study||3
10332965|NCT00328926|11468984|FG002|NOT COMPLETED|Overall Study||2
10332966|NCT00329030|11468994|FG000|STARTED|Overall Study||111
10332967|NCT00329030|11468995|FG001|STARTED|Overall Study||113
10332968|NCT00329030|11468994|FG000|COMPLETED|Overall Study||103
10332969|NCT00329030|11468995|FG001|COMPLETED|Overall Study||107
10332970|NCT00329030|11468994|FG000|NOT COMPLETED|Overall Study||8
10332971|NCT00329030|11468995|FG001|NOT COMPLETED|Overall Study||6
10332972|NCT00329160|11469001|FG000|STARTED|Overall Study||214
10332973|NCT00329160|11469001|FG000|Observation Period|Overall Study||214
10332974|NCT00329160|11469001|FG000|Treatment Period|Overall Study||214
10332975|NCT00329160|11469001|FG000|COMPLETED|Overall Study||126
10332976|NCT00329160|11469001|FG000|NOT COMPLETED|Overall Study||88
10332977|NCT00329238|11469007|FG000|STARTED|Overall Study|2866 were randomized. A total of ten did not receive treatment resulting in 2856 starting study.|1430
10332978|NCT00329238|11469008|FG001|STARTED|Overall Study|2866 were randomized. A total of ten did not receive treatment resulting in 2856 starting study.|1426
10332979|NCT00329238|11469007|FG000|COMPLETED|Overall Study||1154
10332980|NCT00329238|11469008|FG001|COMPLETED|Overall Study||1145
10332981|NCT00329238|11469007|FG000|NOT COMPLETED|Overall Study||276
10332982|NCT00329238|11469008|FG001|NOT COMPLETED|Overall Study||281
10332983|NCT00329303|11469018|FG000|STARTED|Overall Study||34
10332984|NCT00329303|11469019|FG001|STARTED|Overall Study||37
10332985|NCT00329303|11469018|FG000|COMPLETED|Overall Study||32
10332986|NCT00329303|11469019|FG001|COMPLETED|Overall Study||35
10332987|NCT00329303|11469018|FG000|NOT COMPLETED|Overall Study||2
10332988|NCT00329303|11469019|FG001|NOT COMPLETED|Overall Study||2
10332989|NCT00329407|11469026|FG000|STARTED|Overall Study||10
10702084|NCT02573181|11866576|FG000|COMPLETED|Overall Study||127
10702085|NCT02573181|11866577|FG001|COMPLETED|Overall Study||126
10332990|NCT00329407|11469026|FG000|COMPLETED|Overall Study||9
10332991|NCT00329407|11469026|FG000|NOT COMPLETED|Overall Study||1
10332992|NCT00329420|11469033|FG000|STARTED|Re-induction Phase||18
10702086|NCT02573181|11866576|FG000|NOT COMPLETED|Overall Study||0
10332993|NCT00329420|11469034|FG001|STARTED|Re-induction Phase||13
10332994|NCT00329420|11469035|FG002|STARTED|Re-induction Phase||15
10332995|NCT00329420|11469033|FG000|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|12
10332996|NCT00329420|11469034|FG001|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|7
10332997|NCT00329420|11469035|FG002|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|7
10332998|NCT00329420|11469033|FG000|NOT COMPLETED|Re-induction Phase||6
10332999|NCT00329420|11469034|FG001|NOT COMPLETED|Re-induction Phase||6
10333000|NCT00329420|11469035|FG002|NOT COMPLETED|Re-induction Phase||8
10333001|NCT00329420|11469033|FG000|STARTED|4-weekly Dosing Phase (Responders Only)||12
10333002|NCT00329420|11469034|FG001|STARTED|4-weekly Dosing Phase (Responders Only)||7
10333003|NCT00329420|11469035|FG002|STARTED|4-weekly Dosing Phase (Responders Only)||7
10333004|NCT00329420|11469033|FG000|COMPLETED|4-weekly Dosing Phase (Responders Only)||8
10333005|NCT00329420|11469034|FG001|COMPLETED|4-weekly Dosing Phase (Responders Only)||5
10333006|NCT00329420|11469035|FG002|COMPLETED|4-weekly Dosing Phase (Responders Only)||6
10333007|NCT00329420|11469033|FG000|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||4
10333008|NCT00329420|11469034|FG001|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||2
10333009|NCT00329420|11469035|FG002|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||1
10333010|NCT00329433|11469047|FG000|STARTED|Overall Study||61
10333011|NCT00329433|11469048|FG001|STARTED|Overall Study||59
10805243|NCT04019626|11966792|FG004|NOT COMPLETED|Overall Study||6
10333012|NCT00329433|11469047|FG000|COMPLETED|Overall Study||61
10333013|NCT00329433|11469048|FG001|COMPLETED|Overall Study||59
10333014|NCT00329433|11469047|FG000|NOT COMPLETED|Overall Study||0
10333015|NCT00329433|11469048|FG001|NOT COMPLETED|Overall Study||0
10333016|NCT00329524|11469054|FG000|STARTED|Overall Study||5
10333017|NCT00329524|11469054|FG000|COMPLETED|Overall Study||5
10333018|NCT00329524|11469054|FG000|NOT COMPLETED|Overall Study||0
10333019|NCT00329550|11469061|FG000|STARTED|Overall Study||9
10333020|NCT00329550|11469062|FG001|STARTED|Overall Study||15
10333021|NCT00329550|11469063|FG002|STARTED|Overall Study|1 subject in Safety Set is not in Full Analysis Set due to Good Clinical Practice non-compliance.|16
10333022|NCT00329550|11469061|FG000|COMPLETED|Overall Study||5
10333023|NCT00329550|11469062|FG001|COMPLETED|Overall Study||11
10333024|NCT00329550|11469063|FG002|COMPLETED|Overall Study||12
10333025|NCT00329550|11469061|FG000|NOT COMPLETED|Overall Study||4
10333026|NCT00329550|11469062|FG001|NOT COMPLETED|Overall Study||4
10702087|NCT02573181|11866577|FG001|NOT COMPLETED|Overall Study||0
10333027|NCT00329550|11469063|FG002|NOT COMPLETED|Overall Study||4
10338975|NCT00370396|11475939|FG001|STARTED|Overall Study||92
10702088|NCT02573246|11866588|FG000|STARTED|Overall Study||14
10702089|NCT02573246|11866589|FG001|STARTED|Overall Study||15
10702090|NCT02573246|11866590|FG002|STARTED|Overall Study||18
10702091|NCT02573246|11866591|FG003|STARTED|Overall Study||16
10702092|NCT02573246|11866592|FG004|STARTED|Overall Study||15
10702093|NCT02573246|11866588|FG000|COMPLETED|Overall Study||11
10702094|NCT02573246|11866589|FG001|COMPLETED|Overall Study||14
10702095|NCT02573246|11866590|FG002|COMPLETED|Overall Study||15
10333028|NCT00329602|11469075|FG000|STARTED|26-Week Double-Blind Treatment Phase|"Numbers of participants in the Participant Flow section are based on the Safety Population."|207
10333029|NCT00329602|11469076|FG001|STARTED|26-Week Double-Blind Treatment Phase||197
10333030|NCT00329602|11469077|FG002|STARTED|26-Week Double-Blind Treatment Phase||0
10333031|NCT00329602|11469075|FG000|COMPLETED|26-Week Double-Blind Treatment Phase||88
10333032|NCT00329602|11469076|FG001|COMPLETED|26-Week Double-Blind Treatment Phase||98
10333033|NCT00329602|11469077|FG002|COMPLETED|26-Week Double-Blind Treatment Phase||0
10333034|NCT00329602|11469075|FG000|NOT COMPLETED|26-Week Double-Blind Treatment Phase||119
10333035|NCT00329602|11469076|FG001|NOT COMPLETED|26-Week Double-Blind Treatment Phase||99
10333036|NCT00329602|11469077|FG002|NOT COMPLETED|26-Week Double-Blind Treatment Phase||0
10333037|NCT00329602|11469075|FG000|STARTED|40-Week Open-Label Treatment Phase||0
10333038|NCT00329602|11469076|FG001|STARTED|40-Week Open-Label Treatment Phase||0
10333039|NCT00329602|11469077|FG002|STARTED|40-Week Open-Label Treatment Phase|148 and 121 par. randomized to DB placebo and ropinirole IR, respectively, entered the OL phase.|269
10338976|NCT00370396|11475940|FG002|STARTED|Overall Study||283
10456792|NCT01008059|11604618|FG005|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
10456793|NCT01008059|11604619|FG006|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
10456794|NCT01008059|11604620|FG007|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
10456795|NCT01008059|11604613|FG000|STARTED|Ketoconazole Sequential Alfentanil||0
10456796|NCT01008059|11604614|FG001|STARTED|Ketoconazole Sequential Alfentanil||0
10456797|NCT01008059|11604615|FG002|STARTED|Ketoconazole Sequential Alfentanil||0
10456798|NCT01008059|11604616|FG003|STARTED|Ketoconazole Sequential Alfentanil||6
10456799|NCT01008059|11604617|FG004|STARTED|Ketoconazole Sequential Alfentanil||0
10456800|NCT01008059|11604618|FG005|STARTED|Ketoconazole Sequential Alfentanil||0
10456801|NCT01008059|11604619|FG006|STARTED|Ketoconazole Sequential Alfentanil||0
10456802|NCT01008059|11604620|FG007|STARTED|Ketoconazole Sequential Alfentanil||0
10456803|NCT01008059|11604613|FG000|COMPLETED|Ketoconazole Sequential Alfentanil||0
10456804|NCT01008059|11604614|FG001|COMPLETED|Ketoconazole Sequential Alfentanil||0
10456805|NCT01008059|11604615|FG002|COMPLETED|Ketoconazole Sequential Alfentanil||0
10456806|NCT01008059|11604616|FG003|COMPLETED|Ketoconazole Sequential Alfentanil||6
10456807|NCT01008059|11604617|FG004|COMPLETED|Ketoconazole Sequential Alfentanil||0
10456808|NCT01008059|11604618|FG005|COMPLETED|Ketoconazole Sequential Alfentanil||0
10456809|NCT01008059|11604619|FG006|COMPLETED|Ketoconazole Sequential Alfentanil||0
10456810|NCT01008059|11604620|FG007|COMPLETED|Ketoconazole Sequential Alfentanil||0
10456811|NCT01008059|11604613|FG000|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
10456812|NCT01008059|11604614|FG001|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
10456813|NCT01008059|11604615|FG002|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
10456814|NCT01008059|11604616|FG003|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
10456815|NCT01008059|11604617|FG004|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
10456816|NCT01008059|11604618|FG005|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
10456817|NCT01008059|11604619|FG006|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
10456818|NCT01008059|11604620|FG007|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
10456819|NCT01008059|11604613|FG000|STARTED|Control Simultaneous Alfentanil||0
10456820|NCT01008059|11604614|FG001|STARTED|Control Simultaneous Alfentanil||0
10702096|NCT02573246|11866591|FG003|COMPLETED|Overall Study||14
10702097|NCT02573246|11866592|FG004|COMPLETED|Overall Study||11
10702098|NCT02573246|11866588|FG000|NOT COMPLETED|Overall Study||3
10702099|NCT02573246|11866589|FG001|NOT COMPLETED|Overall Study||1
10702100|NCT02573246|11866590|FG002|NOT COMPLETED|Overall Study||3
10702101|NCT02573246|11866591|FG003|NOT COMPLETED|Overall Study||2
10702102|NCT02573246|11866592|FG004|NOT COMPLETED|Overall Study||4
10456821|NCT01008059|11604615|FG002|STARTED|Control Simultaneous Alfentanil||0
10456822|NCT01008059|11604616|FG003|STARTED|Control Simultaneous Alfentanil||0
10456823|NCT01008059|11604617|FG004|STARTED|Control Simultaneous Alfentanil||6
10456824|NCT01008059|11604618|FG005|STARTED|Control Simultaneous Alfentanil||0
10456825|NCT01008059|11604619|FG006|STARTED|Control Simultaneous Alfentanil||0
10456826|NCT01008059|11604620|FG007|STARTED|Control Simultaneous Alfentanil||0
10456827|NCT01008059|11604613|FG000|COMPLETED|Control Simultaneous Alfentanil||0
10456828|NCT01008059|11604614|FG001|COMPLETED|Control Simultaneous Alfentanil||0
10456829|NCT01008059|11604615|FG002|COMPLETED|Control Simultaneous Alfentanil||0
10456830|NCT01008059|11604616|FG003|COMPLETED|Control Simultaneous Alfentanil||0
10456831|NCT01008059|11604617|FG004|COMPLETED|Control Simultaneous Alfentanil||6
10456832|NCT01008059|11604618|FG005|COMPLETED|Control Simultaneous Alfentanil||0
10456833|NCT01008059|11604619|FG006|COMPLETED|Control Simultaneous Alfentanil||0
10456834|NCT01008059|11604620|FG007|COMPLETED|Control Simultaneous Alfentanil||0
10456835|NCT01008059|11604613|FG000|NOT COMPLETED|Control Simultaneous Alfentanil||0
10456836|NCT01008059|11604614|FG001|NOT COMPLETED|Control Simultaneous Alfentanil||0
10456837|NCT01008059|11604615|FG002|NOT COMPLETED|Control Simultaneous Alfentanil||0
10456838|NCT01008059|11604616|FG003|NOT COMPLETED|Control Simultaneous Alfentanil||0
10456839|NCT01008059|11604617|FG004|NOT COMPLETED|Control Simultaneous Alfentanil||0
10456840|NCT01008059|11604618|FG005|NOT COMPLETED|Control Simultaneous Alfentanil||0
10702103|NCT02573311|11866611|FG000|STARTED|Disposition for Part 1|Started are subjects who entered Part 1 and answered the purchase question|1737
10702104|NCT02573311|11866612|FG001|STARTED|Disposition for Part 1|Started are subjects who entered Part 1 and answered the purchase question|364
10702105|NCT02573311|11866611|FG000|COMPLETED|Disposition for Part 1|Completed are the subjects who actually completed Part 1|1730
10456841|NCT01008059|11604619|FG006|NOT COMPLETED|Control Simultaneous Alfentanil||0
10333040|NCT00329602|11469075|FG000|COMPLETED|40-Week Open-Label Treatment Phase||0
10333041|NCT00329602|11469076|FG001|COMPLETED|40-Week Open-Label Treatment Phase||0
10333042|NCT00329602|11469077|FG002|COMPLETED|40-Week Open-Label Treatment Phase||233
10333043|NCT00329602|11469075|FG000|NOT COMPLETED|40-Week Open-Label Treatment Phase||0
10333044|NCT00329602|11469076|FG001|NOT COMPLETED|40-Week Open-Label Treatment Phase||0
10333045|NCT00329602|11469077|FG002|NOT COMPLETED|40-Week Open-Label Treatment Phase||36
10333046|NCT00329641|11469093|FG000|STARTED|Overall Study||25
10333047|NCT00329641|11469093|FG000|Eligible|Overall Study||25
10333048|NCT00329641|11469093|FG000|Eligible and Received Treatment|Overall Study||24
10333049|NCT00329641|11469093|FG000|COMPLETED|Overall Study||19
10333050|NCT00329641|11469093|FG000|NOT COMPLETED|Overall Study||6
10333051|NCT00329719|11469102|FG000|STARTED|Overall Study||12
10333052|NCT00329719|11469103|FG001|STARTED|Overall Study||49
10333053|NCT00329719|11469104|FG002|STARTED|Overall Study||9
10333054|NCT00329719|11469105|FG003|STARTED|Overall Study||45
10333055|NCT00329719|11469102|FG000|COMPLETED|Overall Study||12
10333056|NCT00329719|11469103|FG001|COMPLETED|Overall Study||49
10333057|NCT00329719|11469104|FG002|COMPLETED|Overall Study||9
10333058|NCT00329719|11469105|FG003|COMPLETED|Overall Study||44
10333059|NCT00329719|11469102|FG000|NOT COMPLETED|Overall Study||0
10333060|NCT00329719|11469103|FG001|NOT COMPLETED|Overall Study||0
10333061|NCT00329719|11469104|FG002|NOT COMPLETED|Overall Study||0
10333062|NCT00329719|11469105|FG003|NOT COMPLETED|Overall Study||1
10333063|NCT00329745|11469117|FG000|STARTED|Overall Study||4359
10333064|NCT00329745|11469118|FG001|STARTED|Overall Study||4328
10333065|NCT00329745|11469117|FG000|COMPLETED|Overall Study||4272
10333066|NCT00329745|11469118|FG001|COMPLETED|Overall Study||4226
10333067|NCT00329745|11469117|FG000|NOT COMPLETED|Overall Study||87
10333068|NCT00329745|11469118|FG001|NOT COMPLETED|Overall Study||102
10333069|NCT00329771|11469124|FG000|STARTED|Overall Study||28
10333070|NCT00329771|11469124|FG000|COMPLETED|Overall Study|3 subjects withdrew or were lost to follow-up|25
10333071|NCT00329771|11469124|FG000|NOT COMPLETED|Overall Study||3
10333072|NCT00329784|11469132|FG000|STARTED|Overall Study||270
10333073|NCT00329784|11469133|FG001|STARTED|Overall Study||272
10333074|NCT00329784|11469134|FG002|STARTED|Overall Study||51
10333075|NCT00329784|11469135|FG003|STARTED|Overall Study||47
10333076|NCT00329784|11469132|FG000|COMPLETED|Overall Study||265
10333077|NCT00329784|11469133|FG001|COMPLETED|Overall Study||267
10333078|NCT00329784|11469134|FG002|COMPLETED|Overall Study||51
10333079|NCT00329784|11469135|FG003|COMPLETED|Overall Study||47
10333080|NCT00329784|11469132|FG000|NOT COMPLETED|Overall Study||5
10333081|NCT00329784|11469133|FG001|NOT COMPLETED|Overall Study||5
10333082|NCT00329784|11469134|FG002|NOT COMPLETED|Overall Study||0
10333083|NCT00329784|11469135|FG003|NOT COMPLETED|Overall Study||0
10333084|NCT00329797|11469149|FG000|STARTED|Overall Study||57
10333085|NCT00329797|11469150|FG001|STARTED|Overall Study||52
10333086|NCT00329797|11469149|FG000|COMPLETED|Overall Study||50
10333087|NCT00329797|11469150|FG001|COMPLETED|Overall Study||46
10333088|NCT00329797|11469149|FG000|NOT COMPLETED|Overall Study||7
10333089|NCT00329797|11469150|FG001|NOT COMPLETED|Overall Study||6
10333090|NCT00329836|11469156|FG000|STARTED|Overall Study||41
10333091|NCT00329836|11469156|FG000|COMPLETED|Overall Study||41
10333092|NCT00329836|11469156|FG000|NOT COMPLETED|Overall Study||0
10333093|NCT00329849|11469162|FG000|STARTED|Overall Study||950
10333094|NCT00329849|11469163|FG001|STARTED|Overall Study||550
10333095|NCT00329849|11469162|FG000|COMPLETED|Overall Study||944
10333096|NCT00329849|11469163|FG001|COMPLETED|Overall Study||546
10333097|NCT00329849|11469162|FG000|NOT COMPLETED|Overall Study||6
10333098|NCT00329849|11469163|FG001|NOT COMPLETED|Overall Study||4
10333099|NCT00329901|11469176|FG000|STARTED|Overall Study||361
10333100|NCT00329901|11469177|FG001|STARTED|Overall Study||354
10333101|NCT00329901|11469178|FG002|STARTED|Overall Study||357
10333102|NCT00329901|11469176|FG000|COMPLETED|Overall Study||352
10333103|NCT00329901|11469177|FG001|COMPLETED|Overall Study||349
10333104|NCT00329901|11469178|FG002|COMPLETED|Overall Study||353
10333105|NCT00329901|11469176|FG000|NOT COMPLETED|Overall Study||9
10333106|NCT00329901|11469177|FG001|NOT COMPLETED|Overall Study||5
10333107|NCT00329901|11469178|FG002|NOT COMPLETED|Overall Study||4
10333108|NCT00330161|11469190|FG000|STARTED|Overall Study||29
10333109|NCT00330161|11469190|FG000|COMPLETED|Overall Study||29
10333110|NCT00330161|11469190|FG000|NOT COMPLETED|Overall Study||0
10333111|NCT00330174|11469196|FG000|STARTED|Overall Study||45
10333112|NCT00330174|11469197|FG001|STARTED|Overall Study||45
10333113|NCT00330174|11469196|FG000|COMPLETED|Overall Study||23
10333114|NCT00330174|11469197|FG001|COMPLETED|Overall Study||26
10333115|NCT00330174|11469196|FG000|NOT COMPLETED|Overall Study||22
10333116|NCT00330174|11469197|FG001|NOT COMPLETED|Overall Study||19
10333117|NCT00330187|11469207|FG000|STARTED|Overall Study||37
10333118|NCT00330187|11469208|FG001|STARTED|Overall Study||36
10333119|NCT00330187|11469209|FG002|STARTED|Overall Study||29
10333120|NCT00330187|11469210|FG003|STARTED|Overall Study||32
10333121|NCT00330187|11469207|FG000|COMPLETED|Overall Study||17
10333122|NCT00330187|11469208|FG001|COMPLETED|Overall Study||18
10333123|NCT00330187|11469209|FG002|COMPLETED|Overall Study||11
10333124|NCT00330187|11469210|FG003|COMPLETED|Overall Study||18
10333125|NCT00330187|11469207|FG000|NOT COMPLETED|Overall Study||20
10333126|NCT00330187|11469208|FG001|NOT COMPLETED|Overall Study||18
10333127|NCT00330187|11469209|FG002|NOT COMPLETED|Overall Study||18
10333128|NCT00330187|11469210|FG003|NOT COMPLETED|Overall Study||14
10333129|NCT00330343|11469220|FG000|STARTED|Overall Study||64
10333130|NCT00330343|11469220|FG000|COMPLETED|Overall Study||59
10333131|NCT00330343|11469220|FG000|NOT COMPLETED|Overall Study||5
10333132|NCT00330382|11469226|FG000|STARTED|Overall Study||67
10333133|NCT00330382|11469227|FG001|STARTED|Overall Study||65
10333134|NCT00330382|11469226|FG000|COMPLETED|Overall Study||43
10333135|NCT00330382|11469227|FG001|COMPLETED|Overall Study||48
10333136|NCT00330382|11469226|FG000|NOT COMPLETED|Overall Study||24
10333137|NCT00330382|11469227|FG001|NOT COMPLETED|Overall Study||17
10333138|NCT00330421|11469234|FG000|STARTED|Overall Study||15
10333139|NCT00330421|11469235|FG001|STARTED|Overall Study||0
10333140|NCT00330421|11469234|FG000|COMPLETED|Overall Study||15
10333141|NCT00330421|11469235|FG001|COMPLETED|Overall Study||0
10333142|NCT00330421|11469234|FG000|NOT COMPLETED|Overall Study||0
10333143|NCT00330421|11469235|FG001|NOT COMPLETED|Overall Study||0
10333144|NCT00330460|11469241|FG000|STARTED|Overall Study||595
10333145|NCT00330460|11469242|FG001|STARTED|Overall Study||594
10333146|NCT00330460|11469241|FG000|COMPLETED|Overall Study||553
10333147|NCT00330460|11469242|FG001|COMPLETED|Overall Study||561
10333148|NCT00330460|11469241|FG000|NOT COMPLETED|Overall Study||42
10333149|NCT00330460|11469242|FG001|NOT COMPLETED|Overall Study||33
10333150|NCT00330551|11469250|FG000|STARTED|Overall Study||40
10333151|NCT00330551|11469251|FG001|STARTED|Overall Study||43
10333152|NCT00330551|11469250|FG000|COMPLETED|Overall Study||30
10333153|NCT00330551|11469251|FG001|COMPLETED|Overall Study||27
10333154|NCT00330551|11469250|FG000|NOT COMPLETED|Overall Study||10
10333155|NCT00330551|11469251|FG001|NOT COMPLETED|Overall Study||16
10333156|NCT00330564|11469259|FG000|STARTED|Overall Study||15
10333157|NCT00330564|11469259|FG000|COMPLETED|Overall Study||15
10333158|NCT00330564|11469259|FG000|NOT COMPLETED|Overall Study||0
10333159|NCT00330616|11469263|FG000|STARTED|Overall Study||35
10333160|NCT00330616|11469263|FG000|COMPLETED|Overall Study||14
10333161|NCT00330616|11469263|FG000|NOT COMPLETED|Overall Study||21
10333162|NCT00330668|11469267|FG000|STARTED|BID Dosing Period||114
10333163|NCT00330668|11469267|FG000|COMPLETED|BID Dosing Period||78
10333164|NCT00330668|11469267|FG000|NOT COMPLETED|BID Dosing Period||36
10333165|NCT00330668|11469267|FG000|STARTED|QD Dosing Period||78
10333166|NCT00330668|11469267|FG000|COMPLETED|QD Dosing Period||0
10333167|NCT00330668|11469267|FG000|NOT COMPLETED|QD Dosing Period||78
10333168|NCT00330681|11469273|FG000|STARTED|Overall Study||102
10333169|NCT00330681|11469274|FG001|STARTED|Overall Study||104
10333170|NCT00330681|11469273|FG000|COMPLETED|Overall Study||93
10333171|NCT00330681|11469274|FG001|COMPLETED|Overall Study||90
10333172|NCT00330681|11469273|FG000|NOT COMPLETED|Overall Study||9
10333173|NCT00330681|11469274|FG001|NOT COMPLETED|Overall Study||14
10333174|NCT00330733|11469282|FG000|STARTED|Overall Study||37
10333175|NCT00330733|11469283|FG001|STARTED|Overall Study||34
10333176|NCT00330733|11469282|FG000|Received Study Medication|Overall Study||36
10333177|NCT00330733|11469283|FG001|Received Study Medication|Overall Study||34
10333178|NCT00330733|11469282|FG000|COMPLETED|Overall Study||30
10333179|NCT00330733|11469283|FG001|COMPLETED|Overall Study||29
10333180|NCT00330733|11469282|FG000|NOT COMPLETED|Overall Study||7
10333181|NCT00330733|11469283|FG001|NOT COMPLETED|Overall Study||5
10333182|NCT00330759|11469291|FG000|STARTED|Overall Study||890
10333183|NCT00330759|11469292|FG001|STARTED|Overall Study||886
10333184|NCT00330759|11469291|FG000|Received Investigational Product|Overall Study||878
10333185|NCT00330759|11469292|FG001|Received Investigational Product|Overall Study||878
10333186|NCT00330759|11469291|FG000|COMPLETED|Overall Study||178
10333187|NCT00330759|11469292|FG001|COMPLETED|Overall Study||180
10333188|NCT00330759|11469291|FG000|NOT COMPLETED|Overall Study||712
10333189|NCT00330759|11469292|FG001|NOT COMPLETED|Overall Study||706
10333190|NCT00330863|11469300|FG000|STARTED|Overall Study||153
10333191|NCT00330863|11469301|FG001|STARTED|Overall Study||152
10333192|NCT00330863|11469300|FG000|COMPLETED|Overall Study||72
10333193|NCT00330863|11469301|FG001|COMPLETED|Overall Study||72
10333194|NCT00330863|11469300|FG000|NOT COMPLETED|Overall Study||81
10333195|NCT00330863|11469301|FG001|NOT COMPLETED|Overall Study||80
10333196|NCT00330876|11469307|FG000|STARTED|Overall Study||449
10333197|NCT00330876|11469308|FG001|STARTED|Overall Study||90
10333198|NCT00330876|11469307|FG000|COMPLETED|Overall Study||378
10333199|NCT00330876|11469308|FG001|COMPLETED|Overall Study||77
10333200|NCT00330876|11469307|FG000|NOT COMPLETED|Overall Study||71
10333201|NCT00330876|11469308|FG001|NOT COMPLETED|Overall Study||13
10333202|NCT00330915|11469314|FG000|STARTED|Overall Study||37
10333203|NCT00330915|11469314|FG000|COMPLETED|Overall Study||37
10333204|NCT00330915|11469314|FG000|NOT COMPLETED|Overall Study||0
10333205|NCT00330928|11469318|FG000|STARTED|Overall Study|Subjects that signed consent and were subject to research procedures.|106
10333206|NCT00330928|11469318|FG000|7 Day Phone Contact|Overall Study||99
10333207|NCT00330928|11469318|FG000|1 Year Phone Contact|Overall Study||89
10333208|NCT00330928|11469318|FG000|COMPLETED|Overall Study||89
10333209|NCT00330928|11469318|FG000|NOT COMPLETED|Overall Study||17
10333210|NCT00330967|11469324|FG000|STARTED|Overall Study||0
10333211|NCT00330967|11469325|FG001|STARTED|Overall Study||25
10333212|NCT00330967|11469324|FG000|COMPLETED|Overall Study||0
10333213|NCT00330967|11469325|FG001|COMPLETED|Overall Study||11
10333214|NCT00330967|11469324|FG000|NOT COMPLETED|Overall Study||0
10333215|NCT00330967|11469325|FG001|NOT COMPLETED|Overall Study||14
10333216|NCT00331006|11469331|FG000|STARTED|Screening Phase||23
10333217|NCT00331006|11469331|FG000|COMPLETED|Screening Phase|subjects eligible for the treatment phase if inhibitor titer following Factor VIII was at least 5 BU|16
10333218|NCT00331006|11469331|FG000|NOT COMPLETED|Screening Phase||7
10333219|NCT00331006|11469331|FG000|STARTED|Treatment Phase||16
10333220|NCT00331006|11469331|FG000|COMPLETED|Treatment Phase||15
10333221|NCT00331006|11469331|FG000|NOT COMPLETED|Treatment Phase||1
10333222|NCT00331006|11469331|FG000|STARTED|Follow-Up Phase I||15
10333223|NCT00331006|11469331|FG000|COMPLETED|Follow-Up Phase I||14
10333224|NCT00331006|11469331|FG000|NOT COMPLETED|Follow-Up Phase I||1
10333225|NCT00331006|11469331|FG000|STARTED|Follow-Up Phase II||14
10333226|NCT00331006|11469331|FG000|COMPLETED|Follow-Up Phase II||11
10333227|NCT00331006|11469331|FG000|NOT COMPLETED|Follow-Up Phase II||3
10333228|NCT00331136|11469339|FG000|STARTED|Overall Study||15
10333229|NCT00331136|11469340|FG001|STARTED|Overall Study||15
10333230|NCT00331136|11469341|FG002|STARTED|Overall Study||15
10333231|NCT00331136|11469342|FG003|STARTED|Overall Study||15
10333232|NCT00331136|11469339|FG000|COMPLETED|Overall Study||10
10333233|NCT00331136|11469340|FG001|COMPLETED|Overall Study||8
10333234|NCT00331136|11469341|FG002|COMPLETED|Overall Study||15
10333235|NCT00331136|11469342|FG003|COMPLETED|Overall Study||14
10333236|NCT00331136|11469339|FG000|NOT COMPLETED|Overall Study||5
10333237|NCT00331136|11469340|FG001|NOT COMPLETED|Overall Study||7
10333238|NCT00331136|11469341|FG002|NOT COMPLETED|Overall Study||0
10333239|NCT00331136|11469342|FG003|NOT COMPLETED|Overall Study||1
10333240|NCT00331162|11469354|FG000|STARTED|Overall Study||113
10333241|NCT00331162|11469355|FG001|STARTED|Overall Study||109
10333242|NCT00331162|11469354|FG000|COMPLETED|Overall Study||113
10333243|NCT00331162|11469355|FG001|COMPLETED|Overall Study||109
10333244|NCT00331162|11469354|FG000|NOT COMPLETED|Overall Study||0
10333245|NCT00331162|11469355|FG001|NOT COMPLETED|Overall Study||0
10333246|NCT00331344|11469361|FG000|STARTED|Phase I||3
10333247|NCT00331344|11469362|FG001|STARTED|Phase I||3
10333248|NCT00331344|11469363|FG002|STARTED|Phase I||3
10333249|NCT00331344|11469364|FG003|STARTED|Phase I||6
10333250|NCT00331344|11469365|FG004|STARTED|Phase I||6
10333251|NCT00331344|11469366|FG005|STARTED|Phase I||5
10333252|NCT00331344|11469367|FG006|STARTED|Phase I||4
10333253|NCT00331344|11469368|FG007|STARTED|Phase I|1 participant who was enrolled died prior to initiating protocol therapy.|6
10333254|NCT00331344|11469369|FG008|STARTED|Phase I||0
10333255|NCT00331344|11469361|FG000|COMPLETED|Phase I||3
10333256|NCT00331344|11469362|FG001|COMPLETED|Phase I||3
10333257|NCT00331344|11469363|FG002|COMPLETED|Phase I||3
10333258|NCT00331344|11469364|FG003|COMPLETED|Phase I|1 participant reached dose limiting toxicity|5
10333259|NCT00331344|11469365|FG004|COMPLETED|Phase I|2 participants reached dose limiting toxicity|4
10333260|NCT00331344|11469366|FG005|COMPLETED|Phase I|2 participants reached dose limiting toxicity|3
10333261|NCT00331344|11469367|FG006|COMPLETED|Phase I||4
10333262|NCT00331344|11469368|FG007|COMPLETED|Phase I|1 participant reached dose limiting toxicity|5
10333263|NCT00331344|11469369|FG008|COMPLETED|Phase I||0
10333264|NCT00331344|11469361|FG000|NOT COMPLETED|Phase I||0
10333265|NCT00331344|11469362|FG001|NOT COMPLETED|Phase I||0
10333266|NCT00331344|11469363|FG002|NOT COMPLETED|Phase I||0
10333267|NCT00331344|11469364|FG003|NOT COMPLETED|Phase I||1
10333268|NCT00331344|11469365|FG004|NOT COMPLETED|Phase I||2
10333269|NCT00331344|11469366|FG005|NOT COMPLETED|Phase I||2
10333270|NCT00331344|11469367|FG006|NOT COMPLETED|Phase I||0
10333271|NCT00331344|11469368|FG007|NOT COMPLETED|Phase I||1
10333272|NCT00331344|11469369|FG008|NOT COMPLETED|Phase I||0
10333273|NCT00331344|11469361|FG000|STARTED|Phase II||0
10333274|NCT00331344|11469362|FG001|STARTED|Phase II||0
10333275|NCT00331344|11469363|FG002|STARTED|Phase II||0
10333276|NCT00331344|11469364|FG003|STARTED|Phase II||0
10333277|NCT00331344|11469365|FG004|STARTED|Phase II||0
10333278|NCT00331344|11469366|FG005|STARTED|Phase II||0
10333279|NCT00331344|11469367|FG006|STARTED|Phase II||0
10333280|NCT00331344|11469368|FG007|STARTED|Phase II|6 patients in Phase I Group VIa continued to the Phase II period.|6
10333281|NCT00331344|11469369|FG008|STARTED|Phase II|Protocol enrollment (63) minus 11 ineligible prior to receiving treatment.|52
10333282|NCT00331344|11469361|FG000|COMPLETED|Phase II||0
10333283|NCT00331344|11469362|FG001|COMPLETED|Phase II||0
10333284|NCT00331344|11469363|FG002|COMPLETED|Phase II||0
10333285|NCT00331344|11469364|FG003|COMPLETED|Phase II||0
10333286|NCT00331344|11469365|FG004|COMPLETED|Phase II||0
10333287|NCT00331344|11469366|FG005|COMPLETED|Phase II||0
10333288|NCT00331344|11469367|FG006|COMPLETED|Phase II||0
10333289|NCT00331344|11469368|FG007|COMPLETED|Phase II||6
10333290|NCT00331344|11469369|FG008|COMPLETED|Phase II||48
10333291|NCT00331344|11469361|FG000|NOT COMPLETED|Phase II||0
10333292|NCT00331344|11469362|FG001|NOT COMPLETED|Phase II||0
10456842|NCT01008059|11604620|FG007|NOT COMPLETED|Control Simultaneous Alfentanil||0
10456843|NCT01008059|11604613|FG000|STARTED|Rifampin Simultaneous Alfentanil||0
10333293|NCT00331344|11469363|FG002|NOT COMPLETED|Phase II||0
10333294|NCT00331344|11469364|FG003|NOT COMPLETED|Phase II||0
10333295|NCT00331344|11469365|FG004|NOT COMPLETED|Phase II||0
10333296|NCT00331344|11469366|FG005|NOT COMPLETED|Phase II||0
10333297|NCT00331344|11469367|FG006|NOT COMPLETED|Phase II||0
10333298|NCT00331344|11469368|FG007|NOT COMPLETED|Phase II||0
10333299|NCT00331344|11469369|FG008|NOT COMPLETED|Phase II||4
10333300|NCT00331409|11469382|FG000|STARTED|Overall Study|19 patients were enrolled in the first stage due to 4 patients who withdrew early.|19
10333301|NCT00331409|11469382|FG000|COMPLETED|Overall Study|15 patients accrued to the first stage;if>9 were progression-free at 3 months,enrollment continued.|15
10333302|NCT00331409|11469382|FG000|NOT COMPLETED|Overall Study||4
10333303|NCT00331422|11469386|FG000|STARTED|Overall Study|Patients who met study criteria and received at least one dose of study drug.|7
10333304|NCT00331422|11469386|FG000|COMPLETED|Overall Study|Completed all 6 courses of chemotherapy and had surgery to remove all tumor lesions.|2
10333305|NCT00331422|11469386|FG000|NOT COMPLETED|Overall Study||5
10333306|NCT00331552|11469393|FG000|STARTED|Period 1: Doxil 30 mg/m^2 (Phase I)||3
10333307|NCT00331552|11469394|FG001|STARTED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
10333308|NCT00331552|11469393|FG000|COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||3
10333309|NCT00331552|11469394|FG001|COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
10333310|NCT00331552|11469393|FG000|NOT COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
10333311|NCT00331552|11469394|FG001|NOT COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
10333312|NCT00331552|11469393|FG000|STARTED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
10333313|NCT00331552|11469394|FG001|STARTED|Period 2: Doxil 35 mg/m^2 (Phase I)||3
10333314|NCT00331552|11469393|FG000|COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
10333315|NCT00331552|11469394|FG001|COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||3
10333316|NCT00331552|11469393|FG000|NOT COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
10333317|NCT00331552|11469394|FG001|NOT COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
10333318|NCT00331552|11469393|FG000|STARTED|Period 3: Phase II||24
10333319|NCT00331552|11469394|FG001|STARTED|Period 3: Phase II||0
10333320|NCT00331552|11469393|FG000|COMPLETED|Period 3: Phase II||22
10333321|NCT00331552|11469394|FG001|COMPLETED|Period 3: Phase II||0
10333322|NCT00331552|11469393|FG000|NOT COMPLETED|Period 3: Phase II||2
10333323|NCT00331552|11469394|FG001|NOT COMPLETED|Period 3: Phase II||0
10333324|NCT00331630|11469405|FG000|STARTED|Treatment on Study||30
10333325|NCT00331630|11469405|FG000|Completed 1st Cycle|Treatment on Study||30
10333326|NCT00331630|11469405|FG000|Completed 4 Cycles|Treatment on Study||30
10333327|NCT00331630|11469405|FG000|COMPLETED|Treatment on Study||30
10333328|NCT00331630|11469405|FG000|NOT COMPLETED|Treatment on Study||0
10333329|NCT00331630|11469405|FG000|STARTED|Evaluated for and Completed SOC Surgery||30
10333330|NCT00331630|11469405|FG000|COMPLETED|Evaluated for and Completed SOC Surgery||28
10333331|NCT00331630|11469405|FG000|NOT COMPLETED|Evaluated for and Completed SOC Surgery||2
10333332|NCT00331630|11469405|FG000|STARTED|Follow up for 5 Years|One patient did not enter follow up as was lost to follow up|29
10333333|NCT00331630|11469405|FG000|COMPLETED|Follow up for 5 Years||0
10333334|NCT00331630|11469405|FG000|NOT COMPLETED|Follow up for 5 Years||29
10333335|NCT00331682|11469409|FG000|STARTED|Overall Study||10
10333336|NCT00331682|11469409|FG000|COMPLETED|Overall Study||9
10333337|NCT00331682|11469409|FG000|NOT COMPLETED|Overall Study||1
10333338|NCT00331760|11469415|FG000|STARTED|Overall Study||58
10333339|NCT00331760|11469416|FG001|STARTED|Overall Study||48
10333340|NCT00331760|11469415|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|43
10333341|NCT00331760|11469416|FG001|COMPLETED|Overall Study||40
10333342|NCT00331760|11469415|FG000|NOT COMPLETED|Overall Study||15
10333343|NCT00331760|11469416|FG001|NOT COMPLETED|Overall Study||8
10333344|NCT00331799|11469423|FG000|STARTED|Overall Study||18
10333345|NCT00331799|11469423|FG000|COMPLETED|Overall Study||15
10333346|NCT00331799|11469423|FG000|NOT COMPLETED|Overall Study||3
10333347|NCT00331864|11469429|FG000|STARTED|Overall Study||513
10333348|NCT00331864|11469430|FG001|STARTED|Overall Study||18
10333349|NCT00331864|11469429|FG000|COMPLETED|Overall Study||455
10333350|NCT00331864|11469430|FG001|COMPLETED|Overall Study||14
10333351|NCT00331864|11469429|FG000|NOT COMPLETED|Overall Study||58
10333352|NCT00331864|11469430|FG001|NOT COMPLETED|Overall Study||4
10333353|NCT00332163|11469438|FG000|STARTED|Overall Study||48
10333354|NCT00332163|11469439|FG001|STARTED|Overall Study||47
10333355|NCT00332163|11469438|FG000|Received Treatment|Overall Study||48
10333356|NCT00332163|11469439|FG001|Received Treatment|Overall Study||47
10333357|NCT00332163|11469438|FG000|COMPLETED|Overall Study||48
10333358|NCT00332163|11469439|FG001|COMPLETED|Overall Study||47
10333359|NCT00332163|11469438|FG000|NOT COMPLETED|Overall Study||0
10333360|NCT00332163|11469439|FG001|NOT COMPLETED|Overall Study||0
10333361|NCT00332189|11469445|FG000|STARTED|Overall Study||111
10333362|NCT00332189|11469445|FG000|COMPLETED|Overall Study|Subjects in this extension study continued until there was market approval in their region.|90
10333363|NCT00332189|11469445|FG000|NOT COMPLETED|Overall Study||21
10333364|NCT00332202|11469452|FG000|STARTED|Overall Study||504
10333365|NCT00332202|11469453|FG001|STARTED|Overall Study||254
10333366|NCT00332202|11469452|FG000|Received At Least One Dose of Study Drug|Overall Study||493
10333367|NCT00332202|11469453|FG001|Received At Least One Dose of Study Drug|Overall Study||249
10333368|NCT00332202|11469452|FG000|COMPLETED|Overall Study||263
10333369|NCT00332202|11469453|FG001|COMPLETED|Overall Study||129
10333370|NCT00332202|11469452|FG000|NOT COMPLETED|Overall Study||241
10333371|NCT00332202|11469453|FG001|NOT COMPLETED|Overall Study||125
10333372|NCT00332241|11469470|FG000|STARTED|Overall Study||51
10333373|NCT00332241|11469471|FG001|STARTED|Overall Study||47
10333374|NCT00332241|11469470|FG000|COMPLETED|Overall Study||36
10333375|NCT00332241|11469471|FG001|COMPLETED|Overall Study||39
10333376|NCT00332241|11469470|FG000|NOT COMPLETED|Overall Study||15
10333377|NCT00332241|11469471|FG001|NOT COMPLETED|Overall Study||8
10333378|NCT00332332|11469477|FG000|STARTED|Overall Study||246
10333379|NCT00332332|11469477|FG000|Received Study Medication|Overall Study||230
10333380|NCT00332332|11469477|FG000|COMPLETED|Overall Study||178
10333381|NCT00332332|11469477|FG000|NOT COMPLETED|Overall Study||68
10333382|NCT00332462|11469481|FG000|STARTED|Overall Study|Safety and Intention to treat population.|34
10333383|NCT00332462|11469481|FG000|Patients Treated With Sandimmun® i.v.|Overall Study||34
10333384|NCT00332462|11469481|FG000|Patients Treated With Sandimmun® Optoral|Overall Study||29
10333385|NCT00332462|11469481|FG000|COMPLETED|Overall Study||18
10333386|NCT00332462|11469481|FG000|NOT COMPLETED|Overall Study||16
10333387|NCT00332488|11469491|FG000|STARTED|Initial Treatment Phase (Weeks 0 - 12)||183
10333388|NCT00332488|11469492|FG001|STARTED|Initial Treatment Phase (Weeks 0 - 12)||170
10333389|NCT00332488|11469493|FG002|STARTED|Initial Treatment Phase (Weeks 0 - 12)||175
10333390|NCT00332488|11469491|FG000|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||133
10333391|NCT00332488|11469492|FG001|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||152
10333392|NCT00332488|11469493|FG002|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||119
10333393|NCT00332488|11469491|FG000|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||50
10333394|NCT00332488|11469492|FG001|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||18
10333395|NCT00332488|11469493|FG002|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||56
10333396|NCT00332488|11469491|FG000|STARTED|Transfer Treatment Phase (Weeks 12 - 24)|Subjects on TI who achieved an HbA1c < 7.5% or had an HbA1c decrease from baseline >= 1.0%|29
10333397|NCT00332488|11469492|FG001|STARTED|Transfer Treatment Phase (Weeks 12 - 24)|Subjects on treatment who achieved an HbA1c < 7.5% or had an HbA1c decrease from baseline >= 1.0%|72
10333398|NCT00332488|11469493|FG002|STARTED|Transfer Treatment Phase (Weeks 12 - 24)|Subjects in this arm who met HbA1c criteria + subjects from other arms who did not|254
10333399|NCT00332488|11469491|FG000|COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||27
10333400|NCT00332488|11469492|FG001|COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||70
10333401|NCT00332488|11469493|FG002|COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||233
10333402|NCT00332488|11469491|FG000|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||2
10333403|NCT00332488|11469492|FG001|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||2
10333404|NCT00332488|11469493|FG002|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||21
10333405|NCT00332579|11469505|FG000|STARTED|Overall Study||12
10333406|NCT00332579|11469506|FG001|STARTED|Overall Study||13
10333407|NCT00332579|11469505|FG000|COMPLETED|Overall Study||11
10333408|NCT00332579|11469506|FG001|COMPLETED|Overall Study||12
10333409|NCT00332579|11469505|FG000|NOT COMPLETED|Overall Study||1
10333410|NCT00332579|11469506|FG001|NOT COMPLETED|Overall Study||1
10333420|NCT00332644|11469531|FG000|STARTED|Overall Study||262
10333421|NCT00332644|11469532|FG001|STARTED|Overall Study||260
10333422|NCT00332644|11469533|FG002|STARTED|Overall Study||267
10333423|NCT00332644|11469534|FG003|STARTED|Overall Study||264
10333424|NCT00332644|11469535|FG004|STARTED|Overall Study||262
10333425|NCT00332644|11469536|FG005|STARTED|Overall Study||189
10333426|NCT00332644|11469531|FG000|COMPLETED|Overall Study||250
10333427|NCT00332644|11469532|FG001|COMPLETED|Overall Study||238
10333428|NCT00332644|11469533|FG002|COMPLETED|Overall Study||258
10333429|NCT00332644|11469534|FG003|COMPLETED|Overall Study||244
10333430|NCT00332644|11469535|FG004|COMPLETED|Overall Study||250
10333431|NCT00332644|11469536|FG005|COMPLETED|Overall Study||174
10333432|NCT00332644|11469531|FG000|NOT COMPLETED|Overall Study||12
10333433|NCT00332644|11469532|FG001|NOT COMPLETED|Overall Study||22
10333434|NCT00332644|11469533|FG002|NOT COMPLETED|Overall Study||9
10333435|NCT00332644|11469534|FG003|NOT COMPLETED|Overall Study||20
10333436|NCT00332644|11469535|FG004|NOT COMPLETED|Overall Study||12
10333437|NCT00332644|11469536|FG005|NOT COMPLETED|Overall Study||15
10333438|NCT00332696|11469552|FG000|STARTED|Overall Study||32
10333439|NCT00332696|11469553|FG001|STARTED|Overall Study||32
10333440|NCT00332696|11469552|FG000|Completed Day 14 Visit|Overall Study|Primary Endpoint|21
10333441|NCT00332696|11469553|FG001|Completed Day 14 Visit|Overall Study||15
10333442|NCT00332696|11469552|FG000|COMPLETED|Overall Study|Completed Month 3 Visit|2
10333443|NCT00332696|11469553|FG001|COMPLETED|Overall Study||2
10333444|NCT00332696|11469552|FG000|NOT COMPLETED|Overall Study||30
10333445|NCT00332696|11469553|FG001|NOT COMPLETED|Overall Study||30
10333446|NCT00332709|11469561|FG000|STARTED|Overall Study||40
10333447|NCT00332709|11469562|FG001|STARTED|Overall Study||41
10333448|NCT00332709|11469561|FG000|COMPLETED|Overall Study||24
10333449|NCT00332709|11469562|FG001|COMPLETED|Overall Study||21
10333450|NCT00332709|11469561|FG000|NOT COMPLETED|Overall Study||16
10333451|NCT00332709|11469562|FG001|NOT COMPLETED|Overall Study||20
10333452|NCT00332722|11469570|FG000|STARTED|Overall Study||60
10333453|NCT00332722|11469571|FG001|STARTED|Overall Study||60
10333454|NCT00332722|11469570|FG000|COMPLETED|Overall Study||60
10333455|NCT00332722|11469571|FG001|COMPLETED|Overall Study||60
10333456|NCT00332722|11469570|FG000|NOT COMPLETED|Overall Study||0
10333457|NCT00332722|11469571|FG001|NOT COMPLETED|Overall Study||0
10333458|NCT00332839|11469579|FG000|STARTED|Core (Months 0 - 12)||47
10333459|NCT00332839|11469580|FG001|STARTED|Core (Months 0 - 12)||46
10333460|NCT00332839|11469579|FG000|Safety Set|Core (Months 0 - 12)||47
10333461|NCT00332839|11469580|FG001|Safety Set|Core (Months 0 - 12)||46
10333462|NCT00332839|11469579|FG000|COMPLETED|Core (Months 0 - 12)||37
10333463|NCT00332839|11469580|FG001|COMPLETED|Core (Months 0 - 12)||28
10333464|NCT00332839|11469579|FG000|NOT COMPLETED|Core (Months 0 - 12)||10
10333465|NCT00332839|11469580|FG001|NOT COMPLETED|Core (Months 0 - 12)||18
10333466|NCT00332839|11469579|FG000|STARTED|Follow-up (Months 12 - 60)|Follow-up included core participants (completed or discontinued) who wished to be followed.|33
10333467|NCT00332839|11469580|FG001|STARTED|Follow-up (Months 12 - 60)|Follow-up included core participants (completed or discontinued) who wished to be followed.|34
10333468|NCT00332839|11469579|FG000|COMPLETED|Follow-up (Months 12 - 60)||29
10333469|NCT00332839|11469580|FG001|COMPLETED|Follow-up (Months 12 - 60)||31
10333470|NCT00332839|11469579|FG000|NOT COMPLETED|Follow-up (Months 12 - 60)||4
10333471|NCT00332839|11469580|FG001|NOT COMPLETED|Follow-up (Months 12 - 60)||3
10333472|NCT00333138|11469589|FG000|STARTED|Core Study (6 Months)||93
10333473|NCT00333138|11469590|FG001|STARTED|Core Study (6 Months)||94
10333474|NCT00333138|11469591|FG002|STARTED|Core Study (6 Months)||94
10333475|NCT00333138|11469589|FG000|COMPLETED|Core Study (6 Months)||86
10333476|NCT00333138|11469590|FG001|COMPLETED|Core Study (6 Months)||88
10333477|NCT00333138|11469591|FG002|COMPLETED|Core Study (6 Months)||82
10333478|NCT00333138|11469589|FG000|NOT COMPLETED|Core Study (6 Months)||7
10333479|NCT00333138|11469590|FG001|NOT COMPLETED|Core Study (6 Months)||6
10333480|NCT00333138|11469591|FG002|NOT COMPLETED|Core Study (6 Months)||12
10333481|NCT00333138|11469589|FG000|STARTED|Extension Study (Month6 to End of Study)||83
10333482|NCT00333138|11469590|FG001|STARTED|Extension Study (Month6 to End of Study)||87
10805244|NCT04019626|11966793|FG005|NOT COMPLETED|Overall Study||1
10805245|NCT04023994|11966813|FG000|STARTED|Overall Study||10
10805246|NCT04023994|11966814|FG001|STARTED|Overall Study||4
10805247|NCT04023994|11966815|FG002|STARTED|Overall Study||4
10805248|NCT04023994|11966816|FG003|STARTED|Overall Study||6
10333483|NCT00333138|11469591|FG002|STARTED|Extension Study (Month6 to End of Study)||80
10333484|NCT00333138|11469589|FG000|COMPLETED|Extension Study (Month6 to End of Study)||40
10333485|NCT00333138|11469590|FG001|COMPLETED|Extension Study (Month6 to End of Study)||45
10333486|NCT00333138|11469591|FG002|COMPLETED|Extension Study (Month6 to End of Study)||37
10333487|NCT00333138|11469589|FG000|NOT COMPLETED|Extension Study (Month6 to End of Study)||43
10333488|NCT00333138|11469590|FG001|NOT COMPLETED|Extension Study (Month6 to End of Study)||42
10333489|NCT00333138|11469591|FG002|NOT COMPLETED|Extension Study (Month6 to End of Study)||43
10333490|NCT00333177|11469605|FG000|STARTED|Overall Study||12
10333491|NCT00333177|11469606|FG001|STARTED|Overall Study||17
10333492|NCT00333177|11469607|FG002|STARTED|Overall Study||17
10333493|NCT00333177|11469608|FG003|STARTED|Overall Study||14
10333494|NCT00333177|11469605|FG000|Received Intervention|Overall Study||12
10333495|NCT00333177|11469606|FG001|Received Intervention|Overall Study||16
10333496|NCT00333177|11469607|FG002|Received Intervention|Overall Study||16
10333497|NCT00333177|11469608|FG003|Received Intervention|Overall Study||12
10702106|NCT02573311|11866612|FG001|COMPLETED|Disposition for Part 1|Completed are the subjects who actually completed Part 1|361
10702107|NCT02573311|11866611|FG000|NOT COMPLETED|Disposition for Part 1||7
10702108|NCT02573311|11866612|FG001|NOT COMPLETED|Disposition for Part 1||3
10333498|NCT00333177|11469605|FG000|COMPLETED|Overall Study||12
10333499|NCT00333177|11469606|FG001|COMPLETED|Overall Study||16
10333500|NCT00333177|11469607|FG002|COMPLETED|Overall Study||16
10333501|NCT00333177|11469608|FG003|COMPLETED|Overall Study||12
10333502|NCT00333177|11469605|FG000|NOT COMPLETED|Overall Study||0
10333503|NCT00333177|11469606|FG001|NOT COMPLETED|Overall Study||1
10333504|NCT00333177|11469607|FG002|NOT COMPLETED|Overall Study||1
10333505|NCT00333177|11469608|FG003|NOT COMPLETED|Overall Study||2
10333506|NCT00333359|11469622|FG000|STARTED|Overall Study||199
10333507|NCT00333359|11469623|FG001|STARTED|Overall Study||382
10333508|NCT00333359|11469622|FG000|COMPLETED|Overall Study||126
10333509|NCT00333359|11469623|FG001|COMPLETED|Overall Study||260
10333510|NCT00333359|11469622|FG000|NOT COMPLETED|Overall Study||73
10333511|NCT00333359|11469623|FG001|NOT COMPLETED|Overall Study||122
10333512|NCT00333437|11469631|FG000|STARTED|Overall Study||7
10333513|NCT00333437|11469631|FG000|COMPLETED|Overall Study||7
10333514|NCT00333437|11469631|FG000|NOT COMPLETED|Overall Study||0
10333515|NCT00333606|11469638|FG000|STARTED|Overall Study||30
10333516|NCT00333606|11469639|FG001|STARTED|Overall Study||30
10333517|NCT00333606|11469638|FG000|COMPLETED|Overall Study||30
10333518|NCT00333606|11469639|FG001|COMPLETED|Overall Study||30
10333519|NCT00333606|11469638|FG000|NOT COMPLETED|Overall Study||0
10333520|NCT00333606|11469639|FG001|NOT COMPLETED|Overall Study||0
10333521|NCT00333619|11469649|FG000|STARTED|Overall Study||110
10333522|NCT00333619|11469650|FG001|STARTED|Overall Study||109
10333523|NCT00333619|11469649|FG000|Post-treatment|Overall Study||109
10333524|NCT00333619|11469650|FG001|Post-treatment|Overall Study||109
10333525|NCT00333619|11469649|FG000|3-month Follow-up|Overall Study||101
10333526|NCT00333619|11469650|FG001|3-month Follow-up|Overall Study||105
10333527|NCT00333619|11469649|FG000|COMPLETED|Overall Study||89
10333528|NCT00333619|11469650|FG001|COMPLETED|Overall Study||99
10333529|NCT00333619|11469649|FG000|NOT COMPLETED|Overall Study||21
10702109|NCT02573311|11866611|FG000|STARTED|Disposition for Part 2|Started are subjects who purchased study product and are eligible to enter Part-2 of study.|964
10702110|NCT02573311|11866612|FG001|STARTED|Disposition for Part 2|Started are subjects who purchased study product and are eligible to enter Part-2 of study.|153
10702111|NCT02573311|11866611|FG000|COMPLETED|Disposition for Part 2|Completed are the subjects who completed use phase Part-2 (Week 24 and EOS-P2 interviews).|754
10702112|NCT02573311|11866612|FG001|COMPLETED|Disposition for Part 2|Completed are the subjects who completed use phase Part-2 (Week 24 and EOS-P2 interviews).|127
10702113|NCT02573311|11866611|FG000|NOT COMPLETED|Disposition for Part 2||210
10702114|NCT02573311|11866612|FG001|NOT COMPLETED|Disposition for Part 2||26
10702115|NCT02573350|11866620|FG000|STARTED|Overall Study||137
10702116|NCT02573350|11866621|FG001|STARTED|Overall Study||76
10702117|NCT02573350|11866620|FG000|Efficacy Analysis Population|Overall Study||132
10702118|NCT02573350|11866621|FG001|Efficacy Analysis Population|Overall Study||73
10333530|NCT00333619|11469650|FG001|NOT COMPLETED|Overall Study||10
10333531|NCT00333710|11469661|FG000|STARTED|Overall Study||19
10333532|NCT00333710|11469662|FG001|STARTED|Overall Study||18
10805249|NCT04023994|11966817|FG004|STARTED|Overall Study||6
10333533|NCT00333710|11469663|FG002|STARTED|Overall Study||16
10333534|NCT00333710|11469661|FG000|COMPLETED|Overall Study||8
10333535|NCT00333710|11469662|FG001|COMPLETED|Overall Study||14
10333536|NCT00333710|11469663|FG002|COMPLETED|Overall Study||15
10333537|NCT00333710|11469661|FG000|NOT COMPLETED|Overall Study||11
10333538|NCT00333710|11469662|FG001|NOT COMPLETED|Overall Study||4
10333539|NCT00333710|11469663|FG002|NOT COMPLETED|Overall Study||1
10333540|NCT00333775|11469674|FG000|STARTED|Overall Study||241
10333541|NCT00333775|11469675|FG001|STARTED|Overall Study||248
10333542|NCT00333775|11469676|FG002|STARTED|Overall Study||247
10333543|NCT00333775|11469674|FG000|Received Treatment|Overall Study||238
10333544|NCT00333775|11469675|FG001|Received Treatment|Overall Study||247
10333545|NCT00333775|11469676|FG002|Received Treatment|Overall Study||245
10333546|NCT00333775|11469674|FG000|COMPLETED|Overall Study||0
10333547|NCT00333775|11469675|FG001|COMPLETED|Overall Study||0
10333548|NCT00333775|11469676|FG002|COMPLETED|Overall Study||0
10333549|NCT00333775|11469674|FG000|NOT COMPLETED|Overall Study||241
10333550|NCT00333775|11469675|FG001|NOT COMPLETED|Overall Study||248
10333551|NCT00333775|11469676|FG002|NOT COMPLETED|Overall Study||247
10333552|NCT00333788|11469684|FG000|STARTED|Overall Study|Participant flow based on All Subjects population; Baseline characteristics based on ITT population.|233
10702119|NCT02573350|11866620|FG000|Safety Population|Overall Study||137
10702120|NCT02573350|11866621|FG001|Safety Population|Overall Study||76
10702121|NCT02573350|11866620|FG000|COMPLETED|Overall Study||121
10702122|NCT02573350|11866621|FG001|COMPLETED|Overall Study||67
10702123|NCT02573350|11866620|FG000|NOT COMPLETED|Overall Study||16
10702124|NCT02573350|11866621|FG001|NOT COMPLETED|Overall Study||9
10702125|NCT02573402|11866632|FG000|STARTED|Overall Study||12
10702126|NCT02573402|11866633|FG001|STARTED|Overall Study||7
10333553|NCT00333788|11469684|FG000|COMPLETED|Overall Study||71
10333554|NCT00333788|11469684|FG000|NOT COMPLETED|Overall Study||162
10333555|NCT00333801|11469690|FG000|STARTED|Overall Study||43
10333556|NCT00333801|11469691|FG001|STARTED|Overall Study||42
10333557|NCT00333801|11469690|FG000|COMPLETED|Overall Study||35
10333558|NCT00333801|11469691|FG001|COMPLETED|Overall Study||36
10333559|NCT00333801|11469690|FG000|NOT COMPLETED|Overall Study||8
10333560|NCT00333801|11469691|FG001|NOT COMPLETED|Overall Study||6
10333561|NCT00333814|11469700|FG000|STARTED|Overall Study||76
10333562|NCT00333814|11469701|FG001|STARTED|Overall Study||77
10333563|NCT00333814|11469702|FG002|STARTED|Overall Study||76
10333564|NCT00333814|11469700|FG000|COMPLETED|Overall Study||73
10333565|NCT00333814|11469701|FG001|COMPLETED|Overall Study||73
10333566|NCT00333814|11469702|FG002|COMPLETED|Overall Study||71
10333567|NCT00333814|11469700|FG000|NOT COMPLETED|Overall Study||3
10333568|NCT00333814|11469701|FG001|NOT COMPLETED|Overall Study||4
10333569|NCT00333814|11469702|FG002|NOT COMPLETED|Overall Study||5
10333570|NCT00333840|11469712|FG000|STARTED|First-line Treatment Period||553
10333571|NCT00333840|11469713|FG001|STARTED|First-line Treatment Period||553
10333572|NCT00333840|11469714|FG002|STARTED|First-line Treatment Period||0
10333573|NCT00333840|11469715|FG003|STARTED|First-line Treatment Period||0
10333574|NCT00333840|11469712|FG000|Safety Population; Received Study Drug|First-line Treatment Period||551
10333575|NCT00333840|11469713|FG001|Safety Population; Received Study Drug|First-line Treatment Period||533
10333576|NCT00333840|11469714|FG002|Safety Population; Received Study Drug|First-line Treatment Period||0
10333577|NCT00333840|11469715|FG003|Safety Population; Received Study Drug|First-line Treatment Period||0
10333578|NCT00333840|11469712|FG000|COMPLETED|First-line Treatment Period||267
10333579|NCT00333840|11469713|FG001|COMPLETED|First-line Treatment Period||7
10333580|NCT00333840|11469714|FG002|COMPLETED|First-line Treatment Period||0
10333581|NCT00333840|11469715|FG003|COMPLETED|First-line Treatment Period||0
10333582|NCT00333840|11469712|FG000|NOT COMPLETED|First-line Treatment Period||286
10333583|NCT00333840|11469713|FG001|NOT COMPLETED|First-line Treatment Period||546
10333584|NCT00333840|11469714|FG002|NOT COMPLETED|First-line Treatment Period||0
10333585|NCT00333840|11469715|FG003|NOT COMPLETED|First-line Treatment Period||0
10333586|NCT00333840|11469712|FG000|STARTED|Second-line Treatment Period||0
10333587|NCT00333840|11469713|FG001|STARTED|Second-line Treatment Period||0
10333588|NCT00333840|11469714|FG002|STARTED|Second-line Treatment Period||14
10333589|NCT00333840|11469715|FG003|STARTED|Second-line Treatment Period||363
10333590|NCT00333840|11469712|FG000|COMPLETED|Second-line Treatment Period||0
10333591|NCT00333840|11469713|FG001|COMPLETED|Second-line Treatment Period||0
10333592|NCT00333840|11469714|FG002|COMPLETED|Second-line Treatment Period||0
10333593|NCT00333840|11469715|FG003|COMPLETED|Second-line Treatment Period||175
10333594|NCT00333840|11469712|FG000|NOT COMPLETED|Second-line Treatment Period||0
10333595|NCT00333840|11469713|FG001|NOT COMPLETED|Second-line Treatment Period||0
10333596|NCT00333840|11469714|FG002|NOT COMPLETED|Second-line Treatment Period||14
10333597|NCT00333840|11469715|FG003|NOT COMPLETED|Second-line Treatment Period||188
10333598|NCT00333866|11469733|FG000|STARTED|Overall Study||189
10333599|NCT00333866|11469734|FG001|STARTED|Overall Study||187
10333600|NCT00333866|11469735|FG002|STARTED|Overall Study||184
10333601|NCT00333866|11469736|FG003|STARTED|Overall Study||187
10333602|NCT00333866|11469733|FG000|TREATED|Overall Study||184
10333603|NCT00333866|11469734|FG001|TREATED|Overall Study||184
10333604|NCT00333866|11469735|FG002|TREATED|Overall Study||182
10333605|NCT00333866|11469736|FG003|TREATED|Overall Study||186
10333606|NCT00333866|11469733|FG000|COMPLETED|Overall Study||141
10333607|NCT00333866|11469734|FG001|COMPLETED|Overall Study||123
10333608|NCT00333866|11469735|FG002|COMPLETED|Overall Study||133
10333609|NCT00333866|11469736|FG003|COMPLETED|Overall Study||121
10333610|NCT00333866|11469733|FG000|NOT COMPLETED|Overall Study||48
10333611|NCT00333866|11469734|FG001|NOT COMPLETED|Overall Study||64
10333612|NCT00333866|11469735|FG002|NOT COMPLETED|Overall Study||51
10333613|NCT00333866|11469736|FG003|NOT COMPLETED|Overall Study||66
10333614|NCT00333879|11469746|FG000|STARTED|Overall Study||4
10333615|NCT00333879|11469746|FG000|COMPLETED|Overall Study||4
10333616|NCT00333879|11469746|FG000|NOT COMPLETED|Overall Study||0
10333617|NCT00333970|11469752|FG000|STARTED|Overall Study||50
10333618|NCT00333970|11469753|FG001|STARTED|Overall Study||25
10333619|NCT00333970|11469752|FG000|COMPLETED|Overall Study||37
10333620|NCT00333970|11469753|FG001|COMPLETED|Overall Study||18
10333621|NCT00333970|11469752|FG000|NOT COMPLETED|Overall Study||13
10333622|NCT00333970|11469753|FG001|NOT COMPLETED|Overall Study||7
10333623|NCT00333983|11469762|FG000|STARTED|Overall Study||20
10333624|NCT00333983|11469763|FG001|STARTED|Overall Study||21
10333625|NCT00333983|11469764|FG002|STARTED|Overall Study||21
10333626|NCT00333983|11469762|FG000|COMPLETED|Overall Study||17
10333627|NCT00333983|11469763|FG001|COMPLETED|Overall Study||16
10333628|NCT00333983|11469764|FG002|COMPLETED|Overall Study||19
10333629|NCT00333983|11469762|FG000|NOT COMPLETED|Overall Study||3
10333630|NCT00333983|11469763|FG001|NOT COMPLETED|Overall Study||5
10333631|NCT00333983|11469764|FG002|NOT COMPLETED|Overall Study||2
10333632|NCT00334061|11469772|FG000|STARTED|Overall Study|June 2006|125
10333633|NCT00334061|11469772|FG000|COMPLETED|Overall Study|November 2007|125
10333634|NCT00334061|11469772|FG000|NOT COMPLETED|Overall Study||0
10338977|NCT00370396|11475938|FG000|COMPLETED|Overall Study||726
10338978|NCT00370396|11475939|FG001|COMPLETED|Overall Study||91
10338979|NCT00370396|11475940|FG002|COMPLETED|Overall Study||282
10338980|NCT00370396|11475938|FG000|NOT COMPLETED|Overall Study||11
10338981|NCT00370396|11475939|FG001|NOT COMPLETED|Overall Study||1
10338982|NCT00370396|11475940|FG002|NOT COMPLETED|Overall Study||1
10338983|NCT00370552|11475951|FG000|STARTED|Overall Study|Randomized|46
10338984|NCT00370552|11475952|FG001|STARTED|Overall Study|Randomized|45
10338985|NCT00370552|11475953|FG002|STARTED|Overall Study|Randomized|32
10338986|NCT00370552|11475951|FG000|COMPLETED|Overall Study||0
10338987|NCT00370552|11475952|FG001|COMPLETED|Overall Study||0
10338988|NCT00370552|11475953|FG002|COMPLETED|Overall Study||0
10338989|NCT00370552|11475951|FG000|NOT COMPLETED|Overall Study||46
10338990|NCT00370552|11475952|FG001|NOT COMPLETED|Overall Study||45
10338991|NCT00370552|11475953|FG002|NOT COMPLETED|Overall Study||32
10338992|NCT00370682|11475964|FG000|STARTED|Overall Study||40
10338993|NCT00370682|11475965|FG001|STARTED|Overall Study||40
10338994|NCT00370682|11475966|FG002|STARTED|Overall Study||40
10338995|NCT00370682|11475964|FG000|COMPLETED|Overall Study||40
10338996|NCT00370682|11475965|FG001|COMPLETED|Overall Study||37
10338997|NCT00370682|11475966|FG002|COMPLETED|Overall Study||39
10338998|NCT00370682|11475964|FG000|NOT COMPLETED|Overall Study||0
10338999|NCT00370682|11475965|FG001|NOT COMPLETED|Overall Study||3
10339000|NCT00370682|11475966|FG002|NOT COMPLETED|Overall Study||1
10339001|NCT00370838|11475980|FG000|STARTED|Period 1 (Days 8-50)||7
10339002|NCT00370838|11475981|FG001|STARTED|Period 1 (Days 8-50)||3
10339003|NCT00370838|11475980|FG000|COMPLETED|Period 1 (Days 8-50)||7
10339004|NCT00370838|11475981|FG001|COMPLETED|Period 1 (Days 8-50)||3
10339005|NCT00370838|11475980|FG000|NOT COMPLETED|Period 1 (Days 8-50)||0
10339006|NCT00370838|11475981|FG001|NOT COMPLETED|Period 1 (Days 8-50)||0
10339007|NCT00370838|11475980|FG000|STARTED|Washout (Days 51-64)||7
10339008|NCT00370838|11475981|FG001|STARTED|Washout (Days 51-64)||3
10339009|NCT00370838|11475980|FG000|COMPLETED|Washout (Days 51-64)||7
10339010|NCT00370838|11475981|FG001|COMPLETED|Washout (Days 51-64)||3
10339011|NCT00370838|11475980|FG000|NOT COMPLETED|Washout (Days 51-64)||0
10339012|NCT00370838|11475981|FG001|NOT COMPLETED|Washout (Days 51-64)||0
10339013|NCT00370838|11475980|FG000|STARTED|Period 2 (Days 65-107)||7
10339014|NCT00370838|11475981|FG001|STARTED|Period 2 (Days 65-107)||3
10339015|NCT00370838|11475980|FG000|COMPLETED|Period 2 (Days 65-107)||7
10339016|NCT00370838|11475981|FG001|COMPLETED|Period 2 (Days 65-107)||3
10339017|NCT00370838|11475980|FG000|NOT COMPLETED|Period 2 (Days 65-107)||0
10339018|NCT00370838|11475981|FG001|NOT COMPLETED|Period 2 (Days 65-107)||0
10339019|NCT00370838|11475980|FG000|STARTED|Taper||7
10702127|NCT02573402|11866632|FG000|COMPLETED|Overall Study||12
10702128|NCT02573402|11866633|FG001|COMPLETED|Overall Study||7
10702129|NCT02573402|11866632|FG000|NOT COMPLETED|Overall Study||0
10339020|NCT00370838|11475981|FG001|STARTED|Taper||3
10339021|NCT00370838|11475980|FG000|COMPLETED|Taper||7
10339022|NCT00370838|11475981|FG001|COMPLETED|Taper||3
10339023|NCT00370838|11475980|FG000|NOT COMPLETED|Taper||0
10339024|NCT00370838|11475981|FG001|NOT COMPLETED|Taper||0
10339025|NCT00370994|11475989|FG000|STARTED|Overall Study|Sample size was 200, due to the difficulties of recruiting we changed to 120|60
10339026|NCT00370994|11475990|FG001|STARTED|Overall Study||60
10702130|NCT02573402|11866633|FG001|NOT COMPLETED|Overall Study||0
10339027|NCT00370994|11475989|FG000|COMPLETED|Overall Study||60
10339028|NCT00370994|11475990|FG001|COMPLETED|Overall Study||60
10339029|NCT00370994|11475989|FG000|NOT COMPLETED|Overall Study||0
10339030|NCT00370994|11475990|FG001|NOT COMPLETED|Overall Study||0
10339031|NCT00371137|11475999|FG000|STARTED|Overall Study||183
10702131|NCT02573467|11866643|FG000|STARTED|Double-blind Treatment Epoch||53
10339032|NCT00371137|11476000|FG001|STARTED|Overall Study||182
10339033|NCT00371137|11476001|FG002|STARTED|Overall Study||183
10339034|NCT00371137|11475999|FG000|Treated|Overall Study||183
10339035|NCT00371137|11476000|FG001|Treated|Overall Study||182
10339036|NCT00371137|11476001|FG002|Treated|Overall Study||182
10339037|NCT00371137|11475999|FG000|COMPLETED|Overall Study||111
10339038|NCT00371137|11476000|FG001|COMPLETED|Overall Study||119
10339039|NCT00371137|11476001|FG002|COMPLETED|Overall Study||104
10333635|NCT00334074|11469776|FG000|STARTED|Overall Study||30
10333636|NCT00334074|11469776|FG000|COMPLETED|Overall Study||30
10333637|NCT00334074|11469776|FG000|NOT COMPLETED|Overall Study||0
10333638|NCT00334113|11469783|FG000|STARTED|Overall Study||32
10333639|NCT00334113|11469784|FG001|STARTED|Overall Study||34
10333640|NCT00334113|11469783|FG000|COMPLETED|Overall Study||30
10333641|NCT00334113|11469784|FG001|COMPLETED|Overall Study||31
10333642|NCT00334113|11469783|FG000|NOT COMPLETED|Overall Study||2
10333643|NCT00334113|11469784|FG001|NOT COMPLETED|Overall Study||3
10333644|NCT00334204|11469790|FG000|STARTED|Overall Study||58
10333645|NCT00334204|11469790|FG000|COMPLETED|Overall Study||56
10333646|NCT00334204|11469790|FG000|NOT COMPLETED|Overall Study||2
10333647|NCT00334282|11469797|FG000|STARTED|Overall Study||290
10333648|NCT00334282|11469798|FG001|STARTED|Overall Study||145
10333649|NCT00334282|11469797|FG000|COMPLETED|Overall Study||68
10333650|NCT00334282|11469798|FG001|COMPLETED|Overall Study||37
10333651|NCT00334282|11469797|FG000|NOT COMPLETED|Overall Study||222
10333652|NCT00334282|11469798|FG001|NOT COMPLETED|Overall Study||108
10333653|NCT00334295|11469808|FG000|STARTED|Overall Study||35
10333654|NCT00334295|11469808|FG000|COMPLETED|Overall Study||30
10333655|NCT00334295|11469808|FG000|NOT COMPLETED|Overall Study||5
10333656|NCT00334542|11469812|FG000|STARTED|Overall Study||50
10333657|NCT00334542|11469812|FG000|COMPLETED|Overall Study||45
10333658|NCT00334542|11469812|FG000|NOT COMPLETED|Overall Study||5
10333659|NCT00334633|11469820|FG000|STARTED|Overall Study||197
10333660|NCT00334633|11469821|FG001|STARTED|Overall Study||200
10333661|NCT00334633|11469822|FG002|STARTED|Overall Study||196
10333662|NCT00334633|11469820|FG000|COMPLETED|Overall Study||117
10333663|NCT00334633|11469821|FG001|COMPLETED|Overall Study||118
10333664|NCT00334633|11469822|FG002|COMPLETED|Overall Study||114
10333665|NCT00334633|11469820|FG000|NOT COMPLETED|Overall Study||80
10333666|NCT00334633|11469821|FG001|NOT COMPLETED|Overall Study||82
10333667|NCT00334633|11469822|FG002|NOT COMPLETED|Overall Study||82
10333668|NCT00334737|11469836|FG000|STARTED|Hospital Phase||34
10333669|NCT00334737|11469837|FG001|STARTED|Hospital Phase||34
10333670|NCT00334737|11469838|FG002|STARTED|Hospital Phase||34
10333671|NCT00334737|11469836|FG000|COMPLETED|Hospital Phase||32
10333672|NCT00334737|11469837|FG001|COMPLETED|Hospital Phase||32
10333673|NCT00334737|11469838|FG002|COMPLETED|Hospital Phase||30
10333674|NCT00334737|11469836|FG000|NOT COMPLETED|Hospital Phase||2
10333675|NCT00334737|11469837|FG001|NOT COMPLETED|Hospital Phase||2
10333676|NCT00334737|11469838|FG002|NOT COMPLETED|Hospital Phase||4
10333677|NCT00334737|11469836|FG000|STARTED|Follow up Phase||32
10333678|NCT00334737|11469837|FG001|STARTED|Follow up Phase||32
10456844|NCT01008059|11604614|FG001|STARTED|Rifampin Simultaneous Alfentanil||0
10456845|NCT01008059|11604615|FG002|STARTED|Rifampin Simultaneous Alfentanil||0
10456846|NCT01008059|11604616|FG003|STARTED|Rifampin Simultaneous Alfentanil||0
10456847|NCT01008059|11604617|FG004|STARTED|Rifampin Simultaneous Alfentanil||0
10456848|NCT01008059|11604618|FG005|STARTED|Rifampin Simultaneous Alfentanil||6
10456849|NCT01008059|11604619|FG006|STARTED|Rifampin Simultaneous Alfentanil||0
10456850|NCT01008059|11604620|FG007|STARTED|Rifampin Simultaneous Alfentanil||0
10456851|NCT01008059|11604613|FG000|COMPLETED|Rifampin Simultaneous Alfentanil||0
10456852|NCT01008059|11604614|FG001|COMPLETED|Rifampin Simultaneous Alfentanil||0
10456853|NCT01008059|11604615|FG002|COMPLETED|Rifampin Simultaneous Alfentanil||0
10456854|NCT01008059|11604616|FG003|COMPLETED|Rifampin Simultaneous Alfentanil||0
10456855|NCT01008059|11604617|FG004|COMPLETED|Rifampin Simultaneous Alfentanil||0
10456856|NCT01008059|11604618|FG005|COMPLETED|Rifampin Simultaneous Alfentanil||6
10456857|NCT01008059|11604619|FG006|COMPLETED|Rifampin Simultaneous Alfentanil||0
10456858|NCT01008059|11604620|FG007|COMPLETED|Rifampin Simultaneous Alfentanil||0
10456859|NCT01008059|11604613|FG000|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
10456860|NCT01008059|11604614|FG001|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
10456861|NCT01008059|11604615|FG002|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
10456862|NCT01008059|11604616|FG003|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
10456863|NCT01008059|11604617|FG004|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
10456864|NCT01008059|11604618|FG005|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
10456865|NCT01008059|11604619|FG006|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
10456866|NCT01008059|11604620|FG007|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
10456867|NCT01008059|11604613|FG000|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
10456868|NCT01008059|11604614|FG001|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
10456869|NCT01008059|11604615|FG002|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
10456870|NCT01008059|11604616|FG003|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
10456871|NCT01008059|11604617|FG004|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
10456872|NCT01008059|11604618|FG005|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
10456873|NCT01008059|11604619|FG006|STARTED|Grapefruit Juice Simultaneous Alfentanil||6
10456874|NCT01008059|11604620|FG007|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
10456875|NCT01008059|11604613|FG000|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
10456876|NCT01008059|11604614|FG001|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
10456877|NCT01008059|11604615|FG002|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
10333679|NCT00334737|11469838|FG002|STARTED|Follow up Phase||30
10333680|NCT00334737|11469836|FG000|COMPLETED|Follow up Phase||27
10333681|NCT00334737|11469837|FG001|COMPLETED|Follow up Phase||29
10333682|NCT00334737|11469838|FG002|COMPLETED|Follow up Phase||24
10333683|NCT00334737|11469836|FG000|NOT COMPLETED|Follow up Phase||5
10333684|NCT00334737|11469837|FG001|NOT COMPLETED|Follow up Phase||3
10333685|NCT00334737|11469838|FG002|NOT COMPLETED|Follow up Phase||6
10456878|NCT01008059|11604616|FG003|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
10456879|NCT01008059|11604617|FG004|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
10456880|NCT01008059|11604618|FG005|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
10456881|NCT01008059|11604619|FG006|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||6
10456882|NCT01008059|11604620|FG007|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
10456883|NCT01008059|11604613|FG000|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
10456884|NCT01008059|11604614|FG001|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
10456885|NCT01008059|11604615|FG002|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
10456886|NCT01008059|11604616|FG003|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
10456887|NCT01008059|11604617|FG004|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
10456888|NCT01008059|11604618|FG005|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
10456889|NCT01008059|11604619|FG006|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
10456890|NCT01008059|11604620|FG007|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
10456891|NCT01008059|11604613|FG000|STARTED|Ketoconazole Simultaneous Alfentanil||0
10456892|NCT01008059|11604614|FG001|STARTED|Ketoconazole Simultaneous Alfentanil||0
10456893|NCT01008059|11604615|FG002|STARTED|Ketoconazole Simultaneous Alfentanil||0
10456894|NCT01008059|11604616|FG003|STARTED|Ketoconazole Simultaneous Alfentanil||0
10456895|NCT01008059|11604617|FG004|STARTED|Ketoconazole Simultaneous Alfentanil||0
10456896|NCT01008059|11604618|FG005|STARTED|Ketoconazole Simultaneous Alfentanil||0
10456897|NCT01008059|11604619|FG006|STARTED|Ketoconazole Simultaneous Alfentanil||0
10456898|NCT01008059|11604620|FG007|STARTED|Ketoconazole Simultaneous Alfentanil||6
10456899|NCT01008059|11604613|FG000|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
10456900|NCT01008059|11604614|FG001|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
10456901|NCT01008059|11604615|FG002|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
10456902|NCT01008059|11604616|FG003|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
10456903|NCT01008059|11604617|FG004|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
10456904|NCT01008059|11604618|FG005|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
10456905|NCT01008059|11604619|FG006|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
10456906|NCT01008059|11604620|FG007|COMPLETED|Ketoconazole Simultaneous Alfentanil||6
10456907|NCT01008059|11604613|FG000|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
10456908|NCT01008059|11604614|FG001|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
10456909|NCT01008059|11604615|FG002|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
10456910|NCT01008059|11604616|FG003|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
10456911|NCT01008059|11604617|FG004|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
10574836|NCT01681186|11730211|FG004|COMPLETED|First Intervention||3
10456912|NCT01008059|11604618|FG005|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
10456913|NCT01008059|11604619|FG006|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
10456914|NCT01008059|11604620|FG007|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
10456915|NCT01008150|11604635|FG000|STARTED|Overall Study||43
10456916|NCT01008150|11604636|FG001|STARTED|Overall Study||43
10456917|NCT01008150|11604637|FG002|STARTED|Overall Study||43
10574686|NCT01680159|11729958|FG000|COMPLETED|Screening Period||39
10574687|NCT01680159|11729958|FG000|NOT COMPLETED|Screening Period||7
10574688|NCT01680159|11729958|FG000|STARTED|Increased Dose Period||51
10574689|NCT01680159|11729958|FG000|COMPLETED|Increased Dose Period||43
10574690|NCT01680159|11729958|FG000|NOT COMPLETED|Increased Dose Period||8
10574691|NCT01680172|11729980|FG000|STARTED|Overall Study||3
10574692|NCT01680172|11729981|FG001|STARTED|Overall Study||2
10574693|NCT01680172|11729980|FG000|COMPLETED|Overall Study||3
10574694|NCT01680172|11729981|FG001|COMPLETED|Overall Study||2
10574695|NCT01680172|11729980|FG000|NOT COMPLETED|Overall Study||0
10574696|NCT01680172|11729981|FG001|NOT COMPLETED|Overall Study||0
10574697|NCT01680328|11729987|FG000|STARTED|Overall Study||82
10574698|NCT01680328|11729987|FG000|Subjects Missing Injections|Overall Study|One missed the [1600 μL, 450 μL/s; thighs]; one missed the [400 μL, 300 μL/s; abdomen]|2
10574699|NCT01680328|11729987|FG000|COMPLETED|Overall Study||80
10574700|NCT01680328|11729987|FG000|NOT COMPLETED|Overall Study||2
10574701|NCT01680341|11730024|FG000|STARTED|Overall Study||136
10574702|NCT01680341|11730025|FG001|STARTED|Overall Study||136
10574703|NCT01680341|11730024|FG000|Exposed|Overall Study|One (1) subject withdrew consent prior to exposure to trial product.|135
10574704|NCT01680341|11730025|FG001|Exposed|Overall Study|Two (2) subjects withdrew consent prior to exposure to trial product.|134
10574705|NCT01680341|11730024|FG000|COMPLETED|Overall Study||115
10574706|NCT01680341|11730025|FG001|COMPLETED|Overall Study||119
10574707|NCT01680341|11730024|FG000|NOT COMPLETED|Overall Study||21
10574708|NCT01680341|11730025|FG001|NOT COMPLETED|Overall Study||17
10574709|NCT01680458|11730031|FG000|STARTED|Overall Study||30
10574710|NCT01680458|11730031|FG000|COMPLETED|Overall Study||27
10574711|NCT01680458|11730031|FG000|NOT COMPLETED|Overall Study||3
10574712|NCT01680497|11730035|FG000|STARTED|Overall Study||70
10574713|NCT01680497|11730035|FG000|COMPLETED|Overall Study||68
10574714|NCT01680497|11730035|FG000|NOT COMPLETED|Overall Study||2
10651409|NCT02175771|11811625|FG000|STARTED|Run-In Period (Pre-assignment)|Enrolled; two participants were enrolled but had no enrollment date in their records.|758
10651410|NCT02175771|11811626|FG001|STARTED|Run-In Period (Pre-assignment)||0
10651411|NCT02175771|11811627|FG002|STARTED|Run-In Period (Pre-assignment)||0
10651412|NCT02175771|11811628|FG003|STARTED|Run-In Period (Pre-assignment)||0
10651413|NCT02175771|11811629|FG004|STARTED|Run-In Period (Pre-assignment)||0
10651414|NCT02175771|11811630|FG005|STARTED|Run-In Period (Pre-assignment)||0
10651415|NCT02175771|11811631|FG006|STARTED|Run-In Period (Pre-assignment)||0
10574715|NCT01680549|11730041|FG000|STARTED|Overall Study||25
10574716|NCT01680549|11730042|FG001|STARTED|Overall Study||25
10574717|NCT01680549|11730041|FG000|COMPLETED|Overall Study||20
10574718|NCT01680549|11730042|FG001|COMPLETED|Overall Study||17
10574719|NCT01680549|11730041|FG000|NOT COMPLETED|Overall Study||5
10574720|NCT01680549|11730042|FG001|NOT COMPLETED|Overall Study||8
10574721|NCT01680640|11730056|FG000|STARTED|Overall Study||55
10574722|NCT01680640|11730057|FG001|STARTED|Overall Study||49
10574723|NCT01680640|11730056|FG000|COMPLETED|Overall Study||45
10574724|NCT01680640|11730057|FG001|COMPLETED|Overall Study||44
10574725|NCT01680640|11730056|FG000|NOT COMPLETED|Overall Study||10
10574726|NCT01680640|11730057|FG001|NOT COMPLETED|Overall Study||5
10574727|NCT01680653|11730063|FG000|STARTED|Overall Study||57
10574728|NCT01680653|11730063|FG000|COMPLETED|Overall Study||57
10574729|NCT01680653|11730063|FG000|NOT COMPLETED|Overall Study||0
10574730|NCT01680666|11730075|FG000|STARTED|Overall Study||84
10574731|NCT01680666|11730076|FG001|STARTED|Overall Study||66
10702132|NCT02573467|11866644|FG001|STARTED|Double-blind Treatment Epoch||52
10702133|NCT02573467|11866645|FG002|STARTED|Double-blind Treatment Epoch||51
10702134|NCT02573467|11866646|FG003|STARTED|Double-blind Treatment Epoch||55
10702135|NCT02573467|11866643|FG000|Full Analysis Set|Double-blind Treatment Epoch||53
10805250|NCT04023994|11966818|FG005|STARTED|Overall Study||6
10574732|NCT01680666|11730075|FG000|COMPLETED|Overall Study||84
10574733|NCT01680666|11730076|FG001|COMPLETED|Overall Study||66
10574734|NCT01680666|11730075|FG000|NOT COMPLETED|Overall Study||0
10574735|NCT01680666|11730076|FG001|NOT COMPLETED|Overall Study||0
10574736|NCT01680783|11730085|FG000|STARTED|Overall Study||39
10574737|NCT01680783|11730086|FG001|STARTED|Overall Study||44
10574738|NCT01680783|11730085|FG000|COMPLETED|Overall Study||39
10574739|NCT01680783|11730086|FG001|COMPLETED|Overall Study||44
10574740|NCT01680783|11730085|FG000|NOT COMPLETED|Overall Study||0
10574741|NCT01680783|11730086|FG001|NOT COMPLETED|Overall Study||0
10574742|NCT01680835|11730092|FG000|STARTED|Overall Study||108
10574743|NCT01680835|11730092|FG000|COMPLETED|Overall Study||83
10574744|NCT01680835|11730092|FG000|NOT COMPLETED|Overall Study||25
10574745|NCT01680848|11730096|FG000|STARTED|Overall Study||282
10574746|NCT01680848|11730096|FG000|COMPLETED|Overall Study||189
10574747|NCT01680848|11730096|FG000|NOT COMPLETED|Overall Study||93
10574748|NCT01680861|11730102|FG000|STARTED|Early Post-transplant Period|One patient didn't produce sufficient urine during first 24hr post-transplant (ineligible).|16
10574749|NCT01680861|11730103|FG001|STARTED|Early Post-transplant Period|One patient developed immediate DGF (delayed graft function) and was therefore ineligible.|16
10574750|NCT01680861|11730102|FG000|COMPLETED|Early Post-transplant Period||15
10574751|NCT01680861|11730103|FG001|COMPLETED|Early Post-transplant Period||15
10574752|NCT01680861|11730102|FG000|NOT COMPLETED|Early Post-transplant Period||1
10574753|NCT01680861|11730103|FG001|NOT COMPLETED|Early Post-transplant Period||1
10574754|NCT01680861|11730102|FG000|STARTED|First 12 Months Post-transplant||15
10574755|NCT01680861|11730103|FG001|STARTED|First 12 Months Post-transplant||15
10574756|NCT01680861|11730102|FG000|COMPLETED|First 12 Months Post-transplant||15
10574757|NCT01680861|11730103|FG001|COMPLETED|First 12 Months Post-transplant||15
10574758|NCT01680861|11730102|FG000|NOT COMPLETED|First 12 Months Post-transplant||0
10574759|NCT01680861|11730103|FG001|NOT COMPLETED|First 12 Months Post-transplant||0
10574760|NCT01680887|11730113|FG000|STARTED|Overall Study||80
10574761|NCT01680887|11730114|FG001|STARTED|Overall Study||76
10574762|NCT01680887|11730113|FG000|COMPLETED|Overall Study||51
10574763|NCT01680887|11730114|FG001|COMPLETED|Overall Study||52
10574764|NCT01680887|11730113|FG000|NOT COMPLETED|Overall Study||29
10574765|NCT01680887|11730114|FG001|NOT COMPLETED|Overall Study||24
10574766|NCT01680900|11730122|FG000|STARTED|Overall Study||24
10574767|NCT01680900|11730123|FG001|STARTED|Overall Study||12
10574768|NCT01680900|11730122|FG000|COMPLETED|Overall Study||20
10574769|NCT01680900|11730123|FG001|COMPLETED|Overall Study||11
10574770|NCT01680900|11730122|FG000|NOT COMPLETED|Overall Study||4
10574771|NCT01680900|11730123|FG001|NOT COMPLETED|Overall Study||1
10574772|NCT01680991|11730132|FG000|STARTED|Overall Study||12
10574773|NCT01680991|11730133|FG001|STARTED|Overall Study||23
10574774|NCT01680991|11730134|FG002|STARTED|Overall Study||13
10574775|NCT01680991|11730132|FG000|COMPLETED|Overall Study||4
10574776|NCT01680991|11730133|FG001|COMPLETED|Overall Study||4
10574777|NCT01680991|11730134|FG002|COMPLETED|Overall Study||9
10574778|NCT01680991|11730132|FG000|NOT COMPLETED|Overall Study||8
10574779|NCT01680991|11730133|FG001|NOT COMPLETED|Overall Study||19
10574780|NCT01680991|11730134|FG002|NOT COMPLETED|Overall Study||4
10574781|NCT01681004|11730146|FG000|STARTED|Primary Endpoint: 6 Months||102
10574782|NCT01681004|11730147|FG001|STARTED|Primary Endpoint: 6 Months||46
10574783|NCT01681004|11730146|FG000|Crossover to Surgical Treatment|Primary Endpoint: 6 Months||0
10574784|NCT01681004|11730147|FG001|Crossover to Surgical Treatment|Primary Endpoint: 6 Months|Crossover to surgical treatment allowed per study protocol after the 6-month visit was complete.|39
10574785|NCT01681004|11730146|FG000|COMPLETED|Primary Endpoint: 6 Months||101
10574786|NCT01681004|11730147|FG001|COMPLETED|Primary Endpoint: 6 Months||44
10574787|NCT01681004|11730146|FG000|NOT COMPLETED|Primary Endpoint: 6 Months||1
10702136|NCT02573467|11866644|FG001|Full Analysis Set|Double-blind Treatment Epoch||52
10574788|NCT01681004|11730147|FG001|NOT COMPLETED|Primary Endpoint: 6 Months||2
10574789|NCT01681004|11730146|FG000|STARTED|Study Completion||101
10574790|NCT01681004|11730147|FG001|STARTED|Study Completion||44
10574791|NCT01681004|11730146|FG000|COMPLETED|Study Completion||89
10574792|NCT01681004|11730147|FG001|COMPLETED|Study Completion||36
10574793|NCT01681004|11730146|FG000|NOT COMPLETED|Study Completion||12
10574794|NCT01681004|11730147|FG001|NOT COMPLETED|Study Completion||8
10574795|NCT01681030|11730160|FG000|STARTED|Overall Study||13
10574796|NCT01681030|11730161|FG001|STARTED|Overall Study||18
10574797|NCT01681030|11730162|FG002|STARTED|Overall Study||11
10574798|NCT01681030|11730160|FG000|COMPLETED|Overall Study||13
10574799|NCT01681030|11730161|FG001|COMPLETED|Overall Study||18
10574800|NCT01681030|11730162|FG002|COMPLETED|Overall Study||11
10574801|NCT01681030|11730160|FG000|NOT COMPLETED|Overall Study||0
10574802|NCT01681030|11730161|FG001|NOT COMPLETED|Overall Study||0
10574803|NCT01681030|11730162|FG002|NOT COMPLETED|Overall Study||0
10574804|NCT01681069|11730172|FG000|STARTED|Overall Study||60
10574805|NCT01681069|11730173|FG001|STARTED|Overall Study||60
10574806|NCT01681069|11730172|FG000|Full Analysis Set (FAS)|Overall Study||57
10574807|NCT01681069|11730173|FG001|Full Analysis Set (FAS)|Overall Study||60
10574808|NCT01681069|11730172|FG000|COMPLETED|Overall Study|Valid Case Analysis Set (VAS)|55
10574809|NCT01681069|11730173|FG001|COMPLETED|Overall Study|Valid Case Analysis Set (VAS)|53
10574810|NCT01681069|11730172|FG000|NOT COMPLETED|Overall Study||5
10574811|NCT01681069|11730173|FG001|NOT COMPLETED|Overall Study||7
10574812|NCT01681095|11730181|FG000|STARTED|Overall Study||55
10805251|NCT04023994|11966813|FG000|COMPLETED|Overall Study||10
10805252|NCT04023994|11966814|FG001|COMPLETED|Overall Study||3
10574813|NCT01681095|11730182|FG001|STARTED|Overall Study||55
10574814|NCT01681095|11730181|FG000|COMPLETED|Overall Study||55
10574815|NCT01681095|11730182|FG001|COMPLETED|Overall Study||55
10574816|NCT01681095|11730181|FG000|NOT COMPLETED|Overall Study||0
10574817|NCT01681095|11730182|FG001|NOT COMPLETED|Overall Study||0
10574818|NCT01681121|11730190|FG000|STARTED|Overall Study||44
10574819|NCT01681121|11730191|FG001|STARTED|Overall Study||49
10574820|NCT01681121|11730190|FG000|COMPLETED|Overall Study||36
10574821|NCT01681121|11730191|FG001|COMPLETED|Overall Study||38
10574822|NCT01681121|11730190|FG000|NOT COMPLETED|Overall Study||8
10574823|NCT01681121|11730191|FG001|NOT COMPLETED|Overall Study||11
10574824|NCT01681186|11730207|FG000|STARTED|First Intervention||4
10574825|NCT01681186|11730208|FG001|STARTED|First Intervention||2
10574826|NCT01681186|11730209|FG002|STARTED|First Intervention||2
10574827|NCT01681186|11730210|FG003|STARTED|First Intervention||3
10574828|NCT01681186|11730211|FG004|STARTED|First Intervention||3
10574829|NCT01681186|11730212|FG005|STARTED|First Intervention||2
10574830|NCT01681186|11730213|FG006|STARTED|First Intervention||7
10574831|NCT01681186|11730214|FG007|STARTED|First Intervention||7
10574832|NCT01681186|11730207|FG000|COMPLETED|First Intervention||4
10574833|NCT01681186|11730208|FG001|COMPLETED|First Intervention||2
10574834|NCT01681186|11730209|FG002|COMPLETED|First Intervention||2
10574835|NCT01681186|11730210|FG003|COMPLETED|First Intervention||3
10574837|NCT01681186|11730212|FG005|COMPLETED|First Intervention||2
10574838|NCT01681186|11730213|FG006|COMPLETED|First Intervention||7
10574839|NCT01681186|11730214|FG007|COMPLETED|First Intervention||7
10574840|NCT01681186|11730207|FG000|NOT COMPLETED|First Intervention||0
10574841|NCT01681186|11730208|FG001|NOT COMPLETED|First Intervention||0
10574842|NCT01681186|11730209|FG002|NOT COMPLETED|First Intervention||0
10574843|NCT01681186|11730210|FG003|NOT COMPLETED|First Intervention||0
10574844|NCT01681186|11730211|FG004|NOT COMPLETED|First Intervention||0
10574845|NCT01681186|11730212|FG005|NOT COMPLETED|First Intervention||0
10574846|NCT01681186|11730213|FG006|NOT COMPLETED|First Intervention||0
10574847|NCT01681186|11730214|FG007|NOT COMPLETED|First Intervention||0
10574848|NCT01681186|11730207|FG000|STARTED|Washout Period From First Intervention||4
10574849|NCT01681186|11730208|FG001|STARTED|Washout Period From First Intervention||2
10574850|NCT01681186|11730209|FG002|STARTED|Washout Period From First Intervention||2
10574851|NCT01681186|11730210|FG003|STARTED|Washout Period From First Intervention||3
10574852|NCT01681186|11730211|FG004|STARTED|Washout Period From First Intervention||3
10574853|NCT01681186|11730212|FG005|STARTED|Washout Period From First Intervention||2
10574854|NCT01681186|11730213|FG006|STARTED|Washout Period From First Intervention||7
10574855|NCT01681186|11730214|FG007|STARTED|Washout Period From First Intervention||7
10574856|NCT01681186|11730207|FG000|COMPLETED|Washout Period From First Intervention||4
10574857|NCT01681186|11730208|FG001|COMPLETED|Washout Period From First Intervention||2
10574858|NCT01681186|11730209|FG002|COMPLETED|Washout Period From First Intervention||2
10574859|NCT01681186|11730210|FG003|COMPLETED|Washout Period From First Intervention||3
10574860|NCT01681186|11730211|FG004|COMPLETED|Washout Period From First Intervention||3
10574861|NCT01681186|11730212|FG005|COMPLETED|Washout Period From First Intervention||2
10574862|NCT01681186|11730213|FG006|COMPLETED|Washout Period From First Intervention||7
10574863|NCT01681186|11730214|FG007|COMPLETED|Washout Period From First Intervention||7
10574864|NCT01681186|11730207|FG000|NOT COMPLETED|Washout Period From First Intervention||0
10574865|NCT01681186|11730208|FG001|NOT COMPLETED|Washout Period From First Intervention||0
10574866|NCT01681186|11730209|FG002|NOT COMPLETED|Washout Period From First Intervention||0
10574867|NCT01681186|11730210|FG003|NOT COMPLETED|Washout Period From First Intervention||0
10574868|NCT01681186|11730211|FG004|NOT COMPLETED|Washout Period From First Intervention||0
10574869|NCT01681186|11730212|FG005|NOT COMPLETED|Washout Period From First Intervention||0
10574870|NCT01681186|11730213|FG006|NOT COMPLETED|Washout Period From First Intervention||0
10574871|NCT01681186|11730214|FG007|NOT COMPLETED|Washout Period From First Intervention||0
10574872|NCT01681186|11730207|FG000|STARTED|Second Intervention||4
10574873|NCT01681186|11730208|FG001|STARTED|Second Intervention||2
10805253|NCT04023994|11966815|FG002|COMPLETED|Overall Study||2
10805254|NCT04023994|11966816|FG003|COMPLETED|Overall Study||5
10574874|NCT01681186|11730209|FG002|STARTED|Second Intervention||2
10574875|NCT01681186|11730210|FG003|STARTED|Second Intervention||3
10574876|NCT01681186|11730211|FG004|STARTED|Second Intervention||3
10574877|NCT01681186|11730212|FG005|STARTED|Second Intervention||2
10574878|NCT01681186|11730213|FG006|STARTED|Second Intervention||7
10574879|NCT01681186|11730214|FG007|STARTED|Second Intervention||7
10574880|NCT01681186|11730207|FG000|COMPLETED|Second Intervention||4
10574881|NCT01681186|11730208|FG001|COMPLETED|Second Intervention||2
10574882|NCT01681186|11730209|FG002|COMPLETED|Second Intervention||2
10574883|NCT01681186|11730210|FG003|COMPLETED|Second Intervention||3
10574884|NCT01681186|11730211|FG004|COMPLETED|Second Intervention||3
10574885|NCT01681186|11730212|FG005|COMPLETED|Second Intervention||2
10574886|NCT01681186|11730213|FG006|COMPLETED|Second Intervention||7
10574887|NCT01681186|11730214|FG007|COMPLETED|Second Intervention||7
10574888|NCT01681186|11730207|FG000|NOT COMPLETED|Second Intervention||0
10574889|NCT01681186|11730208|FG001|NOT COMPLETED|Second Intervention||0
10574890|NCT01681186|11730209|FG002|NOT COMPLETED|Second Intervention||0
10574891|NCT01681186|11730210|FG003|NOT COMPLETED|Second Intervention||0
10574892|NCT01681186|11730211|FG004|NOT COMPLETED|Second Intervention||0
10574893|NCT01681186|11730212|FG005|NOT COMPLETED|Second Intervention||0
10574894|NCT01681186|11730213|FG006|NOT COMPLETED|Second Intervention||0
10574895|NCT01681186|11730214|FG007|NOT COMPLETED|Second Intervention||0
10574896|NCT01681186|11730207|FG000|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
10574897|NCT01681186|11730208|FG001|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
10574898|NCT01681186|11730209|FG002|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
10574899|NCT01681186|11730210|FG003|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
10574900|NCT01681186|11730211|FG004|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
10574901|NCT01681186|11730212|FG005|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
10574902|NCT01681186|11730213|FG006|STARTED|Washout Period From Second Intervention||7
10574903|NCT01681186|11730214|FG007|STARTED|Washout Period From Second Intervention||7
10574904|NCT01681186|11730207|FG000|COMPLETED|Washout Period From Second Intervention||0
10574905|NCT01681186|11730208|FG001|COMPLETED|Washout Period From Second Intervention||0
10574906|NCT01681186|11730209|FG002|COMPLETED|Washout Period From Second Intervention||0
10574907|NCT01681186|11730210|FG003|COMPLETED|Washout Period From Second Intervention||0
10574908|NCT01681186|11730211|FG004|COMPLETED|Washout Period From Second Intervention||0
10574909|NCT01681186|11730212|FG005|COMPLETED|Washout Period From Second Intervention||0
10574910|NCT01681186|11730213|FG006|COMPLETED|Washout Period From Second Intervention||6
10574911|NCT01681186|11730214|FG007|COMPLETED|Washout Period From Second Intervention||6
10574912|NCT01681186|11730207|FG000|NOT COMPLETED|Washout Period From Second Intervention||0
10574913|NCT01681186|11730208|FG001|NOT COMPLETED|Washout Period From Second Intervention||0
10574914|NCT01681186|11730209|FG002|NOT COMPLETED|Washout Period From Second Intervention||0
10574915|NCT01681186|11730210|FG003|NOT COMPLETED|Washout Period From Second Intervention||0
10574916|NCT01681186|11730211|FG004|NOT COMPLETED|Washout Period From Second Intervention||0
10574917|NCT01681186|11730212|FG005|NOT COMPLETED|Washout Period From Second Intervention||0
10574918|NCT01681186|11730213|FG006|NOT COMPLETED|Washout Period From Second Intervention||1
10574919|NCT01681186|11730214|FG007|NOT COMPLETED|Washout Period From Second Intervention||1
10574920|NCT01681186|11730207|FG000|STARTED|Third Intervention||0
10574921|NCT01681186|11730208|FG001|STARTED|Third Intervention||0
10574922|NCT01681186|11730209|FG002|STARTED|Third Intervention||0
10574923|NCT01681186|11730210|FG003|STARTED|Third Intervention||0
10574924|NCT01681186|11730211|FG004|STARTED|Third Intervention||0
10574925|NCT01681186|11730212|FG005|STARTED|Third Intervention||0
10574926|NCT01681186|11730213|FG006|STARTED|Third Intervention||6
10574927|NCT01681186|11730214|FG007|STARTED|Third Intervention||6
10574928|NCT01681186|11730207|FG000|COMPLETED|Third Intervention||0
10574929|NCT01681186|11730208|FG001|COMPLETED|Third Intervention||0
10574930|NCT01681186|11730209|FG002|COMPLETED|Third Intervention||0
10574931|NCT01681186|11730210|FG003|COMPLETED|Third Intervention||0
10574932|NCT01681186|11730211|FG004|COMPLETED|Third Intervention||0
10574933|NCT01681186|11730212|FG005|COMPLETED|Third Intervention||0
10574934|NCT01681186|11730213|FG006|COMPLETED|Third Intervention||6
10574935|NCT01681186|11730214|FG007|COMPLETED|Third Intervention||6
10574936|NCT01681186|11730207|FG000|NOT COMPLETED|Third Intervention||0
10574937|NCT01681186|11730208|FG001|NOT COMPLETED|Third Intervention||0
10574938|NCT01681186|11730209|FG002|NOT COMPLETED|Third Intervention||0
10574939|NCT01681186|11730210|FG003|NOT COMPLETED|Third Intervention||0
10574940|NCT01681186|11730211|FG004|NOT COMPLETED|Third Intervention||0
10574941|NCT01681186|11730212|FG005|NOT COMPLETED|Third Intervention||0
10574942|NCT01681186|11730213|FG006|NOT COMPLETED|Third Intervention||0
10574943|NCT01681186|11730214|FG007|NOT COMPLETED|Third Intervention||0
10574944|NCT01681186|11730207|FG000|STARTED|Washout Period From Third Intervention||0
10574945|NCT01681186|11730208|FG001|STARTED|Washout Period From Third Intervention||0
10574946|NCT01681186|11730209|FG002|STARTED|Washout Period From Third Intervention||0
10574947|NCT01681186|11730210|FG003|STARTED|Washout Period From Third Intervention||0
10574948|NCT01681186|11730211|FG004|STARTED|Washout Period From Third Intervention||0
10574949|NCT01681186|11730212|FG005|STARTED|Washout Period From Third Intervention||0
10574950|NCT01681186|11730213|FG006|STARTED|Washout Period From Third Intervention||6
10574951|NCT01681186|11730214|FG007|STARTED|Washout Period From Third Intervention||6
10574952|NCT01681186|11730207|FG000|COMPLETED|Washout Period From Third Intervention||0
10574953|NCT01681186|11730208|FG001|COMPLETED|Washout Period From Third Intervention||0
10574954|NCT01681186|11730209|FG002|COMPLETED|Washout Period From Third Intervention||0
10574955|NCT01681186|11730210|FG003|COMPLETED|Washout Period From Third Intervention||0
10574956|NCT01681186|11730211|FG004|COMPLETED|Washout Period From Third Intervention||0
10574957|NCT01681186|11730212|FG005|COMPLETED|Washout Period From Third Intervention||0
10574958|NCT01681186|11730213|FG006|COMPLETED|Washout Period From Third Intervention||5
10574959|NCT01681186|11730214|FG007|COMPLETED|Washout Period From Third Intervention||6
10574960|NCT01681186|11730207|FG000|NOT COMPLETED|Washout Period From Third Intervention||0
10574961|NCT01681186|11730208|FG001|NOT COMPLETED|Washout Period From Third Intervention||0
10574962|NCT01681186|11730209|FG002|NOT COMPLETED|Washout Period From Third Intervention||0
10574963|NCT01681186|11730210|FG003|NOT COMPLETED|Washout Period From Third Intervention||0
10574964|NCT01681186|11730211|FG004|NOT COMPLETED|Washout Period From Third Intervention||0
10574965|NCT01681186|11730212|FG005|NOT COMPLETED|Washout Period From Third Intervention||0
10574966|NCT01681186|11730213|FG006|NOT COMPLETED|Washout Period From Third Intervention||1
10574967|NCT01681186|11730214|FG007|NOT COMPLETED|Washout Period From Third Intervention||0
10574968|NCT01681186|11730207|FG000|STARTED|Fourth Intervention||0
10574969|NCT01681186|11730208|FG001|STARTED|Fourth Intervention||0
10574970|NCT01681186|11730209|FG002|STARTED|Fourth Intervention||0
10574971|NCT01681186|11730210|FG003|STARTED|Fourth Intervention||0
10574972|NCT01681186|11730211|FG004|STARTED|Fourth Intervention||0
10574973|NCT01681186|11730212|FG005|STARTED|Fourth Intervention||0
10574974|NCT01681186|11730213|FG006|STARTED|Fourth Intervention||5
10574975|NCT01681186|11730214|FG007|STARTED|Fourth Intervention||6
10574976|NCT01681186|11730207|FG000|COMPLETED|Fourth Intervention||0
10574977|NCT01681186|11730208|FG001|COMPLETED|Fourth Intervention||0
10574978|NCT01681186|11730209|FG002|COMPLETED|Fourth Intervention||0
10574979|NCT01681186|11730210|FG003|COMPLETED|Fourth Intervention||0
10574980|NCT01681186|11730211|FG004|COMPLETED|Fourth Intervention||0
10574981|NCT01681186|11730212|FG005|COMPLETED|Fourth Intervention||0
10574982|NCT01681186|11730213|FG006|COMPLETED|Fourth Intervention||5
10574983|NCT01681186|11730214|FG007|COMPLETED|Fourth Intervention||5
10574984|NCT01681186|11730207|FG000|NOT COMPLETED|Fourth Intervention||0
10574985|NCT01681186|11730208|FG001|NOT COMPLETED|Fourth Intervention||0
10574986|NCT01681186|11730209|FG002|NOT COMPLETED|Fourth Intervention||0
10574987|NCT01681186|11730210|FG003|NOT COMPLETED|Fourth Intervention||0
10574988|NCT01681186|11730211|FG004|NOT COMPLETED|Fourth Intervention||0
10574989|NCT01681186|11730212|FG005|NOT COMPLETED|Fourth Intervention||0
10574990|NCT01681186|11730213|FG006|NOT COMPLETED|Fourth Intervention||0
10574991|NCT01681186|11730214|FG007|NOT COMPLETED|Fourth Intervention||1
10574992|NCT01681212|11730244|FG000|STARTED|Overall Study|Enrolled|21
10574993|NCT01681212|11730244|FG000|Received Treatment|Overall Study||15
10574994|NCT01681212|11730244|FG000|COMPLETED|Overall Study|Completed=patients who received treatment; not completed=patients who did not receive treatment|15
10574995|NCT01681212|11730244|FG000|NOT COMPLETED|Overall Study||6
10574996|NCT01681277|11730253|FG000|STARTED|Overall Study||12
10574997|NCT01681277|11730254|FG001|STARTED|Overall Study||9
10574998|NCT01681277|11730255|FG002|STARTED|Overall Study||9
10574999|NCT01681277|11730256|FG003|STARTED|Overall Study||9
10575000|NCT01681277|11730257|FG004|STARTED|Overall Study||9
10575001|NCT01681277|11730253|FG000|COMPLETED|Overall Study||11
10575002|NCT01681277|11730254|FG001|COMPLETED|Overall Study||9
10575003|NCT01681277|11730255|FG002|COMPLETED|Overall Study||9
10575004|NCT01681277|11730256|FG003|COMPLETED|Overall Study||9
10575005|NCT01681277|11730257|FG004|COMPLETED|Overall Study||9
10575006|NCT01681277|11730253|FG000|NOT COMPLETED|Overall Study||1
10575007|NCT01681277|11730254|FG001|NOT COMPLETED|Overall Study||0
10575008|NCT01681277|11730255|FG002|NOT COMPLETED|Overall Study||0
10575009|NCT01681277|11730256|FG003|NOT COMPLETED|Overall Study||0
10575010|NCT01681277|11730257|FG004|NOT COMPLETED|Overall Study||0
10575011|NCT01681368|11730273|FG000|STARTED|Overall Study||11
10575012|NCT01681368|11730273|FG000|COMPLETED|Overall Study||9
10575013|NCT01681368|11730273|FG000|NOT COMPLETED|Overall Study||2
10805255|NCT04023994|11966817|FG004|COMPLETED|Overall Study||6
10805256|NCT04023994|11966818|FG005|COMPLETED|Overall Study||6
10805257|NCT04023994|11966813|FG000|NOT COMPLETED|Overall Study||0
10805258|NCT04023994|11966814|FG001|NOT COMPLETED|Overall Study||1
10805259|NCT04023994|11966815|FG002|NOT COMPLETED|Overall Study||2
10805260|NCT04023994|11966816|FG003|NOT COMPLETED|Overall Study||1
10575020|NCT01681472|11730290|FG000|STARTED|Overall Study||8
10575021|NCT01681472|11730291|FG001|STARTED|Overall Study||8
10575022|NCT01681472|11730292|FG002|STARTED|Overall Study||8
10575023|NCT01681472|11730293|FG003|STARTED|Overall Study||8
10575024|NCT01681472|11730290|FG000|COMPLETED|Overall Study||8
10575025|NCT01681472|11730291|FG001|COMPLETED|Overall Study||7
10575026|NCT01681472|11730292|FG002|COMPLETED|Overall Study||8
10575027|NCT01681472|11730293|FG003|COMPLETED|Overall Study||8
10575028|NCT01681472|11730290|FG000|NOT COMPLETED|Overall Study||0
10575029|NCT01681472|11730291|FG001|NOT COMPLETED|Overall Study||1
10575030|NCT01681472|11730292|FG002|NOT COMPLETED|Overall Study||0
10575031|NCT01681472|11730293|FG003|NOT COMPLETED|Overall Study||0
10575032|NCT01681511|11730314|FG000|STARTED|Overall Study|All randomized subjects in the Lubri-Sil arm.|46
10575033|NCT01681511|11730315|FG001|STARTED|Overall Study|All randomized subjects in the TIC arm.|49
10575034|NCT01681511|11730314|FG000|Intent to Treat (ITT) Population|Overall Study|Any subject receiving the Lubri-Sil treatment after randomization.|45
10575035|NCT01681511|11730315|FG001|Intent to Treat (ITT) Population|Overall Study|Any subject receiving the TIC treatment after randomization.|46
10575036|NCT01681511|11730314|FG000|Evaluable Population|Overall Study|Subjects w/ positive urine culture results also removed from the Lubri-Sil arm of this population.|16
10575037|NCT01681511|11730315|FG001|Evaluable Population|Overall Study|Subjects w/ positive urine culture results also removed from the TIC arm of this population.|14
10575038|NCT01681511|11730314|FG000|COMPLETED|Overall Study||28
10575039|NCT01681511|11730315|FG001|COMPLETED|Overall Study||35
10575040|NCT01681511|11730314|FG000|NOT COMPLETED|Overall Study||18
10575041|NCT01681511|11730315|FG001|NOT COMPLETED|Overall Study||14
10575042|NCT01681576|11730323|FG000|STARTED|Period 1||36
10575043|NCT01681576|11730324|FG001|STARTED|Period 1||36
10575044|NCT01681576|11730323|FG000|COMPLETED|Period 1||34
10575045|NCT01681576|11730324|FG001|COMPLETED|Period 1||36
10575046|NCT01681576|11730323|FG000|NOT COMPLETED|Period 1||2
10575047|NCT01681576|11730324|FG001|NOT COMPLETED|Period 1||0
10575048|NCT01681576|11730323|FG000|STARTED|Period 2|Period 2: Valsartan 320mg|34
10575049|NCT01681576|11730324|FG001|STARTED|Period 2|Period 2: LCZ696 400mg|36
10575050|NCT01681576|11730323|FG000|COMPLETED|Period 2||30
10575051|NCT01681576|11730324|FG001|COMPLETED|Period 2||35
10575052|NCT01681576|11730323|FG000|NOT COMPLETED|Period 2||4
10575053|NCT01681576|11730324|FG001|NOT COMPLETED|Period 2||1
10575054|NCT01681628|11730334|FG000|STARTED|Time 1 (Entry) to Time 2 One Week Later.||128
10575055|NCT01681628|11730335|FG001|STARTED|Time 1 (Entry) to Time 2 One Week Later.||128
10575056|NCT01681628|11730334|FG000|COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||114
10575057|NCT01681628|11730335|FG001|COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||122
10575058|NCT01681628|11730334|FG000|NOT COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||14
10575059|NCT01681628|11730335|FG001|NOT COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||6
10575060|NCT01681628|11730334|FG000|STARTED|Time 2 to Time 3 (One Week Later).|Only wait list group studied in this period.|0
10575061|NCT01681628|11730335|FG001|STARTED|Time 2 to Time 3 (One Week Later).||122
10575062|NCT01681628|11730334|FG000|COMPLETED|Time 2 to Time 3 (One Week Later).|Only wait list group studied in this period.|0
10575063|NCT01681628|11730335|FG001|COMPLETED|Time 2 to Time 3 (One Week Later).||107
10575064|NCT01681628|11730334|FG000|NOT COMPLETED|Time 2 to Time 3 (One Week Later).||0
10575065|NCT01681628|11730335|FG001|NOT COMPLETED|Time 2 to Time 3 (One Week Later).||15
10575066|NCT01681628|11730334|FG000|STARTED|19 Months Follow-up||114
10575067|NCT01681628|11730335|FG001|STARTED|19 Months Follow-up||107
10575068|NCT01681628|11730334|FG000|COMPLETED|19 Months Follow-up||52
10575069|NCT01681628|11730335|FG001|COMPLETED|19 Months Follow-up||64
10575070|NCT01681628|11730334|FG000|NOT COMPLETED|19 Months Follow-up||62
10575071|NCT01681628|11730335|FG001|NOT COMPLETED|19 Months Follow-up||43
10575072|NCT01681771|11730346|FG000|STARTED|Overall Study||25
10575073|NCT01681771|11730347|FG001|STARTED|Overall Study||25
10575074|NCT01681771|11730346|FG000|COMPLETED|Overall Study||21
10575075|NCT01681771|11730347|FG001|COMPLETED|Overall Study||23
10575076|NCT01681771|11730346|FG000|NOT COMPLETED|Overall Study||4
10575077|NCT01681771|11730347|FG001|NOT COMPLETED|Overall Study||2
10575078|NCT01681810|11730353|FG000|STARTED|Overall Study||20
10575079|NCT01681810|11730353|FG000|COMPLETED|Overall Study||20
10575080|NCT01681810|11730353|FG000|NOT COMPLETED|Overall Study||0
10575081|NCT01681836|11730357|FG000|STARTED|First Intervention||6
10575082|NCT01681836|11730358|FG001|STARTED|First Intervention||5
10575083|NCT01681836|11730357|FG000|COMPLETED|First Intervention||6
10575084|NCT01681836|11730358|FG001|COMPLETED|First Intervention||5
10575085|NCT01681836|11730357|FG000|NOT COMPLETED|First Intervention||0
10575086|NCT01681836|11730358|FG001|NOT COMPLETED|First Intervention||0
10575087|NCT01681836|11730357|FG000|STARTED|Washout Period of 3-7 Days||6
10575088|NCT01681836|11730358|FG001|STARTED|Washout Period of 3-7 Days||5
10575089|NCT01681836|11730357|FG000|COMPLETED|Washout Period of 3-7 Days||6
10575090|NCT01681836|11730358|FG001|COMPLETED|Washout Period of 3-7 Days||5
10575091|NCT01681836|11730357|FG000|NOT COMPLETED|Washout Period of 3-7 Days||0
10575092|NCT01681836|11730358|FG001|NOT COMPLETED|Washout Period of 3-7 Days||0
10575093|NCT01681836|11730357|FG000|STARTED|Second Intervention||6
10575094|NCT01681836|11730358|FG001|STARTED|Second Intervention||5
10575095|NCT01681836|11730357|FG000|COMPLETED|Second Intervention||6
10575096|NCT01681836|11730358|FG001|COMPLETED|Second Intervention||4
10575097|NCT01681836|11730357|FG000|NOT COMPLETED|Second Intervention||0
10575098|NCT01681836|11730358|FG001|NOT COMPLETED|Second Intervention||1
10575099|NCT01681849|11730367|FG000|STARTED|Overall Study||15
10575100|NCT01681849|11730368|FG001|STARTED|Overall Study||13
10575101|NCT01681849|11730369|FG002|STARTED|Overall Study||56
10575102|NCT01681849|11730367|FG000|COMPLETED|Overall Study||7
10575103|NCT01681849|11730368|FG001|COMPLETED|Overall Study||6
10575104|NCT01681849|11730369|FG002|COMPLETED|Overall Study||17
10575105|NCT01681849|11730367|FG000|NOT COMPLETED|Overall Study||8
10575106|NCT01681849|11730368|FG001|NOT COMPLETED|Overall Study||7
10575107|NCT01681849|11730369|FG002|NOT COMPLETED|Overall Study||39
10575108|NCT01681992|11730379|FG000|STARTED|Overall Study||1493
10575109|NCT01681992|11730380|FG001|STARTED|Overall Study||1497
10575110|NCT01681992|11730381|FG002|STARTED|Overall Study||1526
10575111|NCT01681992|11730379|FG000|COMPLETED|Overall Study||1427
10575112|NCT01681992|11730380|FG001|COMPLETED|Overall Study||1427
10575113|NCT01681992|11730381|FG002|COMPLETED|Overall Study||1443
10575114|NCT01681992|11730379|FG000|NOT COMPLETED|Overall Study||66
10575115|NCT01681992|11730380|FG001|NOT COMPLETED|Overall Study||70
10575116|NCT01681992|11730381|FG002|NOT COMPLETED|Overall Study||83
10575117|NCT01682031|11730391|FG000|STARTED|Overall Study||8
10575118|NCT01682031|11730392|FG001|STARTED|Overall Study||10
10575119|NCT01682031|11730391|FG000|COMPLETED|Overall Study||7
10575120|NCT01682031|11730392|FG001|COMPLETED|Overall Study||5
10575121|NCT01682031|11730391|FG000|NOT COMPLETED|Overall Study||1
10575122|NCT01682031|11730392|FG001|NOT COMPLETED|Overall Study||5
10575123|NCT01682044|11730398|FG000|STARTED|Overall Study||20
10575124|NCT01682044|11730398|FG000|COMPLETED|Overall Study||16
10575125|NCT01682044|11730398|FG000|NOT COMPLETED|Overall Study||4
10575132|NCT01682135|11730414|FG000|STARTED|Overall Study||6
10575133|NCT01682135|11730415|FG001|STARTED|Overall Study||10
10575134|NCT01682135|11730416|FG002|STARTED|Overall Study||12
10575135|NCT01682135|11730414|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
10575136|NCT01682135|11730415|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
10575137|NCT01682135|11730416|FG002|Received at Least 1 Dose of Study Drug|Overall Study||12
10575138|NCT01682135|11730414|FG000|COMPLETED|Overall Study||6
10575139|NCT01682135|11730415|FG001|COMPLETED|Overall Study||10
10575140|NCT01682135|11730416|FG002|COMPLETED|Overall Study||12
10575141|NCT01682135|11730414|FG000|NOT COMPLETED|Overall Study||0
10575142|NCT01682135|11730415|FG001|NOT COMPLETED|Overall Study||0
10575143|NCT01682135|11730416|FG002|NOT COMPLETED|Overall Study||0
10702137|NCT02573467|11866645|FG002|Full Analysis Set|Double-blind Treatment Epoch||51
10702138|NCT02573467|11866646|FG003|Full Analysis Set|Double-blind Treatment Epoch||55
10702139|NCT02573467|11866643|FG000|COMPLETED|Double-blind Treatment Epoch||0
10702140|NCT02573467|11866644|FG001|COMPLETED|Double-blind Treatment Epoch||0
10702141|NCT02573467|11866645|FG002|COMPLETED|Double-blind Treatment Epoch||0
10702142|NCT02573467|11866646|FG003|COMPLETED|Double-blind Treatment Epoch||0
10456918|NCT01008150|11604638|FG003|STARTED|Overall Study||12
10456919|NCT01008150|11604635|FG000|COMPLETED|Overall Study||42
10456920|NCT01008150|11604636|FG001|COMPLETED|Overall Study||42
10456921|NCT01008150|11604637|FG002|COMPLETED|Overall Study||42
10456922|NCT01008150|11604638|FG003|COMPLETED|Overall Study||12
10456923|NCT01008150|11604635|FG000|NOT COMPLETED|Overall Study||1
10456924|NCT01008150|11604636|FG001|NOT COMPLETED|Overall Study||1
10456925|NCT01008150|11604637|FG002|NOT COMPLETED|Overall Study||1
10456926|NCT01008150|11604638|FG003|NOT COMPLETED|Overall Study||0
10456927|NCT01008280|11604651|FG000|STARTED|Overall Study||88
10702143|NCT02573467|11866643|FG000|NOT COMPLETED|Double-blind Treatment Epoch||53
10575150|NCT01682213|11730440|FG000|STARTED|Overall Study||23
10575151|NCT01682213|11730440|FG000|COMPLETED|Overall Study||21
10575152|NCT01682213|11730440|FG000|NOT COMPLETED|Overall Study||2
10575153|NCT01682460|11730445|FG000|STARTED|Overall Study||15
10575154|NCT01682460|11730445|FG000|COMPLETED|Overall Study||11
10575155|NCT01682460|11730445|FG000|NOT COMPLETED|Overall Study||4
10575156|NCT01682512|11730452|FG000|STARTED|Overall Study||116
10575157|NCT01682512|11730453|FG001|STARTED|Overall Study||111
10575158|NCT01682512|11730454|FG002|STARTED|Overall Study||66
10575159|NCT01682512|11730452|FG000|Randomized in Part-I|Overall Study||66
10575160|NCT01682512|11730453|FG001|Randomized in Part-I|Overall Study||65
10575161|NCT01682512|11730454|FG002|Randomized in Part-I|Overall Study||66
10575162|NCT01682512|11730452|FG000|Randomized in Part-II|Overall Study||50
10575163|NCT01682512|11730453|FG001|Randomized in Part-II|Overall Study||46
10575164|NCT01682512|11730454|FG002|Randomized in Part-II|Overall Study||0
10575165|NCT01682512|11730452|FG000|COMPLETED|Overall Study||44
10575166|NCT01682512|11730453|FG001|COMPLETED|Overall Study||40
10456928|NCT01008280|11604652|FG001|STARTED|Overall Study||92
10456929|NCT01008280|11604651|FG000|COMPLETED|Overall Study||67
10456930|NCT01008280|11604652|FG001|COMPLETED|Overall Study||73
10575167|NCT01682512|11730454|FG002|COMPLETED|Overall Study||48
10575168|NCT01682512|11730452|FG000|NOT COMPLETED|Overall Study||72
10575169|NCT01682512|11730453|FG001|NOT COMPLETED|Overall Study||71
10575170|NCT01682512|11730454|FG002|NOT COMPLETED|Overall Study||18
10575171|NCT01682538|11730462|FG000|STARTED|Overall Study||12
10575172|NCT01682538|11730462|FG000|COMPLETED|Overall Study||12
10575173|NCT01682538|11730462|FG000|NOT COMPLETED|Overall Study||0
10575174|NCT01682603|11730477|FG000|STARTED|Overall Study||37
10575175|NCT01682603|11730477|FG000|COMPLETED|Overall Study||34
10575176|NCT01682603|11730477|FG000|NOT COMPLETED|Overall Study||3
10575177|NCT01682642|11730485|FG000|STARTED|Overall Study||61
10575178|NCT01682642|11730486|FG001|STARTED|Overall Study||59
10575179|NCT01682642|11730485|FG000|COMPLETED|Overall Study||61
10575180|NCT01682642|11730486|FG001|COMPLETED|Overall Study||58
10575181|NCT01682642|11730485|FG000|NOT COMPLETED|Overall Study||0
10575182|NCT01682642|11730486|FG001|NOT COMPLETED|Overall Study||1
10575183|NCT01682681|11730498|FG000|STARTED|Overall Study||1234
10575184|NCT01682681|11730498|FG000|Treated|Overall Study|2 Participants were not compliant with eligibility criteria|1232
10575185|NCT01682681|11730498|FG000|COMPLETED|Overall Study||902
10575186|NCT01682681|11730498|FG000|NOT COMPLETED|Overall Study||332
10575187|NCT01682720|11730506|FG000|STARTED|Overall Study||85
10575188|NCT01682720|11730507|FG001|STARTED|Overall Study||74
10575189|NCT01682720|11730508|FG002|STARTED|Overall Study||12
10575190|NCT01682720|11730509|FG003|STARTED|Overall Study||250
10575191|NCT01682720|11730506|FG000|Included in Full Analysis Set|Overall Study||0
10575192|NCT01682720|11730507|FG001|Included in Full Analysis Set|Overall Study||73
10575193|NCT01682720|11730508|FG002|Included in Full Analysis Set|Overall Study||11
10575194|NCT01682720|11730509|FG003|Included in Full Analysis Set|Overall Study||250
10575195|NCT01682720|11730506|FG000|COMPLETED|Overall Study||0
10575196|NCT01682720|11730507|FG001|COMPLETED|Overall Study||69
10575197|NCT01682720|11730508|FG002|COMPLETED|Overall Study||5
10575198|NCT01682720|11730509|FG003|COMPLETED|Overall Study||211
10575199|NCT01682720|11730506|FG000|NOT COMPLETED|Overall Study||85
10575200|NCT01682720|11730507|FG001|NOT COMPLETED|Overall Study||5
10575201|NCT01682720|11730508|FG002|NOT COMPLETED|Overall Study||7
10575202|NCT01682720|11730509|FG003|NOT COMPLETED|Overall Study||39
10575203|NCT01682759|11730521|FG000|STARTED|Overall Study||376
10575204|NCT01682759|11730522|FG001|STARTED|Overall Study||375
10575205|NCT01682759|11730521|FG000|Treated|Overall Study||375
10575206|NCT01682759|11730522|FG001|Treated|Overall Study||375
10575207|NCT01682759|11730521|FG000|COMPLETED|Overall Study||307
10575208|NCT01682759|11730522|FG001|COMPLETED|Overall Study||305
10575209|NCT01682759|11730521|FG000|NOT COMPLETED|Overall Study||69
10575210|NCT01682759|11730522|FG001|NOT COMPLETED|Overall Study||70
10575211|NCT01682811|11730535|FG000|STARTED|Part 1 Levulan Injection||1
10575212|NCT01682811|11730536|FG001|STARTED|Part 1 Levulan Injection||0
10575213|NCT01682811|11730537|FG002|STARTED|Part 1 Levulan Injection||0
10575214|NCT01682811|11730538|FG003|STARTED|Part 1 Levulan Injection||0
10575215|NCT01682811|11730539|FG004|STARTED|Part 1 Levulan Injection||0
10575216|NCT01682811|11730540|FG005|STARTED|Part 1 Levulan Injection||0
10575217|NCT01682811|11730541|FG006|STARTED|Part 1 Levulan Injection||0
10575218|NCT01682811|11730535|FG000|Control|Part 1 Levulan Injection||1
10575219|NCT01682811|11730536|FG001|Control|Part 1 Levulan Injection||0
10575220|NCT01682811|11730537|FG002|Control|Part 1 Levulan Injection||0
10575221|NCT01682811|11730538|FG003|Control|Part 1 Levulan Injection||0
10575222|NCT01682811|11730539|FG004|Control|Part 1 Levulan Injection||0
10575223|NCT01682811|11730540|FG005|Control|Part 1 Levulan Injection||0
10575224|NCT01682811|11730541|FG006|Control|Part 1 Levulan Injection||0
10575225|NCT01682811|11730535|FG000|Treated 3 Hours|Part 1 Levulan Injection||1
10575226|NCT01682811|11730536|FG001|Treated 3 Hours|Part 1 Levulan Injection||0
10575227|NCT01682811|11730537|FG002|Treated 3 Hours|Part 1 Levulan Injection||0
10575228|NCT01682811|11730538|FG003|Treated 3 Hours|Part 1 Levulan Injection||0
10575229|NCT01682811|11730539|FG004|Treated 3 Hours|Part 1 Levulan Injection||0
10575230|NCT01682811|11730540|FG005|Treated 3 Hours|Part 1 Levulan Injection||0
10575231|NCT01682811|11730541|FG006|Treated 3 Hours|Part 1 Levulan Injection||0
10575232|NCT01682811|11730535|FG000|Treated 24 Hours|Part 1 Levulan Injection||1
10575233|NCT01682811|11730536|FG001|Treated 24 Hours|Part 1 Levulan Injection||0
10575234|NCT01682811|11730537|FG002|Treated 24 Hours|Part 1 Levulan Injection||0
10575235|NCT01682811|11730538|FG003|Treated 24 Hours|Part 1 Levulan Injection||0
10575236|NCT01682811|11730539|FG004|Treated 24 Hours|Part 1 Levulan Injection||0
10575237|NCT01682811|11730540|FG005|Treated 24 Hours|Part 1 Levulan Injection||0
10575238|NCT01682811|11730541|FG006|Treated 24 Hours|Part 1 Levulan Injection||0
10575239|NCT01682811|11730535|FG000|COMPLETED|Part 1 Levulan Injection||1
10575240|NCT01682811|11730536|FG001|COMPLETED|Part 1 Levulan Injection||0
10575241|NCT01682811|11730537|FG002|COMPLETED|Part 1 Levulan Injection||0
10575242|NCT01682811|11730538|FG003|COMPLETED|Part 1 Levulan Injection||0
10575243|NCT01682811|11730539|FG004|COMPLETED|Part 1 Levulan Injection||0
10575244|NCT01682811|11730540|FG005|COMPLETED|Part 1 Levulan Injection||0
10575245|NCT01682811|11730541|FG006|COMPLETED|Part 1 Levulan Injection||0
10575246|NCT01682811|11730535|FG000|NOT COMPLETED|Part 1 Levulan Injection||0
10575247|NCT01682811|11730536|FG001|NOT COMPLETED|Part 1 Levulan Injection||0
10575248|NCT01682811|11730537|FG002|NOT COMPLETED|Part 1 Levulan Injection||0
10575249|NCT01682811|11730538|FG003|NOT COMPLETED|Part 1 Levulan Injection||0
10575250|NCT01682811|11730539|FG004|NOT COMPLETED|Part 1 Levulan Injection||0
10575251|NCT01682811|11730540|FG005|NOT COMPLETED|Part 1 Levulan Injection||0
10575252|NCT01682811|11730541|FG006|NOT COMPLETED|Part 1 Levulan Injection||0
10575253|NCT01682811|11730535|FG000|STARTED|Part 1 Levulan Painting||0
10575254|NCT01682811|11730536|FG001|STARTED|Part 1 Levulan Painting||1
10575255|NCT01682811|11730537|FG002|STARTED|Part 1 Levulan Painting||0
10575256|NCT01682811|11730538|FG003|STARTED|Part 1 Levulan Painting||0
10575257|NCT01682811|11730539|FG004|STARTED|Part 1 Levulan Painting||0
10575258|NCT01682811|11730540|FG005|STARTED|Part 1 Levulan Painting||0
10575259|NCT01682811|11730541|FG006|STARTED|Part 1 Levulan Painting||0
10575260|NCT01682811|11730535|FG000|Control|Part 1 Levulan Painting||0
10575261|NCT01682811|11730536|FG001|Control|Part 1 Levulan Painting||1
10575262|NCT01682811|11730537|FG002|Control|Part 1 Levulan Painting||0
10575263|NCT01682811|11730538|FG003|Control|Part 1 Levulan Painting||0
10575264|NCT01682811|11730539|FG004|Control|Part 1 Levulan Painting||0
10575265|NCT01682811|11730540|FG005|Control|Part 1 Levulan Painting||0
10575266|NCT01682811|11730541|FG006|Control|Part 1 Levulan Painting||0
10575267|NCT01682811|11730535|FG000|Treated 3 Hours|Part 1 Levulan Painting||0
10575268|NCT01682811|11730536|FG001|Treated 3 Hours|Part 1 Levulan Painting||1
10575269|NCT01682811|11730537|FG002|Treated 3 Hours|Part 1 Levulan Painting||0
10575270|NCT01682811|11730538|FG003|Treated 3 Hours|Part 1 Levulan Painting||0
10575271|NCT01682811|11730539|FG004|Treated 3 Hours|Part 1 Levulan Painting||0
10575272|NCT01682811|11730540|FG005|Treated 3 Hours|Part 1 Levulan Painting||0
10575273|NCT01682811|11730541|FG006|Treated 3 Hours|Part 1 Levulan Painting||0
10575274|NCT01682811|11730535|FG000|Treated 24 Hours|Part 1 Levulan Painting||0
10575275|NCT01682811|11730536|FG001|Treated 24 Hours|Part 1 Levulan Painting||1
10575276|NCT01682811|11730537|FG002|Treated 24 Hours|Part 1 Levulan Painting||0
10575277|NCT01682811|11730538|FG003|Treated 24 Hours|Part 1 Levulan Painting||0
10575278|NCT01682811|11730539|FG004|Treated 24 Hours|Part 1 Levulan Painting||0
10575279|NCT01682811|11730540|FG005|Treated 24 Hours|Part 1 Levulan Painting||0
10575280|NCT01682811|11730541|FG006|Treated 24 Hours|Part 1 Levulan Painting||0
10575281|NCT01682811|11730535|FG000|COMPLETED|Part 1 Levulan Painting||0
10575282|NCT01682811|11730536|FG001|COMPLETED|Part 1 Levulan Painting||1
10575283|NCT01682811|11730537|FG002|COMPLETED|Part 1 Levulan Painting||0
10575284|NCT01682811|11730538|FG003|COMPLETED|Part 1 Levulan Painting||0
10575285|NCT01682811|11730539|FG004|COMPLETED|Part 1 Levulan Painting||0
10575286|NCT01682811|11730540|FG005|COMPLETED|Part 1 Levulan Painting||0
10575287|NCT01682811|11730541|FG006|COMPLETED|Part 1 Levulan Painting||0
10575288|NCT01682811|11730535|FG000|NOT COMPLETED|Part 1 Levulan Painting||0
10575289|NCT01682811|11730536|FG001|NOT COMPLETED|Part 1 Levulan Painting||0
10575290|NCT01682811|11730537|FG002|NOT COMPLETED|Part 1 Levulan Painting||0
10575291|NCT01682811|11730538|FG003|NOT COMPLETED|Part 1 Levulan Painting||0
10575292|NCT01682811|11730539|FG004|NOT COMPLETED|Part 1 Levulan Painting||0
10575293|NCT01682811|11730540|FG005|NOT COMPLETED|Part 1 Levulan Painting||0
10575294|NCT01682811|11730541|FG006|NOT COMPLETED|Part 1 Levulan Painting||0
10575295|NCT01682811|11730535|FG000|STARTED|Part 1 Levulan Painted Twice||0
10575296|NCT01682811|11730536|FG001|STARTED|Part 1 Levulan Painted Twice||0
10575297|NCT01682811|11730537|FG002|STARTED|Part 1 Levulan Painted Twice||2
10575298|NCT01682811|11730538|FG003|STARTED|Part 1 Levulan Painted Twice||0
10575299|NCT01682811|11730539|FG004|STARTED|Part 1 Levulan Painted Twice||0
10575300|NCT01682811|11730540|FG005|STARTED|Part 1 Levulan Painted Twice||0
10575301|NCT01682811|11730541|FG006|STARTED|Part 1 Levulan Painted Twice||0
10575302|NCT01682811|11730535|FG000|Control|Part 1 Levulan Painted Twice||0
10575303|NCT01682811|11730536|FG001|Control|Part 1 Levulan Painted Twice||0
10575304|NCT01682811|11730537|FG002|Control|Part 1 Levulan Painted Twice||2
10575305|NCT01682811|11730538|FG003|Control|Part 1 Levulan Painted Twice||0
10575306|NCT01682811|11730539|FG004|Control|Part 1 Levulan Painted Twice||0
10575307|NCT01682811|11730540|FG005|Control|Part 1 Levulan Painted Twice||0
10575308|NCT01682811|11730541|FG006|Control|Part 1 Levulan Painted Twice||0
10575309|NCT01682811|11730535|FG000|Treated 24 Hours|Part 1 Levulan Painted Twice||0
10575310|NCT01682811|11730536|FG001|Treated 24 Hours|Part 1 Levulan Painted Twice||0
10575311|NCT01682811|11730537|FG002|Treated 24 Hours|Part 1 Levulan Painted Twice||2
10575312|NCT01682811|11730538|FG003|Treated 24 Hours|Part 1 Levulan Painted Twice||0
10702147|NCT02573467|11866643|FG000|STARTED|Post-treatment Follow up Epoch||41
10575313|NCT01682811|11730539|FG004|Treated 24 Hours|Part 1 Levulan Painted Twice||0
10575314|NCT01682811|11730540|FG005|Treated 24 Hours|Part 1 Levulan Painted Twice||0
10575315|NCT01682811|11730541|FG006|Treated 24 Hours|Part 1 Levulan Painted Twice||0
10575316|NCT01682811|11730535|FG000|COMPLETED|Part 1 Levulan Painted Twice||0
10575317|NCT01682811|11730536|FG001|COMPLETED|Part 1 Levulan Painted Twice||0
10575318|NCT01682811|11730537|FG002|COMPLETED|Part 1 Levulan Painted Twice||2
10575319|NCT01682811|11730538|FG003|COMPLETED|Part 1 Levulan Painted Twice||0
10575320|NCT01682811|11730539|FG004|COMPLETED|Part 1 Levulan Painted Twice||0
10575321|NCT01682811|11730540|FG005|COMPLETED|Part 1 Levulan Painted Twice||0
10575322|NCT01682811|11730541|FG006|COMPLETED|Part 1 Levulan Painted Twice||0
10575323|NCT01682811|11730535|FG000|NOT COMPLETED|Part 1 Levulan Painted Twice||0
10575324|NCT01682811|11730536|FG001|NOT COMPLETED|Part 1 Levulan Painted Twice||0
10575325|NCT01682811|11730537|FG002|NOT COMPLETED|Part 1 Levulan Painted Twice||0
10575326|NCT01682811|11730538|FG003|NOT COMPLETED|Part 1 Levulan Painted Twice||0
10575327|NCT01682811|11730539|FG004|NOT COMPLETED|Part 1 Levulan Painted Twice||0
10575328|NCT01682811|11730540|FG005|NOT COMPLETED|Part 1 Levulan Painted Twice||0
10575329|NCT01682811|11730541|FG006|NOT COMPLETED|Part 1 Levulan Painted Twice||0
10575330|NCT01682811|11730535|FG000|STARTED|Part 1 Levulan Paint Twice Microneedling||0
10575331|NCT01682811|11730536|FG001|STARTED|Part 1 Levulan Paint Twice Microneedling||0
10575332|NCT01682811|11730537|FG002|STARTED|Part 1 Levulan Paint Twice Microneedling||0
10575333|NCT01682811|11730538|FG003|STARTED|Part 1 Levulan Paint Twice Microneedling||2
10575334|NCT01682811|11730539|FG004|STARTED|Part 1 Levulan Paint Twice Microneedling||0
10575335|NCT01682811|11730540|FG005|STARTED|Part 1 Levulan Paint Twice Microneedling||0
10575336|NCT01682811|11730541|FG006|STARTED|Part 1 Levulan Paint Twice Microneedling||0
10575337|NCT01682811|11730535|FG000|Control|Part 1 Levulan Paint Twice Microneedling||0
10575338|NCT01682811|11730536|FG001|Control|Part 1 Levulan Paint Twice Microneedling||0
10575339|NCT01682811|11730537|FG002|Control|Part 1 Levulan Paint Twice Microneedling||0
10575340|NCT01682811|11730538|FG003|Control|Part 1 Levulan Paint Twice Microneedling||2
10575341|NCT01682811|11730539|FG004|Control|Part 1 Levulan Paint Twice Microneedling||0
10575342|NCT01682811|11730540|FG005|Control|Part 1 Levulan Paint Twice Microneedling||0
10575343|NCT01682811|11730541|FG006|Control|Part 1 Levulan Paint Twice Microneedling||0
10575344|NCT01682811|11730535|FG000|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0
10575345|NCT01682811|11730536|FG001|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0
10575346|NCT01682811|11730537|FG002|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0
10575347|NCT01682811|11730538|FG003|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||2
10575348|NCT01682811|11730539|FG004|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0
10575349|NCT01682811|11730540|FG005|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0
10575350|NCT01682811|11730541|FG006|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0
10575351|NCT01682811|11730535|FG000|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
10575352|NCT01682811|11730536|FG001|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
10805261|NCT04023994|11966817|FG004|NOT COMPLETED|Overall Study||0
10575353|NCT01682811|11730537|FG002|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
10575354|NCT01682811|11730538|FG003|COMPLETED|Part 1 Levulan Paint Twice Microneedling||2
10575355|NCT01682811|11730539|FG004|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
10575356|NCT01682811|11730540|FG005|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
10575357|NCT01682811|11730541|FG006|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
10575358|NCT01682811|11730535|FG000|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
10575359|NCT01682811|11730536|FG001|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
10575360|NCT01682811|11730537|FG002|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
10575361|NCT01682811|11730538|FG003|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
10575362|NCT01682811|11730539|FG004|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
10575363|NCT01682811|11730540|FG005|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
10575364|NCT01682811|11730541|FG006|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
10575365|NCT01682811|11730535|FG000|STARTED|Part 2 Dose Level 1||0
10575366|NCT01682811|11730536|FG001|STARTED|Part 2 Dose Level 1||0
10575367|NCT01682811|11730537|FG002|STARTED|Part 2 Dose Level 1||0
10575368|NCT01682811|11730538|FG003|STARTED|Part 2 Dose Level 1||0
10575369|NCT01682811|11730539|FG004|STARTED|Part 2 Dose Level 1||11
10575370|NCT01682811|11730540|FG005|STARTED|Part 2 Dose Level 1||0
10575371|NCT01682811|11730541|FG006|STARTED|Part 2 Dose Level 1||0
10575372|NCT01682811|11730535|FG000|Control|Part 2 Dose Level 1||0
10575373|NCT01682811|11730536|FG001|Control|Part 2 Dose Level 1||0
10575374|NCT01682811|11730537|FG002|Control|Part 2 Dose Level 1||0
10575375|NCT01682811|11730538|FG003|Control|Part 2 Dose Level 1||0
10575376|NCT01682811|11730539|FG004|Control|Part 2 Dose Level 1||10
10575377|NCT01682811|11730540|FG005|Control|Part 2 Dose Level 1||0
10575378|NCT01682811|11730541|FG006|Control|Part 2 Dose Level 1||0
10575379|NCT01682811|11730535|FG000|Treated|Part 2 Dose Level 1||0
10575380|NCT01682811|11730536|FG001|Treated|Part 2 Dose Level 1||0
10575381|NCT01682811|11730537|FG002|Treated|Part 2 Dose Level 1||0
10575382|NCT01682811|11730538|FG003|Treated|Part 2 Dose Level 1||0
10575383|NCT01682811|11730539|FG004|Treated|Part 2 Dose Level 1||10
10575384|NCT01682811|11730540|FG005|Treated|Part 2 Dose Level 1||0
10575385|NCT01682811|11730541|FG006|Treated|Part 2 Dose Level 1||0
10702144|NCT02573467|11866644|FG001|NOT COMPLETED|Double-blind Treatment Epoch||52
10702145|NCT02573467|11866645|FG002|NOT COMPLETED|Double-blind Treatment Epoch||51
10702146|NCT02573467|11866646|FG003|NOT COMPLETED|Double-blind Treatment Epoch||55
10702148|NCT02573467|11866644|FG001|STARTED|Post-treatment Follow up Epoch||46
10575386|NCT01682811|11730535|FG000|COMPLETED|Part 2 Dose Level 1||0
10575387|NCT01682811|11730536|FG001|COMPLETED|Part 2 Dose Level 1||0
10702149|NCT02573467|11866645|FG002|STARTED|Post-treatment Follow up Epoch||44
10702150|NCT02573467|11866646|FG003|STARTED|Post-treatment Follow up Epoch||47
10702151|NCT02573467|11866643|FG000|COMPLETED|Post-treatment Follow up Epoch||35
10702152|NCT02573467|11866644|FG001|COMPLETED|Post-treatment Follow up Epoch||41
10702153|NCT02573467|11866645|FG002|COMPLETED|Post-treatment Follow up Epoch||34
10575388|NCT01682811|11730537|FG002|COMPLETED|Part 2 Dose Level 1||0
10575389|NCT01682811|11730538|FG003|COMPLETED|Part 2 Dose Level 1||0
10575390|NCT01682811|11730539|FG004|COMPLETED|Part 2 Dose Level 1||0
10575391|NCT01682811|11730540|FG005|COMPLETED|Part 2 Dose Level 1||0
10575392|NCT01682811|11730541|FG006|COMPLETED|Part 2 Dose Level 1||0
10575393|NCT01682811|11730535|FG000|NOT COMPLETED|Part 2 Dose Level 1||0
10575394|NCT01682811|11730536|FG001|NOT COMPLETED|Part 2 Dose Level 1||0
10575395|NCT01682811|11730537|FG002|NOT COMPLETED|Part 2 Dose Level 1||0
10575396|NCT01682811|11730538|FG003|NOT COMPLETED|Part 2 Dose Level 1||0
10575397|NCT01682811|11730539|FG004|NOT COMPLETED|Part 2 Dose Level 1||11
10575398|NCT01682811|11730540|FG005|NOT COMPLETED|Part 2 Dose Level 1||0
10575399|NCT01682811|11730541|FG006|NOT COMPLETED|Part 2 Dose Level 1||0
10575400|NCT01682811|11730535|FG000|STARTED|Part 2 Dose Level 2||0
10575401|NCT01682811|11730536|FG001|STARTED|Part 2 Dose Level 2||0
10575402|NCT01682811|11730537|FG002|STARTED|Part 2 Dose Level 2||0
10575403|NCT01682811|11730538|FG003|STARTED|Part 2 Dose Level 2||0
10575404|NCT01682811|11730539|FG004|STARTED|Part 2 Dose Level 2||0
10575405|NCT01682811|11730540|FG005|STARTED|Part 2 Dose Level 2||3
10575406|NCT01682811|11730541|FG006|STARTED|Part 2 Dose Level 2||0
10575407|NCT01682811|11730535|FG000|Control|Part 2 Dose Level 2||0
10575408|NCT01682811|11730536|FG001|Control|Part 2 Dose Level 2||0
10575409|NCT01682811|11730537|FG002|Control|Part 2 Dose Level 2||0
10575410|NCT01682811|11730538|FG003|Control|Part 2 Dose Level 2||0
10575411|NCT01682811|11730539|FG004|Control|Part 2 Dose Level 2||0
10575412|NCT01682811|11730540|FG005|Control|Part 2 Dose Level 2||3
10575413|NCT01682811|11730541|FG006|Control|Part 2 Dose Level 2||0
10575414|NCT01682811|11730535|FG000|Treated|Part 2 Dose Level 2||0
10575415|NCT01682811|11730536|FG001|Treated|Part 2 Dose Level 2||0
10575416|NCT01682811|11730537|FG002|Treated|Part 2 Dose Level 2||0
10575417|NCT01682811|11730538|FG003|Treated|Part 2 Dose Level 2||0
10575418|NCT01682811|11730539|FG004|Treated|Part 2 Dose Level 2||0
10575419|NCT01682811|11730540|FG005|Treated|Part 2 Dose Level 2||3
10575420|NCT01682811|11730541|FG006|Treated|Part 2 Dose Level 2||0
10575421|NCT01682811|11730535|FG000|COMPLETED|Part 2 Dose Level 2||0
10575422|NCT01682811|11730536|FG001|COMPLETED|Part 2 Dose Level 2||0
10575423|NCT01682811|11730537|FG002|COMPLETED|Part 2 Dose Level 2||0
10575424|NCT01682811|11730538|FG003|COMPLETED|Part 2 Dose Level 2||0
10575425|NCT01682811|11730539|FG004|COMPLETED|Part 2 Dose Level 2||0
10575426|NCT01682811|11730540|FG005|COMPLETED|Part 2 Dose Level 2||0
10575427|NCT01682811|11730541|FG006|COMPLETED|Part 2 Dose Level 2||0
10575428|NCT01682811|11730535|FG000|NOT COMPLETED|Part 2 Dose Level 2||0
10575429|NCT01682811|11730536|FG001|NOT COMPLETED|Part 2 Dose Level 2||0
10575430|NCT01682811|11730537|FG002|NOT COMPLETED|Part 2 Dose Level 2||0
10575431|NCT01682811|11730538|FG003|NOT COMPLETED|Part 2 Dose Level 2||0
10575432|NCT01682811|11730539|FG004|NOT COMPLETED|Part 2 Dose Level 2||0
10575433|NCT01682811|11730540|FG005|NOT COMPLETED|Part 2 Dose Level 2||3
10575434|NCT01682811|11730541|FG006|NOT COMPLETED|Part 2 Dose Level 2||0
10702154|NCT02573467|11866646|FG003|COMPLETED|Post-treatment Follow up Epoch||44
10702155|NCT02573467|11866643|FG000|NOT COMPLETED|Post-treatment Follow up Epoch||6
10575435|NCT01682811|11730535|FG000|STARTED|Part 2 Dose Level 3||0
10575436|NCT01682811|11730536|FG001|STARTED|Part 2 Dose Level 3||0
10575437|NCT01682811|11730537|FG002|STARTED|Part 2 Dose Level 3||0
10575438|NCT01682811|11730538|FG003|STARTED|Part 2 Dose Level 3||0
10575439|NCT01682811|11730539|FG004|STARTED|Part 2 Dose Level 3||0
10575440|NCT01682811|11730540|FG005|STARTED|Part 2 Dose Level 3||0
10575441|NCT01682811|11730541|FG006|STARTED|Part 2 Dose Level 3||0
10575442|NCT01682811|11730535|FG000|Control|Part 2 Dose Level 3||0
10575443|NCT01682811|11730536|FG001|Control|Part 2 Dose Level 3||0
10575444|NCT01682811|11730537|FG002|Control|Part 2 Dose Level 3||0
10575445|NCT01682811|11730538|FG003|Control|Part 2 Dose Level 3||0
10575446|NCT01682811|11730539|FG004|Control|Part 2 Dose Level 3||0
10575447|NCT01682811|11730540|FG005|Control|Part 2 Dose Level 3||0
10575448|NCT01682811|11730541|FG006|Control|Part 2 Dose Level 3||0
10575449|NCT01682811|11730535|FG000|Treated|Part 2 Dose Level 3||0
10575450|NCT01682811|11730536|FG001|Treated|Part 2 Dose Level 3||0
10575451|NCT01682811|11730537|FG002|Treated|Part 2 Dose Level 3||0
10575452|NCT01682811|11730538|FG003|Treated|Part 2 Dose Level 3||0
10575453|NCT01682811|11730539|FG004|Treated|Part 2 Dose Level 3||0
10575454|NCT01682811|11730540|FG005|Treated|Part 2 Dose Level 3||0
10575455|NCT01682811|11730541|FG006|Treated|Part 2 Dose Level 3||0
10575456|NCT01682811|11730535|FG000|COMPLETED|Part 2 Dose Level 3||0
10575457|NCT01682811|11730536|FG001|COMPLETED|Part 2 Dose Level 3||0
10575458|NCT01682811|11730537|FG002|COMPLETED|Part 2 Dose Level 3||0
10575459|NCT01682811|11730538|FG003|COMPLETED|Part 2 Dose Level 3||0
10575460|NCT01682811|11730539|FG004|COMPLETED|Part 2 Dose Level 3||0
10575461|NCT01682811|11730540|FG005|COMPLETED|Part 2 Dose Level 3||0
10575462|NCT01682811|11730541|FG006|COMPLETED|Part 2 Dose Level 3||0
10575463|NCT01682811|11730535|FG000|NOT COMPLETED|Part 2 Dose Level 3||0
10575464|NCT01682811|11730536|FG001|NOT COMPLETED|Part 2 Dose Level 3||0
10575465|NCT01682811|11730537|FG002|NOT COMPLETED|Part 2 Dose Level 3||0
10575466|NCT01682811|11730538|FG003|NOT COMPLETED|Part 2 Dose Level 3||0
10575467|NCT01682811|11730539|FG004|NOT COMPLETED|Part 2 Dose Level 3||0
10575468|NCT01682811|11730540|FG005|NOT COMPLETED|Part 2 Dose Level 3||0
10575469|NCT01682811|11730541|FG006|NOT COMPLETED|Part 2 Dose Level 3||0
10575470|NCT01682837|11730560|FG000|STARTED|Baseline||35
10575471|NCT01682837|11730560|FG000|COMPLETED|Baseline||30
10575472|NCT01682837|11730560|FG000|NOT COMPLETED|Baseline||5
10702156|NCT02573467|11866644|FG001|NOT COMPLETED|Post-treatment Follow up Epoch||5
10575473|NCT01682837|11730560|FG000|STARTED|First Intervention (4 Weeks)||30
10575474|NCT01682837|11730560|FG000|Received KMgCit|First Intervention (4 Weeks)||8
10575475|NCT01682837|11730560|FG000|Received KCit|First Intervention (4 Weeks)||8
10575476|NCT01682837|11730560|FG000|Received KCl|First Intervention (4 Weeks)||7
10575477|NCT01682837|11730560|FG000|Received Placebo|First Intervention (4 Weeks)||7
10575478|NCT01682837|11730560|FG000|COMPLETED|First Intervention (4 Weeks)||30
10575479|NCT01682837|11730560|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
10575480|NCT01682837|11730560|FG000|STARTED|Second Intervention (4 Weeks)||30
10575481|NCT01682837|11730560|FG000|Received KMgCit|Second Intervention (4 Weeks)||7
10575482|NCT01682837|11730560|FG000|Received KCit|Second Intervention (4 Weeks)||6
10575483|NCT01682837|11730560|FG000|Received KCl|Second Intervention (4 Weeks)||8
10575484|NCT01682837|11730560|FG000|Received Placebo|Second Intervention (4 Weeks)||9
10575485|NCT01682837|11730560|FG000|COMPLETED|Second Intervention (4 Weeks)||30
10575486|NCT01682837|11730560|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
10575487|NCT01682837|11730560|FG000|STARTED|Third Intervention (4 Weeks)||30
10575488|NCT01682837|11730560|FG000|Received KMgCit|Third Intervention (4 Weeks)||9
10575489|NCT01682837|11730560|FG000|Received KCit|Third Intervention (4 Weeks)||7
10575490|NCT01682837|11730560|FG000|Received KCl|Third Intervention (4 Weeks)||7
10575491|NCT01682837|11730560|FG000|Received Placebo|Third Intervention (4 Weeks)||7
10575492|NCT01682837|11730560|FG000|COMPLETED|Third Intervention (4 Weeks)||30
10575493|NCT01682837|11730560|FG000|NOT COMPLETED|Third Intervention (4 Weeks)||0
10575494|NCT01682837|11730560|FG000|STARTED|Fourth Intervention (4 Weeks)||30
10575495|NCT01682837|11730560|FG000|Received KMgCit|Fourth Intervention (4 Weeks)||6
10575496|NCT01682837|11730560|FG000|Received KCit|Fourth Intervention (4 Weeks)||9
10575497|NCT01682837|11730560|FG000|Received KCl|Fourth Intervention (4 Weeks)||8
10575498|NCT01682837|11730560|FG000|Received Placebo|Fourth Intervention (4 Weeks)||7
10575499|NCT01682837|11730560|FG000|COMPLETED|Fourth Intervention (4 Weeks)||30
10575500|NCT01682837|11730560|FG000|NOT COMPLETED|Fourth Intervention (4 Weeks)||0
10575501|NCT01682863|11730573|FG000|STARTED|Overall Study||204
10575502|NCT01682863|11730574|FG001|STARTED|Overall Study||204
10575503|NCT01682863|11730575|FG002|STARTED|Overall Study||207
10575504|NCT01682863|11730573|FG000|Safety Set|Overall Study||204
10575505|NCT01682863|11730574|FG001|Safety Set|Overall Study||204
10575506|NCT01682863|11730575|FG002|Safety Set|Overall Study||206
10575507|NCT01682863|11730573|FG000|Full Analysis Set (FAS)|Overall Study|included all randomized patients who received at least one dose of study medication|204
10575508|NCT01682863|11730574|FG001|Full Analysis Set (FAS)|Overall Study||204
10575509|NCT01682863|11730575|FG002|Full Analysis Set (FAS)|Overall Study||206
10575510|NCT01682863|11730573|FG000|Randomized Set|Overall Study||204
10575511|NCT01682863|11730574|FG001|Randomized Set|Overall Study||204
10575512|NCT01682863|11730575|FG002|Randomized Set|Overall Study|1 randomized patient was not treated; experienced an AE prior to receiving any study drug|207
10575513|NCT01682863|11730573|FG000|COMPLETED|Overall Study||177
10575514|NCT01682863|11730574|FG001|COMPLETED|Overall Study||187
10575515|NCT01682863|11730575|FG002|COMPLETED|Overall Study||183
10575516|NCT01682863|11730573|FG000|NOT COMPLETED|Overall Study||27
10575517|NCT01682863|11730574|FG001|NOT COMPLETED|Overall Study||17
10575518|NCT01682863|11730575|FG002|NOT COMPLETED|Overall Study||24
10575519|NCT01682876|11730587|FG000|STARTED|Overall Study||176
10575520|NCT01682876|11730588|FG001|STARTED|Overall Study||183
10575521|NCT01682876|11730589|FG002|STARTED|Overall Study||180
10575522|NCT01682876|11730590|FG003|STARTED|Overall Study||176
10575523|NCT01682876|11730587|FG000|COMPLETED|Overall Study||155
10575524|NCT01682876|11730588|FG001|COMPLETED|Overall Study||163
10575525|NCT01682876|11730589|FG002|COMPLETED|Overall Study||169
10575526|NCT01682876|11730590|FG003|COMPLETED|Overall Study||157
10575527|NCT01682876|11730587|FG000|NOT COMPLETED|Overall Study||21
10575528|NCT01682876|11730588|FG001|NOT COMPLETED|Overall Study||20
10575529|NCT01682876|11730589|FG002|NOT COMPLETED|Overall Study||11
10575530|NCT01682876|11730590|FG003|NOT COMPLETED|Overall Study||19
10575531|NCT01682954|11730605|FG000|STARTED|Overall Study||40
10575532|NCT01682954|11730606|FG001|STARTED|Overall Study||38
10575533|NCT01682954|11730605|FG000|COMPLETED|Overall Study||35
10575534|NCT01682954|11730606|FG001|COMPLETED|Overall Study||33
10575535|NCT01682954|11730605|FG000|NOT COMPLETED|Overall Study||5
10575536|NCT01682954|11730606|FG001|NOT COMPLETED|Overall Study||5
10575537|NCT01683019|11730615|FG000|STARTED|Overall Study||18
10575538|NCT01683019|11730616|FG001|STARTED|Overall Study||15
10575539|NCT01683019|11730617|FG002|STARTED|Overall Study||19
10575540|NCT01683019|11730615|FG000|COMPLETED|Overall Study||16
10575541|NCT01683019|11730616|FG001|COMPLETED|Overall Study||14
10575542|NCT01683019|11730617|FG002|COMPLETED|Overall Study||15
10575543|NCT01683019|11730615|FG000|NOT COMPLETED|Overall Study||2
10575544|NCT01683019|11730616|FG001|NOT COMPLETED|Overall Study||1
10575545|NCT01683019|11730617|FG002|NOT COMPLETED|Overall Study||4
10575546|NCT01683058|11730625|FG000|STARTED|Overall Study||74
10575547|NCT01683058|11730625|FG000|COMPLETED|Overall Study||45
10575548|NCT01683058|11730625|FG000|NOT COMPLETED|Overall Study||29
10575549|NCT01683071|11730636|FG000|STARTED|Part 1||25
10575550|NCT01683071|11730637|FG001|STARTED|Part 1||26
10575551|NCT01683071|11730638|FG002|STARTED|Part 1||25
10575552|NCT01683071|11730639|FG003|STARTED|Part 1||25
10575553|NCT01683071|11730640|FG004|STARTED|Part 1||0
10575554|NCT01683071|11730641|FG005|STARTED|Part 1||0
10575555|NCT01683071|11730636|FG000|COMPLETED|Part 1||21
10575556|NCT01683071|11730637|FG001|COMPLETED|Part 1||22
10575557|NCT01683071|11730638|FG002|COMPLETED|Part 1||22
10575558|NCT01683071|11730639|FG003|COMPLETED|Part 1||20
10702157|NCT02573467|11866645|FG002|NOT COMPLETED|Post-treatment Follow up Epoch||10
10575559|NCT01683071|11730640|FG004|COMPLETED|Part 1||0
10575560|NCT01683071|11730641|FG005|COMPLETED|Part 1||0
10575561|NCT01683071|11730636|FG000|NOT COMPLETED|Part 1||4
10575562|NCT01683071|11730637|FG001|NOT COMPLETED|Part 1||4
10575563|NCT01683071|11730638|FG002|NOT COMPLETED|Part 1||3
10575564|NCT01683071|11730639|FG003|NOT COMPLETED|Part 1||5
10575565|NCT01683071|11730640|FG004|NOT COMPLETED|Part 1||0
10575566|NCT01683071|11730641|FG005|NOT COMPLETED|Part 1||0
10575567|NCT01683071|11730636|FG000|STARTED|Part 2||0
10575568|NCT01683071|11730637|FG001|STARTED|Part 2||0
10575569|NCT01683071|11730638|FG002|STARTED|Part 2||0
10575570|NCT01683071|11730639|FG003|STARTED|Part 2||0
10575571|NCT01683071|11730640|FG004|STARTED|Part 2||99
10575572|NCT01683071|11730641|FG005|STARTED|Part 2||97
10575573|NCT01683071|11730636|FG000|COMPLETED|Part 2||0
10575574|NCT01683071|11730637|FG001|COMPLETED|Part 2||0
10575575|NCT01683071|11730638|FG002|COMPLETED|Part 2||0
10575576|NCT01683071|11730639|FG003|COMPLETED|Part 2||0
10575577|NCT01683071|11730640|FG004|COMPLETED|Part 2||82
10575578|NCT01683071|11730641|FG005|COMPLETED|Part 2||82
10575579|NCT01683071|11730636|FG000|NOT COMPLETED|Part 2||0
10575580|NCT01683071|11730637|FG001|NOT COMPLETED|Part 2||0
10575581|NCT01683071|11730638|FG002|NOT COMPLETED|Part 2||0
10575582|NCT01683071|11730639|FG003|NOT COMPLETED|Part 2||0
10575583|NCT01683071|11730640|FG004|NOT COMPLETED|Part 2||17
10575584|NCT01683071|11730641|FG005|NOT COMPLETED|Part 2||15
10575585|NCT01683266|11730663|FG000|STARTED|Overall Study||274
10575586|NCT01683266|11730664|FG001|STARTED|Overall Study||275
10575587|NCT01683266|11730663|FG000|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|273
10575588|NCT01683266|11730664|FG001|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|273
10575589|NCT01683266|11730663|FG000|COMPLETED|Overall Study||219
10575590|NCT01683266|11730664|FG001|COMPLETED|Overall Study||225
10575591|NCT01683266|11730663|FG000|NOT COMPLETED|Overall Study||55
10575592|NCT01683266|11730664|FG001|NOT COMPLETED|Overall Study||50
10575593|NCT01683331|11730672|FG000|STARTED|Overall Study||18
10575594|NCT01683331|11730673|FG001|STARTED|Overall Study||18
10575595|NCT01683331|11730672|FG000|Began Dosage|Overall Study||18
10575596|NCT01683331|11730673|FG001|Began Dosage|Overall Study||18
10575597|NCT01683331|11730672|FG000|12 Months|Overall Study||18
10575598|NCT01683331|11730673|FG001|12 Months|Overall Study||18
10575599|NCT01683331|11730672|FG000|24 Months|Overall Study||18
10575600|NCT01683331|11730673|FG001|24 Months|Overall Study||18
10575601|NCT01683331|11730672|FG000|COMPLETED|Overall Study||18
10575602|NCT01683331|11730673|FG001|COMPLETED|Overall Study||18
10575603|NCT01683331|11730672|FG000|NOT COMPLETED|Overall Study||0
10575604|NCT01683331|11730673|FG001|NOT COMPLETED|Overall Study||0
10575605|NCT01683383|11730681|FG000|STARTED|Overall Study||50
10575606|NCT01683383|11730682|FG001|STARTED|Overall Study||51
10575607|NCT01683383|11730681|FG000|Transported and Treated|Overall Study||49
10575608|NCT01683383|11730682|FG001|Transported and Treated|Overall Study||51
10575609|NCT01683383|11730681|FG000|COMPLETED|Overall Study||49
10575610|NCT01683383|11730682|FG001|COMPLETED|Overall Study||51
10575611|NCT01683383|11730681|FG000|NOT COMPLETED|Overall Study||1
10575612|NCT01683383|11730682|FG001|NOT COMPLETED|Overall Study||0
10575613|NCT01683409|11730693|FG000|STARTED|Treatment Period (Weeks 1-24)||27
10575614|NCT01683409|11730694|FG001|STARTED|Treatment Period (Weeks 1-24)||25
10575615|NCT01683409|11730695|FG002|STARTED|Treatment Period (Weeks 1-24)||27
10575616|NCT01683409|11730696|FG003|STARTED|Treatment Period (Weeks 1-24)||26
10575617|NCT01683409|11730697|FG004|STARTED|Treatment Period (Weeks 1-24)||25
10575618|NCT01683409|11730693|FG000|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||27
10575619|NCT01683409|11730694|FG001|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||25
10575620|NCT01683409|11730695|FG002|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||26
10575621|NCT01683409|11730696|FG003|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||26
10575622|NCT01683409|11730697|FG004|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||25
10575623|NCT01683409|11730693|FG000|COMPLETED|Treatment Period (Weeks 1-24)||27
10575624|NCT01683409|11730694|FG001|COMPLETED|Treatment Period (Weeks 1-24)||21
10575625|NCT01683409|11730695|FG002|COMPLETED|Treatment Period (Weeks 1-24)||26
10575626|NCT01683409|11730696|FG003|COMPLETED|Treatment Period (Weeks 1-24)||24
10575627|NCT01683409|11730697|FG004|COMPLETED|Treatment Period (Weeks 1-24)||23
10575628|NCT01683409|11730693|FG000|NOT COMPLETED|Treatment Period (Weeks 1-24)||0
10575629|NCT01683409|11730694|FG001|NOT COMPLETED|Treatment Period (Weeks 1-24)||4
10575630|NCT01683409|11730695|FG002|NOT COMPLETED|Treatment Period (Weeks 1-24)||1
10575631|NCT01683409|11730696|FG003|NOT COMPLETED|Treatment Period (Weeks 1-24)||2
10575632|NCT01683409|11730697|FG004|NOT COMPLETED|Treatment Period (Weeks 1-24)||2
10575633|NCT01683409|11730693|FG000|STARTED|Washout Period 1 (Weeks 25-28)||27
10575634|NCT01683409|11730694|FG001|STARTED|Washout Period 1 (Weeks 25-28)||21
10575635|NCT01683409|11730695|FG002|STARTED|Washout Period 1 (Weeks 25-28)||26
10575636|NCT01683409|11730696|FG003|STARTED|Washout Period 1 (Weeks 25-28)||24
10575637|NCT01683409|11730697|FG004|STARTED|Washout Period 1 (Weeks 25-28)||23
10575638|NCT01683409|11730693|FG000|COMPLETED|Washout Period 1 (Weeks 25-28)||24
10575639|NCT01683409|11730694|FG001|COMPLETED|Washout Period 1 (Weeks 25-28)||17
10575640|NCT01683409|11730695|FG002|COMPLETED|Washout Period 1 (Weeks 25-28)||25
10575641|NCT01683409|11730696|FG003|COMPLETED|Washout Period 1 (Weeks 25-28)||22
10575642|NCT01683409|11730697|FG004|COMPLETED|Washout Period 1 (Weeks 25-28)||20
10575643|NCT01683409|11730693|FG000|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||3
10575644|NCT01683409|11730694|FG001|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||4
10575645|NCT01683409|11730695|FG002|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||1
10575646|NCT01683409|11730696|FG003|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||2
10575647|NCT01683409|11730697|FG004|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||3
10575648|NCT01683409|11730693|FG000|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 18 participants.|6
10575649|NCT01683409|11730694|FG001|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 11 participants.|6
10575650|NCT01683409|11730695|FG002|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 17 participants.|8
10575651|NCT01683409|11730696|FG003|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 16 participants.|6
10575652|NCT01683409|11730697|FG004|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 8 participants.|12
10575653|NCT01683409|11730693|FG000|COMPLETED|Washout Period 2 (Weeks 29-32)||6
10575654|NCT01683409|11730694|FG001|COMPLETED|Washout Period 2 (Weeks 29-32)||6
10575655|NCT01683409|11730695|FG002|COMPLETED|Washout Period 2 (Weeks 29-32)||7
10575656|NCT01683409|11730696|FG003|COMPLETED|Washout Period 2 (Weeks 29-32)||6
10575657|NCT01683409|11730697|FG004|COMPLETED|Washout Period 2 (Weeks 29-32)||9
10575658|NCT01683409|11730693|FG000|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
10575659|NCT01683409|11730694|FG001|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
10575660|NCT01683409|11730695|FG002|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||1
10575661|NCT01683409|11730696|FG003|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
10575662|NCT01683409|11730697|FG004|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||3
10575663|NCT01683422|11730723|FG000|STARTED|Overall Study||9
10575664|NCT01683422|11730723|FG000|COMPLETED|Overall Study||9
10575665|NCT01683422|11730723|FG000|NOT COMPLETED|Overall Study||0
10575666|NCT01683526|11730729|FG000|STARTED|Overall Study||60
10575667|NCT01683526|11730730|FG001|STARTED|Overall Study||57
10575668|NCT01683526|11730729|FG000|COMPLETED|Overall Study||60
10575669|NCT01683526|11730730|FG001|COMPLETED|Overall Study||57
10575670|NCT01683526|11730729|FG000|NOT COMPLETED|Overall Study||0
10575671|NCT01683526|11730730|FG001|NOT COMPLETED|Overall Study||0
10575672|NCT01683565|11730738|FG000|STARTED|Overall Study||15
10575673|NCT01683565|11730739|FG001|STARTED|Overall Study||16
10575674|NCT01683565|11730738|FG000|COMPLETED|Overall Study||12
10575675|NCT01683565|11730739|FG001|COMPLETED|Overall Study||15
10575676|NCT01683565|11730738|FG000|NOT COMPLETED|Overall Study||3
10575677|NCT01683565|11730739|FG001|NOT COMPLETED|Overall Study||1
10575678|NCT01683604|11730747|FG000|STARTED|Overall Study||37
10575679|NCT01683604|11730747|FG000|COMPLETED|Overall Study||32
10575680|NCT01683604|11730747|FG000|NOT COMPLETED|Overall Study||5
10575681|NCT01683630|11730758|FG000|STARTED|Overall Study||1404
10575682|NCT01683630|11730759|FG001|STARTED|Overall Study||445
10575683|NCT01683630|11730758|FG000|COMPLETED|Overall Study||1404
10575684|NCT01683630|11730759|FG001|COMPLETED|Overall Study||445
10575685|NCT01683630|11730758|FG000|NOT COMPLETED|Overall Study||0
10575686|NCT01683630|11730759|FG001|NOT COMPLETED|Overall Study||0
10575687|NCT01683812|11730765|FG000|STARTED|Overall Study||23
10575688|NCT01683812|11730765|FG000|COMPLETED|Overall Study||23
10575689|NCT01683812|11730765|FG000|NOT COMPLETED|Overall Study||0
10575690|NCT01683838|11730771|FG000|STARTED|Overall Study||104
10575691|NCT01683838|11730772|FG001|STARTED|Overall Study||100
10575692|NCT01683838|11730771|FG000|Intent to Treat (ITT) Population|Overall Study||103
10575693|NCT01683838|11730772|FG001|Intent to Treat (ITT) Population|Overall Study||100
10575694|NCT01683838|11730771|FG000|Safety Population|Overall Study||103
10575695|NCT01683838|11730772|FG001|Safety Population|Overall Study||100
10575696|NCT01683838|11730771|FG000|Efficacy Population|Overall Study||89
10575697|NCT01683838|11730772|FG001|Efficacy Population|Overall Study||93
10575698|NCT01683838|11730771|FG000|COMPLETED|Overall Study||78
10575699|NCT01683838|11730772|FG001|COMPLETED|Overall Study||88
10575700|NCT01683838|11730771|FG000|NOT COMPLETED|Overall Study||26
10575701|NCT01683838|11730772|FG001|NOT COMPLETED|Overall Study||12
10651416|NCT02175771|11811632|FG007|STARTED|Run-In Period (Pre-assignment)||0
10651417|NCT02175771|11811633|FG008|STARTED|Run-In Period (Pre-assignment)||0
10651418|NCT02175771|11811625|FG000|COMPLETED|Run-In Period (Pre-assignment)||674
10651419|NCT02175771|11811626|FG001|COMPLETED|Run-In Period (Pre-assignment)||0
10651420|NCT02175771|11811627|FG002|COMPLETED|Run-In Period (Pre-assignment)||0
10651421|NCT02175771|11811628|FG003|COMPLETED|Run-In Period (Pre-assignment)||0
10651422|NCT02175771|11811629|FG004|COMPLETED|Run-In Period (Pre-assignment)||0
10651423|NCT02175771|11811630|FG005|COMPLETED|Run-In Period (Pre-assignment)||0
10651424|NCT02175771|11811631|FG006|COMPLETED|Run-In Period (Pre-assignment)||0
10651425|NCT02175771|11811632|FG007|COMPLETED|Run-In Period (Pre-assignment)||0
10651426|NCT02175771|11811633|FG008|COMPLETED|Run-In Period (Pre-assignment)||0
10651427|NCT02175771|11811625|FG000|NOT COMPLETED|Run-In Period (Pre-assignment)||84
10651428|NCT02175771|11811626|FG001|NOT COMPLETED|Run-In Period (Pre-assignment)||0
10651429|NCT02175771|11811627|FG002|NOT COMPLETED|Run-In Period (Pre-assignment)||0
10651430|NCT02175771|11811628|FG003|NOT COMPLETED|Run-In Period (Pre-assignment)||0
10651431|NCT02175771|11811629|FG004|NOT COMPLETED|Run-In Period (Pre-assignment)||0
10651432|NCT02175771|11811630|FG005|NOT COMPLETED|Run-In Period (Pre-assignment)||0
10651433|NCT02175771|11811631|FG006|NOT COMPLETED|Run-In Period (Pre-assignment)||0
10651434|NCT02175771|11811632|FG007|NOT COMPLETED|Run-In Period (Pre-assignment)||0
10651435|NCT02175771|11811633|FG008|NOT COMPLETED|Run-In Period (Pre-assignment)||0
10651436|NCT02175771|11811625|FG000|STARTED|Treatment Period||0
10651437|NCT02175771|11811626|FG001|STARTED|Treatment Period||127
10575702|NCT01683994|11730783|FG000|STARTED|Overall Study||4
10575703|NCT01683994|11730784|FG001|STARTED|Overall Study||8
10575704|NCT01683994|11730785|FG002|STARTED|Overall Study||7
10575705|NCT01683994|11730786|FG003|STARTED|Overall Study||13
10575706|NCT01683994|11730787|FG004|STARTED|Overall Study||13
10575707|NCT01683994|11730783|FG000|# of Patients Who Received Treatment|Overall Study||4
10575708|NCT01683994|11730784|FG001|# of Patients Who Received Treatment|Overall Study||8
10575709|NCT01683994|11730785|FG002|# of Patients Who Received Treatment|Overall Study||7
10575710|NCT01683994|11730786|FG003|# of Patients Who Received Treatment|Overall Study||12
10575711|NCT01683994|11730787|FG004|# of Patients Who Received Treatment|Overall Study||13
10575712|NCT01683994|11730783|FG000|COMPLETED|Overall Study||3
10575713|NCT01683994|11730784|FG001|COMPLETED|Overall Study||8
10575714|NCT01683994|11730785|FG002|COMPLETED|Overall Study||7
10575715|NCT01683994|11730786|FG003|COMPLETED|Overall Study||10
10575716|NCT01683994|11730787|FG004|COMPLETED|Overall Study||12
10575717|NCT01683994|11730783|FG000|NOT COMPLETED|Overall Study||1
10575718|NCT01683994|11730784|FG001|NOT COMPLETED|Overall Study||0
10575719|NCT01683994|11730785|FG002|NOT COMPLETED|Overall Study||0
10575720|NCT01683994|11730786|FG003|NOT COMPLETED|Overall Study||3
10575721|NCT01683994|11730787|FG004|NOT COMPLETED|Overall Study||1
10575722|NCT01684007|11730807|FG000|STARTED|Overall Study||53
10805262|NCT04023994|11966818|FG005|NOT COMPLETED|Overall Study||0
10805263|NCT04022668|11966840|FG000|STARTED|Overall Study||1000
10805264|NCT04022668|11966841|FG001|STARTED|Overall Study||1000
10575723|NCT01684007|11730808|FG001|STARTED|Overall Study||50
10575724|NCT01684007|11730807|FG000|COMPLETED|Overall Study||53
10575725|NCT01684007|11730808|FG001|COMPLETED|Overall Study||50
10575726|NCT01684007|11730807|FG000|NOT COMPLETED|Overall Study||0
10575727|NCT01684007|11730808|FG001|NOT COMPLETED|Overall Study||0
10575728|NCT01684020|11730816|FG000|STARTED|Overall Study||5
10575729|NCT01684020|11730817|FG001|STARTED|Overall Study||5
10575730|NCT01684020|11730816|FG000|COMPLETED|Overall Study||4
10575731|NCT01684020|11730817|FG001|COMPLETED|Overall Study||5
10575732|NCT01684020|11730816|FG000|NOT COMPLETED|Overall Study||1
10575733|NCT01684020|11730817|FG001|NOT COMPLETED|Overall Study||0
10575734|NCT01684033|11730823|FG000|STARTED|Period 1, First 30 Days||99
10575735|NCT01684033|11730824|FG001|STARTED|Period 1, First 30 Days||99
10575736|NCT01684033|11730823|FG000|COMPLETED|Period 1, First 30 Days||95
10575737|NCT01684033|11730824|FG001|COMPLETED|Period 1, First 30 Days||98
10575738|NCT01684033|11730823|FG000|NOT COMPLETED|Period 1, First 30 Days||4
10575739|NCT01684033|11730824|FG001|NOT COMPLETED|Period 1, First 30 Days||1
10575740|NCT01684033|11730823|FG000|STARTED|Period 2, Second 30 Days||95
10575741|NCT01684033|11730824|FG001|STARTED|Period 2, Second 30 Days||98
10575742|NCT01684033|11730823|FG000|COMPLETED|Period 2, Second 30 Days||94
10575743|NCT01684033|11730824|FG001|COMPLETED|Period 2, Second 30 Days||98
10575744|NCT01684033|11730823|FG000|NOT COMPLETED|Period 2, Second 30 Days||1
10575745|NCT01684033|11730824|FG001|NOT COMPLETED|Period 2, Second 30 Days||0
10575746|NCT01684046|11730830|FG000|STARTED|Period 1, First 30 Days||97
10575747|NCT01684046|11730831|FG001|STARTED|Period 1, First 30 Days||95
10575748|NCT01684046|11730830|FG000|COMPLETED|Period 1, First 30 Days||97
10575749|NCT01684046|11730831|FG001|COMPLETED|Period 1, First 30 Days||93
10575750|NCT01684046|11730830|FG000|NOT COMPLETED|Period 1, First 30 Days||0
10575751|NCT01684046|11730831|FG001|NOT COMPLETED|Period 1, First 30 Days||2
10575752|NCT01684046|11730830|FG000|STARTED|Period 2, Second 30 Days||97
10702158|NCT02573467|11866646|FG003|NOT COMPLETED|Post-treatment Follow up Epoch||3
10702159|NCT02573857|11866659|FG000|STARTED|Overall Study||8
10702160|NCT02573857|11866660|FG001|STARTED|Overall Study||8
10805265|NCT04022668|11966842|FG002|STARTED|Overall Study||1000
10805266|NCT04022668|11966840|FG000|COMPLETED|Overall Study||986
10805267|NCT04022668|11966841|FG001|COMPLETED|Overall Study||973
10805268|NCT04022668|11966842|FG002|COMPLETED|Overall Study||1000
10805269|NCT04022668|11966840|FG000|NOT COMPLETED|Overall Study||14
10805270|NCT04022668|11966841|FG001|NOT COMPLETED|Overall Study||27
10805271|NCT04022668|11966842|FG002|NOT COMPLETED|Overall Study||0
10805272|NCT04020822|11966850|FG000|STARTED|Overall Study||19
10575753|NCT01684046|11730831|FG001|STARTED|Period 2, Second 30 Days||93
10575754|NCT01684046|11730830|FG000|COMPLETED|Period 2, Second 30 Days||97
10575755|NCT01684046|11730831|FG001|COMPLETED|Period 2, Second 30 Days||93
10575756|NCT01684046|11730830|FG000|NOT COMPLETED|Period 2, Second 30 Days||0
10575757|NCT01684046|11730831|FG001|NOT COMPLETED|Period 2, Second 30 Days||0
10575758|NCT01684202|11730841|FG000|STARTED|Dose-escalation Period||15
10575759|NCT01684202|11730842|FG001|STARTED|Dose-escalation Period||8
10575760|NCT01684202|11730843|FG002|STARTED|Dose-escalation Period||9
10702161|NCT02573857|11866659|FG000|COMPLETED|Overall Study||8
10702162|NCT02573857|11866660|FG001|COMPLETED|Overall Study||8
10702163|NCT02573857|11866659|FG000|NOT COMPLETED|Overall Study||0
10702164|NCT02573857|11866660|FG001|NOT COMPLETED|Overall Study||0
10702165|NCT02573870|11866668|FG000|STARTED|Overall Study||20
10702166|NCT02573870|11866669|FG001|STARTED|Overall Study||42
10702167|NCT02573870|11866668|FG000|COMPLETED|Overall Study||20
10805273|NCT04020822|11966850|FG000|COMPLETED|Overall Study||19
10575761|NCT01684202|11730844|FG003|STARTED|Dose-escalation Period||11
10702168|NCT02573870|11866669|FG001|COMPLETED|Overall Study||35
10702169|NCT02573870|11866668|FG000|NOT COMPLETED|Overall Study||0
10805274|NCT04020822|11966850|FG000|NOT COMPLETED|Overall Study||0
10805275|NCT04019990|11966854|FG000|STARTED|Overall Study||13
10805276|NCT04019990|11966855|FG001|STARTED|Overall Study||15
10805277|NCT04019990|11966854|FG000|COMPLETED|Overall Study||12
10805278|NCT04019990|11966855|FG001|COMPLETED|Overall Study||12
10575762|NCT01684202|11730841|FG000|COMPLETED|Dose-escalation Period||14
10575763|NCT01684202|11730842|FG001|COMPLETED|Dose-escalation Period||7
10575764|NCT01684202|11730843|FG002|COMPLETED|Dose-escalation Period||9
10575765|NCT01684202|11730844|FG003|COMPLETED|Dose-escalation Period||11
10575766|NCT01684202|11730841|FG000|NOT COMPLETED|Dose-escalation Period||1
10575767|NCT01684202|11730842|FG001|NOT COMPLETED|Dose-escalation Period||1
10575768|NCT01684202|11730843|FG002|NOT COMPLETED|Dose-escalation Period||0
10575769|NCT01684202|11730844|FG003|NOT COMPLETED|Dose-escalation Period||0
10575770|NCT01684202|11730841|FG000|STARTED|Maintenance Period||14
10575771|NCT01684202|11730842|FG001|STARTED|Maintenance Period||7
10575772|NCT01684202|11730843|FG002|STARTED|Maintenance Period||9
10575773|NCT01684202|11730844|FG003|STARTED|Maintenance Period||11
10575774|NCT01684202|11730841|FG000|COMPLETED|Maintenance Period||13
10575775|NCT01684202|11730842|FG001|COMPLETED|Maintenance Period||4
10575776|NCT01684202|11730843|FG002|COMPLETED|Maintenance Period||8
10575777|NCT01684202|11730844|FG003|COMPLETED|Maintenance Period||10
10575778|NCT01684202|11730841|FG000|NOT COMPLETED|Maintenance Period||1
10575779|NCT01684202|11730842|FG001|NOT COMPLETED|Maintenance Period||3
10575780|NCT01684202|11730843|FG002|NOT COMPLETED|Maintenance Period||1
10575781|NCT01684202|11730844|FG003|NOT COMPLETED|Maintenance Period||1
10575782|NCT01684215|11730858|FG000|STARTED|Phase 1, Part 1||6
10575783|NCT01684215|11730859|FG001|STARTED|Phase 1, Part 1||6
10575784|NCT01684215|11730860|FG002|STARTED|Phase 1, Part 1||0
10575785|NCT01684215|11730861|FG003|STARTED|Phase 1, Part 1||0
10575786|NCT01684215|11730858|FG000|Treated|Phase 1, Part 1||6
10575787|NCT01684215|11730859|FG001|Treated|Phase 1, Part 1||6
10575788|NCT01684215|11730860|FG002|Treated|Phase 1, Part 1||0
10575789|NCT01684215|11730861|FG003|Treated|Phase 1, Part 1||0
10575790|NCT01684215|11730858|FG000|COMPLETED|Phase 1, Part 1||0
10575791|NCT01684215|11730859|FG001|COMPLETED|Phase 1, Part 1||0
10575792|NCT01684215|11730860|FG002|COMPLETED|Phase 1, Part 1||0
10575793|NCT01684215|11730861|FG003|COMPLETED|Phase 1, Part 1||0
10575794|NCT01684215|11730858|FG000|NOT COMPLETED|Phase 1, Part 1||6
10575795|NCT01684215|11730859|FG001|NOT COMPLETED|Phase 1, Part 1||6
10575796|NCT01684215|11730860|FG002|NOT COMPLETED|Phase 1, Part 1||0
10575797|NCT01684215|11730861|FG003|NOT COMPLETED|Phase 1, Part 1||0
10575798|NCT01684215|11730858|FG000|STARTED|Phase 1, Part 2||0
10575799|NCT01684215|11730859|FG001|STARTED|Phase 1, Part 2||0
10575800|NCT01684215|11730860|FG002|STARTED|Phase 1, Part 2|Eligible participants who consented for Phase 1 Part 2.|6
10575801|NCT01684215|11730861|FG003|STARTED|Phase 1, Part 2||0
10575802|NCT01684215|11730858|FG000|COMPLETED|Phase 1, Part 2||0
10575803|NCT01684215|11730859|FG001|COMPLETED|Phase 1, Part 2||0
10575804|NCT01684215|11730860|FG002|COMPLETED|Phase 1, Part 2||0
10575805|NCT01684215|11730861|FG003|COMPLETED|Phase 1, Part 2||0
10575806|NCT01684215|11730858|FG000|NOT COMPLETED|Phase 1, Part 2||0
10575807|NCT01684215|11730859|FG001|NOT COMPLETED|Phase 1, Part 2||0
10575808|NCT01684215|11730860|FG002|NOT COMPLETED|Phase 1, Part 2||6
10575809|NCT01684215|11730861|FG003|NOT COMPLETED|Phase 1, Part 2||0
10575810|NCT01684215|11730858|FG000|STARTED|Phase 2||0
10575811|NCT01684215|11730859|FG001|STARTED|Phase 2||0
10575812|NCT01684215|11730860|FG002|STARTED|Phase 2||0
10575813|NCT01684215|11730861|FG003|STARTED|Phase 2|Eligible participants who consented for Phase 2.|43
10575814|NCT01684215|11730858|FG000|Treated|Phase 2||0
10575815|NCT01684215|11730859|FG001|Treated|Phase 2||0
10575816|NCT01684215|11730860|FG002|Treated|Phase 2||0
10575817|NCT01684215|11730861|FG003|Treated|Phase 2||42
10575818|NCT01684215|11730858|FG000|COMPLETED|Phase 2||0
10575819|NCT01684215|11730859|FG001|COMPLETED|Phase 2||0
10575820|NCT01684215|11730860|FG002|COMPLETED|Phase 2||0
10575821|NCT01684215|11730861|FG003|COMPLETED|Phase 2||0
10575822|NCT01684215|11730858|FG000|NOT COMPLETED|Phase 2||0
10575823|NCT01684215|11730859|FG001|NOT COMPLETED|Phase 2||0
10575824|NCT01684215|11730860|FG002|NOT COMPLETED|Phase 2||0
10575825|NCT01684215|11730861|FG003|NOT COMPLETED|Phase 2||43
10575826|NCT01684410|11730877|FG000|STARTED|Overall Study||10
10575827|NCT01684410|11730878|FG001|STARTED|Overall Study||10
10575828|NCT01684410|11730879|FG002|STARTED|Overall Study||10
10575829|NCT01684410|11730877|FG000|COMPLETED|Overall Study||10
10575830|NCT01684410|11730878|FG001|COMPLETED|Overall Study||10
10575831|NCT01684410|11730879|FG002|COMPLETED|Overall Study||10
10575832|NCT01684410|11730877|FG000|NOT COMPLETED|Overall Study||0
10575833|NCT01684410|11730878|FG001|NOT COMPLETED|Overall Study||0
10575834|NCT01684410|11730879|FG002|NOT COMPLETED|Overall Study||0
10702170|NCT02573870|11866669|FG001|NOT COMPLETED|Overall Study||7
10702171|NCT02573883|11866677|FG000|STARTED|Six Month Follow Up||25
10702172|NCT02573883|11866678|FG001|STARTED|Six Month Follow Up||27
10702173|NCT02573883|11866679|FG002|STARTED|Six Month Follow Up||0
10575835|NCT01684423|11730892|FG000|STARTED|Overall Study||11
10575836|NCT01684423|11730893|FG001|STARTED|Overall Study||13
10575837|NCT01684423|11730894|FG002|STARTED|Overall Study||13
10575838|NCT01684423|11730895|FG003|STARTED|Overall Study||19
10702174|NCT02573883|11866680|FG003|STARTED|Six Month Follow Up||0
10702175|NCT02573883|11866677|FG000|COMPLETED|Six Month Follow Up||24
10575839|NCT01684423|11730896|FG004|STARTED|Overall Study||7
10575840|NCT01684423|11730892|FG000|COMPLETED|Overall Study||11
10575841|NCT01684423|11730893|FG001|COMPLETED|Overall Study||13
10575842|NCT01684423|11730894|FG002|COMPLETED|Overall Study||12
10575843|NCT01684423|11730895|FG003|COMPLETED|Overall Study||19
10575844|NCT01684423|11730896|FG004|COMPLETED|Overall Study||7
10575845|NCT01684423|11730892|FG000|NOT COMPLETED|Overall Study||0
10575846|NCT01684423|11730893|FG001|NOT COMPLETED|Overall Study||0
10575847|NCT01684423|11730894|FG002|NOT COMPLETED|Overall Study||1
10575848|NCT01684423|11730895|FG003|NOT COMPLETED|Overall Study||0
10575849|NCT01684423|11730896|FG004|NOT COMPLETED|Overall Study||0
10575850|NCT01684436|11730910|FG000|STARTED|Overall Study||30
10575851|NCT01684436|11730910|FG000|COMPLETED|Overall Study||29
10575852|NCT01684436|11730910|FG000|NOT COMPLETED|Overall Study||1
10575853|NCT01684566|11730916|FG000|STARTED|Overall Study||60
10575854|NCT01684566|11730917|FG001|STARTED|Overall Study||56
10575855|NCT01684566|11730916|FG000|Treated (ITT)|Overall Study||57
10575856|NCT01684566|11730917|FG001|Treated (ITT)|Overall Study||52
10575857|NCT01684566|11730916|FG000|COMPLETED|Overall Study||44
10575858|NCT01684566|11730917|FG001|COMPLETED|Overall Study||49
10575859|NCT01684566|11730916|FG000|NOT COMPLETED|Overall Study||16
10575860|NCT01684566|11730917|FG001|NOT COMPLETED|Overall Study||7
10575861|NCT01684592|11730925|FG000|STARTED|Overall Study||64
10575862|NCT01684592|11730926|FG001|STARTED|Overall Study||64
10575863|NCT01684592|11730925|FG000|COMPLETED|Overall Study||38
10575864|NCT01684592|11730926|FG001|COMPLETED|Overall Study||40
10575865|NCT01684592|11730925|FG000|NOT COMPLETED|Overall Study||26
10575866|NCT01684592|11730926|FG001|NOT COMPLETED|Overall Study||24
10575867|NCT01684748|11730934|FG000|STARTED|First Intervention - 8 Weeks||10
10575868|NCT01684748|11730935|FG001|STARTED|First Intervention - 8 Weeks||10
10575869|NCT01684748|11730934|FG000|COMPLETED|First Intervention - 8 Weeks||8
10575870|NCT01684748|11730935|FG001|COMPLETED|First Intervention - 8 Weeks||8
10575871|NCT01684748|11730934|FG000|NOT COMPLETED|First Intervention - 8 Weeks||2
10575872|NCT01684748|11730935|FG001|NOT COMPLETED|First Intervention - 8 Weeks||2
10575873|NCT01684748|11730934|FG000|STARTED|Second Intervention - 8 Weeks||8
10575874|NCT01684748|11730935|FG001|STARTED|Second Intervention - 8 Weeks||8
10575875|NCT01684748|11730934|FG000|COMPLETED|Second Intervention - 8 Weeks||8
10575876|NCT01684748|11730935|FG001|COMPLETED|Second Intervention - 8 Weeks||8
10575877|NCT01684748|11730934|FG000|NOT COMPLETED|Second Intervention - 8 Weeks||0
10575878|NCT01684748|11730935|FG001|NOT COMPLETED|Second Intervention - 8 Weeks||0
10575879|NCT01684839|11730941|FG000|STARTED|Overall Study||9
10575880|NCT01684839|11730941|FG000|COMPLETED|Overall Study||9
10575881|NCT01684839|11730941|FG000|NOT COMPLETED|Overall Study||0
10575882|NCT01684878|11730949|FG000|STARTED|Part 1: Safety Run in Phase||22
10575883|NCT01684878|11730950|FG001|STARTED|Part 1: Safety Run in Phase||28
10575884|NCT01684878|11730951|FG002|STARTED|Part 1: Safety Run in Phase||0
10575885|NCT01684878|11730952|FG003|STARTED|Part 1: Safety Run in Phase||0
10575886|NCT01684878|11730949|FG000|COMPLETED|Part 1: Safety Run in Phase||6
10575887|NCT01684878|11730950|FG001|COMPLETED|Part 1: Safety Run in Phase||5
10575888|NCT01684878|11730951|FG002|COMPLETED|Part 1: Safety Run in Phase||0
10575889|NCT01684878|11730952|FG003|COMPLETED|Part 1: Safety Run in Phase||0
10575890|NCT01684878|11730949|FG000|NOT COMPLETED|Part 1: Safety Run in Phase||16
10575891|NCT01684878|11730950|FG001|NOT COMPLETED|Part 1: Safety Run in Phase||23
10575892|NCT01684878|11730951|FG002|NOT COMPLETED|Part 1: Safety Run in Phase||0
10575893|NCT01684878|11730952|FG003|NOT COMPLETED|Part 1: Safety Run in Phase||0
10575894|NCT01684878|11730949|FG000|STARTED|Part 2: Randomized Phase||0
10575895|NCT01684878|11730950|FG001|STARTED|Part 2: Randomized Phase||0
10575896|NCT01684878|11730951|FG002|STARTED|Part 2: Randomized Phase||78
10575897|NCT01684878|11730952|FG003|STARTED|Part 2: Randomized Phase||78
10575898|NCT01684878|11730949|FG000|Participants Randomized But Not Treated|Part 2: Randomized Phase||0
10575899|NCT01684878|11730950|FG001|Participants Randomized But Not Treated|Part 2: Randomized Phase||0
10575900|NCT01684878|11730951|FG002|Participants Randomized But Not Treated|Part 2: Randomized Phase||1
10702176|NCT02573883|11866678|FG001|COMPLETED|Six Month Follow Up||27
10702177|NCT02573883|11866679|FG002|COMPLETED|Six Month Follow Up||0
10702178|NCT02573883|11866680|FG003|COMPLETED|Six Month Follow Up||0
10702179|NCT02573883|11866677|FG000|NOT COMPLETED|Six Month Follow Up||1
10702180|NCT02573883|11866678|FG001|NOT COMPLETED|Six Month Follow Up||0
10702181|NCT02573883|11866679|FG002|NOT COMPLETED|Six Month Follow Up||0
10702182|NCT02573883|11866680|FG003|NOT COMPLETED|Six Month Follow Up||0
10702183|NCT02573883|11866677|FG000|STARTED|One Year Follow Up||13
10702184|NCT02573883|11866678|FG001|STARTED|One Year Follow Up||17
10702185|NCT02573883|11866679|FG002|STARTED|One Year Follow Up||11
10702186|NCT02573883|11866680|FG003|STARTED|One Year Follow Up||10
10702187|NCT02573883|11866677|FG000|COMPLETED|One Year Follow Up||11
10702188|NCT02573883|11866678|FG001|COMPLETED|One Year Follow Up||16
10575901|NCT01684878|11730952|FG003|Participants Randomized But Not Treated|Part 2: Randomized Phase||2
10575902|NCT01684878|11730949|FG000|Participants Mis-randomized|Part 2: Randomized Phase||0
10575903|NCT01684878|11730950|FG001|Participants Mis-randomized|Part 2: Randomized Phase||0
10575904|NCT01684878|11730951|FG002|Participants Mis-randomized|Part 2: Randomized Phase||2
10575905|NCT01684878|11730952|FG003|Participants Mis-randomized|Part 2: Randomized Phase||0
10575906|NCT01684878|11730949|FG000|COMPLETED|Part 2: Randomized Phase||0
10575907|NCT01684878|11730950|FG001|COMPLETED|Part 2: Randomized Phase||0
10575908|NCT01684878|11730951|FG002|COMPLETED|Part 2: Randomized Phase||0
10575909|NCT01684878|11730952|FG003|COMPLETED|Part 2: Randomized Phase||0
10575910|NCT01684878|11730949|FG000|NOT COMPLETED|Part 2: Randomized Phase||0
10575911|NCT01684878|11730950|FG001|NOT COMPLETED|Part 2: Randomized Phase||0
10575912|NCT01684878|11730951|FG002|NOT COMPLETED|Part 2: Randomized Phase||78
10575913|NCT01684878|11730952|FG003|NOT COMPLETED|Part 2: Randomized Phase||78
10575914|NCT01684917|11730966|FG000|STARTED|Overall Study||11
10575915|NCT01684917|11730967|FG001|STARTED|Overall Study||7
10575916|NCT01684917|11730968|FG002|STARTED|Overall Study||13
10575917|NCT01684917|11730969|FG003|STARTED|Overall Study||5
10575918|NCT01684917|11730966|FG000|COMPLETED|Overall Study||11
10575919|NCT01684917|11730967|FG001|COMPLETED|Overall Study||7
10575920|NCT01684917|11730968|FG002|COMPLETED|Overall Study||13
10575921|NCT01684917|11730969|FG003|COMPLETED|Overall Study||5
10575922|NCT01684917|11730966|FG000|NOT COMPLETED|Overall Study||0
10575923|NCT01684917|11730967|FG001|NOT COMPLETED|Overall Study||0
10575924|NCT01684917|11730968|FG002|NOT COMPLETED|Overall Study||0
10575925|NCT01684917|11730969|FG003|NOT COMPLETED|Overall Study||0
10575926|NCT01684930|11730981|FG000|STARTED|Overall Study||12
10575927|NCT01684930|11730982|FG001|STARTED|Overall Study||14
10575928|NCT01684930|11730981|FG000|COMPLETED|Overall Study||9
10575929|NCT01684930|11730982|FG001|COMPLETED|Overall Study||13
10575930|NCT01684930|11730981|FG000|NOT COMPLETED|Overall Study||3
10575931|NCT01684930|11730982|FG001|NOT COMPLETED|Overall Study||1
10575932|NCT01684943|11730991|FG000|STARTED|Overall Study||29
10575933|NCT01684943|11730992|FG001|STARTED|Overall Study||3
10575934|NCT01684943|11730993|FG002|STARTED|Overall Study||1
10575935|NCT01684943|11730991|FG000|COMPLETED|Overall Study||20
10575936|NCT01684943|11730992|FG001|COMPLETED|Overall Study||2
10575937|NCT01684943|11730993|FG002|COMPLETED|Overall Study||0
10575938|NCT01684943|11730991|FG000|NOT COMPLETED|Overall Study||9
10575939|NCT01684943|11730992|FG001|NOT COMPLETED|Overall Study||1
10575940|NCT01684943|11730993|FG002|NOT COMPLETED|Overall Study||1
10575941|NCT01685021|11731006|FG000|STARTED|Overall Study||22
10575942|NCT01685021|11731006|FG000|COMPLETED|Overall Study|Last patient last visit date. Study was Terminated prematurely.|6
10575943|NCT01685021|11731006|FG000|NOT COMPLETED|Overall Study||16
10575944|NCT01685047|11731010|FG000|STARTED|Overall Study|481 subjects signed the consent. 1 subject was withdrawn prior to the baseline visit.|481
10575945|NCT01685047|11731010|FG000|COMPLETED|Overall Study||396
10575946|NCT01685047|11731010|FG000|NOT COMPLETED|Overall Study||85
10575947|NCT01685060|11731014|FG000|STARTED|Overall Study||140
10575948|NCT01685060|11731014|FG000|Entered Post-treatment Efficacy f/u|Overall Study||7
10575949|NCT01685060|11731014|FG000|Entered Survival Follow up|Overall Study||98
10575950|NCT01685060|11731014|FG000|Discontinued From Study|Overall Study||35
10575951|NCT01685060|11731014|FG000|COMPLETED|Overall Study||0
10575952|NCT01685060|11731014|FG000|NOT COMPLETED|Overall Study||140
10575953|NCT01685073|11731020|FG000|STARTED|Overall Study|Randomized|62
10575954|NCT01685073|11731021|FG001|STARTED|Overall Study|Randomized|65
10575955|NCT01685073|11731020|FG000|COMPLETED|Overall Study|Retained in treatment through 12 weeks|32
10575956|NCT01685073|11731021|FG001|COMPLETED|Overall Study|Retained in treatment through 12 weeks|33
10575957|NCT01685073|11731020|FG000|NOT COMPLETED|Overall Study||30
10575958|NCT01685073|11731021|FG001|NOT COMPLETED|Overall Study||32
10575959|NCT01685138|11731027|FG000|STARTED|Overall Study||124
10575960|NCT01685138|11731027|FG000|Discontinued From Treatment Phase|Overall Study||124
10575961|NCT01685138|11731027|FG000|Entered Post-treatment Efficacy f/up|Overall Study||10
10575962|NCT01685138|11731027|FG000|Entered Survival Follow-up|Overall Study||63
10575963|NCT01685138|11731027|FG000|Discontinued From Study|Overall Study||51
10575964|NCT01685138|11731027|FG000|COMPLETED|Overall Study||32
10575965|NCT01685138|11731027|FG000|NOT COMPLETED|Overall Study||92
10575966|NCT01685203|11731038|FG000|STARTED|Overall Study||44
10575967|NCT01685203|11731039|FG001|STARTED|Overall Study||42
10575968|NCT01685203|11731040|FG002|STARTED|Overall Study||40
10575969|NCT01685203|11731041|FG003|STARTED|Overall Study||42
10575970|NCT01685203|11731042|FG004|STARTED|Overall Study||49
10575971|NCT01685203|11731043|FG005|STARTED|Overall Study||47
10575972|NCT01685203|11731044|FG006|STARTED|Overall Study||52
10575973|NCT01685203|11731038|FG000|Completed Study Drug|Overall Study||42
10575974|NCT01685203|11731039|FG001|Completed Study Drug|Overall Study||40
10575975|NCT01685203|11731040|FG002|Completed Study Drug|Overall Study||39
10575976|NCT01685203|11731041|FG003|Completed Study Drug|Overall Study||42
10575977|NCT01685203|11731042|FG004|Completed Study Drug|Overall Study||49
10575978|NCT01685203|11731043|FG005|Completed Study Drug|Overall Study||43
10575979|NCT01685203|11731044|FG006|Completed Study Drug|Overall Study||52
10575980|NCT01685203|11731038|FG000|COMPLETED|Overall Study||40
10575981|NCT01685203|11731039|FG001|COMPLETED|Overall Study||39
10575982|NCT01685203|11731040|FG002|COMPLETED|Overall Study||40
10575983|NCT01685203|11731041|FG003|COMPLETED|Overall Study||41
10575984|NCT01685203|11731042|FG004|COMPLETED|Overall Study||49
10575985|NCT01685203|11731043|FG005|COMPLETED|Overall Study||44
10575986|NCT01685203|11731044|FG006|COMPLETED|Overall Study||52
10575987|NCT01685203|11731038|FG000|NOT COMPLETED|Overall Study||4
10575988|NCT01685203|11731039|FG001|NOT COMPLETED|Overall Study||3
10575989|NCT01685203|11731040|FG002|NOT COMPLETED|Overall Study||0
10575990|NCT01685203|11731041|FG003|NOT COMPLETED|Overall Study||1
10575991|NCT01685203|11731042|FG004|NOT COMPLETED|Overall Study||0
10575992|NCT01685203|11731043|FG005|NOT COMPLETED|Overall Study||3
10575993|NCT01685203|11731044|FG006|NOT COMPLETED|Overall Study||0
10575994|NCT01685216|11731060|FG000|STARTED|Overall Study||7
10575995|NCT01685216|11731060|FG000|COMPLETED|Overall Study||6
10575996|NCT01685216|11731060|FG000|NOT COMPLETED|Overall Study||1
10575997|NCT01685229|11731066|FG000|STARTED|Overall Study||146
10575998|NCT01685229|11731067|FG001|STARTED|Overall Study||52
10575999|NCT01685229|11731066|FG000|COMPLETED|Overall Study||120
10576000|NCT01685229|11731067|FG001|COMPLETED|Overall Study||36
10576001|NCT01685229|11731066|FG000|NOT COMPLETED|Overall Study||26
10576002|NCT01685229|11731067|FG001|NOT COMPLETED|Overall Study||16
10576003|NCT01685242|11731078|FG000|STARTED|Overall Study||50
10576004|NCT01685242|11731079|FG001|STARTED|Overall Study||50
10576005|NCT01685242|11731078|FG000|COMPLETED|Overall Study||49
10576006|NCT01685242|11731079|FG001|COMPLETED|Overall Study||47
10576007|NCT01685242|11731078|FG000|NOT COMPLETED|Overall Study||1
10576008|NCT01685242|11731079|FG001|NOT COMPLETED|Overall Study||3
10576009|NCT01685320|11731087|FG000|STARTED|Overall Study||15
10576010|NCT01685320|11731088|FG001|STARTED|Overall Study||15
10576011|NCT01685320|11731087|FG000|COMPLETED|Overall Study||15
10576012|NCT01685320|11731088|FG001|COMPLETED|Overall Study||15
10576013|NCT01685320|11731087|FG000|NOT COMPLETED|Overall Study||0
10576014|NCT01685320|11731088|FG001|NOT COMPLETED|Overall Study||0
10576015|NCT01685372|11731096|FG000|STARTED|Timepoint 1 (T1): Vaccine,1st Blood Draw||7
10576016|NCT01685372|11731097|FG001|STARTED|Timepoint 1 (T1): Vaccine,1st Blood Draw||9
10576017|NCT01685372|11731096|FG000|COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||7
10576018|NCT01685372|11731097|FG001|COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||9
10576019|NCT01685372|11731096|FG000|NOT COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||0
10576020|NCT01685372|11731097|FG001|NOT COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||0
10576021|NCT01685372|11731096|FG000|STARTED|Timepoint 2 (T2): 2nd Blood Draw||7
10576022|NCT01685372|11731097|FG001|STARTED|Timepoint 2 (T2): 2nd Blood Draw||9
10576023|NCT01685372|11731096|FG000|COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||7
10576024|NCT01685372|11731097|FG001|COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||9
10576025|NCT01685372|11731096|FG000|NOT COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||0
10576026|NCT01685372|11731097|FG001|NOT COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||0
10576027|NCT01685372|11731096|FG000|STARTED|Timepoint 3 (T3): 3rd Blood Draw||7
10576028|NCT01685372|11731097|FG001|STARTED|Timepoint 3 (T3): 3rd Blood Draw||9
10576029|NCT01685372|11731096|FG000|COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||4
10576030|NCT01685372|11731097|FG001|COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||5
10576031|NCT01685372|11731096|FG000|NOT COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||3
10576032|NCT01685372|11731097|FG001|NOT COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||4
10576033|NCT01685411|11731103|FG000|STARTED|Overall Study||5
10576034|NCT01685411|11731103|FG000|COMPLETED|Overall Study||5
10576035|NCT01685411|11731103|FG000|NOT COMPLETED|Overall Study||0
10576036|NCT01685437|11731107|FG000|STARTED|Overall Study||189
10576037|NCT01685437|11731107|FG000|COMPLETED|Overall Study||158
10576038|NCT01685437|11731107|FG000|NOT COMPLETED|Overall Study||31
10576039|NCT01685463|11731113|FG000|STARTED|Overall Study||10
10576040|NCT01685463|11731114|FG001|STARTED|Overall Study||8
10576041|NCT01685463|11731113|FG000|COMPLETED|Overall Study||10
10576042|NCT01685463|11731114|FG001|COMPLETED|Overall Study||8
10576043|NCT01685463|11731113|FG000|NOT COMPLETED|Overall Study||0
10576044|NCT01685463|11731114|FG001|NOT COMPLETED|Overall Study||0
10576045|NCT01685567|11731120|FG000|STARTED|Overall Study||219
10576046|NCT01685567|11731120|FG000|COMPLETED|Overall Study||219
10576047|NCT01685567|11731120|FG000|NOT COMPLETED|Overall Study||0
10576048|NCT01685684|11731126|FG000|STARTED|Titration Phase||740
10576049|NCT01685684|11731127|FG001|STARTED|Titration Phase||0
10576050|NCT01685684|11731128|FG002|STARTED|Titration Phase||0
10576051|NCT01685684|11731126|FG000|COMPLETED|Titration Phase||389
10576052|NCT01685684|11731127|FG001|COMPLETED|Titration Phase||0
10576053|NCT01685684|11731128|FG002|COMPLETED|Titration Phase||0
10576054|NCT01685684|11731126|FG000|NOT COMPLETED|Titration Phase||351
10576055|NCT01685684|11731127|FG001|NOT COMPLETED|Titration Phase||0
10576056|NCT01685684|11731128|FG002|NOT COMPLETED|Titration Phase||0
10576057|NCT01685684|11731126|FG000|STARTED|Double-blind Maintenance Phase||0
10576058|NCT01685684|11731127|FG001|STARTED|Double-blind Maintenance Phase||193
10576059|NCT01685684|11731128|FG002|STARTED|Double-blind Maintenance Phase||196
10576060|NCT01685684|11731126|FG000|COMPLETED|Double-blind Maintenance Phase||0
10576061|NCT01685684|11731127|FG001|COMPLETED|Double-blind Maintenance Phase||122
10576062|NCT01685684|11731128|FG002|COMPLETED|Double-blind Maintenance Phase||100
10576063|NCT01685684|11731126|FG000|NOT COMPLETED|Double-blind Maintenance Phase||0
10576064|NCT01685684|11731127|FG001|NOT COMPLETED|Double-blind Maintenance Phase||71
10576065|NCT01685684|11731128|FG002|NOT COMPLETED|Double-blind Maintenance Phase||96
10576066|NCT01685697|11731138|FG000|STARTED|Overall Study||31
10576067|NCT01685697|11731139|FG001|STARTED|Overall Study||31
10576068|NCT01685697|11731138|FG000|COMPLETED|Overall Study||28
10576069|NCT01685697|11731139|FG001|COMPLETED|Overall Study||28
10576070|NCT01685697|11731138|FG000|NOT COMPLETED|Overall Study||3
10805279|NCT04019990|11966854|FG000|NOT COMPLETED|Overall Study||1
10805280|NCT04019990|11966855|FG001|NOT COMPLETED|Overall Study||3
10805281|NCT04017611|11966861|FG000|STARTED|Overall Study||13
10805282|NCT04017611|11966861|FG000|COMPLETED|Overall Study||12
10805283|NCT04017611|11966861|FG000|NOT COMPLETED|Overall Study||1
10805284|NCT04015232|11966867|FG000|STARTED|Overall Study||100
10805285|NCT04015232|11966868|FG001|STARTED|Overall Study||100
10805286|NCT04015232|11966867|FG000|COMPLETED|Overall Study||89
10805287|NCT04015232|11966868|FG001|COMPLETED|Overall Study||93
10805288|NCT04015232|11966867|FG000|NOT COMPLETED|Overall Study||11
10805289|NCT04015232|11966868|FG001|NOT COMPLETED|Overall Study||7
10805290|NCT04016623|11966878|FG000|STARTED|Pair 1 Test / Control Dispense||10
10805291|NCT04016623|11966878|FG000|COMPLETED|Pair 1 Test / Control Dispense||10
10456931|NCT01008280|11604651|FG000|NOT COMPLETED|Overall Study||21
10456932|NCT01008280|11604652|FG001|NOT COMPLETED|Overall Study||19
10456933|NCT01008319|11604660|FG000|STARTED|Overall Study||60
10456934|NCT01008319|11604661|FG001|STARTED|Overall Study||60
10456935|NCT01008319|11604660|FG000|COMPLETED|Overall Study||60
10456936|NCT01008319|11604661|FG001|COMPLETED|Overall Study||60
10456937|NCT01008319|11604660|FG000|NOT COMPLETED|Overall Study||0
10576071|NCT01685697|11731139|FG001|NOT COMPLETED|Overall Study||3
10576072|NCT01685801|11731149|FG000|STARTED|Cycle 1 Period 1 (2 Weeks)||5
10456938|NCT01008319|11604661|FG001|NOT COMPLETED|Overall Study||0
10456939|NCT01008410|11604673|FG000|STARTED|Overall Study||133
10456940|NCT01008410|11604674|FG001|STARTED|Overall Study||132
10456941|NCT01008410|11604673|FG000|Received at Least 1 Dose of Study Drug|Overall Study||133
10456942|NCT01008410|11604674|FG001|Received at Least 1 Dose of Study Drug|Overall Study||132
10456943|NCT01008410|11604673|FG000|COMPLETED|Overall Study||108
10456944|NCT01008410|11604674|FG001|COMPLETED|Overall Study||116
10456945|NCT01008410|11604673|FG000|NOT COMPLETED|Overall Study||25
10456946|NCT01008410|11604674|FG001|NOT COMPLETED|Overall Study||16
10456947|NCT01008423|11604682|FG000|STARTED|Overall Study||134
10456948|NCT01008423|11604683|FG001|STARTED|Overall Study||147
10456949|NCT01008423|11604682|FG000|Received at Least 1 Dose of Study Drug|Overall Study||134
10456950|NCT01008423|11604683|FG001|Received at Least 1 Dose of Study Drug|Overall Study||147
10456951|NCT01008423|11604682|FG000|COMPLETED|Overall Study||115
10456952|NCT01008423|11604683|FG001|COMPLETED|Overall Study||125
10456953|NCT01008423|11604682|FG000|NOT COMPLETED|Overall Study||19
10456954|NCT01008423|11604683|FG001|NOT COMPLETED|Overall Study||22
10456955|NCT01008449|11604691|FG000|STARTED|Overall Study||200
10456956|NCT01008449|11604692|FG001|STARTED|Overall Study||198
10456957|NCT01008449|11604691|FG000|COMPLETED|Overall Study||171
10456958|NCT01008449|11604692|FG001|COMPLETED|Overall Study||179
10456959|NCT01008449|11604691|FG000|NOT COMPLETED|Overall Study||29
10456960|NCT01008449|11604692|FG001|NOT COMPLETED|Overall Study||19
10456961|NCT01008462|11604698|FG000|STARTED|Overall Study||16
10456962|NCT01008462|11604698|FG000|COMPLETED|Overall Study||16
10456963|NCT01008462|11604698|FG000|NOT COMPLETED|Overall Study||0
10456964|NCT01008475|11604709|FG000|STARTED|Overall Study||3
10456965|NCT01008475|11604710|FG001|STARTED|Overall Study||3
10576073|NCT01685801|11731150|FG001|STARTED|Cycle 1 Period 1 (2 Weeks)||6
10576074|NCT01685801|11731151|FG002|STARTED|Cycle 1 Period 1 (2 Weeks)||7
10576075|NCT01685801|11731152|FG003|STARTED|Cycle 1 Period 1 (2 Weeks)||6
10576076|NCT01685801|11731149|FG000|COMPLETED|Cycle 1 Period 1 (2 Weeks)||5
10576077|NCT01685801|11731150|FG001|COMPLETED|Cycle 1 Period 1 (2 Weeks)||6
10576078|NCT01685801|11731151|FG002|COMPLETED|Cycle 1 Period 1 (2 Weeks)||7
10576079|NCT01685801|11731152|FG003|COMPLETED|Cycle 1 Period 1 (2 Weeks)||6
10576080|NCT01685801|11731149|FG000|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
10576081|NCT01685801|11731150|FG001|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
10576082|NCT01685801|11731151|FG002|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
10576083|NCT01685801|11731152|FG003|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
10576084|NCT01685801|11731149|FG000|STARTED|Cycle 1 Period 2 (2 Weeks)||5
10576085|NCT01685801|11731150|FG001|STARTED|Cycle 1 Period 2 (2 Weeks)||6
10576086|NCT01685801|11731151|FG002|STARTED|Cycle 1 Period 2 (2 Weeks)||7
10576087|NCT01685801|11731152|FG003|STARTED|Cycle 1 Period 2 (2 Weeks)||6
10576088|NCT01685801|11731149|FG000|COMPLETED|Cycle 1 Period 2 (2 Weeks)||5
10576089|NCT01685801|11731150|FG001|COMPLETED|Cycle 1 Period 2 (2 Weeks)||6
10576090|NCT01685801|11731151|FG002|COMPLETED|Cycle 1 Period 2 (2 Weeks)||7
10576091|NCT01685801|11731152|FG003|COMPLETED|Cycle 1 Period 2 (2 Weeks)||5
10576092|NCT01685801|11731149|FG000|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
10576093|NCT01685801|11731150|FG001|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
10576094|NCT01685801|11731151|FG002|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
10576095|NCT01685801|11731152|FG003|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||1
10576096|NCT01685801|11731149|FG000|STARTED|Washout Period 1 (4 Weeks)||5
10576097|NCT01685801|11731150|FG001|STARTED|Washout Period 1 (4 Weeks)||6
10576098|NCT01685801|11731151|FG002|STARTED|Washout Period 1 (4 Weeks)||7
10576099|NCT01685801|11731152|FG003|STARTED|Washout Period 1 (4 Weeks)||5
10576100|NCT01685801|11731149|FG000|COMPLETED|Washout Period 1 (4 Weeks)||5
10576101|NCT01685801|11731150|FG001|COMPLETED|Washout Period 1 (4 Weeks)||6
10576102|NCT01685801|11731151|FG002|COMPLETED|Washout Period 1 (4 Weeks)||7
10576103|NCT01685801|11731152|FG003|COMPLETED|Washout Period 1 (4 Weeks)||5
10576104|NCT01685801|11731149|FG000|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
10576105|NCT01685801|11731150|FG001|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
10576106|NCT01685801|11731151|FG002|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
10576107|NCT01685801|11731152|FG003|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
10576108|NCT01685801|11731149|FG000|STARTED|Cycle 2 Period 1 (2 Weeks)||5
10576109|NCT01685801|11731150|FG001|STARTED|Cycle 2 Period 1 (2 Weeks)||6
10576110|NCT01685801|11731151|FG002|STARTED|Cycle 2 Period 1 (2 Weeks)||7
10576111|NCT01685801|11731152|FG003|STARTED|Cycle 2 Period 1 (2 Weeks)||5
10576112|NCT01685801|11731149|FG000|COMPLETED|Cycle 2 Period 1 (2 Weeks)||5
10576113|NCT01685801|11731150|FG001|COMPLETED|Cycle 2 Period 1 (2 Weeks)||6
10576114|NCT01685801|11731151|FG002|COMPLETED|Cycle 2 Period 1 (2 Weeks)||7
10576115|NCT01685801|11731152|FG003|COMPLETED|Cycle 2 Period 1 (2 Weeks)||5
10576116|NCT01685801|11731149|FG000|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
10576117|NCT01685801|11731150|FG001|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
10576118|NCT01685801|11731151|FG002|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
10576119|NCT01685801|11731152|FG003|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
10576120|NCT01685801|11731149|FG000|STARTED|Cycle 2 Period 2 (2 Weeks)||5
10576121|NCT01685801|11731150|FG001|STARTED|Cycle 2 Period 2 (2 Weeks)||6
10576122|NCT01685801|11731151|FG002|STARTED|Cycle 2 Period 2 (2 Weeks)||7
10576123|NCT01685801|11731152|FG003|STARTED|Cycle 2 Period 2 (2 Weeks)||5
10576124|NCT01685801|11731149|FG000|COMPLETED|Cycle 2 Period 2 (2 Weeks)||5
10576125|NCT01685801|11731150|FG001|COMPLETED|Cycle 2 Period 2 (2 Weeks)||5
10456966|NCT01008475|11604711|FG002|STARTED|Overall Study||7
10456967|NCT01008475|11604712|FG003|STARTED|Overall Study||3
10456968|NCT01008475|11604713|FG004|STARTED|Overall Study||72
10576126|NCT01685801|11731151|FG002|COMPLETED|Cycle 2 Period 2 (2 Weeks)||7
10576127|NCT01685801|11731152|FG003|COMPLETED|Cycle 2 Period 2 (2 Weeks)||4
10576128|NCT01685801|11731149|FG000|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||0
10576129|NCT01685801|11731150|FG001|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||1
10576130|NCT01685801|11731151|FG002|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||0
10576131|NCT01685801|11731152|FG003|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||1
10576132|NCT01685801|11731149|FG000|STARTED|Washout Period 2 (4 Weeks)||5
10576133|NCT01685801|11731150|FG001|STARTED|Washout Period 2 (4 Weeks)||5
10576134|NCT01685801|11731151|FG002|STARTED|Washout Period 2 (4 Weeks)||7
10576135|NCT01685801|11731152|FG003|STARTED|Washout Period 2 (4 Weeks)||4
10576136|NCT01685801|11731149|FG000|COMPLETED|Washout Period 2 (4 Weeks)||5
10576137|NCT01685801|11731150|FG001|COMPLETED|Washout Period 2 (4 Weeks)||5
10576138|NCT01685801|11731151|FG002|COMPLETED|Washout Period 2 (4 Weeks)||7
10576139|NCT01685801|11731152|FG003|COMPLETED|Washout Period 2 (4 Weeks)||4
10576140|NCT01685801|11731149|FG000|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
10576141|NCT01685801|11731150|FG001|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
10576142|NCT01685801|11731151|FG002|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
10576143|NCT01685801|11731152|FG003|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
10576144|NCT01685801|11731149|FG000|STARTED|Open-label Period (8 Weeks)||5
10576145|NCT01685801|11731150|FG001|STARTED|Open-label Period (8 Weeks)||5
10576146|NCT01685801|11731151|FG002|STARTED|Open-label Period (8 Weeks)||7
10576147|NCT01685801|11731152|FG003|STARTED|Open-label Period (8 Weeks)||4
10576148|NCT01685801|11731149|FG000|COMPLETED|Open-label Period (8 Weeks)||5
10576149|NCT01685801|11731150|FG001|COMPLETED|Open-label Period (8 Weeks)||5
10576150|NCT01685801|11731151|FG002|COMPLETED|Open-label Period (8 Weeks)||7
10576151|NCT01685801|11731152|FG003|COMPLETED|Open-label Period (8 Weeks)||4
10576152|NCT01685801|11731149|FG000|NOT COMPLETED|Open-label Period (8 Weeks)||0
10576153|NCT01685801|11731150|FG001|NOT COMPLETED|Open-label Period (8 Weeks)||0
10576154|NCT01685801|11731151|FG002|NOT COMPLETED|Open-label Period (8 Weeks)||0
10576155|NCT01685801|11731152|FG003|NOT COMPLETED|Open-label Period (8 Weeks)||0
10576156|NCT01685840|11731171|FG000|STARTED|Overall Study||448
10576157|NCT01685840|11731172|FG001|STARTED|Overall Study||446
10576158|NCT01685840|11731171|FG000|COMPLETED|Overall Study||119
10576159|NCT01685840|11731172|FG001|COMPLETED|Overall Study||114
10805292|NCT04016623|11966878|FG000|NOT COMPLETED|Pair 1 Test / Control Dispense||0
10805293|NCT04016623|11966878|FG000|STARTED|Pair 1 Test /Control Follow up||10
10805294|NCT04016623|11966878|FG000|COMPLETED|Pair 1 Test /Control Follow up||10
10805295|NCT04016623|11966878|FG000|NOT COMPLETED|Pair 1 Test /Control Follow up||0
10805296|NCT04016623|11966878|FG000|STARTED|Pair 2 Test / Control Dispense||10
10805297|NCT04016623|11966878|FG000|COMPLETED|Pair 2 Test / Control Dispense||10
10576160|NCT01685840|11731171|FG000|NOT COMPLETED|Overall Study||329
10576161|NCT01685840|11731172|FG001|NOT COMPLETED|Overall Study||332
10576162|NCT01685983|11731180|FG000|STARTED|Overall Study||82
10576163|NCT01685983|11731180|FG000|COMPLETED|Overall Study||0
10576164|NCT01685983|11731180|FG000|NOT COMPLETED|Overall Study||82
10576165|NCT01685996|11731186|FG000|STARTED|Overall Study||34
10576166|NCT01685996|11731187|FG001|STARTED|Overall Study||40
10576167|NCT01685996|11731186|FG000|COMPLETED|Overall Study||18
10576168|NCT01685996|11731187|FG001|COMPLETED|Overall Study||27
10576169|NCT01685996|11731186|FG000|NOT COMPLETED|Overall Study||16
10576170|NCT01685996|11731187|FG001|NOT COMPLETED|Overall Study||13
10576171|NCT01686152|11731196|FG000|STARTED|Overall Study||252
10576172|NCT01686152|11731197|FG001|STARTED|Overall Study||253
10576173|NCT01686152|11731198|FG002|STARTED|Overall Study||84
10576174|NCT01686152|11731196|FG000|COMPLETED|Overall Study||211
10576175|NCT01686152|11731197|FG001|COMPLETED|Overall Study||218
10576176|NCT01686152|11731198|FG002|COMPLETED|Overall Study||75
10576177|NCT01686152|11731196|FG000|NOT COMPLETED|Overall Study||41
10576178|NCT01686152|11731197|FG001|NOT COMPLETED|Overall Study||35
10576179|NCT01686152|11731198|FG002|NOT COMPLETED|Overall Study||9
10576180|NCT01686165|11731206|FG000|STARTED|Overall Study||5
10576181|NCT01686165|11731206|FG000|COMPLETED|Overall Study||5
10576182|NCT01686165|11731206|FG000|NOT COMPLETED|Overall Study||0
10576183|NCT01686373|11731212|FG000|STARTED|Overall Study||34
10576184|NCT01686373|11731213|FG001|STARTED|Overall Study||40
10576185|NCT01686373|11731212|FG000|Received 15 Treatment Sessions|Overall Study||33
10576186|NCT01686373|11731213|FG001|Received 15 Treatment Sessions|Overall Study||39
10805298|NCT04016623|11966878|FG000|NOT COMPLETED|Pair 2 Test / Control Dispense||0
10805299|NCT04016623|11966878|FG000|STARTED|Pair 2 Test /Control Follow up||10
10805300|NCT04016623|11966878|FG000|COMPLETED|Pair 2 Test /Control Follow up||10
10805301|NCT04016623|11966878|FG000|NOT COMPLETED|Pair 2 Test /Control Follow up||0
10576187|NCT01686373|11731212|FG000|COMPLETED|Overall Study||31
10576188|NCT01686373|11731213|FG001|COMPLETED|Overall Study||38
10576189|NCT01686373|11731212|FG000|NOT COMPLETED|Overall Study||3
10805302|NCT04016623|11966878|FG000|STARTED|Pair 3 Test / Control Dispense||10
10805303|NCT04016623|11966878|FG000|COMPLETED|Pair 3 Test / Control Dispense||10
10576190|NCT01686373|11731213|FG001|NOT COMPLETED|Overall Study||2
10576191|NCT01686438|11731222|FG000|STARTED|Overall Study||15
10576192|NCT01686438|11731223|FG001|STARTED|Overall Study||35
10576193|NCT01686438|11731224|FG002|STARTED|Overall Study||37
10576194|NCT01686438|11731222|FG000|2-Week Follow Up|Overall Study||12
10576195|NCT01686438|11731223|FG001|2-Week Follow Up|Overall Study||31
10576196|NCT01686438|11731224|FG002|2-Week Follow Up|Overall Study||27
10576197|NCT01686438|11731222|FG000|3-Month Follow Up|Overall Study||7
10576198|NCT01686438|11731223|FG001|3-Month Follow Up|Overall Study||21
10576199|NCT01686438|11731224|FG002|3-Month Follow Up|Overall Study||17
10576200|NCT01686438|11731222|FG000|6-Month Follow Up|Overall Study||7
10576201|NCT01686438|11731223|FG001|6-Month Follow Up|Overall Study||26
10576202|NCT01686438|11731224|FG002|6-Month Follow Up|Overall Study||24
10576203|NCT01686438|11731222|FG000|COMPLETED|Overall Study||7
10576204|NCT01686438|11731223|FG001|COMPLETED|Overall Study||26
10576205|NCT01686438|11731224|FG002|COMPLETED|Overall Study||24
10576206|NCT01686438|11731222|FG000|NOT COMPLETED|Overall Study||8
10576207|NCT01686438|11731223|FG001|NOT COMPLETED|Overall Study||9
10576208|NCT01686438|11731224|FG002|NOT COMPLETED|Overall Study||13
10576209|NCT01686451|11731236|FG000|STARTED|Overall Study||33
10576210|NCT01686451|11731237|FG001|STARTED|Overall Study||27
10576211|NCT01686451|11731236|FG000|COMPLETED|Overall Study||33
10576212|NCT01686451|11731237|FG001|COMPLETED|Overall Study||27
10576213|NCT01686451|11731236|FG000|NOT COMPLETED|Overall Study||0
10576214|NCT01686451|11731237|FG001|NOT COMPLETED|Overall Study||0
10576215|NCT01686503|11731249|FG000|STARTED|Overall Study||66
10576216|NCT01686503|11731250|FG001|STARTED|Overall Study||66
10576217|NCT01686503|11731251|FG002|STARTED|Overall Study||66
10576218|NCT01686503|11731252|FG003|STARTED|Overall Study||33
10576219|NCT01686503|11731249|FG000|COMPLETED|Overall Study||65
10576220|NCT01686503|11731250|FG001|COMPLETED|Overall Study||63
10576221|NCT01686503|11731251|FG002|COMPLETED|Overall Study||64
10576222|NCT01686503|11731252|FG003|COMPLETED|Overall Study||32
10576223|NCT01686503|11731249|FG000|NOT COMPLETED|Overall Study||1
10576224|NCT01686503|11731250|FG001|NOT COMPLETED|Overall Study||3
10576225|NCT01686503|11731251|FG002|NOT COMPLETED|Overall Study||2
10576226|NCT01686503|11731252|FG003|NOT COMPLETED|Overall Study||1
10576227|NCT01686568|11731264|FG000|STARTED|Main Study||16
10576228|NCT01686568|11731265|FG001|STARTED|Main Study||15
10576229|NCT01686568|11731264|FG000|COMPLETED|Main Study||14
10576230|NCT01686568|11731265|FG001|COMPLETED|Main Study||11
10576231|NCT01686568|11731264|FG000|NOT COMPLETED|Main Study||2
10576232|NCT01686568|11731265|FG001|NOT COMPLETED|Main Study||4
10576233|NCT01686568|11731264|FG000|STARTED|Sub-Study||14
10576234|NCT01686568|11731265|FG001|STARTED|Sub-Study||11
10576235|NCT01686568|11731264|FG000|COMPLETED|Sub-Study||12
10576236|NCT01686568|11731265|FG001|COMPLETED|Sub-Study||9
10576237|NCT01686568|11731264|FG000|NOT COMPLETED|Sub-Study||2
10576238|NCT01686568|11731265|FG001|NOT COMPLETED|Sub-Study||2
10576239|NCT01686581|11731271|FG000|STARTED|Overall Study||641
10576240|NCT01686581|11731271|FG000|Safety Analysis Set; Received Study Drug|Overall Study||633
10576241|NCT01686581|11731271|FG000|Completed 24 Months|Overall Study||128
10576242|NCT01686581|11731271|FG000|COMPLETED|Overall Study||464
10576243|NCT01686581|11731271|FG000|NOT COMPLETED|Overall Study||177
10576244|NCT01686633|11731278|FG000|STARTED|Overall Study||347
10576245|NCT01686633|11731279|FG001|STARTED|Overall Study||346
10576246|NCT01686633|11731280|FG002|STARTED|Overall Study||346
10576247|NCT01686633|11731278|FG000|COMPLETED|Overall Study||296
10576248|NCT01686633|11731279|FG001|COMPLETED|Overall Study||314
10576249|NCT01686633|11731280|FG002|COMPLETED|Overall Study||321
10576250|NCT01686633|11731278|FG000|NOT COMPLETED|Overall Study||51
10576251|NCT01686633|11731279|FG001|NOT COMPLETED|Overall Study||32
10576252|NCT01686633|11731280|FG002|NOT COMPLETED|Overall Study||25
10576253|NCT01686646|11731292|FG000|STARTED|Overall Study||45
10576254|NCT01686646|11731293|FG001|STARTED|Overall Study||45
10576255|NCT01686646|11731294|FG002|STARTED|Overall Study||75
10576256|NCT01686646|11731295|FG003|STARTED|Overall Study||75
10576257|NCT01686646|11731292|FG000|Intent to Treat Population|Overall Study||45
10576258|NCT01686646|11731293|FG001|Intent to Treat Population|Overall Study||45
10576259|NCT01686646|11731294|FG002|Intent to Treat Population|Overall Study||75
10576260|NCT01686646|11731295|FG003|Intent to Treat Population|Overall Study||75
10576261|NCT01686646|11731292|FG000|Safety Population|Overall Study|One subject randomized to Paracetamol+Caffeine (500/65) group but received 1000/130 combination.|46
10576262|NCT01686646|11731293|FG001|Safety Population|Overall Study||45
10576263|NCT01686646|11731294|FG002|Safety Population|Overall Study||74
10576264|NCT01686646|11731295|FG003|Safety Population|Overall Study||75
10576265|NCT01686646|11731292|FG000|COMPLETED|Overall Study||45
10576266|NCT01686646|11731293|FG001|COMPLETED|Overall Study||45
10576267|NCT01686646|11731294|FG002|COMPLETED|Overall Study||75
10576268|NCT01686646|11731295|FG003|COMPLETED|Overall Study||75
10576269|NCT01686646|11731292|FG000|NOT COMPLETED|Overall Study||0
10576270|NCT01686646|11731293|FG001|NOT COMPLETED|Overall Study||0
10576271|NCT01686646|11731294|FG002|NOT COMPLETED|Overall Study||0
10576272|NCT01686646|11731295|FG003|NOT COMPLETED|Overall Study||0
10576273|NCT01686750|11731307|FG000|STARTED|Overall Study||11001
10576274|NCT01686750|11731308|FG001|STARTED|Overall Study||10725
10576275|NCT01686750|11731307|FG000|COMPLETED|Overall Study||11001
10576276|NCT01686750|11731308|FG001|COMPLETED|Overall Study||10725
10576277|NCT01686750|11731307|FG000|NOT COMPLETED|Overall Study||0
10576278|NCT01686750|11731308|FG001|NOT COMPLETED|Overall Study||0
10576279|NCT01686828|11731320|FG000|STARTED|Overall Study||13
10576280|NCT01686828|11731321|FG001|STARTED|Overall Study||14
10576281|NCT01686828|11731322|FG002|STARTED|Overall Study||13
10576282|NCT01686828|11731323|FG003|STARTED|Overall Study||13
10576283|NCT01686828|11731320|FG000|COMPLETED|Overall Study||12
10576284|NCT01686828|11731321|FG001|COMPLETED|Overall Study||13
10576285|NCT01686828|11731322|FG002|COMPLETED|Overall Study||12
10576286|NCT01686828|11731323|FG003|COMPLETED|Overall Study||13
10576287|NCT01686828|11731320|FG000|NOT COMPLETED|Overall Study||1
10576288|NCT01686828|11731321|FG001|NOT COMPLETED|Overall Study||1
10576289|NCT01686828|11731322|FG002|NOT COMPLETED|Overall Study||1
10576290|NCT01686828|11731323|FG003|NOT COMPLETED|Overall Study||0
10576291|NCT01686932|11731339|FG000|STARTED|Period 1||25
10576292|NCT01686932|11731340|FG001|STARTED|Period 1||26
10576293|NCT01686932|11731339|FG000|COMPLETED|Period 1||24
10576294|NCT01686932|11731340|FG001|COMPLETED|Period 1||25
10576295|NCT01686932|11731339|FG000|NOT COMPLETED|Period 1||1
10576296|NCT01686932|11731340|FG001|NOT COMPLETED|Period 1||1
10576297|NCT01686932|11731339|FG000|STARTED|Period 2||24
10576298|NCT01686932|11731340|FG001|STARTED|Period 2||25
10576299|NCT01686932|11731339|FG000|COMPLETED|Period 2||24
10576300|NCT01686932|11731340|FG001|COMPLETED|Period 2||25
10576301|NCT01686932|11731339|FG000|NOT COMPLETED|Period 2||0
10576302|NCT01686932|11731340|FG001|NOT COMPLETED|Period 2||0
10576303|NCT01686958|11731346|FG000|STARTED|Overall Study||30
10576304|NCT01686958|11731346|FG000|COMPLETED|Overall Study|No. of patients who completed ALL assessments at 12 months post treatment; 1 pt only had PSA test.|29
10576305|NCT01686958|11731346|FG000|NOT COMPLETED|Overall Study||1
10576306|NCT01687036|11731351|FG000|STARTED|Overall Study||10
10576307|NCT01687036|11731351|FG000|COMPLETED|Overall Study||10
10576308|NCT01687036|11731351|FG000|NOT COMPLETED|Overall Study||0
10576309|NCT01687088|11731357|FG000|STARTED|Overall Study||50
10576310|NCT01687088|11731358|FG001|STARTED|Overall Study||50
10576311|NCT01687088|11731357|FG000|COMPLETED|Overall Study||50
10576312|NCT01687088|11731358|FG001|COMPLETED|Overall Study||50
10576313|NCT01687088|11731357|FG000|NOT COMPLETED|Overall Study||0
10576314|NCT01687088|11731358|FG001|NOT COMPLETED|Overall Study||0
10576315|NCT01687101|11731364|FG000|STARTED|Overall Study||32
10576316|NCT01687101|11731364|FG000|COMPLETED|Overall Study||25
10576317|NCT01687101|11731364|FG000|NOT COMPLETED|Overall Study||7
10576318|NCT01687114|11731368|FG000|STARTED|Overall Study||5
10576319|NCT01687114|11731368|FG000|COMPLETED|Overall Study||5
10576320|NCT01687114|11731368|FG000|NOT COMPLETED|Overall Study||0
10576321|NCT01687166|11731376|FG000|STARTED|Overall Study||167
10576322|NCT01687166|11731377|FG001|STARTED|Overall Study||172
10576323|NCT01687166|11731378|FG002|STARTED|Overall Study||56
10576324|NCT01687166|11731379|FG003|STARTED|Overall Study||3
10576325|NCT01687166|11731376|FG000|COMPLETED|Overall Study||139
10576326|NCT01687166|11731377|FG001|COMPLETED|Overall Study||145
10576327|NCT01687166|11731378|FG002|COMPLETED|Overall Study||42
10576328|NCT01687166|11731379|FG003|COMPLETED|Overall Study||1
10333686|NCT00334802|11469848|FG000|STARTED|Overall Study||6
10333687|NCT00334802|11469849|FG001|STARTED|Overall Study||56
10333688|NCT00334802|11469848|FG000|COMPLETED|Overall Study||0
10333689|NCT00334802|11469849|FG001|COMPLETED|Overall Study||16
10333690|NCT00334802|11469848|FG000|NOT COMPLETED|Overall Study||6
10333691|NCT00334802|11469849|FG001|NOT COMPLETED|Overall Study||40
10576329|NCT01687166|11731376|FG000|NOT COMPLETED|Overall Study||28
10576330|NCT01687166|11731377|FG001|NOT COMPLETED|Overall Study||27
10576331|NCT01687166|11731378|FG002|NOT COMPLETED|Overall Study||14
10576332|NCT01687166|11731379|FG003|NOT COMPLETED|Overall Study||2
10576333|NCT01687179|11731387|FG000|STARTED|Overall Study||3
10805304|NCT04016623|11966878|FG000|NOT COMPLETED|Pair 3 Test / Control Dispense||0
10805305|NCT04016623|11966878|FG000|STARTED|Pair 3 Test /Control Follow up||10
10805306|NCT04016623|11966878|FG000|COMPLETED|Pair 3 Test /Control Follow up||10
10576334|NCT01687179|11731388|FG001|STARTED|Overall Study||10
10576335|NCT01687179|11731387|FG000|COMPLETED|Overall Study||2
10576336|NCT01687179|11731388|FG001|COMPLETED|Overall Study||6
10576337|NCT01687179|11731387|FG000|NOT COMPLETED|Overall Study||1
10576338|NCT01687179|11731388|FG001|NOT COMPLETED|Overall Study||4
10576339|NCT01687218|11731400|FG000|STARTED|Overall Study||33
10576340|NCT01687218|11731401|FG001|STARTED|Overall Study||32
10576341|NCT01687218|11731402|FG002|STARTED|Overall Study||31
10576342|NCT01687218|11731403|FG003|STARTED|Overall Study||34
10576343|NCT01687218|11731404|FG004|STARTED|Overall Study||33
10576344|NCT01687218|11731405|FG005|STARTED|Overall Study||32
10576345|NCT01687218|11731400|FG000|COMPLETED|Overall Study||30
10576346|NCT01687218|11731401|FG001|COMPLETED|Overall Study||29
10576347|NCT01687218|11731402|FG002|COMPLETED|Overall Study||30
10576348|NCT01687218|11731403|FG003|COMPLETED|Overall Study||32
10805307|NCT04016623|11966878|FG000|NOT COMPLETED|Pair 3 Test /Control Follow up||0
10805308|NCT04016623|11966878|FG000|STARTED|Pair 4 Test / Control Dispense||10
10805309|NCT04016623|11966878|FG000|COMPLETED|Pair 4 Test / Control Dispense||10
10805310|NCT04016623|11966878|FG000|NOT COMPLETED|Pair 4 Test / Control Dispense||0
10576349|NCT01687218|11731404|FG004|COMPLETED|Overall Study||32
10576350|NCT01687218|11731405|FG005|COMPLETED|Overall Study||32
10576351|NCT01687218|11731400|FG000|NOT COMPLETED|Overall Study||3
10576352|NCT01687218|11731401|FG001|NOT COMPLETED|Overall Study||3
10576353|NCT01687218|11731402|FG002|NOT COMPLETED|Overall Study||1
10576354|NCT01687218|11731403|FG003|NOT COMPLETED|Overall Study||2
10576355|NCT01687218|11731404|FG004|NOT COMPLETED|Overall Study||1
10576356|NCT01687218|11731405|FG005|NOT COMPLETED|Overall Study||0
10576357|NCT01687244|11731415|FG000|STARTED|Overall Study||21
10576358|NCT01687244|11731416|FG001|STARTED|Overall Study||19
10576359|NCT01687244|11731415|FG000|COMPLETED|Overall Study||21
10576360|NCT01687244|11731416|FG001|COMPLETED|Overall Study||19
10576361|NCT01687244|11731415|FG000|NOT COMPLETED|Overall Study||0
10576362|NCT01687244|11731416|FG001|NOT COMPLETED|Overall Study||0
10576363|NCT01687257|11731432|FG000|STARTED|Overall Study||25
10576364|NCT01687257|11731433|FG001|STARTED|Overall Study||4
10576365|NCT01687257|11731434|FG002|STARTED|Overall Study||21
10576366|NCT01687257|11731432|FG000|COMPLETED|Overall Study||17
10576367|NCT01687257|11731433|FG001|COMPLETED|Overall Study||0
10576368|NCT01687257|11731434|FG002|COMPLETED|Overall Study||15
10576369|NCT01687257|11731432|FG000|NOT COMPLETED|Overall Study||8
10576370|NCT01687257|11731433|FG001|NOT COMPLETED|Overall Study||4
10576371|NCT01687257|11731434|FG002|NOT COMPLETED|Overall Study||6
10576372|NCT01687270|11731448|FG000|STARTED|Overall Study||40
10576373|NCT01687270|11731448|FG000|COMPLETED|Overall Study||28
10576374|NCT01687270|11731448|FG000|NOT COMPLETED|Overall Study||12
10576375|NCT01687283|11731454|FG000|STARTED|Overall Study||158
10576376|NCT01687283|11731455|FG001|STARTED|Overall Study||157
10576377|NCT01687283|11731454|FG000|COMPLETED|Overall Study||123
10576378|NCT01687283|11731455|FG001|COMPLETED|Overall Study||130
10576379|NCT01687283|11731454|FG000|NOT COMPLETED|Overall Study||35
10576380|NCT01687283|11731455|FG001|NOT COMPLETED|Overall Study||27
10576381|NCT01687296|11731463|FG000|STARTED|Overall Study||123
10576382|NCT01687296|11731464|FG001|STARTED|Overall Study||128
10576383|NCT01687296|11731463|FG000|COMPLETED|Overall Study||116
10576384|NCT01687296|11731464|FG001|COMPLETED|Overall Study||123
10576385|NCT01687296|11731463|FG000|NOT COMPLETED|Overall Study||7
10576386|NCT01687296|11731464|FG001|NOT COMPLETED|Overall Study||5
10576387|NCT01687387|11731473|FG000|STARTED|Overall Study||51
10576388|NCT01687387|11731474|FG001|STARTED|Overall Study||50
10576389|NCT01687387|11731475|FG002|STARTED|Overall Study||51
10576390|NCT01687387|11731473|FG000|COMPLETED|Overall Study||10
10576391|NCT01687387|11731474|FG001|COMPLETED|Overall Study||12
10576392|NCT01687387|11731475|FG002|COMPLETED|Overall Study||13
10576393|NCT01687387|11731473|FG000|NOT COMPLETED|Overall Study||41
10576394|NCT01687387|11731474|FG001|NOT COMPLETED|Overall Study||38
10805311|NCT04016623|11966878|FG000|STARTED|Pair 4 Test /Control Follow up||10
10805312|NCT04016623|11966878|FG000|COMPLETED|Pair 4 Test /Control Follow up||10
10805313|NCT04016623|11966878|FG000|NOT COMPLETED|Pair 4 Test /Control Follow up||0
10805314|NCT04013737|11966900|FG000|STARTED|Overall Study||18
10805315|NCT04013737|11966901|FG001|STARTED|Overall Study||15
10805316|NCT04013737|11966900|FG000|COMPLETED|Overall Study|12 participants declined to participate in the study|18
10805317|NCT04013737|11966901|FG001|COMPLETED|Overall Study||15
10805318|NCT04013737|11966900|FG000|NOT COMPLETED|Overall Study||0
10805319|NCT04013737|11966901|FG001|NOT COMPLETED|Overall Study||0
10805320|NCT04014062|11966908|FG000|STARTED|Period I: Dosing||71
10805321|NCT04014062|11966909|FG001|STARTED|Period I: Dosing||71
10805322|NCT04014062|11966908|FG000|COMPLETED|Period I: Dosing|Period I: Dosing, includes a washout period of 42 days before starting Period II: Crossover Dosing|64
10576395|NCT01687387|11731475|FG002|NOT COMPLETED|Overall Study||38
10576396|NCT01687400|11731483|FG000|STARTED|Overall Study||114
10576397|NCT01687400|11731483|FG000|COMPLETED|Overall Study||114
10576398|NCT01687400|11731483|FG000|NOT COMPLETED|Overall Study||0
10576399|NCT01687413|11731494|FG000|STARTED|Overall Study||27
10576400|NCT01687413|11731495|FG001|STARTED|Overall Study||15
10576401|NCT01687413|11731494|FG000|COMPLETED|Overall Study||26
10576402|NCT01687413|11731495|FG001|COMPLETED|Overall Study||11
10576403|NCT01687413|11731494|FG000|NOT COMPLETED|Overall Study||1
10805323|NCT04014062|11966909|FG001|COMPLETED|Period I: Dosing|Period I: Dosing, includes a washout period of 42 days before starting Period II: Crossover Dosing|65
10805324|NCT04014062|11966908|FG000|NOT COMPLETED|Period I: Dosing||7
10805325|NCT04014062|11966909|FG001|NOT COMPLETED|Period I: Dosing||6
10805326|NCT04014062|11966908|FG000|STARTED|Period II: Crossover Dosing||64
10805327|NCT04014062|11966909|FG001|STARTED|Period II: Crossover Dosing||65
10805328|NCT04014062|11966908|FG000|COMPLETED|Period II: Crossover Dosing||64
10805329|NCT04014062|11966909|FG001|COMPLETED|Period II: Crossover Dosing||65
10805330|NCT04014062|11966908|FG000|NOT COMPLETED|Period II: Crossover Dosing||0
10805331|NCT04014062|11966909|FG001|NOT COMPLETED|Period II: Crossover Dosing||0
10805332|NCT04013789|11966920|FG000|STARTED|First Wear Period (1 Week)||33
10805333|NCT04013789|11966921|FG001|STARTED|First Wear Period (1 Week)||34
10805334|NCT04013789|11966920|FG000|COMPLETED|First Wear Period (1 Week)||33
10805335|NCT04013789|11966921|FG001|COMPLETED|First Wear Period (1 Week)||34
10805336|NCT04013789|11966920|FG000|NOT COMPLETED|First Wear Period (1 Week)||0
10805337|NCT04013789|11966921|FG001|NOT COMPLETED|First Wear Period (1 Week)||0
10805338|NCT04013789|11966920|FG000|STARTED|Second Wear Period (1 Week)|One subject withdrew from the study between the first wear period and the second wear period.|32
10576404|NCT01687413|11731495|FG001|NOT COMPLETED|Overall Study||4
10576405|NCT01687478|11731521|FG000|STARTED|Overall Study||88
10576406|NCT01687478|11731522|FG001|STARTED|Overall Study||88
10576407|NCT01687478|11731521|FG000|Safety Analysis Set|Overall Study||88
10576408|NCT01687478|11731522|FG001|Safety Analysis Set|Overall Study||87
10805339|NCT04013789|11966921|FG001|STARTED|Second Wear Period (1 Week)||34
10805340|NCT04013789|11966920|FG000|COMPLETED|Second Wear Period (1 Week)||32
10576409|NCT01687478|11731521|FG000|COMPLETED|Overall Study||56
10576410|NCT01687478|11731522|FG001|COMPLETED|Overall Study||49
10576411|NCT01687478|11731521|FG000|NOT COMPLETED|Overall Study||32
10576412|NCT01687478|11731522|FG001|NOT COMPLETED|Overall Study||39
10576413|NCT01687595|11731530|FG000|STARTED|Overall Study||70
10576414|NCT01687595|11731531|FG001|STARTED|Overall Study||10
10576415|NCT01687595|11731530|FG000|Received at Least 1 Dose of Study Drug|Overall Study||70
10576416|NCT01687595|11731531|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
10576417|NCT01687595|11731530|FG000|COMPLETED|Overall Study||0
10576418|NCT01687595|11731531|FG001|COMPLETED|Overall Study||0
10576419|NCT01687595|11731530|FG000|NOT COMPLETED|Overall Study||70
10576420|NCT01687595|11731531|FG001|NOT COMPLETED|Overall Study||10
10576421|NCT01687673|11731537|FG000|STARTED|Overall Study||29
10576422|NCT01687673|11731537|FG000|COMPLETED|Overall Study||28
10576423|NCT01687673|11731537|FG000|NOT COMPLETED|Overall Study||1
10576424|NCT01687712|11731543|FG000|STARTED|Cycle 1||549
10576425|NCT01687712|11731544|FG001|STARTED|Cycle 1||551
10576426|NCT01687712|11731543|FG000|Received hCG|Cycle 1||516
10576427|NCT01687712|11731544|FG001|Received hCG|Cycle 1||520
10576428|NCT01687712|11731543|FG000|Oocyte/Ovum Pick Up|Cycle 1||513
10576429|NCT01687712|11731544|FG001|Oocyte/Ovum Pick Up|Cycle 1||517
10576430|NCT01687712|11731543|FG000|Fertilization Performed|Cycle 1||508
10576431|NCT01687712|11731544|FG001|Fertilization Performed|Cycle 1||512
10576432|NCT01687712|11731543|FG000|Embryo Transfer|Cycle 1||466
10576433|NCT01687712|11731544|FG001|Embryo Transfer|Cycle 1||483
10576434|NCT01687712|11731543|FG000|Biochemical Pregnancy|Cycle 1||163
10576435|NCT01687712|11731544|FG001|Biochemical Pregnancy|Cycle 1||203
10576436|NCT01687712|11731543|FG000|Clinical Pregnancy|Cycle 1||114
10576437|NCT01687712|11731544|FG001|Clinical Pregnancy|Cycle 1||138
10576438|NCT01687712|11731543|FG000|COMPLETED|Cycle 1||101
10576439|NCT01687712|11731544|FG001|COMPLETED|Cycle 1||122
10576440|NCT01687712|11731543|FG000|NOT COMPLETED|Cycle 1||448
10576441|NCT01687712|11731544|FG001|NOT COMPLETED|Cycle 1||429
10576442|NCT01687712|11731543|FG000|STARTED|Cycle 2||109
10576443|NCT01687712|11731544|FG001|STARTED|Cycle 2||120
10576444|NCT01687712|11731543|FG000|Received hCG|Cycle 2||107
10576445|NCT01687712|11731544|FG001|Received hCG|Cycle 2||119
10576446|NCT01687712|11731543|FG000|Oocyte/Ovum Pick Up|Cycle 2||107
10576447|NCT01687712|11731544|FG001|Oocyte/Ovum Pick Up|Cycle 2||119
10576448|NCT01687712|11731543|FG000|Fertilization Performed|Cycle 2||106
10576449|NCT01687712|11731544|FG001|Fertilization Performed|Cycle 2||119
10576450|NCT01687712|11731543|FG000|Embryo Transfer|Cycle 2||101
10576451|NCT01687712|11731544|FG001|Embryo Transfer|Cycle 2||117
10576452|NCT01687712|11731543|FG000|Biochemical Pregnancy|Cycle 2||35
10576453|NCT01687712|11731544|FG001|Biochemical Pregnancy|Cycle 2||43
10576454|NCT01687712|11731543|FG000|Clinical Pregnancy|Cycle 2||17
10576455|NCT01687712|11731544|FG001|Clinical Pregnancy|Cycle 2||26
10576456|NCT01687712|11731543|FG000|COMPLETED|Cycle 2||16
10576457|NCT01687712|11731544|FG001|COMPLETED|Cycle 2||25
10576458|NCT01687712|11731543|FG000|NOT COMPLETED|Cycle 2||93
10576459|NCT01687712|11731544|FG001|NOT COMPLETED|Cycle 2||95
10576460|NCT01687712|11731543|FG000|STARTED|Cycle 3||28
10576461|NCT01687712|11731544|FG001|STARTED|Cycle 3||24
10576462|NCT01687712|11731543|FG000|Received hCG|Cycle 3||27
10576463|NCT01687712|11731544|FG001|Received hCG|Cycle 3||24
10576464|NCT01687712|11731543|FG000|Ooctye/Ovum Pick-Up|Cycle 3||27
10576465|NCT01687712|11731544|FG001|Ooctye/Ovum Pick-Up|Cycle 3||24
10576466|NCT01687712|11731543|FG000|Fertilization Performed|Cycle 3||27
10576467|NCT01687712|11731544|FG001|Fertilization Performed|Cycle 3||24
10576468|NCT01687712|11731543|FG000|Embryo Transfer|Cycle 3||26
10576469|NCT01687712|11731544|FG001|Embryo Transfer|Cycle 3||24
10576470|NCT01687712|11731543|FG000|Biochemically Pregnant|Cycle 3||7
10576471|NCT01687712|11731544|FG001|Biochemically Pregnant|Cycle 3||2
10576472|NCT01687712|11731543|FG000|Clinical Pregnancy|Cycle 3||5
10576473|NCT01687712|11731544|FG001|Clinical Pregnancy|Cycle 3||0
10576474|NCT01687712|11731543|FG000|COMPLETED|Cycle 3||4
10576475|NCT01687712|11731544|FG001|COMPLETED|Cycle 3||0
10576476|NCT01687712|11731543|FG000|NOT COMPLETED|Cycle 3||24
10576477|NCT01687712|11731544|FG001|NOT COMPLETED|Cycle 3||24
10576478|NCT01687790|11731554|FG000|STARTED|Overall Study||60
10576479|NCT01687790|11731554|FG000|COMPLETED|Overall Study||60
10576480|NCT01687790|11731554|FG000|NOT COMPLETED|Overall Study||0
10576481|NCT01687972|11731561|FG000|STARTED|Overall Study||44
10576482|NCT01687972|11731562|FG001|STARTED|Overall Study||44
10576483|NCT01687972|11731561|FG000|COMPLETED|Overall Study||44
10576484|NCT01687972|11731562|FG001|COMPLETED|Overall Study||44
10576485|NCT01687972|11731561|FG000|NOT COMPLETED|Overall Study||0
10576486|NCT01687972|11731562|FG001|NOT COMPLETED|Overall Study||0
10576487|NCT01687998|11731570|FG000|STARTED|Overall Study||6038
10576488|NCT01687998|11731571|FG001|STARTED|Overall Study||6054
10576489|NCT01687998|11731570|FG000|Received at Least One Dose of Study Drug|Overall Study||6036
10576490|NCT01687998|11731571|FG001|Received at Least One Dose of Study Drug|Overall Study||6052
10576491|NCT01687998|11731570|FG000|COMPLETED|Overall Study||5926
10576492|NCT01687998|11731571|FG001|COMPLETED|Overall Study||5934
10576493|NCT01687998|11731570|FG000|NOT COMPLETED|Overall Study||112
10576494|NCT01687998|11731571|FG001|NOT COMPLETED|Overall Study||120
10576495|NCT01688037|11731580|FG000|STARTED|Double-Blind Period (Week 0 to 6)||54
10576496|NCT01688037|11731581|FG001|STARTED|Double-Blind Period (Week 0 to 6)||28
10576497|NCT01688037|11731582|FG002|STARTED|Double-Blind Period (Week 0 to 6)||27
10576498|NCT01688037|11731580|FG000|COMPLETED|Double-Blind Period (Week 0 to 6)||47
10576499|NCT01688037|11731581|FG001|COMPLETED|Double-Blind Period (Week 0 to 6)||25
10576500|NCT01688037|11731582|FG002|COMPLETED|Double-Blind Period (Week 0 to 6)||21
10576501|NCT01688037|11731580|FG000|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||7
10576502|NCT01688037|11731581|FG001|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||3
10576503|NCT01688037|11731582|FG002|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||6
10576504|NCT01688037|11731580|FG000|STARTED|Open-Label Period (Week 6 to 12)||47
10576505|NCT01688037|11731581|FG001|STARTED|Open-Label Period (Week 6 to 12)||25
10576506|NCT01688037|11731582|FG002|STARTED|Open-Label Period (Week 6 to 12)||21
10576507|NCT01688037|11731580|FG000|COMPLETED|Open-Label Period (Week 6 to 12)||42
10651438|NCT02175771|11811627|FG002|STARTED|Treatment Period||42
10576508|NCT01688037|11731581|FG001|COMPLETED|Open-Label Period (Week 6 to 12)||22
10576509|NCT01688037|11731582|FG002|COMPLETED|Open-Label Period (Week 6 to 12)||17
10576510|NCT01688037|11731580|FG000|NOT COMPLETED|Open-Label Period (Week 6 to 12)||5
10576511|NCT01688037|11731581|FG001|NOT COMPLETED|Open-Label Period (Week 6 to 12)||3
10576512|NCT01688037|11731582|FG002|NOT COMPLETED|Open-Label Period (Week 6 to 12)||4
10576513|NCT01688037|11731580|FG000|STARTED|Follow-up Period (Week 12 to 16)||42
10576514|NCT01688037|11731581|FG001|STARTED|Follow-up Period (Week 12 to 16)||22
10576515|NCT01688037|11731582|FG002|STARTED|Follow-up Period (Week 12 to 16)||17
10576516|NCT01688037|11731580|FG000|COMPLETED|Follow-up Period (Week 12 to 16)||42
10576517|NCT01688037|11731581|FG001|COMPLETED|Follow-up Period (Week 12 to 16)||21
10576518|NCT01688037|11731582|FG002|COMPLETED|Follow-up Period (Week 12 to 16)||17
10576519|NCT01688037|11731580|FG000|NOT COMPLETED|Follow-up Period (Week 12 to 16)||0
10576520|NCT01688037|11731581|FG001|NOT COMPLETED|Follow-up Period (Week 12 to 16)||1
10576521|NCT01688037|11731582|FG002|NOT COMPLETED|Follow-up Period (Week 12 to 16)||0
10576522|NCT01688050|11731594|FG000|STARTED|Overall Study||50
10576523|NCT01688050|11731594|FG000|5-Year|Overall Study|Patients eligible for Follow-up at 5 year|22
10702189|NCT02573883|11866679|FG002|COMPLETED|One Year Follow Up||11
10702190|NCT02573883|11866680|FG003|COMPLETED|One Year Follow Up||10
10702191|NCT02573883|11866677|FG000|NOT COMPLETED|One Year Follow Up||2
10702192|NCT02573883|11866678|FG001|NOT COMPLETED|One Year Follow Up||1
10576524|NCT01688050|11731594|FG000|COMPLETED|Overall Study||19
10576525|NCT01688050|11731594|FG000|NOT COMPLETED|Overall Study||31
10576526|NCT01688102|11731600|FG000|STARTED|Overall Study||60
10576527|NCT01688102|11731601|FG001|STARTED|Overall Study||58
10576528|NCT01688102|11731600|FG000|COMPLETED|Overall Study||44
10576529|NCT01688102|11731601|FG001|COMPLETED|Overall Study||40
10576530|NCT01688102|11731600|FG000|NOT COMPLETED|Overall Study||16
10576531|NCT01688102|11731601|FG001|NOT COMPLETED|Overall Study||18
10576532|NCT01688141|11731609|FG000|STARTED|Overall Study||11706
10576533|NCT01688141|11731610|FG001|STARTED|Overall Study||11651
10576534|NCT01688141|11731609|FG000|COMPLETED|Overall Study||11706
10576535|NCT01688141|11731610|FG001|COMPLETED|Overall Study||11651
10576536|NCT01688141|11731609|FG000|NOT COMPLETED|Overall Study||0
10576537|NCT01688141|11731610|FG001|NOT COMPLETED|Overall Study||0
10576538|NCT01688310|11731618|FG000|STARTED|Overall Study||100
10576539|NCT01688310|11731619|FG001|STARTED|Overall Study||100
10576540|NCT01688310|11731618|FG000|COMPLETED|Overall Study||100
10576541|NCT01688310|11731619|FG001|COMPLETED|Overall Study||100
10576542|NCT01688310|11731618|FG000|NOT COMPLETED|Overall Study||0
10576543|NCT01688310|11731619|FG001|NOT COMPLETED|Overall Study||0
10576544|NCT01688336|11731627|FG000|STARTED|Overall Study||9
10576545|NCT01688336|11731627|FG000|COMPLETED|Overall Study||9
10576546|NCT01688336|11731627|FG000|NOT COMPLETED|Overall Study||0
10576547|NCT01688466|11731634|FG000|STARTED|Overall Study||17
10576548|NCT01688466|11731635|FG001|STARTED|Overall Study||17
10576549|NCT01688466|11731634|FG000|COMPLETED|Overall Study||15
10576550|NCT01688466|11731635|FG001|COMPLETED|Overall Study||10
10576551|NCT01688466|11731634|FG000|NOT COMPLETED|Overall Study||2
10576552|NCT01688466|11731635|FG001|NOT COMPLETED|Overall Study||7
10576553|NCT01688596|11731643|FG000|STARTED|Overall Study||67
10576554|NCT01688596|11731644|FG001|STARTED|Overall Study||68
10576555|NCT01688596|11731643|FG000|COMPLETED|Overall Study||59
10576556|NCT01688596|11731644|FG001|COMPLETED|Overall Study||59
10576557|NCT01688596|11731643|FG000|NOT COMPLETED|Overall Study||8
10576558|NCT01688596|11731644|FG001|NOT COMPLETED|Overall Study||9
10576559|NCT01688609|11731650|FG000|STARTED|Overall Study||18
10576560|NCT01688609|11731650|FG000|COMPLETED|Overall Study||18
10576561|NCT01688609|11731650|FG000|NOT COMPLETED|Overall Study||0
10702193|NCT02573883|11866679|FG002|NOT COMPLETED|One Year Follow Up||0
10702194|NCT02573883|11866680|FG003|NOT COMPLETED|One Year Follow Up||0
10702195|NCT02573948|11866695|FG000|STARTED|RDS||603
10702196|NCT02573948|11866695|FG000|COMPLETED|RDS||603
10576562|NCT01688635|11731654|FG000|STARTED|Period 1||45
10576563|NCT01688635|11731655|FG001|STARTED|Period 1||46
10576564|NCT01688635|11731654|FG000|Received at Least 1 Dose of Study Drug|Period 1||45
10576565|NCT01688635|11731655|FG001|Received at Least 1 Dose of Study Drug|Period 1||46
10576566|NCT01688635|11731654|FG000|COMPLETED|Period 1||45
10702197|NCT02573948|11866695|FG000|NOT COMPLETED|RDS||0
10702198|NCT02573948|11866695|FG000|STARTED|Longitudinal Cohort|Not on ART a/o MMT. MSM and FSW were prioritized for enrolling,|250
10702199|NCT02573948|11866695|FG000|COMPLETED|Longitudinal Cohort||194
10702200|NCT02573948|11866695|FG000|NOT COMPLETED|Longitudinal Cohort||56
10702201|NCT02574078|11866715|FG000|STARTED|Pre-Treatment Period||13
10702202|NCT02574078|11866716|FG001|STARTED|Pre-Treatment Period||6
10702203|NCT02574078|11866717|FG002|STARTED|Pre-Treatment Period||9
10702204|NCT02574078|11866718|FG003|STARTED|Pre-Treatment Period||35
10702205|NCT02574078|11866719|FG004|STARTED|Pre-Treatment Period||34
10702206|NCT02574078|11866720|FG005|STARTED|Pre-Treatment Period||35
10702207|NCT02574078|11866721|FG006|STARTED|Pre-Treatment Period||18
10702208|NCT02574078|11866722|FG007|STARTED|Pre-Treatment Period||17
10702209|NCT02574078|11866723|FG008|STARTED|Pre-Treatment Period||26
10702210|NCT02574078|11866724|FG009|STARTED|Pre-Treatment Period||26
10702211|NCT02574078|11866725|FG010|STARTED|Pre-Treatment Period||53
10702212|NCT02574078|11866726|FG011|STARTED|Pre-Treatment Period||56
10702213|NCT02574078|11866727|FG012|STARTED|Pre-Treatment Period||13
10702214|NCT02574078|11866715|FG000|COMPLETED|Pre-Treatment Period||13
10576567|NCT01688635|11731655|FG001|COMPLETED|Period 1||46
10576568|NCT01688635|11731654|FG000|NOT COMPLETED|Period 1||0
10576569|NCT01688635|11731655|FG001|NOT COMPLETED|Period 1||0
10576570|NCT01688635|11731654|FG000|STARTED|Washout 1||45
10576571|NCT01688635|11731655|FG001|STARTED|Washout 1||46
10576572|NCT01688635|11731654|FG000|COMPLETED|Washout 1||44
10576573|NCT01688635|11731655|FG001|COMPLETED|Washout 1||44
10576574|NCT01688635|11731654|FG000|NOT COMPLETED|Washout 1||1
10576575|NCT01688635|11731655|FG001|NOT COMPLETED|Washout 1||2
10576576|NCT01688635|11731654|FG000|STARTED|Period 2||44
10576577|NCT01688635|11731655|FG001|STARTED|Period 2||44
10576578|NCT01688635|11731654|FG000|COMPLETED|Period 2||44
10576579|NCT01688635|11731655|FG001|COMPLETED|Period 2||44
10576580|NCT01688635|11731654|FG000|NOT COMPLETED|Period 2||0
10576581|NCT01688635|11731655|FG001|NOT COMPLETED|Period 2||0
10576582|NCT01688635|11731654|FG000|STARTED|Washout 2||44
10576583|NCT01688635|11731655|FG001|STARTED|Washout 2||44
10576584|NCT01688635|11731654|FG000|COMPLETED|Washout 2||41
10576585|NCT01688635|11731655|FG001|COMPLETED|Washout 2||42
10576586|NCT01688635|11731654|FG000|NOT COMPLETED|Washout 2||3
10576587|NCT01688635|11731655|FG001|NOT COMPLETED|Washout 2||2
10576588|NCT01688635|11731654|FG000|STARTED|Period 3||41
10576589|NCT01688635|11731655|FG001|STARTED|Period 3||42
10576590|NCT01688635|11731654|FG000|COMPLETED|Period 3||41
10576591|NCT01688635|11731655|FG001|COMPLETED|Period 3||42
10576592|NCT01688635|11731654|FG000|NOT COMPLETED|Period 3||0
10576593|NCT01688635|11731655|FG001|NOT COMPLETED|Period 3||0
10576594|NCT01688635|11731654|FG000|STARTED|Washout 3||41
10576595|NCT01688635|11731655|FG001|STARTED|Washout 3||42
10576596|NCT01688635|11731654|FG000|COMPLETED|Washout 3||40
10576597|NCT01688635|11731655|FG001|COMPLETED|Washout 3||42
10576598|NCT01688635|11731654|FG000|NOT COMPLETED|Washout 3||1
10576599|NCT01688635|11731655|FG001|NOT COMPLETED|Washout 3||0
10576600|NCT01688635|11731654|FG000|STARTED|Period 4||40
10576601|NCT01688635|11731655|FG001|STARTED|Period 4||42
10576602|NCT01688635|11731654|FG000|COMPLETED|Period 4||40
10576603|NCT01688635|11731655|FG001|COMPLETED|Period 4||42
10576604|NCT01688635|11731654|FG000|NOT COMPLETED|Period 4||0
10576605|NCT01688635|11731655|FG001|NOT COMPLETED|Period 4||0
10576606|NCT01688726|11731664|FG000|STARTED|Overall Study||46
10576607|NCT01688726|11731665|FG001|STARTED|Overall Study||45
10576608|NCT01688726|11731664|FG000|COMPLETED|Overall Study||45
10576609|NCT01688726|11731665|FG001|COMPLETED|Overall Study||44
10576610|NCT01688726|11731664|FG000|NOT COMPLETED|Overall Study||1
10576611|NCT01688726|11731665|FG001|NOT COMPLETED|Overall Study||1
10576612|NCT01688739|11731685|FG000|STARTED|Overall Study||13
10576613|NCT01688739|11731686|FG001|STARTED|Overall Study||3
10576614|NCT01688739|11731687|FG002|STARTED|Overall Study||3
10576615|NCT01688739|11731688|FG003|STARTED|Overall Study||6
10576616|NCT01688739|11731689|FG004|STARTED|Overall Study||6
10576617|NCT01688739|11731690|FG005|STARTED|Overall Study||6
10576618|NCT01688739|11731691|FG006|STARTED|Overall Study||6
10576619|NCT01688739|11731692|FG007|STARTED|Overall Study||6
10576620|NCT01688739|11731693|FG008|STARTED|Overall Study||6
10576621|NCT01688739|11731694|FG009|STARTED|Overall Study||6
10576622|NCT01688739|11731685|FG000|Received Study Drug|Overall Study||12
10576623|NCT01688739|11731686|FG001|Received Study Drug|Overall Study||3
10576624|NCT01688739|11731687|FG002|Received Study Drug|Overall Study||3
10576625|NCT01688739|11731688|FG003|Received Study Drug|Overall Study||6
10576626|NCT01688739|11731689|FG004|Received Study Drug|Overall Study||6
10576627|NCT01688739|11731690|FG005|Received Study Drug|Overall Study||6
10576628|NCT01688739|11731691|FG006|Received Study Drug|Overall Study||6
10576629|NCT01688739|11731692|FG007|Received Study Drug|Overall Study||6
10576630|NCT01688739|11731693|FG008|Received Study Drug|Overall Study||6
10576631|NCT01688739|11731694|FG009|Received Study Drug|Overall Study||6
10576632|NCT01688739|11731685|FG000|COMPLETED|Overall Study||12
10576633|NCT01688739|11731686|FG001|COMPLETED|Overall Study||3
10805341|NCT04013789|11966921|FG001|COMPLETED|Second Wear Period (1 Week)||34
10805342|NCT04013789|11966920|FG000|NOT COMPLETED|Second Wear Period (1 Week)||0
10805343|NCT04013789|11966921|FG001|NOT COMPLETED|Second Wear Period (1 Week)||0
10805344|NCT04012970|11966931|FG000|STARTED|Intervention Session, 30 Minutes||26
10805345|NCT04012970|11966932|FG001|STARTED|Intervention Session, 30 Minutes||14
10805346|NCT04012970|11966931|FG000|COMPLETED|Intervention Session, 30 Minutes||26
10576634|NCT01688739|11731687|FG002|COMPLETED|Overall Study||3
10576635|NCT01688739|11731688|FG003|COMPLETED|Overall Study||6
10576636|NCT01688739|11731689|FG004|COMPLETED|Overall Study||6
10576637|NCT01688739|11731690|FG005|COMPLETED|Overall Study||6
10576638|NCT01688739|11731691|FG006|COMPLETED|Overall Study||6
10576639|NCT01688739|11731692|FG007|COMPLETED|Overall Study||6
10576640|NCT01688739|11731693|FG008|COMPLETED|Overall Study||6
10576641|NCT01688739|11731694|FG009|COMPLETED|Overall Study||6
10805347|NCT04012970|11966932|FG001|COMPLETED|Intervention Session, 30 Minutes||14
10805348|NCT04012970|11966931|FG000|NOT COMPLETED|Intervention Session, 30 Minutes||0
10576642|NCT01688739|11731685|FG000|NOT COMPLETED|Overall Study||1
10576643|NCT01688739|11731686|FG001|NOT COMPLETED|Overall Study||0
10576644|NCT01688739|11731687|FG002|NOT COMPLETED|Overall Study||0
10576645|NCT01688739|11731688|FG003|NOT COMPLETED|Overall Study||0
10576646|NCT01688739|11731689|FG004|NOT COMPLETED|Overall Study||0
10576647|NCT01688739|11731690|FG005|NOT COMPLETED|Overall Study||0
10576648|NCT01688739|11731691|FG006|NOT COMPLETED|Overall Study||0
10576649|NCT01688739|11731692|FG007|NOT COMPLETED|Overall Study||0
10576650|NCT01688739|11731693|FG008|NOT COMPLETED|Overall Study||0
10576651|NCT01688739|11731694|FG009|NOT COMPLETED|Overall Study||0
10576652|NCT01688830|11731745|FG000|STARTED|Overall Study||21
10576653|NCT01688830|11731746|FG001|STARTED|Overall Study||6
10576654|NCT01688830|11731747|FG002|STARTED|Overall Study||6
10576655|NCT01688830|11731748|FG003|STARTED|Overall Study||6
10576656|NCT01688830|11731749|FG004|STARTED|Overall Study||5
10576657|NCT01688830|11731750|FG005|STARTED|Overall Study||6
10576658|NCT01688830|11731751|FG006|STARTED|Overall Study||12
10576659|NCT01688830|11731752|FG007|STARTED|Overall Study||6
10576660|NCT01688830|11731753|FG008|STARTED|Overall Study||6
10576661|NCT01688830|11731754|FG009|STARTED|Overall Study||6
10576662|NCT01688830|11731755|FG010|STARTED|Overall Study||6
10576663|NCT01688830|11731756|FG011|STARTED|Overall Study||6
10576664|NCT01688830|11731757|FG012|STARTED|Overall Study||6
10576665|NCT01688830|11731758|FG013|STARTED|Overall Study||6
10576666|NCT01688830|11731759|FG014|STARTED|Overall Study||6
10576667|NCT01688830|11731760|FG015|STARTED|Overall Study||9
10576668|NCT01688830|11731761|FG016|STARTED|Overall Study||9
10576669|NCT01688830|11731762|FG017|STARTED|Overall Study||9
10576670|NCT01688830|11731763|FG018|STARTED|Overall Study||8
10576671|NCT01688830|11731764|FG019|STARTED|Overall Study||3
10576672|NCT01688830|11731765|FG020|STARTED|Overall Study||9
10576673|NCT01688830|11731745|FG000|COMPLETED|Overall Study||21
10576674|NCT01688830|11731746|FG001|COMPLETED|Overall Study||6
10576675|NCT01688830|11731747|FG002|COMPLETED|Overall Study||6
10576676|NCT01688830|11731748|FG003|COMPLETED|Overall Study||6
10576677|NCT01688830|11731749|FG004|COMPLETED|Overall Study||5
10576678|NCT01688830|11731750|FG005|COMPLETED|Overall Study||6
10576679|NCT01688830|11731751|FG006|COMPLETED|Overall Study||12
10576680|NCT01688830|11731752|FG007|COMPLETED|Overall Study||6
10576681|NCT01688830|11731753|FG008|COMPLETED|Overall Study||6
10576682|NCT01688830|11731754|FG009|COMPLETED|Overall Study||6
10576683|NCT01688830|11731755|FG010|COMPLETED|Overall Study||5
10576684|NCT01688830|11731756|FG011|COMPLETED|Overall Study||6
10702215|NCT02574078|11866716|FG001|COMPLETED|Pre-Treatment Period||6
10576685|NCT01688830|11731757|FG012|COMPLETED|Overall Study||6
10576686|NCT01688830|11731758|FG013|COMPLETED|Overall Study||6
10576687|NCT01688830|11731759|FG014|COMPLETED|Overall Study||6
10576688|NCT01688830|11731760|FG015|COMPLETED|Overall Study||9
10576689|NCT01688830|11731761|FG016|COMPLETED|Overall Study||9
10576690|NCT01688830|11731762|FG017|COMPLETED|Overall Study||9
10576691|NCT01688830|11731763|FG018|COMPLETED|Overall Study||8
10576692|NCT01688830|11731764|FG019|COMPLETED|Overall Study||3
10576693|NCT01688830|11731765|FG020|COMPLETED|Overall Study||9
10576694|NCT01688830|11731745|FG000|NOT COMPLETED|Overall Study||0
10576695|NCT01688830|11731746|FG001|NOT COMPLETED|Overall Study||0
10576696|NCT01688830|11731747|FG002|NOT COMPLETED|Overall Study||0
10576697|NCT01688830|11731748|FG003|NOT COMPLETED|Overall Study||0
10576698|NCT01688830|11731749|FG004|NOT COMPLETED|Overall Study||0
10576699|NCT01688830|11731750|FG005|NOT COMPLETED|Overall Study||0
10576700|NCT01688830|11731751|FG006|NOT COMPLETED|Overall Study||0
10576701|NCT01688830|11731752|FG007|NOT COMPLETED|Overall Study||0
10576702|NCT01688830|11731753|FG008|NOT COMPLETED|Overall Study||0
10576703|NCT01688830|11731754|FG009|NOT COMPLETED|Overall Study||0
10576704|NCT01688830|11731755|FG010|NOT COMPLETED|Overall Study||1
10576705|NCT01688830|11731756|FG011|NOT COMPLETED|Overall Study||0
10576706|NCT01688830|11731757|FG012|NOT COMPLETED|Overall Study||0
10576707|NCT01688830|11731758|FG013|NOT COMPLETED|Overall Study||0
10576708|NCT01688830|11731759|FG014|NOT COMPLETED|Overall Study||0
10576709|NCT01688830|11731760|FG015|NOT COMPLETED|Overall Study||0
10576710|NCT01688830|11731761|FG016|NOT COMPLETED|Overall Study||0
10576711|NCT01688830|11731762|FG017|NOT COMPLETED|Overall Study||0
10576712|NCT01688830|11731763|FG018|NOT COMPLETED|Overall Study||0
10576713|NCT01688830|11731764|FG019|NOT COMPLETED|Overall Study||0
10576714|NCT01688830|11731765|FG020|NOT COMPLETED|Overall Study||0
10576715|NCT01688843|11731849|FG000|STARTED|Overall Study||1060
10576716|NCT01688843|11731849|FG000|COMPLETED|Overall Study||1060
10576717|NCT01688843|11731849|FG000|NOT COMPLETED|Overall Study||0
10576718|NCT01688856|11731858|FG000|STARTED|Overall Study||28
10576719|NCT01688856|11731859|FG001|STARTED|Overall Study||28
10576720|NCT01688856|11731860|FG002|STARTED|Overall Study||11
10576721|NCT01688856|11731858|FG000|COMPLETED|Overall Study||21
10576722|NCT01688856|11731859|FG001|COMPLETED|Overall Study||24
10576723|NCT01688856|11731860|FG002|COMPLETED|Overall Study||8
10576724|NCT01688856|11731858|FG000|NOT COMPLETED|Overall Study||7
10576725|NCT01688856|11731859|FG001|NOT COMPLETED|Overall Study||4
10576726|NCT01688856|11731860|FG002|NOT COMPLETED|Overall Study||3
10576727|NCT01688882|11731870|FG000|STARTED|Overall Study||13
10576728|NCT01688882|11731871|FG001|STARTED|Overall Study|4 patients who completed 12 weeks of placebo changed to open-label QGE031 treatment.|7
10576729|NCT01688882|11731870|FG000|Safety Follow-up|Overall Study||11
10576730|NCT01688882|11731871|FG001|Safety Follow-up|Overall Study||5
10576731|NCT01688882|11731870|FG000|COMPLETED|Overall Study||10
10576732|NCT01688882|11731871|FG001|COMPLETED|Overall Study|The one patient that discontinued was already switched to open-label QGE031 treatment.|6
10576733|NCT01688882|11731870|FG000|NOT COMPLETED|Overall Study||3
10576734|NCT01688882|11731871|FG001|NOT COMPLETED|Overall Study||1
10576735|NCT01688895|11731881|FG000|STARTED|Overall Study||150
10576736|NCT01688895|11731881|FG000|COMPLETED|Overall Study||150
10576737|NCT01688895|11731881|FG000|NOT COMPLETED|Overall Study||0
10702216|NCT02574078|11866717|FG002|COMPLETED|Pre-Treatment Period||9
10576738|NCT01688921|11731887|FG000|STARTED|Overall Study||627
10576739|NCT01688921|11731888|FG001|STARTED|Overall Study||623
10576740|NCT01688921|11731887|FG000|COMPLETED|Overall Study||611
10576741|NCT01688921|11731888|FG001|COMPLETED|Overall Study||608
10576742|NCT01688921|11731887|FG000|NOT COMPLETED|Overall Study||16
10576743|NCT01688921|11731888|FG001|NOT COMPLETED|Overall Study||15
10576744|NCT01688973|11731897|FG000|STARTED|Overall Study||27
10576745|NCT01688973|11731898|FG001|STARTED|Overall Study||28
10576746|NCT01688973|11731897|FG000|Eligible/Evaluable Patients|Overall Study||25
10576747|NCT01688973|11731898|FG001|Eligible/Evaluable Patients|Overall Study||25
10576748|NCT01688973|11731897|FG000|COMPLETED|Overall Study||25
10576749|NCT01688973|11731898|FG001|COMPLETED|Overall Study||25
10576750|NCT01688973|11731897|FG000|NOT COMPLETED|Overall Study||2
10576751|NCT01688973|11731898|FG001|NOT COMPLETED|Overall Study||3
10576752|NCT01688999|11731908|FG000|STARTED|Overall Study||50
10576753|NCT01688999|11731909|FG001|STARTED|Overall Study||6
10576754|NCT01688999|11731910|FG002|STARTED|Overall Study||13
10576755|NCT01688999|11731908|FG000|COMPLETED|Overall Study||42
10576756|NCT01688999|11731909|FG001|COMPLETED|Overall Study||5
10576757|NCT01688999|11731910|FG002|COMPLETED|Overall Study||10
10576758|NCT01688999|11731908|FG000|NOT COMPLETED|Overall Study||8
10576759|NCT01688999|11731909|FG001|NOT COMPLETED|Overall Study||1
10576760|NCT01688999|11731910|FG002|NOT COMPLETED|Overall Study||3
10576761|NCT01689155|11731917|FG000|STARTED|Overall Study||116
10576762|NCT01689155|11731917|FG000|COMPLETED|Overall Study||116
10576763|NCT01689155|11731917|FG000|NOT COMPLETED|Overall Study||0
10576764|NCT01689207|11731933|FG000|STARTED|Overall Study|Subjects randomised|4
10576765|NCT01689207|11731934|FG001|STARTED|Overall Study|Subjects randomised|8
10576766|NCT01689207|11731935|FG002|STARTED|Overall Study|Subjects randomised|16
10576767|NCT01689207|11731936|FG003|STARTED|Overall Study|Subjects randomised|8
10576768|NCT01689207|11731937|FG004|STARTED|Overall Study|Subjects randomised|4
10576769|NCT01689207|11731938|FG005|STARTED|Overall Study|Subjects randomised|8
10576770|NCT01689207|11731939|FG006|STARTED|Overall Study|Subjects randomised|10
10576771|NCT01689207|11731940|FG007|STARTED|Overall Study|Subjects randomised|10
10576772|NCT01689207|11731941|FG008|STARTED|Overall Study|Subjects randomised|6
10576773|NCT01689207|11731942|FG009|STARTED|Overall Study|Subjects randomised|10
10576774|NCT01689207|11731943|FG010|STARTED|Overall Study|Subjects randomised|8
10576775|NCT01689207|11731933|FG000|COMPLETED|Overall Study|Subjects completed study|4
10576776|NCT01689207|11731934|FG001|COMPLETED|Overall Study|Subjects completed study|7
10576777|NCT01689207|11731935|FG002|COMPLETED|Overall Study|Subjects completed study|16
10576778|NCT01689207|11731936|FG003|COMPLETED|Overall Study|Subjects completed study|8
10576779|NCT01689207|11731937|FG004|COMPLETED|Overall Study|Subjects completed study|2
10576780|NCT01689207|11731938|FG005|COMPLETED|Overall Study|Subjects completed study|7
10576781|NCT01689207|11731939|FG006|COMPLETED|Overall Study|Subjects completed study|10
10576782|NCT01689207|11731940|FG007|COMPLETED|Overall Study|Subjects completed study|10
10576783|NCT01689207|11731941|FG008|COMPLETED|Overall Study|Subjects completed study|5
10576784|NCT01689207|11731942|FG009|COMPLETED|Overall Study|Subjects completed study|10
10576785|NCT01689207|11731943|FG010|COMPLETED|Overall Study|Subjects completed study|8
10576786|NCT01689207|11731933|FG000|NOT COMPLETED|Overall Study||0
10576787|NCT01689207|11731934|FG001|NOT COMPLETED|Overall Study||1
10576788|NCT01689207|11731935|FG002|NOT COMPLETED|Overall Study||0
10576789|NCT01689207|11731936|FG003|NOT COMPLETED|Overall Study||0
10576790|NCT01689207|11731937|FG004|NOT COMPLETED|Overall Study||2
10576791|NCT01689207|11731938|FG005|NOT COMPLETED|Overall Study||1
10576792|NCT01689207|11731939|FG006|NOT COMPLETED|Overall Study||0
10576793|NCT01689207|11731940|FG007|NOT COMPLETED|Overall Study||0
10576794|NCT01689207|11731941|FG008|NOT COMPLETED|Overall Study||1
10576795|NCT01689207|11731942|FG009|NOT COMPLETED|Overall Study||0
10576796|NCT01689207|11731943|FG010|NOT COMPLETED|Overall Study||0
10576797|NCT01689324|11731973|FG000|STARTED|Overall Study||43
10576798|NCT01689324|11731973|FG000|COMPLETED|Overall Study||43
10576799|NCT01689324|11731973|FG000|NOT COMPLETED|Overall Study||0
10576800|NCT01689337|11731977|FG000|STARTED|Overall Study||1
10576801|NCT01689337|11731977|FG000|COMPLETED|Overall Study||0
10576802|NCT01689337|11731977|FG000|NOT COMPLETED|Overall Study||1
10576803|NCT01689350|11731985|FG000|STARTED|Overall Study||47
10576804|NCT01689350|11731986|FG001|STARTED|Overall Study||45
10576805|NCT01689350|11731985|FG000|COMPLETED|Overall Study||47
10576806|NCT01689350|11731986|FG001|COMPLETED|Overall Study||45
10576807|NCT01689350|11731985|FG000|NOT COMPLETED|Overall Study||0
10576808|NCT01689350|11731986|FG001|NOT COMPLETED|Overall Study||0
10651439|NCT02175771|11811628|FG003|STARTED|Treatment Period||126
10651440|NCT02175771|11811629|FG004|STARTED|Treatment Period||41
10651441|NCT02175771|11811630|FG005|STARTED|Treatment Period||120
10651442|NCT02175771|11811631|FG006|STARTED|Treatment Period||41
10651443|NCT02175771|11811632|FG007|STARTED|Treatment Period||133
10651444|NCT02175771|11811633|FG008|STARTED|Treatment Period||44
10651445|NCT02175771|11811625|FG000|COMPLETED|Treatment Period||0
10651446|NCT02175771|11811626|FG001|COMPLETED|Treatment Period||111
10651447|NCT02175771|11811627|FG002|COMPLETED|Treatment Period||35
10651448|NCT02175771|11811628|FG003|COMPLETED|Treatment Period||113
10651449|NCT02175771|11811629|FG004|COMPLETED|Treatment Period||36
10651450|NCT02175771|11811630|FG005|COMPLETED|Treatment Period||110
10651451|NCT02175771|11811631|FG006|COMPLETED|Treatment Period||36
10651452|NCT02175771|11811632|FG007|COMPLETED|Treatment Period||116
10651453|NCT02175771|11811633|FG008|COMPLETED|Treatment Period||38
10651454|NCT02175771|11811625|FG000|NOT COMPLETED|Treatment Period||0
10651455|NCT02175771|11811626|FG001|NOT COMPLETED|Treatment Period||16
10651456|NCT02175771|11811627|FG002|NOT COMPLETED|Treatment Period||7
10651457|NCT02175771|11811628|FG003|NOT COMPLETED|Treatment Period||13
10651458|NCT02175771|11811629|FG004|NOT COMPLETED|Treatment Period||5
10651459|NCT02175771|11811630|FG005|NOT COMPLETED|Treatment Period||10
10651460|NCT02175771|11811631|FG006|NOT COMPLETED|Treatment Period||5
10576809|NCT01689363|11731992|FG000|STARTED|Overall Study||32
10576810|NCT01689363|11731993|FG001|STARTED|Overall Study||32
10576811|NCT01689363|11731994|FG002|STARTED|Overall Study||32
10576812|NCT01689363|11731995|FG003|STARTED|Overall Study||31
10702217|NCT02574078|11866718|FG003|COMPLETED|Pre-Treatment Period||35
10702218|NCT02574078|11866719|FG004|COMPLETED|Pre-Treatment Period||34
10702219|NCT02574078|11866720|FG005|COMPLETED|Pre-Treatment Period||34
10576813|NCT01689363|11731996|FG004|STARTED|Overall Study||31
10576814|NCT01689363|11731997|FG005|STARTED|Overall Study||31
10805349|NCT04012970|11966932|FG001|NOT COMPLETED|Intervention Session, 30 Minutes||0
10805350|NCT04012970|11966931|FG000|STARTED|Control Session, 30 Minutes||26
10805351|NCT04012970|11966932|FG001|STARTED|Control Session, 30 Minutes||14
10805352|NCT04012970|11966931|FG000|COMPLETED|Control Session, 30 Minutes||26
10805353|NCT04012970|11966932|FG001|COMPLETED|Control Session, 30 Minutes||14
10805354|NCT04012970|11966931|FG000|NOT COMPLETED|Control Session, 30 Minutes||0
10805355|NCT04012970|11966932|FG001|NOT COMPLETED|Control Session, 30 Minutes||0
10805356|NCT04013191|11966946|FG000|STARTED|Overall Study||10
10576815|NCT01689363|11731998|FG006|STARTED|Overall Study||32
10576816|NCT01689363|11731999|FG007|STARTED|Overall Study||32
10576817|NCT01689363|11731992|FG000|COMPLETED|Overall Study||32
10702220|NCT02574078|11866721|FG006|COMPLETED|Pre-Treatment Period||14
10702221|NCT02574078|11866722|FG007|COMPLETED|Pre-Treatment Period||14
10805357|NCT04013191|11966947|FG001|STARTED|Overall Study||18
10576818|NCT01689363|11731993|FG001|COMPLETED|Overall Study||31
10576819|NCT01689363|11731994|FG002|COMPLETED|Overall Study||32
10576820|NCT01689363|11731995|FG003|COMPLETED|Overall Study||31
10576821|NCT01689363|11731996|FG004|COMPLETED|Overall Study||31
10576822|NCT01689363|11731997|FG005|COMPLETED|Overall Study||31
10576823|NCT01689363|11731998|FG006|COMPLETED|Overall Study||32
10576824|NCT01689363|11731999|FG007|COMPLETED|Overall Study||32
10576825|NCT01689363|11731992|FG000|NOT COMPLETED|Overall Study||0
10576826|NCT01689363|11731993|FG001|NOT COMPLETED|Overall Study||1
10576827|NCT01689363|11731994|FG002|NOT COMPLETED|Overall Study||0
10576828|NCT01689363|11731995|FG003|NOT COMPLETED|Overall Study||0
10576829|NCT01689363|11731996|FG004|NOT COMPLETED|Overall Study||0
10576830|NCT01689363|11731997|FG005|NOT COMPLETED|Overall Study||0
10576831|NCT01689363|11731998|FG006|NOT COMPLETED|Overall Study||0
10576832|NCT01689363|11731999|FG007|NOT COMPLETED|Overall Study||0
10576833|NCT01689441|11732012|FG000|STARTED|Overall Study||36
10576834|NCT01689441|11732013|FG001|STARTED|Overall Study||31
10576835|NCT01689441|11732012|FG000|COMPLETED|Overall Study||36
10576836|NCT01689441|11732013|FG001|COMPLETED|Overall Study||31
10576837|NCT01689441|11732012|FG000|NOT COMPLETED|Overall Study||0
10576838|NCT01689441|11732013|FG001|NOT COMPLETED|Overall Study||0
10576839|NCT01689532|11732021|FG000|STARTED|Overall Study||61
10576840|NCT01689532|11732022|FG001|STARTED|Overall Study||61
10576841|NCT01689532|11732021|FG000|COMPLETED|Overall Study||47
10576842|NCT01689532|11732022|FG001|COMPLETED|Overall Study||52
10576843|NCT01689532|11732021|FG000|NOT COMPLETED|Overall Study||14
10576844|NCT01689532|11732022|FG001|NOT COMPLETED|Overall Study||9
10576845|NCT01689649|11732028|FG000|STARTED|Overall Study||139
10576846|NCT01689649|11732028|FG000|COMPLETED|Overall Study||117
10576847|NCT01689649|11732028|FG000|NOT COMPLETED|Overall Study||22
10576848|NCT01689701|11732034|FG000|STARTED|Overall Study||27
10576849|NCT01689701|11732035|FG001|STARTED|Overall Study||27
10576850|NCT01689701|11732034|FG000|COMPLETED|Overall Study||22
10702222|NCT02574078|11866723|FG008|COMPLETED|Pre-Treatment Period||25
10805358|NCT04013191|11966946|FG000|Completed Period 1A (Single Dose)|Overall Study||10
10805359|NCT04013191|11966947|FG001|Completed Period 1A (Single Dose)|Overall Study||18
10805360|NCT04013191|11966946|FG000|Completed Period 1B (Multiple Dose)|Overall Study||9
10805361|NCT04013191|11966947|FG001|Completed Period 1B (Multiple Dose)|Overall Study||18
10805362|NCT04013191|11966946|FG000|COMPLETED|Overall Study||9
10805363|NCT04013191|11966947|FG001|COMPLETED|Overall Study||18
10805364|NCT04013191|11966946|FG000|NOT COMPLETED|Overall Study||1
10805365|NCT04013191|11966947|FG001|NOT COMPLETED|Overall Study||0
10805366|NCT04011631|11966957|FG000|STARTED|Overall Study||100
10805367|NCT04011631|11966957|FG000|COMPLETED|Overall Study||100
10805368|NCT04011631|11966957|FG000|NOT COMPLETED|Overall Study||0
10805369|NCT04011735|11966964|FG000|STARTED|Overall Study||133
10805370|NCT04011735|11966965|FG001|STARTED|Overall Study||71
10805371|NCT04011735|11966966|FG002|STARTED|Overall Study||56
10702223|NCT02574078|11866724|FG009|COMPLETED|Pre-Treatment Period||26
10702224|NCT02574078|11866725|FG010|COMPLETED|Pre-Treatment Period||49
10702225|NCT02574078|11866726|FG011|COMPLETED|Pre-Treatment Period||55
10805372|NCT04011735|11966964|FG000|COMPLETED|Overall Study||132
10805373|NCT04011735|11966965|FG001|COMPLETED|Overall Study||70
10702226|NCT02574078|11866727|FG012|COMPLETED|Pre-Treatment Period||13
10805374|NCT04011735|11966966|FG002|COMPLETED|Overall Study||55
10805375|NCT04011735|11966964|FG000|NOT COMPLETED|Overall Study||1
10805376|NCT04011735|11966965|FG001|NOT COMPLETED|Overall Study||1
10805377|NCT04011735|11966966|FG002|NOT COMPLETED|Overall Study||1
10805378|NCT04009577|11966980|FG000|STARTED|Core Study||7
10805379|NCT04009577|11966981|FG001|STARTED|Core Study||3
10576851|NCT01689701|11732035|FG001|COMPLETED|Overall Study||21
10576852|NCT01689701|11732034|FG000|NOT COMPLETED|Overall Study||5
10576853|NCT01689701|11732035|FG001|NOT COMPLETED|Overall Study||6
10576854|NCT01689779|11732043|FG000|STARTED|Overall Study||28
10576855|NCT01689779|11732044|FG001|STARTED|Overall Study||32
10576856|NCT01689779|11732043|FG000|COMPLETED|Overall Study||28
10576857|NCT01689779|11732044|FG001|COMPLETED|Overall Study||32
10576858|NCT01689779|11732043|FG000|NOT COMPLETED|Overall Study||0
10576859|NCT01689779|11732044|FG001|NOT COMPLETED|Overall Study||0
10576860|NCT01689857|11732052|FG000|STARTED|Overall Study||20
10576861|NCT01689857|11732053|FG001|STARTED|Overall Study||20
10576862|NCT01689857|11732052|FG000|COMPLETED|Overall Study||15
10576863|NCT01689857|11732053|FG001|COMPLETED|Overall Study||18
10576864|NCT01689857|11732052|FG000|NOT COMPLETED|Overall Study||5
10576865|NCT01689857|11732053|FG001|NOT COMPLETED|Overall Study||2
10576866|NCT01690000|11732061|FG000|STARTED|Overall Study||40
10576867|NCT01690000|11732062|FG001|STARTED|Overall Study||41
10576868|NCT01690000|11732061|FG000|COMPLETED|Overall Study||37
10576869|NCT01690000|11732062|FG001|COMPLETED|Overall Study||35
10576870|NCT01690000|11732061|FG000|NOT COMPLETED|Overall Study||3
10576871|NCT01690000|11732062|FG001|NOT COMPLETED|Overall Study||6
10576872|NCT01690052|11732068|FG000|STARTED|FIRST INTERVENTION: 4 WEEKS||7
10576873|NCT01690052|11732069|FG001|STARTED|FIRST INTERVENTION: 4 WEEKS||8
10576874|NCT01690052|11732068|FG000|COMPLETED|FIRST INTERVENTION: 4 WEEKS||6
10576875|NCT01690052|11732069|FG001|COMPLETED|FIRST INTERVENTION: 4 WEEKS||6
10576876|NCT01690052|11732068|FG000|NOT COMPLETED|FIRST INTERVENTION: 4 WEEKS||1
10576877|NCT01690052|11732069|FG001|NOT COMPLETED|FIRST INTERVENTION: 4 WEEKS||2
10576878|NCT01690052|11732068|FG000|STARTED|Washout Period of 1 Week||6
10576879|NCT01690052|11732069|FG001|STARTED|Washout Period of 1 Week||6
10576880|NCT01690052|11732068|FG000|COMPLETED|Washout Period of 1 Week||6
10576881|NCT01690052|11732069|FG001|COMPLETED|Washout Period of 1 Week||6
10576882|NCT01690052|11732068|FG000|NOT COMPLETED|Washout Period of 1 Week||0
10576883|NCT01690052|11732069|FG001|NOT COMPLETED|Washout Period of 1 Week||0
10576884|NCT01690052|11732068|FG000|STARTED|SECOND INTERVENTION: 4 WEEKS||6
10576885|NCT01690052|11732069|FG001|STARTED|SECOND INTERVENTION: 4 WEEKS||6
10576886|NCT01690052|11732068|FG000|COMPLETED|SECOND INTERVENTION: 4 WEEKS||6
10576887|NCT01690052|11732069|FG001|COMPLETED|SECOND INTERVENTION: 4 WEEKS||6
10576888|NCT01690052|11732068|FG000|NOT COMPLETED|SECOND INTERVENTION: 4 WEEKS||0
10576889|NCT01690052|11732069|FG001|NOT COMPLETED|SECOND INTERVENTION: 4 WEEKS||0
10576890|NCT01690117|11732077|FG000|STARTED|Overall Study||47
10576891|NCT01690117|11732078|FG001|STARTED|Overall Study||45
10576892|NCT01690117|11732077|FG000|Post-Measurement|Overall Study||41
10576893|NCT01690117|11732078|FG001|Post-Measurement|Overall Study||40
10576894|NCT01690117|11732077|FG000|COMPLETED|Overall Study||31
10576895|NCT01690117|11732078|FG001|COMPLETED|Overall Study||31
10576896|NCT01690117|11732077|FG000|NOT COMPLETED|Overall Study||16
10576897|NCT01690117|11732078|FG001|NOT COMPLETED|Overall Study||14
10576898|NCT01690130|11732088|FG000|STARTED|Overall Study||10
10576899|NCT01690130|11732089|FG001|STARTED|Overall Study||9
10576900|NCT01690130|11732088|FG000|COMPLETED|Overall Study||9
10576901|NCT01690130|11732089|FG001|COMPLETED|Overall Study||9
10576902|NCT01690130|11732088|FG000|NOT COMPLETED|Overall Study||1
10576903|NCT01690130|11732089|FG001|NOT COMPLETED|Overall Study||0
10576904|NCT01690143|11732095|FG000|STARTED|Overall Study||45
10576905|NCT01690143|11732095|FG000|COMPLETED|Overall Study||44
10576906|NCT01690143|11732095|FG000|NOT COMPLETED|Overall Study||1
10576907|NCT01690273|11732103|FG000|STARTED|Overall Study||18
10576908|NCT01690273|11732104|FG001|STARTED|Overall Study||17
10576909|NCT01690273|11732105|FG002|STARTED|Overall Study||20
10576910|NCT01690273|11732103|FG000|COMPLETED|Overall Study||18
10576911|NCT01690273|11732104|FG001|COMPLETED|Overall Study||17
10576912|NCT01690273|11732105|FG002|COMPLETED|Overall Study||20
10576913|NCT01690273|11732103|FG000|NOT COMPLETED|Overall Study||0
10576914|NCT01690273|11732104|FG001|NOT COMPLETED|Overall Study||0
10576915|NCT01690273|11732105|FG002|NOT COMPLETED|Overall Study||0
10576916|NCT01690520|11732119|FG000|STARTED|Overall Study||78
10576917|NCT01690520|11732120|FG001|STARTED|Overall Study||82
10576918|NCT01690520|11732119|FG000|Modified Intent to Treat (mITT)|Overall Study||78
10576919|NCT01690520|11732120|FG001|Modified Intent to Treat (mITT)|Overall Study||80
10576920|NCT01690520|11732119|FG000|COMPLETED|Overall Study||27
10576921|NCT01690520|11732120|FG001|COMPLETED|Overall Study||35
10576922|NCT01690520|11732119|FG000|NOT COMPLETED|Overall Study||51
10805380|NCT04009577|11966982|FG002|STARTED|Core Study||21
10805381|NCT04009577|11966983|FG003|STARTED|Core Study||22
10805382|NCT04009577|11966980|FG000|LEM5|Core Study||7
10805383|NCT04009577|11966981|FG001|LEM5|Core Study||3
10805384|NCT04009577|11966982|FG002|LEM5|Core Study||21
10805385|NCT04009577|11966983|FG003|LEM5|Core Study||5
10805386|NCT04009577|11966980|FG000|LEM10|Core Study||3
10805387|NCT04009577|11966981|FG001|LEM10|Core Study||2
10805388|NCT04009577|11966982|FG002|LEM10|Core Study||10
10805389|NCT04009577|11966983|FG003|LEM10|Core Study||22
10805390|NCT04009577|11966980|FG000|COMPLETED|Core Study||6
10576923|NCT01690520|11732120|FG001|NOT COMPLETED|Overall Study||47
10576924|NCT01690546|11732126|FG000|STARTED|Overall Study||35
10576925|NCT01690546|11732126|FG000|Extended Release Injectable NTX|Overall Study||27
10576926|NCT01690546|11732126|FG000|COMPLETED|Overall Study||26
10576927|NCT01690546|11732126|FG000|NOT COMPLETED|Overall Study||9
10576928|NCT01690663|11732134|FG000|STARTED|Overall Study||23
10576929|NCT01690663|11732135|FG001|STARTED|Overall Study||20
10576930|NCT01690663|11732136|FG002|STARTED|Overall Study||22
10576931|NCT01690663|11732137|FG003|STARTED|Overall Study||24
10576932|NCT01690663|11732134|FG000|COMPLETED|Overall Study||20
10576933|NCT01690663|11732135|FG001|COMPLETED|Overall Study||17
10576934|NCT01690663|11732136|FG002|COMPLETED|Overall Study||19
10576935|NCT01690663|11732137|FG003|COMPLETED|Overall Study||20
10576936|NCT01690663|11732134|FG000|NOT COMPLETED|Overall Study||3
10576937|NCT01690663|11732135|FG001|NOT COMPLETED|Overall Study||3
10805391|NCT04009577|11966981|FG001|COMPLETED|Core Study||3
10576938|NCT01690663|11732136|FG002|NOT COMPLETED|Overall Study||3
10576939|NCT01690663|11732137|FG003|NOT COMPLETED|Overall Study||4
10576940|NCT01690923|11732147|FG000|STARTED|Overall Study||10
10576941|NCT01690923|11732148|FG001|STARTED|Overall Study|1 participant was withdrawn and excluded due to poor fit with the pillows mask|11
10576942|NCT01690923|11732147|FG000|COMPLETED|Overall Study||10
10576943|NCT01690923|11732148|FG001|COMPLETED|Overall Study||10
10576944|NCT01690923|11732147|FG000|NOT COMPLETED|Overall Study||0
10576945|NCT01690923|11732148|FG001|NOT COMPLETED|Overall Study||1
10576946|NCT01690988|11732155|FG000|STARTED|Overall Study||227
10576947|NCT01690988|11732156|FG001|STARTED|Overall Study||222
10576948|NCT01690988|11732157|FG002|STARTED|Overall Study||223
10576949|NCT01690988|11732155|FG000|COMPLETED|Overall Study||221
10576950|NCT01690988|11732156|FG001|COMPLETED|Overall Study||217
10576951|NCT01690988|11732157|FG002|COMPLETED|Overall Study||216
10576952|NCT01690988|11732155|FG000|NOT COMPLETED|Overall Study||6
10576953|NCT01690988|11732156|FG001|NOT COMPLETED|Overall Study||5
10576954|NCT01690988|11732157|FG002|NOT COMPLETED|Overall Study||7
10576955|NCT01691014|11732172|FG000|STARTED|Overall Study||8
10576956|NCT01691014|11732173|FG001|STARTED|Overall Study||26
10576957|NCT01691014|11732174|FG002|STARTED|Overall Study||36
10576958|NCT01691014|11732175|FG003|STARTED|Overall Study||9
10576959|NCT01691014|11732172|FG000|COMPLETED|Overall Study||5
10576960|NCT01691014|11732173|FG001|COMPLETED|Overall Study||11
10576961|NCT01691014|11732174|FG002|COMPLETED|Overall Study||25
10576962|NCT01691014|11732175|FG003|COMPLETED|Overall Study||4
10576963|NCT01691014|11732172|FG000|NOT COMPLETED|Overall Study||3
10576964|NCT01691014|11732173|FG001|NOT COMPLETED|Overall Study||15
10576965|NCT01691014|11732174|FG002|NOT COMPLETED|Overall Study||11
10576966|NCT01691014|11732175|FG003|NOT COMPLETED|Overall Study||5
10576967|NCT01691027|11732185|FG000|STARTED|Scotoma Awareness|Four subjects started scotoma awareness training module|4
10576968|NCT01691027|11732185|FG000|COMPLETED|Scotoma Awareness|Four subjects were able to complete scotoma awareness training module|4
10576969|NCT01691027|11732185|FG000|NOT COMPLETED|Scotoma Awareness||0
10576970|NCT01691027|11732185|FG000|STARTED|Line and Circle Tracing Training|Four subjects started line and circle tracing training module|4
10576971|NCT01691027|11732185|FG000|COMPLETED|Line and Circle Tracing Training|Four subjects were able to complete line and circle tracing training module.|4
10576972|NCT01691027|11732185|FG000|NOT COMPLETED|Line and Circle Tracing Training||0
10576973|NCT01691027|11732185|FG000|STARTED|Video Games Training|Four subjects started video game training module|4
10576974|NCT01691027|11732185|FG000|COMPLETED|Video Games Training|Four subjects were able to complete video games training module|4
10576975|NCT01691027|11732185|FG000|NOT COMPLETED|Video Games Training||0
10576976|NCT01691092|11732190|FG000|STARTED|Overall Study||79
10576977|NCT01691092|11732190|FG000|COMPLETED|Overall Study||38
10576978|NCT01691092|11732190|FG000|NOT COMPLETED|Overall Study||41
10576979|NCT01691105|11732196|FG000|STARTED|Baseline||477
10576980|NCT01691105|11732197|FG001|STARTED|Baseline||567
10576981|NCT01691105|11732196|FG000|COMPLETED|Baseline||477
10576982|NCT01691105|11732197|FG001|COMPLETED|Baseline||567
10576983|NCT01691105|11732196|FG000|NOT COMPLETED|Baseline||0
10805392|NCT04009577|11966982|FG002|COMPLETED|Core Study||17
10805393|NCT04009577|11966983|FG003|COMPLETED|Core Study||17
10805394|NCT04009577|11966980|FG000|NOT COMPLETED|Core Study||1
10805395|NCT04009577|11966981|FG001|NOT COMPLETED|Core Study||0
10805396|NCT04009577|11966982|FG002|NOT COMPLETED|Core Study||4
10805397|NCT04009577|11966983|FG003|NOT COMPLETED|Core Study||5
10805398|NCT04009577|11966980|FG000|STARTED|Extension Phase||6
10805399|NCT04009577|11966981|FG001|STARTED|Extension Phase||3
10805400|NCT04009577|11966982|FG002|STARTED|Extension Phase||17
10805401|NCT04009577|11966983|FG003|STARTED|Extension Phase||17
10805402|NCT04009577|11966980|FG000|Treated|Extension Phase||6
10805403|NCT04009577|11966981|FG001|Treated|Extension Phase||3
10805404|NCT04009577|11966982|FG002|Treated|Extension Phase||15
10805405|NCT04009577|11966983|FG003|Treated|Extension Phase||17
10805406|NCT04009577|11966980|FG000|LEM5|Extension Phase||6
10805407|NCT04009577|11966981|FG001|LEM5|Extension Phase||3
10805408|NCT04009577|11966982|FG002|LEM5|Extension Phase||15
10805409|NCT04009577|11966983|FG003|LEM5|Extension Phase||8
10805410|NCT04009577|11966980|FG000|LEM10|Extension Phase||5
10805411|NCT04009577|11966981|FG001|LEM10|Extension Phase||3
10805412|NCT04009577|11966982|FG002|LEM10|Extension Phase||12
10805413|NCT04009577|11966983|FG003|LEM10|Extension Phase||17
10805414|NCT04009577|11966980|FG000|COMPLETED|Extension Phase||6
10805415|NCT04009577|11966981|FG001|COMPLETED|Extension Phase||3
10805416|NCT04009577|11966982|FG002|COMPLETED|Extension Phase||13
10805417|NCT04009577|11966983|FG003|COMPLETED|Extension Phase||16
10805418|NCT04009577|11966980|FG000|NOT COMPLETED|Extension Phase||0
10805419|NCT04009577|11966981|FG001|NOT COMPLETED|Extension Phase||0
10805420|NCT04009577|11966982|FG002|NOT COMPLETED|Extension Phase||4
10805421|NCT04009577|11966983|FG003|NOT COMPLETED|Extension Phase||1
10805422|NCT04007159|11967009|FG000|STARTED|Induction Phase||280
10805423|NCT04007159|11967009|FG000|COMPLETED|Induction Phase||258
10805424|NCT04007159|11967009|FG000|NOT COMPLETED|Induction Phase||22
10805425|NCT04007159|11967009|FG000|STARTED|Rest Phase||258
10805426|NCT04007159|11967009|FG000|COMPLETED|Rest Phase||258
10805427|NCT04007159|11967009|FG000|NOT COMPLETED|Rest Phase||0
10805428|NCT04007159|11967009|FG000|STARTED|Challenge Phase||258
10805429|NCT04007159|11967009|FG000|COMPLETED|Challenge Phase||255
10805430|NCT04007159|11967009|FG000|NOT COMPLETED|Challenge Phase||3
10805431|NCT04007107|11967020|FG000|STARTED|Treatment Period 1 (Day 1)||26
10805432|NCT04007107|11967021|FG001|STARTED|Treatment Period 1 (Day 1)||26
10805433|NCT04007107|11967022|FG002|STARTED|Treatment Period 1 (Day 1)||25
10702227|NCT02574078|11866715|FG000|NOT COMPLETED|Pre-Treatment Period||0
10702228|NCT02574078|11866716|FG001|NOT COMPLETED|Pre-Treatment Period||0
10576984|NCT01691105|11732197|FG001|NOT COMPLETED|Baseline||0
10576985|NCT01691105|11732196|FG000|STARTED|1 Month Follow-up||477
10576986|NCT01691105|11732197|FG001|STARTED|1 Month Follow-up||567
10576987|NCT01691105|11732196|FG000|COMPLETED|1 Month Follow-up||434
10576988|NCT01691105|11732197|FG001|COMPLETED|1 Month Follow-up||526
10576989|NCT01691105|11732196|FG000|NOT COMPLETED|1 Month Follow-up||43
10576990|NCT01691105|11732197|FG001|NOT COMPLETED|1 Month Follow-up||41
10576991|NCT01691105|11732196|FG000|STARTED|6 Month Follow-up||477
10576992|NCT01691105|11732197|FG001|STARTED|6 Month Follow-up||567
10576993|NCT01691105|11732196|FG000|COMPLETED|6 Month Follow-up||425
10576994|NCT01691105|11732197|FG001|COMPLETED|6 Month Follow-up||496
10576995|NCT01691105|11732196|FG000|NOT COMPLETED|6 Month Follow-up||52
10576996|NCT01691105|11732197|FG001|NOT COMPLETED|6 Month Follow-up||71
10576997|NCT01691105|11732196|FG000|STARTED|12 Month Follow-up||477
10576998|NCT01691105|11732197|FG001|STARTED|12 Month Follow-up||567
10576999|NCT01691105|11732196|FG000|COMPLETED|12 Month Follow-up||405
10577000|NCT01691105|11732197|FG001|COMPLETED|12 Month Follow-up||466
10577001|NCT01691105|11732196|FG000|NOT COMPLETED|12 Month Follow-up||72
10577002|NCT01691105|11732197|FG001|NOT COMPLETED|12 Month Follow-up||101
10577003|NCT01691105|11732196|FG000|STARTED|12 Month Biochemical Verification||477
10577004|NCT01691105|11732197|FG001|STARTED|12 Month Biochemical Verification||567
10577005|NCT01691105|11732196|FG000|COMPLETED|12 Month Biochemical Verification||53
10577006|NCT01691105|11732197|FG001|COMPLETED|12 Month Biochemical Verification||65
10577007|NCT01691105|11732196|FG000|NOT COMPLETED|12 Month Biochemical Verification||424
10577008|NCT01691105|11732197|FG001|NOT COMPLETED|12 Month Biochemical Verification||502
10577009|NCT01691248|11732205|FG000|STARTED|Overall Study|Randomized|305
10577010|NCT01691248|11732206|FG001|STARTED|Overall Study|Randomized|306
10577011|NCT01691248|11732205|FG000|Treated|Overall Study|Received at least 1 dose of study drug|301
10577012|NCT01691248|11732206|FG001|Treated|Overall Study|Received at least 1 dose of study drug|299
10577013|NCT01691248|11732205|FG000|Safety Analysis Set|Overall Study|A participant randomized to Fidaxomicin, received placebo instead.|300
10577014|NCT01691248|11732206|FG001|Safety Analysis Set|Overall Study|A participant randomized to Fidaxomicin, received placebo instead.|300
10577015|NCT01691248|11732205|FG000|COMPLETED|Overall Study||194
10577016|NCT01691248|11732206|FG001|COMPLETED|Overall Study||192
10577017|NCT01691248|11732205|FG000|NOT COMPLETED|Overall Study||111
10577018|NCT01691248|11732206|FG001|NOT COMPLETED|Overall Study||114
10577019|NCT01691313|11732216|FG000|STARTED|Overall Study||22
10577020|NCT01691313|11732217|FG001|STARTED|Overall Study||32
10577021|NCT01691313|11732218|FG002|STARTED|Overall Study||25
10577022|NCT01691313|11732219|FG003|STARTED|Overall Study||25
10577023|NCT01691313|11732216|FG000|COMPLETED|Overall Study||22
10577024|NCT01691313|11732217|FG001|COMPLETED|Overall Study||32
10577025|NCT01691313|11732218|FG002|COMPLETED|Overall Study||25
10577026|NCT01691313|11732219|FG003|COMPLETED|Overall Study||25
10577027|NCT01691313|11732216|FG000|NOT COMPLETED|Overall Study||0
10577028|NCT01691313|11732217|FG001|NOT COMPLETED|Overall Study||0
10577029|NCT01691313|11732218|FG002|NOT COMPLETED|Overall Study||0
10577030|NCT01691313|11732219|FG003|NOT COMPLETED|Overall Study||0
10577031|NCT01691326|11732231|FG000|STARTED|Overall Study||30
10577032|NCT01691326|11732232|FG001|STARTED|Overall Study||30
10577033|NCT01691326|11732231|FG000|COMPLETED|Overall Study||30
10577034|NCT01691326|11732232|FG001|COMPLETED|Overall Study||30
10577035|NCT01691326|11732231|FG000|NOT COMPLETED|Overall Study||0
10577036|NCT01691326|11732232|FG001|NOT COMPLETED|Overall Study||0
10577037|NCT01691339|11732244|FG000|STARTED|Overall Study||50
10577038|NCT01691339|11732245|FG001|STARTED|Overall Study||50
10577039|NCT01691339|11732246|FG002|STARTED|Overall Study||51
10577040|NCT01691339|11732247|FG003|STARTED|Overall Study||49
10577041|NCT01691339|11732244|FG000|COMPLETED|Overall Study||50
10577042|NCT01691339|11732245|FG001|COMPLETED|Overall Study||50
10577043|NCT01691339|11732246|FG002|COMPLETED|Overall Study||51
10577044|NCT01691339|11732247|FG003|COMPLETED|Overall Study||49
10577045|NCT01691339|11732244|FG000|NOT COMPLETED|Overall Study||0
10577046|NCT01691339|11732245|FG001|NOT COMPLETED|Overall Study||0
10577047|NCT01691339|11732246|FG002|NOT COMPLETED|Overall Study||0
10577048|NCT01691339|11732247|FG003|NOT COMPLETED|Overall Study||0
10577049|NCT01691378|11732259|FG000|STARTED|Overall Study||22
10577050|NCT01691378|11732260|FG001|STARTED|Overall Study||22
10577051|NCT01691378|11732259|FG000|COMPLETED|Overall Study||15
10577052|NCT01691378|11732260|FG001|COMPLETED|Overall Study||20
10577053|NCT01691378|11732259|FG000|NOT COMPLETED|Overall Study||7
10577054|NCT01691378|11732260|FG001|NOT COMPLETED|Overall Study||2
10577055|NCT01691430|11732268|FG000|STARTED|Overall Study||92
10577056|NCT01691430|11732269|FG001|STARTED|Overall Study||93
10577057|NCT01691430|11732268|FG000|Received Medication|Overall Study||92
10577058|NCT01691430|11732269|FG001|Received Medication|Overall Study||93
10577059|NCT01691430|11732268|FG000|COMPLETED|Overall Study||70
10577060|NCT01691430|11732269|FG001|COMPLETED|Overall Study||73
10577061|NCT01691430|11732268|FG000|NOT COMPLETED|Overall Study||22
10577062|NCT01691430|11732269|FG001|NOT COMPLETED|Overall Study||20
10577063|NCT01691482|11732275|FG000|STARTED|Treatment Period 1||28
10577064|NCT01691482|11732276|FG001|STARTED|Treatment Period 1||28
10577065|NCT01691482|11732275|FG000|COMPLETED|Treatment Period 1||28
10702229|NCT02574078|11866717|FG002|NOT COMPLETED|Pre-Treatment Period||0
10577066|NCT01691482|11732276|FG001|COMPLETED|Treatment Period 1||28
10577067|NCT01691482|11732275|FG000|NOT COMPLETED|Treatment Period 1||0
10577068|NCT01691482|11732276|FG001|NOT COMPLETED|Treatment Period 1||0
10577069|NCT01691482|11732275|FG000|STARTED|Treatment Period 2||28
10805434|NCT04007107|11967023|FG003|STARTED|Treatment Period 1 (Day 1)||26
10805435|NCT04007107|11967020|FG000|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
10805436|NCT04007107|11967021|FG001|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
10805437|NCT04007107|11967022|FG002|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||25
10805438|NCT04007107|11967023|FG003|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
10577159|NCT01691820|11732403|FG000|NOT COMPLETED|Overall Study||26
10805439|NCT04007107|11967020|FG000|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
10577070|NCT01691482|11732276|FG001|STARTED|Treatment Period 2||28
10577071|NCT01691482|11732275|FG000|COMPLETED|Treatment Period 2||27
10577072|NCT01691482|11732276|FG001|COMPLETED|Treatment Period 2||26
10577073|NCT01691482|11732275|FG000|NOT COMPLETED|Treatment Period 2||1
10577074|NCT01691482|11732276|FG001|NOT COMPLETED|Treatment Period 2||2
10577075|NCT01691508|11732285|FG000|STARTED|Overall Study||66
10577076|NCT01691508|11732286|FG001|STARTED|Overall Study||69
10577077|NCT01691508|11732285|FG000|COMPLETED|Overall Study||62
10577078|NCT01691508|11732286|FG001|COMPLETED|Overall Study||66
10577079|NCT01691508|11732285|FG000|NOT COMPLETED|Overall Study||4
10577080|NCT01691508|11732286|FG001|NOT COMPLETED|Overall Study||3
10577081|NCT01691521|11732295|FG000|STARTED|Overall Study||191
10577082|NCT01691521|11732296|FG001|STARTED|Overall Study||191
10577083|NCT01691521|11732297|FG002|STARTED|Overall Study||194
10577084|NCT01691521|11732295|FG000|COMPLETED|Overall Study||179
10577085|NCT01691521|11732296|FG001|COMPLETED|Overall Study||175
10577086|NCT01691521|11732297|FG002|COMPLETED|Overall Study||185
10577087|NCT01691521|11732295|FG000|NOT COMPLETED|Overall Study||12
10577088|NCT01691521|11732296|FG001|NOT COMPLETED|Overall Study||16
10577089|NCT01691521|11732297|FG002|NOT COMPLETED|Overall Study||9
10577090|NCT01691534|11732313|FG000|STARTED|Overall Study||15
10577091|NCT01691534|11732314|FG001|STARTED|Overall Study||15
10577092|NCT01691534|11732315|FG002|STARTED|Overall Study||15
10577093|NCT01691534|11732316|FG003|STARTED|Overall Study||15
10577094|NCT01691534|11732317|FG004|STARTED|Overall Study||15
10577095|NCT01691534|11732318|FG005|STARTED|Overall Study||15
10577096|NCT01691534|11732319|FG006|STARTED|Overall Study||15
10577097|NCT01691534|11732313|FG000|COMPLETED|Overall Study||15
10577098|NCT01691534|11732314|FG001|COMPLETED|Overall Study||14
10577099|NCT01691534|11732315|FG002|COMPLETED|Overall Study||14
10577100|NCT01691534|11732316|FG003|COMPLETED|Overall Study||14
10577101|NCT01691534|11732317|FG004|COMPLETED|Overall Study||15
10577102|NCT01691534|11732318|FG005|COMPLETED|Overall Study||14
10577103|NCT01691534|11732319|FG006|COMPLETED|Overall Study||14
10577104|NCT01691534|11732313|FG000|NOT COMPLETED|Overall Study||0
10577105|NCT01691534|11732314|FG001|NOT COMPLETED|Overall Study||1
10577106|NCT01691534|11732315|FG002|NOT COMPLETED|Overall Study||1
10577107|NCT01691534|11732316|FG003|NOT COMPLETED|Overall Study||1
10577108|NCT01691534|11732317|FG004|NOT COMPLETED|Overall Study||0
10577109|NCT01691534|11732318|FG005|NOT COMPLETED|Overall Study||1
10577110|NCT01691534|11732319|FG006|NOT COMPLETED|Overall Study||1
10577111|NCT01691560|11732340|FG000|STARTED|Overall Study||34
10577112|NCT01691560|11732341|FG001|STARTED|Overall Study||33
10577113|NCT01691560|11732342|FG002|STARTED|Overall Study||34
10577114|NCT01691560|11732343|FG003|STARTED|Overall Study||33
10577115|NCT01691560|11732340|FG000|COMPLETED|Overall Study||34
10577116|NCT01691560|11732341|FG001|COMPLETED|Overall Study||33
10577117|NCT01691560|11732342|FG002|COMPLETED|Overall Study||34
10577118|NCT01691560|11732343|FG003|COMPLETED|Overall Study||33
10577119|NCT01691560|11732340|FG000|NOT COMPLETED|Overall Study||0
10577120|NCT01691560|11732341|FG001|NOT COMPLETED|Overall Study||0
10577121|NCT01691560|11732342|FG002|NOT COMPLETED|Overall Study||0
10577122|NCT01691560|11732343|FG003|NOT COMPLETED|Overall Study||0
10577123|NCT01691612|11732353|FG000|STARTED|Overall Study||14
10577124|NCT01691612|11732353|FG000|First Visit (Allergen Challenge)|Overall Study||8
10577125|NCT01691612|11732353|FG000|Second Visit (Bronchoscopy)|Overall Study||7
10577126|NCT01691612|11732353|FG000|COMPLETED|Overall Study||7
10577127|NCT01691612|11732353|FG000|NOT COMPLETED|Overall Study||7
10577128|NCT01691690|11732359|FG000|STARTED|Overall Study||125
10577129|NCT01691690|11732360|FG001|STARTED|Overall Study||125
10577130|NCT01691690|11732359|FG000|COMPLETED|Overall Study||118
10577131|NCT01691690|11732360|FG001|COMPLETED|Overall Study||121
10577132|NCT01691690|11732359|FG000|NOT COMPLETED|Overall Study||7
10577133|NCT01691690|11732360|FG001|NOT COMPLETED|Overall Study||4
10577134|NCT01691768|11732371|FG000|STARTED|Overall Study||189
10577135|NCT01691768|11732372|FG001|STARTED|Overall Study||183
10577136|NCT01691768|11732371|FG000|COMPLETED|Overall Study||174
10577137|NCT01691768|11732372|FG001|COMPLETED|Overall Study||167
10577138|NCT01691768|11732371|FG000|NOT COMPLETED|Overall Study||15
10577139|NCT01691768|11732372|FG001|NOT COMPLETED|Overall Study||16
10577140|NCT01691781|11732381|FG000|STARTED|Overall Study||19
10577141|NCT01691781|11732382|FG001|STARTED|Overall Study||22
10577142|NCT01691781|11732381|FG000|COMPLETED|Overall Study||12
10577143|NCT01691781|11732382|FG001|COMPLETED|Overall Study||15
10805440|NCT04007107|11967021|FG001|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
10577144|NCT01691781|11732381|FG000|NOT COMPLETED|Overall Study||7
10577145|NCT01691781|11732382|FG001|NOT COMPLETED|Overall Study||7
10577146|NCT01691794|11732391|FG000|STARTED|Overall Study||3
10577147|NCT01691794|11732392|FG001|STARTED|Overall Study||33
10577148|NCT01691794|11732393|FG002|STARTED|Overall Study||23
10577149|NCT01691794|11732391|FG000|COMPLETED|Overall Study|Completed baseline to End of Study|2
10577150|NCT01691794|11732392|FG001|COMPLETED|Overall Study|Completed baseline to End of Study|15
10577151|NCT01691794|11732393|FG002|COMPLETED|Overall Study|Completed baseline to End of Study|13
10577152|NCT01691794|11732391|FG000|NOT COMPLETED|Overall Study||1
10577153|NCT01691794|11732392|FG001|NOT COMPLETED|Overall Study||18
10577154|NCT01691794|11732393|FG002|NOT COMPLETED|Overall Study||10
10577155|NCT01691820|11732403|FG000|STARTED|Overall Study||210
10577156|NCT01691820|11732404|FG001|STARTED|Overall Study||152
10577157|NCT01691820|11732403|FG000|COMPLETED|Overall Study||184
10577158|NCT01691820|11732404|FG001|COMPLETED|Overall Study||115
10577160|NCT01691820|11732404|FG001|NOT COMPLETED|Overall Study||37
10702230|NCT02574078|11866718|FG003|NOT COMPLETED|Pre-Treatment Period||0
10702231|NCT02574078|11866719|FG004|NOT COMPLETED|Pre-Treatment Period||0
10702232|NCT02574078|11866720|FG005|NOT COMPLETED|Pre-Treatment Period||1
10577170|NCT01691859|11732427|FG000|STARTED|Overall Study||347
10577171|NCT01691859|11732427|FG000|COMPLETED|Overall Study||0
10577172|NCT01691859|11732427|FG000|NOT COMPLETED|Overall Study||347
10577173|NCT01691885|11732431|FG000|STARTED|Treatment Period 1(7-14 Days)||22
10577174|NCT01691885|11732432|FG001|STARTED|Treatment Period 1(7-14 Days)||23
10577175|NCT01691885|11732431|FG000|COMPLETED|Treatment Period 1(7-14 Days)||21
10577176|NCT01691885|11732432|FG001|COMPLETED|Treatment Period 1(7-14 Days)||22
10577177|NCT01691885|11732431|FG000|NOT COMPLETED|Treatment Period 1(7-14 Days)||1
10577178|NCT01691885|11732432|FG001|NOT COMPLETED|Treatment Period 1(7-14 Days)||1
10577179|NCT01691885|11732431|FG000|STARTED|Washout Period (7-9 Days)||21
10577180|NCT01691885|11732432|FG001|STARTED|Washout Period (7-9 Days)||22
10577181|NCT01691885|11732431|FG000|COMPLETED|Washout Period (7-9 Days)||21
10577182|NCT01691885|11732432|FG001|COMPLETED|Washout Period (7-9 Days)||21
10702233|NCT02574078|11866721|FG006|NOT COMPLETED|Pre-Treatment Period||4
10702234|NCT02574078|11866722|FG007|NOT COMPLETED|Pre-Treatment Period||3
10702235|NCT02574078|11866723|FG008|NOT COMPLETED|Pre-Treatment Period||1
10577183|NCT01691885|11732431|FG000|NOT COMPLETED|Washout Period (7-9 Days)||0
10577184|NCT01691885|11732432|FG001|NOT COMPLETED|Washout Period (7-9 Days)||1
10577185|NCT01691885|11732431|FG000|STARTED|Treatment Period 2 (7-14 Days)||21
10577186|NCT01691885|11732432|FG001|STARTED|Treatment Period 2 (7-14 Days)||21
10333692|NCT00334893|11469860|FG000|STARTED|Overall Study||37
10333693|NCT00334893|11469861|FG001|STARTED|Overall Study||37
10333694|NCT00334893|11469860|FG000|COMPLETED|Overall Study||36
10333695|NCT00334893|11469861|FG001|COMPLETED|Overall Study||37
10333696|NCT00334893|11469860|FG000|NOT COMPLETED|Overall Study||1
10577187|NCT01691885|11732431|FG000|COMPLETED|Treatment Period 2 (7-14 Days)||21
10577188|NCT01691885|11732432|FG001|COMPLETED|Treatment Period 2 (7-14 Days)||21
10577189|NCT01691885|11732431|FG000|NOT COMPLETED|Treatment Period 2 (7-14 Days)||0
10577190|NCT01691885|11732432|FG001|NOT COMPLETED|Treatment Period 2 (7-14 Days)||0
10577191|NCT01691898|11732444|FG000|STARTED|Overall Study||63
10577192|NCT01691898|11732445|FG001|STARTED|Overall Study||59
10577193|NCT01691898|11732446|FG002|STARTED|Overall Study||20
10805441|NCT04007107|11967022|FG002|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||25
10805442|NCT04007107|11967023|FG003|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
10805443|NCT04007107|11967020|FG000|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||26
10805444|NCT04007107|11967021|FG001|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||25
10805445|NCT04007107|11967022|FG002|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||25
10577194|NCT01691898|11732447|FG003|STARTED|Overall Study||9
10577195|NCT01691898|11732448|FG004|STARTED|Overall Study||40
10577196|NCT01691898|11732449|FG005|STARTED|Overall Study||40
10577197|NCT01691898|11732444|FG000|COMPLETED|Overall Study||16
10577198|NCT01691898|11732445|FG001|COMPLETED|Overall Study||15
10702236|NCT02574078|11866724|FG009|NOT COMPLETED|Pre-Treatment Period||0
10702237|NCT02574078|11866725|FG010|NOT COMPLETED|Pre-Treatment Period||4
10702238|NCT02574078|11866726|FG011|NOT COMPLETED|Pre-Treatment Period||1
10577199|NCT01691898|11732446|FG002|COMPLETED|Overall Study||11
10577200|NCT01691898|11732447|FG003|COMPLETED|Overall Study||4
10577201|NCT01691898|11732448|FG004|COMPLETED|Overall Study||26
10577202|NCT01691898|11732449|FG005|COMPLETED|Overall Study||5
10577203|NCT01691898|11732444|FG000|NOT COMPLETED|Overall Study||47
10577204|NCT01691898|11732445|FG001|NOT COMPLETED|Overall Study||44
10577205|NCT01691898|11732446|FG002|NOT COMPLETED|Overall Study||9
10577206|NCT01691898|11732447|FG003|NOT COMPLETED|Overall Study||5
10577207|NCT01691898|11732448|FG004|NOT COMPLETED|Overall Study||14
10577208|NCT01691898|11732449|FG005|NOT COMPLETED|Overall Study||35
10577209|NCT01691950|11732483|FG000|STARTED|Overall Study||20
10577210|NCT01691950|11732484|FG001|STARTED|Overall Study||10
10577211|NCT01691950|11732483|FG000|COMPLETED|Overall Study||10
10577212|NCT01691950|11732484|FG001|COMPLETED|Overall Study||10
10577213|NCT01691950|11732483|FG000|NOT COMPLETED|Overall Study||10
10577214|NCT01691950|11732484|FG001|NOT COMPLETED|Overall Study||0
10577215|NCT01692119|11732492|FG000|STARTED|Overall Study||130
10577216|NCT01692119|11732493|FG001|STARTED|Overall Study||128
10333697|NCT00334893|11469861|FG001|NOT COMPLETED|Overall Study||0
10577217|NCT01692119|11732492|FG000|COMPLETED|Overall Study||110
10577218|NCT01692119|11732493|FG001|COMPLETED|Overall Study||127
10577219|NCT01692119|11732492|FG000|NOT COMPLETED|Overall Study||20
10577220|NCT01692119|11732493|FG001|NOT COMPLETED|Overall Study||1
10577221|NCT01692197|11732499|FG000|STARTED|Overall Study||43
10577222|NCT01692197|11732499|FG000|COMPLETED|Overall Study||40
10577223|NCT01692197|11732499|FG000|NOT COMPLETED|Overall Study||3
10577224|NCT01692275|11732510|FG000|STARTED|Overall Study||375
10577225|NCT01692275|11732511|FG001|STARTED|Overall Study||375
10577226|NCT01692275|11732510|FG000|COMPLETED|Overall Study||309
10577227|NCT01692275|11732511|FG001|COMPLETED|Overall Study||316
10577228|NCT01692275|11732510|FG000|NOT COMPLETED|Overall Study||66
10577229|NCT01692275|11732511|FG001|NOT COMPLETED|Overall Study||59
10577230|NCT01692301|11732531|FG000|STARTED|Overall Study|"Started indicates patients in randomized, full analysis and safety set"|229
10577231|NCT01692301|11732532|FG001|STARTED|Overall Study||225
10577232|NCT01692301|11732531|FG000|COMPLETED|Overall Study||184
10577233|NCT01692301|11732532|FG001|COMPLETED|Overall Study||183
10577234|NCT01692301|11732531|FG000|NOT COMPLETED|Overall Study||45
10577235|NCT01692301|11732532|FG001|NOT COMPLETED|Overall Study||42
10577236|NCT01692340|11732541|FG000|STARTED|Overall Study||8
10577237|NCT01692340|11732542|FG001|STARTED|Overall Study||4
10577238|NCT01692340|11732543|FG002|STARTED|Overall Study||0
10577239|NCT01692340|11732541|FG000|COMPLETED|Overall Study||8
10577240|NCT01692340|11732542|FG001|COMPLETED|Overall Study||4
10577241|NCT01692340|11732543|FG002|COMPLETED|Overall Study||0
10577242|NCT01692340|11732541|FG000|NOT COMPLETED|Overall Study||0
10577243|NCT01692340|11732542|FG001|NOT COMPLETED|Overall Study||0
10577244|NCT01692340|11732543|FG002|NOT COMPLETED|Overall Study||0
10577245|NCT01692496|11732552|FG000|STARTED|Overall Study||52
10577246|NCT01692496|11732552|FG000|3 Weeks Pazopanib (Per Protocol PP)|Overall Study||50
10577247|NCT01692496|11732552|FG000|COMPLETED|Overall Study||52
10577248|NCT01692496|11732552|FG000|NOT COMPLETED|Overall Study||0
10577249|NCT01692626|11732556|FG000|STARTED|Overall Study||6
10577250|NCT01692626|11732557|FG001|STARTED|Overall Study||7
10577251|NCT01692626|11732556|FG000|COMPLETED|Overall Study||2
10577252|NCT01692626|11732557|FG001|COMPLETED|Overall Study||1
10577253|NCT01692626|11732556|FG000|NOT COMPLETED|Overall Study||4
10577254|NCT01692626|11732557|FG001|NOT COMPLETED|Overall Study||6
10577255|NCT01692730|11732564|FG000|STARTED|Overall Study||723
10577256|NCT01692730|11732565|FG001|STARTED|Overall Study||729
10577257|NCT01692730|11732564|FG000|COMPLETED|Overall Study||498
10577258|NCT01692730|11732565|FG001|COMPLETED|Overall Study||502
10577259|NCT01692730|11732564|FG000|NOT COMPLETED|Overall Study||225
10577260|NCT01692730|11732565|FG001|NOT COMPLETED|Overall Study||227
10577261|NCT01692743|11732574|FG000|STARTED|Overall Study||117
10577262|NCT01692743|11732575|FG001|STARTED|Overall Study||116
10577263|NCT01692743|11732576|FG002|STARTED|Overall Study||115
10577264|NCT01692743|11732574|FG000|COMPLETED|Overall Study||90
10577265|NCT01692743|11732575|FG001|COMPLETED|Overall Study||81
10577266|NCT01692743|11732576|FG002|COMPLETED|Overall Study||88
10577267|NCT01692743|11732574|FG000|NOT COMPLETED|Overall Study||27
10577268|NCT01692743|11732575|FG001|NOT COMPLETED|Overall Study||35
10577269|NCT01692743|11732576|FG002|NOT COMPLETED|Overall Study||27
10577270|NCT01692756|11732588|FG000|STARTED|Overall Study||12
10577271|NCT01692756|11732589|FG001|STARTED|Overall Study||12
10577272|NCT01692756|11732590|FG002|STARTED|Overall Study||13
10577273|NCT01692756|11732591|FG003|STARTED|Overall Study||12
10577274|NCT01692756|11732588|FG000|COMPLETED|Overall Study||11
10577275|NCT01692756|11732589|FG001|COMPLETED|Overall Study||11
10577276|NCT01692756|11732590|FG002|COMPLETED|Overall Study||11
10577277|NCT01692756|11732591|FG003|COMPLETED|Overall Study||12
10577278|NCT01692756|11732588|FG000|NOT COMPLETED|Overall Study||1
10577279|NCT01692756|11732589|FG001|NOT COMPLETED|Overall Study||1
10577280|NCT01692756|11732590|FG002|NOT COMPLETED|Overall Study||2
10577281|NCT01692756|11732591|FG003|NOT COMPLETED|Overall Study||0
10577282|NCT01692782|11732604|FG000|STARTED|Overall Study||116
10577283|NCT01692782|11732605|FG001|STARTED|Overall Study||115
10577284|NCT01692782|11732606|FG002|STARTED|Overall Study||110
10577285|NCT01692782|11732604|FG000|COMPLETED|Overall Study||96
10805446|NCT04007107|11967023|FG003|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||26
10805447|NCT04007107|11967020|FG000|COMPLETED|Treatment Period 1 (Day 1)||26
10805448|NCT04007107|11967021|FG001|COMPLETED|Treatment Period 1 (Day 1)||26
10805449|NCT04007107|11967022|FG002|COMPLETED|Treatment Period 1 (Day 1)||25
10805450|NCT04007107|11967023|FG003|COMPLETED|Treatment Period 1 (Day 1)||26
10805451|NCT04007107|11967020|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10805452|NCT04007107|11967021|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10805453|NCT04007107|11967022|FG002|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10805454|NCT04007107|11967023|FG003|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10805455|NCT04007107|11967020|FG000|STARTED|Treatment Period 2 (Day 1)||26
10805456|NCT04007107|11967021|FG001|STARTED|Treatment Period 2 (Day 1)||26
10577286|NCT01692782|11732605|FG001|COMPLETED|Overall Study||59
10577287|NCT01692782|11732606|FG002|COMPLETED|Overall Study||100
10805457|NCT04007107|11967022|FG002|STARTED|Treatment Period 2 (Day 1)||25
10805458|NCT04007107|11967023|FG003|STARTED|Treatment Period 2 (Day 1)||26
10805459|NCT04007107|11967020|FG000|COMPLETED|Treatment Period 2 (Day 1)||26
10577288|NCT01692782|11732604|FG000|NOT COMPLETED|Overall Study||20
10577289|NCT01692782|11732605|FG001|NOT COMPLETED|Overall Study||56
10577290|NCT01692782|11732606|FG002|NOT COMPLETED|Overall Study||10
10577291|NCT01692938|11732616|FG000|STARTED|Overall Study||16
10577292|NCT01692938|11732617|FG001|STARTED|Overall Study||16
10577293|NCT01692938|11732616|FG000|COMPLETED|Overall Study||12
10577294|NCT01692938|11732617|FG001|COMPLETED|Overall Study||12
10577295|NCT01692938|11732616|FG000|NOT COMPLETED|Overall Study||4
10577296|NCT01692938|11732617|FG001|NOT COMPLETED|Overall Study||4
10577297|NCT01692951|11732627|FG000|STARTED|Overall Study||37
10577298|NCT01692951|11732628|FG001|STARTED|Overall Study||111
10577299|NCT01692951|11732629|FG002|STARTED|Overall Study||18
10577300|NCT01692951|11732630|FG003|STARTED|Overall Study||54
10577301|NCT01692951|11732627|FG000|COMPLETED|Overall Study||37
10577302|NCT01692951|11732628|FG001|COMPLETED|Overall Study||111
10577303|NCT01692951|11732629|FG002|COMPLETED|Overall Study||18
10577304|NCT01692951|11732630|FG003|COMPLETED|Overall Study||54
10577305|NCT01692951|11732627|FG000|NOT COMPLETED|Overall Study||0
10577306|NCT01692951|11732628|FG001|NOT COMPLETED|Overall Study||0
10577307|NCT01692951|11732629|FG002|NOT COMPLETED|Overall Study||0
10577308|NCT01692951|11732630|FG003|NOT COMPLETED|Overall Study||0
10577309|NCT01692964|11732640|FG000|STARTED|Overall Study||237
10577310|NCT01692964|11732640|FG000|COMPLETED|Overall Study||237
10577311|NCT01692964|11732640|FG000|NOT COMPLETED|Overall Study||0
10577312|NCT01693029|11732647|FG000|STARTED|Overall Study||217
10577313|NCT01693029|11732648|FG001|STARTED|Overall Study||218
10577314|NCT01693029|11732647|FG000|COMPLETED|Overall Study||173
10577315|NCT01693029|11732648|FG001|COMPLETED|Overall Study||161
10577316|NCT01693029|11732647|FG000|NOT COMPLETED|Overall Study||44
10577317|NCT01693029|11732648|FG001|NOT COMPLETED|Overall Study||57
10577318|NCT01693068|11732656|FG000|STARTED|Randomization Period||64
10577319|NCT01693068|11732657|FG001|STARTED|Randomization Period||130
10577320|NCT01693068|11732658|FG002|STARTED|Randomization Period||0
10577321|NCT01693068|11732656|FG000|Treated|Randomization Period||61
10577322|NCT01693068|11732657|FG001|Treated|Randomization Period||130
10577323|NCT01693068|11732658|FG002|Treated|Randomization Period||0
10577324|NCT01693068|11732656|FG000|COMPLETED|Randomization Period||62
10577325|NCT01693068|11732657|FG001|COMPLETED|Randomization Period||125
10577326|NCT01693068|11732658|FG002|COMPLETED|Randomization Period||0
10577327|NCT01693068|11732656|FG000|NOT COMPLETED|Randomization Period||2
10577328|NCT01693068|11732657|FG001|NOT COMPLETED|Randomization Period||5
10577329|NCT01693068|11732658|FG002|NOT COMPLETED|Randomization Period||0
10577330|NCT01693068|11732656|FG000|STARTED|Cross-over (Dacarbazine To Pimasertib)||0
10577331|NCT01693068|11732657|FG001|STARTED|Cross-over (Dacarbazine To Pimasertib)||0
10577332|NCT01693068|11732658|FG002|STARTED|Cross-over (Dacarbazine To Pimasertib)||41
10577333|NCT01693068|11732656|FG000|Treated|Cross-over (Dacarbazine To Pimasertib)||0
10577334|NCT01693068|11732657|FG001|Treated|Cross-over (Dacarbazine To Pimasertib)||0
10577335|NCT01693068|11732658|FG002|Treated|Cross-over (Dacarbazine To Pimasertib)||41
10577336|NCT01693068|11732656|FG000|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
10577337|NCT01693068|11732657|FG001|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
10577338|NCT01693068|11732658|FG002|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||40
10577339|NCT01693068|11732656|FG000|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
10577340|NCT01693068|11732657|FG001|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
10577341|NCT01693068|11732658|FG002|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||1
10577342|NCT01693120|11732666|FG000|STARTED|Enrollment|70 subjects exited the study after consent, but prior to undergoing a study ablation procedure.|199
10577343|NCT01693120|11732666|FG000|COMPLETED|Enrollment|129 of the 199 enrolled subjects underwent a Phased RF study procedure|129
10577344|NCT01693120|11732666|FG000|NOT COMPLETED|Enrollment||70
10577345|NCT01693120|11732666|FG000|STARTED|Phased RF Study Procedure and Follow-up||129
10577346|NCT01693120|11732666|FG000|COMPLETED|Phased RF Study Procedure and Follow-up|112 of the 129 subjects with a Phased RF procedure completed the 6-month follow-up visit|112
10577347|NCT01693120|11732666|FG000|NOT COMPLETED|Phased RF Study Procedure and Follow-up||17
10577348|NCT01693185|11732672|FG000|STARTED|Overall Study||27
10577349|NCT01693185|11732673|FG001|STARTED|Overall Study||33
10577350|NCT01693185|11732672|FG000|COMPLETED|Overall Study||27
10577351|NCT01693185|11732673|FG001|COMPLETED|Overall Study||27
10577352|NCT01693185|11732672|FG000|NOT COMPLETED|Overall Study||0
10577353|NCT01693185|11732673|FG001|NOT COMPLETED|Overall Study||6
10577354|NCT01693250|11732681|FG000|STARTED|Overall Study|3 months post baseline assessment|23
10805460|NCT04007107|11967021|FG001|COMPLETED|Treatment Period 2 (Day 1)||25
10805461|NCT04007107|11967022|FG002|COMPLETED|Treatment Period 2 (Day 1)||25
10805462|NCT04007107|11967023|FG003|COMPLETED|Treatment Period 2 (Day 1)||26
10805463|NCT04007107|11967020|FG000|NOT COMPLETED|Treatment Period 2 (Day 1)||0
10805464|NCT04007107|11967021|FG001|NOT COMPLETED|Treatment Period 2 (Day 1)||1
10805465|NCT04007107|11967022|FG002|NOT COMPLETED|Treatment Period 2 (Day 1)||0
10805466|NCT04007107|11967023|FG003|NOT COMPLETED|Treatment Period 2 (Day 1)||0
10805467|NCT04006795|11967028|FG000|STARTED|Induction Phase||37
10805468|NCT04006795|11967028|FG000|COMPLETED|Induction Phase||37
10805469|NCT04006795|11967028|FG000|NOT COMPLETED|Induction Phase||0
10805470|NCT04006795|11967028|FG000|STARTED|Rest Phase||37
10805471|NCT04006795|11967028|FG000|COMPLETED|Rest Phase||37
10805472|NCT04006795|11967028|FG000|NOT COMPLETED|Rest Phase||0
10805473|NCT04006795|11967028|FG000|STARTED|Challenge Phase||37
10805474|NCT04006795|11967028|FG000|COMPLETED|Challenge Phase||37
10805475|NCT04006795|11967028|FG000|NOT COMPLETED|Challenge Phase||0
10805476|NCT04005885|11967039|FG000|STARTED|First Intervention||26
10805477|NCT04005885|11967040|FG001|STARTED|First Intervention||29
10805478|NCT04005885|11967039|FG000|COMPLETED|First Intervention||25
10805479|NCT04005885|11967040|FG001|COMPLETED|First Intervention||28
10577355|NCT01693250|11732682|FG001|STARTED|Overall Study|three month post baseline assessment|17
10805480|NCT04005885|11967039|FG000|NOT COMPLETED|First Intervention||1
10577356|NCT01693250|11732681|FG000|COMPLETED|Overall Study|21 teens completed 6 months post baseline assessment|21
10577357|NCT01693250|11732682|FG001|COMPLETED|Overall Study|15 teens completed 6 months post baseline assessment|15
10577358|NCT01693250|11732681|FG000|NOT COMPLETED|Overall Study||2
10577359|NCT01693250|11732682|FG001|NOT COMPLETED|Overall Study||2
10577360|NCT01693523|11732693|FG000|STARTED|Overall Study||23
10577361|NCT01693523|11732694|FG001|STARTED|Overall Study||21
10577362|NCT01693523|11732695|FG002|STARTED|Overall Study||35
10577363|NCT01693523|11732693|FG000|COMPLETED|Overall Study||18
10577364|NCT01693523|11732694|FG001|COMPLETED|Overall Study||13
10577365|NCT01693523|11732695|FG002|COMPLETED|Overall Study||27
10577366|NCT01693523|11732693|FG000|NOT COMPLETED|Overall Study||5
10577367|NCT01693523|11732694|FG001|NOT COMPLETED|Overall Study||8
10577368|NCT01693523|11732695|FG002|NOT COMPLETED|Overall Study||8
10577369|NCT01693562|11732725|FG000|STARTED|Escalation Phase||4
10577370|NCT01693562|11732726|FG001|STARTED|Escalation Phase||4
10577371|NCT01693562|11732727|FG002|STARTED|Escalation Phase||3
10577372|NCT01693562|11732728|FG003|STARTED|Escalation Phase||3
10577373|NCT01693562|11732729|FG004|STARTED|Escalation Phase||6
10577374|NCT01693562|11732730|FG005|STARTED|Escalation Phase||7
10577375|NCT01693562|11732731|FG006|STARTED|Escalation Phase||0
10577376|NCT01693562|11732732|FG007|STARTED|Escalation Phase||0
10577377|NCT01693562|11732733|FG008|STARTED|Escalation Phase||0
10577378|NCT01693562|11732734|FG009|STARTED|Escalation Phase||0
10577379|NCT01693562|11732735|FG010|STARTED|Escalation Phase||0
10577380|NCT01693562|11732736|FG011|STARTED|Escalation Phase||0
10577381|NCT01693562|11732737|FG012|STARTED|Escalation Phase||0
10577382|NCT01693562|11732738|FG013|STARTED|Escalation Phase||0
10577383|NCT01693562|11732739|FG014|STARTED|Escalation Phase||0
10577384|NCT01693562|11732740|FG015|STARTED|Escalation Phase||0
10577385|NCT01693562|11732741|FG016|STARTED|Escalation Phase||0
10577386|NCT01693562|11732742|FG017|STARTED|Escalation Phase||0
10577387|NCT01693562|11732743|FG018|STARTED|Escalation Phase||0
10577388|NCT01693562|11732744|FG019|STARTED|Escalation Phase||0
10702239|NCT02574078|11866727|FG012|NOT COMPLETED|Pre-Treatment Period||0
10702240|NCT02574078|11866715|FG000|STARTED|Treatment Period||13
10702241|NCT02574078|11866716|FG001|STARTED|Treatment Period||6
10702242|NCT02574078|11866717|FG002|STARTED|Treatment Period||9
10702243|NCT02574078|11866718|FG003|STARTED|Treatment Period||35
10702244|NCT02574078|11866719|FG004|STARTED|Treatment Period||34
10805481|NCT04005885|11967040|FG001|NOT COMPLETED|First Intervention||1
10805482|NCT04005885|11967039|FG000|STARTED|Second Intervention||25
10805483|NCT04005885|11967040|FG001|STARTED|Second Intervention||28
10805484|NCT04005885|11967039|FG000|COMPLETED|Second Intervention||25
10805485|NCT04005885|11967040|FG001|COMPLETED|Second Intervention||26
10805486|NCT04005885|11967039|FG000|NOT COMPLETED|Second Intervention||0
10805487|NCT04005885|11967040|FG001|NOT COMPLETED|Second Intervention||2
10805488|NCT04005885|11967039|FG000|STARTED|Third Intervention||25
10805489|NCT04005885|11967040|FG001|STARTED|Third Intervention||26
10805490|NCT04005885|11967039|FG000|COMPLETED|Third Intervention||25
10805491|NCT04005885|11967040|FG001|COMPLETED|Third Intervention||26
10805492|NCT04005885|11967039|FG000|NOT COMPLETED|Third Intervention||0
10805493|NCT04005885|11967040|FG001|NOT COMPLETED|Third Intervention||0
10805494|NCT04000815|11967054|FG000|STARTED|Overall Study||29
10805495|NCT04000815|11967055|FG001|STARTED|Overall Study||20
10805496|NCT04000815|11967056|FG002|STARTED|Overall Study||22
10805497|NCT04000815|11967054|FG000|COMPLETED|Overall Study||15
10805498|NCT04000815|11967055|FG001|COMPLETED|Overall Study||15
10805499|NCT04000815|11967056|FG002|COMPLETED|Overall Study||15
10805500|NCT04000815|11967054|FG000|NOT COMPLETED|Overall Study||14
10805501|NCT04000815|11967055|FG001|NOT COMPLETED|Overall Study||5
10805502|NCT04000815|11967056|FG002|NOT COMPLETED|Overall Study||7
10805503|NCT03999944|11967064|FG000|STARTED|First Sleep Night||26
10805504|NCT03999944|11967065|FG001|STARTED|First Sleep Night||26
10805505|NCT03999944|11967064|FG000|COMPLETED|First Sleep Night||22
10805506|NCT03999944|11967065|FG001|COMPLETED|First Sleep Night||24
10805507|NCT03999944|11967064|FG000|NOT COMPLETED|First Sleep Night||4
10805508|NCT03999944|11967065|FG001|NOT COMPLETED|First Sleep Night||2
10805509|NCT03999944|11967064|FG000|STARTED|Second Sleep Night||22
10805510|NCT03999944|11967065|FG001|STARTED|Second Sleep Night||24
10805511|NCT03999944|11967064|FG000|COMPLETED|Second Sleep Night||22
10805512|NCT03999944|11967065|FG001|COMPLETED|Second Sleep Night||20
10805513|NCT03999944|11967064|FG000|NOT COMPLETED|Second Sleep Night||0
10805514|NCT03999944|11967065|FG001|NOT COMPLETED|Second Sleep Night||4
10805515|NCT03995680|11967074|FG000|STARTED|Overall Study||199
10702245|NCT02574078|11866720|FG005|STARTED|Treatment Period||34
10805516|NCT03995680|11967075|FG001|STARTED|Overall Study||198
10805517|NCT03995680|11967074|FG000|COMPLETED|Overall Study||197
10805518|NCT03995680|11967075|FG001|COMPLETED|Overall Study||196
10805519|NCT03995680|11967074|FG000|NOT COMPLETED|Overall Study||2
10805520|NCT03995680|11967075|FG001|NOT COMPLETED|Overall Study||2
10577389|NCT01693562|11732745|FG020|STARTED|Escalation Phase||0
10577390|NCT01693562|11732746|FG021|STARTED|Escalation Phase||0
10702246|NCT02574078|11866721|FG006|STARTED|Treatment Period||14
10577391|NCT01693562|11732747|FG022|STARTED|Escalation Phase||0
10577392|NCT01693562|11732725|FG000|COMPLETED|Escalation Phase||0
10577393|NCT01693562|11732726|FG001|COMPLETED|Escalation Phase||0
10577394|NCT01693562|11732727|FG002|COMPLETED|Escalation Phase||0
10577395|NCT01693562|11732728|FG003|COMPLETED|Escalation Phase||0
10577396|NCT01693562|11732729|FG004|COMPLETED|Escalation Phase||0
10702247|NCT02574078|11866722|FG007|STARTED|Treatment Period||14
10702248|NCT02574078|11866723|FG008|STARTED|Treatment Period||25
10577397|NCT01693562|11732730|FG005|COMPLETED|Escalation Phase||0
10577398|NCT01693562|11732731|FG006|COMPLETED|Escalation Phase||0
10577399|NCT01693562|11732732|FG007|COMPLETED|Escalation Phase||0
10577400|NCT01693562|11732733|FG008|COMPLETED|Escalation Phase||0
10577401|NCT01693562|11732734|FG009|COMPLETED|Escalation Phase||0
10577402|NCT01693562|11732735|FG010|COMPLETED|Escalation Phase||0
10577403|NCT01693562|11732736|FG011|COMPLETED|Escalation Phase||0
10577404|NCT01693562|11732737|FG012|COMPLETED|Escalation Phase||0
10577405|NCT01693562|11732738|FG013|COMPLETED|Escalation Phase||0
10577406|NCT01693562|11732739|FG014|COMPLETED|Escalation Phase||0
10577407|NCT01693562|11732740|FG015|COMPLETED|Escalation Phase||0
10577408|NCT01693562|11732741|FG016|COMPLETED|Escalation Phase||0
10577409|NCT01693562|11732742|FG017|COMPLETED|Escalation Phase||0
10577410|NCT01693562|11732743|FG018|COMPLETED|Escalation Phase||0
10577411|NCT01693562|11732744|FG019|COMPLETED|Escalation Phase||0
10577412|NCT01693562|11732745|FG020|COMPLETED|Escalation Phase||0
10577413|NCT01693562|11732746|FG021|COMPLETED|Escalation Phase||0
10577414|NCT01693562|11732747|FG022|COMPLETED|Escalation Phase||0
10577415|NCT01693562|11732725|FG000|NOT COMPLETED|Escalation Phase||4
10577416|NCT01693562|11732726|FG001|NOT COMPLETED|Escalation Phase||4
10577417|NCT01693562|11732727|FG002|NOT COMPLETED|Escalation Phase||3
10577418|NCT01693562|11732728|FG003|NOT COMPLETED|Escalation Phase||3
10577419|NCT01693562|11732729|FG004|NOT COMPLETED|Escalation Phase||6
10577420|NCT01693562|11732730|FG005|NOT COMPLETED|Escalation Phase||7
10577421|NCT01693562|11732731|FG006|NOT COMPLETED|Escalation Phase||0
10577422|NCT01693562|11732732|FG007|NOT COMPLETED|Escalation Phase||0
10577423|NCT01693562|11732733|FG008|NOT COMPLETED|Escalation Phase||0
10577424|NCT01693562|11732734|FG009|NOT COMPLETED|Escalation Phase||0
10577425|NCT01693562|11732735|FG010|NOT COMPLETED|Escalation Phase||0
10577426|NCT01693562|11732736|FG011|NOT COMPLETED|Escalation Phase||0
10577427|NCT01693562|11732737|FG012|NOT COMPLETED|Escalation Phase||0
10577428|NCT01693562|11732738|FG013|NOT COMPLETED|Escalation Phase||0
10577429|NCT01693562|11732739|FG014|NOT COMPLETED|Escalation Phase||0
10577430|NCT01693562|11732740|FG015|NOT COMPLETED|Escalation Phase||0
10577431|NCT01693562|11732741|FG016|NOT COMPLETED|Escalation Phase||0
10577432|NCT01693562|11732742|FG017|NOT COMPLETED|Escalation Phase||0
10577433|NCT01693562|11732743|FG018|NOT COMPLETED|Escalation Phase||0
10577434|NCT01693562|11732744|FG019|NOT COMPLETED|Escalation Phase||0
10577435|NCT01693562|11732745|FG020|NOT COMPLETED|Escalation Phase||0
10577436|NCT01693562|11732746|FG021|NOT COMPLETED|Escalation Phase||0
10577437|NCT01693562|11732747|FG022|NOT COMPLETED|Escalation Phase||0
10577438|NCT01693562|11732725|FG000|STARTED|Exploration Phase||0
10702249|NCT02574078|11866724|FG009|STARTED|Treatment Period||26
10702250|NCT02574078|11866725|FG010|STARTED|Treatment Period||49
10702251|NCT02574078|11866726|FG011|STARTED|Treatment Period||55
10702252|NCT02574078|11866727|FG012|STARTED|Treatment Period||13
10702253|NCT02574078|11866715|FG000|COMPLETED|Treatment Period||3
10702254|NCT02574078|11866716|FG001|COMPLETED|Treatment Period||0
10702255|NCT02574078|11866717|FG002|COMPLETED|Treatment Period||0
10702256|NCT02574078|11866718|FG003|COMPLETED|Treatment Period||7
10702257|NCT02574078|11866719|FG004|COMPLETED|Treatment Period||3
10702258|NCT02574078|11866720|FG005|COMPLETED|Treatment Period||1
10702259|NCT02574078|11866721|FG006|COMPLETED|Treatment Period||2
10702260|NCT02574078|11866722|FG007|COMPLETED|Treatment Period||2
10702261|NCT02574078|11866723|FG008|COMPLETED|Treatment Period||1
10702262|NCT02574078|11866724|FG009|COMPLETED|Treatment Period||9
10702263|NCT02574078|11866725|FG010|COMPLETED|Treatment Period||4
10702264|NCT02574078|11866726|FG011|COMPLETED|Treatment Period||8
10702265|NCT02574078|11866727|FG012|COMPLETED|Treatment Period||0
10702266|NCT02574078|11866715|FG000|NOT COMPLETED|Treatment Period||10
10702267|NCT02574078|11866716|FG001|NOT COMPLETED|Treatment Period||6
10702268|NCT02574078|11866717|FG002|NOT COMPLETED|Treatment Period||9
10702269|NCT02574078|11866718|FG003|NOT COMPLETED|Treatment Period||28
10702270|NCT02574078|11866719|FG004|NOT COMPLETED|Treatment Period||31
10702271|NCT02574078|11866720|FG005|NOT COMPLETED|Treatment Period||33
10702272|NCT02574078|11866721|FG006|NOT COMPLETED|Treatment Period||12
10702273|NCT02574078|11866722|FG007|NOT COMPLETED|Treatment Period||12
10702274|NCT02574078|11866723|FG008|NOT COMPLETED|Treatment Period||24
10805521|NCT04006366|11967081|FG000|STARTED|Overall Study||6
10805522|NCT04006366|11967081|FG000|COMPLETED|Overall Study||5
10805523|NCT04006366|11967081|FG000|NOT COMPLETED|Overall Study||1
10805524|NCT04006145|11967087|FG000|STARTED|Overall Study||23
10805525|NCT04006145|11967088|FG001|STARTED|Overall Study||24
10805526|NCT04006145|11967087|FG000|Received Treatment|Overall Study||23
10577439|NCT01693562|11732726|FG001|STARTED|Exploration Phase||0
10577440|NCT01693562|11732727|FG002|STARTED|Exploration Phase||0
10577441|NCT01693562|11732728|FG003|STARTED|Exploration Phase||0
10577442|NCT01693562|11732729|FG004|STARTED|Exploration Phase||0
10702275|NCT02574078|11866724|FG009|NOT COMPLETED|Treatment Period||17
10577443|NCT01693562|11732730|FG005|STARTED|Exploration Phase||0
10577444|NCT01693562|11732731|FG006|STARTED|Exploration Phase||21
10577445|NCT01693562|11732732|FG007|STARTED|Exploration Phase||0
10577446|NCT01693562|11732733|FG008|STARTED|Exploration Phase||0
10577447|NCT01693562|11732734|FG009|STARTED|Exploration Phase||0
10577448|NCT01693562|11732735|FG010|STARTED|Exploration Phase||0
10577449|NCT01693562|11732736|FG011|STARTED|Exploration Phase||0
10577450|NCT01693562|11732737|FG012|STARTED|Exploration Phase||0
10702276|NCT02574078|11866725|FG010|NOT COMPLETED|Treatment Period||45
10702277|NCT02574078|11866726|FG011|NOT COMPLETED|Treatment Period||47
10805527|NCT04006145|11967088|FG001|Received Treatment|Overall Study||24
10805528|NCT04006145|11967087|FG000|COMPLETED|Overall Study||22
10805529|NCT04006145|11967088|FG001|COMPLETED|Overall Study||21
10805530|NCT04006145|11967087|FG000|NOT COMPLETED|Overall Study||1
10805531|NCT04006145|11967088|FG001|NOT COMPLETED|Overall Study||3
10805532|NCT04005755|11967094|FG000|STARTED|Overall Study||232
10805533|NCT04005755|11967094|FG000|COMPLETED|Overall Study||215
10805534|NCT04005755|11967094|FG000|NOT COMPLETED|Overall Study||17
10805535|NCT04005586|11967098|FG000|STARTED|Overall Study||25
10805536|NCT04005586|11967098|FG000|COMPLETED|Overall Study||25
10805537|NCT04005586|11967098|FG000|NOT COMPLETED|Overall Study||0
10805538|NCT04005404|11967105|FG000|STARTED|Overall Study||43
10805539|NCT04005404|11967106|FG001|STARTED|Overall Study||34
10805540|NCT04005404|11967107|FG002|STARTED|Overall Study||3
10805541|NCT04005404|11967105|FG000|COMPLETED|Overall Study||42
10805542|NCT04005404|11967106|FG001|COMPLETED|Overall Study||33
10805543|NCT04005404|11967107|FG002|COMPLETED|Overall Study||3
10805544|NCT04005404|11967105|FG000|NOT COMPLETED|Overall Study||1
10805545|NCT04005404|11967106|FG001|NOT COMPLETED|Overall Study||1
10805546|NCT04005404|11967107|FG002|NOT COMPLETED|Overall Study||0
10805547|NCT03993288|11967117|FG000|STARTED|Overall Study||133
10805548|NCT03993288|11967118|FG001|STARTED|Overall Study||134
10805549|NCT03993288|11967117|FG000|Intention-to-treat (ITT) Population|Overall Study||123
10805550|NCT03993288|11967118|FG001|Intention-to-treat (ITT) Population|Overall Study||129
10805551|NCT03993288|11967117|FG000|Safety Analysis Set|Overall Study||133
10805552|NCT03993288|11967118|FG001|Safety Analysis Set|Overall Study||134
10805553|NCT03993288|11967117|FG000|COMPLETED|Overall Study||123
10805554|NCT03993288|11967118|FG001|COMPLETED|Overall Study||129
10805555|NCT03993288|11967117|FG000|NOT COMPLETED|Overall Study||10
10805556|NCT03993288|11967118|FG001|NOT COMPLETED|Overall Study||5
10805557|NCT03990298|11967124|FG000|STARTED|Overall Study||16
10805558|NCT03990298|11967124|FG000|COMPLETED|Overall Study||16
10805559|NCT03990298|11967124|FG000|NOT COMPLETED|Overall Study||0
10805560|NCT03988647|11967128|FG000|STARTED|Overall Study||1
10805561|NCT03988647|11967128|FG000|COMPLETED|Overall Study||1
10805562|NCT03988647|11967128|FG000|NOT COMPLETED|Overall Study||0
10805563|NCT03979872|11967136|FG000|STARTED|Overall Study||22
10702278|NCT02574078|11866727|FG012|NOT COMPLETED|Treatment Period||13
10702279|NCT02574247|11866761|FG000|STARTED|Overall Study||10
10702280|NCT02574247|11866762|FG001|STARTED|Overall Study||8
10702281|NCT02574247|11866763|FG002|STARTED|Overall Study||10
10702282|NCT02574247|11866761|FG000|COMPLETED|Overall Study||5
10702283|NCT02574247|11866762|FG001|COMPLETED|Overall Study||5
10702284|NCT02574247|11866763|FG002|COMPLETED|Overall Study||5
10702285|NCT02574247|11866761|FG000|NOT COMPLETED|Overall Study||5
10702286|NCT02574247|11866762|FG001|NOT COMPLETED|Overall Study||3
10805564|NCT03979872|11967137|FG001|STARTED|Overall Study||23
10805565|NCT03979872|11967138|FG002|STARTED|Overall Study||24
10805566|NCT03979872|11967139|FG003|STARTED|Overall Study||23
10805567|NCT03979872|11967136|FG000|COMPLETED|Overall Study||19
10805568|NCT03979872|11967137|FG001|COMPLETED|Overall Study||15
10805569|NCT03979872|11967138|FG002|COMPLETED|Overall Study||18
10805570|NCT03979872|11967139|FG003|COMPLETED|Overall Study||19
10805571|NCT03979872|11967136|FG000|NOT COMPLETED|Overall Study||3
10805572|NCT03979872|11967137|FG001|NOT COMPLETED|Overall Study||8
10805573|NCT03979872|11967138|FG002|NOT COMPLETED|Overall Study||6
10702287|NCT02574247|11866763|FG002|NOT COMPLETED|Overall Study||5
10702288|NCT02574260|11866773|FG000|STARTED|Overall Study||3
10702289|NCT02574260|11866773|FG000|COMPLETED|Overall Study||2
10702290|NCT02574260|11866773|FG000|NOT COMPLETED|Overall Study||1
10702291|NCT02574312|11866779|FG000|STARTED|Pre-Operative||44
10702292|NCT02574312|11866780|FG001|STARTED|Pre-Operative||44
10702293|NCT02574312|11866779|FG000|COMPLETED|Pre-Operative||44
10702294|NCT02574312|11866780|FG001|COMPLETED|Pre-Operative||44
10702295|NCT02574312|11866779|FG000|NOT COMPLETED|Pre-Operative||0
10702296|NCT02574312|11866780|FG001|NOT COMPLETED|Pre-Operative||0
10702297|NCT02574312|11866779|FG000|STARTED|3 Months Follow-up||44
10702298|NCT02574312|11866780|FG001|STARTED|3 Months Follow-up||44
10702299|NCT02574312|11866779|FG000|COMPLETED|3 Months Follow-up|One subject withdrew consent|43
10702300|NCT02574312|11866780|FG001|COMPLETED|3 Months Follow-up||44
10702301|NCT02574312|11866779|FG000|NOT COMPLETED|3 Months Follow-up||1
10702302|NCT02574312|11866780|FG001|NOT COMPLETED|3 Months Follow-up||0
10702303|NCT02574520|11866790|FG000|STARTED|Overall Study||48
10702304|NCT02574520|11866791|FG001|STARTED|Overall Study||46
10702305|NCT02574520|11866792|FG002|STARTED|Overall Study||153
10702306|NCT02574520|11866793|FG003|STARTED|Overall Study||152
10702307|NCT02574520|11866790|FG000|Dosed|Overall Study||46
10702308|NCT02574520|11866791|FG001|Dosed|Overall Study||46
10702309|NCT02574520|11866792|FG002|Dosed|Overall Study||148
10702310|NCT02574520|11866793|FG003|Dosed|Overall Study||148
10805574|NCT03979872|11967139|FG003|NOT COMPLETED|Overall Study||4
10805575|NCT03978832|11967149|FG000|STARTED|Overall Study|69 participants signed the ICF and entered screening; 25 met eligibility criteria and were enrolled.|69
10805576|NCT03978832|11967149|FG000|Stabilization Period|Overall Study||25
10805577|NCT03978832|11967149|FG000|Treatment Period|Overall Study||23
10805578|NCT03978832|11967149|FG000|COMPLETED|Overall Study||15
10702311|NCT02574520|11866790|FG000|COMPLETED|Overall Study||46
10702312|NCT02574520|11866791|FG001|COMPLETED|Overall Study||46
10702313|NCT02574520|11866792|FG002|COMPLETED|Overall Study||148
10702314|NCT02574520|11866793|FG003|COMPLETED|Overall Study||144
10702315|NCT02574520|11866790|FG000|NOT COMPLETED|Overall Study||2
10702316|NCT02574520|11866791|FG001|NOT COMPLETED|Overall Study||0
10702317|NCT02574520|11866792|FG002|NOT COMPLETED|Overall Study||5
10702318|NCT02574520|11866793|FG003|NOT COMPLETED|Overall Study||8
10702319|NCT02574598|11866805|FG000|STARTED|Overall Study||40
10702320|NCT02574598|11866806|FG001|STARTED|Overall Study||38
10702321|NCT02574598|11866805|FG000|COMPLETED|Overall Study||40
10702322|NCT02574598|11866806|FG001|COMPLETED|Overall Study||38
10702323|NCT02574598|11866805|FG000|NOT COMPLETED|Overall Study||0
10805579|NCT03978832|11967149|FG000|NOT COMPLETED|Overall Study||54
10805580|NCT04005391|11967155|FG000|STARTED|Overall Study|10/23/18|108
10805581|NCT04005391|11967156|FG001|STARTED|Overall Study|10/23/18|100
10702324|NCT02574598|11866806|FG001|NOT COMPLETED|Overall Study||0
10702325|NCT02574637|11866817|FG000|STARTED|Double-blind Period||5
10702326|NCT02574637|11866818|FG001|STARTED|Double-blind Period||5
10702327|NCT02574637|11866819|FG002|STARTED|Double-blind Period||9
10702328|NCT02574637|11866820|FG003|STARTED|Double-blind Period||7
10702329|NCT02574637|11866821|FG004|STARTED|Double-blind Period||3
10702330|NCT02574637|11866822|FG005|STARTED|Double-blind Period||0
10702331|NCT02574637|11866823|FG006|STARTED|Double-blind Period||0
10702332|NCT02574637|11866824|FG007|STARTED|Double-blind Period||0
10702333|NCT02574637|11866825|FG008|STARTED|Double-blind Period||0
10702334|NCT02574637|11866826|FG009|STARTED|Double-blind Period||0
10702335|NCT02574637|11866817|FG000|COMPLETED|Double-blind Period||2
10702336|NCT02574637|11866818|FG001|COMPLETED|Double-blind Period||4
10805582|NCT04005391|11967155|FG000|COMPLETED|Overall Study||101
10805583|NCT04005391|11967156|FG001|COMPLETED|Overall Study||100
10805584|NCT04005391|11967155|FG000|NOT COMPLETED|Overall Study||7
10805585|NCT04005391|11967156|FG001|NOT COMPLETED|Overall Study||0
10805586|NCT04004481|11967166|FG000|STARTED|Overall Study||50
10805587|NCT04004481|11967166|FG000|COMPLETED|Overall Study||47
10805588|NCT04004481|11967166|FG000|NOT COMPLETED|Overall Study||3
10805589|NCT04004260|11967190|FG000|STARTED|Overall Study||79
10805590|NCT04004260|11967191|FG001|STARTED|Overall Study||79
10805591|NCT04004260|11967190|FG000|COMPLETED|Overall Study||37
10577451|NCT01693562|11732738|FG013|STARTED|Exploration Phase||0
10577452|NCT01693562|11732739|FG014|STARTED|Exploration Phase||0
10577453|NCT01693562|11732740|FG015|STARTED|Exploration Phase||0
10577454|NCT01693562|11732741|FG016|STARTED|Exploration Phase||0
10577455|NCT01693562|11732742|FG017|STARTED|Exploration Phase||0
10577456|NCT01693562|11732743|FG018|STARTED|Exploration Phase||0
10805592|NCT04004260|11967191|FG001|COMPLETED|Overall Study||47
10805593|NCT04004260|11967190|FG000|NOT COMPLETED|Overall Study||42
10805594|NCT04004260|11967191|FG001|NOT COMPLETED|Overall Study||32
10805595|NCT03997851|11967197|FG000|STARTED|Overall Study||17
10805596|NCT03997851|11967197|FG000|COMPLETED|Overall Study||17
10805597|NCT03997851|11967197|FG000|NOT COMPLETED|Overall Study||0
10805598|NCT03991715|11967207|FG000|STARTED|Overall Study||5
10805599|NCT03991715|11967207|FG000|COMPLETED|Overall Study||5
10805600|NCT03991715|11967207|FG000|NOT COMPLETED|Overall Study||0
10805601|NCT03990415|11967214|FG000|STARTED|Overall Study||19
10805602|NCT03990415|11967215|FG001|STARTED|Overall Study||19
10805603|NCT03990415|11967216|FG002|STARTED|Overall Study||14
10805604|NCT03990415|11967214|FG000|COMPLETED|Overall Study||15
10805605|NCT03990415|11967215|FG001|COMPLETED|Overall Study||17
10805606|NCT03990415|11967216|FG002|COMPLETED|Overall Study||14
10805607|NCT03990415|11967214|FG000|NOT COMPLETED|Overall Study||4
10805608|NCT03990415|11967215|FG001|NOT COMPLETED|Overall Study||2
10805609|NCT03990415|11967216|FG002|NOT COMPLETED|Overall Study||0
10805610|NCT04002960|11967224|FG000|STARTED|Overall Study||23
10805611|NCT04002960|11967224|FG000|COMPLETED|Overall Study||21
10805612|NCT04002960|11967224|FG000|NOT COMPLETED|Overall Study||2
10805613|NCT04002973|11967228|FG000|STARTED|Overall Study||11
10805614|NCT04002973|11967228|FG000|COMPLETED|Overall Study||11
10805615|NCT04002973|11967228|FG000|NOT COMPLETED|Overall Study||0
10805616|NCT04002648|11967234|FG000|STARTED|Overall Study||104
10805617|NCT04002648|11967235|FG001|STARTED|Overall Study||104
10805618|NCT04002648|11967234|FG000|COMPLETED|Overall Study||102
10805619|NCT04002648|11967235|FG001|COMPLETED|Overall Study||104
10805620|NCT04002648|11967234|FG000|NOT COMPLETED|Overall Study||2
10805621|NCT04002648|11967235|FG001|NOT COMPLETED|Overall Study||0
10805622|NCT03993210|11967243|FG000|STARTED|Overall Study||1
10805623|NCT03993210|11967244|FG001|STARTED|Overall Study||0
10805624|NCT03993210|11967243|FG000|COMPLETED|Overall Study||1
10805625|NCT03993210|11967244|FG001|COMPLETED|Overall Study||0
10577457|NCT01693562|11732744|FG019|STARTED|Exploration Phase||0
10577458|NCT01693562|11732745|FG020|STARTED|Exploration Phase||0
10577459|NCT01693562|11732746|FG021|STARTED|Exploration Phase||0
10577460|NCT01693562|11732747|FG022|STARTED|Exploration Phase||0
10577461|NCT01693562|11732725|FG000|COMPLETED|Exploration Phase||0
10577462|NCT01693562|11732726|FG001|COMPLETED|Exploration Phase||0
10577463|NCT01693562|11732727|FG002|COMPLETED|Exploration Phase||0
10577464|NCT01693562|11732728|FG003|COMPLETED|Exploration Phase||0
10577465|NCT01693562|11732729|FG004|COMPLETED|Exploration Phase||0
10577466|NCT01693562|11732730|FG005|COMPLETED|Exploration Phase||0
10577467|NCT01693562|11732731|FG006|COMPLETED|Exploration Phase||0
10577468|NCT01693562|11732732|FG007|COMPLETED|Exploration Phase||0
10577469|NCT01693562|11732733|FG008|COMPLETED|Exploration Phase||0
10805626|NCT03993210|11967243|FG000|NOT COMPLETED|Overall Study||0
10805627|NCT03993210|11967244|FG001|NOT COMPLETED|Overall Study||0
10805628|NCT03992014|11967254|FG000|STARTED|Treatment Period 1 (8 Days)||6
10805629|NCT03992014|11967254|FG000|COMPLETED|Treatment Period 1 (8 Days)||6
10805630|NCT03992014|11967254|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10702337|NCT02574637|11866819|FG002|COMPLETED|Double-blind Period||2
10577470|NCT01693562|11732734|FG009|COMPLETED|Exploration Phase||0
10577471|NCT01693562|11732735|FG010|COMPLETED|Exploration Phase||0
10577472|NCT01693562|11732736|FG011|COMPLETED|Exploration Phase||0
10577473|NCT01693562|11732737|FG012|COMPLETED|Exploration Phase||0
10577474|NCT01693562|11732738|FG013|COMPLETED|Exploration Phase||0
10577475|NCT01693562|11732739|FG014|COMPLETED|Exploration Phase||0
10577476|NCT01693562|11732740|FG015|COMPLETED|Exploration Phase||0
10577477|NCT01693562|11732741|FG016|COMPLETED|Exploration Phase||0
10577478|NCT01693562|11732742|FG017|COMPLETED|Exploration Phase||0
10577479|NCT01693562|11732743|FG018|COMPLETED|Exploration Phase||0
10577480|NCT01693562|11732744|FG019|COMPLETED|Exploration Phase||0
10577481|NCT01693562|11732745|FG020|COMPLETED|Exploration Phase||0
10577482|NCT01693562|11732746|FG021|COMPLETED|Exploration Phase||0
10577483|NCT01693562|11732747|FG022|COMPLETED|Exploration Phase||0
10577484|NCT01693562|11732725|FG000|NOT COMPLETED|Exploration Phase||0
10577485|NCT01693562|11732726|FG001|NOT COMPLETED|Exploration Phase||0
10577486|NCT01693562|11732727|FG002|NOT COMPLETED|Exploration Phase||0
10805631|NCT03992014|11967254|FG000|STARTED|Washout Period (7 Days)||6
10805632|NCT03992014|11967254|FG000|COMPLETED|Washout Period (7 Days)||6
10805633|NCT03992014|11967254|FG000|NOT COMPLETED|Washout Period (7 Days)||0
10805634|NCT03992014|11967254|FG000|STARTED|Treatment Period 2 (8 Days)||6
10805635|NCT03992014|11967254|FG000|COMPLETED|Treatment Period 2 (8 Days)||6
10805636|NCT03992014|11967254|FG000|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10805637|NCT03990649|11967264|FG000|STARTED|Part A: DB Treatment Period (15 Weeks)||9
10805638|NCT03990649|11967265|FG001|STARTED|Part A: DB Treatment Period (15 Weeks)||15
10805639|NCT03990649|11967266|FG002|STARTED|Part A: DB Treatment Period (15 Weeks)||0
10805640|NCT03990649|11967264|FG000|COMPLETED|Part A: DB Treatment Period (15 Weeks)||6
10805641|NCT03990649|11967265|FG001|COMPLETED|Part A: DB Treatment Period (15 Weeks)||12
10805642|NCT03990649|11967266|FG002|COMPLETED|Part A: DB Treatment Period (15 Weeks)||0
10805643|NCT03990649|11967264|FG000|NOT COMPLETED|Part A: DB Treatment Period (15 Weeks)||3
10805644|NCT03990649|11967265|FG001|NOT COMPLETED|Part A: DB Treatment Period (15 Weeks)||3
10805645|NCT03990649|11967266|FG002|NOT COMPLETED|Part A: DB Treatment Period (15 Weeks)||0
10805646|NCT03990649|11967264|FG000|STARTED|Part B: OL Extension Period (14 Weeks)||0
10805647|NCT03990649|11967265|FG001|STARTED|Part B: OL Extension Period (14 Weeks)||0
10805648|NCT03990649|11967266|FG002|STARTED|Part B: OL Extension Period (14 Weeks)||18
10805649|NCT03990649|11967264|FG000|COMPLETED|Part B: OL Extension Period (14 Weeks)||0
10805650|NCT03990649|11967265|FG001|COMPLETED|Part B: OL Extension Period (14 Weeks)||0
10805651|NCT03990649|11967266|FG002|COMPLETED|Part B: OL Extension Period (14 Weeks)||14
10805652|NCT03990649|11967264|FG000|NOT COMPLETED|Part B: OL Extension Period (14 Weeks)||0
10805653|NCT03990649|11967265|FG001|NOT COMPLETED|Part B: OL Extension Period (14 Weeks)||0
10805654|NCT03990649|11967266|FG002|NOT COMPLETED|Part B: OL Extension Period (14 Weeks)||4
10805655|NCT04002791|11967275|FG000|STARTED|Overall Study||127
10805656|NCT04002791|11967276|FG001|STARTED|Overall Study||126
10805657|NCT04002791|11967275|FG000|COMPLETED|Overall Study||127
10805658|NCT04002791|11967276|FG001|COMPLETED|Overall Study||126
10805659|NCT04002791|11967275|FG000|NOT COMPLETED|Overall Study||0
10805660|NCT04002791|11967276|FG001|NOT COMPLETED|Overall Study||0
10805667|NCT03996694|11967291|FG000|STARTED|First Intervention (1 Day)||3
10805668|NCT03996694|11967292|FG001|STARTED|First Intervention (1 Day)||3
10805669|NCT03996694|11967293|FG002|STARTED|First Intervention (1 Day)||4
10805670|NCT03996694|11967294|FG003|STARTED|First Intervention (1 Day)||3
10805671|NCT03996694|11967295|FG004|STARTED|First Intervention (1 Day)||3
10805672|NCT03996694|11967296|FG005|STARTED|First Intervention (1 Day)||3
10805673|NCT03996694|11967291|FG000|COMPLETED|First Intervention (1 Day)||3
10577487|NCT01693562|11732728|FG003|NOT COMPLETED|Exploration Phase||0
10577488|NCT01693562|11732729|FG004|NOT COMPLETED|Exploration Phase||0
10577489|NCT01693562|11732730|FG005|NOT COMPLETED|Exploration Phase||0
10577490|NCT01693562|11732731|FG006|NOT COMPLETED|Exploration Phase||21
10577491|NCT01693562|11732732|FG007|NOT COMPLETED|Exploration Phase||0
10577492|NCT01693562|11732733|FG008|NOT COMPLETED|Exploration Phase||0
10577493|NCT01693562|11732734|FG009|NOT COMPLETED|Exploration Phase||0
10577494|NCT01693562|11732735|FG010|NOT COMPLETED|Exploration Phase||0
10577495|NCT01693562|11732736|FG011|NOT COMPLETED|Exploration Phase||0
10577496|NCT01693562|11732737|FG012|NOT COMPLETED|Exploration Phase||0
10577497|NCT01693562|11732738|FG013|NOT COMPLETED|Exploration Phase||0
10577498|NCT01693562|11732739|FG014|NOT COMPLETED|Exploration Phase||0
10577499|NCT01693562|11732740|FG015|NOT COMPLETED|Exploration Phase||0
10577500|NCT01693562|11732741|FG016|NOT COMPLETED|Exploration Phase||0
10577501|NCT01693562|11732742|FG017|NOT COMPLETED|Exploration Phase||0
10577502|NCT01693562|11732743|FG018|NOT COMPLETED|Exploration Phase||0
10577503|NCT01693562|11732744|FG019|NOT COMPLETED|Exploration Phase||0
10577504|NCT01693562|11732745|FG020|NOT COMPLETED|Exploration Phase||0
10577505|NCT01693562|11732746|FG021|NOT COMPLETED|Exploration Phase||0
10577506|NCT01693562|11732747|FG022|NOT COMPLETED|Exploration Phase||0
10577507|NCT01693562|11732725|FG000|STARTED|Expansion Phase||0
10577508|NCT01693562|11732726|FG001|STARTED|Expansion Phase||0
10577509|NCT01693562|11732727|FG002|STARTED|Expansion Phase||0
10702338|NCT02574637|11866820|FG003|COMPLETED|Double-blind Period||3
10702339|NCT02574637|11866821|FG004|COMPLETED|Double-blind Period||1
10702340|NCT02574637|11866822|FG005|COMPLETED|Double-blind Period||0
10577510|NCT01693562|11732728|FG003|STARTED|Expansion Phase||0
10577511|NCT01693562|11732729|FG004|STARTED|Expansion Phase||0
10577512|NCT01693562|11732730|FG005|STARTED|Expansion Phase||0
10577513|NCT01693562|11732731|FG006|STARTED|Expansion Phase||0
10577514|NCT01693562|11732732|FG007|STARTED|Expansion Phase||62
10577515|NCT01693562|11732733|FG008|STARTED|Expansion Phase||22
10577516|NCT01693562|11732734|FG009|STARTED|Expansion Phase|2 eligible NSCLC participants from dose-escalation were added to the dose expansion summaries.|304
10577517|NCT01693562|11732735|FG010|STARTED|Expansion Phase||40
10577518|NCT01693562|11732736|FG011|STARTED|Expansion Phase||21
10577519|NCT01693562|11732737|FG012|STARTED|Expansion Phase||24
10577520|NCT01693562|11732738|FG013|STARTED|Expansion Phase||51
10577521|NCT01693562|11732739|FG014|STARTED|Expansion Phase||40
10577522|NCT01693562|11732740|FG015|STARTED|Expansion Phase||31
10577523|NCT01693562|11732741|FG016|STARTED|Expansion Phase||201
10577524|NCT01693562|11732742|FG017|STARTED|Expansion Phase||20
10577525|NCT01693562|11732743|FG018|STARTED|Expansion Phase||47
10577526|NCT01693562|11732744|FG019|STARTED|Expansion Phase||20
10577527|NCT01693562|11732745|FG020|STARTED|Expansion Phase||21
10577528|NCT01693562|11732746|FG021|STARTED|Expansion Phase||62
10577529|NCT01693562|11732747|FG022|STARTED|Expansion Phase||10
10577530|NCT01693562|11732725|FG000|COMPLETED|Expansion Phase||0
10577531|NCT01693562|11732726|FG001|COMPLETED|Expansion Phase||0
10577532|NCT01693562|11732727|FG002|COMPLETED|Expansion Phase||0
10577533|NCT01693562|11732728|FG003|COMPLETED|Expansion Phase||0
10577534|NCT01693562|11732729|FG004|COMPLETED|Expansion Phase||0
10577535|NCT01693562|11732730|FG005|COMPLETED|Expansion Phase||0
10577536|NCT01693562|11732731|FG006|COMPLETED|Expansion Phase||0
10577537|NCT01693562|11732732|FG007|COMPLETED|Expansion Phase||0
10805674|NCT03996694|11967292|FG001|COMPLETED|First Intervention (1 Day)||3
10805675|NCT03996694|11967293|FG002|COMPLETED|First Intervention (1 Day)||4
10805676|NCT03996694|11967294|FG003|COMPLETED|First Intervention (1 Day)||3
10805677|NCT03996694|11967295|FG004|COMPLETED|First Intervention (1 Day)||3
10805678|NCT03996694|11967296|FG005|COMPLETED|First Intervention (1 Day)||3
10805679|NCT03996694|11967291|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10805680|NCT03996694|11967292|FG001|NOT COMPLETED|First Intervention (1 Day)||0
10805681|NCT03996694|11967293|FG002|NOT COMPLETED|First Intervention (1 Day)||0
10805682|NCT03996694|11967294|FG003|NOT COMPLETED|First Intervention (1 Day)||0
10805683|NCT03996694|11967295|FG004|NOT COMPLETED|First Intervention (1 Day)||0
10805684|NCT03996694|11967296|FG005|NOT COMPLETED|First Intervention (1 Day)||0
10805685|NCT03996694|11967291|FG000|STARTED|First Washout (7 Days)||3
10805686|NCT03996694|11967292|FG001|STARTED|First Washout (7 Days)||3
10805687|NCT03996694|11967293|FG002|STARTED|First Washout (7 Days)||4
10577538|NCT01693562|11732733|FG008|COMPLETED|Expansion Phase||0
10577539|NCT01693562|11732734|FG009|COMPLETED|Expansion Phase||4
10577540|NCT01693562|11732735|FG010|COMPLETED|Expansion Phase||0
10702341|NCT02574637|11866823|FG006|COMPLETED|Double-blind Period||0
10702342|NCT02574637|11866824|FG007|COMPLETED|Double-blind Period||0
10702343|NCT02574637|11866825|FG008|COMPLETED|Double-blind Period||0
10702344|NCT02574637|11866826|FG009|COMPLETED|Double-blind Period||0
10702345|NCT02574637|11866817|FG000|NOT COMPLETED|Double-blind Period||3
10702346|NCT02574637|11866818|FG001|NOT COMPLETED|Double-blind Period||1
10702347|NCT02574637|11866819|FG002|NOT COMPLETED|Double-blind Period||7
10702348|NCT02574637|11866820|FG003|NOT COMPLETED|Double-blind Period||4
10702349|NCT02574637|11866821|FG004|NOT COMPLETED|Double-blind Period||2
10702350|NCT02574637|11866822|FG005|NOT COMPLETED|Double-blind Period||0
10702351|NCT02574637|11866823|FG006|NOT COMPLETED|Double-blind Period||0
10702352|NCT02574637|11866824|FG007|NOT COMPLETED|Double-blind Period||0
10702353|NCT02574637|11866825|FG008|NOT COMPLETED|Double-blind Period||0
10702354|NCT02574637|11866826|FG009|NOT COMPLETED|Double-blind Period||0
10702355|NCT02574637|11866817|FG000|STARTED|Open-label (OL) Period||0
10702356|NCT02574637|11866818|FG001|STARTED|Open-label (OL) Period||0
10702357|NCT02574637|11866819|FG002|STARTED|Open-label (OL) Period||0
10333698|NCT00334958|11469871|FG000|STARTED|Overall Study||176
10333699|NCT00334958|11469872|FG001|STARTED|Overall Study|1 participant withdrawn prior to study drug dosing due to not obtaining labs|180
10577541|NCT01693562|11732736|FG011|COMPLETED|Expansion Phase||0
10702358|NCT02574637|11866820|FG003|STARTED|Open-label (OL) Period||0
10702359|NCT02574637|11866821|FG004|STARTED|Open-label (OL) Period||0
10702360|NCT02574637|11866822|FG005|STARTED|Open-label (OL) Period||2
10702361|NCT02574637|11866823|FG006|STARTED|Open-label (OL) Period||3
10702362|NCT02574637|11866824|FG007|STARTED|Open-label (OL) Period||2
10702363|NCT02574637|11866825|FG008|STARTED|Open-label (OL) Period||3
10702364|NCT02574637|11866826|FG009|STARTED|Open-label (OL) Period||1
10702365|NCT02574637|11866817|FG000|COMPLETED|Open-label (OL) Period||0
10577542|NCT01693562|11732737|FG012|COMPLETED|Expansion Phase||1
10577543|NCT01693562|11732738|FG013|COMPLETED|Expansion Phase||0
10577544|NCT01693562|11732739|FG014|COMPLETED|Expansion Phase||0
10577545|NCT01693562|11732740|FG015|COMPLETED|Expansion Phase||0
10702366|NCT02574637|11866818|FG001|COMPLETED|Open-label (OL) Period||0
10702367|NCT02574637|11866819|FG002|COMPLETED|Open-label (OL) Period||0
10702368|NCT02574637|11866820|FG003|COMPLETED|Open-label (OL) Period||0
10702369|NCT02574637|11866821|FG004|COMPLETED|Open-label (OL) Period||0
10702370|NCT02574637|11866822|FG005|COMPLETED|Open-label (OL) Period||0
10702371|NCT02574637|11866823|FG006|COMPLETED|Open-label (OL) Period||1
10702372|NCT02574637|11866824|FG007|COMPLETED|Open-label (OL) Period||1
10577546|NCT01693562|11732741|FG016|COMPLETED|Expansion Phase||4
10577547|NCT01693562|11732742|FG017|COMPLETED|Expansion Phase||0
10577548|NCT01693562|11732743|FG018|COMPLETED|Expansion Phase||0
10577549|NCT01693562|11732744|FG019|COMPLETED|Expansion Phase||0
10577550|NCT01693562|11732745|FG020|COMPLETED|Expansion Phase||0
10577551|NCT01693562|11732746|FG021|COMPLETED|Expansion Phase||0
10577552|NCT01693562|11732747|FG022|COMPLETED|Expansion Phase||0
10577553|NCT01693562|11732725|FG000|NOT COMPLETED|Expansion Phase||0
10577554|NCT01693562|11732726|FG001|NOT COMPLETED|Expansion Phase||0
10577555|NCT01693562|11732727|FG002|NOT COMPLETED|Expansion Phase||0
10577556|NCT01693562|11732728|FG003|NOT COMPLETED|Expansion Phase||0
10577557|NCT01693562|11732729|FG004|NOT COMPLETED|Expansion Phase||0
10805688|NCT03996694|11967294|FG003|STARTED|First Washout (7 Days)||3
10805689|NCT03996694|11967295|FG004|STARTED|First Washout (7 Days)||3
10805690|NCT03996694|11967296|FG005|STARTED|First Washout (7 Days)||3
10805691|NCT03996694|11967291|FG000|COMPLETED|First Washout (7 Days)||3
10805692|NCT03996694|11967292|FG001|COMPLETED|First Washout (7 Days)||2
10805693|NCT03996694|11967293|FG002|COMPLETED|First Washout (7 Days)||2
10805694|NCT03996694|11967294|FG003|COMPLETED|First Washout (7 Days)||3
10805695|NCT03996694|11967295|FG004|COMPLETED|First Washout (7 Days)||3
10805696|NCT03996694|11967296|FG005|COMPLETED|First Washout (7 Days)||3
10805697|NCT03996694|11967291|FG000|NOT COMPLETED|First Washout (7 Days)||0
10805698|NCT03996694|11967292|FG001|NOT COMPLETED|First Washout (7 Days)||1
10805699|NCT03996694|11967293|FG002|NOT COMPLETED|First Washout (7 Days)||2
10805700|NCT03996694|11967294|FG003|NOT COMPLETED|First Washout (7 Days)||0
10805701|NCT03996694|11967295|FG004|NOT COMPLETED|First Washout (7 Days)||0
10805702|NCT03996694|11967296|FG005|NOT COMPLETED|First Washout (7 Days)||0
10805703|NCT03996694|11967291|FG000|STARTED|Second Intervention (1 Day)||3
10805704|NCT03996694|11967292|FG001|STARTED|Second Intervention (1 Day)||2
10805705|NCT03996694|11967293|FG002|STARTED|Second Intervention (1 Day)||2
10805706|NCT03996694|11967294|FG003|STARTED|Second Intervention (1 Day)||3
10805707|NCT03996694|11967295|FG004|STARTED|Second Intervention (1 Day)||3
10805708|NCT03996694|11967296|FG005|STARTED|Second Intervention (1 Day)||3
10805709|NCT03996694|11967291|FG000|COMPLETED|Second Intervention (1 Day)||3
10805710|NCT03996694|11967292|FG001|COMPLETED|Second Intervention (1 Day)||2
10805711|NCT03996694|11967293|FG002|COMPLETED|Second Intervention (1 Day)||2
10805712|NCT03996694|11967294|FG003|COMPLETED|Second Intervention (1 Day)||3
10805713|NCT03996694|11967295|FG004|COMPLETED|Second Intervention (1 Day)||3
10805714|NCT03996694|11967296|FG005|COMPLETED|Second Intervention (1 Day)||3
10805715|NCT03996694|11967291|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10805716|NCT03996694|11967292|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10805717|NCT03996694|11967293|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
10805718|NCT03996694|11967294|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
10805719|NCT03996694|11967295|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
10805720|NCT03996694|11967296|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
10805721|NCT03996694|11967291|FG000|STARTED|Second Washout (7 Days)||3
10805722|NCT03996694|11967292|FG001|STARTED|Second Washout (7 Days)||2
10805723|NCT03996694|11967293|FG002|STARTED|Second Washout (7 Days)||2
10805724|NCT03996694|11967294|FG003|STARTED|Second Washout (7 Days)||3
10805725|NCT03996694|11967295|FG004|STARTED|Second Washout (7 Days)||3
10805726|NCT03996694|11967296|FG005|STARTED|Second Washout (7 Days)||3
10805727|NCT03996694|11967291|FG000|COMPLETED|Second Washout (7 Days)||3
10805728|NCT03996694|11967292|FG001|COMPLETED|Second Washout (7 Days)||2
10805729|NCT03996694|11967293|FG002|COMPLETED|Second Washout (7 Days)||2
10805730|NCT03996694|11967294|FG003|COMPLETED|Second Washout (7 Days)||3
10805731|NCT03996694|11967295|FG004|COMPLETED|Second Washout (7 Days)||3
10805732|NCT03996694|11967296|FG005|COMPLETED|Second Washout (7 Days)||3
10805733|NCT03996694|11967291|FG000|NOT COMPLETED|Second Washout (7 Days)||0
10805734|NCT03996694|11967292|FG001|NOT COMPLETED|Second Washout (7 Days)||0
10805735|NCT03996694|11967293|FG002|NOT COMPLETED|Second Washout (7 Days)||0
10805736|NCT03996694|11967294|FG003|NOT COMPLETED|Second Washout (7 Days)||0
10805737|NCT03996694|11967295|FG004|NOT COMPLETED|Second Washout (7 Days)||0
10805738|NCT03996694|11967296|FG005|NOT COMPLETED|Second Washout (7 Days)||0
10577558|NCT01693562|11732730|FG005|NOT COMPLETED|Expansion Phase||0
10577559|NCT01693562|11732731|FG006|NOT COMPLETED|Expansion Phase||0
10577560|NCT01693562|11732732|FG007|NOT COMPLETED|Expansion Phase||62
10577561|NCT01693562|11732733|FG008|NOT COMPLETED|Expansion Phase||22
10577562|NCT01693562|11732734|FG009|NOT COMPLETED|Expansion Phase||300
10577563|NCT01693562|11732735|FG010|NOT COMPLETED|Expansion Phase||40
10577564|NCT01693562|11732736|FG011|NOT COMPLETED|Expansion Phase||21
10577565|NCT01693562|11732737|FG012|NOT COMPLETED|Expansion Phase||23
10577566|NCT01693562|11732738|FG013|NOT COMPLETED|Expansion Phase||51
10805739|NCT03996694|11967291|FG000|STARTED|Third Intervention (1 Day)||3
10805740|NCT03996694|11967292|FG001|STARTED|Third Intervention (1 Day)||2
10805741|NCT03996694|11967293|FG002|STARTED|Third Intervention (1 Day)||2
10805742|NCT03996694|11967294|FG003|STARTED|Third Intervention (1 Day)||3
10805743|NCT03996694|11967295|FG004|STARTED|Third Intervention (1 Day)||3
10805744|NCT03996694|11967296|FG005|STARTED|Third Intervention (1 Day)||3
10805745|NCT03996694|11967291|FG000|COMPLETED|Third Intervention (1 Day)||3
10805746|NCT03996694|11967292|FG001|COMPLETED|Third Intervention (1 Day)||2
10805747|NCT03996694|11967293|FG002|COMPLETED|Third Intervention (1 Day)||2
10805748|NCT03996694|11967294|FG003|COMPLETED|Third Intervention (1 Day)||3
10805749|NCT03996694|11967295|FG004|COMPLETED|Third Intervention (1 Day)||3
10805750|NCT03996694|11967296|FG005|COMPLETED|Third Intervention (1 Day)||3
10577567|NCT01693562|11732739|FG014|NOT COMPLETED|Expansion Phase||40
10577568|NCT01693562|11732740|FG015|NOT COMPLETED|Expansion Phase||31
10577569|NCT01693562|11732741|FG016|NOT COMPLETED|Expansion Phase||197
10577570|NCT01693562|11732742|FG017|NOT COMPLETED|Expansion Phase||20
10577571|NCT01693562|11732743|FG018|NOT COMPLETED|Expansion Phase||47
10577572|NCT01693562|11732744|FG019|NOT COMPLETED|Expansion Phase||20
10577573|NCT01693562|11732745|FG020|NOT COMPLETED|Expansion Phase||21
10577574|NCT01693562|11732746|FG021|NOT COMPLETED|Expansion Phase||62
10577575|NCT01693562|11732747|FG022|NOT COMPLETED|Expansion Phase||10
10702373|NCT02574637|11866825|FG008|COMPLETED|Open-label (OL) Period||1
10702374|NCT02574637|11866826|FG009|COMPLETED|Open-label (OL) Period||0
10702375|NCT02574637|11866817|FG000|NOT COMPLETED|Open-label (OL) Period||0
10702376|NCT02574637|11866818|FG001|NOT COMPLETED|Open-label (OL) Period||0
10702377|NCT02574637|11866819|FG002|NOT COMPLETED|Open-label (OL) Period||0
10805751|NCT03996694|11967291|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
10577576|NCT01693614|11732833|FG000|STARTED|Overall Study||26
10577577|NCT01693614|11732834|FG001|STARTED|Overall Study||22
10577578|NCT01693614|11732835|FG002|STARTED|Overall Study||24
10577579|NCT01693614|11732833|FG000|COMPLETED|Overall Study||0
10577580|NCT01693614|11732834|FG001|COMPLETED|Overall Study||0
10577581|NCT01693614|11732835|FG002|COMPLETED|Overall Study||0
10577582|NCT01693614|11732833|FG000|NOT COMPLETED|Overall Study||26
10702378|NCT02574637|11866820|FG003|NOT COMPLETED|Open-label (OL) Period||0
10805752|NCT03996694|11967292|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
10805753|NCT03996694|11967293|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
10805754|NCT03996694|11967294|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
10805755|NCT03996694|11967295|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
10805756|NCT03996694|11967296|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
10805757|NCT03996694|11967291|FG000|STARTED|Third Washout (7 Days)||3
10805758|NCT03996694|11967292|FG001|STARTED|Third Washout (7 Days)||2
10805759|NCT03996694|11967293|FG002|STARTED|Third Washout (7 Days)||2
10805760|NCT03996694|11967294|FG003|STARTED|Third Washout (7 Days)||3
10805761|NCT03996694|11967295|FG004|STARTED|Third Washout (7 Days)||3
10805762|NCT03996694|11967296|FG005|STARTED|Third Washout (7 Days)||3
10805763|NCT03996694|11967291|FG000|COMPLETED|Third Washout (7 Days)||3
10805764|NCT03996694|11967292|FG001|COMPLETED|Third Washout (7 Days)||2
10805765|NCT03996694|11967293|FG002|COMPLETED|Third Washout (7 Days)||2
10805766|NCT03996694|11967294|FG003|COMPLETED|Third Washout (7 Days)||3
10805767|NCT03996694|11967295|FG004|COMPLETED|Third Washout (7 Days)||2
10805768|NCT03996694|11967296|FG005|COMPLETED|Third Washout (7 Days)||3
10805769|NCT03996694|11967291|FG000|NOT COMPLETED|Third Washout (7 Days)||0
10805770|NCT03996694|11967292|FG001|NOT COMPLETED|Third Washout (7 Days)||0
10805771|NCT03996694|11967293|FG002|NOT COMPLETED|Third Washout (7 Days)||0
10805772|NCT03996694|11967294|FG003|NOT COMPLETED|Third Washout (7 Days)||0
10805773|NCT03996694|11967295|FG004|NOT COMPLETED|Third Washout (7 Days)||1
10805774|NCT03996694|11967296|FG005|NOT COMPLETED|Third Washout (7 Days)||0
10805775|NCT03996694|11967291|FG000|STARTED|Fourth Intervention (1 Day)||3
10805776|NCT03996694|11967292|FG001|STARTED|Fourth Intervention (1 Day)||2
10805777|NCT03996694|11967293|FG002|STARTED|Fourth Intervention (1 Day)||2
10805778|NCT03996694|11967294|FG003|STARTED|Fourth Intervention (1 Day)||3
10805779|NCT03996694|11967295|FG004|STARTED|Fourth Intervention (1 Day)||2
10805780|NCT03996694|11967296|FG005|STARTED|Fourth Intervention (1 Day)||3
10805781|NCT03996694|11967291|FG000|COMPLETED|Fourth Intervention (1 Day)||3
10805782|NCT03996694|11967292|FG001|COMPLETED|Fourth Intervention (1 Day)||2
10805783|NCT03996694|11967293|FG002|COMPLETED|Fourth Intervention (1 Day)||2
10805784|NCT03996694|11967294|FG003|COMPLETED|Fourth Intervention (1 Day)||3
10805785|NCT03996694|11967295|FG004|COMPLETED|Fourth Intervention (1 Day)||2
10805786|NCT03996694|11967296|FG005|COMPLETED|Fourth Intervention (1 Day)||3
10805787|NCT03996694|11967291|FG000|NOT COMPLETED|Fourth Intervention (1 Day)||0
10805788|NCT03996694|11967292|FG001|NOT COMPLETED|Fourth Intervention (1 Day)||0
10805789|NCT03996694|11967293|FG002|NOT COMPLETED|Fourth Intervention (1 Day)||0
10805790|NCT03996694|11967294|FG003|NOT COMPLETED|Fourth Intervention (1 Day)||0
10805791|NCT03996694|11967295|FG004|NOT COMPLETED|Fourth Intervention (1 Day)||0
10805792|NCT03996694|11967296|FG005|NOT COMPLETED|Fourth Intervention (1 Day)||0
10577583|NCT01693614|11732834|FG001|NOT COMPLETED|Overall Study||22
10577584|NCT01693614|11732835|FG002|NOT COMPLETED|Overall Study||24
10577585|NCT01693900|11732846|FG000|STARTED|Overall Study||25
10577586|NCT01693900|11732847|FG001|STARTED|Overall Study||25
10577587|NCT01693900|11732846|FG000|COMPLETED|Overall Study||25
10577588|NCT01693900|11732847|FG001|COMPLETED|Overall Study||25
10577589|NCT01693900|11732846|FG000|NOT COMPLETED|Overall Study||0
10577590|NCT01693900|11732847|FG001|NOT COMPLETED|Overall Study||0
10577591|NCT01694108|11732855|FG000|STARTED|Overall Study||2129
10577592|NCT01694108|11732856|FG001|STARTED|Overall Study||2133
10577593|NCT01694108|11732855|FG000|COMPLETED|Overall Study|100% follow-up|2129
10702379|NCT02574637|11866821|FG004|NOT COMPLETED|Open-label (OL) Period||0
10702380|NCT02574637|11866822|FG005|NOT COMPLETED|Open-label (OL) Period||2
10702381|NCT02574637|11866823|FG006|NOT COMPLETED|Open-label (OL) Period||2
10702382|NCT02574637|11866824|FG007|NOT COMPLETED|Open-label (OL) Period||1
10702383|NCT02574637|11866825|FG008|NOT COMPLETED|Open-label (OL) Period||2
10805793|NCT03996694|11967291|FG000|STARTED|Fourth Washout (7 Days)||3
10805794|NCT03996694|11967292|FG001|STARTED|Fourth Washout (7 Days)||2
10805795|NCT03996694|11967293|FG002|STARTED|Fourth Washout (7 Days)||2
10805796|NCT03996694|11967294|FG003|STARTED|Fourth Washout (7 Days)||3
10805797|NCT03996694|11967295|FG004|STARTED|Fourth Washout (7 Days)||2
10805798|NCT03996694|11967296|FG005|STARTED|Fourth Washout (7 Days)||3
10577594|NCT01694108|11732856|FG001|COMPLETED|Overall Study|100% follow-up|2133
10577595|NCT01694108|11732855|FG000|NOT COMPLETED|Overall Study||0
10577596|NCT01694108|11732856|FG001|NOT COMPLETED|Overall Study||0
10577597|NCT01694121|11732871|FG000|STARTED|Overall Study||228
10577598|NCT01694121|11732872|FG001|STARTED|Overall Study||227
10577599|NCT01694121|11732871|FG000|COMPLETED|Overall Study||227
10577600|NCT01694121|11732872|FG001|COMPLETED|Overall Study||227
10577601|NCT01694121|11732871|FG000|NOT COMPLETED|Overall Study||1
10577602|NCT01694121|11732872|FG001|NOT COMPLETED|Overall Study||0
10577603|NCT01694186|11732880|FG000|STARTED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|42
10577604|NCT01694186|11732881|FG001|STARTED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|87
10577605|NCT01694186|11732880|FG000|COMPLETED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|36
10577606|NCT01694186|11732881|FG001|COMPLETED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|80
10577607|NCT01694186|11732880|FG000|NOT COMPLETED|Overall Study||6
10577608|NCT01694186|11732881|FG001|NOT COMPLETED|Overall Study||7
10577609|NCT01694199|11732889|FG000|STARTED|Overall Study||71
10577610|NCT01694199|11732890|FG001|STARTED|Overall Study||68
10805799|NCT03996694|11967291|FG000|COMPLETED|Fourth Washout (7 Days)||3
10805800|NCT03996694|11967292|FG001|COMPLETED|Fourth Washout (7 Days)||2
10805801|NCT03996694|11967293|FG002|COMPLETED|Fourth Washout (7 Days)||2
10805802|NCT03996694|11967294|FG003|COMPLETED|Fourth Washout (7 Days)||3
10805803|NCT03996694|11967295|FG004|COMPLETED|Fourth Washout (7 Days)||2
10805804|NCT03996694|11967296|FG005|COMPLETED|Fourth Washout (7 Days)||3
10805805|NCT03996694|11967291|FG000|NOT COMPLETED|Fourth Washout (7 Days)||0
10805806|NCT03996694|11967292|FG001|NOT COMPLETED|Fourth Washout (7 Days)||0
10805807|NCT03996694|11967293|FG002|NOT COMPLETED|Fourth Washout (7 Days)||0
10805808|NCT03996694|11967294|FG003|NOT COMPLETED|Fourth Washout (7 Days)||0
10805809|NCT03996694|11967295|FG004|NOT COMPLETED|Fourth Washout (7 Days)||0
10805810|NCT03996694|11967296|FG005|NOT COMPLETED|Fourth Washout (7 Days)||0
10805811|NCT03996694|11967291|FG000|STARTED|Fifth Intervention (1 Day)||3
10805812|NCT03996694|11967292|FG001|STARTED|Fifth Intervention (1 Day)||2
10805813|NCT03996694|11967293|FG002|STARTED|Fifth Intervention (1 Day)||2
10805814|NCT03996694|11967294|FG003|STARTED|Fifth Intervention (1 Day)||3
10805815|NCT03996694|11967295|FG004|STARTED|Fifth Intervention (1 Day)||2
10805816|NCT03996694|11967296|FG005|STARTED|Fifth Intervention (1 Day)||3
10805817|NCT03996694|11967291|FG000|COMPLETED|Fifth Intervention (1 Day)||3
10805818|NCT03996694|11967292|FG001|COMPLETED|Fifth Intervention (1 Day)||2
10805819|NCT03996694|11967293|FG002|COMPLETED|Fifth Intervention (1 Day)||2
10805820|NCT03996694|11967294|FG003|COMPLETED|Fifth Intervention (1 Day)||3
10805821|NCT03996694|11967295|FG004|COMPLETED|Fifth Intervention (1 Day)||2
10805822|NCT03996694|11967296|FG005|COMPLETED|Fifth Intervention (1 Day)||3
10805823|NCT03996694|11967291|FG000|NOT COMPLETED|Fifth Intervention (1 Day)||0
10805824|NCT03996694|11967292|FG001|NOT COMPLETED|Fifth Intervention (1 Day)||0
10805825|NCT03996694|11967293|FG002|NOT COMPLETED|Fifth Intervention (1 Day)||0
10805826|NCT03996694|11967294|FG003|NOT COMPLETED|Fifth Intervention (1 Day)||0
10805827|NCT03996694|11967295|FG004|NOT COMPLETED|Fifth Intervention (1 Day)||0
10805828|NCT03996694|11967296|FG005|NOT COMPLETED|Fifth Intervention (1 Day)||0
10805829|NCT03996694|11967291|FG000|STARTED|Fifth Washout (7 Days)||3
10805830|NCT03996694|11967292|FG001|STARTED|Fifth Washout (7 Days)||2
10805831|NCT03996694|11967293|FG002|STARTED|Fifth Washout (7 Days)||2
10805832|NCT03996694|11967294|FG003|STARTED|Fifth Washout (7 Days)||3
10805833|NCT03996694|11967295|FG004|STARTED|Fifth Washout (7 Days)||2
10805834|NCT03996694|11967296|FG005|STARTED|Fifth Washout (7 Days)||3
10805835|NCT03996694|11967291|FG000|COMPLETED|Fifth Washout (7 Days)||3
10805836|NCT03996694|11967292|FG001|COMPLETED|Fifth Washout (7 Days)||2
10805837|NCT03996694|11967293|FG002|COMPLETED|Fifth Washout (7 Days)||2
10805838|NCT03996694|11967294|FG003|COMPLETED|Fifth Washout (7 Days)||3
10805839|NCT03996694|11967295|FG004|COMPLETED|Fifth Washout (7 Days)||2
10805840|NCT03996694|11967296|FG005|COMPLETED|Fifth Washout (7 Days)||3
10805841|NCT03996694|11967291|FG000|NOT COMPLETED|Fifth Washout (7 Days)||0
10805842|NCT03996694|11967292|FG001|NOT COMPLETED|Fifth Washout (7 Days)||0
10805843|NCT03996694|11967293|FG002|NOT COMPLETED|Fifth Washout (7 Days)||0
10805844|NCT03996694|11967294|FG003|NOT COMPLETED|Fifth Washout (7 Days)||0
10805845|NCT03996694|11967295|FG004|NOT COMPLETED|Fifth Washout (7 Days)||0
10805846|NCT03996694|11967296|FG005|NOT COMPLETED|Fifth Washout (7 Days)||0
10805847|NCT03996694|11967291|FG000|STARTED|Sixth Intervention (1 Day)||3
10805848|NCT03996694|11967292|FG001|STARTED|Sixth Intervention (1 Day)||2
10805849|NCT03996694|11967293|FG002|STARTED|Sixth Intervention (1 Day)||2
10805850|NCT03996694|11967294|FG003|STARTED|Sixth Intervention (1 Day)||3
10805851|NCT03996694|11967295|FG004|STARTED|Sixth Intervention (1 Day)||2
10805852|NCT03996694|11967296|FG005|STARTED|Sixth Intervention (1 Day)||3
10805853|NCT03996694|11967291|FG000|COMPLETED|Sixth Intervention (1 Day)||3
10805854|NCT03996694|11967292|FG001|COMPLETED|Sixth Intervention (1 Day)||2
10805855|NCT03996694|11967293|FG002|COMPLETED|Sixth Intervention (1 Day)||2
10805856|NCT03996694|11967294|FG003|COMPLETED|Sixth Intervention (1 Day)||3
10805857|NCT03996694|11967295|FG004|COMPLETED|Sixth Intervention (1 Day)||2
10805858|NCT03996694|11967296|FG005|COMPLETED|Sixth Intervention (1 Day)||3
10805859|NCT03996694|11967291|FG000|NOT COMPLETED|Sixth Intervention (1 Day)||0
10805860|NCT03996694|11967292|FG001|NOT COMPLETED|Sixth Intervention (1 Day)||0
10805861|NCT03996694|11967293|FG002|NOT COMPLETED|Sixth Intervention (1 Day)||0
10577611|NCT01694199|11732889|FG000|COMPLETED|Overall Study||71
10577612|NCT01694199|11732890|FG001|COMPLETED|Overall Study||68
10577613|NCT01694199|11732889|FG000|NOT COMPLETED|Overall Study||0
10577614|NCT01694199|11732890|FG001|NOT COMPLETED|Overall Study||0
10577615|NCT01694420|11732896|FG000|STARTED|Overall Study||33
10577616|NCT01694420|11732896|FG000|COMPLETED|Overall Study||30
10577617|NCT01694420|11732896|FG000|NOT COMPLETED|Overall Study||3
10577618|NCT01694433|11732902|FG000|STARTED|Overall Study||33
10577619|NCT01694433|11732903|FG001|STARTED|Overall Study||33
10577620|NCT01694433|11732902|FG000|Baseline Visit|Overall Study||33
10577621|NCT01694433|11732903|FG001|Baseline Visit|Overall Study||32
10577622|NCT01694433|11732902|FG000|COMPLETED|Overall Study||22
10805862|NCT03996694|11967294|FG003|NOT COMPLETED|Sixth Intervention (1 Day)||0
10805863|NCT03996694|11967295|FG004|NOT COMPLETED|Sixth Intervention (1 Day)||0
10805864|NCT03996694|11967296|FG005|NOT COMPLETED|Sixth Intervention (1 Day)||0
10805865|NCT03988907|11967312|FG000|STARTED|Overall Study||8
10805866|NCT03988907|11967313|FG001|STARTED|Overall Study||27
10805867|NCT03988907|11967312|FG000|COMPLETED|Overall Study||8
10805868|NCT03988907|11967313|FG001|COMPLETED|Overall Study||26
10805869|NCT03988907|11967312|FG000|NOT COMPLETED|Overall Study||0
10805870|NCT03988907|11967313|FG001|NOT COMPLETED|Overall Study||1
10805871|NCT03988088|11967327|FG000|STARTED|Single-Dose Pharmacokinetic Study||11
10805872|NCT03988088|11967328|FG001|STARTED|Single-Dose Pharmacokinetic Study||7
10805873|NCT03988088|11967329|FG002|STARTED|Single-Dose Pharmacokinetic Study||0
10805874|NCT03988088|11967330|FG003|STARTED|Single-Dose Pharmacokinetic Study||0
10805875|NCT03988088|11967327|FG000|COMPLETED|Single-Dose Pharmacokinetic Study||11
10805876|NCT03988088|11967328|FG001|COMPLETED|Single-Dose Pharmacokinetic Study||6
10805877|NCT03988088|11967329|FG002|COMPLETED|Single-Dose Pharmacokinetic Study||0
10805878|NCT03988088|11967330|FG003|COMPLETED|Single-Dose Pharmacokinetic Study||0
10805879|NCT03988088|11967327|FG000|NOT COMPLETED|Single-Dose Pharmacokinetic Study||0
10805880|NCT03988088|11967328|FG001|NOT COMPLETED|Single-Dose Pharmacokinetic Study||1
10805881|NCT03988088|11967329|FG002|NOT COMPLETED|Single-Dose Pharmacokinetic Study||0
10805882|NCT03988088|11967330|FG003|NOT COMPLETED|Single-Dose Pharmacokinetic Study||0
10805883|NCT03988088|11967327|FG000|STARTED|Open-Label Addendum||0
10805884|NCT03988088|11967328|FG001|STARTED|Open-Label Addendum||0
10805885|NCT03988088|11967329|FG002|STARTED|Open-Label Addendum|The US participants had the option to enter this optional 3-month open-label extension addendum.|2
10805886|NCT03988088|11967330|FG003|STARTED|Open-Label Addendum|The US participants had the option to enter this optional 3-month open-label extension addendum.|2
10805887|NCT03988088|11967327|FG000|COMPLETED|Open-Label Addendum||0
10805888|NCT03988088|11967328|FG001|COMPLETED|Open-Label Addendum||0
10805889|NCT03988088|11967329|FG002|COMPLETED|Open-Label Addendum||1
10805890|NCT03988088|11967330|FG003|COMPLETED|Open-Label Addendum||2
10805891|NCT03988088|11967327|FG000|NOT COMPLETED|Open-Label Addendum||0
10805892|NCT03988088|11967328|FG001|NOT COMPLETED|Open-Label Addendum||0
10805893|NCT03988088|11967329|FG002|NOT COMPLETED|Open-Label Addendum||1
10805894|NCT03988088|11967330|FG003|NOT COMPLETED|Open-Label Addendum||0
10805895|NCT03980522|11967343|FG000|STARTED|Treatment Period||13
10805896|NCT03980522|11967344|FG001|STARTED|Treatment Period||3
10805897|NCT03980522|11967345|FG002|STARTED|Treatment Period||6
10805898|NCT03980522|11967346|FG003|STARTED|Treatment Period||1
10805899|NCT03980522|11967347|FG004|STARTED|Treatment Period||3
10805900|NCT03980522|11967343|FG000|COMPLETED|Treatment Period||12
10805901|NCT03980522|11967344|FG001|COMPLETED|Treatment Period||3
10805902|NCT03980522|11967345|FG002|COMPLETED|Treatment Period||6
10805903|NCT03980522|11967346|FG003|COMPLETED|Treatment Period||1
10805904|NCT03980522|11967347|FG004|COMPLETED|Treatment Period||3
10805905|NCT03980522|11967343|FG000|NOT COMPLETED|Treatment Period||1
10805906|NCT03980522|11967344|FG001|NOT COMPLETED|Treatment Period||0
10805907|NCT03980522|11967345|FG002|NOT COMPLETED|Treatment Period||0
10805908|NCT03980522|11967346|FG003|NOT COMPLETED|Treatment Period||0
10805909|NCT03980522|11967347|FG004|NOT COMPLETED|Treatment Period||0
10805910|NCT03980522|11967343|FG000|STARTED|Extension Period||12
10805911|NCT03980522|11967344|FG001|STARTED|Extension Period||3
10805912|NCT03980522|11967345|FG002|STARTED|Extension Period|1 participant did not sign the optional Extension Period consent form.|5
10805913|NCT03980522|11967346|FG003|STARTED|Extension Period||1
10805914|NCT03980522|11967347|FG004|STARTED|Extension Period||3
10805915|NCT03980522|11967343|FG000|COMPLETED|Extension Period||12
10805916|NCT03980522|11967344|FG001|COMPLETED|Extension Period||3
10805917|NCT03980522|11967345|FG002|COMPLETED|Extension Period||5
10805918|NCT03980522|11967346|FG003|COMPLETED|Extension Period||1
10805919|NCT03980522|11967347|FG004|COMPLETED|Extension Period||3
10805920|NCT03980522|11967343|FG000|NOT COMPLETED|Extension Period||0
10805921|NCT03980522|11967344|FG001|NOT COMPLETED|Extension Period||0
10805922|NCT03980522|11967345|FG002|NOT COMPLETED|Extension Period||0
10805923|NCT03980522|11967346|FG003|NOT COMPLETED|Extension Period||0
10805924|NCT03980522|11967347|FG004|NOT COMPLETED|Extension Period||0
10805925|NCT03999684|11967359|FG000|STARTED|Overall Study||18
10805926|NCT03999684|11967359|FG000|COMPLETED|Overall Study||18
10805927|NCT03999684|11967359|FG000|NOT COMPLETED|Overall Study||0
10805928|NCT03995784|11967363|FG000|STARTED|Overall Study||6
10805929|NCT03995784|11967363|FG000|COMPLETED|Overall Study||5
10805930|NCT03995784|11967363|FG000|NOT COMPLETED|Overall Study||1
10577623|NCT01694433|11732903|FG001|COMPLETED|Overall Study||29
10577624|NCT01694433|11732902|FG000|NOT COMPLETED|Overall Study||11
10577625|NCT01694433|11732903|FG001|NOT COMPLETED|Overall Study||4
10577626|NCT01694485|11732914|FG000|STARTED|Overall Study||117
10577627|NCT01694485|11732915|FG001|STARTED|Overall Study||22
10577628|NCT01694485|11732916|FG002|STARTED|Overall Study||40
10577629|NCT01694485|11732917|FG003|STARTED|Overall Study||100
10577630|NCT01694485|11732918|FG004|STARTED|Overall Study||80
10577631|NCT01694485|11732914|FG000|Received Treatment|Overall Study||116
10577632|NCT01694485|11732915|FG001|Received Treatment|Overall Study||21
10577633|NCT01694485|11732916|FG002|Received Treatment|Overall Study||40
10577634|NCT01694485|11732917|FG003|Received Treatment|Overall Study||98
10577635|NCT01694485|11732918|FG004|Received Treatment|Overall Study||79
10577636|NCT01694485|11732914|FG000|Completed Week 8 Assessment|Overall Study||106
10577637|NCT01694485|11732915|FG001|Completed Week 8 Assessment|Overall Study||18
10577638|NCT01694485|11732916|FG002|Completed Week 8 Assessment|Overall Study||38
10577639|NCT01694485|11732917|FG003|Completed Week 8 Assessment|Overall Study||94
10577640|NCT01694485|11732918|FG004|Completed Week 8 Assessment|Overall Study||76
10577641|NCT01694485|11732914|FG000|Entered Open-label Period|Overall Study||100
10577642|NCT01694485|11732915|FG001|Entered Open-label Period|Overall Study||19
10577643|NCT01694485|11732916|FG002|Entered Open-label Period|Overall Study||36
10577644|NCT01694485|11732917|FG003|Entered Open-label Period|Overall Study||88
10577645|NCT01694485|11732918|FG004|Entered Open-label Period|Overall Study||68
10577646|NCT01694485|11732914|FG000|COMPLETED|Overall Study||84
10805931|NCT03993392|11967374|FG000|STARTED|Overall Study||26
10805932|NCT03993392|11967374|FG000|Treated With SUBLOCADE|Overall Study||24
10805933|NCT03993392|11967374|FG000|COMPLETED|Overall Study||20
10805934|NCT03993392|11967374|FG000|NOT COMPLETED|Overall Study||6
10805935|NCT03989427|11967381|FG000|STARTED|First Intervention (2 Weeks)||15
10805936|NCT03989427|11967382|FG001|STARTED|First Intervention (2 Weeks)||15
10805937|NCT03989427|11967381|FG000|COMPLETED|First Intervention (2 Weeks)||15
10805938|NCT03989427|11967382|FG001|COMPLETED|First Intervention (2 Weeks)||15
10805939|NCT03989427|11967381|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
10805940|NCT03989427|11967382|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
10805941|NCT03989427|11967381|FG000|STARTED|Washout (1 Week)||15
10805942|NCT03989427|11967382|FG001|STARTED|Washout (1 Week)||15
10805943|NCT03989427|11967381|FG000|COMPLETED|Washout (1 Week)||15
10805944|NCT03989427|11967382|FG001|COMPLETED|Washout (1 Week)||15
10805945|NCT03989427|11967381|FG000|NOT COMPLETED|Washout (1 Week)||0
10805946|NCT03989427|11967382|FG001|NOT COMPLETED|Washout (1 Week)||0
10805947|NCT03989427|11967381|FG000|STARTED|Second Intervention (2 Weeks)||15
10805948|NCT03989427|11967382|FG001|STARTED|Second Intervention (2 Weeks)||15
10805949|NCT03989427|11967381|FG000|COMPLETED|Second Intervention (2 Weeks)||15
10805950|NCT03989427|11967382|FG001|COMPLETED|Second Intervention (2 Weeks)||15
10805951|NCT03989427|11967381|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
10805952|NCT03989427|11967382|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
10805953|NCT03981822|11967397|FG000|STARTED|Overall Study||5
10805954|NCT03981822|11967398|FG001|STARTED|Overall Study||5
10805955|NCT03981822|11967399|FG002|STARTED|Overall Study||5
10805956|NCT03981822|11967400|FG003|STARTED|Overall Study||3
10805957|NCT03981822|11967401|FG004|STARTED|Overall Study||25
10805958|NCT03981822|11967402|FG005|STARTED|Overall Study||23
10805959|NCT03981822|11967403|FG006|STARTED|Overall Study||22
10805960|NCT03981822|11967404|FG007|STARTED|Overall Study||17
10805961|NCT03981822|11967397|FG000|COMPLETED|Overall Study||5
10805962|NCT03981822|11967398|FG001|COMPLETED|Overall Study||3
10805963|NCT03981822|11967399|FG002|COMPLETED|Overall Study||4
10805964|NCT03981822|11967400|FG003|COMPLETED|Overall Study||3
10805965|NCT03981822|11967401|FG004|COMPLETED|Overall Study||17
10805966|NCT03981822|11967402|FG005|COMPLETED|Overall Study||17
10805967|NCT03981822|11967403|FG006|COMPLETED|Overall Study||16
10805968|NCT03981822|11967404|FG007|COMPLETED|Overall Study||12
10805969|NCT03981822|11967397|FG000|NOT COMPLETED|Overall Study||0
10805970|NCT03981822|11967398|FG001|NOT COMPLETED|Overall Study||2
10805971|NCT03981822|11967399|FG002|NOT COMPLETED|Overall Study||1
10805972|NCT03981822|11967400|FG003|NOT COMPLETED|Overall Study||0
10805973|NCT03981822|11967401|FG004|NOT COMPLETED|Overall Study||8
10805974|NCT03981822|11967402|FG005|NOT COMPLETED|Overall Study||6
10805975|NCT03981822|11967403|FG006|NOT COMPLETED|Overall Study||6
10805976|NCT03981822|11967404|FG007|NOT COMPLETED|Overall Study||5
10805977|NCT03992482|11967418|FG000|STARTED|Overall Study||13
10805978|NCT03992482|11967419|FG001|STARTED|Overall Study||14
10805979|NCT03992482|11967418|FG000|COMPLETED|Overall Study||13
10805980|NCT03992482|11967419|FG001|COMPLETED|Overall Study||14
10805981|NCT03992482|11967418|FG000|NOT COMPLETED|Overall Study||0
10805982|NCT03992482|11967419|FG001|NOT COMPLETED|Overall Study||0
10805983|NCT03993119|11967429|FG000|STARTED|Overall Study||192
10805984|NCT03993119|11967430|FG001|STARTED|Overall Study||76
10805985|NCT03993119|11967431|FG002|STARTED|Overall Study||166
10805986|NCT03993119|11967432|FG003|STARTED|Overall Study||66
10805987|NCT03993119|11967429|FG000|COMPLETED|Overall Study||192
10805988|NCT03993119|11967430|FG001|COMPLETED|Overall Study||76
10805989|NCT03993119|11967431|FG002|COMPLETED|Overall Study||166
10805990|NCT03993119|11967432|FG003|COMPLETED|Overall Study||66
10805991|NCT03993119|11967429|FG000|NOT COMPLETED|Overall Study||0
10805992|NCT03993119|11967430|FG001|NOT COMPLETED|Overall Study||0
10805993|NCT03993119|11967431|FG002|NOT COMPLETED|Overall Study||0
10805994|NCT03993119|11967432|FG003|NOT COMPLETED|Overall Study||0
10577647|NCT01694485|11732915|FG001|COMPLETED|Overall Study||15
10805995|NCT03991494|11967457|FG000|STARTED|Overall Study||4
10805996|NCT03991494|11967457|FG000|COMPLETED|Overall Study||0
10805997|NCT03991494|11967457|FG000|NOT COMPLETED|Overall Study||4
10805998|NCT03989570|11967466|FG000|STARTED|Overall Study||31
10805999|NCT03989570|11967467|FG001|STARTED|Overall Study||31
10577648|NCT01694485|11732916|FG002|COMPLETED|Overall Study||27
10577649|NCT01694485|11732917|FG003|COMPLETED|Overall Study||62
10577650|NCT01694485|11732918|FG004|COMPLETED|Overall Study||55
10577651|NCT01694485|11732914|FG000|NOT COMPLETED|Overall Study||33
10702384|NCT02574637|11866826|FG009|NOT COMPLETED|Open-label (OL) Period||1
10702385|NCT02574832|11866847|FG000|STARTED|Overall Study||2
10702386|NCT02574832|11866847|FG000|COMPLETED|Overall Study||2
10702387|NCT02574832|11866847|FG000|NOT COMPLETED|Overall Study||0
10702388|NCT02574845|11866857|FG000|STARTED|Overall Study||3
10702389|NCT02574845|11866858|FG001|STARTED|Overall Study||3
10702390|NCT02574845|11866859|FG002|STARTED|Overall Study||3
10702391|NCT02574845|11866860|FG003|STARTED|Overall Study||3
10702392|NCT02574845|11866861|FG004|STARTED|Overall Study||3
10702393|NCT02574845|11866862|FG005|STARTED|Overall Study||3
10577652|NCT01694485|11732915|FG001|NOT COMPLETED|Overall Study||7
10577653|NCT01694485|11732916|FG002|NOT COMPLETED|Overall Study||13
10577654|NCT01694485|11732917|FG003|NOT COMPLETED|Overall Study||38
10577655|NCT01694485|11732918|FG004|NOT COMPLETED|Overall Study||25
10577656|NCT01694563|11732935|FG000|STARTED|Overall Study||365
10577657|NCT01694563|11732935|FG000|COMPLETED|Overall Study||278
10577658|NCT01694563|11732935|FG000|NOT COMPLETED|Overall Study||87
10577659|NCT01694641|11732944|FG000|STARTED|Overall Study||80
10577660|NCT01694641|11732945|FG001|STARTED|Overall Study||81
10577661|NCT01694641|11732944|FG000|COMPLETED|Overall Study||68
10577662|NCT01694641|11732945|FG001|COMPLETED|Overall Study||71
10577663|NCT01694641|11732944|FG000|NOT COMPLETED|Overall Study||12
10577664|NCT01694641|11732945|FG001|NOT COMPLETED|Overall Study||10
10577665|NCT01694667|11732954|FG000|STARTED|Overall Study||29
10577666|NCT01694667|11732955|FG001|STARTED|Overall Study||28
10577667|NCT01694667|11732954|FG000|COMPLETED|Overall Study||29
10577668|NCT01694667|11732955|FG001|COMPLETED|Overall Study||28
10577669|NCT01694667|11732954|FG000|NOT COMPLETED|Overall Study||0
10577670|NCT01694667|11732955|FG001|NOT COMPLETED|Overall Study||0
10577671|NCT01694706|11732961|FG000|STARTED|Overall Study||5
10577672|NCT01694706|11732962|FG001|STARTED|Overall Study||5
10577673|NCT01694706|11732963|FG002|STARTED|Overall Study||5
10577674|NCT01694706|11732961|FG000|Received Faldaprevir|Overall Study||5
10577675|NCT01694706|11732962|FG001|Received Faldaprevir|Overall Study||5
10577676|NCT01694706|11732963|FG002|Received Faldaprevir|Overall Study||5
10577677|NCT01694706|11732961|FG000|Received Faldaprevir +OMP|Overall Study||5
10577678|NCT01694706|11732962|FG001|Received Faldaprevir +OMP|Overall Study||5
10577679|NCT01694706|11732963|FG002|Received Faldaprevir +OMP|Overall Study||5
10577680|NCT01694706|11732961|FG000|Received Faldaprevir Fed|Overall Study||4
10806000|NCT03989570|11967468|FG002|STARTED|Overall Study||31
10806001|NCT03989570|11967466|FG000|COMPLETED|Overall Study||31
10806002|NCT03989570|11967467|FG001|COMPLETED|Overall Study||31
10806003|NCT03989570|11967468|FG002|COMPLETED|Overall Study||31
10806004|NCT03989570|11967466|FG000|NOT COMPLETED|Overall Study||0
10806005|NCT03989570|11967467|FG001|NOT COMPLETED|Overall Study||0
10806006|NCT03989570|11967468|FG002|NOT COMPLETED|Overall Study||0
10806007|NCT03988803|11967476|FG000|STARTED|Screening||16
10806008|NCT03988803|11967476|FG000|COMPLETED|Screening||16
10806009|NCT03988803|11967476|FG000|NOT COMPLETED|Screening||0
10806010|NCT03988803|11967476|FG000|STARTED|Period 1||16
10806011|NCT03988803|11967476|FG000|COMPLETED|Period 1||16
10806012|NCT03988803|11967476|FG000|NOT COMPLETED|Period 1||0
10806013|NCT03988803|11967476|FG000|STARTED|Period 2||16
10806014|NCT03988803|11967476|FG000|Treated|Period 2||15
10806015|NCT03988803|11967476|FG000|Started Days 1 - 7: Multiple Doses of 5 mg Memantine qd|Period 2||15
10806016|NCT03988803|11967476|FG000|Started Days 8 - 14: Multiple Doses of 10 mg Memantine qd|Period 2||14
10806017|NCT03988803|11967476|FG000|Started Days 15 - 21: Multiple Doses of 15 mg Memantine qd|Period 2||13
10806018|NCT03988803|11967476|FG000|Started Days 22 - 35: Multiple Doses of 20 mg Memantine qd|Period 2||13
10806019|NCT03988803|11967476|FG000|COMPLETED|Period 2||13
10806020|NCT03988803|11967476|FG000|NOT COMPLETED|Period 2||3
10806021|NCT03988803|11967476|FG000|STARTED|Period 3||13
10806022|NCT03988803|11967476|FG000|COMPLETED|Period 3||13
10806023|NCT03988803|11967476|FG000|NOT COMPLETED|Period 3||0
10806024|NCT03987932|11967487|FG000|STARTED|Overall Study||4
10806025|NCT03987932|11967488|FG001|STARTED|Overall Study||3
10806026|NCT03987932|11967489|FG002|STARTED|Overall Study||4
10806027|NCT03987932|11967487|FG000|1 Month|Overall Study||4
10806028|NCT03987932|11967488|FG001|1 Month|Overall Study||2
10806029|NCT03987932|11967489|FG002|1 Month|Overall Study||3
10806030|NCT03987932|11967487|FG000|3 Months|Overall Study||4
10806031|NCT03987932|11967488|FG001|3 Months|Overall Study||2
10806032|NCT03987932|11967489|FG002|3 Months|Overall Study||3
10806033|NCT03987932|11967487|FG000|6 Months|Overall Study||2
10577681|NCT01694706|11732962|FG001|Received Faldaprevir Fed|Overall Study||5
10702394|NCT02574845|11866857|FG000|Received T1|Overall Study||3
10806034|NCT03987932|11967488|FG001|6 Months|Overall Study||2
10806035|NCT03987932|11967489|FG002|6 Months|Overall Study||2
10577682|NCT01694706|11732963|FG002|Received Faldaprevir Fed|Overall Study||5
10577683|NCT01694706|11732961|FG000|COMPLETED|Overall Study||4
10577684|NCT01694706|11732962|FG001|COMPLETED|Overall Study||4
10577685|NCT01694706|11732963|FG002|COMPLETED|Overall Study||5
10577686|NCT01694706|11732961|FG000|NOT COMPLETED|Overall Study||1
10577687|NCT01694706|11732962|FG001|NOT COMPLETED|Overall Study||1
10702395|NCT02574845|11866858|FG001|Received T1|Overall Study||2
10702396|NCT02574845|11866859|FG002|Received T1|Overall Study||3
10806036|NCT03987932|11967487|FG000|COMPLETED|Overall Study||2
10806037|NCT03987932|11967488|FG001|COMPLETED|Overall Study||2
10577688|NCT01694706|11732963|FG002|NOT COMPLETED|Overall Study||0
10577689|NCT01694771|11732974|FG000|STARTED|Overall Study||567
10577690|NCT01694771|11732975|FG001|STARTED|Overall Study||565
10577691|NCT01694771|11732974|FG000|COMPLETED|Overall Study||527
10577692|NCT01694771|11732975|FG001|COMPLETED|Overall Study||525
10577693|NCT01694771|11732974|FG000|NOT COMPLETED|Overall Study||40
10577694|NCT01694771|11732975|FG001|NOT COMPLETED|Overall Study||40
10577695|NCT01694966|11732984|FG000|STARTED|Overall Study||504
10577696|NCT01694966|11732985|FG001|STARTED|Overall Study||247
10577697|NCT01694966|11732986|FG002|STARTED|Overall Study||498
10577698|NCT01694966|11732984|FG000|COMPLETED|Overall Study||470
10577699|NCT01694966|11732985|FG001|COMPLETED|Overall Study||232
10577700|NCT01694966|11732986|FG002|COMPLETED|Overall Study||464
10577701|NCT01694966|11732984|FG000|NOT COMPLETED|Overall Study||34
10577702|NCT01694966|11732985|FG001|NOT COMPLETED|Overall Study||15
10577703|NCT01694966|11732986|FG002|NOT COMPLETED|Overall Study||34
10577704|NCT01695044|11732996|FG000|STARTED|Overall Study||119
10577705|NCT01695044|11732996|FG000|COMPLETED|Overall Study||17
10577706|NCT01695044|11732996|FG000|NOT COMPLETED|Overall Study||102
10577707|NCT01695135|11733006|FG000|STARTED|Double-blind Treatment Phase||71
10577708|NCT01695135|11733007|FG001|STARTED|Double-blind Treatment Phase||143
10577709|NCT01695135|11733008|FG002|STARTED|Double-blind Treatment Phase||0
10577710|NCT01695135|11733009|FG003|STARTED|Double-blind Treatment Phase||0
10577711|NCT01695135|11733006|FG000|COMPLETED|Double-blind Treatment Phase||0
10577712|NCT01695135|11733007|FG001|COMPLETED|Double-blind Treatment Phase||4
10577713|NCT01695135|11733008|FG002|COMPLETED|Double-blind Treatment Phase||0
10577714|NCT01695135|11733009|FG003|COMPLETED|Double-blind Treatment Phase||0
10577715|NCT01695135|11733006|FG000|NOT COMPLETED|Double-blind Treatment Phase||71
10577716|NCT01695135|11733007|FG001|NOT COMPLETED|Double-blind Treatment Phase||139
10577717|NCT01695135|11733008|FG002|NOT COMPLETED|Double-blind Treatment Phase||0
10806050|NCT03988842|11967506|FG000|STARTED|Overall Study||4
10577718|NCT01695135|11733009|FG003|NOT COMPLETED|Double-blind Treatment Phase||0
10577719|NCT01695135|11733006|FG000|STARTED|Open Label Extension Treatment Phase||0
10577720|NCT01695135|11733007|FG001|STARTED|Open Label Extension Treatment Phase||0
10577721|NCT01695135|11733008|FG002|STARTED|Open Label Extension Treatment Phase||49
10577722|NCT01695135|11733009|FG003|STARTED|Open Label Extension Treatment Phase||80
10577723|NCT01695135|11733006|FG000|COMPLETED|Open Label Extension Treatment Phase||0
10577724|NCT01695135|11733007|FG001|COMPLETED|Open Label Extension Treatment Phase||0
10577725|NCT01695135|11733008|FG002|COMPLETED|Open Label Extension Treatment Phase||9
10577726|NCT01695135|11733009|FG003|COMPLETED|Open Label Extension Treatment Phase||10
10577727|NCT01695135|11733006|FG000|NOT COMPLETED|Open Label Extension Treatment Phase||0
10577728|NCT01695135|11733007|FG001|NOT COMPLETED|Open Label Extension Treatment Phase||0
10577729|NCT01695135|11733008|FG002|NOT COMPLETED|Open Label Extension Treatment Phase||40
10577730|NCT01695135|11733009|FG003|NOT COMPLETED|Open Label Extension Treatment Phase||70
10577731|NCT01695239|11733021|FG000|STARTED|Double-Blind (DB) Treatment Period||106
10577732|NCT01695239|11733022|FG001|STARTED|Double-Blind (DB) Treatment Period||101
10577733|NCT01695239|11733023|FG002|STARTED|Double-Blind (DB) Treatment Period||107
10577734|NCT01695239|11733024|FG003|STARTED|Double-Blind (DB) Treatment Period||103
10577735|NCT01695239|11733025|FG004|STARTED|Double-Blind (DB) Treatment Period||0
10577736|NCT01695239|11733026|FG005|STARTED|Double-Blind (DB) Treatment Period||0
10577737|NCT01695239|11733027|FG006|STARTED|Double-Blind (DB) Treatment Period||0
10577738|NCT01695239|11733028|FG007|STARTED|Double-Blind (DB) Treatment Period||0
10577739|NCT01695239|11733029|FG008|STARTED|Double-Blind (DB) Treatment Period||0
10577740|NCT01695239|11733030|FG009|STARTED|Double-Blind (DB) Treatment Period||0
10577741|NCT01695239|11733031|FG010|STARTED|Double-Blind (DB) Treatment Period||0
10577742|NCT01695239|11733032|FG011|STARTED|Double-Blind (DB) Treatment Period||0
10577743|NCT01695239|11733033|FG012|STARTED|Double-Blind (DB) Treatment Period||0
10577744|NCT01695239|11733034|FG013|STARTED|Double-Blind (DB) Treatment Period||0
10577745|NCT01695239|11733021|FG000|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||106
10577746|NCT01695239|11733022|FG001|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||101
10577747|NCT01695239|11733023|FG002|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||107
10577748|NCT01695239|11733024|FG003|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||102
10577749|NCT01695239|11733025|FG004|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
10577750|NCT01695239|11733026|FG005|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
10577751|NCT01695239|11733027|FG006|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
10651461|NCT02175771|11811632|FG007|NOT COMPLETED|Treatment Period||17
10651462|NCT02175771|11811633|FG008|NOT COMPLETED|Treatment Period||6
10651463|NCT02175966|11811653|FG000|STARTED|Treatment Period||14
10651464|NCT02175966|11811654|FG001|STARTED|Treatment Period||14
10651465|NCT02175966|11811653|FG000|COMPLETED|Treatment Period||14
10651466|NCT02175966|11811654|FG001|COMPLETED|Treatment Period||14
10651467|NCT02175966|11811653|FG000|NOT COMPLETED|Treatment Period||0
10651468|NCT02175966|11811654|FG001|NOT COMPLETED|Treatment Period||0
10651469|NCT02175966|11811653|FG000|STARTED|Follow-up Period||14
10651470|NCT02175966|11811654|FG001|STARTED|Follow-up Period||14
10651471|NCT02175966|11811653|FG000|COMPLETED|Follow-up Period||4
10651472|NCT02175966|11811654|FG001|COMPLETED|Follow-up Period||8
10651473|NCT02175966|11811653|FG000|NOT COMPLETED|Follow-up Period||10
10651474|NCT02175966|11811654|FG001|NOT COMPLETED|Follow-up Period||6
10651475|NCT02175979|11811662|FG000|STARTED|Overall Study||140
10702397|NCT02574845|11866860|FG003|Received T1|Overall Study||3
10577752|NCT01695239|11733028|FG007|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
10577753|NCT01695239|11733029|FG008|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
10577754|NCT01695239|11733030|FG009|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
10577755|NCT01695239|11733031|FG010|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
10577756|NCT01695239|11733032|FG011|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
10577757|NCT01695239|11733033|FG012|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
10577758|NCT01695239|11733034|FG013|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
10577759|NCT01695239|11733021|FG000|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||27
10577760|NCT01695239|11733022|FG001|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||9
10577761|NCT01695239|11733023|FG002|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||11
10577762|NCT01695239|11733024|FG003|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||10
10577763|NCT01695239|11733025|FG004|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
10577764|NCT01695239|11733026|FG005|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
10577765|NCT01695239|11733027|FG006|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
10577766|NCT01695239|11733028|FG007|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
10577767|NCT01695239|11733029|FG008|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
10577768|NCT01695239|11733030|FG009|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
10577769|NCT01695239|11733031|FG010|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
10577770|NCT01695239|11733032|FG011|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
10577771|NCT01695239|11733033|FG012|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
10806051|NCT03988842|11967506|FG000|COMPLETED|Overall Study||3
10577772|NCT01695239|11733034|FG013|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
10577773|NCT01695239|11733021|FG000|COMPLETED|Double-Blind (DB) Treatment Period||91
10577774|NCT01695239|11733022|FG001|COMPLETED|Double-Blind (DB) Treatment Period||97
10577775|NCT01695239|11733023|FG002|COMPLETED|Double-Blind (DB) Treatment Period||97
10577776|NCT01695239|11733024|FG003|COMPLETED|Double-Blind (DB) Treatment Period||96
10577777|NCT01695239|11733025|FG004|COMPLETED|Double-Blind (DB) Treatment Period||0
10577778|NCT01695239|11733026|FG005|COMPLETED|Double-Blind (DB) Treatment Period||0
10577779|NCT01695239|11733027|FG006|COMPLETED|Double-Blind (DB) Treatment Period||0
10577780|NCT01695239|11733028|FG007|COMPLETED|Double-Blind (DB) Treatment Period||0
10577781|NCT01695239|11733029|FG008|COMPLETED|Double-Blind (DB) Treatment Period||0
10577782|NCT01695239|11733030|FG009|COMPLETED|Double-Blind (DB) Treatment Period||0
10577783|NCT01695239|11733031|FG010|COMPLETED|Double-Blind (DB) Treatment Period||0
10577784|NCT01695239|11733032|FG011|COMPLETED|Double-Blind (DB) Treatment Period||0
10577785|NCT01695239|11733033|FG012|COMPLETED|Double-Blind (DB) Treatment Period||0
10577786|NCT01695239|11733034|FG013|COMPLETED|Double-Blind (DB) Treatment Period||0
10577787|NCT01695239|11733021|FG000|NOT COMPLETED|Double-Blind (DB) Treatment Period||15
10577788|NCT01695239|11733022|FG001|NOT COMPLETED|Double-Blind (DB) Treatment Period||4
10577789|NCT01695239|11733023|FG002|NOT COMPLETED|Double-Blind (DB) Treatment Period||10
10577790|NCT01695239|11733024|FG003|NOT COMPLETED|Double-Blind (DB) Treatment Period||7
10577791|NCT01695239|11733025|FG004|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
10577792|NCT01695239|11733026|FG005|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
10577793|NCT01695239|11733027|FG006|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
10577794|NCT01695239|11733028|FG007|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
10577795|NCT01695239|11733029|FG008|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
10577796|NCT01695239|11733030|FG009|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
10577797|NCT01695239|11733031|FG010|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
10577798|NCT01695239|11733032|FG011|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
10577799|NCT01695239|11733033|FG012|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
10577800|NCT01695239|11733034|FG013|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
10577801|NCT01695239|11733021|FG000|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
10577802|NCT01695239|11733022|FG001|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
10577803|NCT01695239|11733023|FG002|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
10577804|NCT01695239|11733024|FG003|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
10577805|NCT01695239|11733025|FG004|STARTED|IR Participants (Week 16 Up To Week 24)|IR from placebo who re-randomized to ixeQ4W and IR from ixeQ4W.|24
10577806|NCT01695239|11733026|FG005|STARTED|IR Participants (Week 16 Up To Week 24)|IR from placebo who re-randomized to ixeQ2W and IR from ixeQ2W.|24
10577807|NCT01695239|11733027|FG006|STARTED|IR Participants (Week 16 Up To Week 24)|Adalimumab Q2W (IR) who re-randomized to IxeQ2W or IxeQ4W and PBO for ixe and adalimumab.|9
10577808|NCT01695239|11733028|FG007|STARTED|IR Participants (Week 16 Up To Week 24)||0
10577809|NCT01695239|11733029|FG008|STARTED|IR Participants (Week 16 Up To Week 24)||0
10577810|NCT01695239|11733030|FG009|STARTED|IR Participants (Week 16 Up To Week 24)||0
10577811|NCT01695239|11733031|FG010|STARTED|IR Participants (Week 16 Up To Week 24)||0
10577812|NCT01695239|11733032|FG011|STARTED|IR Participants (Week 16 Up To Week 24)||0
10577813|NCT01695239|11733033|FG012|STARTED|IR Participants (Week 16 Up To Week 24)||0
10577814|NCT01695239|11733034|FG013|STARTED|IR Participants (Week 16 Up To Week 24)||0
10702398|NCT02574845|11866861|FG004|Received T1|Overall Study||2
10577815|NCT01695239|11733021|FG000|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
10577816|NCT01695239|11733022|FG001|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
10577817|NCT01695239|11733023|FG002|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
10577818|NCT01695239|11733024|FG003|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
10577819|NCT01695239|11733025|FG004|COMPLETED|IR Participants (Week 16 Up To Week 24)||24
10577820|NCT01695239|11733026|FG005|COMPLETED|IR Participants (Week 16 Up To Week 24)||24
10577821|NCT01695239|11733027|FG006|COMPLETED|IR Participants (Week 16 Up To Week 24)||9
10577822|NCT01695239|11733028|FG007|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
10577823|NCT01695239|11733029|FG008|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
10577824|NCT01695239|11733030|FG009|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
10577825|NCT01695239|11733031|FG010|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
10577826|NCT01695239|11733032|FG011|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
10577827|NCT01695239|11733033|FG012|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
10702399|NCT02574845|11866862|FG005|Received T1|Overall Study|one subject missed treatment period 2|2
10702400|NCT02574845|11866857|FG000|Received T2|Overall Study||3
10702401|NCT02574845|11866858|FG001|Received T2|Overall Study||3
10702402|NCT02574845|11866859|FG002|Received T2|Overall Study||3
10702403|NCT02574845|11866860|FG003|Received T2|Overall Study||3
10702404|NCT02574845|11866861|FG004|Received T2|Overall Study||2
10806038|NCT03987932|11967489|FG002|COMPLETED|Overall Study||2
10806039|NCT03987932|11967487|FG000|NOT COMPLETED|Overall Study||2
10806040|NCT03987932|11967488|FG001|NOT COMPLETED|Overall Study||1
10806041|NCT03987932|11967489|FG002|NOT COMPLETED|Overall Study||2
10806042|NCT03987191|11967499|FG000|STARTED|Overall Study||17
10806043|NCT03987191|11967500|FG001|STARTED|Overall Study||15
10806044|NCT03987191|11967499|FG000|Data Collected|Overall Study||17
10806045|NCT03987191|11967500|FG001|Data Collected|Overall Study||13
10806046|NCT03987191|11967499|FG000|COMPLETED|Overall Study||17
10806047|NCT03987191|11967500|FG001|COMPLETED|Overall Study||13
10806048|NCT03987191|11967499|FG000|NOT COMPLETED|Overall Study||0
10806049|NCT03987191|11967500|FG001|NOT COMPLETED|Overall Study||2
10806052|NCT03988842|11967506|FG000|NOT COMPLETED|Overall Study||1
10806053|NCT03981861|11967511|FG000|STARTED|Overall Study||12
10806054|NCT03981861|11967511|FG000|COMPLETED|Overall Study||9
10806055|NCT03981861|11967511|FG000|NOT COMPLETED|Overall Study||3
10806056|NCT03974334|11967515|FG000|STARTED|Overall Study||25
10806057|NCT03974334|11967515|FG000|COMPLETED|Overall Study||24
10806058|NCT03974334|11967515|FG000|NOT COMPLETED|Overall Study||1
10806059|NCT03988426|11967519|FG000|STARTED|Overall Study||25
10806060|NCT03988426|11967519|FG000|COMPLETED|Overall Study||24
10806061|NCT03988426|11967519|FG000|NOT COMPLETED|Overall Study||1
10806062|NCT03988374|11967528|FG000|STARTED|Overall Study||104
10806063|NCT03988374|11967529|FG001|STARTED|Overall Study||107
10806064|NCT03988374|11967530|FG002|STARTED|Overall Study||108
10806065|NCT03988374|11967528|FG000|COMPLETED|Overall Study||103
10806066|NCT03988374|11967529|FG001|COMPLETED|Overall Study||105
10806067|NCT03988374|11967530|FG002|COMPLETED|Overall Study||107
10806068|NCT03988374|11967528|FG000|NOT COMPLETED|Overall Study||1
10806069|NCT03988374|11967529|FG001|NOT COMPLETED|Overall Study||2
10806070|NCT03988374|11967530|FG002|NOT COMPLETED|Overall Study||1
10806071|NCT03987074|11967543|FG000|STARTED|Overall Study||21
10806072|NCT03987074|11967544|FG001|STARTED|Overall Study||22
10806073|NCT03987074|11967545|FG002|STARTED|Overall Study||22
10806074|NCT03987074|11967546|FG003|STARTED|Overall Study||22
10806075|NCT03987074|11967547|FG004|STARTED|Overall Study||21
10806076|NCT03987074|11967543|FG000|COMPLETED|Overall Study||18
10806077|NCT03987074|11967544|FG001|COMPLETED|Overall Study||20
10806078|NCT03987074|11967545|FG002|COMPLETED|Overall Study||21
10806079|NCT03987074|11967546|FG003|COMPLETED|Overall Study||18
10806080|NCT03987074|11967547|FG004|COMPLETED|Overall Study||19
10806081|NCT03987074|11967543|FG000|NOT COMPLETED|Overall Study||3
10806082|NCT03987074|11967544|FG001|NOT COMPLETED|Overall Study||2
10806083|NCT03987074|11967545|FG002|NOT COMPLETED|Overall Study||1
10806084|NCT03987074|11967546|FG003|NOT COMPLETED|Overall Study||4
10806085|NCT03987074|11967547|FG004|NOT COMPLETED|Overall Study||2
10577828|NCT01695239|11733034|FG013|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
10702405|NCT02574845|11866862|FG005|Received T2|Overall Study||3
10702406|NCT02574845|11866857|FG000|Received T3|Overall Study|one subject missed treatment period 2|2
10702407|NCT02574845|11866858|FG001|Received T3|Overall Study||2
10702408|NCT02574845|11866859|FG002|Received T3|Overall Study||3
10806086|NCT03977935|11967561|FG000|STARTED|Overall Study||40
10806087|NCT03977935|11967562|FG001|STARTED|Overall Study||40
10806088|NCT03977935|11967561|FG000|COMPLETED|Overall Study||40
10806089|NCT03977935|11967562|FG001|COMPLETED|Overall Study||40
10806090|NCT03977935|11967561|FG000|NOT COMPLETED|Overall Study||0
10806091|NCT03977935|11967562|FG001|NOT COMPLETED|Overall Study||0
10811119|NCT03777059|11972822|FG001|COMPLETED|Follow-Up Period (Weeks 12 to 16)||49
10811120|NCT03777059|11972823|FG002|COMPLETED|Follow-Up Period (Weeks 12 to 16)||32
10811121|NCT03777059|11972824|FG003|COMPLETED|Follow-Up Period (Weeks 12 to 16)||36
10811122|NCT03777059|11972821|FG000|NOT COMPLETED|Follow-Up Period (Weeks 12 to 16)||5
10811123|NCT03777059|11972822|FG001|NOT COMPLETED|Follow-Up Period (Weeks 12 to 16)||5
10811124|NCT03777059|11972823|FG002|NOT COMPLETED|Follow-Up Period (Weeks 12 to 16)||6
10702409|NCT02574845|11866860|FG003|Received T3|Overall Study||3
10702410|NCT02574845|11866861|FG004|Received T3|Overall Study||2
10811125|NCT03777059|11972824|FG003|NOT COMPLETED|Follow-Up Period (Weeks 12 to 16)||9
10702411|NCT02574845|11866862|FG005|Received T3|Overall Study||3
10577829|NCT01695239|11733021|FG000|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
10577830|NCT01695239|11733022|FG001|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
10577831|NCT01695239|11733023|FG002|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
10577832|NCT01695239|11733024|FG003|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
10577833|NCT01695239|11733025|FG004|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
10577834|NCT01695239|11733026|FG005|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
10577835|NCT01695239|11733027|FG006|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
10577836|NCT01695239|11733028|FG007|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
10577837|NCT01695239|11733029|FG008|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
10577838|NCT01695239|11733030|FG009|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
10577839|NCT01695239|11733031|FG010|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
10577840|NCT01695239|11733032|FG011|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
10577841|NCT01695239|11733033|FG012|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
10577842|NCT01695239|11733034|FG013|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
10577843|NCT01695239|11733021|FG000|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
10577844|NCT01695239|11733022|FG001|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
10577845|NCT01695239|11733023|FG002|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
10577846|NCT01695239|11733024|FG003|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
10577847|NCT01695239|11733025|FG004|STARTED|Placebo Washout (Week 24 Up To Week 32)|Only included PBO washout participants.|0
10577848|NCT01695239|11733026|FG005|STARTED|Placebo Washout (Week 24 Up To Week 32)|Only included PBO washout participants.|0
10577849|NCT01695239|11733027|FG006|STARTED|Placebo Washout (Week 24 Up To Week 32)|Only included PBO washout participants.|0
10806092|NCT03988049|11967570|FG000|STARTED|Overall Study||22
10806093|NCT03988049|11967571|FG001|STARTED|Overall Study||22
10806094|NCT03988049|11967570|FG000|COMPLETED|Overall Study||22
10806095|NCT03988049|11967571|FG001|COMPLETED|Overall Study||22
10806096|NCT03988049|11967570|FG000|NOT COMPLETED|Overall Study||0
10806097|NCT03988049|11967571|FG001|NOT COMPLETED|Overall Study||0
10806098|NCT03979820|11967581|FG000|STARTED|Overall Study||13
10806099|NCT03979820|11967582|FG001|STARTED|Overall Study||14
10806100|NCT03979820|11967583|FG002|STARTED|Overall Study||16
10806101|NCT03979820|11967584|FG003|STARTED|Overall Study||10
10806102|NCT03979820|11967581|FG000|COMPLETED|Overall Study||7
10806103|NCT03979820|11967582|FG001|COMPLETED|Overall Study||14
10806104|NCT03979820|11967583|FG002|COMPLETED|Overall Study||15
10806105|NCT03979820|11967584|FG003|COMPLETED|Overall Study||0
10806106|NCT03979820|11967581|FG000|NOT COMPLETED|Overall Study||6
10806107|NCT03979820|11967582|FG001|NOT COMPLETED|Overall Study||0
10806108|NCT03979820|11967583|FG002|NOT COMPLETED|Overall Study||1
10806109|NCT03979820|11967584|FG003|NOT COMPLETED|Overall Study||10
10806110|NCT03972137|11967598|FG000|STARTED|Overall Study||10
10806111|NCT03972137|11967598|FG000|Enrolled|Overall Study||10
10806112|NCT03972137|11967598|FG000|Treatment Completed|Overall Study||6
10806113|NCT03972137|11967598|FG000|Follow-up Completed|Overall Study||4
10806114|NCT03972137|11967598|FG000|COMPLETED|Overall Study||4
10806115|NCT03972137|11967598|FG000|NOT COMPLETED|Overall Study||6
10806116|NCT03970395|11967616|FG000|STARTED|Overall Study||48
10806117|NCT03970395|11967617|FG001|STARTED|Overall Study||48
10806118|NCT03970395|11967616|FG000|COMPLETED|Overall Study||41
10806119|NCT03970395|11967617|FG001|COMPLETED|Overall Study||36
10806120|NCT03970395|11967616|FG000|NOT COMPLETED|Overall Study||7
10806121|NCT03970395|11967617|FG001|NOT COMPLETED|Overall Study||12
10806122|NCT03987620|11967629|FG000|STARTED|Overall Study||303
10806123|NCT03987620|11967630|FG001|STARTED|Overall Study||152
10806124|NCT03987620|11967629|FG000|Withdrawn Before Treatment|Overall Study||5
10806125|NCT03987620|11967630|FG001|Withdrawn Before Treatment|Overall Study||1
10806126|NCT03987620|11967629|FG000|Withdrawn Before TOC|Overall Study||48
10806127|NCT03987620|11967630|FG001|Withdrawn Before TOC|Overall Study||45
10806128|NCT03987620|11967629|FG000|Completed the TOC Visit|Overall Study||250
10806129|NCT03987620|11967630|FG001|Completed the TOC Visit|Overall Study||106
10806130|NCT03987620|11967629|FG000|Withdrawn At or After the TOC Visit|Overall Study||4
10806131|NCT03987620|11967630|FG001|Withdrawn At or After the TOC Visit|Overall Study||4
10806132|NCT03987620|11967629|FG000|COMPLETED|Overall Study||246
10806133|NCT03987620|11967630|FG001|COMPLETED|Overall Study||102
10806134|NCT03987620|11967629|FG000|NOT COMPLETED|Overall Study||57
10806135|NCT03987620|11967630|FG001|NOT COMPLETED|Overall Study||50
10806136|NCT03983317|11967636|FG000|STARTED|Overall Study||25
10806137|NCT03983317|11967636|FG000|COMPLETED|Overall Study||20
10806138|NCT03983317|11967636|FG000|NOT COMPLETED|Overall Study||5
10806139|NCT03985657|11967640|FG000|STARTED|Intervention 1 (One Night)||20
10806140|NCT03985657|11967641|FG001|STARTED|Intervention 1 (One Night)||11
10806141|NCT03985657|11967640|FG000|COMPLETED|Intervention 1 (One Night)||20
10806142|NCT03985657|11967641|FG001|COMPLETED|Intervention 1 (One Night)||10
10806143|NCT03985657|11967640|FG000|NOT COMPLETED|Intervention 1 (One Night)||0
10806144|NCT03985657|11967641|FG001|NOT COMPLETED|Intervention 1 (One Night)||1
10806145|NCT03985657|11967640|FG000|STARTED|Washout (Up to 1 Week)||20
10577850|NCT01695239|11733028|FG007|STARTED|Placebo Washout (Week 24 Up To Week 32)|Adalimumab Q2W responders who re-randomized to IxeQ2W or IxeQ4W and PBO for ixe and adalimumab.|88
10577851|NCT01695239|11733029|FG008|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
10577852|NCT01695239|11733030|FG009|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
10577853|NCT01695239|11733031|FG010|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
10577854|NCT01695239|11733032|FG011|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
10577855|NCT01695239|11733033|FG012|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
10577856|NCT01695239|11733034|FG013|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
10577857|NCT01695239|11733021|FG000|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
10577858|NCT01695239|11733022|FG001|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
10577859|NCT01695239|11733023|FG002|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
10577860|NCT01695239|11733024|FG003|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
10577861|NCT01695239|11733025|FG004|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
10577862|NCT01695239|11733026|FG005|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
10577863|NCT01695239|11733027|FG006|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
10577864|NCT01695239|11733028|FG007|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||77
10577865|NCT01695239|11733029|FG008|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
10577866|NCT01695239|11733030|FG009|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
10702412|NCT02574845|11866857|FG000|Received T4|Overall Study||3
10702413|NCT02574845|11866858|FG001|Received T4|Overall Study||2
10702414|NCT02574845|11866859|FG002|Received T4|Overall Study||3
10702415|NCT02574845|11866860|FG003|Received T4|Overall Study||3
10806146|NCT03985657|11967641|FG001|STARTED|Washout (Up to 1 Week)||10
10806147|NCT03985657|11967640|FG000|COMPLETED|Washout (Up to 1 Week)||20
10806148|NCT03985657|11967641|FG001|COMPLETED|Washout (Up to 1 Week)||10
10806149|NCT03985657|11967640|FG000|NOT COMPLETED|Washout (Up to 1 Week)||0
10806150|NCT03985657|11967641|FG001|NOT COMPLETED|Washout (Up to 1 Week)||0
10806151|NCT03985657|11967640|FG000|STARTED|Intervention 2 (One Night)||20
10806152|NCT03985657|11967641|FG001|STARTED|Intervention 2 (One Night)||10
10806153|NCT03985657|11967640|FG000|COMPLETED|Intervention 2 (One Night)||20
10806154|NCT03985657|11967641|FG001|COMPLETED|Intervention 2 (One Night)||10
10806155|NCT03985657|11967640|FG000|NOT COMPLETED|Intervention 2 (One Night)||0
10806156|NCT03985657|11967641|FG001|NOT COMPLETED|Intervention 2 (One Night)||0
10806157|NCT03981939|11967650|FG000|STARTED|Overall Study||549
10806158|NCT03981939|11967651|FG001|STARTED|Overall Study||1902
10806159|NCT03981939|11967652|FG002|STARTED|Overall Study||581
10806160|NCT03981939|11967650|FG000|COMPLETED|Overall Study||549
10806161|NCT03981939|11967651|FG001|COMPLETED|Overall Study||1902
10806162|NCT03981939|11967652|FG002|COMPLETED|Overall Study||581
10806163|NCT03981939|11967650|FG000|NOT COMPLETED|Overall Study||0
10806164|NCT03981939|11967651|FG001|NOT COMPLETED|Overall Study||0
10806165|NCT03981939|11967652|FG002|NOT COMPLETED|Overall Study||0
10806166|NCT03973905|11967665|FG000|STARTED|Overall Study||107
10806167|NCT03973905|11967666|FG001|STARTED|Overall Study||183
10806168|NCT03973905|11967665|FG000|COMPLETED|Overall Study||107
10806169|NCT03973905|11967666|FG001|COMPLETED|Overall Study||183
10806170|NCT03973905|11967665|FG000|NOT COMPLETED|Overall Study||0
10806171|NCT03973905|11967666|FG001|NOT COMPLETED|Overall Study||0
10806172|NCT03984838|11967672|FG000|STARTED|Overall Study||16
10806173|NCT03984838|11967672|FG000|COMPLETED|Overall Study||16
10806174|NCT03984838|11967672|FG000|NOT COMPLETED|Overall Study||0
10806175|NCT03983941|11967678|FG000|STARTED|Overall Study||2
10806176|NCT03983941|11967679|FG001|STARTED|Overall Study||5
10806177|NCT03983941|11967678|FG000|COMPLETED|Overall Study||2
10806178|NCT03983941|11967679|FG001|COMPLETED|Overall Study||5
10806179|NCT03983941|11967678|FG000|NOT COMPLETED|Overall Study||0
10806180|NCT03983941|11967679|FG001|NOT COMPLETED|Overall Study||0
10806181|NCT03976752|11967687|FG000|STARTED|Overall Study||4
10806182|NCT03976752|11967688|FG001|STARTED|Overall Study||37
10806183|NCT03976752|11967687|FG000|Started Study Arm A|Overall Study||0
10702416|NCT02574845|11866861|FG004|Received T4|Overall Study||2
10702417|NCT02574845|11866862|FG005|Received T4|Overall Study||2
10702418|NCT02574845|11866857|FG000|Received T5|Overall Study||3
10702419|NCT02574845|11866858|FG001|Received T5|Overall Study||2
10702420|NCT02574845|11866859|FG002|Received T5|Overall Study||3
10702421|NCT02574845|11866860|FG003|Received T5|Overall Study||3
10806184|NCT03976752|11967688|FG001|Started Study Arm A|Overall Study||14
10806185|NCT03976752|11967687|FG000|Completed Study Arm A|Overall Study||0
10806186|NCT03976752|11967688|FG001|Completed Study Arm A|Overall Study||8
10806187|NCT03976752|11967687|FG000|Started Study Arm B|Overall Study||0
10806188|NCT03976752|11967688|FG001|Started Study Arm B|Overall Study||8
10806189|NCT03976752|11967687|FG000|Completed Study Arm B|Overall Study||0
10806190|NCT03976752|11967688|FG001|Completed Study Arm B|Overall Study||8
10806191|NCT03976752|11967687|FG000|Started Study Arm C|Overall Study||0
10806192|NCT03976752|11967688|FG001|Started Study Arm C|Overall Study||11
10806193|NCT03976752|11967687|FG000|Completed Study Arm C|Overall Study||0
10806194|NCT03976752|11967688|FG001|Completed Study Arm C|Overall Study||8
10806195|NCT03976752|11967687|FG000|Started Study Arm D|Overall Study||0
10806196|NCT03976752|11967688|FG001|Started Study Arm D|Overall Study||6
10806197|NCT03976752|11967687|FG000|Completed Study Arm D|Overall Study||0
10806198|NCT03976752|11967688|FG001|Completed Study Arm D|Overall Study||4
10806199|NCT03976752|11967687|FG000|COMPLETED|Overall Study||3
10806200|NCT03976752|11967688|FG001|COMPLETED|Overall Study||28
10806201|NCT03976752|11967687|FG000|NOT COMPLETED|Overall Study||1
10806202|NCT03976752|11967688|FG001|NOT COMPLETED|Overall Study||9
10806203|NCT03984825|11967699|FG000|STARTED|Run-in Period (Day -3 to -1)||23
10702422|NCT02574845|11866861|FG004|Received T5|Overall Study||3
10702423|NCT02574845|11866862|FG005|Received T5|Overall Study||2
10702424|NCT02574845|11866857|FG000|Received R|Overall Study||3
10702425|NCT02574845|11866858|FG001|Received R|Overall Study||2
10702426|NCT02574845|11866859|FG002|Received R|Overall Study||3
10702427|NCT02574845|11866860|FG003|Received R|Overall Study||3
10702428|NCT02574845|11866861|FG004|Received R|Overall Study||2
10702429|NCT02574845|11866862|FG005|Received R|Overall Study||3
10702430|NCT02574845|11866857|FG000|COMPLETED|Overall Study||3
10702431|NCT02574845|11866858|FG001|COMPLETED|Overall Study||2
10702432|NCT02574845|11866859|FG002|COMPLETED|Overall Study||3
10702433|NCT02574845|11866860|FG003|COMPLETED|Overall Study||3
10577867|NCT01695239|11733031|FG010|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
10577868|NCT01695239|11733032|FG011|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
10577869|NCT01695239|11733033|FG012|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
10577870|NCT01695239|11733034|FG013|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
10577871|NCT01695239|11733021|FG000|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
10577872|NCT01695239|11733022|FG001|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
10577873|NCT01695239|11733023|FG002|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
10577874|NCT01695239|11733024|FG003|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
10577875|NCT01695239|11733025|FG004|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
10577876|NCT01695239|11733026|FG005|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
10577877|NCT01695239|11733027|FG006|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
10577878|NCT01695239|11733028|FG007|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||11
10577879|NCT01695239|11733029|FG008|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
10577880|NCT01695239|11733030|FG009|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
10577881|NCT01695239|11733031|FG010|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
10577882|NCT01695239|11733032|FG011|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
10577883|NCT01695239|11733033|FG012|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
10577884|NCT01695239|11733034|FG013|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
10577885|NCT01695239|11733021|FG000|STARTED|Extension Long-Term Extension Periods||0
10577886|NCT01695239|11733022|FG001|STARTED|Extension Long-Term Extension Periods||0
10577887|NCT01695239|11733023|FG002|STARTED|Extension Long-Term Extension Periods||0
10577888|NCT01695239|11733024|FG003|STARTED|Extension Long-Term Extension Periods||0
10577889|NCT01695239|11733025|FG004|STARTED|Extension Long-Term Extension Periods||0
10577890|NCT01695239|11733026|FG005|STARTED|Extension Long-Term Extension Periods||0
10577891|NCT01695239|11733027|FG006|STARTED|Extension Long-Term Extension Periods||0
10577892|NCT01695239|11733028|FG007|STARTED|Extension Long-Term Extension Periods|Only included combined extension participants.|0
10577893|NCT01695239|11733029|FG008|STARTED|Extension Long-Term Extension Periods|IxeQ4W who re-randomized to ixeQ4W.|187
10577894|NCT01695239|11733030|FG009|STARTED|Extension Long-Term Extension Periods|IxeQ2W who re-randomized to ixeQ2W.|183
10577895|NCT01695239|11733031|FG010|STARTED|Extension Long-Term Extension Periods||0
10577896|NCT01695239|11733032|FG011|STARTED|Extension Long-Term Extension Periods||0
10577897|NCT01695239|11733033|FG012|STARTED|Extension Long-Term Extension Periods||0
10577898|NCT01695239|11733034|FG013|STARTED|Extension Long-Term Extension Periods||0
10577899|NCT01695239|11733021|FG000|COMPLETED|Extension Long-Term Extension Periods||0
10577900|NCT01695239|11733022|FG001|COMPLETED|Extension Long-Term Extension Periods||0
10577901|NCT01695239|11733023|FG002|COMPLETED|Extension Long-Term Extension Periods||0
10577902|NCT01695239|11733024|FG003|COMPLETED|Extension Long-Term Extension Periods||0
10577903|NCT01695239|11733025|FG004|COMPLETED|Extension Long-Term Extension Periods||0
10577904|NCT01695239|11733026|FG005|COMPLETED|Extension Long-Term Extension Periods||0
10577905|NCT01695239|11733027|FG006|COMPLETED|Extension Long-Term Extension Periods||0
10577906|NCT01695239|11733028|FG007|COMPLETED|Extension Long-Term Extension Periods||0
10577907|NCT01695239|11733029|FG008|COMPLETED|Extension Long-Term Extension Periods||121
10577908|NCT01695239|11733030|FG009|COMPLETED|Extension Long-Term Extension Periods||122
10577909|NCT01695239|11733031|FG010|COMPLETED|Extension Long-Term Extension Periods||0
10577910|NCT01695239|11733032|FG011|COMPLETED|Extension Long-Term Extension Periods||0
10577911|NCT01695239|11733033|FG012|COMPLETED|Extension Long-Term Extension Periods||0
10577912|NCT01695239|11733034|FG013|COMPLETED|Extension Long-Term Extension Periods||0
10577913|NCT01695239|11733021|FG000|NOT COMPLETED|Extension Long-Term Extension Periods||0
10577914|NCT01695239|11733022|FG001|NOT COMPLETED|Extension Long-Term Extension Periods||0
10577915|NCT01695239|11733023|FG002|NOT COMPLETED|Extension Long-Term Extension Periods||0
10577916|NCT01695239|11733024|FG003|NOT COMPLETED|Extension Long-Term Extension Periods||0
10577917|NCT01695239|11733025|FG004|NOT COMPLETED|Extension Long-Term Extension Periods||0
10577918|NCT01695239|11733026|FG005|NOT COMPLETED|Extension Long-Term Extension Periods||0
10702434|NCT02574845|11866861|FG004|COMPLETED|Overall Study||2
10702435|NCT02574845|11866862|FG005|COMPLETED|Overall Study||2
10702436|NCT02574845|11866857|FG000|NOT COMPLETED|Overall Study||0
10702437|NCT02574845|11866858|FG001|NOT COMPLETED|Overall Study||1
10702438|NCT02574845|11866859|FG002|NOT COMPLETED|Overall Study||0
10702439|NCT02574845|11866860|FG003|NOT COMPLETED|Overall Study||0
10702440|NCT02574845|11866861|FG004|NOT COMPLETED|Overall Study||1
10702441|NCT02574845|11866862|FG005|NOT COMPLETED|Overall Study||1
10577919|NCT01695239|11733027|FG006|NOT COMPLETED|Extension Long-Term Extension Periods||0
10577920|NCT01695239|11733028|FG007|NOT COMPLETED|Extension Long-Term Extension Periods||0
10702442|NCT02574858|11866876|FG000|STARTED|Overall Study||25
10702443|NCT02574858|11866876|FG000|COMPLETED|Overall Study||25
10577921|NCT01695239|11733029|FG008|NOT COMPLETED|Extension Long-Term Extension Periods||66
10577922|NCT01695239|11733030|FG009|NOT COMPLETED|Extension Long-Term Extension Periods||61
10577923|NCT01695239|11733031|FG010|NOT COMPLETED|Extension Long-Term Extension Periods||0
10702444|NCT02574858|11866876|FG000|NOT COMPLETED|Overall Study||0
10702445|NCT02575079|11866882|FG000|STARTED|Overall Study||48
10702446|NCT02575079|11866883|FG001|STARTED|Overall Study||71
10702447|NCT02575079|11866882|FG000|COMPLETED|Overall Study||42
10702448|NCT02575079|11866883|FG001|COMPLETED|Overall Study||71
10702449|NCT02575079|11866882|FG000|NOT COMPLETED|Overall Study||6
10702450|NCT02575079|11866883|FG001|NOT COMPLETED|Overall Study||0
10806204|NCT03984825|11967699|FG000|COMPLETED|Run-in Period (Day -3 to -1)||23
10806205|NCT03984825|11967699|FG000|NOT COMPLETED|Run-in Period (Day -3 to -1)||0
10806206|NCT03984825|11967699|FG000|STARTED|Treatment Period 1 (Day 1 to 10)||23
10806207|NCT03984825|11967699|FG000|COMPLETED|Treatment Period 1 (Day 1 to 10)||21
10806208|NCT03984825|11967699|FG000|NOT COMPLETED|Treatment Period 1 (Day 1 to 10)||2
10806209|NCT03984825|11967699|FG000|STARTED|Treatment Period 2 (Day 11 to 21)||21
10806210|NCT03984825|11967699|FG000|COMPLETED|Treatment Period 2 (Day 11 to 21)||17
10806211|NCT03984825|11967699|FG000|NOT COMPLETED|Treatment Period 2 (Day 11 to 21)||4
10806212|NCT03971721|11967708|FG000|STARTED|Overall Study||3
10806213|NCT03971721|11967708|FG000|COMPLETED|Overall Study||3
10806214|NCT03971721|11967708|FG000|NOT COMPLETED|Overall Study||0
10806215|NCT03982433|11967712|FG000|STARTED|Overall Study||8
10806216|NCT03982433|11967712|FG000|COMPLETED|Overall Study||7
10806217|NCT03982433|11967712|FG000|NOT COMPLETED|Overall Study||1
10806218|NCT03979677|11967716|FG000|STARTED|Overall Study|Participants enrolled|41
10806219|NCT03979677|11967716|FG000|COMPLETED|Overall Study|participants completed|28
10806220|NCT03979677|11967716|FG000|NOT COMPLETED|Overall Study||13
10806221|NCT03976466|11967722|FG000|STARTED|Overall Study||44
10806222|NCT03976466|11967723|FG001|STARTED|Overall Study||43
10806223|NCT03976466|11967722|FG000|COMPLETED|Overall Study||43
10806224|NCT03976466|11967723|FG001|COMPLETED|Overall Study||40
10806225|NCT03976466|11967722|FG000|NOT COMPLETED|Overall Study||1
10806226|NCT03976466|11967723|FG001|NOT COMPLETED|Overall Study||3
10806227|NCT03979638|11967733|FG000|STARTED|Period 1||33
10806228|NCT03979638|11967734|FG001|STARTED|Period 1||35
10806229|NCT03979638|11967733|FG000|COMPLETED|Period 1||26
10806230|NCT03979638|11967734|FG001|COMPLETED|Period 1||28
10806231|NCT03979638|11967733|FG000|NOT COMPLETED|Period 1||7
10806232|NCT03979638|11967734|FG001|NOT COMPLETED|Period 1||7
10806233|NCT03979638|11967733|FG000|STARTED|Period 2||26
10806234|NCT03979638|11967734|FG001|STARTED|Period 2||28
10806235|NCT03979638|11967733|FG000|COMPLETED|Period 2||25
10806236|NCT03979638|11967734|FG001|COMPLETED|Period 2||27
10806237|NCT03979638|11967733|FG000|NOT COMPLETED|Period 2||1
10702451|NCT02575300|11866888|FG000|STARTED|Overall Study||20
10702452|NCT02575300|11866888|FG000|COMPLETED|Overall Study||20
10702453|NCT02575300|11866888|FG000|NOT COMPLETED|Overall Study||0
10702454|NCT02575807|11866897|FG000|STARTED|Overall Study||9
10702455|NCT02575807|11866898|FG001|STARTED|Overall Study||4
10702456|NCT02575807|11866899|FG002|STARTED|Overall Study||16
10806238|NCT03979638|11967734|FG001|NOT COMPLETED|Period 2||1
10702457|NCT02575807|11866900|FG003|STARTED|Overall Study||2
10806239|NCT03979274|11967749|FG000|STARTED|Treatment Period 1||22
10806240|NCT03979274|11967750|FG001|STARTED|Treatment Period 1||22
10806241|NCT03979274|11967749|FG000|COMPLETED|Treatment Period 1||22
10806242|NCT03979274|11967750|FG001|COMPLETED|Treatment Period 1||22
10806243|NCT03979274|11967749|FG000|NOT COMPLETED|Treatment Period 1||0
10806244|NCT03979274|11967750|FG001|NOT COMPLETED|Treatment Period 1||0
10806245|NCT03979274|11967749|FG000|STARTED|Treatment Period 2||22
10577924|NCT01695239|11733032|FG011|NOT COMPLETED|Extension Long-Term Extension Periods||0
10577925|NCT01695239|11733033|FG012|NOT COMPLETED|Extension Long-Term Extension Periods||0
10577926|NCT01695239|11733034|FG013|NOT COMPLETED|Extension Long-Term Extension Periods||0
10577927|NCT01695239|11733021|FG000|STARTED|Post-Treatment Follow-Up Period||0
10577928|NCT01695239|11733022|FG001|STARTED|Post-Treatment Follow-Up Period||0
10577929|NCT01695239|11733023|FG002|STARTED|Post-Treatment Follow-Up Period||0
10577930|NCT01695239|11733024|FG003|STARTED|Post-Treatment Follow-Up Period||0
10577931|NCT01695239|11733025|FG004|STARTED|Post-Treatment Follow-Up Period||0
10577932|NCT01695239|11733026|FG005|STARTED|Post-Treatment Follow-Up Period||0
10577933|NCT01695239|11733027|FG006|STARTED|Post-Treatment Follow-Up Period||0
10806246|NCT03979274|11967750|FG001|STARTED|Treatment Period 2||22
10806247|NCT03979274|11967749|FG000|COMPLETED|Treatment Period 2||22
10806248|NCT03979274|11967750|FG001|COMPLETED|Treatment Period 2||21
10806249|NCT03979274|11967749|FG000|NOT COMPLETED|Treatment Period 2||0
10806250|NCT03979274|11967750|FG001|NOT COMPLETED|Treatment Period 2||1
10806251|NCT03979066|11967758|FG000|STARTED|Overall Study||0
10806252|NCT03979066|11967759|FG001|STARTED|Overall Study||0
10806253|NCT03979066|11967758|FG000|COMPLETED|Overall Study||0
10806254|NCT03979066|11967759|FG001|COMPLETED|Overall Study||0
10806255|NCT03979066|11967758|FG000|NOT COMPLETED|Overall Study||0
10806256|NCT03979066|11967759|FG001|NOT COMPLETED|Overall Study||0
10806257|NCT03977727|11967767|FG000|STARTED|First Treatment||20
10806258|NCT03977727|11967768|FG001|STARTED|First Treatment||20
10806259|NCT03977727|11967767|FG000|Received Treatment|First Treatment||20
10806260|NCT03977727|11967768|FG001|Received Treatment|First Treatment||20
10806261|NCT03977727|11967767|FG000|COMPLETED|First Treatment||20
10806262|NCT03977727|11967768|FG001|COMPLETED|First Treatment||20
10806263|NCT03977727|11967767|FG000|NOT COMPLETED|First Treatment||0
10806264|NCT03977727|11967768|FG001|NOT COMPLETED|First Treatment||0
10806265|NCT03977727|11967767|FG000|STARTED|Second Treatment||20
10806266|NCT03977727|11967768|FG001|STARTED|Second Treatment||20
10806267|NCT03977727|11967767|FG000|COMPLETED|Second Treatment||20
10806268|NCT03977727|11967768|FG001|COMPLETED|Second Treatment||17
10806269|NCT03977727|11967767|FG000|NOT COMPLETED|Second Treatment||0
10806270|NCT03977727|11967768|FG001|NOT COMPLETED|Second Treatment||3
10806271|NCT03977155|11967777|FG000|STARTED|Overall Study||43
10806272|NCT03977155|11967778|FG001|STARTED|Overall Study||48
10806273|NCT03977155|11967779|FG002|STARTED|Overall Study||42
10806274|NCT03977155|11967777|FG000|COMPLETED|Overall Study||38
10806275|NCT03977155|11967778|FG001|COMPLETED|Overall Study||46
10806276|NCT03977155|11967779|FG002|COMPLETED|Overall Study||40
10806277|NCT03977155|11967777|FG000|NOT COMPLETED|Overall Study||5
10806278|NCT03977155|11967778|FG001|NOT COMPLETED|Overall Study||2
10806279|NCT03977155|11967779|FG002|NOT COMPLETED|Overall Study||2
10806280|NCT03974802|11967789|FG000|STARTED|Overall Study||41
10806281|NCT03974802|11967789|FG000|COMPLETED|Overall Study||41
10806282|NCT03974802|11967789|FG000|NOT COMPLETED|Overall Study||0
10806283|NCT03970733|11967801|FG000|STARTED|Overall Study||97
10806284|NCT03970733|11967802|FG001|STARTED|Overall Study||98
10806285|NCT03970733|11967803|FG002|STARTED|Overall Study||51
10806286|NCT03970733|11967801|FG000|COMPLETED|Overall Study||93
10806287|NCT03970733|11967802|FG001|COMPLETED|Overall Study||92
10806288|NCT03970733|11967803|FG002|COMPLETED|Overall Study||49
10806289|NCT03970733|11967801|FG000|NOT COMPLETED|Overall Study||4
10806290|NCT03970733|11967802|FG001|NOT COMPLETED|Overall Study||6
10806291|NCT03970733|11967803|FG002|NOT COMPLETED|Overall Study||2
10806292|NCT03968978|11967813|FG000|STARTED|Overall Study||111
10806293|NCT03968978|11967814|FG001|STARTED|Overall Study||105
10806294|NCT03968978|11967813|FG000|COMPLETED|Overall Study||110
10806295|NCT03968978|11967814|FG001|COMPLETED|Overall Study||105
10806296|NCT03968978|11967813|FG000|NOT COMPLETED|Overall Study||1
10806297|NCT03968978|11967814|FG001|NOT COMPLETED|Overall Study||0
10806298|NCT03968848|11967822|FG000|STARTED|Overall Study||8
10806299|NCT03968848|11967823|FG001|STARTED|Overall Study||8
10806300|NCT03968848|11967822|FG000|COMPLETED|Overall Study||8
10806301|NCT03968848|11967823|FG001|COMPLETED|Overall Study||8
10806302|NCT03968848|11967822|FG000|NOT COMPLETED|Overall Study||0
10806303|NCT03968848|11967823|FG001|NOT COMPLETED|Overall Study||0
10806310|NCT03966924|11967838|FG000|STARTED|Overall Study||2
10806311|NCT03966924|11967838|FG000|COMPLETED|Overall Study||2
10577934|NCT01695239|11733028|FG007|STARTED|Post-Treatment Follow-Up Period||0
10806312|NCT03966924|11967838|FG000|NOT COMPLETED|Overall Study||0
10806313|NCT03966911|11967844|FG000|STARTED|Overall Study||169
10806314|NCT03966911|11967845|FG001|STARTED|Overall Study||142
10806315|NCT03966911|11967844|FG000|COMPLETED|Overall Study||160
10806316|NCT03966911|11967845|FG001|COMPLETED|Overall Study||126
10806317|NCT03966911|11967844|FG000|NOT COMPLETED|Overall Study||9
10806318|NCT03966911|11967845|FG001|NOT COMPLETED|Overall Study||16
10806319|NCT03966365|11967855|FG000|STARTED|Overall Study||12
10806320|NCT03966365|11967856|FG001|STARTED|Overall Study||12
10806321|NCT03966365|11967855|FG000|COMPLETED|Overall Study||11
10806322|NCT03966365|11967856|FG001|COMPLETED|Overall Study||12
10806323|NCT03966365|11967855|FG000|NOT COMPLETED|Overall Study||1
10806324|NCT03966365|11967856|FG001|NOT COMPLETED|Overall Study||0
10806325|NCT03965403|11967862|FG000|STARTED|Overall Study||7
10806326|NCT03965403|11967862|FG000|COMPLETED|Overall Study||6
10806327|NCT03965403|11967862|FG000|NOT COMPLETED|Overall Study||1
10806328|NCT03965754|11967870|FG000|STARTED|Overall Study||1422
10806329|NCT03965754|11967871|FG001|STARTED|Overall Study||1425
10806330|NCT03965754|11967872|FG002|STARTED|Overall Study||1425
10806331|NCT03965754|11967873|FG003|STARTED|Overall Study||1425
10806332|NCT03965754|11967870|FG000|COMPLETED|Overall Study||1422
10806333|NCT03965754|11967871|FG001|COMPLETED|Overall Study||1425
10806334|NCT03965754|11967872|FG002|COMPLETED|Overall Study||1425
10806335|NCT03965754|11967873|FG003|COMPLETED|Overall Study||1425
10806336|NCT03965754|11967870|FG000|NOT COMPLETED|Overall Study||0
10806337|NCT03965754|11967871|FG001|NOT COMPLETED|Overall Study||0
10806338|NCT03965754|11967872|FG002|NOT COMPLETED|Overall Study||0
10806339|NCT03965754|11967873|FG003|NOT COMPLETED|Overall Study||0
10806340|NCT03965533|11967890|FG000|STARTED|Part A (112 Days)||2
10806341|NCT03965533|11967891|FG001|STARTED|Part A (112 Days)||6
10806342|NCT03965533|11967892|FG002|STARTED|Part A (112 Days)||2
10806343|NCT03965533|11967893|FG003|STARTED|Part A (112 Days)||6
10806344|NCT03965533|11967894|FG004|STARTED|Part A (112 Days)||0
10806345|NCT03965533|11967895|FG005|STARTED|Part A (112 Days)||0
10806346|NCT03965533|11967896|FG006|STARTED|Part A (112 Days)||0
10806347|NCT03965533|11967890|FG000|COMPLETED|Part A (112 Days)||2
10806348|NCT03965533|11967891|FG001|COMPLETED|Part A (112 Days)||6
10806349|NCT03965533|11967892|FG002|COMPLETED|Part A (112 Days)||2
10806350|NCT03965533|11967893|FG003|COMPLETED|Part A (112 Days)||6
10806351|NCT03965533|11967894|FG004|COMPLETED|Part A (112 Days)||0
10806352|NCT03965533|11967895|FG005|COMPLETED|Part A (112 Days)||0
10806353|NCT03965533|11967896|FG006|COMPLETED|Part A (112 Days)||0
10806354|NCT03965533|11967890|FG000|NOT COMPLETED|Part A (112 Days)||0
10806355|NCT03965533|11967891|FG001|NOT COMPLETED|Part A (112 Days)||0
10806356|NCT03965533|11967892|FG002|NOT COMPLETED|Part A (112 Days)||0
10806357|NCT03965533|11967893|FG003|NOT COMPLETED|Part A (112 Days)||0
10806358|NCT03965533|11967894|FG004|NOT COMPLETED|Part A (112 Days)||0
10806359|NCT03965533|11967895|FG005|NOT COMPLETED|Part A (112 Days)||0
10806360|NCT03965533|11967896|FG006|NOT COMPLETED|Part A (112 Days)||0
10806361|NCT03965533|11967890|FG000|STARTED|Part B (112 Days)||0
10806362|NCT03965533|11967891|FG001|STARTED|Part B (112 Days)||0
10806363|NCT03965533|11967892|FG002|STARTED|Part B (112 Days)||0
10806364|NCT03965533|11967893|FG003|STARTED|Part B (112 Days)||0
10806365|NCT03965533|11967894|FG004|STARTED|Part B (112 Days)||4
10806366|NCT03965533|11967895|FG005|STARTED|Part B (112 Days)||8
10806367|NCT03965533|11967896|FG006|STARTED|Part B (112 Days)||8
10806368|NCT03965533|11967890|FG000|COMPLETED|Part B (112 Days)||0
10806369|NCT03965533|11967891|FG001|COMPLETED|Part B (112 Days)||0
10806370|NCT03965533|11967892|FG002|COMPLETED|Part B (112 Days)||0
10806371|NCT03965533|11967893|FG003|COMPLETED|Part B (112 Days)||0
10806372|NCT03965533|11967894|FG004|COMPLETED|Part B (112 Days)||4
10806373|NCT03965533|11967895|FG005|COMPLETED|Part B (112 Days)||8
10806374|NCT03965533|11967896|FG006|COMPLETED|Part B (112 Days)||8
10806375|NCT03965533|11967890|FG000|NOT COMPLETED|Part B (112 Days)||0
10806376|NCT03965533|11967891|FG001|NOT COMPLETED|Part B (112 Days)||0
10806377|NCT03965533|11967892|FG002|NOT COMPLETED|Part B (112 Days)||0
10806378|NCT03965533|11967893|FG003|NOT COMPLETED|Part B (112 Days)||0
10806379|NCT03965533|11967894|FG004|NOT COMPLETED|Part B (112 Days)||0
10806380|NCT03965533|11967895|FG005|NOT COMPLETED|Part B (112 Days)||0
10806381|NCT03965533|11967896|FG006|NOT COMPLETED|Part B (112 Days)||0
10806382|NCT03965351|11967919|FG000|STARTED|First Intervention (4 Weeks)||3
10806383|NCT03965351|11967920|FG001|STARTED|First Intervention (4 Weeks)||5
10806384|NCT03965351|11967919|FG000|COMPLETED|First Intervention (4 Weeks)||3
10806385|NCT03965351|11967920|FG001|COMPLETED|First Intervention (4 Weeks)||4
10806386|NCT03965351|11967919|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
10806387|NCT03965351|11967920|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1
10806388|NCT03965351|11967919|FG000|STARTED|Wash Out Period (4 Weeks)||3
10806389|NCT03965351|11967920|FG001|STARTED|Wash Out Period (4 Weeks)||4
10806390|NCT03965351|11967919|FG000|COMPLETED|Wash Out Period (4 Weeks)||3
10806391|NCT03965351|11967920|FG001|COMPLETED|Wash Out Period (4 Weeks)||4
10806392|NCT03965351|11967919|FG000|NOT COMPLETED|Wash Out Period (4 Weeks)||0
10806393|NCT03965351|11967920|FG001|NOT COMPLETED|Wash Out Period (4 Weeks)||0
10456969|NCT01008475|11604714|FG005|STARTED|Overall Study||73
10456970|NCT01008475|11604715|FG006|STARTED|Overall Study||71
10456971|NCT01008475|11604709|FG000|Safety Analysis Set|Overall Study||3
10456972|NCT01008475|11604710|FG001|Safety Analysis Set|Overall Study||3
10456973|NCT01008475|11604711|FG002|Safety Analysis Set|Overall Study||7
10456974|NCT01008475|11604712|FG003|Safety Analysis Set|Overall Study||3
10806394|NCT03965351|11967919|FG000|STARTED|Second Intervention (4 Weeks)||3
10806395|NCT03965351|11967920|FG001|STARTED|Second Intervention (4 Weeks)||4
10806396|NCT03965351|11967919|FG000|COMPLETED|Second Intervention (4 Weeks)||3
10806397|NCT03965351|11967920|FG001|COMPLETED|Second Intervention (4 Weeks)||3
10806398|NCT03965351|11967919|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
10806399|NCT03965351|11967920|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1
10806400|NCT03964220|11967928|FG000|STARTED|Overall Study||2619
10806401|NCT03964220|11967929|FG001|STARTED|Overall Study||5238
10806402|NCT03964220|11967928|FG000|COMPLETED|Overall Study||2619
10806403|NCT03964220|11967929|FG001|COMPLETED|Overall Study||5238
10526126|NCT01380093|11678035|FG003|STARTED|Treatment Phase: Washout Period||6
10526127|NCT01380093|11678036|FG004|STARTED|Treatment Phase: Washout Period||6
10526128|NCT01380093|11678037|FG005|STARTED|Treatment Phase: Washout Period||6
10526129|NCT01380093|11678038|FG006|STARTED|Treatment Phase: Washout Period||6
10577935|NCT01695239|11733029|FG008|STARTED|Post-Treatment Follow-Up Period|Only included post-treatment follow-up participants.|0
10577936|NCT01695239|11733030|FG009|STARTED|Post-Treatment Follow-Up Period|Only included post-treatment follow-up participants.|0
10577937|NCT01695239|11733031|FG010|STARTED|Post-Treatment Follow-Up Period|Participants who discontinued early and received PBO.|20
10577938|NCT01695239|11733032|FG011|STARTED|Post-Treatment Follow-Up Period|Participants who discontinued early and received adalimumab.|1
10577939|NCT01695239|11733033|FG012|STARTED|Post-Treatment Follow-Up Period|IxeQ4W participants who entered post-treatment follow-up.|165
10577940|NCT01695239|11733034|FG013|STARTED|Post-Treatment Follow-Up Period|IxeQ2W participants who entered post-treatment follow-up.|171
10577941|NCT01695239|11733021|FG000|COMPLETED|Post-Treatment Follow-Up Period||0
10577942|NCT01695239|11733022|FG001|COMPLETED|Post-Treatment Follow-Up Period||0
10577943|NCT01695239|11733023|FG002|COMPLETED|Post-Treatment Follow-Up Period||0
10577944|NCT01695239|11733024|FG003|COMPLETED|Post-Treatment Follow-Up Period||0
10577945|NCT01695239|11733025|FG004|COMPLETED|Post-Treatment Follow-Up Period||0
10577946|NCT01695239|11733026|FG005|COMPLETED|Post-Treatment Follow-Up Period||0
10577947|NCT01695239|11733027|FG006|COMPLETED|Post-Treatment Follow-Up Period||0
10577948|NCT01695239|11733028|FG007|COMPLETED|Post-Treatment Follow-Up Period||0
10577949|NCT01695239|11733029|FG008|COMPLETED|Post-Treatment Follow-Up Period||0
10577950|NCT01695239|11733030|FG009|COMPLETED|Post-Treatment Follow-Up Period||0
10577951|NCT01695239|11733031|FG010|COMPLETED|Post-Treatment Follow-Up Period||20
10577952|NCT01695239|11733032|FG011|COMPLETED|Post-Treatment Follow-Up Period||0
10577953|NCT01695239|11733033|FG012|COMPLETED|Post-Treatment Follow-Up Period||156
10577954|NCT01695239|11733034|FG013|COMPLETED|Post-Treatment Follow-Up Period||166
10577955|NCT01695239|11733021|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||0
10577956|NCT01695239|11733022|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||0
10577957|NCT01695239|11733023|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||0
10577958|NCT01695239|11733024|FG003|NOT COMPLETED|Post-Treatment Follow-Up Period||0
10577959|NCT01695239|11733025|FG004|NOT COMPLETED|Post-Treatment Follow-Up Period||0
10577960|NCT01695239|11733026|FG005|NOT COMPLETED|Post-Treatment Follow-Up Period||0
10577961|NCT01695239|11733027|FG006|NOT COMPLETED|Post-Treatment Follow-Up Period||0
10577962|NCT01695239|11733028|FG007|NOT COMPLETED|Post-Treatment Follow-Up Period||0
10577963|NCT01695239|11733029|FG008|NOT COMPLETED|Post-Treatment Follow-Up Period||0
10577964|NCT01695239|11733030|FG009|NOT COMPLETED|Post-Treatment Follow-Up Period||0
10577965|NCT01695239|11733031|FG010|NOT COMPLETED|Post-Treatment Follow-Up Period||0
10577966|NCT01695239|11733032|FG011|NOT COMPLETED|Post-Treatment Follow-Up Period||1
10577967|NCT01695239|11733033|FG012|NOT COMPLETED|Post-Treatment Follow-Up Period||9
10577968|NCT01695239|11733034|FG013|NOT COMPLETED|Post-Treatment Follow-Up Period||5
10577969|NCT01695291|11733058|FG000|STARTED|Overall Study||10
10577970|NCT01695291|11733059|FG001|STARTED|Overall Study||21
10577971|NCT01695291|11733058|FG000|COMPLETED|Overall Study||8
10577972|NCT01695291|11733059|FG001|COMPLETED|Overall Study||14
10577973|NCT01695291|11733058|FG000|NOT COMPLETED|Overall Study||2
10577974|NCT01695291|11733059|FG001|NOT COMPLETED|Overall Study||7
10577975|NCT01695304|11733067|FG000|STARTED|Overall Study||120
10577976|NCT01695304|11733068|FG001|STARTED|Overall Study||120
10577977|NCT01695304|11733067|FG000|COMPLETED|Overall Study|2 deaths & 1 drop out in the intervention group, contributed some information over the 26 weeks|120
10577978|NCT01695304|11733068|FG001|COMPLETED|Overall Study|3 deaths & 2 drop out in the intervention group, contributed some information over the 26 weeks|120
10577979|NCT01695304|11733067|FG000|NOT COMPLETED|Overall Study||0
10577980|NCT01695304|11733068|FG001|NOT COMPLETED|Overall Study||0
10577981|NCT01695330|11733076|FG000|STARTED|Overall Study||52
10577982|NCT01695330|11733077|FG001|STARTED|Overall Study||0
10577983|NCT01695330|11733076|FG000|COMPLETED|Overall Study||5
10577984|NCT01695330|11733077|FG001|COMPLETED|Overall Study||0
10577985|NCT01695330|11733076|FG000|NOT COMPLETED|Overall Study||47
10577986|NCT01695330|11733077|FG001|NOT COMPLETED|Overall Study||0
10577987|NCT01695369|11733081|FG000|STARTED|Overall Study||61
10577988|NCT01695369|11733081|FG000|COMPLETED|Overall Study||61
10577989|NCT01695369|11733081|FG000|NOT COMPLETED|Overall Study||0
10577990|NCT01695473|11733087|FG000|STARTED|Overall Study||11
10577991|NCT01695473|11733087|FG000|COMPLETED|Overall Study||11
10577992|NCT01695473|11733087|FG000|NOT COMPLETED|Overall Study||0
10577993|NCT01695668|11733094|FG000|STARTED|Overall Study||38
10577994|NCT01695668|11733095|FG001|STARTED|Overall Study||37
10577995|NCT01695668|11733094|FG000|COMPLETED|Overall Study||23
10577996|NCT01695668|11733095|FG001|COMPLETED|Overall Study||20
10577997|NCT01695668|11733094|FG000|NOT COMPLETED|Overall Study||15
10577998|NCT01695668|11733095|FG001|NOT COMPLETED|Overall Study||17
10577999|NCT01695746|11733101|FG000|STARTED|Overall Study||108
10578000|NCT01695746|11733101|FG000|COMPLETED|Overall Study||96
10578001|NCT01695746|11733101|FG000|NOT COMPLETED|Overall Study||12
10578002|NCT01695772|11733106|FG000|STARTED|Overall Study||50
10578003|NCT01695772|11733106|FG000|COMPLETED|Overall Study||12
10578004|NCT01695772|11733106|FG000|NOT COMPLETED|Overall Study||38
10578005|NCT01695954|11733112|FG000|STARTED|Overall Study||18
10578006|NCT01695954|11733113|FG001|STARTED|Overall Study||16
10578007|NCT01695954|11733112|FG000|COMPLETED|Overall Study||14
10578008|NCT01695954|11733113|FG001|COMPLETED|Overall Study||14
10578009|NCT01695954|11733112|FG000|NOT COMPLETED|Overall Study||4
10578010|NCT01695954|11733113|FG001|NOT COMPLETED|Overall Study||2
10578011|NCT01695993|11733124|FG000|STARTED|Overall Study||81
10578012|NCT01695993|11733125|FG001|STARTED|Overall Study||80
10578013|NCT01695993|11733126|FG002|STARTED|Overall Study||81
10578014|NCT01695993|11733124|FG000|COMPLETED|Overall Study||76
10578015|NCT01695993|11733125|FG001|COMPLETED|Overall Study||75
10578016|NCT01695993|11733126|FG002|COMPLETED|Overall Study||75
10578017|NCT01695993|11733124|FG000|NOT COMPLETED|Overall Study||5
10578018|NCT01695993|11733125|FG001|NOT COMPLETED|Overall Study||5
10578019|NCT01695993|11733126|FG002|NOT COMPLETED|Overall Study||6
10578020|NCT01696032|11733138|FG000|STARTED|Overall Study||14
10578021|NCT01696032|11733139|FG001|STARTED|Overall Study||6
10578022|NCT01696032|11733140|FG002|STARTED|Overall Study||51
10578023|NCT01696032|11733141|FG003|STARTED|Overall Study||49
10578024|NCT01696032|11733138|FG000|COMPLETED|Overall Study||0
10578025|NCT01696032|11733139|FG001|COMPLETED|Overall Study||0
10578026|NCT01696032|11733140|FG002|COMPLETED|Overall Study||0
10578027|NCT01696032|11733141|FG003|COMPLETED|Overall Study||27
10578028|NCT01696032|11733138|FG000|NOT COMPLETED|Overall Study||14
10578029|NCT01696032|11733139|FG001|NOT COMPLETED|Overall Study||6
10578030|NCT01696032|11733140|FG002|NOT COMPLETED|Overall Study||51
10578031|NCT01696032|11733141|FG003|NOT COMPLETED|Overall Study||22
10578032|NCT01696045|11733157|FG000|STARTED|Overall Study||4
10578033|NCT01696045|11733158|FG001|STARTED|Overall Study||8
10578034|NCT01696045|11733157|FG000|COMPLETED|Overall Study||1
10578035|NCT01696045|11733158|FG001|COMPLETED|Overall Study||1
10578036|NCT01696045|11733157|FG000|NOT COMPLETED|Overall Study||3
10578037|NCT01696045|11733158|FG001|NOT COMPLETED|Overall Study||7
10578038|NCT01696058|11733166|FG000|STARTED|Overall Study||566
10578039|NCT01696058|11733167|FG001|STARTED|Overall Study||569
10578040|NCT01696058|11733166|FG000|COMPLETED|Overall Study||523
10578041|NCT01696058|11733167|FG001|COMPLETED|Overall Study||538
10578042|NCT01696058|11733166|FG000|NOT COMPLETED|Overall Study||43
10578043|NCT01696058|11733167|FG001|NOT COMPLETED|Overall Study||31
10578044|NCT01696071|11733173|FG000|STARTED|Treatment Period 1: 4 Weeks||51
10578045|NCT01696071|11733174|FG001|STARTED|Treatment Period 1: 4 Weeks||47
10578046|NCT01696071|11733173|FG000|COMPLETED|Treatment Period 1: 4 Weeks||51
10578047|NCT01696071|11733174|FG001|COMPLETED|Treatment Period 1: 4 Weeks||47
10578048|NCT01696071|11733173|FG000|NOT COMPLETED|Treatment Period 1: 4 Weeks||0
10456975|NCT01008475|11604713|FG004|Safety Analysis Set|Overall Study|1 subject randomized to EMD525797 1000 mg group received only SoC. Hence, reported under SOC group.|73
10456976|NCT01008475|11604714|FG005|Safety Analysis Set|Overall Study||72
10578049|NCT01696071|11733174|FG001|NOT COMPLETED|Treatment Period 1: 4 Weeks||0
10578050|NCT01696071|11733173|FG000|STARTED|Treatment Period 2: 4 Weeks||51
10702458|NCT02575807|11866901|FG004|STARTED|Overall Study||4
10702459|NCT02575807|11866897|FG000|Treated|Overall Study||8
10702460|NCT02575807|11866898|FG001|Treated|Overall Study||4
10702461|NCT02575807|11866899|FG002|Treated|Overall Study||16
10578051|NCT01696071|11733174|FG001|STARTED|Treatment Period 2: 4 Weeks||47
10578052|NCT01696071|11733173|FG000|COMPLETED|Treatment Period 2: 4 Weeks||50
10578053|NCT01696071|11733174|FG001|COMPLETED|Treatment Period 2: 4 Weeks||47
10578054|NCT01696071|11733173|FG000|NOT COMPLETED|Treatment Period 2: 4 Weeks||1
10578055|NCT01696071|11733174|FG001|NOT COMPLETED|Treatment Period 2: 4 Weeks||0
10578056|NCT01696084|11733183|FG000|STARTED|Overall Study||153
10578057|NCT01696084|11733184|FG001|STARTED|Overall Study||156
10578058|NCT01696084|11733183|FG000|COMPLETED|Overall Study||22
10578059|NCT01696084|11733184|FG001|COMPLETED|Overall Study||10
10578060|NCT01696084|11733183|FG000|NOT COMPLETED|Overall Study||131
10578061|NCT01696084|11733184|FG001|NOT COMPLETED|Overall Study||146
10578062|NCT01696188|11733192|FG000|STARTED|Overall Study||41
10578063|NCT01696188|11733193|FG001|STARTED|Overall Study||43
10578064|NCT01696188|11733192|FG000|COMPLETED|Overall Study||40
10578065|NCT01696188|11733193|FG001|COMPLETED|Overall Study||42
10578066|NCT01696188|11733192|FG000|NOT COMPLETED|Overall Study||1
10578067|NCT01696188|11733193|FG001|NOT COMPLETED|Overall Study||1
10578068|NCT01696214|11733203|FG000|STARTED|Overall Study||5
10578069|NCT01696214|11733204|FG001|STARTED|Overall Study||5
10578070|NCT01696214|11733205|FG002|STARTED|Overall Study||5
10702462|NCT02575807|11866900|FG003|Treated|Overall Study||1
10702463|NCT02575807|11866901|FG004|Treated|Overall Study||3
10702464|NCT02575807|11866897|FG000|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
10702465|NCT02575807|11866898|FG001|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
10702466|NCT02575807|11866899|FG002|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
10702467|NCT02575807|11866900|FG003|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
10806404|NCT03964220|11967928|FG000|NOT COMPLETED|Overall Study||0
10806405|NCT03964220|11967929|FG001|NOT COMPLETED|Overall Study||0
10806406|NCT03958955|11967935|FG000|STARTED|Overall Study||27
10578071|NCT01696214|11733206|FG003|STARTED|Overall Study||5
10578072|NCT01696214|11733203|FG000|COMPLETED|Overall Study||4
10578073|NCT01696214|11733204|FG001|COMPLETED|Overall Study||5
10578074|NCT01696214|11733205|FG002|COMPLETED|Overall Study||5
10578075|NCT01696214|11733206|FG003|COMPLETED|Overall Study||5
10578076|NCT01696214|11733203|FG000|NOT COMPLETED|Overall Study||1
10578077|NCT01696214|11733204|FG001|NOT COMPLETED|Overall Study||0
10578078|NCT01696214|11733205|FG002|NOT COMPLETED|Overall Study||0
10578079|NCT01696214|11733206|FG003|NOT COMPLETED|Overall Study||0
10651476|NCT02175979|11811663|FG001|STARTED|Overall Study||140
10651477|NCT02175979|11811662|FG000|COMPLETED|Overall Study||133
10651478|NCT02175979|11811663|FG001|COMPLETED|Overall Study||132
10651479|NCT02175979|11811662|FG000|NOT COMPLETED|Overall Study||7
10651480|NCT02175979|11811663|FG001|NOT COMPLETED|Overall Study||8
10651481|NCT02176005|11811673|FG000|STARTED|Overall Study||14
10651482|NCT02176005|11811674|FG001|STARTED|Overall Study||14
10578080|NCT01696279|11733224|FG000|STARTED|Part 1: Single Dose Lanthanum Carbonate||20
10578081|NCT01696279|11733225|FG001|STARTED|Part 1: Single Dose Lanthanum Carbonate||0
10578082|NCT01696279|11733226|FG002|STARTED|Part 1: Single Dose Lanthanum Carbonate||0
10578083|NCT01696279|11733227|FG003|STARTED|Part 1: Single Dose Lanthanum Carbonate||0
10578084|NCT01696279|11733224|FG000|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||20
10578085|NCT01696279|11733225|FG001|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||0
10578086|NCT01696279|11733226|FG002|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||0
10578087|NCT01696279|11733227|FG003|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||0
10578088|NCT01696279|11733224|FG000|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||19
10578089|NCT01696279|11733225|FG001|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||0
10578090|NCT01696279|11733226|FG002|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||0
10578091|NCT01696279|11733227|FG003|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||0
10578092|NCT01696279|11733224|FG000|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||19
10578093|NCT01696279|11733225|FG001|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
10578094|NCT01696279|11733226|FG002|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
10578095|NCT01696279|11733227|FG003|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
10578096|NCT01696279|11733224|FG000|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||1
10578097|NCT01696279|11733225|FG001|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
10578098|NCT01696279|11733226|FG002|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
10578099|NCT01696279|11733227|FG003|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
10578100|NCT01696279|11733224|FG000|STARTED|Part 2a: Calcium Carbonate + Lanthanum||0
10578101|NCT01696279|11733225|FG001|STARTED|Part 2a: Calcium Carbonate + Lanthanum|19 participants enrolled from Part 1 and 34 new participants enrolled in Part 2a|53
10578102|NCT01696279|11733226|FG002|STARTED|Part 2a: Calcium Carbonate + Lanthanum||0
10578103|NCT01696279|11733227|FG003|STARTED|Part 2a: Calcium Carbonate + Lanthanum||0
10578104|NCT01696279|11733224|FG000|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||0
10578105|NCT01696279|11733225|FG001|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||37
10578106|NCT01696279|11733226|FG002|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||0
10578107|NCT01696279|11733227|FG003|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||0
10578108|NCT01696279|11733224|FG000|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||0
10578109|NCT01696279|11733225|FG001|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||53
10578110|NCT01696279|11733226|FG002|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||0
10578111|NCT01696279|11733227|FG003|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||0
10578112|NCT01696279|11733224|FG000|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||0
10578113|NCT01696279|11733225|FG001|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||17
10578114|NCT01696279|11733226|FG002|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||0
10578115|NCT01696279|11733227|FG003|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||0
10578116|NCT01696279|11733224|FG000|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||0
10578117|NCT01696279|11733225|FG001|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||25
10578118|NCT01696279|11733226|FG002|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||0
10578119|NCT01696279|11733227|FG003|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||0
10578120|NCT01696279|11733224|FG000|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||0
10578121|NCT01696279|11733225|FG001|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||34
10578122|NCT01696279|11733226|FG002|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||0
10578123|NCT01696279|11733227|FG003|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||0
10578124|NCT01696279|11733224|FG000|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
10578125|NCT01696279|11733225|FG001|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||34
10578126|NCT01696279|11733226|FG002|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
10578127|NCT01696279|11733227|FG003|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
10578128|NCT01696279|11733224|FG000|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
10578129|NCT01696279|11733225|FG001|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||19
10578130|NCT01696279|11733226|FG002|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
10578131|NCT01696279|11733227|FG003|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
10578132|NCT01696279|11733224|FG000|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
10578133|NCT01696279|11733225|FG001|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
10578134|NCT01696279|11733226|FG002|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)|9 new participants were enrolled in Part 2b|9
10578135|NCT01696279|11733227|FG003|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
10578136|NCT01696279|11733224|FG000|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
10578137|NCT01696279|11733225|FG001|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
10578138|NCT01696279|11733226|FG002|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||9
10578139|NCT01696279|11733227|FG003|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
10578140|NCT01696279|11733224|FG000|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
10578141|NCT01696279|11733225|FG001|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
10578142|NCT01696279|11733226|FG002|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||9
10578143|NCT01696279|11733227|FG003|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
10578144|NCT01696279|11733224|FG000|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
10578145|NCT01696279|11733225|FG001|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
10578146|NCT01696279|11733226|FG002|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
10578147|NCT01696279|11733227|FG003|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
10578148|NCT01696279|11733224|FG000|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||0
10578149|NCT01696279|11733225|FG001|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||0
10578150|NCT01696279|11733226|FG002|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||9
10578151|NCT01696279|11733227|FG003|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||0
10578152|NCT01696279|11733224|FG000|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
10578153|NCT01696279|11733225|FG001|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
10578154|NCT01696279|11733226|FG002|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||8
10578155|NCT01696279|11733227|FG003|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
10578156|NCT01696279|11733224|FG000|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
10578157|NCT01696279|11733225|FG001|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
10578158|NCT01696279|11733226|FG002|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||1
10578159|NCT01696279|11733227|FG003|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
10578160|NCT01696279|11733224|FG000|STARTED|Part 3: Lanthanum Carbonate (6 Months)||0
10578161|NCT01696279|11733225|FG001|STARTED|Part 3: Lanthanum Carbonate (6 Months)||0
10578162|NCT01696279|11733226|FG002|STARTED|Part 3: Lanthanum Carbonate (6 Months)||0
10578163|NCT01696279|11733227|FG003|STARTED|Part 3: Lanthanum Carbonate (6 Months)|34 participants from Part 2a and 8 participants from Part 2b continued to Part 3|42
10578164|NCT01696279|11733224|FG000|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
10578165|NCT01696279|11733225|FG001|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
10578166|NCT01696279|11733226|FG002|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
10578167|NCT01696279|11733227|FG003|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||34
10578168|NCT01696279|11733224|FG000|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
10578169|NCT01696279|11733225|FG001|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
10578170|NCT01696279|11733226|FG002|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
10578171|NCT01696279|11733227|FG003|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||8
10578172|NCT01696357|11733238|FG000|STARTED|Overall Study||42
10578173|NCT01696357|11733239|FG001|STARTED|Overall Study||42
10578174|NCT01696357|11733238|FG000|COMPLETED|Overall Study||40
10578175|NCT01696357|11733239|FG001|COMPLETED|Overall Study||41
10578176|NCT01696357|11733238|FG000|NOT COMPLETED|Overall Study||2
10578177|NCT01696357|11733239|FG001|NOT COMPLETED|Overall Study||1
10578178|NCT01696396|11733249|FG000|STARTED|Overall Study||100
10578179|NCT01696396|11733250|FG001|STARTED|Overall Study||27
10578180|NCT01696396|11733251|FG002|STARTED|Overall Study||85
10578181|NCT01696396|11733252|FG003|STARTED|Overall Study||42
10578182|NCT01696396|11733249|FG000|Received Study Drug|Overall Study||98
10578183|NCT01696396|11733250|FG001|Received Study Drug|Overall Study||26
10578184|NCT01696396|11733251|FG002|Received Study Drug|Overall Study||84
10578185|NCT01696396|11733252|FG003|Received Study Drug|Overall Study||41
10578186|NCT01696396|11733249|FG000|Entered Open-label Period|Overall Study||84
10578187|NCT01696396|11733250|FG001|Entered Open-label Period|Overall Study||21
10578188|NCT01696396|11733251|FG002|Entered Open-label Period|Overall Study||75
10578189|NCT01696396|11733252|FG003|Entered Open-label Period|Overall Study||37
10578190|NCT01696396|11733249|FG000|COMPLETED|Overall Study||69
10578191|NCT01696396|11733250|FG001|COMPLETED|Overall Study||20
10578192|NCT01696396|11733251|FG002|COMPLETED|Overall Study||59
10702468|NCT02575807|11866901|FG004|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
10702469|NCT02575807|11866897|FG000|NOT COMPLETED|Overall Study||9
10702470|NCT02575807|11866898|FG001|NOT COMPLETED|Overall Study||4
10702471|NCT02575807|11866899|FG002|NOT COMPLETED|Overall Study||16
10702472|NCT02575807|11866900|FG003|NOT COMPLETED|Overall Study||2
10702473|NCT02575807|11866901|FG004|NOT COMPLETED|Overall Study||4
10702474|NCT02575833|11866917|FG000|STARTED|Overall Study||44
10702475|NCT02575833|11866918|FG001|STARTED|Overall Study||45
10702476|NCT02575833|11866917|FG000|Received Study Drug|Overall Study||44
10702477|NCT02575833|11866918|FG001|Received Study Drug|Overall Study||44
10702478|NCT02575833|11866917|FG000|COMPLETED|Overall Study||43
10702479|NCT02575833|11866918|FG001|COMPLETED|Overall Study||44
10702480|NCT02575833|11866917|FG000|NOT COMPLETED|Overall Study||1
10702481|NCT02575833|11866918|FG001|NOT COMPLETED|Overall Study||1
10702482|NCT02575911|11866924|FG000|STARTED|Overall Study||30
10578193|NCT01696396|11733252|FG003|COMPLETED|Overall Study||28
10578194|NCT01696396|11733249|FG000|NOT COMPLETED|Overall Study||31
10578195|NCT01696396|11733250|FG001|NOT COMPLETED|Overall Study||7
10578196|NCT01696396|11733251|FG002|NOT COMPLETED|Overall Study||26
10578197|NCT01696396|11733252|FG003|NOT COMPLETED|Overall Study||14
10578198|NCT01696643|11733268|FG000|STARTED|Overall Study||703
10578199|NCT01696643|11733269|FG001|STARTED|Overall Study||704
10578200|NCT01696643|11733268|FG000|Received at Least 1 Dose of Study Drug|Overall Study||701
10578201|NCT01696643|11733269|FG001|Received at Least 1 Dose of Study Drug|Overall Study|2 participants randomized to placebo took CB-5945. Their results are included in the CB-5945 group.|702
10578202|NCT01696643|11733268|FG000|COMPLETED|Overall Study||174
10578203|NCT01696643|11733269|FG001|COMPLETED|Overall Study||169
10578204|NCT01696643|11733268|FG000|NOT COMPLETED|Overall Study||529
10578205|NCT01696643|11733269|FG001|NOT COMPLETED|Overall Study||535
10578206|NCT01696695|11733275|FG000|STARTED|Overall Study||882
10578207|NCT01696695|11733275|FG000|COMPLETED|Overall Study||0
10578208|NCT01696695|11733275|FG000|NOT COMPLETED|Overall Study||882
10702483|NCT02575911|11866924|FG000|COMPLETED|Overall Study||29
10702484|NCT02575911|11866924|FG000|NOT COMPLETED|Overall Study||1
10702485|NCT02575950|11866936|FG000|STARTED|Overall Study||3
10702486|NCT02575950|11866937|FG001|STARTED|Overall Study||6
10702487|NCT02575950|11866938|FG002|STARTED|Overall Study||6
10578209|NCT01696760|11733281|FG000|STARTED|Overall Study||9
10578210|NCT01696760|11733282|FG001|STARTED|Overall Study||3
10578211|NCT01696760|11733281|FG000|COMPLETED|Overall Study||9
10578212|NCT01696760|11733282|FG001|COMPLETED|Overall Study||3
10578213|NCT01696760|11733281|FG000|NOT COMPLETED|Overall Study||0
10578214|NCT01696760|11733282|FG001|NOT COMPLETED|Overall Study||0
10578215|NCT01696773|11733290|FG000|STARTED|Days 1-13, Washout||6
10578216|NCT01696773|11733291|FG001|STARTED|Days 1-13, Washout||6
10578217|NCT01696773|11733290|FG000|COMPLETED|Days 1-13, Washout||6
10578218|NCT01696773|11733291|FG001|COMPLETED|Days 1-13, Washout||6
10578219|NCT01696773|11733290|FG000|NOT COMPLETED|Days 1-13, Washout||0
10578220|NCT01696773|11733291|FG001|NOT COMPLETED|Days 1-13, Washout||0
10578221|NCT01696773|11733290|FG000|STARTED|Day 14, First Intervention||6
10578222|NCT01696773|11733291|FG001|STARTED|Day 14, First Intervention||6
10578223|NCT01696773|11733290|FG000|COMPLETED|Day 14, First Intervention||6
10578224|NCT01696773|11733291|FG001|COMPLETED|Day 14, First Intervention||6
10578225|NCT01696773|11733290|FG000|NOT COMPLETED|Day 14, First Intervention||0
10578226|NCT01696773|11733291|FG001|NOT COMPLETED|Day 14, First Intervention||0
10578227|NCT01696773|11733290|FG000|STARTED|Days 15-27, Washout||6
10578228|NCT01696773|11733291|FG001|STARTED|Days 15-27, Washout||6
10578229|NCT01696773|11733290|FG000|COMPLETED|Days 15-27, Washout||5
10578230|NCT01696773|11733291|FG001|COMPLETED|Days 15-27, Washout||6
10578231|NCT01696773|11733290|FG000|NOT COMPLETED|Days 15-27, Washout||1
10578232|NCT01696773|11733291|FG001|NOT COMPLETED|Days 15-27, Washout||0
10578233|NCT01696773|11733290|FG000|STARTED|Day 28, Second Intervention||5
10578234|NCT01696773|11733291|FG001|STARTED|Day 28, Second Intervention||6
10578235|NCT01696773|11733290|FG000|COMPLETED|Day 28, Second Intervention||5
10578236|NCT01696773|11733291|FG001|COMPLETED|Day 28, Second Intervention||6
10578237|NCT01696773|11733290|FG000|NOT COMPLETED|Day 28, Second Intervention||0
10578238|NCT01696773|11733291|FG001|NOT COMPLETED|Day 28, Second Intervention||0
10578239|NCT01696877|11733299|FG000|STARTED|Overall Study||15
10578240|NCT01696877|11733300|FG001|STARTED|Overall Study||14
10578241|NCT01696877|11733299|FG000|COMPLETED|Overall Study||15
10578242|NCT01696877|11733300|FG001|COMPLETED|Overall Study||13
10578243|NCT01696877|11733299|FG000|NOT COMPLETED|Overall Study||0
10578244|NCT01696877|11733300|FG001|NOT COMPLETED|Overall Study||1
10578245|NCT01696929|11733308|FG000|STARTED|Overall Study||6
10578246|NCT01696929|11733308|FG000|COMPLETED|Overall Study||5
10578247|NCT01696929|11733308|FG000|NOT COMPLETED|Overall Study||1
10578248|NCT01696942|11733314|FG000|STARTED|Overall Study||5
10578249|NCT01696942|11733315|FG001|STARTED|Overall Study||5
10578250|NCT01696942|11733314|FG000|COMPLETED|Overall Study||3
10578251|NCT01696942|11733315|FG001|COMPLETED|Overall Study||2
10578252|NCT01696942|11733314|FG000|NOT COMPLETED|Overall Study||2
10578253|NCT01696942|11733315|FG001|NOT COMPLETED|Overall Study||3
10578254|NCT01696955|11733323|FG000|STARTED|Main Study||42
10578255|NCT01696955|11733324|FG001|STARTED|Main Study||39
10578256|NCT01696955|11733323|FG000|COMPLETED|Main Study||40
10578257|NCT01696955|11733324|FG001|COMPLETED|Main Study||38
10578258|NCT01696955|11733323|FG000|NOT COMPLETED|Main Study||2
10578259|NCT01696955|11733324|FG001|NOT COMPLETED|Main Study||1
10578260|NCT01696955|11733323|FG000|STARTED|Failure on Cetuximab-Received Tivantinib||0
10578261|NCT01696955|11733324|FG001|STARTED|Failure on Cetuximab-Received Tivantinib||15
10578262|NCT01696955|11733323|FG000|COMPLETED|Failure on Cetuximab-Received Tivantinib||0
10578263|NCT01696955|11733324|FG001|COMPLETED|Failure on Cetuximab-Received Tivantinib|23 patients did not cross over|15
10578264|NCT01696955|11733323|FG000|NOT COMPLETED|Failure on Cetuximab-Received Tivantinib||0
10578265|NCT01696955|11733324|FG001|NOT COMPLETED|Failure on Cetuximab-Received Tivantinib||0
10578266|NCT01697319|11733337|FG000|STARTED|Primary Phase|One subject enrolled but did not receive a single dose of study drug|16
10578267|NCT01697319|11733337|FG000|COMPLETED|Primary Phase||15
10578268|NCT01697319|11733337|FG000|NOT COMPLETED|Primary Phase||1
10578269|NCT01697319|11733337|FG000|STARTED|Extension Phase||15
10578270|NCT01697319|11733337|FG000|COMPLETED|Extension Phase||0
10578271|NCT01697319|11733337|FG000|NOT COMPLETED|Extension Phase||15
10578272|NCT01697345|11733341|FG000|STARTED|Overall Study||13
10578273|NCT01697345|11733341|FG000|COMPLETED|Overall Study|One patient withdrew due to symptoms of recurrent Gardnerella vaginalis.|12
10578274|NCT01697345|11733341|FG000|NOT COMPLETED|Overall Study||1
10578275|NCT01697358|11733362|FG000|STARTED|Period I: Randomization to 6 Months||110
10578276|NCT01697358|11733363|FG001|STARTED|Period I: Randomization to 6 Months||108
10578277|NCT01697358|11733362|FG000|COMPLETED|Period I: Randomization to 6 Months||97
10578278|NCT01697358|11733363|FG001|COMPLETED|Period I: Randomization to 6 Months||107
10578279|NCT01697358|11733362|FG000|NOT COMPLETED|Period I: Randomization to 6 Months||13
10578280|NCT01697358|11733363|FG001|NOT COMPLETED|Period I: Randomization to 6 Months||1
10578281|NCT01697358|11733362|FG000|STARTED|Period II: 6-24M Long-term Follow-up||97
10578282|NCT01697358|11733363|FG001|STARTED|Period II: 6-24M Long-term Follow-up||107
10578283|NCT01697358|11733362|FG000|COMPLETED|Period II: 6-24M Long-term Follow-up||48
10578284|NCT01697358|11733363|FG001|COMPLETED|Period II: 6-24M Long-term Follow-up||52
10578285|NCT01697358|11733362|FG000|NOT COMPLETED|Period II: 6-24M Long-term Follow-up||49
10578286|NCT01697358|11733363|FG001|NOT COMPLETED|Period II: 6-24M Long-term Follow-up||55
10578287|NCT01697449|11733369|FG000|STARTED|Overall Study||191
10578288|NCT01697449|11733369|FG000|COMPLETED|Overall Study||101
10578289|NCT01697449|11733369|FG000|NOT COMPLETED|Overall Study||90
10578290|NCT01697462|11733376|FG000|STARTED|Overall Study||258
10578291|NCT01697462|11733376|FG000|COMPLETED|Overall Study||181
10578292|NCT01697462|11733376|FG000|NOT COMPLETED|Overall Study||77
10578293|NCT01697501|11733380|FG000|STARTED|Overall Study||88
10578294|NCT01697501|11733380|FG000|COMPLETED|Overall Study||86
10578295|NCT01697501|11733380|FG000|NOT COMPLETED|Overall Study||2
10578296|NCT01697579|11733398|FG000|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|74
10578297|NCT01697579|11733399|FG001|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|43
10578298|NCT01697579|11733400|FG002|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|44
10578299|NCT01697579|11733401|FG003|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|41
10578300|NCT01697579|11733402|FG004|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|38
10578301|NCT01697579|11733403|FG005|STARTED|Base Study-Cycle 1|Enrollment in Cycles 2-6 was optional.|0
10578302|NCT01697579|11733404|FG006|STARTED|Base Study-Cycle 1|Enrollment in Cycles 2-6 was optional.|0
10578303|NCT01697579|11733398|FG000|COMPLETED|Base Study-Cycle 1||72
10578304|NCT01697579|11733399|FG001|COMPLETED|Base Study-Cycle 1||42
10578305|NCT01697579|11733400|FG002|COMPLETED|Base Study-Cycle 1||43
10578306|NCT01697579|11733401|FG003|COMPLETED|Base Study-Cycle 1||40
10578307|NCT01697579|11733402|FG004|COMPLETED|Base Study-Cycle 1||35
10578308|NCT01697579|11733403|FG005|COMPLETED|Base Study-Cycle 1||0
10578309|NCT01697579|11733404|FG006|COMPLETED|Base Study-Cycle 1||0
10578310|NCT01697579|11733398|FG000|NOT COMPLETED|Base Study-Cycle 1||2
10578311|NCT01697579|11733399|FG001|NOT COMPLETED|Base Study-Cycle 1||1
10578312|NCT01697579|11733400|FG002|NOT COMPLETED|Base Study-Cycle 1||1
10578313|NCT01697579|11733401|FG003|NOT COMPLETED|Base Study-Cycle 1||1
10578314|NCT01697579|11733402|FG004|NOT COMPLETED|Base Study-Cycle 1||3
10578315|NCT01697579|11733403|FG005|NOT COMPLETED|Base Study-Cycle 1||0
10578316|NCT01697579|11733404|FG006|NOT COMPLETED|Base Study-Cycle 1||0
10578317|NCT01697579|11733398|FG000|STARTED|Optional Extension-Cycles 2-6|47 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 5 mg/kg|0
10578318|NCT01697579|11733399|FG001|STARTED|Optional Extension-Cycles 2-6|33 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
10578319|NCT01697579|11733400|FG002|STARTED|Optional Extension-Cycles 2-6|25 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
10578320|NCT01697579|11733401|FG003|STARTED|Optional Extension-Cycles 2-6|27 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
10578321|NCT01697579|11733402|FG004|STARTED|Optional Extension-Cycles 2-6|21 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
10578322|NCT01697579|11733403|FG005|STARTED|Optional Extension-Cycles 2-6|Enrollment in Cycles 2-6 was optional.|47
10578323|NCT01697579|11733404|FG006|STARTED|Optional Extension-Cycles 2-6|Enrollment in Cycles 2-6 was optional.|106
10578324|NCT01697579|11733398|FG000|COMPLETED|Optional Extension-Cycles 2-6||0
10578325|NCT01697579|11733399|FG001|COMPLETED|Optional Extension-Cycles 2-6||0
10578326|NCT01697579|11733400|FG002|COMPLETED|Optional Extension-Cycles 2-6||0
10578327|NCT01697579|11733401|FG003|COMPLETED|Optional Extension-Cycles 2-6||0
10578328|NCT01697579|11733402|FG004|COMPLETED|Optional Extension-Cycles 2-6||0
10578329|NCT01697579|11733403|FG005|COMPLETED|Optional Extension-Cycles 2-6||12
10578330|NCT01697579|11733404|FG006|COMPLETED|Optional Extension-Cycles 2-6||37
10578331|NCT01697579|11733398|FG000|NOT COMPLETED|Optional Extension-Cycles 2-6||0
10578332|NCT01697579|11733399|FG001|NOT COMPLETED|Optional Extension-Cycles 2-6||0
10578333|NCT01697579|11733400|FG002|NOT COMPLETED|Optional Extension-Cycles 2-6||0
10578334|NCT01697579|11733401|FG003|NOT COMPLETED|Optional Extension-Cycles 2-6||0
10578335|NCT01697579|11733402|FG004|NOT COMPLETED|Optional Extension-Cycles 2-6||0
10578336|NCT01697579|11733403|FG005|NOT COMPLETED|Optional Extension-Cycles 2-6||35
10578337|NCT01697579|11733404|FG006|NOT COMPLETED|Optional Extension-Cycles 2-6||69
10578338|NCT01697592|11733442|FG000|STARTED|Phase A (Up to 24 Weeks)||126
10578339|NCT01697592|11733443|FG001|STARTED|Phase A (Up to 24 Weeks)||65
10578340|NCT01697592|11733444|FG002|STARTED|Phase A (Up to 24 Weeks)||66
10578341|NCT01697592|11733445|FG003|STARTED|Phase A (Up to 24 Weeks)||65
10702488|NCT02575950|11866939|FG003|STARTED|Overall Study||25
10578342|NCT01697592|11733446|FG004|STARTED|Phase A (Up to 24 Weeks)||67
10578343|NCT01697592|11733447|FG005|STARTED|Phase A (Up to 24 Weeks)||63
10578344|NCT01697592|11733448|FG006|STARTED|Phase A (Up to 24 Weeks)||34
10578345|NCT01697592|11733449|FG007|STARTED|Phase A (Up to 24 Weeks)||33
10578346|NCT01697592|11733450|FG008|STARTED|Phase A (Up to 24 Weeks)||34
10578347|NCT01697592|11733451|FG009|STARTED|Phase A (Up to 24 Weeks)||32
10578348|NCT01697592|11733442|FG000|COMPLETED|Phase A (Up to 24 Weeks)||123
10578349|NCT01697592|11733443|FG001|COMPLETED|Phase A (Up to 24 Weeks)||62
10578350|NCT01697592|11733444|FG002|COMPLETED|Phase A (Up to 24 Weeks)||65
10578351|NCT01697592|11733445|FG003|COMPLETED|Phase A (Up to 24 Weeks)||63
10578352|NCT01697592|11733446|FG004|COMPLETED|Phase A (Up to 24 Weeks)||67
10578353|NCT01697592|11733447|FG005|COMPLETED|Phase A (Up to 24 Weeks)||62
10578354|NCT01697592|11733448|FG006|COMPLETED|Phase A (Up to 24 Weeks)||32
10578355|NCT01697592|11733449|FG007|COMPLETED|Phase A (Up to 24 Weeks)||33
10578356|NCT01697592|11733450|FG008|COMPLETED|Phase A (Up to 24 Weeks)||34
10578357|NCT01697592|11733451|FG009|COMPLETED|Phase A (Up to 24 Weeks)||30
10578358|NCT01697592|11733442|FG000|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
10578359|NCT01697592|11733443|FG001|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
10578360|NCT01697592|11733444|FG002|NOT COMPLETED|Phase A (Up to 24 Weeks)||1
10578361|NCT01697592|11733445|FG003|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
10578362|NCT01697592|11733446|FG004|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
10578363|NCT01697592|11733447|FG005|NOT COMPLETED|Phase A (Up to 24 Weeks)||1
10578364|NCT01697592|11733448|FG006|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
10578365|NCT01697592|11733449|FG007|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
10578366|NCT01697592|11733450|FG008|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
10578367|NCT01697592|11733451|FG009|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
10578368|NCT01697592|11733442|FG000|STARTED|Phase B (Week 25 to Week 52)||123
10578369|NCT01697592|11733443|FG001|STARTED|Phase B (Week 25 to Week 52)||62
10578370|NCT01697592|11733444|FG002|STARTED|Phase B (Week 25 to Week 52)||65
10578371|NCT01697592|11733445|FG003|STARTED|Phase B (Week 25 to Week 52)||63
10578372|NCT01697592|11733446|FG004|STARTED|Phase B (Week 25 to Week 52)||67
10578373|NCT01697592|11733447|FG005|STARTED|Phase B (Week 25 to Week 52)||62
10578374|NCT01697592|11733448|FG006|STARTED|Phase B (Week 25 to Week 52)||32
10578375|NCT01697592|11733449|FG007|STARTED|Phase B (Week 25 to Week 52)||33
10578376|NCT01697592|11733450|FG008|STARTED|Phase B (Week 25 to Week 52)||34
10578377|NCT01697592|11733451|FG009|STARTED|Phase B (Week 25 to Week 52)||30
10578378|NCT01697592|11733442|FG000|COMPLETED|Phase B (Week 25 to Week 52)||118
10578379|NCT01697592|11733443|FG001|COMPLETED|Phase B (Week 25 to Week 52)||61
10578380|NCT01697592|11733444|FG002|COMPLETED|Phase B (Week 25 to Week 52)||64
10578381|NCT01697592|11733445|FG003|COMPLETED|Phase B (Week 25 to Week 52)||60
10578382|NCT01697592|11733446|FG004|COMPLETED|Phase B (Week 25 to Week 52)||67
10578383|NCT01697592|11733447|FG005|COMPLETED|Phase B (Week 25 to Week 52)||60
10578384|NCT01697592|11733448|FG006|COMPLETED|Phase B (Week 25 to Week 52)||31
10578385|NCT01697592|11733449|FG007|COMPLETED|Phase B (Week 25 to Week 52)||32
10578386|NCT01697592|11733450|FG008|COMPLETED|Phase B (Week 25 to Week 52)||32
10578387|NCT01697592|11733451|FG009|COMPLETED|Phase B (Week 25 to Week 52)||30
10578388|NCT01697592|11733442|FG000|NOT COMPLETED|Phase B (Week 25 to Week 52)||5
10578389|NCT01697592|11733443|FG001|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
10578390|NCT01697592|11733444|FG002|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
10578391|NCT01697592|11733445|FG003|NOT COMPLETED|Phase B (Week 25 to Week 52)||3
10578392|NCT01697592|11733446|FG004|NOT COMPLETED|Phase B (Week 25 to Week 52)||0
10578393|NCT01697592|11733447|FG005|NOT COMPLETED|Phase B (Week 25 to Week 52)||2
10578394|NCT01697592|11733448|FG006|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
10578395|NCT01697592|11733449|FG007|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
10578396|NCT01697592|11733450|FG008|NOT COMPLETED|Phase B (Week 25 to Week 52)||2
10578397|NCT01697592|11733451|FG009|NOT COMPLETED|Phase B (Week 25 to Week 52)||0
10578398|NCT01697696|11733489|FG000|STARTED|Overall Study||254
10578399|NCT01697696|11733490|FG001|STARTED|Overall Study||257
10578400|NCT01697696|11733489|FG000|Safety Set|Overall Study||251
10578401|NCT01697696|11733490|FG001|Safety Set|Overall Study|Safety set included a patient that was treated, but not randomized|256
10578402|NCT01697696|11733489|FG000|Full Analysis Set (FAS)|Overall Study||251
10578403|NCT01697696|11733490|FG001|Full Analysis Set (FAS)|Overall Study||255
10578404|NCT01697696|11733489|FG000|COMPLETED|Overall Study||207
10578405|NCT01697696|11733490|FG001|COMPLETED|Overall Study||210
10578406|NCT01697696|11733489|FG000|NOT COMPLETED|Overall Study||47
10578407|NCT01697696|11733490|FG001|NOT COMPLETED|Overall Study||47
10578408|NCT01697709|11733498|FG000|STARTED|Overall Study||64
10578409|NCT01697709|11733499|FG001|STARTED|Overall Study||66
10578410|NCT01697709|11733498|FG000|COMPLETED|Overall Study||34
10578411|NCT01697709|11733499|FG001|COMPLETED|Overall Study||38
10578412|NCT01697709|11733498|FG000|NOT COMPLETED|Overall Study||30
10702489|NCT02575950|11866936|FG000|COMPLETED|Overall Study||3
10702490|NCT02575950|11866937|FG001|COMPLETED|Overall Study||5
10702491|NCT02575950|11866938|FG002|COMPLETED|Overall Study||6
10702492|NCT02575950|11866939|FG003|COMPLETED|Overall Study||20
10702493|NCT02575950|11866936|FG000|NOT COMPLETED|Overall Study||0
10702494|NCT02575950|11866937|FG001|NOT COMPLETED|Overall Study||1
10702495|NCT02575950|11866938|FG002|NOT COMPLETED|Overall Study||0
10702496|NCT02575950|11866939|FG003|NOT COMPLETED|Overall Study||5
10702497|NCT02576041|11866947|FG000|STARTED|Placebo (run-in)||18
10702498|NCT02576041|11866947|FG000|COMPLETED|Placebo (run-in)||18
10702499|NCT02576041|11866947|FG000|NOT COMPLETED|Placebo (run-in)||0
10702500|NCT02576041|11866947|FG000|STARTED|Bilastine (Active Treatement)||18
10702501|NCT02576041|11866947|FG000|COMPLETED|Bilastine (Active Treatement)||18
10702502|NCT02576041|11866947|FG000|NOT COMPLETED|Bilastine (Active Treatement)||0
10702503|NCT02576054|11866951|FG000|STARTED|Overall Study||101
10578413|NCT01697709|11733499|FG001|NOT COMPLETED|Overall Study||28
10578414|NCT01697748|11733507|FG000|STARTED|Overall Study||329
10578415|NCT01697748|11733508|FG001|STARTED|Overall Study||328
10578416|NCT01697748|11733507|FG000|COMPLETED|Overall Study||271
10578417|NCT01697748|11733508|FG001|COMPLETED|Overall Study||260
10578418|NCT01697748|11733507|FG000|NOT COMPLETED|Overall Study||58
10578419|NCT01697748|11733508|FG001|NOT COMPLETED|Overall Study||68
10578420|NCT01697956|11733516|FG000|STARTED|Overall Study|enrolled and randomized|67
10578421|NCT01697956|11733517|FG001|STARTED|Overall Study|enrolled and randomized|32
10578422|NCT01697956|11733516|FG000|Per Protocol Population|Overall Study||66
10578423|NCT01697956|11733517|FG001|Per Protocol Population|Overall Study||31
10578424|NCT01697956|11733516|FG000|COMPLETED|Overall Study||66
10578425|NCT01697956|11733517|FG001|COMPLETED|Overall Study||31
10578426|NCT01697956|11733516|FG000|NOT COMPLETED|Overall Study||1
10578427|NCT01697956|11733517|FG001|NOT COMPLETED|Overall Study||1
10578428|NCT01697969|11733529|FG000|STARTED|Overall Study||13
10578429|NCT01697969|11733529|FG000|COMPLETED|Overall Study||10
10702504|NCT02576054|11866951|FG000|Vaccination 1|Overall Study||100
10702505|NCT02576054|11866951|FG000|Vaccination 2|Overall Study||100
10702506|NCT02576054|11866951|FG000|Vaccination 3|Overall Study||100
10702507|NCT02576054|11866951|FG000|COMPLETED|Overall Study||100
10578430|NCT01697969|11733529|FG000|NOT COMPLETED|Overall Study||3
10578431|NCT01698008|11733536|FG000|STARTED|Overall Study||3
10578432|NCT01698008|11733537|FG001|STARTED|Overall Study||2
10578433|NCT01698008|11733536|FG000|COMPLETED|Overall Study||2
10578434|NCT01698008|11733537|FG001|COMPLETED|Overall Study||0
10578435|NCT01698008|11733536|FG000|NOT COMPLETED|Overall Study||1
10578436|NCT01698008|11733537|FG001|NOT COMPLETED|Overall Study||2
10578437|NCT01698268|11733545|FG000|STARTED|Overall Study||25
10578438|NCT01698268|11733546|FG001|STARTED|Overall Study||25
10578439|NCT01698268|11733545|FG000|COMPLETED|Overall Study||23
10578440|NCT01698268|11733546|FG001|COMPLETED|Overall Study||24
10578441|NCT01698268|11733545|FG000|NOT COMPLETED|Overall Study||2
10702508|NCT02576054|11866951|FG000|NOT COMPLETED|Overall Study||1
10702509|NCT02576067|11866959|FG000|STARTED|Overall Study||60
10702510|NCT02576067|11866960|FG001|STARTED|Overall Study||63
10702511|NCT02576067|11866959|FG000|COMPLETED|Overall Study||26
10702512|NCT02576067|11866960|FG001|COMPLETED|Overall Study||27
10702513|NCT02576067|11866959|FG000|NOT COMPLETED|Overall Study||34
10578442|NCT01698268|11733546|FG001|NOT COMPLETED|Overall Study||1
10578443|NCT01698320|11733554|FG000|STARTED|Run-In Period (Week -1 to Day 0)||364
10578444|NCT01698320|11733555|FG001|STARTED|Run-In Period (Week -1 to Day 0)||0
10578445|NCT01698320|11733556|FG002|STARTED|Run-In Period (Week -1 to Day 0)||0
10578446|NCT01698320|11733554|FG000|COMPLETED|Run-In Period (Week -1 to Day 0)||337
10578447|NCT01698320|11733555|FG001|COMPLETED|Run-In Period (Week -1 to Day 0)||0
10578448|NCT01698320|11733556|FG002|COMPLETED|Run-In Period (Week -1 to Day 0)||0
10578449|NCT01698320|11733554|FG000|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||27
10578450|NCT01698320|11733555|FG001|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||0
10578451|NCT01698320|11733556|FG002|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||0
10578452|NCT01698320|11733554|FG000|STARTED|12-Week Double-Blind Period||0
10578453|NCT01698320|11733555|FG001|STARTED|12-Week Double-Blind Period||169
10702514|NCT02576067|11866960|FG001|NOT COMPLETED|Overall Study||36
10702515|NCT02576145|11866968|FG000|STARTED|Overall Study||6
10702516|NCT02576145|11866969|FG001|STARTED|Overall Study||5
10806407|NCT03958955|11967935|FG000|Lesions Treated With Delgocitinib Cream|Overall Study||27
10578454|NCT01698320|11733556|FG002|STARTED|12-Week Double-Blind Period||168
10578455|NCT01698320|11733554|FG000|Safety Population|12-Week Double-Blind Period||0
10578456|NCT01698320|11733555|FG001|Safety Population|12-Week Double-Blind Period|One participant took both placebo and albuterol so is counted in both treatment groups for safety.|170
10578457|NCT01698320|11733556|FG002|Safety Population|12-Week Double-Blind Period||168
10578458|NCT01698320|11733554|FG000|COMPLETED|12-Week Double-Blind Period||0
10578459|NCT01698320|11733555|FG001|COMPLETED|12-Week Double-Blind Period||165
10578460|NCT01698320|11733556|FG002|COMPLETED|12-Week Double-Blind Period||156
10578461|NCT01698320|11733554|FG000|NOT COMPLETED|12-Week Double-Blind Period||0
10578462|NCT01698320|11733555|FG001|NOT COMPLETED|12-Week Double-Blind Period||4
10578463|NCT01698320|11733556|FG002|NOT COMPLETED|12-Week Double-Blind Period||12
10578464|NCT01698320|11733554|FG000|STARTED|40-Week Open-Label Period||0
10578465|NCT01698320|11733555|FG001|STARTED|40-Week Open-Label Period||165
10578466|NCT01698320|11733556|FG002|STARTED|40-Week Open-Label Period||156
10578467|NCT01698320|11733554|FG000|COMPLETED|40-Week Open-Label Period||0
10578468|NCT01698320|11733555|FG001|COMPLETED|40-Week Open-Label Period||146
10578469|NCT01698320|11733556|FG002|COMPLETED|40-Week Open-Label Period||146
10578470|NCT01698320|11733554|FG000|NOT COMPLETED|40-Week Open-Label Period||0
10578471|NCT01698320|11733555|FG001|NOT COMPLETED|40-Week Open-Label Period||19
10578472|NCT01698320|11733556|FG002|NOT COMPLETED|40-Week Open-Label Period||10
10578473|NCT01698333|11733564|FG000|STARTED|Overall Study||25
10578474|NCT01698333|11733564|FG000|COMPLETED|Overall Study||25
10578475|NCT01698333|11733564|FG000|NOT COMPLETED|Overall Study||0
10578476|NCT01698463|11733568|FG000|STARTED|Overall Study||11
10578477|NCT01698463|11733568|FG000|COMPLETED|Overall Study||11
10578478|NCT01698463|11733568|FG000|NOT COMPLETED|Overall Study||0
10578479|NCT01698502|11733574|FG000|STARTED|Overall Study||11
10578480|NCT01698502|11733575|FG001|STARTED|Overall Study||10
10578481|NCT01698502|11733574|FG000|COMPLETED|Overall Study||11
10578482|NCT01698502|11733575|FG001|COMPLETED|Overall Study||10
10578483|NCT01698502|11733574|FG000|NOT COMPLETED|Overall Study||0
10578484|NCT01698502|11733575|FG001|NOT COMPLETED|Overall Study||0
10578485|NCT01698528|11733583|FG000|STARTED|Overall Study||20
10578486|NCT01698528|11733584|FG001|STARTED|Overall Study||20
10578487|NCT01698528|11733583|FG000|COMPLETED|Overall Study||19
10578488|NCT01698528|11733584|FG001|COMPLETED|Overall Study||16
10578489|NCT01698528|11733583|FG000|NOT COMPLETED|Overall Study||1
10578490|NCT01698528|11733584|FG001|NOT COMPLETED|Overall Study||4
10702517|NCT02576145|11866968|FG000|COMPLETED|Overall Study||3
10702518|NCT02576145|11866969|FG001|COMPLETED|Overall Study||4
10806408|NCT03958955|11967935|FG000|Lesions Treated With Delgocitinib Cream Vehicle|Overall Study||27
10806409|NCT03958955|11967935|FG000|COMPLETED|Overall Study||26
10806410|NCT03958955|11967935|FG000|NOT COMPLETED|Overall Study||1
10806411|NCT03965052|11967943|FG000|STARTED|Overall Study||12
10806412|NCT03965052|11967944|FG001|STARTED|Overall Study||12
10806413|NCT03965052|11967943|FG000|COMPLETED|Overall Study||11
10806414|NCT03965052|11967944|FG001|COMPLETED|Overall Study||12
10578491|NCT01698554|11733594|FG000|STARTED|Overall Study||153
10578492|NCT01698554|11733595|FG001|STARTED|Overall Study||157
10578493|NCT01698554|11733596|FG002|STARTED|Overall Study||75
10578494|NCT01698554|11733597|FG003|STARTED|Overall Study||79
10578495|NCT01698554|11733594|FG000|COMPLETED|Overall Study||147
10578496|NCT01698554|11733595|FG001|COMPLETED|Overall Study||147
10806415|NCT03965052|11967943|FG000|NOT COMPLETED|Overall Study||1
10806416|NCT03965052|11967944|FG001|NOT COMPLETED|Overall Study||0
10806417|NCT03965039|11967954|FG000|STARTED|Overall Study||30
10806418|NCT03965039|11967955|FG001|STARTED|Overall Study||30
10806419|NCT03965039|11967956|FG002|STARTED|Overall Study||30
10806420|NCT03965039|11967957|FG003|STARTED|Overall Study||30
10702519|NCT02576145|11866968|FG000|NOT COMPLETED|Overall Study||3
10702520|NCT02576145|11866969|FG001|NOT COMPLETED|Overall Study||1
10702521|NCT02576249|11866977|FG000|STARTED|Overall Study||15
10702522|NCT02576249|11866978|FG001|STARTED|Overall Study||14
10702523|NCT02576249|11866977|FG000|COMPLETED|Overall Study||15
10702524|NCT02576249|11866978|FG001|COMPLETED|Overall Study||14
10702525|NCT02576249|11866977|FG000|NOT COMPLETED|Overall Study||0
10702526|NCT02576249|11866978|FG001|NOT COMPLETED|Overall Study||0
10702527|NCT02576535|11866984|FG000|STARTED|Overall Study||18
10702528|NCT02576535|11866984|FG000|COMPLETED|Overall Study||16
10806421|NCT03965039|11967954|FG000|COMPLETED|Overall Study||30
10806422|NCT03965039|11967955|FG001|COMPLETED|Overall Study||29
10578497|NCT01698554|11733596|FG002|COMPLETED|Overall Study||73
10578498|NCT01698554|11733597|FG003|COMPLETED|Overall Study||77
10578499|NCT01698554|11733594|FG000|NOT COMPLETED|Overall Study||6
10578500|NCT01698554|11733595|FG001|NOT COMPLETED|Overall Study||10
10578501|NCT01698554|11733596|FG002|NOT COMPLETED|Overall Study||2
10578502|NCT01698554|11733597|FG003|NOT COMPLETED|Overall Study||2
10578503|NCT01698684|11733610|FG000|STARTED|Overall Study||145
10578504|NCT01698684|11733611|FG001|STARTED|Overall Study||147
10578505|NCT01698684|11733612|FG002|STARTED|Overall Study||148
10578506|NCT01698684|11733610|FG000|ITT Population|Overall Study||136
10578507|NCT01698684|11733611|FG001|ITT Population|Overall Study||139
10578508|NCT01698684|11733612|FG002|ITT Population|Overall Study||139
10578509|NCT01698684|11733610|FG000|Safety Population|Overall Study||143
10578510|NCT01698684|11733611|FG001|Safety Population|Overall Study||146
10578511|NCT01698684|11733612|FG002|Safety Population|Overall Study||146
10578512|NCT01698684|11733610|FG000|COMPLETED|Overall Study||116
10578513|NCT01698684|11733611|FG001|COMPLETED|Overall Study||124
10578514|NCT01698684|11733612|FG002|COMPLETED|Overall Study||127
10578515|NCT01698684|11733610|FG000|NOT COMPLETED|Overall Study||29
10578516|NCT01698684|11733611|FG001|NOT COMPLETED|Overall Study||23
10578517|NCT01698684|11733612|FG002|NOT COMPLETED|Overall Study||21
10578518|NCT01698710|11733620|FG000|STARTED|Overall Study||5
10578519|NCT01698710|11733620|FG000|COMPLETED|Overall Study||5
10578520|NCT01698710|11733620|FG000|NOT COMPLETED|Overall Study||0
10578521|NCT01698775|11733626|FG000|STARTED|Phase A||107
10578522|NCT01698775|11733627|FG001|STARTED|Phase A||106
10578523|NCT01698775|11733626|FG000|COMPLETED|Phase A||98
10578524|NCT01698775|11733627|FG001|COMPLETED|Phase A||97
10578525|NCT01698775|11733626|FG000|NOT COMPLETED|Phase A||9
10578526|NCT01698775|11733627|FG001|NOT COMPLETED|Phase A||9
10578527|NCT01698775|11733626|FG000|STARTED|Phase B||98
10578528|NCT01698775|11733627|FG001|STARTED|Phase B||97
10578529|NCT01698775|11733626|FG000|COMPLETED|Phase B||84
10578530|NCT01698775|11733627|FG001|COMPLETED|Phase B||86
10578531|NCT01698775|11733626|FG000|NOT COMPLETED|Phase B||14
10578532|NCT01698775|11733627|FG001|NOT COMPLETED|Phase B||11
10702529|NCT02576535|11866984|FG000|NOT COMPLETED|Overall Study||2
10702530|NCT02576587|11866990|FG000|STARTED|Baseline|Total cases baseline visit|161
10702531|NCT02576587|11866991|FG001|STARTED|Baseline|Total controls baseline visit|156
10702532|NCT02576587|11866990|FG000|COMPLETED|Baseline|Baseline visit completed|161
10702533|NCT02576587|11866991|FG001|COMPLETED|Baseline|Baseline visit completed|155
10702534|NCT02576587|11866990|FG000|NOT COMPLETED|Baseline||0
10578533|NCT01698801|11733637|FG000|STARTED|Treatment Phase||26
10578534|NCT01698801|11733637|FG000|COMPLETED|Treatment Phase|Completed includes participants who continued to receive study medication and treatment is ongoing.|15
10578535|NCT01698801|11733637|FG000|NOT COMPLETED|Treatment Phase||11
10578536|NCT01698801|11733637|FG000|STARTED|Follow Up Phase|11 participants did not complete the study and moved into the follow up phase lasting up to 5 years.|11
10578537|NCT01698801|11733637|FG000|COMPLETED|Follow Up Phase|Completed includes participants who remain in follow-up for up to 5 years from start of treatment|6
10578538|NCT01698801|11733637|FG000|NOT COMPLETED|Follow Up Phase||5
10578539|NCT01698814|11733644|FG000|STARTED|Overall Study||331
10578540|NCT01698814|11733645|FG001|STARTED|Overall Study||169
10578541|NCT01698814|11733644|FG000|COMPLETED|Overall Study||329
10578542|NCT01698814|11733645|FG001|COMPLETED|Overall Study||166
10578543|NCT01698814|11733644|FG000|NOT COMPLETED|Overall Study||2
10578544|NCT01698814|11733645|FG001|NOT COMPLETED|Overall Study||3
10578545|NCT01698879|11733654|FG000|STARTED|Overall Study||6
10578546|NCT01698879|11733655|FG001|STARTED|Overall Study||20
10578547|NCT01698879|11733656|FG002|STARTED|Overall Study||20
10578548|NCT01698879|11733654|FG000|COMPLETED|Overall Study||5
10702535|NCT02576587|11866991|FG001|NOT COMPLETED|Baseline||1
10702536|NCT02576587|11866990|FG000|STARTED|Follow up Period (Case Only)|Completed baseline.|161
10702537|NCT02576587|11866991|FG001|STARTED|Follow up Period (Case Only)|Controls not eligible for follow-up|155
10702538|NCT02576587|11866990|FG000|Selected for Follow up|Follow up Period (Case Only)||61
10702539|NCT02576587|11866991|FG001|Selected for Follow up|Follow up Period (Case Only)||0
10702540|NCT02576587|11866990|FG000|COMPLETED|Follow up Period (Case Only)||44
10702541|NCT02576587|11866991|FG001|COMPLETED|Follow up Period (Case Only)||0
10806423|NCT03965039|11967956|FG002|COMPLETED|Overall Study||30
10806424|NCT03965039|11967957|FG003|COMPLETED|Overall Study||29
10806425|NCT03965039|11967954|FG000|NOT COMPLETED|Overall Study||0
10806426|NCT03965039|11967955|FG001|NOT COMPLETED|Overall Study||1
10578549|NCT01698879|11733655|FG001|COMPLETED|Overall Study||20
10578550|NCT01698879|11733656|FG002|COMPLETED|Overall Study||20
10578551|NCT01698879|11733654|FG000|NOT COMPLETED|Overall Study||1
10578552|NCT01698879|11733655|FG001|NOT COMPLETED|Overall Study||0
10578553|NCT01698879|11733656|FG002|NOT COMPLETED|Overall Study||0
10578554|NCT01699022|11733670|FG000|STARTED|Overall Study||17
10578555|NCT01699022|11733670|FG000|COMPLETED|Overall Study||14
10578556|NCT01699022|11733670|FG000|NOT COMPLETED|Overall Study||3
10578557|NCT01699087|11733675|FG000|STARTED|Overall Study||176
10578558|NCT01699087|11733675|FG000|Treated|Overall Study||161
10578559|NCT01699087|11733675|FG000|COMPLETED|Overall Study||152
10578560|NCT01699087|11733675|FG000|NOT COMPLETED|Overall Study||24
10578561|NCT01699178|11733682|FG000|STARTED|Overall Study||88
10578562|NCT01699178|11733683|FG001|STARTED|Overall Study||94
10578563|NCT01699178|11733682|FG000|COMPLETED|Overall Study||69
10578564|NCT01699178|11733683|FG001|COMPLETED|Overall Study||62
10578565|NCT01699178|11733682|FG000|NOT COMPLETED|Overall Study||19
10578566|NCT01699178|11733683|FG001|NOT COMPLETED|Overall Study||32
10578567|NCT01699373|11733691|FG000|STARTED|Overall Study||85
10578568|NCT01699373|11733692|FG001|STARTED|Overall Study||85
10578569|NCT01699373|11733691|FG000|COMPLETED|Overall Study||85
10578570|NCT01699373|11733692|FG001|COMPLETED|Overall Study||85
10578571|NCT01699373|11733691|FG000|NOT COMPLETED|Overall Study||0
10578572|NCT01699373|11733692|FG001|NOT COMPLETED|Overall Study||0
10578573|NCT01699503|11733700|FG000|STARTED|Overall Study||2008
10578574|NCT01699503|11733701|FG001|STARTED|Overall Study||1997
10578575|NCT01699503|11733700|FG000|Baseline|Overall Study||1723
10578576|NCT01699503|11733701|FG001|Baseline|Overall Study||1693
10578577|NCT01699503|11733700|FG000|1 Month Follow-up|Overall Study||998
10578578|NCT01699503|11733701|FG001|1 Month Follow-up|Overall Study||1022
10578579|NCT01699503|11733700|FG000|6 Month Follow-up|Overall Study||903
10578580|NCT01699503|11733701|FG001|6 Month Follow-up|Overall Study||893
10578581|NCT01699503|11733700|FG000|COMPLETED|Overall Study||1008
10578582|NCT01699503|11733701|FG001|COMPLETED|Overall Study||992
10578583|NCT01699503|11733700|FG000|NOT COMPLETED|Overall Study||1000
10578584|NCT01699503|11733701|FG001|NOT COMPLETED|Overall Study||1005
10578585|NCT01699542|11733709|FG000|STARTED|Overall Study||9
10578586|NCT01699542|11733710|FG001|STARTED|Overall Study||9
10578587|NCT01699542|11733709|FG000|COMPLETED|Overall Study||9
10578588|NCT01699542|11733710|FG001|COMPLETED|Overall Study||9
10578589|NCT01699542|11733709|FG000|NOT COMPLETED|Overall Study||0
10578590|NCT01699542|11733710|FG001|NOT COMPLETED|Overall Study||0
10578591|NCT01699607|11733718|FG000|STARTED|Overall Study||6
10578592|NCT01699607|11733719|FG001|STARTED|Overall Study||4
10578593|NCT01699607|11733718|FG000|COMPLETED|Overall Study||6
10578594|NCT01699607|11733719|FG001|COMPLETED|Overall Study||4
10578595|NCT01699607|11733718|FG000|NOT COMPLETED|Overall Study||0
10578596|NCT01699607|11733719|FG001|NOT COMPLETED|Overall Study||0
10578597|NCT01699685|11733726|FG000|STARTED|Period 1||39
10578598|NCT01699685|11733727|FG001|STARTED|Period 1||39
10578599|NCT01699685|11733726|FG000|Safety Population|Period 1||39
10578600|NCT01699685|11733727|FG001|Safety Population|Period 1||38
10578601|NCT01699685|11733726|FG000|Full Analysis Population (FAS)|Period 1||38
10578602|NCT01699685|11733727|FG001|Full Analysis Population (FAS)|Period 1||38
10578603|NCT01699685|11733726|FG000|COMPLETED|Period 1||36
10578604|NCT01699685|11733727|FG001|COMPLETED|Period 1||36
10578605|NCT01699685|11733726|FG000|NOT COMPLETED|Period 1||3
10578606|NCT01699685|11733727|FG001|NOT COMPLETED|Period 1||3
10578607|NCT01699685|11733726|FG000|STARTED|Period 2||36
10578608|NCT01699685|11733727|FG001|STARTED|Period 2||36
10578609|NCT01699685|11733726|FG000|COMPLETED|Period 2||35
10578610|NCT01699685|11733727|FG001|COMPLETED|Period 2||36
10578611|NCT01699685|11733726|FG000|NOT COMPLETED|Period 2||1
10578612|NCT01699685|11733727|FG001|NOT COMPLETED|Period 2||0
10578613|NCT01699698|11733735|FG000|STARTED|Overall Study||44
10578614|NCT01699698|11733736|FG001|STARTED|Overall Study||61
10578615|NCT01699698|11733735|FG000|COMPLETED|Overall Study||42
10578616|NCT01699698|11733736|FG001|COMPLETED|Overall Study||56
10578617|NCT01699698|11733735|FG000|NOT COMPLETED|Overall Study||2
10578618|NCT01699698|11733736|FG001|NOT COMPLETED|Overall Study||5
10578619|NCT01699750|11733745|FG000|STARTED|Overall Study||34
10578620|NCT01699750|11733746|FG001|STARTED|Overall Study||36
10578621|NCT01699750|11733745|FG000|COMPLETED|Overall Study||34
10578622|NCT01699750|11733746|FG001|COMPLETED|Overall Study||33
10578623|NCT01699750|11733745|FG000|NOT COMPLETED|Overall Study||0
10578624|NCT01699750|11733746|FG001|NOT COMPLETED|Overall Study||3
10578625|NCT01699763|11733756|FG000|STARTED|Overall Study||112
10578626|NCT01699763|11733756|FG000|COMPLETED|Overall Study||112
10578627|NCT01699763|11733756|FG000|NOT COMPLETED|Overall Study||0
10578628|NCT01699789|11733762|FG000|STARTED|Overall Study|606 eligible clients enrolled and contacted by telephone for baseline or follow-up survey in RS arm|606
10578629|NCT01699789|11733763|FG001|STARTED|Overall Study|640 eligible clients enrolled and contacted by telephone for baseline or follow-up survey in CEP arm|640
10578630|NCT01699789|11733762|FG000|Baseline|Overall Study||492
10578631|NCT01699789|11733763|FG001|Baseline|Overall Study||489
10578632|NCT01699789|11733762|FG000|6-Month Follow-Up|Overall Study||380
10578633|NCT01699789|11733763|FG001|6-Month Follow-Up|Overall Study||379
10578634|NCT01699789|11733762|FG000|12-Month Follow-Up|Overall Study||364
10578635|NCT01699789|11733763|FG001|12-Month Follow-Up|Overall Study||369
10578636|NCT01699789|11733762|FG000|3-Year Follow-up|Overall Study||293
10578637|NCT01699789|11733763|FG001|3-Year Follow-up|Overall Study||307
10578638|NCT01699789|11733762|FG000|4-Year Follow-up|Overall Study||143
10578639|NCT01699789|11733763|FG001|4-Year Follow-up|Overall Study||140
10578640|NCT01699789|11733762|FG000|COMPLETED|Overall Study|Clients in 44 programs with completed at least 1 data point at baseline, 6, or 12 mo FUP analyzed|504
10578641|NCT01699789|11733763|FG001|COMPLETED|Overall Study|Clients in 46 programs with completed at least 1 data point at baseline, 6, or 12 mo FUP analyzed|514
10578642|NCT01699789|11733762|FG000|NOT COMPLETED|Overall Study||102
10578643|NCT01699789|11733763|FG001|NOT COMPLETED|Overall Study||126
10578644|NCT01699815|11733773|FG000|STARTED|Overall Study||62
10578645|NCT01699815|11733774|FG001|STARTED|Overall Study||64
10578646|NCT01699815|11733773|FG000|COMPLETED|Overall Study||57
10578647|NCT01699815|11733774|FG001|COMPLETED|Overall Study||56
10578648|NCT01699815|11733773|FG000|NOT COMPLETED|Overall Study||5
10578649|NCT01699815|11733774|FG001|NOT COMPLETED|Overall Study||8
10578650|NCT01699867|11733780|FG000|STARTED|Overall Study||50
10578651|NCT01699867|11733780|FG000|COMPLETED|Overall Study||47
10578652|NCT01699867|11733780|FG000|NOT COMPLETED|Overall Study||3
10578653|NCT01700036|11733784|FG000|STARTED|Overall Study||40
10578654|NCT01700036|11733784|FG000|COMPLETED|Overall Study||40
10578655|NCT01700036|11733784|FG000|NOT COMPLETED|Overall Study||0
10578656|NCT01700049|11733788|FG000|STARTED|Overall Study||28
10578657|NCT01700049|11733788|FG000|COMPLETED|Overall Study||27
10578658|NCT01700049|11733788|FG000|NOT COMPLETED|Overall Study||1
10578659|NCT01700140|11733796|FG000|STARTED|Overall Study||61
10578660|NCT01700140|11733797|FG001|STARTED|Overall Study||66
10578661|NCT01700140|11733798|FG002|STARTED|Overall Study||62
10578662|NCT01700140|11733796|FG000|COMPLETED|Overall Study||55
10578663|NCT01700140|11733797|FG001|COMPLETED|Overall Study||57
10578664|NCT01700140|11733798|FG002|COMPLETED|Overall Study||61
10578665|NCT01700140|11733796|FG000|NOT COMPLETED|Overall Study||6
10578666|NCT01700140|11733797|FG001|NOT COMPLETED|Overall Study||9
10578667|NCT01700140|11733798|FG002|NOT COMPLETED|Overall Study||1
10578668|NCT01700179|11733809|FG000|STARTED|Overall Study||8
10578669|NCT01700179|11733809|FG000|COMPLETED|Overall Study||6
10578670|NCT01700179|11733809|FG000|NOT COMPLETED|Overall Study||2
10578671|NCT01700192|11733815|FG000|STARTED|Overall Study||741
10578672|NCT01700192|11733816|FG001|STARTED|Overall Study||741
10578673|NCT01700192|11733815|FG000|Treated|Overall Study||740
10578674|NCT01700192|11733816|FG001|Treated|Overall Study||741
10578675|NCT01700192|11733815|FG000|All Participants as Treated (APaT)|Overall Study|Three participants randomized to receive placebo were given MK-8237 12 DU.|743
10578676|NCT01700192|11733816|FG001|All Participants as Treated (APaT)|Overall Study|Three participants randomized to receive placebo were given MK-8237 12 DU.|738
10578677|NCT01700192|11733815|FG000|COMPLETED|Overall Study||561
10578678|NCT01700192|11733816|FG001|COMPLETED|Overall Study||613
10578679|NCT01700192|11733815|FG000|NOT COMPLETED|Overall Study||180
10578680|NCT01700192|11733816|FG001|NOT COMPLETED|Overall Study||128
10578681|NCT01700205|11733824|FG000|STARTED|Overall Study|Mother-Infant Dyads|59
10578682|NCT01700205|11733825|FG001|STARTED|Overall Study|Mother-Infant Dyads|54
10578683|NCT01700205|11733824|FG000|COMPLETED|Overall Study|Mother-Infant Dyads|44
10578684|NCT01700205|11733825|FG001|COMPLETED|Overall Study|Mother-Infant Dyads|39
10578685|NCT01700205|11733824|FG000|NOT COMPLETED|Overall Study||15
10578686|NCT01700205|11733825|FG001|NOT COMPLETED|Overall Study||15
10578687|NCT01700335|11733831|FG000|STARTED|Overall Study||3
10578688|NCT01700335|11733832|FG001|STARTED|Overall Study||6
10578689|NCT01700335|11733831|FG000|COMPLETED|Overall Study||2
10578690|NCT01700335|11733832|FG001|COMPLETED|Overall Study||2
10578691|NCT01700335|11733831|FG000|NOT COMPLETED|Overall Study||1
10578692|NCT01700335|11733832|FG001|NOT COMPLETED|Overall Study||4
10578693|NCT01700387|11733841|FG000|STARTED|Overall Study||10
10578694|NCT01700387|11733842|FG001|STARTED|Overall Study||10
10578695|NCT01700387|11733841|FG000|COMPLETED|Overall Study||6
10578696|NCT01700387|11733842|FG001|COMPLETED|Overall Study||6
10578697|NCT01700387|11733841|FG000|NOT COMPLETED|Overall Study||4
10578698|NCT01700387|11733842|FG001|NOT COMPLETED|Overall Study||4
10578699|NCT01700517|11733855|FG000|STARTED|Overall Study||40
10578700|NCT01700517|11733856|FG001|STARTED|Overall Study||40
10578701|NCT01700517|11733857|FG002|STARTED|Overall Study||40
10578702|NCT01700517|11733855|FG000|COMPLETED|Overall Study||40
10578703|NCT01700517|11733856|FG001|COMPLETED|Overall Study||40
10578704|NCT01700517|11733857|FG002|COMPLETED|Overall Study||40
10578705|NCT01700517|11733855|FG000|NOT COMPLETED|Overall Study||0
10578706|NCT01700517|11733856|FG001|NOT COMPLETED|Overall Study||0
10578707|NCT01700517|11733857|FG002|NOT COMPLETED|Overall Study||0
10578708|NCT01700530|11733868|FG000|STARTED|Overall Study||9
10578709|NCT01700530|11733869|FG001|STARTED|Overall Study||21
10578710|NCT01700530|11733870|FG002|STARTED|Overall Study||20
10578711|NCT01700530|11733868|FG000|COMPLETED|Overall Study||9
10578712|NCT01700530|11733869|FG001|COMPLETED|Overall Study||18
10578713|NCT01700530|11733870|FG002|COMPLETED|Overall Study||19
10578714|NCT01700530|11733868|FG000|NOT COMPLETED|Overall Study||0
10578715|NCT01700530|11733869|FG001|NOT COMPLETED|Overall Study||3
10578716|NCT01700530|11733870|FG002|NOT COMPLETED|Overall Study||1
10578717|NCT01700621|11733880|FG000|STARTED|Received Study Vaccines||240
10578718|NCT01700621|11733881|FG001|STARTED|Received Study Vaccines||240
10578719|NCT01700621|11733880|FG000|COMPLETED|Received Study Vaccines||240
10578720|NCT01700621|11733881|FG001|COMPLETED|Received Study Vaccines||240
10578721|NCT01700621|11733880|FG000|NOT COMPLETED|Received Study Vaccines||0
10578722|NCT01700621|11733881|FG001|NOT COMPLETED|Received Study Vaccines||0
10578723|NCT01700621|11733880|FG000|STARTED|Analyzed for Immunogenicity||240
10578724|NCT01700621|11733881|FG001|STARTED|Analyzed for Immunogenicity||240
10578725|NCT01700621|11733880|FG000|COMPLETED|Analyzed for Immunogenicity||227
10578726|NCT01700621|11733881|FG001|COMPLETED|Analyzed for Immunogenicity||233
10578727|NCT01700621|11733880|FG000|NOT COMPLETED|Analyzed for Immunogenicity||13
10578728|NCT01700621|11733881|FG001|NOT COMPLETED|Analyzed for Immunogenicity||7
10578729|NCT01700725|11733891|FG000|STARTED|Overall Study||14
10578730|NCT01700725|11733892|FG001|STARTED|Overall Study||14
10578731|NCT01700725|11733893|FG002|STARTED|Overall Study||12
10578732|NCT01700725|11733891|FG000|COMPLETED|Overall Study||14
10578733|NCT01700725|11733892|FG001|COMPLETED|Overall Study||14
10578734|NCT01700725|11733893|FG002|COMPLETED|Overall Study||12
10578735|NCT01700725|11733891|FG000|NOT COMPLETED|Overall Study||0
10578736|NCT01700725|11733892|FG001|NOT COMPLETED|Overall Study||0
10578737|NCT01700725|11733893|FG002|NOT COMPLETED|Overall Study||0
10578738|NCT01700816|11733903|FG000|STARTED|Overall Study||21
10578739|NCT01700816|11733904|FG001|STARTED|Overall Study||19
10578740|NCT01700816|11733903|FG000|COMPLETED|Overall Study||21
10578741|NCT01700816|11733904|FG001|COMPLETED|Overall Study||19
10578742|NCT01700816|11733903|FG000|NOT COMPLETED|Overall Study||0
10578743|NCT01700816|11733904|FG001|NOT COMPLETED|Overall Study||0
10578744|NCT01700829|11733912|FG000|STARTED|Overall Study||41
10578745|NCT01700829|11733913|FG001|STARTED|Overall Study||41
10702542|NCT02576587|11866990|FG000|NOT COMPLETED|Follow up Period (Case Only)||117
10702543|NCT02576587|11866991|FG001|NOT COMPLETED|Follow up Period (Case Only)||155
10702544|NCT02576639|11867004|FG000|STARTED|Overall Study||24
10702545|NCT02576639|11867005|FG001|STARTED|Overall Study||25
10702546|NCT02576639|11867006|FG002|STARTED|Overall Study||25
10702547|NCT02576639|11867007|FG003|STARTED|Overall Study||26
10702548|NCT02576639|11867008|FG004|STARTED|Overall Study||24
10702549|NCT02576639|11867004|FG000|Pharmacodynamic Analysis Set|Overall Study||24
10702550|NCT02576639|11867005|FG001|Pharmacodynamic Analysis Set|Overall Study||24
10702551|NCT02576639|11867006|FG002|Pharmacodynamic Analysis Set|Overall Study||25
10702552|NCT02576639|11867007|FG003|Pharmacodynamic Analysis Set|Overall Study||25
10702553|NCT02576639|11867008|FG004|Pharmacodynamic Analysis Set|Overall Study||25
10578746|NCT01700829|11733912|FG000|COMPLETED|Overall Study||40
10578747|NCT01700829|11733913|FG001|COMPLETED|Overall Study||40
10578748|NCT01700829|11733912|FG000|NOT COMPLETED|Overall Study||1
10578749|NCT01700829|11733913|FG001|NOT COMPLETED|Overall Study||1
10578750|NCT01700907|11733921|FG000|STARTED|Overall Study||10
10578751|NCT01700907|11733922|FG001|STARTED|Overall Study||10
10578752|NCT01700907|11733921|FG000|COMPLETED|Overall Study||10
10578753|NCT01700907|11733922|FG001|COMPLETED|Overall Study||10
10578754|NCT01700907|11733921|FG000|NOT COMPLETED|Overall Study||0
10578755|NCT01700907|11733922|FG001|NOT COMPLETED|Overall Study||0
10578756|NCT01700959|11733934|FG000|STARTED|Overall Study||89
10702554|NCT02576639|11867004|FG000|Pharmacokinetic Analysis Set|Overall Study||0
10702555|NCT02576639|11867005|FG001|Pharmacokinetic Analysis Set|Overall Study||25
10806427|NCT03965039|11967956|FG002|NOT COMPLETED|Overall Study||0
10578757|NCT01700959|11733935|FG001|STARTED|Overall Study||88
10578758|NCT01700959|11733936|FG002|STARTED|Overall Study||105
10578759|NCT01700959|11733937|FG003|STARTED|Overall Study||105
10578760|NCT01700959|11733938|FG004|STARTED|Overall Study||96
10578761|NCT01700959|11733939|FG005|STARTED|Overall Study||97
10578762|NCT01700959|11733934|FG000|COMPLETED|Overall Study||62
10578763|NCT01700959|11733935|FG001|COMPLETED|Overall Study||64
10578764|NCT01700959|11733936|FG002|COMPLETED|Overall Study||65
10578765|NCT01700959|11733937|FG003|COMPLETED|Overall Study||70
10578766|NCT01700959|11733938|FG004|COMPLETED|Overall Study||69
10578767|NCT01700959|11733939|FG005|COMPLETED|Overall Study||72
10578768|NCT01700959|11733934|FG000|NOT COMPLETED|Overall Study||27
10578769|NCT01700959|11733935|FG001|NOT COMPLETED|Overall Study||24
10578770|NCT01700959|11733936|FG002|NOT COMPLETED|Overall Study||40
10578771|NCT01700959|11733937|FG003|NOT COMPLETED|Overall Study||35
10578772|NCT01700959|11733938|FG004|NOT COMPLETED|Overall Study||27
10578773|NCT01700959|11733939|FG005|NOT COMPLETED|Overall Study||25
10578774|NCT01700985|11733957|FG000|STARTED|Overall Study||23
10578775|NCT01700985|11733958|FG001|STARTED|Overall Study||21
10578776|NCT01700985|11733957|FG000|COMPLETED|Overall Study||23
10578777|NCT01700985|11733958|FG001|COMPLETED|Overall Study||20
10578778|NCT01700985|11733957|FG000|NOT COMPLETED|Overall Study||0
10578779|NCT01700985|11733958|FG001|NOT COMPLETED|Overall Study||1
10578780|NCT01701011|11733967|FG000|STARTED|Overall Study||127
10578781|NCT01701011|11733968|FG001|STARTED|Overall Study||126
10578782|NCT01701011|11733969|FG002|STARTED|Overall Study||124
10578783|NCT01701011|11733967|FG000|COMPLETED|Overall Study||92
10578784|NCT01701011|11733968|FG001|COMPLETED|Overall Study||102
10578785|NCT01701011|11733969|FG002|COMPLETED|Overall Study||90
10578786|NCT01701011|11733967|FG000|NOT COMPLETED|Overall Study||35
10578787|NCT01701011|11733968|FG001|NOT COMPLETED|Overall Study||24
10578788|NCT01701011|11733969|FG002|NOT COMPLETED|Overall Study||34
10578789|NCT01701024|11733980|FG000|STARTED|Overall Study||253
10578790|NCT01701024|11733981|FG001|STARTED|Overall Study||245
10578791|NCT01701024|11733980|FG000|COMPLETED|Overall Study||243
10578792|NCT01701024|11733981|FG001|COMPLETED|Overall Study||236
10578793|NCT01701024|11733980|FG000|NOT COMPLETED|Overall Study||10
10578794|NCT01701024|11733981|FG001|NOT COMPLETED|Overall Study||9
10578795|NCT01701037|11733987|FG000|STARTED|Overall Study||13
10578796|NCT01701037|11733987|FG000|COMPLETED|Overall Study||13
10702556|NCT02576639|11867006|FG002|Pharmacokinetic Analysis Set|Overall Study||25
10702557|NCT02576639|11867007|FG003|Pharmacokinetic Analysis Set|Overall Study||26
10578797|NCT01701037|11733987|FG000|NOT COMPLETED|Overall Study||0
10578798|NCT01701063|11733995|FG000|STARTED|Overall Study||13
10578799|NCT01701063|11733996|FG001|STARTED|Overall Study||19
10578800|NCT01701063|11733997|FG002|STARTED|Overall Study||10
10578801|NCT01701063|11733995|FG000|COMPLETED|Overall Study||13
10578802|NCT01701063|11733996|FG001|COMPLETED|Overall Study||18
10578803|NCT01701063|11733997|FG002|COMPLETED|Overall Study||8
10578804|NCT01701063|11733995|FG000|NOT COMPLETED|Overall Study||0
10578805|NCT01701063|11733996|FG001|NOT COMPLETED|Overall Study||1
10578806|NCT01701063|11733997|FG002|NOT COMPLETED|Overall Study||2
10578807|NCT01701102|11734010|FG000|STARTED|Overall Study||22
10578808|NCT01701102|11734011|FG001|STARTED|Overall Study||6
10578809|NCT01701102|11734012|FG002|STARTED|Overall Study||10
10578810|NCT01701102|11734013|FG003|STARTED|Overall Study||18
10578811|NCT01701102|11734010|FG000|COMPLETED|Overall Study||22
10578812|NCT01701102|11734011|FG001|COMPLETED|Overall Study||6
10578813|NCT01701102|11734012|FG002|COMPLETED|Overall Study||10
10578814|NCT01701102|11734013|FG003|COMPLETED|Overall Study||18
10578815|NCT01701102|11734010|FG000|NOT COMPLETED|Overall Study||0
10578816|NCT01701102|11734011|FG001|NOT COMPLETED|Overall Study||0
10578817|NCT01701102|11734012|FG002|NOT COMPLETED|Overall Study||0
10578818|NCT01701102|11734013|FG003|NOT COMPLETED|Overall Study||0
10578819|NCT01701115|11734025|FG000|STARTED|Overall Study||77
10578820|NCT01701115|11734026|FG001|STARTED|Overall Study||77
10578821|NCT01701115|11734025|FG000|COMPLETED|Overall Study||75
10578822|NCT01701115|11734026|FG001|COMPLETED|Overall Study||77
10578823|NCT01701115|11734025|FG000|NOT COMPLETED|Overall Study||2
10578824|NCT01701115|11734026|FG001|NOT COMPLETED|Overall Study||0
10578825|NCT01701193|11734036|FG000|STARTED|Overall Study||18
10578826|NCT01701193|11734037|FG001|STARTED|Overall Study||19
10578827|NCT01701193|11734038|FG002|STARTED|Overall Study||5
10578828|NCT01701193|11734039|FG003|STARTED|Overall Study||5
10578829|NCT01701193|11734036|FG000|COMPLETED|Overall Study||15
10578830|NCT01701193|11734037|FG001|COMPLETED|Overall Study||17
10702558|NCT02576639|11867008|FG004|Pharmacokinetic Analysis Set|Overall Study||24
10702559|NCT02576639|11867004|FG000|Safety Analysis Set|Overall Study||24
10702560|NCT02576639|11867005|FG001|Safety Analysis Set|Overall Study||25
10333700|NCT00334958|11469871|FG000|COMPLETED|Overall Study||139
10333701|NCT00334958|11469872|FG001|COMPLETED|Overall Study||156
10578831|NCT01701193|11734038|FG002|COMPLETED|Overall Study||4
10578832|NCT01701193|11734039|FG003|COMPLETED|Overall Study||3
10578833|NCT01701193|11734036|FG000|NOT COMPLETED|Overall Study||3
10578834|NCT01701193|11734037|FG001|NOT COMPLETED|Overall Study||2
10578835|NCT01701193|11734038|FG002|NOT COMPLETED|Overall Study||1
10578836|NCT01701193|11734039|FG003|NOT COMPLETED|Overall Study||2
10578837|NCT01701245|11734054|FG000|STARTED|Overall Study||49
10578838|NCT01701245|11734055|FG001|STARTED|Overall Study||48
10578839|NCT01701245|11734054|FG000|FAS Unmatched Data|Overall Study|1 patient protocol violation|48
10578840|NCT01701245|11734055|FG001|FAS Unmatched Data|Overall Study|3 patients protocol violation|45
10578841|NCT01701245|11734054|FG000|FAS Matched Data|Overall Study||42
10578842|NCT01701245|11734055|FG001|FAS Matched Data|Overall Study||32
10578843|NCT01701245|11734054|FG000|COMPLETED|Overall Study||37
10578844|NCT01701245|11734055|FG001|COMPLETED|Overall Study||33
10578845|NCT01701245|11734054|FG000|NOT COMPLETED|Overall Study||12
10578846|NCT01701245|11734055|FG001|NOT COMPLETED|Overall Study||15
10578847|NCT01701258|11734065|FG000|STARTED|Assessment and Scheduling||153
10578848|NCT01701258|11734066|FG001|STARTED|Assessment and Scheduling||0
10578849|NCT01701258|11734067|FG002|STARTED|Assessment and Scheduling||0
10578850|NCT01701258|11734068|FG003|STARTED|Assessment and Scheduling||0
10578851|NCT01701258|11734069|FG004|STARTED|Assessment and Scheduling||0
10578852|NCT01701258|11734070|FG005|STARTED|Assessment and Scheduling||0
10578853|NCT01701258|11734071|FG006|STARTED|Assessment and Scheduling||0
10578854|NCT01701258|11734072|FG007|STARTED|Assessment and Scheduling||0
10578855|NCT01701258|11734073|FG008|STARTED|Assessment and Scheduling||0
10578856|NCT01701258|11734074|FG009|STARTED|Assessment and Scheduling||0
10578857|NCT01701258|11734075|FG010|STARTED|Assessment and Scheduling||0
10578858|NCT01701258|11734076|FG011|STARTED|Assessment and Scheduling||0
10578859|NCT01701258|11734077|FG012|STARTED|Assessment and Scheduling||0
10578860|NCT01701258|11734065|FG000|Eligible After Screening Visit|Assessment and Scheduling||96
10578861|NCT01701258|11734066|FG001|Eligible After Screening Visit|Assessment and Scheduling||0
10578862|NCT01701258|11734067|FG002|Eligible After Screening Visit|Assessment and Scheduling||0
10578863|NCT01701258|11734068|FG003|Eligible After Screening Visit|Assessment and Scheduling||0
10578864|NCT01701258|11734069|FG004|Eligible After Screening Visit|Assessment and Scheduling||0
10578865|NCT01701258|11734070|FG005|Eligible After Screening Visit|Assessment and Scheduling||0
10578866|NCT01701258|11734071|FG006|Eligible After Screening Visit|Assessment and Scheduling||0
10578867|NCT01701258|11734072|FG007|Eligible After Screening Visit|Assessment and Scheduling||0
10578868|NCT01701258|11734073|FG008|Eligible After Screening Visit|Assessment and Scheduling||0
10578869|NCT01701258|11734074|FG009|Eligible After Screening Visit|Assessment and Scheduling||0
10578870|NCT01701258|11734075|FG010|Eligible After Screening Visit|Assessment and Scheduling||0
10578871|NCT01701258|11734076|FG011|Eligible After Screening Visit|Assessment and Scheduling||0
10578872|NCT01701258|11734077|FG012|Eligible After Screening Visit|Assessment and Scheduling||0
10578873|NCT01701258|11734065|FG000|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||68
10578874|NCT01701258|11734066|FG001|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
10578943|NCT01701258|11734070|FG005|STARTED|Drug+fMRI (Session 2)||9
10578875|NCT01701258|11734067|FG002|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
10702561|NCT02576639|11867006|FG002|Safety Analysis Set|Overall Study||25
10333702|NCT00334958|11469871|FG000|NOT COMPLETED|Overall Study||37
10702562|NCT02576639|11867007|FG003|Safety Analysis Set|Overall Study||26
10578876|NCT01701258|11734068|FG003|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
10578877|NCT01701258|11734069|FG004|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
10578878|NCT01701258|11734070|FG005|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
10578879|NCT01701258|11734071|FG006|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
10578880|NCT01701258|11734072|FG007|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
10578881|NCT01701258|11734073|FG008|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
10578882|NCT01701258|11734074|FG009|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
10578883|NCT01701258|11734075|FG010|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
10578884|NCT01701258|11734076|FG011|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
10578885|NCT01701258|11734077|FG012|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
10578886|NCT01701258|11734065|FG000|Returned for PET (Session 3)|Assessment and Scheduling||73
10578887|NCT01701258|11734066|FG001|Returned for PET (Session 3)|Assessment and Scheduling||0
10578888|NCT01701258|11734067|FG002|Returned for PET (Session 3)|Assessment and Scheduling||0
10578889|NCT01701258|11734068|FG003|Returned for PET (Session 3)|Assessment and Scheduling||0
10578890|NCT01701258|11734069|FG004|Returned for PET (Session 3)|Assessment and Scheduling||0
10578891|NCT01701258|11734070|FG005|Returned for PET (Session 3)|Assessment and Scheduling||0
10578892|NCT01701258|11734071|FG006|Returned for PET (Session 3)|Assessment and Scheduling||0
10578893|NCT01701258|11734072|FG007|Returned for PET (Session 3)|Assessment and Scheduling||0
10578894|NCT01701258|11734073|FG008|Returned for PET (Session 3)|Assessment and Scheduling||0
10578895|NCT01701258|11734074|FG009|Returned for PET (Session 3)|Assessment and Scheduling||0
10578896|NCT01701258|11734075|FG010|Returned for PET (Session 3)|Assessment and Scheduling||0
10578897|NCT01701258|11734076|FG011|Returned for PET (Session 3)|Assessment and Scheduling||0
10578898|NCT01701258|11734077|FG012|Returned for PET (Session 3)|Assessment and Scheduling||0
10578899|NCT01701258|11734065|FG000|Returned for EEG (Session 4)|Assessment and Scheduling||66
10578900|NCT01701258|11734066|FG001|Returned for EEG (Session 4)|Assessment and Scheduling||0
10578901|NCT01701258|11734067|FG002|Returned for EEG (Session 4)|Assessment and Scheduling||0
10578902|NCT01701258|11734068|FG003|Returned for EEG (Session 4)|Assessment and Scheduling||0
10578903|NCT01701258|11734069|FG004|Returned for EEG (Session 4)|Assessment and Scheduling||0
10578904|NCT01701258|11734070|FG005|Returned for EEG (Session 4)|Assessment and Scheduling||0
10578905|NCT01701258|11734071|FG006|Returned for EEG (Session 4)|Assessment and Scheduling||0
10702563|NCT02576639|11867008|FG004|Safety Analysis Set|Overall Study||24
10702564|NCT02576639|11867004|FG000|COMPLETED|Overall Study||22
10702565|NCT02576639|11867005|FG001|COMPLETED|Overall Study||23
10702566|NCT02576639|11867006|FG002|COMPLETED|Overall Study||23
10702567|NCT02576639|11867007|FG003|COMPLETED|Overall Study||25
10578906|NCT01701258|11734072|FG007|Returned for EEG (Session 4)|Assessment and Scheduling||0
10578907|NCT01701258|11734073|FG008|Returned for EEG (Session 4)|Assessment and Scheduling||0
10578908|NCT01701258|11734074|FG009|Returned for EEG (Session 4)|Assessment and Scheduling||0
10578909|NCT01701258|11734075|FG010|Returned for EEG (Session 4)|Assessment and Scheduling||0
10578910|NCT01701258|11734076|FG011|Returned for EEG (Session 4)|Assessment and Scheduling||0
10578911|NCT01701258|11734077|FG012|Returned for EEG (Session 4)|Assessment and Scheduling||0
10578912|NCT01701258|11734065|FG000|COMPLETED|Assessment and Scheduling||70
10578913|NCT01701258|11734066|FG001|COMPLETED|Assessment and Scheduling||0
10578914|NCT01701258|11734067|FG002|COMPLETED|Assessment and Scheduling||0
10578915|NCT01701258|11734068|FG003|COMPLETED|Assessment and Scheduling||0
10578916|NCT01701258|11734069|FG004|COMPLETED|Assessment and Scheduling||0
10578917|NCT01701258|11734070|FG005|COMPLETED|Assessment and Scheduling||0
10578918|NCT01701258|11734071|FG006|COMPLETED|Assessment and Scheduling||0
10578919|NCT01701258|11734072|FG007|COMPLETED|Assessment and Scheduling||0
10578920|NCT01701258|11734073|FG008|COMPLETED|Assessment and Scheduling||0
10578921|NCT01701258|11734074|FG009|COMPLETED|Assessment and Scheduling||0
10578922|NCT01701258|11734075|FG010|COMPLETED|Assessment and Scheduling||0
10578923|NCT01701258|11734076|FG011|COMPLETED|Assessment and Scheduling||0
10578924|NCT01701258|11734077|FG012|COMPLETED|Assessment and Scheduling||0
10578925|NCT01701258|11734065|FG000|NOT COMPLETED|Assessment and Scheduling||83
10578926|NCT01701258|11734066|FG001|NOT COMPLETED|Assessment and Scheduling||0
10578927|NCT01701258|11734067|FG002|NOT COMPLETED|Assessment and Scheduling||0
10578928|NCT01701258|11734068|FG003|NOT COMPLETED|Assessment and Scheduling||0
10578929|NCT01701258|11734069|FG004|NOT COMPLETED|Assessment and Scheduling||0
10578930|NCT01701258|11734070|FG005|NOT COMPLETED|Assessment and Scheduling||0
10578931|NCT01701258|11734071|FG006|NOT COMPLETED|Assessment and Scheduling||0
10578932|NCT01701258|11734072|FG007|NOT COMPLETED|Assessment and Scheduling||0
10578933|NCT01701258|11734073|FG008|NOT COMPLETED|Assessment and Scheduling||0
10578934|NCT01701258|11734074|FG009|NOT COMPLETED|Assessment and Scheduling||0
10578935|NCT01701258|11734075|FG010|NOT COMPLETED|Assessment and Scheduling||0
10578936|NCT01701258|11734076|FG011|NOT COMPLETED|Assessment and Scheduling||0
10578937|NCT01701258|11734077|FG012|NOT COMPLETED|Assessment and Scheduling||0
10578938|NCT01701258|11734065|FG000|STARTED|Drug+fMRI (Session 2)||0
10578939|NCT01701258|11734066|FG001|STARTED|Drug+fMRI (Session 2)||0
10578940|NCT01701258|11734067|FG002|STARTED|Drug+fMRI (Session 2)||11
10578941|NCT01701258|11734068|FG003|STARTED|Drug+fMRI (Session 2)||11
10578942|NCT01701258|11734069|FG004|STARTED|Drug+fMRI (Session 2)||0
10578944|NCT01701258|11734071|FG006|STARTED|Drug+fMRI (Session 2)||8
10578945|NCT01701258|11734072|FG007|STARTED|Drug+fMRI (Session 2)||0
10578946|NCT01701258|11734073|FG008|STARTED|Drug+fMRI (Session 2)||6
10578947|NCT01701258|11734074|FG009|STARTED|Drug+fMRI (Session 2)||6
10578948|NCT01701258|11734075|FG010|STARTED|Drug+fMRI (Session 2)||0
10578949|NCT01701258|11734076|FG011|STARTED|Drug+fMRI (Session 2)||10
10578950|NCT01701258|11734077|FG012|STARTED|Drug+fMRI (Session 2)||7
10578951|NCT01701258|11734065|FG000|Received Drug Challenge|Drug+fMRI (Session 2)||0
10578952|NCT01701258|11734066|FG001|Received Drug Challenge|Drug+fMRI (Session 2)||0
10578953|NCT01701258|11734067|FG002|Received Drug Challenge|Drug+fMRI (Session 2)||11
10578954|NCT01701258|11734068|FG003|Received Drug Challenge|Drug+fMRI (Session 2)||11
10578955|NCT01701258|11734069|FG004|Received Drug Challenge|Drug+fMRI (Session 2)||0
10578956|NCT01701258|11734070|FG005|Received Drug Challenge|Drug+fMRI (Session 2)||9
10578957|NCT01701258|11734071|FG006|Received Drug Challenge|Drug+fMRI (Session 2)||8
10578958|NCT01701258|11734072|FG007|Received Drug Challenge|Drug+fMRI (Session 2)||0
10578959|NCT01701258|11734073|FG008|Received Drug Challenge|Drug+fMRI (Session 2)||6
10578960|NCT01701258|11734074|FG009|Received Drug Challenge|Drug+fMRI (Session 2)||6
10578961|NCT01701258|11734075|FG010|Received Drug Challenge|Drug+fMRI (Session 2)||0
10578962|NCT01701258|11734076|FG011|Received Drug Challenge|Drug+fMRI (Session 2)||10
10578963|NCT01701258|11734077|FG012|Received Drug Challenge|Drug+fMRI (Session 2)||7
10578964|NCT01701258|11734065|FG000|COMPLETED|Drug+fMRI (Session 2)||0
10578965|NCT01701258|11734066|FG001|COMPLETED|Drug+fMRI (Session 2)||0
10578966|NCT01701258|11734067|FG002|COMPLETED|Drug+fMRI (Session 2)||11
10578967|NCT01701258|11734068|FG003|COMPLETED|Drug+fMRI (Session 2)||11
10578968|NCT01701258|11734069|FG004|COMPLETED|Drug+fMRI (Session 2)||0
10578969|NCT01701258|11734070|FG005|COMPLETED|Drug+fMRI (Session 2)||9
10578970|NCT01701258|11734071|FG006|COMPLETED|Drug+fMRI (Session 2)||8
10578971|NCT01701258|11734072|FG007|COMPLETED|Drug+fMRI (Session 2)||0
10578972|NCT01701258|11734073|FG008|COMPLETED|Drug+fMRI (Session 2)||6
10578973|NCT01701258|11734074|FG009|COMPLETED|Drug+fMRI (Session 2)||6
10578974|NCT01701258|11734075|FG010|COMPLETED|Drug+fMRI (Session 2)||0
10578975|NCT01701258|11734076|FG011|COMPLETED|Drug+fMRI (Session 2)||10
10578976|NCT01701258|11734077|FG012|COMPLETED|Drug+fMRI (Session 2)||7
10578977|NCT01701258|11734065|FG000|NOT COMPLETED|Drug+fMRI (Session 2)||0
10578978|NCT01701258|11734066|FG001|NOT COMPLETED|Drug+fMRI (Session 2)||0
10578979|NCT01701258|11734067|FG002|NOT COMPLETED|Drug+fMRI (Session 2)||0
10578980|NCT01701258|11734068|FG003|NOT COMPLETED|Drug+fMRI (Session 2)||0
10578981|NCT01701258|11734069|FG004|NOT COMPLETED|Drug+fMRI (Session 2)||0
10578982|NCT01701258|11734070|FG005|NOT COMPLETED|Drug+fMRI (Session 2)||0
10578983|NCT01701258|11734071|FG006|NOT COMPLETED|Drug+fMRI (Session 2)||0
10578984|NCT01701258|11734072|FG007|NOT COMPLETED|Drug+fMRI (Session 2)||0
10806428|NCT03965039|11967957|FG003|NOT COMPLETED|Overall Study||1
10806429|NCT03963401|11967973|FG000|STARTED|Initial Period (Day 1 - Week 16)||60
10806430|NCT03963401|11967974|FG001|STARTED|Initial Period (Day 1 - Week 16)||61
10806431|NCT03963401|11967975|FG002|STARTED|Initial Period (Day 1 - Week 16)||16
10806432|NCT03963401|11967976|FG003|STARTED|Initial Period (Day 1 - Week 16)||15
10806433|NCT03963401|11967977|FG004|STARTED|Initial Period (Day 1 - Week 16)||34
10806434|NCT03963401|11967978|FG005|STARTED|Initial Period (Day 1 - Week 16)||33
10806435|NCT03963401|11967973|FG000|Treated|Initial Period (Day 1 - Week 16)||60
10806436|NCT03963401|11967974|FG001|Treated|Initial Period (Day 1 - Week 16)||60
10806437|NCT03963401|11967975|FG002|Treated|Initial Period (Day 1 - Week 16)||16
10806438|NCT03963401|11967976|FG003|Treated|Initial Period (Day 1 - Week 16)||15
10578985|NCT01701258|11734073|FG008|NOT COMPLETED|Drug+fMRI (Session 2)||0
10578986|NCT01701258|11734074|FG009|NOT COMPLETED|Drug+fMRI (Session 2)||0
10578987|NCT01701258|11734075|FG010|NOT COMPLETED|Drug+fMRI (Session 2)||0
10578988|NCT01701258|11734076|FG011|NOT COMPLETED|Drug+fMRI (Session 2)||0
10578989|NCT01701258|11734077|FG012|NOT COMPLETED|Drug+fMRI (Session 2)||0
10578990|NCT01701258|11734065|FG000|STARTED|PET (Session 3)||0
10578991|NCT01701258|11734066|FG001|STARTED|PET (Session 3)||20
10578992|NCT01701258|11734067|FG002|STARTED|PET (Session 3)||0
10578993|NCT01701258|11734068|FG003|STARTED|PET (Session 3)||0
10578994|NCT01701258|11734069|FG004|STARTED|PET (Session 3)||16
10578995|NCT01701258|11734070|FG005|STARTED|PET (Session 3)||0
10578996|NCT01701258|11734071|FG006|STARTED|PET (Session 3)||0
10578997|NCT01701258|11734072|FG007|STARTED|PET (Session 3)||19
10578998|NCT01701258|11734073|FG008|STARTED|PET (Session 3)||0
10578999|NCT01701258|11734074|FG009|STARTED|PET (Session 3)||0
10579000|NCT01701258|11734075|FG010|STARTED|PET (Session 3)||18
10579001|NCT01701258|11734076|FG011|STARTED|PET (Session 3)||0
10579002|NCT01701258|11734077|FG012|STARTED|PET (Session 3)||0
10579003|NCT01701258|11734065|FG000|COMPLETED|PET (Session 3)||0
10579004|NCT01701258|11734066|FG001|COMPLETED|PET (Session 3)||20
10579005|NCT01701258|11734067|FG002|COMPLETED|PET (Session 3)||0
10579006|NCT01701258|11734068|FG003|COMPLETED|PET (Session 3)||0
10579007|NCT01701258|11734069|FG004|COMPLETED|PET (Session 3)||16
10579008|NCT01701258|11734070|FG005|COMPLETED|PET (Session 3)||0
10579009|NCT01701258|11734071|FG006|COMPLETED|PET (Session 3)||0
10579010|NCT01701258|11734072|FG007|COMPLETED|PET (Session 3)||19
10579011|NCT01701258|11734073|FG008|COMPLETED|PET (Session 3)||0
10579012|NCT01701258|11734074|FG009|COMPLETED|PET (Session 3)||0
10579013|NCT01701258|11734075|FG010|COMPLETED|PET (Session 3)||18
10579014|NCT01701258|11734076|FG011|COMPLETED|PET (Session 3)||0
10579015|NCT01701258|11734077|FG012|COMPLETED|PET (Session 3)||0
10579016|NCT01701258|11734065|FG000|NOT COMPLETED|PET (Session 3)||0
10579017|NCT01701258|11734066|FG001|NOT COMPLETED|PET (Session 3)||0
10579018|NCT01701258|11734067|FG002|NOT COMPLETED|PET (Session 3)||0
10579019|NCT01701258|11734068|FG003|NOT COMPLETED|PET (Session 3)||0
10806439|NCT03963401|11967977|FG004|Treated|Initial Period (Day 1 - Week 16)||34
10579020|NCT01701258|11734069|FG004|NOT COMPLETED|PET (Session 3)||0
10579021|NCT01701258|11734070|FG005|NOT COMPLETED|PET (Session 3)||0
10579022|NCT01701258|11734071|FG006|NOT COMPLETED|PET (Session 3)||0
10579023|NCT01701258|11734072|FG007|NOT COMPLETED|PET (Session 3)||0
10579024|NCT01701258|11734073|FG008|NOT COMPLETED|PET (Session 3)||0
10579025|NCT01701258|11734074|FG009|NOT COMPLETED|PET (Session 3)||0
10579026|NCT01701258|11734075|FG010|NOT COMPLETED|PET (Session 3)||0
10579027|NCT01701258|11734076|FG011|NOT COMPLETED|PET (Session 3)||0
10579028|NCT01701258|11734077|FG012|NOT COMPLETED|PET (Session 3)||0
10579029|NCT01701258|11734065|FG000|STARTED|EEG (Session 4)||0
10579030|NCT01701258|11734066|FG001|STARTED|EEG (Session 4)||19
10579031|NCT01701258|11734067|FG002|STARTED|EEG (Session 4)||0
10579032|NCT01701258|11734068|FG003|STARTED|EEG (Session 4)||0
10579033|NCT01701258|11734069|FG004|STARTED|EEG (Session 4)||14
10579034|NCT01701258|11734070|FG005|STARTED|EEG (Session 4)||0
10579035|NCT01701258|11734071|FG006|STARTED|EEG (Session 4)||0
10579036|NCT01701258|11734072|FG007|STARTED|EEG (Session 4)||16
10579037|NCT01701258|11734073|FG008|STARTED|EEG (Session 4)||0
10579038|NCT01701258|11734074|FG009|STARTED|EEG (Session 4)||0
10579039|NCT01701258|11734075|FG010|STARTED|EEG (Session 4)||17
10579040|NCT01701258|11734076|FG011|STARTED|EEG (Session 4)||0
10579041|NCT01701258|11734077|FG012|STARTED|EEG (Session 4)||0
10579042|NCT01701258|11734065|FG000|COMPLETED|EEG (Session 4)||0
10579043|NCT01701258|11734066|FG001|COMPLETED|EEG (Session 4)||19
10579044|NCT01701258|11734067|FG002|COMPLETED|EEG (Session 4)||0
10579045|NCT01701258|11734068|FG003|COMPLETED|EEG (Session 4)||0
10579046|NCT01701258|11734069|FG004|COMPLETED|EEG (Session 4)||14
10579047|NCT01701258|11734070|FG005|COMPLETED|EEG (Session 4)||0
10579048|NCT01701258|11734071|FG006|COMPLETED|EEG (Session 4)||0
10579049|NCT01701258|11734072|FG007|COMPLETED|EEG (Session 4)||16
10579050|NCT01701258|11734073|FG008|COMPLETED|EEG (Session 4)||0
10579051|NCT01701258|11734074|FG009|COMPLETED|EEG (Session 4)||0
10579052|NCT01701258|11734075|FG010|COMPLETED|EEG (Session 4)||17
10579053|NCT01701258|11734076|FG011|COMPLETED|EEG (Session 4)||0
10579054|NCT01701258|11734077|FG012|COMPLETED|EEG (Session 4)||0
10579055|NCT01701258|11734065|FG000|NOT COMPLETED|EEG (Session 4)||0
10579056|NCT01701258|11734066|FG001|NOT COMPLETED|EEG (Session 4)||0
10579057|NCT01701258|11734067|FG002|NOT COMPLETED|EEG (Session 4)||0
10579058|NCT01701258|11734068|FG003|NOT COMPLETED|EEG (Session 4)||0
10579059|NCT01701258|11734069|FG004|NOT COMPLETED|EEG (Session 4)||0
10579060|NCT01701258|11734070|FG005|NOT COMPLETED|EEG (Session 4)||0
10579061|NCT01701258|11734071|FG006|NOT COMPLETED|EEG (Session 4)||0
10579062|NCT01701258|11734072|FG007|NOT COMPLETED|EEG (Session 4)||0
10579063|NCT01701258|11734073|FG008|NOT COMPLETED|EEG (Session 4)||0
10579064|NCT01701258|11734074|FG009|NOT COMPLETED|EEG (Session 4)||0
10579065|NCT01701258|11734075|FG010|NOT COMPLETED|EEG (Session 4)||0
10579066|NCT01701258|11734076|FG011|NOT COMPLETED|EEG (Session 4)||0
10579067|NCT01701258|11734077|FG012|NOT COMPLETED|EEG (Session 4)||0
10579068|NCT01701271|11734105|FG000|STARTED|Overall Study||20
10579069|NCT01701271|11734105|FG000|COMPLETED|Overall Study||20
10579070|NCT01701271|11734105|FG000|NOT COMPLETED|Overall Study||0
10579071|NCT01701362|11734112|FG000|STARTED|Overall Study||275
10579072|NCT01701362|11734113|FG001|STARTED|Overall Study||267
10579073|NCT01701362|11734112|FG000|TREATED|Overall Study||274
10579074|NCT01701362|11734113|FG001|TREATED|Overall Study||265
10579075|NCT01701362|11734112|FG000|COMPLETED|Overall Study||233
10806440|NCT03963401|11967978|FG005|Treated|Initial Period (Day 1 - Week 16)||33
10806441|NCT03963401|11967973|FG000|COMPLETED|Initial Period (Day 1 - Week 16)||57
10806442|NCT03963401|11967974|FG001|COMPLETED|Initial Period (Day 1 - Week 16)||57
10806443|NCT03963401|11967975|FG002|COMPLETED|Initial Period (Day 1 - Week 16)||14
10579076|NCT01701362|11734113|FG001|COMPLETED|Overall Study||211
10579077|NCT01701362|11734112|FG000|NOT COMPLETED|Overall Study||42
10579078|NCT01701362|11734113|FG001|NOT COMPLETED|Overall Study||56
10579079|NCT01701375|11734119|FG000|STARTED|Overall Study||2
10579080|NCT01701375|11734119|FG000|COMPLETED|Overall Study||2
10579081|NCT01701375|11734119|FG000|NOT COMPLETED|Overall Study||0
10579082|NCT01701401|11734127|FG000|STARTED|Overall Study||217
10579083|NCT01701401|11734128|FG001|STARTED|Overall Study||218
10579084|NCT01701401|11734129|FG002|STARTED|Overall Study||217
10579085|NCT01701401|11734130|FG003|STARTED|Overall Study||218
10579086|NCT01701401|11734127|FG000|COMPLETED|Overall Study||207
10579087|NCT01701401|11734128|FG001|COMPLETED|Overall Study||209
10579088|NCT01701401|11734129|FG002|COMPLETED|Overall Study||212
10579089|NCT01701401|11734130|FG003|COMPLETED|Overall Study||212
10579090|NCT01701401|11734127|FG000|NOT COMPLETED|Overall Study||10
10579091|NCT01701401|11734128|FG001|NOT COMPLETED|Overall Study||9
10579092|NCT01701401|11734129|FG002|NOT COMPLETED|Overall Study||5
10579093|NCT01701401|11734130|FG003|NOT COMPLETED|Overall Study||6
10579094|NCT01701414|11734142|FG000|STARTED|Overall Study||19
10579095|NCT01701414|11734143|FG001|STARTED|Overall Study||19
10579096|NCT01701414|11734142|FG000|COMPLETED|Overall Study||18
10579097|NCT01701414|11734143|FG001|COMPLETED|Overall Study||18
10579098|NCT01701414|11734142|FG000|NOT COMPLETED|Overall Study||1
10579099|NCT01701414|11734143|FG001|NOT COMPLETED|Overall Study||1
10579100|NCT01701505|11734155|FG000|STARTED|Overall Study||8
10806444|NCT03963401|11967976|FG003|COMPLETED|Initial Period (Day 1 - Week 16)||13
10579101|NCT01701505|11734156|FG001|STARTED|Overall Study||8
10579102|NCT01701505|11734157|FG002|STARTED|Overall Study||8
10579103|NCT01701505|11734158|FG003|STARTED|Overall Study||8
10579104|NCT01701505|11734159|FG004|STARTED|Overall Study||8
10579105|NCT01701505|11734160|FG005|STARTED|Overall Study||8
10579106|NCT01701505|11734155|FG000|COMPLETED|Overall Study||8
10579107|NCT01701505|11734156|FG001|COMPLETED|Overall Study||8
10579108|NCT01701505|11734157|FG002|COMPLETED|Overall Study||8
10579109|NCT01701505|11734158|FG003|COMPLETED|Overall Study||8
10579110|NCT01701505|11734159|FG004|COMPLETED|Overall Study||8
10579111|NCT01701505|11734160|FG005|COMPLETED|Overall Study||8
10579112|NCT01701505|11734155|FG000|NOT COMPLETED|Overall Study||0
10579113|NCT01701505|11734156|FG001|NOT COMPLETED|Overall Study||0
10579114|NCT01701505|11734157|FG002|NOT COMPLETED|Overall Study||0
10579115|NCT01701505|11734158|FG003|NOT COMPLETED|Overall Study||0
10579116|NCT01701505|11734159|FG004|NOT COMPLETED|Overall Study||0
10579117|NCT01701505|11734160|FG005|NOT COMPLETED|Overall Study||0
10579118|NCT01701973|11734177|FG000|STARTED|Aim 1: First Intervention (1 Day)||23
10579119|NCT01701973|11734178|FG001|STARTED|Aim 1: First Intervention (1 Day)||21
10579120|NCT01701973|11734179|FG002|STARTED|Aim 1: First Intervention (1 Day)||0
10579121|NCT01701973|11734180|FG003|STARTED|Aim 1: First Intervention (1 Day)||0
10579122|NCT01701973|11734181|FG004|STARTED|Aim 1: First Intervention (1 Day)||0
10579123|NCT01701973|11734182|FG005|STARTED|Aim 1: First Intervention (1 Day)||0
10579124|NCT01701973|11734183|FG006|STARTED|Aim 1: First Intervention (1 Day)||0
10579125|NCT01701973|11734184|FG007|STARTED|Aim 1: First Intervention (1 Day)||0
10579126|NCT01701973|11734177|FG000|COMPLETED|Aim 1: First Intervention (1 Day)||23
10579127|NCT01701973|11734178|FG001|COMPLETED|Aim 1: First Intervention (1 Day)||20
10579128|NCT01701973|11734179|FG002|COMPLETED|Aim 1: First Intervention (1 Day)||0
10579129|NCT01701973|11734180|FG003|COMPLETED|Aim 1: First Intervention (1 Day)||0
10579130|NCT01701973|11734181|FG004|COMPLETED|Aim 1: First Intervention (1 Day)||0
10579131|NCT01701973|11734182|FG005|COMPLETED|Aim 1: First Intervention (1 Day)||0
10579132|NCT01701973|11734183|FG006|COMPLETED|Aim 1: First Intervention (1 Day)||0
10579133|NCT01701973|11734184|FG007|COMPLETED|Aim 1: First Intervention (1 Day)||0
10806445|NCT03963401|11967977|FG004|COMPLETED|Initial Period (Day 1 - Week 16)||31
10806446|NCT03963401|11967978|FG005|COMPLETED|Initial Period (Day 1 - Week 16)||31
10806447|NCT03963401|11967973|FG000|NOT COMPLETED|Initial Period (Day 1 - Week 16)||3
10579134|NCT01701973|11734177|FG000|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
10579135|NCT01701973|11734178|FG001|NOT COMPLETED|Aim 1: First Intervention (1 Day)||1
10579136|NCT01701973|11734179|FG002|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
10579137|NCT01701973|11734180|FG003|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
10579138|NCT01701973|11734181|FG004|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
10579139|NCT01701973|11734182|FG005|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
10579140|NCT01701973|11734183|FG006|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
10579141|NCT01701973|11734184|FG007|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
10579142|NCT01701973|11734177|FG000|STARTED|Aim 1: Second Intervention (1 Day)|1 subject was lost to follow-up in between Periods 1 and 2.|22
10579143|NCT01701973|11734178|FG001|STARTED|Aim 1: Second Intervention (1 Day)|3 subjects were lost to follow-up in between Periods 1 and 2.|17
10579144|NCT01701973|11734179|FG002|STARTED|Aim 1: Second Intervention (1 Day)||0
10579145|NCT01701973|11734180|FG003|STARTED|Aim 1: Second Intervention (1 Day)||0
10579146|NCT01701973|11734181|FG004|STARTED|Aim 1: Second Intervention (1 Day)||0
10579147|NCT01701973|11734182|FG005|STARTED|Aim 1: Second Intervention (1 Day)||0
10579148|NCT01701973|11734183|FG006|STARTED|Aim 1: Second Intervention (1 Day)||0
10579149|NCT01701973|11734184|FG007|STARTED|Aim 1: Second Intervention (1 Day)||0
10806448|NCT03963401|11967974|FG001|NOT COMPLETED|Initial Period (Day 1 - Week 16)||4
10806449|NCT03963401|11967975|FG002|NOT COMPLETED|Initial Period (Day 1 - Week 16)||2
10579150|NCT01701973|11734177|FG000|COMPLETED|Aim 1: Second Intervention (1 Day)||22
10579151|NCT01701973|11734178|FG001|COMPLETED|Aim 1: Second Intervention (1 Day)||17
10579152|NCT01701973|11734179|FG002|COMPLETED|Aim 1: Second Intervention (1 Day)||0
10579153|NCT01701973|11734180|FG003|COMPLETED|Aim 1: Second Intervention (1 Day)||0
10579154|NCT01701973|11734181|FG004|COMPLETED|Aim 1: Second Intervention (1 Day)||0
10579155|NCT01701973|11734182|FG005|COMPLETED|Aim 1: Second Intervention (1 Day)||0
10579156|NCT01701973|11734183|FG006|COMPLETED|Aim 1: Second Intervention (1 Day)||0
10579157|NCT01701973|11734184|FG007|COMPLETED|Aim 1: Second Intervention (1 Day)||0
10579158|NCT01701973|11734177|FG000|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
10579159|NCT01701973|11734178|FG001|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
10579160|NCT01701973|11734179|FG002|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
10579161|NCT01701973|11734180|FG003|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
10579162|NCT01701973|11734181|FG004|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
10579163|NCT01701973|11734182|FG005|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
10579164|NCT01701973|11734183|FG006|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
10579165|NCT01701973|11734184|FG007|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
10579166|NCT01701973|11734177|FG000|STARTED|Aim 2: First Intervention (1 Day)||0
10579167|NCT01701973|11734178|FG001|STARTED|Aim 2: First Intervention (1 Day)||0
10579168|NCT01701973|11734179|FG002|STARTED|Aim 2: First Intervention (1 Day)||5
10579169|NCT01701973|11734180|FG003|STARTED|Aim 2: First Intervention (1 Day)||4
10579170|NCT01701973|11734181|FG004|STARTED|Aim 2: First Intervention (1 Day)||2
10579171|NCT01701973|11734182|FG005|STARTED|Aim 2: First Intervention (1 Day)||3
10579172|NCT01701973|11734183|FG006|STARTED|Aim 2: First Intervention (1 Day)||5
10579173|NCT01701973|11734184|FG007|STARTED|Aim 2: First Intervention (1 Day)||4
10579174|NCT01701973|11734177|FG000|COMPLETED|Aim 2: First Intervention (1 Day)||0
10579175|NCT01701973|11734178|FG001|COMPLETED|Aim 2: First Intervention (1 Day)||0
10579176|NCT01701973|11734179|FG002|COMPLETED|Aim 2: First Intervention (1 Day)||5
10806450|NCT03963401|11967976|FG003|NOT COMPLETED|Initial Period (Day 1 - Week 16)||2
10806451|NCT03963401|11967977|FG004|NOT COMPLETED|Initial Period (Day 1 - Week 16)||3
10579177|NCT01701973|11734180|FG003|COMPLETED|Aim 2: First Intervention (1 Day)||4
10579178|NCT01701973|11734181|FG004|COMPLETED|Aim 2: First Intervention (1 Day)||2
10579179|NCT01701973|11734182|FG005|COMPLETED|Aim 2: First Intervention (1 Day)||3
10579180|NCT01701973|11734183|FG006|COMPLETED|Aim 2: First Intervention (1 Day)||5
10579181|NCT01701973|11734184|FG007|COMPLETED|Aim 2: First Intervention (1 Day)||4
10579182|NCT01701973|11734177|FG000|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
10579183|NCT01701973|11734178|FG001|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
10579184|NCT01701973|11734179|FG002|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
10579185|NCT01701973|11734180|FG003|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
10579186|NCT01701973|11734181|FG004|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
10579187|NCT01701973|11734182|FG005|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
10579188|NCT01701973|11734183|FG006|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
10579189|NCT01701973|11734184|FG007|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
10579190|NCT01701973|11734177|FG000|STARTED|Aim 2: Second Intervention (1 Day)||0
10579191|NCT01701973|11734178|FG001|STARTED|Aim 2: Second Intervention (1 Day)||0
10579192|NCT01701973|11734179|FG002|STARTED|Aim 2: Second Intervention (1 Day)||5
10579193|NCT01701973|11734180|FG003|STARTED|Aim 2: Second Intervention (1 Day)||4
10579194|NCT01701973|11734181|FG004|STARTED|Aim 2: Second Intervention (1 Day)||2
10579195|NCT01701973|11734182|FG005|STARTED|Aim 2: Second Intervention (1 Day)||3
10579196|NCT01701973|11734183|FG006|STARTED|Aim 2: Second Intervention (1 Day)||5
10579197|NCT01701973|11734184|FG007|STARTED|Aim 2: Second Intervention (1 Day)|1 subject was lost to follow-up in between Periods 3 and 4.|3
10579198|NCT01701973|11734177|FG000|COMPLETED|Aim 2: Second Intervention (1 Day)||0
10579199|NCT01701973|11734178|FG001|COMPLETED|Aim 2: Second Intervention (1 Day)||0
10579200|NCT01701973|11734179|FG002|COMPLETED|Aim 2: Second Intervention (1 Day)||5
10579201|NCT01701973|11734180|FG003|COMPLETED|Aim 2: Second Intervention (1 Day)||4
10579202|NCT01701973|11734181|FG004|COMPLETED|Aim 2: Second Intervention (1 Day)||2
10579203|NCT01701973|11734182|FG005|COMPLETED|Aim 2: Second Intervention (1 Day)||3
10579204|NCT01701973|11734183|FG006|COMPLETED|Aim 2: Second Intervention (1 Day)||5
10579205|NCT01701973|11734184|FG007|COMPLETED|Aim 2: Second Intervention (1 Day)||3
10579206|NCT01701973|11734177|FG000|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
10579207|NCT01701973|11734178|FG001|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
10579208|NCT01701973|11734179|FG002|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
10579209|NCT01701973|11734180|FG003|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
10579210|NCT01701973|11734181|FG004|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
10579211|NCT01701973|11734182|FG005|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
10579212|NCT01701973|11734183|FG006|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
10579213|NCT01701973|11734184|FG007|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
10579214|NCT01701999|11734226|FG000|STARTED|Overall Study||8
10579215|NCT01701999|11734227|FG001|STARTED|Overall Study||37
10579216|NCT01701999|11734226|FG000|COMPLETED|Overall Study||8
10579217|NCT01701999|11734227|FG001|COMPLETED|Overall Study||37
10579218|NCT01701999|11734226|FG000|NOT COMPLETED|Overall Study||0
10579219|NCT01701999|11734227|FG001|NOT COMPLETED|Overall Study||0
10579220|NCT01702025|11734237|FG000|STARTED|Overall Study||11
10579221|NCT01702025|11734238|FG001|STARTED|Overall Study||10
10579222|NCT01702025|11734239|FG002|STARTED|Overall Study||10
10579223|NCT01702025|11734240|FG003|STARTED|Overall Study||10
10579224|NCT01702025|11734237|FG000|COMPLETED|Overall Study||9
10579225|NCT01702025|11734238|FG001|COMPLETED|Overall Study||9
10579226|NCT01702025|11734239|FG002|COMPLETED|Overall Study||9
10579227|NCT01702025|11734240|FG003|COMPLETED|Overall Study||10
10579228|NCT01702025|11734237|FG000|NOT COMPLETED|Overall Study||2
10579229|NCT01702025|11734238|FG001|NOT COMPLETED|Overall Study||1
10579230|NCT01702025|11734239|FG002|NOT COMPLETED|Overall Study||1
10579231|NCT01702025|11734240|FG003|NOT COMPLETED|Overall Study||0
10579232|NCT01702233|11734257|FG000|STARTED|Overall Study||72
10579233|NCT01702233|11734258|FG001|STARTED|Overall Study||67
10579234|NCT01702233|11734259|FG002|STARTED|Overall Study||36
10579235|NCT01702233|11734257|FG000|Full Analysis Set (ITT)|Overall Study||66
10579236|NCT01702233|11734258|FG001|Full Analysis Set (ITT)|Overall Study||63
10579237|NCT01702233|11734259|FG002|Full Analysis Set (ITT)|Overall Study||31
10579238|NCT01702233|11734257|FG000|Per Protocol Set|Overall Study||58
10579239|NCT01702233|11734258|FG001|Per Protocol Set|Overall Study||58
10579240|NCT01702233|11734259|FG002|Per Protocol Set|Overall Study||27
10579241|NCT01702233|11734257|FG000|COMPLETED|Overall Study||66
10579242|NCT01702233|11734258|FG001|COMPLETED|Overall Study|One of these Patient completed the Trial but had no valid outcome measure after enrolment|64
10579243|NCT01702233|11734259|FG002|COMPLETED|Overall Study||31
10579244|NCT01702233|11734257|FG000|NOT COMPLETED|Overall Study||6
10579245|NCT01702233|11734258|FG001|NOT COMPLETED|Overall Study||3
10579246|NCT01702233|11734259|FG002|NOT COMPLETED|Overall Study||5
10579247|NCT01702246|11734268|FG000|STARTED|Overall Study||24
10579248|NCT01702246|11734268|FG000|COMPLETED|Overall Study||19
10579249|NCT01702246|11734268|FG000|NOT COMPLETED|Overall Study||5
10579250|NCT01702259|11734277|FG000|STARTED|Overall Study||34
10579251|NCT01702259|11734278|FG001|STARTED|Overall Study||34
10579252|NCT01702259|11734277|FG000|COMPLETED|Overall Study||34
10579253|NCT01702259|11734278|FG001|COMPLETED|Overall Study||34
10579254|NCT01702259|11734277|FG000|NOT COMPLETED|Overall Study||0
10579255|NCT01702259|11734278|FG001|NOT COMPLETED|Overall Study||0
10579256|NCT01702298|11734284|FG000|STARTED|Overall Study||42
10579257|NCT01702298|11734284|FG000|COMPLETED|Overall Study||41
10579258|NCT01702298|11734284|FG000|NOT COMPLETED|Overall Study||1
10579259|NCT01702311|11734290|FG000|STARTED|Overall Study||122
10579260|NCT01702311|11734291|FG001|STARTED|Overall Study||113
10579261|NCT01702311|11734290|FG000|COMPLETED|Overall Study||106
10579262|NCT01702311|11734291|FG001|COMPLETED|Overall Study||100
10579263|NCT01702311|11734290|FG000|NOT COMPLETED|Overall Study||16
10579264|NCT01702311|11734291|FG001|NOT COMPLETED|Overall Study||13
10579265|NCT01702363|11734300|FG000|STARTED|Overall Study||131
10579266|NCT01702363|11734300|FG000|COMPLETED|Overall Study||111
10579267|NCT01702363|11734300|FG000|NOT COMPLETED|Overall Study||20
10579268|NCT01702428|11734309|FG000|STARTED|Overall Study||1239
10579269|NCT01702428|11734310|FG001|STARTED|Overall Study||1232
10579270|NCT01702428|11734311|FG002|STARTED|Overall Study||1243
10579271|NCT01702428|11734312|FG003|STARTED|Overall Study||1289
10579272|NCT01702428|11734309|FG000|COMPLETED|Overall Study||1175
10579273|NCT01702428|11734310|FG001|COMPLETED|Overall Study||1162
10579274|NCT01702428|11734311|FG002|COMPLETED|Overall Study||1190
10579275|NCT01702428|11734312|FG003|COMPLETED|Overall Study||1232
10579276|NCT01702428|11734309|FG000|NOT COMPLETED|Overall Study||64
10579277|NCT01702428|11734310|FG001|NOT COMPLETED|Overall Study||70
10579278|NCT01702428|11734311|FG002|NOT COMPLETED|Overall Study||53
10579279|NCT01702428|11734312|FG003|NOT COMPLETED|Overall Study||57
10579280|NCT01702454|11734331|FG000|STARTED|Overall Study||241
10579281|NCT01702454|11734332|FG001|STARTED|Overall Study||229
10579282|NCT01702454|11734331|FG000|COMPLETED|Overall Study||238
10579283|NCT01702454|11734332|FG001|COMPLETED|Overall Study||221
10579284|NCT01702454|11734331|FG000|NOT COMPLETED|Overall Study||3
10579285|NCT01702454|11734332|FG001|NOT COMPLETED|Overall Study||8
10579286|NCT01702519|11734343|FG000|STARTED|Period 1||20
10579287|NCT01702519|11734344|FG001|STARTED|Period 1||20
10579288|NCT01702519|11734343|FG000|COMPLETED|Period 1||20
10579289|NCT01702519|11734344|FG001|COMPLETED|Period 1||20
10579290|NCT01702519|11734343|FG000|NOT COMPLETED|Period 1||0
10579291|NCT01702519|11734344|FG001|NOT COMPLETED|Period 1||0
10579292|NCT01702519|11734343|FG000|STARTED|Washout Period||20
10579293|NCT01702519|11734344|FG001|STARTED|Washout Period||20
10579294|NCT01702519|11734343|FG000|COMPLETED|Washout Period||19
10579295|NCT01702519|11734344|FG001|COMPLETED|Washout Period||18
10579296|NCT01702519|11734343|FG000|NOT COMPLETED|Washout Period||1
10579297|NCT01702519|11734344|FG001|NOT COMPLETED|Washout Period||2
10579298|NCT01702519|11734343|FG000|STARTED|Period 2||19
10579299|NCT01702519|11734344|FG001|STARTED|Period 2||18
10579300|NCT01702519|11734343|FG000|COMPLETED|Period 2||19
10579301|NCT01702519|11734344|FG001|COMPLETED|Period 2||18
10806452|NCT03963401|11967978|FG005|NOT COMPLETED|Initial Period (Day 1 - Week 16)||2
10806453|NCT03963401|11967973|FG000|STARTED|Extension Period (Week 17 - Week 52)||57
10806454|NCT03963401|11967974|FG001|STARTED|Extension Period (Week 17 - Week 52)||57
10806455|NCT03963401|11967975|FG002|STARTED|Extension Period (Week 17 - Week 52)||14
10806456|NCT03963401|11967976|FG003|STARTED|Extension Period (Week 17 - Week 52)||13
10806457|NCT03963401|11967977|FG004|STARTED|Extension Period (Week 17 - Week 52)||31
10806458|NCT03963401|11967978|FG005|STARTED|Extension Period (Week 17 - Week 52)||31
10806459|NCT03963401|11967973|FG000|COMPLETED|Extension Period (Week 17 - Week 52)||43
10806460|NCT03963401|11967974|FG001|COMPLETED|Extension Period (Week 17 - Week 52)||52
10806461|NCT03963401|11967975|FG002|COMPLETED|Extension Period (Week 17 - Week 52)||10
10806462|NCT03963401|11967976|FG003|COMPLETED|Extension Period (Week 17 - Week 52)||12
10579302|NCT01702519|11734343|FG000|NOT COMPLETED|Period 2||0
10579303|NCT01702519|11734344|FG001|NOT COMPLETED|Period 2||0
10579304|NCT01702532|11734356|FG000|STARTED|Overall Study||161
10579305|NCT01702532|11734357|FG001|STARTED|Overall Study||161
10579306|NCT01702532|11734356|FG000|Safety Population|Overall Study||161
10579307|NCT01702532|11734357|FG001|Safety Population|Overall Study|One subject randomized but did not receive the study treatment.|160
10579308|NCT01702532|11734356|FG000|COMPLETED|Overall Study||161
10579309|NCT01702532|11734357|FG001|COMPLETED|Overall Study||160
10579310|NCT01702532|11734356|FG000|NOT COMPLETED|Overall Study||0
10579311|NCT01702532|11734357|FG001|NOT COMPLETED|Overall Study||1
10579312|NCT01702558|11734369|FG000|STARTED|Overall Study||7
10579313|NCT01702558|11734370|FG001|STARTED|Overall Study||5
10579314|NCT01702558|11734371|FG002|STARTED|Overall Study||6
10579315|NCT01702558|11734372|FG003|STARTED|Overall Study||81
10579316|NCT01702558|11734373|FG004|STARTED|Overall Study||80
10579317|NCT01702558|11734369|FG000|COMPLETED|Overall Study||3
10579318|NCT01702558|11734370|FG001|COMPLETED|Overall Study||1
10579319|NCT01702558|11734371|FG002|COMPLETED|Overall Study||1
10579320|NCT01702558|11734372|FG003|COMPLETED|Overall Study||34
10579321|NCT01702558|11734373|FG004|COMPLETED|Overall Study||38
10579322|NCT01702558|11734369|FG000|NOT COMPLETED|Overall Study||4
10806463|NCT03963401|11967977|FG004|COMPLETED|Extension Period (Week 17 - Week 52)||25
10579323|NCT01702558|11734370|FG001|NOT COMPLETED|Overall Study||4
10579324|NCT01702558|11734371|FG002|NOT COMPLETED|Overall Study||5
10579325|NCT01702558|11734372|FG003|NOT COMPLETED|Overall Study||47
10579326|NCT01702558|11734373|FG004|NOT COMPLETED|Overall Study||42
10579327|NCT01702844|11734386|FG000|STARTED|Overall Study||42
10579328|NCT01702844|11734386|FG000|Disease Progression|Overall Study||23
10579329|NCT01702844|11734386|FG000|COMPLETED|Overall Study||23
10579330|NCT01702844|11734386|FG000|NOT COMPLETED|Overall Study||19
10579331|NCT01702961|11734390|FG000|STARTED|Overall Study||75
10579332|NCT01702961|11734390|FG000|COMPLETED|Overall Study||28
10579333|NCT01702961|11734390|FG000|NOT COMPLETED|Overall Study||47
10651483|NCT02176005|11811675|FG002|STARTED|Overall Study||8
10651484|NCT02176005|11811676|FG003|STARTED|Overall Study||8
10651485|NCT02176005|11811673|FG000|COMPLETED|Overall Study||14
10651486|NCT02176005|11811674|FG001|COMPLETED|Overall Study||14
10579334|NCT01702987|11734396|FG000|STARTED|Overall Study||10
10579335|NCT01702987|11734397|FG001|STARTED|Overall Study||12
10579336|NCT01702987|11734396|FG000|COMPLETED|Overall Study||9
10579337|NCT01702987|11734397|FG001|COMPLETED|Overall Study||12
10579338|NCT01702987|11734396|FG000|NOT COMPLETED|Overall Study||1
10579339|NCT01702987|11734397|FG001|NOT COMPLETED|Overall Study||0
10579340|NCT01703000|11734403|FG000|STARTED|Overall Study||100
10579341|NCT01703000|11734403|FG000|COMPLETED|Overall Study||99
10579342|NCT01703000|11734403|FG000|NOT COMPLETED|Overall Study||1
10579343|NCT01703039|11734409|FG000|STARTED|Overall Study||9
10579344|NCT01703039|11734410|FG001|STARTED|Overall Study||12
10579345|NCT01703039|11734409|FG000|COMPLETED|Overall Study||6
10579346|NCT01703039|11734410|FG001|COMPLETED|Overall Study||7
10579347|NCT01703039|11734409|FG000|NOT COMPLETED|Overall Study||3
10579348|NCT01703039|11734410|FG001|NOT COMPLETED|Overall Study||5
10579349|NCT01703065|11734420|FG000|STARTED|Overall Study||9
10579350|NCT01703065|11734421|FG001|STARTED|Overall Study||0
10579351|NCT01703065|11734420|FG000|COMPLETED|Overall Study||8
10579352|NCT01703065|11734421|FG001|COMPLETED|Overall Study||0
10579353|NCT01703065|11734420|FG000|NOT COMPLETED|Overall Study||1
10806464|NCT03963401|11967978|FG005|COMPLETED|Extension Period (Week 17 - Week 52)||26
10806465|NCT03963401|11967973|FG000|NOT COMPLETED|Extension Period (Week 17 - Week 52)||14
10806466|NCT03963401|11967974|FG001|NOT COMPLETED|Extension Period (Week 17 - Week 52)||5
10806467|NCT03963401|11967975|FG002|NOT COMPLETED|Extension Period (Week 17 - Week 52)||4
10806468|NCT03963401|11967976|FG003|NOT COMPLETED|Extension Period (Week 17 - Week 52)||1
10806469|NCT03963401|11967977|FG004|NOT COMPLETED|Extension Period (Week 17 - Week 52)||6
10806470|NCT03963401|11967978|FG005|NOT COMPLETED|Extension Period (Week 17 - Week 52)||5
10806471|NCT03962634|11967998|FG000|STARTED|Overall Study||1
10806472|NCT03962634|11967999|FG001|STARTED|Overall Study||2
10579354|NCT01703065|11734421|FG001|NOT COMPLETED|Overall Study||0
10579355|NCT01703091|11734430|FG000|STARTED|Overall Study||98
10579356|NCT01703091|11734431|FG001|STARTED|Overall Study||99
10579357|NCT01703091|11734430|FG000|Received at Least One Dose of Study Drug|Overall Study||94
10579358|NCT01703091|11734431|FG001|Received at Least One Dose of Study Drug|Overall Study||98
10579359|NCT01703091|11734430|FG000|COMPLETED|Overall Study||89
10579360|NCT01703091|11734431|FG001|COMPLETED|Overall Study||95
10579361|NCT01703091|11734430|FG000|NOT COMPLETED|Overall Study||9
10579362|NCT01703091|11734431|FG001|NOT COMPLETED|Overall Study||4
10579363|NCT01703117|11734439|FG000|STARTED|Overall Study||26
10579364|NCT01703117|11734440|FG001|STARTED|Overall Study||24
10579365|NCT01703117|11734439|FG000|COMPLETED|Overall Study||22
10579366|NCT01703117|11734440|FG001|COMPLETED|Overall Study||20
10579367|NCT01703117|11734439|FG000|NOT COMPLETED|Overall Study||4
10579368|NCT01703117|11734440|FG001|NOT COMPLETED|Overall Study||4
10579369|NCT01703169|11734448|FG000|STARTED|Overall Study||13
10579370|NCT01703169|11734448|FG000|COMPLETED|Overall Study||13
10579371|NCT01703169|11734448|FG000|NOT COMPLETED|Overall Study||0
10579372|NCT01703208|11734454|FG000|STARTED|Overall Study||2100
10579373|NCT01703208|11734455|FG001|STARTED|Overall Study||2102
10579374|NCT01703208|11734454|FG000|Treated|Overall Study||2092
10579375|NCT01703208|11734455|FG001|Treated|Overall Study||2100
10579376|NCT01703208|11734454|FG000|COMPLETED|Overall Study||0
10579377|NCT01703208|11734455|FG001|COMPLETED|Overall Study||0
10579378|NCT01703208|11734454|FG000|NOT COMPLETED|Overall Study||2100
10579379|NCT01703208|11734455|FG001|NOT COMPLETED|Overall Study||2102
10579380|NCT01703221|11734464|FG000|STARTED|Phase A (Up to 24 Weeks)||166
10579381|NCT01703221|11734465|FG001|STARTED|Phase A (Up to 24 Weeks)||165
10579382|NCT01703221|11734466|FG002|STARTED|Phase A (Up to 24 Weeks)||83
10579383|NCT01703221|11734464|FG000|COMPLETED|Phase A (Up to 24 Weeks)||159
10579384|NCT01703221|11734465|FG001|COMPLETED|Phase A (Up to 24 Weeks)||161
10579385|NCT01703221|11734466|FG002|COMPLETED|Phase A (Up to 24 Weeks)||80
10579386|NCT01703221|11734464|FG000|NOT COMPLETED|Phase A (Up to 24 Weeks)||7
10579387|NCT01703221|11734465|FG001|NOT COMPLETED|Phase A (Up to 24 Weeks)||4
10579388|NCT01703221|11734466|FG002|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
10579389|NCT01703221|11734464|FG000|STARTED|Phase B - (Week 25 to 52)||159
10579390|NCT01703221|11734465|FG001|STARTED|Phase B - (Week 25 to 52)||161
10579391|NCT01703221|11734466|FG002|STARTED|Phase B - (Week 25 to 52)||80
10579392|NCT01703221|11734464|FG000|COMPLETED|Phase B - (Week 25 to 52)||143
10579393|NCT01703221|11734465|FG001|COMPLETED|Phase B - (Week 25 to 52)||147
10579394|NCT01703221|11734466|FG002|COMPLETED|Phase B - (Week 25 to 52)||75
10579395|NCT01703221|11734464|FG000|NOT COMPLETED|Phase B - (Week 25 to 52)||16
10579396|NCT01703221|11734465|FG001|NOT COMPLETED|Phase B - (Week 25 to 52)||14
10579397|NCT01703221|11734466|FG002|NOT COMPLETED|Phase B - (Week 25 to 52)||5
10806473|NCT03962634|11967998|FG000|COMPLETED|Overall Study||1
10806474|NCT03962634|11967999|FG001|COMPLETED|Overall Study||2
10806475|NCT03962634|11967998|FG000|NOT COMPLETED|Overall Study||0
10579398|NCT01703260|11734483|FG000|STARTED|Overall Study||7
10579399|NCT01703260|11734484|FG001|STARTED|Overall Study||7
10579400|NCT01703260|11734485|FG002|STARTED|Overall Study||6
10579401|NCT01703260|11734483|FG000|COMPLETED|Overall Study||4
10579402|NCT01703260|11734484|FG001|COMPLETED|Overall Study||3
10579403|NCT01703260|11734485|FG002|COMPLETED|Overall Study||3
10579404|NCT01703260|11734483|FG000|NOT COMPLETED|Overall Study||3
10579405|NCT01703260|11734484|FG001|NOT COMPLETED|Overall Study||4
10579406|NCT01703260|11734485|FG002|NOT COMPLETED|Overall Study||3
10579407|NCT01703286|11734493|FG000|STARTED|Period 1 Including Washout||7
10579408|NCT01703286|11734494|FG001|STARTED|Period 1 Including Washout||7
10579409|NCT01703286|11734495|FG002|STARTED|Period 1 Including Washout||7
10579410|NCT01703286|11734496|FG003|STARTED|Period 1 Including Washout||7
10579411|NCT01703286|11734497|FG004|STARTED|Period 1 Including Washout||7
10579412|NCT01703286|11734498|FG005|STARTED|Period 1 Including Washout||7
10579413|NCT01703286|11734493|FG000|COMPLETED|Period 1 Including Washout||7
10579414|NCT01703286|11734494|FG001|COMPLETED|Period 1 Including Washout||7
10579415|NCT01703286|11734495|FG002|COMPLETED|Period 1 Including Washout||7
10579416|NCT01703286|11734496|FG003|COMPLETED|Period 1 Including Washout||6
10579417|NCT01703286|11734497|FG004|COMPLETED|Period 1 Including Washout||7
10579418|NCT01703286|11734498|FG005|COMPLETED|Period 1 Including Washout||6
10579419|NCT01703286|11734493|FG000|NOT COMPLETED|Period 1 Including Washout||0
10579420|NCT01703286|11734494|FG001|NOT COMPLETED|Period 1 Including Washout||0
10579421|NCT01703286|11734495|FG002|NOT COMPLETED|Period 1 Including Washout||0
10579422|NCT01703286|11734496|FG003|NOT COMPLETED|Period 1 Including Washout||1
10579423|NCT01703286|11734497|FG004|NOT COMPLETED|Period 1 Including Washout||0
10579424|NCT01703286|11734498|FG005|NOT COMPLETED|Period 1 Including Washout||1
10579425|NCT01703286|11734493|FG000|STARTED|Period 2 Including Washout||7
10579426|NCT01703286|11734494|FG001|STARTED|Period 2 Including Washout||7
10579427|NCT01703286|11734495|FG002|STARTED|Period 2 Including Washout||7
10579428|NCT01703286|11734496|FG003|STARTED|Period 2 Including Washout||6
10579429|NCT01703286|11734497|FG004|STARTED|Period 2 Including Washout||7
10579430|NCT01703286|11734498|FG005|STARTED|Period 2 Including Washout||6
10579431|NCT01703286|11734493|FG000|COMPLETED|Period 2 Including Washout||7
10579432|NCT01703286|11734494|FG001|COMPLETED|Period 2 Including Washout||7
10579433|NCT01703286|11734495|FG002|COMPLETED|Period 2 Including Washout||7
10579434|NCT01703286|11734496|FG003|COMPLETED|Period 2 Including Washout||5
10579435|NCT01703286|11734497|FG004|COMPLETED|Period 2 Including Washout||7
10579436|NCT01703286|11734498|FG005|COMPLETED|Period 2 Including Washout||6
10579437|NCT01703286|11734493|FG000|NOT COMPLETED|Period 2 Including Washout||0
10579438|NCT01703286|11734494|FG001|NOT COMPLETED|Period 2 Including Washout||0
10579439|NCT01703286|11734495|FG002|NOT COMPLETED|Period 2 Including Washout||0
10579440|NCT01703286|11734496|FG003|NOT COMPLETED|Period 2 Including Washout||1
10579441|NCT01703286|11734497|FG004|NOT COMPLETED|Period 2 Including Washout||0
10579442|NCT01703286|11734498|FG005|NOT COMPLETED|Period 2 Including Washout||0
10579443|NCT01703286|11734493|FG000|STARTED|Period 3 Including Washout||7
10579444|NCT01703286|11734494|FG001|STARTED|Period 3 Including Washout||7
10579445|NCT01703286|11734495|FG002|STARTED|Period 3 Including Washout||7
10579446|NCT01703286|11734496|FG003|STARTED|Period 3 Including Washout||5
10579447|NCT01703286|11734497|FG004|STARTED|Period 3 Including Washout||7
10579448|NCT01703286|11734498|FG005|STARTED|Period 3 Including Washout||6
10579449|NCT01703286|11734493|FG000|COMPLETED|Period 3 Including Washout||7
10579450|NCT01703286|11734494|FG001|COMPLETED|Period 3 Including Washout||7
10579451|NCT01703286|11734495|FG002|COMPLETED|Period 3 Including Washout||7
10579452|NCT01703286|11734496|FG003|COMPLETED|Period 3 Including Washout||5
10579453|NCT01703286|11734497|FG004|COMPLETED|Period 3 Including Washout||7
10579454|NCT01703286|11734498|FG005|COMPLETED|Period 3 Including Washout||6
10579455|NCT01703286|11734493|FG000|NOT COMPLETED|Period 3 Including Washout||0
10579456|NCT01703286|11734494|FG001|NOT COMPLETED|Period 3 Including Washout||0
10579457|NCT01703286|11734495|FG002|NOT COMPLETED|Period 3 Including Washout||0
10579458|NCT01703286|11734496|FG003|NOT COMPLETED|Period 3 Including Washout||0
10579459|NCT01703286|11734497|FG004|NOT COMPLETED|Period 3 Including Washout||0
10579460|NCT01703286|11734498|FG005|NOT COMPLETED|Period 3 Including Washout||0
10579461|NCT01703507|11734511|FG000|STARTED|Overall Study||6
10579462|NCT01703507|11734512|FG001|STARTED|Overall Study||11
10579463|NCT01703507|11734511|FG000|COMPLETED|Overall Study||5
10579464|NCT01703507|11734512|FG001|COMPLETED|Overall Study||11
10579465|NCT01703507|11734511|FG000|NOT COMPLETED|Overall Study||1
10579466|NCT01703507|11734512|FG001|NOT COMPLETED|Overall Study||0
10579467|NCT01703598|11734518|FG000|STARTED|Overall Study||69
10579468|NCT01703598|11734518|FG000|COMPLETED|Overall Study||69
10579469|NCT01703598|11734518|FG000|NOT COMPLETED|Overall Study||0
10579470|NCT01703663|11734522|FG000|STARTED|First Treatment Period||20
10579471|NCT01703663|11734523|FG001|STARTED|First Treatment Period||20
10579472|NCT01703663|11734522|FG000|COMPLETED|First Treatment Period||20
10579473|NCT01703663|11734523|FG001|COMPLETED|First Treatment Period||20
10579474|NCT01703663|11734522|FG000|NOT COMPLETED|First Treatment Period||0
10579475|NCT01703663|11734523|FG001|NOT COMPLETED|First Treatment Period||0
10702568|NCT02576639|11867008|FG004|COMPLETED|Overall Study||20
10702569|NCT02576639|11867004|FG000|NOT COMPLETED|Overall Study||2
10702570|NCT02576639|11867005|FG001|NOT COMPLETED|Overall Study||2
10702571|NCT02576639|11867006|FG002|NOT COMPLETED|Overall Study||2
10579476|NCT01703663|11734522|FG000|STARTED|Second Treatment Period||11
10702572|NCT02576639|11867007|FG003|NOT COMPLETED|Overall Study||1
10702573|NCT02576639|11867008|FG004|NOT COMPLETED|Overall Study||4
10702574|NCT02576652|11867024|FG000|STARTED|Overall Study||6
10702575|NCT02576652|11867024|FG000|COMPLETED|Overall Study||4
10702576|NCT02576652|11867024|FG000|NOT COMPLETED|Overall Study||2
10702577|NCT02576678|11867031|FG000|STARTED|Overall Study||13
10702578|NCT02576678|11867032|FG001|STARTED|Overall Study||8
10702579|NCT02576678|11867033|FG002|STARTED|Overall Study||21
10702580|NCT02576678|11867031|FG000|Pharmacokinetic (PK) Population|Overall Study||12
10702581|NCT02576678|11867032|FG001|Pharmacokinetic (PK) Population|Overall Study||8
10702582|NCT02576678|11867033|FG002|Pharmacokinetic (PK) Population|Overall Study||18
10702583|NCT02576678|11867031|FG000|COMPLETED|Overall Study||8
10702584|NCT02576678|11867032|FG001|COMPLETED|Overall Study||7
10702585|NCT02576678|11867033|FG002|COMPLETED|Overall Study||16
10702586|NCT02576678|11867031|FG000|NOT COMPLETED|Overall Study||5
10702587|NCT02576678|11867032|FG001|NOT COMPLETED|Overall Study||1
10702588|NCT02576678|11867033|FG002|NOT COMPLETED|Overall Study||5
10702589|NCT02576899|11867043|FG000|STARTED|Overall Study||16
10702590|NCT02576899|11867044|FG001|STARTED|Overall Study||20
10702591|NCT02576899|11867043|FG000|COMPLETED|Overall Study||5
10702592|NCT02576899|11867044|FG001|COMPLETED|Overall Study||7
10702593|NCT02576899|11867043|FG000|NOT COMPLETED|Overall Study||11
10702594|NCT02576899|11867044|FG001|NOT COMPLETED|Overall Study||13
10702595|NCT02576938|11867054|FG000|STARTED|Overall Study||49
10702596|NCT02576938|11867055|FG001|STARTED|Overall Study||37
10702597|NCT02576938|11867056|FG002|STARTED|Overall Study||38
10579477|NCT01703663|11734523|FG001|STARTED|Second Treatment Period||8
10579478|NCT01703663|11734522|FG000|COMPLETED|Second Treatment Period||11
10579479|NCT01703663|11734523|FG001|COMPLETED|Second Treatment Period||8
10579480|NCT01703663|11734522|FG000|NOT COMPLETED|Second Treatment Period||0
10579481|NCT01703663|11734523|FG001|NOT COMPLETED|Second Treatment Period||0
10579482|NCT01703702|11734531|FG000|STARTED|Overall Study||308
10579483|NCT01703702|11734532|FG001|STARTED|Overall Study||310
10579484|NCT01703702|11734531|FG000|COMPLETED|Overall Study||272
10579485|NCT01703702|11734532|FG001|COMPLETED|Overall Study||288
10579486|NCT01703702|11734531|FG000|NOT COMPLETED|Overall Study||36
10579487|NCT01703702|11734532|FG001|NOT COMPLETED|Overall Study||22
10579488|NCT01703741|11734543|FG000|STARTED|Overall Study||145
10579489|NCT01703741|11734543|FG000|Per Protocol (PP) Population|Overall Study|Subjects having 24 hr pharmacokinetic (PK) data for testosterone, with no major protocol violations.|106
10579490|NCT01703741|11734543|FG000|COMPLETED|Overall Study||127
10579491|NCT01703741|11734543|FG000|NOT COMPLETED|Overall Study||18
10579492|NCT01703819|11734549|FG000|STARTED|Overall Study||34
10579493|NCT01703819|11734550|FG001|STARTED|Overall Study||32
10579494|NCT01703819|11734549|FG000|COMPLETED|Overall Study||34
10579495|NCT01703819|11734550|FG001|COMPLETED|Overall Study||30
10579496|NCT01703819|11734549|FG000|NOT COMPLETED|Overall Study||0
10579497|NCT01703819|11734550|FG001|NOT COMPLETED|Overall Study||2
10579498|NCT01703832|11734558|FG000|STARTED|Overall Study||33
10579499|NCT01703832|11734559|FG001|STARTED|Overall Study||32
10579500|NCT01703832|11734558|FG000|COMPLETED|Overall Study||32
10579501|NCT01703832|11734559|FG001|COMPLETED|Overall Study||32
10579502|NCT01703832|11734558|FG000|NOT COMPLETED|Overall Study||1
10579503|NCT01703832|11734559|FG001|NOT COMPLETED|Overall Study||0
10579504|NCT01703845|11734567|FG000|STARTED|Overall Study|started are actually the randomized|16
10579505|NCT01703845|11734568|FG001|STARTED|Overall Study|started are actually the randomized|16
10579506|NCT01703845|11734567|FG000|COMPLETED|Overall Study||13
10579507|NCT01703845|11734568|FG001|COMPLETED|Overall Study||16
10579508|NCT01703845|11734567|FG000|NOT COMPLETED|Overall Study||3
10579509|NCT01703845|11734568|FG001|NOT COMPLETED|Overall Study||0
10579510|NCT01703858|11734579|FG000|STARTED|Overall Study||5
10579511|NCT01703858|11734580|FG001|STARTED|Overall Study||5
10579512|NCT01703858|11734581|FG002|STARTED|Overall Study||5
10579513|NCT01703858|11734579|FG000|COMPLETED|Overall Study||5
10579514|NCT01703858|11734580|FG001|COMPLETED|Overall Study||4
10579515|NCT01703858|11734581|FG002|COMPLETED|Overall Study||5
10579516|NCT01703858|11734579|FG000|NOT COMPLETED|Overall Study||0
10579517|NCT01703858|11734580|FG001|NOT COMPLETED|Overall Study||1
10579518|NCT01703858|11734581|FG002|NOT COMPLETED|Overall Study||0
10579519|NCT01703988|11734598|FG000|STARTED|Overall Study||8
10579520|NCT01703988|11734599|FG001|STARTED|Overall Study||8
10579521|NCT01703988|11734600|FG002|STARTED|Overall Study||9
10579522|NCT01703988|11734601|FG003|STARTED|Overall Study||9
10579523|NCT01703988|11734598|FG000|COMPLETED|Overall Study||8
10579524|NCT01703988|11734599|FG001|COMPLETED|Overall Study||8
10579525|NCT01703988|11734600|FG002|COMPLETED|Overall Study||9
10579526|NCT01703988|11734601|FG003|COMPLETED|Overall Study||8
10579527|NCT01703988|11734598|FG000|NOT COMPLETED|Overall Study||0
10579528|NCT01703988|11734599|FG001|NOT COMPLETED|Overall Study||0
10702598|NCT02576938|11867054|FG000|Received at Least One Dose of Study Drug|Overall Study||49
10702599|NCT02576938|11867055|FG001|Received at Least One Dose of Study Drug|Overall Study||37
10579529|NCT01703988|11734600|FG002|NOT COMPLETED|Overall Study||0
10579530|NCT01703988|11734601|FG003|NOT COMPLETED|Overall Study||1
10579531|NCT01704079|11734614|FG000|STARTED|Overall Study||72
10579532|NCT01704079|11734615|FG001|STARTED|Overall Study||144
10579533|NCT01704079|11734614|FG000|Entered Extension Study|Overall Study||53
10579534|NCT01704079|11734615|FG001|Entered Extension Study|Overall Study||102
10579535|NCT01704079|11734614|FG000|COMPLETED|Overall Study||58
10702600|NCT02576938|11867056|FG002|Received at Least One Dose of Study Drug|Overall Study||38
10702601|NCT02576938|11867054|FG000|COMPLETED|Overall Study||29
10702602|NCT02576938|11867055|FG001|COMPLETED|Overall Study||25
10579536|NCT01704079|11734615|FG001|COMPLETED|Overall Study||121
10579537|NCT01704079|11734614|FG000|NOT COMPLETED|Overall Study||14
10579538|NCT01704079|11734615|FG001|NOT COMPLETED|Overall Study||23
10579539|NCT01704196|11734623|FG000|STARTED|Overall Study||90
10579540|NCT01704196|11734624|FG001|STARTED|Overall Study||89
10579541|NCT01704196|11734623|FG000|COMPLETED|Overall Study||71
10579542|NCT01704196|11734624|FG001|COMPLETED|Overall Study||65
10579543|NCT01704196|11734623|FG000|NOT COMPLETED|Overall Study||19
10579544|NCT01704196|11734624|FG001|NOT COMPLETED|Overall Study||24
10579545|NCT01704261|11734632|FG000|STARTED|Overall Study||154
10579546|NCT01704261|11734633|FG001|STARTED|Overall Study||153
10579547|NCT01704261|11734632|FG000|COMPLETED|Overall Study||141
10579548|NCT01704261|11734633|FG001|COMPLETED|Overall Study||138
10579549|NCT01704261|11734632|FG000|NOT COMPLETED|Overall Study||13
10579550|NCT01704261|11734633|FG001|NOT COMPLETED|Overall Study||15
10579551|NCT01704287|11734642|FG000|STARTED|Initial Treatment Period||180
10579552|NCT01704287|11734643|FG001|STARTED|Initial Treatment Period||181
10579553|NCT01704287|11734644|FG002|STARTED|Initial Treatment Period||179
10579554|NCT01704287|11734645|FG003|STARTED|Initial Treatment Period||0
10579555|NCT01704287|11734646|FG004|STARTED|Initial Treatment Period||0
10579556|NCT01704287|11734642|FG000|Treated|Initial Treatment Period||178
10579557|NCT01704287|11734643|FG001|Treated|Initial Treatment Period||179
10579558|NCT01704287|11734644|FG002|Treated|Initial Treatment Period||171
10579559|NCT01704287|11734645|FG003|Treated|Initial Treatment Period||0
10579560|NCT01704287|11734646|FG004|Treated|Initial Treatment Period||0
10579561|NCT01704287|11734642|FG000|COMPLETED|Initial Treatment Period||33
10579562|NCT01704287|11734643|FG001|COMPLETED|Initial Treatment Period||47
10579563|NCT01704287|11734644|FG002|COMPLETED|Initial Treatment Period||6
10579564|NCT01704287|11734645|FG003|COMPLETED|Initial Treatment Period||0
10579565|NCT01704287|11734646|FG004|COMPLETED|Initial Treatment Period||0
10579566|NCT01704287|11734642|FG000|NOT COMPLETED|Initial Treatment Period||147
10579567|NCT01704287|11734643|FG001|NOT COMPLETED|Initial Treatment Period||134
10579568|NCT01704287|11734644|FG002|NOT COMPLETED|Initial Treatment Period||173
10579569|NCT01704287|11734645|FG003|NOT COMPLETED|Initial Treatment Period||0
10579570|NCT01704287|11734646|FG004|NOT COMPLETED|Initial Treatment Period||0
10579571|NCT01704287|11734642|FG000|STARTED|Switch to Pembrolizumab Treatment Period||0
10579572|NCT01704287|11734643|FG001|STARTED|Switch to Pembrolizumab Treatment Period||0
10579573|NCT01704287|11734644|FG002|STARTED|Switch to Pembrolizumab Treatment Period||0
10579574|NCT01704287|11734645|FG003|STARTED|Switch to Pembrolizumab Treatment Period||53
10579575|NCT01704287|11734646|FG004|STARTED|Switch to Pembrolizumab Treatment Period||45
10579576|NCT01704287|11734642|FG000|COMPLETED|Switch to Pembrolizumab Treatment Period||0
10579577|NCT01704287|11734643|FG001|COMPLETED|Switch to Pembrolizumab Treatment Period||0
10579578|NCT01704287|11734644|FG002|COMPLETED|Switch to Pembrolizumab Treatment Period||0
10579579|NCT01704287|11734645|FG003|COMPLETED|Switch to Pembrolizumab Treatment Period||15
10579580|NCT01704287|11734646|FG004|COMPLETED|Switch to Pembrolizumab Treatment Period||7
10579581|NCT01704287|11734642|FG000|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
10579582|NCT01704287|11734643|FG001|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
10579583|NCT01704287|11734644|FG002|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
10579584|NCT01704287|11734645|FG003|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||38
10579585|NCT01704287|11734646|FG004|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||38
10579586|NCT01704456|11734667|FG000|STARTED|Overall Study||67
10579587|NCT01704456|11734668|FG001|STARTED|Overall Study||63
10579588|NCT01704456|11734667|FG000|COMPLETED|Overall Study||59
10579589|NCT01704456|11734668|FG001|COMPLETED|Overall Study||49
10579590|NCT01704456|11734667|FG000|NOT COMPLETED|Overall Study||8
10579591|NCT01704456|11734668|FG001|NOT COMPLETED|Overall Study||14
10579592|NCT01704495|11734678|FG000|STARTED|Subjects Randomized||162
10579593|NCT01704495|11734679|FG001|STARTED|Subjects Randomized||156
10806476|NCT03962634|11967999|FG001|NOT COMPLETED|Overall Study||0
10579594|NCT01704495|11734680|FG002|STARTED|Subjects Randomized||160
10579595|NCT01704495|11734681|FG003|STARTED|Subjects Randomized||162
10579596|NCT01704495|11734678|FG000|COMPLETED|Subjects Randomized||140
10579597|NCT01704495|11734679|FG001|COMPLETED|Subjects Randomized||141
10579598|NCT01704495|11734680|FG002|COMPLETED|Subjects Randomized||144
10579599|NCT01704495|11734681|FG003|COMPLETED|Subjects Randomized||145
10579600|NCT01704495|11734678|FG000|NOT COMPLETED|Subjects Randomized||22
10579601|NCT01704495|11734679|FG001|NOT COMPLETED|Subjects Randomized||15
10579602|NCT01704495|11734680|FG002|NOT COMPLETED|Subjects Randomized||16
10579603|NCT01704495|11734681|FG003|NOT COMPLETED|Subjects Randomized||17
10579604|NCT01704495|11734678|FG000|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|116
10579605|NCT01704495|11734679|FG001|STARTED|Optional Safety Extension|35 subjects did not enter safety extension|121
10579606|NCT01704495|11734680|FG002|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|114
10579607|NCT01704495|11734681|FG003|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|116
10579608|NCT01704495|11734678|FG000|COMPLETED|Optional Safety Extension||87
10579609|NCT01704495|11734679|FG001|COMPLETED|Optional Safety Extension||88
10579610|NCT01704495|11734680|FG002|COMPLETED|Optional Safety Extension||83
10579611|NCT01704495|11734681|FG003|COMPLETED|Optional Safety Extension||85
10579612|NCT01704495|11734678|FG000|NOT COMPLETED|Optional Safety Extension||29
10579613|NCT01704495|11734679|FG001|NOT COMPLETED|Optional Safety Extension||33
10579614|NCT01704495|11734680|FG002|NOT COMPLETED|Optional Safety Extension||31
10579615|NCT01704495|11734681|FG003|NOT COMPLETED|Optional Safety Extension||31
10579616|NCT01704521|11734693|FG000|STARTED|Overall Study||3
10806477|NCT03962790|11968005|FG000|STARTED|Period 1||48
10579617|NCT01704521|11734694|FG001|STARTED|Overall Study||2
10579618|NCT01704521|11734693|FG000|COMPLETED|Overall Study||3
10579619|NCT01704521|11734694|FG001|COMPLETED|Overall Study||2
10579620|NCT01704521|11734693|FG000|NOT COMPLETED|Overall Study||0
10579621|NCT01704521|11734694|FG001|NOT COMPLETED|Overall Study||0
10579622|NCT01704599|11734700|FG000|STARTED|Overall Study|Study was started January 22, 2010|8
10579623|NCT01704599|11734700|FG000|COMPLETED|Overall Study|11 screened 8 entered study 1 terminated.|7
10579624|NCT01704599|11734700|FG000|NOT COMPLETED|Overall Study||1
10579625|NCT01704651|11734729|FG000|STARTED|Overall Study||71
10579626|NCT01704651|11734730|FG001|STARTED|Overall Study||75
10579627|NCT01704651|11734729|FG000|COMPLETED|Overall Study||66
10579628|NCT01704651|11734730|FG001|COMPLETED|Overall Study||68
10579629|NCT01704651|11734729|FG000|NOT COMPLETED|Overall Study||5
10579630|NCT01704651|11734730|FG001|NOT COMPLETED|Overall Study||7
10579631|NCT01704755|11734738|FG000|STARTED|Overall Study||208
10579632|NCT01704755|11734739|FG001|STARTED|Overall Study||172
10579633|NCT01704755|11734738|FG000|Completed Study Drug|Overall Study||204
10579634|NCT01704755|11734739|FG001|Completed Study Drug|Overall Study||163
10579635|NCT01704755|11734738|FG000|COMPLETED|Overall Study||196
10579636|NCT01704755|11734739|FG001|COMPLETED|Overall Study||165
10579637|NCT01704755|11734738|FG000|NOT COMPLETED|Overall Study||12
10579638|NCT01704755|11734739|FG001|NOT COMPLETED|Overall Study||7
10579639|NCT01704781|11734750|FG000|STARTED|Overall Study||3
10579640|NCT01704781|11734751|FG001|STARTED|Overall Study||3
10579641|NCT01704781|11734752|FG002|STARTED|Overall Study||6
10579642|NCT01704781|11734753|FG003|STARTED|Overall Study||12
10579643|NCT01704781|11734754|FG004|STARTED|Overall Study||12
10579644|NCT01704781|11734750|FG000|COMPLETED|Overall Study||3
10579645|NCT01704781|11734751|FG001|COMPLETED|Overall Study||3
10579646|NCT01704781|11734752|FG002|COMPLETED|Overall Study||6
10579647|NCT01704781|11734753|FG003|COMPLETED|Overall Study||12
10579648|NCT01704781|11734754|FG004|COMPLETED|Overall Study||12
10579649|NCT01704781|11734750|FG000|NOT COMPLETED|Overall Study||0
10579650|NCT01704781|11734751|FG001|NOT COMPLETED|Overall Study||0
10579651|NCT01704781|11734752|FG002|NOT COMPLETED|Overall Study||0
10579652|NCT01704781|11734753|FG003|NOT COMPLETED|Overall Study||0
10579653|NCT01704781|11734754|FG004|NOT COMPLETED|Overall Study||0
10579654|NCT01704846|11734770|FG000|STARTED|Treatment Period 1||30
10579655|NCT01704846|11734771|FG001|STARTED|Treatment Period 1||30
10579656|NCT01704846|11734770|FG000|COMPLETED|Treatment Period 1||30
10579657|NCT01704846|11734771|FG001|COMPLETED|Treatment Period 1||30
10579658|NCT01704846|11734770|FG000|NOT COMPLETED|Treatment Period 1||0
10579659|NCT01704846|11734771|FG001|NOT COMPLETED|Treatment Period 1||0
10579660|NCT01704846|11734770|FG000|STARTED|Treatment Period 2||30
10579661|NCT01704846|11734771|FG001|STARTED|Treatment Period 2||30
10579662|NCT01704846|11734770|FG000|COMPLETED|Treatment Period 2||30
10579663|NCT01704846|11734771|FG001|COMPLETED|Treatment Period 2||29
10579664|NCT01704846|11734770|FG000|NOT COMPLETED|Treatment Period 2||0
10579665|NCT01704846|11734771|FG001|NOT COMPLETED|Treatment Period 2||1
10579666|NCT01704846|11734770|FG000|STARTED|Treatment Period 3||30
10579667|NCT01704846|11734771|FG001|STARTED|Treatment Period 3||29
10579668|NCT01704846|11734770|FG000|COMPLETED|Treatment Period 3||30
10579669|NCT01704846|11734771|FG001|COMPLETED|Treatment Period 3||29
10579670|NCT01704846|11734770|FG000|NOT COMPLETED|Treatment Period 3||0
10579671|NCT01704846|11734771|FG001|NOT COMPLETED|Treatment Period 3||0
10579672|NCT01704846|11734770|FG000|STARTED|Treatment Period 4||30
10579673|NCT01704846|11734771|FG001|STARTED|Treatment Period 4||29
10579674|NCT01704846|11734770|FG000|COMPLETED|Treatment Period 4||30
10579675|NCT01704846|11734771|FG001|COMPLETED|Treatment Period 4||29
10579676|NCT01704846|11734770|FG000|NOT COMPLETED|Treatment Period 4||0
10579677|NCT01704846|11734771|FG001|NOT COMPLETED|Treatment Period 4||0
10579678|NCT01704976|11734779|FG000|STARTED|Overall Study||14
10579679|NCT01704976|11734780|FG001|STARTED|Overall Study||13
10579680|NCT01704976|11734779|FG000|COMPLETED|Overall Study|One participant completed < 11 SR-WBV sessions and was excluded from the statistical analysis|13
10579681|NCT01704976|11734780|FG001|COMPLETED|Overall Study|2 participants completed < 11 SR-WBV sessions, they were excluded from statistical analysis|11
10579682|NCT01704976|11734779|FG000|NOT COMPLETED|Overall Study||1
10579683|NCT01704976|11734780|FG001|NOT COMPLETED|Overall Study||2
10702603|NCT02576938|11867056|FG002|COMPLETED|Overall Study||26
10702604|NCT02576938|11867054|FG000|NOT COMPLETED|Overall Study||20
10702605|NCT02576938|11867055|FG001|NOT COMPLETED|Overall Study||12
10702606|NCT02576938|11867056|FG002|NOT COMPLETED|Overall Study||12
10702607|NCT02576951|11867070|FG000|STARTED|Overall Study||15
10702608|NCT02576951|11867071|FG001|STARTED|Overall Study||3
10579684|NCT01705080|11734789|FG000|STARTED|Overall Study||147
10579685|NCT01705080|11734790|FG001|STARTED|Overall Study||101
10702609|NCT02576951|11867072|FG002|STARTED|Overall Study||80
10702610|NCT02576951|11867073|FG003|STARTED|Overall Study||80
10713720|NCT02680847|11879219|FG000|COMPLETED|Overall Study||11
10579686|NCT01705080|11734791|FG002|STARTED|Overall Study||28
10579687|NCT01705080|11734789|FG000|Renal Artery Ablation Procedure|Overall Study||147
10579688|NCT01705080|11734790|FG001|Renal Artery Ablation Procedure|Overall Study||101
10579689|NCT01705080|11734791|FG002|Renal Artery Ablation Procedure|Overall Study||28
10579690|NCT01705080|11734789|FG000|Discharge Following Renal Artery Ablation Procedure|Overall Study||147
10579691|NCT01705080|11734790|FG001|Discharge Following Renal Artery Ablation Procedure|Overall Study|Reason Not Completed: Withdrawal by Subject=1|100
10579692|NCT01705080|11734791|FG002|Discharge Following Renal Artery Ablation Procedure|Overall Study||28
10579693|NCT01705080|11734789|FG000|COMPLETED|Overall Study||72
10579694|NCT01705080|11734790|FG001|COMPLETED|Overall Study||49
10579695|NCT01705080|11734791|FG002|COMPLETED|Overall Study||12
10579696|NCT01705080|11734789|FG000|NOT COMPLETED|Overall Study||75
10579697|NCT01705080|11734790|FG001|NOT COMPLETED|Overall Study||52
10579698|NCT01705080|11734791|FG002|NOT COMPLETED|Overall Study||16
10579699|NCT01705145|11734799|FG000|STARTED|Part A||9
10579700|NCT01705145|11734799|FG000|COMPLETED|Part A||9
10579701|NCT01705145|11734799|FG000|NOT COMPLETED|Part A||0
10579702|NCT01705145|11734799|FG000|STARTED|Part B|Eight participants from Part A continued in Part B of the study.|34
10579703|NCT01705145|11734799|FG000|COMPLETED|Part B||33
10579704|NCT01705145|11734799|FG000|NOT COMPLETED|Part B||1
10579705|NCT01705236|11734815|FG000|STARTED|Overall Study||87
10579706|NCT01705236|11734815|FG000|COMPLETED|Overall Study||60
10579707|NCT01705236|11734815|FG000|NOT COMPLETED|Overall Study||27
10579708|NCT01705288|11734821|FG000|STARTED|Overall Study||52
10579709|NCT01705288|11734822|FG001|STARTED|Overall Study||51
10579710|NCT01705288|11734821|FG000|COMPLETED|Overall Study||52
10579711|NCT01705288|11734822|FG001|COMPLETED|Overall Study||51
10579712|NCT01705288|11734821|FG000|NOT COMPLETED|Overall Study||0
10579713|NCT01705288|11734822|FG001|NOT COMPLETED|Overall Study||0
10579714|NCT01705496|11734828|FG000|STARTED|Overall Study||23
10579715|NCT01705496|11734828|FG000|COMPLETED|Overall Study||19
10579716|NCT01705496|11734828|FG000|NOT COMPLETED|Overall Study||4
10579717|NCT01705509|11734832|FG000|STARTED|Inclusion CPET||14
10579718|NCT01705509|11734832|FG000|COMPLETED|Inclusion CPET||7
10579719|NCT01705509|11734832|FG000|NOT COMPLETED|Inclusion CPET||7
10579720|NCT01705509|11734832|FG000|STARTED|CPET w/ Ranexa||7
10579721|NCT01705509|11734832|FG000|COMPLETED|CPET w/ Ranexa||5
10579722|NCT01705509|11734832|FG000|NOT COMPLETED|CPET w/ Ranexa||2
10579723|NCT01705574|11734838|FG000|STARTED|Double-Blind Phase||293
10579724|NCT01705574|11734839|FG001|STARTED|Double-Blind Phase||290
10579725|NCT01705574|11734840|FG002|STARTED|Double-Blind Phase||0
10579726|NCT01705574|11734841|FG003|STARTED|Double-Blind Phase||0
10579727|NCT01705574|11734838|FG000|COMPLETED|Double-Blind Phase||260
10579728|NCT01705574|11734839|FG001|COMPLETED|Double-Blind Phase||249
10579729|NCT01705574|11734840|FG002|COMPLETED|Double-Blind Phase||0
10579730|NCT01705574|11734841|FG003|COMPLETED|Double-Blind Phase||0
10579731|NCT01705574|11734838|FG000|NOT COMPLETED|Double-Blind Phase||33
10579732|NCT01705574|11734839|FG001|NOT COMPLETED|Double-Blind Phase||41
10579733|NCT01705574|11734840|FG002|NOT COMPLETED|Double-Blind Phase||0
10579734|NCT01705574|11734841|FG003|NOT COMPLETED|Double-Blind Phase||0
10579735|NCT01705574|11734838|FG000|STARTED|Open-Label Extension Phase||246
10579736|NCT01705574|11734839|FG001|STARTED|Open-Label Extension Phase|Participants either entered the OL GEN arm or OL ATV+RTV+TVD arm.|0
10579737|NCT01705574|11734840|FG002|STARTED|Open-Label Extension Phase|159 participants entered from the DB ATV+RTV+TVD arm.|159
10579738|NCT01705574|11734841|FG003|STARTED|Open-Label Extension Phase|53 participants entered from the DB ATV+ RTV + TVD arm.|53
10579739|NCT01705574|11734838|FG000|COMPLETED|Open-Label Extension Phase||231
10579740|NCT01705574|11734839|FG001|COMPLETED|Open-Label Extension Phase||0
10579741|NCT01705574|11734840|FG002|COMPLETED|Open-Label Extension Phase||148
10579742|NCT01705574|11734841|FG003|COMPLETED|Open-Label Extension Phase||48
10579743|NCT01705574|11734838|FG000|NOT COMPLETED|Open-Label Extension Phase||15
10579744|NCT01705574|11734839|FG001|NOT COMPLETED|Open-Label Extension Phase||0
10579745|NCT01705574|11734840|FG002|NOT COMPLETED|Open-Label Extension Phase||11
10579746|NCT01705574|11734841|FG003|NOT COMPLETED|Open-Label Extension Phase||5
10579747|NCT01705587|11734859|FG000|STARTED|Overall Study||7
10579748|NCT01705587|11734860|FG001|STARTED|Overall Study||6
10579749|NCT01705587|11734859|FG000|COMPLETED|Overall Study||7
10579750|NCT01705587|11734860|FG001|COMPLETED|Overall Study||5
10579751|NCT01705587|11734859|FG000|NOT COMPLETED|Overall Study||0
10579752|NCT01705587|11734860|FG001|NOT COMPLETED|Overall Study||1
10579753|NCT01705652|11734868|FG000|STARTED|Overall Study||9
10579754|NCT01705652|11734869|FG001|STARTED|Overall Study||12
10579755|NCT01705652|11734868|FG000|COMPLETED|Overall Study||6
10579756|NCT01705652|11734869|FG001|COMPLETED|Overall Study||9
10579757|NCT01705652|11734868|FG000|NOT COMPLETED|Overall Study||3
10579758|NCT01705652|11734869|FG001|NOT COMPLETED|Overall Study||3
10579759|NCT01705691|11734877|FG000|STARTED|Overall Study||19
10702611|NCT02576951|11867070|FG000|Received at Least One Dose of Study Drug|Overall Study||15
10702612|NCT02576951|11867071|FG001|Received at Least One Dose of Study Drug|Overall Study||3
10702613|NCT02576951|11867072|FG002|Received at Least One Dose of Study Drug|Overall Study||80
10702614|NCT02576951|11867073|FG003|Received at Least One Dose of Study Drug|Overall Study||80
10702615|NCT02576951|11867070|FG000|COMPLETED|Overall Study||14
10702616|NCT02576951|11867071|FG001|COMPLETED|Overall Study||3
10579760|NCT01705691|11734878|FG001|STARTED|Overall Study||30
10579761|NCT01705691|11734877|FG000|COMPLETED|Overall Study||16
10579762|NCT01705691|11734878|FG001|COMPLETED|Overall Study||24
10579763|NCT01705691|11734877|FG000|NOT COMPLETED|Overall Study||3
10579764|NCT01705691|11734878|FG001|NOT COMPLETED|Overall Study||6
10579765|NCT01705717|11734886|FG000|STARTED|Overall Study||37
10579766|NCT01705717|11734887|FG001|STARTED|Overall Study||12
10579767|NCT01705717|11734886|FG000|COMPLETED|Overall Study||35
10579768|NCT01705717|11734887|FG001|COMPLETED|Overall Study||7
10579769|NCT01705717|11734886|FG000|NOT COMPLETED|Overall Study||2
10579770|NCT01705717|11734887|FG001|NOT COMPLETED|Overall Study||5
10579771|NCT01705730|11734892|FG000|STARTED|Overall Study|Participants who received study drug|68
10579772|NCT01705730|11734892|FG000|COMPLETED|Overall Study||59
10579773|NCT01705730|11734892|FG000|NOT COMPLETED|Overall Study||9
10702617|NCT02576951|11867072|FG002|COMPLETED|Overall Study||78
10702618|NCT02576951|11867073|FG003|COMPLETED|Overall Study||75
10702619|NCT02576951|11867070|FG000|NOT COMPLETED|Overall Study||1
10806478|NCT03962790|11968006|FG001|STARTED|Period 1||46
10806479|NCT03962790|11968005|FG000|COMPLETED|Period 1||45
10806480|NCT03962790|11968006|FG001|COMPLETED|Period 1||44
10579774|NCT01705964|11734898|FG000|STARTED|Overall Study||25
10579775|NCT01705964|11734899|FG001|STARTED|Overall Study||24
10579776|NCT01705964|11734898|FG000|COMPLETED|Overall Study||25
10579777|NCT01705964|11734899|FG001|COMPLETED|Overall Study||24
10579778|NCT01705964|11734898|FG000|NOT COMPLETED|Overall Study||0
10579779|NCT01705964|11734899|FG001|NOT COMPLETED|Overall Study||0
10579780|NCT01706003|11734907|FG000|STARTED|Overall Study||23
10579781|NCT01706003|11734908|FG001|STARTED|Overall Study||22
10579782|NCT01706003|11734907|FG000|COMPLETED|Overall Study||12
10579783|NCT01706003|11734908|FG001|COMPLETED|Overall Study||18
10579784|NCT01706003|11734907|FG000|NOT COMPLETED|Overall Study||11
10579785|NCT01706003|11734908|FG001|NOT COMPLETED|Overall Study||4
10579786|NCT01706081|11734916|FG000|STARTED|Overall Study||40
10579787|NCT01706081|11734917|FG001|STARTED|Overall Study||42
10579788|NCT01706081|11734916|FG000|COMPLETED|Overall Study||40
10579789|NCT01706081|11734917|FG001|COMPLETED|Overall Study||42
10579790|NCT01706081|11734916|FG000|NOT COMPLETED|Overall Study||0
10579791|NCT01706081|11734917|FG001|NOT COMPLETED|Overall Study||0
10579792|NCT01706146|11734923|FG000|STARTED|Overall Study||59
10579793|NCT01706146|11734923|FG000|COMPLETED|Overall Study|1 pt developed permanent AF; 1 pt needed dual antiplatelet therapy; 3 possible TIA; 1 withdraw|53
10579794|NCT01706146|11734923|FG000|NOT COMPLETED|Overall Study||6
10579795|NCT01706159|11734929|FG000|STARTED|Overall Study||14
10579796|NCT01706159|11734930|FG001|STARTED|Overall Study||6
10579797|NCT01706159|11734929|FG000|Exposed|Overall Study|One subject was not exposed to rFXIII.|13
10579798|NCT01706159|11734930|FG001|Exposed|Overall Study|One subject was not exposed to placebo.|5
10579799|NCT01706159|11734929|FG000|Completers (With Baron Score at Week 8)|Overall Study||6
10579800|NCT01706159|11734930|FG001|Completers (With Baron Score at Week 8)|Overall Study||3
10579801|NCT01706159|11734929|FG000|COMPLETED|Overall Study||6
10579802|NCT01706159|11734930|FG001|COMPLETED|Overall Study||4
10579803|NCT01706159|11734929|FG000|NOT COMPLETED|Overall Study||8
10579804|NCT01706159|11734930|FG001|NOT COMPLETED|Overall Study||2
10579805|NCT01706198|11734938|FG000|STARTED|Overall Study||2119
10579806|NCT01706198|11734939|FG001|STARTED|Overall Study||2114
10579807|NCT01706198|11734938|FG000|COMPLETED|Overall Study||1946
10579808|NCT01706198|11734939|FG001|COMPLETED|Overall Study||1920
10579809|NCT01706198|11734938|FG000|NOT COMPLETED|Overall Study||173
10579810|NCT01706198|11734939|FG001|NOT COMPLETED|Overall Study||194
10579811|NCT01706250|11734945|FG000|STARTED|Overall Study||20
10579812|NCT01706250|11734945|FG000|COMPLETED|Overall Study||18
10579813|NCT01706250|11734945|FG000|NOT COMPLETED|Overall Study||2
10579814|NCT01706263|11734954|FG000|STARTED|Overall Study||28
10579815|NCT01706263|11734954|FG000|COMPLETED|Overall Study||28
10579816|NCT01706263|11734954|FG000|NOT COMPLETED|Overall Study||0
10579817|NCT01706328|11734961|FG000|STARTED|2-week Run-in Period||993
10579818|NCT01706328|11734962|FG001|STARTED|2-week Run-in Period||0
10579819|NCT01706328|11734963|FG002|STARTED|2-week Run-in Period||0
10579820|NCT01706328|11734961|FG000|COMPLETED|2-week Run-in Period||828
10579821|NCT01706328|11734962|FG001|COMPLETED|2-week Run-in Period||0
10579822|NCT01706328|11734963|FG002|COMPLETED|2-week Run-in Period||0
10579823|NCT01706328|11734961|FG000|NOT COMPLETED|2-week Run-in Period||165
10579824|NCT01706328|11734962|FG001|NOT COMPLETED|2-week Run-in Period||0
10579825|NCT01706328|11734963|FG002|NOT COMPLETED|2-week Run-in Period||0
10579826|NCT01706328|11734961|FG000|STARTED|12-week Double-blind Treatment Period||0
10579827|NCT01706328|11734962|FG001|STARTED|12-week Double-blind Treatment Period||412
10702620|NCT02576951|11867071|FG001|NOT COMPLETED|Overall Study||0
10702621|NCT02576951|11867072|FG002|NOT COMPLETED|Overall Study||2
10702622|NCT02576951|11867073|FG003|NOT COMPLETED|Overall Study||5
10806481|NCT03962790|11968005|FG000|NOT COMPLETED|Period 1||3
10806482|NCT03962790|11968006|FG001|NOT COMPLETED|Period 1||2
10806483|NCT03962790|11968005|FG000|STARTED|Period 2||45
10806484|NCT03962790|11968006|FG001|STARTED|Period 2||44
10702623|NCT02576977|11867087|FG000|STARTED|Overall Study||126
10702624|NCT02576977|11867088|FG001|STARTED|Overall Study||125
10702625|NCT02576977|11867087|FG000|Treated|Overall Study||122
10702626|NCT02576977|11867088|FG001|Treated|Overall Study||123
10702627|NCT02576977|11867087|FG000|COMPLETED|Overall Study||0
10702628|NCT02576977|11867088|FG001|COMPLETED|Overall Study||0
10702629|NCT02576977|11867087|FG000|NOT COMPLETED|Overall Study||126
10702630|NCT02576977|11867088|FG001|NOT COMPLETED|Overall Study||125
10702631|NCT02576990|11867096|FG000|STARTED|Overall Study||56
10702632|NCT02576990|11867097|FG001|STARTED|Overall Study||24
10702633|NCT02576990|11867096|FG000|Treated|Overall Study||53
10702634|NCT02576990|11867097|FG001|Treated|Overall Study||23
10702635|NCT02576990|11867096|FG000|COMPLETED|Overall Study||0
10806485|NCT03962790|11968005|FG000|COMPLETED|Period 2||45
10806486|NCT03962790|11968006|FG001|COMPLETED|Period 2||44
10579828|NCT01706328|11734963|FG002|STARTED|12-week Double-blind Treatment Period||416
10579829|NCT01706328|11734961|FG000|COMPLETED|12-week Double-blind Treatment Period||0
10579830|NCT01706328|11734962|FG001|COMPLETED|12-week Double-blind Treatment Period||366
10702636|NCT02576990|11867097|FG001|COMPLETED|Overall Study||0
10702637|NCT02576990|11867096|FG000|NOT COMPLETED|Overall Study||56
10806487|NCT03962790|11968005|FG000|NOT COMPLETED|Period 2||0
10806488|NCT03962790|11968006|FG001|NOT COMPLETED|Period 2||0
10702638|NCT02576990|11867097|FG001|NOT COMPLETED|Overall Study||24
10702639|NCT02577003|11867105|FG000|STARTED|Overall Study||73
10702640|NCT02577003|11867106|FG001|STARTED|Overall Study||70
10702641|NCT02577003|11867105|FG000|COMPLETED|Overall Study||71
10702642|NCT02577003|11867106|FG001|COMPLETED|Overall Study||65
10702643|NCT02577003|11867105|FG000|NOT COMPLETED|Overall Study||2
10579831|NCT01706328|11734963|FG002|COMPLETED|12-week Double-blind Treatment Period||371
10579832|NCT01706328|11734961|FG000|NOT COMPLETED|12-week Double-blind Treatment Period||0
10579833|NCT01706328|11734962|FG001|NOT COMPLETED|12-week Double-blind Treatment Period||46
10579834|NCT01706328|11734963|FG002|NOT COMPLETED|12-week Double-blind Treatment Period||45
10579835|NCT01706458|11734971|FG000|STARTED|Overall Study||9
10579836|NCT01706458|11734972|FG001|STARTED|Overall Study||9
10579837|NCT01706458|11734971|FG000|COMPLETED|Overall Study||6
10579838|NCT01706458|11734972|FG001|COMPLETED|Overall Study||5
10579839|NCT01706458|11734971|FG000|NOT COMPLETED|Overall Study||3
10579840|NCT01706458|11734972|FG001|NOT COMPLETED|Overall Study||4
10579841|NCT01706497|11734978|FG000|STARTED|Overall Study||177
10579842|NCT01706497|11734978|FG000|COMPLETED|Overall Study||177
10579843|NCT01706497|11734978|FG000|NOT COMPLETED|Overall Study||0
10579844|NCT01706536|11734987|FG000|STARTED|Overall Study||57
10579845|NCT01706536|11734988|FG001|STARTED|Overall Study||55
10579846|NCT01706536|11734989|FG002|STARTED|Overall Study||54
10579847|NCT01706536|11734990|FG003|STARTED|Overall Study||57
10579848|NCT01706536|11734991|FG004|STARTED|Overall Study||59
10579849|NCT01706536|11734987|FG000|COMPLETED|Overall Study||53
10579850|NCT01706536|11734988|FG001|COMPLETED|Overall Study||51
10579851|NCT01706536|11734989|FG002|COMPLETED|Overall Study||49
10579852|NCT01706536|11734990|FG003|COMPLETED|Overall Study||53
10579853|NCT01706536|11734991|FG004|COMPLETED|Overall Study||57
10579854|NCT01706536|11734987|FG000|NOT COMPLETED|Overall Study||4
10579855|NCT01706536|11734988|FG001|NOT COMPLETED|Overall Study||4
10579856|NCT01706536|11734989|FG002|NOT COMPLETED|Overall Study||5
10579857|NCT01706536|11734990|FG003|NOT COMPLETED|Overall Study||4
10579858|NCT01706536|11734991|FG004|NOT COMPLETED|Overall Study||2
10579859|NCT01706549|11735004|FG000|STARTED|Overall Study||16
10579860|NCT01706549|11735004|FG000|COMPLETED|Overall Study||16
10579861|NCT01706549|11735004|FG000|NOT COMPLETED|Overall Study||0
10579862|NCT01706575|11735008|FG000|STARTED|Overall Study||76
10579863|NCT01706575|11735008|FG000|Treated|Overall Study||70
10579864|NCT01706575|11735008|FG000|COMPLETED|Overall Study||64
10579865|NCT01706575|11735008|FG000|NOT COMPLETED|Overall Study||12
10579866|NCT01706588|11735017|FG000|STARTED|Overall Study||15
10579867|NCT01706588|11735018|FG001|STARTED|Overall Study||15
10579868|NCT01706588|11735019|FG002|STARTED|Overall Study||15
10579869|NCT01706588|11735020|FG003|STARTED|Overall Study||14
10579870|NCT01706588|11735021|FG004|STARTED|Overall Study||16
10579871|NCT01706588|11735017|FG000|COMPLETED|Overall Study||15
10579872|NCT01706588|11735018|FG001|COMPLETED|Overall Study||15
10579873|NCT01706588|11735019|FG002|COMPLETED|Overall Study||15
10579874|NCT01706588|11735020|FG003|COMPLETED|Overall Study||14
10579875|NCT01706588|11735021|FG004|COMPLETED|Overall Study||16
10579876|NCT01706588|11735017|FG000|NOT COMPLETED|Overall Study||0
10579877|NCT01706588|11735018|FG001|NOT COMPLETED|Overall Study||0
10579878|NCT01706588|11735019|FG002|NOT COMPLETED|Overall Study||0
10579879|NCT01706588|11735020|FG003|NOT COMPLETED|Overall Study||0
10579880|NCT01706588|11735021|FG004|NOT COMPLETED|Overall Study||0
10579881|NCT01706666|11735036|FG000|STARTED|Overall Study||1
10579882|NCT01706666|11735037|FG001|STARTED|Overall Study||1
10579883|NCT01706666|11735038|FG002|STARTED|Overall Study||1
10579884|NCT01706666|11735036|FG000|COMPLETED|Overall Study||1
10579885|NCT01706666|11735037|FG001|COMPLETED|Overall Study||1
10579886|NCT01706666|11735038|FG002|COMPLETED|Overall Study||1
10579887|NCT01706666|11735036|FG000|NOT COMPLETED|Overall Study||0
10579888|NCT01706666|11735037|FG001|NOT COMPLETED|Overall Study||0
10579889|NCT01706666|11735038|FG002|NOT COMPLETED|Overall Study||0
10579890|NCT01706770|11735048|FG000|STARTED|Overall Study||33
10579891|NCT01706770|11735049|FG001|STARTED|Overall Study||17
10579892|NCT01706770|11735048|FG000|COMPLETED|Overall Study||31
10579893|NCT01706770|11735049|FG001|COMPLETED|Overall Study||17
10579894|NCT01706770|11735048|FG000|NOT COMPLETED|Overall Study||2
10579895|NCT01706770|11735049|FG001|NOT COMPLETED|Overall Study||0
10579896|NCT01706822|11735055|FG000|STARTED|Overall Study||8
10579897|NCT01706822|11735055|FG000|COMPLETED|Overall Study||8
10579898|NCT01706822|11735055|FG000|NOT COMPLETED|Overall Study||0
10579899|NCT01706926|11735063|FG000|STARTED|Overall Study||81
10579900|NCT01706926|11735064|FG001|STARTED|Overall Study||81
10579901|NCT01706926|11735065|FG002|STARTED|Overall Study||85
10702644|NCT02577003|11867106|FG001|NOT COMPLETED|Overall Study||5
10702645|NCT02577016|11867114|FG000|STARTED|Overall Study||70
10579902|NCT01706926|11735066|FG003|STARTED|Overall Study||79
10579903|NCT01706926|11735063|FG000|COMPLETED|Overall Study||75
10702646|NCT02577016|11867115|FG001|STARTED|Overall Study||71
10702647|NCT02577016|11867114|FG000|COMPLETED|Overall Study||68
10702648|NCT02577016|11867115|FG001|COMPLETED|Overall Study||69
10702649|NCT02577016|11867114|FG000|NOT COMPLETED|Overall Study||2
10579904|NCT01706926|11735064|FG001|COMPLETED|Overall Study||77
10579905|NCT01706926|11735065|FG002|COMPLETED|Overall Study||79
10579906|NCT01706926|11735066|FG003|COMPLETED|Overall Study||74
10579907|NCT01706926|11735063|FG000|NOT COMPLETED|Overall Study||6
10579908|NCT01706926|11735064|FG001|NOT COMPLETED|Overall Study||4
10579909|NCT01706926|11735065|FG002|NOT COMPLETED|Overall Study||6
10579910|NCT01706926|11735066|FG003|NOT COMPLETED|Overall Study||5
10579911|NCT01706952|11735079|FG000|STARTED|Overall Study||45
10579912|NCT01706952|11735079|FG000|COMPLETED|Overall Study||37
10579913|NCT01706952|11735079|FG000|NOT COMPLETED|Overall Study||8
10579914|NCT01706965|11735087|FG000|STARTED|Overall Study||14
10579915|NCT01706965|11735088|FG001|STARTED|Overall Study||13
10579916|NCT01706965|11735087|FG000|COMPLETED|Overall Study||13
10579917|NCT01706965|11735088|FG001|COMPLETED|Overall Study||12
10579918|NCT01706965|11735087|FG000|NOT COMPLETED|Overall Study||1
10579919|NCT01706965|11735088|FG001|NOT COMPLETED|Overall Study||1
10579920|NCT01706978|11735096|FG000|STARTED|Overall Study||47
10579921|NCT01706978|11735097|FG001|STARTED|Overall Study||41
10579922|NCT01706978|11735096|FG000|COMPLETED|Overall Study||38
10579923|NCT01706978|11735097|FG001|COMPLETED|Overall Study||35
10579924|NCT01706978|11735096|FG000|NOT COMPLETED|Overall Study||9
10579925|NCT01706978|11735097|FG001|NOT COMPLETED|Overall Study||6
10579926|NCT01707004|11735103|FG000|STARTED|Overall Study||20
10579927|NCT01707004|11735103|FG000|COMPLETED|Overall Study|3 participants were not eligible to proceed to Bone Marrow Transplant due to significant infections.|17
10579928|NCT01707004|11735103|FG000|NOT COMPLETED|Overall Study||3
10579929|NCT01707030|11735110|FG000|STARTED|Overall Study||67
10579930|NCT01707030|11735111|FG001|STARTED|Overall Study||71
10579931|NCT01707030|11735110|FG000|COMPLETED|Overall Study||56
10579932|NCT01707030|11735111|FG001|COMPLETED|Overall Study||54
10579933|NCT01707030|11735110|FG000|NOT COMPLETED|Overall Study||11
10579934|NCT01707030|11735111|FG001|NOT COMPLETED|Overall Study||17
10579935|NCT01707043|11735123|FG000|STARTED|Overall Study||10
10579936|NCT01707043|11735124|FG001|STARTED|Overall Study||10
10579937|NCT01707043|11735123|FG000|COMPLETED|Overall Study||10
10579938|NCT01707043|11735124|FG001|COMPLETED|Overall Study||10
10579939|NCT01707043|11735123|FG000|NOT COMPLETED|Overall Study||0
10579940|NCT01707043|11735124|FG001|NOT COMPLETED|Overall Study||0
10579941|NCT01707095|11735132|FG000|STARTED|Overall Study||42
10579942|NCT01707095|11735133|FG001|STARTED|Overall Study||42
10579943|NCT01707095|11735132|FG000|COMPLETED|Overall Study||42
10579944|NCT01707095|11735133|FG001|COMPLETED|Overall Study||42
10579945|NCT01707095|11735132|FG000|NOT COMPLETED|Overall Study||0
10579946|NCT01707095|11735133|FG001|NOT COMPLETED|Overall Study||0
10579947|NCT01707108|11735139|FG000|STARTED|Overall Study||60
10579948|NCT01707108|11735139|FG000|1 Year|Overall Study||60
10579949|NCT01707108|11735139|FG000|COMPLETED|Overall Study||60
10579950|NCT01707108|11735139|FG000|NOT COMPLETED|Overall Study||0
10579951|NCT01707147|11735144|FG000|STARTED|Overall Study||3219
10579952|NCT01707147|11735144|FG000|COMPLETED|Overall Study||3119
10579953|NCT01707147|11735144|FG000|NOT COMPLETED|Overall Study||100
10579954|NCT01707225|11735148|FG000|STARTED|Overall Study||10
10579955|NCT01707225|11735148|FG000|COMPLETED|Overall Study||10
10579956|NCT01707225|11735148|FG000|NOT COMPLETED|Overall Study||0
10579957|NCT01707238|11735154|FG000|STARTED|Overall Study||48
10579958|NCT01707238|11735155|FG001|STARTED|Overall Study||52
10579959|NCT01707238|11735154|FG000|COMPLETED|Overall Study||48
10579960|NCT01707238|11735155|FG001|COMPLETED|Overall Study||52
10579961|NCT01707238|11735154|FG000|NOT COMPLETED|Overall Study||0
10579962|NCT01707238|11735155|FG001|NOT COMPLETED|Overall Study||0
10579963|NCT01707290|11735164|FG000|STARTED|Overall Study||121
10579964|NCT01707290|11735165|FG001|STARTED|Overall Study||4
10579965|NCT01707290|11735164|FG000|COMPLETED|Overall Study||35
10579966|NCT01707290|11735165|FG001|COMPLETED|Overall Study||3
10579967|NCT01707290|11735164|FG000|NOT COMPLETED|Overall Study||86
10579968|NCT01707290|11735165|FG001|NOT COMPLETED|Overall Study||1
10579969|NCT01707368|11735174|FG000|STARTED|Overall Study||561
10579970|NCT01707368|11735174|FG000|COMPLETED|Overall Study||393
10579971|NCT01707368|11735174|FG000|NOT COMPLETED|Overall Study||168
10579972|NCT01707381|11735178|FG000|STARTED|Period 1||12
10579973|NCT01707381|11735179|FG001|STARTED|Period 1||13
10579974|NCT01707381|11735178|FG000|COMPLETED|Period 1||10
10579975|NCT01707381|11735179|FG001|COMPLETED|Period 1||11
10579976|NCT01707381|11735178|FG000|NOT COMPLETED|Period 1||2
10579977|NCT01707381|11735179|FG001|NOT COMPLETED|Period 1||2
10579978|NCT01707381|11735178|FG000|STARTED|Period 2||10
10579979|NCT01707381|11735179|FG001|STARTED|Period 2||11
10579980|NCT01707381|11735178|FG000|COMPLETED|Period 2||10
10579981|NCT01707381|11735179|FG001|COMPLETED|Period 2||11
10579982|NCT01707381|11735178|FG000|NOT COMPLETED|Period 2||0
10579983|NCT01707381|11735179|FG001|NOT COMPLETED|Period 2||0
10579984|NCT01707420|11735187|FG000|STARTED|Overall Study||18
10579985|NCT01707420|11735188|FG001|STARTED|Overall Study||18
10579986|NCT01707420|11735187|FG000|COMPLETED|Overall Study||18
10579987|NCT01707420|11735188|FG001|COMPLETED|Overall Study||18
10579988|NCT01707420|11735187|FG000|NOT COMPLETED|Overall Study||0
10579989|NCT01707420|11735188|FG001|NOT COMPLETED|Overall Study||0
10579990|NCT01707472|11735199|FG000|STARTED|Overall Study||4
10579991|NCT01707472|11735200|FG001|STARTED|Overall Study||6
10579992|NCT01707472|11735201|FG002|STARTED|Overall Study||8
10579993|NCT01707472|11735199|FG000|COMPLETED|Overall Study||4
10579994|NCT01707472|11735200|FG001|COMPLETED|Overall Study||6
10579995|NCT01707472|11735201|FG002|COMPLETED|Overall Study||8
10579996|NCT01707472|11735199|FG000|NOT COMPLETED|Overall Study||0
10579997|NCT01707472|11735200|FG001|NOT COMPLETED|Overall Study||0
10579998|NCT01707472|11735201|FG002|NOT COMPLETED|Overall Study||0
10579999|NCT01707654|11735209|FG000|STARTED|Overall Study||9
10580000|NCT01707654|11735209|FG000|COMPLETED|Overall Study||9
10580001|NCT01707654|11735209|FG000|NOT COMPLETED|Overall Study||0
10580002|NCT01707667|11735215|FG000|STARTED|Period 1||7
10580003|NCT01707667|11735216|FG001|STARTED|Period 1||6
10580004|NCT01707667|11735215|FG000|COMPLETED|Period 1||6
10580005|NCT01707667|11735216|FG001|COMPLETED|Period 1||6
10580006|NCT01707667|11735215|FG000|NOT COMPLETED|Period 1||1
10580007|NCT01707667|11735216|FG001|NOT COMPLETED|Period 1||0
10580008|NCT01707667|11735215|FG000|STARTED|Period 2||6
10580009|NCT01707667|11735216|FG001|STARTED|Period 2||6
10580010|NCT01707667|11735215|FG000|COMPLETED|Period 2||6
10580011|NCT01707667|11735216|FG001|COMPLETED|Period 2||6
10580012|NCT01707667|11735215|FG000|NOT COMPLETED|Period 2||0
10580013|NCT01707667|11735216|FG001|NOT COMPLETED|Period 2||0
10580014|NCT01707693|11735224|FG000|STARTED|Overall Study Allocation||59
10580015|NCT01707693|11735225|FG001|STARTED|Overall Study Allocation||62
10580016|NCT01707693|11735224|FG000|COMPLETED|Overall Study Allocation||46
10580017|NCT01707693|11735225|FG001|COMPLETED|Overall Study Allocation||54
10580018|NCT01707693|11735224|FG000|NOT COMPLETED|Overall Study Allocation||13
10580019|NCT01707693|11735225|FG001|NOT COMPLETED|Overall Study Allocation||8
10580020|NCT01707693|11735224|FG000|STARTED|Time 3 Measures @ 6 Mth||46
10580021|NCT01707693|11735225|FG001|STARTED|Time 3 Measures @ 6 Mth||54
10580022|NCT01707693|11735224|FG000|COMPLETED|Time 3 Measures @ 6 Mth||46
10580023|NCT01707693|11735225|FG001|COMPLETED|Time 3 Measures @ 6 Mth||49
10580024|NCT01707693|11735224|FG000|NOT COMPLETED|Time 3 Measures @ 6 Mth||0
10580025|NCT01707693|11735225|FG001|NOT COMPLETED|Time 3 Measures @ 6 Mth||5
10580026|NCT01707992|11735235|FG000|STARTED|Placebo-Controlled Phase (24 Months)||740
10580027|NCT01707992|11735236|FG001|STARTED|Placebo-Controlled Phase (24 Months)||727
10580028|NCT01707992|11735237|FG002|STARTED|Placebo-Controlled Phase (24 Months)||732
10580029|NCT01707992|11735238|FG003|STARTED|Placebo-Controlled Phase (24 Months)||0
10580030|NCT01707992|11735239|FG004|STARTED|Placebo-Controlled Phase (24 Months)||0
10580031|NCT01707992|11735240|FG005|STARTED|Placebo-Controlled Phase (24 Months)||0
10580032|NCT01707992|11735235|FG000|COMPLETED|Placebo-Controlled Phase (24 Months)||596
10580033|NCT01707992|11735236|FG001|COMPLETED|Placebo-Controlled Phase (24 Months)||623
10580034|NCT01707992|11735237|FG002|COMPLETED|Placebo-Controlled Phase (24 Months)||532
10580035|NCT01707992|11735238|FG003|COMPLETED|Placebo-Controlled Phase (24 Months)||0
10580036|NCT01707992|11735239|FG004|COMPLETED|Placebo-Controlled Phase (24 Months)||0
10580037|NCT01707992|11735240|FG005|COMPLETED|Placebo-Controlled Phase (24 Months)||0
10580038|NCT01707992|11735235|FG000|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||144
10580039|NCT01707992|11735236|FG001|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||104
10580040|NCT01707992|11735237|FG002|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||200
10580041|NCT01707992|11735238|FG003|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||0
10580042|NCT01707992|11735239|FG004|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||0
10580043|NCT01707992|11735240|FG005|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||0
10580044|NCT01707992|11735235|FG000|STARTED|Active Treatment Phase (24 Months)||0
10580045|NCT01707992|11735236|FG001|STARTED|Active Treatment Phase (24 Months)||0
10580046|NCT01707992|11735237|FG002|STARTED|Active Treatment Phase (24 Months)||0
10580047|NCT01707992|11735238|FG003|STARTED|Active Treatment Phase (24 Months)||891
10580048|NCT01707992|11735239|FG004|STARTED|Active Treatment Phase (24 Months)||504
10580049|NCT01707992|11735240|FG005|STARTED|Active Treatment Phase (24 Months)||215
10580050|NCT01707992|11735235|FG000|COMPLETED|Active Treatment Phase (24 Months)||0
10580051|NCT01707992|11735236|FG001|COMPLETED|Active Treatment Phase (24 Months)||0
10580052|NCT01707992|11735237|FG002|COMPLETED|Active Treatment Phase (24 Months)||0
10580053|NCT01707992|11735238|FG003|COMPLETED|Active Treatment Phase (24 Months)||7
10580054|NCT01707992|11735239|FG004|COMPLETED|Active Treatment Phase (24 Months)||10
10580055|NCT01707992|11735240|FG005|COMPLETED|Active Treatment Phase (24 Months)||0
10580056|NCT01707992|11735235|FG000|NOT COMPLETED|Active Treatment Phase (24 Months)||0
10580057|NCT01707992|11735236|FG001|NOT COMPLETED|Active Treatment Phase (24 Months)||0
10580058|NCT01707992|11735237|FG002|NOT COMPLETED|Active Treatment Phase (24 Months)||0
10580059|NCT01707992|11735238|FG003|NOT COMPLETED|Active Treatment Phase (24 Months)||884
10580060|NCT01707992|11735239|FG004|NOT COMPLETED|Active Treatment Phase (24 Months)||494
10580061|NCT01707992|11735240|FG005|NOT COMPLETED|Active Treatment Phase (24 Months)||215
10580062|NCT01708122|11735257|FG000|STARTED|Overall Study||27
10580063|NCT01708122|11735258|FG001|STARTED|Overall Study||26
10580064|NCT01708122|11735257|FG000|COMPLETED|Overall Study||27
10580065|NCT01708122|11735258|FG001|COMPLETED|Overall Study||26
10580066|NCT01708122|11735257|FG000|NOT COMPLETED|Overall Study||0
10580067|NCT01708122|11735258|FG001|NOT COMPLETED|Overall Study||0
10580068|NCT01708161|11735270|FG000|STARTED|Overall Study||4
10580069|NCT01708161|11735271|FG001|STARTED|Overall Study||10
10580070|NCT01708161|11735272|FG002|STARTED|Overall Study||10
10580071|NCT01708161|11735273|FG003|STARTED|Overall Study||16
10580072|NCT01708161|11735274|FG004|STARTED|Overall Study||6
10580073|NCT01708161|11735275|FG005|STARTED|Overall Study||1
10580074|NCT01708161|11735270|FG000|COMPLETED|Overall Study||0
10580075|NCT01708161|11735271|FG001|COMPLETED|Overall Study||0
10580076|NCT01708161|11735272|FG002|COMPLETED|Overall Study||0
10580077|NCT01708161|11735273|FG003|COMPLETED|Overall Study||0
10580078|NCT01708161|11735274|FG004|COMPLETED|Overall Study||0
10580079|NCT01708161|11735275|FG005|COMPLETED|Overall Study||0
10580080|NCT01708161|11735270|FG000|NOT COMPLETED|Overall Study||4
10580081|NCT01708161|11735271|FG001|NOT COMPLETED|Overall Study||10
10580082|NCT01708161|11735272|FG002|NOT COMPLETED|Overall Study||10
10580083|NCT01708161|11735273|FG003|NOT COMPLETED|Overall Study||16
10580084|NCT01708161|11735274|FG004|NOT COMPLETED|Overall Study||6
10580085|NCT01708161|11735275|FG005|NOT COMPLETED|Overall Study||1
10580086|NCT01708174|11735292|FG000|STARTED|Treatment Period||2
10580087|NCT01708174|11735293|FG001|STARTED|Treatment Period||16
10580088|NCT01708174|11735294|FG002|STARTED|Treatment Period||4
10580089|NCT01708174|11735292|FG000|Pharmacokinetic Analysis Set|Treatment Period||2
10580090|NCT01708174|11735293|FG001|Pharmacokinetic Analysis Set|Treatment Period||13
10580091|NCT01708174|11735294|FG002|Pharmacokinetic Analysis Set|Treatment Period||0
10580092|NCT01708174|11735292|FG000|COMPLETED|Treatment Period||1
10580093|NCT01708174|11735293|FG001|COMPLETED|Treatment Period||14
10580094|NCT01708174|11735294|FG002|COMPLETED|Treatment Period||3
10580095|NCT01708174|11735292|FG000|NOT COMPLETED|Treatment Period||1
10580096|NCT01708174|11735293|FG001|NOT COMPLETED|Treatment Period||2
10580097|NCT01708174|11735294|FG002|NOT COMPLETED|Treatment Period||1
10580098|NCT01708174|11735292|FG000|STARTED|Survival Follow-up||1
10580099|NCT01708174|11735293|FG001|STARTED|Survival Follow-up||10
10580100|NCT01708174|11735294|FG002|STARTED|Survival Follow-up||0
10580101|NCT01708174|11735292|FG000|COMPLETED|Survival Follow-up||1
10580102|NCT01708174|11735293|FG001|COMPLETED|Survival Follow-up||10
10580103|NCT01708174|11735294|FG002|COMPLETED|Survival Follow-up||0
10580104|NCT01708174|11735292|FG000|NOT COMPLETED|Survival Follow-up||0
10580105|NCT01708174|11735293|FG001|NOT COMPLETED|Survival Follow-up||0
10580106|NCT01708174|11735294|FG002|NOT COMPLETED|Survival Follow-up||0
10580107|NCT01708187|11735305|FG000|STARTED|Overall Study||1
10580108|NCT01708187|11735306|FG001|STARTED|Overall Study||1
10580109|NCT01708187|11735305|FG000|COMPLETED|Overall Study||1
10580110|NCT01708187|11735306|FG001|COMPLETED|Overall Study||0
10580111|NCT01708187|11735305|FG000|NOT COMPLETED|Overall Study||0
10580112|NCT01708187|11735306|FG001|NOT COMPLETED|Overall Study||1
10580113|NCT01708213|11735312|FG000|STARTED|Overall Study||72
10580114|NCT01708213|11735312|FG000|COMPLETED|Overall Study||71
10580115|NCT01708213|11735312|FG000|NOT COMPLETED|Overall Study||1
10580116|NCT01708278|11735322|FG000|STARTED|Overall Study||1
10580117|NCT01708278|11735323|FG001|STARTED|Overall Study||2
10580118|NCT01708278|11735324|FG002|STARTED|Overall Study||2
10580119|NCT01708278|11735325|FG003|STARTED|Overall Study||2
10580120|NCT01708278|11735326|FG004|STARTED|Overall Study||1
10580121|NCT01708278|11735327|FG005|STARTED|Overall Study||1
10580122|NCT01708278|11735322|FG000|COMPLETED|Overall Study||1
10580123|NCT01708278|11735323|FG001|COMPLETED|Overall Study||2
10580124|NCT01708278|11735324|FG002|COMPLETED|Overall Study||2
10580125|NCT01708278|11735325|FG003|COMPLETED|Overall Study||2
10806489|NCT03956225|11968014|FG000|STARTED|Overall Study||119
10806490|NCT03956225|11968015|FG001|STARTED|Overall Study||117
10806491|NCT03956225|11968014|FG000|COMPLETED|Overall Study||114
10806492|NCT03956225|11968015|FG001|COMPLETED|Overall Study||113
10806493|NCT03956225|11968014|FG000|NOT COMPLETED|Overall Study||5
10806494|NCT03956225|11968015|FG001|NOT COMPLETED|Overall Study||4
10806495|NCT03951610|11968024|FG000|STARTED|First Intervention||27
10806496|NCT03951610|11968025|FG001|STARTED|First Intervention||25
10806497|NCT03951610|11968024|FG000|COMPLETED|First Intervention||27
10580126|NCT01708278|11735326|FG004|COMPLETED|Overall Study||1
10580127|NCT01708278|11735327|FG005|COMPLETED|Overall Study||1
10580128|NCT01708278|11735322|FG000|NOT COMPLETED|Overall Study||0
10580129|NCT01708278|11735323|FG001|NOT COMPLETED|Overall Study||0
10580130|NCT01708278|11735324|FG002|NOT COMPLETED|Overall Study||0
10580131|NCT01708278|11735325|FG003|NOT COMPLETED|Overall Study||0
10580132|NCT01708278|11735326|FG004|NOT COMPLETED|Overall Study||0
10580133|NCT01708278|11735327|FG005|NOT COMPLETED|Overall Study||0
10580134|NCT01708291|11735343|FG000|STARTED|Overall Study||21
10580135|NCT01708291|11735344|FG001|STARTED|Overall Study||21
10580136|NCT01708291|11735343|FG000|COMPLETED|Overall Study||19
10580137|NCT01708291|11735344|FG001|COMPLETED|Overall Study||20
10580138|NCT01708291|11735343|FG000|NOT COMPLETED|Overall Study||2
10580139|NCT01708291|11735344|FG001|NOT COMPLETED|Overall Study||1
10580140|NCT01708317|11735350|FG000|STARTED|2010 Control Period|# of ED patients eligible for ACASI, had it been available, in control period|3929
10580141|NCT01708317|11735350|FG000|COMPLETED|2010 Control Period||3929
10580142|NCT01708317|11735350|FG000|NOT COMPLETED|2010 Control Period||0
10580143|NCT01708317|11735350|FG000|STARTED|Initial Education Period|# of ED patients eligible for ACASI, had it been available, in initial education period|982
10580144|NCT01708317|11735350|FG000|COMPLETED|Initial Education Period||982
10580145|NCT01708317|11735350|FG000|NOT COMPLETED|Initial Education Period||0
10580146|NCT01708317|11735350|FG000|STARTED|ACASI + Education Period|# of ED patients eligible for ACASI in the period the ACASI was actually available.|2601
10580147|NCT01708317|11735350|FG000|COMPLETED|ACASI + Education Period||2601
10580148|NCT01708317|11735350|FG000|NOT COMPLETED|ACASI + Education Period||0
10580149|NCT01708317|11735350|FG000|STARTED|Final Education Period|# of ED patients eligible for ACASI, had it been available, in final education period|909
10580150|NCT01708317|11735350|FG000|COMPLETED|Final Education Period||909
10580151|NCT01708317|11735350|FG000|NOT COMPLETED|Final Education Period||0
10580152|NCT01708525|11735357|FG000|STARTED|Overall Study||2
10580153|NCT01708525|11735357|FG000|COMPLETED|Overall Study||2
10580154|NCT01708525|11735357|FG000|NOT COMPLETED|Overall Study||0
10580155|NCT01708590|11735365|FG000|STARTED|Induction Phase||222
10806498|NCT03951610|11968025|FG001|COMPLETED|First Intervention||25
10806499|NCT03951610|11968024|FG000|NOT COMPLETED|First Intervention||0
10580156|NCT01708590|11735366|FG001|STARTED|Induction Phase||219
10806500|NCT03951610|11968025|FG001|NOT COMPLETED|First Intervention||0
10580157|NCT01708590|11735367|FG002|STARTED|Induction Phase||220
10580158|NCT01708590|11735368|FG003|STARTED|Induction Phase||0
10580159|NCT01708590|11735369|FG004|STARTED|Induction Phase||0
10580160|NCT01708590|11735370|FG005|STARTED|Induction Phase||0
10580161|NCT01708590|11735371|FG006|STARTED|Induction Phase||0
10580162|NCT01708590|11735365|FG000|COMPLETED|Induction Phase||212
10580163|NCT01708590|11735366|FG001|COMPLETED|Induction Phase||212
10580164|NCT01708590|11735367|FG002|COMPLETED|Induction Phase||209
10580165|NCT01708590|11735368|FG003|COMPLETED|Induction Phase||0
10580166|NCT01708590|11735369|FG004|COMPLETED|Induction Phase||0
10580167|NCT01708590|11735370|FG005|COMPLETED|Induction Phase||0
10580168|NCT01708590|11735371|FG006|COMPLETED|Induction Phase||0
10580169|NCT01708590|11735365|FG000|NOT COMPLETED|Induction Phase||10
10580170|NCT01708590|11735366|FG001|NOT COMPLETED|Induction Phase||7
10580171|NCT01708590|11735367|FG002|NOT COMPLETED|Induction Phase||11
10580172|NCT01708590|11735368|FG003|NOT COMPLETED|Induction Phase||0
10580173|NCT01708590|11735369|FG004|NOT COMPLETED|Induction Phase||0
10580174|NCT01708590|11735370|FG005|NOT COMPLETED|Induction Phase||0
10580175|NCT01708590|11735371|FG006|NOT COMPLETED|Induction Phase||0
10580176|NCT01708590|11735365|FG000|STARTED|Withdrawal Phase||0
10580177|NCT01708590|11735366|FG001|STARTED|Withdrawal Phase||0
10580178|NCT01708590|11735367|FG002|STARTED|Withdrawal Phase||0
10580179|NCT01708590|11735368|FG003|STARTED|Withdrawal Phase||59
10580180|NCT01708590|11735369|FG004|STARTED|Withdrawal Phase||57
10580181|NCT01708590|11735370|FG005|STARTED|Withdrawal Phase||84
10580182|NCT01708590|11735371|FG006|STARTED|Withdrawal Phase||83
10580183|NCT01708590|11735365|FG000|COMPLETED|Withdrawal Phase||0
10580184|NCT01708590|11735366|FG001|COMPLETED|Withdrawal Phase||0
10580185|NCT01708590|11735367|FG002|COMPLETED|Withdrawal Phase||0
10580186|NCT01708590|11735368|FG003|COMPLETED|Withdrawal Phase||6
10580187|NCT01708590|11735369|FG004|COMPLETED|Withdrawal Phase||45
10580188|NCT01708590|11735370|FG005|COMPLETED|Withdrawal Phase||2
10580189|NCT01708590|11735371|FG006|COMPLETED|Withdrawal Phase||74
10580190|NCT01708590|11735365|FG000|NOT COMPLETED|Withdrawal Phase||0
10580191|NCT01708590|11735366|FG001|NOT COMPLETED|Withdrawal Phase||0
10580192|NCT01708590|11735367|FG002|NOT COMPLETED|Withdrawal Phase||0
10580193|NCT01708590|11735368|FG003|NOT COMPLETED|Withdrawal Phase||53
10580194|NCT01708590|11735369|FG004|NOT COMPLETED|Withdrawal Phase||12
10580195|NCT01708590|11735370|FG005|NOT COMPLETED|Withdrawal Phase||82
10580196|NCT01708590|11735371|FG006|NOT COMPLETED|Withdrawal Phase||9
10580197|NCT01708603|11735388|FG000|STARTED|Overall Study||612
10580198|NCT01708603|11735389|FG001|STARTED|Overall Study||610
10580199|NCT01708603|11735390|FG002|STARTED|Overall Study||300
10580200|NCT01708603|11735391|FG003|STARTED|Overall Study||309
10580201|NCT01708603|11735388|FG000|COMPLETED|Overall Study||597
10580202|NCT01708603|11735389|FG001|COMPLETED|Overall Study||588
10580203|NCT01708603|11735390|FG002|COMPLETED|Overall Study||291
10580204|NCT01708603|11735391|FG003|COMPLETED|Overall Study||300
10580205|NCT01708603|11735388|FG000|NOT COMPLETED|Overall Study||15
10580206|NCT01708603|11735389|FG001|NOT COMPLETED|Overall Study||22
10580207|NCT01708603|11735390|FG002|NOT COMPLETED|Overall Study||9
10580208|NCT01708603|11735391|FG003|NOT COMPLETED|Overall Study||9
10580209|NCT01708629|11735410|FG000|STARTED|Overall Study||624
10580210|NCT01708629|11735411|FG001|STARTED|Overall Study||629
10580211|NCT01708629|11735412|FG002|STARTED|Overall Study||313
10580212|NCT01708629|11735413|FG003|STARTED|Overall Study||315
10580213|NCT01708629|11735410|FG000|COMPLETED|Overall Study||608
10580214|NCT01708629|11735411|FG001|COMPLETED|Overall Study||604
10580215|NCT01708629|11735412|FG002|COMPLETED|Overall Study||303
10580216|NCT01708629|11735413|FG003|COMPLETED|Overall Study||301
10580217|NCT01708629|11735410|FG000|NOT COMPLETED|Overall Study||16
10580218|NCT01708629|11735411|FG001|NOT COMPLETED|Overall Study||25
10580219|NCT01708629|11735412|FG002|NOT COMPLETED|Overall Study||10
10580220|NCT01708629|11735413|FG003|NOT COMPLETED|Overall Study||14
10806501|NCT03951610|11968024|FG000|STARTED|Second Intervention||27
10806502|NCT03951610|11968025|FG001|STARTED|Second Intervention||25
10806503|NCT03951610|11968024|FG000|COMPLETED|Second Intervention||27
10580221|NCT01708902|11735430|FG000|STARTED|Overall Study||147
10580222|NCT01708902|11735431|FG001|STARTED|Overall Study||145
10580223|NCT01708902|11735432|FG002|STARTED|Overall Study||144
10580224|NCT01708902|11735433|FG003|STARTED|Overall Study||147
10580225|NCT01708902|11735434|FG004|STARTED|Overall Study||147
10580226|NCT01708902|11735435|FG005|STARTED|Overall Study||71
10580227|NCT01708902|11735436|FG006|STARTED|Overall Study||72
10580228|NCT01708902|11735430|FG000|COMPLETED|Overall Study||130
10580229|NCT01708902|11735431|FG001|COMPLETED|Overall Study||137
10580230|NCT01708902|11735432|FG002|COMPLETED|Overall Study||127
10580231|NCT01708902|11735433|FG003|COMPLETED|Overall Study||137
10580232|NCT01708902|11735434|FG004|COMPLETED|Overall Study||131
10580233|NCT01708902|11735435|FG005|COMPLETED|Overall Study||64
10580234|NCT01708902|11735436|FG006|COMPLETED|Overall Study||65
10580235|NCT01708902|11735430|FG000|NOT COMPLETED|Overall Study||17
10580236|NCT01708902|11735431|FG001|NOT COMPLETED|Overall Study||8
10580237|NCT01708902|11735432|FG002|NOT COMPLETED|Overall Study||17
10580238|NCT01708902|11735433|FG003|NOT COMPLETED|Overall Study||10
10580239|NCT01708902|11735434|FG004|NOT COMPLETED|Overall Study||16
10580240|NCT01708902|11735435|FG005|NOT COMPLETED|Overall Study||7
10580241|NCT01708902|11735436|FG006|NOT COMPLETED|Overall Study||7
10580242|NCT01708915|11735459|FG000|STARTED|Overall Study||204
10580243|NCT01708915|11735460|FG001|STARTED|Overall Study||201
10580244|NCT01708915|11735461|FG002|STARTED|Overall Study||198
10580245|NCT01708915|11735462|FG003|STARTED|Overall Study||202
10580246|NCT01708915|11735459|FG000|COMPLETED|Overall Study||118
10580247|NCT01708915|11735460|FG001|COMPLETED|Overall Study||139
10580248|NCT01708915|11735461|FG002|COMPLETED|Overall Study||152
10806504|NCT03951610|11968025|FG001|COMPLETED|Second Intervention||25
10580249|NCT01708915|11735462|FG003|COMPLETED|Overall Study||169
10580250|NCT01708915|11735459|FG000|NOT COMPLETED|Overall Study||86
10580251|NCT01708915|11735460|FG001|NOT COMPLETED|Overall Study||62
10580252|NCT01708915|11735461|FG002|NOT COMPLETED|Overall Study||46
10580253|NCT01708915|11735462|FG003|NOT COMPLETED|Overall Study||33
10580254|NCT01708967|11735474|FG000|STARTED|Overall Study||50
10580255|NCT01708967|11735475|FG001|STARTED|Overall Study||50
10580256|NCT01708967|11735474|FG000|COMPLETED|Overall Study||50
10580257|NCT01708967|11735475|FG001|COMPLETED|Overall Study||43
10580258|NCT01708967|11735474|FG000|NOT COMPLETED|Overall Study||0
10580259|NCT01708967|11735475|FG001|NOT COMPLETED|Overall Study||7
10651487|NCT02176005|11811675|FG002|COMPLETED|Overall Study||8
10651488|NCT02176005|11811676|FG003|COMPLETED|Overall Study||8
10651489|NCT02176005|11811673|FG000|NOT COMPLETED|Overall Study||0
10651490|NCT02176005|11811674|FG001|NOT COMPLETED|Overall Study||0
10651491|NCT02176005|11811675|FG002|NOT COMPLETED|Overall Study||0
10651492|NCT02176005|11811676|FG003|NOT COMPLETED|Overall Study||0
10651493|NCT02176018|11811688|FG000|STARTED|Overall Study||22
10651494|NCT02176018|11811689|FG001|STARTED|Overall Study||23
10702650|NCT02577016|11867115|FG001|NOT COMPLETED|Overall Study||2
10651495|NCT02176018|11811688|FG000|COMPLETED|Overall Study||17
10651496|NCT02176018|11811689|FG001|COMPLETED|Overall Study||17
10651497|NCT02176018|11811688|FG000|NOT COMPLETED|Overall Study||5
10651498|NCT02176018|11811689|FG001|NOT COMPLETED|Overall Study||6
10651499|NCT02176031|11811695|FG000|STARTED|Overall Study||21
10651500|NCT02176031|11811695|FG000|COMPLETED|Overall Study||9
10651501|NCT02176031|11811695|FG000|NOT COMPLETED|Overall Study||12
10651502|NCT02176083|11811702|FG000|STARTED|Overall Study||11
10651503|NCT02176083|11811703|FG001|STARTED|Overall Study||27
10651504|NCT02176083|11811702|FG000|COMPLETED|Overall Study||11
10651505|NCT02176083|11811703|FG001|COMPLETED|Overall Study||27
10651506|NCT02176083|11811702|FG000|NOT COMPLETED|Overall Study||0
10651507|NCT02176083|11811703|FG001|NOT COMPLETED|Overall Study||0
10651508|NCT02176226|11811709|FG000|STARTED|Overall Study||105
10651509|NCT02176226|11811709|FG000|COMPLETED|Overall Study||96
10651510|NCT02176226|11811709|FG000|NOT COMPLETED|Overall Study||9
10651511|NCT02176291|11811715|FG000|STARTED|Overall Study||20
10651512|NCT02176291|11811716|FG001|STARTED|Overall Study||11
10651513|NCT02176291|11811715|FG000|COMPLETED|Overall Study||15
10651514|NCT02176291|11811716|FG001|COMPLETED|Overall Study||11
10651515|NCT02176291|11811715|FG000|NOT COMPLETED|Overall Study||5
10651516|NCT02176291|11811716|FG001|NOT COMPLETED|Overall Study||0
10651517|NCT02176343|11811722|FG000|STARTED|Overall Study||31
10651518|NCT02176343|11811722|FG000|COMPLETED|Overall Study||31
10651519|NCT02176343|11811722|FG000|NOT COMPLETED|Overall Study||0
10651520|NCT02176356|11811726|FG000|STARTED|Overall Study||116
10651521|NCT02176356|11811726|FG000|Eligible and Received Treatment|Overall Study||100
10651522|NCT02176356|11811726|FG000|COMPLETED|Overall Study||93
10651523|NCT02176356|11811726|FG000|NOT COMPLETED|Overall Study||23
10651524|NCT02176382|11811732|FG000|STARTED|DATA-HD Study||39
10651525|NCT02176382|11811733|FG001|STARTED|DATA-HD Study||37
10651526|NCT02176382|11811732|FG000|COMPLETED|DATA-HD Study||31
10651527|NCT02176382|11811733|FG001|COMPLETED|DATA-HD Study||29
10651528|NCT02176382|11811732|FG000|NOT COMPLETED|DATA-HD Study||8
10651529|NCT02176382|11811733|FG001|NOT COMPLETED|DATA-HD Study||8
10651530|NCT02176382|11811732|FG000|STARTED|DATA-HD Extension||27
10651531|NCT02176382|11811733|FG001|STARTED|DATA-HD Extension||26
10651532|NCT02176382|11811732|FG000|COMPLETED|DATA-HD Extension||26
10651533|NCT02176382|11811733|FG001|COMPLETED|DATA-HD Extension||26
10651534|NCT02176382|11811732|FG000|NOT COMPLETED|DATA-HD Extension||1
10651535|NCT02176382|11811733|FG001|NOT COMPLETED|DATA-HD Extension||0
10651536|NCT02176408|11811741|FG000|STARTED|Overall Study||15
10651537|NCT02176408|11811742|FG001|STARTED|Overall Study||16
10651538|NCT02176408|11811741|FG000|COMPLETED|Overall Study||9
10651539|NCT02176408|11811742|FG001|COMPLETED|Overall Study||12
10651540|NCT02176408|11811741|FG000|NOT COMPLETED|Overall Study||6
10651541|NCT02176408|11811742|FG001|NOT COMPLETED|Overall Study||4
10651542|NCT02176421|11811748|FG000|STARTED|Overall Study||80
10651543|NCT02176421|11811748|FG000|COMPLETED|Overall Study||75
10651544|NCT02176421|11811748|FG000|NOT COMPLETED|Overall Study||5
10651545|NCT02176486|11811755|FG000|STARTED|Overall Study||3
10651546|NCT02176486|11811756|FG001|STARTED|Overall Study||5
10651547|NCT02176486|11811757|FG002|STARTED|Overall Study||4
10651548|NCT02176486|11811755|FG000|COMPLETED|Overall Study||3
10651549|NCT02176486|11811756|FG001|COMPLETED|Overall Study||5
10651550|NCT02176486|11811757|FG002|COMPLETED|Overall Study||4
10651551|NCT02176486|11811755|FG000|NOT COMPLETED|Overall Study||0
10651552|NCT02176486|11811756|FG001|NOT COMPLETED|Overall Study||0
10651553|NCT02176486|11811757|FG002|NOT COMPLETED|Overall Study||0
10651554|NCT02176525|11811775|FG000|STARTED|Overall Study|15 subjects randomized, 14 subjects treated with at least one dose, 1 subject was not treated|15
10651555|NCT02176525|11811776|FG001|STARTED|Overall Study||9
10651556|NCT02176525|11811777|FG002|STARTED|Overall Study||9
10651557|NCT02176525|11811778|FG003|STARTED|Overall Study||9
10651558|NCT02176525|11811779|FG004|STARTED|Overall Study||8
10651559|NCT02176525|11811780|FG005|STARTED|Overall Study|6 subjects randomized, 5 subjects treated with at least one dose, 1 subject was not treated|6
10651560|NCT02176525|11811781|FG006|STARTED|Overall Study||9
10651561|NCT02176525|11811782|FG007|STARTED|Overall Study||10
10651562|NCT02176525|11811775|FG000|COMPLETED|Overall Study||14
10651563|NCT02176525|11811776|FG001|COMPLETED|Overall Study||9
10651564|NCT02176525|11811777|FG002|COMPLETED|Overall Study||9
10651565|NCT02176525|11811778|FG003|COMPLETED|Overall Study||8
10702651|NCT02577029|11867129|FG000|STARTED|Overall Study||10
10580260|NCT01709032|11735481|FG000|STARTED|Overall Study||9
10580261|NCT01709032|11735481|FG000|COMPLETED|Overall Study||6
10580262|NCT01709032|11735481|FG000|NOT COMPLETED|Overall Study||3
10580263|NCT01709084|11735488|FG000|STARTED|Overall Study||213
10580264|NCT01709084|11735489|FG001|STARTED|Overall Study||213
10580265|NCT01709084|11735488|FG000|Treated|Overall Study||213
10580266|NCT01709084|11735489|FG001|Treated|Overall Study||211
10580267|NCT01709084|11735488|FG000|COMPLETED|Overall Study||197
10580268|NCT01709084|11735489|FG001|COMPLETED|Overall Study||198
10580269|NCT01709084|11735488|FG000|NOT COMPLETED|Overall Study||16
10580270|NCT01709084|11735489|FG001|NOT COMPLETED|Overall Study||15
10580271|NCT01709110|11735497|FG000|STARTED|Overall Study||683
10580272|NCT01709110|11735498|FG001|STARTED|Overall Study||683
10580273|NCT01709110|11735497|FG000|Received at Least One Dose of Study Drug|Overall Study||680
10580274|NCT01709110|11735498|FG001|Received at Least One Dose of Study Drug|Overall Study||680
10580275|NCT01709110|11735497|FG000|COMPLETED|Overall Study||498
10580276|NCT01709110|11735498|FG001|COMPLETED|Overall Study||515
10580277|NCT01709110|11735497|FG000|NOT COMPLETED|Overall Study||185
10580278|NCT01709110|11735498|FG001|NOT COMPLETED|Overall Study||168
10580279|NCT01709149|11735507|FG000|STARTED|Open-label Lead-in Phase||711
10580280|NCT01709149|11735508|FG001|STARTED|Open-label Lead-in Phase||0
10580281|NCT01709149|11735509|FG002|STARTED|Open-label Lead-in Phase||0
10580282|NCT01709149|11735507|FG000|COMPLETED|Open-label Lead-in Phase||596
10580283|NCT01709149|11735508|FG001|COMPLETED|Open-label Lead-in Phase||0
10580284|NCT01709149|11735509|FG002|COMPLETED|Open-label Lead-in Phase||0
10580285|NCT01709149|11735507|FG000|NOT COMPLETED|Open-label Lead-in Phase||115
10580286|NCT01709149|11735508|FG001|NOT COMPLETED|Open-label Lead-in Phase||0
10580287|NCT01709149|11735509|FG002|NOT COMPLETED|Open-label Lead-in Phase||0
10580288|NCT01709149|11735507|FG000|STARTED|Double-blind, Placebo-controlled Phase||0
10580289|NCT01709149|11735508|FG001|STARTED|Double-blind, Placebo-controlled Phase||295
10702652|NCT02577029|11867130|FG001|STARTED|Overall Study||2
10702653|NCT02577029|11867131|FG002|STARTED|Overall Study||7
10702654|NCT02577029|11867132|FG003|STARTED|Overall Study||12
10702655|NCT02577029|11867133|FG004|STARTED|Overall Study||11
10702656|NCT02577029|11867134|FG005|STARTED|Overall Study||13
10702657|NCT02577029|11867135|FG006|STARTED|Overall Study||12
10702658|NCT02577029|11867136|FG007|STARTED|Overall Study||12
10702659|NCT02577029|11867129|FG000|COMPLETED|Overall Study||0
10806505|NCT03951610|11968024|FG000|NOT COMPLETED|Second Intervention||0
10806506|NCT03951610|11968025|FG001|NOT COMPLETED|Second Intervention||0
10806507|NCT03958149|11968033|FG000|STARTED|Overall Study||20
10806508|NCT03958149|11968034|FG001|STARTED|Overall Study||18
10580290|NCT01709149|11735509|FG002|STARTED|Double-blind, Placebo-controlled Phase||301
10580291|NCT01709149|11735507|FG000|COMPLETED|Double-blind, Placebo-controlled Phase||0
10580292|NCT01709149|11735508|FG001|COMPLETED|Double-blind, Placebo-controlled Phase||269
10580293|NCT01709149|11735509|FG002|COMPLETED|Double-blind, Placebo-controlled Phase||204
10580294|NCT01709149|11735507|FG000|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
10580295|NCT01709149|11735508|FG001|NOT COMPLETED|Double-blind, Placebo-controlled Phase||26
10580296|NCT01709149|11735509|FG002|NOT COMPLETED|Double-blind, Placebo-controlled Phase||97
10580297|NCT01709162|11735518|FG000|STARTED|Overall Study|Randomized|18
10580298|NCT01709162|11735519|FG001|STARTED|Overall Study|Randomized|5
10580299|NCT01709162|11735518|FG000|Received Treatment|Overall Study||18
10580300|NCT01709162|11735519|FG001|Received Treatment|Overall Study||4
10580301|NCT01709162|11735518|FG000|Still Receiving Treatment|Overall Study||0
10580302|NCT01709162|11735519|FG001|Still Receiving Treatment|Overall Study||0
10580303|NCT01709162|11735518|FG000|COMPLETED|Overall Study|Completed treatment as per protocol|12
10580304|NCT01709162|11735519|FG001|COMPLETED|Overall Study|Completed treatment as per protocol|0
10580305|NCT01709162|11735518|FG000|NOT COMPLETED|Overall Study||6
10580306|NCT01709162|11735519|FG001|NOT COMPLETED|Overall Study||5
10806509|NCT03958149|11968033|FG000|COMPLETED|Overall Study||20
10580307|NCT01709227|11735527|FG000|STARTED|Overall Study||32
10580308|NCT01709227|11735528|FG001|STARTED|Overall Study||41
10580309|NCT01709227|11735527|FG000|COMPLETED|Overall Study||31
10580310|NCT01709227|11735528|FG001|COMPLETED|Overall Study||32
10580311|NCT01709227|11735527|FG000|NOT COMPLETED|Overall Study||1
10702660|NCT02577029|11867130|FG001|COMPLETED|Overall Study||0
10806510|NCT03958149|11968034|FG001|COMPLETED|Overall Study||17
10806511|NCT03958149|11968033|FG000|NOT COMPLETED|Overall Study||0
10806512|NCT03958149|11968034|FG001|NOT COMPLETED|Overall Study||1
10806513|NCT03953183|11968046|FG000|STARTED|Overall Study||30
10806514|NCT03953183|11968047|FG001|STARTED|Overall Study||30
10806515|NCT03953183|11968046|FG000|COMPLETED|Overall Study||30
10580312|NCT01709227|11735528|FG001|NOT COMPLETED|Overall Study||9
10580313|NCT01709305|11735535|FG000|STARTED|Phase 1||5570
10580314|NCT01709305|11735536|FG001|STARTED|Phase 1||0
10580315|NCT01709305|11735537|FG002|STARTED|Phase 1||0
10580316|NCT01709305|11735538|FG003|STARTED|Phase 1||0
10580317|NCT01709305|11735539|FG004|STARTED|Phase 1||0
10580318|NCT01709305|11735535|FG000|COMPLETED|Phase 1||4933
10580319|NCT01709305|11735536|FG001|COMPLETED|Phase 1||0
10580320|NCT01709305|11735537|FG002|COMPLETED|Phase 1||0
10580321|NCT01709305|11735538|FG003|COMPLETED|Phase 1||0
10580322|NCT01709305|11735539|FG004|COMPLETED|Phase 1||0
10580323|NCT01709305|11735535|FG000|NOT COMPLETED|Phase 1||637
10580324|NCT01709305|11735536|FG001|NOT COMPLETED|Phase 1||0
10580325|NCT01709305|11735537|FG002|NOT COMPLETED|Phase 1||0
10580326|NCT01709305|11735538|FG003|NOT COMPLETED|Phase 1||0
10580327|NCT01709305|11735539|FG004|NOT COMPLETED|Phase 1||0
10580328|NCT01709305|11735535|FG000|STARTED|Phase 2||0
10580329|NCT01709305|11735536|FG001|STARTED|Phase 2||552
10580330|NCT01709305|11735537|FG002|STARTED|Phase 2||550
10580331|NCT01709305|11735538|FG003|STARTED|Phase 2||556
10580332|NCT01709305|11735539|FG004|STARTED|Phase 2||554
10580333|NCT01709305|11735535|FG000|COMPLETED|Phase 2||0
10580334|NCT01709305|11735536|FG001|COMPLETED|Phase 2||500
10580335|NCT01709305|11735537|FG002|COMPLETED|Phase 2||505
10580336|NCT01709305|11735538|FG003|COMPLETED|Phase 2||508
10580337|NCT01709305|11735539|FG004|COMPLETED|Phase 2||507
10580338|NCT01709305|11735535|FG000|NOT COMPLETED|Phase 2||0
10580339|NCT01709305|11735536|FG001|NOT COMPLETED|Phase 2||52
10580340|NCT01709305|11735537|FG002|NOT COMPLETED|Phase 2||45
10580341|NCT01709305|11735538|FG003|NOT COMPLETED|Phase 2||48
10580342|NCT01709305|11735539|FG004|NOT COMPLETED|Phase 2||47
10580343|NCT01709383|11735556|FG000|STARTED|Overall Study||24
10580344|NCT01709383|11735557|FG001|STARTED|Overall Study||14
10580345|NCT01709383|11735556|FG000|Completed Treatment|Overall Study||24
10580346|NCT01709383|11735557|FG001|Completed Treatment|Overall Study||14
10580347|NCT01709383|11735556|FG000|Completed Follow-ups|Overall Study||23
10580348|NCT01709383|11735557|FG001|Completed Follow-ups|Overall Study||14
10580349|NCT01709383|11735556|FG000|Included in Analysis|Overall Study||22
10580350|NCT01709383|11735557|FG001|Included in Analysis|Overall Study||13
10580351|NCT01709383|11735556|FG000|COMPLETED|Overall Study||23
10580352|NCT01709383|11735557|FG001|COMPLETED|Overall Study||14
10580353|NCT01709383|11735556|FG000|NOT COMPLETED|Overall Study||1
10580354|NCT01709383|11735557|FG001|NOT COMPLETED|Overall Study||0
10580355|NCT01709409|11735567|FG000|STARTED|Overall Study||43
10580356|NCT01709409|11735568|FG001|STARTED|Overall Study||45
10580357|NCT01709409|11735567|FG000|COMPLETED|Overall Study||42
10580358|NCT01709409|11735568|FG001|COMPLETED|Overall Study||45
10580359|NCT01709409|11735567|FG000|NOT COMPLETED|Overall Study||1
10580360|NCT01709409|11735568|FG001|NOT COMPLETED|Overall Study||0
10580361|NCT01709422|11735576|FG000|STARTED|Overall Study||70
10580362|NCT01709422|11735577|FG001|STARTED|Overall Study||70
10580363|NCT01709422|11735576|FG000|COMPLETED|Overall Study||70
10580364|NCT01709422|11735577|FG001|COMPLETED|Overall Study||70
10580365|NCT01709422|11735576|FG000|NOT COMPLETED|Overall Study||0
10580366|NCT01709422|11735577|FG001|NOT COMPLETED|Overall Study||0
10580367|NCT01709474|11735587|FG000|STARTED|Overall Study||3
10580368|NCT01709474|11735588|FG001|STARTED|Overall Study||4
10580369|NCT01709474|11735587|FG000|COMPLETED|Overall Study||3
10580370|NCT01709474|11735588|FG001|COMPLETED|Overall Study||4
10580371|NCT01709474|11735587|FG000|NOT COMPLETED|Overall Study||0
10580372|NCT01709474|11735588|FG001|NOT COMPLETED|Overall Study||0
10580373|NCT01709500|11735596|FG000|STARTED|Overall Study||167
10580374|NCT01709500|11735597|FG001|STARTED|Overall Study||82
10580375|NCT01709500|11735596|FG000|Treated|Overall Study||167
10580376|NCT01709500|11735597|FG001|Treated|Overall Study||81
10580377|NCT01709500|11735596|FG000|COMPLETED|Overall Study||0
10580378|NCT01709500|11735597|FG001|COMPLETED|Overall Study||0
10580379|NCT01709500|11735596|FG000|NOT COMPLETED|Overall Study||167
10580380|NCT01709500|11735597|FG001|NOT COMPLETED|Overall Study||82
10580381|NCT01709513|11735606|FG000|STARTED|Overall Study||63
10580382|NCT01709513|11735607|FG001|STARTED|Overall Study||125
10580383|NCT01709513|11735608|FG002|STARTED|Overall Study||126
10580384|NCT01709513|11735606|FG000|Treated|Overall Study||63
10580385|NCT01709513|11735607|FG001|Treated|Overall Study||124
10580386|NCT01709513|11735608|FG002|Treated|Overall Study||126
10580387|NCT01709513|11735606|FG000|COMPLETED|Overall Study||42
10580388|NCT01709513|11735607|FG001|COMPLETED|Overall Study||82
10580389|NCT01709513|11735608|FG002|COMPLETED|Overall Study||96
10580390|NCT01709513|11735606|FG000|NOT COMPLETED|Overall Study||21
10580391|NCT01709513|11735607|FG001|NOT COMPLETED|Overall Study||43
10580392|NCT01709513|11735608|FG002|NOT COMPLETED|Overall Study||30
10580393|NCT01709578|11735622|FG000|STARTED|Overall Study||181
10580394|NCT01709578|11735623|FG001|STARTED|Overall Study||181
10580395|NCT01709578|11735624|FG002|STARTED|Overall Study||184
10580396|NCT01709578|11735622|FG000|COMPLETED|Overall Study||101
10580397|NCT01709578|11735623|FG001|COMPLETED|Overall Study||125
10580398|NCT01709578|11735624|FG002|COMPLETED|Overall Study||133
10580399|NCT01709578|11735622|FG000|NOT COMPLETED|Overall Study||80
10580400|NCT01709578|11735623|FG001|NOT COMPLETED|Overall Study||56
10580401|NCT01709578|11735624|FG002|NOT COMPLETED|Overall Study||51
10580402|NCT01709695|11735634|FG000|STARTED|Overall Study||13
10580403|NCT01709695|11735635|FG001|STARTED|Overall Study||14
10580404|NCT01709695|11735634|FG000|COMPLETED|Overall Study||12
10580405|NCT01709695|11735635|FG001|COMPLETED|Overall Study||13
10580406|NCT01709695|11735634|FG000|NOT COMPLETED|Overall Study||1
10580407|NCT01709695|11735635|FG001|NOT COMPLETED|Overall Study||1
10580408|NCT01709708|11735643|FG000|STARTED|Overall Study||27
10580409|NCT01709708|11735644|FG001|STARTED|Overall Study||14
10580410|NCT01709708|11735643|FG000|COMPLETED|Overall Study||26
10580411|NCT01709708|11735644|FG001|COMPLETED|Overall Study||12
10580412|NCT01709708|11735643|FG000|NOT COMPLETED|Overall Study||1
10580413|NCT01709708|11735644|FG001|NOT COMPLETED|Overall Study||2
10580414|NCT01709721|11735654|FG000|STARTED|Open Label Phase||41
10580415|NCT01709721|11735655|FG001|STARTED|Open Label Phase||40
10580416|NCT01709721|11735656|FG002|STARTED|Open Label Phase||72
10580417|NCT01709721|11735654|FG000|COMPLETED|Open Label Phase||41
10580418|NCT01709721|11735655|FG001|COMPLETED|Open Label Phase||40
10580419|NCT01709721|11735656|FG002|COMPLETED|Open Label Phase||0
10580420|NCT01709721|11735654|FG000|NOT COMPLETED|Open Label Phase||0
10580421|NCT01709721|11735655|FG001|NOT COMPLETED|Open Label Phase||0
10580422|NCT01709721|11735656|FG002|NOT COMPLETED|Open Label Phase||72
10580423|NCT01709721|11735654|FG000|STARTED|Randomized Phase||41
10580424|NCT01709721|11735655|FG001|STARTED|Randomized Phase||40
10580425|NCT01709721|11735656|FG002|STARTED|Randomized Phase||0
10580426|NCT01709721|11735654|FG000|COMPLETED|Randomized Phase||38
10580427|NCT01709721|11735655|FG001|COMPLETED|Randomized Phase||34
10580428|NCT01709721|11735656|FG002|COMPLETED|Randomized Phase||0
10580429|NCT01709721|11735654|FG000|NOT COMPLETED|Randomized Phase||3
10580430|NCT01709721|11735655|FG001|NOT COMPLETED|Randomized Phase||6
10580431|NCT01709721|11735656|FG002|NOT COMPLETED|Randomized Phase||0
10580432|NCT01709747|11735664|FG000|STARTED|Overall Study||364
10580433|NCT01709747|11735664|FG000|COMPLETED|Overall Study||287
10580434|NCT01709747|11735664|FG000|NOT COMPLETED|Overall Study||77
10580435|NCT01709786|11735669|FG000|STARTED|Overall Study||88
10580436|NCT01709786|11735669|FG000|COMPLETED|Overall Study||88
10580437|NCT01709786|11735669|FG000|NOT COMPLETED|Overall Study||0
10580438|NCT01709799|11735678|FG000|STARTED|Overall Study||25
10580439|NCT01709799|11735679|FG001|STARTED|Overall Study||21
10580440|NCT01709799|11735680|FG002|STARTED|Overall Study||18
10580441|NCT01709799|11735678|FG000|COMPLETED|Overall Study||22
10580442|NCT01709799|11735679|FG001|COMPLETED|Overall Study||18
10580443|NCT01709799|11735680|FG002|COMPLETED|Overall Study||15
10580444|NCT01709799|11735678|FG000|NOT COMPLETED|Overall Study||3
10580445|NCT01709799|11735679|FG001|NOT COMPLETED|Overall Study||3
10580446|NCT01709799|11735680|FG002|NOT COMPLETED|Overall Study||3
10580447|NCT01709838|11735688|FG000|STARTED|Overall Study||134
10580448|NCT01709838|11735688|FG000|COMPLETED|Overall Study||67
10580449|NCT01709838|11735688|FG000|NOT COMPLETED|Overall Study||67
10580450|NCT01709864|11735696|FG000|STARTED|Overall Study||222
10580451|NCT01709864|11735697|FG001|STARTED|Overall Study||219
10580452|NCT01709864|11735696|FG000|Full Analysis Set (FAS)|Overall Study|FAS included all randomized patients who received at least one dose of trial drug.|222
10580453|NCT01709864|11735697|FG001|Full Analysis Set (FAS)|Overall Study|FAS included all randomized patients who received at least one dose of trial drug.|216
10580454|NCT01709864|11735696|FG000|Per Protocol Set (PPS)|Overall Study|PPS included all patients in the FAS who did not have any major protocol deviations.|204
10580455|NCT01709864|11735697|FG001|Per Protocol Set (PPS)|Overall Study|PPS included all patients in the FAS who did not have any major protocol deviations.|201
10580456|NCT01709864|11735696|FG000|COMPLETED|Overall Study||215
10580457|NCT01709864|11735697|FG001|COMPLETED|Overall Study||208
10580458|NCT01709864|11735696|FG000|NOT COMPLETED|Overall Study||7
10580459|NCT01709864|11735697|FG001|NOT COMPLETED|Overall Study||11
10580460|NCT01709903|11735705|FG000|STARTED|Overall Study|Randomized set|372
10580461|NCT01709903|11735706|FG001|STARTED|Overall Study|Randomized set|372
10580462|NCT01709903|11735705|FG000|COMPLETED|Overall Study||343
10580463|NCT01709903|11735706|FG001|COMPLETED|Overall Study||333
10580464|NCT01709903|11735705|FG000|NOT COMPLETED|Overall Study||29
10580465|NCT01709903|11735706|FG001|NOT COMPLETED|Overall Study||39
10580466|NCT01710020|11735712|FG000|STARTED|Period 1||12
10580467|NCT01710020|11735712|FG000|COMPLETED|Period 1||11
10580468|NCT01710020|11735712|FG000|NOT COMPLETED|Period 1||1
10580469|NCT01710020|11735712|FG000|STARTED|Washout Period (at Least 14 Days)||11
10702661|NCT02577029|11867131|FG002|COMPLETED|Overall Study||0
10702662|NCT02577029|11867132|FG003|COMPLETED|Overall Study||0
10702663|NCT02577029|11867133|FG004|COMPLETED|Overall Study||0
10702664|NCT02577029|11867134|FG005|COMPLETED|Overall Study||0
10702665|NCT02577029|11867135|FG006|COMPLETED|Overall Study||0
10702666|NCT02577029|11867136|FG007|COMPLETED|Overall Study||0
10702667|NCT02577029|11867129|FG000|NOT COMPLETED|Overall Study||10
10702668|NCT02577029|11867130|FG001|NOT COMPLETED|Overall Study||2
10580470|NCT01710020|11735712|FG000|COMPLETED|Washout Period (at Least 14 Days)||11
10580471|NCT01710020|11735712|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10580472|NCT01710020|11735712|FG000|STARTED|Period 2||11
10580473|NCT01710020|11735712|FG000|COMPLETED|Period 2||11
10580474|NCT01710020|11735712|FG000|NOT COMPLETED|Period 2||0
10580475|NCT01710033|11735722|FG000|STARTED|Stage 1||6
10580476|NCT01710033|11735723|FG001|STARTED|Stage 1||6
10580477|NCT01710033|11735724|FG002|STARTED|Stage 1||6
10580478|NCT01710033|11735725|FG003|STARTED|Stage 1||6
10580479|NCT01710033|11735726|FG004|STARTED|Stage 1||0
10580480|NCT01710033|11735722|FG000|COMPLETED|Stage 1||6
10580481|NCT01710033|11735723|FG001|COMPLETED|Stage 1||6
10580482|NCT01710033|11735724|FG002|COMPLETED|Stage 1||6
10580483|NCT01710033|11735725|FG003|COMPLETED|Stage 1||6
10580484|NCT01710033|11735726|FG004|COMPLETED|Stage 1||0
10580485|NCT01710033|11735722|FG000|NOT COMPLETED|Stage 1||0
10580486|NCT01710033|11735723|FG001|NOT COMPLETED|Stage 1||0
10580487|NCT01710033|11735724|FG002|NOT COMPLETED|Stage 1||0
10580488|NCT01710033|11735725|FG003|NOT COMPLETED|Stage 1||0
10580489|NCT01710033|11735726|FG004|NOT COMPLETED|Stage 1||0
10580490|NCT01710033|11735722|FG000|STARTED|Stage 2||0
10580491|NCT01710033|11735723|FG001|STARTED|Stage 2||0
10580492|NCT01710033|11735724|FG002|STARTED|Stage 2||0
10580493|NCT01710033|11735725|FG003|STARTED|Stage 2||0
10580494|NCT01710033|11735726|FG004|STARTED|Stage 2||4
10580495|NCT01710033|11735722|FG000|COMPLETED|Stage 2||0
10580496|NCT01710033|11735723|FG001|COMPLETED|Stage 2||0
10702669|NCT02577029|11867131|FG002|NOT COMPLETED|Overall Study||7
10580497|NCT01710033|11735724|FG002|COMPLETED|Stage 2||0
10580498|NCT01710033|11735725|FG003|COMPLETED|Stage 2||0
10580499|NCT01710033|11735726|FG004|COMPLETED|Stage 2||3
10580500|NCT01710033|11735722|FG000|NOT COMPLETED|Stage 2||0
10580501|NCT01710033|11735723|FG001|NOT COMPLETED|Stage 2||0
10580502|NCT01710033|11735724|FG002|NOT COMPLETED|Stage 2||0
10580503|NCT01710033|11735725|FG003|NOT COMPLETED|Stage 2||0
10580504|NCT01710033|11735726|FG004|NOT COMPLETED|Stage 2||1
10580505|NCT01710046|11735741|FG000|STARTED|Overall Study||9
10580506|NCT01710046|11735742|FG001|STARTED|Overall Study||3
10580507|NCT01710046|11735741|FG000|COMPLETED|Overall Study||8
10580508|NCT01710046|11735742|FG001|COMPLETED|Overall Study||3
10580509|NCT01710046|11735741|FG000|NOT COMPLETED|Overall Study||1
10580510|NCT01710046|11735742|FG001|NOT COMPLETED|Overall Study||0
10580511|NCT01710137|11735750|FG000|STARTED|Overall Study||89
10580512|NCT01710137|11735751|FG001|STARTED|Overall Study||90
10580513|NCT01710137|11735750|FG000|COMPLETED|Overall Study||65
10580514|NCT01710137|11735751|FG001|COMPLETED|Overall Study||76
10580515|NCT01710137|11735750|FG000|NOT COMPLETED|Overall Study||24
10580516|NCT01710137|11735751|FG001|NOT COMPLETED|Overall Study||14
10580517|NCT01710254|11735757|FG000|STARTED|Overall Study||30
10580518|NCT01710254|11735757|FG000|COMPLETED|Overall Study||30
10580519|NCT01710254|11735757|FG000|NOT COMPLETED|Overall Study||0
10580520|NCT01710306|11735763|FG000|STARTED|Overall Study||86
10580521|NCT01710306|11735764|FG001|STARTED|Overall Study||85
10580522|NCT01710306|11735763|FG000|COMPLETED|Overall Study||68
10580523|NCT01710306|11735764|FG001|COMPLETED|Overall Study||55
10580524|NCT01710306|11735763|FG000|NOT COMPLETED|Overall Study||18
10580525|NCT01710306|11735764|FG001|NOT COMPLETED|Overall Study||30
10580526|NCT01710332|11735773|FG000|STARTED|Overall Study||6
10580527|NCT01710332|11735774|FG001|STARTED|Overall Study||6
10580528|NCT01710332|11735773|FG000|COMPLETED|Overall Study||6
10580529|NCT01710332|11735774|FG001|COMPLETED|Overall Study||6
10580530|NCT01710332|11735773|FG000|NOT COMPLETED|Overall Study||0
10580531|NCT01710332|11735774|FG001|NOT COMPLETED|Overall Study||0
10580532|NCT01710345|11735783|FG000|STARTED|Overall Study|41 patients were randomized to sufentanil 20 mcg, one patient not dosed due to damaged medication.|40
10580533|NCT01710345|11735784|FG001|STARTED|Overall Study||40
10580534|NCT01710345|11735785|FG002|STARTED|Overall Study||20
10580535|NCT01710345|11735783|FG000|COMPLETED|Overall Study||37
10580536|NCT01710345|11735784|FG001|COMPLETED|Overall Study||35
10580537|NCT01710345|11735785|FG002|COMPLETED|Overall Study||19
10580538|NCT01710345|11735783|FG000|NOT COMPLETED|Overall Study||3
10580539|NCT01710345|11735784|FG001|NOT COMPLETED|Overall Study||5
10580540|NCT01710345|11735785|FG002|NOT COMPLETED|Overall Study||1
10580541|NCT01710358|11735796|FG000|STARTED|Treatment Period Part A (Weeks 0 to 24)||489
10580542|NCT01710358|11735797|FG001|STARTED|Treatment Period Part A (Weeks 0 to 24)||488
10580543|NCT01710358|11735798|FG002|STARTED|Treatment Period Part A (Weeks 0 to 24)||330
10580544|NCT01710358|11735796|FG000|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||488
10580545|NCT01710358|11735797|FG001|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||487
10580546|NCT01710358|11735798|FG002|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||330
10580547|NCT01710358|11735796|FG000|Rescued|Treatment Period Part A (Weeks 0 to 24)||128
10580548|NCT01710358|11735797|FG001|Rescued|Treatment Period Part A (Weeks 0 to 24)||35
10580549|NCT01710358|11735798|FG002|Rescued|Treatment Period Part A (Weeks 0 to 24)||40
10580550|NCT01710358|11735796|FG000|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|438
10580551|NCT01710358|11735797|FG001|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|459
10580552|NCT01710358|11735798|FG002|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|307
10580553|NCT01710358|11735796|FG000|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||51
10580554|NCT01710358|11735797|FG001|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||29
10580555|NCT01710358|11735798|FG002|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||23
10580556|NCT01710358|11735796|FG000|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|310
10580557|NCT01710358|11735797|FG001|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|424
10580558|NCT01710358|11735798|FG002|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|267
10580559|NCT01710358|11735796|FG000|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)|Participants originally randomized to placebo received baricitinib during Part B.|306
10580560|NCT01710358|11735797|FG001|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)||424
10580561|NCT01710358|11735798|FG002|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)||267
10580562|NCT01710358|11735796|FG000|Rescued|Treatment Period Part B (Weeks 24 to 52)||5
10580563|NCT01710358|11735797|FG001|Rescued|Treatment Period Part B (Weeks 24 to 52)||8
10806516|NCT03953183|11968047|FG001|COMPLETED|Overall Study||28
10806517|NCT03953183|11968046|FG000|NOT COMPLETED|Overall Study||0
10806518|NCT03953183|11968047|FG001|NOT COMPLETED|Overall Study||2
10806519|NCT03949335|11968055|FG000|STARTED|Overall Study||135
10580564|NCT01710358|11735798|FG002|Rescued|Treatment Period Part B (Weeks 24 to 52)||11
10580565|NCT01710358|11735796|FG000|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|294
10580566|NCT01710358|11735797|FG001|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|402
10580567|NCT01710358|11735798|FG002|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|252
10580568|NCT01710358|11735796|FG000|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||16
10580569|NCT01710358|11735797|FG001|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||22
10580570|NCT01710358|11735798|FG002|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||15
10580571|NCT01710358|11735796|FG000|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
10651566|NCT02176525|11811779|FG004|COMPLETED|Overall Study||7
10806520|NCT03949335|11968056|FG001|STARTED|Overall Study||137
10806521|NCT03949335|11968055|FG000|COMPLETED|Overall Study||132
10806522|NCT03949335|11968056|FG001|COMPLETED|Overall Study||131
10806523|NCT03949335|11968055|FG000|NOT COMPLETED|Overall Study||3
10806524|NCT03949335|11968056|FG001|NOT COMPLETED|Overall Study||6
10580572|NCT01710358|11735797|FG001|STARTED|Rescue Period|Baricitinib 4 mg administered PO QD through Week 52. Participants continued background MTX therapy.|227
10580573|NCT01710358|11735798|FG002|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
10580574|NCT01710358|11735796|FG000|COMPLETED|Rescue Period||0
10580575|NCT01710358|11735797|FG001|COMPLETED|Rescue Period||196
10580576|NCT01710358|11735798|FG002|COMPLETED|Rescue Period||0
10580577|NCT01710358|11735796|FG000|NOT COMPLETED|Rescue Period||0
10580578|NCT01710358|11735797|FG001|NOT COMPLETED|Rescue Period||31
10580579|NCT01710358|11735798|FG002|NOT COMPLETED|Rescue Period||0
10580580|NCT01710358|11735796|FG000|STARTED|Follow-up Period|Participants from treatment who entered the post-treatment follow-up period.|33
10580581|NCT01710358|11735797|FG001|STARTED|Follow-up Period|Rescued participants who entered post-treatment follow-up are included in Baricitinib 4mg follow up.|76
10580582|NCT01710358|11735798|FG002|STARTED|Follow-up Period|Participants from treatment who entered the post-treatment follow-up period.|20
10580583|NCT01710358|11735796|FG000|COMPLETED|Follow-up Period||33
10580584|NCT01710358|11735797|FG001|COMPLETED|Follow-up Period||76
10580585|NCT01710358|11735798|FG002|COMPLETED|Follow-up Period||20
10580586|NCT01710358|11735796|FG000|NOT COMPLETED|Follow-up Period||0
10580587|NCT01710358|11735797|FG001|NOT COMPLETED|Follow-up Period||0
10580588|NCT01710358|11735798|FG002|NOT COMPLETED|Follow-up Period||0
10580589|NCT01710501|11735822|FG000|STARTED|Overall Study||29
10580590|NCT01710501|11735823|FG001|STARTED|Overall Study||28
10580591|NCT01710501|11735824|FG002|STARTED|Overall Study||30
10580592|NCT01710501|11735822|FG000|COMPLETED|Overall Study||27
10580593|NCT01710501|11735823|FG001|COMPLETED|Overall Study||28
10580594|NCT01710501|11735824|FG002|COMPLETED|Overall Study||30
10580595|NCT01710501|11735822|FG000|NOT COMPLETED|Overall Study||2
10580596|NCT01710501|11735823|FG001|NOT COMPLETED|Overall Study||0
10580597|NCT01710501|11735824|FG002|NOT COMPLETED|Overall Study||0
10580598|NCT01710514|11735834|FG000|STARTED|Overall Study||54
10580599|NCT01710514|11735835|FG001|STARTED|Overall Study||54
10580600|NCT01710514|11735834|FG000|Intent-To-Treat (ITT) Analysis Set|Overall Study|All randomised subjects were included in the Intent-To-Treat (ITT) analysis set.|54
10580601|NCT01710514|11735835|FG001|Intent-To-Treat (ITT) Analysis Set|Overall Study|All randomised subjects were included in the ITT analysis set.|54
10580602|NCT01710514|11735834|FG000|Full Analysis Set (FAS)|Overall Study|All randomised and exposed subjects with at least one completed primary efficacy assessment.|46
10580603|NCT01710514|11735835|FG001|Full Analysis Set (FAS)|Overall Study|All randomised and exposed subjects with at least one completed primary efficacy assessment.|48
10580604|NCT01710514|11735834|FG000|FAS With Embryo Transfer (ET)|Overall Study|Data on pregnancy was reported for the subjects with embryo transfer.|43
10580605|NCT01710514|11735835|FG001|FAS With Embryo Transfer (ET)|Overall Study|Data on pregnancy was reported for the subjects with embryo transfer.|47
10580606|NCT01710514|11735834|FG000|Safety Analysis Set|Overall Study|All subjects received at least one dose of Investigational Medicinal Product (IMP).|54
10580607|NCT01710514|11735835|FG001|Safety Analysis Set|Overall Study|All subjects received at least one dose of IMP.|54
10580608|NCT01710514|11735834|FG000|COMPLETED|Overall Study||47
10580609|NCT01710514|11735835|FG001|COMPLETED|Overall Study||47
10580610|NCT01710514|11735834|FG000|NOT COMPLETED|Overall Study||7
10580611|NCT01710514|11735835|FG001|NOT COMPLETED|Overall Study||7
10580612|NCT01710527|11735844|FG000|STARTED|Period 1: Intervention Period 1||16
10580613|NCT01710527|11735845|FG001|STARTED|Period 1: Intervention Period 1||16
10580614|NCT01710527|11735844|FG000|COMPLETED|Period 1: Intervention Period 1||16
10580615|NCT01710527|11735845|FG001|COMPLETED|Period 1: Intervention Period 1||16
10580616|NCT01710527|11735844|FG000|NOT COMPLETED|Period 1: Intervention Period 1||0
10580617|NCT01710527|11735845|FG001|NOT COMPLETED|Period 1: Intervention Period 1||0
10580618|NCT01710527|11735844|FG000|STARTED|Period 2: Washout Period (7 Days)||16
10580619|NCT01710527|11735845|FG001|STARTED|Period 2: Washout Period (7 Days)||16
10580620|NCT01710527|11735844|FG000|COMPLETED|Period 2: Washout Period (7 Days)||16
10580621|NCT01710527|11735845|FG001|COMPLETED|Period 2: Washout Period (7 Days)||15
10580622|NCT01710527|11735844|FG000|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
10580623|NCT01710527|11735845|FG001|NOT COMPLETED|Period 2: Washout Period (7 Days)||1
10580624|NCT01710527|11735844|FG000|STARTED|Period 3: Intervention Period 2||16
10580625|NCT01710527|11735845|FG001|STARTED|Period 3: Intervention Period 2||15
10702670|NCT02577029|11867132|FG003|NOT COMPLETED|Overall Study||12
10702671|NCT02577029|11867133|FG004|NOT COMPLETED|Overall Study||11
10580626|NCT01710527|11735844|FG000|COMPLETED|Period 3: Intervention Period 2||16
10580627|NCT01710527|11735845|FG001|COMPLETED|Period 3: Intervention Period 2||15
10580628|NCT01710527|11735844|FG000|NOT COMPLETED|Period 3: Intervention Period 2||0
10580629|NCT01710527|11735845|FG001|NOT COMPLETED|Period 3: Intervention Period 2||0
10580630|NCT01710657|11735854|FG000|STARTED|Overall Study||184
10580631|NCT01710657|11735855|FG001|STARTED|Overall Study||183
10580632|NCT01710657|11735856|FG002|STARTED|Overall Study||180
10580633|NCT01710657|11735854|FG000|Titration Period (4 Weeks)|Overall Study||184
10580634|NCT01710657|11735855|FG001|Titration Period (4 Weeks)|Overall Study||183
10580635|NCT01710657|11735856|FG002|Titration Period (4 Weeks)|Overall Study||180
10580636|NCT01710657|11735854|FG000|Maintenance Period (12 Weeks)|Overall Study||176
10702672|NCT02577029|11867134|FG005|NOT COMPLETED|Overall Study||13
10702673|NCT02577029|11867135|FG006|NOT COMPLETED|Overall Study||12
10702674|NCT02577029|11867136|FG007|NOT COMPLETED|Overall Study||12
10702675|NCT02577042|11867156|FG000|STARTED|Overall Study||20
10580637|NCT01710657|11735855|FG001|Maintenance Period (12 Weeks)|Overall Study||175
10580638|NCT01710657|11735856|FG002|Maintenance Period (12 Weeks)|Overall Study||168
10580639|NCT01710657|11735854|FG000|COMPLETED|Overall Study||166
10580640|NCT01710657|11735855|FG001|COMPLETED|Overall Study||171
10580641|NCT01710657|11735856|FG002|COMPLETED|Overall Study||148
10580642|NCT01710657|11735854|FG000|NOT COMPLETED|Overall Study||18
10580643|NCT01710657|11735855|FG001|NOT COMPLETED|Overall Study||12
10580644|NCT01710657|11735856|FG002|NOT COMPLETED|Overall Study||32
10580645|NCT01710709|11735864|FG000|STARTED|Overall Study||464
10580646|NCT01710709|11735864|FG000|COMPLETED|Overall Study||291
10580647|NCT01710709|11735864|FG000|NOT COMPLETED|Overall Study||173
10580648|NCT01710787|11735872|FG000|STARTED|Overall Study||44
10580649|NCT01710787|11735873|FG001|STARTED|Overall Study||44
10580650|NCT01710787|11735874|FG002|STARTED|Overall Study||22
10580651|NCT01710787|11735872|FG000|COMPLETED|Overall Study||44
10580652|NCT01710787|11735873|FG001|COMPLETED|Overall Study||44
10580653|NCT01710787|11735874|FG002|COMPLETED|Overall Study||22
10580654|NCT01710787|11735872|FG000|NOT COMPLETED|Overall Study||0
10580655|NCT01710787|11735873|FG001|NOT COMPLETED|Overall Study||0
10580656|NCT01710787|11735874|FG002|NOT COMPLETED|Overall Study||0
10580657|NCT01710800|11735882|FG000|STARTED|Overall Study|63 patients consented to be part of the study|63
10580658|NCT01710800|11735882|FG000|Received PPI Intervention|Overall Study||44
10580659|NCT01710800|11735882|FG000|Received Placebo Intervention|Overall Study||45
10580660|NCT01710800|11735882|FG000|COMPLETED|Overall Study|22 drop outs(consented but did not participate, refused 2nd intervention)|41
10580661|NCT01710800|11735882|FG000|NOT COMPLETED|Overall Study||22
10580662|NCT01710839|11735890|FG000|STARTED|Overall Study||24
10580663|NCT01710839|11735891|FG001|STARTED|Overall Study||6
10580664|NCT01710839|11735890|FG000|COMPLETED|Overall Study||23
10580665|NCT01710839|11735891|FG001|COMPLETED|Overall Study||0
10580666|NCT01710839|11735890|FG000|NOT COMPLETED|Overall Study||1
10580667|NCT01710839|11735891|FG001|NOT COMPLETED|Overall Study||6
10580668|NCT01710891|11735899|FG000|STARTED|Overall Study||95
10580669|NCT01710891|11735900|FG001|STARTED|Overall Study||103
10580670|NCT01710891|11735899|FG000|COMPLETED|Overall Study||95
10580671|NCT01710891|11735900|FG001|COMPLETED|Overall Study||103
10580672|NCT01710891|11735899|FG000|NOT COMPLETED|Overall Study||0
10580673|NCT01710891|11735900|FG001|NOT COMPLETED|Overall Study||0
10580674|NCT01711177|11735909|FG000|STARTED|Overall Study||10
10580675|NCT01711177|11735910|FG001|STARTED|Overall Study||3
10580676|NCT01711177|11735911|FG002|STARTED|Overall Study||3
10580677|NCT01711177|11735909|FG000|COMPLETED|Overall Study||10
10580678|NCT01711177|11735910|FG001|COMPLETED|Overall Study||3
10580679|NCT01711177|11735911|FG002|COMPLETED|Overall Study||3
10580680|NCT01711177|11735909|FG000|NOT COMPLETED|Overall Study||0
10580681|NCT01711177|11735910|FG001|NOT COMPLETED|Overall Study||0
10580682|NCT01711177|11735911|FG002|NOT COMPLETED|Overall Study||0
10580683|NCT01711216|11735919|FG000|STARTED|Overall Study||999
10580684|NCT01711216|11735919|FG000|COMPLETED|Overall Study||782
10580685|NCT01711216|11735919|FG000|NOT COMPLETED|Overall Study||217
10580686|NCT01711294|11735926|FG000|STARTED|Overall Study||121
10580687|NCT01711294|11735927|FG001|STARTED|Overall Study||65
10580688|NCT01711294|11735928|FG002|STARTED|Overall Study||64
10580689|NCT01711294|11735926|FG000|COMPLETED|Overall Study||121
10580690|NCT01711294|11735927|FG001|COMPLETED|Overall Study||65
10580691|NCT01711294|11735928|FG002|COMPLETED|Overall Study||64
10580692|NCT01711294|11735926|FG000|NOT COMPLETED|Overall Study||0
10580693|NCT01711294|11735927|FG001|NOT COMPLETED|Overall Study||0
10580694|NCT01711294|11735928|FG002|NOT COMPLETED|Overall Study||0
10580695|NCT01711359|11735939|FG000|STARTED|Treatment Period||213
10580696|NCT01711359|11735940|FG001|STARTED|Treatment Period||160
10580697|NCT01711359|11735941|FG002|STARTED|Treatment Period||215
10580698|NCT01711359|11735939|FG000|Received at Least One Dose of Study Drug|Treatment Period||210
10580699|NCT01711359|11735940|FG001|Received at Least One Dose of Study Drug|Treatment Period||159
10580700|NCT01711359|11735941|FG002|Received at Least One Dose of Study Drug|Treatment Period||215
10580701|NCT01711359|11735939|FG000|Rescued|Treatment Period||26
10580702|NCT01711359|11735940|FG001|Rescued|Treatment Period||7
10580703|NCT01711359|11735941|FG002|Rescued|Treatment Period||6
10580704|NCT01711359|11735939|FG000|COMPLETED|Treatment Period||161
10580705|NCT01711359|11735940|FG001|COMPLETED|Treatment Period||136
10580706|NCT01711359|11735941|FG002|COMPLETED|Treatment Period||173
10580707|NCT01711359|11735939|FG000|NOT COMPLETED|Treatment Period||52
10580708|NCT01711359|11735940|FG001|NOT COMPLETED|Treatment Period||24
10580709|NCT01711359|11735941|FG002|NOT COMPLETED|Treatment Period||42
10580710|NCT01711359|11735939|FG000|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|25
10580711|NCT01711359|11735940|FG001|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|15
10580712|NCT01711359|11735941|FG002|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|28
10580713|NCT01711359|11735939|FG000|COMPLETED|Follow Up||0
10580714|NCT01711359|11735940|FG001|COMPLETED|Follow Up||0
10580715|NCT01711359|11735941|FG002|COMPLETED|Follow Up||0
10580716|NCT01711359|11735939|FG000|NOT COMPLETED|Follow Up||25
10580717|NCT01711359|11735940|FG001|NOT COMPLETED|Follow Up||15
10580718|NCT01711359|11735941|FG002|NOT COMPLETED|Follow Up||28
10580719|NCT01711372|11735956|FG000|STARTED|Overall Study||66
10580720|NCT01711372|11735957|FG001|STARTED|Overall Study||47
10580721|NCT01711372|11735956|FG000|COMPLETED|Overall Study||66
10580722|NCT01711372|11735957|FG001|COMPLETED|Overall Study||47
10580723|NCT01711372|11735956|FG000|NOT COMPLETED|Overall Study||0
10580724|NCT01711372|11735957|FG001|NOT COMPLETED|Overall Study||0
10580725|NCT01711424|11735962|FG000|STARTED|Overall Study||1209
10580726|NCT01711424|11735962|FG000|COMPLETED|Overall Study||1209
10580727|NCT01711424|11735962|FG000|NOT COMPLETED|Overall Study||0
10580728|NCT01711619|11735968|FG000|STARTED|Overall Study||56
10580729|NCT01711619|11735969|FG001|STARTED|Overall Study||60
10580730|NCT01711619|11735968|FG000|COMPLETED|Overall Study||38
10580731|NCT01711619|11735969|FG001|COMPLETED|Overall Study||36
10580732|NCT01711619|11735968|FG000|NOT COMPLETED|Overall Study||18
10580733|NCT01711619|11735969|FG001|NOT COMPLETED|Overall Study||24
10580734|NCT01711645|11735975|FG000|STARTED|Overall Study||55
10580735|NCT01711645|11735975|FG000|COMPLETED|Overall Study||36
10580736|NCT01711645|11735975|FG000|NOT COMPLETED|Overall Study||19
10580737|NCT01711658|11735981|FG000|STARTED|Overall Study||64
10580738|NCT01711658|11735982|FG001|STARTED|Overall Study||63
10580739|NCT01711658|11735981|FG000|Participants Who Started Protocol Treatment|Overall Study||59
10580740|NCT01711658|11735982|FG001|Participants Who Started Protocol Treatment|Overall Study||60
10580741|NCT01711658|11735981|FG000|COMPLETED|Overall Study||64
10580742|NCT01711658|11735982|FG001|COMPLETED|Overall Study||63
10580743|NCT01711658|11735981|FG000|NOT COMPLETED|Overall Study||0
10580744|NCT01711658|11735982|FG001|NOT COMPLETED|Overall Study||0
10580745|NCT01711736|11735990|FG000|STARTED|Overall Study||299
10580746|NCT01711736|11735991|FG001|STARTED|Overall Study||302
10580747|NCT01711736|11735990|FG000|COMPLETED|Overall Study|Up to Day 180|287
10580748|NCT01711736|11735991|FG001|COMPLETED|Overall Study|Up to Day 180|294
10580749|NCT01711736|11735990|FG000|NOT COMPLETED|Overall Study||12
10580750|NCT01711736|11735991|FG001|NOT COMPLETED|Overall Study||8
10806525|NCT03962738|11968068|FG000|STARTED|Overall Study||258
10806526|NCT03962738|11968069|FG001|STARTED|Overall Study||109
10806527|NCT03962738|11968070|FG002|STARTED|Overall Study||261
10806528|NCT03962738|11968071|FG003|STARTED|Overall Study||218
10806529|NCT03962738|11968068|FG000|Received At Least One Dose of Study Drug|Overall Study||214
10806530|NCT03962738|11968069|FG001|Received At Least One Dose of Study Drug|Overall Study||87
10806531|NCT03962738|11968070|FG002|Received At Least One Dose of Study Drug|Overall Study||208
10806532|NCT03962738|11968071|FG003|Received At Least One Dose of Study Drug|Overall Study||182
10806533|NCT03962738|11968068|FG000|COMPLETED|Overall Study||251
10806534|NCT03962738|11968069|FG001|COMPLETED|Overall Study||109
10806535|NCT03962738|11968070|FG002|COMPLETED|Overall Study||259
10806536|NCT03962738|11968071|FG003|COMPLETED|Overall Study||217
10806537|NCT03962738|11968068|FG000|NOT COMPLETED|Overall Study||7
10806538|NCT03962738|11968069|FG001|NOT COMPLETED|Overall Study||0
10806539|NCT03962738|11968070|FG002|NOT COMPLETED|Overall Study||2
10806540|NCT03962738|11968071|FG003|NOT COMPLETED|Overall Study||1
10806541|NCT03962101|11968089|FG000|STARTED|Overall Study||45
10806542|NCT03962101|11968089|FG000|COMPLETED|Overall Study||41
10806543|NCT03962101|11968089|FG000|NOT COMPLETED|Overall Study||4
10580751|NCT01711853|11735998|FG000|STARTED|Overall Study||19
10580752|NCT01711853|11735998|FG000|COMPLETED|Overall Study||16
10580753|NCT01711853|11735998|FG000|NOT COMPLETED|Overall Study||3
10580754|NCT01711866|11736002|FG000|STARTED|Overall Study||87
10580755|NCT01711866|11736002|FG000|COMPLETED|Overall Study||79
10580756|NCT01711866|11736002|FG000|NOT COMPLETED|Overall Study||8
10580757|NCT01711918|11736006|FG000|STARTED|Overall Study||9
10580758|NCT01711918|11736006|FG000|COMPLETED|Overall Study||7
10580759|NCT01711918|11736006|FG000|NOT COMPLETED|Overall Study||2
10580760|NCT01711983|11736010|FG000|STARTED|6-Month Clinical Success Evaluation||400
10580761|NCT01711983|11736010|FG000|COMPLETED|6-Month Clinical Success Evaluation||368
10580762|NCT01711983|11736010|FG000|NOT COMPLETED|6-Month Clinical Success Evaluation||32
10580763|NCT01711983|11736010|FG000|STARTED|6-Month Closure Evaluation||368
10580764|NCT01711983|11736010|FG000|COMPLETED|6-Month Closure Evaluation||342
10580765|NCT01711983|11736010|FG000|NOT COMPLETED|6-Month Closure Evaluation||26
10580766|NCT01711983|11736010|FG000|STARTED|36-Month Closure Evaluation||342
10580767|NCT01711983|11736010|FG000|COMPLETED|36-Month Closure Evaluation||278
10580768|NCT01711983|11736010|FG000|NOT COMPLETED|36-Month Closure Evaluation||64
10580769|NCT01712009|11736017|FG000|STARTED|Overall Study||198
10580770|NCT01712009|11736018|FG001|STARTED|Overall Study||200
10580771|NCT01712009|11736019|FG002|STARTED|Overall Study||202
10580772|NCT01712009|11736017|FG000|Received Pegfilgrastim|Overall Study||191
10580773|NCT01712009|11736018|FG001|Received Pegfilgrastim|Overall Study||196
10580774|NCT01712009|11736019|FG002|Received Pegfilgrastim|Overall Study||200
10580775|NCT01712009|11736017|FG000|Received Naproxen / Loratadine|Overall Study||0
10580776|NCT01712009|11736018|FG001|Received Naproxen / Loratadine|Overall Study||193
10580777|NCT01712009|11736019|FG002|Received Naproxen / Loratadine|Overall Study||198
10580778|NCT01712009|11736017|FG000|COMPLETED|Overall Study||160
10580779|NCT01712009|11736018|FG001|COMPLETED|Overall Study||171
10806544|NCT03959137|11968094|FG000|STARTED|Overall Study||215
10806545|NCT03959137|11968094|FG000|COMPLETED|Overall Study||209
10806546|NCT03959137|11968094|FG000|NOT COMPLETED|Overall Study||6
10806547|NCT03946124|11968098|FG000|STARTED|Overall Study||74
10806548|NCT03946124|11968098|FG000|COMPLETED|Overall Study||55
10806549|NCT03946124|11968098|FG000|NOT COMPLETED|Overall Study||19
10580780|NCT01712009|11736019|FG002|COMPLETED|Overall Study||181
10580781|NCT01712009|11736017|FG000|NOT COMPLETED|Overall Study||38
10580782|NCT01712009|11736018|FG001|NOT COMPLETED|Overall Study||29
10580783|NCT01712009|11736019|FG002|NOT COMPLETED|Overall Study||21
10580784|NCT01712061|11736029|FG000|STARTED|Overall Study||30
10580785|NCT01712061|11736030|FG001|STARTED|Overall Study||140
10806550|NCT03961308|11968104|FG000|STARTED|Overall Study||102
10580786|NCT01712061|11736031|FG002|STARTED|Overall Study||56
10580787|NCT01712061|11736029|FG000|COMPLETED|Overall Study||20
10580788|NCT01712061|11736030|FG001|COMPLETED|Overall Study||114
10580789|NCT01712061|11736031|FG002|COMPLETED|Overall Study||45
10580790|NCT01712061|11736029|FG000|NOT COMPLETED|Overall Study||10
10580791|NCT01712061|11736030|FG001|NOT COMPLETED|Overall Study||26
10580792|NCT01712061|11736031|FG002|NOT COMPLETED|Overall Study||11
10580793|NCT01712074|11736043|FG000|STARTED|Placebo Run-in Period||195
10580794|NCT01712074|11736044|FG001|STARTED|Placebo Run-in Period||0
10580795|NCT01712074|11736045|FG002|STARTED|Placebo Run-in Period||0
10580796|NCT01712074|11736043|FG000|COMPLETED|Placebo Run-in Period||185
10580797|NCT01712074|11736044|FG001|COMPLETED|Placebo Run-in Period||0
10580798|NCT01712074|11736045|FG002|COMPLETED|Placebo Run-in Period||0
10580799|NCT01712074|11736043|FG000|NOT COMPLETED|Placebo Run-in Period||10
10580800|NCT01712074|11736044|FG001|NOT COMPLETED|Placebo Run-in Period||0
10580801|NCT01712074|11736045|FG002|NOT COMPLETED|Placebo Run-in Period||0
10580802|NCT01712074|11736043|FG000|STARTED|Double Blind Period||0
10580803|NCT01712074|11736044|FG001|STARTED|Double Blind Period||91
10580804|NCT01712074|11736045|FG002|STARTED|Double Blind Period||94
10580805|NCT01712074|11736043|FG000|COMPLETED|Double Blind Period||0
10580806|NCT01712074|11736044|FG001|COMPLETED|Double Blind Period||77
10580807|NCT01712074|11736045|FG002|COMPLETED|Double Blind Period||86
10580808|NCT01712074|11736043|FG000|NOT COMPLETED|Double Blind Period||0
10580809|NCT01712074|11736044|FG001|NOT COMPLETED|Double Blind Period||14
10580810|NCT01712074|11736045|FG002|NOT COMPLETED|Double Blind Period||8
10580811|NCT01712178|11736062|FG000|STARTED|Overall Study||50
10580812|NCT01712178|11736063|FG001|STARTED|Overall Study||50
10580813|NCT01712178|11736062|FG000|COMPLETED|Overall Study||49
10580814|NCT01712178|11736063|FG001|COMPLETED|Overall Study||47
10580815|NCT01712178|11736062|FG000|NOT COMPLETED|Overall Study||1
10580816|NCT01712178|11736063|FG001|NOT COMPLETED|Overall Study||3
10580817|NCT01712204|11736071|FG000|STARTED|Overall Study||41
10580818|NCT01712204|11736072|FG001|STARTED|Overall Study||41
10580819|NCT01712204|11736071|FG000|COMPLETED|Overall Study||33
10580820|NCT01712204|11736072|FG001|COMPLETED|Overall Study||36
10580821|NCT01712204|11736071|FG000|NOT COMPLETED|Overall Study||8
10580822|NCT01712204|11736072|FG001|NOT COMPLETED|Overall Study||5
10580823|NCT01712230|11736081|FG000|STARTED|Overall Study||11
10580824|NCT01712230|11736082|FG001|STARTED|Overall Study||18
10580825|NCT01712230|11736083|FG002|STARTED|Overall Study||18
10580826|NCT01712230|11736081|FG000|COMPLETED|Overall Study||9
10580827|NCT01712230|11736082|FG001|COMPLETED|Overall Study||14
10580828|NCT01712230|11736083|FG002|COMPLETED|Overall Study||11
10580829|NCT01712230|11736081|FG000|NOT COMPLETED|Overall Study||2
10580830|NCT01712230|11736082|FG001|NOT COMPLETED|Overall Study||4
10580831|NCT01712230|11736083|FG002|NOT COMPLETED|Overall Study||7
10580832|NCT01712256|11736091|FG000|STARTED|Overall Study||33
10580833|NCT01712256|11736091|FG000|COMPLETED|Overall Study||32
10580834|NCT01712256|11736091|FG000|NOT COMPLETED|Overall Study||1
10580835|NCT01712334|11736095|FG000|STARTED|Treatment Period 1||44
10580836|NCT01712334|11736096|FG001|STARTED|Treatment Period 1||43
10580837|NCT01712334|11736095|FG000|Received Treatment|Treatment Period 1||44
10580838|NCT01712334|11736096|FG001|Received Treatment|Treatment Period 1||41
10580839|NCT01712334|11736095|FG000|COMPLETED|Treatment Period 1||44
10580840|NCT01712334|11736096|FG001|COMPLETED|Treatment Period 1||41
10580841|NCT01712334|11736095|FG000|NOT COMPLETED|Treatment Period 1||0
10580842|NCT01712334|11736096|FG001|NOT COMPLETED|Treatment Period 1||2
10580843|NCT01712334|11736095|FG000|STARTED|Treatment Period 2||44
10580844|NCT01712334|11736096|FG001|STARTED|Treatment Period 2||41
10580845|NCT01712334|11736095|FG000|COMPLETED|Treatment Period 2||44
10580846|NCT01712334|11736096|FG001|COMPLETED|Treatment Period 2||41
10580847|NCT01712334|11736095|FG000|NOT COMPLETED|Treatment Period 2||0
10580848|NCT01712334|11736096|FG001|NOT COMPLETED|Treatment Period 2||0
10580849|NCT01712360|11736106|FG000|STARTED|Overall Study||22
10580850|NCT01712360|11736107|FG001|STARTED|Overall Study||22
10580851|NCT01712360|11736108|FG002|STARTED|Overall Study||6
10580852|NCT01712360|11736109|FG003|STARTED|Overall Study||6
10580853|NCT01712360|11736106|FG000|COMPLETED|Overall Study||22
10580854|NCT01712360|11736107|FG001|COMPLETED|Overall Study||21
10580855|NCT01712360|11736108|FG002|COMPLETED|Overall Study||6
10580856|NCT01712360|11736109|FG003|COMPLETED|Overall Study||4
10580857|NCT01712360|11736106|FG000|NOT COMPLETED|Overall Study||0
10580858|NCT01712360|11736107|FG001|NOT COMPLETED|Overall Study||1
10580859|NCT01712360|11736108|FG002|NOT COMPLETED|Overall Study||0
10580860|NCT01712360|11736109|FG003|NOT COMPLETED|Overall Study||2
10580861|NCT01712399|11736125|FG000|STARTED|Overall Study||397
10580862|NCT01712399|11736125|FG000|COMPLETED|Overall Study||0
10580863|NCT01712399|11736125|FG000|NOT COMPLETED|Overall Study||397
10580864|NCT01712438|11736129|FG000|STARTED|Overall Study||110
10580865|NCT01712438|11736129|FG000|SAF Population|Overall Study||108
10580866|NCT01712438|11736129|FG000|ITT Population|Overall Study||108
10580867|NCT01712438|11736129|FG000|PP Population|Overall Study||95
10580868|NCT01712438|11736129|FG000|PROPH Population|Overall Study||103
10580869|NCT01712438|11736129|FG000|BLEED Population|Overall Study||94
10580870|NCT01712438|11736129|FG000|SURG Population|Overall Study||24
10580871|NCT01712438|11736129|FG000|COMPLETED|Overall Study||73
10580872|NCT01712438|11736129|FG000|NOT COMPLETED|Overall Study||37
10580873|NCT01712516|11736142|FG000|STARTED|Overall Study||250
10580874|NCT01712516|11736143|FG001|STARTED|Overall Study||251
10580875|NCT01712516|11736144|FG002|STARTED|Overall Study||251
10580876|NCT01712516|11736145|FG003|STARTED|Overall Study||249
10580877|NCT01712516|11736142|FG000|Safety Set|Overall Study||250
10580878|NCT01712516|11736143|FG001|Safety Set|Overall Study||251
10580879|NCT01712516|11736144|FG002|Safety Set|Overall Study||251
10580880|NCT01712516|11736145|FG003|Safety Set|Overall Study||248
10580881|NCT01712516|11736142|FG000|Full Analysis Set|Overall Study||250
10580882|NCT01712516|11736143|FG001|Full Analysis Set|Overall Study||251
10580883|NCT01712516|11736144|FG002|Full Analysis Set|Overall Study||250
10580884|NCT01712516|11736145|FG003|Full Analysis Set|Overall Study||247
10580885|NCT01712516|11736142|FG000|COMPLETED|Overall Study||244
10580886|NCT01712516|11736143|FG001|COMPLETED|Overall Study||241
10580887|NCT01712516|11736144|FG002|COMPLETED|Overall Study||245
10580888|NCT01712516|11736145|FG003|COMPLETED|Overall Study||236
10580889|NCT01712516|11736142|FG000|NOT COMPLETED|Overall Study||6
10580890|NCT01712516|11736143|FG001|NOT COMPLETED|Overall Study||10
10580891|NCT01712516|11736144|FG002|NOT COMPLETED|Overall Study||6
10580892|NCT01712516|11736145|FG003|NOT COMPLETED|Overall Study||13
10580893|NCT01712685|11736155|FG000|STARTED|Overall Study||12
10580894|NCT01712685|11736155|FG000|COMPLETED|Overall Study||11
10580895|NCT01712685|11736155|FG000|NOT COMPLETED|Overall Study||1
10580896|NCT01712711|11736161|FG000|STARTED|Overall Study||20
10580897|NCT01712711|11736162|FG001|STARTED|Overall Study||20
10580898|NCT01712711|11736161|FG000|COMPLETED|Overall Study||20
10580899|NCT01712711|11736162|FG001|COMPLETED|Overall Study||20
10580900|NCT01712711|11736161|FG000|NOT COMPLETED|Overall Study||0
10580901|NCT01712711|11736162|FG001|NOT COMPLETED|Overall Study||0
10580902|NCT01712776|11736170|FG000|STARTED|Overall Study||50
10580903|NCT01712776|11736171|FG001|STARTED|Overall Study||50
10580904|NCT01712776|11736170|FG000|COMPLETED|Overall Study|trial to enroll 50 in each group for total of 100|50
10580905|NCT01712776|11736171|FG001|COMPLETED|Overall Study||50
10580906|NCT01712776|11736170|FG000|NOT COMPLETED|Overall Study||0
10580907|NCT01712776|11736171|FG001|NOT COMPLETED|Overall Study||0
10580908|NCT01712984|11736180|FG000|STARTED|Overall Study||1672
10580909|NCT01712984|11736181|FG001|STARTED|Overall Study||837
10580910|NCT01712984|11736182|FG002|STARTED|Overall Study||846
10580911|NCT01712984|11736180|FG000|COMPLETED|Overall Study||1656
10580912|NCT01712984|11736181|FG001|COMPLETED|Overall Study||821
10580913|NCT01712984|11736182|FG002|COMPLETED|Overall Study||836
10580914|NCT01712984|11736180|FG000|NOT COMPLETED|Overall Study||16
10580915|NCT01712984|11736181|FG001|NOT COMPLETED|Overall Study||16
10580916|NCT01712984|11736182|FG002|NOT COMPLETED|Overall Study||10
10580917|NCT01713036|11736190|FG000|STARTED|Overall Study||6
10580918|NCT01713036|11736190|FG000|COMPLETED|Overall Study||5
10580919|NCT01713036|11736190|FG000|NOT COMPLETED|Overall Study||1
10580920|NCT01713283|11736204|FG000|STARTED|Overall Study||31
10580921|NCT01713283|11736205|FG001|STARTED|Overall Study||29
10580922|NCT01713283|11736204|FG000|COMPLETED|Overall Study||20
10580923|NCT01713283|11736205|FG001|COMPLETED|Overall Study||26
10580924|NCT01713283|11736204|FG000|NOT COMPLETED|Overall Study||11
10580925|NCT01713283|11736205|FG001|NOT COMPLETED|Overall Study||3
10580926|NCT01713348|11736219|FG000|STARTED|Overall Study||29
10580927|NCT01713348|11736220|FG001|STARTED|Overall Study||13
10580928|NCT01713348|11736221|FG002|STARTED|Overall Study||30
10580929|NCT01713348|11736222|FG003|STARTED|Overall Study||15
10580930|NCT01713348|11736219|FG000|COMPLETED|Overall Study||25
10580931|NCT01713348|11736220|FG001|COMPLETED|Overall Study||11
10580932|NCT01713348|11736221|FG002|COMPLETED|Overall Study||28
10580933|NCT01713348|11736222|FG003|COMPLETED|Overall Study||15
10580934|NCT01713348|11736219|FG000|NOT COMPLETED|Overall Study||4
10580935|NCT01713348|11736220|FG001|NOT COMPLETED|Overall Study||2
10580936|NCT01713348|11736221|FG002|NOT COMPLETED|Overall Study||2
10580937|NCT01713348|11736222|FG003|NOT COMPLETED|Overall Study||0
10580938|NCT01713400|11736234|FG000|STARTED|Overall Study||15
10580939|NCT01713400|11736235|FG001|STARTED|Overall Study||15
10580940|NCT01713400|11736234|FG000|COMPLETED|Overall Study||15
10580941|NCT01713400|11736235|FG001|COMPLETED|Overall Study||15
10580942|NCT01713400|11736234|FG000|NOT COMPLETED|Overall Study||0
10580943|NCT01713400|11736235|FG001|NOT COMPLETED|Overall Study||0
10580944|NCT01713530|11736243|FG000|STARTED|Overall Study||138
10580945|NCT01713530|11736244|FG001|STARTED|Overall Study||136
10580946|NCT01713530|11736243|FG000|Exposed|Overall Study|One (1) subject was randomised in error and 1 subject withdrew consent|136
10580947|NCT01713530|11736244|FG001|Exposed|Overall Study|One (1) subject was withdrawn by the investigator|135
10580948|NCT01713530|11736243|FG000|COMPLETED|Overall Study||113
10580949|NCT01713530|11736244|FG001|COMPLETED|Overall Study||117
10580950|NCT01713530|11736243|FG000|NOT COMPLETED|Overall Study||25
10580951|NCT01713530|11736244|FG001|NOT COMPLETED|Overall Study||19
10580952|NCT01713582|11736271|FG000|STARTED|Overall Study|Number treated|3
10580953|NCT01713582|11736272|FG001|STARTED|Overall Study|Number treated|3
10580954|NCT01713582|11736273|FG002|STARTED|Overall Study|Number treated|4
10580955|NCT01713582|11736274|FG003|STARTED|Overall Study|Number treated|3
10580956|NCT01713582|11736275|FG004|STARTED|Overall Study|Number treated|4
10580957|NCT01713582|11736276|FG005|STARTED|Overall Study|Number treated|8
10580958|NCT01713582|11736277|FG006|STARTED|Overall Study|Number treated|7
10580959|NCT01713582|11736278|FG007|STARTED|Overall Study|Number treated|6
10580960|NCT01713582|11736279|FG008|STARTED|Overall Study|Number treated|6
10580961|NCT01713582|11736280|FG009|STARTED|Overall Study|Number treated|18
10580962|NCT01713582|11736281|FG010|STARTED|Overall Study|Number treated|16
10580963|NCT01713582|11736282|FG011|STARTED|Overall Study|Number treated|5
10580964|NCT01713582|11736283|FG012|STARTED|Overall Study|Number treated|3
10580965|NCT01713582|11736284|FG013|STARTED|Overall Study|Number treated|4
10580966|NCT01713582|11736285|FG014|STARTED|Overall Study|Number treated|7
10580967|NCT01713582|11736286|FG015|STARTED|Overall Study|Number treated|6
10580968|NCT01713582|11736287|FG016|STARTED|Overall Study|Number treated|7
10580969|NCT01713582|11736288|FG017|STARTED|Overall Study|Number treated|3
10580970|NCT01713582|11736289|FG018|STARTED|Overall Study|Number treated|5
10580971|NCT01713582|11736290|FG019|STARTED|Overall Study|Number treated|5
10580972|NCT01713582|11736291|FG020|STARTED|Overall Study|Number treated|15
10580973|NCT01713582|11736271|FG000|COMPLETED|Overall Study||0
10580974|NCT01713582|11736272|FG001|COMPLETED|Overall Study||0
10580975|NCT01713582|11736273|FG002|COMPLETED|Overall Study||0
10580976|NCT01713582|11736274|FG003|COMPLETED|Overall Study||0
10580977|NCT01713582|11736275|FG004|COMPLETED|Overall Study||0
10580978|NCT01713582|11736276|FG005|COMPLETED|Overall Study||0
10580979|NCT01713582|11736277|FG006|COMPLETED|Overall Study||0
10580980|NCT01713582|11736278|FG007|COMPLETED|Overall Study||0
10580981|NCT01713582|11736279|FG008|COMPLETED|Overall Study||0
10580982|NCT01713582|11736280|FG009|COMPLETED|Overall Study||0
10580983|NCT01713582|11736281|FG010|COMPLETED|Overall Study||0
10580984|NCT01713582|11736282|FG011|COMPLETED|Overall Study||0
10580985|NCT01713582|11736283|FG012|COMPLETED|Overall Study||0
10580986|NCT01713582|11736284|FG013|COMPLETED|Overall Study||0
10580987|NCT01713582|11736285|FG014|COMPLETED|Overall Study||0
10580988|NCT01713582|11736286|FG015|COMPLETED|Overall Study||0
10580989|NCT01713582|11736287|FG016|COMPLETED|Overall Study||0
10580990|NCT01713582|11736288|FG017|COMPLETED|Overall Study||0
10580991|NCT01713582|11736289|FG018|COMPLETED|Overall Study||0
10580992|NCT01713582|11736290|FG019|COMPLETED|Overall Study||0
10580993|NCT01713582|11736291|FG020|COMPLETED|Overall Study||0
10580994|NCT01713582|11736271|FG000|NOT COMPLETED|Overall Study||3
10580995|NCT01713582|11736272|FG001|NOT COMPLETED|Overall Study||3
10580996|NCT01713582|11736273|FG002|NOT COMPLETED|Overall Study||4
10580997|NCT01713582|11736274|FG003|NOT COMPLETED|Overall Study||3
10580998|NCT01713582|11736275|FG004|NOT COMPLETED|Overall Study||4
10580999|NCT01713582|11736276|FG005|NOT COMPLETED|Overall Study||8
10581000|NCT01713582|11736277|FG006|NOT COMPLETED|Overall Study||7
10581001|NCT01713582|11736278|FG007|NOT COMPLETED|Overall Study||6
10581002|NCT01713582|11736279|FG008|NOT COMPLETED|Overall Study||6
10581003|NCT01713582|11736280|FG009|NOT COMPLETED|Overall Study||18
10581004|NCT01713582|11736281|FG010|NOT COMPLETED|Overall Study||16
10581005|NCT01713582|11736282|FG011|NOT COMPLETED|Overall Study||5
10581006|NCT01713582|11736283|FG012|NOT COMPLETED|Overall Study||3
10581007|NCT01713582|11736284|FG013|NOT COMPLETED|Overall Study||4
10581008|NCT01713582|11736285|FG014|NOT COMPLETED|Overall Study||7
10581009|NCT01713582|11736286|FG015|NOT COMPLETED|Overall Study||6
10581010|NCT01713582|11736287|FG016|NOT COMPLETED|Overall Study||7
10581011|NCT01713582|11736288|FG017|NOT COMPLETED|Overall Study||3
10581012|NCT01713582|11736289|FG018|NOT COMPLETED|Overall Study||5
10581013|NCT01713582|11736290|FG019|NOT COMPLETED|Overall Study||5
10581014|NCT01713582|11736291|FG020|NOT COMPLETED|Overall Study||15
10581015|NCT01713608|11736353|FG000|STARTED|Overall Study||8
10581016|NCT01713608|11736354|FG001|STARTED|Overall Study||6
10581017|NCT01713608|11736355|FG002|STARTED|Overall Study||8
10581018|NCT01713608|11736356|FG003|STARTED|Overall Study||12
10581019|NCT01713608|11736353|FG000|COMPLETED|Overall Study||8
10581020|NCT01713608|11736354|FG001|COMPLETED|Overall Study||6
10581021|NCT01713608|11736355|FG002|COMPLETED|Overall Study||8
10581022|NCT01713608|11736356|FG003|COMPLETED|Overall Study||12
10581023|NCT01713608|11736353|FG000|NOT COMPLETED|Overall Study||0
10581024|NCT01713608|11736354|FG001|NOT COMPLETED|Overall Study||0
10581025|NCT01713608|11736355|FG002|NOT COMPLETED|Overall Study||0
10581026|NCT01713608|11736356|FG003|NOT COMPLETED|Overall Study||0
10581027|NCT01713621|11736367|FG000|STARTED|Overall Study||8
10581028|NCT01713621|11736368|FG001|STARTED|Overall Study||17
10581029|NCT01713621|11736367|FG000|COMPLETED|Overall Study||1
10581030|NCT01713621|11736368|FG001|COMPLETED|Overall Study||1
10581031|NCT01713621|11736367|FG000|NOT COMPLETED|Overall Study||7
10581032|NCT01713621|11736368|FG001|NOT COMPLETED|Overall Study||16
10581033|NCT01713660|11736374|FG000|STARTED|Overall Study||37
10581034|NCT01713660|11736374|FG000|COMPLETED|Overall Study||37
10581035|NCT01713660|11736374|FG000|NOT COMPLETED|Overall Study||0
10581036|NCT01713686|11736378|FG000|STARTED|Overall Study|129 enrolled, 125 treated. 2 withdrew consent prior to treatment; 2 excluded after enrollment.|125
10581037|NCT01713686|11736378|FG000|COMPLETED|Overall Study||110
10581038|NCT01713686|11736378|FG000|NOT COMPLETED|Overall Study||15
10581039|NCT01713868|11736386|FG000|STARTED|Overall Study||400
10581040|NCT01713868|11736387|FG001|STARTED|Overall Study||400
10581041|NCT01713868|11736388|FG002|STARTED|Overall Study||400
10581042|NCT01713868|11736389|FG003|STARTED|Overall Study||400
10581043|NCT01713868|11736386|FG000|COMPLETED|Overall Study||303
10581044|NCT01713868|11736387|FG001|COMPLETED|Overall Study||335
10581045|NCT01713868|11736388|FG002|COMPLETED|Overall Study||320
10581046|NCT01713868|11736389|FG003|COMPLETED|Overall Study||305
10581047|NCT01713868|11736386|FG000|NOT COMPLETED|Overall Study||97
10581048|NCT01713868|11736387|FG001|NOT COMPLETED|Overall Study||65
10581049|NCT01713868|11736388|FG002|NOT COMPLETED|Overall Study||80
10581050|NCT01713868|11736389|FG003|NOT COMPLETED|Overall Study||95
10581051|NCT01713933|11736401|FG000|STARTED|Overall Study||37
10581052|NCT01713933|11736401|FG000|COMPLETED|Overall Study||31
10581053|NCT01713933|11736401|FG000|NOT COMPLETED|Overall Study||6
10581054|NCT01713946|11736408|FG000|STARTED|Overall Study||117
10581055|NCT01713946|11736409|FG001|STARTED|Overall Study||130
10651567|NCT02176525|11811780|FG005|COMPLETED|Overall Study||5
10581056|NCT01713946|11736410|FG002|STARTED|Overall Study|Of the 119 patients initially randomized to the Placebo arm, 5 patients never switched to everolimus|119
10581057|NCT01713946|11736408|FG000|Completed Core Phase|Overall Study||110
10581058|NCT01713946|11736409|FG001|Completed Core Phase|Overall Study||122
10581059|NCT01713946|11736410|FG002|Completed Core Phase|Overall Study||114
10581060|NCT01713946|11736408|FG000|Continued in Ext. Phase|Overall Study||110
10581061|NCT01713946|11736409|FG001|Continued in Ext. Phase|Overall Study||119
10581062|NCT01713946|11736410|FG002|Continued in Ext. Phase|Overall Study||114
10581063|NCT01713946|11736408|FG000|Completed Ext. Phase|Overall Study||79
10581064|NCT01713946|11736409|FG001|Completed Ext. Phase|Overall Study||92
10581065|NCT01713946|11736410|FG002|Completed Ext. Phase|Overall Study||81
10581066|NCT01713946|11736408|FG000|Continued in Post-Ext. Phase|Overall Study||78
10581067|NCT01713946|11736409|FG001|Continued in Post-Ext. Phase|Overall Study||90
10581068|NCT01713946|11736410|FG002|Continued in Post-Ext. Phase|Overall Study||81
10581069|NCT01713946|11736408|FG000|Completed Post-Ext Phase|Overall Study||74
10581070|NCT01713946|11736409|FG001|Completed Post-Ext Phase|Overall Study||85
10581071|NCT01713946|11736410|FG002|Completed Post-Ext Phase|Overall Study||75
10806551|NCT03961308|11968105|FG001|STARTED|Overall Study||102
10806552|NCT03961308|11968104|FG000|COMPLETED|Overall Study||100
10806553|NCT03961308|11968105|FG001|COMPLETED|Overall Study||100
10806554|NCT03961308|11968104|FG000|NOT COMPLETED|Overall Study||2
10806555|NCT03961308|11968105|FG001|NOT COMPLETED|Overall Study||2
10806556|NCT03961295|11968113|FG000|STARTED|Overall Study||12
10581072|NCT01713946|11736408|FG000|Did Not Continue in Ext Phase|Overall Study||0
10581073|NCT01713946|11736409|FG001|Did Not Continue in Ext Phase|Overall Study||3
10581074|NCT01713946|11736410|FG002|Did Not Continue in Ext Phase|Overall Study||0
10581075|NCT01713946|11736408|FG000|Did Not Cont. in Post-Ext Phase|Overall Study||1
10581076|NCT01713946|11736409|FG001|Did Not Cont. in Post-Ext Phase|Overall Study||2
10581077|NCT01713946|11736410|FG002|Did Not Cont. in Post-Ext Phase|Overall Study||0
10581078|NCT01713946|11736408|FG000|COMPLETED|Overall Study||74
10581079|NCT01713946|11736409|FG001|COMPLETED|Overall Study||85
10581080|NCT01713946|11736410|FG002|COMPLETED|Overall Study||75
10581081|NCT01713946|11736408|FG000|NOT COMPLETED|Overall Study||43
10581082|NCT01713946|11736409|FG001|NOT COMPLETED|Overall Study||45
10581083|NCT01713946|11736410|FG002|NOT COMPLETED|Overall Study||44
10581084|NCT01713998|11736439|FG000|STARTED|Overall Study||16
10581085|NCT01713998|11736440|FG001|STARTED|Overall Study||15
10581086|NCT01713998|11736441|FG002|STARTED|Overall Study||16
10806557|NCT03961295|11968114|FG001|STARTED|Overall Study||12
10806558|NCT03961295|11968113|FG000|COMPLETED|Overall Study||12
10806559|NCT03961295|11968114|FG001|COMPLETED|Overall Study||12
10581087|NCT01713998|11736439|FG000|COMPLETED|Overall Study||13
10581088|NCT01713998|11736440|FG001|COMPLETED|Overall Study||15
10581089|NCT01713998|11736441|FG002|COMPLETED|Overall Study||14
10806560|NCT03961295|11968113|FG000|NOT COMPLETED|Overall Study||0
10806561|NCT03961295|11968114|FG001|NOT COMPLETED|Overall Study||0
10581090|NCT01713998|11736439|FG000|NOT COMPLETED|Overall Study||3
10581091|NCT01713998|11736440|FG001|NOT COMPLETED|Overall Study||0
10581092|NCT01713998|11736441|FG002|NOT COMPLETED|Overall Study||2
10581093|NCT01714024|11736452|FG000|STARTED|Overall Study||13
10581094|NCT01714024|11736453|FG001|STARTED|Overall Study||18
10581095|NCT01714024|11736454|FG002|STARTED|Overall Study||11
10581096|NCT01714024|11736452|FG000|COMPLETED|Overall Study||12
10581097|NCT01714024|11736453|FG001|COMPLETED|Overall Study||12
10581098|NCT01714024|11736454|FG002|COMPLETED|Overall Study||8
10581099|NCT01714024|11736452|FG000|NOT COMPLETED|Overall Study||1
10581100|NCT01714024|11736453|FG001|NOT COMPLETED|Overall Study||6
10581101|NCT01714024|11736454|FG002|NOT COMPLETED|Overall Study||3
10581102|NCT01714063|11736471|FG000|STARTED|Overall Study||34
10581103|NCT01714063|11736471|FG000|COMPLETED|Overall Study||32
10581104|NCT01714063|11736471|FG000|NOT COMPLETED|Overall Study||2
10581105|NCT01714232|11736479|FG000|STARTED|Overall Study||106
10581106|NCT01714232|11736479|FG000|COMPLETED|Overall Study||106
10581107|NCT01714232|11736479|FG000|NOT COMPLETED|Overall Study||0
10581108|NCT01714310|11736486|FG000|STARTED|Open Lisdexamfetamine Titration||0
10581109|NCT01714310|11736487|FG001|STARTED|Open Lisdexamfetamine Titration||0
10581110|NCT01714310|11736488|FG002|STARTED|Open Lisdexamfetamine Titration||34
10581111|NCT01714310|11736486|FG000|COMPLETED|Open Lisdexamfetamine Titration||0
10581112|NCT01714310|11736487|FG001|COMPLETED|Open Lisdexamfetamine Titration||0
10581113|NCT01714310|11736488|FG002|COMPLETED|Open Lisdexamfetamine Titration||30
10581114|NCT01714310|11736486|FG000|NOT COMPLETED|Open Lisdexamfetamine Titration||0
10581115|NCT01714310|11736487|FG001|NOT COMPLETED|Open Lisdexamfetamine Titration||0
10581116|NCT01714310|11736488|FG002|NOT COMPLETED|Open Lisdexamfetamine Titration||4
10581117|NCT01714310|11736486|FG000|STARTED|Double Blind Adjunctive Treatment|Adjunctive fluoxetine treatment was initiated at beginning of Period 2, at study week 4.|12
10581118|NCT01714310|11736487|FG001|STARTED|Double Blind Adjunctive Treatment|Adjunctive placebo was initiated at beginning of Period 2, at study week 4.|14
10581119|NCT01714310|11736488|FG002|STARTED|Double Blind Adjunctive Treatment|No one remained on lisdexamfetamine alone in Period 2.|0
10581120|NCT01714310|11736486|FG000|COMPLETED|Double Blind Adjunctive Treatment||10
10651568|NCT02176525|11811781|FG006|COMPLETED|Overall Study||8
10581121|NCT01714310|11736487|FG001|COMPLETED|Double Blind Adjunctive Treatment||11
10581122|NCT01714310|11736488|FG002|COMPLETED|Double Blind Adjunctive Treatment||0
10581123|NCT01714310|11736486|FG000|NOT COMPLETED|Double Blind Adjunctive Treatment||2
10581124|NCT01714310|11736487|FG001|NOT COMPLETED|Double Blind Adjunctive Treatment||3
10581125|NCT01714310|11736488|FG002|NOT COMPLETED|Double Blind Adjunctive Treatment||0
10581126|NCT01714323|11736508|FG000|STARTED|Overall Study||677
10581127|NCT01714323|11736509|FG001|STARTED|Overall Study||680
10581128|NCT01714323|11736508|FG000|COMPLETED|Overall Study||513
10581129|NCT01714323|11736509|FG001|COMPLETED|Overall Study||508
10581130|NCT01714323|11736508|FG000|NOT COMPLETED|Overall Study||164
10581131|NCT01714323|11736509|FG001|NOT COMPLETED|Overall Study||172
10581132|NCT01714336|11736517|FG000|STARTED|Overall Study||69
10581133|NCT01714336|11736518|FG001|STARTED|Overall Study||69
10581134|NCT01714336|11736517|FG000|COMPLETED|Overall Study||69
10581135|NCT01714336|11736518|FG001|COMPLETED|Overall Study||69
10581136|NCT01714336|11736517|FG000|NOT COMPLETED|Overall Study||0
10581137|NCT01714336|11736518|FG001|NOT COMPLETED|Overall Study||0
10581138|NCT01714492|11736524|FG000|STARTED|Overall Study||8
10581139|NCT01714492|11736524|FG000|COMPLETED|Overall Study||8
10581140|NCT01714492|11736524|FG000|NOT COMPLETED|Overall Study||0
10581141|NCT01714505|11736529|FG000|STARTED|Admission 1 (40 Hours)||10
10581142|NCT01714505|11736530|FG001|STARTED|Admission 1 (40 Hours)||10
10581143|NCT01714505|11736529|FG000|COMPLETED|Admission 1 (40 Hours)||9
10581144|NCT01714505|11736530|FG001|COMPLETED|Admission 1 (40 Hours)||9
10581145|NCT01714505|11736529|FG000|NOT COMPLETED|Admission 1 (40 Hours)||1
10581146|NCT01714505|11736530|FG001|NOT COMPLETED|Admission 1 (40 Hours)||1
10581147|NCT01714505|11736529|FG000|STARTED|Admission 2 (40 Hours)||9
10581148|NCT01714505|11736530|FG001|STARTED|Admission 2 (40 Hours)||9
10581149|NCT01714505|11736529|FG000|COMPLETED|Admission 2 (40 Hours)||9
10581150|NCT01714505|11736530|FG001|COMPLETED|Admission 2 (40 Hours)||9
10581151|NCT01714505|11736529|FG000|NOT COMPLETED|Admission 2 (40 Hours)||0
10581152|NCT01714505|11736530|FG001|NOT COMPLETED|Admission 2 (40 Hours)||0
10581153|NCT01714544|11736536|FG000|STARTED|Overall Study||60
10581154|NCT01714544|11736536|FG000|COMPLETED|Overall Study||57
10581155|NCT01714544|11736536|FG000|NOT COMPLETED|Overall Study||3
10581156|NCT01714609|11736542|FG000|STARTED|Overall Study||5
10702676|NCT02577042|11867157|FG001|STARTED|Overall Study||22
10702677|NCT02577042|11867156|FG000|COMPLETED|Overall Study||15
10702678|NCT02577042|11867157|FG001|COMPLETED|Overall Study||19
10702679|NCT02577042|11867156|FG000|NOT COMPLETED|Overall Study||5
10702680|NCT02577042|11867157|FG001|NOT COMPLETED|Overall Study||3
10702681|NCT02577107|11867166|FG000|STARTED|Overall Study||6
10702682|NCT02577107|11867167|FG001|STARTED|Overall Study||6
10702683|NCT02577107|11867166|FG000|COMPLETED|Overall Study||6
10702684|NCT02577107|11867167|FG001|COMPLETED|Overall Study||5
10702685|NCT02577107|11867166|FG000|NOT COMPLETED|Overall Study||0
10702686|NCT02577107|11867167|FG001|NOT COMPLETED|Overall Study||1
10702687|NCT02577146|11867173|FG000|STARTED|Overall Study||74
10702688|NCT02577146|11867173|FG000|COMPLETED|Overall Study||46
10702689|NCT02577146|11867173|FG000|NOT COMPLETED|Overall Study||28
10702690|NCT02577315|11867179|FG000|STARTED|Treatment Period 1 (4 Days)||12
10702691|NCT02577315|11867180|FG001|STARTED|Treatment Period 1 (4 Days)||13
10702692|NCT02577315|11867179|FG000|COMPLETED|Treatment Period 1 (4 Days)||12
10702693|NCT02577315|11867180|FG001|COMPLETED|Treatment Period 1 (4 Days)||12
10702694|NCT02577315|11867179|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||0
10702695|NCT02577315|11867180|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||1
10702696|NCT02577315|11867179|FG000|STARTED|Washout Period (5 Days)||12
10702697|NCT02577315|11867180|FG001|STARTED|Washout Period (5 Days)||12
10702698|NCT02577315|11867179|FG000|COMPLETED|Washout Period (5 Days)||12
10702699|NCT02577315|11867180|FG001|COMPLETED|Washout Period (5 Days)||12
10581157|NCT01714609|11736543|FG001|STARTED|Overall Study||5
10581158|NCT01714609|11736542|FG000|COMPLETED|Overall Study||4
10581159|NCT01714609|11736543|FG001|COMPLETED|Overall Study||5
10581160|NCT01714609|11736542|FG000|NOT COMPLETED|Overall Study||1
10581161|NCT01714609|11736543|FG001|NOT COMPLETED|Overall Study||0
10581162|NCT01714635|11736552|FG000|STARTED|Overall Study||147
10581163|NCT01714635|11736553|FG001|STARTED|Overall Study||150
10581164|NCT01714635|11736554|FG002|STARTED|Overall Study||148
10581165|NCT01714635|11736552|FG000|COMPLETED|Overall Study||145
10581166|NCT01714635|11736553|FG001|COMPLETED|Overall Study||150
10581167|NCT01714635|11736554|FG002|COMPLETED|Overall Study||146
10581168|NCT01714635|11736552|FG000|NOT COMPLETED|Overall Study||2
10581169|NCT01714635|11736553|FG001|NOT COMPLETED|Overall Study||0
10581170|NCT01714635|11736554|FG002|NOT COMPLETED|Overall Study||2
10581171|NCT01714687|11736564|FG000|STARTED|Overall Study||29
10581172|NCT01714687|11736565|FG001|STARTED|Overall Study||30
10581173|NCT01714687|11736564|FG000|COMPLETED|Overall Study||26
10581174|NCT01714687|11736565|FG001|COMPLETED|Overall Study||26
10581175|NCT01714687|11736564|FG000|NOT COMPLETED|Overall Study||3
10581176|NCT01714687|11736565|FG001|NOT COMPLETED|Overall Study||4
10581177|NCT01714726|11736575|FG000|STARTED|Double-Blinded Induction Period||60
10581178|NCT01714726|11736576|FG001|STARTED|Double-Blinded Induction Period||59
10581179|NCT01714726|11736577|FG002|STARTED|Double-Blinded Induction Period||0
10581180|NCT01714726|11736578|FG003|STARTED|Double-Blinded Induction Period||0
10581181|NCT01714726|11736575|FG000|COMPLETED|Double-Blinded Induction Period||52
10702700|NCT02577315|11867179|FG000|NOT COMPLETED|Washout Period (5 Days)||0
10702701|NCT02577315|11867180|FG001|NOT COMPLETED|Washout Period (5 Days)||0
10702702|NCT02577315|11867179|FG000|STARTED|Treatment Period 2 (4 Days)||12
10581182|NCT01714726|11736576|FG001|COMPLETED|Double-Blinded Induction Period||52
10581183|NCT01714726|11736577|FG002|COMPLETED|Double-Blinded Induction Period||0
10581184|NCT01714726|11736578|FG003|COMPLETED|Double-Blinded Induction Period||0
10581185|NCT01714726|11736575|FG000|NOT COMPLETED|Double-Blinded Induction Period||8
10581186|NCT01714726|11736576|FG001|NOT COMPLETED|Double-Blinded Induction Period||7
10581187|NCT01714726|11736577|FG002|NOT COMPLETED|Double-Blinded Induction Period||0
10581188|NCT01714726|11736578|FG003|NOT COMPLETED|Double-Blinded Induction Period||0
10581189|NCT01714726|11736575|FG000|STARTED|Open-Label Period||0
10581190|NCT01714726|11736576|FG001|STARTED|Open-Label Period||0
10581191|NCT01714726|11736577|FG002|STARTED|Open-Label Period||52
10581192|NCT01714726|11736578|FG003|STARTED|Open-Label Period||52
10333703|NCT00334958|11469872|FG001|NOT COMPLETED|Overall Study||24
10333704|NCT00335140|11469878|FG000|STARTED|Overall Study||26
10333705|NCT00335140|11469878|FG000|Eligible|Overall Study||25
10333706|NCT00335140|11469878|FG000|Treated|Overall Study||25
10333707|NCT00335140|11469878|FG000|COMPLETED|Overall Study||25
10333708|NCT00335140|11469878|FG000|NOT COMPLETED|Overall Study||1
10333709|NCT00335153|11469882|FG000|STARTED|Nasojejunal (NJ) Test Period||354
10333710|NCT00335153|11469882|FG000|COMPLETED|Nasojejunal (NJ) Test Period||324
10333711|NCT00335153|11469882|FG000|NOT COMPLETED|Nasojejunal (NJ) Test Period||30
10333712|NCT00335153|11469882|FG000|STARTED|Post-PEG-J Long-Term Treatment Period||324
10333713|NCT00335153|11469882|FG000|COMPLETED|Post-PEG-J Long-Term Treatment Period||272
10333714|NCT00335153|11469882|FG000|NOT COMPLETED|Post-PEG-J Long-Term Treatment Period||52
10333715|NCT00335257|11469889|FG000|STARTED|Overall Study||15542
10333716|NCT00335257|11469890|FG001|STARTED|Overall Study||9377
10333717|NCT00335257|11469891|FG002|STARTED|Overall Study||60190
10333718|NCT00335257|11469889|FG000|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 6.0 years.|15542
10333719|NCT00335257|11469890|FG001|COMPLETED|Overall Study||9377
10333720|NCT00335257|11469891|FG002|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 6.0 years.|60190
10333721|NCT00335257|11469889|FG000|NOT COMPLETED|Overall Study||0
10333722|NCT00335257|11469890|FG001|NOT COMPLETED|Overall Study||0
10581193|NCT01714726|11736575|FG000|COMPLETED|Open-Label Period||0
10581194|NCT01714726|11736576|FG001|COMPLETED|Open-Label Period||0
10581195|NCT01714726|11736577|FG002|COMPLETED|Open-Label Period||33
10581196|NCT01714726|11736578|FG003|COMPLETED|Open-Label Period||24
10581197|NCT01714726|11736575|FG000|NOT COMPLETED|Open-Label Period||0
10581198|NCT01714726|11736576|FG001|NOT COMPLETED|Open-Label Period||0
10581199|NCT01714726|11736577|FG002|NOT COMPLETED|Open-Label Period||19
10581200|NCT01714726|11736578|FG003|NOT COMPLETED|Open-Label Period||28
10581201|NCT01714804|11736590|FG000|STARTED|Overall Study||30
10581202|NCT01714804|11736591|FG001|STARTED|Overall Study||30
10581203|NCT01714804|11736590|FG000|COMPLETED|Overall Study||29
10581204|NCT01714804|11736591|FG001|COMPLETED|Overall Study||30
10581205|NCT01714804|11736590|FG000|NOT COMPLETED|Overall Study||1
10581206|NCT01714804|11736591|FG001|NOT COMPLETED|Overall Study||0
10581207|NCT01714921|11736599|FG000|STARTED|Overall Study||504
10581208|NCT01714921|11736599|FG000|COMPLETED|Overall Study||311
10581209|NCT01714921|11736599|FG000|NOT COMPLETED|Overall Study||193
10651569|NCT02176525|11811782|FG007|COMPLETED|Overall Study||10
10651570|NCT02176525|11811775|FG000|NOT COMPLETED|Overall Study||1
10651571|NCT02176525|11811776|FG001|NOT COMPLETED|Overall Study||0
10651572|NCT02176525|11811777|FG002|NOT COMPLETED|Overall Study||0
10651573|NCT02176525|11811778|FG003|NOT COMPLETED|Overall Study||1
10651574|NCT02176525|11811779|FG004|NOT COMPLETED|Overall Study||1
10651575|NCT02176525|11811780|FG005|NOT COMPLETED|Overall Study||1
10651576|NCT02176525|11811781|FG006|NOT COMPLETED|Overall Study||1
10651577|NCT02176525|11811782|FG007|NOT COMPLETED|Overall Study||0
10651578|NCT02176642|11811810|FG000|STARTED|Overall Study||18
10651579|NCT02176642|11811811|FG001|STARTED|Overall Study||17
10651580|NCT02176642|11811810|FG000|COMPLETED|Overall Study||18
10651581|NCT02176642|11811811|FG001|COMPLETED|Overall Study||16
10651582|NCT02176642|11811810|FG000|NOT COMPLETED|Overall Study||0
10651583|NCT02176642|11811811|FG001|NOT COMPLETED|Overall Study||1
10651584|NCT02176655|11811817|FG000|STARTED|Overall Study||31
10651585|NCT02176655|11811817|FG000|COMPLETED|Overall Study||25
10651586|NCT02176655|11811817|FG000|NOT COMPLETED|Overall Study||6
10651587|NCT02176837|11811822|FG000|STARTED|Overall Study||6
10651588|NCT02176837|11811822|FG000|COMPLETED|Overall Study||0
10651589|NCT02176837|11811822|FG000|NOT COMPLETED|Overall Study||6
10651590|NCT02176928|11811828|FG000|STARTED|Overall Study||21
10651591|NCT02176928|11811829|FG001|STARTED|Overall Study||21
10651592|NCT02176928|11811828|FG000|COMPLETED|Overall Study||19
10651593|NCT02176928|11811829|FG001|COMPLETED|Overall Study||17
10651594|NCT02176928|11811828|FG000|NOT COMPLETED|Overall Study||2
10651595|NCT02176928|11811829|FG001|NOT COMPLETED|Overall Study||4
10333723|NCT00335257|11469891|FG002|NOT COMPLETED|Overall Study||0
10333724|NCT00335283|11469907|FG000|STARTED|Overall Study||36
10333725|NCT00335283|11469908|FG001|STARTED|Overall Study||39
10333726|NCT00335283|11469907|FG000|COMPLETED|Overall Study||30
10651596|NCT02177032|11811839|FG000|STARTED|Overall Study||355
10651597|NCT02177032|11811840|FG001|STARTED|Overall Study||88
10651598|NCT02177032|11811841|FG002|STARTED|Overall Study||354
10651599|NCT02177032|11811842|FG003|STARTED|Overall Study||88
10651600|NCT02177032|11811839|FG000|COMPLETED|Overall Study||350
10651601|NCT02177032|11811840|FG001|COMPLETED|Overall Study||86
10651602|NCT02177032|11811841|FG002|COMPLETED|Overall Study||351
10651603|NCT02177032|11811842|FG003|COMPLETED|Overall Study||88
10651604|NCT02177032|11811839|FG000|NOT COMPLETED|Overall Study||5
10581210|NCT01714947|11736604|FG000|STARTED|Part A||3
10581211|NCT01714947|11736604|FG000|COMPLETED|Part A||3
10581212|NCT01714947|11736604|FG000|NOT COMPLETED|Part A||0
10581213|NCT01714947|11736604|FG000|STARTED|Part B||3
10581214|NCT01714947|11736604|FG000|COMPLETED|Part B||0
10581215|NCT01714947|11736604|FG000|NOT COMPLETED|Part B||3
10581216|NCT01715064|11736610|FG000|STARTED|Overall Study||18
10581217|NCT01715064|11736611|FG001|STARTED|Overall Study||18
10581218|NCT01715064|11736610|FG000|COMPLETED|Overall Study||18
10581219|NCT01715064|11736611|FG001|COMPLETED|Overall Study||18
10581220|NCT01715064|11736610|FG000|NOT COMPLETED|Overall Study||0
10581221|NCT01715064|11736611|FG001|NOT COMPLETED|Overall Study||0
10581222|NCT01715129|11736617|FG000|STARTED|Overall Study||126
10581223|NCT01715129|11736617|FG000|COMPLETED|Overall Study||117
10581224|NCT01715129|11736617|FG000|NOT COMPLETED|Overall Study||9
10581225|NCT01715207|11736623|FG000|STARTED|Overall Study||15
10581226|NCT01715207|11736624|FG001|STARTED|Overall Study||15
10581227|NCT01715207|11736623|FG000|COMPLETED|Overall Study||14
10581228|NCT01715207|11736624|FG001|COMPLETED|Overall Study||14
10581229|NCT01715207|11736623|FG000|NOT COMPLETED|Overall Study||1
10581230|NCT01715207|11736624|FG001|NOT COMPLETED|Overall Study||1
10581231|NCT01715233|11736632|FG000|STARTED|Overall Study||21
10581232|NCT01715233|11736632|FG000|COMPLETED|Overall Study||21
10581233|NCT01715233|11736632|FG000|NOT COMPLETED|Overall Study||0
10581234|NCT01715298|11736639|FG000|STARTED|Overall Study||216
10581235|NCT01715298|11736640|FG001|STARTED|Overall Study||216
10581236|NCT01715298|11736639|FG000|Full Analysis Set (FAS)|Overall Study|patients were analyzed according to the treatment to which they were randomized|215
10581237|NCT01715298|11736640|FG001|Full Analysis Set (FAS)|Overall Study||214
10581238|NCT01715298|11736639|FG000|COMPLETED|Overall Study||209
10581239|NCT01715298|11736640|FG001|COMPLETED|Overall Study||205
10581240|NCT01715298|11736639|FG000|NOT COMPLETED|Overall Study||7
10581241|NCT01715298|11736640|FG001|NOT COMPLETED|Overall Study||11
10581242|NCT01715415|11736648|FG000|STARTED|Double-blind Treatment||297
10581243|NCT01715415|11736649|FG001|STARTED|Double-blind Treatment||98
10581244|NCT01715415|11736648|FG000|Randomized But Not Treated|Double-blind Treatment||0
10581245|NCT01715415|11736649|FG001|Randomized But Not Treated|Double-blind Treatment||1
10581246|NCT01715415|11736648|FG000|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|292
10581247|NCT01715415|11736649|FG001|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|96
10581248|NCT01715415|11736648|FG000|NOT COMPLETED|Double-blind Treatment||5
10581249|NCT01715415|11736649|FG001|NOT COMPLETED|Double-blind Treatment||2
10581250|NCT01715415|11736648|FG000|STARTED|Open-label Treatment|not applicable to this arm|0
10581251|NCT01715415|11736649|FG001|STARTED|Open-label Treatment||96
10581252|NCT01715415|11736648|FG000|COMPLETED|Open-label Treatment|not applicable to this arm|0
10581253|NCT01715415|11736649|FG001|COMPLETED|Open-label Treatment|The number of participants who completed open-label study drug.|94
10581254|NCT01715415|11736648|FG000|NOT COMPLETED|Open-label Treatment||0
10581255|NCT01715415|11736649|FG001|NOT COMPLETED|Open-label Treatment||2
10581256|NCT01715571|11736656|FG000|STARTED|Overall Study||11
10581257|NCT01715571|11736656|FG000|COMPLETED|Overall Study||3
10581258|NCT01715571|11736656|FG000|NOT COMPLETED|Overall Study||8
10581259|NCT01715805|11736660|FG000|STARTED|Placebo + ADT Lead-in Period||1022
10581260|NCT01715805|11736661|FG001|STARTED|Placebo + ADT Lead-in Period||0
10581261|NCT01715805|11736662|FG002|STARTED|Placebo + ADT Lead-in Period||0
10581262|NCT01715805|11736663|FG003|STARTED|Placebo + ADT Lead-in Period||0
10581263|NCT01715805|11736660|FG000|COMPLETED|Placebo + ADT Lead-in Period||807
10581264|NCT01715805|11736661|FG001|COMPLETED|Placebo + ADT Lead-in Period||0
10581265|NCT01715805|11736662|FG002|COMPLETED|Placebo + ADT Lead-in Period||0
10581266|NCT01715805|11736663|FG003|COMPLETED|Placebo + ADT Lead-in Period||0
10581267|NCT01715805|11736660|FG000|NOT COMPLETED|Placebo + ADT Lead-in Period||215
10581268|NCT01715805|11736661|FG001|NOT COMPLETED|Placebo + ADT Lead-in Period||0
10581269|NCT01715805|11736662|FG002|NOT COMPLETED|Placebo + ADT Lead-in Period||0
10581270|NCT01715805|11736663|FG003|NOT COMPLETED|Placebo + ADT Lead-in Period||0
10581271|NCT01715805|11736660|FG000|STARTED|Double-Blind or Continued Treatment||0
10581272|NCT01715805|11736661|FG001|STARTED|Double-Blind or Continued Treatment||261
10581273|NCT01715805|11736662|FG002|STARTED|Double-Blind or Continued Treatment||269
10581274|NCT01715805|11736663|FG003|STARTED|Double-Blind or Continued Treatment||270
10581275|NCT01715805|11736660|FG000|Double-Blind Safety Population|Double-Blind or Continued Treatment||0
10581276|NCT01715805|11736661|FG001|Double-Blind Safety Population|Double-Blind or Continued Treatment||258
10581277|NCT01715805|11736662|FG002|Double-Blind Safety Population|Double-Blind or Continued Treatment||269
10581278|NCT01715805|11736663|FG003|Double-Blind Safety Population|Double-Blind or Continued Treatment||0
10581279|NCT01715805|11736660|FG000|COMPLETED|Double-Blind or Continued Treatment||0
10581280|NCT01715805|11736661|FG001|COMPLETED|Double-Blind or Continued Treatment||222
10581281|NCT01715805|11736662|FG002|COMPLETED|Double-Blind or Continued Treatment||213
10581282|NCT01715805|11736663|FG003|COMPLETED|Double-Blind or Continued Treatment||222
10581283|NCT01715805|11736660|FG000|NOT COMPLETED|Double-Blind or Continued Treatment||0
10581284|NCT01715805|11736661|FG001|NOT COMPLETED|Double-Blind or Continued Treatment||39
10581285|NCT01715805|11736662|FG002|NOT COMPLETED|Double-Blind or Continued Treatment||56
10581286|NCT01715805|11736663|FG003|NOT COMPLETED|Double-Blind or Continued Treatment||48
10581287|NCT01715831|11736671|FG000|STARTED|Overall Study||26
10581288|NCT01715831|11736671|FG000|COMPLETED|Overall Study||25
10581289|NCT01715831|11736671|FG000|NOT COMPLETED|Overall Study||1
10581290|NCT01715857|11736675|FG000|STARTED|Overall Study||4100
10581291|NCT01715857|11736675|FG000|COMPLETED|Overall Study||4004
10581292|NCT01715857|11736675|FG000|NOT COMPLETED|Overall Study||96
10581293|NCT01715883|11736679|FG000|STARTED|Overall Study||3
10581294|NCT01715883|11736679|FG000|COMPLETED|Overall Study||2
10581295|NCT01715883|11736679|FG000|NOT COMPLETED|Overall Study||1
10581296|NCT01715896|11736686|FG000|STARTED|Overall Study||68
10581297|NCT01715896|11736687|FG001|STARTED|Overall Study||70
10581298|NCT01715896|11736686|FG000|COMPLETED|Overall Study||65
10702703|NCT02577315|11867180|FG001|STARTED|Treatment Period 2 (4 Days)||12
10581299|NCT01715896|11736687|FG001|COMPLETED|Overall Study||59
10581300|NCT01715896|11736686|FG000|NOT COMPLETED|Overall Study||3
10581301|NCT01715896|11736687|FG001|NOT COMPLETED|Overall Study||11
10581302|NCT01715948|11736694|FG000|STARTED|Overall Study||9
10581303|NCT01715948|11736694|FG000|COMPLETED|Overall Study||8
10581304|NCT01715948|11736694|FG000|NOT COMPLETED|Overall Study||1
10581305|NCT01716013|11736715|FG000|STARTED|Overall Study||108
10581306|NCT01716013|11736716|FG001|STARTED|Overall Study||54
10581307|NCT01716013|11736715|FG000|COMPLETED|Overall Study||105
10581308|NCT01716013|11736716|FG001|COMPLETED|Overall Study||54
10581309|NCT01716013|11736715|FG000|NOT COMPLETED|Overall Study||3
10581310|NCT01716013|11736716|FG001|NOT COMPLETED|Overall Study||0
10581311|NCT01716039|11736725|FG000|STARTED|Overall Study||4
10581312|NCT01716039|11736726|FG001|STARTED|Overall Study||8
10581313|NCT01716039|11736727|FG002|STARTED|Overall Study||10
10581314|NCT01716039|11736725|FG000|COMPLETED|Overall Study||3
10581315|NCT01716039|11736726|FG001|COMPLETED|Overall Study||6
10581316|NCT01716039|11736727|FG002|COMPLETED|Overall Study||8
10581317|NCT01716039|11736725|FG000|NOT COMPLETED|Overall Study||1
10581318|NCT01716039|11736726|FG001|NOT COMPLETED|Overall Study||2
10581319|NCT01716039|11736727|FG002|NOT COMPLETED|Overall Study||2
10581320|NCT01716104|11736739|FG000|STARTED|Overall Study||125
10581321|NCT01716104|11736740|FG001|STARTED|Overall Study||124
10581322|NCT01716104|11736739|FG000|COMPLETED|Overall Study||119
10581323|NCT01716104|11736740|FG001|COMPLETED|Overall Study||117
10581324|NCT01716104|11736739|FG000|NOT COMPLETED|Overall Study||6
10581325|NCT01716104|11736740|FG001|NOT COMPLETED|Overall Study||7
10581326|NCT01716156|11736749|FG000|STARTED|Overall Study||9
10581327|NCT01716156|11736750|FG001|STARTED|Overall Study||4
10581328|NCT01716156|11736751|FG002|STARTED|Overall Study||13
10581329|NCT01716156|11736749|FG000|COMPLETED|Overall Study||7
10581330|NCT01716156|11736750|FG001|COMPLETED|Overall Study||3
10581331|NCT01716156|11736751|FG002|COMPLETED|Overall Study||11
10581332|NCT01716156|11736749|FG000|NOT COMPLETED|Overall Study||2
10581333|NCT01716156|11736750|FG001|NOT COMPLETED|Overall Study||1
10581334|NCT01716156|11736751|FG002|NOT COMPLETED|Overall Study||2
10581335|NCT01716169|11736763|FG000|STARTED|Overall Study||10
10581336|NCT01716169|11736763|FG000|Standard of Care Dressings Used|Overall Study||7
10581337|NCT01716169|11736763|FG000|COMPLETED|Overall Study||6
10581338|NCT01716169|11736763|FG000|NOT COMPLETED|Overall Study||4
10581339|NCT01716195|11736769|FG000|STARTED|Overall Study||18
10581340|NCT01716195|11736769|FG000|COMPLETED|Overall Study||17
10581341|NCT01716195|11736769|FG000|NOT COMPLETED|Overall Study||1
10581342|NCT01716208|11736773|FG000|STARTED|Overall Study||12
10581343|NCT01716208|11736773|FG000|COMPLETED|Overall Study||12
10581344|NCT01716208|11736773|FG000|NOT COMPLETED|Overall Study||0
10581345|NCT01716221|11736777|FG000|STARTED|Overall Study||1
10581346|NCT01716221|11736777|FG000|COMPLETED|Overall Study||1
10581347|NCT01716221|11736777|FG000|NOT COMPLETED|Overall Study||0
10581348|NCT01716234|11736800|FG000|STARTED|Overall Study||24
10581349|NCT01716234|11736801|FG001|STARTED|Overall Study||22
10581350|NCT01716234|11736802|FG002|STARTED|Overall Study||20
10581351|NCT01716234|11736803|FG003|STARTED|Overall Study||28
10581352|NCT01716234|11736804|FG004|STARTED|Overall Study||15
10581353|NCT01716234|11736805|FG005|STARTED|Overall Study||32
10581354|NCT01716234|11736806|FG006|STARTED|Overall Study||1
10581355|NCT01716234|11736800|FG000|Treated|Overall Study||22
10581356|NCT01716234|11736801|FG001|Treated|Overall Study||21
10581357|NCT01716234|11736802|FG002|Treated|Overall Study||19
10581358|NCT01716234|11736803|FG003|Treated|Overall Study||28
10581359|NCT01716234|11736804|FG004|Treated|Overall Study||15
10581360|NCT01716234|11736805|FG005|Treated|Overall Study||30
10581361|NCT01716234|11736806|FG006|Treated|Overall Study||1
10581362|NCT01716234|11736800|FG000|COMPLETED|Overall Study||14
10581363|NCT01716234|11736801|FG001|COMPLETED|Overall Study||12
10581364|NCT01716234|11736802|FG002|COMPLETED|Overall Study||15
10702704|NCT02577315|11867179|FG000|COMPLETED|Treatment Period 2 (4 Days)||12
10581365|NCT01716234|11736803|FG003|COMPLETED|Overall Study||16
10581366|NCT01716234|11736804|FG004|COMPLETED|Overall Study||10
10581367|NCT01716234|11736805|FG005|COMPLETED|Overall Study||18
10581368|NCT01716234|11736806|FG006|COMPLETED|Overall Study||1
10581369|NCT01716234|11736800|FG000|NOT COMPLETED|Overall Study||10
10581370|NCT01716234|11736801|FG001|NOT COMPLETED|Overall Study||10
10581371|NCT01716234|11736802|FG002|NOT COMPLETED|Overall Study||5
10581372|NCT01716234|11736803|FG003|NOT COMPLETED|Overall Study||12
10581373|NCT01716234|11736804|FG004|NOT COMPLETED|Overall Study||5
10581374|NCT01716234|11736805|FG005|NOT COMPLETED|Overall Study||14
10581375|NCT01716234|11736806|FG006|NOT COMPLETED|Overall Study||0
10581376|NCT01716455|11736828|FG000|STARTED|Overall Study||8
10581377|NCT01716455|11736829|FG001|STARTED|Overall Study||8
10581378|NCT01716455|11736830|FG002|STARTED|Overall Study||8
10581379|NCT01716455|11736831|FG003|STARTED|Overall Study||8
10581380|NCT01716455|11736832|FG004|STARTED|Overall Study||26
10581381|NCT01716455|11736833|FG005|STARTED|Overall Study||8
10581382|NCT01716455|11736828|FG000|COMPLETED|Overall Study||8
10581383|NCT01716455|11736829|FG001|COMPLETED|Overall Study||8
10581384|NCT01716455|11736830|FG002|COMPLETED|Overall Study||8
10581385|NCT01716455|11736831|FG003|COMPLETED|Overall Study||8
10581386|NCT01716455|11736832|FG004|COMPLETED|Overall Study||26
10581387|NCT01716455|11736833|FG005|COMPLETED|Overall Study||8
10581388|NCT01716455|11736828|FG000|NOT COMPLETED|Overall Study||0
10581389|NCT01716455|11736829|FG001|NOT COMPLETED|Overall Study||0
10581390|NCT01716455|11736830|FG002|NOT COMPLETED|Overall Study||0
10581391|NCT01716455|11736831|FG003|NOT COMPLETED|Overall Study||0
10581392|NCT01716455|11736832|FG004|NOT COMPLETED|Overall Study||0
10581393|NCT01716455|11736833|FG005|NOT COMPLETED|Overall Study||0
10581394|NCT01716468|11736844|FG000|STARTED|Overall Study||17
10581395|NCT01716468|11736844|FG000|COMPLETED|Overall Study||11
10581396|NCT01716468|11736844|FG000|NOT COMPLETED|Overall Study||6
10581397|NCT01716520|11736848|FG000|STARTED|Treatment Period 1 (14 Days)||31
10581398|NCT01716520|11736849|FG001|STARTED|Treatment Period 1 (14 Days)||30
10581399|NCT01716520|11736850|FG002|STARTED|Treatment Period 1 (14 Days)||30
10581400|NCT01716520|11736851|FG003|STARTED|Treatment Period 1 (14 Days)||30
10581401|NCT01716520|11736852|FG004|STARTED|Treatment Period 1 (14 Days)||31
10581402|NCT01716520|11736853|FG005|STARTED|Treatment Period 1 (14 Days)||30
10581403|NCT01716520|11736848|FG000|COMPLETED|Treatment Period 1 (14 Days)||29
10581404|NCT01716520|11736849|FG001|COMPLETED|Treatment Period 1 (14 Days)||29
10581405|NCT01716520|11736850|FG002|COMPLETED|Treatment Period 1 (14 Days)||28
10581406|NCT01716520|11736851|FG003|COMPLETED|Treatment Period 1 (14 Days)||29
10581407|NCT01716520|11736852|FG004|COMPLETED|Treatment Period 1 (14 Days)||31
10581408|NCT01716520|11736853|FG005|COMPLETED|Treatment Period 1 (14 Days)||29
10581409|NCT01716520|11736848|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||2
10581410|NCT01716520|11736849|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||1
10581411|NCT01716520|11736850|FG002|NOT COMPLETED|Treatment Period 1 (14 Days)||2
10581412|NCT01716520|11736851|FG003|NOT COMPLETED|Treatment Period 1 (14 Days)||1
10581413|NCT01716520|11736852|FG004|NOT COMPLETED|Treatment Period 1 (14 Days)||0
10581414|NCT01716520|11736853|FG005|NOT COMPLETED|Treatment Period 1 (14 Days)||1
10581415|NCT01716520|11736848|FG000|STARTED|Washout Period 1 (10 to 14 Days)||29
10581416|NCT01716520|11736849|FG001|STARTED|Washout Period 1 (10 to 14 Days)||29
10581417|NCT01716520|11736850|FG002|STARTED|Washout Period 1 (10 to 14 Days)||28
10702705|NCT02577315|11867180|FG001|COMPLETED|Treatment Period 2 (4 Days)||12
10702706|NCT02577315|11867179|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0
10702707|NCT02577315|11867180|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0
10702708|NCT02577445|11867188|FG000|STARTED|Overall Study||14
10702709|NCT02577445|11867189|FG001|STARTED|Overall Study||17
10702710|NCT02577445|11867188|FG000|COMPLETED|Overall Study|study terminated prematurely|0
10702711|NCT02577445|11867189|FG001|COMPLETED|Overall Study|study terminated prematurely|0
10702712|NCT02577445|11867188|FG000|NOT COMPLETED|Overall Study||14
10702713|NCT02577445|11867189|FG001|NOT COMPLETED|Overall Study||17
10581418|NCT01716520|11736851|FG003|STARTED|Washout Period 1 (10 to 14 Days)||29
10581419|NCT01716520|11736852|FG004|STARTED|Washout Period 1 (10 to 14 Days)||31
10581420|NCT01716520|11736853|FG005|STARTED|Washout Period 1 (10 to 14 Days)||29
10581421|NCT01716520|11736848|FG000|COMPLETED|Washout Period 1 (10 to 14 Days)||29
10581422|NCT01716520|11736849|FG001|COMPLETED|Washout Period 1 (10 to 14 Days)||28
10581423|NCT01716520|11736850|FG002|COMPLETED|Washout Period 1 (10 to 14 Days)||27
10581424|NCT01716520|11736851|FG003|COMPLETED|Washout Period 1 (10 to 14 Days)||29
10581425|NCT01716520|11736852|FG004|COMPLETED|Washout Period 1 (10 to 14 Days)||31
10581426|NCT01716520|11736853|FG005|COMPLETED|Washout Period 1 (10 to 14 Days)||27
10581427|NCT01716520|11736848|FG000|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
10581428|NCT01716520|11736849|FG001|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
10581429|NCT01716520|11736850|FG002|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
10581430|NCT01716520|11736851|FG003|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
10581431|NCT01716520|11736852|FG004|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
10581432|NCT01716520|11736853|FG005|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||2
10581433|NCT01716520|11736848|FG000|STARTED|Treatment Period 2 (14 Days)||29
10581434|NCT01716520|11736849|FG001|STARTED|Treatment Period 2 (14 Days)||28
10581435|NCT01716520|11736850|FG002|STARTED|Treatment Period 2 (14 Days)||27
10581436|NCT01716520|11736851|FG003|STARTED|Treatment Period 2 (14 Days)||29
10581437|NCT01716520|11736852|FG004|STARTED|Treatment Period 2 (14 Days)||31
10581438|NCT01716520|11736853|FG005|STARTED|Treatment Period 2 (14 Days)||27
10581439|NCT01716520|11736848|FG000|COMPLETED|Treatment Period 2 (14 Days)||29
10581440|NCT01716520|11736849|FG001|COMPLETED|Treatment Period 2 (14 Days)||28
10581441|NCT01716520|11736850|FG002|COMPLETED|Treatment Period 2 (14 Days)||27
10581442|NCT01716520|11736851|FG003|COMPLETED|Treatment Period 2 (14 Days)||28
10581443|NCT01716520|11736852|FG004|COMPLETED|Treatment Period 2 (14 Days)||29
10702714|NCT02577510|11867196|FG000|STARTED|Overall Study||21
10702715|NCT02577510|11867197|FG001|STARTED|Overall Study||21
10581444|NCT01716520|11736853|FG005|COMPLETED|Treatment Period 2 (14 Days)||27
10581445|NCT01716520|11736848|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||0
10581446|NCT01716520|11736849|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||0
10581447|NCT01716520|11736850|FG002|NOT COMPLETED|Treatment Period 2 (14 Days)||0
10581448|NCT01716520|11736851|FG003|NOT COMPLETED|Treatment Period 2 (14 Days)||1
10581449|NCT01716520|11736852|FG004|NOT COMPLETED|Treatment Period 2 (14 Days)||2
10581450|NCT01716520|11736853|FG005|NOT COMPLETED|Treatment Period 2 (14 Days)||0
10702716|NCT02577510|11867196|FG000|COMPLETED|Overall Study||21
10581451|NCT01716520|11736848|FG000|STARTED|Washout Period 2 (10 to 14 Days)||29
10581452|NCT01716520|11736849|FG001|STARTED|Washout Period 2 (10 to 14 Days)||28
10581453|NCT01716520|11736850|FG002|STARTED|Washout Period 2 (10 to 14 Days)||27
10581454|NCT01716520|11736851|FG003|STARTED|Washout Period 2 (10 to 14 Days)||28
10581455|NCT01716520|11736852|FG004|STARTED|Washout Period 2 (10 to 14 Days)||29
10581456|NCT01716520|11736853|FG005|STARTED|Washout Period 2 (10 to 14 Days)||27
10581457|NCT01716520|11736848|FG000|COMPLETED|Washout Period 2 (10 to 14 Days)||27
10581458|NCT01716520|11736849|FG001|COMPLETED|Washout Period 2 (10 to 14 Days)||27
10581459|NCT01716520|11736850|FG002|COMPLETED|Washout Period 2 (10 to 14 Days)||26
10581460|NCT01716520|11736851|FG003|COMPLETED|Washout Period 2 (10 to 14 Days)||28
10581461|NCT01716520|11736852|FG004|COMPLETED|Washout Period 2 (10 to 14 Days)||29
10581462|NCT01716520|11736853|FG005|COMPLETED|Washout Period 2 (10 to 14 Days)||25
10581463|NCT01716520|11736848|FG000|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||2
10581464|NCT01716520|11736849|FG001|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||1
10581465|NCT01716520|11736850|FG002|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||1
10581466|NCT01716520|11736851|FG003|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
10581467|NCT01716520|11736852|FG004|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
10581468|NCT01716520|11736853|FG005|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||2
10581469|NCT01716520|11736848|FG000|STARTED|Treatment Period 3 (14 Days)||27
10581470|NCT01716520|11736849|FG001|STARTED|Treatment Period 3 (14 Days)||27
10581471|NCT01716520|11736850|FG002|STARTED|Treatment Period 3 (14 Days)||26
10581472|NCT01716520|11736851|FG003|STARTED|Treatment Period 3 (14 Days)||28
10581473|NCT01716520|11736852|FG004|STARTED|Treatment Period 3 (14 Days)||29
10581474|NCT01716520|11736853|FG005|STARTED|Treatment Period 3 (14 Days)||25
10581475|NCT01716520|11736848|FG000|COMPLETED|Treatment Period 3 (14 Days)||27
10581476|NCT01716520|11736849|FG001|COMPLETED|Treatment Period 3 (14 Days)||27
10581477|NCT01716520|11736850|FG002|COMPLETED|Treatment Period 3 (14 Days)||25
10581478|NCT01716520|11736851|FG003|COMPLETED|Treatment Period 3 (14 Days)||28
10581479|NCT01716520|11736852|FG004|COMPLETED|Treatment Period 3 (14 Days)||29
10581480|NCT01716520|11736853|FG005|COMPLETED|Treatment Period 3 (14 Days)||23
10581481|NCT01716520|11736848|FG000|NOT COMPLETED|Treatment Period 3 (14 Days)||0
10581482|NCT01716520|11736849|FG001|NOT COMPLETED|Treatment Period 3 (14 Days)||0
10581483|NCT01716520|11736850|FG002|NOT COMPLETED|Treatment Period 3 (14 Days)||1
10581484|NCT01716520|11736851|FG003|NOT COMPLETED|Treatment Period 3 (14 Days)||0
10581485|NCT01716520|11736852|FG004|NOT COMPLETED|Treatment Period 3 (14 Days)||0
10581486|NCT01716520|11736853|FG005|NOT COMPLETED|Treatment Period 3 (14 Days)||2
10581487|NCT01716533|11736865|FG000|STARTED|Overall Study||7
10581488|NCT01716533|11736866|FG001|STARTED|Overall Study||25
10581489|NCT01716533|11736867|FG002|STARTED|Overall Study||5
10581490|NCT01716533|11736868|FG003|STARTED|Overall Study||9
10581491|NCT01716533|11736865|FG000|COMPLETED|Overall Study||7
10581492|NCT01716533|11736866|FG001|COMPLETED|Overall Study||25
10581493|NCT01716533|11736867|FG002|COMPLETED|Overall Study||0
10581494|NCT01716533|11736868|FG003|COMPLETED|Overall Study||1
10581495|NCT01716533|11736865|FG000|NOT COMPLETED|Overall Study||0
10581496|NCT01716533|11736866|FG001|NOT COMPLETED|Overall Study||0
10581497|NCT01716533|11736867|FG002|NOT COMPLETED|Overall Study||5
10581498|NCT01716533|11736868|FG003|NOT COMPLETED|Overall Study||8
10581499|NCT01716559|11736882|FG000|STARTED|Overall Study||160
10581500|NCT01716559|11736882|FG000|COMPLETED|Overall Study||49
10581501|NCT01716559|11736882|FG000|NOT COMPLETED|Overall Study||111
10581502|NCT01716585|11736888|FG000|STARTED|Double-blind Treatment||477
10581503|NCT01716585|11736889|FG001|STARTED|Double-blind Treatment||159
10581504|NCT01716585|11736888|FG000|Randomized But Not Treated|Double-blind Treatment||4
10581505|NCT01716585|11736889|FG001|Randomized But Not Treated|Double-blind Treatment||1
10581506|NCT01716585|11736888|FG000|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|464
10581507|NCT01716585|11736889|FG001|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|157
10581508|NCT01716585|11736888|FG000|NOT COMPLETED|Double-blind Treatment||13
10581509|NCT01716585|11736889|FG001|NOT COMPLETED|Double-blind Treatment||2
10581510|NCT01716585|11736888|FG000|STARTED|Open-label Treatment|not applicable to this arm|0
10581511|NCT01716585|11736889|FG001|STARTED|Open-label Treatment||157
10581512|NCT01716585|11736888|FG000|COMPLETED|Open-label Treatment|not applicable to this arm|0
10581513|NCT01716585|11736889|FG001|COMPLETED|Open-label Treatment|The number of participants who completed open-label study drug.|150
10581514|NCT01716585|11736888|FG000|NOT COMPLETED|Open-label Treatment||0
10581515|NCT01716585|11736889|FG001|NOT COMPLETED|Open-label Treatment||7
10581516|NCT01716663|11736896|FG000|STARTED|Overall Study|Enrolled = signed informed consent and met eligibility requirements|234
10581517|NCT01716663|11736896|FG000|Safety|Overall Study|Enrolled patients who had a study device inserted.|230
10581518|NCT01716663|11736896|FG000|COMPLETED|Overall Study|Effectiveness population = enrolled and treated (study device inserted and RF energy applied)|228
10581519|NCT01716663|11736896|FG000|NOT COMPLETED|Overall Study||6
10581520|NCT01716715|11736902|FG000|STARTED|Overall Study||57
10581521|NCT01716715|11736903|FG001|STARTED|Overall Study||54
10581522|NCT01716715|11736902|FG000|COMPLETED|Overall Study||55
10581523|NCT01716715|11736903|FG001|COMPLETED|Overall Study||50
10581524|NCT01716715|11736902|FG000|NOT COMPLETED|Overall Study||2
10581525|NCT01716715|11736903|FG001|NOT COMPLETED|Overall Study||4
10581526|NCT01716754|11736915|FG000|STARTED|Overall Study||199
10581527|NCT01716754|11736916|FG001|STARTED|Overall Study||40
10581528|NCT01716754|11736917|FG002|STARTED|Overall Study||135
10581529|NCT01716754|11736918|FG003|STARTED|Overall Study||97
10581530|NCT01716754|11736915|FG000|FAS|Overall Study||199
10581531|NCT01716754|11736916|FG001|FAS|Overall Study||40
10581532|NCT01716754|11736917|FG002|FAS|Overall Study||131
10702717|NCT02577510|11867197|FG001|COMPLETED|Overall Study||21
10702718|NCT02577510|11867196|FG000|NOT COMPLETED|Overall Study||0
10702719|NCT02577510|11867197|FG001|NOT COMPLETED|Overall Study||0
10702720|NCT02577601|11867206|FG000|STARTED|UPA Only (1 Month)||36
10702721|NCT02577601|11867206|FG000|COMPLETED|UPA Only (1 Month)||36
10702722|NCT02577601|11867206|FG000|NOT COMPLETED|UPA Only (1 Month)||0
10581533|NCT01716754|11736918|FG003|FAS|Overall Study||96
10581534|NCT01716754|11736915|FG000|Safety Set|Overall Study||199
10581535|NCT01716754|11736916|FG001|Safety Set|Overall Study||40
10581536|NCT01716754|11736917|FG002|Safety Set|Overall Study||131
10581537|NCT01716754|11736918|FG003|Safety Set|Overall Study||96
10581538|NCT01716754|11736915|FG000|COMPLETED|Overall Study||188
10581539|NCT01716754|11736916|FG001|COMPLETED|Overall Study||36
10581540|NCT01716754|11736917|FG002|COMPLETED|Overall Study||121
10581541|NCT01716754|11736918|FG003|COMPLETED|Overall Study||89
10581542|NCT01716754|11736915|FG000|NOT COMPLETED|Overall Study||11
10581543|NCT01716754|11736916|FG001|NOT COMPLETED|Overall Study||4
10581544|NCT01716754|11736917|FG002|NOT COMPLETED|Overall Study||14
10581545|NCT01716754|11736918|FG003|NOT COMPLETED|Overall Study||8
10581546|NCT01717001|11736929|FG000|STARTED|Overall Study||38
10581547|NCT01717001|11736930|FG001|STARTED|Overall Study||28
10581548|NCT01717001|11736929|FG000|COMPLETED|Overall Study||32
10581549|NCT01717001|11736930|FG001|COMPLETED|Overall Study||24
10581550|NCT01717001|11736929|FG000|NOT COMPLETED|Overall Study||6
10581551|NCT01717001|11736930|FG001|NOT COMPLETED|Overall Study||4
10581552|NCT01717014|11736936|FG000|STARTED|Overall Study||8
10581553|NCT01717014|11736936|FG000|COMPLETED|Overall Study||8
10581554|NCT01717014|11736936|FG000|NOT COMPLETED|Overall Study||0
10581555|NCT01717040|11736942|FG000|STARTED|Overall Study||17
10581556|NCT01717040|11736943|FG001|STARTED|Overall Study||20
10581557|NCT01717040|11736942|FG000|COMPLETED|Overall Study||12
10581558|NCT01717040|11736943|FG001|COMPLETED|Overall Study||15
10581559|NCT01717040|11736942|FG000|NOT COMPLETED|Overall Study||5
10581560|NCT01717040|11736943|FG001|NOT COMPLETED|Overall Study||5
10581561|NCT01717053|11736949|FG000|STARTED|Overall Study||37
10581562|NCT01717053|11736949|FG000|COMPLETED|Overall Study||33
10581563|NCT01717053|11736949|FG000|NOT COMPLETED|Overall Study||4
10581564|NCT01717209|11736953|FG000|STARTED|Overall Study||14
10581565|NCT01717209|11736953|FG000|COMPLETED|Overall Study||14
10581566|NCT01717209|11736953|FG000|NOT COMPLETED|Overall Study||0
10581567|NCT01717287|11736959|FG000|STARTED|Overall Study||4
10581568|NCT01717287|11736960|FG001|STARTED|Overall Study||28
10581569|NCT01717287|11736959|FG000|COMPLETED|Overall Study||4
10581570|NCT01717287|11736960|FG001|COMPLETED|Overall Study||25
10581571|NCT01717287|11736959|FG000|NOT COMPLETED|Overall Study||0
10581572|NCT01717287|11736960|FG001|NOT COMPLETED|Overall Study||3
10581573|NCT01717313|11736968|FG000|STARTED|Phase A (Weeks 0 to 24)||165
10581574|NCT01717313|11736969|FG001|STARTED|Phase A (Weeks 0 to 24)||164
10581575|NCT01717313|11736968|FG000|COMPLETED|Phase A (Weeks 0 to 24)||147
10581576|NCT01717313|11736969|FG001|COMPLETED|Phase A (Weeks 0 to 24)||151
10581577|NCT01717313|11736968|FG000|NOT COMPLETED|Phase A (Weeks 0 to 24)||18
10581578|NCT01717313|11736969|FG001|NOT COMPLETED|Phase A (Weeks 0 to 24)||13
10581579|NCT01717313|11736968|FG000|STARTED|Interphase||147
10581580|NCT01717313|11736969|FG001|STARTED|Interphase||151
10581581|NCT01717313|11736968|FG000|COMPLETED|Interphase||146
10581582|NCT01717313|11736969|FG001|COMPLETED|Interphase||151
10581583|NCT01717313|11736968|FG000|NOT COMPLETED|Interphase||1
10581584|NCT01717313|11736969|FG001|NOT COMPLETED|Interphase||0
10581585|NCT01717313|11736968|FG000|STARTED|Phase B (Weeks 24 to 54)||146
10581586|NCT01717313|11736969|FG001|STARTED|Phase B (Weeks 24 to 54)||151
10581587|NCT01717313|11736968|FG000|COMPLETED|Phase B (Weeks 24 to 54)||134
10581588|NCT01717313|11736969|FG001|COMPLETED|Phase B (Weeks 24 to 54)||135
10702723|NCT02577601|11867206|FG000|STARTED|Washout (1 Month)||33
10702724|NCT02577601|11867206|FG000|COMPLETED|Washout (1 Month)||33
10702725|NCT02577601|11867206|FG000|NOT COMPLETED|Washout (1 Month)||0
10702726|NCT02577601|11867206|FG000|STARTED|UPA+COC (1 Month)||33
10581589|NCT01717313|11736968|FG000|NOT COMPLETED|Phase B (Weeks 24 to 54)||12
10581590|NCT01717313|11736969|FG001|NOT COMPLETED|Phase B (Weeks 24 to 54)||16
10581591|NCT01717326|11736995|FG000|STARTED|Overall Study||25
10581592|NCT01717326|11736996|FG001|STARTED|Overall Study||27
10581593|NCT01717326|11736997|FG002|STARTED|Overall Study||13
10581594|NCT01717326|11736998|FG003|STARTED|Overall Study||30
10581595|NCT01717326|11736999|FG004|STARTED|Overall Study||33
10581596|NCT01717326|11737000|FG005|STARTED|Overall Study||31
10581597|NCT01717326|11737001|FG006|STARTED|Overall Study||31
10581598|NCT01717326|11737002|FG007|STARTED|Overall Study||29
10581599|NCT01717326|11737003|FG008|STARTED|Overall Study||32
10581600|NCT01717326|11737004|FG009|STARTED|Overall Study||31
10581601|NCT01717326|11737005|FG010|STARTED|Overall Study||32
10581602|NCT01717326|11737006|FG011|STARTED|Overall Study||33
10581603|NCT01717326|11737007|FG012|STARTED|Overall Study||33
10581604|NCT01717326|11737008|FG013|STARTED|Overall Study||32
10581605|NCT01717326|11737009|FG014|STARTED|Overall Study||29
10702727|NCT02577601|11867206|FG000|COMPLETED|UPA+COC (1 Month)||33
10581606|NCT01717326|11737010|FG015|STARTED|Overall Study||30
10581607|NCT01717326|11737011|FG016|STARTED|Overall Study||30
10581608|NCT01717326|11737012|FG017|STARTED|Overall Study||31
10581609|NCT01717326|11737013|FG018|STARTED|Overall Study||20
10581610|NCT01717326|11737014|FG019|STARTED|Overall Study||21
10581611|NCT01717326|11736995|FG000|Treated|Overall Study||25
10581612|NCT01717326|11736996|FG001|Treated|Overall Study|Number includes 1 additional participant randomized to A3 but treated on A2|28
10581613|NCT01717326|11736997|FG002|Treated|Overall Study|Number excludes 1 participant randomized to A3 but treated on Arm A2|12
10581614|NCT01717326|11736998|FG003|Treated|Overall Study||30
10581615|NCT01717326|11736999|FG004|Treated|Overall Study||33
10581616|NCT01717326|11737000|FG005|Treated|Overall Study||31
10581617|NCT01717326|11737001|FG006|Treated|Overall Study||31
10581618|NCT01717326|11737002|FG007|Treated|Overall Study||29
10581619|NCT01717326|11737003|FG008|Treated|Overall Study||32
10581620|NCT01717326|11737004|FG009|Treated|Overall Study||31
10581621|NCT01717326|11737005|FG010|Treated|Overall Study||32
10581622|NCT01717326|11737006|FG011|Treated|Overall Study||33
10581623|NCT01717326|11737007|FG012|Treated|Overall Study||33
10581624|NCT01717326|11737008|FG013|Treated|Overall Study||32
10581625|NCT01717326|11737009|FG014|Treated|Overall Study||29
10581626|NCT01717326|11737010|FG015|Treated|Overall Study||30
10581627|NCT01717326|11737011|FG016|Treated|Overall Study||30
10581628|NCT01717326|11737012|FG017|Treated|Overall Study||31
10581629|NCT01717326|11737013|FG018|Treated|Overall Study||20
10581630|NCT01717326|11737014|FG019|Treated|Overall Study||21
10581631|NCT01717326|11736995|FG000|COMPLETED|Overall Study||22
10581632|NCT01717326|11736996|FG001|COMPLETED|Overall Study||26
10581633|NCT01717326|11736997|FG002|COMPLETED|Overall Study||13
10581634|NCT01717326|11736998|FG003|COMPLETED|Overall Study||28
10581635|NCT01717326|11736999|FG004|COMPLETED|Overall Study||31
10581636|NCT01717326|11737000|FG005|COMPLETED|Overall Study||31
10581637|NCT01717326|11737001|FG006|COMPLETED|Overall Study||30
10581638|NCT01717326|11737002|FG007|COMPLETED|Overall Study||29
10581639|NCT01717326|11737003|FG008|COMPLETED|Overall Study||32
10581640|NCT01717326|11737004|FG009|COMPLETED|Overall Study||29
10581641|NCT01717326|11737005|FG010|COMPLETED|Overall Study||30
10581642|NCT01717326|11737006|FG011|COMPLETED|Overall Study||33
10581643|NCT01717326|11737007|FG012|COMPLETED|Overall Study||32
10581644|NCT01717326|11737008|FG013|COMPLETED|Overall Study||32
10581645|NCT01717326|11737009|FG014|COMPLETED|Overall Study||29
10581646|NCT01717326|11737010|FG015|COMPLETED|Overall Study||27
10581647|NCT01717326|11737011|FG016|COMPLETED|Overall Study||29
10581648|NCT01717326|11737012|FG017|COMPLETED|Overall Study||31
10581649|NCT01717326|11737013|FG018|COMPLETED|Overall Study||16
10581650|NCT01717326|11737014|FG019|COMPLETED|Overall Study||15
10581651|NCT01717326|11736995|FG000|NOT COMPLETED|Overall Study||3
10581652|NCT01717326|11736996|FG001|NOT COMPLETED|Overall Study||1
10581653|NCT01717326|11736997|FG002|NOT COMPLETED|Overall Study||0
10581654|NCT01717326|11736998|FG003|NOT COMPLETED|Overall Study||2
10581655|NCT01717326|11736999|FG004|NOT COMPLETED|Overall Study||2
10581656|NCT01717326|11737000|FG005|NOT COMPLETED|Overall Study||0
10581657|NCT01717326|11737001|FG006|NOT COMPLETED|Overall Study||1
10581658|NCT01717326|11737002|FG007|NOT COMPLETED|Overall Study||0
10581659|NCT01717326|11737003|FG008|NOT COMPLETED|Overall Study||0
10581660|NCT01717326|11737004|FG009|NOT COMPLETED|Overall Study||2
10581661|NCT01717326|11737005|FG010|NOT COMPLETED|Overall Study||2
10581662|NCT01717326|11737006|FG011|NOT COMPLETED|Overall Study||0
10581663|NCT01717326|11737007|FG012|NOT COMPLETED|Overall Study||1
10581664|NCT01717326|11737008|FG013|NOT COMPLETED|Overall Study||0
10581665|NCT01717326|11737009|FG014|NOT COMPLETED|Overall Study||0
10581666|NCT01717326|11737010|FG015|NOT COMPLETED|Overall Study||3
10581667|NCT01717326|11737011|FG016|NOT COMPLETED|Overall Study||1
10581668|NCT01717326|11737012|FG017|NOT COMPLETED|Overall Study||0
10581669|NCT01717326|11737013|FG018|NOT COMPLETED|Overall Study||4
10581670|NCT01717326|11737014|FG019|NOT COMPLETED|Overall Study||6
10581671|NCT01717391|11737056|FG000|STARTED|Overall Study||36
10581672|NCT01717391|11737056|FG000|COMPLETED|Overall Study||27
10581673|NCT01717391|11737056|FG000|NOT COMPLETED|Overall Study||9
10581674|NCT01717456|11737064|FG000|STARTED|End of Treatment||11
10581675|NCT01717456|11737065|FG001|STARTED|End of Treatment||8
10581676|NCT01717456|11737064|FG000|COMPLETED|End of Treatment||11
10581677|NCT01717456|11737065|FG001|COMPLETED|End of Treatment||6
10581678|NCT01717456|11737064|FG000|NOT COMPLETED|End of Treatment||0
10581679|NCT01717456|11737065|FG001|NOT COMPLETED|End of Treatment||2
10581680|NCT01717456|11737064|FG000|STARTED|Follow-Up 6 Months After End of Tx||11
10581681|NCT01717456|11737065|FG001|STARTED|Follow-Up 6 Months After End of Tx||6
10581682|NCT01717456|11737064|FG000|COMPLETED|Follow-Up 6 Months After End of Tx||7
10581683|NCT01717456|11737065|FG001|COMPLETED|Follow-Up 6 Months After End of Tx||2
10581684|NCT01717456|11737064|FG000|NOT COMPLETED|Follow-Up 6 Months After End of Tx||4
10581685|NCT01717456|11737065|FG001|NOT COMPLETED|Follow-Up 6 Months After End of Tx||4
10581686|NCT01717521|11737072|FG000|STARTED|Overall Study||20
10581687|NCT01717521|11737072|FG000|COMPLETED|Overall Study||20
10581688|NCT01717521|11737072|FG000|NOT COMPLETED|Overall Study||0
10581689|NCT01717638|11737089|FG000|STARTED|Overall Study||67
10581690|NCT01717638|11737090|FG001|STARTED|Overall Study||61
10581691|NCT01717638|11737091|FG002|STARTED|Overall Study||60
10581692|NCT01717638|11737092|FG003|STARTED|Overall Study||66
10581693|NCT01717638|11737093|FG004|STARTED|Overall Study||64
10581694|NCT01717638|11737094|FG005|STARTED|Overall Study||55
10581695|NCT01717638|11737095|FG006|STARTED|Overall Study||43
10581696|NCT01717638|11737096|FG007|STARTED|Overall Study||29
10581697|NCT01717638|11737097|FG008|STARTED|Overall Study||28
10581698|NCT01717638|11737098|FG009|STARTED|Overall Study||100
10581699|NCT01717638|11737099|FG010|STARTED|Overall Study||11
10581700|NCT01717638|11737100|FG011|STARTED|Overall Study||12
10581701|NCT01717638|11737101|FG012|STARTED|Overall Study||209
10581702|NCT01717638|11737089|FG000|COMPLETED|Overall Study||67
10581703|NCT01717638|11737090|FG001|COMPLETED|Overall Study||60
10581704|NCT01717638|11737091|FG002|COMPLETED|Overall Study||59
10581705|NCT01717638|11737092|FG003|COMPLETED|Overall Study||66
10581706|NCT01717638|11737093|FG004|COMPLETED|Overall Study||63
10581707|NCT01717638|11737094|FG005|COMPLETED|Overall Study||54
10581708|NCT01717638|11737095|FG006|COMPLETED|Overall Study||41
10581709|NCT01717638|11737096|FG007|COMPLETED|Overall Study||28
10581710|NCT01717638|11737097|FG008|COMPLETED|Overall Study||26
10581711|NCT01717638|11737098|FG009|COMPLETED|Overall Study||99
10581712|NCT01717638|11737099|FG010|COMPLETED|Overall Study||11
10581713|NCT01717638|11737100|FG011|COMPLETED|Overall Study||12
10581714|NCT01717638|11737101|FG012|COMPLETED|Overall Study||190
10581715|NCT01717638|11737089|FG000|NOT COMPLETED|Overall Study||0
10581716|NCT01717638|11737090|FG001|NOT COMPLETED|Overall Study||1
10581717|NCT01717638|11737091|FG002|NOT COMPLETED|Overall Study||1
10581718|NCT01717638|11737092|FG003|NOT COMPLETED|Overall Study||0
10581719|NCT01717638|11737093|FG004|NOT COMPLETED|Overall Study||1
10581720|NCT01717638|11737094|FG005|NOT COMPLETED|Overall Study||1
10581721|NCT01717638|11737095|FG006|NOT COMPLETED|Overall Study||2
10702728|NCT02577601|11867206|FG000|NOT COMPLETED|UPA+COC (1 Month)||0
10702729|NCT02577640|11867217|FG000|STARTED|Dose Escalation Group 1||4
10702730|NCT02577640|11867218|FG001|STARTED|Dose Escalation Group 1||0
10702731|NCT02577640|11867219|FG002|STARTED|Dose Escalation Group 1||0
10702732|NCT02577640|11867220|FG003|STARTED|Dose Escalation Group 1||0
10702733|NCT02577640|11867217|FG000|COMPLETED|Dose Escalation Group 1||3
10702734|NCT02577640|11867218|FG001|COMPLETED|Dose Escalation Group 1||0
10702735|NCT02577640|11867219|FG002|COMPLETED|Dose Escalation Group 1||0
10581722|NCT01717638|11737096|FG007|NOT COMPLETED|Overall Study||1
10581723|NCT01717638|11737097|FG008|NOT COMPLETED|Overall Study||2
10581724|NCT01717638|11737098|FG009|NOT COMPLETED|Overall Study||1
10581725|NCT01717638|11737099|FG010|NOT COMPLETED|Overall Study||0
10581726|NCT01717638|11737100|FG011|NOT COMPLETED|Overall Study||0
10581727|NCT01717638|11737101|FG012|NOT COMPLETED|Overall Study||19
10581728|NCT01717742|11737137|FG000|STARTED|Overall Study||48
10581729|NCT01717742|11737138|FG001|STARTED|Overall Study||49
10581730|NCT01717742|11737137|FG000|COMPLETED|Overall Study||43
10581731|NCT01717742|11737138|FG001|COMPLETED|Overall Study||47
10581732|NCT01717742|11737137|FG000|NOT COMPLETED|Overall Study||5
10581733|NCT01717742|11737138|FG001|NOT COMPLETED|Overall Study||2
10581734|NCT01717768|11737154|FG000|STARTED|Part 1 (Duration of 15 Days)||17
10581735|NCT01717768|11737155|FG001|STARTED|Part 1 (Duration of 15 Days)||17
10581736|NCT01717768|11737156|FG002|STARTED|Part 1 (Duration of 15 Days)||0
10581737|NCT01717768|11737157|FG003|STARTED|Part 1 (Duration of 15 Days)||0
10581738|NCT01717768|11737158|FG004|STARTED|Part 1 (Duration of 15 Days)||0
10581739|NCT01717768|11737159|FG005|STARTED|Part 1 (Duration of 15 Days)||0
10581740|NCT01717768|11737160|FG006|STARTED|Part 1 (Duration of 15 Days)||0
10581741|NCT01717768|11737161|FG007|STARTED|Part 1 (Duration of 15 Days)||0
10581742|NCT01717768|11737162|FG008|STARTED|Part 1 (Duration of 15 Days)||0
10581743|NCT01717768|11737163|FG009|STARTED|Part 1 (Duration of 15 Days)||0
10581744|NCT01717768|11737164|FG010|STARTED|Part 1 (Duration of 15 Days)||0
10581745|NCT01717768|11737165|FG011|STARTED|Part 1 (Duration of 15 Days)||0
10581746|NCT01717768|11737154|FG000|COMPLETED|Part 1 (Duration of 15 Days)||17
10581747|NCT01717768|11737155|FG001|COMPLETED|Part 1 (Duration of 15 Days)||16
10581748|NCT01717768|11737156|FG002|COMPLETED|Part 1 (Duration of 15 Days)||0
10581749|NCT01717768|11737157|FG003|COMPLETED|Part 1 (Duration of 15 Days)||0
10581750|NCT01717768|11737158|FG004|COMPLETED|Part 1 (Duration of 15 Days)||0
10581751|NCT01717768|11737159|FG005|COMPLETED|Part 1 (Duration of 15 Days)||0
10581752|NCT01717768|11737160|FG006|COMPLETED|Part 1 (Duration of 15 Days)||0
10581753|NCT01717768|11737161|FG007|COMPLETED|Part 1 (Duration of 15 Days)||0
10581754|NCT01717768|11737162|FG008|COMPLETED|Part 1 (Duration of 15 Days)||0
10581755|NCT01717768|11737163|FG009|COMPLETED|Part 1 (Duration of 15 Days)||0
10581756|NCT01717768|11737164|FG010|COMPLETED|Part 1 (Duration of 15 Days)||0
10581757|NCT01717768|11737165|FG011|COMPLETED|Part 1 (Duration of 15 Days)||0
10581758|NCT01717768|11737154|FG000|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
10581759|NCT01717768|11737155|FG001|NOT COMPLETED|Part 1 (Duration of 15 Days)||1
10581760|NCT01717768|11737156|FG002|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
10581761|NCT01717768|11737157|FG003|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
10581762|NCT01717768|11737158|FG004|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
10702736|NCT02577640|11867220|FG003|COMPLETED|Dose Escalation Group 1||0
10702737|NCT02577640|11867217|FG000|NOT COMPLETED|Dose Escalation Group 1||1
10702738|NCT02577640|11867218|FG001|NOT COMPLETED|Dose Escalation Group 1||0
10702739|NCT02577640|11867219|FG002|NOT COMPLETED|Dose Escalation Group 1||0
10581763|NCT01717768|11737159|FG005|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
10581764|NCT01717768|11737160|FG006|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
10581765|NCT01717768|11737161|FG007|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
10581766|NCT01717768|11737162|FG008|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
10581767|NCT01717768|11737163|FG009|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
10581768|NCT01717768|11737164|FG010|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
10581769|NCT01717768|11737165|FG011|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
10581770|NCT01717768|11737154|FG000|STARTED|Part 2 (Duration of 15 Days)||0
10581771|NCT01717768|11737155|FG001|STARTED|Part 2 (Duration of 15 Days)||0
10581772|NCT01717768|11737156|FG002|STARTED|Part 2 (Duration of 15 Days)||17
10581773|NCT01717768|11737157|FG003|STARTED|Part 2 (Duration of 15 Days)||0
10581774|NCT01717768|11737158|FG004|STARTED|Part 2 (Duration of 15 Days)||0
10581775|NCT01717768|11737159|FG005|STARTED|Part 2 (Duration of 15 Days)||0
10581776|NCT01717768|11737160|FG006|STARTED|Part 2 (Duration of 15 Days)||0
10581777|NCT01717768|11737161|FG007|STARTED|Part 2 (Duration of 15 Days)||0
10581778|NCT01717768|11737162|FG008|STARTED|Part 2 (Duration of 15 Days)||0
10581779|NCT01717768|11737163|FG009|STARTED|Part 2 (Duration of 15 Days)||0
10581780|NCT01717768|11737164|FG010|STARTED|Part 2 (Duration of 15 Days)||0
10581781|NCT01717768|11737165|FG011|STARTED|Part 2 (Duration of 15 Days)||0
10581782|NCT01717768|11737154|FG000|COMPLETED|Part 2 (Duration of 15 Days)||0
10581783|NCT01717768|11737155|FG001|COMPLETED|Part 2 (Duration of 15 Days)||0
10581784|NCT01717768|11737156|FG002|COMPLETED|Part 2 (Duration of 15 Days)||17
10581785|NCT01717768|11737157|FG003|COMPLETED|Part 2 (Duration of 15 Days)||0
10581786|NCT01717768|11737158|FG004|COMPLETED|Part 2 (Duration of 15 Days)||0
10581787|NCT01717768|11737159|FG005|COMPLETED|Part 2 (Duration of 15 Days)||0
10581788|NCT01717768|11737160|FG006|COMPLETED|Part 2 (Duration of 15 Days)||0
10702740|NCT02577640|11867220|FG003|NOT COMPLETED|Dose Escalation Group 1||0
10702741|NCT02577640|11867217|FG000|STARTED|Dose Escalation Group 2||0
10702742|NCT02577640|11867218|FG001|STARTED|Dose Escalation Group 2||3
10702743|NCT02577640|11867219|FG002|STARTED|Dose Escalation Group 2||0
10702744|NCT02577640|11867220|FG003|STARTED|Dose Escalation Group 2||0
10702745|NCT02577640|11867217|FG000|COMPLETED|Dose Escalation Group 2||0
10581789|NCT01717768|11737161|FG007|COMPLETED|Part 2 (Duration of 15 Days)||0
10581790|NCT01717768|11737162|FG008|COMPLETED|Part 2 (Duration of 15 Days)||0
10581791|NCT01717768|11737163|FG009|COMPLETED|Part 2 (Duration of 15 Days)||0
10581792|NCT01717768|11737164|FG010|COMPLETED|Part 2 (Duration of 15 Days)||0
10581793|NCT01717768|11737165|FG011|COMPLETED|Part 2 (Duration of 15 Days)||0
10581794|NCT01717768|11737154|FG000|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
10581795|NCT01717768|11737155|FG001|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
10581796|NCT01717768|11737156|FG002|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
10581797|NCT01717768|11737157|FG003|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
10581798|NCT01717768|11737158|FG004|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
10581799|NCT01717768|11737159|FG005|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
10581800|NCT01717768|11737160|FG006|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
10581801|NCT01717768|11737161|FG007|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
10581802|NCT01717768|11737162|FG008|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
10581803|NCT01717768|11737163|FG009|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
10581804|NCT01717768|11737164|FG010|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
10581805|NCT01717768|11737165|FG011|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
10581806|NCT01717768|11737154|FG000|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10581807|NCT01717768|11737155|FG001|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10581808|NCT01717768|11737156|FG002|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10581809|NCT01717768|11737157|FG003|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||4
10702746|NCT02577640|11867218|FG001|COMPLETED|Dose Escalation Group 2||3
10702747|NCT02577640|11867219|FG002|COMPLETED|Dose Escalation Group 2||0
10702748|NCT02577640|11867220|FG003|COMPLETED|Dose Escalation Group 2||0
10581810|NCT01717768|11737158|FG004|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||5
10581811|NCT01717768|11737159|FG005|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||5
10581812|NCT01717768|11737160|FG006|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10581813|NCT01717768|11737161|FG007|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10581814|NCT01717768|11737162|FG008|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10581815|NCT01717768|11737163|FG009|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10581816|NCT01717768|11737164|FG010|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10581817|NCT01717768|11737165|FG011|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10581818|NCT01717768|11737154|FG000|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10581819|NCT01717768|11737155|FG001|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10581820|NCT01717768|11737156|FG002|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10581821|NCT01717768|11737157|FG003|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||4
10581822|NCT01717768|11737158|FG004|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||5
10581823|NCT01717768|11737159|FG005|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||5
10581824|NCT01717768|11737160|FG006|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10581825|NCT01717768|11737161|FG007|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10581826|NCT01717768|11737162|FG008|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10581827|NCT01717768|11737163|FG009|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10581828|NCT01717768|11737164|FG010|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10581829|NCT01717768|11737165|FG011|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10581830|NCT01717768|11737154|FG000|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10581831|NCT01717768|11737155|FG001|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10702749|NCT02577640|11867217|FG000|NOT COMPLETED|Dose Escalation Group 2||0
10702750|NCT02577640|11867218|FG001|NOT COMPLETED|Dose Escalation Group 2||0
10702751|NCT02577640|11867219|FG002|NOT COMPLETED|Dose Escalation Group 2||0
10702752|NCT02577640|11867220|FG003|NOT COMPLETED|Dose Escalation Group 2||0
10581832|NCT01717768|11737156|FG002|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10581833|NCT01717768|11737157|FG003|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10581834|NCT01717768|11737158|FG004|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10581835|NCT01717768|11737159|FG005|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10581836|NCT01717768|11737160|FG006|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10581837|NCT01717768|11737161|FG007|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10581838|NCT01717768|11737162|FG008|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10581839|NCT01717768|11737163|FG009|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10581840|NCT01717768|11737164|FG010|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10581841|NCT01717768|11737165|FG011|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
10581842|NCT01717768|11737154|FG000|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10581843|NCT01717768|11737155|FG001|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10581844|NCT01717768|11737156|FG002|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10581845|NCT01717768|11737157|FG003|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||4
10581846|NCT01717768|11737158|FG004|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||5
10581847|NCT01717768|11737159|FG005|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||5
10581848|NCT01717768|11737160|FG006|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10581849|NCT01717768|11737161|FG007|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10581850|NCT01717768|11737162|FG008|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10581851|NCT01717768|11737163|FG009|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10581852|NCT01717768|11737164|FG010|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10581853|NCT01717768|11737165|FG011|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10581854|NCT01717768|11737154|FG000|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10581855|NCT01717768|11737155|FG001|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10581856|NCT01717768|11737156|FG002|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10581857|NCT01717768|11737157|FG003|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||4
10581858|NCT01717768|11737158|FG004|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||5
10581859|NCT01717768|11737159|FG005|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||5
10581860|NCT01717768|11737160|FG006|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10581861|NCT01717768|11737161|FG007|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10581862|NCT01717768|11737162|FG008|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10581863|NCT01717768|11737163|FG009|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10581864|NCT01717768|11737164|FG010|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10581865|NCT01717768|11737165|FG011|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10581866|NCT01717768|11737154|FG000|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10581867|NCT01717768|11737155|FG001|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10581868|NCT01717768|11737156|FG002|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10581869|NCT01717768|11737157|FG003|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10581870|NCT01717768|11737158|FG004|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10581871|NCT01717768|11737159|FG005|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10581872|NCT01717768|11737160|FG006|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10581873|NCT01717768|11737161|FG007|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10581874|NCT01717768|11737162|FG008|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10581875|NCT01717768|11737163|FG009|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10581876|NCT01717768|11737164|FG010|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10581877|NCT01717768|11737165|FG011|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
10581878|NCT01717768|11737154|FG000|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10581879|NCT01717768|11737155|FG001|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10581880|NCT01717768|11737156|FG002|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10581881|NCT01717768|11737157|FG003|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||4
10581882|NCT01717768|11737158|FG004|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||5
10702753|NCT02577640|11867217|FG000|STARTED|Dose Escalation Group 3||0
10702754|NCT02577640|11867218|FG001|STARTED|Dose Escalation Group 3||0
10702755|NCT02577640|11867219|FG002|STARTED|Dose Escalation Group 3||3
10702756|NCT02577640|11867220|FG003|STARTED|Dose Escalation Group 3||0
10702757|NCT02577640|11867217|FG000|COMPLETED|Dose Escalation Group 3||0
10702758|NCT02577640|11867218|FG001|COMPLETED|Dose Escalation Group 3||0
10702759|NCT02577640|11867219|FG002|COMPLETED|Dose Escalation Group 3||3
10702760|NCT02577640|11867220|FG003|COMPLETED|Dose Escalation Group 3||0
10702761|NCT02577640|11867217|FG000|NOT COMPLETED|Dose Escalation Group 3||0
10806568|NCT03956862|11968131|FG000|STARTED|Overall Study||50
10581883|NCT01717768|11737159|FG005|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||5
10806569|NCT03956862|11968132|FG001|STARTED|Overall Study||47
10806570|NCT03956862|11968131|FG000|COMPLETED|Overall Study||48
10806571|NCT03956862|11968132|FG001|COMPLETED|Overall Study||45
10806572|NCT03956862|11968131|FG000|NOT COMPLETED|Overall Study||2
10806573|NCT03956862|11968132|FG001|NOT COMPLETED|Overall Study||2
10581884|NCT01717768|11737160|FG006|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10581885|NCT01717768|11737161|FG007|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10581886|NCT01717768|11737162|FG008|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10581887|NCT01717768|11737163|FG009|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10581888|NCT01717768|11737164|FG010|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10581889|NCT01717768|11737165|FG011|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10581890|NCT01717768|11737154|FG000|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10581891|NCT01717768|11737155|FG001|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10581892|NCT01717768|11737156|FG002|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10581893|NCT01717768|11737157|FG003|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||4
10702762|NCT02577640|11867218|FG001|NOT COMPLETED|Dose Escalation Group 3||0
10702763|NCT02577640|11867219|FG002|NOT COMPLETED|Dose Escalation Group 3||0
10581894|NCT01717768|11737158|FG004|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||5
10806574|NCT03954444|11968141|FG000|STARTED|Overall Study||379
10581895|NCT01717768|11737159|FG005|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||5
10581896|NCT01717768|11737160|FG006|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10581897|NCT01717768|11737161|FG007|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10581898|NCT01717768|11737162|FG008|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10581899|NCT01717768|11737163|FG009|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10581900|NCT01717768|11737164|FG010|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10581901|NCT01717768|11737165|FG011|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10581902|NCT01717768|11737154|FG000|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10581903|NCT01717768|11737155|FG001|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10581904|NCT01717768|11737156|FG002|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10581905|NCT01717768|11737157|FG003|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10581906|NCT01717768|11737158|FG004|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10581907|NCT01717768|11737159|FG005|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10581908|NCT01717768|11737160|FG006|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10581909|NCT01717768|11737161|FG007|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10581910|NCT01717768|11737162|FG008|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10581911|NCT01717768|11737163|FG009|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10581912|NCT01717768|11737164|FG010|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10581913|NCT01717768|11737165|FG011|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
10581914|NCT01717768|11737154|FG000|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
10581915|NCT01717768|11737155|FG001|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
10581916|NCT01717768|11737156|FG002|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
10581917|NCT01717768|11737157|FG003|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
10581918|NCT01717768|11737158|FG004|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
10581919|NCT01717768|11737159|FG005|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
10581920|NCT01717768|11737160|FG006|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||17
10581921|NCT01717768|11737161|FG007|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
10581922|NCT01717768|11737162|FG008|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
10581923|NCT01717768|11737163|FG009|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
10581924|NCT01717768|11737164|FG010|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
10581925|NCT01717768|11737165|FG011|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
10581926|NCT01717768|11737154|FG000|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
10581927|NCT01717768|11737155|FG001|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
10581928|NCT01717768|11737156|FG002|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
10581929|NCT01717768|11737157|FG003|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
10581930|NCT01717768|11737158|FG004|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
10581931|NCT01717768|11737159|FG005|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
10581932|NCT01717768|11737160|FG006|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||17
10581933|NCT01717768|11737161|FG007|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
10581934|NCT01717768|11737162|FG008|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||16
10581935|NCT01717768|11737163|FG009|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
10581936|NCT01717768|11737164|FG010|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||16
10581937|NCT01717768|11737165|FG011|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||15
10581938|NCT01717768|11737154|FG000|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
10581939|NCT01717768|11737155|FG001|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
10581940|NCT01717768|11737156|FG002|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
10581941|NCT01717768|11737157|FG003|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
10581942|NCT01717768|11737158|FG004|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
10581943|NCT01717768|11737159|FG005|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
10581944|NCT01717768|11737160|FG006|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
10581945|NCT01717768|11737161|FG007|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
10581946|NCT01717768|11737162|FG008|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
10581947|NCT01717768|11737163|FG009|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
10581948|NCT01717768|11737164|FG010|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
10581949|NCT01717768|11737165|FG011|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||1
10581950|NCT01717768|11737154|FG000|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
10581951|NCT01717768|11737155|FG001|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
10581952|NCT01717768|11737156|FG002|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
10581953|NCT01717768|11737157|FG003|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
10581954|NCT01717768|11737158|FG004|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
10581955|NCT01717768|11737159|FG005|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
10581956|NCT01717768|11737160|FG006|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
10581957|NCT01717768|11737161|FG007|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||17
10581958|NCT01717768|11737162|FG008|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
10581959|NCT01717768|11737163|FG009|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||16
10581960|NCT01717768|11737164|FG010|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
10581961|NCT01717768|11737165|FG011|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
10581962|NCT01717768|11737154|FG000|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
10581963|NCT01717768|11737155|FG001|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
10581964|NCT01717768|11737156|FG002|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
10581965|NCT01717768|11737157|FG003|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
10581966|NCT01717768|11737158|FG004|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
10581967|NCT01717768|11737159|FG005|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
10581968|NCT01717768|11737160|FG006|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
10581969|NCT01717768|11737161|FG007|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||15
10581970|NCT01717768|11737162|FG008|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
10581971|NCT01717768|11737163|FG009|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||15
10581972|NCT01717768|11737164|FG010|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
10581973|NCT01717768|11737165|FG011|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
10581974|NCT01717768|11737154|FG000|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
10581975|NCT01717768|11737155|FG001|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
10581976|NCT01717768|11737156|FG002|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
10581977|NCT01717768|11737157|FG003|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
10581978|NCT01717768|11737158|FG004|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
10581979|NCT01717768|11737159|FG005|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
10581980|NCT01717768|11737160|FG006|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
10581981|NCT01717768|11737161|FG007|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||2
10581982|NCT01717768|11737162|FG008|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
10581983|NCT01717768|11737163|FG009|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||1
10581984|NCT01717768|11737164|FG010|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
10581985|NCT01717768|11737165|FG011|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
10581986|NCT01717859|11737191|FG000|STARTED|Overall Study||54
10581987|NCT01717859|11737191|FG000|3 Month|Overall Study||50
10581988|NCT01717859|11737191|FG000|COMPLETED|Overall Study||44
10581989|NCT01717859|11737191|FG000|NOT COMPLETED|Overall Study||10
10581990|NCT01717872|11737204|FG000|STARTED|Overall Study||25
10581991|NCT01717872|11737205|FG001|STARTED|Overall Study||25
10581992|NCT01717872|11737204|FG000|COMPLETED|Overall Study||25
10581993|NCT01717872|11737205|FG001|COMPLETED|Overall Study||25
10581994|NCT01717872|11737204|FG000|NOT COMPLETED|Overall Study||0
10581995|NCT01717872|11737205|FG001|NOT COMPLETED|Overall Study||0
10581996|NCT01717898|11737215|FG000|STARTED|Overall Study||6
10581997|NCT01717898|11737216|FG001|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
10581998|NCT01717898|11737217|FG002|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
10581999|NCT01717898|11737218|FG003|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
10582000|NCT01717898|11737215|FG000|COMPLETED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
10582001|NCT01717898|11737216|FG001|COMPLETED|Overall Study||0
10582002|NCT01717898|11737217|FG002|COMPLETED|Overall Study||0
10582003|NCT01717898|11737218|FG003|COMPLETED|Overall Study||0
10582004|NCT01717898|11737215|FG000|NOT COMPLETED|Overall Study||6
10582005|NCT01717898|11737216|FG001|NOT COMPLETED|Overall Study||0
10582006|NCT01717898|11737217|FG002|NOT COMPLETED|Overall Study||0
10582007|NCT01717898|11737218|FG003|NOT COMPLETED|Overall Study||0
10582008|NCT01717976|11737230|FG000|STARTED|Overall Study||257
10582009|NCT01717976|11737231|FG001|STARTED|Overall Study||257
10582010|NCT01717976|11737230|FG000|COMPLETED|Overall Study||257
10582011|NCT01717976|11737231|FG001|COMPLETED|Overall Study||256
10582012|NCT01717976|11737230|FG000|NOT COMPLETED|Overall Study||0
10582013|NCT01717976|11737231|FG001|NOT COMPLETED|Overall Study||1
10582014|NCT01717989|11737237|FG000|STARTED|Overall Study||2248
10582015|NCT01717989|11737237|FG000|COMPLETED|Overall Study||1182
10582016|NCT01717989|11737237|FG000|NOT COMPLETED|Overall Study||1066
10582017|NCT01718028|11737258|FG000|STARTED|Overall Study||25
10582018|NCT01718028|11737259|FG001|STARTED|Overall Study||24
10582019|NCT01718028|11737258|FG000|COMPLETED|Overall Study||25
10582020|NCT01718028|11737259|FG001|COMPLETED|Overall Study||24
10582021|NCT01718028|11737258|FG000|NOT COMPLETED|Overall Study||0
10582022|NCT01718028|11737259|FG001|NOT COMPLETED|Overall Study||0
10582023|NCT01718353|11737267|FG000|STARTED|Overall Study||41
10582024|NCT01718353|11737268|FG001|STARTED|Overall Study||22
10582025|NCT01718353|11737267|FG000|Treated|Overall Study||39
10582026|NCT01718353|11737268|FG001|Treated|Overall Study||22
10582027|NCT01718353|11737267|FG000|Treated up to End of Cycle 4|Overall Study|7 participants discontinued before Cycle 5|32
10582028|NCT01718353|11737268|FG001|Treated up to End of Cycle 4|Overall Study|6 participants discontinued before Cycle 5|16
10582029|NCT01718353|11737267|FG000|Treated From Cycle 5|Overall Study|12 participants switched from Treatment A to B & 3 participants switched from Treatment B to A.|23
10582030|NCT01718353|11737268|FG001|Treated From Cycle 5|Overall Study|3 participants switched from Treatment B to A & 12 participants switched from Treatment A to B.|25
10582031|NCT01718353|11737267|FG000|COMPLETED|Overall Study|Participants at study cut-off, Adverse Event (AE), DP & consent withdrawn were considered completed.|29
10582032|NCT01718353|11737268|FG001|COMPLETED|Overall Study|Participants at study cut-off, AE, DP and consent withdrawn were considered completed.|17
10582033|NCT01718353|11737267|FG000|NOT COMPLETED|Overall Study||12
10582034|NCT01718353|11737268|FG001|NOT COMPLETED|Overall Study||5
10582035|NCT01718483|11737278|FG000|STARTED|Overall Study||191
10582036|NCT01718483|11737279|FG001|STARTED|Overall Study||192
10582037|NCT01718483|11737278|FG000|Treated|Overall Study||187
10582038|NCT01718483|11737279|FG001|Treated|Overall Study||192
10582039|NCT01718483|11737278|FG000|COMPLETED|Overall Study||157
10582040|NCT01718483|11737279|FG001|COMPLETED|Overall Study||158
10582041|NCT01718483|11737278|FG000|NOT COMPLETED|Overall Study||34
10582042|NCT01718483|11737279|FG001|NOT COMPLETED|Overall Study||34
10582043|NCT01718509|11737287|FG000|STARTED|Overall Study||195
10582044|NCT01718509|11737288|FG001|STARTED|Overall Study||195
10582045|NCT01718509|11737287|FG000|COMPLETED|Overall Study||147
10582046|NCT01718509|11737288|FG001|COMPLETED|Overall Study||147
10582047|NCT01718509|11737287|FG000|NOT COMPLETED|Overall Study||48
10582048|NCT01718509|11737288|FG001|NOT COMPLETED|Overall Study||48
10582049|NCT01718522|11737294|FG000|STARTED|Overall Study||75
10582050|NCT01718522|11737294|FG000|COMPLETED|Overall Study||67
10582051|NCT01718522|11737294|FG000|NOT COMPLETED|Overall Study||8
10582052|NCT01718535|11737311|FG000|STARTED|Overall Study||131
10582053|NCT01718535|11737312|FG001|STARTED|Overall Study||95
10582054|NCT01718535|11737313|FG002|STARTED|Overall Study||19
10582055|NCT01718535|11737314|FG003|STARTED|Overall Study||8
10582056|NCT01718535|11737315|FG004|STARTED|Overall Study||1
10582057|NCT01718535|11737316|FG005|STARTED|Overall Study||40
10582058|NCT01718535|11737317|FG006|STARTED|Overall Study||11
10582059|NCT01718535|11737318|FG007|STARTED|Overall Study||6
10582060|NCT01718535|11737319|FG008|STARTED|Overall Study||15
10582061|NCT01718535|11737320|FG009|STARTED|Overall Study||1
10582062|NCT01718535|11737311|FG000|First Pass|Overall Study||128
10582063|NCT01718535|11737312|FG001|First Pass|Overall Study||94
10582064|NCT01718535|11737313|FG002|First Pass|Overall Study||19
10582065|NCT01718535|11737314|FG003|First Pass|Overall Study||7
10582066|NCT01718535|11737315|FG004|First Pass|Overall Study||1
10582067|NCT01718535|11737316|FG005|First Pass|Overall Study||39
10582068|NCT01718535|11737317|FG006|First Pass|Overall Study||11
10582069|NCT01718535|11737318|FG007|First Pass|Overall Study||6
10582070|NCT01718535|11737319|FG008|First Pass|Overall Study||15
10582071|NCT01718535|11737320|FG009|First Pass|Overall Study||1
10582072|NCT01718535|11737311|FG000|COMPLETED|Overall Study||130
10582073|NCT01718535|11737312|FG001|COMPLETED|Overall Study||95
10582074|NCT01718535|11737313|FG002|COMPLETED|Overall Study||19
10582075|NCT01718535|11737314|FG003|COMPLETED|Overall Study||7
10582076|NCT01718535|11737315|FG004|COMPLETED|Overall Study||1
10582077|NCT01718535|11737316|FG005|COMPLETED|Overall Study||40
10582078|NCT01718535|11737317|FG006|COMPLETED|Overall Study||11
10582079|NCT01718535|11737318|FG007|COMPLETED|Overall Study||6
10582080|NCT01718535|11737319|FG008|COMPLETED|Overall Study||15
10582081|NCT01718535|11737320|FG009|COMPLETED|Overall Study||1
10582082|NCT01718535|11737311|FG000|NOT COMPLETED|Overall Study||1
10582083|NCT01718535|11737312|FG001|NOT COMPLETED|Overall Study||0
10582084|NCT01718535|11737313|FG002|NOT COMPLETED|Overall Study||0
10582085|NCT01718535|11737314|FG003|NOT COMPLETED|Overall Study||1
10582086|NCT01718535|11737315|FG004|NOT COMPLETED|Overall Study||0
10582087|NCT01718535|11737316|FG005|NOT COMPLETED|Overall Study||0
10582088|NCT01718535|11737317|FG006|NOT COMPLETED|Overall Study||0
10582089|NCT01718535|11737318|FG007|NOT COMPLETED|Overall Study||0
10582090|NCT01718535|11737319|FG008|NOT COMPLETED|Overall Study||0
10582091|NCT01718535|11737320|FG009|NOT COMPLETED|Overall Study||0
10582092|NCT01718691|11737344|FG000|STARTED|Overall Study||60
10582093|NCT01718691|11737345|FG001|STARTED|Overall Study||10
10582094|NCT01718691|11737344|FG000|COMPLETED|Overall Study||42
10582095|NCT01718691|11737345|FG001|COMPLETED|Overall Study||9
10582096|NCT01718691|11737344|FG000|NOT COMPLETED|Overall Study||18
10582097|NCT01718691|11737345|FG001|NOT COMPLETED|Overall Study||1
10582098|NCT01719003|11737364|FG000|STARTED|Overall Study||170
10582099|NCT01719003|11737365|FG001|STARTED|Overall Study||170
10582100|NCT01719003|11737366|FG002|STARTED|Overall Study||171
10582101|NCT01719003|11737367|FG003|STARTED|Overall Study||169
10582102|NCT01719003|11737368|FG004|STARTED|Overall Study||167
10582103|NCT01719003|11737369|FG005|STARTED|Overall Study||172
10582104|NCT01719003|11737370|FG006|STARTED|Overall Study||170
10582105|NCT01719003|11737371|FG007|STARTED|Overall Study||171
10582106|NCT01719003|11737372|FG008|STARTED|Overall Study||53
10582107|NCT01719003|11737364|FG000|COMPLETED|Overall Study||161
10582108|NCT01719003|11737365|FG001|COMPLETED|Overall Study||153
10582109|NCT01719003|11737366|FG002|COMPLETED|Overall Study||154
10582110|NCT01719003|11737367|FG003|COMPLETED|Overall Study||156
10582111|NCT01719003|11737368|FG004|COMPLETED|Overall Study||150
10582112|NCT01719003|11737369|FG005|COMPLETED|Overall Study||160
10582113|NCT01719003|11737370|FG006|COMPLETED|Overall Study||150
10582114|NCT01719003|11737371|FG007|COMPLETED|Overall Study||151
10582115|NCT01719003|11737372|FG008|COMPLETED|Overall Study||49
10582116|NCT01719003|11737364|FG000|NOT COMPLETED|Overall Study||9
10582117|NCT01719003|11737365|FG001|NOT COMPLETED|Overall Study||17
10582118|NCT01719003|11737366|FG002|NOT COMPLETED|Overall Study||17
10582119|NCT01719003|11737367|FG003|NOT COMPLETED|Overall Study||13
10582120|NCT01719003|11737368|FG004|NOT COMPLETED|Overall Study||17
10582121|NCT01719003|11737369|FG005|NOT COMPLETED|Overall Study||12
10582122|NCT01719003|11737370|FG006|NOT COMPLETED|Overall Study||20
10582123|NCT01719003|11737371|FG007|NOT COMPLETED|Overall Study||20
10582124|NCT01719003|11737372|FG008|NOT COMPLETED|Overall Study||4
10582125|NCT01719172|11737391|FG000|STARTED|Overall Study||30
10582126|NCT01719172|11737391|FG000|COMPLETED|Overall Study||28
10582127|NCT01719172|11737391|FG000|NOT COMPLETED|Overall Study||2
10582128|NCT01719224|11737395|FG000|STARTED|Intervention 1: Sleeping Position 1||18
10582129|NCT01719224|11737396|FG001|STARTED|Intervention 1: Sleeping Position 1||18
10582130|NCT01719224|11737395|FG000|COMPLETED|Intervention 1: Sleeping Position 1||14
10582131|NCT01719224|11737396|FG001|COMPLETED|Intervention 1: Sleeping Position 1||16
10582132|NCT01719224|11737395|FG000|NOT COMPLETED|Intervention 1: Sleeping Position 1||4
10582133|NCT01719224|11737396|FG001|NOT COMPLETED|Intervention 1: Sleeping Position 1||2
10582134|NCT01719224|11737395|FG000|STARTED|Intervention 2: Position Change(At 3.5h)||14
10582135|NCT01719224|11737396|FG001|STARTED|Intervention 2: Position Change(At 3.5h)||16
10582136|NCT01719224|11737395|FG000|COMPLETED|Intervention 2: Position Change(At 3.5h)||14
10582137|NCT01719224|11737396|FG001|COMPLETED|Intervention 2: Position Change(At 3.5h)||16
10582138|NCT01719224|11737395|FG000|NOT COMPLETED|Intervention 2: Position Change(At 3.5h)||0
10582139|NCT01719224|11737396|FG001|NOT COMPLETED|Intervention 2: Position Change(At 3.5h)||0
10582140|NCT01719367|11737405|FG000|STARTED|Overall Study||19
10582141|NCT01719367|11737406|FG001|STARTED|Overall Study||19
10582142|NCT01719367|11737405|FG000|COMPLETED|Overall Study||19
10582143|NCT01719367|11737406|FG001|COMPLETED|Overall Study||19
10582144|NCT01719367|11737405|FG000|NOT COMPLETED|Overall Study||0
10582145|NCT01719367|11737406|FG001|NOT COMPLETED|Overall Study||0
10582146|NCT01719380|11737422|FG000|STARTED|Overall Study||2
10582147|NCT01719380|11737423|FG001|STARTED|Overall Study||7
10582148|NCT01719380|11737424|FG002|STARTED|Overall Study||9
10582149|NCT01719380|11737425|FG003|STARTED|Overall Study||8
10582150|NCT01719380|11737426|FG004|STARTED|Overall Study||3
10582151|NCT01719380|11737427|FG005|STARTED|Overall Study||8
10582152|NCT01719380|11737428|FG006|STARTED|Overall Study||10
10582153|NCT01719380|11737429|FG007|STARTED|Overall Study||7
10582154|NCT01719380|11737430|FG008|STARTED|Overall Study||50
10582155|NCT01719380|11737431|FG009|STARTED|Overall Study||52
10582156|NCT01719380|11737422|FG000|COMPLETED|Overall Study||0
10582157|NCT01719380|11737423|FG001|COMPLETED|Overall Study||0
10582158|NCT01719380|11737424|FG002|COMPLETED|Overall Study||0
10582159|NCT01719380|11737425|FG003|COMPLETED|Overall Study||0
10582160|NCT01719380|11737426|FG004|COMPLETED|Overall Study||0
10582161|NCT01719380|11737427|FG005|COMPLETED|Overall Study||0
10582162|NCT01719380|11737428|FG006|COMPLETED|Overall Study||0
10582163|NCT01719380|11737429|FG007|COMPLETED|Overall Study||0
10582164|NCT01719380|11737430|FG008|COMPLETED|Overall Study||0
10582165|NCT01719380|11737431|FG009|COMPLETED|Overall Study||1
10582166|NCT01719380|11737422|FG000|NOT COMPLETED|Overall Study||2
10582167|NCT01719380|11737423|FG001|NOT COMPLETED|Overall Study||7
10582168|NCT01719380|11737424|FG002|NOT COMPLETED|Overall Study||9
10582169|NCT01719380|11737425|FG003|NOT COMPLETED|Overall Study||8
10582170|NCT01719380|11737426|FG004|NOT COMPLETED|Overall Study||3
10582171|NCT01719380|11737427|FG005|NOT COMPLETED|Overall Study||8
10582172|NCT01719380|11737428|FG006|NOT COMPLETED|Overall Study||10
10582173|NCT01719380|11737429|FG007|NOT COMPLETED|Overall Study||7
10582174|NCT01719380|11737430|FG008|NOT COMPLETED|Overall Study||50
10582175|NCT01719380|11737431|FG009|NOT COMPLETED|Overall Study||51
10582176|NCT01719653|11737465|FG000|STARTED|Overall Study||209
10582177|NCT01719653|11737466|FG001|STARTED|Overall Study||213
10582178|NCT01719653|11737467|FG002|STARTED|Overall Study||218
10582179|NCT01719653|11737468|FG003|STARTED|Overall Study||218
10582180|NCT01719653|11737469|FG004|STARTED|Overall Study||221
10582181|NCT01719653|11737465|FG000|COMPLETED|Overall Study||200
10582182|NCT01719653|11737466|FG001|COMPLETED|Overall Study||200
10582183|NCT01719653|11737467|FG002|COMPLETED|Overall Study||200
10582184|NCT01719653|11737468|FG003|COMPLETED|Overall Study||200
10582185|NCT01719653|11737469|FG004|COMPLETED|Overall Study||200
10582186|NCT01719653|11737465|FG000|NOT COMPLETED|Overall Study||9
10582187|NCT01719653|11737466|FG001|NOT COMPLETED|Overall Study||13
10582188|NCT01719653|11737467|FG002|NOT COMPLETED|Overall Study||18
10582189|NCT01719653|11737468|FG003|NOT COMPLETED|Overall Study||18
10582190|NCT01719653|11737469|FG004|NOT COMPLETED|Overall Study||21
10582191|NCT01719757|11737481|FG000|STARTED|Overall Study||359
10582192|NCT01719757|11737481|FG000|COMPLETED|Overall Study||258
10582193|NCT01719757|11737481|FG000|NOT COMPLETED|Overall Study||101
10582194|NCT01719783|11737489|FG000|STARTED|Dose 1||30
10582195|NCT01719783|11737490|FG001|STARTED|Dose 1||10
10582196|NCT01719783|11737489|FG000|COMPLETED|Dose 1||30
10582197|NCT01719783|11737490|FG001|COMPLETED|Dose 1||10
10582198|NCT01719783|11737489|FG000|NOT COMPLETED|Dose 1||0
10582199|NCT01719783|11737490|FG001|NOT COMPLETED|Dose 1||0
10582200|NCT01719783|11737489|FG000|STARTED|Dose 2||30
10582201|NCT01719783|11737490|FG001|STARTED|Dose 2||10
10582202|NCT01719783|11737489|FG000|COMPLETED|Dose 2||29
10582203|NCT01719783|11737490|FG001|COMPLETED|Dose 2||10
10582204|NCT01719783|11737489|FG000|NOT COMPLETED|Dose 2||1
10582205|NCT01719783|11737490|FG001|NOT COMPLETED|Dose 2||0
10582206|NCT01719861|11737516|FG000|STARTED|Cycle 1||6
10582207|NCT01719861|11737516|FG000|COMPLETED|Cycle 1||2
10582208|NCT01719861|11737516|FG000|NOT COMPLETED|Cycle 1||4
10582209|NCT01719861|11737516|FG000|STARTED|Cycle 2||2
10582210|NCT01719861|11737516|FG000|COMPLETED|Cycle 2||1
10582211|NCT01719861|11737516|FG000|NOT COMPLETED|Cycle 2||1
10582212|NCT01719900|11737523|FG000|STARTED|Overall Study||29
10582213|NCT01719900|11737524|FG001|STARTED|Overall Study||24
10582214|NCT01719900|11737523|FG000|COMPLETED|Overall Study||22
10582215|NCT01719900|11737524|FG001|COMPLETED|Overall Study||22
10582216|NCT01719900|11737523|FG000|NOT COMPLETED|Overall Study||7
10582217|NCT01719900|11737524|FG001|NOT COMPLETED|Overall Study||2
10582218|NCT01720043|11737530|FG000|STARTED|Overall Study||8
10582219|NCT01720043|11737530|FG000|COMPLETED|Overall Study||7
10582220|NCT01720043|11737530|FG000|NOT COMPLETED|Overall Study||1
10582221|NCT01720069|11737537|FG000|STARTED|Overall Study||62
10582222|NCT01720069|11737538|FG001|STARTED|Overall Study||71
10582223|NCT01720069|11737539|FG002|STARTED|Overall Study||63
10582224|NCT01720069|11737537|FG000|Full Anaylsis Set|Overall Study||62
10582225|NCT01720069|11737538|FG001|Full Anaylsis Set|Overall Study||71
10582226|NCT01720069|11737539|FG002|Full Anaylsis Set|Overall Study||63
10582227|NCT01720069|11737537|FG000|COMPLETED|Overall Study||57
10582228|NCT01720069|11737538|FG001|COMPLETED|Overall Study||56
10806575|NCT03954444|11968142|FG001|STARTED|Overall Study||382
10806576|NCT03954444|11968143|FG002|STARTED|Overall Study||344
10806577|NCT03954444|11968141|FG000|COMPLETED|Overall Study||366
10806578|NCT03954444|11968142|FG001|COMPLETED|Overall Study||366
10806579|NCT03954444|11968143|FG002|COMPLETED|Overall Study||327
10806580|NCT03954444|11968141|FG000|NOT COMPLETED|Overall Study||13
10806581|NCT03954444|11968142|FG001|NOT COMPLETED|Overall Study||16
10806582|NCT03954444|11968143|FG002|NOT COMPLETED|Overall Study||17
10806583|NCT03953820|11968151|FG000|STARTED|Two-Sequence, Two-Way Crossover||15
10806584|NCT03953820|11968152|FG001|STARTED|Two-Sequence, Two-Way Crossover||16
10806585|NCT03953820|11968153|FG002|STARTED|Two-Sequence, Two-Way Crossover||0
10806586|NCT03953820|11968151|FG000|COMPLETED|Two-Sequence, Two-Way Crossover||13
10806587|NCT03953820|11968152|FG001|COMPLETED|Two-Sequence, Two-Way Crossover||16
10806588|NCT03953820|11968153|FG002|COMPLETED|Two-Sequence, Two-Way Crossover||0
10806589|NCT03953820|11968151|FG000|NOT COMPLETED|Two-Sequence, Two-Way Crossover||2
10806590|NCT03953820|11968152|FG001|NOT COMPLETED|Two-Sequence, Two-Way Crossover||0
10806591|NCT03953820|11968153|FG002|NOT COMPLETED|Two-Sequence, Two-Way Crossover||0
10806592|NCT03953820|11968151|FG000|STARTED|DBF Following High-Fat Meal|This arm did not continue in Period 2.|0
10806593|NCT03953820|11968152|FG001|STARTED|DBF Following High-Fat Meal|This arm did not continue in Period 2.|0
10806594|NCT03953820|11968153|FG002|STARTED|DBF Following High-Fat Meal|Participants in Period 2 completed 1 of the 2 arms in Period 1 and volunteered to continue.|10
10806595|NCT03953820|11968151|FG000|COMPLETED|DBF Following High-Fat Meal||0
10806596|NCT03953820|11968152|FG001|COMPLETED|DBF Following High-Fat Meal||0
10806597|NCT03953820|11968153|FG002|COMPLETED|DBF Following High-Fat Meal||10
10806598|NCT03953820|11968151|FG000|NOT COMPLETED|DBF Following High-Fat Meal||0
10806599|NCT03953820|11968152|FG001|NOT COMPLETED|DBF Following High-Fat Meal||0
10806600|NCT03953820|11968153|FG002|NOT COMPLETED|DBF Following High-Fat Meal||0
10806607|NCT03961100|11968176|FG000|STARTED|Part 1||5
10806608|NCT03961100|11968177|FG001|STARTED|Part 1||5
10806609|NCT03961100|11968178|FG002|STARTED|Part 1||5
10806610|NCT03961100|11968179|FG003|STARTED|Part 1||0
10806611|NCT03961100|11968180|FG004|STARTED|Part 1||0
10806612|NCT03961100|11968176|FG000|COMPLETED|Part 1||5
10806613|NCT03961100|11968177|FG001|COMPLETED|Part 1||5
10806614|NCT03961100|11968178|FG002|COMPLETED|Part 1||5
10806615|NCT03961100|11968179|FG003|COMPLETED|Part 1||0
10806616|NCT03961100|11968180|FG004|COMPLETED|Part 1||0
10806617|NCT03961100|11968176|FG000|NOT COMPLETED|Part 1||0
10806618|NCT03961100|11968177|FG001|NOT COMPLETED|Part 1||0
10806619|NCT03961100|11968178|FG002|NOT COMPLETED|Part 1||0
10806620|NCT03961100|11968179|FG003|NOT COMPLETED|Part 1||0
10806621|NCT03961100|11968180|FG004|NOT COMPLETED|Part 1||0
10806622|NCT03961100|11968176|FG000|STARTED|Part 2||0
10806623|NCT03961100|11968177|FG001|STARTED|Part 2||0
10806624|NCT03961100|11968178|FG002|STARTED|Part 2||0
10806625|NCT03961100|11968179|FG003|STARTED|Part 2||8
10806626|NCT03961100|11968180|FG004|STARTED|Part 2||8
10806627|NCT03961100|11968176|FG000|COMPLETED|Part 2||0
10806628|NCT03961100|11968177|FG001|COMPLETED|Part 2||0
10806629|NCT03961100|11968178|FG002|COMPLETED|Part 2||0
10806630|NCT03961100|11968179|FG003|COMPLETED|Part 2||8
10806631|NCT03961100|11968180|FG004|COMPLETED|Part 2||8
10806632|NCT03961100|11968176|FG000|NOT COMPLETED|Part 2||0
10806633|NCT03961100|11968177|FG001|NOT COMPLETED|Part 2||0
10333727|NCT00335283|11469908|FG001|COMPLETED|Overall Study||34
10333728|NCT00335283|11469907|FG000|NOT COMPLETED|Overall Study||6
10333729|NCT00335283|11469908|FG001|NOT COMPLETED|Overall Study||5
10333730|NCT00335322|11469917|FG000|STARTED|Overall Study||115
10333731|NCT00335322|11469918|FG001|STARTED|Overall Study||107
10582229|NCT01720069|11737539|FG002|COMPLETED|Overall Study||48
10806634|NCT03961100|11968178|FG002|NOT COMPLETED|Part 2||0
10806635|NCT03961100|11968179|FG003|NOT COMPLETED|Part 2||0
10582230|NCT01720069|11737537|FG000|NOT COMPLETED|Overall Study||5
10582231|NCT01720069|11737538|FG001|NOT COMPLETED|Overall Study||15
10582232|NCT01720069|11737539|FG002|NOT COMPLETED|Overall Study||15
10582233|NCT01720173|11737547|FG000|STARTED|Overall Study||30
10582234|NCT01720173|11737547|FG000|COMPLETED|Overall Study||30
10582235|NCT01720173|11737547|FG000|NOT COMPLETED|Overall Study||0
10806636|NCT03961100|11968180|FG004|NOT COMPLETED|Part 2||0
10806637|NCT03950856|11968196|FG000|STARTED|Overall Study||702
10806638|NCT03950856|11968197|FG001|STARTED|Overall Study||704
10806639|NCT03950856|11968198|FG002|STARTED|Overall Study||701
10806640|NCT03950856|11968199|FG003|STARTED|Overall Study||233
10806641|NCT03950856|11968196|FG000|Vaccinated|Overall Study||698
10806642|NCT03950856|11968197|FG001|Vaccinated|Overall Study||704
10806643|NCT03950856|11968198|FG002|Vaccinated|Overall Study||700
10806644|NCT03950856|11968199|FG003|Vaccinated|Overall Study||231
10806645|NCT03950856|11968196|FG000|COMPLETED|Overall Study||683
10806646|NCT03950856|11968197|FG001|COMPLETED|Overall Study||689
10806647|NCT03950856|11968198|FG002|COMPLETED|Overall Study||683
10806648|NCT03950856|11968199|FG003|COMPLETED|Overall Study||227
10806649|NCT03950856|11968196|FG000|NOT COMPLETED|Overall Study||19
10333732|NCT00335322|11469919|FG002|STARTED|Overall Study||105
10806650|NCT03950856|11968197|FG001|NOT COMPLETED|Overall Study||15
10806651|NCT03950856|11968198|FG002|NOT COMPLETED|Overall Study||18
10806652|NCT03950856|11968199|FG003|NOT COMPLETED|Overall Study||6
10582236|NCT01720225|11737553|FG000|STARTED|Overall Study||73
10582237|NCT01720225|11737554|FG001|STARTED|Overall Study||40
10582238|NCT01720225|11737553|FG000|COMPLETED|Overall Study||70
10582239|NCT01720225|11737554|FG001|COMPLETED|Overall Study||39
10582240|NCT01720225|11737553|FG000|NOT COMPLETED|Overall Study||3
10582241|NCT01720225|11737554|FG001|NOT COMPLETED|Overall Study||1
10582242|NCT01720251|11737563|FG000|STARTED|Overall Study||79
10582243|NCT01720251|11737564|FG001|STARTED|Overall Study||79
10582244|NCT01720251|11737565|FG002|STARTED|Overall Study||82
10582245|NCT01720251|11737563|FG000|COMPLETED|Overall Study||78
10582246|NCT01720251|11737564|FG001|COMPLETED|Overall Study||77
10582247|NCT01720251|11737565|FG002|COMPLETED|Overall Study||82
10582248|NCT01720251|11737563|FG000|NOT COMPLETED|Overall Study||1
10582249|NCT01720251|11737564|FG001|NOT COMPLETED|Overall Study||2
10582250|NCT01720251|11737565|FG002|NOT COMPLETED|Overall Study||0
10582251|NCT01720264|11737573|FG000|STARTED|Transplant With Sitagliptin for 15 Days||15
10582252|NCT01720264|11737573|FG000|COMPLETED|Transplant With Sitagliptin for 15 Days||14
10582253|NCT01720264|11737573|FG000|NOT COMPLETED|Transplant With Sitagliptin for 15 Days||1
10582254|NCT01720264|11737573|FG000|STARTED|Post-transplant (Day 16) to 1 Year||14
10582255|NCT01720264|11737573|FG000|COMPLETED|Post-transplant (Day 16) to 1 Year||2
10582256|NCT01720264|11737573|FG000|NOT COMPLETED|Post-transplant (Day 16) to 1 Year||12
10582257|NCT01720277|11737579|FG000|STARTED|Overall Study||1461
10582258|NCT01720277|11737580|FG001|STARTED|Overall Study||1496
10582259|NCT01720277|11737579|FG000|COMPLETED|Overall Study|intent-to-treat approach|958
10582260|NCT01720277|11737580|FG001|COMPLETED|Overall Study|intent-to-treat approach|938
10582261|NCT01720277|11737579|FG000|NOT COMPLETED|Overall Study||503
10582262|NCT01720277|11737580|FG001|NOT COMPLETED|Overall Study||558
10582263|NCT01720316|11737590|FG000|STARTED|Double-Blind Glycine Placebo Crossover||1
10582264|NCT01720316|11737591|FG001|STARTED|Double-Blind Glycine Placebo Crossover||1
10582265|NCT01720316|11737590|FG000|COMPLETED|Double-Blind Glycine Placebo Crossover||1
10582266|NCT01720316|11737591|FG001|COMPLETED|Double-Blind Glycine Placebo Crossover||1
10582267|NCT01720316|11737590|FG000|NOT COMPLETED|Double-Blind Glycine Placebo Crossover||0
10582268|NCT01720316|11737591|FG001|NOT COMPLETED|Double-Blind Glycine Placebo Crossover||0
10582269|NCT01720316|11737590|FG000|STARTED|Open-label Glycine||1
10582270|NCT01720316|11737591|FG001|STARTED|Open-label Glycine||1
10582271|NCT01720316|11737590|FG000|COMPLETED|Open-label Glycine||1
10582272|NCT01720316|11737591|FG001|COMPLETED|Open-label Glycine||1
10582273|NCT01720316|11737590|FG000|NOT COMPLETED|Open-label Glycine||0
10582274|NCT01720316|11737591|FG001|NOT COMPLETED|Open-label Glycine||0
10582275|NCT01720446|11737627|FG000|STARTED|Overall Study||826
10582276|NCT01720446|11737628|FG001|STARTED|Overall Study||822
10582277|NCT01720446|11737629|FG002|STARTED|Overall Study||824
10582278|NCT01720446|11737630|FG003|STARTED|Overall Study||825
10582279|NCT01720446|11737627|FG000|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|164
10582280|NCT01720446|11737628|FG001|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|186
10582281|NCT01720446|11737629|FG002|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|151
10582282|NCT01720446|11737630|FG003|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|159
10582283|NCT01720446|11737627|FG000|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|812
10582284|NCT01720446|11737628|FG001|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|811
10582285|NCT01720446|11737629|FG002|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|804
10582286|NCT01720446|11737630|FG003|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|805
10582287|NCT01720446|11737627|FG000|NOT COMPLETED|Overall Study||14
10582288|NCT01720446|11737628|FG001|NOT COMPLETED|Overall Study||11
10582289|NCT01720446|11737629|FG002|NOT COMPLETED|Overall Study||20
10582290|NCT01720446|11737630|FG003|NOT COMPLETED|Overall Study||20
10582291|NCT01720524|11737645|FG000|STARTED|Part A||29
10582292|NCT01720524|11737646|FG001|STARTED|Part A||30
10582293|NCT01720524|11737645|FG000|COMPLETED|Part A||22
10582294|NCT01720524|11737646|FG001|COMPLETED|Part A||18
10582295|NCT01720524|11737645|FG000|NOT COMPLETED|Part A||7
10582296|NCT01720524|11737646|FG001|NOT COMPLETED|Part A||12
10582297|NCT01720524|11737645|FG000|STARTED|Part B|Participants who did not complete Part A could also participate in Part B.|27
10582298|NCT01720524|11737646|FG001|STARTED|Part B|Participants who did not complete Part A could also participate in Part B.|26
10582299|NCT01720524|11737645|FG000|COMPLETED|Part B||22
10582300|NCT01720524|11737646|FG001|COMPLETED|Part B||17
10582301|NCT01720524|11737645|FG000|NOT COMPLETED|Part B||5
10582302|NCT01720524|11737646|FG001|NOT COMPLETED|Part B||9
10582303|NCT01720602|11737654|FG000|STARTED|Overall Study||15
10582304|NCT01720602|11737654|FG000|COMPLETED|Overall Study||10
10582305|NCT01720602|11737654|FG000|NOT COMPLETED|Overall Study||5
10582306|NCT01720667|11737660|FG000|STARTED|Overall Study||64
10582307|NCT01720667|11737661|FG001|STARTED|Overall Study||42
10333733|NCT00335322|11469917|FG000|COMPLETED|Overall Study||114
10333734|NCT00335322|11469918|FG001|COMPLETED|Overall Study||105
10333735|NCT00335322|11469919|FG002|COMPLETED|Overall Study||103
10333736|NCT00335322|11469917|FG000|NOT COMPLETED|Overall Study||1
10333737|NCT00335322|11469918|FG001|NOT COMPLETED|Overall Study||2
10333738|NCT00335322|11469919|FG002|NOT COMPLETED|Overall Study||2
10333739|NCT00335452|11469934|FG000|STARTED|Overall Study|Randomized|6312
10333740|NCT00335452|11469935|FG001|STARTED|Overall Study|Randomized|6254
10582308|NCT01720667|11737660|FG000|Recieved Second Infusion of Same Drug|Overall Study||50
10582309|NCT01720667|11737661|FG001|Recieved Second Infusion of Same Drug|Overall Study||20
10582310|NCT01720667|11737660|FG000|Recieved Alternate Intervention|Overall Study||45
10582311|NCT01720667|11737661|FG001|Recieved Alternate Intervention|Overall Study||10
10582312|NCT01720667|11737660|FG000|Received 2nd Infusion of Alternate Drug|Overall Study||27
10582313|NCT01720667|11737661|FG001|Received 2nd Infusion of Alternate Drug|Overall Study||6
10582314|NCT01720667|11737660|FG000|Modified ITT|Overall Study||53
10582315|NCT01720667|11737661|FG001|Modified ITT|Overall Study||30
10582316|NCT01720667|11737660|FG000|COMPLETED|Overall Study||60
10582317|NCT01720667|11737661|FG001|COMPLETED|Overall Study||41
10582318|NCT01720667|11737660|FG000|NOT COMPLETED|Overall Study||4
10582319|NCT01720667|11737661|FG001|NOT COMPLETED|Overall Study||1
10582320|NCT01720797|11737671|FG000|STARTED|Overall Study||12
10582321|NCT01720797|11737672|FG001|STARTED|Overall Study||9
10582322|NCT01720797|11737671|FG000|COMPLETED|Overall Study||9
10582323|NCT01720797|11737672|FG001|COMPLETED|Overall Study||9
10582324|NCT01720797|11737671|FG000|NOT COMPLETED|Overall Study||3
10582325|NCT01720797|11737672|FG001|NOT COMPLETED|Overall Study||0
10582326|NCT01721044|11737681|FG000|STARTED|Treatment Period||176
10582327|NCT01721044|11737682|FG001|STARTED|Treatment Period|Randomized to 4mg (N=11) but received 2mg due to moderate renal impairment were included in 4mg arm|174
10582328|NCT01721044|11737683|FG002|STARTED|Treatment Period||177
10582329|NCT01721044|11737681|FG000|Rescue Week 16-24|Treatment Period||56
10582330|NCT01721044|11737682|FG001|Rescue Week 16-24|Treatment Period||38
10582331|NCT01721044|11737683|FG002|Rescue Week 16-24|Treatment Period||33
10582332|NCT01721044|11737681|FG000|COMPLETED|Treatment Period||144
10582333|NCT01721044|11737682|FG001|COMPLETED|Treatment Period||157
10582334|NCT01721044|11737683|FG002|COMPLETED|Treatment Period||158
10582335|NCT01721044|11737681|FG000|NOT COMPLETED|Treatment Period||32
10582336|NCT01721044|11737682|FG001|NOT COMPLETED|Treatment Period||17
10582337|NCT01721044|11737683|FG002|NOT COMPLETED|Treatment Period||19
10582338|NCT01721044|11737681|FG000|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|19
10582339|NCT01721044|11737682|FG001|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|9
10582340|NCT01721044|11737683|FG002|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|20
10582341|NCT01721044|11737681|FG000|COMPLETED|Follow Up||19
10582342|NCT01721044|11737682|FG001|COMPLETED|Follow Up||9
10582343|NCT01721044|11737683|FG002|COMPLETED|Follow Up||20
10582344|NCT01721044|11737681|FG000|NOT COMPLETED|Follow Up||0
10582345|NCT01721044|11737682|FG001|NOT COMPLETED|Follow Up||0
10582346|NCT01721044|11737683|FG002|NOT COMPLETED|Follow Up||0
10582347|NCT01721057|11737705|FG000|STARTED|Treatment Period||228
10582348|NCT01721057|11737706|FG001|STARTED|Treatment Period||229
10582349|NCT01721057|11737707|FG002|STARTED|Treatment Period||227
10582350|NCT01721057|11737708|FG003|STARTED|Treatment Period||0
10582351|NCT01721057|11737709|FG004|STARTED|Treatment Period||0
10582352|NCT01721057|11737710|FG005|STARTED|Treatment Period||0
10582353|NCT01721057|11737711|FG006|STARTED|Treatment Period||0
10582354|NCT01721057|11737705|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||228
10582355|NCT01721057|11737706|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||229
10582356|NCT01721057|11737707|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||227
10582357|NCT01721057|11737708|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||0
10582358|NCT01721057|11737709|FG004|Received at Least 1 Dose of Study Drug|Treatment Period||0
10582359|NCT01721057|11737710|FG005|Received at Least 1 Dose of Study Drug|Treatment Period||0
10582360|NCT01721057|11737711|FG006|Received at Least 1 Dose of Study Drug|Treatment Period||0
10582361|NCT01721057|11737705|FG000|Rescued|Treatment Period||55
10582362|NCT01721057|11737706|FG001|Rescued|Treatment Period||21
10582363|NCT01721057|11737707|FG002|Rescued|Treatment Period||15
10582364|NCT01721057|11737708|FG003|Rescued|Treatment Period||0
10582365|NCT01721057|11737709|FG004|Rescued|Treatment Period||0
10582366|NCT01721057|11737710|FG005|Rescued|Treatment Period||0
10582367|NCT01721057|11737711|FG006|Rescued|Treatment Period||0
10582368|NCT01721057|11737705|FG000|COMPLETED|Treatment Period|"Completers include rescued participants."|200
10582369|NCT01721057|11737706|FG001|COMPLETED|Treatment Period|"Completers include rescued participants."|210
10582370|NCT01721057|11737707|FG002|COMPLETED|Treatment Period|"Completers include rescued participants."|204
10582371|NCT01721057|11737708|FG003|COMPLETED|Treatment Period||0
10582372|NCT01721057|11737709|FG004|COMPLETED|Treatment Period||0
10582373|NCT01721057|11737710|FG005|COMPLETED|Treatment Period||0
10582374|NCT01721057|11737711|FG006|COMPLETED|Treatment Period||0
10582375|NCT01721057|11737705|FG000|NOT COMPLETED|Treatment Period||28
10582376|NCT01721057|11737706|FG001|NOT COMPLETED|Treatment Period||19
10582377|NCT01721057|11737707|FG002|NOT COMPLETED|Treatment Period||23
10582378|NCT01721057|11737708|FG003|NOT COMPLETED|Treatment Period||0
10582379|NCT01721057|11737709|FG004|NOT COMPLETED|Treatment Period||0
10582380|NCT01721057|11737710|FG005|NOT COMPLETED|Treatment Period||0
10582381|NCT01721057|11737711|FG006|NOT COMPLETED|Treatment Period||0
10582382|NCT01721057|11737705|FG000|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
10582383|NCT01721057|11737706|FG001|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
10582384|NCT01721057|11737707|FG002|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
10582385|NCT01721057|11737708|FG003|STARTED|Rescue Period|Participants who were determined to be nonresponders based on tender/swollen joint count.|91
10582386|NCT01721057|11737709|FG004|STARTED|Rescue Period||0
10582387|NCT01721057|11737710|FG005|STARTED|Rescue Period||0
10582388|NCT01721057|11737711|FG006|STARTED|Rescue Period||0
10582389|NCT01721057|11737705|FG000|COMPLETED|Rescue Period||0
10582390|NCT01721057|11737706|FG001|COMPLETED|Rescue Period||0
10582391|NCT01721057|11737707|FG002|COMPLETED|Rescue Period||0
10582392|NCT01721057|11737708|FG003|COMPLETED|Rescue Period||88
10582393|NCT01721057|11737709|FG004|COMPLETED|Rescue Period||0
10582394|NCT01721057|11737710|FG005|COMPLETED|Rescue Period||0
10582395|NCT01721057|11737711|FG006|COMPLETED|Rescue Period||0
10582396|NCT01721057|11737705|FG000|NOT COMPLETED|Rescue Period||0
10582397|NCT01721057|11737706|FG001|NOT COMPLETED|Rescue Period||0
10582398|NCT01721057|11737707|FG002|NOT COMPLETED|Rescue Period||0
10806653|NCT03947983|11968213|FG000|STARTED|Overall Study||19
10806654|NCT03947983|11968214|FG001|STARTED|Overall Study||19
10806655|NCT03947983|11968213|FG000|12 Weeks|Overall Study||15
10806656|NCT03947983|11968214|FG001|12 Weeks|Overall Study||17
10806657|NCT03947983|11968213|FG000|COMPLETED|Overall Study||14
10806658|NCT03947983|11968214|FG001|COMPLETED|Overall Study||13
10806659|NCT03947983|11968213|FG000|NOT COMPLETED|Overall Study||5
10806660|NCT03947983|11968214|FG001|NOT COMPLETED|Overall Study||6
10806661|NCT03960658|11968220|FG000|STARTED|Overall Study||12
10806662|NCT03960658|11968220|FG000|COMPLETED|Overall Study||10
10806663|NCT03960658|11968220|FG000|NOT COMPLETED|Overall Study||2
10806664|NCT03959332|11968226|FG000|STARTED|Overall Study||16
10806665|NCT03959332|11968227|FG001|STARTED|Overall Study||16
10806666|NCT03959332|11968226|FG000|COMPLETED|Overall Study||16
10806667|NCT03959332|11968227|FG001|COMPLETED|Overall Study||16
10806668|NCT03959332|11968226|FG000|NOT COMPLETED|Overall Study||0
10806669|NCT03959332|11968227|FG001|NOT COMPLETED|Overall Study||0
10806670|NCT03959189|11968235|FG000|STARTED|Overall Study||7
10806671|NCT03959189|11968236|FG001|STARTED|Overall Study||5
10806672|NCT03959189|11968235|FG000|COMPLETED|Overall Study||7
10806673|NCT03959189|11968236|FG001|COMPLETED|Overall Study||5
10806674|NCT03959189|11968235|FG000|NOT COMPLETED|Overall Study||0
10806675|NCT03959189|11968236|FG001|NOT COMPLETED|Overall Study||0
10806676|NCT03956550|11968252|FG000|STARTED|Overall Study||88
10806677|NCT03956550|11968253|FG001|STARTED|Overall Study||86
10806678|NCT03956550|11968254|FG002|STARTED|Overall Study||85
10806679|NCT03956550|11968252|FG000|COMPLETED|Overall Study||18
10806680|NCT03956550|11968253|FG001|COMPLETED|Overall Study||14
10806681|NCT03956550|11968254|FG002|COMPLETED|Overall Study||15
10806682|NCT03956550|11968252|FG000|NOT COMPLETED|Overall Study||70
10806683|NCT03956550|11968253|FG001|NOT COMPLETED|Overall Study||72
10806684|NCT03956550|11968254|FG002|NOT COMPLETED|Overall Study||70
10806685|NCT03954158|11968266|FG000|STARTED|Overall Study||20
10806686|NCT03954158|11968267|FG001|STARTED|Overall Study||21
10806687|NCT03954158|11968268|FG002|STARTED|Overall Study||20
10806688|NCT03954158|11968269|FG003|STARTED|Overall Study||20
10806689|NCT03954158|11968266|FG000|COMPLETED|Overall Study||20
10806690|NCT03954158|11968267|FG001|COMPLETED|Overall Study||21
10806691|NCT03954158|11968268|FG002|COMPLETED|Overall Study||20
10806692|NCT03954158|11968269|FG003|COMPLETED|Overall Study||20
10806693|NCT03954158|11968266|FG000|NOT COMPLETED|Overall Study||0
10806694|NCT03954158|11968267|FG001|NOT COMPLETED|Overall Study||0
10806695|NCT03954158|11968268|FG002|NOT COMPLETED|Overall Study||0
10806696|NCT03954158|11968269|FG003|NOT COMPLETED|Overall Study||0
10806697|NCT03958656|11968306|FG000|STARTED|Overall Study||3
10806698|NCT03958656|11968307|FG001|STARTED|Overall Study||4
10806699|NCT03958656|11968308|FG002|STARTED|Overall Study||5
10582399|NCT01721057|11737708|FG003|NOT COMPLETED|Rescue Period||3
10582400|NCT01721057|11737709|FG004|NOT COMPLETED|Rescue Period||0
10582401|NCT01721057|11737710|FG005|NOT COMPLETED|Rescue Period||0
10582402|NCT01721057|11737711|FG006|NOT COMPLETED|Rescue Period||0
10582403|NCT01721057|11737705|FG000|STARTED|Follow Up||0
10582404|NCT01721057|11737706|FG001|STARTED|Follow Up||0
10582405|NCT01721057|11737707|FG002|STARTED|Follow Up||0
10582406|NCT01721057|11737708|FG003|STARTED|Follow Up|Rescued participants who entered post-treatment follow-up are included in Baricitinib 4 mg FollowUp|0
10582407|NCT01721057|11737709|FG004|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|17
10582408|NCT01721057|11737710|FG005|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|19
10582409|NCT01721057|11737711|FG006|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|22
10582410|NCT01721057|11737705|FG000|COMPLETED|Follow Up||0
10582411|NCT01721057|11737706|FG001|COMPLETED|Follow Up||0
10582412|NCT01721057|11737707|FG002|COMPLETED|Follow Up||0
10582413|NCT01721057|11737708|FG003|COMPLETED|Follow Up||0
10582414|NCT01721057|11737709|FG004|COMPLETED|Follow Up||17
10582415|NCT01721057|11737710|FG005|COMPLETED|Follow Up||19
10582416|NCT01721057|11737711|FG006|COMPLETED|Follow Up||22
10582417|NCT01721057|11737705|FG000|NOT COMPLETED|Follow Up||0
10582418|NCT01721057|11737706|FG001|NOT COMPLETED|Follow Up||0
10582419|NCT01721057|11737707|FG002|NOT COMPLETED|Follow Up||0
10582420|NCT01721057|11737708|FG003|NOT COMPLETED|Follow Up||0
10582421|NCT01721057|11737709|FG004|NOT COMPLETED|Follow Up||0
10582422|NCT01721057|11737710|FG005|NOT COMPLETED|Follow Up||0
10582423|NCT01721057|11737711|FG006|NOT COMPLETED|Follow Up||0
10806700|NCT03958656|11968309|FG003|STARTED|Overall Study||1
10806701|NCT03958656|11968306|FG000|COMPLETED|Overall Study||3
10806702|NCT03958656|11968307|FG001|COMPLETED|Overall Study||3
10806703|NCT03958656|11968308|FG002|COMPLETED|Overall Study||3
10806704|NCT03958656|11968309|FG003|COMPLETED|Overall Study||1
10806705|NCT03958656|11968306|FG000|NOT COMPLETED|Overall Study||0
10582424|NCT01721070|11737738|FG000|STARTED|SUF NT 15 mcg||19
10582425|NCT01721070|11737738|FG000|COMPLETED|SUF NT 15 mcg||19
10582426|NCT01721070|11737738|FG000|NOT COMPLETED|SUF NT 15 mcg||0
10582427|NCT01721070|11737738|FG000|STARTED|Ketoconazole 400 mg and SUF NT 15 mcg||19
10582428|NCT01721070|11737738|FG000|COMPLETED|Ketoconazole 400 mg and SUF NT 15 mcg||18
10582429|NCT01721070|11737738|FG000|NOT COMPLETED|Ketoconazole 400 mg and SUF NT 15 mcg||1
10582430|NCT01721096|11737747|FG000|STARTED|Overall Study||323
10582431|NCT01721096|11737748|FG001|STARTED|Overall Study||213
10582432|NCT01721096|11737747|FG000|COMPLETED|Overall Study||3
10582433|NCT01721096|11737748|FG001|COMPLETED|Overall Study||9
10582434|NCT01721096|11737747|FG000|NOT COMPLETED|Overall Study||320
10582435|NCT01721096|11737748|FG001|NOT COMPLETED|Overall Study||204
10582436|NCT01721109|11737756|FG000|STARTED|Overall Study||50
10582437|NCT01721109|11737756|FG000|COMPLETED|Overall Study|34 participants transitioned to commercial Stribild or to an individual patient use (IPU) program|43
10582438|NCT01721109|11737756|FG000|NOT COMPLETED|Overall Study||7
10582439|NCT01721161|11737762|FG000|STARTED|Overall Study||41
10582440|NCT01721161|11737763|FG001|STARTED|Overall Study||41
10582441|NCT01721161|11737762|FG000|COMPLETED|Overall Study||37
10582442|NCT01721161|11737763|FG001|COMPLETED|Overall Study||34
10582443|NCT01721161|11737762|FG000|NOT COMPLETED|Overall Study||4
10582444|NCT01721161|11737763|FG001|NOT COMPLETED|Overall Study||7
10582445|NCT01721200|11737772|FG000|STARTED|Overall Study||62
10582446|NCT01721200|11737773|FG001|STARTED|Overall Study||63
10582447|NCT01721200|11737772|FG000|Completed 2 Week Follow-up|Overall Study||60
10582448|NCT01721200|11737773|FG001|Completed 2 Week Follow-up|Overall Study||61
10582449|NCT01721200|11737772|FG000|COMPLETED|Overall Study||59
10582450|NCT01721200|11737773|FG001|COMPLETED|Overall Study||58
10582451|NCT01721200|11737772|FG000|NOT COMPLETED|Overall Study||3
10582452|NCT01721200|11737773|FG001|NOT COMPLETED|Overall Study||5
10582453|NCT01721226|11737786|FG000|STARTED|Overall Study||55
10582454|NCT01721226|11737787|FG001|STARTED|Overall Study||57
10582455|NCT01721226|11737786|FG000|Baseline|Overall Study||53
10582456|NCT01721226|11737787|FG001|Baseline|Overall Study||57
10582457|NCT01721226|11737786|FG000|Week 12|Overall Study||48
10582458|NCT01721226|11737787|FG001|Week 12|Overall Study||53
10582459|NCT01721226|11737786|FG000|Week 24|Overall Study||50
10582460|NCT01721226|11737787|FG001|Week 24|Overall Study||50
10582461|NCT01721226|11737786|FG000|COMPLETED|Overall Study||50
10582462|NCT01721226|11737787|FG001|COMPLETED|Overall Study||50
10582463|NCT01721226|11737786|FG000|NOT COMPLETED|Overall Study||5
10702764|NCT02577640|11867220|FG003|NOT COMPLETED|Dose Escalation Group 3||0
10702765|NCT02577640|11867217|FG000|STARTED|Maximally Tolerated Dose||0
10702766|NCT02577640|11867218|FG001|STARTED|Maximally Tolerated Dose||0
10702767|NCT02577640|11867219|FG002|STARTED|Maximally Tolerated Dose||0
10702768|NCT02577640|11867220|FG003|STARTED|Maximally Tolerated Dose||1
10702769|NCT02577640|11867217|FG000|COMPLETED|Maximally Tolerated Dose||0
10702770|NCT02577640|11867218|FG001|COMPLETED|Maximally Tolerated Dose||0
10702771|NCT02577640|11867219|FG002|COMPLETED|Maximally Tolerated Dose||0
10702772|NCT02577640|11867220|FG003|COMPLETED|Maximally Tolerated Dose||1
10582464|NCT01721226|11737787|FG001|NOT COMPLETED|Overall Study||7
10582465|NCT01721317|11737795|FG000|STARTED|Overall Study||2
10582466|NCT01721317|11737796|FG001|STARTED|Overall Study||4
10582467|NCT01721317|11737795|FG000|COMPLETED|Overall Study||0
10582468|NCT01721317|11737796|FG001|COMPLETED|Overall Study||0
10582469|NCT01721317|11737795|FG000|NOT COMPLETED|Overall Study||2
10582470|NCT01721317|11737796|FG001|NOT COMPLETED|Overall Study||4
10582471|NCT01721330|11737804|FG000|STARTED|Overall Study||1
10582472|NCT01721330|11737805|FG001|STARTED|Overall Study||2
10582473|NCT01721330|11737804|FG000|COMPLETED|Overall Study||1
10582474|NCT01721330|11737805|FG001|COMPLETED|Overall Study||1
10582475|NCT01721330|11737804|FG000|NOT COMPLETED|Overall Study||0
10582476|NCT01721330|11737805|FG001|NOT COMPLETED|Overall Study||1
10582477|NCT01721369|11737811|FG000|STARTED|Overall Study||581
10582478|NCT01721369|11737811|FG000|COMPLETED|Overall Study||569
10582479|NCT01721369|11737811|FG000|NOT COMPLETED|Overall Study||12
10582480|NCT01721408|11737817|FG000|STARTED|Overall Study|Number of participants treated.|232
10582481|NCT01721408|11737818|FG001|STARTED|Overall Study|Number of participants treated.|231
10582482|NCT01721408|11737817|FG000|COMPLETED|Overall Study||196
10582483|NCT01721408|11737818|FG001|COMPLETED|Overall Study||207
10582484|NCT01721408|11737817|FG000|NOT COMPLETED|Overall Study||36
10582485|NCT01721408|11737818|FG001|NOT COMPLETED|Overall Study||24
10582486|NCT01721447|11737824|FG000|STARTED|Overall Study||100
10582487|NCT01721447|11737824|FG000|COMPLETED|Overall Study||100
10582488|NCT01721447|11737824|FG000|NOT COMPLETED|Overall Study||0
10702773|NCT02577640|11867217|FG000|NOT COMPLETED|Maximally Tolerated Dose||0
10582489|NCT01721460|11737829|FG000|STARTED|Overall Study||6
10582490|NCT01721460|11737829|FG000|COMPLETED|Overall Study||5
10582491|NCT01721460|11737829|FG000|NOT COMPLETED|Overall Study||1
10582492|NCT01721473|11737841|FG000|STARTED|Overall Study||47
10582493|NCT01721473|11737842|FG001|STARTED|Overall Study||22
10582494|NCT01721473|11737843|FG002|STARTED|Overall Study||41
10582495|NCT01721473|11737844|FG003|STARTED|Overall Study||34
10582496|NCT01721473|11737845|FG004|STARTED|Overall Study||22
10582497|NCT01721473|11737846|FG005|STARTED|Overall Study||18
10582498|NCT01721473|11737841|FG000|COMPLETED|Overall Study||47
10582499|NCT01721473|11737842|FG001|COMPLETED|Overall Study||22
10582500|NCT01721473|11737843|FG002|COMPLETED|Overall Study||41
10582501|NCT01721473|11737844|FG003|COMPLETED|Overall Study||34
10582502|NCT01721473|11737845|FG004|COMPLETED|Overall Study||22
10582503|NCT01721473|11737846|FG005|COMPLETED|Overall Study||18
10582504|NCT01721473|11737841|FG000|NOT COMPLETED|Overall Study||0
10582505|NCT01721473|11737842|FG001|NOT COMPLETED|Overall Study||0
10582506|NCT01721473|11737843|FG002|NOT COMPLETED|Overall Study||0
10582507|NCT01721473|11737844|FG003|NOT COMPLETED|Overall Study||0
10582508|NCT01721473|11737845|FG004|NOT COMPLETED|Overall Study||0
10582509|NCT01721473|11737846|FG005|NOT COMPLETED|Overall Study||0
10582510|NCT01721486|11737857|FG000|STARTED|Overall Study||21
10582511|NCT01721486|11737858|FG001|STARTED|Overall Study||20
10582512|NCT01721486|11737857|FG000|COMPLETED|Overall Study||20
10582513|NCT01721486|11737858|FG001|COMPLETED|Overall Study||19
10582514|NCT01721486|11737857|FG000|NOT COMPLETED|Overall Study||1
10582515|NCT01721486|11737858|FG001|NOT COMPLETED|Overall Study||1
10582516|NCT01721564|11737864|FG000|STARTED|Overall Study||8
10582517|NCT01721564|11737864|FG000|COMPLETED|Overall Study||8
10582518|NCT01721564|11737864|FG000|NOT COMPLETED|Overall Study||0
10582519|NCT01721603|11737868|FG000|STARTED|Overall Study||2
10582520|NCT01721603|11737868|FG000|COMPLETED|Overall Study||2
10582521|NCT01721603|11737868|FG000|NOT COMPLETED|Overall Study||0
10582522|NCT01721681|11737872|FG000|STARTED|Overall Study||9
10582523|NCT01721681|11737872|FG000|COMPLETED|Overall Study||9
10582524|NCT01721681|11737872|FG000|NOT COMPLETED|Overall Study||0
10651605|NCT02177032|11811840|FG001|NOT COMPLETED|Overall Study||2
10651606|NCT02177032|11811841|FG002|NOT COMPLETED|Overall Study||3
10651607|NCT02177032|11811842|FG003|NOT COMPLETED|Overall Study||0
10651608|NCT02177123|11811863|FG000|STARTED|Overall Study||107
10651609|NCT02177123|11811863|FG000|COMPLETED|Overall Study||83
10651610|NCT02177123|11811863|FG000|NOT COMPLETED|Overall Study||24
10651611|NCT02177136|11811873|FG000|STARTED|DB Phase||26
10651612|NCT02177136|11811874|FG001|STARTED|DB Phase||26
10651613|NCT02177136|11811875|FG002|STARTED|DB Phase||25
10651614|NCT02177136|11811876|FG003|STARTED|DB Phase||0
10651615|NCT02177136|11811873|FG000|Received At Least 1 Dose Of Study Drug|DB Phase|One participant randomized to receive 1.5 mg OCA titrating to 3 mg OCA withdrew prior to dosing.|25
10651616|NCT02177136|11811874|FG001|Received At Least 1 Dose Of Study Drug|DB Phase||26
10651617|NCT02177136|11811875|FG002|Received At Least 1 Dose Of Study Drug|DB Phase||25
10651618|NCT02177136|11811876|FG003|Received At Least 1 Dose Of Study Drug|DB Phase||0
10651619|NCT02177136|11811873|FG000|COMPLETED|DB Phase||19
10651620|NCT02177136|11811874|FG001|COMPLETED|DB Phase||21
10651621|NCT02177136|11811875|FG002|COMPLETED|DB Phase||21
10651622|NCT02177136|11811876|FG003|COMPLETED|DB Phase||0
10651623|NCT02177136|11811873|FG000|NOT COMPLETED|DB Phase||7
10651624|NCT02177136|11811874|FG001|NOT COMPLETED|DB Phase||5
10651625|NCT02177136|11811875|FG002|NOT COMPLETED|DB Phase||4
10651626|NCT02177136|11811876|FG003|NOT COMPLETED|DB Phase||0
10651627|NCT02177136|11811873|FG000|STARTED|LTSE Phase|Eligible participants who completed the DB phase could enroll in the LTSE phase.|0
10651628|NCT02177136|11811874|FG001|STARTED|LTSE Phase|Eligible participants who completed the DB phase could enroll in the LTSE phase.|0
10651629|NCT02177136|11811875|FG002|STARTED|LTSE Phase|Eligible participants who completed the DB phase could enroll in the LTSE phase.|0
10651630|NCT02177136|11811876|FG003|STARTED|LTSE Phase|Eligible participants who completed the DB phase could enroll in the LTSE phase.|59
10651631|NCT02177136|11811873|FG000|Received At Least 1 Dose Of Study Drug|LTSE Phase||0
10651632|NCT02177136|11811874|FG001|Received At Least 1 Dose Of Study Drug|LTSE Phase||0
10651633|NCT02177136|11811875|FG002|Received At Least 1 Dose Of Study Drug|LTSE Phase||0
10651634|NCT02177136|11811876|FG003|Received At Least 1 Dose Of Study Drug|LTSE Phase||59
10651635|NCT02177136|11811873|FG000|COMPLETED|LTSE Phase||0
10651636|NCT02177136|11811874|FG001|COMPLETED|LTSE Phase||0
10651637|NCT02177136|11811875|FG002|COMPLETED|LTSE Phase||0
10651638|NCT02177136|11811876|FG003|COMPLETED|LTSE Phase||35
10651639|NCT02177136|11811873|FG000|NOT COMPLETED|LTSE Phase||0
10651640|NCT02177136|11811874|FG001|NOT COMPLETED|LTSE Phase||0
10651641|NCT02177136|11811875|FG002|NOT COMPLETED|LTSE Phase||0
10651642|NCT02177136|11811876|FG003|NOT COMPLETED|LTSE Phase||24
10651643|NCT02177201|11811889|FG000|STARTED|Overall Study||80
10651644|NCT02177201|11811890|FG001|STARTED|Overall Study||80
10651645|NCT02177201|11811889|FG000|COMPLETED|Overall Study||77
10702774|NCT02577640|11867218|FG001|NOT COMPLETED|Maximally Tolerated Dose||0
10702775|NCT02577640|11867219|FG002|NOT COMPLETED|Maximally Tolerated Dose||0
10702776|NCT02577640|11867220|FG003|NOT COMPLETED|Maximally Tolerated Dose||0
10702777|NCT02577718|11867232|FG000|STARTED|Overall Study||60
10702778|NCT02577718|11867232|FG000|COMPLETED|Overall Study||52
10651646|NCT02177201|11811890|FG001|COMPLETED|Overall Study||77
10651647|NCT02177201|11811889|FG000|NOT COMPLETED|Overall Study||3
10651648|NCT02177201|11811890|FG001|NOT COMPLETED|Overall Study||3
10651649|NCT02177786|11811900|FG000|STARTED|Overall Study||81
10651650|NCT02177786|11811901|FG001|STARTED|Overall Study||84
10651651|NCT02177786|11811902|FG002|STARTED|Overall Study||84
10651652|NCT02177786|11811903|FG003|STARTED|Overall Study||85
10651653|NCT02177786|11811900|FG000|Randomized and Treated|Overall Study||81
10651654|NCT02177786|11811901|FG001|Randomized and Treated|Overall Study||84
10651655|NCT02177786|11811902|FG002|Randomized and Treated|Overall Study||83
10702779|NCT02577718|11867232|FG000|NOT COMPLETED|Overall Study||8
10651656|NCT02177786|11811903|FG003|Randomized and Treated|Overall Study||85
10651657|NCT02177786|11811900|FG000|COMPLETED|Overall Study||75
10651658|NCT02177786|11811901|FG001|COMPLETED|Overall Study||70
10651659|NCT02177786|11811902|FG002|COMPLETED|Overall Study||66
10651660|NCT02177786|11811903|FG003|COMPLETED|Overall Study||72
10651661|NCT02177786|11811900|FG000|NOT COMPLETED|Overall Study||6
10651662|NCT02177786|11811901|FG001|NOT COMPLETED|Overall Study||14
10651663|NCT02177786|11811902|FG002|NOT COMPLETED|Overall Study||18
10806706|NCT03958656|11968307|FG001|NOT COMPLETED|Overall Study||1
10806707|NCT03958656|11968308|FG002|NOT COMPLETED|Overall Study||2
10806708|NCT03958656|11968309|FG003|NOT COMPLETED|Overall Study||0
10806709|NCT03955133|11968319|FG000|STARTED|Overall Study|participants recruited from 3 care homes|19
10806710|NCT03955133|11968319|FG000|COMPLETED|Overall Study|End of study funding|19
10806711|NCT03955133|11968319|FG000|NOT COMPLETED|Overall Study||0
10582531|NCT01721837|11737885|FG000|STARTED|Overall Study||2120
10582532|NCT01721837|11737885|FG000|COMPLETED|Overall Study||2120
10582533|NCT01721837|11737885|FG000|NOT COMPLETED|Overall Study||0
10582534|NCT01721876|11737891|FG000|STARTED|Overall Study||222
10582535|NCT01721876|11737892|FG001|STARTED|Overall Study||444
10582536|NCT01721876|11737891|FG000|Treated|Overall Study||221
10582537|NCT01721876|11737892|FG001|Treated|Overall Study||440
10582538|NCT01721876|11737891|FG000|COMPLETED|Overall Study||0
10582539|NCT01721876|11737892|FG001|COMPLETED|Overall Study||0
10582540|NCT01721876|11737891|FG000|NOT COMPLETED|Overall Study||222
10582541|NCT01721876|11737892|FG001|NOT COMPLETED|Overall Study||444
10582542|NCT01721954|11737900|FG000|STARTED|Overall Study||105
10582543|NCT01721954|11737901|FG001|STARTED|Overall Study||104
10582544|NCT01721954|11737900|FG000|COMPLETED|Overall Study||35
10582545|NCT01721954|11737901|FG001|COMPLETED|Overall Study||35
10582546|NCT01721954|11737900|FG000|NOT COMPLETED|Overall Study||70
10582547|NCT01721954|11737901|FG001|NOT COMPLETED|Overall Study||69
10582548|NCT01721967|11737907|FG000|STARTED|Overall Study||14
10582549|NCT01721967|11737907|FG000|COMPLETED|Overall Study||11
10582550|NCT01721967|11737907|FG000|NOT COMPLETED|Overall Study||3
10582551|NCT01722045|11737911|FG000|STARTED|Overall Study||154
10582552|NCT01722045|11737911|FG000|COMPLETED|Overall Study||126
10582553|NCT01722045|11737911|FG000|NOT COMPLETED|Overall Study||28
10582554|NCT01722071|11737915|FG000|STARTED|Overall Study||10
10582555|NCT01722071|11737916|FG001|STARTED|Overall Study||10
10582556|NCT01722071|11737915|FG000|COMPLETED|Overall Study||9
10582557|NCT01722071|11737916|FG001|COMPLETED|Overall Study||10
10582558|NCT01722071|11737915|FG000|NOT COMPLETED|Overall Study||1
10582559|NCT01722071|11737916|FG001|NOT COMPLETED|Overall Study||0
10582560|NCT01722097|11737924|FG000|STARTED|Overall Study||55
10582561|NCT01722097|11737925|FG001|STARTED|Overall Study||55
10582562|NCT01722097|11737924|FG000|COMPLETED|Overall Study||49
10582563|NCT01722097|11737925|FG001|COMPLETED|Overall Study||50
10582564|NCT01722097|11737924|FG000|NOT COMPLETED|Overall Study||6
10582565|NCT01722097|11737925|FG001|NOT COMPLETED|Overall Study||5
10582566|NCT01722162|11737933|FG000|STARTED|Overall Study||23
10582567|NCT01722162|11737934|FG001|STARTED|Overall Study||24
10582568|NCT01722162|11737933|FG000|COMPLETED|Overall Study||18
10582569|NCT01722162|11737934|FG001|COMPLETED|Overall Study||18
10582570|NCT01722162|11737933|FG000|NOT COMPLETED|Overall Study||5
10582571|NCT01722162|11737934|FG001|NOT COMPLETED|Overall Study||6
10582572|NCT01722266|11737944|FG000|STARTED|Overall Study||18
10582573|NCT01722266|11737945|FG001|STARTED|Overall Study||18
10582574|NCT01722266|11737946|FG002|STARTED|Overall Study||18
10582575|NCT01722266|11737947|FG003|STARTED|Overall Study|3 withdrew consent; 1 dropped out due to nausea|18
10582576|NCT01722266|11737944|FG000|COMPLETED|Overall Study||17
10582577|NCT01722266|11737945|FG001|COMPLETED|Overall Study||15
10582578|NCT01722266|11737946|FG002|COMPLETED|Overall Study||13
10582579|NCT01722266|11737947|FG003|COMPLETED|Overall Study|3 subjects randomized to 1.2 mg group and 1 to 1.8 mg group tolerated only 0.6 mg|18
10582580|NCT01722266|11737944|FG000|NOT COMPLETED|Overall Study||1
10582581|NCT01722266|11737945|FG001|NOT COMPLETED|Overall Study||3
10582582|NCT01722266|11737946|FG002|NOT COMPLETED|Overall Study||5
10582583|NCT01722266|11737947|FG003|NOT COMPLETED|Overall Study||0
10582584|NCT01722292|11737960|FG000|STARTED|Overall Study||6
10582585|NCT01722292|11737961|FG001|STARTED|Overall Study||6
10582586|NCT01722292|11737962|FG002|STARTED|Overall Study||14
10582587|NCT01722292|11737960|FG000|Received at Least One Dose of Study Drug|Overall Study||6
10582588|NCT01722292|11737961|FG001|Received at Least One Dose of Study Drug|Overall Study||6
10582589|NCT01722292|11737962|FG002|Received at Least One Dose of Study Drug|Overall Study||14
10582590|NCT01722292|11737960|FG000|COMPLETED|Overall Study||6
10582591|NCT01722292|11737961|FG001|COMPLETED|Overall Study||6
10582592|NCT01722292|11737962|FG002|COMPLETED|Overall Study||14
10582593|NCT01722292|11737960|FG000|NOT COMPLETED|Overall Study||0
10582594|NCT01722292|11737961|FG001|NOT COMPLETED|Overall Study||0
10582595|NCT01722292|11737962|FG002|NOT COMPLETED|Overall Study||0
10582596|NCT01722318|11737992|FG000|STARTED|Overall Study||86
10582597|NCT01722318|11737993|FG001|STARTED|Overall Study||85
10582598|NCT01722318|11737994|FG002|STARTED|Overall Study||86
10582599|NCT01722318|11737995|FG003|STARTED|Overall Study||85
10582600|NCT01722318|11737996|FG004|STARTED|Overall Study||86
10582601|NCT01722318|11737992|FG000|COMPLETED|Overall Study||72
10582602|NCT01722318|11737993|FG001|COMPLETED|Overall Study||65
10582603|NCT01722318|11737994|FG002|COMPLETED|Overall Study||66
10582604|NCT01722318|11737995|FG003|COMPLETED|Overall Study||65
10582605|NCT01722318|11737996|FG004|COMPLETED|Overall Study||68
10582606|NCT01722318|11737992|FG000|NOT COMPLETED|Overall Study||14
10582607|NCT01722318|11737993|FG001|NOT COMPLETED|Overall Study||20
10582608|NCT01722318|11737994|FG002|NOT COMPLETED|Overall Study||20
10582609|NCT01722318|11737995|FG003|NOT COMPLETED|Overall Study||20
10582610|NCT01722318|11737996|FG004|NOT COMPLETED|Overall Study||18
10582611|NCT01722435|11738008|FG000|STARTED|Overall Study||78
10582612|NCT01722435|11738008|FG000|COMPLETED|Overall Study||78
10582613|NCT01722435|11738008|FG000|NOT COMPLETED|Overall Study||0
10582614|NCT01722487|11738018|FG000|STARTED|Overall Study||136
10582615|NCT01722487|11738019|FG001|STARTED|Overall Study||133
10582616|NCT01722487|11738018|FG000|COMPLETED|Overall Study|Participants who were still on study or died at study closure|134
10582617|NCT01722487|11738019|FG001|COMPLETED|Overall Study|Participants who were still on study or died at study closure|126
10582618|NCT01722487|11738018|FG000|NOT COMPLETED|Overall Study||2
10582619|NCT01722487|11738019|FG001|NOT COMPLETED|Overall Study||7
10582620|NCT01722552|11738026|FG000|STARTED|Overall Study|Number of subjects enrolled|120
10582621|NCT01722552|11738026|FG000|COMPLETED|Overall Study|Number of subjects who completed the intervention|116
10582622|NCT01722552|11738026|FG000|NOT COMPLETED|Overall Study||4
10582623|NCT01722604|11738034|FG000|STARTED|Overall Study||129
10582624|NCT01722604|11738035|FG001|STARTED|Overall Study||129
10582625|NCT01722604|11738034|FG000|COMPLETED|Overall Study||123
10582626|NCT01722604|11738035|FG001|COMPLETED|Overall Study||120
10582627|NCT01722604|11738034|FG000|NOT COMPLETED|Overall Study||6
10582628|NCT01722604|11738035|FG001|NOT COMPLETED|Overall Study||9
10582629|NCT01722643|11738043|FG000|STARTED|Overall Study||30
10582630|NCT01722643|11738044|FG001|STARTED|Overall Study||31
10582631|NCT01722643|11738043|FG000|COMPLETED|Overall Study||30
10582632|NCT01722643|11738044|FG001|COMPLETED|Overall Study||30
10582633|NCT01722643|11738043|FG000|NOT COMPLETED|Overall Study||0
10582634|NCT01722643|11738044|FG001|NOT COMPLETED|Overall Study||1
10582635|NCT01722669|11738056|FG000|STARTED|Overall Study||5
10582636|NCT01722669|11738057|FG001|STARTED|Overall Study||5
10582637|NCT01722669|11738058|FG002|STARTED|Overall Study||5
10582638|NCT01722669|11738059|FG003|STARTED|Overall Study||5
10582639|NCT01722669|11738060|FG004|STARTED|Overall Study||10
10582640|NCT01722669|11738061|FG005|STARTED|Overall Study|Antiphospholipid Antibody (ARM D): 6 evaluable and 2 withdrew consent without any data collected|8
10582641|NCT01722669|11738056|FG000|COMPLETED|Overall Study||5
10582642|NCT01722669|11738057|FG001|COMPLETED|Overall Study||5
10582643|NCT01722669|11738058|FG002|COMPLETED|Overall Study||5
10582644|NCT01722669|11738059|FG003|COMPLETED|Overall Study||5
10582645|NCT01722669|11738060|FG004|COMPLETED|Overall Study||10
10582646|NCT01722669|11738061|FG005|COMPLETED|Overall Study||6
10582647|NCT01722669|11738056|FG000|NOT COMPLETED|Overall Study||0
10582648|NCT01722669|11738057|FG001|NOT COMPLETED|Overall Study||0
10582649|NCT01722669|11738058|FG002|NOT COMPLETED|Overall Study||0
10582650|NCT01722669|11738059|FG003|NOT COMPLETED|Overall Study||0
10582651|NCT01722669|11738060|FG004|NOT COMPLETED|Overall Study||0
10582652|NCT01722669|11738061|FG005|NOT COMPLETED|Overall Study||2
10582653|NCT01722734|11738084|FG000|STARTED|Overall Study||554
10582654|NCT01722734|11738085|FG001|STARTED|Overall Study||277
10582655|NCT01722734|11738086|FG002|STARTED|Overall Study||309
10582656|NCT01722734|11738084|FG000|COMPLETED|Overall Study||552
10582657|NCT01722734|11738085|FG001|COMPLETED|Overall Study||276
10582658|NCT01722734|11738086|FG002|COMPLETED|Overall Study||307
10582659|NCT01722734|11738084|FG000|NOT COMPLETED|Overall Study||2
10582660|NCT01722734|11738085|FG001|NOT COMPLETED|Overall Study||1
10582661|NCT01722734|11738086|FG002|NOT COMPLETED|Overall Study||2
10582662|NCT01722877|11738094|FG000|STARTED|Overall Study||29
10582663|NCT01722877|11738094|FG000|COMPLETED|Overall Study||27
10582664|NCT01722877|11738094|FG000|NOT COMPLETED|Overall Study||2
10582665|NCT01722994|11738102|FG000|STARTED|Overall Study||49
10582666|NCT01722994|11738103|FG001|STARTED|Overall Study||48
10582667|NCT01722994|11738102|FG000|COMPLETED|Overall Study||24
10582668|NCT01722994|11738103|FG001|COMPLETED|Overall Study||31
10582669|NCT01722994|11738102|FG000|NOT COMPLETED|Overall Study||25
10582670|NCT01722994|11738103|FG001|NOT COMPLETED|Overall Study||17
10582671|NCT01723072|11738113|FG000|STARTED|Overall Study|28-week treatment period and 8-week follow-up period|44
10582672|NCT01723072|11738114|FG001|STARTED|Overall Study|28-week treatment period and 8-week follow-up period|47
10582673|NCT01723072|11738113|FG000|COMPLETED|Overall Study||33
10582674|NCT01723072|11738114|FG001|COMPLETED|Overall Study||26
10582675|NCT01723072|11738113|FG000|NOT COMPLETED|Overall Study||11
10582676|NCT01723072|11738114|FG001|NOT COMPLETED|Overall Study||21
10582677|NCT01723163|11738122|FG000|STARTED|Baseline||156
10582678|NCT01723163|11738123|FG001|STARTED|Baseline||154
10582679|NCT01723163|11738122|FG000|COMPLETED|Baseline||156
10582680|NCT01723163|11738123|FG001|COMPLETED|Baseline||154
10582681|NCT01723163|11738122|FG000|NOT COMPLETED|Baseline||0
10582682|NCT01723163|11738123|FG001|NOT COMPLETED|Baseline||0
10582683|NCT01723163|11738122|FG000|STARTED|Treatment Phase||156
10582684|NCT01723163|11738123|FG001|STARTED|Treatment Phase||154
10582685|NCT01723163|11738122|FG000|COMPLETED|Treatment Phase||137
10582686|NCT01723163|11738123|FG001|COMPLETED|Treatment Phase||147
10582687|NCT01723163|11738122|FG000|NOT COMPLETED|Treatment Phase||19
10582688|NCT01723163|11738123|FG001|NOT COMPLETED|Treatment Phase||7
10582689|NCT01723163|11738122|FG000|STARTED|3-Month Follow-up||137
10582690|NCT01723163|11738123|FG001|STARTED|3-Month Follow-up||147
10582691|NCT01723163|11738122|FG000|COMPLETED|3-Month Follow-up||124
10582692|NCT01723163|11738123|FG001|COMPLETED|3-Month Follow-up||128
10582693|NCT01723163|11738122|FG000|NOT COMPLETED|3-Month Follow-up||13
10582694|NCT01723163|11738123|FG001|NOT COMPLETED|3-Month Follow-up||19
10582695|NCT01723163|11738122|FG000|STARTED|6-Month Follow-up||136
10582696|NCT01723163|11738123|FG001|STARTED|6-Month Follow-up||147
10582697|NCT01723163|11738122|FG000|COMPLETED|6-Month Follow-up||118
10582698|NCT01723163|11738123|FG001|COMPLETED|6-Month Follow-up||132
10582699|NCT01723163|11738122|FG000|NOT COMPLETED|6-Month Follow-up||18
10582700|NCT01723163|11738123|FG001|NOT COMPLETED|6-Month Follow-up||15
10582701|NCT01723163|11738122|FG000|STARTED|12-Month Follow-up||135
10582702|NCT01723163|11738123|FG001|STARTED|12-Month Follow-up||147
10582703|NCT01723163|11738122|FG000|COMPLETED|12-Month Follow-up||111
10582704|NCT01723163|11738123|FG001|COMPLETED|12-Month Follow-up||119
10582705|NCT01723163|11738122|FG000|NOT COMPLETED|12-Month Follow-up||24
10582706|NCT01723163|11738123|FG001|NOT COMPLETED|12-Month Follow-up||28
10582707|NCT01723228|11738131|FG000|STARTED|Overall Study||86
10582708|NCT01723228|11738132|FG001|STARTED|Overall Study||84
10582709|NCT01723228|11738131|FG000|COMPLETED|Overall Study||78
10582710|NCT01723228|11738132|FG001|COMPLETED|Overall Study||73
10582711|NCT01723228|11738131|FG000|NOT COMPLETED|Overall Study||8
10582712|NCT01723228|11738132|FG001|NOT COMPLETED|Overall Study||11
10582713|NCT01723254|11738146|FG000|STARTED|Overall Study||6
10582714|NCT01723254|11738147|FG001|STARTED|Overall Study||21
10582715|NCT01723254|11738148|FG002|STARTED|Overall Study||20
10582716|NCT01723254|11738149|FG003|STARTED|Overall Study||20
10582717|NCT01723254|11738150|FG004|STARTED|Overall Study||20
10582718|NCT01723254|11738151|FG005|STARTED|Overall Study||20
10582719|NCT01723254|11738152|FG006|STARTED|Overall Study||20
10582720|NCT01723254|11738153|FG007|STARTED|Overall Study||63
10582721|NCT01723254|11738146|FG000|COMPLETED|Overall Study||5
10582722|NCT01723254|11738147|FG001|COMPLETED|Overall Study||18
10582723|NCT01723254|11738148|FG002|COMPLETED|Overall Study||17
10582724|NCT01723254|11738149|FG003|COMPLETED|Overall Study||18
10582725|NCT01723254|11738150|FG004|COMPLETED|Overall Study||18
10582726|NCT01723254|11738151|FG005|COMPLETED|Overall Study||18
10582727|NCT01723254|11738152|FG006|COMPLETED|Overall Study||19
10582728|NCT01723254|11738153|FG007|COMPLETED|Overall Study||60
10582729|NCT01723254|11738146|FG000|NOT COMPLETED|Overall Study||1
10582730|NCT01723254|11738147|FG001|NOT COMPLETED|Overall Study||3
10582731|NCT01723254|11738148|FG002|NOT COMPLETED|Overall Study||3
10582732|NCT01723254|11738149|FG003|NOT COMPLETED|Overall Study||2
10582733|NCT01723254|11738150|FG004|NOT COMPLETED|Overall Study||2
10582734|NCT01723254|11738151|FG005|NOT COMPLETED|Overall Study||2
10582735|NCT01723254|11738152|FG006|NOT COMPLETED|Overall Study||1
10582736|NCT01723254|11738153|FG007|NOT COMPLETED|Overall Study||3
10582737|NCT01723384|11738173|FG000|STARTED|Overall Study||15
10582738|NCT01723384|11738174|FG001|STARTED|Overall Study||15
10582739|NCT01723384|11738173|FG000|COMPLETED|Overall Study||15
10582740|NCT01723384|11738174|FG001|COMPLETED|Overall Study||15
10582741|NCT01723384|11738173|FG000|NOT COMPLETED|Overall Study||0
10582742|NCT01723384|11738174|FG001|NOT COMPLETED|Overall Study||0
10582743|NCT01723397|11738182|FG000|STARTED|Study Period 1||7
10582744|NCT01723397|11738183|FG001|STARTED|Study Period 1||7
10582745|NCT01723397|11738182|FG000|COMPLETED|Study Period 1||7
10582746|NCT01723397|11738183|FG001|COMPLETED|Study Period 1||6
10582747|NCT01723397|11738182|FG000|NOT COMPLETED|Study Period 1||0
10582748|NCT01723397|11738183|FG001|NOT COMPLETED|Study Period 1||1
10582749|NCT01723397|11738182|FG000|STARTED|Washout||7
10582750|NCT01723397|11738183|FG001|STARTED|Washout||6
10582751|NCT01723397|11738182|FG000|COMPLETED|Washout||7
10582752|NCT01723397|11738183|FG001|COMPLETED|Washout||6
10582753|NCT01723397|11738182|FG000|NOT COMPLETED|Washout||0
10582754|NCT01723397|11738183|FG001|NOT COMPLETED|Washout||0
10582755|NCT01723397|11738182|FG000|STARTED|Study Period 2||7
10582756|NCT01723397|11738183|FG001|STARTED|Study Period 2||6
10582757|NCT01723397|11738182|FG000|COMPLETED|Study Period 2||7
10582758|NCT01723397|11738183|FG001|COMPLETED|Study Period 2||5
10582759|NCT01723397|11738182|FG000|NOT COMPLETED|Study Period 2||0
10582760|NCT01723397|11738183|FG001|NOT COMPLETED|Study Period 2||1
10582761|NCT01723514|11738197|FG000|STARTED|Overall Study||8
10582762|NCT01723514|11738198|FG001|STARTED|Overall Study||6
10582763|NCT01723514|11738199|FG002|STARTED|Overall Study||6
10582764|NCT01723514|11738200|FG003|STARTED|Overall Study||6
10582765|NCT01723514|11738201|FG004|STARTED|Overall Study||6
10582766|NCT01723514|11738202|FG005|STARTED|Overall Study||4
10582767|NCT01723514|11738203|FG006|STARTED|Overall Study||6
10582768|NCT01723514|11738204|FG007|STARTED|Overall Study||6
10582769|NCT01723514|11738197|FG000|COMPLETED|Overall Study||8
10582770|NCT01723514|11738198|FG001|COMPLETED|Overall Study||6
10582771|NCT01723514|11738199|FG002|COMPLETED|Overall Study||6
10582772|NCT01723514|11738200|FG003|COMPLETED|Overall Study||6
10582773|NCT01723514|11738201|FG004|COMPLETED|Overall Study||6
10582774|NCT01723514|11738202|FG005|COMPLETED|Overall Study||4
10582775|NCT01723514|11738203|FG006|COMPLETED|Overall Study||6
10582776|NCT01723514|11738204|FG007|COMPLETED|Overall Study||6
10582777|NCT01723514|11738197|FG000|NOT COMPLETED|Overall Study||0
10582778|NCT01723514|11738198|FG001|NOT COMPLETED|Overall Study||0
10582779|NCT01723514|11738199|FG002|NOT COMPLETED|Overall Study||0
10582780|NCT01723514|11738200|FG003|NOT COMPLETED|Overall Study||0
10582781|NCT01723514|11738201|FG004|NOT COMPLETED|Overall Study||0
10582782|NCT01723514|11738202|FG005|NOT COMPLETED|Overall Study||0
10582783|NCT01723514|11738203|FG006|NOT COMPLETED|Overall Study||0
10582784|NCT01723514|11738204|FG007|NOT COMPLETED|Overall Study||0
10582785|NCT01723696|11738224|FG000|STARTED|Overall Study||126
10582786|NCT01723696|11738225|FG001|STARTED|Overall Study||126
10582787|NCT01723696|11738224|FG000|COMPLETED|Overall Study||109
10582788|NCT01723696|11738225|FG001|COMPLETED|Overall Study||113
10582789|NCT01723696|11738224|FG000|NOT COMPLETED|Overall Study||17
10582790|NCT01723696|11738225|FG001|NOT COMPLETED|Overall Study||13
10582791|NCT01723722|11738235|FG000|STARTED|Overall Study||20
10582792|NCT01723722|11738236|FG001|STARTED|Overall Study||20
10582793|NCT01723722|11738235|FG000|COMPLETED|Overall Study||20
10582794|NCT01723722|11738236|FG001|COMPLETED|Overall Study||20
10582795|NCT01723722|11738235|FG000|NOT COMPLETED|Overall Study||0
10582796|NCT01723722|11738236|FG001|NOT COMPLETED|Overall Study||0
10582797|NCT01723826|11738246|FG000|STARTED|Overall Study||47
10582798|NCT01723826|11738247|FG001|STARTED|Overall Study||63
10582799|NCT01723826|11738248|FG002|STARTED|Overall Study||101
10582800|NCT01723826|11738249|FG003|STARTED|Overall Study||149
10582801|NCT01723826|11738246|FG000|COMPLETED|Overall Study||20
10582802|NCT01723826|11738247|FG001|COMPLETED|Overall Study||27
10582803|NCT01723826|11738248|FG002|COMPLETED|Overall Study||44
10582804|NCT01723826|11738249|FG003|COMPLETED|Overall Study||59
10582805|NCT01723826|11738246|FG000|NOT COMPLETED|Overall Study||27
10582806|NCT01723826|11738247|FG001|NOT COMPLETED|Overall Study||36
10582807|NCT01723826|11738248|FG002|NOT COMPLETED|Overall Study||57
10582808|NCT01723826|11738249|FG003|NOT COMPLETED|Overall Study||90
10582809|NCT01723904|11738259|FG000|STARTED|Overall Study||90
10582810|NCT01723904|11738259|FG000|COMPLETED|Overall Study||79
10582811|NCT01723904|11738259|FG000|NOT COMPLETED|Overall Study||11
10582812|NCT01724021|11738265|FG000|STARTED|Overall Study||371
10582813|NCT01724021|11738266|FG001|STARTED|Overall Study||369
10582814|NCT01724021|11738265|FG000|COMPLETED|Overall Study||244
10582815|NCT01724021|11738266|FG001|COMPLETED|Overall Study||236
10582816|NCT01724021|11738265|FG000|NOT COMPLETED|Overall Study||127
10582817|NCT01724021|11738266|FG001|NOT COMPLETED|Overall Study||133
10582818|NCT01724060|11738282|FG000|STARTED|Overall Study||10
10582819|NCT01724060|11738283|FG001|STARTED|Overall Study||10
10582820|NCT01724060|11738284|FG002|STARTED|Overall Study||10
10582821|NCT01724060|11738285|FG003|STARTED|Overall Study||10
10582822|NCT01724060|11738286|FG004|STARTED|Overall Study||10
10582823|NCT01724060|11738287|FG005|STARTED|Overall Study||10
10582824|NCT01724060|11738288|FG006|STARTED|Overall Study||10
10582825|NCT01724060|11738289|FG007|STARTED|Overall Study||10
10582826|NCT01724060|11738282|FG000|COMPLETED|Overall Study||10
10582827|NCT01724060|11738283|FG001|COMPLETED|Overall Study||10
10582828|NCT01724060|11738284|FG002|COMPLETED|Overall Study||10
10582829|NCT01724060|11738285|FG003|COMPLETED|Overall Study||10
10582830|NCT01724060|11738286|FG004|COMPLETED|Overall Study||10
10582831|NCT01724060|11738287|FG005|COMPLETED|Overall Study||10
10582832|NCT01724060|11738288|FG006|COMPLETED|Overall Study||10
10582833|NCT01724060|11738289|FG007|COMPLETED|Overall Study||10
10582834|NCT01724060|11738282|FG000|NOT COMPLETED|Overall Study||0
10582835|NCT01724060|11738283|FG001|NOT COMPLETED|Overall Study||0
10582836|NCT01724060|11738284|FG002|NOT COMPLETED|Overall Study||0
10582837|NCT01724060|11738285|FG003|NOT COMPLETED|Overall Study||0
10582838|NCT01724060|11738286|FG004|NOT COMPLETED|Overall Study||0
10582839|NCT01724060|11738287|FG005|NOT COMPLETED|Overall Study||0
10582840|NCT01724060|11738288|FG006|NOT COMPLETED|Overall Study||0
10582841|NCT01724060|11738289|FG007|NOT COMPLETED|Overall Study||0
10582842|NCT01724177|11738307|FG000|STARTED|Overall Study||26
10582843|NCT01724177|11738307|FG000|Safety Population|Overall Study|Safety Population includes participants who received at least one dose of lenalidomide|26
10582844|NCT01724177|11738307|FG000|COMPLETED|Overall Study||0
10582845|NCT01724177|11738307|FG000|NOT COMPLETED|Overall Study||26
10582846|NCT01724216|11738312|FG000|STARTED|Overall Study||11
10582847|NCT01724216|11738312|FG000|COMPLETED|Overall Study||10
10582848|NCT01724216|11738312|FG000|NOT COMPLETED|Overall Study||1
10582849|NCT01724359|11738316|FG000|STARTED|Overall Study||95
10582850|NCT01724359|11738316|FG000|COMPLETED|Overall Study||64
10582851|NCT01724359|11738316|FG000|NOT COMPLETED|Overall Study||31
10582852|NCT01724489|11738324|FG000|STARTED|Overall Study||39
10582853|NCT01724489|11738325|FG001|STARTED|Overall Study||38
10582854|NCT01724489|11738324|FG000|COMPLETED|Overall Study||23
10582855|NCT01724489|11738325|FG001|COMPLETED|Overall Study||26
10582856|NCT01724489|11738324|FG000|NOT COMPLETED|Overall Study||16
10582857|NCT01724489|11738325|FG001|NOT COMPLETED|Overall Study||12
10582858|NCT01724528|11738333|FG000|STARTED|Overall Study||173
10582859|NCT01724528|11738334|FG001|STARTED|Overall Study||173
10582860|NCT01724528|11738333|FG000|COMPLETED|Overall Study||169
10582861|NCT01724528|11738334|FG001|COMPLETED|Overall Study||170
10582862|NCT01724528|11738333|FG000|NOT COMPLETED|Overall Study||4
10582863|NCT01724528|11738334|FG001|NOT COMPLETED|Overall Study||3
10582864|NCT01725126|11738346|FG000|STARTED|Overall Study||4
10582865|NCT01725126|11738347|FG001|STARTED|Overall Study||11
10582866|NCT01725126|11738348|FG002|STARTED|Overall Study||6
10582867|NCT01725126|11738349|FG003|STARTED|Overall Study||14
10582868|NCT01725126|11738350|FG004|STARTED|Overall Study||6
10582869|NCT01725126|11738351|FG005|STARTED|Overall Study||12
10582870|NCT01725126|11738346|FG000|COMPLETED|Overall Study||4
10582871|NCT01725126|11738347|FG001|COMPLETED|Overall Study||10
10582872|NCT01725126|11738348|FG002|COMPLETED|Overall Study||6
10582873|NCT01725126|11738349|FG003|COMPLETED|Overall Study||13
10582874|NCT01725126|11738350|FG004|COMPLETED|Overall Study||6
10582875|NCT01725126|11738351|FG005|COMPLETED|Overall Study||12
10582876|NCT01725126|11738346|FG000|NOT COMPLETED|Overall Study||0
10582877|NCT01725126|11738347|FG001|NOT COMPLETED|Overall Study||1
10582878|NCT01725126|11738348|FG002|NOT COMPLETED|Overall Study||0
10582879|NCT01725126|11738349|FG003|NOT COMPLETED|Overall Study||1
10582880|NCT01725126|11738350|FG004|NOT COMPLETED|Overall Study||0
10582881|NCT01725126|11738351|FG005|NOT COMPLETED|Overall Study||0
10582882|NCT01725217|11738377|FG000|STARTED|Overall Study||66
10582883|NCT01725217|11738378|FG001|STARTED|Overall Study||66
10582884|NCT01725217|11738379|FG002|STARTED|Overall Study||66
10582885|NCT01725217|11738377|FG000|COMPLETED|Overall Study||65
10582886|NCT01725217|11738378|FG001|COMPLETED|Overall Study||66
10582887|NCT01725217|11738379|FG002|COMPLETED|Overall Study||66
10582888|NCT01725217|11738377|FG000|NOT COMPLETED|Overall Study||1
10582889|NCT01725217|11738378|FG001|NOT COMPLETED|Overall Study||0
10582890|NCT01725217|11738379|FG002|NOT COMPLETED|Overall Study||0
10582891|NCT01725282|11738400|FG000|STARTED|Overall Study||44
10582892|NCT01725282|11738401|FG001|STARTED|Overall Study||44
10582893|NCT01725282|11738402|FG002|STARTED|Overall Study||41
10582894|NCT01725282|11738403|FG003|STARTED|Overall Study||43
10582895|NCT01725282|11738400|FG000|COMPLETED|Overall Study||42
10582896|NCT01725282|11738401|FG001|COMPLETED|Overall Study||39
10582897|NCT01725282|11738402|FG002|COMPLETED|Overall Study||33
10582898|NCT01725282|11738403|FG003|COMPLETED|Overall Study||36
10582899|NCT01725282|11738400|FG000|NOT COMPLETED|Overall Study||2
10582900|NCT01725282|11738401|FG001|NOT COMPLETED|Overall Study||5
10806712|NCT03954626|11968324|FG000|STARTED|Overall Study||14
10806713|NCT03954626|11968324|FG000|COMPLETED|Overall Study||14
10806714|NCT03954626|11968324|FG000|NOT COMPLETED|Overall Study||0
10582901|NCT01725282|11738402|FG002|NOT COMPLETED|Overall Study||8
10582902|NCT01725282|11738403|FG003|NOT COMPLETED|Overall Study||7
10582903|NCT01725308|11738416|FG000|STARTED|Treatment Period I||178
10582904|NCT01725308|11738417|FG001|STARTED|Treatment Period I||74
10582905|NCT01725308|11738418|FG002|STARTED|Treatment Period I||179
10582906|NCT01725308|11738416|FG000|Treated|Treatment Period I||177
10582907|NCT01725308|11738417|FG001|Treated|Treatment Period I||74
10582908|NCT01725308|11738418|FG002|Treated|Treatment Period I||179
10582909|NCT01725308|11738416|FG000|COMPLETED|Treatment Period I||134
10582910|NCT01725308|11738417|FG001|COMPLETED|Treatment Period I||60
10582911|NCT01725308|11738418|FG002|COMPLETED|Treatment Period I||138
10582912|NCT01725308|11738416|FG000|NOT COMPLETED|Treatment Period I||44
10582913|NCT01725308|11738417|FG001|NOT COMPLETED|Treatment Period I||14
10582914|NCT01725308|11738418|FG002|NOT COMPLETED|Treatment Period I||41
10582915|NCT01725308|11738416|FG000|STARTED|Treatment Period II||134
10582916|NCT01725308|11738417|FG001|STARTED|Treatment Period II||60
10582917|NCT01725308|11738418|FG002|STARTED|Treatment Period II||138
10582918|NCT01725308|11738416|FG000|Treated|Treatment Period II||120
10582919|NCT01725308|11738417|FG001|Treated|Treatment Period II||53
10582920|NCT01725308|11738418|FG002|Treated|Treatment Period II||130
10582921|NCT01725308|11738416|FG000|COMPLETED|Treatment Period II||79
10582922|NCT01725308|11738417|FG001|COMPLETED|Treatment Period II||31
10582923|NCT01725308|11738418|FG002|COMPLETED|Treatment Period II||74
10582924|NCT01725308|11738416|FG000|NOT COMPLETED|Treatment Period II||55
10582925|NCT01725308|11738417|FG001|NOT COMPLETED|Treatment Period II||29
10582926|NCT01725308|11738418|FG002|NOT COMPLETED|Treatment Period II||64
10582927|NCT01725386|11738435|FG000|STARTED|Overall Study||188
10582928|NCT01725386|11738436|FG001|STARTED|Overall Study||63
10582929|NCT01725386|11738435|FG000|COMPLETED|Overall Study||13
10582930|NCT01725386|11738436|FG001|COMPLETED|Overall Study||17
10582931|NCT01725386|11738435|FG000|NOT COMPLETED|Overall Study||175
10582932|NCT01725386|11738436|FG001|NOT COMPLETED|Overall Study||46
10582933|NCT01725451|11738442|FG000|STARTED|Period 1||8
10582934|NCT01725451|11738443|FG001|STARTED|Period 1||7
10582935|NCT01725451|11738444|FG002|STARTED|Period 1||8
10582936|NCT01725451|11738445|FG003|STARTED|Period 1||7
10582937|NCT01725451|11738442|FG000|COMPLETED|Period 1||7
10582938|NCT01725451|11738443|FG001|COMPLETED|Period 1||7
10582939|NCT01725451|11738444|FG002|COMPLETED|Period 1||8
10582940|NCT01725451|11738445|FG003|COMPLETED|Period 1||7
10582941|NCT01725451|11738442|FG000|NOT COMPLETED|Period 1||1
10582942|NCT01725451|11738443|FG001|NOT COMPLETED|Period 1||0
10582943|NCT01725451|11738444|FG002|NOT COMPLETED|Period 1||0
10582944|NCT01725451|11738445|FG003|NOT COMPLETED|Period 1||0
10582945|NCT01725451|11738442|FG000|STARTED|Washout From Period 1||7
10582946|NCT01725451|11738443|FG001|STARTED|Washout From Period 1||7
10582947|NCT01725451|11738444|FG002|STARTED|Washout From Period 1||8
10582948|NCT01725451|11738445|FG003|STARTED|Washout From Period 1||7
10582949|NCT01725451|11738442|FG000|COMPLETED|Washout From Period 1||7
10582950|NCT01725451|11738443|FG001|COMPLETED|Washout From Period 1||7
10582951|NCT01725451|11738444|FG002|COMPLETED|Washout From Period 1||8
10806715|NCT03951805|11968332|FG000|STARTED|Overall Study||51
10806716|NCT03951805|11968333|FG001|STARTED|Overall Study||51
10582952|NCT01725451|11738445|FG003|COMPLETED|Washout From Period 1||7
10582953|NCT01725451|11738442|FG000|NOT COMPLETED|Washout From Period 1||0
10582954|NCT01725451|11738443|FG001|NOT COMPLETED|Washout From Period 1||0
10582955|NCT01725451|11738444|FG002|NOT COMPLETED|Washout From Period 1||0
10582956|NCT01725451|11738445|FG003|NOT COMPLETED|Washout From Period 1||0
10582957|NCT01725451|11738442|FG000|STARTED|Period 2||7
10582958|NCT01725451|11738443|FG001|STARTED|Period 2||7
10582959|NCT01725451|11738444|FG002|STARTED|Period 2||8
10582960|NCT01725451|11738445|FG003|STARTED|Period 2||7
10582961|NCT01725451|11738442|FG000|COMPLETED|Period 2||7
10582962|NCT01725451|11738443|FG001|COMPLETED|Period 2||7
10582963|NCT01725451|11738444|FG002|COMPLETED|Period 2||8
10582964|NCT01725451|11738445|FG003|COMPLETED|Period 2||7
10582965|NCT01725451|11738442|FG000|NOT COMPLETED|Period 2||0
10582966|NCT01725451|11738443|FG001|NOT COMPLETED|Period 2||0
10582967|NCT01725451|11738444|FG002|NOT COMPLETED|Period 2||0
10582968|NCT01725451|11738445|FG003|NOT COMPLETED|Period 2||0
10582969|NCT01725451|11738442|FG000|STARTED|Washout From Period 2||7
10582970|NCT01725451|11738443|FG001|STARTED|Washout From Period 2||7
10582971|NCT01725451|11738444|FG002|STARTED|Washout From Period 2||8
10582972|NCT01725451|11738445|FG003|STARTED|Washout From Period 2||7
10582973|NCT01725451|11738442|FG000|COMPLETED|Washout From Period 2||7
10582974|NCT01725451|11738443|FG001|COMPLETED|Washout From Period 2||7
10582975|NCT01725451|11738444|FG002|COMPLETED|Washout From Period 2||8
10582976|NCT01725451|11738445|FG003|COMPLETED|Washout From Period 2||7
10582977|NCT01725451|11738442|FG000|NOT COMPLETED|Washout From Period 2||0
10582978|NCT01725451|11738443|FG001|NOT COMPLETED|Washout From Period 2||0
10582979|NCT01725451|11738444|FG002|NOT COMPLETED|Washout From Period 2||0
10582980|NCT01725451|11738445|FG003|NOT COMPLETED|Washout From Period 2||0
10582981|NCT01725451|11738442|FG000|STARTED|Period 3||7
10582982|NCT01725451|11738443|FG001|STARTED|Period 3||7
10582983|NCT01725451|11738444|FG002|STARTED|Period 3||8
10582984|NCT01725451|11738445|FG003|STARTED|Period 3||7
10582985|NCT01725451|11738442|FG000|COMPLETED|Period 3||7
10582986|NCT01725451|11738443|FG001|COMPLETED|Period 3||7
10582987|NCT01725451|11738444|FG002|COMPLETED|Period 3||8
10582988|NCT01725451|11738445|FG003|COMPLETED|Period 3||7
10582989|NCT01725451|11738442|FG000|NOT COMPLETED|Period 3||0
10582990|NCT01725451|11738443|FG001|NOT COMPLETED|Period 3||0
10582991|NCT01725451|11738444|FG002|NOT COMPLETED|Period 3||0
10582992|NCT01725451|11738445|FG003|NOT COMPLETED|Period 3||0
10582993|NCT01725451|11738442|FG000|STARTED|Washout From Period 3||7
10582994|NCT01725451|11738443|FG001|STARTED|Washout From Period 3||7
10582995|NCT01725451|11738444|FG002|STARTED|Washout From Period 3||8
10582996|NCT01725451|11738445|FG003|STARTED|Washout From Period 3||7
10582997|NCT01725451|11738442|FG000|COMPLETED|Washout From Period 3||7
10582998|NCT01725451|11738443|FG001|COMPLETED|Washout From Period 3||6
10582999|NCT01725451|11738444|FG002|COMPLETED|Washout From Period 3||7
10583000|NCT01725451|11738445|FG003|COMPLETED|Washout From Period 3||7
10583001|NCT01725451|11738442|FG000|NOT COMPLETED|Washout From Period 3||0
10583002|NCT01725451|11738443|FG001|NOT COMPLETED|Washout From Period 3||1
10583003|NCT01725451|11738444|FG002|NOT COMPLETED|Washout From Period 3||1
10583004|NCT01725451|11738445|FG003|NOT COMPLETED|Washout From Period 3||0
10583005|NCT01725451|11738442|FG000|STARTED|Period 4||7
10583006|NCT01725451|11738443|FG001|STARTED|Period 4||6
10583007|NCT01725451|11738444|FG002|STARTED|Period 4||7
10583008|NCT01725451|11738445|FG003|STARTED|Period 4||7
10583009|NCT01725451|11738442|FG000|COMPLETED|Period 4||7
10583010|NCT01725451|11738443|FG001|COMPLETED|Period 4||6
10583011|NCT01725451|11738444|FG002|COMPLETED|Period 4||6
10583012|NCT01725451|11738445|FG003|COMPLETED|Period 4||7
10583013|NCT01725451|11738442|FG000|NOT COMPLETED|Period 4||0
10583014|NCT01725451|11738443|FG001|NOT COMPLETED|Period 4||0
10583015|NCT01725451|11738444|FG002|NOT COMPLETED|Period 4||1
10583016|NCT01725451|11738445|FG003|NOT COMPLETED|Period 4||0
10583017|NCT01725451|11738442|FG000|STARTED|Washout From Period 4||7
10583018|NCT01725451|11738443|FG001|STARTED|Washout From Period 4||6
10583019|NCT01725451|11738444|FG002|STARTED|Washout From Period 4||6
10583020|NCT01725451|11738445|FG003|STARTED|Washout From Period 4||7
10583021|NCT01725451|11738442|FG000|COMPLETED|Washout From Period 4||7
10583022|NCT01725451|11738443|FG001|COMPLETED|Washout From Period 4||6
10583023|NCT01725451|11738444|FG002|COMPLETED|Washout From Period 4||6
10583024|NCT01725451|11738445|FG003|COMPLETED|Washout From Period 4||7
10583025|NCT01725451|11738442|FG000|NOT COMPLETED|Washout From Period 4||0
10583026|NCT01725451|11738443|FG001|NOT COMPLETED|Washout From Period 4||0
10583027|NCT01725451|11738444|FG002|NOT COMPLETED|Washout From Period 4||0
10583028|NCT01725451|11738445|FG003|NOT COMPLETED|Washout From Period 4||0
10583029|NCT01725451|11738442|FG000|STARTED|Period 5||7
10583030|NCT01725451|11738443|FG001|STARTED|Period 5||6
10583031|NCT01725451|11738444|FG002|STARTED|Period 5||6
10583032|NCT01725451|11738445|FG003|STARTED|Period 5||7
10583033|NCT01725451|11738442|FG000|COMPLETED|Period 5||7
10583034|NCT01725451|11738443|FG001|COMPLETED|Period 5||6
10583035|NCT01725451|11738444|FG002|COMPLETED|Period 5||6
10583036|NCT01725451|11738445|FG003|COMPLETED|Period 5||7
10583037|NCT01725451|11738442|FG000|NOT COMPLETED|Period 5||0
10583038|NCT01725451|11738443|FG001|NOT COMPLETED|Period 5||0
10583039|NCT01725451|11738444|FG002|NOT COMPLETED|Period 5||0
10583040|NCT01725451|11738445|FG003|NOT COMPLETED|Period 5||0
10583041|NCT01725451|11738442|FG000|STARTED|Washout From Period 5||7
10583042|NCT01725451|11738443|FG001|STARTED|Washout From Period 5||6
10583043|NCT01725451|11738444|FG002|STARTED|Washout From Period 5||6
10583044|NCT01725451|11738445|FG003|STARTED|Washout From Period 5||7
10583045|NCT01725451|11738442|FG000|COMPLETED|Washout From Period 5||7
10583046|NCT01725451|11738443|FG001|COMPLETED|Washout From Period 5||6
10583047|NCT01725451|11738444|FG002|COMPLETED|Washout From Period 5||6
10583048|NCT01725451|11738445|FG003|COMPLETED|Washout From Period 5||7
10583049|NCT01725451|11738442|FG000|NOT COMPLETED|Washout From Period 5||0
10583050|NCT01725451|11738443|FG001|NOT COMPLETED|Washout From Period 5||0
10583051|NCT01725451|11738444|FG002|NOT COMPLETED|Washout From Period 5||0
10583052|NCT01725451|11738445|FG003|NOT COMPLETED|Washout From Period 5||0
10583053|NCT01725451|11738442|FG000|STARTED|Period 6||7
10583054|NCT01725451|11738443|FG001|STARTED|Period 6||6
10583055|NCT01725451|11738444|FG002|STARTED|Period 6||6
10583056|NCT01725451|11738445|FG003|STARTED|Period 6||7
10583057|NCT01725451|11738442|FG000|COMPLETED|Period 6||7
10583058|NCT01725451|11738443|FG001|COMPLETED|Period 6||6
10583059|NCT01725451|11738444|FG002|COMPLETED|Period 6||6
10583060|NCT01725451|11738445|FG003|COMPLETED|Period 6||7
10583061|NCT01725451|11738442|FG000|NOT COMPLETED|Period 6||0
10583062|NCT01725451|11738443|FG001|NOT COMPLETED|Period 6||0
10583063|NCT01725451|11738444|FG002|NOT COMPLETED|Period 6||0
10583064|NCT01725451|11738445|FG003|NOT COMPLETED|Period 6||0
10583065|NCT01725529|11738463|FG000|STARTED|Overall Study||152
10583066|NCT01725529|11738464|FG001|STARTED|Overall Study||153
10583067|NCT01725529|11738465|FG002|STARTED|Overall Study||152
10583068|NCT01725529|11738463|FG000|COMPLETED|Overall Study||137
10583069|NCT01725529|11738464|FG001|COMPLETED|Overall Study||137
10583070|NCT01725529|11738465|FG002|COMPLETED|Overall Study||142
10583071|NCT01725529|11738463|FG000|NOT COMPLETED|Overall Study||15
10583072|NCT01725529|11738464|FG001|NOT COMPLETED|Overall Study||16
10583073|NCT01725529|11738465|FG002|NOT COMPLETED|Overall Study||10
10583074|NCT01725750|11738475|FG000|STARTED|Overall Study||44
10583075|NCT01725750|11738476|FG001|STARTED|Overall Study||44
10583076|NCT01725750|11738475|FG000|COMPLETED|Overall Study||42
10583077|NCT01725750|11738476|FG001|COMPLETED|Overall Study||34
10583078|NCT01725750|11738475|FG000|NOT COMPLETED|Overall Study||2
10583079|NCT01725750|11738476|FG001|NOT COMPLETED|Overall Study||10
10583080|NCT01725815|11738486|FG000|STARTED|Overall Study||198
10583081|NCT01725815|11738487|FG001|STARTED|Overall Study||202
10583082|NCT01725815|11738486|FG000|COMPLETED|Overall Study||198
10583083|NCT01725815|11738487|FG001|COMPLETED|Overall Study||202
10583084|NCT01725815|11738486|FG000|NOT COMPLETED|Overall Study||0
10583085|NCT01725815|11738487|FG001|NOT COMPLETED|Overall Study||0
10583086|NCT01725984|11738495|FG000|STARTED|Overall Study||39
10583087|NCT01725984|11738496|FG001|STARTED|Overall Study||41
10583088|NCT01725984|11738495|FG000|COMPLETED|Overall Study||39
10583089|NCT01725984|11738496|FG001|COMPLETED|Overall Study||41
10583090|NCT01725984|11738495|FG000|NOT COMPLETED|Overall Study||0
10583091|NCT01725984|11738496|FG001|NOT COMPLETED|Overall Study||0
10583092|NCT01726023|11738504|FG000|STARTED|Overall Study||219
10806717|NCT03951805|11968334|FG002|STARTED|Overall Study||52
10806718|NCT03951805|11968335|FG003|STARTED|Overall Study||51
10583093|NCT01726023|11738505|FG001|STARTED|Overall Study||222
10583094|NCT01726023|11738504|FG000|COMPLETED|Overall Study||190
10583095|NCT01726023|11738505|FG001|COMPLETED|Overall Study||196
10583096|NCT01726023|11738504|FG000|NOT COMPLETED|Overall Study||29
10583097|NCT01726023|11738505|FG001|NOT COMPLETED|Overall Study||26
10583098|NCT01726036|11738520|FG000|STARTED|Overall Study||137
10583099|NCT01726036|11738521|FG001|STARTED|Overall Study||137
10583100|NCT01726036|11738520|FG000|COMPLETED|Overall Study||121
10583101|NCT01726036|11738521|FG001|COMPLETED|Overall Study||130
10583102|NCT01726036|11738520|FG000|NOT COMPLETED|Overall Study||16
10583103|NCT01726036|11738521|FG001|NOT COMPLETED|Overall Study||7
10583104|NCT01726049|11738529|FG000|STARTED|Overall Study||26
10583105|NCT01726049|11738530|FG001|STARTED|Overall Study||26
10583106|NCT01726049|11738529|FG000|COMPLETED|Overall Study||21
10583107|NCT01726049|11738530|FG001|COMPLETED|Overall Study||22
10583108|NCT01726049|11738529|FG000|NOT COMPLETED|Overall Study||5
10583109|NCT01726049|11738530|FG001|NOT COMPLETED|Overall Study||4
10583110|NCT01726270|11738536|FG000|STARTED|Part 1, Self-Selection Phase||689
10583111|NCT01726270|11738536|FG000|COMPLETED|Part 1, Self-Selection Phase||679
10583112|NCT01726270|11738536|FG000|NOT COMPLETED|Part 1, Self-Selection Phase||10
10583113|NCT01726270|11738536|FG000|STARTED|Eligibility for Part 2|No. of subjects potentially eligible for Part 2|389
10583114|NCT01726270|11738536|FG000|COMPLETED|Eligibility for Part 2||369
10583115|NCT01726270|11738536|FG000|NOT COMPLETED|Eligibility for Part 2||20
10583116|NCT01726270|11738536|FG000|STARTED|Part 2, Actual-Use Phase|20 subjects were eligible for Part 2 but did not enter Part 2|369
10583117|NCT01726270|11738536|FG000|COMPLETED|Part 2, Actual-Use Phase||330
10583118|NCT01726270|11738536|FG000|NOT COMPLETED|Part 2, Actual-Use Phase||39
10583119|NCT01726335|11738542|FG000|STARTED|Overall Study||53
10583120|NCT01726335|11738542|FG000|COMPLETED|Overall Study||29
10583121|NCT01726335|11738542|FG000|NOT COMPLETED|Overall Study||24
10583122|NCT01726504|11738548|FG000|STARTED|Overall Study||536
10702780|NCT02577822|11867240|FG000|STARTED|Overall Study||27
10702781|NCT02577822|11867241|FG001|STARTED|Overall Study||33
10702782|NCT02577822|11867240|FG000|COMPLETED|Overall Study||21
10702783|NCT02577822|11867241|FG001|COMPLETED|Overall Study||20
10702784|NCT02577822|11867240|FG000|NOT COMPLETED|Overall Study||6
10702785|NCT02577822|11867241|FG001|NOT COMPLETED|Overall Study||13
10702786|NCT02577887|11867247|FG000|STARTED|Overall Study||2101
10702787|NCT02577887|11867247|FG000|6 Month Follow-up|Overall Study||1938
10702788|NCT02577887|11867247|FG000|COMPLETED|Overall Study||1803
10702789|NCT02577887|11867247|FG000|NOT COMPLETED|Overall Study||298
10702790|NCT02577900|11867254|FG000|STARTED|Overall Study||11
10702791|NCT02577900|11867255|FG001|STARTED|Overall Study||10
10702792|NCT02577900|11867256|FG002|STARTED|Overall Study||10
10583123|NCT01726504|11738549|FG001|STARTED|Overall Study||539
10583124|NCT01726504|11738548|FG000|COMPLETED|Overall Study||524
10583125|NCT01726504|11738549|FG001|COMPLETED|Overall Study||511
10702793|NCT02577900|11867254|FG000|COMPLETED|Overall Study||11
10806719|NCT03951805|11968332|FG000|Full Analysis Set (FAS)|Overall Study||51
10583126|NCT01726504|11738548|FG000|NOT COMPLETED|Overall Study||12
10583127|NCT01726504|11738549|FG001|NOT COMPLETED|Overall Study||28
10583128|NCT01726517|11738560|FG000|STARTED|Overall Study||20
10583129|NCT01726517|11738561|FG001|STARTED|Overall Study||21
10583130|NCT01726517|11738562|FG002|STARTED|Overall Study||19
10583131|NCT01726517|11738563|FG003|STARTED|Overall Study||19
10583132|NCT01726517|11738564|FG004|STARTED|Overall Study||21
10583133|NCT01726517|11738560|FG000|COMPLETED|Overall Study||20
10583134|NCT01726517|11738561|FG001|COMPLETED|Overall Study||21
10583135|NCT01726517|11738562|FG002|COMPLETED|Overall Study||18
10583136|NCT01726517|11738563|FG003|COMPLETED|Overall Study||19
10583137|NCT01726517|11738564|FG004|COMPLETED|Overall Study||21
10583138|NCT01726517|11738560|FG000|NOT COMPLETED|Overall Study||0
10583139|NCT01726517|11738561|FG001|NOT COMPLETED|Overall Study||0
10583140|NCT01726517|11738562|FG002|NOT COMPLETED|Overall Study||1
10583141|NCT01726517|11738563|FG003|NOT COMPLETED|Overall Study||0
10583142|NCT01726517|11738564|FG004|NOT COMPLETED|Overall Study||0
10583143|NCT01726621|11738576|FG000|STARTED|Overall Study||55
10583144|NCT01726621|11738576|FG000|COMPLETED|Overall Study||51
10583145|NCT01726621|11738576|FG000|NOT COMPLETED|Overall Study||4
10583146|NCT01726673|11738582|FG000|STARTED|Overall Study||30
10583147|NCT01726673|11738583|FG001|STARTED|Overall Study||24
10583148|NCT01726673|11738582|FG000|COMPLETED|Overall Study||24
10583149|NCT01726673|11738583|FG001|COMPLETED|Overall Study||21
10583150|NCT01726673|11738582|FG000|NOT COMPLETED|Overall Study||6
10583151|NCT01726673|11738583|FG001|NOT COMPLETED|Overall Study||3
10583152|NCT01726738|11738589|FG000|STARTED|Overall Study||17
10583153|NCT01726738|11738589|FG000|COMPLETED|Overall Study||17
10583154|NCT01726738|11738589|FG000|NOT COMPLETED|Overall Study||0
10583155|NCT01726803|11738595|FG000|STARTED|Overall Study||112
10583156|NCT01726803|11738596|FG001|STARTED|Overall Study||108
10583157|NCT01726803|11738595|FG000|COMPLETED|Overall Study||105
10583158|NCT01726803|11738596|FG001|COMPLETED|Overall Study||107
10583159|NCT01726803|11738595|FG000|NOT COMPLETED|Overall Study||7
10583160|NCT01726803|11738596|FG001|NOT COMPLETED|Overall Study||1
10583161|NCT01727024|11738602|FG000|STARTED|Period 1||71
10583162|NCT01727024|11738603|FG001|STARTED|Period 1||68
10583163|NCT01727024|11738602|FG000|COMPLETED|Period 1||68
10583164|NCT01727024|11738603|FG001|COMPLETED|Period 1||64
10583165|NCT01727024|11738602|FG000|NOT COMPLETED|Period 1||3
10583166|NCT01727024|11738603|FG001|NOT COMPLETED|Period 1||4
10583167|NCT01727024|11738602|FG000|STARTED|Period 2||68
10583168|NCT01727024|11738603|FG001|STARTED|Period 2||64
10583169|NCT01727024|11738602|FG000|COMPLETED|Period 2||68
10583170|NCT01727024|11738603|FG001|COMPLETED|Period 2||64
10583171|NCT01727024|11738602|FG000|NOT COMPLETED|Period 2||0
10583172|NCT01727024|11738603|FG001|NOT COMPLETED|Period 2||0
10583173|NCT01727089|11738611|FG000|STARTED|Overall Study||29
10583174|NCT01727089|11738612|FG001|STARTED|Overall Study||30
10583175|NCT01727089|11738611|FG000|COMPLETED|Overall Study||29
10583176|NCT01727089|11738612|FG001|COMPLETED|Overall Study||30
10702794|NCT02577900|11867255|FG001|COMPLETED|Overall Study||10
10702795|NCT02577900|11867256|FG002|COMPLETED|Overall Study||10
10702796|NCT02577900|11867254|FG000|NOT COMPLETED|Overall Study||0
10702797|NCT02577900|11867255|FG001|NOT COMPLETED|Overall Study||0
10702798|NCT02577900|11867256|FG002|NOT COMPLETED|Overall Study||0
10583177|NCT01727089|11738611|FG000|NOT COMPLETED|Overall Study||0
10583178|NCT01727089|11738612|FG001|NOT COMPLETED|Overall Study||0
10583179|NCT01727141|11738622|FG000|STARTED|Overall Study||260
10583180|NCT01727141|11738623|FG001|STARTED|Overall Study||260
10583181|NCT01727141|11738624|FG002|STARTED|Overall Study||261
10583182|NCT01727141|11738625|FG003|STARTED|Overall Study||261
10583183|NCT01727141|11738622|FG000|Safety Set|Overall Study||258
10583184|NCT01727141|11738623|FG001|Safety Set|Overall Study||260
10583185|NCT01727141|11738624|FG002|Safety Set|Overall Study||262
10583186|NCT01727141|11738625|FG003|Safety Set|Overall Study||260
10583187|NCT01727141|11738622|FG000|Full Analysis Set|Overall Study||258
10583188|NCT01727141|11738623|FG001|Full Analysis Set|Overall Study||260
10583189|NCT01727141|11738624|FG002|Full Analysis Set|Overall Study||261
10583190|NCT01727141|11738625|FG003|Full Analysis Set|Overall Study||261
10583191|NCT01727141|11738622|FG000|COMPLETED|Overall Study||255
10583192|NCT01727141|11738623|FG001|COMPLETED|Overall Study||251
10583193|NCT01727141|11738624|FG002|COMPLETED|Overall Study||258
10583194|NCT01727141|11738625|FG003|COMPLETED|Overall Study||246
10583195|NCT01727141|11738622|FG000|NOT COMPLETED|Overall Study||5
10583196|NCT01727141|11738623|FG001|NOT COMPLETED|Overall Study||9
10583197|NCT01727141|11738624|FG002|NOT COMPLETED|Overall Study||3
10583198|NCT01727141|11738625|FG003|NOT COMPLETED|Overall Study||15
10583199|NCT01727154|11738635|FG000|STARTED|Overall Study||139
10583200|NCT01727154|11738635|FG000|COMPLETED|Overall Study||80
10583201|NCT01727154|11738635|FG000|NOT COMPLETED|Overall Study||59
10583202|NCT01727180|11738639|FG000|STARTED|Overall Study||108
10583203|NCT01727180|11738639|FG000|COMPLETED|Overall Study||108
10583204|NCT01727180|11738639|FG000|NOT COMPLETED|Overall Study||0
10583205|NCT01727258|11738646|FG000|STARTED|Overall Study||51
10583206|NCT01727258|11738647|FG001|STARTED|Overall Study||51
10583207|NCT01727258|11738648|FG002|STARTED|Overall Study||51
10583208|NCT01727258|11738646|FG000|COMPLETED|Overall Study||49
10702799|NCT02577978|11867266|FG000|STARTED|Overall Study||32
10702800|NCT02577978|11867267|FG001|STARTED|Overall Study||29
10702801|NCT02577978|11867266|FG000|COMPLETED|Overall Study||25
10702802|NCT02577978|11867267|FG001|COMPLETED|Overall Study||25
10583209|NCT01727258|11738647|FG001|COMPLETED|Overall Study||48
10583210|NCT01727258|11738648|FG002|COMPLETED|Overall Study||50
10583211|NCT01727258|11738646|FG000|NOT COMPLETED|Overall Study||2
10583212|NCT01727258|11738647|FG001|NOT COMPLETED|Overall Study||3
10583213|NCT01727258|11738648|FG002|NOT COMPLETED|Overall Study||1
10583214|NCT01727297|11738656|FG000|STARTED|Overall Study||395
10583215|NCT01727297|11738657|FG001|STARTED|Overall Study||51
10583216|NCT01727297|11738656|FG000|COMPLETED|Overall Study||293
10702803|NCT02577978|11867266|FG000|NOT COMPLETED|Overall Study||7
10583217|NCT01727297|11738657|FG001|COMPLETED|Overall Study||0
10583218|NCT01727297|11738656|FG000|NOT COMPLETED|Overall Study||102
10583219|NCT01727297|11738657|FG001|NOT COMPLETED|Overall Study||51
10583220|NCT01727336|11738676|FG000|STARTED|Part 1 Dalantercept Dose Escalation||6
10583221|NCT01727336|11738677|FG001|STARTED|Part 1 Dalantercept Dose Escalation||9
10583222|NCT01727336|11738678|FG002|STARTED|Part 1 Dalantercept Dose Escalation||14
10583223|NCT01727336|11738679|FG003|STARTED|Part 1 Dalantercept Dose Escalation||0
10583224|NCT01727336|11738680|FG004|STARTED|Part 1 Dalantercept Dose Escalation||0
10583225|NCT01727336|11738681|FG005|STARTED|Part 1 Dalantercept Dose Escalation||0
10583226|NCT01727336|11738676|FG000|COMPLETED|Part 1 Dalantercept Dose Escalation||3
10583227|NCT01727336|11738677|FG001|COMPLETED|Part 1 Dalantercept Dose Escalation||7
10583228|NCT01727336|11738678|FG002|COMPLETED|Part 1 Dalantercept Dose Escalation||6
10583229|NCT01727336|11738679|FG003|COMPLETED|Part 1 Dalantercept Dose Escalation||0
10583230|NCT01727336|11738680|FG004|COMPLETED|Part 1 Dalantercept Dose Escalation||0
10583231|NCT01727336|11738681|FG005|COMPLETED|Part 1 Dalantercept Dose Escalation||0
10583232|NCT01727336|11738676|FG000|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||3
10583233|NCT01727336|11738677|FG001|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||2
10583234|NCT01727336|11738678|FG002|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||8
10583235|NCT01727336|11738679|FG003|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||0
10583236|NCT01727336|11738680|FG004|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||0
10583237|NCT01727336|11738681|FG005|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||0
10583238|NCT01727336|11738676|FG000|STARTED|Part 2 Blinded||0
10583239|NCT01727336|11738677|FG001|STARTED|Part 2 Blinded||0
10583240|NCT01727336|11738678|FG002|STARTED|Part 2 Blinded||0
10583241|NCT01727336|11738679|FG003|STARTED|Part 2 Blinded||0
10583242|NCT01727336|11738680|FG004|STARTED|Part 2 Blinded||63
10583243|NCT01727336|11738681|FG005|STARTED|Part 2 Blinded||68
10583244|NCT01727336|11738676|FG000|COMPLETED|Part 2 Blinded||0
10583245|NCT01727336|11738677|FG001|COMPLETED|Part 2 Blinded||0
10583246|NCT01727336|11738678|FG002|COMPLETED|Part 2 Blinded||0
10583247|NCT01727336|11738679|FG003|COMPLETED|Part 2 Blinded||0
10583248|NCT01727336|11738680|FG004|COMPLETED|Part 2 Blinded||0
10583249|NCT01727336|11738681|FG005|COMPLETED|Part 2 Blinded||0
10583250|NCT01727336|11738676|FG000|NOT COMPLETED|Part 2 Blinded||0
10583251|NCT01727336|11738677|FG001|NOT COMPLETED|Part 2 Blinded||0
10583252|NCT01727336|11738678|FG002|NOT COMPLETED|Part 2 Blinded||0
10583253|NCT01727336|11738679|FG003|NOT COMPLETED|Part 2 Blinded||0
10583254|NCT01727336|11738680|FG004|NOT COMPLETED|Part 2 Blinded||63
10583255|NCT01727336|11738681|FG005|NOT COMPLETED|Part 2 Blinded||68
10583256|NCT01727414|11738703|FG000|STARTED|Overall Study||126
10583257|NCT01727414|11738704|FG001|STARTED|Overall Study||45
10583258|NCT01727414|11738703|FG000|COMPLETED|Overall Study||123
10583259|NCT01727414|11738704|FG001|COMPLETED|Overall Study||45
10583260|NCT01727414|11738703|FG000|NOT COMPLETED|Overall Study||3
10583261|NCT01727414|11738704|FG001|NOT COMPLETED|Overall Study||0
10583262|NCT01727505|11738710|FG000|STARTED|First 24 Hours||14
10583263|NCT01727505|11738711|FG001|STARTED|First 24 Hours||12
10583264|NCT01727505|11738710|FG000|COMPLETED|First 24 Hours||14
10583265|NCT01727505|11738711|FG001|COMPLETED|First 24 Hours||11
10583266|NCT01727505|11738710|FG000|NOT COMPLETED|First 24 Hours||0
10583267|NCT01727505|11738711|FG001|NOT COMPLETED|First 24 Hours||1
10583268|NCT01727505|11738710|FG000|STARTED|Second 24 Hours||14
10583269|NCT01727505|11738711|FG001|STARTED|Second 24 Hours||11
10583270|NCT01727505|11738710|FG000|COMPLETED|Second 24 Hours||14
10583271|NCT01727505|11738711|FG001|COMPLETED|Second 24 Hours||10
10583272|NCT01727505|11738710|FG000|NOT COMPLETED|Second 24 Hours||0
10583273|NCT01727505|11738711|FG001|NOT COMPLETED|Second 24 Hours||1
10583274|NCT01727700|11738720|FG000|STARTED|Overall Study||44
10583275|NCT01727700|11738721|FG001|STARTED|Overall Study||45
10583276|NCT01727700|11738722|FG002|STARTED|Overall Study||44
10583277|NCT01727700|11738720|FG000|COMPLETED|Overall Study||42
10583278|NCT01727700|11738721|FG001|COMPLETED|Overall Study||35
10583279|NCT01727700|11738722|FG002|COMPLETED|Overall Study||42
10583280|NCT01727700|11738720|FG000|NOT COMPLETED|Overall Study||2
10583281|NCT01727700|11738721|FG001|NOT COMPLETED|Overall Study||10
10583282|NCT01727700|11738722|FG002|NOT COMPLETED|Overall Study||2
10583283|NCT01727713|11738730|FG000|STARTED|Overall Study||110
10583284|NCT01727713|11738730|FG000|COMPLETED|Overall Study||75
10583285|NCT01727713|11738730|FG000|NOT COMPLETED|Overall Study||35
10583286|NCT01727726|11738737|FG000|STARTED|Overall Study||197
10583287|NCT01727726|11738738|FG001|STARTED|Overall Study||100
10583288|NCT01727726|11738739|FG002|STARTED|Overall Study||206
10583289|NCT01727726|11738737|FG000|COMPLETED|Overall Study||171
10583290|NCT01727726|11738738|FG001|COMPLETED|Overall Study||86
10583291|NCT01727726|11738739|FG002|COMPLETED|Overall Study||186
10583292|NCT01727726|11738737|FG000|NOT COMPLETED|Overall Study||26
10583293|NCT01727726|11738738|FG001|NOT COMPLETED|Overall Study||14
10583294|NCT01727726|11738739|FG002|NOT COMPLETED|Overall Study||20
10583295|NCT01727765|11738749|FG000|STARTED|Overall Study||8
10583296|NCT01727765|11738750|FG001|STARTED|Overall Study||8
10583297|NCT01727765|11738749|FG000|COMPLETED|Overall Study||8
10583298|NCT01727765|11738750|FG001|COMPLETED|Overall Study||8
10583299|NCT01727765|11738749|FG000|NOT COMPLETED|Overall Study||0
10583300|NCT01727765|11738750|FG001|NOT COMPLETED|Overall Study||0
10583301|NCT01727791|11738756|FG000|STARTED|Overall Study||10
10583302|NCT01727791|11738756|FG000|COMPLETED|Overall Study||10
10583303|NCT01727791|11738756|FG000|NOT COMPLETED|Overall Study||0
10583304|NCT01727895|11738762|FG000|STARTED|Overall Study||10
10583305|NCT01727895|11738763|FG001|STARTED|Overall Study||5
10583306|NCT01727895|11738762|FG000|COMPLETED|Overall Study||10
10583307|NCT01727895|11738763|FG001|COMPLETED|Overall Study||5
10583308|NCT01727895|11738762|FG000|NOT COMPLETED|Overall Study||0
10583309|NCT01727895|11738763|FG001|NOT COMPLETED|Overall Study||0
10583310|NCT01728077|11738771|FG000|STARTED|Overall Study||19
10583311|NCT01728077|11738772|FG001|STARTED|Overall Study||7
10583312|NCT01728077|11738771|FG000|COMPLETED|Overall Study||11
10583313|NCT01728077|11738772|FG001|COMPLETED|Overall Study||2
10583314|NCT01728077|11738771|FG000|NOT COMPLETED|Overall Study||8
10583315|NCT01728077|11738772|FG001|NOT COMPLETED|Overall Study||5
10583316|NCT01728116|11738781|FG000|STARTED|Overall Study|EndoBarrier mITT Subjects|213
10702804|NCT02577978|11867267|FG001|NOT COMPLETED|Overall Study||4
10702805|NCT02577991|11867276|FG000|STARTED|Overall Study||24
10702806|NCT02577991|11867277|FG001|STARTED|Overall Study||27
10702807|NCT02577991|11867278|FG002|STARTED|Overall Study||29
10806720|NCT03951805|11968333|FG001|Full Analysis Set (FAS)|Overall Study||51
10583317|NCT01728116|11738782|FG001|STARTED|Overall Study|Sham mITT subjects|107
10583318|NCT01728116|11738781|FG000|COMPLETED|Overall Study|Completed to Week 78|52
10583319|NCT01728116|11738782|FG001|COMPLETED|Overall Study|Completed to Week 52|60
10583320|NCT01728116|11738781|FG000|NOT COMPLETED|Overall Study||161
10583321|NCT01728116|11738782|FG001|NOT COMPLETED|Overall Study||47
10583322|NCT01728194|11738791|FG000|STARTED|Overall Study||54
10583323|NCT01728194|11738792|FG001|STARTED|Overall Study||67
10583324|NCT01728194|11738791|FG000|COMPLETED|Overall Study||34
10583325|NCT01728194|11738792|FG001|COMPLETED|Overall Study||61
10583326|NCT01728194|11738791|FG000|NOT COMPLETED|Overall Study||20
10583327|NCT01728194|11738792|FG001|NOT COMPLETED|Overall Study||6
10583328|NCT01728246|11738800|FG000|STARTED|Overall Study||242
10583329|NCT01728246|11738801|FG001|STARTED|Overall Study||231
10583330|NCT01728246|11738800|FG000|COMPLETED|Overall Study||206
10583331|NCT01728246|11738801|FG001|COMPLETED|Overall Study||195
10583332|NCT01728246|11738800|FG000|NOT COMPLETED|Overall Study||36
10583333|NCT01728246|11738801|FG001|NOT COMPLETED|Overall Study||36
10583334|NCT01728324|11738810|FG000|STARTED|Termination of DBV||211
10583335|NCT01728324|11738811|FG001|STARTED|Termination of DBV||213
10583336|NCT01728324|11738812|FG002|STARTED|Termination of DBV||72
10583337|NCT01728324|11738810|FG000|COMPLETED|Termination of DBV||173
10583338|NCT01728324|11738811|FG001|COMPLETED|Termination of DBV||177
10583339|NCT01728324|11738812|FG002|COMPLETED|Termination of DBV||58
10583340|NCT01728324|11738810|FG000|NOT COMPLETED|Termination of DBV||38
10583341|NCT01728324|11738811|FG001|NOT COMPLETED|Termination of DBV||36
10583342|NCT01728324|11738812|FG002|NOT COMPLETED|Termination of DBV||14
10583343|NCT01728324|11738810|FG000|STARTED|Termination of FDV||211
10583344|NCT01728324|11738811|FG001|STARTED|Termination of FDV||213
10583345|NCT01728324|11738812|FG002|STARTED|Termination of FDV||72
10583346|NCT01728324|11738810|FG000|COMPLETED|Termination of FDV||173
10583347|NCT01728324|11738811|FG001|COMPLETED|Termination of FDV||177
10583348|NCT01728324|11738812|FG002|COMPLETED|Termination of FDV||58
10583349|NCT01728324|11738810|FG000|NOT COMPLETED|Termination of FDV||38
10583350|NCT01728324|11738811|FG001|NOT COMPLETED|Termination of FDV||36
10583351|NCT01728324|11738812|FG002|NOT COMPLETED|Termination of FDV||14
10583352|NCT01728324|11738810|FG000|STARTED|Termination of RBV||211
10583353|NCT01728324|11738811|FG001|STARTED|Termination of RBV||213
10583354|NCT01728324|11738812|FG002|STARTED|Termination of RBV||72
10583355|NCT01728324|11738810|FG000|COMPLETED|Termination of RBV||172
10583356|NCT01728324|11738811|FG001|COMPLETED|Termination of RBV||176
10583357|NCT01728324|11738812|FG002|COMPLETED|Termination of RBV||57
10583358|NCT01728324|11738810|FG000|NOT COMPLETED|Termination of RBV||39
10583359|NCT01728324|11738811|FG001|NOT COMPLETED|Termination of RBV||37
10583360|NCT01728324|11738812|FG002|NOT COMPLETED|Termination of RBV||15
10583361|NCT01728337|11738822|FG000|STARTED|Overall Study||80
10583362|NCT01728337|11738822|FG000|COMPLETED|Overall Study||80
10583363|NCT01728337|11738822|FG000|NOT COMPLETED|Overall Study||0
10583364|NCT01728376|11738834|FG000|STARTED|Overall Study||22
10702808|NCT02577991|11867276|FG000|COMPLETED|Overall Study||21
10583365|NCT01728376|11738835|FG001|STARTED|Overall Study||11
10583366|NCT01728376|11738836|FG002|STARTED|Overall Study||19
10583367|NCT01728376|11738837|FG003|STARTED|Overall Study||9
10583368|NCT01728376|11738838|FG004|STARTED|Overall Study||14
10583369|NCT01728376|11738839|FG005|STARTED|Overall Study||7
10583370|NCT01728376|11738834|FG000|Treated|Overall Study||22
10702809|NCT02577991|11867277|FG001|COMPLETED|Overall Study||25
10583371|NCT01728376|11738835|FG001|Treated|Overall Study||10
10583372|NCT01728376|11738836|FG002|Treated|Overall Study||19
10583373|NCT01728376|11738837|FG003|Treated|Overall Study||9
10583374|NCT01728376|11738838|FG004|Treated|Overall Study||14
10583375|NCT01728376|11738839|FG005|Treated|Overall Study||7
10702810|NCT02577991|11867278|FG002|COMPLETED|Overall Study||29
10702811|NCT02577991|11867276|FG000|NOT COMPLETED|Overall Study||3
10583376|NCT01728376|11738834|FG000|COMPLETED|Overall Study||18
10583377|NCT01728376|11738835|FG001|COMPLETED|Overall Study||9
10583378|NCT01728376|11738836|FG002|COMPLETED|Overall Study||17
10702812|NCT02577991|11867277|FG001|NOT COMPLETED|Overall Study||2
10702813|NCT02577991|11867278|FG002|NOT COMPLETED|Overall Study||0
10583379|NCT01728376|11738837|FG003|COMPLETED|Overall Study||7
10583380|NCT01728376|11738838|FG004|COMPLETED|Overall Study||12
10583381|NCT01728376|11738839|FG005|COMPLETED|Overall Study||5
10583382|NCT01728376|11738834|FG000|NOT COMPLETED|Overall Study||4
10583383|NCT01728376|11738835|FG001|NOT COMPLETED|Overall Study||2
10702814|NCT02578186|11867286|FG000|STARTED|Period 1 (First of Crossover)||17
10583384|NCT01728376|11738836|FG002|NOT COMPLETED|Overall Study||2
10583385|NCT01728376|11738837|FG003|NOT COMPLETED|Overall Study||2
10583386|NCT01728376|11738838|FG004|NOT COMPLETED|Overall Study||2
10583387|NCT01728376|11738839|FG005|NOT COMPLETED|Overall Study||2
10583388|NCT01728454|11738856|FG000|STARTED|Stage 1 and 2||17
10583389|NCT01728454|11738857|FG001|STARTED|Stage 1 and 2||20
10583390|NCT01728454|11738858|FG002|STARTED|Stage 1 and 2||23
10583391|NCT01728454|11738856|FG000|COMPLETED|Stage 1 and 2||12
10583392|NCT01728454|11738857|FG001|COMPLETED|Stage 1 and 2||16
10702815|NCT02578186|11867287|FG001|STARTED|Period 1 (First of Crossover)||18
10702816|NCT02578186|11867286|FG000|COMPLETED|Period 1 (First of Crossover)||12
10702817|NCT02578186|11867287|FG001|COMPLETED|Period 1 (First of Crossover)||13
10702818|NCT02578186|11867286|FG000|NOT COMPLETED|Period 1 (First of Crossover)||5
10702819|NCT02578186|11867287|FG001|NOT COMPLETED|Period 1 (First of Crossover)||5
10702820|NCT02578186|11867286|FG000|STARTED|Period 2 (Second of Crossover)||12
10583393|NCT01728454|11738858|FG002|COMPLETED|Stage 1 and 2||19
10583394|NCT01728454|11738856|FG000|NOT COMPLETED|Stage 1 and 2||5
10583395|NCT01728454|11738857|FG001|NOT COMPLETED|Stage 1 and 2||4
10583396|NCT01728454|11738858|FG002|NOT COMPLETED|Stage 1 and 2||4
10583397|NCT01728454|11738856|FG000|STARTED|Stage 3|Eligible participants who opted to participate in Stage 3.|6
10583398|NCT01728454|11738857|FG001|STARTED|Stage 3|Eligible participants who opted to participate in Stage 3.|5
10583399|NCT01728454|11738858|FG002|STARTED|Stage 3|Eligible participants who opted to participate in Stage 3.|11
10583400|NCT01728454|11738856|FG000|COMPLETED|Stage 3||3
10583401|NCT01728454|11738857|FG001|COMPLETED|Stage 3||1
10583402|NCT01728454|11738858|FG002|COMPLETED|Stage 3||7
10583403|NCT01728454|11738856|FG000|NOT COMPLETED|Stage 3||3
10583404|NCT01728454|11738857|FG001|NOT COMPLETED|Stage 3||4
10583405|NCT01728454|11738858|FG002|NOT COMPLETED|Stage 3||4
10583406|NCT01728584|11738873|FG000|STARTED|Overall Study|Randomized|36
10583407|NCT01728584|11738874|FG001|STARTED|Overall Study|Randomized - NMB/pressure conditions were changed in 7 (2 to Std/Std, 4 to Deep/Std, 1 to Deep/Low)|30
10583408|NCT01728584|11738875|FG002|STARTED|Overall Study|Randomized|31
10583409|NCT01728584|11738876|FG003|STARTED|Overall Study|Randomized - NMB/pressure conditions were changed in 5 (all to Deep/Std)|30
10583410|NCT01728584|11738873|FG000|COMPLETED|Overall Study||28
10583411|NCT01728584|11738874|FG001|COMPLETED|Overall Study||30
10583412|NCT01728584|11738875|FG002|COMPLETED|Overall Study||30
10583413|NCT01728584|11738876|FG003|COMPLETED|Overall Study||29
10583414|NCT01728584|11738873|FG000|NOT COMPLETED|Overall Study||8
10583415|NCT01728584|11738874|FG001|NOT COMPLETED|Overall Study||0
10583416|NCT01728584|11738875|FG002|NOT COMPLETED|Overall Study||1
10583417|NCT01728584|11738876|FG003|NOT COMPLETED|Overall Study||1
10583418|NCT01728623|11738893|FG000|STARTED|Overall Study||51
10583419|NCT01728623|11738893|FG000|DTC|Overall Study||25
10583420|NCT01728623|11738893|FG000|MTC|Overall Study||9
10583421|NCT01728623|11738893|FG000|ATC|Overall Study||17
10583422|NCT01728623|11738893|FG000|COMPLETED|Overall Study||23
10583423|NCT01728623|11738893|FG000|NOT COMPLETED|Overall Study||28
10583424|NCT01728636|11738902|FG000|STARTED|Overall Study||31
10583425|NCT01728636|11738903|FG001|STARTED|Overall Study||30
10583426|NCT01728636|11738902|FG000|COMPLETED|Overall Study||31
10583427|NCT01728636|11738903|FG001|COMPLETED|Overall Study||30
10583428|NCT01728636|11738902|FG000|NOT COMPLETED|Overall Study||0
10583429|NCT01728636|11738903|FG001|NOT COMPLETED|Overall Study||0
10583430|NCT01728779|11738909|FG000|STARTED|Overall Study||38
10583431|NCT01728779|11738909|FG000|COMPLETED|Overall Study||37
10583432|NCT01728779|11738909|FG000|NOT COMPLETED|Overall Study||1
10583433|NCT01728792|11738918|FG000|STARTED|Overall Study||14
10583434|NCT01728792|11738919|FG001|STARTED|Overall Study||16
10583435|NCT01728792|11738920|FG002|STARTED|Overall Study||17
10583436|NCT01728792|11738921|FG003|STARTED|Overall Study||17
10583437|NCT01728792|11738922|FG004|STARTED|Overall Study||16
10583438|NCT01728792|11738918|FG000|COMPLETED|Overall Study||11
10583439|NCT01728792|11738919|FG001|COMPLETED|Overall Study||14
10583440|NCT01728792|11738920|FG002|COMPLETED|Overall Study||13
10583441|NCT01728792|11738921|FG003|COMPLETED|Overall Study||14
10583442|NCT01728792|11738922|FG004|COMPLETED|Overall Study||16
10583443|NCT01728792|11738918|FG000|NOT COMPLETED|Overall Study||3
10583444|NCT01728792|11738919|FG001|NOT COMPLETED|Overall Study||2
10583445|NCT01728792|11738920|FG002|NOT COMPLETED|Overall Study||4
10583446|NCT01728792|11738921|FG003|NOT COMPLETED|Overall Study||3
10583447|NCT01728792|11738922|FG004|NOT COMPLETED|Overall Study||0
10702821|NCT02578186|11867287|FG001|STARTED|Period 2 (Second of Crossover)||13
10583466|NCT01728844|11738949|FG000|STARTED|Overall Study||22
10583467|NCT01728844|11738950|FG001|STARTED|Overall Study||21
10583468|NCT01728844|11738951|FG002|STARTED|Overall Study||22
10583469|NCT01728844|11738952|FG003|STARTED|Overall Study||23
10583470|NCT01728844|11738949|FG000|COMPLETED|Overall Study||21
10583471|NCT01728844|11738950|FG001|COMPLETED|Overall Study||21
10583472|NCT01728844|11738951|FG002|COMPLETED|Overall Study||22
10583473|NCT01728844|11738952|FG003|COMPLETED|Overall Study||21
10583474|NCT01728844|11738949|FG000|NOT COMPLETED|Overall Study||1
10583475|NCT01728844|11738950|FG001|NOT COMPLETED|Overall Study||0
10583476|NCT01728844|11738951|FG002|NOT COMPLETED|Overall Study||0
10583477|NCT01728844|11738952|FG003|NOT COMPLETED|Overall Study||2
10583478|NCT01729026|11738964|FG000|STARTED|Randomization to 3-month Follow-up||9
10583479|NCT01729026|11738965|FG001|STARTED|Randomization to 3-month Follow-up||10
10583480|NCT01729026|11738964|FG000|COMPLETED|Randomization to 3-month Follow-up||7
10583481|NCT01729026|11738965|FG001|COMPLETED|Randomization to 3-month Follow-up||8
10583482|NCT01729026|11738964|FG000|NOT COMPLETED|Randomization to 3-month Follow-up||2
10583483|NCT01729026|11738965|FG001|NOT COMPLETED|Randomization to 3-month Follow-up||2
10583484|NCT01729026|11738964|FG000|STARTED|3-month to 6-month (Final) Follow-up||7
10583485|NCT01729026|11738965|FG001|STARTED|3-month to 6-month (Final) Follow-up||8
10583486|NCT01729026|11738964|FG000|COMPLETED|3-month to 6-month (Final) Follow-up||6
10583487|NCT01729026|11738965|FG001|COMPLETED|3-month to 6-month (Final) Follow-up||6
10583488|NCT01729026|11738964|FG000|NOT COMPLETED|3-month to 6-month (Final) Follow-up||1
10583489|NCT01729026|11738965|FG001|NOT COMPLETED|3-month to 6-month (Final) Follow-up||2
10583490|NCT01729039|11738976|FG000|STARTED|Overall Study||23
10583491|NCT01729039|11738977|FG001|STARTED|Overall Study||26
10583492|NCT01729039|11738976|FG000|COMPLETED|Overall Study||13
10583493|NCT01729039|11738977|FG001|COMPLETED|Overall Study||14
10583494|NCT01729039|11738976|FG000|NOT COMPLETED|Overall Study||10
10583495|NCT01729039|11738977|FG001|NOT COMPLETED|Overall Study||12
10583496|NCT01729156|11738989|FG000|STARTED|Overall Study||12
10583497|NCT01729156|11738990|FG001|STARTED|Overall Study||12
10583498|NCT01729156|11738991|FG002|STARTED|Overall Study||12
10583499|NCT01729156|11738989|FG000|COMPLETED|Overall Study||11
10583500|NCT01729156|11738990|FG001|COMPLETED|Overall Study||12
10583501|NCT01729156|11738991|FG002|COMPLETED|Overall Study||12
10583502|NCT01729156|11738989|FG000|NOT COMPLETED|Overall Study||1
10583503|NCT01729156|11738990|FG001|NOT COMPLETED|Overall Study||0
10583504|NCT01729156|11738991|FG002|NOT COMPLETED|Overall Study||0
10583505|NCT01729208|11739002|FG000|STARTED|Baseline||70
10583506|NCT01729208|11739003|FG001|STARTED|Baseline||74
10583507|NCT01729208|11739002|FG000|COMPLETED|Baseline||65
10583508|NCT01729208|11739003|FG001|COMPLETED|Baseline||70
10583509|NCT01729208|11739002|FG000|NOT COMPLETED|Baseline||5
10583510|NCT01729208|11739003|FG001|NOT COMPLETED|Baseline||4
10583511|NCT01729208|11739002|FG000|STARTED|12 Months Follow-up||65
10702822|NCT02578186|11867286|FG000|COMPLETED|Period 2 (Second of Crossover)||12
10702823|NCT02578186|11867287|FG001|COMPLETED|Period 2 (Second of Crossover)||13
10702824|NCT02578186|11867286|FG000|NOT COMPLETED|Period 2 (Second of Crossover)||0
10702825|NCT02578186|11867287|FG001|NOT COMPLETED|Period 2 (Second of Crossover)||0
10702826|NCT02578199|11867293|FG000|STARTED|Overall Study||31
10702827|NCT02578199|11867293|FG000|COMPLETED|Overall Study||27
10583512|NCT01729208|11739003|FG001|STARTED|12 Months Follow-up||70
10583513|NCT01729208|11739002|FG000|COMPLETED|12 Months Follow-up||58
10583514|NCT01729208|11739003|FG001|COMPLETED|12 Months Follow-up||60
10583515|NCT01729208|11739002|FG000|NOT COMPLETED|12 Months Follow-up||7
10583516|NCT01729208|11739003|FG001|NOT COMPLETED|12 Months Follow-up||10
10583517|NCT01729208|11739002|FG000|STARTED|24 Months Follow-up||58
10583518|NCT01729208|11739003|FG001|STARTED|24 Months Follow-up||60
10583519|NCT01729208|11739002|FG000|COMPLETED|24 Months Follow-up||55
10583520|NCT01729208|11739003|FG001|COMPLETED|24 Months Follow-up||60
10583521|NCT01729208|11739002|FG000|NOT COMPLETED|24 Months Follow-up||3
10583522|NCT01729208|11739003|FG001|NOT COMPLETED|24 Months Follow-up||0
10583523|NCT01729208|11739002|FG000|STARTED|36 Months Follow-up||55
10583524|NCT01729208|11739003|FG001|STARTED|36 Months Follow-up||60
10583525|NCT01729208|11739002|FG000|COMPLETED|36 Months Follow-up||52
10583526|NCT01729208|11739003|FG001|COMPLETED|36 Months Follow-up||56
10583527|NCT01729208|11739002|FG000|NOT COMPLETED|36 Months Follow-up||3
10702828|NCT02578199|11867293|FG000|NOT COMPLETED|Overall Study||4
10702829|NCT02578238|11867297|FG000|STARTED|Overall Study||143
10702830|NCT02578238|11867297|FG000|COMPLETED|Overall Study||143
10702831|NCT02578238|11867297|FG000|NOT COMPLETED|Overall Study||0
10702832|NCT02578316|11867301|FG000|STARTED|Study Phase||6
10702833|NCT02578316|11867301|FG000|COMPLETED|Study Phase||6
10702834|NCT02578316|11867301|FG000|NOT COMPLETED|Study Phase||0
10583528|NCT01729208|11739003|FG001|NOT COMPLETED|36 Months Follow-up||4
10583529|NCT01729247|11739009|FG000|STARTED|Overall Study||50
10583530|NCT01729247|11739009|FG000|COMPLETED|Overall Study||50
10583531|NCT01729247|11739009|FG000|NOT COMPLETED|Overall Study||0
10583532|NCT01729338|11739020|FG000|STARTED|Overall Study||16
10583533|NCT01729338|11739020|FG000|COMPLETED|Overall Study||14
10583534|NCT01729338|11739020|FG000|NOT COMPLETED|Overall Study||2
10583535|NCT01729494|11739027|FG000|STARTED|Overall Study||107
10583536|NCT01729494|11739028|FG001|STARTED|Overall Study||104
10583537|NCT01729494|11739029|FG002|STARTED|Overall Study||105
10583538|NCT01729494|11739027|FG000|COMPLETED|Overall Study||97
10702835|NCT02578316|11867301|FG000|STARTED|Extension Phase||6
10702836|NCT02578316|11867301|FG000|COMPLETED|Extension Phase||0
10583539|NCT01729494|11739028|FG001|COMPLETED|Overall Study||93
10583540|NCT01729494|11739029|FG002|COMPLETED|Overall Study||94
10583541|NCT01729494|11739027|FG000|NOT COMPLETED|Overall Study||10
10583542|NCT01729494|11739028|FG001|NOT COMPLETED|Overall Study||11
10583543|NCT01729494|11739029|FG002|NOT COMPLETED|Overall Study||11
10583544|NCT01729559|11739039|FG000|STARTED|Overall Study||251
10583545|NCT01729559|11739040|FG001|STARTED|Overall Study||244
10583546|NCT01729559|11739039|FG000|COMPLETED|Overall Study||220
10583547|NCT01729559|11739040|FG001|COMPLETED|Overall Study||216
10583548|NCT01729559|11739039|FG000|NOT COMPLETED|Overall Study||31
10583549|NCT01729559|11739040|FG001|NOT COMPLETED|Overall Study||28
10583550|NCT01729598|11739048|FG000|STARTED|Overall Study||10
10583551|NCT01729598|11739049|FG001|STARTED|Overall Study||4
10583552|NCT01729598|11739048|FG000|COMPLETED|Overall Study||10
10583553|NCT01729598|11739049|FG001|COMPLETED|Overall Study||4
10583554|NCT01729598|11739048|FG000|NOT COMPLETED|Overall Study||0
10583555|NCT01729598|11739049|FG001|NOT COMPLETED|Overall Study||0
10651664|NCT02177786|11811903|FG003|NOT COMPLETED|Overall Study||13
10651665|NCT02177812|11811922|FG000|STARTED|Part 1 (Median of 4 Weeks)||1
10651666|NCT02177812|11811923|FG001|STARTED|Part 1 (Median of 4 Weeks)||2
10651667|NCT02177812|11811924|FG002|STARTED|Part 1 (Median of 4 Weeks)||7
10651668|NCT02177812|11811925|FG003|STARTED|Part 1 (Median of 4 Weeks)||5
10651669|NCT02177812|11811926|FG004|STARTED|Part 1 (Median of 4 Weeks)||6
10651670|NCT02177812|11811927|FG005|STARTED|Part 1 (Median of 4 Weeks)||4
10651671|NCT02177812|11811928|FG006|STARTED|Part 1 (Median of 4 Weeks)||10
10651672|NCT02177812|11811929|FG007|STARTED|Part 1 (Median of 4 Weeks)||6
10651673|NCT02177812|11811930|FG008|STARTED|Part 1 (Median of 4 Weeks)||0
10651674|NCT02177812|11811922|FG000|COMPLETED|Part 1 (Median of 4 Weeks)||1
10651675|NCT02177812|11811923|FG001|COMPLETED|Part 1 (Median of 4 Weeks)||2
10651676|NCT02177812|11811924|FG002|COMPLETED|Part 1 (Median of 4 Weeks)||7
10651677|NCT02177812|11811925|FG003|COMPLETED|Part 1 (Median of 4 Weeks)||4
10651678|NCT02177812|11811926|FG004|COMPLETED|Part 1 (Median of 4 Weeks)||5
10651679|NCT02177812|11811927|FG005|COMPLETED|Part 1 (Median of 4 Weeks)||1
10651680|NCT02177812|11811928|FG006|COMPLETED|Part 1 (Median of 4 Weeks)||1
10651681|NCT02177812|11811929|FG007|COMPLETED|Part 1 (Median of 4 Weeks)||4
10651682|NCT02177812|11811930|FG008|COMPLETED|Part 1 (Median of 4 Weeks)||0
10651683|NCT02177812|11811922|FG000|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
10651684|NCT02177812|11811923|FG001|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
10651685|NCT02177812|11811924|FG002|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
10651686|NCT02177812|11811925|FG003|NOT COMPLETED|Part 1 (Median of 4 Weeks)||1
10651687|NCT02177812|11811926|FG004|NOT COMPLETED|Part 1 (Median of 4 Weeks)||1
10651688|NCT02177812|11811927|FG005|NOT COMPLETED|Part 1 (Median of 4 Weeks)||3
10651689|NCT02177812|11811928|FG006|NOT COMPLETED|Part 1 (Median of 4 Weeks)||9
10702837|NCT02578316|11867301|FG000|NOT COMPLETED|Extension Phase||6
10702838|NCT02578706|11867312|FG000|STARTED|Overall Study||9
10702839|NCT02578706|11867313|FG001|STARTED|Overall Study||10
10702840|NCT02578706|11867314|FG002|STARTED|Overall Study||8
10702841|NCT02578706|11867312|FG000|COMPLETED|Overall Study||8
10702842|NCT02578706|11867313|FG001|COMPLETED|Overall Study||5
10651690|NCT02177812|11811929|FG007|NOT COMPLETED|Part 1 (Median of 4 Weeks)||2
10651691|NCT02177812|11811930|FG008|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
10651692|NCT02177812|11811922|FG000|STARTED|Part 2 (Up to 14 Months)||0
10651693|NCT02177812|11811923|FG001|STARTED|Part 2 (Up to 14 Months)||0
10651694|NCT02177812|11811924|FG002|STARTED|Part 2 (Up to 14 Months)||0
10651695|NCT02177812|11811925|FG003|STARTED|Part 2 (Up to 14 Months)||0
10651696|NCT02177812|11811926|FG004|STARTED|Part 2 (Up to 14 Months)||0
10651697|NCT02177812|11811927|FG005|STARTED|Part 2 (Up to 14 Months)||0
10651698|NCT02177812|11811928|FG006|STARTED|Part 2 (Up to 14 Months)||0
10651699|NCT02177812|11811929|FG007|STARTED|Part 2 (Up to 14 Months)||0
10651700|NCT02177812|11811930|FG008|STARTED|Part 2 (Up to 14 Months)||0
10651701|NCT02177812|11811922|FG000|COMPLETED|Part 2 (Up to 14 Months)||0
10651702|NCT02177812|11811923|FG001|COMPLETED|Part 2 (Up to 14 Months)||0
10651703|NCT02177812|11811924|FG002|COMPLETED|Part 2 (Up to 14 Months)||0
10651704|NCT02177812|11811925|FG003|COMPLETED|Part 2 (Up to 14 Months)||0
10651705|NCT02177812|11811926|FG004|COMPLETED|Part 2 (Up to 14 Months)||0
10651706|NCT02177812|11811927|FG005|COMPLETED|Part 2 (Up to 14 Months)||0
10651707|NCT02177812|11811928|FG006|COMPLETED|Part 2 (Up to 14 Months)||0
10651708|NCT02177812|11811929|FG007|COMPLETED|Part 2 (Up to 14 Months)||0
10651709|NCT02177812|11811930|FG008|COMPLETED|Part 2 (Up to 14 Months)||0
10651710|NCT02177812|11811922|FG000|NOT COMPLETED|Part 2 (Up to 14 Months)||0
10651711|NCT02177812|11811923|FG001|NOT COMPLETED|Part 2 (Up to 14 Months)||0
10651712|NCT02177812|11811924|FG002|NOT COMPLETED|Part 2 (Up to 14 Months)||0
10651713|NCT02177812|11811925|FG003|NOT COMPLETED|Part 2 (Up to 14 Months)||0
10651714|NCT02177812|11811926|FG004|NOT COMPLETED|Part 2 (Up to 14 Months)||0
10651715|NCT02177812|11811927|FG005|NOT COMPLETED|Part 2 (Up to 14 Months)||0
10651716|NCT02177812|11811928|FG006|NOT COMPLETED|Part 2 (Up to 14 Months)||0
10651717|NCT02177812|11811929|FG007|NOT COMPLETED|Part 2 (Up to 14 Months)||0
10651718|NCT02177812|11811930|FG008|NOT COMPLETED|Part 2 (Up to 14 Months)||0
10651719|NCT02177838|11811959|FG000|STARTED|Overall Study||8
10651720|NCT02177838|11811959|FG000|COMPLETED|Overall Study||5
10651721|NCT02177838|11811959|FG000|NOT COMPLETED|Overall Study||3
10651722|NCT02177942|11811965|FG000|STARTED|Overall Study||262
10651723|NCT02177942|11811966|FG001|STARTED|Overall Study||266
10702843|NCT02578706|11867314|FG002|COMPLETED|Overall Study||8
10651724|NCT02177942|11811965|FG000|COMPLETED|Overall Study||185
10702844|NCT02578706|11867312|FG000|NOT COMPLETED|Overall Study||1
10583556|NCT01729728|11739058|FG000|STARTED|Overall Study||21
10583557|NCT01729728|11739059|FG001|STARTED|Overall Study||28
10583558|NCT01729728|11739060|FG002|STARTED|Overall Study||17
10583559|NCT01729728|11739058|FG000|COMPLETED|Overall Study||20
10583560|NCT01729728|11739059|FG001|COMPLETED|Overall Study||22
10583561|NCT01729728|11739060|FG002|COMPLETED|Overall Study||16
10583562|NCT01729728|11739058|FG000|NOT COMPLETED|Overall Study||1
10583563|NCT01729728|11739059|FG001|NOT COMPLETED|Overall Study||6
10583564|NCT01729728|11739060|FG002|NOT COMPLETED|Overall Study||1
10583565|NCT01729819|11739193|FG000|STARTED|Overall Study||49
10583566|NCT01729819|11739194|FG001|STARTED|Overall Study||57
10583567|NCT01729819|11739193|FG000|COMPLETED|Overall Study||43
10583568|NCT01729819|11739194|FG001|COMPLETED|Overall Study||50
10583569|NCT01729819|11739193|FG000|NOT COMPLETED|Overall Study||6
10583570|NCT01729819|11739194|FG001|NOT COMPLETED|Overall Study||7
10583571|NCT01729845|11739206|FG000|STARTED|Safety/Tolerability of Dec/MEC||6
10583572|NCT01729845|11739207|FG001|STARTED|Safety/Tolerability of Dec/MEC||34
10583573|NCT01729845|11739208|FG002|STARTED|Safety/Tolerability of Dec/MEC||12
10583574|NCT01729845|11739206|FG000|COMPLETED|Safety/Tolerability of Dec/MEC||6
10583575|NCT01729845|11739207|FG001|COMPLETED|Safety/Tolerability of Dec/MEC||34
10583576|NCT01729845|11739208|FG002|COMPLETED|Safety/Tolerability of Dec/MEC||12
10583577|NCT01729845|11739206|FG000|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
10583578|NCT01729845|11739207|FG001|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
10583579|NCT01729845|11739208|FG002|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
10583580|NCT01729845|11739206|FG000|STARTED|Efficacy of Dec/MEC||0
10583581|NCT01729845|11739207|FG001|STARTED|Efficacy of Dec/MEC||22
10583582|NCT01729845|11739208|FG002|STARTED|Efficacy of Dec/MEC||0
10583583|NCT01729845|11739206|FG000|COMPLETED|Efficacy of Dec/MEC||0
10583584|NCT01729845|11739207|FG001|COMPLETED|Efficacy of Dec/MEC||22
10583585|NCT01729845|11739208|FG002|COMPLETED|Efficacy of Dec/MEC||0
10583586|NCT01729845|11739206|FG000|NOT COMPLETED|Efficacy of Dec/MEC||0
10583587|NCT01729845|11739207|FG001|NOT COMPLETED|Efficacy of Dec/MEC||0
10583588|NCT01729845|11739208|FG002|NOT COMPLETED|Efficacy of Dec/MEC||0
10583589|NCT01729871|11739220|FG000|STARTED|Overall Study||124
10583590|NCT01729871|11739221|FG001|STARTED|Overall Study||124
10583591|NCT01729871|11739220|FG000|COMPLETED|Overall Study||112
10583592|NCT01729871|11739221|FG001|COMPLETED|Overall Study||101
10583593|NCT01729871|11739220|FG000|NOT COMPLETED|Overall Study||12
10583594|NCT01729871|11739221|FG001|NOT COMPLETED|Overall Study||23
10583595|NCT01729923|11739227|FG000|STARTED|Overall Study||27
10583596|NCT01729923|11739227|FG000|COMPLETED|Overall Study||0
10583597|NCT01729923|11739227|FG000|NOT COMPLETED|Overall Study||27
10583598|NCT01730040|11739238|FG000|STARTED|Overall Study||57
10583599|NCT01730040|11739239|FG001|STARTED|Overall Study||55
10583600|NCT01730040|11739240|FG002|STARTED|Overall Study||57
10583601|NCT01730040|11739241|FG003|STARTED|Overall Study||47
10583602|NCT01730040|11739242|FG004|STARTED|Overall Study||45
10583603|NCT01730040|11739243|FG005|STARTED|Overall Study||47
10583604|NCT01730040|11739244|FG006|STARTED|Overall Study||47
10583605|NCT01730040|11739238|FG000|Treated|Overall Study||57
10583606|NCT01730040|11739239|FG001|Treated|Overall Study||55
10583607|NCT01730040|11739240|FG002|Treated|Overall Study||57
10583608|NCT01730040|11739241|FG003|Treated|Overall Study||47
10583609|NCT01730040|11739242|FG004|Treated|Overall Study||45
10583610|NCT01730040|11739243|FG005|Treated|Overall Study||46
10583611|NCT01730040|11739244|FG006|Treated|Overall Study||47
10583612|NCT01730040|11739238|FG000|COMPLETED|Overall Study||44
10583613|NCT01730040|11739239|FG001|COMPLETED|Overall Study||40
10583614|NCT01730040|11739240|FG002|COMPLETED|Overall Study||46
10583615|NCT01730040|11739241|FG003|COMPLETED|Overall Study||39
10583616|NCT01730040|11739242|FG004|COMPLETED|Overall Study||39
10583617|NCT01730040|11739243|FG005|COMPLETED|Overall Study||40
10583618|NCT01730040|11739244|FG006|COMPLETED|Overall Study||38
10583619|NCT01730040|11739238|FG000|NOT COMPLETED|Overall Study||13
10583620|NCT01730040|11739239|FG001|NOT COMPLETED|Overall Study||15
10583621|NCT01730040|11739240|FG002|NOT COMPLETED|Overall Study||11
10583622|NCT01730040|11739241|FG003|NOT COMPLETED|Overall Study||8
10583623|NCT01730040|11739242|FG004|NOT COMPLETED|Overall Study||6
10583624|NCT01730040|11739243|FG005|NOT COMPLETED|Overall Study||7
10583625|NCT01730040|11739244|FG006|NOT COMPLETED|Overall Study||9
10583626|NCT01730053|11739266|FG000|STARTED|Overall Study||48
10583627|NCT01730053|11739267|FG001|STARTED|Overall Study||48
10583628|NCT01730053|11739268|FG002|STARTED|Overall Study||49
10583629|NCT01730053|11739269|FG003|STARTED|Overall Study||53
10583630|NCT01730053|11739270|FG004|STARTED|Overall Study||53
10583631|NCT01730053|11739271|FG005|STARTED|Overall Study||54
10583632|NCT01730053|11739266|FG000|Treated|Overall Study||48
10583633|NCT01730053|11739267|FG001|Treated|Overall Study||48
10583634|NCT01730053|11739268|FG002|Treated|Overall Study||49
10583635|NCT01730053|11739269|FG003|Treated|Overall Study||53
10583636|NCT01730053|11739270|FG004|Treated|Overall Study||53
10583637|NCT01730053|11739271|FG005|Treated|Overall Study||54
10583638|NCT01730053|11739266|FG000|COMPLETED|Overall Study||43
10583639|NCT01730053|11739267|FG001|COMPLETED|Overall Study||34
10583640|NCT01730053|11739268|FG002|COMPLETED|Overall Study||38
10583641|NCT01730053|11739269|FG003|COMPLETED|Overall Study||45
10583642|NCT01730053|11739270|FG004|COMPLETED|Overall Study||44
10583643|NCT01730053|11739271|FG005|COMPLETED|Overall Study||41
10583644|NCT01730053|11739266|FG000|NOT COMPLETED|Overall Study||5
10583645|NCT01730053|11739267|FG001|NOT COMPLETED|Overall Study||14
10583646|NCT01730053|11739268|FG002|NOT COMPLETED|Overall Study||11
10583647|NCT01730053|11739269|FG003|NOT COMPLETED|Overall Study||8
10583648|NCT01730053|11739270|FG004|NOT COMPLETED|Overall Study||9
10583649|NCT01730053|11739271|FG005|NOT COMPLETED|Overall Study||13
10583650|NCT01730339|11739288|FG000|STARTED|Overall Study||45
10583651|NCT01730339|11739289|FG001|STARTED|Overall Study||55
10583652|NCT01730339|11739288|FG000|COMPLETED|Overall Study||40
10583653|NCT01730339|11739289|FG001|COMPLETED|Overall Study||52
10583654|NCT01730339|11739288|FG000|NOT COMPLETED|Overall Study||5
10583655|NCT01730339|11739289|FG001|NOT COMPLETED|Overall Study||3
10583656|NCT01730378|11739307|FG000|STARTED|Overall Study||84
10583657|NCT01730378|11739308|FG001|STARTED|Overall Study||47
10583658|NCT01730378|11739307|FG000|COMPLETED|Overall Study||83
10583659|NCT01730378|11739308|FG001|COMPLETED|Overall Study||47
10583660|NCT01730378|11739307|FG000|NOT COMPLETED|Overall Study||1
10583661|NCT01730378|11739308|FG001|NOT COMPLETED|Overall Study||0
10583662|NCT01730534|11739317|FG000|STARTED|Overall Study||8582
10583663|NCT01730534|11739318|FG001|STARTED|Overall Study||8578
10583664|NCT01730534|11739317|FG000|COMPLETED|Overall Study||8473
10583665|NCT01730534|11739318|FG001|COMPLETED|Overall Study||8433
10583666|NCT01730534|11739317|FG000|NOT COMPLETED|Overall Study||109
10583667|NCT01730534|11739318|FG001|NOT COMPLETED|Overall Study||145
10583668|NCT01730586|11739324|FG000|STARTED|Overall Study||34
10583669|NCT01730586|11739324|FG000|COMPLETED|Overall Study||21
10583670|NCT01730586|11739324|FG000|NOT COMPLETED|Overall Study||13
10583671|NCT01730729|11739330|FG000|STARTED|Overall Study||20
10583672|NCT01730729|11739330|FG000|Completed 2 Cycles/Reached 1st Response|Overall Study||18
10583673|NCT01730729|11739330|FG000|Treated Cycle 3 and Beyond|Overall Study||6
10583674|NCT01730729|11739330|FG000|COMPLETED|Overall Study||6
10583675|NCT01730729|11739330|FG000|NOT COMPLETED|Overall Study||14
10583676|NCT01730846|11739337|FG000|STARTED|Overall Study||11
10583677|NCT01730846|11739338|FG001|STARTED|Overall Study||11
10583678|NCT01730846|11739339|FG002|STARTED|Overall Study||13
10583679|NCT01730846|11739337|FG000|COMPLETED|Overall Study||11
10583680|NCT01730846|11739338|FG001|COMPLETED|Overall Study||11
10583681|NCT01730846|11739339|FG002|COMPLETED|Overall Study||13
10583682|NCT01730846|11739337|FG000|NOT COMPLETED|Overall Study||0
10583683|NCT01730846|11739338|FG001|NOT COMPLETED|Overall Study||0
10583684|NCT01730846|11739339|FG002|NOT COMPLETED|Overall Study||0
10583685|NCT01730872|11739350|FG000|STARTED|Overall Study||8
10583686|NCT01730872|11739351|FG001|STARTED|Overall Study||5
10583687|NCT01730872|11739352|FG002|STARTED|Overall Study||3
10583688|NCT01730872|11739350|FG000|Full Analysis Set|Overall Study||8
10583689|NCT01730872|11739351|FG001|Full Analysis Set|Overall Study|1 subject did not complete the last post-CAE measurement on Day 6 and was excluded from the FAS|4
10583690|NCT01730872|11739352|FG002|Full Analysis Set|Overall Study||0
10583691|NCT01730872|11739350|FG000|COMPLETED|Overall Study||8
10583692|NCT01730872|11739351|FG001|COMPLETED|Overall Study||5
10583693|NCT01730872|11739352|FG002|COMPLETED|Overall Study||3
10583694|NCT01730872|11739350|FG000|NOT COMPLETED|Overall Study||0
10583695|NCT01730872|11739351|FG001|NOT COMPLETED|Overall Study||0
10583696|NCT01730872|11739352|FG002|NOT COMPLETED|Overall Study||0
10583697|NCT01730950|11739361|FG000|STARTED|Overall Study||90
10583698|NCT01730950|11739362|FG001|STARTED|Overall Study||92
10583699|NCT01730950|11739361|FG000|Eligible Population|Overall Study||84
10583700|NCT01730950|11739362|FG001|Eligible Population|Overall Study||86
10583701|NCT01730950|11739361|FG000|Adverse Event Population|Overall Study||76
10583702|NCT01730950|11739362|FG001|Adverse Event Population|Overall Study||83
10583703|NCT01730950|11739361|FG000|Response Population|Overall Study||78
10583704|NCT01730950|11739362|FG001|Response Population|Overall Study||77
10583705|NCT01730950|11739361|FG000|6-month Progression-free Analysis|Overall Study||79
10583706|NCT01730950|11739362|FG001|6-month Progression-free Analysis|Overall Study||81
10583707|NCT01730950|11739361|FG000|Delayed Toxicity Population|Overall Study||0
10583708|NCT01730950|11739362|FG001|Delayed Toxicity Population|Overall Study||83
10583709|NCT01730950|11739361|FG000|COMPLETED|Overall Study||84
10583710|NCT01730950|11739362|FG001|COMPLETED|Overall Study||86
10583711|NCT01730950|11739361|FG000|NOT COMPLETED|Overall Study||6
10583712|NCT01730950|11739362|FG001|NOT COMPLETED|Overall Study||6
10583713|NCT01731002|11739372|FG000|STARTED|Overall Study||75
10702845|NCT02578706|11867313|FG001|NOT COMPLETED|Overall Study||5
10702846|NCT02578706|11867314|FG002|NOT COMPLETED|Overall Study||0
10702847|NCT02578745|11867324|FG000|STARTED|Overall Study||60
10702848|NCT02578745|11867325|FG001|STARTED|Overall Study||60
10702849|NCT02578745|11867324|FG000|COMPLETED|Overall Study||60
10702850|NCT02578745|11867325|FG001|COMPLETED|Overall Study||60
10702851|NCT02578745|11867324|FG000|NOT COMPLETED|Overall Study||0
10702852|NCT02578745|11867325|FG001|NOT COMPLETED|Overall Study||0
10713721|NCT02680847|11879220|FG001|COMPLETED|Overall Study||6
10806721|NCT03951805|11968334|FG002|Full Analysis Set (FAS)|Overall Study||52
10806722|NCT03951805|11968335|FG003|Full Analysis Set (FAS)|Overall Study||51
10583714|NCT01731002|11739373|FG001|STARTED|Overall Study||72
10583715|NCT01731002|11739374|FG002|STARTED|Overall Study||77
10583716|NCT01731002|11739372|FG000|COMPLETED|Overall Study||71
10583717|NCT01731002|11739373|FG001|COMPLETED|Overall Study||68
10583718|NCT01731002|11739374|FG002|COMPLETED|Overall Study||74
10713722|NCT02680847|11879221|FG002|COMPLETED|Overall Study||4
10713723|NCT02680847|11879219|FG000|NOT COMPLETED|Overall Study||5
10583719|NCT01731002|11739372|FG000|NOT COMPLETED|Overall Study||4
10583720|NCT01731002|11739373|FG001|NOT COMPLETED|Overall Study||4
10583721|NCT01731002|11739374|FG002|NOT COMPLETED|Overall Study||3
10583722|NCT01731041|11739384|FG000|STARTED|Overall Study||30
10583723|NCT01731041|11739385|FG001|STARTED|Overall Study||30
10583724|NCT01731041|11739384|FG000|COMPLETED|Overall Study||30
10583725|NCT01731041|11739385|FG001|COMPLETED|Overall Study||30
10583726|NCT01731041|11739384|FG000|NOT COMPLETED|Overall Study||0
10583727|NCT01731041|11739385|FG001|NOT COMPLETED|Overall Study||0
10583728|NCT01731119|11739391|FG000|STARTED|Overall Study||9
10583729|NCT01731119|11739391|FG000|COMPLETED|Overall Study||7
10583730|NCT01731119|11739391|FG000|NOT COMPLETED|Overall Study||2
10583731|NCT01731171|11739397|FG000|STARTED|Overall Study||33
10583732|NCT01731171|11739398|FG001|STARTED|Overall Study||33
10583733|NCT01731171|11739397|FG000|COMPLETED|Overall Study||26
10583734|NCT01731171|11739398|FG001|COMPLETED|Overall Study||26
10583735|NCT01731171|11739397|FG000|NOT COMPLETED|Overall Study||7
10583736|NCT01731171|11739398|FG001|NOT COMPLETED|Overall Study||7
10583737|NCT01731470|11739404|FG000|STARTED|Overall Study|Number of patients consented to participate in the study|16
10583738|NCT01731470|11739404|FG000|COMPLETED|Overall Study|Number of patients enrolled in the study|14
10583739|NCT01731470|11739404|FG000|NOT COMPLETED|Overall Study||2
10583740|NCT01731600|11739410|FG000|STARTED|Overall Study||34
10583741|NCT01731600|11739411|FG001|STARTED|Overall Study||34
10583742|NCT01731600|11739410|FG000|COMPLETED|Overall Study||28
10583743|NCT01731600|11739411|FG001|COMPLETED|Overall Study||34
10583744|NCT01731600|11739410|FG000|NOT COMPLETED|Overall Study||6
10583745|NCT01731600|11739411|FG001|NOT COMPLETED|Overall Study||0
10583746|NCT01731678|11739421|FG000|STARTED|Overall Study||39
10583747|NCT01731678|11739421|FG000|COMPLETED|Overall Study||32
10583748|NCT01731678|11739421|FG000|NOT COMPLETED|Overall Study||7
10583749|NCT01731691|11739428|FG000|STARTED|Overall Study||3
10583750|NCT01731691|11739429|FG001|STARTED|Overall Study||5
10583751|NCT01731691|11739430|FG002|STARTED|Overall Study||4
10583752|NCT01731691|11739428|FG000|COMPLETED|Overall Study||3
10583753|NCT01731691|11739429|FG001|COMPLETED|Overall Study||5
10583754|NCT01731691|11739430|FG002|COMPLETED|Overall Study||4
10702853|NCT02578862|11867334|FG000|STARTED|Overall Study||37
10702854|NCT02578862|11867335|FG001|STARTED|Overall Study||35
10702855|NCT02578862|11867334|FG000|COMPLETED|Overall Study||37
10702856|NCT02578862|11867335|FG001|COMPLETED|Overall Study||33
10702857|NCT02578862|11867334|FG000|NOT COMPLETED|Overall Study||0
10702858|NCT02578862|11867335|FG001|NOT COMPLETED|Overall Study||2
10702859|NCT02578901|11867343|FG000|STARTED|Overall Study||165
10702860|NCT02578901|11867344|FG001|STARTED|Overall Study||165
10702861|NCT02578901|11867343|FG000|COMPLETED|Overall Study||145
10702862|NCT02578901|11867344|FG001|COMPLETED|Overall Study||144
10702863|NCT02578901|11867343|FG000|NOT COMPLETED|Overall Study||20
10702864|NCT02578901|11867344|FG001|NOT COMPLETED|Overall Study||21
10702865|NCT02578940|11867350|FG000|STARTED|Overall Study||109
10702866|NCT02578940|11867350|FG000|Received 18F-fluciclovine|Overall Study||104
10702867|NCT02578940|11867350|FG000|COMPLETED|Overall Study||103
10702868|NCT02578940|11867350|FG000|NOT COMPLETED|Overall Study||6
10583755|NCT01731691|11739428|FG000|NOT COMPLETED|Overall Study||0
10583756|NCT01731691|11739429|FG001|NOT COMPLETED|Overall Study||0
10583757|NCT01731691|11739430|FG002|NOT COMPLETED|Overall Study||0
10583758|NCT01731886|11739443|FG000|STARTED|Overall Study||31
10583759|NCT01731886|11739444|FG001|STARTED|Overall Study||29
10583760|NCT01731886|11739443|FG000|COMPLETED|Overall Study||29
10583761|NCT01731886|11739444|FG001|COMPLETED|Overall Study||28
10583762|NCT01731886|11739443|FG000|NOT COMPLETED|Overall Study||2
10583763|NCT01731886|11739444|FG001|NOT COMPLETED|Overall Study||1
10583764|NCT01731912|11739451|FG000|STARTED|Overall Study||16
10583765|NCT01731912|11739451|FG000|COMPLETED|Overall Study||14
10583766|NCT01731912|11739451|FG000|NOT COMPLETED|Overall Study||2
10583767|NCT01731938|11739459|FG000|STARTED|Preliminary Part I||51
10583768|NCT01731938|11739460|FG001|STARTED|Preliminary Part I||52
10583769|NCT01731938|11739459|FG000|COMPLETED|Preliminary Part I||48
10583770|NCT01731938|11739460|FG001|COMPLETED|Preliminary Part I||44
10583771|NCT01731938|11739459|FG000|NOT COMPLETED|Preliminary Part I||3
10583772|NCT01731938|11739460|FG001|NOT COMPLETED|Preliminary Part I||8
10583773|NCT01731938|11739459|FG000|STARTED|Primary Part II|Preliminary Part I was for study team familiarization with FS Grifols application.|116
10583774|NCT01731938|11739460|FG001|STARTED|Primary Part II|Subjects from Preliminary Part I were not carried over to Primary Part II to assess safety/efficacy.|108
10583775|NCT01731938|11739459|FG000|COMPLETED|Primary Part II||103
10583776|NCT01731938|11739460|FG001|COMPLETED|Primary Part II||95
10583777|NCT01731938|11739459|FG000|NOT COMPLETED|Primary Part II||13
10583778|NCT01731938|11739460|FG001|NOT COMPLETED|Primary Part II||13
10583779|NCT01731951|11739473|FG000|STARTED|Overall Study||19
10583780|NCT01731951|11739474|FG001|STARTED|Overall Study||16
10583781|NCT01731951|11739475|FG002|STARTED|Overall Study||9
10583782|NCT01731951|11739476|FG003|STARTED|Overall Study||9
10583783|NCT01731951|11739477|FG004|STARTED|Overall Study||18
10583784|NCT01731951|11739478|FG005|STARTED|Overall Study||9
10702869|NCT02578992|11867358|FG000|STARTED|Overall Study|November 2014|65
10702870|NCT02578992|11867359|FG001|STARTED|Overall Study|November 2014|65
10583785|NCT01731951|11739473|FG000|COMPLETED|Overall Study||2
10583786|NCT01731951|11739474|FG001|COMPLETED|Overall Study||1
10583787|NCT01731951|11739475|FG002|COMPLETED|Overall Study||0
10583788|NCT01731951|11739476|FG003|COMPLETED|Overall Study||0
10702871|NCT02578992|11867358|FG000|COMPLETED|Overall Study|October 2015|62
10702872|NCT02578992|11867359|FG001|COMPLETED|Overall Study|October 2015|62
10702873|NCT02578992|11867358|FG000|NOT COMPLETED|Overall Study||3
10583789|NCT01731951|11739477|FG004|COMPLETED|Overall Study||6
10583790|NCT01731951|11739478|FG005|COMPLETED|Overall Study||0
10702874|NCT02578992|11867359|FG001|NOT COMPLETED|Overall Study||3
10702875|NCT02579057|11867373|FG000|STARTED|Overall Study||19
10583791|NCT01731951|11739473|FG000|NOT COMPLETED|Overall Study||17
10583792|NCT01731951|11739474|FG001|NOT COMPLETED|Overall Study||15
10583793|NCT01731951|11739475|FG002|NOT COMPLETED|Overall Study||9
10583794|NCT01731951|11739476|FG003|NOT COMPLETED|Overall Study||9
10583795|NCT01731951|11739477|FG004|NOT COMPLETED|Overall Study||12
10583796|NCT01731951|11739478|FG005|NOT COMPLETED|Overall Study||9
10583797|NCT01731990|11739498|FG000|STARTED|Overall Study|"Started indicates Safety and Pharmacodynamics set ."|18
10583798|NCT01731990|11739499|FG001|STARTED|Overall Study||20
10583799|NCT01731990|11739498|FG000|COMPLETED|Overall Study||14
10583800|NCT01731990|11739499|FG001|COMPLETED|Overall Study||12
10583801|NCT01731990|11739498|FG000|NOT COMPLETED|Overall Study||4
10583802|NCT01731990|11739499|FG001|NOT COMPLETED|Overall Study||8
10806723|NCT03951805|11968332|FG000|Safety Analysis Set (SAS)|Overall Study||51
10806724|NCT03951805|11968333|FG001|Safety Analysis Set (SAS)|Overall Study||51
10583806|NCT01732263|11739511|FG000|STARTED|Overall Study||23
10583807|NCT01732263|11739512|FG001|STARTED|Overall Study||20
10583808|NCT01732263|11739511|FG000|COMPLETED|Overall Study||23
10583809|NCT01732263|11739512|FG001|COMPLETED|Overall Study||20
10583810|NCT01732263|11739511|FG000|NOT COMPLETED|Overall Study||0
10583811|NCT01732263|11739512|FG001|NOT COMPLETED|Overall Study||0
10583812|NCT01732406|11739525|FG000|STARTED|Overall Study||31
10583813|NCT01732406|11739526|FG001|STARTED|Overall Study||60
10583814|NCT01732406|11739527|FG002|STARTED|Overall Study||35
10583815|NCT01732406|11739525|FG000|COMPLETED|Overall Study||31
10583816|NCT01732406|11739526|FG001|COMPLETED|Overall Study||60
10583817|NCT01732406|11739527|FG002|COMPLETED|Overall Study||35
10583818|NCT01732406|11739525|FG000|NOT COMPLETED|Overall Study||0
10583819|NCT01732406|11739526|FG001|NOT COMPLETED|Overall Study||0
10583820|NCT01732406|11739527|FG002|NOT COMPLETED|Overall Study||0
10583821|NCT01732419|11739541|FG000|STARTED|Overall Study||45
10583822|NCT01732419|11739542|FG001|STARTED|Overall Study||45
10583823|NCT01732419|11739541|FG000|COMPLETED|Overall Study||37
10583824|NCT01732419|11739542|FG001|COMPLETED|Overall Study||41
10583825|NCT01732419|11739541|FG000|NOT COMPLETED|Overall Study||8
10583826|NCT01732419|11739542|FG001|NOT COMPLETED|Overall Study||4
10583827|NCT01732445|11739548|FG000|STARTED|Overall Study||14
10583828|NCT01732445|11739548|FG000|COMPLETED|Overall Study||14
10583829|NCT01732445|11739548|FG000|NOT COMPLETED|Overall Study||0
10583830|NCT01732458|11739556|FG000|STARTED|Overall Study||60
10583831|NCT01732458|11739557|FG001|STARTED|Overall Study||58
10583832|NCT01732458|11739558|FG002|STARTED|Overall Study||58
10583833|NCT01732458|11739559|FG003|STARTED|Overall Study||52
10583834|NCT01732458|11739556|FG000|Treated|Overall Study||57
10583835|NCT01732458|11739557|FG001|Treated|Overall Study||55
10583836|NCT01732458|11739558|FG002|Treated|Overall Study||56
10583837|NCT01732458|11739559|FG003|Treated|Overall Study||52
10583838|NCT01732458|11739556|FG000|COMPLETED|Overall Study||57
10583839|NCT01732458|11739557|FG001|COMPLETED|Overall Study||53
10583840|NCT01732458|11739558|FG002|COMPLETED|Overall Study||55
10583841|NCT01732458|11739559|FG003|COMPLETED|Overall Study||50
10583842|NCT01732458|11739556|FG000|NOT COMPLETED|Overall Study||3
10583843|NCT01732458|11739557|FG001|NOT COMPLETED|Overall Study||5
10583844|NCT01732458|11739558|FG002|NOT COMPLETED|Overall Study||3
10583845|NCT01732458|11739559|FG003|NOT COMPLETED|Overall Study||2
10702876|NCT02579057|11867374|FG001|STARTED|Overall Study||21
10583846|NCT01732471|11739581|FG000|STARTED|Overall Study||90
10583847|NCT01732471|11739581|FG000|COMPLETED|Overall Study||89
10583848|NCT01732471|11739581|FG000|NOT COMPLETED|Overall Study||1
10583849|NCT01732484|11739585|FG000|STARTED|Overall Study||100
10583850|NCT01732484|11739585|FG000|Randomized|Overall Study|Randomized implantation SN60WF IOL in on eye and iMics NY-60 in the other eye.|100
10583851|NCT01732484|11739585|FG000|Allocation|Overall Study||100
10583852|NCT01732484|11739585|FG000|COMPLETED|Overall Study||74
10583853|NCT01732484|11739585|FG000|NOT COMPLETED|Overall Study||26
10583854|NCT01732510|11739598|FG000|STARTED|Overall Study||9
10583855|NCT01732510|11739599|FG001|STARTED|Overall Study||9
10583856|NCT01732510|11739600|FG002|STARTED|Overall Study||8
10583857|NCT01732510|11739601|FG003|STARTED|Overall Study||10
10583858|NCT01732510|11739602|FG004|STARTED|Overall Study||8
10583859|NCT01732510|11739603|FG005|STARTED|Overall Study||13
10583860|NCT01732510|11739604|FG006|STARTED|Overall Study||8
10583861|NCT01732510|11739598|FG000|COMPLETED|Overall Study||8
10583862|NCT01732510|11739599|FG001|COMPLETED|Overall Study||4
10583863|NCT01732510|11739600|FG002|COMPLETED|Overall Study||4
10583864|NCT01732510|11739601|FG003|COMPLETED|Overall Study||5
10583865|NCT01732510|11739602|FG004|COMPLETED|Overall Study||3
10583866|NCT01732510|11739603|FG005|COMPLETED|Overall Study||0
10583867|NCT01732510|11739604|FG006|COMPLETED|Overall Study||0
10583868|NCT01732510|11739598|FG000|NOT COMPLETED|Overall Study||1
10583869|NCT01732510|11739599|FG001|NOT COMPLETED|Overall Study||5
10583870|NCT01732510|11739600|FG002|NOT COMPLETED|Overall Study||4
10583871|NCT01732510|11739601|FG003|NOT COMPLETED|Overall Study||5
10583872|NCT01732510|11739602|FG004|NOT COMPLETED|Overall Study||5
10583873|NCT01732510|11739603|FG005|NOT COMPLETED|Overall Study||13
10583874|NCT01732510|11739604|FG006|NOT COMPLETED|Overall Study||8
10702877|NCT02579057|11867373|FG000|COMPLETED|Overall Study||19
10583875|NCT01732536|11739625|FG000|STARTED|Overall Study||53
10583876|NCT01732536|11739626|FG001|STARTED|Overall Study||47
10583877|NCT01732536|11739625|FG000|COMPLETED|Overall Study||52
10583878|NCT01732536|11739626|FG001|COMPLETED|Overall Study||46
10583879|NCT01732536|11739625|FG000|NOT COMPLETED|Overall Study||1
10702878|NCT02579057|11867374|FG001|COMPLETED|Overall Study||21
10583880|NCT01732536|11739626|FG001|NOT COMPLETED|Overall Study||1
10583881|NCT01732549|11739637|FG000|STARTED|Overall Study||71
10583882|NCT01732549|11739638|FG001|STARTED|Overall Study||73
10583883|NCT01732549|11739637|FG000|Ongoing in Treatment Period:Data Cut-off|Overall Study||12
10583884|NCT01732549|11739638|FG001|Ongoing in Treatment Period:Data Cut-off|Overall Study||12
10583885|NCT01732549|11739637|FG000|Withdrawn During Treatment:Data Cut-off|Overall Study|Withdrawn during treatment period 59 (AE 13, Consent withdrawn 13, Disease progression 31, Other 2)|59
10583886|NCT01732549|11739638|FG001|Withdrawn During Treatment:Data Cut-off|Overall Study|Withdrawn during treatment period 61 (AE 3, Consent withdrawn 6, Disease progression 46, Other 6)|61
10583887|NCT01732549|11739637|FG000|Ongoing Treatment Period:Final Analysis|Overall Study||0
10583888|NCT01732549|11739638|FG001|Ongoing Treatment Period:Final Analysis|Overall Study||0
10583889|NCT01732549|11739637|FG000|Withdrawn During Treatment:Final Analysi|Overall Study||71
10583890|NCT01732549|11739638|FG001|Withdrawn During Treatment:Final Analysi|Overall Study||73
10583891|NCT01732549|11739637|FG000|COMPLETED|Overall Study||0
10583892|NCT01732549|11739638|FG001|COMPLETED|Overall Study||0
10583893|NCT01732549|11739637|FG000|NOT COMPLETED|Overall Study||71
10583894|NCT01732549|11739638|FG001|NOT COMPLETED|Overall Study||73
10583895|NCT01732588|11739648|FG000|STARTED|First Intervention (7 Days)||4
10583896|NCT01732588|11739649|FG001|STARTED|First Intervention (7 Days)||3
10583897|NCT01732588|11739650|FG002|STARTED|First Intervention (7 Days)||4
10583898|NCT01732588|11739648|FG000|COMPLETED|First Intervention (7 Days)||4
10583899|NCT01732588|11739649|FG001|COMPLETED|First Intervention (7 Days)||2
10702879|NCT02579057|11867373|FG000|NOT COMPLETED|Overall Study||0
10702880|NCT02579057|11867374|FG001|NOT COMPLETED|Overall Study||0
10702881|NCT02579135|11867382|FG000|STARTED|Overall Study||107
10583900|NCT01732588|11739650|FG002|COMPLETED|First Intervention (7 Days)||4
10583901|NCT01732588|11739648|FG000|NOT COMPLETED|First Intervention (7 Days)||0
10583902|NCT01732588|11739649|FG001|NOT COMPLETED|First Intervention (7 Days)||1
10583903|NCT01732588|11739650|FG002|NOT COMPLETED|First Intervention (7 Days)||0
10583904|NCT01732588|11739648|FG000|STARTED|Second Intervention (7 Days)||4
10583905|NCT01732588|11739649|FG001|STARTED|Second Intervention (7 Days)||2
10583906|NCT01732588|11739650|FG002|STARTED|Second Intervention (7 Days)||4
10583907|NCT01732588|11739648|FG000|COMPLETED|Second Intervention (7 Days)||4
10583908|NCT01732588|11739649|FG001|COMPLETED|Second Intervention (7 Days)||2
10583909|NCT01732588|11739650|FG002|COMPLETED|Second Intervention (7 Days)||4
10583910|NCT01732588|11739648|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
10583911|NCT01732588|11739649|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
10583912|NCT01732588|11739650|FG002|NOT COMPLETED|Second Intervention (7 Days)||0
10583913|NCT01732588|11739648|FG000|STARTED|Third Intervention (7 Days)||4
10583914|NCT01732588|11739649|FG001|STARTED|Third Intervention (7 Days)||2
10583915|NCT01732588|11739650|FG002|STARTED|Third Intervention (7 Days)||4
10583916|NCT01732588|11739648|FG000|COMPLETED|Third Intervention (7 Days)||4
10583917|NCT01732588|11739649|FG001|COMPLETED|Third Intervention (7 Days)||2
10583918|NCT01732588|11739650|FG002|COMPLETED|Third Intervention (7 Days)||4
10583919|NCT01732588|11739648|FG000|NOT COMPLETED|Third Intervention (7 Days)||0
10583920|NCT01732588|11739649|FG001|NOT COMPLETED|Third Intervention (7 Days)||0
10583921|NCT01732588|11739650|FG002|NOT COMPLETED|Third Intervention (7 Days)||0
10583922|NCT01732640|11739658|FG000|STARTED|Overall Study||6
10583923|NCT01732640|11739659|FG001|STARTED|Overall Study||3
10583924|NCT01732640|11739658|FG000|COMPLETED|Overall Study||6
10583925|NCT01732640|11739659|FG001|COMPLETED|Overall Study||1
10583926|NCT01732640|11739658|FG000|NOT COMPLETED|Overall Study||0
10583927|NCT01732640|11739659|FG001|NOT COMPLETED|Overall Study||2
10583928|NCT01732692|11739671|FG000|STARTED|Overall Study||70
10583929|NCT01732692|11739672|FG001|STARTED|Overall Study||70
10583930|NCT01732692|11739671|FG000|COMPLETED|Overall Study||70
10583931|NCT01732692|11739672|FG001|COMPLETED|Overall Study||69
10583932|NCT01732692|11739671|FG000|NOT COMPLETED|Overall Study||0
10583933|NCT01732692|11739672|FG001|NOT COMPLETED|Overall Study||1
10583934|NCT01732718|11739678|FG000|STARTED|First Intervention||7
10583935|NCT01732718|11739679|FG001|STARTED|First Intervention||6
10583936|NCT01732718|11739678|FG000|COMPLETED|First Intervention||7
10583937|NCT01732718|11739679|FG001|COMPLETED|First Intervention||6
10583938|NCT01732718|11739678|FG000|NOT COMPLETED|First Intervention||0
10702882|NCT02579135|11867383|FG001|STARTED|Overall Study||115
10702883|NCT02579135|11867382|FG000|COMPLETED|Overall Study||105
10702884|NCT02579135|11867383|FG001|COMPLETED|Overall Study||106
10702885|NCT02579135|11867382|FG000|NOT COMPLETED|Overall Study||2
10583939|NCT01732718|11739679|FG001|NOT COMPLETED|First Intervention||0
10583940|NCT01732718|11739678|FG000|STARTED|Washout (4 Weeks)||7
10583941|NCT01732718|11739679|FG001|STARTED|Washout (4 Weeks)||6
10583942|NCT01732718|11739678|FG000|COMPLETED|Washout (4 Weeks)||7
10583943|NCT01732718|11739679|FG001|COMPLETED|Washout (4 Weeks)||6
10583944|NCT01732718|11739678|FG000|NOT COMPLETED|Washout (4 Weeks)||0
10583945|NCT01732718|11739679|FG001|NOT COMPLETED|Washout (4 Weeks)||0
10702886|NCT02579135|11867383|FG001|NOT COMPLETED|Overall Study||9
10702887|NCT02579343|11867391|FG000|STARTED|Overall Study||7
10702888|NCT02579343|11867392|FG001|STARTED|Overall Study||6
10583946|NCT01732718|11739678|FG000|STARTED|Second Intervention||7
10583947|NCT01732718|11739679|FG001|STARTED|Second Intervention||6
10583948|NCT01732718|11739678|FG000|COMPLETED|Second Intervention||7
10583949|NCT01732718|11739679|FG001|COMPLETED|Second Intervention||6
10583950|NCT01732718|11739678|FG000|NOT COMPLETED|Second Intervention||0
10702889|NCT02579343|11867391|FG000|COMPLETED|Overall Study||7
10702890|NCT02579343|11867392|FG001|COMPLETED|Overall Study||6
10583951|NCT01732718|11739679|FG001|NOT COMPLETED|Second Intervention||0
10583952|NCT01732757|11739694|FG000|STARTED|Overall Study||53
10583953|NCT01732757|11739695|FG001|STARTED|Overall Study||52
10583954|NCT01732757|11739696|FG002|STARTED|Overall Study||52
10583955|NCT01732757|11739694|FG000|COMPLETED|Overall Study||52
10583956|NCT01732757|11739695|FG001|COMPLETED|Overall Study||52
10583957|NCT01732757|11739696|FG002|COMPLETED|Overall Study||52
10583958|NCT01732757|11739694|FG000|NOT COMPLETED|Overall Study||1
10583959|NCT01732757|11739695|FG001|NOT COMPLETED|Overall Study||0
10583960|NCT01732757|11739696|FG002|NOT COMPLETED|Overall Study||0
10583961|NCT01732770|11739706|FG000|STARTED|Overall Study||322
10583962|NCT01732770|11739707|FG001|STARTED|Overall Study||321
10583963|NCT01732770|11739706|FG000|Received Study Treatment|Overall Study||320
10583964|NCT01732770|11739707|FG001|Received Study Treatment|Overall Study||320
10583965|NCT01732770|11739706|FG000|COMPLETED|Overall Study||312
10583966|NCT01732770|11739707|FG001|COMPLETED|Overall Study||313
10702891|NCT02579343|11867391|FG000|NOT COMPLETED|Overall Study||0
10702892|NCT02579343|11867392|FG001|NOT COMPLETED|Overall Study||0
10702893|NCT02579382|11867402|FG000|STARTED|Main Study Phase||28
10583967|NCT01732770|11739706|FG000|NOT COMPLETED|Overall Study||10
10583968|NCT01732770|11739707|FG001|NOT COMPLETED|Overall Study||8
10583969|NCT01732783|11739716|FG000|STARTED|Overall Study||164
10583970|NCT01732783|11739717|FG001|STARTED|Overall Study||37
10583971|NCT01732783|11739718|FG002|STARTED|Overall Study||12
10583972|NCT01732783|11739716|FG000|COMPLETED|Overall Study|Completed 12-month observation period.|29
10583973|NCT01732783|11739717|FG001|COMPLETED|Overall Study|Completed 12-month observation period.|5
10583974|NCT01732783|11739718|FG002|COMPLETED|Overall Study|Completed 12-month observation period.|2
10583975|NCT01732783|11739716|FG000|NOT COMPLETED|Overall Study||135
10583976|NCT01732783|11739717|FG001|NOT COMPLETED|Overall Study||32
10583977|NCT01732783|11739718|FG002|NOT COMPLETED|Overall Study||10
10583978|NCT01732796|11739729|FG000|STARTED|Overall Study||208
10583979|NCT01732796|11739730|FG001|STARTED|Overall Study||211
10583980|NCT01732796|11739731|FG002|STARTED|Overall Study||51
10583981|NCT01732796|11739729|FG000|COMPLETED|Overall Study||162
10583982|NCT01732796|11739730|FG001|COMPLETED|Overall Study||169
10583983|NCT01732796|11739731|FG002|COMPLETED|Overall Study||38
10583984|NCT01732796|11739729|FG000|NOT COMPLETED|Overall Study||46
10583985|NCT01732796|11739730|FG001|NOT COMPLETED|Overall Study||42
10583986|NCT01732796|11739731|FG002|NOT COMPLETED|Overall Study||13
10651725|NCT02177942|11811966|FG001|COMPLETED|Overall Study||178
10651726|NCT02177942|11811965|FG000|NOT COMPLETED|Overall Study||77
10651727|NCT02177942|11811966|FG001|NOT COMPLETED|Overall Study||88
10651728|NCT02178059|11811976|FG000|STARTED|First Intervention||17
10651729|NCT02178059|11811977|FG001|STARTED|First Intervention||17
10651730|NCT02178059|11811976|FG000|COMPLETED|First Intervention||17
10651731|NCT02178059|11811977|FG001|COMPLETED|First Intervention||17
10651732|NCT02178059|11811976|FG000|NOT COMPLETED|First Intervention||0
10651733|NCT02178059|11811977|FG001|NOT COMPLETED|First Intervention||0
10651734|NCT02178059|11811976|FG000|STARTED|Washout||17
10651735|NCT02178059|11811977|FG001|STARTED|Washout||17
10651736|NCT02178059|11811976|FG000|COMPLETED|Washout||16
10651737|NCT02178059|11811977|FG001|COMPLETED|Washout||17
10651738|NCT02178059|11811976|FG000|NOT COMPLETED|Washout||1
10651739|NCT02178059|11811977|FG001|NOT COMPLETED|Washout||0
10651740|NCT02178059|11811976|FG000|STARTED|Second Intervention||16
10651741|NCT02178059|11811977|FG001|STARTED|Second Intervention||17
10651742|NCT02178059|11811976|FG000|COMPLETED|Second Intervention||16
10651743|NCT02178059|11811977|FG001|COMPLETED|Second Intervention||17
10651744|NCT02178059|11811976|FG000|NOT COMPLETED|Second Intervention||0
10651745|NCT02178059|11811977|FG001|NOT COMPLETED|Second Intervention||0
10651746|NCT02178241|11811983|FG000|STARTED|Overall Study||24
10651747|NCT02178241|11811983|FG000|COMPLETED|Overall Study||24
10651748|NCT02178241|11811983|FG000|NOT COMPLETED|Overall Study||0
10651749|NCT02178475|11811987|FG000|STARTED|Overall Study||943
10651750|NCT02178475|11811987|FG000|Primary Analysis Set|Overall Study|All enrolled participants who met eligibility criteria|844
10651751|NCT02178475|11811987|FG000|COMPLETED|Overall Study||814
10651752|NCT02178475|11811987|FG000|NOT COMPLETED|Overall Study||129
10651753|NCT02178540|11811991|FG000|STARTED|Overall Study||45
10651754|NCT02178540|11811991|FG000|COMPLETED|Overall Study||45
10651755|NCT02178540|11811991|FG000|NOT COMPLETED|Overall Study||0
10651756|NCT02178553|11812000|FG000|STARTED|Overall Study||53
10651757|NCT02178553|11812001|FG001|STARTED|Overall Study||49
10651758|NCT02178553|11812000|FG000|COMPLETED|Overall Study||45
10651759|NCT02178553|11812001|FG001|COMPLETED|Overall Study||39
10651760|NCT02178553|11812000|FG000|NOT COMPLETED|Overall Study||8
10651761|NCT02178553|11812001|FG001|NOT COMPLETED|Overall Study||10
10651762|NCT02178592|11812009|FG000|STARTED|Randomized Phase (Up to Week 52)||69
10651763|NCT02178592|11812010|FG001|STARTED|Randomized Phase (Up to Week 52)||44
10651764|NCT02178592|11812009|FG000|COMPLETED|Randomized Phase (Up to Week 52)||50
10651765|NCT02178592|11812010|FG001|COMPLETED|Randomized Phase (Up to Week 52)||35
10702894|NCT02579382|11867403|FG001|STARTED|Main Study Phase||53
10651766|NCT02178592|11812009|FG000|NOT COMPLETED|Randomized Phase (Up to Week 52)||19
10651767|NCT02178592|11812010|FG001|NOT COMPLETED|Randomized Phase (Up to Week 52)||9
10651768|NCT02178592|11812009|FG000|STARTED|OLE Phase (Week 52 to Week 252)|As OLE phase was optional, 3 participants from DTG arm did not enter OLE from Randomized Phase.|47
10651769|NCT02178592|11812010|FG001|STARTED|OLE Phase (Week 52 to Week 252)|As OLE phase was optional, 16 participants from EFV arm did not enter OLE from Randomized Phase.|19
10651770|NCT02178592|11812009|FG000|COMPLETED|OLE Phase (Week 52 to Week 252)||35
10702895|NCT02579382|11867404|FG002|STARTED|Main Study Phase||56
10583987|NCT04537234|11739743|FG000|STARTED|Overall Study||82
10583988|NCT04537234|11739744|FG001|STARTED|Overall Study||83
10583989|NCT04537234|11739743|FG000|COMPLETED|Overall Study||80
10583990|NCT04537234|11739744|FG001|COMPLETED|Overall Study||83
10583991|NCT04537234|11739743|FG000|NOT COMPLETED|Overall Study||2
10583992|NCT04537234|11739744|FG001|NOT COMPLETED|Overall Study||0
10584004|NCT03813199|11739768|FG000|STARTED|Overall Study||21
10584005|NCT03813199|11739769|FG001|STARTED|Overall Study||19
10584006|NCT03813199|11739770|FG002|STARTED|Overall Study||20
10584007|NCT03813199|11739768|FG000|COMPLETED|Overall Study||18
10584008|NCT03813199|11739769|FG001|COMPLETED|Overall Study||6
10584009|NCT03813199|11739770|FG002|COMPLETED|Overall Study||19
10584010|NCT03813199|11739768|FG000|NOT COMPLETED|Overall Study||3
10584011|NCT03813199|11739769|FG001|NOT COMPLETED|Overall Study||13
10584012|NCT03813199|11739770|FG002|NOT COMPLETED|Overall Study||1
10584013|NCT03478956|11739780|FG000|STARTED|Overall Study||12
10584014|NCT03478956|11739781|FG001|STARTED|Overall Study||12
10584015|NCT03478956|11739780|FG000|Received at Least One Dose of Study Drug|Overall Study||12
10584016|NCT03478956|11739781|FG001|Received at Least One Dose of Study Drug|Overall Study||12
10584017|NCT03478956|11739780|FG000|Completed Randomized Treatment Phase|Overall Study||11
10584018|NCT03478956|11739781|FG001|Completed Randomized Treatment Phase|Overall Study||10
10584019|NCT03478956|11739780|FG000|Started OLE Treatment Phase|Overall Study||11
10584020|NCT03478956|11739781|FG001|Started OLE Treatment Phase|Overall Study||10
10584021|NCT03478956|11739780|FG000|Completed OLE Treatment Phase|Overall Study||0
10584022|NCT03478956|11739781|FG001|Completed OLE Treatment Phase|Overall Study||0
10584023|NCT03478956|11739780|FG000|Started PML Safety Monitoring Phase|Overall Study||1
10584024|NCT03478956|11739781|FG001|Started PML Safety Monitoring Phase|Overall Study||2
10584025|NCT03478956|11739780|FG000|COMPLETED|Overall Study||0
10584026|NCT03478956|11739781|FG001|COMPLETED|Overall Study||0
10584027|NCT03478956|11739780|FG000|NOT COMPLETED|Overall Study||12
10584028|NCT03478956|11739781|FG001|NOT COMPLETED|Overall Study||12
10584029|NCT03348930|11739787|FG000|STARTED|First Intervention (2 Weeks)||10
10584030|NCT03348930|11739788|FG001|STARTED|First Intervention (2 Weeks)||10
10584031|NCT03348930|11739787|FG000|COMPLETED|First Intervention (2 Weeks)||10
10584032|NCT03348930|11739788|FG001|COMPLETED|First Intervention (2 Weeks)||10
10584033|NCT03348930|11739787|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
10584034|NCT03348930|11739788|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
10584035|NCT03348930|11739787|FG000|STARTED|Washout (1 Week)||10
10584036|NCT03348930|11739788|FG001|STARTED|Washout (1 Week)||10
10584037|NCT03348930|11739787|FG000|COMPLETED|Washout (1 Week)||9
10584038|NCT03348930|11739788|FG001|COMPLETED|Washout (1 Week)||9
10584039|NCT03348930|11739787|FG000|NOT COMPLETED|Washout (1 Week)||1
10584040|NCT03348930|11739788|FG001|NOT COMPLETED|Washout (1 Week)||1
10584041|NCT03348930|11739787|FG000|STARTED|Second Intervention (2 Weeks)||9
10584042|NCT03348930|11739788|FG001|STARTED|Second Intervention (2 Weeks)||9
10584043|NCT03348930|11739787|FG000|COMPLETED|Second Intervention (2 Weeks)||9
10584044|NCT03348930|11739788|FG001|COMPLETED|Second Intervention (2 Weeks)||9
10584045|NCT03348930|11739787|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
10584046|NCT03348930|11739788|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
10584047|NCT03282240|11739797|FG000|STARTED|Overall Study||1777
10584048|NCT03282240|11739798|FG001|STARTED|Overall Study||443
10584049|NCT03282240|11739799|FG002|STARTED|Overall Study||450
10584050|NCT03282240|11739797|FG000|COMPLETED|Overall Study||1767
10584051|NCT03282240|11739798|FG001|COMPLETED|Overall Study||440
10584052|NCT03282240|11739799|FG002|COMPLETED|Overall Study||447
10584053|NCT03282240|11739797|FG000|NOT COMPLETED|Overall Study||10
10584054|NCT03282240|11739798|FG001|NOT COMPLETED|Overall Study||3
10584055|NCT03282240|11739799|FG002|NOT COMPLETED|Overall Study||3
10584056|NCT03260868|11739812|FG000|STARTED|Overall Study||8
10584057|NCT03260868|11739813|FG001|STARTED|Overall Study||7
10584058|NCT03260868|11739812|FG000|Safety Population|Overall Study||8
10584059|NCT03260868|11739813|FG001|Safety Population|Overall Study||6
10584060|NCT03260868|11739812|FG000|COMPLETED|Overall Study||5
10584061|NCT03260868|11739813|FG001|COMPLETED|Overall Study||4
10584062|NCT03260868|11739812|FG000|NOT COMPLETED|Overall Study||3
10584063|NCT03260868|11739813|FG001|NOT COMPLETED|Overall Study||3
10584064|NCT03245580|11739821|FG000|STARTED|Overall Study||75
10584065|NCT03245580|11739822|FG001|STARTED|Overall Study||78
10584066|NCT03245580|11739821|FG000|COMPLETED|Overall Study||75
10584067|NCT03245580|11739822|FG001|COMPLETED|Overall Study||78
10806725|NCT03951805|11968334|FG002|Safety Analysis Set (SAS)|Overall Study||52
10806726|NCT03951805|11968335|FG003|Safety Analysis Set (SAS)|Overall Study||51
10806727|NCT03951805|11968332|FG000|COMPLETED|Overall Study||50
10806728|NCT03951805|11968333|FG001|COMPLETED|Overall Study||51
10806729|NCT03951805|11968334|FG002|COMPLETED|Overall Study||52
10806730|NCT03951805|11968335|FG003|COMPLETED|Overall Study||51
10806731|NCT03951805|11968332|FG000|NOT COMPLETED|Overall Study||1
10584068|NCT03245580|11739821|FG000|NOT COMPLETED|Overall Study||0
10584069|NCT03245580|11739822|FG001|NOT COMPLETED|Overall Study||0
10584070|NCT03157037|11739828|FG000|STARTED|Overall Study||15
10584071|NCT03157037|11739828|FG000|COMPLETED|Overall Study||14
10584072|NCT03157037|11739828|FG000|NOT COMPLETED|Overall Study||1
10584073|NCT03143218|11739842|FG000|STARTED|Overall Study||1965
10584074|NCT03143218|11739843|FG001|STARTED|Overall Study||1988
10584075|NCT03143218|11739844|FG002|STARTED|Overall Study||1967
10584076|NCT03143218|11739842|FG000|COMPLETED|Overall Study||1716
10584077|NCT03143218|11739843|FG001|COMPLETED|Overall Study||1734
10806732|NCT03951805|11968333|FG001|NOT COMPLETED|Overall Study||0
10583996|NCT04172701|11739758|FG000|STARTED|Overall Study||6352
10583997|NCT04172701|11739759|FG001|STARTED|Overall Study||2932
10583998|NCT04172701|11739758|FG000|Propensity Score (PS) Matched Population|Overall Study||2444
10583999|NCT04172701|11739759|FG001|Propensity Score (PS) Matched Population|Overall Study||2444
10584000|NCT04172701|11739758|FG000|COMPLETED|Overall Study||6352
10584001|NCT04172701|11739759|FG001|COMPLETED|Overall Study||2932
10584002|NCT04172701|11739758|FG000|NOT COMPLETED|Overall Study||0
10584003|NCT04172701|11739759|FG001|NOT COMPLETED|Overall Study||0
10584078|NCT03143218|11739844|FG002|COMPLETED|Overall Study||1740
10584079|NCT03143218|11739842|FG000|NOT COMPLETED|Overall Study||249
10584080|NCT03143218|11739843|FG001|NOT COMPLETED|Overall Study||254
10584081|NCT03143218|11739844|FG002|NOT COMPLETED|Overall Study||227
10584082|NCT03128931|11739852|FG000|STARTED|Overall Study||45
10584083|NCT03128931|11739852|FG000|COMPLETED|Overall Study||41
10584084|NCT03128931|11739852|FG000|NOT COMPLETED|Overall Study||4
10651771|NCT02178592|11812010|FG001|COMPLETED|OLE Phase (Week 52 to Week 252)||16
10651772|NCT02178592|11812009|FG000|NOT COMPLETED|OLE Phase (Week 52 to Week 252)||12
10651773|NCT02178592|11812010|FG001|NOT COMPLETED|OLE Phase (Week 52 to Week 252)||3
10651774|NCT02178696|11812019|FG000|STARTED|First Assignment and Washout||20
10651775|NCT02178696|11812020|FG001|STARTED|First Assignment and Washout||20
10651776|NCT02178696|11812019|FG000|COMPLETED|First Assignment and Washout||20
10651777|NCT02178696|11812020|FG001|COMPLETED|First Assignment and Washout||20
10651778|NCT02178696|11812019|FG000|NOT COMPLETED|First Assignment and Washout||0
10651779|NCT02178696|11812020|FG001|NOT COMPLETED|First Assignment and Washout||0
10651780|NCT02178696|11812019|FG000|STARTED|Second Assignment After Crossover||20
10651781|NCT02178696|11812020|FG001|STARTED|Second Assignment After Crossover||20
10651782|NCT02178696|11812019|FG000|COMPLETED|Second Assignment After Crossover||20
10702896|NCT02579382|11867405|FG003|STARTED|Main Study Phase||55
10702897|NCT02579382|11867402|FG000|COMPLETED|Main Study Phase||28
10702898|NCT02579382|11867403|FG001|COMPLETED|Main Study Phase||53
10702899|NCT02579382|11867404|FG002|COMPLETED|Main Study Phase||54
10702900|NCT02579382|11867405|FG003|COMPLETED|Main Study Phase||52
10651783|NCT02178696|11812020|FG001|COMPLETED|Second Assignment After Crossover||20
10651784|NCT02178696|11812019|FG000|NOT COMPLETED|Second Assignment After Crossover||0
10651785|NCT02178696|11812020|FG001|NOT COMPLETED|Second Assignment After Crossover||0
10651786|NCT02178696|11812019|FG000|STARTED|Open-label Antidepressant||20
10651787|NCT02178696|11812020|FG001|STARTED|Open-label Antidepressant||20
10651788|NCT02178696|11812019|FG000|COMPLETED|Open-label Antidepressant||14
10651789|NCT02178696|11812020|FG001|COMPLETED|Open-label Antidepressant||13
10651790|NCT02178696|11812019|FG000|NOT COMPLETED|Open-label Antidepressant||6
10651791|NCT02178696|11812020|FG001|NOT COMPLETED|Open-label Antidepressant||7
10651792|NCT02178787|11812033|FG000|STARTED|Overall Study||35
10651793|NCT02178787|11812034|FG001|STARTED|Overall Study||39
10651794|NCT02178787|11812033|FG000|COMPLETED|Overall Study||30
10651795|NCT02178787|11812034|FG001|COMPLETED|Overall Study||30
10651796|NCT02178787|11812033|FG000|NOT COMPLETED|Overall Study||5
10651797|NCT02178787|11812034|FG001|NOT COMPLETED|Overall Study||9
10651798|NCT02178800|11812044|FG000|STARTED|Overall Study||151
10651799|NCT02178800|11812045|FG001|STARTED|Overall Study||48
10651800|NCT02178800|11812044|FG000|COMPLETED|Overall Study|Number of participants who weren't terminated at week 41|131
10651801|NCT02178800|11812045|FG001|COMPLETED|Overall Study|Number of participants who weren't terminated at week 41|42
10651802|NCT02178800|11812044|FG000|NOT COMPLETED|Overall Study||20
10651803|NCT02178800|11812045|FG001|NOT COMPLETED|Overall Study||6
10651804|NCT02178995|11812061|FG000|STARTED|Double Blind||0
10651805|NCT02178995|11812062|FG001|STARTED|Double Blind||16
10651806|NCT02178995|11812063|FG002|STARTED|Double Blind||5
10651807|NCT02178995|11812064|FG003|STARTED|Double Blind||6
10651808|NCT02178995|11812065|FG004|STARTED|Double Blind||6
10651809|NCT02178995|11812066|FG005|STARTED|Double Blind||6
10651810|NCT02178995|11812067|FG006|STARTED|Double Blind||5
10651811|NCT02178995|11812068|FG007|STARTED|Double Blind||6
10651812|NCT02178995|11812069|FG008|STARTED|Double Blind||1
10651813|NCT02178995|11812061|FG000|COMPLETED|Double Blind||0
10651814|NCT02178995|11812062|FG001|COMPLETED|Double Blind||15
10651815|NCT02178995|11812063|FG002|COMPLETED|Double Blind||5
10651816|NCT02178995|11812064|FG003|COMPLETED|Double Blind||6
10651817|NCT02178995|11812065|FG004|COMPLETED|Double Blind||6
10651818|NCT02178995|11812066|FG005|COMPLETED|Double Blind||5
10651819|NCT02178995|11812067|FG006|COMPLETED|Double Blind||5
10651820|NCT02178995|11812068|FG007|COMPLETED|Double Blind||4
10651821|NCT02178995|11812069|FG008|COMPLETED|Double Blind||0
10651822|NCT02178995|11812061|FG000|NOT COMPLETED|Double Blind||0
10651823|NCT02178995|11812062|FG001|NOT COMPLETED|Double Blind||1
10651824|NCT02178995|11812063|FG002|NOT COMPLETED|Double Blind||0
10651825|NCT02178995|11812064|FG003|NOT COMPLETED|Double Blind||0
10651826|NCT02178995|11812065|FG004|NOT COMPLETED|Double Blind||0
10651827|NCT02178995|11812066|FG005|NOT COMPLETED|Double Blind||1
10651828|NCT02178995|11812067|FG006|NOT COMPLETED|Double Blind||0
10651829|NCT02178995|11812068|FG007|NOT COMPLETED|Double Blind||2
10651830|NCT02178995|11812069|FG008|NOT COMPLETED|Double Blind||1
10651831|NCT02178995|11812061|FG000|STARTED|Open Label|2 declined to join open-label. 1 withdrew from double-blind but rejoined open-label due to benefit.|30
10651832|NCT02178995|11812062|FG001|STARTED|Open Label|One was lost to follow-up after completion of visit 4.|14
10584085|NCT02498392|11739858|FG000|STARTED|Double-blind(DB) Lead-in Period(3 Weeks)||160
10584086|NCT02498392|11739859|FG001|STARTED|Double-blind(DB) Lead-in Period(3 Weeks)||0
10584087|NCT02498392|11739858|FG000|Treated|Double-blind(DB) Lead-in Period(3 Weeks)||153
10584088|NCT02498392|11739859|FG001|Treated|Double-blind(DB) Lead-in Period(3 Weeks)||0
10584089|NCT02498392|11739858|FG000|COMPLETED|Double-blind(DB) Lead-in Period(3 Weeks)||153
10584090|NCT02498392|11739859|FG001|COMPLETED|Double-blind(DB) Lead-in Period(3 Weeks)||0
10584091|NCT02498392|11739858|FG000|NOT COMPLETED|Double-blind(DB) Lead-in Period(3 Weeks)||7
10584092|NCT02498392|11739859|FG001|NOT COMPLETED|Double-blind(DB) Lead-in Period(3 Weeks)||0
10584093|NCT02498392|11739858|FG000|STARTED|DB Treatment (6 Weeks)+Withdrawal Period||76
10584094|NCT02498392|11739859|FG001|STARTED|DB Treatment (6 Weeks)+Withdrawal Period||77
10584095|NCT02498392|11739858|FG000|COMPLETED|DB Treatment (6 Weeks)+Withdrawal Period||70
10584096|NCT02498392|11739859|FG001|COMPLETED|DB Treatment (6 Weeks)+Withdrawal Period||67
10584097|NCT02498392|11739858|FG000|NOT COMPLETED|DB Treatment (6 Weeks)+Withdrawal Period||6
10584098|NCT02498392|11739859|FG001|NOT COMPLETED|DB Treatment (6 Weeks)+Withdrawal Period||10
10584099|NCT02478775|11739870|FG000|STARTED|Overall Study||6
10584100|NCT02478775|11739871|FG001|STARTED|Overall Study||27
10584101|NCT02478775|11739872|FG002|STARTED|Overall Study||27
10584102|NCT02478775|11739870|FG000|COMPLETED|Overall Study||6
10584103|NCT02478775|11739871|FG001|COMPLETED|Overall Study||27
10584104|NCT02478775|11739872|FG002|COMPLETED|Overall Study||27
10584105|NCT02478775|11739870|FG000|NOT COMPLETED|Overall Study||0
10584106|NCT02478775|11739871|FG001|NOT COMPLETED|Overall Study||0
10584107|NCT02478775|11739872|FG002|NOT COMPLETED|Overall Study||0
10584108|NCT01899729|11739884|FG000|STARTED|Overall Study||9
10584109|NCT01899729|11739885|FG001|STARTED|Overall Study||9
10584110|NCT01899729|11739886|FG002|STARTED|Overall Study||8
10584111|NCT01899729|11739887|FG003|STARTED|Overall Study||9
10584112|NCT01899729|11739888|FG004|STARTED|Overall Study||11
10584113|NCT01899729|11739884|FG000|COMPLETED|Overall Study||7
10584114|NCT01899729|11739885|FG001|COMPLETED|Overall Study||7
10584115|NCT01899729|11739886|FG002|COMPLETED|Overall Study||6
10584116|NCT01899729|11739887|FG003|COMPLETED|Overall Study||9
10584117|NCT01899729|11739888|FG004|COMPLETED|Overall Study||9
10584118|NCT01899729|11739884|FG000|NOT COMPLETED|Overall Study||2
10584119|NCT01899729|11739885|FG001|NOT COMPLETED|Overall Study||2
10584120|NCT01899729|11739886|FG002|NOT COMPLETED|Overall Study||2
10584121|NCT01899729|11739887|FG003|NOT COMPLETED|Overall Study||0
10584122|NCT01899729|11739888|FG004|NOT COMPLETED|Overall Study||2
10584123|NCT01784848|11739902|FG000|STARTED|Overall Study||50
10584124|NCT01784848|11739903|FG001|STARTED|Overall Study||50
10584125|NCT01784848|11739902|FG000|COMPLETED|Overall Study||49
10584126|NCT01784848|11739903|FG001|COMPLETED|Overall Study||47
10584127|NCT01784848|11739902|FG000|NOT COMPLETED|Overall Study||1
10584128|NCT01784848|11739903|FG001|NOT COMPLETED|Overall Study||3
10584129|NCT01648205|11739909|FG000|STARTED|Placebo||25
10584130|NCT01648205|11739909|FG000|COMPLETED|Placebo||21
10584131|NCT01648205|11739909|FG000|NOT COMPLETED|Placebo||4
10584132|NCT01648205|11739909|FG000|STARTED|Ranolazine||23
10584133|NCT01648205|11739909|FG000|COMPLETED|Ranolazine||18
10584134|NCT01648205|11739909|FG000|NOT COMPLETED|Ranolazine||5
10584135|NCT01312922|11739920|FG000|STARTED|Overall Study||185
10584136|NCT01312922|11739921|FG001|STARTED|Overall Study||185
10584137|NCT01312922|11739922|FG002|STARTED|Overall Study||185
10806733|NCT03951805|11968334|FG002|NOT COMPLETED|Overall Study||0
10806734|NCT03951805|11968335|FG003|NOT COMPLETED|Overall Study||0
10584138|NCT01312922|11739920|FG000|COMPLETED|Overall Study||117
10584139|NCT01312922|11739921|FG001|COMPLETED|Overall Study||131
10584140|NCT01312922|11739922|FG002|COMPLETED|Overall Study||135
10584141|NCT01312922|11739920|FG000|NOT COMPLETED|Overall Study||68
10584142|NCT01312922|11739921|FG001|NOT COMPLETED|Overall Study||54
10584143|NCT01312922|11739922|FG002|NOT COMPLETED|Overall Study||50
10584144|NCT00915681|11739930|FG000|STARTED|Overall Study||148
10584145|NCT00915681|11739930|FG000|COMPLETED|Overall Study||102
10584146|NCT00915681|11739930|FG000|NOT COMPLETED|Overall Study||46
10584147|NCT00145158|11739936|FG000|STARTED|Overall Study||16
10584148|NCT00145158|11739937|FG001|STARTED|Overall Study||7
10584149|NCT00145158|11739936|FG000|COMPLETED|Overall Study||14
10584150|NCT00145158|11739937|FG001|COMPLETED|Overall Study||4
10584151|NCT00145158|11739936|FG000|NOT COMPLETED|Overall Study||2
10584152|NCT00145158|11739937|FG001|NOT COMPLETED|Overall Study||3
10584153|NCT01732809|11739946|FG000|STARTED|Overall Study||9
10584154|NCT01732809|11739947|FG001|STARTED|Overall Study||10
10584155|NCT01732809|11739946|FG000|COMPLETED|Overall Study||9
10584156|NCT01732809|11739947|FG001|COMPLETED|Overall Study||9
10702901|NCT02579382|11867402|FG000|NOT COMPLETED|Main Study Phase||0
10584157|NCT01732809|11739946|FG000|NOT COMPLETED|Overall Study||0
10584158|NCT01732809|11739947|FG001|NOT COMPLETED|Overall Study||1
10584159|NCT01732822|11739955|FG000|STARTED|Overall Study||6930
10584160|NCT01732822|11739956|FG001|STARTED|Overall Study||6955
10584161|NCT01732822|11739955|FG000|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the PACD|6807
10584162|NCT01732822|11739956|FG001|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the PACD|6842
10584163|NCT01732822|11739955|FG000|NOT COMPLETED|Overall Study||123
10584164|NCT01732822|11739956|FG001|NOT COMPLETED|Overall Study||113
10584165|NCT01732835|11739984|FG000|STARTED|6-month Primary Endpoint||68
10584166|NCT01732835|11739984|FG000|COMPLETED|6-month Primary Endpoint||44
10584167|NCT01732835|11739984|FG000|NOT COMPLETED|6-month Primary Endpoint||24
10584168|NCT01732835|11739984|FG000|STARTED|2-year Extended Follow-up||44
10584169|NCT01732835|11739984|FG000|COMPLETED|2-year Extended Follow-up||39
10584170|NCT01732835|11739984|FG000|NOT COMPLETED|2-year Extended Follow-up||5
10584171|NCT01732874|11739990|FG000|STARTED|Overall Study||16
10584172|NCT01732874|11739991|FG001|STARTED|Overall Study||11
10584173|NCT01732874|11739990|FG000|COMPLETED|Overall Study||8
10584174|NCT01732874|11739991|FG001|COMPLETED|Overall Study||8
10584175|NCT01732874|11739990|FG000|NOT COMPLETED|Overall Study||8
10584176|NCT01732874|11739991|FG001|NOT COMPLETED|Overall Study||3
10584177|NCT01733056|11740000|FG000|STARTED|Overall Study||21
10584178|NCT01733056|11740001|FG001|STARTED|Overall Study||10
10584179|NCT01733056|11740002|FG002|STARTED|Overall Study||12
10584180|NCT01733056|11740000|FG000|COMPLETED|Overall Study||21
10702902|NCT02579382|11867403|FG001|NOT COMPLETED|Main Study Phase||0
10702903|NCT02579382|11867404|FG002|NOT COMPLETED|Main Study Phase||2
10702904|NCT02579382|11867405|FG003|NOT COMPLETED|Main Study Phase||3
10702905|NCT02579382|11867402|FG000|STARTED|Optional Treatment Extension Phase(OTEP)|1 participant who completed the Main Study Phase did not enter the OTEP.|27
10702906|NCT02579382|11867403|FG001|STARTED|Optional Treatment Extension Phase(OTEP)|2 participants who completed the Main Study Phase did not enter the OTEP.|51
10702907|NCT02579382|11867404|FG002|STARTED|Optional Treatment Extension Phase(OTEP)||54
10584181|NCT01733056|11740001|FG001|COMPLETED|Overall Study||10
10584182|NCT01733056|11740002|FG002|COMPLETED|Overall Study||12
10584183|NCT01733056|11740000|FG000|NOT COMPLETED|Overall Study||0
10584184|NCT01733056|11740001|FG001|NOT COMPLETED|Overall Study||0
10584185|NCT01733056|11740002|FG002|NOT COMPLETED|Overall Study||0
10584186|NCT01733069|11740015|FG000|STARTED|Overall Study||264
10584187|NCT01733069|11740016|FG001|STARTED|Overall Study||1598
10584188|NCT01733069|11740015|FG000|COMPLETED|Overall Study||264
10584189|NCT01733069|11740016|FG001|COMPLETED|Overall Study||1598
10584190|NCT01733069|11740015|FG000|NOT COMPLETED|Overall Study||0
10584191|NCT01733069|11740016|FG001|NOT COMPLETED|Overall Study||0
10584192|NCT01733121|11740024|FG000|STARTED|Double-Blind Period (Week 0 to 6)||51
10584193|NCT01733121|11740025|FG001|STARTED|Double-Blind Period (Week 0 to 6)||51
10584194|NCT01733121|11740024|FG000|COMPLETED|Double-Blind Period (Week 0 to 6)||44
10584195|NCT01733121|11740025|FG001|COMPLETED|Double-Blind Period (Week 0 to 6)||46
10584196|NCT01733121|11740024|FG000|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||7
10584197|NCT01733121|11740025|FG001|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||5
10584198|NCT01733121|11740024|FG000|STARTED|Follow-Up Period (Week 6 to 8)||44
10584199|NCT01733121|11740025|FG001|STARTED|Follow-Up Period (Week 6 to 8)||46
10584200|NCT01733121|11740024|FG000|COMPLETED|Follow-Up Period (Week 6 to 8)||44
10584201|NCT01733121|11740025|FG001|COMPLETED|Follow-Up Period (Week 6 to 8)||46
10584202|NCT01733121|11740024|FG000|NOT COMPLETED|Follow-Up Period (Week 6 to 8)||0
10584203|NCT01733121|11740025|FG001|NOT COMPLETED|Follow-Up Period (Week 6 to 8)||0
10584204|NCT01733186|11740035|FG000|STARTED|Overall Study||6
10584205|NCT01733186|11740036|FG001|STARTED|Overall Study||6
10584206|NCT01733186|11740035|FG000|COMPLETED|Overall Study||6
10584207|NCT01733186|11740036|FG001|COMPLETED|Overall Study||6
10584208|NCT01733186|11740035|FG000|NOT COMPLETED|Overall Study||0
10584209|NCT01733186|11740036|FG001|NOT COMPLETED|Overall Study||0
10584210|NCT01733212|11740044|FG000|STARTED|Overall Study||116
10584211|NCT01733212|11740045|FG001|STARTED|Overall Study||123
10584212|NCT01733212|11740044|FG000|COMPLETED|Overall Study||116
10584213|NCT01733212|11740045|FG001|COMPLETED|Overall Study||123
10584214|NCT01733212|11740044|FG000|NOT COMPLETED|Overall Study||0
10584215|NCT01733212|11740045|FG001|NOT COMPLETED|Overall Study||0
10584216|NCT01733238|11740051|FG000|STARTED|Overall Study||13
10584217|NCT01733238|11740051|FG000|COMPLETED|Overall Study|8 subjects completed the Induction Phase and 7 subjects started Maintenance Phase|8
10584218|NCT01733238|11740051|FG000|NOT COMPLETED|Overall Study||5
10584219|NCT01733277|11740057|FG000|STARTED|Overall Study||25
10584220|NCT01733277|11740058|FG001|STARTED|Overall Study||25
10584221|NCT01733277|11740057|FG000|COMPLETED|Overall Study||25
10584222|NCT01733277|11740058|FG001|COMPLETED|Overall Study||25
10584223|NCT01733277|11740057|FG000|NOT COMPLETED|Overall Study||0
10584224|NCT01733277|11740058|FG001|NOT COMPLETED|Overall Study||0
10584225|NCT01733316|11740064|FG000|STARTED|Cystagon® Phase||41
10584226|NCT01733316|11740064|FG000|COMPLETED|Cystagon® Phase||41
10584227|NCT01733316|11740064|FG000|NOT COMPLETED|Cystagon® Phase||0
10584228|NCT01733316|11740064|FG000|STARTED|RP103 Phase||41
10584229|NCT01733316|11740064|FG000|COMPLETED|RP103 Phase||40
10584230|NCT01733316|11740064|FG000|NOT COMPLETED|RP103 Phase||1
10584231|NCT01733316|11740064|FG000|STARTED|Long Term Extension Phase|Two participants did not enter the long term follow up period.|38
10584232|NCT01733316|11740064|FG000|COMPLETED|Long Term Extension Phase||33
10584233|NCT01733316|11740064|FG000|NOT COMPLETED|Long Term Extension Phase||5
10584234|NCT01733329|11740077|FG000|STARTED|Overall Study||62
10584235|NCT01733329|11740078|FG001|STARTED|Overall Study||61
10584236|NCT01733329|11740077|FG000|COMPLETED|Overall Study||60
10584237|NCT01733329|11740078|FG001|COMPLETED|Overall Study||60
10584238|NCT01733329|11740077|FG000|NOT COMPLETED|Overall Study||2
10584239|NCT01733329|11740078|FG001|NOT COMPLETED|Overall Study||1
10584240|NCT01733368|11740084|FG000|STARTED|Overall Study||198
10584241|NCT01733368|11740084|FG000|COMPLETED|Overall Study||167
10584242|NCT01733368|11740084|FG000|NOT COMPLETED|Overall Study||31
10584243|NCT01733407|11740092|FG000|STARTED|Overall Study||9
10584244|NCT01733407|11740093|FG001|STARTED|Overall Study||9
10584245|NCT01733407|11740092|FG000|COMPLETED|Overall Study||7
10584246|NCT01733407|11740093|FG001|COMPLETED|Overall Study||9
10584247|NCT01733407|11740092|FG000|NOT COMPLETED|Overall Study||2
10584248|NCT01733407|11740093|FG001|NOT COMPLETED|Overall Study||0
10584249|NCT01733472|11740101|FG000|STARTED|Overall Study||60
10584250|NCT01733472|11740102|FG001|STARTED|Overall Study||60
10584251|NCT01733472|11740101|FG000|COMPLETED|Overall Study||60
10584252|NCT01733472|11740102|FG001|COMPLETED|Overall Study||60
10584253|NCT01733472|11740101|FG000|NOT COMPLETED|Overall Study||0
10584254|NCT01733472|11740102|FG001|NOT COMPLETED|Overall Study||0
10584255|NCT01733628|11740109|FG000|STARTED|Overall Study||143
10584256|NCT01733628|11740109|FG000|COMPLETED|Overall Study||143
10584257|NCT01733628|11740109|FG000|NOT COMPLETED|Overall Study||0
10584258|NCT01733680|11740115|FG000|STARTED|Overall Study||2
10584259|NCT01733680|11740116|FG001|STARTED|Overall Study||1
10584260|NCT01733680|11740115|FG000|COMPLETED|Overall Study||2
10584261|NCT01733680|11740116|FG001|COMPLETED|Overall Study||0
10584262|NCT01733680|11740115|FG000|NOT COMPLETED|Overall Study||0
10584263|NCT01733680|11740116|FG001|NOT COMPLETED|Overall Study||1
10584264|NCT01733732|11740128|FG000|STARTED|Overall Study||27
10584265|NCT01733732|11740129|FG001|STARTED|Overall Study||27
10584266|NCT01733732|11740128|FG000|COMPLETED|Overall Study||25
10584267|NCT01733732|11740129|FG001|COMPLETED|Overall Study||27
10584268|NCT01733732|11740128|FG000|NOT COMPLETED|Overall Study||2
10584269|NCT01733732|11740129|FG001|NOT COMPLETED|Overall Study||0
10584270|NCT01733745|11740147|FG000|STARTED|Overall Study||13
10584271|NCT01733745|11740148|FG001|STARTED|Overall Study||13
10584272|NCT01733745|11740147|FG000|COMPLETED|Overall Study||13
10584273|NCT01733745|11740148|FG001|COMPLETED|Overall Study||13
10584274|NCT01733745|11740147|FG000|NOT COMPLETED|Overall Study||0
10584275|NCT01733745|11740148|FG001|NOT COMPLETED|Overall Study||0
10584276|NCT01733758|11740158|FG000|STARTED|Overall Study||77
10584277|NCT01733758|11740159|FG001|STARTED|Overall Study||160
10584278|NCT01733758|11740160|FG002|STARTED|Overall Study||150
10584279|NCT01733758|11740161|FG003|STARTED|Overall Study||103
10584280|NCT01733758|11740158|FG000|COMPLETED|Overall Study||62
10584281|NCT01733758|11740159|FG001|COMPLETED|Overall Study||148
10584282|NCT01733758|11740160|FG002|COMPLETED|Overall Study||135
10584283|NCT01733758|11740161|FG003|COMPLETED|Overall Study||95
10584284|NCT01733758|11740158|FG000|NOT COMPLETED|Overall Study||15
10584285|NCT01733758|11740159|FG001|NOT COMPLETED|Overall Study||12
10584286|NCT01733758|11740160|FG002|NOT COMPLETED|Overall Study||15
10584287|NCT01733758|11740161|FG003|NOT COMPLETED|Overall Study||8
10584288|NCT01733953|11740175|FG000|STARTED|Overall Study||14
10584289|NCT01733953|11740176|FG001|STARTED|Overall Study||13
10584290|NCT01733953|11740175|FG000|COMPLETED|Overall Study||9
10584291|NCT01733953|11740176|FG001|COMPLETED|Overall Study||6
10584292|NCT01733953|11740175|FG000|NOT COMPLETED|Overall Study||5
10584293|NCT01733953|11740176|FG001|NOT COMPLETED|Overall Study||7
10584294|NCT01734161|11740184|FG000|STARTED|Overall Study||61
10584295|NCT01734161|11740185|FG001|STARTED|Overall Study||61
10584296|NCT01734161|11740184|FG000|COMPLETED|Overall Study||55
10584297|NCT01734161|11740185|FG001|COMPLETED|Overall Study||53
10584298|NCT01734161|11740184|FG000|NOT COMPLETED|Overall Study||6
10584299|NCT01734161|11740185|FG001|NOT COMPLETED|Overall Study||8
10584300|NCT01734239|11740193|FG000|STARTED|Overall Study||52
10584301|NCT01734239|11740194|FG001|STARTED|Overall Study||50
10584302|NCT01734239|11740193|FG000|COMPLETED|Overall Study||52
10584303|NCT01734239|11740194|FG001|COMPLETED|Overall Study||50
10584304|NCT01734239|11740193|FG000|NOT COMPLETED|Overall Study||0
10584305|NCT01734239|11740194|FG001|NOT COMPLETED|Overall Study||0
10584306|NCT01734317|11740199|FG000|STARTED|Overall Study||10
10584307|NCT01734317|11740199|FG000|COMPLETED|Overall Study||10
10584308|NCT01734317|11740199|FG000|NOT COMPLETED|Overall Study||0
10584309|NCT01734382|11740207|FG000|STARTED|Part 1||19
10584310|NCT01734382|11740208|FG001|STARTED|Part 1||0
10584311|NCT01734382|11740209|FG002|STARTED|Part 1||0
10584312|NCT01734382|11740207|FG000|COMPLETED|Part 1||17
10584313|NCT01734382|11740208|FG001|COMPLETED|Part 1||0
10584314|NCT01734382|11740209|FG002|COMPLETED|Part 1||0
10584315|NCT01734382|11740207|FG000|NOT COMPLETED|Part 1||2
10584316|NCT01734382|11740208|FG001|NOT COMPLETED|Part 1||0
10584317|NCT01734382|11740209|FG002|NOT COMPLETED|Part 1||0
10584318|NCT01734382|11740207|FG000|STARTED|Part 2||0
10584319|NCT01734382|11740208|FG001|STARTED|Part 2||7
10584320|NCT01734382|11740209|FG002|STARTED|Part 2||15
10584321|NCT01734382|11740207|FG000|COMPLETED|Part 2||0
10584322|NCT01734382|11740208|FG001|COMPLETED|Part 2||5
10584323|NCT01734382|11740209|FG002|COMPLETED|Part 2||8
10584324|NCT01734382|11740207|FG000|NOT COMPLETED|Part 2||0
10584325|NCT01734382|11740208|FG001|NOT COMPLETED|Part 2||2
10584326|NCT01734382|11740209|FG002|NOT COMPLETED|Part 2||7
10584327|NCT01734395|11740221|FG000|STARTED|Overall Study||1882
10584328|NCT01734395|11740221|FG000|COMPLETED|Overall Study||1472
10584329|NCT01734395|11740221|FG000|NOT COMPLETED|Overall Study||410
10584330|NCT01734434|11740229|FG000|STARTED|Overall Study||500
10584331|NCT01734434|11740230|FG001|STARTED|Overall Study||500
10584332|NCT01734434|11740231|FG002|STARTED|Overall Study||1992
10584333|NCT01734434|11740232|FG003|STARTED|Overall Study||251
10584334|NCT01734434|11740229|FG000|COMPLETED|Overall Study||490
10584335|NCT01734434|11740230|FG001|COMPLETED|Overall Study||488
10584336|NCT01734434|11740231|FG002|COMPLETED|Overall Study||1863
10584337|NCT01734434|11740232|FG003|COMPLETED|Overall Study||228
10584338|NCT01734434|11740229|FG000|NOT COMPLETED|Overall Study||10
10584339|NCT01734434|11740230|FG001|NOT COMPLETED|Overall Study||12
10584340|NCT01734434|11740231|FG002|NOT COMPLETED|Overall Study||129
10584341|NCT01734434|11740232|FG003|NOT COMPLETED|Overall Study||23
10584342|NCT01734525|11740250|FG000|STARTED|Overall Study||85
10584343|NCT01734525|11740250|FG000|COMPLETED|Overall Study||85
10584344|NCT01734525|11740250|FG000|NOT COMPLETED|Overall Study||0
10584345|NCT01734551|11740256|FG000|STARTED|Overall Study||15
10584346|NCT01734551|11740257|FG001|STARTED|Overall Study||16
10584347|NCT01734551|11740256|FG000|COMPLETED|Overall Study||15
10584348|NCT01734551|11740257|FG001|COMPLETED|Overall Study||16
10584349|NCT01734551|11740256|FG000|NOT COMPLETED|Overall Study||0
10584350|NCT01734551|11740257|FG001|NOT COMPLETED|Overall Study||0
10584351|NCT01734655|11740263|FG000|STARTED|Overall Study||40
10584352|NCT01734655|11740263|FG000|COMPLETED|Overall Study||40
10584353|NCT01734655|11740263|FG000|NOT COMPLETED|Overall Study||0
10584354|NCT01734746|11740270|FG000|STARTED|Overall Study||22
10584355|NCT01734746|11740270|FG000|COMPLETED|Overall Study||21
10584356|NCT01734746|11740270|FG000|NOT COMPLETED|Overall Study||1
10584357|NCT01734772|11740277|FG000|STARTED|Overall Study||24
10584358|NCT01734772|11740278|FG001|STARTED|Overall Study||24
10584359|NCT01734772|11740277|FG000|COMPLETED|Overall Study||23
10584360|NCT01734772|11740278|FG001|COMPLETED|Overall Study||21
10584361|NCT01734772|11740277|FG000|NOT COMPLETED|Overall Study||1
10584362|NCT01734772|11740278|FG001|NOT COMPLETED|Overall Study||3
10584363|NCT01734785|11740293|FG000|STARTED|Open-Label Period||0
10584364|NCT01734785|11740294|FG001|STARTED|Open-Label Period||0
10584365|NCT01734785|11740295|FG002|STARTED|Open-Label Period||0
10584366|NCT01734785|11740296|FG003|STARTED|Open-Label Period||606
10584367|NCT01734785|11740293|FG000|COMPLETED|Open-Label Period||0
10584368|NCT01734785|11740294|FG001|COMPLETED|Open-Label Period||0
10584369|NCT01734785|11740295|FG002|COMPLETED|Open-Label Period||0
10584370|NCT01734785|11740296|FG003|COMPLETED|Open-Label Period||333
10584371|NCT01734785|11740293|FG000|NOT COMPLETED|Open-Label Period||0
10584372|NCT01734785|11740294|FG001|NOT COMPLETED|Open-Label Period||0
10584373|NCT01734785|11740295|FG002|NOT COMPLETED|Open-Label Period||0
10584374|NCT01734785|11740296|FG003|NOT COMPLETED|Open-Label Period||273
10584375|NCT01734785|11740293|FG000|STARTED|Double-Blind Period||111
10584376|NCT01734785|11740294|FG001|STARTED|Double-Blind Period||112
10584377|NCT01734785|11740295|FG002|STARTED|Double-Blind Period||110
10584378|NCT01734785|11740296|FG003|STARTED|Double-Blind Period||0
10584379|NCT01734785|11740293|FG000|COMPLETED|Double-Blind Period||106
10584380|NCT01734785|11740294|FG001|COMPLETED|Double-Blind Period||103
10584381|NCT01734785|11740295|FG002|COMPLETED|Double-Blind Period||105
10584382|NCT01734785|11740296|FG003|COMPLETED|Double-Blind Period||0
10584383|NCT01734785|11740293|FG000|NOT COMPLETED|Double-Blind Period||5
10584384|NCT01734785|11740294|FG001|NOT COMPLETED|Double-Blind Period||9
10584385|NCT01734785|11740295|FG002|NOT COMPLETED|Double-Blind Period||5
10584386|NCT01734785|11740296|FG003|NOT COMPLETED|Double-Blind Period||0
10584387|NCT01734811|11740307|FG000|STARTED|Overall Study||58
10584388|NCT01734811|11740308|FG001|STARTED|Overall Study||62
10584389|NCT01734811|11740307|FG000|COMPLETED|Overall Study||54
10584390|NCT01734811|11740308|FG001|COMPLETED|Overall Study||59
10584391|NCT01734811|11740307|FG000|NOT COMPLETED|Overall Study||4
10584392|NCT01734811|11740308|FG001|NOT COMPLETED|Overall Study||3
10651833|NCT02178995|11812063|FG002|STARTED|Open Label||0
10651834|NCT02178995|11812064|FG003|STARTED|Open Label||0
10651835|NCT02178995|11812065|FG004|STARTED|Open Label||0
10702908|NCT02579382|11867405|FG003|STARTED|Optional Treatment Extension Phase(OTEP)|3 participants who completed the Main Study Phase did not enter the OTEP.|49
10702909|NCT02579382|11867402|FG000|COMPLETED|Optional Treatment Extension Phase(OTEP)||26
10702910|NCT02579382|11867403|FG001|COMPLETED|Optional Treatment Extension Phase(OTEP)||44
10702911|NCT02579382|11867404|FG002|COMPLETED|Optional Treatment Extension Phase(OTEP)||50
10702912|NCT02579382|11867405|FG003|COMPLETED|Optional Treatment Extension Phase(OTEP)||44
10702913|NCT02579382|11867402|FG000|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||1
10702914|NCT02579382|11867403|FG001|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||7
10702915|NCT02579382|11867404|FG002|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||4
10702916|NCT02579382|11867405|FG003|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||5
10702917|NCT02579421|11867427|FG000|STARTED|Overall Study||23
10702918|NCT02579421|11867428|FG001|STARTED|Overall Study||23
10702919|NCT02579421|11867429|FG002|STARTED|Overall Study||6
10702920|NCT02579421|11867430|FG003|STARTED|Overall Study||6
10702921|NCT02579421|11867427|FG000|COMPLETED|Overall Study||17
10651836|NCT02178995|11812066|FG005|STARTED|Open Label||0
10651837|NCT02178995|11812067|FG006|STARTED|Open Label||0
10651838|NCT02178995|11812068|FG007|STARTED|Open Label||0
10651839|NCT02178995|11812069|FG008|STARTED|Open Label||0
10651840|NCT02178995|11812061|FG000|COMPLETED|Open Label||28
10651841|NCT02178995|11812062|FG001|COMPLETED|Open Label||14
10651842|NCT02178995|11812063|FG002|COMPLETED|Open Label||0
10651843|NCT02178995|11812064|FG003|COMPLETED|Open Label||0
10651844|NCT02178995|11812065|FG004|COMPLETED|Open Label||0
10651845|NCT02178995|11812066|FG005|COMPLETED|Open Label||0
10651846|NCT02178995|11812067|FG006|COMPLETED|Open Label||0
10651847|NCT02178995|11812068|FG007|COMPLETED|Open Label||0
10651848|NCT02178995|11812069|FG008|COMPLETED|Open Label||0
10651849|NCT02178995|11812061|FG000|NOT COMPLETED|Open Label||2
10651850|NCT02178995|11812062|FG001|NOT COMPLETED|Open Label||0
10651851|NCT02178995|11812063|FG002|NOT COMPLETED|Open Label||0
10651852|NCT02178995|11812064|FG003|NOT COMPLETED|Open Label||0
10651853|NCT02178995|11812065|FG004|NOT COMPLETED|Open Label||0
10651854|NCT02178995|11812066|FG005|NOT COMPLETED|Open Label||0
10651855|NCT02178995|11812067|FG006|NOT COMPLETED|Open Label||0
10651856|NCT02178995|11812068|FG007|NOT COMPLETED|Open Label||0
10651857|NCT02178995|11812069|FG008|NOT COMPLETED|Open Label||0
10651858|NCT02179047|11812095|FG000|STARTED|Overall Study||194
10702922|NCT02579421|11867428|FG001|COMPLETED|Overall Study||18
10702923|NCT02579421|11867429|FG002|COMPLETED|Overall Study||5
10702924|NCT02579421|11867430|FG003|COMPLETED|Overall Study||3
10702925|NCT02579421|11867427|FG000|NOT COMPLETED|Overall Study||6
10702926|NCT02579421|11867428|FG001|NOT COMPLETED|Overall Study||5
10702927|NCT02579421|11867429|FG002|NOT COMPLETED|Overall Study||1
10702928|NCT02579421|11867430|FG003|NOT COMPLETED|Overall Study||3
10702929|NCT02579603|11867442|FG000|STARTED|Overall Study|Started are the randomised patients|52
10702930|NCT02579603|11867443|FG001|STARTED|Overall Study|Started are the randomised patients|53
10702931|NCT02579603|11867442|FG000|Number of Patients Treated|Overall Study||51
10702932|NCT02579603|11867443|FG001|Number of Patients Treated|Overall Study||53
10702933|NCT02579603|11867442|FG000|COMPLETED|Overall Study||48
10702934|NCT02579603|11867443|FG001|COMPLETED|Overall Study||51
10702935|NCT02579603|11867442|FG000|NOT COMPLETED|Overall Study||4
10702936|NCT02579603|11867443|FG001|NOT COMPLETED|Overall Study||2
10702937|NCT02579616|11867450|FG000|STARTED|Overall Study||29
10702938|NCT02579616|11867450|FG000|Treated|Overall Study||26
10702939|NCT02579616|11867450|FG000|COMPLETED|Overall Study||26
10702940|NCT02579616|11867450|FG000|NOT COMPLETED|Overall Study||3
10702941|NCT02579629|11867457|FG000|STARTED|Overall Study||22
10702942|NCT02579629|11867458|FG001|STARTED|Overall Study||20
10702943|NCT02579629|11867459|FG002|STARTED|Overall Study||22
10702944|NCT02579629|11867457|FG000|COMPLETED|Overall Study||20
10702945|NCT02579629|11867458|FG001|COMPLETED|Overall Study||19
10702946|NCT02579629|11867459|FG002|COMPLETED|Overall Study||20
10702947|NCT02579629|11867457|FG000|NOT COMPLETED|Overall Study||2
10702948|NCT02579629|11867458|FG001|NOT COMPLETED|Overall Study||1
10702949|NCT02579629|11867459|FG002|NOT COMPLETED|Overall Study||2
10702950|NCT02579759|11867470|FG000|STARTED|Overall Study||109
10702951|NCT02579759|11867471|FG001|STARTED|Overall Study||113
10702952|NCT02579759|11867472|FG002|STARTED|Overall Study||101
10702953|NCT02579759|11867470|FG000|COMPLETED|Overall Study||85
10702954|NCT02579759|11867471|FG001|COMPLETED|Overall Study||49
10702955|NCT02579759|11867472|FG002|COMPLETED|Overall Study||80
10702956|NCT02579759|11867470|FG000|NOT COMPLETED|Overall Study||24
10702957|NCT02579759|11867471|FG001|NOT COMPLETED|Overall Study||64
10702958|NCT02579759|11867472|FG002|NOT COMPLETED|Overall Study||21
10702959|NCT02579772|11867482|FG000|STARTED|Overall Study||8
10702960|NCT02579772|11867483|FG001|STARTED|Overall Study||5
10702961|NCT02579772|11867482|FG000|COMPLETED|Overall Study||6
10702962|NCT02579772|11867483|FG001|COMPLETED|Overall Study||3
10702963|NCT02579772|11867482|FG000|NOT COMPLETED|Overall Study||2
10702964|NCT02579772|11867483|FG001|NOT COMPLETED|Overall Study||2
10702965|NCT02579863|11867491|FG000|STARTED|Overall Study||156
10702966|NCT02579863|11867492|FG001|STARTED|Overall Study||154
10702967|NCT02579863|11867491|FG000|Treated|Overall Study||154
10702968|NCT02579863|11867492|FG001|Treated|Overall Study||148
10702969|NCT02579863|11867491|FG000|COMPLETED|Overall Study||0
10702970|NCT02579863|11867492|FG001|COMPLETED|Overall Study||0
10702971|NCT02579863|11867491|FG000|NOT COMPLETED|Overall Study||156
10584393|NCT01734850|11740317|FG000|STARTED|Overall Study||4
10584394|NCT01734850|11740318|FG001|STARTED|Overall Study||4
10584395|NCT01734850|11740319|FG002|STARTED|Overall Study||5
10584396|NCT01734850|11740317|FG000|COMPLETED|Overall Study||1
10584397|NCT01734850|11740318|FG001|COMPLETED|Overall Study||2
10584398|NCT01734850|11740319|FG002|COMPLETED|Overall Study||1
10584399|NCT01734850|11740317|FG000|NOT COMPLETED|Overall Study||3
10584400|NCT01734850|11740318|FG001|NOT COMPLETED|Overall Study||2
10584401|NCT01734850|11740319|FG002|NOT COMPLETED|Overall Study||4
10584402|NCT01734889|11740330|FG000|STARTED|Overall Study||18
10584403|NCT01734889|11740330|FG000|COMPLETED|Overall Study||18
10584404|NCT01734889|11740330|FG000|NOT COMPLETED|Overall Study||0
10584405|NCT01734902|11740337|FG000|STARTED|Overall Study||14
10584406|NCT01734902|11740338|FG001|STARTED|Overall Study||16
10584407|NCT01734902|11740337|FG000|COMPLETED|Overall Study||14
10584408|NCT01734902|11740338|FG001|COMPLETED|Overall Study||14
10584409|NCT01734902|11740337|FG000|NOT COMPLETED|Overall Study||0
10702972|NCT02579863|11867492|FG001|NOT COMPLETED|Overall Study||154
10702973|NCT02579876|11867500|FG000|STARTED|Overall Study||15
10702974|NCT02579876|11867501|FG001|STARTED|Overall Study||5
10702975|NCT02579876|11867500|FG000|COMPLETED|Overall Study||14
10702976|NCT02579876|11867501|FG001|COMPLETED|Overall Study||5
10702977|NCT02579876|11867500|FG000|NOT COMPLETED|Overall Study||1
10584410|NCT01734902|11740338|FG001|NOT COMPLETED|Overall Study||2
10584411|NCT01734993|11740344|FG000|STARTED|Overall Study||11
10584412|NCT01734993|11740344|FG000|COMPLETED|Overall Study||9
10702978|NCT02579876|11867501|FG001|NOT COMPLETED|Overall Study||0
10702979|NCT02579915|11867509|FG000|STARTED|Overall Study||19
10702980|NCT02579915|11867510|FG001|STARTED|Overall Study||21
10702981|NCT02579915|11867509|FG000|COMPLETED|Overall Study||9
10702982|NCT02579915|11867510|FG001|COMPLETED|Overall Study||16
10702983|NCT02579915|11867509|FG000|NOT COMPLETED|Overall Study||10
10702984|NCT02579915|11867510|FG001|NOT COMPLETED|Overall Study||5
10584413|NCT01734993|11740344|FG000|NOT COMPLETED|Overall Study||2
10584414|NCT01735175|11740351|FG000|STARTED|Overall Study||159
10584415|NCT01735175|11740352|FG001|STARTED|Overall Study||157
10702985|NCT02579928|11867518|FG000|STARTED|Overall Study||6
10702986|NCT02579928|11867519|FG001|STARTED|Overall Study||11
10702987|NCT02579928|11867518|FG000|COMPLETED|Overall Study||5
10702988|NCT02579928|11867519|FG001|COMPLETED|Overall Study||11
10702989|NCT02579928|11867518|FG000|NOT COMPLETED|Overall Study||1
10702990|NCT02579928|11867519|FG001|NOT COMPLETED|Overall Study||0
10584416|NCT01735175|11740351|FG000|Completed All Cycles|Overall Study||141
10584417|NCT01735175|11740352|FG001|Completed All Cycles|Overall Study||150
10584418|NCT01735175|11740351|FG000|Completed All Treatments as Planned|Overall Study||140
10584419|NCT01735175|11740352|FG001|Completed All Treatments as Planned|Overall Study||150
10584420|NCT01735175|11740351|FG000|Completed the 6-month SFU Visit|Overall Study||120
10584421|NCT01735175|11740352|FG001|Completed the 6-month SFU Visit|Overall Study||138
10584422|NCT01735175|11740351|FG000|COMPLETED|Overall Study||130
10584423|NCT01735175|11740352|FG001|COMPLETED|Overall Study||144
10584424|NCT01735175|11740351|FG000|NOT COMPLETED|Overall Study||29
10584425|NCT01735175|11740352|FG001|NOT COMPLETED|Overall Study||13
10584426|NCT01735201|11740366|FG000|STARTED|Overall Study||45
10584427|NCT01735201|11740367|FG001|STARTED|Overall Study||44
10584428|NCT01735201|11740368|FG002|STARTED|Overall Study||44
10584429|NCT01735201|11740369|FG003|STARTED|Overall Study||44
10584430|NCT01735201|11740370|FG004|STARTED|Overall Study||45
10584431|NCT01735201|11740371|FG005|STARTED|Overall Study||45
10584432|NCT01735201|11740372|FG006|STARTED|Overall Study||45
10584433|NCT01735201|11740373|FG007|STARTED|Overall Study||44
10584434|NCT01735201|11740366|FG000|COMPLETED|Overall Study||42
10584435|NCT01735201|11740367|FG001|COMPLETED|Overall Study||43
10584436|NCT01735201|11740368|FG002|COMPLETED|Overall Study||44
10584437|NCT01735201|11740369|FG003|COMPLETED|Overall Study||42
10584438|NCT01735201|11740370|FG004|COMPLETED|Overall Study||44
10584439|NCT01735201|11740371|FG005|COMPLETED|Overall Study||40
10584440|NCT01735201|11740372|FG006|COMPLETED|Overall Study||42
10584441|NCT01735201|11740373|FG007|COMPLETED|Overall Study||42
10584442|NCT01735201|11740366|FG000|NOT COMPLETED|Overall Study||3
10584443|NCT01735201|11740367|FG001|NOT COMPLETED|Overall Study||1
10584444|NCT01735201|11740368|FG002|NOT COMPLETED|Overall Study||0
10584445|NCT01735201|11740369|FG003|NOT COMPLETED|Overall Study||2
10584446|NCT01735201|11740370|FG004|NOT COMPLETED|Overall Study||1
10584447|NCT01735201|11740371|FG005|NOT COMPLETED|Overall Study||5
10584448|NCT01735201|11740372|FG006|NOT COMPLETED|Overall Study||3
10584449|NCT01735201|11740373|FG007|NOT COMPLETED|Overall Study||2
10584450|NCT01735214|11740391|FG000|STARTED|Overall Study||358
10584451|NCT01735214|11740391|FG000|COMPLETED|Overall Study||358
10584452|NCT01735214|11740391|FG000|NOT COMPLETED|Overall Study||0
10584453|NCT01735279|11740397|FG000|STARTED|Overall Study||29
10584454|NCT01735279|11740398|FG001|STARTED|Overall Study||29
10584455|NCT01735279|11740397|FG000|COMPLETED|Overall Study||18
10584456|NCT01735279|11740398|FG001|COMPLETED|Overall Study||21
10584457|NCT01735279|11740397|FG000|NOT COMPLETED|Overall Study||11
10584458|NCT01735279|11740398|FG001|NOT COMPLETED|Overall Study||8
10584459|NCT01735396|11740404|FG000|STARTED|Overall Study||11
10584460|NCT01735396|11740404|FG000|COMPLETED|Overall Study||10
10584461|NCT01735396|11740404|FG000|NOT COMPLETED|Overall Study||1
10584462|NCT01735617|11740408|FG000|STARTED|Overall Study||16
10584463|NCT01735617|11740408|FG000|COMPLETED|Overall Study||16
10584464|NCT01735617|11740408|FG000|NOT COMPLETED|Overall Study||0
10584465|NCT01735630|11740417|FG000|STARTED|Overall Study||175
10584466|NCT01735630|11740418|FG001|STARTED|Overall Study||175
10584467|NCT01735630|11740417|FG000|COMPLETED|Overall Study||157
10584468|NCT01735630|11740418|FG001|COMPLETED|Overall Study||157
10584469|NCT01735630|11740417|FG000|NOT COMPLETED|Overall Study||18
10584470|NCT01735630|11740418|FG001|NOT COMPLETED|Overall Study||18
10806735|NCT03944785|11968348|FG000|STARTED|2 Month Study Completion||2
10806736|NCT03944785|11968349|FG001|STARTED|2 Month Study Completion||34
10806737|NCT03944785|11968350|FG002|STARTED|2 Month Study Completion||128
10806738|NCT03944785|11968348|FG000|COMPLETED|2 Month Study Completion||2
10806739|NCT03944785|11968349|FG001|COMPLETED|2 Month Study Completion||30
10806740|NCT03944785|11968350|FG002|COMPLETED|2 Month Study Completion||123
10806741|NCT03944785|11968348|FG000|NOT COMPLETED|2 Month Study Completion||0
10806742|NCT03944785|11968349|FG001|NOT COMPLETED|2 Month Study Completion||4
10584471|NCT01735877|11740426|FG000|STARTED|Overall Study||27
10584472|NCT01735877|11740427|FG001|STARTED|Overall Study||21
10584473|NCT01735877|11740426|FG000|COMPLETED|Overall Study||26
10584474|NCT01735877|11740427|FG001|COMPLETED|Overall Study||21
10584475|NCT01735877|11740426|FG000|NOT COMPLETED|Overall Study||1
10584476|NCT01735877|11740427|FG001|NOT COMPLETED|Overall Study||0
10584477|NCT01735916|11740436|FG000|STARTED|Overall Study||18
10584478|NCT01735916|11740437|FG001|STARTED|Overall Study||19
10584479|NCT01735916|11740438|FG002|STARTED|Overall Study||7
10584480|NCT01735916|11740436|FG000|COMPLETED|Overall Study||0
10584481|NCT01735916|11740437|FG001|COMPLETED|Overall Study|Study was cancelled before any subjects completed 24 months of follow-up or met any study endpoints.|0
10584482|NCT01735916|11740438|FG002|COMPLETED|Overall Study|Study was cancelled before any subjects completed 24 months of follow-up or met any study endpoints.|0
10584483|NCT01735916|11740436|FG000|NOT COMPLETED|Overall Study||18
10584484|NCT01735916|11740437|FG001|NOT COMPLETED|Overall Study||19
10806743|NCT03944785|11968350|FG002|NOT COMPLETED|2 Month Study Completion||5
10584485|NCT01735916|11740438|FG002|NOT COMPLETED|Overall Study||7
10584486|NCT01735981|11740447|FG000|STARTED|Allocated||13
10584487|NCT01735981|11740448|FG001|STARTED|Allocated||11
10584488|NCT01735981|11740447|FG000|COMPLETED|Allocated||11
10584489|NCT01735981|11740448|FG001|COMPLETED|Allocated||8
10584490|NCT01735981|11740447|FG000|NOT COMPLETED|Allocated||2
10584491|NCT01735981|11740448|FG001|NOT COMPLETED|Allocated||3
10584492|NCT01735981|11740447|FG000|STARTED|Crossed Over||11
10584493|NCT01735981|11740448|FG001|STARTED|Crossed Over|N=1 lost to cross over before DDR intervention|7
10584494|NCT01735981|11740447|FG000|COMPLETED|Crossed Over||11
10584495|NCT01735981|11740448|FG001|COMPLETED|Crossed Over||7
10584496|NCT01735981|11740447|FG000|NOT COMPLETED|Crossed Over||0
10584497|NCT01735981|11740448|FG001|NOT COMPLETED|Crossed Over||0
10584498|NCT01735994|11740458|FG000|STARTED|Overall Study||263
10584499|NCT01735994|11740459|FG001|STARTED|Overall Study||218
10584500|NCT01735994|11740458|FG000|Post Intervention (3 Weeks)|Overall Study||239
10584501|NCT01735994|11740459|FG001|Post Intervention (3 Weeks)|Overall Study||198
10584502|NCT01735994|11740458|FG000|Follow-Up #1 (6 Months)|Overall Study||213
10584503|NCT01735994|11740459|FG001|Follow-Up #1 (6 Months)|Overall Study||163
10584504|NCT01735994|11740458|FG000|Follow-Up #2 (12 Months)|Overall Study||212
10584505|NCT01735994|11740459|FG001|Follow-Up #2 (12 Months)|Overall Study||174
10584506|NCT01735994|11740458|FG000|COMPLETED|Overall Study||200
10584507|NCT01735994|11740459|FG001|COMPLETED|Overall Study||152
10584508|NCT01735994|11740458|FG000|NOT COMPLETED|Overall Study||63
10584509|NCT01735994|11740459|FG001|NOT COMPLETED|Overall Study||66
10584510|NCT01736085|11740471|FG000|STARTED|Overall Study||529
10584511|NCT01736085|11740472|FG001|STARTED|Overall Study||530
10584512|NCT01736085|11740473|FG002|STARTED|Overall Study||793
10584513|NCT01736085|11740474|FG003|STARTED|Overall Study||530
10584514|NCT01736085|11740475|FG004|STARTED|Overall Study||530
10584515|NCT01736085|11740476|FG005|STARTED|Overall Study||794
10584516|NCT01736085|11740471|FG000|COMPLETED|Overall Study||529
10584517|NCT01736085|11740472|FG001|COMPLETED|Overall Study||530
10584518|NCT01736085|11740473|FG002|COMPLETED|Overall Study||793
10584519|NCT01736085|11740474|FG003|COMPLETED|Overall Study||530
10584520|NCT01736085|11740475|FG004|COMPLETED|Overall Study||530
10584521|NCT01736085|11740476|FG005|COMPLETED|Overall Study||794
10584522|NCT01736085|11740471|FG000|NOT COMPLETED|Overall Study||0
10584523|NCT01736085|11740472|FG001|NOT COMPLETED|Overall Study||0
10584524|NCT01736085|11740473|FG002|NOT COMPLETED|Overall Study||0
10584525|NCT01736085|11740474|FG003|NOT COMPLETED|Overall Study||0
10584526|NCT01736085|11740475|FG004|NOT COMPLETED|Overall Study||0
10584527|NCT01736085|11740476|FG005|NOT COMPLETED|Overall Study||0
10584528|NCT01736124|11740489|FG000|STARTED|Baseline||90
10584529|NCT01736124|11740490|FG001|STARTED|Baseline||90
10584530|NCT01736124|11740489|FG000|COMPLETED|Baseline||90
10584531|NCT01736124|11740490|FG001|COMPLETED|Baseline||90
10584532|NCT01736124|11740489|FG000|NOT COMPLETED|Baseline||0
10584533|NCT01736124|11740490|FG001|NOT COMPLETED|Baseline||0
10584534|NCT01736124|11740489|FG000|STARTED|Post-intervention Assessment||90
10584535|NCT01736124|11740490|FG001|STARTED|Post-intervention Assessment||90
10584536|NCT01736124|11740489|FG000|COMPLETED|Post-intervention Assessment||59
10584537|NCT01736124|11740490|FG001|COMPLETED|Post-intervention Assessment||69
10584538|NCT01736124|11740489|FG000|NOT COMPLETED|Post-intervention Assessment||31
10584539|NCT01736124|11740490|FG001|NOT COMPLETED|Post-intervention Assessment||21
10584540|NCT01736124|11740489|FG000|STARTED|6 Mo. Post-Intervention Assessment|"Includes 3 who were temporarily away at Period 2 who did not permanently withdraw from the study."|62
10584541|NCT01736124|11740490|FG001|STARTED|6 Mo. Post-Intervention Assessment|"Includes 1 who was temporarily away at Period 2 but did not permanently withdraw."|70
10584542|NCT01736124|11740489|FG000|COMPLETED|6 Mo. Post-Intervention Assessment||57
10584543|NCT01736124|11740490|FG001|COMPLETED|6 Mo. Post-Intervention Assessment||58
10584544|NCT01736124|11740489|FG000|NOT COMPLETED|6 Mo. Post-Intervention Assessment||5
10584545|NCT01736124|11740490|FG001|NOT COMPLETED|6 Mo. Post-Intervention Assessment||12
10584546|NCT01736124|11740489|FG000|STARTED|12 Mo. Post-Intervention Assessment|"Includes 1 who was temporarily away at Period 3 but did not permanently withdraw."|58
10584547|NCT01736124|11740490|FG001|STARTED|12 Mo. Post-Intervention Assessment|"Includes 4 who were temporarily away at Period 3 but did not permanently withdraw."|62
10584548|NCT01736124|11740489|FG000|COMPLETED|12 Mo. Post-Intervention Assessment||46
10584549|NCT01736124|11740490|FG001|COMPLETED|12 Mo. Post-Intervention Assessment||50
10584550|NCT01736124|11740489|FG000|NOT COMPLETED|12 Mo. Post-Intervention Assessment||12
10584551|NCT01736124|11740490|FG001|NOT COMPLETED|12 Mo. Post-Intervention Assessment||12
10584552|NCT01736176|11740498|FG000|STARTED|Overall Study|Enrolled participants who underwent the PEG-J placement procedure|39
10584553|NCT01736176|11740498|FG000|Received LCIG|Overall Study||38
10584554|NCT01736176|11740498|FG000|COMPLETED|Overall Study||28
10584555|NCT01736176|11740498|FG000|NOT COMPLETED|Overall Study||11
10584556|NCT01736189|11740506|FG000|STARTED|Overall Study||346
10584557|NCT01736189|11740506|FG000|COMPLETED|Overall Study||300
10584558|NCT01736189|11740506|FG000|NOT COMPLETED|Overall Study||46
10584559|NCT01736215|11740510|FG000|STARTED|Overall Study||33
10584560|NCT01736215|11740510|FG000|Treated|Overall Study||25
10584561|NCT01736215|11740510|FG000|COMPLETED|Overall Study||19
10584562|NCT01736215|11740510|FG000|NOT COMPLETED|Overall Study||14
10584563|NCT01736241|11740521|FG000|STARTED|Overall Study||6
10584564|NCT01736241|11740522|FG001|STARTED|Overall Study||6
10584565|NCT01736241|11740523|FG002|STARTED|Overall Study||6
10584566|NCT01736241|11740524|FG003|STARTED|Overall Study||5
10584567|NCT01736241|11740525|FG004|STARTED|Overall Study||6
10584568|NCT01736241|11740526|FG005|STARTED|Overall Study||6
10584569|NCT01736241|11740527|FG006|STARTED|Overall Study||6
10584570|NCT01736241|11740521|FG000|Received at Least One Dose of Study Drug|Overall Study||6
10584571|NCT01736241|11740522|FG001|Received at Least One Dose of Study Drug|Overall Study||6
10584572|NCT01736241|11740523|FG002|Received at Least One Dose of Study Drug|Overall Study||6
10584573|NCT01736241|11740524|FG003|Received at Least One Dose of Study Drug|Overall Study||5
10584574|NCT01736241|11740525|FG004|Received at Least One Dose of Study Drug|Overall Study||6
10584575|NCT01736241|11740526|FG005|Received at Least One Dose of Study Drug|Overall Study||6
10584576|NCT01736241|11740527|FG006|Received at Least One Dose of Study Drug|Overall Study||6
10584577|NCT01736241|11740521|FG000|COMPLETED|Overall Study||6
10584578|NCT01736241|11740522|FG001|COMPLETED|Overall Study||6
10584579|NCT01736241|11740523|FG002|COMPLETED|Overall Study||6
10584580|NCT01736241|11740524|FG003|COMPLETED|Overall Study||5
10584581|NCT01736241|11740525|FG004|COMPLETED|Overall Study||6
10584582|NCT01736241|11740526|FG005|COMPLETED|Overall Study||6
10584583|NCT01736241|11740527|FG006|COMPLETED|Overall Study||6
10584584|NCT01736241|11740521|FG000|NOT COMPLETED|Overall Study||0
10584585|NCT01736241|11740522|FG001|NOT COMPLETED|Overall Study||0
10584586|NCT01736241|11740523|FG002|NOT COMPLETED|Overall Study||0
10584587|NCT01736241|11740524|FG003|NOT COMPLETED|Overall Study||0
10584588|NCT01736241|11740525|FG004|NOT COMPLETED|Overall Study||0
10584589|NCT01736241|11740526|FG005|NOT COMPLETED|Overall Study||0
10584590|NCT01736241|11740527|FG006|NOT COMPLETED|Overall Study||0
10584591|NCT01736254|11740544|FG000|STARTED|Period 1 (Day 1)||24
10584592|NCT01736254|11740544|FG000|Received at Least One Dose of Study Drug|Period 1 (Day 1)||24
10584593|NCT01736254|11740544|FG000|COMPLETED|Period 1 (Day 1)||24
10584594|NCT01736254|11740544|FG000|NOT COMPLETED|Period 1 (Day 1)||0
10584595|NCT01736254|11740544|FG000|STARTED|Period 2 (Days 2 to 12)||24
10584596|NCT01736254|11740544|FG000|COMPLETED|Period 2 (Days 2 to 12)||21
10584597|NCT01736254|11740544|FG000|NOT COMPLETED|Period 2 (Days 2 to 12)||3
10584598|NCT01736254|11740544|FG000|STARTED|Period 3 (Days 13 to 23)||21
10584599|NCT01736254|11740544|FG000|COMPLETED|Period 3 (Days 13 to 23)||20
10584600|NCT01736254|11740544|FG000|NOT COMPLETED|Period 3 (Days 13 to 23)||1
10584601|NCT01736267|11740552|FG000|STARTED|Overall Study||3
10584602|NCT01736267|11740552|FG000|COMPLETED|Overall Study||3
10584603|NCT01736267|11740552|FG000|NOT COMPLETED|Overall Study||0
10584604|NCT01736358|11740558|FG000|STARTED|Overall Study||25
10584605|NCT01736358|11740559|FG001|STARTED|Overall Study||25
10584606|NCT01736358|11740558|FG000|COMPLETED|Overall Study||20
10584607|NCT01736358|11740559|FG001|COMPLETED|Overall Study||23
10584608|NCT01736358|11740558|FG000|NOT COMPLETED|Overall Study||5
10584609|NCT01736358|11740559|FG001|NOT COMPLETED|Overall Study||2
10584610|NCT01736397|11740567|FG000|STARTED|Overall Study||75
10584611|NCT01736397|11740568|FG001|STARTED|Overall Study||74
10584612|NCT01736397|11740567|FG000|COMPLETED|Overall Study||61
10584613|NCT01736397|11740568|FG001|COMPLETED|Overall Study||50
10584614|NCT01736397|11740567|FG000|NOT COMPLETED|Overall Study||14
10584615|NCT01736397|11740568|FG001|NOT COMPLETED|Overall Study||24
10584616|NCT01736475|11740576|FG000|STARTED|Overall Study||121
10584617|NCT01736475|11740577|FG001|STARTED|Overall Study||17
10584618|NCT01736475|11740576|FG000|COMPLETED|Overall Study||109
10584619|NCT01736475|11740577|FG001|COMPLETED|Overall Study||17
10584620|NCT01736475|11740576|FG000|NOT COMPLETED|Overall Study||12
10584621|NCT01736475|11740577|FG001|NOT COMPLETED|Overall Study||0
10584622|NCT01736527|11740594|FG000|STARTED|Overall Study||12
10584623|NCT01736527|11740594|FG000|COMPLETED|Overall Study||12
10584624|NCT01736527|11740594|FG000|NOT COMPLETED|Overall Study||0
10584625|NCT01736540|11740598|FG000|STARTED|Overall Study||243
10584626|NCT01736540|11740598|FG000|COMPLETED|Overall Study||228
10584627|NCT01736540|11740598|FG000|NOT COMPLETED|Overall Study||15
10584628|NCT01736553|11740611|FG000|STARTED|Overall Study||26
10584629|NCT01736553|11740612|FG001|STARTED|Overall Study||27
10584630|NCT01736553|11740611|FG000|COMPLETED|Overall Study||7
10584631|NCT01736553|11740612|FG001|COMPLETED|Overall Study||23
10584632|NCT01736553|11740611|FG000|NOT COMPLETED|Overall Study||19
10584633|NCT01736553|11740612|FG001|NOT COMPLETED|Overall Study||4
10584634|NCT01736566|11740641|FG000|STARTED|Main Study||51
10584635|NCT01736566|11740642|FG001|STARTED|Main Study||50
10584636|NCT01736566|11740643|FG002|STARTED|Main Study||50
10584637|NCT01736566|11740644|FG003|STARTED|Main Study||52
10584638|NCT01736566|11740645|FG004|STARTED|Main Study||10
10584639|NCT01736566|11740641|FG000|COMPLETED|Main Study||50
10584640|NCT01736566|11740642|FG001|COMPLETED|Main Study||50
10584641|NCT01736566|11740643|FG002|COMPLETED|Main Study||49
10584642|NCT01736566|11740644|FG003|COMPLETED|Main Study||51
10584643|NCT01736566|11740645|FG004|COMPLETED|Main Study||6
10584644|NCT01736566|11740641|FG000|NOT COMPLETED|Main Study||1
10584645|NCT01736566|11740642|FG001|NOT COMPLETED|Main Study||0
10584646|NCT01736566|11740643|FG002|NOT COMPLETED|Main Study||1
10584647|NCT01736566|11740644|FG003|NOT COMPLETED|Main Study||1
10584648|NCT01736566|11740645|FG004|NOT COMPLETED|Main Study||4
10584649|NCT01736566|11740641|FG000|STARTED|Long Term Follow-up||42
10584650|NCT01736566|11740642|FG001|STARTED|Long Term Follow-up||0
10584651|NCT01736566|11740643|FG002|STARTED|Long Term Follow-up||49
10584652|NCT01736566|11740644|FG003|STARTED|Long Term Follow-up||0
10584653|NCT01736566|11740645|FG004|STARTED|Long Term Follow-up||1
10584654|NCT01736566|11740641|FG000|COMPLETED|Long Term Follow-up||0
10584655|NCT01736566|11740642|FG001|COMPLETED|Long Term Follow-up||0
10584656|NCT01736566|11740643|FG002|COMPLETED|Long Term Follow-up||0
10584657|NCT01736566|11740644|FG003|COMPLETED|Long Term Follow-up||0
10584658|NCT01736566|11740645|FG004|COMPLETED|Long Term Follow-up||0
10584659|NCT01736566|11740641|FG000|NOT COMPLETED|Long Term Follow-up||42
10584660|NCT01736566|11740642|FG001|NOT COMPLETED|Long Term Follow-up||0
10584661|NCT01736566|11740643|FG002|NOT COMPLETED|Long Term Follow-up||49
10584662|NCT01736566|11740644|FG003|NOT COMPLETED|Long Term Follow-up||0
10584663|NCT01736566|11740645|FG004|NOT COMPLETED|Long Term Follow-up||1
10584664|NCT01736579|11740672|FG000|STARTED|Overall Study||2
10584665|NCT01736579|11740673|FG001|STARTED|Overall Study||2
10584666|NCT01736579|11740672|FG000|COMPLETED|Overall Study||0
10584667|NCT01736579|11740673|FG001|COMPLETED|Overall Study||0
10584668|NCT01736579|11740672|FG000|NOT COMPLETED|Overall Study||2
10584669|NCT01736579|11740673|FG001|NOT COMPLETED|Overall Study||2
10584670|NCT01736657|11740679|FG000|STARTED|Overall Study||73
10584671|NCT01736657|11740679|FG000|COMPLETED|Overall Study||72
10584672|NCT01736657|11740679|FG000|NOT COMPLETED|Overall Study||1
10584673|NCT01736683|11740688|FG000|STARTED|Overall Study||7
10584674|NCT01736683|11740689|FG001|STARTED|Overall Study||6
10584675|NCT01736683|11740690|FG002|STARTED|Overall Study||21
10584676|NCT01736683|11740691|FG003|STARTED|Overall Study||35
10584677|NCT01736683|11740692|FG004|STARTED|Overall Study||5
10584678|NCT01736683|11740688|FG000|COMPLETED|Overall Study|# who completed treatment|0
10584679|NCT01736683|11740689|FG001|COMPLETED|Overall Study|# who completed treatment|0
10584680|NCT01736683|11740690|FG002|COMPLETED|Overall Study|# who completed treatment|0
10584681|NCT01736683|11740691|FG003|COMPLETED|Overall Study|# who completed treatment|0
10584682|NCT01736683|11740692|FG004|COMPLETED|Overall Study|# who completed treatment|0
10584683|NCT01736683|11740688|FG000|NOT COMPLETED|Overall Study||7
10584684|NCT01736683|11740689|FG001|NOT COMPLETED|Overall Study||6
10584685|NCT01736683|11740690|FG002|NOT COMPLETED|Overall Study||21
10584686|NCT01736683|11740691|FG003|NOT COMPLETED|Overall Study||35
10584687|NCT01736683|11740692|FG004|NOT COMPLETED|Overall Study||5
10584688|NCT01736696|11740713|FG000|STARTED|Overall Study||5
10584689|NCT01736696|11740714|FG001|STARTED|Overall Study||5
10584690|NCT01736696|11740715|FG002|STARTED|Overall Study||10
10584691|NCT01736696|11740716|FG003|STARTED|Overall Study||9
10584692|NCT01736696|11740717|FG004|STARTED|Overall Study||9
10584693|NCT01736696|11740718|FG005|STARTED|Overall Study||8
10584694|NCT01736696|11740719|FG006|STARTED|Overall Study||13
10584695|NCT01736696|11740713|FG000|COMPLETED|Overall Study||5
10584696|NCT01736696|11740714|FG001|COMPLETED|Overall Study||5
10584697|NCT01736696|11740715|FG002|COMPLETED|Overall Study||9
10584698|NCT01736696|11740716|FG003|COMPLETED|Overall Study||9
10584699|NCT01736696|11740717|FG004|COMPLETED|Overall Study||9
10584700|NCT01736696|11740718|FG005|COMPLETED|Overall Study||8
10584701|NCT01736696|11740719|FG006|COMPLETED|Overall Study||13
10584702|NCT01736696|11740713|FG000|NOT COMPLETED|Overall Study||0
10584703|NCT01736696|11740714|FG001|NOT COMPLETED|Overall Study||0
10584704|NCT01736696|11740715|FG002|NOT COMPLETED|Overall Study||1
10584705|NCT01736696|11740716|FG003|NOT COMPLETED|Overall Study||0
10584706|NCT01736696|11740717|FG004|NOT COMPLETED|Overall Study||0
10584707|NCT01736696|11740718|FG005|NOT COMPLETED|Overall Study||0
10584708|NCT01736696|11740719|FG006|NOT COMPLETED|Overall Study||0
10584709|NCT01736852|11740745|FG000|STARTED|Overall Study||65
10584710|NCT01736852|11740746|FG001|STARTED|Overall Study||64
10584711|NCT01736852|11740745|FG000|COMPLETED|Overall Study||63
10584712|NCT01736852|11740746|FG001|COMPLETED|Overall Study||61
10584713|NCT01736852|11740745|FG000|NOT COMPLETED|Overall Study||2
10584714|NCT01736852|11740746|FG001|NOT COMPLETED|Overall Study||3
10584715|NCT01736865|11740754|FG000|STARTED|Overall Study||61
10584716|NCT01736865|11740755|FG001|STARTED|Overall Study||66
10584717|NCT01736865|11740754|FG000|COMPLETED|Overall Study||61
10584718|NCT01736865|11740755|FG001|COMPLETED|Overall Study||66
10584719|NCT01736865|11740754|FG000|NOT COMPLETED|Overall Study||0
10584720|NCT01736865|11740755|FG001|NOT COMPLETED|Overall Study||0
10584721|NCT01736917|11740761|FG000|STARTED|Overall Study||65
10584722|NCT01736917|11740761|FG000|COMPLETED|Overall Study||54
10584723|NCT01736917|11740761|FG000|NOT COMPLETED|Overall Study||11
10584724|NCT01736930|11740767|FG000|STARTED|Overall Study|Each night randomized to have either Predictive Low Glucose suspend or inactive (control).|20
10584725|NCT01736930|11740767|FG000|COMPLETED|Overall Study|Each night randomized to have either Predictive Low Glucose suspend or inactive (control).|19
10584726|NCT01736930|11740767|FG000|NOT COMPLETED|Overall Study||1
10584727|NCT01736943|11740773|FG000|STARTED|Overall Study||25
10702991|NCT02580188|11867527|FG000|STARTED|Overall Study||35
10702992|NCT02580188|11867528|FG001|STARTED|Overall Study||35
10702993|NCT02580188|11867527|FG000|COMPLETED|Overall Study||32
10702994|NCT02580188|11867528|FG001|COMPLETED|Overall Study||32
10702995|NCT02580188|11867527|FG000|NOT COMPLETED|Overall Study||3
10702996|NCT02580188|11867528|FG001|NOT COMPLETED|Overall Study||3
10702997|NCT02580201|11867537|FG000|STARTED|Overall Study||50
10702998|NCT02580201|11867538|FG001|STARTED|Overall Study||104
10702999|NCT02580201|11867537|FG000|COMPLETED|Overall Study||50
10584728|NCT01736943|11740773|FG000|COMPLETED|Overall Study||25
10584729|NCT01736943|11740773|FG000|NOT COMPLETED|Overall Study||0
10584730|NCT01737268|11740777|FG000|STARTED|Overall Study||20
10584731|NCT01737268|11740777|FG000|Treated|Overall Study||20
10584732|NCT01737268|11740777|FG000|COMPLETED|Overall Study||11
10584733|NCT01737268|11740777|FG000|NOT COMPLETED|Overall Study||9
10584734|NCT01737281|11740784|FG000|STARTED|Overall Study||969
10584735|NCT01737281|11740785|FG001|STARTED|Overall Study||969
10584736|NCT01737281|11740784|FG000|COMPLETED|Overall Study||603
10584737|NCT01737281|11740785|FG001|COMPLETED|Overall Study||689
10584738|NCT01737281|11740784|FG000|NOT COMPLETED|Overall Study||366
10584739|NCT01737281|11740785|FG001|NOT COMPLETED|Overall Study||280
10584740|NCT01737398|11740793|FG000|STARTED|Overall Study||113
10584741|NCT01737398|11740794|FG001|STARTED|Overall Study||60
10584742|NCT01737398|11740793|FG000|Received at Least 1 Dose of Study Drug|Overall Study||112
10584743|NCT01737398|11740794|FG001|Received at Least 1 Dose of Study Drug|Overall Study||60
10584744|NCT01737398|11740793|FG000|Safety Set|Overall Study||112
10584745|NCT01737398|11740794|FG001|Safety Set|Overall Study||60
10703000|NCT02580201|11867538|FG001|COMPLETED|Overall Study||104
10703001|NCT02580201|11867537|FG000|NOT COMPLETED|Overall Study||0
10703002|NCT02580201|11867538|FG001|NOT COMPLETED|Overall Study||0
10584746|NCT01737398|11740793|FG000|COMPLETED|Overall Study||87
10584747|NCT01737398|11740794|FG001|COMPLETED|Overall Study||52
10584748|NCT01737398|11740793|FG000|NOT COMPLETED|Overall Study||26
10584749|NCT01737398|11740794|FG001|NOT COMPLETED|Overall Study||8
10584750|NCT01737593|11740806|FG000|STARTED|Overall Study||37
10584751|NCT01737593|11740807|FG001|STARTED|Overall Study||32
10584752|NCT01737593|11740808|FG002|STARTED|Overall Study||39
10584753|NCT01737593|11740806|FG000|COMPLETED|Overall Study||37
10584754|NCT01737593|11740807|FG001|COMPLETED|Overall Study||32
10584755|NCT01737593|11740808|FG002|COMPLETED|Overall Study||39
10584756|NCT01737593|11740806|FG000|NOT COMPLETED|Overall Study||0
10584757|NCT01737593|11740807|FG001|NOT COMPLETED|Overall Study||0
10584758|NCT01737593|11740808|FG002|NOT COMPLETED|Overall Study||0
10584759|NCT01737684|11740821|FG000|STARTED|Overall Study||8
10584760|NCT01737684|11740822|FG001|STARTED|Overall Study||8
10584761|NCT01737684|11740823|FG002|STARTED|Overall Study|Participants with mild hepatic insufficiency were not enrolled in study.|0
10584762|NCT01737684|11740821|FG000|COMPLETED|Overall Study||8
10584763|NCT01737684|11740822|FG001|COMPLETED|Overall Study||8
10584764|NCT01737684|11740823|FG002|COMPLETED|Overall Study|Participants with mild hepatic insufficiency were not enrolled in study.|0
10584765|NCT01737684|11740821|FG000|NOT COMPLETED|Overall Study||0
10584766|NCT01737684|11740822|FG001|NOT COMPLETED|Overall Study||0
10584767|NCT01737684|11740823|FG002|NOT COMPLETED|Overall Study||0
10584768|NCT01737697|11740834|FG000|STARTED|Acute Phase-Initial 48 Hours||158
10584769|NCT01737697|11740835|FG001|STARTED|Acute Phase-Initial 48 Hours||154
10584770|NCT01737697|11740836|FG002|STARTED|Acute Phase-Initial 48 Hours||141
10584771|NCT01737697|11740837|FG003|STARTED|Acute Phase-Initial 48 Hours||158
10584772|NCT01737697|11740838|FG004|STARTED|Acute Phase-Initial 48 Hours||143
10584773|NCT01737697|11740839|FG005|STARTED|Acute Phase-Initial 48 Hours||0
10584774|NCT01737697|11740840|FG006|STARTED|Acute Phase-Initial 48 Hours||0
10584775|NCT01737697|11740841|FG007|STARTED|Acute Phase-Initial 48 Hours||0
10584776|NCT01737697|11740842|FG008|STARTED|Acute Phase-Initial 48 Hours||0
10584777|NCT01737697|11740843|FG009|STARTED|Acute Phase-Initial 48 Hours||0
10584778|NCT01737697|11740844|FG010|STARTED|Acute Phase-Initial 48 Hours||0
10584779|NCT01737697|11740845|FG011|STARTED|Acute Phase-Initial 48 Hours||0
10584780|NCT01737697|11740846|FG012|STARTED|Acute Phase-Initial 48 Hours||0
10584781|NCT01737697|11740847|FG013|STARTED|Acute Phase-Initial 48 Hours||0
10584782|NCT01737697|11740848|FG014|STARTED|Acute Phase-Initial 48 Hours||0
10584783|NCT01737697|11740834|FG000|COMPLETED|Acute Phase-Initial 48 Hours||157
10584784|NCT01737697|11740835|FG001|COMPLETED|Acute Phase-Initial 48 Hours||150
10584785|NCT01737697|11740836|FG002|COMPLETED|Acute Phase-Initial 48 Hours||137
10584786|NCT01737697|11740837|FG003|COMPLETED|Acute Phase-Initial 48 Hours||152
10584787|NCT01737697|11740838|FG004|COMPLETED|Acute Phase-Initial 48 Hours||140
10584788|NCT01737697|11740839|FG005|COMPLETED|Acute Phase-Initial 48 Hours||0
10584789|NCT01737697|11740840|FG006|COMPLETED|Acute Phase-Initial 48 Hours||0
10584790|NCT01737697|11740841|FG007|COMPLETED|Acute Phase-Initial 48 Hours||0
10584791|NCT01737697|11740842|FG008|COMPLETED|Acute Phase-Initial 48 Hours||0
10584792|NCT01737697|11740843|FG009|COMPLETED|Acute Phase-Initial 48 Hours||0
10584793|NCT01737697|11740844|FG010|COMPLETED|Acute Phase-Initial 48 Hours||0
10584794|NCT01737697|11740845|FG011|COMPLETED|Acute Phase-Initial 48 Hours||0
10584795|NCT01737697|11740846|FG012|COMPLETED|Acute Phase-Initial 48 Hours||0
10584796|NCT01737697|11740847|FG013|COMPLETED|Acute Phase-Initial 48 Hours||0
10584797|NCT01737697|11740848|FG014|COMPLETED|Acute Phase-Initial 48 Hours||0
10584798|NCT01737697|11740834|FG000|NOT COMPLETED|Acute Phase-Initial 48 Hours||1
10584799|NCT01737697|11740835|FG001|NOT COMPLETED|Acute Phase-Initial 48 Hours||4
10584800|NCT01737697|11740836|FG002|NOT COMPLETED|Acute Phase-Initial 48 Hours||4
10584801|NCT01737697|11740837|FG003|NOT COMPLETED|Acute Phase-Initial 48 Hours||6
10584802|NCT01737697|11740838|FG004|NOT COMPLETED|Acute Phase-Initial 48 Hours||3
10584803|NCT01737697|11740839|FG005|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
10584804|NCT01737697|11740840|FG006|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
10584805|NCT01737697|11740841|FG007|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
10584806|NCT01737697|11740842|FG008|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
10584807|NCT01737697|11740843|FG009|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
10584808|NCT01737697|11740844|FG010|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
10584809|NCT01737697|11740845|FG011|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
10584810|NCT01737697|11740846|FG012|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
10584811|NCT01737697|11740847|FG013|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
10584812|NCT01737697|11740848|FG014|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
10584813|NCT01737697|11740834|FG000|STARTED|Subacute Phase||0
10584814|NCT01737697|11740835|FG001|STARTED|Subacute Phase||0
10584815|NCT01737697|11740836|FG002|STARTED|Subacute Phase||0
10584816|NCT01737697|11740837|FG003|STARTED|Subacute Phase||0
10584817|NCT01737697|11740838|FG004|STARTED|Subacute Phase||0
10584818|NCT01737697|11740839|FG005|STARTED|Subacute Phase||41
10584819|NCT01737697|11740840|FG006|STARTED|Subacute Phase||49
10584820|NCT01737697|11740841|FG007|STARTED|Subacute Phase||46
10584821|NCT01737697|11740842|FG008|STARTED|Subacute Phase||54
10584822|NCT01737697|11740843|FG009|STARTED|Subacute Phase||68
10584823|NCT01737697|11740844|FG010|STARTED|Subacute Phase||65
10584824|NCT01737697|11740845|FG011|STARTED|Subacute Phase||61
10584825|NCT01737697|11740846|FG012|STARTED|Subacute Phase||63
10584826|NCT01737697|11740847|FG013|STARTED|Subacute Phase||46
10584827|NCT01737697|11740848|FG014|STARTED|Subacute Phase||50
10584828|NCT01737697|11740834|FG000|COMPLETED|Subacute Phase||0
10584829|NCT01737697|11740835|FG001|COMPLETED|Subacute Phase||0
10584830|NCT01737697|11740836|FG002|COMPLETED|Subacute Phase||0
10584831|NCT01737697|11740837|FG003|COMPLETED|Subacute Phase||0
10584832|NCT01737697|11740838|FG004|COMPLETED|Subacute Phase||0
10584833|NCT01737697|11740839|FG005|COMPLETED|Subacute Phase||38
10584834|NCT01737697|11740840|FG006|COMPLETED|Subacute Phase||48
10584835|NCT01737697|11740841|FG007|COMPLETED|Subacute Phase||43
10584836|NCT01737697|11740842|FG008|COMPLETED|Subacute Phase||52
10584837|NCT01737697|11740843|FG009|COMPLETED|Subacute Phase||66
10584838|NCT01737697|11740844|FG010|COMPLETED|Subacute Phase||59
10584839|NCT01737697|11740845|FG011|COMPLETED|Subacute Phase||58
10584840|NCT01737697|11740846|FG012|COMPLETED|Subacute Phase||61
10584841|NCT01737697|11740847|FG013|COMPLETED|Subacute Phase||44
10584842|NCT01737697|11740848|FG014|COMPLETED|Subacute Phase||49
10584843|NCT01737697|11740834|FG000|NOT COMPLETED|Subacute Phase||0
10584844|NCT01737697|11740835|FG001|NOT COMPLETED|Subacute Phase||0
10584845|NCT01737697|11740836|FG002|NOT COMPLETED|Subacute Phase||0
10584846|NCT01737697|11740837|FG003|NOT COMPLETED|Subacute Phase||0
10584847|NCT01737697|11740838|FG004|NOT COMPLETED|Subacute Phase||0
10584848|NCT01737697|11740839|FG005|NOT COMPLETED|Subacute Phase||3
10584849|NCT01737697|11740840|FG006|NOT COMPLETED|Subacute Phase||1
10584850|NCT01737697|11740841|FG007|NOT COMPLETED|Subacute Phase||3
10584851|NCT01737697|11740842|FG008|NOT COMPLETED|Subacute Phase||2
10584852|NCT01737697|11740843|FG009|NOT COMPLETED|Subacute Phase||2
10584853|NCT01737697|11740844|FG010|NOT COMPLETED|Subacute Phase||6
10584854|NCT01737697|11740845|FG011|NOT COMPLETED|Subacute Phase||3
10584855|NCT01737697|11740846|FG012|NOT COMPLETED|Subacute Phase||2
10584856|NCT01737697|11740847|FG013|NOT COMPLETED|Subacute Phase||2
10584857|NCT01737697|11740848|FG014|NOT COMPLETED|Subacute Phase||1
10584858|NCT01737710|11740886|FG000|STARTED|Overall Study||114
10584859|NCT01737710|11740887|FG001|STARTED|Overall Study||105
10584860|NCT01737710|11740888|FG002|STARTED|Overall Study||105
10584861|NCT01737710|11740889|FG003|STARTED|Overall Study||23
10584862|NCT01737710|11740890|FG004|STARTED|Overall Study||21
10584863|NCT01737710|11740886|FG000|COMPLETED|Overall Study||112
10584864|NCT01737710|11740887|FG001|COMPLETED|Overall Study||101
10584865|NCT01737710|11740888|FG002|COMPLETED|Overall Study||102
10584866|NCT01737710|11740889|FG003|COMPLETED|Overall Study||23
10584867|NCT01737710|11740890|FG004|COMPLETED|Overall Study||21
10584868|NCT01737710|11740886|FG000|NOT COMPLETED|Overall Study||2
10584869|NCT01737710|11740887|FG001|NOT COMPLETED|Overall Study||4
10584870|NCT01737710|11740888|FG002|NOT COMPLETED|Overall Study||3
10584871|NCT01737710|11740889|FG003|NOT COMPLETED|Overall Study||0
10584872|NCT01737710|11740890|FG004|NOT COMPLETED|Overall Study||0
10584873|NCT01737762|11740903|FG000|STARTED|Overall Study||77
10584874|NCT01737762|11740904|FG001|STARTED|Overall Study||78
10584875|NCT01737762|11740903|FG000|COMPLETED|Overall Study||57
10584876|NCT01737762|11740904|FG001|COMPLETED|Overall Study||61
10584877|NCT01737762|11740903|FG000|NOT COMPLETED|Overall Study||20
10703003|NCT02580240|11867547|FG000|STARTED|Overall Study||62
10703004|NCT02580240|11867548|FG001|STARTED|Overall Study||58
10703005|NCT02580240|11867547|FG000|COMPLETED|Overall Study||60
10703006|NCT02580240|11867548|FG001|COMPLETED|Overall Study||58
10584878|NCT01737762|11740904|FG001|NOT COMPLETED|Overall Study||17
10584879|NCT01737840|11740912|FG000|STARTED|Overall Study||35
10584880|NCT01737840|11740913|FG001|STARTED|Overall Study||35
10584881|NCT01737840|11740912|FG000|COMPLETED|Overall Study||33
10584882|NCT01737840|11740913|FG001|COMPLETED|Overall Study||33
10584883|NCT01737840|11740912|FG000|NOT COMPLETED|Overall Study||2
10584884|NCT01737840|11740913|FG001|NOT COMPLETED|Overall Study||2
10584885|NCT01737879|11740921|FG000|STARTED|Overall Study||41
10584886|NCT01737879|11740921|FG000|Received Peginesatide|Overall Study||34
10584887|NCT01737879|11740921|FG000|Transitioned to Epoetin Alfa|Overall Study||0
10584888|NCT01737879|11740921|FG000|COMPLETED|Overall Study||0
10584889|NCT01737879|11740921|FG000|NOT COMPLETED|Overall Study||41
10584890|NCT01737931|11740928|FG000|STARTED|Overall Study||38
10584891|NCT01737931|11740929|FG001|STARTED|Overall Study||40
10584892|NCT01737931|11740930|FG002|STARTED|Overall Study||39
10584893|NCT01737931|11740928|FG000|COMPLETED|Overall Study||38
10584894|NCT01737931|11740929|FG001|COMPLETED|Overall Study||38
10584895|NCT01737931|11740930|FG002|COMPLETED|Overall Study||38
10584896|NCT01737931|11740928|FG000|NOT COMPLETED|Overall Study||0
10456977|NCT01008475|11604715|FG006|Safety Analysis Set|Overall Study||69
10456978|NCT01008475|11604709|FG000|COMPLETED|Overall Study||3
10456979|NCT01008475|11604710|FG001|COMPLETED|Overall Study||3
10456980|NCT01008475|11604711|FG002|COMPLETED|Overall Study||7
10584897|NCT01737931|11740929|FG001|NOT COMPLETED|Overall Study||2
10584898|NCT01737931|11740930|FG002|NOT COMPLETED|Overall Study||1
10584899|NCT01737944|11740940|FG000|STARTED|Overall Study||9
10584900|NCT01737944|11740941|FG001|STARTED|Overall Study||9
10703007|NCT02580240|11867547|FG000|NOT COMPLETED|Overall Study||2
10456981|NCT01008475|11604712|FG003|COMPLETED|Overall Study||3
10584901|NCT01737944|11740942|FG002|STARTED|Overall Study|10 patients randomized, one patient discontinued before first study drug dose|9
10584902|NCT01737944|11740943|FG003|STARTED|Overall Study|10 patients randomized, one patient discontinued before first study drug dose|9
10584903|NCT01737944|11740940|FG000|COMPLETED|Overall Study||9
10584904|NCT01737944|11740941|FG001|COMPLETED|Overall Study||9
10584905|NCT01737944|11740942|FG002|COMPLETED|Overall Study||9
10584906|NCT01737944|11740943|FG003|COMPLETED|Overall Study||9
10584907|NCT01737944|11740940|FG000|NOT COMPLETED|Overall Study||0
10584908|NCT01737944|11740941|FG001|NOT COMPLETED|Overall Study||0
10584909|NCT01737944|11740942|FG002|NOT COMPLETED|Overall Study||0
10584910|NCT01737944|11740943|FG003|NOT COMPLETED|Overall Study||0
10584911|NCT01737996|11740955|FG000|STARTED|Overall Study||8
10584912|NCT01737996|11740956|FG001|STARTED|Overall Study||8
10584913|NCT01737996|11740957|FG002|STARTED|Overall Study||16
10584914|NCT01737996|11740955|FG000|COMPLETED|Overall Study||8
10584915|NCT01737996|11740956|FG001|COMPLETED|Overall Study||7
10584916|NCT01737996|11740957|FG002|COMPLETED|Overall Study|One patient withdrew consent after the first dose due to private reasons.|14
10584917|NCT01737996|11740955|FG000|NOT COMPLETED|Overall Study||0
10584918|NCT01737996|11740956|FG001|NOT COMPLETED|Overall Study||1
10584919|NCT01737996|11740957|FG002|NOT COMPLETED|Overall Study||2
10584920|NCT01738191|11740967|FG000|STARTED|Overall Study||15
10584921|NCT01738191|11740968|FG001|STARTED|Overall Study||15
10584922|NCT01738191|11740967|FG000|COMPLETED|Overall Study||11
10584923|NCT01738191|11740968|FG001|COMPLETED|Overall Study||14
10584924|NCT01738191|11740967|FG000|NOT COMPLETED|Overall Study||4
10584925|NCT01738191|11740968|FG001|NOT COMPLETED|Overall Study||1
10584926|NCT01738321|11740976|FG000|STARTED|Overall Study||33
10584927|NCT01738321|11740977|FG001|STARTED|Overall Study||30
10584928|NCT01738321|11740976|FG000|COMPLETED|Overall Study||33
10584929|NCT01738321|11740977|FG001|COMPLETED|Overall Study||30
10584930|NCT01738321|11740976|FG000|NOT COMPLETED|Overall Study||0
10584931|NCT01738321|11740977|FG001|NOT COMPLETED|Overall Study||0
10584932|NCT01738438|11740983|FG000|STARTED|Overall Study||35
10584933|NCT01738438|11740983|FG000|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
10584934|NCT01738438|11740983|FG000|NOT COMPLETED|Overall Study||35
10584935|NCT01738477|11740989|FG000|STARTED|Overall Study||37
10584936|NCT01738477|11740990|FG001|STARTED|Overall Study||128
10584937|NCT01738477|11740989|FG000|COMPLETED|Overall Study||36
10584938|NCT01738477|11740990|FG001|COMPLETED|Overall Study||124
10584939|NCT01738477|11740989|FG000|NOT COMPLETED|Overall Study||1
10584940|NCT01738477|11740990|FG001|NOT COMPLETED|Overall Study||4
10584941|NCT01738503|11741004|FG000|STARTED|Induction/Stabilization (Days -14 to -1)||124
10584942|NCT01738503|11741005|FG001|STARTED|Induction/Stabilization (Days -14 to -1)||0
10584943|NCT01738503|11741006|FG002|STARTED|Induction/Stabilization (Days -14 to -1)||0
10584944|NCT01738503|11741007|FG003|STARTED|Induction/Stabilization (Days -14 to -1)||0
10584945|NCT01738503|11741008|FG004|STARTED|Induction/Stabilization (Days -14 to -1)||0
10584946|NCT01738503|11741009|FG005|STARTED|Induction/Stabilization (Days -14 to -1)||0
10584947|NCT01738503|11741010|FG006|STARTED|Induction/Stabilization (Days -14 to -1)||0
10584948|NCT01738503|11741004|FG000|COMPLETED|Induction/Stabilization (Days -14 to -1)||89
10584949|NCT01738503|11741005|FG001|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
10584950|NCT01738503|11741006|FG002|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
10584951|NCT01738503|11741007|FG003|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
10584952|NCT01738503|11741008|FG004|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
10584953|NCT01738503|11741009|FG005|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
10584954|NCT01738503|11741010|FG006|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
10584955|NCT01738503|11741004|FG000|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||35
10584956|NCT01738503|11741005|FG001|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
10584957|NCT01738503|11741006|FG002|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
10584958|NCT01738503|11741007|FG003|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
10584959|NCT01738503|11741008|FG004|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
10584960|NCT01738503|11741009|FG005|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
10584961|NCT01738503|11741010|FG006|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
10584962|NCT01738503|11741004|FG000|STARTED|Treatment Period||0
10584963|NCT01738503|11741005|FG001|STARTED|Treatment Period||15
10584964|NCT01738503|11741006|FG002|STARTED|Treatment Period||15
10584965|NCT01738503|11741007|FG003|STARTED|Treatment Period||15
10584966|NCT01738503|11741008|FG004|STARTED|Treatment Period||15
10584967|NCT01738503|11741009|FG005|STARTED|Treatment Period||15
10584968|NCT01738503|11741010|FG006|STARTED|Treatment Period||14
10584969|NCT01738503|11741004|FG000|COMPLETED|Treatment Period||0
10584970|NCT01738503|11741005|FG001|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|10
10584971|NCT01738503|11741006|FG002|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|10
10584972|NCT01738503|11741007|FG003|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|9
10584973|NCT01738503|11741008|FG004|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|7
10584974|NCT01738503|11741009|FG005|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|9
10584975|NCT01738503|11741010|FG006|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|6
10584976|NCT01738503|11741004|FG000|NOT COMPLETED|Treatment Period||0
10584977|NCT01738503|11741005|FG001|NOT COMPLETED|Treatment Period||5
10584978|NCT01738503|11741006|FG002|NOT COMPLETED|Treatment Period||5
10584979|NCT01738503|11741007|FG003|NOT COMPLETED|Treatment Period||6
10584980|NCT01738503|11741008|FG004|NOT COMPLETED|Treatment Period||8
10584981|NCT01738503|11741009|FG005|NOT COMPLETED|Treatment Period||6
10584982|NCT01738503|11741010|FG006|NOT COMPLETED|Treatment Period||8
10584983|NCT01738503|11741004|FG000|STARTED|PET Imaging Sub-study||0
10584984|NCT01738503|11741005|FG001|STARTED|PET Imaging Sub-study||0
10584985|NCT01738503|11741006|FG002|STARTED|PET Imaging Sub-study||0
10584986|NCT01738503|11741007|FG003|STARTED|PET Imaging Sub-study||0
10584987|NCT01738503|11741008|FG004|STARTED|PET Imaging Sub-study||0
10703008|NCT02580240|11867548|FG001|NOT COMPLETED|Overall Study||0
10703009|NCT02580318|11867554|FG000|STARTED|Overall Study||54
10703010|NCT02580318|11867554|FG000|Poor Effort|Overall Study||53
10703011|NCT02580318|11867554|FG000|Hyperventilation (Immediate)|Overall Study||54
10584988|NCT01738503|11741009|FG005|STARTED|PET Imaging Sub-study||3
10584989|NCT01738503|11741010|FG006|STARTED|PET Imaging Sub-study||2
10584990|NCT01738503|11741004|FG000|COMPLETED|PET Imaging Sub-study||0
10584991|NCT01738503|11741005|FG001|COMPLETED|PET Imaging Sub-study||0
10584992|NCT01738503|11741006|FG002|COMPLETED|PET Imaging Sub-study||0
10584993|NCT01738503|11741007|FG003|COMPLETED|PET Imaging Sub-study||0
10584994|NCT01738503|11741008|FG004|COMPLETED|PET Imaging Sub-study||0
10584995|NCT01738503|11741009|FG005|COMPLETED|PET Imaging Sub-study|Completion defined as a total of 12 injections plus all PET images|1
10584996|NCT01738503|11741010|FG006|COMPLETED|PET Imaging Sub-study|Completion defined as a total of 6 injections plus all PET images|1
10584997|NCT01738503|11741004|FG000|NOT COMPLETED|PET Imaging Sub-study||0
10584998|NCT01738503|11741005|FG001|NOT COMPLETED|PET Imaging Sub-study||0
10584999|NCT01738503|11741006|FG002|NOT COMPLETED|PET Imaging Sub-study||0
10585000|NCT01738503|11741007|FG003|NOT COMPLETED|PET Imaging Sub-study||0
10585001|NCT01738503|11741008|FG004|NOT COMPLETED|PET Imaging Sub-study||0
10585002|NCT01738503|11741009|FG005|NOT COMPLETED|PET Imaging Sub-study||2
10585003|NCT01738503|11741010|FG006|NOT COMPLETED|PET Imaging Sub-study||1
10585004|NCT01738581|11741034|FG000|STARTED|Overall Study||5
10585005|NCT01738581|11741035|FG001|STARTED|Overall Study||4
10585006|NCT01738581|11741034|FG000|COMPLETED|Overall Study||4
10585007|NCT01738581|11741035|FG001|COMPLETED|Overall Study||4
10585008|NCT01738581|11741034|FG000|NOT COMPLETED|Overall Study||1
10585009|NCT01738581|11741035|FG001|NOT COMPLETED|Overall Study||0
10585010|NCT01738594|11741044|FG000|STARTED|Registration and Treatment Start||0
10585011|NCT01738594|11741045|FG001|STARTED|Registration and Treatment Start||3
10585012|NCT01738594|11741046|FG002|STARTED|Registration and Treatment Start||0
10585013|NCT01738594|11741047|FG003|STARTED|Registration and Treatment Start||0
10585014|NCT01738594|11741048|FG004|STARTED|Registration and Treatment Start||1
10585015|NCT01738594|11741049|FG005|STARTED|Registration and Treatment Start||3
10585016|NCT01738594|11741050|FG006|STARTED|Registration and Treatment Start||0
10585017|NCT01738594|11741051|FG007|STARTED|Registration and Treatment Start||0
10585018|NCT01738594|11741044|FG000|Registered to Study|Registration and Treatment Start||0
10585019|NCT01738594|11741045|FG001|Registered to Study|Registration and Treatment Start||3
10585020|NCT01738594|11741046|FG002|Registered to Study|Registration and Treatment Start||0
10585021|NCT01738594|11741047|FG003|Registered to Study|Registration and Treatment Start||0
10585022|NCT01738594|11741048|FG004|Registered to Study|Registration and Treatment Start||1
10585023|NCT01738594|11741049|FG005|Registered to Study|Registration and Treatment Start||3
10585024|NCT01738594|11741050|FG006|Registered to Study|Registration and Treatment Start||0
10585025|NCT01738594|11741051|FG007|Registered to Study|Registration and Treatment Start||0
10585026|NCT01738594|11741044|FG000|Treatment Started|Registration and Treatment Start||0
10585027|NCT01738594|11741045|FG001|Treatment Started|Registration and Treatment Start||2
10585028|NCT01738594|11741046|FG002|Treatment Started|Registration and Treatment Start||0
10585029|NCT01738594|11741047|FG003|Treatment Started|Registration and Treatment Start||0
10585030|NCT01738594|11741048|FG004|Treatment Started|Registration and Treatment Start||1
10585031|NCT01738594|11741049|FG005|Treatment Started|Registration and Treatment Start||3
10585032|NCT01738594|11741050|FG006|Treatment Started|Registration and Treatment Start||0
10585033|NCT01738594|11741051|FG007|Treatment Started|Registration and Treatment Start||0
10585034|NCT01738594|11741044|FG000|COMPLETED|Registration and Treatment Start||0
10585035|NCT01738594|11741045|FG001|COMPLETED|Registration and Treatment Start||2
10585036|NCT01738594|11741046|FG002|COMPLETED|Registration and Treatment Start||0
10585037|NCT01738594|11741047|FG003|COMPLETED|Registration and Treatment Start||0
10585038|NCT01738594|11741048|FG004|COMPLETED|Registration and Treatment Start||1
10585039|NCT01738594|11741049|FG005|COMPLETED|Registration and Treatment Start||3
10585040|NCT01738594|11741050|FG006|COMPLETED|Registration and Treatment Start||0
10585041|NCT01738594|11741051|FG007|COMPLETED|Registration and Treatment Start||0
10585042|NCT01738594|11741044|FG000|NOT COMPLETED|Registration and Treatment Start||0
10585043|NCT01738594|11741045|FG001|NOT COMPLETED|Registration and Treatment Start||1
10585044|NCT01738594|11741046|FG002|NOT COMPLETED|Registration and Treatment Start||0
10585045|NCT01738594|11741047|FG003|NOT COMPLETED|Registration and Treatment Start||0
10585046|NCT01738594|11741048|FG004|NOT COMPLETED|Registration and Treatment Start||0
10585047|NCT01738594|11741049|FG005|NOT COMPLETED|Registration and Treatment Start||0
10585048|NCT01738594|11741050|FG006|NOT COMPLETED|Registration and Treatment Start||0
10585049|NCT01738594|11741051|FG007|NOT COMPLETED|Registration and Treatment Start||0
10703012|NCT02580318|11867554|FG000|Hyperventilation (5 Minutes)|Overall Study||54
10703013|NCT02580318|11867554|FG000|Hyperventilation (10 Minutes)|Overall Study||54
10703014|NCT02580318|11867554|FG000|Drinking Water (Immediate)|Overall Study||51
10703015|NCT02580318|11867554|FG000|Drinking Water (5 Minutes)|Overall Study||54
10585050|NCT01738594|11741044|FG000|STARTED|Completed 2 Cycles/Reached 1st Response||0
10585051|NCT01738594|11741045|FG001|STARTED|Completed 2 Cycles/Reached 1st Response||2
10585052|NCT01738594|11741046|FG002|STARTED|Completed 2 Cycles/Reached 1st Response||0
10585053|NCT01738594|11741047|FG003|STARTED|Completed 2 Cycles/Reached 1st Response||0
10585054|NCT01738594|11741048|FG004|STARTED|Completed 2 Cycles/Reached 1st Response||1
10585055|NCT01738594|11741049|FG005|STARTED|Completed 2 Cycles/Reached 1st Response||3
10585056|NCT01738594|11741050|FG006|STARTED|Completed 2 Cycles/Reached 1st Response||0
10585057|NCT01738594|11741051|FG007|STARTED|Completed 2 Cycles/Reached 1st Response||0
10585058|NCT01738594|11741044|FG000|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
10585059|NCT01738594|11741045|FG001|COMPLETED|Completed 2 Cycles/Reached 1st Response||2
10585060|NCT01738594|11741046|FG002|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
10585061|NCT01738594|11741047|FG003|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
10585062|NCT01738594|11741048|FG004|COMPLETED|Completed 2 Cycles/Reached 1st Response||1
10585063|NCT01738594|11741049|FG005|COMPLETED|Completed 2 Cycles/Reached 1st Response||2
10585064|NCT01738594|11741050|FG006|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
10585065|NCT01738594|11741051|FG007|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
10585066|NCT01738594|11741044|FG000|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
10703016|NCT02580318|11867554|FG000|COMPLETED|Overall Study||54
10703017|NCT02580318|11867554|FG000|NOT COMPLETED|Overall Study||0
10585067|NCT01738594|11741045|FG001|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
10585068|NCT01738594|11741046|FG002|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
10585069|NCT01738594|11741047|FG003|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
10585070|NCT01738594|11741048|FG004|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
10585071|NCT01738594|11741049|FG005|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||1
10585072|NCT01738594|11741050|FG006|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
10585073|NCT01738594|11741051|FG007|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
10585074|NCT01738594|11741044|FG000|STARTED|Completed 4 Cycles of Treatment||0
10585075|NCT01738594|11741045|FG001|STARTED|Completed 4 Cycles of Treatment||2
10585076|NCT01738594|11741046|FG002|STARTED|Completed 4 Cycles of Treatment||0
10585077|NCT01738594|11741047|FG003|STARTED|Completed 4 Cycles of Treatment||0
10585078|NCT01738594|11741048|FG004|STARTED|Completed 4 Cycles of Treatment||1
10585079|NCT01738594|11741049|FG005|STARTED|Completed 4 Cycles of Treatment||2
10585080|NCT01738594|11741050|FG006|STARTED|Completed 4 Cycles of Treatment||0
10585081|NCT01738594|11741051|FG007|STARTED|Completed 4 Cycles of Treatment||0
10585082|NCT01738594|11741044|FG000|COMPLETED|Completed 4 Cycles of Treatment||0
10585083|NCT01738594|11741045|FG001|COMPLETED|Completed 4 Cycles of Treatment||0
10585084|NCT01738594|11741046|FG002|COMPLETED|Completed 4 Cycles of Treatment||0
10585085|NCT01738594|11741047|FG003|COMPLETED|Completed 4 Cycles of Treatment||0
10585086|NCT01738594|11741048|FG004|COMPLETED|Completed 4 Cycles of Treatment||1
10585087|NCT01738594|11741049|FG005|COMPLETED|Completed 4 Cycles of Treatment||1
10585088|NCT01738594|11741050|FG006|COMPLETED|Completed 4 Cycles of Treatment||0
10585089|NCT01738594|11741051|FG007|COMPLETED|Completed 4 Cycles of Treatment||0
10585090|NCT01738594|11741044|FG000|NOT COMPLETED|Completed 4 Cycles of Treatment||0
10585091|NCT01738594|11741045|FG001|NOT COMPLETED|Completed 4 Cycles of Treatment||2
10585092|NCT01738594|11741046|FG002|NOT COMPLETED|Completed 4 Cycles of Treatment||0
10585093|NCT01738594|11741047|FG003|NOT COMPLETED|Completed 4 Cycles of Treatment||0
10585094|NCT01738594|11741048|FG004|NOT COMPLETED|Completed 4 Cycles of Treatment||0
10585095|NCT01738594|11741049|FG005|NOT COMPLETED|Completed 4 Cycles of Treatment||1
10585096|NCT01738594|11741050|FG006|NOT COMPLETED|Completed 4 Cycles of Treatment||0
10585097|NCT01738594|11741051|FG007|NOT COMPLETED|Completed 4 Cycles of Treatment||0
10585098|NCT01738594|11741044|FG000|STARTED|Went on to Continue Treatment Cycle 5||0
10585099|NCT01738594|11741045|FG001|STARTED|Went on to Continue Treatment Cycle 5||0
10585100|NCT01738594|11741046|FG002|STARTED|Went on to Continue Treatment Cycle 5||0
10585101|NCT01738594|11741047|FG003|STARTED|Went on to Continue Treatment Cycle 5||0
10585102|NCT01738594|11741048|FG004|STARTED|Went on to Continue Treatment Cycle 5||1
10585103|NCT01738594|11741049|FG005|STARTED|Went on to Continue Treatment Cycle 5||1
10585104|NCT01738594|11741050|FG006|STARTED|Went on to Continue Treatment Cycle 5||0
10585105|NCT01738594|11741051|FG007|STARTED|Went on to Continue Treatment Cycle 5||0
10585106|NCT01738594|11741044|FG000|COMPLETED|Went on to Continue Treatment Cycle 5||0
10585107|NCT01738594|11741045|FG001|COMPLETED|Went on to Continue Treatment Cycle 5||0
10585108|NCT01738594|11741046|FG002|COMPLETED|Went on to Continue Treatment Cycle 5||0
10585109|NCT01738594|11741047|FG003|COMPLETED|Went on to Continue Treatment Cycle 5||0
10585110|NCT01738594|11741048|FG004|COMPLETED|Went on to Continue Treatment Cycle 5||0
10585111|NCT01738594|11741049|FG005|COMPLETED|Went on to Continue Treatment Cycle 5||0
10585112|NCT01738594|11741050|FG006|COMPLETED|Went on to Continue Treatment Cycle 5||0
10585113|NCT01738594|11741051|FG007|COMPLETED|Went on to Continue Treatment Cycle 5||0
10585114|NCT01738594|11741044|FG000|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
10585115|NCT01738594|11741045|FG001|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
10585116|NCT01738594|11741046|FG002|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
10585117|NCT01738594|11741047|FG003|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
10585118|NCT01738594|11741048|FG004|NOT COMPLETED|Went on to Continue Treatment Cycle 5||1
10585119|NCT01738594|11741049|FG005|NOT COMPLETED|Went on to Continue Treatment Cycle 5||1
10585120|NCT01738594|11741050|FG006|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
10585121|NCT01738594|11741051|FG007|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
10585122|NCT01738594|11741044|FG000|STARTED|Follow up for 1 Year||0
10585123|NCT01738594|11741045|FG001|STARTED|Follow up for 1 Year||2
10585124|NCT01738594|11741046|FG002|STARTED|Follow up for 1 Year||0
10585125|NCT01738594|11741047|FG003|STARTED|Follow up for 1 Year||0
10585126|NCT01738594|11741048|FG004|STARTED|Follow up for 1 Year||1
10585127|NCT01738594|11741049|FG005|STARTED|Follow up for 1 Year||3
10585128|NCT01738594|11741050|FG006|STARTED|Follow up for 1 Year||0
10585129|NCT01738594|11741051|FG007|STARTED|Follow up for 1 Year||0
10585130|NCT01738594|11741044|FG000|COMPLETED|Follow up for 1 Year||0
10585131|NCT01738594|11741045|FG001|COMPLETED|Follow up for 1 Year||2
10585132|NCT01738594|11741046|FG002|COMPLETED|Follow up for 1 Year||0
10585133|NCT01738594|11741047|FG003|COMPLETED|Follow up for 1 Year||0
10703018|NCT02580357|11867561|FG000|STARTED|Overall Study||18
10585134|NCT01738594|11741048|FG004|COMPLETED|Follow up for 1 Year||1
10585135|NCT01738594|11741049|FG005|COMPLETED|Follow up for 1 Year||0
10585136|NCT01738594|11741050|FG006|COMPLETED|Follow up for 1 Year||0
10585137|NCT01738594|11741051|FG007|COMPLETED|Follow up for 1 Year||0
10585138|NCT01738594|11741044|FG000|NOT COMPLETED|Follow up for 1 Year||0
10585139|NCT01738594|11741045|FG001|NOT COMPLETED|Follow up for 1 Year||0
10585140|NCT01738594|11741046|FG002|NOT COMPLETED|Follow up for 1 Year||0
10585141|NCT01738594|11741047|FG003|NOT COMPLETED|Follow up for 1 Year||0
10585142|NCT01738594|11741048|FG004|NOT COMPLETED|Follow up for 1 Year||0
10585143|NCT01738594|11741049|FG005|NOT COMPLETED|Follow up for 1 Year||3
10585144|NCT01738594|11741050|FG006|NOT COMPLETED|Follow up for 1 Year||0
10585145|NCT01738594|11741051|FG007|NOT COMPLETED|Follow up for 1 Year||0
10585146|NCT01738646|11741061|FG000|STARTED|Overall Study||40
10585147|NCT01738646|11741061|FG000|COMPLETED|Overall Study|Participants who discontinued study drug for any reason.|38
10585148|NCT01738646|11741061|FG000|NOT COMPLETED|Overall Study||2
10585149|NCT01738672|11741066|FG000|STARTED|Overall Study||16
10585150|NCT01738672|11741066|FG000|COMPLETED|Overall Study||11
10585151|NCT01738672|11741066|FG000|NOT COMPLETED|Overall Study||5
10585152|NCT01738737|11741075|FG000|STARTED|Overall Study||29
10585153|NCT01738737|11741076|FG001|STARTED|Overall Study||29
10585154|NCT01738737|11741077|FG002|STARTED|Overall Study||29
10585155|NCT01738737|11741078|FG003|STARTED|Overall Study||29
10585156|NCT01738737|11741079|FG004|STARTED|Overall Study||29
10585157|NCT01738737|11741075|FG000|COMPLETED|Overall Study||25
10585158|NCT01738737|11741076|FG001|COMPLETED|Overall Study||25
10585159|NCT01738737|11741077|FG002|COMPLETED|Overall Study||25
10585160|NCT01738737|11741078|FG003|COMPLETED|Overall Study||25
10585161|NCT01738737|11741079|FG004|COMPLETED|Overall Study||25
10585162|NCT01738737|11741075|FG000|NOT COMPLETED|Overall Study||4
10585163|NCT01738737|11741076|FG001|NOT COMPLETED|Overall Study||4
10585164|NCT01738737|11741077|FG002|NOT COMPLETED|Overall Study||4
10585165|NCT01738737|11741078|FG003|NOT COMPLETED|Overall Study||4
10585166|NCT01738737|11741079|FG004|NOT COMPLETED|Overall Study||4
10585167|NCT01738750|11741093|FG000|STARTED|Overall Study||49
10585168|NCT01738750|11741094|FG001|STARTED|Overall Study||51
10585169|NCT01738750|11741093|FG000|COMPLETED|Overall Study||49
10585170|NCT01738750|11741094|FG001|COMPLETED|Overall Study||51
10585171|NCT01738750|11741093|FG000|NOT COMPLETED|Overall Study||0
10585172|NCT01738750|11741094|FG001|NOT COMPLETED|Overall Study||0
10585173|NCT01738919|11741104|FG000|STARTED|Overall Study||15
10585174|NCT01738919|11741105|FG001|STARTED|Overall Study||17
10585175|NCT01738919|11741104|FG000|COMPLETED|Overall Study||14
10585176|NCT01738919|11741105|FG001|COMPLETED|Overall Study||14
10585177|NCT01738919|11741104|FG000|NOT COMPLETED|Overall Study||1
10585178|NCT01738919|11741105|FG001|NOT COMPLETED|Overall Study||3
10585179|NCT01738971|11741116|FG000|STARTED|Overall Study|54 participants recruited to this arm|54
10585180|NCT01738971|11741117|FG001|STARTED|Overall Study|58 participants recruited to this arm|58
10585181|NCT01738971|11741118|FG002|STARTED|Overall Study|56 participants recruited to this arm|56
10585182|NCT01738971|11741116|FG000|COMPLETED|Overall Study|35 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|35
10585183|NCT01738971|11741117|FG001|COMPLETED|Overall Study|28 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|28
10585184|NCT01738971|11741118|FG002|COMPLETED|Overall Study|39 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|39
10585185|NCT01738971|11741116|FG000|NOT COMPLETED|Overall Study||19
10585186|NCT01738971|11741117|FG001|NOT COMPLETED|Overall Study||30
10585187|NCT01738971|11741118|FG002|NOT COMPLETED|Overall Study||17
10585188|NCT01738984|11741128|FG000|STARTED|Overall Study||250
10585189|NCT01738984|11741129|FG001|STARTED|Overall Study||249
10585190|NCT01738984|11741128|FG000|COMPLETED|Overall Study||186
10585191|NCT01738984|11741129|FG001|COMPLETED|Overall Study||210
10585192|NCT01738984|11741128|FG000|NOT COMPLETED|Overall Study||64
10585193|NCT01738984|11741129|FG001|NOT COMPLETED|Overall Study||39
10585194|NCT01739231|11741141|FG000|STARTED|Part A||24
10585195|NCT01739231|11741142|FG001|STARTED|Part A||24
10585196|NCT01739231|11741143|FG002|STARTED|Part A||12
10585197|NCT01739231|11741144|FG003|STARTED|Part A||0
10585198|NCT01739231|11741141|FG000|Received All 3 Vaccinations|Part A||21
10585199|NCT01739231|11741142|FG001|Received All 3 Vaccinations|Part A||20
10585200|NCT01739231|11741143|FG002|Received All 3 Vaccinations|Part A||12
10585201|NCT01739231|11741144|FG003|Received All 3 Vaccinations|Part A||0
10585202|NCT01739231|11741141|FG000|COMPLETED|Part A||20
10585203|NCT01739231|11741142|FG001|COMPLETED|Part A||17
10585204|NCT01739231|11741143|FG002|COMPLETED|Part A||12
10585205|NCT01739231|11741144|FG003|COMPLETED|Part A||0
10585206|NCT01739231|11741141|FG000|NOT COMPLETED|Part A||4
10585207|NCT01739231|11741142|FG001|NOT COMPLETED|Part A||7
10585208|NCT01739231|11741143|FG002|NOT COMPLETED|Part A||0
10585209|NCT01739231|11741144|FG003|NOT COMPLETED|Part A||0
10585210|NCT01739231|11741141|FG000|STARTED|Part B||20
10585211|NCT01739231|11741142|FG001|STARTED|Part B||17
10585212|NCT01739231|11741143|FG002|STARTED|Part B||12
10585213|NCT01739231|11741144|FG003|STARTED|Part B||21
10585214|NCT01739231|11741141|FG000|Challenged|Part B||13
10585215|NCT01739231|11741142|FG001|Challenged|Part B||13
10585216|NCT01739231|11741143|FG002|Challenged|Part B||10
10585217|NCT01739231|11741144|FG003|Challenged|Part B||21
10585218|NCT01739231|11741141|FG000|COMPLETED|Part B||13
10585219|NCT01739231|11741142|FG001|COMPLETED|Part B||12
10585220|NCT01739231|11741143|FG002|COMPLETED|Part B||10
10585221|NCT01739231|11741144|FG003|COMPLETED|Part B||19
10585222|NCT01739231|11741141|FG000|NOT COMPLETED|Part B||7
10585223|NCT01739231|11741142|FG001|NOT COMPLETED|Part B||5
10585224|NCT01739231|11741143|FG002|NOT COMPLETED|Part B||2
10585225|NCT01739231|11741144|FG003|NOT COMPLETED|Part B||2
10585226|NCT01739309|11741162|FG000|STARTED|Overall Study||28
10585227|NCT01739309|11741162|FG000|Received at Least One Dose of Study Drug|Overall Study||28
10585228|NCT01739309|11741162|FG000|Death Due to Any Cause|Overall Study||17
10585229|NCT01739309|11741162|FG000|Alive and on Study, Off Treatment|Overall Study||8
10585230|NCT01739309|11741162|FG000|COMPLETED|Overall Study||25
10585231|NCT01739309|11741162|FG000|NOT COMPLETED|Overall Study||3
10585232|NCT01739335|11741170|FG000|STARTED|Overall Study||41
10585233|NCT01739335|11741171|FG001|STARTED|Overall Study||40
10585234|NCT01739335|11741170|FG000|COMPLETED|Overall Study||34
10585235|NCT01739335|11741171|FG001|COMPLETED|Overall Study||35
10585236|NCT01739335|11741170|FG000|NOT COMPLETED|Overall Study||7
10585237|NCT01739335|11741171|FG001|NOT COMPLETED|Overall Study||5
10585238|NCT01739348|11741185|FG000|STARTED|Part I (Base Study)||703
10585239|NCT01739348|11741186|FG001|STARTED|Part I (Base Study)||700
10585240|NCT01739348|11741187|FG002|STARTED|Part I (Base Study)||103
10585241|NCT01739348|11741188|FG003|STARTED|Part I (Base Study)||705
10585242|NCT01739348|11741185|FG000|Treated|Part I (Base Study)||702
10585243|NCT01739348|11741186|FG001|Treated|Part I (Base Study)||700
10585244|NCT01739348|11741187|FG002|Treated|Part I (Base Study)||103
10585245|NCT01739348|11741188|FG003|Treated|Part I (Base Study)||705
10585246|NCT01739348|11741185|FG000|COMPLETED|Part I (Base Study)||501
10585247|NCT01739348|11741186|FG001|COMPLETED|Part I (Base Study)||497
10585248|NCT01739348|11741187|FG002|COMPLETED|Part I (Base Study)||77
10585249|NCT01739348|11741188|FG003|COMPLETED|Part I (Base Study)||516
10585250|NCT01739348|11741185|FG000|NOT COMPLETED|Part I (Base Study)||202
10585251|NCT01739348|11741186|FG001|NOT COMPLETED|Part I (Base Study)||203
10585252|NCT01739348|11741187|FG002|NOT COMPLETED|Part I (Base Study)||26
10585253|NCT01739348|11741188|FG003|NOT COMPLETED|Part I (Base Study)||189
10585254|NCT01739348|11741185|FG000|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|379
10585255|NCT01739348|11741186|FG001|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|366
10585256|NCT01739348|11741187|FG002|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|61
10585257|NCT01739348|11741188|FG003|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|396
10585258|NCT01739348|11741185|FG000|Treated|Part II (Extension Study)||379
10585259|NCT01739348|11741186|FG001|Treated|Part II (Extension Study)||365
10585260|NCT01739348|11741187|FG002|Treated|Part II (Extension Study)||61
10585261|NCT01739348|11741188|FG003|Treated|Part II (Extension Study)||394
10585262|NCT01739348|11741185|FG000|COMPLETED|Part II (Extension Study)||0
10585263|NCT01739348|11741186|FG001|COMPLETED|Part II (Extension Study)||0
10585264|NCT01739348|11741187|FG002|COMPLETED|Part II (Extension Study)||0
10585265|NCT01739348|11741188|FG003|COMPLETED|Part II (Extension Study)||0
10585266|NCT01739348|11741185|FG000|NOT COMPLETED|Part II (Extension Study)||379
10585267|NCT01739348|11741186|FG001|NOT COMPLETED|Part II (Extension Study)||366
10585268|NCT01739348|11741187|FG002|NOT COMPLETED|Part II (Extension Study)||61
10585269|NCT01739348|11741188|FG003|NOT COMPLETED|Part II (Extension Study)||396
10585270|NCT01739361|11741204|FG000|STARTED|Overall Study||21
10585271|NCT01739361|11741205|FG001|STARTED|Overall Study||23
10585272|NCT01739361|11741204|FG000|COMPLETED|Overall Study||18
10585273|NCT01739361|11741205|FG001|COMPLETED|Overall Study||22
10585274|NCT01739361|11741204|FG000|NOT COMPLETED|Overall Study||3
10585275|NCT01739361|11741205|FG001|NOT COMPLETED|Overall Study||1
10585276|NCT01739400|11741213|FG000|STARTED|Overall Study||109
10585277|NCT01739400|11741214|FG001|STARTED|Overall Study||108
10585278|NCT01739400|11741213|FG000|Treated With 10 mg Macitentan|Overall Study||109
10585279|NCT01739400|11741214|FG001|Treated With 10 mg Macitentan|Overall Study||108
10585280|NCT01739400|11741213|FG000|COMPLETED|Overall Study||92
10585281|NCT01739400|11741214|FG001|COMPLETED|Overall Study||99
10585282|NCT01739400|11741213|FG000|NOT COMPLETED|Overall Study||17
10585283|NCT01739400|11741214|FG001|NOT COMPLETED|Overall Study||9
10585284|NCT01739595|11741222|FG000|STARTED|Overall Study||112
10585285|NCT01739595|11741223|FG001|STARTED|Overall Study||22
10585286|NCT01739595|11741224|FG002|STARTED|Overall Study||47
10585287|NCT01739595|11741222|FG000|COMPLETED|Overall Study||99
10585288|NCT01739595|11741223|FG001|COMPLETED|Overall Study||21
10585289|NCT01739595|11741224|FG002|COMPLETED|Overall Study||45
10585290|NCT01739595|11741222|FG000|NOT COMPLETED|Overall Study||13
10585291|NCT01739595|11741223|FG001|NOT COMPLETED|Overall Study||1
10585292|NCT01739595|11741224|FG002|NOT COMPLETED|Overall Study||2
10585293|NCT01739699|11741233|FG000|STARTED|Overall Study||70
10585294|NCT01739699|11741234|FG001|STARTED|Overall Study||70
10585295|NCT01739699|11741233|FG000|COMPLETED|Overall Study||66
10585296|NCT01739699|11741234|FG001|COMPLETED|Overall Study||65
10585297|NCT01739699|11741233|FG000|NOT COMPLETED|Overall Study||4
10585298|NCT01739699|11741234|FG001|NOT COMPLETED|Overall Study||5
10585299|NCT01739764|11741243|FG000|STARTED|Overall Study||29
10585300|NCT01739764|11741244|FG001|STARTED|Overall Study||40
10585301|NCT01739764|11741245|FG002|STARTED|Overall Study||146
10585302|NCT01739764|11741243|FG000|COMPLETED|Overall Study||3
10585303|NCT01739764|11741244|FG001|COMPLETED|Overall Study||4
10585304|NCT01739764|11741245|FG002|COMPLETED|Overall Study||20
10585305|NCT01739764|11741243|FG000|NOT COMPLETED|Overall Study||26
10585306|NCT01739764|11741244|FG001|NOT COMPLETED|Overall Study||36
10585307|NCT01739764|11741245|FG002|NOT COMPLETED|Overall Study||126
10585308|NCT01739790|11741255|FG000|STARTED|Overall Study||24
10585309|NCT01739790|11741256|FG001|STARTED|Overall Study||27
10585310|NCT01739790|11741255|FG000|COMPLETED|Overall Study||22
10585311|NCT01739790|11741256|FG001|COMPLETED|Overall Study||23
10585312|NCT01739790|11741255|FG000|NOT COMPLETED|Overall Study||2
10585313|NCT01739790|11741256|FG001|NOT COMPLETED|Overall Study||4
10585314|NCT01739803|11741264|FG000|STARTED|Overall Study||76
10585315|NCT01739803|11741265|FG001|STARTED|Overall Study||74
10585316|NCT01739803|11741264|FG000|COMPLETED|Overall Study||67
10585317|NCT01739803|11741265|FG001|COMPLETED|Overall Study||68
10585318|NCT01739803|11741264|FG000|NOT COMPLETED|Overall Study||9
10585319|NCT01739803|11741265|FG001|NOT COMPLETED|Overall Study||6
10585320|NCT01739933|11741273|FG000|STARTED|Overall Study|Underwent randomization and received study drug|214
10585321|NCT01739933|11741274|FG001|STARTED|Overall Study|Underwent randomization and received study drug|208
10585322|NCT01739933|11741273|FG000|Discharged From Hospital and Eligible for Follow-up|Overall Study||140
10585323|NCT01739933|11741274|FG001|Discharged From Hospital and Eligible for Follow-up|Overall Study||147
10585324|NCT01739933|11741273|FG000|COMPLETED|Overall Study|97% of those eligible (alive and who did not withdraw)|108
10585325|NCT01739933|11741274|FG001|COMPLETED|Overall Study|91% of those eligible (alive and who did not withdraw)|101
10585326|NCT01739933|11741273|FG000|NOT COMPLETED|Overall Study||106
10585327|NCT01739933|11741274|FG001|NOT COMPLETED|Overall Study||107
10585328|NCT01740089|11741283|FG000|STARTED|First 12 Weeks of Treatment||50
10585329|NCT01740089|11741284|FG001|STARTED|First 12 Weeks of Treatment||50
10585330|NCT01740089|11741285|FG002|STARTED|First 12 Weeks of Treatment||50
10585331|NCT01740089|11741283|FG000|COMPLETED|First 12 Weeks of Treatment||50
10585332|NCT01740089|11741284|FG001|COMPLETED|First 12 Weeks of Treatment|"Withdrawn due to:~AE before W12 (n=1) Withdrew consent before W12 (n=1)"|48
10585333|NCT01740089|11741285|FG002|COMPLETED|First 12 Weeks of Treatment|"Withdrawn due to:~AE before W12 (n=2)"|48
10585334|NCT01740089|11741283|FG000|NOT COMPLETED|First 12 Weeks of Treatment||0
10585335|NCT01740089|11741284|FG001|NOT COMPLETED|First 12 Weeks of Treatment||2
10585336|NCT01740089|11741285|FG002|NOT COMPLETED|First 12 Weeks of Treatment||2
10585337|NCT01740089|11741283|FG000|STARTED|After 12 Weeks||50
10585338|NCT01740089|11741284|FG001|STARTED|After 12 Weeks||48
10585339|NCT01740089|11741285|FG002|STARTED|After 12 Weeks||48
10585340|NCT01740089|11741283|FG000|COMPLETED|After 12 Weeks|"Withdrawn due to:~No EVR (n=3) AE (n=2) No EOT (n=1) Non-compliance (n=1)"|43
10806744|NCT03944785|11968348|FG000|STARTED|4 Month Study Optional Extension||1
10806745|NCT03944785|11968349|FG001|STARTED|4 Month Study Optional Extension||10
10806746|NCT03944785|11968350|FG002|STARTED|4 Month Study Optional Extension||64
10585341|NCT01740089|11741284|FG001|COMPLETED|After 12 Weeks|"Withdrawn due to:~Withdrawn consent (n=1) No EVR (n=1) Non-compliance (n=1)"|45
10585342|NCT01740089|11741285|FG002|COMPLETED|After 12 Weeks|"Withdrawn due to:~No EVR (n=4) AE (n=5) Non-attendance of visit (n=1) Withdrawn consent (n=1)"|37
10585343|NCT01740089|11741283|FG000|NOT COMPLETED|After 12 Weeks||7
10585344|NCT01740089|11741284|FG001|NOT COMPLETED|After 12 Weeks||3
10585345|NCT01740089|11741285|FG002|NOT COMPLETED|After 12 Weeks||11
10585346|NCT01740128|11741296|FG000|STARTED|Overall Study||10
10585347|NCT01740128|11741297|FG001|STARTED|Overall Study||11
10585348|NCT01740128|11741296|FG000|COMPLETED|Overall Study||4
10585349|NCT01740128|11741297|FG001|COMPLETED|Overall Study||4
10585350|NCT01740128|11741296|FG000|NOT COMPLETED|Overall Study||6
10585351|NCT01740128|11741297|FG001|NOT COMPLETED|Overall Study||7
10585352|NCT01740206|11741305|FG000|STARTED|Overall Study||14
10585353|NCT01740206|11741306|FG001|STARTED|Overall Study||34
10585354|NCT01740206|11741305|FG000|COMPLETED|Overall Study||14
10585355|NCT01740206|11741306|FG001|COMPLETED|Overall Study||34
10585356|NCT01740206|11741305|FG000|NOT COMPLETED|Overall Study||0
10585357|NCT01740206|11741306|FG001|NOT COMPLETED|Overall Study||0
10585358|NCT01740258|11741312|FG000|STARTED|Overall Study||68
10585359|NCT01740258|11741312|FG000|Entered Part A|Overall Study||68
10585360|NCT01740258|11741312|FG000|Entered Part B|Overall Study||62
10585361|NCT01740258|11741312|FG000|Entered Part C|Overall Study||20
10585362|NCT01740258|11741312|FG000|Entered Part D|Overall Study||42
10585363|NCT01740258|11741312|FG000|COMPLETED|Overall Study||68
10585364|NCT01740258|11741312|FG000|NOT COMPLETED|Overall Study||0
10585365|NCT01740323|11741318|FG000|STARTED|Overall Study||15
10585366|NCT01740323|11741319|FG001|STARTED|Overall Study||15
10585367|NCT01740323|11741318|FG000|COMPLETED|Overall Study||13
10585368|NCT01740323|11741319|FG001|COMPLETED|Overall Study||15
10585369|NCT01740323|11741318|FG000|NOT COMPLETED|Overall Study||2
10585370|NCT01740323|11741319|FG001|NOT COMPLETED|Overall Study||0
10585371|NCT01740362|11741329|FG000|STARTED|Overall Study||6
10585372|NCT01740362|11741330|FG001|STARTED|Overall Study||6
10585373|NCT01740362|11741331|FG002|STARTED|Overall Study||6
10585374|NCT01740362|11741332|FG003|STARTED|Overall Study||6
10585375|NCT01740362|11741329|FG000|COMPLETED|Overall Study||6
10585376|NCT01740362|11741330|FG001|COMPLETED|Overall Study||6
10585377|NCT01740362|11741331|FG002|COMPLETED|Overall Study||6
10585378|NCT01740362|11741332|FG003|COMPLETED|Overall Study||6
10585379|NCT01740362|11741329|FG000|NOT COMPLETED|Overall Study||0
10585380|NCT01740362|11741330|FG001|NOT COMPLETED|Overall Study||0
10585381|NCT01740362|11741331|FG002|NOT COMPLETED|Overall Study||0
10585382|NCT01740362|11741332|FG003|NOT COMPLETED|Overall Study||0
10585383|NCT01740388|11741344|FG000|STARTED|Overall Study||64
10585384|NCT01740388|11741345|FG001|STARTED|Overall Study||72
10585385|NCT01740388|11741344|FG000|COMPLETED|Overall Study||18
10585386|NCT01740388|11741345|FG001|COMPLETED|Overall Study||28
10806747|NCT03944785|11968348|FG000|COMPLETED|4 Month Study Optional Extension||0
10585387|NCT01740388|11741344|FG000|NOT COMPLETED|Overall Study||46
10585388|NCT01740388|11741345|FG001|NOT COMPLETED|Overall Study||44
10585389|NCT01740401|11741351|FG000|STARTED|Overall Study||10
10585390|NCT01740401|11741351|FG000|COMPLETED|Overall Study||0
10585391|NCT01740401|11741351|FG000|NOT COMPLETED|Overall Study||10
10585392|NCT01740414|11741357|FG000|STARTED|Overall Study||12
10585393|NCT01740414|11741358|FG001|STARTED|Overall Study||16
10585394|NCT01740414|11741357|FG000|COMPLETED|Overall Study||3
10585395|NCT01740414|11741358|FG001|COMPLETED|Overall Study||8
10585396|NCT01740414|11741357|FG000|NOT COMPLETED|Overall Study||9
10585397|NCT01740414|11741358|FG001|NOT COMPLETED|Overall Study||8
10585398|NCT01740440|11741369|FG000|STARTED|Overall Study||30
10585399|NCT01740440|11741369|FG000|COMPLETED|Overall Study||27
10585400|NCT01740440|11741369|FG000|NOT COMPLETED|Overall Study||3
10585401|NCT01740713|11741377|FG000|STARTED|Overall Study||6
10585402|NCT01740713|11741378|FG001|STARTED|Overall Study||8
10585403|NCT01740713|11741379|FG002|STARTED|Overall Study||7
10585404|NCT01740713|11741377|FG000|COMPLETED|Overall Study||6
10585405|NCT01740713|11741378|FG001|COMPLETED|Overall Study||6
10585406|NCT01740713|11741379|FG002|COMPLETED|Overall Study||6
10585407|NCT01740713|11741377|FG000|NOT COMPLETED|Overall Study||0
10585408|NCT01740713|11741378|FG001|NOT COMPLETED|Overall Study||2
10585409|NCT01740713|11741379|FG002|NOT COMPLETED|Overall Study||1
10585410|NCT01740726|11741391|FG000|STARTED|Overall Study||0
10585411|NCT01740726|11741392|FG001|STARTED|Overall Study||1
10585412|NCT01740726|11741391|FG000|COMPLETED|Overall Study||0
10585413|NCT01740726|11741392|FG001|COMPLETED|Overall Study||1
10585414|NCT01740726|11741391|FG000|NOT COMPLETED|Overall Study||0
10585415|NCT01740726|11741392|FG001|NOT COMPLETED|Overall Study||0
10585416|NCT01740791|11741404|FG000|STARTED|Overall Study||22
10585417|NCT01740791|11741405|FG001|STARTED|Overall Study||7
10585418|NCT01740791|11741406|FG002|STARTED|Overall Study||17
10585419|NCT01740791|11741407|FG003|STARTED|Overall Study||14
10585420|NCT01740791|11741408|FG004|STARTED|Overall Study||9
10585421|NCT01740791|11741409|FG005|STARTED|Overall Study||34
10585422|NCT01740791|11741404|FG000|COMPLETED|Overall Study||10
10585423|NCT01740791|11741405|FG001|COMPLETED|Overall Study||4
10585424|NCT01740791|11741406|FG002|COMPLETED|Overall Study||11
10585425|NCT01740791|11741407|FG003|COMPLETED|Overall Study||7
10585426|NCT01740791|11741408|FG004|COMPLETED|Overall Study||6
10585427|NCT01740791|11741409|FG005|COMPLETED|Overall Study||23
10585428|NCT01740791|11741404|FG000|NOT COMPLETED|Overall Study||12
10585429|NCT01740791|11741405|FG001|NOT COMPLETED|Overall Study||3
10585430|NCT01740791|11741406|FG002|NOT COMPLETED|Overall Study||6
10585431|NCT01740791|11741407|FG003|NOT COMPLETED|Overall Study||7
10585432|NCT01740791|11741408|FG004|NOT COMPLETED|Overall Study||3
10585433|NCT01740791|11741409|FG005|NOT COMPLETED|Overall Study||11
10585434|NCT01740817|11741464|FG000|STARTED|First Intervention (48 h)||8
10585435|NCT01740817|11741465|FG001|STARTED|First Intervention (48 h)||4
10585436|NCT01740817|11741464|FG000|COMPLETED|First Intervention (48 h)||8
10585437|NCT01740817|11741465|FG001|COMPLETED|First Intervention (48 h)||4
10585438|NCT01740817|11741464|FG000|NOT COMPLETED|First Intervention (48 h)||0
10585439|NCT01740817|11741465|FG001|NOT COMPLETED|First Intervention (48 h)||0
10585440|NCT01740817|11741464|FG000|STARTED|Washout (4-6 Weeks)||8
10585441|NCT01740817|11741465|FG001|STARTED|Washout (4-6 Weeks)||4
10585442|NCT01740817|11741464|FG000|COMPLETED|Washout (4-6 Weeks)||8
10585443|NCT01740817|11741465|FG001|COMPLETED|Washout (4-6 Weeks)||4
10585444|NCT01740817|11741464|FG000|NOT COMPLETED|Washout (4-6 Weeks)||0
10585445|NCT01740817|11741465|FG001|NOT COMPLETED|Washout (4-6 Weeks)||0
10585446|NCT01740817|11741464|FG000|STARTED|Second Intervention (48 h)||8
10585447|NCT01740817|11741465|FG001|STARTED|Second Intervention (48 h)||4
10585448|NCT01740817|11741464|FG000|COMPLETED|Second Intervention (48 h)||8
10585449|NCT01740817|11741465|FG001|COMPLETED|Second Intervention (48 h)||4
10585450|NCT01740817|11741464|FG000|NOT COMPLETED|Second Intervention (48 h)||0
10585451|NCT01740817|11741465|FG001|NOT COMPLETED|Second Intervention (48 h)||0
10585452|NCT01741012|11741471|FG000|STARTED|Overall Study||37
10585453|NCT01741012|11741471|FG000|COMPLETED|Overall Study||34
10585454|NCT01741012|11741471|FG000|NOT COMPLETED|Overall Study||3
10585455|NCT01741259|11741478|FG000|STARTED|Overall Study||133
10585456|NCT01741259|11741479|FG001|STARTED|Overall Study||135
10585457|NCT01741259|11741478|FG000|COMPLETED|Overall Study||127
10585458|NCT01741259|11741479|FG001|COMPLETED|Overall Study||129
10585459|NCT01741259|11741478|FG000|NOT COMPLETED|Overall Study||6
10806748|NCT03944785|11968349|FG001|COMPLETED|4 Month Study Optional Extension||8
10806749|NCT03944785|11968350|FG002|COMPLETED|4 Month Study Optional Extension||41
10585460|NCT01741259|11741479|FG001|NOT COMPLETED|Overall Study||6
10585461|NCT01741272|11741487|FG000|STARTED|Overall Study||92
10585462|NCT01741272|11741488|FG001|STARTED|Overall Study||97
10585463|NCT01741272|11741487|FG000|COMPLETED|Overall Study||92
10585464|NCT01741272|11741488|FG001|COMPLETED|Overall Study||97
10585465|NCT01741272|11741487|FG000|NOT COMPLETED|Overall Study||0
10585466|NCT01741272|11741488|FG001|NOT COMPLETED|Overall Study||0
10585467|NCT01741350|11741496|FG000|STARTED|Study Intervention||149
10585468|NCT01741350|11741497|FG001|STARTED|Study Intervention||155
10585469|NCT01741350|11741496|FG000|COMPLETED|Study Intervention||149
10585470|NCT01741350|11741497|FG001|COMPLETED|Study Intervention||155
10585471|NCT01741350|11741496|FG000|NOT COMPLETED|Study Intervention||0
10585472|NCT01741350|11741497|FG001|NOT COMPLETED|Study Intervention||0
10585473|NCT01741350|11741496|FG000|STARTED|Post Intervention Assessment (at Week 4)||149
10585474|NCT01741350|11741497|FG001|STARTED|Post Intervention Assessment (at Week 4)||155
10585475|NCT01741350|11741496|FG000|COMPLETED|Post Intervention Assessment (at Week 4)||135
10585476|NCT01741350|11741497|FG001|COMPLETED|Post Intervention Assessment (at Week 4)||141
10585477|NCT01741350|11741496|FG000|NOT COMPLETED|Post Intervention Assessment (at Week 4)||14
10585478|NCT01741350|11741497|FG001|NOT COMPLETED|Post Intervention Assessment (at Week 4)||14
10585479|NCT01741350|11741496|FG000|STARTED|3-Month Follow-up Assessment||135
10585480|NCT01741350|11741497|FG001|STARTED|3-Month Follow-up Assessment||141
10585481|NCT01741350|11741496|FG000|COMPLETED|3-Month Follow-up Assessment||129
10585482|NCT01741350|11741497|FG001|COMPLETED|3-Month Follow-up Assessment||119
10585483|NCT01741350|11741496|FG000|NOT COMPLETED|3-Month Follow-up Assessment||6
10585484|NCT01741350|11741497|FG001|NOT COMPLETED|3-Month Follow-up Assessment||22
10585485|NCT01741350|11741496|FG000|STARTED|6-Month Follow-up Assessment||129
10585486|NCT01741350|11741497|FG001|STARTED|6-Month Follow-up Assessment||119
10585487|NCT01741350|11741496|FG000|COMPLETED|6-Month Follow-up Assessment||114
10585488|NCT01741350|11741497|FG001|COMPLETED|6-Month Follow-up Assessment||111
10585489|NCT01741350|11741496|FG000|NOT COMPLETED|6-Month Follow-up Assessment||15
10585490|NCT01741350|11741497|FG001|NOT COMPLETED|6-Month Follow-up Assessment||8
10585491|NCT01741350|11741496|FG000|STARTED|12-Month Follow-up Assessment||114
10585492|NCT01741350|11741497|FG001|STARTED|12-Month Follow-up Assessment||111
10585493|NCT01741350|11741496|FG000|COMPLETED|12-Month Follow-up Assessment||111
10585494|NCT01741350|11741497|FG001|COMPLETED|12-Month Follow-up Assessment||109
10585495|NCT01741350|11741496|FG000|NOT COMPLETED|12-Month Follow-up Assessment||3
10585496|NCT01741350|11741497|FG001|NOT COMPLETED|12-Month Follow-up Assessment||2
10585497|NCT01741454|11741507|FG000|STARTED|Overall Study||49
10585498|NCT01741454|11741508|FG001|STARTED|Overall Study||50
10585499|NCT01741454|11741509|FG002|STARTED|Overall Study||39
10585500|NCT01741454|11741510|FG003|STARTED|Overall Study||43
10585501|NCT01741454|11741507|FG000|COMPLETED|Overall Study||36
10585502|NCT01741454|11741508|FG001|COMPLETED|Overall Study||44
10585503|NCT01741454|11741509|FG002|COMPLETED|Overall Study||22
10585504|NCT01741454|11741510|FG003|COMPLETED|Overall Study||21
10585505|NCT01741454|11741507|FG000|NOT COMPLETED|Overall Study||13
10585506|NCT01741454|11741508|FG001|NOT COMPLETED|Overall Study||6
10585507|NCT01741454|11741509|FG002|NOT COMPLETED|Overall Study||17
10585508|NCT01741454|11741510|FG003|NOT COMPLETED|Overall Study||22
10585509|NCT01741532|11741526|FG000|STARTED|Overall Study||59
10585510|NCT01741532|11741527|FG001|STARTED|Overall Study||30
10585511|NCT01741532|11741526|FG000|Exposed|Overall Study||58
10585512|NCT01741532|11741527|FG001|Exposed|Overall Study||30
10585513|NCT01741532|11741526|FG000|Provided Post-baseline Efficacy Data|Overall Study||58
10585514|NCT01741532|11741527|FG001|Provided Post-baseline Efficacy Data|Overall Study||28
10585515|NCT01741532|11741526|FG000|COMPLETED|Overall Study||49
10585516|NCT01741532|11741527|FG001|COMPLETED|Overall Study||27
10585517|NCT01741532|11741526|FG000|NOT COMPLETED|Overall Study||10
10585518|NCT01741532|11741527|FG001|NOT COMPLETED|Overall Study||3
10585519|NCT01741545|11741539|FG000|STARTED|Treatment Period||12
10585520|NCT01741545|11741540|FG001|STARTED|Treatment Period||39
10585521|NCT01741545|11741539|FG000|COMPLETED|Treatment Period||11
10585522|NCT01741545|11741540|FG001|COMPLETED|Treatment Period||35
10585523|NCT01741545|11741539|FG000|NOT COMPLETED|Treatment Period||1
10585524|NCT01741545|11741540|FG001|NOT COMPLETED|Treatment Period||4
10585525|NCT01741545|11741539|FG000|STARTED|Follow-up Period (24 Weeks)|1 participant re-joined Cohort A in follow-up period.|12
10585526|NCT01741545|11741540|FG001|STARTED|Follow-up Period (24 Weeks)|4 participants re-joined Cohort B in follow-up period.|39
10585527|NCT01741545|11741539|FG000|COMPLETED|Follow-up Period (24 Weeks)||11
10585528|NCT01741545|11741540|FG001|COMPLETED|Follow-up Period (24 Weeks)||37
10585529|NCT01741545|11741539|FG000|NOT COMPLETED|Follow-up Period (24 Weeks)||1
10585530|NCT01741545|11741540|FG001|NOT COMPLETED|Follow-up Period (24 Weeks)||2
10585531|NCT01741688|11741546|FG000|STARTED|Overall Study||16
10585532|NCT01741688|11741546|FG000|COMPLETED|Overall Study||13
10585533|NCT01741688|11741546|FG000|NOT COMPLETED|Overall Study||3
10651859|NCT02179047|11812096|FG001|STARTED|Overall Study||20
10651860|NCT02179047|11812095|FG000|COMPLETED|Overall Study||187
10651861|NCT02179047|11812096|FG001|COMPLETED|Overall Study||20
10651862|NCT02179047|11812095|FG000|NOT COMPLETED|Overall Study||7
10651863|NCT02179047|11812096|FG001|NOT COMPLETED|Overall Study||0
10651864|NCT02179177|11812115|FG000|STARTED|Overall Study||8
10651865|NCT02179177|11812116|FG001|STARTED|Overall Study||8
10651866|NCT02179177|11812115|FG000|COMPLETED|Overall Study||6
10651867|NCT02179177|11812116|FG001|COMPLETED|Overall Study||6
10651868|NCT02179177|11812115|FG000|NOT COMPLETED|Overall Study||2
10651869|NCT02179177|11812116|FG001|NOT COMPLETED|Overall Study||2
10651870|NCT02179190|11812122|FG000|STARTED|Enrollment||138
10651871|NCT02179190|11812122|FG000|COMPLETED|Enrollment||127
10651872|NCT02179190|11812122|FG000|NOT COMPLETED|Enrollment||11
10651873|NCT02179190|11812122|FG000|STARTED|Index Procedure With Barrel VRD Attempt||127
10651874|NCT02179190|11812122|FG000|COMPLETED|Index Procedure With Barrel VRD Attempt||120
10651875|NCT02179190|11812122|FG000|NOT COMPLETED|Index Procedure With Barrel VRD Attempt||7
10651876|NCT02179190|11812122|FG000|STARTED|Follow-Up Post Barrel VRD Implanted||120
10651877|NCT02179190|11812122|FG000|COMPLETED|Follow-Up Post Barrel VRD Implanted||111
10651878|NCT02179190|11812122|FG000|NOT COMPLETED|Follow-Up Post Barrel VRD Implanted||9
10651879|NCT02179398|11812128|FG000|STARTED|Overall Study||134
10651880|NCT02179398|11812129|FG001|STARTED|Overall Study||144
10651881|NCT02179398|11812128|FG000|COMPLETED|Overall Study||131
10651882|NCT02179398|11812129|FG001|COMPLETED|Overall Study||140
10651883|NCT02179398|11812128|FG000|NOT COMPLETED|Overall Study||3
10585534|NCT01741701|11741553|FG000|STARTED|Overall Study||18
10585535|NCT01741701|11741554|FG001|STARTED|Overall Study||15
10585536|NCT01741701|11741553|FG000|COMPLETED|Overall Study||13
10585537|NCT01741701|11741554|FG001|COMPLETED|Overall Study||13
10585538|NCT01741701|11741553|FG000|NOT COMPLETED|Overall Study||5
10585539|NCT01741701|11741554|FG001|NOT COMPLETED|Overall Study||2
10585540|NCT01741792|11741563|FG000|STARTED|Overall Study|3 participants were not considered evaluable and were replaced as specified in the protocol.|9
10585541|NCT01741792|11741564|FG001|STARTED|Overall Study|Cohort 2 was closed to enrollment on recommendation of the data monitoring committee|2
10585542|NCT01741792|11741565|FG002|STARTED|Overall Study||14
10585543|NCT01741792|11741563|FG000|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|7
10585544|NCT01741792|11741564|FG001|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|1
10585545|NCT01741792|11741565|FG002|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|13
10585546|NCT01741792|11741563|FG000|COMPLETED|Overall Study||3
10585547|NCT01741792|11741564|FG001|COMPLETED|Overall Study||1
10585548|NCT01741792|11741565|FG002|COMPLETED|Overall Study||2
10585549|NCT01741792|11741563|FG000|NOT COMPLETED|Overall Study||6
10585550|NCT01741792|11741564|FG001|NOT COMPLETED|Overall Study||1
10585551|NCT01741792|11741565|FG002|NOT COMPLETED|Overall Study||12
10585552|NCT01742065|11741581|FG000|STARTED|Overall Study|20059 patients were analyzed in 13 clinics.|20059
10585553|NCT01742065|11741582|FG001|STARTED|Overall Study|21134 patients were analyzed in 13 clinics.|21134
10585554|NCT01742065|11741581|FG000|COMPLETED|Overall Study|20059 patients were analyzed in 13 clinics.|20059
10585555|NCT01742065|11741582|FG001|COMPLETED|Overall Study|21134 patients were analyzed in 13 clinics.|21134
10585556|NCT01742065|11741581|FG000|NOT COMPLETED|Overall Study||0
10585557|NCT01742065|11741582|FG001|NOT COMPLETED|Overall Study||0
10585558|NCT01742078|11741597|FG000|STARTED|Overall Study||6
10703019|NCT02580357|11867562|FG001|STARTED|Overall Study||18
10703020|NCT02580357|11867563|FG002|STARTED|Overall Study||18
10703021|NCT02580357|11867561|FG000|COMPLETED|Overall Study||15
10703022|NCT02580357|11867562|FG001|COMPLETED|Overall Study||18
10703023|NCT02580357|11867563|FG002|COMPLETED|Overall Study||18
10703024|NCT02580357|11867561|FG000|NOT COMPLETED|Overall Study||3
10703025|NCT02580357|11867562|FG001|NOT COMPLETED|Overall Study||0
10703026|NCT02580357|11867563|FG002|NOT COMPLETED|Overall Study||0
10703027|NCT02580591|11867575|FG000|STARTED|Overall Study||242
10585559|NCT01742078|11741598|FG001|STARTED|Overall Study||6
10585560|NCT01742078|11741599|FG002|STARTED|Overall Study||6
10585561|NCT01742078|11741600|FG003|STARTED|Overall Study||6
10585562|NCT01742078|11741601|FG004|STARTED|Overall Study||6
10585563|NCT01742078|11741602|FG005|STARTED|Overall Study||6
10585564|NCT01742078|11741603|FG006|STARTED|Overall Study||6
10585565|NCT01742078|11741604|FG007|STARTED|Overall Study||6
10585566|NCT01742078|11741605|FG008|STARTED|Overall Study||12
10585567|NCT01742078|11741597|FG000|RECEIVED STUDY DRUG|Overall Study||6
10585568|NCT01742078|11741598|FG001|RECEIVED STUDY DRUG|Overall Study||6
10585569|NCT01742078|11741599|FG002|RECEIVED STUDY DRUG|Overall Study||6
10585570|NCT01742078|11741600|FG003|RECEIVED STUDY DRUG|Overall Study||6
10585571|NCT01742078|11741601|FG004|RECEIVED STUDY DRUG|Overall Study||6
10585572|NCT01742078|11741602|FG005|RECEIVED STUDY DRUG|Overall Study||6
10585573|NCT01742078|11741603|FG006|RECEIVED STUDY DRUG|Overall Study||6
10585574|NCT01742078|11741604|FG007|RECEIVED STUDY DRUG|Overall Study||6
10585575|NCT01742078|11741605|FG008|RECEIVED STUDY DRUG|Overall Study||12
10585576|NCT01742078|11741597|FG000|COMPLETED|Overall Study||6
10585577|NCT01742078|11741598|FG001|COMPLETED|Overall Study||6
10585578|NCT01742078|11741599|FG002|COMPLETED|Overall Study||6
10585579|NCT01742078|11741600|FG003|COMPLETED|Overall Study||5
10585580|NCT01742078|11741601|FG004|COMPLETED|Overall Study||6
10585581|NCT01742078|11741602|FG005|COMPLETED|Overall Study||6
10585582|NCT01742078|11741603|FG006|COMPLETED|Overall Study||6
10585583|NCT01742078|11741604|FG007|COMPLETED|Overall Study||6
10585584|NCT01742078|11741605|FG008|COMPLETED|Overall Study||12
10585585|NCT01742078|11741597|FG000|NOT COMPLETED|Overall Study||0
10585586|NCT01742078|11741598|FG001|NOT COMPLETED|Overall Study||0
10585587|NCT01742078|11741599|FG002|NOT COMPLETED|Overall Study||0
10585588|NCT01742078|11741600|FG003|NOT COMPLETED|Overall Study||1
10585589|NCT01742078|11741601|FG004|NOT COMPLETED|Overall Study||0
10585590|NCT01742078|11741602|FG005|NOT COMPLETED|Overall Study||0
10585591|NCT01742078|11741603|FG006|NOT COMPLETED|Overall Study||0
10585592|NCT01742078|11741604|FG007|NOT COMPLETED|Overall Study||0
10585593|NCT01742078|11741605|FG008|NOT COMPLETED|Overall Study||0
10703028|NCT02580591|11867576|FG001|STARTED|Overall Study||242
10585594|NCT01742091|11741633|FG000|STARTED|Overall Study||9
10703029|NCT02580591|11867577|FG002|STARTED|Overall Study||248
10703030|NCT02580591|11867578|FG003|STARTED|Overall Study||245
10703031|NCT02580591|11867575|FG000|Treated|Overall Study||241
10585595|NCT01742091|11741634|FG001|STARTED|Overall Study||11
10585596|NCT01742091|11741635|FG002|STARTED|Overall Study||10
10585597|NCT01742091|11741636|FG003|STARTED|Overall Study||9
10703032|NCT02580591|11867576|FG001|Treated|Overall Study||241
10703033|NCT02580591|11867577|FG002|Treated|Overall Study||248
10703034|NCT02580591|11867578|FG003|Treated|Overall Study||245
10703035|NCT02580591|11867575|FG000|COMPLETED|Overall Study||224
10585598|NCT01742091|11741637|FG004|STARTED|Overall Study||8
10585599|NCT01742091|11741638|FG005|STARTED|Overall Study||12
10585600|NCT01742091|11741633|FG000|RECEIVED STUDY DRUG|Overall Study||9
10585601|NCT01742091|11741634|FG001|RECEIVED STUDY DRUG|Overall Study||11
10585602|NCT01742091|11741635|FG002|RECEIVED STUDY DRUG|Overall Study||10
10585603|NCT01742091|11741636|FG003|RECEIVED STUDY DRUG|Overall Study||9
10585604|NCT01742091|11741637|FG004|RECEIVED STUDY DRUG|Overall Study||8
10585605|NCT01742091|11741638|FG005|RECEIVED STUDY DRUG|Overall Study||12
10585606|NCT01742091|11741633|FG000|COMPLETED|Overall Study||9
10585607|NCT01742091|11741634|FG001|COMPLETED|Overall Study||11
10585608|NCT01742091|11741635|FG002|COMPLETED|Overall Study||10
10585609|NCT01742091|11741636|FG003|COMPLETED|Overall Study||8
10585610|NCT01742091|11741637|FG004|COMPLETED|Overall Study||7
10585611|NCT01742091|11741638|FG005|COMPLETED|Overall Study||10
10585612|NCT01742091|11741633|FG000|NOT COMPLETED|Overall Study||0
10585613|NCT01742091|11741634|FG001|NOT COMPLETED|Overall Study||0
10585614|NCT01742091|11741635|FG002|NOT COMPLETED|Overall Study||0
10585615|NCT01742091|11741636|FG003|NOT COMPLETED|Overall Study||1
10585616|NCT01742091|11741637|FG004|NOT COMPLETED|Overall Study||1
10585617|NCT01742091|11741638|FG005|NOT COMPLETED|Overall Study||2
10585618|NCT01742117|11741654|FG000|STARTED|Overall Study||2641
10585619|NCT01742117|11741655|FG001|STARTED|Overall Study||2635
10585620|NCT01742117|11741654|FG000|COMPLETED|Overall Study||2641
10585621|NCT01742117|11741655|FG001|COMPLETED|Overall Study||2635
10585622|NCT01742117|11741654|FG000|NOT COMPLETED|Overall Study||0
10585623|NCT01742117|11741655|FG001|NOT COMPLETED|Overall Study||0
10585624|NCT01742208|11741664|FG000|STARTED|Overall Study||3
10585625|NCT01742208|11741665|FG001|STARTED|Overall Study||17
10585626|NCT01742208|11741666|FG002|STARTED|Overall Study||16
10585627|NCT01742208|11741664|FG000|COMPLETED|Overall Study||3
10585628|NCT01742208|11741665|FG001|COMPLETED|Overall Study||17
10585629|NCT01742208|11741666|FG002|COMPLETED|Overall Study||16
10585630|NCT01742208|11741664|FG000|NOT COMPLETED|Overall Study||0
10585631|NCT01742208|11741665|FG001|NOT COMPLETED|Overall Study||0
10585632|NCT01742208|11741666|FG002|NOT COMPLETED|Overall Study||0
10585633|NCT01742286|11741683|FG000|STARTED|Escalation Phase||5
10585634|NCT01742286|11741684|FG001|STARTED|Escalation Phase||12
10585635|NCT01742286|11741685|FG002|STARTED|Escalation Phase||6
10585636|NCT01742286|11741686|FG003|STARTED|Escalation Phase||2
10585637|NCT01742286|11741687|FG004|STARTED|Escalation Phase||4
10585638|NCT01742286|11741688|FG005|STARTED|Escalation Phase||5
10585639|NCT01742286|11741689|FG006|STARTED|Escalation Phase||6
10585640|NCT01742286|11741683|FG000|Ended Treatment = Not Completed)|Escalation Phase||5
10585641|NCT01742286|11741684|FG001|Ended Treatment = Not Completed)|Escalation Phase||12
10585642|NCT01742286|11741685|FG002|Ended Treatment = Not Completed)|Escalation Phase||6
10585643|NCT01742286|11741686|FG003|Ended Treatment = Not Completed)|Escalation Phase||2
10585644|NCT01742286|11741687|FG004|Ended Treatment = Not Completed)|Escalation Phase||4
10585645|NCT01742286|11741688|FG005|Ended Treatment = Not Completed)|Escalation Phase||5
10585646|NCT01742286|11741689|FG006|Ended Treatment = Not Completed)|Escalation Phase||6
10585647|NCT01742286|11741683|FG000|COMPLETED|Escalation Phase||0
10585648|NCT01742286|11741684|FG001|COMPLETED|Escalation Phase||0
10585649|NCT01742286|11741685|FG002|COMPLETED|Escalation Phase||0
10585650|NCT01742286|11741686|FG003|COMPLETED|Escalation Phase||0
10585651|NCT01742286|11741687|FG004|COMPLETED|Escalation Phase||0
10585652|NCT01742286|11741688|FG005|COMPLETED|Escalation Phase||0
10585653|NCT01742286|11741689|FG006|COMPLETED|Escalation Phase||0
10585654|NCT01742286|11741683|FG000|NOT COMPLETED|Escalation Phase||5
10585655|NCT01742286|11741684|FG001|NOT COMPLETED|Escalation Phase||12
10585656|NCT01742286|11741685|FG002|NOT COMPLETED|Escalation Phase||6
10585657|NCT01742286|11741686|FG003|NOT COMPLETED|Escalation Phase||2
10585658|NCT01742286|11741687|FG004|NOT COMPLETED|Escalation Phase||4
10585659|NCT01742286|11741688|FG005|NOT COMPLETED|Escalation Phase||5
10585660|NCT01742286|11741689|FG006|NOT COMPLETED|Escalation Phase||6
10585661|NCT01742286|11741683|FG000|STARTED|Expansion Phase||0
10585662|NCT01742286|11741684|FG001|STARTED|Expansion Phase||0
10585663|NCT01742286|11741685|FG002|STARTED|Expansion Phase||7
10585664|NCT01742286|11741686|FG003|STARTED|Expansion Phase||0
10585665|NCT01742286|11741687|FG004|STARTED|Expansion Phase||0
10585666|NCT01742286|11741688|FG005|STARTED|Expansion Phase||0
10585667|NCT01742286|11741689|FG006|STARTED|Expansion Phase||36
10585668|NCT01742286|11741683|FG000|End of Treatment = Not Ccompleted|Expansion Phase||0
10585669|NCT01742286|11741684|FG001|End of Treatment = Not Ccompleted|Expansion Phase||0
10585670|NCT01742286|11741685|FG002|End of Treatment = Not Ccompleted|Expansion Phase||7
10585671|NCT01742286|11741686|FG003|End of Treatment = Not Ccompleted|Expansion Phase||0
10585672|NCT01742286|11741687|FG004|End of Treatment = Not Ccompleted|Expansion Phase||0
10585673|NCT01742286|11741688|FG005|End of Treatment = Not Ccompleted|Expansion Phase||0
10585674|NCT01742286|11741689|FG006|End of Treatment = Not Ccompleted|Expansion Phase||36
10585675|NCT01742286|11741683|FG000|COMPLETED|Expansion Phase||0
10585676|NCT01742286|11741684|FG001|COMPLETED|Expansion Phase||0
10585677|NCT01742286|11741685|FG002|COMPLETED|Expansion Phase||0
10585678|NCT01742286|11741686|FG003|COMPLETED|Expansion Phase||0
10585679|NCT01742286|11741687|FG004|COMPLETED|Expansion Phase||0
10585680|NCT01742286|11741688|FG005|COMPLETED|Expansion Phase||0
10585681|NCT01742286|11741689|FG006|COMPLETED|Expansion Phase||0
10585682|NCT01742286|11741683|FG000|NOT COMPLETED|Expansion Phase||0
10585683|NCT01742286|11741684|FG001|NOT COMPLETED|Expansion Phase||0
10585684|NCT01742286|11741685|FG002|NOT COMPLETED|Expansion Phase||7
10585685|NCT01742286|11741686|FG003|NOT COMPLETED|Expansion Phase||0
10585686|NCT01742286|11741687|FG004|NOT COMPLETED|Expansion Phase||0
10585687|NCT01742286|11741688|FG005|NOT COMPLETED|Expansion Phase||0
10585688|NCT01742286|11741689|FG006|NOT COMPLETED|Expansion Phase||36
10585689|NCT01742364|11741716|FG000|STARTED|Overall Study||33
10585690|NCT01742364|11741717|FG001|STARTED|Overall Study||33
10585691|NCT01742364|11741718|FG002|STARTED|Overall Study||15
10585692|NCT01742364|11741719|FG003|STARTED|Overall Study||15
10585693|NCT01742364|11741716|FG000|COMPLETED|Overall Study||33
10585694|NCT01742364|11741717|FG001|COMPLETED|Overall Study||33
10585695|NCT01742364|11741718|FG002|COMPLETED|Overall Study||15
10585696|NCT01742364|11741719|FG003|COMPLETED|Overall Study||15
10585697|NCT01742364|11741716|FG000|NOT COMPLETED|Overall Study||0
10585698|NCT01742364|11741717|FG001|NOT COMPLETED|Overall Study||0
10585699|NCT01742364|11741718|FG002|NOT COMPLETED|Overall Study||0
10585700|NCT01742364|11741719|FG003|NOT COMPLETED|Overall Study||0
10585701|NCT01742832|11741732|FG000|STARTED|Overall Study||20
10585702|NCT01742832|11741733|FG001|STARTED|Overall Study||28
10585703|NCT01742832|11741732|FG000|COMPLETED|Overall Study||19
10585704|NCT01742832|11741733|FG001|COMPLETED|Overall Study||23
10585705|NCT01742832|11741732|FG000|NOT COMPLETED|Overall Study||1
10585706|NCT01742832|11741733|FG001|NOT COMPLETED|Overall Study||5
10585707|NCT01742897|11741739|FG000|STARTED|Overall Study||35
10585708|NCT01742897|11741739|FG000|Treated|Overall Study||33
10585709|NCT01742897|11741739|FG000|COMPLETED|Overall Study||30
10585710|NCT01742897|11741739|FG000|NOT COMPLETED|Overall Study||5
10585711|NCT01742936|11741745|FG000|STARTED|Overall Study||50
10585712|NCT01742936|11741746|FG001|STARTED|Overall Study||50
10585713|NCT01742936|11741745|FG000|COMPLETED|Overall Study||50
10585714|NCT01742936|11741746|FG001|COMPLETED|Overall Study||50
10585715|NCT01742936|11741745|FG000|NOT COMPLETED|Overall Study||0
10585716|NCT01742936|11741746|FG001|NOT COMPLETED|Overall Study||0
10585717|NCT01742949|11741752|FG000|STARTED|Overall Study||20
10585718|NCT01742949|11741753|FG001|STARTED|Overall Study||20
10585719|NCT01742949|11741752|FG000|COMPLETED|Overall Study||20
10806750|NCT03944785|11968348|FG000|NOT COMPLETED|4 Month Study Optional Extension||1
10806751|NCT03944785|11968349|FG001|NOT COMPLETED|4 Month Study Optional Extension||2
10806752|NCT03944785|11968350|FG002|NOT COMPLETED|4 Month Study Optional Extension||23
10806753|NCT03950622|11968360|FG000|STARTED|Overall Study||604
10806754|NCT03950622|11968361|FG001|STARTED|Overall Study||601
10585720|NCT01742949|11741753|FG001|COMPLETED|Overall Study||20
10585721|NCT01742949|11741752|FG000|NOT COMPLETED|Overall Study||0
10585722|NCT01742949|11741753|FG001|NOT COMPLETED|Overall Study||0
10585723|NCT01743001|11741764|FG000|STARTED|Overall Study||114
10585724|NCT01743001|11741765|FG001|STARTED|Overall Study||112
10585725|NCT01743001|11741764|FG000|COMPLETED|Overall Study||111
10585726|NCT01743001|11741765|FG001|COMPLETED|Overall Study||112
10585727|NCT01743001|11741764|FG000|NOT COMPLETED|Overall Study||3
10585728|NCT01743001|11741765|FG001|NOT COMPLETED|Overall Study||0
10585729|NCT01743027|11741775|FG000|STARTED|Overall Study||98
10585730|NCT01743027|11741776|FG001|STARTED|Overall Study||99
10585731|NCT01743027|11741777|FG002|STARTED|Overall Study||99
10585732|NCT01743027|11741778|FG003|STARTED|Overall Study||49
10585733|NCT01743027|11741775|FG000|COMPLETED|Overall Study||93
10585734|NCT01743027|11741776|FG001|COMPLETED|Overall Study||94
10585735|NCT01743027|11741777|FG002|COMPLETED|Overall Study||90
10585736|NCT01743027|11741778|FG003|COMPLETED|Overall Study||48
10585737|NCT01743027|11741775|FG000|NOT COMPLETED|Overall Study||5
10585738|NCT01743027|11741776|FG001|NOT COMPLETED|Overall Study||5
10585739|NCT01743027|11741777|FG002|NOT COMPLETED|Overall Study||9
10585740|NCT01743027|11741778|FG003|NOT COMPLETED|Overall Study||1
10585741|NCT01743040|11741788|FG000|STARTED|Overall Study||1014
10585742|NCT01743040|11741788|FG000|CADence Testing|Overall Study||1013
10585743|NCT01743040|11741788|FG000|Nuclear Stress Test|Overall Study||992
10585744|NCT01743040|11741788|FG000|CT and/or Standard Angiogram|Overall Study||785
10585745|NCT01743040|11741788|FG000|COMPLETED|Overall Study||785
10585746|NCT01743040|11741788|FG000|NOT COMPLETED|Overall Study||229
10585747|NCT01743092|11741794|FG000|STARTED|Overall Study||33
10585748|NCT01743092|11741795|FG001|STARTED|Overall Study||26
10585749|NCT01743092|11741794|FG000|COMPLETED|Overall Study||19
10585750|NCT01743092|11741795|FG001|COMPLETED|Overall Study||11
10585751|NCT01743092|11741794|FG000|NOT COMPLETED|Overall Study||14
10585752|NCT01743092|11741795|FG001|NOT COMPLETED|Overall Study||15
10585753|NCT01743131|11741805|FG000|STARTED|Overall Study||73
10585754|NCT01743131|11741806|FG001|STARTED|Overall Study||69
10585755|NCT01743131|11741807|FG002|STARTED|Overall Study||43
10585756|NCT01743131|11741808|FG003|STARTED|Overall Study||1
10806755|NCT03950622|11968360|FG000|Vaccinated|Overall Study||602
10806756|NCT03950622|11968361|FG001|Vaccinated|Overall Study||600
10585757|NCT01743131|11741809|FG004|STARTED|Overall Study||127
10585758|NCT01743131|11741805|FG000|Not Included in Analysis|Overall Study||0
10585759|NCT01743131|11741806|FG001|Not Included in Analysis|Overall Study||0
10585760|NCT01743131|11741807|FG002|Not Included in Analysis|Overall Study||0
10585761|NCT01743131|11741808|FG003|Not Included in Analysis|Overall Study||1
10585762|NCT01743131|11741809|FG004|Not Included in Analysis|Overall Study||0
10585763|NCT01743131|11741805|FG000|COMPLETED|Overall Study||73
10585764|NCT01743131|11741806|FG001|COMPLETED|Overall Study||69
10585765|NCT01743131|11741807|FG002|COMPLETED|Overall Study||43
10585766|NCT01743131|11741808|FG003|COMPLETED|Overall Study||1
10585767|NCT01743131|11741809|FG004|COMPLETED|Overall Study||127
10585768|NCT01743131|11741805|FG000|NOT COMPLETED|Overall Study||0
10585769|NCT01743131|11741806|FG001|NOT COMPLETED|Overall Study||0
10585770|NCT01743131|11741807|FG002|NOT COMPLETED|Overall Study||0
10585771|NCT01743131|11741808|FG003|NOT COMPLETED|Overall Study||0
10585772|NCT01743131|11741809|FG004|NOT COMPLETED|Overall Study||0
10585773|NCT01743469|11741822|FG000|STARTED|Active Treatment Phase||53
10585774|NCT01743469|11741823|FG001|STARTED|Active Treatment Phase||55
10585775|NCT01743469|11741824|FG002|STARTED|Active Treatment Phase||38
10585776|NCT01743469|11741825|FG003|STARTED|Active Treatment Phase||21
10585777|NCT01743469|11741822|FG000|COMPLETED|Active Treatment Phase||0
10585778|NCT01743469|11741823|FG001|COMPLETED|Active Treatment Phase||0
10585779|NCT01743469|11741824|FG002|COMPLETED|Active Treatment Phase||0
10585780|NCT01743469|11741825|FG003|COMPLETED|Active Treatment Phase||0
10585781|NCT01743469|11741822|FG000|NOT COMPLETED|Active Treatment Phase||53
10585782|NCT01743469|11741823|FG001|NOT COMPLETED|Active Treatment Phase||55
10585783|NCT01743469|11741824|FG002|NOT COMPLETED|Active Treatment Phase||38
10585784|NCT01743469|11741825|FG003|NOT COMPLETED|Active Treatment Phase||21
10585785|NCT01743469|11741822|FG000|STARTED|Follow-up Period - Post-Treatment||51
10585786|NCT01743469|11741823|FG001|STARTED|Follow-up Period - Post-Treatment||53
10585787|NCT01743469|11741824|FG002|STARTED|Follow-up Period - Post-Treatment||37
10585788|NCT01743469|11741825|FG003|STARTED|Follow-up Period - Post-Treatment||21
10585789|NCT01743469|11741822|FG000|COMPLETED|Follow-up Period - Post-Treatment||6
10585790|NCT01743469|11741823|FG001|COMPLETED|Follow-up Period - Post-Treatment||5
10585791|NCT01743469|11741824|FG002|COMPLETED|Follow-up Period - Post-Treatment||14
10585792|NCT01743469|11741825|FG003|COMPLETED|Follow-up Period - Post-Treatment||5
10585793|NCT01743469|11741822|FG000|NOT COMPLETED|Follow-up Period - Post-Treatment||45
10585794|NCT01743469|11741823|FG001|NOT COMPLETED|Follow-up Period - Post-Treatment||48
10585795|NCT01743469|11741824|FG002|NOT COMPLETED|Follow-up Period - Post-Treatment||23
10585796|NCT01743469|11741825|FG003|NOT COMPLETED|Follow-up Period - Post-Treatment||16
10585797|NCT01743521|11741839|FG000|STARTED|Overall Study||7
10585798|NCT01743521|11741840|FG001|STARTED|Overall Study||3
10585799|NCT01743521|11741841|FG002|STARTED|Overall Study||2
10585800|NCT01743521|11741842|FG003|STARTED|Overall Study||2
10585801|NCT01743521|11741839|FG000|COMPLETED|Overall Study||7
10585802|NCT01743521|11741840|FG001|COMPLETED|Overall Study||3
10585803|NCT01743521|11741841|FG002|COMPLETED|Overall Study||2
10585804|NCT01743521|11741842|FG003|COMPLETED|Overall Study||2
10585805|NCT01743521|11741839|FG000|NOT COMPLETED|Overall Study||0
10585806|NCT01743521|11741840|FG001|NOT COMPLETED|Overall Study||0
10585807|NCT01743521|11741841|FG002|NOT COMPLETED|Overall Study||0
10585808|NCT01743521|11741842|FG003|NOT COMPLETED|Overall Study||0
10585809|NCT01743560|11741850|FG000|STARTED|Overall Study||52
10585810|NCT01743560|11741850|FG000|Full Analysis Set (FAS)|Overall Study|≥ 1 dose study drug|49
10585811|NCT01743560|11741850|FG000|Safety Analysis Set (SAF)|Overall Study|≥ 1 dose study drug +1 post baseline safety assessment|49
10585812|NCT01743560|11741850|FG000|COMPLETED|Overall Study||9
10585813|NCT01743560|11741850|FG000|NOT COMPLETED|Overall Study||43
10585814|NCT01743677|11741863|FG000|STARTED|First Intervention Period||10
10585815|NCT01743677|11741864|FG001|STARTED|First Intervention Period||10
10585816|NCT01743677|11741865|FG002|STARTED|First Intervention Period||10
10585817|NCT01743677|11741866|FG003|STARTED|First Intervention Period||10
10585818|NCT01743677|11741867|FG004|STARTED|First Intervention Period||10
10585819|NCT01743677|11741868|FG005|STARTED|First Intervention Period||10
10585820|NCT01743677|11741863|FG000|COMPLETED|First Intervention Period||10
10585821|NCT01743677|11741864|FG001|COMPLETED|First Intervention Period||10
10585822|NCT01743677|11741865|FG002|COMPLETED|First Intervention Period||10
10585823|NCT01743677|11741866|FG003|COMPLETED|First Intervention Period||10
10585824|NCT01743677|11741867|FG004|COMPLETED|First Intervention Period||10
10585825|NCT01743677|11741868|FG005|COMPLETED|First Intervention Period||10
10585826|NCT01743677|11741863|FG000|NOT COMPLETED|First Intervention Period||0
10806757|NCT03950622|11968360|FG000|COMPLETED|Overall Study||596
10806758|NCT03950622|11968361|FG001|COMPLETED|Overall Study||594
10806759|NCT03950622|11968360|FG000|NOT COMPLETED|Overall Study||8
10806760|NCT03950622|11968361|FG001|NOT COMPLETED|Overall Study||7
10806761|NCT03949621|11968369|FG000|STARTED|Overall Study||12
10806762|NCT03949621|11968370|FG001|STARTED|Overall Study||12
10806763|NCT03949621|11968369|FG000|COMPLETED|Overall Study||12
10806764|NCT03949621|11968370|FG001|COMPLETED|Overall Study||12
10806765|NCT03949621|11968369|FG000|NOT COMPLETED|Overall Study||0
10806766|NCT03949621|11968370|FG001|NOT COMPLETED|Overall Study||0
10806767|NCT03949244|11968379|FG000|STARTED|Overall Study||12
10806768|NCT03949244|11968380|FG001|STARTED|Overall Study||21
10806769|NCT03949244|11968381|FG002|STARTED|Overall Study||14
10806770|NCT03949244|11968379|FG000|COMPLETED|Overall Study||12
10806771|NCT03949244|11968380|FG001|COMPLETED|Overall Study||21
10806772|NCT03949244|11968381|FG002|COMPLETED|Overall Study||14
10806773|NCT03949244|11968379|FG000|NOT COMPLETED|Overall Study||0
10806774|NCT03949244|11968380|FG001|NOT COMPLETED|Overall Study||0
10806775|NCT03949244|11968381|FG002|NOT COMPLETED|Overall Study||0
10585827|NCT01743677|11741864|FG001|NOT COMPLETED|First Intervention Period||0
10806782|NCT03948386|11968401|FG000|STARTED|Overall Study||52
10806783|NCT03948386|11968402|FG001|STARTED|Overall Study||54
10806784|NCT03948386|11968403|FG002|STARTED|Overall Study||53
10806785|NCT03948386|11968401|FG000|COMPLETED|Overall Study||51
10806786|NCT03948386|11968402|FG001|COMPLETED|Overall Study||53
10806787|NCT03948386|11968403|FG002|COMPLETED|Overall Study||50
10585828|NCT01743677|11741865|FG002|NOT COMPLETED|First Intervention Period||0
10585829|NCT01743677|11741866|FG003|NOT COMPLETED|First Intervention Period||0
10585830|NCT01743677|11741867|FG004|NOT COMPLETED|First Intervention Period||0
10806788|NCT03948386|11968401|FG000|NOT COMPLETED|Overall Study||1
10585831|NCT01743677|11741868|FG005|NOT COMPLETED|First Intervention Period||0
10585832|NCT01743677|11741863|FG000|STARTED|Washout Period 1 (at Least 7 Days)||10
10585833|NCT01743677|11741864|FG001|STARTED|Washout Period 1 (at Least 7 Days)||10
10585834|NCT01743677|11741865|FG002|STARTED|Washout Period 1 (at Least 7 Days)||10
10585835|NCT01743677|11741866|FG003|STARTED|Washout Period 1 (at Least 7 Days)||10
10585836|NCT01743677|11741867|FG004|STARTED|Washout Period 1 (at Least 7 Days)||10
10585837|NCT01743677|11741868|FG005|STARTED|Washout Period 1 (at Least 7 Days)||10
10585838|NCT01743677|11741863|FG000|COMPLETED|Washout Period 1 (at Least 7 Days)||10
10585839|NCT01743677|11741864|FG001|COMPLETED|Washout Period 1 (at Least 7 Days)||10
10585840|NCT01743677|11741865|FG002|COMPLETED|Washout Period 1 (at Least 7 Days)||10
10585841|NCT01743677|11741866|FG003|COMPLETED|Washout Period 1 (at Least 7 Days)||10
10585842|NCT01743677|11741867|FG004|COMPLETED|Washout Period 1 (at Least 7 Days)||10
10585843|NCT01743677|11741868|FG005|COMPLETED|Washout Period 1 (at Least 7 Days)||10
10585844|NCT01743677|11741863|FG000|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
10585845|NCT01743677|11741864|FG001|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
10585846|NCT01743677|11741865|FG002|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
10585847|NCT01743677|11741866|FG003|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
10585848|NCT01743677|11741867|FG004|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
10585849|NCT01743677|11741868|FG005|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
10585850|NCT01743677|11741863|FG000|STARTED|Second Intervention Period||10
10585851|NCT01743677|11741864|FG001|STARTED|Second Intervention Period||10
10585852|NCT01743677|11741865|FG002|STARTED|Second Intervention Period||10
10585853|NCT01743677|11741866|FG003|STARTED|Second Intervention Period||10
10585854|NCT01743677|11741867|FG004|STARTED|Second Intervention Period||10
10585855|NCT01743677|11741868|FG005|STARTED|Second Intervention Period||10
10585856|NCT01743677|11741863|FG000|COMPLETED|Second Intervention Period||10
10585857|NCT01743677|11741864|FG001|COMPLETED|Second Intervention Period||10
10585858|NCT01743677|11741865|FG002|COMPLETED|Second Intervention Period||10
10585859|NCT01743677|11741866|FG003|COMPLETED|Second Intervention Period||10
10585860|NCT01743677|11741867|FG004|COMPLETED|Second Intervention Period||10
10585861|NCT01743677|11741868|FG005|COMPLETED|Second Intervention Period||10
10585862|NCT01743677|11741863|FG000|NOT COMPLETED|Second Intervention Period||0
10585863|NCT01743677|11741864|FG001|NOT COMPLETED|Second Intervention Period||0
10585864|NCT01743677|11741865|FG002|NOT COMPLETED|Second Intervention Period||0
10585865|NCT01743677|11741866|FG003|NOT COMPLETED|Second Intervention Period||0
10585866|NCT01743677|11741867|FG004|NOT COMPLETED|Second Intervention Period||0
10585867|NCT01743677|11741868|FG005|NOT COMPLETED|Second Intervention Period||0
10585868|NCT01743677|11741863|FG000|STARTED|Washout Period 2 (at Least 7 Days)||10
10585869|NCT01743677|11741864|FG001|STARTED|Washout Period 2 (at Least 7 Days)||10
10585870|NCT01743677|11741865|FG002|STARTED|Washout Period 2 (at Least 7 Days)||10
10585871|NCT01743677|11741866|FG003|STARTED|Washout Period 2 (at Least 7 Days)||10
10585872|NCT01743677|11741867|FG004|STARTED|Washout Period 2 (at Least 7 Days)||10
10585873|NCT01743677|11741868|FG005|STARTED|Washout Period 2 (at Least 7 Days)||10
10585874|NCT01743677|11741863|FG000|COMPLETED|Washout Period 2 (at Least 7 Days)||10
10585875|NCT01743677|11741864|FG001|COMPLETED|Washout Period 2 (at Least 7 Days)||10
10585876|NCT01743677|11741865|FG002|COMPLETED|Washout Period 2 (at Least 7 Days)||10
10585877|NCT01743677|11741866|FG003|COMPLETED|Washout Period 2 (at Least 7 Days)||10
10585878|NCT01743677|11741867|FG004|COMPLETED|Washout Period 2 (at Least 7 Days)||10
10585879|NCT01743677|11741868|FG005|COMPLETED|Washout Period 2 (at Least 7 Days)||10
10585880|NCT01743677|11741863|FG000|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
10585881|NCT01743677|11741864|FG001|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
10585882|NCT01743677|11741865|FG002|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
10585883|NCT01743677|11741866|FG003|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
10585884|NCT01743677|11741867|FG004|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
10585885|NCT01743677|11741868|FG005|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
10585886|NCT01743677|11741863|FG000|STARTED|Third Intervention Period||10
10585887|NCT01743677|11741864|FG001|STARTED|Third Intervention Period||10
10585888|NCT01743677|11741865|FG002|STARTED|Third Intervention Period||10
10585889|NCT01743677|11741866|FG003|STARTED|Third Intervention Period||10
10585890|NCT01743677|11741867|FG004|STARTED|Third Intervention Period||10
10585891|NCT01743677|11741868|FG005|STARTED|Third Intervention Period||10
10585892|NCT01743677|11741863|FG000|COMPLETED|Third Intervention Period||10
10585893|NCT01743677|11741864|FG001|COMPLETED|Third Intervention Period||10
10585894|NCT01743677|11741865|FG002|COMPLETED|Third Intervention Period||10
10585895|NCT01743677|11741866|FG003|COMPLETED|Third Intervention Period||10
10585896|NCT01743677|11741867|FG004|COMPLETED|Third Intervention Period||10
10585897|NCT01743677|11741868|FG005|COMPLETED|Third Intervention Period||10
10585898|NCT01743677|11741863|FG000|NOT COMPLETED|Third Intervention Period||0
10585899|NCT01743677|11741864|FG001|NOT COMPLETED|Third Intervention Period||0
10585900|NCT01743677|11741865|FG002|NOT COMPLETED|Third Intervention Period||0
10585901|NCT01743677|11741866|FG003|NOT COMPLETED|Third Intervention Period||0
10585902|NCT01743677|11741867|FG004|NOT COMPLETED|Third Intervention Period||0
10585903|NCT01743677|11741868|FG005|NOT COMPLETED|Third Intervention Period||0
10585904|NCT01743729|11741880|FG000|STARTED|Overall Study|One participant from placebo arm included in Lifitegrast arm for safety analysis set (N=359).|358
10585905|NCT01743729|11741881|FG001|STARTED|Overall Study|One placebo participant was considered for Lifitegrast arm; Placebo safety analysis set (N= 359).|360
10585906|NCT01743729|11741880|FG000|COMPLETED|Overall Study||321
10585907|NCT01743729|11741881|FG001|COMPLETED|Overall Study||348
10585908|NCT01743729|11741880|FG000|NOT COMPLETED|Overall Study||37
10585909|NCT01743729|11741881|FG001|NOT COMPLETED|Overall Study||12
10585910|NCT01743859|11741887|FG000|STARTED|Overall Study||37
10585911|NCT01743859|11741887|FG000|COMPLETED|Overall Study||28
10585912|NCT01743859|11741887|FG000|NOT COMPLETED|Overall Study||9
10585913|NCT01743963|11741893|FG000|STARTED|Overall Study||21
10585914|NCT01743963|11741894|FG001|STARTED|Overall Study||17
10585915|NCT01743963|11741893|FG000|COMPLETED|Overall Study||21
10585916|NCT01743963|11741894|FG001|COMPLETED|Overall Study||17
10585917|NCT01743963|11741893|FG000|NOT COMPLETED|Overall Study||0
10585918|NCT01743963|11741894|FG001|NOT COMPLETED|Overall Study||0
10585919|NCT01743976|11741902|FG000|STARTED|Overall Study||2
10585920|NCT01743976|11741903|FG001|STARTED|Overall Study||3
10585921|NCT01743976|11741902|FG000|COMPLETED|Overall Study||2
10585922|NCT01743976|11741903|FG001|COMPLETED|Overall Study||3
10585923|NCT01743976|11741902|FG000|NOT COMPLETED|Overall Study||0
10585924|NCT01743976|11741903|FG001|NOT COMPLETED|Overall Study||0
10585925|NCT01743989|11741912|FG000|STARTED|Treatment Phase||120
10585926|NCT01743989|11741913|FG001|STARTED|Treatment Phase||119
10585927|NCT01743989|11741914|FG002|STARTED|Treatment Phase||381
10585928|NCT01743989|11741912|FG000|Participants Who Signed Informed Consent|Treatment Phase||120
10585929|NCT01743989|11741913|FG001|Participants Who Signed Informed Consent|Treatment Phase||118
10585930|NCT01743989|11741914|FG002|Participants Who Signed Informed Consent|Treatment Phase||381
10585931|NCT01743989|11741912|FG000|COMPLETED|Treatment Phase||119
10585932|NCT01743989|11741913|FG001|COMPLETED|Treatment Phase||104
10585933|NCT01743989|11741914|FG002|COMPLETED|Treatment Phase||0
10585934|NCT01743989|11741912|FG000|NOT COMPLETED|Treatment Phase||1
10585935|NCT01743989|11741913|FG001|NOT COMPLETED|Treatment Phase||15
10585936|NCT01743989|11741914|FG002|NOT COMPLETED|Treatment Phase||381
10585937|NCT01743989|11741912|FG000|STARTED|TFR Phase||119
10585938|NCT01743989|11741913|FG001|STARTED|TFR Phase||104
10585939|NCT01743989|11741914|FG002|STARTED|TFR Phase||0
10585940|NCT01743989|11741912|FG000|COMPLETED|TFR Phase||37
10703036|NCT02580591|11867576|FG001|COMPLETED|Overall Study||232
10703037|NCT02580591|11867577|FG002|COMPLETED|Overall Study||235
10703038|NCT02580591|11867578|FG003|COMPLETED|Overall Study||233
10703039|NCT02580591|11867575|FG000|NOT COMPLETED|Overall Study||18
10703040|NCT02580591|11867576|FG001|NOT COMPLETED|Overall Study||10
10703041|NCT02580591|11867577|FG002|NOT COMPLETED|Overall Study||13
10703042|NCT02580591|11867578|FG003|NOT COMPLETED|Overall Study||12
10703043|NCT02580799|11867588|FG000|STARTED|Overall Study||30
10806789|NCT03948386|11968402|FG001|NOT COMPLETED|Overall Study||1
10806790|NCT03948386|11968403|FG002|NOT COMPLETED|Overall Study||3
10806791|NCT03948334|11968413|FG000|STARTED|Overall Study||60
10806792|NCT03948334|11968414|FG001|STARTED|Overall Study||63
10806793|NCT03948334|11968413|FG000|COMPLETED|Overall Study||0
10806794|NCT03948334|11968414|FG001|COMPLETED|Overall Study||0
10806795|NCT03948334|11968413|FG000|NOT COMPLETED|Overall Study||60
10806796|NCT03948334|11968414|FG001|NOT COMPLETED|Overall Study||63
10806797|NCT03946059|11968430|FG000|STARTED|Overall Study||13
10585941|NCT01743989|11741913|FG001|COMPLETED|TFR Phase||36
10585942|NCT01743989|11741914|FG002|COMPLETED|TFR Phase||0
10585943|NCT01743989|11741912|FG000|NOT COMPLETED|TFR Phase||82
10585944|NCT01743989|11741913|FG001|NOT COMPLETED|TFR Phase||68
10585945|NCT01743989|11741914|FG002|NOT COMPLETED|TFR Phase||0
10585946|NCT01743989|11741912|FG000|STARTED|Re-treatment Phase||74
10585947|NCT01743989|11741913|FG001|STARTED|Re-treatment Phase||55
10585948|NCT01743989|11741914|FG002|STARTED|Re-treatment Phase||0
10585949|NCT01743989|11741912|FG000|COMPLETED|Re-treatment Phase||58
10585950|NCT01743989|11741913|FG001|COMPLETED|Re-treatment Phase||46
10585951|NCT01743989|11741914|FG002|COMPLETED|Re-treatment Phase||0
10585952|NCT01743989|11741912|FG000|NOT COMPLETED|Re-treatment Phase||16
10585953|NCT01743989|11741913|FG001|NOT COMPLETED|Re-treatment Phase||9
10703044|NCT02580799|11867588|FG000|COMPLETED|Overall Study||30
10703045|NCT02580799|11867588|FG000|NOT COMPLETED|Overall Study||0
10703046|NCT02580877|11867594|FG000|STARTED|Overall Study||45
10703047|NCT02580877|11867595|FG001|STARTED|Overall Study||47
10703048|NCT02580877|11867594|FG000|COMPLETED|Overall Study||44
10703049|NCT02580877|11867595|FG001|COMPLETED|Overall Study||43
10703050|NCT02580877|11867594|FG000|NOT COMPLETED|Overall Study||1
10703051|NCT02580877|11867595|FG001|NOT COMPLETED|Overall Study||4
10703052|NCT02581111|11867604|FG000|STARTED|Overall Study||98
10585954|NCT01743989|11741914|FG002|NOT COMPLETED|Re-treatment Phase||0
10585955|NCT01744197|11741927|FG000|STARTED|Overall Study||32
10703053|NCT02581111|11867605|FG001|STARTED|Overall Study||101
10703054|NCT02581111|11867604|FG000|COMPLETED|Overall Study||96
10703055|NCT02581111|11867605|FG001|COMPLETED|Overall Study||94
10703056|NCT02581111|11867604|FG000|NOT COMPLETED|Overall Study||2
10703057|NCT02581111|11867605|FG001|NOT COMPLETED|Overall Study||7
10703058|NCT02581163|11867611|FG000|STARTED|Overall Study||311
10703059|NCT02581163|11867611|FG000|COMPLETED|Overall Study||282
10703060|NCT02581163|11867611|FG000|NOT COMPLETED|Overall Study||29
10703061|NCT02581189|11867618|FG000|STARTED|Overall Study||534
10703062|NCT02581189|11867618|FG000|COMPLETED|Overall Study||481
10806798|NCT03946059|11968431|FG001|STARTED|Overall Study||12
10806799|NCT03946059|11968430|FG000|COMPLETED|Overall Study||13
10806800|NCT03946059|11968431|FG001|COMPLETED|Overall Study||11
10585956|NCT01744197|11741928|FG001|STARTED|Overall Study||29
10585957|NCT01744197|11741927|FG000|COMPLETED|Overall Study||28
10585958|NCT01744197|11741928|FG001|COMPLETED|Overall Study||26
10585959|NCT01744197|11741927|FG000|NOT COMPLETED|Overall Study||4
10585960|NCT01744197|11741928|FG001|NOT COMPLETED|Overall Study||3
10585961|NCT01744340|11741936|FG000|STARTED|Overall Study||8
10585962|NCT01744340|11741937|FG001|STARTED|Overall Study||15
10585963|NCT01744340|11741936|FG000|COMPLETED|Overall Study||8
10585964|NCT01744340|11741937|FG001|COMPLETED|Overall Study||15
10585965|NCT01744340|11741936|FG000|NOT COMPLETED|Overall Study||0
10585966|NCT01744340|11741937|FG001|NOT COMPLETED|Overall Study||0
10585967|NCT01744353|11741946|FG000|STARTED|Overall Study||6
10585968|NCT01744353|11741947|FG001|STARTED|Overall Study||26
10585969|NCT01744353|11741948|FG002|STARTED|Overall Study||3
10585970|NCT01744353|11741946|FG000|COMPLETED|Overall Study||6
10585971|NCT01744353|11741947|FG001|COMPLETED|Overall Study||26
10585972|NCT01744353|11741948|FG002|COMPLETED|Overall Study||3
10585973|NCT01744353|11741946|FG000|NOT COMPLETED|Overall Study||0
10585974|NCT01744353|11741947|FG001|NOT COMPLETED|Overall Study||0
10585975|NCT01744353|11741948|FG002|NOT COMPLETED|Overall Study||0
10585976|NCT01744392|11741954|FG000|STARTED|Overall Study||23
10585977|NCT01744392|11741954|FG000|COMPLETED|Overall Study||22
10585978|NCT01744392|11741954|FG000|NOT COMPLETED|Overall Study||1
10585979|NCT01744483|11741962|FG000|STARTED|Overall Study||44
10585980|NCT01744483|11741963|FG001|STARTED|Overall Study||35
10585981|NCT01744483|11741964|FG002|STARTED|Overall Study||38
10585982|NCT01744483|11741962|FG000|COMPLETED|Overall Study||15
10585983|NCT01744483|11741963|FG001|COMPLETED|Overall Study||13
10585984|NCT01744483|11741964|FG002|COMPLETED|Overall Study||10
10585985|NCT01744483|11741962|FG000|NOT COMPLETED|Overall Study||29
10585986|NCT01744483|11741963|FG001|NOT COMPLETED|Overall Study||22
10585987|NCT01744483|11741964|FG002|NOT COMPLETED|Overall Study||28
10585988|NCT01744496|11741974|FG000|STARTED|Titration Period||33
10585989|NCT01744496|11741975|FG001|STARTED|Titration Period||35
10585990|NCT01744496|11741974|FG000|COMPLETED|Titration Period||31
10585991|NCT01744496|11741975|FG001|COMPLETED|Titration Period||33
10585992|NCT01744496|11741974|FG000|NOT COMPLETED|Titration Period||2
10585993|NCT01744496|11741975|FG001|NOT COMPLETED|Titration Period||2
10585994|NCT01744496|11741974|FG000|STARTED|Maintenance Period||31
10585995|NCT01744496|11741975|FG001|STARTED|Maintenance Period||33
10585996|NCT01744496|11741974|FG000|COMPLETED|Maintenance Period||27
10585997|NCT01744496|11741975|FG001|COMPLETED|Maintenance Period||29
10585998|NCT01744496|11741974|FG000|NOT COMPLETED|Maintenance Period||4
10585999|NCT01744496|11741975|FG001|NOT COMPLETED|Maintenance Period||4
10586000|NCT01744574|11741985|FG000|STARTED|Overall Study||57
10586001|NCT01744574|11741986|FG001|STARTED|Overall Study||56
10586002|NCT01744574|11741987|FG002|STARTED|Overall Study||52
10586003|NCT01744574|11741988|FG003|STARTED|Overall Study||51
10586004|NCT01744574|11741985|FG000|COMPLETED|Overall Study||33
10586005|NCT01744574|11741986|FG001|COMPLETED|Overall Study||31
10586006|NCT01744574|11741987|FG002|COMPLETED|Overall Study||32
10586007|NCT01744574|11741988|FG003|COMPLETED|Overall Study||40
10586008|NCT01744574|11741985|FG000|NOT COMPLETED|Overall Study||24
10586009|NCT01744574|11741986|FG001|NOT COMPLETED|Overall Study||25
10586010|NCT01744574|11741987|FG002|NOT COMPLETED|Overall Study||20
10586011|NCT01744574|11741988|FG003|NOT COMPLETED|Overall Study||11
10586012|NCT01744665|11741998|FG000|STARTED|Monitoring Phase||59
10586013|NCT01744665|11741998|FG000|COMPLETED|Monitoring Phase||41
10586014|NCT01744665|11741998|FG000|NOT COMPLETED|Monitoring Phase||18
10586015|NCT01744665|11741998|FG000|STARTED|Consolidation Phase||41
10586016|NCT01744665|11741998|FG000|COMPLETED|Consolidation Phase||22
10586017|NCT01744665|11741998|FG000|NOT COMPLETED|Consolidation Phase||19
10586018|NCT01744665|11741998|FG000|STARTED|Treatment Free Remission Phase||32
10586019|NCT01744665|11741998|FG000|COMPLETED|Treatment Free Remission Phase||32
10586020|NCT01744665|11741998|FG000|NOT COMPLETED|Treatment Free Remission Phase||0
10586021|NCT01744665|11741998|FG000|STARTED|Re-initiation Phase||17
10586022|NCT01744665|11741998|FG000|COMPLETED|Re-initiation Phase||4
10586023|NCT01744665|11741998|FG000|NOT COMPLETED|Re-initiation Phase||13
10586024|NCT01744691|11742005|FG000|STARTED|Overall Study|Participants who received study treatment|144
10586025|NCT01744691|11742005|FG000|COMPLETED|Overall Study|Participants who were on study treatment at the time of the primary analysis|101
10586026|NCT01744691|11742005|FG000|NOT COMPLETED|Overall Study||43
10586027|NCT01744704|11742021|FG000|STARTED|Overall Study||3
10586028|NCT01744704|11742022|FG001|STARTED|Overall Study||3
10586029|NCT01744704|11742023|FG002|STARTED|Overall Study||3
10586030|NCT01744704|11742024|FG003|STARTED|Overall Study||6
10586031|NCT01744704|11742025|FG004|STARTED|Overall Study||6
10586032|NCT01744704|11742026|FG005|STARTED|Overall Study||7
10586033|NCT01744704|11742027|FG006|STARTED|Overall Study||6
10586034|NCT01744704|11742028|FG007|STARTED|Overall Study||9
10586035|NCT01744704|11742029|FG008|STARTED|Overall Study||3
10586036|NCT01744704|11742030|FG009|STARTED|Overall Study||9
10586037|NCT01744704|11742031|FG010|STARTED|Overall Study||9
10586038|NCT01744704|11742032|FG011|STARTED|Overall Study||10
10586039|NCT01744704|11742021|FG000|COMPLETED|Overall Study||3
10586040|NCT01744704|11742022|FG001|COMPLETED|Overall Study||3
10586041|NCT01744704|11742023|FG002|COMPLETED|Overall Study||3
10586042|NCT01744704|11742024|FG003|COMPLETED|Overall Study||6
10586043|NCT01744704|11742025|FG004|COMPLETED|Overall Study||6
10586044|NCT01744704|11742026|FG005|COMPLETED|Overall Study||7
10586045|NCT01744704|11742027|FG006|COMPLETED|Overall Study||6
10586046|NCT01744704|11742028|FG007|COMPLETED|Overall Study||9
10586047|NCT01744704|11742029|FG008|COMPLETED|Overall Study||3
10586048|NCT01744704|11742030|FG009|COMPLETED|Overall Study||9
10586049|NCT01744704|11742031|FG010|COMPLETED|Overall Study||9
10586050|NCT01744704|11742032|FG011|COMPLETED|Overall Study||10
10586051|NCT01744704|11742021|FG000|NOT COMPLETED|Overall Study||0
10586052|NCT01744704|11742022|FG001|NOT COMPLETED|Overall Study||0
10586053|NCT01744704|11742023|FG002|NOT COMPLETED|Overall Study||0
10586054|NCT01744704|11742024|FG003|NOT COMPLETED|Overall Study||0
10586055|NCT01744704|11742025|FG004|NOT COMPLETED|Overall Study||0
10586056|NCT01744704|11742026|FG005|NOT COMPLETED|Overall Study||0
10586057|NCT01744704|11742027|FG006|NOT COMPLETED|Overall Study||0
10586058|NCT01744704|11742028|FG007|NOT COMPLETED|Overall Study||0
10586059|NCT01744704|11742029|FG008|NOT COMPLETED|Overall Study||0
10586060|NCT01744704|11742030|FG009|NOT COMPLETED|Overall Study||0
10586061|NCT01744704|11742031|FG010|NOT COMPLETED|Overall Study||0
10586062|NCT01744704|11742032|FG011|NOT COMPLETED|Overall Study||0
10586063|NCT01744730|11742064|FG000|STARTED|Overall Study||4
10586064|NCT01744730|11742065|FG001|STARTED|Overall Study||3
10586065|NCT01744730|11742066|FG002|STARTED|Overall Study||4
10586066|NCT01744730|11742067|FG003|STARTED|Overall Study||11
10586067|NCT01744730|11742068|FG004|STARTED|Overall Study|Please note this study (NCT01431326) is ongoing and data only represents a subset of this study.|178
10586068|NCT01744730|11742064|FG000|COMPLETED|Overall Study||4
10586069|NCT01744730|11742065|FG001|COMPLETED|Overall Study||3
10586070|NCT01744730|11742066|FG002|COMPLETED|Overall Study||4
10586071|NCT01744730|11742067|FG003|COMPLETED|Overall Study||11
10586072|NCT01744730|11742068|FG004|COMPLETED|Overall Study|Please note this study (NCT01431326) is ongoing and data only represents a subset of this study.|178
10586073|NCT01744730|11742064|FG000|NOT COMPLETED|Overall Study||0
10586074|NCT01744730|11742065|FG001|NOT COMPLETED|Overall Study||0
10586075|NCT01744730|11742066|FG002|NOT COMPLETED|Overall Study||0
10586076|NCT01744730|11742067|FG003|NOT COMPLETED|Overall Study||0
10586077|NCT01744730|11742068|FG004|NOT COMPLETED|Overall Study||0
10586078|NCT01744782|11742081|FG000|STARTED|Overall Study||17
10586079|NCT01744782|11742081|FG000|COMPLETED|Overall Study||16
10586080|NCT01744782|11742081|FG000|NOT COMPLETED|Overall Study||1
10586081|NCT01744821|11742089|FG000|STARTED|Overall Study||1
10586082|NCT01744821|11742090|FG001|STARTED|Overall Study||3
10586083|NCT01744821|11742091|FG002|STARTED|Overall Study||2
10586084|NCT01744821|11742092|FG003|STARTED|Overall Study||1
10586085|NCT01744821|11742089|FG000|COMPLETED|Overall Study||1
10586086|NCT01744821|11742090|FG001|COMPLETED|Overall Study||3
10586087|NCT01744821|11742091|FG002|COMPLETED|Overall Study||2
10586088|NCT01744821|11742092|FG003|COMPLETED|Overall Study||1
10586089|NCT01744821|11742089|FG000|NOT COMPLETED|Overall Study||0
10586090|NCT01744821|11742090|FG001|NOT COMPLETED|Overall Study||0
10586091|NCT01744821|11742091|FG002|NOT COMPLETED|Overall Study||0
10586092|NCT01744821|11742092|FG003|NOT COMPLETED|Overall Study||0
10586093|NCT01744860|11742102|FG000|STARTED|Overall Study||420
10586094|NCT01744860|11742102|FG000|COMPLETED|Overall Study||420
10586095|NCT01744860|11742102|FG000|NOT COMPLETED|Overall Study||0
10586096|NCT01744977|11742116|FG000|STARTED|Overall Study||120
10586097|NCT01744977|11742117|FG001|STARTED|Overall Study||120
10586098|NCT01744977|11742116|FG000|6 Month Completed|Overall Study||113
10586099|NCT01744977|11742117|FG001|6 Month Completed|Overall Study||115
10586100|NCT01744977|11742116|FG000|COMPLETED|Overall Study||109
10586101|NCT01744977|11742117|FG001|COMPLETED|Overall Study||115
10586102|NCT01744977|11742116|FG000|NOT COMPLETED|Overall Study||11
10586103|NCT01744977|11742117|FG001|NOT COMPLETED|Overall Study||5
10586104|NCT01745055|11742123|FG000|STARTED|Overall Study||12
10586105|NCT01745055|11742123|FG000|COMPLETED|Overall Study||12
10586106|NCT01745055|11742123|FG000|NOT COMPLETED|Overall Study||0
10586107|NCT01745094|11742136|FG000|STARTED|Overall Study||35
10586108|NCT01745094|11742137|FG001|STARTED|Overall Study||37
10586109|NCT01745094|11742138|FG002|STARTED|Overall Study||58
10586110|NCT01745094|11742139|FG003|STARTED|Overall Study||93
10586111|NCT01745094|11742136|FG000|COMPLETED|Overall Study||30
10586112|NCT01745094|11742137|FG001|COMPLETED|Overall Study||37
10586113|NCT01745094|11742138|FG002|COMPLETED|Overall Study||46
10586114|NCT01745094|11742139|FG003|COMPLETED|Overall Study||90
10586115|NCT01745094|11742136|FG000|NOT COMPLETED|Overall Study||5
10586116|NCT01745094|11742137|FG001|NOT COMPLETED|Overall Study||0
10586117|NCT01745094|11742138|FG002|NOT COMPLETED|Overall Study||12
10586118|NCT01745094|11742139|FG003|NOT COMPLETED|Overall Study||3
10586119|NCT01745120|11742154|FG000|STARTED|Overall Study||11
10586120|NCT01745120|11742155|FG001|STARTED|Overall Study||8
10586121|NCT01745120|11742154|FG000|COMPLETED|Overall Study||10
10586122|NCT01745120|11742155|FG001|COMPLETED|Overall Study||8
10586123|NCT01745120|11742154|FG000|NOT COMPLETED|Overall Study||1
10586124|NCT01745120|11742155|FG001|NOT COMPLETED|Overall Study||0
10586125|NCT01745133|11742167|FG000|STARTED|Overall Study||19
10586126|NCT01745133|11742168|FG001|STARTED|Overall Study||20
10586127|NCT01745133|11742169|FG002|STARTED|Overall Study||19
10586128|NCT01745133|11742167|FG000|COMPLETED|Overall Study||13
10586129|NCT01745133|11742168|FG001|COMPLETED|Overall Study||16
10586130|NCT01745133|11742169|FG002|COMPLETED|Overall Study||15
10586131|NCT01745133|11742167|FG000|NOT COMPLETED|Overall Study||6
10586132|NCT01745133|11742168|FG001|NOT COMPLETED|Overall Study||4
10586133|NCT01745133|11742169|FG002|NOT COMPLETED|Overall Study||4
10586134|NCT01745146|11742179|FG000|STARTED|Overall Study||30
10586135|NCT01745146|11742180|FG001|STARTED|Overall Study||60
10586136|NCT01745146|11742179|FG000|Allocation to Intervention|Overall Study||30
10586137|NCT01745146|11742180|FG001|Allocation to Intervention|Overall Study||60
10586138|NCT01745146|11742179|FG000|Primary Outcome Assessment|Overall Study||27
10586139|NCT01745146|11742180|FG001|Primary Outcome Assessment|Overall Study||57
10586140|NCT01745146|11742179|FG000|Analysis|Overall Study||27
10586141|NCT01745146|11742180|FG001|Analysis|Overall Study||57
10806801|NCT03946059|11968430|FG000|NOT COMPLETED|Overall Study||0
10806802|NCT03946059|11968431|FG001|NOT COMPLETED|Overall Study||1
10806803|NCT03944707|11968441|FG000|STARTED|Overall Study||47
10806804|NCT03944707|11968442|FG001|STARTED|Overall Study||29
10806805|NCT03944707|11968441|FG000|PK Analysis Set|Overall Study||33
10806806|NCT03944707|11968442|FG001|PK Analysis Set|Overall Study||0
10586142|NCT01745146|11742179|FG000|COMPLETED|Overall Study||27
10586143|NCT01745146|11742180|FG001|COMPLETED|Overall Study||57
10586144|NCT01745146|11742179|FG000|NOT COMPLETED|Overall Study||3
10586145|NCT01745146|11742180|FG001|NOT COMPLETED|Overall Study||3
10586146|NCT01745211|11742187|FG000|STARTED|Overall Study||45
10586147|NCT01745211|11742187|FG000|COMPLETED|Overall Study||27
10586148|NCT01745211|11742187|FG000|NOT COMPLETED|Overall Study||18
10586149|NCT01745367|11742193|FG000|STARTED|Overall Study||8
10586150|NCT01745367|11742194|FG001|STARTED|Overall Study||22
10586151|NCT01745367|11742193|FG000|Treated|Overall Study||8
10586152|NCT01745367|11742194|FG001|Treated|Overall Study||21
10586153|NCT01745367|11742193|FG000|COMPLETED|Overall Study||0
10586154|NCT01745367|11742194|FG001|COMPLETED|Overall Study||0
10586155|NCT01745367|11742193|FG000|NOT COMPLETED|Overall Study||8
10586156|NCT01745367|11742194|FG001|NOT COMPLETED|Overall Study||22
10586157|NCT01745380|11742202|FG000|STARTED|Overall Study||100
10586158|NCT01745380|11742203|FG001|STARTED|Overall Study||50
10586159|NCT01745380|11742202|FG000|COMPLETED|Overall Study||99
10586160|NCT01745380|11742203|FG001|COMPLETED|Overall Study||49
10586161|NCT01745380|11742202|FG000|NOT COMPLETED|Overall Study||1
10586162|NCT01745380|11742203|FG001|NOT COMPLETED|Overall Study||1
10586163|NCT01745393|11742211|FG000|STARTED|Treatment to End-of-treatment Assessment||163
10586164|NCT01745393|11742212|FG001|STARTED|Treatment to End-of-treatment Assessment||164
10586165|NCT01745393|11742211|FG000|Received Treatment|Treatment to End-of-treatment Assessment|Behavioral counseling = TSE-reduction and cessation counseling via telephone|147
10586166|NCT01745393|11742212|FG001|Received Treatment|Treatment to End-of-treatment Assessment|Attention control = nutrition education via telephone|144
10586167|NCT01745393|11742211|FG000|COMPLETED|Treatment to End-of-treatment Assessment||142
10586168|NCT01745393|11742212|FG001|COMPLETED|Treatment to End-of-treatment Assessment||156
10586169|NCT01745393|11742211|FG000|NOT COMPLETED|Treatment to End-of-treatment Assessment||21
10586170|NCT01745393|11742212|FG001|NOT COMPLETED|Treatment to End-of-treatment Assessment||8
10586171|NCT01745393|11742211|FG000|STARTED|12-month Follow-up||142
10586172|NCT01745393|11742212|FG001|STARTED|12-month Follow-up||156
10586173|NCT01745393|11742211|FG000|COMPLETED|12-month Follow-up||136
10586174|NCT01745393|11742212|FG001|COMPLETED|12-month Follow-up||151
10586175|NCT01745393|11742211|FG000|NOT COMPLETED|12-month Follow-up||6
10586176|NCT01745393|11742212|FG001|NOT COMPLETED|12-month Follow-up||5
10586177|NCT01745627|11742218|FG000|STARTED|Overall Study||42
10586178|NCT01745627|11742218|FG000|COMPLETED|Overall Study||20
10586179|NCT01745627|11742218|FG000|NOT COMPLETED|Overall Study||22
10586180|NCT01745822|11742224|FG000|STARTED|Overall Study|168 mothers and 163 infants|331
10586181|NCT01745822|11742225|FG001|STARTED|Overall Study|163 mothers and 160 infants|323
10586182|NCT01745822|11742224|FG000|COMPLETED|Overall Study||331
10586183|NCT01745822|11742225|FG001|COMPLETED|Overall Study||323
10586184|NCT01745822|11742224|FG000|NOT COMPLETED|Overall Study||0
10586185|NCT01745822|11742225|FG001|NOT COMPLETED|Overall Study||0
10586186|NCT01745848|11742231|FG000|STARTED|Overall Study||26
10586187|NCT01745848|11742231|FG000|COMPLETED|Overall Study||20
10586188|NCT01745848|11742231|FG000|NOT COMPLETED|Overall Study||6
10586189|NCT01745952|11742235|FG000|STARTED|Overall Study||4
10586190|NCT01745952|11742236|FG001|STARTED|Overall Study||4
10586191|NCT01745952|11742237|FG002|STARTED|Overall Study||3
10586192|NCT01745952|11742235|FG000|COMPLETED|Overall Study||3
10586193|NCT01745952|11742236|FG001|COMPLETED|Overall Study|data of one patient not used due to no seizure diary entries on multiple occasions|3
10586194|NCT01745952|11742237|FG002|COMPLETED|Overall Study||3
10586195|NCT01745952|11742235|FG000|NOT COMPLETED|Overall Study||1
10586196|NCT01745952|11742236|FG001|NOT COMPLETED|Overall Study||1
10586197|NCT01745952|11742237|FG002|NOT COMPLETED|Overall Study||0
10586198|NCT01746017|11742262|FG000|STARTED|Period 1||2
10586199|NCT01746017|11742263|FG001|STARTED|Period 1||2
10586200|NCT01746017|11742264|FG002|STARTED|Period 1||2
10586201|NCT01746017|11742265|FG003|STARTED|Period 1||2
10586202|NCT01746017|11742266|FG004|STARTED|Period 1||2
10586203|NCT01746017|11742267|FG005|STARTED|Period 1||2
10586204|NCT01746017|11742268|FG006|STARTED|Period 1||3
10586205|NCT01746017|11742269|FG007|STARTED|Period 1||2
10586206|NCT01746017|11742270|FG008|STARTED|Period 1||3
10586207|NCT01746017|11742271|FG009|STARTED|Period 1||3
10586208|NCT01746017|11742272|FG010|STARTED|Period 1||3
10586209|NCT01746017|11742262|FG000|Received at Least 1 Dose of Study Drug|Period 1||2
10586210|NCT01746017|11742263|FG001|Received at Least 1 Dose of Study Drug|Period 1||2
10586211|NCT01746017|11742264|FG002|Received at Least 1 Dose of Study Drug|Period 1||2
10586212|NCT01746017|11742265|FG003|Received at Least 1 Dose of Study Drug|Period 1||2
10806807|NCT03944707|11968441|FG000|PD Analysis Set|Overall Study||47
10806808|NCT03944707|11968442|FG001|PD Analysis Set|Overall Study||29
10806809|NCT03944707|11968441|FG000|COMPLETED|Overall Study||35
10806810|NCT03944707|11968442|FG001|COMPLETED|Overall Study||19
10806811|NCT03944707|11968441|FG000|NOT COMPLETED|Overall Study||12
10586213|NCT01746017|11742266|FG004|Received at Least 1 Dose of Study Drug|Period 1||2
10586214|NCT01746017|11742267|FG005|Received at Least 1 Dose of Study Drug|Period 1||2
10586215|NCT01746017|11742268|FG006|Received at Least 1 Dose of Study Drug|Period 1||3
10651884|NCT02179398|11812129|FG001|NOT COMPLETED|Overall Study||4
10586216|NCT01746017|11742269|FG007|Received at Least 1 Dose of Study Drug|Period 1||2
10586217|NCT01746017|11742270|FG008|Received at Least 1 Dose of Study Drug|Period 1||3
10586218|NCT01746017|11742271|FG009|Received at Least 1 Dose of Study Drug|Period 1||3
10586219|NCT01746017|11742272|FG010|Received at Least 1 Dose of Study Drug|Period 1||3
10586220|NCT01746017|11742262|FG000|COMPLETED|Period 1||2
10586221|NCT01746017|11742263|FG001|COMPLETED|Period 1||2
10586222|NCT01746017|11742264|FG002|COMPLETED|Period 1||2
10586223|NCT01746017|11742265|FG003|COMPLETED|Period 1||2
10586224|NCT01746017|11742266|FG004|COMPLETED|Period 1||2
10586225|NCT01746017|11742267|FG005|COMPLETED|Period 1||2
10586226|NCT01746017|11742268|FG006|COMPLETED|Period 1||2
10586227|NCT01746017|11742269|FG007|COMPLETED|Period 1||2
10586228|NCT01746017|11742270|FG008|COMPLETED|Period 1||3
10586229|NCT01746017|11742271|FG009|COMPLETED|Period 1||3
10586230|NCT01746017|11742272|FG010|COMPLETED|Period 1||3
10586231|NCT01746017|11742262|FG000|NOT COMPLETED|Period 1||0
10586232|NCT01746017|11742263|FG001|NOT COMPLETED|Period 1||0
10586233|NCT01746017|11742264|FG002|NOT COMPLETED|Period 1||0
10586234|NCT01746017|11742265|FG003|NOT COMPLETED|Period 1||0
10586235|NCT01746017|11742266|FG004|NOT COMPLETED|Period 1||0
10586236|NCT01746017|11742267|FG005|NOT COMPLETED|Period 1||0
10586237|NCT01746017|11742268|FG006|NOT COMPLETED|Period 1||1
10586238|NCT01746017|11742269|FG007|NOT COMPLETED|Period 1||0
10586239|NCT01746017|11742270|FG008|NOT COMPLETED|Period 1||0
10586240|NCT01746017|11742271|FG009|NOT COMPLETED|Period 1||0
10586241|NCT01746017|11742272|FG010|NOT COMPLETED|Period 1||0
10586242|NCT01746017|11742262|FG000|STARTED|Period 2||2
10586243|NCT01746017|11742263|FG001|STARTED|Period 2||2
10586244|NCT01746017|11742264|FG002|STARTED|Period 2||2
10586245|NCT01746017|11742265|FG003|STARTED|Period 2||2
10586246|NCT01746017|11742266|FG004|STARTED|Period 2||2
10586247|NCT01746017|11742267|FG005|STARTED|Period 2||2
10586248|NCT01746017|11742268|FG006|STARTED|Period 2||2
10586249|NCT01746017|11742269|FG007|STARTED|Period 2||2
10586250|NCT01746017|11742270|FG008|STARTED|Period 2||3
10586251|NCT01746017|11742271|FG009|STARTED|Period 2||3
10586252|NCT01746017|11742272|FG010|STARTED|Period 2||3
10586253|NCT01746017|11742262|FG000|COMPLETED|Period 2||2
10586254|NCT01746017|11742263|FG001|COMPLETED|Period 2||2
10586255|NCT01746017|11742264|FG002|COMPLETED|Period 2||2
10586256|NCT01746017|11742265|FG003|COMPLETED|Period 2||2
10586257|NCT01746017|11742266|FG004|COMPLETED|Period 2||2
10586258|NCT01746017|11742267|FG005|COMPLETED|Period 2||2
10586259|NCT01746017|11742268|FG006|COMPLETED|Period 2||2
10586260|NCT01746017|11742269|FG007|COMPLETED|Period 2||2
10586261|NCT01746017|11742270|FG008|COMPLETED|Period 2||3
10586262|NCT01746017|11742271|FG009|COMPLETED|Period 2||3
10586263|NCT01746017|11742272|FG010|COMPLETED|Period 2||3
10586264|NCT01746017|11742262|FG000|NOT COMPLETED|Period 2||0
10586265|NCT01746017|11742263|FG001|NOT COMPLETED|Period 2||0
10586266|NCT01746017|11742264|FG002|NOT COMPLETED|Period 2||0
10586267|NCT01746017|11742265|FG003|NOT COMPLETED|Period 2||0
10586268|NCT01746017|11742266|FG004|NOT COMPLETED|Period 2||0
10586269|NCT01746017|11742267|FG005|NOT COMPLETED|Period 2||0
10586270|NCT01746017|11742268|FG006|NOT COMPLETED|Period 2||0
10586271|NCT01746017|11742269|FG007|NOT COMPLETED|Period 2||0
10586272|NCT01746017|11742270|FG008|NOT COMPLETED|Period 2||0
10586273|NCT01746017|11742271|FG009|NOT COMPLETED|Period 2||0
10586274|NCT01746017|11742272|FG010|NOT COMPLETED|Period 2||0
10586275|NCT01746017|11742262|FG000|STARTED|Period 3||2
10586276|NCT01746017|11742263|FG001|STARTED|Period 3||2
10586277|NCT01746017|11742264|FG002|STARTED|Period 3||2
10586278|NCT01746017|11742265|FG003|STARTED|Period 3||2
10586279|NCT01746017|11742266|FG004|STARTED|Period 3||2
10586280|NCT01746017|11742267|FG005|STARTED|Period 3||2
10586281|NCT01746017|11742268|FG006|STARTED|Period 3||2
10586282|NCT01746017|11742269|FG007|STARTED|Period 3||2
10586283|NCT01746017|11742270|FG008|STARTED|Period 3||3
10586284|NCT01746017|11742271|FG009|STARTED|Period 3||3
10586285|NCT01746017|11742272|FG010|STARTED|Period 3||3
10586286|NCT01746017|11742262|FG000|COMPLETED|Period 3||2
10586287|NCT01746017|11742263|FG001|COMPLETED|Period 3||2
10586288|NCT01746017|11742264|FG002|COMPLETED|Period 3||2
10586289|NCT01746017|11742265|FG003|COMPLETED|Period 3||2
10586290|NCT01746017|11742266|FG004|COMPLETED|Period 3||2
10586291|NCT01746017|11742267|FG005|COMPLETED|Period 3||1
10586292|NCT01746017|11742268|FG006|COMPLETED|Period 3||2
10586293|NCT01746017|11742269|FG007|COMPLETED|Period 3||2
10586294|NCT01746017|11742270|FG008|COMPLETED|Period 3||3
10586295|NCT01746017|11742271|FG009|COMPLETED|Period 3||3
10586296|NCT01746017|11742272|FG010|COMPLETED|Period 3||3
10586297|NCT01746017|11742262|FG000|NOT COMPLETED|Period 3||0
10586298|NCT01746017|11742263|FG001|NOT COMPLETED|Period 3||0
10586299|NCT01746017|11742264|FG002|NOT COMPLETED|Period 3||0
10586300|NCT01746017|11742265|FG003|NOT COMPLETED|Period 3||0
10586301|NCT01746017|11742266|FG004|NOT COMPLETED|Period 3||0
10586302|NCT01746017|11742267|FG005|NOT COMPLETED|Period 3||1
10586303|NCT01746017|11742268|FG006|NOT COMPLETED|Period 3||0
10586304|NCT01746017|11742269|FG007|NOT COMPLETED|Period 3||0
10586305|NCT01746017|11742270|FG008|NOT COMPLETED|Period 3||0
10586306|NCT01746017|11742271|FG009|NOT COMPLETED|Period 3||0
10586307|NCT01746017|11742272|FG010|NOT COMPLETED|Period 3||0
10586308|NCT01746017|11742262|FG000|STARTED|Period 4||2
10586309|NCT01746017|11742263|FG001|STARTED|Period 4||2
10586310|NCT01746017|11742264|FG002|STARTED|Period 4||2
10586311|NCT01746017|11742265|FG003|STARTED|Period 4||2
10586312|NCT01746017|11742266|FG004|STARTED|Period 4||2
10586313|NCT01746017|11742267|FG005|STARTED|Period 4||1
10586314|NCT01746017|11742268|FG006|STARTED|Period 4||2
10586315|NCT01746017|11742269|FG007|STARTED|Period 4||2
10586316|NCT01746017|11742270|FG008|STARTED|Period 4|Part B occurred only for 3 periods.|0
10586317|NCT01746017|11742271|FG009|STARTED|Period 4|Part B occurred only for 3 periods.|0
10586318|NCT01746017|11742272|FG010|STARTED|Period 4|Part B occurred only for 3 periods.|0
10586319|NCT01746017|11742262|FG000|COMPLETED|Period 4||2
10586320|NCT01746017|11742263|FG001|COMPLETED|Period 4||2
10586321|NCT01746017|11742264|FG002|COMPLETED|Period 4||2
10586322|NCT01746017|11742265|FG003|COMPLETED|Period 4||2
10586323|NCT01746017|11742266|FG004|COMPLETED|Period 4||2
10586324|NCT01746017|11742267|FG005|COMPLETED|Period 4||1
10586325|NCT01746017|11742268|FG006|COMPLETED|Period 4||2
10586326|NCT01746017|11742269|FG007|COMPLETED|Period 4||2
10586327|NCT01746017|11742270|FG008|COMPLETED|Period 4||0
10586328|NCT01746017|11742271|FG009|COMPLETED|Period 4||0
10586329|NCT01746017|11742272|FG010|COMPLETED|Period 4||0
10586330|NCT01746017|11742262|FG000|NOT COMPLETED|Period 4||0
10586331|NCT01746017|11742263|FG001|NOT COMPLETED|Period 4||0
10586332|NCT01746017|11742264|FG002|NOT COMPLETED|Period 4||0
10586333|NCT01746017|11742265|FG003|NOT COMPLETED|Period 4||0
10586334|NCT01746017|11742266|FG004|NOT COMPLETED|Period 4||0
10586335|NCT01746017|11742267|FG005|NOT COMPLETED|Period 4||0
10586336|NCT01746017|11742268|FG006|NOT COMPLETED|Period 4||0
10586337|NCT01746017|11742269|FG007|NOT COMPLETED|Period 4||0
10586338|NCT01746017|11742270|FG008|NOT COMPLETED|Period 4||0
10586339|NCT01746017|11742271|FG009|NOT COMPLETED|Period 4||0
10586340|NCT01746017|11742272|FG010|NOT COMPLETED|Period 4||0
10586341|NCT01746043|11742315|FG000|STARTED|Overall Study||5
10586342|NCT01746043|11742316|FG001|STARTED|Overall Study||4
10586343|NCT01746043|11742317|FG002|STARTED|Overall Study||5
10586344|NCT01746043|11742318|FG003|STARTED|Overall Study||5
10586345|NCT01746043|11742315|FG000|COMPLETED|Overall Study||5
10586346|NCT01746043|11742316|FG001|COMPLETED|Overall Study||4
10586347|NCT01746043|11742317|FG002|COMPLETED|Overall Study||5
10586348|NCT01746043|11742318|FG003|COMPLETED|Overall Study||5
10586349|NCT01746043|11742315|FG000|NOT COMPLETED|Overall Study||0
10586350|NCT01746043|11742316|FG001|NOT COMPLETED|Overall Study||0
10586351|NCT01746043|11742317|FG002|NOT COMPLETED|Overall Study||0
10586352|NCT01746043|11742318|FG003|NOT COMPLETED|Overall Study||0
10586353|NCT01746095|11742332|FG000|STARTED|Overall Study||20
10586354|NCT01746095|11742333|FG001|STARTED|Overall Study||20
10586355|NCT01746095|11742334|FG002|STARTED|Overall Study||24
10586356|NCT01746095|11742335|FG003|STARTED|Overall Study||23
10586357|NCT01746095|11742332|FG000|COMPLETED|Overall Study||16
10586358|NCT01746095|11742333|FG001|COMPLETED|Overall Study||16
10586359|NCT01746095|11742334|FG002|COMPLETED|Overall Study||11
10586360|NCT01746095|11742335|FG003|COMPLETED|Overall Study||15
10586361|NCT01746095|11742332|FG000|NOT COMPLETED|Overall Study||4
10586362|NCT01746095|11742333|FG001|NOT COMPLETED|Overall Study||4
10586363|NCT01746095|11742334|FG002|NOT COMPLETED|Overall Study||13
10586364|NCT01746095|11742335|FG003|NOT COMPLETED|Overall Study||8
10586365|NCT01746108|11742348|FG000|STARTED|Overall Study||18
10586366|NCT01746108|11742349|FG001|STARTED|Overall Study||28
10586367|NCT01746108|11742350|FG002|STARTED|Overall Study||6
10586368|NCT01746108|11742348|FG000|COMPLETED|Overall Study||18
10586369|NCT01746108|11742349|FG001|COMPLETED|Overall Study||24
10586370|NCT01746108|11742350|FG002|COMPLETED|Overall Study||6
10586371|NCT01746108|11742348|FG000|NOT COMPLETED|Overall Study||0
10586372|NCT01746108|11742349|FG001|NOT COMPLETED|Overall Study||4
10586373|NCT01746108|11742350|FG002|NOT COMPLETED|Overall Study||0
10586374|NCT01746225|11742369|FG000|STARTED|Overall Study||83
10586375|NCT01746225|11742370|FG001|STARTED|Overall Study||86
10586376|NCT01746225|11742371|FG002|STARTED|Overall Study||86
10586377|NCT01746225|11742369|FG000|COMPLETED|Overall Study||43
10586378|NCT01746225|11742370|FG001|COMPLETED|Overall Study||40
10586379|NCT01746225|11742371|FG002|COMPLETED|Overall Study||43
10586380|NCT01746225|11742369|FG000|NOT COMPLETED|Overall Study||40
10586381|NCT01746225|11742370|FG001|NOT COMPLETED|Overall Study||46
10586382|NCT01746225|11742371|FG002|NOT COMPLETED|Overall Study||43
10703063|NCT02581189|11867618|FG000|NOT COMPLETED|Overall Study||53
10703064|NCT02581202|11867625|FG000|STARTED|Overall Study||216
10703065|NCT02581202|11867625|FG000|COMPLETED|Overall Study||202
10703066|NCT02581202|11867625|FG000|NOT COMPLETED|Overall Study||14
10703067|NCT02581345|11867632|FG000|STARTED|Part 1: up to Week 16||286
10586383|NCT01746264|11742379|FG000|STARTED|Overall Study||19
10586384|NCT01746264|11742379|FG000|COMPLETED|Overall Study||19
10586385|NCT01746264|11742379|FG000|NOT COMPLETED|Overall Study||0
10586386|NCT01746368|11742385|FG000|STARTED|Overall Study||33
10586387|NCT01746368|11742386|FG001|STARTED|Overall Study||17
10586388|NCT01746368|11742385|FG000|Recieved Allocated Intervention|Overall Study||31
10586389|NCT01746368|11742386|FG001|Recieved Allocated Intervention|Overall Study||8
10586390|NCT01746368|11742385|FG000|Assessment Completed|Overall Study||31
10586391|NCT01746368|11742386|FG001|Assessment Completed|Overall Study||16
10586392|NCT01746368|11742385|FG000|Analyzed for AD Completion Rate|Overall Study||32
10586393|NCT01746368|11742386|FG001|Analyzed for AD Completion Rate|Overall Study||17
10586394|NCT01746368|11742385|FG000|Analyzed for Satisfaction|Overall Study||30
10586395|NCT01746368|11742386|FG001|Analyzed for Satisfaction|Overall Study||16
10586396|NCT01746368|11742385|FG000|COMPLETED|Overall Study||31
10586397|NCT01746368|11742386|FG001|COMPLETED|Overall Study||16
10586398|NCT01746368|11742385|FG000|NOT COMPLETED|Overall Study||2
10703068|NCT02581345|11867633|FG001|STARTED|Part 1: up to Week 16||286
10703069|NCT02581345|11867634|FG002|STARTED|Part 1: up to Week 16||0
10586399|NCT01746368|11742386|FG001|NOT COMPLETED|Overall Study||1
10586400|NCT01746420|11742397|FG000|STARTED|Overall Study||20
10586401|NCT01746420|11742398|FG001|STARTED|Overall Study||20
10586402|NCT01746420|11742399|FG002|STARTED|Overall Study||20
10586403|NCT01746420|11742400|FG003|STARTED|Overall Study||20
10586404|NCT01746420|11742401|FG004|STARTED|Overall Study||20
10586405|NCT01746420|11742397|FG000|COMPLETED|Overall Study||17
10586406|NCT01746420|11742398|FG001|COMPLETED|Overall Study||18
10586407|NCT01746420|11742399|FG002|COMPLETED|Overall Study||17
10586408|NCT01746420|11742400|FG003|COMPLETED|Overall Study||20
10586409|NCT01746420|11742401|FG004|COMPLETED|Overall Study||20
10586410|NCT01746420|11742397|FG000|NOT COMPLETED|Overall Study||3
10586411|NCT01746420|11742398|FG001|NOT COMPLETED|Overall Study||2
10586412|NCT01746420|11742399|FG002|NOT COMPLETED|Overall Study||3
10586413|NCT01746420|11742400|FG003|NOT COMPLETED|Overall Study||0
10586414|NCT01746420|11742401|FG004|NOT COMPLETED|Overall Study||0
10586415|NCT01746511|11742416|FG000|STARTED|Overall Study||40
10586416|NCT01746511|11742417|FG001|STARTED|Overall Study||39
10586417|NCT01746511|11742416|FG000|COMPLETED|Overall Study||40
10586418|NCT01746511|11742417|FG001|COMPLETED|Overall Study||39
10586419|NCT01746511|11742416|FG000|NOT COMPLETED|Overall Study||0
10586420|NCT01746511|11742417|FG001|NOT COMPLETED|Overall Study||0
10586421|NCT01746732|11742423|FG000|STARTED|Lead-In Period||23
10586422|NCT01746732|11742424|FG001|STARTED|Lead-In Period||0
10586423|NCT01746732|11742425|FG002|STARTED|Lead-In Period||0
10586424|NCT01746732|11742423|FG000|Participants Received at Least 1 Dose|Lead-In Period||22
10586425|NCT01746732|11742424|FG001|Participants Received at Least 1 Dose|Lead-In Period||0
10586426|NCT01746732|11742425|FG002|Participants Received at Least 1 Dose|Lead-In Period||0
10586427|NCT01746732|11742423|FG000|COMPLETED|Lead-In Period||22
10586428|NCT01746732|11742424|FG001|COMPLETED|Lead-In Period||0
10586429|NCT01746732|11742425|FG002|COMPLETED|Lead-In Period||0
10586430|NCT01746732|11742423|FG000|NOT COMPLETED|Lead-In Period||1
10586431|NCT01746732|11742424|FG001|NOT COMPLETED|Lead-In Period||0
10586432|NCT01746732|11742425|FG002|NOT COMPLETED|Lead-In Period||0
10586433|NCT01746732|11742423|FG000|STARTED|Period 1||0
10586434|NCT01746732|11742424|FG001|STARTED|Period 1||11
10586435|NCT01746732|11742425|FG002|STARTED|Period 1||11
10586436|NCT01746732|11742423|FG000|COMPLETED|Period 1||0
10586437|NCT01746732|11742424|FG001|COMPLETED|Period 1||10
10586438|NCT01746732|11742425|FG002|COMPLETED|Period 1||11
10586439|NCT01746732|11742423|FG000|NOT COMPLETED|Period 1||0
10586440|NCT01746732|11742424|FG001|NOT COMPLETED|Period 1||1
10586441|NCT01746732|11742425|FG002|NOT COMPLETED|Period 1||0
10586442|NCT01746732|11742423|FG000|STARTED|Period 2||0
10586443|NCT01746732|11742424|FG001|STARTED|Period 2||10
10586444|NCT01746732|11742425|FG002|STARTED|Period 2||11
10586445|NCT01746732|11742423|FG000|COMPLETED|Period 2||0
10586446|NCT01746732|11742424|FG001|COMPLETED|Period 2||10
10586447|NCT01746732|11742425|FG002|COMPLETED|Period 2||7
10586448|NCT01746732|11742423|FG000|NOT COMPLETED|Period 2||0
10586449|NCT01746732|11742424|FG001|NOT COMPLETED|Period 2||0
10586450|NCT01746732|11742425|FG002|NOT COMPLETED|Period 2||4
10586451|NCT01746745|11742433|FG000|STARTED|Overall Study||6
10586452|NCT01746745|11742433|FG000|Received Study Drug|Overall Study||6
10586453|NCT01746745|11742433|FG000|COMPLETED|Overall Study||6
10586454|NCT01746745|11742433|FG000|NOT COMPLETED|Overall Study||0
10586455|NCT01746784|11742442|FG000|STARTED|Overall Study||19
10586456|NCT01746784|11742443|FG001|STARTED|Overall Study||10
10586457|NCT01746784|11742444|FG002|STARTED|Overall Study||9
10586458|NCT01746784|11742445|FG003|STARTED|Overall Study||9
10586459|NCT01746784|11742446|FG004|STARTED|Overall Study||19
10586460|NCT01746784|11742442|FG000|Enrolled|Overall Study||19
10586461|NCT01746784|11742443|FG001|Enrolled|Overall Study||10
10586462|NCT01746784|11742444|FG002|Enrolled|Overall Study||9
10586463|NCT01746784|11742445|FG003|Enrolled|Overall Study||9
10586464|NCT01746784|11742446|FG004|Enrolled|Overall Study||19
10586465|NCT01746784|11742442|FG000|COMPLETED|Overall Study||19
10586466|NCT01746784|11742443|FG001|COMPLETED|Overall Study||10
10586467|NCT01746784|11742444|FG002|COMPLETED|Overall Study||9
10586468|NCT01746784|11742445|FG003|COMPLETED|Overall Study||9
10586469|NCT01746784|11742446|FG004|COMPLETED|Overall Study||19
10586470|NCT01746784|11742442|FG000|NOT COMPLETED|Overall Study||0
10586471|NCT01746784|11742443|FG001|NOT COMPLETED|Overall Study||0
10586472|NCT01746784|11742444|FG002|NOT COMPLETED|Overall Study||0
10586473|NCT01746784|11742445|FG003|NOT COMPLETED|Overall Study||0
10586474|NCT01746784|11742446|FG004|NOT COMPLETED|Overall Study||0
10703070|NCT02581345|11867635|FG003|STARTED|Part 1: up to Week 16||0
10703071|NCT02581345|11867632|FG000|COMPLETED|Part 1: up to Week 16||271
10703072|NCT02581345|11867633|FG001|COMPLETED|Part 1: up to Week 16||263
10703073|NCT02581345|11867634|FG002|COMPLETED|Part 1: up to Week 16||0
10703074|NCT02581345|11867635|FG003|COMPLETED|Part 1: up to Week 16||0
10586475|NCT01746862|11742469|FG000|STARTED|Overall Study||60
10703075|NCT02581345|11867632|FG000|NOT COMPLETED|Part 1: up to Week 16||15
10703076|NCT02581345|11867633|FG001|NOT COMPLETED|Part 1: up to Week 16||23
10703077|NCT02581345|11867634|FG002|NOT COMPLETED|Part 1: up to Week 16||0
10586476|NCT01746862|11742470|FG001|STARTED|Overall Study||30
10586477|NCT01746862|11742469|FG000|Treated|Overall Study||59
10586478|NCT01746862|11742470|FG001|Treated|Overall Study||30
10586479|NCT01746862|11742469|FG000|COMPLETED|Overall Study||52
10586480|NCT01746862|11742470|FG001|COMPLETED|Overall Study||27
10586481|NCT01746862|11742469|FG000|NOT COMPLETED|Overall Study||8
10586482|NCT01746862|11742470|FG001|NOT COMPLETED|Overall Study||3
10586483|NCT01746901|11742477|FG000|STARTED|Naloxone Challenge Phase||75
10703078|NCT02581345|11867635|FG003|NOT COMPLETED|Part 1: up to Week 16||0
10703079|NCT02581345|11867632|FG000|STARTED|Part 2: Week 17 to Week 47||271
10703080|NCT02581345|11867633|FG001|STARTED|Part 2: Week 17 to Week 47||0
10703081|NCT02581345|11867634|FG002|STARTED|Part 2: Week 17 to Week 47||132
10703082|NCT02581345|11867635|FG003|STARTED|Part 2: Week 17 to Week 47||131
10703083|NCT02581345|11867632|FG000|COMPLETED|Part 2: Week 17 to Week 47||242
10703084|NCT02581345|11867633|FG001|COMPLETED|Part 2: Week 17 to Week 47||0
10703085|NCT02581345|11867634|FG002|COMPLETED|Part 2: Week 17 to Week 47||117
10586484|NCT01746901|11742478|FG001|STARTED|Naloxone Challenge Phase||0
10586485|NCT01746901|11742479|FG002|STARTED|Naloxone Challenge Phase||0
10586486|NCT01746901|11742480|FG003|STARTED|Naloxone Challenge Phase||0
10586487|NCT01746901|11742481|FG004|STARTED|Naloxone Challenge Phase||0
10586488|NCT01746901|11742482|FG005|STARTED|Naloxone Challenge Phase||0
10586489|NCT01746901|11742483|FG006|STARTED|Naloxone Challenge Phase||0
10586490|NCT01746901|11742484|FG007|STARTED|Naloxone Challenge Phase||0
10586491|NCT01746901|11742485|FG008|STARTED|Naloxone Challenge Phase||0
10586492|NCT01746901|11742477|FG000|COMPLETED|Naloxone Challenge Phase||72
10586493|NCT01746901|11742478|FG001|COMPLETED|Naloxone Challenge Phase||0
10586494|NCT01746901|11742479|FG002|COMPLETED|Naloxone Challenge Phase||0
10586495|NCT01746901|11742480|FG003|COMPLETED|Naloxone Challenge Phase||0
10586496|NCT01746901|11742481|FG004|COMPLETED|Naloxone Challenge Phase||0
10586497|NCT01746901|11742482|FG005|COMPLETED|Naloxone Challenge Phase||0
10586498|NCT01746901|11742483|FG006|COMPLETED|Naloxone Challenge Phase||0
10586499|NCT01746901|11742484|FG007|COMPLETED|Naloxone Challenge Phase||0
10586500|NCT01746901|11742485|FG008|COMPLETED|Naloxone Challenge Phase||0
10586501|NCT01746901|11742477|FG000|NOT COMPLETED|Naloxone Challenge Phase||3
10586502|NCT01746901|11742478|FG001|NOT COMPLETED|Naloxone Challenge Phase||0
10586503|NCT01746901|11742479|FG002|NOT COMPLETED|Naloxone Challenge Phase||0
10586504|NCT01746901|11742480|FG003|NOT COMPLETED|Naloxone Challenge Phase||0
10586505|NCT01746901|11742481|FG004|NOT COMPLETED|Naloxone Challenge Phase||0
10586506|NCT01746901|11742482|FG005|NOT COMPLETED|Naloxone Challenge Phase||0
10586507|NCT01746901|11742483|FG006|NOT COMPLETED|Naloxone Challenge Phase||0
10586508|NCT01746901|11742484|FG007|NOT COMPLETED|Naloxone Challenge Phase||0
10586509|NCT01746901|11742485|FG008|NOT COMPLETED|Naloxone Challenge Phase||0
10586510|NCT01746901|11742477|FG000|STARTED|Drug Discrimination Phase: Day 1||0
10586511|NCT01746901|11742478|FG001|STARTED|Drug Discrimination Phase: Day 1||36
10586512|NCT01746901|11742479|FG002|STARTED|Drug Discrimination Phase: Day 1||36
10586513|NCT01746901|11742480|FG003|STARTED|Drug Discrimination Phase: Day 1||0
10586514|NCT01746901|11742481|FG004|STARTED|Drug Discrimination Phase: Day 1||0
10586515|NCT01746901|11742482|FG005|STARTED|Drug Discrimination Phase: Day 1||0
10586516|NCT01746901|11742483|FG006|STARTED|Drug Discrimination Phase: Day 1||0
10586517|NCT01746901|11742484|FG007|STARTED|Drug Discrimination Phase: Day 1||0
10586518|NCT01746901|11742485|FG008|STARTED|Drug Discrimination Phase: Day 1||0
10586519|NCT01746901|11742477|FG000|COMPLETED|Drug Discrimination Phase: Day 1||0
10586520|NCT01746901|11742478|FG001|COMPLETED|Drug Discrimination Phase: Day 1||33
10586521|NCT01746901|11742479|FG002|COMPLETED|Drug Discrimination Phase: Day 1||36
10586522|NCT01746901|11742480|FG003|COMPLETED|Drug Discrimination Phase: Day 1||0
10586523|NCT01746901|11742481|FG004|COMPLETED|Drug Discrimination Phase: Day 1||0
10586524|NCT01746901|11742482|FG005|COMPLETED|Drug Discrimination Phase: Day 1||0
10586525|NCT01746901|11742483|FG006|COMPLETED|Drug Discrimination Phase: Day 1||0
10586526|NCT01746901|11742484|FG007|COMPLETED|Drug Discrimination Phase: Day 1||0
10586527|NCT01746901|11742485|FG008|COMPLETED|Drug Discrimination Phase: Day 1||0
10586528|NCT01746901|11742477|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
10586529|NCT01746901|11742478|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 1||3
10586530|NCT01746901|11742479|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
10586531|NCT01746901|11742480|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
10586532|NCT01746901|11742481|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
10586533|NCT01746901|11742482|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
10586534|NCT01746901|11742483|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
10586535|NCT01746901|11742484|FG007|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
10586536|NCT01746901|11742485|FG008|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
10586537|NCT01746901|11742477|FG000|STARTED|Drug Discrimination Phase: Day 2||0
10586538|NCT01746901|11742478|FG001|STARTED|Drug Discrimination Phase: Day 2||33
10586539|NCT01746901|11742479|FG002|STARTED|Drug Discrimination Phase: Day 2||36
10586540|NCT01746901|11742480|FG003|STARTED|Drug Discrimination Phase: Day 2||0
10586541|NCT01746901|11742481|FG004|STARTED|Drug Discrimination Phase: Day 2||0
10586542|NCT01746901|11742482|FG005|STARTED|Drug Discrimination Phase: Day 2||0
10586543|NCT01746901|11742483|FG006|STARTED|Drug Discrimination Phase: Day 2||0
10586544|NCT01746901|11742484|FG007|STARTED|Drug Discrimination Phase: Day 2||0
10586545|NCT01746901|11742485|FG008|STARTED|Drug Discrimination Phase: Day 2||0
10586546|NCT01746901|11742477|FG000|COMPLETED|Drug Discrimination Phase: Day 2||0
10586547|NCT01746901|11742478|FG001|COMPLETED|Drug Discrimination Phase: Day 2||19
10586548|NCT01746901|11742479|FG002|COMPLETED|Drug Discrimination Phase: Day 2||22
10586549|NCT01746901|11742480|FG003|COMPLETED|Drug Discrimination Phase: Day 2||0
10586550|NCT01746901|11742481|FG004|COMPLETED|Drug Discrimination Phase: Day 2||0
10586551|NCT01746901|11742482|FG005|COMPLETED|Drug Discrimination Phase: Day 2||0
10586552|NCT01746901|11742483|FG006|COMPLETED|Drug Discrimination Phase: Day 2||0
10586553|NCT01746901|11742484|FG007|COMPLETED|Drug Discrimination Phase: Day 2||0
10703086|NCT02581345|11867635|FG003|COMPLETED|Part 2: Week 17 to Week 47||119
10586554|NCT01746901|11742485|FG008|COMPLETED|Drug Discrimination Phase: Day 2||0
10586555|NCT01746901|11742477|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
10586556|NCT01746901|11742478|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 2||14
10586557|NCT01746901|11742479|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 2||14
10586558|NCT01746901|11742480|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
10586559|NCT01746901|11742481|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
10586560|NCT01746901|11742482|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
10586561|NCT01746901|11742483|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
10586562|NCT01746901|11742484|FG007|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
10586563|NCT01746901|11742485|FG008|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
10586564|NCT01746901|11742477|FG000|STARTED|Treatment Phase: First Intervention||0
10586565|NCT01746901|11742478|FG001|STARTED|Treatment Phase: First Intervention||0
10586566|NCT01746901|11742479|FG002|STARTED|Treatment Phase: First Intervention||0
10586567|NCT01746901|11742480|FG003|STARTED|Treatment Phase: First Intervention||6
10586568|NCT01746901|11742481|FG004|STARTED|Treatment Phase: First Intervention||6
10586569|NCT01746901|11742482|FG005|STARTED|Treatment Phase: First Intervention||7
10586570|NCT01746901|11742483|FG006|STARTED|Treatment Phase: First Intervention||8
10586571|NCT01746901|11742484|FG007|STARTED|Treatment Phase: First Intervention||7
10586572|NCT01746901|11742485|FG008|STARTED|Treatment Phase: First Intervention||7
10586573|NCT01746901|11742477|FG000|COMPLETED|Treatment Phase: First Intervention||0
10586574|NCT01746901|11742478|FG001|COMPLETED|Treatment Phase: First Intervention||0
10586575|NCT01746901|11742479|FG002|COMPLETED|Treatment Phase: First Intervention||0
10586576|NCT01746901|11742480|FG003|COMPLETED|Treatment Phase: First Intervention||6
10586577|NCT01746901|11742481|FG004|COMPLETED|Treatment Phase: First Intervention||6
10586578|NCT01746901|11742482|FG005|COMPLETED|Treatment Phase: First Intervention||7
10586579|NCT01746901|11742483|FG006|COMPLETED|Treatment Phase: First Intervention||7
10586580|NCT01746901|11742484|FG007|COMPLETED|Treatment Phase: First Intervention||7
10586581|NCT01746901|11742485|FG008|COMPLETED|Treatment Phase: First Intervention||7
10586582|NCT01746901|11742477|FG000|NOT COMPLETED|Treatment Phase: First Intervention||0
10586583|NCT01746901|11742478|FG001|NOT COMPLETED|Treatment Phase: First Intervention||0
10586584|NCT01746901|11742479|FG002|NOT COMPLETED|Treatment Phase: First Intervention||0
10586585|NCT01746901|11742480|FG003|NOT COMPLETED|Treatment Phase: First Intervention||0
10586586|NCT01746901|11742481|FG004|NOT COMPLETED|Treatment Phase: First Intervention||0
10586587|NCT01746901|11742482|FG005|NOT COMPLETED|Treatment Phase: First Intervention||0
10586588|NCT01746901|11742483|FG006|NOT COMPLETED|Treatment Phase: First Intervention||1
10586589|NCT01746901|11742484|FG007|NOT COMPLETED|Treatment Phase: First Intervention||0
10586590|NCT01746901|11742485|FG008|NOT COMPLETED|Treatment Phase: First Intervention||0
10586591|NCT01746901|11742477|FG000|STARTED|Treatment Phase: Washout Period 1||0
10586592|NCT01746901|11742478|FG001|STARTED|Treatment Phase: Washout Period 1||0
10586593|NCT01746901|11742479|FG002|STARTED|Treatment Phase: Washout Period 1||0
10586594|NCT01746901|11742480|FG003|STARTED|Treatment Phase: Washout Period 1||6
10586595|NCT01746901|11742481|FG004|STARTED|Treatment Phase: Washout Period 1||6
10586596|NCT01746901|11742482|FG005|STARTED|Treatment Phase: Washout Period 1||7
10586597|NCT01746901|11742483|FG006|STARTED|Treatment Phase: Washout Period 1||7
10586598|NCT01746901|11742484|FG007|STARTED|Treatment Phase: Washout Period 1||7
10586599|NCT01746901|11742485|FG008|STARTED|Treatment Phase: Washout Period 1||7
10586600|NCT01746901|11742477|FG000|COMPLETED|Treatment Phase: Washout Period 1||0
10586601|NCT01746901|11742478|FG001|COMPLETED|Treatment Phase: Washout Period 1||0
10586602|NCT01746901|11742479|FG002|COMPLETED|Treatment Phase: Washout Period 1||0
10586603|NCT01746901|11742480|FG003|COMPLETED|Treatment Phase: Washout Period 1||6
10586604|NCT01746901|11742481|FG004|COMPLETED|Treatment Phase: Washout Period 1||6
10586605|NCT01746901|11742482|FG005|COMPLETED|Treatment Phase: Washout Period 1||7
10586606|NCT01746901|11742483|FG006|COMPLETED|Treatment Phase: Washout Period 1||7
10586607|NCT01746901|11742484|FG007|COMPLETED|Treatment Phase: Washout Period 1||7
10586608|NCT01746901|11742485|FG008|COMPLETED|Treatment Phase: Washout Period 1||7
10586609|NCT01746901|11742477|FG000|NOT COMPLETED|Treatment Phase: Washout Period 1||0
10586610|NCT01746901|11742478|FG001|NOT COMPLETED|Treatment Phase: Washout Period 1||0
10586611|NCT01746901|11742479|FG002|NOT COMPLETED|Treatment Phase: Washout Period 1||0
10586612|NCT01746901|11742480|FG003|NOT COMPLETED|Treatment Phase: Washout Period 1||0
10586613|NCT01746901|11742481|FG004|NOT COMPLETED|Treatment Phase: Washout Period 1||0
10586614|NCT01746901|11742482|FG005|NOT COMPLETED|Treatment Phase: Washout Period 1||0
10586615|NCT01746901|11742483|FG006|NOT COMPLETED|Treatment Phase: Washout Period 1||0
10586616|NCT01746901|11742484|FG007|NOT COMPLETED|Treatment Phase: Washout Period 1||0
10586617|NCT01746901|11742485|FG008|NOT COMPLETED|Treatment Phase: Washout Period 1||0
10586618|NCT01746901|11742477|FG000|STARTED|Treatment Phase: Second Intervention||0
10586619|NCT01746901|11742478|FG001|STARTED|Treatment Phase: Second Intervention||0
10586620|NCT01746901|11742479|FG002|STARTED|Treatment Phase: Second Intervention||0
10586621|NCT01746901|11742480|FG003|STARTED|Treatment Phase: Second Intervention||6
10586622|NCT01746901|11742481|FG004|STARTED|Treatment Phase: Second Intervention||6
10586623|NCT01746901|11742482|FG005|STARTED|Treatment Phase: Second Intervention||7
10586624|NCT01746901|11742483|FG006|STARTED|Treatment Phase: Second Intervention||7
10586625|NCT01746901|11742484|FG007|STARTED|Treatment Phase: Second Intervention||7
10586626|NCT01746901|11742485|FG008|STARTED|Treatment Phase: Second Intervention||7
10586627|NCT01746901|11742477|FG000|COMPLETED|Treatment Phase: Second Intervention||0
10586628|NCT01746901|11742478|FG001|COMPLETED|Treatment Phase: Second Intervention||0
10586629|NCT01746901|11742479|FG002|COMPLETED|Treatment Phase: Second Intervention||0
10586630|NCT01746901|11742480|FG003|COMPLETED|Treatment Phase: Second Intervention||6
10586631|NCT01746901|11742481|FG004|COMPLETED|Treatment Phase: Second Intervention||6
10586632|NCT01746901|11742482|FG005|COMPLETED|Treatment Phase: Second Intervention||7
10586633|NCT01746901|11742483|FG006|COMPLETED|Treatment Phase: Second Intervention||7
10586634|NCT01746901|11742484|FG007|COMPLETED|Treatment Phase: Second Intervention||6
10333741|NCT00335452|11469936|FG002|STARTED|Overall Study|Randomized|6267
10333742|NCT00335452|11469937|FG003|STARTED|Overall Study|Randomized|6253
10333743|NCT00335452|11469934|FG000|TREATED WITH CLOPIDOGREL|Overall Study||6271
10333744|NCT00335452|11469935|FG001|TREATED WITH CLOPIDOGREL|Overall Study||6218
10333745|NCT00335452|11469936|FG002|TREATED WITH CLOPIDOGREL|Overall Study||6228
10333746|NCT00335452|11469937|FG003|TREATED WITH CLOPIDOGREL|Overall Study||6217
10333747|NCT00335452|11469934|FG000|TREATED WITH ASA|Overall Study||6302
10333748|NCT00335452|11469935|FG001|TREATED WITH ASA|Overall Study||6251
10333749|NCT00335452|11469936|FG002|TREATED WITH ASA|Overall Study||6261
10586635|NCT01746901|11742485|FG008|COMPLETED|Treatment Phase: Second Intervention||7
10586636|NCT01746901|11742477|FG000|NOT COMPLETED|Treatment Phase: Second Intervention||0
10586637|NCT01746901|11742478|FG001|NOT COMPLETED|Treatment Phase: Second Intervention||0
10586638|NCT01746901|11742479|FG002|NOT COMPLETED|Treatment Phase: Second Intervention||0
10586639|NCT01746901|11742480|FG003|NOT COMPLETED|Treatment Phase: Second Intervention||0
10586640|NCT01746901|11742481|FG004|NOT COMPLETED|Treatment Phase: Second Intervention||0
10586641|NCT01746901|11742482|FG005|NOT COMPLETED|Treatment Phase: Second Intervention||0
10586642|NCT01746901|11742483|FG006|NOT COMPLETED|Treatment Phase: Second Intervention||0
10586643|NCT01746901|11742484|FG007|NOT COMPLETED|Treatment Phase: Second Intervention||1
10586644|NCT01746901|11742485|FG008|NOT COMPLETED|Treatment Phase: Second Intervention||0
10586645|NCT01746901|11742477|FG000|STARTED|Treatment Phase: Washout Period 2||0
10586646|NCT01746901|11742478|FG001|STARTED|Treatment Phase: Washout Period 2||0
10586647|NCT01746901|11742479|FG002|STARTED|Treatment Phase: Washout Period 2||0
10586648|NCT01746901|11742480|FG003|STARTED|Treatment Phase: Washout Period 2||6
10586649|NCT01746901|11742481|FG004|STARTED|Treatment Phase: Washout Period 2||6
10586650|NCT01746901|11742482|FG005|STARTED|Treatment Phase: Washout Period 2||7
10586651|NCT01746901|11742483|FG006|STARTED|Treatment Phase: Washout Period 2||7
10586652|NCT01746901|11742484|FG007|STARTED|Treatment Phase: Washout Period 2||6
10586653|NCT01746901|11742485|FG008|STARTED|Treatment Phase: Washout Period 2||7
10586654|NCT01746901|11742477|FG000|COMPLETED|Treatment Phase: Washout Period 2||0
10586655|NCT01746901|11742478|FG001|COMPLETED|Treatment Phase: Washout Period 2||0
10586656|NCT01746901|11742479|FG002|COMPLETED|Treatment Phase: Washout Period 2||0
10586657|NCT01746901|11742480|FG003|COMPLETED|Treatment Phase: Washout Period 2||6
10586658|NCT01746901|11742481|FG004|COMPLETED|Treatment Phase: Washout Period 2||6
10586659|NCT01746901|11742482|FG005|COMPLETED|Treatment Phase: Washout Period 2||7
10586660|NCT01746901|11742483|FG006|COMPLETED|Treatment Phase: Washout Period 2||7
10586661|NCT01746901|11742484|FG007|COMPLETED|Treatment Phase: Washout Period 2||6
10586662|NCT01746901|11742485|FG008|COMPLETED|Treatment Phase: Washout Period 2||7
10586663|NCT01746901|11742477|FG000|NOT COMPLETED|Treatment Phase: Washout Period 2||0
10586664|NCT01746901|11742478|FG001|NOT COMPLETED|Treatment Phase: Washout Period 2||0
10586665|NCT01746901|11742479|FG002|NOT COMPLETED|Treatment Phase: Washout Period 2||0
10586666|NCT01746901|11742480|FG003|NOT COMPLETED|Treatment Phase: Washout Period 2||0
10586667|NCT01746901|11742481|FG004|NOT COMPLETED|Treatment Phase: Washout Period 2||0
10586668|NCT01746901|11742482|FG005|NOT COMPLETED|Treatment Phase: Washout Period 2||0
10586669|NCT01746901|11742483|FG006|NOT COMPLETED|Treatment Phase: Washout Period 2||0
10586670|NCT01746901|11742484|FG007|NOT COMPLETED|Treatment Phase: Washout Period 2||0
10586671|NCT01746901|11742485|FG008|NOT COMPLETED|Treatment Phase: Washout Period 2||0
10586672|NCT01746901|11742477|FG000|STARTED|Treatment Phase: Third Intervention||0
10586673|NCT01746901|11742478|FG001|STARTED|Treatment Phase: Third Intervention||0
10586674|NCT01746901|11742479|FG002|STARTED|Treatment Phase: Third Intervention||0
10586675|NCT01746901|11742480|FG003|STARTED|Treatment Phase: Third Intervention||6
10586676|NCT01746901|11742481|FG004|STARTED|Treatment Phase: Third Intervention||6
10586677|NCT01746901|11742482|FG005|STARTED|Treatment Phase: Third Intervention||7
10586678|NCT01746901|11742483|FG006|STARTED|Treatment Phase: Third Intervention||7
10586679|NCT01746901|11742484|FG007|STARTED|Treatment Phase: Third Intervention||6
10586680|NCT01746901|11742485|FG008|STARTED|Treatment Phase: Third Intervention||7
10586681|NCT01746901|11742477|FG000|COMPLETED|Treatment Phase: Third Intervention||0
10586682|NCT01746901|11742478|FG001|COMPLETED|Treatment Phase: Third Intervention||0
10586683|NCT01746901|11742479|FG002|COMPLETED|Treatment Phase: Third Intervention||0
10586684|NCT01746901|11742480|FG003|COMPLETED|Treatment Phase: Third Intervention||6
10586685|NCT01746901|11742481|FG004|COMPLETED|Treatment Phase: Third Intervention||6
10586686|NCT01746901|11742482|FG005|COMPLETED|Treatment Phase: Third Intervention||6
10586687|NCT01746901|11742483|FG006|COMPLETED|Treatment Phase: Third Intervention||6
10586688|NCT01746901|11742484|FG007|COMPLETED|Treatment Phase: Third Intervention||6
10586689|NCT01746901|11742485|FG008|COMPLETED|Treatment Phase: Third Intervention||7
10586690|NCT01746901|11742477|FG000|NOT COMPLETED|Treatment Phase: Third Intervention||0
10586691|NCT01746901|11742478|FG001|NOT COMPLETED|Treatment Phase: Third Intervention||0
10651885|NCT02179424|11812143|FG000|STARTED|Overall Study||76
10333750|NCT00335452|11469937|FG003|TREATED WITH ASA|Overall Study||6247
10333751|NCT00335452|11469934|FG000|COMPLETED|Overall Study|Completed 30 days follow-up period|6154
10333752|NCT00335452|11469935|FG001|COMPLETED|Overall Study|Completed 30 days follow-up period|6107
10586692|NCT01746901|11742479|FG002|NOT COMPLETED|Treatment Phase: Third Intervention||0
10586693|NCT01746901|11742480|FG003|NOT COMPLETED|Treatment Phase: Third Intervention||0
10586694|NCT01746901|11742481|FG004|NOT COMPLETED|Treatment Phase: Third Intervention||0
10586695|NCT01746901|11742482|FG005|NOT COMPLETED|Treatment Phase: Third Intervention||1
10586696|NCT01746901|11742483|FG006|NOT COMPLETED|Treatment Phase: Third Intervention||1
10586697|NCT01746901|11742484|FG007|NOT COMPLETED|Treatment Phase: Third Intervention||0
10586698|NCT01746901|11742485|FG008|NOT COMPLETED|Treatment Phase: Third Intervention||0
10586699|NCT01746901|11742477|FG000|STARTED|Treatment Phase: Washout Period 3||0
10586700|NCT01746901|11742478|FG001|STARTED|Treatment Phase: Washout Period 3||0
10586701|NCT01746901|11742479|FG002|STARTED|Treatment Phase: Washout Period 3||0
10586702|NCT01746901|11742480|FG003|STARTED|Treatment Phase: Washout Period 3||6
10586703|NCT01746901|11742481|FG004|STARTED|Treatment Phase: Washout Period 3||6
10586704|NCT01746901|11742482|FG005|STARTED|Treatment Phase: Washout Period 3||6
10586705|NCT01746901|11742483|FG006|STARTED|Treatment Phase: Washout Period 3||6
10586706|NCT01746901|11742484|FG007|STARTED|Treatment Phase: Washout Period 3||6
10586707|NCT01746901|11742485|FG008|STARTED|Treatment Phase: Washout Period 3||7
10586708|NCT01746901|11742477|FG000|COMPLETED|Treatment Phase: Washout Period 3||0
10586709|NCT01746901|11742478|FG001|COMPLETED|Treatment Phase: Washout Period 3||0
10586710|NCT01746901|11742479|FG002|COMPLETED|Treatment Phase: Washout Period 3||0
10586711|NCT01746901|11742480|FG003|COMPLETED|Treatment Phase: Washout Period 3||6
10586712|NCT01746901|11742481|FG004|COMPLETED|Treatment Phase: Washout Period 3||6
10586713|NCT01746901|11742482|FG005|COMPLETED|Treatment Phase: Washout Period 3||6
10586714|NCT01746901|11742483|FG006|COMPLETED|Treatment Phase: Washout Period 3||6
10586715|NCT01746901|11742484|FG007|COMPLETED|Treatment Phase: Washout Period 3||6
10586716|NCT01746901|11742485|FG008|COMPLETED|Treatment Phase: Washout Period 3||7
10586717|NCT01746901|11742477|FG000|NOT COMPLETED|Treatment Phase: Washout Period 3||0
10586718|NCT01746901|11742478|FG001|NOT COMPLETED|Treatment Phase: Washout Period 3||0
10586719|NCT01746901|11742479|FG002|NOT COMPLETED|Treatment Phase: Washout Period 3||0
10586720|NCT01746901|11742480|FG003|NOT COMPLETED|Treatment Phase: Washout Period 3||0
10586721|NCT01746901|11742481|FG004|NOT COMPLETED|Treatment Phase: Washout Period 3||0
10586722|NCT01746901|11742482|FG005|NOT COMPLETED|Treatment Phase: Washout Period 3||0
10586723|NCT01746901|11742483|FG006|NOT COMPLETED|Treatment Phase: Washout Period 3||0
10586724|NCT01746901|11742484|FG007|NOT COMPLETED|Treatment Phase: Washout Period 3||0
10586725|NCT01746901|11742485|FG008|NOT COMPLETED|Treatment Phase: Washout Period 3||0
10586726|NCT01746901|11742477|FG000|STARTED|Treatment Phase: Fourth Intervention||0
10586727|NCT01746901|11742478|FG001|STARTED|Treatment Phase: Fourth Intervention||0
10586728|NCT01746901|11742479|FG002|STARTED|Treatment Phase: Fourth Intervention||0
10586729|NCT01746901|11742480|FG003|STARTED|Treatment Phase: Fourth Intervention||6
10586730|NCT01746901|11742481|FG004|STARTED|Treatment Phase: Fourth Intervention||6
10586731|NCT01746901|11742482|FG005|STARTED|Treatment Phase: Fourth Intervention||6
10586732|NCT01746901|11742483|FG006|STARTED|Treatment Phase: Fourth Intervention||6
10586733|NCT01746901|11742484|FG007|STARTED|Treatment Phase: Fourth Intervention||6
10586734|NCT01746901|11742485|FG008|STARTED|Treatment Phase: Fourth Intervention||7
10586735|NCT01746901|11742477|FG000|COMPLETED|Treatment Phase: Fourth Intervention||0
10586736|NCT01746901|11742478|FG001|COMPLETED|Treatment Phase: Fourth Intervention||0
10586737|NCT01746901|11742479|FG002|COMPLETED|Treatment Phase: Fourth Intervention||0
10586738|NCT01746901|11742480|FG003|COMPLETED|Treatment Phase: Fourth Intervention||5
10586739|NCT01746901|11742481|FG004|COMPLETED|Treatment Phase: Fourth Intervention||6
10586740|NCT01746901|11742482|FG005|COMPLETED|Treatment Phase: Fourth Intervention||5
10586741|NCT01746901|11742483|FG006|COMPLETED|Treatment Phase: Fourth Intervention||5
10586742|NCT01746901|11742484|FG007|COMPLETED|Treatment Phase: Fourth Intervention||6
10586743|NCT01746901|11742485|FG008|COMPLETED|Treatment Phase: Fourth Intervention||5
10586744|NCT01746901|11742477|FG000|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
10586745|NCT01746901|11742478|FG001|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
10586746|NCT01746901|11742479|FG002|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
10586747|NCT01746901|11742480|FG003|NOT COMPLETED|Treatment Phase: Fourth Intervention||1
10586748|NCT01746901|11742481|FG004|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
10586749|NCT01746901|11742482|FG005|NOT COMPLETED|Treatment Phase: Fourth Intervention||1
10586750|NCT01746901|11742483|FG006|NOT COMPLETED|Treatment Phase: Fourth Intervention||1
10586751|NCT01746901|11742484|FG007|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
10586752|NCT01746901|11742485|FG008|NOT COMPLETED|Treatment Phase: Fourth Intervention||2
10586753|NCT01746901|11742477|FG000|STARTED|Treatment Phase: Washout Period 4||0
10586754|NCT01746901|11742478|FG001|STARTED|Treatment Phase: Washout Period 4||0
10806812|NCT03944707|11968442|FG001|NOT COMPLETED|Overall Study||10
10806813|NCT03944668|11968448|FG000|STARTED|Overall Study|Enrolled in Study|17
10806814|NCT03944668|11968448|FG000|Able to Use Patient Data|Overall Study|3 Patient's Data Unusable|14
10586755|NCT01746901|11742479|FG002|STARTED|Treatment Phase: Washout Period 4||0
10586756|NCT01746901|11742480|FG003|STARTED|Treatment Phase: Washout Period 4||5
10586757|NCT01746901|11742481|FG004|STARTED|Treatment Phase: Washout Period 4||6
10586758|NCT01746901|11742482|FG005|STARTED|Treatment Phase: Washout Period 4||5
10586759|NCT01746901|11742483|FG006|STARTED|Treatment Phase: Washout Period 4||5
10586760|NCT01746901|11742484|FG007|STARTED|Treatment Phase: Washout Period 4||6
10806815|NCT03944668|11968448|FG000|Participated in Intervention|Overall Study|Started Cardiac Rehabilitation|10
10806816|NCT03944668|11968448|FG000|COMPLETED|Overall Study|Completed 75% of Comprehensive Cardiac Rehabilitation Sessions|8
10806817|NCT03944668|11968448|FG000|NOT COMPLETED|Overall Study||9
10586761|NCT01746901|11742485|FG008|STARTED|Treatment Phase: Washout Period 4||5
10586762|NCT01746901|11742477|FG000|COMPLETED|Treatment Phase: Washout Period 4||0
10586763|NCT01746901|11742478|FG001|COMPLETED|Treatment Phase: Washout Period 4||0
10586764|NCT01746901|11742479|FG002|COMPLETED|Treatment Phase: Washout Period 4||0
10586765|NCT01746901|11742480|FG003|COMPLETED|Treatment Phase: Washout Period 4||5
10586766|NCT01746901|11742481|FG004|COMPLETED|Treatment Phase: Washout Period 4||6
10586767|NCT01746901|11742482|FG005|COMPLETED|Treatment Phase: Washout Period 4||5
10586768|NCT01746901|11742483|FG006|COMPLETED|Treatment Phase: Washout Period 4||5
10586769|NCT01746901|11742484|FG007|COMPLETED|Treatment Phase: Washout Period 4||6
10586770|NCT01746901|11742485|FG008|COMPLETED|Treatment Phase: Washout Period 4||5
10586771|NCT01746901|11742477|FG000|NOT COMPLETED|Treatment Phase: Washout Period 4||0
10586772|NCT01746901|11742478|FG001|NOT COMPLETED|Treatment Phase: Washout Period 4||0
10586773|NCT01746901|11742479|FG002|NOT COMPLETED|Treatment Phase: Washout Period 4||0
10586774|NCT01746901|11742480|FG003|NOT COMPLETED|Treatment Phase: Washout Period 4||0
10586775|NCT01746901|11742481|FG004|NOT COMPLETED|Treatment Phase: Washout Period 4||0
10586776|NCT01746901|11742482|FG005|NOT COMPLETED|Treatment Phase: Washout Period 4||0
10586777|NCT01746901|11742483|FG006|NOT COMPLETED|Treatment Phase: Washout Period 4||0
10586778|NCT01746901|11742484|FG007|NOT COMPLETED|Treatment Phase: Washout Period 4||0
10586779|NCT01746901|11742485|FG008|NOT COMPLETED|Treatment Phase: Washout Period 4||0
10586780|NCT01746901|11742477|FG000|STARTED|Treatment Phase: Fifth Intervention||0
10586781|NCT01746901|11742478|FG001|STARTED|Treatment Phase: Fifth Intervention||0
10806818|NCT03943160|11968453|FG000|STARTED|Overall Study||50
10806819|NCT03943160|11968453|FG000|COMPLETED|Overall Study||50
10806820|NCT03943160|11968453|FG000|NOT COMPLETED|Overall Study||0
10586782|NCT01746901|11742479|FG002|STARTED|Treatment Phase: Fifth Intervention||0
10586783|NCT01746901|11742480|FG003|STARTED|Treatment Phase: Fifth Intervention||5
10586784|NCT01746901|11742481|FG004|STARTED|Treatment Phase: Fifth Intervention||6
10586785|NCT01746901|11742482|FG005|STARTED|Treatment Phase: Fifth Intervention||5
10586786|NCT01746901|11742483|FG006|STARTED|Treatment Phase: Fifth Intervention||5
10586787|NCT01746901|11742484|FG007|STARTED|Treatment Phase: Fifth Intervention||6
10586788|NCT01746901|11742485|FG008|STARTED|Treatment Phase: Fifth Intervention||5
10586789|NCT01746901|11742477|FG000|COMPLETED|Treatment Phase: Fifth Intervention||0
10586790|NCT01746901|11742478|FG001|COMPLETED|Treatment Phase: Fifth Intervention||0
10586791|NCT01746901|11742479|FG002|COMPLETED|Treatment Phase: Fifth Intervention||0
10586792|NCT01746901|11742480|FG003|COMPLETED|Treatment Phase: Fifth Intervention||5
10586793|NCT01746901|11742481|FG004|COMPLETED|Treatment Phase: Fifth Intervention||6
10586794|NCT01746901|11742482|FG005|COMPLETED|Treatment Phase: Fifth Intervention||5
10586795|NCT01746901|11742483|FG006|COMPLETED|Treatment Phase: Fifth Intervention||5
10586796|NCT01746901|11742484|FG007|COMPLETED|Treatment Phase: Fifth Intervention||6
10586797|NCT01746901|11742485|FG008|COMPLETED|Treatment Phase: Fifth Intervention||5
10586798|NCT01746901|11742477|FG000|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
10806821|NCT03943095|11968459|FG000|STARTED|Overall Study||52
10806822|NCT03943095|11968460|FG001|STARTED|Overall Study||52
10806823|NCT03943095|11968459|FG000|COMPLETED|Overall Study||51
10806824|NCT03943095|11968460|FG001|COMPLETED|Overall Study||51
10806825|NCT03943095|11968459|FG000|NOT COMPLETED|Overall Study||1
10806826|NCT03943095|11968460|FG001|NOT COMPLETED|Overall Study||1
10586799|NCT01746901|11742478|FG001|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
10586800|NCT01746901|11742479|FG002|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
10586801|NCT01746901|11742480|FG003|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
10586802|NCT01746901|11742481|FG004|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
10586803|NCT01746901|11742482|FG005|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
10586804|NCT01746901|11742483|FG006|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
10586805|NCT01746901|11742484|FG007|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
10586806|NCT01746901|11742485|FG008|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
10586807|NCT01746901|11742477|FG000|STARTED|Treatment Phase: Washout Period 5||0
10586808|NCT01746901|11742478|FG001|STARTED|Treatment Phase: Washout Period 5||0
10586809|NCT01746901|11742479|FG002|STARTED|Treatment Phase: Washout Period 5||0
10586810|NCT01746901|11742480|FG003|STARTED|Treatment Phase: Washout Period 5||5
10586811|NCT01746901|11742481|FG004|STARTED|Treatment Phase: Washout Period 5||6
10586812|NCT01746901|11742482|FG005|STARTED|Treatment Phase: Washout Period 5||5
10586813|NCT01746901|11742483|FG006|STARTED|Treatment Phase: Washout Period 5||5
10586814|NCT01746901|11742484|FG007|STARTED|Treatment Phase: Washout Period 5||6
10586815|NCT01746901|11742485|FG008|STARTED|Treatment Phase: Washout Period 5||5
10586816|NCT01746901|11742477|FG000|COMPLETED|Treatment Phase: Washout Period 5||0
10586817|NCT01746901|11742478|FG001|COMPLETED|Treatment Phase: Washout Period 5||0
10586818|NCT01746901|11742479|FG002|COMPLETED|Treatment Phase: Washout Period 5||0
10586819|NCT01746901|11742480|FG003|COMPLETED|Treatment Phase: Washout Period 5||5
10703087|NCT02581345|11867632|FG000|NOT COMPLETED|Part 2: Week 17 to Week 47||29
10703088|NCT02581345|11867633|FG001|NOT COMPLETED|Part 2: Week 17 to Week 47||0
10703089|NCT02581345|11867634|FG002|NOT COMPLETED|Part 2: Week 17 to Week 47||15
10703090|NCT02581345|11867635|FG003|NOT COMPLETED|Part 2: Week 17 to Week 47||12
10703091|NCT02581384|11867653|FG000|STARTED|Overall Study||3
10806854|NCT03942042|11968519|FG000|STARTED|Induction Dosing Period (12 Weeks)||7
10806855|NCT03942042|11968520|FG001|STARTED|Induction Dosing Period (12 Weeks)||5
10806856|NCT03942042|11968519|FG000|Received at Least One Dose of Study Drug|Induction Dosing Period (12 Weeks)||7
10586820|NCT01746901|11742481|FG004|COMPLETED|Treatment Phase: Washout Period 5||6
10586821|NCT01746901|11742482|FG005|COMPLETED|Treatment Phase: Washout Period 5||5
10586822|NCT01746901|11742483|FG006|COMPLETED|Treatment Phase: Washout Period 5||5
10586823|NCT01746901|11742484|FG007|COMPLETED|Treatment Phase: Washout Period 5||6
10586824|NCT01746901|11742485|FG008|COMPLETED|Treatment Phase: Washout Period 5||5
10586825|NCT01746901|11742477|FG000|NOT COMPLETED|Treatment Phase: Washout Period 5||0
10586826|NCT01746901|11742478|FG001|NOT COMPLETED|Treatment Phase: Washout Period 5||0
10703092|NCT02581384|11867654|FG001|STARTED|Overall Study||2
10703093|NCT02581384|11867653|FG000|COMPLETED|Overall Study||3
10703094|NCT02581384|11867654|FG001|COMPLETED|Overall Study||2
10703095|NCT02581384|11867653|FG000|NOT COMPLETED|Overall Study||0
10703096|NCT02581384|11867654|FG001|NOT COMPLETED|Overall Study||0
10703097|NCT02581410|11867663|FG000|STARTED|Vaccination Phase||215
10586827|NCT01746901|11742479|FG002|NOT COMPLETED|Treatment Phase: Washout Period 5||0
10586828|NCT01746901|11742480|FG003|NOT COMPLETED|Treatment Phase: Washout Period 5||0
10586829|NCT01746901|11742481|FG004|NOT COMPLETED|Treatment Phase: Washout Period 5||0
10586830|NCT01746901|11742482|FG005|NOT COMPLETED|Treatment Phase: Washout Period 5||0
10586831|NCT01746901|11742483|FG006|NOT COMPLETED|Treatment Phase: Washout Period 5||0
10586832|NCT01746901|11742484|FG007|NOT COMPLETED|Treatment Phase: Washout Period 5||0
10586833|NCT01746901|11742485|FG008|NOT COMPLETED|Treatment Phase: Washout Period 5||0
10586834|NCT01746901|11742477|FG000|STARTED|Treatment Phase: Sixth Intervention||0
10586835|NCT01746901|11742478|FG001|STARTED|Treatment Phase: Sixth Intervention||0
10586836|NCT01746901|11742479|FG002|STARTED|Treatment Phase: Sixth Intervention||0
10586837|NCT01746901|11742480|FG003|STARTED|Treatment Phase: Sixth Intervention||5
10586838|NCT01746901|11742481|FG004|STARTED|Treatment Phase: Sixth Intervention||6
10586839|NCT01746901|11742482|FG005|STARTED|Treatment Phase: Sixth Intervention||5
10586840|NCT01746901|11742483|FG006|STARTED|Treatment Phase: Sixth Intervention||5
10586841|NCT01746901|11742484|FG007|STARTED|Treatment Phase: Sixth Intervention||6
10586842|NCT01746901|11742485|FG008|STARTED|Treatment Phase: Sixth Intervention||5
10586843|NCT01746901|11742477|FG000|COMPLETED|Treatment Phase: Sixth Intervention||0
10586844|NCT01746901|11742478|FG001|COMPLETED|Treatment Phase: Sixth Intervention||0
10586845|NCT01746901|11742479|FG002|COMPLETED|Treatment Phase: Sixth Intervention||0
10586846|NCT01746901|11742480|FG003|COMPLETED|Treatment Phase: Sixth Intervention||5
10586847|NCT01746901|11742481|FG004|COMPLETED|Treatment Phase: Sixth Intervention||6
10586848|NCT01746901|11742482|FG005|COMPLETED|Treatment Phase: Sixth Intervention||5
10586849|NCT01746901|11742483|FG006|COMPLETED|Treatment Phase: Sixth Intervention||5
10586850|NCT01746901|11742484|FG007|COMPLETED|Treatment Phase: Sixth Intervention||6
10586851|NCT01746901|11742485|FG008|COMPLETED|Treatment Phase: Sixth Intervention||5
10586852|NCT01746901|11742477|FG000|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
10586853|NCT01746901|11742478|FG001|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
10586854|NCT01746901|11742479|FG002|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
10586855|NCT01746901|11742480|FG003|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
10586856|NCT01746901|11742481|FG004|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
10586857|NCT01746901|11742482|FG005|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
10586858|NCT01746901|11742483|FG006|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
10586859|NCT01746901|11742484|FG007|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
10586860|NCT01746901|11742485|FG008|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
10586861|NCT01746940|11742525|FG000|STARTED|Safety and Efficacy First Phase||39
10586862|NCT01746940|11742526|FG001|STARTED|Safety and Efficacy First Phase||41
10586863|NCT01746940|11742527|FG002|STARTED|Safety and Efficacy First Phase||40
10586864|NCT01746940|11742528|FG003|STARTED|Safety and Efficacy First Phase||3
10586865|NCT01746940|11742525|FG000|COMPLETED|Safety and Efficacy First Phase||39
10586866|NCT01746940|11742526|FG001|COMPLETED|Safety and Efficacy First Phase||41
10586867|NCT01746940|11742527|FG002|COMPLETED|Safety and Efficacy First Phase||40
10586868|NCT01746940|11742528|FG003|COMPLETED|Safety and Efficacy First Phase||0
10586869|NCT01746940|11742525|FG000|NOT COMPLETED|Safety and Efficacy First Phase||0
10586870|NCT01746940|11742526|FG001|NOT COMPLETED|Safety and Efficacy First Phase||0
10586871|NCT01746940|11742527|FG002|NOT COMPLETED|Safety and Efficacy First Phase||0
10586872|NCT01746940|11742528|FG003|NOT COMPLETED|Safety and Efficacy First Phase||3
10586873|NCT01746940|11742525|FG000|STARTED|Safety Second Phase||18
10586874|NCT01746940|11742526|FG001|STARTED|Safety Second Phase||18
10586875|NCT01746940|11742527|FG002|STARTED|Safety Second Phase||0
10586876|NCT01746940|11742528|FG003|STARTED|Safety Second Phase||0
10586877|NCT01746940|11742525|FG000|COMPLETED|Safety Second Phase||18
10586878|NCT01746940|11742526|FG001|COMPLETED|Safety Second Phase||18
10586879|NCT01746940|11742527|FG002|COMPLETED|Safety Second Phase||0
10586880|NCT01746940|11742528|FG003|COMPLETED|Safety Second Phase||0
10586881|NCT01746940|11742525|FG000|NOT COMPLETED|Safety Second Phase||0
10586882|NCT01746940|11742526|FG001|NOT COMPLETED|Safety Second Phase||0
10586883|NCT01746940|11742527|FG002|NOT COMPLETED|Safety Second Phase||0
10586884|NCT01746940|11742528|FG003|NOT COMPLETED|Safety Second Phase||0
10586885|NCT01746979|11742538|FG000|STARTED|Overall Study||346
10586886|NCT01746979|11742539|FG001|STARTED|Overall Study||347
10586887|NCT01746979|11742538|FG000|COMPLETED|Overall Study||0
10586888|NCT01746979|11742539|FG001|COMPLETED|Overall Study||0
10586889|NCT01746979|11742538|FG000|NOT COMPLETED|Overall Study||346
10586890|NCT01746979|11742539|FG001|NOT COMPLETED|Overall Study||347
10586891|NCT01747330|11742545|FG000|STARTED|Overall Study||40
10586892|NCT01747330|11742545|FG000|COMPLETED|Overall Study||40
10586893|NCT01747330|11742545|FG000|NOT COMPLETED|Overall Study||0
10586894|NCT01747343|11742549|FG000|STARTED|Baseline||4
10586895|NCT01747343|11742549|FG000|COMPLETED|Baseline||4
10586896|NCT01747343|11742549|FG000|NOT COMPLETED|Baseline||0
10586897|NCT01747343|11742549|FG000|STARTED|Underwear||4
10586898|NCT01747343|11742549|FG000|COMPLETED|Underwear||4
10586899|NCT01747343|11742549|FG000|NOT COMPLETED|Underwear||0
10586900|NCT01747343|11742549|FG000|STARTED|Underwear/Differential Reinforcement||4
10586901|NCT01747343|11742549|FG000|COMPLETED|Underwear/Differential Reinforcement||4
10586902|NCT01747343|11742549|FG000|NOT COMPLETED|Underwear/Differential Reinforcement||0
10586903|NCT01747486|11742555|FG000|STARTED|Stage 1||15
10586904|NCT01747486|11742556|FG001|STARTED|Stage 1||15
10586905|NCT01747486|11742555|FG000|COMPLETED|Stage 1||3
10586906|NCT01747486|11742556|FG001|COMPLETED|Stage 1||2
10586907|NCT01747486|11742555|FG000|NOT COMPLETED|Stage 1||12
10586908|NCT01747486|11742556|FG001|NOT COMPLETED|Stage 1||13
10586909|NCT01747486|11742555|FG000|STARTED|Stage 2||12
10586910|NCT01747486|11742556|FG001|STARTED|Stage 2||0
10586911|NCT01747486|11742555|FG000|COMPLETED|Stage 2||3
10586912|NCT01747486|11742556|FG001|COMPLETED|Stage 2||0
10586913|NCT01747486|11742555|FG000|NOT COMPLETED|Stage 2||9
10586914|NCT01747486|11742556|FG001|NOT COMPLETED|Stage 2||0
10586915|NCT01747499|11742567|FG000|STARTED|Overall Study||3
10586916|NCT01747499|11742568|FG001|STARTED|Overall Study||3
10586917|NCT01747499|11742569|FG002|STARTED|Overall Study||3
10586918|NCT01747499|11742570|FG003|STARTED|Overall Study||6
10456982|NCT01008475|11604713|FG004|COMPLETED|Overall Study||67
10456983|NCT01008475|11604714|FG005|COMPLETED|Overall Study||67
10456984|NCT01008475|11604715|FG006|COMPLETED|Overall Study||67
10456985|NCT01008475|11604709|FG000|NOT COMPLETED|Overall Study||0
10456986|NCT01008475|11604710|FG001|NOT COMPLETED|Overall Study||0
10456987|NCT01008475|11604711|FG002|NOT COMPLETED|Overall Study||0
10456988|NCT01008475|11604712|FG003|NOT COMPLETED|Overall Study||0
10456989|NCT01008475|11604713|FG004|NOT COMPLETED|Overall Study||5
10456990|NCT01008475|11604714|FG005|NOT COMPLETED|Overall Study||6
10456991|NCT01008475|11604715|FG006|NOT COMPLETED|Overall Study||4
10456992|NCT01008553|11604731|FG000|STARTED|Period 1 (Titration Period)||258
10586919|NCT01747499|11742571|FG004|STARTED|Overall Study||39
10586920|NCT01747499|11742567|FG000|COMPLETED|Overall Study||2
10586921|NCT01747499|11742568|FG001|COMPLETED|Overall Study||2
10586922|NCT01747499|11742569|FG002|COMPLETED|Overall Study||3
10586923|NCT01747499|11742570|FG003|COMPLETED|Overall Study||4
10586924|NCT01747499|11742571|FG004|COMPLETED|Overall Study||24
10586925|NCT01747499|11742567|FG000|NOT COMPLETED|Overall Study||1
10586926|NCT01747499|11742568|FG001|NOT COMPLETED|Overall Study||1
10586927|NCT01747499|11742569|FG002|NOT COMPLETED|Overall Study||0
10586928|NCT01747499|11742570|FG003|NOT COMPLETED|Overall Study||2
10586929|NCT01747499|11742571|FG004|NOT COMPLETED|Overall Study||15
10586930|NCT01747551|11742587|FG000|STARTED|Overall Study||43
10586931|NCT01747551|11742588|FG001|STARTED|Overall Study||21
10586932|NCT01747551|11742587|FG000|COMPLETED|Overall Study||0
10586933|NCT01747551|11742588|FG001|COMPLETED|Overall Study||0
10586934|NCT01747551|11742587|FG000|NOT COMPLETED|Overall Study||43
10586935|NCT01747551|11742588|FG001|NOT COMPLETED|Overall Study||21
10586936|NCT01747629|11742596|FG000|STARTED|Overall Study||85
10586937|NCT01747629|11742597|FG001|STARTED|Overall Study||75
10586938|NCT01747629|11742596|FG000|Treated|Overall Study|Safety set and full analysis set|84
10586939|NCT01747629|11742597|FG001|Treated|Overall Study|Safety set and full analysis set|75
10456993|NCT01008553|11604732|FG001|STARTED|Period 1 (Titration Period)||0
10586940|NCT01747629|11742596|FG000|COMPLETED|Overall Study||77
10586941|NCT01747629|11742597|FG001|COMPLETED|Overall Study||69
10586942|NCT01747629|11742596|FG000|NOT COMPLETED|Overall Study||8
10586943|NCT01747629|11742597|FG001|NOT COMPLETED|Overall Study||6
10586944|NCT01747655|11742603|FG000|STARTED|Temporary Naso-jejunal Tube Period|Main Analysis Set (MAS): participants with baseline and 1 further visit and ≥ 1 Duodopa treatment|64
10586945|NCT01747655|11742604|FG001|STARTED|Temporary Naso-jejunal Tube Period||0
10586946|NCT01747655|11742603|FG000|COMPLETED|Temporary Naso-jejunal Tube Period||64
10586947|NCT01747655|11742604|FG001|COMPLETED|Temporary Naso-jejunal Tube Period||0
10586948|NCT01747655|11742603|FG000|NOT COMPLETED|Temporary Naso-jejunal Tube Period||0
10586949|NCT01747655|11742604|FG001|NOT COMPLETED|Temporary Naso-jejunal Tube Period||0
10586950|NCT01747655|11742603|FG000|STARTED|PEG-J Period (Duodopa Treatment)|Dudopa MAS: Participants in the MAS that received Duodopa via PEG-J.|58
10586951|NCT01747655|11742604|FG001|STARTED|PEG-J Period (Duodopa Treatment)|Participants in the MAS that returned to SoC (no PEG-J introduced; did not meet selection criteria)|6
10586952|NCT01747655|11742603|FG000|COMPLETED|PEG-J Period (Duodopa Treatment)||44
10586953|NCT01747655|11742604|FG001|COMPLETED|PEG-J Period (Duodopa Treatment)||6
10586954|NCT01747655|11742603|FG000|NOT COMPLETED|PEG-J Period (Duodopa Treatment)||14
10586955|NCT01747655|11742604|FG001|NOT COMPLETED|PEG-J Period (Duodopa Treatment)||0
10586956|NCT01747655|11742603|FG000|STARTED|PEG-J Period (Continued Treatment)||41
10586957|NCT01747655|11742604|FG001|STARTED|PEG-J Period (Continued Treatment)|SoC MAS: 6 SoC participants plus 9 participants who received Duodopa via PEG-J then returned to SoC|15
10586958|NCT01747655|11742603|FG000|COMPLETED|PEG-J Period (Continued Treatment)||41
10586959|NCT01747655|11742604|FG001|COMPLETED|PEG-J Period (Continued Treatment)||15
10586960|NCT01747655|11742603|FG000|NOT COMPLETED|PEG-J Period (Continued Treatment)||0
10586961|NCT01747655|11742604|FG001|NOT COMPLETED|PEG-J Period (Continued Treatment)||0
10586962|NCT01747772|11742610|FG000|STARTED|Overall Study||180
10586963|NCT01747772|11742610|FG000|Analysis Population|Overall Study|All participants who completed the study and had adequate SWE and liver biopsy data.|164
10586964|NCT01747772|11742610|FG000|COMPLETED|Overall Study||171
10586965|NCT01747772|11742610|FG000|NOT COMPLETED|Overall Study||9
10586966|NCT01747811|11742620|FG000|STARTED|Overall Study||16
10586967|NCT01747811|11742621|FG001|STARTED|Overall Study||16
10586968|NCT01747811|11742620|FG000|COMPLETED|Overall Study||14
10586969|NCT01747811|11742621|FG001|COMPLETED|Overall Study||12
10586970|NCT01747811|11742620|FG000|NOT COMPLETED|Overall Study||2
10586971|NCT01747811|11742621|FG001|NOT COMPLETED|Overall Study||4
10586972|NCT01747837|11742631|FG000|STARTED|Overall Study||25
10586973|NCT01747837|11742632|FG001|STARTED|Overall Study||23
10586974|NCT01747837|11742631|FG000|COMPLETED|Overall Study||16
10586975|NCT01747837|11742632|FG001|COMPLETED|Overall Study||17
10586976|NCT01747837|11742631|FG000|NOT COMPLETED|Overall Study||9
10586977|NCT01747837|11742632|FG001|NOT COMPLETED|Overall Study||6
10586978|NCT01747850|11742641|FG000|STARTED|Overall Study||5
10586979|NCT01747850|11742642|FG001|STARTED|Overall Study||20
10586980|NCT01747850|11742643|FG002|STARTED|Overall Study||20
10586981|NCT01747850|11742641|FG000|COMPLETED|Overall Study||4
10586982|NCT01747850|11742642|FG001|COMPLETED|Overall Study||13
10586983|NCT01747850|11742643|FG002|COMPLETED|Overall Study||14
10586984|NCT01747850|11742641|FG000|NOT COMPLETED|Overall Study||1
10586985|NCT01747850|11742642|FG001|NOT COMPLETED|Overall Study||7
10586986|NCT01747850|11742643|FG002|NOT COMPLETED|Overall Study||6
10586987|NCT01747876|11742666|FG000|STARTED|Overall Study||5
10586988|NCT01747876|11742667|FG001|STARTED|Overall Study||15
10586989|NCT01747876|11742668|FG002|STARTED|Overall Study||12
10586990|NCT01747876|11742666|FG000|COMPLETED|Overall Study||0
10586991|NCT01747876|11742667|FG001|COMPLETED|Overall Study||0
10586992|NCT01747876|11742668|FG002|COMPLETED|Overall Study||0
10586993|NCT01747876|11742666|FG000|NOT COMPLETED|Overall Study||5
10586994|NCT01747876|11742667|FG001|NOT COMPLETED|Overall Study||15
10586995|NCT01747876|11742668|FG002|NOT COMPLETED|Overall Study||12
10586996|NCT01747915|11742682|FG000|STARTED|Overall Study||75
10586997|NCT01747915|11742683|FG001|STARTED|Overall Study||72
10586998|NCT01747915|11742684|FG002|STARTED|Overall Study||72
10586999|NCT01747915|11742682|FG000|COMPLETED|Overall Study||60
10587000|NCT01747915|11742683|FG001|COMPLETED|Overall Study||61
10587001|NCT01747915|11742684|FG002|COMPLETED|Overall Study||66
10587002|NCT01747915|11742682|FG000|NOT COMPLETED|Overall Study||15
10587003|NCT01747915|11742683|FG001|NOT COMPLETED|Overall Study||11
10587004|NCT01747915|11742684|FG002|NOT COMPLETED|Overall Study||6
10587005|NCT01747928|11742700|FG000|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
10587006|NCT01747928|11742701|FG001|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
10587007|NCT01747928|11742702|FG002|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
10587008|NCT01747928|11742703|FG003|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
10587009|NCT01747928|11742704|FG004|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
10587010|NCT01747928|11742705|FG005|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
10806880|NCT03923530|11968539|FG000|NOT COMPLETED|Overall Study||4
10587011|NCT01747928|11742706|FG006|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
10587012|NCT01747928|11742707|FG007|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
10587013|NCT01747928|11742700|FG000|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
10587014|NCT01747928|11742701|FG001|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
10587015|NCT01747928|11742702|FG002|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
10587016|NCT01747928|11742703|FG003|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
10587017|NCT01747928|11742704|FG004|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
10587018|NCT01747928|11742705|FG005|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
10587019|NCT01747928|11742706|FG006|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
10587020|NCT01747928|11742707|FG007|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
10587021|NCT01747928|11742700|FG000|NOT COMPLETED|Overall Study||0
10587022|NCT01747928|11742701|FG001|NOT COMPLETED|Overall Study||0
10587023|NCT01747928|11742702|FG002|NOT COMPLETED|Overall Study||0
10587024|NCT01747928|11742703|FG003|NOT COMPLETED|Overall Study||0
10587025|NCT01747928|11742704|FG004|NOT COMPLETED|Overall Study||0
10587026|NCT01747928|11742705|FG005|NOT COMPLETED|Overall Study||0
10587027|NCT01747928|11742706|FG006|NOT COMPLETED|Overall Study||0
10587028|NCT01747928|11742707|FG007|NOT COMPLETED|Overall Study||0
10587029|NCT01748045|11742728|FG000|STARTED|Overall Study||2
10587030|NCT01748045|11742729|FG001|STARTED|Overall Study||1
10587031|NCT01748045|11742728|FG000|COMPLETED|Overall Study||2
10587032|NCT01748045|11742729|FG001|COMPLETED|Overall Study||1
10587033|NCT01748045|11742728|FG000|NOT COMPLETED|Overall Study||0
10587034|NCT01748045|11742729|FG001|NOT COMPLETED|Overall Study||0
10587035|NCT01748071|11742744|FG000|STARTED|Overall Study||40
10587036|NCT01748071|11742745|FG001|STARTED|Overall Study||40
10587037|NCT01748071|11742746|FG002|STARTED|Overall Study||40
10587038|NCT01748071|11742744|FG000|COMPLETED|Overall Study||38
10587039|NCT01748071|11742745|FG001|COMPLETED|Overall Study||38
10587040|NCT01748071|11742746|FG002|COMPLETED|Overall Study||40
10587041|NCT01748071|11742744|FG000|NOT COMPLETED|Overall Study||2
10587042|NCT01748071|11742745|FG001|NOT COMPLETED|Overall Study||2
10587043|NCT01748071|11742746|FG002|NOT COMPLETED|Overall Study||0
10587044|NCT01748227|11742754|FG000|STARTED|Overall Study||20
10587045|NCT01748227|11742754|FG000|COMPLETED|Overall Study||17
10587046|NCT01748227|11742754|FG000|NOT COMPLETED|Overall Study||3
10587047|NCT01748240|11742759|FG000|STARTED|Overall Study||21
10587048|NCT01748240|11742759|FG000|COMPLETED|Overall Study||21
10587049|NCT01748240|11742759|FG000|NOT COMPLETED|Overall Study||0
10587050|NCT01748292|11742765|FG000|STARTED|Overall Study||20
10587051|NCT01748292|11742766|FG001|STARTED|Overall Study||40
10587052|NCT01748292|11742765|FG000|COMPLETED|Overall Study||18
10587053|NCT01748292|11742766|FG001|COMPLETED|Overall Study||28
10587054|NCT01748292|11742765|FG000|NOT COMPLETED|Overall Study||2
10587055|NCT01748292|11742766|FG001|NOT COMPLETED|Overall Study||12
10587056|NCT01748552|11742784|FG000|STARTED|Intervention Period 1 and Washout||3
10587057|NCT01748552|11742785|FG001|STARTED|Intervention Period 1 and Washout||3
10587058|NCT01748552|11742786|FG002|STARTED|Intervention Period 1 and Washout||3
10587059|NCT01748552|11742787|FG003|STARTED|Intervention Period 1 and Washout||3
10587060|NCT01748552|11742788|FG004|STARTED|Intervention Period 1 and Washout||3
10587061|NCT01748552|11742789|FG005|STARTED|Intervention Period 1 and Washout||3
10587062|NCT01748552|11742790|FG006|STARTED|Intervention Period 1 and Washout||3
10587063|NCT01748552|11742791|FG007|STARTED|Intervention Period 1 and Washout||3
10587064|NCT01748552|11742792|FG008|STARTED|Intervention Period 1 and Washout||3
10587065|NCT01748552|11742793|FG009|STARTED|Intervention Period 1 and Washout||3
10587066|NCT01748552|11742794|FG010|STARTED|Intervention Period 1 and Washout||3
10587067|NCT01748552|11742795|FG011|STARTED|Intervention Period 1 and Washout||3
10587068|NCT01748552|11742784|FG000|COMPLETED|Intervention Period 1 and Washout||3
10587069|NCT01748552|11742785|FG001|COMPLETED|Intervention Period 1 and Washout||3
10587070|NCT01748552|11742786|FG002|COMPLETED|Intervention Period 1 and Washout||3
10587071|NCT01748552|11742787|FG003|COMPLETED|Intervention Period 1 and Washout||3
10587072|NCT01748552|11742788|FG004|COMPLETED|Intervention Period 1 and Washout||3
10587073|NCT01748552|11742789|FG005|COMPLETED|Intervention Period 1 and Washout||3
10587074|NCT01748552|11742790|FG006|COMPLETED|Intervention Period 1 and Washout||3
10587075|NCT01748552|11742791|FG007|COMPLETED|Intervention Period 1 and Washout||3
10587076|NCT01748552|11742792|FG008|COMPLETED|Intervention Period 1 and Washout||3
10587077|NCT01748552|11742793|FG009|COMPLETED|Intervention Period 1 and Washout||3
10587078|NCT01748552|11742794|FG010|COMPLETED|Intervention Period 1 and Washout||3
10587079|NCT01748552|11742795|FG011|COMPLETED|Intervention Period 1 and Washout||3
10587080|NCT01748552|11742784|FG000|NOT COMPLETED|Intervention Period 1 and Washout||0
10587081|NCT01748552|11742785|FG001|NOT COMPLETED|Intervention Period 1 and Washout||0
10587082|NCT01748552|11742786|FG002|NOT COMPLETED|Intervention Period 1 and Washout||0
10587083|NCT01748552|11742787|FG003|NOT COMPLETED|Intervention Period 1 and Washout||0
10587084|NCT01748552|11742788|FG004|NOT COMPLETED|Intervention Period 1 and Washout||0
10587085|NCT01748552|11742789|FG005|NOT COMPLETED|Intervention Period 1 and Washout||0
10587086|NCT01748552|11742790|FG006|NOT COMPLETED|Intervention Period 1 and Washout||0
10806881|NCT03914417|11968543|FG000|STARTED|Overall Study||21
10587087|NCT01748552|11742791|FG007|NOT COMPLETED|Intervention Period 1 and Washout||0
10587088|NCT01748552|11742792|FG008|NOT COMPLETED|Intervention Period 1 and Washout||0
10587089|NCT01748552|11742793|FG009|NOT COMPLETED|Intervention Period 1 and Washout||0
10587090|NCT01748552|11742794|FG010|NOT COMPLETED|Intervention Period 1 and Washout||0
10587091|NCT01748552|11742795|FG011|NOT COMPLETED|Intervention Period 1 and Washout||0
10587092|NCT01748552|11742784|FG000|STARTED|Intervention Period 2 and Washout||3
10587093|NCT01748552|11742785|FG001|STARTED|Intervention Period 2 and Washout||3
10587094|NCT01748552|11742786|FG002|STARTED|Intervention Period 2 and Washout||3
10587095|NCT01748552|11742787|FG003|STARTED|Intervention Period 2 and Washout||3
10587096|NCT01748552|11742788|FG004|STARTED|Intervention Period 2 and Washout||3
10587097|NCT01748552|11742789|FG005|STARTED|Intervention Period 2 and Washout||3
10587098|NCT01748552|11742790|FG006|STARTED|Intervention Period 2 and Washout||3
10587099|NCT01748552|11742791|FG007|STARTED|Intervention Period 2 and Washout||3
10587100|NCT01748552|11742792|FG008|STARTED|Intervention Period 2 and Washout||3
10587101|NCT01748552|11742793|FG009|STARTED|Intervention Period 2 and Washout||3
10587102|NCT01748552|11742794|FG010|STARTED|Intervention Period 2 and Washout||3
10587103|NCT01748552|11742795|FG011|STARTED|Intervention Period 2 and Washout||3
10587104|NCT01748552|11742784|FG000|COMPLETED|Intervention Period 2 and Washout||3
10587105|NCT01748552|11742785|FG001|COMPLETED|Intervention Period 2 and Washout||3
10587106|NCT01748552|11742786|FG002|COMPLETED|Intervention Period 2 and Washout||2
10587107|NCT01748552|11742787|FG003|COMPLETED|Intervention Period 2 and Washout||3
10587108|NCT01748552|11742788|FG004|COMPLETED|Intervention Period 2 and Washout||3
10587109|NCT01748552|11742789|FG005|COMPLETED|Intervention Period 2 and Washout||3
10587110|NCT01748552|11742790|FG006|COMPLETED|Intervention Period 2 and Washout||0
10587111|NCT01748552|11742791|FG007|COMPLETED|Intervention Period 2 and Washout||0
10587112|NCT01748552|11742792|FG008|COMPLETED|Intervention Period 2 and Washout||0
10587113|NCT01748552|11742793|FG009|COMPLETED|Intervention Period 2 and Washout||3
10587114|NCT01748552|11742794|FG010|COMPLETED|Intervention Period 2 and Washout||3
10587115|NCT01748552|11742795|FG011|COMPLETED|Intervention Period 2 and Washout||3
10587116|NCT01748552|11742784|FG000|NOT COMPLETED|Intervention Period 2 and Washout||0
10587117|NCT01748552|11742785|FG001|NOT COMPLETED|Intervention Period 2 and Washout||0
10587118|NCT01748552|11742786|FG002|NOT COMPLETED|Intervention Period 2 and Washout||1
10587119|NCT01748552|11742787|FG003|NOT COMPLETED|Intervention Period 2 and Washout||0
10587120|NCT01748552|11742788|FG004|NOT COMPLETED|Intervention Period 2 and Washout||0
10587121|NCT01748552|11742789|FG005|NOT COMPLETED|Intervention Period 2 and Washout||0
10587122|NCT01748552|11742790|FG006|NOT COMPLETED|Intervention Period 2 and Washout||3
10587123|NCT01748552|11742791|FG007|NOT COMPLETED|Intervention Period 2 and Washout||3
10587124|NCT01748552|11742792|FG008|NOT COMPLETED|Intervention Period 2 and Washout||3
10587125|NCT01748552|11742793|FG009|NOT COMPLETED|Intervention Period 2 and Washout||0
10587126|NCT01748552|11742794|FG010|NOT COMPLETED|Intervention Period 2 and Washout||0
10587127|NCT01748552|11742795|FG011|NOT COMPLETED|Intervention Period 2 and Washout||0
10587128|NCT01748552|11742784|FG000|STARTED|Intervention Period 3 and Washout||3
10587129|NCT01748552|11742785|FG001|STARTED|Intervention Period 3 and Washout||3
10587130|NCT01748552|11742786|FG002|STARTED|Intervention Period 3 and Washout||2
10587131|NCT01748552|11742787|FG003|STARTED|Intervention Period 3 and Washout||3
10587132|NCT01748552|11742788|FG004|STARTED|Intervention Period 3 and Washout||3
10587133|NCT01748552|11742789|FG005|STARTED|Intervention Period 3 and Washout||3
10587134|NCT01748552|11742790|FG006|STARTED|Intervention Period 3 and Washout||0
10587135|NCT01748552|11742791|FG007|STARTED|Intervention Period 3 and Washout||0
10587136|NCT01748552|11742792|FG008|STARTED|Intervention Period 3 and Washout||0
10587137|NCT01748552|11742793|FG009|STARTED|Intervention Period 3 and Washout||3
10587138|NCT01748552|11742794|FG010|STARTED|Intervention Period 3 and Washout||3
10587139|NCT01748552|11742795|FG011|STARTED|Intervention Period 3 and Washout||3
10806857|NCT03942042|11968520|FG001|Received at Least One Dose of Study Drug|Induction Dosing Period (12 Weeks)||5
10806858|NCT03942042|11968519|FG000|Participants With GIS=1 at Week 12|Induction Dosing Period (12 Weeks)||4
10806859|NCT03942042|11968520|FG001|Participants With GIS=1 at Week 12|Induction Dosing Period (12 Weeks)||0
10806860|NCT03942042|11968519|FG000|Participants Who Completed Week 12 With GIS >= 2|Induction Dosing Period (12 Weeks)||2
10806861|NCT03942042|11968520|FG001|Participants Who Completed Week 12 With GIS >= 2|Induction Dosing Period (12 Weeks)||4
10806862|NCT03942042|11968519|FG000|COMPLETED|Induction Dosing Period (12 Weeks)||6
10806863|NCT03942042|11968520|FG001|COMPLETED|Induction Dosing Period (12 Weeks)||4
10806864|NCT03942042|11968519|FG000|NOT COMPLETED|Induction Dosing Period (12 Weeks)||1
10806865|NCT03942042|11968520|FG001|NOT COMPLETED|Induction Dosing Period (12 Weeks)||1
10806866|NCT03942042|11968519|FG000|STARTED|Maintenance Dosing Period (8 Weeks)|Only participants with GIS ≥2 at Week 12 and based on investigators' discretion continued to maintenance dosing period.|2
10806867|NCT03942042|11968520|FG001|STARTED|Maintenance Dosing Period (8 Weeks)||4
10806868|NCT03942042|11968519|FG000|COMPLETED|Maintenance Dosing Period (8 Weeks)||2
10806869|NCT03942042|11968520|FG001|COMPLETED|Maintenance Dosing Period (8 Weeks)||4
10806870|NCT03942042|11968519|FG000|NOT COMPLETED|Maintenance Dosing Period (8 Weeks)||0
10806871|NCT03942042|11968520|FG001|NOT COMPLETED|Maintenance Dosing Period (8 Weeks)||0
10806872|NCT03938337|11968532|FG000|STARTED|Overall Study||1
10806873|NCT03938337|11968533|FG001|STARTED|Overall Study||0
10806874|NCT03938337|11968532|FG000|COMPLETED|Overall Study||1
10806875|NCT03938337|11968533|FG001|COMPLETED|Overall Study||0
10806876|NCT03938337|11968532|FG000|NOT COMPLETED|Overall Study||0
10806877|NCT03938337|11968533|FG001|NOT COMPLETED|Overall Study||0
10806878|NCT03923530|11968539|FG000|STARTED|Overall Study||12
10806879|NCT03923530|11968539|FG000|COMPLETED|Overall Study||8
10806882|NCT03914417|11968543|FG000|COMPLETED|Overall Study||19
10806883|NCT03914417|11968543|FG000|NOT COMPLETED|Overall Study||2
10806884|NCT03913377|11968549|FG000|STARTED|Period 1||21
10806885|NCT03913377|11968550|FG001|STARTED|Period 1||22
10806886|NCT03913377|11968551|FG002|STARTED|Period 1||22
10806887|NCT03913377|11968549|FG000|COMPLETED|Period 1||21
10806888|NCT03913377|11968550|FG001|COMPLETED|Period 1||21
10806889|NCT03913377|11968551|FG002|COMPLETED|Period 1||21
10806890|NCT03913377|11968549|FG000|NOT COMPLETED|Period 1||0
10806891|NCT03913377|11968550|FG001|NOT COMPLETED|Period 1||1
10806892|NCT03913377|11968551|FG002|NOT COMPLETED|Period 1||1
10806893|NCT03913377|11968549|FG000|STARTED|Period 2||0
10587140|NCT01748552|11742784|FG000|COMPLETED|Intervention Period 3 and Washout||3
10587141|NCT01748552|11742785|FG001|COMPLETED|Intervention Period 3 and Washout||3
10587142|NCT01748552|11742786|FG002|COMPLETED|Intervention Period 3 and Washout||2
10587143|NCT01748552|11742787|FG003|COMPLETED|Intervention Period 3 and Washout||3
10587144|NCT01748552|11742788|FG004|COMPLETED|Intervention Period 3 and Washout||3
10703098|NCT02581410|11867664|FG001|STARTED|Vaccination Phase||215
10806894|NCT03913377|11968550|FG001|STARTED|Period 2||21
10806895|NCT03913377|11968551|FG002|STARTED|Period 2||21
10587145|NCT01748552|11742789|FG005|COMPLETED|Intervention Period 3 and Washout||3
10587146|NCT01748552|11742790|FG006|COMPLETED|Intervention Period 3 and Washout||0
10587147|NCT01748552|11742791|FG007|COMPLETED|Intervention Period 3 and Washout||0
10587148|NCT01748552|11742792|FG008|COMPLETED|Intervention Period 3 and Washout||0
10587149|NCT01748552|11742793|FG009|COMPLETED|Intervention Period 3 and Washout||3
10587150|NCT01748552|11742794|FG010|COMPLETED|Intervention Period 3 and Washout||3
10587151|NCT01748552|11742795|FG011|COMPLETED|Intervention Period 3 and Washout||3
10587152|NCT01748552|11742784|FG000|NOT COMPLETED|Intervention Period 3 and Washout||0
10587153|NCT01748552|11742785|FG001|NOT COMPLETED|Intervention Period 3 and Washout||0
10587154|NCT01748552|11742786|FG002|NOT COMPLETED|Intervention Period 3 and Washout||0
10587155|NCT01748552|11742787|FG003|NOT COMPLETED|Intervention Period 3 and Washout||0
10587156|NCT01748552|11742788|FG004|NOT COMPLETED|Intervention Period 3 and Washout||0
10587157|NCT01748552|11742789|FG005|NOT COMPLETED|Intervention Period 3 and Washout||0
10587158|NCT01748552|11742790|FG006|NOT COMPLETED|Intervention Period 3 and Washout||0
10587159|NCT01748552|11742791|FG007|NOT COMPLETED|Intervention Period 3 and Washout||0
10587160|NCT01748552|11742792|FG008|NOT COMPLETED|Intervention Period 3 and Washout||0
10587161|NCT01748552|11742793|FG009|NOT COMPLETED|Intervention Period 3 and Washout||0
10587162|NCT01748552|11742794|FG010|NOT COMPLETED|Intervention Period 3 and Washout||0
10587163|NCT01748552|11742795|FG011|NOT COMPLETED|Intervention Period 3 and Washout||0
10587164|NCT01748643|11742837|FG000|STARTED|Overall Study||30
10587165|NCT01748643|11742838|FG001|STARTED|Overall Study||30
10587166|NCT01748643|11742837|FG000|COMPLETED|Overall Study||30
10587167|NCT01748643|11742838|FG001|COMPLETED|Overall Study||30
10587168|NCT01748643|11742837|FG000|NOT COMPLETED|Overall Study||0
10587169|NCT01748643|11742838|FG001|NOT COMPLETED|Overall Study||0
10587170|NCT01748695|11742844|FG000|STARTED|First Intervention (4 Weeks)||14
10587171|NCT01748695|11742845|FG001|STARTED|First Intervention (4 Weeks)||11
10587172|NCT01748695|11742844|FG000|COMPLETED|First Intervention (4 Weeks)||14
10587173|NCT01748695|11742845|FG001|COMPLETED|First Intervention (4 Weeks)||11
10587174|NCT01748695|11742844|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
10587175|NCT01748695|11742845|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
10587176|NCT01748695|11742844|FG000|STARTED|Second Intervention (4 Weeks)||14
10587177|NCT01748695|11742845|FG001|STARTED|Second Intervention (4 Weeks)||11
10587178|NCT01748695|11742844|FG000|COMPLETED|Second Intervention (4 Weeks)||14
10587179|NCT01748695|11742845|FG001|COMPLETED|Second Intervention (4 Weeks)||11
10587180|NCT01748695|11742844|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
10587181|NCT01748695|11742845|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
10806896|NCT03913377|11968549|FG000|COMPLETED|Period 2||0
10806897|NCT03913377|11968550|FG001|COMPLETED|Period 2||21
10806898|NCT03913377|11968551|FG002|COMPLETED|Period 2||21
10806899|NCT03913377|11968549|FG000|NOT COMPLETED|Period 2||0
10806900|NCT03913377|11968550|FG001|NOT COMPLETED|Period 2||0
10806901|NCT03913377|11968551|FG002|NOT COMPLETED|Period 2||0
10806902|NCT03937791|11968558|FG000|STARTED|Overall Study||1
10806903|NCT03937791|11968558|FG000|COMPLETED|Overall Study||1
10806904|NCT03937791|11968558|FG000|NOT COMPLETED|Overall Study||0
10806905|NCT03937778|11968562|FG000|STARTED|Overall Study||7
10806906|NCT03937778|11968562|FG000|COMPLETED|Overall Study||5
10806907|NCT03937778|11968562|FG000|NOT COMPLETED|Overall Study||2
10806908|NCT03937479|11968571|FG000|STARTED|Overall Study||83
10587182|NCT01748760|11742853|FG000|STARTED|Overall Study||25
10587183|NCT01748760|11742854|FG001|STARTED|Overall Study||25
10587184|NCT01748760|11742853|FG000|COMPLETED|Overall Study||19
10703099|NCT02581410|11867663|FG000|COMPLETED|Vaccination Phase||213
10703100|NCT02581410|11867664|FG001|COMPLETED|Vaccination Phase||212
10703101|NCT02581410|11867663|FG000|NOT COMPLETED|Vaccination Phase||2
10703102|NCT02581410|11867664|FG001|NOT COMPLETED|Vaccination Phase||3
10703103|NCT02581410|11867663|FG000|STARTED|End of Study Phase||215
10703104|NCT02581410|11867664|FG001|STARTED|End of Study Phase||215
10703105|NCT02581410|11867663|FG000|COMPLETED|End of Study Phase||210
10703106|NCT02581410|11867664|FG001|COMPLETED|End of Study Phase||204
10703107|NCT02581410|11867663|FG000|NOT COMPLETED|End of Study Phase||5
10703108|NCT02581410|11867664|FG001|NOT COMPLETED|End of Study Phase||11
10703109|NCT02581475|11867673|FG000|STARTED|Overall Study||193
10703110|NCT02581475|11867674|FG001|STARTED|Overall Study||193
10703111|NCT02581475|11867673|FG000|COMPLETED|Overall Study||182
10703112|NCT02581475|11867674|FG001|COMPLETED|Overall Study||178
10703113|NCT02581475|11867673|FG000|NOT COMPLETED|Overall Study||11
10703114|NCT02581475|11867674|FG001|NOT COMPLETED|Overall Study||15
10703115|NCT02581488|11867682|FG000|STARTED|Overall Study||51
10703116|NCT02581488|11867683|FG001|STARTED|Overall Study||51
10703117|NCT02581488|11867682|FG000|COMPLETED|Overall Study||42
10703118|NCT02581488|11867683|FG001|COMPLETED|Overall Study||40
10703119|NCT02581488|11867682|FG000|NOT COMPLETED|Overall Study||9
10703120|NCT02581488|11867683|FG001|NOT COMPLETED|Overall Study||11
10703121|NCT02581839|11867689|FG000|STARTED|Overall Study||9
10703122|NCT02581839|11867689|FG000|COMPLETED|Overall Study||9
10806909|NCT03937479|11968572|FG001|STARTED|Overall Study||85
10587185|NCT01748760|11742854|FG001|COMPLETED|Overall Study||23
10587186|NCT01748760|11742853|FG000|NOT COMPLETED|Overall Study||6
10587187|NCT01748760|11742854|FG001|NOT COMPLETED|Overall Study||2
10587188|NCT01748799|11742868|FG000|STARTED|Overall Study||6
10587189|NCT01748799|11742869|FG001|STARTED|Overall Study||1
10587190|NCT01748799|11742870|FG002|STARTED|Overall Study||1
10587191|NCT01748799|11742871|FG003|STARTED|Overall Study||2
10587192|NCT01748799|11742872|FG004|STARTED|Overall Study||1
10587193|NCT01748799|11742873|FG005|STARTED|Overall Study||2
10587194|NCT01748799|11742874|FG006|STARTED|Overall Study||2
10587195|NCT01748799|11742875|FG007|STARTED|Overall Study||1
10587196|NCT01748799|11742868|FG000|Completed SAU of Fixed Dose Placebo|Overall Study||2
10587197|NCT01748799|11742869|FG001|Completed SAU of Fixed Dose Placebo|Overall Study||1
10587198|NCT01748799|11742870|FG002|Completed SAU of Fixed Dose Placebo|Overall Study||1
10587199|NCT01748799|11742871|FG003|Completed SAU of Fixed Dose Placebo|Overall Study||2
10587200|NCT01748799|11742872|FG004|Completed SAU of Fixed Dose Placebo|Overall Study||1
10587201|NCT01748799|11742873|FG005|Completed SAU of Fixed Dose Placebo|Overall Study||1
10587202|NCT01748799|11742874|FG006|Completed SAU of Fixed Dose Placebo|Overall Study||1
10587203|NCT01748799|11742875|FG007|Completed SAU of Fixed Dose Placebo|Overall Study||1
10587204|NCT01748799|11742868|FG000|Completed Fixed Dose Placebo|Overall Study||2
10587205|NCT01748799|11742869|FG001|Completed Fixed Dose Placebo|Overall Study||1
10587206|NCT01748799|11742870|FG002|Completed Fixed Dose Placebo|Overall Study||1
10587207|NCT01748799|11742871|FG003|Completed Fixed Dose Placebo|Overall Study||2
10587208|NCT01748799|11742872|FG004|Completed Fixed Dose Placebo|Overall Study||1
10587209|NCT01748799|11742873|FG005|Completed Fixed Dose Placebo|Overall Study||1
10587210|NCT01748799|11742874|FG006|Completed Fixed Dose Placebo|Overall Study||1
10587211|NCT01748799|11742875|FG007|Completed Fixed Dose Placebo|Overall Study||1
10587212|NCT01748799|11742868|FG000|Completed SAU of Fixed Dose Sativex|Overall Study||1
10587213|NCT01748799|11742869|FG001|Completed SAU of Fixed Dose Sativex|Overall Study||1
10587214|NCT01748799|11742870|FG002|Completed SAU of Fixed Dose Sativex|Overall Study||1
10587215|NCT01748799|11742871|FG003|Completed SAU of Fixed Dose Sativex|Overall Study||2
10587216|NCT01748799|11742872|FG004|Completed SAU of Fixed Dose Sativex|Overall Study||1
10587217|NCT01748799|11742873|FG005|Completed SAU of Fixed Dose Sativex|Overall Study||1
10587218|NCT01748799|11742874|FG006|Completed SAU of Fixed Dose Sativex|Overall Study||1
10587219|NCT01748799|11742875|FG007|Completed SAU of Fixed Dose Sativex|Overall Study||1
10587220|NCT01748799|11742868|FG000|Completed Fixed Dose Sativex|Overall Study||1
10587221|NCT01748799|11742869|FG001|Completed Fixed Dose Sativex|Overall Study||1
10587222|NCT01748799|11742870|FG002|Completed Fixed Dose Sativex|Overall Study||1
10587223|NCT01748799|11742871|FG003|Completed Fixed Dose Sativex|Overall Study||2
10587224|NCT01748799|11742872|FG004|Completed Fixed Dose Sativex|Overall Study||1
10587225|NCT01748799|11742873|FG005|Completed Fixed Dose Sativex|Overall Study||1
10587226|NCT01748799|11742874|FG006|Completed Fixed Dose Sativex|Overall Study||1
10587227|NCT01748799|11742875|FG007|Completed Fixed Dose Sativex|Overall Study||1
10587228|NCT01748799|11742868|FG000|Completed SAU of Self-titrated Placebo|Overall Study||5
10587229|NCT01748799|11742869|FG001|Completed SAU of Self-titrated Placebo|Overall Study||1
10587230|NCT01748799|11742870|FG002|Completed SAU of Self-titrated Placebo|Overall Study||1
10587231|NCT01748799|11742871|FG003|Completed SAU of Self-titrated Placebo|Overall Study||2
10587232|NCT01748799|11742872|FG004|Completed SAU of Self-titrated Placebo|Overall Study||1
10587233|NCT01748799|11742873|FG005|Completed SAU of Self-titrated Placebo|Overall Study||2
10587234|NCT01748799|11742874|FG006|Completed SAU of Self-titrated Placebo|Overall Study||1
10587235|NCT01748799|11742875|FG007|Completed SAU of Self-titrated Placebo|Overall Study||1
10587236|NCT01748799|11742868|FG000|Completed Self-titrated Placebo|Overall Study||4
10587237|NCT01748799|11742869|FG001|Completed Self-titrated Placebo|Overall Study||1
10587238|NCT01748799|11742870|FG002|Completed Self-titrated Placebo|Overall Study||1
10587239|NCT01748799|11742871|FG003|Completed Self-titrated Placebo|Overall Study||2
10587240|NCT01748799|11742872|FG004|Completed Self-titrated Placebo|Overall Study||1
10587241|NCT01748799|11742873|FG005|Completed Self-titrated Placebo|Overall Study||2
10587242|NCT01748799|11742874|FG006|Completed Self-titrated Placebo|Overall Study||1
10587243|NCT01748799|11742875|FG007|Completed Self-titrated Placebo|Overall Study||1
10587244|NCT01748799|11742868|FG000|Completed SAU of Self-titrated Sativex|Overall Study||2
10587245|NCT01748799|11742869|FG001|Completed SAU of Self-titrated Sativex|Overall Study||1
10587246|NCT01748799|11742870|FG002|Completed SAU of Self-titrated Sativex|Overall Study||1
10587247|NCT01748799|11742871|FG003|Completed SAU of Self-titrated Sativex|Overall Study||2
10587248|NCT01748799|11742872|FG004|Completed SAU of Self-titrated Sativex|Overall Study||1
10587249|NCT01748799|11742873|FG005|Completed SAU of Self-titrated Sativex|Overall Study||2
10587250|NCT01748799|11742874|FG006|Completed SAU of Self-titrated Sativex|Overall Study||1
10587251|NCT01748799|11742875|FG007|Completed SAU of Self-titrated Sativex|Overall Study||1
10587252|NCT01748799|11742868|FG000|Completed Self-titrated Sativex|Overall Study||1
10587253|NCT01748799|11742869|FG001|Completed Self-titrated Sativex|Overall Study||1
10587254|NCT01748799|11742870|FG002|Completed Self-titrated Sativex|Overall Study||1
10587255|NCT01748799|11742871|FG003|Completed Self-titrated Sativex|Overall Study||2
10587256|NCT01748799|11742872|FG004|Completed Self-titrated Sativex|Overall Study||1
10587257|NCT01748799|11742873|FG005|Completed Self-titrated Sativex|Overall Study||1
10587258|NCT01748799|11742874|FG006|Completed Self-titrated Sativex|Overall Study||1
10587259|NCT01748799|11742875|FG007|Completed Self-titrated Sativex|Overall Study||1
10587260|NCT01748799|11742868|FG000|COMPLETED|Overall Study||1
10587261|NCT01748799|11742869|FG001|COMPLETED|Overall Study||1
10587262|NCT01748799|11742870|FG002|COMPLETED|Overall Study||1
10587263|NCT01748799|11742871|FG003|COMPLETED|Overall Study||2
10587264|NCT01748799|11742872|FG004|COMPLETED|Overall Study||1
10587265|NCT01748799|11742873|FG005|COMPLETED|Overall Study||1
10587266|NCT01748799|11742874|FG006|COMPLETED|Overall Study||1
10587267|NCT01748799|11742875|FG007|COMPLETED|Overall Study||1
10587268|NCT01748799|11742868|FG000|NOT COMPLETED|Overall Study||5
10587269|NCT01748799|11742869|FG001|NOT COMPLETED|Overall Study||0
10587270|NCT01748799|11742870|FG002|NOT COMPLETED|Overall Study||0
10587271|NCT01748799|11742871|FG003|NOT COMPLETED|Overall Study||0
10587272|NCT01748799|11742872|FG004|NOT COMPLETED|Overall Study||0
10587273|NCT01748799|11742873|FG005|NOT COMPLETED|Overall Study||1
10587274|NCT01748799|11742874|FG006|NOT COMPLETED|Overall Study||1
10587275|NCT01748799|11742875|FG007|NOT COMPLETED|Overall Study||0
10587276|NCT01748825|11742911|FG000|STARTED|Dose Escalation||6
10587277|NCT01748825|11742912|FG001|STARTED|Dose Escalation||4
10587278|NCT01748825|11742913|FG002|STARTED|Dose Escalation||6
10587279|NCT01748825|11742914|FG003|STARTED|Dose Escalation||3
10587280|NCT01748825|11742915|FG004|STARTED|Dose Escalation||3
10587281|NCT01748825|11742916|FG005|STARTED|Dose Escalation||6
10587282|NCT01748825|11742917|FG006|STARTED|Dose Escalation||3
10587283|NCT01748825|11742918|FG007|STARTED|Dose Escalation||3
10587284|NCT01748825|11742919|FG008|STARTED|Dose Escalation||0
10587285|NCT01748825|11742920|FG009|STARTED|Dose Escalation||0
10587286|NCT01748825|11742911|FG000|COMPLETED|Dose Escalation||4
10587287|NCT01748825|11742912|FG001|COMPLETED|Dose Escalation||2
10587288|NCT01748825|11742913|FG002|COMPLETED|Dose Escalation||6
10587289|NCT01748825|11742914|FG003|COMPLETED|Dose Escalation||2
10587290|NCT01748825|11742915|FG004|COMPLETED|Dose Escalation||2
10806910|NCT03937479|11968573|FG002|STARTED|Overall Study||82
10806911|NCT03937479|11968574|FG003|STARTED|Overall Study||82
10806912|NCT03937479|11968575|FG004|STARTED|Overall Study||84
10806913|NCT03937479|11968571|FG000|Received Treatment|Overall Study||83
10806914|NCT03937479|11968572|FG001|Received Treatment|Overall Study||83
10806915|NCT03937479|11968573|FG002|Received Treatment|Overall Study||81
10806916|NCT03937479|11968574|FG003|Received Treatment|Overall Study||82
10806917|NCT03937479|11968575|FG004|Received Treatment|Overall Study||84
10806918|NCT03937479|11968571|FG000|COMPLETED|Overall Study||73
10806919|NCT03937479|11968572|FG001|COMPLETED|Overall Study||70
10806920|NCT03937479|11968573|FG002|COMPLETED|Overall Study||75
10806921|NCT03937479|11968574|FG003|COMPLETED|Overall Study||76
10806922|NCT03937479|11968575|FG004|COMPLETED|Overall Study||79
10806923|NCT03937479|11968571|FG000|NOT COMPLETED|Overall Study||10
10806924|NCT03937479|11968572|FG001|NOT COMPLETED|Overall Study||15
10806925|NCT03937479|11968573|FG002|NOT COMPLETED|Overall Study||7
10806926|NCT03937479|11968574|FG003|NOT COMPLETED|Overall Study||6
10806927|NCT03937479|11968575|FG004|NOT COMPLETED|Overall Study||5
10806928|NCT03936387|11968587|FG000|STARTED|Overall Study||10
10806929|NCT03936387|11968587|FG000|COMPLETED|Overall Study||10
10806930|NCT03936387|11968587|FG000|NOT COMPLETED|Overall Study||0
10806931|NCT03935399|11968593|FG000|STARTED|First Study Day||5
10806932|NCT03935399|11968594|FG001|STARTED|First Study Day||5
10806933|NCT03935399|11968593|FG000|COMPLETED|First Study Day||5
10806934|NCT03935399|11968594|FG001|COMPLETED|First Study Day||5
10806935|NCT03935399|11968593|FG000|NOT COMPLETED|First Study Day||0
10587291|NCT01748825|11742916|FG005|COMPLETED|Dose Escalation||4
10806936|NCT03935399|11968594|FG001|NOT COMPLETED|First Study Day||0
10587292|NCT01748825|11742917|FG006|COMPLETED|Dose Escalation||2
10587293|NCT01748825|11742918|FG007|COMPLETED|Dose Escalation||3
10806937|NCT03935399|11968593|FG000|STARTED|Second Study Day||5
10806938|NCT03935399|11968594|FG001|STARTED|Second Study Day||5
10806939|NCT03935399|11968593|FG000|COMPLETED|Second Study Day||5
10587294|NCT01748825|11742919|FG008|COMPLETED|Dose Escalation||0
10587295|NCT01748825|11742920|FG009|COMPLETED|Dose Escalation||0
10587296|NCT01748825|11742911|FG000|NOT COMPLETED|Dose Escalation||2
10587297|NCT01748825|11742912|FG001|NOT COMPLETED|Dose Escalation||2
10587298|NCT01748825|11742913|FG002|NOT COMPLETED|Dose Escalation||0
10587299|NCT01748825|11742914|FG003|NOT COMPLETED|Dose Escalation||1
10587300|NCT01748825|11742915|FG004|NOT COMPLETED|Dose Escalation||1
10587301|NCT01748825|11742916|FG005|NOT COMPLETED|Dose Escalation||2
10587302|NCT01748825|11742917|FG006|NOT COMPLETED|Dose Escalation||1
10587303|NCT01748825|11742918|FG007|NOT COMPLETED|Dose Escalation||0
10587304|NCT01748825|11742919|FG008|NOT COMPLETED|Dose Escalation||0
10587305|NCT01748825|11742920|FG009|NOT COMPLETED|Dose Escalation||0
10587306|NCT01748825|11742911|FG000|STARTED|Dose Expansion||0
10587307|NCT01748825|11742912|FG001|STARTED|Dose Expansion||0
10587308|NCT01748825|11742913|FG002|STARTED|Dose Expansion||0
10587309|NCT01748825|11742914|FG003|STARTED|Dose Expansion||0
10587310|NCT01748825|11742915|FG004|STARTED|Dose Expansion||0
10587311|NCT01748825|11742916|FG005|STARTED|Dose Expansion||0
10587312|NCT01748825|11742917|FG006|STARTED|Dose Expansion||0
10587313|NCT01748825|11742918|FG007|STARTED|Dose Expansion||0
10587314|NCT01748825|11742919|FG008|STARTED|Dose Expansion||13
10587315|NCT01748825|11742920|FG009|STARTED|Dose Expansion||20
10587316|NCT01748825|11742911|FG000|COMPLETED|Dose Expansion||0
10587317|NCT01748825|11742912|FG001|COMPLETED|Dose Expansion||0
10587318|NCT01748825|11742913|FG002|COMPLETED|Dose Expansion||0
10587319|NCT01748825|11742914|FG003|COMPLETED|Dose Expansion||0
10587320|NCT01748825|11742915|FG004|COMPLETED|Dose Expansion||0
10587321|NCT01748825|11742916|FG005|COMPLETED|Dose Expansion||0
10587322|NCT01748825|11742917|FG006|COMPLETED|Dose Expansion||0
10587323|NCT01748825|11742918|FG007|COMPLETED|Dose Expansion||0
10587324|NCT01748825|11742919|FG008|COMPLETED|Dose Expansion||11
10587325|NCT01748825|11742920|FG009|COMPLETED|Dose Expansion||15
10587326|NCT01748825|11742911|FG000|NOT COMPLETED|Dose Expansion||0
10587327|NCT01748825|11742912|FG001|NOT COMPLETED|Dose Expansion||0
10587328|NCT01748825|11742913|FG002|NOT COMPLETED|Dose Expansion||0
10587329|NCT01748825|11742914|FG003|NOT COMPLETED|Dose Expansion||0
10587330|NCT01748825|11742915|FG004|NOT COMPLETED|Dose Expansion||0
10587331|NCT01748825|11742916|FG005|NOT COMPLETED|Dose Expansion||0
10587332|NCT01748825|11742917|FG006|NOT COMPLETED|Dose Expansion||0
10587333|NCT01748825|11742918|FG007|NOT COMPLETED|Dose Expansion||0
10587334|NCT01748825|11742919|FG008|NOT COMPLETED|Dose Expansion||2
10587335|NCT01748825|11742920|FG009|NOT COMPLETED|Dose Expansion||5
10587336|NCT01748916|11742949|FG000|STARTED|Overall Study||2
10587337|NCT01748916|11742950|FG001|STARTED|Overall Study||3
10587338|NCT01748916|11742951|FG002|STARTED|Overall Study||2
10587339|NCT01748916|11742952|FG003|STARTED|Overall Study||3
10587340|NCT01748916|11742953|FG004|STARTED|Overall Study||3
10587341|NCT01748916|11742954|FG005|STARTED|Overall Study||3
10587342|NCT01748916|11742949|FG000|COMPLETED|Overall Study||2
10587343|NCT01748916|11742950|FG001|COMPLETED|Overall Study||3
10587344|NCT01748916|11742951|FG002|COMPLETED|Overall Study||2
10587345|NCT01748916|11742952|FG003|COMPLETED|Overall Study||3
10587346|NCT01748916|11742953|FG004|COMPLETED|Overall Study||3
10587347|NCT01748916|11742954|FG005|COMPLETED|Overall Study||3
10587348|NCT01748916|11742949|FG000|NOT COMPLETED|Overall Study||0
10587349|NCT01748916|11742950|FG001|NOT COMPLETED|Overall Study||0
10587350|NCT01748916|11742951|FG002|NOT COMPLETED|Overall Study||0
10587351|NCT01748916|11742952|FG003|NOT COMPLETED|Overall Study||0
10587352|NCT01748916|11742953|FG004|NOT COMPLETED|Overall Study||0
10587353|NCT01748916|11742954|FG005|NOT COMPLETED|Overall Study||0
10587354|NCT01748942|11742964|FG000|STARTED|Overall Study||39
10587355|NCT01748942|11742965|FG001|STARTED|Overall Study||37
10587356|NCT01748942|11742964|FG000|COMPLETED|Overall Study||35
10587357|NCT01748942|11742965|FG001|COMPLETED|Overall Study||33
10587358|NCT01748942|11742964|FG000|NOT COMPLETED|Overall Study||4
10587359|NCT01748942|11742965|FG001|NOT COMPLETED|Overall Study||4
10587360|NCT01748955|11742973|FG000|STARTED|Overall Study||6
10806940|NCT03935399|11968594|FG001|COMPLETED|Second Study Day||5
10806941|NCT03935399|11968593|FG000|NOT COMPLETED|Second Study Day||0
10806942|NCT03935399|11968594|FG001|NOT COMPLETED|Second Study Day||0
10806943|NCT03936608|11968602|FG000|STARTED|Overall Study||2
10806944|NCT03936608|11968603|FG001|STARTED|Overall Study||2
10806945|NCT03936608|11968602|FG000|COMPLETED|Overall Study||0
10806946|NCT03936608|11968603|FG001|COMPLETED|Overall Study||0
10806947|NCT03936608|11968602|FG000|NOT COMPLETED|Overall Study||2
10806948|NCT03936608|11968603|FG001|NOT COMPLETED|Overall Study||2
10806949|NCT03936244|11968611|FG000|STARTED|Overall Study||57
10806950|NCT03936244|11968612|FG001|STARTED|Overall Study||43
10587361|NCT01748955|11742974|FG001|STARTED|Overall Study||9
10587362|NCT01748955|11742973|FG000|COMPLETED|Overall Study||3
10587363|NCT01748955|11742974|FG001|COMPLETED|Overall Study||4
10587364|NCT01748955|11742973|FG000|NOT COMPLETED|Overall Study||3
10587365|NCT01748955|11742974|FG001|NOT COMPLETED|Overall Study||5
10587366|NCT01748994|11742982|FG000|STARTED|Overall Study||31
10587367|NCT01748994|11742983|FG001|STARTED|Overall Study||32
10587368|NCT01748994|11742982|FG000|COMPLETED|Overall Study||23
10806951|NCT03936244|11968611|FG000|COMPLETED|Overall Study||45
10587369|NCT01748994|11742983|FG001|COMPLETED|Overall Study||26
10587370|NCT01748994|11742982|FG000|NOT COMPLETED|Overall Study||8
10587371|NCT01748994|11742983|FG001|NOT COMPLETED|Overall Study||6
10651886|NCT02179424|11812144|FG001|STARTED|Overall Study||11
10806952|NCT03936244|11968612|FG001|COMPLETED|Overall Study||39
10806953|NCT03936244|11968611|FG000|NOT COMPLETED|Overall Study||12
10587372|NCT01749033|11742992|FG000|STARTED|Overall Study||150
10587373|NCT01749033|11742993|FG001|STARTED|Overall Study||150
10587374|NCT01749033|11742994|FG002|STARTED|Overall Study||150
10587375|NCT01749033|11742992|FG000|COMPLETED|Overall Study||147
10587376|NCT01749033|11742993|FG001|COMPLETED|Overall Study||145
10587377|NCT01749033|11742994|FG002|COMPLETED|Overall Study||149
10587378|NCT01749033|11742992|FG000|NOT COMPLETED|Overall Study||3
10587379|NCT01749033|11742993|FG001|NOT COMPLETED|Overall Study||5
10587380|NCT01749033|11742994|FG002|NOT COMPLETED|Overall Study||1
10587381|NCT01749215|11743005|FG000|STARTED|Overall Study||72
10587382|NCT01749215|11743006|FG001|STARTED|Overall Study||79
10587383|NCT01749215|11743005|FG000|COMPLETED|Overall Study||47
10587384|NCT01749215|11743006|FG001|COMPLETED|Overall Study||53
10587385|NCT01749215|11743005|FG000|NOT COMPLETED|Overall Study||25
10587386|NCT01749215|11743006|FG001|NOT COMPLETED|Overall Study||26
10587387|NCT01749293|11743012|FG000|STARTED|Overall Study||3
10587388|NCT01749293|11743012|FG000|COMPLETED|Overall Study||3
10587389|NCT01749293|11743012|FG000|NOT COMPLETED|Overall Study||0
10587390|NCT01749410|11743017|FG000|STARTED|Overall Study||33
10587391|NCT01749410|11743017|FG000|COMPLETED|Overall Study||33
10587392|NCT01749410|11743017|FG000|NOT COMPLETED|Overall Study||0
10587393|NCT01749501|11743023|FG000|STARTED|Overall Study||22
10587394|NCT01749501|11743024|FG001|STARTED|Overall Study||23
10587395|NCT01749501|11743023|FG000|COMPLETED|Overall Study||22
10587396|NCT01749501|11743024|FG001|COMPLETED|Overall Study||23
10587397|NCT01749501|11743023|FG000|NOT COMPLETED|Overall Study||0
10587398|NCT01749501|11743024|FG001|NOT COMPLETED|Overall Study||0
10587399|NCT01749605|11743032|FG000|STARTED|Overall Study||18
10587400|NCT01749605|11743033|FG001|STARTED|Overall Study||17
10587401|NCT01749605|11743032|FG000|COMPLETED|Overall Study||14
10587402|NCT01749605|11743033|FG001|COMPLETED|Overall Study||14
10587403|NCT01749605|11743032|FG000|NOT COMPLETED|Overall Study||4
10587404|NCT01749605|11743033|FG001|NOT COMPLETED|Overall Study||3
10587405|NCT01749631|11743039|FG000|STARTED|Overall Study||97
10587406|NCT01749631|11743039|FG000|COMPLETED|Overall Study||97
10587407|NCT01749631|11743039|FG000|NOT COMPLETED|Overall Study||0
10587408|NCT01749735|11743045|FG000|STARTED|Overall Study||2
10587409|NCT01749735|11743046|FG001|STARTED|Overall Study||0
10587410|NCT01749735|11743045|FG000|COMPLETED|Overall Study||1
10806954|NCT03936244|11968612|FG001|NOT COMPLETED|Overall Study||4
10806955|NCT03935126|11968619|FG000|STARTED|Overall Study||3
10806956|NCT03935126|11968619|FG000|COMPLETED|Overall Study||0
10806957|NCT03935126|11968619|FG000|NOT COMPLETED|Overall Study||3
10806958|NCT03928327|11968625|FG000|STARTED|Period 1||12
10806959|NCT03928327|11968626|FG001|STARTED|Period 1||12
10806960|NCT03928327|11968625|FG000|COMPLETED|Period 1||12
10806961|NCT03928327|11968626|FG001|COMPLETED|Period 1||12
10806962|NCT03928327|11968625|FG000|NOT COMPLETED|Period 1||0
10806963|NCT03928327|11968626|FG001|NOT COMPLETED|Period 1||0
10806964|NCT03928327|11968625|FG000|STARTED|Washout Period||12
10806965|NCT03928327|11968626|FG001|STARTED|Washout Period||12
10806966|NCT03928327|11968625|FG000|COMPLETED|Washout Period||12
10806967|NCT03928327|11968626|FG001|COMPLETED|Washout Period||12
10806968|NCT03928327|11968625|FG000|NOT COMPLETED|Washout Period||0
10806969|NCT03928327|11968626|FG001|NOT COMPLETED|Washout Period||0
10806970|NCT03928327|11968625|FG000|STARTED|Period 2||12
10806971|NCT03928327|11968626|FG001|STARTED|Period 2||12
10806972|NCT03928327|11968625|FG000|COMPLETED|Period 2||12
10806973|NCT03928327|11968626|FG001|COMPLETED|Period 2||12
10806974|NCT03928327|11968625|FG000|NOT COMPLETED|Period 2||0
10806975|NCT03928327|11968626|FG001|NOT COMPLETED|Period 2||0
10806976|NCT03933462|11968638|FG000|STARTED|Overall Study||10
10806977|NCT03933462|11968639|FG001|STARTED|Overall Study||10
10806978|NCT03933462|11968638|FG000|Crossover|Overall Study||8
10806979|NCT03933462|11968639|FG001|Crossover|Overall Study||10
10806980|NCT03933462|11968638|FG000|COMPLETED|Overall Study||8
10806981|NCT03933462|11968639|FG001|COMPLETED|Overall Study||10
10806982|NCT03933462|11968638|FG000|NOT COMPLETED|Overall Study||2
10806983|NCT03933462|11968639|FG001|NOT COMPLETED|Overall Study||0
10806984|NCT03933774|11968647|FG000|STARTED|Overall Study||12
10806985|NCT03933774|11968648|FG001|STARTED|Overall Study||13
10806986|NCT03933774|11968647|FG000|COMPLETED|Overall Study||10
10806987|NCT03933774|11968648|FG001|COMPLETED|Overall Study||11
10587411|NCT01749735|11743046|FG001|COMPLETED|Overall Study||0
10587412|NCT01749735|11743045|FG000|NOT COMPLETED|Overall Study||1
10587413|NCT01749735|11743046|FG001|NOT COMPLETED|Overall Study||0
10587414|NCT01749800|11743055|FG000|STARTED|Overall Study|3 subjects did not show significant attention span deficit (required inclusion criterion)|6
10587415|NCT01749800|11743056|FG001|STARTED|Overall Study|1 subject showed significant motor impairments but decided to undergo therapy (exclusion criterion)|1
10587416|NCT01749800|11743057|FG002|STARTED|Overall Study||0
10806988|NCT03933774|11968647|FG000|NOT COMPLETED|Overall Study||2
10806989|NCT03933774|11968648|FG001|NOT COMPLETED|Overall Study||2
10806990|NCT03931330|11968654|FG000|STARTED|Overall Study||8
10806991|NCT03931330|11968654|FG000|4 Weeks of Neuromodulation|Overall Study|at 4 weeks of neuromodulation|7
10806992|NCT03931330|11968654|FG000|COMPLETED|Overall Study||7
10806993|NCT03931330|11968654|FG000|NOT COMPLETED|Overall Study||1
10806994|NCT03918811|11968661|FG000|STARTED|Overall Study||367
10587417|NCT01749800|11743055|FG000|COMPLETED|Overall Study||3
10587418|NCT01749800|11743056|FG001|COMPLETED|Overall Study||0
10587419|NCT01749800|11743057|FG002|COMPLETED|Overall Study||0
10587420|NCT01749800|11743055|FG000|NOT COMPLETED|Overall Study||3
10587421|NCT01749800|11743056|FG001|NOT COMPLETED|Overall Study||1
10587422|NCT01749800|11743057|FG002|NOT COMPLETED|Overall Study||0
10703123|NCT02581839|11867689|FG000|NOT COMPLETED|Overall Study||0
10703124|NCT02581865|11867696|FG000|STARTED|Overall Study||40
10703125|NCT02581865|11867697|FG001|STARTED|Overall Study||42
10703126|NCT02581865|11867698|FG002|STARTED|Overall Study||42
10703127|NCT02581865|11867696|FG000|COMPLETED|Overall Study||36
10703128|NCT02581865|11867697|FG001|COMPLETED|Overall Study||35
10703129|NCT02581865|11867698|FG002|COMPLETED|Overall Study||26
10806995|NCT03918811|11968662|FG001|STARTED|Overall Study||358
10587423|NCT01749904|11743067|FG000|STARTED|Overall Study|randomized population|286
10587424|NCT01749904|11743068|FG001|STARTED|Overall Study|randomized population|134
10587425|NCT01749904|11743067|FG000|COMPLETED|Overall Study|randomized population|264
10587426|NCT01749904|11743068|FG001|COMPLETED|Overall Study|randomized population|123
10587427|NCT01749904|11743067|FG000|NOT COMPLETED|Overall Study||22
10587428|NCT01749904|11743068|FG001|NOT COMPLETED|Overall Study||11
10587429|NCT01749930|11743080|FG000|STARTED|Overall Study|randomized population|283
10587430|NCT01749930|11743081|FG001|STARTED|Overall Study|randomized population|137
10587431|NCT01749930|11743080|FG000|COMPLETED|Overall Study|randomized population|253
10587432|NCT01749930|11743081|FG001|COMPLETED|Overall Study|randomized population|125
10587433|NCT01749930|11743080|FG000|NOT COMPLETED|Overall Study||30
10587434|NCT01749930|11743081|FG001|NOT COMPLETED|Overall Study||12
10587435|NCT01749956|11743091|FG000|STARTED|Overall Study||39
10587436|NCT01749956|11743091|FG000|COMPLETED|Overall Study||24
10587437|NCT01749956|11743091|FG000|NOT COMPLETED|Overall Study||15
10587438|NCT01749982|11743100|FG000|STARTED|Overall Study||15
10587439|NCT01749982|11743101|FG001|STARTED|Overall Study||15
10587440|NCT01749982|11743102|FG002|STARTED|Overall Study||15
10587441|NCT01749982|11743103|FG003|STARTED|Overall Study||15
10587442|NCT01749982|11743100|FG000|COMPLETED|Overall Study||15
10587443|NCT01749982|11743101|FG001|COMPLETED|Overall Study||15
10587444|NCT01749982|11743102|FG002|COMPLETED|Overall Study||15
10587445|NCT01749982|11743103|FG003|COMPLETED|Overall Study||12
10587446|NCT01749982|11743100|FG000|NOT COMPLETED|Overall Study||0
10587447|NCT01749982|11743101|FG001|NOT COMPLETED|Overall Study||0
10587448|NCT01749982|11743102|FG002|NOT COMPLETED|Overall Study||0
10587449|NCT01749982|11743103|FG003|NOT COMPLETED|Overall Study||3
10587450|NCT01749995|11743113|FG000|STARTED|Overall Study||200
10587451|NCT01749995|11743113|FG000|COMPLETED|Overall Study||196
10587452|NCT01749995|11743113|FG000|NOT COMPLETED|Overall Study||4
10587453|NCT01750086|11743119|FG000|STARTED|Overall Study||13
10587454|NCT01750086|11743120|FG001|STARTED|Overall Study||14
10587455|NCT01750086|11743119|FG000|COMPLETED|Overall Study||12
10587456|NCT01750086|11743120|FG001|COMPLETED|Overall Study||13
10587457|NCT01750086|11743119|FG000|NOT COMPLETED|Overall Study||1
10587458|NCT01750086|11743120|FG001|NOT COMPLETED|Overall Study||1
10587459|NCT01750190|11743128|FG000|STARTED|Overall Study||616
10587460|NCT01750190|11743129|FG001|STARTED|Overall Study||306
10587461|NCT01750190|11743128|FG000|Safety Population|Overall Study||611
10587462|NCT01750190|11743129|FG001|Safety Population|Overall Study||305
10587463|NCT01750190|11743128|FG000|Full Analysis Set (FAS)|Overall Study||608
10587464|NCT01750190|11743129|FG001|Full Analysis Set (FAS)|Overall Study||305
10587465|NCT01750190|11743128|FG000|COMPLETED|Overall Study||349
10587466|NCT01750190|11743129|FG001|COMPLETED|Overall Study||98
10587467|NCT01750190|11743128|FG000|NOT COMPLETED|Overall Study||267
10587468|NCT01750190|11743129|FG001|NOT COMPLETED|Overall Study||208
10587469|NCT01750229|11743135|FG000|STARTED|Randomized Crossover Phase||30
10587470|NCT01750229|11743135|FG000|Subject Received Sham|Randomized Crossover Phase||24
10587471|NCT01750229|11743135|FG000|Subjects Received 1200 Hz|Randomized Crossover Phase||24
10587472|NCT01750229|11743135|FG000|Subjects Received 3030 Hz|Randomized Crossover Phase||24
10587473|NCT01750229|11743135|FG000|Subjects Received 5882 Hz|Randomized Crossover Phase||24
10587474|NCT01750229|11743135|FG000|Protocol Violation|Randomized Crossover Phase||4
10587475|NCT01750229|11743135|FG000|COMPLETED|Randomized Crossover Phase||28
10587476|NCT01750229|11743135|FG000|NOT COMPLETED|Randomized Crossover Phase||2
10587477|NCT01750229|11743135|FG000|STARTED|Long-term Follow-up Phase|Four subjects who had protocol violations continued to be followed in long-term follow-up phase.|28
10587478|NCT01750229|11743135|FG000|COMPLETED|Long-term Follow-up Phase||25
10587479|NCT01750229|11743135|FG000|NOT COMPLETED|Long-term Follow-up Phase||3
10587480|NCT01750242|11743145|FG000|STARTED|Overall Study||23
10587481|NCT01750242|11743145|FG000|Readable Images|Overall Study|Subjects with readable images were analyzed and there were 3 subjects with unreadable images.|20
10587482|NCT01750242|11743145|FG000|COMPLETED|Overall Study||20
10587483|NCT01750242|11743145|FG000|NOT COMPLETED|Overall Study||3
10587484|NCT01750255|11743152|FG000|STARTED|Overall Study||49
10587485|NCT01750255|11743153|FG001|STARTED|Overall Study||43
10587486|NCT01750255|11743152|FG000|COMPLETED|Overall Study||43
10587487|NCT01750255|11743153|FG001|COMPLETED|Overall Study||38
10587488|NCT01750255|11743152|FG000|NOT COMPLETED|Overall Study||6
10587489|NCT01750255|11743153|FG001|NOT COMPLETED|Overall Study||5
10703130|NCT02581865|11867696|FG000|NOT COMPLETED|Overall Study||4
10703131|NCT02581865|11867697|FG001|NOT COMPLETED|Overall Study||7
10703132|NCT02581865|11867698|FG002|NOT COMPLETED|Overall Study||16
10703133|NCT02581891|11867711|FG000|STARTED|Overall Study||135
10703134|NCT02581891|11867712|FG001|STARTED|Overall Study||136
10587490|NCT01750268|11743162|FG000|STARTED|Overall Study||15
10587491|NCT01750268|11743163|FG001|STARTED|Overall Study||17
10587492|NCT01750268|11743162|FG000|COMPLETED|Overall Study||13
10587493|NCT01750268|11743163|FG001|COMPLETED|Overall Study||12
10587494|NCT01750268|11743162|FG000|NOT COMPLETED|Overall Study||2
10587495|NCT01750268|11743163|FG001|NOT COMPLETED|Overall Study||5
10587496|NCT01750294|11743169|FG000|STARTED|Overall Study||14
10587497|NCT01750294|11743169|FG000|COMPLETED|Overall Study||12
10587498|NCT01750294|11743169|FG000|NOT COMPLETED|Overall Study||2
10587499|NCT01750346|11743176|FG000|STARTED|Overall Study||3
10587500|NCT01750346|11743177|FG001|STARTED|Overall Study||2
10587501|NCT01750346|11743178|FG002|STARTED|Overall Study||3
10587502|NCT01750346|11743176|FG000|COMPLETED|Overall Study||2
10587503|NCT01750346|11743177|FG001|COMPLETED|Overall Study||2
10587504|NCT01750346|11743178|FG002|COMPLETED|Overall Study||3
10587505|NCT01750346|11743176|FG000|NOT COMPLETED|Overall Study||1
10587506|NCT01750346|11743177|FG001|NOT COMPLETED|Overall Study||0
10587507|NCT01750346|11743178|FG002|NOT COMPLETED|Overall Study||0
10587508|NCT01750398|11743186|FG000|STARTED|ADT Lead In Phase||33
10587509|NCT01750398|11743186|FG000|COMPLETED|ADT Lead In Phase||29
10587510|NCT01750398|11743186|FG000|NOT COMPLETED|ADT Lead In Phase||4
10587511|NCT01750398|11743186|FG000|STARTED|Bipolar Androgen Thearpy Phase||29
10587512|NCT01750398|11743186|FG000|COMPLETED|Bipolar Androgen Thearpy Phase||26
10587513|NCT01750398|11743186|FG000|NOT COMPLETED|Bipolar Androgen Thearpy Phase||3
10587514|NCT01750502|11743192|FG000|STARTED|Overall Study||70
10587515|NCT01750502|11743193|FG001|STARTED|Overall Study||186
10587516|NCT01750502|11743192|FG000|COMPLETED|Overall Study||70
10587517|NCT01750502|11743193|FG001|COMPLETED|Overall Study||186
10587518|NCT01750502|11743192|FG000|NOT COMPLETED|Overall Study||0
10587519|NCT01750502|11743193|FG001|NOT COMPLETED|Overall Study||0
10587520|NCT01750684|11743206|FG000|STARTED|Overall Study||6
10587521|NCT01750684|11743207|FG001|STARTED|Overall Study||7
10587522|NCT01750684|11743206|FG000|COMPLETED|Overall Study||4
10587523|NCT01750684|11743207|FG001|COMPLETED|Overall Study||5
10587524|NCT01750684|11743206|FG000|NOT COMPLETED|Overall Study||2
10587525|NCT01750684|11743207|FG001|NOT COMPLETED|Overall Study||2
10587526|NCT01750697|11743214|FG000|STARTED|Overall Study||25
10587527|NCT01750697|11743214|FG000|Completed|Overall Study||25
10587528|NCT01750697|11743214|FG000|Follow-up Phase|Overall Study|Completed required follow-up|24
10587529|NCT01750697|11743214|FG000|COMPLETED|Overall Study|Completed to CCO. 6 participants entered Extended Safety Follow-up, 10 participants completed Study.|16
10587530|NCT01750697|11743214|FG000|NOT COMPLETED|Overall Study||9
10587531|NCT01750840|11743221|FG000|STARTED|Overall Study||8
10587532|NCT01750840|11743221|FG000|COMPLETED|Overall Study||4
10806996|NCT03918811|11968661|FG000|COMPLETED|Overall Study||363
10806997|NCT03918811|11968662|FG001|COMPLETED|Overall Study||345
10806998|NCT03918811|11968661|FG000|NOT COMPLETED|Overall Study||4
10806999|NCT03918811|11968662|FG001|NOT COMPLETED|Overall Study||13
10811126|NCT03772522|11972836|FG000|STARTED|Pre-intervention||12
10811127|NCT03772522|11972837|FG001|STARTED|Pre-intervention||15
10811128|NCT03772522|11972836|FG000|COMPLETED|Pre-intervention||9
10811129|NCT03772522|11972837|FG001|COMPLETED|Pre-intervention||11
10811130|NCT03772522|11972836|FG000|NOT COMPLETED|Pre-intervention||3
10811131|NCT03772522|11972837|FG001|NOT COMPLETED|Pre-intervention||4
10811132|NCT03772522|11972836|FG000|STARTED|Intervention||9
10811133|NCT03772522|11972837|FG001|STARTED|Intervention||11
10811134|NCT03772522|11972836|FG000|COMPLETED|Intervention||8
10811135|NCT03772522|11972837|FG001|COMPLETED|Intervention||11
10811136|NCT03772522|11972836|FG000|NOT COMPLETED|Intervention||1
10811137|NCT03772522|11972837|FG001|NOT COMPLETED|Intervention||0
10811138|NCT03772522|11972836|FG000|STARTED|Post-intervention Follow-up||8
10811139|NCT03772522|11972837|FG001|STARTED|Post-intervention Follow-up||11
10811140|NCT03772522|11972836|FG000|COMPLETED|Post-intervention Follow-up||7
10811141|NCT03772522|11972837|FG001|COMPLETED|Post-intervention Follow-up||11
10811142|NCT03772522|11972836|FG000|NOT COMPLETED|Post-intervention Follow-up||1
10811143|NCT03772522|11972837|FG001|NOT COMPLETED|Post-intervention Follow-up||0
10811144|NCT03772327|11972849|FG000|STARTED|Overall Study||30
10811145|NCT03772327|11972850|FG001|STARTED|Overall Study||33
10811146|NCT03772327|11972849|FG000|Week 0 Visit|Overall Study|2 participants were lost to follow up after randomization prior to any study interventions.|28
10811147|NCT03772327|11972850|FG001|Week 0 Visit|Overall Study||33
10811148|NCT03772327|11972849|FG000|COMPLETED|Overall Study||25
10811149|NCT03772327|11972850|FG001|COMPLETED|Overall Study||26
10811150|NCT03772327|11972849|FG000|NOT COMPLETED|Overall Study||5
10811151|NCT03772327|11972850|FG001|NOT COMPLETED|Overall Study||7
10811152|NCT03777865|11972856|FG000|STARTED|Overall Study||100
10811153|NCT03777865|11972856|FG000|COMPLETED|Overall Study||100
10811154|NCT03777865|11972856|FG000|NOT COMPLETED|Overall Study||0
10811155|NCT03774576|11972860|FG000|STARTED|Period 1||14
10811156|NCT03774576|11972860|FG000|COMPLETED|Period 1||14
10811157|NCT03774576|11972860|FG000|NOT COMPLETED|Period 1||0
10811158|NCT03774576|11972860|FG000|STARTED|Period 2||14
10811159|NCT03774576|11972860|FG000|COMPLETED|Period 2||13
10811160|NCT03774576|11972860|FG000|NOT COMPLETED|Period 2||1
10811161|NCT03776539|11972873|FG000|STARTED|Overall Study||6
10811162|NCT03776539|11972874|FG001|STARTED|Overall Study||6
10811163|NCT03776539|11972875|FG002|STARTED|Overall Study||6
10811164|NCT03776539|11972876|FG003|STARTED|Overall Study||6
10811165|NCT03776539|11972873|FG000|COMPLETED|Overall Study||6
10587533|NCT01750840|11743221|FG000|NOT COMPLETED|Overall Study||4
10587534|NCT01750879|11743228|FG000|STARTED|Overall Study||30
10811166|NCT03776539|11972874|FG001|COMPLETED|Overall Study||6
10811167|NCT03776539|11972875|FG002|COMPLETED|Overall Study||6
10811168|NCT03776539|11972876|FG003|COMPLETED|Overall Study||6
10587535|NCT01750879|11743229|FG001|STARTED|Overall Study||11
10587536|NCT01750879|11743228|FG000|DBPCFC2|Overall Study||20
10587537|NCT01750879|11743229|FG001|DBPCFC2|Overall Study||8
10587538|NCT01750879|11743228|FG000|DBPCFC3|Overall Study||20
10703135|NCT02581891|11867711|FG000|Completed Treatment|Overall Study||120
10703136|NCT02581891|11867712|FG001|Completed Treatment|Overall Study||117
10703137|NCT02581891|11867711|FG000|COMPLETED|Overall Study||119
10587539|NCT01750879|11743229|FG001|DBPCFC3|Overall Study||0
10587540|NCT01750879|11743228|FG000|COMPLETED|Overall Study||20
10587541|NCT01750879|11743229|FG001|COMPLETED|Overall Study||8
10587542|NCT01750879|11743228|FG000|NOT COMPLETED|Overall Study||10
10587543|NCT01750879|11743229|FG001|NOT COMPLETED|Overall Study||3
10587544|NCT01750918|11743256|FG000|STARTED|Overall Study||3
10587545|NCT01750918|11743257|FG001|STARTED|Overall Study||4
10587546|NCT01750918|11743258|FG002|STARTED|Overall Study||36
10587547|NCT01750918|11743259|FG003|STARTED|Overall Study||50
10587548|NCT01750918|11743260|FG004|STARTED|Overall Study||13
10587549|NCT01750918|11743261|FG005|STARTED|Overall Study||20
10587550|NCT01750918|11743262|FG006|STARTED|Overall Study||20
10587551|NCT01750918|11743263|FG007|STARTED|Overall Study||20
10587552|NCT01750918|11743256|FG000|Pharmacokinetic Population|Overall Study||3
10587553|NCT01750918|11743257|FG001|Pharmacokinetic Population|Overall Study||4
10587554|NCT01750918|11743258|FG002|Pharmacokinetic Population|Overall Study||35
10587555|NCT01750918|11743259|FG003|Pharmacokinetic Population|Overall Study||48
10587556|NCT01750918|11743260|FG004|Pharmacokinetic Population|Overall Study||12
10587557|NCT01750918|11743261|FG005|Pharmacokinetic Population|Overall Study||19
10587558|NCT01750918|11743262|FG006|Pharmacokinetic Population|Overall Study||18
10587559|NCT01750918|11743263|FG007|Pharmacokinetic Population|Overall Study||20
10587560|NCT01750918|11743256|FG000|Biomarker Population|Overall Study||3
10587561|NCT01750918|11743257|FG001|Biomarker Population|Overall Study||4
10587562|NCT01750918|11743258|FG002|Biomarker Population|Overall Study||36
10587563|NCT01750918|11743259|FG003|Biomarker Population|Overall Study||50
10587564|NCT01750918|11743260|FG004|Biomarker Population|Overall Study||13
10587565|NCT01750918|11743261|FG005|Biomarker Population|Overall Study||17
10587566|NCT01750918|11743262|FG006|Biomarker Population|Overall Study||19
10587567|NCT01750918|11743263|FG007|Biomarker Population|Overall Study||20
10587568|NCT01750918|11743256|FG000|Crossover Population|Overall Study||0
10587569|NCT01750918|11743257|FG001|Crossover Population|Overall Study||0
10587570|NCT01750918|11743258|FG002|Crossover Population|Overall Study||0
10587571|NCT01750918|11743259|FG003|Crossover Population|Overall Study||0
10587572|NCT01750918|11743260|FG004|Crossover Population|Overall Study||4
10587573|NCT01750918|11743261|FG005|Crossover Population|Overall Study||2
10587574|NCT01750918|11743262|FG006|Crossover Population|Overall Study||5
10587575|NCT01750918|11743263|FG007|Crossover Population|Overall Study||5
10587576|NCT01750918|11743256|FG000|COMPLETED|Overall Study||3
10587577|NCT01750918|11743257|FG001|COMPLETED|Overall Study||4
10587578|NCT01750918|11743258|FG002|COMPLETED|Overall Study||28
10587579|NCT01750918|11743259|FG003|COMPLETED|Overall Study||44
10587580|NCT01750918|11743260|FG004|COMPLETED|Overall Study||12
10587581|NCT01750918|11743261|FG005|COMPLETED|Overall Study||17
10587582|NCT01750918|11743262|FG006|COMPLETED|Overall Study||17
10587583|NCT01750918|11743263|FG007|COMPLETED|Overall Study||16
10587584|NCT01750918|11743256|FG000|NOT COMPLETED|Overall Study||0
10587585|NCT01750918|11743257|FG001|NOT COMPLETED|Overall Study||0
10587586|NCT01750918|11743258|FG002|NOT COMPLETED|Overall Study||8
10587587|NCT01750918|11743259|FG003|NOT COMPLETED|Overall Study||6
10587588|NCT01750918|11743260|FG004|NOT COMPLETED|Overall Study||1
10587589|NCT01750918|11743261|FG005|NOT COMPLETED|Overall Study||3
10587590|NCT01750918|11743262|FG006|NOT COMPLETED|Overall Study||3
10587591|NCT01750918|11743263|FG007|NOT COMPLETED|Overall Study||4
10587592|NCT01750931|11743293|FG000|STARTED|Period 1||14
10587593|NCT01750931|11743294|FG001|STARTED|Period 1||14
10587594|NCT01750931|11743293|FG000|COMPLETED|Period 1||14
10587595|NCT01750931|11743294|FG001|COMPLETED|Period 1||14
10587596|NCT01750931|11743293|FG000|NOT COMPLETED|Period 1||0
10587597|NCT01750931|11743294|FG001|NOT COMPLETED|Period 1||0
10587598|NCT01750931|11743293|FG000|STARTED|Wash Out||14
10587599|NCT01750931|11743294|FG001|STARTED|Wash Out||14
10587600|NCT01750931|11743293|FG000|COMPLETED|Wash Out||14
10587601|NCT01750931|11743294|FG001|COMPLETED|Wash Out||14
10703138|NCT02581891|11867712|FG001|COMPLETED|Overall Study||117
10703139|NCT02581891|11867711|FG000|NOT COMPLETED|Overall Study||16
10703140|NCT02581891|11867712|FG001|NOT COMPLETED|Overall Study||19
10703141|NCT02581995|11867719|FG000|STARTED|Overall Study||560
10703142|NCT02581995|11867719|FG000|Treated|Overall Study||560
10703143|NCT02581995|11867719|FG000|COMPLETED|Overall Study||529
10703144|NCT02581995|11867719|FG000|NOT COMPLETED|Overall Study||31
10703145|NCT02582151|11867725|FG000|STARTED|Overall Study||14
10703146|NCT02582151|11867726|FG001|STARTED|Overall Study||16
10703147|NCT02582151|11867725|FG000|COMPLETED|Overall Study||12
10703148|NCT02582151|11867726|FG001|COMPLETED|Overall Study||16
10703149|NCT02582151|11867725|FG000|NOT COMPLETED|Overall Study||2
10703150|NCT02582151|11867726|FG001|NOT COMPLETED|Overall Study||0
10703151|NCT02582216|11867732|FG000|STARTED|Overall Study||22
10587602|NCT01750931|11743293|FG000|NOT COMPLETED|Wash Out||0
10587603|NCT01750931|11743294|FG001|NOT COMPLETED|Wash Out||0
10587604|NCT01750931|11743293|FG000|STARTED|Period 2||14
10587605|NCT01750931|11743294|FG001|STARTED|Period 2||14
10587606|NCT01750931|11743293|FG000|COMPLETED|Period 2||14
10587607|NCT01750931|11743294|FG001|COMPLETED|Period 2||14
10587608|NCT01750931|11743293|FG000|NOT COMPLETED|Period 2||0
10587609|NCT01750931|11743294|FG001|NOT COMPLETED|Period 2||0
10587610|NCT01751022|11743303|FG000|STARTED|Overall Study||499
10587611|NCT01751022|11743304|FG001|STARTED|Overall Study||326
10703152|NCT02582216|11867732|FG000|COMPLETED|Overall Study||22
10703153|NCT02582216|11867732|FG000|NOT COMPLETED|Overall Study||0
10703154|NCT02582242|11867739|FG000|STARTED|Overall Study||220
10703155|NCT02582242|11867740|FG001|STARTED|Overall Study||217
10703156|NCT02582242|11867739|FG000|COMPLETED|Overall Study||200
10703157|NCT02582242|11867740|FG001|COMPLETED|Overall Study||200
10703158|NCT02582242|11867739|FG000|NOT COMPLETED|Overall Study||20
10807000|NCT03933618|11968674|FG000|STARTED|Baseline||4
10807001|NCT03933618|11968675|FG001|STARTED|Baseline||4
10587612|NCT01751022|11743305|FG002|STARTED|Overall Study||300
10587613|NCT01751022|11743303|FG000|COMPLETED|Overall Study|6 month visit|443
10587614|NCT01751022|11743304|FG001|COMPLETED|Overall Study|6 month visit|282
10587615|NCT01751022|11743305|FG002|COMPLETED|Overall Study|6 month visit|273
10587616|NCT01751022|11743303|FG000|NOT COMPLETED|Overall Study||56
10587617|NCT01751022|11743304|FG001|NOT COMPLETED|Overall Study||44
10587618|NCT01751022|11743305|FG002|NOT COMPLETED|Overall Study||27
10587619|NCT01751061|11743334|FG000|STARTED|Overall Study||210
10587620|NCT01751061|11743335|FG001|STARTED|Overall Study||206
10587621|NCT01751061|11743334|FG000|COMPLETED|Overall Study||154
10587622|NCT01751061|11743335|FG001|COMPLETED|Overall Study||172
10587623|NCT01751061|11743334|FG000|NOT COMPLETED|Overall Study||56
10587624|NCT01751061|11743335|FG001|NOT COMPLETED|Overall Study||34
10587625|NCT01751087|11743344|FG000|STARTED|Overall Study||100
10587626|NCT01751087|11743345|FG001|STARTED|Overall Study||100
10587627|NCT01751087|11743346|FG002|STARTED|Overall Study||100
10587628|NCT01751087|11743344|FG000|COMPLETED|Overall Study||99
10587629|NCT01751087|11743345|FG001|COMPLETED|Overall Study||100
10587630|NCT01751087|11743346|FG002|COMPLETED|Overall Study||99
10587631|NCT01751087|11743344|FG000|NOT COMPLETED|Overall Study||1
10587632|NCT01751087|11743345|FG001|NOT COMPLETED|Overall Study||0
10587633|NCT01751087|11743346|FG002|NOT COMPLETED|Overall Study||1
10587634|NCT01751113|11743354|FG000|STARTED|Treatment Period 1 (4 Weeks)||8
10587635|NCT01751113|11743355|FG001|STARTED|Treatment Period 1 (4 Weeks)||8
10587636|NCT01751113|11743356|FG002|STARTED|Treatment Period 1 (4 Weeks)||9
10587637|NCT01751113|11743357|FG003|STARTED|Treatment Period 1 (4 Weeks)||9
10587638|NCT01751113|11743358|FG004|STARTED|Treatment Period 1 (4 Weeks)||9
10587639|NCT01751113|11743359|FG005|STARTED|Treatment Period 1 (4 Weeks)||10
10587640|NCT01751113|11743354|FG000|COMPLETED|Treatment Period 1 (4 Weeks)||8
10587641|NCT01751113|11743355|FG001|COMPLETED|Treatment Period 1 (4 Weeks)||8
10587642|NCT01751113|11743356|FG002|COMPLETED|Treatment Period 1 (4 Weeks)||9
10587643|NCT01751113|11743357|FG003|COMPLETED|Treatment Period 1 (4 Weeks)||8
10587644|NCT01751113|11743358|FG004|COMPLETED|Treatment Period 1 (4 Weeks)||8
10587645|NCT01751113|11743359|FG005|COMPLETED|Treatment Period 1 (4 Weeks)||10
10587646|NCT01751113|11743354|FG000|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
10587647|NCT01751113|11743355|FG001|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
10587648|NCT01751113|11743356|FG002|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
10587649|NCT01751113|11743357|FG003|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
10587650|NCT01751113|11743358|FG004|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
10587651|NCT01751113|11743359|FG005|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
10587652|NCT01751113|11743354|FG000|STARTED|Washout Period 1 (2 Weeks)||8
10587653|NCT01751113|11743355|FG001|STARTED|Washout Period 1 (2 Weeks)||8
10587654|NCT01751113|11743356|FG002|STARTED|Washout Period 1 (2 Weeks)||9
10587655|NCT01751113|11743357|FG003|STARTED|Washout Period 1 (2 Weeks)||8
10587656|NCT01751113|11743358|FG004|STARTED|Washout Period 1 (2 Weeks)||8
10587657|NCT01751113|11743359|FG005|STARTED|Washout Period 1 (2 Weeks)||10
10587658|NCT01751113|11743354|FG000|COMPLETED|Washout Period 1 (2 Weeks)||8
10587659|NCT01751113|11743355|FG001|COMPLETED|Washout Period 1 (2 Weeks)||8
10587660|NCT01751113|11743356|FG002|COMPLETED|Washout Period 1 (2 Weeks)||9
10587661|NCT01751113|11743357|FG003|COMPLETED|Washout Period 1 (2 Weeks)||8
10587662|NCT01751113|11743358|FG004|COMPLETED|Washout Period 1 (2 Weeks)||8
10587663|NCT01751113|11743359|FG005|COMPLETED|Washout Period 1 (2 Weeks)||10
10587664|NCT01751113|11743354|FG000|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
10587665|NCT01751113|11743355|FG001|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
10587666|NCT01751113|11743356|FG002|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
10587667|NCT01751113|11743357|FG003|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
10587668|NCT01751113|11743358|FG004|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
10587669|NCT01751113|11743359|FG005|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
10587670|NCT01751113|11743354|FG000|STARTED|Treatment Period 2 (4 Weeks)||8
10587671|NCT01751113|11743355|FG001|STARTED|Treatment Period 2 (4 Weeks)||8
10587672|NCT01751113|11743356|FG002|STARTED|Treatment Period 2 (4 Weeks)||9
10587673|NCT01751113|11743357|FG003|STARTED|Treatment Period 2 (4 Weeks)||8
10587674|NCT01751113|11743358|FG004|STARTED|Treatment Period 2 (4 Weeks)||8
10703159|NCT02582242|11867740|FG001|NOT COMPLETED|Overall Study||17
10703160|NCT02582255|11867748|FG000|STARTED|Overall Study||50
10703161|NCT02582255|11867749|FG001|STARTED|Overall Study||50
10703162|NCT02582255|11867748|FG000|COMPLETED|Overall Study||50
10703163|NCT02582255|11867749|FG001|COMPLETED|Overall Study||47
10703164|NCT02582255|11867748|FG000|NOT COMPLETED|Overall Study||0
10703165|NCT02582255|11867749|FG001|NOT COMPLETED|Overall Study||3
10587675|NCT01751113|11743359|FG005|STARTED|Treatment Period 2 (4 Weeks)||10
10587676|NCT01751113|11743354|FG000|COMPLETED|Treatment Period 2 (4 Weeks)||8
10587677|NCT01751113|11743355|FG001|COMPLETED|Treatment Period 2 (4 Weeks)||8
10587678|NCT01751113|11743356|FG002|COMPLETED|Treatment Period 2 (4 Weeks)||9
10703166|NCT02582515|11867758|FG000|STARTED|Overall Study||9
10703167|NCT02582515|11867759|FG001|STARTED|Overall Study||11
10587679|NCT01751113|11743357|FG003|COMPLETED|Treatment Period 2 (4 Weeks)||8
10587680|NCT01751113|11743358|FG004|COMPLETED|Treatment Period 2 (4 Weeks)||8
10587681|NCT01751113|11743359|FG005|COMPLETED|Treatment Period 2 (4 Weeks)||10
10587682|NCT01751113|11743354|FG000|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
10587683|NCT01751113|11743355|FG001|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
10587684|NCT01751113|11743356|FG002|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
10587685|NCT01751113|11743357|FG003|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
10587686|NCT01751113|11743358|FG004|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
10587687|NCT01751113|11743359|FG005|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
10587688|NCT01751113|11743354|FG000|STARTED|Washout Period 2 (2 Weeks)||8
10587689|NCT01751113|11743355|FG001|STARTED|Washout Period 2 (2 Weeks)||8
10587690|NCT01751113|11743356|FG002|STARTED|Washout Period 2 (2 Weeks)||9
10587691|NCT01751113|11743357|FG003|STARTED|Washout Period 2 (2 Weeks)||8
10587692|NCT01751113|11743358|FG004|STARTED|Washout Period 2 (2 Weeks)||8
10587693|NCT01751113|11743359|FG005|STARTED|Washout Period 2 (2 Weeks)||10
10587694|NCT01751113|11743354|FG000|COMPLETED|Washout Period 2 (2 Weeks)||8
10587695|NCT01751113|11743355|FG001|COMPLETED|Washout Period 2 (2 Weeks)||8
10587696|NCT01751113|11743356|FG002|COMPLETED|Washout Period 2 (2 Weeks)||9
10587697|NCT01751113|11743357|FG003|COMPLETED|Washout Period 2 (2 Weeks)||8
10587698|NCT01751113|11743358|FG004|COMPLETED|Washout Period 2 (2 Weeks)||8
10587699|NCT01751113|11743359|FG005|COMPLETED|Washout Period 2 (2 Weeks)||10
10587700|NCT01751113|11743354|FG000|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
10587701|NCT01751113|11743355|FG001|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
10587702|NCT01751113|11743356|FG002|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
10587703|NCT01751113|11743357|FG003|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
10587704|NCT01751113|11743358|FG004|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
10587705|NCT01751113|11743359|FG005|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
10587706|NCT01751113|11743354|FG000|STARTED|Treatment Period 3 (4 Weeks)||8
10587707|NCT01751113|11743355|FG001|STARTED|Treatment Period 3 (4 Weeks)||8
10587708|NCT01751113|11743356|FG002|STARTED|Treatment Period 3 (4 Weeks)||9
10587709|NCT01751113|11743357|FG003|STARTED|Treatment Period 3 (4 Weeks)||8
10587710|NCT01751113|11743358|FG004|STARTED|Treatment Period 3 (4 Weeks)||8
10587711|NCT01751113|11743359|FG005|STARTED|Treatment Period 3 (4 Weeks)||10
10587712|NCT01751113|11743354|FG000|COMPLETED|Treatment Period 3 (4 Weeks)||8
10587713|NCT01751113|11743355|FG001|COMPLETED|Treatment Period 3 (4 Weeks)||8
10587714|NCT01751113|11743356|FG002|COMPLETED|Treatment Period 3 (4 Weeks)||9
10587715|NCT01751113|11743357|FG003|COMPLETED|Treatment Period 3 (4 Weeks)||8
10587716|NCT01751113|11743358|FG004|COMPLETED|Treatment Period 3 (4 Weeks)||8
10587717|NCT01751113|11743359|FG005|COMPLETED|Treatment Period 3 (4 Weeks)||9
10587718|NCT01751113|11743354|FG000|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
10703168|NCT02582515|11867758|FG000|Received Study Intervention|Overall Study||9
10807002|NCT03933618|11968676|FG002|STARTED|Baseline||4
10807003|NCT03933618|11968677|FG003|STARTED|Baseline||4
10807004|NCT03933618|11968678|FG004|STARTED|Baseline||4
10587719|NCT01751113|11743355|FG001|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
10587720|NCT01751113|11743356|FG002|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
10703169|NCT02582515|11867759|FG001|Received Study Intervention|Overall Study||10
10703170|NCT02582515|11867758|FG000|COMPLETED|Overall Study||9
10703171|NCT02582515|11867759|FG001|COMPLETED|Overall Study||10
10703172|NCT02582515|11867758|FG000|NOT COMPLETED|Overall Study||0
10703173|NCT02582515|11867759|FG001|NOT COMPLETED|Overall Study||1
10703174|NCT02582632|11867765|FG000|STARTED|Overall Study||166
10703175|NCT02582632|11867765|FG000|COMPLETED|Overall Study||165
10703176|NCT02582632|11867765|FG000|NOT COMPLETED|Overall Study||1
10703177|NCT02582658|11867769|FG000|STARTED|Overall Study||171
10703178|NCT02582658|11867769|FG000|COMPLETED|Overall Study||146
10703179|NCT02582658|11867769|FG000|NOT COMPLETED|Overall Study||25
10703180|NCT02582671|11867773|FG000|STARTED|Overall Study||101
10703181|NCT02582671|11867773|FG000|COMPLETED|Overall Study||99
10703182|NCT02582671|11867773|FG000|NOT COMPLETED|Overall Study||2
10703183|NCT02582684|11867778|FG000|STARTED|Overall Study||122
10703184|NCT02582684|11867778|FG000|COMPLETED|Overall Study||105
10703185|NCT02582684|11867778|FG000|NOT COMPLETED|Overall Study||17
10703186|NCT02582814|11867784|FG000|STARTED|Overall Study||76
10703187|NCT02582814|11867785|FG001|STARTED|Overall Study||75
10703188|NCT02582814|11867784|FG000|COMPLETED|Overall Study||67
10703189|NCT02582814|11867785|FG001|COMPLETED|Overall Study||68
10703190|NCT02582814|11867784|FG000|NOT COMPLETED|Overall Study||9
10703191|NCT02582814|11867785|FG001|NOT COMPLETED|Overall Study||7
10703192|NCT02582840|11867794|FG000|STARTED|Overall Study||14
10703193|NCT02582840|11867795|FG001|STARTED|Overall Study||14
10703194|NCT02582840|11867796|FG002|STARTED|Overall Study||14
10703195|NCT02582840|11867794|FG000|COMPLETED|Overall Study||14
10703196|NCT02582840|11867795|FG001|COMPLETED|Overall Study||14
10703197|NCT02582840|11867796|FG002|COMPLETED|Overall Study||14
10703198|NCT02582840|11867794|FG000|NOT COMPLETED|Overall Study||0
10587721|NCT01751113|11743357|FG003|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
10703199|NCT02582840|11867795|FG001|NOT COMPLETED|Overall Study||0
10703200|NCT02582840|11867796|FG002|NOT COMPLETED|Overall Study||0
10703201|NCT02582866|11867806|FG000|STARTED|Overall Study||106
10703202|NCT02582866|11867806|FG000|COMPLETED|Overall Study||84
10587722|NCT01751113|11743358|FG004|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
10587723|NCT01751113|11743359|FG005|NOT COMPLETED|Treatment Period 3 (4 Weeks)||1
10807005|NCT03933618|11968679|FG005|STARTED|Baseline||4
10703203|NCT02582866|11867806|FG000|NOT COMPLETED|Overall Study||22
10703204|NCT02582970|11867810|FG000|STARTED|Overall Study||40
10587724|NCT01751139|11743368|FG000|STARTED|Overall Study||3300
10587725|NCT01751139|11743368|FG000|COMPLETED|Overall Study||1033
10587726|NCT01751139|11743368|FG000|NOT COMPLETED|Overall Study||2267
10587727|NCT01751165|11743375|FG000|STARTED|Overall Study||119
10587728|NCT01751165|11743376|FG001|STARTED|Overall Study||119
10587729|NCT01751165|11743377|FG002|STARTED|Overall Study||116
10587730|NCT01751165|11743375|FG000|COMPLETED|Overall Study||117
10587731|NCT01751165|11743376|FG001|COMPLETED|Overall Study||116
10587732|NCT01751165|11743377|FG002|COMPLETED|Overall Study||113
10587733|NCT01751165|11743375|FG000|NOT COMPLETED|Overall Study||2
10587734|NCT01751165|11743376|FG001|NOT COMPLETED|Overall Study||3
10587735|NCT01751165|11743377|FG002|NOT COMPLETED|Overall Study||3
10587736|NCT01751178|11743390|FG000|STARTED|Overall Study||108
10587737|NCT01751178|11743391|FG001|STARTED|Overall Study||109
10587738|NCT01751178|11743392|FG002|STARTED|Overall Study||107
10587739|NCT01751178|11743390|FG000|COMPLETED|Overall Study||105
10587740|NCT01751178|11743391|FG001|COMPLETED|Overall Study||109
10587741|NCT01751178|11743392|FG002|COMPLETED|Overall Study||105
10587742|NCT01751178|11743390|FG000|NOT COMPLETED|Overall Study||3
10587743|NCT01751178|11743391|FG001|NOT COMPLETED|Overall Study||0
10587744|NCT01751178|11743392|FG002|NOT COMPLETED|Overall Study||2
10587745|NCT01751230|11743406|FG000|STARTED|Overall Study||20
10587746|NCT01751230|11743407|FG001|STARTED|Overall Study||20
10587747|NCT01751230|11743406|FG000|COMPLETED|Overall Study||19
10587748|NCT01751230|11743407|FG001|COMPLETED|Overall Study||16
10587749|NCT01751230|11743406|FG000|NOT COMPLETED|Overall Study||1
10587750|NCT01751230|11743407|FG001|NOT COMPLETED|Overall Study||4
10587751|NCT01751308|11743422|FG000|STARTED|Phase 1||6
10587752|NCT01751308|11743423|FG001|STARTED|Phase 1||3
10587753|NCT01751308|11743424|FG002|STARTED|Phase 1||7
10587754|NCT01751308|11743425|FG003|STARTED|Phase 1||7
10587755|NCT01751308|11743426|FG004|STARTED|Phase 1|Phase 1 and Phase 2 were separate populations.|0
10587756|NCT01751308|11743422|FG000|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|6
10587757|NCT01751308|11743423|FG001|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|3
10587758|NCT01751308|11743424|FG002|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|7
10587759|NCT01751308|11743425|FG003|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|7
10587760|NCT01751308|11743426|FG004|COMPLETED|Phase 1||0
10587761|NCT01751308|11743422|FG000|NOT COMPLETED|Phase 1||0
10587762|NCT01751308|11743423|FG001|NOT COMPLETED|Phase 1||0
10587763|NCT01751308|11743424|FG002|NOT COMPLETED|Phase 1||0
10587764|NCT01751308|11743425|FG003|NOT COMPLETED|Phase 1||0
10587765|NCT01751308|11743426|FG004|NOT COMPLETED|Phase 1||0
10587766|NCT01751308|11743422|FG000|STARTED|Phase 2||0
10587767|NCT01751308|11743423|FG001|STARTED|Phase 2||0
10587768|NCT01751308|11743424|FG002|STARTED|Phase 2||0
10587769|NCT01751308|11743425|FG003|STARTED|Phase 2||0
10587770|NCT01751308|11743426|FG004|STARTED|Phase 2|Phase 1 and Phase 2 were separate populations.|16
10587771|NCT01751308|11743422|FG000|COMPLETED|Phase 2||0
10703205|NCT02582970|11867810|FG000|COMPLETED|Overall Study||40
10703206|NCT02582970|11867810|FG000|NOT COMPLETED|Overall Study||0
10703207|NCT02582983|11867814|FG000|STARTED|Overall Study||23
10703208|NCT02582983|11867814|FG000|COMPLETED|Overall Study||17
10703209|NCT02582983|11867814|FG000|NOT COMPLETED|Overall Study||6
10703210|NCT02583230|11867818|FG000|STARTED|Overall Study||11
10703211|NCT02583230|11867818|FG000|COMPLETED|Overall Study||11
10703212|NCT02583230|11867818|FG000|NOT COMPLETED|Overall Study||0
10807006|NCT03933618|11968674|FG000|COMPLETED|Baseline||4
10587772|NCT01751308|11743423|FG001|COMPLETED|Phase 2||0
10703213|NCT02583256|11867826|FG000|STARTED|Overall Study||403
10703214|NCT02583256|11867827|FG001|STARTED|Overall Study||403
10703215|NCT02583256|11867828|FG002|STARTED|Overall Study||402
10703216|NCT02583256|11867829|FG003|STARTED|Overall Study||393
10703217|NCT02583256|11867826|FG000|Exposed|Overall Study||403
10703218|NCT02583256|11867827|FG001|Exposed|Overall Study||403
10703219|NCT02583256|11867828|FG002|Exposed|Overall Study||402
10703220|NCT02583256|11867829|FG003|Exposed|Overall Study||393
10703221|NCT02583256|11867826|FG000|COMPLETED|Overall Study||400
10703222|NCT02583256|11867827|FG001|COMPLETED|Overall Study||401
10703223|NCT02583256|11867828|FG002|COMPLETED|Overall Study||400
10703224|NCT02583256|11867829|FG003|COMPLETED|Overall Study||390
10703225|NCT02583256|11867826|FG000|NOT COMPLETED|Overall Study||3
10703226|NCT02583256|11867827|FG001|NOT COMPLETED|Overall Study||2
10703227|NCT02583256|11867828|FG002|NOT COMPLETED|Overall Study||2
10703228|NCT02583256|11867829|FG003|NOT COMPLETED|Overall Study||3
10587773|NCT01751308|11743424|FG002|COMPLETED|Phase 2||0
10587774|NCT01751308|11743425|FG003|COMPLETED|Phase 2||0
10587775|NCT01751308|11743426|FG004|COMPLETED|Phase 2|DP, AE and death were considered as completed (defined in protocol)|16
10587776|NCT01751308|11743422|FG000|NOT COMPLETED|Phase 2||0
10587777|NCT01751308|11743423|FG001|NOT COMPLETED|Phase 2||0
10587778|NCT01751308|11743424|FG002|NOT COMPLETED|Phase 2||0
10587779|NCT01751308|11743425|FG003|NOT COMPLETED|Phase 2||0
10587780|NCT01751308|11743426|FG004|NOT COMPLETED|Phase 2||0
10587781|NCT01751386|11743444|FG000|STARTED|Overall Study||20
10703229|NCT02583360|11867843|FG000|STARTED|Overall Study||60
10703230|NCT02583360|11867844|FG001|STARTED|Overall Study||49
10587782|NCT01751386|11743445|FG001|STARTED|Overall Study||19
10587783|NCT01751386|11743444|FG000|COMPLETED|Overall Study||18
10587784|NCT01751386|11743445|FG001|COMPLETED|Overall Study||16
10587785|NCT01751386|11743444|FG000|NOT COMPLETED|Overall Study||2
10587786|NCT01751386|11743445|FG001|NOT COMPLETED|Overall Study||3
10587787|NCT01751399|11743455|FG000|STARTED|Overall Study||12
10587788|NCT01751399|11743456|FG001|STARTED|Overall Study||8
10587789|NCT01751399|11743457|FG002|STARTED|Overall Study||8
10587790|NCT01751399|11743458|FG003|STARTED|Overall Study||7
10587791|NCT01751399|11743455|FG000|Received 1 Dose of Study Drug|Overall Study||12
10587792|NCT01751399|11743456|FG001|Received 1 Dose of Study Drug|Overall Study||8
10587793|NCT01751399|11743457|FG002|Received 1 Dose of Study Drug|Overall Study||8
10587794|NCT01751399|11743458|FG003|Received 1 Dose of Study Drug|Overall Study||7
10587795|NCT01751399|11743455|FG000|COMPLETED|Overall Study||12
10587796|NCT01751399|11743456|FG001|COMPLETED|Overall Study||8
10587797|NCT01751399|11743457|FG002|COMPLETED|Overall Study||8
10587798|NCT01751399|11743458|FG003|COMPLETED|Overall Study||7
10587799|NCT01751399|11743455|FG000|NOT COMPLETED|Overall Study||0
10587800|NCT01751399|11743456|FG001|NOT COMPLETED|Overall Study||0
10587801|NCT01751399|11743457|FG002|NOT COMPLETED|Overall Study||0
10587802|NCT01751399|11743458|FG003|NOT COMPLETED|Overall Study||0
10587803|NCT01751412|11743468|FG000|STARTED|Overall Study||12
10587804|NCT01751412|11743468|FG000|COMPLETED|Overall Study||11
10587805|NCT01751412|11743468|FG000|NOT COMPLETED|Overall Study||1
10587806|NCT01751451|11743475|FG000|STARTED|Overall Study||42
10587807|NCT01751451|11743476|FG001|STARTED|Overall Study||40
10587808|NCT01751451|11743477|FG002|STARTED|Overall Study||42
10587809|NCT01751451|11743475|FG000|COMPLETED|Overall Study||42
10587810|NCT01751451|11743476|FG001|COMPLETED|Overall Study||40
10587811|NCT01751451|11743477|FG002|COMPLETED|Overall Study||42
10587812|NCT01751451|11743475|FG000|NOT COMPLETED|Overall Study||0
10587813|NCT01751451|11743476|FG001|NOT COMPLETED|Overall Study||0
10587814|NCT01751451|11743477|FG002|NOT COMPLETED|Overall Study||0
10587815|NCT01751568|11743488|FG000|STARTED|Overall Study||13
10587816|NCT01751568|11743489|FG001|STARTED|Overall Study||14
10587817|NCT01751568|11743490|FG002|STARTED|Overall Study||13
10587818|NCT01751568|11743488|FG000|COMPLETED|Overall Study||12
10587819|NCT01751568|11743489|FG001|COMPLETED|Overall Study||14
10587820|NCT01751568|11743490|FG002|COMPLETED|Overall Study||13
10587821|NCT01751568|11743488|FG000|NOT COMPLETED|Overall Study||1
10587822|NCT01751568|11743489|FG001|NOT COMPLETED|Overall Study||0
10587823|NCT01751568|11743490|FG002|NOT COMPLETED|Overall Study||0
10587824|NCT01751646|11743500|FG000|STARTED|Overall Study||109
10587825|NCT01751646|11743501|FG001|STARTED|Overall Study||105
10587826|NCT01751646|11743500|FG000|COMPLETED|Overall Study||98
10587827|NCT01751646|11743501|FG001|COMPLETED|Overall Study||87
10587828|NCT01751646|11743500|FG000|NOT COMPLETED|Overall Study||11
10587829|NCT01751646|11743501|FG001|NOT COMPLETED|Overall Study||18
10587830|NCT01751724|11743513|FG000|STARTED|Overall Study||42
10587831|NCT01751724|11743514|FG001|STARTED|Overall Study||44
10587832|NCT01751724|11743513|FG000|COMPLETED|Overall Study||41
10587833|NCT01751724|11743514|FG001|COMPLETED|Overall Study||42
10587834|NCT01751724|11743513|FG000|NOT COMPLETED|Overall Study||1
10587835|NCT01751724|11743514|FG001|NOT COMPLETED|Overall Study||2
10587836|NCT01751802|11743522|FG000|STARTED|Overall Study||5
10587837|NCT01751802|11743523|FG001|STARTED|Overall Study||4
10587838|NCT01751802|11743522|FG000|Completed Period 1|Overall Study||2
10587839|NCT01751802|11743523|FG001|Completed Period 1|Overall Study||4
10587840|NCT01751802|11743522|FG000|Completed Period 2|Overall Study||2
10703231|NCT02583360|11867843|FG000|COMPLETED|Overall Study||60
10703232|NCT02583360|11867844|FG001|COMPLETED|Overall Study||49
10703233|NCT02583360|11867843|FG000|NOT COMPLETED|Overall Study||0
10703234|NCT02583360|11867844|FG001|NOT COMPLETED|Overall Study||0
10703235|NCT02583399|11867850|FG000|STARTED|Overall Study||30
10703236|NCT02583399|11867850|FG000|COMPLETED|Overall Study||24
10703237|NCT02583399|11867850|FG000|NOT COMPLETED|Overall Study||6
10703238|NCT02583425|11867854|FG000|STARTED|Screening||27
10703239|NCT02583425|11867854|FG000|COMPLETED|Screening||15
10703240|NCT02583425|11867854|FG000|NOT COMPLETED|Screening||12
10807007|NCT03933618|11968675|FG001|COMPLETED|Baseline||4
10807008|NCT03933618|11968676|FG002|COMPLETED|Baseline||4
10703241|NCT02583425|11867854|FG000|STARTED|Baseline||15
10703242|NCT02583425|11867854|FG000|COMPLETED|Baseline||10
10807009|NCT03933618|11968677|FG003|COMPLETED|Baseline||4
10807010|NCT03933618|11968678|FG004|COMPLETED|Baseline||4
10807011|NCT03933618|11968679|FG005|COMPLETED|Baseline||4
10807012|NCT03933618|11968674|FG000|NOT COMPLETED|Baseline||0
10807013|NCT03933618|11968675|FG001|NOT COMPLETED|Baseline||0
10587841|NCT01751802|11743523|FG001|Completed Period 2|Overall Study||1
10587842|NCT01751802|11743522|FG000|Completed Period 3|Overall Study||2
10587843|NCT01751802|11743523|FG001|Completed Period 3|Overall Study||1
10587844|NCT01751802|11743522|FG000|COMPLETED|Overall Study||1
10587845|NCT01751802|11743523|FG001|COMPLETED|Overall Study||2
10587846|NCT01751802|11743522|FG000|NOT COMPLETED|Overall Study||4
10587847|NCT01751802|11743523|FG001|NOT COMPLETED|Overall Study||2
10587848|NCT01751867|11743537|FG000|STARTED|Overall Study||36
10587849|NCT01751867|11743538|FG001|STARTED|Overall Study||99
10587850|NCT01751867|11743537|FG000|Treated|Overall Study||34
10587851|NCT01751867|11743538|FG001|Treated|Overall Study||98
10587852|NCT01751867|11743537|FG000|COMPLETED|Overall Study||0
10703243|NCT02583425|11867854|FG000|NOT COMPLETED|Baseline||5
10703244|NCT02583425|11867854|FG000|STARTED|Treatment Period||10
10703245|NCT02583425|11867854|FG000|COMPLETED|Treatment Period||9
10587853|NCT01751867|11743538|FG001|COMPLETED|Overall Study||0
10703246|NCT02583425|11867854|FG000|NOT COMPLETED|Treatment Period||1
10807014|NCT03933618|11968676|FG002|NOT COMPLETED|Baseline||0
10587854|NCT01751867|11743537|FG000|NOT COMPLETED|Overall Study||36
10587855|NCT01751867|11743538|FG001|NOT COMPLETED|Overall Study||99
10587856|NCT01751971|11743546|FG000|STARTED|Overall Study||22
10587857|NCT01751971|11743547|FG001|STARTED|Overall Study||25
10587858|NCT01751971|11743546|FG000|COMPLETED|Overall Study||20
10587859|NCT01751971|11743547|FG001|COMPLETED|Overall Study||24
10587860|NCT01751971|11743546|FG000|NOT COMPLETED|Overall Study||2
10587861|NCT01751971|11743547|FG001|NOT COMPLETED|Overall Study||1
10587862|NCT01752036|11743559|FG000|STARTED|Overall Study||33
10587863|NCT01752036|11743559|FG000|COMPLETED|Overall Study||31
10587864|NCT01752036|11743559|FG000|NOT COMPLETED|Overall Study||2
10587865|NCT01752400|11743564|FG000|STARTED|Overall Study||6
10587866|NCT01752400|11743564|FG000|COMPLETED|Overall Study||6
10587867|NCT01752400|11743564|FG000|NOT COMPLETED|Overall Study||0
10587868|NCT01752413|11743570|FG000|STARTED|Overall Study||170
10587869|NCT01752413|11743571|FG001|STARTED|Overall Study||27
10587870|NCT01752413|11743570|FG000|COMPLETED|Overall Study||58
10587871|NCT01752413|11743571|FG001|COMPLETED|Overall Study||6
10587872|NCT01752413|11743570|FG000|NOT COMPLETED|Overall Study||112
10587873|NCT01752413|11743571|FG001|NOT COMPLETED|Overall Study||21
10587874|NCT01752426|11743577|FG000|STARTED|Overall Study||30
10587875|NCT01752426|11743577|FG000|COMPLETED|Overall Study||30
10587876|NCT01752426|11743577|FG000|NOT COMPLETED|Overall Study||0
10587877|NCT01752634|11743587|FG000|STARTED|Up to Week 24 (Primary Analysis)||99
10587878|NCT01752634|11743588|FG001|STARTED|Up to Week 24 (Primary Analysis)||100
10587879|NCT01752634|11743589|FG002|STARTED|Up to Week 24 (Primary Analysis)||100
10587880|NCT01752634|11743590|FG003|STARTED|Up to Week 24 (Primary Analysis)||43
10587881|NCT01752634|11743591|FG004|STARTED|Up to Week 24 (Primary Analysis)||45
10587882|NCT01752634|11743592|FG005|STARTED|Up to Week 24 (Primary Analysis)||10
10587883|NCT01752634|11743587|FG000|COMPLETED|Up to Week 24 (Primary Analysis)||93
10587884|NCT01752634|11743588|FG001|COMPLETED|Up to Week 24 (Primary Analysis)||95
10587885|NCT01752634|11743589|FG002|COMPLETED|Up to Week 24 (Primary Analysis)||97
10587886|NCT01752634|11743590|FG003|COMPLETED|Up to Week 24 (Primary Analysis)||43
10587887|NCT01752634|11743591|FG004|COMPLETED|Up to Week 24 (Primary Analysis)||45
10587888|NCT01752634|11743592|FG005|COMPLETED|Up to Week 24 (Primary Analysis)||0
10587889|NCT01752634|11743587|FG000|NOT COMPLETED|Up to Week 24 (Primary Analysis)||6
10587890|NCT01752634|11743588|FG001|NOT COMPLETED|Up to Week 24 (Primary Analysis)||5
10587891|NCT01752634|11743589|FG002|NOT COMPLETED|Up to Week 24 (Primary Analysis)||3
10587892|NCT01752634|11743590|FG003|NOT COMPLETED|Up to Week 24 (Primary Analysis)||0
10587893|NCT01752634|11743591|FG004|NOT COMPLETED|Up to Week 24 (Primary Analysis)||0
10587894|NCT01752634|11743592|FG005|NOT COMPLETED|Up to Week 24 (Primary Analysis)||10
10587895|NCT01752634|11743587|FG000|STARTED|Week 24 to Week 260||93
10587896|NCT01752634|11743588|FG001|STARTED|Week 24 to Week 260||95
10587897|NCT01752634|11743589|FG002|STARTED|Week 24 to Week 260||97
10587898|NCT01752634|11743590|FG003|STARTED|Week 24 to Week 260||43
10587899|NCT01752634|11743591|FG004|STARTED|Week 24 to Week 260||45
10587900|NCT01752634|11743592|FG005|STARTED|Week 24 to Week 260||0
10587901|NCT01752634|11743587|FG000|COMPLETED|Week 24 to Week 260||59
10587902|NCT01752634|11743588|FG001|COMPLETED|Week 24 to Week 260||65
10587903|NCT01752634|11743589|FG002|COMPLETED|Week 24 to Week 260||64
10587904|NCT01752634|11743590|FG003|COMPLETED|Week 24 to Week 260||29
10587905|NCT01752634|11743591|FG004|COMPLETED|Week 24 to Week 260||31
10587906|NCT01752634|11743592|FG005|COMPLETED|Week 24 to Week 260||0
10587907|NCT01752634|11743587|FG000|NOT COMPLETED|Week 24 to Week 260||34
10587908|NCT01752634|11743588|FG001|NOT COMPLETED|Week 24 to Week 260||30
10587909|NCT01752634|11743589|FG002|NOT COMPLETED|Week 24 to Week 260||33
10587910|NCT01752634|11743590|FG003|NOT COMPLETED|Week 24 to Week 260||14
10587911|NCT01752634|11743591|FG004|NOT COMPLETED|Week 24 to Week 260||14
10587912|NCT01752634|11743592|FG005|NOT COMPLETED|Week 24 to Week 260||0
10587913|NCT01752712|11743604|FG000|STARTED|Overall Study||31
10587914|NCT01752712|11743605|FG001|STARTED|Overall Study||31
10587915|NCT01752712|11743604|FG000|COMPLETED|Overall Study||22
10587916|NCT01752712|11743605|FG001|COMPLETED|Overall Study||21
10587917|NCT01752712|11743604|FG000|NOT COMPLETED|Overall Study||9
10587918|NCT01752712|11743605|FG001|NOT COMPLETED|Overall Study||10
10587919|NCT01752842|11743613|FG000|STARTED|Overall Study||34
10587920|NCT01752842|11743614|FG001|STARTED|Overall Study||36
10587921|NCT01752842|11743613|FG000|COMPLETED|Overall Study||31
10587922|NCT01752842|11743614|FG001|COMPLETED|Overall Study||34
10587923|NCT01752842|11743613|FG000|NOT COMPLETED|Overall Study||3
10587924|NCT01752842|11743614|FG001|NOT COMPLETED|Overall Study||2
10587925|NCT01752855|11743622|FG000|STARTED|Overall Study||44
10587926|NCT01752855|11743623|FG001|STARTED|Overall Study||44
10587927|NCT01752855|11743622|FG000|COMPLETED|Overall Study||43
10587928|NCT01752855|11743623|FG001|COMPLETED|Overall Study||40
10587929|NCT01752855|11743622|FG000|NOT COMPLETED|Overall Study||1
10587930|NCT01752855|11743623|FG001|NOT COMPLETED|Overall Study||4
10587931|NCT01752907|11743631|FG000|STARTED|Overall Study||151
10587932|NCT01752907|11743632|FG001|STARTED|Overall Study||153
10587933|NCT01752907|11743631|FG000|Received Pegfilgrastim|Overall Study||149
10587934|NCT01752907|11743632|FG001|Received Pegfilgrastim|Overall Study||151
10587935|NCT01752907|11743631|FG000|COMPLETED|Overall Study||139
10587936|NCT01752907|11743632|FG001|COMPLETED|Overall Study||133
10587937|NCT01752907|11743631|FG000|NOT COMPLETED|Overall Study||12
10587938|NCT01752907|11743632|FG001|NOT COMPLETED|Overall Study||20
10587939|NCT01752933|11743640|FG000|STARTED|Treatment|Includes all patients who received any treatment|4
10587940|NCT01752933|11743641|FG001|STARTED|Treatment|Includes all patients who received any treatment|46
10587941|NCT01752933|11743640|FG000|COMPLETED|Treatment|Completion not applicable for this survival study|0
10587942|NCT01752933|11743641|FG001|COMPLETED|Treatment|Completion not applicable for this survival study|0
10587943|NCT01752933|11743640|FG000|NOT COMPLETED|Treatment||4
10587944|NCT01752933|11743641|FG001|NOT COMPLETED|Treatment||46
10587945|NCT01752933|11743640|FG000|STARTED|Overall Study and Follow-up|Includes all patients who received any treatment|4
10587946|NCT01752933|11743641|FG001|STARTED|Overall Study and Follow-up|Includes all patients who received any treatment|46
10587947|NCT01752933|11743640|FG000|COMPLETED|Overall Study and Follow-up|Completion not applicable for this survival study|0
10587948|NCT01752933|11743641|FG001|COMPLETED|Overall Study and Follow-up|Completion not applicable for this survival study|0
10587949|NCT01752933|11743640|FG000|NOT COMPLETED|Overall Study and Follow-up||4
10587950|NCT01752933|11743641|FG001|NOT COMPLETED|Overall Study and Follow-up||46
10587951|NCT01752985|11743651|FG000|STARTED|Treatment Period||29
10587952|NCT01752985|11743652|FG001|STARTED|Treatment Period||30
10587953|NCT01752985|11743653|FG002|STARTED|Treatment Period||29
10587954|NCT01752985|11743651|FG000|COMPLETED|Treatment Period||25
10587955|NCT01752985|11743652|FG001|COMPLETED|Treatment Period||27
10587956|NCT01752985|11743653|FG002|COMPLETED|Treatment Period||24
10587957|NCT01752985|11743651|FG000|NOT COMPLETED|Treatment Period||4
10587958|NCT01752985|11743652|FG001|NOT COMPLETED|Treatment Period||3
10587959|NCT01752985|11743653|FG002|NOT COMPLETED|Treatment Period||5
10587960|NCT01752985|11743651|FG000|STARTED|Follow-up Period|Includes 25 participants in this period and 3 participants re-joined for follow-up|28
10587961|NCT01752985|11743652|FG001|STARTED|Follow-up Period||27
10587962|NCT01752985|11743653|FG002|STARTED|Follow-up Period|Includes 24 participants in this period and 2 participants re-joined for follow-up|26
10587963|NCT01752985|11743651|FG000|COMPLETED|Follow-up Period||28
10587964|NCT01752985|11743652|FG001|COMPLETED|Follow-up Period||27
10587965|NCT01752985|11743653|FG002|COMPLETED|Follow-up Period||26
10703247|NCT02583477|11867861|FG000|STARTED|Overall Study||3
10703248|NCT02583477|11867862|FG001|STARTED|Overall Study||20
10703249|NCT02583477|11867861|FG000|Received Treatment|Overall Study||3
10703250|NCT02583477|11867862|FG001|Received Treatment|Overall Study||20
10703251|NCT02583477|11867861|FG000|Completed Treatment|Overall Study||0
10587966|NCT01752985|11743651|FG000|NOT COMPLETED|Follow-up Period||0
10587967|NCT01752985|11743652|FG001|NOT COMPLETED|Follow-up Period||0
10587968|NCT01752985|11743653|FG002|NOT COMPLETED|Follow-up Period||0
10587969|NCT01753076|11743663|FG000|STARTED|Overall Study||151
10587970|NCT01753076|11743664|FG001|STARTED|Overall Study||152
10587971|NCT01753076|11743663|FG000|COMPLETED|Overall Study||110
10587972|NCT01753076|11743664|FG001|COMPLETED|Overall Study||106
10587973|NCT01753076|11743663|FG000|NOT COMPLETED|Overall Study||41
10587974|NCT01753076|11743664|FG001|NOT COMPLETED|Overall Study||46
10587975|NCT01753115|11743675|FG000|STARTED|Overall Study||44
10587976|NCT01753115|11743676|FG001|STARTED|Overall Study||40
10587977|NCT01753115|11743677|FG002|STARTED|Overall Study||70
10587978|NCT01753115|11743675|FG000|Treated|Overall Study||38
10587979|NCT01753115|11743676|FG001|Treated|Overall Study||39
10587980|NCT01753115|11743677|FG002|Treated|Overall Study||67
10587981|NCT01753115|11743675|FG000|COMPLETED|Overall Study||32
10587982|NCT01753115|11743676|FG001|COMPLETED|Overall Study||25
10587983|NCT01753115|11743677|FG002|COMPLETED|Overall Study||56
10587984|NCT01753115|11743675|FG000|NOT COMPLETED|Overall Study||12
10587985|NCT01753115|11743676|FG001|NOT COMPLETED|Overall Study||15
10587986|NCT01753115|11743677|FG002|NOT COMPLETED|Overall Study||14
10587987|NCT01753193|11743685|FG000|STARTED|Overall Study||218
10587988|NCT01753193|11743685|FG000|COMPLETED|Overall Study||172
10587989|NCT01753193|11743685|FG000|NOT COMPLETED|Overall Study||46
10587990|NCT01753297|11743691|FG000|STARTED|Overall Study||117
10587991|NCT01753297|11743692|FG001|STARTED|Overall Study||109
10587992|NCT01753297|11743691|FG000|Received Triptorelin Treatment|Overall Study||0
10587993|NCT01753297|11743692|FG001|Received Triptorelin Treatment|Overall Study||105
10587994|NCT01753297|11743691|FG000|COMPLETED|Overall Study||76
10587995|NCT01753297|11743692|FG001|COMPLETED|Overall Study||73
10587996|NCT01753297|11743691|FG000|NOT COMPLETED|Overall Study||41
10587997|NCT01753297|11743692|FG001|NOT COMPLETED|Overall Study||36
10587998|NCT01753310|11743702|FG000|STARTED|Overall Study||89
10587999|NCT01753310|11743703|FG001|STARTED|Overall Study||45
10588000|NCT01753310|11743702|FG000|COMPLETED|Overall Study||57
10588001|NCT01753310|11743703|FG001|COMPLETED|Overall Study||21
10588002|NCT01753310|11743702|FG000|NOT COMPLETED|Overall Study||32
10588003|NCT01753310|11743703|FG001|NOT COMPLETED|Overall Study||24
10588004|NCT01753323|11743712|FG000|STARTED|Overall Study||11
10588005|NCT01753323|11743713|FG001|STARTED|Overall Study||10
10588006|NCT01753323|11743714|FG002|STARTED|Overall Study||22
10588007|NCT01753323|11743712|FG000|Pharmacodynamic (PD) Set|Overall Study||10
10588008|NCT01753323|11743713|FG001|Pharmacodynamic (PD) Set|Overall Study||10
10588009|NCT01753323|11743714|FG002|Pharmacodynamic (PD) Set|Overall Study||21
10588010|NCT01753323|11743712|FG000|Pharmacokinetic(PK) Set|Overall Study||10
10588011|NCT01753323|11743713|FG001|Pharmacokinetic(PK) Set|Overall Study||10
10588012|NCT01753323|11743714|FG002|Pharmacokinetic(PK) Set|Overall Study||21
10588013|NCT01753323|11743712|FG000|Safety Set|Overall Study||11
10588014|NCT01753323|11743713|FG001|Safety Set|Overall Study||10
10588015|NCT01753323|11743714|FG002|Safety Set|Overall Study||22
10588016|NCT01753323|11743712|FG000|Intent-to-treat Analysis Set|Overall Study||11
10588017|NCT01753323|11743713|FG001|Intent-to-treat Analysis Set|Overall Study||10
10588018|NCT01753323|11743714|FG002|Intent-to-treat Analysis Set|Overall Study||22
10588019|NCT01753323|11743712|FG000|COMPLETED|Overall Study||10
10588020|NCT01753323|11743713|FG001|COMPLETED|Overall Study||10
10588021|NCT01753323|11743714|FG002|COMPLETED|Overall Study||13
10588022|NCT01753323|11743712|FG000|NOT COMPLETED|Overall Study||1
10588023|NCT01753323|11743713|FG001|NOT COMPLETED|Overall Study||0
10588024|NCT01753323|11743714|FG002|NOT COMPLETED|Overall Study||9
10588025|NCT01753336|11743723|FG000|STARTED|Overall Study||112
10588026|NCT01753336|11743723|FG000|Cycle 1|Overall Study||112
10588027|NCT01753336|11743723|FG000|Cycle 2|Overall Study||98
10588028|NCT01753336|11743723|FG000|Cycle 3|Overall Study||93
10588029|NCT01753336|11743723|FG000|COMPLETED|Overall Study||92
10588030|NCT01753336|11743723|FG000|NOT COMPLETED|Overall Study||20
10588031|NCT01753362|11743729|FG000|STARTED|Overall Study||36
10588032|NCT01753362|11743730|FG001|STARTED|Overall Study||48
10588033|NCT01753362|11743729|FG000|COMPLETED|Overall Study||26
10588034|NCT01753362|11743730|FG001|COMPLETED|Overall Study||40
10588035|NCT01753362|11743729|FG000|NOT COMPLETED|Overall Study||10
10588036|NCT01753362|11743730|FG001|NOT COMPLETED|Overall Study||8
10588037|NCT01753401|11743738|FG000|STARTED|Double-blind Period (8 Weeks)||12
10588038|NCT01753401|11743739|FG001|STARTED|Double-blind Period (8 Weeks)||26
10588039|NCT01753401|11743740|FG002|STARTED|Double-blind Period (8 Weeks)|This arm was not included in the double-blind period|0
10588040|NCT01753401|11743741|FG003|STARTED|Double-blind Period (8 Weeks)|This arm was not included in the double-blind period|0
10588041|NCT01753401|11743738|FG000|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||11
10588042|NCT01753401|11743739|FG001|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||25
10807078|NCT03931785|11968699|FG002|COMPLETED|Overall Study||84
10588043|NCT01753401|11743740|FG002|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||0
10588044|NCT01753401|11743741|FG003|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||0
10588045|NCT01753401|11743738|FG000|COMPLETED|Double-blind Period (8 Weeks)||11
10588046|NCT01753401|11743739|FG001|COMPLETED|Double-blind Period (8 Weeks)||22
10588047|NCT01753401|11743740|FG002|COMPLETED|Double-blind Period (8 Weeks)||0
10588048|NCT01753401|11743741|FG003|COMPLETED|Double-blind Period (8 Weeks)||0
10588049|NCT01753401|11743738|FG000|NOT COMPLETED|Double-blind Period (8 Weeks)||1
10588050|NCT01753401|11743739|FG001|NOT COMPLETED|Double-blind Period (8 Weeks)||4
10588051|NCT01753401|11743740|FG002|NOT COMPLETED|Double-blind Period (8 Weeks)||0
10588052|NCT01753401|11743741|FG003|NOT COMPLETED|Double-blind Period (8 Weeks)||0
10588053|NCT01753401|11743738|FG000|STARTED|Open Label Period (44 Weeks)|This arm was not included in the open label period|0
10807015|NCT03933618|11968677|FG003|NOT COMPLETED|Baseline||0
10807016|NCT03933618|11968678|FG004|NOT COMPLETED|Baseline||0
10807017|NCT03933618|11968679|FG005|NOT COMPLETED|Baseline||0
10807018|NCT03933618|11968674|FG000|STARTED|Baseline to Week 8||4
10807019|NCT03933618|11968675|FG001|STARTED|Baseline to Week 8||4
10807020|NCT03933618|11968676|FG002|STARTED|Baseline to Week 8||4
10807021|NCT03933618|11968677|FG003|STARTED|Baseline to Week 8||4
10807022|NCT03933618|11968678|FG004|STARTED|Baseline to Week 8||4
10807023|NCT03933618|11968679|FG005|STARTED|Baseline to Week 8||4
10807024|NCT03933618|11968674|FG000|COMPLETED|Baseline to Week 8||4
10807025|NCT03933618|11968675|FG001|COMPLETED|Baseline to Week 8||4
10807026|NCT03933618|11968676|FG002|COMPLETED|Baseline to Week 8||4
10807027|NCT03933618|11968677|FG003|COMPLETED|Baseline to Week 8||4
10807028|NCT03933618|11968678|FG004|COMPLETED|Baseline to Week 8||4
10807029|NCT03933618|11968679|FG005|COMPLETED|Baseline to Week 8||4
10807030|NCT03933618|11968674|FG000|NOT COMPLETED|Baseline to Week 8||0
10807031|NCT03933618|11968675|FG001|NOT COMPLETED|Baseline to Week 8||0
10807032|NCT03933618|11968676|FG002|NOT COMPLETED|Baseline to Week 8||0
10807033|NCT03933618|11968677|FG003|NOT COMPLETED|Baseline to Week 8||0
10807034|NCT03933618|11968678|FG004|NOT COMPLETED|Baseline to Week 8||0
10807035|NCT03933618|11968679|FG005|NOT COMPLETED|Baseline to Week 8||0
10807036|NCT03933618|11968674|FG000|STARTED|Week 8 to Week 16||4
10807037|NCT03933618|11968675|FG001|STARTED|Week 8 to Week 16||4
10807038|NCT03933618|11968676|FG002|STARTED|Week 8 to Week 16||4
10807039|NCT03933618|11968677|FG003|STARTED|Week 8 to Week 16||4
10807040|NCT03933618|11968678|FG004|STARTED|Week 8 to Week 16||4
10807041|NCT03933618|11968679|FG005|STARTED|Week 8 to Week 16||4
10588054|NCT01753401|11743739|FG001|STARTED|Open Label Period (44 Weeks)|This arm was not included in the open label period|0
10807042|NCT03933618|11968674|FG000|COMPLETED|Week 8 to Week 16||4
10807043|NCT03933618|11968675|FG001|COMPLETED|Week 8 to Week 16||4
10807044|NCT03933618|11968676|FG002|COMPLETED|Week 8 to Week 16||4
10807045|NCT03933618|11968677|FG003|COMPLETED|Week 8 to Week 16||4
10807046|NCT03933618|11968678|FG004|COMPLETED|Week 8 to Week 16||4
10807047|NCT03933618|11968679|FG005|COMPLETED|Week 8 to Week 16||4
10588055|NCT01753401|11743740|FG002|STARTED|Open Label Period (44 Weeks)||11
10588056|NCT01753401|11743741|FG003|STARTED|Open Label Period (44 Weeks)||22
10588057|NCT01753401|11743738|FG000|mITT|Open Label Period (44 Weeks)||0
10588058|NCT01753401|11743739|FG001|mITT|Open Label Period (44 Weeks)||0
10588059|NCT01753401|11743740|FG002|mITT|Open Label Period (44 Weeks)||11
10588060|NCT01753401|11743741|FG003|mITT|Open Label Period (44 Weeks)||22
10588061|NCT01753401|11743738|FG000|Safety Analysis Set|Open Label Period (44 Weeks)||0
10588062|NCT01753401|11743739|FG001|Safety Analysis Set|Open Label Period (44 Weeks)||0
10588063|NCT01753401|11743740|FG002|Safety Analysis Set|Open Label Period (44 Weeks)||11
10588064|NCT01753401|11743741|FG003|Safety Analysis Set|Open Label Period (44 Weeks)||22
10588065|NCT01753401|11743738|FG000|COMPLETED|Open Label Period (44 Weeks)||0
10807048|NCT03933618|11968674|FG000|NOT COMPLETED|Week 8 to Week 16||0
10807049|NCT03933618|11968675|FG001|NOT COMPLETED|Week 8 to Week 16||0
10807050|NCT03933618|11968676|FG002|NOT COMPLETED|Week 8 to Week 16||0
10807051|NCT03933618|11968677|FG003|NOT COMPLETED|Week 8 to Week 16||0
10807052|NCT03933618|11968678|FG004|NOT COMPLETED|Week 8 to Week 16||0
10807053|NCT03933618|11968679|FG005|NOT COMPLETED|Week 8 to Week 16||0
10807054|NCT03933618|11968674|FG000|STARTED|Week 16 to Week 24||4
10807055|NCT03933618|11968675|FG001|STARTED|Week 16 to Week 24||4
10807056|NCT03933618|11968676|FG002|STARTED|Week 16 to Week 24||4
10807057|NCT03933618|11968677|FG003|STARTED|Week 16 to Week 24||4
10807058|NCT03933618|11968678|FG004|STARTED|Week 16 to Week 24||4
10807059|NCT03933618|11968679|FG005|STARTED|Week 16 to Week 24||4
10807060|NCT03933618|11968674|FG000|COMPLETED|Week 16 to Week 24||4
10807061|NCT03933618|11968675|FG001|COMPLETED|Week 16 to Week 24||4
10807062|NCT03933618|11968676|FG002|COMPLETED|Week 16 to Week 24||4
10807063|NCT03933618|11968677|FG003|COMPLETED|Week 16 to Week 24||4
10807064|NCT03933618|11968678|FG004|COMPLETED|Week 16 to Week 24||4
10807065|NCT03933618|11968679|FG005|COMPLETED|Week 16 to Week 24||4
10807066|NCT03933618|11968674|FG000|NOT COMPLETED|Week 16 to Week 24||0
10807067|NCT03933618|11968675|FG001|NOT COMPLETED|Week 16 to Week 24||0
10807068|NCT03933618|11968676|FG002|NOT COMPLETED|Week 16 to Week 24||0
10807069|NCT03933618|11968677|FG003|NOT COMPLETED|Week 16 to Week 24||0
10807070|NCT03933618|11968678|FG004|NOT COMPLETED|Week 16 to Week 24||0
10807071|NCT03933618|11968679|FG005|NOT COMPLETED|Week 16 to Week 24||0
10807072|NCT03931785|11968697|FG000|STARTED|Overall Study||97
10807073|NCT03931785|11968698|FG001|STARTED|Overall Study||97
10807074|NCT03931785|11968699|FG002|STARTED|Overall Study||97
10807075|NCT03931785|11968700|FG003|STARTED|Overall Study||97
10807076|NCT03931785|11968697|FG000|COMPLETED|Overall Study||92
10807077|NCT03931785|11968698|FG001|COMPLETED|Overall Study||90
10807079|NCT03931785|11968700|FG003|COMPLETED|Overall Study||86
10807080|NCT03931785|11968697|FG000|NOT COMPLETED|Overall Study||5
10807081|NCT03931785|11968698|FG001|NOT COMPLETED|Overall Study||7
10807082|NCT03931785|11968699|FG002|NOT COMPLETED|Overall Study||13
10807083|NCT03931785|11968700|FG003|NOT COMPLETED|Overall Study||11
10807084|NCT03930641|11968710|FG000|STARTED|Overall Study||34
10807085|NCT03930641|11968710|FG000|COMPLETED|Overall Study||34
10807086|NCT03930641|11968710|FG000|NOT COMPLETED|Overall Study||0
10807087|NCT03927846|11968716|FG000|STARTED|Overall Study||30
10807088|NCT03927846|11968717|FG001|STARTED|Overall Study||30
10807089|NCT03927846|11968716|FG000|COMPLETED|Overall Study||20
10807090|NCT03927846|11968717|FG001|COMPLETED|Overall Study||19
10807091|NCT03927846|11968716|FG000|NOT COMPLETED|Overall Study||10
10807092|NCT03927846|11968717|FG001|NOT COMPLETED|Overall Study||11
10807093|NCT03927105|11968723|FG000|STARTED|Overall Study||4
10807094|NCT03927105|11968723|FG000|Began Treatment|Overall Study||3
10807095|NCT03927105|11968723|FG000|Follow-up|Overall Study||3
10807096|NCT03927105|11968723|FG000|COMPLETED|Overall Study||0
10807097|NCT03927105|11968723|FG000|NOT COMPLETED|Overall Study||4
10807098|NCT03923933|11968729|FG000|STARTED|Overall Study||17
10807099|NCT03923933|11968730|FG001|STARTED|Overall Study||17
10807100|NCT03923933|11968729|FG000|COMPLETED|Overall Study||16
10807101|NCT03923933|11968730|FG001|COMPLETED|Overall Study||16
10807102|NCT03923933|11968729|FG000|NOT COMPLETED|Overall Study||1
10807103|NCT03923933|11968730|FG001|NOT COMPLETED|Overall Study||1
10807104|NCT03909295|11968736|FG000|STARTED|Overall Study||52
10807105|NCT03909295|11968736|FG000|Safety Set (SAF)|Overall Study||52
10807106|NCT03909295|11968736|FG000|COMPLETED|Overall Study||0
10807107|NCT03909295|11968736|FG000|NOT COMPLETED|Overall Study||52
10807108|NCT03908970|11968742|FG000|STARTED|Overall Study||182
10807109|NCT03908970|11968743|FG001|STARTED|Overall Study||182
10807110|NCT03908970|11968742|FG000|COMPLETED|Overall Study||165
10807111|NCT03908970|11968743|FG001|COMPLETED|Overall Study||135
10807112|NCT03908970|11968742|FG000|NOT COMPLETED|Overall Study||17
10807113|NCT03908970|11968743|FG001|NOT COMPLETED|Overall Study||47
10807114|NCT03897179|11968749|FG000|STARTED|Overall Study||27
10807115|NCT03897179|11968749|FG000|COMPLETED|Overall Study||26
10807116|NCT03897179|11968749|FG000|NOT COMPLETED|Overall Study||1
10807117|NCT03930264|11968755|FG000|STARTED|Overall Study||15
10807118|NCT03930264|11968756|FG001|STARTED|Overall Study||15
10588066|NCT01753401|11743739|FG001|COMPLETED|Open Label Period (44 Weeks)||0
10807119|NCT03930264|11968755|FG000|COMPLETED|Overall Study||15
10807120|NCT03930264|11968756|FG001|COMPLETED|Overall Study||14
10807121|NCT03930264|11968755|FG000|NOT COMPLETED|Overall Study||0
10807122|NCT03930264|11968756|FG001|NOT COMPLETED|Overall Study||1
10807123|NCT03929367|11968762|FG000|STARTED|Overall Study||11
10807124|NCT03929367|11968762|FG000|COMPLETED|Overall Study||11
10588067|NCT01753401|11743740|FG002|COMPLETED|Open Label Period (44 Weeks)||7
10588068|NCT01753401|11743741|FG003|COMPLETED|Open Label Period (44 Weeks)||13
10588069|NCT01753401|11743738|FG000|NOT COMPLETED|Open Label Period (44 Weeks)||0
10588070|NCT01753401|11743739|FG001|NOT COMPLETED|Open Label Period (44 Weeks)||0
10588071|NCT01753401|11743740|FG002|NOT COMPLETED|Open Label Period (44 Weeks)||4
10588072|NCT01753401|11743741|FG003|NOT COMPLETED|Open Label Period (44 Weeks)||9
10588073|NCT01753518|11743753|FG000|STARTED|Intention-to-Treat Analysis||110
10588074|NCT01753518|11743754|FG001|STARTED|Intention-to-Treat Analysis||110
10588075|NCT01753518|11743753|FG000|COMPLETED|Intention-to-Treat Analysis||103
10588076|NCT01753518|11743754|FG001|COMPLETED|Intention-to-Treat Analysis||103
10588077|NCT01753518|11743753|FG000|NOT COMPLETED|Intention-to-Treat Analysis||7
10588078|NCT01753518|11743754|FG001|NOT COMPLETED|Intention-to-Treat Analysis||7
10588079|NCT01753518|11743753|FG000|STARTED|Postpartum Follow-up||103
10588080|NCT01753518|11743754|FG001|STARTED|Postpartum Follow-up||103
10588081|NCT01753518|11743753|FG000|COMPLETED|Postpartum Follow-up||81
10588082|NCT01753518|11743754|FG001|COMPLETED|Postpartum Follow-up||88
10588083|NCT01753518|11743753|FG000|NOT COMPLETED|Postpartum Follow-up||22
10588084|NCT01753518|11743754|FG001|NOT COMPLETED|Postpartum Follow-up||15
10588085|NCT01753557|11743762|FG000|STARTED|Overall Study||35
10588086|NCT01753557|11743763|FG001|STARTED|Overall Study||19
10588087|NCT01753557|11743762|FG000|COMPLETED|Overall Study||35
10588088|NCT01753557|11743763|FG001|COMPLETED|Overall Study||19
10588089|NCT01753557|11743762|FG000|NOT COMPLETED|Overall Study||0
10588090|NCT01753557|11743763|FG001|NOT COMPLETED|Overall Study||0
10588091|NCT01753570|11743773|FG000|STARTED|Overall Study||30
10588092|NCT01753570|11743774|FG001|STARTED|Overall Study||30
10588093|NCT01753570|11743775|FG002|STARTED|Overall Study||14
10588094|NCT01753570|11743773|FG000|COMPLETED|Overall Study||28
10588095|NCT01753570|11743774|FG001|COMPLETED|Overall Study||25
10588096|NCT01753570|11743775|FG002|COMPLETED|Overall Study||13
10588097|NCT01753570|11743773|FG000|NOT COMPLETED|Overall Study||2
10588098|NCT01753570|11743774|FG001|NOT COMPLETED|Overall Study||5
10588099|NCT01753570|11743775|FG002|NOT COMPLETED|Overall Study||1
10588100|NCT01753713|11743786|FG000|STARTED|Overall Study||14
10588101|NCT01753713|11743787|FG001|STARTED|Overall Study||19
10703252|NCT02583477|11867862|FG001|Completed Treatment|Overall Study||0
10703253|NCT02583477|11867861|FG000|COMPLETED|Overall Study||0
10807125|NCT03929367|11968762|FG000|NOT COMPLETED|Overall Study||0
10588102|NCT01753713|11743786|FG000|COMPLETED|Overall Study||14
10588103|NCT01753713|11743787|FG001|COMPLETED|Overall Study||19
10588104|NCT01753713|11743786|FG000|NOT COMPLETED|Overall Study||0
10588105|NCT01753713|11743787|FG001|NOT COMPLETED|Overall Study||0
10588106|NCT01753739|11743798|FG000|STARTED|Overall Study||124
10588107|NCT01753739|11743799|FG001|STARTED|Overall Study||123
10588108|NCT01753739|11743800|FG002|STARTED|Overall Study||123
10588109|NCT01753739|11743801|FG003|STARTED|Overall Study||124
10588110|NCT01753739|11743802|FG004|STARTED|Overall Study||123
10588111|NCT01753739|11743798|FG000|COMPLETED|Overall Study||120
10588112|NCT01753739|11743799|FG001|COMPLETED|Overall Study||118
10588113|NCT01753739|11743800|FG002|COMPLETED|Overall Study||118
10588114|NCT01753739|11743801|FG003|COMPLETED|Overall Study||117
10588115|NCT01753739|11743802|FG004|COMPLETED|Overall Study||120
10588116|NCT01753739|11743798|FG000|NOT COMPLETED|Overall Study||4
10588117|NCT01753739|11743799|FG001|NOT COMPLETED|Overall Study||5
10588118|NCT01753739|11743800|FG002|NOT COMPLETED|Overall Study||5
10588119|NCT01753739|11743801|FG003|NOT COMPLETED|Overall Study||7
10588120|NCT01753739|11743802|FG004|NOT COMPLETED|Overall Study||3
10703254|NCT02583477|11867862|FG001|COMPLETED|Overall Study||0
10703255|NCT02583477|11867861|FG000|NOT COMPLETED|Overall Study||3
10703256|NCT02583477|11867862|FG001|NOT COMPLETED|Overall Study||20
10807126|NCT03928522|11968771|FG000|STARTED|Overall Study||12
10807127|NCT03928522|11968772|FG001|STARTED|Overall Study||12
10807128|NCT03928522|11968773|FG002|STARTED|Overall Study||12
10703257|NCT02583711|11867872|FG000|STARTED|Overall Study||11
10703258|NCT02583711|11867873|FG001|STARTED|Overall Study||38
10807129|NCT03928522|11968774|FG003|STARTED|Overall Study||12
10807130|NCT03928522|11968775|FG004|STARTED|Overall Study||12
10588127|NCT01753856|11743825|FG000|STARTED|Overall Study||33
10588128|NCT01753856|11743826|FG001|STARTED|Overall Study||36
10651887|NCT02179424|11812145|FG002|STARTED|Overall Study||516
10651888|NCT02179424|11812146|FG003|STARTED|Overall Study||39
10651889|NCT02179424|11812143|FG000|COMPLETED|Overall Study||76
10651890|NCT02179424|11812144|FG001|COMPLETED|Overall Study||11
10651891|NCT02179424|11812145|FG002|COMPLETED|Overall Study||516
10651892|NCT02179424|11812146|FG003|COMPLETED|Overall Study||39
10651893|NCT02179424|11812143|FG000|NOT COMPLETED|Overall Study||0
10651894|NCT02179424|11812144|FG001|NOT COMPLETED|Overall Study||0
10651895|NCT02179424|11812145|FG002|NOT COMPLETED|Overall Study||0
10651896|NCT02179424|11812146|FG003|NOT COMPLETED|Overall Study||0
10651897|NCT02179515|11812160|FG000|STARTED|Overall Study||3
10651898|NCT02179515|11812161|FG001|STARTED|Overall Study||17
10651899|NCT02179515|11812162|FG002|STARTED|Overall Study||18
10651900|NCT02179515|11812160|FG000|COMPLETED|Overall Study||1
10651901|NCT02179515|11812161|FG001|COMPLETED|Overall Study||1
10651902|NCT02179515|11812162|FG002|COMPLETED|Overall Study||4
10651903|NCT02179515|11812160|FG000|NOT COMPLETED|Overall Study||2
10588129|NCT01753856|11743825|FG000|Received at Least 1 Dose of Study Drug|Overall Study||33
10588130|NCT01753856|11743826|FG001|Received at Least 1 Dose of Study Drug|Overall Study||36
10588131|NCT01753856|11743825|FG000|Completed 3-Month Bone Biopsy|Overall Study||31
10588132|NCT01753856|11743826|FG001|Completed 3-Month Bone Biopsy|Overall Study||35
10588133|NCT01753856|11743825|FG000|COMPLETED|Overall Study||30
10588134|NCT01753856|11743826|FG001|COMPLETED|Overall Study||34
10588135|NCT01753856|11743825|FG000|NOT COMPLETED|Overall Study||3
10588136|NCT01753856|11743826|FG001|NOT COMPLETED|Overall Study||2
10588137|NCT01753999|11743835|FG000|STARTED|Period 1 - Initial Assignment||155
10588138|NCT01753999|11743836|FG001|STARTED|Period 1 - Initial Assignment||162
10588139|NCT01753999|11743835|FG000|Received Intervention|Period 1 - Initial Assignment||144
10588140|NCT01753999|11743836|FG001|Received Intervention|Period 1 - Initial Assignment||146
10588141|NCT01753999|11743835|FG000|COMPLETED|Period 1 - Initial Assignment||116
10588142|NCT01753999|11743836|FG001|COMPLETED|Period 1 - Initial Assignment||112
10588143|NCT01753999|11743835|FG000|NOT COMPLETED|Period 1 - Initial Assignment||39
10588144|NCT01753999|11743836|FG001|NOT COMPLETED|Period 1 - Initial Assignment||50
10588145|NCT01753999|11743835|FG000|STARTED|Period 2 -Cross to Alternate Arm||116
10588146|NCT01753999|11743836|FG001|STARTED|Period 2 -Cross to Alternate Arm||112
10588147|NCT01753999|11743835|FG000|Received Intervention|Period 2 -Cross to Alternate Arm||103
10588148|NCT01753999|11743836|FG001|Received Intervention|Period 2 -Cross to Alternate Arm||95
10588149|NCT01753999|11743835|FG000|COMPLETED|Period 2 -Cross to Alternate Arm||99
10588150|NCT01753999|11743836|FG001|COMPLETED|Period 2 -Cross to Alternate Arm||89
10588151|NCT01753999|11743835|FG000|NOT COMPLETED|Period 2 -Cross to Alternate Arm||17
10588152|NCT01753999|11743836|FG001|NOT COMPLETED|Period 2 -Cross to Alternate Arm||23
10588153|NCT01754129|11743847|FG000|STARTED|Overall Study||148
10588154|NCT01754129|11743847|FG000|Visit 1 (Enrollment Day)|Overall Study||145
10807131|NCT03928522|11968771|FG000|COMPLETED|Overall Study||12
10807132|NCT03928522|11968772|FG001|COMPLETED|Overall Study||12
10807133|NCT03928522|11968773|FG002|COMPLETED|Overall Study||12
10807134|NCT03928522|11968774|FG003|COMPLETED|Overall Study||12
10807135|NCT03928522|11968775|FG004|COMPLETED|Overall Study||12
10807136|NCT03928522|11968771|FG000|NOT COMPLETED|Overall Study||0
10807137|NCT03928522|11968772|FG001|NOT COMPLETED|Overall Study||0
10807138|NCT03928522|11968773|FG002|NOT COMPLETED|Overall Study||0
10807139|NCT03928522|11968774|FG003|NOT COMPLETED|Overall Study||0
10807140|NCT03928522|11968775|FG004|NOT COMPLETED|Overall Study||0
10807141|NCT03910439|11968787|FG000|STARTED|Overall Study||4
10807142|NCT03910439|11968787|FG000|COMPLETED|Overall Study||4
10807143|NCT03910439|11968787|FG000|NOT COMPLETED|Overall Study||0
10807144|NCT03907241|11968798|FG000|STARTED|Overall Study||27
10807145|NCT03907241|11968798|FG000|COMPLETED|Overall Study||23
10807146|NCT03907241|11968798|FG000|NOT COMPLETED|Overall Study||4
10807147|NCT03927950|11968813|FG000|STARTED|Overall Study||135
10807148|NCT03927950|11968813|FG000|COMPLETED|Overall Study||126
10807149|NCT03927950|11968813|FG000|NOT COMPLETED|Overall Study||9
10807150|NCT03927781|11968818|FG000|STARTED|Overall Study||10
10807151|NCT03927781|11968818|FG000|COMPLETED|Overall Study||10
10807152|NCT03927781|11968818|FG000|NOT COMPLETED|Overall Study||0
10807153|NCT03927209|11968824|FG000|STARTED|Overall Study||5
10807154|NCT03927209|11968825|FG001|STARTED|Overall Study||5
10807155|NCT03927209|11968824|FG000|COMPLETED|Overall Study||5
10807156|NCT03927209|11968825|FG001|COMPLETED|Overall Study||5
10807157|NCT03927209|11968824|FG000|NOT COMPLETED|Overall Study||0
10807158|NCT03927209|11968825|FG001|NOT COMPLETED|Overall Study||0
10807159|NCT03920670|11968835|FG000|STARTED|Overall Study||60
10807160|NCT03920670|11968836|FG001|STARTED|Overall Study||60
10807161|NCT03920670|11968835|FG000|COMPLETED|Overall Study||57
10588155|NCT01754129|11743847|FG000|Visit 2 (Year 1)|Overall Study||129
10588156|NCT01754129|11743847|FG000|Visit 3 (Year 2)|Overall Study||115
10588157|NCT01754129|11743847|FG000|COMPLETED|Overall Study||115
10588158|NCT01754129|11743847|FG000|NOT COMPLETED|Overall Study||33
10588159|NCT01754194|11743860|FG000|STARTED|Overall Study||169
10588160|NCT01754194|11743861|FG001|STARTED|Overall Study||124
10588161|NCT01754194|11743860|FG000|COMPLETED|Overall Study||117
10588162|NCT01754194|11743861|FG001|COMPLETED|Overall Study||97
10588163|NCT01754194|11743860|FG000|NOT COMPLETED|Overall Study||52
10588164|NCT01754194|11743861|FG001|NOT COMPLETED|Overall Study||27
10588165|NCT01754207|11743869|FG000|STARTED|Overall Study||20
10807162|NCT03920670|11968836|FG001|COMPLETED|Overall Study||58
10807163|NCT03920670|11968835|FG000|NOT COMPLETED|Overall Study||3
10807164|NCT03920670|11968836|FG001|NOT COMPLETED|Overall Study||2
10807165|NCT03919422|11968844|FG000|STARTED|Overall Study||40
10807166|NCT03919422|11968845|FG001|STARTED|Overall Study||40
10807167|NCT03919422|11968844|FG000|COMPLETED|Overall Study||40
10807168|NCT03919422|11968845|FG001|COMPLETED|Overall Study||40
10807169|NCT03919422|11968844|FG000|NOT COMPLETED|Overall Study||0
10588166|NCT01754207|11743869|FG000|COMPLETED|Overall Study||17
10588167|NCT01754207|11743869|FG000|NOT COMPLETED|Overall Study||3
10588168|NCT01754259|11743875|FG000|STARTED|Overall Study||23
10807170|NCT03919422|11968845|FG001|NOT COMPLETED|Overall Study||0
10807171|NCT03907579|11968851|FG000|STARTED|Overall Study||100
10807172|NCT03907579|11968851|FG000|COMPLETED|Overall Study||100
10807173|NCT03907579|11968851|FG000|NOT COMPLETED|Overall Study||0
10807174|NCT03898063|11968857|FG000|STARTED|Overall Study||74
10807175|NCT03898063|11968858|FG001|STARTED|Overall Study||74
10807176|NCT03898063|11968857|FG000|COMPLETED|Overall Study||64
10588169|NCT01754259|11743876|FG001|STARTED|Overall Study||24
10588170|NCT01754259|11743875|FG000|COMPLETED|Overall Study||18
10588171|NCT01754259|11743876|FG001|COMPLETED|Overall Study||18
10588172|NCT01754259|11743875|FG000|NOT COMPLETED|Overall Study||5
10588173|NCT01754259|11743876|FG001|NOT COMPLETED|Overall Study||6
10588174|NCT01754350|11743884|FG000|STARTED|Overall Study||25
10588175|NCT01754350|11743885|FG001|STARTED|Overall Study||25
10588176|NCT01754350|11743884|FG000|COMPLETED|Overall Study||20
10588177|NCT01754350|11743885|FG001|COMPLETED|Overall Study||22
10588178|NCT01754350|11743884|FG000|NOT COMPLETED|Overall Study||5
10588179|NCT01754350|11743885|FG001|NOT COMPLETED|Overall Study||3
10588180|NCT01754376|11743891|FG000|STARTED|Overall Study||6
10588181|NCT01754376|11743891|FG000|Completed 2-week Lead in of Vemurafenib|Overall Study||6
10588182|NCT01754376|11743891|FG000|COMPLETED|Overall Study||3
10588183|NCT01754376|11743891|FG000|NOT COMPLETED|Overall Study||3
10588184|NCT01754389|11743899|FG000|STARTED|Overall Study||46
10588185|NCT01754389|11743900|FG001|STARTED|Overall Study||45
10588186|NCT01754389|11743901|FG002|STARTED|Overall Study||47
10588187|NCT01754389|11743899|FG000|COMPLETED|Overall Study||46
10588188|NCT01754389|11743900|FG001|COMPLETED|Overall Study||45
10588189|NCT01754389|11743901|FG002|COMPLETED|Overall Study||47
10588190|NCT01754389|11743899|FG000|NOT COMPLETED|Overall Study||0
10588191|NCT01754389|11743900|FG001|NOT COMPLETED|Overall Study||0
10588192|NCT01754389|11743901|FG002|NOT COMPLETED|Overall Study||0
10588193|NCT01754402|11743912|FG000|STARTED|Overall Study||6
10588194|NCT01754402|11743913|FG001|STARTED|Overall Study||2
10588195|NCT01754402|11743914|FG002|STARTED|Overall Study||30
10588196|NCT01754402|11743912|FG000|COMPLETED|Overall Study||4
10588197|NCT01754402|11743913|FG001|COMPLETED|Overall Study||0
10588198|NCT01754402|11743914|FG002|COMPLETED|Overall Study||26
10588199|NCT01754402|11743912|FG000|NOT COMPLETED|Overall Study||2
10588200|NCT01754402|11743913|FG001|NOT COMPLETED|Overall Study||2
10588201|NCT01754402|11743914|FG002|NOT COMPLETED|Overall Study||4
10588202|NCT01754467|11743923|FG000|STARTED|Overall Study||9
10588203|NCT01754467|11743923|FG000|COMPLETED|Overall Study||8
10588204|NCT01754467|11743923|FG000|NOT COMPLETED|Overall Study||1
10588205|NCT01754480|11743929|FG000|STARTED|Part I + Part II (Overall Study)||163
10588206|NCT01754480|11743930|FG001|STARTED|Part I + Part II (Overall Study)||162
10588207|NCT01754480|11743929|FG000|Completed Study up to Week 6|Part I + Part II (Overall Study)||147
10588208|NCT01754480|11743930|FG001|Completed Study up to Week 6|Part I + Part II (Overall Study)||153
10588209|NCT01754480|11743929|FG000|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6 (not required for 2 pediatric subjects)|138
10588210|NCT01754480|11743930|FG001|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6 (not required for 3 pediatric subjects)|139
10588211|NCT01754480|11743929|FG000|NOT COMPLETED|Part I + Part II (Overall Study)||25
10588212|NCT01754480|11743930|FG001|NOT COMPLETED|Part I + Part II (Overall Study)||23
10588213|NCT01754480|11743929|FG000|STARTED|Primary Part II||111
10588214|NCT01754480|11743930|FG001|STARTED|Primary Part II||113
10588215|NCT01754480|11743929|FG000|Completed Study up to Week 6|Primary Part II||100
10588216|NCT01754480|11743930|FG001|Completed Study up to Week 6|Primary Part II||108
10588217|NCT01754480|11743929|FG000|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6 (not required for pediatric subjects)|96
10588218|NCT01754480|11743930|FG001|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6 (not required for pediatric subjects)|102
10588219|NCT01754480|11743929|FG000|NOT COMPLETED|Primary Part II||15
10588220|NCT01754480|11743930|FG001|NOT COMPLETED|Primary Part II||11
10588221|NCT01754493|11743937|FG000|STARTED|Overall Study||17
10588222|NCT01754493|11743937|FG000|COMPLETED|Overall Study||10
10588223|NCT01754493|11743937|FG000|NOT COMPLETED|Overall Study||7
10588224|NCT01754519|11743941|FG000|STARTED|Overall Study||1
10588225|NCT01754519|11743941|FG000|COMPLETED|Overall Study||1
10588226|NCT01754519|11743941|FG000|NOT COMPLETED|Overall Study||0
10588227|NCT01754623|11743945|FG000|STARTED|Overall Study||9
10588228|NCT01754623|11743945|FG000|COMPLETED|Overall Study||9
10588229|NCT01754623|11743945|FG000|NOT COMPLETED|Overall Study||0
10588230|NCT01754688|11743951|FG000|STARTED|Overall Study||624
10588231|NCT01754688|11743951|FG000|COMPLETED|Overall Study||624
10588232|NCT01754688|11743951|FG000|NOT COMPLETED|Overall Study||0
10588233|NCT01754714|11743960|FG000|STARTED|Overall Study||27
10588234|NCT01754714|11743961|FG001|STARTED|Overall Study||27
10588235|NCT01754714|11743962|FG002|STARTED|Overall Study||26
10588236|NCT01754714|11743963|FG003|STARTED|Overall Study||28
10588237|NCT01754714|11743960|FG000|COMPLETED|Overall Study||27
10588238|NCT01754714|11743961|FG001|COMPLETED|Overall Study||26
10807177|NCT03898063|11968858|FG001|COMPLETED|Overall Study||66
10807178|NCT03898063|11968857|FG000|NOT COMPLETED|Overall Study||10
10807179|NCT03898063|11968858|FG001|NOT COMPLETED|Overall Study||8
10807180|NCT03895307|11968868|FG000|STARTED|Overall Study||21
10807181|NCT03895307|11968869|FG001|STARTED|Overall Study||20
10807182|NCT03895307|11968870|FG002|STARTED|Overall Study||22
10807183|NCT03895307|11968871|FG003|STARTED|Overall Study||21
10807184|NCT03895307|11968868|FG000|COMPLETED|Overall Study||19
10588239|NCT01754714|11743962|FG002|COMPLETED|Overall Study||24
10588240|NCT01754714|11743963|FG003|COMPLETED|Overall Study||27
10588241|NCT01754714|11743960|FG000|NOT COMPLETED|Overall Study||0
10588242|NCT01754714|11743961|FG001|NOT COMPLETED|Overall Study||1
10588243|NCT01754714|11743962|FG002|NOT COMPLETED|Overall Study||2
10588244|NCT01754714|11743963|FG003|NOT COMPLETED|Overall Study||1
10807185|NCT03895307|11968869|FG001|COMPLETED|Overall Study||20
10807186|NCT03895307|11968870|FG002|COMPLETED|Overall Study||20
10807187|NCT03895307|11968871|FG003|COMPLETED|Overall Study||21
10807188|NCT03895307|11968868|FG000|NOT COMPLETED|Overall Study||2
10588245|NCT01754727|11743974|FG000|STARTED|Overall Study||452
10588246|NCT01754727|11743974|FG000|COMPLETED|Overall Study||450
10588247|NCT01754727|11743974|FG000|NOT COMPLETED|Overall Study||2
10588248|NCT01754753|11743980|FG000|STARTED|Overall Study||78
10588249|NCT01754753|11743981|FG001|STARTED|Overall Study||79
10588250|NCT01754753|11743980|FG000|COMPLETED|Overall Study||26
10588251|NCT01754753|11743981|FG001|COMPLETED|Overall Study||30
10588252|NCT01754753|11743980|FG000|NOT COMPLETED|Overall Study||52
10588253|NCT01754753|11743981|FG001|NOT COMPLETED|Overall Study||49
10703259|NCT02583711|11867874|FG002|STARTED|Overall Study||10
10703260|NCT02583711|11867872|FG000|COMPLETED|Overall Study||11
10703261|NCT02583711|11867873|FG001|COMPLETED|Overall Study||28
10703262|NCT02583711|11867874|FG002|COMPLETED|Overall Study||10
10703263|NCT02583711|11867872|FG000|NOT COMPLETED|Overall Study||0
10703264|NCT02583711|11867873|FG001|NOT COMPLETED|Overall Study||10
10703265|NCT02583711|11867874|FG002|NOT COMPLETED|Overall Study||0
10703266|NCT02584140|11867884|FG000|STARTED|Overall Study||136
10703267|NCT02584140|11867884|FG000|COMPLETED|Overall Study||83
10703268|NCT02584140|11867884|FG000|NOT COMPLETED|Overall Study||53
10807189|NCT03895307|11968869|FG001|NOT COMPLETED|Overall Study||0
10807190|NCT03895307|11968870|FG002|NOT COMPLETED|Overall Study||2
10807191|NCT03895307|11968871|FG003|NOT COMPLETED|Overall Study||0
10807192|NCT03926208|11968883|FG000|STARTED|Overall Study||119
10807193|NCT03926208|11968884|FG001|STARTED|Overall Study||123
10807194|NCT03926208|11968883|FG000|COMPLETED|Overall Study||119
10807195|NCT03926208|11968884|FG001|COMPLETED|Overall Study||123
10807196|NCT03926208|11968883|FG000|NOT COMPLETED|Overall Study||0
10807197|NCT03926208|11968884|FG001|NOT COMPLETED|Overall Study||0
10807198|NCT03926065|11968890|FG000|STARTED|Study Week 1||11
10807199|NCT03926065|11968891|FG001|STARTED|Study Week 1||9
10807200|NCT03926065|11968892|FG002|STARTED|Study Week 1||14
10807201|NCT03926065|11968893|FG003|STARTED|Study Week 1||18
10807202|NCT03926065|11968894|FG004|STARTED|Study Week 1||15
10807203|NCT03926065|11968890|FG000|COMPLETED|Study Week 1||11
10807204|NCT03926065|11968891|FG001|COMPLETED|Study Week 1||9
10807205|NCT03926065|11968892|FG002|COMPLETED|Study Week 1||14
10807206|NCT03926065|11968893|FG003|COMPLETED|Study Week 1||18
10807207|NCT03926065|11968894|FG004|COMPLETED|Study Week 1||15
10807208|NCT03926065|11968890|FG000|NOT COMPLETED|Study Week 1||0
10807209|NCT03926065|11968891|FG001|NOT COMPLETED|Study Week 1||0
10807210|NCT03926065|11968892|FG002|NOT COMPLETED|Study Week 1||0
10807211|NCT03926065|11968893|FG003|NOT COMPLETED|Study Week 1||0
10807212|NCT03926065|11968894|FG004|NOT COMPLETED|Study Week 1||0
10807213|NCT03926065|11968890|FG000|STARTED|Study Week 2||11
10807214|NCT03926065|11968891|FG001|STARTED|Study Week 2||9
10807215|NCT03926065|11968892|FG002|STARTED|Study Week 2||14
10807216|NCT03926065|11968893|FG003|STARTED|Study Week 2||18
10807217|NCT03926065|11968894|FG004|STARTED|Study Week 2||15
10807218|NCT03926065|11968890|FG000|COMPLETED|Study Week 2||11
10807219|NCT03926065|11968891|FG001|COMPLETED|Study Week 2||9
10807220|NCT03926065|11968892|FG002|COMPLETED|Study Week 2||14
10807221|NCT03926065|11968893|FG003|COMPLETED|Study Week 2||18
10807222|NCT03926065|11968894|FG004|COMPLETED|Study Week 2||15
10807223|NCT03926065|11968890|FG000|NOT COMPLETED|Study Week 2||0
10807224|NCT03926065|11968891|FG001|NOT COMPLETED|Study Week 2||0
10807225|NCT03926065|11968892|FG002|NOT COMPLETED|Study Week 2||0
10807226|NCT03926065|11968893|FG003|NOT COMPLETED|Study Week 2||0
10807227|NCT03926065|11968894|FG004|NOT COMPLETED|Study Week 2||0
10807228|NCT03926065|11968890|FG000|STARTED|Study Week 3||11
10807229|NCT03926065|11968891|FG001|STARTED|Study Week 3||9
10807230|NCT03926065|11968892|FG002|STARTED|Study Week 3||14
10807231|NCT03926065|11968893|FG003|STARTED|Study Week 3||18
10807232|NCT03926065|11968894|FG004|STARTED|Study Week 3||15
10807233|NCT03926065|11968890|FG000|COMPLETED|Study Week 3||11
10807234|NCT03926065|11968891|FG001|COMPLETED|Study Week 3||9
10807235|NCT03926065|11968892|FG002|COMPLETED|Study Week 3||14
10807236|NCT03926065|11968893|FG003|COMPLETED|Study Week 3||18
10588254|NCT01754766|11743990|FG000|STARTED|Overall Study||31
10703269|NCT02584257|11867888|FG000|STARTED|Period 1||9
10807237|NCT03926065|11968894|FG004|COMPLETED|Study Week 3||15
10807238|NCT03926065|11968890|FG000|NOT COMPLETED|Study Week 3||0
10807239|NCT03926065|11968891|FG001|NOT COMPLETED|Study Week 3||0
10807240|NCT03926065|11968892|FG002|NOT COMPLETED|Study Week 3||0
10807241|NCT03926065|11968893|FG003|NOT COMPLETED|Study Week 3||0
10807242|NCT03926065|11968894|FG004|NOT COMPLETED|Study Week 3||0
10807243|NCT03926065|11968890|FG000|STARTED|Study Week 4||11
10807244|NCT03926065|11968891|FG001|STARTED|Study Week 4||9
10588255|NCT01754766|11743991|FG001|STARTED|Overall Study||29
10588256|NCT01754766|11743992|FG002|STARTED|Overall Study||30
10588257|NCT01754766|11743990|FG000|COMPLETED|Overall Study||30
10703270|NCT02584257|11867889|FG001|STARTED|Period 1||9
10703271|NCT02584257|11867890|FG002|STARTED|Period 1||9
10703272|NCT02584257|11867891|FG003|STARTED|Period 1||8
10703273|NCT02584257|11867892|FG004|STARTED|Period 1||10
10703274|NCT02584257|11867893|FG005|STARTED|Period 1||10
10807245|NCT03926065|11968892|FG002|STARTED|Study Week 4||14
10807246|NCT03926065|11968893|FG003|STARTED|Study Week 4||18
10807247|NCT03926065|11968894|FG004|STARTED|Study Week 4||15
10807248|NCT03926065|11968890|FG000|COMPLETED|Study Week 4||11
10807249|NCT03926065|11968891|FG001|COMPLETED|Study Week 4||9
10807250|NCT03926065|11968892|FG002|COMPLETED|Study Week 4||14
10807251|NCT03926065|11968893|FG003|COMPLETED|Study Week 4||18
10807252|NCT03926065|11968894|FG004|COMPLETED|Study Week 4||15
10807253|NCT03926065|11968890|FG000|NOT COMPLETED|Study Week 4||0
10807254|NCT03926065|11968891|FG001|NOT COMPLETED|Study Week 4||0
10588258|NCT01754766|11743991|FG001|COMPLETED|Overall Study||28
10588259|NCT01754766|11743992|FG002|COMPLETED|Overall Study||30
10588260|NCT01754766|11743990|FG000|NOT COMPLETED|Overall Study||1
10588261|NCT01754766|11743991|FG001|NOT COMPLETED|Overall Study||1
10588262|NCT01754766|11743992|FG002|NOT COMPLETED|Overall Study||0
10588263|NCT01754909|11744002|FG000|STARTED|Overall Study||20
10588264|NCT01754909|11744003|FG001|STARTED|Overall Study||23
10588265|NCT01754909|11744002|FG000|COMPLETED|Overall Study||20
10588266|NCT01754909|11744003|FG001|COMPLETED|Overall Study||23
10588267|NCT01754909|11744002|FG000|NOT COMPLETED|Overall Study||0
10588268|NCT01754909|11744003|FG001|NOT COMPLETED|Overall Study||0
10588269|NCT01754922|11744011|FG000|STARTED|Overall Study||32
10588270|NCT01754922|11744012|FG001|STARTED|Overall Study||18
10588271|NCT01754922|11744011|FG000|COMPLETED|Overall Study||32
10588272|NCT01754922|11744012|FG001|COMPLETED|Overall Study||17
10588273|NCT01754922|11744011|FG000|NOT COMPLETED|Overall Study||0
10588274|NCT01754922|11744012|FG001|NOT COMPLETED|Overall Study||1
10588275|NCT01755026|11744021|FG000|STARTED|Overall Study||11
10588276|NCT01755026|11744022|FG001|STARTED|Overall Study||12
10588277|NCT01755026|11744021|FG000|COMPLETED|Overall Study||9
10588278|NCT01755026|11744022|FG001|COMPLETED|Overall Study||11
10588279|NCT01755026|11744021|FG000|NOT COMPLETED|Overall Study||2
10588280|NCT01755026|11744022|FG001|NOT COMPLETED|Overall Study||1
10588281|NCT01755091|11744031|FG000|STARTED|Overall Study||26
10588282|NCT01755091|11744032|FG001|STARTED|Overall Study||22
10588283|NCT01755091|11744033|FG002|STARTED|Overall Study||27
10588284|NCT01755091|11744031|FG000|COMPLETED|Overall Study||17
10588285|NCT01755091|11744032|FG001|COMPLETED|Overall Study||19
10588286|NCT01755091|11744033|FG002|COMPLETED|Overall Study||20
10588287|NCT01755091|11744031|FG000|NOT COMPLETED|Overall Study||9
10588288|NCT01755091|11744032|FG001|NOT COMPLETED|Overall Study||3
10588289|NCT01755091|11744033|FG002|NOT COMPLETED|Overall Study||7
10588290|NCT01755143|11744043|FG000|STARTED|Overall Study||177
10588291|NCT01755143|11744044|FG001|STARTED|Overall Study||89
10588292|NCT01755143|11744043|FG000|COMPLETED|Overall Study||166
10588293|NCT01755143|11744044|FG001|COMPLETED|Overall Study||86
10588294|NCT01755143|11744043|FG000|NOT COMPLETED|Overall Study||11
10588295|NCT01755143|11744044|FG001|NOT COMPLETED|Overall Study||3
10651904|NCT02179515|11812161|FG001|NOT COMPLETED|Overall Study||16
10651905|NCT02179515|11812162|FG002|NOT COMPLETED|Overall Study||14
10651906|NCT02179671|11812179|FG000|STARTED|Overall Study||1
10651907|NCT02179671|11812180|FG001|STARTED|Overall Study||1
10651908|NCT02179671|11812181|FG002|STARTED|Overall Study||2
10651909|NCT02179671|11812182|FG003|STARTED|Overall Study||14
10651910|NCT02179671|11812183|FG004|STARTED|Overall Study||14
10651911|NCT02179671|11812179|FG000|COMPLETED|Overall Study||0
10651912|NCT02179671|11812180|FG001|COMPLETED|Overall Study||0
10651913|NCT02179671|11812181|FG002|COMPLETED|Overall Study||1
10651914|NCT02179671|11812182|FG003|COMPLETED|Overall Study||1
10651915|NCT02179671|11812183|FG004|COMPLETED|Overall Study||1
10651916|NCT02179671|11812179|FG000|NOT COMPLETED|Overall Study||1
10651917|NCT02179671|11812180|FG001|NOT COMPLETED|Overall Study||1
10651918|NCT02179671|11812181|FG002|NOT COMPLETED|Overall Study||1
10651919|NCT02179671|11812182|FG003|NOT COMPLETED|Overall Study||13
10651920|NCT02179671|11812183|FG004|NOT COMPLETED|Overall Study||13
10651921|NCT02179788|11812197|FG000|STARTED|Overall Study||10
10651922|NCT02179788|11812198|FG001|STARTED|Overall Study||5
10651923|NCT02179788|11812197|FG000|COMPLETED|Overall Study||10
10651924|NCT02179788|11812198|FG001|COMPLETED|Overall Study||5
10651925|NCT02179788|11812197|FG000|NOT COMPLETED|Overall Study||0
10651926|NCT02179788|11812198|FG001|NOT COMPLETED|Overall Study||0
10651927|NCT02179892|11812206|FG000|STARTED|Overall Study||5
10651928|NCT02179892|11812207|FG001|STARTED|Overall Study||4
10651929|NCT02179892|11812206|FG000|COMPLETED|Overall Study||5
10651930|NCT02179892|11812207|FG001|COMPLETED|Overall Study||4
10651931|NCT02179892|11812206|FG000|NOT COMPLETED|Overall Study||0
10651932|NCT02179892|11812207|FG001|NOT COMPLETED|Overall Study||0
10651933|NCT02179918|11812218|FG000|STARTED|Overall Study||5
10651934|NCT02179918|11812219|FG001|STARTED|Overall Study||3
10651935|NCT02179918|11812220|FG002|STARTED|Overall Study||3
10651936|NCT02179918|11812221|FG003|STARTED|Overall Study||3
10651937|NCT02179918|11812222|FG004|STARTED|Overall Study||9
10651938|NCT02179918|11812218|FG000|COMPLETED|Overall Study||1
10651939|NCT02179918|11812219|FG001|COMPLETED|Overall Study||0
10651940|NCT02179918|11812220|FG002|COMPLETED|Overall Study||1
10651941|NCT02179918|11812221|FG003|COMPLETED|Overall Study||0
10651942|NCT02179918|11812222|FG004|COMPLETED|Overall Study||1
10651943|NCT02179918|11812218|FG000|NOT COMPLETED|Overall Study||4
10651944|NCT02179918|11812219|FG001|NOT COMPLETED|Overall Study||3
10651945|NCT02179918|11812220|FG002|NOT COMPLETED|Overall Study||2
10651946|NCT02179918|11812221|FG003|NOT COMPLETED|Overall Study||3
10651947|NCT02179918|11812222|FG004|NOT COMPLETED|Overall Study||8
10651948|NCT02180061|11812237|FG000|STARTED|Overall Study||34
10651949|NCT02180061|11812238|FG001|STARTED|Overall Study||8
10651950|NCT02180061|11812237|FG000|COMPLETED|Overall Study||9
10651951|NCT02180061|11812238|FG001|COMPLETED|Overall Study||0
10651952|NCT02180061|11812237|FG000|NOT COMPLETED|Overall Study||25
10651953|NCT02180061|11812238|FG001|NOT COMPLETED|Overall Study||8
10651954|NCT02180100|11812246|FG000|STARTED|Overall Study||70
10651955|NCT02180100|11812247|FG001|STARTED|Overall Study||70
10651956|NCT02180100|11812246|FG000|COMPLETED|Overall Study||58
10651957|NCT02180100|11812247|FG001|COMPLETED|Overall Study||66
10651958|NCT02180100|11812246|FG000|NOT COMPLETED|Overall Study||12
10588296|NCT01755156|11744052|FG000|STARTED|Phase A (Weeks 0-24)||201
10588297|NCT01755156|11744053|FG001|STARTED|Phase A (Weeks 0-24)||201
10588298|NCT01755156|11744052|FG000|COMPLETED|Phase A (Weeks 0-24)||184
10588299|NCT01755156|11744053|FG001|COMPLETED|Phase A (Weeks 0-24)||177
10588300|NCT01755156|11744052|FG000|NOT COMPLETED|Phase A (Weeks 0-24)||17
10588301|NCT01755156|11744053|FG001|NOT COMPLETED|Phase A (Weeks 0-24)||24
10588302|NCT01755156|11744052|FG000|STARTED|Phase B (Weeks 24-104)|1 participant who completed Phase A did not continue to Phase B.|183
10588303|NCT01755156|11744053|FG001|STARTED|Phase B (Weeks 24-104)||177
10588304|NCT01755156|11744052|FG000|COMPLETED|Phase B (Weeks 24-104)||144
10588305|NCT01755156|11744053|FG001|COMPLETED|Phase B (Weeks 24-104)||141
10588306|NCT01755156|11744052|FG000|NOT COMPLETED|Phase B (Weeks 24-104)||39
10588307|NCT01755156|11744053|FG001|NOT COMPLETED|Phase B (Weeks 24-104)||36
10588308|NCT01755169|11744067|FG000|STARTED|Overall Study||2
10588309|NCT01755169|11744068|FG001|STARTED|Overall Study||1
10588310|NCT01755169|11744069|FG002|STARTED|Overall Study||0
10588311|NCT01755169|11744070|FG003|STARTED|Overall Study||1
10588312|NCT01755169|11744067|FG000|COMPLETED|Overall Study||2
10588313|NCT01755169|11744068|FG001|COMPLETED|Overall Study||1
10588314|NCT01755169|11744069|FG002|COMPLETED|Overall Study||0
10588315|NCT01755169|11744070|FG003|COMPLETED|Overall Study||1
10588316|NCT01755169|11744067|FG000|NOT COMPLETED|Overall Study||0
10588317|NCT01755169|11744068|FG001|NOT COMPLETED|Overall Study||0
10588318|NCT01755169|11744069|FG002|NOT COMPLETED|Overall Study||0
10588319|NCT01755169|11744070|FG003|NOT COMPLETED|Overall Study||0
10588320|NCT01755195|11744080|FG000|STARTED|Overall Study||55
10588321|NCT01755195|11744080|FG000|COMPLETED|Overall Study||42
10588322|NCT01755195|11744080|FG000|NOT COMPLETED|Overall Study||13
10588323|NCT01755234|11744086|FG000|STARTED|Overall Study||45
10588324|NCT01755234|11744087|FG001|STARTED|Overall Study||45
10588325|NCT01755234|11744086|FG000|COMPLETED|Overall Study||30
10588326|NCT01755234|11744087|FG001|COMPLETED|Overall Study||37
10588327|NCT01755234|11744086|FG000|NOT COMPLETED|Overall Study||15
10588328|NCT01755234|11744087|FG001|NOT COMPLETED|Overall Study||8
10588329|NCT01755416|11744093|FG000|STARTED|First Intervention ( Upto 2 Days)||9
10588330|NCT01755416|11744094|FG001|STARTED|First Intervention ( Upto 2 Days)||9
10588331|NCT01755416|11744093|FG000|COMPLETED|First Intervention ( Upto 2 Days)||8
10588332|NCT01755416|11744094|FG001|COMPLETED|First Intervention ( Upto 2 Days)||7
10588333|NCT01755416|11744093|FG000|NOT COMPLETED|First Intervention ( Upto 2 Days)||1
10588334|NCT01755416|11744094|FG001|NOT COMPLETED|First Intervention ( Upto 2 Days)||2
10588335|NCT01755416|11744093|FG000|STARTED|Second Intervention (Upto 2 Days)||8
10588336|NCT01755416|11744094|FG001|STARTED|Second Intervention (Upto 2 Days)||7
10588337|NCT01755416|11744093|FG000|COMPLETED|Second Intervention (Upto 2 Days)||8
10588338|NCT01755416|11744094|FG001|COMPLETED|Second Intervention (Upto 2 Days)||7
10588429|NCT01755858|11744162|FG000|NOT COMPLETED|Overall Study||1
10588339|NCT01755416|11744093|FG000|NOT COMPLETED|Second Intervention (Upto 2 Days)||0
10588340|NCT01755416|11744094|FG001|NOT COMPLETED|Second Intervention (Upto 2 Days)||0
10588341|NCT01755455|11744100|FG000|STARTED|First Intervention (6 Weeks)||11
10588342|NCT01755455|11744101|FG001|STARTED|First Intervention (6 Weeks)||11
10588343|NCT01755455|11744100|FG000|COMPLETED|First Intervention (6 Weeks)||11
10588344|NCT01755455|11744101|FG001|COMPLETED|First Intervention (6 Weeks)||11
10588345|NCT01755455|11744100|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
10588346|NCT01755455|11744101|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
10588347|NCT01755455|11744100|FG000|STARTED|Washout (4 Weeks)||11
10588348|NCT01755455|11744101|FG001|STARTED|Washout (4 Weeks)||11
10588349|NCT01755455|11744100|FG000|COMPLETED|Washout (4 Weeks)||11
10588350|NCT01755455|11744101|FG001|COMPLETED|Washout (4 Weeks)||11
10588351|NCT01755455|11744100|FG000|NOT COMPLETED|Washout (4 Weeks)||0
10588352|NCT01755455|11744101|FG001|NOT COMPLETED|Washout (4 Weeks)||0
10588353|NCT01755455|11744100|FG000|STARTED|Second Intervention (6 Weeks)||11
10588354|NCT01755455|11744101|FG001|STARTED|Second Intervention (6 Weeks)||11
10588355|NCT01755455|11744100|FG000|COMPLETED|Second Intervention (6 Weeks)||11
10588356|NCT01755455|11744101|FG001|COMPLETED|Second Intervention (6 Weeks)||11
10588357|NCT01755455|11744100|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
10588358|NCT01755455|11744101|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
10588359|NCT01755546|11744107|FG000|STARTED|Screened and Taper (Rollover and DeNovo)||304
10588360|NCT01755546|11744107|FG000|COMPLETED|Screened and Taper (Rollover and DeNovo)||294
10588361|NCT01755546|11744107|FG000|NOT COMPLETED|Screened and Taper (Rollover and DeNovo)||10
10588362|NCT01755546|11744107|FG000|STARTED|Titration Phase||294
10588363|NCT01755546|11744107|FG000|COMPLETED|Titration Phase||224
10588364|NCT01755546|11744107|FG000|NOT COMPLETED|Titration Phase||70
10588365|NCT01755546|11744107|FG000|STARTED|Long Term Treatment||224
10588366|NCT01755546|11744107|FG000|COMPLETED|Long Term Treatment||103
10588367|NCT01755546|11744107|FG000|NOT COMPLETED|Long Term Treatment||121
10588368|NCT01755598|11744113|FG000|STARTED|Overall Study||1786
10588369|NCT01755598|11744114|FG001|STARTED|Overall Study||1787
10588370|NCT01755598|11744113|FG000|COMPLETED|Overall Study||1521
10588371|NCT01755598|11744114|FG001|COMPLETED|Overall Study||1504
10588372|NCT01755598|11744113|FG000|NOT COMPLETED|Overall Study||265
10588373|NCT01755598|11744114|FG001|NOT COMPLETED|Overall Study||283
10588374|NCT01755637|11744120|FG000|STARTED|Period 1||28
10588375|NCT01755637|11744121|FG001|STARTED|Period 1||28
10588376|NCT01755637|11744120|FG000|COMPLETED|Period 1||28
10588377|NCT01755637|11744121|FG001|COMPLETED|Period 1||27
10588378|NCT01755637|11744120|FG000|NOT COMPLETED|Period 1||0
10588379|NCT01755637|11744121|FG001|NOT COMPLETED|Period 1||1
10588380|NCT01755637|11744120|FG000|STARTED|Period 2||28
10588381|NCT01755637|11744121|FG001|STARTED|Period 2||27
10588382|NCT01755637|11744120|FG000|COMPLETED|Period 2||28
10588383|NCT01755637|11744121|FG001|COMPLETED|Period 2||27
10588384|NCT01755637|11744120|FG000|NOT COMPLETED|Period 2||0
10588385|NCT01755637|11744121|FG001|NOT COMPLETED|Period 2||0
10588386|NCT01755702|11744133|FG000|STARTED|Period I||66
10588387|NCT01755702|11744133|FG000|Received Paracetamol|Period I||16
10588388|NCT01755702|11744133|FG000|Received Placebo|Period I||17
10588389|NCT01755702|11744133|FG000|Received Ibuprofen|Period I||16
10588390|NCT01755702|11744133|FG000|Received Paracetamol/Caffeine|Period I||17
10588391|NCT01755702|11744133|FG000|COMPLETED|Period I||66
10588392|NCT01755702|11744133|FG000|NOT COMPLETED|Period I||0
10588393|NCT01755702|11744133|FG000|STARTED|Wash Out Period I||66
10588394|NCT01755702|11744133|FG000|COMPLETED|Wash Out Period I||63
10588395|NCT01755702|11744133|FG000|NOT COMPLETED|Wash Out Period I||3
10588396|NCT01755702|11744133|FG000|STARTED|Period II||63
10588397|NCT01755702|11744133|FG000|Received Ibuprofen|Period II||11
10588398|NCT01755702|11744133|FG000|Received Placebo|Period II||15
10588399|NCT01755702|11744133|FG000|Received Paracetamol/Caffeine|Period II||20
10588400|NCT01755702|11744133|FG000|Received Paracetamol|Period II||17
10588401|NCT01755702|11744133|FG000|COMPLETED|Period II||63
10588402|NCT01755702|11744133|FG000|NOT COMPLETED|Period II||0
10588403|NCT01755702|11744133|FG000|STARTED|Washout Period II||63
10588404|NCT01755702|11744133|FG000|COMPLETED|Washout Period II||58
10588405|NCT01755702|11744133|FG000|NOT COMPLETED|Washout Period II||5
10588406|NCT01755702|11744133|FG000|STARTED|Period III||58
10588407|NCT01755702|11744133|FG000|Received Paracetamol|Period III||17
10588408|NCT01755702|11744133|FG000|Received Placebo|Period III||13
10588409|NCT01755702|11744133|FG000|Received Paracetamol/Caffeine|Period III||10
10588410|NCT01755702|11744133|FG000|Received Ibuprofen|Period III||18
10588411|NCT01755702|11744133|FG000|COMPLETED|Period III||58
10588412|NCT01755702|11744133|FG000|NOT COMPLETED|Period III||0
10588413|NCT01755767|11744147|FG000|STARTED|Overall Study||28
10588414|NCT01755767|11744148|FG001|STARTED|Overall Study||15
10588415|NCT01755767|11744149|FG002|STARTED|Overall Study||226
10588416|NCT01755767|11744150|FG003|STARTED|Overall Study||114
10588417|NCT01755767|11744147|FG000|COMPLETED|Overall Study||0
10588418|NCT01755767|11744148|FG001|COMPLETED|Overall Study||0
10588419|NCT01755767|11744149|FG002|COMPLETED|Overall Study||0
10588420|NCT01755767|11744150|FG003|COMPLETED|Overall Study||0
10588421|NCT01755767|11744147|FG000|NOT COMPLETED|Overall Study||28
10588422|NCT01755767|11744148|FG001|NOT COMPLETED|Overall Study||15
10588423|NCT01755767|11744149|FG002|NOT COMPLETED|Overall Study||226
10588424|NCT01755767|11744150|FG003|NOT COMPLETED|Overall Study||114
10588425|NCT01755858|11744162|FG000|STARTED|Overall Study||7
10588426|NCT01755858|11744163|FG001|STARTED|Overall Study||9
10588427|NCT01755858|11744162|FG000|COMPLETED|Overall Study||6
10588428|NCT01755858|11744163|FG001|COMPLETED|Overall Study||8
10588430|NCT01755858|11744163|FG001|NOT COMPLETED|Overall Study||1
10588431|NCT01755949|11744177|FG000|STARTED|Overall Study||5
10588432|NCT01755949|11744178|FG001|STARTED|Overall Study||5
10588433|NCT01755949|11744179|FG002|STARTED|Overall Study||4
10588434|NCT01755949|11744180|FG003|STARTED|Overall Study||5
10588435|NCT01755949|11744181|FG004|STARTED|Overall Study||4
10588436|NCT01755949|11744182|FG005|STARTED|Overall Study||3
10588437|NCT01755949|11744177|FG000|COMPLETED|Overall Study||5
10588438|NCT01755949|11744178|FG001|COMPLETED|Overall Study||5
10588439|NCT01755949|11744179|FG002|COMPLETED|Overall Study||4
10588440|NCT01755949|11744180|FG003|COMPLETED|Overall Study||5
10588441|NCT01755949|11744181|FG004|COMPLETED|Overall Study||4
10588442|NCT01755949|11744182|FG005|COMPLETED|Overall Study||3
10588443|NCT01755949|11744177|FG000|NOT COMPLETED|Overall Study||0
10588444|NCT01755949|11744178|FG001|NOT COMPLETED|Overall Study||0
10588445|NCT01755949|11744179|FG002|NOT COMPLETED|Overall Study||0
10588446|NCT01755949|11744180|FG003|NOT COMPLETED|Overall Study||0
10588447|NCT01755949|11744181|FG004|NOT COMPLETED|Overall Study||0
10588448|NCT01755949|11744182|FG005|NOT COMPLETED|Overall Study||0
10588449|NCT01756053|11744196|FG000|STARTED|Period 1 (10 Days)||8
10588450|NCT01756053|11744197|FG001|STARTED|Period 1 (10 Days)||9
10588451|NCT01756053|11744196|FG000|COMPLETED|Period 1 (10 Days)||7
10588452|NCT01756053|11744197|FG001|COMPLETED|Period 1 (10 Days)||8
10588453|NCT01756053|11744196|FG000|NOT COMPLETED|Period 1 (10 Days)||1
10588454|NCT01756053|11744197|FG001|NOT COMPLETED|Period 1 (10 Days)||1
10588455|NCT01756053|11744196|FG000|STARTED|Washout Period (~21 Days)||7
10588456|NCT01756053|11744197|FG001|STARTED|Washout Period (~21 Days)||8
10588457|NCT01756053|11744196|FG000|COMPLETED|Washout Period (~21 Days)||7
10588458|NCT01756053|11744197|FG001|COMPLETED|Washout Period (~21 Days)||8
10588459|NCT01756053|11744196|FG000|NOT COMPLETED|Washout Period (~21 Days)||0
10588460|NCT01756053|11744197|FG001|NOT COMPLETED|Washout Period (~21 Days)||0
10588461|NCT01756053|11744196|FG000|STARTED|Period 2 (10 Days)||7
10588462|NCT01756053|11744197|FG001|STARTED|Period 2 (10 Days)||8
10588463|NCT01756053|11744196|FG000|COMPLETED|Period 2 (10 Days)||7
10588464|NCT01756053|11744197|FG001|COMPLETED|Period 2 (10 Days)||6
10588465|NCT01756053|11744196|FG000|NOT COMPLETED|Period 2 (10 Days)||0
10588466|NCT01756053|11744197|FG001|NOT COMPLETED|Period 2 (10 Days)||2
10588467|NCT01756079|11744203|FG000|STARTED|Lead-in: Day 0 to Week 4||58
10588468|NCT01756079|11744203|FG000|COMPLETED|Lead-in: Day 0 to Week 4||58
10588469|NCT01756079|11744203|FG000|NOT COMPLETED|Lead-in: Day 0 to Week 4||0
10588470|NCT01756079|11744203|FG000|STARTED|Treatment / Follow-up: Week 4 to Week 72||58
10588471|NCT01756079|11744203|FG000|Treated in Treatment Period|Treatment / Follow-up: Week 4 to Week 72||54
10588472|NCT01756079|11744203|FG000|COMPLETED|Treatment / Follow-up: Week 4 to Week 72||23
10588473|NCT01756079|11744203|FG000|NOT COMPLETED|Treatment / Follow-up: Week 4 to Week 72||35
10588474|NCT01756157|11744208|FG000|STARTED|First Intervention Period||23
10588475|NCT01756157|11744209|FG001|STARTED|First Intervention Period||24
10588476|NCT01756157|11744208|FG000|COMPLETED|First Intervention Period||22
10588477|NCT01756157|11744209|FG001|COMPLETED|First Intervention Period||22
10588478|NCT01756157|11744208|FG000|NOT COMPLETED|First Intervention Period||1
10588479|NCT01756157|11744209|FG001|NOT COMPLETED|First Intervention Period||2
10588480|NCT01756157|11744208|FG000|STARTED|Washout Period (at Least 7 Days)||22
10588481|NCT01756157|11744209|FG001|STARTED|Washout Period (at Least 7 Days)||22
10588482|NCT01756157|11744208|FG000|COMPLETED|Washout Period (at Least 7 Days)||22
10588483|NCT01756157|11744209|FG001|COMPLETED|Washout Period (at Least 7 Days)||22
10588484|NCT01756157|11744208|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
10588485|NCT01756157|11744209|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
10588486|NCT01756157|11744208|FG000|STARTED|Second Intervention Period||22
10588487|NCT01756157|11744209|FG001|STARTED|Second Intervention Period||22
10588488|NCT01756157|11744208|FG000|COMPLETED|Second Intervention Period||22
10588489|NCT01756157|11744209|FG001|COMPLETED|Second Intervention Period||22
10588490|NCT01756157|11744208|FG000|NOT COMPLETED|Second Intervention Period||0
10588491|NCT01756157|11744209|FG001|NOT COMPLETED|Second Intervention Period||0
10588492|NCT01756209|11744219|FG000|STARTED|Overall Study||40
10588493|NCT01756209|11744220|FG001|STARTED|Overall Study||40
10588494|NCT01756209|11744221|FG002|STARTED|Overall Study||40
10588495|NCT01756209|11744222|FG003|STARTED|Overall Study||40
10588496|NCT01756209|11744219|FG000|COMPLETED|Overall Study||40
10588497|NCT01756209|11744220|FG001|COMPLETED|Overall Study||40
10588498|NCT01756209|11744221|FG002|COMPLETED|Overall Study||40
10588499|NCT01756209|11744222|FG003|COMPLETED|Overall Study||40
10588500|NCT01756209|11744219|FG000|NOT COMPLETED|Overall Study||0
10588501|NCT01756209|11744220|FG001|NOT COMPLETED|Overall Study||0
10588502|NCT01756209|11744221|FG002|NOT COMPLETED|Overall Study||0
10588503|NCT01756209|11744222|FG003|NOT COMPLETED|Overall Study||0
10588504|NCT01756235|11744232|FG000|STARTED|Overall Study||462
10588505|NCT01756235|11744232|FG000|COMPLETED|Overall Study||460
10588506|NCT01756235|11744232|FG000|NOT COMPLETED|Overall Study||2
10588507|NCT01756274|11744236|FG000|STARTED|Overall Study||162
10588508|NCT01756274|11744236|FG000|COMPLETED|Overall Study||159
10588509|NCT01756274|11744236|FG000|NOT COMPLETED|Overall Study||3
10588510|NCT01756300|11744241|FG000|STARTED|Overall Study|Subjects underwent renal denervation treatment with the study catheter.|35
10588511|NCT01756300|11744241|FG000|COMPLETED|Overall Study|Subjects with follow up available at 12 months|33
10588512|NCT01756300|11744241|FG000|NOT COMPLETED|Overall Study||2
10588513|NCT01756352|11744262|FG000|STARTED|Overall Study||13
10588514|NCT01756352|11744262|FG000|COMPLETED|Overall Study||12
10588515|NCT01756352|11744262|FG000|NOT COMPLETED|Overall Study||1
10588516|NCT01756391|11744266|FG000|STARTED|Overall Study||351
10588517|NCT01756391|11744266|FG000|COMPLETED|Overall Study||319
10588518|NCT01756391|11744266|FG000|NOT COMPLETED|Overall Study||32
10588519|NCT01756456|11744276|FG000|STARTED|Treatment Period: Phase I/II||7
10588520|NCT01756456|11744277|FG001|STARTED|Treatment Period: Phase I/II||7
10588521|NCT01756456|11744278|FG002|STARTED|Treatment Period: Phase I/II||4
10807255|NCT03926065|11968892|FG002|NOT COMPLETED|Study Week 4||0
10807256|NCT03926065|11968893|FG003|NOT COMPLETED|Study Week 4||0
10703275|NCT02584257|11867894|FG006|STARTED|Period 1||18
10703276|NCT02584257|11867895|FG007|STARTED|Period 1||9
10703277|NCT02584257|11867896|FG008|STARTED|Period 1||9
10588522|NCT01756456|11744279|FG003|STARTED|Treatment Period: Phase I/II||52
10588523|NCT01756456|11744280|FG004|STARTED|Treatment Period: Phase I/II||52
10588524|NCT01756456|11744281|FG005|STARTED|Treatment Period: Phase I/II||52
10588525|NCT01756456|11744276|FG000|COMPLETED|Treatment Period: Phase I/II||6
10588526|NCT01756456|11744277|FG001|COMPLETED|Treatment Period: Phase I/II||6
10588527|NCT01756456|11744278|FG002|COMPLETED|Treatment Period: Phase I/II||2
10588528|NCT01756456|11744279|FG003|COMPLETED|Treatment Period: Phase I/II||45
10588529|NCT01756456|11744280|FG004|COMPLETED|Treatment Period: Phase I/II||39
10588530|NCT01756456|11744281|FG005|COMPLETED|Treatment Period: Phase I/II||48
10588531|NCT01756456|11744276|FG000|NOT COMPLETED|Treatment Period: Phase I/II||1
10588532|NCT01756456|11744277|FG001|NOT COMPLETED|Treatment Period: Phase I/II||1
10588533|NCT01756456|11744278|FG002|NOT COMPLETED|Treatment Period: Phase I/II||2
10588534|NCT01756456|11744279|FG003|NOT COMPLETED|Treatment Period: Phase I/II||7
10588535|NCT01756456|11744280|FG004|NOT COMPLETED|Treatment Period: Phase I/II||13
10588536|NCT01756456|11744281|FG005|NOT COMPLETED|Treatment Period: Phase I/II||4
10588537|NCT01756456|11744276|FG000|STARTED|Follow Up Period Phase I/II||6
10588538|NCT01756456|11744277|FG001|STARTED|Follow Up Period Phase I/II||6
10588539|NCT01756456|11744278|FG002|STARTED|Follow Up Period Phase I/II||2
10703278|NCT02584257|11867888|FG000|COMPLETED|Period 1||9
10703279|NCT02584257|11867889|FG001|COMPLETED|Period 1||9
10703280|NCT02584257|11867890|FG002|COMPLETED|Period 1||9
10703281|NCT02584257|11867891|FG003|COMPLETED|Period 1||8
10703282|NCT02584257|11867892|FG004|COMPLETED|Period 1||10
10703283|NCT02584257|11867893|FG005|COMPLETED|Period 1||10
10588540|NCT01756456|11744279|FG003|STARTED|Follow Up Period Phase I/II||45
10588541|NCT01756456|11744280|FG004|STARTED|Follow Up Period Phase I/II||39
10703284|NCT02584257|11867894|FG006|COMPLETED|Period 1||17
10703285|NCT02584257|11867895|FG007|COMPLETED|Period 1||9
10703286|NCT02584257|11867896|FG008|COMPLETED|Period 1||9
10703287|NCT02584257|11867888|FG000|NOT COMPLETED|Period 1||0
10588542|NCT01756456|11744281|FG005|STARTED|Follow Up Period Phase I/II||48
10588543|NCT01756456|11744276|FG000|COMPLETED|Follow Up Period Phase I/II||5
10588544|NCT01756456|11744277|FG001|COMPLETED|Follow Up Period Phase I/II||5
10588545|NCT01756456|11744278|FG002|COMPLETED|Follow Up Period Phase I/II||1
10588546|NCT01756456|11744279|FG003|COMPLETED|Follow Up Period Phase I/II||12
10588547|NCT01756456|11744280|FG004|COMPLETED|Follow Up Period Phase I/II||13
10588548|NCT01756456|11744281|FG005|COMPLETED|Follow Up Period Phase I/II||15
10588549|NCT01756456|11744276|FG000|NOT COMPLETED|Follow Up Period Phase I/II||1
10588550|NCT01756456|11744277|FG001|NOT COMPLETED|Follow Up Period Phase I/II||1
10588551|NCT01756456|11744278|FG002|NOT COMPLETED|Follow Up Period Phase I/II||1
10588552|NCT01756456|11744279|FG003|NOT COMPLETED|Follow Up Period Phase I/II||33
10588553|NCT01756456|11744280|FG004|NOT COMPLETED|Follow Up Period Phase I/II||26
10588554|NCT01756456|11744281|FG005|NOT COMPLETED|Follow Up Period Phase I/II||33
10588555|NCT01756833|11744306|FG000|STARTED|Overall Study||133
10588556|NCT01756833|11744307|FG001|STARTED|Overall Study||128
10588557|NCT01756833|11744306|FG000|COMPLETED|Overall Study||129
10588558|NCT01756833|11744307|FG001|COMPLETED|Overall Study||125
10588559|NCT01756833|11744306|FG000|NOT COMPLETED|Overall Study||4
10588560|NCT01756833|11744307|FG001|NOT COMPLETED|Overall Study||3
10588561|NCT01756846|11744315|FG000|STARTED|Overall Study||1833
10588562|NCT01756846|11744316|FG001|STARTED|Overall Study||1833
10588563|NCT01756846|11744315|FG000|COMPLETED|Overall Study||1827
10588564|NCT01756846|11744316|FG001|COMPLETED|Overall Study||1821
10588565|NCT01756846|11744315|FG000|NOT COMPLETED|Overall Study||6
10588566|NCT01756846|11744316|FG001|NOT COMPLETED|Overall Study||12
10588567|NCT01756885|11744324|FG000|STARTED|Overall Study||102
10588568|NCT01756885|11744325|FG001|STARTED|Overall Study||105
10588569|NCT01756885|11744324|FG000|COMPLETED|Overall Study||79
10588570|NCT01756885|11744325|FG001|COMPLETED|Overall Study||79
10588571|NCT01756885|11744324|FG000|NOT COMPLETED|Overall Study||23
10588572|NCT01756885|11744325|FG001|NOT COMPLETED|Overall Study||26
10588573|NCT01756898|11744335|FG000|STARTED|Overall Study||92
10588574|NCT01756898|11744336|FG001|STARTED|Overall Study||92
10588575|NCT01756898|11744337|FG002|STARTED|Overall Study||93
10588576|NCT01756898|11744338|FG003|STARTED|Overall Study||93
10588577|NCT01756898|11744335|FG000|COMPLETED|Overall Study||73
10588578|NCT01756898|11744336|FG001|COMPLETED|Overall Study||73
10588579|NCT01756898|11744337|FG002|COMPLETED|Overall Study||76
10588580|NCT01756898|11744338|FG003|COMPLETED|Overall Study||77
10588581|NCT01756898|11744335|FG000|NOT COMPLETED|Overall Study||19
10588582|NCT01756898|11744336|FG001|NOT COMPLETED|Overall Study||19
10588583|NCT01756898|11744337|FG002|NOT COMPLETED|Overall Study||17
10588584|NCT01756898|11744338|FG003|NOT COMPLETED|Overall Study||16
10807257|NCT03926065|11968894|FG004|NOT COMPLETED|Study Week 4||0
10807258|NCT03909100|11968904|FG000|STARTED|Overall Study||120
10807259|NCT03909100|11968904|FG000|Safety Population|Overall Study||112
10807260|NCT03909100|11968904|FG000|Received Treatment in Session 2|Overall Study||107
10807261|NCT03909100|11968904|FG000|Evaluable Population|Overall Study||106
10807262|NCT03909100|11968904|FG000|COMPLETED|Overall Study||105
10807263|NCT03909100|11968904|FG000|NOT COMPLETED|Overall Study||15
10807264|NCT03905642|11968911|FG000|STARTED|Overall Study||49
10807265|NCT03905642|11968911|FG000|COMPLETED|Overall Study||41
10807266|NCT03905642|11968911|FG000|NOT COMPLETED|Overall Study||8
10807267|NCT03892889|11968915|FG000|STARTED|Overall Study||277
10807268|NCT03892889|11968915|FG000|COMPLETED|Overall Study||73
10807269|NCT03892889|11968915|FG000|NOT COMPLETED|Overall Study||204
10807270|NCT03921723|11968919|FG000|STARTED|Period 1 (4 Days)||22
10807271|NCT03921723|11968919|FG000|COMPLETED|Period 1 (4 Days)||22
10807272|NCT03921723|11968919|FG000|NOT COMPLETED|Period 1 (4 Days)||0
10807273|NCT03921723|11968919|FG000|STARTED|Period 2 (4 Days)||22
10807274|NCT03921723|11968919|FG000|COMPLETED|Period 2 (4 Days)||19
10807275|NCT03921723|11968919|FG000|NOT COMPLETED|Period 2 (4 Days)||3
10807276|NCT03921723|11968919|FG000|STARTED|Period 3 (4 Days)||19
10807277|NCT03921723|11968919|FG000|COMPLETED|Period 3 (4 Days)||18
10807278|NCT03921723|11968919|FG000|NOT COMPLETED|Period 3 (4 Days)||1
10807279|NCT03921190|11968929|FG000|STARTED|Overall Study||56
10807280|NCT03921190|11968930|FG001|STARTED|Overall Study||64
10807281|NCT03921190|11968929|FG000|COMPLETED|Overall Study||56
10807282|NCT03921190|11968930|FG001|COMPLETED|Overall Study||64
10807283|NCT03921190|11968929|FG000|NOT COMPLETED|Overall Study||0
10807284|NCT03921190|11968930|FG001|NOT COMPLETED|Overall Study||0
10807285|NCT03920865|11968941|FG000|STARTED|Overall Study||8
10807286|NCT03920865|11968942|FG001|STARTED|Overall Study||8
10807287|NCT03920865|11968943|FG002|STARTED|Overall Study||10
10807288|NCT03920865|11968941|FG000|COMPLETED|Overall Study||8
10588585|NCT01756976|11744353|FG000|STARTED|Overall Study||76
10588586|NCT01756976|11744354|FG001|STARTED|Overall Study||8
10588587|NCT01756976|11744353|FG000|COMPLETED|Overall Study||73
10588588|NCT01756976|11744354|FG001|COMPLETED|Overall Study||8
10588589|NCT01756976|11744353|FG000|NOT COMPLETED|Overall Study||3
10588590|NCT01756976|11744354|FG001|NOT COMPLETED|Overall Study||0
10588591|NCT01757067|11744362|FG000|STARTED|Overall Study||2
10588592|NCT01757067|11744363|FG001|STARTED|Overall Study|The study was closed due to low enrollment.|1
10588593|NCT01757067|11744362|FG000|COMPLETED|Overall Study|The study was closed due to low enrollment.|2
10588594|NCT01757067|11744363|FG001|COMPLETED|Overall Study|The study was closed due to low enrollment.|1
10807289|NCT03920865|11968942|FG001|COMPLETED|Overall Study||8
10807290|NCT03920865|11968943|FG002|COMPLETED|Overall Study||10
10807291|NCT03920865|11968941|FG000|NOT COMPLETED|Overall Study||0
10807292|NCT03920865|11968942|FG001|NOT COMPLETED|Overall Study||0
10588595|NCT01757067|11744362|FG000|NOT COMPLETED|Overall Study||0
10588596|NCT01757067|11744363|FG001|NOT COMPLETED|Overall Study||0
10588597|NCT01757171|11744371|FG000|STARTED|Overall Study||61
10588598|NCT01757171|11744372|FG001|STARTED|Overall Study||24
10588599|NCT01757171|11744371|FG000|COMPLETED|Overall Study||53
10588600|NCT01757171|11744372|FG001|COMPLETED|Overall Study||23
10588601|NCT01757171|11744371|FG000|NOT COMPLETED|Overall Study||8
10703288|NCT02584257|11867889|FG001|NOT COMPLETED|Period 1||0
10703289|NCT02584257|11867890|FG002|NOT COMPLETED|Period 1||0
10703290|NCT02584257|11867891|FG003|NOT COMPLETED|Period 1||0
10807293|NCT03920865|11968943|FG002|NOT COMPLETED|Overall Study||0
10807294|NCT03918239|11968963|FG000|STARTED|Overall Study||94
10807295|NCT03918239|11968964|FG001|STARTED|Overall Study||96
10588602|NCT01757171|11744372|FG001|NOT COMPLETED|Overall Study||1
10588603|NCT01757184|11744380|FG000|STARTED|Double-blind Period||36
10588604|NCT01757184|11744381|FG001|STARTED|Double-blind Period||30
10588605|NCT01757184|11744382|FG002|STARTED|Double-blind Period||0
10588606|NCT01757184|11744383|FG003|STARTED|Double-blind Period||0
10588607|NCT01757184|11744380|FG000|Received at Least 1 Dose of Study Drug|Double-blind Period||36
10588608|NCT01757184|11744381|FG001|Received at Least 1 Dose of Study Drug|Double-blind Period||30
10588609|NCT01757184|11744382|FG002|Received at Least 1 Dose of Study Drug|Double-blind Period||0
10588610|NCT01757184|11744383|FG003|Received at Least 1 Dose of Study Drug|Double-blind Period||0
10807296|NCT03918239|11968963|FG000|COMPLETED|Overall Study||84
10807297|NCT03918239|11968964|FG001|COMPLETED|Overall Study||89
10807298|NCT03918239|11968963|FG000|NOT COMPLETED|Overall Study||10
10807299|NCT03918239|11968964|FG001|NOT COMPLETED|Overall Study||7
10807300|NCT03917823|11968972|FG000|STARTED|Overall Study||2
10807301|NCT03917823|11968973|FG001|STARTED|Overall Study||2
10807302|NCT03917823|11968972|FG000|COMPLETED|Overall Study||1
10807303|NCT03917823|11968973|FG001|COMPLETED|Overall Study||0
10807304|NCT03917823|11968972|FG000|NOT COMPLETED|Overall Study||1
10807305|NCT03917823|11968973|FG001|NOT COMPLETED|Overall Study||2
10807306|NCT03911752|11968982|FG000|STARTED|Overall Study||8
10807307|NCT03911752|11968983|FG001|STARTED|Overall Study||2
10807308|NCT03911752|11968984|FG002|STARTED|Overall Study||2
10807309|NCT03911752|11968982|FG000|COMPLETED|Overall Study||8
10807310|NCT03911752|11968983|FG001|COMPLETED|Overall Study||2
10807311|NCT03911752|11968984|FG002|COMPLETED|Overall Study||2
10807312|NCT03911752|11968982|FG000|NOT COMPLETED|Overall Study||0
10807313|NCT03911752|11968983|FG001|NOT COMPLETED|Overall Study||0
10807314|NCT03911752|11968984|FG002|NOT COMPLETED|Overall Study||0
10807315|NCT03902613|11968994|FG000|STARTED|Overall Study||1
10807316|NCT03902613|11968994|FG000|COMPLETED|Overall Study||0
10807317|NCT03902613|11968994|FG000|NOT COMPLETED|Overall Study||1
10807318|NCT03902574|11969001|FG000|STARTED|Overall Study||7
10807319|NCT03902574|11969002|FG001|STARTED|Overall Study||7
10807320|NCT03902574|11969003|FG002|STARTED|Overall Study||7
10807321|NCT03902574|11969001|FG000|COMPLETED|Overall Study||7
10807322|NCT03902574|11969002|FG001|COMPLETED|Overall Study||7
10807323|NCT03902574|11969003|FG002|COMPLETED|Overall Study||6
10807324|NCT03902574|11969001|FG000|NOT COMPLETED|Overall Study||0
10807325|NCT03902574|11969002|FG001|NOT COMPLETED|Overall Study||0
10807326|NCT03902574|11969003|FG002|NOT COMPLETED|Overall Study||1
10807327|NCT03914950|11969011|FG000|STARTED|Overall Study||174
10807328|NCT03914950|11969011|FG000|COMPLETED|Overall Study||120
10807329|NCT03914950|11969011|FG000|NOT COMPLETED|Overall Study||54
10807330|NCT03911843|11969023|FG000|STARTED|Overall Study||26
10588611|NCT01757184|11744380|FG000|COMPLETED|Double-blind Period||35
10703291|NCT02584257|11867892|FG004|NOT COMPLETED|Period 1||0
10703292|NCT02584257|11867893|FG005|NOT COMPLETED|Period 1||0
10703293|NCT02584257|11867894|FG006|NOT COMPLETED|Period 1||1
10703294|NCT02584257|11867895|FG007|NOT COMPLETED|Period 1||0
10703295|NCT02584257|11867896|FG008|NOT COMPLETED|Period 1||0
10703296|NCT02584257|11867888|FG000|STARTED|Period 2||9
10703297|NCT02584257|11867889|FG001|STARTED|Period 2||9
10703298|NCT02584257|11867890|FG002|STARTED|Period 2||9
10703299|NCT02584257|11867891|FG003|STARTED|Period 2||8
10703300|NCT02584257|11867892|FG004|STARTED|Period 2||10
10703301|NCT02584257|11867893|FG005|STARTED|Period 2||10
10703302|NCT02584257|11867894|FG006|STARTED|Period 2||17
10703303|NCT02584257|11867895|FG007|STARTED|Period 2||9
10703304|NCT02584257|11867896|FG008|STARTED|Period 2||9
10703305|NCT02584257|11867888|FG000|COMPLETED|Period 2||8
10703306|NCT02584257|11867889|FG001|COMPLETED|Period 2||8
10807331|NCT03911843|11969024|FG001|STARTED|Overall Study||38
10807332|NCT03911843|11969023|FG000|COMPLETED|Overall Study||22
10807333|NCT03911843|11969024|FG001|COMPLETED|Overall Study||37
10807334|NCT03911843|11969023|FG000|NOT COMPLETED|Overall Study||4
10807335|NCT03911843|11969024|FG001|NOT COMPLETED|Overall Study||1
10807336|NCT03896633|11969032|FG000|STARTED|Overall Study||321
10703307|NCT02584257|11867890|FG002|COMPLETED|Period 2||9
10703308|NCT02584257|11867891|FG003|COMPLETED|Period 2||8
10807337|NCT03896633|11969033|FG001|STARTED|Overall Study||316
10807338|NCT03896633|11969032|FG000|COMPLETED|Overall Study||312
10807339|NCT03896633|11969033|FG001|COMPLETED|Overall Study||306
10807340|NCT03896633|11969032|FG000|NOT COMPLETED|Overall Study||9
10807341|NCT03896633|11969033|FG001|NOT COMPLETED|Overall Study||10
10807342|NCT03894813|11969041|FG000|STARTED|Overall Study||63
10703309|NCT02584257|11867892|FG004|COMPLETED|Period 2||10
10807343|NCT03894813|11969042|FG001|STARTED|Overall Study||63
10703310|NCT02584257|11867893|FG005|COMPLETED|Period 2||10
10703311|NCT02584257|11867894|FG006|COMPLETED|Period 2||17
10703312|NCT02584257|11867895|FG007|COMPLETED|Period 2||9
10703313|NCT02584257|11867896|FG008|COMPLETED|Period 2||9
10807344|NCT03894813|11969041|FG000|COMPLETED|Overall Study||52
10807345|NCT03894813|11969042|FG001|COMPLETED|Overall Study||47
10588612|NCT01757184|11744381|FG001|COMPLETED|Double-blind Period||30
10588613|NCT01757184|11744382|FG002|COMPLETED|Double-blind Period||0
10588614|NCT01757184|11744383|FG003|COMPLETED|Double-blind Period||0
10588615|NCT01757184|11744380|FG000|NOT COMPLETED|Double-blind Period||1
10588616|NCT01757184|11744381|FG001|NOT COMPLETED|Double-blind Period||0
10588617|NCT01757184|11744382|FG002|NOT COMPLETED|Double-blind Period||0
10588618|NCT01757184|11744383|FG003|NOT COMPLETED|Double-blind Period||0
10588619|NCT01757184|11744380|FG000|STARTED|Open-label Period||0
10703314|NCT02584257|11867888|FG000|NOT COMPLETED|Period 2||1
10807346|NCT03894813|11969041|FG000|NOT COMPLETED|Overall Study||11
10807347|NCT03894813|11969042|FG001|NOT COMPLETED|Overall Study||16
10807348|NCT03911960|11969050|FG000|STARTED|Overall Study||9
10807349|NCT03911960|11969051|FG001|STARTED|Overall Study||5
10807350|NCT03911960|11969050|FG000|COMPLETED|Overall Study||4
10807351|NCT03911960|11969051|FG001|COMPLETED|Overall Study||2
10807352|NCT03911960|11969050|FG000|NOT COMPLETED|Overall Study||5
10807353|NCT03911960|11969051|FG001|NOT COMPLETED|Overall Study||3
10807354|NCT03907072|11969061|FG000|STARTED|Overall Study||2
10807355|NCT03907072|11969062|FG001|STARTED|Overall Study||2
10807356|NCT03907072|11969063|FG002|STARTED|Overall Study||2
10807357|NCT03907072|11969061|FG000|COMPLETED|Overall Study||0
10807358|NCT03907072|11969062|FG001|COMPLETED|Overall Study||0
10807359|NCT03907072|11969063|FG002|COMPLETED|Overall Study||0
10807360|NCT03907072|11969061|FG000|NOT COMPLETED|Overall Study||2
10807361|NCT03907072|11969062|FG001|NOT COMPLETED|Overall Study||2
10588620|NCT01757184|11744381|FG001|STARTED|Open-label Period||0
10651959|NCT02180100|11812247|FG001|NOT COMPLETED|Overall Study||4
10651960|NCT02180165|11812257|FG000|STARTED|Overall Study||15
10651961|NCT02180165|11812258|FG001|STARTED|Overall Study||7
10703315|NCT02584257|11867889|FG001|NOT COMPLETED|Period 2||1
10703316|NCT02584257|11867890|FG002|NOT COMPLETED|Period 2||0
10703317|NCT02584257|11867891|FG003|NOT COMPLETED|Period 2||0
10703318|NCT02584257|11867892|FG004|NOT COMPLETED|Period 2||0
10703319|NCT02584257|11867893|FG005|NOT COMPLETED|Period 2||0
10703320|NCT02584257|11867894|FG006|NOT COMPLETED|Period 2||0
10703321|NCT02584257|11867895|FG007|NOT COMPLETED|Period 2||0
10703322|NCT02584257|11867896|FG008|NOT COMPLETED|Period 2||0
10703323|NCT02584257|11867888|FG000|STARTED|Period 3||8
10703324|NCT02584257|11867889|FG001|STARTED|Period 3||8
10703325|NCT02584257|11867890|FG002|STARTED|Period 3||9
10703326|NCT02584257|11867891|FG003|STARTED|Period 3||8
10703327|NCT02584257|11867892|FG004|STARTED|Period 3||10
10703328|NCT02584257|11867893|FG005|STARTED|Period 3||10
10703329|NCT02584257|11867894|FG006|STARTED|Period 3||17
10703330|NCT02584257|11867895|FG007|STARTED|Period 3||9
10703331|NCT02584257|11867896|FG008|STARTED|Period 3||9
10703332|NCT02584257|11867888|FG000|COMPLETED|Period 3||8
10703333|NCT02584257|11867889|FG001|COMPLETED|Period 3||8
10703334|NCT02584257|11867890|FG002|COMPLETED|Period 3||9
10703335|NCT02584257|11867891|FG003|COMPLETED|Period 3||8
10703336|NCT02584257|11867892|FG004|COMPLETED|Period 3||10
10703337|NCT02584257|11867893|FG005|COMPLETED|Period 3||10
10703338|NCT02584257|11867894|FG006|COMPLETED|Period 3||17
10703339|NCT02584257|11867895|FG007|COMPLETED|Period 3||9
10703340|NCT02584257|11867896|FG008|COMPLETED|Period 3||9
10703341|NCT02584257|11867888|FG000|NOT COMPLETED|Period 3||0
10703342|NCT02584257|11867889|FG001|NOT COMPLETED|Period 3||0
10703343|NCT02584257|11867890|FG002|NOT COMPLETED|Period 3||0
10703344|NCT02584257|11867891|FG003|NOT COMPLETED|Period 3||0
10703345|NCT02584257|11867892|FG004|NOT COMPLETED|Period 3||0
10703346|NCT02584257|11867893|FG005|NOT COMPLETED|Period 3||0
10703347|NCT02584257|11867894|FG006|NOT COMPLETED|Period 3||0
10703348|NCT02584257|11867895|FG007|NOT COMPLETED|Period 3||0
10703349|NCT02584257|11867896|FG008|NOT COMPLETED|Period 3||0
10703350|NCT02584257|11867888|FG000|STARTED|Period 4||8
10703351|NCT02584257|11867889|FG001|STARTED|Period 4||8
10703352|NCT02584257|11867890|FG002|STARTED|Period 4||9
10703353|NCT02584257|11867891|FG003|STARTED|Period 4||8
10703354|NCT02584257|11867892|FG004|STARTED|Period 4||10
10703355|NCT02584257|11867893|FG005|STARTED|Period 4||10
10807362|NCT03907072|11969063|FG002|NOT COMPLETED|Overall Study||2
10807363|NCT03906448|11969073|FG000|STARTED|Overall Study||1
10807364|NCT03906448|11969074|FG001|STARTED|Overall Study||0
10807365|NCT03906448|11969073|FG000|COMPLETED|Overall Study||1
10807366|NCT03906448|11969074|FG001|COMPLETED|Overall Study||0
10651962|NCT02180165|11812259|FG002|STARTED|Overall Study||63
10651963|NCT02180165|11812260|FG003|STARTED|Overall Study||31
10651964|NCT02180165|11812257|FG000|Treated Participants|Overall Study||15
10651965|NCT02180165|11812258|FG001|Treated Participants|Overall Study||7
10651966|NCT02180165|11812259|FG002|Treated Participants|Overall Study||62
10651967|NCT02180165|11812260|FG003|Treated Participants|Overall Study||31
10651968|NCT02180165|11812257|FG000|Type of Aspergillosis|Overall Study|Chronic Pulmonary Aspergillosis|15
10654626|NCT02203591|11815405|FG000|NOT COMPLETED|Overall Study||147
10588621|NCT01757184|11744382|FG002|STARTED|Open-label Period|1 participant who did not complete Double-blind Period due to AE rechallenged for Open-label Period|36
10588622|NCT01757184|11744383|FG003|STARTED|Open-label Period||30
10588623|NCT01757184|11744380|FG000|Received at Least 1 Dose of Study Drug|Open-label Period||0
10588624|NCT01757184|11744381|FG001|Received at Least 1 Dose of Study Drug|Open-label Period||0
10588625|NCT01757184|11744382|FG002|Received at Least 1 Dose of Study Drug|Open-label Period||36
10588626|NCT01757184|11744383|FG003|Received at Least 1 Dose of Study Drug|Open-label Period||30
10588627|NCT01757184|11744380|FG000|COMPLETED|Open-label Period||0
10588628|NCT01757184|11744381|FG001|COMPLETED|Open-label Period||0
10807367|NCT03906448|11969073|FG000|NOT COMPLETED|Overall Study||0
10807368|NCT03906448|11969074|FG001|NOT COMPLETED|Overall Study||0
10807369|NCT03911401|11969083|FG000|STARTED|Overall Study||83
10807370|NCT03911401|11969084|FG001|STARTED|Overall Study||85
10807371|NCT03911401|11969085|FG002|STARTED|Overall Study||83
10807372|NCT03911401|11969083|FG000|COMPLETED|Overall Study||76
10807373|NCT03911401|11969084|FG001|COMPLETED|Overall Study||76
10807374|NCT03911401|11969085|FG002|COMPLETED|Overall Study||58
10807375|NCT03911401|11969083|FG000|NOT COMPLETED|Overall Study||7
10807376|NCT03911401|11969084|FG001|NOT COMPLETED|Overall Study||9
10807377|NCT03911401|11969085|FG002|NOT COMPLETED|Overall Study||25
10807378|NCT03909763|11969093|FG000|STARTED|Overall Study||55
10807379|NCT03909763|11969093|FG000|COMPLETED|Overall Study||45
10807380|NCT03909763|11969093|FG000|NOT COMPLETED|Overall Study||10
10807381|NCT03909009|11969099|FG000|STARTED|Overall Study||10
10807382|NCT03909009|11969100|FG001|STARTED|Overall Study||10
10807383|NCT03909009|11969099|FG000|COMPLETED|Overall Study||10
10807384|NCT03909009|11969100|FG001|COMPLETED|Overall Study||10
10807385|NCT03909009|11969099|FG000|NOT COMPLETED|Overall Study||0
10807386|NCT03909009|11969100|FG001|NOT COMPLETED|Overall Study||0
10807387|NCT03906968|11969106|FG000|STARTED|Overall Study||40
10807388|NCT03906968|11969106|FG000|COMPLETED|Overall Study||40
10807389|NCT03906968|11969106|FG000|NOT COMPLETED|Overall Study||0
10807390|NCT03904420|11969112|FG000|STARTED|Overall Study||2
10807391|NCT03904420|11969113|FG001|STARTED|Overall Study||2
10807392|NCT03904420|11969112|FG000|COMPLETED|Overall Study||0
10807393|NCT03904420|11969113|FG001|COMPLETED|Overall Study||0
10807394|NCT03904420|11969112|FG000|NOT COMPLETED|Overall Study||2
10807395|NCT03904420|11969113|FG001|NOT COMPLETED|Overall Study||2
10807396|NCT03903822|11969127|FG000|STARTED|Treatment Phase (6 Weeks)||37
10807397|NCT03903822|11969128|FG001|STARTED|Treatment Phase (6 Weeks)||37
10807398|NCT03903822|11969129|FG002|STARTED|Treatment Phase (6 Weeks)||36
10807399|NCT03903822|11969130|FG003|STARTED|Treatment Phase (6 Weeks)||37
10807400|NCT03903822|11969131|FG004|STARTED|Treatment Phase (6 Weeks)||36
10807401|NCT03903822|11969132|FG005|STARTED|Treatment Phase (6 Weeks)||36
10807402|NCT03903822|11969133|FG006|STARTED|Treatment Phase (6 Weeks)||36
10807403|NCT03903822|11969134|FG007|STARTED|Treatment Phase (6 Weeks)||37
10807404|NCT03903822|11969127|FG000|COMPLETED|Treatment Phase (6 Weeks)||28
10807405|NCT03903822|11969128|FG001|COMPLETED|Treatment Phase (6 Weeks)||27
10807406|NCT03903822|11969129|FG002|COMPLETED|Treatment Phase (6 Weeks)||33
10807407|NCT03903822|11969130|FG003|COMPLETED|Treatment Phase (6 Weeks)||32
10807408|NCT03903822|11969131|FG004|COMPLETED|Treatment Phase (6 Weeks)||31
10807409|NCT03903822|11969132|FG005|COMPLETED|Treatment Phase (6 Weeks)||25
10807410|NCT03903822|11969133|FG006|COMPLETED|Treatment Phase (6 Weeks)||31
10807411|NCT03903822|11969134|FG007|COMPLETED|Treatment Phase (6 Weeks)||33
10807412|NCT03903822|11969127|FG000|NOT COMPLETED|Treatment Phase (6 Weeks)||9
10807413|NCT03903822|11969128|FG001|NOT COMPLETED|Treatment Phase (6 Weeks)||10
10807414|NCT03903822|11969129|FG002|NOT COMPLETED|Treatment Phase (6 Weeks)||3
10807415|NCT03903822|11969130|FG003|NOT COMPLETED|Treatment Phase (6 Weeks)||5
10807416|NCT03903822|11969131|FG004|NOT COMPLETED|Treatment Phase (6 Weeks)||5
10807417|NCT03903822|11969132|FG005|NOT COMPLETED|Treatment Phase (6 Weeks)||11
10807418|NCT03903822|11969133|FG006|NOT COMPLETED|Treatment Phase (6 Weeks)||5
10807419|NCT03903822|11969134|FG007|NOT COMPLETED|Treatment Phase (6 Weeks)||4
10807420|NCT03903822|11969127|FG000|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|37
10807421|NCT03903822|11969128|FG001|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|37
10807422|NCT03903822|11969129|FG002|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|36
10807423|NCT03903822|11969130|FG003|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|37
10807424|NCT03903822|11969131|FG004|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|36
10807425|NCT03903822|11969132|FG005|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|36
10807426|NCT03903822|11969133|FG006|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|36
10807427|NCT03903822|11969134|FG007|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|37
10807428|NCT03903822|11969127|FG000|COMPLETED|Follow up Phase (4 Weeks)||29
10807429|NCT03903822|11969128|FG001|COMPLETED|Follow up Phase (4 Weeks)||29
10807430|NCT03903822|11969129|FG002|COMPLETED|Follow up Phase (4 Weeks)||32
10807431|NCT03903822|11969130|FG003|COMPLETED|Follow up Phase (4 Weeks)||33
10807432|NCT03903822|11969131|FG004|COMPLETED|Follow up Phase (4 Weeks)||32
10807433|NCT03903822|11969132|FG005|COMPLETED|Follow up Phase (4 Weeks)||28
10807434|NCT03903822|11969133|FG006|COMPLETED|Follow up Phase (4 Weeks)||31
10588629|NCT01757184|11744382|FG002|COMPLETED|Open-label Period||32
10807435|NCT03903822|11969134|FG007|COMPLETED|Follow up Phase (4 Weeks)||31
10588630|NCT01757184|11744383|FG003|COMPLETED|Open-label Period||27
10588631|NCT01757184|11744380|FG000|NOT COMPLETED|Open-label Period||0
10588632|NCT01757184|11744381|FG001|NOT COMPLETED|Open-label Period||0
10588633|NCT01757184|11744382|FG002|NOT COMPLETED|Open-label Period||4
10703356|NCT02584257|11867894|FG006|STARTED|Period 4||17
10703357|NCT02584257|11867895|FG007|STARTED|Period 4||9
10703358|NCT02584257|11867896|FG008|STARTED|Period 4||9
10703359|NCT02584257|11867888|FG000|COMPLETED|Period 4||8
10703360|NCT02584257|11867889|FG001|COMPLETED|Period 4||8
10807436|NCT03903822|11969127|FG000|NOT COMPLETED|Follow up Phase (4 Weeks)||8
10807437|NCT03903822|11969128|FG001|NOT COMPLETED|Follow up Phase (4 Weeks)||8
10807438|NCT03903822|11969129|FG002|NOT COMPLETED|Follow up Phase (4 Weeks)||4
10807439|NCT03903822|11969130|FG003|NOT COMPLETED|Follow up Phase (4 Weeks)||4
10807440|NCT03903822|11969131|FG004|NOT COMPLETED|Follow up Phase (4 Weeks)||4
10807441|NCT03903822|11969132|FG005|NOT COMPLETED|Follow up Phase (4 Weeks)||8
10807442|NCT03903822|11969133|FG006|NOT COMPLETED|Follow up Phase (4 Weeks)||5
10807443|NCT03903822|11969134|FG007|NOT COMPLETED|Follow up Phase (4 Weeks)||6
10807444|NCT03905096|11969154|FG000|STARTED|Period 1 for Trial Part 1 and 2||18
10807445|NCT03905096|11969155|FG001|STARTED|Period 1 for Trial Part 1 and 2||14
10807446|NCT03905096|11969154|FG000|COMPLETED|Period 1 for Trial Part 1 and 2||18
10807447|NCT03905096|11969155|FG001|COMPLETED|Period 1 for Trial Part 1 and 2||14
10807448|NCT03905096|11969154|FG000|NOT COMPLETED|Period 1 for Trial Part 1 and 2||0
10807449|NCT03905096|11969155|FG001|NOT COMPLETED|Period 1 for Trial Part 1 and 2||0
10807450|NCT03905096|11969154|FG000|STARTED|Period 2 for Trial Part 1 and 2||18
10807451|NCT03905096|11969155|FG001|STARTED|Period 2 for Trial Part 1 and 2||14
10807452|NCT03905096|11969154|FG000|COMPLETED|Period 2 for Trial Part 1 and 2||17
10807453|NCT03905096|11969155|FG001|COMPLETED|Period 2 for Trial Part 1 and 2||14
10807454|NCT03905096|11969154|FG000|NOT COMPLETED|Period 2 for Trial Part 1 and 2||1
10807455|NCT03905096|11969155|FG001|NOT COMPLETED|Period 2 for Trial Part 1 and 2||0
10807456|NCT03899064|11969168|FG000|STARTED|Overall Study||58
10807457|NCT03899064|11969168|FG000|MC2-01 Cream, Irradiation|Overall Study||58
10807458|NCT03899064|11969168|FG000|MC2-01 Cream, No Irradiation|Overall Study||58
10807459|NCT03899064|11969168|FG000|MC2-01 Vehicle, Irradiation|Overall Study||58
10807460|NCT03899064|11969168|FG000|MC2-01 Vehicle, no Irradiation|Overall Study||58
10807461|NCT03899064|11969168|FG000|Control, Irradiation|Overall Study||58
10807462|NCT03899064|11969168|FG000|COMPLETED|Overall Study||51
10807463|NCT03899064|11969168|FG000|NOT COMPLETED|Overall Study||7
10807464|NCT03903159|11969172|FG000|STARTED|Overall Study||15
10807465|NCT03903159|11969172|FG000|COMPLETED|Overall Study||10
10807466|NCT03903159|11969172|FG000|NOT COMPLETED|Overall Study||5
10807467|NCT03902392|11969178|FG000|STARTED|Overall Study||25
10807468|NCT03902392|11969179|FG001|STARTED|Overall Study||25
10807469|NCT03902392|11969178|FG000|COMPLETED|Overall Study||18
10807470|NCT03902392|11969179|FG001|COMPLETED|Overall Study||18
10807471|NCT03902392|11969178|FG000|NOT COMPLETED|Overall Study||7
10588634|NCT01757184|11744383|FG003|NOT COMPLETED|Open-label Period||3
10588635|NCT01757197|11744397|FG000|STARTED|Overall Study||2
10588636|NCT01757197|11744397|FG000|COMPLETED|Overall Study||0
10588637|NCT01757197|11744397|FG000|NOT COMPLETED|Overall Study||2
10588638|NCT01757275|11744403|FG000|STARTED|Overall Study||111
10588639|NCT01757275|11744404|FG001|STARTED|Overall Study||111
10703361|NCT02584257|11867890|FG002|COMPLETED|Period 4||9
10703362|NCT02584257|11867891|FG003|COMPLETED|Period 4||8
10703363|NCT02584257|11867892|FG004|COMPLETED|Period 4||10
10703364|NCT02584257|11867893|FG005|COMPLETED|Period 4||10
10703365|NCT02584257|11867894|FG006|COMPLETED|Period 4||17
10703366|NCT02584257|11867895|FG007|COMPLETED|Period 4||9
10703367|NCT02584257|11867896|FG008|COMPLETED|Period 4||9
10703368|NCT02584257|11867888|FG000|NOT COMPLETED|Period 4||0
10703369|NCT02584257|11867889|FG001|NOT COMPLETED|Period 4||0
10703370|NCT02584257|11867890|FG002|NOT COMPLETED|Period 4||0
10703371|NCT02584257|11867891|FG003|NOT COMPLETED|Period 4||0
10703372|NCT02584257|11867892|FG004|NOT COMPLETED|Period 4||0
10703373|NCT02584257|11867893|FG005|NOT COMPLETED|Period 4||0
10703374|NCT02584257|11867894|FG006|NOT COMPLETED|Period 4||0
10703375|NCT02584257|11867895|FG007|NOT COMPLETED|Period 4||0
10703376|NCT02584257|11867896|FG008|NOT COMPLETED|Period 4||0
10703377|NCT02584257|11867888|FG000|STARTED|Period 5||8
10703378|NCT02584257|11867889|FG001|STARTED|Period 5||8
10703379|NCT02584257|11867890|FG002|STARTED|Period 5||9
10703380|NCT02584257|11867891|FG003|STARTED|Period 5||8
10703381|NCT02584257|11867892|FG004|STARTED|Period 5||10
10703382|NCT02584257|11867893|FG005|STARTED|Period 5||10
10703383|NCT02584257|11867894|FG006|STARTED|Period 5||17
10703384|NCT02584257|11867895|FG007|STARTED|Period 5||9
10703385|NCT02584257|11867896|FG008|STARTED|Period 5||9
10703386|NCT02584257|11867888|FG000|COMPLETED|Period 5||8
10703387|NCT02584257|11867889|FG001|COMPLETED|Period 5||8
10703388|NCT02584257|11867890|FG002|COMPLETED|Period 5||9
10703389|NCT02584257|11867891|FG003|COMPLETED|Period 5||8
10703390|NCT02584257|11867892|FG004|COMPLETED|Period 5||10
10703391|NCT02584257|11867893|FG005|COMPLETED|Period 5||10
10703392|NCT02584257|11867894|FG006|COMPLETED|Period 5||17
10703393|NCT02584257|11867895|FG007|COMPLETED|Period 5||9
10703394|NCT02584257|11867896|FG008|COMPLETED|Period 5||9
10703395|NCT02584257|11867888|FG000|NOT COMPLETED|Period 5||0
10588640|NCT01757275|11744403|FG000|COMPLETED|Overall Study||102
10703396|NCT02584257|11867889|FG001|NOT COMPLETED|Period 5||0
10703397|NCT02584257|11867890|FG002|NOT COMPLETED|Period 5||0
10703398|NCT02584257|11867891|FG003|NOT COMPLETED|Period 5||0
10588641|NCT01757275|11744404|FG001|COMPLETED|Overall Study||98
10588642|NCT01757275|11744403|FG000|NOT COMPLETED|Overall Study||9
10588643|NCT01757275|11744404|FG001|NOT COMPLETED|Overall Study||13
10588644|NCT01757288|11744413|FG000|STARTED|Overall Study||6
10588645|NCT01757288|11744414|FG001|STARTED|Overall Study||46
10588646|NCT01757288|11744415|FG002|STARTED|Overall Study||46
10588647|NCT01757288|11744413|FG000|COMPLETED|Overall Study||6
10588648|NCT01757288|11744414|FG001|COMPLETED|Overall Study||38
10807472|NCT03902392|11969179|FG001|NOT COMPLETED|Overall Study||7
10807473|NCT03901105|11969185|FG000|STARTED|Overall Study||205
10807474|NCT03901105|11969185|FG000|COMPLETED|Overall Study||205
10807475|NCT03901105|11969185|FG000|NOT COMPLETED|Overall Study||0
10807476|NCT03895853|11969197|FG000|STARTED|Overall Study||0
10807477|NCT03895853|11969198|FG001|STARTED|Overall Study||2
10807478|NCT03895853|11969197|FG000|COMPLETED|Overall Study||0
10807479|NCT03895853|11969198|FG001|COMPLETED|Overall Study||2
10807480|NCT03895853|11969197|FG000|NOT COMPLETED|Overall Study||0
10807481|NCT03895853|11969198|FG001|NOT COMPLETED|Overall Study||0
10807482|NCT03901313|11969204|FG000|STARTED|Overall Study||4
10807483|NCT03901313|11969205|FG001|STARTED|Overall Study||4
10807484|NCT03901313|11969206|FG002|STARTED|Overall Study||4
10807485|NCT03901313|11969207|FG003|STARTED|Overall Study||4
10807486|NCT03901313|11969208|FG004|STARTED|Overall Study||4
10807487|NCT03901313|11969209|FG005|STARTED|Overall Study||4
10807488|NCT03901313|11969204|FG000|COMPLETED|Overall Study||4
10807489|NCT03901313|11969205|FG001|COMPLETED|Overall Study||4
10807490|NCT03901313|11969206|FG002|COMPLETED|Overall Study||4
10807491|NCT03901313|11969207|FG003|COMPLETED|Overall Study||4
10807492|NCT03901313|11969208|FG004|COMPLETED|Overall Study||4
10807493|NCT03901313|11969209|FG005|COMPLETED|Overall Study||4
10807494|NCT03901313|11969204|FG000|NOT COMPLETED|Overall Study||0
10807495|NCT03901313|11969205|FG001|NOT COMPLETED|Overall Study||0
10807496|NCT03901313|11969206|FG002|NOT COMPLETED|Overall Study||0
10807497|NCT03901313|11969207|FG003|NOT COMPLETED|Overall Study||0
10807498|NCT03901313|11969208|FG004|NOT COMPLETED|Overall Study||0
10807499|NCT03901313|11969209|FG005|NOT COMPLETED|Overall Study||0
10807500|NCT03901092|11969217|FG000|STARTED|Overall Study||83
10807501|NCT03901092|11969218|FG001|STARTED|Overall Study||159
10807502|NCT03901092|11969217|FG000|COMPLETED|Overall Study||83
10807503|NCT03901092|11969218|FG001|COMPLETED|Overall Study||159
10807504|NCT03901092|11969217|FG000|NOT COMPLETED|Overall Study||0
10807505|NCT03901092|11969218|FG001|NOT COMPLETED|Overall Study||0
10807506|NCT03900728|11969235|FG000|STARTED|Overall Study||40
10807507|NCT03900728|11969236|FG001|STARTED|Overall Study||57
10807508|NCT03900728|11969237|FG002|STARTED|Overall Study||39
10807509|NCT03900728|11969235|FG000|COMPLETED|Overall Study||40
10807510|NCT03900728|11969236|FG001|COMPLETED|Overall Study||57
10807511|NCT03900728|11969237|FG002|COMPLETED|Overall Study||35
10807512|NCT03900728|11969235|FG000|NOT COMPLETED|Overall Study||0
10807513|NCT03900728|11969236|FG001|NOT COMPLETED|Overall Study||0
10807514|NCT03900728|11969237|FG002|NOT COMPLETED|Overall Study||4
10807515|NCT03900299|11969247|FG000|STARTED|Overall Study||56
10807516|NCT03900299|11969248|FG001|STARTED|Overall Study||58
10807517|NCT03900299|11969247|FG000|COMPLETED|Overall Study||56
10807518|NCT03900299|11969248|FG001|COMPLETED|Overall Study||58
10807519|NCT03900299|11969247|FG000|NOT COMPLETED|Overall Study||0
10807520|NCT03900299|11969248|FG001|NOT COMPLETED|Overall Study||0
10807521|NCT03898349|11969257|FG000|STARTED|Overall Study||125
10807522|NCT03898349|11969258|FG001|STARTED|Overall Study||625
10807523|NCT03898349|11969257|FG000|COMPLETED|Overall Study||15
10807524|NCT03898349|11969258|FG001|COMPLETED|Overall Study||15
10807525|NCT03898349|11969257|FG000|NOT COMPLETED|Overall Study||110
10807526|NCT03898349|11969258|FG001|NOT COMPLETED|Overall Study||610
10807527|NCT03897634|11969264|FG000|STARTED|Overall Study||22
10807528|NCT03897634|11969264|FG000|COMPLETED|Overall Study||22
10807529|NCT03897634|11969264|FG000|NOT COMPLETED|Overall Study||0
10807530|NCT03895372|11969276|FG000|STARTED|Investigational Treatment Period||23
10807531|NCT03895372|11969277|FG001|STARTED|Investigational Treatment Period||22
10807532|NCT03895372|11969278|FG002|STARTED|Investigational Treatment Period||11
10807533|NCT03895372|11969279|FG003|STARTED|Investigational Treatment Period||11
10807534|NCT03895372|11969280|FG004|STARTED|Investigational Treatment Period||12
10807535|NCT03895372|11969281|FG005|STARTED|Investigational Treatment Period||11
10807536|NCT03895372|11969282|FG006|STARTED|Investigational Treatment Period||45
10807537|NCT03895372|11969283|FG007|STARTED|Investigational Treatment Period||43
10807538|NCT03895372|11969276|FG000|COMPLETED|Investigational Treatment Period||19
10807539|NCT03895372|11969277|FG001|COMPLETED|Investigational Treatment Period||19
10807540|NCT03895372|11969278|FG002|COMPLETED|Investigational Treatment Period||10
10807541|NCT03895372|11969279|FG003|COMPLETED|Investigational Treatment Period||9
10807542|NCT03895372|11969280|FG004|COMPLETED|Investigational Treatment Period||12
10807543|NCT03895372|11969281|FG005|COMPLETED|Investigational Treatment Period||9
10807544|NCT03895372|11969282|FG006|COMPLETED|Investigational Treatment Period||37
10807545|NCT03895372|11969283|FG007|COMPLETED|Investigational Treatment Period||38
10807546|NCT03895372|11969276|FG000|NOT COMPLETED|Investigational Treatment Period||4
10588649|NCT01757288|11744415|FG002|COMPLETED|Overall Study||37
10588650|NCT01757288|11744413|FG000|NOT COMPLETED|Overall Study||0
10588651|NCT01757288|11744414|FG001|NOT COMPLETED|Overall Study||8
10588652|NCT01757288|11744415|FG002|NOT COMPLETED|Overall Study||9
10807547|NCT03895372|11969277|FG001|NOT COMPLETED|Investigational Treatment Period||3
10811169|NCT03776539|11972873|FG000|NOT COMPLETED|Overall Study||0
10588653|NCT01757301|11744426|FG000|STARTED|Overall Study||147
10588654|NCT01757301|11744427|FG001|STARTED|Overall Study||147
10588655|NCT01757301|11744426|FG000|COMPLETED|Overall Study||134
10588656|NCT01757301|11744427|FG001|COMPLETED|Overall Study||133
10588657|NCT01757301|11744426|FG000|NOT COMPLETED|Overall Study||13
10588658|NCT01757301|11744427|FG001|NOT COMPLETED|Overall Study||14
10588659|NCT01757392|11744435|FG000|STARTED|Overall Study||39
10588660|NCT01757392|11744435|FG000|COMPLETED|Overall Study||35
10588661|NCT01757392|11744435|FG000|NOT COMPLETED|Overall Study||4
10588662|NCT01757405|11744441|FG000|STARTED|Overall Study||18
10588663|NCT01757405|11744442|FG001|STARTED|Overall Study||20
10588664|NCT01757405|11744441|FG000|COMPLETED|Overall Study||17
10588665|NCT01757405|11744442|FG001|COMPLETED|Overall Study||18
10588666|NCT01757405|11744441|FG000|NOT COMPLETED|Overall Study||1
10588667|NCT01757405|11744442|FG001|NOT COMPLETED|Overall Study||2
10588668|NCT01757561|11744452|FG000|STARTED|Overall Study||38
10588669|NCT01757561|11744453|FG001|STARTED|Overall Study||34
10588670|NCT01757561|11744454|FG002|STARTED|Overall Study||38
10588671|NCT01757561|11744455|FG003|STARTED|Overall Study||34
10588672|NCT01757561|11744452|FG000|COMPLETED|Overall Study||32
10588673|NCT01757561|11744453|FG001|COMPLETED|Overall Study||28
10703399|NCT02584257|11867892|FG004|NOT COMPLETED|Period 5||0
10703400|NCT02584257|11867893|FG005|NOT COMPLETED|Period 5||0
10588674|NCT01757561|11744454|FG002|COMPLETED|Overall Study||31
10588675|NCT01757561|11744455|FG003|COMPLETED|Overall Study||25
10588676|NCT01757561|11744452|FG000|NOT COMPLETED|Overall Study||6
10588677|NCT01757561|11744453|FG001|NOT COMPLETED|Overall Study||6
10588678|NCT01757561|11744454|FG002|NOT COMPLETED|Overall Study||7
10588679|NCT01757561|11744455|FG003|NOT COMPLETED|Overall Study||9
10588680|NCT01757678|11744465|FG000|STARTED|Overall Study||276
10588681|NCT01757678|11744465|FG000|COMPLETED|Overall Study||276
10588682|NCT01757678|11744465|FG000|NOT COMPLETED|Overall Study||0
10588683|NCT01757691|11744473|FG000|STARTED|Overall Study||2
10588684|NCT01757691|11744474|FG001|STARTED|Overall Study||0
10588685|NCT01757691|11744473|FG000|COMPLETED|Overall Study||0
10588686|NCT01757691|11744474|FG001|COMPLETED|Overall Study||0
10588687|NCT01757691|11744473|FG000|NOT COMPLETED|Overall Study||2
10588688|NCT01757691|11744474|FG001|NOT COMPLETED|Overall Study||0
10588689|NCT01757704|11744482|FG000|STARTED|Overall Study|One patient was excluded at start of surgery due to opening of the pleurae during sternotomy.|11
10588690|NCT01757704|11744483|FG001|STARTED|Overall Study|Two patients excluded intraoperatively due to failure to obtain TCD signals and one due to adhesion.|13
10588691|NCT01757704|11744482|FG000|COMPLETED|Overall Study||10
10588692|NCT01757704|11744483|FG001|COMPLETED|Overall Study||10
10588693|NCT01757704|11744482|FG000|NOT COMPLETED|Overall Study||1
10588694|NCT01757704|11744483|FG001|NOT COMPLETED|Overall Study||3
10588695|NCT01757717|11744489|FG000|STARTED|Overall Study||3
10588696|NCT01757717|11744489|FG000|COMPLETED|Overall Study||3
10588697|NCT01757717|11744489|FG000|NOT COMPLETED|Overall Study||0
10588698|NCT01757821|11744493|FG000|STARTED|Overall Study|11 subjects|11
10588699|NCT01757821|11744493|FG000|COMPLETED|Overall Study|10 subjects|10
10588700|NCT01757821|11744493|FG000|NOT COMPLETED|Overall Study||1
10588701|NCT01757847|11744503|FG000|STARTED|Overall Study||44
10588702|NCT01757847|11744504|FG001|STARTED|Overall Study||46
10588703|NCT01757847|11744503|FG000|COMPLETED|Overall Study||41
10588704|NCT01757847|11744504|FG001|COMPLETED|Overall Study||42
10588705|NCT01757847|11744503|FG000|NOT COMPLETED|Overall Study||3
10588706|NCT01757847|11744504|FG001|NOT COMPLETED|Overall Study||4
10588707|NCT01757964|11744512|FG000|STARTED|Overall Study||9
10588708|NCT01757964|11744513|FG001|STARTED|Overall Study||4
10588709|NCT01757964|11744512|FG000|COMPLETED|Overall Study||9
10588710|NCT01757964|11744513|FG001|COMPLETED|Overall Study||4
10588711|NCT01757964|11744512|FG000|NOT COMPLETED|Overall Study||0
10588712|NCT01757964|11744513|FG001|NOT COMPLETED|Overall Study||0
10588713|NCT01758289|11744517|FG000|STARTED|Overall Study||105
10588714|NCT01758289|11744517|FG000|COMPLETED|Overall Study||52
10588715|NCT01758289|11744517|FG000|NOT COMPLETED|Overall Study||53
10588716|NCT01758432|11744532|FG000|STARTED|Overall Study||18
10588717|NCT01758432|11744533|FG001|STARTED|Overall Study||6
10588718|NCT01758432|11744534|FG002|STARTED|Overall Study||6
10588719|NCT01758432|11744535|FG003|STARTED|Overall Study||6
10588720|NCT01758432|11744536|FG004|STARTED|Overall Study||6
10588721|NCT01758432|11744537|FG005|STARTED|Overall Study||6
10588722|NCT01758432|11744538|FG006|STARTED|Overall Study||6
10588723|NCT01758432|11744532|FG000|COMPLETED|Overall Study||18
10588724|NCT01758432|11744533|FG001|COMPLETED|Overall Study||6
10588725|NCT01758432|11744534|FG002|COMPLETED|Overall Study||6
10588726|NCT01758432|11744535|FG003|COMPLETED|Overall Study||6
10588727|NCT01758432|11744536|FG004|COMPLETED|Overall Study||6
10588728|NCT01758432|11744537|FG005|COMPLETED|Overall Study||6
10588729|NCT01758432|11744538|FG006|COMPLETED|Overall Study||6
10588730|NCT01758432|11744532|FG000|NOT COMPLETED|Overall Study||0
10588731|NCT01758432|11744533|FG001|NOT COMPLETED|Overall Study||0
10588732|NCT01758432|11744534|FG002|NOT COMPLETED|Overall Study||0
10588733|NCT01758432|11744535|FG003|NOT COMPLETED|Overall Study||0
10588734|NCT01758432|11744536|FG004|NOT COMPLETED|Overall Study||0
10588735|NCT01758432|11744537|FG005|NOT COMPLETED|Overall Study||0
10588736|NCT01758432|11744538|FG006|NOT COMPLETED|Overall Study||0
10588737|NCT01758523|11744556|FG000|STARTED|Overall Study||74
10588738|NCT01758523|11744557|FG001|STARTED|Overall Study||68
10588739|NCT01758523|11744556|FG000|Attended >/= 1 Visit Post-randomization|Overall Study||68
10588740|NCT01758523|11744557|FG001|Attended >/= 1 Visit Post-randomization|Overall Study||67
10703401|NCT02584257|11867894|FG006|NOT COMPLETED|Period 5||0
10588741|NCT01758523|11744556|FG000|COMPLETED|Overall Study||53
10588742|NCT01758523|11744557|FG001|COMPLETED|Overall Study||54
10588743|NCT01758523|11744556|FG000|NOT COMPLETED|Overall Study||21
10588744|NCT01758523|11744557|FG001|NOT COMPLETED|Overall Study||14
10588745|NCT01758588|11744569|FG000|STARTED|Overall Study||5
10588746|NCT01758588|11744570|FG001|STARTED|Overall Study||3
10807548|NCT03895372|11969278|FG002|NOT COMPLETED|Investigational Treatment Period||1
10807549|NCT03895372|11969279|FG003|NOT COMPLETED|Investigational Treatment Period||2
10807550|NCT03895372|11969280|FG004|NOT COMPLETED|Investigational Treatment Period||0
10807551|NCT03895372|11969281|FG005|NOT COMPLETED|Investigational Treatment Period||2
10807552|NCT03895372|11969282|FG006|NOT COMPLETED|Investigational Treatment Period||8
10807553|NCT03895372|11969283|FG007|NOT COMPLETED|Investigational Treatment Period||5
10807554|NCT03895372|11969276|FG000|STARTED|Extension Treatment Period||19
10807555|NCT03895372|11969277|FG001|STARTED|Extension Treatment Period||19
10807556|NCT03895372|11969278|FG002|STARTED|Extension Treatment Period||10
10807557|NCT03895372|11969279|FG003|STARTED|Extension Treatment Period||9
10807558|NCT03895372|11969280|FG004|STARTED|Extension Treatment Period||12
10807559|NCT03895372|11969281|FG005|STARTED|Extension Treatment Period||9
10807560|NCT03895372|11969282|FG006|STARTED|Extension Treatment Period||37
10807561|NCT03895372|11969283|FG007|STARTED|Extension Treatment Period||38
10807562|NCT03895372|11969276|FG000|COMPLETED|Extension Treatment Period||16
10807563|NCT03895372|11969277|FG001|COMPLETED|Extension Treatment Period||14
10807564|NCT03895372|11969278|FG002|COMPLETED|Extension Treatment Period||10
10807565|NCT03895372|11969279|FG003|COMPLETED|Extension Treatment Period||8
10807566|NCT03895372|11969280|FG004|COMPLETED|Extension Treatment Period||9
10807567|NCT03895372|11969281|FG005|COMPLETED|Extension Treatment Period||8
10807568|NCT03895372|11969282|FG006|COMPLETED|Extension Treatment Period||33
10807569|NCT03895372|11969283|FG007|COMPLETED|Extension Treatment Period||32
10807570|NCT03895372|11969276|FG000|NOT COMPLETED|Extension Treatment Period||3
10807571|NCT03895372|11969277|FG001|NOT COMPLETED|Extension Treatment Period||5
10807572|NCT03895372|11969278|FG002|NOT COMPLETED|Extension Treatment Period||0
10807573|NCT03895372|11969279|FG003|NOT COMPLETED|Extension Treatment Period||1
10807574|NCT03895372|11969280|FG004|NOT COMPLETED|Extension Treatment Period||3
10807575|NCT03895372|11969281|FG005|NOT COMPLETED|Extension Treatment Period||1
10807576|NCT03895372|11969282|FG006|NOT COMPLETED|Extension Treatment Period||4
10807577|NCT03895372|11969283|FG007|NOT COMPLETED|Extension Treatment Period||6
10807578|NCT03896022|11969309|FG000|STARTED|Overall Study||74
10807579|NCT03896022|11969310|FG001|STARTED|Overall Study||51
10807580|NCT03896022|11969311|FG002|STARTED|Overall Study||52
10807581|NCT03896022|11969309|FG000|COMPLETED|Overall Study||70
10807582|NCT03896022|11969310|FG001|COMPLETED|Overall Study||51
10807583|NCT03896022|11969311|FG002|COMPLETED|Overall Study||52
10807584|NCT03896022|11969309|FG000|NOT COMPLETED|Overall Study||4
10807585|NCT03896022|11969310|FG001|NOT COMPLETED|Overall Study||0
10807586|NCT03896022|11969311|FG002|NOT COMPLETED|Overall Study||0
10807587|NCT03891862|11969323|FG000|STARTED|Open-label Period||135
10807588|NCT03891862|11969324|FG001|STARTED|Open-label Period||0
10807589|NCT03891862|11969325|FG002|STARTED|Open-label Period||0
10807590|NCT03891862|11969323|FG000|Safety Analysis Set|Open-label Period||132
10807591|NCT03891862|11969324|FG001|Safety Analysis Set|Open-label Period||0
10807592|NCT03891862|11969325|FG002|Safety Analysis Set|Open-label Period||0
10807593|NCT03891862|11969323|FG000|COMPLETED|Open-label Period||119
10807594|NCT03891862|11969324|FG001|COMPLETED|Open-label Period||0
10807595|NCT03891862|11969325|FG002|COMPLETED|Open-label Period||0
10807596|NCT03891862|11969323|FG000|NOT COMPLETED|Open-label Period||16
10807597|NCT03891862|11969324|FG001|NOT COMPLETED|Open-label Period||0
10807598|NCT03891862|11969325|FG002|NOT COMPLETED|Open-label Period||0
10807599|NCT03891862|11969323|FG000|STARTED|Placebo-controlled Period and Follow-up||0
10807600|NCT03891862|11969324|FG001|STARTED|Placebo-controlled Period and Follow-up||59
10807601|NCT03891862|11969325|FG002|STARTED|Placebo-controlled Period and Follow-up||59
10807602|NCT03891862|11969323|FG000|Persistence of Effect Analysis Set|Placebo-controlled Period and Follow-up||0
10807603|NCT03891862|11969324|FG001|Persistence of Effect Analysis Set|Placebo-controlled Period and Follow-up||58
10807604|NCT03891862|11969325|FG002|Persistence of Effect Analysis Set|Placebo-controlled Period and Follow-up||59
10807605|NCT03891862|11969323|FG000|Completed Placebo-controlled Period|Placebo-controlled Period and Follow-up||0
10807606|NCT03891862|11969324|FG001|Completed Placebo-controlled Period|Placebo-controlled Period and Follow-up||53
10807607|NCT03891862|11969325|FG002|Completed Placebo-controlled Period|Placebo-controlled Period and Follow-up||56
10807608|NCT03891862|11969323|FG000|COMPLETED|Placebo-controlled Period and Follow-up||0
10807609|NCT03891862|11969324|FG001|COMPLETED|Placebo-controlled Period and Follow-up||53
10807610|NCT03891862|11969325|FG002|COMPLETED|Placebo-controlled Period and Follow-up||55
10807611|NCT03891862|11969323|FG000|NOT COMPLETED|Placebo-controlled Period and Follow-up||0
10807612|NCT03891862|11969324|FG001|NOT COMPLETED|Placebo-controlled Period and Follow-up||6
10807613|NCT03891862|11969325|FG002|NOT COMPLETED|Placebo-controlled Period and Follow-up||4
10807614|NCT03894449|11969337|FG000|STARTED|Overall Study||15
10807615|NCT03894449|11969338|FG001|STARTED|Overall Study||15
10807616|NCT03894449|11969339|FG002|STARTED|Overall Study||15
10588747|NCT01758588|11744569|FG000|COMPLETED|Overall Study||5
10588748|NCT01758588|11744570|FG001|COMPLETED|Overall Study||3
10588749|NCT01758588|11744569|FG000|NOT COMPLETED|Overall Study||0
10588750|NCT01758588|11744570|FG001|NOT COMPLETED|Overall Study||0
10588751|NCT01758731|11744578|FG000|STARTED|Overall Study||17
10588752|NCT01758731|11744578|FG000|COMPLETED|Overall Study||16
10588753|NCT01758731|11744578|FG000|NOT COMPLETED|Overall Study||1
10588754|NCT01758900|11744584|FG000|STARTED|Overall Study||106
10588755|NCT01758900|11744585|FG001|STARTED|Overall Study||108
10588756|NCT01758900|11744584|FG000|COMPLETED|Overall Study||99
10588757|NCT01758900|11744585|FG001|COMPLETED|Overall Study||100
10588758|NCT01758900|11744584|FG000|NOT COMPLETED|Overall Study||7
10588759|NCT01758900|11744585|FG001|NOT COMPLETED|Overall Study||8
10588760|NCT01759160|11744593|FG000|STARTED|Overall Study||30
10588761|NCT01759160|11744594|FG001|STARTED|Overall Study||30
10588762|NCT01759160|11744593|FG000|COMPLETED|Overall Study||30
10588763|NCT01759160|11744594|FG001|COMPLETED|Overall Study||30
10588764|NCT01759160|11744593|FG000|NOT COMPLETED|Overall Study||0
10588765|NCT01759160|11744594|FG001|NOT COMPLETED|Overall Study||0
10588766|NCT01759251|11744600|FG000|STARTED|30 Days Treatment Period||309
10588767|NCT01759251|11744600|FG000|COMPLETED|30 Days Treatment Period||305
10588768|NCT01759251|11744600|FG000|NOT COMPLETED|30 Days Treatment Period||4
10588769|NCT01759251|11744600|FG000|STARTED|60 Days Treatment Period||305
10588770|NCT01759251|11744600|FG000|COMPLETED|60 Days Treatment Period||305
10588771|NCT01759251|11744600|FG000|NOT COMPLETED|60 Days Treatment Period||0
10588772|NCT01759251|11744600|FG000|STARTED|Follow-up Period||305
10588773|NCT01759251|11744600|FG000|COMPLETED|Follow-up Period||305
10588774|NCT01759251|11744600|FG000|NOT COMPLETED|Follow-up Period||0
10588775|NCT01759264|11744604|FG000|STARTED|Overall Study||101
10588776|NCT01759264|11744604|FG000|COMPLETED|Overall Study||91
10588777|NCT01759264|11744604|FG000|NOT COMPLETED|Overall Study||10
10588778|NCT01759277|11744611|FG000|STARTED|Overall Study||41
10588779|NCT01759277|11744612|FG001|STARTED|Overall Study||39
10588780|NCT01759277|11744611|FG000|COMPLETED|Overall Study||41
10588781|NCT01759277|11744612|FG001|COMPLETED|Overall Study||39
10588782|NCT01759277|11744611|FG000|NOT COMPLETED|Overall Study||0
10588783|NCT01759277|11744612|FG001|NOT COMPLETED|Overall Study||0
10588784|NCT01759290|11744620|FG000|STARTED|Overall Study||1800
10588785|NCT01759290|11744620|FG000|COMPLETED|Overall Study||1719
10588786|NCT01759290|11744620|FG000|NOT COMPLETED|Overall Study||81
10588787|NCT01759368|11744626|FG000|STARTED|Overall Study||47
10588788|NCT01759368|11744627|FG001|STARTED|Overall Study||47
10588789|NCT01759368|11744626|FG000|COMPLETED|Overall Study||46
10588790|NCT01759368|11744627|FG001|COMPLETED|Overall Study||47
10588791|NCT01759368|11744626|FG000|NOT COMPLETED|Overall Study||1
10588792|NCT01759368|11744627|FG001|NOT COMPLETED|Overall Study||0
10588793|NCT01759381|11744637|FG000|STARTED|Overall Study||8
10588794|NCT01759381|11744638|FG001|STARTED|Overall Study||11
10588795|NCT01759381|11744637|FG000|COMPLETED|Overall Study||7
10588796|NCT01759381|11744638|FG001|COMPLETED|Overall Study||11
10588797|NCT01759381|11744637|FG000|NOT COMPLETED|Overall Study||1
10588798|NCT01759381|11744638|FG001|NOT COMPLETED|Overall Study||0
10588799|NCT01759407|11744646|FG000|STARTED|Overall Study||10
10588800|NCT01759407|11744647|FG001|STARTED|Overall Study||9
10588801|NCT01759407|11744646|FG000|COMPLETED|Overall Study||10
10588802|NCT01759407|11744647|FG001|COMPLETED|Overall Study||7
10588803|NCT01759407|11744646|FG000|NOT COMPLETED|Overall Study||0
10588804|NCT01759407|11744647|FG001|NOT COMPLETED|Overall Study||2
10588805|NCT01759420|11744653|FG000|STARTED|Overall Study||28
10588806|NCT01759420|11744653|FG000|COMPLETED|Overall Study||22
10807617|NCT03894449|11969340|FG003|STARTED|Overall Study||15
10807618|NCT03894449|11969341|FG004|STARTED|Overall Study||15
10807619|NCT03894449|11969337|FG000|COMPLETED|Overall Study||15
10807620|NCT03894449|11969338|FG001|COMPLETED|Overall Study||15
10807621|NCT03894449|11969339|FG002|COMPLETED|Overall Study||15
10807622|NCT03894449|11969340|FG003|COMPLETED|Overall Study||15
10588807|NCT01759420|11744653|FG000|NOT COMPLETED|Overall Study||6
10588808|NCT01759446|11744662|FG000|STARTED|Overall Study||9
10588809|NCT01759446|11744663|FG001|STARTED|Overall Study||9
10588810|NCT01759446|11744664|FG002|STARTED|Overall Study||9
10588811|NCT01759446|11744665|FG003|STARTED|Overall Study||9
10588812|NCT01759446|11744666|FG004|STARTED|Overall Study||8
10807623|NCT03894449|11969341|FG004|COMPLETED|Overall Study||15
10807624|NCT03894449|11969337|FG000|NOT COMPLETED|Overall Study||0
10807625|NCT03894449|11969338|FG001|NOT COMPLETED|Overall Study||0
10588813|NCT01759446|11744662|FG000|COMPLETED|Overall Study||8
10588814|NCT01759446|11744663|FG001|COMPLETED|Overall Study||8
10588815|NCT01759446|11744664|FG002|COMPLETED|Overall Study||8
10588816|NCT01759446|11744665|FG003|COMPLETED|Overall Study||8
10588817|NCT01759446|11744666|FG004|COMPLETED|Overall Study||8
10588818|NCT01759446|11744662|FG000|NOT COMPLETED|Overall Study||1
10588819|NCT01759446|11744663|FG001|NOT COMPLETED|Overall Study||1
10588820|NCT01759446|11744664|FG002|NOT COMPLETED|Overall Study||1
10588821|NCT01759446|11744665|FG003|NOT COMPLETED|Overall Study||1
10588822|NCT01759446|11744666|FG004|NOT COMPLETED|Overall Study||0
10588823|NCT01759511|11744678|FG000|STARTED|Overall Study||34
10588824|NCT01759511|11744678|FG000|COMPLETED|Overall Study||0
10588825|NCT01759511|11744678|FG000|NOT COMPLETED|Overall Study||34
10588826|NCT01759602|11744682|FG000|STARTED|Overall Study||10
10588827|NCT01759602|11744682|FG000|COMPLETED|Overall Study||10
10588828|NCT01759602|11744682|FG000|NOT COMPLETED|Overall Study||0
10588829|NCT01759862|11744688|FG000|STARTED|Overall Study||23
10588830|NCT01759862|11744689|FG001|STARTED|Overall Study||27
10588831|NCT01759862|11744688|FG000|COMPLETED|Overall Study||20
10588832|NCT01759862|11744689|FG001|COMPLETED|Overall Study||25
10588833|NCT01759862|11744688|FG000|NOT COMPLETED|Overall Study||3
10588834|NCT01759862|11744689|FG001|NOT COMPLETED|Overall Study||2
10588835|NCT01760187|11744705|FG000|STARTED|Overall Study||20
10588836|NCT01760187|11744706|FG001|STARTED|Overall Study||12
10588837|NCT01760187|11744707|FG002|STARTED|Overall Study||12
10588838|NCT01760187|11744708|FG003|STARTED|Overall Study||12
10588839|NCT01760187|11744709|FG004|STARTED|Overall Study||16
10588840|NCT01760187|11744705|FG000|COMPLETED|Overall Study||19
10588841|NCT01760187|11744706|FG001|COMPLETED|Overall Study||12
10588842|NCT01760187|11744707|FG002|COMPLETED|Overall Study||12
10588843|NCT01760187|11744708|FG003|COMPLETED|Overall Study||10
10588844|NCT01760187|11744709|FG004|COMPLETED|Overall Study||16
10588845|NCT01760187|11744705|FG000|NOT COMPLETED|Overall Study||1
10588846|NCT01760187|11744706|FG001|NOT COMPLETED|Overall Study||0
10588847|NCT01760187|11744707|FG002|NOT COMPLETED|Overall Study||0
10588848|NCT01760187|11744708|FG003|NOT COMPLETED|Overall Study||2
10588849|NCT01760187|11744709|FG004|NOT COMPLETED|Overall Study||0
10588850|NCT01760239|11744731|FG000|STARTED|Overall Study||17037
10588851|NCT01760239|11744732|FG001|STARTED|Overall Study||14542
10588852|NCT01760239|11744731|FG000|COMPLETED|Overall Study||296
10588853|NCT01760239|11744732|FG001|COMPLETED|Overall Study||226
10588854|NCT01760239|11744731|FG000|NOT COMPLETED|Overall Study||16741
10588855|NCT01760239|11744732|FG001|NOT COMPLETED|Overall Study||14316
10588856|NCT01760304|11744741|FG000|STARTED|Overall Study||2
10588857|NCT01760304|11744742|FG001|STARTED|Overall Study||3
10588858|NCT01760304|11744741|FG000|COMPLETED|Overall Study||2
10588859|NCT01760304|11744742|FG001|COMPLETED|Overall Study||3
10588860|NCT01760304|11744741|FG000|NOT COMPLETED|Overall Study||0
10588861|NCT01760304|11744742|FG001|NOT COMPLETED|Overall Study||0
10588890|NCT01760473|11744775|FG000|STARTED|Overall Study||27
10588891|NCT01760473|11744775|FG000|COMPLETED|Overall Study||12
10588892|NCT01760473|11744775|FG000|NOT COMPLETED|Overall Study||15
10588893|NCT01760733|11744787|FG000|STARTED|Waiting List|All patients included started in the waiting list group.|289
10588894|NCT01760733|11744787|FG000|COMPLETED|Waiting List|217 patients have been transplanted|217
10588895|NCT01760733|11744787|FG000|NOT COMPLETED|Waiting List||72
10588896|NCT01760733|11744787|FG000|STARTED|Transplanted||217
10588897|NCT01760733|11744787|FG000|COMPLETED|Transplanted||0
10807626|NCT03894449|11969339|FG002|NOT COMPLETED|Overall Study||0
10807627|NCT03894449|11969340|FG003|NOT COMPLETED|Overall Study||0
10807628|NCT03894449|11969341|FG004|NOT COMPLETED|Overall Study||0
10807629|NCT03892564|11969353|FG000|STARTED|Overall Study||35
10807630|NCT03892564|11969353|FG000|MC2-01 Cream + Irridiation|Overall Study||35
10807631|NCT03892564|11969353|FG000|MC2-01 Cream + Non-irridiation|Overall Study||35
10588898|NCT01760733|11744787|FG000|NOT COMPLETED|Transplanted||217
10588899|NCT01760785|11744794|FG000|STARTED|Overall Study||23
10588900|NCT01760785|11744795|FG001|STARTED|Overall Study||27
10588901|NCT01760785|11744794|FG000|COMPLETED|Overall Study||23
10588902|NCT01760785|11744795|FG001|COMPLETED|Overall Study||27
10588903|NCT01760785|11744794|FG000|NOT COMPLETED|Overall Study||0
10588904|NCT01760785|11744795|FG001|NOT COMPLETED|Overall Study||0
10588905|NCT01760876|11744801|FG000|STARTED|Overall Study||106
10588906|NCT01760876|11744801|FG000|COMPLETED|Overall Study|12 months clinical FU of last patient in July 2015.|100
10588907|NCT01760876|11744801|FG000|NOT COMPLETED|Overall Study||6
10588908|NCT01760954|11744809|FG000|STARTED|Treatment Period (6 Months)||149
10588909|NCT01760954|11744810|FG001|STARTED|Treatment Period (6 Months)||138
10588910|NCT01760954|11744811|FG002|STARTED|Treatment Period (6 Months)||108
10588911|NCT01760954|11744812|FG003|STARTED|Treatment Period (6 Months)||109
10588912|NCT01760954|11744809|FG000|COMPLETED|Treatment Period (6 Months)||116
10588913|NCT01760954|11744810|FG001|COMPLETED|Treatment Period (6 Months)||110
10588914|NCT01760954|11744811|FG002|COMPLETED|Treatment Period (6 Months)||87
10588915|NCT01760954|11744812|FG003|COMPLETED|Treatment Period (6 Months)||83
10588916|NCT01760954|11744809|FG000|NOT COMPLETED|Treatment Period (6 Months)||33
10588917|NCT01760954|11744810|FG001|NOT COMPLETED|Treatment Period (6 Months)||28
10588918|NCT01760954|11744811|FG002|NOT COMPLETED|Treatment Period (6 Months)||21
10588919|NCT01760954|11744812|FG003|NOT COMPLETED|Treatment Period (6 Months)||26
10588920|NCT01760954|11744809|FG000|STARTED|Post-treatment Follow-up (12 Months)||126
10588921|NCT01760954|11744810|FG001|STARTED|Post-treatment Follow-up (12 Months)||118
10588922|NCT01760954|11744811|FG002|STARTED|Post-treatment Follow-up (12 Months)||86
10588923|NCT01760954|11744812|FG003|STARTED|Post-treatment Follow-up (12 Months)||87
10588924|NCT01760954|11744809|FG000|COMPLETED|Post-treatment Follow-up (12 Months)||96
10588925|NCT01760954|11744810|FG001|COMPLETED|Post-treatment Follow-up (12 Months)||83
10588926|NCT01760954|11744811|FG002|COMPLETED|Post-treatment Follow-up (12 Months)||65
10588927|NCT01760954|11744812|FG003|COMPLETED|Post-treatment Follow-up (12 Months)||67
10588928|NCT01760954|11744809|FG000|NOT COMPLETED|Post-treatment Follow-up (12 Months)||30
10588929|NCT01760954|11744810|FG001|NOT COMPLETED|Post-treatment Follow-up (12 Months)||35
10588930|NCT01760954|11744811|FG002|NOT COMPLETED|Post-treatment Follow-up (12 Months)||21
10588931|NCT01760954|11744812|FG003|NOT COMPLETED|Post-treatment Follow-up (12 Months)||20
10588932|NCT01761019|11744822|FG000|STARTED|Overall Study||8
10588933|NCT01761019|11744822|FG000|COMPLETED|Overall Study||8
10588934|NCT01761019|11744822|FG000|NOT COMPLETED|Overall Study||0
10588935|NCT01761084|11744828|FG000|STARTED|Overall Study||71
10588936|NCT01761084|11744829|FG001|STARTED|Overall Study||70
10588937|NCT01761084|11744828|FG000|COMPLETED|Overall Study||66
10588938|NCT01761084|11744829|FG001|COMPLETED|Overall Study||64
10588939|NCT01761084|11744828|FG000|NOT COMPLETED|Overall Study||5
10588940|NCT01761084|11744829|FG001|NOT COMPLETED|Overall Study||6
10588941|NCT01761162|11744836|FG000|STARTED|Overall Study||229
10588942|NCT01761162|11744836|FG000|COMPLETED|Overall Study||226
10588943|NCT01761162|11744836|FG000|NOT COMPLETED|Overall Study||3
10588944|NCT01761175|11744842|FG000|STARTED|Overall Study||112
10588945|NCT01761175|11744843|FG001|STARTED|Overall Study||112
10588946|NCT01761175|11744842|FG000|COMPLETED|Overall Study||112
10588947|NCT01761175|11744843|FG001|COMPLETED|Overall Study||112
10588948|NCT01761175|11744842|FG000|NOT COMPLETED|Overall Study||0
10588949|NCT01761175|11744843|FG001|NOT COMPLETED|Overall Study||0
10588950|NCT01761279|11744850|FG000|STARTED|Overall Study||84
10588951|NCT01761279|11744850|FG000|COMPLETED|Overall Study||84
10588952|NCT01761279|11744850|FG000|NOT COMPLETED|Overall Study||0
10588953|NCT01761292|11744858|FG000|STARTED|Part 1||20
10588954|NCT01761292|11744858|FG000|Patients Receiving Drug in Part 1|Part 1|One patient was enrolled in Part 1 and started treatment in Part 2.|19
10588955|NCT01761292|11744858|FG000|COMPLETED|Part 1||18
10588956|NCT01761292|11744858|FG000|NOT COMPLETED|Part 1||2
10588957|NCT01761292|11744858|FG000|STARTED|Part 2|1 pt was enrolled in Part 1 but started the treatment in Part 2. So 19 pts started Part 2.|19
10588958|NCT01761292|11744858|FG000|COMPLETED|Part 2||19
10588959|NCT01761292|11744858|FG000|NOT COMPLETED|Part 2||0
10588960|NCT01761292|11744858|FG000|STARTED|Extension 1||19
10588961|NCT01761292|11744858|FG000|COMPLETED|Extension 1||18
10588962|NCT01761292|11744858|FG000|NOT COMPLETED|Extension 1||1
10588963|NCT01761292|11744858|FG000|STARTED|Extension 2||18
10588964|NCT01761292|11744858|FG000|COMPLETED|Extension 2||18
10588965|NCT01761292|11744858|FG000|NOT COMPLETED|Extension 2||0
10588966|NCT01761292|11744858|FG000|STARTED|Extension 3||18
10588967|NCT01761292|11744858|FG000|COMPLETED|Extension 3||18
10588968|NCT01761292|11744858|FG000|NOT COMPLETED|Extension 3||0
10588969|NCT01761565|11744869|FG000|STARTED|Single Dose of SUF NT 15 mcg||40
10588970|NCT01761565|11744869|FG000|COMPLETED|Single Dose of SUF NT 15 mcg||40
10588971|NCT01761565|11744869|FG000|NOT COMPLETED|Single Dose of SUF NT 15 mcg||0
10588972|NCT01761565|11744869|FG000|STARTED|40 Consecutive Doses of SUF 15 mcg|Subject was withdrawn from the study prior to the second arm/period due to non-compliance|39
10588973|NCT01761565|11744869|FG000|COMPLETED|40 Consecutive Doses of SUF 15 mcg||38
10588974|NCT01761565|11744869|FG000|NOT COMPLETED|40 Consecutive Doses of SUF 15 mcg||1
10588975|NCT01761643|11744879|FG000|STARTED|Overall Study||198
10588976|NCT01761643|11744880|FG001|STARTED|Overall Study||200
10588977|NCT01761643|11744879|FG000|COMPLETED|Overall Study||166
10588978|NCT01761643|11744880|FG001|COMPLETED|Overall Study||158
10588979|NCT01761643|11744879|FG000|NOT COMPLETED|Overall Study||32
10588980|NCT01761643|11744880|FG001|NOT COMPLETED|Overall Study||42
10588981|NCT01761747|11744886|FG000|STARTED|Overall Study||3
10588982|NCT01761747|11744886|FG000|COMPLETED|Overall Study||2
10588983|NCT01761747|11744886|FG000|NOT COMPLETED|Overall Study||1
10588984|NCT01762059|11744890|FG000|STARTED|Overall Study||20
10588985|NCT01762059|11744890|FG000|COMPLETED|Overall Study||20
10588986|NCT01762059|11744890|FG000|NOT COMPLETED|Overall Study||0
10588987|NCT01762345|11744899|FG000|STARTED|Overall Study||83
10588988|NCT01762345|11744899|FG000|COMPLETED|Overall Study||76
10588989|NCT01762345|11744899|FG000|NOT COMPLETED|Overall Study||7
10588990|NCT01762501|11744906|FG000|STARTED|Overall Study||359
10588991|NCT01762501|11744907|FG001|STARTED|Overall Study||359
10588992|NCT01762501|11744906|FG000|COMPLETED|Overall Study||332
10588993|NCT01762501|11744907|FG001|COMPLETED|Overall Study||336
10588994|NCT01762501|11744906|FG000|NOT COMPLETED|Overall Study||27
10588995|NCT01762501|11744907|FG001|NOT COMPLETED|Overall Study||23
10588996|NCT01762631|11744915|FG000|STARTED|Overall Study||53
10588997|NCT01762631|11744916|FG001|STARTED|Overall Study||22
10588998|NCT01762631|11744915|FG000|COMPLETED|Overall Study||53
10588999|NCT01762631|11744916|FG001|COMPLETED|Overall Study||22
10589000|NCT01762631|11744915|FG000|NOT COMPLETED|Overall Study||0
10589001|NCT01762631|11744916|FG001|NOT COMPLETED|Overall Study||0
10589002|NCT01762722|11744924|FG000|STARTED|Overall Study||12
10589003|NCT01762722|11744925|FG001|STARTED|Overall Study||11
10589004|NCT01762722|11744924|FG000|COMPLETED|Overall Study||12
10589005|NCT01762722|11744925|FG001|COMPLETED|Overall Study||11
10589006|NCT01762722|11744924|FG000|NOT COMPLETED|Overall Study||0
10589007|NCT01762722|11744925|FG001|NOT COMPLETED|Overall Study||0
10589008|NCT01762800|11744933|FG000|STARTED|Overall Study||202
10589009|NCT01762800|11744934|FG001|STARTED|Overall Study||204
10589010|NCT01762800|11744933|FG000|COMPLETED|Overall Study||183
10589011|NCT01762800|11744934|FG001|COMPLETED|Overall Study||183
10589012|NCT01762800|11744933|FG000|NOT COMPLETED|Overall Study||19
10589013|NCT01762800|11744934|FG001|NOT COMPLETED|Overall Study||21
10589014|NCT01762904|11744946|FG000|STARTED|Overall Study|January, 2013|135
10589015|NCT01762904|11744946|FG000|COMPLETED|Overall Study|October, 2013|135
10589016|NCT01762904|11744946|FG000|NOT COMPLETED|Overall Study||0
10589017|NCT01762943|11744955|FG000|STARTED|Overall Study||19
10589018|NCT01762943|11744956|FG001|STARTED|Overall Study||17
10589019|NCT01762943|11744955|FG000|Hypogonadism|Overall Study||18
10589020|NCT01762943|11744956|FG001|Hypogonadism|Overall Study||15
10589021|NCT01762943|11744955|FG000|Addback|Overall Study||16
10589022|NCT01762943|11744956|FG001|Addback|Overall Study||15
10589023|NCT01762943|11744955|FG000|Withdrawal|Overall Study||15
10589024|NCT01762943|11744956|FG001|Withdrawal|Overall Study||15
10589025|NCT01762943|11744955|FG000|COMPLETED|Overall Study||15
10589026|NCT01762943|11744956|FG001|COMPLETED|Overall Study||15
10589027|NCT01762943|11744955|FG000|NOT COMPLETED|Overall Study||4
10589028|NCT01762943|11744956|FG001|NOT COMPLETED|Overall Study||2
10589029|NCT01762982|11744962|FG000|STARTED|Overall Study||36
10589030|NCT01762982|11744962|FG000|Received Saline Water|Overall Study||36
10589031|NCT01762982|11744962|FG000|Received Benzalkonium Chloride|Overall Study||36
10589032|NCT01762982|11744962|FG000|Received SLS|Overall Study||36
10589033|NCT01762982|11744962|FG000|Received Empty Finn Chamber|Overall Study||36
10589034|NCT01762982|11744962|FG000|COMPLETED|Overall Study||36
10589035|NCT01762982|11744962|FG000|NOT COMPLETED|Overall Study||0
10589036|NCT01763047|11744972|FG000|STARTED|Period 1||139
10589037|NCT01763047|11744973|FG001|STARTED|Period 1||137
10589038|NCT01763047|11744972|FG000|Myopes|Period 1||77
10589039|NCT01763047|11744973|FG001|Myopes|Period 1||76
10589040|NCT01763047|11744972|FG000|Hyperopes|Period 1||62
10589041|NCT01763047|11744973|FG001|Hyperopes|Period 1||61
10589042|NCT01763047|11744972|FG000|COMPLETED|Period 1||130
10589043|NCT01763047|11744973|FG001|COMPLETED|Period 1||126
10589044|NCT01763047|11744972|FG000|NOT COMPLETED|Period 1||9
10589045|NCT01763047|11744973|FG001|NOT COMPLETED|Period 1||11
10589046|NCT01763047|11744972|FG000|STARTED|Period 2||130
10589047|NCT01763047|11744973|FG001|STARTED|Period 2||126
10589048|NCT01763047|11744972|FG000|Myopes|Period 2||74
10589049|NCT01763047|11744973|FG001|Myopes|Period 2||72
10589050|NCT01763047|11744972|FG000|Hyperopes|Period 2||56
10589051|NCT01763047|11744973|FG001|Hyperopes|Period 2||54
10589052|NCT01763047|11744972|FG000|COMPLETED|Period 2||126
10589053|NCT01763047|11744973|FG001|COMPLETED|Period 2||121
10589054|NCT01763047|11744972|FG000|NOT COMPLETED|Period 2||4
10589055|NCT01763047|11744973|FG001|NOT COMPLETED|Period 2||5
10589056|NCT01763164|11744984|FG000|STARTED|Treatment Phase||269
10589057|NCT01763164|11744985|FG001|STARTED|Treatment Phase||133
10589058|NCT01763164|11744984|FG000|Treated/Safety Set|Treatment Phase||269
10589059|NCT01763164|11744985|FG001|Treated/Safety Set|Treatment Phase||114
10589060|NCT01763164|11744984|FG000|Full Analysis Set|Treatment Phase||269
10589061|NCT01763164|11744985|FG001|Full Analysis Set|Treatment Phase||133
10589062|NCT01763164|11744984|FG000|COMPLETED|Treatment Phase||0
10589063|NCT01763164|11744985|FG001|COMPLETED|Treatment Phase||0
10589064|NCT01763164|11744984|FG000|NOT COMPLETED|Treatment Phase||269
10589065|NCT01763164|11744985|FG001|NOT COMPLETED|Treatment Phase||133
10589066|NCT01763164|11744984|FG000|STARTED|Follow up Phase|Participants were followed up after completion or discontinuation of treatment.|200
10589067|NCT01763164|11744985|FG001|STARTED|Follow up Phase|Participants were followed up after completion or discontinuation of treatment.|78
10589068|NCT01763164|11744984|FG000|COMPLETED|Follow up Phase||3
10589069|NCT01763164|11744985|FG001|COMPLETED|Follow up Phase||3
10589070|NCT01763164|11744984|FG000|NOT COMPLETED|Follow up Phase||197
10589071|NCT01763164|11744985|FG001|NOT COMPLETED|Follow up Phase||75
10589072|NCT01763203|11744993|FG000|STARTED|Overall Study||241
10589073|NCT01763203|11744994|FG001|STARTED|Overall Study||246
10589074|NCT01763203|11744993|FG000|COMPLETED|Overall Study||208
10589075|NCT01763203|11744994|FG001|COMPLETED|Overall Study||204
10589076|NCT01763203|11744993|FG000|NOT COMPLETED|Overall Study||33
10589077|NCT01763203|11744994|FG001|NOT COMPLETED|Overall Study||42
10589078|NCT01763333|11745014|FG000|STARTED|Overall Study||6
10589079|NCT01763333|11745015|FG001|STARTED|Overall Study||6
10589080|NCT01763333|11745016|FG002|STARTED|Overall Study||6
10589081|NCT01763333|11745017|FG003|STARTED|Overall Study||6
10589082|NCT01763333|11745018|FG004|STARTED|Overall Study||4
10589083|NCT01763333|11745019|FG005|STARTED|Overall Study||6
10589084|NCT01763333|11745020|FG006|STARTED|Overall Study||5
10589085|NCT01763333|11745021|FG007|STARTED|Overall Study||6
10589086|NCT01763333|11745022|FG008|STARTED|Overall Study||5
10589087|NCT01763333|11745023|FG009|STARTED|Overall Study||18
10589088|NCT01763333|11745024|FG010|STARTED|Overall Study||3
10589089|NCT01763333|11745025|FG011|STARTED|Overall Study||3
10589090|NCT01763333|11745026|FG012|STARTED|Overall Study||3
10589091|NCT01763333|11745027|FG013|STARTED|Overall Study||3
10589092|NCT01763333|11745014|FG000|COMPLETED|Overall Study||6
10589093|NCT01763333|11745015|FG001|COMPLETED|Overall Study||6
10589094|NCT01763333|11745016|FG002|COMPLETED|Overall Study||6
10589095|NCT01763333|11745017|FG003|COMPLETED|Overall Study||6
10589096|NCT01763333|11745018|FG004|COMPLETED|Overall Study||4
10589097|NCT01763333|11745019|FG005|COMPLETED|Overall Study||6
10589098|NCT01763333|11745020|FG006|COMPLETED|Overall Study||5
10589099|NCT01763333|11745021|FG007|COMPLETED|Overall Study||6
10589100|NCT01763333|11745022|FG008|COMPLETED|Overall Study||5
10589101|NCT01763333|11745023|FG009|COMPLETED|Overall Study||18
10589102|NCT01763333|11745024|FG010|COMPLETED|Overall Study||3
10703402|NCT02584257|11867895|FG007|NOT COMPLETED|Period 5||0
10589103|NCT01763333|11745025|FG011|COMPLETED|Overall Study||3
10589104|NCT01763333|11745026|FG012|COMPLETED|Overall Study||3
10589105|NCT01763333|11745027|FG013|COMPLETED|Overall Study||3
10589106|NCT01763333|11745014|FG000|NOT COMPLETED|Overall Study||0
10589107|NCT01763333|11745015|FG001|NOT COMPLETED|Overall Study||0
10589108|NCT01763333|11745016|FG002|NOT COMPLETED|Overall Study||0
10589109|NCT01763333|11745017|FG003|NOT COMPLETED|Overall Study||0
10589110|NCT01763333|11745018|FG004|NOT COMPLETED|Overall Study||0
10589111|NCT01763333|11745019|FG005|NOT COMPLETED|Overall Study||0
10589112|NCT01763333|11745020|FG006|NOT COMPLETED|Overall Study||0
10589113|NCT01763333|11745021|FG007|NOT COMPLETED|Overall Study||0
10589114|NCT01763333|11745022|FG008|NOT COMPLETED|Overall Study||0
10589115|NCT01763333|11745023|FG009|NOT COMPLETED|Overall Study||0
10589116|NCT01763333|11745024|FG010|NOT COMPLETED|Overall Study||0
10589117|NCT01763333|11745025|FG011|NOT COMPLETED|Overall Study||0
10589118|NCT01763333|11745026|FG012|NOT COMPLETED|Overall Study||0
10589119|NCT01763333|11745027|FG013|NOT COMPLETED|Overall Study||0
10589120|NCT01763346|11745063|FG000|STARTED|Overall Study|"Five subjects who enrolled in the study refused to initiate metformin therapy, thus did not start"|44
10589121|NCT01763346|11745064|FG001|STARTED|Overall Study|"Six subjects randomized to gastric banding refused the banding surgery and, thus, did not start"|44
10589122|NCT01763346|11745063|FG000|Received Intervention|Overall Study||39
10589123|NCT01763346|11745064|FG001|Received Intervention|Overall Study||38
10589124|NCT01763346|11745063|FG000|COMPLETED|Overall Study||34
10589125|NCT01763346|11745064|FG001|COMPLETED|Overall Study||36
10589126|NCT01763346|11745063|FG000|NOT COMPLETED|Overall Study||10
10589127|NCT01763346|11745064|FG001|NOT COMPLETED|Overall Study||8
10589128|NCT01763567|11745070|FG000|STARTED|Overall Study||19
10589129|NCT01763567|11745070|FG000|COMPLETED|Overall Study||19
10589130|NCT01763567|11745070|FG000|NOT COMPLETED|Overall Study||0
10589131|NCT01763606|11745076|FG000|STARTED|Overall Study||10
10589132|NCT01763606|11745077|FG001|STARTED|Overall Study||10
10589133|NCT01763606|11745076|FG000|COMPLETED|Overall Study||10
10589134|NCT01763606|11745077|FG001|COMPLETED|Overall Study||10
10589135|NCT01763606|11745076|FG000|NOT COMPLETED|Overall Study||0
10589136|NCT01763606|11745077|FG001|NOT COMPLETED|Overall Study||0
10589137|NCT01763645|11745086|FG000|STARTED|Overall Study||69
10589138|NCT01763645|11745087|FG001|STARTED|Overall Study||69
10589139|NCT01763645|11745086|FG000|Received at Least 1 Dose of Study Drug|Overall Study||68
10589140|NCT01763645|11745087|FG001|Received at Least 1 Dose of Study Drug|Overall Study||66
10589141|NCT01763645|11745086|FG000|COMPLETED|Overall Study|Completed the study according the protocol.|43
10589142|NCT01763645|11745087|FG001|COMPLETED|Overall Study|Completed the study according the protocol.|45
10589143|NCT01763645|11745086|FG000|NOT COMPLETED|Overall Study||26
10589144|NCT01763645|11745087|FG001|NOT COMPLETED|Overall Study||24
10589145|NCT01763684|11745096|FG000|STARTED|Overall Study||133
10589146|NCT01763684|11745097|FG001|STARTED|Overall Study||133
10589147|NCT01763684|11745096|FG000|Completed Surgery|Overall Study||126
10589148|NCT01763684|11745097|FG001|Completed Surgery|Overall Study||127
10589149|NCT01763684|11745096|FG000|COMPLETED|Overall Study||0
10589150|NCT01763684|11745097|FG001|COMPLETED|Overall Study||0
10589151|NCT01763684|11745096|FG000|NOT COMPLETED|Overall Study||133
10589152|NCT01763684|11745097|FG001|NOT COMPLETED|Overall Study||133
10651969|NCT02180165|11812258|FG001|Type of Aspergillosis|Overall Study|Chronic Pulmonary Aspergillosis|7
10651970|NCT02180165|11812259|FG002|Type of Aspergillosis|Overall Study|Invasive Aspergillosis and Chronic Pulmonary Aspergillosis|57
10651971|NCT02180165|11812260|FG003|Type of Aspergillosis|Overall Study|Invasive Aspergillosis and Chronic Pulmonary Aspergillosis|27
10651972|NCT02180165|11812257|FG000|COMPLETED|Overall Study||4
10651973|NCT02180165|11812258|FG001|COMPLETED|Overall Study||6
10651974|NCT02180165|11812259|FG002|COMPLETED|Overall Study||34
10651975|NCT02180165|11812260|FG003|COMPLETED|Overall Study||25
10651976|NCT02180165|11812257|FG000|NOT COMPLETED|Overall Study||11
10651977|NCT02180165|11812258|FG001|NOT COMPLETED|Overall Study||1
10651978|NCT02180165|11812259|FG002|NOT COMPLETED|Overall Study||29
10651979|NCT02180165|11812260|FG003|NOT COMPLETED|Overall Study||6
10651980|NCT02180230|11812272|FG000|STARTED|Overall Study||38
10651981|NCT02180230|11812272|FG000|COMPLETED|Overall Study||31
10651982|NCT02180230|11812272|FG000|NOT COMPLETED|Overall Study||7
10651983|NCT02180438|11812276|FG000|STARTED|Overall Study||30
10651984|NCT02180438|11812276|FG000|COMPLETED|Overall Study||29
10651985|NCT02180438|11812276|FG000|NOT COMPLETED|Overall Study||1
10651986|NCT02180646|11812282|FG000|STARTED|First Intervention (7 Days)||6
10651987|NCT02180646|11812283|FG001|STARTED|First Intervention (7 Days)||6
10651988|NCT02180646|11812282|FG000|COMPLETED|First Intervention (7 Days)||6
10651989|NCT02180646|11812283|FG001|COMPLETED|First Intervention (7 Days)||6
10651990|NCT02180646|11812282|FG000|NOT COMPLETED|First Intervention (7 Days)||0
10651991|NCT02180646|11812283|FG001|NOT COMPLETED|First Intervention (7 Days)||0
10651992|NCT02180646|11812282|FG000|STARTED|Washout (7 Days)||6
10651993|NCT02180646|11812283|FG001|STARTED|Washout (7 Days)||6
10589153|NCT01763827|11745109|FG000|STARTED|Overall Study||77
10589154|NCT01763827|11745110|FG001|STARTED|Overall Study||78
10589155|NCT01763827|11745111|FG002|STARTED|Overall Study||77
10589156|NCT01763827|11745112|FG003|STARTED|Overall Study||77
10589157|NCT01763827|11745113|FG004|STARTED|Overall Study||153
10589158|NCT01763827|11745114|FG005|STARTED|Overall Study||153
10589159|NCT01763827|11745109|FG000|Received at Least 1 Dose of Study Drug|Overall Study||76
10589160|NCT01763827|11745110|FG001|Received at Least 1 Dose of Study Drug|Overall Study||78
10589161|NCT01763827|11745111|FG002|Received at Least 1 Dose of Study Drug|Overall Study||77
10589162|NCT01763827|11745112|FG003|Received at Least 1 Dose of Study Drug|Overall Study||77
10589163|NCT01763827|11745113|FG004|Received at Least 1 Dose of Study Drug|Overall Study||153
10589164|NCT01763827|11745114|FG005|Received at Least 1 Dose of Study Drug|Overall Study||153
10589165|NCT01763827|11745109|FG000|COMPLETED|Overall Study||74
10589166|NCT01763827|11745110|FG001|COMPLETED|Overall Study||77
10589167|NCT01763827|11745111|FG002|COMPLETED|Overall Study||73
10589168|NCT01763827|11745112|FG003|COMPLETED|Overall Study||76
10589169|NCT01763827|11745113|FG004|COMPLETED|Overall Study||147
10589170|NCT01763827|11745114|FG005|COMPLETED|Overall Study||151
10589171|NCT01763827|11745109|FG000|NOT COMPLETED|Overall Study||3
10589172|NCT01763827|11745110|FG001|NOT COMPLETED|Overall Study||1
10589173|NCT01763827|11745111|FG002|NOT COMPLETED|Overall Study||4
10589174|NCT01763827|11745112|FG003|NOT COMPLETED|Overall Study||1
10589175|NCT01763827|11745113|FG004|NOT COMPLETED|Overall Study||6
10589176|NCT01763827|11745114|FG005|NOT COMPLETED|Overall Study||2
10589177|NCT01763866|11745152|FG000|STARTED|Overall Study||56
10589178|NCT01763866|11745153|FG001|STARTED|Overall Study||55
10589179|NCT01763866|11745154|FG002|STARTED|Overall Study||56
10589180|NCT01763866|11745155|FG003|STARTED|Overall Study||55
10589181|NCT01763866|11745156|FG004|STARTED|Overall Study||110
10589182|NCT01763866|11745157|FG005|STARTED|Overall Study||110
10589183|NCT01763866|11745158|FG006|STARTED|Overall Study||55
10589184|NCT01763866|11745159|FG007|STARTED|Overall Study||55
10589185|NCT01763866|11745160|FG008|STARTED|Overall Study||56
10589186|NCT01763866|11745161|FG009|STARTED|Overall Study||54
10589187|NCT01763866|11745162|FG010|STARTED|Overall Study||110
10589188|NCT01763866|11745163|FG011|STARTED|Overall Study||110
10589189|NCT01763866|11745164|FG012|STARTED|Overall Study||58
10589190|NCT01763866|11745165|FG013|STARTED|Overall Study||57
10589191|NCT01763866|11745166|FG014|STARTED|Overall Study||114
10589192|NCT01763866|11745167|FG015|STARTED|Overall Study||115
10589193|NCT01763866|11745168|FG016|STARTED|Overall Study||56
10589194|NCT01763866|11745169|FG017|STARTED|Overall Study||56
10589195|NCT01763866|11745170|FG018|STARTED|Overall Study||111
10589196|NCT01763866|11745171|FG019|STARTED|Overall Study||112
10589197|NCT01763866|11745172|FG020|STARTED|Overall Study||56
10589198|NCT01763866|11745173|FG021|STARTED|Overall Study||55
10589199|NCT01763866|11745174|FG022|STARTED|Overall Study||112
10589200|NCT01763866|11745175|FG023|STARTED|Overall Study||115
10589201|NCT01763866|11745152|FG000|Received Treatment|Overall Study||56
10589202|NCT01763866|11745153|FG001|Received Treatment|Overall Study||55
10589203|NCT01763866|11745154|FG002|Received Treatment|Overall Study||56
10589204|NCT01763866|11745155|FG003|Received Treatment|Overall Study||55
10589205|NCT01763866|11745156|FG004|Received Treatment|Overall Study||110
10589206|NCT01763866|11745157|FG005|Received Treatment|Overall Study||110
10589207|NCT01763866|11745158|FG006|Received Treatment|Overall Study||55
10589208|NCT01763866|11745159|FG007|Received Treatment|Overall Study||55
10589209|NCT01763866|11745160|FG008|Received Treatment|Overall Study||56
10589210|NCT01763866|11745161|FG009|Received Treatment|Overall Study||54
10589211|NCT01763866|11745162|FG010|Received Treatment|Overall Study||109
10589212|NCT01763866|11745163|FG011|Received Treatment|Overall Study||110
10589213|NCT01763866|11745164|FG012|Received Treatment|Overall Study||58
10589214|NCT01763866|11745165|FG013|Received Treatment|Overall Study||57
10589215|NCT01763866|11745166|FG014|Received Treatment|Overall Study||113
10589216|NCT01763866|11745167|FG015|Received Treatment|Overall Study||115
10589217|NCT01763866|11745168|FG016|Received Treatment|Overall Study||56
10589218|NCT01763866|11745169|FG017|Received Treatment|Overall Study||55
10589219|NCT01763866|11745170|FG018|Received Treatment|Overall Study||111
10589220|NCT01763866|11745171|FG019|Received Treatment|Overall Study||112
10589221|NCT01763866|11745172|FG020|Received Treatment|Overall Study||56
10589222|NCT01763866|11745173|FG021|Received Treatment|Overall Study||55
10589223|NCT01763866|11745174|FG022|Received Treatment|Overall Study||112
10589224|NCT01763866|11745175|FG023|Received Treatment|Overall Study||115
10589225|NCT01763866|11745152|FG000|COMPLETED|Overall Study||54
10589226|NCT01763866|11745153|FG001|COMPLETED|Overall Study||54
10589227|NCT01763866|11745154|FG002|COMPLETED|Overall Study||51
10589228|NCT01763866|11745155|FG003|COMPLETED|Overall Study||55
10589229|NCT01763866|11745156|FG004|COMPLETED|Overall Study||108
10589230|NCT01763866|11745157|FG005|COMPLETED|Overall Study||107
10589231|NCT01763866|11745158|FG006|COMPLETED|Overall Study||48
10589232|NCT01763866|11745159|FG007|COMPLETED|Overall Study||55
10589233|NCT01763866|11745160|FG008|COMPLETED|Overall Study||53
10589234|NCT01763866|11745161|FG009|COMPLETED|Overall Study||53
10589235|NCT01763866|11745162|FG010|COMPLETED|Overall Study||102
10589236|NCT01763866|11745163|FG011|COMPLETED|Overall Study||108
10589237|NCT01763866|11745164|FG012|COMPLETED|Overall Study||54
10589238|NCT01763866|11745165|FG013|COMPLETED|Overall Study||57
10589239|NCT01763866|11745166|FG014|COMPLETED|Overall Study||102
10589240|NCT01763866|11745167|FG015|COMPLETED|Overall Study||112
10589241|NCT01763866|11745168|FG016|COMPLETED|Overall Study||55
10589242|NCT01763866|11745169|FG017|COMPLETED|Overall Study||55
10589243|NCT01763866|11745170|FG018|COMPLETED|Overall Study||105
10589244|NCT01763866|11745171|FG019|COMPLETED|Overall Study||110
10589245|NCT01763866|11745172|FG020|COMPLETED|Overall Study||52
10589246|NCT01763866|11745173|FG021|COMPLETED|Overall Study||54
10703403|NCT02584257|11867896|FG008|NOT COMPLETED|Period 5||0
10703404|NCT02584452|11867910|FG000|STARTED|Overall Study||34
10703405|NCT02584452|11867911|FG001|STARTED|Overall Study||23
10703406|NCT02584452|11867910|FG000|COMPLETED|Overall Study||32
10703407|NCT02584452|11867911|FG001|COMPLETED|Overall Study||21
10703408|NCT02584452|11867910|FG000|NOT COMPLETED|Overall Study||2
10703409|NCT02584452|11867911|FG001|NOT COMPLETED|Overall Study||2
10703410|NCT02584504|11867921|FG000|STARTED|Double-blind Treatment|Randomized|54
10703411|NCT02584504|11867922|FG001|STARTED|Double-blind Treatment|Randomized|53
10703412|NCT02584504|11867923|FG002|STARTED|Double-blind Treatment|Randomized|56
10703413|NCT02584504|11867921|FG000|ITT Population|Double-blind Treatment||54
10703414|NCT02584504|11867922|FG001|ITT Population|Double-blind Treatment||53
10589247|NCT01763866|11745174|FG022|COMPLETED|Overall Study||109
10589248|NCT01763866|11745175|FG023|COMPLETED|Overall Study||113
10589249|NCT01763866|11745152|FG000|NOT COMPLETED|Overall Study||2
10589250|NCT01763866|11745153|FG001|NOT COMPLETED|Overall Study||1
10589251|NCT01763866|11745154|FG002|NOT COMPLETED|Overall Study||5
10589252|NCT01763866|11745155|FG003|NOT COMPLETED|Overall Study||0
10589253|NCT01763866|11745156|FG004|NOT COMPLETED|Overall Study||2
10589254|NCT01763866|11745157|FG005|NOT COMPLETED|Overall Study||3
10589255|NCT01763866|11745158|FG006|NOT COMPLETED|Overall Study||7
10589256|NCT01763866|11745159|FG007|NOT COMPLETED|Overall Study||0
10589257|NCT01763866|11745160|FG008|NOT COMPLETED|Overall Study||3
10589258|NCT01763866|11745161|FG009|NOT COMPLETED|Overall Study||1
10589259|NCT01763866|11745162|FG010|NOT COMPLETED|Overall Study||8
10589260|NCT01763866|11745163|FG011|NOT COMPLETED|Overall Study||2
10589261|NCT01763866|11745164|FG012|NOT COMPLETED|Overall Study||4
10589262|NCT01763866|11745165|FG013|NOT COMPLETED|Overall Study||0
10589263|NCT01763866|11745166|FG014|NOT COMPLETED|Overall Study||12
10589264|NCT01763866|11745167|FG015|NOT COMPLETED|Overall Study||3
10589265|NCT01763866|11745168|FG016|NOT COMPLETED|Overall Study||1
10589266|NCT01763866|11745169|FG017|NOT COMPLETED|Overall Study||1
10589267|NCT01763866|11745170|FG018|NOT COMPLETED|Overall Study||6
10589268|NCT01763866|11745171|FG019|NOT COMPLETED|Overall Study||2
10589269|NCT01763866|11745172|FG020|NOT COMPLETED|Overall Study||4
10589270|NCT01763866|11745173|FG021|NOT COMPLETED|Overall Study||1
10589271|NCT01763866|11745174|FG022|NOT COMPLETED|Overall Study||3
10589272|NCT01763866|11745175|FG023|NOT COMPLETED|Overall Study||2
10589273|NCT01763905|11745229|FG000|STARTED|Overall Study||51
10589274|NCT01763905|11745230|FG001|STARTED|Overall Study||51
10589275|NCT01763905|11745231|FG002|STARTED|Overall Study||103
10589276|NCT01763905|11745232|FG003|STARTED|Overall Study||102
10589277|NCT01763905|11745229|FG000|COMPLETED|Overall Study||45
10589278|NCT01763905|11745230|FG001|COMPLETED|Overall Study||50
10589279|NCT01763905|11745231|FG002|COMPLETED|Overall Study||94
10589280|NCT01763905|11745232|FG003|COMPLETED|Overall Study||101
10589281|NCT01763905|11745229|FG000|NOT COMPLETED|Overall Study||6
10589282|NCT01763905|11745230|FG001|NOT COMPLETED|Overall Study||1
10589283|NCT01763905|11745231|FG002|NOT COMPLETED|Overall Study||9
10589284|NCT01763905|11745232|FG003|NOT COMPLETED|Overall Study||1
10589285|NCT01763918|11745246|FG000|STARTED|Overall Study||55
10589286|NCT01763918|11745247|FG001|STARTED|Overall Study||55
10589287|NCT01763918|11745248|FG002|STARTED|Overall Study||111
10589288|NCT01763918|11745249|FG003|STARTED|Overall Study||110
10589289|NCT01763918|11745246|FG000|Received Treatment|Overall Study||54
10589290|NCT01763918|11745247|FG001|Received Treatment|Overall Study||55
10589291|NCT01763918|11745248|FG002|Received Treatment|Overall Study||110
10589292|NCT01763918|11745249|FG003|Received Treatment|Overall Study||110
10589293|NCT01763918|11745246|FG000|COMPLETED|Overall Study||49
10589294|NCT01763918|11745247|FG001|COMPLETED|Overall Study||54
10589295|NCT01763918|11745248|FG002|COMPLETED|Overall Study||101
10589296|NCT01763918|11745249|FG003|COMPLETED|Overall Study||108
10589297|NCT01763918|11745246|FG000|NOT COMPLETED|Overall Study||6
10589298|NCT01763918|11745247|FG001|NOT COMPLETED|Overall Study||1
10589299|NCT01763918|11745248|FG002|NOT COMPLETED|Overall Study||10
10589300|NCT01763918|11745249|FG003|NOT COMPLETED|Overall Study||2
10589301|NCT01763931|11745261|FG000|STARTED|Overall Study||2
10589302|NCT01763931|11745262|FG001|STARTED|Overall Study||4
10589303|NCT01763931|11745261|FG000|COMPLETED|Overall Study||2
10589304|NCT01763931|11745262|FG001|COMPLETED|Overall Study||3
10589305|NCT01763931|11745261|FG000|NOT COMPLETED|Overall Study||0
10589306|NCT01763931|11745262|FG001|NOT COMPLETED|Overall Study||1
10589307|NCT01763970|11745268|FG000|STARTED|Overall Study||14
10589308|NCT01763970|11745268|FG000|COMPLETED|Overall Study||14
10589309|NCT01763970|11745268|FG000|NOT COMPLETED|Overall Study||0
10703415|NCT02584504|11867923|FG002|ITT Population|Double-blind Treatment||56
10703416|NCT02584504|11867921|FG000|mITT Population|Double-blind Treatment||54
10703417|NCT02584504|11867922|FG001|mITT Population|Double-blind Treatment||53
10703418|NCT02584504|11867923|FG002|mITT Population|Double-blind Treatment||56
10589310|NCT01763996|11745275|FG000|STARTED|Treatment Period 1||15
10589311|NCT01763996|11745276|FG001|STARTED|Treatment Period 1||15
10589312|NCT01763996|11745275|FG000|COMPLETED|Treatment Period 1||15
10589313|NCT01763996|11745276|FG001|COMPLETED|Treatment Period 1||15
10589314|NCT01763996|11745275|FG000|NOT COMPLETED|Treatment Period 1||0
10589315|NCT01763996|11745276|FG001|NOT COMPLETED|Treatment Period 1||0
10589316|NCT01763996|11745275|FG000|STARTED|Treatment Period 2||15
10589317|NCT01763996|11745276|FG001|STARTED|Treatment Period 2||15
10703419|NCT02584504|11867921|FG000|Safety Population|Double-blind Treatment||54
10703420|NCT02584504|11867922|FG001|Safety Population|Double-blind Treatment||53
10589318|NCT01763996|11745275|FG000|COMPLETED|Treatment Period 2||15
10589319|NCT01763996|11745276|FG001|COMPLETED|Treatment Period 2||14
10589320|NCT01763996|11745275|FG000|NOT COMPLETED|Treatment Period 2||0
10589321|NCT01763996|11745276|FG001|NOT COMPLETED|Treatment Period 2||1
10589322|NCT01764022|11745284|FG000|STARTED|Overall Study||115
10589323|NCT01764022|11745285|FG001|STARTED|Overall Study||110
10589324|NCT01764022|11745284|FG000|Received at Least 1 Dose of Study Drug|Overall Study||113
10589325|NCT01764022|11745285|FG001|Received at Least 1 Dose of Study Drug|Overall Study||110
10589326|NCT01764022|11745284|FG000|COMPLETED|Overall Study||107
10589327|NCT01764022|11745285|FG001|COMPLETED|Overall Study||96
10589328|NCT01764022|11745284|FG000|NOT COMPLETED|Overall Study||8
10589329|NCT01764022|11745285|FG001|NOT COMPLETED|Overall Study||14
10589330|NCT01764256|11745297|FG000|STARTED|Received All Vaccinations||12
10589331|NCT01764256|11745298|FG001|STARTED|Received All Vaccinations||12
10589332|NCT01764256|11745299|FG002|STARTED|Received All Vaccinations||12
10589333|NCT01764256|11745300|FG003|STARTED|Received All Vaccinations||12
10589334|NCT01764256|11745297|FG000|COMPLETED|Received All Vaccinations||10
10589335|NCT01764256|11745298|FG001|COMPLETED|Received All Vaccinations||11
10589336|NCT01764256|11745299|FG002|COMPLETED|Received All Vaccinations||11
10589337|NCT01764256|11745300|FG003|COMPLETED|Received All Vaccinations||12
10589338|NCT01764256|11745297|FG000|NOT COMPLETED|Received All Vaccinations||2
10589339|NCT01764256|11745298|FG001|NOT COMPLETED|Received All Vaccinations||1
10589340|NCT01764256|11745299|FG002|NOT COMPLETED|Received All Vaccinations||1
10589341|NCT01764256|11745300|FG003|NOT COMPLETED|Received All Vaccinations||0
10589342|NCT01764256|11745297|FG000|STARTED|Completed Study||10
10589343|NCT01764256|11745298|FG001|STARTED|Completed Study||11
10589344|NCT01764256|11745299|FG002|STARTED|Completed Study||11
10589345|NCT01764256|11745300|FG003|STARTED|Completed Study||12
10589346|NCT01764256|11745297|FG000|COMPLETED|Completed Study||10
10589347|NCT01764256|11745298|FG001|COMPLETED|Completed Study||11
10589348|NCT01764256|11745299|FG002|COMPLETED|Completed Study||11
10589349|NCT01764256|11745300|FG003|COMPLETED|Completed Study||11
10589350|NCT01764256|11745297|FG000|NOT COMPLETED|Completed Study||0
10589351|NCT01764256|11745298|FG001|NOT COMPLETED|Completed Study||0
10589352|NCT01764256|11745299|FG002|NOT COMPLETED|Completed Study||0
10589353|NCT01764256|11745300|FG003|NOT COMPLETED|Completed Study||1
10589354|NCT01764386|11745316|FG000|STARTED|Controlled Treatment Period (CTP)||153
10589355|NCT01764386|11745317|FG001|STARTED|Controlled Treatment Period (CTP)||89
10589356|NCT01764386|11745316|FG000|COMPLETED|Controlled Treatment Period (CTP)|Completed the 26-week Controlled Treatment Period.|71
10589357|NCT01764386|11745317|FG001|COMPLETED|Controlled Treatment Period (CTP)|Completed the 26-week Controlled Treatment Period.|82
10589358|NCT01764386|11745316|FG000|NOT COMPLETED|Controlled Treatment Period (CTP)||82
10589359|NCT01764386|11745317|FG001|NOT COMPLETED|Controlled Treatment Period (CTP)||7
10589360|NCT01764386|11745316|FG000|STARTED|Uncontrolled Treatment Period (UTP)||71
10589361|NCT01764386|11745317|FG001|STARTED|Uncontrolled Treatment Period (UTP)|One subject completed the 26-week CTP, but did not continue in the UTP.|81
10589362|NCT01764386|11745316|FG000|Completed 52 Weeks|Uncontrolled Treatment Period (UTP)||61
10589363|NCT01764386|11745317|FG001|Completed 52 Weeks|Uncontrolled Treatment Period (UTP)||35
10589364|NCT01764386|11745316|FG000|COMPLETED|Uncontrolled Treatment Period (UTP)|Completed the 78-week study.|55
10589365|NCT01764386|11745317|FG001|COMPLETED|Uncontrolled Treatment Period (UTP)|Completed the 78-week study.|28
10589366|NCT01764386|11745316|FG000|NOT COMPLETED|Uncontrolled Treatment Period (UTP)||16
10589367|NCT01764386|11745317|FG001|NOT COMPLETED|Uncontrolled Treatment Period (UTP)||53
10589368|NCT01764464|11745326|FG000|STARTED|First Intervention|Started Gralise|16
10589369|NCT01764464|11745327|FG001|STARTED|First Intervention|Started Placebo|16
10589370|NCT01764464|11745326|FG000|COMPLETED|First Intervention|Completed Gralise|14
10589371|NCT01764464|11745327|FG001|COMPLETED|First Intervention|Completed Placebo|13
10589372|NCT01764464|11745326|FG000|NOT COMPLETED|First Intervention||2
10589373|NCT01764464|11745327|FG001|NOT COMPLETED|First Intervention||3
10589374|NCT01764464|11745326|FG000|STARTED|Second Intervention (Cross-over)|Started Placebo|14
10589375|NCT01764464|11745327|FG001|STARTED|Second Intervention (Cross-over)|Started Gralise|13
10589376|NCT01764464|11745326|FG000|COMPLETED|Second Intervention (Cross-over)|Completed Placebo|12
10589377|NCT01764464|11745327|FG001|COMPLETED|Second Intervention (Cross-over)|Completed Gralise|13
10589378|NCT01764464|11745326|FG000|NOT COMPLETED|Second Intervention (Cross-over)||2
10589379|NCT01764464|11745327|FG001|NOT COMPLETED|Second Intervention (Cross-over)||0
10589380|NCT01764607|11745333|FG000|STARTED|Overall Study||1
10589381|NCT01764607|11745333|FG000|COMPLETED|Overall Study||1
10589382|NCT01764607|11745333|FG000|NOT COMPLETED|Overall Study||0
10703421|NCT02584504|11867923|FG002|Safety Population|Double-blind Treatment||56
10589391|NCT01764659|11745346|FG000|STARTED|Overall Study||14
10589392|NCT01764659|11745346|FG000|COMPLETED|Overall Study||12
10589393|NCT01764659|11745346|FG000|NOT COMPLETED|Overall Study||2
10589394|NCT01764685|11745354|FG000|STARTED|Overall Study||0
10589395|NCT01764685|11745355|FG001|STARTED|Overall Study||4
10589396|NCT01764685|11745354|FG000|COMPLETED|Overall Study||0
10589397|NCT01764685|11745355|FG001|COMPLETED|Overall Study||3
10589398|NCT01764685|11745354|FG000|NOT COMPLETED|Overall Study||0
10589399|NCT01764685|11745355|FG001|NOT COMPLETED|Overall Study||1
10589400|NCT01764841|11745365|FG000|STARTED|Overall Study||141
10589401|NCT01764841|11745366|FG001|STARTED|Overall Study||137
10589402|NCT01764841|11745367|FG002|STARTED|Overall Study||70
10589403|NCT01764841|11745368|FG003|STARTED|Overall Study||68
10589404|NCT01764841|11745365|FG000|Participants Received Treatment|Overall Study|safety population|141
10589405|NCT01764841|11745366|FG001|Participants Received Treatment|Overall Study|safety population|136
10589406|NCT01764841|11745367|FG002|Participants Received Treatment|Overall Study|safety population|69
10589407|NCT01764841|11745368|FG003|Participants Received Treatment|Overall Study|safety population|68
10589408|NCT01764841|11745365|FG000|COMPLETED|Overall Study||118
10589409|NCT01764841|11745366|FG001|COMPLETED|Overall Study||111
10589410|NCT01764841|11745367|FG002|COMPLETED|Overall Study||56
10589411|NCT01764841|11745368|FG003|COMPLETED|Overall Study||49
10589412|NCT01764841|11745365|FG000|NOT COMPLETED|Overall Study||23
10589413|NCT01764841|11745366|FG001|NOT COMPLETED|Overall Study||26
10589414|NCT01764841|11745367|FG002|NOT COMPLETED|Overall Study||14
10589415|NCT01764841|11745368|FG003|NOT COMPLETED|Overall Study||19
10589416|NCT01764854|11745382|FG000|STARTED|Overall Study||8
10589417|NCT01764854|11745383|FG001|STARTED|Overall Study||8
10589418|NCT01764854|11745384|FG002|STARTED|Overall Study||37
10589419|NCT01764854|11745385|FG003|STARTED|Overall Study||35
10807632|NCT03892564|11969353|FG000|MC2-01 Vehicle + Irridiation|Overall Study||35
10807633|NCT03892564|11969353|FG000|MC2-01 Vehicle + Non-irridiation|Overall Study||35
10807634|NCT03892564|11969353|FG000|Control Site|Overall Study||35
10807635|NCT03892564|11969353|FG000|COMPLETED|Overall Study||33
10807636|NCT03892564|11969353|FG000|NOT COMPLETED|Overall Study||2
10807637|NCT03892707|11969360|FG000|STARTED|Overall Study||250
10807638|NCT03892707|11969361|FG001|STARTED|Overall Study||250
10807639|NCT03892707|11969360|FG000|Started Study Treatment at Baseline|Overall Study||244
10807640|NCT03892707|11969361|FG001|Started Study Treatment at Baseline|Overall Study||250
10589420|NCT01764854|11745382|FG000|COMPLETED|Overall Study||8
10589421|NCT01764854|11745383|FG001|COMPLETED|Overall Study||8
10589422|NCT01764854|11745384|FG002|COMPLETED|Overall Study||31
10589423|NCT01764854|11745385|FG003|COMPLETED|Overall Study||33
10589424|NCT01764854|11745382|FG000|NOT COMPLETED|Overall Study||0
10589425|NCT01764854|11745383|FG001|NOT COMPLETED|Overall Study||0
10807641|NCT03892707|11969360|FG000|COMPLETED|Overall Study||244
10807642|NCT03892707|11969361|FG001|COMPLETED|Overall Study||244
10807643|NCT03892707|11969360|FG000|NOT COMPLETED|Overall Study||6
10807644|NCT03892707|11969361|FG001|NOT COMPLETED|Overall Study||6
10807645|NCT03892460|11969370|FG000|STARTED|Overall Study||30
10807646|NCT03892460|11969371|FG001|STARTED|Overall Study||24
10807647|NCT03892460|11969370|FG000|Randomization|Overall Study||25
10807648|NCT03892460|11969371|FG001|Randomization|Overall Study||20
10589426|NCT01764854|11745384|FG002|NOT COMPLETED|Overall Study||6
10589427|NCT01764854|11745385|FG003|NOT COMPLETED|Overall Study||2
10589428|NCT01764919|11745395|FG000|STARTED|Overall Study||4
10589429|NCT01764919|11745395|FG000|COMPLETED|Overall Study||4
10589430|NCT01764919|11745395|FG000|NOT COMPLETED|Overall Study||0
10589431|NCT01764945|11745407|FG000|STARTED|Overall Study||5
10589432|NCT01764945|11745408|FG001|STARTED|Overall Study||5
10589433|NCT01764945|11745409|FG002|STARTED|Overall Study||5
10589434|NCT01764945|11745410|FG003|STARTED|Overall Study||5
10589435|NCT01764945|11745411|FG004|STARTED|Overall Study||10
10589436|NCT01764945|11745412|FG005|STARTED|Overall Study||8
10589437|NCT01764945|11745413|FG006|STARTED|Overall Study||9
10589438|NCT01764945|11745414|FG007|STARTED|Overall Study||9
10589439|NCT01764945|11745407|FG000|COMPLETED|Overall Study||5
10589440|NCT01764945|11745408|FG001|COMPLETED|Overall Study||4
10589441|NCT01764945|11745409|FG002|COMPLETED|Overall Study||5
10589442|NCT01764945|11745410|FG003|COMPLETED|Overall Study||5
10589443|NCT01764945|11745411|FG004|COMPLETED|Overall Study||10
10589444|NCT01764945|11745412|FG005|COMPLETED|Overall Study||8
10589445|NCT01764945|11745413|FG006|COMPLETED|Overall Study||8
10589446|NCT01764945|11745414|FG007|COMPLETED|Overall Study||9
10589447|NCT01764945|11745407|FG000|NOT COMPLETED|Overall Study||0
10589448|NCT01764945|11745408|FG001|NOT COMPLETED|Overall Study||1
10589449|NCT01764945|11745409|FG002|NOT COMPLETED|Overall Study||0
10589450|NCT01764945|11745410|FG003|NOT COMPLETED|Overall Study||0
10589451|NCT01764945|11745411|FG004|NOT COMPLETED|Overall Study||0
10589452|NCT01764945|11745412|FG005|NOT COMPLETED|Overall Study||0
10807649|NCT03892460|11969370|FG000|COMPLETED|Overall Study||18
10807650|NCT03892460|11969371|FG001|COMPLETED|Overall Study||19
10807651|NCT03892460|11969370|FG000|NOT COMPLETED|Overall Study||12
10807652|NCT03892460|11969371|FG001|NOT COMPLETED|Overall Study||5
10807653|NCT03891641|11969380|FG000|STARTED|Overall Study||10
10589453|NCT01764945|11745413|FG006|NOT COMPLETED|Overall Study||1
10589454|NCT01764945|11745414|FG007|NOT COMPLETED|Overall Study||0
10589455|NCT01765153|11745434|FG000|STARTED|Training Phase 1||10
10589456|NCT01765153|11745435|FG001|STARTED|Training Phase 1||11
10589457|NCT01765153|11745434|FG000|COMPLETED|Training Phase 1||9
10589458|NCT01765153|11745435|FG001|COMPLETED|Training Phase 1||10
10807654|NCT03891641|11969381|FG001|STARTED|Overall Study||7
10589459|NCT01765153|11745434|FG000|NOT COMPLETED|Training Phase 1||1
10589460|NCT01765153|11745435|FG001|NOT COMPLETED|Training Phase 1||1
10589461|NCT01765153|11745434|FG000|STARTED|Rest Phase 1||9
10589462|NCT01765153|11745435|FG001|STARTED|Rest Phase 1||10
10589463|NCT01765153|11745434|FG000|COMPLETED|Rest Phase 1||9
10589464|NCT01765153|11745435|FG001|COMPLETED|Rest Phase 1||9
10589465|NCT01765153|11745434|FG000|NOT COMPLETED|Rest Phase 1||0
10589466|NCT01765153|11745435|FG001|NOT COMPLETED|Rest Phase 1||1
10589467|NCT01765153|11745434|FG000|STARTED|Training Phase 2|1st subject didn't use same training(phase 1) as subsequent participants Phase 1 and 2 data removed.|10
10589468|NCT01765153|11745435|FG001|STARTED|Training Phase 2||9
10589469|NCT01765153|11745434|FG000|COMPLETED|Training Phase 2||10
10589470|NCT01765153|11745435|FG001|COMPLETED|Training Phase 2||8
10589471|NCT01765153|11745434|FG000|NOT COMPLETED|Training Phase 2||0
10589472|NCT01765153|11745435|FG001|NOT COMPLETED|Training Phase 2||1
10589473|NCT01765153|11745434|FG000|STARTED|Rest Phase 2||10
10589474|NCT01765153|11745435|FG001|STARTED|Rest Phase 2||8
10589475|NCT01765153|11745434|FG000|COMPLETED|Rest Phase 2||8
10589476|NCT01765153|11745435|FG001|COMPLETED|Rest Phase 2||7
10589477|NCT01765153|11745434|FG000|NOT COMPLETED|Rest Phase 2||2
10589478|NCT01765153|11745435|FG001|NOT COMPLETED|Rest Phase 2||1
10589479|NCT01765179|11745445|FG000|STARTED|Overall Study||144
10589480|NCT01765179|11745445|FG000|COMPLETED|Overall Study||117
10589481|NCT01765179|11745445|FG000|NOT COMPLETED|Overall Study||27
10589482|NCT01765192|11745451|FG000|STARTED|Treatment Period 1||32
10589483|NCT01765192|11745452|FG001|STARTED|Treatment Period 1||32
10589484|NCT01765192|11745451|FG000|COMPLETED|Treatment Period 1||32
10589485|NCT01765192|11745452|FG001|COMPLETED|Treatment Period 1||31
10589486|NCT01765192|11745451|FG000|NOT COMPLETED|Treatment Period 1||0
10589487|NCT01765192|11745452|FG001|NOT COMPLETED|Treatment Period 1||1
10589488|NCT01765192|11745451|FG000|STARTED|Washout Period||32
10589489|NCT01765192|11745452|FG001|STARTED|Washout Period||31
10589490|NCT01765192|11745451|FG000|COMPLETED|Washout Period||30
10589491|NCT01765192|11745452|FG001|COMPLETED|Washout Period||30
10589492|NCT01765192|11745451|FG000|NOT COMPLETED|Washout Period||2
10589493|NCT01765192|11745452|FG001|NOT COMPLETED|Washout Period||1
10589494|NCT01765192|11745451|FG000|STARTED|Treatment Period 2||30
10589495|NCT01765192|11745452|FG001|STARTED|Treatment Period 2||30
10589496|NCT01765192|11745451|FG000|COMPLETED|Treatment Period 2||30
10589497|NCT01765192|11745452|FG001|COMPLETED|Treatment Period 2||28
10589498|NCT01765192|11745451|FG000|NOT COMPLETED|Treatment Period 2||0
10589499|NCT01765192|11745452|FG001|NOT COMPLETED|Treatment Period 2||2
10589500|NCT01765192|11745451|FG000|STARTED|End of Treatment Period 2 to Final Visit||30
10589501|NCT01765192|11745452|FG001|STARTED|End of Treatment Period 2 to Final Visit||28
10589502|NCT01765192|11745451|FG000|COMPLETED|End of Treatment Period 2 to Final Visit||30
10589503|NCT01765192|11745452|FG001|COMPLETED|End of Treatment Period 2 to Final Visit||27
10589504|NCT01765192|11745451|FG000|NOT COMPLETED|End of Treatment Period 2 to Final Visit||0
10589505|NCT01765192|11745452|FG001|NOT COMPLETED|End of Treatment Period 2 to Final Visit||1
10589506|NCT01765270|11745460|FG000|STARTED|Overall Study||5
10589507|NCT01765270|11745461|FG001|STARTED|Overall Study||7
10589508|NCT01765270|11745460|FG000|COMPLETED|Overall Study||4
10589509|NCT01765270|11745461|FG001|COMPLETED|Overall Study||6
10589510|NCT01765270|11745460|FG000|NOT COMPLETED|Overall Study||1
10589511|NCT01765270|11745461|FG001|NOT COMPLETED|Overall Study||1
10589512|NCT01765426|11745472|FG000|STARTED|Overall Study||18
10589513|NCT01765426|11745473|FG001|STARTED|Overall Study||17
10589514|NCT01765426|11745474|FG002|STARTED|Overall Study||17
10589515|NCT01765426|11745475|FG003|STARTED|Overall Study||15
10589516|NCT01765426|11745472|FG000|Completed All Vaccinations|Overall Study||17
10589517|NCT01765426|11745473|FG001|Completed All Vaccinations|Overall Study||16
10589518|NCT01765426|11745474|FG002|Completed All Vaccinations|Overall Study||17
10589519|NCT01765426|11745475|FG003|Completed All Vaccinations|Overall Study||15
10589520|NCT01765426|11745472|FG000|COMPLETED|Overall Study||18
10589521|NCT01765426|11745473|FG001|COMPLETED|Overall Study||16
10589522|NCT01765426|11745474|FG002|COMPLETED|Overall Study||17
10589523|NCT01765426|11745475|FG003|COMPLETED|Overall Study||15
10589524|NCT01765426|11745472|FG000|NOT COMPLETED|Overall Study||0
10589525|NCT01765426|11745473|FG001|NOT COMPLETED|Overall Study||1
10589526|NCT01765426|11745474|FG002|NOT COMPLETED|Overall Study||0
10589527|NCT01765426|11745475|FG003|NOT COMPLETED|Overall Study||0
10589528|NCT01765465|11745487|FG000|STARTED|Overall Study||71
10589529|NCT01765465|11745488|FG001|STARTED|Overall Study||67
10589530|NCT01765465|11745487|FG000|COMPLETED|Overall Study||64
10703422|NCT02584504|11867921|FG000|COMPLETED|Double-blind Treatment||54
10703423|NCT02584504|11867922|FG001|COMPLETED|Double-blind Treatment||51
10703424|NCT02584504|11867923|FG002|COMPLETED|Double-blind Treatment||55
10589531|NCT01765465|11745488|FG001|COMPLETED|Overall Study||63
10589532|NCT01765465|11745487|FG000|NOT COMPLETED|Overall Study||7
10589533|NCT01765465|11745488|FG001|NOT COMPLETED|Overall Study||4
10589534|NCT01765530|11745498|FG000|STARTED|Overall Study||37
10589535|NCT01765530|11745499|FG001|STARTED|Overall Study||37
10589536|NCT01765530|11745498|FG000|COMPLETED|Overall Study||36
10589537|NCT01765530|11745499|FG001|COMPLETED|Overall Study||36
10589538|NCT01765530|11745498|FG000|NOT COMPLETED|Overall Study||1
10589539|NCT01765530|11745499|FG001|NOT COMPLETED|Overall Study||1
10589540|NCT01765543|11745505|FG000|STARTED|Overall Study||27
10703425|NCT02584504|11867921|FG000|NOT COMPLETED|Double-blind Treatment||0
10589541|NCT01765543|11745505|FG000|COMPLETED|Overall Study||24
10589542|NCT01765543|11745505|FG000|NOT COMPLETED|Overall Study||3
10589543|NCT01765569|11745513|FG000|STARTED|Period A||29
10589544|NCT01765569|11745513|FG000|COMPLETED|Period A||29
10589545|NCT01765569|11745513|FG000|NOT COMPLETED|Period A||0
10589546|NCT01765569|11745513|FG000|STARTED|Period B||29
10589547|NCT01765569|11745513|FG000|COMPLETED|Period B||28
10589548|NCT01765569|11745513|FG000|NOT COMPLETED|Period B||1
10589549|NCT01765569|11745513|FG000|STARTED|Period C||28
10589550|NCT01765569|11745513|FG000|COMPLETED|Period C||27
10589551|NCT01765569|11745513|FG000|NOT COMPLETED|Period C||1
10589552|NCT01765582|11745523|FG000|STARTED|Overall Study||93
10589553|NCT01765582|11745524|FG001|STARTED|Overall Study||92
10589554|NCT01765582|11745525|FG002|STARTED|Overall Study||95
10589555|NCT01765582|11745523|FG000|COMPLETED|Overall Study||0
10589556|NCT01765582|11745524|FG001|COMPLETED|Overall Study||0
10589557|NCT01765582|11745525|FG002|COMPLETED|Overall Study||0
10589558|NCT01765582|11745523|FG000|NOT COMPLETED|Overall Study||93
10589559|NCT01765582|11745524|FG001|NOT COMPLETED|Overall Study||92
10589560|NCT01765582|11745525|FG002|NOT COMPLETED|Overall Study||95
10589561|NCT01765647|11745534|FG000|STARTED|Overall Study|One began the run-in period, but was withdrawn prior to beginning treatment with AGY|10
10589562|NCT01765647|11745534|FG000|COMPLETED|Overall Study|10 entered the AGY treatment phase and all 10 completed treatment.|10
10589563|NCT01765647|11745534|FG000|NOT COMPLETED|Overall Study||0
10589564|NCT01765673|11745538|FG000|STARTED|Overall Study||12
10589565|NCT01765673|11745538|FG000|COMPLETED|Overall Study||11
10589566|NCT01765673|11745538|FG000|NOT COMPLETED|Overall Study||1
10589567|NCT01765712|11745547|FG000|STARTED|Overall Study||27
10589568|NCT01765712|11745548|FG001|STARTED|Overall Study||23
10589569|NCT01765712|11745547|FG000|COMPLETED|Overall Study||27
10589570|NCT01765712|11745548|FG001|COMPLETED|Overall Study||23
10589571|NCT01765712|11745547|FG000|NOT COMPLETED|Overall Study||0
10589572|NCT01765712|11745548|FG001|NOT COMPLETED|Overall Study||0
10589573|NCT01765751|11745557|FG000|STARTED|Overall Study||16
10589574|NCT01765751|11745558|FG001|STARTED|Overall Study||16
10589575|NCT01765751|11745559|FG002|STARTED|Overall Study||16
10589576|NCT01765751|11745557|FG000|COMPLETED|Overall Study||16
10589577|NCT01765751|11745558|FG001|COMPLETED|Overall Study||14
10589578|NCT01765751|11745559|FG002|COMPLETED|Overall Study||15
10589579|NCT01765751|11745557|FG000|NOT COMPLETED|Overall Study||0
10589580|NCT01765751|11745558|FG001|NOT COMPLETED|Overall Study||2
10589581|NCT01765751|11745559|FG002|NOT COMPLETED|Overall Study||1
10589582|NCT01765764|11745573|FG000|STARTED|Treatment Period||118
10589583|NCT01765764|11745574|FG001|STARTED|Treatment Period||118
10589584|NCT01765764|11745575|FG002|STARTED|Treatment Period||121
10589585|NCT01765764|11745573|FG000|COMPLETED|Treatment Period||115
10589586|NCT01765764|11745574|FG001|COMPLETED|Treatment Period||109
10589587|NCT01765764|11745575|FG002|COMPLETED|Treatment Period||115
10589588|NCT01765764|11745573|FG000|NOT COMPLETED|Treatment Period||3
10589589|NCT01765764|11745574|FG001|NOT COMPLETED|Treatment Period||9
10589590|NCT01765764|11745575|FG002|NOT COMPLETED|Treatment Period||6
10589591|NCT01765764|11745573|FG000|STARTED|Post-treatment Period|1 participant did not enter the Post-treatment Period. [Personal Reasons]|114
10589592|NCT01765764|11745574|FG001|STARTED|Post-treatment Period|2 participants did not enter the Post-treatment Period [2 Lost-to-Follow-up (LFU)]|107
10589593|NCT01765764|11745575|FG002|STARTED|Post-treatment Period|3 participants did not enter the Post-treatment Period [1 Personal Reasons,2 LFU].|112
10589594|NCT01765764|11745573|FG000|COMPLETED|Post-treatment Period||114
10589595|NCT01765764|11745574|FG001|COMPLETED|Post-treatment Period||107
10589596|NCT01765764|11745575|FG002|COMPLETED|Post-treatment Period||112
10589597|NCT01765764|11745573|FG000|NOT COMPLETED|Post-treatment Period||0
10589598|NCT01765764|11745574|FG001|NOT COMPLETED|Post-treatment Period||0
10589599|NCT01765764|11745575|FG002|NOT COMPLETED|Post-treatment Period||0
10589600|NCT01765803|11745583|FG000|STARTED|Overall Study||6
10589601|NCT01765803|11745583|FG000|COMPLETED|Overall Study||6
10589602|NCT01765803|11745583|FG000|NOT COMPLETED|Overall Study||0
10589603|NCT01765920|11745589|FG000|STARTED|Overall Study||169
10589604|NCT01765920|11745590|FG001|STARTED|Overall Study||173
10589605|NCT01765920|11745589|FG000|COMPLETED|Overall Study||167
10589606|NCT01765920|11745590|FG001|COMPLETED|Overall Study||167
10589607|NCT01765920|11745589|FG000|NOT COMPLETED|Overall Study||2
10589608|NCT01765920|11745590|FG001|NOT COMPLETED|Overall Study||6
10589609|NCT01765972|11745596|FG000|STARTED|Overall Study||6
10589610|NCT01765972|11745597|FG001|STARTED|Overall Study||6
10589611|NCT01765972|11745598|FG002|STARTED|Overall Study||6
10589612|NCT01765972|11745599|FG003|STARTED|Overall Study||6
10589613|NCT01765972|11745596|FG000|COMPLETED|Overall Study||6
10589614|NCT01765972|11745597|FG001|COMPLETED|Overall Study||6
10589615|NCT01765972|11745598|FG002|COMPLETED|Overall Study||6
10589616|NCT01765972|11745599|FG003|COMPLETED|Overall Study||6
10589617|NCT01765972|11745596|FG000|NOT COMPLETED|Overall Study||0
10589618|NCT01765972|11745597|FG001|NOT COMPLETED|Overall Study||0
10589619|NCT01765972|11745598|FG002|NOT COMPLETED|Overall Study||0
10589620|NCT01765972|11745599|FG003|NOT COMPLETED|Overall Study||0
10589621|NCT01766024|11745611|FG000|STARTED|Overall Study||16
10589622|NCT01766024|11745612|FG001|STARTED|Overall Study||16
10589623|NCT01766024|11745611|FG000|COMPLETED|Overall Study||16
10589624|NCT01766024|11745612|FG001|COMPLETED|Overall Study||16
10589625|NCT01766024|11745611|FG000|NOT COMPLETED|Overall Study||0
10589626|NCT01766024|11745612|FG001|NOT COMPLETED|Overall Study||0
10589627|NCT01766037|11745622|FG000|STARTED|Overall Study||111
10589628|NCT01766037|11745623|FG001|STARTED|Overall Study||60
10589629|NCT01766037|11745622|FG000|COMPLETED|Overall Study||82
10589630|NCT01766037|11745623|FG001|COMPLETED|Overall Study||31
10589631|NCT01766037|11745622|FG000|NOT COMPLETED|Overall Study||29
10589632|NCT01766037|11745623|FG001|NOT COMPLETED|Overall Study||29
10589633|NCT01766050|11745629|FG000|STARTED|Overall Study||22
10589634|NCT01766050|11745629|FG000|COMPLETED|Overall Study||18
10589635|NCT01766050|11745629|FG000|NOT COMPLETED|Overall Study||4
10589636|NCT01766076|11745649|FG000|STARTED|Overall Study||15
10589637|NCT01766076|11745650|FG001|STARTED|Overall Study||15
10589638|NCT01766076|11745649|FG000|COMPLETED|Overall Study||15
10589639|NCT01766076|11745650|FG001|COMPLETED|Overall Study||15
10589640|NCT01766076|11745649|FG000|NOT COMPLETED|Overall Study||0
10589641|NCT01766076|11745650|FG001|NOT COMPLETED|Overall Study||0
10589642|NCT01766102|11745658|FG000|STARTED|Overall Study||36
10589643|NCT01766102|11745659|FG001|STARTED|Overall Study||36
10589644|NCT01766102|11745658|FG000|COMPLETED|Overall Study||36
10589645|NCT01766102|11745659|FG001|COMPLETED|Overall Study||36
10589646|NCT01766102|11745658|FG000|NOT COMPLETED|Overall Study||0
10589647|NCT01766102|11745659|FG001|NOT COMPLETED|Overall Study||0
10589648|NCT01766206|11745665|FG000|STARTED|Overall Study||3939
10589649|NCT01766206|11745665|FG000|COMPLETED|Overall Study||3888
10589650|NCT01766206|11745665|FG000|NOT COMPLETED|Overall Study||51
10589651|NCT01766219|11745672|FG000|STARTED|Overall Study||4
10589652|NCT01766219|11745673|FG001|STARTED|Overall Study||2
10589653|NCT01766219|11745674|FG002|STARTED|Overall Study||11
10703426|NCT02584504|11867922|FG001|NOT COMPLETED|Double-blind Treatment||2
10703427|NCT02584504|11867923|FG002|NOT COMPLETED|Double-blind Treatment||1
10703428|NCT02584504|11867921|FG000|STARTED|Open-label Treatment||54
10703429|NCT02584504|11867922|FG001|STARTED|Open-label Treatment||51
10589654|NCT01766219|11745672|FG000|COMPLETED|Overall Study||4
10589655|NCT01766219|11745673|FG001|COMPLETED|Overall Study||2
10589656|NCT01766219|11745674|FG002|COMPLETED|Overall Study||11
10589657|NCT01766219|11745672|FG000|NOT COMPLETED|Overall Study||0
10589658|NCT01766219|11745673|FG001|NOT COMPLETED|Overall Study||0
10589659|NCT01766219|11745674|FG002|NOT COMPLETED|Overall Study||0
10589660|NCT01766310|11745685|FG000|STARTED|Overall Study||24
10589661|NCT01766310|11745686|FG001|STARTED|Overall Study||26
10589662|NCT01766310|11745685|FG000|COMPLETED|Overall Study||23
10589663|NCT01766310|11745686|FG001|COMPLETED|Overall Study||23
10589664|NCT01766310|11745685|FG000|NOT COMPLETED|Overall Study||1
10589665|NCT01766310|11745686|FG001|NOT COMPLETED|Overall Study||3
10589666|NCT01766336|11745694|FG000|STARTED|Overall Study||150
10589667|NCT01766336|11745695|FG001|STARTED|Overall Study||146
10589668|NCT01766336|11745694|FG000|COMPLETED|Overall Study||60
10589669|NCT01766336|11745695|FG001|COMPLETED|Overall Study||71
10589670|NCT01766336|11745694|FG000|NOT COMPLETED|Overall Study||90
10589671|NCT01766336|11745695|FG001|NOT COMPLETED|Overall Study||75
10589672|NCT01766401|11745703|FG000|STARTED|Overall Study||198
10589673|NCT01766401|11745704|FG001|STARTED|Overall Study||200
10589674|NCT01766401|11745703|FG000|COMPLETED|Overall Study||161
10589675|NCT01766401|11745704|FG001|COMPLETED|Overall Study||144
10589676|NCT01766401|11745703|FG000|NOT COMPLETED|Overall Study||37
10589677|NCT01766401|11745704|FG001|NOT COMPLETED|Overall Study||56
10589678|NCT01766440|11745710|FG000|STARTED|Overall Study||18
10589679|NCT01766440|11745710|FG000|COMPLETED|Overall Study||17
10589680|NCT01766440|11745710|FG000|NOT COMPLETED|Overall Study||1
10589681|NCT01766466|11745716|FG000|STARTED|Day 1||6
10589682|NCT01766466|11745717|FG001|STARTED|Day 1||0
10589683|NCT01766466|11745718|FG002|STARTED|Day 1||6
10589684|NCT01766466|11745719|FG003|STARTED|Day 1||0
10589685|NCT01766466|11745716|FG000|COMPLETED|Day 1||6
10589686|NCT01766466|11745717|FG001|COMPLETED|Day 1||0
10589687|NCT01766466|11745718|FG002|COMPLETED|Day 1||6
10589688|NCT01766466|11745719|FG003|COMPLETED|Day 1||0
10589689|NCT01766466|11745716|FG000|NOT COMPLETED|Day 1||0
10589690|NCT01766466|11745717|FG001|NOT COMPLETED|Day 1||0
10589691|NCT01766466|11745718|FG002|NOT COMPLETED|Day 1||0
10589692|NCT01766466|11745719|FG003|NOT COMPLETED|Day 1||0
10589693|NCT01766466|11745716|FG000|STARTED|Day 5||0
10589694|NCT01766466|11745717|FG001|STARTED|Day 5||6
10589695|NCT01766466|11745718|FG002|STARTED|Day 5||0
10589696|NCT01766466|11745719|FG003|STARTED|Day 5||6
10589697|NCT01766466|11745716|FG000|COMPLETED|Day 5||0
10589698|NCT01766466|11745717|FG001|COMPLETED|Day 5||6
10589699|NCT01766466|11745718|FG002|COMPLETED|Day 5||0
10589700|NCT01766466|11745719|FG003|COMPLETED|Day 5||6
10589701|NCT01766466|11745716|FG000|NOT COMPLETED|Day 5||0
10589702|NCT01766466|11745717|FG001|NOT COMPLETED|Day 5||0
10589703|NCT01766466|11745718|FG002|NOT COMPLETED|Day 5||0
10589704|NCT01766466|11745719|FG003|NOT COMPLETED|Day 5||0
10589705|NCT01766713|11745730|FG000|STARTED|Overall Study||25
10589706|NCT01766713|11745731|FG001|STARTED|Overall Study||25
10589707|NCT01766713|11745730|FG000|COMPLETED|Overall Study||23
10589708|NCT01766713|11745731|FG001|COMPLETED|Overall Study||22
10589709|NCT01766713|11745730|FG000|NOT COMPLETED|Overall Study||2
10589710|NCT01766713|11745731|FG001|NOT COMPLETED|Overall Study||3
10589711|NCT01766778|11745739|FG000|STARTED|Overall Study|Intent to treat population|56
10589712|NCT01766778|11745740|FG001|STARTED|Overall Study||61
10589713|NCT01766778|11745739|FG000|COMPLETED|Overall Study||51
10589714|NCT01766778|11745740|FG001|COMPLETED|Overall Study||57
10589715|NCT01766778|11745739|FG000|NOT COMPLETED|Overall Study||5
10589716|NCT01766778|11745740|FG001|NOT COMPLETED|Overall Study||4
10589717|NCT01766817|11745749|FG000|STARTED|Overall Study||48
10589718|NCT01766817|11745750|FG001|STARTED|Overall Study||48
10589719|NCT01766817|11745751|FG002|STARTED|Overall Study||47
10589720|NCT01766817|11745749|FG000|COMPLETED|Overall Study||37
10589721|NCT01766817|11745750|FG001|COMPLETED|Overall Study||37
10589722|NCT01766817|11745751|FG002|COMPLETED|Overall Study||34
10589723|NCT01766817|11745749|FG000|NOT COMPLETED|Overall Study||11
10589724|NCT01766817|11745750|FG001|NOT COMPLETED|Overall Study||11
10589725|NCT01766817|11745751|FG002|NOT COMPLETED|Overall Study||13
10589726|NCT01766921|11745761|FG000|STARTED|Overall Study||700
10589727|NCT01766921|11745762|FG001|STARTED|Overall Study||693
10589728|NCT01766921|11745761|FG000|COMPLETED|Overall Study||676
10589729|NCT01766921|11745762|FG001|COMPLETED|Overall Study||676
10589730|NCT01766921|11745761|FG000|NOT COMPLETED|Overall Study||24
10589731|NCT01766921|11745762|FG001|NOT COMPLETED|Overall Study||17
10589732|NCT01766986|11745772|FG000|STARTED|Overall Study||41
10589733|NCT01766986|11745773|FG001|STARTED|Overall Study||51
10589734|NCT01766986|11745774|FG002|STARTED|Overall Study||38
10589735|NCT01766986|11745772|FG000|COMPLETED|Overall Study||41
10589736|NCT01766986|11745773|FG001|COMPLETED|Overall Study||51
10589737|NCT01766986|11745774|FG002|COMPLETED|Overall Study||38
10589738|NCT01766986|11745772|FG000|NOT COMPLETED|Overall Study||0
10589739|NCT01766986|11745773|FG001|NOT COMPLETED|Overall Study||0
10589740|NCT01766986|11745774|FG002|NOT COMPLETED|Overall Study||0
10589741|NCT01767064|11745784|FG000|STARTED|Overall Study||7
10589742|NCT01767064|11745785|FG001|STARTED|Overall Study||7
10589743|NCT01767064|11745784|FG000|COMPLETED|Overall Study||7
10589744|NCT01767064|11745785|FG001|COMPLETED|Overall Study||7
10589745|NCT01767064|11745784|FG000|NOT COMPLETED|Overall Study||0
10589746|NCT01767064|11745785|FG001|NOT COMPLETED|Overall Study||0
10589747|NCT01767103|11745794|FG000|STARTED|Overall Study||7
10589748|NCT01767103|11745795|FG001|STARTED|Overall Study||7
10589749|NCT01767103|11745796|FG002|STARTED|Overall Study||7
10589750|NCT01767103|11745794|FG000|COMPLETED|Overall Study||7
10589751|NCT01767103|11745795|FG001|COMPLETED|Overall Study||7
10589752|NCT01767103|11745796|FG002|COMPLETED|Overall Study||7
10589753|NCT01767103|11745794|FG000|NOT COMPLETED|Overall Study||0
10589754|NCT01767103|11745795|FG001|NOT COMPLETED|Overall Study||0
10589755|NCT01767103|11745796|FG002|NOT COMPLETED|Overall Study||0
10589756|NCT01767116|11745807|FG000|STARTED|Overall Study||210
10589757|NCT01767116|11745808|FG001|STARTED|Overall Study||209
10589758|NCT01767116|11745807|FG000|COMPLETED|Overall Study||208
10589759|NCT01767116|11745808|FG001|COMPLETED|Overall Study||207
10589760|NCT01767116|11745807|FG000|NOT COMPLETED|Overall Study||2
10589761|NCT01767116|11745808|FG001|NOT COMPLETED|Overall Study||2
10589762|NCT01767142|11745814|FG000|STARTED|Overall Study|Each subject was treated on a single thigh. therefore the number of units is 40.|40
10589763|NCT01767142|11745814|FG000|COMPLETED|Overall Study||37
10589764|NCT01767142|11745814|FG000|NOT COMPLETED|Overall Study||3
10589765|NCT01767155|11745820|FG000|STARTED|Overall Study|Patients allocated to AEZS-108|256
10589766|NCT01767155|11745821|FG001|STARTED|Overall Study|Patients allocated to doxorubicin|255
10589767|NCT01767155|11745820|FG000|Modified ITT (mITT)|Overall Study||252
10589768|NCT01767155|11745821|FG001|Modified ITT (mITT)|Overall Study||249
10589769|NCT01767155|11745820|FG000|Safety Population (SAF)|Overall Study||252
10589770|NCT01767155|11745821|FG001|Safety Population (SAF)|Overall Study||249
10589771|NCT01767155|11745820|FG000|COMPLETED|Overall Study||243
10589772|NCT01767155|11745821|FG001|COMPLETED|Overall Study||240
10589773|NCT01767155|11745820|FG000|NOT COMPLETED|Overall Study||13
10589774|NCT01767155|11745821|FG001|NOT COMPLETED|Overall Study||15
10589775|NCT01767285|11745829|FG000|STARTED|Overall Study||29
10589776|NCT01767285|11745830|FG001|STARTED|Overall Study||30
10589777|NCT01767285|11745829|FG000|COMPLETED|Overall Study||22
10589778|NCT01767285|11745830|FG001|COMPLETED|Overall Study||24
10589779|NCT01767285|11745829|FG000|NOT COMPLETED|Overall Study||7
10589780|NCT01767285|11745830|FG001|NOT COMPLETED|Overall Study||6
10589781|NCT01767376|11745839|FG000|STARTED|Overall Study||231
10589782|NCT01767376|11745840|FG001|STARTED|Overall Study||228
10589783|NCT01767376|11745841|FG002|STARTED|Overall Study||232
10589784|NCT01767376|11745839|FG000|COMPLETED|Overall Study||227
10807655|NCT03891641|11969380|FG000|COMPLETED|Overall Study||8
10807656|NCT03891641|11969381|FG001|COMPLETED|Overall Study||5
10807657|NCT03891641|11969380|FG000|NOT COMPLETED|Overall Study||2
10807658|NCT03891641|11969381|FG001|NOT COMPLETED|Overall Study||2
10807659|NCT03889704|11969387|FG000|STARTED|Overall Study||2
10589785|NCT01767376|11745840|FG001|COMPLETED|Overall Study||225
10589786|NCT01767376|11745841|FG002|COMPLETED|Overall Study||232
10589787|NCT01767376|11745839|FG000|NOT COMPLETED|Overall Study||4
10589788|NCT01767376|11745840|FG001|NOT COMPLETED|Overall Study||3
10589789|NCT01767376|11745841|FG002|NOT COMPLETED|Overall Study||0
10589790|NCT01767415|11745851|FG000|STARTED|Overall Study||10
10589791|NCT01767415|11745851|FG000|COMPLETED|Overall Study||10
10589792|NCT01767415|11745851|FG000|NOT COMPLETED|Overall Study||0
10589793|NCT01767467|11745857|FG000|STARTED|Vaccination Phase (up to Month 2)||283
10589794|NCT01767467|11745858|FG001|STARTED|Vaccination Phase (up to Month 2)||279
10589795|NCT01767467|11745857|FG000|COMPLETED|Vaccination Phase (up to Month 2)||266
10589796|NCT01767467|11745858|FG001|COMPLETED|Vaccination Phase (up to Month 2)||259
10589797|NCT01767467|11745857|FG000|NOT COMPLETED|Vaccination Phase (up to Month 2)||17
10589798|NCT01767467|11745858|FG001|NOT COMPLETED|Vaccination Phase (up to Month 2)||20
10589799|NCT01767467|11745857|FG000|STARTED|End of Study Phase (up to Month 13)||283
10589800|NCT01767467|11745858|FG001|STARTED|End of Study Phase (up to Month 13)||279
10807660|NCT03889704|11969387|FG000|COMPLETED|Overall Study||1
10589801|NCT01767467|11745857|FG000|COMPLETED|End of Study Phase (up to Month 13)||236
10589802|NCT01767467|11745858|FG001|COMPLETED|End of Study Phase (up to Month 13)||216
10589803|NCT01767467|11745857|FG000|NOT COMPLETED|End of Study Phase (up to Month 13)||47
10589804|NCT01767467|11745858|FG001|NOT COMPLETED|End of Study Phase (up to Month 13)||63
10589805|NCT01767493|11745871|FG000|STARTED|Overall Study||19
10589806|NCT01767493|11745871|FG000|COMPLETED|Overall Study||16
10589807|NCT01767493|11745871|FG000|NOT COMPLETED|Overall Study||3
10589808|NCT01767506|11745877|FG000|STARTED|Overall Study|"26 communities were randomized to intervention group~The study was conducted at the community level."|
10589809|NCT01767506|11745878|FG001|STARTED|Overall Study|"26 communities were randomized to control group~The study was conducted at the community level."|
10589810|NCT01767506|11745877|FG000|COMPLETED|Overall Study|The study was conducted at the community level.|
10589811|NCT01767506|11745878|FG001|COMPLETED|Overall Study|The study was conducted at the community level.|
10589812|NCT01767506|11745877|FG000|NOT COMPLETED|Overall Study||
10589813|NCT01767506|11745878|FG001|NOT COMPLETED|Overall Study||
10589814|NCT01767519|11745887|FG000|STARTED|Overall Study||145
10589815|NCT01767519|11745888|FG001|STARTED|Overall Study||151
10589816|NCT01767519|11745889|FG002|STARTED|Overall Study||60
10589817|NCT01767519|11745887|FG000|COMPLETED|Overall Study||131
10589818|NCT01767519|11745888|FG001|COMPLETED|Overall Study||138
10589819|NCT01767519|11745889|FG002|COMPLETED|Overall Study||55
10589820|NCT01767519|11745887|FG000|NOT COMPLETED|Overall Study||14
10589821|NCT01767519|11745888|FG001|NOT COMPLETED|Overall Study||13
10589822|NCT01767519|11745889|FG002|NOT COMPLETED|Overall Study||5
10589823|NCT01767597|11745899|FG000|STARTED|Overall Study||500
10589824|NCT01767597|11745900|FG001|STARTED|Overall Study||500
10589825|NCT01767597|11745899|FG000|COMPLETED|Overall Study||496
10589826|NCT01767597|11745900|FG001|COMPLETED|Overall Study||499
10589827|NCT01767597|11745899|FG000|NOT COMPLETED|Overall Study||4
10589828|NCT01767597|11745900|FG001|NOT COMPLETED|Overall Study||1
10589829|NCT01767636|11745906|FG000|STARTED|Overall Study||38
10589830|NCT01767636|11745906|FG000|COMPLETED|Overall Study||35
10589831|NCT01767636|11745906|FG000|NOT COMPLETED|Overall Study||3
10589832|NCT01767688|11745912|FG000|STARTED|Overall Study||8
10589833|NCT01767688|11745913|FG001|STARTED|Overall Study||8
10589834|NCT01767688|11745912|FG000|COMPLETED|Overall Study||8
10589835|NCT01767688|11745913|FG001|COMPLETED|Overall Study||8
10589836|NCT01767688|11745912|FG000|NOT COMPLETED|Overall Study||0
10589837|NCT01767688|11745913|FG001|NOT COMPLETED|Overall Study||0
10589838|NCT01767701|11745919|FG000|STARTED|Overall Study|All 20 patients who entered the treatment phase completed the six months trial period.|20
10589839|NCT01767701|11745919|FG000|COMPLETED|Overall Study||20
10589840|NCT01767701|11745919|FG000|NOT COMPLETED|Overall Study||0
10589841|NCT01767792|11745924|FG000|STARTED|Overall Study||22
10589842|NCT01767792|11745924|FG000|COMPLETED|Overall Study||20
10589843|NCT01767792|11745924|FG000|NOT COMPLETED|Overall Study||2
10589844|NCT01767857|11745931|FG000|STARTED|Overall Study||430
10589845|NCT01767857|11745932|FG001|STARTED|Overall Study||213
10589846|NCT01767857|11745931|FG000|Treated|Overall Study||411
10589847|NCT01767857|11745932|FG001|Treated|Overall Study||200
10589848|NCT01767857|11745931|FG000|COMPLETED|Overall Study||0
10589849|NCT01767857|11745932|FG001|COMPLETED|Overall Study||0
10589850|NCT01767857|11745931|FG000|NOT COMPLETED|Overall Study||430
10589851|NCT01767857|11745932|FG001|NOT COMPLETED|Overall Study||213
10589852|NCT01767909|11745941|FG000|STARTED|Overall Study||121
10589853|NCT01767909|11745942|FG001|STARTED|Overall Study||119
10589854|NCT01767909|11745941|FG000|COMPLETED|Overall Study||108
10589855|NCT01767909|11745942|FG001|COMPLETED|Overall Study||107
10589856|NCT01767909|11745941|FG000|NOT COMPLETED|Overall Study||13
10589857|NCT01767909|11745942|FG001|NOT COMPLETED|Overall Study||12
10589858|NCT01767935|11745950|FG000|STARTED|Overall Study||1
10589859|NCT01767935|11745950|FG000|COMPLETED|Overall Study||1
10589860|NCT01767935|11745950|FG000|NOT COMPLETED|Overall Study||0
10589861|NCT01767987|11745956|FG000|STARTED|Overall Study||4
10589862|NCT01767987|11745957|FG001|STARTED|Overall Study||2
10703430|NCT02584504|11867923|FG002|STARTED|Open-label Treatment||55
10703431|NCT02584504|11867921|FG000|Treated|Open-label Treatment||54
10703432|NCT02584504|11867922|FG001|Treated|Open-label Treatment||50
10703433|NCT02584504|11867923|FG002|Treated|Open-label Treatment||54
10589863|NCT01767987|11745956|FG000|COMPLETED|Overall Study||0
10589864|NCT01767987|11745957|FG001|COMPLETED|Overall Study||1
10589865|NCT01767987|11745956|FG000|NOT COMPLETED|Overall Study||4
10589866|NCT01767987|11745957|FG001|NOT COMPLETED|Overall Study||1
10589867|NCT01768000|11745967|FG000|STARTED|Overall Study||10
10589868|NCT01768000|11745968|FG001|STARTED|Overall Study||10
10589869|NCT01768000|11745969|FG002|STARTED|Overall Study||10
10589870|NCT01768000|11745970|FG003|STARTED|Overall Study||10
10589871|NCT01768000|11745967|FG000|COMPLETED|Overall Study||9
10589872|NCT01768000|11745968|FG001|COMPLETED|Overall Study||8
10703434|NCT02584504|11867921|FG000|COMPLETED|Open-label Treatment||52
10589873|NCT01768000|11745969|FG002|COMPLETED|Overall Study||9
10589874|NCT01768000|11745970|FG003|COMPLETED|Overall Study||8
10589875|NCT01768000|11745967|FG000|NOT COMPLETED|Overall Study||1
10589876|NCT01768000|11745968|FG001|NOT COMPLETED|Overall Study||2
10589877|NCT01768000|11745969|FG002|NOT COMPLETED|Overall Study||1
10589878|NCT01768000|11745970|FG003|NOT COMPLETED|Overall Study||2
10589879|NCT01768013|11745982|FG000|STARTED|Overall Study||13
10589880|NCT01768013|11745982|FG000|COMPLETED|Overall Study||13
10589881|NCT01768013|11745982|FG000|NOT COMPLETED|Overall Study||0
10589882|NCT01768117|11745986|FG000|STARTED|Overall Study||13
10703435|NCT02584504|11867922|FG001|COMPLETED|Open-label Treatment||47
10589883|NCT01768117|11745986|FG000|COMPLETED|Overall Study||7
10589884|NCT01768117|11745986|FG000|NOT COMPLETED|Overall Study||6
10589885|NCT01768286|11745994|FG000|STARTED|Overall Study||109
10589886|NCT01768286|11745995|FG001|STARTED|Overall Study||111
10589887|NCT01768286|11745996|FG002|STARTED|Overall Study||110
10589888|NCT01768286|11745997|FG003|STARTED|Overall Study||111
10589889|NCT01768286|11745994|FG000|COMPLETED|Overall Study||102
10589890|NCT01768286|11745995|FG001|COMPLETED|Overall Study||107
10589891|NCT01768286|11745996|FG002|COMPLETED|Overall Study||108
10589892|NCT01768286|11745997|FG003|COMPLETED|Overall Study||110
10589893|NCT01768286|11745994|FG000|NOT COMPLETED|Overall Study||7
10589894|NCT01768286|11745995|FG001|NOT COMPLETED|Overall Study||4
10589895|NCT01768286|11745996|FG002|NOT COMPLETED|Overall Study||2
10589896|NCT01768286|11745997|FG003|NOT COMPLETED|Overall Study||1
10589897|NCT01768325|11746009|FG000|STARTED|Overall Study||37
10589898|NCT01768325|11746010|FG001|STARTED|Overall Study||41
10589899|NCT01768325|11746009|FG000|COMPLETED|Overall Study||37
10589900|NCT01768325|11746010|FG001|COMPLETED|Overall Study||41
10589901|NCT01768325|11746009|FG000|NOT COMPLETED|Overall Study||0
10589902|NCT01768325|11746010|FG001|NOT COMPLETED|Overall Study||0
10589903|NCT01768520|11746021|FG000|STARTED|Overall Study||152
10589904|NCT01768520|11746022|FG001|STARTED|Overall Study||147
10589905|NCT01768520|11746023|FG002|STARTED|Overall Study||39
10589906|NCT01768520|11746021|FG000|COMPLETED|Overall Study||120
10589907|NCT01768520|11746022|FG001|COMPLETED|Overall Study||121
10589908|NCT01768520|11746023|FG002|COMPLETED|Overall Study||30
10589909|NCT01768520|11746021|FG000|NOT COMPLETED|Overall Study||32
10589910|NCT01768520|11746022|FG001|NOT COMPLETED|Overall Study||26
10589911|NCT01768520|11746023|FG002|NOT COMPLETED|Overall Study||9
10589912|NCT01768559|11746034|FG000|STARTED|Overall Study||298
10589913|NCT01768559|11746035|FG001|STARTED|Overall Study||298
10589914|NCT01768559|11746036|FG002|STARTED|Overall Study||298
10589915|NCT01768559|11746034|FG000|Treated|Overall Study||298
10589916|NCT01768559|11746035|FG001|Treated|Overall Study|1 participant received Insulin Glulisine TID (for more than 50%)|298
10589917|NCT01768559|11746036|FG002|Treated|Overall Study|4 participants received Insulin Glulisine QD (for more than 50%)|297
10589918|NCT01768559|11746034|FG000|COMPLETED|Overall Study||268
10589919|NCT01768559|11746035|FG001|COMPLETED|Overall Study||281
10589920|NCT01768559|11746036|FG002|COMPLETED|Overall Study||285
10589921|NCT01768559|11746034|FG000|NOT COMPLETED|Overall Study||30
10589922|NCT01768559|11746035|FG001|NOT COMPLETED|Overall Study||17
10589923|NCT01768559|11746036|FG002|NOT COMPLETED|Overall Study||13
10589924|NCT01768572|11746051|FG000|STARTED|Overall Study||49
10589925|NCT01768572|11746052|FG001|STARTED|Overall Study||51
10589926|NCT01768572|11746053|FG002|STARTED|Overall Study||102
10589927|NCT01768572|11746051|FG000|COMPLETED|Overall Study||40
10589928|NCT01768572|11746052|FG001|COMPLETED|Overall Study||39
10589929|NCT01768572|11746053|FG002|COMPLETED|Overall Study||96
10589930|NCT01768572|11746051|FG000|NOT COMPLETED|Overall Study||9
10589931|NCT01768572|11746052|FG001|NOT COMPLETED|Overall Study||12
10589932|NCT01768572|11746053|FG002|NOT COMPLETED|Overall Study||6
10589933|NCT01768637|11746063|FG000|STARTED|Overall Study||29
10589934|NCT01768637|11746064|FG001|STARTED|Overall Study||19
10589935|NCT01768637|11746063|FG000|Completed Visit 1|Overall Study||28
10589936|NCT01768637|11746064|FG001|Completed Visit 1|Overall Study||16
10589937|NCT01768637|11746063|FG000|Completed Visit 2|Overall Study||26
10589938|NCT01768637|11746064|FG001|Completed Visit 2|Overall Study||13
10589939|NCT01768637|11746063|FG000|COMPLETED|Overall Study||26
10589940|NCT01768637|11746064|FG001|COMPLETED|Overall Study||12
10589941|NCT01768637|11746063|FG000|NOT COMPLETED|Overall Study||3
10589942|NCT01768637|11746064|FG001|NOT COMPLETED|Overall Study||7
10589943|NCT01768676|11746072|FG000|STARTED|Overall Study||90
10589944|NCT01768676|11746073|FG001|STARTED|Overall Study||91
10589945|NCT01768676|11746072|FG000|COMPLETED|Overall Study||66
10589946|NCT01768676|11746073|FG001|COMPLETED|Overall Study||60
10589947|NCT01768676|11746072|FG000|NOT COMPLETED|Overall Study||24
10589948|NCT01768676|11746073|FG001|NOT COMPLETED|Overall Study||31
10589949|NCT01768832|11746082|FG000|STARTED|Overall Study||41
10589950|NCT01768832|11746083|FG001|STARTED|Overall Study||43
10589951|NCT01768832|11746084|FG002|STARTED|Overall Study||35
10589952|NCT01768832|11746082|FG000|COMPLETED|Overall Study||31
10589953|NCT01768832|11746083|FG001|COMPLETED|Overall Study||39
10589954|NCT01768832|11746084|FG002|COMPLETED|Overall Study||26
10589955|NCT01768832|11746082|FG000|NOT COMPLETED|Overall Study||10
10589956|NCT01768832|11746083|FG001|NOT COMPLETED|Overall Study||4
10589957|NCT01768832|11746084|FG002|NOT COMPLETED|Overall Study||9
10589958|NCT01768845|11746092|FG000|STARTED|Overall Study||34
10589959|NCT01768845|11746092|FG000|COMPLETED|Overall Study||11
10589960|NCT01768845|11746092|FG000|NOT COMPLETED|Overall Study||23
10589961|NCT01768858|11746096|FG000|STARTED|Overall Study||96
10589962|NCT01768858|11746096|FG000|COMPLETED|Overall Study||74
10589963|NCT01768858|11746096|FG000|NOT COMPLETED|Overall Study||22
10589964|NCT01769105|11746102|FG000|STARTED|First Intervention||16
10589965|NCT01769105|11746103|FG001|STARTED|First Intervention||19
10589966|NCT01769105|11746102|FG000|COMPLETED|First Intervention||14
10589967|NCT01769105|11746103|FG001|COMPLETED|First Intervention||17
10589968|NCT01769105|11746102|FG000|NOT COMPLETED|First Intervention||2
10589969|NCT01769105|11746103|FG001|NOT COMPLETED|First Intervention||2
10589970|NCT01769105|11746102|FG000|STARTED|Cross-over||14
10589971|NCT01769105|11746103|FG001|STARTED|Cross-over|Cross-over was only intended for the Lid margin hygiene group|0
10589972|NCT01769105|11746102|FG000|COMPLETED|Cross-over||9
10589973|NCT01769105|11746103|FG001|COMPLETED|Cross-over|Was not intended by the study protocol|0
10589974|NCT01769105|11746102|FG000|NOT COMPLETED|Cross-over||5
10589975|NCT01769105|11746103|FG001|NOT COMPLETED|Cross-over||0
10589976|NCT01769170|11746113|FG000|STARTED|Overall Study||303
10589977|NCT01769170|11746114|FG001|STARTED|Overall Study||149
10589978|NCT01769170|11746113|FG000|COMPLETED|Overall Study||232
10589979|NCT01769170|11746114|FG001|COMPLETED|Overall Study||122
10807661|NCT03889704|11969387|FG000|NOT COMPLETED|Overall Study||1
10807662|NCT03889444|11969391|FG000|STARTED|Overall Study||141
10807663|NCT03889444|11969391|FG000|COMPLETED|Overall Study||141
10589980|NCT01769170|11746113|FG000|NOT COMPLETED|Overall Study||71
10589981|NCT01769170|11746114|FG001|NOT COMPLETED|Overall Study||27
10589982|NCT01769196|11746122|FG000|STARTED|Overall Study||272
10589983|NCT01769196|11746123|FG001|STARTED|Overall Study||272
10589984|NCT01769196|11746122|FG000|COMPLETED|Overall Study||0
10589985|NCT01769196|11746123|FG001|COMPLETED|Overall Study||0
10589986|NCT01769196|11746122|FG000|NOT COMPLETED|Overall Study||272
10589987|NCT01769196|11746123|FG001|NOT COMPLETED|Overall Study||272
10589988|NCT01769209|11746129|FG000|STARTED|Overall Study||18
10589989|NCT01769209|11746129|FG000|COMPLETED|Overall Study||18
10589990|NCT01769209|11746129|FG000|NOT COMPLETED|Overall Study||0
10589991|NCT01769222|11746135|FG000|STARTED|Overall Study||3
10589992|NCT01769222|11746136|FG001|STARTED|Overall Study||0
10589993|NCT01769222|11746135|FG000|COMPLETED|Overall Study||3
10589994|NCT01769222|11746136|FG001|COMPLETED|Overall Study||0
10589995|NCT01769222|11746135|FG000|NOT COMPLETED|Overall Study||0
10589996|NCT01769222|11746136|FG001|NOT COMPLETED|Overall Study||0
10589997|NCT01769248|11746144|FG000|STARTED|Overall Study||70
10589998|NCT01769248|11746145|FG001|STARTED|Overall Study||70
10589999|NCT01769248|11746144|FG000|Participants Who Crossed-over|Overall Study||28
10590000|NCT01769248|11746145|FG001|Participants Who Crossed-over|Overall Study||12
10590001|NCT01769248|11746144|FG000|COMPLETED|Overall Study||42
10590002|NCT01769248|11746145|FG001|COMPLETED|Overall Study||58
10590003|NCT01769248|11746144|FG000|NOT COMPLETED|Overall Study||28
10590004|NCT01769248|11746145|FG001|NOT COMPLETED|Overall Study||12
10590005|NCT01769274|11746153|FG000|STARTED|Part A||5
10590006|NCT01769274|11746154|FG001|STARTED|Part A||0
10590007|NCT01769274|11746155|FG002|STARTED|Part A||0
10590008|NCT01769274|11746153|FG000|COMPLETED|Part A||5
10590009|NCT01769274|11746154|FG001|COMPLETED|Part A||0
10590010|NCT01769274|11746155|FG002|COMPLETED|Part A||0
10590011|NCT01769274|11746153|FG000|NOT COMPLETED|Part A||0
10590012|NCT01769274|11746154|FG001|NOT COMPLETED|Part A||0
10590013|NCT01769274|11746155|FG002|NOT COMPLETED|Part A||0
10590014|NCT01769274|11746153|FG000|STARTED|Part B:Treatment Session1-Period1||0
10590015|NCT01769274|11746154|FG001|STARTED|Part B:Treatment Session1-Period1||2
10590016|NCT01769274|11746155|FG002|STARTED|Part B:Treatment Session1-Period1||3
10590017|NCT01769274|11746153|FG000|COMPLETED|Part B:Treatment Session1-Period1||0
10590018|NCT01769274|11746154|FG001|COMPLETED|Part B:Treatment Session1-Period1||2
10590019|NCT01769274|11746155|FG002|COMPLETED|Part B:Treatment Session1-Period1||3
10590020|NCT01769274|11746153|FG000|NOT COMPLETED|Part B:Treatment Session1-Period1||0
10590021|NCT01769274|11746154|FG001|NOT COMPLETED|Part B:Treatment Session1-Period1||0
10590022|NCT01769274|11746155|FG002|NOT COMPLETED|Part B:Treatment Session1-Period1||0
10590023|NCT01769274|11746153|FG000|STARTED|Washout Period||0
10590024|NCT01769274|11746154|FG001|STARTED|Washout Period||2
10590025|NCT01769274|11746155|FG002|STARTED|Washout Period||3
10590026|NCT01769274|11746153|FG000|COMPLETED|Washout Period||0
10590027|NCT01769274|11746154|FG001|COMPLETED|Washout Period||2
10590028|NCT01769274|11746155|FG002|COMPLETED|Washout Period||3
10590029|NCT01769274|11746153|FG000|NOT COMPLETED|Washout Period||0
10590030|NCT01769274|11746154|FG001|NOT COMPLETED|Washout Period||0
10590031|NCT01769274|11746155|FG002|NOT COMPLETED|Washout Period||0
10590032|NCT01769274|11746153|FG000|STARTED|Part B:Treatment Session1-Period2||0
10590033|NCT01769274|11746154|FG001|STARTED|Part B:Treatment Session1-Period2||2
10590034|NCT01769274|11746155|FG002|STARTED|Part B:Treatment Session1-Period2||3
10590035|NCT01769274|11746153|FG000|COMPLETED|Part B:Treatment Session1-Period2||0
10590036|NCT01769274|11746154|FG001|COMPLETED|Part B:Treatment Session1-Period2||2
10590037|NCT01769274|11746155|FG002|COMPLETED|Part B:Treatment Session1-Period2||3
10590038|NCT01769274|11746153|FG000|NOT COMPLETED|Part B:Treatment Session1-Period2||0
10590039|NCT01769274|11746154|FG001|NOT COMPLETED|Part B:Treatment Session1-Period2||0
10590040|NCT01769274|11746155|FG002|NOT COMPLETED|Part B:Treatment Session1-Period2||0
10590041|NCT01769274|11746153|FG000|STARTED|Washout Period||0
10590042|NCT01769274|11746154|FG001|STARTED|Washout Period||2
10590043|NCT01769274|11746155|FG002|STARTED|Washout Period||3
10590044|NCT01769274|11746153|FG000|COMPLETED|Washout Period||0
10590045|NCT01769274|11746154|FG001|COMPLETED|Washout Period||2
10590046|NCT01769274|11746155|FG002|COMPLETED|Washout Period||3
10590047|NCT01769274|11746153|FG000|NOT COMPLETED|Washout Period||0
10590048|NCT01769274|11746154|FG001|NOT COMPLETED|Washout Period||0
10590049|NCT01769274|11746155|FG002|NOT COMPLETED|Washout Period||0
10590050|NCT01769274|11746153|FG000|STARTED|Part B:Treatment Session2-Period3||0
10590051|NCT01769274|11746154|FG001|STARTED|Part B:Treatment Session2-Period3||2
10590052|NCT01769274|11746155|FG002|STARTED|Part B:Treatment Session2-Period3||3
10590053|NCT01769274|11746153|FG000|COMPLETED|Part B:Treatment Session2-Period3||0
10590054|NCT01769274|11746154|FG001|COMPLETED|Part B:Treatment Session2-Period3||2
10807664|NCT03889444|11969391|FG000|NOT COMPLETED|Overall Study||0
10590055|NCT01769274|11746155|FG002|COMPLETED|Part B:Treatment Session2-Period3||3
10590056|NCT01769274|11746153|FG000|NOT COMPLETED|Part B:Treatment Session2-Period3||0
10807665|NCT03888755|11969395|FG000|STARTED|Overall Study||8
10807666|NCT03888755|11969395|FG000|COMPLETED|Overall Study||8
10590057|NCT01769274|11746154|FG001|NOT COMPLETED|Part B:Treatment Session2-Period3||0
10590058|NCT01769274|11746155|FG002|NOT COMPLETED|Part B:Treatment Session2-Period3||0
10590059|NCT01769274|11746153|FG000|STARTED|Washout Period||0
10590060|NCT01769274|11746154|FG001|STARTED|Washout Period||2
10590061|NCT01769274|11746155|FG002|STARTED|Washout Period||3
10590062|NCT01769274|11746153|FG000|COMPLETED|Washout Period||0
10590063|NCT01769274|11746154|FG001|COMPLETED|Washout Period||2
10590064|NCT01769274|11746155|FG002|COMPLETED|Washout Period||3
10590065|NCT01769274|11746153|FG000|NOT COMPLETED|Washout Period||0
10590066|NCT01769274|11746154|FG001|NOT COMPLETED|Washout Period||0
10590067|NCT01769274|11746155|FG002|NOT COMPLETED|Washout Period||0
10590068|NCT01769274|11746153|FG000|STARTED|Part B:Treatment Session2-Period4||0
10590069|NCT01769274|11746154|FG001|STARTED|Part B:Treatment Session2-Period4||2
10590070|NCT01769274|11746155|FG002|STARTED|Part B:Treatment Session2-Period4||3
10333753|NCT00335452|11469936|FG002|COMPLETED|Overall Study|Completed 30 days follow-up period|6108
10333754|NCT00335452|11469937|FG003|COMPLETED|Overall Study|Completed 30 days follow-up period|6122
10333755|NCT00335452|11469934|FG000|NOT COMPLETED|Overall Study||158
10333756|NCT00335452|11469935|FG001|NOT COMPLETED|Overall Study||147
10333757|NCT00335452|11469936|FG002|NOT COMPLETED|Overall Study||159
10333758|NCT00335452|11469937|FG003|NOT COMPLETED|Overall Study||131
10333759|NCT00335478|11469952|FG000|STARTED|Overall Study||54
10333760|NCT00335478|11469952|FG000|COMPLETED|Overall Study||30
10590071|NCT01769274|11746153|FG000|COMPLETED|Part B:Treatment Session2-Period4||0
10590072|NCT01769274|11746154|FG001|COMPLETED|Part B:Treatment Session2-Period4||2
10590073|NCT01769274|11746155|FG002|COMPLETED|Part B:Treatment Session2-Period4||3
10590074|NCT01769274|11746153|FG000|NOT COMPLETED|Part B:Treatment Session2-Period4||0
10590075|NCT01769274|11746154|FG001|NOT COMPLETED|Part B:Treatment Session2-Period4||0
10590076|NCT01769274|11746155|FG002|NOT COMPLETED|Part B:Treatment Session2-Period4||0
10590077|NCT01769326|11746170|FG000|STARTED|Overall Study||11
10590078|NCT01769326|11746171|FG001|STARTED|Overall Study||12
10590079|NCT01769326|11746172|FG002|STARTED|Overall Study||9
10590080|NCT01769326|11746173|FG003|STARTED|Overall Study||8
10590081|NCT01769326|11746170|FG000|COMPLETED|Overall Study||9
10590082|NCT01769326|11746171|FG001|COMPLETED|Overall Study||8
10590083|NCT01769326|11746172|FG002|COMPLETED|Overall Study||8
10590084|NCT01769326|11746173|FG003|COMPLETED|Overall Study||8
10590085|NCT01769326|11746170|FG000|NOT COMPLETED|Overall Study||2
10590086|NCT01769326|11746171|FG001|NOT COMPLETED|Overall Study||4
10590087|NCT01769326|11746172|FG002|NOT COMPLETED|Overall Study||1
10590088|NCT01769326|11746173|FG003|NOT COMPLETED|Overall Study||0
10590089|NCT01769339|11746183|FG000|STARTED|Overall Study||115
10590090|NCT01769339|11746183|FG000|COMPLETED|Overall Study||72
10590091|NCT01769339|11746183|FG000|NOT COMPLETED|Overall Study||43
10590092|NCT01769352|11746191|FG000|STARTED|Overall Study||13
10590093|NCT01769352|11746192|FG001|STARTED|Overall Study||12
10590094|NCT01769352|11746193|FG002|STARTED|Overall Study||9
10590095|NCT01769352|11746194|FG003|STARTED|Overall Study||8
10590096|NCT01769352|11746191|FG000|COMPLETED|Overall Study||13
10590097|NCT01769352|11746192|FG001|COMPLETED|Overall Study||12
10590098|NCT01769352|11746193|FG002|COMPLETED|Overall Study||9
10590099|NCT01769352|11746194|FG003|COMPLETED|Overall Study||8
10590100|NCT01769352|11746191|FG000|NOT COMPLETED|Overall Study||0
10590101|NCT01769352|11746192|FG001|NOT COMPLETED|Overall Study||0
10590102|NCT01769352|11746193|FG002|NOT COMPLETED|Overall Study||0
10590103|NCT01769352|11746194|FG003|NOT COMPLETED|Overall Study||0
10590104|NCT01769365|11746208|FG000|STARTED|Overall Study||102
10590105|NCT01769365|11746209|FG001|STARTED|Overall Study||102
10590106|NCT01769365|11746210|FG002|STARTED|Overall Study||103
10590107|NCT01769365|11746208|FG000|COMPLETED|Overall Study||102
10590108|NCT01769365|11746209|FG001|COMPLETED|Overall Study||100
10590109|NCT01769365|11746210|FG002|COMPLETED|Overall Study||101
10590110|NCT01769365|11746208|FG000|NOT COMPLETED|Overall Study||0
10590111|NCT01769365|11746209|FG001|NOT COMPLETED|Overall Study||2
10590112|NCT01769365|11746210|FG002|NOT COMPLETED|Overall Study||2
10590113|NCT01769378|11746220|FG000|STARTED|Overall Study||240
10590114|NCT01769378|11746221|FG001|STARTED|Overall Study||60
10590115|NCT01769378|11746220|FG000|Received at Least 1 Dose of Study Drug|Overall Study||239
10590116|NCT01769378|11746221|FG001|Received at Least 1 Dose of Study Drug|Overall Study||60
10590117|NCT01769378|11746220|FG000|COMPLETED|Overall Study|Completed the study on study treatment|215
10590118|NCT01769378|11746221|FG001|COMPLETED|Overall Study|Completed the study on study treatment|56
10590119|NCT01769378|11746220|FG000|NOT COMPLETED|Overall Study||25
10590120|NCT01769378|11746221|FG001|NOT COMPLETED|Overall Study||4
10651994|NCT02180646|11812282|FG000|COMPLETED|Washout (7 Days)||6
10651995|NCT02180646|11812283|FG001|COMPLETED|Washout (7 Days)||6
10651996|NCT02180646|11812282|FG000|NOT COMPLETED|Washout (7 Days)||0
10651997|NCT02180646|11812283|FG001|NOT COMPLETED|Washout (7 Days)||0
10651998|NCT02180646|11812282|FG000|STARTED|Second Intervention (7 Days)||6
10651999|NCT02180646|11812283|FG001|STARTED|Second Intervention (7 Days)||6
10652000|NCT02180646|11812282|FG000|COMPLETED|Second Intervention (7 Days)||6
10652001|NCT02180646|11812283|FG001|COMPLETED|Second Intervention (7 Days)||6
10652002|NCT02180646|11812282|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
10652003|NCT02180646|11812283|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
10652004|NCT02180659|11812293|FG000|STARTED|Overall Study||87
10652005|NCT02180659|11812294|FG001|STARTED|Overall Study|N=90 randomized, however N=89 received study medication|89
10652006|NCT02180659|11812293|FG000|COMPLETED|Overall Study||81
10652007|NCT02180659|11812294|FG001|COMPLETED|Overall Study||84
10590121|NCT01769391|11746229|FG000|STARTED|Overall Study||110
10590122|NCT01769391|11746230|FG001|STARTED|Overall Study||57
10590123|NCT01769391|11746229|FG000|Received at Least One Dose of Study Drug|Overall Study||106
10590124|NCT01769391|11746230|FG001|Received at Least One Dose of Study Drug|Overall Study||55
10590125|NCT01769391|11746229|FG000|COMPLETED|Overall Study||93
10590126|NCT01769391|11746230|FG001|COMPLETED|Overall Study||48
10590127|NCT01769391|11746229|FG000|NOT COMPLETED|Overall Study||17
10590128|NCT01769391|11746230|FG001|NOT COMPLETED|Overall Study||9
10590129|NCT01769404|11746242|FG000|STARTED|Treatment Period 1||12
10590130|NCT01769404|11746243|FG001|STARTED|Treatment Period 1||13
10590131|NCT01769404|11746242|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
10590132|NCT01769404|11746243|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1||13
10590133|NCT01769404|11746242|FG000|COMPLETED|Treatment Period 1||7
10590134|NCT01769404|11746243|FG001|COMPLETED|Treatment Period 1||13
10590135|NCT01769404|11746242|FG000|NOT COMPLETED|Treatment Period 1||5
10590136|NCT01769404|11746243|FG001|NOT COMPLETED|Treatment Period 1||0
10590137|NCT01769404|11746242|FG000|STARTED|Treatment Period 2||7
10590138|NCT01769404|11746243|FG001|STARTED|Treatment Period 2||13
10590139|NCT01769404|11746242|FG000|COMPLETED|Treatment Period 2||0
10590140|NCT01769404|11746243|FG001|COMPLETED|Treatment Period 2||13
10590141|NCT01769404|11746242|FG000|NOT COMPLETED|Treatment Period 2||7
10590142|NCT01769404|11746243|FG001|NOT COMPLETED|Treatment Period 2||0
10590143|NCT01769456|11746251|FG000|STARTED|Overall Study|1 subject inadvertently enrolled, discontin'd after baseline, re-enrolled later and completed study|78
10590144|NCT01769456|11746251|FG000|COMPLETED|Overall Study||41
10590145|NCT01769456|11746251|FG000|NOT COMPLETED|Overall Study||37
10590146|NCT01769469|11746256|FG000|STARTED|Overall Study||101
10590147|NCT01769469|11746256|FG000|COMPLETED|Overall Study||66
10590148|NCT01769469|11746256|FG000|NOT COMPLETED|Overall Study||35
10590149|NCT01769508|11746262|FG000|STARTED|Overall Study||12
10590150|NCT01769508|11746262|FG000|COMPLETED|Overall Study||6
10590151|NCT01769508|11746262|FG000|NOT COMPLETED|Overall Study||6
10590152|NCT01769573|11746271|FG000|STARTED|Overall Study||10
10590153|NCT01769573|11746272|FG001|STARTED|Overall Study||6
10590154|NCT01769573|11746273|FG002|STARTED|Overall Study||10
10590155|NCT01769573|11746274|FG003|STARTED|Overall Study||0
10590156|NCT01769573|11746275|FG004|STARTED|Overall Study||10
10590157|NCT01769573|11746271|FG000|COMPLETED|Overall Study||10
10590158|NCT01769573|11746272|FG001|COMPLETED|Overall Study||6
10590159|NCT01769573|11746273|FG002|COMPLETED|Overall Study||10
10590160|NCT01769573|11746274|FG003|COMPLETED|Overall Study||0
10590161|NCT01769573|11746275|FG004|COMPLETED|Overall Study||10
10590162|NCT01769573|11746271|FG000|NOT COMPLETED|Overall Study||0
10590163|NCT01769573|11746272|FG001|NOT COMPLETED|Overall Study||0
10590164|NCT01769573|11746273|FG002|NOT COMPLETED|Overall Study||0
10590165|NCT01769573|11746274|FG003|NOT COMPLETED|Overall Study||0
10590166|NCT01769573|11746275|FG004|NOT COMPLETED|Overall Study||0
10590167|NCT01769586|11746289|FG000|STARTED|Overall Study||100
10590168|NCT01769586|11746290|FG001|STARTED|Overall Study||100
10590169|NCT01769586|11746289|FG000|COMPLETED|Overall Study||100
10590170|NCT01769586|11746290|FG001|COMPLETED|Overall Study||100
10590171|NCT01769586|11746289|FG000|NOT COMPLETED|Overall Study||0
10590172|NCT01769586|11746290|FG001|NOT COMPLETED|Overall Study||0
10590173|NCT01769612|11746296|FG000|STARTED|Overall Study||168
10590174|NCT01769612|11746296|FG000|COMPLETED|Overall Study||168
10590175|NCT01769612|11746296|FG000|NOT COMPLETED|Overall Study||0
10590176|NCT01770145|11746302|FG000|STARTED|Baseline||127
10590177|NCT01770145|11746302|FG000|COMPLETED|Baseline||101
10590178|NCT01770145|11746302|FG000|NOT COMPLETED|Baseline||26
10590179|NCT01770145|11746302|FG000|STARTED|Treatment||101
10590180|NCT01770145|11746302|FG000|COMPLETED|Treatment||97
10590181|NCT01770145|11746302|FG000|NOT COMPLETED|Treatment||4
10590182|NCT01770314|11746308|FG000|STARTED|Overall Study||86
10590183|NCT01770314|11746309|FG001|STARTED|Overall Study||90
10590184|NCT01770314|11746308|FG000|Contributed Data to Baseline|Overall Study||68
10590185|NCT01770314|11746309|FG001|Contributed Data to Baseline|Overall Study||72
10590186|NCT01770314|11746308|FG000|Contributed Data to Post-test|Overall Study||65
10590187|NCT01770314|11746309|FG001|Contributed Data to Post-test|Overall Study||67
10590188|NCT01770314|11746308|FG000|Contributed Data to One-month Follow-up|Overall Study||61
10590189|NCT01770314|11746309|FG001|Contributed Data to One-month Follow-up|Overall Study||66
10590190|NCT01770314|11746308|FG000|COMPLETED|Overall Study||86
10590191|NCT01770314|11746309|FG001|COMPLETED|Overall Study||90
10590192|NCT01770314|11746308|FG000|NOT COMPLETED|Overall Study||0
10590193|NCT01770314|11746309|FG001|NOT COMPLETED|Overall Study||0
10590194|NCT01770353|11746317|FG000|STARTED|Overall Study||15
10590195|NCT01770353|11746318|FG001|STARTED|Overall Study||30
10590196|NCT01770353|11746317|FG000|Received FMX|Overall Study|2 subjects excluded from MM-398 safety population.|15
10590197|NCT01770353|11746318|FG001|Received FMX|Overall Study|1 subject excluded from MM-398 safety population.|30
10590198|NCT01770353|11746317|FG000|Received FMX and MM-398|Overall Study||13
10590199|NCT01770353|11746318|FG001|Received FMX and MM-398|Overall Study||29
10590200|NCT01770353|11746317|FG000|COMPLETED|Overall Study||9
10590201|NCT01770353|11746318|FG001|COMPLETED|Overall Study||18
10590202|NCT01770353|11746317|FG000|NOT COMPLETED|Overall Study||6
10590203|NCT01770353|11746318|FG001|NOT COMPLETED|Overall Study||12
10590204|NCT01770366|11746334|FG000|STARTED|Overall Study||4
10590205|NCT01770366|11746335|FG001|STARTED|Overall Study||6
10590206|NCT01770366|11746334|FG000|COMPLETED|Overall Study||2
10590207|NCT01770366|11746335|FG001|COMPLETED|Overall Study||4
10590208|NCT01770366|11746334|FG000|NOT COMPLETED|Overall Study||2
10590209|NCT01770366|11746335|FG001|NOT COMPLETED|Overall Study||2
10590210|NCT01770379|11746344|FG000|STARTED|Overall Study||80
10590211|NCT01770379|11746345|FG001|STARTED|Overall Study||81
10590212|NCT01770379|11746346|FG002|STARTED|Overall Study||81
10590213|NCT01770379|11746344|FG000|COMPLETED|Overall Study||41
10590214|NCT01770379|11746345|FG001|COMPLETED|Overall Study||37
10590215|NCT01770379|11746346|FG002|COMPLETED|Overall Study||39
10590216|NCT01770379|11746344|FG000|NOT COMPLETED|Overall Study||39
10590217|NCT01770379|11746345|FG001|NOT COMPLETED|Overall Study||44
10590218|NCT01770379|11746346|FG002|NOT COMPLETED|Overall Study||42
10590219|NCT01770392|11746356|FG000|STARTED|Nintedanib||26
10590220|NCT01770392|11746356|FG000|COMPLETED|Nintedanib||26
10590221|NCT01770392|11746356|FG000|NOT COMPLETED|Nintedanib||0
10590222|NCT01770392|11746356|FG000|STARTED|Washout Period of at Least 14 Days||26
10590223|NCT01770392|11746356|FG000|COMPLETED|Washout Period of at Least 14 Days||25
10590224|NCT01770392|11746356|FG000|NOT COMPLETED|Washout Period of at Least 14 Days||1
10590225|NCT01770392|11746356|FG000|STARTED|Nintedanib+ Rifampicin||25
10590226|NCT01770392|11746356|FG000|COMPLETED|Nintedanib+ Rifampicin||25
10590227|NCT01770392|11746356|FG000|NOT COMPLETED|Nintedanib+ Rifampicin||0
10590228|NCT01770431|11746368|FG000|STARTED|Overall Study||696
10590229|NCT01770431|11746369|FG001|STARTED|Overall Study||348
10590230|NCT01770431|11746368|FG000|COMPLETED|Overall Study||686
10590231|NCT01770431|11746369|FG001|COMPLETED|Overall Study||316
10590232|NCT01770431|11746368|FG000|NOT COMPLETED|Overall Study||10
10590233|NCT01770431|11746369|FG001|NOT COMPLETED|Overall Study||32
10590234|NCT01770483|11746378|FG000|STARTED|Overall Study||33
10590235|NCT01770483|11746379|FG001|STARTED|Overall Study||33
10590236|NCT01770483|11746378|FG000|COMPLETED|Overall Study||33
10590237|NCT01770483|11746379|FG001|COMPLETED|Overall Study||33
10590238|NCT01770483|11746378|FG000|NOT COMPLETED|Overall Study||0
10590239|NCT01770483|11746379|FG001|NOT COMPLETED|Overall Study||0
10590240|NCT01770509|11746387|FG000|STARTED|Overall Study||12
10590241|NCT01770509|11746388|FG001|STARTED|Overall Study||17
10590242|NCT01770509|11746387|FG000|COMPLETED|Overall Study||11
10590243|NCT01770509|11746388|FG001|COMPLETED|Overall Study||14
10590244|NCT01770509|11746387|FG000|NOT COMPLETED|Overall Study||1
10590245|NCT01770509|11746388|FG001|NOT COMPLETED|Overall Study||3
10590246|NCT01770652|11746398|FG000|STARTED|Overall Study||8
10590247|NCT01770652|11746399|FG001|STARTED|Overall Study||8
10590248|NCT01770652|11746400|FG002|STARTED|Overall Study||8
10590249|NCT01770652|11746401|FG003|STARTED|Overall Study||8
10590250|NCT01770652|11746398|FG000|COMPLETED|Overall Study||8
10590251|NCT01770652|11746399|FG001|COMPLETED|Overall Study||8
10590252|NCT01770652|11746400|FG002|COMPLETED|Overall Study||8
10590253|NCT01770652|11746401|FG003|COMPLETED|Overall Study||8
10590254|NCT01770652|11746398|FG000|NOT COMPLETED|Overall Study||0
10590255|NCT01770652|11746399|FG001|NOT COMPLETED|Overall Study||0
10590256|NCT01770652|11746400|FG002|NOT COMPLETED|Overall Study||0
10590257|NCT01770652|11746401|FG003|NOT COMPLETED|Overall Study||0
10590258|NCT01770691|11746415|FG000|STARTED|Overall Study||7
10590259|NCT01770691|11746415|FG000|COMPLETED|Overall Study||7
10590260|NCT01770691|11746415|FG000|NOT COMPLETED|Overall Study||0
10590261|NCT01770743|11746427|FG000|STARTED|Overall Study||44
10590262|NCT01770743|11746428|FG001|STARTED|Overall Study||34
10590263|NCT01770743|11746429|FG002|STARTED|Overall Study||23
10590264|NCT01770743|11746430|FG003|STARTED|Overall Study||44
10590265|NCT01770743|11746431|FG004|STARTED|Overall Study||23
10590266|NCT01770743|11746427|FG000|Treated|Overall Study||44
10590267|NCT01770743|11746428|FG001|Treated|Overall Study||34
10590268|NCT01770743|11746429|FG002|Treated|Overall Study||23
10590269|NCT01770743|11746430|FG003|Treated|Overall Study||44
10590270|NCT01770743|11746431|FG004|Treated|Overall Study||23
10590271|NCT01770743|11746427|FG000|COMPLETED|Overall Study||42
10590272|NCT01770743|11746428|FG001|COMPLETED|Overall Study||31
10590273|NCT01770743|11746429|FG002|COMPLETED|Overall Study||22
10590274|NCT01770743|11746430|FG003|COMPLETED|Overall Study||42
10590275|NCT01770743|11746431|FG004|COMPLETED|Overall Study||21
10590276|NCT01770743|11746427|FG000|NOT COMPLETED|Overall Study||2
10590277|NCT01770743|11746428|FG001|NOT COMPLETED|Overall Study||3
10590278|NCT01770743|11746429|FG002|NOT COMPLETED|Overall Study||1
10590279|NCT01770743|11746430|FG003|NOT COMPLETED|Overall Study||2
10590280|NCT01770743|11746431|FG004|NOT COMPLETED|Overall Study||2
10590281|NCT01770860|11746443|FG000|STARTED|Overall Study|Forty-six subjects were enrolled but one subject withdrew before randomization.|46
10590282|NCT01770860|11746443|FG000|Randomization|Overall Study|One participant withdrew before randomization|45
10590283|NCT01770860|11746443|FG000|COMPLETED|Overall Study||40
10590284|NCT01770860|11746443|FG000|NOT COMPLETED|Overall Study||6
10590285|NCT01770912|11746453|FG000|STARTED|Overall Study||12
10590286|NCT01770912|11746454|FG001|STARTED|Overall Study||12
10590287|NCT01770912|11746453|FG000|COMPLETED|Overall Study||10
10590288|NCT01770912|11746454|FG001|COMPLETED|Overall Study||12
10590289|NCT01770912|11746453|FG000|NOT COMPLETED|Overall Study||2
10590290|NCT01770912|11746454|FG001|NOT COMPLETED|Overall Study||0
10590291|NCT01771055|11746462|FG000|STARTED|Overall Study||4
10590292|NCT01771055|11746463|FG001|STARTED|Overall Study||3
10590293|NCT01771055|11746462|FG000|COMPLETED|Overall Study||4
10590294|NCT01771055|11746463|FG001|COMPLETED|Overall Study||3
10590295|NCT01771055|11746462|FG000|NOT COMPLETED|Overall Study||0
10590296|NCT01771055|11746463|FG001|NOT COMPLETED|Overall Study||0
10590297|NCT01771172|11746469|FG000|STARTED|Overall Study||48
10590298|NCT01771172|11746469|FG000|COMPLETED|Overall Study||46
10590299|NCT01771172|11746469|FG000|NOT COMPLETED|Overall Study||2
10590300|NCT01771250|11746473|FG000|STARTED|Period 1||8
10590301|NCT01771250|11746474|FG001|STARTED|Period 1||7
10590302|NCT01771250|11746473|FG000|Received at Least One Dose of Study Drug|Period 1||7
10590303|NCT01771250|11746474|FG001|Received at Least One Dose of Study Drug|Period 1||7
10590304|NCT01771250|11746473|FG000|COMPLETED|Period 1||7
10590305|NCT01771250|11746474|FG001|COMPLETED|Period 1||7
10590306|NCT01771250|11746473|FG000|NOT COMPLETED|Period 1||1
10590307|NCT01771250|11746474|FG001|NOT COMPLETED|Period 1||0
10590308|NCT01771250|11746473|FG000|STARTED|Period 2||7
10590309|NCT01771250|11746474|FG001|STARTED|Period 2||7
10590310|NCT01771250|11746473|FG000|COMPLETED|Period 2||7
10590311|NCT01771250|11746474|FG001|COMPLETED|Period 2||7
10590312|NCT01771250|11746473|FG000|NOT COMPLETED|Period 2||0
10590313|NCT01771250|11746474|FG001|NOT COMPLETED|Period 2||0
10590314|NCT01771627|11746482|FG000|STARTED|Overall Study||200
10590315|NCT01771627|11746483|FG001|STARTED|Overall Study||100
10590316|NCT01771627|11746482|FG000|COMPLETED|Overall Study||92
10590317|NCT01771627|11746483|FG001|COMPLETED|Overall Study||50
10590318|NCT01771627|11746482|FG000|NOT COMPLETED|Overall Study||108
10590319|NCT01771627|11746483|FG001|NOT COMPLETED|Overall Study||50
10590320|NCT01771666|11746489|FG000|STARTED|Overall Study||23
10590321|NCT01771666|11746489|FG000|COMPLETED|Overall Study||23
10590322|NCT01771666|11746489|FG000|NOT COMPLETED|Overall Study||0
10590323|NCT01771731|11746495|FG000|STARTED|Overall Study||13
10590324|NCT01771731|11746496|FG001|STARTED|Overall Study||14
10590325|NCT01771731|11746495|FG000|COMPLETED|Overall Study||11
10590326|NCT01771731|11746496|FG001|COMPLETED|Overall Study||12
10590327|NCT01771731|11746495|FG000|NOT COMPLETED|Overall Study||2
10590328|NCT01771731|11746496|FG001|NOT COMPLETED|Overall Study||2
10590329|NCT01771809|11746504|FG000|STARTED|Overall Study||164
10590330|NCT01771809|11746505|FG001|STARTED|Overall Study||166
10590331|NCT01771809|11746504|FG000|COMPLETED|Overall Study||93
10590332|NCT01771809|11746505|FG001|COMPLETED|Overall Study||83
10590333|NCT01771809|11746504|FG000|NOT COMPLETED|Overall Study||71
10590334|NCT01771809|11746505|FG001|NOT COMPLETED|Overall Study||83
10590335|NCT01771913|11746513|FG000|STARTED|Overall Study||9
10590336|NCT01771913|11746514|FG001|STARTED|Overall Study||11
10590337|NCT01771913|11746513|FG000|COMPLETED|Overall Study||8
10590338|NCT01771913|11746514|FG001|COMPLETED|Overall Study||11
10590339|NCT01771913|11746513|FG000|NOT COMPLETED|Overall Study||1
10590340|NCT01771913|11746514|FG001|NOT COMPLETED|Overall Study||0
10590341|NCT01771952|11746522|FG000|STARTED|Overall Study||45
10590342|NCT01771952|11746523|FG001|STARTED|Overall Study||41
10590343|NCT01771952|11746522|FG000|COMPLETED|Overall Study||42
10590344|NCT01771952|11746523|FG001|COMPLETED|Overall Study||38
10590345|NCT01771952|11746522|FG000|NOT COMPLETED|Overall Study||3
10590346|NCT01771952|11746523|FG001|NOT COMPLETED|Overall Study||3
10590347|NCT01771965|11746531|FG000|STARTED|Overall Study||10
10590348|NCT01771965|11746532|FG001|STARTED|Overall Study||9
10590349|NCT01771965|11746531|FG000|COMPLETED|Overall Study||7
10590350|NCT01771965|11746532|FG001|COMPLETED|Overall Study||4
10590351|NCT01771965|11746531|FG000|NOT COMPLETED|Overall Study||3
10590352|NCT01771965|11746532|FG001|NOT COMPLETED|Overall Study||5
10590353|NCT01771991|11746540|FG000|STARTED|Overall Study||38
10590354|NCT01771991|11746541|FG001|STARTED|Overall Study||36
10590355|NCT01771991|11746540|FG000|Started Treatment|Overall Study||37
10590356|NCT01771991|11746541|FG001|Started Treatment|Overall Study||34
10590357|NCT01771991|11746540|FG000|COMPLETED|Overall Study||30
10590358|NCT01771991|11746541|FG001|COMPLETED|Overall Study||30
10590359|NCT01771991|11746540|FG000|NOT COMPLETED|Overall Study||8
10590360|NCT01771991|11746541|FG001|NOT COMPLETED|Overall Study||6
10590361|NCT01772134|11746551|FG000|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|207
10590362|NCT01772134|11746552|FG001|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|204
10590363|NCT01772134|11746553|FG002|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|206
10590364|NCT01772134|11746551|FG000|Received Randomized Study Medication|Overall Study||205
10590365|NCT01772134|11746552|FG001|Received Randomized Study Medication|Overall Study||204
10590366|NCT01772134|11746553|FG002|Received Randomized Study Medication|Overall Study||205
10590367|NCT01772134|11746551|FG000|COMPLETED|Overall Study||178
10590368|NCT01772134|11746552|FG001|COMPLETED|Overall Study||190
10590369|NCT01772134|11746553|FG002|COMPLETED|Overall Study||184
10590370|NCT01772134|11746551|FG000|NOT COMPLETED|Overall Study||29
10590371|NCT01772134|11746552|FG001|NOT COMPLETED|Overall Study||14
10590372|NCT01772134|11746553|FG002|NOT COMPLETED|Overall Study||22
10590373|NCT01772147|11746564|FG000|STARTED|Overall Study||201
10590374|NCT01772147|11746565|FG001|STARTED|Overall Study||203
10590375|NCT01772147|11746566|FG002|STARTED|Overall Study||202
10590376|NCT01772147|11746564|FG000|COMPLETED|Overall Study||170
10590377|NCT01772147|11746565|FG001|COMPLETED|Overall Study||178
10590378|NCT01772147|11746566|FG002|COMPLETED|Overall Study||184
10590379|NCT01772147|11746564|FG000|NOT COMPLETED|Overall Study||31
10590380|NCT01772147|11746565|FG001|NOT COMPLETED|Overall Study||25
10590381|NCT01772147|11746566|FG002|NOT COMPLETED|Overall Study||18
10590382|NCT01772160|11746574|FG000|STARTED|Overall Study||394
10590383|NCT01772160|11746574|FG000|COMPLETED|Overall Study||346
10590384|NCT01772160|11746574|FG000|NOT COMPLETED|Overall Study||48
10590385|NCT01772316|11746578|FG000|STARTED|Overall Study||47
10590386|NCT01772316|11746578|FG000|COMPLETED|Overall Study||40
10590387|NCT01772316|11746578|FG000|NOT COMPLETED|Overall Study||7
10590388|NCT01772368|11746582|FG000|STARTED|Overall Study||72
10590389|NCT01772368|11746582|FG000|Received Fp MDPI 100 mcg|Overall Study||67
10590390|NCT01772368|11746582|FG000|Received FS MDPI 100/6.25 mcg|Overall Study||68
10590391|NCT01772368|11746582|FG000|Received FS MDPI 100/12.5mcg|Overall Study||69
10590392|NCT01772368|11746582|FG000|Received FS MDPI 100/25 mcg|Overall Study||67
10590393|NCT01772368|11746582|FG000|Received FS MDPI 100/50 mcg|Overall Study||68
10590394|NCT01772368|11746582|FG000|Received Advair Diskus 100/50 mcg|Overall Study||66
10590395|NCT01772368|11746582|FG000|COMPLETED|Overall Study||65
10590396|NCT01772368|11746582|FG000|NOT COMPLETED|Overall Study||7
10590397|NCT01772537|11746601|FG000|STARTED|Overall Study||5
10590398|NCT01772537|11746602|FG001|STARTED|Overall Study||3
10590399|NCT01772537|11746603|FG002|STARTED|Overall Study||6
10590400|NCT01772537|11746601|FG000|COMPLETED|Overall Study||4
10590401|NCT01772537|11746602|FG001|COMPLETED|Overall Study||3
10590402|NCT01772537|11746603|FG002|COMPLETED|Overall Study||6
10590403|NCT01772537|11746601|FG000|NOT COMPLETED|Overall Study||1
10590404|NCT01772537|11746602|FG001|NOT COMPLETED|Overall Study||0
10590405|NCT01772537|11746603|FG002|NOT COMPLETED|Overall Study||0
10590406|NCT01772550|11746616|FG000|STARTED|Overall Study||102
10590407|NCT01772550|11746617|FG001|STARTED|Overall Study||103
10590408|NCT01772550|11746618|FG002|STARTED|Overall Study||33
10590409|NCT01772550|11746616|FG000|CT Pancreas|Overall Study||40
10590410|NCT01772550|11746617|FG001|CT Pancreas|Overall Study||36
10590411|NCT01772550|11746618|FG002|CT Pancreas|Overall Study||8
10590412|NCT01772550|11746616|FG000|CT Angiogram|Overall Study||24
10590413|NCT01772550|11746617|FG001|CT Angiogram|Overall Study||25
10590414|NCT01772550|11746618|FG002|CT Angiogram|Overall Study||4
10590415|NCT01772550|11746616|FG000|CT Liver|Overall Study||18
10590416|NCT01772550|11746617|FG001|CT Liver|Overall Study||14
10590417|NCT01772550|11746618|FG002|CT Liver|Overall Study||8
10590418|NCT01772550|11746616|FG000|CT Kidney|Overall Study||12
10590419|NCT01772550|11746617|FG001|CT Kidney|Overall Study||19
10590420|NCT01772550|11746618|FG002|CT Kidney|Overall Study||6
10590421|NCT01772550|11746616|FG000|CT Cardiac|Overall Study||7
10590422|NCT01772550|11746617|FG001|CT Cardiac|Overall Study||7
10590423|NCT01772550|11746618|FG002|CT Cardiac|Overall Study||1
10590424|NCT01772550|11746616|FG000|COMPLETED|Overall Study||101
10590425|NCT01772550|11746617|FG001|COMPLETED|Overall Study||102
10590426|NCT01772550|11746618|FG002|COMPLETED|Overall Study||27
10590427|NCT01772550|11746616|FG000|NOT COMPLETED|Overall Study||1
10590428|NCT01772550|11746617|FG001|NOT COMPLETED|Overall Study||1
10703436|NCT02584504|11867923|FG002|COMPLETED|Open-label Treatment||47
10703437|NCT02584504|11867921|FG000|NOT COMPLETED|Open-label Treatment||2
10703438|NCT02584504|11867922|FG001|NOT COMPLETED|Open-label Treatment||4
10703439|NCT02584504|11867923|FG002|NOT COMPLETED|Open-label Treatment||8
10703440|NCT02584608|11867935|FG000|STARTED|Overall Study||12
10703441|NCT02584608|11867935|FG000|COMPLETED|Overall Study||12
10590429|NCT01772550|11746618|FG002|NOT COMPLETED|Overall Study||6
10590430|NCT01772576|11746626|FG000|STARTED|Overall Study||167
10590431|NCT01772576|11746626|FG000|COMPLETED|Overall Study||133
10590432|NCT01772576|11746626|FG000|NOT COMPLETED|Overall Study||34
10590433|NCT01772654|11746632|FG000|STARTED|Overall Study||2
10590434|NCT01772654|11746633|FG001|STARTED|Overall Study||15
10590435|NCT01772654|11746632|FG000|COMPLETED|Overall Study||2
10590436|NCT01772654|11746633|FG001|COMPLETED|Overall Study||15
10590437|NCT01772654|11746632|FG000|NOT COMPLETED|Overall Study||0
10590438|NCT01772654|11746633|FG001|NOT COMPLETED|Overall Study||0
10590439|NCT01772693|11746641|FG000|STARTED|Overall Study||20
10590440|NCT01772693|11746642|FG001|STARTED|Overall Study||7
10590441|NCT01772693|11746641|FG000|COMPLETED|Overall Study||14
10590442|NCT01772693|11746642|FG001|COMPLETED|Overall Study||6
10590443|NCT01772693|11746641|FG000|NOT COMPLETED|Overall Study||6
10590444|NCT01772693|11746642|FG001|NOT COMPLETED|Overall Study||1
10590445|NCT01772758|11746652|FG000|STARTED|Overall Study||18
10590446|NCT01772758|11746653|FG001|STARTED|Overall Study||17
10590447|NCT01772758|11746654|FG002|STARTED|Overall Study||12
10590448|NCT01772758|11746655|FG003|STARTED|Overall Study||17
10590449|NCT01772758|11746652|FG000|COMPLETED|Overall Study||18
10590450|NCT01772758|11746653|FG001|COMPLETED|Overall Study||17
10590451|NCT01772758|11746654|FG002|COMPLETED|Overall Study||12
10590452|NCT01772758|11746655|FG003|COMPLETED|Overall Study||17
10590453|NCT01772758|11746652|FG000|NOT COMPLETED|Overall Study||0
10590454|NCT01772758|11746653|FG001|NOT COMPLETED|Overall Study||0
10590455|NCT01772758|11746654|FG002|NOT COMPLETED|Overall Study||0
10590456|NCT01772758|11746655|FG003|NOT COMPLETED|Overall Study||0
10590457|NCT01772823|11746667|FG000|STARTED|Behavioral Intervention (BL -3MV or PCC)||128
10590458|NCT01772823|11746668|FG001|STARTED|Behavioral Intervention (BL -3MV or PCC)||72
10590459|NCT01772823|11746667|FG000|COMPLETED|Behavioral Intervention (BL -3MV or PCC)||116
10590460|NCT01772823|11746668|FG001|COMPLETED|Behavioral Intervention (BL -3MV or PCC)||70
10590461|NCT01772823|11746667|FG000|NOT COMPLETED|Behavioral Intervention (BL -3MV or PCC)||12
10590462|NCT01772823|11746668|FG001|NOT COMPLETED|Behavioral Intervention (BL -3MV or PCC)||2
10590463|NCT01772823|11746667|FG000|STARTED|Treatment Phase (Week 0- Week 48)||116
10590464|NCT01772823|11746668|FG001|STARTED|Treatment Phase (Week 0- Week 48)||70
10590465|NCT01772823|11746667|FG000|COMPLETED|Treatment Phase (Week 0- Week 48)||88
10590466|NCT01772823|11746668|FG001|COMPLETED|Treatment Phase (Week 0- Week 48)||52
10590467|NCT01772823|11746667|FG000|NOT COMPLETED|Treatment Phase (Week 0- Week 48)||28
10590468|NCT01772823|11746668|FG001|NOT COMPLETED|Treatment Phase (Week 0- Week 48)||18
10590469|NCT01772823|11746667|FG000|STARTED|Extension Phase (Visits 24,48wks Post tx|25 of the 88 subjects that completed the Treatment Phase were not eligible for the Extension Phase|63
10590470|NCT01772823|11746668|FG001|STARTED|Extension Phase (Visits 24,48wks Post tx|10 of the 52 subjects that completed the Treatment Phase were not eligible for the Extension Phase|42
10590471|NCT01772823|11746667|FG000|COMPLETED|Extension Phase (Visits 24,48wks Post tx||53
10590472|NCT01772823|11746668|FG001|COMPLETED|Extension Phase (Visits 24,48wks Post tx||33
10590473|NCT01772823|11746667|FG000|NOT COMPLETED|Extension Phase (Visits 24,48wks Post tx||10
10590474|NCT01772823|11746668|FG001|NOT COMPLETED|Extension Phase (Visits 24,48wks Post tx||9
10590475|NCT01773070|11746679|FG000|STARTED|Overall Study||478
10590476|NCT01773070|11746679|FG000|COMPLETED|Overall Study||397
10590477|NCT01773070|11746679|FG000|NOT COMPLETED|Overall Study||81
10590478|NCT01773109|11746683|FG000|STARTED|Overall Study||40
10807667|NCT03888755|11969395|FG000|NOT COMPLETED|Overall Study||0
10807668|NCT03888391|11969401|FG000|STARTED|Overall Study||18
10807669|NCT03888391|11969401|FG000|COMPLETED|Overall Study||3
10807670|NCT03888391|11969401|FG000|NOT COMPLETED|Overall Study||15
10807671|NCT03888482|11969407|FG000|STARTED|First Wear Period (8 -1/+2 Days)||76
10590479|NCT01773109|11746683|FG000|COMPLETED|Overall Study||37
10590480|NCT01773109|11746683|FG000|NOT COMPLETED|Overall Study||3
10590481|NCT01773122|11746691|FG000|STARTED|Overall Study||20
10590482|NCT01773122|11746692|FG001|STARTED|Overall Study||19
10590483|NCT01773122|11746693|FG002|STARTED|Overall Study||19
10590484|NCT01773122|11746694|FG003|STARTED|Overall Study||19
10590485|NCT01773122|11746691|FG000|COMPLETED|Overall Study||17
10590486|NCT01773122|11746692|FG001|COMPLETED|Overall Study||18
10590487|NCT01773122|11746693|FG002|COMPLETED|Overall Study||19
10590488|NCT01773122|11746694|FG003|COMPLETED|Overall Study||18
10590489|NCT01773122|11746691|FG000|NOT COMPLETED|Overall Study||3
10590490|NCT01773122|11746692|FG001|NOT COMPLETED|Overall Study||1
10590491|NCT01773122|11746693|FG002|NOT COMPLETED|Overall Study||0
10590492|NCT01773122|11746694|FG003|NOT COMPLETED|Overall Study||1
10590493|NCT01773135|11746706|FG000|STARTED|Overall Study||262
10590494|NCT01773135|11746706|FG000|COMPLETED|Overall Study||262
10590495|NCT01773135|11746706|FG000|NOT COMPLETED|Overall Study||0
10590496|NCT01773187|11746713|FG000|STARTED|Overall Study||220
10590497|NCT01773187|11746714|FG001|STARTED|Overall Study||107
10590498|NCT01773187|11746713|FG000|COMPLETED|Overall Study||167
10590499|NCT01773187|11746714|FG001|COMPLETED|Overall Study||75
10590500|NCT01773187|11746713|FG000|NOT COMPLETED|Overall Study||53
10590501|NCT01773187|11746714|FG001|NOT COMPLETED|Overall Study||32
10590502|NCT01773226|11746720|FG000|STARTED|Overall Study||11
10590503|NCT01773226|11746720|FG000|COMPLETED|Overall Study|Withdrawal of one subject after one-month assessment due to persistent OA symptoms|10
10590504|NCT01773226|11746720|FG000|NOT COMPLETED|Overall Study||1
10590505|NCT01773291|11746727|FG000|STARTED|Overall Study||8
10590506|NCT01773291|11746728|FG001|STARTED|Overall Study||9
10590507|NCT01773291|11746729|FG002|STARTED|Overall Study||7
10590508|NCT01773291|11746727|FG000|COMPLETED|Overall Study||7
10590509|NCT01773291|11746728|FG001|COMPLETED|Overall Study||9
10590510|NCT01773291|11746729|FG002|COMPLETED|Overall Study||6
10590511|NCT01773291|11746727|FG000|NOT COMPLETED|Overall Study||1
10590512|NCT01773291|11746728|FG001|NOT COMPLETED|Overall Study||0
10590513|NCT01773291|11746729|FG002|NOT COMPLETED|Overall Study||1
10590514|NCT01773421|11746742|FG000|STARTED|Treatment Phase||7
10590515|NCT01773421|11746743|FG001|STARTED|Treatment Phase||8
10590516|NCT01773421|11746744|FG002|STARTED|Treatment Phase||19
10590517|NCT01773421|11746745|FG003|STARTED|Treatment Phase||7
10590518|NCT01773421|11746746|FG004|STARTED|Treatment Phase||0
10590519|NCT01773421|11746747|FG005|STARTED|Treatment Phase||0
10590520|NCT01773421|11746748|FG006|STARTED|Treatment Phase||0
10590521|NCT01773421|11746742|FG000|COMPLETED|Treatment Phase||7
10590522|NCT01773421|11746743|FG001|COMPLETED|Treatment Phase||8
10590523|NCT01773421|11746744|FG002|COMPLETED|Treatment Phase||13
10590524|NCT01773421|11746745|FG003|COMPLETED|Treatment Phase||5
10590525|NCT01773421|11746746|FG004|COMPLETED|Treatment Phase||0
10590526|NCT01773421|11746747|FG005|COMPLETED|Treatment Phase||0
10590527|NCT01773421|11746748|FG006|COMPLETED|Treatment Phase||0
10590528|NCT01773421|11746742|FG000|NOT COMPLETED|Treatment Phase||0
10590529|NCT01773421|11746743|FG001|NOT COMPLETED|Treatment Phase||0
10590530|NCT01773421|11746744|FG002|NOT COMPLETED|Treatment Phase||6
10590531|NCT01773421|11746745|FG003|NOT COMPLETED|Treatment Phase||2
10590532|NCT01773421|11746746|FG004|NOT COMPLETED|Treatment Phase||0
10590533|NCT01773421|11746747|FG005|NOT COMPLETED|Treatment Phase||0
10590534|NCT01773421|11746748|FG006|NOT COMPLETED|Treatment Phase||0
10590535|NCT01773421|11746742|FG000|STARTED|Extension Phase||0
10590536|NCT01773421|11746743|FG001|STARTED|Extension Phase||0
10590537|NCT01773421|11746744|FG002|STARTED|Extension Phase||0
10590538|NCT01773421|11746745|FG003|STARTED|Extension Phase||0
10590539|NCT01773421|11746746|FG004|STARTED|Extension Phase||15
10590540|NCT01773421|11746747|FG005|STARTED|Extension Phase||3
10590541|NCT01773421|11746748|FG006|STARTED|Extension Phase||0
10590542|NCT01773421|11746742|FG000|COMPLETED|Extension Phase||0
10590543|NCT01773421|11746743|FG001|COMPLETED|Extension Phase||0
10590544|NCT01773421|11746744|FG002|COMPLETED|Extension Phase||0
10590545|NCT01773421|11746745|FG003|COMPLETED|Extension Phase||0
10807672|NCT03888482|11969408|FG001|STARTED|First Wear Period (8 -1/+2 Days)||75
10590546|NCT01773421|11746746|FG004|COMPLETED|Extension Phase||12
10590547|NCT01773421|11746747|FG005|COMPLETED|Extension Phase||1
10590548|NCT01773421|11746748|FG006|COMPLETED|Extension Phase||0
10590549|NCT01773421|11746742|FG000|NOT COMPLETED|Extension Phase||0
10590550|NCT01773421|11746743|FG001|NOT COMPLETED|Extension Phase||0
10590551|NCT01773421|11746744|FG002|NOT COMPLETED|Extension Phase||0
10590552|NCT01773421|11746745|FG003|NOT COMPLETED|Extension Phase||0
10590553|NCT01773421|11746746|FG004|NOT COMPLETED|Extension Phase||3
10590554|NCT01773421|11746747|FG005|NOT COMPLETED|Extension Phase||2
10590555|NCT01773421|11746748|FG006|NOT COMPLETED|Extension Phase||0
10590556|NCT01773473|11746766|FG000|STARTED|Overall Study||207
10590557|NCT01773473|11746767|FG001|STARTED|Overall Study||196
10590558|NCT01773473|11746766|FG000|Received at Least 1 Dose of Study Drug|Overall Study||207
10590559|NCT01773473|11746767|FG001|Received at Least 1 Dose of Study Drug|Overall Study||196
10590560|NCT01773473|11746766|FG000|COMPLETED|Overall Study||191
10590561|NCT01773473|11746767|FG001|COMPLETED|Overall Study||177
10590562|NCT01773473|11746766|FG000|NOT COMPLETED|Overall Study||16
10590563|NCT01773473|11746767|FG001|NOT COMPLETED|Overall Study||19
10590564|NCT01773889|11746773|FG000|STARTED|Overall Study||2
10590565|NCT01773889|11746773|FG000|COMPLETED|Overall Study||0
10590566|NCT01773889|11746773|FG000|NOT COMPLETED|Overall Study||2
10590567|NCT01773954|11746777|FG000|STARTED|Overall Study||40
10590568|NCT01773954|11746777|FG000|COMPLETED|Overall Study||31
10590569|NCT01773954|11746777|FG000|NOT COMPLETED|Overall Study||9
10590570|NCT01773967|11746783|FG000|STARTED|Overall Study||483
10590571|NCT01773967|11746784|FG001|STARTED|Overall Study||488
10590572|NCT01773967|11746783|FG000|COMPLETED|Overall Study||468
10590573|NCT01773967|11746784|FG001|COMPLETED|Overall Study||475
10590574|NCT01773967|11746783|FG000|NOT COMPLETED|Overall Study||15
10590575|NCT01773967|11746784|FG001|NOT COMPLETED|Overall Study||13
10590576|NCT01773993|11746790|FG000|STARTED|Overall Study||534
10590577|NCT01773993|11746790|FG000|COMPLETED|Overall Study|Number of participants whose survey form were collected and included in analyses is shown.|499
10590578|NCT01773993|11746790|FG000|NOT COMPLETED|Overall Study||35
10590579|NCT01774045|11746796|FG000|STARTED|Overall Study||23
10590580|NCT01774045|11746797|FG001|STARTED|Overall Study||7
10590581|NCT01774045|11746796|FG000|COMPLETED|Overall Study||23
10703442|NCT02584608|11867935|FG000|NOT COMPLETED|Overall Study||0
10703443|NCT02584660|11867941|FG000|STARTED|Overall Study||51
10703444|NCT02584660|11867942|FG001|STARTED|Overall Study||63
10703445|NCT02584660|11867941|FG000|Treated|Overall Study||49
10703446|NCT02584660|11867942|FG001|Treated|Overall Study||63
10703447|NCT02584660|11867941|FG000|COMPLETED|Overall Study||44
10703448|NCT02584660|11867942|FG001|COMPLETED|Overall Study||55
10703449|NCT02584660|11867941|FG000|NOT COMPLETED|Overall Study||7
10703450|NCT02584660|11867942|FG001|NOT COMPLETED|Overall Study||8
10703451|NCT02584673|11867950|FG000|STARTED|Overall Study||15
10703452|NCT02584673|11867951|FG001|STARTED|Overall Study||15
10590582|NCT01774045|11746797|FG001|COMPLETED|Overall Study||7
10590583|NCT01774045|11746796|FG000|NOT COMPLETED|Overall Study||0
10590584|NCT01774045|11746797|FG001|NOT COMPLETED|Overall Study||0
10590585|NCT01774084|11746806|FG000|STARTED|Overall Study||11
10590586|NCT01774084|11746807|FG001|STARTED|Overall Study||12
10590587|NCT01774084|11746806|FG000|COMPLETED|Overall Study||10
10590588|NCT01774084|11746807|FG001|COMPLETED|Overall Study||12
10590589|NCT01774084|11746806|FG000|NOT COMPLETED|Overall Study||1
10590590|NCT01774084|11746807|FG001|NOT COMPLETED|Overall Study||0
10590591|NCT01774097|11746815|FG000|STARTED|Overall Study||40
10590592|NCT01774097|11746816|FG001|STARTED|Overall Study||42
10590593|NCT01774097|11746815|FG000|COMPLETED|Overall Study||38
10590594|NCT01774097|11746816|FG001|COMPLETED|Overall Study||40
10590595|NCT01774097|11746815|FG000|NOT COMPLETED|Overall Study||2
10590596|NCT01774097|11746816|FG001|NOT COMPLETED|Overall Study||2
10590597|NCT01774110|11746824|FG000|STARTED|Overall Study||12
10590598|NCT01774110|11746824|FG000|COMPLETED|Overall Study||5
10590599|NCT01774110|11746824|FG000|NOT COMPLETED|Overall Study||7
10590600|NCT01774149|11746831|FG000|STARTED|Overall Study||15
10590601|NCT01774149|11746832|FG001|STARTED|Overall Study||15
10590602|NCT01774149|11746831|FG000|COMPLETED|Overall Study||14
10590603|NCT01774149|11746832|FG001|COMPLETED|Overall Study||12
10590604|NCT01774149|11746831|FG000|NOT COMPLETED|Overall Study||1
10590605|NCT01774149|11746832|FG001|NOT COMPLETED|Overall Study||3
10590606|NCT01774305|11746840|FG000|STARTED|Overall Study||71
10590607|NCT01774305|11746841|FG001|STARTED|Overall Study||71
10590608|NCT01774305|11746840|FG000|COMPLETED|Overall Study||70
10590609|NCT01774305|11746841|FG001|COMPLETED|Overall Study||71
10590610|NCT01774305|11746840|FG000|NOT COMPLETED|Overall Study||1
10590611|NCT01774305|11746841|FG001|NOT COMPLETED|Overall Study||0
10590612|NCT01774344|11746849|FG000|STARTED|Overall Study||194
10590613|NCT01774344|11746850|FG001|STARTED|Overall Study||379
10590614|NCT01774344|11746849|FG000|Treated|Overall Study||193
10590615|NCT01774344|11746850|FG001|Treated|Overall Study||374
10590616|NCT01774344|11746849|FG000|Entered Survival FU|Overall Study||145
10590617|NCT01774344|11746850|FG001|Entered Survival FU|Overall Study||291
10590618|NCT01774344|11746849|FG000|COMPLETED|Overall Study||132
10590619|NCT01774344|11746850|FG001|COMPLETED|Overall Study||258
10590620|NCT01774344|11746849|FG000|NOT COMPLETED|Overall Study||62
10590621|NCT01774344|11746850|FG001|NOT COMPLETED|Overall Study||121
10590622|NCT01774591|11746858|FG000|STARTED|Overall Study||10
10590623|NCT01774591|11746859|FG001|STARTED|Overall Study||11
10703453|NCT02584673|11867950|FG000|COMPLETED|Overall Study||15
10703454|NCT02584673|11867951|FG001|COMPLETED|Overall Study||15
10703455|NCT02584673|11867950|FG000|NOT COMPLETED|Overall Study||0
10703456|NCT02584673|11867951|FG001|NOT COMPLETED|Overall Study||0
10703457|NCT02584686|11867959|FG000|STARTED|Overall Study||12
10590624|NCT01774591|11746858|FG000|COMPLETED|Overall Study||9
10590625|NCT01774591|11746859|FG001|COMPLETED|Overall Study||7
10590626|NCT01774591|11746858|FG000|NOT COMPLETED|Overall Study||1
10590627|NCT01774591|11746859|FG001|NOT COMPLETED|Overall Study||4
10590628|NCT01774604|11746867|FG000|STARTED|Overall Study||223
10590629|NCT01774604|11746868|FG001|STARTED|Overall Study||226
10590630|NCT01774604|11746867|FG000|COMPLETED|Overall Study||223
10590631|NCT01774604|11746868|FG001|COMPLETED|Overall Study||226
10590632|NCT01774604|11746867|FG000|NOT COMPLETED|Overall Study||0
10590633|NCT01774604|11746868|FG001|NOT COMPLETED|Overall Study||0
10590634|NCT01774760|11746874|FG000|STARTED|Overall Study||10
10590635|NCT01774760|11746874|FG000|COMPLETED|Overall Study||10
10590636|NCT01774760|11746874|FG000|NOT COMPLETED|Overall Study||0
10590637|NCT01774786|11746880|FG000|STARTED|Overall Study||388
10590638|NCT01774786|11746881|FG001|STARTED|Overall Study||392
10590639|NCT01774786|11746880|FG000|Did Not Receive Any Study Treatment|Overall Study|2 patients found ineligible after enrollment and 2 patients died before treatment.|4
10590640|NCT01774786|11746881|FG001|Did Not Receive Any Study Treatment|Overall Study|All 3 patients found ineligible for the study after enrollment and before treatment.|3
10590641|NCT01774786|11746880|FG000|Received at Least One Dose of Pertuzumab|Overall Study||384
10590642|NCT01774786|11746881|FG001|Received at Least One Dose of Pertuzumab|Overall Study|One participant randomized to placebo arm received 1 dose of pertuzumab by error.|1
10590643|NCT01774786|11746880|FG000|Received Placebo (No Pertuzumab)|Overall Study||0
10590644|NCT01774786|11746881|FG001|Received Placebo (No Pertuzumab)|Overall Study||388
10590645|NCT01774786|11746880|FG000|COMPLETED|Overall Study||60
10590646|NCT01774786|11746881|FG001|COMPLETED|Overall Study||46
10590647|NCT01774786|11746880|FG000|NOT COMPLETED|Overall Study||328
10590648|NCT01774786|11746881|FG001|NOT COMPLETED|Overall Study||346
10590649|NCT01774799|11746891|FG000|STARTED|Overall Study||212
10590650|NCT01774799|11746892|FG001|STARTED|Overall Study||190
10590651|NCT01774799|11746893|FG002|STARTED|Overall Study||212
10590652|NCT01774799|11746894|FG003|STARTED|Overall Study||190
10590653|NCT01774799|11746891|FG000|COMPLETED|Overall Study||211
10590654|NCT01774799|11746892|FG001|COMPLETED|Overall Study||189
10590655|NCT01774799|11746893|FG002|COMPLETED|Overall Study||212
10590656|NCT01774799|11746894|FG003|COMPLETED|Overall Study||190
10590657|NCT01774799|11746891|FG000|NOT COMPLETED|Overall Study||1
10590658|NCT01774799|11746892|FG001|NOT COMPLETED|Overall Study||1
10590659|NCT01774799|11746893|FG002|NOT COMPLETED|Overall Study||0
10590660|NCT01774799|11746894|FG003|NOT COMPLETED|Overall Study||0
10590661|NCT01774851|11746902|FG000|STARTED|Overall Study||42
10590662|NCT01774851|11746903|FG001|STARTED|Overall Study||42
10590663|NCT01774851|11746902|FG000|COMPLETED|Overall Study||42
10590664|NCT01774851|11746903|FG001|COMPLETED|Overall Study||42
10590665|NCT01774851|11746902|FG000|NOT COMPLETED|Overall Study||0
10703458|NCT02584686|11867960|FG001|STARTED|Overall Study||12
10703459|NCT02584686|11867959|FG000|COMPLETED|Overall Study||12
10590666|NCT01774851|11746903|FG001|NOT COMPLETED|Overall Study||0
10590667|NCT01774903|11746909|FG000|STARTED|Overall Study||45
10590668|NCT01774903|11746909|FG000|COMPLETED|Overall Study||34
10590669|NCT01774903|11746909|FG000|NOT COMPLETED|Overall Study||11
10590670|NCT01774929|11746914|FG000|STARTED|Overall Study||35
10590671|NCT01774929|11746914|FG000|COMPLETED|Overall Study||32
10590672|NCT01774929|11746914|FG000|NOT COMPLETED|Overall Study||3
10590673|NCT01774968|11746920|FG000|STARTED|Overall Study||162
10590674|NCT01774968|11746921|FG001|STARTED|Overall Study||163
10590675|NCT01774968|11746920|FG000|Received at Least 1 Dose of Study Drug|Overall Study||162
10590676|NCT01774968|11746921|FG001|Received at Least 1 Dose of Study Drug|Overall Study||161
10590677|NCT01774968|11746920|FG000|COMPLETED|Overall Study||132
10590678|NCT01774968|11746921|FG001|COMPLETED|Overall Study||128
10590679|NCT01774968|11746920|FG000|NOT COMPLETED|Overall Study||30
10590680|NCT01774968|11746921|FG001|NOT COMPLETED|Overall Study||35
10590681|NCT01774981|11746935|FG000|STARTED|Overall Study||3
10590682|NCT01774981|11746936|FG001|STARTED|Overall Study||4
10590683|NCT01774981|11746937|FG002|STARTED|Overall Study||4
10590684|NCT01774981|11746938|FG003|STARTED|Overall Study||4
10590685|NCT01774981|11746939|FG004|STARTED|Overall Study||6
10590686|NCT01774981|11746940|FG005|STARTED|Overall Study||14
10590687|NCT01774981|11746941|FG006|STARTED|Overall Study||13
10590688|NCT01774981|11746942|FG007|STARTED|Overall Study||12
10590689|NCT01774981|11746935|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
10590690|NCT01774981|11746936|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4
10590691|NCT01774981|11746937|FG002|Received at Least 1 Dose of Study Drug|Overall Study||4
10590692|NCT01774981|11746938|FG003|Received at Least 1 Dose of Study Drug|Overall Study||4
10590693|NCT01774981|11746939|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
10590694|NCT01774981|11746940|FG005|Received at Least 1 Dose of Study Drug|Overall Study||14
10590695|NCT01774981|11746941|FG006|Received at Least 1 Dose of Study Drug|Overall Study||13
10590696|NCT01774981|11746942|FG007|Received at Least 1 Dose of Study Drug|Overall Study||12
10590697|NCT01774981|11746935|FG000|COMPLETED|Overall Study||3
10590698|NCT01774981|11746936|FG001|COMPLETED|Overall Study||4
10590699|NCT01774981|11746937|FG002|COMPLETED|Overall Study||4
10703460|NCT02584686|11867960|FG001|COMPLETED|Overall Study||12
10590700|NCT01774981|11746938|FG003|COMPLETED|Overall Study||4
10590701|NCT01774981|11746939|FG004|COMPLETED|Overall Study||5
10590702|NCT01774981|11746940|FG005|COMPLETED|Overall Study||13
10590703|NCT01774981|11746941|FG006|COMPLETED|Overall Study||13
10590704|NCT01774981|11746942|FG007|COMPLETED|Overall Study||11
10590705|NCT01774981|11746935|FG000|NOT COMPLETED|Overall Study||0
10590706|NCT01774981|11746936|FG001|NOT COMPLETED|Overall Study||0
10590707|NCT01774981|11746937|FG002|NOT COMPLETED|Overall Study||0
10590708|NCT01774981|11746938|FG003|NOT COMPLETED|Overall Study||0
10590709|NCT01774981|11746939|FG004|NOT COMPLETED|Overall Study||1
10590710|NCT01774981|11746940|FG005|NOT COMPLETED|Overall Study||1
10590711|NCT01774981|11746941|FG006|NOT COMPLETED|Overall Study||0
10590712|NCT01774981|11746942|FG007|NOT COMPLETED|Overall Study||1
10590713|NCT01775124|11746967|FG000|STARTED|Core Period||168
10590714|NCT01775124|11746968|FG001|STARTED|Core Period||166
10590715|NCT01775124|11746967|FG000|Full Analysis Set|Core Period||167
10590716|NCT01775124|11746968|FG001|Full Analysis Set|Core Period||166
10590717|NCT01775124|11746967|FG000|Per Protocol Set|Core Period||157
10590718|NCT01775124|11746968|FG001|Per Protocol Set|Core Period||155
10590719|NCT01775124|11746967|FG000|Safety Set|Core Period|1 patient was mis-randomized & 1 patient discontinued due to AE. No treatment given|166
10590720|NCT01775124|11746968|FG001|Safety Set|Core Period||166
10590721|NCT01775124|11746967|FG000|COMPLETED|Core Period||157
10590722|NCT01775124|11746968|FG001|COMPLETED|Core Period||156
10590723|NCT01775124|11746967|FG000|NOT COMPLETED|Core Period||11
10590724|NCT01775124|11746968|FG001|NOT COMPLETED|Core Period||10
10703461|NCT02584686|11867959|FG000|NOT COMPLETED|Overall Study||0
10703462|NCT02584686|11867960|FG001|NOT COMPLETED|Overall Study||0
10703463|NCT02584725|11867970|FG000|STARTED|Overall Study||28
10703464|NCT02584725|11867971|FG001|STARTED|Overall Study||28
10703465|NCT02584725|11867972|FG002|STARTED|Overall Study||28
10703466|NCT02584725|11867970|FG000|COMPLETED|Overall Study||28
10590725|NCT01775124|11746967|FG000|STARTED|Extension Period||157
10590726|NCT01775124|11746968|FG001|STARTED|Extension Period||156
10590727|NCT01775124|11746967|FG000|COMPLETED|Extension Period||145
10590728|NCT01775124|11746968|FG001|COMPLETED|Extension Period||138
10590729|NCT01775124|11746967|FG000|NOT COMPLETED|Extension Period||12
10590730|NCT01775124|11746968|FG001|NOT COMPLETED|Extension Period||18
10590731|NCT01775137|11746975|FG000|STARTED|Overall Study||45
10590732|NCT01775137|11746975|FG000|COMPLETED|Overall Study||34
10590733|NCT01775137|11746975|FG000|NOT COMPLETED|Overall Study||11
10590734|NCT01775189|11746982|FG000|STARTED|Naloxone Challenge Phase||45
10590735|NCT01775189|11746983|FG001|STARTED|Naloxone Challenge Phase||0
10590736|NCT01775189|11746984|FG002|STARTED|Naloxone Challenge Phase||0
10590737|NCT01775189|11746985|FG003|STARTED|Naloxone Challenge Phase||0
10590738|NCT01775189|11746986|FG004|STARTED|Naloxone Challenge Phase||0
10590739|NCT01775189|11746987|FG005|STARTED|Naloxone Challenge Phase||0
10590740|NCT01775189|11746988|FG006|STARTED|Naloxone Challenge Phase||0
10590741|NCT01775189|11746982|FG000|COMPLETED|Naloxone Challenge Phase||45
10590742|NCT01775189|11746983|FG001|COMPLETED|Naloxone Challenge Phase||0
10590743|NCT01775189|11746984|FG002|COMPLETED|Naloxone Challenge Phase||0
10590744|NCT01775189|11746985|FG003|COMPLETED|Naloxone Challenge Phase||0
10590745|NCT01775189|11746986|FG004|COMPLETED|Naloxone Challenge Phase||0
10590746|NCT01775189|11746987|FG005|COMPLETED|Naloxone Challenge Phase||0
10590747|NCT01775189|11746988|FG006|COMPLETED|Naloxone Challenge Phase||0
10590748|NCT01775189|11746982|FG000|NOT COMPLETED|Naloxone Challenge Phase||0
10590749|NCT01775189|11746983|FG001|NOT COMPLETED|Naloxone Challenge Phase||0
10590750|NCT01775189|11746984|FG002|NOT COMPLETED|Naloxone Challenge Phase||0
10590751|NCT01775189|11746985|FG003|NOT COMPLETED|Naloxone Challenge Phase||0
10590752|NCT01775189|11746986|FG004|NOT COMPLETED|Naloxone Challenge Phase||0
10590753|NCT01775189|11746987|FG005|NOT COMPLETED|Naloxone Challenge Phase||0
10590754|NCT01775189|11746988|FG006|NOT COMPLETED|Naloxone Challenge Phase||0
10590755|NCT01775189|11746982|FG000|STARTED|Drug Discrimination Phase: Day 1||0
10590756|NCT01775189|11746983|FG001|STARTED|Drug Discrimination Phase: Day 1||22
10590757|NCT01775189|11746984|FG002|STARTED|Drug Discrimination Phase: Day 1||23
10590758|NCT01775189|11746985|FG003|STARTED|Drug Discrimination Phase: Day 1||0
10590759|NCT01775189|11746986|FG004|STARTED|Drug Discrimination Phase: Day 1||0
10590760|NCT01775189|11746987|FG005|STARTED|Drug Discrimination Phase: Day 1||0
10590761|NCT01775189|11746988|FG006|STARTED|Drug Discrimination Phase: Day 1||0
10590762|NCT01775189|11746982|FG000|COMPLETED|Drug Discrimination Phase: Day 1||0
10590763|NCT01775189|11746983|FG001|COMPLETED|Drug Discrimination Phase: Day 1||19
10590764|NCT01775189|11746984|FG002|COMPLETED|Drug Discrimination Phase: Day 1||23
10590765|NCT01775189|11746985|FG003|COMPLETED|Drug Discrimination Phase: Day 1||0
10590766|NCT01775189|11746986|FG004|COMPLETED|Drug Discrimination Phase: Day 1||0
10590767|NCT01775189|11746987|FG005|COMPLETED|Drug Discrimination Phase: Day 1||0
10590768|NCT01775189|11746988|FG006|COMPLETED|Drug Discrimination Phase: Day 1||0
10590769|NCT01775189|11746982|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
10703467|NCT02584725|11867971|FG001|COMPLETED|Overall Study||28
10703468|NCT02584725|11867972|FG002|COMPLETED|Overall Study||28
10703469|NCT02584725|11867970|FG000|NOT COMPLETED|Overall Study||0
10703470|NCT02584725|11867971|FG001|NOT COMPLETED|Overall Study||0
10703471|NCT02584725|11867972|FG002|NOT COMPLETED|Overall Study||0
10590770|NCT01775189|11746983|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 1||3
10590771|NCT01775189|11746984|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
10590772|NCT01775189|11746985|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
10590773|NCT01775189|11746986|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
10590774|NCT01775189|11746987|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
10590775|NCT01775189|11746988|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
10590776|NCT01775189|11746982|FG000|STARTED|Drug Discrimination Phase: Day 2||0
10590777|NCT01775189|11746983|FG001|STARTED|Drug Discrimination Phase: Day 2||19
10703472|NCT02584790|11867980|FG000|STARTED|Overall Study||55
10703473|NCT02584790|11867980|FG000|COMPLETED|Overall Study||40
10703474|NCT02584790|11867980|FG000|NOT COMPLETED|Overall Study||15
10703475|NCT02584855|11867984|FG000|STARTED|Open-Label Treatment Period||394
10713724|NCT02680847|11879220|FG001|NOT COMPLETED|Overall Study||3
10590778|NCT01775189|11746984|FG002|STARTED|Drug Discrimination Phase: Day 2||23
10590779|NCT01775189|11746985|FG003|STARTED|Drug Discrimination Phase: Day 2||0
10590780|NCT01775189|11746986|FG004|STARTED|Drug Discrimination Phase: Day 2||0
10590781|NCT01775189|11746987|FG005|STARTED|Drug Discrimination Phase: Day 2||0
10590782|NCT01775189|11746988|FG006|STARTED|Drug Discrimination Phase: Day 2||0
10590783|NCT01775189|11746982|FG000|COMPLETED|Drug Discrimination Phase: Day 2||0
10590784|NCT01775189|11746983|FG001|COMPLETED|Drug Discrimination Phase: Day 2||16
10590785|NCT01775189|11746984|FG002|COMPLETED|Drug Discrimination Phase: Day 2||16
10590786|NCT01775189|11746985|FG003|COMPLETED|Drug Discrimination Phase: Day 2||0
10590787|NCT01775189|11746986|FG004|COMPLETED|Drug Discrimination Phase: Day 2||0
10590788|NCT01775189|11746987|FG005|COMPLETED|Drug Discrimination Phase: Day 2||0
10590789|NCT01775189|11746988|FG006|COMPLETED|Drug Discrimination Phase: Day 2||0
10590790|NCT01775189|11746982|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
10590791|NCT01775189|11746983|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 2||3
10590792|NCT01775189|11746984|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 2||7
10590793|NCT01775189|11746985|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
10590794|NCT01775189|11746986|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
10590795|NCT01775189|11746987|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
10590796|NCT01775189|11746988|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
10590797|NCT01775189|11746982|FG000|STARTED|Treatment Phase: First Intervention||0
10590798|NCT01775189|11746983|FG001|STARTED|Treatment Phase: First Intervention||0
10590799|NCT01775189|11746984|FG002|STARTED|Treatment Phase: First Intervention||0
10590800|NCT01775189|11746985|FG003|STARTED|Treatment Phase: First Intervention||8
10590801|NCT01775189|11746986|FG004|STARTED|Treatment Phase: First Intervention||8
10590802|NCT01775189|11746987|FG005|STARTED|Treatment Phase: First Intervention||8
10590803|NCT01775189|11746988|FG006|STARTED|Treatment Phase: First Intervention||8
10590804|NCT01775189|11746982|FG000|COMPLETED|Treatment Phase: First Intervention||0
10590805|NCT01775189|11746983|FG001|COMPLETED|Treatment Phase: First Intervention||0
10590806|NCT01775189|11746984|FG002|COMPLETED|Treatment Phase: First Intervention||0
10590807|NCT01775189|11746985|FG003|COMPLETED|Treatment Phase: First Intervention||8
10590808|NCT01775189|11746986|FG004|COMPLETED|Treatment Phase: First Intervention||8
10590809|NCT01775189|11746987|FG005|COMPLETED|Treatment Phase: First Intervention||8
10590810|NCT01775189|11746988|FG006|COMPLETED|Treatment Phase: First Intervention||8
10590811|NCT01775189|11746982|FG000|NOT COMPLETED|Treatment Phase: First Intervention||0
10590812|NCT01775189|11746983|FG001|NOT COMPLETED|Treatment Phase: First Intervention||0
10590813|NCT01775189|11746984|FG002|NOT COMPLETED|Treatment Phase: First Intervention||0
10590814|NCT01775189|11746985|FG003|NOT COMPLETED|Treatment Phase: First Intervention||0
10590815|NCT01775189|11746986|FG004|NOT COMPLETED|Treatment Phase: First Intervention||0
10590816|NCT01775189|11746987|FG005|NOT COMPLETED|Treatment Phase: First Intervention||0
10590817|NCT01775189|11746988|FG006|NOT COMPLETED|Treatment Phase: First Intervention||0
10590818|NCT01775189|11746982|FG000|STARTED|Treatment Phase: Washout Period 1||0
10590819|NCT01775189|11746983|FG001|STARTED|Treatment Phase: Washout Period 1||0
10590820|NCT01775189|11746984|FG002|STARTED|Treatment Phase: Washout Period 1||0
10590821|NCT01775189|11746985|FG003|STARTED|Treatment Phase: Washout Period 1||8
10807673|NCT03888482|11969407|FG000|COMPLETED|First Wear Period (8 -1/+2 Days)||76
10590822|NCT01775189|11746986|FG004|STARTED|Treatment Phase: Washout Period 1||8
10590823|NCT01775189|11746987|FG005|STARTED|Treatment Phase: Washout Period 1||8
10590824|NCT01775189|11746988|FG006|STARTED|Treatment Phase: Washout Period 1||8
10590825|NCT01775189|11746982|FG000|COMPLETED|Treatment Phase: Washout Period 1||0
10590826|NCT01775189|11746983|FG001|COMPLETED|Treatment Phase: Washout Period 1||0
10590827|NCT01775189|11746984|FG002|COMPLETED|Treatment Phase: Washout Period 1||0
10590828|NCT01775189|11746985|FG003|COMPLETED|Treatment Phase: Washout Period 1||8
10590829|NCT01775189|11746986|FG004|COMPLETED|Treatment Phase: Washout Period 1||8
10590830|NCT01775189|11746987|FG005|COMPLETED|Treatment Phase: Washout Period 1||7
10590831|NCT01775189|11746988|FG006|COMPLETED|Treatment Phase: Washout Period 1||8
10590832|NCT01775189|11746982|FG000|NOT COMPLETED|Treatment Phase: Washout Period 1||0
10590833|NCT01775189|11746983|FG001|NOT COMPLETED|Treatment Phase: Washout Period 1||0
10590834|NCT01775189|11746984|FG002|NOT COMPLETED|Treatment Phase: Washout Period 1||0
10590835|NCT01775189|11746985|FG003|NOT COMPLETED|Treatment Phase: Washout Period 1||0
10590836|NCT01775189|11746986|FG004|NOT COMPLETED|Treatment Phase: Washout Period 1||0
10590837|NCT01775189|11746987|FG005|NOT COMPLETED|Treatment Phase: Washout Period 1||1
10590838|NCT01775189|11746988|FG006|NOT COMPLETED|Treatment Phase: Washout Period 1||0
10590839|NCT01775189|11746982|FG000|STARTED|Treatment Phase: Second Intervention||0
10590840|NCT01775189|11746983|FG001|STARTED|Treatment Phase: Second Intervention||0
10590841|NCT01775189|11746984|FG002|STARTED|Treatment Phase: Second Intervention||0
10590842|NCT01775189|11746985|FG003|STARTED|Treatment Phase: Second Intervention||8
10590843|NCT01775189|11746986|FG004|STARTED|Treatment Phase: Second Intervention||8
10590844|NCT01775189|11746987|FG005|STARTED|Treatment Phase: Second Intervention||7
10590845|NCT01775189|11746988|FG006|STARTED|Treatment Phase: Second Intervention||8
10590846|NCT01775189|11746982|FG000|COMPLETED|Treatment Phase: Second Intervention||0
10590847|NCT01775189|11746983|FG001|COMPLETED|Treatment Phase: Second Intervention||0
10590848|NCT01775189|11746984|FG002|COMPLETED|Treatment Phase: Second Intervention||0
10590849|NCT01775189|11746985|FG003|COMPLETED|Treatment Phase: Second Intervention||8
10807674|NCT03888482|11969408|FG001|COMPLETED|First Wear Period (8 -1/+2 Days)||75
10807675|NCT03888482|11969407|FG000|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0
10590850|NCT01775189|11746986|FG004|COMPLETED|Treatment Phase: Second Intervention||8
10590851|NCT01775189|11746987|FG005|COMPLETED|Treatment Phase: Second Intervention||7
10590852|NCT01775189|11746988|FG006|COMPLETED|Treatment Phase: Second Intervention||8
10590853|NCT01775189|11746982|FG000|NOT COMPLETED|Treatment Phase: Second Intervention||0
10590854|NCT01775189|11746983|FG001|NOT COMPLETED|Treatment Phase: Second Intervention||0
10590855|NCT01775189|11746984|FG002|NOT COMPLETED|Treatment Phase: Second Intervention||0
10590856|NCT01775189|11746985|FG003|NOT COMPLETED|Treatment Phase: Second Intervention||0
10590857|NCT01775189|11746986|FG004|NOT COMPLETED|Treatment Phase: Second Intervention||0
10590858|NCT01775189|11746987|FG005|NOT COMPLETED|Treatment Phase: Second Intervention||0
10590859|NCT01775189|11746988|FG006|NOT COMPLETED|Treatment Phase: Second Intervention||0
10590860|NCT01775189|11746982|FG000|STARTED|Treatment Phase: Washout Period 2||0
10590861|NCT01775189|11746983|FG001|STARTED|Treatment Phase: Washout Period 2||0
10590862|NCT01775189|11746984|FG002|STARTED|Treatment Phase: Washout Period 2||0
10590863|NCT01775189|11746985|FG003|STARTED|Treatment Phase: Washout Period 2||8
10590864|NCT01775189|11746986|FG004|STARTED|Treatment Phase: Washout Period 2||8
10590865|NCT01775189|11746987|FG005|STARTED|Treatment Phase: Washout Period 2||7
10590866|NCT01775189|11746988|FG006|STARTED|Treatment Phase: Washout Period 2||8
10590867|NCT01775189|11746982|FG000|COMPLETED|Treatment Phase: Washout Period 2||0
10590868|NCT01775189|11746983|FG001|COMPLETED|Treatment Phase: Washout Period 2||0
10590869|NCT01775189|11746984|FG002|COMPLETED|Treatment Phase: Washout Period 2||0
10590870|NCT01775189|11746985|FG003|COMPLETED|Treatment Phase: Washout Period 2||7
10590871|NCT01775189|11746986|FG004|COMPLETED|Treatment Phase: Washout Period 2||8
10590872|NCT01775189|11746987|FG005|COMPLETED|Treatment Phase: Washout Period 2||7
10590873|NCT01775189|11746988|FG006|COMPLETED|Treatment Phase: Washout Period 2||8
10590874|NCT01775189|11746982|FG000|NOT COMPLETED|Treatment Phase: Washout Period 2||0
10590875|NCT01775189|11746983|FG001|NOT COMPLETED|Treatment Phase: Washout Period 2||0
10590876|NCT01775189|11746984|FG002|NOT COMPLETED|Treatment Phase: Washout Period 2||0
10590877|NCT01775189|11746985|FG003|NOT COMPLETED|Treatment Phase: Washout Period 2||1
10590878|NCT01775189|11746986|FG004|NOT COMPLETED|Treatment Phase: Washout Period 2||0
10590879|NCT01775189|11746987|FG005|NOT COMPLETED|Treatment Phase: Washout Period 2||0
10590880|NCT01775189|11746988|FG006|NOT COMPLETED|Treatment Phase: Washout Period 2||0
10590881|NCT01775189|11746982|FG000|STARTED|Treatment Phase: Third Intervention||0
10590882|NCT01775189|11746983|FG001|STARTED|Treatment Phase: Third Intervention||0
10590883|NCT01775189|11746984|FG002|STARTED|Treatment Phase: Third Intervention||0
10590884|NCT01775189|11746985|FG003|STARTED|Treatment Phase: Third Intervention||7
10590885|NCT01775189|11746986|FG004|STARTED|Treatment Phase: Third Intervention||8
10590886|NCT01775189|11746987|FG005|STARTED|Treatment Phase: Third Intervention||7
10590887|NCT01775189|11746988|FG006|STARTED|Treatment Phase: Third Intervention||8
10590888|NCT01775189|11746982|FG000|COMPLETED|Treatment Phase: Third Intervention||0
10590889|NCT01775189|11746983|FG001|COMPLETED|Treatment Phase: Third Intervention||0
10590890|NCT01775189|11746984|FG002|COMPLETED|Treatment Phase: Third Intervention||0
10590891|NCT01775189|11746985|FG003|COMPLETED|Treatment Phase: Third Intervention||7
10590892|NCT01775189|11746986|FG004|COMPLETED|Treatment Phase: Third Intervention||8
10590893|NCT01775189|11746987|FG005|COMPLETED|Treatment Phase: Third Intervention||7
10590894|NCT01775189|11746988|FG006|COMPLETED|Treatment Phase: Third Intervention||8
10590895|NCT01775189|11746982|FG000|NOT COMPLETED|Treatment Phase: Third Intervention||0
10590896|NCT01775189|11746983|FG001|NOT COMPLETED|Treatment Phase: Third Intervention||0
10590897|NCT01775189|11746984|FG002|NOT COMPLETED|Treatment Phase: Third Intervention||0
10590898|NCT01775189|11746985|FG003|NOT COMPLETED|Treatment Phase: Third Intervention||0
10590899|NCT01775189|11746986|FG004|NOT COMPLETED|Treatment Phase: Third Intervention||0
10590900|NCT01775189|11746987|FG005|NOT COMPLETED|Treatment Phase: Third Intervention||0
10590901|NCT01775189|11746988|FG006|NOT COMPLETED|Treatment Phase: Third Intervention||0
10590902|NCT01775189|11746982|FG000|STARTED|Treatment Phase: Washout Period 3||0
10590903|NCT01775189|11746983|FG001|STARTED|Treatment Phase: Washout Period 3||0
10590904|NCT01775189|11746984|FG002|STARTED|Treatment Phase: Washout Period 3||0
10590905|NCT01775189|11746985|FG003|STARTED|Treatment Phase: Washout Period 3||7
10590906|NCT01775189|11746986|FG004|STARTED|Treatment Phase: Washout Period 3||8
10590907|NCT01775189|11746987|FG005|STARTED|Treatment Phase: Washout Period 3||7
10590908|NCT01775189|11746988|FG006|STARTED|Treatment Phase: Washout Period 3||8
10590909|NCT01775189|11746982|FG000|COMPLETED|Treatment Phase: Washout Period 3||0
10590910|NCT01775189|11746983|FG001|COMPLETED|Treatment Phase: Washout Period 3||0
10590911|NCT01775189|11746984|FG002|COMPLETED|Treatment Phase: Washout Period 3||0
10590912|NCT01775189|11746985|FG003|COMPLETED|Treatment Phase: Washout Period 3||6
10590913|NCT01775189|11746986|FG004|COMPLETED|Treatment Phase: Washout Period 3||8
10590914|NCT01775189|11746987|FG005|COMPLETED|Treatment Phase: Washout Period 3||7
10590915|NCT01775189|11746988|FG006|COMPLETED|Treatment Phase: Washout Period 3||7
10590916|NCT01775189|11746982|FG000|NOT COMPLETED|Treatment Phase: Washout Period 3||0
10590917|NCT01775189|11746983|FG001|NOT COMPLETED|Treatment Phase: Washout Period 3||0
10590918|NCT01775189|11746984|FG002|NOT COMPLETED|Treatment Phase: Washout Period 3||0
10590919|NCT01775189|11746985|FG003|NOT COMPLETED|Treatment Phase: Washout Period 3||1
10590920|NCT01775189|11746986|FG004|NOT COMPLETED|Treatment Phase: Washout Period 3||0
10590921|NCT01775189|11746987|FG005|NOT COMPLETED|Treatment Phase: Washout Period 3||0
10590922|NCT01775189|11746988|FG006|NOT COMPLETED|Treatment Phase: Washout Period 3||1
10590923|NCT01775189|11746982|FG000|STARTED|Treatment Phase: Fourth Intervention||0
10590924|NCT01775189|11746983|FG001|STARTED|Treatment Phase: Fourth Intervention||0
10590925|NCT01775189|11746984|FG002|STARTED|Treatment Phase: Fourth Intervention||0
10590926|NCT01775189|11746985|FG003|STARTED|Treatment Phase: Fourth Intervention||6
10590927|NCT01775189|11746986|FG004|STARTED|Treatment Phase: Fourth Intervention||8
10590928|NCT01775189|11746987|FG005|STARTED|Treatment Phase: Fourth Intervention||7
10590929|NCT01775189|11746988|FG006|STARTED|Treatment Phase: Fourth Intervention||7
10590930|NCT01775189|11746982|FG000|COMPLETED|Treatment Phase: Fourth Intervention||0
10590931|NCT01775189|11746983|FG001|COMPLETED|Treatment Phase: Fourth Intervention||0
10590932|NCT01775189|11746984|FG002|COMPLETED|Treatment Phase: Fourth Intervention||0
10590933|NCT01775189|11746985|FG003|COMPLETED|Treatment Phase: Fourth Intervention||6
10590934|NCT01775189|11746986|FG004|COMPLETED|Treatment Phase: Fourth Intervention||8
10590935|NCT01775189|11746987|FG005|COMPLETED|Treatment Phase: Fourth Intervention||7
10590936|NCT01775189|11746988|FG006|COMPLETED|Treatment Phase: Fourth Intervention||7
10590937|NCT01775189|11746982|FG000|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
10590938|NCT01775189|11746983|FG001|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
10590939|NCT01775189|11746984|FG002|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
10590940|NCT01775189|11746985|FG003|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
10590941|NCT01775189|11746986|FG004|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
10590942|NCT01775189|11746987|FG005|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
10590943|NCT01775189|11746988|FG006|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
10590944|NCT01775371|11747018|FG000|STARTED|Overall Study||306
10590945|NCT01775371|11747019|FG001|STARTED|Overall Study||330
10590946|NCT01775371|11747018|FG000|COMPLETED|Overall Study||306
10590947|NCT01775371|11747019|FG001|COMPLETED|Overall Study||330
10590948|NCT01775371|11747018|FG000|NOT COMPLETED|Overall Study||0
10590949|NCT01775371|11747019|FG001|NOT COMPLETED|Overall Study||0
10590950|NCT01775410|11747027|FG000|STARTED|Overall Study||4
10590951|NCT01775410|11747027|FG000|COMPLETED|Overall Study||4
10590952|NCT01775410|11747027|FG000|NOT COMPLETED|Overall Study||0
10590953|NCT01775501|11747031|FG000|STARTED|Overall Study||40
10590954|NCT01775501|11747031|FG000|COMPLETED|Overall Study||39
10590955|NCT01775501|11747031|FG000|NOT COMPLETED|Overall Study||1
10590956|NCT01775553|11747035|FG000|STARTED|Overall Study||13
10590957|NCT01775553|11747035|FG000|COMPLETED|Overall Study||0
10590958|NCT01775553|11747035|FG000|NOT COMPLETED|Overall Study||13
10590959|NCT01775670|11747041|FG000|STARTED|Overall Study||1
10590960|NCT01775670|11747042|FG001|STARTED|Overall Study||3
10590961|NCT01775670|11747041|FG000|COMPLETED|Overall Study||0
10590962|NCT01775670|11747042|FG001|COMPLETED|Overall Study||2
10590963|NCT01775670|11747041|FG000|NOT COMPLETED|Overall Study||1
10590964|NCT01775670|11747042|FG001|NOT COMPLETED|Overall Study||1
10590965|NCT01775722|11747048|FG000|STARTED|Overall Study||22
10590966|NCT01775722|11747048|FG000|COMPLETED|Overall Study||20
10590967|NCT01775722|11747048|FG000|NOT COMPLETED|Overall Study||2
10590968|NCT01775735|11747056|FG000|STARTED|Intervention (6 Months)||8
10590969|NCT01775735|11747057|FG001|STARTED|Intervention (6 Months)||7
10590970|NCT01775735|11747056|FG000|COMPLETED|Intervention (6 Months)||8
10590971|NCT01775735|11747057|FG001|COMPLETED|Intervention (6 Months)||7
10590972|NCT01775735|11747056|FG000|NOT COMPLETED|Intervention (6 Months)||0
10590973|NCT01775735|11747057|FG001|NOT COMPLETED|Intervention (6 Months)||0
10590974|NCT01775735|11747056|FG000|STARTED|Open Label (24 Months)||8
10590975|NCT01775735|11747057|FG001|STARTED|Open Label (24 Months)||7
10590976|NCT01775735|11747056|FG000|COMPLETED|Open Label (24 Months)||7
10590977|NCT01775735|11747057|FG001|COMPLETED|Open Label (24 Months)||3
10590978|NCT01775735|11747056|FG000|NOT COMPLETED|Open Label (24 Months)||1
10590979|NCT01775735|11747057|FG001|NOT COMPLETED|Open Label (24 Months)||4
10590980|NCT01775774|11747066|FG000|STARTED|Overall Study||3
10590981|NCT01775774|11747067|FG001|STARTED|Overall Study||3
10590982|NCT01775774|11747068|FG002|STARTED|Overall Study||3
10590983|NCT01775774|11747066|FG000|COMPLETED|Overall Study||3
10590984|NCT01775774|11747067|FG001|COMPLETED|Overall Study||3
10590985|NCT01775774|11747068|FG002|COMPLETED|Overall Study||3
10590986|NCT01775774|11747066|FG000|NOT COMPLETED|Overall Study||0
10590987|NCT01775774|11747067|FG001|NOT COMPLETED|Overall Study||0
10590988|NCT01775774|11747068|FG002|NOT COMPLETED|Overall Study||0
10590989|NCT01775787|11747076|FG000|STARTED|First 7-10 Days||13
10590990|NCT01775787|11747077|FG001|STARTED|First 7-10 Days||14
10590991|NCT01775787|11747076|FG000|COMPLETED|First 7-10 Days||12
10590992|NCT01775787|11747077|FG001|COMPLETED|First 7-10 Days||8
10590993|NCT01775787|11747076|FG000|NOT COMPLETED|First 7-10 Days||1
10590994|NCT01775787|11747077|FG001|NOT COMPLETED|First 7-10 Days||6
10590995|NCT01775787|11747076|FG000|STARTED|Second 7-10 Days||12
10590996|NCT01775787|11747077|FG001|STARTED|Second 7-10 Days||8
10590997|NCT01775787|11747076|FG000|COMPLETED|Second 7-10 Days||12
10590998|NCT01775787|11747077|FG001|COMPLETED|Second 7-10 Days||6
10590999|NCT01775787|11747076|FG000|NOT COMPLETED|Second 7-10 Days||0
10591000|NCT01775787|11747077|FG001|NOT COMPLETED|Second 7-10 Days||2
10591001|NCT01775800|11747087|FG000|STARTED|Overall Study||8
10591002|NCT01775800|11747088|FG001|STARTED|Overall Study||8
10591003|NCT01775800|11747087|FG000|COMPLETED|Overall Study||8
10591004|NCT01775800|11747088|FG001|COMPLETED|Overall Study||8
10591005|NCT01775800|11747087|FG000|NOT COMPLETED|Overall Study||0
10591006|NCT01775800|11747088|FG001|NOT COMPLETED|Overall Study||0
10591007|NCT01775852|11747097|FG000|STARTED|Overall Study||31
10591008|NCT01775852|11747098|FG001|STARTED|Overall Study||14
10591009|NCT01775852|11747097|FG000|COMPLETED|Overall Study||31
10591010|NCT01775852|11747098|FG001|COMPLETED|Overall Study||13
10591011|NCT01775852|11747097|FG000|NOT COMPLETED|Overall Study||0
10591012|NCT01775852|11747098|FG001|NOT COMPLETED|Overall Study||1
10591013|NCT01775865|11747107|FG000|STARTED|Overall Study||14
10591014|NCT01775865|11747108|FG001|STARTED|Overall Study||14
10591015|NCT01775865|11747109|FG002|STARTED|Overall Study||17
10591016|NCT01775865|11747107|FG000|COMPLETED|Overall Study||11
10591017|NCT01775865|11747108|FG001|COMPLETED|Overall Study||13
10591018|NCT01775865|11747109|FG002|COMPLETED|Overall Study||17
10591019|NCT01775865|11747107|FG000|NOT COMPLETED|Overall Study||3
10591020|NCT01775865|11747108|FG001|NOT COMPLETED|Overall Study||1
10591021|NCT01775865|11747109|FG002|NOT COMPLETED|Overall Study||0
10591022|NCT01775904|11747122|FG000|STARTED|LY2886721 ODT (no Water, Fasting)||26
10591023|NCT01775904|11747122|FG000|Received at Least One Dose of Drug|LY2886721 ODT (no Water, Fasting)||26
10591024|NCT01775904|11747122|FG000|COMPLETED|LY2886721 ODT (no Water, Fasting)||26
10591025|NCT01775904|11747122|FG000|NOT COMPLETED|LY2886721 ODT (no Water, Fasting)||0
10591026|NCT01775904|11747122|FG000|STARTED|First Washout (7 Days)||26
10591027|NCT01775904|11747122|FG000|COMPLETED|First Washout (7 Days)||26
10591028|NCT01775904|11747122|FG000|NOT COMPLETED|First Washout (7 Days)||0
10591029|NCT01775904|11747122|FG000|STARTED|LY2886721 Capsule (Water, Fasting)||26
10591030|NCT01775904|11747122|FG000|Received at Least One Dose of Drug|LY2886721 Capsule (Water, Fasting)||26
10591031|NCT01775904|11747122|FG000|COMPLETED|LY2886721 Capsule (Water, Fasting)||25
10591032|NCT01775904|11747122|FG000|NOT COMPLETED|LY2886721 Capsule (Water, Fasting)||1
10591033|NCT01775904|11747122|FG000|STARTED|Second Washout (7 Days)||25
10591034|NCT01775904|11747122|FG000|COMPLETED|Second Washout (7 Days)||25
10591035|NCT01775904|11747122|FG000|NOT COMPLETED|Second Washout (7 Days)||0
10591036|NCT01775904|11747122|FG000|STARTED|LY2886721 ODT (Water, Fed)||25
10591037|NCT01775904|11747122|FG000|Received at Least One Dose of Drug|LY2886721 ODT (Water, Fed)||25
10591038|NCT01775904|11747122|FG000|COMPLETED|LY2886721 ODT (Water, Fed)||25
10591039|NCT01775904|11747122|FG000|NOT COMPLETED|LY2886721 ODT (Water, Fed)||0
10591040|NCT01775904|11747122|FG000|STARTED|Third Washout (7 Days)||25
10591041|NCT01775904|11747122|FG000|COMPLETED|Third Washout (7 Days)||25
10591042|NCT01775904|11747122|FG000|NOT COMPLETED|Third Washout (7 Days)||0
10591043|NCT01775904|11747122|FG000|STARTED|LY2886721 ODT (Water, Fasting)||25
10591044|NCT01775904|11747122|FG000|Received at Least One Dose of Drug|LY2886721 ODT (Water, Fasting)|One participant was not dosed in this period due to an adverse event (AE).|24
10591045|NCT01775904|11747122|FG000|COMPLETED|LY2886721 ODT (Water, Fasting)||24
10591046|NCT01775904|11747122|FG000|NOT COMPLETED|LY2886721 ODT (Water, Fasting)||1
10591047|NCT01775930|11747132|FG000|STARTED|Overall Study||10
10591048|NCT01775930|11747132|FG000|COMPLETED|Overall Study||9
10591049|NCT01775930|11747132|FG000|NOT COMPLETED|Overall Study||1
10591050|NCT01775995|11747138|FG000|STARTED|Overall Study||21
10591051|NCT01775995|11747139|FG001|STARTED|Overall Study||14
10591052|NCT01775995|11747138|FG000|COMPLETED|Overall Study|One experimental participant was unable to reach at 26 week follow up|20
10591053|NCT01775995|11747139|FG001|COMPLETED|Overall Study|One control participant was unable to reach at 26 week follow up|13
10591054|NCT01775995|11747138|FG000|NOT COMPLETED|Overall Study||1
10591055|NCT01775995|11747139|FG001|NOT COMPLETED|Overall Study||1
10591056|NCT01776008|11747145|FG000|STARTED|Overall Study||16
10591057|NCT01776008|11747145|FG000|COMPLETED|Overall Study||14
10591058|NCT01776008|11747145|FG000|NOT COMPLETED|Overall Study||2
10703476|NCT02584855|11867985|FG001|STARTED|Open-Label Treatment Period|Participants completed Open-Label Treatment Period.|0
10703477|NCT02584855|11867986|FG002|STARTED|Open-Label Treatment Period|Participants were randomized to this arm during double-blind withdrawal period.|0
10591059|NCT01776268|11747151|FG000|STARTED|Overall Study||48
10703478|NCT02584855|11867987|FG003|STARTED|Open-Label Treatment Period|Participants were randomized to this arm during double-blind withdrawal period.|0
10591060|NCT01776268|11747152|FG001|STARTED|Overall Study||51
10591061|NCT01776268|11747151|FG000|COMPLETED|Overall Study||48
10591062|NCT01776268|11747152|FG001|COMPLETED|Overall Study||51
10591063|NCT01776268|11747151|FG000|NOT COMPLETED|Overall Study||0
10591064|NCT01776268|11747152|FG001|NOT COMPLETED|Overall Study||0
10591065|NCT01776424|11747162|FG000|STARTED|Overall Study||9152
10703479|NCT02584855|11867988|FG004|STARTED|Open-Label Treatment Period||0
10703480|NCT02584855|11867989|FG005|STARTED|Open-Label Treatment Period||0
10591066|NCT01776424|11747163|FG001|STARTED|Overall Study||9117
10591067|NCT01776424|11747164|FG002|STARTED|Overall Study||9126
10591068|NCT01776424|11747162|FG000|Treated|Overall Study||9134
10591069|NCT01776424|11747163|FG001|Treated|Overall Study||9110
10591070|NCT01776424|11747164|FG002|Treated|Overall Study||9107
10591071|NCT01776424|11747162|FG000|COMPLETED|Overall Study||9132
10591072|NCT01776424|11747163|FG001|COMPLETED|Overall Study||9098
10591073|NCT01776424|11747164|FG002|COMPLETED|Overall Study||9102
10591074|NCT01776424|11747162|FG000|NOT COMPLETED|Overall Study||20
10591075|NCT01776424|11747163|FG001|NOT COMPLETED|Overall Study||19
10591076|NCT01776424|11747164|FG002|NOT COMPLETED|Overall Study||24
10591077|NCT01776541|11747174|FG000|STARTED|Overall Study||488
10591078|NCT01776541|11747175|FG001|STARTED|Overall Study||491
10591079|NCT01776541|11747174|FG000|COMPLETED|Overall Study||432
10591080|NCT01776541|11747175|FG001|COMPLETED|Overall Study||416
10591081|NCT01776541|11747174|FG000|NOT COMPLETED|Overall Study||56
10591082|NCT01776541|11747175|FG001|NOT COMPLETED|Overall Study||75
10591083|NCT01776554|11747184|FG000|STARTED|Overall Study||332
10591084|NCT01776554|11747185|FG001|STARTED|Overall Study||330
10591085|NCT01776554|11747184|FG000|COMPLETED|Overall Study||315
10591086|NCT01776554|11747185|FG001|COMPLETED|Overall Study||307
10591087|NCT01776554|11747184|FG000|NOT COMPLETED|Overall Study||17
10591088|NCT01776554|11747185|FG001|NOT COMPLETED|Overall Study||23
10591089|NCT01776632|11747194|FG000|STARTED|Overall Study||217
10591090|NCT01776632|11747195|FG001|STARTED|Overall Study||219
10591091|NCT01776632|11747194|FG000|COMPLETED|Overall Study||190
10591092|NCT01776632|11747195|FG001|COMPLETED|Overall Study||190
10591093|NCT01776632|11747194|FG000|NOT COMPLETED|Overall Study||27
10591094|NCT01776632|11747195|FG001|NOT COMPLETED|Overall Study||29
10591095|NCT01776645|11747203|FG000|STARTED|Overall Study||28
10591096|NCT01776645|11747204|FG001|STARTED|Overall Study||28
10591097|NCT01776645|11747203|FG000|COMPLETED|Overall Study||14
10591098|NCT01776645|11747204|FG001|COMPLETED|Overall Study||14
10591099|NCT01776645|11747203|FG000|NOT COMPLETED|Overall Study||14
10591100|NCT01776645|11747204|FG001|NOT COMPLETED|Overall Study||14
10652008|NCT02180659|11812293|FG000|NOT COMPLETED|Overall Study||6
10652009|NCT02180659|11812294|FG001|NOT COMPLETED|Overall Study||5
10652010|NCT02180672|11812302|FG000|STARTED|Overall Study||91
10652011|NCT02180672|11812303|FG001|STARTED|Overall Study||43
10652012|NCT02180672|11812302|FG000|COMPLETED|Overall Study||86
10652013|NCT02180672|11812303|FG001|COMPLETED|Overall Study||36
10652014|NCT02180672|11812302|FG000|NOT COMPLETED|Overall Study||5
10652015|NCT02180672|11812303|FG001|NOT COMPLETED|Overall Study||7
10652016|NCT02180828|11812311|FG000|STARTED|Overall Study||120
10652017|NCT02180828|11812312|FG001|STARTED|Overall Study||120
10652018|NCT02180828|11812311|FG000|COMPLETED|Overall Study||115
10652019|NCT02180828|11812312|FG001|COMPLETED|Overall Study||113
10652020|NCT02180828|11812311|FG000|NOT COMPLETED|Overall Study||5
10652021|NCT02180828|11812312|FG001|NOT COMPLETED|Overall Study||7
10652022|NCT02180893|11812320|FG000|STARTED|Overall Study||30
10652023|NCT02180893|11812321|FG001|STARTED|Overall Study||30
10652024|NCT02180893|11812320|FG000|COMPLETED|Overall Study||27
10652025|NCT02180893|11812321|FG001|COMPLETED|Overall Study||23
10652026|NCT02180893|11812320|FG000|NOT COMPLETED|Overall Study||3
10652027|NCT02180893|11812321|FG001|NOT COMPLETED|Overall Study||7
10652028|NCT02181075|11812329|FG000|STARTED|Overall Study||6
10652029|NCT02181075|11812330|FG001|STARTED|Overall Study||4
10652030|NCT02181075|11812329|FG000|COMPLETED|Overall Study||6
10652031|NCT02181075|11812330|FG001|COMPLETED|Overall Study||4
10652032|NCT02181075|11812329|FG000|NOT COMPLETED|Overall Study||0
10652033|NCT02181075|11812330|FG001|NOT COMPLETED|Overall Study||0
10652034|NCT02181127|11812340|FG000|STARTED|Overall Study||22
10652035|NCT02181127|11812340|FG000|COMPLETED|Overall Study||22
10652036|NCT02181127|11812340|FG000|NOT COMPLETED|Overall Study||0
10652037|NCT02181140|11812347|FG000|STARTED|Overall Study||56
10652038|NCT02181140|11812347|FG000|COMPLETED|Overall Study||56
10652039|NCT02181140|11812347|FG000|NOT COMPLETED|Overall Study||0
10652040|NCT02181231|11812355|FG000|STARTED|Overall Study||12
10652041|NCT02181231|11812356|FG001|STARTED|Overall Study||6
10652042|NCT02181231|11812355|FG000|COMPLETED|Overall Study||10
10652043|NCT02181231|11812356|FG001|COMPLETED|Overall Study||6
10652044|NCT02181231|11812355|FG000|NOT COMPLETED|Overall Study||2
10652045|NCT02181231|11812356|FG001|NOT COMPLETED|Overall Study||0
10652046|NCT02181296|11812364|FG000|STARTED|Overall Study||25
10652047|NCT02181296|11812365|FG001|STARTED|Overall Study||25
10652048|NCT02181296|11812364|FG000|COMPLETED|Overall Study||18
10652049|NCT02181296|11812365|FG001|COMPLETED|Overall Study||19
10652050|NCT02181296|11812364|FG000|NOT COMPLETED|Overall Study||7
10652051|NCT02181296|11812365|FG001|NOT COMPLETED|Overall Study||6
10652052|NCT02181387|11812373|FG000|STARTED|Overall Study||14
10652053|NCT02181387|11812374|FG001|STARTED|Overall Study||19
10652054|NCT02181387|11812373|FG000|COMPLETED|Overall Study||12
10652055|NCT02181387|11812374|FG001|COMPLETED|Overall Study||15
10652056|NCT02181387|11812373|FG000|NOT COMPLETED|Overall Study||2
10652057|NCT02181387|11812374|FG001|NOT COMPLETED|Overall Study||4
10652058|NCT02181400|11812383|FG000|STARTED|Overall Study||7
10652059|NCT02181400|11812384|FG001|STARTED|Overall Study||7
10652060|NCT02181400|11812385|FG002|STARTED|Overall Study||7
10652061|NCT02181400|11812383|FG000|COMPLETED|Overall Study||7
10652062|NCT02181400|11812384|FG001|COMPLETED|Overall Study||7
10652063|NCT02181400|11812385|FG002|COMPLETED|Overall Study||7
10652064|NCT02181400|11812383|FG000|NOT COMPLETED|Overall Study||0
10652065|NCT02181400|11812384|FG001|NOT COMPLETED|Overall Study||0
10652066|NCT02181400|11812385|FG002|NOT COMPLETED|Overall Study||0
10652067|NCT02181426|11812397|FG000|STARTED|Overall Study||28
10652068|NCT02181426|11812398|FG001|STARTED|Overall Study||28
10652069|NCT02181426|11812399|FG002|STARTED|Overall Study||28
10652070|NCT02181426|11812400|FG003|STARTED|Overall Study||28
10652071|NCT02181426|11812397|FG000|COMPLETED|Overall Study||28
10652072|NCT02181426|11812398|FG001|COMPLETED|Overall Study||28
10652073|NCT02181426|11812399|FG002|COMPLETED|Overall Study||28
10652074|NCT02181426|11812400|FG003|COMPLETED|Overall Study||28
10652075|NCT02181426|11812397|FG000|NOT COMPLETED|Overall Study||0
10652076|NCT02181426|11812398|FG001|NOT COMPLETED|Overall Study||0
10652077|NCT02181426|11812399|FG002|NOT COMPLETED|Overall Study||0
10652078|NCT02181426|11812400|FG003|NOT COMPLETED|Overall Study||0
10652079|NCT02181504|11812413|FG000|STARTED|Overall Study||10
10652080|NCT02181504|11812414|FG001|STARTED|Overall Study||10
10652081|NCT02181504|11812415|FG002|STARTED|Overall Study||5
10652082|NCT02181504|11812413|FG000|COMPLETED|Overall Study||9
10652083|NCT02181504|11812414|FG001|COMPLETED|Overall Study||9
10652084|NCT02181504|11812415|FG002|COMPLETED|Overall Study||4
10652085|NCT02181504|11812413|FG000|NOT COMPLETED|Overall Study||1
10652086|NCT02181504|11812414|FG001|NOT COMPLETED|Overall Study||1
10591101|NCT01777126|11747211|FG000|STARTED|Overall Study||48
10591102|NCT01777126|11747212|FG001|STARTED|Overall Study||46
10591103|NCT01777126|11747211|FG000|COMPLETED|Overall Study||48
10591104|NCT01777126|11747212|FG001|COMPLETED|Overall Study||46
10591105|NCT01777126|11747211|FG000|NOT COMPLETED|Overall Study||0
10591106|NCT01777126|11747212|FG001|NOT COMPLETED|Overall Study||0
10591107|NCT01777139|11747220|FG000|STARTED|Primary Reporting Phase (Up to 4 Years)||30
10591108|NCT01777139|11747221|FG001|STARTED|Primary Reporting Phase (Up to 4 Years)||0
10591109|NCT01777139|11747220|FG000|COMPLETED|Primary Reporting Phase (Up to 4 Years)||0
10591110|NCT01777139|11747221|FG001|COMPLETED|Primary Reporting Phase (Up to 4 Years)||0
10591111|NCT01777139|11747220|FG000|NOT COMPLETED|Primary Reporting Phase (Up to 4 Years)||30
10591112|NCT01777139|11747221|FG001|NOT COMPLETED|Primary Reporting Phase (Up to 4 Years)||0
10591113|NCT01777139|11747220|FG000|STARTED|SFUCP (Up to 1.4 Years)||0
10591114|NCT01777139|11747221|FG001|STARTED|SFUCP (Up to 1.4 Years)||4
10591115|NCT01777139|11747220|FG000|COMPLETED|SFUCP (Up to 1.4 Years)||0
10591116|NCT01777139|11747221|FG001|COMPLETED|SFUCP (Up to 1.4 Years)||0
10591117|NCT01777139|11747220|FG000|NOT COMPLETED|SFUCP (Up to 1.4 Years)||0
10591118|NCT01777139|11747221|FG001|NOT COMPLETED|SFUCP (Up to 1.4 Years)||4
10591119|NCT01777152|11747230|FG000|STARTED|Overall Study||226
10591120|NCT01777152|11747231|FG001|STARTED|Overall Study||226
10591121|NCT01777152|11747230|FG000|COMPLETED|Overall Study||131
10591122|NCT01777152|11747231|FG001|COMPLETED|Overall Study||116
10591123|NCT01777152|11747230|FG000|NOT COMPLETED|Overall Study||95
10591124|NCT01777152|11747231|FG001|NOT COMPLETED|Overall Study||110
10591125|NCT01777191|11747240|FG000|STARTED|Treatment Period (Per) (Week 0-Week 12)||102
10591126|NCT01777191|11747241|FG001|STARTED|Treatment Period (Per) (Week 0-Week 12)||102
10591127|NCT01777191|11747240|FG000|COMPLETED|Treatment Period (Per) (Week 0-Week 12)||96
10591128|NCT01777191|11747241|FG001|COMPLETED|Treatment Period (Per) (Week 0-Week 12)||94
10591129|NCT01777191|11747240|FG000|NOT COMPLETED|Treatment Period (Per) (Week 0-Week 12)||6
10591130|NCT01777191|11747241|FG001|NOT COMPLETED|Treatment Period (Per) (Week 0-Week 12)||8
10591131|NCT01777191|11747240|FG000|STARTED|Safety Extension Per (Week 12-Week 48)|Participation in the safety extension period was optional.|94
10591132|NCT01777191|11747241|FG001|STARTED|Safety Extension Per (Week 12-Week 48)|Participation in the safety extension period was optional.|91
10591133|NCT01777191|11747240|FG000|COMPLETED|Safety Extension Per (Week 12-Week 48)||85
10591134|NCT01777191|11747241|FG001|COMPLETED|Safety Extension Per (Week 12-Week 48)||78
10591135|NCT01777191|11747240|FG000|NOT COMPLETED|Safety Extension Per (Week 12-Week 48)||9
10591136|NCT01777191|11747241|FG001|NOT COMPLETED|Safety Extension Per (Week 12-Week 48)||13
10591137|NCT01777217|11747252|FG000|STARTED|Overall Study||4
10591138|NCT01777217|11747253|FG001|STARTED|Overall Study||4
10591139|NCT01777217|11747252|FG000|COMPLETED|Overall Study||4
10591140|NCT01777217|11747253|FG001|COMPLETED|Overall Study||4
10591141|NCT01777217|11747252|FG000|NOT COMPLETED|Overall Study||0
10591142|NCT01777217|11747253|FG001|NOT COMPLETED|Overall Study||0
10591143|NCT01777269|11747261|FG000|STARTED|Overall Study||246
10591144|NCT01777269|11747262|FG001|STARTED|Overall Study||243
10591145|NCT01777269|11747261|FG000|COMPLETED|Overall Study||191
10591146|NCT01777269|11747262|FG001|COMPLETED|Overall Study||184
10591147|NCT01777269|11747261|FG000|NOT COMPLETED|Overall Study||55
10591148|NCT01777269|11747262|FG001|NOT COMPLETED|Overall Study||59
10591149|NCT01777282|11747273|FG000|STARTED|Overall Study||120
10591150|NCT01777282|11747274|FG001|STARTED|Overall Study||67
10591151|NCT01777282|11747275|FG002|STARTED|Overall Study||65
10591152|NCT01777282|11747276|FG003|STARTED|Overall Study||61
10591153|NCT01777282|11747277|FG004|STARTED|Overall Study||61
10591154|NCT01777282|11747273|FG000|Completing Treatment Period|Overall Study||109
10591155|NCT01777282|11747274|FG001|Completing Treatment Period|Overall Study||63
10591156|NCT01777282|11747275|FG002|Completing Treatment Period|Overall Study||59
10591157|NCT01777282|11747276|FG003|Completing Treatment Period|Overall Study||59
10591158|NCT01777282|11747277|FG004|Completing Treatment Period|Overall Study||54
10591159|NCT01777282|11747273|FG000|Completing Follow-up Period|Overall Study||109
10591160|NCT01777282|11747274|FG001|Completing Follow-up Period|Overall Study||63
10591161|NCT01777282|11747275|FG002|Completing Follow-up Period|Overall Study||59
10591162|NCT01777282|11747276|FG003|Completing Follow-up Period|Overall Study||59
10591163|NCT01777282|11747277|FG004|Completing Follow-up Period|Overall Study||54
10591164|NCT01777282|11747273|FG000|COMPLETED|Overall Study||109
10591165|NCT01777282|11747274|FG001|COMPLETED|Overall Study||63
10591166|NCT01777282|11747275|FG002|COMPLETED|Overall Study||59
10591167|NCT01777282|11747276|FG003|COMPLETED|Overall Study||59
10591168|NCT01777282|11747277|FG004|COMPLETED|Overall Study||54
10591169|NCT01777282|11747273|FG000|NOT COMPLETED|Overall Study||11
10591170|NCT01777282|11747274|FG001|NOT COMPLETED|Overall Study||4
10591171|NCT01777282|11747275|FG002|NOT COMPLETED|Overall Study||6
10591172|NCT01777282|11747276|FG003|NOT COMPLETED|Overall Study||2
10591173|NCT01777282|11747277|FG004|NOT COMPLETED|Overall Study||7
10591174|NCT01777308|11747291|FG000|STARTED|Overall Study||119
10591175|NCT01777308|11747292|FG001|STARTED|Overall Study||37
10591176|NCT01777308|11747291|FG000|Completed up to Month 73|Overall Study||118
10591177|NCT01777308|11747292|FG001|Completed up to Month 73|Overall Study||37
10591178|NCT01777308|11747291|FG000|COMPLETED|Overall Study||105
10591179|NCT01777308|11747292|FG001|COMPLETED|Overall Study||34
10591180|NCT01777308|11747291|FG000|NOT COMPLETED|Overall Study||14
10591181|NCT01777308|11747292|FG001|NOT COMPLETED|Overall Study||3
10591182|NCT01777321|11747301|FG000|STARTED|Overall Study||30
10591183|NCT01777321|11747302|FG001|STARTED|Overall Study||30
10591184|NCT01777321|11747301|FG000|COMPLETED|Overall Study||30
10591185|NCT01777321|11747302|FG001|COMPLETED|Overall Study||29
10591186|NCT01777321|11747301|FG000|NOT COMPLETED|Overall Study||0
10591187|NCT01777321|11747302|FG001|NOT COMPLETED|Overall Study||1
10591188|NCT01777334|11747310|FG000|STARTED|Overall Study||454
10591189|NCT01777334|11747311|FG001|STARTED|Overall Study||451
10591190|NCT01777334|11747310|FG000|COMPLETED|Overall Study||401
10591191|NCT01777334|11747311|FG001|COMPLETED|Overall Study||388
10591192|NCT01777334|11747310|FG000|NOT COMPLETED|Overall Study||53
10591193|NCT01777334|11747311|FG001|NOT COMPLETED|Overall Study||63
10591194|NCT01777412|11747317|FG000|STARTED|Overall Study||10
10591195|NCT01777412|11747317|FG000|COMPLETED|Overall Study||10
10591196|NCT01777412|11747317|FG000|NOT COMPLETED|Overall Study||0
10591197|NCT01777425|11747321|FG000|STARTED|Overall Study||389
10591198|NCT01777425|11747321|FG000|COMPLETED|Overall Study||389
10591199|NCT01777425|11747321|FG000|NOT COMPLETED|Overall Study||0
10591200|NCT01777438|11747328|FG000|STARTED|Overall Study||352
10591201|NCT01777438|11747329|FG001|STARTED|Overall Study||82
10591202|NCT01777438|11747328|FG000|COMPLETED|Overall Study||352
10591203|NCT01777438|11747329|FG001|COMPLETED|Overall Study||82
10591204|NCT01777438|11747328|FG000|NOT COMPLETED|Overall Study||0
10591205|NCT01777438|11747329|FG001|NOT COMPLETED|Overall Study||0
10591206|NCT01777490|11747339|FG000|STARTED|Overall Study||123
10591207|NCT01777490|11747340|FG001|STARTED|Overall Study||123
10591208|NCT01777490|11747341|FG002|STARTED|Overall Study||119
10591209|NCT01777490|11747342|FG003|STARTED|Overall Study||119
10591210|NCT01777490|11747339|FG000|COMPLETED|Overall Study||123
10591211|NCT01777490|11747340|FG001|COMPLETED|Overall Study||123
10591212|NCT01777490|11747341|FG002|COMPLETED|Overall Study||118
10591213|NCT01777490|11747342|FG003|COMPLETED|Overall Study||118
10591214|NCT01777490|11747339|FG000|NOT COMPLETED|Overall Study||0
10591215|NCT01777490|11747340|FG001|NOT COMPLETED|Overall Study||0
10591216|NCT01777490|11747341|FG002|NOT COMPLETED|Overall Study||1
10591217|NCT01777490|11747342|FG003|NOT COMPLETED|Overall Study||1
10591218|NCT01777542|11747354|FG000|STARTED|First Intervention (20 Weeks)||15
10591219|NCT01777542|11747355|FG001|STARTED|First Intervention (20 Weeks)||15
10591220|NCT01777542|11747354|FG000|COMPLETED|First Intervention (20 Weeks)||15
10591221|NCT01777542|11747355|FG001|COMPLETED|First Intervention (20 Weeks)||15
10591222|NCT01777542|11747354|FG000|NOT COMPLETED|First Intervention (20 Weeks)||0
10591223|NCT01777542|11747355|FG001|NOT COMPLETED|First Intervention (20 Weeks)||0
10591224|NCT01777542|11747354|FG000|STARTED|Washout Period (28 +/- 2 Weeks)||15
10591225|NCT01777542|11747355|FG001|STARTED|Washout Period (28 +/- 2 Weeks)||15
10591226|NCT01777542|11747354|FG000|COMPLETED|Washout Period (28 +/- 2 Weeks)||15
10591227|NCT01777542|11747355|FG001|COMPLETED|Washout Period (28 +/- 2 Weeks)||15
10591228|NCT01777542|11747354|FG000|NOT COMPLETED|Washout Period (28 +/- 2 Weeks)||0
10591229|NCT01777542|11747355|FG001|NOT COMPLETED|Washout Period (28 +/- 2 Weeks)||0
10591230|NCT01777542|11747354|FG000|STARTED|Second Intervention (20 Weeks)||15
10591231|NCT01777542|11747355|FG001|STARTED|Second Intervention (20 Weeks)||15
10591232|NCT01777542|11747354|FG000|COMPLETED|Second Intervention (20 Weeks)||15
10591233|NCT01777542|11747355|FG001|COMPLETED|Second Intervention (20 Weeks)||14
10591234|NCT01777542|11747354|FG000|NOT COMPLETED|Second Intervention (20 Weeks)||0
10591235|NCT01777542|11747355|FG001|NOT COMPLETED|Second Intervention (20 Weeks)||1
10591236|NCT01777568|11747364|FG000|STARTED|Overall Study||2853
10591237|NCT01777568|11747365|FG001|STARTED|Overall Study||2896
10591238|NCT01777568|11747364|FG000|COMPLETED|Overall Study||2853
10591239|NCT01777568|11747365|FG001|COMPLETED|Overall Study||2896
10591240|NCT01777568|11747364|FG000|NOT COMPLETED|Overall Study||0
10591241|NCT01777568|11747365|FG001|NOT COMPLETED|Overall Study||0
10591242|NCT01777581|11747373|FG000|STARTED|Overall Study|Includes one subject screened/consented but not assigned to either arm.|8
10591243|NCT01777581|11747374|FG001|STARTED|Overall Study|Includes one subject screened/consented but not assigned to either arm.|5
10591244|NCT01777581|11747373|FG000|COMPLETED|Overall Study||5
10591245|NCT01777581|11747374|FG001|COMPLETED|Overall Study||3
10591246|NCT01777581|11747373|FG000|NOT COMPLETED|Overall Study||3
10591247|NCT01777581|11747374|FG001|NOT COMPLETED|Overall Study||2
10591248|NCT01777620|11747382|FG000|STARTED|Overall Study||63
10591249|NCT01777620|11747383|FG001|STARTED|Overall Study||62
10591250|NCT01777620|11747382|FG000|COMPLETED|Overall Study||62
10591251|NCT01777620|11747383|FG001|COMPLETED|Overall Study||62
10591252|NCT01777620|11747382|FG000|NOT COMPLETED|Overall Study||1
10591253|NCT01777620|11747383|FG001|NOT COMPLETED|Overall Study||0
10591254|NCT01777763|11747391|FG000|STARTED|Overall Study||20
10591255|NCT01777763|11747392|FG001|STARTED|Overall Study||210
10591256|NCT01777763|11747391|FG000|COMPLETED|Overall Study||16
10703481|NCT02584855|11867984|FG000|Received at Least One Dose of Study Drug|Open-Label Treatment Period||394
10703482|NCT02584855|11867985|FG001|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
10703483|NCT02584855|11867986|FG002|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
10703484|NCT02584855|11867987|FG003|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
10591257|NCT01777763|11747392|FG001|COMPLETED|Overall Study||163
10591258|NCT01777763|11747391|FG000|NOT COMPLETED|Overall Study||4
10591259|NCT01777763|11747392|FG001|NOT COMPLETED|Overall Study||47
10591260|NCT01777776|11747402|FG000|STARTED|Overall Study||6
10591261|NCT01777776|11747403|FG001|STARTED|Overall Study||12
10591262|NCT01777776|11747404|FG002|STARTED|Overall Study||6
10591263|NCT01777776|11747405|FG003|STARTED|Overall Study||4
10591264|NCT01777776|11747402|FG000|COMPLETED|Overall Study||0
10591265|NCT01777776|11747403|FG001|COMPLETED|Overall Study||0
10591266|NCT01777776|11747404|FG002|COMPLETED|Overall Study||0
10591267|NCT01777776|11747405|FG003|COMPLETED|Overall Study||0
10591268|NCT01777776|11747402|FG000|NOT COMPLETED|Overall Study||6
10591269|NCT01777776|11747403|FG001|NOT COMPLETED|Overall Study||12
10591270|NCT01777776|11747404|FG002|NOT COMPLETED|Overall Study||6
10591271|NCT01777776|11747405|FG003|NOT COMPLETED|Overall Study||4
10591272|NCT01777932|11747424|FG000|STARTED|Overall Study||220
10591273|NCT01777932|11747424|FG000|COMPLETED|Overall Study||15
10591274|NCT01777932|11747424|FG000|NOT COMPLETED|Overall Study||205
10591275|NCT01777945|11747428|FG000|STARTED|Overall Study||46
10591276|NCT01777945|11747428|FG000|Evaluable Participants|Overall Study||45
10591277|NCT01777945|11747428|FG000|COMPLETED|Overall Study||46
10591278|NCT01777945|11747428|FG000|NOT COMPLETED|Overall Study||0
10591279|NCT01777997|11747432|FG000|STARTED|12 Week lead-in of no ART||38
10591280|NCT01777997|11747432|FG000|COMPLETED|12 Week lead-in of no ART||36
10591281|NCT01777997|11747432|FG000|NOT COMPLETED|12 Week lead-in of no ART||2
10591282|NCT01777997|11747432|FG000|STARTED|Weeks 0 to 24/48 on ART||36
10591283|NCT01777997|11747432|FG000|COMPLETED|Weeks 0 to 24/48 on ART|7 of these participants opted not to continue ART into next period|35
10591284|NCT01777997|11747432|FG000|NOT COMPLETED|Weeks 0 to 24/48 on ART||1
10591285|NCT01777997|11747432|FG000|STARTED|Weeks 48 to 72/96 on ART||28
10591286|NCT01777997|11747432|FG000|COMPLETED|Weeks 48 to 72/96 on ART||26
10591287|NCT01777997|11747432|FG000|NOT COMPLETED|Weeks 48 to 72/96 on ART||2
10591288|NCT01778010|11747436|FG000|STARTED|Overall Study||13
10591289|NCT01778010|11747436|FG000|COMPLETED|Overall Study||8
10591290|NCT01778010|11747436|FG000|NOT COMPLETED|Overall Study||5
10591291|NCT01778023|11747455|FG000|STARTED|Overall Study||36
10591292|NCT01778023|11747456|FG001|STARTED|Overall Study||18
10591293|NCT01778023|11747455|FG000|Exposed|Overall Study||36
10591294|NCT01778023|11747456|FG001|Exposed|Overall Study||15
10591295|NCT01778023|11747455|FG000|COMPLETED|Overall Study||36
10591296|NCT01778023|11747456|FG001|COMPLETED|Overall Study||15
10591297|NCT01778023|11747455|FG000|NOT COMPLETED|Overall Study||0
10591298|NCT01778023|11747456|FG001|NOT COMPLETED|Overall Study||3
10591299|NCT01778049|11747464|FG000|STARTED|Open Label Treatment Period||354
10591300|NCT01778049|11747465|FG001|STARTED|Open Label Treatment Period||355
10591301|NCT01778049|11747466|FG002|STARTED|Open Label Treatment Period||0
10591302|NCT01778049|11747467|FG003|STARTED|Open Label Treatment Period||0
10591303|NCT01778049|11747468|FG004|STARTED|Open Label Treatment Period||0
10591304|NCT01778049|11747469|FG005|STARTED|Open Label Treatment Period||0
10591305|NCT01778049|11747464|FG000|COMPLETED|Open Label Treatment Period||256
10591306|NCT01778049|11747465|FG001|COMPLETED|Open Label Treatment Period||226
10591307|NCT01778049|11747466|FG002|COMPLETED|Open Label Treatment Period||0
10591308|NCT01778049|11747467|FG003|COMPLETED|Open Label Treatment Period||0
10591309|NCT01778049|11747468|FG004|COMPLETED|Open Label Treatment Period||0
10591310|NCT01778049|11747469|FG005|COMPLETED|Open Label Treatment Period||0
10591311|NCT01778049|11747464|FG000|NOT COMPLETED|Open Label Treatment Period||98
10591312|NCT01778049|11747465|FG001|NOT COMPLETED|Open Label Treatment Period||129
10591313|NCT01778049|11747466|FG002|NOT COMPLETED|Open Label Treatment Period||0
10591314|NCT01778049|11747467|FG003|NOT COMPLETED|Open Label Treatment Period||0
10591315|NCT01778049|11747468|FG004|NOT COMPLETED|Open Label Treatment Period||0
10591316|NCT01778049|11747469|FG005|NOT COMPLETED|Open Label Treatment Period||0
10591317|NCT01778049|11747464|FG000|STARTED|Double Blind Treatment Period||0
10591318|NCT01778049|11747465|FG001|STARTED|Double Blind Treatment Period||0
10591319|NCT01778049|11747466|FG002|STARTED|Double Blind Treatment Period||126
10591320|NCT01778049|11747467|FG003|STARTED|Double Blind Treatment Period||130
10591321|NCT01778049|11747468|FG004|STARTED|Double Blind Treatment Period||114
10591322|NCT01778049|11747469|FG005|STARTED|Double Blind Treatment Period||112
10591323|NCT01778049|11747464|FG000|COMPLETED|Double Blind Treatment Period||0
10591324|NCT01778049|11747465|FG001|COMPLETED|Double Blind Treatment Period||0
10591325|NCT01778049|11747466|FG002|COMPLETED|Double Blind Treatment Period||111
10591326|NCT01778049|11747467|FG003|COMPLETED|Double Blind Treatment Period||118
10591327|NCT01778049|11747468|FG004|COMPLETED|Double Blind Treatment Period||102
10591328|NCT01778049|11747469|FG005|COMPLETED|Double Blind Treatment Period||105
10591329|NCT01778049|11747464|FG000|NOT COMPLETED|Double Blind Treatment Period||0
10591330|NCT01778049|11747465|FG001|NOT COMPLETED|Double Blind Treatment Period||0
10591331|NCT01778049|11747466|FG002|NOT COMPLETED|Double Blind Treatment Period||15
10591332|NCT01778049|11747467|FG003|NOT COMPLETED|Double Blind Treatment Period||12
10591333|NCT01778049|11747468|FG004|NOT COMPLETED|Double Blind Treatment Period||12
10591334|NCT01778049|11747469|FG005|NOT COMPLETED|Double Blind Treatment Period||7
10591335|NCT01778062|11747483|FG000|STARTED|Overall Study||68
10591336|NCT01778062|11747484|FG001|STARTED|Overall Study||68
10591337|NCT01778062|11747483|FG000|Safety Set|Overall Study||68
10591338|NCT01778062|11747484|FG001|Safety Set|Overall Study||68
10591339|NCT01778062|11747483|FG000|Intent to Treat (ITT)|Overall Study||68
10591340|NCT01778062|11747484|FG001|Intent to Treat (ITT)|Overall Study|One failed to perform primary efficacy evaluation and was excluded, 135 were included in the ITT set|67
10591341|NCT01778062|11747483|FG000|COMPLETED|Overall Study||62
10713725|NCT02680847|11879221|FG002|NOT COMPLETED|Overall Study||3
10591342|NCT01778062|11747484|FG001|COMPLETED|Overall Study||57
10591343|NCT01778062|11747483|FG000|NOT COMPLETED|Overall Study||6
10591344|NCT01778062|11747484|FG001|NOT COMPLETED|Overall Study||11
10591345|NCT01778127|11747493|FG000|STARTED|Overall Study||33
10591346|NCT01778127|11747494|FG001|STARTED|Overall Study||33
10591347|NCT01778127|11747495|FG002|STARTED|Overall Study||32
10591348|NCT01778127|11747493|FG000|COMPLETED|Overall Study||25
10591349|NCT01778127|11747494|FG001|COMPLETED|Overall Study||31
10591350|NCT01778127|11747495|FG002|COMPLETED|Overall Study||26
10591351|NCT01778127|11747493|FG000|NOT COMPLETED|Overall Study||8
10591352|NCT01778127|11747494|FG001|NOT COMPLETED|Overall Study||2
10591353|NCT01778127|11747495|FG002|NOT COMPLETED|Overall Study||6
10591354|NCT01778179|11747505|FG000|STARTED|Overall Study||25
10591355|NCT01778179|11747506|FG001|STARTED|Overall Study||25
10591356|NCT01778179|11747505|FG000|COMPLETED|Overall Study||23
10591357|NCT01778179|11747506|FG001|COMPLETED|Overall Study||22
10591358|NCT01778179|11747505|FG000|NOT COMPLETED|Overall Study||2
10591359|NCT01778179|11747506|FG001|NOT COMPLETED|Overall Study||3
10591360|NCT01778296|11747512|FG000|STARTED|Overall Study|There were 12 patients included in the study in the initial stage.|12
10591361|NCT01778296|11747512|FG000|COMPLETED|Overall Study|No patient was lost to follow-up.|12
10591362|NCT01778296|11747512|FG000|NOT COMPLETED|Overall Study||0
10591363|NCT01778426|11747518|FG000|STARTED|Overall Study - Full Analysis Set (FAS)||264
10591364|NCT01778426|11747519|FG001|STARTED|Overall Study - Full Analysis Set (FAS)||138
10591365|NCT01778426|11747518|FG000|COMPLETED|Overall Study - Full Analysis Set (FAS)||208
10591366|NCT01778426|11747519|FG001|COMPLETED|Overall Study - Full Analysis Set (FAS)||113
10591367|NCT01778426|11747518|FG000|NOT COMPLETED|Overall Study - Full Analysis Set (FAS)||56
10591368|NCT01778426|11747519|FG001|NOT COMPLETED|Overall Study - Full Analysis Set (FAS)||25
10591369|NCT01778426|11747518|FG000|STARTED|Intention-To-Treat (ITT) - Completer||198
10591370|NCT01778426|11747519|FG001|STARTED|Intention-To-Treat (ITT) - Completer|Not applicable: ITT-completer contains only primo-implant subjects.|0
10591371|NCT01778426|11747518|FG000|COMPLETED|Intention-To-Treat (ITT) - Completer||198
10591372|NCT01778426|11747519|FG001|COMPLETED|Intention-To-Treat (ITT) - Completer|Not applicable: ITT-completer contains only primo-implant subjects.|0
10591373|NCT01778426|11747518|FG000|NOT COMPLETED|Intention-To-Treat (ITT) - Completer||0
10591374|NCT01778426|11747519|FG001|NOT COMPLETED|Intention-To-Treat (ITT) - Completer||0
10591375|NCT01778465|11747528|FG000|STARTED|First Intervention (7 Days)||3
10591376|NCT01778465|11747529|FG001|STARTED|First Intervention (7 Days)||4
10591377|NCT01778465|11747528|FG000|COMPLETED|First Intervention (7 Days)||3
10591378|NCT01778465|11747529|FG001|COMPLETED|First Intervention (7 Days)||4
10456994|NCT01008553|11604733|FG002|STARTED|Period 1 (Titration Period)||0
10456995|NCT01008553|11604731|FG000|COMPLETED|Period 1 (Titration Period)||163
10456996|NCT01008553|11604732|FG001|COMPLETED|Period 1 (Titration Period)||0
10456997|NCT01008553|11604733|FG002|COMPLETED|Period 1 (Titration Period)||0
10456998|NCT01008553|11604731|FG000|NOT COMPLETED|Period 1 (Titration Period)||95
10591379|NCT01778465|11747528|FG000|NOT COMPLETED|First Intervention (7 Days)||0
10591380|NCT01778465|11747529|FG001|NOT COMPLETED|First Intervention (7 Days)||0
10591381|NCT01778465|11747528|FG000|STARTED|Second Intervention (7 Days)||3
10591382|NCT01778465|11747529|FG001|STARTED|Second Intervention (7 Days)||4
10591383|NCT01778465|11747528|FG000|COMPLETED|Second Intervention (7 Days)||3
10591384|NCT01778465|11747529|FG001|COMPLETED|Second Intervention (7 Days)||4
10591385|NCT01778465|11747528|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
10591386|NCT01778465|11747529|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
10591387|NCT01778530|11747538|FG000|STARTED|Overall Study||2
10591388|NCT01778530|11747538|FG000|COMPLETED|Overall Study||0
10591389|NCT01778530|11747538|FG000|NOT COMPLETED|Overall Study||2
10591390|NCT01778556|11747544|FG000|STARTED|Intervention 1 (5 Days)||15
10591391|NCT01778556|11747545|FG001|STARTED|Intervention 1 (5 Days)||10
10591392|NCT01778556|11747544|FG000|COMPLETED|Intervention 1 (5 Days)||15
10591393|NCT01778556|11747545|FG001|COMPLETED|Intervention 1 (5 Days)||8
10591394|NCT01778556|11747544|FG000|NOT COMPLETED|Intervention 1 (5 Days)||0
10591395|NCT01778556|11747545|FG001|NOT COMPLETED|Intervention 1 (5 Days)||2
10591396|NCT01778556|11747544|FG000|STARTED|Intervention 2 (14 Days)||15
10591397|NCT01778556|11747545|FG001|STARTED|Intervention 2 (14 Days)||8
10591398|NCT01778556|11747544|FG000|COMPLETED|Intervention 2 (14 Days)||14
10591399|NCT01778556|11747545|FG001|COMPLETED|Intervention 2 (14 Days)||8
10591400|NCT01778556|11747544|FG000|NOT COMPLETED|Intervention 2 (14 Days)||1
10591401|NCT01778556|11747545|FG001|NOT COMPLETED|Intervention 2 (14 Days)||0
10591402|NCT01778556|11747544|FG000|STARTED|Long-term Follow-up||15
10591403|NCT01778556|11747545|FG001|STARTED|Long-term Follow-up|no long-term follow-up period in on-leptin arm|0
10591404|NCT01778556|11747544|FG000|COMPLETED|Long-term Follow-up||14
10591405|NCT01778556|11747545|FG001|COMPLETED|Long-term Follow-up|no long-term follow-up period in on-leptin arm|0
10591406|NCT01778556|11747544|FG000|NOT COMPLETED|Long-term Follow-up||1
10591407|NCT01778556|11747545|FG001|NOT COMPLETED|Long-term Follow-up||0
10591408|NCT01778634|11747556|FG000|STARTED|Overall Study||61
10591409|NCT01778634|11747557|FG001|STARTED|Overall Study||60
10591410|NCT01778634|11747556|FG000|COMPLETED|Overall Study||61
10591411|NCT01778634|11747557|FG001|COMPLETED|Overall Study||60
10591412|NCT01778634|11747556|FG000|NOT COMPLETED|Overall Study||0
10591413|NCT01778634|11747557|FG001|NOT COMPLETED|Overall Study||0
10591414|NCT01778751|11747566|FG000|STARTED|Overall Study||25
10591415|NCT01778751|11747567|FG001|STARTED|Overall Study||25
10591416|NCT01778751|11747566|FG000|COMPLETED|Overall Study||23
10591417|NCT01778751|11747567|FG001|COMPLETED|Overall Study||23
10591418|NCT01778751|11747566|FG000|NOT COMPLETED|Overall Study||2
10591419|NCT01778751|11747567|FG001|NOT COMPLETED|Overall Study||2
10591420|NCT01778855|11747575|FG000|STARTED|Overall Study||2
10591421|NCT01778855|11747576|FG001|STARTED|Overall Study||4
10591422|NCT01778855|11747575|FG000|COMPLETED|Overall Study||2
10591423|NCT01778855|11747576|FG001|COMPLETED|Overall Study||3
10591424|NCT01778855|11747575|FG000|NOT COMPLETED|Overall Study||0
10591425|NCT01778855|11747576|FG001|NOT COMPLETED|Overall Study||1
10591426|NCT01778985|11747584|FG000|STARTED|Overall Study||15
10591427|NCT01778985|11747585|FG001|STARTED|Overall Study||15
10591428|NCT01778985|11747584|FG000|COMPLETED|Overall Study||8
10591429|NCT01778985|11747585|FG001|COMPLETED|Overall Study||12
10591430|NCT01778985|11747584|FG000|NOT COMPLETED|Overall Study||7
10591431|NCT01778985|11747585|FG001|NOT COMPLETED|Overall Study||3
10591432|NCT01779024|11747591|FG000|STARTED|1st Visit - Alcohol Self-Administration||8
10591433|NCT01779024|11747592|FG001|STARTED|1st Visit - Alcohol Self-Administration||9
10591434|NCT01779024|11747591|FG000|COMPLETED|1st Visit - Alcohol Self-Administration||8
10591435|NCT01779024|11747592|FG001|COMPLETED|1st Visit - Alcohol Self-Administration||9
10591436|NCT01779024|11747591|FG000|NOT COMPLETED|1st Visit - Alcohol Self-Administration||0
10591437|NCT01779024|11747592|FG001|NOT COMPLETED|1st Visit - Alcohol Self-Administration||0
10591438|NCT01779024|11747591|FG000|STARTED|2nd Visit - Alcohol Self-Administration||8
10591439|NCT01779024|11747592|FG001|STARTED|2nd Visit - Alcohol Self-Administration||9
10591440|NCT01779024|11747591|FG000|COMPLETED|2nd Visit - Alcohol Self-Administration||6
10591441|NCT01779024|11747592|FG001|COMPLETED|2nd Visit - Alcohol Self-Administration||9
10591442|NCT01779024|11747591|FG000|NOT COMPLETED|2nd Visit - Alcohol Self-Administration||2
10591443|NCT01779024|11747592|FG001|NOT COMPLETED|2nd Visit - Alcohol Self-Administration||0
10591444|NCT01779024|11747591|FG000|STARTED|1st Visit - Functional MRI||6
10591445|NCT01779024|11747592|FG001|STARTED|1st Visit - Functional MRI||7
10591446|NCT01779024|11747591|FG000|COMPLETED|1st Visit - Functional MRI||4
10591447|NCT01779024|11747592|FG001|COMPLETED|1st Visit - Functional MRI||5
10591448|NCT01779024|11747591|FG000|NOT COMPLETED|1st Visit - Functional MRI||2
10591449|NCT01779024|11747592|FG001|NOT COMPLETED|1st Visit - Functional MRI||2
10591450|NCT01779024|11747591|FG000|STARTED|2nd Visit - Functional MRI||5
10591451|NCT01779024|11747592|FG001|STARTED|2nd Visit - Functional MRI||6
10591452|NCT01779024|11747591|FG000|COMPLETED|2nd Visit - Functional MRI||5
10591453|NCT01779024|11747592|FG001|COMPLETED|2nd Visit - Functional MRI||6
10591454|NCT01779024|11747591|FG000|NOT COMPLETED|2nd Visit - Functional MRI||0
10591455|NCT01779024|11747592|FG001|NOT COMPLETED|2nd Visit - Functional MRI||0
10591456|NCT01779141|11747598|FG000|STARTED|Overall Study||481
10591457|NCT01779141|11747598|FG000|COMPLETED|Overall Study||300
10591458|NCT01779141|11747598|FG000|NOT COMPLETED|Overall Study||181
10591459|NCT01779167|11747602|FG000|STARTED|Overall Study||4
10591460|NCT01779167|11747602|FG000|COMPLETED|Overall Study||3
10591461|NCT01779167|11747602|FG000|NOT COMPLETED|Overall Study||1
10591462|NCT01779219|11747608|FG000|STARTED|Overall Study|First interim analysis|21
10591463|NCT01779219|11747609|FG001|STARTED|Overall Study|First interim analysis|21
10591464|NCT01779219|11747608|FG000|COMPLETED|Overall Study|First interim analysis|21
10591465|NCT01779219|11747609|FG001|COMPLETED|Overall Study|First interim analysis|21
10591466|NCT01779219|11747608|FG000|NOT COMPLETED|Overall Study||0
10591467|NCT01779219|11747609|FG001|NOT COMPLETED|Overall Study||0
10591468|NCT01779375|11747617|FG000|STARTED|Overall Study||47
10591469|NCT01779375|11747618|FG001|STARTED|Overall Study||44
10591470|NCT01779375|11747617|FG000|COMPLETED|Overall Study||45
10591471|NCT01779375|11747618|FG001|COMPLETED|Overall Study||41
10591472|NCT01779375|11747617|FG000|NOT COMPLETED|Overall Study||2
10591473|NCT01779375|11747618|FG001|NOT COMPLETED|Overall Study||3
10591474|NCT01779440|11747628|FG000|STARTED|Overall Study||30
10591475|NCT01779440|11747629|FG001|STARTED|Overall Study||28
10591476|NCT01779440|11747628|FG000|COMPLETED|Overall Study||27
10591477|NCT01779440|11747629|FG001|COMPLETED|Overall Study||23
10591478|NCT01779440|11747628|FG000|NOT COMPLETED|Overall Study||3
10591479|NCT01779440|11747629|FG001|NOT COMPLETED|Overall Study||5
10591480|NCT01779648|11747637|FG000|STARTED|Overall Study||28
10591481|NCT01779648|11747638|FG001|STARTED|Overall Study||27
10591482|NCT01779648|11747637|FG000|COMPLETED|Overall Study||27
10591483|NCT01779648|11747638|FG001|COMPLETED|Overall Study||27
10591484|NCT01779648|11747637|FG000|NOT COMPLETED|Overall Study||1
10591485|NCT01779648|11747638|FG001|NOT COMPLETED|Overall Study||0
10591486|NCT01779700|11747646|FG000|STARTED|Overall Study||18
10591487|NCT01779700|11747647|FG001|STARTED|Overall Study||22
10591488|NCT01779700|11747646|FG000|COMPLETED|Overall Study||14
10591489|NCT01779700|11747647|FG001|COMPLETED|Overall Study||17
10591490|NCT01779700|11747646|FG000|NOT COMPLETED|Overall Study||4
10591491|NCT01779700|11747647|FG001|NOT COMPLETED|Overall Study||5
10591492|NCT01779856|11747653|FG000|STARTED|Overall Study||81
10591493|NCT01779856|11747653|FG000|COMPLETED|Overall Study||57
10591494|NCT01779856|11747653|FG000|NOT COMPLETED|Overall Study||24
10591495|NCT01779869|11747664|FG000|STARTED|Overall Study||16
10591496|NCT01779869|11747664|FG000|COMPLETED|Overall Study||14
10591497|NCT01779869|11747664|FG000|NOT COMPLETED|Overall Study||2
10591498|NCT01780324|11747670|FG000|STARTED|Overall Study||41
10591499|NCT01780324|11747671|FG001|STARTED|Overall Study||39
10591500|NCT01780324|11747670|FG000|COMPLETED|Overall Study||40
10591501|NCT01780324|11747671|FG001|COMPLETED|Overall Study||33
10591502|NCT01780324|11747670|FG000|NOT COMPLETED|Overall Study||1
10591503|NCT01780324|11747671|FG001|NOT COMPLETED|Overall Study||6
10591504|NCT01780337|11747679|FG000|STARTED|Overall Study||6
10591505|NCT01780337|11747680|FG001|STARTED|Overall Study||6
10591506|NCT01780337|11747679|FG000|COMPLETED|Overall Study||6
10591507|NCT01780337|11747680|FG001|COMPLETED|Overall Study||6
10591508|NCT01780337|11747679|FG000|NOT COMPLETED|Overall Study||0
10591509|NCT01780337|11747680|FG001|NOT COMPLETED|Overall Study||0
10591510|NCT01780350|11747686|FG000|STARTED|Overall Study||200
10591511|NCT01780350|11747686|FG000|COMPLETED|Overall Study||200
10591512|NCT01780350|11747686|FG000|NOT COMPLETED|Overall Study||0
10591513|NCT01780389|11747690|FG000|STARTED|Overall Study||5
10652087|NCT02181504|11812415|FG002|NOT COMPLETED|Overall Study||1
10591514|NCT01780389|11747690|FG000|COMPLETED|Overall Study|One patient discontinued due to adverse event.|4
10591515|NCT01780389|11747690|FG000|NOT COMPLETED|Overall Study||1
10591516|NCT01780454|11747695|FG000|STARTED|Overall Study||2
10591517|NCT01780454|11747695|FG000|COMPLETED|Overall Study||2
10591518|NCT01780454|11747695|FG000|NOT COMPLETED|Overall Study||0
10591519|NCT01780506|11747701|FG000|STARTED|Double-Blind Phase||438
10591520|NCT01780506|11747702|FG001|STARTED|Double-Blind Phase||434
10591521|NCT01780506|11747701|FG000|COMPLETED|Double-Blind Phase||368
10591522|NCT01780506|11747702|FG001|COMPLETED|Double-Blind Phase||356
10591523|NCT01780506|11747701|FG000|NOT COMPLETED|Double-Blind Phase||70
10591524|NCT01780506|11747702|FG001|NOT COMPLETED|Double-Blind Phase||78
10591525|NCT01780506|11747701|FG000|STARTED|Open-Label Extension Phase|278 participants completed the Double-Blind Phase but did not enter the Open-Label Extension Phase|90
10591526|NCT01780506|11747702|FG001|STARTED|Open-Label Extension Phase|261 participants completed the Double-Blind Phase but did not enter the Open-Label Extension Phase|95
10591527|NCT01780506|11747701|FG000|COMPLETED|Open-Label Extension Phase||90
10591528|NCT01780506|11747702|FG001|COMPLETED|Open-Label Extension Phase||94
10591529|NCT01780506|11747701|FG000|NOT COMPLETED|Open-Label Extension Phase||0
10591530|NCT01780506|11747702|FG001|NOT COMPLETED|Open-Label Extension Phase||1
10807676|NCT03888482|11969408|FG001|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0
10807677|NCT03888482|11969407|FG000|STARTED|Second Wear (8 -1/+2 Days)|2 subjects were discontinued between Treatment 1 and Treatment 2.|74
10807678|NCT03888482|11969408|FG001|STARTED|Second Wear (8 -1/+2 Days)||75
10807679|NCT03888482|11969407|FG000|COMPLETED|Second Wear (8 -1/+2 Days)||73
10591537|NCT01780584|11747725|FG000|STARTED|Overall Study||15
10591538|NCT01780584|11747726|FG001|STARTED|Overall Study||15
10591539|NCT01780584|11747727|FG002|STARTED|Overall Study||15
10591540|NCT01780584|11747725|FG000|COMPLETED|Overall Study||14
10591541|NCT01780584|11747726|FG001|COMPLETED|Overall Study||14
10591542|NCT01780584|11747727|FG002|COMPLETED|Overall Study||13
10591543|NCT01780584|11747725|FG000|NOT COMPLETED|Overall Study||1
10591544|NCT01780584|11747726|FG001|NOT COMPLETED|Overall Study||1
10591545|NCT01780584|11747727|FG002|NOT COMPLETED|Overall Study||2
10591546|NCT01780662|11747738|FG000|STARTED|Overall Study||3
10591547|NCT01780662|11747739|FG001|STARTED|Overall Study||13
10591548|NCT01780662|11747740|FG002|STARTED|Overall Study||30
10591549|NCT01780662|11747738|FG000|COMPLETED|Overall Study||2
10591550|NCT01780662|11747739|FG001|COMPLETED|Overall Study||7
10591551|NCT01780662|11747740|FG002|COMPLETED|Overall Study||20
10591552|NCT01780662|11747738|FG000|NOT COMPLETED|Overall Study||1
10591553|NCT01780662|11747739|FG001|NOT COMPLETED|Overall Study||6
10591554|NCT01780662|11747740|FG002|NOT COMPLETED|Overall Study||10
10591555|NCT01780831|11747753|FG000|STARTED|Overall Study||10
10591556|NCT01780831|11747754|FG001|STARTED|Overall Study||6
10591557|NCT01780831|11747755|FG002|STARTED|Overall Study||26
10591558|NCT01780831|11747756|FG003|STARTED|Overall Study||10
10591559|NCT01780831|11747753|FG000|COMPLETED|Overall Study||10
10591560|NCT01780831|11747754|FG001|COMPLETED|Overall Study||6
10591561|NCT01780831|11747755|FG002|COMPLETED|Overall Study||22
10591562|NCT01780831|11747756|FG003|COMPLETED|Overall Study||9
10591563|NCT01780831|11747753|FG000|NOT COMPLETED|Overall Study||0
10591564|NCT01780831|11747754|FG001|NOT COMPLETED|Overall Study||0
10591565|NCT01780831|11747755|FG002|NOT COMPLETED|Overall Study||4
10591566|NCT01780831|11747756|FG003|NOT COMPLETED|Overall Study||1
10591567|NCT01780870|11747815|FG000|STARTED|Overall Study||0
10591568|NCT01780870|11747816|FG001|STARTED|Overall Study||5
10591569|NCT01780870|11747815|FG000|COMPLETED|Overall Study||0
10591570|NCT01780870|11747816|FG001|COMPLETED|Overall Study||5
10591571|NCT01780870|11747815|FG000|NOT COMPLETED|Overall Study||0
10591572|NCT01780870|11747816|FG001|NOT COMPLETED|Overall Study||0
10591573|NCT01780922|11747822|FG000|STARTED|First Intervention (1 Day)||2
10591574|NCT01780922|11747823|FG001|STARTED|First Intervention (1 Day)||2
10591575|NCT01780922|11747824|FG002|STARTED|First Intervention (1 Day)||2
10591576|NCT01780922|11747825|FG003|STARTED|First Intervention (1 Day)||2
10591577|NCT01780922|11747826|FG004|STARTED|First Intervention (1 Day)||2
10591578|NCT01780922|11747827|FG005|STARTED|First Intervention (1 Day)||2
10591579|NCT01780922|11747822|FG000|COMPLETED|First Intervention (1 Day)||2
10591580|NCT01780922|11747823|FG001|COMPLETED|First Intervention (1 Day)||2
10591581|NCT01780922|11747824|FG002|COMPLETED|First Intervention (1 Day)||2
10591582|NCT01780922|11747825|FG003|COMPLETED|First Intervention (1 Day)||2
10591583|NCT01780922|11747826|FG004|COMPLETED|First Intervention (1 Day)||2
10591584|NCT01780922|11747827|FG005|COMPLETED|First Intervention (1 Day)||2
10591585|NCT01780922|11747822|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10591586|NCT01780922|11747823|FG001|NOT COMPLETED|First Intervention (1 Day)||0
10591587|NCT01780922|11747824|FG002|NOT COMPLETED|First Intervention (1 Day)||0
10591588|NCT01780922|11747825|FG003|NOT COMPLETED|First Intervention (1 Day)||0
10591589|NCT01780922|11747826|FG004|NOT COMPLETED|First Intervention (1 Day)||0
10591590|NCT01780922|11747827|FG005|NOT COMPLETED|First Intervention (1 Day)||0
10591591|NCT01780922|11747822|FG000|STARTED|Washout (7 Days)||2
10591592|NCT01780922|11747823|FG001|STARTED|Washout (7 Days)||2
10591593|NCT01780922|11747824|FG002|STARTED|Washout (7 Days)||2
10591594|NCT01780922|11747825|FG003|STARTED|Washout (7 Days)||2
10591595|NCT01780922|11747826|FG004|STARTED|Washout (7 Days)||2
10591596|NCT01780922|11747827|FG005|STARTED|Washout (7 Days)||2
10591597|NCT01780922|11747822|FG000|COMPLETED|Washout (7 Days)||2
10591598|NCT01780922|11747823|FG001|COMPLETED|Washout (7 Days)||2
10591599|NCT01780922|11747824|FG002|COMPLETED|Washout (7 Days)||2
10591600|NCT01780922|11747825|FG003|COMPLETED|Washout (7 Days)||2
10591601|NCT01780922|11747826|FG004|COMPLETED|Washout (7 Days)||2
10591602|NCT01780922|11747827|FG005|COMPLETED|Washout (7 Days)||2
10591603|NCT01780922|11747822|FG000|NOT COMPLETED|Washout (7 Days)||0
10591604|NCT01780922|11747823|FG001|NOT COMPLETED|Washout (7 Days)||0
10591605|NCT01780922|11747824|FG002|NOT COMPLETED|Washout (7 Days)||0
10591606|NCT01780922|11747825|FG003|NOT COMPLETED|Washout (7 Days)||0
10591607|NCT01780922|11747826|FG004|NOT COMPLETED|Washout (7 Days)||0
10591608|NCT01780922|11747827|FG005|NOT COMPLETED|Washout (7 Days)||0
10591609|NCT01780922|11747822|FG000|STARTED|Second Intervention (1 Day)||2
10591610|NCT01780922|11747823|FG001|STARTED|Second Intervention (1 Day)||2
10591611|NCT01780922|11747824|FG002|STARTED|Second Intervention (1 Day)||2
10591612|NCT01780922|11747825|FG003|STARTED|Second Intervention (1 Day)||2
10591613|NCT01780922|11747826|FG004|STARTED|Second Intervention (1 Day)||2
10591614|NCT01780922|11747827|FG005|STARTED|Second Intervention (1 Day)||2
10591615|NCT01780922|11747822|FG000|COMPLETED|Second Intervention (1 Day)||2
10591616|NCT01780922|11747823|FG001|COMPLETED|Second Intervention (1 Day)||2
10591617|NCT01780922|11747824|FG002|COMPLETED|Second Intervention (1 Day)||2
10591618|NCT01780922|11747825|FG003|COMPLETED|Second Intervention (1 Day)||2
10591619|NCT01780922|11747826|FG004|COMPLETED|Second Intervention (1 Day)||2
10591620|NCT01780922|11747827|FG005|COMPLETED|Second Intervention (1 Day)||2
10591621|NCT01780922|11747822|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10591622|NCT01780922|11747823|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10591623|NCT01780922|11747824|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
10591624|NCT01780922|11747825|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
10591625|NCT01780922|11747826|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
10591626|NCT01780922|11747827|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
10591627|NCT01780922|11747822|FG000|STARTED|Washout (7 Days)||2
10591628|NCT01780922|11747823|FG001|STARTED|Washout (7 Days)||2
10591629|NCT01780922|11747824|FG002|STARTED|Washout (7 Days)||2
10591630|NCT01780922|11747825|FG003|STARTED|Washout (7 Days)||2
10591631|NCT01780922|11747826|FG004|STARTED|Washout (7 Days)||2
10591632|NCT01780922|11747827|FG005|STARTED|Washout (7 Days)||2
10591633|NCT01780922|11747822|FG000|COMPLETED|Washout (7 Days)||2
10591634|NCT01780922|11747823|FG001|COMPLETED|Washout (7 Days)||2
10591635|NCT01780922|11747824|FG002|COMPLETED|Washout (7 Days)||2
10591636|NCT01780922|11747825|FG003|COMPLETED|Washout (7 Days)||2
10591637|NCT01780922|11747826|FG004|COMPLETED|Washout (7 Days)||2
10591638|NCT01780922|11747827|FG005|COMPLETED|Washout (7 Days)||2
10591639|NCT01780922|11747822|FG000|NOT COMPLETED|Washout (7 Days)||0
10591640|NCT01780922|11747823|FG001|NOT COMPLETED|Washout (7 Days)||0
10591641|NCT01780922|11747824|FG002|NOT COMPLETED|Washout (7 Days)||0
10591642|NCT01780922|11747825|FG003|NOT COMPLETED|Washout (7 Days)||0
10591643|NCT01780922|11747826|FG004|NOT COMPLETED|Washout (7 Days)||0
10591644|NCT01780922|11747827|FG005|NOT COMPLETED|Washout (7 Days)||0
10591645|NCT01780922|11747822|FG000|STARTED|Third Intervention (1 Day)||2
10591646|NCT01780922|11747823|FG001|STARTED|Third Intervention (1 Day)||2
10591647|NCT01780922|11747824|FG002|STARTED|Third Intervention (1 Day)||2
10591648|NCT01780922|11747825|FG003|STARTED|Third Intervention (1 Day)||2
10591649|NCT01780922|11747826|FG004|STARTED|Third Intervention (1 Day)||2
10591650|NCT01780922|11747827|FG005|STARTED|Third Intervention (1 Day)||2
10591651|NCT01780922|11747822|FG000|COMPLETED|Third Intervention (1 Day)||2
10591652|NCT01780922|11747823|FG001|COMPLETED|Third Intervention (1 Day)||2
10591653|NCT01780922|11747824|FG002|COMPLETED|Third Intervention (1 Day)||2
10591654|NCT01780922|11747825|FG003|COMPLETED|Third Intervention (1 Day)||2
10591655|NCT01780922|11747826|FG004|COMPLETED|Third Intervention (1 Day)||2
10591656|NCT01780922|11747827|FG005|COMPLETED|Third Intervention (1 Day)||2
10591657|NCT01780922|11747822|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
10591658|NCT01780922|11747823|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
10591659|NCT01780922|11747824|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
10591660|NCT01780922|11747825|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
10591661|NCT01780922|11747826|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
10591662|NCT01780922|11747827|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
10591663|NCT01780935|11747837|FG000|STARTED|Overall Study||335
10591664|NCT01780935|11747838|FG001|STARTED|Overall Study||336
10591665|NCT01780935|11747837|FG000|Safety Set|Overall Study||334
10591666|NCT01780935|11747838|FG001|Safety Set|Overall Study||336
10591667|NCT01780935|11747837|FG000|COMPLETED|Overall Study||0
10591668|NCT01780935|11747838|FG001|COMPLETED|Overall Study||0
10591669|NCT01780935|11747837|FG000|NOT COMPLETED|Overall Study||335
10591670|NCT01780935|11747838|FG001|NOT COMPLETED|Overall Study||336
10591671|NCT01780974|11747846|FG000|STARTED|Overall Study||21
10591672|NCT01780974|11747847|FG001|STARTED|Overall Study||21
10591673|NCT01780974|11747846|FG000|COMPLETED|Overall Study||19
10591674|NCT01780974|11747847|FG001|COMPLETED|Overall Study||18
10591675|NCT01780974|11747846|FG000|NOT COMPLETED|Overall Study||2
10591676|NCT01780974|11747847|FG001|NOT COMPLETED|Overall Study||3
10591677|NCT01780987|11747855|FG000|STARTED|Overall Study||40
10591678|NCT01780987|11747856|FG001|STARTED|Overall Study|Including one participant who withdrew from the study prior to receiving any study medication.|40
10591679|NCT01780987|11747855|FG000|COMPLETED|Overall Study||37
10591680|NCT01780987|11747856|FG001|COMPLETED|Overall Study||34
10591681|NCT01780987|11747855|FG000|NOT COMPLETED|Overall Study||3
10591682|NCT01780987|11747856|FG001|NOT COMPLETED|Overall Study||6
10591683|NCT01781078|11747864|FG000|STARTED|Overall Study|Randomized post implantation|229
10591684|NCT01781078|11747865|FG001|STARTED|Overall Study|Randomized post implantation|118
10591685|NCT01781078|11747866|FG002|STARTED|Overall Study||16
10591686|NCT01781078|11747864|FG000|COMPLETED|Overall Study|Patients having completed the MRI + 1 month (Primary endpoint assessment)|217
10591687|NCT01781078|11747865|FG001|COMPLETED|Overall Study|Patients having completed the MRI + 1 month (Primary endpoint assessment)|113
10591688|NCT01781078|11747866|FG002|COMPLETED|Overall Study||0
10591689|NCT01781078|11747864|FG000|NOT COMPLETED|Overall Study||12
10591690|NCT01781078|11747865|FG001|NOT COMPLETED|Overall Study||5
10591691|NCT01781078|11747866|FG002|NOT COMPLETED|Overall Study||16
10591692|NCT01781169|11747877|FG000|STARTED|Overall Study||22
10591693|NCT01781169|11747878|FG001|STARTED|Overall Study||21
10591694|NCT01781169|11747877|FG000|COMPLETED|Overall Study||21
10591695|NCT01781169|11747878|FG001|COMPLETED|Overall Study||21
10591696|NCT01781169|11747877|FG000|NOT COMPLETED|Overall Study||1
10591697|NCT01781169|11747878|FG001|NOT COMPLETED|Overall Study||0
10591698|NCT01781208|11747884|FG000|STARTED|Overall Study||62
10591699|NCT01781208|11747884|FG000|Overall Study|Overall Study||62
10591700|NCT01781208|11747884|FG000|COMPLETED|Overall Study||62
10591701|NCT01781208|11747884|FG000|NOT COMPLETED|Overall Study||0
10591702|NCT01781234|11747891|FG000|STARTED|Overall Study||27
10591703|NCT01781234|11747892|FG001|STARTED|Overall Study||24
10591704|NCT01781234|11747891|FG000|COMPLETED|Overall Study||18
10591705|NCT01781234|11747892|FG001|COMPLETED|Overall Study||21
10591706|NCT01781234|11747891|FG000|NOT COMPLETED|Overall Study||9
10591707|NCT01781234|11747892|FG001|NOT COMPLETED|Overall Study||3
10591708|NCT01781286|11747900|FG000|STARTED|Overall Study||7
10591709|NCT01781286|11747901|FG001|STARTED|Overall Study||4
10591710|NCT01781286|11747902|FG002|STARTED|Overall Study||9
10591711|NCT01781286|11747903|FG003|STARTED|Overall Study||8
10591712|NCT01781286|11747904|FG004|STARTED|Overall Study||6
10591713|NCT01781286|11747905|FG005|STARTED|Overall Study||3
10591714|NCT01781286|11747900|FG000|Started 1st Intervention|Overall Study||6
10591715|NCT01781286|11747901|FG001|Started 1st Intervention|Overall Study||4
10591716|NCT01781286|11747902|FG002|Started 1st Intervention|Overall Study||9
10591717|NCT01781286|11747903|FG003|Started 1st Intervention|Overall Study||8
10591718|NCT01781286|11747904|FG004|Started 1st Intervention|Overall Study||6
10591719|NCT01781286|11747905|FG005|Started 1st Intervention|Overall Study||2
10591720|NCT01781286|11747900|FG000|Started 2nd Intervention|Overall Study||5
10591721|NCT01781286|11747901|FG001|Started 2nd Intervention|Overall Study||4
10591722|NCT01781286|11747902|FG002|Started 2nd Intervention|Overall Study||9
10591723|NCT01781286|11747903|FG003|Started 2nd Intervention|Overall Study||8
10591724|NCT01781286|11747904|FG004|Started 2nd Intervention|Overall Study||6
10591725|NCT01781286|11747905|FG005|Started 2nd Intervention|Overall Study||2
10591726|NCT01781286|11747900|FG000|Started 3rd Intervention|Overall Study||5
10591727|NCT01781286|11747901|FG001|Started 3rd Intervention|Overall Study||4
10591728|NCT01781286|11747902|FG002|Started 3rd Intervention|Overall Study||7
10591729|NCT01781286|11747903|FG003|Started 3rd Intervention|Overall Study||7
10591730|NCT01781286|11747904|FG004|Started 3rd Intervention|Overall Study||6
10591731|NCT01781286|11747905|FG005|Started 3rd Intervention|Overall Study||2
10591732|NCT01781286|11747900|FG000|COMPLETED|Overall Study||5
10591733|NCT01781286|11747901|FG001|COMPLETED|Overall Study||4
10591734|NCT01781286|11747902|FG002|COMPLETED|Overall Study||7
10591735|NCT01781286|11747903|FG003|COMPLETED|Overall Study||7
10591736|NCT01781286|11747904|FG004|COMPLETED|Overall Study||6
10591737|NCT01781286|11747905|FG005|COMPLETED|Overall Study||2
10591738|NCT01781286|11747900|FG000|NOT COMPLETED|Overall Study||2
10591739|NCT01781286|11747901|FG001|NOT COMPLETED|Overall Study||0
10591740|NCT01781286|11747902|FG002|NOT COMPLETED|Overall Study||2
10591741|NCT01781286|11747903|FG003|NOT COMPLETED|Overall Study||1
10591742|NCT01781286|11747904|FG004|NOT COMPLETED|Overall Study||0
10591743|NCT01781286|11747905|FG005|NOT COMPLETED|Overall Study||1
10591744|NCT01781299|11747917|FG000|STARTED|Overall Study||4
10591745|NCT01781299|11747918|FG001|STARTED|Overall Study||5
10591746|NCT01781299|11747917|FG000|COMPLETED|Overall Study||4
10591747|NCT01781299|11747918|FG001|COMPLETED|Overall Study||4
10591748|NCT01781299|11747917|FG000|NOT COMPLETED|Overall Study||0
10591749|NCT01781299|11747918|FG001|NOT COMPLETED|Overall Study||1
10591750|NCT01781403|11747924|FG000|STARTED|Overall Study||2
10591751|NCT01781403|11747925|FG001|STARTED|Overall Study||2
10591752|NCT01781403|11747926|FG002|STARTED|Overall Study||18
10591753|NCT01781403|11747924|FG000|COMPLETED|Overall Study||2
10591754|NCT01781403|11747925|FG001|COMPLETED|Overall Study||2
10591755|NCT01781403|11747926|FG002|COMPLETED|Overall Study||18
10591756|NCT01781403|11747924|FG000|NOT COMPLETED|Overall Study||0
10591757|NCT01781403|11747925|FG001|NOT COMPLETED|Overall Study||0
10591758|NCT01781403|11747926|FG002|NOT COMPLETED|Overall Study||0
10591759|NCT01781429|11747951|FG000|STARTED|Overall Study||1
10591760|NCT01781429|11747952|FG001|STARTED|Overall Study||1
10591761|NCT01781429|11747953|FG002|STARTED|Overall Study||1
10591762|NCT01781429|11747954|FG003|STARTED|Overall Study||1
10591763|NCT01781429|11747955|FG004|STARTED|Overall Study||1
10591764|NCT01781429|11747956|FG005|STARTED|Overall Study||4
10591765|NCT01781429|11747957|FG006|STARTED|Overall Study||7
10591766|NCT01781429|11747958|FG007|STARTED|Overall Study||4
10591767|NCT01781429|11747959|FG008|STARTED|Overall Study||7
10591768|NCT01781429|11747960|FG009|STARTED|Overall Study||24
10591769|NCT01781429|11747961|FG010|STARTED|Overall Study||18
10591770|NCT01781429|11747962|FG011|STARTED|Overall Study||21
10591771|NCT01781429|11747963|FG012|STARTED|Overall Study||22
10591772|NCT01781429|11747964|FG013|STARTED|Overall Study||8
10591773|NCT01781429|11747965|FG014|STARTED|Overall Study||16
10591774|NCT01781429|11747966|FG015|STARTED|Overall Study||0
10591775|NCT01781429|11747951|FG000|COMPLETED|Overall Study||0
10591776|NCT01781429|11747952|FG001|COMPLETED|Overall Study||0
10591777|NCT01781429|11747953|FG002|COMPLETED|Overall Study||0
10591778|NCT01781429|11747954|FG003|COMPLETED|Overall Study||0
10591779|NCT01781429|11747955|FG004|COMPLETED|Overall Study||0
10591780|NCT01781429|11747956|FG005|COMPLETED|Overall Study||0
10591781|NCT01781429|11747957|FG006|COMPLETED|Overall Study||0
10591782|NCT01781429|11747958|FG007|COMPLETED|Overall Study||0
10591783|NCT01781429|11747959|FG008|COMPLETED|Overall Study||0
10591784|NCT01781429|11747960|FG009|COMPLETED|Overall Study||0
10591785|NCT01781429|11747961|FG010|COMPLETED|Overall Study||0
10591786|NCT01781429|11747962|FG011|COMPLETED|Overall Study||0
10591787|NCT01781429|11747963|FG012|COMPLETED|Overall Study||0
10591788|NCT01781429|11747964|FG013|COMPLETED|Overall Study||0
10591789|NCT01781429|11747965|FG014|COMPLETED|Overall Study||0
10591790|NCT01781429|11747966|FG015|COMPLETED|Overall Study||0
10591791|NCT01781429|11747951|FG000|NOT COMPLETED|Overall Study||1
10591792|NCT01781429|11747952|FG001|NOT COMPLETED|Overall Study||1
10591793|NCT01781429|11747953|FG002|NOT COMPLETED|Overall Study||1
10591794|NCT01781429|11747954|FG003|NOT COMPLETED|Overall Study||1
10591795|NCT01781429|11747955|FG004|NOT COMPLETED|Overall Study||1
10591796|NCT01781429|11747956|FG005|NOT COMPLETED|Overall Study||4
10591797|NCT01781429|11747957|FG006|NOT COMPLETED|Overall Study||7
10591798|NCT01781429|11747958|FG007|NOT COMPLETED|Overall Study||4
10591799|NCT01781429|11747959|FG008|NOT COMPLETED|Overall Study||7
10591800|NCT01781429|11747960|FG009|NOT COMPLETED|Overall Study||24
10591801|NCT01781429|11747961|FG010|NOT COMPLETED|Overall Study||18
10591802|NCT01781429|11747962|FG011|NOT COMPLETED|Overall Study||21
10591803|NCT01781429|11747963|FG012|NOT COMPLETED|Overall Study||22
10591804|NCT01781429|11747964|FG013|NOT COMPLETED|Overall Study||8
10591805|NCT01781429|11747965|FG014|NOT COMPLETED|Overall Study||16
10591806|NCT01781429|11747966|FG015|NOT COMPLETED|Overall Study||0
10591807|NCT01781468|11748002|FG000|STARTED|Overall Study||109
10591808|NCT01781468|11748003|FG001|STARTED|Overall Study||110
10591809|NCT01781468|11748004|FG002|STARTED|Overall Study||109
10591810|NCT01781468|11748002|FG000|COMPLETED|Overall Study||103
10591811|NCT01781468|11748003|FG001|COMPLETED|Overall Study||97
10591812|NCT01781468|11748004|FG002|COMPLETED|Overall Study||97
10591813|NCT01781468|11748002|FG000|NOT COMPLETED|Overall Study||6
10591814|NCT01781468|11748003|FG001|NOT COMPLETED|Overall Study||13
10591815|NCT01781468|11748004|FG002|NOT COMPLETED|Overall Study||12
10591816|NCT01781481|11748013|FG000|STARTED|Overall Study||148
10591817|NCT01781481|11748013|FG000|COMPLETED|Overall Study||148
10591818|NCT01781481|11748013|FG000|NOT COMPLETED|Overall Study||0
10591819|NCT01781572|11748069|FG000|STARTED|MEK162 45mg BID+LEE011 200mg||16
10591820|NCT01781572|11748070|FG001|STARTED|MEK162 45mg BID+LEE011 200mg||6
10591821|NCT01781572|11748071|FG002|STARTED|MEK162 45mg BID+LEE011 200mg||41
10591822|NCT01781572|11748069|FG000|COMPLETED|MEK162 45mg BID+LEE011 200mg||0
10591823|NCT01781572|11748070|FG001|COMPLETED|MEK162 45mg BID+LEE011 200mg||0
10591824|NCT01781572|11748071|FG002|COMPLETED|MEK162 45mg BID+LEE011 200mg||0
10591825|NCT01781572|11748069|FG000|NOT COMPLETED|MEK162 45mg BID+LEE011 200mg||16
10591826|NCT01781572|11748070|FG001|NOT COMPLETED|MEK162 45mg BID+LEE011 200mg||6
10591827|NCT01781572|11748071|FG002|NOT COMPLETED|MEK162 45mg BID+LEE011 200mg||41
10591828|NCT01781572|11748069|FG000|STARTED|MEK162 45mg BID+LEE011 250mg||3
10591829|NCT01781572|11748070|FG001|STARTED|MEK162 45mg BID+LEE011 250mg||0
10591830|NCT01781572|11748071|FG002|STARTED|MEK162 45mg BID+LEE011 250mg||0
10591831|NCT01781572|11748069|FG000|COMPLETED|MEK162 45mg BID+LEE011 250mg||0
10591832|NCT01781572|11748070|FG001|COMPLETED|MEK162 45mg BID+LEE011 250mg||0
10591833|NCT01781572|11748071|FG002|COMPLETED|MEK162 45mg BID+LEE011 250mg||0
10591834|NCT01781572|11748069|FG000|NOT COMPLETED|MEK162 45mg BID+LEE011 250mg||3
10591835|NCT01781572|11748070|FG001|NOT COMPLETED|MEK162 45mg BID+LEE011 250mg||0
10591836|NCT01781572|11748071|FG002|NOT COMPLETED|MEK162 45mg BID+LEE011 250mg||0
10591837|NCT01781572|11748069|FG000|STARTED|MEK162 30mg BID+LEE011 300mg||4
10591838|NCT01781572|11748070|FG001|STARTED|MEK162 30mg BID+LEE011 300mg||2
10591839|NCT01781572|11748071|FG002|STARTED|MEK162 30mg BID+LEE011 300mg||0
10591840|NCT01781572|11748069|FG000|COMPLETED|MEK162 30mg BID+LEE011 300mg||0
10591841|NCT01781572|11748070|FG001|COMPLETED|MEK162 30mg BID+LEE011 300mg||0
10591842|NCT01781572|11748071|FG002|COMPLETED|MEK162 30mg BID+LEE011 300mg||0
10591843|NCT01781572|11748069|FG000|NOT COMPLETED|MEK162 30mg BID+LEE011 300mg||4
10591844|NCT01781572|11748070|FG001|NOT COMPLETED|MEK162 30mg BID+LEE011 300mg||2
10591845|NCT01781572|11748071|FG002|NOT COMPLETED|MEK162 30mg BID+LEE011 300mg||0
10591846|NCT01781572|11748069|FG000|STARTED|MEK162 45mg BID+LEE011 300mg||6
10591847|NCT01781572|11748070|FG001|STARTED|MEK162 45mg BID+LEE011 300mg||4
10591848|NCT01781572|11748071|FG002|STARTED|MEK162 45mg BID+LEE011 300mg||0
10591849|NCT01781572|11748069|FG000|COMPLETED|MEK162 45mg BID+LEE011 300mg||0
10591850|NCT01781572|11748070|FG001|COMPLETED|MEK162 45mg BID+LEE011 300mg||0
10591851|NCT01781572|11748071|FG002|COMPLETED|MEK162 45mg BID+LEE011 300mg||0
10591852|NCT01781572|11748069|FG000|NOT COMPLETED|MEK162 45mg BID+LEE011 300mg||6
10591853|NCT01781572|11748070|FG001|NOT COMPLETED|MEK162 45mg BID+LEE011 300mg||4
10591854|NCT01781572|11748071|FG002|NOT COMPLETED|MEK162 45mg BID+LEE011 300mg||0
10591855|NCT01781572|11748069|FG000|STARTED|MEK162 30mg LEE011 200mg||0
10591856|NCT01781572|11748070|FG001|STARTED|MEK162 30mg LEE011 200mg||5
10591857|NCT01781572|11748071|FG002|STARTED|MEK162 30mg LEE011 200mg||0
10591858|NCT01781572|11748069|FG000|COMPLETED|MEK162 30mg LEE011 200mg||0
10591859|NCT01781572|11748070|FG001|COMPLETED|MEK162 30mg LEE011 200mg||0
10591860|NCT01781572|11748071|FG002|COMPLETED|MEK162 30mg LEE011 200mg||0
10591861|NCT01781572|11748069|FG000|NOT COMPLETED|MEK162 30mg LEE011 200mg||0
10591862|NCT01781572|11748070|FG001|NOT COMPLETED|MEK162 30mg LEE011 200mg||5
10591863|NCT01781572|11748071|FG002|NOT COMPLETED|MEK162 30mg LEE011 200mg||0
10591864|NCT01781572|11748069|FG000|STARTED|MEK162 45mg LEE011 450mg||0
10591865|NCT01781572|11748070|FG001|STARTED|MEK162 45mg LEE011 450mg||9
10591866|NCT01781572|11748071|FG002|STARTED|MEK162 45mg LEE011 450mg||0
10591867|NCT01781572|11748069|FG000|COMPLETED|MEK162 45mg LEE011 450mg||0
10591868|NCT01781572|11748070|FG001|COMPLETED|MEK162 45mg LEE011 450mg||0
10591869|NCT01781572|11748071|FG002|COMPLETED|MEK162 45mg LEE011 450mg||0
10591870|NCT01781572|11748069|FG000|NOT COMPLETED|MEK162 45mg LEE011 450mg||0
10591871|NCT01781572|11748070|FG001|NOT COMPLETED|MEK162 45mg LEE011 450mg||9
10591872|NCT01781572|11748071|FG002|NOT COMPLETED|MEK162 45mg LEE011 450mg||0
10591873|NCT01781572|11748069|FG000|STARTED|MEK162 45mg LEE011 600mg||0
10591874|NCT01781572|11748070|FG001|STARTED|MEK162 45mg LEE011 600mg||6
10591875|NCT01781572|11748071|FG002|STARTED|MEK162 45mg LEE011 600mg||0
10591876|NCT01781572|11748069|FG000|COMPLETED|MEK162 45mg LEE011 600mg||0
10591877|NCT01781572|11748070|FG001|COMPLETED|MEK162 45mg LEE011 600mg||0
10591878|NCT01781572|11748071|FG002|COMPLETED|MEK162 45mg LEE011 600mg||0
10591879|NCT01781572|11748069|FG000|NOT COMPLETED|MEK162 45mg LEE011 600mg||0
10591880|NCT01781572|11748070|FG001|NOT COMPLETED|MEK162 45mg LEE011 600mg||6
10591881|NCT01781572|11748071|FG002|NOT COMPLETED|MEK162 45mg LEE011 600mg||0
10591882|NCT01781611|11748102|FG000|STARTED|Overall Study||13
10591883|NCT01781611|11748103|FG001|STARTED|Overall Study||5
10591884|NCT01781611|11748102|FG000|COMPLETED|Overall Study||9
10591885|NCT01781611|11748103|FG001|COMPLETED|Overall Study||5
10591886|NCT01781611|11748102|FG000|NOT COMPLETED|Overall Study||4
10591887|NCT01781611|11748103|FG001|NOT COMPLETED|Overall Study||0
10591888|NCT01781806|11748111|FG000|STARTED|Overall Study||297
10591889|NCT01781806|11748112|FG001|STARTED|Overall Study||4
10591890|NCT01781806|11748111|FG000|Week 0|Overall Study||297
10591891|NCT01781806|11748112|FG001|Week 0|Overall Study||4
10591892|NCT01781806|11748111|FG000|Week 4|Overall Study||284
10591893|NCT01781806|11748112|FG001|Week 4|Overall Study||4
10591894|NCT01781806|11748111|FG000|Week 8|Overall Study||278
10591895|NCT01781806|11748112|FG001|Week 8|Overall Study||4
10591896|NCT01781806|11748111|FG000|Week 12|Overall Study||272
10591897|NCT01781806|11748112|FG001|Week 12|Overall Study||2
10591898|NCT01781806|11748111|FG000|Week 24|Overall Study||260
10591899|NCT01781806|11748112|FG001|Week 24|Overall Study||1
10591900|NCT01781806|11748111|FG000|Week 36|Overall Study||247
10591901|NCT01781806|11748112|FG001|Week 36|Overall Study||1
10591902|NCT01781806|11748111|FG000|Week 48|Overall Study||222
10591903|NCT01781806|11748112|FG001|Week 48|Overall Study||1
10591904|NCT01781806|11748111|FG000|COMPLETED|Overall Study||218
10591905|NCT01781806|11748112|FG001|COMPLETED|Overall Study||1
10591906|NCT01781806|11748111|FG000|NOT COMPLETED|Overall Study||79
10591907|NCT01781806|11748112|FG001|NOT COMPLETED|Overall Study||3
10591908|NCT01781832|11748119|FG000|STARTED|Overall Study||26
10591909|NCT01781832|11748119|FG000|COMPLETED|Overall Study||25
10591910|NCT01781832|11748119|FG000|NOT COMPLETED|Overall Study||1
10591911|NCT01781962|11748123|FG000|STARTED|Overall Study||206
10591912|NCT01781962|11748123|FG000|COMPLETED|Overall Study||201
10591913|NCT01781962|11748123|FG000|NOT COMPLETED|Overall Study||5
10591914|NCT01781975|11748129|FG000|STARTED|Overall Study||45
10591915|NCT01781975|11748130|FG001|STARTED|Overall Study||22
10591916|NCT01781975|11748129|FG000|Treatment Period|Overall Study||44
10591917|NCT01781975|11748130|FG001|Treatment Period|Overall Study||22
10591918|NCT01781975|11748129|FG000|Follow-Up Period|Overall Study||43
10591919|NCT01781975|11748130|FG001|Follow-Up Period|Overall Study||21
10591920|NCT01781975|11748129|FG000|COMPLETED|Overall Study||43
10591921|NCT01781975|11748130|FG001|COMPLETED|Overall Study||21
10591922|NCT01781975|11748129|FG000|NOT COMPLETED|Overall Study||2
10591923|NCT01781975|11748130|FG001|NOT COMPLETED|Overall Study||1
10591924|NCT01782131|11748138|FG000|STARTED|Overall Study||293
10591925|NCT01782131|11748139|FG001|STARTED|Overall Study||292
10591926|NCT01782131|11748138|FG000|Treated|Overall Study||288
10591927|NCT01782131|11748139|FG001|Treated|Overall Study||287
10591928|NCT01782131|11748138|FG000|COMPLETED|Overall Study||184
10591929|NCT01782131|11748139|FG001|COMPLETED|Overall Study||177
10591930|NCT01782131|11748138|FG000|NOT COMPLETED|Overall Study||109
10591931|NCT01782131|11748139|FG001|NOT COMPLETED|Overall Study||115
10591932|NCT01782209|11748145|FG000|STARTED|Overall Study||335
10591933|NCT01782209|11748145|FG000|COMPLETED|Overall Study||225
10591934|NCT01782209|11748145|FG000|NOT COMPLETED|Overall Study||110
10703485|NCT02584855|11867988|FG004|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
10703486|NCT02584855|11867989|FG005|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
10703487|NCT02584855|11867984|FG000|Met Randomization Criteria|Open-Label Treatment Period||158
10703488|NCT02584855|11867985|FG001|Met Randomization Criteria|Open-Label Treatment Period||0
10703489|NCT02584855|11867986|FG002|Met Randomization Criteria|Open-Label Treatment Period||0
10703490|NCT02584855|11867987|FG003|Met Randomization Criteria|Open-Label Treatment Period||0
10591935|NCT01782222|11748152|FG000|STARTED|Overall Study||40
10591936|NCT01782222|11748153|FG001|STARTED|Overall Study||41
10591937|NCT01782222|11748154|FG002|STARTED|Overall Study||41
10591938|NCT01782222|11748152|FG000|COMPLETED|Overall Study||32
10591939|NCT01782222|11748153|FG001|COMPLETED|Overall Study||30
10591940|NCT01782222|11748154|FG002|COMPLETED|Overall Study||37
10591941|NCT01782222|11748152|FG000|NOT COMPLETED|Overall Study||8
10591942|NCT01782222|11748153|FG001|NOT COMPLETED|Overall Study||11
10591943|NCT01782222|11748154|FG002|NOT COMPLETED|Overall Study||4
10703491|NCT02584855|11867988|FG004|Met Randomization Criteria|Open-Label Treatment Period||0
10703492|NCT02584855|11867989|FG005|Met Randomization Criteria|Open-Label Treatment Period||0
10703493|NCT02584855|11867984|FG000|Non-randomized|Open-Label Treatment Period||133
10703494|NCT02584855|11867985|FG001|Non-randomized|Open-Label Treatment Period||0
10703495|NCT02584855|11867986|FG002|Non-randomized|Open-Label Treatment Period||0
10703496|NCT02584855|11867987|FG003|Non-randomized|Open-Label Treatment Period||0
10703497|NCT02584855|11867988|FG004|Non-randomized|Open-Label Treatment Period||0
10703498|NCT02584855|11867989|FG005|Non-randomized|Open-Label Treatment Period||0
10703499|NCT02584855|11867984|FG000|COMPLETED|Open-Label Treatment Period||291
10703500|NCT02584855|11867985|FG001|COMPLETED|Open-Label Treatment Period||0
10703501|NCT02584855|11867986|FG002|COMPLETED|Open-Label Treatment Period||0
10703502|NCT02584855|11867987|FG003|COMPLETED|Open-Label Treatment Period||0
10703503|NCT02584855|11867988|FG004|COMPLETED|Open-Label Treatment Period||0
10703504|NCT02584855|11867989|FG005|COMPLETED|Open-Label Treatment Period||0
10703505|NCT02584855|11867984|FG000|NOT COMPLETED|Open-Label Treatment Period||103
10703506|NCT02584855|11867985|FG001|NOT COMPLETED|Open-Label Treatment Period||0
10703507|NCT02584855|11867986|FG002|NOT COMPLETED|Open-Label Treatment Period||0
10703508|NCT02584855|11867987|FG003|NOT COMPLETED|Open-Label Treatment Period||0
10703509|NCT02584855|11867988|FG004|NOT COMPLETED|Open-Label Treatment Period||0
10703510|NCT02584855|11867989|FG005|NOT COMPLETED|Open-Label Treatment Period||0
10703511|NCT02584855|11867984|FG000|STARTED|Double-Blind Withdrawal Period||0
10703512|NCT02584855|11867985|FG001|STARTED|Double-Blind Withdrawal Period|Participants completed open label but did not meet criteria for double-blind withdrawal period.|133
10703513|NCT02584855|11867986|FG002|STARTED|Double-Blind Withdrawal Period|Participants completed open label and met criteria for double-blind withdrawal period.|79
10703514|NCT02584855|11867987|FG003|STARTED|Double-Blind Withdrawal Period|Participants completed open label and met criteria for double-blind withdrawal period.|79
10703515|NCT02584855|11867988|FG004|STARTED|Double-Blind Withdrawal Period||0
10703516|NCT02584855|11867989|FG005|STARTED|Double-Blind Withdrawal Period||0
10703517|NCT02584855|11867984|FG000|Relapsed|Double-Blind Withdrawal Period||0
10703518|NCT02584855|11867985|FG001|Relapsed|Double-Blind Withdrawal Period||0
10807680|NCT03888482|11969408|FG001|COMPLETED|Second Wear (8 -1/+2 Days)||74
10807681|NCT03888482|11969407|FG000|NOT COMPLETED|Second Wear (8 -1/+2 Days)||1
10807682|NCT03888482|11969408|FG001|NOT COMPLETED|Second Wear (8 -1/+2 Days)||1
10807683|NCT03888274|11969416|FG000|STARTED|Overall Study||30
10807684|NCT03888274|11969416|FG000|COMPLETED|Overall Study||30
10807685|NCT03888274|11969416|FG000|NOT COMPLETED|Overall Study||0
10807686|NCT03888365|11969422|FG000|STARTED|Cohort A Peak Level/Cohort B Period 1||20
10807687|NCT03888365|11969423|FG001|STARTED|Cohort A Peak Level/Cohort B Period 1||23
10591944|NCT01782313|11748162|FG000|STARTED|Reached First Response/Completed 2 Cycle||58
10591945|NCT01782313|11748162|FG000|COMPLETED|Reached First Response/Completed 2 Cycle||52
10591946|NCT01782313|11748162|FG000|NOT COMPLETED|Reached First Response/Completed 2 Cycle||6
10591947|NCT01782313|11748162|FG000|STARTED|Treated Cycle 3||52
10591948|NCT01782313|11748162|FG000|COMPLETED|Treated Cycle 3||31
10591949|NCT01782313|11748162|FG000|NOT COMPLETED|Treated Cycle 3||21
10807688|NCT03888365|11969422|FG000|Safety Population|Cohort A Peak Level/Cohort B Period 1||20
10807689|NCT03888365|11969423|FG001|Safety Population|Cohort A Peak Level/Cohort B Period 1||23
10807690|NCT03888365|11969422|FG000|COMPLETED|Cohort A Peak Level/Cohort B Period 1||20
10807691|NCT03888365|11969423|FG001|COMPLETED|Cohort A Peak Level/Cohort B Period 1||23
10807692|NCT03888365|11969422|FG000|NOT COMPLETED|Cohort A Peak Level/Cohort B Period 1||0
10807693|NCT03888365|11969423|FG001|NOT COMPLETED|Cohort A Peak Level/Cohort B Period 1||0
10807694|NCT03888365|11969422|FG000|STARTED|Rest - At Least 1 h||20
10807695|NCT03888365|11969423|FG001|STARTED|Rest - At Least 1 h||23
10807696|NCT03888365|11969422|FG000|COMPLETED|Rest - At Least 1 h||20
10807697|NCT03888365|11969423|FG001|COMPLETED|Rest - At Least 1 h||23
10591950|NCT01782313|11748162|FG000|STARTED|Treated Cycle 4/Reached 16 Week Response||31
10591951|NCT01782313|11748162|FG000|COMPLETED|Treated Cycle 4/Reached 16 Week Response||25
10591952|NCT01782313|11748162|FG000|NOT COMPLETED|Treated Cycle 4/Reached 16 Week Response||6
10591953|NCT01782313|11748162|FG000|STARTED|Continued Treatment After 16 Weeks||25
10591954|NCT01782313|11748162|FG000|COMPLETED|Continued Treatment After 16 Weeks||18
10591955|NCT01782313|11748162|FG000|NOT COMPLETED|Continued Treatment After 16 Weeks||7
10591956|NCT01782313|11748162|FG000|STARTED|Survival Follow up||58
10591957|NCT01782313|11748162|FG000|COMPLETED|Survival Follow up||57
10591958|NCT01782313|11748162|FG000|NOT COMPLETED|Survival Follow up||1
10591959|NCT01782326|11748168|FG000|STARTED|Planned Treatment Epoch||1680
10591960|NCT01782326|11748169|FG001|STARTED|Planned Treatment Epoch||1682
10591961|NCT01782326|11748168|FG000|Full Analysis Set (FAS)|Planned Treatment Epoch||1675
10591962|NCT01782326|11748169|FG001|Full Analysis Set (FAS)|Planned Treatment Epoch||1679
10591963|NCT01782326|11748168|FG000|Per-protocol Set (PPS)|Planned Treatment Epoch||1528
10591964|NCT01782326|11748169|FG001|Per-protocol Set (PPS)|Planned Treatment Epoch||1556
10591965|NCT01782326|11748168|FG000|Serial Spirometry Set|Planned Treatment Epoch||280
10591966|NCT01782326|11748169|FG001|Serial Spirometry Set|Planned Treatment Epoch||279
10591967|NCT01782326|11748168|FG000|Safety Set (SAF)|Planned Treatment Epoch||1678
10591968|NCT01782326|11748169|FG001|Safety Set (SAF)|Planned Treatment Epoch||1680
10591969|NCT01782326|11748168|FG000|Urine Cortisol Set|Planned Treatment Epoch||266
10591970|NCT01782326|11748169|FG001|Urine Cortisol Set|Planned Treatment Epoch||269
10591971|NCT01782326|11748168|FG000|COMPLETED|Planned Treatment Epoch||1478
10591972|NCT01782326|11748169|FG001|COMPLETED|Planned Treatment Epoch||1474
10591973|NCT01782326|11748168|FG000|NOT COMPLETED|Planned Treatment Epoch||202
10591974|NCT01782326|11748169|FG001|NOT COMPLETED|Planned Treatment Epoch||208
10591975|NCT01782326|11748168|FG000|STARTED|Double-blind Treatment||1678
10591976|NCT01782326|11748169|FG001|STARTED|Double-blind Treatment||1680
10591977|NCT01782326|11748168|FG000|COMPLETED|Double-blind Treatment||1400
10591978|NCT01782326|11748169|FG001|COMPLETED|Double-blind Treatment||1360
10591979|NCT01782326|11748168|FG000|NOT COMPLETED|Double-blind Treatment||278
10591980|NCT01782326|11748169|FG001|NOT COMPLETED|Double-blind Treatment||320
10591981|NCT01782378|11748177|FG000|STARTED|First Series||32
10591982|NCT01782378|11748178|FG001|STARTED|First Series||31
10591983|NCT01782378|11748177|FG000|COMPLETED|First Series||25
10591984|NCT01782378|11748178|FG001|COMPLETED|First Series||23
10591985|NCT01782378|11748177|FG000|NOT COMPLETED|First Series||7
10591986|NCT01782378|11748178|FG001|NOT COMPLETED|First Series||8
10591987|NCT01782378|11748177|FG000|STARTED|Second Series||31
10591988|NCT01782378|11748178|FG001|STARTED|Second Series||32
10591989|NCT01782378|11748177|FG000|COMPLETED|Second Series||5
10591990|NCT01782378|11748178|FG001|COMPLETED|Second Series||0
10591991|NCT01782378|11748177|FG000|NOT COMPLETED|Second Series||26
10591992|NCT01782378|11748178|FG001|NOT COMPLETED|Second Series||32
10591993|NCT01782469|11748184|FG000|STARTED|Overall Study||16
10591994|NCT01782469|11748184|FG000|COMPLETED|Overall Study||15
10591995|NCT01782469|11748184|FG000|NOT COMPLETED|Overall Study||1
10591996|NCT01782482|11748190|FG000|STARTED|Overall Study||281
10591997|NCT01782482|11748191|FG001|STARTED|Overall Study||280
10591998|NCT01782482|11748190|FG000|COMPLETED|Overall Study||271
10591999|NCT01782482|11748191|FG001|COMPLETED|Overall Study||270
10592000|NCT01782482|11748190|FG000|NOT COMPLETED|Overall Study||10
10592001|NCT01782482|11748191|FG001|NOT COMPLETED|Overall Study||10
10592002|NCT01782495|11748208|FG000|STARTED|Overall Study||34
10592003|NCT01782495|11748209|FG001|STARTED|Overall Study||27
10592004|NCT01782495|11748210|FG002|STARTED|Overall Study||13
10592005|NCT01782495|11748211|FG003|STARTED|Overall Study||4
10592006|NCT01782495|11748212|FG004|STARTED|Overall Study||2
10592007|NCT01782495|11748213|FG005|STARTED|Overall Study||22
10592008|NCT01782495|11748214|FG006|STARTED|Overall Study||12
10592009|NCT01782495|11748215|FG007|STARTED|Overall Study||9
10592010|NCT01782495|11748216|FG008|STARTED|Overall Study||3
10592011|NCT01782495|11748217|FG009|STARTED|Overall Study||2
10592012|NCT01782495|11748218|FG010|STARTED|Overall Study||1
10592013|NCT01782495|11748208|FG000|COMPLETED|Overall Study||34
10592014|NCT01782495|11748209|FG001|COMPLETED|Overall Study||26
10592015|NCT01782495|11748210|FG002|COMPLETED|Overall Study||13
10592016|NCT01782495|11748211|FG003|COMPLETED|Overall Study||4
10592017|NCT01782495|11748212|FG004|COMPLETED|Overall Study||2
10592018|NCT01782495|11748213|FG005|COMPLETED|Overall Study||22
10592019|NCT01782495|11748214|FG006|COMPLETED|Overall Study||12
10592020|NCT01782495|11748215|FG007|COMPLETED|Overall Study||6
10592021|NCT01782495|11748216|FG008|COMPLETED|Overall Study||3
10592022|NCT01782495|11748217|FG009|COMPLETED|Overall Study||2
10592023|NCT01782495|11748218|FG010|COMPLETED|Overall Study||1
10592024|NCT01782495|11748208|FG000|NOT COMPLETED|Overall Study||0
10592025|NCT01782495|11748209|FG001|NOT COMPLETED|Overall Study||1
10592026|NCT01782495|11748210|FG002|NOT COMPLETED|Overall Study||0
10592027|NCT01782495|11748211|FG003|NOT COMPLETED|Overall Study||0
10592028|NCT01782495|11748212|FG004|NOT COMPLETED|Overall Study||0
10592029|NCT01782495|11748213|FG005|NOT COMPLETED|Overall Study||0
10592030|NCT01782495|11748214|FG006|NOT COMPLETED|Overall Study||0
10592031|NCT01782495|11748215|FG007|NOT COMPLETED|Overall Study||3
10592032|NCT01782495|11748216|FG008|NOT COMPLETED|Overall Study||0
10592033|NCT01782495|11748217|FG009|NOT COMPLETED|Overall Study||0
10592034|NCT01782495|11748218|FG010|NOT COMPLETED|Overall Study||0
10592035|NCT01782664|11748248|FG000|STARTED|Overall Study||14
10592036|NCT01782664|11748249|FG001|STARTED|Overall Study||15
10592037|NCT01782664|11748250|FG002|STARTED|Overall Study||16
10592038|NCT01782664|11748251|FG003|STARTED|Overall Study||14
10592039|NCT01782664|11748252|FG004|STARTED|Overall Study||6
10592040|NCT01782664|11748253|FG005|STARTED|Overall Study||2
10592041|NCT01782664|11748248|FG000|COMPLETED|Overall Study||8
10592042|NCT01782664|11748249|FG001|COMPLETED|Overall Study||10
10592043|NCT01782664|11748250|FG002|COMPLETED|Overall Study||12
10592044|NCT01782664|11748251|FG003|COMPLETED|Overall Study||9
10592045|NCT01782664|11748252|FG004|COMPLETED|Overall Study||6
10807698|NCT03888365|11969422|FG000|NOT COMPLETED|Rest - At Least 1 h||0
10807699|NCT03888365|11969423|FG001|NOT COMPLETED|Rest - At Least 1 h||0
10807700|NCT03888365|11969422|FG000|STARTED|Cohort A Trough Level/Cohort B Period 2||20
10807701|NCT03888365|11969423|FG001|STARTED|Cohort A Trough Level/Cohort B Period 2||23
10592046|NCT01782664|11748253|FG005|COMPLETED|Overall Study||2
10592047|NCT01782664|11748248|FG000|NOT COMPLETED|Overall Study||6
10592048|NCT01782664|11748249|FG001|NOT COMPLETED|Overall Study||5
10592049|NCT01782664|11748250|FG002|NOT COMPLETED|Overall Study||4
10592050|NCT01782664|11748251|FG003|NOT COMPLETED|Overall Study||5
10592051|NCT01782664|11748252|FG004|NOT COMPLETED|Overall Study||0
10592052|NCT01782664|11748253|FG005|NOT COMPLETED|Overall Study||0
10592053|NCT01782690|11748267|FG000|STARTED|Overall Study||338
10592054|NCT01782690|11748267|FG000|COMPLETED|Overall Study||39
10592055|NCT01782690|11748267|FG000|NOT COMPLETED|Overall Study||299
10592056|NCT01782742|11748273|FG000|STARTED|Double-blind Treatment Phase||16
10592057|NCT01782742|11748274|FG001|STARTED|Double-blind Treatment Phase||4
10592058|NCT01782742|11748273|FG000|COMPLETED|Double-blind Treatment Phase||15
10592059|NCT01782742|11748274|FG001|COMPLETED|Double-blind Treatment Phase||4
10592060|NCT01782742|11748273|FG000|NOT COMPLETED|Double-blind Treatment Phase||1
10592061|NCT01782742|11748274|FG001|NOT COMPLETED|Double-blind Treatment Phase||0
10592062|NCT01782742|11748273|FG000|STARTED|Open Label Phase||19
10592063|NCT01782742|11748274|FG001|STARTED|Open Label Phase||0
10592064|NCT01782742|11748273|FG000|COMPLETED|Open Label Phase||19
10592065|NCT01782742|11748274|FG001|COMPLETED|Open Label Phase||0
10592066|NCT01782742|11748273|FG000|NOT COMPLETED|Open Label Phase||0
10592067|NCT01782742|11748274|FG001|NOT COMPLETED|Open Label Phase||0
10592068|NCT01782833|11748282|FG000|STARTED|Overall Study||3635
10592069|NCT01782833|11748282|FG000|COMPLETED|Overall Study||3365
10592070|NCT01782833|11748282|FG000|NOT COMPLETED|Overall Study||270
10592071|NCT01782859|11748288|FG000|STARTED|Overall Study||20
10592072|NCT01782859|11748289|FG001|STARTED|Overall Study||20
10592073|NCT01782859|11748288|FG000|COMPLETED|Overall Study||14
10592074|NCT01782859|11748289|FG001|COMPLETED|Overall Study||13
10592075|NCT01782859|11748288|FG000|NOT COMPLETED|Overall Study||6
10592076|NCT01782859|11748289|FG001|NOT COMPLETED|Overall Study||7
10592077|NCT01782872|11748300|FG000|STARTED|Overall Study||20
10592078|NCT01782872|11748301|FG001|STARTED|Overall Study||20
10592079|NCT01782872|11748302|FG002|STARTED|Overall Study||20
10592080|NCT01782872|11748303|FG003|STARTED|Overall Study||20
10592081|NCT01782872|11748300|FG000|COMPLETED|Overall Study||20
10592082|NCT01782872|11748301|FG001|COMPLETED|Overall Study||19
10592083|NCT01782872|11748302|FG002|COMPLETED|Overall Study||20
10592084|NCT01782872|11748303|FG003|COMPLETED|Overall Study||19
10592085|NCT01782872|11748300|FG000|NOT COMPLETED|Overall Study||0
10592086|NCT01782872|11748301|FG001|NOT COMPLETED|Overall Study||1
10592087|NCT01782872|11748302|FG002|NOT COMPLETED|Overall Study||0
10592088|NCT01782872|11748303|FG003|NOT COMPLETED|Overall Study||1
10592089|NCT01782885|11748315|FG000|STARTED|Overall Study||36
10592090|NCT01782885|11748316|FG001|STARTED|Overall Study||39
10807702|NCT03888365|11969422|FG000|COMPLETED|Cohort A Trough Level/Cohort B Period 2||20
10807703|NCT03888365|11969423|FG001|COMPLETED|Cohort A Trough Level/Cohort B Period 2||23
10807704|NCT03888365|11969422|FG000|NOT COMPLETED|Cohort A Trough Level/Cohort B Period 2||0
10807705|NCT03888365|11969423|FG001|NOT COMPLETED|Cohort A Trough Level/Cohort B Period 2||0
10592091|NCT01782885|11748315|FG000|COMPLETED|Overall Study||32
10592092|NCT01782885|11748316|FG001|COMPLETED|Overall Study||33
10592093|NCT01782885|11748315|FG000|NOT COMPLETED|Overall Study||4
10592094|NCT01782885|11748316|FG001|NOT COMPLETED|Overall Study||6
10592095|NCT01782898|11748324|FG000|STARTED|Overall Study||35
10592096|NCT01782898|11748325|FG001|STARTED|Overall Study||35
10592097|NCT01782898|11748324|FG000|COMPLETED|Overall Study||29
10592098|NCT01782898|11748325|FG001|COMPLETED|Overall Study||29
10592099|NCT01782898|11748324|FG000|NOT COMPLETED|Overall Study||6
10592100|NCT01782898|11748325|FG001|NOT COMPLETED|Overall Study||6
10592101|NCT01782963|11748331|FG000|STARTED|Overall Study||50
10592102|NCT01782963|11748331|FG000|COMPLETED|Overall Study||50
10592103|NCT01782963|11748331|FG000|NOT COMPLETED|Overall Study||0
10592104|NCT01783054|11748339|FG000|STARTED|Overall Study||2
10592105|NCT01783054|11748339|FG000|COMPLETED|Overall Study||2
10592106|NCT01783054|11748339|FG000|NOT COMPLETED|Overall Study||0
10592107|NCT01783080|11748343|FG000|STARTED|Overall Study||16
10703519|NCT02584855|11867986|FG002|Relapsed|Double-Blind Withdrawal Period||67
10703520|NCT02584855|11867987|FG003|Relapsed|Double-Blind Withdrawal Period||30
10703521|NCT02584855|11867988|FG004|Relapsed|Double-Blind Withdrawal Period||0
10703522|NCT02584855|11867989|FG005|Relapsed|Double-Blind Withdrawal Period||0
10703523|NCT02584855|11867984|FG000|COMPLETED|Double-Blind Withdrawal Period||0
10703524|NCT02584855|11867985|FG001|COMPLETED|Double-Blind Withdrawal Period||118
10592108|NCT01783080|11748343|FG000|COMPLETED|Overall Study||16
10592109|NCT01783080|11748343|FG000|NOT COMPLETED|Overall Study||0
10592110|NCT01783236|11748349|FG000|STARTED|Overall Study||8
10592111|NCT01783236|11748350|FG001|STARTED|Overall Study||8
10592112|NCT01783236|11748349|FG000|COMPLETED|Overall Study||6
10592113|NCT01783236|11748350|FG001|COMPLETED|Overall Study||8
10592114|NCT01783236|11748349|FG000|NOT COMPLETED|Overall Study||2
10592115|NCT01783236|11748350|FG001|NOT COMPLETED|Overall Study||0
10652088|NCT02181517|11812427|FG000|STARTED|Overall Study||10
10652089|NCT02181517|11812428|FG001|STARTED|Overall Study||10
10652090|NCT02181517|11812429|FG002|STARTED|Overall Study||5
10652091|NCT02181517|11812427|FG000|COMPLETED|Overall Study||10
10652092|NCT02181517|11812428|FG001|COMPLETED|Overall Study||10
10652093|NCT02181517|11812429|FG002|COMPLETED|Overall Study||5
10652094|NCT02181517|11812427|FG000|NOT COMPLETED|Overall Study||0
10652095|NCT02181517|11812428|FG001|NOT COMPLETED|Overall Study||0
10652096|NCT02181517|11812429|FG002|NOT COMPLETED|Overall Study||0
10652097|NCT02181530|11812437|FG000|STARTED|Overall Study||43
10652098|NCT02181530|11812437|FG000|COMPLETED|Overall Study||43
10807706|NCT03888469|11969432|FG000|STARTED|First Wear Period (8 -1/+2 Days)||46
10703525|NCT02584855|11867986|FG002|COMPLETED|Double-Blind Withdrawal Period||77
10703526|NCT02584855|11867987|FG003|COMPLETED|Double-Blind Withdrawal Period||78
10703527|NCT02584855|11867988|FG004|COMPLETED|Double-Blind Withdrawal Period||0
10807707|NCT03888469|11969433|FG001|STARTED|First Wear Period (8 -1/+2 Days)||46
10652099|NCT02181530|11812437|FG000|NOT COMPLETED|Overall Study||0
10652100|NCT02181556|11812441|FG000|STARTED|Overall Study||41
10652101|NCT02181556|11812441|FG000|COMPLETED|Overall Study||40
10652102|NCT02181556|11812441|FG000|NOT COMPLETED|Overall Study||1
10652103|NCT02181634|11812445|FG000|STARTED|Overall Study||74
10652104|NCT02181634|11812445|FG000|Eligible and Treated|Overall Study||73
10652105|NCT02181634|11812445|FG000|COMPLETED|Overall Study||2
10652106|NCT02181634|11812445|FG000|NOT COMPLETED|Overall Study||72
10652107|NCT02181673|11812451|FG000|STARTED|Up to Week 24||239
10592116|NCT01783418|11748358|FG000|STARTED|Overall Study||8
10592117|NCT01783418|11748359|FG001|STARTED|Overall Study||6
10592118|NCT01783418|11748358|FG000|COMPLETED|Overall Study||7
10592119|NCT01783418|11748359|FG001|COMPLETED|Overall Study||6
10592120|NCT01783418|11748358|FG000|NOT COMPLETED|Overall Study||1
10592121|NCT01783418|11748359|FG001|NOT COMPLETED|Overall Study||0
10592122|NCT01783444|11748368|FG000|STARTED|Treatment Phase||104
10592123|NCT01783444|11748369|FG001|STARTED|Treatment Phase||103
10592124|NCT01783444|11748370|FG002|STARTED|Treatment Phase||102
10592125|NCT01783444|11748368|FG000|Safety Set|Treatment Phase||104
10592126|NCT01783444|11748369|FG001|Safety Set|Treatment Phase||103
10592127|NCT01783444|11748370|FG002|Safety Set|Treatment Phase||102
10592128|NCT01783444|11748368|FG000|COMPLETED|Treatment Phase||0
10592129|NCT01783444|11748369|FG001|COMPLETED|Treatment Phase||0
10592130|NCT01783444|11748370|FG002|COMPLETED|Treatment Phase||0
10592131|NCT01783444|11748368|FG000|NOT COMPLETED|Treatment Phase||104
10592132|NCT01783444|11748369|FG001|NOT COMPLETED|Treatment Phase||103
10592133|NCT01783444|11748370|FG002|NOT COMPLETED|Treatment Phase||102
10592134|NCT01783444|11748368|FG000|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Follow-Up Phase|96
10592135|NCT01783444|11748369|FG001|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Follow-Up Phase|93
10592136|NCT01783444|11748370|FG002|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Follow-Up Phase|91
10592137|NCT01783444|11748368|FG000|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
10592138|NCT01783444|11748369|FG001|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
10592139|NCT01783444|11748370|FG002|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
10592140|NCT01783444|11748368|FG000|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||96
10592141|NCT01783444|11748369|FG001|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||93
10592142|NCT01783444|11748370|FG002|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||91
10592143|NCT01783470|11748379|FG000|STARTED|Overall Study||6
10592144|NCT01783470|11748380|FG001|STARTED|Overall Study|Single-dose|6
10592145|NCT01783470|11748379|FG000|COMPLETED|Overall Study||6
10592146|NCT01783470|11748380|FG001|COMPLETED|Overall Study||6
10592147|NCT01783470|11748379|FG000|NOT COMPLETED|Overall Study||0
10592148|NCT01783470|11748380|FG001|NOT COMPLETED|Overall Study||0
10592149|NCT01783483|11748389|FG000|STARTED|Overall Study||120
10592150|NCT01783483|11748390|FG001|STARTED|Overall Study||116
10592151|NCT01783483|11748389|FG000|COMPLETED|Overall Study||100
10592152|NCT01783483|11748390|FG001|COMPLETED|Overall Study||101
10592153|NCT01783483|11748389|FG000|NOT COMPLETED|Overall Study||20
10592154|NCT01783483|11748390|FG001|NOT COMPLETED|Overall Study||15
10592155|NCT01783496|11748402|FG000|STARTED|Overall Study||10
10703528|NCT02584855|11867989|FG005|COMPLETED|Double-Blind Withdrawal Period||0
10703529|NCT02584855|11867984|FG000|NOT COMPLETED|Double-Blind Withdrawal Period||0
10703530|NCT02584855|11867985|FG001|NOT COMPLETED|Double-Blind Withdrawal Period||15
10703531|NCT02584855|11867986|FG002|NOT COMPLETED|Double-Blind Withdrawal Period||2
10703532|NCT02584855|11867987|FG003|NOT COMPLETED|Double-Blind Withdrawal Period||1
10703533|NCT02584855|11867988|FG004|NOT COMPLETED|Double-Blind Withdrawal Period||0
10592156|NCT01783496|11748403|FG001|STARTED|Overall Study||10
10592157|NCT01783496|11748404|FG002|STARTED|Overall Study||10
10592158|NCT01783496|11748405|FG003|STARTED|Overall Study||10
10592159|NCT01783496|11748406|FG004|STARTED|Overall Study||5
10592160|NCT01783496|11748407|FG005|STARTED|Overall Study||5
10592161|NCT01783496|11748402|FG000|COMPLETED|Overall Study||9
10592162|NCT01783496|11748403|FG001|COMPLETED|Overall Study||10
10592163|NCT01783496|11748404|FG002|COMPLETED|Overall Study||10
10592164|NCT01783496|11748405|FG003|COMPLETED|Overall Study||8
10592165|NCT01783496|11748406|FG004|COMPLETED|Overall Study||5
10592166|NCT01783496|11748407|FG005|COMPLETED|Overall Study||4
10592167|NCT01783496|11748402|FG000|NOT COMPLETED|Overall Study||1
10592168|NCT01783496|11748403|FG001|NOT COMPLETED|Overall Study||0
10592169|NCT01783496|11748404|FG002|NOT COMPLETED|Overall Study||0
10592170|NCT01783496|11748405|FG003|NOT COMPLETED|Overall Study||2
10592171|NCT01783496|11748406|FG004|NOT COMPLETED|Overall Study||0
10592172|NCT01783496|11748407|FG005|NOT COMPLETED|Overall Study||1
10592173|NCT01783522|11748423|FG000|STARTED|Overall Study||4
10592174|NCT01783522|11748424|FG001|STARTED|Overall Study||5
10592175|NCT01783522|11748423|FG000|COMPLETED|Overall Study||4
10592176|NCT01783522|11748424|FG001|COMPLETED|Overall Study||5
10592177|NCT01783522|11748423|FG000|NOT COMPLETED|Overall Study||0
10592178|NCT01783522|11748424|FG001|NOT COMPLETED|Overall Study||0
10592179|NCT01783548|11748432|FG000|STARTED|Overall Study|Randomized|362
10592180|NCT01783548|11748433|FG001|STARTED|Overall Study|Randomized|185
10592181|NCT01783548|11748432|FG000|Full Analysis Set (FAS)|Overall Study||358
10592182|NCT01783548|11748433|FG001|Full Analysis Set (FAS)|Overall Study||184
10703534|NCT02584855|11867989|FG005|NOT COMPLETED|Double-Blind Withdrawal Period||0
10703535|NCT02584855|11867984|FG000|STARTED|Post Treatment Follow-up Period||0
10703536|NCT02584855|11867985|FG001|STARTED|Post Treatment Follow-up Period||0
10703537|NCT02584855|11867986|FG002|STARTED|Post Treatment Follow-up Period||0
10703538|NCT02584855|11867987|FG003|STARTED|Post Treatment Follow-up Period||0
10592183|NCT01783548|11748432|FG000|COMPLETED|Overall Study||328
10592184|NCT01783548|11748433|FG001|COMPLETED|Overall Study||167
10592185|NCT01783548|11748432|FG000|NOT COMPLETED|Overall Study||34
10592186|NCT01783548|11748433|FG001|NOT COMPLETED|Overall Study||18
10592187|NCT01783561|11748441|FG000|STARTED|Overall Study||11
10592188|NCT01783561|11748442|FG001|STARTED|Overall Study||10
10592189|NCT01783561|11748441|FG000|COMPLETED|Overall Study||11
10592190|NCT01783561|11748442|FG001|COMPLETED|Overall Study||10
10592191|NCT01783561|11748441|FG000|NOT COMPLETED|Overall Study||0
10592192|NCT01783561|11748442|FG001|NOT COMPLETED|Overall Study||0
10592193|NCT01783574|11748450|FG000|STARTED|Overall Study||51
10592194|NCT01783574|11748451|FG001|STARTED|Overall Study||50
10592195|NCT01783574|11748450|FG000|COMPLETED|Overall Study||46
10592196|NCT01783574|11748451|FG001|COMPLETED|Overall Study||41
10592197|NCT01783574|11748450|FG000|NOT COMPLETED|Overall Study||5
10592198|NCT01783574|11748451|FG001|NOT COMPLETED|Overall Study||9
10592199|NCT01783639|11748457|FG000|STARTED|Overall Study||120
10592200|NCT01783639|11748457|FG000|COMPLETED|Overall Study||120
10592201|NCT01783639|11748457|FG000|NOT COMPLETED|Overall Study||0
10592202|NCT01783678|11748467|FG000|STARTED|Overall Study||19
10592203|NCT01783678|11748468|FG001|STARTED|Overall Study||112
10592204|NCT01783678|11748469|FG002|STARTED|Overall Study||6
10592205|NCT01783678|11748470|FG003|STARTED|Overall Study||58
10592206|NCT01783678|11748471|FG004|STARTED|Overall Study||49
10592207|NCT01783678|11748472|FG005|STARTED|Overall Study||31
10592208|NCT01783678|11748467|FG000|COMPLETED|Overall Study||17
10592209|NCT01783678|11748468|FG001|COMPLETED|Overall Study||94
10592210|NCT01783678|11748469|FG002|COMPLETED|Overall Study||5
10592211|NCT01783678|11748470|FG003|COMPLETED|Overall Study||50
10592212|NCT01783678|11748471|FG004|COMPLETED|Overall Study||42
10592213|NCT01783678|11748472|FG005|COMPLETED|Overall Study||26
10592214|NCT01783678|11748467|FG000|NOT COMPLETED|Overall Study||2
10592215|NCT01783678|11748468|FG001|NOT COMPLETED|Overall Study||18
10592216|NCT01783678|11748469|FG002|NOT COMPLETED|Overall Study||1
10592217|NCT01783678|11748470|FG003|NOT COMPLETED|Overall Study||8
10592218|NCT01783678|11748471|FG004|NOT COMPLETED|Overall Study||7
10592219|NCT01783678|11748472|FG005|NOT COMPLETED|Overall Study||5
10592220|NCT01783730|11748487|FG000|STARTED|Overall Study||163
10592221|NCT01783730|11748487|FG000|COMPLETED|Overall Study||157
10592222|NCT01783730|11748487|FG000|NOT COMPLETED|Overall Study||6
10592223|NCT01783743|11748493|FG000|STARTED|Screening of Subjects by CTA During MDA||13509
10592224|NCT01783743|11748494|FG001|STARTED|Screening of Subjects by CTA During MDA||13964
10592225|NCT01783743|11748493|FG000|COMPLETED|Screening of Subjects by CTA During MDA||10082
10592226|NCT01783743|11748494|FG001|COMPLETED|Screening of Subjects by CTA During MDA||9525
10592227|NCT01783743|11748493|FG000|NOT COMPLETED|Screening of Subjects by CTA During MDA||3427
10592228|NCT01783743|11748494|FG001|NOT COMPLETED|Screening of Subjects by CTA During MDA||4439
10592229|NCT01783743|11748493|FG000|STARTED|Rescreening of Subjects by Senior Grader||13509
10592230|NCT01783743|11748494|FG001|STARTED|Rescreening of Subjects by Senior Grader||13964
10592231|NCT01783743|11748493|FG000|TT Positive Cases Screened by CTA|Rescreening of Subjects by Senior Grader||46
10592232|NCT01783743|11748494|FG001|TT Positive Cases Screened by CTA|Rescreening of Subjects by Senior Grader||409
10592233|NCT01783743|11748493|FG000|Random Sample From Non TT Cases by CTA|Rescreening of Subjects by Senior Grader||1721
10592234|NCT01783743|11748494|FG001|Random Sample From Non TT Cases by CTA|Rescreening of Subjects by Senior Grader||1786
10592235|NCT01783743|11748493|FG000|Random Sample From Subject Absent at MDA|Rescreening of Subjects by Senior Grader||846
10592236|NCT01783743|11748494|FG001|Random Sample From Subject Absent at MDA|Rescreening of Subjects by Senior Grader||849
10592237|NCT01783743|11748493|FG000|COMPLETED|Rescreening of Subjects by Senior Grader||2613
10592238|NCT01783743|11748494|FG001|COMPLETED|Rescreening of Subjects by Senior Grader||3044
10592239|NCT01783743|11748493|FG000|NOT COMPLETED|Rescreening of Subjects by Senior Grader||10896
10592240|NCT01783743|11748494|FG001|NOT COMPLETED|Rescreening of Subjects by Senior Grader||10920
10592241|NCT01783821|11748502|FG000|STARTED|Overall Study||30
10592242|NCT01783821|11748503|FG001|STARTED|Overall Study||31
10592243|NCT01783821|11748502|FG000|COMPLETED|Overall Study||29
10592244|NCT01783821|11748503|FG001|COMPLETED|Overall Study||30
10592245|NCT01783821|11748502|FG000|NOT COMPLETED|Overall Study||1
10592246|NCT01783821|11748503|FG001|NOT COMPLETED|Overall Study||1
10592247|NCT01783847|11748512|FG000|STARTED|Overall Study||85
10592248|NCT01783847|11748513|FG001|STARTED|Overall Study||16
10592249|NCT01783847|11748514|FG002|STARTED|Overall Study||16
10592250|NCT01783847|11748512|FG000|COMPLETED|Overall Study||69
10592251|NCT01783847|11748513|FG001|COMPLETED|Overall Study||15
10592252|NCT01783847|11748514|FG002|COMPLETED|Overall Study||16
10592253|NCT01783847|11748512|FG000|NOT COMPLETED|Overall Study||16
10592254|NCT01783847|11748513|FG001|NOT COMPLETED|Overall Study||1
10592255|NCT01783847|11748514|FG002|NOT COMPLETED|Overall Study||0
10592256|NCT01783860|11748527|FG000|STARTED|Overall Study||50
10592257|NCT01783860|11748528|FG001|STARTED|Overall Study||50
10592258|NCT01783860|11748527|FG000|COMPLETED|Overall Study||50
10592259|NCT01783860|11748528|FG001|COMPLETED|Overall Study||50
10592260|NCT01783860|11748527|FG000|NOT COMPLETED|Overall Study||0
10592261|NCT01783860|11748528|FG001|NOT COMPLETED|Overall Study||0
10592262|NCT01783886|11748537|FG000|STARTED|Overall Study||127
10592263|NCT01783886|11748538|FG001|STARTED|Overall Study||127
10592264|NCT01783886|11748539|FG002|STARTED|Overall Study||127
10592265|NCT01783886|11748537|FG000|Participants Received Treatment|Overall Study||127
10592266|NCT01783886|11748538|FG001|Participants Received Treatment|Overall Study||127
10592267|NCT01783886|11748539|FG002|Participants Received Treatment|Overall Study||124
10592268|NCT01783886|11748537|FG000|COMPLETED|Overall Study||122
10592269|NCT01783886|11748538|FG001|COMPLETED|Overall Study||116
10592270|NCT01783886|11748539|FG002|COMPLETED|Overall Study||117
10592271|NCT01783886|11748537|FG000|NOT COMPLETED|Overall Study||5
10592272|NCT01783886|11748538|FG001|NOT COMPLETED|Overall Study||11
10592273|NCT01783886|11748539|FG002|NOT COMPLETED|Overall Study||10
10592274|NCT01783912|11748550|FG000|STARTED|Overall Study||118
10592275|NCT01783912|11748551|FG001|STARTED|Overall Study||104
10592276|NCT01783912|11748552|FG002|STARTED|Overall Study||48
10592277|NCT01783912|11748550|FG000|COMPLETED|Overall Study||88
10592278|NCT01783912|11748551|FG001|COMPLETED|Overall Study||58
10592279|NCT01783912|11748552|FG002|COMPLETED|Overall Study||25
10592280|NCT01783912|11748550|FG000|NOT COMPLETED|Overall Study||30
10592281|NCT01783912|11748551|FG001|NOT COMPLETED|Overall Study||46
10592282|NCT01783912|11748552|FG002|NOT COMPLETED|Overall Study||23
10592283|NCT01783938|11748562|FG000|STARTED|Overall Study||68
10592284|NCT01783938|11748563|FG001|STARTED|Overall Study||70
10592285|NCT01783938|11748562|FG000|COMPLETED|Overall Study||11
10592286|NCT01783938|11748563|FG001|COMPLETED|Overall Study||9
10592287|NCT01783938|11748562|FG000|NOT COMPLETED|Overall Study||57
10592288|NCT01783938|11748563|FG001|NOT COMPLETED|Overall Study||61
10592289|NCT01783990|11748571|FG000|STARTED|Overall Study||130
10592290|NCT01783990|11748572|FG001|STARTED|Overall Study||20
10592291|NCT01783990|11748571|FG000|COMPLETED|Overall Study||125
10592292|NCT01783990|11748572|FG001|COMPLETED|Overall Study||18
10592293|NCT01783990|11748571|FG000|NOT COMPLETED|Overall Study||5
10592294|NCT01783990|11748572|FG001|NOT COMPLETED|Overall Study||2
10592295|NCT01784029|11748583|FG000|STARTED|Overall Study||61
10592296|NCT01784029|11748584|FG001|STARTED|Overall Study||59
10592297|NCT01784029|11748585|FG002|STARTED|Overall Study||63
10592298|NCT01784029|11748583|FG000|COMPLETED|Overall Study||42
10592299|NCT01784029|11748584|FG001|COMPLETED|Overall Study||39
10592300|NCT01784029|11748585|FG002|COMPLETED|Overall Study||41
10592301|NCT01784029|11748583|FG000|NOT COMPLETED|Overall Study||19
10592302|NCT01784029|11748584|FG001|NOT COMPLETED|Overall Study||20
10592303|NCT01784029|11748585|FG002|NOT COMPLETED|Overall Study||22
10592304|NCT01784055|11748593|FG000|STARTED|Overall Study||126
10592305|NCT01784055|11748593|FG000|COMPLETED|Overall Study||100
10592306|NCT01784055|11748593|FG000|NOT COMPLETED|Overall Study||26
10592307|NCT01784068|11748597|FG000|STARTED|NTCS Phase||215
10592308|NCT01784068|11748598|FG001|STARTED|NTCS Phase||0
10592309|NCT01784068|11748597|FG000|NTRI Phase|NTCS Phase||86
10592310|NCT01784068|11748598|FG001|NTRI Phase|NTCS Phase||0
10592311|NCT01784068|11748597|FG000|NTCT Phase|NTCS Phase||13
10592312|NCT01784068|11748598|FG001|NTCT Phase|NTCS Phase||0
10592313|NCT01784068|11748597|FG000|TFR-2 Phase|NTCS Phase||8
10592314|NCT01784068|11748598|FG001|TFR-2 Phase|NTCS Phase||0
10592315|NCT01784068|11748597|FG000|NTCT-P Phase|NTCS Phase||2
10592316|NCT01784068|11748598|FG001|NTCT-P Phase|NTCS Phase||0
10592317|NCT01784068|11748597|FG000|NTRI-2|NTCS Phase||0
10592318|NCT01784068|11748598|FG001|NTRI-2|NTCS Phase||0
10592319|NCT01784068|11748597|FG000|COMPLETED|NTCS Phase||0
10592320|NCT01784068|11748598|FG001|COMPLETED|NTCS Phase||0
10592321|NCT01784068|11748597|FG000|NOT COMPLETED|NTCS Phase||215
10592322|NCT01784068|11748598|FG001|NOT COMPLETED|NTCS Phase||0
10592323|NCT01784068|11748597|FG000|STARTED|TFR Phase||0
10592324|NCT01784068|11748598|FG001|STARTED|TFR Phase||190
10592325|NCT01784068|11748597|FG000|COMPLETED|TFR Phase||0
10592326|NCT01784068|11748598|FG001|COMPLETED|TFR Phase||97
10592327|NCT01784068|11748597|FG000|NOT COMPLETED|TFR Phase||0
10592328|NCT01784068|11748598|FG001|NOT COMPLETED|TFR Phase||93
10592329|NCT01784211|11748611|FG000|STARTED|Part A (Days 1-15)||38
10592330|NCT01784211|11748612|FG001|STARTED|Part A (Days 1-15)||38
10592331|NCT01784211|11748613|FG002|STARTED|Part A (Days 1-15)||0
10592332|NCT01784211|11748614|FG003|STARTED|Part A (Days 1-15)||0
10592333|NCT01784211|11748615|FG004|STARTED|Part A (Days 1-15)||0
10592334|NCT01784211|11748616|FG005|STARTED|Part A (Days 1-15)||0
10592335|NCT01784211|11748611|FG000|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||37
10592336|NCT01784211|11748612|FG001|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||38
10592337|NCT01784211|11748613|FG002|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
10592338|NCT01784211|11748614|FG003|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
10592339|NCT01784211|11748615|FG004|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
10592340|NCT01784211|11748616|FG005|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
10592341|NCT01784211|11748611|FG000|Entered Part B|Part A (Days 1-15)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|19
10592342|NCT01784211|11748612|FG001|Entered Part B|Part A (Days 1-15)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|21
10592343|NCT01784211|11748613|FG002|Entered Part B|Part A (Days 1-15)||0
10592344|NCT01784211|11748614|FG003|Entered Part B|Part A (Days 1-15)||0
10592345|NCT01784211|11748615|FG004|Entered Part B|Part A (Days 1-15)||0
10592346|NCT01784211|11748616|FG005|Entered Part B|Part A (Days 1-15)||0
10592347|NCT01784211|11748611|FG000|COMPLETED|Part A (Days 1-15)||35
10592348|NCT01784211|11748612|FG001|COMPLETED|Part A (Days 1-15)||36
10592349|NCT01784211|11748613|FG002|COMPLETED|Part A (Days 1-15)||0
10592350|NCT01784211|11748614|FG003|COMPLETED|Part A (Days 1-15)||0
10592351|NCT01784211|11748615|FG004|COMPLETED|Part A (Days 1-15)||0
10592352|NCT01784211|11748616|FG005|COMPLETED|Part A (Days 1-15)||0
10592353|NCT01784211|11748611|FG000|NOT COMPLETED|Part A (Days 1-15)||3
10592354|NCT01784211|11748612|FG001|NOT COMPLETED|Part A (Days 1-15)||2
10592355|NCT01784211|11748613|FG002|NOT COMPLETED|Part A (Days 1-15)||0
10592356|NCT01784211|11748614|FG003|NOT COMPLETED|Part A (Days 1-15)||0
10592357|NCT01784211|11748615|FG004|NOT COMPLETED|Part A (Days 1-15)||0
10592358|NCT01784211|11748616|FG005|NOT COMPLETED|Part A (Days 1-15)||0
10592359|NCT01784211|11748611|FG000|STARTED|Part B (Days 16-21)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|0
10592360|NCT01784211|11748612|FG001|STARTED|Part B (Days 16-21)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|0
10592361|NCT01784211|11748613|FG002|STARTED|Part B (Days 16-21)||10
10592362|NCT01784211|11748614|FG003|STARTED|Part B (Days 16-21)||9
10592363|NCT01784211|11748615|FG004|STARTED|Part B (Days 16-21)||11
10592364|NCT01784211|11748616|FG005|STARTED|Part B (Days 16-21)||10
10592365|NCT01784211|11748611|FG000|COMPLETED|Part B (Days 16-21)||0
10592366|NCT01784211|11748612|FG001|COMPLETED|Part B (Days 16-21)||0
10592367|NCT01784211|11748613|FG002|COMPLETED|Part B (Days 16-21)||10
10592368|NCT01784211|11748614|FG003|COMPLETED|Part B (Days 16-21)||9
10592369|NCT01784211|11748615|FG004|COMPLETED|Part B (Days 16-21)||11
10592370|NCT01784211|11748616|FG005|COMPLETED|Part B (Days 16-21)||10
10592371|NCT01784211|11748611|FG000|NOT COMPLETED|Part B (Days 16-21)||0
10592372|NCT01784211|11748612|FG001|NOT COMPLETED|Part B (Days 16-21)||0
10592373|NCT01784211|11748613|FG002|NOT COMPLETED|Part B (Days 16-21)||0
10592374|NCT01784211|11748614|FG003|NOT COMPLETED|Part B (Days 16-21)||0
10592375|NCT01784211|11748615|FG004|NOT COMPLETED|Part B (Days 16-21)||0
10592376|NCT01784211|11748616|FG005|NOT COMPLETED|Part B (Days 16-21)||0
10592377|NCT01784419|11748628|FG000|STARTED|Overall Study||10
10592378|NCT01784419|11748628|FG000|COMPLETED|Overall Study||7
10592379|NCT01784419|11748628|FG000|NOT COMPLETED|Overall Study||3
10592380|NCT01784523|11748634|FG000|STARTED|Overall Study||7
10592381|NCT01784523|11748635|FG001|STARTED|Overall Study||4
10592382|NCT01784523|11748634|FG000|COMPLETED|Overall Study||0
10592383|NCT01784523|11748635|FG001|COMPLETED|Overall Study||0
10592384|NCT01784523|11748634|FG000|NOT COMPLETED|Overall Study||7
10592385|NCT01784523|11748635|FG001|NOT COMPLETED|Overall Study||4
10592386|NCT01784588|11748643|FG000|STARTED|Overall Study||141
10592387|NCT01784588|11748644|FG001|STARTED|Overall Study||140
10592388|NCT01784588|11748643|FG000|COMPLETED|Overall Study||104
10592389|NCT01784588|11748644|FG001|COMPLETED|Overall Study||108
10592390|NCT01784588|11748643|FG000|NOT COMPLETED|Overall Study||37
10592391|NCT01784588|11748644|FG001|NOT COMPLETED|Overall Study||32
10592392|NCT01784614|11748650|FG000|STARTED|Period 1||3
10592393|NCT01784614|11748651|FG001|STARTED|Period 1||3
10592394|NCT01784614|11748652|FG002|STARTED|Period 1||3
10592395|NCT01784614|11748653|FG003|STARTED|Period 1||3
10592396|NCT01784614|11748654|FG004|STARTED|Period 1||3
10592397|NCT01784614|11748655|FG005|STARTED|Period 1||3
10592398|NCT01784614|11748656|FG006|STARTED|Period 1||3
10592399|NCT01784614|11748657|FG007|STARTED|Period 1||3
10592400|NCT01784614|11748650|FG000|Received at Least 1 Dose of Study Drug|Period 1||3
10592401|NCT01784614|11748651|FG001|Received at Least 1 Dose of Study Drug|Period 1||3
10592402|NCT01784614|11748652|FG002|Received at Least 1 Dose of Study Drug|Period 1||3
10592403|NCT01784614|11748653|FG003|Received at Least 1 Dose of Study Drug|Period 1||3
10592404|NCT01784614|11748654|FG004|Received at Least 1 Dose of Study Drug|Period 1||3
10592405|NCT01784614|11748655|FG005|Received at Least 1 Dose of Study Drug|Period 1||3
10592406|NCT01784614|11748656|FG006|Received at Least 1 Dose of Study Drug|Period 1||3
10592407|NCT01784614|11748657|FG007|Received at Least 1 Dose of Study Drug|Period 1||3
10592408|NCT01784614|11748650|FG000|COMPLETED|Period 1||3
10592409|NCT01784614|11748651|FG001|COMPLETED|Period 1||3
10592410|NCT01784614|11748652|FG002|COMPLETED|Period 1||3
10703539|NCT02584855|11867988|FG004|STARTED|Post Treatment Follow-up Period||355
10703540|NCT02584855|11867989|FG005|STARTED|Post Treatment Follow-up Period||12
10703541|NCT02584855|11867984|FG000|COMPLETED|Post Treatment Follow-up Period||0
10703542|NCT02584855|11867985|FG001|COMPLETED|Post Treatment Follow-up Period||0
10703543|NCT02584855|11867986|FG002|COMPLETED|Post Treatment Follow-up Period||0
10703544|NCT02584855|11867987|FG003|COMPLETED|Post Treatment Follow-up Period||0
10592411|NCT01784614|11748653|FG003|COMPLETED|Period 1||3
10592412|NCT01784614|11748654|FG004|COMPLETED|Period 1||3
10592413|NCT01784614|11748655|FG005|COMPLETED|Period 1||3
10592414|NCT01784614|11748656|FG006|COMPLETED|Period 1||3
10592415|NCT01784614|11748657|FG007|COMPLETED|Period 1|One participant withdrew consent after completed Period 1 and did not enter Period 2.|3
10592416|NCT01784614|11748650|FG000|NOT COMPLETED|Period 1||0
10592417|NCT01784614|11748651|FG001|NOT COMPLETED|Period 1||0
10592418|NCT01784614|11748652|FG002|NOT COMPLETED|Period 1||0
10592419|NCT01784614|11748653|FG003|NOT COMPLETED|Period 1||0
10592420|NCT01784614|11748654|FG004|NOT COMPLETED|Period 1||0
10592421|NCT01784614|11748655|FG005|NOT COMPLETED|Period 1||0
10592422|NCT01784614|11748656|FG006|NOT COMPLETED|Period 1||0
10592423|NCT01784614|11748657|FG007|NOT COMPLETED|Period 1||0
10592424|NCT01784614|11748650|FG000|STARTED|Period 2||3
10592425|NCT01784614|11748651|FG001|STARTED|Period 2||3
10592426|NCT01784614|11748652|FG002|STARTED|Period 2||3
10592427|NCT01784614|11748653|FG003|STARTED|Period 2||3
10592428|NCT01784614|11748654|FG004|STARTED|Period 2||3
10592429|NCT01784614|11748655|FG005|STARTED|Period 2||3
10592430|NCT01784614|11748656|FG006|STARTED|Period 2||3
10703545|NCT02584855|11867988|FG004|COMPLETED|Post Treatment Follow-up Period||347
10592431|NCT01784614|11748657|FG007|STARTED|Period 2||2
10592432|NCT01784614|11748650|FG000|COMPLETED|Period 2||3
10592433|NCT01784614|11748651|FG001|COMPLETED|Period 2|One participant withdrew consent after completed Period 2 and did not enter Period 3.|3
10703546|NCT02584855|11867989|FG005|COMPLETED|Post Treatment Follow-up Period||12
10703547|NCT02584855|11867984|FG000|NOT COMPLETED|Post Treatment Follow-up Period||0
10592434|NCT01784614|11748652|FG002|COMPLETED|Period 2||3
10592435|NCT01784614|11748653|FG003|COMPLETED|Period 2||3
10592436|NCT01784614|11748654|FG004|COMPLETED|Period 2||3
10592437|NCT01784614|11748655|FG005|COMPLETED|Period 2||3
10592438|NCT01784614|11748656|FG006|COMPLETED|Period 2||3
10592439|NCT01784614|11748657|FG007|COMPLETED|Period 2||2
10592440|NCT01784614|11748650|FG000|NOT COMPLETED|Period 2||0
10592441|NCT01784614|11748651|FG001|NOT COMPLETED|Period 2||0
10592442|NCT01784614|11748652|FG002|NOT COMPLETED|Period 2||0
10592443|NCT01784614|11748653|FG003|NOT COMPLETED|Period 2||0
10592444|NCT01784614|11748654|FG004|NOT COMPLETED|Period 2||0
10592445|NCT01784614|11748655|FG005|NOT COMPLETED|Period 2||0
10592446|NCT01784614|11748656|FG006|NOT COMPLETED|Period 2||0
10592447|NCT01784614|11748657|FG007|NOT COMPLETED|Period 2||0
10592448|NCT01784614|11748650|FG000|STARTED|Period 3||3
10592449|NCT01784614|11748651|FG001|STARTED|Period 3||2
10592450|NCT01784614|11748652|FG002|STARTED|Period 3||3
10592451|NCT01784614|11748653|FG003|STARTED|Period 3||3
10592452|NCT01784614|11748654|FG004|STARTED|Period 3||3
10592453|NCT01784614|11748655|FG005|STARTED|Period 3||3
10592454|NCT01784614|11748656|FG006|STARTED|Period 3||3
10592455|NCT01784614|11748657|FG007|STARTED|Period 3||2
10592456|NCT01784614|11748650|FG000|COMPLETED|Period 3||3
10592457|NCT01784614|11748651|FG001|COMPLETED|Period 3||2
10592458|NCT01784614|11748652|FG002|COMPLETED|Period 3||3
10592459|NCT01784614|11748653|FG003|COMPLETED|Period 3||3
10592460|NCT01784614|11748654|FG004|COMPLETED|Period 3||3
10592461|NCT01784614|11748655|FG005|COMPLETED|Period 3||3
10592462|NCT01784614|11748656|FG006|COMPLETED|Period 3||3
10592463|NCT01784614|11748657|FG007|COMPLETED|Period 3||2
10592464|NCT01784614|11748650|FG000|NOT COMPLETED|Period 3||0
10592465|NCT01784614|11748651|FG001|NOT COMPLETED|Period 3||0
10592466|NCT01784614|11748652|FG002|NOT COMPLETED|Period 3||0
10592467|NCT01784614|11748653|FG003|NOT COMPLETED|Period 3||0
10592468|NCT01784614|11748654|FG004|NOT COMPLETED|Period 3||0
10592469|NCT01784614|11748655|FG005|NOT COMPLETED|Period 3||0
10592470|NCT01784614|11748656|FG006|NOT COMPLETED|Period 3||0
10592471|NCT01784614|11748657|FG007|NOT COMPLETED|Period 3||0
10592472|NCT01784614|11748650|FG000|STARTED|Period 4||3
10592473|NCT01784614|11748651|FG001|STARTED|Period 4||2
10592474|NCT01784614|11748652|FG002|STARTED|Period 4||3
10592475|NCT01784614|11748653|FG003|STARTED|Period 4||3
10592476|NCT01784614|11748654|FG004|STARTED|Period 4||3
10592477|NCT01784614|11748655|FG005|STARTED|Period 4||3
10592478|NCT01784614|11748656|FG006|STARTED|Period 4||3
10592479|NCT01784614|11748657|FG007|STARTED|Period 4||2
10592480|NCT01784614|11748650|FG000|COMPLETED|Period 4||3
10592481|NCT01784614|11748651|FG001|COMPLETED|Period 4||2
10592482|NCT01784614|11748652|FG002|COMPLETED|Period 4||3
10592483|NCT01784614|11748653|FG003|COMPLETED|Period 4||3
10592484|NCT01784614|11748654|FG004|COMPLETED|Period 4||3
10592485|NCT01784614|11748655|FG005|COMPLETED|Period 4||3
10592486|NCT01784614|11748656|FG006|COMPLETED|Period 4||3
10592487|NCT01784614|11748657|FG007|COMPLETED|Period 4||2
10333761|NCT00335478|11469952|FG000|NOT COMPLETED|Overall Study||24
10333762|NCT00335504|11469960|FG000|STARTED|Overall Study||22
10333763|NCT00335504|11469961|FG001|STARTED|Overall Study||21
10333764|NCT00335504|11469962|FG002|STARTED|Overall Study||20
10333765|NCT00335504|11469963|FG003|STARTED|Overall Study||22
10333766|NCT00335504|11469960|FG000|COMPLETED|Overall Study||22
10333767|NCT00335504|11469961|FG001|COMPLETED|Overall Study||21
10333768|NCT00335504|11469962|FG002|COMPLETED|Overall Study||20
10333769|NCT00335504|11469963|FG003|COMPLETED|Overall Study||22
10333770|NCT00335504|11469960|FG000|NOT COMPLETED|Overall Study||0
10333771|NCT00335504|11469961|FG001|NOT COMPLETED|Overall Study||0
10333772|NCT00335504|11469962|FG002|NOT COMPLETED|Overall Study||0
10333773|NCT00335504|11469963|FG003|NOT COMPLETED|Overall Study||0
10333774|NCT00335517|11469973|FG000|STARTED|Overall Study||100
10333775|NCT00335517|11469973|FG000|COMPLETED|Overall Study|Due to pharmacy error two patients were enolled and recieved EREM, but were not included in analysis|98
10333776|NCT00335517|11469973|FG000|NOT COMPLETED|Overall Study||2
10333777|NCT00335556|11469983|FG000|STARTED|Overall Study||68
10333778|NCT00335556|11469984|FG001|STARTED|Overall Study||98
10592488|NCT01784614|11748650|FG000|NOT COMPLETED|Period 4||0
10592489|NCT01784614|11748651|FG001|NOT COMPLETED|Period 4||0
10592490|NCT01784614|11748652|FG002|NOT COMPLETED|Period 4||0
10592491|NCT01784614|11748653|FG003|NOT COMPLETED|Period 4||0
10592492|NCT01784614|11748654|FG004|NOT COMPLETED|Period 4||0
10592493|NCT01784614|11748655|FG005|NOT COMPLETED|Period 4||0
10592494|NCT01784614|11748656|FG006|NOT COMPLETED|Period 4||0
10592495|NCT01784614|11748657|FG007|NOT COMPLETED|Period 4||0
10592496|NCT01784666|11748680|FG000|STARTED|Overall Study||1
10592497|NCT01784666|11748681|FG001|STARTED|Overall Study||0
10592498|NCT01784666|11748682|FG002|STARTED|Overall Study||1
10592499|NCT01784666|11748680|FG000|COMPLETED|Overall Study||1
10333779|NCT00335556|11469985|FG002|STARTED|Overall Study||7
10592500|NCT01784666|11748681|FG001|COMPLETED|Overall Study||0
10592501|NCT01784666|11748682|FG002|COMPLETED|Overall Study||1
10592502|NCT01784666|11748680|FG000|NOT COMPLETED|Overall Study||0
10592503|NCT01784666|11748681|FG001|NOT COMPLETED|Overall Study||0
10333780|NCT00335556|11469986|FG003|STARTED|Overall Study||10
10333781|NCT00335556|11469987|FG004|STARTED|Overall Study||78
10333782|NCT00335556|11469988|FG005|STARTED|Overall Study||30
10333783|NCT00335556|11469983|FG000|COMPLETED|Overall Study||66
10592504|NCT01784666|11748682|FG002|NOT COMPLETED|Overall Study||0
10592505|NCT01784770|11748690|FG000|STARTED|Overall Study||21
10592506|NCT01784770|11748690|FG000|COMPLETED|Overall Study||21
10592507|NCT01784770|11748690|FG000|NOT COMPLETED|Overall Study||0
10592508|NCT01784796|11748696|FG000|STARTED|Overall Study|These are participants who provided informed consent|87
10592509|NCT01784796|11748697|FG001|STARTED|Overall Study|These are participants who provided informed consent|77
10592510|NCT01784796|11748696|FG000|Baseline Data Collected|Overall Study||75
10592511|NCT01784796|11748697|FG001|Baseline Data Collected|Overall Study||61
10592512|NCT01784796|11748696|FG000|4 Week Data Collection|Overall Study||48
10592513|NCT01784796|11748697|FG001|4 Week Data Collection|Overall Study||41
10592514|NCT01784796|11748696|FG000|8 wk Data Collection|Overall Study||50
10592515|NCT01784796|11748697|FG001|8 wk Data Collection|Overall Study||46
10592516|NCT01784796|11748696|FG000|COMPLETED|Overall Study||39
10592517|NCT01784796|11748697|FG001|COMPLETED|Overall Study||34
10592518|NCT01784796|11748696|FG000|NOT COMPLETED|Overall Study||48
10592519|NCT01784796|11748697|FG001|NOT COMPLETED|Overall Study||43
10592520|NCT01784861|11748710|FG000|STARTED|Overall Study||3
10592521|NCT01784861|11748711|FG001|STARTED|Overall Study||3
10592522|NCT01784861|11748712|FG002|STARTED|Overall Study||4
10592523|NCT01784861|11748713|FG003|STARTED|Overall Study||8
10592524|NCT01784861|11748714|FG004|STARTED|Overall Study||3
10592525|NCT01784861|11748715|FG005|STARTED|Overall Study||2
10592526|NCT01784861|11748710|FG000|COMPLETED|Overall Study||3
10592527|NCT01784861|11748711|FG001|COMPLETED|Overall Study||3
10592528|NCT01784861|11748712|FG002|COMPLETED|Overall Study||3
10592529|NCT01784861|11748713|FG003|COMPLETED|Overall Study||3
10592530|NCT01784861|11748714|FG004|COMPLETED|Overall Study||2
10592531|NCT01784861|11748715|FG005|COMPLETED|Overall Study||1
10592532|NCT01784861|11748710|FG000|NOT COMPLETED|Overall Study||0
10592533|NCT01784861|11748711|FG001|NOT COMPLETED|Overall Study||0
10592534|NCT01784861|11748712|FG002|NOT COMPLETED|Overall Study||1
10592535|NCT01784861|11748713|FG003|NOT COMPLETED|Overall Study||5
10592536|NCT01784861|11748714|FG004|NOT COMPLETED|Overall Study||1
10592537|NCT01784861|11748715|FG005|NOT COMPLETED|Overall Study||1
10592538|NCT01784926|11748733|FG000|STARTED|Overall Study||54
10592539|NCT01784926|11748734|FG001|STARTED|Overall Study||50
10592540|NCT01784926|11748733|FG000|COMPLETED|Overall Study||43
10592541|NCT01784926|11748734|FG001|COMPLETED|Overall Study||42
10592542|NCT01784926|11748733|FG000|NOT COMPLETED|Overall Study||11
10592543|NCT01784926|11748734|FG001|NOT COMPLETED|Overall Study||8
10592544|NCT01784965|11748742|FG000|STARTED|Overall Study||33
10592545|NCT01784965|11748743|FG001|STARTED|Overall Study||35
10592546|NCT01784965|11748742|FG000|COMPLETED|Overall Study||27
10592547|NCT01784965|11748743|FG001|COMPLETED|Overall Study||24
10592548|NCT01784965|11748742|FG000|NOT COMPLETED|Overall Study||6
10592549|NCT01784965|11748743|FG001|NOT COMPLETED|Overall Study||11
10592550|NCT01785069|11748755|FG000|STARTED|Overall Study||107
10592551|NCT01785069|11748756|FG001|STARTED|Overall Study||76
10592552|NCT01785069|11748757|FG002|STARTED|Overall Study||104
10592553|NCT01785069|11748758|FG003|STARTED|Overall Study||68
10592554|NCT01785069|11748755|FG000|COMPLETED|Overall Study||95
10592555|NCT01785069|11748756|FG001|COMPLETED|Overall Study||64
10592556|NCT01785069|11748757|FG002|COMPLETED|Overall Study||91
10592557|NCT01785069|11748758|FG003|COMPLETED|Overall Study||54
10592558|NCT01785069|11748755|FG000|NOT COMPLETED|Overall Study||12
10592559|NCT01785069|11748756|FG001|NOT COMPLETED|Overall Study||12
10592560|NCT01785069|11748757|FG002|NOT COMPLETED|Overall Study||13
10592561|NCT01785069|11748758|FG003|NOT COMPLETED|Overall Study||14
10592562|NCT01785095|11748768|FG000|STARTED|Overall Study||27
10592563|NCT01785095|11748768|FG000|COMPLETED|Overall Study||24
10592564|NCT01785095|11748768|FG000|NOT COMPLETED|Overall Study||3
10592565|NCT01785134|11748777|FG000|STARTED|Overall Study||41
10592566|NCT01785134|11748778|FG001|STARTED|Overall Study||40
10592567|NCT01785134|11748777|FG000|COMPLETED|Overall Study||29
10592568|NCT01785134|11748778|FG001|COMPLETED|Overall Study||33
10592569|NCT01785134|11748777|FG000|NOT COMPLETED|Overall Study||12
10592570|NCT01785134|11748778|FG001|NOT COMPLETED|Overall Study||7
10592571|NCT01785160|11748784|FG000|STARTED|Treatment Period 1: Raltegravir||25
10592572|NCT01785160|11748784|FG000|COMPLETED|Treatment Period 1: Raltegravir||24
10592573|NCT01785160|11748784|FG000|NOT COMPLETED|Treatment Period 1: Raltegravir||1
10592574|NCT01785160|11748784|FG000|STARTED|Washout Period of at Least 7 Days||24
10592575|NCT01785160|11748784|FG000|COMPLETED|Washout Period of at Least 7 Days||23
10592576|NCT01785160|11748784|FG000|NOT COMPLETED|Washout Period of at Least 7 Days||1
10592577|NCT01785160|11748784|FG000|STARTED|Treatment Period 2: Raltegravir + Faldap||23
10592578|NCT01785160|11748784|FG000|COMPLETED|Treatment Period 2: Raltegravir + Faldap||23
10592579|NCT01785160|11748784|FG000|NOT COMPLETED|Treatment Period 2: Raltegravir + Faldap||0
10592580|NCT01785186|11748795|FG000|STARTED|Overall Study||59
10592581|NCT01785186|11748796|FG001|STARTED|Overall Study||63
10592582|NCT01785186|11748797|FG002|STARTED|Overall Study||57
10592583|NCT01785186|11748798|FG003|STARTED|Overall Study||63
10592584|NCT01785186|11748799|FG004|STARTED|Overall Study||123
10592585|NCT01785186|11748795|FG000|COMPLETED|Overall Study||53
10592586|NCT01785186|11748796|FG001|COMPLETED|Overall Study||57
10592587|NCT01785186|11748797|FG002|COMPLETED|Overall Study||52
10592588|NCT01785186|11748798|FG003|COMPLETED|Overall Study||58
10592589|NCT01785186|11748799|FG004|COMPLETED|Overall Study||117
10592590|NCT01785186|11748795|FG000|NOT COMPLETED|Overall Study||6
10592591|NCT01785186|11748796|FG001|NOT COMPLETED|Overall Study||6
10592592|NCT01785186|11748797|FG002|NOT COMPLETED|Overall Study||5
10592593|NCT01785186|11748798|FG003|NOT COMPLETED|Overall Study||5
10592594|NCT01785186|11748799|FG004|NOT COMPLETED|Overall Study||6
10592601|NCT01785472|11748825|FG000|STARTED|Overall Study||479
10592602|NCT01785472|11748826|FG001|STARTED|Overall Study||473
10592603|NCT01785472|11748827|FG002|STARTED|Overall Study||486
10592604|NCT01785472|11748825|FG000|Full Analysis Set (FAS)|Overall Study||479
10592605|NCT01785472|11748826|FG001|Full Analysis Set (FAS)|Overall Study||472
10592606|NCT01785472|11748827|FG002|Full Analysis Set (FAS)|Overall Study||484
10592607|NCT01785472|11748825|FG000|Safety Set (SAF)|Overall Study||478
10592608|NCT01785472|11748826|FG001|Safety Set (SAF)|Overall Study||472
10592609|NCT01785472|11748827|FG002|Safety Set (SAF)|Overall Study||484
10592610|NCT01785472|11748825|FG000|COMPLETED|Overall Study||455
10592611|NCT01785472|11748826|FG001|COMPLETED|Overall Study||454
10592612|NCT01785472|11748827|FG002|COMPLETED|Overall Study||464
10592613|NCT01785472|11748825|FG000|NOT COMPLETED|Overall Study||24
10592614|NCT01785472|11748826|FG001|NOT COMPLETED|Overall Study||19
10592615|NCT01785472|11748827|FG002|NOT COMPLETED|Overall Study||22
10592616|NCT01785524|11748839|FG000|STARTED|Overall Study||7
10592617|NCT01785524|11748840|FG001|STARTED|Overall Study||4
10592618|NCT01785524|11748839|FG000|COMPLETED|Overall Study||5
10592619|NCT01785524|11748840|FG001|COMPLETED|Overall Study||2
10592620|NCT01785524|11748839|FG000|NOT COMPLETED|Overall Study||2
10592621|NCT01785524|11748840|FG001|NOT COMPLETED|Overall Study||2
10592622|NCT01785602|11748848|FG000|STARTED|Overall Study||76
10592623|NCT01785602|11748849|FG001|STARTED|Overall Study||27
10592624|NCT01785602|11748848|FG000|COMPLETED|Overall Study||63
10592625|NCT01785602|11748849|FG001|COMPLETED|Overall Study||18
10592626|NCT01785602|11748848|FG000|NOT COMPLETED|Overall Study||13
10592627|NCT01785602|11748849|FG001|NOT COMPLETED|Overall Study||9
10592628|NCT01785615|11748858|FG000|STARTED|Dietary Phase||0
10592629|NCT01785615|11748859|FG001|STARTED|Dietary Phase||0
10592630|NCT01785615|11748860|FG002|STARTED|Dietary Phase||35
10592631|NCT01785615|11748861|FG003|STARTED|Dietary Phase||140
10592632|NCT01785615|11748858|FG000|COMPLETED|Dietary Phase||0
10592633|NCT01785615|11748859|FG001|COMPLETED|Dietary Phase||0
10592634|NCT01785615|11748860|FG002|COMPLETED|Dietary Phase||35
10592635|NCT01785615|11748861|FG003|COMPLETED|Dietary Phase||116
10592636|NCT01785615|11748858|FG000|NOT COMPLETED|Dietary Phase||0
10592637|NCT01785615|11748859|FG001|NOT COMPLETED|Dietary Phase||0
10592638|NCT01785615|11748860|FG002|NOT COMPLETED|Dietary Phase||0
10592639|NCT01785615|11748861|FG003|NOT COMPLETED|Dietary Phase||24
10592640|NCT01785615|11748858|FG000|STARTED|Atorvastatin Phase||44
10592641|NCT01785615|11748859|FG001|STARTED|Atorvastatin Phase||44
10592642|NCT01785615|11748860|FG002|STARTED|Atorvastatin Phase||0
10592643|NCT01785615|11748861|FG003|STARTED|Atorvastatin Phase||0
10592644|NCT01785615|11748858|FG000|COMPLETED|Atorvastatin Phase||44
10592645|NCT01785615|11748859|FG001|COMPLETED|Atorvastatin Phase||44
10592646|NCT01785615|11748860|FG002|COMPLETED|Atorvastatin Phase||0
10592647|NCT01785615|11748861|FG003|COMPLETED|Atorvastatin Phase||0
10592648|NCT01785615|11748858|FG000|NOT COMPLETED|Atorvastatin Phase||0
10592649|NCT01785615|11748859|FG001|NOT COMPLETED|Atorvastatin Phase||0
10592650|NCT01785615|11748860|FG002|NOT COMPLETED|Atorvastatin Phase||0
10592651|NCT01785615|11748861|FG003|NOT COMPLETED|Atorvastatin Phase||0
10592652|NCT01785628|11748875|FG000|STARTED|Overall Study||15
10592653|NCT01785628|11748876|FG001|STARTED|Overall Study||15
10592654|NCT01785628|11748875|FG000|COMPLETED|Overall Study||13
10592655|NCT01785628|11748876|FG001|COMPLETED|Overall Study||12
10592656|NCT01785628|11748875|FG000|NOT COMPLETED|Overall Study||2
10592657|NCT01785628|11748876|FG001|NOT COMPLETED|Overall Study||3
10592658|NCT01785680|11748884|FG000|STARTED|Overall Study||1100
10592659|NCT01785680|11748885|FG001|STARTED|Overall Study||857
10592660|NCT01785680|11748884|FG000|COMPLETED|Overall Study||1100
10592661|NCT01785680|11748885|FG001|COMPLETED|Overall Study||857
10592662|NCT01785680|11748884|FG000|NOT COMPLETED|Overall Study||0
10592663|NCT01785680|11748885|FG001|NOT COMPLETED|Overall Study||0
10592664|NCT01785810|11748891|FG000|STARTED|Overall Study||37
10592665|NCT01785810|11748891|FG000|COMPLETED|Overall Study||29
10592666|NCT01785810|11748891|FG000|NOT COMPLETED|Overall Study||8
10592667|NCT01785849|11748897|FG000|STARTED|Overall Study||254
10592668|NCT01785849|11748898|FG001|STARTED|Overall Study||254
10592669|NCT01785849|11748897|FG000|Received Treatment|Overall Study||254
10592670|NCT01785849|11748898|FG001|Received Treatment|Overall Study||251
10592671|NCT01785849|11748897|FG000|COMPLETED|Overall Study||193
10592672|NCT01785849|11748898|FG001|COMPLETED|Overall Study||220
10592673|NCT01785849|11748897|FG000|NOT COMPLETED|Overall Study||61
10592674|NCT01785849|11748898|FG001|NOT COMPLETED|Overall Study||34
10592675|NCT01785875|11748904|FG000|STARTED|Overall Study||384
10592676|NCT01785875|11748905|FG001|STARTED|Overall Study||384
10592677|NCT01785875|11748906|FG002|STARTED|Overall Study||123
10592678|NCT01785875|11748904|FG000|Received Etelcalcetide|Overall Study||383
10592679|NCT01785875|11748905|FG001|Received Etelcalcetide|Overall Study||384
10592680|NCT01785875|11748906|FG002|Received Etelcalcetide|Overall Study||123
10592681|NCT01785875|11748904|FG000|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|90
10592682|NCT01785875|11748905|FG001|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|95
10592683|NCT01785875|11748906|FG002|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|16
10592684|NCT01785875|11748904|FG000|NOT COMPLETED|Overall Study||294
10592685|NCT01785875|11748905|FG001|NOT COMPLETED|Overall Study||289
10592686|NCT01785875|11748906|FG002|NOT COMPLETED|Overall Study||107
10592687|NCT01786109|11748920|FG000|STARTED|Overall Study||24
10592688|NCT01786109|11748921|FG001|STARTED|Overall Study||24
10592689|NCT01786109|11748922|FG002|STARTED|Overall Study||27
10592690|NCT01786109|11748920|FG000|COMPLETED|Overall Study||23
10592691|NCT01786109|11748921|FG001|COMPLETED|Overall Study||24
10592692|NCT01786109|11748922|FG002|COMPLETED|Overall Study||25
10592693|NCT01786109|11748920|FG000|NOT COMPLETED|Overall Study||1
10592694|NCT01786109|11748921|FG001|NOT COMPLETED|Overall Study||0
10592695|NCT01786109|11748922|FG002|NOT COMPLETED|Overall Study||2
10592696|NCT01786148|11748932|FG000|STARTED|Overall Study||77
10592697|NCT01786148|11748933|FG001|STARTED|Overall Study||72
10592698|NCT01786148|11748932|FG000|COMPLETED|Overall Study||55
10592699|NCT01786148|11748933|FG001|COMPLETED|Overall Study||50
10592700|NCT01786148|11748932|FG000|NOT COMPLETED|Overall Study||22
10592701|NCT01786148|11748933|FG001|NOT COMPLETED|Overall Study||22
10592702|NCT01786161|11748941|FG000|STARTED|Overall Study||22
10592703|NCT01786161|11748942|FG001|STARTED|Overall Study||22
10592704|NCT01786161|11748941|FG000|COMPLETED|Overall Study||22
10592705|NCT01786161|11748942|FG001|COMPLETED|Overall Study||22
10592706|NCT01786161|11748941|FG000|NOT COMPLETED|Overall Study||0
10592707|NCT01786161|11748942|FG001|NOT COMPLETED|Overall Study||0
10592708|NCT01786174|11748952|FG000|STARTED|Overall Study||18
10592709|NCT01786174|11748953|FG001|STARTED|Overall Study||10
10592710|NCT01786174|11748952|FG000|Randomized|Overall Study||19
10592711|NCT01786174|11748953|FG001|Randomized|Overall Study||11
10592712|NCT01786174|11748952|FG000|COMPLETED|Overall Study||16
10592713|NCT01786174|11748953|FG001|COMPLETED|Overall Study||10
10592714|NCT01786174|11748952|FG000|NOT COMPLETED|Overall Study||2
10592715|NCT01786174|11748953|FG001|NOT COMPLETED|Overall Study||0
10592716|NCT01786187|11748961|FG000|STARTED|Overall Study||40
10592717|NCT01786187|11748962|FG001|STARTED|Overall Study||47
10592718|NCT01786187|11748961|FG000|COMPLETED|Overall Study||35
10592719|NCT01786187|11748962|FG001|COMPLETED|Overall Study||37
10592720|NCT01786187|11748961|FG000|NOT COMPLETED|Overall Study||5
10592721|NCT01786187|11748962|FG001|NOT COMPLETED|Overall Study||10
10592722|NCT01786239|11748973|FG000|STARTED|Overall Study||25
10592723|NCT01786239|11748974|FG001|STARTED|Overall Study||25
10592724|NCT01786239|11748973|FG000|COMPLETED|Overall Study||14
10592725|NCT01786239|11748974|FG001|COMPLETED|Overall Study||14
10592726|NCT01786239|11748973|FG000|NOT COMPLETED|Overall Study||11
10592727|NCT01786239|11748974|FG001|NOT COMPLETED|Overall Study||11
10592728|NCT01786252|11748982|FG000|STARTED|Overall Study||7
10592729|NCT01786252|11748983|FG001|STARTED|Overall Study||8
10592730|NCT01786252|11748982|FG000|COMPLETED|Overall Study||7
10592731|NCT01786252|11748983|FG001|COMPLETED|Overall Study||8
10592732|NCT01786252|11748982|FG000|NOT COMPLETED|Overall Study||0
10592733|NCT01786252|11748983|FG001|NOT COMPLETED|Overall Study||0
10592734|NCT01786330|11748991|FG000|STARTED|Overall Study||30
10592735|NCT01786330|11748992|FG001|STARTED|Overall Study||30
10592736|NCT01786330|11748991|FG000|COMPLETED|Overall Study||29
10592737|NCT01786330|11748992|FG001|COMPLETED|Overall Study||27
10592738|NCT01786330|11748991|FG000|NOT COMPLETED|Overall Study||1
10592739|NCT01786330|11748992|FG001|NOT COMPLETED|Overall Study||3
10592740|NCT01786343|11749000|FG000|STARTED|Overall Study||28
10592741|NCT01786343|11749001|FG001|STARTED|Overall Study||46
10592742|NCT01786343|11749000|FG000|COMPLETED|Overall Study||28
10592743|NCT01786343|11749001|FG001|COMPLETED|Overall Study||46
10592744|NCT01786343|11749000|FG000|NOT COMPLETED|Overall Study||0
10592745|NCT01786343|11749001|FG001|NOT COMPLETED|Overall Study||0
10592746|NCT01786512|11749018|FG000|STARTED|Overall Study||11
10592747|NCT01786512|11749019|FG001|STARTED|Overall Study||11
10592748|NCT01786512|11749020|FG002|STARTED|Overall Study||14
10592749|NCT01786512|11749021|FG003|STARTED|Overall Study||13
10592750|NCT01786512|11749022|FG004|STARTED|Overall Study||10
10592751|NCT01786512|11749023|FG005|STARTED|Overall Study||11
10592752|NCT01786512|11749024|FG006|STARTED|Overall Study||12
10592753|NCT01786512|11749025|FG007|STARTED|Overall Study||14
10592754|NCT01786512|11749026|FG008|STARTED|Overall Study||149
10592755|NCT01786512|11749027|FG009|STARTED|Overall Study||150
10592756|NCT01786512|11749028|FG010|STARTED|Overall Study||149
10592757|NCT01786512|11749018|FG000|Received Study Treatment|Overall Study||11
10592758|NCT01786512|11749019|FG001|Received Study Treatment|Overall Study||10
10592759|NCT01786512|11749020|FG002|Received Study Treatment|Overall Study||14
10592760|NCT01786512|11749021|FG003|Received Study Treatment|Overall Study||13
10592761|NCT01786512|11749022|FG004|Received Study Treatment|Overall Study||10
10592762|NCT01786512|11749023|FG005|Received Study Treatment|Overall Study||11
10592763|NCT01786512|11749024|FG006|Received Study Treatment|Overall Study||11
10592764|NCT01786512|11749025|FG007|Received Study Treatment|Overall Study||14
10592765|NCT01786512|11749026|FG008|Received Study Treatment|Overall Study||149
10592766|NCT01786512|11749027|FG009|Received Study Treatment|Overall Study||150
10592767|NCT01786512|11749028|FG010|Received Study Treatment|Overall Study||146
10592768|NCT01786512|11749018|FG000|COMPLETED|Overall Study||11
10592769|NCT01786512|11749019|FG001|COMPLETED|Overall Study||10
10592770|NCT01786512|11749020|FG002|COMPLETED|Overall Study||14
10592771|NCT01786512|11749021|FG003|COMPLETED|Overall Study||13
10592772|NCT01786512|11749022|FG004|COMPLETED|Overall Study||10
10592773|NCT01786512|11749023|FG005|COMPLETED|Overall Study||11
10592774|NCT01786512|11749024|FG006|COMPLETED|Overall Study||11
10592775|NCT01786512|11749025|FG007|COMPLETED|Overall Study||14
10592776|NCT01786512|11749026|FG008|COMPLETED|Overall Study||145
10592777|NCT01786512|11749027|FG009|COMPLETED|Overall Study||145
10592778|NCT01786512|11749028|FG010|COMPLETED|Overall Study||137
10592779|NCT01786512|11749018|FG000|NOT COMPLETED|Overall Study||0
10592780|NCT01786512|11749019|FG001|NOT COMPLETED|Overall Study||1
10592781|NCT01786512|11749020|FG002|NOT COMPLETED|Overall Study||0
10592782|NCT01786512|11749021|FG003|NOT COMPLETED|Overall Study||0
10592783|NCT01786512|11749022|FG004|NOT COMPLETED|Overall Study||0
10592784|NCT01786512|11749023|FG005|NOT COMPLETED|Overall Study||0
10592785|NCT01786512|11749024|FG006|NOT COMPLETED|Overall Study||1
10592786|NCT01786512|11749025|FG007|NOT COMPLETED|Overall Study||0
10592787|NCT01786512|11749026|FG008|NOT COMPLETED|Overall Study||4
10592788|NCT01786512|11749027|FG009|NOT COMPLETED|Overall Study||5
10592789|NCT01786512|11749028|FG010|NOT COMPLETED|Overall Study||12
10592790|NCT01786551|11749060|FG000|STARTED|Overall Study||16
10592791|NCT01786551|11749060|FG000|COMPLETED|Overall Study||14
10592792|NCT01786551|11749060|FG000|NOT COMPLETED|Overall Study||2
10592793|NCT01786564|11749064|FG000|STARTED|Overall Study||120
10592794|NCT01786564|11749064|FG000|COMPLETED|Overall Study||56
10592795|NCT01786564|11749064|FG000|NOT COMPLETED|Overall Study||64
10592796|NCT01786603|11749070|FG000|STARTED|Overall Study||60
10592797|NCT01786603|11749071|FG001|STARTED|Overall Study||20
10592798|NCT01786603|11749070|FG000|COMPLETED|Overall Study||42
10592799|NCT01786603|11749071|FG001|COMPLETED|Overall Study||8
10592800|NCT01786603|11749070|FG000|NOT COMPLETED|Overall Study||18
10592801|NCT01786603|11749071|FG001|NOT COMPLETED|Overall Study||12
10592802|NCT01786629|11749079|FG000|STARTED|Overall Study||169
10592803|NCT01786629|11749080|FG001|STARTED|Overall Study||169
10592804|NCT01786629|11749079|FG000|COMPLETED|Overall Study||169
10592805|NCT01786629|11749080|FG001|COMPLETED|Overall Study||164
10592806|NCT01786629|11749079|FG000|NOT COMPLETED|Overall Study||0
10592807|NCT01786629|11749080|FG001|NOT COMPLETED|Overall Study||5
10592808|NCT01786668|11749090|FG000|STARTED|Overall Study||52
10592809|NCT01786668|11749091|FG001|STARTED|Overall Study||52
10592810|NCT01786668|11749092|FG002|STARTED|Overall Study||52
10592811|NCT01786668|11749093|FG003|STARTED|Overall Study||51
10592812|NCT01786668|11749090|FG000|COMPLETED|Overall Study||51
10592813|NCT01786668|11749091|FG001|COMPLETED|Overall Study||51
10592814|NCT01786668|11749092|FG002|COMPLETED|Overall Study||47
10592815|NCT01786668|11749093|FG003|COMPLETED|Overall Study||47
10592816|NCT01786668|11749090|FG000|NOT COMPLETED|Overall Study||1
10592817|NCT01786668|11749091|FG001|NOT COMPLETED|Overall Study||1
10592818|NCT01786668|11749092|FG002|NOT COMPLETED|Overall Study||5
10592819|NCT01786668|11749093|FG003|NOT COMPLETED|Overall Study||4
10592820|NCT01786707|11749105|FG000|STARTED|Overall Study||1
10592821|NCT01786707|11749106|FG001|STARTED|Overall Study||1
10592822|NCT01786707|11749105|FG000|COMPLETED|Overall Study||0
10592823|NCT01786707|11749106|FG001|COMPLETED|Overall Study||0
10592824|NCT01786707|11749105|FG000|NOT COMPLETED|Overall Study||1
10592825|NCT01786707|11749106|FG001|NOT COMPLETED|Overall Study||1
10592826|NCT01786876|11749112|FG000|STARTED|Overall Study||6
10592827|NCT01786876|11749112|FG000|COMPLETED|Overall Study||6
10592828|NCT01786876|11749112|FG000|NOT COMPLETED|Overall Study||0
10592829|NCT01786902|11749118|FG000|STARTED|Overall Study||36
10592830|NCT01786902|11749119|FG001|STARTED|Overall Study||34
10592831|NCT01786902|11749118|FG000|COMPLETED|Overall Study||32
10592832|NCT01786902|11749119|FG001|COMPLETED|Overall Study||31
10592833|NCT01786902|11749118|FG000|NOT COMPLETED|Overall Study||4
10592834|NCT01786902|11749119|FG001|NOT COMPLETED|Overall Study||3
10592835|NCT01786954|11749125|FG000|STARTED|Overall Study||34
10592836|NCT01786954|11749126|FG001|STARTED|Overall Study||34
10592837|NCT01786954|11749125|FG000|COMPLETED|Overall Study||34
10592838|NCT01786954|11749126|FG001|COMPLETED|Overall Study||34
10592839|NCT01786954|11749125|FG000|NOT COMPLETED|Overall Study||0
10703548|NCT02584855|11867985|FG001|NOT COMPLETED|Post Treatment Follow-up Period||0
10703549|NCT02584855|11867986|FG002|NOT COMPLETED|Post Treatment Follow-up Period||0
10703550|NCT02584855|11867987|FG003|NOT COMPLETED|Post Treatment Follow-up Period||0
10703551|NCT02584855|11867988|FG004|NOT COMPLETED|Post Treatment Follow-up Period||8
10703552|NCT02584855|11867989|FG005|NOT COMPLETED|Post Treatment Follow-up Period||0
10703553|NCT02584868|11868004|FG000|STARTED|Overall Study||44
10592840|NCT01786954|11749126|FG001|NOT COMPLETED|Overall Study||0
10592841|NCT01786967|11749136|FG000|STARTED|Overall Study||61
10592842|NCT01786967|11749136|FG000|Extensive Metabolizers|Overall Study||54
10592843|NCT01786967|11749136|FG000|Poor Metabolizers|Overall Study||4
10592844|NCT01786967|11749136|FG000|Metabolizer Status Undetermined|Overall Study||3
10592845|NCT01786967|11749136|FG000|COMPLETED|Overall Study||61
10592846|NCT01786967|11749136|FG000|NOT COMPLETED|Overall Study||0
10592847|NCT01786993|11749147|FG000|STARTED|Overall Study||201
10592848|NCT01786993|11749148|FG001|STARTED|Overall Study||180
10592849|NCT01786993|11749147|FG000|Per Protocol Population at 9 Months|Overall Study||189
10592850|NCT01786993|11749148|FG001|Per Protocol Population at 9 Months|Overall Study||170
10592851|NCT01786993|11749147|FG000|COMPLETED|Overall Study||189
10592852|NCT01786993|11749148|FG001|COMPLETED|Overall Study||170
10592853|NCT01786993|11749147|FG000|NOT COMPLETED|Overall Study||12
10592854|NCT01786993|11749148|FG001|NOT COMPLETED|Overall Study||10
10592855|NCT01787006|11749157|FG000|STARTED|Overall Study||35
10592856|NCT01787006|11749158|FG001|STARTED|Overall Study||39
10592857|NCT01787006|11749157|FG000|COMPLETED|Overall Study||32
10592858|NCT01787006|11749158|FG001|COMPLETED|Overall Study||36
10592859|NCT01787006|11749157|FG000|NOT COMPLETED|Overall Study||3
10592860|NCT01787006|11749158|FG001|NOT COMPLETED|Overall Study||3
10592861|NCT01787032|11749170|FG000|STARTED|Overall Study||3
10592862|NCT01787032|11749171|FG001|STARTED|Overall Study||3
10592863|NCT01787032|11749172|FG002|STARTED|Overall Study||3
10592864|NCT01787032|11749173|FG003|STARTED|Overall Study||3
10592865|NCT01787032|11749174|FG004|STARTED|Overall Study||4
10592866|NCT01787032|11749175|FG005|STARTED|Overall Study||4
10592867|NCT01787032|11749170|FG000|Received R|Overall Study||3
10592868|NCT01787032|11749171|FG001|Received R|Overall Study||3
10592869|NCT01787032|11749172|FG002|Received R|Overall Study||3
10592870|NCT01787032|11749173|FG003|Received R|Overall Study||3
10592871|NCT01787032|11749174|FG004|Received R|Overall Study||4
10592872|NCT01787032|11749175|FG005|Received R|Overall Study||3
10592873|NCT01787032|11749170|FG000|Received T1|Overall Study||3
10703554|NCT02584868|11868005|FG001|STARTED|Overall Study||44
10703555|NCT02584868|11868004|FG000|COMPLETED|Overall Study||44
10703556|NCT02584868|11868005|FG001|COMPLETED|Overall Study||44
10592874|NCT01787032|11749171|FG001|Received T1|Overall Study||3
10592875|NCT01787032|11749172|FG002|Received T1|Overall Study||3
10592876|NCT01787032|11749173|FG003|Received T1|Overall Study||3
10592877|NCT01787032|11749174|FG004|Received T1|Overall Study||3
10592878|NCT01787032|11749175|FG005|Received T1|Overall Study||4
10592879|NCT01787032|11749170|FG000|Received T2|Overall Study||3
10592880|NCT01787032|11749171|FG001|Received T2|Overall Study||3
10592881|NCT01787032|11749172|FG002|Received T2|Overall Study||3
10592882|NCT01787032|11749173|FG003|Received T2|Overall Study||3
10592883|NCT01787032|11749174|FG004|Received T2|Overall Study||4
10592884|NCT01787032|11749175|FG005|Received T2|Overall Study||4
10592885|NCT01787032|11749170|FG000|COMPLETED|Overall Study||3
10592886|NCT01787032|11749171|FG001|COMPLETED|Overall Study||3
10592887|NCT01787032|11749172|FG002|COMPLETED|Overall Study||3
10592888|NCT01787032|11749173|FG003|COMPLETED|Overall Study||3
10592889|NCT01787032|11749174|FG004|COMPLETED|Overall Study||3
10592890|NCT01787032|11749175|FG005|COMPLETED|Overall Study||3
10592891|NCT01787032|11749170|FG000|NOT COMPLETED|Overall Study||0
10592892|NCT01787032|11749171|FG001|NOT COMPLETED|Overall Study||0
10592893|NCT01787032|11749172|FG002|NOT COMPLETED|Overall Study||0
10592894|NCT01787032|11749173|FG003|NOT COMPLETED|Overall Study||0
10592895|NCT01787032|11749174|FG004|NOT COMPLETED|Overall Study||1
10592896|NCT01787032|11749175|FG005|NOT COMPLETED|Overall Study||1
10592897|NCT01787097|11749185|FG000|STARTED|Overall Study|Study started in 2012/2013|8
10592898|NCT01787097|11749186|FG001|STARTED|Overall Study||7
10592899|NCT01787097|11749187|FG002|STARTED|Overall Study||7
10592900|NCT01787097|11749188|FG003|STARTED|Overall Study||9
10592901|NCT01787097|11749185|FG000|COMPLETED|Overall Study|Study completed|7
10592902|NCT01787097|11749186|FG001|COMPLETED|Overall Study||7
10592903|NCT01787097|11749187|FG002|COMPLETED|Overall Study||7
10592904|NCT01787097|11749188|FG003|COMPLETED|Overall Study||9
10592905|NCT01787097|11749185|FG000|NOT COMPLETED|Overall Study||1
10592906|NCT01787097|11749186|FG001|NOT COMPLETED|Overall Study||0
10592907|NCT01787097|11749187|FG002|NOT COMPLETED|Overall Study||0
10592908|NCT01787097|11749188|FG003|NOT COMPLETED|Overall Study||0
10592909|NCT01787175|11749210|FG000|STARTED|Overall Study||30
10592910|NCT01787175|11749211|FG001|STARTED|Overall Study||28
10592911|NCT01787175|11749210|FG000|COMPLETED|Overall Study||30
10592912|NCT01787175|11749211|FG001|COMPLETED|Overall Study||28
10592913|NCT01787175|11749210|FG000|NOT COMPLETED|Overall Study||0
10592914|NCT01787175|11749211|FG001|NOT COMPLETED|Overall Study||0
10592915|NCT01787188|11749220|FG000|STARTED|Overall Study||139
10592916|NCT01787188|11749221|FG001|STARTED|Overall Study||130
10592917|NCT01787188|11749222|FG002|STARTED|Overall Study||134
10592918|NCT01787188|11749220|FG000|COMPLETED|Overall Study||122
10592919|NCT01787188|11749221|FG001|COMPLETED|Overall Study||112
10592920|NCT01787188|11749222|FG002|COMPLETED|Overall Study||116
10592921|NCT01787188|11749220|FG000|NOT COMPLETED|Overall Study||17
10592922|NCT01787188|11749221|FG001|NOT COMPLETED|Overall Study||18
10592923|NCT01787188|11749222|FG002|NOT COMPLETED|Overall Study||18
10592924|NCT01787240|11749232|FG000|STARTED|Overall Study||15
10592925|NCT01787240|11749233|FG001|STARTED|Overall Study||5
10592926|NCT01787240|11749232|FG000|COMPLETED|Overall Study||10
10592927|NCT01787240|11749233|FG001|COMPLETED|Overall Study||4
10592928|NCT01787240|11749232|FG000|NOT COMPLETED|Overall Study||5
10592929|NCT01787240|11749233|FG001|NOT COMPLETED|Overall Study||1
10592930|NCT01787279|11749242|FG000|STARTED|Overall Study||59
10592931|NCT01787279|11749242|FG000|COMPLETED|Overall Study||56
10592932|NCT01787279|11749242|FG000|NOT COMPLETED|Overall Study||3
10592933|NCT01787292|11749246|FG000|STARTED|Crossover Exercise Interventions|Participants in this group performed aerobic training prior to cross-over to balance training.|17
10592934|NCT01787292|11749247|FG001|STARTED|Crossover Exercise Interventions|Participants in this group performed balance training prior to cross-over to aerobic training.|16
10592935|NCT01787292|11749246|FG000|COMPLETED|Crossover Exercise Interventions|Participants completed the 12-week in-house program and cross-over into the balance program.|15
10592936|NCT01787292|11749247|FG001|COMPLETED|Crossover Exercise Interventions|These participants completed the 12-week in-house program and cross-over into the balance program.|14
10592937|NCT01787292|11749246|FG000|NOT COMPLETED|Crossover Exercise Interventions||2
10592938|NCT01787292|11749247|FG001|NOT COMPLETED|Crossover Exercise Interventions||2
10592939|NCT01787292|11749246|FG000|STARTED|Home Based Exercise Program||15
10592940|NCT01787292|11749247|FG001|STARTED|Home Based Exercise Program||14
10592941|NCT01787292|11749246|FG000|COMPLETED|Home Based Exercise Program||12
10592942|NCT01787292|11749247|FG001|COMPLETED|Home Based Exercise Program||13
10592943|NCT01787292|11749246|FG000|NOT COMPLETED|Home Based Exercise Program||3
10592944|NCT01787292|11749247|FG001|NOT COMPLETED|Home Based Exercise Program||1
10592945|NCT01787331|11749258|FG000|STARTED|Overall Study||21
10592946|NCT01787331|11749258|FG000|COMPLETED|Overall Study||19
10592947|NCT01787331|11749258|FG000|NOT COMPLETED|Overall Study||2
10703557|NCT02584868|11868004|FG000|NOT COMPLETED|Overall Study||0
10703558|NCT02584868|11868005|FG001|NOT COMPLETED|Overall Study||0
10703559|NCT02584959|11868014|FG000|STARTED|Period 1||31
10592948|NCT01787383|11749264|FG000|STARTED|Overall Study||101
10592949|NCT01787383|11749265|FG001|STARTED|Overall Study||98
10592950|NCT01787383|11749264|FG000|COMPLETED|Overall Study||92
10703560|NCT02584959|11868015|FG001|STARTED|Period 1||29
10592951|NCT01787383|11749265|FG001|COMPLETED|Overall Study||76
10592952|NCT01787383|11749264|FG000|NOT COMPLETED|Overall Study||9
10592953|NCT01787383|11749265|FG001|NOT COMPLETED|Overall Study||22
10592954|NCT01787461|11749281|FG000|STARTED|Overall Study||96
10592955|NCT01787461|11749282|FG001|STARTED|Overall Study||98
10592956|NCT01787461|11749281|FG000|COMPLETED|Overall Study||82
10592957|NCT01787461|11749282|FG001|COMPLETED|Overall Study||89
10592958|NCT01787461|11749281|FG000|NOT COMPLETED|Overall Study||14
10592959|NCT01787461|11749282|FG001|NOT COMPLETED|Overall Study||9
10592960|NCT01787591|11749290|FG000|STARTED|Period 1 (Cross-over Arm 1)||5
10592961|NCT01787591|11749291|FG001|STARTED|Period 1 (Cross-over Arm 1)||5
10592962|NCT01787591|11749292|FG002|STARTED|Period 1 (Cross-over Arm 1)||5
10592963|NCT01787591|11749293|FG003|STARTED|Period 1 (Cross-over Arm 1)||6
10592964|NCT01787591|11749290|FG000|COMPLETED|Period 1 (Cross-over Arm 1)||5
10592965|NCT01787591|11749291|FG001|COMPLETED|Period 1 (Cross-over Arm 1)||5
10592966|NCT01787591|11749292|FG002|COMPLETED|Period 1 (Cross-over Arm 1)||5
10592967|NCT01787591|11749293|FG003|COMPLETED|Period 1 (Cross-over Arm 1)||5
10592968|NCT01787591|11749290|FG000|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
10592969|NCT01787591|11749291|FG001|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
10592970|NCT01787591|11749292|FG002|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
10592971|NCT01787591|11749293|FG003|NOT COMPLETED|Period 1 (Cross-over Arm 1)||1
10592972|NCT01787591|11749290|FG000|STARTED|Period 2 (Cross-over Arm 2)||5
10592973|NCT01787591|11749291|FG001|STARTED|Period 2 (Cross-over Arm 2)||5
10592974|NCT01787591|11749292|FG002|STARTED|Period 2 (Cross-over Arm 2)||5
10592975|NCT01787591|11749293|FG003|STARTED|Period 2 (Cross-over Arm 2)||5
10592976|NCT01787591|11749290|FG000|COMPLETED|Period 2 (Cross-over Arm 2)||5
10592977|NCT01787591|11749291|FG001|COMPLETED|Period 2 (Cross-over Arm 2)||5
10592978|NCT01787591|11749292|FG002|COMPLETED|Period 2 (Cross-over Arm 2)||5
10592979|NCT01787591|11749293|FG003|COMPLETED|Period 2 (Cross-over Arm 2)||5
10592980|NCT01787591|11749290|FG000|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
10592981|NCT01787591|11749291|FG001|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
10592982|NCT01787591|11749292|FG002|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
10592983|NCT01787591|11749293|FG003|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
10592984|NCT01787591|11749290|FG000|STARTED|Period 3 (Cross-over Arm 3)||5
10592985|NCT01787591|11749291|FG001|STARTED|Period 3 (Cross-over Arm 3)||5
10592986|NCT01787591|11749292|FG002|STARTED|Period 3 (Cross-over Arm 3)||5
10592987|NCT01787591|11749293|FG003|STARTED|Period 3 (Cross-over Arm 3)||5
10592988|NCT01787591|11749290|FG000|COMPLETED|Period 3 (Cross-over Arm 3)||5
10592989|NCT01787591|11749291|FG001|COMPLETED|Period 3 (Cross-over Arm 3)||5
10592990|NCT01787591|11749292|FG002|COMPLETED|Period 3 (Cross-over Arm 3)||5
10592991|NCT01787591|11749293|FG003|COMPLETED|Period 3 (Cross-over Arm 3)||5
10592992|NCT01787591|11749290|FG000|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
10592993|NCT01787591|11749291|FG001|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
10592994|NCT01787591|11749292|FG002|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
10592995|NCT01787591|11749293|FG003|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
10592996|NCT01787591|11749290|FG000|STARTED|Period 4 (Cross-over Arm 4)||5
10592997|NCT01787591|11749291|FG001|STARTED|Period 4 (Cross-over Arm 4)||5
10592998|NCT01787591|11749292|FG002|STARTED|Period 4 (Cross-over Arm 4)||5
10592999|NCT01787591|11749293|FG003|STARTED|Period 4 (Cross-over Arm 4)||5
10593000|NCT01787591|11749290|FG000|COMPLETED|Period 4 (Cross-over Arm 4)||5
10593001|NCT01787591|11749291|FG001|COMPLETED|Period 4 (Cross-over Arm 4)||5
10593002|NCT01787591|11749292|FG002|COMPLETED|Period 4 (Cross-over Arm 4)||5
10593003|NCT01787591|11749293|FG003|COMPLETED|Period 4 (Cross-over Arm 4)||5
10593004|NCT01787591|11749290|FG000|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
10593005|NCT01787591|11749291|FG001|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
10593006|NCT01787591|11749292|FG002|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
10593007|NCT01787591|11749293|FG003|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
10593008|NCT01787604|11749306|FG000|STARTED|Overall Study||32
10593009|NCT01787604|11749307|FG001|STARTED|Overall Study||32
10593010|NCT01787604|11749306|FG000|COMPLETED|Overall Study||28
10593011|NCT01787604|11749307|FG001|COMPLETED|Overall Study||28
10593012|NCT01787604|11749306|FG000|NOT COMPLETED|Overall Study||4
10593013|NCT01787604|11749307|FG001|NOT COMPLETED|Overall Study||4
10593014|NCT01787760|11749316|FG000|STARTED|Overall Study||51
10593015|NCT01787760|11749317|FG001|STARTED|Overall Study||50
10593016|NCT01787760|11749318|FG002|STARTED|Overall Study||51
10593017|NCT01787760|11749316|FG000|COMPLETED|Overall Study||25
10593018|NCT01787760|11749317|FG001|COMPLETED|Overall Study||34
10593019|NCT01787760|11749318|FG002|COMPLETED|Overall Study||46
10593020|NCT01787760|11749316|FG000|NOT COMPLETED|Overall Study||26
10593021|NCT01787760|11749317|FG001|NOT COMPLETED|Overall Study||16
10593022|NCT01787760|11749318|FG002|NOT COMPLETED|Overall Study||5
10593023|NCT01787799|11749327|FG000|STARTED|Overall Study||100
10593024|NCT01787799|11749327|FG000|COMPLETED|Overall Study||100
10593025|NCT01787799|11749327|FG000|NOT COMPLETED|Overall Study||0
10593026|NCT01787825|11749331|FG000|STARTED|Overall Study||60
10593027|NCT01787825|11749332|FG001|STARTED|Overall Study||61
10593028|NCT01787825|11749331|FG000|COMPLETED|Overall Study||54
10593029|NCT01787825|11749332|FG001|COMPLETED|Overall Study||60
10593030|NCT01787825|11749331|FG000|NOT COMPLETED|Overall Study||6
10593031|NCT01787825|11749332|FG001|NOT COMPLETED|Overall Study||1
10593032|NCT01787838|11749339|FG000|STARTED|Overall Study|This is the number who met Centers for Disease Control and Prevention guidelines for vaccine.|2509
10593033|NCT01787838|11749339|FG000|COMPLETED|Overall Study|This is the number of patients successfully immunized in a one year period.|1096
10593034|NCT01787838|11749339|FG000|NOT COMPLETED|Overall Study||1413
10593035|NCT01787916|11749343|FG000|STARTED|First Intervention (24 Weeks)||8
10593036|NCT01787916|11749344|FG001|STARTED|First Intervention (24 Weeks)||7
10593037|NCT01787916|11749343|FG000|COMPLETED|First Intervention (24 Weeks)||8
10593038|NCT01787916|11749344|FG001|COMPLETED|First Intervention (24 Weeks)||7
10593039|NCT01787916|11749343|FG000|NOT COMPLETED|First Intervention (24 Weeks)||0
10593040|NCT01787916|11749344|FG001|NOT COMPLETED|First Intervention (24 Weeks)||0
10593041|NCT01787916|11749343|FG000|STARTED|Washout (4 Weeks)||8
10593042|NCT01787916|11749344|FG001|STARTED|Washout (4 Weeks)||7
10593043|NCT01787916|11749343|FG000|COMPLETED|Washout (4 Weeks)||8
10593044|NCT01787916|11749344|FG001|COMPLETED|Washout (4 Weeks)||7
10593045|NCT01787916|11749343|FG000|NOT COMPLETED|Washout (4 Weeks)||0
10593046|NCT01787916|11749344|FG001|NOT COMPLETED|Washout (4 Weeks)||0
10593047|NCT01787916|11749343|FG000|STARTED|Second Intervention (24 Weeks)||8
10593048|NCT01787916|11749344|FG001|STARTED|Second Intervention (24 Weeks)||7
10593049|NCT01787916|11749343|FG000|COMPLETED|Second Intervention (24 Weeks)||8
10593050|NCT01787916|11749344|FG001|COMPLETED|Second Intervention (24 Weeks)||7
10593051|NCT01787916|11749343|FG000|NOT COMPLETED|Second Intervention (24 Weeks)||0
10593052|NCT01787916|11749344|FG001|NOT COMPLETED|Second Intervention (24 Weeks)||0
10593053|NCT01788046|11749352|FG000|STARTED|Overall Study||260
10593054|NCT01788046|11749353|FG001|STARTED|Overall Study||255
10593055|NCT01788046|11749352|FG000|Received Treatment|Overall Study||259
10593056|NCT01788046|11749353|FG001|Received Treatment|Overall Study||252
10593057|NCT01788046|11749352|FG000|COMPLETED|Overall Study||204
10593058|NCT01788046|11749353|FG001|COMPLETED|Overall Study||218
10593059|NCT01788046|11749352|FG000|NOT COMPLETED|Overall Study||56
10593060|NCT01788046|11749353|FG001|NOT COMPLETED|Overall Study||37
10593061|NCT01788150|11749361|FG000|STARTED|Overall Study||108
10593062|NCT01788150|11749362|FG001|STARTED|Overall Study||51
10593063|NCT01788150|11749361|FG000|COMPLETED|Overall Study||95
10593064|NCT01788150|11749362|FG001|COMPLETED|Overall Study||48
10593065|NCT01788150|11749361|FG000|NOT COMPLETED|Overall Study||13
10593066|NCT01788150|11749362|FG001|NOT COMPLETED|Overall Study||3
10593067|NCT01788163|11749377|FG000|STARTED|Overall Study||1458
10593068|NCT01788163|11749378|FG001|STARTED|Overall Study||271
10593069|NCT01788163|11749379|FG002|STARTED|Overall Study||62
10593070|NCT01788163|11749380|FG003|STARTED|Overall Study||71
10593071|NCT01788163|11749381|FG004|STARTED|Overall Study||94
10593072|NCT01788163|11749382|FG005|STARTED|Overall Study||102
10593073|NCT01788163|11749383|FG006|STARTED|Overall Study||50
10593074|NCT01788163|11749384|FG007|STARTED|Overall Study||302
10593075|NCT01788163|11749385|FG008|STARTED|Overall Study||972
10593076|NCT01788163|11749377|FG000|COMPLETED|Overall Study||1403
10593077|NCT01788163|11749378|FG001|COMPLETED|Overall Study||271
10593078|NCT01788163|11749379|FG002|COMPLETED|Overall Study||62
10593079|NCT01788163|11749380|FG003|COMPLETED|Overall Study||71
10593080|NCT01788163|11749381|FG004|COMPLETED|Overall Study||94
10593081|NCT01788163|11749382|FG005|COMPLETED|Overall Study||95
10593082|NCT01788163|11749383|FG006|COMPLETED|Overall Study||49
10593083|NCT01788163|11749384|FG007|COMPLETED|Overall Study||254
10593084|NCT01788163|11749385|FG008|COMPLETED|Overall Study||956
10593085|NCT01788163|11749377|FG000|NOT COMPLETED|Overall Study||55
10593086|NCT01788163|11749378|FG001|NOT COMPLETED|Overall Study||0
10593087|NCT01788163|11749379|FG002|NOT COMPLETED|Overall Study||0
10593088|NCT01788163|11749380|FG003|NOT COMPLETED|Overall Study||0
10593089|NCT01788163|11749381|FG004|NOT COMPLETED|Overall Study||0
10593090|NCT01788163|11749382|FG005|NOT COMPLETED|Overall Study||7
10593091|NCT01788163|11749383|FG006|NOT COMPLETED|Overall Study||1
10593092|NCT01788163|11749384|FG007|NOT COMPLETED|Overall Study||48
10593093|NCT01788163|11749385|FG008|NOT COMPLETED|Overall Study||16
10593094|NCT01788215|11749466|FG000|STARTED|Overall Study||5
10593095|NCT01788215|11749467|FG001|STARTED|Overall Study||5
10593096|NCT01788215|11749466|FG000|12 Weeks of Doxycycline or Placebo|Overall Study||5
10593097|NCT01788215|11749467|FG001|12 Weeks of Doxycycline or Placebo|Overall Study||5
10593098|NCT01788215|11749466|FG000|COMPLETED|Overall Study||3
10593099|NCT01788215|11749467|FG001|COMPLETED|Overall Study||4
10593100|NCT01788215|11749466|FG000|NOT COMPLETED|Overall Study||2
10593101|NCT01788215|11749467|FG001|NOT COMPLETED|Overall Study||1
10593102|NCT01788228|11749475|FG000|STARTED|Overall Study||49
10593103|NCT01788228|11749476|FG001|STARTED|Overall Study||1
10593104|NCT01788228|11749475|FG000|COMPLETED|Overall Study||48
10593105|NCT01788228|11749476|FG001|COMPLETED|Overall Study||1
10593106|NCT01788228|11749475|FG000|NOT COMPLETED|Overall Study||1
10593107|NCT01788228|11749476|FG001|NOT COMPLETED|Overall Study||0
10593108|NCT01788358|11749485|FG000|STARTED|Overall Study||508
10593109|NCT01788358|11749485|FG000|Treated|Overall Study||508
10593110|NCT01788358|11749485|FG000|Completed Week 28|Overall Study||417
10593111|NCT01788358|11749485|FG000|Entered Extension to Week 52|Overall Study|Only the first 200 subjects who completed Week 28 visit, continued treatment up to 52 weeks.|200
10593112|NCT01788358|11749485|FG000|Completed Week 52|Overall Study||193
10593113|NCT01788358|11749485|FG000|COMPLETED|Overall Study|217 subjects completed the study at Week 28 while the remaining 193 subjects completed at Week 52|410
10593114|NCT01788358|11749485|FG000|NOT COMPLETED|Overall Study||98
10593115|NCT01788423|11749492|FG000|STARTED|Overall Study||53
10593116|NCT01788423|11749493|FG001|STARTED|Overall Study||55
10593117|NCT01788423|11749494|FG002|STARTED|Overall Study||55
10593118|NCT01788423|11749492|FG000|COMPLETED|Overall Study||53
10593119|NCT01788423|11749493|FG001|COMPLETED|Overall Study|Four participants were unable to self-select hearing aids.|51
10652108|NCT02181673|11812452|FG001|STARTED|Up to Week 24||0
10593120|NCT01788423|11749494|FG002|COMPLETED|Overall Study|Three people developed unrelated health problems and two were unable to fit/use hearing aids.|50
10593121|NCT01788423|11749492|FG000|NOT COMPLETED|Overall Study||0
10593122|NCT01788423|11749493|FG001|NOT COMPLETED|Overall Study||4
10593123|NCT01788423|11749494|FG002|NOT COMPLETED|Overall Study||5
10593124|NCT01788566|11749502|FG000|STARTED|Overall Study||61
10593125|NCT01788566|11749502|FG000|COMPLETED|Overall Study||53
10593126|NCT01788566|11749502|FG000|NOT COMPLETED|Overall Study||8
10593127|NCT01788631|11749508|FG000|STARTED|Overall Study||52
10593128|NCT01788631|11749509|FG001|STARTED|Overall Study||44
10593129|NCT01788631|11749508|FG000|Randomized|Overall Study||53
10593130|NCT01788631|11749509|FG001|Randomized|Overall Study||47
10593131|NCT01788631|11749508|FG000|COMPLETED|Overall Study||49
10593132|NCT01788631|11749509|FG001|COMPLETED|Overall Study||43
10593133|NCT01788631|11749508|FG000|NOT COMPLETED|Overall Study||3
10593134|NCT01788631|11749509|FG001|NOT COMPLETED|Overall Study||1
10593135|NCT01788943|11749517|FG000|STARTED|Overall Study|Recruitment for study began.|13
10593136|NCT01788943|11749518|FG001|STARTED|Overall Study||12
10593137|NCT01788943|11749517|FG000|COMPLETED|Overall Study|2FA-PET Brain Image Analysis Completion Date|12
10593138|NCT01788943|11749518|FG001|COMPLETED|Overall Study||12
10593139|NCT01788943|11749517|FG000|NOT COMPLETED|Overall Study||1
10593140|NCT01788943|11749518|FG001|NOT COMPLETED|Overall Study||0
10593141|NCT01789047|11749526|FG000|STARTED|Overall Study||21
10593142|NCT01789047|11749527|FG001|STARTED|Overall Study||21
10593143|NCT01789047|11749526|FG000|COMPLETED|Overall Study||17
10593144|NCT01789047|11749527|FG001|COMPLETED|Overall Study||17
10593145|NCT01789047|11749526|FG000|NOT COMPLETED|Overall Study||4
10593146|NCT01789047|11749527|FG001|NOT COMPLETED|Overall Study||4
10593147|NCT01789138|11749535|FG000|STARTED|Overall Study||254
10593148|NCT01789138|11749536|FG001|STARTED|Overall Study||258
10593149|NCT01789138|11749535|FG000|COMPLETED|Overall Study||213
10593150|NCT01789138|11749536|FG001|COMPLETED|Overall Study||206
10593151|NCT01789138|11749535|FG000|NOT COMPLETED|Overall Study||41
10593152|NCT01789138|11749536|FG001|NOT COMPLETED|Overall Study||52
10652109|NCT02181673|11812453|FG002|STARTED|Up to Week 24||241
10652110|NCT02181673|11812451|FG000|Treated|Up to Week 24||239
10652111|NCT02181673|11812452|FG001|Treated|Up to Week 24||0
10652112|NCT02181673|11812453|FG002|Treated|Up to Week 24||240
10652113|NCT02181673|11812451|FG000|COMPLETED|Up to Week 24||222
10652114|NCT02181673|11812452|FG001|COMPLETED|Up to Week 24||0
10652115|NCT02181673|11812453|FG002|COMPLETED|Up to Week 24||230
10652116|NCT02181673|11812451|FG000|NOT COMPLETED|Up to Week 24||17
10652117|NCT02181673|11812452|FG001|NOT COMPLETED|Up to Week 24||0
10652118|NCT02181673|11812453|FG002|NOT COMPLETED|Up to Week 24||11
10652119|NCT02181673|11812451|FG000|STARTED|Week 24-Week 60||0
10652120|NCT02181673|11812452|FG001|STARTED|Week 24-Week 60||222
10652121|NCT02181673|11812453|FG002|STARTED|Week 24-Week 60||230
10652122|NCT02181673|11812451|FG000|Treated|Week 24-Week 60||0
10652123|NCT02181673|11812452|FG001|Treated|Week 24-Week 60||220
10652124|NCT02181673|11812453|FG002|Treated|Week 24-Week 60||230
10652125|NCT02181673|11812451|FG000|COMPLETED|Week 24-Week 60||0
10652126|NCT02181673|11812452|FG001|COMPLETED|Week 24-Week 60||214
10807708|NCT03888469|11969432|FG000|COMPLETED|First Wear Period (8 -1/+2 Days)||46
10807709|NCT03888469|11969433|FG001|COMPLETED|First Wear Period (8 -1/+2 Days)||46
10807710|NCT03888469|11969432|FG000|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0
10807711|NCT03888469|11969433|FG001|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0
10807712|NCT03888469|11969432|FG000|STARTED|Second Wear Period (8 -1/+2 Days)||46
10807713|NCT03888469|11969433|FG001|STARTED|Second Wear Period (8 -1/+2 Days)||46
10807714|NCT03888469|11969432|FG000|COMPLETED|Second Wear Period (8 -1/+2 Days)||46
10807715|NCT03888469|11969433|FG001|COMPLETED|Second Wear Period (8 -1/+2 Days)||46
10807716|NCT03888469|11969432|FG000|NOT COMPLETED|Second Wear Period (8 -1/+2 Days)||0
10807717|NCT03888469|11969433|FG001|NOT COMPLETED|Second Wear Period (8 -1/+2 Days)||0
10807718|NCT03887442|11969443|FG000|STARTED|Overall Study||9
10807719|NCT03887442|11969444|FG001|STARTED|Overall Study||8
10807720|NCT03887442|11969443|FG000|COMPLETED|Overall Study||8
10652127|NCT02181673|11812453|FG002|COMPLETED|Week 24-Week 60||213
10652128|NCT02181673|11812451|FG000|NOT COMPLETED|Week 24-Week 60||0
10652129|NCT02181673|11812452|FG001|NOT COMPLETED|Week 24-Week 60||8
10652130|NCT02181673|11812453|FG002|NOT COMPLETED|Week 24-Week 60||17
10652131|NCT02181738|11812464|FG000|STARTED|Overall Study||63
10652132|NCT02181738|11812465|FG001|STARTED|Overall Study||80
10652133|NCT02181738|11812466|FG002|STARTED|Overall Study||100
10652134|NCT02181738|11812467|FG003|STARTED|Overall Study||51
10652135|NCT02181738|11812464|FG000|COMPLETED|Overall Study||61
10652136|NCT02181738|11812465|FG001|COMPLETED|Overall Study||71
10652137|NCT02181738|11812466|FG002|COMPLETED|Overall Study||90
10652138|NCT02181738|11812467|FG003|COMPLETED|Overall Study||49
10652139|NCT02181738|11812464|FG000|NOT COMPLETED|Overall Study||2
10652140|NCT02181738|11812465|FG001|NOT COMPLETED|Overall Study||9
10652141|NCT02181738|11812466|FG002|NOT COMPLETED|Overall Study||10
10652142|NCT02181738|11812467|FG003|NOT COMPLETED|Overall Study||2
10652143|NCT02181803|11812486|FG000|STARTED|Overall Study||1
10652144|NCT02181803|11812487|FG001|STARTED|Overall Study||13
10652145|NCT02181803|11812488|FG002|STARTED|Overall Study||4
10652146|NCT02181803|11812489|FG003|STARTED|Overall Study||13
10652147|NCT02181803|11812490|FG004|STARTED|Overall Study||6
10652148|NCT02181803|11812491|FG005|STARTED|Overall Study||6
10807721|NCT03887442|11969444|FG001|COMPLETED|Overall Study||8
10652149|NCT02181803|11812492|FG006|STARTED|Overall Study||9
10652150|NCT02181803|11812493|FG007|STARTED|Overall Study||1
10652151|NCT02181803|11812494|FG008|STARTED|Overall Study||2
10593153|NCT01789203|11749544|FG000|STARTED|Overall Study||133
10593154|NCT01789203|11749545|FG001|STARTED|Overall Study||67
10593155|NCT01789203|11749544|FG000|COMPLETED|Overall Study||124
10593156|NCT01789203|11749545|FG001|COMPLETED|Overall Study||63
10593157|NCT01789203|11749544|FG000|NOT COMPLETED|Overall Study||9
10593158|NCT01789203|11749545|FG001|NOT COMPLETED|Overall Study||4
10593159|NCT01789255|11749553|FG000|STARTED|Overall Study||12
10593160|NCT01789255|11749553|FG000|COMPLETED|Overall Study||12
10593161|NCT01789255|11749553|FG000|NOT COMPLETED|Overall Study||0
10593162|NCT01789281|11749559|FG000|STARTED|Overall Study||22
10593163|NCT01789281|11749560|FG001|STARTED|Overall Study||12
10593164|NCT01789281|11749559|FG000|COMPLETED|Overall Study||0
10593165|NCT01789281|11749560|FG001|COMPLETED|Overall Study||2
10593166|NCT01789281|11749559|FG000|NOT COMPLETED|Overall Study||22
10593167|NCT01789281|11749560|FG001|NOT COMPLETED|Overall Study||10
10593168|NCT01789320|11749567|FG000|STARTED|Overall Study||11
10593169|NCT01789320|11749567|FG000|COMPLETED|Overall Study||9
10703561|NCT02584959|11868016|FG002|STARTED|Period 1||15
10703562|NCT02584959|11868014|FG000|COMPLETED|Period 1||28
10593170|NCT01789320|11749567|FG000|NOT COMPLETED|Overall Study||2
10593171|NCT01789476|11749573|FG000|STARTED|Overall Study||34
10593172|NCT01789476|11749574|FG001|STARTED|Overall Study||17
10593173|NCT01789476|11749573|FG000|COMPLETED|Overall Study||26
10593174|NCT01789476|11749574|FG001|COMPLETED|Overall Study||15
10593175|NCT01789476|11749573|FG000|NOT COMPLETED|Overall Study||8
10593176|NCT01789476|11749574|FG001|NOT COMPLETED|Overall Study||2
10593177|NCT01789567|11749580|FG000|STARTED|Overall Study||20
10593178|NCT01789567|11749580|FG000|COMPLETED|Overall Study||14
10593179|NCT01789567|11749580|FG000|NOT COMPLETED|Overall Study||6
10593180|NCT01789606|11749586|FG000|STARTED|Overall Study||251
10593181|NCT01789606|11749587|FG001|STARTED|Overall Study||832
10593182|NCT01789606|11749586|FG000|COMPLETED|Overall Study||228
10593183|NCT01789606|11749587|FG001|COMPLETED|Overall Study||382
10593184|NCT01789606|11749586|FG000|NOT COMPLETED|Overall Study||23
10593185|NCT01789606|11749587|FG001|NOT COMPLETED|Overall Study||450
10593186|NCT01789775|11749594|FG000|STARTED|Overall Study||55
10593187|NCT01789775|11749595|FG001|STARTED|Overall Study||57
10593188|NCT01789775|11749594|FG000|COMPLETED|Overall Study||53
10593189|NCT01789775|11749595|FG001|COMPLETED|Overall Study||50
10593190|NCT01789775|11749594|FG000|NOT COMPLETED|Overall Study||2
10593191|NCT01789775|11749595|FG001|NOT COMPLETED|Overall Study||7
10593192|NCT01789814|11749603|FG000|STARTED|Overall Study||12
10593193|NCT01789814|11749604|FG001|STARTED|Overall Study||12
10593194|NCT01789814|11749603|FG000|COMPLETED|Overall Study||12
10593195|NCT01789814|11749604|FG001|COMPLETED|Overall Study||12
10593196|NCT01789814|11749603|FG000|NOT COMPLETED|Overall Study||0
10593197|NCT01789814|11749604|FG001|NOT COMPLETED|Overall Study||0
10593198|NCT01789840|11749612|FG000|STARTED|Overall Study||52
10456999|NCT01008553|11604732|FG001|NOT COMPLETED|Period 1 (Titration Period)||0
10457000|NCT01008553|11604733|FG002|NOT COMPLETED|Period 1 (Titration Period)||0
10457001|NCT01008553|11604731|FG000|STARTED|Period 2 (Double-Blind Period)||0
10457002|NCT01008553|11604732|FG001|STARTED|Period 2 (Double-Blind Period)||84
10457003|NCT01008553|11604733|FG002|STARTED|Period 2 (Double-Blind Period)||79
10457004|NCT01008553|11604731|FG000|COMPLETED|Period 2 (Double-Blind Period)||0
10593199|NCT01789840|11749613|FG001|STARTED|Overall Study||7
10593200|NCT01789840|11749612|FG000|COMPLETED|Overall Study||52
10593201|NCT01789840|11749613|FG001|COMPLETED|Overall Study||6
10593202|NCT01789840|11749612|FG000|NOT COMPLETED|Overall Study||0
10593203|NCT01789840|11749613|FG001|NOT COMPLETED|Overall Study||1
10593204|NCT01789905|11749621|FG000|STARTED|Overall Study||116
10593205|NCT01789905|11749621|FG000|COMPLETED|Overall Study||116
10593206|NCT01789905|11749621|FG000|NOT COMPLETED|Overall Study||0
10593207|NCT01789970|11749627|FG000|STARTED|Open-label Titration Period||625
10593208|NCT01789970|11749628|FG001|STARTED|Open-label Titration Period||0
10593209|NCT01789970|11749629|FG002|STARTED|Open-label Titration Period||0
10593210|NCT01789970|11749627|FG000|Safety Analysis Set|Open-label Titration Period|Two enrolled patients were not treated|623
10593211|NCT01789970|11749628|FG001|Safety Analysis Set|Open-label Titration Period||0
10593212|NCT01789970|11749629|FG002|Safety Analysis Set|Open-label Titration Period||0
10593213|NCT01789970|11749627|FG000|COMPLETED|Open-label Titration Period||371
10593214|NCT01789970|11749628|FG001|COMPLETED|Open-label Titration Period||0
10593215|NCT01789970|11749629|FG002|COMPLETED|Open-label Titration Period||0
10593216|NCT01789970|11749627|FG000|NOT COMPLETED|Open-label Titration Period||254
10593217|NCT01789970|11749628|FG001|NOT COMPLETED|Open-label Titration Period||0
10593218|NCT01789970|11749629|FG002|NOT COMPLETED|Open-label Titration Period||0
10593219|NCT01789970|11749627|FG000|STARTED|Double-blind Treatment Period (12 Weeks)||0
10593220|NCT01789970|11749628|FG001|STARTED|Double-blind Treatment Period (12 Weeks)||180
10593221|NCT01789970|11749629|FG002|STARTED|Double-blind Treatment Period (12 Weeks)||191
10457005|NCT01008553|11604732|FG001|COMPLETED|Period 2 (Double-Blind Period)||47
10457006|NCT01008553|11604733|FG002|COMPLETED|Period 2 (Double-Blind Period)||28
10457007|NCT01008553|11604731|FG000|NOT COMPLETED|Period 2 (Double-Blind Period)||0
10593222|NCT01789970|11749627|FG000|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)||0
10593223|NCT01789970|11749628|FG001|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)|One participant was randomized but not treated.|179
10703563|NCT02584959|11868015|FG001|COMPLETED|Period 1||25
10593224|NCT01789970|11749629|FG002|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)||191
10593225|NCT01789970|11749627|FG000|COMPLETED|Double-blind Treatment Period (12 Weeks)||0
10593226|NCT01789970|11749628|FG001|COMPLETED|Double-blind Treatment Period (12 Weeks)||130
10457008|NCT01008553|11604732|FG001|NOT COMPLETED|Period 2 (Double-Blind Period)||37
10593227|NCT01789970|11749629|FG002|COMPLETED|Double-blind Treatment Period (12 Weeks)||147
10593228|NCT01789970|11749627|FG000|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||0
10593229|NCT01789970|11749628|FG001|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||50
10593230|NCT01789970|11749629|FG002|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||44
10593231|NCT01790048|11749645|FG000|STARTED|Overall Study||1156
10593232|NCT01790048|11749646|FG001|STARTED|Overall Study||1103
10593233|NCT01790048|11749645|FG000|COMPLETED|Overall Study||1144
10593234|NCT01790048|11749646|FG001|COMPLETED|Overall Study||1086
10593235|NCT01790048|11749645|FG000|NOT COMPLETED|Overall Study||12
10593236|NCT01790048|11749646|FG001|NOT COMPLETED|Overall Study||17
10593237|NCT01790113|11749656|FG000|STARTED|Overall Study||79
10593238|NCT01790113|11749657|FG001|STARTED|Overall Study||224
10593239|NCT01790113|11749656|FG000|COMPLETED|Overall Study||76
10593240|NCT01790113|11749657|FG001|COMPLETED|Overall Study||149
10593241|NCT01790113|11749656|FG000|NOT COMPLETED|Overall Study||3
10593242|NCT01790113|11749657|FG001|NOT COMPLETED|Overall Study||75
10593243|NCT01790126|11749666|FG000|STARTED|Overall Study||30
10593244|NCT01790126|11749667|FG001|STARTED|Overall Study||29
10593245|NCT01790126|11749668|FG002|STARTED|Overall Study||31
10593246|NCT01790126|11749666|FG000|Treated|Overall Study||29
10593247|NCT01790126|11749667|FG001|Treated|Overall Study||29
10593248|NCT01790126|11749668|FG002|Treated|Overall Study||31
10593249|NCT01790126|11749666|FG000|COMPLETED|Overall Study||0
10593250|NCT01790126|11749667|FG001|COMPLETED|Overall Study||0
10593251|NCT01790126|11749668|FG002|COMPLETED|Overall Study||0
10593252|NCT01790126|11749666|FG000|NOT COMPLETED|Overall Study||30
10593253|NCT01790126|11749667|FG001|NOT COMPLETED|Overall Study||29
10593254|NCT01790126|11749668|FG002|NOT COMPLETED|Overall Study||31
10593255|NCT01790178|11749679|FG000|STARTED|Overall Study||16
10593256|NCT01790178|11749680|FG001|STARTED|Overall Study||24
10593257|NCT01790178|11749679|FG000|COMPLETED|Overall Study||16
10593258|NCT01790178|11749680|FG001|COMPLETED|Overall Study||24
10593259|NCT01790178|11749679|FG000|NOT COMPLETED|Overall Study||0
10593260|NCT01790178|11749680|FG001|NOT COMPLETED|Overall Study||0
10593261|NCT01790243|11749688|FG000|STARTED|Overall Study||1029
10593262|NCT01790243|11749689|FG001|STARTED|Overall Study||160
10593263|NCT01790243|11749688|FG000|COMPLETED|Overall Study||739
10593264|NCT01790243|11749689|FG001|COMPLETED|Overall Study||117
10593265|NCT01790243|11749688|FG000|NOT COMPLETED|Overall Study||290
10593266|NCT01790243|11749689|FG001|NOT COMPLETED|Overall Study||43
10593267|NCT01790295|11749695|FG000|STARTED|Overall Study||21
10593268|NCT01790295|11749695|FG000|COMPLETED|Overall Study||10
10593269|NCT01790295|11749695|FG000|NOT COMPLETED|Overall Study||11
10593270|NCT01790438|11749702|FG000|STARTED|Overall Study||428
10593271|NCT01790438|11749703|FG001|STARTED|Overall Study||213
10593272|NCT01790438|11749702|FG000|Received at Least One Dose of Study Drug|Overall Study||427
10593273|NCT01790438|11749703|FG001|Received at Least One Dose of Study Drug|Overall Study||212
10593274|NCT01790438|11749702|FG000|COMPLETED|Overall Study||393
10593275|NCT01790438|11749703|FG001|COMPLETED|Overall Study||202
10593276|NCT01790438|11749702|FG000|NOT COMPLETED|Overall Study||35
10593277|NCT01790438|11749703|FG001|NOT COMPLETED|Overall Study||11
10593278|NCT01790490|11749714|FG000|STARTED|Overall Study||3
10593279|NCT01790490|11749715|FG001|STARTED|Overall Study||3
10593280|NCT01790490|11749716|FG002|STARTED|Overall Study||2
10593281|NCT01790490|11749714|FG000|COMPLETED|Overall Study||3
10593282|NCT01790490|11749715|FG001|COMPLETED|Overall Study||3
10593283|NCT01790490|11749716|FG002|COMPLETED|Overall Study||2
10593284|NCT01790490|11749714|FG000|NOT COMPLETED|Overall Study||0
10593285|NCT01790490|11749715|FG001|NOT COMPLETED|Overall Study||0
10593286|NCT01790490|11749716|FG002|NOT COMPLETED|Overall Study||0
10593287|NCT01790503|11749738|FG000|STARTED|Overall Study||3
10593288|NCT01790503|11749739|FG001|STARTED|Overall Study||1
10593289|NCT01790503|11749740|FG002|STARTED|Overall Study||1
10593290|NCT01790503|11749741|FG003|STARTED|Overall Study||2
10593291|NCT01790503|11749742|FG004|STARTED|Overall Study||5
10593292|NCT01790503|11749743|FG005|STARTED|Overall Study||5
10593293|NCT01790503|11749744|FG006|STARTED|Overall Study||1
10593294|NCT01790503|11749745|FG007|STARTED|Overall Study||1
10593295|NCT01790503|11749746|FG008|STARTED|Overall Study||3
10593296|NCT01790503|11749747|FG009|STARTED|Overall Study||27
10593297|NCT01790503|11749748|FG010|STARTED|Overall Study||16
10593298|NCT01790503|11749738|FG000|COMPLETED|Overall Study||0
10593299|NCT01790503|11749739|FG001|COMPLETED|Overall Study||0
10593300|NCT01790503|11749740|FG002|COMPLETED|Overall Study||0
10593301|NCT01790503|11749741|FG003|COMPLETED|Overall Study||0
10593302|NCT01790503|11749742|FG004|COMPLETED|Overall Study||0
10593303|NCT01790503|11749743|FG005|COMPLETED|Overall Study||0
10593304|NCT01790503|11749744|FG006|COMPLETED|Overall Study||0
10593305|NCT01790503|11749745|FG007|COMPLETED|Overall Study||0
10593306|NCT01790503|11749746|FG008|COMPLETED|Overall Study||0
10593307|NCT01790503|11749747|FG009|COMPLETED|Overall Study||1
10593308|NCT01790503|11749748|FG010|COMPLETED|Overall Study||0
10593309|NCT01790503|11749738|FG000|NOT COMPLETED|Overall Study||3
10593310|NCT01790503|11749739|FG001|NOT COMPLETED|Overall Study||1
10593311|NCT01790503|11749740|FG002|NOT COMPLETED|Overall Study||1
10593312|NCT01790503|11749741|FG003|NOT COMPLETED|Overall Study||2
10593313|NCT01790503|11749742|FG004|NOT COMPLETED|Overall Study||5
10593314|NCT01790503|11749743|FG005|NOT COMPLETED|Overall Study||5
10593315|NCT01790503|11749744|FG006|NOT COMPLETED|Overall Study||1
10593316|NCT01790503|11749745|FG007|NOT COMPLETED|Overall Study||1
10593317|NCT01790503|11749746|FG008|NOT COMPLETED|Overall Study||3
10593318|NCT01790503|11749747|FG009|NOT COMPLETED|Overall Study||26
10593319|NCT01790503|11749748|FG010|NOT COMPLETED|Overall Study||16
10593320|NCT01790516|11749787|FG000|STARTED|Overall Study||1
10593321|NCT01790516|11749788|FG001|STARTED|Overall Study||1
10593322|NCT01790516|11749787|FG000|COMPLETED|Overall Study||0
10593323|NCT01790516|11749788|FG001|COMPLETED|Overall Study||1
10593324|NCT01790516|11749787|FG000|NOT COMPLETED|Overall Study||1
10593325|NCT01790516|11749788|FG001|NOT COMPLETED|Overall Study||0
10593326|NCT01790568|11749794|FG000|STARTED|Overall Study||12
10593327|NCT01790568|11749795|FG001|STARTED|Overall Study||26
10593328|NCT01790568|11749794|FG000|COMPLETED|Overall Study||12
10593329|NCT01790568|11749795|FG001|COMPLETED|Overall Study||25
10593330|NCT01790568|11749794|FG000|NOT COMPLETED|Overall Study||0
10593331|NCT01790568|11749795|FG001|NOT COMPLETED|Overall Study||1
10593332|NCT01790581|11749801|FG000|STARTED|Overall Study||12
10593333|NCT01790581|11749802|FG001|STARTED|Overall Study||12
10593334|NCT01790581|11749801|FG000|COMPLETED|Overall Study||12
10593335|NCT01790581|11749802|FG001|COMPLETED|Overall Study||12
10593336|NCT01790581|11749801|FG000|NOT COMPLETED|Overall Study||0
10593337|NCT01790581|11749802|FG001|NOT COMPLETED|Overall Study||0
10593338|NCT01790594|11749810|FG000|STARTED|Overall Study||22
10593339|NCT01790594|11749811|FG001|STARTED|Overall Study||21
10593340|NCT01790594|11749812|FG002|STARTED|Overall Study||3
10593341|NCT01790594|11749810|FG000|COMPLETED|Overall Study||17
10593342|NCT01790594|11749811|FG001|COMPLETED|Overall Study||18
10593343|NCT01790594|11749812|FG002|COMPLETED|Overall Study||0
10593344|NCT01790594|11749810|FG000|NOT COMPLETED|Overall Study||5
10593345|NCT01790594|11749811|FG001|NOT COMPLETED|Overall Study||3
10593346|NCT01790594|11749812|FG002|NOT COMPLETED|Overall Study||3
10593347|NCT01790633|11749821|FG000|STARTED|Overall Study||163
10593348|NCT01790633|11749822|FG001|STARTED|Overall Study||164
10593349|NCT01790633|11749821|FG000|COMPLETED|Overall Study||115
10593350|NCT01790633|11749822|FG001|COMPLETED|Overall Study||159
10593351|NCT01790633|11749821|FG000|NOT COMPLETED|Overall Study||48
10593352|NCT01790633|11749822|FG001|NOT COMPLETED|Overall Study||5
10593353|NCT01790659|11749831|FG000|STARTED|Overall Study||201
10593354|NCT01790659|11749832|FG001|STARTED|Overall Study||198
10593355|NCT01790659|11749831|FG000|COMPLETED|Overall Study||195
10593356|NCT01790659|11749832|FG001|COMPLETED|Overall Study||192
10593357|NCT01790659|11749831|FG000|NOT COMPLETED|Overall Study||6
10593358|NCT01790659|11749832|FG001|NOT COMPLETED|Overall Study||6
10593359|NCT01790685|11749840|FG000|STARTED|Overall Study||23
10593360|NCT01790685|11749841|FG001|STARTED|Overall Study||17
10593361|NCT01790685|11749840|FG000|COMPLETED|Overall Study||23
10593362|NCT01790685|11749841|FG001|COMPLETED|Overall Study||17
10593363|NCT01790685|11749840|FG000|NOT COMPLETED|Overall Study||0
10593364|NCT01790685|11749841|FG001|NOT COMPLETED|Overall Study||0
10593365|NCT01790750|11749847|FG000|STARTED|Overall Study||50
10593366|NCT01790750|11749847|FG000|COMPLETED|Overall Study||50
10593367|NCT01790750|11749847|FG000|NOT COMPLETED|Overall Study||0
10593368|NCT01790828|11749852|FG000|STARTED|Overall Study||42
10593369|NCT01790828|11749852|FG000|COMPLETED|Overall Study||8
10593370|NCT01790828|11749852|FG000|NOT COMPLETED|Overall Study||34
10593371|NCT01790932|11749856|FG000|STARTED|Overall Study||50
10593372|NCT01790932|11749856|FG000|COMPLETED|Overall Study||0
10593373|NCT01790932|11749856|FG000|NOT COMPLETED|Overall Study||50
10593374|NCT01790984|11749862|FG000|STARTED|First Dietary Intervention (12 Weeks)||6
10593375|NCT01790984|11749863|FG001|STARTED|First Dietary Intervention (12 Weeks)||8
10593376|NCT01790984|11749864|FG002|STARTED|First Dietary Intervention (12 Weeks)||6
10593377|NCT01790984|11749865|FG003|STARTED|First Dietary Intervention (12 Weeks)||7
10593378|NCT01790984|11749862|FG000|COMPLETED|First Dietary Intervention (12 Weeks)||5
10593379|NCT01790984|11749863|FG001|COMPLETED|First Dietary Intervention (12 Weeks)||7
10593380|NCT01790984|11749864|FG002|COMPLETED|First Dietary Intervention (12 Weeks)||6
10593381|NCT01790984|11749865|FG003|COMPLETED|First Dietary Intervention (12 Weeks)||7
10593382|NCT01790984|11749862|FG000|NOT COMPLETED|First Dietary Intervention (12 Weeks)||1
10593383|NCT01790984|11749863|FG001|NOT COMPLETED|First Dietary Intervention (12 Weeks)||1
10593384|NCT01790984|11749864|FG002|NOT COMPLETED|First Dietary Intervention (12 Weeks)||0
10593385|NCT01790984|11749865|FG003|NOT COMPLETED|First Dietary Intervention (12 Weeks)||0
10593386|NCT01790984|11749862|FG000|STARTED|Wash-out (4 Weeks)||5
10593387|NCT01790984|11749863|FG001|STARTED|Wash-out (4 Weeks)||7
10593388|NCT01790984|11749864|FG002|STARTED|Wash-out (4 Weeks)||6
10593389|NCT01790984|11749865|FG003|STARTED|Wash-out (4 Weeks)||7
10593390|NCT01790984|11749862|FG000|COMPLETED|Wash-out (4 Weeks)||5
10593391|NCT01790984|11749863|FG001|COMPLETED|Wash-out (4 Weeks)||7
10593392|NCT01790984|11749864|FG002|COMPLETED|Wash-out (4 Weeks)||6
10593393|NCT01790984|11749865|FG003|COMPLETED|Wash-out (4 Weeks)||7
10593394|NCT01790984|11749862|FG000|NOT COMPLETED|Wash-out (4 Weeks)||0
10593395|NCT01790984|11749863|FG001|NOT COMPLETED|Wash-out (4 Weeks)||0
10593396|NCT01790984|11749864|FG002|NOT COMPLETED|Wash-out (4 Weeks)||0
10593397|NCT01790984|11749865|FG003|NOT COMPLETED|Wash-out (4 Weeks)||0
10593398|NCT01790984|11749862|FG000|STARTED|Second Dietary Intervention (12 Weeks)||5
10593399|NCT01790984|11749863|FG001|STARTED|Second Dietary Intervention (12 Weeks)||7
10593400|NCT01790984|11749864|FG002|STARTED|Second Dietary Intervention (12 Weeks)||6
10593401|NCT01790984|11749865|FG003|STARTED|Second Dietary Intervention (12 Weeks)||7
10593402|NCT01790984|11749862|FG000|COMPLETED|Second Dietary Intervention (12 Weeks)||5
10593403|NCT01790984|11749863|FG001|COMPLETED|Second Dietary Intervention (12 Weeks)||7
10593404|NCT01790984|11749864|FG002|COMPLETED|Second Dietary Intervention (12 Weeks)||6
10593405|NCT01790984|11749865|FG003|COMPLETED|Second Dietary Intervention (12 Weeks)||7
10593406|NCT01790984|11749862|FG000|NOT COMPLETED|Second Dietary Intervention (12 Weeks)||0
10593407|NCT01790984|11749863|FG001|NOT COMPLETED|Second Dietary Intervention (12 Weeks)||0
10593408|NCT01790984|11749864|FG002|NOT COMPLETED|Second Dietary Intervention (12 Weeks)||0
10593409|NCT01790984|11749865|FG003|NOT COMPLETED|Second Dietary Intervention (12 Weeks)||0
10593410|NCT01791127|11749888|FG000|STARTED|Overall Study||1758
10593411|NCT01791127|11749888|FG000|COMPLETED|Overall Study||286
10593412|NCT01791127|11749888|FG000|NOT COMPLETED|Overall Study||1472
10593413|NCT01791153|11749909|FG000|STARTED|Part 1: Blinded Period||100
10593414|NCT01791153|11749910|FG001|STARTED|Part 1: Blinded Period||49
10593415|NCT01791153|11749911|FG002|STARTED|Part 1: Blinded Period||50
10593416|NCT01791153|11749912|FG003|STARTED|Part 1: Blinded Period||51
10593417|NCT01791153|11749913|FG004|STARTED|Part 1: Blinded Period||0
10593418|NCT01791153|11749914|FG005|STARTED|Part 1: Blinded Period||0
10593419|NCT01791153|11749915|FG006|STARTED|Part 1: Blinded Period||0
10593420|NCT01791153|11749916|FG007|STARTED|Part 1: Blinded Period||0
10593421|NCT01791153|11749909|FG000|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|85
10593422|NCT01791153|11749910|FG001|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|41
10593423|NCT01791153|11749911|FG002|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|44
10593424|NCT01791153|11749912|FG003|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|46
10593425|NCT01791153|11749913|FG004|COMPLETED|Part 1: Blinded Period||0
10593426|NCT01791153|11749914|FG005|COMPLETED|Part 1: Blinded Period||0
10593427|NCT01791153|11749915|FG006|COMPLETED|Part 1: Blinded Period||0
10593428|NCT01791153|11749916|FG007|COMPLETED|Part 1: Blinded Period||0
10593429|NCT01791153|11749909|FG000|NOT COMPLETED|Part 1: Blinded Period||15
10593430|NCT01791153|11749910|FG001|NOT COMPLETED|Part 1: Blinded Period||8
10593431|NCT01791153|11749911|FG002|NOT COMPLETED|Part 1: Blinded Period||6
10593432|NCT01791153|11749912|FG003|NOT COMPLETED|Part 1: Blinded Period||5
10593433|NCT01791153|11749913|FG004|NOT COMPLETED|Part 1: Blinded Period||0
10593434|NCT01791153|11749914|FG005|NOT COMPLETED|Part 1: Blinded Period||0
10593435|NCT01791153|11749915|FG006|NOT COMPLETED|Part 1: Blinded Period||0
10593436|NCT01791153|11749916|FG007|NOT COMPLETED|Part 1: Blinded Period||0
10593437|NCT01791153|11749909|FG000|STARTED|Part 2: Open-label Period||0
10593438|NCT01791153|11749910|FG001|STARTED|Part 2: Open-label Period||0
10807722|NCT03887442|11969443|FG000|NOT COMPLETED|Overall Study||1
10807723|NCT03887442|11969444|FG001|NOT COMPLETED|Overall Study||0
10807724|NCT03887286|11969452|FG000|STARTED|Overall Study||47
10807725|NCT03887286|11969452|FG000|COMPLETED|Overall Study||47
10807726|NCT03887286|11969452|FG000|NOT COMPLETED|Overall Study||0
10807727|NCT03881007|11969459|FG000|STARTED|First 3 Months||172
10807728|NCT03881007|11969460|FG001|STARTED|First 3 Months||171
10807729|NCT03881007|11969459|FG000|COMPLETED|First 3 Months||121
10807730|NCT03881007|11969460|FG001|COMPLETED|First 3 Months||119
10807731|NCT03881007|11969459|FG000|NOT COMPLETED|First 3 Months||51
10593439|NCT01791153|11749911|FG002|STARTED|Part 2: Open-label Period||0
10593440|NCT01791153|11749912|FG003|STARTED|Part 2: Open-label Period||0
10593441|NCT01791153|11749913|FG004|STARTED|Part 2: Open-label Period||40
10593442|NCT01791153|11749914|FG005|STARTED|Part 2: Open-label Period||58
10593443|NCT01791153|11749915|FG006|STARTED|Part 2: Open-label Period||50
10593444|NCT01791153|11749916|FG007|STARTED|Part 2: Open-label Period||67
10593445|NCT01791153|11749909|FG000|COMPLETED|Part 2: Open-label Period||0
10593446|NCT01791153|11749910|FG001|COMPLETED|Part 2: Open-label Period||0
10593447|NCT01791153|11749911|FG002|COMPLETED|Part 2: Open-label Period||0
10593448|NCT01791153|11749912|FG003|COMPLETED|Part 2: Open-label Period||0
10593449|NCT01791153|11749913|FG004|COMPLETED|Part 2: Open-label Period||38
10593450|NCT01791153|11749914|FG005|COMPLETED|Part 2: Open-label Period||54
10593451|NCT01791153|11749915|FG006|COMPLETED|Part 2: Open-label Period||44
10593452|NCT01791153|11749916|FG007|COMPLETED|Part 2: Open-label Period||61
10593453|NCT01791153|11749909|FG000|NOT COMPLETED|Part 2: Open-label Period||0
10593454|NCT01791153|11749910|FG001|NOT COMPLETED|Part 2: Open-label Period||0
10593455|NCT01791153|11749911|FG002|NOT COMPLETED|Part 2: Open-label Period||0
10593456|NCT01791153|11749912|FG003|NOT COMPLETED|Part 2: Open-label Period||0
10593457|NCT01791153|11749913|FG004|NOT COMPLETED|Part 2: Open-label Period||2
10593458|NCT01791153|11749914|FG005|NOT COMPLETED|Part 2: Open-label Period||4
10593459|NCT01791153|11749915|FG006|NOT COMPLETED|Part 2: Open-label Period||6
10593460|NCT01791153|11749916|FG007|NOT COMPLETED|Part 2: Open-label Period||6
10593461|NCT01791205|11749933|FG000|STARTED|Phase I||152
10593462|NCT01791205|11749934|FG001|STARTED|Phase I||152
10593463|NCT01791205|11749933|FG000|COMPLETED|Phase I||152
10593464|NCT01791205|11749934|FG001|COMPLETED|Phase I||152
10593465|NCT01791205|11749933|FG000|NOT COMPLETED|Phase I||0
10593466|NCT01791205|11749934|FG001|NOT COMPLETED|Phase I||0
10593467|NCT01791205|11749933|FG000|STARTED|Phase II|Participants who received tocilizumab monotherapy in Phase I was observed in Phase II.|104
10593468|NCT01791205|11749934|FG001|STARTED|Phase II||0
10593469|NCT01791205|11749933|FG000|COMPLETED|Phase II||92
10593470|NCT01791205|11749934|FG001|COMPLETED|Phase II||0
10593471|NCT01791205|11749933|FG000|NOT COMPLETED|Phase II||12
10593472|NCT01791205|11749934|FG001|NOT COMPLETED|Phase II||0
10593473|NCT01791244|11749942|FG000|STARTED|Overall Study||46
10807732|NCT03881007|11969460|FG001|NOT COMPLETED|First 3 Months||52
10807733|NCT03881007|11969459|FG000|STARTED|Last 3 Months||121
10807734|NCT03881007|11969460|FG001|STARTED|Last 3 Months||119
10807735|NCT03881007|11969459|FG000|COMPLETED|Last 3 Months||77
10807736|NCT03881007|11969460|FG001|COMPLETED|Last 3 Months||74
10807737|NCT03881007|11969459|FG000|NOT COMPLETED|Last 3 Months||44
10593474|NCT01791244|11749943|FG001|STARTED|Overall Study||47
10593475|NCT01791244|11749942|FG000|Intent to Treat (ITT)|Overall Study||38
10593476|NCT01791244|11749943|FG001|Intent to Treat (ITT)|Overall Study||39
10593477|NCT01791244|11749942|FG000|COMPLETED|Overall Study||31
10593478|NCT01791244|11749943|FG001|COMPLETED|Overall Study||29
10593479|NCT01791244|11749942|FG000|NOT COMPLETED|Overall Study||15
10593480|NCT01791244|11749943|FG001|NOT COMPLETED|Overall Study||18
10593481|NCT01791413|11749953|FG000|STARTED|Overall Study||20
10593482|NCT01791413|11749954|FG001|STARTED|Overall Study||20
10593483|NCT01791413|11749953|FG000|COMPLETED|Overall Study||15
10593484|NCT01791413|11749954|FG001|COMPLETED|Overall Study||19
10593485|NCT01791413|11749953|FG000|NOT COMPLETED|Overall Study||5
10593486|NCT01791413|11749954|FG001|NOT COMPLETED|Overall Study||1
10593487|NCT01791465|11749961|FG000|STARTED|Overall Study||6
10593488|NCT01791465|11749961|FG000|COMPLETED|Overall Study||6
10593489|NCT01791465|11749961|FG000|NOT COMPLETED|Overall Study||0
10593490|NCT01791491|11749966|FG000|STARTED|Overall Study|Reasons for enrollment and non-treatment: 1 withdrew consent and 6 no longer met study criteria.|9
10593491|NCT01791491|11749966|FG000|COMPLETED|Overall Study||9
10593492|NCT01791491|11749966|FG000|NOT COMPLETED|Overall Study||0
10593493|NCT01791517|11749973|FG000|STARTED|Phase I: Period 1||19
10593494|NCT01791517|11749974|FG001|STARTED|Phase I: Period 1||20
10593495|NCT01791517|11749975|FG002|STARTED|Phase I: Period 1||20
10593496|NCT01791517|11749976|FG003|STARTED|Phase I: Period 1||19
10593497|NCT01791517|11749977|FG004|STARTED|Phase I: Period 1||20
10593498|NCT01791517|11749978|FG005|STARTED|Phase I: Period 1||20
10593499|NCT01791517|11749979|FG006|STARTED|Phase I: Period 1||20
10593500|NCT01791517|11749980|FG007|STARTED|Phase I: Period 1||20
10593501|NCT01791517|11749981|FG008|STARTED|Phase I: Period 1||20
10593502|NCT01791517|11749982|FG009|STARTED|Phase I: Period 1||20
10593503|NCT01791517|11749983|FG010|STARTED|Phase I: Period 1||18
10593504|NCT01791517|11749984|FG011|STARTED|Phase I: Period 1||20
10593505|NCT01791517|11749973|FG000|COMPLETED|Phase I: Period 1||18
10593506|NCT01791517|11749974|FG001|COMPLETED|Phase I: Period 1||18
10593507|NCT01791517|11749975|FG002|COMPLETED|Phase I: Period 1||18
10593508|NCT01791517|11749976|FG003|COMPLETED|Phase I: Period 1||17
10593509|NCT01791517|11749977|FG004|COMPLETED|Phase I: Period 1||19
10593510|NCT01791517|11749978|FG005|COMPLETED|Phase I: Period 1||19
10593511|NCT01791517|11749979|FG006|COMPLETED|Phase I: Period 1||19
10593512|NCT01791517|11749980|FG007|COMPLETED|Phase I: Period 1||20
10593513|NCT01791517|11749981|FG008|COMPLETED|Phase I: Period 1||19
10593514|NCT01791517|11749982|FG009|COMPLETED|Phase I: Period 1||19
10593515|NCT01791517|11749983|FG010|COMPLETED|Phase I: Period 1||18
10593516|NCT01791517|11749984|FG011|COMPLETED|Phase I: Period 1||19
10593517|NCT01791517|11749973|FG000|NOT COMPLETED|Phase I: Period 1||1
10593518|NCT01791517|11749974|FG001|NOT COMPLETED|Phase I: Period 1||2
10593519|NCT01791517|11749975|FG002|NOT COMPLETED|Phase I: Period 1||2
10593520|NCT01791517|11749976|FG003|NOT COMPLETED|Phase I: Period 1||2
10593521|NCT01791517|11749977|FG004|NOT COMPLETED|Phase I: Period 1||1
10593522|NCT01791517|11749978|FG005|NOT COMPLETED|Phase I: Period 1||1
10593523|NCT01791517|11749979|FG006|NOT COMPLETED|Phase I: Period 1||1
10593524|NCT01791517|11749980|FG007|NOT COMPLETED|Phase I: Period 1||0
10593525|NCT01791517|11749981|FG008|NOT COMPLETED|Phase I: Period 1||1
10593526|NCT01791517|11749982|FG009|NOT COMPLETED|Phase I: Period 1||1
10593527|NCT01791517|11749983|FG010|NOT COMPLETED|Phase I: Period 1||0
10593528|NCT01791517|11749984|FG011|NOT COMPLETED|Phase I: Period 1||1
10593529|NCT01791517|11749973|FG000|STARTED|Phase I: Period 2||18
10593530|NCT01791517|11749974|FG001|STARTED|Phase I: Period 2||18
10593531|NCT01791517|11749975|FG002|STARTED|Phase I: Period 2||18
10593532|NCT01791517|11749976|FG003|STARTED|Phase I: Period 2||17
10593533|NCT01791517|11749977|FG004|STARTED|Phase I: Period 2||19
10593534|NCT01791517|11749978|FG005|STARTED|Phase I: Period 2||19
10593535|NCT01791517|11749979|FG006|STARTED|Phase I: Period 2||19
10593536|NCT01791517|11749980|FG007|STARTED|Phase I: Period 2||20
10593537|NCT01791517|11749981|FG008|STARTED|Phase I: Period 2||19
10593538|NCT01791517|11749982|FG009|STARTED|Phase I: Period 2||19
10593539|NCT01791517|11749983|FG010|STARTED|Phase I: Period 2||18
10593540|NCT01791517|11749984|FG011|STARTED|Phase I: Period 2||19
10593541|NCT01791517|11749973|FG000|COMPLETED|Phase I: Period 2||17
10593542|NCT01791517|11749974|FG001|COMPLETED|Phase I: Period 2||15
10593543|NCT01791517|11749975|FG002|COMPLETED|Phase I: Period 2||16
10593544|NCT01791517|11749976|FG003|COMPLETED|Phase I: Period 2||16
10593545|NCT01791517|11749977|FG004|COMPLETED|Phase I: Period 2||19
10593546|NCT01791517|11749978|FG005|COMPLETED|Phase I: Period 2||18
10593547|NCT01791517|11749979|FG006|COMPLETED|Phase I: Period 2||19
10593548|NCT01791517|11749980|FG007|COMPLETED|Phase I: Period 2||20
10593549|NCT01791517|11749981|FG008|COMPLETED|Phase I: Period 2||19
10593550|NCT01791517|11749982|FG009|COMPLETED|Phase I: Period 2||18
10593551|NCT01791517|11749983|FG010|COMPLETED|Phase I: Period 2||16
10593552|NCT01791517|11749984|FG011|COMPLETED|Phase I: Period 2||19
10593553|NCT01791517|11749973|FG000|NOT COMPLETED|Phase I: Period 2||1
10593554|NCT01791517|11749974|FG001|NOT COMPLETED|Phase I: Period 2||3
10593555|NCT01791517|11749975|FG002|NOT COMPLETED|Phase I: Period 2||2
10593556|NCT01791517|11749976|FG003|NOT COMPLETED|Phase I: Period 2||1
10593557|NCT01791517|11749977|FG004|NOT COMPLETED|Phase I: Period 2||0
10593558|NCT01791517|11749978|FG005|NOT COMPLETED|Phase I: Period 2||1
10593559|NCT01791517|11749979|FG006|NOT COMPLETED|Phase I: Period 2||0
10593560|NCT01791517|11749980|FG007|NOT COMPLETED|Phase I: Period 2||0
10593561|NCT01791517|11749981|FG008|NOT COMPLETED|Phase I: Period 2||0
10593562|NCT01791517|11749982|FG009|NOT COMPLETED|Phase I: Period 2||1
10593563|NCT01791517|11749983|FG010|NOT COMPLETED|Phase I: Period 2||2
10593564|NCT01791517|11749984|FG011|NOT COMPLETED|Phase I: Period 2||0
10593565|NCT01791517|11749973|FG000|STARTED|Phase I: Period 3||17
10593566|NCT01791517|11749974|FG001|STARTED|Phase I: Period 3||15
10593567|NCT01791517|11749975|FG002|STARTED|Phase I: Period 3||16
10593568|NCT01791517|11749976|FG003|STARTED|Phase I: Period 3||16
10593569|NCT01791517|11749977|FG004|STARTED|Phase I: Period 3||19
10593570|NCT01791517|11749978|FG005|STARTED|Phase I: Period 3||18
10593571|NCT01791517|11749979|FG006|STARTED|Phase I: Period 3||19
10593572|NCT01791517|11749980|FG007|STARTED|Phase I: Period 3||20
10593573|NCT01791517|11749981|FG008|STARTED|Phase I: Period 3||19
10593574|NCT01791517|11749982|FG009|STARTED|Phase I: Period 3||18
10593575|NCT01791517|11749983|FG010|STARTED|Phase I: Period 3||16
10593576|NCT01791517|11749984|FG011|STARTED|Phase I: Period 3||19
10593577|NCT01791517|11749973|FG000|COMPLETED|Phase I: Period 3||17
10593578|NCT01791517|11749974|FG001|COMPLETED|Phase I: Period 3||14
10593579|NCT01791517|11749975|FG002|COMPLETED|Phase I: Period 3||16
10593580|NCT01791517|11749976|FG003|COMPLETED|Phase I: Period 3||15
10593581|NCT01791517|11749977|FG004|COMPLETED|Phase I: Period 3||18
10593582|NCT01791517|11749978|FG005|COMPLETED|Phase I: Period 3||18
10593583|NCT01791517|11749979|FG006|COMPLETED|Phase I: Period 3||19
10593584|NCT01791517|11749980|FG007|COMPLETED|Phase I: Period 3||20
10593585|NCT01791517|11749981|FG008|COMPLETED|Phase I: Period 3||19
10593586|NCT01791517|11749982|FG009|COMPLETED|Phase I: Period 3||18
10593587|NCT01791517|11749983|FG010|COMPLETED|Phase I: Period 3||16
10593588|NCT01791517|11749984|FG011|COMPLETED|Phase I: Period 3||18
10593589|NCT01791517|11749973|FG000|NOT COMPLETED|Phase I: Period 3||0
10593590|NCT01791517|11749974|FG001|NOT COMPLETED|Phase I: Period 3||1
10593591|NCT01791517|11749975|FG002|NOT COMPLETED|Phase I: Period 3||0
10593592|NCT01791517|11749976|FG003|NOT COMPLETED|Phase I: Period 3||1
10593593|NCT01791517|11749977|FG004|NOT COMPLETED|Phase I: Period 3||1
10593594|NCT01791517|11749978|FG005|NOT COMPLETED|Phase I: Period 3||0
10593595|NCT01791517|11749979|FG006|NOT COMPLETED|Phase I: Period 3||0
10593596|NCT01791517|11749980|FG007|NOT COMPLETED|Phase I: Period 3||0
10593597|NCT01791517|11749981|FG008|NOT COMPLETED|Phase I: Period 3||0
10593598|NCT01791517|11749982|FG009|NOT COMPLETED|Phase I: Period 3||0
10593599|NCT01791517|11749983|FG010|NOT COMPLETED|Phase I: Period 3||0
10593600|NCT01791517|11749984|FG011|NOT COMPLETED|Phase I: Period 3||1
10593601|NCT01791517|11749973|FG000|STARTED|Phase I: Period 4||17
10593602|NCT01791517|11749974|FG001|STARTED|Phase I: Period 4||14
10593603|NCT01791517|11749975|FG002|STARTED|Phase I: Period 4||16
10593604|NCT01791517|11749976|FG003|STARTED|Phase I: Period 4||15
10593605|NCT01791517|11749977|FG004|STARTED|Phase I: Period 4||18
10593606|NCT01791517|11749978|FG005|STARTED|Phase I: Period 4||18
10593607|NCT01791517|11749979|FG006|STARTED|Phase I: Period 4||19
10593608|NCT01791517|11749980|FG007|STARTED|Phase I: Period 4||20
10593609|NCT01791517|11749981|FG008|STARTED|Phase I: Period 4||19
10593610|NCT01791517|11749982|FG009|STARTED|Phase I: Period 4||18
10593611|NCT01791517|11749983|FG010|STARTED|Phase I: Period 4||16
10593612|NCT01791517|11749984|FG011|STARTED|Phase I: Period 4||18
10593613|NCT01791517|11749973|FG000|COMPLETED|Phase I: Period 4||17
10593614|NCT01791517|11749974|FG001|COMPLETED|Phase I: Period 4||14
10593615|NCT01791517|11749975|FG002|COMPLETED|Phase I: Period 4||16
10593616|NCT01791517|11749976|FG003|COMPLETED|Phase I: Period 4||15
10593617|NCT01791517|11749977|FG004|COMPLETED|Phase I: Period 4||18
10593618|NCT01791517|11749978|FG005|COMPLETED|Phase I: Period 4||18
10593619|NCT01791517|11749979|FG006|COMPLETED|Phase I: Period 4||19
10593620|NCT01791517|11749980|FG007|COMPLETED|Phase I: Period 4||20
10593621|NCT01791517|11749981|FG008|COMPLETED|Phase I: Period 4||19
10593622|NCT01791517|11749982|FG009|COMPLETED|Phase I: Period 4||18
10593623|NCT01791517|11749983|FG010|COMPLETED|Phase I: Period 4||16
10593624|NCT01791517|11749984|FG011|COMPLETED|Phase I: Period 4||18
10593625|NCT01791517|11749973|FG000|NOT COMPLETED|Phase I: Period 4||0
10593626|NCT01791517|11749974|FG001|NOT COMPLETED|Phase I: Period 4||0
10593627|NCT01791517|11749975|FG002|NOT COMPLETED|Phase I: Period 4||0
10593628|NCT01791517|11749976|FG003|NOT COMPLETED|Phase I: Period 4||0
10593629|NCT01791517|11749977|FG004|NOT COMPLETED|Phase I: Period 4||0
10593630|NCT01791517|11749978|FG005|NOT COMPLETED|Phase I: Period 4||0
10593631|NCT01791517|11749979|FG006|NOT COMPLETED|Phase I: Period 4||0
10593632|NCT01791517|11749980|FG007|NOT COMPLETED|Phase I: Period 4||0
10593633|NCT01791517|11749981|FG008|NOT COMPLETED|Phase I: Period 4||0
10593634|NCT01791517|11749982|FG009|NOT COMPLETED|Phase I: Period 4||0
10593635|NCT01791517|11749983|FG010|NOT COMPLETED|Phase I: Period 4||0
10593636|NCT01791517|11749984|FG011|NOT COMPLETED|Phase I: Period 4||0
10593637|NCT01791517|11749973|FG000|STARTED|Phase II||17
10593638|NCT01791517|11749974|FG001|STARTED|Phase II||14
10593639|NCT01791517|11749975|FG002|STARTED|Phase II||16
10593640|NCT01791517|11749976|FG003|STARTED|Phase II||15
10593641|NCT01791517|11749977|FG004|STARTED|Phase II||18
10593642|NCT01791517|11749978|FG005|STARTED|Phase II||18
10593643|NCT01791517|11749979|FG006|STARTED|Phase II||19
10593644|NCT01791517|11749980|FG007|STARTED|Phase II||20
10593645|NCT01791517|11749981|FG008|STARTED|Phase II||19
10593646|NCT01791517|11749982|FG009|STARTED|Phase II||18
10593647|NCT01791517|11749983|FG010|STARTED|Phase II||16
10593648|NCT01791517|11749984|FG011|STARTED|Phase II||18
10593649|NCT01791517|11749973|FG000|COMPLETED|Phase II||15
10593650|NCT01791517|11749974|FG001|COMPLETED|Phase II||14
10593651|NCT01791517|11749975|FG002|COMPLETED|Phase II||15
10593652|NCT01791517|11749976|FG003|COMPLETED|Phase II||15
10593653|NCT01791517|11749977|FG004|COMPLETED|Phase II||16
10593654|NCT01791517|11749978|FG005|COMPLETED|Phase II||14
10593655|NCT01791517|11749979|FG006|COMPLETED|Phase II||17
10593656|NCT01791517|11749980|FG007|COMPLETED|Phase II||17
10593657|NCT01791517|11749981|FG008|COMPLETED|Phase II||17
10593658|NCT01791517|11749982|FG009|COMPLETED|Phase II||15
10593659|NCT01791517|11749983|FG010|COMPLETED|Phase II||15
10593660|NCT01791517|11749984|FG011|COMPLETED|Phase II||17
10593661|NCT01791517|11749973|FG000|NOT COMPLETED|Phase II||2
10593662|NCT01791517|11749974|FG001|NOT COMPLETED|Phase II||0
10593663|NCT01791517|11749975|FG002|NOT COMPLETED|Phase II||1
10593664|NCT01791517|11749976|FG003|NOT COMPLETED|Phase II||0
10593665|NCT01791517|11749977|FG004|NOT COMPLETED|Phase II||2
10593666|NCT01791517|11749978|FG005|NOT COMPLETED|Phase II||4
10593667|NCT01791517|11749979|FG006|NOT COMPLETED|Phase II||2
10593668|NCT01791517|11749980|FG007|NOT COMPLETED|Phase II||3
10593669|NCT01791517|11749981|FG008|NOT COMPLETED|Phase II||2
10593670|NCT01791517|11749982|FG009|NOT COMPLETED|Phase II||3
10593671|NCT01791517|11749983|FG010|NOT COMPLETED|Phase II||1
10593672|NCT01791517|11749984|FG011|NOT COMPLETED|Phase II||1
10593673|NCT01791725|11750005|FG000|STARTED|Overall Study||12
10593674|NCT01791725|11750006|FG001|STARTED|Overall Study||5
10593675|NCT01791725|11750007|FG002|STARTED|Overall Study||6
10593676|NCT01791725|11750005|FG000|COMPLETED|Overall Study||12
10593677|NCT01791725|11750006|FG001|COMPLETED|Overall Study||4
10593678|NCT01791725|11750007|FG002|COMPLETED|Overall Study||6
10593679|NCT01791725|11750005|FG000|NOT COMPLETED|Overall Study||0
10593680|NCT01791725|11750006|FG001|NOT COMPLETED|Overall Study||1
10593681|NCT01791725|11750007|FG002|NOT COMPLETED|Overall Study||0
10593682|NCT01791803|11750019|FG000|STARTED|Overall Study||41
10593683|NCT01791803|11750020|FG001|STARTED|Overall Study||41
10593684|NCT01791803|11750021|FG002|STARTED|Overall Study||40
10593685|NCT01791803|11750022|FG003|STARTED|Overall Study||42
10593686|NCT01791803|11750019|FG000|COMPLETED|Overall Study||41
10593687|NCT01791803|11750020|FG001|COMPLETED|Overall Study||39
10593688|NCT01791803|11750021|FG002|COMPLETED|Overall Study||38
10593689|NCT01791803|11750022|FG003|COMPLETED|Overall Study||37
10593690|NCT01791803|11750019|FG000|NOT COMPLETED|Overall Study||0
10593691|NCT01791803|11750020|FG001|NOT COMPLETED|Overall Study||2
10593692|NCT01791803|11750021|FG002|NOT COMPLETED|Overall Study||2
10593693|NCT01791803|11750022|FG003|NOT COMPLETED|Overall Study||5
10593694|NCT01791894|11750035|FG000|STARTED|Overall Study||5
10593695|NCT01791894|11750035|FG000|COMPLETED|Overall Study||4
10593696|NCT01791894|11750035|FG000|NOT COMPLETED|Overall Study||1
10593697|NCT01791972|11750042|FG000|STARTED|Overall Study||19
10593698|NCT01791972|11750043|FG001|STARTED|Overall Study||19
10593699|NCT01791972|11750042|FG000|COMPLETED|Overall Study||19
10593700|NCT01791972|11750043|FG001|COMPLETED|Overall Study||19
10593701|NCT01791972|11750042|FG000|NOT COMPLETED|Overall Study||0
10593702|NCT01791972|11750043|FG001|NOT COMPLETED|Overall Study||0
10593703|NCT01792024|11750049|FG000|STARTED|Overall Study||27
10593704|NCT01792024|11750049|FG000|COMPLETED|Overall Study||27
10593705|NCT01792024|11750049|FG000|NOT COMPLETED|Overall Study||0
10593706|NCT01792115|11750056|FG000|STARTED|Overall Study||7
10593707|NCT01792115|11750057|FG001|STARTED|Overall Study||7
10593708|NCT01792115|11750058|FG002|STARTED|Overall Study||8
10593709|NCT01792115|11750056|FG000|COMPLETED|Overall Study||7
10593710|NCT01792115|11750057|FG001|COMPLETED|Overall Study||6
10593711|NCT01792115|11750058|FG002|COMPLETED|Overall Study||8
10593712|NCT01792115|11750056|FG000|NOT COMPLETED|Overall Study||0
10593713|NCT01792115|11750057|FG001|NOT COMPLETED|Overall Study||1
10593714|NCT01792115|11750058|FG002|NOT COMPLETED|Overall Study||0
10593715|NCT01792284|11750066|FG000|STARTED|Lead-in Period||212
10593716|NCT01792284|11750067|FG001|STARTED|Lead-in Period||0
10593717|NCT01792284|11750068|FG002|STARTED|Lead-in Period||0
10593718|NCT01792284|11750066|FG000|COMPLETED|Lead-in Period|Participants that completed the Lead-in Period were randomized and entered Randomization Period 1.|182
10593719|NCT01792284|11750067|FG001|COMPLETED|Lead-in Period||0
10593720|NCT01792284|11750068|FG002|COMPLETED|Lead-in Period||0
10593721|NCT01792284|11750066|FG000|NOT COMPLETED|Lead-in Period||30
10593722|NCT01792284|11750067|FG001|NOT COMPLETED|Lead-in Period||0
10593723|NCT01792284|11750068|FG002|NOT COMPLETED|Lead-in Period||0
10593724|NCT01792284|11750066|FG000|STARTED|Randomization Period 1||0
10593725|NCT01792284|11750067|FG001|STARTED|Randomization Period 1||92
10593726|NCT01792284|11750068|FG002|STARTED|Randomization Period 1||90
10593727|NCT01792284|11750066|FG000|Received at Least 1 Dose of Study Drug|Randomization Period 1||0
10593728|NCT01792284|11750067|FG001|Received at Least 1 Dose of Study Drug|Randomization Period 1||92
10593729|NCT01792284|11750068|FG002|Received at Least 1 Dose of Study Drug|Randomization Period 1||90
10593730|NCT01792284|11750066|FG000|COMPLETED|Randomization Period 1||0
10593731|NCT01792284|11750067|FG001|COMPLETED|Randomization Period 1||90
10593732|NCT01792284|11750068|FG002|COMPLETED|Randomization Period 1||85
10593733|NCT01792284|11750066|FG000|NOT COMPLETED|Randomization Period 1||0
10593734|NCT01792284|11750067|FG001|NOT COMPLETED|Randomization Period 1||2
10593735|NCT01792284|11750068|FG002|NOT COMPLETED|Randomization Period 1||5
10593736|NCT01792284|11750066|FG000|STARTED|Randomization Period 2||0
10593737|NCT01792284|11750067|FG001|STARTED|Randomization Period 2||90
10593738|NCT01792284|11750068|FG002|STARTED|Randomization Period 2||85
10593739|NCT01792284|11750066|FG000|Received at Least 1 Dose of Study Drug|Randomization Period 2||0
10593740|NCT01792284|11750067|FG001|Received at Least 1 Dose of Study Drug|Randomization Period 2||90
10593741|NCT01792284|11750068|FG002|Received at Least 1 Dose of Study Drug|Randomization Period 2||85
10593742|NCT01792284|11750066|FG000|COMPLETED|Randomization Period 2||0
10593743|NCT01792284|11750067|FG001|COMPLETED|Randomization Period 2||87
10593744|NCT01792284|11750068|FG002|COMPLETED|Randomization Period 2||85
10593745|NCT01792284|11750066|FG000|NOT COMPLETED|Randomization Period 2||0
10593746|NCT01792284|11750067|FG001|NOT COMPLETED|Randomization Period 2||3
10593747|NCT01792284|11750068|FG002|NOT COMPLETED|Randomization Period 2||0
10807738|NCT03881007|11969460|FG001|NOT COMPLETED|Last 3 Months||45
10807739|NCT03878602|11969468|FG000|STARTED|Overall Study||75
10807740|NCT03878602|11969469|FG001|STARTED|Overall Study||67
10807741|NCT03878602|11969468|FG000|COMPLETED|Overall Study||66
10807742|NCT03878602|11969469|FG001|COMPLETED|Overall Study||66
10807743|NCT03878602|11969468|FG000|NOT COMPLETED|Overall Study||9
10807744|NCT03878602|11969469|FG001|NOT COMPLETED|Overall Study||1
10807745|NCT03875118|11969479|FG000|STARTED|Overall Study||34
10807746|NCT03875118|11969480|FG001|STARTED|Overall Study||34
10593748|NCT01792518|11750078|FG000|STARTED|Overall Study||178
10593749|NCT01792518|11750079|FG001|STARTED|Overall Study||182
10593750|NCT01792518|11750078|FG000|COMPLETED|Overall Study||170
10593751|NCT01792518|11750079|FG001|COMPLETED|Overall Study||175
10593752|NCT01792518|11750078|FG000|NOT COMPLETED|Overall Study||8
10593753|NCT01792518|11750079|FG001|NOT COMPLETED|Overall Study||7
10593754|NCT01792635|11750088|FG000|STARTED|Part A||6
10593755|NCT01792635|11750089|FG001|STARTED|Part A||0
10593756|NCT01792635|11750090|FG002|STARTED|Part A||0
10593757|NCT01792635|11750088|FG000|COMPLETED|Part A||6
10593758|NCT01792635|11750089|FG001|COMPLETED|Part A||0
10593759|NCT01792635|11750090|FG002|COMPLETED|Part A||0
10807747|NCT03875118|11969479|FG000|COMPLETED|Overall Study||30
10807748|NCT03875118|11969480|FG001|COMPLETED|Overall Study||30
10807749|NCT03875118|11969479|FG000|NOT COMPLETED|Overall Study||4
10807750|NCT03875118|11969480|FG001|NOT COMPLETED|Overall Study||4
10807751|NCT03873987|11969488|FG000|STARTED|Overall Study||52
10807752|NCT03873987|11969489|FG001|STARTED|Overall Study||50
10807753|NCT03873987|11969488|FG000|COMPLETED|Overall Study||50
10807754|NCT03873987|11969489|FG001|COMPLETED|Overall Study||49
10807755|NCT03873987|11969488|FG000|NOT COMPLETED|Overall Study||2
10807756|NCT03873987|11969489|FG001|NOT COMPLETED|Overall Study||1
10807757|NCT03870893|11969498|FG000|STARTED|Overall Study||23
10807758|NCT03870893|11969499|FG001|STARTED|Overall Study||24
10593760|NCT01792635|11750088|FG000|NOT COMPLETED|Part A||0
10593761|NCT01792635|11750089|FG001|NOT COMPLETED|Part A||0
10593762|NCT01792635|11750090|FG002|NOT COMPLETED|Part A||0
10593763|NCT01792635|11750088|FG000|STARTED|Part B||0
10593764|NCT01792635|11750089|FG001|STARTED|Part B||6
10593765|NCT01792635|11750090|FG002|STARTED|Part B||7
10593766|NCT01792635|11750088|FG000|COMPLETED|Part B||0
10593767|NCT01792635|11750089|FG001|COMPLETED|Part B||2
10593768|NCT01792635|11750090|FG002|COMPLETED|Part B||3
10593769|NCT01792635|11750088|FG000|NOT COMPLETED|Part B||0
10593770|NCT01792635|11750089|FG001|NOT COMPLETED|Part B||4
10807759|NCT03870893|11969498|FG000|COMPLETED|Overall Study||23
10807760|NCT03870893|11969499|FG001|COMPLETED|Overall Study||23
10593771|NCT01792635|11750090|FG002|NOT COMPLETED|Part B||4
10593772|NCT01792817|11750101|FG000|STARTED|Phase 1 Double Blind Period||77
10593773|NCT01792817|11750102|FG001|STARTED|Phase 1 Double Blind Period||73
10593774|NCT01792817|11750103|FG002|STARTED|Phase 1 Double Blind Period||0
10593775|NCT01792817|11750101|FG000|COMPLETED|Phase 1 Double Blind Period||58
10593776|NCT01792817|11750102|FG001|COMPLETED|Phase 1 Double Blind Period||42
10593777|NCT01792817|11750103|FG002|COMPLETED|Phase 1 Double Blind Period||0
10593778|NCT01792817|11750101|FG000|NOT COMPLETED|Phase 1 Double Blind Period||19
10593779|NCT01792817|11750102|FG001|NOT COMPLETED|Phase 1 Double Blind Period||31
10593780|NCT01792817|11750103|FG002|NOT COMPLETED|Phase 1 Double Blind Period||0
10593781|NCT01792817|11750101|FG000|STARTED|Phase 2 Open Label||0
10593782|NCT01792817|11750102|FG001|STARTED|Phase 2 Open Label||0
10593783|NCT01792817|11750103|FG002|STARTED|Phase 2 Open Label||100
10593784|NCT01792817|11750101|FG000|COMPLETED|Phase 2 Open Label||0
10593785|NCT01792817|11750102|FG001|COMPLETED|Phase 2 Open Label||0
10593786|NCT01792817|11750103|FG002|COMPLETED|Phase 2 Open Label||74
10593787|NCT01792817|11750101|FG000|NOT COMPLETED|Phase 2 Open Label||0
10593788|NCT01792817|11750102|FG001|NOT COMPLETED|Phase 2 Open Label||0
10593789|NCT01792817|11750103|FG002|NOT COMPLETED|Phase 2 Open Label||26
10593790|NCT01792830|11750121|FG000|STARTED|Overall Study||84
10593791|NCT01792830|11750122|FG001|STARTED|Overall Study||3
10593792|NCT01792830|11750123|FG002|STARTED|Overall Study||4
10593793|NCT01792830|11750124|FG003|STARTED|Overall Study||21
10593794|NCT01792830|11750125|FG004|STARTED|Overall Study||2
10593795|NCT01792830|11750126|FG005|STARTED|Overall Study||4
10593796|NCT01792830|11750127|FG006|STARTED|Overall Study||14
10593797|NCT01792830|11750128|FG007|STARTED|Overall Study||7
10593798|NCT01792830|11750129|FG008|STARTED|Overall Study||20
10593799|NCT01792830|11750130|FG009|STARTED|Overall Study||4
10593800|NCT01792830|11750131|FG010|STARTED|Overall Study||12
10593801|NCT01792830|11750121|FG000|COMPLETED|Overall Study||59
10593802|NCT01792830|11750122|FG001|COMPLETED|Overall Study||3
10593803|NCT01792830|11750123|FG002|COMPLETED|Overall Study||4
10593804|NCT01792830|11750124|FG003|COMPLETED|Overall Study||18
10593805|NCT01792830|11750125|FG004|COMPLETED|Overall Study||1
10807761|NCT03870893|11969498|FG000|NOT COMPLETED|Overall Study||0
10807762|NCT03870893|11969499|FG001|NOT COMPLETED|Overall Study||1
10807763|NCT03887299|11969508|FG000|STARTED|Overall Study||77
10807764|NCT03887299|11969509|FG001|STARTED|Overall Study||77
10807765|NCT03887299|11969508|FG000|COMPLETED|Overall Study||77
10807766|NCT03887299|11969509|FG001|COMPLETED|Overall Study||77
10807767|NCT03887299|11969508|FG000|NOT COMPLETED|Overall Study||0
10807768|NCT03887299|11969509|FG001|NOT COMPLETED|Overall Study||0
10593806|NCT01792830|11750126|FG005|COMPLETED|Overall Study||3
10593807|NCT01792830|11750127|FG006|COMPLETED|Overall Study||12
10807769|NCT03878758|11969515|FG000|STARTED|Overall Study||158
10593808|NCT01792830|11750128|FG007|COMPLETED|Overall Study||6
10593809|NCT01792830|11750129|FG008|COMPLETED|Overall Study||11
10593810|NCT01792830|11750130|FG009|COMPLETED|Overall Study||4
10593811|NCT01792830|11750131|FG010|COMPLETED|Overall Study||9
10593812|NCT01792830|11750121|FG000|NOT COMPLETED|Overall Study||25
10593813|NCT01792830|11750122|FG001|NOT COMPLETED|Overall Study||0
10593814|NCT01792830|11750123|FG002|NOT COMPLETED|Overall Study||0
10593815|NCT01792830|11750124|FG003|NOT COMPLETED|Overall Study||3
10593816|NCT01792830|11750125|FG004|NOT COMPLETED|Overall Study||1
10593817|NCT01792830|11750126|FG005|NOT COMPLETED|Overall Study||1
10593818|NCT01792830|11750127|FG006|NOT COMPLETED|Overall Study||2
10593819|NCT01792830|11750128|FG007|NOT COMPLETED|Overall Study||1
10593820|NCT01792830|11750129|FG008|NOT COMPLETED|Overall Study||9
10593821|NCT01792830|11750130|FG009|NOT COMPLETED|Overall Study||0
10593822|NCT01792830|11750131|FG010|NOT COMPLETED|Overall Study||3
10593823|NCT01792986|11750161|FG000|STARTED|Overall Study||12
10593824|NCT01792986|11750161|FG000|COMPLETED|Overall Study||12
10593825|NCT01792986|11750161|FG000|NOT COMPLETED|Overall Study||0
10593826|NCT01793051|11750167|FG000|STARTED|Overall Study||43
10593827|NCT01793051|11750168|FG001|STARTED|Overall Study||44
10593828|NCT01793051|11750167|FG000|COMPLETED|Overall Study||33
10593829|NCT01793051|11750168|FG001|COMPLETED|Overall Study||36
10593830|NCT01793051|11750167|FG000|NOT COMPLETED|Overall Study||10
10593831|NCT01793051|11750168|FG001|NOT COMPLETED|Overall Study||8
10593832|NCT01793142|11750174|FG000|STARTED|Overall Study||3430
10593833|NCT01793142|11750174|FG000|Treated|Overall Study||3423
10593834|NCT01793142|11750174|FG000|COMPLETED|Overall Study||3423
10593835|NCT01793142|11750174|FG000|NOT COMPLETED|Overall Study||7
10593836|NCT01793285|11750178|FG000|STARTED|Overall Study||85
10593837|NCT01793285|11750178|FG000|COMPLETED|Overall Study||85
10593838|NCT01793285|11750178|FG000|NOT COMPLETED|Overall Study||0
10593839|NCT01793688|11750182|FG000|STARTED|Overall Study||982
10593840|NCT01793688|11750182|FG000|COMPLETED|Overall Study||980
10593841|NCT01793688|11750182|FG000|NOT COMPLETED|Overall Study||2
10593842|NCT01793792|11750186|FG000|STARTED|Overall Study|153 treated: 1 attempted no device implanted, 152 device implanted.|153
10593843|NCT01793792|11750186|FG000|Treated|Overall Study|153 Treated, 152 implanted with device, 1 attempted no device implanted|153
10593844|NCT01793792|11750186|FG000|COMPLETED|Overall Study||141
10593845|NCT01793792|11750186|FG000|NOT COMPLETED|Overall Study||12
10593846|NCT01793883|11750193|FG000|STARTED|Overall Study||213
10593847|NCT01793883|11750194|FG001|STARTED|Overall Study||214
10593848|NCT01793883|11750195|FG002|STARTED|Overall Study||212
10593849|NCT01793883|11750193|FG000|COMPLETED|Overall Study||201
10593850|NCT01793883|11750194|FG001|COMPLETED|Overall Study||204
10593851|NCT01793883|11750195|FG002|COMPLETED|Overall Study||204
10593852|NCT01793883|11750193|FG000|NOT COMPLETED|Overall Study||12
10593853|NCT01793883|11750194|FG001|NOT COMPLETED|Overall Study||10
10593854|NCT01793883|11750195|FG002|NOT COMPLETED|Overall Study||8
10593855|NCT01793909|11750205|FG000|STARTED|Overall Study||30
10593856|NCT01793909|11750206|FG001|STARTED|Overall Study||25
10593857|NCT01793909|11750205|FG000|COMPLETED|Overall Study||20
10593858|NCT01793909|11750206|FG001|COMPLETED|Overall Study||20
10593859|NCT01793909|11750205|FG000|NOT COMPLETED|Overall Study||10
10593860|NCT01793909|11750206|FG001|NOT COMPLETED|Overall Study||5
10593861|NCT01793935|11750214|FG000|STARTED|Overall Study||34
10593862|NCT01793935|11750215|FG001|STARTED|Overall Study||34
10593863|NCT01793935|11750214|FG000|COMPLETED|Overall Study||28
10593864|NCT01793935|11750215|FG001|COMPLETED|Overall Study||31
10593865|NCT01793935|11750214|FG000|NOT COMPLETED|Overall Study||6
10593866|NCT01793935|11750215|FG001|NOT COMPLETED|Overall Study||3
10593867|NCT01794000|11750223|FG000|STARTED|Double-Blind Phase (DBP)||171
10593868|NCT01794000|11750224|FG001|STARTED|Double-Blind Phase (DBP)||170
10593869|NCT01794000|11750223|FG000|Received at Least One Dose of Drug|Double-Blind Phase (DBP)||170
10593870|NCT01794000|11750224|FG001|Received at Least One Dose of Drug|Double-Blind Phase (DBP)||170
10593871|NCT01794000|11750223|FG000|Discontinued During Double Blind Phase|Double-Blind Phase (DBP)||169
10593872|NCT01794000|11750224|FG001|Discontinued During Double Blind Phase|Double-Blind Phase (DBP)||166
10593873|NCT01794000|11750223|FG000|COMPLETED|Double-Blind Phase (DBP)||2
10593874|NCT01794000|11750224|FG001|COMPLETED|Double-Blind Phase (DBP)||4
10593875|NCT01794000|11750223|FG000|NOT COMPLETED|Double-Blind Phase (DBP)||169
10593876|NCT01794000|11750224|FG001|NOT COMPLETED|Double-Blind Phase (DBP)||166
10593877|NCT01794000|11750223|FG000|STARTED|Open-Label Extension Phase (OLE)|Pts. who had not permanently discontinued study drug and concluded DBP were eligible to enter OLE|3
10593878|NCT01794000|11750224|FG001|STARTED|Open-Label Extension Phase (OLE)|Placebo arm was not applicable to Open-Label Extension Phase|0
10593879|NCT01794000|11750223|FG000|COMPLETED|Open-Label Extension Phase (OLE)||0
10593880|NCT01794000|11750224|FG001|COMPLETED|Open-Label Extension Phase (OLE)||0
10593881|NCT01794000|11750223|FG000|NOT COMPLETED|Open-Label Extension Phase (OLE)||3
10593882|NCT01794000|11750224|FG001|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
10593883|NCT01794039|11750233|FG000|STARTED|Overall Study||5
10593884|NCT01794039|11750234|FG001|STARTED|Overall Study||4
10593885|NCT01794039|11750233|FG000|COMPLETED|Overall Study||5
10593886|NCT01794039|11750234|FG001|COMPLETED|Overall Study||4
10593887|NCT01794039|11750233|FG000|NOT COMPLETED|Overall Study||0
10593888|NCT01794039|11750234|FG001|NOT COMPLETED|Overall Study||0
10593889|NCT01794117|11750246|FG000|STARTED|Overall Study||1
10593890|NCT01794117|11750247|FG001|STARTED|Overall Study||3
10593891|NCT01794117|11750248|FG002|STARTED|Overall Study||2
10593892|NCT01794117|11750249|FG003|STARTED|Overall Study||12
10593893|NCT01794117|11750246|FG000|COMPLETED|Overall Study||0
10593894|NCT01794117|11750247|FG001|COMPLETED|Overall Study||0
10593895|NCT01794117|11750248|FG002|COMPLETED|Overall Study||2
10593896|NCT01794117|11750249|FG003|COMPLETED|Overall Study||12
10593897|NCT01794117|11750246|FG000|NOT COMPLETED|Overall Study||1
10593898|NCT01794117|11750247|FG001|NOT COMPLETED|Overall Study||3
10593899|NCT01794117|11750248|FG002|NOT COMPLETED|Overall Study||0
10593900|NCT01794117|11750249|FG003|NOT COMPLETED|Overall Study||0
10593901|NCT01794299|11750260|FG000|STARTED|Overall Study||31
10593902|NCT01794299|11750260|FG000|COMPLETED|Overall Study||9
10593903|NCT01794299|11750260|FG000|NOT COMPLETED|Overall Study||22
10593904|NCT01794312|11750266|FG000|STARTED|Overall Study||74
10593905|NCT01794312|11750267|FG001|STARTED|Overall Study||78
10593906|NCT01794312|11750266|FG000|COMPLETED|Overall Study||68
10593907|NCT01794312|11750267|FG001|COMPLETED|Overall Study||67
10593908|NCT01794312|11750266|FG000|NOT COMPLETED|Overall Study||6
10593909|NCT01794312|11750267|FG001|NOT COMPLETED|Overall Study||11
10593910|NCT01794455|11750275|FG000|STARTED|Overall Study||0
10593911|NCT01794455|11750276|FG001|STARTED|Overall Study||1
10593912|NCT01794455|11750275|FG000|COMPLETED|Overall Study||0
10593913|NCT01794455|11750276|FG001|COMPLETED|Overall Study||1
10593914|NCT01794455|11750275|FG000|NOT COMPLETED|Overall Study||0
10593915|NCT01794455|11750276|FG001|NOT COMPLETED|Overall Study||0
10593916|NCT01794689|11750286|FG000|STARTED|Intervention 1 (2 Nights)||25
10593917|NCT01794689|11750287|FG001|STARTED|Intervention 1 (2 Nights)||29
10593918|NCT01794689|11750288|FG002|STARTED|Intervention 1 (2 Nights)||24
10593919|NCT01794689|11750289|FG003|STARTED|Intervention 1 (2 Nights)||22
10593920|NCT01794689|11750286|FG000|COMPLETED|Intervention 1 (2 Nights)||20
10593921|NCT01794689|11750287|FG001|COMPLETED|Intervention 1 (2 Nights)||27
10593922|NCT01794689|11750288|FG002|COMPLETED|Intervention 1 (2 Nights)||21
10593923|NCT01794689|11750289|FG003|COMPLETED|Intervention 1 (2 Nights)||18
10593924|NCT01794689|11750286|FG000|NOT COMPLETED|Intervention 1 (2 Nights)||5
10593925|NCT01794689|11750287|FG001|NOT COMPLETED|Intervention 1 (2 Nights)||2
10593926|NCT01794689|11750288|FG002|NOT COMPLETED|Intervention 1 (2 Nights)||3
10593927|NCT01794689|11750289|FG003|NOT COMPLETED|Intervention 1 (2 Nights)||4
10593928|NCT01794689|11750286|FG000|STARTED|Washout (2 Weeks)||20
10593929|NCT01794689|11750287|FG001|STARTED|Washout (2 Weeks)||27
10593930|NCT01794689|11750288|FG002|STARTED|Washout (2 Weeks)||21
10593931|NCT01794689|11750289|FG003|STARTED|Washout (2 Weeks)||18
10593932|NCT01794689|11750286|FG000|COMPLETED|Washout (2 Weeks)||20
10593933|NCT01794689|11750287|FG001|COMPLETED|Washout (2 Weeks)||27
10593934|NCT01794689|11750288|FG002|COMPLETED|Washout (2 Weeks)||21
10593935|NCT01794689|11750289|FG003|COMPLETED|Washout (2 Weeks)||18
10593936|NCT01794689|11750286|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10593937|NCT01794689|11750287|FG001|NOT COMPLETED|Washout (2 Weeks)||0
10593938|NCT01794689|11750288|FG002|NOT COMPLETED|Washout (2 Weeks)||0
10593939|NCT01794689|11750289|FG003|NOT COMPLETED|Washout (2 Weeks)||0
10593940|NCT01794689|11750286|FG000|STARTED|Intervention 2 (2 Nights)||20
10593941|NCT01794689|11750287|FG001|STARTED|Intervention 2 (2 Nights)||27
10593942|NCT01794689|11750288|FG002|STARTED|Intervention 2 (2 Nights)||21
10593943|NCT01794689|11750289|FG003|STARTED|Intervention 2 (2 Nights)||18
10593944|NCT01794689|11750286|FG000|COMPLETED|Intervention 2 (2 Nights)||20
10593945|NCT01794689|11750287|FG001|COMPLETED|Intervention 2 (2 Nights)||27
10593946|NCT01794689|11750288|FG002|COMPLETED|Intervention 2 (2 Nights)||21
10593947|NCT01794689|11750289|FG003|COMPLETED|Intervention 2 (2 Nights)||18
10593948|NCT01794689|11750286|FG000|NOT COMPLETED|Intervention 2 (2 Nights)||0
10593949|NCT01794689|11750287|FG001|NOT COMPLETED|Intervention 2 (2 Nights)||0
10593950|NCT01794689|11750288|FG002|NOT COMPLETED|Intervention 2 (2 Nights)||0
10593951|NCT01794689|11750289|FG003|NOT COMPLETED|Intervention 2 (2 Nights)||0
10593952|NCT01794702|11750308|FG000|STARTED|Overall Study||18
10593953|NCT01794702|11750309|FG001|STARTED|Overall Study||0
10593954|NCT01794702|11750310|FG002|STARTED|Overall Study||47
10593955|NCT01794702|11750308|FG000|COMPLETED|Overall Study||18
10593956|NCT01794702|11750309|FG001|COMPLETED|Overall Study||0
10593957|NCT01794702|11750310|FG002|COMPLETED|Overall Study||47
10593958|NCT01794702|11750308|FG000|NOT COMPLETED|Overall Study||0
10593959|NCT01794702|11750309|FG001|NOT COMPLETED|Overall Study||0
10593960|NCT01794702|11750310|FG002|NOT COMPLETED|Overall Study||0
10593961|NCT01794741|11750320|FG000|STARTED|Overall Study||304
10593962|NCT01794741|11750321|FG001|STARTED|Overall Study||101
10593963|NCT01794741|11750320|FG000|COMPLETED|Overall Study||285
10593964|NCT01794741|11750321|FG001|COMPLETED|Overall Study||92
10593965|NCT01794741|11750320|FG000|NOT COMPLETED|Overall Study||19
10593966|NCT01794741|11750321|FG001|NOT COMPLETED|Overall Study||9
10593967|NCT01794780|11750335|FG000|STARTED|Overall Study||32
10593968|NCT01794780|11750336|FG001|STARTED|Overall Study||276
10593969|NCT01794780|11750337|FG002|STARTED|Overall Study||813
10593970|NCT01794780|11750338|FG003|STARTED|Overall Study||283
10593971|NCT01794780|11750339|FG004|STARTED|Overall Study||9
10593972|NCT01794780|11750340|FG005|STARTED|Overall Study||632
10593973|NCT01794780|11750341|FG006|STARTED|Overall Study||154
10593974|NCT01794780|11750342|FG007|STARTED|Overall Study||30
10593975|NCT01794780|11750335|FG000|COMPLETED|Overall Study||15
10593976|NCT01794780|11750336|FG001|COMPLETED|Overall Study||180
10593977|NCT01794780|11750337|FG002|COMPLETED|Overall Study||571
10593978|NCT01794780|11750338|FG003|COMPLETED|Overall Study||200
10593979|NCT01794780|11750339|FG004|COMPLETED|Overall Study||6
10593980|NCT01794780|11750340|FG005|COMPLETED|Overall Study||452
10593981|NCT01794780|11750341|FG006|COMPLETED|Overall Study||112
10593982|NCT01794780|11750342|FG007|COMPLETED|Overall Study||21
10593983|NCT01794780|11750335|FG000|NOT COMPLETED|Overall Study||17
10593984|NCT01794780|11750336|FG001|NOT COMPLETED|Overall Study||96
10703564|NCT02584959|11868016|FG002|COMPLETED|Period 1||15
10703565|NCT02584959|11868014|FG000|NOT COMPLETED|Period 1||3
10593985|NCT01794780|11750337|FG002|NOT COMPLETED|Overall Study||242
10593986|NCT01794780|11750338|FG003|NOT COMPLETED|Overall Study||83
10593987|NCT01794780|11750339|FG004|NOT COMPLETED|Overall Study||3
10593988|NCT01794780|11750340|FG005|NOT COMPLETED|Overall Study||180
10593989|NCT01794780|11750341|FG006|NOT COMPLETED|Overall Study||42
10593990|NCT01794780|11750342|FG007|NOT COMPLETED|Overall Study||9
10593991|NCT01794806|11750369|FG000|STARTED|Overall Study||31
10593992|NCT01794806|11750370|FG001|STARTED|Overall Study||28
10593993|NCT01794806|11750369|FG000|1 Week|Overall Study||28
10593994|NCT01794806|11750370|FG001|1 Week|Overall Study||28
10593995|NCT01794806|11750369|FG000|4 Weeks|Overall Study||26
10593996|NCT01794806|11750370|FG001|4 Weeks|Overall Study||27
10593997|NCT01794806|11750369|FG000|COMPLETED|Overall Study||26
10593998|NCT01794806|11750370|FG001|COMPLETED|Overall Study||27
10593999|NCT01794806|11750369|FG000|NOT COMPLETED|Overall Study||5
10594000|NCT01794806|11750370|FG001|NOT COMPLETED|Overall Study||1
10594001|NCT01794845|11750376|FG000|STARTED|Overall Study||5
10594002|NCT01794845|11750376|FG000|COMPLETED|Overall Study||4
10594003|NCT01794845|11750376|FG000|NOT COMPLETED|Overall Study||1
10594004|NCT01794923|11750383|FG000|STARTED|Overall Study||83
10594005|NCT01794923|11750384|FG001|STARTED|Overall Study||60
10594006|NCT01794923|11750385|FG002|STARTED|Overall Study||62
10594007|NCT01794923|11750383|FG000|COMPLETED|Overall Study||83
10594008|NCT01794923|11750384|FG001|COMPLETED|Overall Study||60
10594009|NCT01794923|11750385|FG002|COMPLETED|Overall Study||61
10594010|NCT01794923|11750383|FG000|NOT COMPLETED|Overall Study||0
10594011|NCT01794923|11750384|FG001|NOT COMPLETED|Overall Study||0
10594012|NCT01794923|11750385|FG002|NOT COMPLETED|Overall Study||1
10594013|NCT01794949|11750395|FG000|STARTED|Overall Study||7
10594014|NCT01794949|11750396|FG001|STARTED|Overall Study||1
10594015|NCT01794949|11750395|FG000|6 Month Follow-up|Overall Study||6
10594016|NCT01794949|11750396|FG001|6 Month Follow-up|Overall Study||1
10594017|NCT01794949|11750395|FG000|COMPLETED|Overall Study||6
10594018|NCT01794949|11750396|FG001|COMPLETED|Overall Study||1
10594019|NCT01794949|11750395|FG000|NOT COMPLETED|Overall Study||1
10594020|NCT01794949|11750396|FG001|NOT COMPLETED|Overall Study||0
10594021|NCT01795079|11750404|FG000|STARTED|Overall Study||16
10594022|NCT01795079|11750405|FG001|STARTED|Overall Study||15
10594023|NCT01795079|11750404|FG000|COMPLETED|Overall Study||13
10594024|NCT01795079|11750405|FG001|COMPLETED|Overall Study||12
10594025|NCT01795079|11750404|FG000|NOT COMPLETED|Overall Study||3
10594026|NCT01795079|11750405|FG001|NOT COMPLETED|Overall Study||3
10594027|NCT01795105|11750411|FG000|STARTED|Overall Study||692
10594028|NCT01795105|11750411|FG000|COMPLETED|Overall Study||648
10594029|NCT01795105|11750411|FG000|NOT COMPLETED|Overall Study||44
10594030|NCT01795495|11750419|FG000|STARTED|Overall Study||20
10594031|NCT01795495|11750420|FG001|STARTED|Overall Study||22
10594032|NCT01795495|11750421|FG002|STARTED|Overall Study||21
10594033|NCT01795495|11750419|FG000|COMPLETED|Overall Study||19
10594034|NCT01795495|11750420|FG001|COMPLETED|Overall Study||22
10594035|NCT01795495|11750421|FG002|COMPLETED|Overall Study||19
10594036|NCT01795495|11750419|FG000|NOT COMPLETED|Overall Study||1
10594037|NCT01795495|11750420|FG001|NOT COMPLETED|Overall Study||0
10594038|NCT01795495|11750421|FG002|NOT COMPLETED|Overall Study||2
10594039|NCT01795534|11750429|FG000|STARTED|First Intervention (First Shot)||5
10594040|NCT01795534|11750430|FG001|STARTED|First Intervention (First Shot)||5
10594041|NCT01795534|11750429|FG000|COMPLETED|First Intervention (First Shot)||5
10594042|NCT01795534|11750430|FG001|COMPLETED|First Intervention (First Shot)||5
10594043|NCT01795534|11750429|FG000|NOT COMPLETED|First Intervention (First Shot)||0
10594044|NCT01795534|11750430|FG001|NOT COMPLETED|First Intervention (First Shot)||0
10594045|NCT01795534|11750429|FG000|STARTED|Wash Out Period (4 Days)||5
10594046|NCT01795534|11750430|FG001|STARTED|Wash Out Period (4 Days)||5
10594047|NCT01795534|11750429|FG000|COMPLETED|Wash Out Period (4 Days)||5
10594048|NCT01795534|11750430|FG001|COMPLETED|Wash Out Period (4 Days)||5
10594049|NCT01795534|11750429|FG000|NOT COMPLETED|Wash Out Period (4 Days)||0
10594050|NCT01795534|11750430|FG001|NOT COMPLETED|Wash Out Period (4 Days)||0
10594051|NCT01795534|11750429|FG000|STARTED|Second Intervention (Second Shot)||5
10594052|NCT01795534|11750430|FG001|STARTED|Second Intervention (Second Shot)||5
10594053|NCT01795534|11750429|FG000|COMPLETED|Second Intervention (Second Shot)||5
10594054|NCT01795534|11750430|FG001|COMPLETED|Second Intervention (Second Shot)||5
10594055|NCT01795534|11750429|FG000|NOT COMPLETED|Second Intervention (Second Shot)||0
10594056|NCT01795534|11750430|FG001|NOT COMPLETED|Second Intervention (Second Shot)||0
10594057|NCT01795547|11750438|FG000|STARTED|Overall Study||148
10594058|NCT01795547|11750439|FG001|STARTED|Overall Study||147
10594059|NCT01795547|11750438|FG000|COMPLETED|Overall Study||100
10594060|NCT01795547|11750439|FG001|COMPLETED|Overall Study||83
10594061|NCT01795547|11750438|FG000|NOT COMPLETED|Overall Study||48
10594062|NCT01795547|11750439|FG001|NOT COMPLETED|Overall Study||64
10594063|NCT01795638|11750449|FG000|STARTED|Overall Study||27
10703566|NCT02584959|11868015|FG001|NOT COMPLETED|Period 1||4
10703567|NCT02584959|11868016|FG002|NOT COMPLETED|Period 1||0
10594064|NCT01795638|11750450|FG001|STARTED|Overall Study||26
10594065|NCT01795638|11750449|FG000|COMPLETED|Overall Study||14
10703568|NCT02584959|11868014|FG000|STARTED|Period 2||28
10594066|NCT01795638|11750450|FG001|COMPLETED|Overall Study||15
10594067|NCT01795638|11750449|FG000|NOT COMPLETED|Overall Study||13
10594068|NCT01795638|11750450|FG001|NOT COMPLETED|Overall Study||11
10594069|NCT01795716|11750458|FG000|STARTED|First Intervention (13 Days)||10
10594070|NCT01795716|11750459|FG001|STARTED|First Intervention (13 Days)||11
10594071|NCT01795716|11750458|FG000|COMPLETED|First Intervention (13 Days)||10
10594072|NCT01795716|11750459|FG001|COMPLETED|First Intervention (13 Days)||11
10594073|NCT01795716|11750458|FG000|NOT COMPLETED|First Intervention (13 Days)||0
10594074|NCT01795716|11750459|FG001|NOT COMPLETED|First Intervention (13 Days)||0
10594075|NCT01795716|11750458|FG000|STARTED|Washout (10 Days)||10
10594076|NCT01795716|11750459|FG001|STARTED|Washout (10 Days)||11
10594077|NCT01795716|11750458|FG000|COMPLETED|Washout (10 Days)||10
10594078|NCT01795716|11750459|FG001|COMPLETED|Washout (10 Days)||11
10594079|NCT01795716|11750458|FG000|NOT COMPLETED|Washout (10 Days)||0
10594080|NCT01795716|11750459|FG001|NOT COMPLETED|Washout (10 Days)||0
10594081|NCT01795716|11750458|FG000|STARTED|Second Intervention (13 Days)||10
10594082|NCT01795716|11750459|FG001|STARTED|Second Intervention (13 Days)||11
10594083|NCT01795716|11750458|FG000|COMPLETED|Second Intervention (13 Days)||10
10594084|NCT01795716|11750459|FG001|COMPLETED|Second Intervention (13 Days)||11
10594085|NCT01795716|11750458|FG000|NOT COMPLETED|Second Intervention (13 Days)||0
10594086|NCT01795716|11750459|FG001|NOT COMPLETED|Second Intervention (13 Days)||0
10594087|NCT01795833|11750469|FG000|STARTED|Overall Study||1031
10594088|NCT01795833|11750470|FG001|STARTED|Overall Study||1031
10594089|NCT01795833|11750469|FG000|COMPLETED|Overall Study||881
10594090|NCT01795833|11750470|FG001|COMPLETED|Overall Study||882
10594091|NCT01795833|11750469|FG000|NOT COMPLETED|Overall Study||150
10594092|NCT01795833|11750470|FG001|NOT COMPLETED|Overall Study||149
10594093|NCT01795859|11750478|FG000|STARTED|Overall Study||45
10594094|NCT01795859|11750479|FG001|STARTED|Overall Study||45
10594095|NCT01795859|11750478|FG000|COMPLETED|Overall Study||44
10594096|NCT01795859|11750479|FG001|COMPLETED|Overall Study||43
10594097|NCT01795859|11750478|FG000|NOT COMPLETED|Overall Study||1
10594098|NCT01795859|11750479|FG001|NOT COMPLETED|Overall Study||2
10594099|NCT01795898|11750485|FG000|STARTED|Overall Study||237
10594100|NCT01795898|11750485|FG000|COMPLETED|Overall Study||177
10594101|NCT01795898|11750485|FG000|NOT COMPLETED|Overall Study||60
10594102|NCT01795937|11750492|FG000|STARTED|Overall Study||18
10594103|NCT01795937|11750493|FG001|STARTED|Overall Study||16
10594104|NCT01795937|11750494|FG002|STARTED|Overall Study||17
10594105|NCT01795937|11750492|FG000|COMPLETED|Overall Study||17
10594106|NCT01795937|11750493|FG001|COMPLETED|Overall Study||15
10594107|NCT01795937|11750494|FG002|COMPLETED|Overall Study||17
10594108|NCT01795937|11750492|FG000|NOT COMPLETED|Overall Study||1
10594109|NCT01795937|11750493|FG001|NOT COMPLETED|Overall Study||1
10594110|NCT01795937|11750494|FG002|NOT COMPLETED|Overall Study||0
10594111|NCT01796236|11750512|FG000|STARTED|Overall Study||51
10594112|NCT01796236|11750513|FG001|STARTED|Overall Study||52
10594113|NCT01796236|11750512|FG000|COMPLETED|Overall Study||49
10594114|NCT01796236|11750513|FG001|COMPLETED|Overall Study||50
10594115|NCT01796236|11750512|FG000|NOT COMPLETED|Overall Study||2
10594116|NCT01796236|11750513|FG001|NOT COMPLETED|Overall Study||2
10594117|NCT01796301|11750522|FG000|STARTED|Overall Study||218
10594118|NCT01796301|11750523|FG001|STARTED|Overall Study||218
10594119|NCT01796301|11750522|FG000|Received Treatment|Overall Study||214
10594120|NCT01796301|11750523|FG001|Received Treatment|Overall Study||218
10594121|NCT01796301|11750522|FG000|COMPLETED|Overall Study||200
10594122|NCT01796301|11750523|FG001|COMPLETED|Overall Study||198
10594123|NCT01796301|11750522|FG000|NOT COMPLETED|Overall Study||18
10594124|NCT01796301|11750523|FG001|NOT COMPLETED|Overall Study||20
10594125|NCT01796392|11750531|FG000|STARTED|Overall Study||128
10594126|NCT01796392|11750532|FG001|STARTED|Overall Study||62
10594127|NCT01796392|11750531|FG000|COMPLETED|Overall Study|119 active subjects at 12-months|119
10594128|NCT01796392|11750532|FG001|COMPLETED|Overall Study|59 active subjects at 12-months|59
10594129|NCT01796392|11750531|FG000|NOT COMPLETED|Overall Study||9
10594130|NCT01796392|11750532|FG001|NOT COMPLETED|Overall Study||3
10594131|NCT01796470|11750543|FG000|STARTED|Overall Study||35
10594132|NCT01796470|11750544|FG001|STARTED|Overall Study||14
10594133|NCT01796470|11750545|FG002|STARTED|Overall Study||6
10594134|NCT01796470|11750546|FG003|STARTED|Overall Study||3
10594135|NCT01796470|11750547|FG004|STARTED|Overall Study||8
10594136|NCT01796470|11750543|FG000|Entospletinib Monotherapy|Overall Study||4
10594137|NCT01796470|11750544|FG001|Entospletinib Monotherapy|Overall Study||4
10594138|NCT01796470|11750545|FG002|Entospletinib Monotherapy|Overall Study||0
10594139|NCT01796470|11750546|FG003|Entospletinib Monotherapy|Overall Study||0
10594140|NCT01796470|11750547|FG004|Entospletinib Monotherapy|Overall Study||0
10594141|NCT01796470|11750543|FG000|COMPLETED|Overall Study||0
10594142|NCT01796470|11750544|FG001|COMPLETED|Overall Study||0
10594143|NCT01796470|11750545|FG002|COMPLETED|Overall Study||0
10594144|NCT01796470|11750546|FG003|COMPLETED|Overall Study||0
10594145|NCT01796470|11750547|FG004|COMPLETED|Overall Study||0
10594146|NCT01796470|11750543|FG000|NOT COMPLETED|Overall Study||35
10594147|NCT01796470|11750544|FG001|NOT COMPLETED|Overall Study||14
10594148|NCT01796470|11750545|FG002|NOT COMPLETED|Overall Study||6
10594149|NCT01796470|11750546|FG003|NOT COMPLETED|Overall Study||3
10594150|NCT01796470|11750547|FG004|NOT COMPLETED|Overall Study||8
10594151|NCT01796548|11750563|FG000|STARTED|Overall Study||17
10594152|NCT01796548|11750563|FG000|Treated|Overall Study||15
10594153|NCT01796548|11750563|FG000|COMPLETED|Overall Study||14
10594154|NCT01796548|11750563|FG000|NOT COMPLETED|Overall Study||3
10594155|NCT01796665|11750570|FG000|STARTED|Overall Study||474
10594156|NCT01796665|11750571|FG001|STARTED|Overall Study||469
10594157|NCT01796665|11750572|FG002|STARTED|Overall Study||237
10594158|NCT01796665|11750570|FG000|COMPLETED|Overall Study||416
10594159|NCT01796665|11750571|FG001|COMPLETED|Overall Study||396
10594160|NCT01796665|11750572|FG002|COMPLETED|Overall Study||195
10594161|NCT01796665|11750570|FG000|NOT COMPLETED|Overall Study||58
10594162|NCT01796665|11750571|FG001|NOT COMPLETED|Overall Study||73
10594163|NCT01796665|11750572|FG002|NOT COMPLETED|Overall Study||42
10594164|NCT01796860|11750580|FG000|STARTED|Overall Study||10
10594165|NCT01796860|11750580|FG000|COMPLETED|Overall Study||7
10594166|NCT01796860|11750580|FG000|NOT COMPLETED|Overall Study||3
10594167|NCT01796912|11750584|FG000|STARTED|First Intervention||10
10703569|NCT02584959|11868015|FG001|STARTED|Period 2||25
10703570|NCT02584959|11868016|FG002|STARTED|Period 2||15
10703571|NCT02584959|11868014|FG000|COMPLETED|Period 2||22
10703572|NCT02584959|11868015|FG001|COMPLETED|Period 2||24
10703573|NCT02584959|11868016|FG002|COMPLETED|Period 2||13
10703574|NCT02584959|11868014|FG000|NOT COMPLETED|Period 2||6
10703575|NCT02584959|11868015|FG001|NOT COMPLETED|Period 2||1
10703576|NCT02584959|11868016|FG002|NOT COMPLETED|Period 2||2
10703577|NCT02584998|11868036|FG000|STARTED|Overall Study||260
10703578|NCT02584998|11868037|FG001|STARTED|Overall Study||261
10703579|NCT02584998|11868038|FG002|STARTED|Overall Study||261
10594168|NCT01796912|11750585|FG001|STARTED|First Intervention||10
10594169|NCT01796912|11750584|FG000|COMPLETED|First Intervention||10
10594170|NCT01796912|11750585|FG001|COMPLETED|First Intervention||10
10594171|NCT01796912|11750584|FG000|NOT COMPLETED|First Intervention||0
10594172|NCT01796912|11750585|FG001|NOT COMPLETED|First Intervention||0
10594173|NCT01796912|11750584|FG000|STARTED|Washout||10
10594174|NCT01796912|11750585|FG001|STARTED|Washout||10
10594175|NCT01796912|11750584|FG000|COMPLETED|Washout||10
10594176|NCT01796912|11750585|FG001|COMPLETED|Washout||10
10594177|NCT01796912|11750584|FG000|NOT COMPLETED|Washout||0
10594178|NCT01796912|11750585|FG001|NOT COMPLETED|Washout||0
10594179|NCT01796912|11750584|FG000|STARTED|Second Intervention||10
10594180|NCT01796912|11750585|FG001|STARTED|Second Intervention||10
10594181|NCT01796912|11750584|FG000|COMPLETED|Second Intervention||10
10594182|NCT01796912|11750585|FG001|COMPLETED|Second Intervention||10
10594183|NCT01796912|11750584|FG000|NOT COMPLETED|Second Intervention||0
10594184|NCT01796912|11750585|FG001|NOT COMPLETED|Second Intervention||0
10594185|NCT01796964|11750595|FG000|STARTED|Overall Study||44
10594186|NCT01796964|11750596|FG001|STARTED|Overall Study||45
10594187|NCT01796964|11750595|FG000|COMPLETED|Overall Study||41
10594188|NCT01796964|11750596|FG001|COMPLETED|Overall Study||42
10594189|NCT01796964|11750595|FG000|NOT COMPLETED|Overall Study||3
10594190|NCT01796964|11750596|FG001|NOT COMPLETED|Overall Study||3
10594191|NCT01796977|11750603|FG000|STARTED|Overall Study||27
10594192|NCT01796977|11750603|FG000|COMPLETED|Overall Study||27
10594193|NCT01796977|11750603|FG000|NOT COMPLETED|Overall Study||0
10594194|NCT01797029|11750614|FG000|STARTED|Overall Study||1174
10594195|NCT01797029|11750615|FG001|STARTED|Overall Study||587
10594196|NCT01797029|11750614|FG000|COMPLETED|Overall Study||1015
10594197|NCT01797029|11750615|FG001|COMPLETED|Overall Study||526
10594198|NCT01797029|11750614|FG000|NOT COMPLETED|Overall Study||159
10594199|NCT01797029|11750615|FG001|NOT COMPLETED|Overall Study||61
10594200|NCT01797081|11750625|FG000|STARTED|Overall Study||104
10594201|NCT01797081|11750626|FG001|STARTED|Overall Study||99
10594202|NCT01797081|11750627|FG002|STARTED|Overall Study||48
10594203|NCT01797081|11750628|FG003|STARTED|Overall Study||49
10594204|NCT01797081|11750625|FG000|COMPLETED|Overall Study||90
10594205|NCT01797081|11750626|FG001|COMPLETED|Overall Study||95
10594206|NCT01797081|11750627|FG002|COMPLETED|Overall Study||43
10594207|NCT01797081|11750628|FG003|COMPLETED|Overall Study||40
10594208|NCT01797081|11750625|FG000|NOT COMPLETED|Overall Study||14
10594209|NCT01797081|11750626|FG001|NOT COMPLETED|Overall Study||4
10594210|NCT01797081|11750627|FG002|NOT COMPLETED|Overall Study||5
10594211|NCT01797081|11750628|FG003|NOT COMPLETED|Overall Study||9
10594212|NCT01797094|11750638|FG000|STARTED|Overall Study||48
10594213|NCT01797094|11750639|FG001|STARTED|Overall Study||53
10594214|NCT01797094|11750638|FG000|COMPLETED|Overall Study||42
10594215|NCT01797094|11750639|FG001|COMPLETED|Overall Study||51
10594216|NCT01797094|11750638|FG000|NOT COMPLETED|Overall Study||6
10594217|NCT01797094|11750639|FG001|NOT COMPLETED|Overall Study||2
10594218|NCT01797120|11750647|FG000|STARTED|Overall Study||66
10594219|NCT01797120|11750648|FG001|STARTED|Overall Study||65
10594220|NCT01797120|11750647|FG000|COMPLETED|Overall Study||0
10594221|NCT01797120|11750648|FG001|COMPLETED|Overall Study||0
10594222|NCT01797120|11750647|FG000|NOT COMPLETED|Overall Study||66
10594223|NCT01797120|11750648|FG001|NOT COMPLETED|Overall Study||65
10594224|NCT01797159|11750654|FG000|STARTED|Overall Study||20
10594225|NCT01797159|11750654|FG000|COMPLETED|Overall Study||20
10703580|NCT02584998|11868036|FG000|COMPLETED|Overall Study||260
10703581|NCT02584998|11868037|FG001|COMPLETED|Overall Study||261
10703582|NCT02584998|11868038|FG002|COMPLETED|Overall Study||261
10594226|NCT01797159|11750654|FG000|NOT COMPLETED|Overall Study||0
10652152|NCT02181803|11812486|FG000|COMPLETED|Overall Study||1
10652153|NCT02181803|11812487|FG001|COMPLETED|Overall Study||9
10652154|NCT02181803|11812488|FG002|COMPLETED|Overall Study||4
10652155|NCT02181803|11812489|FG003|COMPLETED|Overall Study||11
10652156|NCT02181803|11812490|FG004|COMPLETED|Overall Study||6
10652157|NCT02181803|11812491|FG005|COMPLETED|Overall Study||6
10652158|NCT02181803|11812492|FG006|COMPLETED|Overall Study||8
10652159|NCT02181803|11812493|FG007|COMPLETED|Overall Study||0
10652160|NCT02181803|11812494|FG008|COMPLETED|Overall Study||2
10652161|NCT02181803|11812486|FG000|NOT COMPLETED|Overall Study||0
10652162|NCT02181803|11812487|FG001|NOT COMPLETED|Overall Study||4
10703583|NCT02584998|11868036|FG000|NOT COMPLETED|Overall Study||0
10594227|NCT01797185|11750662|FG000|STARTED|Overall Study||162
10594228|NCT01797185|11750663|FG001|STARTED|Overall Study||163
10594229|NCT01797185|11750664|FG002|STARTED|Overall Study||50
10594230|NCT01797185|11750662|FG000|COMPLETED|Overall Study||134
10594231|NCT01797185|11750663|FG001|COMPLETED|Overall Study||125
10594232|NCT01797185|11750664|FG002|COMPLETED|Overall Study||38
10594233|NCT01797185|11750662|FG000|NOT COMPLETED|Overall Study||28
10594234|NCT01797185|11750663|FG001|NOT COMPLETED|Overall Study||38
10594235|NCT01797185|11750664|FG002|NOT COMPLETED|Overall Study||12
10594236|NCT01797263|11750674|FG000|STARTED|Overall Study||129
10594237|NCT01797263|11750675|FG001|STARTED|Overall Study||127
10594238|NCT01797263|11750674|FG000|1 Month|Overall Study||96
10594239|NCT01797263|11750675|FG001|1 Month|Overall Study||87
10594240|NCT01797263|11750674|FG000|3 Month|Overall Study||87
10594241|NCT01797263|11750675|FG001|3 Month|Overall Study||84
10594242|NCT01797263|11750674|FG000|6 Month|Overall Study||90
10594243|NCT01797263|11750675|FG001|6 Month|Overall Study||85
10594244|NCT01797263|11750674|FG000|9 Month|Overall Study||92
10594245|NCT01797263|11750675|FG001|9 Month|Overall Study||87
10594246|NCT01797263|11750674|FG000|COMPLETED|Overall Study||92
10594247|NCT01797263|11750675|FG001|COMPLETED|Overall Study||87
10594248|NCT01797263|11750674|FG000|NOT COMPLETED|Overall Study||37
10594249|NCT01797263|11750675|FG001|NOT COMPLETED|Overall Study||40
10594250|NCT01797302|11750684|FG000|STARTED|Overall Study||75
10594251|NCT01797302|11750685|FG001|STARTED|Overall Study||74
10594252|NCT01797302|11750686|FG002|STARTED|Overall Study||76
10594253|NCT01797302|11750684|FG000|3 Month Visit|Overall Study||60
10594254|NCT01797302|11750685|FG001|3 Month Visit|Overall Study||57
10594255|NCT01797302|11750686|FG002|3 Month Visit|Overall Study||57
10594256|NCT01797302|11750684|FG000|COMPLETED|Overall Study||58
10594257|NCT01797302|11750685|FG001|COMPLETED|Overall Study||48
10594258|NCT01797302|11750686|FG002|COMPLETED|Overall Study||50
10594259|NCT01797302|11750684|FG000|NOT COMPLETED|Overall Study||17
10594260|NCT01797302|11750685|FG001|NOT COMPLETED|Overall Study||26
10594261|NCT01797302|11750686|FG002|NOT COMPLETED|Overall Study||26
10594262|NCT01797328|11750696|FG000|STARTED|Overall Study||16
10594263|NCT01797328|11750697|FG001|STARTED|Overall Study||12
10594264|NCT01797328|11750696|FG000|COMPLETED|Overall Study||14
10594265|NCT01797328|11750697|FG001|COMPLETED|Overall Study||12
10594266|NCT01797328|11750696|FG000|NOT COMPLETED|Overall Study||2
10594267|NCT01797328|11750697|FG001|NOT COMPLETED|Overall Study||0
10594268|NCT01797432|11750703|FG000|STARTED|Overall Study||14
10594269|NCT01797432|11750703|FG000|COMPLETED|Overall Study||10
10594270|NCT01797432|11750703|FG000|NOT COMPLETED|Overall Study||4
10594271|NCT01797445|11750709|FG000|STARTED|Double-Blind Phase||435
10594272|NCT01797445|11750710|FG001|STARTED|Double-Blind Phase||437
10594273|NCT01797445|11750709|FG000|COMPLETED|Double-Blind Phase||348
10594274|NCT01797445|11750710|FG001|COMPLETED|Double-Blind Phase||348
10594275|NCT01797445|11750709|FG000|NOT COMPLETED|Double-Blind Phase||87
10594276|NCT01797445|11750710|FG001|NOT COMPLETED|Double-Blind Phase||89
10594277|NCT01797445|11750709|FG000|STARTED|Open-Label Extension Phase|207 participants completed the Double-Blind Phase, but did not enter the Open-Label Extension Phase.|141
10594278|NCT01797445|11750710|FG001|STARTED|Open-Label Extension Phase|229 participants completed the Double-Blind Phase, but did not enter the Open-Label Extension Phase.|119
10594279|NCT01797445|11750709|FG000|COMPLETED|Open-Label Extension Phase||140
10594280|NCT01797445|11750710|FG001|COMPLETED|Open-Label Extension Phase||119
10594281|NCT01797445|11750709|FG000|NOT COMPLETED|Open-Label Extension Phase||1
10594282|NCT01797445|11750710|FG001|NOT COMPLETED|Open-Label Extension Phase||0
10594292|NCT01797471|11750740|FG000|STARTED|Overall Study||1
10594293|NCT01797471|11750740|FG000|COMPLETED|Overall Study||1
10594294|NCT01797471|11750740|FG000|NOT COMPLETED|Overall Study||0
10594295|NCT01797484|11750746|FG000|STARTED|Overall Study||10
10594296|NCT01797484|11750747|FG001|STARTED|Overall Study||10
10594297|NCT01797484|11750746|FG000|COMPLETED|Overall Study||10
10594298|NCT01797484|11750747|FG001|COMPLETED|Overall Study||10
10594299|NCT01797484|11750746|FG000|NOT COMPLETED|Overall Study||0
10594300|NCT01797484|11750747|FG001|NOT COMPLETED|Overall Study||0
10594301|NCT01797536|11750757|FG000|STARTED|Overall Study||8
10594302|NCT01797536|11750758|FG001|STARTED|Overall Study|Includes 3 participants from mild arm who were mistakenly re-enrolled and also dosed in moderate arm|11
10594303|NCT01797536|11750759|FG002|STARTED|Overall Study||7
10594304|NCT01797536|11750760|FG003|STARTED|Overall Study||8
10594305|NCT01797536|11750757|FG000|COMPLETED|Overall Study||8
10594306|NCT01797536|11750758|FG001|COMPLETED|Overall Study||10
10594307|NCT01797536|11750759|FG002|COMPLETED|Overall Study||7
10594308|NCT01797536|11750760|FG003|COMPLETED|Overall Study||8
10594309|NCT01797536|11750757|FG000|NOT COMPLETED|Overall Study||0
10594310|NCT01797536|11750758|FG001|NOT COMPLETED|Overall Study||1
10594311|NCT01797536|11750759|FG002|NOT COMPLETED|Overall Study||0
10594312|NCT01797536|11750760|FG003|NOT COMPLETED|Overall Study||0
10594313|NCT01797562|11750770|FG000|STARTED|Overall Study||116
10594314|NCT01797562|11750770|FG000|COMPLETED|Overall Study||111
10594315|NCT01797562|11750770|FG000|NOT COMPLETED|Overall Study||5
10594316|NCT01797575|11750779|FG000|STARTED|Baseline Allocation||5
10594317|NCT01797575|11750780|FG001|STARTED|Baseline Allocation||9
10594318|NCT01797575|11750781|FG002|STARTED|Baseline Allocation||9
10594319|NCT01797575|11750782|FG003|STARTED|Baseline Allocation||15
10594320|NCT01797575|11750779|FG000|COMPLETED|Baseline Allocation||4
10594321|NCT01797575|11750780|FG001|COMPLETED|Baseline Allocation||8
10594322|NCT01797575|11750781|FG002|COMPLETED|Baseline Allocation||4
10594323|NCT01797575|11750782|FG003|COMPLETED|Baseline Allocation||8
10594324|NCT01797575|11750779|FG000|NOT COMPLETED|Baseline Allocation||1
10594325|NCT01797575|11750780|FG001|NOT COMPLETED|Baseline Allocation||1
10594326|NCT01797575|11750781|FG002|NOT COMPLETED|Baseline Allocation||5
10594327|NCT01797575|11750782|FG003|NOT COMPLETED|Baseline Allocation||7
10594328|NCT01797575|11750779|FG000|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|4
10594329|NCT01797575|11750780|FG001|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|5
10594330|NCT01797575|11750781|FG002|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|5
10594331|NCT01797575|11750782|FG003|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|10
10594332|NCT01797575|11750779|FG000|COMPLETED|Week 8 Re-Randomization||4
10594333|NCT01797575|11750780|FG001|COMPLETED|Week 8 Re-Randomization||5
10594334|NCT01797575|11750781|FG002|COMPLETED|Week 8 Re-Randomization||4
10594335|NCT01797575|11750782|FG003|COMPLETED|Week 8 Re-Randomization||7
10594336|NCT01797575|11750779|FG000|NOT COMPLETED|Week 8 Re-Randomization||0
10594337|NCT01797575|11750780|FG001|NOT COMPLETED|Week 8 Re-Randomization||0
10594338|NCT01797575|11750781|FG002|NOT COMPLETED|Week 8 Re-Randomization||1
10594339|NCT01797575|11750782|FG003|NOT COMPLETED|Week 8 Re-Randomization||3
10594340|NCT01797705|11750796|FG000|STARTED|Overall Study||33
10594341|NCT01797705|11750796|FG000|COMPLETED|Overall Study||28
10594342|NCT01797705|11750796|FG000|NOT COMPLETED|Overall Study||5
10594343|NCT01797731|11750802|FG000|STARTED|Overall Study||50
10594344|NCT01797731|11750803|FG001|STARTED|Overall Study||50
10594345|NCT01797731|11750802|FG000|COMPLETED|Overall Study|3 were excluded due to not having proper radiographs for adequate follow up|47
10594346|NCT01797731|11750803|FG001|COMPLETED|Overall Study|3 excluded due to not having proper radiographs for adequate follow up|47
10594347|NCT01797731|11750802|FG000|NOT COMPLETED|Overall Study||3
10594348|NCT01797731|11750803|FG001|NOT COMPLETED|Overall Study||3
10594349|NCT01797783|11750811|FG000|STARTED|Overall Study||52
10594350|NCT01797783|11750812|FG001|STARTED|Overall Study||27
10594351|NCT01797783|11750811|FG000|COMPLETED|Overall Study||50
10594352|NCT01797783|11750812|FG001|COMPLETED|Overall Study||26
10594353|NCT01797783|11750811|FG000|NOT COMPLETED|Overall Study||2
10594354|NCT01797783|11750812|FG001|NOT COMPLETED|Overall Study||1
10594355|NCT01797822|11750826|FG000|STARTED|Overall Study||20
10594356|NCT01797822|11750826|FG000|COMPLETED|Overall Study|The protocol is now closed.|20
10594357|NCT01797822|11750826|FG000|NOT COMPLETED|Overall Study||0
10594358|NCT01797835|11750834|FG000|STARTED|Overall Study||153
10594359|NCT01797835|11750835|FG001|STARTED|Overall Study||141
10594360|NCT01797835|11750834|FG000|COMPLETED|Overall Study||122
10594361|NCT01797835|11750835|FG001|COMPLETED|Overall Study||114
10594362|NCT01797835|11750834|FG000|NOT COMPLETED|Overall Study||31
10594363|NCT01797835|11750835|FG001|NOT COMPLETED|Overall Study||27
10594364|NCT01797965|11750845|FG000|STARTED|Overall Study||597
10594365|NCT01797965|11750846|FG001|STARTED|Overall Study||607
10594366|NCT01797965|11750847|FG002|STARTED|Overall Study||70
10594367|NCT01797965|11750848|FG003|STARTED|Overall Study||227
10594368|NCT01797965|11750845|FG000|COMPLETED|Overall Study||48
10594369|NCT01797965|11750846|FG001|COMPLETED|Overall Study||38
10594370|NCT01797965|11750847|FG002|COMPLETED|Overall Study||62
10594371|NCT01797965|11750848|FG003|COMPLETED|Overall Study||154
10594372|NCT01797965|11750845|FG000|NOT COMPLETED|Overall Study||549
10594373|NCT01797965|11750846|FG001|NOT COMPLETED|Overall Study||569
10594374|NCT01797965|11750847|FG002|NOT COMPLETED|Overall Study||8
10594375|NCT01797965|11750848|FG003|NOT COMPLETED|Overall Study||73
10594376|NCT01798056|11750861|FG000|STARTED|Overall Study||117
10594377|NCT01798056|11750862|FG001|STARTED|Overall Study||115
10594378|NCT01798056|11750861|FG000|COMPLETED|Overall Study||90
10594379|NCT01798056|11750862|FG001|COMPLETED|Overall Study||90
10594380|NCT01798056|11750861|FG000|NOT COMPLETED|Overall Study||27
10594381|NCT01798056|11750862|FG001|NOT COMPLETED|Overall Study||25
10594382|NCT01798134|11750870|FG000|STARTED|Overall Study||25
10594383|NCT01798134|11750870|FG000|COMPLETED|Overall Study||9
10594384|NCT01798134|11750870|FG000|NOT COMPLETED|Overall Study||16
10594385|NCT01798186|11750878|FG000|STARTED|Overall Study||6
10594386|NCT01798186|11750879|FG001|STARTED|Overall Study||6
10594387|NCT01798186|11750880|FG002|STARTED|Overall Study||6
10594388|NCT01798186|11750881|FG003|STARTED|Overall Study||8
10594389|NCT01798186|11750878|FG000|COMPLETED|Overall Study||6
10594390|NCT01798186|11750879|FG001|COMPLETED|Overall Study||6
10594391|NCT01798186|11750880|FG002|COMPLETED|Overall Study||6
10594392|NCT01798186|11750881|FG003|COMPLETED|Overall Study||8
10594393|NCT01798186|11750878|FG000|NOT COMPLETED|Overall Study||0
10594394|NCT01798186|11750879|FG001|NOT COMPLETED|Overall Study||0
10594395|NCT01798186|11750880|FG002|NOT COMPLETED|Overall Study||0
10594396|NCT01798186|11750881|FG003|NOT COMPLETED|Overall Study||0
10594397|NCT01798225|11750896|FG000|STARTED|Overall Study||57
10594398|NCT01798225|11750897|FG001|STARTED|Overall Study||56
10594399|NCT01798225|11750896|FG000|COMPLETED|Overall Study||57
10594400|NCT01798225|11750897|FG001|COMPLETED|Overall Study||53
10594401|NCT01798225|11750896|FG000|NOT COMPLETED|Overall Study||0
10594402|NCT01798225|11750897|FG001|NOT COMPLETED|Overall Study||3
10594403|NCT01798264|11750907|FG000|STARTED|Overall Study||12
10594404|NCT01798264|11750908|FG001|STARTED|Overall Study||11
10594405|NCT01798264|11750909|FG002|STARTED|Overall Study||10
10594406|NCT01798264|11750910|FG003|STARTED|Overall Study||11
10594407|NCT01798264|11750907|FG000|COMPLETED|Overall Study||11
10594408|NCT01798264|11750908|FG001|COMPLETED|Overall Study||11
10594409|NCT01798264|11750909|FG002|COMPLETED|Overall Study||10
10594410|NCT01798264|11750910|FG003|COMPLETED|Overall Study||7
10594411|NCT01798264|11750907|FG000|NOT COMPLETED|Overall Study||1
10594412|NCT01798264|11750908|FG001|NOT COMPLETED|Overall Study||0
10594413|NCT01798264|11750909|FG002|NOT COMPLETED|Overall Study||0
10594414|NCT01798264|11750910|FG003|NOT COMPLETED|Overall Study||4
10594415|NCT01798316|11750922|FG000|STARTED|Overall Study||52
10594416|NCT01798316|11750923|FG001|STARTED|Overall Study||53
10594417|NCT01798316|11750922|FG000|COMPLETED|Overall Study||52
10594418|NCT01798316|11750923|FG001|COMPLETED|Overall Study||53
10594419|NCT01798316|11750922|FG000|NOT COMPLETED|Overall Study||0
10594420|NCT01798316|11750923|FG001|NOT COMPLETED|Overall Study||0
10594421|NCT01798394|11750933|FG000|STARTED|Overall Study||24
10594422|NCT01798394|11750934|FG001|STARTED|Overall Study||22
10594423|NCT01798394|11750933|FG000|COMPLETED|Overall Study||21
10594424|NCT01798394|11750934|FG001|COMPLETED|Overall Study||19
10594425|NCT01798394|11750933|FG000|NOT COMPLETED|Overall Study||3
10594426|NCT01798394|11750934|FG001|NOT COMPLETED|Overall Study||3
10594427|NCT01798485|11750942|FG000|STARTED|Overall Study||347
10594428|NCT01798485|11750943|FG001|STARTED|Overall Study||349
10594429|NCT01798485|11750942|FG000|Safety Population as of 23 Dec 2015|Overall Study||338
10594430|NCT01798485|11750943|FG001|Safety Population as of 23 Dec 2015|Overall Study||342
10594431|NCT01798485|11750942|FG000|Randomized as of 19 October 2015|Overall Study||335
10594432|NCT01798485|11750943|FG001|Randomized as of 19 October 2015|Overall Study||337
10594433|NCT01798485|11750942|FG000|COMPLETED|Overall Study||1
10594434|NCT01798485|11750943|FG001|COMPLETED|Overall Study||59
10594435|NCT01798485|11750942|FG000|NOT COMPLETED|Overall Study||346
10594436|NCT01798485|11750943|FG001|NOT COMPLETED|Overall Study||290
10594437|NCT01798550|11750951|FG000|STARTED|Overall Study||30
10594438|NCT01798550|11750952|FG001|STARTED|Overall Study||32
10594439|NCT01798550|11750951|FG000|COMPLETED|Overall Study||28
10594440|NCT01798550|11750952|FG001|COMPLETED|Overall Study||26
10594441|NCT01798550|11750951|FG000|NOT COMPLETED|Overall Study||2
10594442|NCT01798550|11750952|FG001|NOT COMPLETED|Overall Study||6
10594443|NCT01798589|11750958|FG000|STARTED|Overall Study||16
10594444|NCT01798589|11750958|FG000|COMPLETED|Overall Study||16
10594445|NCT01798589|11750958|FG000|NOT COMPLETED|Overall Study||0
10594446|NCT01798641|11750968|FG000|STARTED|First Intervention (6 Weeks)||19
10594447|NCT01798641|11750969|FG001|STARTED|First Intervention (6 Weeks)||19
10594448|NCT01798641|11750968|FG000|COMPLETED|First Intervention (6 Weeks)||19
10594449|NCT01798641|11750969|FG001|COMPLETED|First Intervention (6 Weeks)||19
10594450|NCT01798641|11750968|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
10594451|NCT01798641|11750969|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
10594452|NCT01798641|11750968|FG000|STARTED|Second Intervention (6 Weeks)||19
10594453|NCT01798641|11750969|FG001|STARTED|Second Intervention (6 Weeks)||19
10703584|NCT02584998|11868037|FG001|NOT COMPLETED|Overall Study||0
10703585|NCT02584998|11868038|FG002|NOT COMPLETED|Overall Study||0
10703586|NCT02585245|11868046|FG000|STARTED|Overall Study||607
10703587|NCT02585245|11868046|FG000|COMPLETED|Overall Study||594
10703588|NCT02585245|11868046|FG000|NOT COMPLETED|Overall Study||13
10703589|NCT02585700|11868053|FG000|STARTED|Overall Study||30
10703590|NCT02585700|11868054|FG001|STARTED|Overall Study||30
10703591|NCT02585700|11868053|FG000|COMPLETED|Overall Study||30
10703592|NCT02585700|11868054|FG001|COMPLETED|Overall Study||30
10703593|NCT02585700|11868053|FG000|NOT COMPLETED|Overall Study||0
10703594|NCT02585700|11868054|FG001|NOT COMPLETED|Overall Study||0
10703595|NCT02585713|11868062|FG000|STARTED|Overall Study||150
10703596|NCT02585713|11868063|FG001|STARTED|Overall Study||150
10703597|NCT02585713|11868062|FG000|COMPLETED|Overall Study||145
10703598|NCT02585713|11868063|FG001|COMPLETED|Overall Study||142
10703599|NCT02585713|11868062|FG000|NOT COMPLETED|Overall Study||5
10703600|NCT02585713|11868063|FG001|NOT COMPLETED|Overall Study||8
10703601|NCT02585778|11868073|FG000|STARTED|Overall Study|Randomized|345
10703602|NCT02585778|11868074|FG001|STARTED|Overall Study|Randomized|172
10703603|NCT02585778|11868073|FG000|Treated (Safety Population)|Overall Study||344
10594454|NCT01798641|11750968|FG000|COMPLETED|Second Intervention (6 Weeks)||19
10594455|NCT01798641|11750969|FG001|COMPLETED|Second Intervention (6 Weeks)||19
10594456|NCT01798641|11750968|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
10594457|NCT01798641|11750969|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
10594458|NCT01798706|11750978|FG000|STARTED|Overall Study||176
10594459|NCT01798706|11750979|FG001|STARTED|Overall Study||174
10594460|NCT01798706|11750978|FG000|COMPLETED|Overall Study||155
10594461|NCT01798706|11750979|FG001|COMPLETED|Overall Study||153
10594462|NCT01798706|11750978|FG000|NOT COMPLETED|Overall Study||21
10594463|NCT01798706|11750979|FG001|NOT COMPLETED|Overall Study||21
10594464|NCT01798849|11750988|FG000|STARTED|Overall Study||8
10594465|NCT01798849|11750989|FG001|STARTED|Overall Study||8
10703604|NCT02585778|11868074|FG001|Treated (Safety Population)|Overall Study||170
10703605|NCT02585778|11868073|FG000|ITT Population|Overall Study||336
10703606|NCT02585778|11868074|FG001|ITT Population|Overall Study||167
10652163|NCT02181803|11812488|FG002|NOT COMPLETED|Overall Study||0
10594466|NCT01798849|11750990|FG002|STARTED|Overall Study|1 participant discontinued after Period 1 and was replaced for Periods 2-4|9
10594467|NCT01798849|11750988|FG000|COMPLETED|Overall Study||8
10594468|NCT01798849|11750989|FG001|COMPLETED|Overall Study||8
10594469|NCT01798849|11750990|FG002|COMPLETED|Overall Study||8
10594470|NCT01798849|11750988|FG000|NOT COMPLETED|Overall Study||0
10594471|NCT01798849|11750989|FG001|NOT COMPLETED|Overall Study||0
10594472|NCT01798849|11750990|FG002|NOT COMPLETED|Overall Study||1
10594473|NCT01798927|11751027|FG000|STARTED|Overall Study||4
10594474|NCT01798927|11751027|FG000|COMPLETED|Overall Study||3
10594475|NCT01798927|11751027|FG000|NOT COMPLETED|Overall Study||1
10594476|NCT01798966|11751031|FG000|STARTED|Overall Study||10
10594477|NCT01798966|11751031|FG000|COMPLETED|Overall Study||10
10594478|NCT01798966|11751031|FG000|NOT COMPLETED|Overall Study||0
10594479|NCT01798992|11751040|FG000|STARTED|Overall Study||4
10594480|NCT01798992|11751041|FG001|STARTED|Overall Study||19
10594481|NCT01798992|11751042|FG002|STARTED|Overall Study||16
10594482|NCT01798992|11751043|FG003|STARTED|Overall Study||17
10594483|NCT01798992|11751040|FG000|COMPLETED|Overall Study||4
10594484|NCT01798992|11751041|FG001|COMPLETED|Overall Study||17
10594485|NCT01798992|11751042|FG002|COMPLETED|Overall Study||14
10594486|NCT01798992|11751043|FG003|COMPLETED|Overall Study||16
10594487|NCT01798992|11751040|FG000|NOT COMPLETED|Overall Study||0
10594488|NCT01798992|11751041|FG001|NOT COMPLETED|Overall Study||2
10594489|NCT01798992|11751042|FG002|NOT COMPLETED|Overall Study||2
10594490|NCT01798992|11751043|FG003|NOT COMPLETED|Overall Study||1
10594491|NCT01799135|11751052|FG000|STARTED|Overall Study||6
10594492|NCT01799135|11751052|FG000|COMPLETED|Overall Study||6
10594493|NCT01799135|11751052|FG000|NOT COMPLETED|Overall Study||0
10594494|NCT01799213|11751058|FG000|STARTED|Overall Study||180
10594495|NCT01799213|11751059|FG001|STARTED|Overall Study||184
10594496|NCT01799213|11751058|FG000|COMPLETED|Overall Study||173
10594497|NCT01799213|11751059|FG001|COMPLETED|Overall Study||178
10594498|NCT01799213|11751058|FG000|NOT COMPLETED|Overall Study||7
10594499|NCT01799213|11751059|FG001|NOT COMPLETED|Overall Study||6
10594500|NCT01799226|11751073|FG000|STARTED|Overall Study||16
10594501|NCT01799226|11751074|FG001|STARTED|Overall Study||16
10594502|NCT01799226|11751073|FG000|Right Stent Side|Overall Study||8
10594503|NCT01799226|11751074|FG001|Right Stent Side|Overall Study||8
10594504|NCT01799226|11751073|FG000|Left Stent Side|Overall Study||8
10594505|NCT01799226|11751074|FG001|Left Stent Side|Overall Study||8
10594506|NCT01799226|11751073|FG000|COMPLETED|Overall Study||14
10594507|NCT01799226|11751074|FG001|COMPLETED|Overall Study||16
10807770|NCT03878758|11969515|FG000|COMPLETED|Overall Study||154
10807771|NCT03878758|11969515|FG000|NOT COMPLETED|Overall Study||4
10807772|NCT03849300|11969532|FG000|STARTED|Overall Study||42
10807773|NCT03849300|11969533|FG001|STARTED|Overall Study||42
10807774|NCT03849300|11969534|FG002|STARTED|Overall Study||32
10807775|NCT03849300|11969535|FG003|STARTED|Overall Study||31
10807776|NCT03849300|11969532|FG000|COMPLETED|Overall Study||37
10807777|NCT03849300|11969533|FG001|COMPLETED|Overall Study||35
10807778|NCT03849300|11969534|FG002|COMPLETED|Overall Study||28
10807779|NCT03849300|11969535|FG003|COMPLETED|Overall Study||25
10807780|NCT03849300|11969532|FG000|NOT COMPLETED|Overall Study||5
10807781|NCT03849300|11969533|FG001|NOT COMPLETED|Overall Study||7
10807782|NCT03849300|11969534|FG002|NOT COMPLETED|Overall Study||4
10807783|NCT03849300|11969535|FG003|NOT COMPLETED|Overall Study||6
10807784|NCT03887429|11969551|FG000|STARTED|Overall Study||8
10807785|NCT03887429|11969552|FG001|STARTED|Overall Study||9
10594508|NCT01799226|11751073|FG000|NOT COMPLETED|Overall Study||2
10594509|NCT01799226|11751074|FG001|NOT COMPLETED|Overall Study||0
10594510|NCT01799239|11751080|FG000|STARTED|Period 1 (7 Days)|It was uncertain in which order the product were tested for 1 subject. Subject is excl from analysis|15
10594511|NCT01799239|11751081|FG001|STARTED|Period 1 (7 Days)|It was uncertain in which order the product were tested for 1 subject. Subject is excl from analysis|16
10594512|NCT01799239|11751080|FG000|COMPLETED|Period 1 (7 Days)||12
10594513|NCT01799239|11751081|FG001|COMPLETED|Period 1 (7 Days)||15
10594514|NCT01799239|11751080|FG000|NOT COMPLETED|Period 1 (7 Days)||3
10594515|NCT01799239|11751081|FG001|NOT COMPLETED|Period 1 (7 Days)||1
10594516|NCT01799239|11751080|FG000|STARTED|Period 2 (7 Days)||13
10594517|NCT01799239|11751081|FG001|STARTED|Period 2 (7 Days)||15
10594518|NCT01799239|11751080|FG000|COMPLETED|Period 2 (7 Days)||11
10594519|NCT01799239|11751081|FG001|COMPLETED|Period 2 (7 Days)||14
10594520|NCT01799239|11751080|FG000|NOT COMPLETED|Period 2 (7 Days)||2
10594521|NCT01799239|11751081|FG001|NOT COMPLETED|Period 2 (7 Days)||1
10594522|NCT01799278|11751087|FG000|STARTED|Overall Study||60
10594523|NCT01799278|11751087|FG000|COMPLETED|Overall Study||60
10594524|NCT01799278|11751087|FG000|NOT COMPLETED|Overall Study||0
10594525|NCT01799590|11751098|FG000|STARTED|Overall Study||111
10594526|NCT01799590|11751099|FG001|STARTED|Overall Study||94
10594527|NCT01799590|11751100|FG002|STARTED|Overall Study||91
10594528|NCT01799590|11751098|FG000|COMPLETED|Overall Study||85
10594529|NCT01799590|11751099|FG001|COMPLETED|Overall Study||78
10594530|NCT01799590|11751100|FG002|COMPLETED|Overall Study||77
10594531|NCT01799590|11751098|FG000|NOT COMPLETED|Overall Study||26
10594532|NCT01799590|11751099|FG001|NOT COMPLETED|Overall Study||16
10594533|NCT01799590|11751100|FG002|NOT COMPLETED|Overall Study||14
10807786|NCT03887429|11969553|FG002|STARTED|Overall Study||9
10807787|NCT03887429|11969554|FG003|STARTED|Overall Study||8
10807788|NCT03887429|11969551|FG000|Completed First Intervention (5 Days)|Overall Study||7
10807789|NCT03887429|11969552|FG001|Completed First Intervention (5 Days)|Overall Study||8
10807790|NCT03887429|11969553|FG002|Completed First Intervention (5 Days)|Overall Study||7
10594534|NCT01799720|11751111|FG000|STARTED|Overall Study||20
10594535|NCT01799720|11751112|FG001|STARTED|Overall Study||18
10594536|NCT01799720|11751113|FG002|STARTED|Overall Study||19
10594537|NCT01799720|11751111|FG000|Began the Treatment|Overall Study||20
10594538|NCT01799720|11751112|FG001|Began the Treatment|Overall Study||18
10594539|NCT01799720|11751113|FG002|Began the Treatment|Overall Study||19
10594540|NCT01799720|11751111|FG000|Began the Treatment and Finished it|Overall Study||17
10594541|NCT01799720|11751112|FG001|Began the Treatment and Finished it|Overall Study||17
10594542|NCT01799720|11751113|FG002|Began the Treatment and Finished it|Overall Study||18
10594543|NCT01799720|11751111|FG000|COMPLETED|Overall Study||17
10594544|NCT01799720|11751112|FG001|COMPLETED|Overall Study||17
10594545|NCT01799720|11751113|FG002|COMPLETED|Overall Study||18
10594546|NCT01799720|11751111|FG000|NOT COMPLETED|Overall Study||3
10594547|NCT01799720|11751112|FG001|NOT COMPLETED|Overall Study||1
10594548|NCT01799720|11751113|FG002|NOT COMPLETED|Overall Study||1
10594549|NCT01799889|11751133|FG000|STARTED|Overall Study||41
10594550|NCT01799889|11751134|FG001|STARTED|Overall Study||41
10594551|NCT01799889|11751135|FG002|STARTED|Overall Study||44
10594552|NCT01799889|11751136|FG003|STARTED|Overall Study||39
10594553|NCT01799889|11751137|FG004|STARTED|Overall Study||49
10594554|NCT01799889|11751138|FG005|STARTED|Overall Study||20
10594555|NCT01799889|11751139|FG006|STARTED|Overall Study||21
10594556|NCT01799889|11751140|FG007|STARTED|Overall Study||20
10594557|NCT01799889|11751141|FG008|STARTED|Overall Study||33
10594558|NCT01799889|11751142|FG009|STARTED|Overall Study||8
10594559|NCT01799889|11751143|FG010|STARTED|Overall Study||7
10594560|NCT01799889|11751144|FG011|STARTED|Overall Study||3
10594561|NCT01799889|11751133|FG000|COMPLETED|Overall Study||0
10594562|NCT01799889|11751134|FG001|COMPLETED|Overall Study||0
10594563|NCT01799889|11751135|FG002|COMPLETED|Overall Study||0
10594564|NCT01799889|11751136|FG003|COMPLETED|Overall Study||0
10594565|NCT01799889|11751137|FG004|COMPLETED|Overall Study||0
10594566|NCT01799889|11751138|FG005|COMPLETED|Overall Study||0
10594567|NCT01799889|11751139|FG006|COMPLETED|Overall Study||0
10594568|NCT01799889|11751140|FG007|COMPLETED|Overall Study||0
10594569|NCT01799889|11751141|FG008|COMPLETED|Overall Study||0
10594570|NCT01799889|11751142|FG009|COMPLETED|Overall Study||0
10594571|NCT01799889|11751143|FG010|COMPLETED|Overall Study||0
10594572|NCT01799889|11751144|FG011|COMPLETED|Overall Study||0
10594573|NCT01799889|11751133|FG000|NOT COMPLETED|Overall Study||41
10594574|NCT01799889|11751134|FG001|NOT COMPLETED|Overall Study||41
10594575|NCT01799889|11751135|FG002|NOT COMPLETED|Overall Study||44
10594576|NCT01799889|11751136|FG003|NOT COMPLETED|Overall Study||39
10594577|NCT01799889|11751137|FG004|NOT COMPLETED|Overall Study||49
10594578|NCT01799889|11751138|FG005|NOT COMPLETED|Overall Study||20
10594579|NCT01799889|11751139|FG006|NOT COMPLETED|Overall Study||21
10594580|NCT01799889|11751140|FG007|NOT COMPLETED|Overall Study||20
10594581|NCT01799889|11751141|FG008|NOT COMPLETED|Overall Study||33
10594582|NCT01799889|11751142|FG009|NOT COMPLETED|Overall Study||8
10594583|NCT01799889|11751143|FG010|NOT COMPLETED|Overall Study||7
10594584|NCT01799889|11751144|FG011|NOT COMPLETED|Overall Study||3
10594585|NCT01799941|11751181|FG000|STARTED|Overall Study||367
10594586|NCT01799941|11751181|FG000|COMPLETED|Overall Study||271
10594587|NCT01799941|11751181|FG000|NOT COMPLETED|Overall Study||96
10594588|NCT01799993|11751193|FG000|STARTED|Overall Study||362
10594589|NCT01799993|11751194|FG001|STARTED|Overall Study||363
10594590|NCT01799993|11751193|FG000|ITT Population|Overall Study||354
10594591|NCT01799993|11751194|FG001|ITT Population|Overall Study||358
10594592|NCT01799993|11751193|FG000|mITT Population|Overall Study||255
10594593|NCT01799993|11751194|FG001|mITT Population|Overall Study||253
10594594|NCT01799993|11751193|FG000|COMPLETED|Overall Study||229
10594595|NCT01799993|11751194|FG001|COMPLETED|Overall Study||235
10594596|NCT01799993|11751193|FG000|NOT COMPLETED|Overall Study||133
10594597|NCT01799993|11751194|FG001|NOT COMPLETED|Overall Study||128
10594598|NCT01800058|11751200|FG000|STARTED|Overall Study||66
10594599|NCT01800058|11751200|FG000|COMPLETED|Overall Study||65
10594600|NCT01800058|11751200|FG000|NOT COMPLETED|Overall Study||1
10594601|NCT01800201|11751207|FG000|STARTED|Overall Study||506
10594602|NCT01800201|11751208|FG001|STARTED|Overall Study||1003
10594603|NCT01800201|11751207|FG000|COMPLETED|Overall Study||503
10594604|NCT01800201|11751208|FG001|COMPLETED|Overall Study||1000
10594605|NCT01800201|11751207|FG000|NOT COMPLETED|Overall Study||3
10594606|NCT01800201|11751208|FG001|NOT COMPLETED|Overall Study||3
10594607|NCT01800318|11751219|FG000|STARTED|Overall Study||39
10594608|NCT01800318|11751220|FG001|STARTED|Overall Study||42
10594609|NCT01800318|11751221|FG002|STARTED|Overall Study||41
10594610|NCT01800318|11751222|FG003|STARTED|Overall Study||40
10594611|NCT01800318|11751219|FG000|COMPLETED|Overall Study||37
10594612|NCT01800318|11751220|FG001|COMPLETED|Overall Study||37
10594613|NCT01800318|11751221|FG002|COMPLETED|Overall Study||40
10594614|NCT01800318|11751222|FG003|COMPLETED|Overall Study||39
10594615|NCT01800318|11751219|FG000|NOT COMPLETED|Overall Study||2
10594616|NCT01800318|11751220|FG001|NOT COMPLETED|Overall Study||5
10594617|NCT01800318|11751221|FG002|NOT COMPLETED|Overall Study||1
10594618|NCT01800318|11751222|FG003|NOT COMPLETED|Overall Study||1
10594619|NCT01800786|11751238|FG000|STARTED|Overall Study||17
10594620|NCT01800786|11751239|FG001|STARTED|Overall Study||16
10594621|NCT01800786|11751238|FG000|COMPLETED|Overall Study||15
10594622|NCT01800786|11751239|FG001|COMPLETED|Overall Study||15
10594623|NCT01800786|11751238|FG000|NOT COMPLETED|Overall Study||2
10594624|NCT01800786|11751239|FG001|NOT COMPLETED|Overall Study||1
10594625|NCT01800838|11751249|FG000|STARTED|Overall Study||1
10594626|NCT01800838|11751250|FG001|STARTED|Overall Study||1
10594627|NCT01800838|11751251|FG002|STARTED|Overall Study||7
10594628|NCT01800838|11751252|FG003|STARTED|Overall Study||2
10594629|NCT01800838|11751249|FG000|COMPLETED|Overall Study||1
10594630|NCT01800838|11751250|FG001|COMPLETED|Overall Study||1
10594631|NCT01800838|11751251|FG002|COMPLETED|Overall Study||7
10594632|NCT01800838|11751252|FG003|COMPLETED|Overall Study||2
10594633|NCT01800838|11751249|FG000|NOT COMPLETED|Overall Study||0
10594634|NCT01800838|11751250|FG001|NOT COMPLETED|Overall Study||0
10594635|NCT01800838|11751251|FG002|NOT COMPLETED|Overall Study||0
10594636|NCT01800838|11751252|FG003|NOT COMPLETED|Overall Study||0
10594637|NCT01800877|11751258|FG000|STARTED|Overall Study||60
10594638|NCT01800877|11751259|FG001|STARTED|Overall Study||60
10594639|NCT01800877|11751258|FG000|COMPLETED|Overall Study||58
10594640|NCT01800877|11751259|FG001|COMPLETED|Overall Study||60
10594641|NCT01800877|11751258|FG000|NOT COMPLETED|Overall Study||2
10594642|NCT01800877|11751259|FG001|NOT COMPLETED|Overall Study||0
10594643|NCT01800890|11751265|FG000|STARTED|Test Period 1||3
10594644|NCT01800890|11751266|FG001|STARTED|Test Period 1||3
10594645|NCT01800890|11751267|FG002|STARTED|Test Period 1||3
10594646|NCT01800890|11751268|FG003|STARTED|Test Period 1||3
10594647|NCT01800890|11751269|FG004|STARTED|Test Period 1||4
10594648|NCT01800890|11751270|FG005|STARTED|Test Period 1||4
10594649|NCT01800890|11751271|FG006|STARTED|Test Period 1||3
10594650|NCT01800890|11751272|FG007|STARTED|Test Period 1||3
10594651|NCT01800890|11751273|FG008|STARTED|Test Period 1||3
10594652|NCT01800890|11751265|FG000|COMPLETED|Test Period 1||3
10594653|NCT01800890|11751266|FG001|COMPLETED|Test Period 1||3
10594654|NCT01800890|11751267|FG002|COMPLETED|Test Period 1||3
10594655|NCT01800890|11751268|FG003|COMPLETED|Test Period 1||2
10594656|NCT01800890|11751269|FG004|COMPLETED|Test Period 1||4
10594657|NCT01800890|11751270|FG005|COMPLETED|Test Period 1||4
10594658|NCT01800890|11751271|FG006|COMPLETED|Test Period 1||3
10594659|NCT01800890|11751272|FG007|COMPLETED|Test Period 1||3
10594660|NCT01800890|11751273|FG008|COMPLETED|Test Period 1||3
10594661|NCT01800890|11751265|FG000|NOT COMPLETED|Test Period 1||0
10594662|NCT01800890|11751266|FG001|NOT COMPLETED|Test Period 1||0
10594663|NCT01800890|11751267|FG002|NOT COMPLETED|Test Period 1||0
10594664|NCT01800890|11751268|FG003|NOT COMPLETED|Test Period 1||1
10594665|NCT01800890|11751269|FG004|NOT COMPLETED|Test Period 1||0
10594666|NCT01800890|11751270|FG005|NOT COMPLETED|Test Period 1||0
10594667|NCT01800890|11751271|FG006|NOT COMPLETED|Test Period 1||0
10594668|NCT01800890|11751272|FG007|NOT COMPLETED|Test Period 1||0
10594669|NCT01800890|11751273|FG008|NOT COMPLETED|Test Period 1||0
10594670|NCT01800890|11751265|FG000|STARTED|Test Period 2||3
10594671|NCT01800890|11751266|FG001|STARTED|Test Period 2||3
10594672|NCT01800890|11751267|FG002|STARTED|Test Period 2||3
10594673|NCT01800890|11751268|FG003|STARTED|Test Period 2||2
10594674|NCT01800890|11751269|FG004|STARTED|Test Period 2||4
10594675|NCT01800890|11751270|FG005|STARTED|Test Period 2||4
10594676|NCT01800890|11751271|FG006|STARTED|Test Period 2||3
10594677|NCT01800890|11751272|FG007|STARTED|Test Period 2||3
10594678|NCT01800890|11751273|FG008|STARTED|Test Period 2||3
10594679|NCT01800890|11751265|FG000|COMPLETED|Test Period 2||3
10594680|NCT01800890|11751266|FG001|COMPLETED|Test Period 2||3
10594681|NCT01800890|11751267|FG002|COMPLETED|Test Period 2||3
10594682|NCT01800890|11751268|FG003|COMPLETED|Test Period 2||2
10594683|NCT01800890|11751269|FG004|COMPLETED|Test Period 2||4
10594684|NCT01800890|11751270|FG005|COMPLETED|Test Period 2||4
10594685|NCT01800890|11751271|FG006|COMPLETED|Test Period 2||3
10594686|NCT01800890|11751272|FG007|COMPLETED|Test Period 2||3
10594687|NCT01800890|11751273|FG008|COMPLETED|Test Period 2||3
10594688|NCT01800890|11751265|FG000|NOT COMPLETED|Test Period 2||0
10594689|NCT01800890|11751266|FG001|NOT COMPLETED|Test Period 2||0
10594690|NCT01800890|11751267|FG002|NOT COMPLETED|Test Period 2||0
10594691|NCT01800890|11751268|FG003|NOT COMPLETED|Test Period 2||0
10594692|NCT01800890|11751269|FG004|NOT COMPLETED|Test Period 2||0
10594693|NCT01800890|11751270|FG005|NOT COMPLETED|Test Period 2||0
10594694|NCT01800890|11751271|FG006|NOT COMPLETED|Test Period 2||0
10594695|NCT01800890|11751272|FG007|NOT COMPLETED|Test Period 2||0
10594696|NCT01800890|11751273|FG008|NOT COMPLETED|Test Period 2||0
10703607|NCT02585778|11868073|FG000|mITT Population|Overall Study||333
10703608|NCT02585778|11868074|FG001|mITT Population|Overall Study||164
10703609|NCT02585778|11868073|FG000|T1DM Participants|Overall Study||51
10703610|NCT02585778|11868074|FG001|T1DM Participants|Overall Study||25
10703611|NCT02585778|11868073|FG000|T2DM Participants|Overall Study||294
10703612|NCT02585778|11868074|FG001|T2DM Participants|Overall Study||147
10594697|NCT01800890|11751265|FG000|STARTED|Test Period 3||3
10594698|NCT01800890|11751266|FG001|STARTED|Test Period 3||3
10594699|NCT01800890|11751267|FG002|STARTED|Test Period 3||3
10594700|NCT01800890|11751268|FG003|STARTED|Test Period 3||2
10594701|NCT01800890|11751269|FG004|STARTED|Test Period 3||4
10594702|NCT01800890|11751270|FG005|STARTED|Test Period 3||4
10594703|NCT01800890|11751271|FG006|STARTED|Test Period 3||3
10594704|NCT01800890|11751272|FG007|STARTED|Test Period 3||3
10594705|NCT01800890|11751273|FG008|STARTED|Test Period 3||3
10594706|NCT01800890|11751265|FG000|COMPLETED|Test Period 3||3
10594707|NCT01800890|11751266|FG001|COMPLETED|Test Period 3||3
10594708|NCT01800890|11751267|FG002|COMPLETED|Test Period 3||3
10594709|NCT01800890|11751268|FG003|COMPLETED|Test Period 3||2
10594710|NCT01800890|11751269|FG004|COMPLETED|Test Period 3||4
10594711|NCT01800890|11751270|FG005|COMPLETED|Test Period 3||4
10594712|NCT01800890|11751271|FG006|COMPLETED|Test Period 3||3
10594713|NCT01800890|11751272|FG007|COMPLETED|Test Period 3||3
10594714|NCT01800890|11751273|FG008|COMPLETED|Test Period 3||3
10594715|NCT01800890|11751265|FG000|NOT COMPLETED|Test Period 3||0
10594716|NCT01800890|11751266|FG001|NOT COMPLETED|Test Period 3||0
10594717|NCT01800890|11751267|FG002|NOT COMPLETED|Test Period 3||0
10594718|NCT01800890|11751268|FG003|NOT COMPLETED|Test Period 3||0
10594719|NCT01800890|11751269|FG004|NOT COMPLETED|Test Period 3||0
10594720|NCT01800890|11751270|FG005|NOT COMPLETED|Test Period 3||0
10594721|NCT01800890|11751271|FG006|NOT COMPLETED|Test Period 3||0
10594722|NCT01800890|11751272|FG007|NOT COMPLETED|Test Period 3||0
10594723|NCT01800890|11751273|FG008|NOT COMPLETED|Test Period 3||0
10594724|NCT01800903|11751283|FG000|STARTED|First Test Period||7
10594725|NCT01800903|11751284|FG001|STARTED|First Test Period||6
10594726|NCT01800903|11751285|FG002|STARTED|First Test Period||4
10594727|NCT01800903|11751286|FG003|STARTED|First Test Period||7
10594728|NCT01800903|11751287|FG004|STARTED|First Test Period||6
10594729|NCT01800903|11751288|FG005|STARTED|First Test Period||6
10594730|NCT01800903|11751283|FG000|COMPLETED|First Test Period||7
10594731|NCT01800903|11751284|FG001|COMPLETED|First Test Period||6
10594732|NCT01800903|11751285|FG002|COMPLETED|First Test Period||4
10594733|NCT01800903|11751286|FG003|COMPLETED|First Test Period||7
10594734|NCT01800903|11751287|FG004|COMPLETED|First Test Period||6
10594735|NCT01800903|11751288|FG005|COMPLETED|First Test Period||6
10594736|NCT01800903|11751283|FG000|NOT COMPLETED|First Test Period||0
10594737|NCT01800903|11751284|FG001|NOT COMPLETED|First Test Period||0
10594738|NCT01800903|11751285|FG002|NOT COMPLETED|First Test Period||0
10594739|NCT01800903|11751286|FG003|NOT COMPLETED|First Test Period||0
10594740|NCT01800903|11751287|FG004|NOT COMPLETED|First Test Period||0
10594741|NCT01800903|11751288|FG005|NOT COMPLETED|First Test Period||0
10594742|NCT01800903|11751283|FG000|STARTED|Second Test Period||7
10594743|NCT01800903|11751284|FG001|STARTED|Second Test Period||6
10594744|NCT01800903|11751285|FG002|STARTED|Second Test Period||4
10594745|NCT01800903|11751286|FG003|STARTED|Second Test Period||7
10594746|NCT01800903|11751287|FG004|STARTED|Second Test Period||6
10594747|NCT01800903|11751288|FG005|STARTED|Second Test Period||6
10594748|NCT01800903|11751283|FG000|COMPLETED|Second Test Period||6
10594749|NCT01800903|11751284|FG001|COMPLETED|Second Test Period||6
10594750|NCT01800903|11751285|FG002|COMPLETED|Second Test Period||4
10594751|NCT01800903|11751286|FG003|COMPLETED|Second Test Period||7
10594752|NCT01800903|11751287|FG004|COMPLETED|Second Test Period||6
10594753|NCT01800903|11751288|FG005|COMPLETED|Second Test Period||6
10594754|NCT01800903|11751283|FG000|NOT COMPLETED|Second Test Period||1
10594755|NCT01800903|11751284|FG001|NOT COMPLETED|Second Test Period||0
10594756|NCT01800903|11751285|FG002|NOT COMPLETED|Second Test Period||0
10594757|NCT01800903|11751286|FG003|NOT COMPLETED|Second Test Period||0
10594758|NCT01800903|11751287|FG004|NOT COMPLETED|Second Test Period||0
10594759|NCT01800903|11751288|FG005|NOT COMPLETED|Second Test Period||0
10594760|NCT01800903|11751283|FG000|STARTED|Third Test Period||6
10594761|NCT01800903|11751284|FG001|STARTED|Third Test Period||6
10594762|NCT01800903|11751285|FG002|STARTED|Third Test Period||4
10594763|NCT01800903|11751286|FG003|STARTED|Third Test Period||7
10594764|NCT01800903|11751287|FG004|STARTED|Third Test Period||6
10594765|NCT01800903|11751288|FG005|STARTED|Third Test Period||6
10594766|NCT01800903|11751283|FG000|COMPLETED|Third Test Period||6
10594767|NCT01800903|11751284|FG001|COMPLETED|Third Test Period||6
10594768|NCT01800903|11751285|FG002|COMPLETED|Third Test Period||4
10594769|NCT01800903|11751286|FG003|COMPLETED|Third Test Period||7
10594770|NCT01800903|11751287|FG004|COMPLETED|Third Test Period||6
10594771|NCT01800903|11751288|FG005|COMPLETED|Third Test Period||6
10594772|NCT01800903|11751283|FG000|NOT COMPLETED|Third Test Period||0
10594773|NCT01800903|11751284|FG001|NOT COMPLETED|Third Test Period||0
10594774|NCT01800903|11751285|FG002|NOT COMPLETED|Third Test Period||0
10594775|NCT01800903|11751286|FG003|NOT COMPLETED|Third Test Period||0
10594776|NCT01800903|11751287|FG004|NOT COMPLETED|Third Test Period||0
10594777|NCT01800903|11751288|FG005|NOT COMPLETED|Third Test Period||0
10594778|NCT01800916|11751294|FG000|STARTED|Test Period 1 (1 Week)||7
10594779|NCT01800916|11751295|FG001|STARTED|Test Period 1 (1 Week)||7
10594780|NCT01800916|11751296|FG002|STARTED|Test Period 1 (1 Week)||7
10594781|NCT01800916|11751297|FG003|STARTED|Test Period 1 (1 Week)||7
10594782|NCT01800916|11751298|FG004|STARTED|Test Period 1 (1 Week)||8
10594783|NCT01800916|11751299|FG005|STARTED|Test Period 1 (1 Week)||7
10594784|NCT01800916|11751300|FG006|STARTED|Test Period 1 (1 Week)||7
10594785|NCT01800916|11751301|FG007|STARTED|Test Period 1 (1 Week)||7
10594786|NCT01800916|11751302|FG008|STARTED|Test Period 1 (1 Week)||7
10594787|NCT01800916|11751294|FG000|COMPLETED|Test Period 1 (1 Week)||7
10594788|NCT01800916|11751295|FG001|COMPLETED|Test Period 1 (1 Week)||7
10594789|NCT01800916|11751296|FG002|COMPLETED|Test Period 1 (1 Week)||7
10594790|NCT01800916|11751297|FG003|COMPLETED|Test Period 1 (1 Week)||6
10594791|NCT01800916|11751298|FG004|COMPLETED|Test Period 1 (1 Week)||7
10594792|NCT01800916|11751299|FG005|COMPLETED|Test Period 1 (1 Week)||7
10594793|NCT01800916|11751300|FG006|COMPLETED|Test Period 1 (1 Week)||7
10594794|NCT01800916|11751301|FG007|COMPLETED|Test Period 1 (1 Week)||7
10594795|NCT01800916|11751302|FG008|COMPLETED|Test Period 1 (1 Week)||7
10594796|NCT01800916|11751294|FG000|NOT COMPLETED|Test Period 1 (1 Week)||0
10594797|NCT01800916|11751295|FG001|NOT COMPLETED|Test Period 1 (1 Week)||0
10594798|NCT01800916|11751296|FG002|NOT COMPLETED|Test Period 1 (1 Week)||0
10594799|NCT01800916|11751297|FG003|NOT COMPLETED|Test Period 1 (1 Week)||1
10594800|NCT01800916|11751298|FG004|NOT COMPLETED|Test Period 1 (1 Week)||1
10594801|NCT01800916|11751299|FG005|NOT COMPLETED|Test Period 1 (1 Week)||0
10594802|NCT01800916|11751300|FG006|NOT COMPLETED|Test Period 1 (1 Week)||0
10594803|NCT01800916|11751301|FG007|NOT COMPLETED|Test Period 1 (1 Week)||0
10594804|NCT01800916|11751302|FG008|NOT COMPLETED|Test Period 1 (1 Week)||0
10594805|NCT01800916|11751294|FG000|STARTED|Test Period 2 (1 Week)||7
10594806|NCT01800916|11751295|FG001|STARTED|Test Period 2 (1 Week)||7
10594807|NCT01800916|11751296|FG002|STARTED|Test Period 2 (1 Week)||7
10594808|NCT01800916|11751297|FG003|STARTED|Test Period 2 (1 Week)||6
10594809|NCT01800916|11751298|FG004|STARTED|Test Period 2 (1 Week)||7
10594810|NCT01800916|11751299|FG005|STARTED|Test Period 2 (1 Week)||7
10594811|NCT01800916|11751300|FG006|STARTED|Test Period 2 (1 Week)||7
10594812|NCT01800916|11751301|FG007|STARTED|Test Period 2 (1 Week)||7
10594813|NCT01800916|11751302|FG008|STARTED|Test Period 2 (1 Week)||7
10594814|NCT01800916|11751294|FG000|COMPLETED|Test Period 2 (1 Week)||7
10594815|NCT01800916|11751295|FG001|COMPLETED|Test Period 2 (1 Week)||7
10594816|NCT01800916|11751296|FG002|COMPLETED|Test Period 2 (1 Week)||7
10594817|NCT01800916|11751297|FG003|COMPLETED|Test Period 2 (1 Week)||6
10594818|NCT01800916|11751298|FG004|COMPLETED|Test Period 2 (1 Week)||7
10594819|NCT01800916|11751299|FG005|COMPLETED|Test Period 2 (1 Week)||7
10594820|NCT01800916|11751300|FG006|COMPLETED|Test Period 2 (1 Week)||7
10594821|NCT01800916|11751301|FG007|COMPLETED|Test Period 2 (1 Week)||7
10594822|NCT01800916|11751302|FG008|COMPLETED|Test Period 2 (1 Week)||7
10594823|NCT01800916|11751294|FG000|NOT COMPLETED|Test Period 2 (1 Week)||0
10594824|NCT01800916|11751295|FG001|NOT COMPLETED|Test Period 2 (1 Week)||0
10594825|NCT01800916|11751296|FG002|NOT COMPLETED|Test Period 2 (1 Week)||0
10594826|NCT01800916|11751297|FG003|NOT COMPLETED|Test Period 2 (1 Week)||0
10594827|NCT01800916|11751298|FG004|NOT COMPLETED|Test Period 2 (1 Week)||0
10594828|NCT01800916|11751299|FG005|NOT COMPLETED|Test Period 2 (1 Week)||0
10594829|NCT01800916|11751300|FG006|NOT COMPLETED|Test Period 2 (1 Week)||0
10594830|NCT01800916|11751301|FG007|NOT COMPLETED|Test Period 2 (1 Week)||0
10594831|NCT01800916|11751302|FG008|NOT COMPLETED|Test Period 2 (1 Week)||0
10594832|NCT01800916|11751294|FG000|STARTED|Test Period 3 (1 Week)||7
10594833|NCT01800916|11751295|FG001|STARTED|Test Period 3 (1 Week)||7
10594834|NCT01800916|11751296|FG002|STARTED|Test Period 3 (1 Week)||7
10594835|NCT01800916|11751297|FG003|STARTED|Test Period 3 (1 Week)||6
10594836|NCT01800916|11751298|FG004|STARTED|Test Period 3 (1 Week)||7
10594837|NCT01800916|11751299|FG005|STARTED|Test Period 3 (1 Week)||7
10594838|NCT01800916|11751300|FG006|STARTED|Test Period 3 (1 Week)||7
10594839|NCT01800916|11751301|FG007|STARTED|Test Period 3 (1 Week)||7
10594840|NCT01800916|11751302|FG008|STARTED|Test Period 3 (1 Week)||7
10594841|NCT01800916|11751294|FG000|COMPLETED|Test Period 3 (1 Week)||7
10594842|NCT01800916|11751295|FG001|COMPLETED|Test Period 3 (1 Week)||7
10594843|NCT01800916|11751296|FG002|COMPLETED|Test Period 3 (1 Week)||7
10594844|NCT01800916|11751297|FG003|COMPLETED|Test Period 3 (1 Week)||6
10594845|NCT01800916|11751298|FG004|COMPLETED|Test Period 3 (1 Week)||7
10594846|NCT01800916|11751299|FG005|COMPLETED|Test Period 3 (1 Week)||7
10594847|NCT01800916|11751300|FG006|COMPLETED|Test Period 3 (1 Week)||7
10594848|NCT01800916|11751301|FG007|COMPLETED|Test Period 3 (1 Week)||7
10594849|NCT01800916|11751302|FG008|COMPLETED|Test Period 3 (1 Week)||7
10594850|NCT01800916|11751294|FG000|NOT COMPLETED|Test Period 3 (1 Week)||0
10594851|NCT01800916|11751295|FG001|NOT COMPLETED|Test Period 3 (1 Week)||0
10594852|NCT01800916|11751296|FG002|NOT COMPLETED|Test Period 3 (1 Week)||0
10594853|NCT01800916|11751297|FG003|NOT COMPLETED|Test Period 3 (1 Week)||0
10594854|NCT01800916|11751298|FG004|NOT COMPLETED|Test Period 3 (1 Week)||0
10594855|NCT01800916|11751299|FG005|NOT COMPLETED|Test Period 3 (1 Week)||0
10594856|NCT01800916|11751300|FG006|NOT COMPLETED|Test Period 3 (1 Week)||0
10594857|NCT01800916|11751301|FG007|NOT COMPLETED|Test Period 3 (1 Week)||0
10594858|NCT01800916|11751302|FG008|NOT COMPLETED|Test Period 3 (1 Week)||0
10594859|NCT01800968|11751314|FG000|STARTED|Overall Study||154
10594860|NCT01800968|11751315|FG001|STARTED|Overall Study||146
10594861|NCT01800968|11751314|FG000|COMPLETED|Overall Study||118
10594862|NCT01800968|11751315|FG001|COMPLETED|Overall Study||114
10594863|NCT01800968|11751314|FG000|NOT COMPLETED|Overall Study||36
10594864|NCT01800968|11751315|FG001|NOT COMPLETED|Overall Study||32
10594865|NCT01801007|11751321|FG000|STARTED|Overall Study||145
10703613|NCT02585778|11868073|FG000|COMPLETED|Overall Study||312
10703614|NCT02585778|11868074|FG001|COMPLETED|Overall Study||157
10703615|NCT02585778|11868073|FG000|NOT COMPLETED|Overall Study||33
10703616|NCT02585778|11868074|FG001|NOT COMPLETED|Overall Study||15
10703617|NCT02585830|11868084|FG000|STARTED|Overall Study||25
10703618|NCT02585830|11868084|FG000|COMPLETED|Overall Study||22
10594866|NCT01801007|11751321|FG000|COMPLETED|Overall Study||134
10594867|NCT01801007|11751321|FG000|NOT COMPLETED|Overall Study||11
10594868|NCT01801111|11751325|FG000|STARTED|Overall Study||138
10703619|NCT02585830|11868084|FG000|NOT COMPLETED|Overall Study||3
10811170|NCT03776539|11972874|FG001|NOT COMPLETED|Overall Study||0
10594869|NCT01801111|11751325|FG000|COMPLETED|Overall Study||0
10594870|NCT01801111|11751325|FG000|NOT COMPLETED|Overall Study||138
10594871|NCT01801124|11751329|FG000|STARTED|Overall Study||13
10594872|NCT01801124|11751329|FG000|COMPLETED|Overall Study||13
10594873|NCT01801124|11751329|FG000|NOT COMPLETED|Overall Study||0
10594874|NCT01801241|11751335|FG000|STARTED|Overall Study||29
10594875|NCT01801241|11751336|FG001|STARTED|Overall Study||27
10594876|NCT01801241|11751335|FG000|COMPLETED|Overall Study||21
10703620|NCT02585843|11868090|FG000|STARTED|Overall Study||10
10594877|NCT01801241|11751336|FG001|COMPLETED|Overall Study||25
10594878|NCT01801241|11751335|FG000|NOT COMPLETED|Overall Study||8
10594879|NCT01801241|11751336|FG001|NOT COMPLETED|Overall Study||2
10703621|NCT02585843|11868091|FG001|STARTED|Overall Study||10
10594880|NCT01801280|11751346|FG000|STARTED|Period 1|Each period lasted 10-14 weeks|5
10594881|NCT01801280|11751347|FG001|STARTED|Period 1||5
10594882|NCT01801280|11751348|FG002|STARTED|Period 1||5
10594883|NCT01801280|11751349|FG003|STARTED|Period 1||5
10594884|NCT01801280|11751346|FG000|COMPLETED|Period 1||5
10594885|NCT01801280|11751347|FG001|COMPLETED|Period 1||4
10594886|NCT01801280|11751348|FG002|COMPLETED|Period 1||5
10594887|NCT01801280|11751349|FG003|COMPLETED|Period 1||5
10594888|NCT01801280|11751346|FG000|NOT COMPLETED|Period 1||0
10594889|NCT01801280|11751347|FG001|NOT COMPLETED|Period 1||1
10594890|NCT01801280|11751348|FG002|NOT COMPLETED|Period 1||0
10594891|NCT01801280|11751349|FG003|NOT COMPLETED|Period 1||0
10594892|NCT01801280|11751346|FG000|STARTED|Period 2||5
10594893|NCT01801280|11751347|FG001|STARTED|Period 2||4
10594894|NCT01801280|11751348|FG002|STARTED|Period 2||5
10594895|NCT01801280|11751349|FG003|STARTED|Period 2||5
10594896|NCT01801280|11751346|FG000|COMPLETED|Period 2||4
10594897|NCT01801280|11751347|FG001|COMPLETED|Period 2||4
10594898|NCT01801280|11751348|FG002|COMPLETED|Period 2||5
10594899|NCT01801280|11751349|FG003|COMPLETED|Period 2||5
10594900|NCT01801280|11751346|FG000|NOT COMPLETED|Period 2||1
10594901|NCT01801280|11751347|FG001|NOT COMPLETED|Period 2||0
10703622|NCT02585843|11868090|FG000|COMPLETED|Overall Study||9
10703623|NCT02585843|11868091|FG001|COMPLETED|Overall Study||10
10703624|NCT02585843|11868090|FG000|NOT COMPLETED|Overall Study||1
10703625|NCT02585843|11868091|FG001|NOT COMPLETED|Overall Study||0
10703626|NCT02585895|11868099|FG000|STARTED|Primary Period||20
10703627|NCT02585895|11868100|FG001|STARTED|Primary Period||19
10703628|NCT02585895|11868099|FG000|COMPLETED|Primary Period||20
10703629|NCT02585895|11868100|FG001|COMPLETED|Primary Period||19
10807791|NCT03887429|11969554|FG003|Completed First Intervention (5 Days)|Overall Study||7
10807792|NCT03887429|11969551|FG000|Completed Washout (9 Days)|Overall Study||7
10807793|NCT03887429|11969552|FG001|Completed Washout (9 Days)|Overall Study||8
10807794|NCT03887429|11969553|FG002|Completed Washout (9 Days)|Overall Study||7
10807795|NCT03887429|11969554|FG003|Completed Washout (9 Days)|Overall Study||7
10807796|NCT03887429|11969551|FG000|Completed Second Intervention (5 Days)|Overall Study||7
10807797|NCT03887429|11969552|FG001|Completed Second Intervention (5 Days)|Overall Study||8
10807798|NCT03887429|11969553|FG002|Completed Second Intervention (5 Days)|Overall Study||7
10807799|NCT03887429|11969554|FG003|Completed Second Intervention (5 Days)|Overall Study||7
10807800|NCT03887429|11969551|FG000|COMPLETED|Overall Study||7
10807801|NCT03887429|11969552|FG001|COMPLETED|Overall Study||8
10807802|NCT03887429|11969553|FG002|COMPLETED|Overall Study||7
10807803|NCT03887429|11969554|FG003|COMPLETED|Overall Study||7
10807804|NCT03887429|11969551|FG000|NOT COMPLETED|Overall Study||1
10807805|NCT03887429|11969552|FG001|NOT COMPLETED|Overall Study||1
10807806|NCT03887429|11969553|FG002|NOT COMPLETED|Overall Study||2
10807807|NCT03887429|11969554|FG003|NOT COMPLETED|Overall Study||1
10807808|NCT03886701|11969569|FG000|STARTED|Period 1: Study Days 1-4||11
10807809|NCT03886701|11969569|FG000|COMPLETED|Period 1: Study Days 1-4||11
10807810|NCT03886701|11969569|FG000|NOT COMPLETED|Period 1: Study Days 1-4||0
10807811|NCT03886701|11969569|FG000|STARTED|Period 2: Study Days 7-21||11
10807812|NCT03886701|11969569|FG000|COMPLETED|Period 2: Study Days 7-21||11
10807813|NCT03886701|11969569|FG000|NOT COMPLETED|Period 2: Study Days 7-21||0
10594902|NCT01801280|11751348|FG002|NOT COMPLETED|Period 2||0
10594903|NCT01801280|11751349|FG003|NOT COMPLETED|Period 2||0
10594904|NCT01801280|11751346|FG000|STARTED|Period 3||4
10594905|NCT01801280|11751347|FG001|STARTED|Period 3||4
10594906|NCT01801280|11751348|FG002|STARTED|Period 3||5
10594907|NCT01801280|11751349|FG003|STARTED|Period 3||5
10594908|NCT01801280|11751346|FG000|COMPLETED|Period 3||4
10594909|NCT01801280|11751347|FG001|COMPLETED|Period 3||4
10594910|NCT01801280|11751348|FG002|COMPLETED|Period 3||5
10594911|NCT01801280|11751349|FG003|COMPLETED|Period 3||5
10594912|NCT01801280|11751346|FG000|NOT COMPLETED|Period 3||0
10594913|NCT01801280|11751347|FG001|NOT COMPLETED|Period 3||0
10594914|NCT01801280|11751348|FG002|NOT COMPLETED|Period 3||0
10594915|NCT01801280|11751349|FG003|NOT COMPLETED|Period 3||0
10594916|NCT01801280|11751346|FG000|STARTED|Period 4||4
10594917|NCT01801280|11751347|FG001|STARTED|Period 4||4
10594918|NCT01801280|11751348|FG002|STARTED|Period 4||5
10594919|NCT01801280|11751349|FG003|STARTED|Period 4||5
10594920|NCT01801280|11751346|FG000|COMPLETED|Period 4||4
10594921|NCT01801280|11751347|FG001|COMPLETED|Period 4||4
10703630|NCT02585895|11868099|FG000|NOT COMPLETED|Primary Period||0
10703631|NCT02585895|11868100|FG001|NOT COMPLETED|Primary Period||0
10807814|NCT03883113|11969577|FG000|STARTED|Overall Study||87
10807815|NCT03883113|11969578|FG001|STARTED|Overall Study||58
10594922|NCT01801280|11751348|FG002|COMPLETED|Period 4||4
10594923|NCT01801280|11751349|FG003|COMPLETED|Period 4||5
10594924|NCT01801280|11751346|FG000|NOT COMPLETED|Period 4||0
10594925|NCT01801280|11751347|FG001|NOT COMPLETED|Period 4||0
10594926|NCT01801280|11751348|FG002|NOT COMPLETED|Period 4||1
10594927|NCT01801280|11751349|FG003|NOT COMPLETED|Period 4||0
10594928|NCT01801358|11751365|FG000|STARTED|Overall Study||6
10594929|NCT01801358|11751366|FG001|STARTED|Overall Study||6
10594930|NCT01801358|11751367|FG002|STARTED|Overall Study||6
10594931|NCT01801358|11751368|FG003|STARTED|Overall Study||6
10807816|NCT03883113|11969577|FG000|COMPLETED|Overall Study||71
10594932|NCT01801358|11751369|FG004|STARTED|Overall Study||6
10594933|NCT01801358|11751370|FG005|STARTED|Overall Study||8
10594934|NCT01801358|11751365|FG000|COMPLETED|Overall Study||0
10594935|NCT01801358|11751366|FG001|COMPLETED|Overall Study||0
10594936|NCT01801358|11751367|FG002|COMPLETED|Overall Study||0
10594937|NCT01801358|11751368|FG003|COMPLETED|Overall Study||0
10594938|NCT01801358|11751369|FG004|COMPLETED|Overall Study||0
10594939|NCT01801358|11751370|FG005|COMPLETED|Overall Study||0
10594940|NCT01801358|11751365|FG000|NOT COMPLETED|Overall Study||6
10594941|NCT01801358|11751366|FG001|NOT COMPLETED|Overall Study||6
10594942|NCT01801358|11751367|FG002|NOT COMPLETED|Overall Study||6
10594943|NCT01801358|11751368|FG003|NOT COMPLETED|Overall Study||6
10594944|NCT01801358|11751369|FG004|NOT COMPLETED|Overall Study||6
10594945|NCT01801358|11751370|FG005|NOT COMPLETED|Overall Study||8
10594946|NCT01801436|11751405|FG000|STARTED|Overall Study||14
10594947|NCT01801436|11751405|FG000|COMPLETED|Overall Study||5
10594948|NCT01801436|11751405|FG000|NOT COMPLETED|Overall Study||9
10594949|NCT01801449|11751409|FG000|STARTED|Overall Study||6
10594950|NCT01801449|11751409|FG000|COMPLETED|Overall Study||6
10594951|NCT01801449|11751409|FG000|NOT COMPLETED|Overall Study||0
10594952|NCT01801475|11751417|FG000|STARTED|Overall Study||10
10594953|NCT01801475|11751418|FG001|STARTED|Overall Study||30
10594954|NCT01801475|11751419|FG002|STARTED|Overall Study||10
10594955|NCT01801475|11751420|FG003|STARTED|Overall Study||10
10594956|NCT01801475|11751421|FG004|STARTED|Overall Study||40
10594957|NCT01801475|11751417|FG000|COMPLETED|Overall Study||10
10594958|NCT01801475|11751418|FG001|COMPLETED|Overall Study||30
10594959|NCT01801475|11751419|FG002|COMPLETED|Overall Study||10
10594960|NCT01801475|11751420|FG003|COMPLETED|Overall Study||10
10594961|NCT01801475|11751421|FG004|COMPLETED|Overall Study||39
10594962|NCT01801475|11751417|FG000|NOT COMPLETED|Overall Study||0
10594963|NCT01801475|11751418|FG001|NOT COMPLETED|Overall Study||0
10594964|NCT01801475|11751419|FG002|NOT COMPLETED|Overall Study||0
10594965|NCT01801475|11751420|FG003|NOT COMPLETED|Overall Study||0
10594966|NCT01801475|11751421|FG004|NOT COMPLETED|Overall Study||1
10594967|NCT01801735|11751430|FG000|STARTED|Overall Study||600
10594968|NCT01801735|11751430|FG000|COMPLETED|Overall Study||390
10594969|NCT01801735|11751430|FG000|NOT COMPLETED|Overall Study||210
10594970|NCT01801865|11751434|FG000|STARTED|Overall Study||657
10594971|NCT01801865|11751434|FG000|COMPLETED|Overall Study||615
10594972|NCT01801865|11751434|FG000|NOT COMPLETED|Overall Study||42
10594973|NCT01801917|11751442|FG000|STARTED|Period 1 - Randomized||7
10594974|NCT01801917|11751443|FG001|STARTED|Period 1 - Randomized||2
10594975|NCT01801917|11751444|FG002|STARTED|Period 1 - Randomized||4
10594976|NCT01801917|11751445|FG003|STARTED|Period 1 - Randomized||1
10594977|NCT01801917|11751442|FG000|COMPLETED|Period 1 - Randomized||6
10594978|NCT01801917|11751443|FG001|COMPLETED|Period 1 - Randomized||2
10594979|NCT01801917|11751444|FG002|COMPLETED|Period 1 - Randomized||3
10594980|NCT01801917|11751445|FG003|COMPLETED|Period 1 - Randomized||1
10594981|NCT01801917|11751442|FG000|NOT COMPLETED|Period 1 - Randomized||1
10594982|NCT01801917|11751443|FG001|NOT COMPLETED|Period 1 - Randomized||0
10594983|NCT01801917|11751444|FG002|NOT COMPLETED|Period 1 - Randomized||1
10594984|NCT01801917|11751445|FG003|NOT COMPLETED|Period 1 - Randomized||0
10594985|NCT01801917|11751442|FG000|STARTED|Extension - All Active||6
10594986|NCT01801917|11751443|FG001|STARTED|Extension - All Active||0
10594987|NCT01801917|11751444|FG002|STARTED|Extension - All Active||3
10594988|NCT01801917|11751445|FG003|STARTED|Extension - All Active||0
10594989|NCT01801917|11751442|FG000|COMPLETED|Extension - All Active||6
10594990|NCT01801917|11751443|FG001|COMPLETED|Extension - All Active||0
10594991|NCT01801917|11751444|FG002|COMPLETED|Extension - All Active||3
10594992|NCT01801917|11751445|FG003|COMPLETED|Extension - All Active||0
10594993|NCT01801917|11751442|FG000|NOT COMPLETED|Extension - All Active||0
10594994|NCT01801917|11751443|FG001|NOT COMPLETED|Extension - All Active||0
10594995|NCT01801917|11751444|FG002|NOT COMPLETED|Extension - All Active||0
10594996|NCT01801917|11751445|FG003|NOT COMPLETED|Extension - All Active||0
10594997|NCT01801930|11751460|FG000|STARTED|Overall Study||6
10594998|NCT01801930|11751461|FG001|STARTED|Overall Study||6
10594999|NCT01801930|11751462|FG002|STARTED|Overall Study||6
10595000|NCT01801930|11751463|FG003|STARTED|Overall Study||6
10595001|NCT01801930|11751460|FG000|COMPLETED|Overall Study||0
10595002|NCT01801930|11751461|FG001|COMPLETED|Overall Study||0
10595003|NCT01801930|11751462|FG002|COMPLETED|Overall Study||0
10595004|NCT01801930|11751463|FG003|COMPLETED|Overall Study||0
10595005|NCT01801930|11751460|FG000|NOT COMPLETED|Overall Study||6
10595006|NCT01801930|11751461|FG001|NOT COMPLETED|Overall Study||6
10703632|NCT02585895|11868099|FG000|STARTED|Post-primary Period||20
10703633|NCT02585895|11868100|FG001|STARTED|Post-primary Period||19
10703634|NCT02585895|11868099|FG000|COMPLETED|Post-primary Period||20
10703635|NCT02585895|11868100|FG001|COMPLETED|Post-primary Period||19
10703636|NCT02585895|11868099|FG000|NOT COMPLETED|Post-primary Period||0
10595007|NCT01801930|11751462|FG002|NOT COMPLETED|Overall Study||6
10595008|NCT01801930|11751463|FG003|NOT COMPLETED|Overall Study||6
10595009|NCT01801982|11751473|FG000|STARTED|Overall Study||1
10595010|NCT01801982|11751473|FG000|COMPLETED|Overall Study||0
10595011|NCT01801982|11751473|FG000|NOT COMPLETED|Overall Study||1
10703637|NCT02585895|11868100|FG001|NOT COMPLETED|Post-primary Period||0
10595012|NCT01802073|11751479|FG000|STARTED|Overall Study||14
10595013|NCT01802073|11751480|FG001|STARTED|Overall Study||20
10595014|NCT01802073|11751479|FG000|COMPLETED|Overall Study||9
10595015|NCT01802073|11751480|FG001|COMPLETED|Overall Study||9
10595016|NCT01802073|11751479|FG000|NOT COMPLETED|Overall Study||5
10595017|NCT01802073|11751480|FG001|NOT COMPLETED|Overall Study||11
10595018|NCT01802151|11751490|FG000|STARTED|Overall Study||20
10595019|NCT01802151|11751491|FG001|STARTED|Overall Study||21
10595020|NCT01802151|11751492|FG002|STARTED|Overall Study||22
10595021|NCT01802151|11751493|FG003|STARTED|Overall Study||20
10595022|NCT01802151|11751490|FG000|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
10595023|NCT01802151|11751491|FG001|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|21
10595024|NCT01802151|11751492|FG002|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
10595025|NCT01802151|11751493|FG003|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
10595026|NCT01802151|11751490|FG000|NOT COMPLETED|Overall Study||0
10595027|NCT01802151|11751491|FG001|NOT COMPLETED|Overall Study||0
10595028|NCT01802151|11751492|FG002|NOT COMPLETED|Overall Study||2
10595029|NCT01802151|11751493|FG003|NOT COMPLETED|Overall Study||0
10595030|NCT01802216|11751505|FG000|STARTED|Baseline||17
10595031|NCT01802216|11751506|FG001|STARTED|Baseline||34
10595032|NCT01802216|11751505|FG000|COMPLETED|Baseline||17
10595033|NCT01802216|11751506|FG001|COMPLETED|Baseline||34
10595034|NCT01802216|11751505|FG000|NOT COMPLETED|Baseline||0
10595035|NCT01802216|11751506|FG001|NOT COMPLETED|Baseline||0
10595036|NCT01802216|11751505|FG000|STARTED|4 Month Visit||17
10595037|NCT01802216|11751506|FG001|STARTED|4 Month Visit||34
10595038|NCT01802216|11751505|FG000|COMPLETED|4 Month Visit||14
10595039|NCT01802216|11751506|FG001|COMPLETED|4 Month Visit||30
10595040|NCT01802216|11751505|FG000|NOT COMPLETED|4 Month Visit||3
10595041|NCT01802216|11751506|FG001|NOT COMPLETED|4 Month Visit||4
10595042|NCT01802216|11751505|FG000|STARTED|8 Month Visit||17
10595043|NCT01802216|11751506|FG001|STARTED|8 Month Visit||34
10595044|NCT01802216|11751505|FG000|COMPLETED|8 Month Visit||14
10595045|NCT01802216|11751506|FG001|COMPLETED|8 Month Visit||29
10595046|NCT01802216|11751505|FG000|NOT COMPLETED|8 Month Visit||3
10595047|NCT01802216|11751506|FG001|NOT COMPLETED|8 Month Visit||5
10595048|NCT01802216|11751505|FG000|STARTED|12 Month Visit||17
10703638|NCT02585934|11868111|FG000|STARTED|Overall Study||661
10703639|NCT02585934|11868112|FG001|STARTED|Overall Study||654
10703640|NCT02585934|11868111|FG000|Safety Population|Overall Study||656
10703641|NCT02585934|11868112|FG001|Safety Population|Overall Study||651
10703642|NCT02585934|11868111|FG000|Intent to Treat (ITT)|Overall Study||643
10703643|NCT02585934|11868112|FG001|Intent to Treat (ITT)|Overall Study||633
10703644|NCT02585934|11868111|FG000|Per Protocol (PP)|Overall Study||603
10703645|NCT02585934|11868112|FG001|Per Protocol (PP)|Overall Study||582
10595049|NCT01802216|11751506|FG001|STARTED|12 Month Visit||34
10595050|NCT01802216|11751505|FG000|COMPLETED|12 Month Visit||14
10595051|NCT01802216|11751506|FG001|COMPLETED|12 Month Visit||30
10595052|NCT01802216|11751505|FG000|NOT COMPLETED|12 Month Visit||3
10595053|NCT01802216|11751506|FG001|NOT COMPLETED|12 Month Visit||4
10595054|NCT01802320|11751512|FG000|STARTED|Overall Study||18
10595055|NCT01802320|11751512|FG000|COMPLETED|Overall Study||16
10595056|NCT01802320|11751512|FG000|NOT COMPLETED|Overall Study||2
10595057|NCT01802333|11751519|FG000|STARTED|Overall Study||263
10595058|NCT01802333|11751520|FG001|STARTED|Overall Study||267
10595059|NCT01802333|11751521|FG002|STARTED|Overall Study||224
10595060|NCT01802333|11751519|FG000|High Risk Patients|Overall Study||60
10595061|NCT01802333|11751520|FG001|High Risk Patients|Overall Study||61
10595062|NCT01802333|11751521|FG002|High Risk Patients|Overall Study||38
10595063|NCT01802333|11751519|FG000|High Risk Patients Achieved CR/CRi|Overall Study||38
10595064|NCT01802333|11751520|FG001|High Risk Patients Achieved CR/CRi|Overall Study||40
10595065|NCT01802333|11751521|FG002|High Risk Patients Achieved CR/CRi|Overall Study||29
10595066|NCT01802333|11751519|FG000|Known NPM1 Status at Baseline|Overall Study||169
10595067|NCT01802333|11751520|FG001|Known NPM1 Status at Baseline|Overall Study||156
10595068|NCT01802333|11751521|FG002|Known NPM1 Status at Baseline|Overall Study||142
10595069|NCT01802333|11751519|FG000|Known Cytogenetic Risk at Baseline|Overall Study||252
10595070|NCT01802333|11751520|FG001|Known Cytogenetic Risk at Baseline|Overall Study||250
10595071|NCT01802333|11751521|FG002|Known Cytogenetic Risk at Baseline|Overall Study||210
10595072|NCT01802333|11751519|FG000|COMPLETED|Overall Study||214
10595073|NCT01802333|11751520|FG001|COMPLETED|Overall Study||206
10595074|NCT01802333|11751521|FG002|COMPLETED|Overall Study||161
10595075|NCT01802333|11751519|FG000|NOT COMPLETED|Overall Study||49
10595076|NCT01802333|11751520|FG001|NOT COMPLETED|Overall Study||61
10595077|NCT01802333|11751521|FG002|NOT COMPLETED|Overall Study||63
10595078|NCT01802385|11751537|FG000|STARTED|Overall Study||231
10595079|NCT01802385|11751538|FG001|STARTED|Overall Study||229
10595080|NCT01802385|11751537|FG000|COMPLETED|Overall Study||125
10595081|NCT01802385|11751538|FG001|COMPLETED|Overall Study||109
10595082|NCT01802385|11751537|FG000|NOT COMPLETED|Overall Study||106
10595083|NCT01802385|11751538|FG001|NOT COMPLETED|Overall Study||120
10595084|NCT01802411|11751546|FG000|STARTED|Overall Study||96
10595085|NCT01802411|11751547|FG001|STARTED|Overall Study||95
10595086|NCT01802411|11751546|FG000|COMPLETED|Overall Study||82
10595087|NCT01802411|11751547|FG001|COMPLETED|Overall Study||74
10595088|NCT01802411|11751546|FG000|NOT COMPLETED|Overall Study||14
10595089|NCT01802411|11751547|FG001|NOT COMPLETED|Overall Study||21
10595090|NCT01802437|11751555|FG000|STARTED|Overall Study||20
10595091|NCT01802437|11751556|FG001|STARTED|Overall Study||20
10595092|NCT01802437|11751555|FG000|COMPLETED|Overall Study||16
10595093|NCT01802437|11751556|FG001|COMPLETED|Overall Study||16
10595094|NCT01802437|11751555|FG000|NOT COMPLETED|Overall Study||4
10595095|NCT01802437|11751556|FG001|NOT COMPLETED|Overall Study||4
10595096|NCT01802515|11751565|FG000|STARTED|Overall Study||5
10595097|NCT01802515|11751566|FG001|STARTED|Overall Study||5
10703646|NCT02585934|11868111|FG000|COMPLETED|Overall Study||592
10703647|NCT02585934|11868112|FG001|COMPLETED|Overall Study||581
10595098|NCT01802515|11751567|FG002|STARTED|Overall Study||4
10595099|NCT01802515|11751565|FG000|COMPLETED|Overall Study||2
10595100|NCT01802515|11751566|FG001|COMPLETED|Overall Study||5
10595101|NCT01802515|11751567|FG002|COMPLETED|Overall Study||4
10595102|NCT01802515|11751565|FG000|NOT COMPLETED|Overall Study||3
10595103|NCT01802515|11751566|FG001|NOT COMPLETED|Overall Study||0
10595104|NCT01802515|11751567|FG002|NOT COMPLETED|Overall Study||0
10595105|NCT01802554|11751577|FG000|STARTED|Overall Study||51
10595106|NCT01802554|11751578|FG001|STARTED|Overall Study||49
10595107|NCT01802554|11751577|FG000|COMPLETED|Overall Study||43
10595108|NCT01802554|11751578|FG001|COMPLETED|Overall Study||43
10595109|NCT01802554|11751577|FG000|NOT COMPLETED|Overall Study||8
10595110|NCT01802554|11751578|FG001|NOT COMPLETED|Overall Study||6
10595111|NCT01802580|11751586|FG000|STARTED|Overall Study||20
10595112|NCT01802580|11751587|FG001|STARTED|Overall Study||20
10595113|NCT01802580|11751586|FG000|COMPLETED|Overall Study||11
10595114|NCT01802580|11751587|FG001|COMPLETED|Overall Study||9
10595115|NCT01802580|11751586|FG000|NOT COMPLETED|Overall Study||9
10595116|NCT01802580|11751587|FG001|NOT COMPLETED|Overall Study||11
10595117|NCT01802710|11751595|FG000|STARTED|From T0 to T1||76
10595118|NCT01802710|11751596|FG001|STARTED|From T0 to T1||82
10595119|NCT01802710|11751595|FG000|COMPLETED|From T0 to T1||60
10595120|NCT01802710|11751596|FG001|COMPLETED|From T0 to T1||72
10595121|NCT01802710|11751595|FG000|NOT COMPLETED|From T0 to T1||16
10595122|NCT01802710|11751596|FG001|NOT COMPLETED|From T0 to T1||10
10595123|NCT01802710|11751595|FG000|STARTED|From T1 to T2||60
10595124|NCT01802710|11751596|FG001|STARTED|From T1 to T2||72
10595125|NCT01802710|11751595|FG000|COMPLETED|From T1 to T2||58
10595126|NCT01802710|11751596|FG001|COMPLETED|From T1 to T2||70
10595127|NCT01802710|11751595|FG000|NOT COMPLETED|From T1 to T2||2
10595128|NCT01802710|11751596|FG001|NOT COMPLETED|From T1 to T2||2
10595129|NCT01802775|11751606|FG000|STARTED|Overall Study||102
10595130|NCT01802775|11751607|FG001|STARTED|Overall Study||101
10595131|NCT01802775|11751606|FG000|Received Drug (Safety Analysis Set)|Overall Study||101
10595132|NCT01802775|11751607|FG001|Received Drug (Safety Analysis Set)|Overall Study||100
10595133|NCT01802775|11751606|FG000|COMPLETED|Overall Study||96
10595134|NCT01802775|11751607|FG001|COMPLETED|Overall Study||89
10595135|NCT01802775|11751606|FG000|NOT COMPLETED|Overall Study||6
10595136|NCT01802775|11751607|FG001|NOT COMPLETED|Overall Study||12
10595137|NCT01802879|11751613|FG000|STARTED|Overall Study||8
10595138|NCT01802879|11751613|FG000|COMPLETED|Overall Study||0
10595139|NCT01802879|11751613|FG000|NOT COMPLETED|Overall Study||8
10595140|NCT01803074|11751631|FG000|STARTED|Period 1: Part A (HIV-1 Clade B)||8
10595141|NCT01803074|11751632|FG001|STARTED|Period 1: Part A (HIV-1 Clade B)||8
10595142|NCT01803074|11751633|FG002|STARTED|Period 1: Part A (HIV-1 Clade B)||8
10595143|NCT01803074|11751634|FG003|STARTED|Period 1: Part A (HIV-1 Clade B)||8
10595144|NCT01803074|11751635|FG004|STARTED|Period 1: Part A (HIV-1 Clade B)||8
10595145|NCT01803074|11751636|FG005|STARTED|Period 1: Part A (HIV-1 Clade B)||8
10595146|NCT01803074|11751637|FG006|STARTED|Period 1: Part A (HIV-1 Clade B)||12
10595147|NCT01803074|11751638|FG007|STARTED|Period 1: Part A (HIV-1 Clade B)||0
10595148|NCT01803074|11751639|FG008|STARTED|Period 1: Part A (HIV-1 Clade B)||0
10595149|NCT01803074|11751640|FG009|STARTED|Period 1: Part A (HIV-1 Clade B)||0
10595150|NCT01803074|11751641|FG010|STARTED|Period 1: Part A (HIV-1 Clade B)||0
10595151|NCT01803074|11751642|FG011|STARTED|Period 1: Part A (HIV-1 Clade B)||0
10595152|NCT01803074|11751643|FG012|STARTED|Period 1: Part A (HIV-1 Clade B)||0
10595153|NCT01803074|11751644|FG013|STARTED|Period 1: Part A (HIV-1 Clade B)||0
10595154|NCT01803074|11751631|FG000|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
10595155|NCT01803074|11751632|FG001|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
10595156|NCT01803074|11751633|FG002|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
10595157|NCT01803074|11751634|FG003|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
10595158|NCT01803074|11751635|FG004|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
10595159|NCT01803074|11751636|FG005|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
10595160|NCT01803074|11751637|FG006|COMPLETED|Period 1: Part A (HIV-1 Clade B)||12
10595161|NCT01803074|11751638|FG007|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
10595162|NCT01803074|11751639|FG008|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
10595163|NCT01803074|11751640|FG009|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
10595164|NCT01803074|11751641|FG010|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
10595165|NCT01803074|11751642|FG011|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
10595166|NCT01803074|11751643|FG012|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
10595167|NCT01803074|11751644|FG013|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
10595168|NCT01803074|11751631|FG000|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
10595169|NCT01803074|11751632|FG001|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
10595170|NCT01803074|11751633|FG002|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
10595171|NCT01803074|11751634|FG003|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
10595172|NCT01803074|11751635|FG004|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
10595173|NCT01803074|11751636|FG005|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
10595174|NCT01803074|11751637|FG006|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
10807817|NCT03883113|11969578|FG001|COMPLETED|Overall Study||46
10807818|NCT03883113|11969577|FG000|NOT COMPLETED|Overall Study||16
10807819|NCT03883113|11969578|FG001|NOT COMPLETED|Overall Study||12
10595175|NCT01803074|11751638|FG007|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
10595176|NCT01803074|11751639|FG008|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
10595177|NCT01803074|11751640|FG009|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
10807820|NCT03880227|11969600|FG000|STARTED|First Visit||20
10807821|NCT03880227|11969601|FG001|STARTED|First Visit||21
10703648|NCT02585934|11868111|FG000|NOT COMPLETED|Overall Study||69
10807822|NCT03880227|11969602|FG002|STARTED|First Visit||22
10595178|NCT01803074|11751641|FG010|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
10595179|NCT01803074|11751642|FG011|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
10595180|NCT01803074|11751643|FG012|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
10595181|NCT01803074|11751644|FG013|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
10595182|NCT01803074|11751631|FG000|STARTED|Period 2: Part B (HIV-1 Clade B)||0
10595183|NCT01803074|11751632|FG001|STARTED|Period 2: Part B (HIV-1 Clade B)||0
10595184|NCT01803074|11751633|FG002|STARTED|Period 2: Part B (HIV-1 Clade B)||0
10595185|NCT01803074|11751634|FG003|STARTED|Period 2: Part B (HIV-1 Clade B)||0
10703649|NCT02585934|11868112|FG001|NOT COMPLETED|Overall Study||73
10595186|NCT01803074|11751635|FG004|STARTED|Period 2: Part B (HIV-1 Clade B)||0
10595187|NCT01803074|11751636|FG005|STARTED|Period 2: Part B (HIV-1 Clade B)||0
10595188|NCT01803074|11751637|FG006|STARTED|Period 2: Part B (HIV-1 Clade B)||0
10595189|NCT01803074|11751638|FG007|STARTED|Period 2: Part B (HIV-1 Clade B)||8
10595190|NCT01803074|11751639|FG008|STARTED|Period 2: Part B (HIV-1 Clade B)||8
10595191|NCT01803074|11751640|FG009|STARTED|Period 2: Part B (HIV-1 Clade B)||4
10595192|NCT01803074|11751641|FG010|STARTED|Period 2: Part B (HIV-1 Clade B)||8
10595193|NCT01803074|11751642|FG011|STARTED|Period 2: Part B (HIV-1 Clade B)||0
10595194|NCT01803074|11751643|FG012|STARTED|Period 2: Part B (HIV-1 Clade B)||0
10595195|NCT01803074|11751644|FG013|STARTED|Period 2: Part B (HIV-1 Clade B)||0
10595196|NCT01803074|11751631|FG000|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
10595197|NCT01803074|11751632|FG001|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
10595198|NCT01803074|11751633|FG002|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
10595199|NCT01803074|11751634|FG003|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
10595200|NCT01803074|11751635|FG004|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
10595274|NCT01803269|11751697|FG002|STARTED|Overall Study||14
10595201|NCT01803074|11751636|FG005|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
10595202|NCT01803074|11751637|FG006|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
10595203|NCT01803074|11751638|FG007|COMPLETED|Period 2: Part B (HIV-1 Clade B)||8
10595204|NCT01803074|11751639|FG008|COMPLETED|Period 2: Part B (HIV-1 Clade B)||8
10595205|NCT01803074|11751640|FG009|COMPLETED|Period 2: Part B (HIV-1 Clade B)||4
10595206|NCT01803074|11751641|FG010|COMPLETED|Period 2: Part B (HIV-1 Clade B)||8
10595207|NCT01803074|11751642|FG011|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
10595208|NCT01803074|11751643|FG012|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
10595209|NCT01803074|11751644|FG013|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
10595210|NCT01803074|11751631|FG000|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
10595211|NCT01803074|11751632|FG001|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
10595212|NCT01803074|11751633|FG002|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
10595213|NCT01803074|11751634|FG003|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
10595214|NCT01803074|11751635|FG004|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
10595215|NCT01803074|11751636|FG005|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
10595216|NCT01803074|11751637|FG006|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
10595217|NCT01803074|11751638|FG007|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
10595218|NCT01803074|11751639|FG008|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
10595219|NCT01803074|11751640|FG009|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
10595220|NCT01803074|11751641|FG010|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
10595221|NCT01803074|11751642|FG011|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
10595222|NCT01803074|11751643|FG012|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
10595223|NCT01803074|11751644|FG013|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
10595224|NCT01803074|11751631|FG000|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
10595225|NCT01803074|11751632|FG001|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
10595226|NCT01803074|11751633|FG002|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
10595227|NCT01803074|11751634|FG003|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
10595228|NCT01803074|11751635|FG004|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
10595229|NCT01803074|11751636|FG005|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
10595230|NCT01803074|11751637|FG006|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
10595231|NCT01803074|11751638|FG007|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
10595232|NCT01803074|11751639|FG008|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
10595233|NCT01803074|11751640|FG009|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
10595234|NCT01803074|11751641|FG010|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
10595235|NCT01803074|11751642|FG011|STARTED|Period 3: Part C (HIV-1 Clade C Only)||8
10595236|NCT01803074|11751643|FG012|STARTED|Period 3: Part C (HIV-1 Clade C Only)||7
10595237|NCT01803074|11751644|FG013|STARTED|Period 3: Part C (HIV-1 Clade C Only)||4
10595238|NCT01803074|11751631|FG000|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
10595239|NCT01803074|11751632|FG001|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
10595240|NCT01803074|11751633|FG002|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
10595241|NCT01803074|11751634|FG003|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
10595242|NCT01803074|11751635|FG004|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
10595243|NCT01803074|11751636|FG005|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
10595244|NCT01803074|11751637|FG006|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
10595245|NCT01803074|11751638|FG007|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
10595246|NCT01803074|11751639|FG008|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
10595247|NCT01803074|11751640|FG009|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
10703650|NCT02585960|11868126|FG000|STARTED|PK/Safety Assessment Period||57
10703651|NCT02585960|11868127|FG001|STARTED|PK/Safety Assessment Period||58
10703652|NCT02585960|11868128|FG002|STARTED|PK/Safety Assessment Period||6
10595248|NCT01803074|11751641|FG010|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
10595249|NCT01803074|11751642|FG011|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||8
10595250|NCT01803074|11751643|FG012|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||7
10595251|NCT01803074|11751644|FG013|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||4
10595252|NCT01803074|11751631|FG000|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
10595253|NCT01803074|11751632|FG001|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
10595254|NCT01803074|11751633|FG002|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
10595255|NCT01803074|11751634|FG003|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
10595256|NCT01803074|11751635|FG004|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
10595257|NCT01803074|11751636|FG005|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
10595258|NCT01803074|11751637|FG006|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
10595259|NCT01803074|11751638|FG007|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
10595260|NCT01803074|11751639|FG008|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
10595261|NCT01803074|11751640|FG009|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
10595262|NCT01803074|11751641|FG010|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
10595263|NCT01803074|11751642|FG011|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
10595264|NCT01803074|11751643|FG012|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
10595265|NCT01803074|11751644|FG013|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
10595266|NCT01803204|11751685|FG000|STARTED|Overall Study||20
10595267|NCT01803204|11751686|FG001|STARTED|Overall Study||20
10595268|NCT01803204|11751685|FG000|COMPLETED|Overall Study||20
10595269|NCT01803204|11751686|FG001|COMPLETED|Overall Study||20
10595270|NCT01803204|11751685|FG000|NOT COMPLETED|Overall Study||0
10595271|NCT01803204|11751686|FG001|NOT COMPLETED|Overall Study||0
10595272|NCT01803269|11751695|FG000|STARTED|Overall Study||7
10595273|NCT01803269|11751696|FG001|STARTED|Overall Study||8
10595275|NCT01803269|11751695|FG000|COMPLETED|Overall Study||4
10595276|NCT01803269|11751696|FG001|COMPLETED|Overall Study||8
10595277|NCT01803269|11751697|FG002|COMPLETED|Overall Study||14
10595278|NCT01803269|11751695|FG000|NOT COMPLETED|Overall Study||3
10595279|NCT01803269|11751696|FG001|NOT COMPLETED|Overall Study||0
10595280|NCT01803269|11751697|FG002|NOT COMPLETED|Overall Study||0
10595281|NCT01803282|11751717|FG000|STARTED|Overall Study||4
10595282|NCT01803282|11751718|FG001|STARTED|Overall Study||3
10595283|NCT01803282|11751719|FG002|STARTED|Overall Study||6
10595284|NCT01803282|11751720|FG003|STARTED|Overall Study||36
10595285|NCT01803282|11751721|FG004|STARTED|Overall Study||11
10595286|NCT01803282|11751722|FG005|STARTED|Overall Study||10
10595287|NCT01803282|11751723|FG006|STARTED|Overall Study||41
10595288|NCT01803282|11751724|FG007|STARTED|Overall Study||46
10595289|NCT01803282|11751725|FG008|STARTED|Overall Study||11
10595290|NCT01803282|11751726|FG009|STARTED|Overall Study||45
10595291|NCT01803282|11751727|FG010|STARTED|Overall Study||8
10595292|NCT01803282|11751728|FG011|STARTED|Overall Study||15
10595293|NCT01803282|11751717|FG000|COMPLETED|Overall Study||0
10595294|NCT01803282|11751718|FG001|COMPLETED|Overall Study||0
10595295|NCT01803282|11751719|FG002|COMPLETED|Overall Study||0
10595296|NCT01803282|11751720|FG003|COMPLETED|Overall Study||0
10595297|NCT01803282|11751721|FG004|COMPLETED|Overall Study||0
10595298|NCT01803282|11751722|FG005|COMPLETED|Overall Study||0
10595299|NCT01803282|11751723|FG006|COMPLETED|Overall Study||0
10595300|NCT01803282|11751724|FG007|COMPLETED|Overall Study||0
10595301|NCT01803282|11751725|FG008|COMPLETED|Overall Study||0
10595302|NCT01803282|11751726|FG009|COMPLETED|Overall Study||0
10595303|NCT01803282|11751727|FG010|COMPLETED|Overall Study||0
10595304|NCT01803282|11751728|FG011|COMPLETED|Overall Study||0
10595305|NCT01803282|11751717|FG000|NOT COMPLETED|Overall Study||4
10595306|NCT01803282|11751718|FG001|NOT COMPLETED|Overall Study||3
10595307|NCT01803282|11751719|FG002|NOT COMPLETED|Overall Study||6
10595308|NCT01803282|11751720|FG003|NOT COMPLETED|Overall Study||36
10595309|NCT01803282|11751721|FG004|NOT COMPLETED|Overall Study||11
10595310|NCT01803282|11751722|FG005|NOT COMPLETED|Overall Study||10
10595311|NCT01803282|11751723|FG006|NOT COMPLETED|Overall Study||41
10595312|NCT01803282|11751724|FG007|NOT COMPLETED|Overall Study||46
10595313|NCT01803282|11751725|FG008|NOT COMPLETED|Overall Study||11
10595314|NCT01803282|11751726|FG009|NOT COMPLETED|Overall Study||45
10595315|NCT01803282|11751727|FG010|NOT COMPLETED|Overall Study||8
10595316|NCT01803282|11751728|FG011|NOT COMPLETED|Overall Study||15
10595317|NCT01803464|11751758|FG000|STARTED|Overall Study||5
10595318|NCT01803464|11751759|FG001|STARTED|Overall Study||4
10595319|NCT01803464|11751760|FG002|STARTED|Overall Study||10
10595320|NCT01803464|11751761|FG003|STARTED|Overall Study||10
10595321|NCT01803464|11751758|FG000|COMPLETED|Overall Study||4
10595322|NCT01803464|11751759|FG001|COMPLETED|Overall Study||4
10595323|NCT01803464|11751760|FG002|COMPLETED|Overall Study||6
10703653|NCT02585960|11868126|FG000|Completed 1st 6 Month Period|PK/Safety Assessment Period||57
10703654|NCT02585960|11868127|FG001|Completed 1st 6 Month Period|PK/Safety Assessment Period||53
10703655|NCT02585960|11868128|FG002|Completed 1st 6 Month Period|PK/Safety Assessment Period||0
10703656|NCT02585960|11868126|FG000|Completed 2nd 6 Month Period|PK/Safety Assessment Period||52
10703657|NCT02585960|11868127|FG001|Completed 2nd 6 Month Period|PK/Safety Assessment Period||48
10703658|NCT02585960|11868128|FG002|Completed 2nd 6 Month Period|PK/Safety Assessment Period||0
10595324|NCT01803464|11751761|FG003|COMPLETED|Overall Study||10
10595325|NCT01803464|11751758|FG000|NOT COMPLETED|Overall Study||1
10595326|NCT01803464|11751759|FG001|NOT COMPLETED|Overall Study||0
10807823|NCT03880227|11969603|FG003|STARTED|First Visit||18
10595327|NCT01803464|11751760|FG002|NOT COMPLETED|Overall Study||4
10595328|NCT01803464|11751761|FG003|NOT COMPLETED|Overall Study||0
10595329|NCT01803607|11751777|FG000|STARTED|Overall Study||68
10595330|NCT01803607|11751778|FG001|STARTED|Overall Study||67
10595331|NCT01803607|11751777|FG000|COMPLETED|Overall Study||0
10595332|NCT01803607|11751778|FG001|COMPLETED|Overall Study||0
10595333|NCT01803607|11751777|FG000|NOT COMPLETED|Overall Study||68
10595334|NCT01803607|11751778|FG001|NOT COMPLETED|Overall Study||67
10595335|NCT01803646|11751786|FG000|STARTED|Overall Study||204
10595336|NCT01803646|11751787|FG001|STARTED|Overall Study||139
10595337|NCT01803646|11751786|FG000|COMPLETED|Overall Study||187
10595338|NCT01803646|11751787|FG001|COMPLETED|Overall Study||129
10595339|NCT01803646|11751786|FG000|NOT COMPLETED|Overall Study||17
10595340|NCT01803646|11751787|FG001|NOT COMPLETED|Overall Study||10
10595341|NCT01803737|11751795|FG000|STARTED|Overall Study||13
10595342|NCT01803737|11751796|FG001|STARTED|Overall Study||13
10595343|NCT01803737|11751795|FG000|COMPLETED|Overall Study||12
10595344|NCT01803737|11751796|FG001|COMPLETED|Overall Study||10
10595345|NCT01803737|11751795|FG000|NOT COMPLETED|Overall Study||1
10595346|NCT01803737|11751796|FG001|NOT COMPLETED|Overall Study||3
10595347|NCT01803880|11751805|FG000|STARTED|Overall Study||19
10595348|NCT01803880|11751806|FG001|STARTED|Overall Study||28
10595349|NCT01803880|11751807|FG002|STARTED|Overall Study||29
10595350|NCT01803880|11751805|FG000|COMPLETED|Overall Study||13
10595351|NCT01803880|11751806|FG001|COMPLETED|Overall Study||18
10595352|NCT01803880|11751807|FG002|COMPLETED|Overall Study||14
10595353|NCT01803880|11751805|FG000|NOT COMPLETED|Overall Study||6
10595354|NCT01803880|11751806|FG001|NOT COMPLETED|Overall Study||10
10595355|NCT01803880|11751807|FG002|NOT COMPLETED|Overall Study||15
10595356|NCT01804036|11751819|FG000|STARTED|Overall Study||31
10595357|NCT01804036|11751820|FG001|STARTED|Overall Study||41
10595358|NCT01804036|11751819|FG000|COMPLETED|Overall Study||18
10595359|NCT01804036|11751820|FG001|COMPLETED|Overall Study||21
10595360|NCT01804036|11751819|FG000|NOT COMPLETED|Overall Study||13
10595361|NCT01804036|11751820|FG001|NOT COMPLETED|Overall Study||20
10595362|NCT01804049|11751829|FG000|STARTED|Overall Study||43
10595363|NCT01804049|11751830|FG001|STARTED|Overall Study||77
10595364|NCT01804049|11751829|FG000|COMPLETED|Overall Study||32
10595365|NCT01804049|11751830|FG001|COMPLETED|Overall Study||45
10595366|NCT01804049|11751829|FG000|NOT COMPLETED|Overall Study||11
10595367|NCT01804049|11751830|FG001|NOT COMPLETED|Overall Study||32
10595368|NCT01804062|11751838|FG000|STARTED|Overall Study||30
10595369|NCT01804062|11751838|FG000|COMPLETED|Overall Study||30
10595370|NCT01804062|11751838|FG000|NOT COMPLETED|Overall Study||0
10595371|NCT01804075|11751844|FG000|STARTED|Overall Study||15
10595372|NCT01804075|11751845|FG001|STARTED|Overall Study||16
10595373|NCT01804075|11751844|FG000|COMPLETED|Overall Study||15
10595374|NCT01804075|11751845|FG001|COMPLETED|Overall Study||16
10595375|NCT01804075|11751844|FG000|NOT COMPLETED|Overall Study||0
10595376|NCT01804075|11751845|FG001|NOT COMPLETED|Overall Study||0
10595377|NCT01804101|11751855|FG000|STARTED|Overall Study||38
10595378|NCT01804101|11751856|FG001|STARTED|Overall Study||10
10595379|NCT01804101|11751855|FG000|COMPLETED|Overall Study||38
10595380|NCT01804101|11751856|FG001|COMPLETED|Overall Study||10
10595381|NCT01804101|11751855|FG000|NOT COMPLETED|Overall Study||0
10595382|NCT01804101|11751856|FG001|NOT COMPLETED|Overall Study||0
10595383|NCT01804114|11751866|FG000|STARTED|Overall Study||17
10595384|NCT01804114|11751867|FG001|STARTED|Overall Study||12
10595385|NCT01804114|11751866|FG000|COMPLETED|Overall Study||17
10595386|NCT01804114|11751867|FG001|COMPLETED|Overall Study||12
10595387|NCT01804114|11751866|FG000|NOT COMPLETED|Overall Study||0
10595388|NCT01804114|11751867|FG001|NOT COMPLETED|Overall Study||0
10595389|NCT01804140|11751873|FG000|STARTED|Overall Study|This includes all the participants who were enrolled for this study.|662
10595390|NCT01804140|11751873|FG000|COMPLETED|Overall Study|This includes all the participants with mutation results from the sampling or biopsy procedures.|548
10595391|NCT01804140|11751873|FG000|NOT COMPLETED|Overall Study||114
10595392|NCT01804257|11751877|FG000|STARTED|Overall Study||28
10807824|NCT03880227|11969600|FG000|COMPLETED|First Visit||19
10807825|NCT03880227|11969601|FG001|COMPLETED|First Visit||21
10807826|NCT03880227|11969602|FG002|COMPLETED|First Visit||22
10807827|NCT03880227|11969603|FG003|COMPLETED|First Visit||18
10595393|NCT01804257|11751877|FG000|COMPLETED|Overall Study||27
10595394|NCT01804257|11751877|FG000|NOT COMPLETED|Overall Study||1
10595395|NCT01804465|11751883|FG000|STARTED|Overall Study||24
10595396|NCT01804465|11751884|FG001|STARTED|Overall Study||26
10595397|NCT01804465|11751883|FG000|COMPLETED|Overall Study||24
10595398|NCT01804465|11751884|FG001|COMPLETED|Overall Study||26
10595399|NCT01804465|11751883|FG000|NOT COMPLETED|Overall Study||0
10595400|NCT01804465|11751884|FG001|NOT COMPLETED|Overall Study||0
10652164|NCT02181803|11812489|FG003|NOT COMPLETED|Overall Study||2
10652165|NCT02181803|11812490|FG004|NOT COMPLETED|Overall Study||0
10807828|NCT03880227|11969600|FG000|NOT COMPLETED|First Visit||1
10807829|NCT03880227|11969601|FG001|NOT COMPLETED|First Visit||0
10652166|NCT02181803|11812491|FG005|NOT COMPLETED|Overall Study||0
10652167|NCT02181803|11812492|FG006|NOT COMPLETED|Overall Study||1
10652168|NCT02181803|11812493|FG007|NOT COMPLETED|Overall Study||1
10652169|NCT02181803|11812494|FG008|NOT COMPLETED|Overall Study||0
10654516|NCT02203032|11815295|FG002|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||26
10654517|NCT02203032|11815296|FG003|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||46
10654518|NCT02203071|11815306|FG000|STARTED|Overall Study||13
10807830|NCT03880227|11969602|FG002|NOT COMPLETED|First Visit||0
10595401|NCT01804582|11751892|FG000|STARTED|Overall Study||177
10595402|NCT01804582|11751893|FG001|STARTED|Overall Study||173
10595403|NCT01804582|11751892|FG000|COMPLETED|Overall Study||128
10595404|NCT01804582|11751893|FG001|COMPLETED|Overall Study||117
10595405|NCT01804582|11751892|FG000|NOT COMPLETED|Overall Study||49
10595406|NCT01804582|11751893|FG001|NOT COMPLETED|Overall Study||56
10595407|NCT01804673|11751900|FG000|STARTED|Overall Study||174
10595408|NCT01804673|11751900|FG000|Completed Hour 24|Overall Study||170
10595409|NCT01804673|11751900|FG000|Completed Hour 48|Overall Study||79
10595410|NCT01804673|11751900|FG000|Completed Hour 72|Overall Study||36
10595411|NCT01804673|11751900|FG000|COMPLETED|Overall Study||34
10595412|NCT01804673|11751900|FG000|NOT COMPLETED|Overall Study||140
10595413|NCT01804842|11751907|FG000|STARTED|Overall Study||9
10595414|NCT01804842|11751908|FG001|STARTED|Overall Study||8
10595415|NCT01804842|11751909|FG002|STARTED|Overall Study||9
10595416|NCT01804842|11751907|FG000|Completed Treatment A|Overall Study||9
10595417|NCT01804842|11751908|FG001|Completed Treatment A|Overall Study||6
10595418|NCT01804842|11751909|FG002|Completed Treatment A|Overall Study||8
10595419|NCT01804842|11751907|FG000|Completed Treatment B|Overall Study||8
10595420|NCT01804842|11751908|FG001|Completed Treatment B|Overall Study||8
10595421|NCT01804842|11751909|FG002|Completed Treatment B|Overall Study||8
10595422|NCT01804842|11751907|FG000|Completed Treatment C|Overall Study||7
10595423|NCT01804842|11751908|FG001|Completed Treatment C|Overall Study||7
10595424|NCT01804842|11751909|FG002|Completed Treatment C|Overall Study||9
10595425|NCT01804842|11751907|FG000|COMPLETED|Overall Study||6
10595426|NCT01804842|11751908|FG001|COMPLETED|Overall Study||6
10595427|NCT01804842|11751909|FG002|COMPLETED|Overall Study||8
10595428|NCT01804842|11751907|FG000|NOT COMPLETED|Overall Study||3
10595429|NCT01804842|11751908|FG001|NOT COMPLETED|Overall Study||2
10595430|NCT01804842|11751909|FG002|NOT COMPLETED|Overall Study||1
10595431|NCT01804881|11751919|FG000|STARTED|Overall Study||16
10595432|NCT01804881|11751920|FG001|STARTED|Overall Study||14
10595433|NCT01804881|11751919|FG000|COMPLETED|Overall Study||11
10595434|NCT01804881|11751920|FG001|COMPLETED|Overall Study||10
10595435|NCT01804881|11751919|FG000|NOT COMPLETED|Overall Study||5
10595436|NCT01804881|11751920|FG001|NOT COMPLETED|Overall Study||4
10595437|NCT01804946|11751930|FG000|STARTED|Overall Study||81
10595438|NCT01804946|11751931|FG001|STARTED|Overall Study||80
10595439|NCT01804946|11751930|FG000|COMPLETED|Overall Study||79
10595440|NCT01804946|11751931|FG001|COMPLETED|Overall Study||76
10595441|NCT01804946|11751930|FG000|NOT COMPLETED|Overall Study||2
10595442|NCT01804946|11751931|FG001|NOT COMPLETED|Overall Study||4
10595443|NCT01805024|11751943|FG000|STARTED|Overall Study||4
10595444|NCT01805024|11751944|FG001|STARTED|Overall Study||4
10595445|NCT01805024|11751945|FG002|STARTED|Overall Study||4
10595446|NCT01805024|11751946|FG003|STARTED|Overall Study||8
10595447|NCT01805024|11751943|FG000|COMPLETED|Overall Study||4
10595448|NCT01805024|11751944|FG001|COMPLETED|Overall Study||4
10595449|NCT01805024|11751945|FG002|COMPLETED|Overall Study||4
10595450|NCT01805024|11751946|FG003|COMPLETED|Overall Study||8
10595451|NCT01805024|11751943|FG000|NOT COMPLETED|Overall Study||0
10595452|NCT01805024|11751944|FG001|NOT COMPLETED|Overall Study||0
10595453|NCT01805024|11751945|FG002|NOT COMPLETED|Overall Study||0
10595454|NCT01805024|11751946|FG003|NOT COMPLETED|Overall Study||0
10595455|NCT01805037|11751956|FG000|STARTED|Induction (4 Weeks)||0
10595456|NCT01805037|11751957|FG001|STARTED|Induction (4 Weeks)||20
10595457|NCT01805037|11751956|FG000|Received Dose of Study Drug|Induction (4 Weeks)||0
10595458|NCT01805037|11751957|FG001|Received Dose of Study Drug|Induction (4 Weeks)||20
10595459|NCT01805037|11751956|FG000|COMPLETED|Induction (4 Weeks)||0
10595460|NCT01805037|11751957|FG001|COMPLETED|Induction (4 Weeks)||20
10595461|NCT01805037|11751956|FG000|NOT COMPLETED|Induction (4 Weeks)||0
10595462|NCT01805037|11751957|FG001|NOT COMPLETED|Induction (4 Weeks)||0
10595463|NCT01805037|11751956|FG000|STARTED|Consolidation (Optional, 4 Weeks)||0
10595464|NCT01805037|11751957|FG001|STARTED|Consolidation (Optional, 4 Weeks)|Consolidation is optional for patients who have a partial or complete response during induction.|6
10595465|NCT01805037|11751956|FG000|Received Dose of Study Drug|Consolidation (Optional, 4 Weeks)||0
10595466|NCT01805037|11751957|FG001|Received Dose of Study Drug|Consolidation (Optional, 4 Weeks)||6
10595467|NCT01805037|11751956|FG000|COMPLETED|Consolidation (Optional, 4 Weeks)||0
10595468|NCT01805037|11751957|FG001|COMPLETED|Consolidation (Optional, 4 Weeks)||6
10595469|NCT01805037|11751956|FG000|NOT COMPLETED|Consolidation (Optional, 4 Weeks)||0
10595470|NCT01805037|11751957|FG001|NOT COMPLETED|Consolidation (Optional, 4 Weeks)||0
10595471|NCT01805037|11751956|FG000|STARTED|1st Cycle of Maintenance (3 Weeks)||0
10595472|NCT01805037|11751957|FG001|STARTED|1st Cycle of Maintenance (3 Weeks)|Consolidation is optional for patients who have a partial or complete response during induction|20
10595473|NCT01805037|11751956|FG000|Received Dose of Study Drug|1st Cycle of Maintenance (3 Weeks)||0
10595474|NCT01805037|11751957|FG001|Received Dose of Study Drug|1st Cycle of Maintenance (3 Weeks)||14
10595475|NCT01805037|11751956|FG000|COMPLETED|1st Cycle of Maintenance (3 Weeks)||0
10595476|NCT01805037|11751957|FG001|COMPLETED|1st Cycle of Maintenance (3 Weeks)||14
10595477|NCT01805037|11751956|FG000|NOT COMPLETED|1st Cycle of Maintenance (3 Weeks)||0
10595478|NCT01805037|11751957|FG001|NOT COMPLETED|1st Cycle of Maintenance (3 Weeks)||6
10595479|NCT01805037|11751956|FG000|STARTED|2nd Cycle of Maintenance and Beyond||0
10595480|NCT01805037|11751957|FG001|STARTED|2nd Cycle of Maintenance and Beyond||14
10595481|NCT01805037|11751956|FG000|Received Dose of Study Drug|2nd Cycle of Maintenance and Beyond||0
10595482|NCT01805037|11751957|FG001|Received Dose of Study Drug|2nd Cycle of Maintenance and Beyond||14
10652170|NCT02181816|11812539|FG000|STARTED|Overall Study||1090
10595483|NCT01805037|11751956|FG000|COMPLETED|2nd Cycle of Maintenance and Beyond||0
10595484|NCT01805037|11751957|FG001|COMPLETED|2nd Cycle of Maintenance and Beyond||2
10595485|NCT01805037|11751956|FG000|NOT COMPLETED|2nd Cycle of Maintenance and Beyond||0
10595486|NCT01805037|11751957|FG001|NOT COMPLETED|2nd Cycle of Maintenance and Beyond||12
10595487|NCT01805037|11751956|FG000|STARTED|Follow Up (up to 3 Years)||0
10595488|NCT01805037|11751957|FG001|STARTED|Follow Up (up to 3 Years)|Patients who received at least one dose of study treatment go into follow-up.|20
10595489|NCT01805037|11751956|FG000|COMPLETED|Follow Up (up to 3 Years)||0
10595490|NCT01805037|11751957|FG001|COMPLETED|Follow Up (up to 3 Years)||14
10595491|NCT01805037|11751956|FG000|NOT COMPLETED|Follow Up (up to 3 Years)||0
10595492|NCT01805037|11751957|FG001|NOT COMPLETED|Follow Up (up to 3 Years)||6
10595493|NCT01805089|11751963|FG000|STARTED|Overall Study||48
10595494|NCT01805089|11751964|FG001|STARTED|Overall Study||47
10595495|NCT01805089|11751963|FG000|COMPLETED|Overall Study||43
10595496|NCT01805089|11751964|FG001|COMPLETED|Overall Study||43
10595497|NCT01805089|11751963|FG000|NOT COMPLETED|Overall Study||5
10595498|NCT01805089|11751964|FG001|NOT COMPLETED|Overall Study||4
10595499|NCT01805154|11751970|FG000|STARTED|Overall Study||1529
10595500|NCT01805154|11751970|FG000|COMPLETED|Overall Study||1175
10595501|NCT01805154|11751970|FG000|NOT COMPLETED|Overall Study||354
10595502|NCT01805180|11751979|FG000|STARTED|Lead-in Donor Phase||7
10595503|NCT01805180|11751980|FG001|STARTED|Lead-in Donor Phase|pivotal trial subjects were not screened or enrolled in this period.|0
10595504|NCT01805180|11751981|FG002|STARTED|Lead-in Donor Phase|pivotal trial subjects were not screened or enrolled in this period.|0
10595505|NCT01805180|11751979|FG000|COMPLETED|Lead-in Donor Phase||6
10595506|NCT01805180|11751980|FG001|COMPLETED|Lead-in Donor Phase||0
10595507|NCT01805180|11751981|FG002|COMPLETED|Lead-in Donor Phase||0
10595508|NCT01805180|11751979|FG000|NOT COMPLETED|Lead-in Donor Phase||1
10595509|NCT01805180|11751980|FG001|NOT COMPLETED|Lead-in Donor Phase||0
10595510|NCT01805180|11751981|FG002|NOT COMPLETED|Lead-in Donor Phase||0
10595511|NCT01805180|11751979|FG000|STARTED|Pivotal Randomization Through Study Exit|lead-in donors were not randomized and did not participate in this period.|0
10595512|NCT01805180|11751980|FG001|STARTED|Pivotal Randomization Through Study Exit||22
10595513|NCT01805180|11751981|FG002|STARTED|Pivotal Randomization Through Study Exit||20
10595514|NCT01805180|11751979|FG000|COMPLETED|Pivotal Randomization Through Study Exit||0
10595515|NCT01805180|11751980|FG001|COMPLETED|Pivotal Randomization Through Study Exit||17
10595516|NCT01805180|11751981|FG002|COMPLETED|Pivotal Randomization Through Study Exit||15
10595517|NCT01805180|11751979|FG000|NOT COMPLETED|Pivotal Randomization Through Study Exit||0
10595518|NCT01805180|11751980|FG001|NOT COMPLETED|Pivotal Randomization Through Study Exit||5
10595519|NCT01805180|11751981|FG002|NOT COMPLETED|Pivotal Randomization Through Study Exit||5
10595520|NCT01805297|11751991|FG000|STARTED|Overall Study||6
10595521|NCT01805297|11751992|FG001|STARTED|Overall Study||6
10595522|NCT01805297|11751991|FG000|COMPLETED|Overall Study||4
10595523|NCT01805297|11751992|FG001|COMPLETED|Overall Study||3
10595524|NCT01805297|11751991|FG000|NOT COMPLETED|Overall Study||2
10595525|NCT01805297|11751992|FG001|NOT COMPLETED|Overall Study||3
10595526|NCT01805323|11751999|FG000|STARTED|Overall Study||101
10595527|NCT01805323|11751999|FG000|COMPLETED|Overall Study||101
10595528|NCT01805323|11751999|FG000|NOT COMPLETED|Overall Study||0
10595529|NCT01805440|11752006|FG000|STARTED|Overall Study||19
10595530|NCT01805440|11752007|FG001|STARTED|Overall Study||17
10595531|NCT01805440|11752008|FG002|STARTED|Overall Study||26
10595532|NCT01805440|11752006|FG000|COMPLETED|Overall Study||18
10595533|NCT01805440|11752007|FG001|COMPLETED|Overall Study||17
10595534|NCT01805440|11752008|FG002|COMPLETED|Overall Study||26
10595535|NCT01805440|11752006|FG000|NOT COMPLETED|Overall Study||1
10595536|NCT01805440|11752007|FG001|NOT COMPLETED|Overall Study||0
10595537|NCT01805440|11752008|FG002|NOT COMPLETED|Overall Study||0
10595538|NCT01805687|11752015|FG000|STARTED|Overall Study||25
10595539|NCT01805687|11752015|FG000|COMPLETED|Overall Study||25
10595540|NCT01805687|11752015|FG000|NOT COMPLETED|Overall Study||0
10595541|NCT01805791|11752022|FG000|STARTED|Overall Study||66
10595542|NCT01805791|11752023|FG001|STARTED|Overall Study||67
10595543|NCT01805791|11752024|FG002|STARTED|Overall Study||68
10595544|NCT01805791|11752022|FG000|COMPLETED|Overall Study||44
10595545|NCT01805791|11752023|FG001|COMPLETED|Overall Study||50
10595546|NCT01805791|11752024|FG002|COMPLETED|Overall Study||48
10595547|NCT01805791|11752022|FG000|NOT COMPLETED|Overall Study||22
10595548|NCT01805791|11752023|FG001|NOT COMPLETED|Overall Study||17
10595549|NCT01805791|11752024|FG002|NOT COMPLETED|Overall Study||20
10595550|NCT01805882|11752041|FG000|STARTED|Overall Study||20
10595551|NCT01805882|11752042|FG001|STARTED|Overall Study||20
10595552|NCT01805882|11752043|FG002|STARTED|Overall Study||20
10595553|NCT01805882|11752044|FG003|STARTED|Overall Study||34
10595554|NCT01805882|11752045|FG004|STARTED|Overall Study||14
10595555|NCT01805882|11752046|FG005|STARTED|Overall Study||21
10595556|NCT01805882|11752047|FG006|STARTED|Overall Study||50
10595557|NCT01805882|11752048|FG007|STARTED|Overall Study||25
10595558|NCT01805882|11752049|FG008|STARTED|Overall Study||25
10595559|NCT01805882|11752041|FG000|COMPLETED|Overall Study||20
10595560|NCT01805882|11752042|FG001|COMPLETED|Overall Study||20
10595561|NCT01805882|11752043|FG002|COMPLETED|Overall Study||19
10595562|NCT01805882|11752044|FG003|COMPLETED|Overall Study||32
10595563|NCT01805882|11752045|FG004|COMPLETED|Overall Study||14
10595564|NCT01805882|11752046|FG005|COMPLETED|Overall Study||20
10595565|NCT01805882|11752047|FG006|COMPLETED|Overall Study||48
10595566|NCT01805882|11752048|FG007|COMPLETED|Overall Study||25
10595567|NCT01805882|11752049|FG008|COMPLETED|Overall Study||24
10595568|NCT01805882|11752041|FG000|NOT COMPLETED|Overall Study||0
10595569|NCT01805882|11752042|FG001|NOT COMPLETED|Overall Study||0
10595570|NCT01805882|11752043|FG002|NOT COMPLETED|Overall Study||1
10595571|NCT01805882|11752044|FG003|NOT COMPLETED|Overall Study||2
10595572|NCT01805882|11752045|FG004|NOT COMPLETED|Overall Study||0
10595573|NCT01805882|11752046|FG005|NOT COMPLETED|Overall Study||1
10595574|NCT01805882|11752047|FG006|NOT COMPLETED|Overall Study||2
10595575|NCT01805882|11752048|FG007|NOT COMPLETED|Overall Study||0
10595576|NCT01805882|11752049|FG008|NOT COMPLETED|Overall Study||1
10595577|NCT01805895|11752071|FG000|STARTED|Overall Study||8
10595578|NCT01805895|11752072|FG001|STARTED|Overall Study||8
10595579|NCT01805895|11752071|FG000|COMPLETED|Overall Study||8
10595580|NCT01805895|11752072|FG001|COMPLETED|Overall Study||8
10595581|NCT01805895|11752071|FG000|NOT COMPLETED|Overall Study||0
10595582|NCT01805895|11752072|FG001|NOT COMPLETED|Overall Study||0
10595583|NCT01806064|11752083|FG000|STARTED|Overall Study||3
10595584|NCT01806064|11752084|FG001|STARTED|Overall Study||15
10595585|NCT01806064|11752085|FG002|STARTED|Overall Study||5
10595586|NCT01806064|11752086|FG003|STARTED|Overall Study||75
10595587|NCT01806064|11752087|FG004|STARTED|Overall Study||75
10595588|NCT01806064|11752083|FG000|COMPLETED|Overall Study||3
10595589|NCT01806064|11752084|FG001|COMPLETED|Overall Study||15
10595590|NCT01806064|11752085|FG002|COMPLETED|Overall Study||5
10595591|NCT01806064|11752086|FG003|COMPLETED|Overall Study||74
10595592|NCT01806064|11752087|FG004|COMPLETED|Overall Study||73
10595593|NCT01806064|11752083|FG000|NOT COMPLETED|Overall Study||0
10595594|NCT01806064|11752084|FG001|NOT COMPLETED|Overall Study||0
10595595|NCT01806064|11752085|FG002|NOT COMPLETED|Overall Study||0
10595596|NCT01806064|11752086|FG003|NOT COMPLETED|Overall Study||1
10595597|NCT01806064|11752087|FG004|NOT COMPLETED|Overall Study||2
10595598|NCT01806168|11752106|FG000|STARTED|Overall Study||11
10703659|NCT02585960|11868126|FG000|COMPLETED|PK/Safety Assessment Period||52
10703660|NCT02585960|11868127|FG001|COMPLETED|PK/Safety Assessment Period||48
10703661|NCT02585960|11868128|FG002|COMPLETED|PK/Safety Assessment Period||0
10703662|NCT02585960|11868126|FG000|NOT COMPLETED|PK/Safety Assessment Period||5
10703663|NCT02585960|11868127|FG001|NOT COMPLETED|PK/Safety Assessment Period||10
10703664|NCT02585960|11868128|FG002|NOT COMPLETED|PK/Safety Assessment Period||6
10703665|NCT02585960|11868126|FG000|STARTED|Prophylactic Treatment Period||52
10703666|NCT02585960|11868127|FG001|STARTED|Prophylactic Treatment Period||48
10703667|NCT02585960|11868128|FG002|STARTED|Prophylactic Treatment Period||0
10703668|NCT02585960|11868126|FG000|COMPLETED|Prophylactic Treatment Period||52
10703669|NCT02585960|11868127|FG001|COMPLETED|Prophylactic Treatment Period||43
10703670|NCT02585960|11868128|FG002|COMPLETED|Prophylactic Treatment Period||0
10703671|NCT02585960|11868126|FG000|NOT COMPLETED|Prophylactic Treatment Period||0
10703672|NCT02585960|11868127|FG001|NOT COMPLETED|Prophylactic Treatment Period||5
10703673|NCT02585960|11868128|FG002|NOT COMPLETED|Prophylactic Treatment Period||0
10703674|NCT02585999|11868139|FG000|STARTED|Overall Study||28
10703675|NCT02585999|11868139|FG000|COMPLETED|Overall Study|28 participants enrolled; 2 withdrew prior to starting, leaving 26 to complete study activity.|26
10807831|NCT03880227|11969603|FG003|NOT COMPLETED|First Visit||0
10595599|NCT01806168|11752107|FG001|STARTED|Overall Study||10
10595600|NCT01806168|11752108|FG002|STARTED|Overall Study||10
10595601|NCT01806168|11752106|FG000|Received Allocated Intervention|Overall Study||11
10595602|NCT01806168|11752107|FG001|Received Allocated Intervention|Overall Study||9
10595603|NCT01806168|11752108|FG002|Received Allocated Intervention|Overall Study||9
10595604|NCT01806168|11752106|FG000|COMPLETED|Overall Study||10
10595605|NCT01806168|11752107|FG001|COMPLETED|Overall Study||9
10595606|NCT01806168|11752108|FG002|COMPLETED|Overall Study||7
10595607|NCT01806168|11752106|FG000|NOT COMPLETED|Overall Study||1
10595608|NCT01806168|11752107|FG001|NOT COMPLETED|Overall Study||1
10595609|NCT01806168|11752108|FG002|NOT COMPLETED|Overall Study||3
10807832|NCT03880227|11969600|FG000|STARTED|1 Week Washout/ Delay||19
10595610|NCT01806259|11752121|FG000|STARTED|Overall Study||96
10595611|NCT01806259|11752122|FG001|STARTED|Overall Study||107
10595612|NCT01806259|11752121|FG000|COMPLETED|Overall Study||96
10595613|NCT01806259|11752122|FG001|COMPLETED|Overall Study||107
10595614|NCT01806259|11752121|FG000|NOT COMPLETED|Overall Study||0
10595615|NCT01806259|11752122|FG001|NOT COMPLETED|Overall Study||0
10595616|NCT01806298|11752129|FG000|STARTED|Overall Study||78
10595617|NCT01806298|11752129|FG000|COMPLETED|Overall Study||68
10595618|NCT01806298|11752129|FG000|NOT COMPLETED|Overall Study||10
10595619|NCT01806389|11752133|FG000|STARTED|Overall Study||14
10595620|NCT01806389|11752133|FG000|COMPLETED|Overall Study||10
10595621|NCT01806389|11752133|FG000|NOT COMPLETED|Overall Study||4
10595622|NCT01806506|11752149|FG000|STARTED|Overall Study||36
10595623|NCT01806506|11752150|FG001|STARTED|Overall Study||36
10595624|NCT01806506|11752149|FG000|1 Month|Overall Study||36
10595625|NCT01806506|11752150|FG001|1 Month|Overall Study||36
10595626|NCT01806506|11752149|FG000|3 Months|Overall Study|1 patient (reason - lost contact)|35
10595627|NCT01806506|11752150|FG001|3 Months|Overall Study||36
10595628|NCT01806506|11752149|FG000|6 Months|Overall Study|1 patient (reason - lost contact)|34
10595629|NCT01806506|11752150|FG001|6 Months|Overall Study||36
10595630|NCT01806506|11752149|FG000|9 Months|Overall Study||34
10595631|NCT01806506|11752150|FG001|9 Months|Overall Study|1 patient (reason - lost contact)|35
10595632|NCT01806506|11752149|FG000|COMPLETED|Overall Study||34
10595633|NCT01806506|11752150|FG001|COMPLETED|Overall Study||35
10595634|NCT01806506|11752149|FG000|NOT COMPLETED|Overall Study||2
10595635|NCT01806506|11752150|FG001|NOT COMPLETED|Overall Study||1
10595636|NCT01806545|11752158|FG000|STARTED|Overall Study||29
10807833|NCT03880227|11969601|FG001|STARTED|1 Week Washout/ Delay||21
10807834|NCT03880227|11969602|FG002|STARTED|1 Week Washout/ Delay||22
10807835|NCT03880227|11969603|FG003|STARTED|1 Week Washout/ Delay||18
10807836|NCT03880227|11969600|FG000|COMPLETED|1 Week Washout/ Delay||19
10595637|NCT01806545|11752159|FG001|STARTED|Overall Study||35
10595638|NCT01806545|11752158|FG000|COMPLETED|Overall Study||23
10595639|NCT01806545|11752159|FG001|COMPLETED|Overall Study||30
10595640|NCT01806545|11752158|FG000|NOT COMPLETED|Overall Study||6
10595641|NCT01806545|11752159|FG001|NOT COMPLETED|Overall Study||5
10595642|NCT01806571|11752165|FG000|STARTED|Overall Study||34
10595643|NCT01806571|11752165|FG000|COMPLETED|Overall Study||34
10595644|NCT01806571|11752165|FG000|NOT COMPLETED|Overall Study||0
10595645|NCT01806584|11752171|FG000|STARTED|Overall Study||14
10595646|NCT01806584|11752172|FG001|STARTED|Overall Study||18
10595647|NCT01806584|11752171|FG000|COMPLETED|Overall Study||0
10595648|NCT01806584|11752172|FG001|COMPLETED|Overall Study||0
10595649|NCT01806584|11752171|FG000|NOT COMPLETED|Overall Study||14
10595650|NCT01806584|11752172|FG001|NOT COMPLETED|Overall Study||18
10595651|NCT01806597|11752181|FG000|STARTED|Period 1 (Baseline to Week 16)||68
10595652|NCT01806597|11752182|FG001|STARTED|Period 1 (Baseline to Week 16)||69
10595653|NCT01806597|11752183|FG002|STARTED|Period 1 (Baseline to Week 16)||0
10595654|NCT01806597|11752184|FG003|STARTED|Period 1 (Baseline to Week 16)||0
10595655|NCT01806597|11752185|FG004|STARTED|Period 1 (Baseline to Week 16)||68
10595656|NCT01806597|11752186|FG005|STARTED|Period 1 (Baseline to Week 16)||0
10595657|NCT01806597|11752181|FG000|COMPLETED|Period 1 (Baseline to Week 16)||63
10595658|NCT01806597|11752182|FG001|COMPLETED|Period 1 (Baseline to Week 16)||64
10595659|NCT01806597|11752183|FG002|COMPLETED|Period 1 (Baseline to Week 16)||0
10595660|NCT01806597|11752184|FG003|COMPLETED|Period 1 (Baseline to Week 16)||0
10595661|NCT01806597|11752185|FG004|COMPLETED|Period 1 (Baseline to Week 16)||63
10595662|NCT01806597|11752186|FG005|COMPLETED|Period 1 (Baseline to Week 16)||0
10595663|NCT01806597|11752181|FG000|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
10595664|NCT01806597|11752182|FG001|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
10595665|NCT01806597|11752183|FG002|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
10595666|NCT01806597|11752184|FG003|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
10595667|NCT01806597|11752185|FG004|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
10595668|NCT01806597|11752186|FG005|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
10595669|NCT01806597|11752181|FG000|STARTED|Treatment Period 2 (Week 16 to Week 132)||63
10595670|NCT01806597|11752182|FG001|STARTED|Treatment Period 2 (Week 16 to Week 132)||64
10703676|NCT02585999|11868139|FG000|NOT COMPLETED|Overall Study||2
10703677|NCT02586012|11868144|FG000|STARTED|Overall Study||5
10703678|NCT02586012|11868145|FG001|STARTED|Overall Study||5
10703679|NCT02586012|11868146|FG002|STARTED|Overall Study||5
10595671|NCT01806597|11752183|FG002|STARTED|Treatment Period 2 (Week 16 to Week 132)||31
10595672|NCT01806597|11752184|FG003|STARTED|Treatment Period 2 (Week 16 to Week 132)||31
10595673|NCT01806597|11752185|FG004|STARTED|Treatment Period 2 (Week 16 to Week 132)||1
10595674|NCT01806597|11752186|FG005|STARTED|Treatment Period 2 (Week 16 to Week 132)||0
10595675|NCT01806597|11752181|FG000|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||24
10595676|NCT01806597|11752182|FG001|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||44
10595677|NCT01806597|11752183|FG002|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||17
10595678|NCT01806597|11752184|FG003|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||20
10595679|NCT01806597|11752185|FG004|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
10595680|NCT01806597|11752186|FG005|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
10595681|NCT01806597|11752181|FG000|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||39
10595682|NCT01806597|11752182|FG001|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||20
10595683|NCT01806597|11752183|FG002|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||14
10595684|NCT01806597|11752184|FG003|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||11
10595685|NCT01806597|11752185|FG004|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||1
10595686|NCT01806597|11752186|FG005|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
10595687|NCT01806597|11752181|FG000|STARTED|Follow-up Period (Week 132 to Week 140)||0
10595688|NCT01806597|11752182|FG001|STARTED|Follow-up Period (Week 132 to Week 140)||0
10595689|NCT01806597|11752183|FG002|STARTED|Follow-up Period (Week 132 to Week 140)||0
10595690|NCT01806597|11752184|FG003|STARTED|Follow-up Period (Week 132 to Week 140)||0
10595691|NCT01806597|11752185|FG004|STARTED|Follow-up Period (Week 132 to Week 140)||3
10595692|NCT01806597|11752186|FG005|STARTED|Follow-up Period (Week 132 to Week 140)||161
10595693|NCT01806597|11752181|FG000|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
10595694|NCT01806597|11752182|FG001|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
10595695|NCT01806597|11752183|FG002|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
10595696|NCT01806597|11752184|FG003|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
10595697|NCT01806597|11752185|FG004|COMPLETED|Follow-up Period (Week 132 to Week 140)||3
10595698|NCT01806597|11752186|FG005|COMPLETED|Follow-up Period (Week 132 to Week 140)||149
10595699|NCT01806597|11752181|FG000|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
10595700|NCT01806597|11752182|FG001|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
10703680|NCT02586012|11868147|FG003|STARTED|Overall Study||5
10703681|NCT02586012|11868148|FG004|STARTED|Overall Study||5
10703682|NCT02586012|11868149|FG005|STARTED|Overall Study||5
10595701|NCT01806597|11752183|FG002|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
10703683|NCT02586012|11868144|FG000|COMPLETED|Overall Study||4
10703684|NCT02586012|11868145|FG001|COMPLETED|Overall Study||2
10703685|NCT02586012|11868146|FG002|COMPLETED|Overall Study||4
10703686|NCT02586012|11868147|FG003|COMPLETED|Overall Study||3
10595702|NCT01806597|11752184|FG003|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
10595703|NCT01806597|11752185|FG004|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
10595704|NCT01806597|11752186|FG005|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||12
10595705|NCT01806623|11752200|FG000|STARTED|Overall Study||157
10595706|NCT01806623|11752200|FG000|COMPLETED|Overall Study||99
10595707|NCT01806623|11752200|FG000|NOT COMPLETED|Overall Study||58
10595708|NCT01806662|11752204|FG000|STARTED|First Intervention (Weeks 0-16)||16
10595709|NCT01806662|11752205|FG001|STARTED|First Intervention (Weeks 0-16)||16
10595710|NCT01806662|11752204|FG000|Received Intervention|First Intervention (Weeks 0-16)||12
10595711|NCT01806662|11752205|FG001|Received Intervention|First Intervention (Weeks 0-16)||15
10595712|NCT01806662|11752204|FG000|COMPLETED|First Intervention (Weeks 0-16)||12
10595713|NCT01806662|11752205|FG001|COMPLETED|First Intervention (Weeks 0-16)||15
10595714|NCT01806662|11752204|FG000|NOT COMPLETED|First Intervention (Weeks 0-16)||4
10595715|NCT01806662|11752205|FG001|NOT COMPLETED|First Intervention (Weeks 0-16)||1
10595716|NCT01806662|11752204|FG000|STARTED|Second Intervention (Weeks 16-32)||12
10595717|NCT01806662|11752205|FG001|STARTED|Second Intervention (Weeks 16-32)||15
10595718|NCT01806662|11752204|FG000|COMPLETED|Second Intervention (Weeks 16-32)||10
10595719|NCT01806662|11752205|FG001|COMPLETED|Second Intervention (Weeks 16-32)||11
10595720|NCT01806662|11752204|FG000|NOT COMPLETED|Second Intervention (Weeks 16-32)||2
10595721|NCT01806662|11752205|FG001|NOT COMPLETED|Second Intervention (Weeks 16-32)||4
10595722|NCT01806675|11752214|FG000|STARTED|Overall Study||11
10595723|NCT01806675|11752215|FG001|STARTED|Overall Study||6
10595724|NCT01806675|11752216|FG002|STARTED|Overall Study||8
10595725|NCT01806675|11752214|FG000|COMPLETED|Overall Study||11
10595726|NCT01806675|11752215|FG001|COMPLETED|Overall Study||6
10595727|NCT01806675|11752216|FG002|COMPLETED|Overall Study||8
10595728|NCT01806675|11752214|FG000|NOT COMPLETED|Overall Study||0
10595729|NCT01806675|11752215|FG001|NOT COMPLETED|Overall Study||0
10595730|NCT01806675|11752216|FG002|NOT COMPLETED|Overall Study||0
10595790|NCT01806688|11752227|FG001|NOT COMPLETED|Second Intervention Pita Study||0
10595860|NCT01807026|11752291|FG001|COMPLETED|Overall Study||2
10595861|NCT01807026|11752292|FG002|COMPLETED|Overall Study||10
10595862|NCT01807026|11752293|FG003|COMPLETED|Overall Study||2
10595731|NCT01806688|11752226|FG000|STARTED|First Intervention Seed Study|"Participants received one of the following:~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats~placebo comparator reference product, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts~placebo comparator non-caloric control water"|38
10595732|NCT01806688|11752227|FG001|STARTED|First Intervention Seed Study|"Participants received one of the following:~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats~placebo comparator reference product, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts~placebo comparator non-caloric control water"|0
10595733|NCT01806688|11752226|FG000|Experimental Snack #1|First Intervention Seed Study|Received experimental snack #1 at the first visit, a 30g serving of buckwheat groats|13
10595734|NCT01806688|11752227|FG001|Experimental Snack #1|First Intervention Seed Study|Received experimental snack #1 at the first visit, a 30g serving of buckwheat groats|0
10595735|NCT01806688|11752226|FG000|Placebo Comparator Reference Product #1|First Intervention Seed Study|Received the placebo comparator reference product #1 at the first visit, a 32g serving of corn nuts|13
10595736|NCT01806688|11752227|FG001|Placebo Comparator Reference Product #1|First Intervention Seed Study|Received the placebo comparator reference product #1 at the first visit, a 32g serving of corn nuts|0
10595737|NCT01806688|11752226|FG000|Placebo Comparator Non-caloric Control #1|First Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at the first visit|12
10595738|NCT01806688|11752227|FG001|Placebo Comparator Non-caloric Control #1|First Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at the first visit|0
10595739|NCT01806688|11752226|FG000|COMPLETED|First Intervention Seed Study||38
10595740|NCT01806688|11752227|FG001|COMPLETED|First Intervention Seed Study||0
10595741|NCT01806688|11752226|FG000|NOT COMPLETED|First Intervention Seed Study||0
10595742|NCT01806688|11752227|FG001|NOT COMPLETED|First Intervention Seed Study||0
10595743|NCT01806688|11752226|FG000|STARTED|Second Intervention Seed Study|"Participants received one of the following they hadn't previously received at visit 1:~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats~placebo comparator reference product #1, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts~placebo comparator non-caloric control #1, water"|38
10652171|NCT02181816|11812539|FG000|COMPLETED|Overall Study||1031
10807837|NCT03880227|11969601|FG001|COMPLETED|1 Week Washout/ Delay||20
10807838|NCT03880227|11969602|FG002|COMPLETED|1 Week Washout/ Delay||19
10807839|NCT03880227|11969603|FG003|COMPLETED|1 Week Washout/ Delay||18
10807840|NCT03880227|11969600|FG000|NOT COMPLETED|1 Week Washout/ Delay||0
10807841|NCT03880227|11969601|FG001|NOT COMPLETED|1 Week Washout/ Delay||1
10807842|NCT03880227|11969602|FG002|NOT COMPLETED|1 Week Washout/ Delay||3
10807843|NCT03880227|11969603|FG003|NOT COMPLETED|1 Week Washout/ Delay||0
10807844|NCT03880227|11969600|FG000|STARTED|Second Visit||19
10807845|NCT03880227|11969601|FG001|STARTED|Second Visit||20
10807846|NCT03880227|11969602|FG002|STARTED|Second Visit||19
10807847|NCT03880227|11969603|FG003|STARTED|Second Visit||18
10807848|NCT03880227|11969600|FG000|COMPLETED|Second Visit||19
10807849|NCT03880227|11969601|FG001|COMPLETED|Second Visit||20
10807850|NCT03880227|11969602|FG002|COMPLETED|Second Visit||19
10807851|NCT03880227|11969603|FG003|COMPLETED|Second Visit||18
10807852|NCT03880227|11969600|FG000|NOT COMPLETED|Second Visit||0
10807853|NCT03880227|11969601|FG001|NOT COMPLETED|Second Visit||0
10807854|NCT03880227|11969602|FG002|NOT COMPLETED|Second Visit||0
10807855|NCT03880227|11969603|FG003|NOT COMPLETED|Second Visit||0
10807856|NCT03876743|11969617|FG000|STARTED|Overall Study||54
10807857|NCT03876743|11969618|FG001|STARTED|Overall Study||51
10807858|NCT03876743|11969619|FG002|STARTED|Overall Study||46
10595744|NCT01806688|11752227|FG001|STARTED|Second Intervention Seed Study|"Participants received one of the following they hadn't previously received at visit 1:~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats~placebo comparator reference product #1, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts~placebo comparator non-caloric control #1, water"|0
10595745|NCT01806688|11752226|FG000|Experimental Snack #1|Second Intervention Seed Study|Received the experimental snack #1, a 30g serving of buckwheat groats at visit 2|13
10595746|NCT01806688|11752227|FG001|Experimental Snack #1|Second Intervention Seed Study|Received the experimental snack #1, a 30g serving of buckwheat groats at visit 2|0
10595747|NCT01806688|11752226|FG000|Placebo Comparator Reference Product #1|Second Intervention Seed Study|Received the Placebo comparator reference product #1, a 32g serving of corn nuts at visit 2|13
10595748|NCT01806688|11752227|FG001|Placebo Comparator Reference Product #1|Second Intervention Seed Study|Received the Placebo comparator reference product #1, a 32g serving of corn nuts at visit 2|0
10595749|NCT01806688|11752226|FG000|Placebo Comparator Non-caloric Control #1|Second Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at visit 2|12
10595750|NCT01806688|11752227|FG001|Placebo Comparator Non-caloric Control #1|Second Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at visit 2|0
10595751|NCT01806688|11752226|FG000|COMPLETED|Second Intervention Seed Study||38
10595752|NCT01806688|11752227|FG001|COMPLETED|Second Intervention Seed Study||0
10595753|NCT01806688|11752226|FG000|NOT COMPLETED|Second Intervention Seed Study||0
10595754|NCT01806688|11752227|FG001|NOT COMPLETED|Second Intervention Seed Study||0
10595755|NCT01806688|11752226|FG000|STARTED|Third Intervention Seed Study|"Participants received one of the following they hadn't previously received at visit 1 or visit 2:~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats~placebo comparator reference product, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts~placebo comparator non-caloric control water"|38
10595857|NCT01807026|11752294|FG004|Received at Least One Dose of Study Drug|Overall Study||9
10595858|NCT01807026|11752295|FG005|Received at Least One Dose of Study Drug|Overall Study||3
10595859|NCT01807026|11752290|FG000|COMPLETED|Overall Study||10
10595756|NCT01806688|11752227|FG001|STARTED|Third Intervention Seed Study|"Participants received one of the following they hadn't previously received at visit 1 or visit 2:~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats~placebo comparator reference product, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts~placebo comparator non-caloric control water"|0
10595757|NCT01806688|11752226|FG000|Experimental Snack #1|Third Intervention Seed Study|Received the Experimental snack #1, a 30g serving of buckwheat groats at visit 3|12
10595758|NCT01806688|11752227|FG001|Experimental Snack #1|Third Intervention Seed Study|Received the Experimental snack #1, a 30g serving of buckwheat groats at visit 3|0
10595759|NCT01806688|11752226|FG000|Placebo Comparator Reference Product #1|Third Intervention Seed Study|Received the placebo comparator reference product #1, a 32g serving of corn nuts at visit 3|12
10595760|NCT01806688|11752227|FG001|Placebo Comparator Reference Product #1|Third Intervention Seed Study|Received the placebo comparator reference product #1, a 32g serving of corn nuts at visit 3|0
10595761|NCT01806688|11752226|FG000|Placebo Comparator Non-caloric Control #1|Third Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at visit 3|14
10595762|NCT01806688|11752227|FG001|Placebo Comparator Non-caloric Control #1|Third Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at visit 3|0
10595763|NCT01806688|11752226|FG000|COMPLETED|Third Intervention Seed Study||38
10595764|NCT01806688|11752227|FG001|COMPLETED|Third Intervention Seed Study||0
10595765|NCT01806688|11752226|FG000|NOT COMPLETED|Third Intervention Seed Study||0
10595766|NCT01806688|11752227|FG001|NOT COMPLETED|Third Intervention Seed Study||0
10595767|NCT01806688|11752226|FG000|STARTED|First Intervention Pita Study|"Participants received one of the following:~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread~placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread~placebo comparator non-caloric control water"|0
10595768|NCT01806688|11752227|FG001|STARTED|First Intervention Pita Study|"Participants received one of the following:~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread~placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread~placebo comparator non-caloric control water"|38
10595769|NCT01806688|11752226|FG000|Experimental Snack #2|First Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the first visit|0
10595770|NCT01806688|11752227|FG001|Experimental Snack #2|First Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the first visit|14
10595771|NCT01806688|11752226|FG000|Placebo Comparator Reference Product #2|First Intervention Pita Study|Received the placebo comparator reference product #2 at the first visit, a 50g serving of rice bread|0
10595772|NCT01806688|11752227|FG001|Placebo Comparator Reference Product #2|First Intervention Pita Study|Received the placebo comparator reference product #2 at the first visit, a 50g serving of rice bread|12
10595773|NCT01806688|11752226|FG000|Placebo Comparator Non-caloric Control #2|First Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the first visit|0
10595774|NCT01806688|11752227|FG001|Placebo Comparator Non-caloric Control #2|First Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the first visit|12
10595775|NCT01806688|11752226|FG000|COMPLETED|First Intervention Pita Study||0
10595776|NCT01806688|11752227|FG001|COMPLETED|First Intervention Pita Study||38
10703687|NCT02586012|11868148|FG004|COMPLETED|Overall Study||4
10703688|NCT02586012|11868149|FG005|COMPLETED|Overall Study||2
10703689|NCT02586012|11868144|FG000|NOT COMPLETED|Overall Study||1
10703690|NCT02586012|11868145|FG001|NOT COMPLETED|Overall Study||3
10703691|NCT02586012|11868146|FG002|NOT COMPLETED|Overall Study||1
10703692|NCT02586012|11868147|FG003|NOT COMPLETED|Overall Study||2
10595777|NCT01806688|11752226|FG000|NOT COMPLETED|First Intervention Pita Study||0
10595778|NCT01806688|11752227|FG001|NOT COMPLETED|First Intervention Pita Study||0
10595779|NCT01806688|11752226|FG000|STARTED|Second Intervention Pita Study|"Participants received one of the following:~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread~placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread~placebo comparator non-caloric control water"|0
10595780|NCT01806688|11752227|FG001|STARTED|Second Intervention Pita Study|"Participants received one of the following:~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread~placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread~placebo comparator non-caloric control water"|38
10595781|NCT01806688|11752226|FG000|Experimental Snack #2|Second Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the second visit|0
10595782|NCT01806688|11752227|FG001|Experimental Snack #2|Second Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the second visit|12
10595783|NCT01806688|11752226|FG000|Placebo Comparator Reference Product #2|Second Intervention Pita Study|Received the placebo comparator reference product #2 at the second visit, a 50g serving of rice bread|0
10595784|NCT01806688|11752227|FG001|Placebo Comparator Reference Product #2|Second Intervention Pita Study|Received the placebo comparator reference product #2 at the second visit, a 50g serving of rice bread|13
10595785|NCT01806688|11752226|FG000|Placebo Comparator Non-caloric Control #2|Second Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the second visit|0
10595786|NCT01806688|11752227|FG001|Placebo Comparator Non-caloric Control #2|Second Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the second visit|13
10595787|NCT01806688|11752226|FG000|COMPLETED|Second Intervention Pita Study||0
10595788|NCT01806688|11752227|FG001|COMPLETED|Second Intervention Pita Study||38
10595789|NCT01806688|11752226|FG000|NOT COMPLETED|Second Intervention Pita Study||0
10595791|NCT01806688|11752226|FG000|STARTED|Third Intervention Pita Study|"Participants received one of the following:~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread placebo comparator non-caloric control water"|0
10595792|NCT01806688|11752227|FG001|STARTED|Third Intervention Pita Study|"Participants received one of the following:~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread placebo comparator non-caloric control water"|38
10595793|NCT01806688|11752226|FG000|Experimental Snack #2|Third Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the third visit|0
10595794|NCT01806688|11752227|FG001|Experimental Snack #2|Third Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the third visit|12
10595795|NCT01806688|11752226|FG000|Placebo Comparator Reference Product #2|Third Intervention Pita Study|Received the placebo comparator reference product #2 at the third visit, a 50g serving of rice bread|0
10595796|NCT01806688|11752227|FG001|Placebo Comparator Reference Product #2|Third Intervention Pita Study|Received the placebo comparator reference product #2 at the third visit, a 50g serving of rice bread|13
10595797|NCT01806688|11752226|FG000|Placebo Comparator Non-caloric Control #2|Third Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the third visit|0
10595798|NCT01806688|11752227|FG001|Placebo Comparator Non-caloric Control #2|Third Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the third visit|13
10595799|NCT01806688|11752226|FG000|COMPLETED|Third Intervention Pita Study||0
10595800|NCT01806688|11752227|FG001|COMPLETED|Third Intervention Pita Study||38
10595801|NCT01806688|11752226|FG000|NOT COMPLETED|Third Intervention Pita Study||0
10595802|NCT01806688|11752227|FG001|NOT COMPLETED|Third Intervention Pita Study||0
10595803|NCT01806714|11752238|FG000|STARTED|Overall Study||2093
10595804|NCT01806714|11752239|FG001|STARTED|Overall Study||2089
10595805|NCT01806714|11752238|FG000|COMPLETED|Overall Study||1893
10595806|NCT01806714|11752239|FG001|COMPLETED|Overall Study||1919
10595807|NCT01806714|11752238|FG000|NOT COMPLETED|Overall Study||200
10595808|NCT01806714|11752239|FG001|NOT COMPLETED|Overall Study||170
10595809|NCT01806740|11752245|FG000|STARTED|Overall Study||37
10595810|NCT01806740|11752245|FG000|COMPLETED|Overall Study||31
10595811|NCT01806740|11752245|FG000|NOT COMPLETED|Overall Study||6
10595812|NCT01806779|11752254|FG000|STARTED|Overall Study||90
10595813|NCT01806779|11752255|FG001|STARTED|Overall Study||84
10595814|NCT01806779|11752256|FG002|STARTED|Overall Study|All 197 subjects received nicotine patches but 23 dropped before receiving other study drugs.|23
10595815|NCT01806779|11752254|FG000|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|90
10595816|NCT01806779|11752255|FG001|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|84
10595817|NCT01806779|11752256|FG002|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|2
10595818|NCT01806779|11752254|FG000|Randomized at Visit 2|Overall Study||90
10595819|NCT01806779|11752255|FG001|Randomized at Visit 2|Overall Study||84
10595820|NCT01806779|11752256|FG002|Randomized at Visit 2|Overall Study||0
10595821|NCT01806779|11752254|FG000|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|87
10595822|NCT01806779|11752255|FG001|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|83
10595823|NCT01806779|11752256|FG002|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|0
10595824|NCT01806779|11752254|FG000|COMPLETED|Overall Study||48
10595825|NCT01806779|11752255|FG001|COMPLETED|Overall Study||40
10595826|NCT01806779|11752256|FG002|COMPLETED|Overall Study||0
10595827|NCT01806779|11752254|FG000|NOT COMPLETED|Overall Study||42
10595828|NCT01806779|11752255|FG001|NOT COMPLETED|Overall Study||44
10595829|NCT01806779|11752256|FG002|NOT COMPLETED|Overall Study||23
10595830|NCT01806857|11752263|FG000|STARTED|Overall Study||31
10595831|NCT01806857|11752264|FG001|STARTED|Overall Study||29
10595832|NCT01806857|11752263|FG000|COMPLETED|Overall Study||30
10595833|NCT01806857|11752264|FG001|COMPLETED|Overall Study||29
10595834|NCT01806857|11752263|FG000|NOT COMPLETED|Overall Study||1
10595835|NCT01806857|11752264|FG001|NOT COMPLETED|Overall Study||0
10595836|NCT01806896|11752273|FG000|STARTED|Overall Study||20
10595837|NCT01806896|11752274|FG001|STARTED|Overall Study||17
10595838|NCT01806896|11752273|FG000|Received Treatment|Overall Study||19
10595839|NCT01806896|11752274|FG001|Received Treatment|Overall Study||17
10595840|NCT01806896|11752273|FG000|COMPLETED|Overall Study||17
10595841|NCT01806896|11752274|FG001|COMPLETED|Overall Study||17
10595842|NCT01806896|11752273|FG000|NOT COMPLETED|Overall Study||3
10595843|NCT01806896|11752274|FG001|NOT COMPLETED|Overall Study||0
10595844|NCT01807000|11752280|FG000|STARTED|Overall Study||6
10595845|NCT01807000|11752280|FG000|COMPLETED|Overall Study||6
10595846|NCT01807000|11752280|FG000|NOT COMPLETED|Overall Study||0
10595847|NCT01807026|11752290|FG000|STARTED|Overall Study||10
10595848|NCT01807026|11752291|FG001|STARTED|Overall Study||2
10595849|NCT01807026|11752292|FG002|STARTED|Overall Study||10
10595850|NCT01807026|11752293|FG003|STARTED|Overall Study||2
10595851|NCT01807026|11752294|FG004|STARTED|Overall Study||9
10595852|NCT01807026|11752295|FG005|STARTED|Overall Study||3
10595853|NCT01807026|11752290|FG000|Received at Least One Dose of Study Drug|Overall Study||10
10595854|NCT01807026|11752291|FG001|Received at Least One Dose of Study Drug|Overall Study||2
10595855|NCT01807026|11752292|FG002|Received at Least One Dose of Study Drug|Overall Study||10
10595856|NCT01807026|11752293|FG003|Received at Least One Dose of Study Drug|Overall Study||2
10595863|NCT01807026|11752294|FG004|COMPLETED|Overall Study||9
10595864|NCT01807026|11752295|FG005|COMPLETED|Overall Study||3
10595865|NCT01807026|11752290|FG000|NOT COMPLETED|Overall Study||0
10595866|NCT01807026|11752291|FG001|NOT COMPLETED|Overall Study||0
10595867|NCT01807026|11752292|FG002|NOT COMPLETED|Overall Study||0
10595868|NCT01807026|11752293|FG003|NOT COMPLETED|Overall Study||0
10595869|NCT01807026|11752294|FG004|NOT COMPLETED|Overall Study||0
10595870|NCT01807026|11752295|FG005|NOT COMPLETED|Overall Study||0
10595871|NCT01807065|11752316|FG000|STARTED|Overall Study||25
10595872|NCT01807065|11752317|FG001|STARTED|Overall Study||26
10595873|NCT01807065|11752316|FG000|COMPLETED|Overall Study||24
10595874|NCT01807065|11752317|FG001|COMPLETED|Overall Study||25
10595875|NCT01807065|11752316|FG000|NOT COMPLETED|Overall Study||1
10595876|NCT01807065|11752317|FG001|NOT COMPLETED|Overall Study||1
10595877|NCT01807091|11752323|FG000|STARTED|Overall Study||17
10595878|NCT01807091|11752323|FG000|COMPLETED|Overall Study||17
10595879|NCT01807091|11752323|FG000|NOT COMPLETED|Overall Study||0
10595880|NCT01807104|11752329|FG000|STARTED|Overall Study||43
10595881|NCT01807104|11752330|FG001|STARTED|Overall Study||44
10595882|NCT01807104|11752329|FG000|COMPLETED|Overall Study||39
10595883|NCT01807104|11752330|FG001|COMPLETED|Overall Study||40
10595884|NCT01807104|11752329|FG000|NOT COMPLETED|Overall Study||4
10595885|NCT01807104|11752330|FG001|NOT COMPLETED|Overall Study||4
10595886|NCT01807156|11752336|FG000|STARTED|Overall Study||7
10595887|NCT01807156|11752336|FG000|COMPLETED|Overall Study||6
10595888|NCT01807156|11752336|FG000|NOT COMPLETED|Overall Study||1
10595889|NCT01807221|11752346|FG000|STARTED|Overall Study||224
10595890|NCT01807221|11752347|FG001|STARTED|Overall Study||173
10595891|NCT01807221|11752348|FG002|STARTED|Overall Study||165
10595892|NCT01807221|11752349|FG003|STARTED|Overall Study||169
10595893|NCT01807221|11752350|FG004|STARTED|Overall Study||170
10595894|NCT01807221|11752351|FG005|STARTED|Overall Study||165
10595895|NCT01807221|11752346|FG000|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||221
10595896|NCT01807221|11752347|FG001|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||172
10595897|NCT01807221|11752348|FG002|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||163
10595898|NCT01807221|11752349|FG003|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||167
10595899|NCT01807221|11752350|FG004|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||169
10595900|NCT01807221|11752351|FG005|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||163
10595901|NCT01807221|11752346|FG000|COMPLETED|Overall Study||144
10595902|NCT01807221|11752347|FG001|COMPLETED|Overall Study||121
10595903|NCT01807221|11752348|FG002|COMPLETED|Overall Study||122
10595904|NCT01807221|11752349|FG003|COMPLETED|Overall Study||123
10595905|NCT01807221|11752350|FG004|COMPLETED|Overall Study||134
10595906|NCT01807221|11752351|FG005|COMPLETED|Overall Study||124
10595907|NCT01807221|11752346|FG000|NOT COMPLETED|Overall Study||80
10595908|NCT01807221|11752347|FG001|NOT COMPLETED|Overall Study||52
10595909|NCT01807221|11752348|FG002|NOT COMPLETED|Overall Study||43
10595910|NCT01807221|11752349|FG003|NOT COMPLETED|Overall Study||46
10595911|NCT01807221|11752350|FG004|NOT COMPLETED|Overall Study||36
10595912|NCT01807221|11752351|FG005|NOT COMPLETED|Overall Study||41
10595913|NCT01807234|11752371|FG000|STARTED|Overall Study||12
10595914|NCT01807234|11752372|FG001|STARTED|Overall Study||12
10595915|NCT01807234|11752373|FG002|STARTED|Overall Study||12
10595916|NCT01807234|11752374|FG003|STARTED|Overall Study||12
10595917|NCT01807234|11752375|FG004|STARTED|Overall Study||12
10595918|NCT01807234|11752376|FG005|STARTED|Overall Study||12
10595919|NCT01807234|11752371|FG000|Randomized, But Did Not Take Drug|Overall Study||3
10595920|NCT01807234|11752372|FG001|Randomized, But Did Not Take Drug|Overall Study||5
10595921|NCT01807234|11752373|FG002|Randomized, But Did Not Take Drug|Overall Study||2
10595922|NCT01807234|11752374|FG003|Randomized, But Did Not Take Drug|Overall Study||1
10595923|NCT01807234|11752375|FG004|Randomized, But Did Not Take Drug|Overall Study||4
10595924|NCT01807234|11752376|FG005|Randomized, But Did Not Take Drug|Overall Study||3
10595925|NCT01807234|11752371|FG000|Completed Only 1 Attack|Overall Study||2
10595926|NCT01807234|11752372|FG001|Completed Only 1 Attack|Overall Study||1
10595927|NCT01807234|11752373|FG002|Completed Only 1 Attack|Overall Study||0
10595928|NCT01807234|11752374|FG003|Completed Only 1 Attack|Overall Study||1
10595929|NCT01807234|11752375|FG004|Completed Only 1 Attack|Overall Study||0
10595930|NCT01807234|11752376|FG005|Completed Only 1 Attack|Overall Study||1
10595931|NCT01807234|11752371|FG000|COMPLETED|Overall Study||7
10595932|NCT01807234|11752372|FG001|COMPLETED|Overall Study||6
10595933|NCT01807234|11752373|FG002|COMPLETED|Overall Study||10
10595934|NCT01807234|11752374|FG003|COMPLETED|Overall Study||10
10595935|NCT01807234|11752375|FG004|COMPLETED|Overall Study||8
10595936|NCT01807234|11752376|FG005|COMPLETED|Overall Study||8
10595937|NCT01807234|11752371|FG000|NOT COMPLETED|Overall Study||5
10595938|NCT01807234|11752372|FG001|NOT COMPLETED|Overall Study||6
10595939|NCT01807234|11752373|FG002|NOT COMPLETED|Overall Study||2
10595940|NCT01807234|11752374|FG003|NOT COMPLETED|Overall Study||2
10595941|NCT01807234|11752375|FG004|NOT COMPLETED|Overall Study||4
10595942|NCT01807234|11752376|FG005|NOT COMPLETED|Overall Study||4
10595943|NCT01807299|11752390|FG000|STARTED|Overall Study||14
10595944|NCT01807299|11752391|FG001|STARTED|Overall Study||14
10595945|NCT01807299|11752392|FG002|STARTED|Overall Study||12
10595946|NCT01807299|11752393|FG003|STARTED|Overall Study||13
10595947|NCT01807299|11752390|FG000|COMPLETED|Overall Study||11
10595948|NCT01807299|11752391|FG001|COMPLETED|Overall Study||13
10595949|NCT01807299|11752392|FG002|COMPLETED|Overall Study||12
10595950|NCT01807299|11752393|FG003|COMPLETED|Overall Study||11
10595951|NCT01807299|11752390|FG000|NOT COMPLETED|Overall Study||3
10595952|NCT01807299|11752391|FG001|NOT COMPLETED|Overall Study||1
10595953|NCT01807299|11752392|FG002|NOT COMPLETED|Overall Study||0
10595954|NCT01807299|11752393|FG003|NOT COMPLETED|Overall Study||2
10703693|NCT02586012|11868148|FG004|NOT COMPLETED|Overall Study||1
10703694|NCT02586012|11868149|FG005|NOT COMPLETED|Overall Study||3
10595958|NCT01807520|11752410|FG000|STARTED|Treatment Period 1 (0-16 Weeks)||67
10595959|NCT01807520|11752411|FG001|STARTED|Treatment Period 1 (0-16 Weeks)||66
10595960|NCT01807520|11752412|FG002|STARTED|Treatment Period 1 (0-16 Weeks)||65
10595961|NCT01807520|11752413|FG003|STARTED|Treatment Period 1 (0-16 Weeks)||0
10595962|NCT01807520|11752414|FG004|STARTED|Treatment Period 1 (0-16 Weeks)||0
10595963|NCT01807520|11752415|FG005|STARTED|Treatment Period 1 (0-16 Weeks)||0
10595964|NCT01807520|11752416|FG006|STARTED|Treatment Period 1 (0-16 Weeks)||0
10595965|NCT01807520|11752410|FG000|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||67
10595966|NCT01807520|11752411|FG001|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||66
10595967|NCT01807520|11752412|FG002|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||65
10595968|NCT01807520|11752413|FG003|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
10595969|NCT01807520|11752414|FG004|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
10595970|NCT01807520|11752415|FG005|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
10595971|NCT01807520|11752416|FG006|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
10595972|NCT01807520|11752410|FG000|Safety Set|Treatment Period 1 (0-16 Weeks)||67
10595973|NCT01807520|11752411|FG001|Safety Set|Treatment Period 1 (0-16 Weeks)||65
10595974|NCT01807520|11752412|FG002|Safety Set|Treatment Period 1 (0-16 Weeks)||65
10595975|NCT01807520|11752413|FG003|Safety Set|Treatment Period 1 (0-16 Weeks)||0
10595976|NCT01807520|11752414|FG004|Safety Set|Treatment Period 1 (0-16 Weeks)||0
10595977|NCT01807520|11752415|FG005|Safety Set|Treatment Period 1 (0-16 Weeks)||0
10595978|NCT01807520|11752416|FG006|Safety Set|Treatment Period 1 (0-16 Weeks)||0
10595979|NCT01807520|11752410|FG000|COMPLETED|Treatment Period 1 (0-16 Weeks)||63
10595980|NCT01807520|11752411|FG001|COMPLETED|Treatment Period 1 (0-16 Weeks)||65
10595981|NCT01807520|11752412|FG002|COMPLETED|Treatment Period 1 (0-16 Weeks)||58
10595982|NCT01807520|11752413|FG003|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
10595983|NCT01807520|11752414|FG004|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
10595984|NCT01807520|11752415|FG005|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
10595985|NCT01807520|11752416|FG006|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
10595986|NCT01807520|11752410|FG000|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||4
10703695|NCT02586064|11868160|FG000|STARTED|Overall Study||61
10703696|NCT02586064|11868161|FG001|STARTED|Overall Study||54
10595987|NCT01807520|11752411|FG001|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||1
10595988|NCT01807520|11752412|FG002|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||7
10595989|NCT01807520|11752413|FG003|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
10595990|NCT01807520|11752414|FG004|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
10595991|NCT01807520|11752415|FG005|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
10595992|NCT01807520|11752416|FG006|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
10595993|NCT01807520|11752410|FG000|STARTED|Treatment Period 2 (16-132 Weeks)||63
10595994|NCT01807520|11752411|FG001|STARTED|Treatment Period 2 (16-132 Weeks)||65
10595995|NCT01807520|11752412|FG002|STARTED|Treatment Period 2 (16-132 Weeks)||0
10595996|NCT01807520|11752413|FG003|STARTED|Treatment Period 2 (16-132 Weeks)||29
10595997|NCT01807520|11752414|FG004|STARTED|Treatment Period 2 (16-132 Weeks)||29
10595998|NCT01807520|11752415|FG005|STARTED|Treatment Period 2 (16-132 Weeks)||0
10595999|NCT01807520|11752416|FG006|STARTED|Treatment Period 2 (16-132 Weeks)||0
10596000|NCT01807520|11752410|FG000|Safety Set|Treatment Period 2 (16-132 Weeks)||63
10596001|NCT01807520|11752411|FG001|Safety Set|Treatment Period 2 (16-132 Weeks)||65
10596002|NCT01807520|11752412|FG002|Safety Set|Treatment Period 2 (16-132 Weeks)||0
10596003|NCT01807520|11752413|FG003|Safety Set|Treatment Period 2 (16-132 Weeks)||29
10596004|NCT01807520|11752414|FG004|Safety Set|Treatment Period 2 (16-132 Weeks)||29
10596005|NCT01807520|11752415|FG005|Safety Set|Treatment Period 2 (16-132 Weeks)||0
10596006|NCT01807520|11752416|FG006|Safety Set|Treatment Period 2 (16-132 Weeks)||0
10596007|NCT01807520|11752410|FG000|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||67
10596008|NCT01807520|11752411|FG001|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||66
10596009|NCT01807520|11752412|FG002|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
10596010|NCT01807520|11752413|FG003|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||29
10596011|NCT01807520|11752414|FG004|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||29
10596012|NCT01807520|11752415|FG005|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
10596013|NCT01807520|11752416|FG006|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
10596014|NCT01807520|11752410|FG000|COMPLETED|Treatment Period 2 (16-132 Weeks)||38
10596015|NCT01807520|11752411|FG001|COMPLETED|Treatment Period 2 (16-132 Weeks)||47
10596016|NCT01807520|11752412|FG002|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
10596017|NCT01807520|11752413|FG003|COMPLETED|Treatment Period 2 (16-132 Weeks)||22
10596018|NCT01807520|11752414|FG004|COMPLETED|Treatment Period 2 (16-132 Weeks)||24
10596019|NCT01807520|11752415|FG005|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
10596020|NCT01807520|11752416|FG006|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
10596021|NCT01807520|11752410|FG000|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||25
10596022|NCT01807520|11752411|FG001|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||18
10596023|NCT01807520|11752412|FG002|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
10596024|NCT01807520|11752413|FG003|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||7
10596025|NCT01807520|11752414|FG004|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||5
10596026|NCT01807520|11752415|FG005|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
10596027|NCT01807520|11752416|FG006|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
10596028|NCT01807520|11752410|FG000|STARTED|Follow-up Period (132-140 Weeks)||0
10596029|NCT01807520|11752411|FG001|STARTED|Follow-up Period (132-140 Weeks)||0
10596030|NCT01807520|11752412|FG002|STARTED|Follow-up Period (132-140 Weeks)|These participants discontinued from Treatment Period 1.|2
10596031|NCT01807520|11752413|FG003|STARTED|Follow-up Period (132-140 Weeks)||0
10596032|NCT01807520|11752414|FG004|STARTED|Follow-up Period (132-140 Weeks)||0
10596033|NCT01807520|11752415|FG005|STARTED|Follow-up Period (132-140 Weeks)|These participants received AIN457150mg during treatment period 1 and/or treatment period 2.|81
10596034|NCT01807520|11752416|FG006|STARTED|Follow-up Period (132-140 Weeks)|These participants received AIN457 300mg during treatment period 1 and/or treatment period 2.|76
10596035|NCT01807520|11752410|FG000|COMPLETED|Follow-up Period (132-140 Weeks)||0
10596036|NCT01807520|11752411|FG001|COMPLETED|Follow-up Period (132-140 Weeks)||0
10596037|NCT01807520|11752412|FG002|COMPLETED|Follow-up Period (132-140 Weeks)||2
10596038|NCT01807520|11752413|FG003|COMPLETED|Follow-up Period (132-140 Weeks)||0
10596039|NCT01807520|11752414|FG004|COMPLETED|Follow-up Period (132-140 Weeks)||0
10596040|NCT01807520|11752415|FG005|COMPLETED|Follow-up Period (132-140 Weeks)||77
10596041|NCT01807520|11752416|FG006|COMPLETED|Follow-up Period (132-140 Weeks)||75
10596042|NCT01807520|11752410|FG000|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
10596043|NCT01807520|11752411|FG001|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
10596044|NCT01807520|11752412|FG002|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
10596045|NCT01807520|11752413|FG003|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
10596046|NCT01807520|11752414|FG004|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
10596047|NCT01807520|11752415|FG005|NOT COMPLETED|Follow-up Period (132-140 Weeks)||4
10596048|NCT01807520|11752416|FG006|NOT COMPLETED|Follow-up Period (132-140 Weeks)||1
10596049|NCT01807585|11752430|FG000|STARTED|Overall Study||20
10596050|NCT01807585|11752431|FG001|STARTED|Overall Study||108
10596051|NCT01807585|11752432|FG002|STARTED|Overall Study||114
10596052|NCT01807585|11752430|FG000|3 Mos|Overall Study||20
10596053|NCT01807585|11752431|FG001|3 Mos|Overall Study||108
10596054|NCT01807585|11752432|FG002|3 Mos|Overall Study||113
10596055|NCT01807585|11752430|FG000|COMPLETED|Overall Study||19
10596056|NCT01807585|11752431|FG001|COMPLETED|Overall Study||104
10596057|NCT01807585|11752432|FG002|COMPLETED|Overall Study||108
10596058|NCT01807585|11752430|FG000|NOT COMPLETED|Overall Study||1
10596059|NCT01807585|11752431|FG001|NOT COMPLETED|Overall Study||4
10596060|NCT01807585|11752432|FG002|NOT COMPLETED|Overall Study||6
10596061|NCT01807598|11752443|FG000|STARTED|Overall Study||10
10596062|NCT01807598|11752443|FG000|COMPLETED|Overall Study||4
10596063|NCT01807598|11752443|FG000|NOT COMPLETED|Overall Study||6
10596064|NCT01807624|11752447|FG000|STARTED|Overall Study||24
10596065|NCT01807624|11752447|FG000|COMPLETED|Overall Study||24
10596066|NCT01807624|11752447|FG000|NOT COMPLETED|Overall Study||0
10596067|NCT01807637|11752453|FG000|STARTED|Baseline||4
10596068|NCT01807637|11752454|FG001|STARTED|Baseline||2
10596069|NCT01807637|11752453|FG000|COMPLETED|Baseline||4
10596070|NCT01807637|11752454|FG001|COMPLETED|Baseline||2
10596071|NCT01807637|11752453|FG000|NOT COMPLETED|Baseline||0
10596072|NCT01807637|11752454|FG001|NOT COMPLETED|Baseline||0
10596073|NCT01807637|11752453|FG000|STARTED|One Week||4
10596074|NCT01807637|11752454|FG001|STARTED|One Week||2
10596075|NCT01807637|11752453|FG000|COMPLETED|One Week||4
10596076|NCT01807637|11752454|FG001|COMPLETED|One Week||2
10596077|NCT01807637|11752453|FG000|NOT COMPLETED|One Week||0
10596078|NCT01807637|11752454|FG001|NOT COMPLETED|One Week||0
10596079|NCT01807637|11752453|FG000|STARTED|One Month||4
10596080|NCT01807637|11752454|FG001|STARTED|One Month||2
10596081|NCT01807637|11752453|FG000|COMPLETED|One Month||4
10596082|NCT01807637|11752454|FG001|COMPLETED|One Month||2
10596083|NCT01807637|11752453|FG000|NOT COMPLETED|One Month||0
10596084|NCT01807637|11752454|FG001|NOT COMPLETED|One Month||0
10596085|NCT01807650|11752462|FG000|STARTED|Overall Study||112
10596086|NCT01807650|11752462|FG000|COMPLETED|Overall Study||92
10596087|NCT01807650|11752462|FG000|NOT COMPLETED|Overall Study||20
10596088|NCT01807871|11752505|FG000|STARTED|Overall Study||356
10596089|NCT01807871|11752506|FG001|STARTED|Overall Study||345
10596090|NCT01807871|11752505|FG000|COMPLETED|Overall Study||178
10703697|NCT02586064|11868160|FG000|COMPLETED|Overall Study||43
10703698|NCT02586064|11868161|FG001|COMPLETED|Overall Study||26
10703699|NCT02586064|11868160|FG000|NOT COMPLETED|Overall Study||18
10596091|NCT01807871|11752506|FG001|COMPLETED|Overall Study||127
10596092|NCT01807871|11752505|FG000|NOT COMPLETED|Overall Study||178
10596093|NCT01807871|11752506|FG001|NOT COMPLETED|Overall Study||218
10596094|NCT01807923|11752515|FG000|STARTED|Overall Study||187
10596095|NCT01807923|11752516|FG001|STARTED|Overall Study||185
10596096|NCT01807923|11752517|FG002|STARTED|Overall Study||187
10596097|NCT01807923|11752515|FG000|COMPLETED|Overall Study||182
10596098|NCT01807923|11752516|FG001|COMPLETED|Overall Study||179
10596099|NCT01807923|11752517|FG002|COMPLETED|Overall Study||176
10596100|NCT01807923|11752515|FG000|NOT COMPLETED|Overall Study||5
10596101|NCT01807923|11752516|FG001|NOT COMPLETED|Overall Study||6
10596102|NCT01807923|11752517|FG002|NOT COMPLETED|Overall Study||11
10596103|NCT01807949|11752530|FG000|STARTED|Overall Study||187
10596104|NCT01807949|11752531|FG001|STARTED|Overall Study||187
10596105|NCT01807949|11752532|FG002|STARTED|Overall Study||189
10596106|NCT01807949|11752530|FG000|COMPLETED|Overall Study||185
10596107|NCT01807949|11752531|FG001|COMPLETED|Overall Study||180
10596108|NCT01807949|11752532|FG002|COMPLETED|Overall Study||180
10596109|NCT01807949|11752530|FG000|NOT COMPLETED|Overall Study||2
10596110|NCT01807949|11752531|FG001|NOT COMPLETED|Overall Study||7
10596111|NCT01807949|11752532|FG002|NOT COMPLETED|Overall Study||9
10596112|NCT01808066|11752542|FG000|STARTED|Overall Study||21
10596113|NCT01808066|11752542|FG000|COMPLETED|Overall Study||6
10596114|NCT01808066|11752542|FG000|NOT COMPLETED|Overall Study||15
10596115|NCT01808092|11752549|FG000|STARTED|Overall Study||409
10596116|NCT01808092|11752550|FG001|STARTED|Overall Study||408
10596117|NCT01808092|11752549|FG000|COMPLETED|Overall Study||355
10596118|NCT01808092|11752550|FG001|COMPLETED|Overall Study||363
10596119|NCT01808092|11752549|FG000|NOT COMPLETED|Overall Study||54
10703700|NCT02586064|11868161|FG001|NOT COMPLETED|Overall Study||28
10703701|NCT02586077|11868170|FG000|STARTED|Overall Study||36
10703702|NCT02586077|11868170|FG000|COMPLETED|Overall Study||28
10703703|NCT02586077|11868170|FG000|NOT COMPLETED|Overall Study||8
10807859|NCT03876743|11969620|FG003|STARTED|Overall Study||50
10807860|NCT03876743|11969617|FG000|COMPLETED|Overall Study||48
10807861|NCT03876743|11969618|FG001|COMPLETED|Overall Study||47
10807862|NCT03876743|11969619|FG002|COMPLETED|Overall Study||42
10807863|NCT03876743|11969620|FG003|COMPLETED|Overall Study||43
10807864|NCT03876743|11969617|FG000|NOT COMPLETED|Overall Study||6
10807865|NCT03876743|11969618|FG001|NOT COMPLETED|Overall Study||4
10807866|NCT03876743|11969619|FG002|NOT COMPLETED|Overall Study||4
10807867|NCT03876743|11969620|FG003|NOT COMPLETED|Overall Study||7
10807868|NCT03885934|11969640|FG000|STARTED|Overall Study||64
10807869|NCT03885934|11969641|FG001|STARTED|Overall Study||64
10807870|NCT03885934|11969642|FG002|STARTED|Overall Study||62
10703704|NCT02586155|11868177|FG000|STARTED|Overall Study||1215
10703705|NCT02586155|11868178|FG001|STARTED|Overall Study||1210
10703706|NCT02586155|11868177|FG000|Final Number Randomized|Overall Study||1212
10807871|NCT03885934|11969643|FG003|STARTED|Overall Study||64
10807872|NCT03885934|11969644|FG004|STARTED|Overall Study||177
10807873|NCT03885934|11969645|FG005|STARTED|Overall Study||175
10596120|NCT01808092|11752550|FG001|NOT COMPLETED|Overall Study||45
10596121|NCT01808118|11752556|FG000|STARTED|Period 1||673
10807874|NCT03885934|11969640|FG000|PCV Dose 1|Overall Study||64
10596122|NCT01808118|11752557|FG001|STARTED|Period 1||0
10596123|NCT01808118|11752558|FG002|STARTED|Period 1||0
10596124|NCT01808118|11752556|FG000|COMPLETED|Period 1||305
10596125|NCT01808118|11752557|FG001|COMPLETED|Period 1||0
10596126|NCT01808118|11752558|FG002|COMPLETED|Period 1||0
10596127|NCT01808118|11752556|FG000|NOT COMPLETED|Period 1||368
10596128|NCT01808118|11752557|FG001|NOT COMPLETED|Period 1||0
10596129|NCT01808118|11752558|FG002|NOT COMPLETED|Period 1||0
10703707|NCT02586155|11868178|FG001|Final Number Randomized|Overall Study||1206
10703708|NCT02586155|11868177|FG000|COMPLETED|Overall Study||1088
10703709|NCT02586155|11868178|FG001|COMPLETED|Overall Study||1083
10703710|NCT02586155|11868177|FG000|NOT COMPLETED|Overall Study||127
10333784|NCT00335556|11469984|FG001|COMPLETED|Overall Study||64
10333785|NCT00335556|11469985|FG002|COMPLETED|Overall Study||2
10333786|NCT00335556|11469986|FG003|COMPLETED|Overall Study||5
10333787|NCT00335556|11469987|FG004|COMPLETED|Overall Study||77
10333788|NCT00335556|11469988|FG005|COMPLETED|Overall Study||29
10333789|NCT00335556|11469983|FG000|NOT COMPLETED|Overall Study||2
10333790|NCT00335556|11469984|FG001|NOT COMPLETED|Overall Study||34
10333791|NCT00335556|11469985|FG002|NOT COMPLETED|Overall Study||5
10333792|NCT00335556|11469986|FG003|NOT COMPLETED|Overall Study||5
10333793|NCT00335556|11469987|FG004|NOT COMPLETED|Overall Study||1
10333794|NCT00335556|11469988|FG005|NOT COMPLETED|Overall Study||1
10596130|NCT01808118|11752556|FG000|STARTED|Period 2||0
10596131|NCT01808118|11752557|FG001|STARTED|Period 2||153
10596132|NCT01808118|11752558|FG002|STARTED|Period 2||152
10596133|NCT01808118|11752556|FG000|COMPLETED|Period 2||0
10596134|NCT01808118|11752557|FG001|COMPLETED|Period 2||140
10596135|NCT01808118|11752558|FG002|COMPLETED|Period 2||144
10596136|NCT01808118|11752556|FG000|NOT COMPLETED|Period 2||0
10596137|NCT01808118|11752557|FG001|NOT COMPLETED|Period 2||13
10596138|NCT01808118|11752558|FG002|NOT COMPLETED|Period 2||8
10596139|NCT01808144|11752574|FG000|STARTED|Overall Study||97
10596140|NCT01808144|11752575|FG001|STARTED|Overall Study||99
10596141|NCT01808144|11752574|FG000|COMPLETED|Overall Study||57
10596142|NCT01808144|11752575|FG001|COMPLETED|Overall Study||51
10596143|NCT01808144|11752574|FG000|NOT COMPLETED|Overall Study||40
10596144|NCT01808144|11752575|FG001|NOT COMPLETED|Overall Study||48
10596145|NCT01808196|11752581|FG000|STARTED|Overall Study||6
10596146|NCT01808196|11752581|FG000|COMPLETED|Overall Study||5
10596147|NCT01808196|11752581|FG000|NOT COMPLETED|Overall Study||1
10596148|NCT01808209|11752587|FG000|STARTED|Overall Study||33
10596149|NCT01808209|11752588|FG001|STARTED|Overall Study||27
10596150|NCT01808209|11752587|FG000|COMPLETED|Overall Study||33
10596151|NCT01808209|11752588|FG001|COMPLETED|Overall Study||26
10596152|NCT01808209|11752587|FG000|NOT COMPLETED|Overall Study||0
10596153|NCT01808209|11752588|FG001|NOT COMPLETED|Overall Study||1
10596154|NCT01808222|11752598|FG000|STARTED|Overall Study||25
10596155|NCT01808222|11752598|FG000|Completed Fluciclovine PET-CT Scan|Overall Study||25
10596156|NCT01808222|11752598|FG000|Completed mpMR Scan|Overall Study||24
10596157|NCT01808222|11752598|FG000|COMPLETED|Overall Study||24
10596158|NCT01808222|11752598|FG000|NOT COMPLETED|Overall Study||1
10596159|NCT01808248|11752604|FG000|STARTED|Overall Study||47
10596160|NCT01808248|11752604|FG000|Completed Posttreatment Week 12 Visit|Overall Study||45
10596161|NCT01808248|11752604|FG000|COMPLETED|Overall Study||42
10596162|NCT01808248|11752604|FG000|NOT COMPLETED|Overall Study||5
10596163|NCT01808313|11752610|FG000|STARTED|Overall Study||133
10596164|NCT01808313|11752610|FG000|COMPLETED|Overall Study||123
10596165|NCT01808313|11752610|FG000|NOT COMPLETED|Overall Study||10
10596166|NCT01808326|11752614|FG000|STARTED|Overall Study||5
10596167|NCT01808326|11752614|FG000|COMPLETED|Overall Study||5
10596168|NCT01808326|11752614|FG000|NOT COMPLETED|Overall Study||0
10596169|NCT01808339|11752618|FG000|STARTED|Treatment Period 1 (14 Days)||4
10596170|NCT01808339|11752619|FG001|STARTED|Treatment Period 1 (14 Days)||4
10596171|NCT01808339|11752620|FG002|STARTED|Treatment Period 1 (14 Days)||4
10596172|NCT01808339|11752621|FG003|STARTED|Treatment Period 1 (14 Days)||4
10596173|NCT01808339|11752622|FG004|STARTED|Treatment Period 1 (14 Days)||6
10596174|NCT01808339|11752623|FG005|STARTED|Treatment Period 1 (14 Days)||6
10596175|NCT01808339|11752618|FG000|COMPLETED|Treatment Period 1 (14 Days)||4
10596176|NCT01808339|11752619|FG001|COMPLETED|Treatment Period 1 (14 Days)||3
10596177|NCT01808339|11752620|FG002|COMPLETED|Treatment Period 1 (14 Days)||4
10596178|NCT01808339|11752621|FG003|COMPLETED|Treatment Period 1 (14 Days)||2
10596179|NCT01808339|11752622|FG004|COMPLETED|Treatment Period 1 (14 Days)||4
10596180|NCT01808339|11752623|FG005|COMPLETED|Treatment Period 1 (14 Days)||5
10596181|NCT01808339|11752618|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||0
10596182|NCT01808339|11752619|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||1
10596183|NCT01808339|11752620|FG002|NOT COMPLETED|Treatment Period 1 (14 Days)||0
10596184|NCT01808339|11752621|FG003|NOT COMPLETED|Treatment Period 1 (14 Days)||2
10596185|NCT01808339|11752622|FG004|NOT COMPLETED|Treatment Period 1 (14 Days)||2
10596186|NCT01808339|11752623|FG005|NOT COMPLETED|Treatment Period 1 (14 Days)||1
10596187|NCT01808339|11752618|FG000|STARTED|Washout Period 1 (14-21 Days)||4
10596188|NCT01808339|11752619|FG001|STARTED|Washout Period 1 (14-21 Days)||3
10596189|NCT01808339|11752620|FG002|STARTED|Washout Period 1 (14-21 Days)||4
10596190|NCT01808339|11752621|FG003|STARTED|Washout Period 1 (14-21 Days)||2
10596191|NCT01808339|11752622|FG004|STARTED|Washout Period 1 (14-21 Days)||4
10596192|NCT01808339|11752623|FG005|STARTED|Washout Period 1 (14-21 Days)||5
10596193|NCT01808339|11752618|FG000|COMPLETED|Washout Period 1 (14-21 Days)||4
10596194|NCT01808339|11752619|FG001|COMPLETED|Washout Period 1 (14-21 Days)||3
10596195|NCT01808339|11752620|FG002|COMPLETED|Washout Period 1 (14-21 Days)||4
10596196|NCT01808339|11752621|FG003|COMPLETED|Washout Period 1 (14-21 Days)||2
10596197|NCT01808339|11752622|FG004|COMPLETED|Washout Period 1 (14-21 Days)||4
10596198|NCT01808339|11752623|FG005|COMPLETED|Washout Period 1 (14-21 Days)||5
10596199|NCT01808339|11752618|FG000|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
10596200|NCT01808339|11752619|FG001|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
10596201|NCT01808339|11752620|FG002|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
10596202|NCT01808339|11752621|FG003|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
10596203|NCT01808339|11752622|FG004|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
10596204|NCT01808339|11752623|FG005|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
10596205|NCT01808339|11752618|FG000|STARTED|Treatment Period 2 (14 Days)||4
10596206|NCT01808339|11752619|FG001|STARTED|Treatment Period 2 (14 Days)||3
10596207|NCT01808339|11752620|FG002|STARTED|Treatment Period 2 (14 Days)||4
10596208|NCT01808339|11752621|FG003|STARTED|Treatment Period 2 (14 Days)||2
10596209|NCT01808339|11752622|FG004|STARTED|Treatment Period 2 (14 Days)||4
10596210|NCT01808339|11752623|FG005|STARTED|Treatment Period 2 (14 Days)||5
10596211|NCT01808339|11752618|FG000|COMPLETED|Treatment Period 2 (14 Days)||4
10596212|NCT01808339|11752619|FG001|COMPLETED|Treatment Period 2 (14 Days)||3
10596213|NCT01808339|11752620|FG002|COMPLETED|Treatment Period 2 (14 Days)||4
10596214|NCT01808339|11752621|FG003|COMPLETED|Treatment Period 2 (14 Days)||2
10596215|NCT01808339|11752622|FG004|COMPLETED|Treatment Period 2 (14 Days)||4
10596216|NCT01808339|11752623|FG005|COMPLETED|Treatment Period 2 (14 Days)||5
10596217|NCT01808339|11752618|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||0
10596218|NCT01808339|11752619|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||0
10596219|NCT01808339|11752620|FG002|NOT COMPLETED|Treatment Period 2 (14 Days)||0
10596220|NCT01808339|11752621|FG003|NOT COMPLETED|Treatment Period 2 (14 Days)||0
10596221|NCT01808339|11752622|FG004|NOT COMPLETED|Treatment Period 2 (14 Days)||0
10596222|NCT01808339|11752623|FG005|NOT COMPLETED|Treatment Period 2 (14 Days)||0
10596223|NCT01808339|11752618|FG000|STARTED|Washout Period 2 (14-21 Days)||4
10596224|NCT01808339|11752619|FG001|STARTED|Washout Period 2 (14-21 Days)||3
10596225|NCT01808339|11752620|FG002|STARTED|Washout Period 2 (14-21 Days)||4
10596226|NCT01808339|11752621|FG003|STARTED|Washout Period 2 (14-21 Days)||2
10596227|NCT01808339|11752622|FG004|STARTED|Washout Period 2 (14-21 Days)||4
10596228|NCT01808339|11752623|FG005|STARTED|Washout Period 2 (14-21 Days)||5
10596229|NCT01808339|11752618|FG000|COMPLETED|Washout Period 2 (14-21 Days)||4
10596230|NCT01808339|11752619|FG001|COMPLETED|Washout Period 2 (14-21 Days)||3
10596231|NCT01808339|11752620|FG002|COMPLETED|Washout Period 2 (14-21 Days)||4
10596232|NCT01808339|11752621|FG003|COMPLETED|Washout Period 2 (14-21 Days)||2
10596233|NCT01808339|11752622|FG004|COMPLETED|Washout Period 2 (14-21 Days)||4
10596234|NCT01808339|11752623|FG005|COMPLETED|Washout Period 2 (14-21 Days)||5
10596235|NCT01808339|11752618|FG000|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
10596236|NCT01808339|11752619|FG001|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
10596237|NCT01808339|11752620|FG002|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
10596238|NCT01808339|11752621|FG003|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
10596239|NCT01808339|11752622|FG004|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
10596240|NCT01808339|11752623|FG005|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
10596241|NCT01808339|11752618|FG000|STARTED|Treatment Period 3 (14 Days)||4
10596242|NCT01808339|11752619|FG001|STARTED|Treatment Period 3 (14 Days)||3
10596243|NCT01808339|11752620|FG002|STARTED|Treatment Period 3 (14 Days)||4
10596244|NCT01808339|11752621|FG003|STARTED|Treatment Period 3 (14 Days)||2
10596245|NCT01808339|11752622|FG004|STARTED|Treatment Period 3 (14 Days)||4
10596246|NCT01808339|11752623|FG005|STARTED|Treatment Period 3 (14 Days)||5
10703711|NCT02586155|11868178|FG001|NOT COMPLETED|Overall Study||127
10703712|NCT02586233|11868191|FG000|STARTED|Overall Study||7
10703713|NCT02586233|11868192|FG001|STARTED|Overall Study||7
10703714|NCT02586233|11868193|FG002|STARTED|Overall Study||13
10703715|NCT02586233|11868194|FG003|STARTED|Overall Study||17
10703716|NCT02586233|11868195|FG004|STARTED|Overall Study||18
10703717|NCT02586233|11868196|FG005|STARTED|Overall Study||18
10703718|NCT02586233|11868197|FG006|STARTED|Overall Study||26
10596247|NCT01808339|11752618|FG000|COMPLETED|Treatment Period 3 (14 Days)||4
10596248|NCT01808339|11752619|FG001|COMPLETED|Treatment Period 3 (14 Days)||3
10596249|NCT01808339|11752620|FG002|COMPLETED|Treatment Period 3 (14 Days)||3
10596250|NCT01808339|11752621|FG003|COMPLETED|Treatment Period 3 (14 Days)||2
10596251|NCT01808339|11752622|FG004|COMPLETED|Treatment Period 3 (14 Days)||4
10596252|NCT01808339|11752623|FG005|COMPLETED|Treatment Period 3 (14 Days)||5
10596253|NCT01808339|11752618|FG000|NOT COMPLETED|Treatment Period 3 (14 Days)||0
10703719|NCT02586233|11868191|FG000|COMPLETED|Overall Study||7
10703720|NCT02586233|11868192|FG001|COMPLETED|Overall Study||5
10703721|NCT02586233|11868193|FG002|COMPLETED|Overall Study||13
10703722|NCT02586233|11868194|FG003|COMPLETED|Overall Study||17
10703723|NCT02586233|11868195|FG004|COMPLETED|Overall Study||16
10703724|NCT02586233|11868196|FG005|COMPLETED|Overall Study||16
10596254|NCT01808339|11752619|FG001|NOT COMPLETED|Treatment Period 3 (14 Days)||0
10596255|NCT01808339|11752620|FG002|NOT COMPLETED|Treatment Period 3 (14 Days)||1
10596256|NCT01808339|11752621|FG003|NOT COMPLETED|Treatment Period 3 (14 Days)||0
10596257|NCT01808339|11752622|FG004|NOT COMPLETED|Treatment Period 3 (14 Days)||0
10596258|NCT01808339|11752623|FG005|NOT COMPLETED|Treatment Period 3 (14 Days)||0
10596259|NCT01808508|11752634|FG000|STARTED|Overall Study||11
10596260|NCT01808508|11752635|FG001|STARTED|Overall Study||9
10596261|NCT01808508|11752636|FG002|STARTED|Overall Study||3
10596262|NCT01808508|11752634|FG000|COMPLETED|Overall Study||10
10596263|NCT01808508|11752635|FG001|COMPLETED|Overall Study||9
10596264|NCT01808508|11752636|FG002|COMPLETED|Overall Study||3
10596265|NCT01808508|11752634|FG000|NOT COMPLETED|Overall Study||1
10596266|NCT01808508|11752635|FG001|NOT COMPLETED|Overall Study||0
10596267|NCT01808508|11752636|FG002|NOT COMPLETED|Overall Study||0
10596268|NCT01808534|11752644|FG000|STARTED|Overall Study||5
10596269|NCT01808534|11752644|FG000|COMPLETED|Overall Study||1
10703725|NCT02586233|11868197|FG006|COMPLETED|Overall Study||24
10703726|NCT02586233|11868191|FG000|NOT COMPLETED|Overall Study||0
10703727|NCT02586233|11868192|FG001|NOT COMPLETED|Overall Study||2
10703728|NCT02586233|11868193|FG002|NOT COMPLETED|Overall Study||0
10596270|NCT01808534|11752644|FG000|NOT COMPLETED|Overall Study||4
10596271|NCT01808547|11752650|FG000|STARTED|Overall Study||174
10596272|NCT01808547|11752651|FG001|STARTED|Overall Study||94
10596273|NCT01808547|11752650|FG000|Safety Population|Overall Study||170
10596274|NCT01808547|11752651|FG001|Safety Population|Overall Study||85
10596275|NCT01808547|11752650|FG000|mITT Population|Overall Study||168
10596276|NCT01808547|11752651|FG001|mITT Population|Overall Study||85
10596277|NCT01808547|11752650|FG000|COMPLETED|Overall Study||137
10596278|NCT01808547|11752651|FG001|COMPLETED|Overall Study||48
10596279|NCT01808547|11752650|FG000|NOT COMPLETED|Overall Study||37
10596280|NCT01808547|11752651|FG001|NOT COMPLETED|Overall Study||46
10596281|NCT01808560|11752660|FG000|STARTED|Randomization and Treatment Allocation||18
10596282|NCT01808560|11752661|FG001|STARTED|Randomization and Treatment Allocation||16
10596283|NCT01808560|11752662|FG002|STARTED|Randomization and Treatment Allocation||0
10596284|NCT01808560|11752660|FG000|COMPLETED|Randomization and Treatment Allocation||18
10596285|NCT01808560|11752661|FG001|COMPLETED|Randomization and Treatment Allocation||16
10596286|NCT01808560|11752662|FG002|COMPLETED|Randomization and Treatment Allocation||0
10596287|NCT01808560|11752660|FG000|NOT COMPLETED|Randomization and Treatment Allocation||0
10596288|NCT01808560|11752661|FG001|NOT COMPLETED|Randomization and Treatment Allocation||0
10596289|NCT01808560|11752662|FG002|NOT COMPLETED|Randomization and Treatment Allocation||0
10596290|NCT01808560|11752660|FG000|STARTED|1-Month After Cataract Surgery|ITT: 2 subjects withdrew b/c they were unable to complete cataract surgery scheduled for both eyes|16
10596291|NCT01808560|11752661|FG001|STARTED|1-Month After Cataract Surgery|ITT: 3 subjects withdrew b/c they were unable to complete cataract surgery scheduled for both eyes|13
10596292|NCT01808560|11752662|FG002|STARTED|1-Month After Cataract Surgery||0
10596293|NCT01808560|11752660|FG000|COMPLETED|1-Month After Cataract Surgery||16
10596294|NCT01808560|11752661|FG001|COMPLETED|1-Month After Cataract Surgery||13
10596295|NCT01808560|11752662|FG002|COMPLETED|1-Month After Cataract Surgery||0
10596296|NCT01808560|11752660|FG000|NOT COMPLETED|1-Month After Cataract Surgery||0
10596297|NCT01808560|11752661|FG001|NOT COMPLETED|1-Month After Cataract Surgery||0
10596298|NCT01808560|11752662|FG002|NOT COMPLETED|1-Month After Cataract Surgery||0
10596299|NCT01808560|11752660|FG000|STARTED|3-Month After Cataract Surgery||17
10596300|NCT01808560|11752661|FG001|STARTED|3-Month After Cataract Surgery||13
10596301|NCT01808560|11752662|FG002|STARTED|3-Month After Cataract Surgery||0
10596302|NCT01808560|11752660|FG000|COMPLETED|3-Month After Cataract Surgery||17
10596303|NCT01808560|11752661|FG001|COMPLETED|3-Month After Cataract Surgery||13
10596304|NCT01808560|11752662|FG002|COMPLETED|3-Month After Cataract Surgery||0
10596305|NCT01808560|11752660|FG000|NOT COMPLETED|3-Month After Cataract Surgery||0
10596306|NCT01808560|11752661|FG001|NOT COMPLETED|3-Month After Cataract Surgery||0
10596307|NCT01808560|11752662|FG002|NOT COMPLETED|3-Month After Cataract Surgery||0
10596308|NCT01808560|11752660|FG000|STARTED|Crossover Treatment||0
10596309|NCT01808560|11752661|FG001|STARTED|Crossover Treatment||0
10596310|NCT01808560|11752662|FG002|STARTED|Crossover Treatment|Post-Treatment Group Received Crossover LipiFlow treatment 3 Months after cataract surgery|13
10596311|NCT01808560|11752660|FG000|COMPLETED|Crossover Treatment||0
10596312|NCT01808560|11752661|FG001|COMPLETED|Crossover Treatment||0
10596313|NCT01808560|11752662|FG002|COMPLETED|Crossover Treatment||13
10596314|NCT01808560|11752660|FG000|NOT COMPLETED|Crossover Treatment||0
10596315|NCT01808560|11752661|FG001|NOT COMPLETED|Crossover Treatment||0
10596316|NCT01808560|11752662|FG002|NOT COMPLETED|Crossover Treatment||0
10596317|NCT01808560|11752660|FG000|STARTED|4-Month After Cataract Surgery||0
10596318|NCT01808560|11752661|FG001|STARTED|4-Month After Cataract Surgery||0
10596319|NCT01808560|11752662|FG002|STARTED|4-Month After Cataract Surgery||13
10596320|NCT01808560|11752660|FG000|COMPLETED|4-Month After Cataract Surgery||0
10596321|NCT01808560|11752661|FG001|COMPLETED|4-Month After Cataract Surgery||0
10596322|NCT01808560|11752662|FG002|COMPLETED|4-Month After Cataract Surgery||13
10596323|NCT01808560|11752660|FG000|NOT COMPLETED|4-Month After Cataract Surgery||0
10596324|NCT01808560|11752661|FG001|NOT COMPLETED|4-Month After Cataract Surgery||0
10596325|NCT01808560|11752662|FG002|NOT COMPLETED|4-Month After Cataract Surgery||0
10596326|NCT01808573|11752672|FG000|STARTED|Overall Study||307
10596327|NCT01808573|11752673|FG001|STARTED|Overall Study||314
10596328|NCT01808573|11752672|FG000|Received Treatment|Overall Study||303
10596329|NCT01808573|11752673|FG001|Received Treatment|Overall Study||311
10596330|NCT01808573|11752672|FG000|COMPLETED|Overall Study||0
10596331|NCT01808573|11752673|FG001|COMPLETED|Overall Study||0
10596332|NCT01808573|11752672|FG000|NOT COMPLETED|Overall Study||307
10596333|NCT01808573|11752673|FG001|NOT COMPLETED|Overall Study||314
10596334|NCT01808612|11752682|FG000|STARTED|Treatment Period||169
10596335|NCT01808612|11752683|FG001|STARTED|Treatment Period||84
10596336|NCT01808612|11752684|FG002|STARTED|Treatment Period||260
10596337|NCT01808612|11752682|FG000|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|168
10596338|NCT01808612|11752683|FG001|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|83
10596339|NCT01808612|11752684|FG002|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|259
10596340|NCT01808612|11752682|FG000|COMPLETED|Treatment Period|67 participants who completed the Treatment Period did not enter the Discontinuation Period.|154
10596341|NCT01808612|11752683|FG001|COMPLETED|Treatment Period|39 participants who completed the Treatment Period did not enter the Discontinuation Period.|77
10596342|NCT01808612|11752684|FG002|COMPLETED|Treatment Period|101 participants who completed the Treatment Period did not enter the Discontinuation Period.|246
10596343|NCT01808612|11752682|FG000|NOT COMPLETED|Treatment Period||15
10596344|NCT01808612|11752683|FG001|NOT COMPLETED|Treatment Period||7
10596345|NCT01808612|11752684|FG002|NOT COMPLETED|Treatment Period||14
10596346|NCT01808612|11752682|FG000|STARTED|Discontinuation Period||87
10596347|NCT01808612|11752683|FG001|STARTED|Discontinuation Period||38
10596348|NCT01808612|11752684|FG002|STARTED|Discontinuation Period||145
10596349|NCT01808612|11752682|FG000|COMPLETED|Discontinuation Period||85
10596350|NCT01808612|11752683|FG001|COMPLETED|Discontinuation Period||37
10596351|NCT01808612|11752684|FG002|COMPLETED|Discontinuation Period||145
10596352|NCT01808612|11752682|FG000|NOT COMPLETED|Discontinuation Period||2
10596353|NCT01808612|11752683|FG001|NOT COMPLETED|Discontinuation Period||1
10596354|NCT01808612|11752684|FG002|NOT COMPLETED|Discontinuation Period||0
10596355|NCT01808651|11752698|FG000|STARTED|Study Period 1||99
10596356|NCT01808651|11752699|FG001|STARTED|Study Period 1||65
10596357|NCT01808651|11752700|FG002|STARTED|Study Period 1||36
10596358|NCT01808651|11752698|FG000|Received at Least One Dose of Study Drug|Study Period 1||98
10596359|NCT01808651|11752699|FG001|Received at Least One Dose of Study Drug|Study Period 1||65
10457009|NCT01008553|11604733|FG002|NOT COMPLETED|Period 2 (Double-Blind Period)||51
10457010|NCT01008605|11604742|FG000|STARTED|Overall Study||48
10457011|NCT01008605|11604742|FG000|COMPLETED|Overall Study||48
10596360|NCT01808651|11752700|FG002|Received at Least One Dose of Study Drug|Study Period 1||36
10596361|NCT01808651|11752698|FG000|COMPLETED|Study Period 1||73
10596362|NCT01808651|11752699|FG001|COMPLETED|Study Period 1||48
10596363|NCT01808651|11752700|FG002|COMPLETED|Study Period 1||31
10596364|NCT01808651|11752698|FG000|NOT COMPLETED|Study Period 1||26
10596365|NCT01808651|11752699|FG001|NOT COMPLETED|Study Period 1||17
10703729|NCT02586233|11868194|FG003|NOT COMPLETED|Overall Study||0
10703730|NCT02586233|11868195|FG004|NOT COMPLETED|Overall Study||2
10703731|NCT02586233|11868196|FG005|NOT COMPLETED|Overall Study||2
10703732|NCT02586233|11868197|FG006|NOT COMPLETED|Overall Study||2
10703733|NCT02586415|11868219|FG000|STARTED|Overall Study||92
10703734|NCT02586415|11868220|FG001|STARTED|Overall Study||90
10703735|NCT02586415|11868219|FG000|24 Hour Assessment|Overall Study||91
10703736|NCT02586415|11868220|FG001|24 Hour Assessment|Overall Study||90
10703737|NCT02586415|11868219|FG000|Day 30 Assessment|Overall Study||81
10596366|NCT01808651|11752700|FG002|NOT COMPLETED|Study Period 1||5
10596367|NCT01808651|11752698|FG000|STARTED|Study Period 2||77
10596368|NCT01808651|11752699|FG001|STARTED|Study Period 2||52
10596369|NCT01808651|11752700|FG002|STARTED|Study Period 2||33
10596370|NCT01808651|11752698|FG000|COMPLETED|Study Period 2|9 Pts who DC'd from Study Period 1 and 68 Pts who completed Study Period 1 entered Study Period 2.|77
10596371|NCT01808651|11752699|FG001|COMPLETED|Study Period 2|5 Pts who DC'd from Study Period 1 and 47 Pts who completed Study Period 1 entered Study Period 2.|52
10596372|NCT01808651|11752700|FG002|COMPLETED|Study Period 2|3 Pts who DC'd from Study Period 1 and 30 pts who completed Study Period 1 entered Study Period 2.|33
10596373|NCT01808651|11752698|FG000|NOT COMPLETED|Study Period 2||0
10596374|NCT01808651|11752699|FG001|NOT COMPLETED|Study Period 2||0
10596375|NCT01808651|11752700|FG002|NOT COMPLETED|Study Period 2||0
10596376|NCT01808690|11752713|FG000|STARTED|Overall Study||25
10596377|NCT01808690|11752714|FG001|STARTED|Overall Study||23
10596378|NCT01808690|11752713|FG000|COMPLETED|Overall Study||24
10596379|NCT01808690|11752714|FG001|COMPLETED|Overall Study||21
10596380|NCT01808690|11752713|FG000|NOT COMPLETED|Overall Study||1
10596381|NCT01808690|11752714|FG001|NOT COMPLETED|Overall Study||2
10596382|NCT01808755|11752720|FG000|STARTED|Overall Study||30
10596383|NCT01808755|11752721|FG001|STARTED|Overall Study||30
10596384|NCT01808755|11752720|FG000|COMPLETED|Overall Study||30
10596385|NCT01808755|11752721|FG001|COMPLETED|Overall Study||30
10596386|NCT01808755|11752720|FG000|NOT COMPLETED|Overall Study||0
10596387|NCT01808755|11752721|FG001|NOT COMPLETED|Overall Study||0
10596388|NCT01808963|11752726|FG000|STARTED|Overall Study||13
10596389|NCT01808963|11752726|FG000|COMPLETED|Overall Study||13
10596390|NCT01808963|11752726|FG000|NOT COMPLETED|Overall Study||0
10596391|NCT01809054|11752732|FG000|STARTED|Overall Study||27
10596392|NCT01809054|11752733|FG001|STARTED|Overall Study||22
10596393|NCT01809054|11752732|FG000|COMPLETED|Overall Study||27
10596394|NCT01809054|11752733|FG001|COMPLETED|Overall Study||22
10596395|NCT01809054|11752732|FG000|NOT COMPLETED|Overall Study||0
10596396|NCT01809054|11752733|FG001|NOT COMPLETED|Overall Study||0
10596397|NCT01809106|11752743|FG000|STARTED|Overall Study||130
10703738|NCT02586415|11868220|FG001|Day 30 Assessment|Overall Study||70
10703739|NCT02586415|11868219|FG000|Day 90 Assessment|Overall Study||78
10703740|NCT02586415|11868220|FG001|Day 90 Assessment|Overall Study||65
10703741|NCT02586415|11868219|FG000|COMPLETED|Overall Study||78
10703742|NCT02586415|11868220|FG001|COMPLETED|Overall Study||65
10703743|NCT02586415|11868219|FG000|NOT COMPLETED|Overall Study||14
10703744|NCT02586415|11868220|FG001|NOT COMPLETED|Overall Study||25
10703745|NCT02586493|11868227|FG000|STARTED|Overall Study||278
10703746|NCT02586493|11868227|FG000|COMPLETED|Overall Study||266
10596398|NCT01809106|11752744|FG001|STARTED|Overall Study||130
10596399|NCT01809106|11752745|FG002|STARTED|Overall Study||130
10596400|NCT01809106|11752746|FG003|STARTED|Overall Study||128
10596401|NCT01809106|11752743|FG000|COMPLETED|Overall Study||122
10596402|NCT01809106|11752744|FG001|COMPLETED|Overall Study||125
10596403|NCT01809106|11752745|FG002|COMPLETED|Overall Study||127
10596404|NCT01809106|11752746|FG003|COMPLETED|Overall Study||124
10596405|NCT01809106|11752743|FG000|NOT COMPLETED|Overall Study||8
10596406|NCT01809106|11752744|FG001|NOT COMPLETED|Overall Study||5
10596407|NCT01809106|11752745|FG002|NOT COMPLETED|Overall Study||3
10596408|NCT01809106|11752746|FG003|NOT COMPLETED|Overall Study||4
10703747|NCT02586493|11868227|FG000|NOT COMPLETED|Overall Study||12
10596409|NCT01809132|11752759|FG000|STARTED|Overall Study||53
10596410|NCT01809132|11752760|FG001|STARTED|Overall Study||50
10596411|NCT01809132|11752761|FG002|STARTED|Overall Study|Subject was consented but withdrew prior to randomization and initiation of treatment.|1
10596412|NCT01809132|11752759|FG000|COMPLETED|Overall Study||53
10596413|NCT01809132|11752760|FG001|COMPLETED|Overall Study||50
10596414|NCT01809132|11752761|FG002|COMPLETED|Overall Study||0
10596415|NCT01809132|11752759|FG000|NOT COMPLETED|Overall Study||0
10596416|NCT01809132|11752760|FG001|NOT COMPLETED|Overall Study||0
10596417|NCT01809132|11752761|FG002|NOT COMPLETED|Overall Study||1
10596418|NCT01809197|11752771|FG000|STARTED|Overall Study||187
10596419|NCT01809197|11752772|FG001|STARTED|Overall Study||185
10596420|NCT01809197|11752771|FG000|COMPLETED|Overall Study||177
10596421|NCT01809197|11752772|FG001|COMPLETED|Overall Study||177
10596422|NCT01809197|11752771|FG000|NOT COMPLETED|Overall Study||10
10596423|NCT01809197|11752772|FG001|NOT COMPLETED|Overall Study||8
10596424|NCT01809210|11752785|FG000|STARTED|Overall Study||3
10596425|NCT01809210|11752786|FG001|STARTED|Overall Study||9
10596426|NCT01809210|11752787|FG002|STARTED|Overall Study||7
10596427|NCT01809210|11752788|FG003|STARTED|Overall Study||3
10596428|NCT01809210|11752789|FG004|STARTED|Overall Study||6
10596429|NCT01809210|11752790|FG005|STARTED|Overall Study||15
10596430|NCT01809210|11752791|FG006|STARTED|Overall Study||12
10596431|NCT01809210|11752785|FG000|COMPLETED|Overall Study||2
10596432|NCT01809210|11752786|FG001|COMPLETED|Overall Study||8
10596433|NCT01809210|11752787|FG002|COMPLETED|Overall Study||4
10596434|NCT01809210|11752788|FG003|COMPLETED|Overall Study||2
10596435|NCT01809210|11752789|FG004|COMPLETED|Overall Study||4
10596436|NCT01809210|11752790|FG005|COMPLETED|Overall Study||12
10596437|NCT01809210|11752791|FG006|COMPLETED|Overall Study||7
10596438|NCT01809210|11752785|FG000|NOT COMPLETED|Overall Study||1
10596439|NCT01809210|11752786|FG001|NOT COMPLETED|Overall Study||1
10596440|NCT01809210|11752787|FG002|NOT COMPLETED|Overall Study||3
10596441|NCT01809210|11752788|FG003|NOT COMPLETED|Overall Study||1
10596442|NCT01809210|11752789|FG004|NOT COMPLETED|Overall Study||2
10596443|NCT01809210|11752790|FG005|NOT COMPLETED|Overall Study||3
10596444|NCT01809210|11752791|FG006|NOT COMPLETED|Overall Study||5
10596445|NCT01809262|11752807|FG000|STARTED|Period 1 (First Dose + Washout)||4
10596446|NCT01809262|11752808|FG001|STARTED|Period 1 (First Dose + Washout)||4
10596447|NCT01809262|11752809|FG002|STARTED|Period 1 (First Dose + Washout)||4
10596448|NCT01809262|11752810|FG003|STARTED|Period 1 (First Dose + Washout)||3
10596449|NCT01809262|11752811|FG004|STARTED|Period 1 (First Dose + Washout)||4
10596450|NCT01809262|11752812|FG005|STARTED|Period 1 (First Dose + Washout)||3
10596451|NCT01809262|11752813|FG006|STARTED|Period 1 (First Dose + Washout)||3
10596452|NCT01809262|11752814|FG007|STARTED|Period 1 (First Dose + Washout)||4
10596453|NCT01809262|11752815|FG008|STARTED|Period 1 (First Dose + Washout)||3
10596454|NCT01809262|11752816|FG009|STARTED|Period 1 (First Dose + Washout)||4
10596455|NCT01809262|11752807|FG000|COMPLETED|Period 1 (First Dose + Washout)||4
10596456|NCT01809262|11752808|FG001|COMPLETED|Period 1 (First Dose + Washout)||4
10596457|NCT01809262|11752809|FG002|COMPLETED|Period 1 (First Dose + Washout)||4
10596458|NCT01809262|11752810|FG003|COMPLETED|Period 1 (First Dose + Washout)||3
10596459|NCT01809262|11752811|FG004|COMPLETED|Period 1 (First Dose + Washout)||3
10596460|NCT01809262|11752812|FG005|COMPLETED|Period 1 (First Dose + Washout)||3
10596461|NCT01809262|11752813|FG006|COMPLETED|Period 1 (First Dose + Washout)||3
10596462|NCT01809262|11752814|FG007|COMPLETED|Period 1 (First Dose + Washout)||4
10596463|NCT01809262|11752815|FG008|COMPLETED|Period 1 (First Dose + Washout)||3
10596464|NCT01809262|11752816|FG009|COMPLETED|Period 1 (First Dose + Washout)||4
10596465|NCT01809262|11752807|FG000|NOT COMPLETED|Period 1 (First Dose + Washout)||0
10596466|NCT01809262|11752808|FG001|NOT COMPLETED|Period 1 (First Dose + Washout)||0
10596467|NCT01809262|11752809|FG002|NOT COMPLETED|Period 1 (First Dose + Washout)||0
10596468|NCT01809262|11752810|FG003|NOT COMPLETED|Period 1 (First Dose + Washout)||0
10596469|NCT01809262|11752811|FG004|NOT COMPLETED|Period 1 (First Dose + Washout)||1
10596470|NCT01809262|11752812|FG005|NOT COMPLETED|Period 1 (First Dose + Washout)||0
10596471|NCT01809262|11752813|FG006|NOT COMPLETED|Period 1 (First Dose + Washout)||0
10596472|NCT01809262|11752814|FG007|NOT COMPLETED|Period 1 (First Dose + Washout)||0
10596473|NCT01809262|11752815|FG008|NOT COMPLETED|Period 1 (First Dose + Washout)||0
10596474|NCT01809262|11752816|FG009|NOT COMPLETED|Period 1 (First Dose + Washout)||0
10596475|NCT01809262|11752807|FG000|STARTED|Period 2 (Second Dose + Washout)||4
10596476|NCT01809262|11752808|FG001|STARTED|Period 2 (Second Dose + Washout)||4
10596477|NCT01809262|11752809|FG002|STARTED|Period 2 (Second Dose + Washout)||4
10596478|NCT01809262|11752810|FG003|STARTED|Period 2 (Second Dose + Washout)||3
10596479|NCT01809262|11752811|FG004|STARTED|Period 2 (Second Dose + Washout)||3
10596480|NCT01809262|11752812|FG005|STARTED|Period 2 (Second Dose + Washout)||3
10596481|NCT01809262|11752813|FG006|STARTED|Period 2 (Second Dose + Washout)||3
10596482|NCT01809262|11752814|FG007|STARTED|Period 2 (Second Dose + Washout)||4
10596483|NCT01809262|11752815|FG008|STARTED|Period 2 (Second Dose + Washout)||3
10596484|NCT01809262|11752816|FG009|STARTED|Period 2 (Second Dose + Washout)||4
10596485|NCT01809262|11752807|FG000|COMPLETED|Period 2 (Second Dose + Washout)||4
10596486|NCT01809262|11752808|FG001|COMPLETED|Period 2 (Second Dose + Washout)||4
10596487|NCT01809262|11752809|FG002|COMPLETED|Period 2 (Second Dose + Washout)||4
10596488|NCT01809262|11752810|FG003|COMPLETED|Period 2 (Second Dose + Washout)||3
10596489|NCT01809262|11752811|FG004|COMPLETED|Period 2 (Second Dose + Washout)||3
10596490|NCT01809262|11752812|FG005|COMPLETED|Period 2 (Second Dose + Washout)||3
10596491|NCT01809262|11752813|FG006|COMPLETED|Period 2 (Second Dose + Washout)||3
10596492|NCT01809262|11752814|FG007|COMPLETED|Period 2 (Second Dose + Washout)||4
10596493|NCT01809262|11752815|FG008|COMPLETED|Period 2 (Second Dose + Washout)||3
10596494|NCT01809262|11752816|FG009|COMPLETED|Period 2 (Second Dose + Washout)||4
10596495|NCT01809262|11752807|FG000|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
10596496|NCT01809262|11752808|FG001|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
10596497|NCT01809262|11752809|FG002|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
10596498|NCT01809262|11752810|FG003|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
10596499|NCT01809262|11752811|FG004|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
10596500|NCT01809262|11752812|FG005|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
10596501|NCT01809262|11752813|FG006|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
10596502|NCT01809262|11752814|FG007|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
10596503|NCT01809262|11752815|FG008|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
10596504|NCT01809262|11752816|FG009|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
10596505|NCT01809262|11752807|FG000|STARTED|Period 3 (Third Dose + Washout)||4
10596506|NCT01809262|11752808|FG001|STARTED|Period 3 (Third Dose + Washout)||4
10596507|NCT01809262|11752809|FG002|STARTED|Period 3 (Third Dose + Washout)||4
10596508|NCT01809262|11752810|FG003|STARTED|Period 3 (Third Dose + Washout)||3
10596509|NCT01809262|11752811|FG004|STARTED|Period 3 (Third Dose + Washout)||3
10596510|NCT01809262|11752812|FG005|STARTED|Period 3 (Third Dose + Washout)||3
10596511|NCT01809262|11752813|FG006|STARTED|Period 3 (Third Dose + Washout)||3
10596512|NCT01809262|11752814|FG007|STARTED|Period 3 (Third Dose + Washout)||4
10596513|NCT01809262|11752815|FG008|STARTED|Period 3 (Third Dose + Washout)||3
10596514|NCT01809262|11752816|FG009|STARTED|Period 3 (Third Dose + Washout)||4
10596515|NCT01809262|11752807|FG000|COMPLETED|Period 3 (Third Dose + Washout)||4
10596516|NCT01809262|11752808|FG001|COMPLETED|Period 3 (Third Dose + Washout)||3
10596517|NCT01809262|11752809|FG002|COMPLETED|Period 3 (Third Dose + Washout)||4
10596518|NCT01809262|11752810|FG003|COMPLETED|Period 3 (Third Dose + Washout)||3
10596519|NCT01809262|11752811|FG004|COMPLETED|Period 3 (Third Dose + Washout)||3
10596520|NCT01809262|11752812|FG005|COMPLETED|Period 3 (Third Dose + Washout)||3
10596521|NCT01809262|11752813|FG006|COMPLETED|Period 3 (Third Dose + Washout)||3
10596522|NCT01809262|11752814|FG007|COMPLETED|Period 3 (Third Dose + Washout)||4
10596523|NCT01809262|11752815|FG008|COMPLETED|Period 3 (Third Dose + Washout)||3
10596524|NCT01809262|11752816|FG009|COMPLETED|Period 3 (Third Dose + Washout)||4
10596525|NCT01809262|11752807|FG000|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
10596526|NCT01809262|11752808|FG001|NOT COMPLETED|Period 3 (Third Dose + Washout)||1
10596527|NCT01809262|11752809|FG002|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
10596528|NCT01809262|11752810|FG003|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
10596529|NCT01809262|11752811|FG004|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
10596530|NCT01809262|11752812|FG005|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
10596531|NCT01809262|11752813|FG006|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
10596532|NCT01809262|11752814|FG007|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
10596533|NCT01809262|11752815|FG008|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
10596534|NCT01809262|11752816|FG009|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
10596535|NCT01809262|11752807|FG000|STARTED|Period 4 (Fourth Dose + Washout)||4
10596536|NCT01809262|11752808|FG001|STARTED|Period 4 (Fourth Dose + Washout)||3
10596537|NCT01809262|11752809|FG002|STARTED|Period 4 (Fourth Dose + Washout)||4
10596538|NCT01809262|11752810|FG003|STARTED|Period 4 (Fourth Dose + Washout)||3
10596539|NCT01809262|11752811|FG004|STARTED|Period 4 (Fourth Dose + Washout)||3
10596540|NCT01809262|11752812|FG005|STARTED|Period 4 (Fourth Dose + Washout)||3
10596541|NCT01809262|11752813|FG006|STARTED|Period 4 (Fourth Dose + Washout)||3
10596542|NCT01809262|11752814|FG007|STARTED|Period 4 (Fourth Dose + Washout)||4
10596543|NCT01809262|11752815|FG008|STARTED|Period 4 (Fourth Dose + Washout)||3
10596544|NCT01809262|11752816|FG009|STARTED|Period 4 (Fourth Dose + Washout)||4
10596545|NCT01809262|11752807|FG000|COMPLETED|Period 4 (Fourth Dose + Washout)||4
10596546|NCT01809262|11752808|FG001|COMPLETED|Period 4 (Fourth Dose + Washout)||3
10596547|NCT01809262|11752809|FG002|COMPLETED|Period 4 (Fourth Dose + Washout)||4
10596548|NCT01809262|11752810|FG003|COMPLETED|Period 4 (Fourth Dose + Washout)||3
10596549|NCT01809262|11752811|FG004|COMPLETED|Period 4 (Fourth Dose + Washout)||3
10596550|NCT01809262|11752812|FG005|COMPLETED|Period 4 (Fourth Dose + Washout)||3
10596551|NCT01809262|11752813|FG006|COMPLETED|Period 4 (Fourth Dose + Washout)||3
10596552|NCT01809262|11752814|FG007|COMPLETED|Period 4 (Fourth Dose + Washout)||4
10596553|NCT01809262|11752815|FG008|COMPLETED|Period 4 (Fourth Dose + Washout)||3
10596554|NCT01809262|11752816|FG009|COMPLETED|Period 4 (Fourth Dose + Washout)||4
10596555|NCT01809262|11752807|FG000|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
10596556|NCT01809262|11752808|FG001|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
10596557|NCT01809262|11752809|FG002|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
10596558|NCT01809262|11752810|FG003|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
10596559|NCT01809262|11752811|FG004|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
10596560|NCT01809262|11752812|FG005|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
10596561|NCT01809262|11752813|FG006|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
10596562|NCT01809262|11752814|FG007|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
10596563|NCT01809262|11752815|FG008|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
10596564|NCT01809262|11752816|FG009|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
10596565|NCT01809262|11752807|FG000|STARTED|Period 5 (Fifth Dose + Washout)||4
10596566|NCT01809262|11752808|FG001|STARTED|Period 5 (Fifth Dose + Washout)||3
10596567|NCT01809262|11752809|FG002|STARTED|Period 5 (Fifth Dose + Washout)||4
10596568|NCT01809262|11752810|FG003|STARTED|Period 5 (Fifth Dose + Washout)||3
10596569|NCT01809262|11752811|FG004|STARTED|Period 5 (Fifth Dose + Washout)||3
10596570|NCT01809262|11752812|FG005|STARTED|Period 5 (Fifth Dose + Washout)||3
10596571|NCT01809262|11752813|FG006|STARTED|Period 5 (Fifth Dose + Washout)||3
10596572|NCT01809262|11752814|FG007|STARTED|Period 5 (Fifth Dose + Washout)||4
10596573|NCT01809262|11752815|FG008|STARTED|Period 5 (Fifth Dose + Washout)||3
10596574|NCT01809262|11752816|FG009|STARTED|Period 5 (Fifth Dose + Washout)||4
10596575|NCT01809262|11752807|FG000|COMPLETED|Period 5 (Fifth Dose + Washout)||4
10596576|NCT01809262|11752808|FG001|COMPLETED|Period 5 (Fifth Dose + Washout)||3
10596577|NCT01809262|11752809|FG002|COMPLETED|Period 5 (Fifth Dose + Washout)||4
10596578|NCT01809262|11752810|FG003|COMPLETED|Period 5 (Fifth Dose + Washout)||3
10596579|NCT01809262|11752811|FG004|COMPLETED|Period 5 (Fifth Dose + Washout)||3
10596580|NCT01809262|11752812|FG005|COMPLETED|Period 5 (Fifth Dose + Washout)||3
10596581|NCT01809262|11752813|FG006|COMPLETED|Period 5 (Fifth Dose + Washout)||3
10596582|NCT01809262|11752814|FG007|COMPLETED|Period 5 (Fifth Dose + Washout)||4
10596583|NCT01809262|11752815|FG008|COMPLETED|Period 5 (Fifth Dose + Washout)||3
10596584|NCT01809262|11752816|FG009|COMPLETED|Period 5 (Fifth Dose + Washout)||4
10596585|NCT01809262|11752807|FG000|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
10596586|NCT01809262|11752808|FG001|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
10596587|NCT01809262|11752809|FG002|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
10596588|NCT01809262|11752810|FG003|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
10596589|NCT01809262|11752811|FG004|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
10596590|NCT01809262|11752812|FG005|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
10596591|NCT01809262|11752813|FG006|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
10596592|NCT01809262|11752814|FG007|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
10596593|NCT01809262|11752815|FG008|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
10596594|NCT01809262|11752816|FG009|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
10596595|NCT01809314|11752828|FG000|STARTED|Overall Study||1167
10596596|NCT01809314|11752828|FG000|COMPLETED|Overall Study||422
10596597|NCT01809314|11752828|FG000|NOT COMPLETED|Overall Study||745
10596598|NCT01809327|11752837|FG000|STARTED|Overall Study||237
10596599|NCT01809327|11752838|FG001|STARTED|Overall Study||237
10596600|NCT01809327|11752839|FG002|STARTED|Overall Study||238
10596601|NCT01809327|11752840|FG003|STARTED|Overall Study||237
10596602|NCT01809327|11752841|FG004|STARTED|Overall Study||237
10596603|NCT01809327|11752837|FG000|COMPLETED|Overall Study||205
10596604|NCT01809327|11752838|FG001|COMPLETED|Overall Study||211
10596605|NCT01809327|11752839|FG002|COMPLETED|Overall Study||216
10596606|NCT01809327|11752840|FG003|COMPLETED|Overall Study||225
10596607|NCT01809327|11752841|FG004|COMPLETED|Overall Study||212
10596608|NCT01809327|11752837|FG000|NOT COMPLETED|Overall Study||32
10596609|NCT01809327|11752838|FG001|NOT COMPLETED|Overall Study||26
10596610|NCT01809327|11752839|FG002|NOT COMPLETED|Overall Study||22
10596611|NCT01809327|11752840|FG003|NOT COMPLETED|Overall Study||12
10596612|NCT01809327|11752841|FG004|NOT COMPLETED|Overall Study||25
10596613|NCT01809639|11752855|FG000|STARTED|Overall Study||18
10596614|NCT01809639|11752856|FG001|STARTED|Overall Study||7
10596615|NCT01809639|11752855|FG000|COMPLETED|Overall Study||18
10596616|NCT01809639|11752856|FG001|COMPLETED|Overall Study||7
10596617|NCT01809639|11752855|FG000|NOT COMPLETED|Overall Study||0
10596618|NCT01809639|11752856|FG001|NOT COMPLETED|Overall Study||0
10596619|NCT01809834|11752862|FG000|STARTED|Overall Study||44
10596620|NCT01809834|11752862|FG000|COMPLETED|Overall Study||44
10596621|NCT01809834|11752862|FG000|NOT COMPLETED|Overall Study||0
10596622|NCT01809938|11752868|FG000|STARTED|First Intervention (170 Minutes)||5
10596623|NCT01809938|11752869|FG001|STARTED|First Intervention (170 Minutes)||5
10596624|NCT01809938|11752868|FG000|COMPLETED|First Intervention (170 Minutes)||5
10596625|NCT01809938|11752869|FG001|COMPLETED|First Intervention (170 Minutes)||5
10596626|NCT01809938|11752868|FG000|NOT COMPLETED|First Intervention (170 Minutes)||0
10596627|NCT01809938|11752869|FG001|NOT COMPLETED|First Intervention (170 Minutes)||0
10596628|NCT01809938|11752868|FG000|STARTED|Washout (Not Less Than 24 Hours)||5
10596629|NCT01809938|11752869|FG001|STARTED|Washout (Not Less Than 24 Hours)||5
10596630|NCT01809938|11752868|FG000|COMPLETED|Washout (Not Less Than 24 Hours)||5
10596631|NCT01809938|11752869|FG001|COMPLETED|Washout (Not Less Than 24 Hours)||5
10596632|NCT01809938|11752868|FG000|NOT COMPLETED|Washout (Not Less Than 24 Hours)||0
10596633|NCT01809938|11752869|FG001|NOT COMPLETED|Washout (Not Less Than 24 Hours)||0
10596634|NCT01809938|11752868|FG000|STARTED|Second Intervention (170 Minutes)||5
10596635|NCT01809938|11752869|FG001|STARTED|Second Intervention (170 Minutes)||5
10596636|NCT01809938|11752868|FG000|COMPLETED|Second Intervention (170 Minutes)||5
10703748|NCT02586506|11868231|FG000|STARTED|Overall Study||259
10703749|NCT02586506|11868231|FG000|COMPLETED|Overall Study||250
10703750|NCT02586506|11868231|FG000|NOT COMPLETED|Overall Study||9
10703751|NCT02586727|11868237|FG000|STARTED|Overall Study||20
10596637|NCT01809938|11752869|FG001|COMPLETED|Second Intervention (170 Minutes)||5
10596638|NCT01809938|11752868|FG000|NOT COMPLETED|Second Intervention (170 Minutes)||0
10596639|NCT01809938|11752869|FG001|NOT COMPLETED|Second Intervention (170 Minutes)||0
10596640|NCT01810016|11752877|FG000|STARTED|Overall Study||5
10596641|NCT01810016|11752878|FG001|STARTED|Overall Study||2
10596642|NCT01810016|11752879|FG002|STARTED|Overall Study||1
10596643|NCT01810016|11752877|FG000|COMPLETED|Overall Study||4
10596644|NCT01810016|11752878|FG001|COMPLETED|Overall Study||1
10703752|NCT02586727|11868238|FG001|STARTED|Overall Study||20
10596645|NCT01810016|11752879|FG002|COMPLETED|Overall Study||0
10596646|NCT01810016|11752877|FG000|NOT COMPLETED|Overall Study||1
10703753|NCT02586727|11868237|FG000|COMPLETED|Overall Study||19
10703754|NCT02586727|11868238|FG001|COMPLETED|Overall Study||20
10596647|NCT01810016|11752878|FG001|NOT COMPLETED|Overall Study||1
10596648|NCT01810016|11752879|FG002|NOT COMPLETED|Overall Study||1
10596649|NCT01810042|11752887|FG000|STARTED|Overall Study||49
10596650|NCT01810042|11752887|FG000|COMPLETED|Overall Study||39
10596651|NCT01810042|11752887|FG000|NOT COMPLETED|Overall Study||10
10596652|NCT01810263|11752893|FG000|STARTED|Overall Study||16
10596653|NCT01810263|11752894|FG001|STARTED|Overall Study||18
10596654|NCT01810263|11752893|FG000|COMPLETED|Overall Study|2014 July|8
10596655|NCT01810263|11752894|FG001|COMPLETED|Overall Study||11
10596656|NCT01810263|11752893|FG000|NOT COMPLETED|Overall Study||8
10596657|NCT01810263|11752894|FG001|NOT COMPLETED|Overall Study||7
10596658|NCT01810289|11752902|FG000|STARTED|Overall Study||7277
10596659|NCT01810289|11752903|FG001|STARTED|Overall Study||4747
10596660|NCT01810289|11752902|FG000|COMPLETED|Overall Study||7277
10596661|NCT01810289|11752903|FG001|COMPLETED|Overall Study||4747
10596662|NCT01810289|11752902|FG000|NOT COMPLETED|Overall Study||0
10596663|NCT01810289|11752903|FG001|NOT COMPLETED|Overall Study||0
10596664|NCT01810380|11752912|FG000|STARTED|Overall Study||163
10596665|NCT01810380|11752913|FG001|STARTED|Overall Study||151
10596666|NCT01810380|11752914|FG002|STARTED|Overall Study||154
10596667|NCT01810380|11752912|FG000|Treated|Overall Study||161
10596668|NCT01810380|11752913|FG001|Treated|Overall Study||150
10596669|NCT01810380|11752914|FG002|Treated|Overall Study||153
10596670|NCT01810380|11752912|FG000|COMPLETED|Overall Study||108
10596671|NCT01810380|11752913|FG001|COMPLETED|Overall Study||113
10596672|NCT01810380|11752914|FG002|COMPLETED|Overall Study||122
10596673|NCT01810380|11752912|FG000|NOT COMPLETED|Overall Study||55
10596674|NCT01810380|11752913|FG001|NOT COMPLETED|Overall Study||38
10596675|NCT01810380|11752914|FG002|NOT COMPLETED|Overall Study||32
10596676|NCT01810432|11752922|FG000|STARTED|Period 1||20
10596677|NCT01810432|11752923|FG001|STARTED|Period 1||20
10596678|NCT01810432|11752922|FG000|Received at Least 1 Dose of Study Drug|Period 1||20
10596679|NCT01810432|11752923|FG001|Received at Least 1 Dose of Study Drug|Period 1||20
10596680|NCT01810432|11752922|FG000|COMPLETED|Period 1||20
10596681|NCT01810432|11752923|FG001|COMPLETED|Period 1||20
10596682|NCT01810432|11752922|FG000|NOT COMPLETED|Period 1||0
10596683|NCT01810432|11752923|FG001|NOT COMPLETED|Period 1||0
10596684|NCT01810432|11752922|FG000|STARTED|Washout||20
10596685|NCT01810432|11752923|FG001|STARTED|Washout||20
10596686|NCT01810432|11752922|FG000|COMPLETED|Washout||19
10596687|NCT01810432|11752923|FG001|COMPLETED|Washout||19
10596688|NCT01810432|11752922|FG000|NOT COMPLETED|Washout||1
10596689|NCT01810432|11752923|FG001|NOT COMPLETED|Washout||1
10596690|NCT01810432|11752922|FG000|STARTED|Period 2||19
10596691|NCT01810432|11752923|FG001|STARTED|Period 2||19
10596692|NCT01810432|11752922|FG000|Received at Least 1 Dose of Study Drug|Period 2||19
10596693|NCT01810432|11752923|FG001|Received at Least 1 Dose of Study Drug|Period 2||19
10596694|NCT01810432|11752922|FG000|COMPLETED|Period 2||15
10596695|NCT01810432|11752923|FG001|COMPLETED|Period 2||17
10596696|NCT01810432|11752922|FG000|NOT COMPLETED|Period 2||4
10596697|NCT01810432|11752923|FG001|NOT COMPLETED|Period 2||2
10596698|NCT01810666|11752929|FG000|STARTED|Overall Study||30
10596699|NCT01810666|11752929|FG000|COMPLETED|Overall Study||30
10596700|NCT01810666|11752929|FG000|NOT COMPLETED|Overall Study||0
10596701|NCT01810692|11752935|FG000|STARTED|Overall Study||77
10596702|NCT01810692|11752936|FG001|STARTED|Overall Study||77
10596703|NCT01810692|11752935|FG000|COMPLETED|Overall Study||77
10596704|NCT01810692|11752936|FG001|COMPLETED|Overall Study||77
10596705|NCT01810692|11752935|FG000|NOT COMPLETED|Overall Study||0
10596706|NCT01810692|11752936|FG001|NOT COMPLETED|Overall Study||0
10596707|NCT01810783|11752942|FG000|STARTED|Overall Study||210
10596708|NCT01810783|11752942|FG000|COMPLETED|Overall Study||101
10596709|NCT01810783|11752942|FG000|NOT COMPLETED|Overall Study||109
10596710|NCT01810939|11752946|FG000|STARTED|Part A Treatment Period||243
10596711|NCT01810939|11752947|FG001|STARTED|Part A Treatment Period||0
10596712|NCT01810939|11752948|FG002|STARTED|Part A Treatment Period||0
10596713|NCT01810939|11752946|FG000|COMPLETED|Part A Treatment Period||219
10596714|NCT01810939|11752947|FG001|COMPLETED|Part A Treatment Period||0
10596715|NCT01810939|11752948|FG002|COMPLETED|Part A Treatment Period||0
10596716|NCT01810939|11752946|FG000|NOT COMPLETED|Part A Treatment Period||24
10596717|NCT01810939|11752947|FG001|NOT COMPLETED|Part A Treatment Period||0
10596718|NCT01810939|11752948|FG002|NOT COMPLETED|Part A Treatment Period||0
10596719|NCT01810939|11752946|FG000|STARTED|Part B Placebo-Controlled Withdrawal||0
10596720|NCT01810939|11752947|FG001|STARTED|Part B Placebo-Controlled Withdrawal|Part A participants with Part A baseline serum potassium ≥ 5.5 mEq/L who responded to treatment|55
10596721|NCT01810939|11752948|FG002|STARTED|Part B Placebo-Controlled Withdrawal|Part A participants with Part A baseline serum potassium ≥ 5.5 mEq/L who responded to treatment|52
10596722|NCT01810939|11752946|FG000|COMPLETED|Part B Placebo-Controlled Withdrawal||0
10596723|NCT01810939|11752947|FG001|COMPLETED|Part B Placebo-Controlled Withdrawal||45
10596724|NCT01810939|11752948|FG002|COMPLETED|Part B Placebo-Controlled Withdrawal||30
10596725|NCT01810939|11752946|FG000|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||0
10596726|NCT01810939|11752947|FG001|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||10
10596727|NCT01810939|11752948|FG002|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||22
10596728|NCT01810952|11752959|FG000|STARTED|Overall Study||20
10596729|NCT01810952|11752960|FG001|STARTED|Overall Study||17
10596730|NCT01810952|11752959|FG000|COMPLETED|Overall Study||20
10596731|NCT01810952|11752960|FG001|COMPLETED|Overall Study||17
10596732|NCT01810952|11752959|FG000|NOT COMPLETED|Overall Study||0
10596733|NCT01810952|11752960|FG001|NOT COMPLETED|Overall Study||0
10596734|NCT01810991|11752972|FG000|STARTED|Overall Study||19
10596735|NCT01810991|11752972|FG000|COMPLETED|Overall Study||17
10596736|NCT01810991|11752972|FG000|NOT COMPLETED|Overall Study||2
10596737|NCT01811004|11752978|FG000|STARTED|Overall Study||9
10596738|NCT01811004|11752979|FG001|STARTED|Overall Study||8
10596739|NCT01811004|11752978|FG000|COMPLETED|Overall Study||8
10596740|NCT01811004|11752979|FG001|COMPLETED|Overall Study||5
10596741|NCT01811004|11752978|FG000|NOT COMPLETED|Overall Study||1
10596742|NCT01811004|11752979|FG001|NOT COMPLETED|Overall Study||3
10652172|NCT02181816|11812539|FG000|NOT COMPLETED|Overall Study||59
10652173|NCT02181829|11812543|FG000|STARTED|Overall Study||10
10652174|NCT02181829|11812543|FG000|COMPLETED|Overall Study||10
10652175|NCT02181829|11812543|FG000|NOT COMPLETED|Overall Study||0
10652176|NCT02181842|11812547|FG000|STARTED|Overall Study||246
10652177|NCT02181842|11812547|FG000|COMPLETED|Overall Study||244
10652178|NCT02181842|11812547|FG000|NOT COMPLETED|Overall Study||2
10652179|NCT02182115|11812553|FG000|STARTED|Overall Study||53
10652180|NCT02182115|11812554|FG001|STARTED|Overall Study||57
10652181|NCT02182115|11812553|FG000|COMPLETED|Overall Study||53
10652182|NCT02182115|11812554|FG001|COMPLETED|Overall Study||57
10652183|NCT02182115|11812553|FG000|NOT COMPLETED|Overall Study||0
10652184|NCT02182115|11812554|FG001|NOT COMPLETED|Overall Study||0
10652185|NCT02182440|11812564|FG000|STARTED|Overall Study||116
10652186|NCT02182440|11812565|FG001|STARTED|Overall Study||39
10652187|NCT02182440|11812566|FG002|STARTED|Overall Study||35
10652188|NCT02182440|11812567|FG003|STARTED|Overall Study||111
10652189|NCT02182440|11812564|FG000|ITTcombined|Overall Study||116
10652190|NCT02182440|11812565|FG001|ITTcombined|Overall Study||31
10652191|NCT02182440|11812566|FG002|ITTcombined|Overall Study||32
10652192|NCT02182440|11812567|FG003|ITTcombined|Overall Study||111
10652193|NCT02182440|11812564|FG000|ITTinterim|Overall Study||30
10652194|NCT02182440|11812565|FG001|ITTinterim|Overall Study||31
10652195|NCT02182440|11812566|FG002|ITTinterim|Overall Study||32
10652196|NCT02182440|11812567|FG003|ITTinterim|Overall Study||29
10652197|NCT02182440|11812564|FG000|Safety Population|Overall Study||112
10652198|NCT02182440|11812565|FG001|Safety Population|Overall Study||38
10652199|NCT02182440|11812566|FG002|Safety Population|Overall Study||35
10652200|NCT02182440|11812567|FG003|Safety Population|Overall Study||109
10652201|NCT02182440|11812564|FG000|COMPLETED|Overall Study||71
10652202|NCT02182440|11812565|FG001|COMPLETED|Overall Study||25
10652203|NCT02182440|11812566|FG002|COMPLETED|Overall Study||24
10652204|NCT02182440|11812567|FG003|COMPLETED|Overall Study||81
10652205|NCT02182440|11812564|FG000|NOT COMPLETED|Overall Study||45
10652206|NCT02182440|11812565|FG001|NOT COMPLETED|Overall Study||14
10652207|NCT02182440|11812566|FG002|NOT COMPLETED|Overall Study||11
10652208|NCT02182440|11812567|FG003|NOT COMPLETED|Overall Study||30
10652209|NCT02182492|11812581|FG000|STARTED|Overall Study|CRSsNP: 28; Non-Eos CRSwNP: 34; Eos CRSwNP: 31|93
10652210|NCT02182492|11812582|FG001|STARTED|Overall Study|CRSsNP: 30; Non-Eos CRSwNP: 32; Eos CRSwNP: 32|94
10652211|NCT02182492|11812581|FG000|COMPLETED|Overall Study|CRSsNP: 27; Non-Eos CRSwNP: 31; Eos CRSwNP: 28|86
10652212|NCT02182492|11812582|FG001|COMPLETED|Overall Study|CRSsNP: 29; Non-Eos CRSwNP: 28; Eos CRSwNP: 29|86
10652213|NCT02182492|11812581|FG000|NOT COMPLETED|Overall Study||7
10652214|NCT02182492|11812582|FG001|NOT COMPLETED|Overall Study||8
10652215|NCT02182804|11812588|FG000|STARTED|Overall Study||44
10652216|NCT02182804|11812588|FG000|COMPLETED|Overall Study||44
10652217|NCT02182804|11812588|FG000|NOT COMPLETED|Overall Study||0
10652218|NCT02182830|11812594|FG000|STARTED|Overall Study||83
10652219|NCT02182830|11812595|FG001|STARTED|Overall Study||83
10652220|NCT02182830|11812594|FG000|Randomised Set (RS)|Overall Study|From started, 2 duplicate patients and 2 patients from one site were removed|79
10652221|NCT02182830|11812595|FG001|Randomised Set (RS)|Overall Study|From started, 1 patient from one site was removed|82
10652222|NCT02182830|11812594|FG000|Treated Set (TS)|Overall Study|From RS, 1 duplicate patient and 1 non treated patient was removed|77
10652223|NCT02182830|11812595|FG001|Treated Set (TS)|Overall Study|From RS, 1 duplicate patient and 1 non treated patient was removed|80
10652224|NCT02182830|11812594|FG000|COMPLETED|Overall Study||68
10652225|NCT02182830|11812595|FG001|COMPLETED|Overall Study||68
10652226|NCT02182830|11812594|FG000|NOT COMPLETED|Overall Study||15
10652227|NCT02182830|11812595|FG001|NOT COMPLETED|Overall Study||15
10652228|NCT02182843|11812601|FG000|STARTED|Overall Study||81
10652229|NCT02182843|11812601|FG000|COMPLETED|Overall Study||71
10652230|NCT02182843|11812601|FG000|NOT COMPLETED|Overall Study||10
10652231|NCT02182895|11812607|FG000|STARTED|Overall Study||35
10652232|NCT02182895|11812608|FG001|STARTED|Overall Study||37
10652233|NCT02182895|11812607|FG000|COMPLETED|Overall Study||33
10652234|NCT02182895|11812608|FG001|COMPLETED|Overall Study||33
10652235|NCT02182895|11812607|FG000|NOT COMPLETED|Overall Study||2
10652236|NCT02182895|11812608|FG001|NOT COMPLETED|Overall Study||4
10652237|NCT02182947|11812614|FG000|STARTED|Overall Study||45
10652238|NCT02182947|11812614|FG000|COMPLETED|Overall Study||27
10652239|NCT02182947|11812614|FG000|NOT COMPLETED|Overall Study||18
10652240|NCT02182973|11812620|FG000|STARTED|Overall Study||12
10652241|NCT02182973|11812621|FG001|STARTED|Overall Study||9
10652242|NCT02182973|11812620|FG000|COMPLETED|Overall Study||9
10652243|NCT02182973|11812621|FG001|COMPLETED|Overall Study||9
10652244|NCT02182973|11812620|FG000|NOT COMPLETED|Overall Study||3
10652245|NCT02182973|11812621|FG001|NOT COMPLETED|Overall Study||0
10652246|NCT02182999|11812630|FG000|STARTED|Overall Study||25
10652247|NCT02182999|11812631|FG001|STARTED|Overall Study||25
10652248|NCT02182999|11812630|FG000|COMPLETED|Overall Study||20
10652249|NCT02182999|11812631|FG001|COMPLETED|Overall Study||22
10652250|NCT02182999|11812630|FG000|NOT COMPLETED|Overall Study||5
10596743|NCT01811030|11752987|FG000|STARTED|Overall Study||33
10596744|NCT01811030|11752987|FG000|COMPLETED|Overall Study||20
10596745|NCT01811030|11752987|FG000|NOT COMPLETED|Overall Study||13
10596746|NCT01811147|11752995|FG000|STARTED|Overall Study||51
10596747|NCT01811147|11752996|FG001|STARTED|Overall Study||56
10596748|NCT01811147|11752997|FG002|STARTED|Overall Study||49
10596749|NCT01811147|11752998|FG003|STARTED|Overall Study||33
10596750|NCT01811147|11752995|FG000|COMPLETED|Overall Study||15
10596751|NCT01811147|11752996|FG001|COMPLETED|Overall Study||11
10596752|NCT01811147|11752997|FG002|COMPLETED|Overall Study||6
10596753|NCT01811147|11752998|FG003|COMPLETED|Overall Study||4
10596754|NCT01811147|11752995|FG000|NOT COMPLETED|Overall Study||36
10596755|NCT01811147|11752996|FG001|NOT COMPLETED|Overall Study||45
10596756|NCT01811147|11752997|FG002|NOT COMPLETED|Overall Study||43
10596757|NCT01811147|11752998|FG003|NOT COMPLETED|Overall Study||29
10596758|NCT01811186|11753010|FG000|STARTED|Overall Study||132
10596759|NCT01811186|11753011|FG001|STARTED|Overall Study||126
10596760|NCT01811186|11753010|FG000|COMPLETED|Overall Study||61
10596761|NCT01811186|11753011|FG001|COMPLETED|Overall Study||64
10596762|NCT01811186|11753010|FG000|NOT COMPLETED|Overall Study||71
10596763|NCT01811186|11753011|FG001|NOT COMPLETED|Overall Study||62
10596764|NCT01811212|11753021|FG000|STARTED|Overall Study||25
10596765|NCT01811212|11753021|FG000|COMPLETED|Overall Study||25
10596766|NCT01811212|11753021|FG000|NOT COMPLETED|Overall Study||0
10596767|NCT01811225|11753025|FG000|STARTED|Treatment Period 1||49
10596768|NCT01811225|11753026|FG001|STARTED|Treatment Period 1||46
10596769|NCT01811225|11753025|FG000|COMPLETED|Treatment Period 1|53 completed one arm of the cross-over and 43 completed two arms of the cross-over|24
10703755|NCT02586727|11868237|FG000|NOT COMPLETED|Overall Study||1
10703756|NCT02586727|11868238|FG001|NOT COMPLETED|Overall Study||0
10703757|NCT02586805|11868248|FG000|STARTED|Overall Study||41
10703758|NCT02586805|11868249|FG001|STARTED|Overall Study||28
10703759|NCT02586805|11868250|FG002|STARTED|Overall Study||29
10703760|NCT02586805|11868251|FG003|STARTED|Overall Study||27
10703761|NCT02586805|11868248|FG000|COMPLETED|Overall Study||35
10703762|NCT02586805|11868249|FG001|COMPLETED|Overall Study||27
10703763|NCT02586805|11868250|FG002|COMPLETED|Overall Study||26
10596770|NCT01811225|11753026|FG001|COMPLETED|Treatment Period 1||29
10596771|NCT01811225|11753025|FG000|NOT COMPLETED|Treatment Period 1||25
10596772|NCT01811225|11753026|FG001|NOT COMPLETED|Treatment Period 1||17
10596773|NCT01811225|11753025|FG000|STARTED|Treatment Period 2||24
10596774|NCT01811225|11753026|FG001|STARTED|Treatment Period 2||29
10596775|NCT01811225|11753025|FG000|COMPLETED|Treatment Period 2||20
10596776|NCT01811225|11753026|FG001|COMPLETED|Treatment Period 2||23
10596777|NCT01811225|11753025|FG000|NOT COMPLETED|Treatment Period 2||4
10596778|NCT01811225|11753026|FG001|NOT COMPLETED|Treatment Period 2||6
10596779|NCT01811238|11753032|FG000|STARTED|Overall Study|First patient was recruited on 26 Sep. 2012.|240
10596780|NCT01811238|11753032|FG000|Safety Set|Overall Study|20 subjects excluded from the safety set due to study drug not administered.|220
10596856|NCT01811303|11753040|FG003|NOT COMPLETED|Washout (2 Days or More)||0
10596781|NCT01811238|11753032|FG000|ITT Set|Overall Study|11 subjects excluded from ITT set due to no primary efficacy assessment(5) and IC/EC violation(6).|209
10596782|NCT01811238|11753032|FG000|PP Set|Overall Study|89 subjects excluded from PP set due to various reasons.|120
10596783|NCT01811238|11753032|FG000|COMPLETED|Overall Study|159 subjects regardless PP set completed study visit.|159
10596784|NCT01811238|11753032|FG000|NOT COMPLETED|Overall Study||81
10596785|NCT01811303|11753037|FG000|STARTED|First Intervention (1 Day)||4
10596786|NCT01811303|11753038|FG001|STARTED|First Intervention (1 Day)||4
10596787|NCT01811303|11753039|FG002|STARTED|First Intervention (1 Day)||4
10596788|NCT01811303|11753040|FG003|STARTED|First Intervention (1 Day)||2
10596789|NCT01811303|11753037|FG000|COMPLETED|First Intervention (1 Day)||4
10596790|NCT01811303|11753038|FG001|COMPLETED|First Intervention (1 Day)||4
10596791|NCT01811303|11753039|FG002|COMPLETED|First Intervention (1 Day)||4
10596792|NCT01811303|11753040|FG003|COMPLETED|First Intervention (1 Day)||2
10596793|NCT01811303|11753037|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10596794|NCT01811303|11753038|FG001|NOT COMPLETED|First Intervention (1 Day)||0
10596795|NCT01811303|11753039|FG002|NOT COMPLETED|First Intervention (1 Day)||0
10596796|NCT01811303|11753040|FG003|NOT COMPLETED|First Intervention (1 Day)||0
10596797|NCT01811303|11753037|FG000|STARTED|Washout (2 Days or More)||4
10596798|NCT01811303|11753038|FG001|STARTED|Washout (2 Days or More)||4
10596799|NCT01811303|11753039|FG002|STARTED|Washout (2 Days or More)||4
10596800|NCT01811303|11753040|FG003|STARTED|Washout (2 Days or More)||2
10596801|NCT01811303|11753037|FG000|COMPLETED|Washout (2 Days or More)||4
10596802|NCT01811303|11753038|FG001|COMPLETED|Washout (2 Days or More)||4
10596803|NCT01811303|11753039|FG002|COMPLETED|Washout (2 Days or More)||4
10596804|NCT01811303|11753040|FG003|COMPLETED|Washout (2 Days or More)||2
10596805|NCT01811303|11753037|FG000|NOT COMPLETED|Washout (2 Days or More)||0
10596806|NCT01811303|11753038|FG001|NOT COMPLETED|Washout (2 Days or More)||0
10596807|NCT01811303|11753039|FG002|NOT COMPLETED|Washout (2 Days or More)||0
10703764|NCT02586805|11868251|FG003|COMPLETED|Overall Study||25
10703765|NCT02586805|11868248|FG000|NOT COMPLETED|Overall Study||6
10703766|NCT02586805|11868249|FG001|NOT COMPLETED|Overall Study||1
10703767|NCT02586805|11868250|FG002|NOT COMPLETED|Overall Study||3
10596808|NCT01811303|11753040|FG003|NOT COMPLETED|Washout (2 Days or More)||0
10596809|NCT01811303|11753037|FG000|STARTED|Second Intervention (1 Day)||4
10596810|NCT01811303|11753038|FG001|STARTED|Second Intervention (1 Day)||4
10596811|NCT01811303|11753039|FG002|STARTED|Second Intervention (1 Day)||4
10703768|NCT02586805|11868251|FG003|NOT COMPLETED|Overall Study||2
10703769|NCT02586896|11868263|FG000|STARTED|Overall Study||150
10596812|NCT01811303|11753040|FG003|STARTED|Second Intervention (1 Day)||2
10596813|NCT01811303|11753037|FG000|COMPLETED|Second Intervention (1 Day)||4
10596814|NCT01811303|11753038|FG001|COMPLETED|Second Intervention (1 Day)||4
10596815|NCT01811303|11753039|FG002|COMPLETED|Second Intervention (1 Day)||4
10596816|NCT01811303|11753040|FG003|COMPLETED|Second Intervention (1 Day)||2
10596817|NCT01811303|11753037|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10596818|NCT01811303|11753038|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10596819|NCT01811303|11753039|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
10596820|NCT01811303|11753040|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
10596821|NCT01811303|11753037|FG000|STARTED|Washout (2 Days or More)||4
10596822|NCT01811303|11753038|FG001|STARTED|Washout (2 Days or More)||4
10596823|NCT01811303|11753039|FG002|STARTED|Washout (2 Days or More)||4
10596824|NCT01811303|11753040|FG003|STARTED|Washout (2 Days or More)||2
10596825|NCT01811303|11753037|FG000|COMPLETED|Washout (2 Days or More)||4
10596826|NCT01811303|11753038|FG001|COMPLETED|Washout (2 Days or More)||4
10596827|NCT01811303|11753039|FG002|COMPLETED|Washout (2 Days or More)||4
10596828|NCT01811303|11753040|FG003|COMPLETED|Washout (2 Days or More)||2
10596829|NCT01811303|11753037|FG000|NOT COMPLETED|Washout (2 Days or More)||0
10596830|NCT01811303|11753038|FG001|NOT COMPLETED|Washout (2 Days or More)||0
10596831|NCT01811303|11753039|FG002|NOT COMPLETED|Washout (2 Days or More)||0
10596832|NCT01811303|11753040|FG003|NOT COMPLETED|Washout (2 Days or More)||0
10596833|NCT01811303|11753037|FG000|STARTED|Third Intervention (1 Day)||4
10596834|NCT01811303|11753038|FG001|STARTED|Third Intervention (1 Day)||4
10596835|NCT01811303|11753039|FG002|STARTED|Third Intervention (1 Day)||4
10596836|NCT01811303|11753040|FG003|STARTED|Third Intervention (1 Day)||2
10596837|NCT01811303|11753037|FG000|COMPLETED|Third Intervention (1 Day)||4
10596838|NCT01811303|11753038|FG001|COMPLETED|Third Intervention (1 Day)||4
10596839|NCT01811303|11753039|FG002|COMPLETED|Third Intervention (1 Day)||4
10596840|NCT01811303|11753040|FG003|COMPLETED|Third Intervention (1 Day)||2
10596841|NCT01811303|11753037|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
10596842|NCT01811303|11753038|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
10596843|NCT01811303|11753039|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
10596844|NCT01811303|11753040|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
10596845|NCT01811303|11753037|FG000|STARTED|Washout (2 Days or More)||4
10596846|NCT01811303|11753038|FG001|STARTED|Washout (2 Days or More)||4
10596847|NCT01811303|11753039|FG002|STARTED|Washout (2 Days or More)||4
10596848|NCT01811303|11753040|FG003|STARTED|Washout (2 Days or More)||2
10596849|NCT01811303|11753037|FG000|COMPLETED|Washout (2 Days or More)||4
10596850|NCT01811303|11753038|FG001|COMPLETED|Washout (2 Days or More)||4
10596851|NCT01811303|11753039|FG002|COMPLETED|Washout (2 Days or More)||4
10596852|NCT01811303|11753040|FG003|COMPLETED|Washout (2 Days or More)||2
10596853|NCT01811303|11753037|FG000|NOT COMPLETED|Washout (2 Days or More)||0
10596854|NCT01811303|11753038|FG001|NOT COMPLETED|Washout (2 Days or More)||0
10596855|NCT01811303|11753039|FG002|NOT COMPLETED|Washout (2 Days or More)||0
10596857|NCT01811303|11753037|FG000|STARTED|Fourth Intervention (1 Day)||4
10596858|NCT01811303|11753038|FG001|STARTED|Fourth Intervention (1 Day)||4
10596859|NCT01811303|11753039|FG002|STARTED|Fourth Intervention (1 Day)||4
10596860|NCT01811303|11753040|FG003|STARTED|Fourth Intervention (1 Day)||2
10596861|NCT01811303|11753037|FG000|COMPLETED|Fourth Intervention (1 Day)||4
10596862|NCT01811303|11753038|FG001|COMPLETED|Fourth Intervention (1 Day)||4
10596863|NCT01811303|11753039|FG002|COMPLETED|Fourth Intervention (1 Day)||4
10596864|NCT01811303|11753040|FG003|COMPLETED|Fourth Intervention (1 Day)||2
10596865|NCT01811303|11753037|FG000|NOT COMPLETED|Fourth Intervention (1 Day)||0
10596866|NCT01811303|11753038|FG001|NOT COMPLETED|Fourth Intervention (1 Day)||0
10596867|NCT01811303|11753039|FG002|NOT COMPLETED|Fourth Intervention (1 Day)||0
10596868|NCT01811303|11753040|FG003|NOT COMPLETED|Fourth Intervention (1 Day)||0
10596869|NCT01811316|11753051|FG000|STARTED|Overall Study||21
10596870|NCT01811316|11753052|FG001|STARTED|Overall Study||22
10596871|NCT01811316|11753053|FG002|STARTED|Overall Study||19
10596872|NCT01811316|11753051|FG000|Visit 4 Weeks|Overall Study||19
10596873|NCT01811316|11753052|FG001|Visit 4 Weeks|Overall Study||22
10596874|NCT01811316|11753053|FG002|Visit 4 Weeks|Overall Study||19
10596875|NCT01811316|11753051|FG000|Visit 12 Weeks|Overall Study||18
10596876|NCT01811316|11753052|FG001|Visit 12 Weeks|Overall Study||22
10596877|NCT01811316|11753053|FG002|Visit 12 Weeks|Overall Study||19
10596878|NCT01811316|11753051|FG000|COMPLETED|Overall Study||18
10596879|NCT01811316|11753052|FG001|COMPLETED|Overall Study||22
10596880|NCT01811316|11753053|FG002|COMPLETED|Overall Study||19
10596881|NCT01811316|11753051|FG000|NOT COMPLETED|Overall Study||3
10596882|NCT01811316|11753052|FG001|NOT COMPLETED|Overall Study||0
10596883|NCT01811316|11753053|FG002|NOT COMPLETED|Overall Study||0
10596884|NCT01811355|11753061|FG000|STARTED|First Dose||11
10596885|NCT01811355|11753062|FG001|STARTED|First Dose||12
10596886|NCT01811355|11753061|FG000|COMPLETED|First Dose||9
10596887|NCT01811355|11753062|FG001|COMPLETED|First Dose||12
10596888|NCT01811355|11753061|FG000|NOT COMPLETED|First Dose||2
10596889|NCT01811355|11753062|FG001|NOT COMPLETED|First Dose||0
10596890|NCT01811355|11753061|FG000|STARTED|Washout||9
10596891|NCT01811355|11753062|FG001|STARTED|Washout||12
10596892|NCT01811355|11753061|FG000|COMPLETED|Washout||9
10596893|NCT01811355|11753062|FG001|COMPLETED|Washout||12
10596894|NCT01811355|11753061|FG000|NOT COMPLETED|Washout||0
10596895|NCT01811355|11753062|FG001|NOT COMPLETED|Washout||0
10596896|NCT01811355|11753061|FG000|STARTED|Second Dose||9
10596897|NCT01811355|11753062|FG001|STARTED|Second Dose||12
10596898|NCT01811355|11753061|FG000|COMPLETED|Second Dose||9
10596899|NCT01811355|11753062|FG001|COMPLETED|Second Dose||12
10596900|NCT01811355|11753061|FG000|NOT COMPLETED|Second Dose||0
10596901|NCT01811355|11753062|FG001|NOT COMPLETED|Second Dose||0
10596902|NCT01811472|11753073|FG000|STARTED|Overall Study||20
10596903|NCT01811472|11753074|FG001|STARTED|Overall Study||11
10596904|NCT01811472|11753075|FG002|STARTED|Overall Study||21
10596905|NCT01811472|11753073|FG000|COMPLETED|Overall Study||18
10596906|NCT01811472|11753074|FG001|COMPLETED|Overall Study||11
10596907|NCT01811472|11753075|FG002|COMPLETED|Overall Study||16
10596908|NCT01811472|11753073|FG000|NOT COMPLETED|Overall Study||2
10596909|NCT01811472|11753074|FG001|NOT COMPLETED|Overall Study||0
10596910|NCT01811472|11753075|FG002|NOT COMPLETED|Overall Study||5
10596911|NCT01811485|11753087|FG000|STARTED|Overall Study|"Started indicates randomized patients"|56
10596912|NCT01811485|11753088|FG001|STARTED|Overall Study||59
10596913|NCT01811485|11753089|FG002|STARTED|Overall Study||56
10596914|NCT01811485|11753087|FG000|COMPLETED|Overall Study||54
10596915|NCT01811485|11753088|FG001|COMPLETED|Overall Study||55
10596916|NCT01811485|11753089|FG002|COMPLETED|Overall Study||51
10596917|NCT01811485|11753087|FG000|NOT COMPLETED|Overall Study||2
10596918|NCT01811485|11753088|FG001|NOT COMPLETED|Overall Study||4
10596919|NCT01811485|11753089|FG002|NOT COMPLETED|Overall Study||5
10596920|NCT01811563|11753102|FG000|STARTED|Overall Study||25
10596921|NCT01811563|11753103|FG001|STARTED|Overall Study||23
10596922|NCT01811563|11753102|FG000|COMPLETED|Overall Study||20
10596923|NCT01811563|11753103|FG001|COMPLETED|Overall Study||20
10596924|NCT01811563|11753102|FG000|NOT COMPLETED|Overall Study||5
10596925|NCT01811563|11753103|FG001|NOT COMPLETED|Overall Study||3
10596926|NCT01811654|11753111|FG000|STARTED|Overall Study||14
10596927|NCT01811654|11753112|FG001|STARTED|Overall Study||16
10596928|NCT01811654|11753111|FG000|COMPLETED|Overall Study||14
10596929|NCT01811654|11753112|FG001|COMPLETED|Overall Study||16
10596930|NCT01811654|11753111|FG000|NOT COMPLETED|Overall Study||0
10596931|NCT01811654|11753112|FG001|NOT COMPLETED|Overall Study||0
10596932|NCT01811680|11753118|FG000|STARTED|Overall Study||10
10596933|NCT01811680|11753118|FG000|COMPLETED|Overall Study||10
10596934|NCT01811680|11753118|FG000|NOT COMPLETED|Overall Study||0
10596935|NCT01811693|11753126|FG000|STARTED|Overall Study||4
10596936|NCT01811693|11753127|FG001|STARTED|Overall Study||0
10596937|NCT01811693|11753128|FG002|STARTED|Overall Study||0
10596938|NCT01811693|11753126|FG000|COMPLETED|Overall Study||4
10596939|NCT01811693|11753127|FG001|COMPLETED|Overall Study||0
10596940|NCT01811693|11753128|FG002|COMPLETED|Overall Study||0
10596941|NCT01811693|11753126|FG000|NOT COMPLETED|Overall Study||0
10596942|NCT01811693|11753127|FG001|NOT COMPLETED|Overall Study||0
10596943|NCT01811693|11753128|FG002|NOT COMPLETED|Overall Study||0
10596944|NCT01811706|11753132|FG000|STARTED|First Intervention ( 4 Weeks)||10
10596945|NCT01811706|11753133|FG001|STARTED|First Intervention ( 4 Weeks)||10
10596946|NCT01811706|11753132|FG000|COMPLETED|First Intervention ( 4 Weeks)||9
10596947|NCT01811706|11753133|FG001|COMPLETED|First Intervention ( 4 Weeks)||10
10596948|NCT01811706|11753132|FG000|NOT COMPLETED|First Intervention ( 4 Weeks)||1
10596949|NCT01811706|11753133|FG001|NOT COMPLETED|First Intervention ( 4 Weeks)||0
10596950|NCT01811706|11753132|FG000|STARTED|Washout ( 2 Weeks)||9
10596951|NCT01811706|11753133|FG001|STARTED|Washout ( 2 Weeks)||10
10596952|NCT01811706|11753132|FG000|COMPLETED|Washout ( 2 Weeks)||9
10596953|NCT01811706|11753133|FG001|COMPLETED|Washout ( 2 Weeks)||10
10596954|NCT01811706|11753132|FG000|NOT COMPLETED|Washout ( 2 Weeks)||0
10596955|NCT01811706|11753133|FG001|NOT COMPLETED|Washout ( 2 Weeks)||0
10596956|NCT01811706|11753132|FG000|STARTED|Second Intervention (4 Weeks)||9
10596957|NCT01811706|11753133|FG001|STARTED|Second Intervention (4 Weeks)||10
10596958|NCT01811706|11753132|FG000|COMPLETED|Second Intervention (4 Weeks)||9
10596959|NCT01811706|11753133|FG001|COMPLETED|Second Intervention (4 Weeks)||10
10596960|NCT01811706|11753132|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
10596961|NCT01811706|11753133|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
10596962|NCT01811732|11753143|FG000|STARTED|Overall Study||331
10596963|NCT01811732|11753144|FG001|STARTED|Overall Study||329
10596964|NCT01811732|11753143|FG000|COMPLETED|Overall Study||276
10596965|NCT01811732|11753144|FG001|COMPLETED|Overall Study||271
10596966|NCT01811732|11753143|FG000|NOT COMPLETED|Overall Study||55
10596967|NCT01811732|11753144|FG001|NOT COMPLETED|Overall Study||58
10596968|NCT01811875|11753151|FG000|STARTED|Overall Study||7
10596969|NCT01811875|11753151|FG000|COMPLETED|Overall Study||5
10596970|NCT01811875|11753151|FG000|NOT COMPLETED|Overall Study||2
10596971|NCT01811940|11753157|FG000|STARTED|Overall Study||64
10596972|NCT01811940|11753158|FG001|STARTED|Overall Study||63
10596973|NCT01811940|11753157|FG000|COMPLETED|Overall Study||42
10596974|NCT01811940|11753158|FG001|COMPLETED|Overall Study||37
10596975|NCT01811940|11753157|FG000|NOT COMPLETED|Overall Study||22
10596976|NCT01811940|11753158|FG001|NOT COMPLETED|Overall Study||26
10596977|NCT01811953|11753170|FG000|STARTED|Overall Study||6
10596978|NCT01811953|11753171|FG001|STARTED|Overall Study||6
10596979|NCT01811953|11753172|FG002|STARTED|Overall Study||6
10596980|NCT01811953|11753173|FG003|STARTED|Overall Study||6
10596981|NCT01811953|11753174|FG004|STARTED|Overall Study||12
10596982|NCT01811953|11753175|FG005|STARTED|Overall Study||12
10596983|NCT01811953|11753170|FG000|COMPLETED|Overall Study||6
10596984|NCT01811953|11753171|FG001|COMPLETED|Overall Study||6
10596985|NCT01811953|11753172|FG002|COMPLETED|Overall Study||6
10596986|NCT01811953|11753173|FG003|COMPLETED|Overall Study||5
10596987|NCT01811953|11753174|FG004|COMPLETED|Overall Study||11
10596988|NCT01811953|11753175|FG005|COMPLETED|Overall Study||11
10596989|NCT01811953|11753170|FG000|NOT COMPLETED|Overall Study||0
10596990|NCT01811953|11753171|FG001|NOT COMPLETED|Overall Study||0
10596991|NCT01811953|11753172|FG002|NOT COMPLETED|Overall Study||0
10596992|NCT01811953|11753173|FG003|NOT COMPLETED|Overall Study||1
10596993|NCT01811953|11753174|FG004|NOT COMPLETED|Overall Study||1
10596994|NCT01811953|11753175|FG005|NOT COMPLETED|Overall Study||1
10596995|NCT01812005|11753191|FG000|STARTED|Overall Study||1
10596996|NCT01812005|11753192|FG001|STARTED|Overall Study||13
10596997|NCT01812005|11753191|FG000|COMPLETED|Overall Study||1
10596998|NCT01812005|11753192|FG001|COMPLETED|Overall Study||13
10596999|NCT01812005|11753191|FG000|NOT COMPLETED|Overall Study||0
10597000|NCT01812005|11753192|FG001|NOT COMPLETED|Overall Study||0
10597001|NCT01812044|11753201|FG000|STARTED|Overall Study||17
10597002|NCT01812044|11753202|FG001|STARTED|Overall Study||17
10597003|NCT01812044|11753203|FG002|STARTED|Overall Study||16
10597004|NCT01812044|11753201|FG000|COMPLETED|Overall Study||17
10597005|NCT01812044|11753202|FG001|COMPLETED|Overall Study||17
10597006|NCT01812044|11753203|FG002|COMPLETED|Overall Study||16
10597007|NCT01812044|11753201|FG000|NOT COMPLETED|Overall Study||0
10597008|NCT01812044|11753202|FG001|NOT COMPLETED|Overall Study||0
10597009|NCT01812044|11753203|FG002|NOT COMPLETED|Overall Study||0
10597010|NCT01812057|11753213|FG000|STARTED|Overall Study||25
10597011|NCT01812057|11753214|FG001|STARTED|Overall Study||24
10597012|NCT01812057|11753213|FG000|COMPLETED|Overall Study||23
10597013|NCT01812057|11753214|FG001|COMPLETED|Overall Study||24
10597014|NCT01812057|11753213|FG000|NOT COMPLETED|Overall Study||2
10597015|NCT01812057|11753214|FG001|NOT COMPLETED|Overall Study||0
10597016|NCT01812109|11753224|FG000|STARTED|Overall Study||154
10597017|NCT01812109|11753224|FG000|With Torsion|Overall Study||36
10597018|NCT01812109|11753224|FG000|Without Torsion|Overall Study||85
10597019|NCT01812109|11753224|FG000|COMPLETED|Overall Study||121
10597020|NCT01812109|11753224|FG000|NOT COMPLETED|Overall Study||33
10597021|NCT01812473|11753230|FG000|STARTED|Overall Study||22
10597022|NCT01812473|11753231|FG001|STARTED|Overall Study||13
10597023|NCT01812473|11753230|FG000|COMPLETED|Overall Study||22
10597024|NCT01812473|11753231|FG001|COMPLETED|Overall Study||13
10597025|NCT01812473|11753230|FG000|NOT COMPLETED|Overall Study||0
10597026|NCT01812473|11753231|FG001|NOT COMPLETED|Overall Study||0
10597027|NCT01812655|11753240|FG000|STARTED|Overall Study|Virtual Reality-Patients used an interactive VR program during their burn wound care procedure.|9
10597028|NCT01812655|11753241|FG001|STARTED|Overall Study|Passive Distraction-Patients watched a movie during their burn wound care.|11
10597029|NCT01812655|11753242|FG002|STARTED|Overall Study|Nurses provided their usual, standard care throughout the entire burn wound care.|10
10597030|NCT01812655|11753240|FG000|COMPLETED|Overall Study||8
10597031|NCT01812655|11753241|FG001|COMPLETED|Overall Study||10
10597032|NCT01812655|11753242|FG002|COMPLETED|Overall Study||10
10597033|NCT01812655|11753240|FG000|NOT COMPLETED|Overall Study||1
10597034|NCT01812655|11753241|FG001|NOT COMPLETED|Overall Study||1
10597035|NCT01812655|11753242|FG002|NOT COMPLETED|Overall Study||0
10597036|NCT01812668|11753253|FG000|STARTED|Overall Study||20
10597037|NCT01812668|11753253|FG000|COMPLETED|Overall Study||20
10597038|NCT01812668|11753253|FG000|NOT COMPLETED|Overall Study||0
10597039|NCT01812681|11753259|FG000|STARTED|Overall Study||60
10597040|NCT01812681|11753260|FG001|STARTED|Overall Study||24
10597041|NCT01812681|11753259|FG000|COMPLETED|Overall Study||57
10597042|NCT01812681|11753260|FG001|COMPLETED|Overall Study||24
10597043|NCT01812681|11753259|FG000|NOT COMPLETED|Overall Study||3
10597044|NCT01812681|11753260|FG001|NOT COMPLETED|Overall Study||0
10597045|NCT01812707|11753270|FG000|STARTED|Overall Study||25
10597046|NCT01812707|11753271|FG001|STARTED|Overall Study||25
10597047|NCT01812707|11753272|FG002|STARTED|Overall Study||25
10597048|NCT01812707|11753273|FG003|STARTED|Overall Study||25
10597049|NCT01812707|11753270|FG000|Treated|Overall Study||25
10597050|NCT01812707|11753271|FG001|Treated|Overall Study||25
10597051|NCT01812707|11753272|FG002|Treated|Overall Study||25
10597052|NCT01812707|11753273|FG003|Treated|Overall Study||25
10597053|NCT01812707|11753270|FG000|COMPLETED|Overall Study||23
10597054|NCT01812707|11753271|FG001|COMPLETED|Overall Study||25
10597055|NCT01812707|11753272|FG002|COMPLETED|Overall Study||25
10597056|NCT01812707|11753273|FG003|COMPLETED|Overall Study||23
10597057|NCT01812707|11753270|FG000|NOT COMPLETED|Overall Study||2
10597058|NCT01812707|11753271|FG001|NOT COMPLETED|Overall Study||0
10597059|NCT01812707|11753272|FG002|NOT COMPLETED|Overall Study||0
10597060|NCT01812707|11753273|FG003|NOT COMPLETED|Overall Study||2
10597061|NCT01812759|11753287|FG000|STARTED|Overall Study||1
10597062|NCT01812759|11753288|FG001|STARTED|Overall Study||1
10597063|NCT01812759|11753289|FG002|STARTED|Overall Study||1
10597064|NCT01812759|11753287|FG000|COMPLETED|Overall Study||1
10597065|NCT01812759|11753288|FG001|COMPLETED|Overall Study||1
10597066|NCT01812759|11753289|FG002|COMPLETED|Overall Study||0
10597067|NCT01812759|11753287|FG000|NOT COMPLETED|Overall Study||0
10597068|NCT01812759|11753288|FG001|NOT COMPLETED|Overall Study||0
10597069|NCT01812759|11753289|FG002|NOT COMPLETED|Overall Study||1
10597070|NCT01812837|11753300|FG000|STARTED|Overall Study||17
10597071|NCT01812837|11753301|FG001|STARTED|Overall Study||17
10597072|NCT01812837|11753302|FG002|STARTED|Overall Study||17
10597073|NCT01812837|11753300|FG000|COMPLETED|Overall Study||15
10597074|NCT01812837|11753301|FG001|COMPLETED|Overall Study||16
10597075|NCT01812837|11753302|FG002|COMPLETED|Overall Study||17
10597076|NCT01812837|11753300|FG000|NOT COMPLETED|Overall Study||2
10597077|NCT01812837|11753301|FG001|NOT COMPLETED|Overall Study||1
10597078|NCT01812837|11753302|FG002|NOT COMPLETED|Overall Study||0
10597079|NCT01813019|11753312|FG000|STARTED|Overall Study||24
10597080|NCT01813019|11753313|FG001|STARTED|Overall Study||26
10597081|NCT01813019|11753312|FG000|COMPLETED|Overall Study||17
10597082|NCT01813019|11753313|FG001|COMPLETED|Overall Study||20
10597083|NCT01813019|11753312|FG000|NOT COMPLETED|Overall Study||7
10597084|NCT01813019|11753313|FG001|NOT COMPLETED|Overall Study||6
10703770|NCT02586896|11868264|FG001|STARTED|Overall Study||150
10703771|NCT02586896|11868263|FG000|3-Month Follow-up|Overall Study||126
10703772|NCT02586896|11868264|FG001|3-Month Follow-up|Overall Study||123
10703773|NCT02586896|11868263|FG000|COMPLETED|Overall Study||131
10703774|NCT02586896|11868264|FG001|COMPLETED|Overall Study||133
10703775|NCT02586896|11868263|FG000|NOT COMPLETED|Overall Study||19
10703776|NCT02586896|11868264|FG001|NOT COMPLETED|Overall Study||17
10597085|NCT01813058|11753321|FG000|STARTED|Overall Study||60
10597086|NCT01813058|11753322|FG001|STARTED|Overall Study||60
10597087|NCT01813058|11753321|FG000|COMPLETED|Overall Study||55
10597088|NCT01813058|11753322|FG001|COMPLETED|Overall Study||56
10597089|NCT01813058|11753321|FG000|NOT COMPLETED|Overall Study||5
10597090|NCT01813058|11753322|FG001|NOT COMPLETED|Overall Study||4
10597091|NCT01813071|11753337|FG000|STARTED|Overall Study||10
10807875|NCT03885934|11969641|FG001|PCV Dose 1|Overall Study||64
10807876|NCT03885934|11969642|FG002|PCV Dose 1|Overall Study||62
10807877|NCT03885934|11969643|FG003|PCV Dose 1|Overall Study||64
10807878|NCT03885934|11969644|FG004|PCV Dose 1|Overall Study||177
10807879|NCT03885934|11969645|FG005|PCV Dose 1|Overall Study||175
10807880|NCT03885934|11969640|FG000|PCV Dose 2|Overall Study||63
10597092|NCT01813071|11753338|FG001|STARTED|Overall Study||10
10597093|NCT01813071|11753339|FG002|STARTED|Overall Study||10
10597094|NCT01813071|11753340|FG003|STARTED|Overall Study||9
10597095|NCT01813071|11753341|FG004|STARTED|Overall Study||12
10597096|NCT01813071|11753342|FG005|STARTED|Overall Study||12
10597097|NCT01813071|11753343|FG006|STARTED|Overall Study||12
10597098|NCT01813071|11753344|FG007|STARTED|Overall Study||12
10597099|NCT01813071|11753345|FG008|STARTED|Overall Study||16
10597100|NCT01813071|11753337|FG000|COMPLETED|Overall Study||10
10597101|NCT01813071|11753338|FG001|COMPLETED|Overall Study||10
10597102|NCT01813071|11753339|FG002|COMPLETED|Overall Study||10
10597103|NCT01813071|11753340|FG003|COMPLETED|Overall Study||9
10597104|NCT01813071|11753341|FG004|COMPLETED|Overall Study||11
10597105|NCT01813071|11753342|FG005|COMPLETED|Overall Study||5
10597106|NCT01813071|11753343|FG006|COMPLETED|Overall Study||9
10597107|NCT01813071|11753344|FG007|COMPLETED|Overall Study||7
10597108|NCT01813071|11753345|FG008|COMPLETED|Overall Study||13
10597109|NCT01813071|11753337|FG000|NOT COMPLETED|Overall Study||0
10597110|NCT01813071|11753338|FG001|NOT COMPLETED|Overall Study||0
10597111|NCT01813071|11753339|FG002|NOT COMPLETED|Overall Study||0
10597112|NCT01813071|11753340|FG003|NOT COMPLETED|Overall Study||0
10597113|NCT01813071|11753341|FG004|NOT COMPLETED|Overall Study||1
10597114|NCT01813071|11753342|FG005|NOT COMPLETED|Overall Study||7
10597115|NCT01813071|11753343|FG006|NOT COMPLETED|Overall Study||3
10597116|NCT01813071|11753344|FG007|NOT COMPLETED|Overall Study||5
10597117|NCT01813071|11753345|FG008|NOT COMPLETED|Overall Study||3
10597118|NCT01813110|11753379|FG000|STARTED|Overall Study||10
10597119|NCT01813110|11753380|FG001|STARTED|Overall Study||11
10597120|NCT01813110|11753379|FG000|COMPLETED|Overall Study||10
10597121|NCT01813110|11753380|FG001|COMPLETED|Overall Study||10
10597122|NCT01813110|11753379|FG000|NOT COMPLETED|Overall Study||0
10597123|NCT01813110|11753380|FG001|NOT COMPLETED|Overall Study||1
10597124|NCT01813149|11753389|FG000|STARTED|Overall Study||90
10597125|NCT01813149|11753390|FG001|STARTED|Overall Study||38
10597126|NCT01813149|11753389|FG000|COMPLETED|Overall Study||90
10597127|NCT01813149|11753390|FG001|COMPLETED|Overall Study||38
10597128|NCT01813149|11753389|FG000|NOT COMPLETED|Overall Study||0
10597129|NCT01813149|11753390|FG001|NOT COMPLETED|Overall Study||0
10597130|NCT01813214|11753403|FG000|STARTED|Overall Study||3
10597131|NCT01813214|11753404|FG001|STARTED|Overall Study||2
10597132|NCT01813214|11753403|FG000|COMPLETED|Overall Study||3
10597133|NCT01813214|11753404|FG001|COMPLETED|Overall Study||2
10597134|NCT01813214|11753403|FG000|NOT COMPLETED|Overall Study||0
10597135|NCT01813214|11753404|FG001|NOT COMPLETED|Overall Study||0
10597136|NCT01813357|11753412|FG000|STARTED|Overall Study||40
10597137|NCT01813357|11753413|FG001|STARTED|Overall Study||44
10597138|NCT01813357|11753412|FG000|COMPLETED|Overall Study||35
10597139|NCT01813357|11753413|FG001|COMPLETED|Overall Study||38
10597140|NCT01813357|11753412|FG000|NOT COMPLETED|Overall Study||5
10597141|NCT01813357|11753413|FG001|NOT COMPLETED|Overall Study||6
10597142|NCT01813422|11753421|FG000|STARTED|Overall Study||486
10597143|NCT01813422|11753422|FG001|STARTED|Overall Study||484
10703777|NCT02586909|11868270|FG000|STARTED|Overall Study||1099
10703778|NCT02586909|11868270|FG000|COMPLETED|Overall Study||151
10703779|NCT02586909|11868270|FG000|NOT COMPLETED|Overall Study||948
10703780|NCT02586974|11868276|FG000|STARTED|Overall Study||32
10807881|NCT03885934|11969641|FG001|PCV Dose 2|Overall Study||64
10703781|NCT02586974|11868277|FG001|STARTED|Overall Study||32
10807882|NCT03885934|11969642|FG002|PCV Dose 2|Overall Study||62
10807883|NCT03885934|11969643|FG003|PCV Dose 2|Overall Study||64
10597144|NCT01813422|11753421|FG000|Received Treatment|Overall Study||484
10597145|NCT01813422|11753422|FG001|Received Treatment|Overall Study||484
10597146|NCT01813422|11753421|FG000|COMPLETED|Overall Study||466
10597147|NCT01813422|11753422|FG001|COMPLETED|Overall Study||468
10597148|NCT01813422|11753421|FG000|NOT COMPLETED|Overall Study||20
10597149|NCT01813422|11753422|FG001|NOT COMPLETED|Overall Study||16
10597150|NCT01813474|11753431|FG000|STARTED|Overall Study||4
10597151|NCT01813474|11753432|FG001|STARTED|Overall Study||7
10597152|NCT01813474|11753433|FG002|STARTED|Overall Study||12
10597153|NCT01813474|11753431|FG000|COMPLETED|Overall Study|ongoing study at final data cut off|1
10597154|NCT01813474|11753432|FG001|COMPLETED|Overall Study||0
10597155|NCT01813474|11753433|FG002|COMPLETED|Overall Study|ongoing study at final data cut off|1
10597156|NCT01813474|11753431|FG000|NOT COMPLETED|Overall Study||3
10597157|NCT01813474|11753432|FG001|NOT COMPLETED|Overall Study||7
10597158|NCT01813474|11753433|FG002|NOT COMPLETED|Overall Study||11
10597159|NCT01813721|11753442|FG000|STARTED|Overall Study|Indicates number of participants enrolled|1007
10597160|NCT01813721|11753442|FG000|COMPLETED|Overall Study||943
10597161|NCT01813721|11753442|FG000|NOT COMPLETED|Overall Study||64
10597162|NCT01813734|11753464|FG000|STARTED|Overall Study||9
10597163|NCT01813734|11753464|FG000|COMPLETED|Overall Study||9
10597164|NCT01813734|11753464|FG000|NOT COMPLETED|Overall Study||0
10597165|NCT01813890|11753471|FG000|STARTED|Overall Study||20
10597166|NCT01813890|11753472|FG001|STARTED|Overall Study||21
10597167|NCT01813890|11753473|FG002|STARTED|Overall Study||19
10597168|NCT01813890|11753471|FG000|COMPLETED|Overall Study||11
10597169|NCT01813890|11753472|FG001|COMPLETED|Overall Study||17
10597170|NCT01813890|11753473|FG002|COMPLETED|Overall Study||13
10597171|NCT01813890|11753471|FG000|NOT COMPLETED|Overall Study||9
10597172|NCT01813890|11753472|FG001|NOT COMPLETED|Overall Study||4
10597173|NCT01813890|11753473|FG002|NOT COMPLETED|Overall Study||6
10597174|NCT01814007|11753481|FG000|STARTED|Overall Study||35
10597175|NCT01814007|11753481|FG000|COMPLETED|Overall Study||34
10597176|NCT01814007|11753481|FG000|NOT COMPLETED|Overall Study||1
10597177|NCT01814046|11753488|FG000|STARTED|Drug Administration||22
10597178|NCT01814046|11753489|FG001|STARTED|Drug Administration||2
10597179|NCT01814046|11753490|FG002|STARTED|Drug Administration||0
10597180|NCT01814046|11753488|FG000|COMPLETED|Drug Administration||21
10597181|NCT01814046|11753489|FG001|COMPLETED|Drug Administration||2
10597182|NCT01814046|11753490|FG002|COMPLETED|Drug Administration||0
10597183|NCT01814046|11753488|FG000|NOT COMPLETED|Drug Administration||1
10597184|NCT01814046|11753489|FG001|NOT COMPLETED|Drug Administration||0
10597185|NCT01814046|11753490|FG002|NOT COMPLETED|Drug Administration||0
10597186|NCT01814046|11753488|FG000|STARTED|Retreatment||0
10597187|NCT01814046|11753489|FG001|STARTED|Retreatment||0
10597188|NCT01814046|11753490|FG002|STARTED|Retreatment||3
10597189|NCT01814046|11753488|FG000|COMPLETED|Retreatment||0
10597190|NCT01814046|11753489|FG001|COMPLETED|Retreatment||0
10597191|NCT01814046|11753490|FG002|COMPLETED|Retreatment||3
10597192|NCT01814046|11753488|FG000|NOT COMPLETED|Retreatment||0
10597193|NCT01814046|11753489|FG001|NOT COMPLETED|Retreatment||0
10597194|NCT01814046|11753490|FG002|NOT COMPLETED|Retreatment||0
10597195|NCT01814072|11753529|FG000|STARTED|Overall Study||18
10597196|NCT01814072|11753530|FG001|STARTED|Overall Study||18
10597197|NCT01814072|11753531|FG002|STARTED|Overall Study||18
10597198|NCT01814072|11753532|FG003|STARTED|Overall Study||18
10597199|NCT01814072|11753533|FG004|STARTED|Overall Study||18
10597200|NCT01814072|11753534|FG005|STARTED|Overall Study||18
10597201|NCT01814072|11753535|FG006|STARTED|Overall Study||18
10597202|NCT01814072|11753536|FG007|STARTED|Overall Study||18
10597203|NCT01814072|11753537|FG008|STARTED|Overall Study||19
10597204|NCT01814072|11753538|FG009|STARTED|Overall Study||18
10597205|NCT01814072|11753539|FG010|STARTED|Overall Study||18
10597206|NCT01814072|11753540|FG011|STARTED|Overall Study||18
10597207|NCT01814072|11753541|FG012|STARTED|Overall Study||18
10597208|NCT01814072|11753542|FG013|STARTED|Overall Study||18
10597209|NCT01814072|11753543|FG014|STARTED|Overall Study||18
10597210|NCT01814072|11753544|FG015|STARTED|Overall Study||18
10597211|NCT01814072|11753545|FG016|STARTED|Overall Study||17
10597212|NCT01814072|11753546|FG017|STARTED|Overall Study||18
10597213|NCT01814072|11753547|FG018|STARTED|Overall Study||17
10597214|NCT01814072|11753548|FG019|STARTED|Overall Study||16
10597215|NCT01814072|11753549|FG020|STARTED|Overall Study||16
10597216|NCT01814072|11753550|FG021|STARTED|Overall Study||17
10597217|NCT01814072|11753551|FG022|STARTED|Overall Study||17
10597218|NCT01814072|11753552|FG023|STARTED|Overall Study||18
10597219|NCT01814072|11753553|FG024|STARTED|Overall Study||17
10597220|NCT01814072|11753554|FG025|STARTED|Overall Study||16
10597221|NCT01814072|11753555|FG026|STARTED|Overall Study||18
10597222|NCT01814072|11753556|FG027|STARTED|Overall Study||17
10597223|NCT01814072|11753557|FG028|STARTED|Overall Study||18
10597224|NCT01814072|11753558|FG029|STARTED|Overall Study||17
10597225|NCT01814072|11753559|FG030|STARTED|Overall Study||17
10597226|NCT01814072|11753560|FG031|STARTED|Overall Study||17
10597227|NCT01814072|11753529|FG000|3-mo Visit|Overall Study||15
10597228|NCT01814072|11753530|FG001|3-mo Visit|Overall Study||18
10597229|NCT01814072|11753531|FG002|3-mo Visit|Overall Study||16
10597230|NCT01814072|11753532|FG003|3-mo Visit|Overall Study||18
10597231|NCT01814072|11753533|FG004|3-mo Visit|Overall Study||15
10597232|NCT01814072|11753534|FG005|3-mo Visit|Overall Study||15
10597233|NCT01814072|11753535|FG006|3-mo Visit|Overall Study||16
10597234|NCT01814072|11753536|FG007|3-mo Visit|Overall Study||18
10597235|NCT01814072|11753537|FG008|3-mo Visit|Overall Study||18
10597236|NCT01814072|11753538|FG009|3-mo Visit|Overall Study||15
10597237|NCT01814072|11753539|FG010|3-mo Visit|Overall Study||18
10597238|NCT01814072|11753540|FG011|3-mo Visit|Overall Study||17
10597239|NCT01814072|11753541|FG012|3-mo Visit|Overall Study||16
10597240|NCT01814072|11753542|FG013|3-mo Visit|Overall Study||16
10597241|NCT01814072|11753543|FG014|3-mo Visit|Overall Study||16
10597242|NCT01814072|11753544|FG015|3-mo Visit|Overall Study||16
10597243|NCT01814072|11753545|FG016|3-mo Visit|Overall Study||16
10597244|NCT01814072|11753546|FG017|3-mo Visit|Overall Study||16
10597245|NCT01814072|11753547|FG018|3-mo Visit|Overall Study||14
10597246|NCT01814072|11753548|FG019|3-mo Visit|Overall Study||13
10597247|NCT01814072|11753549|FG020|3-mo Visit|Overall Study||15
10597248|NCT01814072|11753550|FG021|3-mo Visit|Overall Study||17
10597249|NCT01814072|11753551|FG022|3-mo Visit|Overall Study||15
10597250|NCT01814072|11753552|FG023|3-mo Visit|Overall Study||18
10597251|NCT01814072|11753553|FG024|3-mo Visit|Overall Study||13
10597252|NCT01814072|11753554|FG025|3-mo Visit|Overall Study||14
10597253|NCT01814072|11753555|FG026|3-mo Visit|Overall Study||17
10597254|NCT01814072|11753556|FG027|3-mo Visit|Overall Study||14
10597255|NCT01814072|11753557|FG028|3-mo Visit|Overall Study||15
10597256|NCT01814072|11753558|FG029|3-mo Visit|Overall Study||16
10597257|NCT01814072|11753559|FG030|3-mo Visit|Overall Study||16
10597258|NCT01814072|11753560|FG031|3-mo Visit|Overall Study||17
10597259|NCT01814072|11753529|FG000|Intent to Treat|Overall Study||4
10597260|NCT01814072|11753530|FG001|Intent to Treat|Overall Study||2
10597261|NCT01814072|11753531|FG002|Intent to Treat|Overall Study||3
10597262|NCT01814072|11753532|FG003|Intent to Treat|Overall Study||0
10597263|NCT01814072|11753533|FG004|Intent to Treat|Overall Study||4
10597264|NCT01814072|11753534|FG005|Intent to Treat|Overall Study||6
10703782|NCT02586974|11868276|FG000|COMPLETED|Overall Study||32
10703783|NCT02586974|11868277|FG001|COMPLETED|Overall Study||32
10703784|NCT02586974|11868276|FG000|NOT COMPLETED|Overall Study||0
10597265|NCT01814072|11753535|FG006|Intent to Treat|Overall Study||4
10597266|NCT01814072|11753536|FG007|Intent to Treat|Overall Study||1
10597267|NCT01814072|11753537|FG008|Intent to Treat|Overall Study||3
10597268|NCT01814072|11753538|FG009|Intent to Treat|Overall Study||5
10597269|NCT01814072|11753539|FG010|Intent to Treat|Overall Study||1
10597270|NCT01814072|11753540|FG011|Intent to Treat|Overall Study||2
10597271|NCT01814072|11753541|FG012|Intent to Treat|Overall Study||3
10597272|NCT01814072|11753542|FG013|Intent to Treat|Overall Study||2
10597273|NCT01814072|11753543|FG014|Intent to Treat|Overall Study||3
10597274|NCT01814072|11753544|FG015|Intent to Treat|Overall Study||2
10597275|NCT01814072|11753545|FG016|Intent to Treat|Overall Study||3
10597276|NCT01814072|11753546|FG017|Intent to Treat|Overall Study||1
10597277|NCT01814072|11753547|FG018|Intent to Treat|Overall Study||3
10597278|NCT01814072|11753548|FG019|Intent to Treat|Overall Study||5
10597279|NCT01814072|11753549|FG020|Intent to Treat|Overall Study||2
10597280|NCT01814072|11753550|FG021|Intent to Treat|Overall Study||1
10597281|NCT01814072|11753551|FG022|Intent to Treat|Overall Study||4
10597282|NCT01814072|11753552|FG023|Intent to Treat|Overall Study||1
10597283|NCT01814072|11753553|FG024|Intent to Treat|Overall Study||6
10597284|NCT01814072|11753554|FG025|Intent to Treat|Overall Study||2
10597285|NCT01814072|11753555|FG026|Intent to Treat|Overall Study||2
10597286|NCT01814072|11753556|FG027|Intent to Treat|Overall Study||4
10597287|NCT01814072|11753557|FG028|Intent to Treat|Overall Study||4
10597288|NCT01814072|11753558|FG029|Intent to Treat|Overall Study||3
10597289|NCT01814072|11753559|FG030|Intent to Treat|Overall Study||2
10597290|NCT01814072|11753560|FG031|Intent to Treat|Overall Study||0
10597291|NCT01814072|11753529|FG000|COMPLETED|Overall Study||14
10597292|NCT01814072|11753530|FG001|COMPLETED|Overall Study||16
10597293|NCT01814072|11753531|FG002|COMPLETED|Overall Study||15
10597294|NCT01814072|11753532|FG003|COMPLETED|Overall Study||18
10597295|NCT01814072|11753533|FG004|COMPLETED|Overall Study||14
10597296|NCT01814072|11753534|FG005|COMPLETED|Overall Study||12
10597297|NCT01814072|11753535|FG006|COMPLETED|Overall Study||14
10597298|NCT01814072|11753536|FG007|COMPLETED|Overall Study||17
10597299|NCT01814072|11753537|FG008|COMPLETED|Overall Study||16
10597300|NCT01814072|11753538|FG009|COMPLETED|Overall Study||13
10597301|NCT01814072|11753539|FG010|COMPLETED|Overall Study||17
10597302|NCT01814072|11753540|FG011|COMPLETED|Overall Study||16
10597303|NCT01814072|11753541|FG012|COMPLETED|Overall Study||15
10597304|NCT01814072|11753542|FG013|COMPLETED|Overall Study||16
10597305|NCT01814072|11753543|FG014|COMPLETED|Overall Study||15
10597306|NCT01814072|11753544|FG015|COMPLETED|Overall Study||16
10597307|NCT01814072|11753545|FG016|COMPLETED|Overall Study||14
10597308|NCT01814072|11753546|FG017|COMPLETED|Overall Study||17
10597309|NCT01814072|11753547|FG018|COMPLETED|Overall Study||14
10597310|NCT01814072|11753548|FG019|COMPLETED|Overall Study||11
10597311|NCT01814072|11753549|FG020|COMPLETED|Overall Study||14
10597312|NCT01814072|11753550|FG021|COMPLETED|Overall Study||16
10597313|NCT01814072|11753551|FG022|COMPLETED|Overall Study||13
10703785|NCT02586974|11868277|FG001|NOT COMPLETED|Overall Study||0
10703786|NCT02587065|11868285|FG000|STARTED|Overall Study||193
10703787|NCT02587065|11868285|FG000|COMPLETED|Overall Study||166
10703788|NCT02587065|11868285|FG000|NOT COMPLETED|Overall Study||27
10703789|NCT02587117|11868291|FG000|STARTED|Overall Study||13
10597314|NCT01814072|11753552|FG023|COMPLETED|Overall Study||17
10597315|NCT01814072|11753553|FG024|COMPLETED|Overall Study||11
10597316|NCT01814072|11753554|FG025|COMPLETED|Overall Study||14
10597317|NCT01814072|11753555|FG026|COMPLETED|Overall Study||16
10597318|NCT01814072|11753556|FG027|COMPLETED|Overall Study||13
10597319|NCT01814072|11753557|FG028|COMPLETED|Overall Study||14
10597320|NCT01814072|11753558|FG029|COMPLETED|Overall Study||14
10597321|NCT01814072|11753559|FG030|COMPLETED|Overall Study||15
10597322|NCT01814072|11753560|FG031|COMPLETED|Overall Study||17
10597323|NCT01814072|11753529|FG000|NOT COMPLETED|Overall Study||4
10597324|NCT01814072|11753530|FG001|NOT COMPLETED|Overall Study||2
10597325|NCT01814072|11753531|FG002|NOT COMPLETED|Overall Study||3
10597326|NCT01814072|11753532|FG003|NOT COMPLETED|Overall Study||0
10597327|NCT01814072|11753533|FG004|NOT COMPLETED|Overall Study||4
10597328|NCT01814072|11753534|FG005|NOT COMPLETED|Overall Study||6
10597329|NCT01814072|11753535|FG006|NOT COMPLETED|Overall Study||4
10597330|NCT01814072|11753536|FG007|NOT COMPLETED|Overall Study||1
10597331|NCT01814072|11753537|FG008|NOT COMPLETED|Overall Study||3
10597332|NCT01814072|11753538|FG009|NOT COMPLETED|Overall Study||5
10597333|NCT01814072|11753539|FG010|NOT COMPLETED|Overall Study||1
10597334|NCT01814072|11753540|FG011|NOT COMPLETED|Overall Study||2
10597335|NCT01814072|11753541|FG012|NOT COMPLETED|Overall Study||3
10597336|NCT01814072|11753542|FG013|NOT COMPLETED|Overall Study||2
10597337|NCT01814072|11753543|FG014|NOT COMPLETED|Overall Study||3
10597338|NCT01814072|11753544|FG015|NOT COMPLETED|Overall Study||2
10597339|NCT01814072|11753545|FG016|NOT COMPLETED|Overall Study||3
10597340|NCT01814072|11753546|FG017|NOT COMPLETED|Overall Study||1
10597341|NCT01814072|11753547|FG018|NOT COMPLETED|Overall Study||3
10597342|NCT01814072|11753548|FG019|NOT COMPLETED|Overall Study||5
10597343|NCT01814072|11753549|FG020|NOT COMPLETED|Overall Study||2
10597344|NCT01814072|11753550|FG021|NOT COMPLETED|Overall Study||1
10597345|NCT01814072|11753551|FG022|NOT COMPLETED|Overall Study||4
10597346|NCT01814072|11753552|FG023|NOT COMPLETED|Overall Study||1
10597347|NCT01814072|11753553|FG024|NOT COMPLETED|Overall Study||6
10597348|NCT01814072|11753554|FG025|NOT COMPLETED|Overall Study||2
10597349|NCT01814072|11753555|FG026|NOT COMPLETED|Overall Study||2
10597350|NCT01814072|11753556|FG027|NOT COMPLETED|Overall Study||4
10597351|NCT01814072|11753557|FG028|NOT COMPLETED|Overall Study||4
10597352|NCT01814072|11753558|FG029|NOT COMPLETED|Overall Study||3
10597353|NCT01814072|11753559|FG030|NOT COMPLETED|Overall Study||2
10597354|NCT01814072|11753560|FG031|NOT COMPLETED|Overall Study||0
10597355|NCT01814137|11753602|FG000|STARTED|Overall Study||20
10597356|NCT01814137|11753603|FG001|STARTED|Overall Study||20
10597357|NCT01814137|11753602|FG000|COMPLETED|Overall Study||15
10597358|NCT01814137|11753603|FG001|COMPLETED|Overall Study||15
10597359|NCT01814137|11753602|FG000|NOT COMPLETED|Overall Study||5
10597360|NCT01814137|11753603|FG001|NOT COMPLETED|Overall Study||5
10597361|NCT01814241|11753609|FG000|STARTED|Overall Study||20
10597362|NCT01814241|11753609|FG000|COMPLETED|Overall Study||16
10597363|NCT01814241|11753609|FG000|NOT COMPLETED|Overall Study||4
10597364|NCT01814332|11753616|FG000|STARTED|Overall Study||63
10597365|NCT01814332|11753617|FG001|STARTED|Overall Study||65
10597366|NCT01814332|11753616|FG000|COMPLETED|Overall Study||47
10597367|NCT01814332|11753617|FG001|COMPLETED|Overall Study||49
10597368|NCT01814332|11753616|FG000|NOT COMPLETED|Overall Study||16
10597369|NCT01814332|11753617|FG001|NOT COMPLETED|Overall Study||16
10597370|NCT01814371|11753625|FG000|STARTED|Overall Study||248
10597371|NCT01814371|11753626|FG001|STARTED|Overall Study||226
10597372|NCT01814371|11753625|FG000|COMPLETED|Overall Study||218
10597373|NCT01814371|11753626|FG001|COMPLETED|Overall Study||199
10597374|NCT01814371|11753625|FG000|NOT COMPLETED|Overall Study||30
10597375|NCT01814371|11753626|FG001|NOT COMPLETED|Overall Study||27
10597376|NCT01814397|11753635|FG000|STARTED|Overall Study||50
10597377|NCT01814397|11753635|FG000|3 Month Evaluation|Overall Study||43
10597378|NCT01814397|11753635|FG000|COMPLETED|Overall Study||36
10597379|NCT01814397|11753635|FG000|NOT COMPLETED|Overall Study||14
10597380|NCT01814553|11753641|FG000|STARTED|Overall Study||18
10597381|NCT01814553|11753642|FG001|STARTED|Overall Study||22
10597382|NCT01814553|11753641|FG000|COMPLETED|Overall Study||0
10597383|NCT01814553|11753642|FG001|COMPLETED|Overall Study||0
10597384|NCT01814553|11753641|FG000|NOT COMPLETED|Overall Study||18
10597385|NCT01814553|11753642|FG001|NOT COMPLETED|Overall Study||22
10597386|NCT01814670|11753648|FG000|STARTED|Overall Study||185
10597387|NCT01814670|11753648|FG000|COMPLETED|Overall Study||173
10597388|NCT01814670|11753648|FG000|NOT COMPLETED|Overall Study||12
10597389|NCT01814696|11753654|FG000|STARTED|Overall Study||15
10597390|NCT01814696|11753655|FG001|STARTED|Overall Study||11
10597391|NCT01814696|11753654|FG000|COMPLETED|Overall Study||13
10597392|NCT01814696|11753655|FG001|COMPLETED|Overall Study||11
10597393|NCT01814696|11753654|FG000|NOT COMPLETED|Overall Study||2
10597394|NCT01814696|11753655|FG001|NOT COMPLETED|Overall Study||0
10597395|NCT01814748|11753663|FG000|STARTED|Overall Study||102
10597396|NCT01814748|11753664|FG001|STARTED|Overall Study||101
10597397|NCT01814748|11753663|FG000|COMPLETED|Overall Study||94
10597398|NCT01814748|11753664|FG001|COMPLETED|Overall Study||94
10597399|NCT01814748|11753663|FG000|NOT COMPLETED|Overall Study||8
10597400|NCT01814748|11753664|FG001|NOT COMPLETED|Overall Study||7
10597401|NCT01814761|11753672|FG000|STARTED|Overall Study||42
10597402|NCT01814761|11753673|FG001|STARTED|Overall Study||270
10597403|NCT01814761|11753672|FG000|COMPLETED|Overall Study||34
10597404|NCT01814761|11753673|FG001|COMPLETED|Overall Study||240
10597405|NCT01814761|11753672|FG000|NOT COMPLETED|Overall Study||8
10597406|NCT01814761|11753673|FG001|NOT COMPLETED|Overall Study||30
10597407|NCT01814774|11753679|FG000|STARTED|Overall Study||48
10597408|NCT01814774|11753679|FG000|COMPLETED|Overall Study||48
10597409|NCT01814774|11753679|FG000|NOT COMPLETED|Overall Study||0
10597410|NCT01814787|11753687|FG000|STARTED|Overall Study||685
10597411|NCT01814787|11753688|FG001|STARTED|Overall Study||684
10597412|NCT01814787|11753687|FG000|COMPLETED|Overall Study||685
10597413|NCT01814787|11753688|FG001|COMPLETED|Overall Study||684
10597414|NCT01814787|11753687|FG000|NOT COMPLETED|Overall Study||0
10597415|NCT01814787|11753688|FG001|NOT COMPLETED|Overall Study||0
10597416|NCT01814800|11753694|FG000|STARTED|Overall Study||59
10597417|NCT01814800|11753694|FG000|COMPLETED|Overall Study||54
10597418|NCT01814800|11753694|FG000|NOT COMPLETED|Overall Study||5
10597419|NCT01814813|11753701|FG000|STARTED|Overall Study||29
10597420|NCT01814813|11753702|FG001|STARTED|Overall Study||30
10597421|NCT01814813|11753703|FG002|STARTED|Overall Study||31
10597422|NCT01814813|11753701|FG000|COMPLETED|Overall Study||29
10597423|NCT01814813|11753702|FG001|COMPLETED|Overall Study||30
10597424|NCT01814813|11753703|FG002|COMPLETED|Overall Study||31
10597425|NCT01814813|11753701|FG000|NOT COMPLETED|Overall Study||0
10597426|NCT01814813|11753702|FG001|NOT COMPLETED|Overall Study||0
10597427|NCT01814813|11753703|FG002|NOT COMPLETED|Overall Study||0
10597428|NCT01814878|11753713|FG000|STARTED|Overall Study||162
10597429|NCT01814878|11753714|FG001|STARTED|Overall Study||158
10597430|NCT01814878|11753713|FG000|COMPLETED|Overall Study||116
10597431|NCT01814878|11753714|FG001|COMPLETED|Overall Study||128
10597432|NCT01814878|11753713|FG000|NOT COMPLETED|Overall Study||46
10597433|NCT01814878|11753714|FG001|NOT COMPLETED|Overall Study||30
10597434|NCT01815008|11753720|FG000|STARTED|Overall Study|Had difficulty in completing enrollment|19
10597435|NCT01815008|11753720|FG000|COMPLETED|Overall Study|transcriptomic data was available on 9 participants only|15
10597436|NCT01815008|11753720|FG000|NOT COMPLETED|Overall Study||4
10597437|NCT01815099|11753726|FG000|STARTED|Overall Study||4
10597438|NCT01815099|11753726|FG000|Began rTMS Treatment|Overall Study||3
10597439|NCT01815099|11753726|FG000|COMPLETED|Overall Study||2
10597440|NCT01815099|11753726|FG000|NOT COMPLETED|Overall Study||2
10597441|NCT01815138|11753733|FG000|STARTED|Overall Study||34
10597442|NCT01815138|11753734|FG001|STARTED|Overall Study||37
10597443|NCT01815138|11753733|FG000|COMPLETED|Overall Study||26
10597444|NCT01815138|11753734|FG001|COMPLETED|Overall Study||31
10597445|NCT01815138|11753733|FG000|NOT COMPLETED|Overall Study||8
10597446|NCT01815138|11753734|FG001|NOT COMPLETED|Overall Study||6
10597447|NCT01815229|11753743|FG000|STARTED|Overall Study||13
10597448|NCT01815229|11753744|FG001|STARTED|Overall Study||18
10597449|NCT01815229|11753745|FG002|STARTED|Overall Study||51
10597450|NCT01815229|11753743|FG000|COMPLETED|Overall Study||13
10597451|NCT01815229|11753744|FG001|COMPLETED|Overall Study||18
10597452|NCT01815229|11753745|FG002|COMPLETED|Overall Study||0
10597453|NCT01815229|11753743|FG000|NOT COMPLETED|Overall Study||0
10597454|NCT01815229|11753744|FG001|NOT COMPLETED|Overall Study||0
10597455|NCT01815229|11753745|FG002|NOT COMPLETED|Overall Study||51
10597456|NCT01815333|11753752|FG000|STARTED|Overall Study||10
10597457|NCT01815333|11753752|FG000|COMPLETED|Overall Study||10
10597458|NCT01815333|11753752|FG000|NOT COMPLETED|Overall Study||0
10597459|NCT01815424|11753759|FG000|STARTED|Week 0 to 16||90
10597460|NCT01815424|11753760|FG001|STARTED|Week 0 to 16||88
10597461|NCT01815424|11753761|FG002|STARTED|Week 0 to 16||88
10597462|NCT01815424|11753762|FG003|STARTED|Week 0 to 16||0
10597463|NCT01815424|11753763|FG004|STARTED|Week 0 to 16||0
10597464|NCT01815424|11753759|FG000|COMPLETED|Week 0 to 16||83
10597465|NCT01815424|11753760|FG001|COMPLETED|Week 0 to 16||84
10597466|NCT01815424|11753761|FG002|COMPLETED|Week 0 to 16||77
10597467|NCT01815424|11753762|FG003|COMPLETED|Week 0 to 16||0
10597468|NCT01815424|11753763|FG004|COMPLETED|Week 0 to 16||0
10597469|NCT01815424|11753759|FG000|NOT COMPLETED|Week 0 to 16||7
10597470|NCT01815424|11753760|FG001|NOT COMPLETED|Week 0 to 16||4
10597471|NCT01815424|11753761|FG002|NOT COMPLETED|Week 0 to 16||11
10597472|NCT01815424|11753762|FG003|NOT COMPLETED|Week 0 to 16||0
10597473|NCT01815424|11753763|FG004|NOT COMPLETED|Week 0 to 16||0
10597474|NCT01815424|11753759|FG000|STARTED|Week 16 to 52||83
10597475|NCT01815424|11753760|FG001|STARTED|Week 16 to 52||84
10597476|NCT01815424|11753761|FG002|STARTED|Week 16 to 52||0
10597477|NCT01815424|11753762|FG003|STARTED|Week 16 to 52||38
10597478|NCT01815424|11753763|FG004|STARTED|Week 16 to 52||39
10597479|NCT01815424|11753759|FG000|COMPLETED|Week 16 to 52||81
10597480|NCT01815424|11753760|FG001|COMPLETED|Week 16 to 52||79
10597481|NCT01815424|11753761|FG002|COMPLETED|Week 16 to 52||0
10597482|NCT01815424|11753762|FG003|COMPLETED|Week 16 to 52||35
10597483|NCT01815424|11753763|FG004|COMPLETED|Week 16 to 52||36
10597484|NCT01815424|11753759|FG000|NOT COMPLETED|Week 16 to 52||2
10597485|NCT01815424|11753760|FG001|NOT COMPLETED|Week 16 to 52||5
10597486|NCT01815424|11753761|FG002|NOT COMPLETED|Week 16 to 52||0
10597487|NCT01815424|11753762|FG003|NOT COMPLETED|Week 16 to 52||3
10597488|NCT01815424|11753763|FG004|NOT COMPLETED|Week 16 to 52||3
10597489|NCT01815502|11753778|FG000|STARTED|Overall Study||10
10597490|NCT01815502|11753779|FG001|STARTED|Overall Study||10
10597491|NCT01815502|11753778|FG000|COMPLETED|Overall Study||10
10597492|NCT01815502|11753779|FG001|COMPLETED|Overall Study||10
10597493|NCT01815502|11753778|FG000|NOT COMPLETED|Overall Study||0
10703790|NCT02587117|11868292|FG001|STARTED|Overall Study||15
10703791|NCT02587117|11868291|FG000|COMPLETED|Overall Study||13
10703792|NCT02587117|11868292|FG001|COMPLETED|Overall Study||15
10703793|NCT02587117|11868291|FG000|NOT COMPLETED|Overall Study||0
10597494|NCT01815502|11753779|FG001|NOT COMPLETED|Overall Study||0
10597495|NCT01815515|11753788|FG000|STARTED|Overall Study||17
10597496|NCT01815515|11753788|FG000|COMPLETED|Overall Study||17
10597497|NCT01815515|11753788|FG000|NOT COMPLETED|Overall Study||0
10597498|NCT01815645|11753794|FG000|STARTED|Overall Study||32
10597499|NCT01815645|11753795|FG001|STARTED|Overall Study||33
10703794|NCT02587117|11868292|FG001|NOT COMPLETED|Overall Study||0
10703795|NCT02587143|11868300|FG000|STARTED|Overall Study||66
10703796|NCT02587143|11868301|FG001|STARTED|Overall Study||60
10703797|NCT02587143|11868300|FG000|COMPLETED|Overall Study||65
10597500|NCT01815645|11753794|FG000|COMPLETED|Overall Study||32
10597501|NCT01815645|11753795|FG001|COMPLETED|Overall Study||33
10597502|NCT01815645|11753794|FG000|NOT COMPLETED|Overall Study||0
10597503|NCT01815645|11753795|FG001|NOT COMPLETED|Overall Study||0
10597504|NCT01815671|11753805|FG000|STARTED|Overall Study||88
10597505|NCT01815671|11753806|FG001|STARTED|Overall Study||85
10597506|NCT01815671|11753805|FG000|COMPLETED|Overall Study||88
10597507|NCT01815671|11753806|FG001|COMPLETED|Overall Study||85
10597508|NCT01815671|11753805|FG000|NOT COMPLETED|Overall Study||0
10597509|NCT01815671|11753806|FG001|NOT COMPLETED|Overall Study||0
10597510|NCT01815736|11753814|FG000|STARTED|Randomized Treatment Phase-Up to Week 96||963
10597511|NCT01815736|11753815|FG001|STARTED|Randomized Treatment Phase-Up to Week 96||480
10597512|NCT01815736|11753814|FG000|COMPLETED|Randomized Treatment Phase-Up to Week 96||914
10597513|NCT01815736|11753815|FG001|COMPLETED|Randomized Treatment Phase-Up to Week 96||445
10597514|NCT01815736|11753814|FG000|NOT COMPLETED|Randomized Treatment Phase-Up to Week 96||49
10597515|NCT01815736|11753815|FG001|NOT COMPLETED|Randomized Treatment Phase-Up to Week 96||35
10597516|NCT01815736|11753814|FG000|STARTED|Extension Treatment Phase- After Week 96|9 participants who completed the Randomized Treatment Phase did not continue in the Extension E/C/F/TAF Treatment Phase.|905
10597517|NCT01815736|11753815|FG001|STARTED|Extension Treatment Phase- After Week 96|21 participants who completed the Randomized Treatment Phase did not continue in the Extension E/C/F/TAF Treatment Phase.|424
10597518|NCT01815736|11753814|FG000|COMPLETED|Extension Treatment Phase- After Week 96||854
10597519|NCT01815736|11753815|FG001|COMPLETED|Extension Treatment Phase- After Week 96||398
10597520|NCT01815736|11753814|FG000|NOT COMPLETED|Extension Treatment Phase- After Week 96||51
10597521|NCT01815736|11753815|FG001|NOT COMPLETED|Extension Treatment Phase- After Week 96||26
10597522|NCT01815840|11753825|FG000|STARTED|Overall Study||116
10597523|NCT01815840|11753826|FG001|STARTED|Overall Study||113
10597524|NCT01815840|11753825|FG000|COMPLETED|Overall Study||57
10597525|NCT01815840|11753826|FG001|COMPLETED|Overall Study||50
10597526|NCT01815840|11753825|FG000|NOT COMPLETED|Overall Study||59
10597527|NCT01815840|11753826|FG001|NOT COMPLETED|Overall Study||63
10597528|NCT01815918|11753834|FG000|STARTED|Overall Study||30
10597529|NCT01815918|11753835|FG001|STARTED|Overall Study||30
10597530|NCT01815918|11753834|FG000|COMPLETED|Overall Study||12
10597531|NCT01815918|11753835|FG001|COMPLETED|Overall Study||11
10597532|NCT01815918|11753834|FG000|NOT COMPLETED|Overall Study||18
10597533|NCT01815918|11753835|FG001|NOT COMPLETED|Overall Study||19
10597534|NCT01816048|11753845|FG000|STARTED|Overall Study||8
10597535|NCT01816048|11753845|FG000|COMPLETED|Overall Study||2
10597536|NCT01816048|11753845|FG000|NOT COMPLETED|Overall Study||6
10597537|NCT01816061|11753852|FG000|STARTED|Overall Study||40
10597538|NCT01816061|11753853|FG001|STARTED|Overall Study||51
10597539|NCT01816061|11753852|FG000|COMPLETED|Overall Study||27
10597540|NCT01816061|11753853|FG001|COMPLETED|Overall Study||27
10597541|NCT01816061|11753852|FG000|NOT COMPLETED|Overall Study||13
10597542|NCT01816061|11753853|FG001|NOT COMPLETED|Overall Study||24
10597543|NCT01816074|11753863|FG000|STARTED|Phase 1||11
10597544|NCT01816074|11753864|FG001|STARTED|Phase 1||9
10597545|NCT01816074|11753865|FG002|STARTED|Phase 1||11
10597546|NCT01816074|11753866|FG003|STARTED|Phase 1||10
10597547|NCT01816074|11753863|FG000|COMPLETED|Phase 1||11
10597548|NCT01816074|11753864|FG001|COMPLETED|Phase 1||9
10597549|NCT01816074|11753865|FG002|COMPLETED|Phase 1||10
10597550|NCT01816074|11753866|FG003|COMPLETED|Phase 1||10
10597551|NCT01816074|11753863|FG000|NOT COMPLETED|Phase 1||0
10597552|NCT01816074|11753864|FG001|NOT COMPLETED|Phase 1||0
10597553|NCT01816074|11753865|FG002|NOT COMPLETED|Phase 1||1
10597554|NCT01816074|11753866|FG003|NOT COMPLETED|Phase 1||0
10597555|NCT01816074|11753863|FG000|STARTED|Phase 2||11
10597556|NCT01816074|11753864|FG001|STARTED|Phase 2||9
10597557|NCT01816074|11753865|FG002|STARTED|Phase 2||10
10597558|NCT01816074|11753866|FG003|STARTED|Phase 2||10
10597559|NCT01816074|11753863|FG000|COMPLETED|Phase 2||9
10597560|NCT01816074|11753864|FG001|COMPLETED|Phase 2||7
10597561|NCT01816074|11753865|FG002|COMPLETED|Phase 2||10
10597562|NCT01816074|11753866|FG003|COMPLETED|Phase 2||9
10597563|NCT01816074|11753863|FG000|NOT COMPLETED|Phase 2||2
10597564|NCT01816074|11753864|FG001|NOT COMPLETED|Phase 2||2
10597565|NCT01816074|11753865|FG002|NOT COMPLETED|Phase 2||0
10597566|NCT01816074|11753866|FG003|NOT COMPLETED|Phase 2||1
10597567|NCT01816230|11753890|FG000|STARTED|Overall Study||36
10597568|NCT01816230|11753890|FG000|COMPLETED|Overall Study||36
10597569|NCT01816230|11753890|FG000|NOT COMPLETED|Overall Study||0
10597570|NCT01816243|11753894|FG000|STARTED|Overall Study||39
10597571|NCT01816243|11753894|FG000|COMPLETED|Overall Study||27
10597572|NCT01816243|11753894|FG000|NOT COMPLETED|Overall Study||12
10597573|NCT01816295|11753900|FG000|STARTED|Double Blind Phase||357
10597574|NCT01816295|11753901|FG001|STARTED|Double Blind Phase||358
10597575|NCT01816295|11753900|FG000|Received Study Drug|Double Blind Phase||356
10597576|NCT01816295|11753901|FG001|Received Study Drug|Double Blind Phase||354
10597577|NCT01816295|11753900|FG000|COMPLETED|Double Blind Phase||294
10597578|NCT01816295|11753901|FG001|COMPLETED|Double Blind Phase||302
10597579|NCT01816295|11753900|FG000|NOT COMPLETED|Double Blind Phase||63
10597580|NCT01816295|11753901|FG001|NOT COMPLETED|Double Blind Phase||56
10597581|NCT01816295|11753900|FG000|STARTED|OLE Phase|Participants who completed the DBP and still met eligibility criteria had option to enroll in OLE.|275
10597582|NCT01816295|11753901|FG001|STARTED|OLE Phase|Participants who completed the DBP and still met eligibility criteria had option to enroll in OLE.|283
10597583|NCT01816295|11753900|FG000|COMPLETED|OLE Phase||222
10597584|NCT01816295|11753901|FG001|COMPLETED|OLE Phase||227
10597585|NCT01816295|11753900|FG000|NOT COMPLETED|OLE Phase||53
10597586|NCT01816295|11753901|FG001|NOT COMPLETED|OLE Phase||56
10597587|NCT01816451|11753911|FG000|STARTED|Overall Study||13
10597588|NCT01816451|11753912|FG001|STARTED|Overall Study||11
10597589|NCT01816451|11753913|FG002|STARTED|Overall Study||8
10597590|NCT01816451|11753911|FG000|COMPLETED|Overall Study||13
10597591|NCT01816451|11753912|FG001|COMPLETED|Overall Study||11
10597592|NCT01816451|11753913|FG002|COMPLETED|Overall Study||8
10597593|NCT01816451|11753911|FG000|NOT COMPLETED|Overall Study||0
10597594|NCT01816451|11753912|FG001|NOT COMPLETED|Overall Study||0
10597595|NCT01816451|11753913|FG002|NOT COMPLETED|Overall Study||0
10597596|NCT01816477|11753925|FG000|STARTED|Overall Study||43
10597597|NCT01816477|11753926|FG001|STARTED|Overall Study||42
10597598|NCT01816477|11753925|FG000|COMPLETED|Overall Study||27
10597599|NCT01816477|11753926|FG001|COMPLETED|Overall Study||41
10597600|NCT01816477|11753925|FG000|NOT COMPLETED|Overall Study||16
10597601|NCT01816477|11753926|FG001|NOT COMPLETED|Overall Study||1
10597602|NCT01816594|11753934|FG000|STARTED|Overall Study||25
10597603|NCT01816594|11753935|FG001|STARTED|Overall Study||25
10597604|NCT01816594|11753934|FG000|Randomized to the wt Cohort|Overall Study|wt = PIK3CA wild-type|21
10597605|NCT01816594|11753935|FG001|Randomized to the wt Cohort|Overall Study|wt = PIK3CA wild-type|21
10597606|NCT01816594|11753934|FG000|Randomized to the mt Cohort|Overall Study|mt = PIK3CA mutant|4
10597607|NCT01816594|11753935|FG001|Randomized to the mt Cohort|Overall Study|mt = PIK3CA mutant|4
10597608|NCT01816594|11753934|FG000|COMPLETED|Overall Study||14
10597609|NCT01816594|11753935|FG001|COMPLETED|Overall Study||23
10597610|NCT01816594|11753934|FG000|NOT COMPLETED|Overall Study||11
10597611|NCT01816594|11753935|FG001|NOT COMPLETED|Overall Study||2
10597612|NCT01816685|11753949|FG000|STARTED|Overall Study||68
10597613|NCT01816685|11753950|FG001|STARTED|Overall Study||67
10597614|NCT01816685|11753949|FG000|COMPLETED|Overall Study||58
10597615|NCT01816685|11753950|FG001|COMPLETED|Overall Study||56
10597616|NCT01816685|11753949|FG000|NOT COMPLETED|Overall Study||10
10597617|NCT01816685|11753950|FG001|NOT COMPLETED|Overall Study||11
10597618|NCT01816711|11753958|FG000|STARTED|Overall Study||121
10597619|NCT01816711|11753959|FG001|STARTED|Overall Study||83
10597620|NCT01816711|11753958|FG000|COMPLETED|Overall Study||121
10597621|NCT01816711|11753959|FG001|COMPLETED|Overall Study||83
10597622|NCT01816711|11753958|FG000|NOT COMPLETED|Overall Study||0
10597623|NCT01816711|11753959|FG001|NOT COMPLETED|Overall Study||0
10597624|NCT01816763|11753968|FG000|STARTED|Overall Study||195
10597625|NCT01816763|11753969|FG001|STARTED|Overall Study||194
10597626|NCT01816763|11753970|FG002|STARTED|Overall Study||180
10597627|NCT01816763|11753968|FG000|COMPLETED|Overall Study||191
10597628|NCT01816763|11753969|FG001|COMPLETED|Overall Study||179
10597629|NCT01816763|11753970|FG002|COMPLETED|Overall Study||169
10597630|NCT01816763|11753968|FG000|NOT COMPLETED|Overall Study||4
10597631|NCT01816763|11753969|FG001|NOT COMPLETED|Overall Study||15
10597632|NCT01816763|11753970|FG002|NOT COMPLETED|Overall Study||11
10597633|NCT01816776|11753983|FG000|STARTED|Overall Study||73
10597634|NCT01816776|11753984|FG001|STARTED|Overall Study||78
10597635|NCT01816776|11753983|FG000|6 Month Primary Effectiveness Assessed|Overall Study||68
10597636|NCT01816776|11753984|FG001|6 Month Primary Effectiveness Assessed|Overall Study||73
10597637|NCT01816776|11753983|FG000|COMPLETED|Overall Study||60
10597638|NCT01816776|11753984|FG001|COMPLETED|Overall Study||70
10597639|NCT01816776|11753983|FG000|NOT COMPLETED|Overall Study||13
10597640|NCT01816776|11753984|FG001|NOT COMPLETED|Overall Study||8
10597641|NCT01816893|11753992|FG000|STARTED|Euglycemic Clamp/ Hypoglycemic Clamp||11
10597642|NCT01816893|11753993|FG001|STARTED|Euglycemic Clamp/ Hypoglycemic Clamp||11
10597643|NCT01816893|11753992|FG000|COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||11
10597644|NCT01816893|11753993|FG001|COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||11
10597645|NCT01816893|11753992|FG000|NOT COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||0
10597646|NCT01816893|11753993|FG001|NOT COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||0
10597647|NCT01816893|11753992|FG000|STARTED|Washout Period||11
10597648|NCT01816893|11753993|FG001|STARTED|Washout Period||11
10597649|NCT01816893|11753992|FG000|COMPLETED|Washout Period||9
10597650|NCT01816893|11753993|FG001|COMPLETED|Washout Period||11
10597651|NCT01816893|11753992|FG000|NOT COMPLETED|Washout Period||2
10597652|NCT01816893|11753993|FG001|NOT COMPLETED|Washout Period||0
10597653|NCT01816893|11753992|FG000|STARTED|Hypoglycemic Clamp/ Euglycemic Clamp||9
10597654|NCT01816893|11753993|FG001|STARTED|Hypoglycemic Clamp/ Euglycemic Clamp||11
10597655|NCT01816893|11753992|FG000|COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||9
10703798|NCT02587143|11868301|FG001|COMPLETED|Overall Study||60
10703799|NCT02587143|11868300|FG000|NOT COMPLETED|Overall Study||1
10703800|NCT02587143|11868301|FG001|NOT COMPLETED|Overall Study||0
10713726|NCT02681094|11879232|FG000|STARTED|1 -Modified Enrolled Participants Set||293
10597656|NCT01816893|11753993|FG001|COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||11
10597657|NCT01816893|11753992|FG000|NOT COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||0
10597658|NCT01816893|11753993|FG001|NOT COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||0
10597659|NCT01816906|11754001|FG000|STARTED|Six Months||41
10597660|NCT01816906|11754002|FG001|STARTED|Six Months||41
10597661|NCT01816906|11754001|FG000|COMPLETED|Six Months||20
10597662|NCT01816906|11754002|FG001|COMPLETED|Six Months||19
10597663|NCT01816906|11754001|FG000|NOT COMPLETED|Six Months||21
10597664|NCT01816906|11754002|FG001|NOT COMPLETED|Six Months||22
10597665|NCT01816906|11754001|FG000|STARTED|12 Months||20
10597666|NCT01816906|11754002|FG001|STARTED|12 Months||19
10597667|NCT01816906|11754001|FG000|COMPLETED|12 Months||16
10597668|NCT01816906|11754002|FG001|COMPLETED|12 Months||14
10597669|NCT01816906|11754001|FG000|NOT COMPLETED|12 Months||4
10597670|NCT01816906|11754002|FG001|NOT COMPLETED|12 Months||5
10597671|NCT01816945|11754011|FG000|STARTED|Overall Study||23
10597672|NCT01816945|11754012|FG001|STARTED|Overall Study||24
10713727|NCT02681094|11879233|FG001|STARTED|1 -Modified Enrolled Participants Set|A participant was randomized but did not receive treatment|294
10713728|NCT02681094|11879234|FG002|STARTED|1 -Modified Enrolled Participants Set|A participant was randomized but did not receive treatment|296
10597673|NCT01816945|11754011|FG000|COMPLETED|Overall Study||21
10597674|NCT01816945|11754012|FG001|COMPLETED|Overall Study||19
10597675|NCT01816945|11754011|FG000|NOT COMPLETED|Overall Study||2
10597676|NCT01816945|11754012|FG001|NOT COMPLETED|Overall Study||5
10597677|NCT01816984|11754018|FG000|STARTED|Overall Study||12
10597678|NCT01816984|11754018|FG000|COMPLETED|Overall Study||11
10597679|NCT01816984|11754018|FG000|NOT COMPLETED|Overall Study||1
10597680|NCT01817075|11754024|FG000|STARTED|Overall Study||88
10597681|NCT01817075|11754025|FG001|STARTED|Overall Study||89
10597682|NCT01817075|11754024|FG000|COMPLETED|Overall Study||41
10597683|NCT01817075|11754025|FG001|COMPLETED|Overall Study||54
10597684|NCT01817075|11754024|FG000|NOT COMPLETED|Overall Study||47
10597685|NCT01817075|11754025|FG001|NOT COMPLETED|Overall Study||35
10597686|NCT01817374|11754031|FG000|STARTED|Overall Study||6
10597687|NCT01817374|11754031|FG000|COMPLETED|Overall Study||6
10597688|NCT01817374|11754031|FG000|NOT COMPLETED|Overall Study||0
10597689|NCT01817491|11754039|FG000|STARTED|Overall Study||32
10597690|NCT01817491|11754040|FG001|STARTED|Overall Study||28
10597691|NCT01817491|11754039|FG000|COMPLETED|Overall Study||28
10597692|NCT01817491|11754040|FG001|COMPLETED|Overall Study||28
10597693|NCT01817491|11754039|FG000|NOT COMPLETED|Overall Study||4
10597694|NCT01817491|11754040|FG001|NOT COMPLETED|Overall Study||0
10597695|NCT01817530|11754055|FG000|STARTED|Overall Study||65
10597696|NCT01817530|11754056|FG001|STARTED|Overall Study||65
10597697|NCT01817530|11754057|FG002|STARTED|Overall Study||64
10597698|NCT01817530|11754058|FG003|STARTED|Overall Study||65
10597699|NCT01817530|11754059|FG004|STARTED|Overall Study||78
10597700|NCT01817530|11754060|FG005|STARTED|Overall Study||77
10597701|NCT01817530|11754061|FG006|STARTED|Overall Study||76
10597702|NCT01817530|11754062|FG007|STARTED|Overall Study||77
10597703|NCT01817530|11754055|FG000|COMPLETED|Overall Study||50
10597704|NCT01817530|11754056|FG001|COMPLETED|Overall Study||52
10597705|NCT01817530|11754057|FG002|COMPLETED|Overall Study||53
10597706|NCT01817530|11754058|FG003|COMPLETED|Overall Study||52
10597707|NCT01817530|11754059|FG004|COMPLETED|Overall Study||67
10597708|NCT01817530|11754060|FG005|COMPLETED|Overall Study||58
10597709|NCT01817530|11754061|FG006|COMPLETED|Overall Study||53
10597710|NCT01817530|11754062|FG007|COMPLETED|Overall Study||53
10597711|NCT01817530|11754055|FG000|NOT COMPLETED|Overall Study||15
10597712|NCT01817530|11754056|FG001|NOT COMPLETED|Overall Study||13
10597713|NCT01817530|11754057|FG002|NOT COMPLETED|Overall Study||11
10597714|NCT01817530|11754058|FG003|NOT COMPLETED|Overall Study||13
10597715|NCT01817530|11754059|FG004|NOT COMPLETED|Overall Study||11
10597716|NCT01817530|11754060|FG005|NOT COMPLETED|Overall Study||19
10597717|NCT01817530|11754061|FG006|NOT COMPLETED|Overall Study||23
10597718|NCT01817530|11754062|FG007|NOT COMPLETED|Overall Study||24
10597719|NCT01817582|11754083|FG000|STARTED|Overall Study||33
10597720|NCT01817582|11754084|FG001|STARTED|Overall Study||36
10597721|NCT01817582|11754085|FG002|STARTED|Overall Study||33
10597722|NCT01817582|11754083|FG000|Received at Least 1 Dose of Study Drug|Overall Study||33
10597723|NCT01817582|11754084|FG001|Received at Least 1 Dose of Study Drug|Overall Study||36
10597724|NCT01817582|11754085|FG002|Received at Least 1 Dose of Study Drug|Overall Study||33
10597725|NCT01817582|11754083|FG000|COMPLETED|Overall Study||31
10597726|NCT01817582|11754084|FG001|COMPLETED|Overall Study||35
10597727|NCT01817582|11754085|FG002|COMPLETED|Overall Study||33
10597728|NCT01817582|11754083|FG000|NOT COMPLETED|Overall Study||2
10597729|NCT01817582|11754084|FG001|NOT COMPLETED|Overall Study||1
10597730|NCT01817582|11754085|FG002|NOT COMPLETED|Overall Study||0
10597731|NCT01817712|11754095|FG000|STARTED|Overall Study||271
10597732|NCT01817712|11754096|FG001|STARTED|Overall Study||270
10597733|NCT01817712|11754095|FG000|COMPLETED|Overall Study|Primary Outcome Assessed over 18 months|250
10597734|NCT01817712|11754096|FG001|COMPLETED|Overall Study|Primary Outcome assessed over 18 months|240
10597735|NCT01817712|11754095|FG000|NOT COMPLETED|Overall Study||21
10597736|NCT01817712|11754096|FG001|NOT COMPLETED|Overall Study||30
10597737|NCT01817725|11754102|FG000|STARTED|Overall Study||20
10597738|NCT01817725|11754102|FG000|COMPLETED|Overall Study||19
10597739|NCT01817725|11754102|FG000|NOT COMPLETED|Overall Study||1
10597740|NCT01817764|11754108|FG000|STARTED|Overall Study||353
10597741|NCT01817764|11754109|FG001|STARTED|Overall Study||353
10597742|NCT01817764|11754108|FG000|COMPLETED|Overall Study||319
10597743|NCT01817764|11754109|FG001|COMPLETED|Overall Study||315
10597744|NCT01817764|11754108|FG000|NOT COMPLETED|Overall Study||34
10597745|NCT01817764|11754109|FG001|NOT COMPLETED|Overall Study||38
10807884|NCT03885934|11969644|FG004|PCV Dose 2|Overall Study||0
10597746|NCT01817777|11754117|FG000|STARTED|Observational Phase (8 Weeks)||36
10597747|NCT01817777|11754118|FG001|STARTED|Observational Phase (8 Weeks)||0
10597748|NCT01817777|11754119|FG002|STARTED|Observational Phase (8 Weeks)||0
10807885|NCT03885934|11969645|FG005|PCV Dose 2|Overall Study||0
10807886|NCT03885934|11969640|FG000|PCV Dose 3|Overall Study||63
10597749|NCT01817777|11754117|FG000|COMPLETED|Observational Phase (8 Weeks)||31
10597750|NCT01817777|11754118|FG001|COMPLETED|Observational Phase (8 Weeks)||0
10597751|NCT01817777|11754119|FG002|COMPLETED|Observational Phase (8 Weeks)||0
10597752|NCT01817777|11754117|FG000|NOT COMPLETED|Observational Phase (8 Weeks)||5
10597753|NCT01817777|11754118|FG001|NOT COMPLETED|Observational Phase (8 Weeks)||0
10597754|NCT01817777|11754119|FG002|NOT COMPLETED|Observational Phase (8 Weeks)||0
10597755|NCT01817777|11754117|FG000|STARTED|Interventional Phase (20 Weeks)||0
10597756|NCT01817777|11754118|FG001|STARTED|Interventional Phase (20 Weeks)||16
10597757|NCT01817777|11754119|FG002|STARTED|Interventional Phase (20 Weeks)||15
10597758|NCT01817777|11754117|FG000|COMPLETED|Interventional Phase (20 Weeks)||0
10597759|NCT01817777|11754118|FG001|COMPLETED|Interventional Phase (20 Weeks)||11
10597760|NCT01817777|11754119|FG002|COMPLETED|Interventional Phase (20 Weeks)||10
10597761|NCT01817777|11754117|FG000|NOT COMPLETED|Interventional Phase (20 Weeks)||0
10597762|NCT01817777|11754118|FG001|NOT COMPLETED|Interventional Phase (20 Weeks)||5
10597763|NCT01817777|11754119|FG002|NOT COMPLETED|Interventional Phase (20 Weeks)||5
10652251|NCT02182999|11812631|FG001|NOT COMPLETED|Overall Study||3
10652252|NCT02183519|11812639|FG000|STARTED|Overall Study||28
10652253|NCT02183519|11812640|FG001|STARTED|Overall Study||16
10652254|NCT02183519|11812639|FG000|COMPLETED|Overall Study||25
10652255|NCT02183519|11812640|FG001|COMPLETED|Overall Study||13
10652256|NCT02183519|11812639|FG000|NOT COMPLETED|Overall Study||3
10652257|NCT02183519|11812640|FG001|NOT COMPLETED|Overall Study||3
10652258|NCT02183675|11812652|FG000|STARTED|Treatment Period 1 (10 Days)||6
10652259|NCT02183675|11812653|FG001|STARTED|Treatment Period 1 (10 Days)||6
10652260|NCT02183675|11812654|FG002|STARTED|Treatment Period 1 (10 Days)||6
10652261|NCT02183675|11812655|FG003|STARTED|Treatment Period 1 (10 Days)||6
10652262|NCT02183675|11812656|FG004|STARTED|Treatment Period 1 (10 Days)||6
10652263|NCT02183675|11812657|FG005|STARTED|Treatment Period 1 (10 Days)||6
10652264|NCT02183675|11812652|FG000|COMPLETED|Treatment Period 1 (10 Days)||6
10652265|NCT02183675|11812653|FG001|COMPLETED|Treatment Period 1 (10 Days)||6
10652266|NCT02183675|11812654|FG002|COMPLETED|Treatment Period 1 (10 Days)||6
10652267|NCT02183675|11812655|FG003|COMPLETED|Treatment Period 1 (10 Days)||6
10652268|NCT02183675|11812656|FG004|COMPLETED|Treatment Period 1 (10 Days)||6
10652269|NCT02183675|11812657|FG005|COMPLETED|Treatment Period 1 (10 Days)||6
10652270|NCT02183675|11812652|FG000|NOT COMPLETED|Treatment Period 1 (10 Days)||0
10652271|NCT02183675|11812653|FG001|NOT COMPLETED|Treatment Period 1 (10 Days)||0
10652272|NCT02183675|11812654|FG002|NOT COMPLETED|Treatment Period 1 (10 Days)||0
10652273|NCT02183675|11812655|FG003|NOT COMPLETED|Treatment Period 1 (10 Days)||0
10652274|NCT02183675|11812656|FG004|NOT COMPLETED|Treatment Period 1 (10 Days)||0
10652275|NCT02183675|11812657|FG005|NOT COMPLETED|Treatment Period 1 (10 Days)||0
10652276|NCT02183675|11812652|FG000|STARTED|Treatment Period 2 (10 Days)||6
10652277|NCT02183675|11812653|FG001|STARTED|Treatment Period 2 (10 Days)||6
10652278|NCT02183675|11812654|FG002|STARTED|Treatment Period 2 (10 Days)||6
10652279|NCT02183675|11812655|FG003|STARTED|Treatment Period 2 (10 Days)||6
10652280|NCT02183675|11812656|FG004|STARTED|Treatment Period 2 (10 Days)||6
10652281|NCT02183675|11812657|FG005|STARTED|Treatment Period 2 (10 Days)||6
10652282|NCT02183675|11812652|FG000|COMPLETED|Treatment Period 2 (10 Days)||6
10652283|NCT02183675|11812653|FG001|COMPLETED|Treatment Period 2 (10 Days)||6
10652284|NCT02183675|11812654|FG002|COMPLETED|Treatment Period 2 (10 Days)||6
10652285|NCT02183675|11812655|FG003|COMPLETED|Treatment Period 2 (10 Days)||6
10652286|NCT02183675|11812656|FG004|COMPLETED|Treatment Period 2 (10 Days)||6
10652287|NCT02183675|11812657|FG005|COMPLETED|Treatment Period 2 (10 Days)|Patients withdrew after completion of treatment period 2 but before beginning of treatment period 3|4
10652288|NCT02183675|11812652|FG000|NOT COMPLETED|Treatment Period 2 (10 Days)||0
10652289|NCT02183675|11812653|FG001|NOT COMPLETED|Treatment Period 2 (10 Days)||0
10652290|NCT02183675|11812654|FG002|NOT COMPLETED|Treatment Period 2 (10 Days)||0
10652291|NCT02183675|11812655|FG003|NOT COMPLETED|Treatment Period 2 (10 Days)||0
10652292|NCT02183675|11812656|FG004|NOT COMPLETED|Treatment Period 2 (10 Days)||0
10652293|NCT02183675|11812657|FG005|NOT COMPLETED|Treatment Period 2 (10 Days)||2
10652294|NCT02183675|11812652|FG000|STARTED|Treatment Period 3 (10 Days)||6
10652295|NCT02183675|11812653|FG001|STARTED|Treatment Period 3 (10 Days)||6
10652296|NCT02183675|11812654|FG002|STARTED|Treatment Period 3 (10 Days)||6
10652297|NCT02183675|11812655|FG003|STARTED|Treatment Period 3 (10 Days)||6
10652298|NCT02183675|11812656|FG004|STARTED|Treatment Period 3 (10 Days)||6
10652299|NCT02183675|11812657|FG005|STARTED|Treatment Period 3 (10 Days)||4
10652300|NCT02183675|11812652|FG000|COMPLETED|Treatment Period 3 (10 Days)||6
10652301|NCT02183675|11812653|FG001|COMPLETED|Treatment Period 3 (10 Days)||6
10652302|NCT02183675|11812654|FG002|COMPLETED|Treatment Period 3 (10 Days)||6
10652303|NCT02183675|11812655|FG003|COMPLETED|Treatment Period 3 (10 Days)||6
10652304|NCT02183675|11812656|FG004|COMPLETED|Treatment Period 3 (10 Days)||6
10652305|NCT02183675|11812657|FG005|COMPLETED|Treatment Period 3 (10 Days)||4
10652306|NCT02183675|11812652|FG000|NOT COMPLETED|Treatment Period 3 (10 Days)||0
10652307|NCT02183675|11812653|FG001|NOT COMPLETED|Treatment Period 3 (10 Days)||0
10652308|NCT02183675|11812654|FG002|NOT COMPLETED|Treatment Period 3 (10 Days)||0
10652309|NCT02183675|11812655|FG003|NOT COMPLETED|Treatment Period 3 (10 Days)||0
10652310|NCT02183675|11812656|FG004|NOT COMPLETED|Treatment Period 3 (10 Days)||0
10652311|NCT02183675|11812657|FG005|NOT COMPLETED|Treatment Period 3 (10 Days)||0
10652312|NCT02183792|11812669|FG000|STARTED|Overall Study||18
10652313|NCT02183792|11812670|FG001|STARTED|Overall Study||15
10652314|NCT02183792|11812669|FG000|COMPLETED|Overall Study||18
10652315|NCT02183792|11812670|FG001|COMPLETED|Overall Study||15
10652316|NCT02183792|11812669|FG000|NOT COMPLETED|Overall Study||0
10652317|NCT02183792|11812670|FG001|NOT COMPLETED|Overall Study||0
10652318|NCT02184143|11812678|FG000|STARTED|Overall Study|124 participants randomized; 118 participant received intervention|124
10652319|NCT02184143|11812679|FG001|STARTED|Overall Study|124 participants randomized; 121 received intervention|124
10652320|NCT02184143|11812678|FG000|COMPLETED|Overall Study|114 patients completed PROs. 98 actigraph valid wear time.|114
10652321|NCT02184143|11812679|FG001|COMPLETED|Overall Study|117 patients completed PROs. 100 actigraph valid wear time.|117
10652322|NCT02184143|11812678|FG000|NOT COMPLETED|Overall Study||10
10652323|NCT02184143|11812679|FG001|NOT COMPLETED|Overall Study||7
10597764|NCT01817790|11754127|FG000|STARTED|Overall Study||314
10597765|NCT01817790|11754128|FG001|STARTED|Overall Study||312
10597766|NCT01817790|11754127|FG000|COMPLETED|Overall Study||310
10597767|NCT01817790|11754128|FG001|COMPLETED|Overall Study||304
10597768|NCT01817790|11754127|FG000|NOT COMPLETED|Overall Study||4
10597769|NCT01817790|11754128|FG001|NOT COMPLETED|Overall Study||8
10597770|NCT01817855|11754140|FG000|STARTED|Overall Study||23
10597771|NCT01817855|11754141|FG001|STARTED|Overall Study||8
10597772|NCT01817855|11754142|FG002|STARTED|Overall Study||11
10597773|NCT01817855|11754143|FG003|STARTED|Overall Study||5
10597774|NCT01817855|11754140|FG000|COMPLETED|Overall Study||23
10597775|NCT01817855|11754141|FG001|COMPLETED|Overall Study||6
10597776|NCT01817855|11754142|FG002|COMPLETED|Overall Study||9
10597777|NCT01817855|11754143|FG003|COMPLETED|Overall Study||5
10597778|NCT01817855|11754140|FG000|NOT COMPLETED|Overall Study||0
10597779|NCT01817855|11754141|FG001|NOT COMPLETED|Overall Study||2
10597780|NCT01817855|11754142|FG002|NOT COMPLETED|Overall Study||2
10597781|NCT01817855|11754143|FG003|NOT COMPLETED|Overall Study||0
10597782|NCT01817907|11754161|FG000|STARTED|First Intervention||8
10597783|NCT01817907|11754162|FG001|STARTED|First Intervention||7
10597784|NCT01817907|11754161|FG000|COMPLETED|First Intervention||8
10597785|NCT01817907|11754162|FG001|COMPLETED|First Intervention||7
10597786|NCT01817907|11754161|FG000|NOT COMPLETED|First Intervention||0
10597787|NCT01817907|11754162|FG001|NOT COMPLETED|First Intervention||0
10597788|NCT01817907|11754161|FG000|STARTED|Washout Period||8
10597789|NCT01817907|11754162|FG001|STARTED|Washout Period||7
10597790|NCT01817907|11754161|FG000|COMPLETED|Washout Period||8
10597791|NCT01817907|11754162|FG001|COMPLETED|Washout Period||7
10597792|NCT01817907|11754161|FG000|NOT COMPLETED|Washout Period||0
10597793|NCT01817907|11754162|FG001|NOT COMPLETED|Washout Period||0
10597794|NCT01817907|11754161|FG000|STARTED|Second Intervention||8
10597795|NCT01817907|11754162|FG001|STARTED|Second Intervention||7
10597796|NCT01817907|11754161|FG000|COMPLETED|Second Intervention||8
10597797|NCT01817907|11754162|FG001|COMPLETED|Second Intervention||7
10597798|NCT01817907|11754161|FG000|NOT COMPLETED|Second Intervention||0
10597799|NCT01817907|11754162|FG001|NOT COMPLETED|Second Intervention||0
10597800|NCT01817959|11754170|FG000|STARTED|Overall Study||29
10597801|NCT01817959|11754171|FG001|STARTED|Overall Study||19
10597802|NCT01817959|11754170|FG000|COMPLETED|Overall Study||25
10597803|NCT01817959|11754171|FG001|COMPLETED|Overall Study||16
10703801|NCT02587221|11868309|FG000|STARTED|Overall Study||3394
10703802|NCT02587221|11868310|FG001|STARTED|Overall Study||3396
10703803|NCT02587221|11868309|FG000|Treated|Overall Study||3379
10703804|NCT02587221|11868310|FG001|Treated|Overall Study||3382
10597804|NCT01817959|11754170|FG000|NOT COMPLETED|Overall Study||4
10597805|NCT01817959|11754171|FG001|NOT COMPLETED|Overall Study||3
10597806|NCT01818063|11754179|FG000|STARTED|Overall Study||5
10597807|NCT01818063|11754180|FG001|STARTED|Overall Study||4
10597808|NCT01818063|11754179|FG000|COMPLETED|Overall Study||5
10597809|NCT01818063|11754180|FG001|COMPLETED|Overall Study||4
10597810|NCT01818063|11754179|FG000|NOT COMPLETED|Overall Study||0
10597811|NCT01818063|11754180|FG001|NOT COMPLETED|Overall Study||0
10597812|NCT01818141|11754188|FG000|STARTED|Overall Study||18
10597813|NCT01818141|11754189|FG001|STARTED|Overall Study||16
10597814|NCT01818141|11754188|FG000|COMPLETED|Overall Study||15
10597815|NCT01818141|11754189|FG001|COMPLETED|Overall Study||13
10597816|NCT01818141|11754188|FG000|NOT COMPLETED|Overall Study||3
10597817|NCT01818141|11754189|FG001|NOT COMPLETED|Overall Study||3
10597818|NCT01818245|11754197|FG000|STARTED|Intervention A||30
10597819|NCT01818245|11754198|FG001|STARTED|Intervention A|Participants didn't participate in separate interventions and received 1 dose of LY2605541 on Day 1.|22
10597820|NCT01818245|11754197|FG000|Received One Dose of Study Drug|Intervention A||30
10597821|NCT01818245|11754198|FG001|Received One Dose of Study Drug|Intervention A||22
10597822|NCT01818245|11754197|FG000|COMPLETED|Intervention A||30
10597823|NCT01818245|11754198|FG001|COMPLETED|Intervention A||22
10597824|NCT01818245|11754197|FG000|NOT COMPLETED|Intervention A||0
10597825|NCT01818245|11754198|FG001|NOT COMPLETED|Intervention A||0
10597826|NCT01818245|11754197|FG000|STARTED|Washout (16-28 Days)||30
10597827|NCT01818245|11754198|FG001|STARTED|Washout (16-28 Days)||0
10597828|NCT01818245|11754197|FG000|COMPLETED|Washout (16-28 Days)||30
10597829|NCT01818245|11754198|FG001|COMPLETED|Washout (16-28 Days)||0
10597830|NCT01818245|11754197|FG000|NOT COMPLETED|Washout (16-28 Days)||0
10597831|NCT01818245|11754198|FG001|NOT COMPLETED|Washout (16-28 Days)||0
10597832|NCT01818245|11754197|FG000|STARTED|Intervention B||30
10597833|NCT01818245|11754198|FG001|STARTED|Intervention B||0
10597834|NCT01818245|11754197|FG000|COMPLETED|Intervention B||30
10597835|NCT01818245|11754198|FG001|COMPLETED|Intervention B||0
10597836|NCT01818245|11754197|FG000|NOT COMPLETED|Intervention B||0
10597837|NCT01818245|11754198|FG001|NOT COMPLETED|Intervention B||0
10597838|NCT01818245|11754197|FG000|STARTED|Washout (16-28 Days)||30
10597839|NCT01818245|11754198|FG001|STARTED|Washout (16-28 Days)||0
10703805|NCT02587221|11868309|FG000|COMPLETED|Overall Study||3263
10597840|NCT01818245|11754197|FG000|COMPLETED|Washout (16-28 Days)||30
10597841|NCT01818245|11754198|FG001|COMPLETED|Washout (16-28 Days)||0
10597842|NCT01818245|11754197|FG000|NOT COMPLETED|Washout (16-28 Days)||0
10597843|NCT01818245|11754198|FG001|NOT COMPLETED|Washout (16-28 Days)||0
10597844|NCT01818245|11754197|FG000|STARTED|Intervention C||30
10597845|NCT01818245|11754198|FG001|STARTED|Intervention C||0
10597846|NCT01818245|11754197|FG000|COMPLETED|Intervention C||30
10597847|NCT01818245|11754198|FG001|COMPLETED|Intervention C||0
10703806|NCT02587221|11868310|FG001|COMPLETED|Overall Study||3273
10597848|NCT01818245|11754197|FG000|NOT COMPLETED|Intervention C||0
10807887|NCT03885934|11969641|FG001|PCV Dose 3|Overall Study||64
10807888|NCT03885934|11969642|FG002|PCV Dose 3|Overall Study||0
10807889|NCT03885934|11969643|FG003|PCV Dose 3|Overall Study||0
10597849|NCT01818245|11754198|FG001|NOT COMPLETED|Intervention C||0
10597850|NCT01818258|11754211|FG000|STARTED|Overall Study||25
10807890|NCT03885934|11969644|FG004|PCV Dose 3|Overall Study||0
10807891|NCT03885934|11969645|FG005|PCV Dose 3|Overall Study||0
10807892|NCT03885934|11969640|FG000|COMPLETED|Overall Study||63
10807893|NCT03885934|11969641|FG001|COMPLETED|Overall Study||64
10807894|NCT03885934|11969642|FG002|COMPLETED|Overall Study||62
10807895|NCT03885934|11969643|FG003|COMPLETED|Overall Study||64
10597851|NCT01818258|11754212|FG001|STARTED|Overall Study||27
10597852|NCT01818258|11754211|FG000|COMPLETED|Overall Study||22
10597853|NCT01818258|11754212|FG001|COMPLETED|Overall Study||24
10807896|NCT03885934|11969644|FG004|COMPLETED|Overall Study||177
10807897|NCT03885934|11969645|FG005|COMPLETED|Overall Study||175
10597854|NCT01818258|11754211|FG000|NOT COMPLETED|Overall Study||3
10597855|NCT01818258|11754212|FG001|NOT COMPLETED|Overall Study||3
10597856|NCT01818284|11754221|FG000|STARTED|Overall Study||11
10597857|NCT01818284|11754222|FG001|STARTED|Overall Study||11
10597858|NCT01818284|11754221|FG000|COMPLETED|Overall Study||7
10597859|NCT01818284|11754222|FG001|COMPLETED|Overall Study||5
10597860|NCT01818284|11754221|FG000|NOT COMPLETED|Overall Study||4
10597861|NCT01818284|11754222|FG001|NOT COMPLETED|Overall Study||6
10597862|NCT01818297|11754229|FG000|STARTED|Blinded Phase (Randomization - 3 Months)||32
10597863|NCT01818297|11754230|FG001|STARTED|Blinded Phase (Randomization - 3 Months)||30
10597864|NCT01818297|11754229|FG000|Week 1|Blinded Phase (Randomization - 3 Months)||32
10597865|NCT01818297|11754230|FG001|Week 1|Blinded Phase (Randomization - 3 Months)||30
10597866|NCT01818297|11754229|FG000|Week 6|Blinded Phase (Randomization - 3 Months)||32
10597867|NCT01818297|11754230|FG001|Week 6|Blinded Phase (Randomization - 3 Months)||29
10597868|NCT01818297|11754229|FG000|COMPLETED|Blinded Phase (Randomization - 3 Months)||32
10597869|NCT01818297|11754230|FG001|COMPLETED|Blinded Phase (Randomization - 3 Months)||29
10597870|NCT01818297|11754229|FG000|NOT COMPLETED|Blinded Phase (Randomization - 3 Months)||0
10597871|NCT01818297|11754230|FG001|NOT COMPLETED|Blinded Phase (Randomization - 3 Months)||1
10597872|NCT01818297|11754229|FG000|STARTED|Open Label Phase (3-12 Months)||32
10597873|NCT01818297|11754230|FG001|STARTED|Open Label Phase (3-12 Months)||29
10597874|NCT01818297|11754229|FG000|COMPLETED|Open Label Phase (3-12 Months)||14
10597875|NCT01818297|11754230|FG001|COMPLETED|Open Label Phase (3-12 Months)||19
10597876|NCT01818297|11754229|FG000|NOT COMPLETED|Open Label Phase (3-12 Months)||18
10597877|NCT01818297|11754230|FG001|NOT COMPLETED|Open Label Phase (3-12 Months)||10
10597878|NCT01818336|11754236|FG000|STARTED|Overall Study||391
10597879|NCT01818336|11754237|FG001|STARTED|Overall Study||59
10597880|NCT01818336|11754236|FG000|COMPLETED|Overall Study||391
10597881|NCT01818336|11754237|FG001|COMPLETED|Overall Study||47
10597882|NCT01818336|11754236|FG000|NOT COMPLETED|Overall Study||0
10597883|NCT01818336|11754237|FG001|NOT COMPLETED|Overall Study||12
10597884|NCT01818414|11754245|FG000|STARTED|Overall Study||14
10597885|NCT01818414|11754246|FG001|STARTED|Overall Study||15
10597886|NCT01818414|11754245|FG000|COMPLETED|Overall Study||14
10597887|NCT01818414|11754246|FG001|COMPLETED|Overall Study||15
10597888|NCT01818414|11754245|FG000|NOT COMPLETED|Overall Study||0
10597889|NCT01818414|11754246|FG001|NOT COMPLETED|Overall Study||0
10597890|NCT01818427|11754256|FG000|STARTED|Overall Study||239
10597891|NCT01818427|11754257|FG001|STARTED|Overall Study||284
10597892|NCT01818427|11754256|FG000|COMPLETED|Overall Study||230
10597893|NCT01818427|11754257|FG001|COMPLETED|Overall Study||271
10597894|NCT01818427|11754256|FG000|NOT COMPLETED|Overall Study||9
10597895|NCT01818427|11754257|FG001|NOT COMPLETED|Overall Study||13
10597896|NCT01818492|11754263|FG000|STARTED|Overall Study||45
10597897|NCT01818492|11754263|FG000|COMPLETED|Overall Study||35
10597898|NCT01818492|11754263|FG000|NOT COMPLETED|Overall Study||10
10597899|NCT01818518|11754274|FG000|STARTED|Overall Study||310
10597900|NCT01818518|11754275|FG001|STARTED|Overall Study||263
10597901|NCT01818518|11754276|FG002|STARTED|Overall Study||288
10597902|NCT01818518|11754277|FG003|STARTED|Overall Study||59
10597903|NCT01818518|11754278|FG004|STARTED|Overall Study||38
10597904|NCT01818518|11754279|FG005|STARTED|Overall Study||37
10597905|NCT01818518|11754274|FG000|COMPLETED|Overall Study||310
10597906|NCT01818518|11754275|FG001|COMPLETED|Overall Study||263
10597907|NCT01818518|11754276|FG002|COMPLETED|Overall Study||288
10597908|NCT01818518|11754277|FG003|COMPLETED|Overall Study||59
10597909|NCT01818518|11754278|FG004|COMPLETED|Overall Study||38
10807898|NCT03885934|11969640|FG000|NOT COMPLETED|Overall Study||1
10807899|NCT03885934|11969641|FG001|NOT COMPLETED|Overall Study||0
10807900|NCT03885934|11969642|FG002|NOT COMPLETED|Overall Study||0
10807901|NCT03885934|11969643|FG003|NOT COMPLETED|Overall Study||0
10597910|NCT01818518|11754279|FG005|COMPLETED|Overall Study||37
10597911|NCT01818518|11754274|FG000|NOT COMPLETED|Overall Study||0
10597912|NCT01818518|11754275|FG001|NOT COMPLETED|Overall Study||0
10597913|NCT01818518|11754276|FG002|NOT COMPLETED|Overall Study||0
10597914|NCT01818518|11754277|FG003|NOT COMPLETED|Overall Study||0
10597915|NCT01818518|11754278|FG004|NOT COMPLETED|Overall Study||0
10597916|NCT01818518|11754279|FG005|NOT COMPLETED|Overall Study||0
10597917|NCT01818531|11754295|FG000|STARTED|Overall Study||75
10597918|NCT01818531|11754296|FG001|STARTED|Overall Study||75
10597919|NCT01818531|11754295|FG000|COMPLETED|Overall Study||74
10597920|NCT01818531|11754296|FG001|COMPLETED|Overall Study||73
10597921|NCT01818531|11754295|FG000|NOT COMPLETED|Overall Study||1
10597922|NCT01818531|11754296|FG001|NOT COMPLETED|Overall Study||2
10597923|NCT01818596|11754304|FG000|STARTED|Overall Study||246
10597924|NCT01818596|11754305|FG001|STARTED|Overall Study||6
10597925|NCT01818596|11754304|FG000|COMPLETED|Overall Study||215
10597926|NCT01818596|11754305|FG001|COMPLETED|Overall Study||6
10597927|NCT01818596|11754304|FG000|NOT COMPLETED|Overall Study||31
10597928|NCT01818596|11754305|FG001|NOT COMPLETED|Overall Study||0
10597929|NCT01818700|11754312|FG000|STARTED|Overall Study|The No. of enrolled patients|245
10597930|NCT01818700|11754312|FG000|Safety Set|Overall Study|4 subjects were not study drug administered.|241
10597931|NCT01818700|11754312|FG000|FAS Set|Overall Study|31 subjects excluded from FAS due to no assessment of primary efficacy(26) and IC/EC violation(5).|210
10807902|NCT03885934|11969644|FG004|NOT COMPLETED|Overall Study||0
10807903|NCT03885934|11969645|FG005|NOT COMPLETED|Overall Study||0
10807904|NCT03885726|11969659|FG000|STARTED|Overall Study||32
10807905|NCT03885726|11969659|FG000|COMPLETED|Overall Study||28
10807906|NCT03885726|11969659|FG000|NOT COMPLETED|Overall Study||4
10807907|NCT03885154|11969671|FG000|STARTED|Overall Study||12
10807908|NCT03885154|11969672|FG001|STARTED|Overall Study||10
10807909|NCT03885154|11969673|FG002|STARTED|Overall Study||0
10597932|NCT01818700|11754312|FG000|PP Set|Overall Study|105 subjects excluded from PP set due to various reasons.|105
10597933|NCT01818700|11754312|FG000|COMPLETED|Overall Study|104 subjects dropped out this study prior to study completion.|141
10597934|NCT01818700|11754312|FG000|NOT COMPLETED|Overall Study||104
10597935|NCT01818726|11754320|FG000|STARTED|Overall Study||10
10597936|NCT01818726|11754321|FG001|STARTED|Overall Study||5
10597937|NCT01818726|11754320|FG000|COMPLETED|Overall Study||4
10597938|NCT01818726|11754321|FG001|COMPLETED|Overall Study||3
10597939|NCT01818726|11754320|FG000|NOT COMPLETED|Overall Study||6
10597940|NCT01818726|11754321|FG001|NOT COMPLETED|Overall Study||2
10597944|NCT01818752|11754334|FG000|STARTED|Overall Study||477
10597945|NCT01818752|11754335|FG001|STARTED|Overall Study||478
10597946|NCT01818752|11754334|FG000|Received Treatment|Overall Study||470
10597947|NCT01818752|11754335|FG001|Received Treatment|Overall Study||474
10597948|NCT01818752|11754334|FG000|COMPLETED|Overall Study|Completed treatment|290
10597949|NCT01818752|11754335|FG001|COMPLETED|Overall Study|Completed treatment|280
10597950|NCT01818752|11754334|FG000|NOT COMPLETED|Overall Study||187
10597951|NCT01818752|11754335|FG001|NOT COMPLETED|Overall Study||198
10597952|NCT01818765|11754341|FG000|STARTED|Overall Study||20
10597953|NCT01818765|11754341|FG000|COMPLETED|Overall Study||18
10597954|NCT01818765|11754341|FG000|NOT COMPLETED|Overall Study||2
10597955|NCT01818804|11754348|FG000|STARTED|Overall Study||73
10597956|NCT01818804|11754349|FG001|STARTED|Overall Study||72
10597957|NCT01818804|11754348|FG000|COMPLETED|Overall Study||68
10597958|NCT01818804|11754349|FG001|COMPLETED|Overall Study||65
10597959|NCT01818804|11754348|FG000|NOT COMPLETED|Overall Study||5
10597960|NCT01818804|11754349|FG001|NOT COMPLETED|Overall Study||7
10597961|NCT01819129|11754357|FG000|STARTED|Overall Study||345
10597962|NCT01819129|11754358|FG001|STARTED|Overall Study||344
10597963|NCT01819129|11754357|FG000|Exposed|Overall Study||341
10597964|NCT01819129|11754358|FG001|Exposed|Overall Study||341
10597965|NCT01819129|11754357|FG000|COMPLETED|Overall Study||301
10597966|NCT01819129|11754358|FG001|COMPLETED|Overall Study||305
10597967|NCT01819129|11754357|FG000|NOT COMPLETED|Overall Study||44
10597968|NCT01819129|11754358|FG001|NOT COMPLETED|Overall Study||39
10597969|NCT01819194|11754364|FG000|STARTED|Overall Study||62
10597970|NCT01819194|11754364|FG000|COMPLETED|Overall Study||60
10597971|NCT01819194|11754364|FG000|NOT COMPLETED|Overall Study||2
10597972|NCT01819233|11754368|FG000|STARTED|Overall Study||38
10597973|NCT01819233|11754368|FG000|COMPLETED|Overall Study||32
10597974|NCT01819233|11754368|FG000|NOT COMPLETED|Overall Study||6
10597975|NCT01819272|11754378|FG000|STARTED|Overall Study||41
10597976|NCT01819272|11754379|FG001|STARTED|Overall Study||39
10597977|NCT01819272|11754380|FG002|STARTED|Overall Study||40
10597978|NCT01819272|11754381|FG003|STARTED|Overall Study||40
10597979|NCT01819272|11754382|FG004|STARTED|Overall Study||40
10597980|NCT01819272|11754383|FG005|STARTED|Overall Study||40
10597981|NCT01819272|11754378|FG000|COMPLETED|Overall Study||35
10597982|NCT01819272|11754379|FG001|COMPLETED|Overall Study||36
10597983|NCT01819272|11754380|FG002|COMPLETED|Overall Study||37
10597984|NCT01819272|11754381|FG003|COMPLETED|Overall Study||35
10597985|NCT01819272|11754382|FG004|COMPLETED|Overall Study||36
10597986|NCT01819272|11754383|FG005|COMPLETED|Overall Study||33
10597987|NCT01819272|11754378|FG000|NOT COMPLETED|Overall Study||6
10597988|NCT01819272|11754379|FG001|NOT COMPLETED|Overall Study||3
10597989|NCT01819272|11754380|FG002|NOT COMPLETED|Overall Study||3
10807910|NCT03885154|11969674|FG003|STARTED|Overall Study||2
10807911|NCT03885154|11969671|FG000|COMPLETED|Overall Study||12
10597990|NCT01819272|11754381|FG003|NOT COMPLETED|Overall Study||5
10597991|NCT01819272|11754382|FG004|NOT COMPLETED|Overall Study||4
10597992|NCT01819272|11754383|FG005|NOT COMPLETED|Overall Study||7
10597993|NCT01819311|11754399|FG000|STARTED|Treatment Phase (4 Weeks)||33
10597994|NCT01819311|11754400|FG001|STARTED|Treatment Phase (4 Weeks)||31
10807912|NCT03885154|11969672|FG001|COMPLETED|Overall Study||10
10597995|NCT01819311|11754399|FG000|COMPLETED|Treatment Phase (4 Weeks)||31
10597996|NCT01819311|11754400|FG001|COMPLETED|Treatment Phase (4 Weeks)||30
10597997|NCT01819311|11754399|FG000|NOT COMPLETED|Treatment Phase (4 Weeks)||2
10597998|NCT01819311|11754400|FG001|NOT COMPLETED|Treatment Phase (4 Weeks)||1
10597999|NCT01819311|11754399|FG000|STARTED|Follow-up Phase (8 Weeks)||31
10598000|NCT01819311|11754400|FG001|STARTED|Follow-up Phase (8 Weeks)||30
10598001|NCT01819311|11754399|FG000|COMPLETED|Follow-up Phase (8 Weeks)||24
10598002|NCT01819311|11754400|FG001|COMPLETED|Follow-up Phase (8 Weeks)||23
10598003|NCT01819311|11754399|FG000|NOT COMPLETED|Follow-up Phase (8 Weeks)||7
10598004|NCT01819311|11754400|FG001|NOT COMPLETED|Follow-up Phase (8 Weeks)||7
10598005|NCT01819415|11754410|FG000|STARTED|Overall Study||10
10598006|NCT01819415|11754411|FG001|STARTED|Overall Study||10
10598007|NCT01819415|11754412|FG002|STARTED|Overall Study||10
10598008|NCT01819415|11754413|FG003|STARTED|Overall Study||10
10598009|NCT01819415|11754410|FG000|COMPLETED|Overall Study||7
10598010|NCT01819415|11754411|FG001|COMPLETED|Overall Study||6
10598011|NCT01819415|11754412|FG002|COMPLETED|Overall Study||9
10598012|NCT01819415|11754413|FG003|COMPLETED|Overall Study||8
10598013|NCT01819415|11754410|FG000|NOT COMPLETED|Overall Study||3
10598014|NCT01819415|11754411|FG001|NOT COMPLETED|Overall Study||4
10598015|NCT01819415|11754412|FG002|NOT COMPLETED|Overall Study||1
10598016|NCT01819415|11754413|FG003|NOT COMPLETED|Overall Study||2
10598017|NCT01819506|11754425|FG000|STARTED|Overall Study||51
10598018|NCT01819506|11754426|FG001|STARTED|Overall Study||52
10598019|NCT01819506|11754425|FG000|COMPLETED|Overall Study||43
10703807|NCT02587221|11868309|FG000|NOT COMPLETED|Overall Study||131
10703808|NCT02587221|11868310|FG001|NOT COMPLETED|Overall Study||123
10703809|NCT02587234|11868318|FG000|STARTED|Overall Study||11
10598020|NCT01819506|11754426|FG001|COMPLETED|Overall Study||47
10598021|NCT01819506|11754425|FG000|NOT COMPLETED|Overall Study||8
10598022|NCT01819506|11754426|FG001|NOT COMPLETED|Overall Study||5
10598023|NCT01819597|11754432|FG000|STARTED|Overall Study||52
10598024|NCT01819597|11754432|FG000|COMPLETED|Overall Study||52
10598025|NCT01819597|11754432|FG000|NOT COMPLETED|Overall Study||0
10598026|NCT01819727|11754438|FG000|STARTED|Overall Study||131
10598027|NCT01819727|11754439|FG001|STARTED|Overall Study||130
10598028|NCT01819727|11754438|FG000|COMPLETED|Overall Study||111
10598029|NCT01819727|11754439|FG001|COMPLETED|Overall Study||102
10598030|NCT01819727|11754438|FG000|NOT COMPLETED|Overall Study||20
10598031|NCT01819727|11754439|FG001|NOT COMPLETED|Overall Study||28
10598032|NCT01819844|11754445|FG000|STARTED|Overall Study||12
10598033|NCT01819844|11754445|FG000|COMPLETED|Overall Study||12
10598034|NCT01819844|11754445|FG000|NOT COMPLETED|Overall Study||0
10598035|NCT01819883|11754452|FG000|STARTED|Overall Study||20
10598036|NCT01819883|11754453|FG001|STARTED|Overall Study||20
10598037|NCT01819883|11754452|FG000|COMPLETED|Overall Study||16
10598038|NCT01819883|11754453|FG001|COMPLETED|Overall Study||20
10598039|NCT01819883|11754452|FG000|NOT COMPLETED|Overall Study||4
10598040|NCT01819883|11754453|FG001|NOT COMPLETED|Overall Study||0
10598041|NCT01819922|11754458|FG000|STARTED|First Intervention Period (1 Day)||6
10598042|NCT01819922|11754459|FG001|STARTED|First Intervention Period (1 Day)||6
10598043|NCT01819922|11754458|FG000|COMPLETED|First Intervention Period (1 Day)||6
10598044|NCT01819922|11754459|FG001|COMPLETED|First Intervention Period (1 Day)||6
10598045|NCT01819922|11754458|FG000|NOT COMPLETED|First Intervention Period (1 Day)||0
10598046|NCT01819922|11754459|FG001|NOT COMPLETED|First Intervention Period (1 Day)||0
10598047|NCT01819922|11754458|FG000|STARTED|Washout Period (at Least 7-10 Days)||6
10598048|NCT01819922|11754459|FG001|STARTED|Washout Period (at Least 7-10 Days)||6
10598049|NCT01819922|11754458|FG000|COMPLETED|Washout Period (at Least 7-10 Days)||6
10598050|NCT01819922|11754459|FG001|COMPLETED|Washout Period (at Least 7-10 Days)||6
10598051|NCT01819922|11754458|FG000|NOT COMPLETED|Washout Period (at Least 7-10 Days)||0
10598052|NCT01819922|11754459|FG001|NOT COMPLETED|Washout Period (at Least 7-10 Days)||0
10598053|NCT01819922|11754458|FG000|STARTED|Second Intervention Period (1 Day)||6
10598054|NCT01819922|11754459|FG001|STARTED|Second Intervention Period (1 Day)||6
10598055|NCT01819922|11754458|FG000|COMPLETED|Second Intervention Period (1 Day)||6
10598056|NCT01819922|11754459|FG001|COMPLETED|Second Intervention Period (1 Day)||6
10598057|NCT01819922|11754458|FG000|NOT COMPLETED|Second Intervention Period (1 Day)||0
10598058|NCT01819922|11754459|FG001|NOT COMPLETED|Second Intervention Period (1 Day)||0
10598059|NCT01819935|11754467|FG000|STARTED|Overall Study||328
10598060|NCT01819935|11754468|FG001|STARTED|Overall Study||4943
10598061|NCT01819935|11754467|FG000|COMPLETED|Overall Study||328
10598062|NCT01819935|11754468|FG001|COMPLETED|Overall Study||4943
10598063|NCT01819935|11754467|FG000|NOT COMPLETED|Overall Study||0
10598064|NCT01819935|11754468|FG001|NOT COMPLETED|Overall Study||0
10598065|NCT01820260|11754488|FG000|STARTED|Phase 1 (Part 1)||3
10598066|NCT01820260|11754489|FG001|STARTED|Phase 1 (Part 1)||12
10703810|NCT02587234|11868319|FG001|STARTED|Overall Study||10
10703811|NCT02587234|11868318|FG000|COMPLETED|Overall Study||10
10703812|NCT02587234|11868319|FG001|COMPLETED|Overall Study||7
10703813|NCT02587234|11868318|FG000|NOT COMPLETED|Overall Study||1
10703814|NCT02587234|11868319|FG001|NOT COMPLETED|Overall Study||3
10703815|NCT02587351|11868327|FG000|STARTED|Overall Study||268
10598067|NCT01820260|11754490|FG002|STARTED|Phase 1 (Part 1)||10
10598068|NCT01820260|11754491|FG003|STARTED|Phase 1 (Part 1)||12
10598069|NCT01820260|11754492|FG004|STARTED|Phase 1 (Part 1)||12
10598070|NCT01820260|11754493|FG005|STARTED|Phase 1 (Part 1)||10
10598071|NCT01820260|11754494|FG006|STARTED|Phase 1 (Part 1)||12
10598072|NCT01820260|11754495|FG007|STARTED|Phase 1 (Part 1)||11
10598073|NCT01820260|11754496|FG008|STARTED|Phase 1 (Part 1)||0
10598074|NCT01820260|11754497|FG009|STARTED|Phase 1 (Part 1)||0
10598075|NCT01820260|11754498|FG010|STARTED|Phase 1 (Part 1)||0
10703816|NCT02587351|11868328|FG001|STARTED|Overall Study||264
10703817|NCT02587351|11868327|FG000|COMPLETED|Overall Study||268
10598076|NCT01820260|11754499|FG011|STARTED|Phase 1 (Part 1)||0
10598077|NCT01820260|11754500|FG012|STARTED|Phase 1 (Part 1)||0
10598078|NCT01820260|11754501|FG013|STARTED|Phase 1 (Part 1)||0
10598079|NCT01820260|11754488|FG000|COMPLETED|Phase 1 (Part 1)||3
10598080|NCT01820260|11754489|FG001|COMPLETED|Phase 1 (Part 1)||12
10598081|NCT01820260|11754490|FG002|COMPLETED|Phase 1 (Part 1)||10
10598082|NCT01820260|11754491|FG003|COMPLETED|Phase 1 (Part 1)||12
10598083|NCT01820260|11754492|FG004|COMPLETED|Phase 1 (Part 1)||12
10598084|NCT01820260|11754493|FG005|COMPLETED|Phase 1 (Part 1)||10
10598085|NCT01820260|11754494|FG006|COMPLETED|Phase 1 (Part 1)||11
10598086|NCT01820260|11754495|FG007|COMPLETED|Phase 1 (Part 1)||11
10598087|NCT01820260|11754496|FG008|COMPLETED|Phase 1 (Part 1)||0
10598088|NCT01820260|11754497|FG009|COMPLETED|Phase 1 (Part 1)||0
10598089|NCT01820260|11754498|FG010|COMPLETED|Phase 1 (Part 1)||0
10598090|NCT01820260|11754499|FG011|COMPLETED|Phase 1 (Part 1)||0
10598091|NCT01820260|11754500|FG012|COMPLETED|Phase 1 (Part 1)||0
10598092|NCT01820260|11754501|FG013|COMPLETED|Phase 1 (Part 1)||0
10598093|NCT01820260|11754488|FG000|NOT COMPLETED|Phase 1 (Part 1)||0
10598094|NCT01820260|11754489|FG001|NOT COMPLETED|Phase 1 (Part 1)||0
10598095|NCT01820260|11754490|FG002|NOT COMPLETED|Phase 1 (Part 1)||0
10598096|NCT01820260|11754491|FG003|NOT COMPLETED|Phase 1 (Part 1)||0
10598097|NCT01820260|11754492|FG004|NOT COMPLETED|Phase 1 (Part 1)||0
10598098|NCT01820260|11754493|FG005|NOT COMPLETED|Phase 1 (Part 1)||0
10598099|NCT01820260|11754494|FG006|NOT COMPLETED|Phase 1 (Part 1)||1
10598100|NCT01820260|11754495|FG007|NOT COMPLETED|Phase 1 (Part 1)||0
10598101|NCT01820260|11754496|FG008|NOT COMPLETED|Phase 1 (Part 1)||0
10598102|NCT01820260|11754497|FG009|NOT COMPLETED|Phase 1 (Part 1)||0
10598103|NCT01820260|11754498|FG010|NOT COMPLETED|Phase 1 (Part 1)||0
10598104|NCT01820260|11754499|FG011|NOT COMPLETED|Phase 1 (Part 1)||0
10598105|NCT01820260|11754500|FG012|NOT COMPLETED|Phase 1 (Part 1)||0
10598106|NCT01820260|11754501|FG013|NOT COMPLETED|Phase 1 (Part 1)||0
10598107|NCT01820260|11754488|FG000|STARTED|Phase 2 (Part 2)||0
10598108|NCT01820260|11754489|FG001|STARTED|Phase 2 (Part 2)||0
10598109|NCT01820260|11754490|FG002|STARTED|Phase 2 (Part 2)||0
10598110|NCT01820260|11754491|FG003|STARTED|Phase 2 (Part 2)||0
10598111|NCT01820260|11754492|FG004|STARTED|Phase 2 (Part 2)||0
10598112|NCT01820260|11754493|FG005|STARTED|Phase 2 (Part 2)||0
10598113|NCT01820260|11754494|FG006|STARTED|Phase 2 (Part 2)||0
10598114|NCT01820260|11754495|FG007|STARTED|Phase 2 (Part 2)||0
10598115|NCT01820260|11754496|FG008|STARTED|Phase 2 (Part 2)||64
10598116|NCT01820260|11754497|FG009|STARTED|Phase 2 (Part 2)||62
10598117|NCT01820260|11754498|FG010|STARTED|Phase 2 (Part 2)||61
10598118|NCT01820260|11754499|FG011|STARTED|Phase 2 (Part 2)||64
10598119|NCT01820260|11754500|FG012|STARTED|Phase 2 (Part 2)||31
10598120|NCT01820260|11754501|FG013|STARTED|Phase 2 (Part 2)||31
10598121|NCT01820260|11754488|FG000|COMPLETED|Phase 2 (Part 2)||0
10598122|NCT01820260|11754489|FG001|COMPLETED|Phase 2 (Part 2)||0
10598123|NCT01820260|11754490|FG002|COMPLETED|Phase 2 (Part 2)||0
10598124|NCT01820260|11754491|FG003|COMPLETED|Phase 2 (Part 2)||0
10598125|NCT01820260|11754492|FG004|COMPLETED|Phase 2 (Part 2)||0
10598126|NCT01820260|11754493|FG005|COMPLETED|Phase 2 (Part 2)||0
10598127|NCT01820260|11754494|FG006|COMPLETED|Phase 2 (Part 2)||0
10598128|NCT01820260|11754495|FG007|COMPLETED|Phase 2 (Part 2)||0
10598129|NCT01820260|11754496|FG008|COMPLETED|Phase 2 (Part 2)||64
10598130|NCT01820260|11754497|FG009|COMPLETED|Phase 2 (Part 2)||61
10598131|NCT01820260|11754498|FG010|COMPLETED|Phase 2 (Part 2)||61
10598132|NCT01820260|11754499|FG011|COMPLETED|Phase 2 (Part 2)||64
10598133|NCT01820260|11754500|FG012|COMPLETED|Phase 2 (Part 2)||31
10598134|NCT01820260|11754501|FG013|COMPLETED|Phase 2 (Part 2)||31
10598135|NCT01820260|11754488|FG000|NOT COMPLETED|Phase 2 (Part 2)||0
10598136|NCT01820260|11754489|FG001|NOT COMPLETED|Phase 2 (Part 2)||0
10598137|NCT01820260|11754490|FG002|NOT COMPLETED|Phase 2 (Part 2)||0
10598138|NCT01820260|11754491|FG003|NOT COMPLETED|Phase 2 (Part 2)||0
10598139|NCT01820260|11754492|FG004|NOT COMPLETED|Phase 2 (Part 2)||0
10598140|NCT01820260|11754493|FG005|NOT COMPLETED|Phase 2 (Part 2)||0
10598141|NCT01820260|11754494|FG006|NOT COMPLETED|Phase 2 (Part 2)||0
10598142|NCT01820260|11754495|FG007|NOT COMPLETED|Phase 2 (Part 2)||0
10598143|NCT01820260|11754496|FG008|NOT COMPLETED|Phase 2 (Part 2)||0
10598144|NCT01820260|11754497|FG009|NOT COMPLETED|Phase 2 (Part 2)||1
10598145|NCT01820260|11754498|FG010|NOT COMPLETED|Phase 2 (Part 2)||0
10598146|NCT01820260|11754499|FG011|NOT COMPLETED|Phase 2 (Part 2)||0
10598147|NCT01820260|11754500|FG012|NOT COMPLETED|Phase 2 (Part 2)||0
10598148|NCT01820260|11754501|FG013|NOT COMPLETED|Phase 2 (Part 2)||0
10598149|NCT01820364|11754537|FG000|STARTED|Part I: LGX818||15
10598150|NCT01820364|11754538|FG001|STARTED|Part I: LGX818||0
10598151|NCT01820364|11754537|FG000|COMPLETED|Part I: LGX818||1
10598152|NCT01820364|11754538|FG001|COMPLETED|Part I: LGX818||0
10598153|NCT01820364|11754537|FG000|NOT COMPLETED|Part I: LGX818||14
10598154|NCT01820364|11754538|FG001|NOT COMPLETED|Part I: LGX818||0
10598155|NCT01820364|11754537|FG000|STARTED|Part II: LGX818 + MEK162||0
10598156|NCT01820364|11754538|FG001|STARTED|Part II: LGX818 + MEK162||1
10598157|NCT01820364|11754537|FG000|COMPLETED|Part II: LGX818 + MEK162||0
10598158|NCT01820364|11754538|FG001|COMPLETED|Part II: LGX818 + MEK162||0
10598159|NCT01820364|11754537|FG000|NOT COMPLETED|Part II: LGX818 + MEK162||0
10598160|NCT01820364|11754538|FG001|NOT COMPLETED|Part II: LGX818 + MEK162||1
10598161|NCT01820416|11754547|FG000|STARTED|Overall Study||12
10598162|NCT01820416|11754548|FG001|STARTED|Overall Study||12
10598163|NCT01820416|11754549|FG002|STARTED|Overall Study||11
10598164|NCT01820416|11754547|FG000|COMPLETED|Overall Study||9
10598165|NCT01820416|11754548|FG001|COMPLETED|Overall Study||10
10598166|NCT01820416|11754549|FG002|COMPLETED|Overall Study||11
10598167|NCT01820416|11754547|FG000|NOT COMPLETED|Overall Study||3
10598168|NCT01820416|11754548|FG001|NOT COMPLETED|Overall Study||2
10598169|NCT01820416|11754549|FG002|NOT COMPLETED|Overall Study||0
10598170|NCT01820559|11754560|FG000|STARTED|Overall Study||136
10598171|NCT01820559|11754561|FG001|STARTED|Overall Study||135
10598172|NCT01820559|11754562|FG002|STARTED|Overall Study||139
10598173|NCT01820559|11754560|FG000|Randomized and Treated|Overall Study||136
10598174|NCT01820559|11754561|FG001|Randomized and Treated|Overall Study||135
10598175|NCT01820559|11754562|FG002|Randomized and Treated|Overall Study||139
10598176|NCT01820559|11754560|FG000|Completed Tutration Period|Overall Study||130
10598177|NCT01820559|11754561|FG001|Completed Tutration Period|Overall Study||134
10598178|NCT01820559|11754562|FG002|Completed Tutration Period|Overall Study||131
10598179|NCT01820559|11754560|FG000|Entered Maintenance Period|Overall Study||129
10598180|NCT01820559|11754561|FG001|Entered Maintenance Period|Overall Study||133
10598181|NCT01820559|11754562|FG002|Entered Maintenance Period|Overall Study||129
10598182|NCT01820559|11754560|FG000|Completed Maintenance Period|Overall Study||122
10598183|NCT01820559|11754561|FG001|Completed Maintenance Period|Overall Study||123
10598184|NCT01820559|11754562|FG002|Completed Maintenance Period|Overall Study||110
10598185|NCT01820559|11754560|FG000|COMPLETED|Overall Study||122
10598186|NCT01820559|11754561|FG001|COMPLETED|Overall Study||122
10598187|NCT01820559|11754562|FG002|COMPLETED|Overall Study||110
10598188|NCT01820559|11754560|FG000|NOT COMPLETED|Overall Study||14
10598189|NCT01820559|11754561|FG001|NOT COMPLETED|Overall Study||13
10598190|NCT01820559|11754562|FG002|NOT COMPLETED|Overall Study||29
10598191|NCT01820572|11754572|FG000|STARTED|Randomization||223
10598192|NCT01820572|11754573|FG001|STARTED|Randomization||223
10598193|NCT01820572|11754572|FG000|COMPLETED|Randomization||221
10598194|NCT01820572|11754573|FG001|COMPLETED|Randomization||222
10598195|NCT01820572|11754572|FG000|NOT COMPLETED|Randomization||2
10598196|NCT01820572|11754573|FG001|NOT COMPLETED|Randomization||1
10598197|NCT01820572|11754572|FG000|STARTED|Treatment Period||221
10598198|NCT01820572|11754573|FG001|STARTED|Treatment Period||222
10598199|NCT01820572|11754572|FG000|COMPLETED|Treatment Period||195
10598200|NCT01820572|11754573|FG001|COMPLETED|Treatment Period||186
10598201|NCT01820572|11754572|FG000|NOT COMPLETED|Treatment Period||26
10598202|NCT01820572|11754573|FG001|NOT COMPLETED|Treatment Period||36
10598203|NCT01820585|11754583|FG000|STARTED|Overall Study||131
10598204|NCT01820585|11754584|FG001|STARTED|Overall Study||130
10598205|NCT01820585|11754585|FG002|STARTED|Overall Study||135
10598206|NCT01820585|11754586|FG003|STARTED|Overall Study||132
10598207|NCT01820585|11754583|FG000|Randomized and Treated|Overall Study||131
10598208|NCT01820585|11754584|FG001|Randomized and Treated|Overall Study||130
10598209|NCT01820585|11754585|FG002|Randomized and Treated|Overall Study||135
10598210|NCT01820585|11754586|FG003|Randomized and Treated|Overall Study||132
10598211|NCT01820585|11754583|FG000|Full Analysis Set|Overall Study||131
10598212|NCT01820585|11754584|FG001|Full Analysis Set|Overall Study||130
10598213|NCT01820585|11754585|FG002|Full Analysis Set|Overall Study||135
10598214|NCT01820585|11754586|FG003|Full Analysis Set|Overall Study||129
10598215|NCT01820585|11754583|FG000|Completed Titration Period|Overall Study||128
10598216|NCT01820585|11754584|FG001|Completed Titration Period|Overall Study||125
10598217|NCT01820585|11754585|FG002|Completed Titration Period|Overall Study||131
10598218|NCT01820585|11754586|FG003|Completed Titration Period|Overall Study||126
10598219|NCT01820585|11754583|FG000|Entered Maintenance Period|Overall Study||128
10598220|NCT01820585|11754584|FG001|Entered Maintenance Period|Overall Study||124
10598221|NCT01820585|11754585|FG002|Entered Maintenance Period|Overall Study||131
10598222|NCT01820585|11754586|FG003|Entered Maintenance Period|Overall Study||123
10598223|NCT01820585|11754583|FG000|Completed Maintenance Period|Overall Study||105
10598224|NCT01820585|11754584|FG001|Completed Maintenance Period|Overall Study||98
10598225|NCT01820585|11754585|FG002|Completed Maintenance Period|Overall Study||101
10598226|NCT01820585|11754586|FG003|Completed Maintenance Period|Overall Study||84
10598227|NCT01820585|11754583|FG000|COMPLETED|Overall Study||104
10598228|NCT01820585|11754584|FG001|COMPLETED|Overall Study||98
10598229|NCT01820585|11754585|FG002|COMPLETED|Overall Study||101
10598230|NCT01820585|11754586|FG003|COMPLETED|Overall Study||83
10598231|NCT01820585|11754583|FG000|NOT COMPLETED|Overall Study||27
10598232|NCT01820585|11754584|FG001|NOT COMPLETED|Overall Study||32
10598233|NCT01820585|11754585|FG002|NOT COMPLETED|Overall Study||34
10598234|NCT01820585|11754586|FG003|NOT COMPLETED|Overall Study||49
10598235|NCT01820637|11754596|FG000|STARTED|Overall Study||57
10598236|NCT01820637|11754596|FG000|COMPLETED|Overall Study||54
10598237|NCT01820637|11754596|FG000|NOT COMPLETED|Overall Study||3
10598238|NCT01820754|11754600|FG000|STARTED|Overall Study||24
10598239|NCT01820754|11754600|FG000|COMPLETED|Overall Study||24
10598240|NCT01820754|11754600|FG000|NOT COMPLETED|Overall Study||0
10598241|NCT01821105|11754604|FG000|STARTED|Overall Study||21
10598242|NCT01821105|11754604|FG000|COMPLETED|Overall Study||21
10598243|NCT01821105|11754604|FG000|NOT COMPLETED|Overall Study||0
10598244|NCT01821118|11754610|FG000|STARTED|Overall Study||24
10598245|NCT01821118|11754611|FG001|STARTED|Overall Study||12
10598246|NCT01821118|11754610|FG000|COMPLETED|Overall Study||24
10598247|NCT01821118|11754611|FG001|COMPLETED|Overall Study||11
10598248|NCT01821118|11754610|FG000|NOT COMPLETED|Overall Study||0
10598249|NCT01821118|11754611|FG001|NOT COMPLETED|Overall Study||1
10598250|NCT01821300|11754619|FG000|STARTED|Overall Study||154
10598251|NCT01821300|11754620|FG001|STARTED|Overall Study||103
10598252|NCT01821300|11754619|FG000|COMPLETED|Overall Study||154
10598253|NCT01821300|11754620|FG001|COMPLETED|Overall Study||103
10598254|NCT01821300|11754619|FG000|NOT COMPLETED|Overall Study||0
10598255|NCT01821300|11754620|FG001|NOT COMPLETED|Overall Study||0
10598256|NCT01821326|11754632|FG000|STARTED|Overall Study||339
10598257|NCT01821326|11754632|FG000|COMPLETED|Overall Study||339
10598258|NCT01821326|11754632|FG000|NOT COMPLETED|Overall Study||0
10598259|NCT01821352|11754638|FG000|STARTED|Overall Study||28
10598260|NCT01821352|11754639|FG001|STARTED|Overall Study||25
10598261|NCT01821352|11754638|FG000|COMPLETED|Overall Study||28
10598262|NCT01821352|11754639|FG001|COMPLETED|Overall Study||25
10598263|NCT01821352|11754638|FG000|NOT COMPLETED|Overall Study||0
10598264|NCT01821352|11754639|FG001|NOT COMPLETED|Overall Study||0
10598265|NCT01821378|11754648|FG000|STARTED|Overall Study||101
10598266|NCT01821378|11754649|FG001|STARTED|Overall Study||199
10598267|NCT01821378|11754650|FG002|STARTED|Overall Study||112
10598268|NCT01821378|11754648|FG000|COMPLETED|Overall Study||74
10598269|NCT01821378|11754649|FG001|COMPLETED|Overall Study||145
10598270|NCT01821378|11754650|FG002|COMPLETED|Overall Study||70
10598271|NCT01821378|11754648|FG000|NOT COMPLETED|Overall Study||27
10598272|NCT01821378|11754649|FG001|NOT COMPLETED|Overall Study||54
10598273|NCT01821378|11754650|FG002|NOT COMPLETED|Overall Study||42
10598274|NCT01821391|11754665|FG000|STARTED|Overall Study||108
10598275|NCT01821391|11754666|FG001|STARTED|Overall Study||23
10598276|NCT01821391|11754665|FG000|COMPLETED|Overall Study||107
10598277|NCT01821391|11754666|FG001|COMPLETED|Overall Study||23
10598278|NCT01821391|11754665|FG000|NOT COMPLETED|Overall Study||1
10598279|NCT01821391|11754666|FG001|NOT COMPLETED|Overall Study||0
10598280|NCT01821417|11754676|FG000|STARTED|Overall Study||37
10598281|NCT01821417|11754677|FG001|STARTED|Overall Study||31
10598282|NCT01821417|11754676|FG000|COMPLETED|Overall Study||37
10598283|NCT01821417|11754677|FG001|COMPLETED|Overall Study||31
10598284|NCT01821417|11754676|FG000|NOT COMPLETED|Overall Study||0
10598285|NCT01821417|11754677|FG001|NOT COMPLETED|Overall Study||0
10598286|NCT01821534|11754683|FG000|STARTED|Overall Study||201
10598287|NCT01821534|11754683|FG000|COMPLETED|Overall Study||201
10598288|NCT01821534|11754683|FG000|NOT COMPLETED|Overall Study||0
10598289|NCT01821560|11754689|FG000|STARTED|Overall Study||22
10598290|NCT01821560|11754690|FG001|STARTED|Overall Study||22
10598291|NCT01821560|11754689|FG000|COMPLETED|Overall Study||16
10598292|NCT01821560|11754690|FG001|COMPLETED|Overall Study||15
10598293|NCT01821560|11754689|FG000|NOT COMPLETED|Overall Study||6
10598294|NCT01821560|11754690|FG001|NOT COMPLETED|Overall Study||7
10598295|NCT01821625|11754696|FG000|STARTED|Overall Study||7
10598296|NCT01821625|11754696|FG000|COMPLETED|Overall Study||1
10598297|NCT01821625|11754696|FG000|NOT COMPLETED|Overall Study||6
10598298|NCT01821729|11754700|FG000|STARTED|Overall Study||50
10598299|NCT01821729|11754700|FG000|Received Chemoradiotherapy|Overall Study||45
10598300|NCT01821729|11754700|FG000|Underwent Attempted Surgery|Overall Study||42
10598301|NCT01821729|11754700|FG000|COMPLETED|Overall Study||49
10598302|NCT01821729|11754700|FG000|NOT COMPLETED|Overall Study||1
10598303|NCT01821807|11754706|FG000|STARTED|Overall Study||150
10807913|NCT03885154|11969673|FG002|COMPLETED|Overall Study||0
10598304|NCT01821807|11754707|FG001|STARTED|Overall Study||110
10598305|NCT01821807|11754706|FG000|COMPLETED|Overall Study||147
10598306|NCT01821807|11754707|FG001|COMPLETED|Overall Study||109
10598307|NCT01821807|11754706|FG000|NOT COMPLETED|Overall Study||3
10598308|NCT01821807|11754707|FG001|NOT COMPLETED|Overall Study||1
10598309|NCT01821937|11754715|FG000|STARTED|Overall Study||10
10598310|NCT01821937|11754716|FG001|STARTED|Overall Study||15
10598311|NCT01821937|11754715|FG000|COMPLETED|Overall Study||10
10598312|NCT01821937|11754716|FG001|COMPLETED|Overall Study|2 patients discontinued during Single dose period,1 Patient discontinued during Multiple dose period|12
10598313|NCT01821937|11754715|FG000|NOT COMPLETED|Overall Study||0
10598314|NCT01821937|11754716|FG001|NOT COMPLETED|Overall Study||3
10598315|NCT01822119|11754724|FG000|STARTED|Overall Study||27
10598316|NCT01822119|11754724|FG000|COMPLETED|Overall Study||27
10598317|NCT01822119|11754724|FG000|NOT COMPLETED|Overall Study||0
10598318|NCT01822132|11754730|FG000|STARTED|Overall Study||25
10598319|NCT01822132|11754731|FG001|STARTED|Overall Study||27
10598320|NCT01822132|11754730|FG000|COMPLETED|Overall Study||21
10598321|NCT01822132|11754731|FG001|COMPLETED|Overall Study||25
10598322|NCT01822132|11754730|FG000|NOT COMPLETED|Overall Study||4
10598323|NCT01822132|11754731|FG001|NOT COMPLETED|Overall Study||2
10598324|NCT01822197|11754743|FG000|STARTED|Overall Study||30
10598325|NCT01822197|11754743|FG000|COMPLETED|Overall Study||30
10598326|NCT01822197|11754743|FG000|NOT COMPLETED|Overall Study||0
10598327|NCT01822223|11754749|FG000|STARTED|Overall Study||10
10807914|NCT03885154|11969674|FG003|COMPLETED|Overall Study||2
10598328|NCT01822223|11754750|FG001|STARTED|Overall Study||10
10598329|NCT01822223|11754749|FG000|COMPLETED|Overall Study||10
10598330|NCT01822223|11754750|FG001|COMPLETED|Overall Study||9
10598331|NCT01822223|11754749|FG000|NOT COMPLETED|Overall Study||0
10598332|NCT01822223|11754750|FG001|NOT COMPLETED|Overall Study||1
10598333|NCT01822301|11754758|FG000|STARTED|Overall Study||5
10598334|NCT01822301|11754758|FG000|COMPLETED|Overall Study||5
10598335|NCT01822301|11754758|FG000|NOT COMPLETED|Overall Study||0
10598336|NCT01822353|11754771|FG000|STARTED|Overall Study||10
10598337|NCT01822353|11754772|FG001|STARTED|Overall Study||9
10598338|NCT01822353|11754773|FG002|STARTED|Overall Study||4
10598339|NCT01822353|11754771|FG000|COMPLETED|Overall Study||6
10598340|NCT01822353|11754772|FG001|COMPLETED|Overall Study||4
10598341|NCT01822353|11754773|FG002|COMPLETED|Overall Study||3
10598342|NCT01822353|11754771|FG000|NOT COMPLETED|Overall Study||4
10598343|NCT01822353|11754772|FG001|NOT COMPLETED|Overall Study||5
10598344|NCT01822353|11754773|FG002|NOT COMPLETED|Overall Study||1
10598345|NCT01822366|11754788|FG000|STARTED|Overall Study||320
10598346|NCT01822366|11754789|FG001|STARTED|Overall Study||320
10598347|NCT01822366|11754790|FG002|STARTED|Overall Study||320
10598348|NCT01822366|11754791|FG003|STARTED|Overall Study||320
10598349|NCT01822366|11754788|FG000|COMPLETED|Overall Study||315
10598350|NCT01822366|11754789|FG001|COMPLETED|Overall Study||298
10598351|NCT01822366|11754790|FG002|COMPLETED|Overall Study||315
10598352|NCT01822366|11754791|FG003|COMPLETED|Overall Study||298
10598353|NCT01822366|11754788|FG000|NOT COMPLETED|Overall Study||5
10598354|NCT01822366|11754789|FG001|NOT COMPLETED|Overall Study||22
10598355|NCT01822366|11754790|FG002|NOT COMPLETED|Overall Study||5
10598356|NCT01822366|11754791|FG003|NOT COMPLETED|Overall Study||22
10598357|NCT01822457|11754821|FG000|STARTED|Overall Study||20
10598358|NCT01822457|11754822|FG001|STARTED|Overall Study||17
10598359|NCT01822457|11754821|FG000|COMPLETED|Overall Study||16
10598360|NCT01822457|11754822|FG001|COMPLETED|Overall Study||12
10598361|NCT01822457|11754821|FG000|NOT COMPLETED|Overall Study||4
10598362|NCT01822457|11754822|FG001|NOT COMPLETED|Overall Study||5
10598363|NCT01822496|11754832|FG000|STARTED|Overall Study||16
10598364|NCT01822496|11754833|FG001|STARTED|Overall Study||23
10598365|NCT01822496|11754834|FG002|STARTED|Overall Study||9
10598366|NCT01822496|11754835|FG003|STARTED|Overall Study||11
10598367|NCT01822496|11754832|FG000|Eligible|Overall Study||14
10598368|NCT01822496|11754833|FG001|Eligible|Overall Study||21
10598369|NCT01822496|11754834|FG002|Eligible|Overall Study||9
10598370|NCT01822496|11754835|FG003|Eligible|Overall Study||7
10598371|NCT01822496|11754832|FG000|Eligible With Disease Assessment|Overall Study||10
10598372|NCT01822496|11754833|FG001|Eligible With Disease Assessment|Overall Study||15
10598373|NCT01822496|11754834|FG002|Eligible With Disease Assessment|Overall Study||6
10598374|NCT01822496|11754835|FG003|Eligible With Disease Assessment|Overall Study||4
10598375|NCT01822496|11754832|FG000|Eligible and Started Study Treatment|Overall Study||14
10598376|NCT01822496|11754833|FG001|Eligible and Started Study Treatment|Overall Study||20
10598377|NCT01822496|11754834|FG002|Eligible and Started Study Treatment|Overall Study||9
10598378|NCT01822496|11754835|FG003|Eligible and Started Study Treatment|Overall Study||7
10598379|NCT01822496|11754832|FG000|COMPLETED|Overall Study||14
10598380|NCT01822496|11754833|FG001|COMPLETED|Overall Study||21
10598381|NCT01822496|11754834|FG002|COMPLETED|Overall Study||9
10598382|NCT01822496|11754835|FG003|COMPLETED|Overall Study||7
10598383|NCT01822496|11754832|FG000|NOT COMPLETED|Overall Study||2
10598384|NCT01822496|11754833|FG001|NOT COMPLETED|Overall Study||2
10598385|NCT01822496|11754834|FG002|NOT COMPLETED|Overall Study||0
10598386|NCT01822496|11754835|FG003|NOT COMPLETED|Overall Study||4
10598387|NCT01822535|11754847|FG000|STARTED|Visit 1 - Tetraplegia and Able-Bodied||17
10598388|NCT01822535|11754848|FG001|STARTED|Visit 1 - Tetraplegia and Able-Bodied||13
10598389|NCT01822535|11754847|FG000|COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||11
10598390|NCT01822535|11754848|FG001|COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||11
10598391|NCT01822535|11754847|FG000|NOT COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||6
10598392|NCT01822535|11754848|FG001|NOT COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||2
10598393|NCT01822535|11754847|FG000|STARTED|Visit 2 - Tetraplegia Only - Drug|These subjects were individuals who completed Visit 1 of testing.|11
10598394|NCT01822535|11754848|FG001|STARTED|Visit 2 - Tetraplegia Only - Drug|Able-bodied subjects were not enrolled for a second visit.|0
10598395|NCT01822535|11754847|FG000|COMPLETED|Visit 2 - Tetraplegia Only - Drug||10
10598396|NCT01822535|11754848|FG001|COMPLETED|Visit 2 - Tetraplegia Only - Drug||0
10598397|NCT01822535|11754847|FG000|NOT COMPLETED|Visit 2 - Tetraplegia Only - Drug||1
10598398|NCT01822535|11754848|FG001|NOT COMPLETED|Visit 2 - Tetraplegia Only - Drug||0
10598399|NCT01822548|11754859|FG000|STARTED|Overall Study|Received allocated intervention n=38 Did not receive allocated intervention (only metformin) n=2|40
10598400|NCT01822548|11754860|FG001|STARTED|Overall Study||24
10598401|NCT01822548|11754859|FG000|Discontinued Intervention|Overall Study||0
10598402|NCT01822548|11754860|FG001|Discontinued Intervention|Overall Study||5
10598403|NCT01822548|11754859|FG000|COMPLETED|Overall Study||40
10598404|NCT01822548|11754860|FG001|COMPLETED|Overall Study||24
10598405|NCT01822548|11754859|FG000|NOT COMPLETED|Overall Study||0
10598406|NCT01822548|11754860|FG001|NOT COMPLETED|Overall Study||0
10598407|NCT01822561|11754866|FG000|STARTED|Overall Study||15
10598408|NCT01822561|11754866|FG000|COMPLETED|Overall Study||13
10598409|NCT01822561|11754866|FG000|NOT COMPLETED|Overall Study||2
10598410|NCT01822574|11754877|FG000|STARTED|Overall Study||30
10598411|NCT01822574|11754878|FG001|STARTED|Overall Study||30
10598412|NCT01822574|11754879|FG002|STARTED|Overall Study||30
10598413|NCT01822574|11754877|FG000|COMPLETED|Overall Study||30
10598414|NCT01822574|11754878|FG001|COMPLETED|Overall Study||30
10598415|NCT01822574|11754879|FG002|COMPLETED|Overall Study||30
10598416|NCT01822574|11754877|FG000|NOT COMPLETED|Overall Study||0
10598417|NCT01822574|11754878|FG001|NOT COMPLETED|Overall Study||0
10598418|NCT01822574|11754879|FG002|NOT COMPLETED|Overall Study||0
10598419|NCT01822587|11754890|FG000|STARTED|Overall Study||59
10598420|NCT01822587|11754891|FG001|STARTED|Overall Study||60
10598421|NCT01822587|11754892|FG002|STARTED|Overall Study||62
10598422|NCT01822587|11754890|FG000|COMPLETED|Overall Study||43
10598423|NCT01822587|11754891|FG001|COMPLETED|Overall Study||45
10598424|NCT01822587|11754892|FG002|COMPLETED|Overall Study||44
10598425|NCT01822587|11754890|FG000|NOT COMPLETED|Overall Study||16
10598426|NCT01822587|11754891|FG001|NOT COMPLETED|Overall Study||15
10598427|NCT01822587|11754892|FG002|NOT COMPLETED|Overall Study||18
10598428|NCT01822665|11754900|FG000|STARTED|Overall Study||28
10652324|NCT02184169|11812689|FG000|STARTED|Overall Study||21
10598429|NCT01822665|11754900|FG000|Received Ibuprofen Tablet (400 mg)|Overall Study|5 participants did not complete; Period 3(2:adverse events;1:other reason); Period 4(2:other reason)|23
10598430|NCT01822665|11754900|FG000|Received Placebo Tablet|Overall Study|5 participants did not complete; Period 2(1:other reason); Period 4(3:adverse event; 1:other reason)|23
10598431|NCT01822665|11754900|FG000|Received Ibuprofen Capsule (400 mg)|Overall Study|Two participants, each in period 3 and period 4 did not complete treatment for 'other reason'.|24
10598432|NCT01822665|11754900|FG000|Received Paracetamol Tablet (1000 mg)|Overall Study||28
10598433|NCT01822665|11754900|FG000|COMPLETED|Overall Study||20
10598434|NCT01822665|11754900|FG000|NOT COMPLETED|Overall Study||8
10598435|NCT01822678|11754921|FG000|STARTED|Overall Study||57
10598436|NCT01822678|11754922|FG001|STARTED|Overall Study||64
10598437|NCT01822678|11754923|FG002|STARTED|Overall Study||40
10598438|NCT01822678|11754921|FG000|Treated|Overall Study||57
10598439|NCT01822678|11754922|FG001|Treated|Overall Study||64
10598440|NCT01822678|11754923|FG002|Treated|Overall Study||40
10598441|NCT01822678|11754921|FG000|Safety Population|Overall Study||57
10598442|NCT01822678|11754922|FG001|Safety Population|Overall Study||64
10598443|NCT01822678|11754923|FG002|Safety Population|Overall Study||40
10598444|NCT01822678|11754921|FG000|Intention-to-Treat Population (ITT)|Overall Study||57
10598445|NCT01822678|11754922|FG001|Intention-to-Treat Population (ITT)|Overall Study|1 patient was excluded from the ITT population because he did not have post baseline efficacy data|63
10598446|NCT01822678|11754923|FG002|Intention-to-Treat Population (ITT)|Overall Study||40
10598447|NCT01822678|11754921|FG000|Per Protocol Population|Overall Study||45
10598448|NCT01822678|11754922|FG001|Per Protocol Population|Overall Study||52
10598449|NCT01822678|11754923|FG002|Per Protocol Population|Overall Study||34
10598450|NCT01822678|11754921|FG000|COMPLETED|Overall Study||45
10598451|NCT01822678|11754922|FG001|COMPLETED|Overall Study||49
10598452|NCT01822678|11754923|FG002|COMPLETED|Overall Study||29
10598453|NCT01822678|11754921|FG000|NOT COMPLETED|Overall Study||12
10598454|NCT01822678|11754922|FG001|NOT COMPLETED|Overall Study||15
10598455|NCT01822678|11754923|FG002|NOT COMPLETED|Overall Study||11
10598456|NCT01822691|11754931|FG000|STARTED|Overall Study||15
10598457|NCT01822691|11754931|FG000|COMPLETED|Overall Study||13
10598458|NCT01822691|11754931|FG000|NOT COMPLETED|Overall Study||2
10598459|NCT01822756|11754940|FG000|STARTED|Overall Study||16
10598460|NCT01822756|11754941|FG001|STARTED|Overall Study||4
10598461|NCT01822756|11754942|FG002|STARTED|Overall Study||10
10598462|NCT01822756|11754943|FG003|STARTED|Overall Study||4
10703818|NCT02587351|11868328|FG001|COMPLETED|Overall Study||264
10703819|NCT02587351|11868327|FG000|NOT COMPLETED|Overall Study||0
10703820|NCT02587351|11868328|FG001|NOT COMPLETED|Overall Study||0
10703821|NCT02587819|11868334|FG000|STARTED|Overall Study||21
10703822|NCT02587819|11868334|FG000|Exposed|Overall Study||21
10703823|NCT02587819|11868334|FG000|COMPLETED|Overall Study||19
10703824|NCT02587819|11868334|FG000|NOT COMPLETED|Overall Study||2
10703825|NCT02587962|11868344|FG000|STARTED|Overall Study||3
10807915|NCT03885154|11969671|FG000|NOT COMPLETED|Overall Study||0
10807916|NCT03885154|11969672|FG001|NOT COMPLETED|Overall Study||0
10807917|NCT03885154|11969673|FG002|NOT COMPLETED|Overall Study||0
10807918|NCT03885154|11969674|FG003|NOT COMPLETED|Overall Study||0
10598463|NCT01822756|11754944|FG004|STARTED|Overall Study||8
10598464|NCT01822756|11754940|FG000|Discontinued From the Study|Overall Study||16
10598465|NCT01822756|11754941|FG001|Discontinued From the Study|Overall Study||4
10598466|NCT01822756|11754942|FG002|Discontinued From the Study|Overall Study||10
10598467|NCT01822756|11754943|FG003|Discontinued From the Study|Overall Study||4
10598468|NCT01822756|11754944|FG004|Discontinued From the Study|Overall Study||7
10598469|NCT01822756|11754940|FG000|COMPLETED|Overall Study||0
10598470|NCT01822756|11754941|FG001|COMPLETED|Overall Study||0
10598471|NCT01822756|11754942|FG002|COMPLETED|Overall Study||0
10598472|NCT01822756|11754943|FG003|COMPLETED|Overall Study||0
10598473|NCT01822756|11754944|FG004|COMPLETED|Overall Study||1
10598474|NCT01822756|11754940|FG000|NOT COMPLETED|Overall Study||16
10598475|NCT01822756|11754941|FG001|NOT COMPLETED|Overall Study||4
10598476|NCT01822756|11754942|FG002|NOT COMPLETED|Overall Study||10
10598477|NCT01822756|11754943|FG003|NOT COMPLETED|Overall Study||4
10598478|NCT01822756|11754944|FG004|NOT COMPLETED|Overall Study||7
10598479|NCT01822821|11754958|FG000|STARTED|Overall Study||75
10598480|NCT01822821|11754959|FG001|STARTED|Overall Study||75
10598481|NCT01822821|11754958|FG000|COMPLETED|Overall Study||73
10703826|NCT02587962|11868345|FG001|STARTED|Overall Study||3
10807919|NCT03883386|11969684|FG000|STARTED|First Assignment||2
10807920|NCT03883386|11969685|FG001|STARTED|First Assignment||1
10807921|NCT03883386|11969684|FG000|Surveys Begun|First Assignment||1
10807922|NCT03883386|11969685|FG001|Surveys Begun|First Assignment||1
10807923|NCT03883386|11969684|FG000|COMPLETED|First Assignment||0
10598482|NCT01822821|11754959|FG001|COMPLETED|Overall Study||74
10598483|NCT01822821|11754958|FG000|NOT COMPLETED|Overall Study||2
10598484|NCT01822821|11754959|FG001|NOT COMPLETED|Overall Study||1
10598485|NCT01822886|11754965|FG000|STARTED|Overall Study||20
10598486|NCT01822886|11754965|FG000|COMPLETED|Overall Study||5
10598487|NCT01822886|11754965|FG000|NOT COMPLETED|Overall Study||15
10703827|NCT02587962|11868346|FG002|STARTED|Overall Study||6
10703828|NCT02587962|11868347|FG003|STARTED|Overall Study||7
10703829|NCT02587962|11868348|FG004|STARTED|Overall Study||15
10807924|NCT03883386|11969685|FG001|COMPLETED|First Assignment||0
10807925|NCT03883386|11969684|FG000|NOT COMPLETED|First Assignment||2
10807926|NCT03883386|11969685|FG001|NOT COMPLETED|First Assignment||1
10807927|NCT03883386|11969684|FG000|STARTED|Washout and Second Assignment||0
10807928|NCT03883386|11969685|FG001|STARTED|Washout and Second Assignment||0
10598488|NCT01822899|11754971|FG000|STARTED|Overall Study||358
10598489|NCT01822899|11754972|FG001|STARTED|Overall Study||358
10598490|NCT01822899|11754971|FG000|COMPLETED|Overall Study||334
10598491|NCT01822899|11754972|FG001|COMPLETED|Overall Study||340
10598492|NCT01822899|11754971|FG000|NOT COMPLETED|Overall Study||24
10598493|NCT01822899|11754972|FG001|NOT COMPLETED|Overall Study||18
10598494|NCT01822925|11754982|FG000|STARTED|Overall Study||32
10598495|NCT01822925|11754983|FG001|STARTED|Overall Study||32
10598496|NCT01822925|11754984|FG002|STARTED|Overall Study||32
10598497|NCT01822925|11754985|FG003|STARTED|Overall Study||32
10598498|NCT01822925|11754982|FG000|COMPLETED|Overall Study||26
10598499|NCT01822925|11754983|FG001|COMPLETED|Overall Study||30
10598500|NCT01822925|11754984|FG002|COMPLETED|Overall Study||29
10598501|NCT01822925|11754985|FG003|COMPLETED|Overall Study||27
10598502|NCT01822925|11754982|FG000|NOT COMPLETED|Overall Study||6
10598503|NCT01822925|11754983|FG001|NOT COMPLETED|Overall Study||2
10598504|NCT01822925|11754984|FG002|NOT COMPLETED|Overall Study||3
10598505|NCT01822925|11754985|FG003|NOT COMPLETED|Overall Study||5
10598506|NCT01823107|11754995|FG000|STARTED|Overall Study||25
10598507|NCT01823107|11754995|FG000|COMPLETED|Overall Study||24
10598508|NCT01823107|11754995|FG000|NOT COMPLETED|Overall Study||1
10598509|NCT01823146|11755001|FG000|STARTED|Overall Study||55
10598510|NCT01823146|11755002|FG001|STARTED|Overall Study||51
10598511|NCT01823146|11755001|FG000|COMPLETED|Overall Study||53
10598512|NCT01823146|11755002|FG001|COMPLETED|Overall Study||49
10598513|NCT01823146|11755001|FG000|NOT COMPLETED|Overall Study||2
10598514|NCT01823146|11755002|FG001|NOT COMPLETED|Overall Study||2
10598515|NCT01823224|11755010|FG000|STARTED|Overall Study||34
10598516|NCT01823224|11755011|FG001|STARTED|Overall Study||33
10598517|NCT01823224|11755010|FG000|COMPLETED|Overall Study||28
10598518|NCT01823224|11755011|FG001|COMPLETED|Overall Study||22
10598519|NCT01823224|11755010|FG000|NOT COMPLETED|Overall Study||6
10598520|NCT01823224|11755011|FG001|NOT COMPLETED|Overall Study||11
10598521|NCT01823289|11755019|FG000|STARTED|Overall Study||71
10598522|NCT01823289|11755019|FG000|COMPLETED|Overall Study||47
10598523|NCT01823289|11755019|FG000|NOT COMPLETED|Overall Study||24
10598524|NCT01823328|11755025|FG000|STARTED|Overall Study||70
10598525|NCT01823328|11755026|FG001|STARTED|Overall Study||73
10598526|NCT01823328|11755025|FG000|COMPLETED|Overall Study||62
10598527|NCT01823328|11755026|FG001|COMPLETED|Overall Study||67
10598528|NCT01823328|11755025|FG000|NOT COMPLETED|Overall Study||8
10598529|NCT01823328|11755026|FG001|NOT COMPLETED|Overall Study||6
10598530|NCT01823341|11755032|FG000|STARTED|Overall Study||97
10598531|NCT01823341|11755032|FG000|COMPLETED|Overall Study||82
10598532|NCT01823341|11755032|FG000|NOT COMPLETED|Overall Study||15
10598533|NCT01823497|11755041|FG000|STARTED|Overall Study||19
10598534|NCT01823497|11755042|FG001|STARTED|Overall Study||17
10598535|NCT01823497|11755041|FG000|COMPLETED|Overall Study||16
10598536|NCT01823497|11755042|FG001|COMPLETED|Overall Study||9
10598537|NCT01823497|11755041|FG000|NOT COMPLETED|Overall Study||3
10598538|NCT01823497|11755042|FG001|NOT COMPLETED|Overall Study||8
10598539|NCT01823510|11755048|FG000|STARTED|Days 1-7||10
10598540|NCT01823510|11755049|FG001|STARTED|Days 1-7||10
10598541|NCT01823510|11755048|FG000|COMPLETED|Days 1-7||10
10598542|NCT01823510|11755049|FG001|COMPLETED|Days 1-7||10
10598543|NCT01823510|11755048|FG000|NOT COMPLETED|Days 1-7||0
10598544|NCT01823510|11755049|FG001|NOT COMPLETED|Days 1-7||0
10598545|NCT01823510|11755048|FG000|STARTED|Days 8-21||10
10598546|NCT01823510|11755049|FG001|STARTED|Days 8-21||10
10598547|NCT01823510|11755048|FG000|COMPLETED|Days 8-21||10
10598548|NCT01823510|11755049|FG001|COMPLETED|Days 8-21||10
10598549|NCT01823510|11755048|FG000|NOT COMPLETED|Days 8-21||0
10598550|NCT01823510|11755049|FG001|NOT COMPLETED|Days 8-21||0
10598551|NCT01823510|11755048|FG000|STARTED|Days 22-28||10
10598552|NCT01823510|11755049|FG001|STARTED|Days 22-28||10
10598553|NCT01823510|11755048|FG000|COMPLETED|Days 22-28||10
10598554|NCT01823510|11755049|FG001|COMPLETED|Days 22-28||10
10598555|NCT01823510|11755048|FG000|NOT COMPLETED|Days 22-28||0
10703830|NCT02587962|11868344|FG000|COMPLETED|Overall Study||1
10703831|NCT02587962|11868345|FG001|COMPLETED|Overall Study||0
10598556|NCT01823510|11755049|FG001|NOT COMPLETED|Days 22-28||0
10598557|NCT01823536|11755061|FG000|STARTED|Overall Study||73
10598558|NCT01823536|11755062|FG001|STARTED|Overall Study||103
10598559|NCT01823536|11755063|FG002|STARTED|Overall Study||120
10598560|NCT01823536|11755064|FG003|STARTED|Overall Study||66
10598561|NCT01823536|11755065|FG004|STARTED|Overall Study||101
10598562|NCT01823536|11755066|FG005|STARTED|Overall Study||2
10598563|NCT01823536|11755061|FG000|COMPLETED|Overall Study||71
10598564|NCT01823536|11755062|FG001|COMPLETED|Overall Study||101
10598565|NCT01823536|11755063|FG002|COMPLETED|Overall Study||119
10598566|NCT01823536|11755064|FG003|COMPLETED|Overall Study||64
10598567|NCT01823536|11755065|FG004|COMPLETED|Overall Study||99
10598568|NCT01823536|11755066|FG005|COMPLETED|Overall Study||2
10598569|NCT01823536|11755061|FG000|NOT COMPLETED|Overall Study||2
10703832|NCT02587962|11868346|FG002|COMPLETED|Overall Study||0
10598570|NCT01823536|11755062|FG001|NOT COMPLETED|Overall Study||2
10598571|NCT01823536|11755063|FG002|NOT COMPLETED|Overall Study||1
10598572|NCT01823536|11755064|FG003|NOT COMPLETED|Overall Study||2
10598573|NCT01823536|11755065|FG004|NOT COMPLETED|Overall Study||2
10598574|NCT01823536|11755066|FG005|NOT COMPLETED|Overall Study||0
10598575|NCT01823614|11755085|FG000|STARTED|Overall Study||179
10598576|NCT01823614|11755086|FG001|STARTED|Overall Study||140
10598577|NCT01823614|11755087|FG002|STARTED|Overall Study||176
10598578|NCT01823614|11755088|FG003|STARTED|Overall Study||122
10598579|NCT01823614|11755089|FG004|STARTED|Overall Study||172
10598580|NCT01823614|11755090|FG005|STARTED|Overall Study||154
10598581|NCT01823614|11755085|FG000|COMPLETED|Overall Study||179
10598582|NCT01823614|11755086|FG001|COMPLETED|Overall Study||140
10598583|NCT01823614|11755087|FG002|COMPLETED|Overall Study||176
10598584|NCT01823614|11755088|FG003|COMPLETED|Overall Study||122
10598585|NCT01823614|11755089|FG004|COMPLETED|Overall Study||172
10598586|NCT01823614|11755090|FG005|COMPLETED|Overall Study||154
10598587|NCT01823614|11755085|FG000|NOT COMPLETED|Overall Study||0
10598588|NCT01823614|11755086|FG001|NOT COMPLETED|Overall Study||0
10598589|NCT01823614|11755087|FG002|NOT COMPLETED|Overall Study||0
10598590|NCT01823614|11755088|FG003|NOT COMPLETED|Overall Study||0
10598591|NCT01823614|11755089|FG004|NOT COMPLETED|Overall Study||0
10598592|NCT01823614|11755090|FG005|NOT COMPLETED|Overall Study||0
10598593|NCT01823653|11755110|FG000|STARTED|Overall Study||60
10598594|NCT01823653|11755110|FG000|COMPLETED|Overall Study||60
10598595|NCT01823653|11755110|FG000|NOT COMPLETED|Overall Study||0
10598596|NCT01823679|11755117|FG000|STARTED|Overall Study||2
10598597|NCT01823679|11755117|FG000|COMPLETED|Overall Study||1
10598598|NCT01823679|11755117|FG000|NOT COMPLETED|Overall Study||1
10598599|NCT01823835|11755137|FG000|STARTED|Overall Study||3
10598600|NCT01823835|11755138|FG001|STARTED|Overall Study||4
10598601|NCT01823835|11755139|FG002|STARTED|Overall Study||4
10598602|NCT01823835|11755140|FG003|STARTED|Overall Study||6
10598603|NCT01823835|11755141|FG004|STARTED|Overall Study||6
10598604|NCT01823835|11755142|FG005|STARTED|Overall Study||6
10598605|NCT01823835|11755143|FG006|STARTED|Overall Study||6
10598606|NCT01823835|11755144|FG007|STARTED|Overall Study||3
10598607|NCT01823835|11755145|FG008|STARTED|Overall Study||3
10598608|NCT01823835|11755146|FG009|STARTED|Overall Study||19
10598609|NCT01823835|11755147|FG010|STARTED|Overall Study||10
10598610|NCT01823835|11755148|FG011|STARTED|Overall Study||53
10598611|NCT01823835|11755149|FG012|STARTED|Overall Study||19
10598612|NCT01823835|11755150|FG013|STARTED|Overall Study||4
10598613|NCT01823835|11755151|FG014|STARTED|Overall Study||6
10598614|NCT01823835|11755137|FG000|COMPLETED|Overall Study||0
10598615|NCT01823835|11755138|FG001|COMPLETED|Overall Study||0
10598616|NCT01823835|11755139|FG002|COMPLETED|Overall Study||0
10598617|NCT01823835|11755140|FG003|COMPLETED|Overall Study||0
10598618|NCT01823835|11755141|FG004|COMPLETED|Overall Study||0
10598619|NCT01823835|11755142|FG005|COMPLETED|Overall Study||0
10598620|NCT01823835|11755143|FG006|COMPLETED|Overall Study||0
10598621|NCT01823835|11755144|FG007|COMPLETED|Overall Study||0
10598622|NCT01823835|11755145|FG008|COMPLETED|Overall Study||0
10598623|NCT01823835|11755146|FG009|COMPLETED|Overall Study||0
10598624|NCT01823835|11755147|FG010|COMPLETED|Overall Study||0
10598625|NCT01823835|11755148|FG011|COMPLETED|Overall Study||0
10598626|NCT01823835|11755149|FG012|COMPLETED|Overall Study||0
10598627|NCT01823835|11755150|FG013|COMPLETED|Overall Study||0
10598628|NCT01823835|11755151|FG014|COMPLETED|Overall Study||0
10598629|NCT01823835|11755137|FG000|NOT COMPLETED|Overall Study||3
10598630|NCT01823835|11755138|FG001|NOT COMPLETED|Overall Study||4
10598631|NCT01823835|11755139|FG002|NOT COMPLETED|Overall Study||4
10598632|NCT01823835|11755140|FG003|NOT COMPLETED|Overall Study||6
10598633|NCT01823835|11755141|FG004|NOT COMPLETED|Overall Study||6
10598634|NCT01823835|11755142|FG005|NOT COMPLETED|Overall Study||6
10598635|NCT01823835|11755143|FG006|NOT COMPLETED|Overall Study||6
10598636|NCT01823835|11755144|FG007|NOT COMPLETED|Overall Study||3
10598637|NCT01823835|11755145|FG008|NOT COMPLETED|Overall Study||3
10598638|NCT01823835|11755146|FG009|NOT COMPLETED|Overall Study||19
10598639|NCT01823835|11755147|FG010|NOT COMPLETED|Overall Study||10
10598640|NCT01823835|11755148|FG011|NOT COMPLETED|Overall Study||53
10598641|NCT01823835|11755149|FG012|NOT COMPLETED|Overall Study||19
10598642|NCT01823835|11755150|FG013|NOT COMPLETED|Overall Study||4
10598643|NCT01823835|11755151|FG014|NOT COMPLETED|Overall Study||6
10598644|NCT01823861|11755193|FG000|STARTED|4 Month Follow up||249
10598645|NCT01823861|11755194|FG001|STARTED|4 Month Follow up||251
10598646|NCT01823861|11755193|FG000|COMPLETED|4 Month Follow up||211
10598647|NCT01823861|11755194|FG001|COMPLETED|4 Month Follow up||220
10598648|NCT01823861|11755193|FG000|NOT COMPLETED|4 Month Follow up||38
10598649|NCT01823861|11755194|FG001|NOT COMPLETED|4 Month Follow up||31
10598650|NCT01823861|11755193|FG000|STARTED|12 Month Follow up||211
10598651|NCT01823861|11755194|FG001|STARTED|12 Month Follow up||220
10598652|NCT01823861|11755193|FG000|COMPLETED|12 Month Follow up||169
10598653|NCT01823861|11755194|FG001|COMPLETED|12 Month Follow up||159
10598654|NCT01823861|11755193|FG000|NOT COMPLETED|12 Month Follow up||42
10598655|NCT01823861|11755194|FG001|NOT COMPLETED|12 Month Follow up||61
10598656|NCT01823991|11755202|FG000|STARTED|Overall Study||18
10598657|NCT01823991|11755203|FG001|STARTED|Overall Study||18
10598658|NCT01823991|11755202|FG000|COMPLETED|Overall Study||10
10598659|NCT01823991|11755203|FG001|COMPLETED|Overall Study||13
10598660|NCT01823991|11755202|FG000|NOT COMPLETED|Overall Study||8
10598661|NCT01823991|11755203|FG001|NOT COMPLETED|Overall Study||5
10598662|NCT01824082|11755215|FG000|STARTED|Initial Treatment||71
10598663|NCT01824082|11755216|FG001|STARTED|Initial Treatment||73
10598664|NCT01824082|11755215|FG000|COMPLETED|Initial Treatment||71
10598665|NCT01824082|11755216|FG001|COMPLETED|Initial Treatment||73
10598666|NCT01824082|11755215|FG000|NOT COMPLETED|Initial Treatment||0
10598667|NCT01824082|11755216|FG001|NOT COMPLETED|Initial Treatment||0
10598668|NCT01824082|11755215|FG000|STARTED|Optional Crossover Treatment||40
10598669|NCT01824082|11755216|FG001|STARTED|Optional Crossover Treatment||25
10598670|NCT01824082|11755215|FG000|COMPLETED|Optional Crossover Treatment||40
10598671|NCT01824082|11755216|FG001|COMPLETED|Optional Crossover Treatment||25
10598672|NCT01824082|11755215|FG000|NOT COMPLETED|Optional Crossover Treatment||0
10598673|NCT01824082|11755216|FG001|NOT COMPLETED|Optional Crossover Treatment||0
10598674|NCT01824160|11755226|FG000|STARTED|Overall Study||50
10598675|NCT01824160|11755226|FG000|COMPLETED|Overall Study||50
10598676|NCT01824160|11755226|FG000|NOT COMPLETED|Overall Study||0
10598677|NCT01824290|11755232|FG000|STARTED|Period 1: Double Blind||18
10598678|NCT01824290|11755233|FG001|STARTED|Period 1: Double Blind||17
10598679|NCT01824290|11755234|FG002|STARTED|Period 1: Double Blind||0
10598680|NCT01824290|11755235|FG003|STARTED|Period 1: Double Blind||0
10598681|NCT01824290|11755232|FG000|Received at Least One Dose of Study Drug|Period 1: Double Blind||18
10598682|NCT01824290|11755233|FG001|Received at Least One Dose of Study Drug|Period 1: Double Blind||17
10598683|NCT01824290|11755234|FG002|Received at Least One Dose of Study Drug|Period 1: Double Blind||0
10598684|NCT01824290|11755235|FG003|Received at Least One Dose of Study Drug|Period 1: Double Blind||0
10598685|NCT01824290|11755232|FG000|Received 20 mg|Period 1: Double Blind||0
10598686|NCT01824290|11755233|FG001|Received 20 mg|Period 1: Double Blind||4
10598687|NCT01824290|11755234|FG002|Received 20 mg|Period 1: Double Blind||0
10598688|NCT01824290|11755235|FG003|Received 20 mg|Period 1: Double Blind||0
10598689|NCT01824290|11755232|FG000|Received 40 mg|Period 1: Double Blind||0
10598690|NCT01824290|11755233|FG001|Received 40 mg|Period 1: Double Blind||13
10598691|NCT01824290|11755234|FG002|Received 40 mg|Period 1: Double Blind||0
10598692|NCT01824290|11755235|FG003|Received 40 mg|Period 1: Double Blind||0
10598693|NCT01824290|11755232|FG000|COMPLETED|Period 1: Double Blind||15
10598694|NCT01824290|11755233|FG001|COMPLETED|Period 1: Double Blind||15
10598695|NCT01824290|11755234|FG002|COMPLETED|Period 1: Double Blind||0
10598696|NCT01824290|11755235|FG003|COMPLETED|Period 1: Double Blind||0
10598697|NCT01824290|11755232|FG000|NOT COMPLETED|Period 1: Double Blind||3
10598698|NCT01824290|11755233|FG001|NOT COMPLETED|Period 1: Double Blind||2
10598699|NCT01824290|11755234|FG002|NOT COMPLETED|Period 1: Double Blind||0
10598700|NCT01824290|11755235|FG003|NOT COMPLETED|Period 1: Double Blind||0
10598701|NCT01824290|11755232|FG000|STARTED|Period 2: Open-Label Treatment||0
10598702|NCT01824290|11755233|FG001|STARTED|Period 2: Open-Label Treatment||0
10598703|NCT01824290|11755234|FG002|STARTED|Period 2: Open-Label Treatment|As per the protocol, period 2 eligibility were participants who completed period 1 or experienced clinical worsening (CW) in period 1. 1 participant that had CW in period 1 continued to period 2.|16
10598704|NCT01824290|11755235|FG003|STARTED|Period 2: Open-Label Treatment|As per the protocol, period 2 eligibility were participants who completed period 1 or experienced clinical worsening (CW) in period 1. 1 participant that had CW in period 1 continued to period 2.|16
10598705|NCT01824290|11755232|FG000|Received 20 mg|Period 2: Open-Label Treatment||0
10598706|NCT01824290|11755233|FG001|Received 20 mg|Period 2: Open-Label Treatment||0
10598707|NCT01824290|11755234|FG002|Received 20 mg|Period 2: Open-Label Treatment||3
10598708|NCT01824290|11755235|FG003|Received 20 mg|Period 2: Open-Label Treatment||3
10598709|NCT01824290|11755232|FG000|Received 40 mg|Period 2: Open-Label Treatment||0
10598710|NCT01824290|11755233|FG001|Received 40 mg|Period 2: Open-Label Treatment||0
10598711|NCT01824290|11755234|FG002|Received 40 mg|Period 2: Open-Label Treatment||13
10598712|NCT01824290|11755235|FG003|Received 40 mg|Period 2: Open-Label Treatment||13
10598713|NCT01824290|11755232|FG000|COMPLETED|Period 2: Open-Label Treatment||0
10598714|NCT01824290|11755233|FG001|COMPLETED|Period 2: Open-Label Treatment||0
10598715|NCT01824290|11755234|FG002|COMPLETED|Period 2: Open-Label Treatment||13
10598716|NCT01824290|11755235|FG003|COMPLETED|Period 2: Open-Label Treatment||13
10598785|NCT01824498|11755308|FG001|NOT COMPLETED|1st Intervention (8 Weeks)||0
10598717|NCT01824290|11755232|FG000|NOT COMPLETED|Period 2: Open-Label Treatment||0
10598718|NCT01824290|11755233|FG001|NOT COMPLETED|Period 2: Open-Label Treatment||0
10598719|NCT01824290|11755234|FG002|NOT COMPLETED|Period 2: Open-Label Treatment||3
10598720|NCT01824290|11755235|FG003|NOT COMPLETED|Period 2: Open-Label Treatment||3
10598721|NCT01824303|11755249|FG000|STARTED|Randomized Study||16
10598722|NCT01824303|11755250|FG001|STARTED|Randomized Study||14
10598723|NCT01824303|11755249|FG000|COMPLETED|Randomized Study||14
10598724|NCT01824303|11755250|FG001|COMPLETED|Randomized Study||13
10598725|NCT01824303|11755249|FG000|NOT COMPLETED|Randomized Study||2
10598726|NCT01824303|11755250|FG001|NOT COMPLETED|Randomized Study||1
10598727|NCT01824303|11755249|FG000|STARTED|Open Label Extension|2 participants completed the Randomized Study but did not enter the Open Label Extension.|12
10598728|NCT01824303|11755250|FG001|STARTED|Open Label Extension|2 participants completed the Randomized Study but did not enter the Open Label Extension.|11
10598729|NCT01824303|11755249|FG000|COMPLETED|Open Label Extension||12
10598730|NCT01824303|11755250|FG001|COMPLETED|Open Label Extension||11
10598731|NCT01824303|11755249|FG000|NOT COMPLETED|Open Label Extension||0
10598732|NCT01824303|11755250|FG001|NOT COMPLETED|Open Label Extension||0
10598733|NCT01824342|11755260|FG000|STARTED|Overall Study||11
10598734|NCT01824342|11755261|FG001|STARTED|Overall Study||7
10598735|NCT01824342|11755260|FG000|COMPLETED|Overall Study||2
10598736|NCT01824342|11755261|FG001|COMPLETED|Overall Study||2
10598737|NCT01824342|11755260|FG000|NOT COMPLETED|Overall Study||9
10598738|NCT01824342|11755261|FG001|NOT COMPLETED|Overall Study||5
10652325|NCT02184169|11812690|FG001|STARTED|Overall Study||6
10652326|NCT02184169|11812689|FG000|COMPLETED|Overall Study||21
10652327|NCT02184169|11812690|FG001|COMPLETED|Overall Study||6
10652328|NCT02184169|11812689|FG000|NOT COMPLETED|Overall Study||0
10652329|NCT02184169|11812690|FG001|NOT COMPLETED|Overall Study||0
10652330|NCT02184208|11812698|FG000|STARTED|Overall Study||278
10652331|NCT02184208|11812698|FG000|COMPLETED|Overall Study||222
10652332|NCT02184208|11812698|FG000|NOT COMPLETED|Overall Study||56
10652333|NCT02184442|11812706|FG000|STARTED|Overall Study||284
10652334|NCT02184442|11812707|FG001|STARTED|Overall Study||276
10598739|NCT01824355|11755267|FG000|STARTED|Overall Study||113
10598740|NCT01824355|11755267|FG000|COMPLETED|Overall Study||110
10598741|NCT01824355|11755267|FG000|NOT COMPLETED|Overall Study||3
10807929|NCT03883386|11969684|FG000|COMPLETED|Washout and Second Assignment||0
10807930|NCT03883386|11969685|FG001|COMPLETED|Washout and Second Assignment||0
10807931|NCT03883386|11969684|FG000|NOT COMPLETED|Washout and Second Assignment||0
10807932|NCT03883386|11969685|FG001|NOT COMPLETED|Washout and Second Assignment||0
10807933|NCT03882528|11969691|FG000|STARTED|Overall Study||12
10807934|NCT03882528|11969691|FG000|COMPLETED|Overall Study||12
10598742|NCT01824394|11755274|FG000|STARTED|Overall Study||174
10598743|NCT01824394|11755275|FG001|STARTED|Overall Study||169
10598744|NCT01824394|11755276|FG002|STARTED|Overall Study||125
10598745|NCT01824394|11755274|FG000|Intent to Treat Population|Overall Study||151
10598746|NCT01824394|11755275|FG001|Intent to Treat Population|Overall Study||149
10598747|NCT01824394|11755276|FG002|Intent to Treat Population|Overall Study|Calibration Roll-in patients are not included in the ITT|0
10598748|NCT01824394|11755274|FG000|Safety Population|Overall Study||151
10598749|NCT01824394|11755275|FG001|Safety Population|Overall Study||149
10598750|NCT01824394|11755276|FG002|Safety Population|Overall Study|Calibration Roll-in patients are included in the safety population|104
10598751|NCT01824394|11755274|FG000|Per-Protocol Population|Overall Study||150
10598752|NCT01824394|11755275|FG001|Per-Protocol Population|Overall Study||148
10598753|NCT01824394|11755276|FG002|Per-Protocol Population|Overall Study|Calibration Roll-in patients are not included in the per protocol population|0
10598754|NCT01824394|11755274|FG000|COMPLETED|Overall Study||55
10598755|NCT01824394|11755275|FG001|COMPLETED|Overall Study||53
10598756|NCT01824394|11755276|FG002|COMPLETED|Overall Study||51
10598757|NCT01824394|11755274|FG000|NOT COMPLETED|Overall Study||119
10598758|NCT01824394|11755275|FG001|NOT COMPLETED|Overall Study||116
10598759|NCT01824394|11755276|FG002|NOT COMPLETED|Overall Study||74
10598760|NCT01824446|11755284|FG000|STARTED|Overall Study||6
10598761|NCT01824446|11755284|FG000|COMPLETED|Overall Study||6
10598762|NCT01824446|11755284|FG000|NOT COMPLETED|Overall Study||0
10598763|NCT01824472|11755291|FG000|STARTED|Overall Study||17
10598764|NCT01824472|11755292|FG001|STARTED|Overall Study||13
10598765|NCT01824472|11755293|FG002|STARTED|Overall Study||15
10598766|NCT01824472|11755291|FG000|COMPLETED|Overall Study||16
10598767|NCT01824472|11755292|FG001|COMPLETED|Overall Study||6
10598768|NCT01824472|11755293|FG002|COMPLETED|Overall Study||11
10598769|NCT01824472|11755291|FG000|NOT COMPLETED|Overall Study||1
10598770|NCT01824472|11755292|FG001|NOT COMPLETED|Overall Study||7
10598771|NCT01824472|11755293|FG002|NOT COMPLETED|Overall Study||4
10598772|NCT01824498|11755307|FG000|STARTED|1st Intervention (8 Weeks)||5
10598773|NCT01824498|11755308|FG001|STARTED|1st Intervention (8 Weeks)||2
10598774|NCT01824498|11755309|FG002|STARTED|1st Intervention (8 Weeks)||6
10598775|NCT01824498|11755310|FG003|STARTED|1st Intervention (8 Weeks)||3
10598776|NCT01824498|11755311|FG004|STARTED|1st Intervention (8 Weeks)||4
10598777|NCT01824498|11755312|FG005|STARTED|1st Intervention (8 Weeks)||4
10598778|NCT01824498|11755307|FG000|COMPLETED|1st Intervention (8 Weeks)||5
10598779|NCT01824498|11755308|FG001|COMPLETED|1st Intervention (8 Weeks)||2
10598780|NCT01824498|11755309|FG002|COMPLETED|1st Intervention (8 Weeks)||6
10598781|NCT01824498|11755310|FG003|COMPLETED|1st Intervention (8 Weeks)||3
10598782|NCT01824498|11755311|FG004|COMPLETED|1st Intervention (8 Weeks)||4
10598783|NCT01824498|11755312|FG005|COMPLETED|1st Intervention (8 Weeks)||4
10598784|NCT01824498|11755307|FG000|NOT COMPLETED|1st Intervention (8 Weeks)||0
10598786|NCT01824498|11755309|FG002|NOT COMPLETED|1st Intervention (8 Weeks)||0
10598787|NCT01824498|11755310|FG003|NOT COMPLETED|1st Intervention (8 Weeks)||0
10598788|NCT01824498|11755311|FG004|NOT COMPLETED|1st Intervention (8 Weeks)||0
10598789|NCT01824498|11755312|FG005|NOT COMPLETED|1st Intervention (8 Weeks)||0
10598790|NCT01824498|11755307|FG000|STARTED|Washout (8 Weeks)|2 dropped out|5
10598791|NCT01824498|11755308|FG001|STARTED|Washout (8 Weeks)||2
10598792|NCT01824498|11755309|FG002|STARTED|Washout (8 Weeks)|2 dropped out|6
10598793|NCT01824498|11755310|FG003|STARTED|Washout (8 Weeks)|1 dropped out|3
10598794|NCT01824498|11755311|FG004|STARTED|Washout (8 Weeks)|1 dropped out|4
10598795|NCT01824498|11755312|FG005|STARTED|Washout (8 Weeks)||4
10598796|NCT01824498|11755307|FG000|COMPLETED|Washout (8 Weeks)||3
10598797|NCT01824498|11755308|FG001|COMPLETED|Washout (8 Weeks)||2
10598798|NCT01824498|11755309|FG002|COMPLETED|Washout (8 Weeks)||4
10598799|NCT01824498|11755310|FG003|COMPLETED|Washout (8 Weeks)||2
10598800|NCT01824498|11755311|FG004|COMPLETED|Washout (8 Weeks)||3
10598801|NCT01824498|11755312|FG005|COMPLETED|Washout (8 Weeks)||4
10598802|NCT01824498|11755307|FG000|NOT COMPLETED|Washout (8 Weeks)||2
10598803|NCT01824498|11755308|FG001|NOT COMPLETED|Washout (8 Weeks)||0
10598804|NCT01824498|11755309|FG002|NOT COMPLETED|Washout (8 Weeks)||2
10598805|NCT01824498|11755310|FG003|NOT COMPLETED|Washout (8 Weeks)||1
10807935|NCT03882528|11969691|FG000|NOT COMPLETED|Overall Study||0
10807936|NCT03882801|11969697|FG000|STARTED|Period 1||12
10807937|NCT03882801|11969698|FG001|STARTED|Period 1||12
10807938|NCT03882801|11969697|FG000|Treated|Period 1|1 participant did not receive any dose of study drug|11
10807939|NCT03882801|11969698|FG001|Treated|Period 1||12
10598806|NCT01824498|11755311|FG004|NOT COMPLETED|Washout (8 Weeks)||1
10598807|NCT01824498|11755312|FG005|NOT COMPLETED|Washout (8 Weeks)||0
10598808|NCT01824498|11755307|FG000|STARTED|2nd Intervention (8 Weeks)||3
10598809|NCT01824498|11755308|FG001|STARTED|2nd Intervention (8 Weeks)||2
10598810|NCT01824498|11755309|FG002|STARTED|2nd Intervention (8 Weeks)||4
10598811|NCT01824498|11755310|FG003|STARTED|2nd Intervention (8 Weeks)||2
10598812|NCT01824498|11755311|FG004|STARTED|2nd Intervention (8 Weeks)||3
10598813|NCT01824498|11755312|FG005|STARTED|2nd Intervention (8 Weeks)||4
10598814|NCT01824498|11755307|FG000|COMPLETED|2nd Intervention (8 Weeks)||3
10598815|NCT01824498|11755308|FG001|COMPLETED|2nd Intervention (8 Weeks)||2
10598816|NCT01824498|11755309|FG002|COMPLETED|2nd Intervention (8 Weeks)||4
10598817|NCT01824498|11755310|FG003|COMPLETED|2nd Intervention (8 Weeks)||2
10598818|NCT01824498|11755311|FG004|COMPLETED|2nd Intervention (8 Weeks)||3
10598819|NCT01824498|11755312|FG005|COMPLETED|2nd Intervention (8 Weeks)||4
10598820|NCT01824498|11755307|FG000|NOT COMPLETED|2nd Intervention (8 Weeks)||0
10598821|NCT01824498|11755308|FG001|NOT COMPLETED|2nd Intervention (8 Weeks)||0
10598822|NCT01824498|11755309|FG002|NOT COMPLETED|2nd Intervention (8 Weeks)||0
10598823|NCT01824498|11755310|FG003|NOT COMPLETED|2nd Intervention (8 Weeks)||0
10598824|NCT01824498|11755311|FG004|NOT COMPLETED|2nd Intervention (8 Weeks)||0
10598825|NCT01824498|11755312|FG005|NOT COMPLETED|2nd Intervention (8 Weeks)||0
10598826|NCT01824498|11755307|FG000|STARTED|Washout (8 Weeks)||3
10598827|NCT01824498|11755308|FG001|STARTED|Washout (8 Weeks)||2
10598828|NCT01824498|11755309|FG002|STARTED|Washout (8 Weeks)||4
10598829|NCT01824498|11755310|FG003|STARTED|Washout (8 Weeks)||2
10598830|NCT01824498|11755311|FG004|STARTED|Washout (8 Weeks)||3
10598831|NCT01824498|11755312|FG005|STARTED|Washout (8 Weeks)||4
10598832|NCT01824498|11755307|FG000|COMPLETED|Washout (8 Weeks)||3
10598833|NCT01824498|11755308|FG001|COMPLETED|Washout (8 Weeks)||2
10598834|NCT01824498|11755309|FG002|COMPLETED|Washout (8 Weeks)||4
10598835|NCT01824498|11755310|FG003|COMPLETED|Washout (8 Weeks)||2
10598836|NCT01824498|11755311|FG004|COMPLETED|Washout (8 Weeks)||3
10598837|NCT01824498|11755312|FG005|COMPLETED|Washout (8 Weeks)||4
10598838|NCT01824498|11755307|FG000|NOT COMPLETED|Washout (8 Weeks)||0
10598839|NCT01824498|11755308|FG001|NOT COMPLETED|Washout (8 Weeks)||0
10598840|NCT01824498|11755309|FG002|NOT COMPLETED|Washout (8 Weeks)||0
10598841|NCT01824498|11755310|FG003|NOT COMPLETED|Washout (8 Weeks)||0
10598842|NCT01824498|11755311|FG004|NOT COMPLETED|Washout (8 Weeks)||0
10598843|NCT01824498|11755312|FG005|NOT COMPLETED|Washout (8 Weeks)||0
10598844|NCT01824498|11755307|FG000|STARTED|3rd Intervention (8 Weeks)||3
10598845|NCT01824498|11755308|FG001|STARTED|3rd Intervention (8 Weeks)||2
10598846|NCT01824498|11755309|FG002|STARTED|3rd Intervention (8 Weeks)||4
10598847|NCT01824498|11755310|FG003|STARTED|3rd Intervention (8 Weeks)||2
10598848|NCT01824498|11755311|FG004|STARTED|3rd Intervention (8 Weeks)||3
10598849|NCT01824498|11755312|FG005|STARTED|3rd Intervention (8 Weeks)||4
10598850|NCT01824498|11755307|FG000|COMPLETED|3rd Intervention (8 Weeks)||3
10598851|NCT01824498|11755308|FG001|COMPLETED|3rd Intervention (8 Weeks)||2
10598852|NCT01824498|11755309|FG002|COMPLETED|3rd Intervention (8 Weeks)||4
10598853|NCT01824498|11755310|FG003|COMPLETED|3rd Intervention (8 Weeks)||2
10598854|NCT01824498|11755311|FG004|COMPLETED|3rd Intervention (8 Weeks)||3
10598855|NCT01824498|11755312|FG005|COMPLETED|3rd Intervention (8 Weeks)||4
10457012|NCT01008605|11604742|FG000|NOT COMPLETED|Overall Study||0
10457013|NCT01008618|11604754|FG000|STARTED|Period 1 (Titration Period)||218
10457014|NCT01008618|11604755|FG001|STARTED|Period 1 (Titration Period)||0
10457015|NCT01008618|11604756|FG002|STARTED|Period 1 (Titration Period)||0
10457016|NCT01008618|11604754|FG000|COMPLETED|Period 1 (Titration Period)||150
10457017|NCT01008618|11604755|FG001|COMPLETED|Period 1 (Titration Period)||0
10457018|NCT01008618|11604756|FG002|COMPLETED|Period 1 (Titration Period)||0
10457019|NCT01008618|11604754|FG000|NOT COMPLETED|Period 1 (Titration Period)||68
10457020|NCT01008618|11604755|FG001|NOT COMPLETED|Period 1 (Titration Period)||0
10457021|NCT01008618|11604756|FG002|NOT COMPLETED|Period 1 (Titration Period)||0
10457022|NCT01008618|11604754|FG000|STARTED|Period 2 (Double-Blind Period)||0
10457023|NCT01008618|11604755|FG001|STARTED|Period 2 (Double-Blind Period)||73
10598856|NCT01824498|11755307|FG000|NOT COMPLETED|3rd Intervention (8 Weeks)||0
10598857|NCT01824498|11755308|FG001|NOT COMPLETED|3rd Intervention (8 Weeks)||0
10598858|NCT01824498|11755309|FG002|NOT COMPLETED|3rd Intervention (8 Weeks)||0
10598859|NCT01824498|11755310|FG003|NOT COMPLETED|3rd Intervention (8 Weeks)||0
10598860|NCT01824498|11755311|FG004|NOT COMPLETED|3rd Intervention (8 Weeks)||0
10598861|NCT01824498|11755312|FG005|NOT COMPLETED|3rd Intervention (8 Weeks)||0
10598862|NCT01824576|11755320|FG000|STARTED|Overall Study||9
10598863|NCT01824576|11755320|FG000|COMPLETED|Overall Study||7
10598864|NCT01824576|11755320|FG000|NOT COMPLETED|Overall Study||2
10598865|NCT01824589|11755328|FG000|STARTED|Overall Study||1
10598866|NCT01824589|11755329|FG001|STARTED|Overall Study||0
10598867|NCT01824589|11755330|FG002|STARTED|Overall Study||0
10598868|NCT01824589|11755331|FG003|STARTED|Overall Study||0
10598869|NCT01824589|11755328|FG000|COMPLETED|Overall Study||1
10598870|NCT01824589|11755329|FG001|COMPLETED|Overall Study||0
10598871|NCT01824589|11755330|FG002|COMPLETED|Overall Study||0
10598872|NCT01824589|11755331|FG003|COMPLETED|Overall Study||0
10598873|NCT01824589|11755328|FG000|NOT COMPLETED|Overall Study||0
10598874|NCT01824589|11755329|FG001|NOT COMPLETED|Overall Study||0
10598875|NCT01824589|11755330|FG002|NOT COMPLETED|Overall Study||0
10598876|NCT01824589|11755331|FG003|NOT COMPLETED|Overall Study||0
10598877|NCT01824602|11755345|FG000|STARTED|Overall Study||11
10598878|NCT01824602|11755346|FG001|STARTED|Overall Study||8
10598879|NCT01824602|11755347|FG002|STARTED|Overall Study||9
10598880|NCT01824602|11755348|FG003|STARTED|Overall Study||10
10598881|NCT01824602|11755345|FG000|Safety Population|Overall Study||11
10598882|NCT01824602|11755346|FG001|Safety Population|Overall Study||8
10598883|NCT01824602|11755347|FG002|Safety Population|Overall Study||9
10598884|NCT01824602|11755348|FG003|Safety Population|Overall Study||10
10598885|NCT01824602|11755345|FG000|Intent-to-treat Population|Overall Study||11
10598886|NCT01824602|11755346|FG001|Intent-to-treat Population|Overall Study||8
10598887|NCT01824602|11755347|FG002|Intent-to-treat Population|Overall Study||9
10598888|NCT01824602|11755348|FG003|Intent-to-treat Population|Overall Study||9
10598889|NCT01824602|11755345|FG000|COMPLETED|Overall Study||10
10598890|NCT01824602|11755346|FG001|COMPLETED|Overall Study||8
10598891|NCT01824602|11755347|FG002|COMPLETED|Overall Study||5
10598892|NCT01824602|11755348|FG003|COMPLETED|Overall Study||5
10598893|NCT01824602|11755345|FG000|NOT COMPLETED|Overall Study||1
10598894|NCT01824602|11755346|FG001|NOT COMPLETED|Overall Study||0
10598895|NCT01824602|11755347|FG002|NOT COMPLETED|Overall Study||4
10598896|NCT01824602|11755348|FG003|NOT COMPLETED|Overall Study||5
10598897|NCT01824693|11755361|FG000|STARTED|Overall Study||6
10598898|NCT01824693|11755362|FG001|STARTED|Overall Study||9
10598899|NCT01824693|11755363|FG002|STARTED|Overall Study||15
10598900|NCT01824693|11755361|FG000|COMPLETED|Overall Study||5
10598901|NCT01824693|11755362|FG001|COMPLETED|Overall Study||2
10598902|NCT01824693|11755363|FG002|COMPLETED|Overall Study||0
10598903|NCT01824693|11755361|FG000|NOT COMPLETED|Overall Study||1
10598904|NCT01824693|11755362|FG001|NOT COMPLETED|Overall Study||7
10598905|NCT01824693|11755363|FG002|NOT COMPLETED|Overall Study||15
10598906|NCT01824823|11755372|FG000|STARTED|Overall Study||2
10598907|NCT01824823|11755373|FG001|STARTED|Overall Study||1
10598908|NCT01824823|11755372|FG000|COMPLETED|Overall Study||0
10598909|NCT01824823|11755373|FG001|COMPLETED|Overall Study||0
10598910|NCT01824823|11755372|FG000|NOT COMPLETED|Overall Study||2
10598911|NCT01824823|11755373|FG001|NOT COMPLETED|Overall Study||1
10598912|NCT01824901|11755379|FG000|STARTED|Overall Study||2
10598913|NCT01824901|11755380|FG001|STARTED|Overall Study||0
10598914|NCT01824901|11755381|FG002|STARTED|Overall Study||0
10598915|NCT01824901|11755382|FG003|STARTED|Overall Study||0
10598916|NCT01824901|11755379|FG000|COMPLETED|Overall Study||2
10598917|NCT01824901|11755380|FG001|COMPLETED|Overall Study||0
10598918|NCT01824901|11755381|FG002|COMPLETED|Overall Study||0
10598919|NCT01824901|11755382|FG003|COMPLETED|Overall Study||0
10598920|NCT01824901|11755379|FG000|NOT COMPLETED|Overall Study||0
10598921|NCT01824901|11755380|FG001|NOT COMPLETED|Overall Study||0
10598922|NCT01824901|11755381|FG002|NOT COMPLETED|Overall Study||0
10598923|NCT01824901|11755382|FG003|NOT COMPLETED|Overall Study||0
10598924|NCT01824979|11755388|FG000|STARTED|Overall Study||50
10598925|NCT01824979|11755389|FG001|STARTED|Overall Study||50
10598926|NCT01824979|11755388|FG000|COMPLETED|Overall Study||37
10598927|NCT01824979|11755389|FG001|COMPLETED|Overall Study||37
10598928|NCT01824979|11755388|FG000|NOT COMPLETED|Overall Study||13
10598929|NCT01824979|11755389|FG001|NOT COMPLETED|Overall Study||13
10598930|NCT01825057|11755398|FG000|STARTED|Patient Study Flow||336
10807940|NCT03882801|11969697|FG000|COMPLETED|Period 1||10
10807941|NCT03882801|11969698|FG001|COMPLETED|Period 1||10
10807942|NCT03882801|11969697|FG000|NOT COMPLETED|Period 1||2
10807943|NCT03882801|11969698|FG001|NOT COMPLETED|Period 1||2
10807944|NCT03882801|11969697|FG000|STARTED|Washout Period||10
10807945|NCT03882801|11969698|FG001|STARTED|Washout Period||10
10807946|NCT03882801|11969697|FG000|COMPLETED|Washout Period||10
10807947|NCT03882801|11969698|FG001|COMPLETED|Washout Period||9
10807948|NCT03882801|11969697|FG000|NOT COMPLETED|Washout Period||0
10807949|NCT03882801|11969698|FG001|NOT COMPLETED|Washout Period||1
10807950|NCT03882801|11969697|FG000|STARTED|Period 2||10
10807951|NCT03882801|11969698|FG001|STARTED|Period 2||9
10807952|NCT03882801|11969697|FG000|COMPLETED|Period 2||10
10807953|NCT03882801|11969698|FG001|COMPLETED|Period 2||8
10807954|NCT03882801|11969697|FG000|NOT COMPLETED|Period 2||0
10807955|NCT03882801|11969698|FG001|NOT COMPLETED|Period 2||1
10807956|NCT03882424|11969709|FG000|STARTED|Overall Study||38
10807957|NCT03882424|11969710|FG001|STARTED|Overall Study||38
10807958|NCT03882424|11969711|FG002|STARTED|Overall Study||38
10807959|NCT03882424|11969709|FG000|COMPLETED|Overall Study||34
10807960|NCT03882424|11969710|FG001|COMPLETED|Overall Study||38
10807961|NCT03882424|11969711|FG002|COMPLETED|Overall Study||38
10807962|NCT03882424|11969709|FG000|NOT COMPLETED|Overall Study||4
10807963|NCT03882424|11969710|FG001|NOT COMPLETED|Overall Study||0
10807964|NCT03882424|11969711|FG002|NOT COMPLETED|Overall Study||0
10807965|NCT03881163|11969719|FG000|STARTED|Overall Study||24
10807966|NCT03881163|11969719|FG000|COMPLETED|Overall Study||24
10598931|NCT01825057|11755399|FG001|STARTED|Patient Study Flow||379
10598932|NCT01825057|11755400|FG002|STARTED|Patient Study Flow||458
10598933|NCT01825057|11755398|FG000|COMPLETED|Patient Study Flow||336
10598934|NCT01825057|11755399|FG001|COMPLETED|Patient Study Flow||379
10598935|NCT01825057|11755400|FG002|COMPLETED|Patient Study Flow||458
10807967|NCT03881163|11969719|FG000|NOT COMPLETED|Overall Study||0
10598936|NCT01825057|11755398|FG000|NOT COMPLETED|Patient Study Flow||0
10598937|NCT01825057|11755399|FG001|NOT COMPLETED|Patient Study Flow||0
10598938|NCT01825057|11755400|FG002|NOT COMPLETED|Patient Study Flow||0
10598939|NCT01825057|11755398|FG000|STARTED|Provider Study Flow||13
10598940|NCT01825057|11755399|FG001|STARTED|Provider Study Flow||12
10598941|NCT01825057|11755400|FG002|STARTED|Provider Study Flow||13
10807968|NCT03881670|11969727|FG000|STARTED|Overall Study||12
10807969|NCT03881670|11969728|FG001|STARTED|Overall Study||12
10807970|NCT03881670|11969727|FG000|Completed First Intervention|Overall Study||12
10807971|NCT03881670|11969728|FG001|Completed First Intervention|Overall Study||12
10598942|NCT01825057|11755398|FG000|COMPLETED|Provider Study Flow||13
10598943|NCT01825057|11755399|FG001|COMPLETED|Provider Study Flow||12
10598944|NCT01825057|11755400|FG002|COMPLETED|Provider Study Flow||13
10598945|NCT01825057|11755398|FG000|NOT COMPLETED|Provider Study Flow||0
10598946|NCT01825057|11755399|FG001|NOT COMPLETED|Provider Study Flow||0
10598947|NCT01825057|11755400|FG002|NOT COMPLETED|Provider Study Flow||0
10598948|NCT01825122|11755413|FG000|STARTED|Overall Study||77
10598949|NCT01825122|11755414|FG001|STARTED|Overall Study||78
10598950|NCT01825122|11755413|FG000|COMPLETED|Overall Study||67
10598951|NCT01825122|11755414|FG001|COMPLETED|Overall Study||59
10598952|NCT01825122|11755413|FG000|NOT COMPLETED|Overall Study||10
10598953|NCT01825122|11755414|FG001|NOT COMPLETED|Overall Study||19
10598954|NCT01825200|11755422|FG000|STARTED|Overall Study||1319
10598955|NCT01825200|11755423|FG001|STARTED|Overall Study||1321
10598956|NCT01825200|11755422|FG000|COMPLETED|Overall Study||1314
10598957|NCT01825200|11755423|FG001|COMPLETED|Overall Study||1314
10598958|NCT01825200|11755422|FG000|NOT COMPLETED|Overall Study||5
10598959|NCT01825200|11755423|FG001|NOT COMPLETED|Overall Study||7
10598960|NCT01825408|11755433|FG000|STARTED|Overall Study||7
10598961|NCT01825408|11755434|FG001|STARTED|Overall Study||7
10598962|NCT01825408|11755435|FG002|STARTED|Overall Study||14
10598963|NCT01825408|11755436|FG003|STARTED|Overall Study||12
10598964|NCT01825408|11755433|FG000|COMPLETED|Overall Study||7
10598965|NCT01825408|11755434|FG001|COMPLETED|Overall Study||7
10598966|NCT01825408|11755435|FG002|COMPLETED|Overall Study||14
10598967|NCT01825408|11755436|FG003|COMPLETED|Overall Study||12
10598968|NCT01825408|11755433|FG000|NOT COMPLETED|Overall Study||0
10598969|NCT01825408|11755434|FG001|NOT COMPLETED|Overall Study||0
10598970|NCT01825408|11755435|FG002|NOT COMPLETED|Overall Study||0
10598971|NCT01825408|11755436|FG003|NOT COMPLETED|Overall Study||0
10598972|NCT01825512|11755448|FG000|STARTED|Baseline||194
10598973|NCT01825512|11755449|FG001|STARTED|Baseline||199
10598974|NCT01825512|11755448|FG000|COMPLETED|Baseline||193
10598975|NCT01825512|11755449|FG001|COMPLETED|Baseline||197
10598976|NCT01825512|11755448|FG000|NOT COMPLETED|Baseline||1
10598977|NCT01825512|11755449|FG001|NOT COMPLETED|Baseline||2
10598978|NCT01825512|11755448|FG000|STARTED|Treatment||193
10598979|NCT01825512|11755449|FG001|STARTED|Treatment||197
10598980|NCT01825512|11755448|FG000|COMPLETED|Treatment||140
10598981|NCT01825512|11755449|FG001|COMPLETED|Treatment||170
10598982|NCT01825512|11755448|FG000|NOT COMPLETED|Treatment||53
10598983|NCT01825512|11755449|FG001|NOT COMPLETED|Treatment||27
10598984|NCT01825577|11755455|FG000|STARTED|Overall Study||14
10598985|NCT01825577|11755455|FG000|COMPLETED|Overall Study||6
10598986|NCT01825577|11755455|FG000|NOT COMPLETED|Overall Study||8
10598987|NCT01825655|11755461|FG000|STARTED|Overall Study||0
10598988|NCT01825655|11755462|FG001|STARTED|Overall Study||2
10598989|NCT01825655|11755461|FG000|COMPLETED|Overall Study||0
10598990|NCT01825655|11755462|FG001|COMPLETED|Overall Study||2
10598991|NCT01825655|11755461|FG000|NOT COMPLETED|Overall Study||0
10598992|NCT01825655|11755462|FG001|NOT COMPLETED|Overall Study||0
10598993|NCT01825785|11755475|FG000|STARTED|Overall Study||12
10598994|NCT01825785|11755476|FG001|STARTED|Overall Study||6
10598995|NCT01825785|11755477|FG002|STARTED|Overall Study||6
10598996|NCT01825785|11755478|FG003|STARTED|Overall Study||6
10598997|NCT01825785|11755479|FG004|STARTED|Overall Study||6
10598998|NCT01825785|11755480|FG005|STARTED|Overall Study||6
10598999|NCT01825785|11755481|FG006|STARTED|Overall Study||6
10599000|NCT01825785|11755475|FG000|COMPLETED|Overall Study||12
10599001|NCT01825785|11755476|FG001|COMPLETED|Overall Study||6
10599002|NCT01825785|11755477|FG002|COMPLETED|Overall Study||6
10599003|NCT01825785|11755478|FG003|COMPLETED|Overall Study||6
10599004|NCT01825785|11755479|FG004|COMPLETED|Overall Study||4
10599005|NCT01825785|11755480|FG005|COMPLETED|Overall Study||5
10599006|NCT01825785|11755481|FG006|COMPLETED|Overall Study||6
10599007|NCT01825785|11755475|FG000|NOT COMPLETED|Overall Study||0
10599008|NCT01825785|11755476|FG001|NOT COMPLETED|Overall Study||0
10599009|NCT01825785|11755477|FG002|NOT COMPLETED|Overall Study||0
10599010|NCT01825785|11755478|FG003|NOT COMPLETED|Overall Study||0
10599011|NCT01825785|11755479|FG004|NOT COMPLETED|Overall Study||2
10599012|NCT01825785|11755480|FG005|NOT COMPLETED|Overall Study||1
10599013|NCT01825785|11755481|FG006|NOT COMPLETED|Overall Study||0
10599014|NCT01825798|11755505|FG000|STARTED|Overall Study||32
10599015|NCT01825798|11755506|FG001|STARTED|Overall Study||28
10599016|NCT01825798|11755505|FG000|COMPLETED|Overall Study||30
10599017|NCT01825798|11755506|FG001|COMPLETED|Overall Study||23
10599018|NCT01825798|11755505|FG000|NOT COMPLETED|Overall Study||2
10599019|NCT01825798|11755506|FG001|NOT COMPLETED|Overall Study||5
10599020|NCT01825837|11755516|FG000|STARTED|PART I||0
10599021|NCT01825837|11755517|FG001|STARTED|PART I||0
10599022|NCT01825837|11755518|FG002|STARTED|PART I||0
10599023|NCT01825837|11755519|FG003|STARTED|PART I||104
10599024|NCT01825837|11755516|FG000|Enrolled|PART I||0
10599025|NCT01825837|11755517|FG001|Enrolled|PART I||0
10599026|NCT01825837|11755518|FG002|Enrolled|PART I||0
10599027|NCT01825837|11755519|FG003|Enrolled|PART I||104
10599028|NCT01825837|11755516|FG000|Safety Population (Open-Label)|PART I||0
10599029|NCT01825837|11755517|FG001|Safety Population (Open-Label)|PART I||0
10599030|NCT01825837|11755518|FG002|Safety Population (Open-Label)|PART I||0
10599031|NCT01825837|11755519|FG003|Safety Population (Open-Label)|PART I||104
10599032|NCT01825837|11755516|FG000|COMPLETED|PART I||0
10599033|NCT01825837|11755517|FG001|COMPLETED|PART I||0
10599034|NCT01825837|11755518|FG002|COMPLETED|PART I||0
10599035|NCT01825837|11755519|FG003|COMPLETED|PART I||87
10599036|NCT01825837|11755516|FG000|NOT COMPLETED|PART I||0
10599037|NCT01825837|11755517|FG001|NOT COMPLETED|PART I||0
10599038|NCT01825837|11755518|FG002|NOT COMPLETED|PART I||0
10599039|NCT01825837|11755519|FG003|NOT COMPLETED|PART I||17
10599040|NCT01825837|11755516|FG000|STARTED|PART II||35
10599041|NCT01825837|11755517|FG001|STARTED|PART II||26
10599042|NCT01825837|11755518|FG002|STARTED|PART II||26
10599043|NCT01825837|11755519|FG003|STARTED|PART II||0
10599044|NCT01825837|11755516|FG000|Randomized Patients|PART II||35
10599045|NCT01825837|11755517|FG001|Randomized Patients|PART II||26
10599046|NCT01825837|11755518|FG002|Randomized Patients|PART II||26
10599047|NCT01825837|11755519|FG003|Randomized Patients|PART II||0
10599048|NCT01825837|11755516|FG000|Safety Population (Double-Blind)|PART II||35
10599049|NCT01825837|11755517|FG001|Safety Population (Double-Blind)|PART II||26
10599050|NCT01825837|11755518|FG002|Safety Population (Double-Blind)|PART II||26
10599051|NCT01825837|11755519|FG003|Safety Population (Double-Blind)|PART II||0
10599052|NCT01825837|11755516|FG000|Intent-to-Treat Population|PART II||34
10599053|NCT01825837|11755517|FG001|Intent-to-Treat Population|PART II||25
10599054|NCT01825837|11755518|FG002|Intent-to-Treat Population|PART II||26
10599055|NCT01825837|11755519|FG003|Intent-to-Treat Population|PART II||0
10599056|NCT01825837|11755516|FG000|Per-Protocol Population|PART II||32
10599057|NCT01825837|11755517|FG001|Per-Protocol Population|PART II||23
10599058|NCT01825837|11755518|FG002|Per-Protocol Population|PART II||24
10599059|NCT01825837|11755519|FG003|Per-Protocol Population|PART II||0
10599060|NCT01825837|11755516|FG000|COMPLETED|PART II||16
10599061|NCT01825837|11755517|FG001|COMPLETED|PART II||12
10599062|NCT01825837|11755518|FG002|COMPLETED|PART II||7
10599063|NCT01825837|11755519|FG003|COMPLETED|PART II||0
10599064|NCT01825837|11755516|FG000|NOT COMPLETED|PART II||19
10599065|NCT01825837|11755517|FG001|NOT COMPLETED|PART II||14
10599066|NCT01825837|11755518|FG002|NOT COMPLETED|PART II||19
10599067|NCT01825837|11755519|FG003|NOT COMPLETED|PART II||0
10599068|NCT01825876|11755527|FG000|STARTED|Period 1||17
10599069|NCT01825876|11755528|FG001|STARTED|Period 1||0
10599070|NCT01825876|11755527|FG000|Received 1 Dose of Study Drug|Period 1||17
10599071|NCT01825876|11755528|FG001|Received 1 Dose of Study Drug|Period 1||0
10599072|NCT01825876|11755527|FG000|COMPLETED|Period 1||17
10599073|NCT01825876|11755528|FG001|COMPLETED|Period 1||0
10599074|NCT01825876|11755527|FG000|NOT COMPLETED|Period 1||0
10599075|NCT01825876|11755528|FG001|NOT COMPLETED|Period 1||0
10599076|NCT01825876|11755527|FG000|STARTED|Period 2|Participants received a different treatment in Period 2.|0
10599077|NCT01825876|11755528|FG001|STARTED|Period 2|Participants received a different treatment in Period 1.|17
10599078|NCT01825876|11755527|FG000|Received 1 Dose of Study Drug|Period 2||0
10599079|NCT01825876|11755528|FG001|Received 1 Dose of Study Drug|Period 2||17
10599080|NCT01825876|11755527|FG000|COMPLETED|Period 2||0
10599081|NCT01825876|11755528|FG001|COMPLETED|Period 2||16
10599082|NCT01825876|11755527|FG000|NOT COMPLETED|Period 2||0
10599083|NCT01825876|11755528|FG001|NOT COMPLETED|Period 2||1
10599084|NCT01825889|11755539|FG000|STARTED|Overall Study||10
10807972|NCT03881670|11969727|FG000|Completed Second Intervetion|Overall Study||12
10807973|NCT03881670|11969728|FG001|Completed Second Intervetion|Overall Study||12
10807974|NCT03881670|11969727|FG000|COMPLETED|Overall Study||12
10807975|NCT03881670|11969728|FG001|COMPLETED|Overall Study||12
10807976|NCT03881670|11969727|FG000|NOT COMPLETED|Overall Study||0
10807977|NCT03881670|11969728|FG001|NOT COMPLETED|Overall Study||0
10811171|NCT03776539|11972875|FG002|NOT COMPLETED|Overall Study||0
10811172|NCT03776539|11972876|FG003|NOT COMPLETED|Overall Study||0
10811173|NCT03772041|11972888|FG000|STARTED|Overall Study||149
10811174|NCT03772041|11972889|FG001|STARTED|Overall Study||145
10811175|NCT03772041|11972888|FG000|COMPLETED|Overall Study||135
10811176|NCT03772041|11972889|FG001|COMPLETED|Overall Study||135
10811177|NCT03772041|11972888|FG000|NOT COMPLETED|Overall Study||14
10811178|NCT03772041|11972889|FG001|NOT COMPLETED|Overall Study||10
10811179|NCT03775681|11972895|FG000|STARTED|Overall Study||33
10811180|NCT03775681|11972895|FG000|COMPLETED|Overall Study||30
10811181|NCT03775681|11972895|FG000|NOT COMPLETED|Overall Study||3
10811182|NCT03774823|11972901|FG000|STARTED|Overall Study||5
10811183|NCT03774823|11972902|FG001|STARTED|Overall Study||5
10811184|NCT03774823|11972901|FG000|COMPLETED|Overall Study||4
10811185|NCT03774823|11972902|FG001|COMPLETED|Overall Study||4
10811186|NCT03774823|11972901|FG000|NOT COMPLETED|Overall Study||1
10811187|NCT03774823|11972902|FG001|NOT COMPLETED|Overall Study||1
10811188|NCT03774745|11972910|FG000|STARTED|Overall Study||6
10811189|NCT03774745|11972911|FG001|STARTED|Overall Study||6
10811190|NCT03774745|11972910|FG000|Follow-Up 1|Overall Study||5
10811191|NCT03774745|11972911|FG001|Follow-Up 1|Overall Study||6
10811192|NCT03774745|11972910|FG000|Follow-up 2|Overall Study||4
10811193|NCT03774745|11972911|FG001|Follow-up 2|Overall Study||2
10811194|NCT03774745|11972910|FG000|COMPLETED|Overall Study||4
10811195|NCT03774745|11972911|FG001|COMPLETED|Overall Study||2
10811196|NCT03774745|11972910|FG000|NOT COMPLETED|Overall Study||2
10811197|NCT03774745|11972911|FG001|NOT COMPLETED|Overall Study||4
10811198|NCT03774433|11972917|FG000|STARTED|Overall Study||114
10599085|NCT01825889|11755540|FG001|STARTED|Overall Study||10
10599086|NCT01825889|11755539|FG000|Received One Dose of Study Drug|Overall Study||10
10599087|NCT01825889|11755540|FG001|Received One Dose of Study Drug|Overall Study||10
10599088|NCT01825889|11755539|FG000|COMPLETED|Overall Study||10
10599089|NCT01825889|11755540|FG001|COMPLETED|Overall Study||10
10599090|NCT01825889|11755539|FG000|NOT COMPLETED|Overall Study||0
10599091|NCT01825889|11755540|FG001|NOT COMPLETED|Overall Study||0
10599092|NCT01825941|11755548|FG000|STARTED|Overall Study||104
10599093|NCT01825941|11755549|FG001|STARTED|Overall Study||104
10599094|NCT01825941|11755548|FG000|COMPLETED|Overall Study||100
10599095|NCT01825941|11755549|FG001|COMPLETED|Overall Study||103
10599096|NCT01825941|11755548|FG000|NOT COMPLETED|Overall Study||4
10599097|NCT01825941|11755549|FG001|NOT COMPLETED|Overall Study||1
10599098|NCT01826201|11755555|FG000|STARTED|Overall Study|Subjects in each arm are same|21
10599099|NCT01826201|11755555|FG000|COMPLETED|Overall Study||17
10599100|NCT01826201|11755555|FG000|NOT COMPLETED|Overall Study||4
10599101|NCT01826214|11755563|FG000|STARTED|Overall Study||35
10599102|NCT01826214|11755564|FG001|STARTED|Overall Study|35 patients were randomized but only 34 patients received at least one dose of study drug|34
10599103|NCT01826214|11755563|FG000|Untreated|Overall Study|Untreated = did not receive study drug|0
10599104|NCT01826214|11755564|FG001|Untreated|Overall Study|Untreated = did not receive study drug|1
10599105|NCT01826214|11755563|FG000|Treated|Overall Study|Treated = received at least one dose of study drug|35
10599106|NCT01826214|11755564|FG001|Treated|Overall Study|Treated = received at least one dose of study drug|34
10599107|NCT01826214|11755563|FG000|COMPLETED|Overall Study||0
10599108|NCT01826214|11755564|FG001|COMPLETED|Overall Study||0
10599109|NCT01826214|11755563|FG000|NOT COMPLETED|Overall Study||35
10599110|NCT01826214|11755564|FG001|NOT COMPLETED|Overall Study||34
10599111|NCT01826227|11755570|FG000|STARTED|Overall Study||5
10599112|NCT01826227|11755570|FG000|COMPLETED|Overall Study||5
10599113|NCT01826227|11755570|FG000|NOT COMPLETED|Overall Study||0
10599114|NCT01826370|11755574|FG000|STARTED|Overall Study||678
10599115|NCT01826370|11755574|FG000|COMPLETED|Overall Study||658
10599116|NCT01826370|11755574|FG000|NOT COMPLETED|Overall Study||20
10599117|NCT01826422|11755580|FG000|STARTED|Overall Study||18
10599118|NCT01826422|11755581|FG001|STARTED|Overall Study||22
10599119|NCT01826422|11755580|FG000|COMPLETED|Overall Study||17
10599120|NCT01826422|11755581|FG001|COMPLETED|Overall Study||19
10599121|NCT01826422|11755580|FG000|NOT COMPLETED|Overall Study||1
10599122|NCT01826422|11755581|FG001|NOT COMPLETED|Overall Study||3
10599123|NCT01826448|11755589|FG000|STARTED|Overall Study||4
10599124|NCT01826448|11755590|FG001|STARTED|Overall Study||9
10599125|NCT01826448|11755589|FG000|COMPLETED|Overall Study||0
10599126|NCT01826448|11755590|FG001|COMPLETED|Overall Study||0
10599127|NCT01826448|11755589|FG000|NOT COMPLETED|Overall Study||4
10599128|NCT01826448|11755590|FG001|NOT COMPLETED|Overall Study||9
10599129|NCT01826487|11755598|FG000|STARTED|Overall Study||115
10599130|NCT01826487|11755599|FG001|STARTED|Overall Study||115
10599131|NCT01826487|11755598|FG000|As-treated Population|Overall Study||115
10599132|NCT01826487|11755599|FG001|As-treated Population|Overall Study||115
10599133|NCT01826487|11755598|FG000|ITT Population|Overall Study||114
10599134|NCT01826487|11755599|FG001|ITT Population|Overall Study||114
10599135|NCT01826487|11755598|FG000|COMPLETED|Overall Study||111
10599136|NCT01826487|11755599|FG001|COMPLETED|Overall Study||110
10599137|NCT01826487|11755598|FG000|NOT COMPLETED|Overall Study||4
10599138|NCT01826487|11755599|FG001|NOT COMPLETED|Overall Study||5
10599139|NCT01826513|11755609|FG000|STARTED|Overall Study||5
10599140|NCT01826513|11755610|FG001|STARTED|Overall Study||10
10599141|NCT01826513|11755611|FG002|STARTED|Overall Study||10
10599142|NCT01826513|11755609|FG000|COMPLETED|Overall Study||5
10599143|NCT01826513|11755610|FG001|COMPLETED|Overall Study||10
10599144|NCT01826513|11755611|FG002|COMPLETED|Overall Study||10
10599145|NCT01826513|11755609|FG000|NOT COMPLETED|Overall Study||0
10599146|NCT01826513|11755610|FG001|NOT COMPLETED|Overall Study||0
10599147|NCT01826513|11755611|FG002|NOT COMPLETED|Overall Study||0
10599148|NCT01826604|11755620|FG000|STARTED|Overall Study||144
10599149|NCT01826604|11755621|FG001|STARTED|Overall Study||157
10599150|NCT01826604|11755620|FG000|COMPLETED|Overall Study||136
10599151|NCT01826604|11755621|FG001|COMPLETED|Overall Study||148
10599152|NCT01826604|11755620|FG000|NOT COMPLETED|Overall Study||8
10599153|NCT01826604|11755621|FG001|NOT COMPLETED|Overall Study||9
10599154|NCT01826812|11755629|FG000|STARTED|Overall Study||167
10599155|NCT01826812|11755630|FG001|STARTED|Overall Study||33
10807978|NCT03880266|11969744|FG000|STARTED|Overall Study||12
10807979|NCT03880266|11969745|FG001|STARTED|Overall Study||6
10807980|NCT03880266|11969746|FG002|STARTED|Overall Study||12
10807981|NCT03880266|11969747|FG003|STARTED|Overall Study||4
10807982|NCT03880266|11969748|FG004|STARTED|Overall Study||12
10807983|NCT03880266|11969749|FG005|STARTED|Overall Study||6
10807984|NCT03880266|11969750|FG006|STARTED|Overall Study||13
10807985|NCT03880266|11969751|FG007|STARTED|Overall Study||7
10807986|NCT03880266|11969744|FG000|COMPLETED|Overall Study||12
10807987|NCT03880266|11969745|FG001|COMPLETED|Overall Study||5
10807988|NCT03880266|11969746|FG002|COMPLETED|Overall Study||11
10807989|NCT03880266|11969747|FG003|COMPLETED|Overall Study||4
10807990|NCT03880266|11969748|FG004|COMPLETED|Overall Study||12
10807991|NCT03880266|11969749|FG005|COMPLETED|Overall Study||6
10807992|NCT03880266|11969750|FG006|COMPLETED|Overall Study||13
10807993|NCT03880266|11969751|FG007|COMPLETED|Overall Study||7
10807994|NCT03880266|11969744|FG000|NOT COMPLETED|Overall Study||0
10807995|NCT03880266|11969745|FG001|NOT COMPLETED|Overall Study||1
10599156|NCT01826812|11755629|FG000|COMPLETED|Overall Study||167
10599157|NCT01826812|11755630|FG001|COMPLETED|Overall Study||32
10807996|NCT03880266|11969746|FG002|NOT COMPLETED|Overall Study||1
10807997|NCT03880266|11969747|FG003|NOT COMPLETED|Overall Study||0
10807998|NCT03880266|11969748|FG004|NOT COMPLETED|Overall Study||0
10599158|NCT01826812|11755629|FG000|NOT COMPLETED|Overall Study||0
10599159|NCT01826812|11755630|FG001|NOT COMPLETED|Overall Study||1
10599160|NCT01826825|11755640|FG000|STARTED|Overall Study||100
10599161|NCT01826825|11755641|FG001|STARTED|Overall Study||100
10807999|NCT03880266|11969749|FG005|NOT COMPLETED|Overall Study||0
10808000|NCT03880266|11969750|FG006|NOT COMPLETED|Overall Study||0
10599162|NCT01826825|11755640|FG000|COMPLETED|Overall Study||100
10599163|NCT01826825|11755641|FG001|COMPLETED|Overall Study||98
10599164|NCT01826825|11755640|FG000|NOT COMPLETED|Overall Study||0
10599165|NCT01826825|11755641|FG001|NOT COMPLETED|Overall Study||2
10599166|NCT01826851|11755651|FG000|STARTED|Overall Study||38
10599167|NCT01826851|11755652|FG001|STARTED|Overall Study||41
10599168|NCT01826851|11755651|FG000|COMPLETED|Overall Study||38
10599169|NCT01826851|11755652|FG001|COMPLETED|Overall Study||41
10599170|NCT01826851|11755651|FG000|NOT COMPLETED|Overall Study||0
10599171|NCT01826851|11755652|FG001|NOT COMPLETED|Overall Study||0
10599172|NCT01826981|11755673|FG000|STARTED|Overall Study||19
10599173|NCT01826981|11755674|FG001|STARTED|Overall Study||10
10599174|NCT01826981|11755675|FG002|STARTED|Overall Study||25
10599175|NCT01826981|11755676|FG003|STARTED|Overall Study||26
10599176|NCT01826981|11755677|FG004|STARTED|Overall Study||25
10599177|NCT01826981|11755678|FG005|STARTED|Overall Study||26
10599178|NCT01826981|11755679|FG006|STARTED|Overall Study||25
10599179|NCT01826981|11755680|FG007|STARTED|Overall Study||51
10599180|NCT01826981|11755681|FG008|STARTED|Overall Study||20
10599181|NCT01826981|11755682|FG009|STARTED|Overall Study||27
10599182|NCT01826981|11755683|FG010|STARTED|Overall Study||24
10599183|NCT01826981|11755684|FG011|STARTED|Overall Study||27
10599184|NCT01826981|11755685|FG012|STARTED|Overall Study||26
10599185|NCT01826981|11755686|FG013|STARTED|Overall Study||20
10599186|NCT01826981|11755687|FG014|STARTED|Overall Study||8
10599187|NCT01826981|11755673|FG000|COMPLETED|Overall Study||19
10599188|NCT01826981|11755674|FG001|COMPLETED|Overall Study||9
10599189|NCT01826981|11755675|FG002|COMPLETED|Overall Study||25
10599190|NCT01826981|11755676|FG003|COMPLETED|Overall Study||26
10599191|NCT01826981|11755677|FG004|COMPLETED|Overall Study||18
10599192|NCT01826981|11755678|FG005|COMPLETED|Overall Study||25
10599193|NCT01826981|11755679|FG006|COMPLETED|Overall Study||24
10599194|NCT01826981|11755680|FG007|COMPLETED|Overall Study||40
10599195|NCT01826981|11755681|FG008|COMPLETED|Overall Study||13
10599196|NCT01826981|11755682|FG009|COMPLETED|Overall Study||26
10599197|NCT01826981|11755683|FG010|COMPLETED|Overall Study||22
10599198|NCT01826981|11755684|FG011|COMPLETED|Overall Study||25
10599199|NCT01826981|11755685|FG012|COMPLETED|Overall Study||25
10599200|NCT01826981|11755686|FG013|COMPLETED|Overall Study||15
10599201|NCT01826981|11755687|FG014|COMPLETED|Overall Study||8
10599202|NCT01826981|11755673|FG000|NOT COMPLETED|Overall Study||0
10599203|NCT01826981|11755674|FG001|NOT COMPLETED|Overall Study||1
10599204|NCT01826981|11755675|FG002|NOT COMPLETED|Overall Study||0
10599205|NCT01826981|11755676|FG003|NOT COMPLETED|Overall Study||0
10599206|NCT01826981|11755677|FG004|NOT COMPLETED|Overall Study||7
10599207|NCT01826981|11755678|FG005|NOT COMPLETED|Overall Study||1
10599208|NCT01826981|11755679|FG006|NOT COMPLETED|Overall Study||1
10599209|NCT01826981|11755680|FG007|NOT COMPLETED|Overall Study||11
10599210|NCT01826981|11755681|FG008|NOT COMPLETED|Overall Study||7
10599211|NCT01826981|11755682|FG009|NOT COMPLETED|Overall Study||1
10599212|NCT01826981|11755683|FG010|NOT COMPLETED|Overall Study||2
10599213|NCT01826981|11755684|FG011|NOT COMPLETED|Overall Study||2
10599214|NCT01826981|11755685|FG012|NOT COMPLETED|Overall Study||1
10599215|NCT01826981|11755686|FG013|NOT COMPLETED|Overall Study||5
10599216|NCT01826981|11755687|FG014|NOT COMPLETED|Overall Study||0
10599217|NCT01827046|11755725|FG000|STARTED|Overall Study||250
10599218|NCT01827046|11755726|FG001|STARTED|Overall Study||249
10599219|NCT01827046|11755725|FG000|COMPLETED|Overall Study||249
10599220|NCT01827046|11755726|FG001|COMPLETED|Overall Study||240
10599221|NCT01827046|11755725|FG000|NOT COMPLETED|Overall Study||1
10599222|NCT01827046|11755726|FG001|NOT COMPLETED|Overall Study||9
10599223|NCT01827163|11755732|FG000|STARTED|Overall Study||20
10599224|NCT01827163|11755732|FG000|COMPLETED|Overall Study||9
10599225|NCT01827163|11755732|FG000|NOT COMPLETED|Overall Study||11
10599226|NCT01827254|11755736|FG000|STARTED|Overall Study||61
10599227|NCT01827254|11755736|FG000|Evaluable Population|Overall Study||52
10599228|NCT01827254|11755736|FG000|COMPLETED|Overall Study||2
10599229|NCT01827254|11755736|FG000|NOT COMPLETED|Overall Study||59
10599230|NCT01827267|11755746|FG000|STARTED|Overall Study|18 subjects were randomized but 17 received treatment.|18
10599231|NCT01827267|11755747|FG001|STARTED|Overall Study|44 subjects were randomized; 43 subjects were treated.|44
10599232|NCT01827267|11755746|FG000|Received Study Drug|Overall Study||17
10599233|NCT01827267|11755747|FG001|Received Study Drug|Overall Study||43
10599234|NCT01827267|11755746|FG000|Crossed Over to Neratinib + Temsirolimus|Overall Study||11
10599235|NCT01827267|11755747|FG001|Crossed Over to Neratinib + Temsirolimus|Overall Study||0
10599236|NCT01827267|11755746|FG000|COMPLETED|Overall Study||13
10599237|NCT01827267|11755747|FG001|COMPLETED|Overall Study||32
10599238|NCT01827267|11755746|FG000|NOT COMPLETED|Overall Study||5
10599239|NCT01827267|11755747|FG001|NOT COMPLETED|Overall Study||12
10599240|NCT01827306|11755756|FG000|STARTED|Overall Study||21
10599241|NCT01827306|11755757|FG001|STARTED|Overall Study||13
10599242|NCT01827306|11755756|FG000|COMPLETED|Overall Study||10
10599243|NCT01827306|11755757|FG001|COMPLETED|Overall Study||8
10599244|NCT01827306|11755756|FG000|NOT COMPLETED|Overall Study||11
10599245|NCT01827306|11755757|FG001|NOT COMPLETED|Overall Study||5
10599246|NCT01827319|11755763|FG000|STARTED|Overall Study||203
10599247|NCT01827319|11755763|FG000|COMPLETED|Overall Study||200
10599248|NCT01827319|11755763|FG000|NOT COMPLETED|Overall Study||3
10599249|NCT01827332|11755769|FG000|STARTED|Overall Study||8
10599250|NCT01827332|11755770|FG001|STARTED|Overall Study||8
10599251|NCT01827332|11755769|FG000|COMPLETED|Overall Study||6
10599252|NCT01827332|11755770|FG001|COMPLETED|Overall Study||7
10599253|NCT01827332|11755769|FG000|NOT COMPLETED|Overall Study||2
10599254|NCT01827332|11755770|FG001|NOT COMPLETED|Overall Study||1
10599255|NCT01827358|11755778|FG000|STARTED|Overall Study||80
10599256|NCT01827358|11755779|FG001|STARTED|Overall Study||75
10599257|NCT01827358|11755778|FG000|COMPLETED|Overall Study||45
10599258|NCT01827358|11755779|FG001|COMPLETED|Overall Study||44
10599259|NCT01827358|11755778|FG000|NOT COMPLETED|Overall Study||35
10599260|NCT01827358|11755779|FG001|NOT COMPLETED|Overall Study||31
10599261|NCT01827371|11755789|FG000|STARTED|Overall Study||115
10599262|NCT01827371|11755790|FG001|STARTED|Overall Study||96
10599263|NCT01827371|11755791|FG002|STARTED|Overall Study||104
10599264|NCT01827371|11755792|FG003|STARTED|Overall Study||120
10599265|NCT01827371|11755789|FG000|COMPLETED|Overall Study||102
10599266|NCT01827371|11755790|FG001|COMPLETED|Overall Study||89
10599267|NCT01827371|11755791|FG002|COMPLETED|Overall Study||93
10599268|NCT01827371|11755792|FG003|COMPLETED|Overall Study||97
10599269|NCT01827371|11755789|FG000|NOT COMPLETED|Overall Study||13
10599270|NCT01827371|11755790|FG001|NOT COMPLETED|Overall Study||7
10599271|NCT01827371|11755791|FG002|NOT COMPLETED|Overall Study||11
10599272|NCT01827371|11755792|FG003|NOT COMPLETED|Overall Study||23
10599273|NCT01827462|11755805|FG000|STARTED|Overall Study||59
10599274|NCT01827462|11755806|FG001|STARTED|Overall Study||37
10599275|NCT01827462|11755807|FG002|STARTED|Overall Study||40
10599276|NCT01827462|11755805|FG000|COMPLETED|Overall Study||18
10599277|NCT01827462|11755806|FG001|COMPLETED|Overall Study||19
10599278|NCT01827462|11755807|FG002|COMPLETED|Overall Study||12
10599279|NCT01827462|11755805|FG000|NOT COMPLETED|Overall Study||41
10599280|NCT01827462|11755806|FG001|NOT COMPLETED|Overall Study||18
10599281|NCT01827462|11755807|FG002|NOT COMPLETED|Overall Study||28
10599282|NCT01827475|11755821|FG000|STARTED|Overall Study||30
10599283|NCT01827475|11755822|FG001|STARTED|Overall Study||30
10599284|NCT01827475|11755823|FG002|STARTED|Overall Study||30
10599285|NCT01827475|11755821|FG000|COMPLETED|Overall Study||30
10599286|NCT01827475|11755822|FG001|COMPLETED|Overall Study||30
10599287|NCT01827475|11755823|FG002|COMPLETED|Overall Study||30
10599288|NCT01827475|11755821|FG000|NOT COMPLETED|Overall Study||0
10599289|NCT01827475|11755822|FG001|NOT COMPLETED|Overall Study||0
10599290|NCT01827475|11755823|FG002|NOT COMPLETED|Overall Study||0
10599291|NCT01827592|11755834|FG000|STARTED|Overall Study|Randomized patients.|126
10599292|NCT01827592|11755835|FG001|STARTED|Overall Study|Randomized patients.|126
10599293|NCT01827592|11755836|FG002|STARTED|Overall Study|Randomized patients.|124
10599294|NCT01827592|11755834|FG000|Safety Analysis Set|Overall Study|1 patient withdrew consent before getting the treatment.|125
10599295|NCT01827592|11755835|FG001|Safety Analysis Set|Overall Study||126
10599296|NCT01827592|11755836|FG002|Safety Analysis Set|Overall Study||124
10599297|NCT01827592|11755834|FG000|COMPLETED|Overall Study||52
10599298|NCT01827592|11755835|FG001|COMPLETED|Overall Study||46
10599299|NCT01827592|11755836|FG002|COMPLETED|Overall Study||48
10599300|NCT01827592|11755834|FG000|NOT COMPLETED|Overall Study||74
10599301|NCT01827592|11755835|FG001|NOT COMPLETED|Overall Study||80
10599302|NCT01827592|11755836|FG002|NOT COMPLETED|Overall Study||76
10599303|NCT01827670|11755846|FG000|STARTED|Overall Study||60
10599304|NCT01827670|11755847|FG001|STARTED|Overall Study||59
10599305|NCT01827670|11755846|FG000|COMPLETED|Overall Study||57
10599306|NCT01827670|11755847|FG001|COMPLETED|Overall Study||56
10599307|NCT01827670|11755846|FG000|NOT COMPLETED|Overall Study||3
10599308|NCT01827670|11755847|FG001|NOT COMPLETED|Overall Study||3
10599309|NCT01827787|11755860|FG000|STARTED|Overall Study||45
10599310|NCT01827787|11755861|FG001|STARTED|Overall Study||38
10599311|NCT01827787|11755860|FG000|COMPLETED|Overall Study||45
10599312|NCT01827787|11755861|FG001|COMPLETED|Overall Study||38
10599313|NCT01827787|11755860|FG000|NOT COMPLETED|Overall Study||0
10599314|NCT01827787|11755861|FG001|NOT COMPLETED|Overall Study||0
10599315|NCT01827839|11755870|FG000|STARTED|Overall Study||96
10599316|NCT01827839|11755870|FG000|COMPLETED|Overall Study||93
10599317|NCT01827839|11755870|FG000|NOT COMPLETED|Overall Study||3
10599318|NCT01827930|11755884|FG000|STARTED|Overall Study||24
10599319|NCT01827930|11755885|FG001|STARTED|Overall Study||25
10599320|NCT01827930|11755886|FG002|STARTED|Overall Study||19
10599321|NCT01827930|11755884|FG000|COMPLETED|Overall Study||24
10599322|NCT01827930|11755885|FG001|COMPLETED|Overall Study||25
10599323|NCT01827930|11755886|FG002|COMPLETED|Overall Study||19
10599324|NCT01827930|11755884|FG000|NOT COMPLETED|Overall Study||0
10599325|NCT01827930|11755885|FG001|NOT COMPLETED|Overall Study||0
10599326|NCT01827930|11755886|FG002|NOT COMPLETED|Overall Study||0
10599327|NCT01827943|11755894|FG000|STARTED|Overall Study||54
10599328|NCT01827943|11755894|FG000|Safety Population|Overall Study||53
10599329|NCT01827943|11755894|FG000|COMPLETED|Overall Study||45
10703833|NCT02587962|11868347|FG003|COMPLETED|Overall Study||1
10703834|NCT02587962|11868348|FG004|COMPLETED|Overall Study||0
10599330|NCT01827943|11755894|FG000|NOT COMPLETED|Overall Study||9
10599331|NCT01828034|11755902|FG000|STARTED|Overall Study||3
10599332|NCT01828034|11755903|FG001|STARTED|Overall Study||6
10599333|NCT01828034|11755904|FG002|STARTED|Overall Study||3
10599334|NCT01828034|11755905|FG003|STARTED|Overall Study||30
10599335|NCT01828034|11755902|FG000|COMPLETED|Overall Study||3
10599336|NCT01828034|11755903|FG001|COMPLETED|Overall Study||6
10599337|NCT01828034|11755904|FG002|COMPLETED|Overall Study||3
10599338|NCT01828034|11755905|FG003|COMPLETED|Overall Study||29
10599339|NCT01828034|11755902|FG000|NOT COMPLETED|Overall Study||0
10599340|NCT01828034|11755903|FG001|NOT COMPLETED|Overall Study||0
10599341|NCT01828034|11755904|FG002|NOT COMPLETED|Overall Study||0
10599342|NCT01828034|11755905|FG003|NOT COMPLETED|Overall Study||1
10703835|NCT02587962|11868344|FG000|NOT COMPLETED|Overall Study||2
10703836|NCT02587962|11868345|FG001|NOT COMPLETED|Overall Study||3
10703837|NCT02587962|11868346|FG002|NOT COMPLETED|Overall Study||6
10703838|NCT02587962|11868347|FG003|NOT COMPLETED|Overall Study||6
10599343|NCT01828073|11755914|FG000|STARTED|Overall Study||22
10599344|NCT01828073|11755915|FG001|STARTED|Overall Study||18
10599345|NCT01828073|11755914|FG000|COMPLETED|Overall Study||21
10599346|NCT01828073|11755915|FG001|COMPLETED|Overall Study||16
10599347|NCT01828073|11755914|FG000|NOT COMPLETED|Overall Study||1
10599348|NCT01828073|11755915|FG001|NOT COMPLETED|Overall Study||2
10599349|NCT01828164|11755927|FG000|STARTED|Overall Study|11 out of 60 subjects did not meet inclusion criteria after enrollment.|49
10599350|NCT01828164|11755927|FG000|COMPLETED|Overall Study||32
10599351|NCT01828164|11755927|FG000|NOT COMPLETED|Overall Study||17
10599352|NCT01828216|11755937|FG000|STARTED|Overall Study||159
10599353|NCT01828216|11755938|FG001|STARTED|Overall Study||157
10599354|NCT01828216|11755937|FG000|COMPLETED|Overall Study||159
10599355|NCT01828216|11755938|FG001|COMPLETED|Overall Study||157
10599356|NCT01828216|11755937|FG000|NOT COMPLETED|Overall Study||0
10599357|NCT01828216|11755938|FG001|NOT COMPLETED|Overall Study||0
10599358|NCT01828255|11755948|FG000|STARTED|Overall Study||20
10599359|NCT01828255|11755949|FG001|STARTED|Overall Study||20
10599360|NCT01828255|11755948|FG000|COMPLETED|Overall Study||20
10599361|NCT01828255|11755949|FG001|COMPLETED|Overall Study||20
10599362|NCT01828255|11755948|FG000|NOT COMPLETED|Overall Study||0
10599363|NCT01828255|11755949|FG001|NOT COMPLETED|Overall Study||0
10599364|NCT01828281|11755959|FG000|STARTED|Overall Study||45
10599365|NCT01828281|11755960|FG001|STARTED|Overall Study||45
10599366|NCT01828281|11755959|FG000|COMPLETED|Overall Study||44
10599367|NCT01828281|11755960|FG001|COMPLETED|Overall Study||45
10599368|NCT01828281|11755959|FG000|NOT COMPLETED|Overall Study||1
10599369|NCT01828281|11755960|FG001|NOT COMPLETED|Overall Study||0
10599370|NCT01828476|11755969|FG000|STARTED|Overall Study||13
10599371|NCT01828476|11755970|FG001|STARTED|Overall Study||0
10599372|NCT01828476|11755969|FG000|COMPLETED|Overall Study||13
10599373|NCT01828476|11755970|FG001|COMPLETED|Overall Study||0
10599374|NCT01828476|11755969|FG000|NOT COMPLETED|Overall Study||0
10599375|NCT01828476|11755970|FG001|NOT COMPLETED|Overall Study||0
10599376|NCT01828515|11755978|FG000|STARTED|First Intervention (19 Days)||13
10599377|NCT01828515|11755979|FG001|STARTED|First Intervention (19 Days)||11
10599378|NCT01828515|11755978|FG000|COMPLETED|First Intervention (19 Days)||11
10599379|NCT01828515|11755979|FG001|COMPLETED|First Intervention (19 Days)||9
10599380|NCT01828515|11755978|FG000|NOT COMPLETED|First Intervention (19 Days)||2
10599381|NCT01828515|11755979|FG001|NOT COMPLETED|First Intervention (19 Days)||2
10599382|NCT01828515|11755978|FG000|STARTED|Washout (23 Days)||11
10599383|NCT01828515|11755979|FG001|STARTED|Washout (23 Days)||9
10599384|NCT01828515|11755978|FG000|COMPLETED|Washout (23 Days)||6
10599385|NCT01828515|11755979|FG001|COMPLETED|Washout (23 Days)||8
10599386|NCT01828515|11755978|FG000|NOT COMPLETED|Washout (23 Days)||5
10599387|NCT01828515|11755979|FG001|NOT COMPLETED|Washout (23 Days)||1
10599388|NCT01828515|11755978|FG000|STARTED|Second Intervention (19 Days)||6
10599389|NCT01828515|11755979|FG001|STARTED|Second Intervention (19 Days)||8
10599390|NCT01828515|11755978|FG000|COMPLETED|Second Intervention (19 Days)||6
10599391|NCT01828515|11755979|FG001|COMPLETED|Second Intervention (19 Days)||5
10599392|NCT01828515|11755978|FG000|NOT COMPLETED|Second Intervention (19 Days)||0
10599393|NCT01828515|11755979|FG001|NOT COMPLETED|Second Intervention (19 Days)||3
10599394|NCT01828554|11755985|FG000|STARTED|Overall Study||8
10599395|NCT01828554|11755985|FG000|COMPLETED|Overall Study||8
10599396|NCT01828554|11755985|FG000|NOT COMPLETED|Overall Study||0
10599397|NCT01828567|11755991|FG000|STARTED|Overall Study||208
10599398|NCT01828567|11755992|FG001|STARTED|Overall Study||209
10599399|NCT01828567|11755991|FG000|1 Month|Overall Study||172
10599400|NCT01828567|11755992|FG001|1 Month|Overall Study||192
10599401|NCT01828567|11755991|FG000|COMPLETED|Overall Study||177
10599402|NCT01828567|11755992|FG001|COMPLETED|Overall Study||199
10599403|NCT01828567|11755991|FG000|NOT COMPLETED|Overall Study||31
10599404|NCT01828567|11755992|FG001|NOT COMPLETED|Overall Study||10
10599405|NCT01828593|11756001|FG000|STARTED|Placebo-Controlled Phase||36
10599406|NCT01828593|11756002|FG001|STARTED|Placebo-Controlled Phase||34
10599407|NCT01828593|11756003|FG002|STARTED|Placebo-Controlled Phase||33
10599408|NCT01828593|11756001|FG000|COMPLETED|Placebo-Controlled Phase||36
10599409|NCT01828593|11756002|FG001|COMPLETED|Placebo-Controlled Phase||34
10599410|NCT01828593|11756003|FG002|COMPLETED|Placebo-Controlled Phase||32
10599411|NCT01828593|11756001|FG000|NOT COMPLETED|Placebo-Controlled Phase||0
10599412|NCT01828593|11756002|FG001|NOT COMPLETED|Placebo-Controlled Phase||0
10599413|NCT01828593|11756003|FG002|NOT COMPLETED|Placebo-Controlled Phase||1
10599414|NCT01828593|11756001|FG000|STARTED|Placebo-Free Phase|Placebo subjects took either SBI 2.5 or 5.0 g in the placebo-free phase|0
10599415|NCT01828593|11756002|FG001|STARTED|Placebo-Free Phase|SBI 2.5 g includes SBI 2.5 plus placebo who started taking SBI at Wk 4|55
10599416|NCT01828593|11756003|FG002|STARTED|Placebo-Free Phase|SBI 5.0 g includes SBI 5.0 plus placebo who started taking SBI at Wk 4|47
10599417|NCT01828593|11756001|FG000|COMPLETED|Placebo-Free Phase|Placebo subjects took either SBI 2.5 or 5.0 g in the placebo-free phase|0
10599418|NCT01828593|11756002|FG001|COMPLETED|Placebo-Free Phase|SBI 2.5 g includes SBI 2.5 plus placebo who started taking SBI at Wk 4|49
10599419|NCT01828593|11756003|FG002|COMPLETED|Placebo-Free Phase|SBI 5.0 g includes SBI 5.0 plus placebo who started taking SBI at Wk 4|41
10599420|NCT01828593|11756001|FG000|NOT COMPLETED|Placebo-Free Phase||0
10599421|NCT01828593|11756002|FG001|NOT COMPLETED|Placebo-Free Phase||6
10703839|NCT02587962|11868348|FG004|NOT COMPLETED|Overall Study||15
10599422|NCT01828593|11756003|FG002|NOT COMPLETED|Placebo-Free Phase||6
10599423|NCT01828983|11756016|FG000|STARTED|Overall Study||80
10808001|NCT03880266|11969751|FG007|NOT COMPLETED|Overall Study||0
10808002|NCT03856320|11969771|FG000|STARTED|Overall Study||20
10808003|NCT03856320|11969772|FG001|STARTED|Overall Study||22
10808004|NCT03856320|11969771|FG000|COMPLETED|Overall Study||20
10808005|NCT03856320|11969772|FG001|COMPLETED|Overall Study||20
10599424|NCT01828983|11756017|FG001|STARTED|Overall Study||81
10599425|NCT01828983|11756016|FG000|COMPLETED|Overall Study||80
10599426|NCT01828983|11756017|FG001|COMPLETED|Overall Study||81
10599427|NCT01828983|11756016|FG000|NOT COMPLETED|Overall Study||0
10599428|NCT01828983|11756017|FG001|NOT COMPLETED|Overall Study||0
10599429|NCT01829048|11756028|FG000|STARTED|Overall Study||6
10599430|NCT01829048|11756029|FG001|STARTED|Overall Study||8
10599431|NCT01829048|11756030|FG002|STARTED|Overall Study||7
10599432|NCT01829048|11756031|FG003|STARTED|Overall Study||14
10599433|NCT01829048|11756032|FG004|STARTED|Overall Study||2
10599434|NCT01829048|11756028|FG000|COMPLETED|Overall Study||6
10599435|NCT01829048|11756029|FG001|COMPLETED|Overall Study||8
10599436|NCT01829048|11756030|FG002|COMPLETED|Overall Study||7
10599437|NCT01829048|11756031|FG003|COMPLETED|Overall Study||12
10599438|NCT01829048|11756032|FG004|COMPLETED|Overall Study||2
10599439|NCT01829048|11756028|FG000|NOT COMPLETED|Overall Study||0
10599440|NCT01829048|11756029|FG001|NOT COMPLETED|Overall Study||0
10599441|NCT01829048|11756030|FG002|NOT COMPLETED|Overall Study||0
10599442|NCT01829048|11756031|FG003|NOT COMPLETED|Overall Study||2
10599443|NCT01829048|11756032|FG004|NOT COMPLETED|Overall Study||0
10599444|NCT01829113|11756047|FG000|STARTED|Overall Study|Three patients were enrolled and randomized but never received treatment.|77
10599445|NCT01829113|11756048|FG001|STARTED|Overall Study|Two patients were enrolled and randomized but never received treatment.|78
10703840|NCT02588092|11868373|FG000|STARTED|Overall Study||4
10703841|NCT02588092|11868374|FG001|STARTED|Overall Study||3
10703842|NCT02588092|11868375|FG002|STARTED|Overall Study||3
10703843|NCT02588092|11868376|FG003|STARTED|Overall Study||3
10703844|NCT02588092|11868377|FG004|STARTED|Overall Study||3
10703845|NCT02588092|11868378|FG005|STARTED|Overall Study||3
10703846|NCT02588092|11868379|FG006|STARTED|Overall Study||3
10703847|NCT02588092|11868380|FG007|STARTED|Overall Study||4
10703848|NCT02588092|11868381|FG008|STARTED|Overall Study||6
10703849|NCT02588092|11868382|FG009|STARTED|Overall Study||3
10703850|NCT02588092|11868373|FG000|COMPLETED|Overall Study||0
10703851|NCT02588092|11868374|FG001|COMPLETED|Overall Study||0
10599446|NCT01829113|11756047|FG000|COMPLETED|Overall Study||0
10599447|NCT01829113|11756048|FG001|COMPLETED|Overall Study||0
10599448|NCT01829113|11756047|FG000|NOT COMPLETED|Overall Study||77
10599449|NCT01829113|11756048|FG001|NOT COMPLETED|Overall Study||78
10599450|NCT01829165|11756058|FG000|STARTED|Overall Study||20
10599451|NCT01829165|11756059|FG001|STARTED|Overall Study||13
10599452|NCT01829165|11756058|FG000|COMPLETED|Overall Study||18
10599453|NCT01829165|11756059|FG001|COMPLETED|Overall Study||13
10599454|NCT01829165|11756058|FG000|NOT COMPLETED|Overall Study||2
10599455|NCT01829165|11756059|FG001|NOT COMPLETED|Overall Study||0
10599456|NCT01829191|11756067|FG000|STARTED|Overall Study||63
10599457|NCT01829191|11756068|FG001|STARTED|Overall Study||64
10599458|NCT01829191|11756067|FG000|COMPLETED|Overall Study||56
10599459|NCT01829191|11756068|FG001|COMPLETED|Overall Study||50
10599460|NCT01829191|11756067|FG000|NOT COMPLETED|Overall Study||7
10599461|NCT01829191|11756068|FG001|NOT COMPLETED|Overall Study||14
10703852|NCT02588092|11868375|FG002|COMPLETED|Overall Study||0
10703853|NCT02588092|11868376|FG003|COMPLETED|Overall Study||0
10599462|NCT01829217|11756073|FG000|STARTED|Overall Study||13
10599463|NCT01829217|11756073|FG000|COMPLETED|Overall Study||13
10599464|NCT01829217|11756073|FG000|NOT COMPLETED|Overall Study||0
10599465|NCT01829230|11756079|FG000|STARTED|Overall Study||40
10599466|NCT01829230|11756080|FG001|STARTED|Overall Study||42
10599467|NCT01829230|11756079|FG000|COMPLETED|Overall Study||39
10599468|NCT01829230|11756080|FG001|COMPLETED|Overall Study||38
10599469|NCT01829230|11756079|FG000|NOT COMPLETED|Overall Study||1
10599470|NCT01829230|11756080|FG001|NOT COMPLETED|Overall Study||4
10599471|NCT01829243|11756086|FG000|STARTED|First Intervention||11
10599472|NCT01829243|11756087|FG001|STARTED|First Intervention||15
10599473|NCT01829243|11756086|FG000|COMPLETED|First Intervention||7
10599474|NCT01829243|11756087|FG001|COMPLETED|First Intervention||13
10599475|NCT01829243|11756086|FG000|NOT COMPLETED|First Intervention||4
10703854|NCT02588092|11868377|FG004|COMPLETED|Overall Study||0
10703855|NCT02588092|11868378|FG005|COMPLETED|Overall Study||0
10808006|NCT03856320|11969771|FG000|NOT COMPLETED|Overall Study||0
10808007|NCT03856320|11969772|FG001|NOT COMPLETED|Overall Study||2
10599476|NCT01829243|11756087|FG001|NOT COMPLETED|First Intervention||2
10599477|NCT01829243|11756086|FG000|STARTED|Washout Period of 1 Week||7
10599478|NCT01829243|11756087|FG001|STARTED|Washout Period of 1 Week||13
10599479|NCT01829243|11756086|FG000|COMPLETED|Washout Period of 1 Week||7
10599480|NCT01829243|11756087|FG001|COMPLETED|Washout Period of 1 Week||13
10599481|NCT01829243|11756086|FG000|NOT COMPLETED|Washout Period of 1 Week||0
10703856|NCT02588092|11868379|FG006|COMPLETED|Overall Study||0
10808008|NCT03848871|11969778|FG000|STARTED|Overall Study||20
10599482|NCT01829243|11756087|FG001|NOT COMPLETED|Washout Period of 1 Week||0
10599483|NCT01829243|11756086|FG000|STARTED|Second Intervention||7
10703857|NCT02588092|11868380|FG007|COMPLETED|Overall Study||0
10703858|NCT02588092|11868381|FG008|COMPLETED|Overall Study||0
10703859|NCT02588092|11868382|FG009|COMPLETED|Overall Study||0
10599484|NCT01829243|11756087|FG001|STARTED|Second Intervention||13
10599485|NCT01829243|11756086|FG000|COMPLETED|Second Intervention||7
10599486|NCT01829243|11756087|FG001|COMPLETED|Second Intervention||13
10599487|NCT01829243|11756086|FG000|NOT COMPLETED|Second Intervention||0
10599488|NCT01829243|11756087|FG001|NOT COMPLETED|Second Intervention||0
10599489|NCT01829295|11756097|FG000|STARTED|0-6 Months||107
10599490|NCT01829295|11756098|FG001|STARTED|0-6 Months||109
10599491|NCT01829295|11756099|FG002|STARTED|0-6 Months||0
10599492|NCT01829295|11756100|FG003|STARTED|0-6 Months||0
10599493|NCT01829295|11756097|FG000|COMPLETED|0-6 Months||96
10599494|NCT01829295|11756098|FG001|COMPLETED|0-6 Months||98
10599495|NCT01829295|11756099|FG002|COMPLETED|0-6 Months||0
10599496|NCT01829295|11756100|FG003|COMPLETED|0-6 Months||0
10599497|NCT01829295|11756097|FG000|NOT COMPLETED|0-6 Months||11
10599498|NCT01829295|11756098|FG001|NOT COMPLETED|0-6 Months||11
10599499|NCT01829295|11756099|FG002|NOT COMPLETED|0-6 Months||0
10599500|NCT01829295|11756100|FG003|NOT COMPLETED|0-6 Months||0
10599501|NCT01829295|11756097|FG000|STARTED|6-12 Months|64 patients were a treatment success on methotrexate at 6 mo and had the option to continue|64
10599502|NCT01829295|11756098|FG001|STARTED|6-12 Months|56 patients were a treatment success on mycophenolate mofetil at 6 mo and had the option to continue|56
10599503|NCT01829295|11756099|FG002|STARTED|6-12 Months|32 patients failed methotrexate within the first 6 months|32
10599504|NCT01829295|11756100|FG003|STARTED|6-12 Months|42 patients failed on mycophenolate mofetil within the first 6 months|42
10599505|NCT01829295|11756097|FG000|COMPLETED|6-12 Months||60
10599506|NCT01829295|11756098|FG001|COMPLETED|6-12 Months||54
10599507|NCT01829295|11756099|FG002|COMPLETED|6-12 Months||20
10599508|NCT01829295|11756100|FG003|COMPLETED|6-12 Months||29
10599509|NCT01829295|11756097|FG000|NOT COMPLETED|6-12 Months||4
10599510|NCT01829295|11756098|FG001|NOT COMPLETED|6-12 Months||2
10599511|NCT01829295|11756099|FG002|NOT COMPLETED|6-12 Months||12
10599512|NCT01829295|11756100|FG003|NOT COMPLETED|6-12 Months||13
10599513|NCT01829347|11756112|FG000|STARTED|VTI-210||9
10599514|NCT01829347|11756113|FG001|STARTED|VTI-210||9
10599515|NCT01829347|11756112|FG000|COMPLETED|VTI-210||3
10599516|NCT01829347|11756113|FG001|COMPLETED|VTI-210||6
10599517|NCT01829347|11756112|FG000|NOT COMPLETED|VTI-210||6
10599518|NCT01829347|11756113|FG001|NOT COMPLETED|VTI-210||3
10599519|NCT01829347|11756112|FG000|STARTED|VTI-210E||3
10599520|NCT01829347|11756113|FG001|STARTED|VTI-210E||6
10599521|NCT01829347|11756112|FG000|COMPLETED|VTI-210E||0
10599522|NCT01829347|11756113|FG001|COMPLETED|VTI-210E||0
10599523|NCT01829347|11756112|FG000|NOT COMPLETED|VTI-210E||3
10599524|NCT01829347|11756113|FG001|NOT COMPLETED|VTI-210E||6
10599525|NCT01829360|11756123|FG000|STARTED|Overall Study||8
10599526|NCT01829360|11756124|FG001|STARTED|Overall Study||9
10599527|NCT01829360|11756125|FG002|STARTED|Overall Study||10
10599528|NCT01829360|11756126|FG003|STARTED|Overall Study||8
10599529|NCT01829360|11756123|FG000|COMPLETED|Overall Study||8
10599530|NCT01829360|11756124|FG001|COMPLETED|Overall Study||9
10703860|NCT02588092|11868373|FG000|NOT COMPLETED|Overall Study||4
10703861|NCT02588092|11868374|FG001|NOT COMPLETED|Overall Study||3
10703862|NCT02588092|11868375|FG002|NOT COMPLETED|Overall Study||3
10703863|NCT02588092|11868376|FG003|NOT COMPLETED|Overall Study||3
10703864|NCT02588092|11868377|FG004|NOT COMPLETED|Overall Study||3
10703865|NCT02588092|11868378|FG005|NOT COMPLETED|Overall Study||3
10703866|NCT02588092|11868379|FG006|NOT COMPLETED|Overall Study||3
10703867|NCT02588092|11868380|FG007|NOT COMPLETED|Overall Study||4
10703868|NCT02588092|11868381|FG008|NOT COMPLETED|Overall Study||6
10703869|NCT02588092|11868382|FG009|NOT COMPLETED|Overall Study||3
10599531|NCT01829360|11756125|FG002|COMPLETED|Overall Study||9
10599532|NCT01829360|11756126|FG003|COMPLETED|Overall Study||8
10599533|NCT01829360|11756123|FG000|NOT COMPLETED|Overall Study||0
10599534|NCT01829360|11756124|FG001|NOT COMPLETED|Overall Study||0
10599535|NCT01829360|11756125|FG002|NOT COMPLETED|Overall Study||1
10599536|NCT01829360|11756126|FG003|NOT COMPLETED|Overall Study||0
10599537|NCT01829399|11756142|FG000|STARTED|Visit 1||12
10599538|NCT01829399|11756143|FG001|STARTED|Visit 1||12
10599539|NCT01829399|11756142|FG000|COMPLETED|Visit 1||12
10599540|NCT01829399|11756143|FG001|COMPLETED|Visit 1||12
10599541|NCT01829399|11756142|FG000|NOT COMPLETED|Visit 1||0
10599542|NCT01829399|11756143|FG001|NOT COMPLETED|Visit 1||0
10599543|NCT01829399|11756142|FG000|STARTED|Visit 2 (One Month Later)||12
10599544|NCT01829399|11756143|FG001|STARTED|Visit 2 (One Month Later)||12
10599545|NCT01829399|11756142|FG000|COMPLETED|Visit 2 (One Month Later)||12
10599546|NCT01829399|11756143|FG001|COMPLETED|Visit 2 (One Month Later)||12
10599547|NCT01829399|11756142|FG000|NOT COMPLETED|Visit 2 (One Month Later)||0
10599548|NCT01829399|11756143|FG001|NOT COMPLETED|Visit 2 (One Month Later)||0
10599549|NCT01829425|11756153|FG000|STARTED|Overall Study||78
10599550|NCT01829425|11756154|FG001|STARTED|Overall Study||74
10599551|NCT01829425|11756153|FG000|COMPLETED|Overall Study|completed primary outcome 2 month f/u N=72|72
10599552|NCT01829425|11756154|FG001|COMPLETED|Overall Study|completed primary outcome 2 month f/u N=70|70
10599553|NCT01829425|11756153|FG000|NOT COMPLETED|Overall Study||6
10599554|NCT01829425|11756154|FG001|NOT COMPLETED|Overall Study||4
10599555|NCT01829464|11756163|FG000|STARTED|Overall Study||30
10599556|NCT01829464|11756164|FG001|STARTED|Overall Study||31
10599557|NCT01829464|11756165|FG002|STARTED|Overall Study||29
10599558|NCT01829464|11756163|FG000|COMPLETED|Overall Study||2
10599559|NCT01829464|11756164|FG001|COMPLETED|Overall Study||2
10599560|NCT01829464|11756165|FG002|COMPLETED|Overall Study||3
10599561|NCT01829464|11756163|FG000|NOT COMPLETED|Overall Study||28
10599562|NCT01829464|11756164|FG001|NOT COMPLETED|Overall Study||29
10599563|NCT01829464|11756165|FG002|NOT COMPLETED|Overall Study||26
10599564|NCT01829503|11756173|FG000|STARTED|Overall Study||44
10599565|NCT01829503|11756173|FG000|COMPLETED|Overall Study||44
10599566|NCT01829503|11756173|FG000|NOT COMPLETED|Overall Study||0
10599567|NCT01829516|11756179|FG000|STARTED|First Intervention||18
10599568|NCT01829516|11756180|FG001|STARTED|First Intervention||14
10599569|NCT01829516|11756179|FG000|COMPLETED|First Intervention||18
10599570|NCT01829516|11756180|FG001|COMPLETED|First Intervention||14
10599571|NCT01829516|11756179|FG000|NOT COMPLETED|First Intervention||0
10599572|NCT01829516|11756180|FG001|NOT COMPLETED|First Intervention||0
10599573|NCT01829516|11756179|FG000|STARTED|Washout Period - 1 Week||18
10599574|NCT01829516|11756180|FG001|STARTED|Washout Period - 1 Week||14
10599575|NCT01829516|11756179|FG000|COMPLETED|Washout Period - 1 Week||18
10599576|NCT01829516|11756180|FG001|COMPLETED|Washout Period - 1 Week||14
10599577|NCT01829516|11756179|FG000|NOT COMPLETED|Washout Period - 1 Week||0
10599578|NCT01829516|11756180|FG001|NOT COMPLETED|Washout Period - 1 Week||0
10599579|NCT01829516|11756179|FG000|STARTED|2nd Intervention||18
10599580|NCT01829516|11756180|FG001|STARTED|2nd Intervention||14
10599581|NCT01829516|11756179|FG000|COMPLETED|2nd Intervention||18
10599582|NCT01829516|11756180|FG001|COMPLETED|2nd Intervention||14
10599583|NCT01829516|11756179|FG000|NOT COMPLETED|2nd Intervention||0
10599584|NCT01829516|11756180|FG001|NOT COMPLETED|2nd Intervention||0
10599585|NCT01829919|11756188|FG000|STARTED|Overall Study||24
10599586|NCT01829919|11756188|FG000|COMPLETED|Overall Study||24
10599587|NCT01829919|11756188|FG000|NOT COMPLETED|Overall Study||0
10599588|NCT01829997|11756192|FG000|STARTED|Overall Study||22
10599589|NCT01829997|11756192|FG000|COMPLETED|Overall Study||16
10599590|NCT01829997|11756192|FG000|NOT COMPLETED|Overall Study||6
10599591|NCT01830127|11756198|FG000|STARTED|Overall Study||18
10599592|NCT01830127|11756199|FG001|STARTED|Overall Study||17
10599593|NCT01830127|11756198|FG000|COMPLETED|Overall Study||13
10599594|NCT01830127|11756199|FG001|COMPLETED|Overall Study||8
10599595|NCT01830127|11756198|FG000|NOT COMPLETED|Overall Study||5
10599596|NCT01830127|11756199|FG001|NOT COMPLETED|Overall Study||9
10599597|NCT01830140|11756207|FG000|STARTED|Overall Study||233
10599598|NCT01830140|11756208|FG001|STARTED|Overall Study||233
10599599|NCT01830140|11756207|FG000|COMPLETED|Overall Study||226
10599600|NCT01830140|11756208|FG001|COMPLETED|Overall Study||229
10599601|NCT01830140|11756207|FG000|NOT COMPLETED|Overall Study||7
10599602|NCT01830140|11756208|FG001|NOT COMPLETED|Overall Study||4
10599603|NCT01830205|11756218|FG000|STARTED|Overall Study||12
10599604|NCT01830205|11756219|FG001|STARTED|Overall Study||6
10599605|NCT01830205|11756220|FG002|STARTED|Overall Study||6
10599606|NCT01830205|11756221|FG003|STARTED|Overall Study||12
10599607|NCT01830205|11756218|FG000|COMPLETED|Overall Study||12
10599608|NCT01830205|11756219|FG001|COMPLETED|Overall Study||6
10599609|NCT01830205|11756220|FG002|COMPLETED|Overall Study||6
10599610|NCT01830205|11756221|FG003|COMPLETED|Overall Study||12
10599611|NCT01830205|11756218|FG000|NOT COMPLETED|Overall Study||0
10599612|NCT01830205|11756219|FG001|NOT COMPLETED|Overall Study||0
10599613|NCT01830205|11756220|FG002|NOT COMPLETED|Overall Study||0
10599614|NCT01830205|11756221|FG003|NOT COMPLETED|Overall Study||0
10599615|NCT01830543|11756245|FG000|STARTED|Overall Study||709
10599616|NCT01830543|11756246|FG001|STARTED|Overall Study||709
10599617|NCT01830543|11756247|FG002|STARTED|Overall Study||706
10599618|NCT01830543|11756245|FG000|Treated|Overall Study||696
10599619|NCT01830543|11756246|FG001|Treated|Overall Study||706
10599620|NCT01830543|11756247|FG002|Treated|Overall Study||697
10599621|NCT01830543|11756245|FG000|COMPLETED|Overall Study||550
10599622|NCT01830543|11756246|FG001|COMPLETED|Overall Study||557
10599623|NCT01830543|11756247|FG002|COMPLETED|Overall Study||492
10599624|NCT01830543|11756245|FG000|NOT COMPLETED|Overall Study||159
10599625|NCT01830543|11756246|FG001|NOT COMPLETED|Overall Study||152
10599626|NCT01830543|11756247|FG002|NOT COMPLETED|Overall Study||214
10599627|NCT01830595|11756255|FG000|STARTED|First Period||26
10599628|NCT01830595|11756256|FG001|STARTED|First Period||28
10599629|NCT01830595|11756255|FG000|Received at Least One Dose|First Period||26
10599630|NCT01830595|11756256|FG001|Received at Least One Dose|First Period||28
10599631|NCT01830595|11756255|FG000|COMPLETED|First Period||25
10599632|NCT01830595|11756256|FG001|COMPLETED|First Period||25
10599633|NCT01830595|11756255|FG000|NOT COMPLETED|First Period||1
10599634|NCT01830595|11756256|FG001|NOT COMPLETED|First Period||3
10599635|NCT01830595|11756255|FG000|STARTED|Washout||25
10599636|NCT01830595|11756256|FG001|STARTED|Washout||25
10599637|NCT01830595|11756255|FG000|COMPLETED|Washout||23
10599638|NCT01830595|11756256|FG001|COMPLETED|Washout||23
10599639|NCT01830595|11756255|FG000|NOT COMPLETED|Washout||2
10599640|NCT01830595|11756256|FG001|NOT COMPLETED|Washout||2
10599641|NCT01830595|11756255|FG000|STARTED|Second Period||23
10599642|NCT01830595|11756256|FG001|STARTED|Second Period||23
10599643|NCT01830595|11756255|FG000|COMPLETED|Second Period||23
10599644|NCT01830595|11756256|FG001|COMPLETED|Second Period||23
10599645|NCT01830595|11756255|FG000|NOT COMPLETED|Second Period||0
10599646|NCT01830595|11756256|FG001|NOT COMPLETED|Second Period||0
10599647|NCT01830621|11756264|FG000|STARTED|Overall Study||138
10599648|NCT01830621|11756265|FG001|STARTED|Overall Study||144
10599649|NCT01830621|11756264|FG000|COMPLETED|Overall Study||138
10599650|NCT01830621|11756265|FG001|COMPLETED|Overall Study||144
10599651|NCT01830621|11756264|FG000|NOT COMPLETED|Overall Study||0
10599652|NCT01830621|11756265|FG001|NOT COMPLETED|Overall Study||0
10599653|NCT01830699|11756273|FG000|STARTED|Overall Study||13
10599654|NCT01830699|11756274|FG001|STARTED|Overall Study||20
10599655|NCT01830699|11756273|FG000|COMPLETED|Overall Study||13
10599656|NCT01830699|11756274|FG001|COMPLETED|Overall Study||20
10599657|NCT01830699|11756273|FG000|NOT COMPLETED|Overall Study||0
10599658|NCT01830699|11756274|FG001|NOT COMPLETED|Overall Study||0
10599659|NCT01830816|11756283|FG000|STARTED|Overall Study||20
10599660|NCT01830816|11756284|FG001|STARTED|Overall Study||14
10599661|NCT01830816|11756285|FG002|STARTED|Overall Study||7
10599662|NCT01830816|11756283|FG000|Pharmacokinetic-Evaluable Population|Overall Study|Participants are considered to have completed study treatment if they are PK evaluable.|18
10599663|NCT01830816|11756284|FG001|Pharmacokinetic-Evaluable Population|Overall Study||14
10599664|NCT01830816|11756285|FG002|Pharmacokinetic-Evaluable Population|Overall Study||6
10599665|NCT01830816|11756283|FG000|COMPLETED|Overall Study||0
10599666|NCT01830816|11756284|FG001|COMPLETED|Overall Study||0
10599667|NCT01830816|11756285|FG002|COMPLETED|Overall Study||0
10599668|NCT01830816|11756283|FG000|NOT COMPLETED|Overall Study||20
10599669|NCT01830816|11756284|FG001|NOT COMPLETED|Overall Study||14
10599670|NCT01830816|11756285|FG002|NOT COMPLETED|Overall Study||7
10599671|NCT01830842|11756298|FG000|STARTED|Overall Study||30
10599672|NCT01830842|11756299|FG001|STARTED|Overall Study||24
10599673|NCT01830842|11756298|FG000|COMPLETED|Overall Study||25
10599674|NCT01830842|11756299|FG001|COMPLETED|Overall Study||22
10599675|NCT01830842|11756298|FG000|NOT COMPLETED|Overall Study||5
10599676|NCT01830842|11756299|FG001|NOT COMPLETED|Overall Study||2
10599677|NCT01830855|11756309|FG000|STARTED|Overall Study||1508
10599678|NCT01830855|11756310|FG001|STARTED|Overall Study||598
10599679|NCT01830855|11756311|FG002|STARTED|Overall Study||587
10599680|NCT01830855|11756312|FG003|STARTED|Overall Study||897
10599681|NCT01830855|11756309|FG000|COMPLETED|Overall Study||1353
10599682|NCT01830855|11756310|FG001|COMPLETED|Overall Study||537
10599683|NCT01830855|11756311|FG002|COMPLETED|Overall Study||521
10599684|NCT01830855|11756312|FG003|COMPLETED|Overall Study||815
10599685|NCT01830855|11756309|FG000|NOT COMPLETED|Overall Study||155
10599686|NCT01830855|11756310|FG001|NOT COMPLETED|Overall Study||61
10599687|NCT01830855|11756311|FG002|NOT COMPLETED|Overall Study||66
10599688|NCT01830855|11756312|FG003|NOT COMPLETED|Overall Study||82
10599689|NCT01830881|11756329|FG000|STARTED|Overall Study||62
10599690|NCT01830881|11756330|FG001|STARTED|Overall Study||62
10599691|NCT01830881|11756329|FG000|COMPLETED|Overall Study||62
10599692|NCT01830881|11756330|FG001|COMPLETED|Overall Study||61
10599693|NCT01830881|11756329|FG000|NOT COMPLETED|Overall Study||0
10599694|NCT01830881|11756330|FG001|NOT COMPLETED|Overall Study||1
10599695|NCT01830920|11756343|FG000|STARTED|Overall Study||126
10599696|NCT01830920|11756344|FG001|STARTED|Overall Study||46
10599697|NCT01830920|11756345|FG002|STARTED|Overall Study||48
10599698|NCT01830920|11756346|FG003|STARTED|Overall Study||125
10599699|NCT01830920|11756347|FG004|STARTED|Overall Study||107
10599700|NCT01830920|11756343|FG000|Received Allocated Drug|Overall Study||115
10599701|NCT01830920|11756344|FG001|Received Allocated Drug|Overall Study||45
10599702|NCT01830920|11756345|FG002|Received Allocated Drug|Overall Study||47
10599703|NCT01830920|11756346|FG003|Received Allocated Drug|Overall Study||119
10599704|NCT01830920|11756347|FG004|Received Allocated Drug|Overall Study||105
10599705|NCT01830920|11756343|FG000|COMPLETED|Overall Study||105
10599706|NCT01830920|11756344|FG001|COMPLETED|Overall Study||40
10599707|NCT01830920|11756345|FG002|COMPLETED|Overall Study||40
10599708|NCT01830920|11756346|FG003|COMPLETED|Overall Study||109
10599709|NCT01830920|11756347|FG004|COMPLETED|Overall Study||99
10599710|NCT01830920|11756343|FG000|NOT COMPLETED|Overall Study||21
10599711|NCT01830920|11756344|FG001|NOT COMPLETED|Overall Study||6
10599712|NCT01830920|11756345|FG002|NOT COMPLETED|Overall Study||8
10599713|NCT01830920|11756346|FG003|NOT COMPLETED|Overall Study||16
10599714|NCT01830920|11756347|FG004|NOT COMPLETED|Overall Study||8
10599715|NCT01830933|11756361|FG000|STARTED|Overall Study||823
10599716|NCT01830933|11756362|FG001|STARTED|Overall Study||812
10599717|NCT01830933|11756361|FG000|Completed Meet-up|Overall Study||675
10599718|NCT01830933|11756362|FG001|Completed Meet-up|Overall Study||603
10599719|NCT01830933|11756361|FG000|COMPLETED|Overall Study||655
10599720|NCT01830933|11756362|FG001|COMPLETED|Overall Study||580
10599721|NCT01830933|11756361|FG000|NOT COMPLETED|Overall Study||168
10599722|NCT01830933|11756362|FG001|NOT COMPLETED|Overall Study||232
10599723|NCT01830972|11756370|FG000|STARTED|Part I||46
10599724|NCT01830972|11756371|FG001|STARTED|Part I|Not applicable; participants in this arm entered during Part 2.|0
10599725|NCT01830972|11756370|FG000|COMPLETED|Part I||46
10599726|NCT01830972|11756371|FG001|COMPLETED|Part I|Not applicable; participants in this arm entered during Part 2.|0
10599727|NCT01830972|11756370|FG000|NOT COMPLETED|Part I||0
10599728|NCT01830972|11756371|FG001|NOT COMPLETED|Part I||0
10599729|NCT01830972|11756370|FG000|STARTED|Part II||46
10599730|NCT01830972|11756371|FG001|STARTED|Part II|Entered study at Part 2|13
10599731|NCT01830972|11756370|FG000|COMPLETED|Part II||44
10599732|NCT01830972|11756371|FG001|COMPLETED|Part II||11
10599733|NCT01830972|11756370|FG000|NOT COMPLETED|Part II||2
10599734|NCT01830972|11756371|FG001|NOT COMPLETED|Part II||2
10599735|NCT01830972|11756370|FG000|STARTED|Part III|2 participants withdrew consent and did not enter Part 3|44
10599736|NCT01830972|11756371|FG001|STARTED|Part III||11
10599737|NCT01830972|11756370|FG000|COMPLETED|Part III||42
10599738|NCT01830972|11756371|FG001|COMPLETED|Part III||11
10599739|NCT01830972|11756370|FG000|NOT COMPLETED|Part III||2
10599740|NCT01830972|11756371|FG001|NOT COMPLETED|Part III||0
10599741|NCT01830972|11756370|FG000|STARTED|Part IV||42
10599742|NCT01830972|11756371|FG001|STARTED|Part IV||11
10599743|NCT01830972|11756370|FG000|COMPLETED|Part IV||39
10599744|NCT01830972|11756371|FG001|COMPLETED|Part IV||10
10599745|NCT01830972|11756370|FG000|NOT COMPLETED|Part IV||3
10703870|NCT04960228|11868410|FG000|STARTED|Overall Study||1098
10703871|NCT04960228|11868411|FG001|STARTED|Overall Study||999
10808009|NCT03848871|11969778|FG000|COMPLETED|Overall Study||20
10599746|NCT01830972|11756371|FG001|NOT COMPLETED|Part IV||1
10599747|NCT01831089|11756393|FG000|STARTED|Cohort I: Dose Level 1||3
10599748|NCT01831089|11756394|FG001|STARTED|Cohort I: Dose Level 1||0
10599749|NCT01831089|11756395|FG002|STARTED|Cohort I: Dose Level 1||0
10599750|NCT01831089|11756396|FG003|STARTED|Cohort I: Dose Level 1||0
10599751|NCT01831089|11756397|FG004|STARTED|Cohort I: Dose Level 1||0
10808010|NCT03848871|11969778|FG000|NOT COMPLETED|Overall Study||0
10808011|NCT03880474|11969784|FG000|STARTED|Overall Study||1077
10808012|NCT03880474|11969785|FG001|STARTED|Overall Study||1075
10808013|NCT03880474|11969784|FG000|COMPLETED|Overall Study||1054
10808014|NCT03880474|11969785|FG001|COMPLETED|Overall Study||1055
10808015|NCT03880474|11969784|FG000|NOT COMPLETED|Overall Study||23
10808016|NCT03880474|11969785|FG001|NOT COMPLETED|Overall Study||20
10808017|NCT03878160|11969794|FG000|STARTED|Overall Study||7
10808018|NCT03878160|11969795|FG001|STARTED|Overall Study||9
10599752|NCT01831089|11756398|FG005|STARTED|Cohort I: Dose Level 1||0
10599753|NCT01831089|11756393|FG000|COMPLETED|Cohort I: Dose Level 1||0
10599754|NCT01831089|11756394|FG001|COMPLETED|Cohort I: Dose Level 1||0
10599755|NCT01831089|11756395|FG002|COMPLETED|Cohort I: Dose Level 1||0
10599756|NCT01831089|11756396|FG003|COMPLETED|Cohort I: Dose Level 1||0
10599757|NCT01831089|11756397|FG004|COMPLETED|Cohort I: Dose Level 1||0
10599758|NCT01831089|11756398|FG005|COMPLETED|Cohort I: Dose Level 1||0
10599759|NCT01831089|11756393|FG000|NOT COMPLETED|Cohort I: Dose Level 1||3
10599760|NCT01831089|11756394|FG001|NOT COMPLETED|Cohort I: Dose Level 1||0
10599761|NCT01831089|11756395|FG002|NOT COMPLETED|Cohort I: Dose Level 1||0
10599762|NCT01831089|11756396|FG003|NOT COMPLETED|Cohort I: Dose Level 1||0
10599763|NCT01831089|11756397|FG004|NOT COMPLETED|Cohort I: Dose Level 1||0
10599764|NCT01831089|11756398|FG005|NOT COMPLETED|Cohort I: Dose Level 1||0
10599765|NCT01831089|11756393|FG000|STARTED|Cohort II: Dose Level 2||0
10599766|NCT01831089|11756394|FG001|STARTED|Cohort II: Dose Level 2||3
10599767|NCT01831089|11756395|FG002|STARTED|Cohort II: Dose Level 2||0
10599768|NCT01831089|11756396|FG003|STARTED|Cohort II: Dose Level 2||0
10599769|NCT01831089|11756397|FG004|STARTED|Cohort II: Dose Level 2||0
10599770|NCT01831089|11756398|FG005|STARTED|Cohort II: Dose Level 2||0
10599771|NCT01831089|11756393|FG000|COMPLETED|Cohort II: Dose Level 2||0
10599772|NCT01831089|11756394|FG001|COMPLETED|Cohort II: Dose Level 2||0
10599773|NCT01831089|11756395|FG002|COMPLETED|Cohort II: Dose Level 2||0
10599774|NCT01831089|11756396|FG003|COMPLETED|Cohort II: Dose Level 2||0
10599775|NCT01831089|11756397|FG004|COMPLETED|Cohort II: Dose Level 2||0
10599776|NCT01831089|11756398|FG005|COMPLETED|Cohort II: Dose Level 2||0
10599777|NCT01831089|11756393|FG000|NOT COMPLETED|Cohort II: Dose Level 2||0
10599778|NCT01831089|11756394|FG001|NOT COMPLETED|Cohort II: Dose Level 2||3
10599779|NCT01831089|11756395|FG002|NOT COMPLETED|Cohort II: Dose Level 2||0
10599780|NCT01831089|11756396|FG003|NOT COMPLETED|Cohort II: Dose Level 2||0
10599781|NCT01831089|11756397|FG004|NOT COMPLETED|Cohort II: Dose Level 2||0
10599782|NCT01831089|11756398|FG005|NOT COMPLETED|Cohort II: Dose Level 2||0
10599783|NCT01831089|11756393|FG000|STARTED|Cohort III: Dose Level 3||0
10599784|NCT01831089|11756394|FG001|STARTED|Cohort III: Dose Level 3||0
10808019|NCT03878160|11969796|FG002|STARTED|Overall Study||11
10808020|NCT03878160|11969794|FG000|COMPLETED|Overall Study||5
10808021|NCT03878160|11969795|FG001|COMPLETED|Overall Study||8
10808022|NCT03878160|11969796|FG002|COMPLETED|Overall Study||10
10808023|NCT03878160|11969794|FG000|NOT COMPLETED|Overall Study||2
10808024|NCT03878160|11969795|FG001|NOT COMPLETED|Overall Study||1
10808025|NCT03878160|11969796|FG002|NOT COMPLETED|Overall Study||1
10808026|NCT03864627|11969806|FG000|STARTED|Overall Study||11
10808027|NCT03864627|11969807|FG001|STARTED|Overall Study||22
10808028|NCT03864627|11969806|FG000|COMPLETED|Overall Study||7
10808029|NCT03864627|11969807|FG001|COMPLETED|Overall Study||10
10808030|NCT03864627|11969806|FG000|NOT COMPLETED|Overall Study||4
10808031|NCT03864627|11969807|FG001|NOT COMPLETED|Overall Study||12
10808032|NCT03861000|11969816|FG000|STARTED|Overall Study||2
10808033|NCT03861000|11969817|FG001|STARTED|Overall Study||1
10808034|NCT03861000|11969816|FG000|COMPLETED|Overall Study||2
10599785|NCT01831089|11756395|FG002|STARTED|Cohort III: Dose Level 3||6
10599786|NCT01831089|11756396|FG003|STARTED|Cohort III: Dose Level 3||0
10599787|NCT01831089|11756397|FG004|STARTED|Cohort III: Dose Level 3||0
10703872|NCT04960228|11868410|FG000|COMPLETED|Overall Study||810
10703873|NCT04960228|11868411|FG001|COMPLETED|Overall Study||813
10703874|NCT04960228|11868410|FG000|NOT COMPLETED|Overall Study||288
10703875|NCT04960228|11868411|FG001|NOT COMPLETED|Overall Study||186
10703876|NCT03922477|11868417|FG000|STARTED|Overall Study||13
10703877|NCT03922477|11868417|FG000|COMPLETED|Overall Study||0
10808035|NCT03861000|11969817|FG001|COMPLETED|Overall Study||1
10808036|NCT03861000|11969816|FG000|NOT COMPLETED|Overall Study||0
10808037|NCT03861000|11969817|FG001|NOT COMPLETED|Overall Study||0
10599788|NCT01831089|11756398|FG005|STARTED|Cohort III: Dose Level 3||0
10599789|NCT01831089|11756393|FG000|COMPLETED|Cohort III: Dose Level 3||0
10599790|NCT01831089|11756394|FG001|COMPLETED|Cohort III: Dose Level 3||0
10599791|NCT01831089|11756395|FG002|COMPLETED|Cohort III: Dose Level 3||0
10599792|NCT01831089|11756396|FG003|COMPLETED|Cohort III: Dose Level 3||0
10599793|NCT01831089|11756397|FG004|COMPLETED|Cohort III: Dose Level 3||0
10703878|NCT03922477|11868417|FG000|NOT COMPLETED|Overall Study||13
10703879|NCT03688074|11868423|FG000|STARTED|Overall Study||59
10703880|NCT03688074|11868424|FG001|STARTED|Overall Study||57
10808038|NCT03848403|11969822|FG000|STARTED|Period 1 (Day 1)||24
10599794|NCT01831089|11756398|FG005|COMPLETED|Cohort III: Dose Level 3||0
10599795|NCT01831089|11756393|FG000|NOT COMPLETED|Cohort III: Dose Level 3||0
10599796|NCT01831089|11756394|FG001|NOT COMPLETED|Cohort III: Dose Level 3||0
10599797|NCT01831089|11756395|FG002|NOT COMPLETED|Cohort III: Dose Level 3||6
10599798|NCT01831089|11756396|FG003|NOT COMPLETED|Cohort III: Dose Level 3||0
10599799|NCT01831089|11756397|FG004|NOT COMPLETED|Cohort III: Dose Level 3||0
10599800|NCT01831089|11756398|FG005|NOT COMPLETED|Cohort III: Dose Level 3||0
10599801|NCT01831089|11756393|FG000|STARTED|Cohort IV: Dose Level 4||0
10599802|NCT01831089|11756394|FG001|STARTED|Cohort IV: Dose Level 4||0
10599803|NCT01831089|11756395|FG002|STARTED|Cohort IV: Dose Level 4||0
10599804|NCT01831089|11756396|FG003|STARTED|Cohort IV: Dose Level 4||6
10599805|NCT01831089|11756397|FG004|STARTED|Cohort IV: Dose Level 4||0
10599806|NCT01831089|11756398|FG005|STARTED|Cohort IV: Dose Level 4||0
10599807|NCT01831089|11756393|FG000|COMPLETED|Cohort IV: Dose Level 4||0
10599808|NCT01831089|11756394|FG001|COMPLETED|Cohort IV: Dose Level 4||0
10599809|NCT01831089|11756395|FG002|COMPLETED|Cohort IV: Dose Level 4||0
10599810|NCT01831089|11756396|FG003|COMPLETED|Cohort IV: Dose Level 4||0
10599811|NCT01831089|11756397|FG004|COMPLETED|Cohort IV: Dose Level 4||0
10599812|NCT01831089|11756398|FG005|COMPLETED|Cohort IV: Dose Level 4||0
10599813|NCT01831089|11756393|FG000|NOT COMPLETED|Cohort IV: Dose Level 4||0
10599814|NCT01831089|11756394|FG001|NOT COMPLETED|Cohort IV: Dose Level 4||0
10599815|NCT01831089|11756395|FG002|NOT COMPLETED|Cohort IV: Dose Level 4||0
10703881|NCT03688074|11868423|FG000|COMPLETED|Overall Study||58
10703882|NCT03688074|11868424|FG001|COMPLETED|Overall Study||56
10703883|NCT03688074|11868423|FG000|NOT COMPLETED|Overall Study||1
10703884|NCT03688074|11868424|FG001|NOT COMPLETED|Overall Study||1
10703885|NCT03342001|11868430|FG000|STARTED|Overall Study||11
10703886|NCT03342001|11868430|FG000|COMPLETED|Overall Study||9
10599816|NCT01831089|11756396|FG003|NOT COMPLETED|Cohort IV: Dose Level 4||6
10599817|NCT01831089|11756397|FG004|NOT COMPLETED|Cohort IV: Dose Level 4||0
10599818|NCT01831089|11756398|FG005|NOT COMPLETED|Cohort IV: Dose Level 4||0
10599819|NCT01831089|11756393|FG000|STARTED|Cohort V: Dose Level 5||0
10599820|NCT01831089|11756394|FG001|STARTED|Cohort V: Dose Level 5||0
10599821|NCT01831089|11756395|FG002|STARTED|Cohort V: Dose Level 5||0
10599822|NCT01831089|11756396|FG003|STARTED|Cohort V: Dose Level 5||0
10599823|NCT01831089|11756397|FG004|STARTED|Cohort V: Dose Level 5||37
10599824|NCT01831089|11756398|FG005|STARTED|Cohort V: Dose Level 5||0
10599825|NCT01831089|11756393|FG000|COMPLETED|Cohort V: Dose Level 5||0
10599826|NCT01831089|11756394|FG001|COMPLETED|Cohort V: Dose Level 5||0
10599827|NCT01831089|11756395|FG002|COMPLETED|Cohort V: Dose Level 5||0
10599828|NCT01831089|11756396|FG003|COMPLETED|Cohort V: Dose Level 5||0
10599829|NCT01831089|11756397|FG004|COMPLETED|Cohort V: Dose Level 5||0
10599830|NCT01831089|11756398|FG005|COMPLETED|Cohort V: Dose Level 5||0
10599831|NCT01831089|11756393|FG000|NOT COMPLETED|Cohort V: Dose Level 5||0
10599832|NCT01831089|11756394|FG001|NOT COMPLETED|Cohort V: Dose Level 5||0
10599833|NCT01831089|11756395|FG002|NOT COMPLETED|Cohort V: Dose Level 5||0
10599834|NCT01831089|11756396|FG003|NOT COMPLETED|Cohort V: Dose Level 5||0
10599835|NCT01831089|11756397|FG004|NOT COMPLETED|Cohort V: Dose Level 5||37
10599836|NCT01831089|11756398|FG005|NOT COMPLETED|Cohort V: Dose Level 5||0
10599837|NCT01831089|11756393|FG000|STARTED|Cohort B: Arm B||0
10599838|NCT01831089|11756394|FG001|STARTED|Cohort B: Arm B||0
10599839|NCT01831089|11756395|FG002|STARTED|Cohort B: Arm B||0
10599840|NCT01831089|11756396|FG003|STARTED|Cohort B: Arm B||0
10599841|NCT01831089|11756397|FG004|STARTED|Cohort B: Arm B||0
10599842|NCT01831089|11756398|FG005|STARTED|Cohort B: Arm B||14
10599843|NCT01831089|11756393|FG000|COMPLETED|Cohort B: Arm B||0
10599844|NCT01831089|11756394|FG001|COMPLETED|Cohort B: Arm B||0
10599845|NCT01831089|11756395|FG002|COMPLETED|Cohort B: Arm B||0
10599846|NCT01831089|11756396|FG003|COMPLETED|Cohort B: Arm B||0
10599847|NCT01831089|11756397|FG004|COMPLETED|Cohort B: Arm B||0
10599848|NCT01831089|11756398|FG005|COMPLETED|Cohort B: Arm B||0
10599849|NCT01831089|11756393|FG000|NOT COMPLETED|Cohort B: Arm B||0
10599850|NCT01831089|11756394|FG001|NOT COMPLETED|Cohort B: Arm B||0
10599851|NCT01831089|11756395|FG002|NOT COMPLETED|Cohort B: Arm B||0
10599852|NCT01831089|11756396|FG003|NOT COMPLETED|Cohort B: Arm B||0
10599853|NCT01831089|11756397|FG004|NOT COMPLETED|Cohort B: Arm B||0
10599854|NCT01831089|11756398|FG005|NOT COMPLETED|Cohort B: Arm B||14
10703887|NCT03342001|11868430|FG000|NOT COMPLETED|Overall Study||2
10703888|NCT02871934|11868436|FG000|STARTED|Overall Study||193
10703889|NCT02871934|11868437|FG001|STARTED|Overall Study||215
10703890|NCT02871934|11868436|FG000|COMPLETED|Overall Study||193
10808039|NCT03848403|11969823|FG001|STARTED|Period 1 (Day 1)||24
10808040|NCT03848403|11969824|FG002|STARTED|Period 1 (Day 1)||22
10808041|NCT03848403|11969822|FG000|Received Intervention|Period 1 (Day 1)||24
10808042|NCT03848403|11969823|FG001|Received Intervention|Period 1 (Day 1)||24
10599855|NCT01831154|11756416|FG000|STARTED|Overall Study|Study Institutional Review Board (IRB) approval 11-11-2009, first subjects enrolled 6-7-2010|15
10599856|NCT01831154|11756417|FG001|STARTED|Overall Study|Study IRB approval 11-11-2009, first subjects enrolled 6-7-2010|11
10599857|NCT01831154|11756418|FG002|STARTED|Overall Study|Study IRB approval 11-11-2009, first subjects enrolled 6-7-2010|11
10599858|NCT01831154|11756416|FG000|COMPLETED|Overall Study||15
10599859|NCT01831154|11756417|FG001|COMPLETED|Overall Study||11
10599860|NCT01831154|11756418|FG002|COMPLETED|Overall Study||11
10808043|NCT03848403|11969824|FG002|Received Intervention|Period 1 (Day 1)||22
10808044|NCT03848403|11969822|FG000|COMPLETED|Period 1 (Day 1)||24
10808045|NCT03848403|11969823|FG001|COMPLETED|Period 1 (Day 1)||24
10703891|NCT02871934|11868437|FG001|COMPLETED|Overall Study||215
10703892|NCT02871934|11868436|FG000|NOT COMPLETED|Overall Study||0
10599861|NCT01831154|11756416|FG000|NOT COMPLETED|Overall Study||0
10599862|NCT01831154|11756417|FG001|NOT COMPLETED|Overall Study||0
10599863|NCT01831154|11756418|FG002|NOT COMPLETED|Overall Study||0
10652335|NCT02184442|11812706|FG000|As-Treated|Overall Study||282
10652336|NCT02184442|11812707|FG001|As-Treated|Overall Study||271
10652337|NCT02184442|11812706|FG000|Valve-Implant|Overall Study||280
10652338|NCT02184442|11812707|FG001|Valve-Implant|Overall Study||263
10652339|NCT02184442|11812706|FG000|COMPLETED|Overall Study||220
10652340|NCT02184442|11812707|FG001|COMPLETED|Overall Study||200
10652341|NCT02184442|11812706|FG000|NOT COMPLETED|Overall Study||64
10652342|NCT02184442|11812707|FG001|NOT COMPLETED|Overall Study||76
10652343|NCT02184455|11812713|FG000|STARTED|Overall Study||11
10652344|NCT02184455|11812713|FG000|COMPLETED|Overall Study||10
10652345|NCT02184455|11812713|FG000|NOT COMPLETED|Overall Study||1
10652346|NCT02184494|11812720|FG000|STARTED|Overall Study||13
10652347|NCT02184494|11812721|FG001|STARTED|Overall Study||13
10652348|NCT02184494|11812722|FG002|STARTED|Overall Study||8
10652349|NCT02184494|11812720|FG000|COMPLETED|Overall Study||12
10652350|NCT02184494|11812721|FG001|COMPLETED|Overall Study||11
10652351|NCT02184494|11812722|FG002|COMPLETED|Overall Study||8
10652352|NCT02184494|11812720|FG000|NOT COMPLETED|Overall Study||1
10652353|NCT02184494|11812721|FG001|NOT COMPLETED|Overall Study||2
10652354|NCT02184494|11812722|FG002|NOT COMPLETED|Overall Study||0
10652355|NCT02184572|11812732|FG000|STARTED|Overall Study||1164
10652356|NCT02184572|11812733|FG001|STARTED|Overall Study||572
10652357|NCT02184572|11812732|FG000|COMPLETED|Overall Study||1117
10652358|NCT02184572|11812733|FG001|COMPLETED|Overall Study||542
10652359|NCT02184572|11812732|FG000|NOT COMPLETED|Overall Study||47
10652360|NCT02184572|11812733|FG001|NOT COMPLETED|Overall Study||30
10652361|NCT02184611|11812743|FG000|STARTED|Overall Study||101
10652362|NCT02184611|11812744|FG001|STARTED|Overall Study||205
10652363|NCT02184611|11812743|FG000|COMPLETED|Overall Study||80
10652364|NCT02184611|11812744|FG001|COMPLETED|Overall Study||177
10652365|NCT02184611|11812743|FG000|NOT COMPLETED|Overall Study||21
10652366|NCT02184611|11812744|FG001|NOT COMPLETED|Overall Study||28
10652367|NCT02184624|11812755|FG000|STARTED|Overall Study||171
10652368|NCT02184624|11812756|FG001|STARTED|Overall Study||80
10652369|NCT02184624|11812757|FG002|STARTED|Overall Study||100
10652370|NCT02184624|11812758|FG003|STARTED|Overall Study||118
10652371|NCT02184624|11812759|FG004|STARTED|Overall Study||98
10652372|NCT02184624|11812755|FG000|COMPLETED|Overall Study||171
10652373|NCT02184624|11812756|FG001|COMPLETED|Overall Study||80
10652374|NCT02184624|11812757|FG002|COMPLETED|Overall Study||100
10652375|NCT02184624|11812758|FG003|COMPLETED|Overall Study||118
10652376|NCT02184624|11812759|FG004|COMPLETED|Overall Study||98
10652377|NCT02184624|11812755|FG000|NOT COMPLETED|Overall Study||0
10652378|NCT02184624|11812756|FG001|NOT COMPLETED|Overall Study||0
10652379|NCT02184624|11812757|FG002|NOT COMPLETED|Overall Study||0
10652380|NCT02184624|11812758|FG003|NOT COMPLETED|Overall Study||0
10652381|NCT02184624|11812759|FG004|NOT COMPLETED|Overall Study||0
10652382|NCT02184988|11812771|FG000|STARTED|Overall Study||352
10652383|NCT02184988|11812771|FG000|COMPLETED|Overall Study||297
10652384|NCT02184988|11812771|FG000|NOT COMPLETED|Overall Study||55
10652385|NCT02185014|11812775|FG000|STARTED|Overall Study||252
10652386|NCT02185014|11812775|FG000|COMPLETED|Overall Study||198
10652387|NCT02185014|11812775|FG000|NOT COMPLETED|Overall Study||54
10652388|NCT02185040|11812784|FG000|STARTED|Part 1 Treatment Phase||8
10652389|NCT02185040|11812785|FG001|STARTED|Part 1 Treatment Phase||8
10652390|NCT02185040|11812786|FG002|STARTED|Part 1 Treatment Phase||8
10652391|NCT02185040|11812787|FG003|STARTED|Part 1 Treatment Phase||9
10652392|NCT02185040|11812788|FG004|STARTED|Part 1 Treatment Phase||9
10652393|NCT02185040|11812789|FG005|STARTED|Part 1 Treatment Phase||0
10652394|NCT02185040|11812790|FG006|STARTED|Part 1 Treatment Phase||0
10652395|NCT02185040|11812784|FG000|COMPLETED|Part 1 Treatment Phase||7
10652396|NCT02185040|11812785|FG001|COMPLETED|Part 1 Treatment Phase||6
10652397|NCT02185040|11812786|FG002|COMPLETED|Part 1 Treatment Phase||7
10652398|NCT02185040|11812787|FG003|COMPLETED|Part 1 Treatment Phase||7
10652399|NCT02185040|11812788|FG004|COMPLETED|Part 1 Treatment Phase||6
10652400|NCT02185040|11812789|FG005|COMPLETED|Part 1 Treatment Phase||0
10652401|NCT02185040|11812790|FG006|COMPLETED|Part 1 Treatment Phase||0
10652402|NCT02185040|11812784|FG000|NOT COMPLETED|Part 1 Treatment Phase||1
10652403|NCT02185040|11812785|FG001|NOT COMPLETED|Part 1 Treatment Phase||2
10652404|NCT02185040|11812786|FG002|NOT COMPLETED|Part 1 Treatment Phase||1
10652405|NCT02185040|11812787|FG003|NOT COMPLETED|Part 1 Treatment Phase||2
10652406|NCT02185040|11812788|FG004|NOT COMPLETED|Part 1 Treatment Phase||3
10652407|NCT02185040|11812789|FG005|NOT COMPLETED|Part 1 Treatment Phase||0
10652408|NCT02185040|11812790|FG006|NOT COMPLETED|Part 1 Treatment Phase||0
10652409|NCT02185040|11812784|FG000|STARTED|Active Treatment Extension Phase||0
10652410|NCT02185040|11812785|FG001|STARTED|Active Treatment Extension Phase||0
10652411|NCT02185040|11812786|FG002|STARTED|Active Treatment Extension Phase||0
10652412|NCT02185040|11812787|FG003|STARTED|Active Treatment Extension Phase||0
10652413|NCT02185040|11812788|FG004|STARTED|Active Treatment Extension Phase||0
10652414|NCT02185040|11812789|FG005|STARTED|Active Treatment Extension Phase||9
10652415|NCT02185040|11812790|FG006|STARTED|Active Treatment Extension Phase||8
10652416|NCT02185040|11812784|FG000|COMPLETED|Active Treatment Extension Phase||0
10652417|NCT02185040|11812785|FG001|COMPLETED|Active Treatment Extension Phase||0
10652418|NCT02185040|11812786|FG002|COMPLETED|Active Treatment Extension Phase||0
10652419|NCT02185040|11812787|FG003|COMPLETED|Active Treatment Extension Phase||0
10652420|NCT02185040|11812788|FG004|COMPLETED|Active Treatment Extension Phase||0
10599864|NCT01831219|11756428|FG000|STARTED|Overall Study||73
10599865|NCT01831219|11756429|FG001|STARTED|Overall Study||45
10599866|NCT01831219|11756428|FG000|COMPLETED|Overall Study||40
10599867|NCT01831219|11756429|FG001|COMPLETED|Overall Study||21
10599868|NCT01831219|11756428|FG000|NOT COMPLETED|Overall Study||33
10599869|NCT01831219|11756429|FG001|NOT COMPLETED|Overall Study||24
10599870|NCT01831232|11756435|FG000|STARTED|Overall Study||24
10599871|NCT01831232|11756435|FG000|COMPLETED|Overall Study||24
10599872|NCT01831232|11756435|FG000|NOT COMPLETED|Overall Study||0
10599873|NCT01831258|11756439|FG000|STARTED|Overall Study||35
10599874|NCT01831258|11756440|FG001|STARTED|Overall Study||35
10599875|NCT01831258|11756439|FG000|COMPLETED|Overall Study||30
10599876|NCT01831258|11756440|FG001|COMPLETED|Overall Study||32
10599877|NCT01831258|11756439|FG000|NOT COMPLETED|Overall Study||5
10599878|NCT01831258|11756440|FG001|NOT COMPLETED|Overall Study||3
10599879|NCT01831427|11756459|FG000|STARTED|Overall Study||5
10599880|NCT01831427|11756460|FG001|STARTED|Overall Study||5
10599881|NCT01831427|11756461|FG002|STARTED|Overall Study||5
10599882|NCT01831427|11756462|FG003|STARTED|Overall Study||5
10599883|NCT01831427|11756463|FG004|STARTED|Overall Study||4
10599884|NCT01831427|11756464|FG005|STARTED|Overall Study||8
10599885|NCT01831427|11756465|FG006|STARTED|Overall Study||8
10599886|NCT01831427|11756466|FG007|STARTED|Overall Study||8
10599887|NCT01831427|11756467|FG008|STARTED|Overall Study||8
10599888|NCT01831427|11756468|FG009|STARTED|Overall Study||10
10599889|NCT01831427|11756469|FG010|STARTED|Overall Study||8
10599890|NCT01831427|11756459|FG000|COMPLETED|Overall Study||5
10599891|NCT01831427|11756460|FG001|COMPLETED|Overall Study||4
10808046|NCT03848403|11969824|FG002|COMPLETED|Period 1 (Day 1)||22
10808047|NCT03848403|11969822|FG000|NOT COMPLETED|Period 1 (Day 1)||0
10808048|NCT03848403|11969823|FG001|NOT COMPLETED|Period 1 (Day 1)||0
10808049|NCT03848403|11969824|FG002|NOT COMPLETED|Period 1 (Day 1)||0
10808050|NCT03848403|11969822|FG000|STARTED|Period 2 (Day 8)||24
10808051|NCT03848403|11969823|FG001|STARTED|Period 2 (Day 8)||24
10808052|NCT03848403|11969824|FG002|STARTED|Period 2 (Day 8)||22
10808053|NCT03848403|11969822|FG000|Received at Least One Dose of Study Drug|Period 2 (Day 8)||24
10808054|NCT03848403|11969823|FG001|Received at Least One Dose of Study Drug|Period 2 (Day 8)||24
10808055|NCT03848403|11969824|FG002|Received at Least One Dose of Study Drug|Period 2 (Day 8)||22
10808056|NCT03848403|11969822|FG000|COMPLETED|Period 2 (Day 8)||15
10808057|NCT03848403|11969823|FG001|COMPLETED|Period 2 (Day 8)||15
10808058|NCT03848403|11969824|FG002|COMPLETED|Period 2 (Day 8)||15
10808059|NCT03848403|11969822|FG000|NOT COMPLETED|Period 2 (Day 8)||9
10808060|NCT03848403|11969823|FG001|NOT COMPLETED|Period 2 (Day 8)||9
10599892|NCT01831427|11756461|FG002|COMPLETED|Overall Study||5
10599893|NCT01831427|11756462|FG003|COMPLETED|Overall Study||4
10599894|NCT01831427|11756463|FG004|COMPLETED|Overall Study||4
10599895|NCT01831427|11756464|FG005|COMPLETED|Overall Study||7
10599896|NCT01831427|11756465|FG006|COMPLETED|Overall Study||6
10599897|NCT01831427|11756466|FG007|COMPLETED|Overall Study||7
10599898|NCT01831427|11756467|FG008|COMPLETED|Overall Study||8
10599899|NCT01831427|11756468|FG009|COMPLETED|Overall Study||9
10599900|NCT01831427|11756469|FG010|COMPLETED|Overall Study||5
10599901|NCT01831427|11756459|FG000|NOT COMPLETED|Overall Study||0
10599902|NCT01831427|11756460|FG001|NOT COMPLETED|Overall Study||1
10599903|NCT01831427|11756461|FG002|NOT COMPLETED|Overall Study||0
10599904|NCT01831427|11756462|FG003|NOT COMPLETED|Overall Study||1
10599905|NCT01831427|11756463|FG004|NOT COMPLETED|Overall Study||0
10599906|NCT01831427|11756464|FG005|NOT COMPLETED|Overall Study||1
10599907|NCT01831427|11756465|FG006|NOT COMPLETED|Overall Study||2
10808061|NCT03848403|11969824|FG002|NOT COMPLETED|Period 2 (Day 8)||7
10808062|NCT03848403|11969822|FG000|STARTED|Period 3 (Day 15)||15
10808063|NCT03848403|11969823|FG001|STARTED|Period 3 (Day 15)||15
10808064|NCT03848403|11969824|FG002|STARTED|Period 3 (Day 15)||15
10808065|NCT03848403|11969822|FG000|COMPLETED|Period 3 (Day 15)||15
10808066|NCT03848403|11969823|FG001|COMPLETED|Period 3 (Day 15)||15
10808067|NCT03848403|11969824|FG002|COMPLETED|Period 3 (Day 15)||15
10808068|NCT03848403|11969822|FG000|NOT COMPLETED|Period 3 (Day 15)||0
10808069|NCT03848403|11969823|FG001|NOT COMPLETED|Period 3 (Day 15)||0
10808070|NCT03848403|11969824|FG002|NOT COMPLETED|Period 3 (Day 15)||0
10808071|NCT03847233|11969832|FG000|STARTED|Index Procedure||31
10599908|NCT01831427|11756466|FG007|NOT COMPLETED|Overall Study||1
10599909|NCT01831427|11756467|FG008|NOT COMPLETED|Overall Study||0
10599910|NCT01831427|11756468|FG009|NOT COMPLETED|Overall Study||1
10808072|NCT03847233|11969832|FG000|COMPLETED|Index Procedure||31
10808073|NCT03847233|11969832|FG000|NOT COMPLETED|Index Procedure||0
10808074|NCT03847233|11969832|FG000|STARTED|6 Month After Index Procedure||31
10599911|NCT01831427|11756469|FG010|NOT COMPLETED|Overall Study||3
10599912|NCT01831466|11756516|FG000|STARTED|Overall Study|Treated|71
10599913|NCT01831466|11756517|FG001|STARTED|Overall Study|Treated|70
10599914|NCT01831466|11756518|FG002|STARTED|Overall Study|Treated|71
10599915|NCT01831466|11756519|FG003|STARTED|Overall Study|Treated|70
10599916|NCT01831466|11756520|FG004|STARTED|Overall Study|Treated|74
10599917|NCT01831466|11756521|FG005|STARTED|Overall Study|Treated|74
10599918|NCT01831466|11756522|FG006|STARTED|Overall Study|Treated|7
10599919|NCT01831466|11756523|FG007|STARTED|Overall Study|Treated|7
10599920|NCT01831466|11756524|FG008|STARTED|Overall Study|Treated|7
10599921|NCT01831466|11756525|FG009|STARTED|Overall Study|Treated|7
10599922|NCT01831466|11756526|FG010|STARTED|Overall Study|Treated|6
10599923|NCT01831466|11756527|FG011|STARTED|Overall Study|Treated|7
10599924|NCT01831466|11756516|FG000|COMPLETED|Overall Study||55
10599925|NCT01831466|11756517|FG001|COMPLETED|Overall Study||52
10599926|NCT01831466|11756518|FG002|COMPLETED|Overall Study||48
10599927|NCT01831466|11756519|FG003|COMPLETED|Overall Study||51
10599928|NCT01831466|11756520|FG004|COMPLETED|Overall Study||57
10599929|NCT01831466|11756521|FG005|COMPLETED|Overall Study||48
10599930|NCT01831466|11756522|FG006|COMPLETED|Overall Study||6
10599931|NCT01831466|11756523|FG007|COMPLETED|Overall Study||5
10599932|NCT01831466|11756524|FG008|COMPLETED|Overall Study||4
10599933|NCT01831466|11756525|FG009|COMPLETED|Overall Study||2
10599934|NCT01831466|11756526|FG010|COMPLETED|Overall Study||4
10599935|NCT01831466|11756527|FG011|COMPLETED|Overall Study||3
10599936|NCT01831466|11756516|FG000|NOT COMPLETED|Overall Study||16
10599937|NCT01831466|11756517|FG001|NOT COMPLETED|Overall Study||18
10599938|NCT01831466|11756518|FG002|NOT COMPLETED|Overall Study||23
10599939|NCT01831466|11756519|FG003|NOT COMPLETED|Overall Study||19
10599940|NCT01831466|11756520|FG004|NOT COMPLETED|Overall Study||17
10599941|NCT01831466|11756521|FG005|NOT COMPLETED|Overall Study||26
10599942|NCT01831466|11756522|FG006|NOT COMPLETED|Overall Study||1
10599943|NCT01831466|11756523|FG007|NOT COMPLETED|Overall Study||2
10599944|NCT01831466|11756524|FG008|NOT COMPLETED|Overall Study||3
10599945|NCT01831466|11756525|FG009|NOT COMPLETED|Overall Study||5
10599946|NCT01831466|11756526|FG010|NOT COMPLETED|Overall Study||2
10599947|NCT01831466|11756527|FG011|NOT COMPLETED|Overall Study||4
10599948|NCT01831544|11756547|FG000|STARTED|Overall Study||11
10599949|NCT01831544|11756547|FG000|COMPLETED|Overall Study||8
10599950|NCT01831544|11756547|FG000|NOT COMPLETED|Overall Study||3
10599951|NCT01831726|11756551|FG000|STARTED|Overall Study||80
10599952|NCT01831726|11756551|FG000|COMPLETED|Overall Study||0
10599953|NCT01831726|11756551|FG000|NOT COMPLETED|Overall Study||80
10599954|NCT01831765|11756558|FG000|STARTED|Overall Study||381
10599955|NCT01831765|11756559|FG001|STARTED|Overall Study||382
10599956|NCT01831765|11756560|FG002|STARTED|Overall Study||380
10599957|NCT01831765|11756558|FG000|Completed 26 Weeks|Overall Study||351
10599958|NCT01831765|11756559|FG001|Completed 26 Weeks|Overall Study||355
10599959|NCT01831765|11756560|FG002|Completed 26 Weeks|Overall Study||356
10599960|NCT01831765|11756558|FG000|Completed 52 Weeks|Overall Study||337
10599961|NCT01831765|11756559|FG001|Completed 52 Weeks|Overall Study|This arm did not continue in the trial after 26 weeks ( 26 to 52 weeks).|0
10599962|NCT01831765|11756560|FG002|Completed 52 Weeks|Overall Study||338
10703893|NCT02871934|11868437|FG001|NOT COMPLETED|Overall Study||0
10703894|NCT02859558|11868448|FG000|STARTED|Step 1||49
10703895|NCT02859558|11868449|FG001|STARTED|Step 1||79
10703896|NCT02859558|11868450|FG002|STARTED|Step 1||60
10703897|NCT02859558|11868451|FG003|STARTED|Step 1||4
10703898|NCT02859558|11868452|FG004|STARTED|Step 1||3
10808075|NCT03847233|11969832|FG000|COMPLETED|6 Month After Index Procedure||30
10808076|NCT03847233|11969832|FG000|NOT COMPLETED|6 Month After Index Procedure||1
10808077|NCT03879603|11969843|FG000|STARTED|Overall Study||5
10808078|NCT03879603|11969844|FG001|STARTED|Overall Study||5
10808079|NCT03879603|11969845|FG002|STARTED|Overall Study||5
10808080|NCT03879603|11969846|FG003|STARTED|Overall Study||5
10808081|NCT03879603|11969847|FG004|STARTED|Overall Study||5
10808082|NCT03879603|11969848|FG005|STARTED|Overall Study||5
10808083|NCT03879603|11969843|FG000|Received First Product Administration|Overall Study||5
10808084|NCT03879603|11969844|FG001|Received First Product Administration|Overall Study||5
10808085|NCT03879603|11969845|FG002|Received First Product Administration|Overall Study||5
10808086|NCT03879603|11969846|FG003|Received First Product Administration|Overall Study||5
10808087|NCT03879603|11969847|FG004|Received First Product Administration|Overall Study||5
10808088|NCT03879603|11969848|FG005|Received First Product Administration|Overall Study||5
10808089|NCT03879603|11969843|FG000|Received All Product Administrations|Overall Study|Second administration not completed due to a grade 3 neutropenia not related to study product.|4
10808090|NCT03879603|11969844|FG001|Received All Product Administrations|Overall Study||5
10808091|NCT03879603|11969845|FG002|Received All Product Administrations|Overall Study||5
10808092|NCT03879603|11969846|FG003|Received All Product Administrations|Overall Study||5
10808093|NCT03879603|11969847|FG004|Received All Product Administrations|Overall Study||5
10808094|NCT03879603|11969848|FG005|Received All Product Administrations|Overall Study||5
10808095|NCT03879603|11969843|FG000|COMPLETED|Overall Study||5
10808096|NCT03879603|11969844|FG001|COMPLETED|Overall Study||5
10808097|NCT03879603|11969845|FG002|COMPLETED|Overall Study||5
10808098|NCT03879603|11969846|FG003|COMPLETED|Overall Study||5
10808099|NCT03879603|11969847|FG004|COMPLETED|Overall Study||5
10808100|NCT03879603|11969848|FG005|COMPLETED|Overall Study||5
10808101|NCT03879603|11969843|FG000|NOT COMPLETED|Overall Study||0
10703899|NCT02859558|11868448|FG000|Completed Week 48|Step 1||41
10703900|NCT02859558|11868449|FG001|Completed Week 48|Step 1||68
10703901|NCT02859558|11868450|FG002|Completed Week 48|Step 1||50
10599963|NCT01831765|11756558|FG000|COMPLETED|Overall Study||337
10599964|NCT01831765|11756559|FG001|COMPLETED|Overall Study||355
10599965|NCT01831765|11756560|FG002|COMPLETED|Overall Study||338
10599966|NCT01831765|11756558|FG000|NOT COMPLETED|Overall Study||44
10599967|NCT01831765|11756559|FG001|NOT COMPLETED|Overall Study||27
10599968|NCT01831765|11756560|FG002|NOT COMPLETED|Overall Study||42
10599969|NCT01831791|11756570|FG000|STARTED|Overall Study||120
10599970|NCT01831791|11756570|FG000|COMPLETED|Overall Study||110
10703902|NCT02859558|11868451|FG003|Completed Week 48|Step 1||0
10703903|NCT02859558|11868452|FG004|Completed Week 48|Step 1||0
10703904|NCT02859558|11868448|FG000|COMPLETED|Step 1||37
10703905|NCT02859558|11868449|FG001|COMPLETED|Step 1||67
10599971|NCT01831791|11756570|FG000|NOT COMPLETED|Overall Study||10
10599972|NCT01831804|11756583|FG000|STARTED|Overall Study||4
10599973|NCT01831804|11756584|FG001|STARTED|Overall Study||3
10599974|NCT01831804|11756585|FG002|STARTED|Overall Study||9
10599975|NCT01831804|11756586|FG003|STARTED|Overall Study||5
10599976|NCT01831804|11756587|FG004|STARTED|Overall Study||5
10599977|NCT01831804|11756588|FG005|STARTED|Overall Study||3
10599978|NCT01831804|11756589|FG006|STARTED|Overall Study||4
10599979|NCT01831804|11756590|FG007|STARTED|Overall Study||26
10599980|NCT01831804|11756591|FG008|STARTED|Overall Study||4
10599981|NCT01831804|11756583|FG000|COMPLETED|Overall Study||3
10599982|NCT01831804|11756584|FG001|COMPLETED|Overall Study||1
10599983|NCT01831804|11756585|FG002|COMPLETED|Overall Study||3
10599984|NCT01831804|11756586|FG003|COMPLETED|Overall Study||5
10599985|NCT01831804|11756587|FG004|COMPLETED|Overall Study||3
10599986|NCT01831804|11756588|FG005|COMPLETED|Overall Study||3
10599987|NCT01831804|11756589|FG006|COMPLETED|Overall Study||3
10599988|NCT01831804|11756590|FG007|COMPLETED|Overall Study||23
10599989|NCT01831804|11756591|FG008|COMPLETED|Overall Study||2
10599990|NCT01831804|11756583|FG000|NOT COMPLETED|Overall Study||1
10599991|NCT01831804|11756584|FG001|NOT COMPLETED|Overall Study||2
10599992|NCT01831804|11756585|FG002|NOT COMPLETED|Overall Study||6
10599993|NCT01831804|11756586|FG003|NOT COMPLETED|Overall Study||0
10599994|NCT01831804|11756587|FG004|NOT COMPLETED|Overall Study||2
10599995|NCT01831804|11756588|FG005|NOT COMPLETED|Overall Study||0
10599996|NCT01831804|11756589|FG006|NOT COMPLETED|Overall Study||1
10599997|NCT01831804|11756590|FG007|NOT COMPLETED|Overall Study||3
10599998|NCT01831804|11756591|FG008|NOT COMPLETED|Overall Study||2
10599999|NCT01831817|11756624|FG000|STARTED|Overall Study||35
10808102|NCT03879603|11969844|FG001|NOT COMPLETED|Overall Study||0
10808103|NCT03879603|11969845|FG002|NOT COMPLETED|Overall Study||0
10808104|NCT03879603|11969846|FG003|NOT COMPLETED|Overall Study||0
10808105|NCT03879603|11969847|FG004|NOT COMPLETED|Overall Study||0
10808106|NCT03879603|11969848|FG005|NOT COMPLETED|Overall Study||0
10808107|NCT03878745|11969864|FG000|STARTED|Overall Study||55
10808108|NCT03878745|11969864|FG000|COMPLETED|Overall Study||55
10808109|NCT03878745|11969864|FG000|NOT COMPLETED|Overall Study||0
10600000|NCT01831817|11756625|FG001|STARTED|Overall Study||34
10600001|NCT01831817|11756626|FG002|STARTED|Overall Study||35
10600002|NCT01831817|11756627|FG003|STARTED|Overall Study||36
10600003|NCT01831817|11756624|FG000|COMPLETED|Overall Study||31
10600004|NCT01831817|11756625|FG001|COMPLETED|Overall Study||34
10600005|NCT01831817|11756626|FG002|COMPLETED|Overall Study||35
10600006|NCT01831817|11756627|FG003|COMPLETED|Overall Study||36
10600007|NCT01831817|11756624|FG000|NOT COMPLETED|Overall Study||4
10600008|NCT01831817|11756625|FG001|NOT COMPLETED|Overall Study||0
10600009|NCT01831817|11756626|FG002|NOT COMPLETED|Overall Study||0
10600010|NCT01831817|11756627|FG003|NOT COMPLETED|Overall Study||0
10600011|NCT01831856|11756639|FG000|STARTED|Overall Study||67
10600012|NCT01831856|11756640|FG001|STARTED|Overall Study||67
10600013|NCT01831856|11756639|FG000|COMPLETED|Overall Study||33
10600014|NCT01831856|11756640|FG001|COMPLETED|Overall Study||30
10600015|NCT01831856|11756639|FG000|NOT COMPLETED|Overall Study||34
10600016|NCT01831856|11756640|FG001|NOT COMPLETED|Overall Study||37
10600017|NCT01831921|11756648|FG000|STARTED|Overall Study||150
10600018|NCT01831921|11756649|FG001|STARTED|Overall Study||75
10600019|NCT01831921|11756648|FG000|6 Months|Overall Study||122
10600020|NCT01831921|11756649|FG001|6 Months|Overall Study||63
10703906|NCT02859558|11868450|FG002|COMPLETED|Step 1||49
10703907|NCT02859558|11868451|FG003|COMPLETED|Step 1||4
10808110|NCT03848221|11969879|FG000|STARTED|Overall Study||25
10808111|NCT03848221|11969880|FG001|STARTED|Overall Study||24
10808112|NCT03848221|11969881|FG002|STARTED|Overall Study||24
10808113|NCT03848221|11969879|FG000|COMPLETED|Overall Study||25
10808114|NCT03848221|11969880|FG001|COMPLETED|Overall Study||24
10808115|NCT03848221|11969881|FG002|COMPLETED|Overall Study||24
10600021|NCT01831921|11756648|FG000|12 Months|Overall Study|All participants were followed for 12 months to 24 months, depending on date of randomization.|120
10600022|NCT01831921|11756649|FG001|12 Months|Overall Study||62
10600023|NCT01831921|11756648|FG000|18 Months|Overall Study|Of 118 eligible for this visit.|90
10600024|NCT01831921|11756649|FG001|18 Months|Overall Study|Of 59 eligible for this visit.|49
10703908|NCT02859558|11868452|FG004|COMPLETED|Step 1||0
10703909|NCT02859558|11868448|FG000|NOT COMPLETED|Step 1||12
10703910|NCT02859558|11868449|FG001|NOT COMPLETED|Step 1||12
10703911|NCT02859558|11868450|FG002|NOT COMPLETED|Step 1||11
10703912|NCT02859558|11868451|FG003|NOT COMPLETED|Step 1||0
10703913|NCT02859558|11868452|FG004|NOT COMPLETED|Step 1||3
10703914|NCT02859558|11868448|FG000|STARTED|Step 2||25
10703915|NCT02859558|11868449|FG001|STARTED|Step 2||39
10703916|NCT02859558|11868450|FG002|STARTED|Step 2||21
10703917|NCT02859558|11868451|FG003|STARTED|Step 2||0
10600025|NCT01831921|11756648|FG000|COMPLETED|Overall Study|Of 85 eligible for this visit.|66
10600026|NCT01831921|11756649|FG001|COMPLETED|Overall Study|Of 42 eligible for this visit.|36
10600027|NCT01831921|11756648|FG000|NOT COMPLETED|Overall Study||84
10600028|NCT01831921|11756649|FG001|NOT COMPLETED|Overall Study||39
10600029|NCT01831934|11756660|FG000|STARTED|Overall Study||12
10808116|NCT03848221|11969879|FG000|NOT COMPLETED|Overall Study||0
10808117|NCT03848221|11969880|FG001|NOT COMPLETED|Overall Study||0
10703918|NCT02859558|11868452|FG004|STARTED|Step 2||0
10600030|NCT01831934|11756661|FG001|STARTED|Overall Study||10
10600031|NCT01831934|11756660|FG000|COMPLETED|Overall Study|Volunteer consented but not enrolled after reporting a prior bad reaction to influenza vaccine.|11
10600032|NCT01831934|11756661|FG001|COMPLETED|Overall Study||10
10600033|NCT01831934|11756660|FG000|NOT COMPLETED|Overall Study||1
10600034|NCT01831934|11756661|FG001|NOT COMPLETED|Overall Study||0
10600035|NCT01831960|11756669|FG000|STARTED|Overall Study||20
10600036|NCT01831960|11756670|FG001|STARTED|Overall Study||22
10600037|NCT01831960|11756669|FG000|COMPLETED|Overall Study||20
10600038|NCT01831960|11756670|FG001|COMPLETED|Overall Study||22
10600039|NCT01831960|11756669|FG000|NOT COMPLETED|Overall Study||0
10600040|NCT01831960|11756670|FG001|NOT COMPLETED|Overall Study||0
10600041|NCT01832038|11756677|FG000|STARTED|Overall Study||473
10600042|NCT01832038|11756677|FG000|COMPLETED|Overall Study||238
10600043|NCT01832038|11756677|FG000|NOT COMPLETED|Overall Study||235
10600044|NCT01832090|11756684|FG000|STARTED|Overall Study||89
10600045|NCT01832090|11756685|FG001|STARTED|Overall Study||29
10600046|NCT01832090|11756684|FG000|COMPLETED|Overall Study||83
10600047|NCT01832090|11756685|FG001|COMPLETED|Overall Study||28
10600048|NCT01832090|11756684|FG000|NOT COMPLETED|Overall Study||6
10600049|NCT01832090|11756685|FG001|NOT COMPLETED|Overall Study||1
10600050|NCT01832155|11756713|FG000|STARTED|Beginning of Study: Baseline at 0 Week||18
10600051|NCT01832155|11756714|FG001|STARTED|Beginning of Study: Baseline at 0 Week||18
10600052|NCT01832155|11756713|FG000|COMPLETED|Beginning of Study: Baseline at 0 Week||17
10600053|NCT01832155|11756714|FG001|COMPLETED|Beginning of Study: Baseline at 0 Week||18
10600054|NCT01832155|11756713|FG000|NOT COMPLETED|Beginning of Study: Baseline at 0 Week||1
10600055|NCT01832155|11756714|FG001|NOT COMPLETED|Beginning of Study: Baseline at 0 Week||0
10600056|NCT01832155|11756713|FG000|STARTED|Mid-point of Study: 0 - 4 Weeks||17
10600057|NCT01832155|11756714|FG001|STARTED|Mid-point of Study: 0 - 4 Weeks||18
10600058|NCT01832155|11756713|FG000|COMPLETED|Mid-point of Study: 0 - 4 Weeks||16
10600059|NCT01832155|11756714|FG001|COMPLETED|Mid-point of Study: 0 - 4 Weeks||18
10600060|NCT01832155|11756713|FG000|NOT COMPLETED|Mid-point of Study: 0 - 4 Weeks||1
10808118|NCT03848221|11969881|FG002|NOT COMPLETED|Overall Study||0
10808119|NCT03878108|11969891|FG000|STARTED|Overall Study||11
10808120|NCT03878108|11969892|FG001|STARTED|Overall Study||10
10808121|NCT03878108|11969891|FG000|Completed First Phase|Overall Study||10
10808122|NCT03878108|11969892|FG001|Completed First Phase|Overall Study||10
10808123|NCT03878108|11969891|FG000|COMPLETED|Overall Study||10
10808124|NCT03878108|11969892|FG001|COMPLETED|Overall Study||10
10808125|NCT03878108|11969891|FG000|NOT COMPLETED|Overall Study||1
10808126|NCT03878108|11969892|FG001|NOT COMPLETED|Overall Study||0
10808127|NCT03877432|11969898|FG000|STARTED|Overall Study||10
10808128|NCT03877432|11969898|FG000|COMPLETED|Overall Study||10
10808129|NCT03877432|11969898|FG000|NOT COMPLETED|Overall Study||0
10808130|NCT03877237|11969908|FG000|STARTED|Overall Study||156
10808131|NCT03877237|11969909|FG001|STARTED|Overall Study||157
10808132|NCT03877237|11969908|FG000|Treated|Overall Study||156
10808133|NCT03877237|11969909|FG001|Treated|Overall Study||157
10808134|NCT03877237|11969908|FG000|COMPLETED|Overall Study||151
10808135|NCT03877237|11969909|FG001|COMPLETED|Overall Study||151
10808136|NCT03877237|11969908|FG000|NOT COMPLETED|Overall Study||5
10808137|NCT03877237|11969909|FG001|NOT COMPLETED|Overall Study||6
10808138|NCT03866434|11969915|FG000|STARTED|Overall Study||20
10808139|NCT03866434|11969915|FG000|COMPLETED|Overall Study||20
10808140|NCT03866434|11969915|FG000|NOT COMPLETED|Overall Study||0
10808141|NCT03863210|11969921|FG000|STARTED|Overall Study|March 1st, 2014.|104
10808142|NCT03863210|11969921|FG000|COMPLETED|Overall Study|September 1st, 2014.|102
10808143|NCT03863210|11969921|FG000|NOT COMPLETED|Overall Study||2
10808144|NCT03859323|11969938|FG000|STARTED|Overall Study||5
10808145|NCT03859323|11969939|FG001|STARTED|Overall Study||5
10808146|NCT03859323|11969940|FG002|STARTED|Overall Study||5
10808147|NCT03859323|11969941|FG003|STARTED|Overall Study||5
10808148|NCT03859323|11969942|FG004|STARTED|Overall Study||5
10808149|NCT03859323|11969943|FG005|STARTED|Overall Study||5
10808150|NCT03859323|11969944|FG006|STARTED|Overall Study||12
10808151|NCT03859323|11969945|FG007|STARTED|Overall Study||10
10808152|NCT03859323|11969946|FG008|STARTED|Overall Study||10
10808153|NCT03859323|11969947|FG009|STARTED|Overall Study||10
10808154|NCT03859323|11969948|FG010|STARTED|Overall Study||10
10808155|NCT03859323|11969949|FG011|STARTED|Overall Study||12
10808156|NCT03859323|11969950|FG012|STARTED|Overall Study||10
10808157|NCT03859323|11969938|FG000|COMPLETED|Overall Study||5
10808158|NCT03859323|11969939|FG001|COMPLETED|Overall Study||5
10808159|NCT03859323|11969940|FG002|COMPLETED|Overall Study||4
10808160|NCT03859323|11969941|FG003|COMPLETED|Overall Study||5
10808161|NCT03859323|11969942|FG004|COMPLETED|Overall Study||5
10808162|NCT03859323|11969943|FG005|COMPLETED|Overall Study||4
10808163|NCT03859323|11969944|FG006|COMPLETED|Overall Study||11
10808164|NCT03859323|11969945|FG007|COMPLETED|Overall Study||10
10600061|NCT01832155|11756714|FG001|NOT COMPLETED|Mid-point of Study: 0 - 4 Weeks||0
10808165|NCT03859323|11969946|FG008|COMPLETED|Overall Study||10
10808166|NCT03859323|11969947|FG009|COMPLETED|Overall Study||8
10808167|NCT03859323|11969948|FG010|COMPLETED|Overall Study||9
10808168|NCT03859323|11969949|FG011|COMPLETED|Overall Study||10
10808169|NCT03859323|11969950|FG012|COMPLETED|Overall Study||9
10808170|NCT03859323|11969938|FG000|NOT COMPLETED|Overall Study||0
10808171|NCT03859323|11969939|FG001|NOT COMPLETED|Overall Study||0
10600062|NCT01832155|11756713|FG000|STARTED|End of Study: 4 - 8 Weeks||16
10600063|NCT01832155|11756714|FG001|STARTED|End of Study: 4 - 8 Weeks||18
10600064|NCT01832155|11756713|FG000|COMPLETED|End of Study: 4 - 8 Weeks||16
10600065|NCT01832155|11756714|FG001|COMPLETED|End of Study: 4 - 8 Weeks||18
10600066|NCT01832155|11756713|FG000|NOT COMPLETED|End of Study: 4 - 8 Weeks||0
10600067|NCT01832155|11756714|FG001|NOT COMPLETED|End of Study: 4 - 8 Weeks||0
10600068|NCT01832259|11756728|FG000|STARTED|Overall Study||15
10600069|NCT01832259|11756729|FG001|STARTED|Overall Study||15
10600070|NCT01832259|11756728|FG000|COMPLETED|Overall Study||15
10600071|NCT01832259|11756729|FG001|COMPLETED|Overall Study||15
10600072|NCT01832259|11756728|FG000|NOT COMPLETED|Overall Study||0
10600073|NCT01832259|11756729|FG001|NOT COMPLETED|Overall Study||0
10600074|NCT01832480|11756737|FG000|STARTED|Overall Study||311
10600075|NCT01832480|11756738|FG001|STARTED|Overall Study||312
10600076|NCT01832480|11756737|FG000|COMPLETED|Overall Study||270
10600077|NCT01832480|11756738|FG001|COMPLETED|Overall Study||270
10600078|NCT01832480|11756737|FG000|NOT COMPLETED|Overall Study||41
10600079|NCT01832480|11756738|FG001|NOT COMPLETED|Overall Study||42
10600080|NCT01832493|11756744|FG000|STARTED|Overall Study||50
10600081|NCT01832493|11756744|FG000|COMPLETED|Overall Study||42
10600082|NCT01832493|11756744|FG000|NOT COMPLETED|Overall Study||8
10600083|NCT01832506|11756751|FG000|STARTED|Overall Study||3
10600084|NCT01832506|11756752|FG001|STARTED|Overall Study||3
10600085|NCT01832506|11756753|FG002|STARTED|Overall Study||6
10600086|NCT01832506|11756751|FG000|COMPLETED|Overall Study||3
10600087|NCT01832506|11756752|FG001|COMPLETED|Overall Study||3
10600088|NCT01832506|11756753|FG002|COMPLETED|Overall Study||6
10600089|NCT01832506|11756751|FG000|NOT COMPLETED|Overall Study||0
10600090|NCT01832506|11756752|FG001|NOT COMPLETED|Overall Study||0
10600091|NCT01832506|11756753|FG002|NOT COMPLETED|Overall Study||0
10600092|NCT01832532|11756768|FG000|STARTED|Overall Study||23
10600093|NCT01832532|11756769|FG001|STARTED|Overall Study||11
10600094|NCT01832532|11756768|FG000|COMPLETED|Overall Study||18
10600095|NCT01832532|11756769|FG001|COMPLETED|Overall Study||9
10600096|NCT01832532|11756768|FG000|NOT COMPLETED|Overall Study||5
10600097|NCT01832532|11756769|FG001|NOT COMPLETED|Overall Study||2
10600098|NCT01832610|11756775|FG000|STARTED|Overall Study||101
10600099|NCT01832610|11756775|FG000|COMPLETED|Overall Study||97
10600100|NCT01832610|11756775|FG000|NOT COMPLETED|Overall Study||4
10600101|NCT01832727|11756788|FG000|STARTED|Overall Study||9
10600102|NCT01832727|11756789|FG001|STARTED|Overall Study||7
10600103|NCT01832727|11756790|FG002|STARTED|Overall Study||3
10600104|NCT01832727|11756791|FG003|STARTED|Overall Study||4
10600105|NCT01832727|11756792|FG004|STARTED|Overall Study||4
10600106|NCT01832727|11756793|FG005|STARTED|Overall Study||6
10600107|NCT01832727|11756794|FG006|STARTED|Overall Study||8
10600108|NCT01832727|11756795|FG007|STARTED|Overall Study||6
10600109|NCT01832727|11756796|FG008|STARTED|Overall Study||18
10600110|NCT01832727|11756788|FG000|COMPLETED|Overall Study||0
10703919|NCT02859558|11868448|FG000|COMPLETED|Step 2||0
10703920|NCT02859558|11868449|FG001|COMPLETED|Step 2||0
10703921|NCT02859558|11868450|FG002|COMPLETED|Step 2||0
10703922|NCT02859558|11868451|FG003|COMPLETED|Step 2||0
10808172|NCT03859323|11969940|FG002|NOT COMPLETED|Overall Study||1
10808173|NCT03859323|11969941|FG003|NOT COMPLETED|Overall Study||0
10808174|NCT03859323|11969942|FG004|NOT COMPLETED|Overall Study||0
10808175|NCT03859323|11969943|FG005|NOT COMPLETED|Overall Study||1
10600111|NCT01832727|11756789|FG001|COMPLETED|Overall Study||0
10600112|NCT01832727|11756790|FG002|COMPLETED|Overall Study||0
10703923|NCT02859558|11868452|FG004|COMPLETED|Step 2||0
10703924|NCT02859558|11868448|FG000|NOT COMPLETED|Step 2||25
10703925|NCT02859558|11868449|FG001|NOT COMPLETED|Step 2||39
10703926|NCT02859558|11868450|FG002|NOT COMPLETED|Step 2||21
10703927|NCT02859558|11868451|FG003|NOT COMPLETED|Step 2||0
10703928|NCT02859558|11868452|FG004|NOT COMPLETED|Step 2||0
10703929|NCT02818920|11868462|FG000|STARTED|Overall Study||30
10703930|NCT02818920|11868462|FG000|Completed Surgery|Overall Study||25
10703931|NCT02818920|11868462|FG000|Received Adjuvant Therapy|Overall Study||17
10703932|NCT02818920|11868462|FG000|COMPLETED|Overall Study||12
10703933|NCT02818920|11868462|FG000|NOT COMPLETED|Overall Study||18
10703934|NCT02481310|11868469|FG000|STARTED|Induction Treatment (6 Cycles)||1
10703935|NCT02481310|11868470|FG001|STARTED|Induction Treatment (6 Cycles)||36
10703936|NCT02481310|11868471|FG002|STARTED|Induction Treatment (6 Cycles)||1
10703937|NCT02481310|11868469|FG000|Reached First Evaluable Response|Induction Treatment (6 Cycles)||1
10703938|NCT02481310|11868470|FG001|Reached First Evaluable Response|Induction Treatment (6 Cycles)||34
10703939|NCT02481310|11868471|FG002|Reached First Evaluable Response|Induction Treatment (6 Cycles)||1
10703940|NCT02481310|11868469|FG000|Complete 6 Cycles|Induction Treatment (6 Cycles)||1
10600113|NCT01832727|11756791|FG003|COMPLETED|Overall Study||0
10600114|NCT01832727|11756792|FG004|COMPLETED|Overall Study||0
10600115|NCT01832727|11756793|FG005|COMPLETED|Overall Study||0
10600116|NCT01832727|11756794|FG006|COMPLETED|Overall Study||0
10600117|NCT01832727|11756795|FG007|COMPLETED|Overall Study||0
10600118|NCT01832727|11756796|FG008|COMPLETED|Overall Study||0
10600119|NCT01832727|11756788|FG000|NOT COMPLETED|Overall Study||9
10600120|NCT01832727|11756789|FG001|NOT COMPLETED|Overall Study||7
10600121|NCT01832727|11756790|FG002|NOT COMPLETED|Overall Study||3
10600122|NCT01832727|11756791|FG003|NOT COMPLETED|Overall Study||4
10703941|NCT02481310|11868470|FG001|Complete 6 Cycles|Induction Treatment (6 Cycles)||30
10703942|NCT02481310|11868471|FG002|Complete 6 Cycles|Induction Treatment (6 Cycles)||1
10703943|NCT02481310|11868469|FG000|COMPLETED|Induction Treatment (6 Cycles)||1
10808176|NCT03859323|11969944|FG006|NOT COMPLETED|Overall Study||1
10600123|NCT01832727|11756792|FG004|NOT COMPLETED|Overall Study||4
10600124|NCT01832727|11756793|FG005|NOT COMPLETED|Overall Study||6
10600125|NCT01832727|11756794|FG006|NOT COMPLETED|Overall Study||8
10600126|NCT01832727|11756795|FG007|NOT COMPLETED|Overall Study||6
10600127|NCT01832727|11756796|FG008|NOT COMPLETED|Overall Study||18
10600128|NCT01832753|11756828|FG000|STARTED|Observation Phase (Months 0-6)||5
10600129|NCT01832753|11756829|FG001|STARTED|Observation Phase (Months 0-6)||4
10600130|NCT01832753|11756830|FG002|STARTED|Observation Phase (Months 0-6)||3
10600131|NCT01832753|11756828|FG000|COMPLETED|Observation Phase (Months 0-6)||5
10600132|NCT01832753|11756829|FG001|COMPLETED|Observation Phase (Months 0-6)||4
10600133|NCT01832753|11756830|FG002|COMPLETED|Observation Phase (Months 0-6)||1
10600134|NCT01832753|11756828|FG000|NOT COMPLETED|Observation Phase (Months 0-6)||0
10600135|NCT01832753|11756829|FG001|NOT COMPLETED|Observation Phase (Months 0-6)||0
10600136|NCT01832753|11756830|FG002|NOT COMPLETED|Observation Phase (Months 0-6)||2
10600137|NCT01832753|11756828|FG000|STARTED|Randomization Phase (Months 6-12)||5
10600138|NCT01832753|11756829|FG001|STARTED|Randomization Phase (Months 6-12)||4
10600139|NCT01832753|11756830|FG002|STARTED|Randomization Phase (Months 6-12)|1 subject was not randomized as they did not meet inclusion criteria at the end of observation phase|0
10600140|NCT01832753|11756828|FG000|COMPLETED|Randomization Phase (Months 6-12)||4
10600141|NCT01832753|11756829|FG001|COMPLETED|Randomization Phase (Months 6-12)||3
10600142|NCT01832753|11756830|FG002|COMPLETED|Randomization Phase (Months 6-12)||0
10600143|NCT01832753|11756828|FG000|NOT COMPLETED|Randomization Phase (Months 6-12)||1
10600144|NCT01832753|11756829|FG001|NOT COMPLETED|Randomization Phase (Months 6-12)||1
10600145|NCT01832753|11756830|FG002|NOT COMPLETED|Randomization Phase (Months 6-12)||0
10600146|NCT01832753|11756828|FG000|STARTED|Open Label Dose Phase (Months 12-18)||3
10600147|NCT01832753|11756829|FG001|STARTED|Open Label Dose Phase (Months 12-18)||3
10600148|NCT01832753|11756830|FG002|STARTED|Open Label Dose Phase (Months 12-18)||0
10600149|NCT01832753|11756828|FG000|COMPLETED|Open Label Dose Phase (Months 12-18)||3
10600150|NCT01832753|11756829|FG001|COMPLETED|Open Label Dose Phase (Months 12-18)||3
10600151|NCT01832753|11756830|FG002|COMPLETED|Open Label Dose Phase (Months 12-18)||0
10600152|NCT01832753|11756828|FG000|NOT COMPLETED|Open Label Dose Phase (Months 12-18)||0
10600153|NCT01832753|11756829|FG001|NOT COMPLETED|Open Label Dose Phase (Months 12-18)||0
10600154|NCT01832753|11756830|FG002|NOT COMPLETED|Open Label Dose Phase (Months 12-18)||0
10600155|NCT01832766|11756839|FG000|STARTED|First Intervention||7
10600156|NCT01832766|11756840|FG001|STARTED|First Intervention||6
10600157|NCT01832766|11756839|FG000|COMPLETED|First Intervention||7
10600158|NCT01832766|11756840|FG001|COMPLETED|First Intervention|one participant did not return for cross over visit|6
10600159|NCT01832766|11756839|FG000|NOT COMPLETED|First Intervention||0
10600160|NCT01832766|11756840|FG001|NOT COMPLETED|First Intervention||0
10600161|NCT01832766|11756839|FG000|STARTED|Washout||7
10600162|NCT01832766|11756840|FG001|STARTED|Washout||6
10600163|NCT01832766|11756839|FG000|COMPLETED|Washout||7
10600164|NCT01832766|11756840|FG001|COMPLETED|Washout||5
10600165|NCT01832766|11756839|FG000|NOT COMPLETED|Washout||0
10600166|NCT01832766|11756840|FG001|NOT COMPLETED|Washout||1
10600167|NCT01832766|11756839|FG000|STARTED|Second Intervention||7
10600168|NCT01832766|11756840|FG001|STARTED|Second Intervention||5
10600169|NCT01832766|11756839|FG000|COMPLETED|Second Intervention||7
10600170|NCT01832766|11756840|FG001|COMPLETED|Second Intervention||5
10600171|NCT01832766|11756839|FG000|NOT COMPLETED|Second Intervention||0
10600172|NCT01832766|11756840|FG001|NOT COMPLETED|Second Intervention||0
10600173|NCT01832818|11756846|FG000|STARTED|Overall Study||14
10600174|NCT01832818|11756846|FG000|COMPLETED|Overall Study||8
10600175|NCT01832818|11756846|FG000|NOT COMPLETED|Overall Study||6
10600176|NCT01832961|11756850|FG000|STARTED|First Intervention||8
10600177|NCT01832961|11756851|FG001|STARTED|First Intervention||7
10600178|NCT01832961|11756850|FG000|COMPLETED|First Intervention||8
10600179|NCT01832961|11756851|FG001|COMPLETED|First Intervention||7
10600180|NCT01832961|11756850|FG000|NOT COMPLETED|First Intervention||0
10600181|NCT01832961|11756851|FG001|NOT COMPLETED|First Intervention||0
10600182|NCT01832961|11756850|FG000|STARTED|Washout||8
10600183|NCT01832961|11756851|FG001|STARTED|Washout||7
10333795|NCT00335725|11470009|FG000|STARTED|Overall Study||75
10333796|NCT00335725|11470010|FG001|STARTED|Overall Study||76
10333797|NCT00335725|11470009|FG000|COMPLETED|Overall Study||71
10333798|NCT00335725|11470010|FG001|COMPLETED|Overall Study||71
10333799|NCT00335725|11470009|FG000|NOT COMPLETED|Overall Study||4
10333800|NCT00335725|11470010|FG001|NOT COMPLETED|Overall Study||5
10333801|NCT00335738|11470019|FG000|STARTED|Overall Study||108
10333802|NCT00335738|11470020|FG001|STARTED|Overall Study||223
10333803|NCT00335738|11470019|FG000|COMPLETED|Overall Study||97
10333804|NCT00335738|11470020|FG001|COMPLETED|Overall Study||219
10600184|NCT01832961|11756850|FG000|COMPLETED|Washout||8
10600185|NCT01832961|11756851|FG001|COMPLETED|Washout||7
10600186|NCT01832961|11756850|FG000|NOT COMPLETED|Washout||0
10600187|NCT01832961|11756851|FG001|NOT COMPLETED|Washout||0
10600188|NCT01832961|11756850|FG000|STARTED|Second Intervention||8
10600189|NCT01832961|11756851|FG001|STARTED|Second Intervention||7
10600190|NCT01832961|11756850|FG000|COMPLETED|Second Intervention||8
10600191|NCT01832961|11756851|FG001|COMPLETED|Second Intervention||7
10600192|NCT01832961|11756850|FG000|NOT COMPLETED|Second Intervention||0
10600193|NCT01832961|11756851|FG001|NOT COMPLETED|Second Intervention||0
10600194|NCT01832961|11756850|FG000|STARTED|Third Intervention||8
10600195|NCT01832961|11756851|FG001|STARTED|Third Intervention||7
10333805|NCT00335738|11470019|FG000|NOT COMPLETED|Overall Study||11
10333806|NCT00335738|11470020|FG001|NOT COMPLETED|Overall Study||4
10333807|NCT00335764|11470032|FG000|STARTED|Overall Study||17
10600196|NCT01832961|11756850|FG000|COMPLETED|Third Intervention||8
10600197|NCT01832961|11756851|FG001|COMPLETED|Third Intervention||7
10600198|NCT01832961|11756850|FG000|NOT COMPLETED|Third Intervention||0
10600199|NCT01832961|11756851|FG001|NOT COMPLETED|Third Intervention||0
10600200|NCT01833026|11756868|FG000|STARTED|Overall Study||22
10600201|NCT01833026|11756869|FG001|STARTED|Overall Study||34
10600202|NCT01833026|11756868|FG000|COMPLETED|Overall Study||22
10600203|NCT01833026|11756869|FG001|COMPLETED|Overall Study||34
10600204|NCT01833026|11756868|FG000|NOT COMPLETED|Overall Study||0
10600205|NCT01833026|11756869|FG001|NOT COMPLETED|Overall Study||0
10600206|NCT01833065|11756878|FG000|STARTED|Overall Study|Randomized patients - As treated|65
10600207|NCT01833065|11756879|FG001|STARTED|Overall Study|Randomized patients - As treated|53
10600208|NCT01833065|11756880|FG002|STARTED|Overall Study|Randomized patients - As treated|35
10600209|NCT01833065|11756881|FG003|STARTED|Overall Study|Randomized patients - As treated|50
10808177|NCT03859323|11969945|FG007|NOT COMPLETED|Overall Study||0
10808178|NCT03859323|11969946|FG008|NOT COMPLETED|Overall Study||0
10808179|NCT03859323|11969947|FG009|NOT COMPLETED|Overall Study||2
10808180|NCT03859323|11969948|FG010|NOT COMPLETED|Overall Study||1
10808181|NCT03859323|11969949|FG011|NOT COMPLETED|Overall Study||2
10808182|NCT03859323|11969950|FG012|NOT COMPLETED|Overall Study||1
10808183|NCT03867838|11969989|FG000|STARTED|Overall Study||6
10808184|NCT03867838|11969989|FG000|COMPLETED|Overall Study||6
10808185|NCT03867838|11969989|FG000|NOT COMPLETED|Overall Study||0
10808186|NCT03855059|11969995|FG000|STARTED|Overall Study||25
10808187|NCT03855059|11969996|FG001|STARTED|Overall Study||25
10808188|NCT03855059|11969995|FG000|COMPLETED|Overall Study||23
10808189|NCT03855059|11969996|FG001|COMPLETED|Overall Study||25
10808190|NCT03855059|11969995|FG000|NOT COMPLETED|Overall Study||2
10808191|NCT03855059|11969996|FG001|NOT COMPLETED|Overall Study||0
10808192|NCT03852537|11970004|FG000|STARTED|Overall Study||23
10808193|NCT03852537|11970005|FG001|STARTED|Overall Study||21
10808194|NCT03852537|11970004|FG000|COMPLETED|Overall Study||23
10808195|NCT03852537|11970005|FG001|COMPLETED|Overall Study||21
10808196|NCT03852537|11970004|FG000|NOT COMPLETED|Overall Study||0
10808197|NCT03852537|11970005|FG001|NOT COMPLETED|Overall Study||0
10808198|NCT03875859|11970011|FG000|STARTED|Overall Study||4
10808199|NCT03875859|11970011|FG000|COMPLETED|Overall Study||4
10808200|NCT03875859|11970011|FG000|NOT COMPLETED|Overall Study||0
10808201|NCT03875508|11970015|FG000|STARTED|Overall Study||108
10808202|NCT03875508|11970015|FG000|COMPLETED|Overall Study||96
10808203|NCT03875508|11970015|FG000|NOT COMPLETED|Overall Study||12
10808204|NCT03869333|11970023|FG000|STARTED|Overall Study||14
10808205|NCT03869333|11970024|FG001|STARTED|Overall Study||16
10808206|NCT03869333|11970025|FG002|STARTED|Overall Study||16
10808207|NCT03869333|11970026|FG003|STARTED|Overall Study||12
10808208|NCT03869333|11970023|FG000|Received First Dose|Overall Study||14
10808209|NCT03869333|11970024|FG001|Received First Dose|Overall Study||16
10808210|NCT03869333|11970025|FG002|Received First Dose|Overall Study||16
10808211|NCT03869333|11970026|FG003|Received First Dose|Overall Study||12
10808212|NCT03869333|11970023|FG000|Received Second Dose|Overall Study||13
10808213|NCT03869333|11970024|FG001|Received Second Dose|Overall Study||15
10808214|NCT03869333|11970025|FG002|Received Second Dose|Overall Study||16
10808215|NCT03869333|11970026|FG003|Received Second Dose|Overall Study||12
10808216|NCT03869333|11970023|FG000|Received Third Dose|Overall Study||13
10808217|NCT03869333|11970024|FG001|Received Third Dose|Overall Study||15
10808218|NCT03869333|11970025|FG002|Received Third Dose|Overall Study||16
10808219|NCT03869333|11970026|FG003|Received Third Dose|Overall Study||11
10808220|NCT03869333|11970023|FG000|COMPLETED|Overall Study||12
10808221|NCT03869333|11970024|FG001|COMPLETED|Overall Study||15
10808222|NCT03869333|11970025|FG002|COMPLETED|Overall Study||16
10808223|NCT03869333|11970026|FG003|COMPLETED|Overall Study||12
10808224|NCT03869333|11970023|FG000|NOT COMPLETED|Overall Study||2
10808225|NCT03869333|11970024|FG001|NOT COMPLETED|Overall Study||1
10808226|NCT03869333|11970025|FG002|NOT COMPLETED|Overall Study||0
10808227|NCT03869333|11970026|FG003|NOT COMPLETED|Overall Study||0
10808228|NCT03864900|11970038|FG000|STARTED|Overall Study||36
10808229|NCT03864900|11970039|FG001|STARTED|Overall Study||36
10808230|NCT03864900|11970038|FG000|COMPLETED|Overall Study||33
10808231|NCT03864900|11970039|FG001|COMPLETED|Overall Study||30
10808232|NCT03864900|11970038|FG000|NOT COMPLETED|Overall Study||3
10808233|NCT03864900|11970039|FG001|NOT COMPLETED|Overall Study||6
10600210|NCT01833065|11756882|FG004|STARTED|Overall Study|Randomized patients - As treated|110
10600211|NCT01833065|11756878|FG000|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
10600212|NCT01833065|11756879|FG001|Intention-to-treat Analysis Set|Overall Study|Randomized patients|53
10600213|NCT01833065|11756880|FG002|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
10808234|NCT03863795|11970049|FG000|STARTED|Overall Study||306
10808235|NCT03863795|11970050|FG001|STARTED|Overall Study||269
10808236|NCT03863795|11970051|FG002|STARTED|Overall Study||244
10808237|NCT03863795|11970052|FG003|STARTED|Overall Study||281
10808238|NCT03863795|11970049|FG000|COMPLETED|Overall Study||306
10808239|NCT03863795|11970050|FG001|COMPLETED|Overall Study||269
10808240|NCT03863795|11970051|FG002|COMPLETED|Overall Study||244
10808241|NCT03863795|11970052|FG003|COMPLETED|Overall Study||281
10808242|NCT03863795|11970049|FG000|NOT COMPLETED|Overall Study||0
10808243|NCT03863795|11970050|FG001|NOT COMPLETED|Overall Study||0
10808244|NCT03863795|11970051|FG002|NOT COMPLETED|Overall Study||0
10808245|NCT03863795|11970052|FG003|NOT COMPLETED|Overall Study||0
10808246|NCT03875482|11970064|FG000|STARTED|Overall Study||105
10808247|NCT03875482|11970065|FG001|STARTED|Overall Study||52
10808248|NCT03875482|11970064|FG000|COMPLETED|Overall Study||92
10808249|NCT03875482|11970065|FG001|COMPLETED|Overall Study||32
10808250|NCT03875482|11970064|FG000|NOT COMPLETED|Overall Study||13
10808251|NCT03875482|11970065|FG001|NOT COMPLETED|Overall Study||20
10808252|NCT03874377|11970071|FG000|STARTED|Overall Study||11
10808253|NCT03874377|11970071|FG000|COMPLETED|Overall Study||8
10808254|NCT03874377|11970071|FG000|NOT COMPLETED|Overall Study||3
10808255|NCT03863496|11970075|FG000|STARTED|Overall Study||71
10600214|NCT01833065|11756881|FG003|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
10600215|NCT01833065|11756882|FG004|Intention-to-treat Analysis Set|Overall Study|Randomized patients|111
10600216|NCT01833065|11756878|FG000|COMPLETED|Overall Study||41
10600217|NCT01833065|11756879|FG001|COMPLETED|Overall Study||40
10600218|NCT01833065|11756880|FG002|COMPLETED|Overall Study||23
10600219|NCT01833065|11756881|FG003|COMPLETED|Overall Study||41
10600220|NCT01833065|11756882|FG004|COMPLETED|Overall Study||74
10600221|NCT01833065|11756878|FG000|NOT COMPLETED|Overall Study||24
10600222|NCT01833065|11756879|FG001|NOT COMPLETED|Overall Study||13
10600223|NCT01833065|11756880|FG002|NOT COMPLETED|Overall Study||12
10600224|NCT01833065|11756881|FG003|NOT COMPLETED|Overall Study||9
10600225|NCT01833065|11756882|FG004|NOT COMPLETED|Overall Study||36
10600226|NCT01833078|11756892|FG000|STARTED|Overall Study||5
10600227|NCT01833078|11756892|FG000|COMPLETED|Overall Study||5
10600228|NCT01833078|11756892|FG000|NOT COMPLETED|Overall Study||0
10600229|NCT01833117|11756898|FG000|STARTED|Overall Study||43
10600230|NCT01833117|11756899|FG001|STARTED|Overall Study||19
10600231|NCT01833117|11756898|FG000|COMPLETED|Overall Study||43
10600232|NCT01833117|11756899|FG001|COMPLETED|Overall Study||19
10600233|NCT01833117|11756898|FG000|NOT COMPLETED|Overall Study||0
10600234|NCT01833117|11756899|FG001|NOT COMPLETED|Overall Study||0
10600235|NCT01833130|11756907|FG000|STARTED|Overall Study||25
10808256|NCT03863496|11970075|FG000|COMPLETED|Overall Study||71
10808257|NCT03863496|11970075|FG000|NOT COMPLETED|Overall Study||0
10808258|NCT03874013|11970083|FG000|STARTED|Overall Study||22
10808259|NCT03874013|11970084|FG001|STARTED|Overall Study||22
10808260|NCT03874013|11970083|FG000|COMPLETED|Overall Study||22
10808261|NCT03874013|11970084|FG001|COMPLETED|Overall Study||21
10808262|NCT03874013|11970083|FG000|NOT COMPLETED|Overall Study||0
10808263|NCT03874013|11970084|FG001|NOT COMPLETED|Overall Study||1
10808264|NCT03873116|11970093|FG000|STARTED|Overall Study||6
10808265|NCT03873116|11970094|FG001|STARTED|Overall Study||7
10808266|NCT03873116|11970095|FG002|STARTED|Overall Study||6
10808267|NCT03873116|11970093|FG000|COMPLETED|Overall Study||6
10808268|NCT03873116|11970094|FG001|COMPLETED|Overall Study||7
10808269|NCT03873116|11970095|FG002|COMPLETED|Overall Study||5
10808270|NCT03873116|11970093|FG000|NOT COMPLETED|Overall Study||0
10808271|NCT03873116|11970094|FG001|NOT COMPLETED|Overall Study||0
10808272|NCT03873116|11970095|FG002|NOT COMPLETED|Overall Study||1
10808273|NCT03872843|11970105|FG000|STARTED|Overall Study||12
10808274|NCT03872843|11970106|FG001|STARTED|Overall Study||10
10808275|NCT03872843|11970105|FG000|COMPLETED|Overall Study||7
10808276|NCT03872843|11970106|FG001|COMPLETED|Overall Study||3
10808277|NCT03872843|11970105|FG000|NOT COMPLETED|Overall Study||5
10808278|NCT03872843|11970106|FG001|NOT COMPLETED|Overall Study||7
10808279|NCT03870997|11970118|FG000|STARTED|Overall Study||15702
10808280|NCT03870997|11970119|FG001|STARTED|Overall Study||15702
10808281|NCT03870997|11970120|FG002|STARTED|Overall Study||15756
10808282|NCT03870997|11970121|FG003|STARTED|Overall Study||15757
10808283|NCT03870997|11970122|FG004|STARTED|Overall Study||15702
10808284|NCT03870997|11970123|FG005|STARTED|Overall Study||15702
10808285|NCT03870997|11970118|FG000|COMPLETED|Overall Study||5158
10808286|NCT03870997|11970119|FG001|COMPLETED|Overall Study||5271
10808287|NCT03870997|11970120|FG002|COMPLETED|Overall Study||4778
10808288|NCT03870997|11970121|FG003|COMPLETED|Overall Study||4810
10808289|NCT03870997|11970122|FG004|COMPLETED|Overall Study||5114
10808290|NCT03870997|11970123|FG005|COMPLETED|Overall Study||5171
10808291|NCT03870997|11970118|FG000|NOT COMPLETED|Overall Study||10544
10808292|NCT03870997|11970119|FG001|NOT COMPLETED|Overall Study||10431
10808293|NCT03870997|11970120|FG002|NOT COMPLETED|Overall Study||10978
10808294|NCT03870997|11970121|FG003|NOT COMPLETED|Overall Study||10947
10808295|NCT03870997|11970122|FG004|NOT COMPLETED|Overall Study||10588
10808296|NCT03870997|11970123|FG005|NOT COMPLETED|Overall Study||10531
10808297|NCT03869684|11970135|FG000|STARTED|Overall Study||3
10808298|NCT03869684|11970136|FG001|STARTED|Overall Study||5
10808299|NCT03869684|11970137|FG002|STARTED|Overall Study||5
10808300|NCT03869684|11970135|FG000|COMPLETED|Overall Study||1
10600236|NCT01833130|11756908|FG001|STARTED|Overall Study||27
10808301|NCT03869684|11970136|FG001|COMPLETED|Overall Study||2
10808302|NCT03869684|11970137|FG002|COMPLETED|Overall Study||2
10808303|NCT03869684|11970135|FG000|NOT COMPLETED|Overall Study||2
10808304|NCT03869684|11970136|FG001|NOT COMPLETED|Overall Study||3
10808305|NCT03869684|11970137|FG002|NOT COMPLETED|Overall Study||3
10600237|NCT01833130|11756907|FG000|COMPLETED|Overall Study||15
10600238|NCT01833130|11756908|FG001|COMPLETED|Overall Study||8
10600239|NCT01833130|11756907|FG000|NOT COMPLETED|Overall Study||10
10600240|NCT01833130|11756908|FG001|NOT COMPLETED|Overall Study||19
10600241|NCT01833143|11756914|FG000|STARTED|Overall Study||17
10600242|NCT01833143|11756914|FG000|COMPLETED|Overall Study||16
10808306|NCT03861338|11970145|FG000|STARTED|Overall Study||10
10808307|NCT03861338|11970145|FG000|COMPLETED|Overall Study||8
10808308|NCT03861338|11970145|FG000|NOT COMPLETED|Overall Study||2
10808309|NCT03858335|11970151|FG000|STARTED|Overall Study||16
10808310|NCT03858335|11970152|FG001|STARTED|Overall Study||16
10808311|NCT03858335|11970151|FG000|COMPLETED|Overall Study||12
10600243|NCT01833143|11756914|FG000|NOT COMPLETED|Overall Study||1
10600244|NCT01833169|11756918|FG000|STARTED|Overall Study||146
10600245|NCT01833169|11756918|FG000|Consented to be Followed for Survival|Overall Study||128
10600246|NCT01833169|11756918|FG000|COMPLETED|Overall Study||0
10600247|NCT01833169|11756918|FG000|NOT COMPLETED|Overall Study||146
10600248|NCT01833247|11756922|FG000|STARTED|Overall Study||12
10600249|NCT01833247|11756922|FG000|COMPLETED|Overall Study||12
10600250|NCT01833247|11756922|FG000|NOT COMPLETED|Overall Study||0
10600251|NCT01833403|11756926|FG000|STARTED|Overall Study||4
10600252|NCT01833403|11756926|FG000|COMPLETED|Overall Study||4
10600253|NCT01833403|11756926|FG000|NOT COMPLETED|Overall Study||0
10600254|NCT01833455|11756933|FG000|STARTED|Overall Study||4
10600255|NCT01833455|11756934|FG001|STARTED|Overall Study||4
10600256|NCT01833455|11756933|FG000|Completed 1st Baseline|Overall Study||4
10600257|NCT01833455|11756934|FG001|Completed 1st Baseline|Overall Study||4
10600258|NCT01833455|11756933|FG000|Completed 1st Intervention|Overall Study||3
10600259|NCT01833455|11756934|FG001|Completed 1st Intervention|Overall Study||4
10600260|NCT01833455|11756933|FG000|Completed 2nd Baseline (Washout)|Overall Study||3
10600261|NCT01833455|11756934|FG001|Completed 2nd Baseline (Washout)|Overall Study||4
10600262|NCT01833455|11756933|FG000|COMPLETED|Overall Study||3
10600263|NCT01833455|11756934|FG001|COMPLETED|Overall Study||4
10600264|NCT01833455|11756933|FG000|NOT COMPLETED|Overall Study||1
10600265|NCT01833455|11756934|FG001|NOT COMPLETED|Overall Study||0
10600266|NCT01833481|11756955|FG000|STARTED|Overall Study||10
10600267|NCT01833481|11756956|FG001|STARTED|Overall Study||10
10600268|NCT01833481|11756957|FG002|STARTED|Overall Study||10
10600269|NCT01833481|11756955|FG000|COMPLETED|Overall Study||10
10600270|NCT01833481|11756956|FG001|COMPLETED|Overall Study||10
10600271|NCT01833481|11756957|FG002|COMPLETED|Overall Study||10
10600272|NCT01833481|11756955|FG000|NOT COMPLETED|Overall Study||0
10600273|NCT01833481|11756956|FG001|NOT COMPLETED|Overall Study||0
10600274|NCT01833481|11756957|FG002|NOT COMPLETED|Overall Study||0
10600275|NCT01833494|11756965|FG000|STARTED|Overall Study||161
10600276|NCT01833494|11756965|FG000|COMPLETED|Overall Study||116
10600277|NCT01833494|11756965|FG000|NOT COMPLETED|Overall Study||45
10600278|NCT01833520|11756971|FG000|STARTED|Overall Study||3
10600279|NCT01833520|11756972|FG001|STARTED|Overall Study||3
10600280|NCT01833520|11756973|FG002|STARTED|Overall Study||9
10600281|NCT01833520|11756974|FG003|STARTED|Overall Study||3
10600282|NCT01833520|11756971|FG000|COMPLETED|Overall Study||0
10600283|NCT01833520|11756972|FG001|COMPLETED|Overall Study||0
10703944|NCT02481310|11868470|FG001|COMPLETED|Induction Treatment (6 Cycles)||30
10703945|NCT02481310|11868471|FG002|COMPLETED|Induction Treatment (6 Cycles)||1
10808312|NCT03858335|11970152|FG001|COMPLETED|Overall Study||12
10808313|NCT03858335|11970151|FG000|NOT COMPLETED|Overall Study||4
10808314|NCT03858335|11970152|FG001|NOT COMPLETED|Overall Study||4
10808315|NCT03857243|11970160|FG000|STARTED|Overall Study||1
10808316|NCT03857243|11970161|FG001|STARTED|Overall Study||1
10808317|NCT03857243|11970160|FG000|COMPLETED|Overall Study||1
10808318|NCT03857243|11970161|FG001|COMPLETED|Overall Study||1
10808319|NCT03857243|11970160|FG000|NOT COMPLETED|Overall Study||0
10808320|NCT03857243|11970161|FG001|NOT COMPLETED|Overall Study||0
10808321|NCT03851744|11970169|FG000|STARTED|Overall Study||4
10808322|NCT03851744|11970170|FG001|STARTED|Overall Study||6
10808323|NCT03851744|11970169|FG000|COMPLETED|Overall Study||4
10808324|NCT03851744|11970170|FG001|COMPLETED|Overall Study||4
10808325|NCT03851744|11970169|FG000|NOT COMPLETED|Overall Study||0
10808326|NCT03851744|11970170|FG001|NOT COMPLETED|Overall Study||2
10808327|NCT03849937|11970176|FG000|STARTED|Overall Study||147
10808328|NCT03849937|11970177|FG001|STARTED|Overall Study||72
10808329|NCT03849937|11970176|FG000|COMPLETED|Overall Study||94
10808330|NCT03849937|11970177|FG001|COMPLETED|Overall Study||35
10600284|NCT01833520|11756973|FG002|COMPLETED|Overall Study||1
10600285|NCT01833520|11756974|FG003|COMPLETED|Overall Study||0
10600286|NCT01833520|11756971|FG000|NOT COMPLETED|Overall Study||3
10600287|NCT01833520|11756972|FG001|NOT COMPLETED|Overall Study||3
10600288|NCT01833520|11756973|FG002|NOT COMPLETED|Overall Study||8
10703946|NCT02481310|11868469|FG000|NOT COMPLETED|Induction Treatment (6 Cycles)||0
10703947|NCT02481310|11868470|FG001|NOT COMPLETED|Induction Treatment (6 Cycles)||6
10703948|NCT02481310|11868471|FG002|NOT COMPLETED|Induction Treatment (6 Cycles)||0
10703949|NCT02481310|11868469|FG000|STARTED|Maintenance Treatment||1
10703950|NCT02481310|11868470|FG001|STARTED|Maintenance Treatment|9 patients that competed induction did not start maintenance treatment.|21
10703951|NCT02481310|11868471|FG002|STARTED|Maintenance Treatment||1
10808331|NCT03849937|11970176|FG000|NOT COMPLETED|Overall Study||53
10808332|NCT03849937|11970177|FG001|NOT COMPLETED|Overall Study||37
10808333|NCT03848416|11970191|FG000|STARTED|Overall Study||33
10808334|NCT03848416|11970192|FG001|STARTED|Overall Study||33
10808335|NCT03848416|11970193|FG002|STARTED|Overall Study||33
10600289|NCT01833520|11756974|FG003|NOT COMPLETED|Overall Study||3
10600290|NCT01833533|11756988|FG000|STARTED|Overall Study||100
10600291|NCT01833533|11756989|FG001|STARTED|Overall Study||205
10600292|NCT01833533|11756988|FG000|COMPLETED|Overall Study||94
10600293|NCT01833533|11756989|FG001|COMPLETED|Overall Study||184
10600294|NCT01833533|11756988|FG000|NOT COMPLETED|Overall Study||6
10600295|NCT01833533|11756989|FG001|NOT COMPLETED|Overall Study||21
10808336|NCT03848416|11970191|FG000|Received at Least One Dose of Study Drug|Overall Study||33
10808337|NCT03848416|11970192|FG001|Received at Least One Dose of Study Drug|Overall Study||33
10808338|NCT03848416|11970193|FG002|Received at Least One Dose of Study Drug|Overall Study||33
10808339|NCT03848416|11970191|FG000|COMPLETED|Overall Study||32
10600296|NCT01833546|11756999|FG000|STARTED|Overall Study||3
10600297|NCT01833546|11757000|FG001|STARTED|Overall Study||3
10600298|NCT01833546|11757001|FG002|STARTED|Overall Study||8
10600299|NCT01833546|11757002|FG003|STARTED|Overall Study||6
10600300|NCT01833546|11756999|FG000|COMPLETED|Overall Study||3
10600301|NCT01833546|11757000|FG001|COMPLETED|Overall Study||3
10600302|NCT01833546|11757001|FG002|COMPLETED|Overall Study||8
10600303|NCT01833546|11757002|FG003|COMPLETED|Overall Study||6
10600304|NCT01833546|11756999|FG000|NOT COMPLETED|Overall Study||0
10600305|NCT01833546|11757000|FG001|NOT COMPLETED|Overall Study||0
10600306|NCT01833546|11757001|FG002|NOT COMPLETED|Overall Study||0
10600307|NCT01833546|11757002|FG003|NOT COMPLETED|Overall Study||0
10600308|NCT01833741|11757013|FG000|STARTED|Overall Study||1137
10600309|NCT01833741|11757013|FG000|COMPLETED|Overall Study||997
10600310|NCT01833741|11757013|FG000|NOT COMPLETED|Overall Study||140
10600320|NCT01833832|11757030|FG000|STARTED|Overall Study||11
10600321|NCT01833832|11757030|FG000|COMPLETED|Overall Study||10
10600322|NCT01833832|11757030|FG000|NOT COMPLETED|Overall Study||1
10600323|NCT01833845|11757034|FG000|STARTED|Overall Study||4
10600324|NCT01833845|11757034|FG000|COMPLETED|Overall Study||4
10600325|NCT01833845|11757034|FG000|NOT COMPLETED|Overall Study||0
10600326|NCT01833897|11757038|FG000|STARTED|Overall Study||8
10600327|NCT01833897|11757038|FG000|COMPLETED|Overall Study||7
10600328|NCT01833897|11757038|FG000|NOT COMPLETED|Overall Study||1
10600329|NCT01833936|11757044|FG000|STARTED|Overall Study||20
10600330|NCT01833936|11757045|FG001|STARTED|Overall Study||20
10600331|NCT01833936|11757044|FG000|COMPLETED|Overall Study||16
10600332|NCT01833936|11757045|FG001|COMPLETED|Overall Study||18
10600333|NCT01833936|11757044|FG000|NOT COMPLETED|Overall Study||4
10600334|NCT01833936|11757045|FG001|NOT COMPLETED|Overall Study||2
10600335|NCT01833988|11757051|FG000|STARTED|Overall Study||16
10600336|NCT01833988|11757052|FG001|STARTED|Overall Study||16
10600337|NCT01833988|11757051|FG000|COMPLETED|Overall Study||16
10600338|NCT01833988|11757052|FG001|COMPLETED|Overall Study||16
10600339|NCT01833988|11757051|FG000|NOT COMPLETED|Overall Study||0
10600340|NCT01833988|11757052|FG001|NOT COMPLETED|Overall Study||0
10600341|NCT01834027|11757065|FG000|STARTED|Overall Study||28
10600342|NCT01834027|11757066|FG001|STARTED|Overall Study||28
10600343|NCT01834027|11757065|FG000|COMPLETED|Overall Study||28
10600344|NCT01834027|11757066|FG001|COMPLETED|Overall Study||28
10600345|NCT01834027|11757065|FG000|NOT COMPLETED|Overall Study||0
10600346|NCT01834027|11757066|FG001|NOT COMPLETED|Overall Study||0
10600347|NCT01834222|11757072|FG000|STARTED|Overall Study||659
10600348|NCT01834222|11757072|FG000|Treated|Overall Study||658
10600349|NCT01834222|11757072|FG000|COMPLETED|Overall Study||658
10600350|NCT01834222|11757072|FG000|NOT COMPLETED|Overall Study||1
10600351|NCT01834261|11757078|FG000|STARTED|MIT fMRI and MEG Resting State Study||11
10600352|NCT01834261|11757079|FG001|STARTED|MIT fMRI and MEG Resting State Study||10
10600353|NCT01834261|11757078|FG000|COMPLETED|MIT fMRI and MEG Resting State Study|Enrollment completed in March 2014.|10
10600354|NCT01834261|11757079|FG001|COMPLETED|MIT fMRI and MEG Resting State Study||9
10600355|NCT01834261|11757078|FG000|NOT COMPLETED|MIT fMRI and MEG Resting State Study||1
10600356|NCT01834261|11757079|FG001|NOT COMPLETED|MIT fMRI and MEG Resting State Study||1
10600357|NCT01834261|11757078|FG000|STARTED|MGH Rest + Nueroeconomic Task fMRI|Subjects who dropped out/were excluded (10), did so before they received either Oxytocin or Placebo.|10
10600358|NCT01834261|11757079|FG001|STARTED|MGH Rest + Nueroeconomic Task fMRI||10
10600359|NCT01834261|11757078|FG000|COMPLETED|MGH Rest + Nueroeconomic Task fMRI|Enrollment completed in May 2015.|10
10600360|NCT01834261|11757079|FG001|COMPLETED|MGH Rest + Nueroeconomic Task fMRI||10
10600361|NCT01834261|11757078|FG000|NOT COMPLETED|MGH Rest + Nueroeconomic Task fMRI||0
10600362|NCT01834261|11757079|FG001|NOT COMPLETED|MGH Rest + Nueroeconomic Task fMRI||0
10600363|NCT01834274|11757087|FG000|STARTED|Overall Study||50
10600364|NCT01834274|11757088|FG001|STARTED|Overall Study||46
10600365|NCT01834274|11757087|FG000|COMPLETED|Overall Study||3
10600366|NCT01834274|11757088|FG001|COMPLETED|Overall Study||5
10600367|NCT01834274|11757087|FG000|NOT COMPLETED|Overall Study||47
10600368|NCT01834274|11757088|FG001|NOT COMPLETED|Overall Study||41
10600369|NCT01834326|11757096|FG000|STARTED|Overall Study||10
10600370|NCT01834326|11757097|FG001|STARTED|Overall Study||8
10600371|NCT01834326|11757096|FG000|COMPLETED|Overall Study||8
10600372|NCT01834326|11757097|FG001|COMPLETED|Overall Study||2
10600373|NCT01834326|11757096|FG000|NOT COMPLETED|Overall Study||2
10600374|NCT01834326|11757097|FG001|NOT COMPLETED|Overall Study||6
10600375|NCT01834404|11757105|FG000|STARTED|Overall Study||12
10600376|NCT01834404|11757106|FG001|STARTED|Overall Study||12
10600377|NCT01834404|11757105|FG000|COMPLETED|Overall Study||12
10600378|NCT01834404|11757106|FG001|COMPLETED|Overall Study||12
10600379|NCT01834404|11757105|FG000|NOT COMPLETED|Overall Study||0
10600380|NCT01834404|11757106|FG001|NOT COMPLETED|Overall Study||0
10600381|NCT01834586|11757112|FG000|STARTED|Overall Study||30
10600382|NCT01834586|11757112|FG000|COMPLETED|Overall Study||29
10600383|NCT01834586|11757112|FG000|NOT COMPLETED|Overall Study||1
10600384|NCT01834651|11757116|FG000|STARTED|Overall Study||17
10600385|NCT01834651|11757116|FG000|COMPLETED|Overall Study|Evaluable for primary outcome assessment at 12 weeks|16
10600386|NCT01834651|11757116|FG000|NOT COMPLETED|Overall Study||1
10600387|NCT01834716|11757124|FG000|STARTED|Overall Study||4
10600388|NCT01834716|11757125|FG001|STARTED|Overall Study||12
10600389|NCT01834716|11757124|FG000|COMPLETED|Overall Study||4
10600390|NCT01834716|11757125|FG001|COMPLETED|Overall Study||11
10600391|NCT01834716|11757124|FG000|NOT COMPLETED|Overall Study||0
10600392|NCT01834716|11757125|FG001|NOT COMPLETED|Overall Study||1
10600393|NCT01834729|11757135|FG000|STARTED|Overall Study||18
10600394|NCT01834729|11757136|FG001|STARTED|Overall Study||20
10600395|NCT01834729|11757137|FG002|STARTED|Overall Study||18
10600396|NCT01834729|11757138|FG003|STARTED|Overall Study||18
10600397|NCT01834729|11757135|FG000|COMPLETED|Overall Study||17
10600398|NCT01834729|11757136|FG001|COMPLETED|Overall Study||19
10600399|NCT01834729|11757137|FG002|COMPLETED|Overall Study||15
10600400|NCT01834729|11757138|FG003|COMPLETED|Overall Study||16
10600401|NCT01834729|11757135|FG000|NOT COMPLETED|Overall Study||1
10600402|NCT01834729|11757136|FG001|NOT COMPLETED|Overall Study||1
10600403|NCT01834729|11757137|FG002|NOT COMPLETED|Overall Study||3
10600404|NCT01834729|11757138|FG003|NOT COMPLETED|Overall Study||2
10600405|NCT01835015|11757154|FG000|STARTED|Overall Study||6
10600406|NCT01835015|11757155|FG001|STARTED|Overall Study||6
10600407|NCT01835015|11757156|FG002|STARTED|Overall Study||7
10600408|NCT01835015|11757157|FG003|STARTED|Overall Study||6
10600409|NCT01835015|11757158|FG004|STARTED|Overall Study||6
10600410|NCT01835015|11757154|FG000|COMPLETED|Overall Study||6
10600411|NCT01835015|11757155|FG001|COMPLETED|Overall Study||6
10600412|NCT01835015|11757156|FG002|COMPLETED|Overall Study||6
10600413|NCT01835015|11757157|FG003|COMPLETED|Overall Study||6
10600414|NCT01835015|11757158|FG004|COMPLETED|Overall Study||6
10600415|NCT01835015|11757154|FG000|NOT COMPLETED|Overall Study||0
10600416|NCT01835015|11757155|FG001|NOT COMPLETED|Overall Study||0
10600417|NCT01835015|11757156|FG002|NOT COMPLETED|Overall Study||1
10600418|NCT01835015|11757157|FG003|NOT COMPLETED|Overall Study||0
10600419|NCT01835015|11757158|FG004|NOT COMPLETED|Overall Study||0
10600420|NCT01835132|11757171|FG000|STARTED|Initial Phase||8
10600421|NCT01835132|11757171|FG000|COMPLETED|Initial Phase||6
10600422|NCT01835132|11757171|FG000|NOT COMPLETED|Initial Phase||2
10600423|NCT01835132|11757171|FG000|STARTED|1st Extension Phase||6
10600424|NCT01835132|11757171|FG000|COMPLETED|1st Extension Phase|Completed 52 Weeks|6
10600425|NCT01835132|11757171|FG000|NOT COMPLETED|1st Extension Phase||0
10600426|NCT01835132|11757171|FG000|STARTED|2nd Extension Phase - As Needed (PRN)|PRN extension - Participants starting this phase may not equal those who completed the 1st extension|3
10600427|NCT01835132|11757171|FG000|COMPLETED|2nd Extension Phase - As Needed (PRN)||3
10600428|NCT01835132|11757171|FG000|NOT COMPLETED|2nd Extension Phase - As Needed (PRN)||0
10600429|NCT01835158|11757177|FG000|STARTED|Overall Study||79
10600430|NCT01835158|11757178|FG001|STARTED|Overall Study||78
10600431|NCT01835158|11757177|FG000|COMPLETED|Overall Study||78
10600432|NCT01835158|11757178|FG001|COMPLETED|Overall Study||72
10600433|NCT01835158|11757177|FG000|NOT COMPLETED|Overall Study||1
10600434|NCT01835158|11757178|FG001|NOT COMPLETED|Overall Study||6
10600435|NCT01835223|11757186|FG000|STARTED|Overall Study||30
10600436|NCT01835223|11757187|FG001|STARTED|Overall Study||3
10600437|NCT01835223|11757186|FG000|COMPLETED|Overall Study||21
10600438|NCT01835223|11757187|FG001|COMPLETED|Overall Study||2
10600439|NCT01835223|11757186|FG000|NOT COMPLETED|Overall Study||9
10600440|NCT01835223|11757187|FG001|NOT COMPLETED|Overall Study||1
10600441|NCT01835262|11757197|FG000|STARTED|Overall Study||45
10600442|NCT01835262|11757198|FG001|STARTED|Overall Study||45
10600443|NCT01835262|11757197|FG000|COMPLETED|Overall Study||45
10600444|NCT01835262|11757198|FG001|COMPLETED|Overall Study||45
10600445|NCT01835262|11757197|FG000|NOT COMPLETED|Overall Study||0
10600446|NCT01835262|11757198|FG001|NOT COMPLETED|Overall Study||0
10600447|NCT01835379|11757206|FG000|STARTED|Overall Study||41
10600448|NCT01835379|11757207|FG001|STARTED|Overall Study||41
10600449|NCT01835379|11757206|FG000|COMPLETED|Overall Study||41
10600450|NCT01835379|11757207|FG001|COMPLETED|Overall Study||41
10600451|NCT01835379|11757206|FG000|NOT COMPLETED|Overall Study||0
10600452|NCT01835379|11757207|FG001|NOT COMPLETED|Overall Study||0
10600453|NCT01835431|11757215|FG000|STARTED|Overall Study||182
10600454|NCT01835431|11757216|FG001|STARTED|Overall Study||180
10600455|NCT01835431|11757215|FG000|Exposed|Overall Study|One subject was withdrawn before exposure.|181
10600456|NCT01835431|11757216|FG001|Exposed|Overall Study|One subject was withdrawn before exposure|179
10600457|NCT01835431|11757215|FG000|COMPLETED|Overall Study||174
10600458|NCT01835431|11757216|FG001|COMPLETED|Overall Study||168
10600459|NCT01835431|11757215|FG000|NOT COMPLETED|Overall Study||8
10600460|NCT01835431|11757216|FG001|NOT COMPLETED|Overall Study||12
10600461|NCT01835470|11757222|FG000|STARTED|Short Term Treatment Period (to Week 16)||20
10600462|NCT01835470|11757222|FG000|COMPLETED|Short Term Treatment Period (to Week 16)||20
10600463|NCT01835470|11757222|FG000|NOT COMPLETED|Short Term Treatment Period (to Week 16)||0
10600464|NCT01835470|11757222|FG000|STARTED|Long Term Treatment Period||20
10600465|NCT01835470|11757222|FG000|COMPLETED|Long Term Treatment Period|Completed LT period|16
10600466|NCT01835470|11757222|FG000|NOT COMPLETED|Long Term Treatment Period||4
10600467|NCT01835496|11757227|FG000|STARTED|Overall Study||8
10600468|NCT01835496|11757227|FG000|COMPLETED|Overall Study||8
10600469|NCT01835496|11757227|FG000|NOT COMPLETED|Overall Study||0
10600470|NCT01835548|11757233|FG000|STARTED|Screening/Washout Period||0
10600471|NCT01835548|11757234|FG001|STARTED|Screening/Washout Period||0
10600472|NCT01835548|11757235|FG002|STARTED|Screening/Washout Period||87
10600473|NCT01835548|11757233|FG000|COMPLETED|Screening/Washout Period||0
10600474|NCT01835548|11757234|FG001|COMPLETED|Screening/Washout Period||0
10600475|NCT01835548|11757235|FG002|COMPLETED|Screening/Washout Period||87
10600476|NCT01835548|11757233|FG000|NOT COMPLETED|Screening/Washout Period||0
10600477|NCT01835548|11757234|FG001|NOT COMPLETED|Screening/Washout Period||0
10600478|NCT01835548|11757235|FG002|NOT COMPLETED|Screening/Washout Period||0
10600479|NCT01835548|11757233|FG000|STARTED|Dose Optimization Period||0
10600480|NCT01835548|11757234|FG001|STARTED|Dose Optimization Period||0
10600481|NCT01835548|11757235|FG002|STARTED|Dose Optimization Period||87
10600482|NCT01835548|11757233|FG000|COMPLETED|Dose Optimization Period||0
10600483|NCT01835548|11757234|FG001|COMPLETED|Dose Optimization Period||0
10600484|NCT01835548|11757235|FG002|COMPLETED|Dose Optimization Period||85
10600485|NCT01835548|11757233|FG000|NOT COMPLETED|Dose Optimization Period||0
10600486|NCT01835548|11757234|FG001|NOT COMPLETED|Dose Optimization Period||0
10600487|NCT01835548|11757235|FG002|NOT COMPLETED|Dose Optimization Period||2
10600488|NCT01835548|11757233|FG000|STARTED|Dose Stabilization Period||0
10600489|NCT01835548|11757234|FG001|STARTED|Dose Stabilization Period||0
10600490|NCT01835548|11757235|FG002|STARTED|Dose Stabilization Period||85
10808340|NCT03848416|11970192|FG001|COMPLETED|Overall Study||33
10808341|NCT03848416|11970193|FG002|COMPLETED|Overall Study||32
10808342|NCT03848416|11970191|FG000|NOT COMPLETED|Overall Study||1
10808343|NCT03848416|11970192|FG001|NOT COMPLETED|Overall Study||0
10808344|NCT03848416|11970193|FG002|NOT COMPLETED|Overall Study||1
10808345|NCT03847987|11970203|FG000|STARTED|Overall Study||16
10808346|NCT03847987|11970204|FG001|STARTED|Overall Study||8
10808347|NCT03847987|11970203|FG000|COMPLETED|Overall Study||13
10808348|NCT03847987|11970204|FG001|COMPLETED|Overall Study||8
10808349|NCT03847987|11970203|FG000|NOT COMPLETED|Overall Study||3
10808350|NCT03847987|11970204|FG001|NOT COMPLETED|Overall Study||0
10808351|NCT03854253|11970223|FG000|STARTED|Overall Study||50
10808352|NCT03854253|11970224|FG001|STARTED|Overall Study||50
10808353|NCT03854253|11970223|FG000|COMPLETED|Overall Study||49
10808354|NCT03854253|11970224|FG001|COMPLETED|Overall Study||50
10808355|NCT03854253|11970223|FG000|NOT COMPLETED|Overall Study||1
10808356|NCT03854253|11970224|FG001|NOT COMPLETED|Overall Study||0
10808357|NCT03870737|11970230|FG000|STARTED|Overall Study||22
10808358|NCT03870737|11970230|FG000|COMPLETED|Overall Study||20
10808359|NCT03870737|11970230|FG000|NOT COMPLETED|Overall Study||2
10808360|NCT03860181|11970238|FG000|STARTED|Overall Study||21
10808361|NCT03860181|11970239|FG001|STARTED|Overall Study||22
10808362|NCT03860181|11970240|FG002|STARTED|Overall Study||25
10808363|NCT03860181|11970241|FG003|STARTED|Overall Study||21
10808364|NCT03860181|11970238|FG000|COMPLETED|Overall Study||21
10808365|NCT03860181|11970239|FG001|COMPLETED|Overall Study||22
10808366|NCT03860181|11970240|FG002|COMPLETED|Overall Study||25
10808367|NCT03860181|11970241|FG003|COMPLETED|Overall Study||21
10808368|NCT03860181|11970238|FG000|NOT COMPLETED|Overall Study||0
10808369|NCT03860181|11970239|FG001|NOT COMPLETED|Overall Study||0
10808370|NCT03860181|11970240|FG002|NOT COMPLETED|Overall Study||0
10808371|NCT03860181|11970241|FG003|NOT COMPLETED|Overall Study||0
10808372|NCT03856944|11970262|FG000|STARTED|Overall Study||29
10808373|NCT03856944|11970262|FG000|COMPLETED|Overall Study||29
10808374|NCT03856944|11970262|FG000|NOT COMPLETED|Overall Study||0
10808375|NCT03853551|11970266|FG000|STARTED|Overall Study||60
10808376|NCT03853551|11970266|FG000|COMPLETED|Overall Study||51
10808377|NCT03853551|11970266|FG000|NOT COMPLETED|Overall Study||9
10808378|NCT03870555|11970273|FG000|STARTED|Period 1 (2 Days)||2
10808379|NCT03870555|11970274|FG001|STARTED|Period 1 (2 Days)||2
10808380|NCT03870555|11970275|FG002|STARTED|Period 1 (2 Days)||2
10808381|NCT03870555|11970273|FG000|COMPLETED|Period 1 (2 Days)||2
10808382|NCT03870555|11970274|FG001|COMPLETED|Period 1 (2 Days)||2
10808383|NCT03870555|11970275|FG002|COMPLETED|Period 1 (2 Days)||2
10808384|NCT03870555|11970273|FG000|NOT COMPLETED|Period 1 (2 Days)||0
10808385|NCT03870555|11970274|FG001|NOT COMPLETED|Period 1 (2 Days)||0
10808386|NCT03870555|11970275|FG002|NOT COMPLETED|Period 1 (2 Days)||0
10808387|NCT03870555|11970273|FG000|STARTED|Washout Period (at Least 16 Days)||2
10600491|NCT01835548|11757233|FG000|COMPLETED|Dose Stabilization Period||0
10600492|NCT01835548|11757234|FG001|COMPLETED|Dose Stabilization Period||0
10808388|NCT03870555|11970274|FG001|STARTED|Washout Period (at Least 16 Days)||2
10808389|NCT03870555|11970275|FG002|STARTED|Washout Period (at Least 16 Days)||2
10808390|NCT03870555|11970273|FG000|COMPLETED|Washout Period (at Least 16 Days)||2
10808391|NCT03870555|11970274|FG001|COMPLETED|Washout Period (at Least 16 Days)||2
10808392|NCT03870555|11970275|FG002|COMPLETED|Washout Period (at Least 16 Days)||2
10808393|NCT03870555|11970273|FG000|NOT COMPLETED|Washout Period (at Least 16 Days)||0
10808394|NCT03870555|11970274|FG001|NOT COMPLETED|Washout Period (at Least 16 Days)||0
10808395|NCT03870555|11970275|FG002|NOT COMPLETED|Washout Period (at Least 16 Days)||0
10808396|NCT03870555|11970273|FG000|STARTED|Period 2 (2 Days)||2
10808397|NCT03870555|11970274|FG001|STARTED|Period 2 (2 Days)||2
10808398|NCT03870555|11970275|FG002|STARTED|Period 2 (2 Days)||2
10808399|NCT03870555|11970273|FG000|COMPLETED|Period 2 (2 Days)||2
10808400|NCT03870555|11970274|FG001|COMPLETED|Period 2 (2 Days)||2
10808401|NCT03870555|11970275|FG002|COMPLETED|Period 2 (2 Days)||2
10808402|NCT03870555|11970273|FG000|NOT COMPLETED|Period 2 (2 Days)||0
10808403|NCT03870555|11970274|FG001|NOT COMPLETED|Period 2 (2 Days)||0
10808404|NCT03870555|11970275|FG002|NOT COMPLETED|Period 2 (2 Days)||0
10808405|NCT03870555|11970273|FG000|STARTED|Washout Period (at Least 16 Days)||2
10600493|NCT01835548|11757235|FG002|COMPLETED|Dose Stabilization Period||85
10600494|NCT01835548|11757233|FG000|NOT COMPLETED|Dose Stabilization Period||0
10600495|NCT01835548|11757234|FG001|NOT COMPLETED|Dose Stabilization Period||0
10600496|NCT01835548|11757235|FG002|NOT COMPLETED|Dose Stabilization Period||0
10600497|NCT01835548|11757233|FG000|STARTED|Double-Blind Treatment Period||44
10600498|NCT01835548|11757234|FG001|STARTED|Double-Blind Treatment Period||41
10600499|NCT01835548|11757235|FG002|STARTED|Double-Blind Treatment Period||0
10600500|NCT01835548|11757233|FG000|COMPLETED|Double-Blind Treatment Period||44
10600501|NCT01835548|11757234|FG001|COMPLETED|Double-Blind Treatment Period||39
10600502|NCT01835548|11757235|FG002|COMPLETED|Double-Blind Treatment Period||0
10600503|NCT01835548|11757233|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
10600504|NCT01835548|11757234|FG001|NOT COMPLETED|Double-Blind Treatment Period||2
10600505|NCT01835548|11757235|FG002|NOT COMPLETED|Double-Blind Treatment Period||0
10600506|NCT01835587|11757251|FG000|STARTED|Overall Study||3
10600507|NCT01835587|11757252|FG001|STARTED|Overall Study||4
10600508|NCT01835587|11757253|FG002|STARTED|Overall Study||4
10600509|NCT01835587|11757254|FG003|STARTED|Overall Study||19
10600510|NCT01835587|11757251|FG000|COMPLETED|Overall Study||1
10600511|NCT01835587|11757252|FG001|COMPLETED|Overall Study||0
10600512|NCT01835587|11757253|FG002|COMPLETED|Overall Study||2
10600513|NCT01835587|11757254|FG003|COMPLETED|Overall Study||10
10600514|NCT01835587|11757251|FG000|NOT COMPLETED|Overall Study||2
10600515|NCT01835587|11757252|FG001|NOT COMPLETED|Overall Study||4
10600516|NCT01835587|11757253|FG002|NOT COMPLETED|Overall Study||2
10600517|NCT01835587|11757254|FG003|NOT COMPLETED|Overall Study||9
10600518|NCT01835626|11757271|FG000|STARTED|Overall Study||24
10600519|NCT01835626|11757271|FG000|COMPLETED|Overall Study||17
10600520|NCT01835626|11757271|FG000|NOT COMPLETED|Overall Study||7
10600521|NCT01835743|11757277|FG000|STARTED|Overall Study||37
10600522|NCT01835743|11757278|FG001|STARTED|Overall Study||32
10600523|NCT01835743|11757277|FG000|COMPLETED|Overall Study||37
10600524|NCT01835743|11757278|FG001|COMPLETED|Overall Study||32
10600525|NCT01835743|11757277|FG000|NOT COMPLETED|Overall Study||0
10600526|NCT01835743|11757278|FG001|NOT COMPLETED|Overall Study||0
10600527|NCT01835756|11757286|FG000|STARTED|Overall Study||31
10600528|NCT01835756|11757287|FG001|STARTED|Overall Study||31
10600529|NCT01835756|11757286|FG000|COMPLETED|Overall Study||31
10600530|NCT01835756|11757287|FG001|COMPLETED|Overall Study||31
10600531|NCT01835756|11757286|FG000|NOT COMPLETED|Overall Study||0
10600532|NCT01835756|11757287|FG001|NOT COMPLETED|Overall Study||0
10600533|NCT01835899|11757298|FG000|STARTED|Overall Study||6
10600534|NCT01835899|11757299|FG001|STARTED|Overall Study||9
10600535|NCT01835899|11757300|FG002|STARTED|Overall Study||9
10600536|NCT01835899|11757298|FG000|COMPLETED|Overall Study||6
10600537|NCT01835899|11757299|FG001|COMPLETED|Overall Study||8
10600538|NCT01835899|11757300|FG002|COMPLETED|Overall Study||8
10600539|NCT01835899|11757298|FG000|NOT COMPLETED|Overall Study||0
10600540|NCT01835899|11757299|FG001|NOT COMPLETED|Overall Study||1
10600541|NCT01835899|11757300|FG002|NOT COMPLETED|Overall Study||1
10600542|NCT01835912|11757310|FG000|STARTED|Overall Study||10
10600543|NCT01835912|11757310|FG000|Acute|Overall Study||10
10600544|NCT01835912|11757310|FG000|Acute Placebo|Overall Study||10
10600545|NCT01835912|11757310|FG000|Chronic|Overall Study||10
10600546|NCT01835912|11757310|FG000|Chronic Placebo|Overall Study||10
10600547|NCT01835912|11757310|FG000|COMPLETED|Overall Study||10
10600548|NCT01835912|11757310|FG000|NOT COMPLETED|Overall Study||0
10600549|NCT01836029|11757322|FG000|STARTED|Overall Study||100
10600550|NCT01836029|11757323|FG001|STARTED|Overall Study||95
10600551|NCT01836029|11757322|FG000|COMPLETED|Overall Study||100
10600552|NCT01836029|11757323|FG001|COMPLETED|Overall Study||95
10600553|NCT01836029|11757322|FG000|NOT COMPLETED|Overall Study||0
10600554|NCT01836029|11757323|FG001|NOT COMPLETED|Overall Study||0
10600555|NCT01836042|11757332|FG000|STARTED|Overall Study||51
10600556|NCT01836042|11757333|FG001|STARTED|Overall Study||35
10600557|NCT01836042|11757334|FG002|STARTED|Overall Study||22
10600558|NCT01836042|11757332|FG000|COMPLETED|Overall Study||51
10600559|NCT01836042|11757333|FG001|COMPLETED|Overall Study||35
10600560|NCT01836042|11757334|FG002|COMPLETED|Overall Study||22
10600561|NCT01836042|11757332|FG000|NOT COMPLETED|Overall Study||0
10600562|NCT01836042|11757333|FG001|NOT COMPLETED|Overall Study||0
10600563|NCT01836042|11757334|FG002|NOT COMPLETED|Overall Study||0
10600564|NCT01836133|11757342|FG000|STARTED|Overall Study||70
10600565|NCT01836133|11757342|FG000|COMPLETED|Overall Study||70
10600566|NCT01836133|11757342|FG000|NOT COMPLETED|Overall Study||0
10600567|NCT01836185|11757350|FG000|STARTED|Overall Study||10
10600568|NCT01836185|11757351|FG001|STARTED|Overall Study||8
10600569|NCT01836185|11757352|FG002|STARTED|Overall Study||8
10600570|NCT01836185|11757353|FG003|STARTED|Overall Study||6
10600571|NCT01836185|11757350|FG000|Received Single Dose of Study Treatment|Overall Study||10
10600572|NCT01836185|11757351|FG001|Received Single Dose of Study Treatment|Overall Study||8
10600573|NCT01836185|11757352|FG002|Received Single Dose of Study Treatment|Overall Study||8
10600574|NCT01836185|11757353|FG003|Received Single Dose of Study Treatment|Overall Study||6
10600575|NCT01836185|11757350|FG000|COMPLETED|Overall Study||10
10600576|NCT01836185|11757351|FG001|COMPLETED|Overall Study||8
10600577|NCT01836185|11757352|FG002|COMPLETED|Overall Study||8
10600578|NCT01836185|11757353|FG003|COMPLETED|Overall Study||6
10600579|NCT01836185|11757350|FG000|NOT COMPLETED|Overall Study||0
10600580|NCT01836185|11757351|FG001|NOT COMPLETED|Overall Study||0
10600581|NCT01836185|11757352|FG002|NOT COMPLETED|Overall Study||0
10600582|NCT01836185|11757353|FG003|NOT COMPLETED|Overall Study||0
10600583|NCT01836198|11757365|FG000|STARTED|Part A, Period 1||15
10600584|NCT01836198|11757366|FG001|STARTED|Part A, Period 1||15
10600585|NCT01836198|11757367|FG002|STARTED|Part A, Period 1||0
10600586|NCT01836198|11757365|FG000|Received at Least 1 Dose of Study Drug|Part A, Period 1||15
10600587|NCT01836198|11757366|FG001|Received at Least 1 Dose of Study Drug|Part A, Period 1||15
10600588|NCT01836198|11757367|FG002|Received at Least 1 Dose of Study Drug|Part A, Period 1||0
10600589|NCT01836198|11757365|FG000|COMPLETED|Part A, Period 1||15
10600590|NCT01836198|11757366|FG001|COMPLETED|Part A, Period 1||15
10600591|NCT01836198|11757367|FG002|COMPLETED|Part A, Period 1||0
10600592|NCT01836198|11757365|FG000|NOT COMPLETED|Part A, Period 1||0
10600593|NCT01836198|11757366|FG001|NOT COMPLETED|Part A, Period 1||0
10600594|NCT01836198|11757367|FG002|NOT COMPLETED|Part A, Period 1||0
10600595|NCT01836198|11757365|FG000|STARTED|Part A, Period 2||15
10600596|NCT01836198|11757366|FG001|STARTED|Part A, Period 2||15
10600597|NCT01836198|11757367|FG002|STARTED|Part A, Period 2||0
10600598|NCT01836198|11757365|FG000|Completed Part A, Entered Part B|Part A, Period 2||6
10600599|NCT01836198|11757366|FG001|Completed Part A, Entered Part B|Part A, Period 2||6
10600600|NCT01836198|11757367|FG002|Completed Part A, Entered Part B|Part A, Period 2||0
10600601|NCT01836198|11757365|FG000|COMPLETED|Part A, Period 2||15
10600602|NCT01836198|11757366|FG001|COMPLETED|Part A, Period 2||14
10600603|NCT01836198|11757367|FG002|COMPLETED|Part A, Period 2||0
10600604|NCT01836198|11757365|FG000|NOT COMPLETED|Part A, Period 2||0
10600605|NCT01836198|11757366|FG001|NOT COMPLETED|Part A, Period 2||1
10600606|NCT01836198|11757367|FG002|NOT COMPLETED|Part A, Period 2||0
10600607|NCT01836198|11757365|FG000|STARTED|Part B||0
10600608|NCT01836198|11757366|FG001|STARTED|Part B||0
10600609|NCT01836198|11757367|FG002|STARTED|Part B||12
10600610|NCT01836198|11757365|FG000|Received at Least 1 Dose of Study Drug|Part B||0
10600611|NCT01836198|11757366|FG001|Received at Least 1 Dose of Study Drug|Part B||0
10600612|NCT01836198|11757367|FG002|Received at Least 1 Dose of Study Drug|Part B||12
10600613|NCT01836198|11757365|FG000|COMPLETED|Part B||0
10600614|NCT01836198|11757366|FG001|COMPLETED|Part B||0
10600615|NCT01836198|11757367|FG002|COMPLETED|Part B||12
10600616|NCT01836198|11757365|FG000|NOT COMPLETED|Part B||0
10600617|NCT01836198|11757366|FG001|NOT COMPLETED|Part B||0
10600618|NCT01836198|11757367|FG002|NOT COMPLETED|Part B||0
10600619|NCT01836276|11757385|FG000|STARTED|Overall Study||224
10808406|NCT03870555|11970274|FG001|STARTED|Washout Period (at Least 16 Days)||2
10808407|NCT03870555|11970275|FG002|STARTED|Washout Period (at Least 16 Days)||2
10808408|NCT03870555|11970273|FG000|COMPLETED|Washout Period (at Least 16 Days)||2
10808409|NCT03870555|11970274|FG001|COMPLETED|Washout Period (at Least 16 Days)||2
10808410|NCT03870555|11970275|FG002|COMPLETED|Washout Period (at Least 16 Days)||2
10808411|NCT03870555|11970273|FG000|NOT COMPLETED|Washout Period (at Least 16 Days)||0
10808412|NCT03870555|11970274|FG001|NOT COMPLETED|Washout Period (at Least 16 Days)||0
10808413|NCT03870555|11970275|FG002|NOT COMPLETED|Washout Period (at Least 16 Days)||0
10808414|NCT03870555|11970273|FG000|STARTED|Period 3 (2 Days)||2
10808415|NCT03870555|11970274|FG001|STARTED|Period 3 (2 Days)||2
10808416|NCT03870555|11970275|FG002|STARTED|Period 3 (2 Days)||2
10808417|NCT03870555|11970273|FG000|COMPLETED|Period 3 (2 Days)||1
10808418|NCT03870555|11970274|FG001|COMPLETED|Period 3 (2 Days)||2
10808419|NCT03870555|11970275|FG002|COMPLETED|Period 3 (2 Days)||2
10808420|NCT03870555|11970273|FG000|NOT COMPLETED|Period 3 (2 Days)||1
10808421|NCT03870555|11970274|FG001|NOT COMPLETED|Period 3 (2 Days)||0
10808422|NCT03870555|11970275|FG002|NOT COMPLETED|Period 3 (2 Days)||0
10808423|NCT03861845|11970289|FG000|STARTED|Overall Study||6
10808424|NCT03861845|11970290|FG001|STARTED|Overall Study||5
10808425|NCT03861845|11970291|FG002|STARTED|Overall Study||4
10808426|NCT03861845|11970289|FG000|COMPLETED|Overall Study||6
10808427|NCT03861845|11970290|FG001|COMPLETED|Overall Study||5
10808428|NCT03861845|11970291|FG002|COMPLETED|Overall Study||4
10808429|NCT03861845|11970289|FG000|NOT COMPLETED|Overall Study||0
10808430|NCT03861845|11970290|FG001|NOT COMPLETED|Overall Study||0
10808431|NCT03861845|11970291|FG002|NOT COMPLETED|Overall Study||0
10808432|NCT03851094|11970301|FG000|STARTED|Overall Study||111
10808433|NCT03851094|11970302|FG001|STARTED|Overall Study||55
10808434|NCT03851094|11970301|FG000|COMPLETED|Overall Study||111
10808435|NCT03851094|11970302|FG001|COMPLETED|Overall Study||51
10808436|NCT03851094|11970301|FG000|NOT COMPLETED|Overall Study||0
10808437|NCT03851094|11970302|FG001|NOT COMPLETED|Overall Study||4
10808447|NCT03868631|11970325|FG000|STARTED|Baseline to Week 6||30
10600620|NCT01836276|11757386|FG001|STARTED|Overall Study||225
10600621|NCT01836276|11757385|FG000|Week 4|Overall Study||198
10600622|NCT01836276|11757386|FG001|Week 4|Overall Study||186
10600623|NCT01836276|11757385|FG000|Week 12|Overall Study||183
10600624|NCT01836276|11757386|FG001|Week 12|Overall Study||165
10600625|NCT01836276|11757385|FG000|COMPLETED|Overall Study||196
10600626|NCT01836276|11757386|FG001|COMPLETED|Overall Study||174
10600627|NCT01836276|11757385|FG000|NOT COMPLETED|Overall Study||28
10600628|NCT01836276|11757386|FG001|NOT COMPLETED|Overall Study||51
10600659|NCT01836458|11757405|FG000|STARTED|Overall Study||7
10600660|NCT01836458|11757406|FG001|STARTED|Overall Study||4
10600661|NCT01836458|11757407|FG002|STARTED|Overall Study||7
10600662|NCT01836458|11757408|FG003|STARTED|Overall Study||7
10600663|NCT01836458|11757405|FG000|COMPLETED|Overall Study||4
10600664|NCT01836458|11757406|FG001|COMPLETED|Overall Study||2
10600665|NCT01836458|11757407|FG002|COMPLETED|Overall Study||2
10600666|NCT01836458|11757408|FG003|COMPLETED|Overall Study||1
10600667|NCT01836458|11757405|FG000|NOT COMPLETED|Overall Study||3
10600668|NCT01836458|11757406|FG001|NOT COMPLETED|Overall Study||2
10600669|NCT01836458|11757407|FG002|NOT COMPLETED|Overall Study||5
10808448|NCT03868631|11970326|FG001|STARTED|Baseline to Week 6||31
10808449|NCT03868631|11970325|FG000|COMPLETED|Baseline to Week 6||26
10808450|NCT03868631|11970326|FG001|COMPLETED|Baseline to Week 6||27
10808451|NCT03868631|11970325|FG000|NOT COMPLETED|Baseline to Week 6||4
10808452|NCT03868631|11970326|FG001|NOT COMPLETED|Baseline to Week 6||4
10808453|NCT03868631|11970325|FG000|STARTED|Week 6 to Week 12 (Study Completion)||26
10808454|NCT03868631|11970326|FG001|STARTED|Week 6 to Week 12 (Study Completion)||27
10808455|NCT03868631|11970325|FG000|COMPLETED|Week 6 to Week 12 (Study Completion)||22
10808456|NCT03868631|11970326|FG001|COMPLETED|Week 6 to Week 12 (Study Completion)||26
10808457|NCT03868631|11970325|FG000|NOT COMPLETED|Week 6 to Week 12 (Study Completion)||4
10808458|NCT03868631|11970326|FG001|NOT COMPLETED|Week 6 to Week 12 (Study Completion)||1
10808459|NCT03865953|11970334|FG000|STARTED|First Intervention (4 Weeks)||25
10808460|NCT03865953|11970335|FG001|STARTED|First Intervention (4 Weeks)||28
10808461|NCT03865953|11970334|FG000|COMPLETED|First Intervention (4 Weeks)||23
10808462|NCT03865953|11970335|FG001|COMPLETED|First Intervention (4 Weeks)||27
10808463|NCT03865953|11970334|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2
10808464|NCT03865953|11970335|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1
10808465|NCT03865953|11970334|FG000|STARTED|Washout/Baseline Period (3 Weeks)||23
10808466|NCT03865953|11970335|FG001|STARTED|Washout/Baseline Period (3 Weeks)||27
10808467|NCT03865953|11970334|FG000|COMPLETED|Washout/Baseline Period (3 Weeks)||23
10808468|NCT03865953|11970335|FG001|COMPLETED|Washout/Baseline Period (3 Weeks)||27
10808469|NCT03865953|11970334|FG000|NOT COMPLETED|Washout/Baseline Period (3 Weeks)||0
10808470|NCT03865953|11970335|FG001|NOT COMPLETED|Washout/Baseline Period (3 Weeks)||0
10808471|NCT03865953|11970334|FG000|STARTED|Second Intervention (4 Weeks)||23
10808472|NCT03865953|11970335|FG001|STARTED|Second Intervention (4 Weeks)||27
10808473|NCT03865953|11970334|FG000|COMPLETED|Second Intervention (4 Weeks)||23
10808474|NCT03865953|11970335|FG001|COMPLETED|Second Intervention (4 Weeks)||25
10808475|NCT03865953|11970334|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
10808476|NCT03865953|11970335|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||2
10808477|NCT03865381|11970341|FG000|STARTED|Overall Study||60
10808478|NCT03865381|11970341|FG000|COMPLETED|Overall Study||55
10808479|NCT03865381|11970341|FG000|NOT COMPLETED|Overall Study||5
10808480|NCT03865446|11970347|FG000|STARTED|Overall Study||8
10808481|NCT03865446|11970348|FG001|STARTED|Overall Study||8
10600670|NCT01836458|11757408|FG003|NOT COMPLETED|Overall Study||6
10600671|NCT01836471|11757423|FG000|STARTED|Overall Study||93
10600672|NCT01836471|11757424|FG001|STARTED|Overall Study||94
10600673|NCT01836471|11757425|FG002|STARTED|Overall Study||51
10600674|NCT01836471|11757426|FG003|STARTED|Overall Study||42
10600675|NCT01836471|11757427|FG004|STARTED|Overall Study||54
10600676|NCT01836471|11757423|FG000|COMPLETED|Overall Study||82
10600677|NCT01836471|11757424|FG001|COMPLETED|Overall Study||85
10703952|NCT02481310|11868469|FG000|Started Maintenance Treatment|Maintenance Treatment||1
10703953|NCT02481310|11868470|FG001|Started Maintenance Treatment|Maintenance Treatment||21
10703954|NCT02481310|11868471|FG002|Started Maintenance Treatment|Maintenance Treatment||1
10703955|NCT02481310|11868469|FG000|COMPLETED|Maintenance Treatment||1
10808482|NCT03865446|11970347|FG000|COMPLETED|Overall Study||8
10808483|NCT03865446|11970348|FG001|COMPLETED|Overall Study||8
10600678|NCT01836471|11757425|FG002|COMPLETED|Overall Study||49
10600679|NCT01836471|11757426|FG003|COMPLETED|Overall Study||40
10600680|NCT01836471|11757427|FG004|COMPLETED|Overall Study||49
10600681|NCT01836471|11757423|FG000|NOT COMPLETED|Overall Study||11
10600682|NCT01836471|11757424|FG001|NOT COMPLETED|Overall Study||9
10600683|NCT01836471|11757425|FG002|NOT COMPLETED|Overall Study||2
10600684|NCT01836471|11757426|FG003|NOT COMPLETED|Overall Study||2
10600685|NCT01836471|11757427|FG004|NOT COMPLETED|Overall Study||5
10600686|NCT01836523|11757444|FG000|STARTED|Overall Study||351
10600687|NCT01836523|11757445|FG001|STARTED|Overall Study||350
10600688|NCT01836523|11757446|FG002|STARTED|Overall Study||349
10600689|NCT01836523|11757447|FG003|STARTED|Overall Study||348
10600690|NCT01836523|11757444|FG000|Exposed|Overall Study||350
10703956|NCT02481310|11868470|FG001|COMPLETED|Maintenance Treatment||21
10703957|NCT02481310|11868471|FG002|COMPLETED|Maintenance Treatment||1
10703958|NCT02481310|11868469|FG000|NOT COMPLETED|Maintenance Treatment||0
10808484|NCT03865446|11970347|FG000|NOT COMPLETED|Overall Study||0
10808485|NCT03865446|11970348|FG001|NOT COMPLETED|Overall Study||0
10808486|NCT03862027|11970354|FG000|STARTED|Overall Study||1
10808487|NCT03862027|11970354|FG000|COMPLETED|Overall Study||1
10808488|NCT03862027|11970354|FG000|NOT COMPLETED|Overall Study||0
10808489|NCT03859960|11970360|FG000|STARTED|Overall Study||14
10808490|NCT03859960|11970361|FG001|STARTED|Overall Study||19
10808491|NCT03859960|11970360|FG000|COMPLETED|Overall Study||14
10808492|NCT03859960|11970361|FG001|COMPLETED|Overall Study||19
10808493|NCT03859960|11970360|FG000|NOT COMPLETED|Overall Study||0
10808494|NCT03859960|11970361|FG001|NOT COMPLETED|Overall Study||0
10808495|NCT03868059|11970369|FG000|STARTED|Overall Study||138
10808496|NCT03868059|11970369|FG000|COMPLETED|Overall Study||126
10808497|NCT03868059|11970369|FG000|NOT COMPLETED|Overall Study||12
10808498|NCT03868254|11970375|FG000|STARTED|Overall Study||98
10808499|NCT03868254|11970376|FG001|STARTED|Overall Study||76
10808500|NCT03868254|11970375|FG000|COMPLETED|Overall Study||98
10808501|NCT03868254|11970376|FG001|COMPLETED|Overall Study||76
10808502|NCT03868254|11970375|FG000|NOT COMPLETED|Overall Study||0
10808503|NCT03868254|11970376|FG001|NOT COMPLETED|Overall Study||0
10808504|NCT03865407|11970384|FG000|STARTED|Overall Study||10
10808505|NCT03865407|11970385|FG001|STARTED|Overall Study||7
10808506|NCT03865407|11970384|FG000|COMPLETED|Overall Study||7
10808507|NCT03865407|11970385|FG001|COMPLETED|Overall Study||7
10808508|NCT03865407|11970384|FG000|NOT COMPLETED|Overall Study||3
10808509|NCT03865407|11970385|FG001|NOT COMPLETED|Overall Study||0
10808510|NCT03857230|11970393|FG000|STARTED|Period 1 (Primapur-Gonal-F)||12
10808511|NCT03857230|11970394|FG001|STARTED|Period 1 (Primapur-Gonal-F)||12
10703959|NCT02481310|11868470|FG001|NOT COMPLETED|Maintenance Treatment||0
10703960|NCT02481310|11868471|FG002|NOT COMPLETED|Maintenance Treatment||0
10703961|NCT02481310|11868469|FG000|STARTED|Follow up||1
10703962|NCT02481310|11868470|FG001|STARTED|Follow up|2 patients died prior to entering follow up, 1 patient withdrew consent and 1 patient currently on treatment.|32
10703963|NCT02481310|11868471|FG002|STARTED|Follow up||1
10808512|NCT03857230|11970393|FG000|COMPLETED|Period 1 (Primapur-Gonal-F)||12
10600691|NCT01836523|11757445|FG001|Exposed|Overall Study||348
10600692|NCT01836523|11757446|FG002|Exposed|Overall Study||347
10600693|NCT01836523|11757447|FG003|Exposed|Overall Study||348
10600694|NCT01836523|11757444|FG000|COMPLETED|Overall Study||300
10600695|NCT01836523|11757445|FG001|COMPLETED|Overall Study||265
10600696|NCT01836523|11757446|FG002|COMPLETED|Overall Study||258
10703964|NCT02481310|11868469|FG000|COMPLETED|Follow up||1
10808513|NCT03857230|11970394|FG001|COMPLETED|Period 1 (Primapur-Gonal-F)||12
10808514|NCT03857230|11970393|FG000|NOT COMPLETED|Period 1 (Primapur-Gonal-F)||0
10808515|NCT03857230|11970394|FG001|NOT COMPLETED|Period 1 (Primapur-Gonal-F)||0
10600697|NCT01836523|11757447|FG003|COMPLETED|Overall Study||274
10600698|NCT01836523|11757444|FG000|NOT COMPLETED|Overall Study||51
10600699|NCT01836523|11757445|FG001|NOT COMPLETED|Overall Study||85
10600700|NCT01836523|11757446|FG002|NOT COMPLETED|Overall Study||91
10600701|NCT01836523|11757447|FG003|NOT COMPLETED|Overall Study||74
10600702|NCT01836549|11757463|FG000|STARTED|Overall Study||1
10600703|NCT01836549|11757464|FG001|STARTED|Overall Study||1
10600704|NCT01836549|11757465|FG002|STARTED|Overall Study||1
10600705|NCT01836549|11757466|FG003|STARTED|Overall Study||9
10600706|NCT01836549|11757467|FG004|STARTED|Overall Study||18
10600707|NCT01836549|11757468|FG005|STARTED|Overall Study||4
10600708|NCT01836549|11757469|FG006|STARTED|Overall Study||9
10600709|NCT01836549|11757463|FG000|COMPLETED|Overall Study||1
10600710|NCT01836549|11757464|FG001|COMPLETED|Overall Study||1
10600711|NCT01836549|11757465|FG002|COMPLETED|Overall Study||0
10600712|NCT01836549|11757466|FG003|COMPLETED|Overall Study||8
10600713|NCT01836549|11757467|FG004|COMPLETED|Overall Study||18
10600714|NCT01836549|11757468|FG005|COMPLETED|Overall Study||4
10600715|NCT01836549|11757469|FG006|COMPLETED|Overall Study||8
10600716|NCT01836549|11757463|FG000|NOT COMPLETED|Overall Study||0
10600717|NCT01836549|11757464|FG001|NOT COMPLETED|Overall Study||0
10600718|NCT01836549|11757465|FG002|NOT COMPLETED|Overall Study||1
10600719|NCT01836549|11757466|FG003|NOT COMPLETED|Overall Study||1
10600720|NCT01836549|11757467|FG004|NOT COMPLETED|Overall Study||0
10600721|NCT01836549|11757468|FG005|NOT COMPLETED|Overall Study||0
10333808|NCT00335764|11470033|FG001|STARTED|Overall Study||13
10333809|NCT00335764|11470034|FG002|STARTED|Overall Study||24
10600722|NCT01836549|11757469|FG006|NOT COMPLETED|Overall Study||1
10600723|NCT01837069|11757487|FG000|STARTED|Overall Study||103
10600724|NCT01837069|11757488|FG001|STARTED|Overall Study||95
10600725|NCT01837069|11757487|FG000|COMPLETED|Overall Study||103
10600726|NCT01837069|11757488|FG001|COMPLETED|Overall Study||95
10600727|NCT01837069|11757487|FG000|NOT COMPLETED|Overall Study||0
10600728|NCT01837069|11757488|FG001|NOT COMPLETED|Overall Study||0
10600729|NCT01837524|11757496|FG000|STARTED|Overall Study||28
10600730|NCT01837524|11757497|FG001|STARTED|Overall Study||27
10600731|NCT01837524|11757496|FG000|COMPLETED|Overall Study||25
10600732|NCT01837524|11757497|FG001|COMPLETED|Overall Study||25
10808516|NCT03857230|11970393|FG000|STARTED|Period 2 (Gonal-F-Primapur)||12
10808517|NCT03857230|11970394|FG001|STARTED|Period 2 (Gonal-F-Primapur)||12
10808518|NCT03857230|11970393|FG000|COMPLETED|Period 2 (Gonal-F-Primapur)||12
10808519|NCT03857230|11970394|FG001|COMPLETED|Period 2 (Gonal-F-Primapur)||12
10808520|NCT03857230|11970393|FG000|NOT COMPLETED|Period 2 (Gonal-F-Primapur)||0
10808521|NCT03857230|11970394|FG001|NOT COMPLETED|Period 2 (Gonal-F-Primapur)||0
10808522|NCT03865329|11970400|FG000|STARTED|Overall Study||9
10808523|NCT03865329|11970400|FG000|COMPLETED|Overall Study||9
10808524|NCT03865329|11970400|FG000|NOT COMPLETED|Overall Study||0
10808525|NCT03864653|11970404|FG000|STARTED|Overall Study||39
10808526|NCT03864653|11970404|FG000|COMPLETED|Overall Study||38
10808527|NCT03864653|11970404|FG000|NOT COMPLETED|Overall Study||1
10808528|NCT03862482|11970411|FG000|STARTED|Overall Study|Eight participants (forty implant units) were randomly allocated to Configuration 1 by study coordinator. Each participant was also randomly assigned one of the three implant units (B or SW or SC) on a rotating basis to one of five sites between mental foramen. As a result, an equal number of each implant unit type was placed at each the five sites|8
10808529|NCT03862482|11970412|FG001|STARTED|Overall Study|Eight participants (forty implant units) were randomly allocated to Configuration 2 by study coordinator. Each participant was also randomly assigned one of the three implant units (B or SW or SC) on a rotating basis to one of five sites between mental foramen. As a result, an equal number of each implant unit type was placed at each the five sites|8
10808530|NCT03862482|11970413|FG002|STARTED|Overall Study|Six participants (thirty implant units) were randomly allocated to Configuration 3 by study coordinator. Each participant was also randomly assigned one of the three implant units (B or SW or SC) on a rotating basis to one of five sites between mental foramen. As a result, an equal number of each implant unit type was placed at each the five sites|6
10808531|NCT03862482|11970411|FG000|COMPLETED|Overall Study|Sixteen B, 16 SW, and eight SC implant units were placed on a rotating basis at the five sites for a total of 40 implant units. Of these, one implant unit (SW) had fractured and was subsequently excluded from all future analyses|8
10808532|NCT03862482|11970412|FG001|COMPLETED|Overall Study|Eight B, 16 SW, and 16 SC implant units were placed on a rotating basis at the five sites for a total of 40 implant units. Of these, two implant units (one B, one SW) were removed from all future analyses due to technical issues with radiographs|8
10808533|NCT03862482|11970413|FG002|COMPLETED|Overall Study|Twelve B, six SW, and 12 SC implant units were placed on a rotating basis at the five sites for a total of 30 implant units|6
10808534|NCT03862482|11970411|FG000|NOT COMPLETED|Overall Study||0
10808535|NCT03862482|11970412|FG001|NOT COMPLETED|Overall Study||0
10808536|NCT03862482|11970413|FG002|NOT COMPLETED|Overall Study||0
10808537|NCT03853213|11970421|FG000|STARTED|Overall Study||11
10808538|NCT03853213|11970422|FG001|STARTED|Overall Study||9
10808539|NCT03853213|11970421|FG000|COMPLETED|Overall Study||10
10808540|NCT03853213|11970422|FG001|COMPLETED|Overall Study||7
10808541|NCT03853213|11970421|FG000|NOT COMPLETED|Overall Study||1
10808542|NCT03853213|11970422|FG001|NOT COMPLETED|Overall Study||2
10808543|NCT03847610|11970428|FG000|STARTED|Overall Study||11
10808544|NCT03847610|11970428|FG000|COMPLETED|Overall Study||10
10808545|NCT03847610|11970428|FG000|NOT COMPLETED|Overall Study||1
10600733|NCT01837524|11757496|FG000|NOT COMPLETED|Overall Study||3
10600734|NCT01837524|11757497|FG001|NOT COMPLETED|Overall Study||2
10600735|NCT01837537|11757503|FG000|STARTED|Overall Study||90
10333810|NCT00335764|11470035|FG003|STARTED|Overall Study||19
10600736|NCT01837537|11757503|FG000|COMPLETED|Overall Study||90
10600737|NCT01837537|11757503|FG000|NOT COMPLETED|Overall Study||0
10600738|NCT01837550|11757509|FG000|STARTED|T0-T1, 5 Weeks||37
10600739|NCT01837550|11757510|FG001|STARTED|T0-T1, 5 Weeks||37
10600740|NCT01837550|11757509|FG000|COMPLETED|T0-T1, 5 Weeks||37
10600741|NCT01837550|11757510|FG001|COMPLETED|T0-T1, 5 Weeks||37
10600742|NCT01837550|11757509|FG000|NOT COMPLETED|T0-T1, 5 Weeks||0
10600743|NCT01837550|11757510|FG001|NOT COMPLETED|T0-T1, 5 Weeks||0
10600744|NCT01837550|11757509|FG000|STARTED|T0-T2, 6 Months Follow-up||37
10600745|NCT01837550|11757510|FG001|STARTED|T0-T2, 6 Months Follow-up||37
10600746|NCT01837550|11757509|FG000|COMPLETED|T0-T2, 6 Months Follow-up||37
10600747|NCT01837550|11757510|FG001|COMPLETED|T0-T2, 6 Months Follow-up||37
10600748|NCT01837550|11757509|FG000|NOT COMPLETED|T0-T2, 6 Months Follow-up||0
10600749|NCT01837550|11757510|FG001|NOT COMPLETED|T0-T2, 6 Months Follow-up||0
10600750|NCT01837654|11757518|FG000|STARTED|Overall Study||11
10600751|NCT01837654|11757519|FG001|STARTED|Overall Study||11
10600752|NCT01837654|11757518|FG000|COMPLETED|Overall Study||11
10600753|NCT01837654|11757519|FG001|COMPLETED|Overall Study||11
10600754|NCT01837654|11757518|FG000|NOT COMPLETED|Overall Study||0
10600755|NCT01837654|11757519|FG001|NOT COMPLETED|Overall Study||0
10600756|NCT01837680|11757527|FG000|STARTED|Overall Study||52
10600757|NCT01837680|11757528|FG001|STARTED|Overall Study||53
10600758|NCT01837680|11757527|FG000|COMPLETED|Overall Study||42
10600759|NCT01837680|11757528|FG001|COMPLETED|Overall Study||45
10600760|NCT01837680|11757527|FG000|NOT COMPLETED|Overall Study||10
10600761|NCT01837680|11757528|FG001|NOT COMPLETED|Overall Study||8
10600762|NCT01837719|11757534|FG000|STARTED|Period 1: Days 1-7 (Treatment A or B)|Received treatment|64
10600763|NCT01837719|11757534|FG000|COMPLETED|Period 1: Days 1-7 (Treatment A or B)||64
10600764|NCT01837719|11757534|FG000|NOT COMPLETED|Period 1: Days 1-7 (Treatment A or B)||0
10600765|NCT01837719|11757534|FG000|STARTED|Period 2: Days 8-14 (Treatment B or A)||64
10600766|NCT01837719|11757534|FG000|COMPLETED|Period 2: Days 8-14 (Treatment B or A)||63
10600767|NCT01837719|11757534|FG000|NOT COMPLETED|Period 2: Days 8-14 (Treatment B or A)||1
10600768|NCT01837719|11757534|FG000|STARTED|Period 3: Days 15-21 (Treatment C or D)||63
10600769|NCT01837719|11757534|FG000|COMPLETED|Period 3: Days 15-21 (Treatment C or D)||63
10600770|NCT01837719|11757534|FG000|NOT COMPLETED|Period 3: Days 15-21 (Treatment C or D)||0
10600771|NCT01837719|11757534|FG000|STARTED|Period 4: Days 22-28 (Treatment D or C)||63
10600772|NCT01837719|11757534|FG000|COMPLETED|Period 4: Days 22-28 (Treatment D or C)|Number finishing period; 32 patients were discharged following Period 4, as per protocol|63
10808546|NCT03850093|11970435|FG000|STARTED|Overall Study||22
10808547|NCT03850093|11970436|FG001|STARTED|Overall Study||22
10808548|NCT03850093|11970437|FG002|STARTED|Overall Study||19
10808549|NCT03850093|11970435|FG000|COMPLETED|Overall Study||21
10808550|NCT03850093|11970436|FG001|COMPLETED|Overall Study||22
10808551|NCT03850093|11970437|FG002|COMPLETED|Overall Study||17
10808552|NCT03850093|11970435|FG000|NOT COMPLETED|Overall Study||1
10808553|NCT03850093|11970436|FG001|NOT COMPLETED|Overall Study||0
10808554|NCT03850093|11970437|FG002|NOT COMPLETED|Overall Study||2
10808555|NCT03848208|11970455|FG000|STARTED|Overall Study||18
10808556|NCT03848208|11970456|FG001|STARTED|Overall Study||6
10808557|NCT03848208|11970457|FG002|STARTED|Overall Study||6
10808558|NCT03848208|11970458|FG003|STARTED|Overall Study||6
10808559|NCT03848208|11970459|FG004|STARTED|Overall Study||6
10808560|NCT03848208|11970460|FG005|STARTED|Overall Study||6
10808561|NCT03848208|11970461|FG006|STARTED|Overall Study||6
10808562|NCT03848208|11970462|FG007|STARTED|Overall Study||6
10808563|NCT03848208|11970463|FG008|STARTED|Overall Study||6
10808564|NCT03848208|11970464|FG009|STARTED|Overall Study||6
10808565|NCT03848208|11970455|FG000|COMPLETED|Overall Study||18
10808566|NCT03848208|11970456|FG001|COMPLETED|Overall Study||6
10808567|NCT03848208|11970457|FG002|COMPLETED|Overall Study||6
10808568|NCT03848208|11970458|FG003|COMPLETED|Overall Study||6
10808569|NCT03848208|11970459|FG004|COMPLETED|Overall Study||6
10808570|NCT03848208|11970460|FG005|COMPLETED|Overall Study||6
10808571|NCT03848208|11970461|FG006|COMPLETED|Overall Study||6
10808572|NCT03848208|11970462|FG007|COMPLETED|Overall Study||6
10808573|NCT03848208|11970463|FG008|COMPLETED|Overall Study||6
10808574|NCT03848208|11970464|FG009|COMPLETED|Overall Study||6
10808575|NCT03848208|11970455|FG000|NOT COMPLETED|Overall Study||0
10808576|NCT03848208|11970456|FG001|NOT COMPLETED|Overall Study||0
10808577|NCT03848208|11970457|FG002|NOT COMPLETED|Overall Study||0
10808578|NCT03848208|11970458|FG003|NOT COMPLETED|Overall Study||0
10808579|NCT03848208|11970459|FG004|NOT COMPLETED|Overall Study||0
10808580|NCT03848208|11970460|FG005|NOT COMPLETED|Overall Study||0
10808581|NCT03848208|11970461|FG006|NOT COMPLETED|Overall Study||0
10600773|NCT01837719|11757534|FG000|NOT COMPLETED|Period 4: Days 22-28 (Treatment D or C)||0
10600774|NCT01837719|11757534|FG000|STARTED|Period 5: Days 29-31 (Treatment E)|Reflects the 31 patients remaining after 32 were discharged at the end of Period 4, as per protocol|31
10600775|NCT01837719|11757534|FG000|COMPLETED|Period 5: Days 29-31 (Treatment E)||30
10600776|NCT01837719|11757534|FG000|NOT COMPLETED|Period 5: Days 29-31 (Treatment E)||1
10600777|NCT01837797|11757552|FG000|STARTED|Period 1||129
10808582|NCT03848208|11970462|FG007|NOT COMPLETED|Overall Study||0
10808583|NCT03848208|11970463|FG008|NOT COMPLETED|Overall Study||0
10808584|NCT03848208|11970464|FG009|NOT COMPLETED|Overall Study||0
10808585|NCT03847389|11970498|FG000|STARTED|Overall Study||8
10808586|NCT03847389|11970499|FG001|STARTED|Overall Study|Start of Cohort 2 can only happen if less than or equal to 40% of subjects in Cohort 1 had HPA axis suppression.|0
10808587|NCT03847389|11970500|FG002|STARTED|Overall Study|Start of Cohort 3 can only happen if less than or equal to 40% of subjects in Cohort 2 had HPA axis suppression.|0
10808588|NCT03847389|11970498|FG000|COMPLETED|Overall Study||8
10600778|NCT01837797|11757553|FG001|STARTED|Period 1||0
10600779|NCT01837797|11757554|FG002|STARTED|Period 1||0
10600780|NCT01837797|11757555|FG003|STARTED|Period 1||0
10600781|NCT01837797|11757556|FG004|STARTED|Period 1||0
10600782|NCT01837797|11757552|FG000|COMPLETED|Period 1||27
10600783|NCT01837797|11757553|FG001|COMPLETED|Period 1||0
10600784|NCT01837797|11757554|FG002|COMPLETED|Period 1||0
10600785|NCT01837797|11757555|FG003|COMPLETED|Period 1||0
10600786|NCT01837797|11757556|FG004|COMPLETED|Period 1||0
10600787|NCT01837797|11757552|FG000|NOT COMPLETED|Period 1||102
10600788|NCT01837797|11757553|FG001|NOT COMPLETED|Period 1||0
10600789|NCT01837797|11757554|FG002|NOT COMPLETED|Period 1||0
10600790|NCT01837797|11757555|FG003|NOT COMPLETED|Period 1||0
10600791|NCT01837797|11757556|FG004|NOT COMPLETED|Period 1||0
10600792|NCT01837797|11757552|FG000|STARTED|Period 2||0
10600793|NCT01837797|11757553|FG001|STARTED|Period 2||6
10600794|NCT01837797|11757554|FG002|STARTED|Period 2||3
10600795|NCT01837797|11757555|FG003|STARTED|Period 2||6
10600796|NCT01837797|11757556|FG004|STARTED|Period 2||0
10600797|NCT01837797|11757552|FG000|COMPLETED|Period 2||0
10600798|NCT01837797|11757553|FG001|COMPLETED|Period 2||1
10600799|NCT01837797|11757554|FG002|COMPLETED|Period 2||1
10600800|NCT01837797|11757555|FG003|COMPLETED|Period 2||1
10600801|NCT01837797|11757556|FG004|COMPLETED|Period 2||0
10600802|NCT01837797|11757552|FG000|NOT COMPLETED|Period 2||0
10600803|NCT01837797|11757553|FG001|NOT COMPLETED|Period 2||5
10600804|NCT01837797|11757554|FG002|NOT COMPLETED|Period 2||2
10600805|NCT01837797|11757555|FG003|NOT COMPLETED|Period 2||5
10600806|NCT01837797|11757556|FG004|NOT COMPLETED|Period 2||0
10600807|NCT01837797|11757552|FG000|STARTED|Period 3||0
10600808|NCT01837797|11757553|FG001|STARTED|Period 3||0
10600809|NCT01837797|11757554|FG002|STARTED|Period 3||0
10600810|NCT01837797|11757555|FG003|STARTED|Period 3||0
10600811|NCT01837797|11757556|FG004|STARTED|Period 3||47
10600812|NCT01837797|11757552|FG000|COMPLETED|Period 3||0
10600813|NCT01837797|11757553|FG001|COMPLETED|Period 3||0
10600814|NCT01837797|11757554|FG002|COMPLETED|Period 3||0
10600815|NCT01837797|11757555|FG003|COMPLETED|Period 3||0
10600816|NCT01837797|11757556|FG004|COMPLETED|Period 3||24
10600817|NCT01837797|11757552|FG000|NOT COMPLETED|Period 3||0
10600818|NCT01837797|11757553|FG001|NOT COMPLETED|Period 3||0
10600819|NCT01837797|11757554|FG002|NOT COMPLETED|Period 3||0
10600820|NCT01837797|11757555|FG003|NOT COMPLETED|Period 3||0
10600821|NCT01837797|11757556|FG004|NOT COMPLETED|Period 3||23
10600822|NCT01837823|11757564|FG000|STARTED|Overall Study||91
10600823|NCT01837823|11757564|FG000|COMPLETED|Overall Study||85
10600824|NCT01837823|11757564|FG000|NOT COMPLETED|Overall Study||6
10600825|NCT01837901|11757575|FG000|STARTED|Overall Study||22
10600826|NCT01837901|11757576|FG001|STARTED|Overall Study||21
10600827|NCT01837901|11757577|FG002|STARTED|Overall Study||20
10600828|NCT01837901|11757575|FG000|COMPLETED|Overall Study||20
10600829|NCT01837901|11757576|FG001|COMPLETED|Overall Study||15
10600830|NCT01837901|11757577|FG002|COMPLETED|Overall Study||17
10600831|NCT01837901|11757575|FG000|NOT COMPLETED|Overall Study||2
10600832|NCT01837901|11757576|FG001|NOT COMPLETED|Overall Study||6
10600833|NCT01837901|11757577|FG002|NOT COMPLETED|Overall Study||3
10600834|NCT01837966|11757587|FG000|STARTED|Overall Study||47
10600835|NCT01837966|11757588|FG001|STARTED|Overall Study||46
10600836|NCT01837966|11757587|FG000|COMPLETED|Overall Study||45
10600837|NCT01837966|11757588|FG001|COMPLETED|Overall Study||45
10600838|NCT01837966|11757587|FG000|NOT COMPLETED|Overall Study||2
10600839|NCT01837966|11757588|FG001|NOT COMPLETED|Overall Study||1
10600840|NCT01838044|11757596|FG000|STARTED|Overall Study||89
10600841|NCT01838044|11757597|FG001|STARTED|Overall Study||91
10600842|NCT01838044|11757596|FG000|COMPLETED|Overall Study||81
10600843|NCT01838044|11757597|FG001|COMPLETED|Overall Study||75
10600844|NCT01838044|11757596|FG000|NOT COMPLETED|Overall Study||8
10600845|NCT01838044|11757597|FG001|NOT COMPLETED|Overall Study||16
10652421|NCT02185040|11812789|FG005|COMPLETED|Active Treatment Extension Phase||6
10652422|NCT02185040|11812790|FG006|COMPLETED|Active Treatment Extension Phase||1
10652423|NCT02185040|11812784|FG000|NOT COMPLETED|Active Treatment Extension Phase||0
10652424|NCT02185040|11812785|FG001|NOT COMPLETED|Active Treatment Extension Phase||0
10652425|NCT02185040|11812786|FG002|NOT COMPLETED|Active Treatment Extension Phase||0
10652426|NCT02185040|11812787|FG003|NOT COMPLETED|Active Treatment Extension Phase||0
10652427|NCT02185040|11812788|FG004|NOT COMPLETED|Active Treatment Extension Phase||0
10652428|NCT02185040|11812789|FG005|NOT COMPLETED|Active Treatment Extension Phase||3
10652429|NCT02185040|11812790|FG006|NOT COMPLETED|Active Treatment Extension Phase||7
10808589|NCT03847389|11970499|FG001|COMPLETED|Overall Study||0
10808590|NCT03847389|11970500|FG002|COMPLETED|Overall Study||0
10808591|NCT03847389|11970498|FG000|NOT COMPLETED|Overall Study||0
10808592|NCT03847389|11970499|FG001|NOT COMPLETED|Overall Study||0
10652430|NCT02185053|11812810|FG000|STARTED|Solifenacin Dose Escalation Phase||41
10652431|NCT02185053|11812811|FG001|STARTED|Solifenacin Dose Escalation Phase||0
10652432|NCT02185053|11812812|FG002|STARTED|Solifenacin Dose Escalation Phase||0
10652433|NCT02185053|11812810|FG000|COMPLETED|Solifenacin Dose Escalation Phase||38
10808593|NCT03847389|11970500|FG002|NOT COMPLETED|Overall Study||0
10652434|NCT02185053|11812811|FG001|COMPLETED|Solifenacin Dose Escalation Phase||0
10652435|NCT02185053|11812812|FG002|COMPLETED|Solifenacin Dose Escalation Phase||0
10808594|NCT03862040|11970511|FG000|STARTED|Overall Study||7
10652436|NCT02185053|11812810|FG000|NOT COMPLETED|Solifenacin Dose Escalation Phase||3
10652437|NCT02185053|11812811|FG001|NOT COMPLETED|Solifenacin Dose Escalation Phase||0
10652438|NCT02185053|11812812|FG002|NOT COMPLETED|Solifenacin Dose Escalation Phase||0
10600846|NCT01838200|11757606|FG000|STARTED|Overall Study||3
10600847|NCT01838200|11757607|FG001|STARTED|Overall Study||2
10600848|NCT01838200|11757606|FG000|COMPLETED|Overall Study||0
10600849|NCT01838200|11757607|FG001|COMPLETED|Overall Study||0
10600850|NCT01838200|11757606|FG000|NOT COMPLETED|Overall Study||3
10600851|NCT01838200|11757607|FG001|NOT COMPLETED|Overall Study||2
10600852|NCT01838213|11757615|FG000|STARTED|Overall Study||247
10600853|NCT01838213|11757616|FG001|STARTED|Overall Study||453
10600854|NCT01838213|11757615|FG000|COMPLETED|Overall Study||81
10600855|NCT01838213|11757616|FG001|COMPLETED|Overall Study||262
10600856|NCT01838213|11757615|FG000|NOT COMPLETED|Overall Study||166
10600857|NCT01838213|11757616|FG001|NOT COMPLETED|Overall Study||191
10600858|NCT01838226|11757624|FG000|STARTED|Overall Study||202
10600859|NCT01838226|11757625|FG001|STARTED|Overall Study||199
10600860|NCT01838226|11757624|FG000|COMPLETED|Overall Study||126
10600861|NCT01838226|11757625|FG001|COMPLETED|Overall Study||128
10600862|NCT01838226|11757624|FG000|NOT COMPLETED|Overall Study||76
10600863|NCT01838226|11757625|FG001|NOT COMPLETED|Overall Study||71
10808595|NCT03862040|11970511|FG000|COMPLETED|Overall Study||7
10808596|NCT03862040|11970511|FG000|NOT COMPLETED|Overall Study||0
10808597|NCT03861936|11970518|FG000|STARTED|Overall Study||48
10808598|NCT03861936|11970519|FG001|STARTED|Overall Study||53
10808599|NCT03861936|11970520|FG002|STARTED|Overall Study||49
10808600|NCT03861936|11970518|FG000|COMPLETED|Overall Study||34
10808601|NCT03861936|11970519|FG001|COMPLETED|Overall Study||43
10808602|NCT03861936|11970520|FG002|COMPLETED|Overall Study||39
10808603|NCT03861936|11970518|FG000|NOT COMPLETED|Overall Study||14
10808604|NCT03861936|11970519|FG001|NOT COMPLETED|Overall Study||10
10808605|NCT03861936|11970520|FG002|NOT COMPLETED|Overall Study||10
10808606|NCT03859739|11970532|FG000|STARTED|Overall Study||5
10808607|NCT03859739|11970533|FG001|STARTED|Overall Study||6
10808608|NCT03859739|11970534|FG002|STARTED|Overall Study||6
10808609|NCT03859739|11970535|FG003|STARTED|Overall Study||4
10808610|NCT03859739|11970532|FG000|COMPLETED|Overall Study||5
10808611|NCT03859739|11970533|FG001|COMPLETED|Overall Study||6
10808612|NCT03859739|11970534|FG002|COMPLETED|Overall Study||6
10808613|NCT03859739|11970535|FG003|COMPLETED|Overall Study||4
10808614|NCT03859739|11970532|FG000|NOT COMPLETED|Overall Study||0
10808615|NCT03859739|11970533|FG001|NOT COMPLETED|Overall Study||0
10808616|NCT03859739|11970534|FG002|NOT COMPLETED|Overall Study||0
10808617|NCT03859739|11970535|FG003|NOT COMPLETED|Overall Study||0
10808618|NCT03857750|11970547|FG000|STARTED|Overall Study||16
10808619|NCT03857750|11970548|FG001|STARTED|Overall Study||16
10808620|NCT03857750|11970547|FG000|COMPLETED|Overall Study||16
10808621|NCT03857750|11970548|FG001|COMPLETED|Overall Study||16
10808622|NCT03857750|11970547|FG000|NOT COMPLETED|Overall Study||0
10808623|NCT03857750|11970548|FG001|NOT COMPLETED|Overall Study||0
10808624|NCT03856255|11970554|FG000|STARTED|Overall Study||23
10808625|NCT03856255|11970554|FG000|COMPLETED|Overall Study||23
10808626|NCT03856255|11970554|FG000|NOT COMPLETED|Overall Study||0
10808627|NCT03850509|11970560|FG000|STARTED|Overall Study||2
10808628|NCT03850509|11970561|FG001|STARTED|Overall Study||1
10808629|NCT03850509|11970560|FG000|COMPLETED|Overall Study||0
10808630|NCT03850509|11970561|FG001|COMPLETED|Overall Study||0
10808631|NCT03850509|11970560|FG000|NOT COMPLETED|Overall Study||2
10808632|NCT03850509|11970561|FG001|NOT COMPLETED|Overall Study||1
10808633|NCT03860753|11970569|FG000|STARTED|Overall Study||4
10808634|NCT03860753|11970570|FG001|STARTED|Overall Study||0
10808635|NCT03860753|11970569|FG000|COMPLETED|Overall Study||4
10808636|NCT03860753|11970570|FG001|COMPLETED|Overall Study||0
10808637|NCT03860753|11970569|FG000|NOT COMPLETED|Overall Study||0
10808638|NCT03860753|11970570|FG001|NOT COMPLETED|Overall Study||0
10808639|NCT03848455|11970579|FG000|STARTED|Overall Study||90
10808640|NCT03848455|11970580|FG001|STARTED|Overall Study||125
10808641|NCT03848455|11970581|FG002|STARTED|Overall Study||23
10808642|NCT03848455|11970579|FG000|COMPLETED|Overall Study||90
10808643|NCT03848455|11970580|FG001|COMPLETED|Overall Study||125
10808644|NCT03848455|11970581|FG002|COMPLETED|Overall Study||23
10808645|NCT03848455|11970579|FG000|NOT COMPLETED|Overall Study||0
10808646|NCT03848455|11970580|FG001|NOT COMPLETED|Overall Study||0
10808647|NCT03848455|11970581|FG002|NOT COMPLETED|Overall Study||0
10808648|NCT03858894|11970592|FG000|STARTED|Overall Study||48
10808649|NCT03858894|11970593|FG001|STARTED|Overall Study||50
10808650|NCT03858894|11970592|FG000|COMPLETED|Overall Study||44
10808651|NCT03858894|11970593|FG001|COMPLETED|Overall Study||50
10808652|NCT03858894|11970592|FG000|NOT COMPLETED|Overall Study||4
10808653|NCT03858894|11970593|FG001|NOT COMPLETED|Overall Study||0
10808654|NCT03856164|11970601|FG000|STARTED|Overall Study||55
10808655|NCT03856164|11970602|FG001|STARTED|Overall Study||55
10808656|NCT03856164|11970601|FG000|COMPLETED|Overall Study||55
10808657|NCT03856164|11970602|FG001|COMPLETED|Overall Study||55
10808658|NCT03856164|11970601|FG000|NOT COMPLETED|Overall Study||0
10808659|NCT03856164|11970602|FG001|NOT COMPLETED|Overall Study||0
10808660|NCT03850275|11970616|FG000|STARTED|Overall Study||5
10808661|NCT03850275|11970617|FG001|STARTED|Overall Study||5
10808662|NCT03850275|11970618|FG002|STARTED|Overall Study||5
10808663|NCT03850275|11970619|FG003|STARTED|Overall Study||5
10808664|NCT03850275|11970620|FG004|STARTED|Overall Study||5
10808665|NCT03850275|11970621|FG005|STARTED|Overall Study||5
10808666|NCT03850275|11970616|FG000|COMPLETED|Overall Study||5
10600864|NCT01838304|11757633|FG000|STARTED|Overall Study||20
10600865|NCT01838304|11757634|FG001|STARTED|Overall Study||20
10600866|NCT01838304|11757633|FG000|COMPLETED|Overall Study||19
10808667|NCT03850275|11970617|FG001|COMPLETED|Overall Study||5
10600867|NCT01838304|11757634|FG001|COMPLETED|Overall Study||20
10600868|NCT01838304|11757633|FG000|NOT COMPLETED|Overall Study||1
10600869|NCT01838304|11757634|FG001|NOT COMPLETED|Overall Study||0
10600870|NCT01838317|11757642|FG000|STARTED|Overall Study||9
10600871|NCT01838317|11757643|FG001|STARTED|Overall Study||5
10600872|NCT01838317|11757642|FG000|COMPLETED|Overall Study||9
10600873|NCT01838317|11757643|FG001|COMPLETED|Overall Study||5
10600874|NCT01838317|11757642|FG000|NOT COMPLETED|Overall Study||0
10600875|NCT01838317|11757643|FG001|NOT COMPLETED|Overall Study||0
10600876|NCT01838447|11757651|FG000|STARTED|Overall Study||22
10600877|NCT01838447|11757652|FG001|STARTED|Overall Study||24
10600878|NCT01838447|11757651|FG000|COMPLETED|Overall Study||20
10808668|NCT03850275|11970618|FG002|COMPLETED|Overall Study||5
10808669|NCT03850275|11970619|FG003|COMPLETED|Overall Study||5
10808670|NCT03850275|11970620|FG004|COMPLETED|Overall Study||5
10808671|NCT03850275|11970621|FG005|COMPLETED|Overall Study||5
10808672|NCT03850275|11970616|FG000|NOT COMPLETED|Overall Study||0
10808673|NCT03850275|11970617|FG001|NOT COMPLETED|Overall Study||0
10808674|NCT03850275|11970618|FG002|NOT COMPLETED|Overall Study||0
10808675|NCT03850275|11970619|FG003|NOT COMPLETED|Overall Study||0
10808676|NCT03850275|11970620|FG004|NOT COMPLETED|Overall Study||0
10808677|NCT03850275|11970621|FG005|NOT COMPLETED|Overall Study||0
10808678|NCT03851016|11970646|FG000|STARTED|First Intervention (3 Weeks)||12
10808679|NCT03851016|11970647|FG001|STARTED|First Intervention (3 Weeks)||12
10808680|NCT03851016|11970646|FG000|COMPLETED|First Intervention (3 Weeks)||11
10808681|NCT03851016|11970647|FG001|COMPLETED|First Intervention (3 Weeks)||10
10808682|NCT03851016|11970646|FG000|NOT COMPLETED|First Intervention (3 Weeks)||1
10808683|NCT03851016|11970647|FG001|NOT COMPLETED|First Intervention (3 Weeks)||2
10600879|NCT01838447|11757652|FG001|COMPLETED|Overall Study||21
10600880|NCT01838447|11757651|FG000|NOT COMPLETED|Overall Study||2
10808684|NCT03851016|11970646|FG000|STARTED|Washout (1 Week)||11
10808685|NCT03851016|11970647|FG001|STARTED|Washout (1 Week)||10
10808686|NCT03851016|11970646|FG000|COMPLETED|Washout (1 Week)||11
10808687|NCT03851016|11970647|FG001|COMPLETED|Washout (1 Week)||10
10808688|NCT03851016|11970646|FG000|NOT COMPLETED|Washout (1 Week)||0
10808689|NCT03851016|11970647|FG001|NOT COMPLETED|Washout (1 Week)||0
10808690|NCT03851016|11970646|FG000|STARTED|Second Intervention (3 Weeks)||11
10808691|NCT03851016|11970647|FG001|STARTED|Second Intervention (3 Weeks)||10
10808692|NCT03851016|11970646|FG000|COMPLETED|Second Intervention (3 Weeks)||11
10600881|NCT01838447|11757652|FG001|NOT COMPLETED|Overall Study||3
10600882|NCT01838499|11757660|FG000|STARTED|Overall Study||55
10600883|NCT01838499|11757661|FG001|STARTED|Overall Study||54
10600884|NCT01838499|11757660|FG000|COMPLETED|Overall Study||31
10600885|NCT01838499|11757661|FG001|COMPLETED|Overall Study||37
10600886|NCT01838499|11757660|FG000|NOT COMPLETED|Overall Study||24
10600887|NCT01838499|11757661|FG001|NOT COMPLETED|Overall Study||17
10600888|NCT01838551|11757667|FG000|STARTED|Overall Study|94 subjects were enrolled and received at least 1 dose of levoketoconazole|94
10600889|NCT01838551|11757667|FG000|COMPLETED|Overall Study|46 subjects completed the Extended Evaluation phase|46
10600890|NCT01838551|11757667|FG000|NOT COMPLETED|Overall Study||48
10600891|NCT01838590|11757675|FG000|STARTED|Overall Study||52
10600892|NCT01838590|11757676|FG001|STARTED|Overall Study||51
10600893|NCT01838590|11757675|FG000|COMPLETED|Overall Study||40
10600894|NCT01838590|11757676|FG001|COMPLETED|Overall Study||46
10600895|NCT01838590|11757675|FG000|NOT COMPLETED|Overall Study||12
10600896|NCT01838590|11757676|FG001|NOT COMPLETED|Overall Study||5
10600897|NCT01838616|11757688|FG000|STARTED|Titration Period||130
10600898|NCT01838616|11757689|FG001|STARTED|Titration Period||128
10600899|NCT01838616|11757688|FG000|No Post Baseline Pain Intensity Values|Titration Period||0
10600900|NCT01838616|11757689|FG001|No Post Baseline Pain Intensity Values|Titration Period||2
10600901|NCT01838616|11757688|FG000|Major Protocol Deviations|Titration Period||13
10600902|NCT01838616|11757689|FG001|Major Protocol Deviations|Titration Period||16
10600903|NCT01838616|11757688|FG000|Switched to Pick-up Arm|Titration Period||0
10600904|NCT01838616|11757689|FG001|Switched to Pick-up Arm|Titration Period||43
10600905|NCT01838616|11757688|FG000|Full Analysis Set|Titration Period||130
10600906|NCT01838616|11757689|FG001|Full Analysis Set|Titration Period||128
10600907|NCT01838616|11757688|FG000|Per Protocol Set|Titration Period||117
10600908|NCT01838616|11757689|FG001|Per Protocol Set|Titration Period||112
10600909|NCT01838616|11757688|FG000|COMPLETED|Titration Period||100
10600910|NCT01838616|11757689|FG001|COMPLETED|Titration Period||62
10600911|NCT01838616|11757688|FG000|NOT COMPLETED|Titration Period||30
10600912|NCT01838616|11757689|FG001|NOT COMPLETED|Titration Period||66
10600913|NCT01838616|11757688|FG000|STARTED|Continuation Period||100
10600914|NCT01838616|11757689|FG001|STARTED|Continuation Period||62
10600915|NCT01838616|11757688|FG000|Switched to Pick-up Arm|Continuation Period||0
10600916|NCT01838616|11757689|FG001|Switched to Pick-up Arm|Continuation Period||7
10600917|NCT01838616|11757688|FG000|COMPLETED|Continuation Period||86
10600918|NCT01838616|11757689|FG001|COMPLETED|Continuation Period||48
10600919|NCT01838616|11757688|FG000|NOT COMPLETED|Continuation Period||14
10600920|NCT01838616|11757689|FG001|NOT COMPLETED|Continuation Period||14
10600921|NCT01838616|11757688|FG000|STARTED|Pick-up Arm|Switch to Tapentadol (PR) after Oxycodone/Naloxone (PR) treatment discontinuation.|50
10600922|NCT01838616|11757689|FG001|STARTED|Pick-up Arm||0
10600923|NCT01838616|11757688|FG000|Full Analysis Set|Pick-up Arm||49
10600924|NCT01838616|11757689|FG001|Full Analysis Set|Pick-up Arm||0
10600925|NCT01838616|11757688|FG000|COMPLETED|Pick-up Arm|Participants completed the tapentadol pick-up arm after initially on oxycodone/naloxone PR treatment|35
10600926|NCT01838616|11757689|FG001|COMPLETED|Pick-up Arm||0
10600927|NCT01838616|11757688|FG000|NOT COMPLETED|Pick-up Arm||15
10600928|NCT01838616|11757689|FG001|NOT COMPLETED|Pick-up Arm||0
10600929|NCT01838642|11757700|FG000|STARTED|Overall Study||3
10600930|NCT01838642|11757700|FG000|COMPLETED|Overall Study||2
10600931|NCT01838642|11757700|FG000|NOT COMPLETED|Overall Study||1
10600932|NCT01838655|11757705|FG000|STARTED|Overall Study||5
10600933|NCT01838655|11757705|FG000|COMPLETED|Overall Study||5
10600934|NCT01838655|11757705|FG000|NOT COMPLETED|Overall Study||0
10600935|NCT01838681|11757709|FG000|STARTED|Period A||1986
10600936|NCT01838681|11757710|FG001|STARTED|Period A||0
10600937|NCT01838681|11757711|FG002|STARTED|Period A||0
10600938|NCT01838681|11757712|FG003|STARTED|Period A||0
10600939|NCT01838681|11757709|FG000|COMPLETED|Period A||1661
10600940|NCT01838681|11757710|FG001|COMPLETED|Period A||0
10600941|NCT01838681|11757711|FG002|COMPLETED|Period A||0
10600942|NCT01838681|11757712|FG003|COMPLETED|Period A||0
10600943|NCT01838681|11757709|FG000|NOT COMPLETED|Period A||325
10600944|NCT01838681|11757710|FG001|NOT COMPLETED|Period A||0
10600945|NCT01838681|11757711|FG002|NOT COMPLETED|Period A||0
10600946|NCT01838681|11757712|FG003|NOT COMPLETED|Period A||0
10600947|NCT01838681|11757709|FG000|STARTED|Period B/A+||0
10600948|NCT01838681|11757710|FG001|STARTED|Period B/A+||442
10600949|NCT01838681|11757711|FG002|STARTED|Period B/A+||444
10600950|NCT01838681|11757712|FG003|STARTED|Period B/A+||770
10600951|NCT01838681|11757709|FG000|COMPLETED|Period B/A+||0
10600952|NCT01838681|11757710|FG001|COMPLETED|Period B/A+||380
10600953|NCT01838681|11757711|FG002|COMPLETED|Period B/A+||349
10600954|NCT01838681|11757712|FG003|COMPLETED|Period B/A+||653
10600955|NCT01838681|11757709|FG000|NOT COMPLETED|Period B/A+||0
10600956|NCT01838681|11757710|FG001|NOT COMPLETED|Period B/A+||62
10600957|NCT01838681|11757711|FG002|NOT COMPLETED|Period B/A+||95
10600958|NCT01838681|11757712|FG003|NOT COMPLETED|Period B/A+||117
10600959|NCT01838694|11757720|FG000|STARTED|Overall Study||8
10600960|NCT01838694|11757721|FG001|STARTED|Overall Study||22
10600961|NCT01838694|11757720|FG000|COMPLETED|Overall Study||8
10600962|NCT01838694|11757721|FG001|COMPLETED|Overall Study||21
10600963|NCT01838694|11757720|FG000|NOT COMPLETED|Overall Study||0
10600964|NCT01838694|11757721|FG001|NOT COMPLETED|Overall Study||1
10600965|NCT01838785|11757730|FG000|STARTED|Overall Study||25
10600966|NCT01838785|11757730|FG000|COMPLETED|Overall Study||25
10600967|NCT01838785|11757730|FG000|NOT COMPLETED|Overall Study||0
10600968|NCT01838863|11757736|FG000|STARTED|Overall Study||75
10600969|NCT01838863|11757737|FG001|STARTED|Overall Study||69
10600970|NCT01838863|11757736|FG000|COMPLETED|Overall Study||65
10600971|NCT01838863|11757737|FG001|COMPLETED|Overall Study||60
10600972|NCT01838863|11757736|FG000|NOT COMPLETED|Overall Study||10
10600973|NCT01838863|11757737|FG001|NOT COMPLETED|Overall Study||9
10600974|NCT01838876|11757743|FG000|STARTED|Overall Study||442
10600975|NCT01838876|11757743|FG000|Safety Population; Received Study Drug|Overall Study||345
10600976|NCT01838876|11757743|FG000|Entered Safety Follow-up Period|Overall Study||287
10600977|NCT01838876|11757743|FG000|COMPLETED|Overall Study||209
10600978|NCT01838876|11757743|FG000|NOT COMPLETED|Overall Study||233
10600979|NCT01838941|11757749|FG000|STARTED|Overall Study||12
10600980|NCT01838941|11757749|FG000|COMPLETED|Overall Study||10
10600981|NCT01838941|11757749|FG000|NOT COMPLETED|Overall Study||2
10600982|NCT01838980|11757754|FG000|STARTED|Overall Study||15
10600983|NCT01838980|11757754|FG000|COMPLETED|Overall Study||15
10600984|NCT01838980|11757754|FG000|NOT COMPLETED|Overall Study||0
10600985|NCT01839058|11757760|FG000|STARTED|Overall Study||21
10600986|NCT01839058|11757761|FG001|STARTED|Overall Study||19
10600987|NCT01839058|11757760|FG000|COMPLETED|Overall Study||17
10600988|NCT01839058|11757761|FG001|COMPLETED|Overall Study||16
10600989|NCT01839058|11757760|FG000|NOT COMPLETED|Overall Study||4
10600990|NCT01839058|11757761|FG001|NOT COMPLETED|Overall Study||3
10600991|NCT01839110|11757770|FG000|STARTED|Overall Study||7
10600992|NCT01839110|11757771|FG001|STARTED|Overall Study||6
10600993|NCT01839110|11757772|FG002|STARTED|Overall Study||9
10600994|NCT01839110|11757770|FG000|COMPLETED|Overall Study||4
10600995|NCT01839110|11757771|FG001|COMPLETED|Overall Study||4
10600996|NCT01839110|11757772|FG002|COMPLETED|Overall Study||6
10600997|NCT01839110|11757770|FG000|NOT COMPLETED|Overall Study||3
10600998|NCT01839110|11757771|FG001|NOT COMPLETED|Overall Study||2
10600999|NCT01839110|11757772|FG002|NOT COMPLETED|Overall Study||3
10601000|NCT01839188|11757780|FG000|STARTED|Overall Study||385
10601001|NCT01839188|11757780|FG000|Treated|Overall Study||385
10601002|NCT01839188|11757780|FG000|COMPLETED|Overall Study|N=1 treated participant withdrew before receiving V3|384
10601003|NCT01839188|11757780|FG000|NOT COMPLETED|Overall Study||1
10601004|NCT01839279|11757792|FG000|STARTED|Overall Study||72
10601005|NCT01839279|11757793|FG001|STARTED|Overall Study||32
10601006|NCT01839279|11757794|FG002|STARTED|Overall Study||32
10703965|NCT02481310|11868470|FG001|COMPLETED|Follow up||29
10703966|NCT02481310|11868471|FG002|COMPLETED|Follow up||1
10703967|NCT02481310|11868469|FG000|NOT COMPLETED|Follow up||0
10703968|NCT02481310|11868470|FG001|NOT COMPLETED|Follow up||3
10703969|NCT02481310|11868471|FG002|NOT COMPLETED|Follow up||0
10713729|NCT02681094|11879232|FG000|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||273
10713730|NCT02681094|11879233|FG001|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||276
10713731|NCT02681094|11879234|FG002|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||283
10713732|NCT02681094|11879232|FG000|COMPLETED|1 -Modified Enrolled Participants Set||256
10713733|NCT02681094|11879233|FG001|COMPLETED|1 -Modified Enrolled Participants Set||255
10713734|NCT02681094|11879234|FG002|COMPLETED|1 -Modified Enrolled Participants Set||243
10713735|NCT02681094|11879232|FG000|NOT COMPLETED|1 -Modified Enrolled Participants Set||37
10713736|NCT02681094|11879233|FG001|NOT COMPLETED|1 -Modified Enrolled Participants Set||39
10713737|NCT02681094|11879234|FG002|NOT COMPLETED|1 -Modified Enrolled Participants Set||53
10713738|NCT02681094|11879232|FG000|STARTED|2 - Enrolled Participants Set|Population was used for the sensitivity analysis to assess the robustness of the treatment effect.|301
10713739|NCT02681094|11879233|FG001|STARTED|2 - Enrolled Participants Set|Population was used for the sensitivity analysis to assess the robustness of the treatment effect.|302
10713740|NCT02681094|11879234|FG002|STARTED|2 - Enrolled Participants Set|Population was used for the sensitivity analysis to assess the robustness of the treatment effect.|302
10601007|NCT01839279|11757792|FG000|QT/QTc Analysis Set|Overall Study||72
10601008|NCT01839279|11757793|FG001|QT/QTc Analysis Set|Overall Study||32
10601009|NCT01839279|11757794|FG002|QT/QTc Analysis Set|Overall Study||32
10601010|NCT01839279|11757792|FG000|PK Analysis Set|Overall Study||70
10601011|NCT01839279|11757793|FG001|PK Analysis Set|Overall Study||0
10601012|NCT01839279|11757794|FG002|PK Analysis Set|Overall Study||0
10601013|NCT01839279|11757792|FG000|Moxifloxacin/Placebo Analysis Set|Overall Study||0
10601014|NCT01839279|11757793|FG001|Moxifloxacin/Placebo Analysis Set|Overall Study||31
10601015|NCT01839279|11757794|FG002|Moxifloxacin/Placebo Analysis Set|Overall Study||30
10601016|NCT01839279|11757792|FG000|PK/QTc Analysis Set|Overall Study||70
10601017|NCT01839279|11757793|FG001|PK/QTc Analysis Set|Overall Study||0
10601018|NCT01839279|11757794|FG002|PK/QTc Analysis Set|Overall Study||0
10601019|NCT01839279|11757792|FG000|COMPLETED|Overall Study||59
10601020|NCT01839279|11757793|FG001|COMPLETED|Overall Study||30
10601021|NCT01839279|11757794|FG002|COMPLETED|Overall Study||30
10601022|NCT01839279|11757792|FG000|NOT COMPLETED|Overall Study||13
10601023|NCT01839279|11757793|FG001|NOT COMPLETED|Overall Study||2
10601024|NCT01839279|11757794|FG002|NOT COMPLETED|Overall Study||2
10601025|NCT01839318|11757809|FG000|STARTED|Period 1, First Day of Wear||4
10601026|NCT01839318|11757810|FG001|STARTED|Period 1, First Day of Wear||4
10601027|NCT01839318|11757811|FG002|STARTED|Period 1, First Day of Wear||5
10601028|NCT01839318|11757812|FG003|STARTED|Period 1, First Day of Wear||6
10601029|NCT01839318|11757813|FG004|STARTED|Period 1, First Day of Wear||7
10601030|NCT01839318|11757814|FG005|STARTED|Period 1, First Day of Wear||2
10601031|NCT01839318|11757809|FG000|COMPLETED|Period 1, First Day of Wear||4
10601032|NCT01839318|11757810|FG001|COMPLETED|Period 1, First Day of Wear||4
10601033|NCT01839318|11757811|FG002|COMPLETED|Period 1, First Day of Wear||5
10601034|NCT01839318|11757812|FG003|COMPLETED|Period 1, First Day of Wear||6
10601035|NCT01839318|11757813|FG004|COMPLETED|Period 1, First Day of Wear||7
10601036|NCT01839318|11757814|FG005|COMPLETED|Period 1, First Day of Wear||2
10601037|NCT01839318|11757809|FG000|NOT COMPLETED|Period 1, First Day of Wear||0
10601038|NCT01839318|11757810|FG001|NOT COMPLETED|Period 1, First Day of Wear||0
10601039|NCT01839318|11757811|FG002|NOT COMPLETED|Period 1, First Day of Wear||0
10601040|NCT01839318|11757812|FG003|NOT COMPLETED|Period 1, First Day of Wear||0
10601041|NCT01839318|11757813|FG004|NOT COMPLETED|Period 1, First Day of Wear||0
10601042|NCT01839318|11757814|FG005|NOT COMPLETED|Period 1, First Day of Wear||0
10601043|NCT01839318|11757809|FG000|STARTED|Period 2, Second Day of Wear||4
10601044|NCT01839318|11757810|FG001|STARTED|Period 2, Second Day of Wear||4
10601045|NCT01839318|11757811|FG002|STARTED|Period 2, Second Day of Wear||5
10601046|NCT01839318|11757812|FG003|STARTED|Period 2, Second Day of Wear||6
10601047|NCT01839318|11757813|FG004|STARTED|Period 2, Second Day of Wear||7
10601048|NCT01839318|11757814|FG005|STARTED|Period 2, Second Day of Wear||2
10601049|NCT01839318|11757809|FG000|COMPLETED|Period 2, Second Day of Wear||4
10601050|NCT01839318|11757810|FG001|COMPLETED|Period 2, Second Day of Wear||4
10601051|NCT01839318|11757811|FG002|COMPLETED|Period 2, Second Day of Wear||5
10601052|NCT01839318|11757812|FG003|COMPLETED|Period 2, Second Day of Wear||6
10601053|NCT01839318|11757813|FG004|COMPLETED|Period 2, Second Day of Wear||7
10601054|NCT01839318|11757814|FG005|COMPLETED|Period 2, Second Day of Wear||2
10601055|NCT01839318|11757809|FG000|NOT COMPLETED|Period 2, Second Day of Wear||0
10601056|NCT01839318|11757810|FG001|NOT COMPLETED|Period 2, Second Day of Wear||0
10601057|NCT01839318|11757811|FG002|NOT COMPLETED|Period 2, Second Day of Wear||0
10601058|NCT01839318|11757812|FG003|NOT COMPLETED|Period 2, Second Day of Wear||0
10601059|NCT01839318|11757813|FG004|NOT COMPLETED|Period 2, Second Day of Wear||0
10601060|NCT01839318|11757814|FG005|NOT COMPLETED|Period 2, Second Day of Wear||0
10601061|NCT01839318|11757809|FG000|STARTED|Period 3, Third Day of Wear||4
10601062|NCT01839318|11757810|FG001|STARTED|Period 3, Third Day of Wear||4
10601063|NCT01839318|11757811|FG002|STARTED|Period 3, Third Day of Wear||5
10601064|NCT01839318|11757812|FG003|STARTED|Period 3, Third Day of Wear||6
10601065|NCT01839318|11757813|FG004|STARTED|Period 3, Third Day of Wear||7
10601066|NCT01839318|11757814|FG005|STARTED|Period 3, Third Day of Wear||2
10601067|NCT01839318|11757809|FG000|COMPLETED|Period 3, Third Day of Wear||4
10601068|NCT01839318|11757810|FG001|COMPLETED|Period 3, Third Day of Wear||4
10601069|NCT01839318|11757811|FG002|COMPLETED|Period 3, Third Day of Wear||5
10703970|NCT02343952|11868475|FG000|STARTED|Study Treatment||93
10703971|NCT02343952|11868475|FG000|COMPLETED|Study Treatment||40
10703972|NCT02343952|11868475|FG000|NOT COMPLETED|Study Treatment||53
10703973|NCT02343952|11868475|FG000|STARTED|Follow up||83
10703974|NCT02343952|11868475|FG000|COMPLETED|Follow up||38
10703975|NCT02343952|11868475|FG000|NOT COMPLETED|Follow up||45
10703976|NCT02326155|11868481|FG000|STARTED|Overall Study||407
10703977|NCT02326155|11868482|FG001|STARTED|Overall Study||63
10703978|NCT02326155|11868481|FG000|COMPLETED|Overall Study||13
10703979|NCT02326155|11868482|FG001|COMPLETED|Overall Study||1
10703980|NCT02326155|11868481|FG000|NOT COMPLETED|Overall Study||394
10601070|NCT01839318|11757812|FG003|COMPLETED|Period 3, Third Day of Wear||6
10601071|NCT01839318|11757813|FG004|COMPLETED|Period 3, Third Day of Wear||7
10601072|NCT01839318|11757814|FG005|COMPLETED|Period 3, Third Day of Wear||2
10703981|NCT02326155|11868482|FG001|NOT COMPLETED|Overall Study||62
10703982|NCT02304367|11868488|FG000|STARTED|Overall Study|14 participants with TIO; 1 participant with ENS; 2 participants with XLH|17
10601073|NCT01839318|11757809|FG000|NOT COMPLETED|Period 3, Third Day of Wear||0
10601074|NCT01839318|11757810|FG001|NOT COMPLETED|Period 3, Third Day of Wear||0
10601075|NCT01839318|11757811|FG002|NOT COMPLETED|Period 3, Third Day of Wear||0
10601076|NCT01839318|11757812|FG003|NOT COMPLETED|Period 3, Third Day of Wear||0
10601077|NCT01839318|11757813|FG004|NOT COMPLETED|Period 3, Third Day of Wear||0
10601078|NCT01839318|11757814|FG005|NOT COMPLETED|Period 3, Third Day of Wear||0
10601079|NCT01839487|11757824|FG000|STARTED|Run-in Phase (Maximum Exposure:295 Days)||16
10601080|NCT01839487|11757825|FG001|STARTED|Run-in Phase (Maximum Exposure:295 Days)||7
10601081|NCT01839487|11757826|FG002|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0
10601082|NCT01839487|11757827|FG003|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0
10601083|NCT01839487|11757828|FG004|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0
10601084|NCT01839487|11757829|FG005|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0
10601085|NCT01839487|11757824|FG000|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
10601086|NCT01839487|11757825|FG001|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
10601087|NCT01839487|11757826|FG002|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
10601088|NCT01839487|11757827|FG003|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
10601089|NCT01839487|11757828|FG004|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
10601090|NCT01839487|11757829|FG005|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
10601091|NCT01839487|11757824|FG000|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||16
10601092|NCT01839487|11757825|FG001|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||7
10601093|NCT01839487|11757826|FG002|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
10601094|NCT01839487|11757827|FG003|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
10601095|NCT01839487|11757828|FG004|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
10601096|NCT01839487|11757829|FG005|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
10601097|NCT01839487|11757824|FG000|STARTED|Phase 2 (Maximum Exposure:935 Days)||0
10601098|NCT01839487|11757825|FG001|STARTED|Phase 2 (Maximum Exposure:935 Days)||0
10601099|NCT01839487|11757826|FG002|STARTED|Phase 2 (Maximum Exposure:935 Days)||61
10601100|NCT01839487|11757827|FG003|STARTED|Phase 2 (Maximum Exposure:935 Days)||62
10601101|NCT01839487|11757828|FG004|STARTED|Phase 2 (Maximum Exposure:935 Days)||89
10601102|NCT01839487|11757829|FG005|STARTED|Phase 2 (Maximum Exposure:935 Days)||44
10601103|NCT01839487|11757824|FG000|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
10601104|NCT01839487|11757825|FG001|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
10601105|NCT01839487|11757826|FG002|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
10601106|NCT01839487|11757827|FG003|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
10601107|NCT01839487|11757828|FG004|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||1
10601108|NCT01839487|11757829|FG005|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
10601109|NCT01839487|11757824|FG000|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
10601110|NCT01839487|11757825|FG001|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
10601111|NCT01839487|11757826|FG002|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||61
10601112|NCT01839487|11757827|FG003|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||62
10601113|NCT01839487|11757828|FG004|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||88
10601114|NCT01839487|11757829|FG005|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||44
10601115|NCT01839604|11757842|FG000|STARTED|Overall Study||6
10601116|NCT01839604|11757843|FG001|STARTED|Overall Study||6
10601117|NCT01839604|11757844|FG002|STARTED|Overall Study||7
10601118|NCT01839604|11757845|FG003|STARTED|Overall Study||5
10703983|NCT02304367|11868488|FG000|Completed 48 Weeks of Study Drug|Overall Study||16
10703984|NCT02304367|11868488|FG000|Completed 144 Weeks of Study Drug|Overall Study||12
10601119|NCT01839604|11757846|FG004|STARTED|Overall Study||15
10601120|NCT01839604|11757842|FG000|COMPLETED|Overall Study||6
10601121|NCT01839604|11757843|FG001|COMPLETED|Overall Study||6
10601122|NCT01839604|11757844|FG002|COMPLETED|Overall Study||7
10601123|NCT01839604|11757845|FG003|COMPLETED|Overall Study||5
10601124|NCT01839604|11757846|FG004|COMPLETED|Overall Study||15
10601125|NCT01839604|11757842|FG000|NOT COMPLETED|Overall Study||0
10601126|NCT01839604|11757843|FG001|NOT COMPLETED|Overall Study||0
10601127|NCT01839604|11757844|FG002|NOT COMPLETED|Overall Study||0
10601128|NCT01839604|11757845|FG003|NOT COMPLETED|Overall Study||0
10601129|NCT01839604|11757846|FG004|NOT COMPLETED|Overall Study||0
10601130|NCT01839656|11757860|FG000|STARTED|Overall Study||5
10601131|NCT01839656|11757861|FG001|STARTED|Overall Study||16
10601132|NCT01839656|11757860|FG000|Completed Loading Dose Period|Overall Study||4
10601133|NCT01839656|11757861|FG001|Completed Loading Dose Period|Overall Study||15
10601134|NCT01839656|11757860|FG000|COMPLETED|Overall Study||2
10601135|NCT01839656|11757861|FG001|COMPLETED|Overall Study||0
10601136|NCT01839656|11757860|FG000|NOT COMPLETED|Overall Study||3
10601137|NCT01839656|11757861|FG001|NOT COMPLETED|Overall Study||16
10601138|NCT01839695|11757867|FG000|STARTED|Overall Study||9
10601139|NCT01839695|11757867|FG000|COMPLETED|Overall Study||9
10601140|NCT01839695|11757867|FG000|NOT COMPLETED|Overall Study||0
10601141|NCT01839708|11757873|FG000|STARTED|Overall Study||387
10601142|NCT01839708|11757874|FG001|STARTED|Overall Study||182
10601143|NCT01839708|11757873|FG000|COMPLETED|Overall Study||311
10601144|NCT01839708|11757874|FG001|COMPLETED|Overall Study||115
10601145|NCT01839708|11757873|FG000|NOT COMPLETED|Overall Study||76
10601146|NCT01839708|11757874|FG001|NOT COMPLETED|Overall Study||67
10601147|NCT01839799|11757882|FG000|STARTED|Overall Study||17
10601148|NCT01839799|11757883|FG001|STARTED|Overall Study||15
10601149|NCT01839799|11757882|FG000|COMPLETED|Overall Study||17
10601150|NCT01839799|11757883|FG001|COMPLETED|Overall Study||15
10601151|NCT01839799|11757882|FG000|NOT COMPLETED|Overall Study||0
10601152|NCT01839799|11757883|FG001|NOT COMPLETED|Overall Study||0
10601153|NCT01839916|11757889|FG000|STARTED|Overall Study||77
10601154|NCT01839916|11757889|FG000|COMPLETED|Overall Study||36
10601155|NCT01839916|11757889|FG000|NOT COMPLETED|Overall Study||41
10601156|NCT01840072|11757895|FG000|STARTED|Overall Study||2038
10601157|NCT01840072|11757896|FG001|STARTED|Overall Study||2033
10601158|NCT01840072|11757895|FG000|COMPLETED|Overall Study||2031
10601159|NCT01840072|11757896|FG001|COMPLETED|Overall Study||1986
10601160|NCT01840072|11757895|FG000|NOT COMPLETED|Overall Study||7
10601161|NCT01840072|11757896|FG001|NOT COMPLETED|Overall Study||47
10601162|NCT01840163|11757906|FG000|STARTED|First Follow up -Primary Outcome||267
10601163|NCT01840163|11757907|FG001|STARTED|First Follow up -Primary Outcome||270
10601164|NCT01840163|11757906|FG000|COMPLETED|First Follow up -Primary Outcome||248
10601165|NCT01840163|11757907|FG001|COMPLETED|First Follow up -Primary Outcome||254
10601166|NCT01840163|11757906|FG000|NOT COMPLETED|First Follow up -Primary Outcome||19
10601167|NCT01840163|11757907|FG001|NOT COMPLETED|First Follow up -Primary Outcome||16
10601168|NCT01840163|11757906|FG000|STARTED|Systemic Follow Up-secondary Outcome|From primary outcome to secondary outcome prd 1 participant withdrew and 1 became deceased|265
10601169|NCT01840163|11757907|FG001|STARTED|Systemic Follow Up-secondary Outcome|4 participants became unreachable and lost to follow up before sending 9 mo follow up|266
10601170|NCT01840163|11757906|FG000|COMPLETED|Systemic Follow Up-secondary Outcome||174
10601171|NCT01840163|11757907|FG001|COMPLETED|Systemic Follow Up-secondary Outcome||191
10601172|NCT01840163|11757906|FG000|NOT COMPLETED|Systemic Follow Up-secondary Outcome||91
10601173|NCT01840163|11757907|FG001|NOT COMPLETED|Systemic Follow Up-secondary Outcome||75
10601174|NCT01840228|11757915|FG000|STARTED|Overall Study||19
10601175|NCT01840228|11757916|FG001|STARTED|Overall Study||19
10601176|NCT01840228|11757915|FG000|COMPLETED|Overall Study||18
10601177|NCT01840228|11757916|FG001|COMPLETED|Overall Study||18
10601178|NCT01840228|11757915|FG000|NOT COMPLETED|Overall Study||1
10601179|NCT01840228|11757916|FG001|NOT COMPLETED|Overall Study||1
10601180|NCT01840319|11757926|FG000|STARTED|Overall Study||156
10601181|NCT01840319|11757926|FG000|COMPLETED|Overall Study||156
10601182|NCT01840319|11757926|FG000|NOT COMPLETED|Overall Study||0
10601183|NCT01840345|11757930|FG000|STARTED|Overall Study||11
10601184|NCT01840345|11757930|FG000|COMPLETED|Overall Study||10
10601185|NCT01840345|11757930|FG000|NOT COMPLETED|Overall Study||1
10601186|NCT01840410|11757936|FG000|STARTED|Overall Study||119
10601187|NCT01840410|11757937|FG001|STARTED|Overall Study||59
10601188|NCT01840410|11757936|FG000|Safety Set|Overall Study||119
10601189|NCT01840410|11757937|FG001|Safety Set|Overall Study|52 received ranibizumab at or after Month 2;7 did not receive ranibizumab any time during the study|59
10601190|NCT01840410|11757936|FG000|Full Analysis Set|Overall Study||119
10601191|NCT01840410|11757937|FG001|Full Analysis Set|Overall Study||59
10601192|NCT01840410|11757936|FG000|COMPLETED|Overall Study||112
10601193|NCT01840410|11757937|FG001|COMPLETED|Overall Study||55
10601194|NCT01840410|11757936|FG000|NOT COMPLETED|Overall Study||7
10601195|NCT01840410|11757937|FG001|NOT COMPLETED|Overall Study||4
10601196|NCT01840579|11757955|FG000|STARTED|Overall Study||3
10601197|NCT01840579|11757956|FG001|STARTED|Overall Study||7
10601198|NCT01840579|11757957|FG002|STARTED|Overall Study||6
10601199|NCT01840579|11757958|FG003|STARTED|Overall Study||6
10601200|NCT01840579|11757959|FG004|STARTED|Overall Study||8
10601201|NCT01840579|11757960|FG005|STARTED|Overall Study||6
10601202|NCT01840579|11757961|FG006|STARTED|Overall Study||6
10601203|NCT01840579|11757962|FG007|STARTED|Overall Study||6
10601204|NCT01840579|11757963|FG008|STARTED|Overall Study||6
10601205|NCT01840579|11757964|FG009|STARTED|Overall Study||3
10601206|NCT01840579|11757955|FG000|COMPLETED|Overall Study||0
10601207|NCT01840579|11757956|FG001|COMPLETED|Overall Study||0
10601208|NCT01840579|11757957|FG002|COMPLETED|Overall Study||4
10601209|NCT01840579|11757958|FG003|COMPLETED|Overall Study||3
10601210|NCT01840579|11757959|FG004|COMPLETED|Overall Study||4
10601211|NCT01840579|11757960|FG005|COMPLETED|Overall Study||2
10601212|NCT01840579|11757961|FG006|COMPLETED|Overall Study||4
10601213|NCT01840579|11757962|FG007|COMPLETED|Overall Study||3
10601214|NCT01840579|11757963|FG008|COMPLETED|Overall Study||3
10601215|NCT01840579|11757964|FG009|COMPLETED|Overall Study||0
10601216|NCT01840579|11757955|FG000|NOT COMPLETED|Overall Study||3
10601217|NCT01840579|11757956|FG001|NOT COMPLETED|Overall Study||7
10601218|NCT01840579|11757957|FG002|NOT COMPLETED|Overall Study||2
10601219|NCT01840579|11757958|FG003|NOT COMPLETED|Overall Study||3
10601220|NCT01840579|11757959|FG004|NOT COMPLETED|Overall Study||4
10601221|NCT01840579|11757960|FG005|NOT COMPLETED|Overall Study||4
10601222|NCT01840579|11757961|FG006|NOT COMPLETED|Overall Study||2
10601223|NCT01840579|11757962|FG007|NOT COMPLETED|Overall Study||3
10601224|NCT01840579|11757963|FG008|NOT COMPLETED|Overall Study||3
10601225|NCT01840579|11757964|FG009|NOT COMPLETED|Overall Study||3
10601226|NCT01840605|11758000|FG000|STARTED|Overall Study||151
10601227|NCT01840605|11758001|FG001|STARTED|Overall Study||152
10601228|NCT01840605|11758000|FG000|COMPLETED|Overall Study||149
10601229|NCT01840605|11758001|FG001|COMPLETED|Overall Study||150
10601230|NCT01840605|11758000|FG000|NOT COMPLETED|Overall Study||2
10601231|NCT01840605|11758001|FG001|NOT COMPLETED|Overall Study||2
10601232|NCT01840722|11758009|FG000|STARTED|Overall Study||201
10601233|NCT01840722|11758010|FG001|STARTED|Overall Study||199
10601234|NCT01840722|11758009|FG000|COMPLETED|Overall Study||201
10601235|NCT01840722|11758010|FG001|COMPLETED|Overall Study||130
10601236|NCT01840722|11758009|FG000|NOT COMPLETED|Overall Study||0
10601237|NCT01840722|11758010|FG001|NOT COMPLETED|Overall Study||69
10601238|NCT01840943|11758018|FG000|STARTED|Overall Study||14
10601239|NCT01840943|11758019|FG001|STARTED|Overall Study||12
10601240|NCT01840943|11758018|FG000|COMPLETED|Overall Study||1
10601241|NCT01840943|11758019|FG001|COMPLETED|Overall Study||0
10601242|NCT01840943|11758018|FG000|NOT COMPLETED|Overall Study||13
10601243|NCT01840943|11758019|FG001|NOT COMPLETED|Overall Study||12
10601244|NCT01841021|11758025|FG000|STARTED|Overall Study||1
10601245|NCT01841021|11758025|FG000|COMPLETED|Overall Study||1
10601246|NCT01841021|11758025|FG000|NOT COMPLETED|Overall Study||0
10601247|NCT01841047|11758029|FG000|STARTED|Overall Study||48
10601248|NCT01841047|11758029|FG000|COMPLETED|Overall Study||48
10601249|NCT01841047|11758029|FG000|NOT COMPLETED|Overall Study||0
10601250|NCT01841060|11758033|FG000|STARTED|Overall Study||42
10601251|NCT01841060|11758033|FG000|COMPLETED|Overall Study||32
10601252|NCT01841060|11758033|FG000|NOT COMPLETED|Overall Study||10
10601253|NCT01841073|11758039|FG000|STARTED|Overall Study||22
10601254|NCT01841073|11758040|FG001|STARTED|Overall Study||22
10601255|NCT01841073|11758039|FG000|COMPLETED|Overall Study||20
10601256|NCT01841073|11758040|FG001|COMPLETED|Overall Study||19
10601257|NCT01841073|11758039|FG000|NOT COMPLETED|Overall Study||2
10601258|NCT01841073|11758040|FG001|NOT COMPLETED|Overall Study||3
10601259|NCT01841216|11758050|FG000|STARTED|Overall Study||15
10601260|NCT01841216|11758051|FG001|STARTED|Overall Study||15
10601261|NCT01841216|11758050|FG000|COMPLETED|Overall Study||15
10601262|NCT01841216|11758051|FG001|COMPLETED|Overall Study||15
10601263|NCT01841216|11758050|FG000|NOT COMPLETED|Overall Study||0
10601264|NCT01841216|11758051|FG001|NOT COMPLETED|Overall Study||0
10601265|NCT01841281|11758059|FG000|STARTED|First Intervention (12 Weeks)||11
10601266|NCT01841281|11758060|FG001|STARTED|First Intervention (12 Weeks)||12
10601267|NCT01841281|11758061|FG002|STARTED|First Intervention (12 Weeks)||13
10601268|NCT01841281|11758062|FG003|STARTED|First Intervention (12 Weeks)||14
10601269|NCT01841281|11758059|FG000|COMPLETED|First Intervention (12 Weeks)||11
10601270|NCT01841281|11758060|FG001|COMPLETED|First Intervention (12 Weeks)||12
10601271|NCT01841281|11758061|FG002|COMPLETED|First Intervention (12 Weeks)||13
10601272|NCT01841281|11758062|FG003|COMPLETED|First Intervention (12 Weeks)||14
10601273|NCT01841281|11758059|FG000|NOT COMPLETED|First Intervention (12 Weeks)||0
10601274|NCT01841281|11758060|FG001|NOT COMPLETED|First Intervention (12 Weeks)||0
10601275|NCT01841281|11758061|FG002|NOT COMPLETED|First Intervention (12 Weeks)||0
10601276|NCT01841281|11758062|FG003|NOT COMPLETED|First Intervention (12 Weeks)||0
10601277|NCT01841281|11758059|FG000|STARTED|Washout (6 Weeks)||11
10601278|NCT01841281|11758060|FG001|STARTED|Washout (6 Weeks)||12
10601279|NCT01841281|11758061|FG002|STARTED|Washout (6 Weeks)||13
10601280|NCT01841281|11758062|FG003|STARTED|Washout (6 Weeks)||14
10601281|NCT01841281|11758059|FG000|COMPLETED|Washout (6 Weeks)||9
10601282|NCT01841281|11758060|FG001|COMPLETED|Washout (6 Weeks)||9
10601283|NCT01841281|11758061|FG002|COMPLETED|Washout (6 Weeks)||10
10601284|NCT01841281|11758062|FG003|COMPLETED|Washout (6 Weeks)||13
10601285|NCT01841281|11758059|FG000|NOT COMPLETED|Washout (6 Weeks)||2
10601286|NCT01841281|11758060|FG001|NOT COMPLETED|Washout (6 Weeks)||3
10601287|NCT01841281|11758061|FG002|NOT COMPLETED|Washout (6 Weeks)||3
10601288|NCT01841281|11758062|FG003|NOT COMPLETED|Washout (6 Weeks)||1
10601289|NCT01841281|11758059|FG000|STARTED|Second Intervention (12 Weeks)||9
10601290|NCT01841281|11758060|FG001|STARTED|Second Intervention (12 Weeks)||9
10601291|NCT01841281|11758061|FG002|STARTED|Second Intervention (12 Weeks)||10
10601292|NCT01841281|11758062|FG003|STARTED|Second Intervention (12 Weeks)||13
10601293|NCT01841281|11758059|FG000|COMPLETED|Second Intervention (12 Weeks)||9
10601294|NCT01841281|11758060|FG001|COMPLETED|Second Intervention (12 Weeks)||6
10601295|NCT01841281|11758061|FG002|COMPLETED|Second Intervention (12 Weeks)||10
10601296|NCT01841281|11758062|FG003|COMPLETED|Second Intervention (12 Weeks)||13
10601297|NCT01841281|11758059|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0
10601298|NCT01841281|11758060|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||3
10601299|NCT01841281|11758061|FG002|NOT COMPLETED|Second Intervention (12 Weeks)||0
10601300|NCT01841281|11758062|FG003|NOT COMPLETED|Second Intervention (12 Weeks)||0
10601301|NCT01841554|11758078|FG000|STARTED|Overall Study||61
10601302|NCT01841554|11758078|FG000|Implanted|Overall Study||60
10601303|NCT01841554|11758078|FG000|1 Year Follow Up|Overall Study||42
10703985|NCT02304367|11868488|FG000|COMPLETED|Overall Study||9
10601304|NCT01841554|11758078|FG000|COMPLETED|Overall Study||42
10601305|NCT01841554|11758078|FG000|NOT COMPLETED|Overall Study||19
10601306|NCT01841567|11758082|FG000|STARTED|Overall Study||60
10601307|NCT01841567|11758082|FG000|COMPLETED|Overall Study||57
10601308|NCT01841567|11758082|FG000|NOT COMPLETED|Overall Study||3
10601309|NCT01841593|11758088|FG000|STARTED|First Intervention (Days 1 to 7)||12
10601310|NCT01841593|11758089|FG001|STARTED|First Intervention (Days 1 to 7)||7
10601311|NCT01841593|11758088|FG000|COMPLETED|First Intervention (Days 1 to 7)||12
10601312|NCT01841593|11758089|FG001|COMPLETED|First Intervention (Days 1 to 7)||6
10601313|NCT01841593|11758088|FG000|NOT COMPLETED|First Intervention (Days 1 to 7)||0
10601314|NCT01841593|11758089|FG001|NOT COMPLETED|First Intervention (Days 1 to 7)||1
10601315|NCT01841593|11758088|FG000|STARTED|Second Intervention (Days 8 to 14)||12
10601316|NCT01841593|11758089|FG001|STARTED|Second Intervention (Days 8 to 14)||6
10601317|NCT01841593|11758088|FG000|COMPLETED|Second Intervention (Days 8 to 14)||11
10601318|NCT01841593|11758089|FG001|COMPLETED|Second Intervention (Days 8 to 14)||6
10601319|NCT01841593|11758088|FG000|NOT COMPLETED|Second Intervention (Days 8 to 14)||1
10601320|NCT01841593|11758089|FG001|NOT COMPLETED|Second Intervention (Days 8 to 14)||0
10601321|NCT01841593|11758088|FG000|STARTED|Third Intervention (Days 15 to 21)||11
10601322|NCT01841593|11758089|FG001|STARTED|Third Intervention (Days 15 to 21)||6
10601323|NCT01841593|11758088|FG000|COMPLETED|Third Intervention (Days 15 to 21)||11
10601324|NCT01841593|11758089|FG001|COMPLETED|Third Intervention (Days 15 to 21)||6
10601325|NCT01841593|11758088|FG000|NOT COMPLETED|Third Intervention (Days 15 to 21)||0
10601326|NCT01841593|11758089|FG001|NOT COMPLETED|Third Intervention (Days 15 to 21)||0
10601327|NCT01841606|11758101|FG000|STARTED|Overall Study||25
10601328|NCT01841606|11758102|FG001|STARTED|Overall Study||27
10601329|NCT01841606|11758101|FG000|COMPLETED|Overall Study||25
10601330|NCT01841606|11758102|FG001|COMPLETED|Overall Study||27
10601331|NCT01841606|11758101|FG000|NOT COMPLETED|Overall Study||0
10601332|NCT01841606|11758102|FG001|NOT COMPLETED|Overall Study||0
10601333|NCT01841619|11758108|FG000|STARTED|Overall Study||16
10601334|NCT01841619|11758108|FG000|COMPLETED|Overall Study||16
10601335|NCT01841619|11758108|FG000|NOT COMPLETED|Overall Study||0
10601336|NCT01841632|11758112|FG000|STARTED|Overall Study||3
10703986|NCT02304367|11868488|FG000|NOT COMPLETED|Overall Study||8
10601337|NCT01841632|11758112|FG000|COMPLETED|Overall Study||3
10601338|NCT01841632|11758112|FG000|NOT COMPLETED|Overall Study||0
10601339|NCT01841697|11758118|FG000|STARTED|Overall Study||322
10601340|NCT01841697|11758119|FG001|STARTED|Overall Study||320
10601341|NCT01841697|11758118|FG000|COMPLETED|Overall Study||302
10601342|NCT01841697|11758119|FG001|COMPLETED|Overall Study||302
10601343|NCT01841697|11758118|FG000|NOT COMPLETED|Overall Study||20
10601344|NCT01841697|11758119|FG001|NOT COMPLETED|Overall Study||18
10601345|NCT01841762|11758125|FG000|STARTED|Screening Period||335
10601346|NCT01841762|11758125|FG000|COMPLETED|Screening Period||284
10601347|NCT01841762|11758125|FG000|NOT COMPLETED|Screening Period||51
10601348|NCT01841762|11758125|FG000|STARTED|Treatment Period||284
10601349|NCT01841762|11758125|FG000|COMPLETED|Treatment Period||252
10601350|NCT01841762|11758125|FG000|NOT COMPLETED|Treatment Period||32
10601351|NCT01841762|11758125|FG000|STARTED|Post-Treatment Safety Follow-Up Period||284
10601352|NCT01841762|11758125|FG000|COMPLETED|Post-Treatment Safety Follow-Up Period||269
10601353|NCT01841762|11758125|FG000|NOT COMPLETED|Post-Treatment Safety Follow-Up Period||15
10601354|NCT01841970|11758129|FG000|STARTED|Overall Study||20
10601355|NCT01841970|11758129|FG000|COMPLETED|Overall Study||9
10601356|NCT01841970|11758129|FG000|NOT COMPLETED|Overall Study||11
10601357|NCT01842061|11758138|FG000|STARTED|Overall Study||13
10601358|NCT01842061|11758139|FG001|STARTED|Overall Study||12
10601359|NCT01842061|11758138|FG000|COMPLETED|Overall Study||12
10601360|NCT01842061|11758139|FG001|COMPLETED|Overall Study||8
10601361|NCT01842061|11758138|FG000|NOT COMPLETED|Overall Study||1
10601362|NCT01842061|11758139|FG001|NOT COMPLETED|Overall Study||4
10601363|NCT01842308|11758150|FG000|STARTED|Overall Study||6
10601364|NCT01842308|11758151|FG001|STARTED|Overall Study||3
10601365|NCT01842308|11758152|FG002|STARTED|Overall Study||3
10601366|NCT01842308|11758153|FG003|STARTED|Overall Study||2
10601367|NCT01842308|11758154|FG004|STARTED|Overall Study||36
10601368|NCT01842308|11758150|FG000|COMPLETED|Overall Study||6
10601369|NCT01842308|11758151|FG001|COMPLETED|Overall Study||3
10601370|NCT01842308|11758152|FG002|COMPLETED|Overall Study||3
10601371|NCT01842308|11758153|FG003|COMPLETED|Overall Study||2
10601372|NCT01842308|11758154|FG004|COMPLETED|Overall Study||35
10601373|NCT01842308|11758150|FG000|NOT COMPLETED|Overall Study||0
10601374|NCT01842308|11758151|FG001|NOT COMPLETED|Overall Study||0
10601375|NCT01842308|11758152|FG002|NOT COMPLETED|Overall Study||0
10601376|NCT01842308|11758153|FG003|NOT COMPLETED|Overall Study||0
10601377|NCT01842308|11758154|FG004|NOT COMPLETED|Overall Study||1
10601378|NCT01842334|11758169|FG000|STARTED|Overall Study||5
10601379|NCT01842334|11758170|FG001|STARTED|Overall Study||7
10601380|NCT01842334|11758169|FG000|COMPLETED|Overall Study||2
10601381|NCT01842334|11758170|FG001|COMPLETED|Overall Study||3
10601382|NCT01842334|11758169|FG000|NOT COMPLETED|Overall Study||3
10601383|NCT01842334|11758170|FG001|NOT COMPLETED|Overall Study||4
10601384|NCT01842438|11758178|FG000|STARTED|T1: Immediately After the Intervention||42
10601385|NCT01842438|11758179|FG001|STARTED|T1: Immediately After the Intervention||44
10601386|NCT01842438|11758178|FG000|COMPLETED|T1: Immediately After the Intervention||36
10601387|NCT01842438|11758179|FG001|COMPLETED|T1: Immediately After the Intervention||36
10601388|NCT01842438|11758178|FG000|NOT COMPLETED|T1: Immediately After the Intervention||6
10601389|NCT01842438|11758179|FG001|NOT COMPLETED|T1: Immediately After the Intervention||8
10601390|NCT01842438|11758178|FG000|STARTED|T2: 6month Follow-up||36
10601391|NCT01842438|11758179|FG001|STARTED|T2: 6month Follow-up||36
10601392|NCT01842438|11758178|FG000|COMPLETED|T2: 6month Follow-up||32
10601393|NCT01842438|11758179|FG001|COMPLETED|T2: 6month Follow-up||32
10601394|NCT01842438|11758178|FG000|NOT COMPLETED|T2: 6month Follow-up||4
10601395|NCT01842438|11758179|FG001|NOT COMPLETED|T2: 6month Follow-up||4
10601396|NCT01842464|11758189|FG000|STARTED|Overall Study||44
10601397|NCT01842464|11758189|FG000|COMPLETED|Overall Study||44
10601398|NCT01842464|11758189|FG000|NOT COMPLETED|Overall Study||0
10601399|NCT01842581|11758196|FG000|STARTED|Overall Study||113
10601400|NCT01842581|11758197|FG001|STARTED|Overall Study||109
10601401|NCT01842581|11758196|FG000|Received at Least 1 Dose of Study Drug|Overall Study||113
10601402|NCT01842581|11758197|FG001|Received at Least 1 Dose of Study Drug|Overall Study||108
10601403|NCT01842581|11758196|FG000|COMPLETED|Overall Study||69
10601404|NCT01842581|11758197|FG001|COMPLETED|Overall Study||79
10601405|NCT01842581|11758196|FG000|NOT COMPLETED|Overall Study||44
10601406|NCT01842581|11758197|FG001|NOT COMPLETED|Overall Study||30
10601407|NCT01842594|11758203|FG000|STARTED|Overall Study||13
10601408|NCT01842594|11758203|FG000|COMPLETED|Overall Study||10
10601409|NCT01842594|11758203|FG000|NOT COMPLETED|Overall Study||3
10601410|NCT01842607|11758207|FG000|STARTED|Overall Study||651
10601411|NCT01842607|11758207|FG000|COMPLETED|Overall Study||585
10601412|NCT01842607|11758207|FG000|NOT COMPLETED|Overall Study||66
10601413|NCT01842620|11758211|FG000|STARTED|Period 1||13
10601414|NCT01842620|11758212|FG001|STARTED|Period 1||12
10601415|NCT01842620|11758211|FG000|COMPLETED|Period 1||12
10601416|NCT01842620|11758212|FG001|COMPLETED|Period 1||12
10601417|NCT01842620|11758211|FG000|NOT COMPLETED|Period 1||1
10601418|NCT01842620|11758212|FG001|NOT COMPLETED|Period 1||0
10601419|NCT01842620|11758211|FG000|STARTED|Washout Period||12
10601420|NCT01842620|11758212|FG001|STARTED|Washout Period||12
10601421|NCT01842620|11758211|FG000|COMPLETED|Washout Period||12
10601422|NCT01842620|11758212|FG001|COMPLETED|Washout Period||12
10601423|NCT01842620|11758211|FG000|NOT COMPLETED|Washout Period||0
10601424|NCT01842620|11758212|FG001|NOT COMPLETED|Washout Period||0
10601425|NCT01842620|11758211|FG000|STARTED|Period 2||12
10601426|NCT01842620|11758212|FG001|STARTED|Period 2||12
10601427|NCT01842620|11758211|FG000|COMPLETED|Period 2||12
10601428|NCT01842620|11758212|FG001|COMPLETED|Period 2||12
10601429|NCT01842620|11758211|FG000|NOT COMPLETED|Period 2||0
10601430|NCT01842620|11758212|FG001|NOT COMPLETED|Period 2||0
10703987|NCT01810705|11868501|FG000|STARTED|Overall Study||83
10703988|NCT01810705|11868502|FG001|STARTED|Overall Study||40
10703989|NCT01810705|11868501|FG000|COMPLETED|Overall Study||10
10703990|NCT01810705|11868502|FG001|COMPLETED|Overall Study||5
10703991|NCT01810705|11868501|FG000|NOT COMPLETED|Overall Study||73
10703992|NCT01810705|11868502|FG001|NOT COMPLETED|Overall Study||35
10703993|NCT02588261|11868510|FG000|STARTED|Overall Study||267
10703994|NCT02588261|11868511|FG001|STARTED|Overall Study||263
10601431|NCT01842633|11758221|FG000|STARTED|Overall Study||65
10601432|NCT01842633|11758222|FG001|STARTED|Overall Study||66
10601433|NCT01842633|11758223|FG002|STARTED|Overall Study||34
10601434|NCT01842633|11758221|FG000|COMPLETED|Overall Study||62
10601435|NCT01842633|11758222|FG001|COMPLETED|Overall Study||64
10601436|NCT01842633|11758223|FG002|COMPLETED|Overall Study||34
10601437|NCT01842633|11758221|FG000|NOT COMPLETED|Overall Study||3
10601438|NCT01842633|11758222|FG001|NOT COMPLETED|Overall Study||2
10601439|NCT01842633|11758223|FG002|NOT COMPLETED|Overall Study||0
10601440|NCT01842646|11758233|FG000|STARTED|Overall Study||35
10601441|NCT01842646|11758233|FG000|COMPLETED|Overall Study||35
10601442|NCT01842646|11758233|FG000|NOT COMPLETED|Overall Study||0
10601443|NCT01842789|11758239|FG000|STARTED|Overall Study||10
10601444|NCT01842789|11758240|FG001|STARTED|Overall Study||8
10601445|NCT01842789|11758239|FG000|COMPLETED|Overall Study||10
10601446|NCT01842789|11758240|FG001|COMPLETED|Overall Study||8
10601447|NCT01842789|11758239|FG000|NOT COMPLETED|Overall Study||0
10601448|NCT01842789|11758240|FG001|NOT COMPLETED|Overall Study||0
10601449|NCT01842815|11758247|FG000|STARTED|Overall Study||20
10601450|NCT01842815|11758247|FG000|COMPLETED|Overall Study||16
10601451|NCT01842815|11758247|FG000|NOT COMPLETED|Overall Study||4
10601452|NCT01842841|11758252|FG000|STARTED|Overall Study||5
10601453|NCT01842841|11758252|FG000|COMPLETED|Overall Study||5
10601454|NCT01842841|11758252|FG000|NOT COMPLETED|Overall Study||0
10601455|NCT01842906|11758258|FG000|STARTED|Overall Study||115
10601456|NCT01842906|11758259|FG001|STARTED|Overall Study||104
10601457|NCT01842906|11758258|FG000|COMPLETED|Overall Study||115
10601458|NCT01842906|11758259|FG001|COMPLETED|Overall Study||104
10601459|NCT01842906|11758258|FG000|NOT COMPLETED|Overall Study||0
10601460|NCT01842906|11758259|FG001|NOT COMPLETED|Overall Study||0
10601461|NCT01842958|11758267|FG000|STARTED|Overall Study||25
10601462|NCT01842958|11758268|FG001|STARTED|Overall Study||25
10601463|NCT01842958|11758267|FG000|Randomized|Overall Study|One subject was randomized to 3.3 mm implant, but received the 4.1 mm implant.|25
10601464|NCT01842958|11758268|FG001|Randomized|Overall Study||25
10601465|NCT01842958|11758267|FG000|COMPLETED|Overall Study||24
10601466|NCT01842958|11758268|FG001|COMPLETED|Overall Study||24
10601467|NCT01842958|11758267|FG000|NOT COMPLETED|Overall Study||1
10601468|NCT01842958|11758268|FG001|NOT COMPLETED|Overall Study||1
10601469|NCT01843023|11758276|FG000|STARTED|Overall Study||144
10601470|NCT01843023|11758277|FG001|STARTED|Overall Study||144
10601471|NCT01843023|11758276|FG000|3 Months|Overall Study||110
10601472|NCT01843023|11758277|FG001|3 Months|Overall Study||114
10601473|NCT01843023|11758276|FG000|COMPLETED|Overall Study||111
10601474|NCT01843023|11758277|FG001|COMPLETED|Overall Study||109
10601475|NCT01843023|11758276|FG000|NOT COMPLETED|Overall Study||33
10601476|NCT01843023|11758277|FG001|NOT COMPLETED|Overall Study||35
10601477|NCT01843062|11758285|FG000|STARTED|Overall Study||155
10601478|NCT01843062|11758286|FG001|STARTED|Overall Study||78
10601479|NCT01843062|11758285|FG000|Intention to Treat (ITT) Analysis Set|Overall Study||155
10601480|NCT01843062|11758286|FG001|Intention to Treat (ITT) Analysis Set|Overall Study||78
10601481|NCT01843062|11758285|FG000|Safety Analysis Set|Overall Study||154
10601482|NCT01843062|11758286|FG001|Safety Analysis Set|Overall Study||77
10601483|NCT01843062|11758285|FG000|BRAF/NRAS Mutation Positive Analysis Set|Overall Study||91
10601484|NCT01843062|11758286|FG001|BRAF/NRAS Mutation Positive Analysis Set|Overall Study||51
10601485|NCT01843062|11758285|FG000|Ongoing at Primary Analysis Data Cut-off|Overall Study||134
10601486|NCT01843062|11758286|FG001|Ongoing at Primary Analysis Data Cut-off|Overall Study||71
10601487|NCT01843062|11758285|FG000|COMPLETED|Overall Study||133
10601488|NCT01843062|11758286|FG001|COMPLETED|Overall Study||69
10601489|NCT01843062|11758285|FG000|NOT COMPLETED|Overall Study||22
10601490|NCT01843062|11758286|FG001|NOT COMPLETED|Overall Study||9
10601491|NCT01843192|11758295|FG000|STARTED|Overall Study||26
10601492|NCT01843192|11758296|FG001|STARTED|Overall Study||34
10601493|NCT01843192|11758297|FG002|STARTED|Overall Study||11
10601494|NCT01843192|11758295|FG000|COMPLETED|Overall Study||24
10601495|NCT01843192|11758296|FG001|COMPLETED|Overall Study||28
10703995|NCT02588261|11868510|FG000|Treated|Overall Study||265
10703996|NCT02588261|11868511|FG001|Treated|Overall Study||262
10601496|NCT01843192|11758297|FG002|COMPLETED|Overall Study||9
10601497|NCT01843192|11758295|FG000|NOT COMPLETED|Overall Study||2
10601498|NCT01843192|11758296|FG001|NOT COMPLETED|Overall Study||6
10601499|NCT01843192|11758297|FG002|NOT COMPLETED|Overall Study||2
10703997|NCT02588261|11868510|FG000|COMPLETED|Overall Study||0
10601500|NCT01843205|11758305|FG000|STARTED|First Treatment (11 Days)||5
10601501|NCT01843205|11758306|FG001|STARTED|First Treatment (11 Days)||4
10601502|NCT01843205|11758305|FG000|COMPLETED|First Treatment (11 Days)|4 completing subjects switched to buspirone for Condition 2.|4
10601503|NCT01843205|11758306|FG001|COMPLETED|First Treatment (11 Days)|4 completing subjects switched to placebo for Condition 2.|4
10601504|NCT01843205|11758305|FG000|NOT COMPLETED|First Treatment (11 Days)||1
10601505|NCT01843205|11758306|FG001|NOT COMPLETED|First Treatment (11 Days)||0
10601506|NCT01843205|11758305|FG000|STARTED|Second Treatment (11 Days)||4
10601507|NCT01843205|11758306|FG001|STARTED|Second Treatment (11 Days)||4
10601508|NCT01843205|11758305|FG000|COMPLETED|Second Treatment (11 Days)||4
10601509|NCT01843205|11758306|FG001|COMPLETED|Second Treatment (11 Days)||4
10601510|NCT01843205|11758305|FG000|NOT COMPLETED|Second Treatment (11 Days)||0
10601511|NCT01843205|11758306|FG001|NOT COMPLETED|Second Treatment (11 Days)||0
10601512|NCT01843348|11758315|FG000|STARTED|Overall Study||205
10601513|NCT01843348|11758316|FG001|STARTED|Overall Study||208
10601514|NCT01843348|11758317|FG002|STARTED|Overall Study||199
10601515|NCT01843348|11758315|FG000|Safety Analysis Set (SAS)|Overall Study|One participant received TAC + Certican in error - analyzed with TAC + Certican arm|204
10601516|NCT01843348|11758316|FG001|Safety Analysis Set (SAS)|Overall Study|Two participants received TAC + Certican in other arms in errorr - analyzed with TAC + Certican arm|210
10601517|NCT01843348|11758317|FG002|Safety Analysis Set (SAS)|Overall Study|One participant received TAC + Certican in error - analyzed with TAC + Certican arm|198
10601518|NCT01843348|11758315|FG000|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|205
10601519|NCT01843348|11758316|FG001|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|208
10601520|NCT01843348|11758317|FG002|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|199
10601521|NCT01843348|11758315|FG000|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|147
10601522|NCT01843348|11758316|FG001|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|111
10601523|NCT01843348|11758317|FG002|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|80
10601524|NCT01843348|11758315|FG000|COMPLETED|Overall Study||182
10601525|NCT01843348|11758316|FG001|COMPLETED|Overall Study||168
10601526|NCT01843348|11758317|FG002|COMPLETED|Overall Study||158
10601527|NCT01843348|11758315|FG000|NOT COMPLETED|Overall Study||23
10601528|NCT01843348|11758316|FG001|NOT COMPLETED|Overall Study||40
10601529|NCT01843348|11758317|FG002|NOT COMPLETED|Overall Study||41
10601530|NCT01843465|11758327|FG000|STARTED|Overall Study|This study had no follow-up. It focused in the acute setting of cryoballoon ablation.|34
10601531|NCT01843465|11758327|FG000|COMPLETED|Overall Study||34
10601532|NCT01843465|11758327|FG000|NOT COMPLETED|Overall Study||0
10601533|NCT01843621|11758331|FG000|STARTED|Overall Study||7
10601534|NCT01843621|11758331|FG000|COMPLETED|Overall Study||7
10601535|NCT01843621|11758331|FG000|NOT COMPLETED|Overall Study||0
10601536|NCT01843660|11758343|FG000|STARTED|Overall Study||1059
10601537|NCT01843660|11758343|FG000|COMPLETED|Overall Study||1029
10601538|NCT01843660|11758343|FG000|NOT COMPLETED|Overall Study||30
10601539|NCT01843673|11758347|FG000|STARTED|Overall Study||16
10601540|NCT01843673|11758347|FG000|COMPLETED|Overall Study||10
10601541|NCT01843673|11758347|FG000|NOT COMPLETED|Overall Study||6
10601542|NCT01843751|11758355|FG000|STARTED|Overall Study||11
10601543|NCT01843751|11758356|FG001|STARTED|Overall Study||10
10601544|NCT01843751|11758355|FG000|COMPLETED|Overall Study||0
10601545|NCT01843751|11758356|FG001|COMPLETED|Overall Study||3
10601546|NCT01843751|11758355|FG000|NOT COMPLETED|Overall Study||11
10601547|NCT01843751|11758356|FG001|NOT COMPLETED|Overall Study||7
10601548|NCT01843777|11758364|FG000|STARTED|Overall Study|Number of participants randomized to standard-of-care.|11
10601549|NCT01843777|11758365|FG001|STARTED|Overall Study|Number of participants randomized to treatment.|10
10601550|NCT01843777|11758364|FG000|Per Protocol Population|Overall Study||11
10601551|NCT01843777|11758365|FG001|Per Protocol Population|Overall Study|A subject was randomized to treatment but received standard of care and is not in the analyses.|9
10601552|NCT01843777|11758364|FG000|COMPLETED|Overall Study|Final number of standard-of-care participants.|10
10601553|NCT01843777|11758365|FG001|COMPLETED|Overall Study|Number of subjects who received the treatment that completed collection of outcome measures|10
10601554|NCT01843777|11758364|FG000|NOT COMPLETED|Overall Study||1
10601555|NCT01843777|11758365|FG001|NOT COMPLETED|Overall Study||0
10601556|NCT01843803|11758373|FG000|STARTED|Overall Study||137
10601557|NCT01843803|11758374|FG001|STARTED|Overall Study||139
10601558|NCT01843803|11758373|FG000|COMPLETED|Overall Study||136
10601559|NCT01843803|11758374|FG001|COMPLETED|Overall Study||136
10601560|NCT01843803|11758373|FG000|NOT COMPLETED|Overall Study||1
10601561|NCT01843803|11758374|FG001|NOT COMPLETED|Overall Study||3
10601562|NCT01843842|11758382|FG000|STARTED|Overall Study||154
10601563|NCT01843842|11758383|FG001|STARTED|Overall Study||152
10601564|NCT01843842|11758382|FG000|COMPLETED|Overall Study||153
10601565|NCT01843842|11758383|FG001|COMPLETED|Overall Study||151
10601566|NCT01843842|11758382|FG000|NOT COMPLETED|Overall Study||1
10601567|NCT01843842|11758383|FG001|NOT COMPLETED|Overall Study||1
10601568|NCT01843920|11758391|FG000|STARTED|Overall Study||12
10601569|NCT01843920|11758392|FG001|STARTED|Overall Study||9
10601570|NCT01843920|11758391|FG000|COMPLETED|Overall Study||12
10601571|NCT01843920|11758392|FG001|COMPLETED|Overall Study||9
10601572|NCT01843920|11758391|FG000|NOT COMPLETED|Overall Study||0
10601573|NCT01843920|11758392|FG001|NOT COMPLETED|Overall Study||0
10601574|NCT01843933|11758400|FG000|STARTED|Overall Study||104
10601575|NCT01843933|11758401|FG001|STARTED|Overall Study||107
10601576|NCT01843933|11758400|FG000|COMPLETED|Overall Study||98
10601577|NCT01843933|11758401|FG001|COMPLETED|Overall Study||103
10601578|NCT01843933|11758400|FG000|NOT COMPLETED|Overall Study||6
10601579|NCT01843933|11758401|FG001|NOT COMPLETED|Overall Study||4
10601580|NCT01843972|11758417|FG000|STARTED|Overall Study||13
10601581|NCT01843972|11758418|FG001|STARTED|Overall Study||6
10601582|NCT01843972|11758419|FG002|STARTED|Overall Study||5
10601583|NCT01843972|11758420|FG003|STARTED|Overall Study||6
10601584|NCT01843972|11758421|FG004|STARTED|Overall Study||6
10601585|NCT01843972|11758422|FG005|STARTED|Overall Study||6
10601586|NCT01843972|11758423|FG006|STARTED|Overall Study||5
10601587|NCT01843972|11758424|FG007|STARTED|Overall Study||5
10601588|NCT01843972|11758425|FG008|STARTED|Overall Study||17
10601589|NCT01843972|11758426|FG009|STARTED|Overall Study||12
10601590|NCT01843972|11758417|FG000|COMPLETED|Overall Study||13
10601591|NCT01843972|11758418|FG001|COMPLETED|Overall Study||6
10601592|NCT01843972|11758419|FG002|COMPLETED|Overall Study||5
10601593|NCT01843972|11758420|FG003|COMPLETED|Overall Study||6
10601594|NCT01843972|11758421|FG004|COMPLETED|Overall Study||5
10601595|NCT01843972|11758422|FG005|COMPLETED|Overall Study||6
10601596|NCT01843972|11758423|FG006|COMPLETED|Overall Study||5
10601597|NCT01843972|11758424|FG007|COMPLETED|Overall Study||5
10601598|NCT01843972|11758425|FG008|COMPLETED|Overall Study||17
10601599|NCT01843972|11758426|FG009|COMPLETED|Overall Study||12
10601600|NCT01843972|11758417|FG000|NOT COMPLETED|Overall Study||0
10601601|NCT01843972|11758418|FG001|NOT COMPLETED|Overall Study||0
10601602|NCT01843972|11758419|FG002|NOT COMPLETED|Overall Study||0
10601603|NCT01843972|11758420|FG003|NOT COMPLETED|Overall Study||0
10601604|NCT01843972|11758421|FG004|NOT COMPLETED|Overall Study||1
10601605|NCT01843972|11758422|FG005|NOT COMPLETED|Overall Study||0
10601606|NCT01843972|11758423|FG006|NOT COMPLETED|Overall Study||0
10601607|NCT01843972|11758424|FG007|NOT COMPLETED|Overall Study||0
10601608|NCT01843972|11758425|FG008|NOT COMPLETED|Overall Study||0
10601609|NCT01843972|11758426|FG009|NOT COMPLETED|Overall Study||0
10601610|NCT01844076|11758466|FG000|STARTED|Overall Study||3
10601611|NCT01844076|11758467|FG001|STARTED|Overall Study||6
10601612|NCT01844076|11758468|FG002|STARTED|Overall Study||3
10601613|NCT01844076|11758469|FG003|STARTED|Overall Study||7
10601614|NCT01844076|11758466|FG000|COMPLETED|Overall Study||1
10601615|NCT01844076|11758467|FG001|COMPLETED|Overall Study||6
10601616|NCT01844076|11758468|FG002|COMPLETED|Overall Study||3
10601617|NCT01844076|11758469|FG003|COMPLETED|Overall Study||7
10601618|NCT01844076|11758466|FG000|NOT COMPLETED|Overall Study||2
10601619|NCT01844076|11758467|FG001|NOT COMPLETED|Overall Study||0
10601620|NCT01844076|11758468|FG002|NOT COMPLETED|Overall Study||0
10601621|NCT01844076|11758469|FG003|NOT COMPLETED|Overall Study||0
10601622|NCT01844115|11758481|FG000|STARTED|Overall Study||202
10601623|NCT01844115|11758482|FG001|STARTED|Overall Study||202
10601624|NCT01844115|11758481|FG000|COMPLETED|Overall Study||163
10601625|NCT01844115|11758482|FG001|COMPLETED|Overall Study||144
10601626|NCT01844115|11758481|FG000|NOT COMPLETED|Overall Study||39
10601627|NCT01844115|11758482|FG001|NOT COMPLETED|Overall Study||58
10601628|NCT01844193|11758490|FG000|STARTED|Overall Study||19
10601629|NCT01844193|11758491|FG001|STARTED|Overall Study||21
10601630|NCT01844193|11758490|FG000|COMPLETED|Overall Study||13
10601631|NCT01844193|11758491|FG001|COMPLETED|Overall Study||15
10601632|NCT01844193|11758490|FG000|NOT COMPLETED|Overall Study||6
10601633|NCT01844193|11758491|FG001|NOT COMPLETED|Overall Study||6
10601634|NCT01844284|11758499|FG000|STARTED|Overall Study|Intent-to-treat (ITT) population|266
10601635|NCT01844284|11758500|FG001|STARTED|Overall Study|Intent-to-treat (ITT) population|134
10601636|NCT01844284|11758499|FG000|COMPLETED|Overall Study||254
10601637|NCT01844284|11758500|FG001|COMPLETED|Overall Study||127
10601638|NCT01844284|11758499|FG000|NOT COMPLETED|Overall Study||12
10601639|NCT01844284|11758500|FG001|NOT COMPLETED|Overall Study||7
10601640|NCT01844375|11758508|FG000|STARTED|Overall Study||35
10601641|NCT01844375|11758509|FG001|STARTED|Overall Study||35
10601642|NCT01844375|11758508|FG000|COMPLETED|Overall Study||34
10601643|NCT01844375|11758509|FG001|COMPLETED|Overall Study||34
10601644|NCT01844375|11758508|FG000|NOT COMPLETED|Overall Study||1
10601645|NCT01844375|11758509|FG001|NOT COMPLETED|Overall Study||1
10601646|NCT01844388|11758517|FG000|STARTED|Overall Study||244
10601647|NCT01844388|11758518|FG001|STARTED|Overall Study||121
10601648|NCT01844388|11758517|FG000|COMPLETED|Overall Study||236
10601649|NCT01844388|11758518|FG001|COMPLETED|Overall Study||114
10601650|NCT01844388|11758517|FG000|NOT COMPLETED|Overall Study||8
10601651|NCT01844388|11758518|FG001|NOT COMPLETED|Overall Study||7
10601652|NCT01844479|11758524|FG000|STARTED|First Intervention up to 30 Minutes||14
10601653|NCT01844479|11758525|FG001|STARTED|First Intervention up to 30 Minutes||13
10601654|NCT01844479|11758524|FG000|COMPLETED|First Intervention up to 30 Minutes||14
10601655|NCT01844479|11758525|FG001|COMPLETED|First Intervention up to 30 Minutes||13
10601656|NCT01844479|11758524|FG000|NOT COMPLETED|First Intervention up to 30 Minutes||0
10601657|NCT01844479|11758525|FG001|NOT COMPLETED|First Intervention up to 30 Minutes||0
10601658|NCT01844479|11758524|FG000|STARTED|Second Intervention up to 30 Minutes||14
10601659|NCT01844479|11758525|FG001|STARTED|Second Intervention up to 30 Minutes||13
10601660|NCT01844479|11758524|FG000|COMPLETED|Second Intervention up to 30 Minutes||14
10601661|NCT01844479|11758525|FG001|COMPLETED|Second Intervention up to 30 Minutes||13
10601662|NCT01844479|11758524|FG000|NOT COMPLETED|Second Intervention up to 30 Minutes||0
10601663|NCT01844479|11758525|FG001|NOT COMPLETED|Second Intervention up to 30 Minutes||0
10601664|NCT01844531|11758536|FG000|STARTED|Overall Study||6
10601665|NCT01844531|11758537|FG001|STARTED|Overall Study||6
10703998|NCT02588261|11868511|FG001|COMPLETED|Overall Study||0
10703999|NCT02588261|11868510|FG000|NOT COMPLETED|Overall Study||267
10704000|NCT02588261|11868511|FG001|NOT COMPLETED|Overall Study||263
10601666|NCT01844531|11758538|FG002|STARTED|Overall Study||6
10601667|NCT01844531|11758539|FG003|STARTED|Overall Study||6
10601668|NCT01844531|11758536|FG000|COMPLETED|Overall Study||6
10601669|NCT01844531|11758537|FG001|COMPLETED|Overall Study||5
10601670|NCT01844531|11758538|FG002|COMPLETED|Overall Study||6
10601671|NCT01844531|11758539|FG003|COMPLETED|Overall Study||6
10601672|NCT01844531|11758536|FG000|NOT COMPLETED|Overall Study||0
10601673|NCT01844531|11758537|FG001|NOT COMPLETED|Overall Study||1
10601674|NCT01844531|11758538|FG002|NOT COMPLETED|Overall Study||0
10601675|NCT01844531|11758539|FG003|NOT COMPLETED|Overall Study||0
10601676|NCT01844583|11758551|FG000|STARTED|Overall Study||26
10601677|NCT01844583|11758552|FG001|STARTED|Overall Study||29
10601678|NCT01844583|11758551|FG000|COMPLETED|Overall Study|Completed=Completed protocol-specified dosing and PK/ECG assessment.|18
10601679|NCT01844583|11758552|FG001|COMPLETED|Overall Study||19
10601680|NCT01844583|11758551|FG000|NOT COMPLETED|Overall Study||8
10601681|NCT01844583|11758552|FG001|NOT COMPLETED|Overall Study||10
10601682|NCT01844687|11758563|FG000|STARTED|Visit 1||50
10601683|NCT01844687|11758563|FG000|COMPLETED|Visit 1||42
10601684|NCT01844687|11758563|FG000|NOT COMPLETED|Visit 1||8
10601685|NCT01844687|11758563|FG000|STARTED|Visit 2||42
10601686|NCT01844687|11758563|FG000|COMPLETED|Visit 2||40
10601687|NCT01844687|11758563|FG000|NOT COMPLETED|Visit 2||2
10601688|NCT01844687|11758563|FG000|STARTED|Visit 3||40
10601689|NCT01844687|11758563|FG000|COMPLETED|Visit 3||35
10601690|NCT01844687|11758563|FG000|NOT COMPLETED|Visit 3||5
10601691|NCT01844687|11758563|FG000|STARTED|Visit 4||35
10601692|NCT01844687|11758563|FG000|COMPLETED|Visit 4||31
10601693|NCT01844687|11758563|FG000|NOT COMPLETED|Visit 4||4
10601694|NCT01844687|11758563|FG000|STARTED|Visit 5||31
10601695|NCT01844687|11758563|FG000|COMPLETED|Visit 5||31
10601696|NCT01844687|11758563|FG000|NOT COMPLETED|Visit 5||0
10601697|NCT01844687|11758563|FG000|STARTED|Visit 6||31
10601698|NCT01844687|11758563|FG000|COMPLETED|Visit 6||31
10601699|NCT01844687|11758563|FG000|NOT COMPLETED|Visit 6||0
10601700|NCT01844687|11758563|FG000|STARTED|Visit 7||31
10601701|NCT01844687|11758563|FG000|COMPLETED|Visit 7||31
10601702|NCT01844687|11758563|FG000|NOT COMPLETED|Visit 7||0
10601703|NCT01844687|11758563|FG000|STARTED|Visit 8||31
10601704|NCT01844687|11758563|FG000|COMPLETED|Visit 8||31
10601705|NCT01844687|11758563|FG000|NOT COMPLETED|Visit 8||0
10601706|NCT01844700|11758587|FG000|STARTED|Overall Study||4
10601707|NCT01844700|11758588|FG001|STARTED|Overall Study||3
10601708|NCT01844700|11758587|FG000|COMPLETED|Overall Study||1
10601709|NCT01844700|11758588|FG001|COMPLETED|Overall Study||2
10601710|NCT01844700|11758587|FG000|NOT COMPLETED|Overall Study||3
10601711|NCT01844700|11758588|FG001|NOT COMPLETED|Overall Study||1
10601712|NCT01844765|11758596|FG000|STARTED|Overall Study||34
10601713|NCT01844765|11758597|FG001|STARTED|Overall Study||25
10601714|NCT01844765|11758596|FG000|Treated|Overall Study||33
10601715|NCT01844765|11758597|FG001|Treated|Overall Study||25
10601716|NCT01844765|11758596|FG000|Untreated|Overall Study|Did not receive study drug due to adverse event (AE).|1
10601717|NCT01844765|11758597|FG001|Untreated|Overall Study||0
10601718|NCT01844765|11758596|FG000|COMPLETED|Overall Study||19
10601719|NCT01844765|11758597|FG001|COMPLETED|Overall Study||10
10601720|NCT01844765|11758596|FG000|NOT COMPLETED|Overall Study||15
10601721|NCT01844765|11758597|FG001|NOT COMPLETED|Overall Study||15
10652439|NCT02185053|11812810|FG000|STARTED|Donepezil Dose Escalation Phase||0
10652440|NCT02185053|11812811|FG001|STARTED|Donepezil Dose Escalation Phase||38
10652441|NCT02185053|11812812|FG002|STARTED|Donepezil Dose Escalation Phase||0
10652442|NCT02185053|11812810|FG000|COMPLETED|Donepezil Dose Escalation Phase||0
10652443|NCT02185053|11812811|FG001|COMPLETED|Donepezil Dose Escalation Phase||33
10652444|NCT02185053|11812812|FG002|COMPLETED|Donepezil Dose Escalation Phase||0
10652445|NCT02185053|11812810|FG000|NOT COMPLETED|Donepezil Dose Escalation Phase||0
10652446|NCT02185053|11812811|FG001|NOT COMPLETED|Donepezil Dose Escalation Phase||5
10652447|NCT02185053|11812812|FG002|NOT COMPLETED|Donepezil Dose Escalation Phase||0
10652448|NCT02185053|11812810|FG000|STARTED|Donepezil Dose Maintenance Phase||0
10652449|NCT02185053|11812811|FG001|STARTED|Donepezil Dose Maintenance Phase||0
10652450|NCT02185053|11812812|FG002|STARTED|Donepezil Dose Maintenance Phase||33
10704001|NCT02588339|11868517|FG000|STARTED|Overall Study||42
10652451|NCT02185053|11812810|FG000|COMPLETED|Donepezil Dose Maintenance Phase||0
10652452|NCT02185053|11812811|FG001|COMPLETED|Donepezil Dose Maintenance Phase||0
10652453|NCT02185053|11812812|FG002|COMPLETED|Donepezil Dose Maintenance Phase||30
10652454|NCT02185053|11812810|FG000|NOT COMPLETED|Donepezil Dose Maintenance Phase||0
10652455|NCT02185053|11812811|FG001|NOT COMPLETED|Donepezil Dose Maintenance Phase||0
10652456|NCT02185053|11812812|FG002|NOT COMPLETED|Donepezil Dose Maintenance Phase||3
10652457|NCT02185105|11812821|FG000|STARTED|Overall Study||30
10652458|NCT02185105|11812821|FG000|COMPLETED|Overall Study||30
10652459|NCT02185105|11812821|FG000|NOT COMPLETED|Overall Study||0
10652460|NCT02185131|11812834|FG000|STARTED|Overall Study||7
10601722|NCT01844778|11758611|FG000|STARTED|Overall Study||14
10601723|NCT01844778|11758612|FG001|STARTED|Overall Study||28
10601724|NCT01844778|11758613|FG002|STARTED|Overall Study||18
10601725|NCT01844778|11758611|FG000|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||14
10601726|NCT01844778|11758612|FG001|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||28
10601727|NCT01844778|11758613|FG002|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||18
10601728|NCT01844778|11758611|FG000|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||12
10601729|NCT01844778|11758612|FG001|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||25
10601730|NCT01844778|11758613|FG002|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||15
10601731|NCT01844778|11758611|FG000|COMPLETED|Overall Study||12
10601732|NCT01844778|11758612|FG001|COMPLETED|Overall Study||25
10601733|NCT01844778|11758613|FG002|COMPLETED|Overall Study||14
10601734|NCT01844778|11758611|FG000|NOT COMPLETED|Overall Study||2
10601735|NCT01844778|11758612|FG001|NOT COMPLETED|Overall Study||3
10601736|NCT01844778|11758613|FG002|NOT COMPLETED|Overall Study||4
10601737|NCT01844817|11758627|FG000|STARTED|Enrolled and Randomized||66
10601738|NCT01844817|11758628|FG001|STARTED|Enrolled and Randomized||66
10601739|NCT01844817|11758627|FG000|COMPLETED|Enrolled and Randomized||64
10601740|NCT01844817|11758628|FG001|COMPLETED|Enrolled and Randomized||63
10601741|NCT01844817|11758627|FG000|NOT COMPLETED|Enrolled and Randomized||2
10601742|NCT01844817|11758628|FG001|NOT COMPLETED|Enrolled and Randomized||3
10601743|NCT01844817|11758627|FG000|STARTED|Treatment||64
10601744|NCT01844817|11758628|FG001|STARTED|Treatment||63
10601745|NCT01844817|11758627|FG000|COMPLETED|Treatment||0
10601746|NCT01844817|11758628|FG001|COMPLETED|Treatment||0
10601747|NCT01844817|11758627|FG000|NOT COMPLETED|Treatment||64
10601748|NCT01844817|11758628|FG001|NOT COMPLETED|Treatment||63
10601749|NCT01844830|11758637|FG000|STARTED|Overall Study||60
10601750|NCT01844830|11758638|FG001|STARTED|Overall Study||30
10601751|NCT01844830|11758637|FG000|100 µL Dose|Overall Study||16
10601752|NCT01844830|11758638|FG001|100 µL Dose|Overall Study||8
10601753|NCT01844830|11758637|FG000|200 µL Dose|Overall Study||24
10601754|NCT01844830|11758638|FG001|200 µL Dose|Overall Study||12
10601755|NCT01844830|11758637|FG000|400 µL Dose|Overall Study||20
10601756|NCT01844830|11758638|FG001|400 µL Dose|Overall Study||10
10601757|NCT01844830|11758637|FG000|COMPLETED|Overall Study||59
10601758|NCT01844830|11758638|FG001|COMPLETED|Overall Study||30
10601759|NCT01844830|11758637|FG000|NOT COMPLETED|Overall Study||1
10601760|NCT01844830|11758638|FG001|NOT COMPLETED|Overall Study||0
10601761|NCT01844895|11758644|FG000|STARTED|Day 1 to Day 28 - Pre-filled Syringe||120
10601762|NCT01844895|11758644|FG000|COMPLETED|Day 1 to Day 28 - Pre-filled Syringe||117
10601763|NCT01844895|11758644|FG000|NOT COMPLETED|Day 1 to Day 28 - Pre-filled Syringe||3
10601764|NCT01844895|11758644|FG000|STARTED|Day 29 - Day113 - Autoinjector||117
10601765|NCT01844895|11758644|FG000|COMPLETED|Day 29 - Day113 - Autoinjector||111
10601766|NCT01844895|11758644|FG000|NOT COMPLETED|Day 29 - Day113 - Autoinjector||6
10601767|NCT01845025|11758659|FG000|STARTED|Overall Study||411
10601768|NCT01845025|11758660|FG001|STARTED|Overall Study||409
10601769|NCT01845025|11758659|FG000|COMPLETED|Overall Study||326
10601770|NCT01845025|11758660|FG001|COMPLETED|Overall Study||332
10601771|NCT01845025|11758659|FG000|NOT COMPLETED|Overall Study||85
10601772|NCT01845025|11758660|FG001|NOT COMPLETED|Overall Study||77
10601773|NCT01845077|11758669|FG000|STARTED|Treatment Period 1||12
10601774|NCT01845077|11758670|FG001|STARTED|Treatment Period 1||12
10601775|NCT01845077|11758671|FG002|STARTED|Treatment Period 1||12
10601776|NCT01845077|11758672|FG003|STARTED|Treatment Period 1||12
10601777|NCT01845077|11758673|FG004|STARTED|Treatment Period 1||12
10601778|NCT01845077|11758674|FG005|STARTED|Treatment Period 1||12
10601779|NCT01845077|11758669|FG000|COMPLETED|Treatment Period 1||12
10601780|NCT01845077|11758670|FG001|COMPLETED|Treatment Period 1||12
10601781|NCT01845077|11758671|FG002|COMPLETED|Treatment Period 1||12
10601782|NCT01845077|11758672|FG003|COMPLETED|Treatment Period 1||12
10601783|NCT01845077|11758673|FG004|COMPLETED|Treatment Period 1||12
10601784|NCT01845077|11758674|FG005|COMPLETED|Treatment Period 1||12
10601785|NCT01845077|11758669|FG000|NOT COMPLETED|Treatment Period 1||0
10601786|NCT01845077|11758670|FG001|NOT COMPLETED|Treatment Period 1||0
10601787|NCT01845077|11758671|FG002|NOT COMPLETED|Treatment Period 1||0
10601788|NCT01845077|11758672|FG003|NOT COMPLETED|Treatment Period 1||0
10601789|NCT01845077|11758673|FG004|NOT COMPLETED|Treatment Period 1||0
10601790|NCT01845077|11758674|FG005|NOT COMPLETED|Treatment Period 1||0
10601791|NCT01845077|11758669|FG000|STARTED|Washout Period||12
10601792|NCT01845077|11758670|FG001|STARTED|Washout Period||12
10601793|NCT01845077|11758671|FG002|STARTED|Washout Period||12
10601794|NCT01845077|11758672|FG003|STARTED|Washout Period||12
10601795|NCT01845077|11758673|FG004|STARTED|Washout Period||12
10601796|NCT01845077|11758674|FG005|STARTED|Washout Period||12
10601797|NCT01845077|11758669|FG000|COMPLETED|Washout Period||11
10601798|NCT01845077|11758670|FG001|COMPLETED|Washout Period||11
10601799|NCT01845077|11758671|FG002|COMPLETED|Washout Period||11
10601800|NCT01845077|11758672|FG003|COMPLETED|Washout Period||10
10601801|NCT01845077|11758673|FG004|COMPLETED|Washout Period||11
10601802|NCT01845077|11758674|FG005|COMPLETED|Washout Period||11
10601803|NCT01845077|11758669|FG000|NOT COMPLETED|Washout Period||1
10601804|NCT01845077|11758670|FG001|NOT COMPLETED|Washout Period||1
10601805|NCT01845077|11758671|FG002|NOT COMPLETED|Washout Period||1
10601806|NCT01845077|11758672|FG003|NOT COMPLETED|Washout Period||2
10601807|NCT01845077|11758673|FG004|NOT COMPLETED|Washout Period||1
10601808|NCT01845077|11758674|FG005|NOT COMPLETED|Washout Period||1
10601809|NCT01845077|11758669|FG000|STARTED|Treatment Period 2||11
10601810|NCT01845077|11758670|FG001|STARTED|Treatment Period 2||11
10601811|NCT01845077|11758671|FG002|STARTED|Treatment Period 2||11
10601812|NCT01845077|11758672|FG003|STARTED|Treatment Period 2||10
10601813|NCT01845077|11758673|FG004|STARTED|Treatment Period 2||11
10601814|NCT01845077|11758674|FG005|STARTED|Treatment Period 2||11
10601815|NCT01845077|11758669|FG000|COMPLETED|Treatment Period 2||11
10601816|NCT01845077|11758670|FG001|COMPLETED|Treatment Period 2||11
10601817|NCT01845077|11758671|FG002|COMPLETED|Treatment Period 2||11
10601818|NCT01845077|11758672|FG003|COMPLETED|Treatment Period 2||10
10601819|NCT01845077|11758673|FG004|COMPLETED|Treatment Period 2||11
10601820|NCT01845077|11758674|FG005|COMPLETED|Treatment Period 2||11
10601821|NCT01845077|11758669|FG000|NOT COMPLETED|Treatment Period 2||0
10601822|NCT01845077|11758670|FG001|NOT COMPLETED|Treatment Period 2||0
10601823|NCT01845077|11758671|FG002|NOT COMPLETED|Treatment Period 2||0
10601824|NCT01845077|11758672|FG003|NOT COMPLETED|Treatment Period 2||0
10601825|NCT01845077|11758673|FG004|NOT COMPLETED|Treatment Period 2||0
10601826|NCT01845077|11758674|FG005|NOT COMPLETED|Treatment Period 2||0
10601827|NCT01845103|11758689|FG000|STARTED|Overall Study||1
10601828|NCT01845103|11758689|FG000|COMPLETED|Overall Study||1
10601829|NCT01845103|11758689|FG000|NOT COMPLETED|Overall Study||0
10601830|NCT01845155|11758695|FG000|STARTED|Overall Study||146
10601831|NCT01845155|11758696|FG001|STARTED|Overall Study||144
10601832|NCT01845155|11758695|FG000|COMPLETED|Overall Study||145
10601833|NCT01845155|11758696|FG001|COMPLETED|Overall Study||144
10601834|NCT01845155|11758695|FG000|NOT COMPLETED|Overall Study||1
10601835|NCT01845155|11758696|FG001|NOT COMPLETED|Overall Study||0
10601836|NCT01845220|11758702|FG000|STARTED|Overall Study||30
10601837|NCT01845220|11758703|FG001|STARTED|Overall Study||30
10601838|NCT01845220|11758702|FG000|COMPLETED|Overall Study||30
10601839|NCT01845220|11758703|FG001|COMPLETED|Overall Study||30
10601840|NCT01845220|11758702|FG000|NOT COMPLETED|Overall Study||0
10601841|NCT01845220|11758703|FG001|NOT COMPLETED|Overall Study||0
10601842|NCT01845636|11758709|FG000|STARTED|Overall Study||41
10704002|NCT02588339|11868517|FG000|COMPLETED|Overall Study||39
10704003|NCT02588339|11868517|FG000|NOT COMPLETED|Overall Study||3
10704004|NCT02588573|11868523|FG000|STARTED|Overall Study||45
10704005|NCT02588573|11868524|FG001|STARTED|Overall Study||45
10704006|NCT02588573|11868523|FG000|Randomized Eye Etafilcon A|Overall Study||45
10704007|NCT02588573|11868524|FG001|Randomized Eye Etafilcon A|Overall Study||45
10704008|NCT02588573|11868523|FG000|Randomized Eye Somofilcon A|Overall Study||45
10704009|NCT02588573|11868524|FG001|Randomized Eye Somofilcon A|Overall Study||45
10704010|NCT02588573|11868523|FG000|COMPLETED|Overall Study||45
10704011|NCT02588573|11868524|FG001|COMPLETED|Overall Study||45
10601843|NCT01845636|11758709|FG000|COMPLETED|Overall Study||37
10601844|NCT01845636|11758709|FG000|NOT COMPLETED|Overall Study||4
10601845|NCT01845792|11758715|FG000|STARTED|Overall Study||5
10601846|NCT01845792|11758716|FG001|STARTED|Overall Study||2
10601847|NCT01845792|11758715|FG000|COMPLETED|Overall Study||5
10601848|NCT01845792|11758716|FG001|COMPLETED|Overall Study||2
10601849|NCT01845792|11758715|FG000|NOT COMPLETED|Overall Study||0
10601850|NCT01845792|11758716|FG001|NOT COMPLETED|Overall Study||0
10601851|NCT01845818|11758724|FG000|STARTED|Overall Study||126
10601852|NCT01845818|11758725|FG001|STARTED|Overall Study||57
10601853|NCT01845818|11758724|FG000|COMPLETED|Overall Study||81
10601854|NCT01845818|11758725|FG001|COMPLETED|Overall Study||40
10601855|NCT01845818|11758724|FG000|NOT COMPLETED|Overall Study||45
10601856|NCT01845818|11758725|FG001|NOT COMPLETED|Overall Study||17
10601857|NCT01845831|11758735|FG000|STARTED|Inpatient Phase||140
10601858|NCT01845831|11758736|FG001|STARTED|Inpatient Phase||139
10601859|NCT01845831|11758737|FG002|STARTED|Inpatient Phase||0
10601860|NCT01845831|11758738|FG003|STARTED|Inpatient Phase||0
10601861|NCT01845831|11758739|FG004|STARTED|Inpatient Phase||0
10601862|NCT01845831|11758735|FG000|COMPLETED|Inpatient Phase||139
10601863|NCT01845831|11758736|FG001|COMPLETED|Inpatient Phase||138
10601864|NCT01845831|11758737|FG002|COMPLETED|Inpatient Phase||0
10601865|NCT01845831|11758738|FG003|COMPLETED|Inpatient Phase||0
10601866|NCT01845831|11758739|FG004|COMPLETED|Inpatient Phase||0
10601867|NCT01845831|11758735|FG000|NOT COMPLETED|Inpatient Phase||1
10601868|NCT01845831|11758736|FG001|NOT COMPLETED|Inpatient Phase||1
10601869|NCT01845831|11758737|FG002|NOT COMPLETED|Inpatient Phase||0
10601870|NCT01845831|11758738|FG003|NOT COMPLETED|Inpatient Phase||0
10601871|NCT01845831|11758739|FG004|NOT COMPLETED|Inpatient Phase||0
10601872|NCT01845831|11758735|FG000|STARTED|Outpatient Phase||0
10601873|NCT01845831|11758736|FG001|STARTED|Outpatient Phase||0
10601874|NCT01845831|11758737|FG002|STARTED|Outpatient Phase||68
10601875|NCT01845831|11758738|FG003|STARTED|Outpatient Phase||98
10601876|NCT01845831|11758739|FG004|STARTED|Outpatient Phase||87
10601877|NCT01845831|11758735|FG000|COMPLETED|Outpatient Phase||0
10704012|NCT02588573|11868523|FG000|NOT COMPLETED|Overall Study||0
10704013|NCT02588573|11868524|FG001|NOT COMPLETED|Overall Study||0
10601878|NCT01845831|11758736|FG001|COMPLETED|Outpatient Phase||0
10601879|NCT01845831|11758737|FG002|COMPLETED|Outpatient Phase||68
10601880|NCT01845831|11758738|FG003|COMPLETED|Outpatient Phase||98
10601881|NCT01845831|11758739|FG004|COMPLETED|Outpatient Phase||87
10601882|NCT01845831|11758735|FG000|NOT COMPLETED|Outpatient Phase||0
10601883|NCT01845831|11758736|FG001|NOT COMPLETED|Outpatient Phase||0
10601884|NCT01845831|11758737|FG002|NOT COMPLETED|Outpatient Phase||0
10601885|NCT01845831|11758738|FG003|NOT COMPLETED|Outpatient Phase||0
10601886|NCT01845831|11758739|FG004|NOT COMPLETED|Outpatient Phase||0
10601887|NCT01845974|11758752|FG000|STARTED|Overall Study||4
10601888|NCT01845974|11758753|FG001|STARTED|Overall Study||9
10601889|NCT01845974|11758752|FG000|COMPLETED|Overall Study||3
10601890|NCT01845974|11758753|FG001|COMPLETED|Overall Study||9
10601891|NCT01845974|11758752|FG000|NOT COMPLETED|Overall Study||1
10601892|NCT01845974|11758753|FG001|NOT COMPLETED|Overall Study||0
10601893|NCT01846039|11758759|FG000|STARTED|Overall Study||29
10601894|NCT01846039|11758759|FG000|COMPLETED|Overall Study||27
10601895|NCT01846039|11758759|FG000|NOT COMPLETED|Overall Study||2
10601896|NCT01846104|11758763|FG000|STARTED|Overall Study||4
10601897|NCT01846104|11758763|FG000|COMPLETED|Overall Study||3
10601898|NCT01846104|11758763|FG000|NOT COMPLETED|Overall Study||1
10601899|NCT01846208|11758770|FG000|STARTED|Overall Study||28
10601900|NCT01846208|11758771|FG001|STARTED|Overall Study||24
10601901|NCT01846208|11758772|FG002|STARTED|Overall Study||40
10601902|NCT01846208|11758770|FG000|Initiatiated Treatment|Overall Study||27
10601903|NCT01846208|11758771|FG001|Initiatiated Treatment|Overall Study||23
10601904|NCT01846208|11758772|FG002|Initiatiated Treatment|Overall Study||39
10601905|NCT01846208|11758770|FG000|Year 1 Desensitization OFC|Overall Study||23
10601906|NCT01846208|11758771|FG001|Year 1 Desensitization OFC|Overall Study||20
10601907|NCT01846208|11758772|FG002|Year 1 Desensitization OFC|Overall Study||34
10601908|NCT01846208|11758770|FG000|Year 2 Desensitization OFC|Overall Study||19
10601909|NCT01846208|11758771|FG001|Year 2 Desensitization OFC|Overall Study||20
10601910|NCT01846208|11758772|FG002|Year 2 Desensitization OFC|Overall Study||33
10601911|NCT01846208|11758770|FG000|Year 2 Sustained Unresponsiveness OFC|Overall Study||4
10601912|NCT01846208|11758771|FG001|Year 2 Sustained Unresponsiveness OFC|Overall Study||18
10601913|NCT01846208|11758772|FG002|Year 2 Sustained Unresponsiveness OFC|Overall Study||21
10601914|NCT01846208|11758770|FG000|COMPLETED|Overall Study||19
10601915|NCT01846208|11758771|FG001|COMPLETED|Overall Study||20
10601916|NCT01846208|11758772|FG002|COMPLETED|Overall Study||32
10601917|NCT01846208|11758770|FG000|NOT COMPLETED|Overall Study||9
10601918|NCT01846208|11758771|FG001|NOT COMPLETED|Overall Study||4
10601919|NCT01846208|11758772|FG002|NOT COMPLETED|Overall Study||8
10601920|NCT01846221|11758782|FG000|STARTED|Overall Study||50
10601921|NCT01846221|11758783|FG001|STARTED|Overall Study||51
10601922|NCT01846221|11758782|FG000|COMPLETED|Overall Study||47
10601923|NCT01846221|11758783|FG001|COMPLETED|Overall Study||51
10601924|NCT01846221|11758782|FG000|NOT COMPLETED|Overall Study||3
10601925|NCT01846221|11758783|FG001|NOT COMPLETED|Overall Study||0
10601926|NCT01846299|11758791|FG000|STARTED|Overall Study||118
10601927|NCT01846299|11758792|FG001|STARTED|Overall Study||60
10601928|NCT01846299|11758791|FG000|Full Analysis Set|Overall Study|One participant did not receive study treatment prior to discontinuation.|117
10601929|NCT01846299|11758792|FG001|Full Analysis Set|Overall Study||60
10601930|NCT01846299|11758791|FG000|Safety Set|Overall Study|Two participants randomized to sham received ranibizumab at Month 1.|119
10601931|NCT01846299|11758792|FG001|Safety Set|Overall Study||58
10601932|NCT01846299|11758791|FG000|COMPLETED|Overall Study||106
10601933|NCT01846299|11758792|FG001|COMPLETED|Overall Study||50
10601934|NCT01846299|11758791|FG000|NOT COMPLETED|Overall Study||12
10601935|NCT01846299|11758792|FG001|NOT COMPLETED|Overall Study||10
10601936|NCT01846416|11758803|FG000|STARTED|Treatment Phase||31
10601937|NCT01846416|11758804|FG001|STARTED|Treatment Phase||93
10601938|NCT01846416|11758805|FG002|STARTED|Treatment Phase||13
10601939|NCT01846416|11758803|FG000|COMPLETED|Treatment Phase||0
10601940|NCT01846416|11758804|FG001|COMPLETED|Treatment Phase||0
10601941|NCT01846416|11758805|FG002|COMPLETED|Treatment Phase||0
10704014|NCT02588586|11868542|FG000|STARTED|Overall Study||17
10601942|NCT01846416|11758803|FG000|NOT COMPLETED|Treatment Phase||31
10601943|NCT01846416|11758804|FG001|NOT COMPLETED|Treatment Phase||93
10601944|NCT01846416|11758805|FG002|NOT COMPLETED|Treatment Phase||13
10601945|NCT01846416|11758803|FG000|STARTED|Survival Follow-up||28
10601946|NCT01846416|11758804|FG001|STARTED|Survival Follow-up||80
10601947|NCT01846416|11758805|FG002|STARTED|Survival Follow-up||12
10601948|NCT01846416|11758803|FG000|COMPLETED|Survival Follow-up||0
10601949|NCT01846416|11758804|FG001|COMPLETED|Survival Follow-up||0
10601950|NCT01846416|11758805|FG002|COMPLETED|Survival Follow-up||0
10601951|NCT01846416|11758803|FG000|NOT COMPLETED|Survival Follow-up||28
10601952|NCT01846416|11758804|FG001|NOT COMPLETED|Survival Follow-up||80
10601953|NCT01846416|11758805|FG002|NOT COMPLETED|Survival Follow-up||12
10601954|NCT01846442|11758818|FG000|STARTED|Overall Study||54
10601955|NCT01846442|11758819|FG001|STARTED|Overall Study||54
10601956|NCT01846442|11758820|FG002|STARTED|Overall Study||56
10601957|NCT01846442|11758821|FG003|STARTED|Overall Study||54
10601958|NCT01846442|11758818|FG000|Safety Population|Overall Study||54
10601959|NCT01846442|11758819|FG001|Safety Population|Overall Study||53
10601960|NCT01846442|11758820|FG002|Safety Population|Overall Study||56
10601961|NCT01846442|11758821|FG003|Safety Population|Overall Study||54
10601962|NCT01846442|11758818|FG000|ITT Population|Overall Study||53
10601963|NCT01846442|11758819|FG001|ITT Population|Overall Study||53
10601964|NCT01846442|11758820|FG002|ITT Population|Overall Study||56
10601965|NCT01846442|11758821|FG003|ITT Population|Overall Study||54
10601966|NCT01846442|11758818|FG000|COMPLETED|Overall Study||48
10601967|NCT01846442|11758819|FG001|COMPLETED|Overall Study||48
10601968|NCT01846442|11758820|FG002|COMPLETED|Overall Study||52
10601969|NCT01846442|11758821|FG003|COMPLETED|Overall Study||51
10601970|NCT01846442|11758818|FG000|NOT COMPLETED|Overall Study||6
10601971|NCT01846442|11758819|FG001|NOT COMPLETED|Overall Study||6
10601972|NCT01846442|11758820|FG002|NOT COMPLETED|Overall Study||4
10601973|NCT01846442|11758821|FG003|NOT COMPLETED|Overall Study||3
10601974|NCT01846455|11758836|FG000|STARTED|Overall Study||9
10601975|NCT01846455|11758837|FG001|STARTED|Overall Study||8
10601976|NCT01846455|11758838|FG002|STARTED|Overall Study||8
10601977|NCT01846455|11758839|FG003|STARTED|Overall Study||10
10601978|NCT01846455|11758840|FG004|STARTED|Overall Study||8
10601979|NCT01846455|11758836|FG000|PK Population|Overall Study||6
10601980|NCT01846455|11758837|FG001|PK Population|Overall Study||7
10601981|NCT01846455|11758838|FG002|PK Population|Overall Study||6
10601982|NCT01846455|11758839|FG003|PK Population|Overall Study||6
10601983|NCT01846455|11758840|FG004|PK Population|Overall Study||8
10601984|NCT01846455|11758836|FG000|COMPLETED|Overall Study||9
10601985|NCT01846455|11758837|FG001|COMPLETED|Overall Study||8
10601986|NCT01846455|11758838|FG002|COMPLETED|Overall Study||8
10601987|NCT01846455|11758839|FG003|COMPLETED|Overall Study||10
10601988|NCT01846455|11758840|FG004|COMPLETED|Overall Study||8
10601989|NCT01846455|11758836|FG000|NOT COMPLETED|Overall Study||0
10601990|NCT01846455|11758837|FG001|NOT COMPLETED|Overall Study||0
10601991|NCT01846455|11758838|FG002|NOT COMPLETED|Overall Study||0
10601992|NCT01846455|11758839|FG003|NOT COMPLETED|Overall Study||0
10601993|NCT01846455|11758840|FG004|NOT COMPLETED|Overall Study||0
10601994|NCT01846494|11758854|FG000|STARTED|Overall Study||50
10601995|NCT01846494|11758855|FG001|STARTED|Overall Study||63
10601996|NCT01846494|11758854|FG000|COMPLETED|Overall Study||20
10601997|NCT01846494|11758855|FG001|COMPLETED|Overall Study||25
10601998|NCT01846494|11758854|FG000|NOT COMPLETED|Overall Study||30
10601999|NCT01846494|11758855|FG001|NOT COMPLETED|Overall Study||38
10602000|NCT01846507|11758861|FG000|STARTED|Overall Study||32
10602001|NCT01846507|11758861|FG000|COMPLETED|Overall Study||25
10602002|NCT01846507|11758861|FG000|NOT COMPLETED|Overall Study||7
10602003|NCT01846611|11758869|FG000|STARTED|Overall Study||289
10602004|NCT01846611|11758870|FG001|STARTED|Overall Study||287
10602005|NCT01846611|11758869|FG000|Treated|Overall Study||286
10602006|NCT01846611|11758870|FG001|Treated|Overall Study||282
10602007|NCT01846611|11758869|FG000|COMPLETED|Overall Study||251
10602008|NCT01846611|11758870|FG001|COMPLETED|Overall Study||244
10602009|NCT01846611|11758869|FG000|NOT COMPLETED|Overall Study||38
10602010|NCT01846611|11758870|FG001|NOT COMPLETED|Overall Study||43
10602011|NCT01846624|11758876|FG000|STARTED|Overall Study||13
10602012|NCT01846624|11758876|FG000|COMPLETED|Overall Study||12
10602013|NCT01846624|11758876|FG000|NOT COMPLETED|Overall Study||1
10602014|NCT01846702|11758887|FG000|STARTED|Overall Study||6
10602015|NCT01846702|11758888|FG001|STARTED|Overall Study||6
10602016|NCT01846702|11758889|FG002|STARTED|Overall Study||7
10602017|NCT01846702|11758890|FG003|STARTED|Overall Study||6
10704015|NCT02588586|11868542|FG000|COMPLETED|Overall Study||15
10704016|NCT02588586|11868542|FG000|NOT COMPLETED|Overall Study||2
10602018|NCT01846702|11758891|FG004|STARTED|Overall Study||6
10602019|NCT01846702|11758892|FG005|STARTED|Overall Study||6
10602020|NCT01846702|11758893|FG006|STARTED|Overall Study||6
10602021|NCT01846702|11758887|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
10602022|NCT01846702|11758888|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
10602023|NCT01846702|11758889|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
10602024|NCT01846702|11758890|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
10602025|NCT01846702|11758891|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
10602026|NCT01846702|11758892|FG005|Received at Least 1 Dose of Study Drug|Overall Study||6
10602027|NCT01846702|11758893|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
10602028|NCT01846702|11758887|FG000|COMPLETED|Overall Study||6
10602029|NCT01846702|11758888|FG001|COMPLETED|Overall Study||6
10602030|NCT01846702|11758889|FG002|COMPLETED|Overall Study||6
10602031|NCT01846702|11758890|FG003|COMPLETED|Overall Study||6
10602032|NCT01846702|11758891|FG004|COMPLETED|Overall Study||6
10602033|NCT01846702|11758892|FG005|COMPLETED|Overall Study||6
10602034|NCT01846702|11758893|FG006|COMPLETED|Overall Study||6
10602035|NCT01846702|11758887|FG000|NOT COMPLETED|Overall Study||0
10602036|NCT01846702|11758888|FG001|NOT COMPLETED|Overall Study||0
10602037|NCT01846702|11758889|FG002|NOT COMPLETED|Overall Study||1
10602038|NCT01846702|11758890|FG003|NOT COMPLETED|Overall Study||0
10602039|NCT01846702|11758891|FG004|NOT COMPLETED|Overall Study||0
10704017|NCT02588599|11868546|FG000|STARTED|Overall Study||54
10602040|NCT01846702|11758892|FG005|NOT COMPLETED|Overall Study||0
10602041|NCT01846702|11758893|FG006|NOT COMPLETED|Overall Study||0
10602042|NCT01846728|11758917|FG000|STARTED|Overall Study||6
10602043|NCT01846728|11758917|FG000|COMPLETED|Overall Study||6
10602044|NCT01846728|11758917|FG000|NOT COMPLETED|Overall Study||0
10704018|NCT02588599|11868546|FG000|COMPLETED|Overall Study||54
10602045|NCT01846741|11758921|FG000|STARTED|Baseline Visit||22
10602046|NCT01846741|11758921|FG000|COMPLETED|Baseline Visit||20
10602047|NCT01846741|11758921|FG000|NOT COMPLETED|Baseline Visit||2
10602048|NCT01846741|11758921|FG000|STARTED|Implantation to 18-Month/End of Study||20
10704019|NCT02588599|11868546|FG000|NOT COMPLETED|Overall Study||0
10704020|NCT02588612|11868550|FG000|STARTED|Overall Study||10
10602049|NCT01846741|11758921|FG000|COMPLETED|Implantation to 18-Month/End of Study||20
10602050|NCT01846741|11758921|FG000|NOT COMPLETED|Implantation to 18-Month/End of Study||0
10602051|NCT01846871|11758960|FG000|STARTED|Overall Study||10
10602052|NCT01846871|11758960|FG000|COMPLETED|Overall Study||10
10602053|NCT01846871|11758960|FG000|NOT COMPLETED|Overall Study||0
10602054|NCT01846988|11758971|FG000|STARTED|APAP Pressurize Comparison (4-8 Weeks)||15
10602055|NCT01846988|11758972|FG001|STARTED|APAP Pressurize Comparison (4-8 Weeks)||0
10602056|NCT01846988|11758973|FG002|STARTED|APAP Pressurize Comparison (4-8 Weeks)||0
10602057|NCT01846988|11758971|FG000|COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||15
10602058|NCT01846988|11758972|FG001|COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0
10602059|NCT01846988|11758973|FG002|COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0
10602060|NCT01846988|11758971|FG000|NOT COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0
10602061|NCT01846988|11758972|FG001|NOT COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0
10602062|NCT01846988|11758973|FG002|NOT COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0
10602063|NCT01846988|11758971|FG000|STARTED|Intervention #1 - 4 Weeks||0
10602064|NCT01846988|11758972|FG001|STARTED|Intervention #1 - 4 Weeks|Only 10 of 15 participants completing Comparison period started periods 1 & 2|5
10602065|NCT01846988|11758973|FG002|STARTED|Intervention #1 - 4 Weeks||5
10602066|NCT01846988|11758971|FG000|COMPLETED|Intervention #1 - 4 Weeks||0
10602067|NCT01846988|11758972|FG001|COMPLETED|Intervention #1 - 4 Weeks||5
10602068|NCT01846988|11758973|FG002|COMPLETED|Intervention #1 - 4 Weeks||5
10602069|NCT01846988|11758971|FG000|NOT COMPLETED|Intervention #1 - 4 Weeks||0
10602070|NCT01846988|11758972|FG001|NOT COMPLETED|Intervention #1 - 4 Weeks||0
10602071|NCT01846988|11758973|FG002|NOT COMPLETED|Intervention #1 - 4 Weeks||0
10602072|NCT01846988|11758971|FG000|STARTED|Intervention #2 - 4 Weeks||0
10602073|NCT01846988|11758972|FG001|STARTED|Intervention #2 - 4 Weeks||5
10602074|NCT01846988|11758973|FG002|STARTED|Intervention #2 - 4 Weeks||5
10602075|NCT01846988|11758971|FG000|COMPLETED|Intervention #2 - 4 Weeks||0
10602076|NCT01846988|11758972|FG001|COMPLETED|Intervention #2 - 4 Weeks||5
10602077|NCT01846988|11758973|FG002|COMPLETED|Intervention #2 - 4 Weeks||5
10602078|NCT01846988|11758971|FG000|NOT COMPLETED|Intervention #2 - 4 Weeks||0
10602079|NCT01846988|11758972|FG001|NOT COMPLETED|Intervention #2 - 4 Weeks||0
10602080|NCT01846988|11758973|FG002|NOT COMPLETED|Intervention #2 - 4 Weeks||0
10602081|NCT01847001|11758990|FG000|STARTED|Overall Study||10
10602082|NCT01847001|11758990|FG000|COMPLETED|Overall Study||10
10602083|NCT01847001|11758990|FG000|NOT COMPLETED|Overall Study||0
10602084|NCT01847014|11758995|FG000|STARTED|Baseline Extension Visit||4
10602085|NCT01847014|11758995|FG000|COMPLETED|Baseline Extension Visit||4
10602086|NCT01847014|11758995|FG000|NOT COMPLETED|Baseline Extension Visit||0
10602087|NCT01847014|11758995|FG000|STARTED|Completion of Extension Study||4
10602088|NCT01847014|11758995|FG000|COMPLETED|Completion of Extension Study||0
10602089|NCT01847014|11758995|FG000|NOT COMPLETED|Completion of Extension Study||4
10602090|NCT01847027|11759001|FG000|STARTED|Overall Study||11
10602091|NCT01847027|11759002|FG001|STARTED|Overall Study||12
10602092|NCT01847027|11759001|FG000|COMPLETED|Overall Study||10
10602093|NCT01847027|11759002|FG001|COMPLETED|Overall Study||10
10704021|NCT02588612|11868550|FG000|Received T-cell Infusion|Overall Study||5
10704022|NCT02588612|11868550|FG000|COMPLETED|Overall Study||5
10704023|NCT02588612|11868550|FG000|NOT COMPLETED|Overall Study||5
10602094|NCT01847027|11759001|FG000|NOT COMPLETED|Overall Study||1
10602095|NCT01847027|11759002|FG001|NOT COMPLETED|Overall Study||2
10602096|NCT01847092|11759010|FG000|STARTED|Overall Study||77
10602097|NCT01847092|11759011|FG001|STARTED|Overall Study||77
10602098|NCT01847092|11759010|FG000|COMPLETED|Overall Study||51
10602099|NCT01847092|11759011|FG001|COMPLETED|Overall Study||66
10602100|NCT01847092|11759010|FG000|NOT COMPLETED|Overall Study||26
10602101|NCT01847092|11759011|FG001|NOT COMPLETED|Overall Study||11
10602102|NCT01847131|11759019|FG000|STARTED|Overall Study||25
10602103|NCT01847131|11759020|FG001|STARTED|Overall Study||25
10602104|NCT01847131|11759019|FG000|COMPLETED|Overall Study||25
10602105|NCT01847131|11759020|FG001|COMPLETED|Overall Study||25
10602106|NCT01847131|11759019|FG000|NOT COMPLETED|Overall Study||0
10602107|NCT01847131|11759020|FG001|NOT COMPLETED|Overall Study||0
10602108|NCT01847196|11759026|FG000|STARTED|Overall Study|Includes all subjects in which Angel Catheter placement was attempted.|5
10602109|NCT01847196|11759026|FG000|COMPLETED|Overall Study||5
10602110|NCT01847196|11759026|FG000|NOT COMPLETED|Overall Study||0
10602111|NCT01847209|11759030|FG000|STARTED|Overall Study||25
10602112|NCT01847209|11759030|FG000|COMPLETED|Overall Study||23
10602113|NCT01847209|11759030|FG000|NOT COMPLETED|Overall Study||2
10602114|NCT01847313|11759036|FG000|STARTED|Overall Study||10
10602115|NCT01847313|11759037|FG001|STARTED|Overall Study||10
10602116|NCT01847313|11759036|FG000|COMPLETED|Overall Study||10
10602117|NCT01847313|11759037|FG001|COMPLETED|Overall Study||8
10704024|NCT02588664|11868556|FG000|STARTED|Overall Study||3193
10704025|NCT02588664|11868557|FG001|STARTED|Overall Study||2689
10704026|NCT02588664|11868556|FG000|COMPLETED|Overall Study||1832
10602118|NCT01847313|11759036|FG000|NOT COMPLETED|Overall Study||0
10602119|NCT01847313|11759037|FG001|NOT COMPLETED|Overall Study||2
10602120|NCT01847430|11759043|FG000|STARTED|Overall Study||302
10602121|NCT01847430|11759043|FG000|COMPLETED|Overall Study||302
10602122|NCT01847430|11759043|FG000|NOT COMPLETED|Overall Study||0
10602123|NCT01847443|11759047|FG000|STARTED|Study Period 1||21
10602124|NCT01847443|11759048|FG001|STARTED|Study Period 1||21
10602125|NCT01847443|11759049|FG002|STARTED|Study Period 1||21
10602126|NCT01847443|11759050|FG003|STARTED|Study Period 1||21
10602127|NCT01847443|11759047|FG000|COMPLETED|Study Period 1||21
10602128|NCT01847443|11759048|FG001|COMPLETED|Study Period 1||20
10602129|NCT01847443|11759049|FG002|COMPLETED|Study Period 1||21
10602130|NCT01847443|11759050|FG003|COMPLETED|Study Period 1||21
10602131|NCT01847443|11759047|FG000|NOT COMPLETED|Study Period 1||0
10602132|NCT01847443|11759048|FG001|NOT COMPLETED|Study Period 1||1
10602133|NCT01847443|11759049|FG002|NOT COMPLETED|Study Period 1||0
10602134|NCT01847443|11759050|FG003|NOT COMPLETED|Study Period 1||0
10602135|NCT01847443|11759047|FG000|STARTED|Washout Period Before Study Period 2||21
10602136|NCT01847443|11759048|FG001|STARTED|Washout Period Before Study Period 2||20
10602137|NCT01847443|11759049|FG002|STARTED|Washout Period Before Study Period 2||21
10602138|NCT01847443|11759050|FG003|STARTED|Washout Period Before Study Period 2||21
10602139|NCT01847443|11759047|FG000|COMPLETED|Washout Period Before Study Period 2||19
10602140|NCT01847443|11759048|FG001|COMPLETED|Washout Period Before Study Period 2||19
10602141|NCT01847443|11759049|FG002|COMPLETED|Washout Period Before Study Period 2||21
10602142|NCT01847443|11759050|FG003|COMPLETED|Washout Period Before Study Period 2||21
10602143|NCT01847443|11759047|FG000|NOT COMPLETED|Washout Period Before Study Period 2||2
10602144|NCT01847443|11759048|FG001|NOT COMPLETED|Washout Period Before Study Period 2||1
10602145|NCT01847443|11759049|FG002|NOT COMPLETED|Washout Period Before Study Period 2||0
10602146|NCT01847443|11759050|FG003|NOT COMPLETED|Washout Period Before Study Period 2||0
10602147|NCT01847443|11759047|FG000|STARTED|Study Period 2||19
10602148|NCT01847443|11759048|FG001|STARTED|Study Period 2||19
10602149|NCT01847443|11759049|FG002|STARTED|Study Period 2||21
10602150|NCT01847443|11759050|FG003|STARTED|Study Period 2||21
10602151|NCT01847443|11759047|FG000|COMPLETED|Study Period 2||19
10602152|NCT01847443|11759048|FG001|COMPLETED|Study Period 2||19
10602153|NCT01847443|11759049|FG002|COMPLETED|Study Period 2||21
10602154|NCT01847443|11759050|FG003|COMPLETED|Study Period 2||21
10602155|NCT01847443|11759047|FG000|NOT COMPLETED|Study Period 2||0
10602156|NCT01847443|11759048|FG001|NOT COMPLETED|Study Period 2||0
10602157|NCT01847443|11759049|FG002|NOT COMPLETED|Study Period 2||0
10602158|NCT01847443|11759050|FG003|NOT COMPLETED|Study Period 2||0
10602159|NCT01847443|11759047|FG000|STARTED|Washout Period Before Study Period 3||19
10602160|NCT01847443|11759048|FG001|STARTED|Washout Period Before Study Period 3||19
10602161|NCT01847443|11759049|FG002|STARTED|Washout Period Before Study Period 3||21
10602162|NCT01847443|11759050|FG003|STARTED|Washout Period Before Study Period 3||21
10602163|NCT01847443|11759047|FG000|COMPLETED|Washout Period Before Study Period 3||18
10602164|NCT01847443|11759048|FG001|COMPLETED|Washout Period Before Study Period 3||19
10602165|NCT01847443|11759049|FG002|COMPLETED|Washout Period Before Study Period 3||21
10602166|NCT01847443|11759050|FG003|COMPLETED|Washout Period Before Study Period 3||21
10602167|NCT01847443|11759047|FG000|NOT COMPLETED|Washout Period Before Study Period 3||1
10602168|NCT01847443|11759048|FG001|NOT COMPLETED|Washout Period Before Study Period 3||0
10602169|NCT01847443|11759049|FG002|NOT COMPLETED|Washout Period Before Study Period 3||0
10602170|NCT01847443|11759050|FG003|NOT COMPLETED|Washout Period Before Study Period 3||0
10602171|NCT01847443|11759047|FG000|STARTED|Study Period 3||18
10602172|NCT01847443|11759048|FG001|STARTED|Study Period 3||19
10602173|NCT01847443|11759049|FG002|STARTED|Study Period 3||21
10602174|NCT01847443|11759050|FG003|STARTED|Study Period 3||21
10602175|NCT01847443|11759047|FG000|COMPLETED|Study Period 3||18
10602176|NCT01847443|11759048|FG001|COMPLETED|Study Period 3||19
10602177|NCT01847443|11759049|FG002|COMPLETED|Study Period 3||21
10602178|NCT01847443|11759050|FG003|COMPLETED|Study Period 3||21
10602179|NCT01847443|11759047|FG000|NOT COMPLETED|Study Period 3||0
10602180|NCT01847443|11759048|FG001|NOT COMPLETED|Study Period 3||0
10602181|NCT01847443|11759049|FG002|NOT COMPLETED|Study Period 3||0
10602182|NCT01847443|11759050|FG003|NOT COMPLETED|Study Period 3||0
10602183|NCT01847443|11759047|FG000|STARTED|Washout Period Before Study Period 4||18
10602184|NCT01847443|11759048|FG001|STARTED|Washout Period Before Study Period 4||19
10602185|NCT01847443|11759049|FG002|STARTED|Washout Period Before Study Period 4||21
10602186|NCT01847443|11759050|FG003|STARTED|Washout Period Before Study Period 4||21
10602187|NCT01847443|11759047|FG000|COMPLETED|Washout Period Before Study Period 4||16
10602188|NCT01847443|11759048|FG001|COMPLETED|Washout Period Before Study Period 4||19
10602189|NCT01847443|11759049|FG002|COMPLETED|Washout Period Before Study Period 4||21
10602190|NCT01847443|11759050|FG003|COMPLETED|Washout Period Before Study Period 4||21
10602191|NCT01847443|11759047|FG000|NOT COMPLETED|Washout Period Before Study Period 4||2
10602192|NCT01847443|11759048|FG001|NOT COMPLETED|Washout Period Before Study Period 4||0
10602193|NCT01847443|11759049|FG002|NOT COMPLETED|Washout Period Before Study Period 4||0
10602194|NCT01847443|11759050|FG003|NOT COMPLETED|Washout Period Before Study Period 4||0
10602195|NCT01847443|11759047|FG000|STARTED|Study Period 4||16
10602196|NCT01847443|11759048|FG001|STARTED|Study Period 4||19
10602197|NCT01847443|11759049|FG002|STARTED|Study Period 4||21
10457024|NCT01008618|11604756|FG002|STARTED|Period 2 (Double-Blind Period)||77
10457025|NCT01008618|11604754|FG000|COMPLETED|Period 2 (Double-Blind Period)||0
10457026|NCT01008618|11604755|FG001|COMPLETED|Period 2 (Double-Blind Period)||37
10457027|NCT01008618|11604756|FG002|COMPLETED|Period 2 (Double-Blind Period)||39
10602198|NCT01847443|11759050|FG003|STARTED|Study Period 4||21
10602199|NCT01847443|11759047|FG000|COMPLETED|Study Period 4||16
10602200|NCT01847443|11759048|FG001|COMPLETED|Study Period 4||19
10602201|NCT01847443|11759049|FG002|COMPLETED|Study Period 4||21
10602202|NCT01847443|11759050|FG003|COMPLETED|Study Period 4||21
10602203|NCT01847443|11759047|FG000|NOT COMPLETED|Study Period 4||0
10457028|NCT01008618|11604754|FG000|NOT COMPLETED|Period 2 (Double-Blind Period)||0
10602204|NCT01847443|11759048|FG001|NOT COMPLETED|Study Period 4||0
10602205|NCT01847443|11759049|FG002|NOT COMPLETED|Study Period 4||0
10602206|NCT01847443|11759050|FG003|NOT COMPLETED|Study Period 4||0
10602207|NCT01847469|11759064|FG000|STARTED|Overall Study||18
10602208|NCT01847469|11759065|FG001|STARTED|Overall Study||6
10602209|NCT01847469|11759064|FG000|COMPLETED|Overall Study||9
10602210|NCT01847469|11759065|FG001|COMPLETED|Overall Study||3
10602211|NCT01847469|11759064|FG000|NOT COMPLETED|Overall Study||9
10602212|NCT01847469|11759065|FG001|NOT COMPLETED|Overall Study||3
10602213|NCT01847547|11759073|FG000|STARTED|Overall Study||2991
10602214|NCT01847547|11759074|FG001|STARTED|Overall Study||2991
10602215|NCT01847547|11759073|FG000|COMPLETED|Overall Study||2991
10602216|NCT01847547|11759074|FG001|COMPLETED|Overall Study||2991
10602217|NCT01847547|11759073|FG000|NOT COMPLETED|Overall Study||0
10602218|NCT01847547|11759074|FG001|NOT COMPLETED|Overall Study||0
10602219|NCT01847560|11759091|FG000|STARTED|Overall Study||13464
10602220|NCT01847560|11759092|FG001|STARTED|Overall Study||19955
10602221|NCT01847560|11759093|FG002|STARTED|Overall Study||9731
10602222|NCT01847560|11759094|FG003|STARTED|Overall Study||56655
10602223|NCT01847560|11759095|FG004|STARTED|Overall Study||27731
10602224|NCT01847560|11759096|FG005|STARTED|Overall Study||28343
10602225|NCT01847560|11759097|FG006|STARTED|Overall Study||40971
10602226|NCT01847560|11759098|FG007|STARTED|Overall Study||19829
10602227|NCT01847560|11759099|FG008|STARTED|Overall Study||77547
10602228|NCT01847560|11759100|FG009|STARTED|Overall Study||39438
10602229|NCT01847560|11759091|FG000|COMPLETED|Overall Study||13464
10602230|NCT01847560|11759092|FG001|COMPLETED|Overall Study||19955
10602231|NCT01847560|11759093|FG002|COMPLETED|Overall Study||9731
10602232|NCT01847560|11759094|FG003|COMPLETED|Overall Study||56655
10602233|NCT01847560|11759095|FG004|COMPLETED|Overall Study||27731
10602234|NCT01847560|11759096|FG005|COMPLETED|Overall Study||28343
10602235|NCT01847560|11759097|FG006|COMPLETED|Overall Study||40971
10602236|NCT01847560|11759098|FG007|COMPLETED|Overall Study||19829
10602237|NCT01847560|11759099|FG008|COMPLETED|Overall Study||77547
10602238|NCT01847560|11759100|FG009|COMPLETED|Overall Study||39438
10602239|NCT01847560|11759091|FG000|NOT COMPLETED|Overall Study||0
10602240|NCT01847560|11759092|FG001|NOT COMPLETED|Overall Study||0
10602241|NCT01847560|11759093|FG002|NOT COMPLETED|Overall Study||0
10602242|NCT01847560|11759094|FG003|NOT COMPLETED|Overall Study||0
10602243|NCT01847560|11759095|FG004|NOT COMPLETED|Overall Study||0
10602244|NCT01847560|11759096|FG005|NOT COMPLETED|Overall Study||0
10602245|NCT01847560|11759097|FG006|NOT COMPLETED|Overall Study||0
10602246|NCT01847560|11759098|FG007|NOT COMPLETED|Overall Study||0
10602247|NCT01847560|11759099|FG008|NOT COMPLETED|Overall Study||0
10602248|NCT01847560|11759100|FG009|NOT COMPLETED|Overall Study||0
10602249|NCT01847638|11759144|FG000|STARTED|Overall Study||25
10602250|NCT01847638|11759145|FG001|STARTED|Overall Study||25
10602251|NCT01847638|11759144|FG000|COMPLETED|Overall Study||25
10602252|NCT01847638|11759145|FG001|COMPLETED|Overall Study||25
10602253|NCT01847638|11759144|FG000|NOT COMPLETED|Overall Study||0
10602254|NCT01847638|11759145|FG001|NOT COMPLETED|Overall Study||0
10602255|NCT01847755|11759151|FG000|STARTED|Overall Study||18
10602256|NCT01847755|11759151|FG000|COMPLETED|Overall Study||13
10602257|NCT01847755|11759151|FG000|NOT COMPLETED|Overall Study||5
10602258|NCT01847885|11759157|FG000|STARTED|Initial Enrollment (Consented)||88
10602259|NCT01847885|11759158|FG001|STARTED|Initial Enrollment (Consented)||0
10602260|NCT01847885|11759159|FG002|STARTED|Initial Enrollment (Consented)||0
10602261|NCT01847885|11759157|FG000|Randomized|Initial Enrollment (Consented)||46
10602262|NCT01847885|11759158|FG001|Randomized|Initial Enrollment (Consented)||0
10602263|NCT01847885|11759159|FG002|Randomized|Initial Enrollment (Consented)||0
10602264|NCT01847885|11759157|FG000|Full Analysis Set|Initial Enrollment (Consented)||43
10602265|NCT01847885|11759158|FG001|Full Analysis Set|Initial Enrollment (Consented)||0
10602266|NCT01847885|11759159|FG002|Full Analysis Set|Initial Enrollment (Consented)||0
10602267|NCT01847885|11759157|FG000|Safety Set|Initial Enrollment (Consented)||41
10602268|NCT01847885|11759158|FG001|Safety Set|Initial Enrollment (Consented)||0
10602269|NCT01847885|11759159|FG002|Safety Set|Initial Enrollment (Consented)||0
10602270|NCT01847885|11759157|FG000|Per Protocol Set|Initial Enrollment (Consented)||40
10602271|NCT01847885|11759158|FG001|Per Protocol Set|Initial Enrollment (Consented)||0
10602272|NCT01847885|11759159|FG002|Per Protocol Set|Initial Enrollment (Consented)||0
10602273|NCT01847885|11759157|FG000|COMPLETED|Initial Enrollment (Consented)||40
10602274|NCT01847885|11759158|FG001|COMPLETED|Initial Enrollment (Consented)||0
10602275|NCT01847885|11759159|FG002|COMPLETED|Initial Enrollment (Consented)||0
10602276|NCT01847885|11759157|FG000|NOT COMPLETED|Initial Enrollment (Consented)||48
10602277|NCT01847885|11759158|FG001|NOT COMPLETED|Initial Enrollment (Consented)||0
10602278|NCT01847885|11759159|FG002|NOT COMPLETED|Initial Enrollment (Consented)||0
10602279|NCT01847885|11759157|FG000|STARTED|Randomization||0
10602280|NCT01847885|11759158|FG001|STARTED|Randomization||31
10602281|NCT01847885|11759159|FG002|STARTED|Randomization||15
10602282|NCT01847885|11759157|FG000|Full Analysis Set|Randomization||0
10602283|NCT01847885|11759158|FG001|Full Analysis Set|Randomization||28
10602284|NCT01847885|11759159|FG002|Full Analysis Set|Randomization||15
10602285|NCT01847885|11759157|FG000|Safety Set|Randomization||0
10602286|NCT01847885|11759158|FG001|Safety Set|Randomization||28
10602287|NCT01847885|11759159|FG002|Safety Set|Randomization||13
10602288|NCT01847885|11759157|FG000|Per Protocol Set|Randomization||0
10602289|NCT01847885|11759158|FG001|Per Protocol Set|Randomization||27
10602290|NCT01847885|11759159|FG002|Per Protocol Set|Randomization||13
10602291|NCT01847885|11759157|FG000|COMPLETED|Randomization||0
10602292|NCT01847885|11759158|FG001|COMPLETED|Randomization||27
10602293|NCT01847885|11759159|FG002|COMPLETED|Randomization||13
10602294|NCT01847885|11759157|FG000|NOT COMPLETED|Randomization||0
10602295|NCT01847885|11759158|FG001|NOT COMPLETED|Randomization||4
10602296|NCT01847885|11759159|FG002|NOT COMPLETED|Randomization||2
10602297|NCT01848041|11759174|FG000|STARTED|Overall Study||15
10602298|NCT01848041|11759175|FG001|STARTED|Overall Study||16
10602299|NCT01848041|11759176|FG002|STARTED|Overall Study||15
10602300|NCT01848041|11759174|FG000|COMPLETED|Overall Study||15
10602301|NCT01848041|11759175|FG001|COMPLETED|Overall Study||16
10602302|NCT01848041|11759176|FG002|COMPLETED|Overall Study||15
10602303|NCT01848041|11759174|FG000|NOT COMPLETED|Overall Study||0
10602304|NCT01848041|11759175|FG001|NOT COMPLETED|Overall Study||0
10602305|NCT01848041|11759176|FG002|NOT COMPLETED|Overall Study||0
10602306|NCT01848054|11759189|FG000|STARTED|Induction Phase||155
10602307|NCT01848054|11759190|FG001|STARTED|Induction Phase||155
10602308|NCT01848054|11759189|FG000|COMPLETED|Induction Phase||132
10602309|NCT01848054|11759190|FG001|COMPLETED|Induction Phase||147
10602310|NCT01848054|11759189|FG000|NOT COMPLETED|Induction Phase||23
10602311|NCT01848054|11759190|FG001|NOT COMPLETED|Induction Phase||8
10602312|NCT01848054|11759189|FG000|STARTED|Stabilization/Maintenance||132
10602313|NCT01848054|11759190|FG001|STARTED|Stabilization/Maintenance||147
10602314|NCT01848054|11759189|FG000|COMPLETED|Stabilization/Maintenance||92
10602315|NCT01848054|11759190|FG001|COMPLETED|Stabilization/Maintenance||107
10602316|NCT01848054|11759189|FG000|NOT COMPLETED|Stabilization/Maintenance||40
10602317|NCT01848054|11759190|FG001|NOT COMPLETED|Stabilization/Maintenance||40
10602318|NCT01848067|11759200|FG000|STARTED|Overall Study||9
10602319|NCT01848067|11759200|FG000|COMPLETED|Overall Study||9
10602320|NCT01848067|11759200|FG000|NOT COMPLETED|Overall Study||0
10602321|NCT01848145|11759204|FG000|STARTED|Infusion 1: Week 1, Day 1 - 226 Minutes||34
10602400|NCT01848457|11759275|FG001|STARTED|Overall Study||3
10602401|NCT01848457|11759276|FG002|STARTED|Overall Study||3
10602322|NCT01848145|11759204|FG000|Completed Within 15min of Infusion Time|Infusion 1: Week 1, Day 1 - 226 Minutes|Number of patients who completed within 15 minutes (min) of infusion time.|1
10602323|NCT01848145|11759204|FG000|COMPLETED|Infusion 1: Week 1, Day 1 - 226 Minutes|Includes participants that completed Infusion 1 and proceeded to the next infusion, Infusion 2.|33
10602324|NCT01848145|11759204|FG000|NOT COMPLETED|Infusion 1: Week 1, Day 1 - 226 Minutes||1
10602325|NCT01848145|11759204|FG000|STARTED|Infusion 2: Week 1, Day 3 - 167 Minutes||33
10602326|NCT01848145|11759204|FG000|Completed Within 15min of Infusion Time|Infusion 2: Week 1, Day 3 - 167 Minutes||24
10602327|NCT01848145|11759204|FG000|COMPLETED|Infusion 2: Week 1, Day 3 - 167 Minutes|Includes participants that completed Infusion 2 and proceeded to the next infusion, Infusion 3.|31
10602328|NCT01848145|11759204|FG000|NOT COMPLETED|Infusion 2: Week 1, Day 3 - 167 Minutes||2
10602329|NCT01848145|11759204|FG000|STARTED|Infusion 3: Week 2, Day 1 - 120 Minutes||31
10602330|NCT01848145|11759204|FG000|Completed Within 15min of Infusion Time|Infusion 3: Week 2, Day 1 - 120 Minutes||26
10602331|NCT01848145|11759204|FG000|COMPLETED|Infusion 3: Week 2, Day 1 - 120 Minutes||30
10602332|NCT01848145|11759204|FG000|NOT COMPLETED|Infusion 3: Week 2, Day 1 - 120 Minutes||1
10602333|NCT01848145|11759204|FG000|STARTED|Subsequent Infusions: Weeks 3-8||30
10602334|NCT01848145|11759204|FG000|COMPLETED|Subsequent Infusions: Weeks 3-8||20
10602335|NCT01848145|11759204|FG000|NOT COMPLETED|Subsequent Infusions: Weeks 3-8||10
10602336|NCT01848158|11759210|FG000|STARTED|Overall Study||10
10602337|NCT01848158|11759211|FG001|STARTED|Overall Study||7
10602338|NCT01848158|11759210|FG000|COMPLETED|Overall Study||10
10602339|NCT01848158|11759211|FG001|COMPLETED|Overall Study||7
10602340|NCT01848158|11759210|FG000|NOT COMPLETED|Overall Study||0
10602341|NCT01848158|11759211|FG001|NOT COMPLETED|Overall Study||0
10602342|NCT01848184|11759217|FG000|STARTED|Overall Study||126
10602343|NCT01848184|11759217|FG000|COMPLETED|Overall Study||100
10602344|NCT01848184|11759217|FG000|NOT COMPLETED|Overall Study||26
10602345|NCT01848210|11759229|FG000|STARTED|Overall Study||411
10602346|NCT01848210|11759230|FG001|STARTED|Overall Study||418
10602347|NCT01848210|11759229|FG000|Safety Population-Received Study Drug|Overall Study||394
10602348|NCT01848210|11759230|FG001|Safety Population-Received Study Drug|Overall Study||398
10602349|NCT01848210|11759229|FG000|Intent-to-Treat (ITT) Population|Overall Study||383
10602350|NCT01848210|11759230|FG001|Intent-to-Treat (ITT) Population|Overall Study||388
10602351|NCT01848210|11759229|FG000|Per Protocol Population|Overall Study||222
10602352|NCT01848210|11759230|FG001|Per Protocol Population|Overall Study||245
10602353|NCT01848210|11759229|FG000|COMPLETED|Overall Study||323
10602354|NCT01848210|11759230|FG001|COMPLETED|Overall Study||340
10602355|NCT01848210|11759229|FG000|NOT COMPLETED|Overall Study||88
10602356|NCT01848210|11759230|FG001|NOT COMPLETED|Overall Study||78
10602357|NCT01848288|11759236|FG000|STARTED|Overall Study||100
10602358|NCT01848288|11759236|FG000|COMPLETED|Overall Study|Two subjects were discontinued prior to undergoing surgery.|97
10602359|NCT01848288|11759236|FG000|NOT COMPLETED|Overall Study||3
10602360|NCT01848353|11759245|FG000|STARTED|Phase 1||38
10602361|NCT01848353|11759246|FG001|STARTED|Phase 1||43
10602362|NCT01848353|11759247|FG002|STARTED|Phase 1||20
10602363|NCT01848353|11759248|FG003|STARTED|Phase 1||19
10602364|NCT01848353|11759245|FG000|COMPLETED|Phase 1||35
10602365|NCT01848353|11759246|FG001|COMPLETED|Phase 1||42
10602366|NCT01848353|11759247|FG002|COMPLETED|Phase 1||20
10602367|NCT01848353|11759248|FG003|COMPLETED|Phase 1||19
10602368|NCT01848353|11759245|FG000|NOT COMPLETED|Phase 1||3
10602369|NCT01848353|11759246|FG001|NOT COMPLETED|Phase 1||1
10602370|NCT01848353|11759247|FG002|NOT COMPLETED|Phase 1||0
10602371|NCT01848353|11759248|FG003|NOT COMPLETED|Phase 1||0
10602372|NCT01848353|11759245|FG000|STARTED|Phase 2|26 participants from Phase 1 intervention (both groups) withdrew and did not complete Phase 2|23
10652461|NCT02185131|11812835|FG001|STARTED|Overall Study||9
10602373|NCT01848353|11759246|FG001|STARTED|Phase 2|26 participants from Phase 1 intervention (both groups) withdrew and did not complete Phase 2|28
10602374|NCT01848353|11759247|FG002|STARTED|Phase 2|Normal weight participants only completed baseline testing in Phase 1.|0
10602375|NCT01848353|11759248|FG003|STARTED|Phase 2|Normal weight participants only completed baseline testing in Phase 1.|0
10602376|NCT01848353|11759245|FG000|COMPLETED|Phase 2||20
10602377|NCT01848353|11759246|FG001|COMPLETED|Phase 2||26
10602378|NCT01848353|11759247|FG002|COMPLETED|Phase 2||0
10602379|NCT01848353|11759248|FG003|COMPLETED|Phase 2||0
10602380|NCT01848353|11759245|FG000|NOT COMPLETED|Phase 2||3
10602381|NCT01848353|11759246|FG001|NOT COMPLETED|Phase 2||2
10602382|NCT01848353|11759247|FG002|NOT COMPLETED|Phase 2||0
10602383|NCT01848353|11759248|FG003|NOT COMPLETED|Phase 2||0
10602384|NCT01848353|11759245|FG000|STARTED|Phase 3|31 participants from Phase 2 intervention (both groups) withdrew and did not complete Phase 3|5
10602385|NCT01848353|11759246|FG001|STARTED|Phase 3|31 participants from Phase 2 intervention (both groups) withdrew and did not complete Phase 3|10
10602386|NCT01848353|11759247|FG002|STARTED|Phase 3|Normal weight participants only completed baseline testing in Phase 1.|0
10602387|NCT01848353|11759248|FG003|STARTED|Phase 3|Normal weight participants only completed baseline testing in Phase 1.|0
10602388|NCT01848353|11759245|FG000|COMPLETED|Phase 3||4
10602389|NCT01848353|11759246|FG001|COMPLETED|Phase 3||9
10602390|NCT01848353|11759247|FG002|COMPLETED|Phase 3||0
10602391|NCT01848353|11759248|FG003|COMPLETED|Phase 3||0
10602392|NCT01848353|11759245|FG000|NOT COMPLETED|Phase 3||1
10602393|NCT01848353|11759246|FG001|NOT COMPLETED|Phase 3||1
10602394|NCT01848353|11759247|FG002|NOT COMPLETED|Phase 3||0
10602395|NCT01848353|11759248|FG003|NOT COMPLETED|Phase 3||0
10602396|NCT01848366|11759266|FG000|STARTED|Overall Study||8
10602397|NCT01848366|11759266|FG000|COMPLETED|Overall Study||8
10602398|NCT01848366|11759266|FG000|NOT COMPLETED|Overall Study||0
10602399|NCT01848457|11759274|FG000|STARTED|Overall Study||4
10602402|NCT01848457|11759277|FG003|STARTED|Overall Study||3
10602403|NCT01848457|11759274|FG000|Baseline|Overall Study||4
10602404|NCT01848457|11759275|FG001|Baseline|Overall Study||3
10602405|NCT01848457|11759276|FG002|Baseline|Overall Study||3
10602406|NCT01848457|11759277|FG003|Baseline|Overall Study||3
10602407|NCT01848457|11759274|FG000|Cycle 1|Overall Study||4
10602408|NCT01848457|11759275|FG001|Cycle 1|Overall Study||3
10602409|NCT01848457|11759276|FG002|Cycle 1|Overall Study||3
10602410|NCT01848457|11759277|FG003|Cycle 1|Overall Study||3
10602411|NCT01848457|11759274|FG000|Cycle 2|Overall Study||3
10602412|NCT01848457|11759275|FG001|Cycle 2|Overall Study||3
10602413|NCT01848457|11759276|FG002|Cycle 2|Overall Study||3
10602414|NCT01848457|11759277|FG003|Cycle 2|Overall Study||3
10602415|NCT01848457|11759274|FG000|Cycle 3|Overall Study||3
10602416|NCT01848457|11759275|FG001|Cycle 3|Overall Study||3
10602417|NCT01848457|11759276|FG002|Cycle 3|Overall Study||3
10602418|NCT01848457|11759277|FG003|Cycle 3|Overall Study||3
10602419|NCT01848457|11759274|FG000|Cycle 4|Overall Study||3
10602420|NCT01848457|11759275|FG001|Cycle 4|Overall Study||3
10602421|NCT01848457|11759276|FG002|Cycle 4|Overall Study||3
10602422|NCT01848457|11759277|FG003|Cycle 4|Overall Study||3
10602423|NCT01848457|11759274|FG000|COMPLETED|Overall Study||3
10602424|NCT01848457|11759275|FG001|COMPLETED|Overall Study||3
10602425|NCT01848457|11759276|FG002|COMPLETED|Overall Study||3
10602426|NCT01848457|11759277|FG003|COMPLETED|Overall Study||3
10602427|NCT01848457|11759274|FG000|NOT COMPLETED|Overall Study||1
10602428|NCT01848457|11759275|FG001|NOT COMPLETED|Overall Study||0
10602429|NCT01848457|11759276|FG002|NOT COMPLETED|Overall Study||0
10602430|NCT01848457|11759277|FG003|NOT COMPLETED|Overall Study||0
10602431|NCT01848483|11759297|FG000|STARTED|Overall Study||61
10602432|NCT01848483|11759298|FG001|STARTED|Overall Study||60
10602433|NCT01848483|11759297|FG000|COMPLETED|Overall Study||50
10602434|NCT01848483|11759298|FG001|COMPLETED|Overall Study||49
10602435|NCT01848483|11759297|FG000|NOT COMPLETED|Overall Study||11
10602436|NCT01848483|11759298|FG001|NOT COMPLETED|Overall Study||11
10602437|NCT01848756|11759305|FG000|STARTED|Overall Study||15
10602438|NCT01848756|11759305|FG000|COMPLETED|Overall Study|Cycle 1|12
10602439|NCT01848756|11759305|FG000|NOT COMPLETED|Overall Study||3
10602440|NCT01848821|11759312|FG000|STARTED|Overall Study||7
10602441|NCT01848821|11759313|FG001|STARTED|Overall Study||7
10602442|NCT01848821|11759312|FG000|COMPLETED|Overall Study||7
10602443|NCT01848821|11759313|FG001|COMPLETED|Overall Study||7
10602444|NCT01848821|11759312|FG000|NOT COMPLETED|Overall Study||0
10602445|NCT01848821|11759313|FG001|NOT COMPLETED|Overall Study||0
10602446|NCT01848834|11759324|FG000|STARTED|Overall Study||32
10602447|NCT01848834|11759325|FG001|STARTED|Overall Study||61
10602448|NCT01848834|11759326|FG002|STARTED|Overall Study||33
10602449|NCT01848834|11759327|FG003|STARTED|Overall Study||39
10602450|NCT01848834|11759328|FG004|STARTED|Overall Study||132
10602451|NCT01848834|11759324|FG000|Treated|Overall Study||32
10602452|NCT01848834|11759325|FG001|Treated|Overall Study||60
10602453|NCT01848834|11759326|FG002|Treated|Overall Study||33
10602454|NCT01848834|11759327|FG003|Treated|Overall Study||39
10602455|NCT01848834|11759328|FG004|Treated|Overall Study||132
10602456|NCT01848834|11759324|FG000|COMPLETED|Overall Study|Completed means two-year treatment completed|13
10602457|NCT01848834|11759325|FG001|COMPLETED|Overall Study|Completed means two-year treatment completed|13
10602458|NCT01848834|11759326|FG002|COMPLETED|Overall Study|Completed means two-year treatment completed|9
10602459|NCT01848834|11759327|FG003|COMPLETED|Overall Study|Completed means two-year treatment completed|13
10602460|NCT01848834|11759328|FG004|COMPLETED|Overall Study|Completed means two-year treatment completed|38
10602461|NCT01848834|11759324|FG000|NOT COMPLETED|Overall Study||19
10602462|NCT01848834|11759325|FG001|NOT COMPLETED|Overall Study||48
10602463|NCT01848834|11759326|FG002|NOT COMPLETED|Overall Study||24
10602464|NCT01848834|11759327|FG003|NOT COMPLETED|Overall Study||26
10602465|NCT01848834|11759328|FG004|NOT COMPLETED|Overall Study||94
10602466|NCT01848847|11759346|FG000|STARTED|Overall Study||51
10602467|NCT01848847|11759347|FG001|STARTED|Overall Study||51
10602468|NCT01848847|11759346|FG000|COMPLETED|Overall Study||49
10602469|NCT01848847|11759347|FG001|COMPLETED|Overall Study||48
10602470|NCT01848847|11759346|FG000|NOT COMPLETED|Overall Study||2
10602471|NCT01848847|11759347|FG001|NOT COMPLETED|Overall Study||3
10602472|NCT01848899|11759355|FG000|STARTED|Overall Study||50
10602473|NCT01848899|11759356|FG001|STARTED|Overall Study||50
10602474|NCT01848899|11759355|FG000|COMPLETED|Overall Study||50
10602475|NCT01848899|11759356|FG001|COMPLETED|Overall Study||50
10602476|NCT01848899|11759355|FG000|NOT COMPLETED|Overall Study||0
10602477|NCT01848899|11759356|FG001|NOT COMPLETED|Overall Study||0
10602478|NCT01848938|11759364|FG000|STARTED|Overall Study||62
10602479|NCT01848938|11759365|FG001|STARTED|Overall Study||61
10602480|NCT01848938|11759364|FG000|COMPLETED|Overall Study||61
10602481|NCT01848938|11759365|FG001|COMPLETED|Overall Study||60
10602482|NCT01848938|11759364|FG000|NOT COMPLETED|Overall Study||1
10602483|NCT01848938|11759365|FG001|NOT COMPLETED|Overall Study||1
10602484|NCT01848977|11759371|FG000|STARTED|Overall Study||20
10602485|NCT01848977|11759371|FG000|COMPLETED|Overall Study||20
10602486|NCT01848977|11759371|FG000|NOT COMPLETED|Overall Study||0
10602487|NCT01848990|11759383|FG000|STARTED|Overall Study||227
10602488|NCT01848990|11759384|FG001|STARTED|Overall Study||115
10602489|NCT01848990|11759385|FG002|STARTED|Overall Study|One participant was randomized and withdrew consent before start of study treatment.|114
10602490|NCT01848990|11759383|FG000|Received at Least 1 Dose of Study Drug|Overall Study||227
10602491|NCT01848990|11759384|FG001|Received at Least 1 Dose of Study Drug|Overall Study||115
10602492|NCT01848990|11759385|FG002|Received at Least 1 Dose of Study Drug|Overall Study||113
10602493|NCT01848990|11759383|FG000|Completed Month 6|Overall Study||194
10602494|NCT01848990|11759384|FG001|Completed Month 6|Overall Study||106
10602495|NCT01848990|11759385|FG002|Completed Month 6|Overall Study||103
10602496|NCT01848990|11759383|FG000|COMPLETED|Overall Study||181
10602497|NCT01848990|11759384|FG001|COMPLETED|Overall Study||95
10602498|NCT01848990|11759385|FG002|COMPLETED|Overall Study||98
10602499|NCT01848990|11759383|FG000|NOT COMPLETED|Overall Study||46
10602500|NCT01848990|11759384|FG001|NOT COMPLETED|Overall Study||20
10602501|NCT01848990|11759385|FG002|NOT COMPLETED|Overall Study||16
10602502|NCT01849055|11759403|FG000|STARTED|Overall Study||8
10602503|NCT01849055|11759404|FG001|STARTED|Overall Study||8
10602504|NCT01849055|11759405|FG002|STARTED|Overall Study||8
10602505|NCT01849055|11759406|FG003|STARTED|Overall Study||8
10602506|NCT01849055|11759407|FG004|STARTED|Overall Study||8
10602507|NCT01849055|11759408|FG005|STARTED|Overall Study||8
10602508|NCT01849055|11759403|FG000|COMPLETED|Overall Study||8
10602509|NCT01849055|11759404|FG001|COMPLETED|Overall Study||8
10602510|NCT01849055|11759405|FG002|COMPLETED|Overall Study||7
10602511|NCT01849055|11759406|FG003|COMPLETED|Overall Study||8
10602512|NCT01849055|11759407|FG004|COMPLETED|Overall Study||8
10602513|NCT01849055|11759408|FG005|COMPLETED|Overall Study||8
10602514|NCT01849055|11759403|FG000|NOT COMPLETED|Overall Study||0
10602515|NCT01849055|11759404|FG001|NOT COMPLETED|Overall Study||0
10602516|NCT01849055|11759405|FG002|NOT COMPLETED|Overall Study||1
10602517|NCT01849055|11759406|FG003|NOT COMPLETED|Overall Study||0
10602518|NCT01849055|11759407|FG004|NOT COMPLETED|Overall Study||0
10602519|NCT01849055|11759408|FG005|NOT COMPLETED|Overall Study||0
10602520|NCT01849068|11759428|FG000|STARTED|Overall Study||10
10602521|NCT01849068|11759429|FG001|STARTED|Overall Study||10
10602522|NCT01849068|11759428|FG000|COMPLETED|Overall Study||10
10602523|NCT01849068|11759429|FG001|COMPLETED|Overall Study||10
10602524|NCT01849068|11759428|FG000|NOT COMPLETED|Overall Study||0
10602525|NCT01849068|11759429|FG001|NOT COMPLETED|Overall Study||0
10602526|NCT01849172|11759437|FG000|STARTED|Overall Study||180
10602527|NCT01849172|11759438|FG001|STARTED|Overall Study||180
10602528|NCT01849172|11759437|FG000|COMPLETED|Overall Study||173
10602529|NCT01849172|11759438|FG001|COMPLETED|Overall Study||174
10602530|NCT01849172|11759437|FG000|NOT COMPLETED|Overall Study||7
10602531|NCT01849172|11759438|FG001|NOT COMPLETED|Overall Study||6
10602532|NCT01849276|11759444|FG000|STARTED|Registered to the Study||2
10602533|NCT01849276|11759444|FG000|COMPLETED|Registered to the Study||2
10602534|NCT01849276|11759444|FG000|NOT COMPLETED|Registered to the Study||0
10602535|NCT01849276|11759444|FG000|STARTED|Completed Treatment||2
10602536|NCT01849276|11759444|FG000|COMPLETED|Completed Treatment||2
10602537|NCT01849276|11759444|FG000|NOT COMPLETED|Completed Treatment||0
10602538|NCT01849276|11759444|FG000|STARTED|Followed for Survival for 5 Years||2
10602539|NCT01849276|11759444|FG000|COMPLETED|Followed for Survival for 5 Years||0
10602540|NCT01849276|11759444|FG000|NOT COMPLETED|Followed for Survival for 5 Years||2
10602541|NCT01849289|11759450|FG000|STARTED|Overall Study||555
10602542|NCT01849289|11759451|FG001|STARTED|Overall Study||278
10602543|NCT01849289|11759450|FG000|Exposed|Overall Study|2 subjects withdrew prior to exposure of trial products|553
10602544|NCT01849289|11759451|FG001|Exposed|Overall Study||278
10602545|NCT01849289|11759450|FG000|COMPLETED|Overall Study||523
10602546|NCT01849289|11759451|FG001|COMPLETED|Overall Study||254
10704027|NCT02588664|11868557|FG001|COMPLETED|Overall Study||1644
10704028|NCT02588664|11868556|FG000|NOT COMPLETED|Overall Study||1361
10704029|NCT02588664|11868557|FG001|NOT COMPLETED|Overall Study||1045
10704030|NCT02588833|11868565|FG000|STARTED|Part 1|One subject was enrolled in both cohorts, this subject was enrolled twice.|3
10704031|NCT02588833|11868566|FG001|STARTED|Part 1|One subject was enrolled in both cohorts, this subject was enrolled twice.|20
10704032|NCT02588833|11868565|FG000|COMPLETED|Part 1||2
10704033|NCT02588833|11868566|FG001|COMPLETED|Part 1||20
10704034|NCT02588833|11868565|FG000|NOT COMPLETED|Part 1||1
10704035|NCT02588833|11868566|FG001|NOT COMPLETED|Part 1||0
10704036|NCT02588833|11868565|FG000|STARTED|Part 2A|Part 2A is not applicable since Cohort 1 subjects proceeded immediately to Part 3.|0
10704037|NCT02588833|11868566|FG001|STARTED|Part 2A||20
10704038|NCT02588833|11868565|FG000|COMPLETED|Part 2A||0
10704039|NCT02588833|11868566|FG001|COMPLETED|Part 2A||18
10602547|NCT01849289|11759450|FG000|NOT COMPLETED|Overall Study||32
10602548|NCT01849289|11759451|FG001|NOT COMPLETED|Overall Study||24
10602549|NCT01849419|11759457|FG000|STARTED|Overall Study||65
10602550|NCT01849419|11759457|FG000|COMPLETED|Overall Study||65
10602551|NCT01849419|11759457|FG000|NOT COMPLETED|Overall Study||0
10602552|NCT01849458|11759462|FG000|STARTED|Overall Study||50
10602553|NCT01849458|11759462|FG000|6 Months Follow-up|Overall Study||50
10602554|NCT01849458|11759462|FG000|COMPLETED|Overall Study||46
10602555|NCT01849458|11759462|FG000|NOT COMPLETED|Overall Study||4
10602556|NCT01849497|11759468|FG000|STARTED|Overall Study||75
10602557|NCT01849497|11759469|FG001|STARTED|Overall Study||74
10602558|NCT01849497|11759468|FG000|Received Treatment|Overall Study||75
10602559|NCT01849497|11759469|FG001|Received Treatment|Overall Study||74
10602560|NCT01849497|11759468|FG000|COMPLETED|Overall Study||74
10602561|NCT01849497|11759469|FG001|COMPLETED|Overall Study||70
10602562|NCT01849497|11759468|FG000|NOT COMPLETED|Overall Study||1
10602563|NCT01849497|11759469|FG001|NOT COMPLETED|Overall Study||4
10602564|NCT01849562|11759478|FG000|STARTED|Overall Study||10
10602565|NCT01849562|11759479|FG001|STARTED|Overall Study||10
10602566|NCT01849562|11759480|FG002|STARTED|Overall Study||10
10602567|NCT01849562|11759478|FG000|COMPLETED|Overall Study||8
10602568|NCT01849562|11759479|FG001|COMPLETED|Overall Study||10
10602569|NCT01849562|11759480|FG002|COMPLETED|Overall Study||10
10602570|NCT01849562|11759478|FG000|NOT COMPLETED|Overall Study||2
10602571|NCT01849562|11759479|FG001|NOT COMPLETED|Overall Study||0
10602572|NCT01849562|11759480|FG002|NOT COMPLETED|Overall Study||0
10602579|NCT01849588|11759500|FG000|STARTED|Overall Study||3
10602580|NCT01849588|11759500|FG000|COMPLETED|Overall Study||0
10602581|NCT01849588|11759500|FG000|NOT COMPLETED|Overall Study||3
10602582|NCT01849692|11759506|FG000|STARTED|Overall Study||10
10602583|NCT01849692|11759507|FG001|STARTED|Overall Study||3
10602584|NCT01849692|11759508|FG002|STARTED|Overall Study||10
10602585|NCT01849692|11759509|FG003|STARTED|Overall Study||3
10602586|NCT01849692|11759510|FG004|STARTED|Overall Study||10
10602587|NCT01849692|11759511|FG005|STARTED|Overall Study||3
10602588|NCT01849692|11759512|FG006|STARTED|Overall Study||10
10602589|NCT01849692|11759513|FG007|STARTED|Overall Study||3
10602590|NCT01849692|11759506|FG000|COMPLETED|Overall Study||10
10602591|NCT01849692|11759507|FG001|COMPLETED|Overall Study||3
10602592|NCT01849692|11759508|FG002|COMPLETED|Overall Study||10
10602593|NCT01849692|11759509|FG003|COMPLETED|Overall Study||3
10602594|NCT01849692|11759510|FG004|COMPLETED|Overall Study||10
10602595|NCT01849692|11759511|FG005|COMPLETED|Overall Study||3
10602596|NCT01849692|11759512|FG006|COMPLETED|Overall Study||10
10602597|NCT01849692|11759513|FG007|COMPLETED|Overall Study||3
10602598|NCT01849692|11759506|FG000|NOT COMPLETED|Overall Study||0
10602599|NCT01849692|11759507|FG001|NOT COMPLETED|Overall Study||0
10602600|NCT01849692|11759508|FG002|NOT COMPLETED|Overall Study||0
10602601|NCT01849692|11759509|FG003|NOT COMPLETED|Overall Study||0
10602602|NCT01849692|11759510|FG004|NOT COMPLETED|Overall Study||0
10602603|NCT01849692|11759511|FG005|NOT COMPLETED|Overall Study||0
10602604|NCT01849692|11759512|FG006|NOT COMPLETED|Overall Study||0
10602605|NCT01849692|11759513|FG007|NOT COMPLETED|Overall Study||0
10602606|NCT01849770|11759537|FG000|STARTED|Overall Study||20
10704040|NCT02588833|11868565|FG000|NOT COMPLETED|Part 2A||0
10704041|NCT02588833|11868566|FG001|NOT COMPLETED|Part 2A||2
10704042|NCT02588833|11868565|FG000|STARTED|Part 2B||0
10602607|NCT01849770|11759538|FG001|STARTED|Overall Study||19
10602608|NCT01849770|11759539|FG002|STARTED|Overall Study||20
10602609|NCT01849770|11759537|FG000|COMPLETED|Overall Study||20
10602610|NCT01849770|11759538|FG001|COMPLETED|Overall Study||15
10602611|NCT01849770|11759539|FG002|COMPLETED|Overall Study||19
10704043|NCT02588833|11868566|FG001|STARTED|Part 2B||18
10704044|NCT02588833|11868565|FG000|COMPLETED|Part 2B||0
10602612|NCT01849770|11759537|FG000|NOT COMPLETED|Overall Study||0
10602613|NCT01849770|11759538|FG001|NOT COMPLETED|Overall Study||4
10602614|NCT01849770|11759539|FG002|NOT COMPLETED|Overall Study||1
10602615|NCT01849822|11759549|FG000|STARTED|Overall Study||1
10602616|NCT01849822|11759549|FG000|COMPLETED|Overall Study||1
10602617|NCT01849822|11759549|FG000|NOT COMPLETED|Overall Study||0
10602618|NCT01849848|11759553|FG000|STARTED|Overall Study||17
10704045|NCT02588833|11868566|FG001|COMPLETED|Part 2B||17
10602619|NCT01849848|11759553|FG000|COMPLETED|Overall Study||13
10602620|NCT01849848|11759553|FG000|NOT COMPLETED|Overall Study||4
10602621|NCT01850030|11759559|FG000|STARTED|Overall Study||520
10602622|NCT01850030|11759560|FG001|STARTED|Overall Study||511
10602623|NCT01850030|11759559|FG000|COMPLETED|Overall Study||173
10602624|NCT01850030|11759560|FG001|COMPLETED|Overall Study||142
10602625|NCT01850030|11759559|FG000|NOT COMPLETED|Overall Study||347
10602626|NCT01850030|11759560|FG001|NOT COMPLETED|Overall Study||369
10602627|NCT01850394|11759569|FG000|STARTED|Overall Study||45
10602628|NCT01850394|11759570|FG001|STARTED|Overall Study||45
10602629|NCT01850394|11759571|FG002|STARTED|Overall Study||45
10602630|NCT01850394|11759569|FG000|COMPLETED|Overall Study||45
10602631|NCT01850394|11759570|FG001|COMPLETED|Overall Study||45
10602632|NCT01850394|11759571|FG002|COMPLETED|Overall Study||45
10602633|NCT01850394|11759569|FG000|NOT COMPLETED|Overall Study||0
10602634|NCT01850394|11759570|FG001|NOT COMPLETED|Overall Study||0
10602635|NCT01850394|11759571|FG002|NOT COMPLETED|Overall Study||0
10602636|NCT01850446|11759581|FG000|STARTED|Overall Study||92
10602637|NCT01850446|11759582|FG001|STARTED|Overall Study||92
10602638|NCT01850446|11759581|FG000|COMPLETED|Overall Study||87
10602639|NCT01850446|11759582|FG001|COMPLETED|Overall Study||90
10602640|NCT01850446|11759581|FG000|NOT COMPLETED|Overall Study||5
10602641|NCT01850446|11759582|FG001|NOT COMPLETED|Overall Study||2
10602642|NCT01850485|11759590|FG000|STARTED|Overall Study||9
10602643|NCT01850485|11759591|FG001|STARTED|Overall Study||13
10704046|NCT02588833|11868565|FG000|NOT COMPLETED|Part 2B||0
10704047|NCT02588833|11868566|FG001|NOT COMPLETED|Part 2B||1
10704048|NCT02588833|11868565|FG000|STARTED|Part 2C||0
10704049|NCT02588833|11868566|FG001|STARTED|Part 2C|17 subjects completed Part 2B and 3 entered extension study without participating in Part 2C.|14
10704050|NCT02588833|11868565|FG000|COMPLETED|Part 2C||0
10704051|NCT02588833|11868566|FG001|COMPLETED|Part 2C||12
10704052|NCT02588833|11868565|FG000|NOT COMPLETED|Part 2C||0
10704053|NCT02588833|11868566|FG001|NOT COMPLETED|Part 2C||2
10704054|NCT02588833|11868565|FG000|STARTED|Part 3 (Safety Follow-up)|Only subjects who did not enter extension study or Part 2C entered Part 3.|3
10704055|NCT02588833|11868566|FG001|STARTED|Part 3 (Safety Follow-up)|Only subjects who did not enter extension study or Part 2C entered Part 3.|4
10704056|NCT02588833|11868565|FG000|COMPLETED|Part 3 (Safety Follow-up)||3
10704057|NCT02588833|11868566|FG001|COMPLETED|Part 3 (Safety Follow-up)||2
10704058|NCT02588833|11868565|FG000|NOT COMPLETED|Part 3 (Safety Follow-up)||0
10704059|NCT02588833|11868566|FG001|NOT COMPLETED|Part 3 (Safety Follow-up)||2
10704060|NCT02588872|11868575|FG000|STARTED|Overall Study||59
10704061|NCT02588872|11868576|FG001|STARTED|Overall Study||52
10704062|NCT02588872|11868575|FG000|COMPLETED|Overall Study||59
10704063|NCT02588872|11868576|FG001|COMPLETED|Overall Study||52
10704064|NCT02588872|11868575|FG000|NOT COMPLETED|Overall Study||0
10704065|NCT02588872|11868576|FG001|NOT COMPLETED|Overall Study||0
10704066|NCT02588976|11868582|FG000|STARTED|Overall Study||30
10704067|NCT02588976|11868582|FG000|COMPLETED|Overall Study||30
10704068|NCT02588976|11868582|FG000|NOT COMPLETED|Overall Study||0
10704069|NCT02589067|11868589|FG000|STARTED|Overall Study||33
10602644|NCT01850485|11759590|FG000|COMPLETED|Overall Study||9
10602645|NCT01850485|11759591|FG001|COMPLETED|Overall Study||13
10602646|NCT01850485|11759590|FG000|NOT COMPLETED|Overall Study||0
10602647|NCT01850485|11759591|FG001|NOT COMPLETED|Overall Study||0
10602648|NCT01850550|11759599|FG000|STARTED|Overall Study||40
10602649|NCT01850550|11759600|FG001|STARTED|Overall Study||40
10602650|NCT01850550|11759599|FG000|COMPLETED|Overall Study||40
10602651|NCT01850550|11759600|FG001|COMPLETED|Overall Study||37
10602652|NCT01850550|11759599|FG000|NOT COMPLETED|Overall Study||0
10602653|NCT01850550|11759600|FG001|NOT COMPLETED|Overall Study||3
10602654|NCT01850589|11759608|FG000|STARTED|Overall Study||22
10602655|NCT01850589|11759609|FG001|STARTED|Overall Study||22
10602656|NCT01850589|11759608|FG000|COMPLETED|Overall Study||14
10602657|NCT01850589|11759609|FG001|COMPLETED|Overall Study||22
10602658|NCT01850589|11759608|FG000|NOT COMPLETED|Overall Study||8
10602659|NCT01850589|11759609|FG001|NOT COMPLETED|Overall Study||0
10602660|NCT01850602|11759617|FG000|STARTED|Overall Study||108
10602661|NCT01850602|11759618|FG001|STARTED|Overall Study||105
10602662|NCT01850602|11759617|FG000|COMPLETED|Overall Study||94
10602663|NCT01850602|11759618|FG001|COMPLETED|Overall Study||87
10602664|NCT01850602|11759617|FG000|NOT COMPLETED|Overall Study||14
10602665|NCT01850602|11759618|FG001|NOT COMPLETED|Overall Study||18
10602666|NCT01850615|11759626|FG000|STARTED|Overall Study||116
10602667|NCT01850615|11759627|FG001|STARTED|Overall Study||120
10602668|NCT01850615|11759626|FG000|Exposed|Overall Study||115
10602669|NCT01850615|11759627|FG001|Exposed|Overall Study||120
10602670|NCT01850615|11759626|FG000|COMPLETED|Overall Study||107
10602671|NCT01850615|11759627|FG001|COMPLETED|Overall Study||115
10602672|NCT01850615|11759626|FG000|NOT COMPLETED|Overall Study||9
10602673|NCT01850615|11759627|FG001|NOT COMPLETED|Overall Study||5
10602674|NCT01850641|11759633|FG000|STARTED|Overall Study||35
10602675|NCT01850641|11759633|FG000|COMPLETED|Overall Study||30
10602676|NCT01850641|11759633|FG000|NOT COMPLETED|Overall Study||5
10602677|NCT01850745|11759640|FG000|STARTED|Overall Study||147
10704070|NCT02589067|11868590|FG001|STARTED|Overall Study||34
10704071|NCT02589067|11868589|FG000|COMPLETED|Overall Study||28
10704072|NCT02589067|11868590|FG001|COMPLETED|Overall Study||28
10704073|NCT02589067|11868589|FG000|NOT COMPLETED|Overall Study||5
10602678|NCT01850745|11759641|FG001|STARTED|Overall Study||169
10602679|NCT01850745|11759642|FG002|STARTED|Overall Study||131
10602680|NCT01850745|11759640|FG000|COMPLETED|Overall Study||147
10602681|NCT01850745|11759641|FG001|COMPLETED|Overall Study||169
10602682|NCT01850745|11759642|FG002|COMPLETED|Overall Study||131
10602683|NCT01850745|11759640|FG000|NOT COMPLETED|Overall Study||0
10602684|NCT01850745|11759641|FG001|NOT COMPLETED|Overall Study||0
10602685|NCT01850745|11759642|FG002|NOT COMPLETED|Overall Study||0
10602686|NCT01850823|11759653|FG000|STARTED|Overall Study||175
10602687|NCT01850823|11759654|FG001|STARTED|Overall Study||350
10602688|NCT01850823|11759655|FG002|STARTED|Overall Study||355
10602689|NCT01850823|11759653|FG000|COMPLETED|Overall Study||172
10602690|NCT01850823|11759654|FG001|COMPLETED|Overall Study||347
10602691|NCT01850823|11759655|FG002|COMPLETED|Overall Study||345
10602692|NCT01850823|11759653|FG000|NOT COMPLETED|Overall Study||3
10602693|NCT01850823|11759654|FG001|NOT COMPLETED|Overall Study||3
10602694|NCT01850823|11759655|FG002|NOT COMPLETED|Overall Study||10
10602695|NCT01851330|11759668|FG000|STARTED|Overall Study||215
10602696|NCT01851330|11759669|FG001|STARTED|Overall Study||216
10602697|NCT01851330|11759670|FG002|STARTED|Overall Study||216
10602698|NCT01851330|11759668|FG000|COMPLETED|Overall Study||202
10602699|NCT01851330|11759669|FG001|COMPLETED|Overall Study||200
10602700|NCT01851330|11759670|FG002|COMPLETED|Overall Study||204
10602701|NCT01851330|11759668|FG000|NOT COMPLETED|Overall Study||13
10602702|NCT01851330|11759669|FG001|NOT COMPLETED|Overall Study||16
10602703|NCT01851330|11759670|FG002|NOT COMPLETED|Overall Study||12
10602704|NCT01851590|11759681|FG000|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|23
10602705|NCT01851590|11759682|FG001|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|25
10602706|NCT01851590|11759683|FG002|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|25
10602707|NCT01851590|11759681|FG000|At 3 Month: End of Terbinafine Treatment|Overall Study|Topical Resin Lacquer treatment continues ->|23
10602708|NCT01851590|11759682|FG001|At 3 Month: End of Terbinafine Treatment|Overall Study|Topical Amorolfine Lacquer Treatment continues ->|24
10602709|NCT01851590|11759683|FG002|At 3 Month: End of Terbinafine Treatment|Overall Study|End of oral Terbinafine treatment. Washout period of the Terbinafine treatment arm begins.|22
10602710|NCT01851590|11759681|FG000|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|23
10652495|NCT02185534|11812871|FG002|NOT COMPLETED|First Period||0
10602711|NCT01851590|11759682|FG001|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|24
10602712|NCT01851590|11759683|FG002|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|22
10602713|NCT01851590|11759681|FG000|At 9 Month: End of Topical Treatments|Overall Study|End of topical Resin Lacquer treatment. Washout period of the Resin Lacquer treatment arm begins.|23
10602714|NCT01851590|11759682|FG001|At 9 Month: End of Topical Treatments|Overall Study|End of topical Amorolfine Lacquer treatment. Washout period of the Amorolfine treatment arm begins.|24
10602715|NCT01851590|11759683|FG002|At 9 Month: End of Topical Treatments|Overall Study|Washout period of the Terbinafine treatment arm continues.|22
10602716|NCT01851590|11759681|FG000|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|23
10602717|NCT01851590|11759682|FG001|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|24
10602718|NCT01851590|11759683|FG002|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|22
10602719|NCT01851590|11759681|FG000|COMPLETED|Overall Study|All patients (23) were included in the ITT population and final outcome analyses.|23
10602720|NCT01851590|11759682|FG001|COMPLETED|Overall Study|All patients (25) were included in the ITT population and final outcome analyses.|24
10602721|NCT01851590|11759683|FG002|COMPLETED|Overall Study|All patients (25) were included in the ITT population and final outcome analyses.|22
10602722|NCT01851590|11759681|FG000|NOT COMPLETED|Overall Study||0
10602723|NCT01851590|11759682|FG001|NOT COMPLETED|Overall Study||1
10602724|NCT01851590|11759683|FG002|NOT COMPLETED|Overall Study||3
10602725|NCT01851655|11759697|FG000|STARTED|Overall Study||12
10602726|NCT01851655|11759698|FG001|STARTED|Overall Study||12
10602727|NCT01851655|11759697|FG000|COMPLETED|Overall Study||12
10602728|NCT01851655|11759698|FG001|COMPLETED|Overall Study||12
10602729|NCT01851655|11759697|FG000|NOT COMPLETED|Overall Study||0
10602730|NCT01851655|11759698|FG001|NOT COMPLETED|Overall Study||0
10602731|NCT01851720|11759706|FG000|STARTED|Overall Study||0
10602732|NCT01851720|11759707|FG001|STARTED|Overall Study||1
10602733|NCT01851720|11759706|FG000|COMPLETED|Overall Study||0
10602734|NCT01851720|11759707|FG001|COMPLETED|Overall Study||0
10602735|NCT01851720|11759706|FG000|NOT COMPLETED|Overall Study||0
10602736|NCT01851720|11759707|FG001|NOT COMPLETED|Overall Study||1
10602737|NCT01851772|11759713|FG000|STARTED|Overall Study||3
10602738|NCT01851772|11759713|FG000|COMPLETED|Overall Study||3
10602739|NCT01851772|11759713|FG000|NOT COMPLETED|Overall Study||0
10602740|NCT01851863|11759721|FG000|STARTED|Overall Study||65
10602741|NCT01851863|11759722|FG001|STARTED|Overall Study||66
10602742|NCT01851863|11759723|FG002|STARTED|Overall Study||65
10602743|NCT01851863|11759724|FG003|STARTED|Overall Study||66
10602744|NCT01851863|11759721|FG000|COMPLETED|Overall Study||60
10602745|NCT01851863|11759722|FG001|COMPLETED|Overall Study||57
10602746|NCT01851863|11759723|FG002|COMPLETED|Overall Study||60
10602747|NCT01851863|11759724|FG003|COMPLETED|Overall Study||63
10602748|NCT01851863|11759721|FG000|NOT COMPLETED|Overall Study||5
10602749|NCT01851863|11759722|FG001|NOT COMPLETED|Overall Study||9
10602750|NCT01851863|11759723|FG002|NOT COMPLETED|Overall Study||5
10602751|NCT01851863|11759724|FG003|NOT COMPLETED|Overall Study||3
10602752|NCT01851876|11759739|FG000|STARTED|Overall Study||56
10602753|NCT01851876|11759740|FG001|STARTED|Overall Study||62
10602754|NCT01851876|11759739|FG000|COMPLETED|Overall Study||56
10602755|NCT01851876|11759740|FG001|COMPLETED|Overall Study||62
10602756|NCT01851876|11759739|FG000|NOT COMPLETED|Overall Study||0
10602757|NCT01851876|11759740|FG001|NOT COMPLETED|Overall Study||0
10652462|NCT02185131|11812834|FG000|COMPLETED|Overall Study||6
10652463|NCT02185131|11812835|FG001|COMPLETED|Overall Study||8
10652464|NCT02185131|11812834|FG000|NOT COMPLETED|Overall Study||1
10652465|NCT02185131|11812835|FG001|NOT COMPLETED|Overall Study||1
10652466|NCT02185183|11812841|FG000|STARTED|Overall Study||14
10652467|NCT02185183|11812841|FG000|COMPLETED|Overall Study||14
10652468|NCT02185183|11812841|FG000|NOT COMPLETED|Overall Study||0
10652469|NCT02185339|11812847|FG000|STARTED|Overall Study||30
10652470|NCT02185339|11812848|FG001|STARTED|Overall Study||31
10652471|NCT02185339|11812847|FG000|COMPLETED|Overall Study||30
10652472|NCT02185339|11812848|FG001|COMPLETED|Overall Study||30
10652473|NCT02185339|11812847|FG000|NOT COMPLETED|Overall Study||0
10652474|NCT02185339|11812848|FG001|NOT COMPLETED|Overall Study||1
10652475|NCT02185404|11812854|FG000|STARTED|Overall Study||6
10652476|NCT02185404|11812854|FG000|COMPLETED|Overall Study||6
10652477|NCT02185404|11812854|FG000|NOT COMPLETED|Overall Study||0
10652478|NCT02185521|11812858|FG000|STARTED|Overall Study||127
10652479|NCT02185521|11812858|FG000|COMPLETED|Overall Study||125
10652480|NCT02185521|11812858|FG000|NOT COMPLETED|Overall Study||2
10652481|NCT02185534|11812869|FG000|STARTED|First Period||14
10652482|NCT02185534|11812870|FG001|STARTED|First Period||14
10652483|NCT02185534|11812871|FG002|STARTED|First Period||14
10652484|NCT02185534|11812872|FG003|STARTED|First Period||14
10652485|NCT02185534|11812873|FG004|STARTED|First Period||14
10652486|NCT02185534|11812874|FG005|STARTED|First Period||14
10652487|NCT02185534|11812869|FG000|COMPLETED|First Period||14
10652488|NCT02185534|11812870|FG001|COMPLETED|First Period||14
10652489|NCT02185534|11812871|FG002|COMPLETED|First Period||14
10652490|NCT02185534|11812872|FG003|COMPLETED|First Period||13
10652491|NCT02185534|11812873|FG004|COMPLETED|First Period||14
10652492|NCT02185534|11812874|FG005|COMPLETED|First Period||14
10652493|NCT02185534|11812869|FG000|NOT COMPLETED|First Period||0
10652494|NCT02185534|11812870|FG001|NOT COMPLETED|First Period||0
10704074|NCT02589067|11868590|FG001|NOT COMPLETED|Overall Study||6
10704075|NCT02589171|11868599|FG000|STARTED|Overall Study||35
10704076|NCT02589171|11868600|FG001|STARTED|Overall Study||35
10704077|NCT02589171|11868599|FG000|Day 1 Follow up|Overall Study||35
10652496|NCT02185534|11812872|FG003|NOT COMPLETED|First Period||1
10652497|NCT02185534|11812873|FG004|NOT COMPLETED|First Period||0
10652498|NCT02185534|11812874|FG005|NOT COMPLETED|First Period||0
10652499|NCT02185534|11812869|FG000|STARTED|First Washout Period||14
10652500|NCT02185534|11812870|FG001|STARTED|First Washout Period||14
10652501|NCT02185534|11812871|FG002|STARTED|First Washout Period||14
10652502|NCT02185534|11812872|FG003|STARTED|First Washout Period||13
10652503|NCT02185534|11812873|FG004|STARTED|First Washout Period||14
10652504|NCT02185534|11812874|FG005|STARTED|First Washout Period||14
10652505|NCT02185534|11812869|FG000|COMPLETED|First Washout Period||13
10652506|NCT02185534|11812870|FG001|COMPLETED|First Washout Period||14
10652507|NCT02185534|11812871|FG002|COMPLETED|First Washout Period||14
10652508|NCT02185534|11812872|FG003|COMPLETED|First Washout Period||13
10652509|NCT02185534|11812873|FG004|COMPLETED|First Washout Period||13
10652510|NCT02185534|11812874|FG005|COMPLETED|First Washout Period||13
10652511|NCT02185534|11812869|FG000|NOT COMPLETED|First Washout Period||1
10652512|NCT02185534|11812870|FG001|NOT COMPLETED|First Washout Period||0
10652513|NCT02185534|11812871|FG002|NOT COMPLETED|First Washout Period||0
10652514|NCT02185534|11812872|FG003|NOT COMPLETED|First Washout Period||0
10652515|NCT02185534|11812873|FG004|NOT COMPLETED|First Washout Period||1
10652516|NCT02185534|11812874|FG005|NOT COMPLETED|First Washout Period||1
10652517|NCT02185534|11812869|FG000|STARTED|Second Period||13
10652518|NCT02185534|11812870|FG001|STARTED|Second Period||14
10652519|NCT02185534|11812871|FG002|STARTED|Second Period||14
10652520|NCT02185534|11812872|FG003|STARTED|Second Period||13
10652521|NCT02185534|11812873|FG004|STARTED|Second Period||13
10652522|NCT02185534|11812874|FG005|STARTED|Second Period||13
10652523|NCT02185534|11812869|FG000|COMPLETED|Second Period||13
10652524|NCT02185534|11812870|FG001|COMPLETED|Second Period||14
10652525|NCT02185534|11812871|FG002|COMPLETED|Second Period||14
10704078|NCT02589171|11868600|FG001|Day 1 Follow up|Overall Study||35
10704079|NCT02589171|11868599|FG000|Week 1 Follow up|Overall Study||35
10704080|NCT02589171|11868600|FG001|Week 1 Follow up|Overall Study||34
10652526|NCT02185534|11812872|FG003|COMPLETED|Second Period||13
10652527|NCT02185534|11812873|FG004|COMPLETED|Second Period||13
10652528|NCT02185534|11812874|FG005|COMPLETED|Second Period||13
10652529|NCT02185534|11812869|FG000|NOT COMPLETED|Second Period||0
10652530|NCT02185534|11812870|FG001|NOT COMPLETED|Second Period||0
10652531|NCT02185534|11812871|FG002|NOT COMPLETED|Second Period||0
10652532|NCT02185534|11812872|FG003|NOT COMPLETED|Second Period||0
10652533|NCT02185534|11812873|FG004|NOT COMPLETED|Second Period||0
10652534|NCT02185534|11812874|FG005|NOT COMPLETED|Second Period||0
10652535|NCT02185534|11812869|FG000|STARTED|Second Washout Period||13
10652536|NCT02185534|11812870|FG001|STARTED|Second Washout Period||14
10652537|NCT02185534|11812871|FG002|STARTED|Second Washout Period||14
10652538|NCT02185534|11812872|FG003|STARTED|Second Washout Period||13
10652539|NCT02185534|11812873|FG004|STARTED|Second Washout Period||13
10652540|NCT02185534|11812874|FG005|STARTED|Second Washout Period||13
10602758|NCT01852019|11759748|FG000|STARTED|Day 1||3
10602759|NCT01852019|11759749|FG001|STARTED|Day 1||3
10602760|NCT01852019|11759750|FG002|STARTED|Day 1||6
10602761|NCT01852019|11759751|FG003|STARTED|Day 1||0
10602762|NCT01852019|11759752|FG004|STARTED|Day 1||0
10602763|NCT01852019|11759748|FG000|COMPLETED|Day 1||3
10602764|NCT01852019|11759749|FG001|COMPLETED|Day 1||3
10602765|NCT01852019|11759750|FG002|COMPLETED|Day 1||6
10602766|NCT01852019|11759751|FG003|COMPLETED|Day 1||0
10602767|NCT01852019|11759752|FG004|COMPLETED|Day 1||0
10602768|NCT01852019|11759748|FG000|NOT COMPLETED|Day 1||0
10602769|NCT01852019|11759749|FG001|NOT COMPLETED|Day 1||0
10602770|NCT01852019|11759750|FG002|NOT COMPLETED|Day 1||0
10602771|NCT01852019|11759751|FG003|NOT COMPLETED|Day 1||0
10602772|NCT01852019|11759752|FG004|NOT COMPLETED|Day 1||0
10602773|NCT01852019|11759748|FG000|STARTED|Day 8||0
10602774|NCT01852019|11759749|FG001|STARTED|Day 8||0
10602775|NCT01852019|11759750|FG002|STARTED|Day 8||0
10602776|NCT01852019|11759751|FG003|STARTED|Day 8||6
10602777|NCT01852019|11759752|FG004|STARTED|Day 8||6
10602778|NCT01852019|11759748|FG000|COMPLETED|Day 8||0
10602779|NCT01852019|11759749|FG001|COMPLETED|Day 8||0
10602780|NCT01852019|11759750|FG002|COMPLETED|Day 8||0
10602781|NCT01852019|11759751|FG003|COMPLETED|Day 8||6
10602782|NCT01852019|11759752|FG004|COMPLETED|Day 8||6
10602783|NCT01852019|11759748|FG000|NOT COMPLETED|Day 8||0
10602784|NCT01852019|11759749|FG001|NOT COMPLETED|Day 8||0
10602785|NCT01852019|11759750|FG002|NOT COMPLETED|Day 8||0
10602786|NCT01852019|11759751|FG003|NOT COMPLETED|Day 8||0
10602787|NCT01852019|11759752|FG004|NOT COMPLETED|Day 8||0
10602788|NCT01852032|11759765|FG000|STARTED|Overall Study||23
10602789|NCT01852032|11759765|FG000|COMPLETED|Overall Study||23
10602790|NCT01852032|11759765|FG000|NOT COMPLETED|Overall Study||0
10602791|NCT01852045|11759772|FG000|STARTED|Overall Study||39
10602792|NCT01852045|11759773|FG001|STARTED|Overall Study||45
10602793|NCT01852045|11759774|FG002|STARTED|Overall Study||30
10602794|NCT01852045|11759772|FG000|mITT Population|Overall Study||38
10602795|NCT01852045|11759773|FG001|mITT Population|Overall Study||45
10602796|NCT01852045|11759774|FG002|mITT Population|Overall Study||30
10333811|NCT00335764|11470036|FG004|STARTED|Overall Study||19
10333812|NCT00335764|11470032|FG000|COMPLETED|Overall Study||16
10333813|NCT00335764|11470033|FG001|COMPLETED|Overall Study||13
10333814|NCT00335764|11470034|FG002|COMPLETED|Overall Study||24
10333815|NCT00335764|11470035|FG003|COMPLETED|Overall Study||19
10333816|NCT00335764|11470036|FG004|COMPLETED|Overall Study||18
10333817|NCT00335764|11470032|FG000|NOT COMPLETED|Overall Study||1
10333818|NCT00335764|11470033|FG001|NOT COMPLETED|Overall Study||0
10333819|NCT00335764|11470034|FG002|NOT COMPLETED|Overall Study||0
10602797|NCT01852045|11759772|FG000|Safety Population|Overall Study||38
10602798|NCT01852045|11759773|FG001|Safety Population|Overall Study||45
10602799|NCT01852045|11759774|FG002|Safety Population|Overall Study||30
10602800|NCT01852045|11759772|FG000|COMPLETED|Overall Study||33
10602801|NCT01852045|11759773|FG001|COMPLETED|Overall Study||41
10602802|NCT01852045|11759774|FG002|COMPLETED|Overall Study||26
10602803|NCT01852045|11759772|FG000|NOT COMPLETED|Overall Study||6
10602804|NCT01852045|11759773|FG001|NOT COMPLETED|Overall Study||4
10333820|NCT00335764|11470035|FG003|NOT COMPLETED|Overall Study||0
10333821|NCT00335764|11470036|FG004|NOT COMPLETED|Overall Study||1
10333822|NCT00335829|11470072|FG000|STARTED|Overall Study||26
10602805|NCT01852045|11759774|FG002|NOT COMPLETED|Overall Study||4
10602806|NCT01852058|11759785|FG000|STARTED|Treatment Cycle 1, Occurred in Study 120||31
10602807|NCT01852058|11759786|FG001|STARTED|Treatment Cycle 1, Occurred in Study 120||39
10602808|NCT01852058|11759787|FG002|STARTED|Treatment Cycle 1, Occurred in Study 120||25
10602809|NCT01852058|11759788|FG003|STARTED|Treatment Cycle 1, Occurred in Study 120||0
10602810|NCT01852058|11759789|FG004|STARTED|Treatment Cycle 1, Occurred in Study 120||0
10602811|NCT01852058|11759790|FG005|STARTED|Treatment Cycle 1, Occurred in Study 120||0
10602812|NCT01852058|11759791|FG006|STARTED|Treatment Cycle 1, Occurred in Study 120||0
10602813|NCT01852058|11759792|FG007|STARTED|Treatment Cycle 1, Occurred in Study 120||0
10602814|NCT01852058|11759793|FG008|STARTED|Treatment Cycle 1, Occurred in Study 120||0
10602815|NCT01852058|11759794|FG009|STARTED|Treatment Cycle 1, Occurred in Study 120||0
10602816|NCT01852058|11759795|FG010|STARTED|Treatment Cycle 1, Occurred in Study 120||0
10602817|NCT01852058|11759796|FG011|STARTED|Treatment Cycle 1, Occurred in Study 120||0
10602818|NCT01852058|11759785|FG000|COMPLETED|Treatment Cycle 1, Occurred in Study 120||30
10602819|NCT01852058|11759786|FG001|COMPLETED|Treatment Cycle 1, Occurred in Study 120||39
10602820|NCT01852058|11759787|FG002|COMPLETED|Treatment Cycle 1, Occurred in Study 120||25
10602821|NCT01852058|11759788|FG003|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
10602822|NCT01852058|11759789|FG004|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
10602823|NCT01852058|11759790|FG005|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
10602824|NCT01852058|11759791|FG006|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
10602825|NCT01852058|11759792|FG007|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
10602826|NCT01852058|11759793|FG008|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
10602827|NCT01852058|11759794|FG009|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
10602828|NCT01852058|11759795|FG010|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
10602829|NCT01852058|11759796|FG011|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
10602830|NCT01852058|11759785|FG000|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||1
10602831|NCT01852058|11759786|FG001|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
10602832|NCT01852058|11759787|FG002|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
10602833|NCT01852058|11759788|FG003|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
10602834|NCT01852058|11759789|FG004|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
10602835|NCT01852058|11759790|FG005|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
10602836|NCT01852058|11759791|FG006|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
10602837|NCT01852058|11759792|FG007|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
10602838|NCT01852058|11759793|FG008|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
10602839|NCT01852058|11759794|FG009|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
10602840|NCT01852058|11759795|FG010|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
10602841|NCT01852058|11759796|FG011|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
10602842|NCT01852058|11759785|FG000|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
10602843|NCT01852058|11759786|FG001|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
10602844|NCT01852058|11759787|FG002|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
10602845|NCT01852058|11759788|FG003|STARTED|Treatment Cycle2:Retreatment 1,Study 121||9
10602846|NCT01852058|11759789|FG004|STARTED|Treatment Cycle2:Retreatment 1,Study 121||45
10602847|NCT01852058|11759790|FG005|STARTED|Treatment Cycle2:Retreatment 1,Study 121||36
10602848|NCT01852058|11759791|FG006|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
10602849|NCT01852058|11759792|FG007|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
10602850|NCT01852058|11759793|FG008|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
10602851|NCT01852058|11759794|FG009|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
10602852|NCT01852058|11759795|FG010|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
10602853|NCT01852058|11759796|FG011|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
10602854|NCT01852058|11759785|FG000|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
10602855|NCT01852058|11759786|FG001|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
10602856|NCT01852058|11759787|FG002|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
10602857|NCT01852058|11759788|FG003|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||8
10602858|NCT01852058|11759789|FG004|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||38
10602859|NCT01852058|11759790|FG005|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||27
10602860|NCT01852058|11759791|FG006|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
10602861|NCT01852058|11759792|FG007|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
10602862|NCT01852058|11759793|FG008|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
10602863|NCT01852058|11759794|FG009|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
10602864|NCT01852058|11759795|FG010|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
10602865|NCT01852058|11759796|FG011|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
10602866|NCT01852058|11759785|FG000|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
10602867|NCT01852058|11759786|FG001|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
10602868|NCT01852058|11759787|FG002|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
10602869|NCT01852058|11759788|FG003|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||1
10602870|NCT01852058|11759789|FG004|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||7
10602871|NCT01852058|11759790|FG005|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||9
10602872|NCT01852058|11759791|FG006|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
10602873|NCT01852058|11759792|FG007|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
10602874|NCT01852058|11759793|FG008|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
10602875|NCT01852058|11759794|FG009|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
10704081|NCT02589171|11868599|FG000|Week 6 Follow up|Overall Study||28
10704082|NCT02589171|11868600|FG001|Week 6 Follow up|Overall Study||30
10704083|NCT02589171|11868599|FG000|COMPLETED|Overall Study||28
10704084|NCT02589171|11868600|FG001|COMPLETED|Overall Study||30
10704085|NCT02589171|11868599|FG000|NOT COMPLETED|Overall Study||7
10704086|NCT02589171|11868600|FG001|NOT COMPLETED|Overall Study||5
10704087|NCT02589405|11868606|FG000|STARTED|Overall Study||50
10704088|NCT02589405|11868606|FG000|COMPLETED|Overall Study||46
10704089|NCT02589405|11868606|FG000|NOT COMPLETED|Overall Study||4
10704090|NCT02589626|11868612|FG000|STARTED|Overall Study|Entered are treated patients|32
10602876|NCT01852058|11759795|FG010|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
10602877|NCT01852058|11759796|FG011|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
10602878|NCT01852058|11759785|FG000|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
10602879|NCT01852058|11759786|FG001|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
10602880|NCT01852058|11759787|FG002|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
10602881|NCT01852058|11759788|FG003|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
10602882|NCT01852058|11759789|FG004|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
10602883|NCT01852058|11759790|FG005|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
10602884|NCT01852058|11759791|FG006|STARTED|Treatment Cycle3:Retreatment 2,Study 121||5
10704091|NCT02589626|11868613|FG001|STARTED|Overall Study|Entered are treated patients|33
10704092|NCT02589626|11868612|FG000|COMPLETED|Overall Study||29
10704093|NCT02589626|11868613|FG001|COMPLETED|Overall Study||31
10704094|NCT02589626|11868612|FG000|NOT COMPLETED|Overall Study||3
10704095|NCT02589626|11868613|FG001|NOT COMPLETED|Overall Study||2
10602885|NCT01852058|11759792|FG007|STARTED|Treatment Cycle3:Retreatment 2,Study 121||16
10602886|NCT01852058|11759793|FG008|STARTED|Treatment Cycle3:Retreatment 2,Study 121||34
10602887|NCT01852058|11759794|FG009|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
10602888|NCT01852058|11759795|FG010|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
10602889|NCT01852058|11759796|FG011|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
10602890|NCT01852058|11759785|FG000|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
10602891|NCT01852058|11759786|FG001|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
10602892|NCT01852058|11759787|FG002|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
10602893|NCT01852058|11759788|FG003|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
10602894|NCT01852058|11759789|FG004|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
10602895|NCT01852058|11759790|FG005|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
10602896|NCT01852058|11759791|FG006|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||5
10602897|NCT01852058|11759792|FG007|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||15
10602898|NCT01852058|11759793|FG008|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||33
10602899|NCT01852058|11759794|FG009|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
10602900|NCT01852058|11759795|FG010|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
10602901|NCT01852058|11759796|FG011|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
10602902|NCT01852058|11759785|FG000|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
10602903|NCT01852058|11759786|FG001|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
10602904|NCT01852058|11759787|FG002|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
10602905|NCT01852058|11759788|FG003|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
10602906|NCT01852058|11759789|FG004|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
10602907|NCT01852058|11759790|FG005|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
10602908|NCT01852058|11759791|FG006|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
10602909|NCT01852058|11759792|FG007|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||1
10704096|NCT02589639|11868622|FG000|STARTED|Overall Study||90
10704097|NCT02589639|11868623|FG001|STARTED|Overall Study||89
10704098|NCT02589639|11868624|FG002|STARTED|Overall Study||90
10704099|NCT02589639|11868622|FG000|Treated|Overall Study||90
10704100|NCT02589639|11868623|FG001|Treated|Overall Study||86
10704101|NCT02589639|11868624|FG002|Treated|Overall Study||90
10704102|NCT02589639|11868622|FG000|COMPLETED|Overall Study||80
10704103|NCT02589639|11868623|FG001|COMPLETED|Overall Study||79
10602910|NCT01852058|11759793|FG008|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||1
10602911|NCT01852058|11759794|FG009|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
10602912|NCT01852058|11759795|FG010|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
10602913|NCT01852058|11759796|FG011|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
10602914|NCT01852058|11759785|FG000|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
10704104|NCT02589639|11868624|FG002|COMPLETED|Overall Study||86
10704105|NCT02589639|11868622|FG000|NOT COMPLETED|Overall Study||10
10704106|NCT02589639|11868623|FG001|NOT COMPLETED|Overall Study||10
10704107|NCT02589639|11868624|FG002|NOT COMPLETED|Overall Study||4
10704108|NCT02589665|11868636|FG000|STARTED|Induction Period||63
10704109|NCT02589665|11868637|FG001|STARTED|Induction Period||63
10704110|NCT02589665|11868638|FG002|STARTED|Induction Period||62
10704111|NCT02589665|11868639|FG003|STARTED|Induction Period||61
10704112|NCT02589665|11868640|FG004|STARTED|Induction Period|Participants were assigned to this arm during maintenance period.|0
10704113|NCT02589665|11868641|FG005|STARTED|Induction Period|Participants were assigned to this arm during maintenance period.|0
10704114|NCT02589665|11868642|FG006|STARTED|Induction Period|Participants were assigned to this arm during maintenance period.|0
10704115|NCT02589665|11868643|FG007|STARTED|Induction Period||0
10704116|NCT02589665|11868644|FG008|STARTED|Induction Period||0
10704117|NCT02589665|11868645|FG009|STARTED|Induction Period||0
10704118|NCT02589665|11868636|FG000|Received at Least One Dose of Study Drug|Induction Period||63
10704119|NCT02589665|11868637|FG001|Received at Least One Dose of Study Drug|Induction Period||63
10704120|NCT02589665|11868638|FG002|Received at Least One Dose of Study Drug|Induction Period||62
10704121|NCT02589665|11868639|FG003|Received at Least One Dose of Study Drug|Induction Period||60
10704122|NCT02589665|11868640|FG004|Received at Least One Dose of Study Drug|Induction Period||0
10602915|NCT01852058|11759786|FG001|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
10602916|NCT01852058|11759787|FG002|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
10602917|NCT01852058|11759788|FG003|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
10602918|NCT01852058|11759789|FG004|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
10602919|NCT01852058|11759790|FG005|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
10602920|NCT01852058|11759791|FG006|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
10602921|NCT01852058|11759792|FG007|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
10602922|NCT01852058|11759793|FG008|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
10602923|NCT01852058|11759794|FG009|STARTED|Treatment Cycle4:Retreatment 3,Study 121||3
10602924|NCT01852058|11759795|FG010|STARTED|Treatment Cycle4:Retreatment 3,Study 121||4
10602925|NCT01852058|11759796|FG011|STARTED|Treatment Cycle4:Retreatment 3,Study 121||4
10602926|NCT01852058|11759785|FG000|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
10602927|NCT01852058|11759786|FG001|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
10602928|NCT01852058|11759787|FG002|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
10602929|NCT01852058|11759788|FG003|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
10602930|NCT01852058|11759789|FG004|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
10602931|NCT01852058|11759790|FG005|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
10602932|NCT01852058|11759791|FG006|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
10602933|NCT01852058|11759792|FG007|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
10602934|NCT01852058|11759793|FG008|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
10602935|NCT01852058|11759794|FG009|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||3
10602936|NCT01852058|11759795|FG010|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||4
10602937|NCT01852058|11759796|FG011|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||4
10602938|NCT01852058|11759785|FG000|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
10602939|NCT01852058|11759786|FG001|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
10602940|NCT01852058|11759787|FG002|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
10602941|NCT01852058|11759788|FG003|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
10602942|NCT01852058|11759789|FG004|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
10602943|NCT01852058|11759790|FG005|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
10602944|NCT01852058|11759791|FG006|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
10602945|NCT01852058|11759792|FG007|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
10602946|NCT01852058|11759793|FG008|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
10602947|NCT01852058|11759794|FG009|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
10602948|NCT01852058|11759795|FG010|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
10602949|NCT01852058|11759796|FG011|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
10602956|NCT01852084|11759850|FG000|STARTED|Overall Study||79
10602957|NCT01852084|11759851|FG001|STARTED|Overall Study||80
10602958|NCT01852084|11759852|FG002|STARTED|Overall Study||20
10602959|NCT01852084|11759853|FG003|STARTED|Overall Study||12
10602960|NCT01852084|11759850|FG000|COMPLETED|Overall Study||79
10602961|NCT01852084|11759851|FG001|COMPLETED|Overall Study||80
10602962|NCT01852084|11759852|FG002|COMPLETED|Overall Study||18
10602963|NCT01852084|11759853|FG003|COMPLETED|Overall Study||12
10602964|NCT01852084|11759850|FG000|NOT COMPLETED|Overall Study||0
10602965|NCT01852084|11759851|FG001|NOT COMPLETED|Overall Study||0
10602966|NCT01852084|11759852|FG002|NOT COMPLETED|Overall Study||2
10602967|NCT01852084|11759853|FG003|NOT COMPLETED|Overall Study||0
10602968|NCT01852110|11759865|FG000|STARTED|Overall Study||120
10602969|NCT01852110|11759866|FG001|STARTED|Overall Study||120
10602970|NCT01852110|11759867|FG002|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
10602971|NCT01852110|11759868|FG003|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
10602972|NCT01852110|11759869|FG004|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
10602973|NCT01852110|11759870|FG005|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
10602974|NCT01852110|11759865|FG000|Treated|Overall Study||119
10602975|NCT01852110|11759866|FG001|Treated|Overall Study||120
10602976|NCT01852110|11759867|FG002|Treated|Overall Study||0
10602977|NCT01852110|11759868|FG003|Treated|Overall Study||0
10602978|NCT01852110|11759869|FG004|Treated|Overall Study||0
10602979|NCT01852110|11759870|FG005|Treated|Overall Study||0
10602980|NCT01852110|11759865|FG000|COMPLETED|Overall Study||70
10602981|NCT01852110|11759866|FG001|COMPLETED|Overall Study||74
10602982|NCT01852110|11759867|FG002|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
10602983|NCT01852110|11759868|FG003|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
10602984|NCT01852110|11759869|FG004|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
10602985|NCT01852110|11759870|FG005|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
10602986|NCT01852110|11759865|FG000|NOT COMPLETED|Overall Study||50
10602987|NCT01852110|11759866|FG001|NOT COMPLETED|Overall Study||46
10602988|NCT01852110|11759867|FG002|NOT COMPLETED|Overall Study||0
10602989|NCT01852110|11759868|FG003|NOT COMPLETED|Overall Study||0
10602990|NCT01852110|11759869|FG004|NOT COMPLETED|Overall Study||0
10602991|NCT01852110|11759870|FG005|NOT COMPLETED|Overall Study||0
10602992|NCT01852162|11759886|FG000|STARTED|Overall Study||18
10602993|NCT01852162|11759887|FG001|STARTED|Overall Study||17
10602994|NCT01852162|11759886|FG000|COMPLETED|Overall Study||14
10602995|NCT01852162|11759887|FG001|COMPLETED|Overall Study||16
10602996|NCT01852162|11759886|FG000|NOT COMPLETED|Overall Study||4
10602997|NCT01852162|11759887|FG001|NOT COMPLETED|Overall Study||1
10602998|NCT01852175|11759895|FG000|STARTED|Overall Study||55
10602999|NCT01852175|11759896|FG001|STARTED|Overall Study||55
10603000|NCT01852175|11759895|FG000|COMPLETED|Overall Study||55
10603001|NCT01852175|11759896|FG001|COMPLETED|Overall Study||55
10603002|NCT01852175|11759895|FG000|NOT COMPLETED|Overall Study||0
10603003|NCT01852175|11759896|FG001|NOT COMPLETED|Overall Study||0
10603004|NCT01852201|11759904|FG000|STARTED|Overall Study||21
10603005|NCT01852201|11759905|FG001|STARTED|Overall Study||12
10603006|NCT01852201|11759904|FG000|COMPLETED|Overall Study||21
10603007|NCT01852201|11759905|FG001|COMPLETED|Overall Study||12
10603008|NCT01852201|11759904|FG000|NOT COMPLETED|Overall Study||0
10603009|NCT01852201|11759905|FG001|NOT COMPLETED|Overall Study||0
10603010|NCT01852214|11759912|FG000|STARTED|Period 1||26
10603011|NCT01852214|11759913|FG001|STARTED|Period 1||24
10603012|NCT01852214|11759912|FG000|COMPLETED|Period 1||25
10603013|NCT01852214|11759913|FG001|COMPLETED|Period 1||21
10603014|NCT01852214|11759912|FG000|NOT COMPLETED|Period 1||1
10603015|NCT01852214|11759913|FG001|NOT COMPLETED|Period 1||3
10603016|NCT01852214|11759912|FG000|STARTED|Washout Period||25
10603017|NCT01852214|11759913|FG001|STARTED|Washout Period||21
10603018|NCT01852214|11759912|FG000|COMPLETED|Washout Period||25
10603019|NCT01852214|11759913|FG001|COMPLETED|Washout Period||20
10603020|NCT01852214|11759912|FG000|NOT COMPLETED|Washout Period||0
10603021|NCT01852214|11759913|FG001|NOT COMPLETED|Washout Period||1
10603022|NCT01852214|11759912|FG000|STARTED|Period 2||25
10603023|NCT01852214|11759913|FG001|STARTED|Period 2||20
10603024|NCT01852214|11759912|FG000|COMPLETED|Period 2||25
10603025|NCT01852214|11759913|FG001|COMPLETED|Period 2||20
10603026|NCT01852214|11759912|FG000|NOT COMPLETED|Period 2||0
10603027|NCT01852214|11759913|FG001|NOT COMPLETED|Period 2||0
10603028|NCT01852292|11759922|FG000|STARTED|Overall Study||79
10603029|NCT01852292|11759923|FG001|STARTED|Overall Study||79
10603030|NCT01852292|11759922|FG000|COMPLETED|Overall Study|Completed = participants who were ongoing and did not discontinue study treatment per protocol|0
10603031|NCT01852292|11759923|FG001|COMPLETED|Overall Study|Completed = participants who were ongoing and did not discontinue study treatment per protocol|0
10603032|NCT01852292|11759922|FG000|NOT COMPLETED|Overall Study||79
10603033|NCT01852292|11759923|FG001|NOT COMPLETED|Overall Study||79
10603034|NCT01852344|11759933|FG000|STARTED|Overall Study||27
10603035|NCT01852344|11759934|FG001|STARTED|Overall Study||27
10603036|NCT01852344|11759935|FG002|STARTED|Overall Study||27
10603037|NCT01852344|11759936|FG003|STARTED|Overall Study||27
10603038|NCT01852344|11759933|FG000|Actual Participation in First Assignment|Overall Study||27
10603039|NCT01852344|11759934|FG001|Actual Participation in First Assignment|Overall Study||27
10603040|NCT01852344|11759935|FG002|Actual Participation in First Assignment|Overall Study||27
10603041|NCT01852344|11759936|FG003|Actual Participation in First Assignment|Overall Study||27
10603042|NCT01852344|11759933|FG000|COMPLETED|Overall Study||27
10603043|NCT01852344|11759934|FG001|COMPLETED|Overall Study||27
10603044|NCT01852344|11759935|FG002|COMPLETED|Overall Study||27
10603045|NCT01852344|11759936|FG003|COMPLETED|Overall Study||27
10603046|NCT01852344|11759933|FG000|NOT COMPLETED|Overall Study||0
10603047|NCT01852344|11759934|FG001|NOT COMPLETED|Overall Study||0
10603048|NCT01852344|11759935|FG002|NOT COMPLETED|Overall Study||0
10603049|NCT01852344|11759936|FG003|NOT COMPLETED|Overall Study||0
10603050|NCT01852383|11759947|FG000|STARTED|Overall Study||30
10603051|NCT01852383|11759947|FG000|COMPLETED|Overall Study||19
10603052|NCT01852383|11759947|FG000|NOT COMPLETED|Overall Study||11
10603053|NCT01852513|11759954|FG000|STARTED|Overall Study||20
10603054|NCT01852513|11759955|FG001|STARTED|Overall Study||19
10603055|NCT01852513|11759954|FG000|COMPLETED|Overall Study||20
10603056|NCT01852513|11759955|FG001|COMPLETED|Overall Study||19
10603057|NCT01852513|11759954|FG000|NOT COMPLETED|Overall Study||0
10603058|NCT01852513|11759955|FG001|NOT COMPLETED|Overall Study||0
10603059|NCT01852591|11759961|FG000|STARTED|Overall Study||8
10603060|NCT01852591|11759961|FG000|COMPLETED|Overall Study||5
10603061|NCT01852591|11759961|FG000|NOT COMPLETED|Overall Study||3
10603062|NCT01852669|11759967|FG000|STARTED|Overall Study||71
10603063|NCT01852669|11759968|FG001|STARTED|Overall Study||69
10603064|NCT01852669|11759967|FG000|COMPLETED|Overall Study||71
10652541|NCT02185534|11812869|FG000|COMPLETED|Second Washout Period||13
10603065|NCT01852669|11759968|FG001|COMPLETED|Overall Study|Randomisation error. Patient has protocol violation which necessitated exclusion from analysis|68
10603066|NCT01852669|11759967|FG000|NOT COMPLETED|Overall Study||0
10603067|NCT01852669|11759968|FG001|NOT COMPLETED|Overall Study||1
10603068|NCT01852799|11759974|FG000|STARTED|Overall Study||18
10603069|NCT01852799|11759974|FG000|COMPLETED|Overall Study||0
10603070|NCT01852799|11759974|FG000|NOT COMPLETED|Overall Study||18
10603071|NCT01852825|11759981|FG000|STARTED|Overall Study||16
10603072|NCT01852825|11759982|FG001|STARTED|Overall Study||7
10603073|NCT01852825|11759983|FG002|STARTED|Overall Study||3
10603074|NCT01852825|11759981|FG000|COMPLETED|Overall Study||14
10603075|NCT01852825|11759982|FG001|COMPLETED|Overall Study||7
10603076|NCT01852825|11759983|FG002|COMPLETED|Overall Study||3
10603077|NCT01852825|11759981|FG000|NOT COMPLETED|Overall Study||2
10603078|NCT01852825|11759982|FG001|NOT COMPLETED|Overall Study||0
10603079|NCT01852825|11759983|FG002|NOT COMPLETED|Overall Study||0
10603080|NCT01852942|11759993|FG000|STARTED|Overall Study||25
10603081|NCT01852942|11759994|FG001|STARTED|Overall Study||27
10603082|NCT01852942|11759993|FG000|COMPLETED|Overall Study||20
10603083|NCT01852942|11759994|FG001|COMPLETED|Overall Study||21
10603084|NCT01852942|11759993|FG000|NOT COMPLETED|Overall Study||5
10603085|NCT01852942|11759994|FG001|NOT COMPLETED|Overall Study||6
10603086|NCT01852955|11760003|FG000|STARTED|Overall Study||35
10603087|NCT01852955|11760004|FG001|STARTED|Overall Study||35
10603088|NCT01852955|11760003|FG000|COMPLETED|Overall Study||33
10603089|NCT01852955|11760004|FG001|COMPLETED|Overall Study||32
10603090|NCT01852955|11760003|FG000|NOT COMPLETED|Overall Study||2
10603091|NCT01852955|11760004|FG001|NOT COMPLETED|Overall Study||3
10603092|NCT01853046|11760012|FG000|STARTED|Overall Study||18
10603093|NCT01853046|11760013|FG001|STARTED|Overall Study||6
10603094|NCT01853046|11760012|FG000|Received Treatment|Overall Study||18
10603095|NCT01853046|11760013|FG001|Received Treatment|Overall Study||6
10603096|NCT01853046|11760012|FG000|COMPLETED|Overall Study||0
10603097|NCT01853046|11760013|FG001|COMPLETED|Overall Study||0
10603098|NCT01853046|11760012|FG000|NOT COMPLETED|Overall Study||18
10603099|NCT01853046|11760013|FG001|NOT COMPLETED|Overall Study||6
10603100|NCT01853072|11760022|FG000|STARTED|Overall Study||308
10603101|NCT01853072|11760023|FG001|STARTED|Overall Study||307
10603102|NCT01853072|11760022|FG000|Randomized|Overall Study||308
10603103|NCT01853072|11760023|FG001|Randomized|Overall Study||307
10603104|NCT01853072|11760022|FG000|Treated (Safety Analysis Set)|Overall Study||301
10603105|NCT01853072|11760023|FG001|Treated (Safety Analysis Set)|Overall Study||302
10603106|NCT01853072|11760022|FG000|Full Analysis Set|Overall Study||298
10603107|NCT01853072|11760023|FG001|Full Analysis Set|Overall Study||300
10603108|NCT01853072|11760022|FG000|COMPLETED|Overall Study||296
10603109|NCT01853072|11760023|FG001|COMPLETED|Overall Study||286
10603110|NCT01853072|11760022|FG000|NOT COMPLETED|Overall Study||12
10603111|NCT01853072|11760023|FG001|NOT COMPLETED|Overall Study||21
10603112|NCT01853085|11760031|FG000|STARTED|Overall Study||1830
10603113|NCT01853085|11760031|FG000|COMPLETED|Overall Study||1595
10603114|NCT01853085|11760031|FG000|NOT COMPLETED|Overall Study||235
10603115|NCT01853137|11760037|FG000|STARTED|Overall Study||25
10603116|NCT01853137|11760038|FG001|STARTED|Overall Study||18
10603117|NCT01853137|11760037|FG000|COMPLETED|Overall Study||21
10603118|NCT01853137|11760038|FG001|COMPLETED|Overall Study||17
10603119|NCT01853137|11760037|FG000|NOT COMPLETED|Overall Study||4
10603120|NCT01853137|11760038|FG001|NOT COMPLETED|Overall Study||1
10603121|NCT01853215|11760045|FG000|STARTED|Overall Study||24
10603122|NCT01853215|11760045|FG000|COMPLETED|Overall Study||24
10603123|NCT01853215|11760045|FG000|NOT COMPLETED|Overall Study||0
10603124|NCT01853228|11760050|FG000|STARTED|Phase 1||9
10603125|NCT01853228|11760051|FG001|STARTED|Phase 1||7
10603126|NCT01853228|11760050|FG000|COMPLETED|Phase 1||0
10603127|NCT01853228|11760051|FG001|COMPLETED|Phase 1|Participants who completed Phase 1 moved to Phase 2.|7
10603128|NCT01853228|11760050|FG000|NOT COMPLETED|Phase 1||9
10603129|NCT01853228|11760051|FG001|NOT COMPLETED|Phase 1||0
10603130|NCT01853228|11760050|FG000|STARTED|Phase 2||0
10603131|NCT01853228|11760051|FG001|STARTED|Phase 2|1 additional participant was enrolled, making total of 8 participants evaluable in Phase 2.|8
10603132|NCT01853228|11760050|FG000|COMPLETED|Phase 2||0
10603133|NCT01853228|11760051|FG001|COMPLETED|Phase 2||0
10603134|NCT01853228|11760050|FG000|NOT COMPLETED|Phase 2||0
10603135|NCT01853228|11760051|FG001|NOT COMPLETED|Phase 2||8
10603136|NCT01853254|11760056|FG000|STARTED|Overall Study||272
10603137|NCT01853254|11760056|FG000|COMPLETED|Overall Study||168
10603138|NCT01853254|11760056|FG000|NOT COMPLETED|Overall Study||104
10603139|NCT01853280|11760062|FG000|STARTED|Overall Study||22
10603140|NCT01853280|11760063|FG001|STARTED|Overall Study||22
10603141|NCT01853280|11760062|FG000|COMPLETED|Overall Study||20
10603142|NCT01853280|11760063|FG001|COMPLETED|Overall Study||16
10603143|NCT01853280|11760062|FG000|NOT COMPLETED|Overall Study||2
10603144|NCT01853280|11760063|FG001|NOT COMPLETED|Overall Study||6
10603145|NCT01853332|11760069|FG000|STARTED|Overall Study||210
10603146|NCT01853332|11760069|FG000|COMPLETED|Overall Study||151
10603147|NCT01853332|11760069|FG000|NOT COMPLETED|Overall Study||59
10603148|NCT01853371|11760076|FG000|STARTED|Overall Study||10
10603149|NCT01853371|11760077|FG001|STARTED|Overall Study||10
10603150|NCT01853371|11760076|FG000|COMPLETED|Overall Study||10
10603151|NCT01853371|11760077|FG001|COMPLETED|Overall Study||8
10603152|NCT01853371|11760076|FG000|NOT COMPLETED|Overall Study||0
10603153|NCT01853371|11760077|FG001|NOT COMPLETED|Overall Study||2
10603154|NCT01853384|11760085|FG000|STARTED|Randomized||131
10603155|NCT01853384|11760086|FG001|STARTED|Randomized||121
10603156|NCT01853384|11760085|FG000|COMPLETED|Randomized||69
10603157|NCT01853384|11760086|FG001|COMPLETED|Randomized||75
10603158|NCT01853384|11760085|FG000|NOT COMPLETED|Randomized||62
10603159|NCT01853384|11760086|FG001|NOT COMPLETED|Randomized||46
10603160|NCT01853384|11760085|FG000|STARTED|Enrolled in Follow up Period||96
10603161|NCT01853384|11760086|FG001|STARTED|Enrolled in Follow up Period||94
10603162|NCT01853384|11760085|FG000|Not Enrolled in Follow-up|Enrolled in Follow up Period||35
10603163|NCT01853384|11760086|FG001|Not Enrolled in Follow-up|Enrolled in Follow up Period||27
10603164|NCT01853384|11760085|FG000|COMPLETED|Enrolled in Follow up Period||96
10603165|NCT01853384|11760086|FG001|COMPLETED|Enrolled in Follow up Period||94
10603166|NCT01853384|11760085|FG000|NOT COMPLETED|Enrolled in Follow up Period||0
10603167|NCT01853384|11760086|FG001|NOT COMPLETED|Enrolled in Follow up Period||0
10603168|NCT01853384|11760085|FG000|STARTED|Completed Follow up Visit 1||96
10603169|NCT01853384|11760086|FG001|STARTED|Completed Follow up Visit 1||94
10603170|NCT01853384|11760085|FG000|COMPLETED|Completed Follow up Visit 1||82
10603171|NCT01853384|11760086|FG001|COMPLETED|Completed Follow up Visit 1||85
10603172|NCT01853384|11760085|FG000|NOT COMPLETED|Completed Follow up Visit 1||14
10603173|NCT01853384|11760086|FG001|NOT COMPLETED|Completed Follow up Visit 1||9
10603174|NCT01853384|11760085|FG000|STARTED|Completed Follow up Visit 2||96
10603175|NCT01853384|11760086|FG001|STARTED|Completed Follow up Visit 2||94
10603176|NCT01853384|11760085|FG000|COMPLETED|Completed Follow up Visit 2||93
10603177|NCT01853384|11760086|FG001|COMPLETED|Completed Follow up Visit 2||91
10603178|NCT01853384|11760085|FG000|NOT COMPLETED|Completed Follow up Visit 2||3
10603179|NCT01853384|11760086|FG001|NOT COMPLETED|Completed Follow up Visit 2||3
10603180|NCT01853397|11760096|FG000|STARTED|Overall Study||18
10603181|NCT01853397|11760097|FG001|STARTED|Overall Study||20
10603182|NCT01853397|11760098|FG002|STARTED|Overall Study||17
10603183|NCT01853397|11760099|FG003|STARTED|Overall Study||17
10603184|NCT01853397|11760096|FG000|COMPLETED|Overall Study||18
10603185|NCT01853397|11760097|FG001|COMPLETED|Overall Study||20
10603186|NCT01853397|11760098|FG002|COMPLETED|Overall Study||17
10603187|NCT01853397|11760099|FG003|COMPLETED|Overall Study||15
10603188|NCT01853397|11760096|FG000|NOT COMPLETED|Overall Study||0
10603189|NCT01853397|11760097|FG001|NOT COMPLETED|Overall Study||0
10603190|NCT01853397|11760098|FG002|NOT COMPLETED|Overall Study||0
10603191|NCT01853397|11760099|FG003|NOT COMPLETED|Overall Study||2
10603192|NCT01853462|11760111|FG000|STARTED|Overall Study||11
10603193|NCT01853462|11760112|FG001|STARTED|Overall Study||11
10603194|NCT01853462|11760111|FG000|COMPLETED|Overall Study||10
10603195|NCT01853462|11760112|FG001|COMPLETED|Overall Study||10
10603196|NCT01853462|11760111|FG000|NOT COMPLETED|Overall Study||1
10603197|NCT01853462|11760112|FG001|NOT COMPLETED|Overall Study||1
10603198|NCT01853475|11760123|FG000|STARTED|Overall Study||8
10603199|NCT01853475|11760124|FG001|STARTED|Overall Study||8
10603200|NCT01853475|11760125|FG002|STARTED|Overall Study||8
10603201|NCT01853475|11760123|FG000|COMPLETED|Overall Study||8
10603202|NCT01853475|11760124|FG001|COMPLETED|Overall Study||7
10603203|NCT01853475|11760125|FG002|COMPLETED|Overall Study||8
10603204|NCT01853475|11760123|FG000|NOT COMPLETED|Overall Study||0
10603205|NCT01853475|11760124|FG001|NOT COMPLETED|Overall Study||1
10603206|NCT01853475|11760125|FG002|NOT COMPLETED|Overall Study||0
10603207|NCT01853553|11760135|FG000|STARTED|Overall Study||29
10603208|NCT01853553|11760136|FG001|STARTED|Overall Study||32
10603209|NCT01853553|11760135|FG000|COMPLETED|Overall Study||28
10603210|NCT01853553|11760136|FG001|COMPLETED|Overall Study||32
10603211|NCT01853553|11760135|FG000|NOT COMPLETED|Overall Study||1
10603212|NCT01853553|11760136|FG001|NOT COMPLETED|Overall Study||0
10603213|NCT01853605|11760146|FG000|STARTED|Overall Study||1939
10603214|NCT01853605|11760147|FG001|STARTED|Overall Study||693
10603215|NCT01853605|11760148|FG002|STARTED|Overall Study||751
10603216|NCT01853605|11760149|FG003|STARTED|Overall Study||428
10603217|NCT01853605|11760146|FG000|COMPLETED|Overall Study||1939
10603218|NCT01853605|11760147|FG001|COMPLETED|Overall Study||693
10603219|NCT01853605|11760148|FG002|COMPLETED|Overall Study||751
10603220|NCT01853605|11760149|FG003|COMPLETED|Overall Study||428
10603221|NCT01853605|11760146|FG000|NOT COMPLETED|Overall Study||0
10603222|NCT01853605|11760147|FG001|NOT COMPLETED|Overall Study||0
10603223|NCT01853605|11760148|FG002|NOT COMPLETED|Overall Study||0
10603224|NCT01853605|11760149|FG003|NOT COMPLETED|Overall Study||0
10603225|NCT01853618|11760164|FG000|STARTED|Overall Study||8
10603226|NCT01853618|11760165|FG001|STARTED|Overall Study||12
10603227|NCT01853618|11760166|FG002|STARTED|Overall Study||12
10603228|NCT01853618|11760167|FG003|STARTED|Overall Study||9
10603229|NCT01853618|11760168|FG004|STARTED|Overall Study||20
10704123|NCT02589665|11868641|FG005|Received at Least One Dose of Study Drug|Induction Period||0
10704124|NCT02589665|11868642|FG006|Received at Least One Dose of Study Drug|Induction Period||0
10603230|NCT01853618|11760164|FG000|COMPLETED|Overall Study||6
10603231|NCT01853618|11760165|FG001|COMPLETED|Overall Study||10
10704125|NCT02589665|11868643|FG007|Received at Least One Dose of Study Drug|Induction Period||0
10603232|NCT01853618|11760166|FG002|COMPLETED|Overall Study||10
10603233|NCT01853618|11760167|FG003|COMPLETED|Overall Study||8
10603234|NCT01853618|11760168|FG004|COMPLETED|Overall Study||17
10603235|NCT01853618|11760164|FG000|NOT COMPLETED|Overall Study||2
10603236|NCT01853618|11760165|FG001|NOT COMPLETED|Overall Study||2
10603237|NCT01853618|11760166|FG002|NOT COMPLETED|Overall Study||2
10603238|NCT01853618|11760167|FG003|NOT COMPLETED|Overall Study||1
10603239|NCT01853618|11760168|FG004|NOT COMPLETED|Overall Study||3
10603240|NCT01853644|11760181|FG000|STARTED|Registration and Treatment Start||31
10603241|NCT01853644|11760181|FG000|Registered|Registration and Treatment Start||31
10603242|NCT01853644|11760181|FG000|Started Treatment|Registration and Treatment Start||30
10603243|NCT01853644|11760181|FG000|COMPLETED|Registration and Treatment Start||30
10603244|NCT01853644|11760181|FG000|NOT COMPLETED|Registration and Treatment Start||1
10603245|NCT01853644|11760181|FG000|STARTED|Reached First Response/Complete 2 Cycles||30
10603246|NCT01853644|11760181|FG000|COMPLETED|Reached First Response/Complete 2 Cycles||24
10603247|NCT01853644|11760181|FG000|NOT COMPLETED|Reached First Response/Complete 2 Cycles||6
10603248|NCT01853644|11760181|FG000|STARTED|Continued Treatment After First Response||24
10603249|NCT01853644|11760181|FG000|COMPLETED|Continued Treatment After First Response||12
10603250|NCT01853644|11760181|FG000|NOT COMPLETED|Continued Treatment After First Response||12
10603251|NCT01853644|11760181|FG000|STARTED|Follow up for 3 Years or Until Death|All patients that are treated on the study go into the follow up period|30
10603252|NCT01853644|11760181|FG000|COMPLETED|Follow up for 3 Years or Until Death||30
10603253|NCT01853644|11760181|FG000|NOT COMPLETED|Follow up for 3 Years or Until Death||0
10603254|NCT01853696|11760187|FG000|STARTED|Overall Study||84
10704126|NCT02589665|11868644|FG008|Received at Least One Dose of Study Drug|Induction Period||0
10704127|NCT02589665|11868645|FG009|Received at Least One Dose of Study Drug|Induction Period||0
10704128|NCT02589665|11868636|FG000|COMPLETED|Induction Period||60
10704129|NCT02589665|11868637|FG001|COMPLETED|Induction Period||61
10603255|NCT01853696|11760188|FG001|STARTED|Overall Study||83
10603256|NCT01853696|11760187|FG000|COMPLETED|Overall Study||78
10603257|NCT01853696|11760188|FG001|COMPLETED|Overall Study||78
10603258|NCT01853696|11760187|FG000|NOT COMPLETED|Overall Study||6
10603259|NCT01853696|11760188|FG001|NOT COMPLETED|Overall Study||5
10603260|NCT01853774|11760196|FG000|STARTED|Overall Study||257
10603261|NCT01853774|11760197|FG001|STARTED|Overall Study||162
10603262|NCT01853774|11760196|FG000|COMPLETED|Overall Study||211
10603263|NCT01853774|11760197|FG001|COMPLETED|Overall Study||134
10603264|NCT01853774|11760196|FG000|NOT COMPLETED|Overall Study||46
10603265|NCT01853774|11760197|FG001|NOT COMPLETED|Overall Study||28
10603266|NCT01853839|11760205|FG000|STARTED|Overall Study||2092
10603267|NCT01853839|11760205|FG000|COMPLETED|Overall Study||1663
10603268|NCT01853839|11760205|FG000|NOT COMPLETED|Overall Study||429
10603269|NCT01853878|11760215|FG000|STARTED|Overall Study||86
10603270|NCT01853878|11760216|FG001|STARTED|Overall Study||47
10603271|NCT01853878|11760215|FG000|COMPLETED|Overall Study||23
10603272|NCT01853878|11760216|FG001|COMPLETED|Overall Study||3
10603273|NCT01853878|11760215|FG000|NOT COMPLETED|Overall Study||63
10603274|NCT01853878|11760216|FG001|NOT COMPLETED|Overall Study||44
10603275|NCT01853930|11760224|FG000|STARTED|Overall Study||25
10603276|NCT01853930|11760225|FG001|STARTED|Overall Study||8
10603277|NCT01853930|11760224|FG000|COMPLETED|Overall Study||25
10603278|NCT01853930|11760225|FG001|COMPLETED|Overall Study||8
10603279|NCT01853930|11760224|FG000|NOT COMPLETED|Overall Study||0
10603280|NCT01853930|11760225|FG001|NOT COMPLETED|Overall Study||0
10603281|NCT01854034|11760231|FG000|STARTED|Overall Study||29
10603282|NCT01854034|11760231|FG000|COMPLETED|Overall Study||29
10603283|NCT01854034|11760231|FG000|NOT COMPLETED|Overall Study||0
10603284|NCT01854047|11760240|FG000|STARTED|Overall Study||158
10603285|NCT01854047|11760241|FG001|STARTED|Overall Study||157
10603286|NCT01854047|11760242|FG002|STARTED|Overall Study||150
10603287|NCT01854047|11760243|FG003|STARTED|Overall Study||157
10603288|NCT01854047|11760244|FG004|STARTED|Overall Study||154
10603289|NCT01854047|11760240|FG000|Treated|Overall Study||158
10603290|NCT01854047|11760241|FG001|Treated|Overall Study||156
10603291|NCT01854047|11760242|FG002|Treated|Overall Study||148
10603292|NCT01854047|11760243|FG003|Treated|Overall Study||157
10603293|NCT01854047|11760244|FG004|Treated|Overall Study||150
10603294|NCT01854047|11760240|FG000|Completed 12-week Study Treatment|Overall Study||153
10603295|NCT01854047|11760241|FG001|Completed 12-week Study Treatment|Overall Study||149
10603296|NCT01854047|11760242|FG002|Completed 12-week Study Treatment|Overall Study||141
10603297|NCT01854047|11760243|FG003|Completed 12-week Study Treatment|Overall Study||146
10603298|NCT01854047|11760244|FG004|Completed 12-week Study Treatment|Overall Study||143
10603299|NCT01854047|11760240|FG000|COMPLETED|Overall Study||146
10603300|NCT01854047|11760241|FG001|COMPLETED|Overall Study||149
10603301|NCT01854047|11760242|FG002|COMPLETED|Overall Study||137
10603302|NCT01854047|11760243|FG003|COMPLETED|Overall Study||142
10603303|NCT01854047|11760244|FG004|COMPLETED|Overall Study||135
10603304|NCT01854047|11760240|FG000|NOT COMPLETED|Overall Study||12
10603305|NCT01854047|11760241|FG001|NOT COMPLETED|Overall Study||8
10603306|NCT01854047|11760242|FG002|NOT COMPLETED|Overall Study||13
10603307|NCT01854047|11760243|FG003|NOT COMPLETED|Overall Study||15
10603308|NCT01854047|11760244|FG004|NOT COMPLETED|Overall Study||19
10603309|NCT01854138|11760258|FG000|STARTED|Overall Study|historical control with waiver of authorization; no informed consent signed|400
10603310|NCT01854138|11760259|FG001|STARTED|Overall Study||248
10603311|NCT01854138|11760258|FG000|COMPLETED|Overall Study||400
10603312|NCT01854138|11760259|FG001|COMPLETED|Overall Study||196
10603313|NCT01854138|11760258|FG000|NOT COMPLETED|Overall Study||0
10603314|NCT01854138|11760259|FG001|NOT COMPLETED|Overall Study||52
10603315|NCT01854177|11760266|FG000|STARTED|Overall Study||10
10603316|NCT01854177|11760266|FG000|COMPLETED|Overall Study||10
10603317|NCT01854177|11760266|FG000|NOT COMPLETED|Overall Study||0
10603318|NCT01854242|11760272|FG000|STARTED|Overall Study||50
10603319|NCT01854242|11760272|FG000|COMPLETED|Overall Study||50
10603320|NCT01854242|11760272|FG000|NOT COMPLETED|Overall Study||0
10603321|NCT01854281|11760280|FG000|STARTED|Overall Study||15
10603322|NCT01854281|11760281|FG001|STARTED|Overall Study||19
10603323|NCT01854281|11760282|FG002|STARTED|Overall Study||5
10603324|NCT01854281|11760283|FG003|STARTED|Overall Study||8
10603325|NCT01854281|11760280|FG000|COMPLETED|Overall Study||15
10603326|NCT01854281|11760281|FG001|COMPLETED|Overall Study||19
10603327|NCT01854281|11760282|FG002|COMPLETED|Overall Study||5
10603328|NCT01854281|11760283|FG003|COMPLETED|Overall Study||8
10603329|NCT01854281|11760280|FG000|NOT COMPLETED|Overall Study||0
10603330|NCT01854281|11760281|FG001|NOT COMPLETED|Overall Study||0
10603331|NCT01854281|11760282|FG002|NOT COMPLETED|Overall Study||0
10603332|NCT01854281|11760283|FG003|NOT COMPLETED|Overall Study||0
10603333|NCT01854359|11760295|FG000|STARTED|Overall Study||31
10603334|NCT01854359|11760296|FG001|STARTED|Overall Study||30
10603335|NCT01854359|11760295|FG000|COMPLETED|Overall Study||26
10603336|NCT01854359|11760296|FG001|COMPLETED|Overall Study||22
10603337|NCT01854359|11760295|FG000|NOT COMPLETED|Overall Study||5
10603338|NCT01854359|11760296|FG001|NOT COMPLETED|Overall Study||8
10603339|NCT01854528|11760312|FG000|STARTED|Overall Study||101
10603340|NCT01854528|11760313|FG001|STARTED|Overall Study||47
10603341|NCT01854528|11760312|FG000|COMPLETED|Overall Study||101
10603342|NCT01854528|11760313|FG001|COMPLETED|Overall Study||32
10603343|NCT01854528|11760312|FG000|NOT COMPLETED|Overall Study||0
10603344|NCT01854528|11760313|FG001|NOT COMPLETED|Overall Study||15
10603345|NCT01854593|11760321|FG000|STARTED|Overall Study||34
10603346|NCT01854593|11760322|FG001|STARTED|Overall Study||35
10603347|NCT01854593|11760321|FG000|COMPLETED|Overall Study||32
10603348|NCT01854593|11760322|FG001|COMPLETED|Overall Study||34
10603349|NCT01854593|11760321|FG000|NOT COMPLETED|Overall Study||2
10603350|NCT01854593|11760322|FG001|NOT COMPLETED|Overall Study||1
10603351|NCT01854632|11760331|FG000|STARTED|Overall Study||1174
10603352|NCT01854632|11760332|FG001|STARTED|Overall Study||587
10603353|NCT01854632|11760331|FG000|COMPLETED|Overall Study||1148
10603354|NCT01854632|11760332|FG001|COMPLETED|Overall Study||574
10603355|NCT01854632|11760331|FG000|NOT COMPLETED|Overall Study||26
10603356|NCT01854632|11760332|FG001|NOT COMPLETED|Overall Study||13
10603357|NCT01854645|11760343|FG000|STARTED|Overall Study||527
10603358|NCT01854645|11760344|FG001|STARTED|Overall Study||451
10603359|NCT01854645|11760345|FG002|STARTED|Overall Study||452
10603360|NCT01854645|11760346|FG003|STARTED|Overall Study||453
10603361|NCT01854645|11760347|FG004|STARTED|Overall Study||220
10603362|NCT01854645|11760343|FG000|COMPLETED|Overall Study||429
10603363|NCT01854645|11760344|FG001|COMPLETED|Overall Study||345
10603364|NCT01854645|11760345|FG002|COMPLETED|Overall Study||370
10603365|NCT01854645|11760346|FG003|COMPLETED|Overall Study||391
10704130|NCT02589665|11868638|FG002|COMPLETED|Induction Period||60
10603366|NCT01854645|11760347|FG004|COMPLETED|Overall Study||160
10603367|NCT01854645|11760343|FG000|NOT COMPLETED|Overall Study||98
10603368|NCT01854645|11760344|FG001|NOT COMPLETED|Overall Study||106
10603369|NCT01854645|11760345|FG002|NOT COMPLETED|Overall Study||82
10603370|NCT01854645|11760346|FG003|NOT COMPLETED|Overall Study||62
10603371|NCT01854645|11760347|FG004|NOT COMPLETED|Overall Study||60
10603372|NCT01854658|11760363|FG000|STARTED|Overall Study||439
10603373|NCT01854658|11760364|FG001|STARTED|Overall Study||440
10603374|NCT01854658|11760365|FG002|STARTED|Overall Study||512
10603375|NCT01854658|11760366|FG003|STARTED|Overall Study||224
10603376|NCT01854658|11760363|FG000|COMPLETED|Overall Study||346
10603377|NCT01854658|11760364|FG001|COMPLETED|Overall Study||365
10603378|NCT01854658|11760365|FG002|COMPLETED|Overall Study||432
10603379|NCT01854658|11760366|FG003|COMPLETED|Overall Study||165
10603380|NCT01854658|11760363|FG000|NOT COMPLETED|Overall Study||93
10603381|NCT01854658|11760364|FG001|NOT COMPLETED|Overall Study||75
10603382|NCT01854658|11760365|FG002|NOT COMPLETED|Overall Study||80
10603383|NCT01854658|11760366|FG003|NOT COMPLETED|Overall Study||59
10603384|NCT01854697|11760381|FG000|STARTED|Overall Study||69
10603385|NCT01854697|11760382|FG001|STARTED|Overall Study||34
10603386|NCT01854697|11760383|FG002|STARTED|Overall Study||84
10603387|NCT01854697|11760384|FG003|STARTED|Overall Study||83
10603388|NCT01854697|11760385|FG004|STARTED|Overall Study||41
10603389|NCT01854697|11760381|FG000|COMPLETED|Overall Study||63
10603390|NCT01854697|11760382|FG001|COMPLETED|Overall Study||31
10603391|NCT01854697|11760383|FG002|COMPLETED|Overall Study||82
10603392|NCT01854697|11760384|FG003|COMPLETED|Overall Study||80
10603393|NCT01854697|11760385|FG004|COMPLETED|Overall Study||39
10603394|NCT01854697|11760381|FG000|NOT COMPLETED|Overall Study||6
10603395|NCT01854697|11760382|FG001|NOT COMPLETED|Overall Study||3
10603396|NCT01854697|11760383|FG002|NOT COMPLETED|Overall Study||2
10603397|NCT01854697|11760384|FG003|NOT COMPLETED|Overall Study||3
10603398|NCT01854697|11760385|FG004|NOT COMPLETED|Overall Study||2
10603399|NCT01854710|11760395|FG000|STARTED|Overall Study||10
10603400|NCT01854710|11760396|FG001|STARTED|Overall Study||10
10603401|NCT01854710|11760397|FG002|STARTED|Overall Study||10
10704131|NCT02589665|11868639|FG003|COMPLETED|Induction Period||57
10603402|NCT01854710|11760398|FG003|STARTED|Overall Study||10
10603403|NCT01854710|11760399|FG004|STARTED|Overall Study||10
10603404|NCT01854710|11760400|FG005|STARTED|Overall Study||10
10603405|NCT01854710|11760395|FG000|COMPLETED|Overall Study||6
10603406|NCT01854710|11760396|FG001|COMPLETED|Overall Study||7
10603407|NCT01854710|11760397|FG002|COMPLETED|Overall Study||8
10603408|NCT01854710|11760398|FG003|COMPLETED|Overall Study||8
10603409|NCT01854710|11760399|FG004|COMPLETED|Overall Study||8
10603410|NCT01854710|11760400|FG005|COMPLETED|Overall Study||8
10603411|NCT01854710|11760395|FG000|NOT COMPLETED|Overall Study||4
10603412|NCT01854710|11760396|FG001|NOT COMPLETED|Overall Study||3
10603413|NCT01854710|11760397|FG002|NOT COMPLETED|Overall Study||2
10603414|NCT01854710|11760398|FG003|NOT COMPLETED|Overall Study||2
10704132|NCT02589665|11868640|FG004|COMPLETED|Induction Period||0
10603415|NCT01854710|11760399|FG004|NOT COMPLETED|Overall Study||2
10603416|NCT01854710|11760400|FG005|NOT COMPLETED|Overall Study||2
10603417|NCT01854827|11760410|FG000|STARTED|Overall Study||30
10603418|NCT01854827|11760410|FG000|COMPLETED|Overall Study||29
10603419|NCT01854827|11760410|FG000|NOT COMPLETED|Overall Study||1
10603420|NCT01854879|11760414|FG000|STARTED|Overall Study|97 consented|97
10603421|NCT01854879|11760414|FG000|COMPLETED|Overall Study|92 had matched endpoint data|92
10603422|NCT01854879|11760414|FG000|NOT COMPLETED|Overall Study||5
10603423|NCT01854905|11760418|FG000|STARTED|Overall Study||400
10603424|NCT01854905|11760418|FG000|COMPLETED|Overall Study||400
10603425|NCT01854905|11760418|FG000|NOT COMPLETED|Overall Study||0
10603426|NCT01854918|11760424|FG000|STARTED|SOC-controlled Period (Year 1)||1227
10603427|NCT01854918|11760425|FG001|STARTED|SOC-controlled Period (Year 1)||2454
10603428|NCT01854918|11760424|FG000|Received Evolocumab|SOC-controlled Period (Year 1)|5 participants received evolocumab in error|5
10603429|NCT01854918|11760425|FG001|Received Evolocumab|SOC-controlled Period (Year 1)||2452
10603430|NCT01854918|11760424|FG000|COMPLETED|SOC-controlled Period (Year 1)||1197
10603431|NCT01854918|11760425|FG001|COMPLETED|SOC-controlled Period (Year 1)||2391
10603432|NCT01854918|11760424|FG000|NOT COMPLETED|SOC-controlled Period (Year 1)||30
10603433|NCT01854918|11760425|FG001|NOT COMPLETED|SOC-controlled Period (Year 1)||63
10603434|NCT01854918|11760424|FG000|STARTED|All-IP Period (Years 2 and 3)||1197
10603435|NCT01854918|11760425|FG001|STARTED|All-IP Period (Years 2 and 3)||2391
10603436|NCT01854918|11760424|FG000|Received Evolocumab|All-IP Period (Years 2 and 3)||1152
10603437|NCT01854918|11760425|FG001|Received Evolocumab|All-IP Period (Years 2 and 3)||2291
10603438|NCT01854918|11760424|FG000|COMPLETED|All-IP Period (Years 2 and 3)||1079
10603439|NCT01854918|11760425|FG001|COMPLETED|All-IP Period (Years 2 and 3)||2196
10603440|NCT01854918|11760424|FG000|NOT COMPLETED|All-IP Period (Years 2 and 3)||118
10603441|NCT01854918|11760425|FG001|NOT COMPLETED|All-IP Period (Years 2 and 3)||195
10603442|NCT01854944|11760441|FG000|STARTED|Overall Study||4
10603443|NCT01854944|11760442|FG001|STARTED|Overall Study||4
10603444|NCT01854944|11760443|FG002|STARTED|Overall Study||4
10603445|NCT01854944|11760441|FG000|COMPLETED|Overall Study||4
10603446|NCT01854944|11760442|FG001|COMPLETED|Overall Study||4
10603447|NCT01854944|11760443|FG002|COMPLETED|Overall Study||3
10603448|NCT01854944|11760441|FG000|NOT COMPLETED|Overall Study||0
10603449|NCT01854944|11760442|FG001|NOT COMPLETED|Overall Study||0
10603450|NCT01854944|11760443|FG002|NOT COMPLETED|Overall Study||1
10603451|NCT01855048|11760471|FG000|STARTED|Overall Study||9
10603452|NCT01855048|11760472|FG001|STARTED|Overall Study||3
10603453|NCT01855048|11760473|FG002|STARTED|Overall Study||6
10603454|NCT01855048|11760474|FG003|STARTED|Overall Study||6
10603455|NCT01855048|11760475|FG004|STARTED|Overall Study||6
10603456|NCT01855048|11760476|FG005|STARTED|Overall Study||6
10603457|NCT01855048|11760471|FG000|COMPLETED|Overall Study||9
10603458|NCT01855048|11760472|FG001|COMPLETED|Overall Study||2
10603459|NCT01855048|11760473|FG002|COMPLETED|Overall Study||6
10603460|NCT01855048|11760474|FG003|COMPLETED|Overall Study||6
10603461|NCT01855048|11760475|FG004|COMPLETED|Overall Study||5
10603462|NCT01855048|11760476|FG005|COMPLETED|Overall Study||6
10603463|NCT01855048|11760471|FG000|NOT COMPLETED|Overall Study||0
10603464|NCT01855048|11760472|FG001|NOT COMPLETED|Overall Study||1
10603465|NCT01855048|11760473|FG002|NOT COMPLETED|Overall Study||0
10603466|NCT01855048|11760474|FG003|NOT COMPLETED|Overall Study||0
10603467|NCT01855048|11760475|FG004|NOT COMPLETED|Overall Study||1
10603468|NCT01855048|11760476|FG005|NOT COMPLETED|Overall Study||0
10603469|NCT01855074|11760500|FG000|STARTED|Overall Study||80
10603470|NCT01855074|11760500|FG000|Treated|Overall Study||79
10603471|NCT01855074|11760500|FG000|COMPLETED|Overall Study||66
10603472|NCT01855074|11760500|FG000|NOT COMPLETED|Overall Study||14
10603473|NCT01855126|11760506|FG000|STARTED|First Intervention (8 Weeks)||24
10603474|NCT01855126|11760507|FG001|STARTED|First Intervention (8 Weeks)||22
10603475|NCT01855126|11760506|FG000|COMPLETED|First Intervention (8 Weeks)||20
10603476|NCT01855126|11760507|FG001|COMPLETED|First Intervention (8 Weeks)||16
10603477|NCT01855126|11760506|FG000|NOT COMPLETED|First Intervention (8 Weeks)||4
10603478|NCT01855126|11760507|FG001|NOT COMPLETED|First Intervention (8 Weeks)||6
10603479|NCT01855126|11760506|FG000|STARTED|Washout Period (2 Weeks)||20
10603480|NCT01855126|11760507|FG001|STARTED|Washout Period (2 Weeks)||16
10603481|NCT01855126|11760506|FG000|COMPLETED|Washout Period (2 Weeks)||20
10603482|NCT01855126|11760507|FG001|COMPLETED|Washout Period (2 Weeks)||16
10603483|NCT01855126|11760506|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
10603484|NCT01855126|11760507|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0
10603485|NCT01855126|11760506|FG000|STARTED|Second Intervention (8 Weeks)||20
10603486|NCT01855126|11760507|FG001|STARTED|Second Intervention (8 Weeks)||16
10603487|NCT01855126|11760506|FG000|COMPLETED|Second Intervention (8 Weeks)||18
10603488|NCT01855126|11760507|FG001|COMPLETED|Second Intervention (8 Weeks)||14
10603489|NCT01855126|11760506|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||2
10603490|NCT01855126|11760507|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||2
10603491|NCT01855243|11760520|FG000|STARTED|Overall Study||20
10603492|NCT01855243|11760521|FG001|STARTED|Overall Study||21
10603493|NCT01855243|11760522|FG002|STARTED|Overall Study||22
10603494|NCT01855243|11760520|FG000|COMPLETED|Overall Study||19
10603495|NCT01855243|11760521|FG001|COMPLETED|Overall Study||21
10603496|NCT01855243|11760522|FG002|COMPLETED|Overall Study||22
10603497|NCT01855243|11760520|FG000|NOT COMPLETED|Overall Study||1
10603498|NCT01855243|11760521|FG001|NOT COMPLETED|Overall Study||0
10603499|NCT01855243|11760522|FG002|NOT COMPLETED|Overall Study||0
10603500|NCT01855360|11760530|FG000|STARTED|Overall Study||40
10603501|NCT01855360|11760530|FG000|COMPLETED|Overall Study||30
10603502|NCT01855360|11760530|FG000|NOT COMPLETED|Overall Study||10
10603503|NCT01855399|11760536|FG000|STARTED|6 Month||146
10603504|NCT01855399|11760537|FG001|STARTED|6 Month||144
10603505|NCT01855399|11760536|FG000|COMPLETED|6 Month||126
10603506|NCT01855399|11760537|FG001|COMPLETED|6 Month||129
10603507|NCT01855399|11760536|FG000|NOT COMPLETED|6 Month||20
10603508|NCT01855399|11760537|FG001|NOT COMPLETED|6 Month||15
10603509|NCT01855399|11760536|FG000|STARTED|12 Month||126
10603510|NCT01855399|11760537|FG001|STARTED|12 Month||129
10603511|NCT01855399|11760536|FG000|COMPLETED|12 Month||119
10603512|NCT01855399|11760537|FG001|COMPLETED|12 Month||118
10603513|NCT01855399|11760536|FG000|NOT COMPLETED|12 Month||7
10603514|NCT01855399|11760537|FG001|NOT COMPLETED|12 Month||11
10603515|NCT01855425|11760543|FG000|STARTED|Overall Study||96
10603516|NCT01855425|11760543|FG000|COMPLETED|Overall Study||76
10603517|NCT01855425|11760543|FG000|NOT COMPLETED|Overall Study||20
10603518|NCT01855750|11760549|FG000|STARTED|Overall Study||419
10603519|NCT01855750|11760550|FG001|STARTED|Overall Study||419
10603520|NCT01855750|11760549|FG000|Treated|Overall Study|3 participants not treated:2 withdrew consent and 1 not treated per Sponsor/investigator's decision.|416
10603521|NCT01855750|11760550|FG001|Treated|Overall Study|1 participant not treated: withdrew consent.|418
10603522|NCT01855750|11760549|FG000|COMPLETED|Overall Study||0
10603523|NCT01855750|11760550|FG001|COMPLETED|Overall Study||0
10603524|NCT01855750|11760549|FG000|NOT COMPLETED|Overall Study||419
10603525|NCT01855750|11760550|FG001|NOT COMPLETED|Overall Study||419
10603526|NCT01855789|11760556|FG000|STARTED|1) Baseline up to Week 24||718
10603527|NCT01855789|11760557|FG001|STARTED|1) Baseline up to Week 24||0
10603528|NCT01855789|11760558|FG002|STARTED|1) Baseline up to Week 24||0
10603529|NCT01855789|11760559|FG003|STARTED|1) Baseline up to Week 24||0
10603530|NCT01855789|11760556|FG000|COMPLETED|1) Baseline up to Week 24||602
10603531|NCT01855789|11760557|FG001|COMPLETED|1) Baseline up to Week 24||0
10603532|NCT01855789|11760558|FG002|COMPLETED|1) Baseline up to Week 24||0
10603533|NCT01855789|11760559|FG003|COMPLETED|1) Baseline up to Week 24||0
10603534|NCT01855789|11760556|FG000|NOT COMPLETED|1) Baseline up to Week 24||116
10603535|NCT01855789|11760557|FG001|NOT COMPLETED|1) Baseline up to Week 24||0
10603536|NCT01855789|11760558|FG002|NOT COMPLETED|1) Baseline up to Week 24||0
10603537|NCT01855789|11760559|FG003|NOT COMPLETED|1) Baseline up to Week 24||0
10603538|NCT01855789|11760556|FG000|STARTED|2) Week 24 up to End of Study||0
10603539|NCT01855789|11760557|FG001|STARTED|2) Week 24 up to End of Study||147
10603540|NCT01855789|11760558|FG002|STARTED|2) Week 24 up to End of Study||147
10603541|NCT01855789|11760559|FG003|STARTED|2) Week 24 up to End of Study||308
10603542|NCT01855789|11760556|FG000|COMPLETED|2) Week 24 up to End of Study||0
10603543|NCT01855789|11760557|FG001|COMPLETED|2) Week 24 up to End of Study||132
10603544|NCT01855789|11760558|FG002|COMPLETED|2) Week 24 up to End of Study||129
10603545|NCT01855789|11760559|FG003|COMPLETED|2) Week 24 up to End of Study||250
10603546|NCT01855789|11760556|FG000|NOT COMPLETED|2) Week 24 up to End of Study||0
10603547|NCT01855789|11760557|FG001|NOT COMPLETED|2) Week 24 up to End of Study||15
10603548|NCT01855789|11760558|FG002|NOT COMPLETED|2) Week 24 up to End of Study||18
10603549|NCT01855789|11760559|FG003|NOT COMPLETED|2) Week 24 up to End of Study||58
10603550|NCT01855828|11760565|FG000|STARTED|Overall Study||50
10603551|NCT01855828|11760565|FG000|COMPLETED|Overall Study||48
10603552|NCT01855828|11760565|FG000|NOT COMPLETED|Overall Study||2
10603553|NCT01855919|11760576|FG000|STARTED|Overall Study||232
10603554|NCT01855919|11760577|FG001|STARTED|Overall Study||226
10603555|NCT01855919|11760576|FG000|Received at Least 1 Dose of Study Drug|Overall Study||232
10603556|NCT01855919|11760577|FG001|Received at Least 1 Dose of Study Drug|Overall Study||226
10603557|NCT01855919|11760576|FG000|COMPLETED|Overall Study||209
10603558|NCT01855919|11760577|FG001|COMPLETED|Overall Study||200
10603559|NCT01855919|11760576|FG000|NOT COMPLETED|Overall Study||23
10603560|NCT01855919|11760577|FG001|NOT COMPLETED|Overall Study||26
10603561|NCT01855945|11760596|FG000|STARTED|Overall Study||54
10603562|NCT01855945|11760597|FG001|STARTED|Overall Study||55
10603563|NCT01855945|11760598|FG002|STARTED|Overall Study||51
10603564|NCT01855945|11760599|FG003|STARTED|Overall Study||53
10603565|NCT01855945|11760600|FG004|STARTED|Overall Study||51
10603566|NCT01855945|11760601|FG005|STARTED|Overall Study||53
10603567|NCT01855945|11760602|FG006|STARTED|Overall Study||53
10603568|NCT01855945|11760603|FG007|STARTED|Overall Study||55
10603569|NCT01855945|11760604|FG008|STARTED|Overall Study||48
10603570|NCT01855945|11760605|FG009|STARTED|Overall Study||51
10603571|NCT01855945|11760606|FG010|STARTED|Overall Study||51
10603572|NCT01855945|11760607|FG011|STARTED|Overall Study||52
10603573|NCT01855945|11760596|FG000|COMPLETED|Overall Study||38
10603574|NCT01855945|11760597|FG001|COMPLETED|Overall Study||44
10603575|NCT01855945|11760598|FG002|COMPLETED|Overall Study||39
10603576|NCT01855945|11760599|FG003|COMPLETED|Overall Study||49
10603577|NCT01855945|11760600|FG004|COMPLETED|Overall Study||50
10603578|NCT01855945|11760601|FG005|COMPLETED|Overall Study||50
10603579|NCT01855945|11760602|FG006|COMPLETED|Overall Study||43
10603580|NCT01855945|11760603|FG007|COMPLETED|Overall Study||47
10603581|NCT01855945|11760604|FG008|COMPLETED|Overall Study||46
10603582|NCT01855945|11760605|FG009|COMPLETED|Overall Study||49
10603583|NCT01855945|11760606|FG010|COMPLETED|Overall Study||46
10603584|NCT01855945|11760607|FG011|COMPLETED|Overall Study||49
10603585|NCT01855945|11760596|FG000|NOT COMPLETED|Overall Study||16
10603586|NCT01855945|11760597|FG001|NOT COMPLETED|Overall Study||11
10603587|NCT01855945|11760598|FG002|NOT COMPLETED|Overall Study||12
10603588|NCT01855945|11760599|FG003|NOT COMPLETED|Overall Study||4
10603589|NCT01855945|11760600|FG004|NOT COMPLETED|Overall Study||1
10603590|NCT01855945|11760601|FG005|NOT COMPLETED|Overall Study||3
10603591|NCT01855945|11760602|FG006|NOT COMPLETED|Overall Study||10
10603592|NCT01855945|11760603|FG007|NOT COMPLETED|Overall Study||8
10603593|NCT01855945|11760604|FG008|NOT COMPLETED|Overall Study||2
10603594|NCT01855945|11760605|FG009|NOT COMPLETED|Overall Study||2
10603595|NCT01855945|11760606|FG010|NOT COMPLETED|Overall Study||5
10603596|NCT01855945|11760607|FG011|NOT COMPLETED|Overall Study||3
10603597|NCT01855958|11760672|FG000|STARTED|Overall Study||13
10603598|NCT01855958|11760673|FG001|STARTED|Overall Study||13
10603599|NCT01855958|11760672|FG000|COMPLETED|Overall Study||12
10603600|NCT01855958|11760673|FG001|COMPLETED|Overall Study||13
10603601|NCT01855958|11760672|FG000|NOT COMPLETED|Overall Study||1
10603602|NCT01855958|11760673|FG001|NOT COMPLETED|Overall Study||0
10603603|NCT01855997|11760681|FG000|STARTED|Overall Study||1669
10603604|NCT01855997|11760681|FG000|COMPLETED|Overall Study||1669
10603605|NCT01855997|11760681|FG000|NOT COMPLETED|Overall Study||0
10603606|NCT01856114|11760695|FG000|STARTED|Overall Study||11
10603607|NCT01856114|11760696|FG001|STARTED|Overall Study||11
10603608|NCT01856114|11760695|FG000|COMPLETED|Overall Study||9
10603609|NCT01856114|11760696|FG001|COMPLETED|Overall Study||11
10603610|NCT01856114|11760695|FG000|NOT COMPLETED|Overall Study||2
10603611|NCT01856114|11760696|FG001|NOT COMPLETED|Overall Study||0
10603612|NCT01856218|11760702|FG000|STARTED|First Phase||3
10603613|NCT01856218|11760702|FG000|COMPLETED|First Phase||3
10603614|NCT01856218|11760702|FG000|NOT COMPLETED|First Phase||0
10603615|NCT01856218|11760702|FG000|STARTED|Long-Term Extension Phase||3
10603616|NCT01856218|11760702|FG000|COMPLETED|Long-Term Extension Phase||3
10603617|NCT01856218|11760702|FG000|NOT COMPLETED|Long-Term Extension Phase||0
10603618|NCT01856257|11760709|FG000|STARTED|Overall Study||29
10603619|NCT01856257|11760710|FG001|STARTED|Overall Study||29
10603620|NCT01856257|11760711|FG002|STARTED|Overall Study||11
10603621|NCT01856257|11760712|FG003|STARTED|Overall Study||2
10603622|NCT01856257|11760709|FG000|COMPLETED|Overall Study||26
10603623|NCT01856257|11760710|FG001|COMPLETED|Overall Study||28
10603624|NCT01856257|11760711|FG002|COMPLETED|Overall Study||11
10603625|NCT01856257|11760712|FG003|COMPLETED|Overall Study||0
10603626|NCT01856257|11760709|FG000|NOT COMPLETED|Overall Study||3
10603627|NCT01856257|11760710|FG001|NOT COMPLETED|Overall Study||1
10603628|NCT01856257|11760711|FG002|NOT COMPLETED|Overall Study||0
10603629|NCT01856257|11760712|FG003|NOT COMPLETED|Overall Study||2
10603630|NCT01856309|11760725|FG000|STARTED|Overall Study||305
10603631|NCT01856309|11760726|FG001|STARTED|Overall Study||291
10603632|NCT01856309|11760727|FG002|STARTED|Overall Study||606
10603633|NCT01856309|11760728|FG003|STARTED|Overall Study||618
10603634|NCT01856309|11760725|FG000|Participants From Study CNTO136ARA3002|Overall Study||197
10603635|NCT01856309|11760726|FG001|Participants From Study CNTO136ARA3002|Overall Study||187
10603636|NCT01856309|11760727|FG002|Participants From Study CNTO136ARA3002|Overall Study||405
10603637|NCT01856309|11760728|FG003|Participants From Study CNTO136ARA3002|Overall Study||412
10603638|NCT01856309|11760725|FG000|Participants From Study CNTO136ARA3003|Overall Study||108
10603639|NCT01856309|11760726|FG001|Participants From Study CNTO136ARA3003|Overall Study||104
10603640|NCT01856309|11760727|FG002|Participants From Study CNTO136ARA3003|Overall Study||201
10603641|NCT01856309|11760728|FG003|Participants From Study CNTO136ARA3003|Overall Study||206
10603642|NCT01856309|11760725|FG000|Treated Partcipants|Overall Study||305
10603643|NCT01856309|11760726|FG001|Treated Partcipants|Overall Study||290
10603644|NCT01856309|11760727|FG002|Treated Partcipants|Overall Study||605
10603645|NCT01856309|11760728|FG003|Treated Partcipants|Overall Study||618
10603646|NCT01856309|11760725|FG000|COMPLETED|Overall Study||6
10603647|NCT01856309|11760726|FG001|COMPLETED|Overall Study||3
10603648|NCT01856309|11760727|FG002|COMPLETED|Overall Study||11
10603649|NCT01856309|11760728|FG003|COMPLETED|Overall Study||9
10603650|NCT01856309|11760725|FG000|NOT COMPLETED|Overall Study||299
10603651|NCT01856309|11760726|FG001|NOT COMPLETED|Overall Study||288
10603652|NCT01856309|11760727|FG002|NOT COMPLETED|Overall Study||595
10603653|NCT01856309|11760728|FG003|NOT COMPLETED|Overall Study||609
10603654|NCT01856491|11760738|FG000|STARTED|Overall Study||167
10603655|NCT01856491|11760738|FG000|COMPLETED|Overall Study||152
10603656|NCT01856491|11760738|FG000|NOT COMPLETED|Overall Study||15
10603657|NCT01856530|11760744|FG000|STARTED|Overall Study||27
10603658|NCT01856530|11760745|FG001|STARTED|Overall Study||27
10603659|NCT01856530|11760744|FG000|COMPLETED|Overall Study||27
10603660|NCT01856530|11760745|FG001|COMPLETED|Overall Study||27
10603661|NCT01856530|11760744|FG000|NOT COMPLETED|Overall Study||0
10603662|NCT01856530|11760745|FG001|NOT COMPLETED|Overall Study||0
10603663|NCT01856543|11760753|FG000|STARTED|Overall Study||73
10603664|NCT01856543|11760754|FG001|STARTED|Overall Study||70
10603665|NCT01856543|11760753|FG000|COMPLETED|Overall Study||60
10603666|NCT01856543|11760754|FG001|COMPLETED|Overall Study||64
10603667|NCT01856543|11760753|FG000|NOT COMPLETED|Overall Study||13
10603668|NCT01856543|11760754|FG001|NOT COMPLETED|Overall Study||6
10603669|NCT01856569|11760761|FG000|STARTED|Overall Study||152
10603670|NCT01856569|11760761|FG000|Full Analysis Set|Overall Study||144
10603671|NCT01856569|11760761|FG000|COMPLETED|Overall Study||139
10603672|NCT01856569|11760761|FG000|NOT COMPLETED|Overall Study||13
10333823|NCT00335829|11470072|FG000|Received Bevacizumab|Overall Study||26
10333824|NCT00335829|11470072|FG000|Received First TACE|Overall Study|1 patient left after receiving bevacizumab but prior to first TACE|25
10333825|NCT00335829|11470072|FG000|COMPLETED|Overall Study||23
10333826|NCT00335829|11470072|FG000|NOT COMPLETED|Overall Study||3
10333827|NCT00335959|11470076|FG000|STARTED|Overall Study||7
10333828|NCT00335959|11470076|FG000|Eligible|Overall Study||6
10333829|NCT00335959|11470076|FG000|Eligible and Began Protocol Therapy|Overall Study||6
10333830|NCT00335959|11470076|FG000|COMPLETED|Overall Study||4
10333831|NCT00335959|11470076|FG000|NOT COMPLETED|Overall Study||3
10603673|NCT01856582|11760765|FG000|STARTED|Overall Study||23
10603674|NCT01856582|11760765|FG000|COMPLETED|Overall Study||22
10603675|NCT01856582|11760765|FG000|NOT COMPLETED|Overall Study||1
10603676|NCT01856595|11760778|FG000|STARTED|Overall Study||18
10603677|NCT01856595|11760779|FG001|STARTED|Overall Study||12
10603678|NCT01856595|11760780|FG002|STARTED|Overall Study||12
10603679|NCT01856595|11760781|FG003|STARTED|Overall Study||12
10603680|NCT01856595|11760782|FG004|STARTED|Overall Study||14
10603681|NCT01856595|11760783|FG005|STARTED|Overall Study||12
10603682|NCT01856595|11760784|FG006|STARTED|Overall Study||13
10603683|NCT01856595|11760785|FG007|STARTED|Overall Study||10
10603684|NCT01856595|11760786|FG008|STARTED|Overall Study||14
10603685|NCT01856595|11760778|FG000|COMPLETED|Overall Study||18
10603686|NCT01856595|11760779|FG001|COMPLETED|Overall Study||11
10603687|NCT01856595|11760780|FG002|COMPLETED|Overall Study||12
10603688|NCT01856595|11760781|FG003|COMPLETED|Overall Study||12
10603689|NCT01856595|11760782|FG004|COMPLETED|Overall Study||14
10603690|NCT01856595|11760783|FG005|COMPLETED|Overall Study||12
10603691|NCT01856595|11760784|FG006|COMPLETED|Overall Study||12
10603692|NCT01856595|11760785|FG007|COMPLETED|Overall Study||10
10603693|NCT01856595|11760786|FG008|COMPLETED|Overall Study||14
10603694|NCT01856595|11760778|FG000|NOT COMPLETED|Overall Study||0
10603695|NCT01856595|11760779|FG001|NOT COMPLETED|Overall Study||1
10603696|NCT01856595|11760780|FG002|NOT COMPLETED|Overall Study||0
10808693|NCT03851016|11970647|FG001|COMPLETED|Second Intervention (3 Weeks)||10
10808694|NCT03851016|11970646|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
10808695|NCT03851016|11970647|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
10808696|NCT03850496|11970656|FG000|STARTED|Overall Study||26
10603697|NCT01856595|11760781|FG003|NOT COMPLETED|Overall Study||0
10603698|NCT01856595|11760782|FG004|NOT COMPLETED|Overall Study||0
10603699|NCT01856595|11760783|FG005|NOT COMPLETED|Overall Study||0
10603700|NCT01856595|11760784|FG006|NOT COMPLETED|Overall Study||1
10603701|NCT01856595|11760785|FG007|NOT COMPLETED|Overall Study||0
10603702|NCT01856595|11760786|FG008|NOT COMPLETED|Overall Study||0
10603703|NCT01856673|11760824|FG000|STARTED|Overall Study||175
10603704|NCT01856673|11760825|FG001|STARTED|Overall Study||175
10603705|NCT01856673|11760826|FG002|STARTED|Overall Study||171
10603706|NCT01856673|11760824|FG000|Buenaventura Participants|Overall Study||92
10603707|NCT01856673|11760825|FG001|Buenaventura Participants|Overall Study||89
10603708|NCT01856673|11760826|FG002|Buenaventura Participants|Overall Study||88
10603709|NCT01856673|11760824|FG000|Quibdó Participants|Overall Study||83
10603710|NCT01856673|11760825|FG001|Quibdó Participants|Overall Study||86
10603711|NCT01856673|11760826|FG002|Quibdó Participants|Overall Study||83
10603712|NCT01856673|11760824|FG000|COMPLETED|Overall Study|A percentage of 75.1% completed the follow-up (exit survey)|80
10603713|NCT01856673|11760825|FG001|COMPLETED|Overall Study|A percentage of 80.9% completed the follow-up (exit survey)|90
10603714|NCT01856673|11760826|FG002|COMPLETED|Overall Study||137
10603715|NCT01856673|11760824|FG000|NOT COMPLETED|Overall Study||95
10603716|NCT01856673|11760825|FG001|NOT COMPLETED|Overall Study||85
10603717|NCT01856673|11760826|FG002|NOT COMPLETED|Overall Study||34
10603718|NCT01856686|11760836|FG000|STARTED|Overall Study||31
10603719|NCT01856686|11760837|FG001|STARTED|Overall Study||33
10603720|NCT01856686|11760836|FG000|COMPLETED|Overall Study||26
10603721|NCT01856686|11760837|FG001|COMPLETED|Overall Study||22
10603722|NCT01856686|11760836|FG000|NOT COMPLETED|Overall Study||5
10603723|NCT01856686|11760837|FG001|NOT COMPLETED|Overall Study||11
10603724|NCT01856712|11760845|FG000|STARTED|Overall Study||23
10603725|NCT01856712|11760846|FG001|STARTED|Overall Study|1 received oral in error thus randomized.|22
10603726|NCT01856712|11760845|FG000|Lost to 14 Day Follow up|Overall Study||6
10603727|NCT01856712|11760846|FG001|Lost to 14 Day Follow up|Overall Study||2
10603728|NCT01856712|11760845|FG000|Lost to 45 Day Follow up|Overall Study||1
10603729|NCT01856712|11760846|FG001|Lost to 45 Day Follow up|Overall Study||1
10603730|NCT01856712|11760845|FG000|COMPLETED|Overall Study||16
10808697|NCT03850496|11970657|FG001|STARTED|Overall Study||25
10333832|NCT00335972|11470083|FG000|STARTED|Overall Study||71
10333833|NCT00335972|11470084|FG001|STARTED|Overall Study||71
10603731|NCT01856712|11760846|FG001|COMPLETED|Overall Study||19
10603732|NCT01856712|11760845|FG000|NOT COMPLETED|Overall Study||7
10603733|NCT01856712|11760846|FG001|NOT COMPLETED|Overall Study||3
10603734|NCT01856764|11760858|FG000|STARTED|Overall Study||20
10603735|NCT01856764|11760859|FG001|STARTED|Overall Study||20
10603736|NCT01856764|11760858|FG000|COMPLETED|Overall Study||20
10603737|NCT01856764|11760859|FG001|COMPLETED|Overall Study||20
10603738|NCT01856764|11760858|FG000|NOT COMPLETED|Overall Study||0
10603739|NCT01856764|11760859|FG001|NOT COMPLETED|Overall Study||0
10603740|NCT01856790|11760865|FG000|STARTED|Closed Loop Control||15
10808698|NCT03850496|11970658|FG002|STARTED|Overall Study||25
10603741|NCT01856790|11760865|FG000|COMPLETED|Closed Loop Control||13
10603742|NCT01856790|11760865|FG000|NOT COMPLETED|Closed Loop Control||2
10603743|NCT01856790|11760865|FG000|STARTED|Closed Loop Control + Liraglutide||13
10603744|NCT01856790|11760865|FG000|COMPLETED|Closed Loop Control + Liraglutide||11
10603745|NCT01856790|11760865|FG000|NOT COMPLETED|Closed Loop Control + Liraglutide||2
10603746|NCT01856907|11760879|FG000|STARTED|Overall Study||12
10603747|NCT01856907|11760880|FG001|STARTED|Overall Study||12
10603748|NCT01856907|11760881|FG002|STARTED|Overall Study||12
10603749|NCT01856907|11760879|FG000|COMPLETED|Overall Study||12
10603750|NCT01856907|11760880|FG001|COMPLETED|Overall Study||9
10603751|NCT01856907|11760881|FG002|COMPLETED|Overall Study||12
10603752|NCT01856907|11760879|FG000|NOT COMPLETED|Overall Study||0
10603753|NCT01856907|11760880|FG001|NOT COMPLETED|Overall Study||3
10603754|NCT01856907|11760881|FG002|NOT COMPLETED|Overall Study||0
10603755|NCT01856933|11760892|FG000|STARTED|Overall Study||6
10603756|NCT01856933|11760892|FG000|COMPLETED|Overall Study||6
10603757|NCT01856933|11760892|FG000|NOT COMPLETED|Overall Study||0
10603758|NCT01857102|11760896|FG000|STARTED|Period 1||58
10603759|NCT01857102|11760897|FG001|STARTED|Period 1||56
10603760|NCT01857102|11760896|FG000|Habitual Users|Period 1||51
10603761|NCT01857102|11760897|FG001|Habitual Users|Period 1||52
10603762|NCT01857102|11760896|FG000|Neophtyes|Period 1||7
10603763|NCT01857102|11760897|FG001|Neophtyes|Period 1||4
10603764|NCT01857102|11760896|FG000|COMPLETED|Period 1||55
10603765|NCT01857102|11760897|FG001|COMPLETED|Period 1||51
10603766|NCT01857102|11760896|FG000|NOT COMPLETED|Period 1||3
10603767|NCT01857102|11760897|FG001|NOT COMPLETED|Period 1||5
10603768|NCT01857102|11760896|FG000|STARTED|Period 2||55
10603769|NCT01857102|11760897|FG001|STARTED|Period 2||51
10603770|NCT01857102|11760896|FG000|Habitual Users|Period 2||48
10603771|NCT01857102|11760897|FG001|Habitual Users|Period 2||47
10603772|NCT01857102|11760896|FG000|Neophytes|Period 2||7
10603773|NCT01857102|11760897|FG001|Neophytes|Period 2||4
10603774|NCT01857102|11760896|FG000|COMPLETED|Period 2||53
10603775|NCT01857102|11760897|FG001|COMPLETED|Period 2||51
10603776|NCT01857102|11760896|FG000|NOT COMPLETED|Period 2||2
10603777|NCT01857102|11760897|FG001|NOT COMPLETED|Period 2||0
10603778|NCT01857206|11760907|FG000|STARTED|Overall Study||1372
10603779|NCT01857206|11760908|FG001|STARTED|Overall Study||683
10603780|NCT01857206|11760907|FG000|COMPLETED|Overall Study||1359
10603781|NCT01857206|11760908|FG001|COMPLETED|Overall Study||673
10603782|NCT01857206|11760907|FG000|NOT COMPLETED|Overall Study||13
10603783|NCT01857206|11760908|FG001|NOT COMPLETED|Overall Study||10
10603784|NCT01857232|11760923|FG000|STARTED|Overall Study||69
10603785|NCT01857232|11760924|FG001|STARTED|Overall Study||67
10603786|NCT01857232|11760925|FG002|STARTED|Overall Study||67
10603787|NCT01857232|11760926|FG003|STARTED|Overall Study||70
10603788|NCT01857232|11760927|FG004|STARTED|Overall Study||69
10603789|NCT01857232|11760923|FG000|Evaluable ITT|Overall Study||66
10603790|NCT01857232|11760924|FG001|Evaluable ITT|Overall Study||66
10603791|NCT01857232|11760925|FG002|Evaluable ITT|Overall Study||63
10603792|NCT01857232|11760926|FG003|Evaluable ITT|Overall Study||68
10603793|NCT01857232|11760927|FG004|Evaluable ITT|Overall Study||65
10603794|NCT01857232|11760923|FG000|COMPLETED|Overall Study||61
10603795|NCT01857232|11760924|FG001|COMPLETED|Overall Study||65
10603796|NCT01857232|11760925|FG002|COMPLETED|Overall Study||63
10603797|NCT01857232|11760926|FG003|COMPLETED|Overall Study||68
10603798|NCT01857232|11760927|FG004|COMPLETED|Overall Study||63
10603799|NCT01857232|11760923|FG000|NOT COMPLETED|Overall Study||8
10603800|NCT01857232|11760924|FG001|NOT COMPLETED|Overall Study||2
10603801|NCT01857232|11760925|FG002|NOT COMPLETED|Overall Study||4
10603802|NCT01857232|11760926|FG003|NOT COMPLETED|Overall Study||2
10603803|NCT01857232|11760927|FG004|NOT COMPLETED|Overall Study||6
10603804|NCT01857258|11760942|FG000|STARTED|First Intervention (3 h Postprandially)||8
10603805|NCT01857258|11760943|FG001|STARTED|First Intervention (3 h Postprandially)||7
10603806|NCT01857258|11760942|FG000|COMPLETED|First Intervention (3 h Postprandially)||8
10603807|NCT01857258|11760943|FG001|COMPLETED|First Intervention (3 h Postprandially)||7
10603808|NCT01857258|11760942|FG000|NOT COMPLETED|First Intervention (3 h Postprandially)||0
10603809|NCT01857258|11760943|FG001|NOT COMPLETED|First Intervention (3 h Postprandially)||0
10603810|NCT01857258|11760942|FG000|STARTED|Wash-out Period (7 Days)||8
10603811|NCT01857258|11760943|FG001|STARTED|Wash-out Period (7 Days)||7
10603812|NCT01857258|11760942|FG000|COMPLETED|Wash-out Period (7 Days)||8
10603813|NCT01857258|11760943|FG001|COMPLETED|Wash-out Period (7 Days)||7
10603814|NCT01857258|11760942|FG000|NOT COMPLETED|Wash-out Period (7 Days)||0
10603815|NCT01857258|11760943|FG001|NOT COMPLETED|Wash-out Period (7 Days)||0
10603816|NCT01857258|11760942|FG000|STARTED|Second Intervention (3 h Postprandially)||8
10603817|NCT01857258|11760943|FG001|STARTED|Second Intervention (3 h Postprandially)||7
10603818|NCT01857258|11760942|FG000|COMPLETED|Second Intervention (3 h Postprandially)||8
10603819|NCT01857258|11760943|FG001|COMPLETED|Second Intervention (3 h Postprandially)||7
10603820|NCT01857258|11760942|FG000|NOT COMPLETED|Second Intervention (3 h Postprandially)||0
10603821|NCT01857258|11760943|FG001|NOT COMPLETED|Second Intervention (3 h Postprandially)||0
10603822|NCT01857297|11760953|FG000|STARTED|Overall Study||60
10603823|NCT01857297|11760954|FG001|STARTED|Overall Study||60
10603824|NCT01857297|11760953|FG000|COMPLETED|Overall Study||60
10603825|NCT01857297|11760954|FG001|COMPLETED|Overall Study||60
10603826|NCT01857297|11760953|FG000|NOT COMPLETED|Overall Study||0
10603827|NCT01857297|11760954|FG001|NOT COMPLETED|Overall Study||0
10603828|NCT01857310|11760962|FG000|STARTED|Primary Analysis: Live Birth|Male partner|1185
10603829|NCT01857310|11760963|FG001|STARTED|Primary Analysis: Live Birth|Male partner|1185
10603830|NCT01857310|11760962|FG000|COMPLETED|Primary Analysis: Live Birth|Chart abstraction of whether live birth occurred|1185
10603831|NCT01857310|11760963|FG001|COMPLETED|Primary Analysis: Live Birth|Chart abstraction of whether live birth occurred|1185
10603832|NCT01857310|11760962|FG000|NOT COMPLETED|Primary Analysis: Live Birth||0
10603833|NCT01857310|11760963|FG001|NOT COMPLETED|Primary Analysis: Live Birth||0
10603834|NCT01857310|11760962|FG000|STARTED|Secondary Analysis: Semen Quality at 6m|Male partner|1185
10603835|NCT01857310|11760963|FG001|STARTED|Secondary Analysis: Semen Quality at 6m|Male partner|1185
10603836|NCT01857310|11760962|FG000|COMPLETED|Secondary Analysis: Semen Quality at 6m|Completed 6-month study visit|870
10603837|NCT01857310|11760963|FG001|COMPLETED|Secondary Analysis: Semen Quality at 6m|Completed 6-month study visit|903
10603838|NCT01857310|11760962|FG000|NOT COMPLETED|Secondary Analysis: Semen Quality at 6m||315
10603839|NCT01857310|11760963|FG001|NOT COMPLETED|Secondary Analysis: Semen Quality at 6m||282
10652542|NCT02185534|11812870|FG001|COMPLETED|Second Washout Period||14
10652543|NCT02185534|11812871|FG002|COMPLETED|Second Washout Period||14
10652544|NCT02185534|11812872|FG003|COMPLETED|Second Washout Period||13
10652545|NCT02185534|11812873|FG004|COMPLETED|Second Washout Period||13
10652546|NCT02185534|11812874|FG005|COMPLETED|Second Washout Period||13
10652547|NCT02185534|11812869|FG000|NOT COMPLETED|Second Washout Period||0
10652548|NCT02185534|11812870|FG001|NOT COMPLETED|Second Washout Period||0
10652549|NCT02185534|11812871|FG002|NOT COMPLETED|Second Washout Period||0
10652550|NCT02185534|11812872|FG003|NOT COMPLETED|Second Washout Period||0
10652551|NCT02185534|11812873|FG004|NOT COMPLETED|Second Washout Period||0
10652552|NCT02185534|11812874|FG005|NOT COMPLETED|Second Washout Period||0
10652553|NCT02185534|11812869|FG000|STARTED|Third Period||13
10652554|NCT02185534|11812870|FG001|STARTED|Third Period||14
10652555|NCT02185534|11812871|FG002|STARTED|Third Period||14
10652556|NCT02185534|11812872|FG003|STARTED|Third Period||13
10652557|NCT02185534|11812873|FG004|STARTED|Third Period||13
10652558|NCT02185534|11812874|FG005|STARTED|Third Period||13
10652559|NCT02185534|11812869|FG000|COMPLETED|Third Period||13
10652560|NCT02185534|11812870|FG001|COMPLETED|Third Period||14
10652561|NCT02185534|11812871|FG002|COMPLETED|Third Period||14
10652562|NCT02185534|11812872|FG003|COMPLETED|Third Period||13
10652563|NCT02185534|11812873|FG004|COMPLETED|Third Period||13
10652564|NCT02185534|11812874|FG005|COMPLETED|Third Period||13
10652565|NCT02185534|11812869|FG000|NOT COMPLETED|Third Period||0
10652566|NCT02185534|11812870|FG001|NOT COMPLETED|Third Period||0
10652567|NCT02185534|11812871|FG002|NOT COMPLETED|Third Period||0
10652568|NCT02185534|11812872|FG003|NOT COMPLETED|Third Period||0
10652569|NCT02185534|11812873|FG004|NOT COMPLETED|Third Period||0
10652570|NCT02185534|11812874|FG005|NOT COMPLETED|Third Period||0
10652571|NCT02185729|11812883|FG000|STARTED|0 Hour (Baseline) of Saline Infusion||12
10652572|NCT02185729|11812883|FG000|COMPLETED|0 Hour (Baseline) of Saline Infusion||12
10652573|NCT02185729|11812883|FG000|NOT COMPLETED|0 Hour (Baseline) of Saline Infusion||0
10652574|NCT02185729|11812883|FG000|STARTED|4 Hours Into Saline Infusion||12
10652575|NCT02185729|11812883|FG000|COMPLETED|4 Hours Into Saline Infusion||12
10652576|NCT02185729|11812883|FG000|NOT COMPLETED|4 Hours Into Saline Infusion||0
10652577|NCT02185729|11812883|FG000|STARTED|24 Hours Into Saline Infusion||12
10652578|NCT02185729|11812883|FG000|COMPLETED|24 Hours Into Saline Infusion||12
10652579|NCT02185729|11812883|FG000|NOT COMPLETED|24 Hours Into Saline Infusion||0
10652580|NCT02185729|11812883|FG000|STARTED|0 Hour (Baseline) of Intralipid Infusion||12
10652581|NCT02185729|11812883|FG000|COMPLETED|0 Hour (Baseline) of Intralipid Infusion||12
10652582|NCT02185729|11812883|FG000|NOT COMPLETED|0 Hour (Baseline) of Intralipid Infusion||0
10652583|NCT02185729|11812883|FG000|STARTED|4 Hours Into Intralipid Infusion||12
10652584|NCT02185729|11812883|FG000|COMPLETED|4 Hours Into Intralipid Infusion||12
10652585|NCT02185729|11812883|FG000|NOT COMPLETED|4 Hours Into Intralipid Infusion||0
10652586|NCT02185729|11812883|FG000|STARTED|24 Hours Into Intralipid Infusion||12
10652587|NCT02185729|11812883|FG000|COMPLETED|24 Hours Into Intralipid Infusion||12
10652588|NCT02185729|11812883|FG000|NOT COMPLETED|24 Hours Into Intralipid Infusion||0
10652589|NCT02185729|11812883|FG000|STARTED|0 Hour (Baseline) of ClinOleic Infusion||12
10652590|NCT02185729|11812883|FG000|COMPLETED|0 Hour (Baseline) of ClinOleic Infusion||12
10652591|NCT02185729|11812883|FG000|NOT COMPLETED|0 Hour (Baseline) of ClinOleic Infusion||0
10652592|NCT02185729|11812883|FG000|STARTED|4 Hours Into ClinOleic Infusion||12
10652593|NCT02185729|11812883|FG000|COMPLETED|4 Hours Into ClinOleic Infusion||12
10652594|NCT02185729|11812883|FG000|NOT COMPLETED|4 Hours Into ClinOleic Infusion||0
10652595|NCT02185729|11812883|FG000|STARTED|24 Hours Into ClinOleic Infusion||12
10652596|NCT02185729|11812883|FG000|COMPLETED|24 Hours Into ClinOleic Infusion||12
10652597|NCT02185729|11812883|FG000|NOT COMPLETED|24 Hours Into ClinOleic Infusion||0
10652598|NCT02185729|11812883|FG000|STARTED|0 Hour (Baseline) of Dextrose Infusion||12
10652599|NCT02185729|11812883|FG000|COMPLETED|0 Hour (Baseline) of Dextrose Infusion||12
10652600|NCT02185729|11812883|FG000|NOT COMPLETED|0 Hour (Baseline) of Dextrose Infusion||0
10652601|NCT02185729|11812883|FG000|STARTED|4 Hours Into Dextrose Infusion||12
10652602|NCT02185729|11812883|FG000|COMPLETED|4 Hours Into Dextrose Infusion||12
10652603|NCT02185729|11812883|FG000|NOT COMPLETED|4 Hours Into Dextrose Infusion||0
10652604|NCT02185729|11812883|FG000|STARTED|24 Hours Into Dextrose Infusion||12
10652605|NCT02185729|11812883|FG000|COMPLETED|24 Hours Into Dextrose Infusion||12
10652606|NCT02185729|11812883|FG000|NOT COMPLETED|24 Hours Into Dextrose Infusion||0
10652607|NCT02185794|11812896|FG000|STARTED|Overall Study||9
10652608|NCT02185794|11812897|FG001|STARTED|Overall Study||20
10652609|NCT02185794|11812898|FG002|STARTED|Overall Study||33
10652610|NCT02185794|11812899|FG003|STARTED|Overall Study||16
10603840|NCT01857323|11760969|FG000|STARTED|Overall Study|36 day treatment cohort: 45 participants 50 day treatment cohort: 272 participants|317
10603841|NCT01857323|11760969|FG000|Safety Population|Overall Study|One enrolled participant was lost to follow-up.|316
10603842|NCT01857323|11760969|FG000|COMPLETED|Overall Study||253
10603843|NCT01857323|11760969|FG000|NOT COMPLETED|Overall Study||64
10652611|NCT02185794|11812900|FG004|STARTED|Overall Study||7
10652612|NCT02185794|11812901|FG005|STARTED|Overall Study||16
10652613|NCT02185794|11812896|FG000|COMPLETED|Overall Study||4
10652614|NCT02185794|11812897|FG001|COMPLETED|Overall Study||7
10652615|NCT02185794|11812898|FG002|COMPLETED|Overall Study||17
10652616|NCT02185794|11812899|FG003|COMPLETED|Overall Study||8
10652617|NCT02185794|11812900|FG004|COMPLETED|Overall Study||4
10652618|NCT02185794|11812901|FG005|COMPLETED|Overall Study||0
10652619|NCT02185794|11812896|FG000|NOT COMPLETED|Overall Study||5
10652620|NCT02185794|11812897|FG001|NOT COMPLETED|Overall Study||13
10652621|NCT02185794|11812898|FG002|NOT COMPLETED|Overall Study||16
10652622|NCT02185794|11812899|FG003|NOT COMPLETED|Overall Study||8
10652623|NCT02185794|11812900|FG004|NOT COMPLETED|Overall Study||3
10652624|NCT02185794|11812901|FG005|NOT COMPLETED|Overall Study||16
10652625|NCT02186015|11812931|FG000|STARTED|Overall Study||11
10652626|NCT02186015|11812932|FG001|STARTED|Overall Study||31
10652627|NCT02186015|11812931|FG000|COMPLETED|Overall Study||10
10652628|NCT02186015|11812932|FG001|COMPLETED|Overall Study||31
10652629|NCT02186015|11812931|FG000|NOT COMPLETED|Overall Study||1
10652630|NCT02186015|11812932|FG001|NOT COMPLETED|Overall Study||0
10652631|NCT02186171|11812941|FG000|STARTED|Overall Study||82
10652632|NCT02186171|11812942|FG001|STARTED|Overall Study||163
10652633|NCT02186171|11812941|FG000|Received Treatment|Overall Study||81
10652634|NCT02186171|11812942|FG001|Received Treatment|Overall Study||163
10652635|NCT02186171|11812941|FG000|COMPLETED|Overall Study||78
10652636|NCT02186171|11812942|FG001|COMPLETED|Overall Study||148
10652637|NCT02186171|11812941|FG000|NOT COMPLETED|Overall Study||4
10652638|NCT02186171|11812942|FG001|NOT COMPLETED|Overall Study||15
10652639|NCT02186210|11812950|FG000|STARTED|Overall Study||20
10652640|NCT02186210|11812951|FG001|STARTED|Overall Study||20
10652641|NCT02186210|11812950|FG000|COMPLETED|Overall Study||20
10652642|NCT02186210|11812951|FG001|COMPLETED|Overall Study||20
10652643|NCT02186210|11812950|FG000|NOT COMPLETED|Overall Study||0
10652644|NCT02186210|11812951|FG001|NOT COMPLETED|Overall Study||0
10652645|NCT02186223|11812959|FG000|STARTED|Overall Study||172
10652646|NCT02186223|11812959|FG000|Device Placed|Overall Study||163
10652647|NCT02186223|11812959|FG000|COMPLETED|Overall Study||151
10652648|NCT02186223|11812959|FG000|NOT COMPLETED|Overall Study||21
10652649|NCT02186301|11812967|FG000|STARTED|Overall Study||20
10652650|NCT02186301|11812968|FG001|STARTED|Overall Study||30
10652651|NCT02186301|11812969|FG002|STARTED|Overall Study||50
10652652|NCT02186301|11812967|FG000|COMPLETED|Overall Study|Patients who are off study for any reason.|0
10652653|NCT02186301|11812968|FG001|COMPLETED|Overall Study|Patients who are off study for any reason.|0
10652654|NCT02186301|11812969|FG002|COMPLETED|Overall Study|Patients who are off study for any reason.|0
10652655|NCT02186301|11812967|FG000|NOT COMPLETED|Overall Study||20
10652656|NCT02186301|11812968|FG001|NOT COMPLETED|Overall Study||30
10652657|NCT02186301|11812969|FG002|NOT COMPLETED|Overall Study||50
10652658|NCT02186509|11812979|FG000|STARTED|Overall Study||17
10652659|NCT02186509|11812979|FG000|COMPLETED|Overall Study||17
10652660|NCT02186509|11812979|FG000|NOT COMPLETED|Overall Study||0
10652661|NCT02186561|11812983|FG000|STARTED|Enrollment||197
10652662|NCT02186561|11812983|FG000|COMPLETED|Enrollment||141
10652663|NCT02186561|11812983|FG000|NOT COMPLETED|Enrollment||56
10652664|NCT02186561|11812983|FG000|STARTED|Subjects Implanted With Device||141
10652665|NCT02186561|11812983|FG000|COMPLETED|Subjects Implanted With Device||141
10652666|NCT02186561|11812983|FG000|NOT COMPLETED|Subjects Implanted With Device||0
10652667|NCT02186561|11812983|FG000|STARTED|30-Day Post Index Procedure Visit||141
10652668|NCT02186561|11812983|FG000|COMPLETED|30-Day Post Index Procedure Visit||140
10652669|NCT02186561|11812983|FG000|NOT COMPLETED|30-Day Post Index Procedure Visit||1
10652670|NCT02186561|11812983|FG000|STARTED|180- Day Post Index Procedure Visit||141
10652671|NCT02186561|11812983|FG000|COMPLETED|180- Day Post Index Procedure Visit||134
10652672|NCT02186561|11812983|FG000|NOT COMPLETED|180- Day Post Index Procedure Visit||7
10652673|NCT02186561|11812983|FG000|STARTED|1- Year Post Index Procedure Visit||141
10652674|NCT02186561|11812983|FG000|COMPLETED|1- Year Post Index Procedure Visit||139
10652675|NCT02186561|11812983|FG000|NOT COMPLETED|1- Year Post Index Procedure Visit||2
10652676|NCT02186561|11812983|FG000|STARTED|2 - Year Post Index Procedure Visit||141
10652677|NCT02186561|11812983|FG000|COMPLETED|2 - Year Post Index Procedure Visit||134
10652678|NCT02186561|11812983|FG000|NOT COMPLETED|2 - Year Post Index Procedure Visit||7
10652679|NCT02186561|11812983|FG000|STARTED|3 - Year Post Index Procedure Visit||141
10652680|NCT02186561|11812983|FG000|COMPLETED|3 - Year Post Index Procedure Visit||128
10603844|NCT01857362|11760973|FG000|STARTED|Overall Study||6
10603845|NCT01857362|11760974|FG001|STARTED|Overall Study||6
10603846|NCT01857362|11760973|FG000|COMPLETED|Overall Study||6
10603847|NCT01857362|11760974|FG001|COMPLETED|Overall Study||6
10603848|NCT01857362|11760973|FG000|NOT COMPLETED|Overall Study||0
10603849|NCT01857362|11760974|FG001|NOT COMPLETED|Overall Study||0
10603850|NCT01857531|11760980|FG000|STARTED|Overall Study||16
10603851|NCT01857531|11760980|FG000|COMPLETED|Overall Study||12
10603852|NCT01857531|11760980|FG000|NOT COMPLETED|Overall Study||4
10603853|NCT01857583|11760988|FG000|STARTED|Overall Study||30
10603854|NCT01857583|11760989|FG001|STARTED|Overall Study||7
10603855|NCT01857583|11760990|FG002|STARTED|Overall Study||22
10603856|NCT01857583|11760991|FG003|STARTED|Overall Study||21
10603857|NCT01857583|11760988|FG000|Safety Analysis Population|Overall Study||30
10603858|NCT01857583|11760989|FG001|Safety Analysis Population|Overall Study||7
10603859|NCT01857583|11760990|FG002|Safety Analysis Population|Overall Study||22
10603860|NCT01857583|11760991|FG003|Safety Analysis Population|Overall Study||20
10603861|NCT01857583|11760988|FG000|COMPLETED|Overall Study||29
10603862|NCT01857583|11760989|FG001|COMPLETED|Overall Study||6
10603863|NCT01857583|11760990|FG002|COMPLETED|Overall Study||19
10603864|NCT01857583|11760991|FG003|COMPLETED|Overall Study||17
10603865|NCT01857583|11760988|FG000|NOT COMPLETED|Overall Study||1
10603866|NCT01857583|11760989|FG001|NOT COMPLETED|Overall Study||1
10603867|NCT01857583|11760990|FG002|NOT COMPLETED|Overall Study||3
10603868|NCT01857583|11760991|FG003|NOT COMPLETED|Overall Study||4
10603869|NCT01857622|11761004|FG000|STARTED|Overall Study||50
10603870|NCT01857622|11761005|FG001|STARTED|Overall Study||22
10603871|NCT01857622|11761006|FG002|STARTED|Overall Study||21
10603872|NCT01857622|11761004|FG000|COMPLETED|Overall Study||39
10603873|NCT01857622|11761005|FG001|COMPLETED|Overall Study||21
10603874|NCT01857622|11761006|FG002|COMPLETED|Overall Study||19
10603875|NCT01857622|11761004|FG000|NOT COMPLETED|Overall Study||11
10603876|NCT01857622|11761005|FG001|NOT COMPLETED|Overall Study||1
10603877|NCT01857622|11761006|FG002|NOT COMPLETED|Overall Study||2
10603878|NCT01857713|11761014|FG000|STARTED|Overall Study||95
10603879|NCT01857713|11761014|FG000|COMPLETED|Overall Study||89
10603880|NCT01857713|11761014|FG000|NOT COMPLETED|Overall Study||6
10603881|NCT01857869|11761030|FG000|STARTED|Primary/Challenge Phase||34
10603882|NCT01857869|11761031|FG001|STARTED|Primary/Challenge Phase||17
10603883|NCT01857869|11761032|FG002|STARTED|Primary/Challenge Phase||12
10603884|NCT01857869|11761033|FG003|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
10603885|NCT01857869|11761034|FG004|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
10603886|NCT01857869|11761035|FG005|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
10603887|NCT01857869|11761036|FG006|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
10603888|NCT01857869|11761037|FG007|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
10603889|NCT01857869|11761038|FG008|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
10603890|NCT01857869|11761039|FG009|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
10603891|NCT01857869|11761030|FG000|COMPLETED|Primary/Challenge Phase||29
10603892|NCT01857869|11761031|FG001|COMPLETED|Primary/Challenge Phase||16
10603893|NCT01857869|11761032|FG002|COMPLETED|Primary/Challenge Phase||12
10603894|NCT01857869|11761033|FG003|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
10603895|NCT01857869|11761034|FG004|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
10603896|NCT01857869|11761035|FG005|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
10603897|NCT01857869|11761036|FG006|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
10603898|NCT01857869|11761037|FG007|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
10603899|NCT01857869|11761038|FG008|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
10603900|NCT01857869|11761039|FG009|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
10603901|NCT01857869|11761030|FG000|NOT COMPLETED|Primary/Challenge Phase||5
10603902|NCT01857869|11761031|FG001|NOT COMPLETED|Primary/Challenge Phase||1
10603903|NCT01857869|11761032|FG002|NOT COMPLETED|Primary/Challenge Phase||0
10603904|NCT01857869|11761033|FG003|NOT COMPLETED|Primary/Challenge Phase||0
10603905|NCT01857869|11761034|FG004|NOT COMPLETED|Primary/Challenge Phase||0
10603906|NCT01857869|11761035|FG005|NOT COMPLETED|Primary/Challenge Phase||0
10603907|NCT01857869|11761036|FG006|NOT COMPLETED|Primary/Challenge Phase||0
10603908|NCT01857869|11761037|FG007|NOT COMPLETED|Primary/Challenge Phase||0
10603909|NCT01857869|11761038|FG008|NOT COMPLETED|Primary/Challenge Phase||0
10603910|NCT01857869|11761039|FG009|NOT COMPLETED|Primary/Challenge Phase||0
10652681|NCT02186561|11812983|FG000|NOT COMPLETED|3 - Year Post Index Procedure Visit||13
10603911|NCT01857869|11761030|FG000|STARTED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
10603912|NCT01857869|11761031|FG001|STARTED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
10603913|NCT01857869|11761032|FG002|STARTED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
10603914|NCT01857869|11761033|FG003|STARTED|Booster/Rechallenge Phase||9
10603915|NCT01857869|11761034|FG004|STARTED|Booster/Rechallenge Phase||10
10603916|NCT01857869|11761035|FG005|STARTED|Booster/Rechallenge Phase||2
10603917|NCT01857869|11761036|FG006|STARTED|Booster/Rechallenge Phase||5
10603918|NCT01857869|11761037|FG007|STARTED|Booster/Rechallenge Phase||4
10603919|NCT01857869|11761038|FG008|STARTED|Booster/Rechallenge Phase||3
10603920|NCT01857869|11761039|FG009|STARTED|Booster/Rechallenge Phase||6
10603921|NCT01857869|11761030|FG000|COMPLETED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
10603922|NCT01857869|11761031|FG001|COMPLETED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
10603923|NCT01857869|11761032|FG002|COMPLETED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
10603924|NCT01857869|11761033|FG003|COMPLETED|Booster/Rechallenge Phase||7
10603925|NCT01857869|11761034|FG004|COMPLETED|Booster/Rechallenge Phase||10
10603926|NCT01857869|11761035|FG005|COMPLETED|Booster/Rechallenge Phase||2
10603927|NCT01857869|11761036|FG006|COMPLETED|Booster/Rechallenge Phase||5
10603928|NCT01857869|11761037|FG007|COMPLETED|Booster/Rechallenge Phase||4
10603929|NCT01857869|11761038|FG008|COMPLETED|Booster/Rechallenge Phase||3
10603930|NCT01857869|11761039|FG009|COMPLETED|Booster/Rechallenge Phase||6
10603931|NCT01857869|11761030|FG000|NOT COMPLETED|Booster/Rechallenge Phase||0
10603932|NCT01857869|11761031|FG001|NOT COMPLETED|Booster/Rechallenge Phase||0
10603933|NCT01857869|11761032|FG002|NOT COMPLETED|Booster/Rechallenge Phase||0
10603934|NCT01857869|11761033|FG003|NOT COMPLETED|Booster/Rechallenge Phase||2
10603935|NCT01857869|11761034|FG004|NOT COMPLETED|Booster/Rechallenge Phase||0
10603936|NCT01857869|11761035|FG005|NOT COMPLETED|Booster/Rechallenge Phase||0
10603937|NCT01857869|11761036|FG006|NOT COMPLETED|Booster/Rechallenge Phase||0
10603938|NCT01857869|11761037|FG007|NOT COMPLETED|Booster/Rechallenge Phase||0
10603939|NCT01857869|11761038|FG008|NOT COMPLETED|Booster/Rechallenge Phase||0
10603940|NCT01857869|11761039|FG009|NOT COMPLETED|Booster/Rechallenge Phase||0
10603941|NCT01857882|11761064|FG000|STARTED|Overall Study||21
10603942|NCT01857882|11761065|FG001|STARTED|Overall Study||20
10603943|NCT01857882|11761064|FG000|COMPLETED|Overall Study||21
10603944|NCT01857882|11761065|FG001|COMPLETED|Overall Study||20
10603945|NCT01857882|11761064|FG000|NOT COMPLETED|Overall Study||0
10603946|NCT01857882|11761065|FG001|NOT COMPLETED|Overall Study||0
10603947|NCT01857973|11761071|FG000|STARTED|Overall Study||78
10603948|NCT01857973|11761071|FG000|Exploratory A Phase|Overall Study||9
10603949|NCT01857973|11761071|FG000|Xploratory B Phase|Overall Study||9
10603950|NCT01857973|11761071|FG000|Phase 1|Overall Study||17
10603951|NCT01857973|11761071|FG000|Phase 2|Overall Study||14
10603952|NCT01857973|11761071|FG000|Phase 3|Overall Study||10
10603953|NCT01857973|11761071|FG000|Phase 4|Overall Study||10
10603954|NCT01857973|11761071|FG000|Phase 6|Overall Study||4
10603955|NCT01857973|11761071|FG000|Phase 7|Overall Study||4
10603956|NCT01857973|11761071|FG000|COMPLETED|Overall Study||73
10603957|NCT01857973|11761071|FG000|NOT COMPLETED|Overall Study||5
10603958|NCT01857986|11761077|FG000|STARTED|Overall Study||39
10603959|NCT01857986|11761078|FG001|STARTED|Overall Study||37
10603960|NCT01857986|11761077|FG000|COMPLETED|Overall Study||34
10603961|NCT01857986|11761078|FG001|COMPLETED|Overall Study||30
10603962|NCT01857986|11761077|FG000|NOT COMPLETED|Overall Study||5
10603963|NCT01857986|11761078|FG001|NOT COMPLETED|Overall Study||7
10603964|NCT01858194|11761086|FG000|STARTED|Overall Study||8
10603965|NCT01858194|11761087|FG001|STARTED|Overall Study||9
10603966|NCT01858194|11761086|FG000|COMPLETED|Overall Study|All patients in Control arm completed.|8
10603967|NCT01858194|11761087|FG001|COMPLETED|Overall Study||7
10603968|NCT01858194|11761086|FG000|NOT COMPLETED|Overall Study||0
10603969|NCT01858194|11761087|FG001|NOT COMPLETED|Overall Study||2
10603970|NCT01858363|11761097|FG000|STARTED|Overall Study||222
10603971|NCT01858363|11761098|FG001|STARTED|Overall Study||72
10603972|NCT01858363|11761097|FG000|Pre-discharge Visit|Overall Study||219
10603973|NCT01858363|11761098|FG001|Pre-discharge Visit|Overall Study||72
10603974|NCT01858363|11761097|FG000|1-month Visit|Overall Study||214
10603975|NCT01858363|11761098|FG001|1-month Visit|Overall Study||68
10603976|NCT01858363|11761097|FG000|6-month Visit|Overall Study||208
10603977|NCT01858363|11761098|FG001|6-month Visit|Overall Study||64
10603978|NCT01858363|11761097|FG000|12-month Vist|Overall Study||205
10603979|NCT01858363|11761098|FG001|12-month Vist|Overall Study||61
10603980|NCT01858363|11761097|FG000|24-month Visit|Overall Study||184
10603981|NCT01858363|11761098|FG001|24-month Visit|Overall Study||58
10603982|NCT01858363|11761097|FG000|36-month Visit|Overall Study||169
10603983|NCT01858363|11761098|FG001|36-month Visit|Overall Study||53
10603984|NCT01858363|11761097|FG000|48-month Visit|Overall Study||157
10603985|NCT01858363|11761098|FG001|48-month Visit|Overall Study||53
10603986|NCT01858363|11761097|FG000|COMPLETED|Overall Study||146
10603987|NCT01858363|11761098|FG001|COMPLETED|Overall Study||46
10603988|NCT01858363|11761097|FG000|NOT COMPLETED|Overall Study||76
10603989|NCT01858363|11761098|FG001|NOT COMPLETED|Overall Study||26
10603990|NCT01858376|11761104|FG000|STARTED|Overall Study||24
10603991|NCT01858376|11761104|FG000|COMPLETED|Overall Study||20
10603992|NCT01858376|11761104|FG000|NOT COMPLETED|Overall Study||4
10603993|NCT01858389|11761110|FG000|STARTED|Overall Study|Enrolled|16
10603994|NCT01858389|11761111|FG001|STARTED|Overall Study|Enrolled|25
10603995|NCT01858389|11761110|FG000|Received Treatment|Overall Study||16
10603996|NCT01858389|11761111|FG001|Received Treatment|Overall Study||22
10603997|NCT01858389|11761110|FG000|COMPLETED|Overall Study||0
10603998|NCT01858389|11761111|FG001|COMPLETED|Overall Study||0
10603999|NCT01858389|11761110|FG000|NOT COMPLETED|Overall Study||16
10604000|NCT01858389|11761111|FG001|NOT COMPLETED|Overall Study||25
10604001|NCT01858428|11761121|FG000|STARTED|Overall Study|EverCross™ Balloon Catheter now a product of Medtronic|100
10604002|NCT01858428|11761122|FG001|STARTED|Overall Study||200
10604003|NCT01858428|11761121|FG000|COMPLETED|Overall Study||99
10604004|NCT01858428|11761122|FG001|COMPLETED|Overall Study||190
10604005|NCT01858428|11761121|FG000|NOT COMPLETED|Overall Study||1
10604006|NCT01858428|11761122|FG001|NOT COMPLETED|Overall Study||10
10604007|NCT01858532|11761132|FG000|STARTED|Overall Study||1325
10604008|NCT01858532|11761133|FG001|STARTED|Overall Study||1323
10604009|NCT01858532|11761134|FG002|STARTED|Overall Study||509
10604010|NCT01858532|11761135|FG003|STARTED|Overall Study||511
10604011|NCT01858532|11761132|FG000|COMPLETED|Overall Study||1144
10604012|NCT01858532|11761133|FG001|COMPLETED|Overall Study||1131
10604013|NCT01858532|11761134|FG002|COMPLETED|Overall Study||411
10604014|NCT01858532|11761135|FG003|COMPLETED|Overall Study||418
10604015|NCT01858532|11761132|FG000|NOT COMPLETED|Overall Study||181
10604016|NCT01858532|11761133|FG001|NOT COMPLETED|Overall Study||192
10604017|NCT01858532|11761134|FG002|NOT COMPLETED|Overall Study||98
10604018|NCT01858532|11761135|FG003|NOT COMPLETED|Overall Study||93
10604019|NCT01858545|11761147|FG000|STARTED|Overall Study||27
10604020|NCT01858545|11761148|FG001|STARTED|Overall Study||29
10604021|NCT01858545|11761147|FG000|COMPLETED|Overall Study||23
10604022|NCT01858545|11761148|FG001|COMPLETED|Overall Study||23
10604023|NCT01858545|11761147|FG000|NOT COMPLETED|Overall Study||4
10604024|NCT01858545|11761148|FG001|NOT COMPLETED|Overall Study||6
10604025|NCT01858558|11761156|FG000|STARTED|Overall Study||70
10604026|NCT01858558|11761157|FG001|STARTED|Overall Study||31
10604027|NCT01858558|11761156|FG000|COMPLETED|Overall Study||61
10604028|NCT01858558|11761157|FG001|COMPLETED|Overall Study||29
10604029|NCT01858558|11761156|FG000|NOT COMPLETED|Overall Study||9
10604030|NCT01858558|11761157|FG001|NOT COMPLETED|Overall Study||2
10604031|NCT01858636|11761163|FG000|STARTED|Overall Study|Subjects consented|235
10604032|NCT01858636|11761163|FG000|Device Deployment|Overall Study||211
10604033|NCT01858636|11761163|FG000|COMPLETED|Overall Study||207
10604034|NCT01858636|11761163|FG000|NOT COMPLETED|Overall Study||28
10604035|NCT01858701|11761168|FG000|STARTED|Period 1, First 30 Days of Wear||20
10604036|NCT01858701|11761169|FG001|STARTED|Period 1, First 30 Days of Wear||20
10604037|NCT01858701|11761168|FG000|COMPLETED|Period 1, First 30 Days of Wear||20
10604038|NCT01858701|11761169|FG001|COMPLETED|Period 1, First 30 Days of Wear||19
10604039|NCT01858701|11761168|FG000|NOT COMPLETED|Period 1, First 30 Days of Wear||0
10604040|NCT01858701|11761169|FG001|NOT COMPLETED|Period 1, First 30 Days of Wear||1
10604041|NCT01858701|11761168|FG000|STARTED|Washout Period, 1-13 Days||20
10604042|NCT01858701|11761169|FG001|STARTED|Washout Period, 1-13 Days||19
10604043|NCT01858701|11761168|FG000|COMPLETED|Washout Period, 1-13 Days||18
10604044|NCT01858701|11761169|FG001|COMPLETED|Washout Period, 1-13 Days||17
10604045|NCT01858701|11761168|FG000|NOT COMPLETED|Washout Period, 1-13 Days||2
10604046|NCT01858701|11761169|FG001|NOT COMPLETED|Washout Period, 1-13 Days||2
10604047|NCT01858701|11761168|FG000|STARTED|Period 2, Second 30 Days of Wear||18
10604048|NCT01858701|11761169|FG001|STARTED|Period 2, Second 30 Days of Wear||17
10604049|NCT01858701|11761168|FG000|COMPLETED|Period 2, Second 30 Days of Wear||18
10604050|NCT01858701|11761169|FG001|COMPLETED|Period 2, Second 30 Days of Wear||16
10604051|NCT01858701|11761168|FG000|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
10604052|NCT01858701|11761169|FG001|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
10604053|NCT01858753|11761177|FG000|STARTED|Overall Study||5
10604054|NCT01858753|11761178|FG001|STARTED|Overall Study||0
10604055|NCT01858753|11761177|FG000|COMPLETED|Overall Study||0
10604056|NCT01858753|11761178|FG001|COMPLETED|Overall Study||0
10604057|NCT01858753|11761177|FG000|NOT COMPLETED|Overall Study||5
10604058|NCT01858753|11761178|FG001|NOT COMPLETED|Overall Study||0
10604059|NCT01858766|11761203|FG000|STARTED|Overall Study||27
10604060|NCT01858766|11761204|FG001|STARTED|Overall Study||28
10604061|NCT01858766|11761205|FG002|STARTED|Overall Study||11
10604062|NCT01858766|11761206|FG003|STARTED|Overall Study||10
10604063|NCT01858766|11761207|FG004|STARTED|Overall Study||27
10604064|NCT01858766|11761208|FG005|STARTED|Overall Study||28
10604065|NCT01858766|11761209|FG006|STARTED|Overall Study||7
10604066|NCT01858766|11761210|FG007|STARTED|Overall Study||7
10604067|NCT01858766|11761211|FG008|STARTED|Overall Study||1
10604068|NCT01858766|11761212|FG009|STARTED|Overall Study||4
10604069|NCT01858766|11761213|FG010|STARTED|Overall Study||5
10604070|NCT01858766|11761214|FG011|STARTED|Overall Study||30
10604071|NCT01858766|11761215|FG012|STARTED|Overall Study||30
10604072|NCT01858766|11761216|FG013|STARTED|Overall Study||29
10604073|NCT01858766|11761217|FG014|STARTED|Overall Study||31
10604074|NCT01858766|11761218|FG015|STARTED|Overall Study||26
10604075|NCT01858766|11761219|FG016|STARTED|Overall Study||25
10604076|NCT01858766|11761220|FG017|STARTED|Overall Study||27
10604077|NCT01858766|11761221|FG018|STARTED|Overall Study||26
10604078|NCT01858766|11761203|FG000|COMPLETED|Overall Study||26
10604079|NCT01858766|11761204|FG001|COMPLETED|Overall Study||28
10604080|NCT01858766|11761205|FG002|COMPLETED|Overall Study||10
10604081|NCT01858766|11761206|FG003|COMPLETED|Overall Study||10
10604082|NCT01858766|11761207|FG004|COMPLETED|Overall Study||26
10604083|NCT01858766|11761208|FG005|COMPLETED|Overall Study||24
10604084|NCT01858766|11761209|FG006|COMPLETED|Overall Study||7
10604085|NCT01858766|11761210|FG007|COMPLETED|Overall Study||5
10604086|NCT01858766|11761211|FG008|COMPLETED|Overall Study||1
10604087|NCT01858766|11761212|FG009|COMPLETED|Overall Study||4
10604088|NCT01858766|11761213|FG010|COMPLETED|Overall Study||5
10604089|NCT01858766|11761214|FG011|COMPLETED|Overall Study||25
10604090|NCT01858766|11761215|FG012|COMPLETED|Overall Study||25
10604091|NCT01858766|11761216|FG013|COMPLETED|Overall Study||26
10604092|NCT01858766|11761217|FG014|COMPLETED|Overall Study||23
10604093|NCT01858766|11761218|FG015|COMPLETED|Overall Study||20
10604094|NCT01858766|11761219|FG016|COMPLETED|Overall Study||22
10604095|NCT01858766|11761220|FG017|COMPLETED|Overall Study||23
10604096|NCT01858766|11761221|FG018|COMPLETED|Overall Study||22
10604097|NCT01858766|11761203|FG000|NOT COMPLETED|Overall Study||1
10604098|NCT01858766|11761204|FG001|NOT COMPLETED|Overall Study||0
10604099|NCT01858766|11761205|FG002|NOT COMPLETED|Overall Study||1
10604100|NCT01858766|11761206|FG003|NOT COMPLETED|Overall Study||0
10604101|NCT01858766|11761207|FG004|NOT COMPLETED|Overall Study||1
10604102|NCT01858766|11761208|FG005|NOT COMPLETED|Overall Study||4
10604103|NCT01858766|11761209|FG006|NOT COMPLETED|Overall Study||0
10604104|NCT01858766|11761210|FG007|NOT COMPLETED|Overall Study||2
10604105|NCT01858766|11761211|FG008|NOT COMPLETED|Overall Study||0
10604106|NCT01858766|11761212|FG009|NOT COMPLETED|Overall Study||0
10604107|NCT01858766|11761213|FG010|NOT COMPLETED|Overall Study||0
10604108|NCT01858766|11761214|FG011|NOT COMPLETED|Overall Study||5
10604109|NCT01858766|11761215|FG012|NOT COMPLETED|Overall Study||5
10604110|NCT01858766|11761216|FG013|NOT COMPLETED|Overall Study||3
10604111|NCT01858766|11761217|FG014|NOT COMPLETED|Overall Study||8
10604112|NCT01858766|11761218|FG015|NOT COMPLETED|Overall Study||6
10604113|NCT01858766|11761219|FG016|NOT COMPLETED|Overall Study||3
10604114|NCT01858766|11761220|FG017|NOT COMPLETED|Overall Study||4
10604115|NCT01858766|11761221|FG018|NOT COMPLETED|Overall Study||4
10604116|NCT01859013|11761256|FG000|STARTED|Overall Study||16
10604117|NCT01859013|11761257|FG001|STARTED|Overall Study||14
10604118|NCT01859013|11761256|FG000|COMPLETED|Overall Study||12
10604119|NCT01859013|11761257|FG001|COMPLETED|Overall Study||9
10604120|NCT01859013|11761256|FG000|NOT COMPLETED|Overall Study||4
10604121|NCT01859013|11761257|FG001|NOT COMPLETED|Overall Study||5
10604122|NCT01859078|11761263|FG000|STARTED|Overall Study||28
10604123|NCT01859078|11761263|FG000|COMPLETED|Overall Study||28
10604124|NCT01859078|11761263|FG000|NOT COMPLETED|Overall Study||0
10604125|NCT01859143|11761271|FG000|STARTED|Overall Study||240
10604126|NCT01859143|11761272|FG001|STARTED|Overall Study|One participant in this group received trivalent influenza vaccine on Day 1.|60
10604127|NCT01859143|11761271|FG000|COMPLETED|Overall Study||238
10604128|NCT01859143|11761272|FG001|COMPLETED|Overall Study||60
10604129|NCT01859143|11761271|FG000|NOT COMPLETED|Overall Study||2
10604130|NCT01859143|11761272|FG001|NOT COMPLETED|Overall Study||0
10604131|NCT01859195|11761281|FG000|STARTED|Overall Study||24
10604132|NCT01859195|11761282|FG001|STARTED|Overall Study||12
10604133|NCT01859195|11761281|FG000|COMPLETED|Overall Study||24
10604134|NCT01859195|11761282|FG001|COMPLETED|Overall Study||12
10604135|NCT01859195|11761281|FG000|NOT COMPLETED|Overall Study||0
10604136|NCT01859195|11761282|FG001|NOT COMPLETED|Overall Study||0
10604137|NCT01859247|11761298|FG000|STARTED|Overall Study||1
10604138|NCT01859247|11761299|FG001|STARTED|Overall Study||1
10604139|NCT01859247|11761300|FG002|STARTED|Overall Study||1
10604140|NCT01859247|11761301|FG003|STARTED|Overall Study||1
10604141|NCT01859247|11761302|FG004|STARTED|Overall Study||1
10604142|NCT01859247|11761303|FG005|STARTED|Overall Study||1
10604143|NCT01859247|11761304|FG006|STARTED|Overall Study||1
10604144|NCT01859247|11761305|FG007|STARTED|Overall Study||1
10604145|NCT01859247|11761298|FG000|COMPLETED|Overall Study||1
10604146|NCT01859247|11761299|FG001|COMPLETED|Overall Study||1
10604147|NCT01859247|11761300|FG002|COMPLETED|Overall Study||1
10604148|NCT01859247|11761301|FG003|COMPLETED|Overall Study||1
10604149|NCT01859247|11761302|FG004|COMPLETED|Overall Study||1
10604150|NCT01859247|11761303|FG005|COMPLETED|Overall Study||1
10604151|NCT01859247|11761304|FG006|COMPLETED|Overall Study||1
10604152|NCT01859247|11761305|FG007|COMPLETED|Overall Study||1
10604153|NCT01859247|11761298|FG000|NOT COMPLETED|Overall Study||0
10604154|NCT01859247|11761299|FG001|NOT COMPLETED|Overall Study||0
10604155|NCT01859247|11761300|FG002|NOT COMPLETED|Overall Study||0
10604156|NCT01859247|11761301|FG003|NOT COMPLETED|Overall Study||0
10604157|NCT01859247|11761302|FG004|NOT COMPLETED|Overall Study||0
10604158|NCT01859247|11761303|FG005|NOT COMPLETED|Overall Study||0
10604159|NCT01859247|11761304|FG006|NOT COMPLETED|Overall Study||0
10604160|NCT01859247|11761305|FG007|NOT COMPLETED|Overall Study||0
10604161|NCT01859312|11761324|FG000|STARTED|Overall Study||8
10604162|NCT01859312|11761324|FG000|COMPLETED|Overall Study|Based on medication & supply accountability, one participant was found to be partially non-compliant|8
10604163|NCT01859312|11761324|FG000|NOT COMPLETED|Overall Study||0
10604164|NCT01859325|11761331|FG000|STARTED|Overall Study||15
10604165|NCT01859325|11761332|FG001|STARTED|Overall Study||16
10604166|NCT01859325|11761333|FG002|STARTED|Overall Study||2
10604167|NCT01859325|11761331|FG000|COMPLETED|Overall Study||12
10604168|NCT01859325|11761332|FG001|COMPLETED|Overall Study||12
10604169|NCT01859325|11761333|FG002|COMPLETED|Overall Study||2
10604170|NCT01859325|11761331|FG000|NOT COMPLETED|Overall Study||3
10604171|NCT01859325|11761332|FG001|NOT COMPLETED|Overall Study||4
10604172|NCT01859325|11761333|FG002|NOT COMPLETED|Overall Study||0
10604173|NCT01859390|11761341|FG000|STARTED|Overall Study||36
10604174|NCT01859390|11761342|FG001|STARTED|Overall Study||37
10604175|NCT01859390|11761341|FG000|Withdrawals|Overall Study||2
10604176|NCT01859390|11761342|FG001|Withdrawals|Overall Study||2
10604177|NCT01859390|11761341|FG000|COMPLETED|Overall Study||35
10604178|NCT01859390|11761342|FG001|COMPLETED|Overall Study||30
10604179|NCT01859390|11761341|FG000|NOT COMPLETED|Overall Study||1
10604180|NCT01859390|11761342|FG001|NOT COMPLETED|Overall Study||7
10604181|NCT01859403|11761350|FG000|STARTED|Primary Endpoint Measure||21
10604182|NCT01859403|11761351|FG001|STARTED|Primary Endpoint Measure||30
10604183|NCT01859403|11761350|FG000|COMPLETED|Primary Endpoint Measure||20
10604184|NCT01859403|11761351|FG001|COMPLETED|Primary Endpoint Measure||26
10604185|NCT01859403|11761350|FG000|NOT COMPLETED|Primary Endpoint Measure||1
10604186|NCT01859403|11761351|FG001|NOT COMPLETED|Primary Endpoint Measure||4
10604187|NCT01859403|11761350|FG000|STARTED|Secondary Endpoint Measure||20
10604188|NCT01859403|11761351|FG001|STARTED|Secondary Endpoint Measure||26
10604189|NCT01859403|11761350|FG000|COMPLETED|Secondary Endpoint Measure||14
10604190|NCT01859403|11761351|FG001|COMPLETED|Secondary Endpoint Measure||18
10604191|NCT01859403|11761350|FG000|NOT COMPLETED|Secondary Endpoint Measure||6
10604192|NCT01859403|11761351|FG001|NOT COMPLETED|Secondary Endpoint Measure||8
10604193|NCT01859494|11761357|FG000|STARTED|Overall Study||219
10604194|NCT01859494|11761357|FG000|COMPLETED|Overall Study||218
10604195|NCT01859494|11761357|FG000|NOT COMPLETED|Overall Study||1
10604196|NCT01859507|11761361|FG000|STARTED|Overall Study||32
10604197|NCT01859507|11761361|FG000|COMPLETED|Overall Study||28
10604198|NCT01859507|11761361|FG000|NOT COMPLETED|Overall Study||4
10604199|NCT01859598|11761366|FG000|STARTED|Visit 2 at 3 Months|At visit 1, patients remained at baseline, N=18995|18995
10604200|NCT01859598|11761366|FG000|COMPLETED|Visit 2 at 3 Months||17253
10604201|NCT01859598|11761366|FG000|NOT COMPLETED|Visit 2 at 3 Months||1742
10604202|NCT01859598|11761366|FG000|STARTED|Visit 3 at 6 Months||17253
10604203|NCT01859598|11761366|FG000|COMPLETED|Visit 3 at 6 Months|Loss to follow-up, N=1517; Come back at visit 3, N=605;|16341
10604204|NCT01859598|11761366|FG000|NOT COMPLETED|Visit 3 at 6 Months||912
10604205|NCT01859611|11761372|FG000|STARTED|Overall Study||51
10604206|NCT01859611|11761372|FG000|COMPLETED|Overall Study||43
10604207|NCT01859611|11761372|FG000|NOT COMPLETED|Overall Study||8
10604208|NCT01859637|11761376|FG000|STARTED|Overall Study||6
10604209|NCT01859637|11761376|FG000|COMPLETED|Overall Study||6
10604210|NCT01859637|11761376|FG000|NOT COMPLETED|Overall Study||0
10604211|NCT01859702|11761380|FG000|STARTED|Overall Study||36
10604212|NCT01859702|11761380|FG000|COMPLETED|Overall Study||31
10604213|NCT01859702|11761380|FG000|NOT COMPLETED|Overall Study||5
10604214|NCT01859715|11761387|FG000|STARTED|Overall Study||141
10604215|NCT01859715|11761388|FG001|STARTED|Overall Study||91
10604216|NCT01859715|11761389|FG002|STARTED|Overall Study||116
10604217|NCT01859715|11761387|FG000|COMPLETED|Overall Study||125
10604218|NCT01859715|11761388|FG001|COMPLETED|Overall Study||83
10604219|NCT01859715|11761389|FG002|COMPLETED|Overall Study||93
10604220|NCT01859715|11761387|FG000|NOT COMPLETED|Overall Study||16
10604221|NCT01859715|11761388|FG001|NOT COMPLETED|Overall Study||8
10604222|NCT01859715|11761389|FG002|NOT COMPLETED|Overall Study||23
10604223|NCT01859741|11761407|FG000|STARTED|Overall Study||3
10604224|NCT01859741|11761408|FG001|STARTED|Overall Study||3
10604225|NCT01859741|11761409|FG002|STARTED|Overall Study||6
10604226|NCT01859741|11761410|FG003|STARTED|Overall Study||3
10604227|NCT01859741|11761411|FG004|STARTED|Overall Study||6
10604228|NCT01859741|11761412|FG005|STARTED|Overall Study||6
10604229|NCT01859741|11761413|FG006|STARTED|Overall Study||72
10604230|NCT01859741|11761414|FG007|STARTED|Overall Study||73
10604231|NCT01859741|11761407|FG000|COMPLETED|Overall Study||0
10604232|NCT01859741|11761408|FG001|COMPLETED|Overall Study||0
10604233|NCT01859741|11761409|FG002|COMPLETED|Overall Study||0
10604234|NCT01859741|11761410|FG003|COMPLETED|Overall Study||0
10604235|NCT01859741|11761411|FG004|COMPLETED|Overall Study||0
10604236|NCT01859741|11761412|FG005|COMPLETED|Overall Study||0
10604237|NCT01859741|11761413|FG006|COMPLETED|Overall Study||2
10604238|NCT01859741|11761414|FG007|COMPLETED|Overall Study||3
10604239|NCT01859741|11761407|FG000|NOT COMPLETED|Overall Study||3
10604240|NCT01859741|11761408|FG001|NOT COMPLETED|Overall Study||3
10604241|NCT01859741|11761409|FG002|NOT COMPLETED|Overall Study||6
10604242|NCT01859741|11761410|FG003|NOT COMPLETED|Overall Study||3
10604243|NCT01859741|11761411|FG004|NOT COMPLETED|Overall Study||6
10604244|NCT01859741|11761412|FG005|NOT COMPLETED|Overall Study||6
10604245|NCT01859741|11761413|FG006|NOT COMPLETED|Overall Study||70
10604246|NCT01859741|11761414|FG007|NOT COMPLETED|Overall Study||70
10604247|NCT01859793|11761434|FG000|STARTED|First Intervention (8 Weeks)||20
10604248|NCT01859793|11761435|FG001|STARTED|First Intervention (8 Weeks)||18
10604249|NCT01859793|11761434|FG000|COMPLETED|First Intervention (8 Weeks)||15
10604250|NCT01859793|11761435|FG001|COMPLETED|First Intervention (8 Weeks)||17
10604251|NCT01859793|11761434|FG000|NOT COMPLETED|First Intervention (8 Weeks)||5
10604252|NCT01859793|11761435|FG001|NOT COMPLETED|First Intervention (8 Weeks)||1
10604253|NCT01859793|11761434|FG000|STARTED|Washout Period (4 Weeks)||15
10604254|NCT01859793|11761435|FG001|STARTED|Washout Period (4 Weeks)||17
10604255|NCT01859793|11761434|FG000|COMPLETED|Washout Period (4 Weeks)||14
10604256|NCT01859793|11761435|FG001|COMPLETED|Washout Period (4 Weeks)||16
10604257|NCT01859793|11761434|FG000|NOT COMPLETED|Washout Period (4 Weeks)||1
10604258|NCT01859793|11761435|FG001|NOT COMPLETED|Washout Period (4 Weeks)||1
10604259|NCT01859793|11761434|FG000|STARTED|2nd Intervention Period||14
10604260|NCT01859793|11761435|FG001|STARTED|2nd Intervention Period||16
10604261|NCT01859793|11761434|FG000|COMPLETED|2nd Intervention Period||14
10604262|NCT01859793|11761435|FG001|COMPLETED|2nd Intervention Period||16
10604263|NCT01859793|11761434|FG000|NOT COMPLETED|2nd Intervention Period||0
10604264|NCT01859793|11761435|FG001|NOT COMPLETED|2nd Intervention Period||0
10604265|NCT01859923|11761445|FG000|STARTED|Overall Study||7
10604266|NCT01859923|11761446|FG001|STARTED|Overall Study||6
10604267|NCT01859923|11761447|FG002|STARTED|Overall Study||12
10604268|NCT01859923|11761448|FG003|STARTED|Overall Study||12
10604269|NCT01859923|11761445|FG000|COMPLETED|Overall Study||7
10604270|NCT01859923|11761446|FG001|COMPLETED|Overall Study||6
10604271|NCT01859923|11761447|FG002|COMPLETED|Overall Study||11
10604272|NCT01859923|11761448|FG003|COMPLETED|Overall Study||11
10604273|NCT01859923|11761445|FG000|NOT COMPLETED|Overall Study||0
10604274|NCT01859923|11761446|FG001|NOT COMPLETED|Overall Study||0
10604275|NCT01859923|11761447|FG002|NOT COMPLETED|Overall Study||1
10604276|NCT01859923|11761448|FG003|NOT COMPLETED|Overall Study||1
10604277|NCT01859949|11761463|FG000|STARTED|Overall Study|Treated participants|29
10604278|NCT01859949|11761464|FG001|STARTED|Overall Study|Treated participants|32
10604279|NCT01859949|11761463|FG000|COMPLETED|Overall Study||15
10604280|NCT01859949|11761464|FG001|COMPLETED|Overall Study||15
10604281|NCT01859949|11761463|FG000|NOT COMPLETED|Overall Study||14
10604282|NCT01859949|11761464|FG001|NOT COMPLETED|Overall Study||17
10604283|NCT01859988|11761476|FG000|STARTED|Overall Study||63
10604284|NCT01859988|11761477|FG001|STARTED|Overall Study||64
10604285|NCT01859988|11761478|FG002|STARTED|Overall Study||62
10604286|NCT01859988|11761479|FG003|STARTED|Overall Study||65
10604287|NCT01859988|11761480|FG004|STARTED|Overall Study||65
10604288|NCT01859988|11761481|FG005|STARTED|Overall Study||61
10604289|NCT01859988|11761476|FG000|Treated|Overall Study||63
10604290|NCT01859988|11761477|FG001|Treated|Overall Study||64
10604291|NCT01859988|11761478|FG002|Treated|Overall Study||61
10604292|NCT01859988|11761479|FG003|Treated|Overall Study||65
10604293|NCT01859988|11761480|FG004|Treated|Overall Study||65
10604294|NCT01859988|11761481|FG005|Treated|Overall Study||61
10604295|NCT01859988|11761476|FG000|COMPLETED|Overall Study||52
10604296|NCT01859988|11761477|FG001|COMPLETED|Overall Study||52
10604297|NCT01859988|11761478|FG002|COMPLETED|Overall Study||34
10604298|NCT01859988|11761479|FG003|COMPLETED|Overall Study||55
10604299|NCT01859988|11761480|FG004|COMPLETED|Overall Study||42
10604300|NCT01859988|11761481|FG005|COMPLETED|Overall Study||42
10604301|NCT01859988|11761476|FG000|NOT COMPLETED|Overall Study||11
10604302|NCT01859988|11761477|FG001|NOT COMPLETED|Overall Study||12
10604303|NCT01859988|11761478|FG002|NOT COMPLETED|Overall Study||28
10604304|NCT01859988|11761479|FG003|NOT COMPLETED|Overall Study||10
10604305|NCT01859988|11761480|FG004|NOT COMPLETED|Overall Study||23
10604306|NCT01859988|11761481|FG005|NOT COMPLETED|Overall Study||19
10604307|NCT01860079|11761497|FG000|STARTED|Overall Study||384
10604308|NCT01860079|11761498|FG001|STARTED|Overall Study||385
10604309|NCT01860079|11761497|FG000|COMPLETED|Overall Study||370
10604310|NCT01860079|11761498|FG001|COMPLETED|Overall Study||363
10604311|NCT01860079|11761497|FG000|NOT COMPLETED|Overall Study||14
10604312|NCT01860079|11761498|FG001|NOT COMPLETED|Overall Study||22
10604313|NCT01860170|11761507|FG000|STARTED|Overall Study||3
10604314|NCT01860170|11761508|FG001|STARTED|Overall Study||3
10604315|NCT01860170|11761509|FG002|STARTED|Overall Study||22
10604316|NCT01860170|11761507|FG000|COMPLETED|Overall Study||3
10604317|NCT01860170|11761508|FG001|COMPLETED|Overall Study||3
10604318|NCT01860170|11761509|FG002|COMPLETED|Overall Study||22
10604319|NCT01860170|11761507|FG000|NOT COMPLETED|Overall Study||0
10604320|NCT01860170|11761508|FG001|NOT COMPLETED|Overall Study||0
10604321|NCT01860170|11761509|FG002|NOT COMPLETED|Overall Study||0
10604322|NCT01860287|11761520|FG000|STARTED|Overall Study||18
10604323|NCT01860287|11761521|FG001|STARTED|Overall Study||15
10604324|NCT01860287|11761522|FG002|STARTED|Overall Study||15
10604325|NCT01860287|11761520|FG000|COMPLETED|Overall Study||18
10604326|NCT01860287|11761521|FG001|COMPLETED|Overall Study||15
10604327|NCT01860287|11761522|FG002|COMPLETED|Overall Study||15
10604328|NCT01860287|11761520|FG000|NOT COMPLETED|Overall Study||0
10604329|NCT01860287|11761521|FG001|NOT COMPLETED|Overall Study||0
10604330|NCT01860287|11761522|FG002|NOT COMPLETED|Overall Study||0
10604331|NCT01860521|11761532|FG000|STARTED|Overall Study|September 2011|52
10604332|NCT01860521|11761533|FG001|STARTED|Overall Study|September 2011|52
10604333|NCT01860521|11761532|FG000|COMPLETED|Overall Study|June 2013|52
10604334|NCT01860521|11761533|FG001|COMPLETED|Overall Study|June 2013|52
10604335|NCT01860521|11761532|FG000|NOT COMPLETED|Overall Study||0
10604336|NCT01860521|11761533|FG001|NOT COMPLETED|Overall Study||0
10604337|NCT01860534|11761541|FG000|STARTED|ROP #1||14
10604338|NCT01860534|11761542|FG001|STARTED|ROP #1||14
10604339|NCT01860534|11761541|FG000|COMPLETED|ROP #1||14
10604340|NCT01860534|11761542|FG001|COMPLETED|ROP #1||13
10604341|NCT01860534|11761541|FG000|NOT COMPLETED|ROP #1||0
10604342|NCT01860534|11761542|FG001|NOT COMPLETED|ROP #1||1
10604343|NCT01860534|11761541|FG000|STARTED|ROP #2||14
10604344|NCT01860534|11761542|FG001|STARTED|ROP #2||13
10604345|NCT01860534|11761541|FG000|COMPLETED|ROP #2||13
10604346|NCT01860534|11761542|FG001|COMPLETED|ROP #2||13
10604347|NCT01860534|11761541|FG000|NOT COMPLETED|ROP #2||1
10604348|NCT01860534|11761542|FG001|NOT COMPLETED|ROP #2||0
10604349|NCT01860573|11761552|FG000|STARTED|Overall Study||83
10604350|NCT01860573|11761553|FG001|STARTED|Overall Study||85
10604351|NCT01860573|11761552|FG000|COMPLETED|Overall Study||83
10604352|NCT01860573|11761553|FG001|COMPLETED|Overall Study||85
10604353|NCT01860573|11761552|FG000|NOT COMPLETED|Overall Study||0
10604354|NCT01860573|11761553|FG001|NOT COMPLETED|Overall Study||0
10604355|NCT01860586|11761559|FG000|STARTED|Overall Study||20
10604356|NCT01860586|11761559|FG000|COMPLETED|Overall Study||20
10604357|NCT01860586|11761559|FG000|NOT COMPLETED|Overall Study||0
10604358|NCT01860651|11761566|FG000|STARTED|Overall Study||56
10604359|NCT01860651|11761567|FG001|STARTED|Overall Study||47
10604360|NCT01860651|11761566|FG000|COMPLETED|Overall Study||31
10604361|NCT01860651|11761567|FG001|COMPLETED|Overall Study||39
10604362|NCT01860651|11761566|FG000|NOT COMPLETED|Overall Study||25
10604363|NCT01860651|11761567|FG001|NOT COMPLETED|Overall Study||8
10604364|NCT01860677|11761579|FG000|STARTED|First Intervention (1 Day)||8
10604365|NCT01860677|11761580|FG001|STARTED|First Intervention (1 Day)||0
10604366|NCT01860677|11761579|FG000|COMPLETED|First Intervention (1 Day)||8
10604367|NCT01860677|11761580|FG001|COMPLETED|First Intervention (1 Day)||0
10604368|NCT01860677|11761579|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10604369|NCT01860677|11761580|FG001|NOT COMPLETED|First Intervention (1 Day)||0
10604370|NCT01860677|11761579|FG000|STARTED|Second Intervention (1 Day)||8
10604371|NCT01860677|11761580|FG001|STARTED|Second Intervention (1 Day)||0
10604372|NCT01860677|11761579|FG000|COMPLETED|Second Intervention (1 Day)||1
10604373|NCT01860677|11761580|FG001|COMPLETED|Second Intervention (1 Day)||0
10604374|NCT01860677|11761579|FG000|NOT COMPLETED|Second Intervention (1 Day)||7
10604375|NCT01860677|11761580|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10604376|NCT01860703|11761587|FG000|STARTED|Overall Study||13
10604377|NCT01860703|11761588|FG001|STARTED|Overall Study||13
10604378|NCT01860703|11761589|FG002|STARTED|Overall Study||12
10604379|NCT01860703|11761590|FG003|STARTED|Overall Study||12
10604380|NCT01860703|11761587|FG000|COMPLETED|Overall Study||11
10604381|NCT01860703|11761588|FG001|COMPLETED|Overall Study||8
10604382|NCT01860703|11761589|FG002|COMPLETED|Overall Study||11
10604383|NCT01860703|11761590|FG003|COMPLETED|Overall Study||10
10604384|NCT01860703|11761587|FG000|NOT COMPLETED|Overall Study||2
10604385|NCT01860703|11761588|FG001|NOT COMPLETED|Overall Study||5
10604386|NCT01860703|11761589|FG002|NOT COMPLETED|Overall Study||1
10604387|NCT01860703|11761590|FG003|NOT COMPLETED|Overall Study||2
10604388|NCT01860807|11761608|FG000|STARTED|Overall Study||64
10604389|NCT01860807|11761609|FG001|STARTED|Overall Study||61
10604390|NCT01860807|11761608|FG000|COMPLETED|Overall Study||34
10604391|NCT01860807|11761609|FG001|COMPLETED|Overall Study||32
10604392|NCT01860807|11761608|FG000|NOT COMPLETED|Overall Study||30
10604393|NCT01860807|11761609|FG001|NOT COMPLETED|Overall Study||29
10604394|NCT01860846|11761615|FG000|STARTED|Overall Study||106
10604395|NCT01860846|11761615|FG000|Month 1|Overall Study||97
10604396|NCT01860846|11761615|FG000|Month 2|Overall Study||83
10604397|NCT01860846|11761615|FG000|Month 4|Overall Study||82
10604398|NCT01860846|11761615|FG000|Month 6|Overall Study||85
10604399|NCT01860846|11761615|FG000|Month 12|Overall Study||73
10604400|NCT01860846|11761615|FG000|COMPLETED|Overall Study||73
10604401|NCT01860846|11761615|FG000|NOT COMPLETED|Overall Study||33
10604402|NCT01860950|11761625|FG000|STARTED|Overall Study||14
10604403|NCT01860950|11761626|FG001|STARTED|Overall Study||15
10604404|NCT01860950|11761627|FG002|STARTED|Overall Study||10
10604405|NCT01860950|11761628|FG003|STARTED|Overall Study||13
10604406|NCT01860950|11761629|FG004|STARTED|Overall Study||14
10604407|NCT01860950|11761630|FG005|STARTED|Overall Study||13
10604408|NCT01860950|11761625|FG000|COMPLETED|Overall Study||14
10604409|NCT01860950|11761626|FG001|COMPLETED|Overall Study||15
10604410|NCT01860950|11761627|FG002|COMPLETED|Overall Study||10
10604411|NCT01860950|11761628|FG003|COMPLETED|Overall Study||13
10604412|NCT01860950|11761629|FG004|COMPLETED|Overall Study||14
10604413|NCT01860950|11761630|FG005|COMPLETED|Overall Study||13
10604414|NCT01860950|11761625|FG000|NOT COMPLETED|Overall Study||0
10604415|NCT01860950|11761626|FG001|NOT COMPLETED|Overall Study||0
10604416|NCT01860950|11761627|FG002|NOT COMPLETED|Overall Study||0
10604417|NCT01860950|11761628|FG003|NOT COMPLETED|Overall Study||0
10604418|NCT01860950|11761629|FG004|NOT COMPLETED|Overall Study||0
10604419|NCT01860950|11761630|FG005|NOT COMPLETED|Overall Study||0
10604420|NCT01860989|11761645|FG000|STARTED|Overall Study||11
10604421|NCT01860989|11761645|FG000|COMPLETED|Overall Study||6
10604422|NCT01860989|11761645|FG000|NOT COMPLETED|Overall Study||5
10604423|NCT01861002|11761649|FG000|STARTED|Overall Study||15
10604424|NCT01861002|11761649|FG000|COMPLETED|Overall Study||14
10604425|NCT01861002|11761649|FG000|NOT COMPLETED|Overall Study||1
10604426|NCT01861028|11761657|FG000|STARTED|Overall Study||44
10604427|NCT01861028|11761657|FG000|COMPLETED|Overall Study||44
10604428|NCT01861028|11761657|FG000|NOT COMPLETED|Overall Study||0
10604429|NCT01861054|11761664|FG000|STARTED|Overall Study||18
10604430|NCT01861054|11761665|FG001|STARTED|Overall Study||2
10604431|NCT01861054|11761664|FG000|Safety Population|Overall Study||18
10604432|NCT01861054|11761665|FG001|Safety Population|Overall Study||2
10604433|NCT01861054|11761664|FG000|PK Population|Overall Study||4
10604434|NCT01861054|11761665|FG001|PK Population|Overall Study||2
10604435|NCT01861054|11761664|FG000|COMPLETED|Overall Study||18
10604436|NCT01861054|11761665|FG001|COMPLETED|Overall Study||2
10604437|NCT01861054|11761664|FG000|NOT COMPLETED|Overall Study||0
10604438|NCT01861054|11761665|FG001|NOT COMPLETED|Overall Study||0
10604439|NCT01861301|11761674|FG000|STARTED|Overall Study||18
10604440|NCT01861301|11761674|FG000|COMPLETED|Overall Study||18
10604441|NCT01861301|11761674|FG000|NOT COMPLETED|Overall Study||0
10604442|NCT01861457|11761681|FG000|STARTED|Overall Study||20
10604443|NCT01861457|11761682|FG001|STARTED|Overall Study||19
10604444|NCT01861457|11761681|FG000|COMPLETED|Overall Study||20
10604445|NCT01861457|11761682|FG001|COMPLETED|Overall Study||19
10604446|NCT01861457|11761681|FG000|NOT COMPLETED|Overall Study||0
10604447|NCT01861457|11761682|FG001|NOT COMPLETED|Overall Study||0
10604448|NCT01861522|11761690|FG000|STARTED|Overall Study||240
10604449|NCT01861522|11761691|FG001|STARTED|Overall Study|One subject who did not receive any study drug was excluded from the FAS and the Safety Analysis Set|232
10604450|NCT01861522|11761690|FG000|COMPLETED|Overall Study||237
10604451|NCT01861522|11761691|FG001|COMPLETED|Overall Study||232
10604452|NCT01861522|11761690|FG000|NOT COMPLETED|Overall Study||3
10604453|NCT01861522|11761691|FG001|NOT COMPLETED|Overall Study||0
10604454|NCT01861574|11761701|FG000|STARTED|Overall Study||28
10604455|NCT01861574|11761702|FG001|STARTED|Overall Study||25
10604456|NCT01861574|11761703|FG002|STARTED|Overall Study||27
10604457|NCT01861574|11761704|FG003|STARTED|Overall Study||28
10604458|NCT01861574|11761701|FG000|COMPLETED|Overall Study||28
10604459|NCT01861574|11761702|FG001|COMPLETED|Overall Study||25
10604460|NCT01861574|11761703|FG002|COMPLETED|Overall Study||27
10604461|NCT01861574|11761704|FG003|COMPLETED|Overall Study||28
10604462|NCT01861574|11761701|FG000|NOT COMPLETED|Overall Study||0
10604463|NCT01861574|11761702|FG001|NOT COMPLETED|Overall Study||0
10604464|NCT01861574|11761703|FG002|NOT COMPLETED|Overall Study||0
10604465|NCT01861574|11761704|FG003|NOT COMPLETED|Overall Study||0
10604466|NCT01861587|11761719|FG000|STARTED|Overall Study||14
10604467|NCT01861587|11761720|FG001|STARTED|Overall Study||13
10604468|NCT01861587|11761719|FG000|COMPLETED|Overall Study||14
10604469|NCT01861587|11761720|FG001|COMPLETED|Overall Study||13
10604470|NCT01861587|11761719|FG000|NOT COMPLETED|Overall Study||0
10604471|NCT01861587|11761720|FG001|NOT COMPLETED|Overall Study||0
10604472|NCT01861665|11761732|FG000|STARTED|Overall Study||10
10604473|NCT01861665|11761733|FG001|STARTED|Overall Study||17
10604474|NCT01861665|11761732|FG000|COMPLETED|Overall Study||10
10604475|NCT01861665|11761733|FG001|COMPLETED|Overall Study||17
10604476|NCT01861665|11761732|FG000|NOT COMPLETED|Overall Study||0
10604477|NCT01861665|11761733|FG001|NOT COMPLETED|Overall Study||0
10604478|NCT01861704|11761741|FG000|STARTED|Overall Study||70
10604479|NCT01861704|11761742|FG001|STARTED|Overall Study||107
10604480|NCT01861704|11761741|FG000|COMPLETED|Overall Study||67
10604481|NCT01861704|11761742|FG001|COMPLETED|Overall Study||104
10604482|NCT01861704|11761741|FG000|NOT COMPLETED|Overall Study||3
10604483|NCT01861704|11761742|FG001|NOT COMPLETED|Overall Study||3
10604484|NCT01861756|11761750|FG000|STARTED|Overall Study||101
10604485|NCT01861756|11761751|FG001|STARTED|Overall Study||103
10604486|NCT01861756|11761750|FG000|COMPLETED|Overall Study||88
10604487|NCT01861756|11761751|FG001|COMPLETED|Overall Study||85
10604488|NCT01861756|11761750|FG000|NOT COMPLETED|Overall Study||13
10604489|NCT01861756|11761751|FG001|NOT COMPLETED|Overall Study||18
10604490|NCT01861925|11761760|FG000|STARTED|Overall Study||34
10604491|NCT01861925|11761761|FG001|STARTED|Overall Study||8
10604492|NCT01861925|11761762|FG002|STARTED|Overall Study||8
10604493|NCT01861925|11761760|FG000|COMPLETED|Overall Study||34
10604494|NCT01861925|11761761|FG001|COMPLETED|Overall Study||8
10604495|NCT01861925|11761762|FG002|COMPLETED|Overall Study||8
10604496|NCT01861925|11761760|FG000|NOT COMPLETED|Overall Study||0
10604497|NCT01861925|11761761|FG001|NOT COMPLETED|Overall Study||0
10604498|NCT01861925|11761762|FG002|NOT COMPLETED|Overall Study||0
10604499|NCT01862029|11761771|FG000|STARTED|Overall Study||9
10604500|NCT01862029|11761771|FG000|COMPLETED|Overall Study||8
10604501|NCT01862029|11761771|FG000|NOT COMPLETED|Overall Study||1
10604502|NCT01862133|11761776|FG000|STARTED|Overall Study||105
10604503|NCT01862133|11761777|FG001|STARTED|Overall Study||31
10604504|NCT01862133|11761776|FG000|Returned During 6 mo Study|Overall Study||92
10604505|NCT01862133|11761777|FG001|Returned During 6 mo Study|Overall Study||31
10604506|NCT01862133|11761776|FG000|COMPLETED|Overall Study|All 105 patients recorded preferences; 92 (88%) returned to the study clinic during the 6 mo. study|105
10604507|NCT01862133|11761777|FG001|COMPLETED|Overall Study||31
10604508|NCT01862133|11761776|FG000|NOT COMPLETED|Overall Study||0
10604509|NCT01862133|11761777|FG001|NOT COMPLETED|Overall Study||0
10604510|NCT01862159|11761783|FG000|STARTED|Overall Study||25038
10604511|NCT01862159|11761783|FG000|COMPLETED|Overall Study||25038
10604512|NCT01862159|11761783|FG000|NOT COMPLETED|Overall Study||0
10604513|NCT01862250|11761787|FG000|STARTED|Overall Study||12
10604514|NCT01862250|11761787|FG000|COMPLETED|Overall Study||8
10604515|NCT01862250|11761787|FG000|NOT COMPLETED|Overall Study||4
10604516|NCT01862328|11761798|FG000|STARTED|Overall Study||4
10604517|NCT01862328|11761799|FG001|STARTED|Overall Study||18
10604518|NCT01862328|11761800|FG002|STARTED|Overall Study||6
10604519|NCT01862328|11761801|FG003|STARTED|Overall Study||7
10604520|NCT01862328|11761802|FG004|STARTED|Overall Study||12
10604521|NCT01862328|11761803|FG005|STARTED|Overall Study||7
10604522|NCT01862328|11761804|FG006|STARTED|Overall Study||10
10604523|NCT01862328|11761798|FG000|COMPLETED|Overall Study||0
10604524|NCT01862328|11761799|FG001|COMPLETED|Overall Study||0
10604525|NCT01862328|11761800|FG002|COMPLETED|Overall Study||0
10604526|NCT01862328|11761801|FG003|COMPLETED|Overall Study||0
10604527|NCT01862328|11761802|FG004|COMPLETED|Overall Study||0
10604528|NCT01862328|11761803|FG005|COMPLETED|Overall Study||0
10704133|NCT02589665|11868641|FG005|COMPLETED|Induction Period||0
10704134|NCT02589665|11868642|FG006|COMPLETED|Induction Period||0
10704135|NCT02589665|11868643|FG007|COMPLETED|Induction Period||0
10704136|NCT02589665|11868644|FG008|COMPLETED|Induction Period||0
10704137|NCT02589665|11868645|FG009|COMPLETED|Induction Period||0
10704138|NCT02589665|11868636|FG000|NOT COMPLETED|Induction Period||3
10704139|NCT02589665|11868637|FG001|NOT COMPLETED|Induction Period||2
10704140|NCT02589665|11868638|FG002|NOT COMPLETED|Induction Period||2
10704141|NCT02589665|11868639|FG003|NOT COMPLETED|Induction Period||4
10704142|NCT02589665|11868640|FG004|NOT COMPLETED|Induction Period||0
10704143|NCT02589665|11868641|FG005|NOT COMPLETED|Induction Period||0
10704144|NCT02589665|11868642|FG006|NOT COMPLETED|Induction Period||0
10704145|NCT02589665|11868643|FG007|NOT COMPLETED|Induction Period||0
10704146|NCT02589665|11868644|FG008|NOT COMPLETED|Induction Period||0
10704147|NCT02589665|11868645|FG009|NOT COMPLETED|Induction Period||0
10704148|NCT02589665|11868636|FG000|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0
10704149|NCT02589665|11868637|FG001|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0
10704150|NCT02589665|11868638|FG002|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0
10704151|NCT02589665|11868639|FG003|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0
10704152|NCT02589665|11868640|FG004|STARTED|Maintenance Period|Only participants with a response were re-randomized in maintenance period.|13
10704153|NCT02589665|11868641|FG005|STARTED|Maintenance Period|Only participants with a response were re-randomized in maintenance period.|47
10704154|NCT02589665|11868642|FG006|STARTED|Maintenance Period|Only participants with a response were re-randomized in maintenance period.|46
10704155|NCT02589665|11868643|FG007|STARTED|Maintenance Period||0
10704156|NCT02589665|11868644|FG008|STARTED|Maintenance Period||0
10704157|NCT02589665|11868645|FG009|STARTED|Maintenance Period||0
10704158|NCT02589665|11868636|FG000|COMPLETED|Maintenance Period||0
10704159|NCT02589665|11868637|FG001|COMPLETED|Maintenance Period||0
10704160|NCT02589665|11868638|FG002|COMPLETED|Maintenance Period||0
10704161|NCT02589665|11868639|FG003|COMPLETED|Maintenance Period||0
10704162|NCT02589665|11868640|FG004|COMPLETED|Maintenance Period||0
10604529|NCT01862328|11761804|FG006|COMPLETED|Overall Study||0
10604530|NCT01862328|11761798|FG000|NOT COMPLETED|Overall Study||4
10604531|NCT01862328|11761799|FG001|NOT COMPLETED|Overall Study||18
10604532|NCT01862328|11761800|FG002|NOT COMPLETED|Overall Study||6
10604533|NCT01862328|11761801|FG003|NOT COMPLETED|Overall Study||7
10604534|NCT01862328|11761802|FG004|NOT COMPLETED|Overall Study||12
10604535|NCT01862328|11761803|FG005|NOT COMPLETED|Overall Study||7
10604536|NCT01862328|11761804|FG006|NOT COMPLETED|Overall Study||10
10604537|NCT01862419|11761828|FG000|STARTED|Overall Study||1201
10604538|NCT01862419|11761829|FG001|STARTED|Overall Study||1192
10604539|NCT01862419|11761828|FG000|COMPLETED|Overall Study||1201
10604540|NCT01862419|11761829|FG001|COMPLETED|Overall Study||1192
10604541|NCT01862419|11761828|FG000|NOT COMPLETED|Overall Study||0
10604542|NCT01862419|11761829|FG001|NOT COMPLETED|Overall Study||0
10604543|NCT01862484|11761837|FG000|STARTED|Overall Study||15
10604544|NCT01862484|11761838|FG001|STARTED|Overall Study||14
10604545|NCT01862484|11761837|FG000|COMPLETED|Overall Study||13
10604546|NCT01862484|11761838|FG001|COMPLETED|Overall Study||6
10604547|NCT01862484|11761837|FG000|NOT COMPLETED|Overall Study||2
10604548|NCT01862484|11761838|FG001|NOT COMPLETED|Overall Study||8
10604549|NCT01862536|11761846|FG000|STARTED|Overall Study||13
10604550|NCT01862536|11761847|FG001|STARTED|Overall Study||23
10604551|NCT01862536|11761846|FG000|COMPLETED|Overall Study||10
10604552|NCT01862536|11761847|FG001|COMPLETED|Overall Study||16
10604553|NCT01862536|11761846|FG000|NOT COMPLETED|Overall Study||3
10604554|NCT01862536|11761847|FG001|NOT COMPLETED|Overall Study||7
10604555|NCT01862614|11761855|FG000|STARTED|First Appointment.|Received articaine injection at first appointment.|40
10604556|NCT01862614|11761856|FG001|STARTED|First Appointment.|Received buffered articaine at first appointment.|40
10604557|NCT01862614|11761855|FG000|COMPLETED|First Appointment.||40
10604558|NCT01862614|11761856|FG001|COMPLETED|First Appointment.||40
10604559|NCT01862614|11761855|FG000|NOT COMPLETED|First Appointment.||0
10604560|NCT01862614|11761856|FG001|NOT COMPLETED|First Appointment.||0
10604561|NCT01862614|11761855|FG000|STARTED|2 Week Washout Period.||40
10604562|NCT01862614|11761856|FG001|STARTED|2 Week Washout Period.||40
10704163|NCT02589665|11868641|FG005|COMPLETED|Maintenance Period||0
10604563|NCT01862614|11761855|FG000|COMPLETED|2 Week Washout Period.||40
10604564|NCT01862614|11761856|FG001|COMPLETED|2 Week Washout Period.||40
10604565|NCT01862614|11761855|FG000|NOT COMPLETED|2 Week Washout Period.||0
10604566|NCT01862614|11761856|FG001|NOT COMPLETED|2 Week Washout Period.||0
10604567|NCT01862614|11761855|FG000|STARTED|Second Appointment.|Received buffered articaine at second appointment.|40
10604568|NCT01862614|11761856|FG001|STARTED|Second Appointment.|Received articaine at second appointment.|40
10604569|NCT01862614|11761855|FG000|COMPLETED|Second Appointment.||40
10604570|NCT01862614|11761856|FG001|COMPLETED|Second Appointment.||40
10604571|NCT01862614|11761855|FG000|NOT COMPLETED|Second Appointment.||0
10604572|NCT01862614|11761856|FG001|NOT COMPLETED|Second Appointment.||0
10604573|NCT01862640|11761866|FG000|STARTED|Overall Study||20
10604574|NCT01862640|11761867|FG001|STARTED|Overall Study||137
10604575|NCT01862640|11761868|FG002|STARTED|Overall Study||140
10604576|NCT01862640|11761869|FG003|STARTED|Overall Study||136
10604577|NCT01862640|11761866|FG000|COMPLETED|Overall Study||13
10604578|NCT01862640|11761867|FG001|COMPLETED|Overall Study||121
10604579|NCT01862640|11761868|FG002|COMPLETED|Overall Study||122
10604580|NCT01862640|11761869|FG003|COMPLETED|Overall Study||121
10604581|NCT01862640|11761866|FG000|NOT COMPLETED|Overall Study||7
10604582|NCT01862640|11761867|FG001|NOT COMPLETED|Overall Study||16
10604583|NCT01862640|11761868|FG002|NOT COMPLETED|Overall Study||18
10604584|NCT01862640|11761869|FG003|NOT COMPLETED|Overall Study||15
10604585|NCT01862796|11761881|FG000|STARTED|Overall Study||19
10604586|NCT01862796|11761882|FG001|STARTED|Overall Study||18
10604587|NCT01862796|11761883|FG002|STARTED|Overall Study||24
10604588|NCT01862796|11761881|FG000|COMPLETED|Overall Study||19
10604589|NCT01862796|11761882|FG001|COMPLETED|Overall Study||18
10604590|NCT01862796|11761883|FG002|COMPLETED|Overall Study||23
10604591|NCT01862796|11761881|FG000|NOT COMPLETED|Overall Study||0
10604592|NCT01862796|11761882|FG001|NOT COMPLETED|Overall Study||0
10604593|NCT01862796|11761883|FG002|NOT COMPLETED|Overall Study||1
10604594|NCT01862874|11761893|FG000|STARTED|Overall Study|Randomized participants|562
10604595|NCT01862874|11761894|FG001|STARTED|Overall Study|Randomized participants|562
10704164|NCT02589665|11868642|FG006|COMPLETED|Maintenance Period||0
10704165|NCT02589665|11868643|FG007|COMPLETED|Maintenance Period||0
10704166|NCT02589665|11868644|FG008|COMPLETED|Maintenance Period||0
10704167|NCT02589665|11868645|FG009|COMPLETED|Maintenance Period||0
10704168|NCT02589665|11868636|FG000|NOT COMPLETED|Maintenance Period||0
10704169|NCT02589665|11868637|FG001|NOT COMPLETED|Maintenance Period||0
10604596|NCT01862874|11761893|FG000|Vaccination 1|Overall Study||561
10604597|NCT01862874|11761894|FG001|Vaccination 1|Overall Study||562
10604598|NCT01862874|11761893|FG000|Vaccination 2|Overall Study||539
10604599|NCT01862874|11761894|FG001|Vaccination 2|Overall Study||542
10604600|NCT01862874|11761893|FG000|Vaccination 3|Overall Study||530
10604601|NCT01862874|11761894|FG001|Vaccination 3|Overall Study||532
10604602|NCT01862874|11761893|FG000|COMPLETED|Overall Study||483
10604603|NCT01862874|11761894|FG001|COMPLETED|Overall Study||485
10604604|NCT01862874|11761893|FG000|NOT COMPLETED|Overall Study||79
10604605|NCT01862874|11761894|FG001|NOT COMPLETED|Overall Study||77
10604606|NCT01862991|11761903|FG000|STARTED|Overall Study||24
10604607|NCT01862991|11761904|FG001|STARTED|Overall Study||28
10604608|NCT01862991|11761905|FG002|STARTED|Overall Study||28
10604609|NCT01862991|11761903|FG000|COMPLETED|Overall Study||21
10604610|NCT01862991|11761904|FG001|COMPLETED|Overall Study||27
10604611|NCT01862991|11761905|FG002|COMPLETED|Overall Study||27
10604612|NCT01862991|11761903|FG000|NOT COMPLETED|Overall Study||3
10604613|NCT01862991|11761904|FG001|NOT COMPLETED|Overall Study||1
10604614|NCT01862991|11761905|FG002|NOT COMPLETED|Overall Study||1
10604615|NCT01863017|11761915|FG000|STARTED|Overall Study||12
10604616|NCT01863017|11761916|FG001|STARTED|Overall Study||19
10604617|NCT01863017|11761915|FG000|Normal Weight Participants|Overall Study||5
10604618|NCT01863017|11761916|FG001|Normal Weight Participants|Overall Study||5
10604619|NCT01863017|11761915|FG000|Obese Participants|Overall Study||4
10604620|NCT01863017|11761916|FG001|Obese Participants|Overall Study||7
10604621|NCT01863017|11761915|FG000|Participants With PWS|Overall Study||3
10604622|NCT01863017|11761916|FG001|Participants With PWS|Overall Study||7
10604623|NCT01863017|11761915|FG000|COMPLETED|Overall Study||12
10604624|NCT01863017|11761916|FG001|COMPLETED|Overall Study||19
10604625|NCT01863017|11761915|FG000|NOT COMPLETED|Overall Study||0
10604626|NCT01863017|11761916|FG001|NOT COMPLETED|Overall Study||0
10604627|NCT01863030|11761922|FG000|STARTED|Baseline||31
10604628|NCT01863030|11761922|FG000|COMPLETED|Baseline||31
10604629|NCT01863030|11761922|FG000|NOT COMPLETED|Baseline||0
10604630|NCT01863030|11761922|FG000|STARTED|Follow up||31
10604631|NCT01863030|11761922|FG000|2 Weeks|Follow up||31
10604632|NCT01863030|11761922|FG000|3 Months|Follow up||28
10604633|NCT01863030|11761922|FG000|6 Months|Follow up||29
10604634|NCT01863030|11761922|FG000|12 Months|Follow up||26
10704170|NCT02589665|11868638|FG002|NOT COMPLETED|Maintenance Period||0
10704171|NCT02589665|11868639|FG003|NOT COMPLETED|Maintenance Period||0
10604635|NCT01863030|11761922|FG000|24 Months|Follow up||13
10604636|NCT01863030|11761922|FG000|COMPLETED|Follow up||13
10604637|NCT01863030|11761922|FG000|NOT COMPLETED|Follow up||18
10604638|NCT01863134|11761929|FG000|STARTED|Overall Study||72
10604639|NCT01863134|11761930|FG001|STARTED|Overall Study||68
10604640|NCT01863134|11761929|FG000|COMPLETED|Overall Study||72
10604641|NCT01863134|11761930|FG001|COMPLETED|Overall Study||68
10604642|NCT01863134|11761929|FG000|NOT COMPLETED|Overall Study||0
10604643|NCT01863134|11761930|FG001|NOT COMPLETED|Overall Study||0
10604644|NCT01863368|11761938|FG000|STARTED|Phase I, Day 0 to Day 35||46
10604645|NCT01863368|11761939|FG001|STARTED|Phase I, Day 0 to Day 35||48
10604646|NCT01863368|11761938|FG000|Treated|Phase I, Day 0 to Day 35||46
10604647|NCT01863368|11761939|FG001|Treated|Phase I, Day 0 to Day 35||47
10604648|NCT01863368|11761938|FG000|COMPLETED|Phase I, Day 0 to Day 35||43
10604649|NCT01863368|11761939|FG001|COMPLETED|Phase I, Day 0 to Day 35||41
10604650|NCT01863368|11761938|FG000|NOT COMPLETED|Phase I, Day 0 to Day 35||3
10604651|NCT01863368|11761939|FG001|NOT COMPLETED|Phase I, Day 0 to Day 35||7
10604652|NCT01863368|11761938|FG000|STARTED|Phase II, Day 35 to Day 90||43
10604653|NCT01863368|11761939|FG001|STARTED|Phase II, Day 35 to Day 90||41
10604654|NCT01863368|11761938|FG000|COMPLETED|Phase II, Day 35 to Day 90||41
10604655|NCT01863368|11761939|FG001|COMPLETED|Phase II, Day 35 to Day 90||41
10604656|NCT01863368|11761938|FG000|NOT COMPLETED|Phase II, Day 35 to Day 90||2
10604657|NCT01863368|11761939|FG001|NOT COMPLETED|Phase II, Day 35 to Day 90||0
10604658|NCT01863433|11761946|FG000|STARTED|Overall Study||120
10604659|NCT01863433|11761946|FG000|COMPLETED|Overall Study|1 subject was withdrawn from the study due to evidence of substance abuse.|119
10604660|NCT01863433|11761946|FG000|NOT COMPLETED|Overall Study||1
10604661|NCT01863498|11761952|FG000|STARTED|Overall Study||33
10604662|NCT01863498|11761953|FG001|STARTED|Overall Study||32
10604663|NCT01863498|11761952|FG000|COMPLETED|Overall Study||33
10604664|NCT01863498|11761953|FG001|COMPLETED|Overall Study||32
10604665|NCT01863498|11761952|FG000|NOT COMPLETED|Overall Study||0
10604666|NCT01863498|11761953|FG001|NOT COMPLETED|Overall Study||0
10604667|NCT01863563|11761959|FG000|STARTED|Overall Study||100
10604668|NCT01863563|11761959|FG000|COMPLETED|Overall Study||100
10604669|NCT01863563|11761959|FG000|NOT COMPLETED|Overall Study||0
10604670|NCT01863667|11761965|FG000|STARTED|Overall Study||33
10604671|NCT01863667|11761966|FG001|STARTED|Overall Study||32
10604672|NCT01863667|11761965|FG000|COMPLETED|Overall Study||0
10604673|NCT01863667|11761966|FG001|COMPLETED|Overall Study||0
10604674|NCT01863667|11761965|FG000|NOT COMPLETED|Overall Study||33
10604675|NCT01863667|11761966|FG001|NOT COMPLETED|Overall Study||32
10604676|NCT01863680|11761972|FG000|STARTED|Overall Study||178
10604677|NCT01863680|11761972|FG000|Subjects Started COS Treatment|Overall Study||169
10604678|NCT01863680|11761972|FG000|Subjects Received hCG Injection|Overall Study||162
10604679|NCT01863680|11761972|FG000|Subjects Received Study Drug|Overall Study||149
10604680|NCT01863680|11761972|FG000|Subjects Who Have Undergone IVF/ET|Overall Study||123
10604681|NCT01863680|11761972|FG000|COMPLETED|Overall Study||121
10604682|NCT01863680|11761972|FG000|NOT COMPLETED|Overall Study||57
10604683|NCT01863732|11761980|FG000|STARTED|Overall Study||100
10604684|NCT01863732|11761981|FG001|STARTED|Overall Study||87
10604685|NCT01863732|11761982|FG002|STARTED|Overall Study||46
10604686|NCT01863732|11761983|FG003|STARTED|Overall Study||41
10604687|NCT01863732|11761980|FG000|COMPLETED|Overall Study||87
10604688|NCT01863732|11761981|FG001|COMPLETED|Overall Study||75
10604689|NCT01863732|11761982|FG002|COMPLETED|Overall Study||35
10604690|NCT01863732|11761983|FG003|COMPLETED|Overall Study||33
10604691|NCT01863732|11761980|FG000|NOT COMPLETED|Overall Study||13
10604692|NCT01863732|11761981|FG001|NOT COMPLETED|Overall Study||12
10604693|NCT01863732|11761982|FG002|NOT COMPLETED|Overall Study||11
10604694|NCT01863732|11761983|FG003|NOT COMPLETED|Overall Study||8
10604695|NCT01863758|11761992|FG000|STARTED|Pharmacokinetic Assessment||66
10604696|NCT01863758|11761992|FG000|COMPLETED|Pharmacokinetic Assessment||66
10604697|NCT01863758|11761992|FG000|NOT COMPLETED|Pharmacokinetic Assessment||0
10604698|NCT01863758|11761992|FG000|STARTED|Prophylactic Treatment-Phase I||66
10604699|NCT01863758|11761992|FG000|COMPLETED|Prophylactic Treatment-Phase I||66
10604700|NCT01863758|11761992|FG000|NOT COMPLETED|Prophylactic Treatment-Phase I||0
10604701|NCT01863758|11761992|FG000|STARTED|Prophylactic Treatment-Phase II||66
10604702|NCT01863758|11761992|FG000|COMPLETED|Prophylactic Treatment-Phase II||64
10604703|NCT01863758|11761992|FG000|NOT COMPLETED|Prophylactic Treatment-Phase II||2
10604704|NCT01863771|11761996|FG000|STARTED|Induction Phase||144
10604705|NCT01863771|11761997|FG001|STARTED|Induction Phase||0
10604706|NCT01863771|11761998|FG002|STARTED|Induction Phase||0
10604707|NCT01863771|11761999|FG003|STARTED|Induction Phase||0
10604708|NCT01863771|11761996|FG000|COMPLETED|Induction Phase|Same participants who completed the induction phase participated in the maintenance phase.|123
10604709|NCT01863771|11761997|FG001|COMPLETED|Induction Phase||0
10604710|NCT01863771|11761998|FG002|COMPLETED|Induction Phase||0
10604711|NCT01863771|11761999|FG003|COMPLETED|Induction Phase||0
10604712|NCT01863771|11761996|FG000|NOT COMPLETED|Induction Phase||21
10604713|NCT01863771|11761997|FG001|NOT COMPLETED|Induction Phase||0
10604714|NCT01863771|11761998|FG002|NOT COMPLETED|Induction Phase||0
10604715|NCT01863771|11761999|FG003|NOT COMPLETED|Induction Phase||0
10604716|NCT01863771|11761996|FG000|STARTED|Maintenance Phase||0
10604717|NCT01863771|11761997|FG001|STARTED|Maintenance Phase||32
10604718|NCT01863771|11761998|FG002|STARTED|Maintenance Phase||31
10604719|NCT01863771|11761999|FG003|STARTED|Maintenance Phase||60
10604720|NCT01863771|11761996|FG000|COMPLETED|Maintenance Phase||0
10604721|NCT01863771|11761997|FG001|COMPLETED|Maintenance Phase||27
10604722|NCT01863771|11761998|FG002|COMPLETED|Maintenance Phase||19
10604723|NCT01863771|11761999|FG003|COMPLETED|Maintenance Phase||17
10604724|NCT01863771|11761996|FG000|NOT COMPLETED|Maintenance Phase||0
10604725|NCT01863771|11761997|FG001|NOT COMPLETED|Maintenance Phase||5
10604726|NCT01863771|11761998|FG002|NOT COMPLETED|Maintenance Phase||12
10604727|NCT01863771|11761999|FG003|NOT COMPLETED|Maintenance Phase||43
10604728|NCT01863849|11762009|FG000|STARTED|Overall Study||60
10604729|NCT01863849|11762010|FG001|STARTED|Overall Study||60
10604730|NCT01863849|11762009|FG000|COMPLETED|Overall Study||59
10604731|NCT01863849|11762010|FG001|COMPLETED|Overall Study||60
10604732|NCT01863849|11762009|FG000|NOT COMPLETED|Overall Study||1
10604733|NCT01863849|11762010|FG001|NOT COMPLETED|Overall Study||0
10604734|NCT01863953|11762020|FG000|STARTED|Overall Study||38
10604735|NCT01863953|11762021|FG001|STARTED|Overall Study||36
10604736|NCT01863953|11762022|FG002|STARTED|Overall Study||38
10604737|NCT01863953|11762020|FG000|COMPLETED|Overall Study||38
10604738|NCT01863953|11762021|FG001|COMPLETED|Overall Study||36
10604739|NCT01863953|11762022|FG002|COMPLETED|Overall Study||37
10604740|NCT01863953|11762020|FG000|NOT COMPLETED|Overall Study||0
10604741|NCT01863953|11762021|FG001|NOT COMPLETED|Overall Study||0
10604742|NCT01863953|11762022|FG002|NOT COMPLETED|Overall Study||1
10604743|NCT01864005|11762032|FG000|STARTED|Overall Study||29
10604744|NCT01864005|11762033|FG001|STARTED|Overall Study||31
10604745|NCT01864005|11762032|FG000|COMPLETED|Overall Study||26
10604746|NCT01864005|11762033|FG001|COMPLETED|Overall Study||25
10604747|NCT01864005|11762032|FG000|NOT COMPLETED|Overall Study||3
10604748|NCT01864005|11762033|FG001|NOT COMPLETED|Overall Study||6
10604749|NCT01864148|11762044|FG000|STARTED|Overall Study||93
10604750|NCT01864148|11762045|FG001|STARTED|Overall Study||45
10604751|NCT01864148|11762046|FG002|STARTED|Overall Study||95
10604752|NCT01864148|11762047|FG003|STARTED|Overall Study||94
10604753|NCT01864148|11762048|FG004|STARTED|Overall Study||92
10604754|NCT01864148|11762044|FG000|Randomized and Dosed|Overall Study||93
10604755|NCT01864148|11762045|FG001|Randomized and Dosed|Overall Study||45
10604756|NCT01864148|11762046|FG002|Randomized and Dosed|Overall Study||95
10604757|NCT01864148|11762047|FG003|Randomized and Dosed|Overall Study||93
10604758|NCT01864148|11762048|FG004|Randomized and Dosed|Overall Study||92
10604759|NCT01864148|11762044|FG000|COMPLETED|Overall Study||73
10604760|NCT01864148|11762045|FG001|COMPLETED|Overall Study||40
10604761|NCT01864148|11762046|FG002|COMPLETED|Overall Study||84
10604762|NCT01864148|11762047|FG003|COMPLETED|Overall Study||68
10604763|NCT01864148|11762048|FG004|COMPLETED|Overall Study||69
10604764|NCT01864148|11762044|FG000|NOT COMPLETED|Overall Study||20
10604765|NCT01864148|11762045|FG001|NOT COMPLETED|Overall Study||5
10604766|NCT01864148|11762046|FG002|NOT COMPLETED|Overall Study||11
10604767|NCT01864148|11762047|FG003|NOT COMPLETED|Overall Study||26
10604768|NCT01864148|11762048|FG004|NOT COMPLETED|Overall Study||23
10604769|NCT01864174|11762067|FG000|STARTED|Double Blind Treatment - All Treated||283
10604770|NCT01864174|11762068|FG001|STARTED|Double Blind Treatment - All Treated||285
10604771|NCT01864174|11762067|FG000|COMPLETED|Double Blind Treatment - All Treated||268
10604772|NCT01864174|11762068|FG001|COMPLETED|Double Blind Treatment - All Treated||271
10604773|NCT01864174|11762067|FG000|NOT COMPLETED|Double Blind Treatment - All Treated||15
10604774|NCT01864174|11762068|FG001|NOT COMPLETED|Double Blind Treatment - All Treated||14
10604775|NCT01864174|11762067|FG000|STARTED|Double Blind - Compliant Randomized||268
10604776|NCT01864174|11762068|FG001|STARTED|Double Blind - Compliant Randomized||271
10604777|NCT01864174|11762067|FG000|COMPLETED|Double Blind - Compliant Randomized||245
10604778|NCT01864174|11762068|FG001|COMPLETED|Double Blind - Compliant Randomized||245
10604779|NCT01864174|11762067|FG000|NOT COMPLETED|Double Blind - Compliant Randomized||23
10604780|NCT01864174|11762068|FG001|NOT COMPLETED|Double Blind - Compliant Randomized||26
10604781|NCT01864174|11762067|FG000|STARTED|Off Treatment Follow-Up||9
10604782|NCT01864174|11762068|FG001|STARTED|Off Treatment Follow-Up||1
10604783|NCT01864174|11762067|FG000|COMPLETED|Off Treatment Follow-Up||6
10604784|NCT01864174|11762068|FG001|COMPLETED|Off Treatment Follow-Up||1
10604785|NCT01864174|11762067|FG000|NOT COMPLETED|Off Treatment Follow-Up||3
10604786|NCT01864174|11762068|FG001|NOT COMPLETED|Off Treatment Follow-Up||0
10604787|NCT01864200|11762076|FG000|STARTED|Overall Study||45
10604788|NCT01864200|11762077|FG001|STARTED|Overall Study||29
10604789|NCT01864200|11762076|FG000|COMPLETED|Overall Study||43
10604790|NCT01864200|11762077|FG001|COMPLETED|Overall Study||26
10604791|NCT01864200|11762076|FG000|NOT COMPLETED|Overall Study||2
10604792|NCT01864200|11762077|FG001|NOT COMPLETED|Overall Study||3
10652682|NCT02186587|11812991|FG000|STARTED|Overall Study||28
10652683|NCT02186587|11812992|FG001|STARTED|Overall Study||0
10652684|NCT02186587|11812991|FG000|COMPLETED|Overall Study||23
10652685|NCT02186587|11812992|FG001|COMPLETED|Overall Study||0
10652686|NCT02186587|11812991|FG000|NOT COMPLETED|Overall Study||5
10652687|NCT02186587|11812992|FG001|NOT COMPLETED|Overall Study||0
10652688|NCT02186652|11812999|FG000|STARTED|Overall Study||19
10652689|NCT02186652|11813000|FG001|STARTED|Overall Study||22
10652690|NCT02186652|11812999|FG000|COMPLETED|Overall Study||17
10652691|NCT02186652|11813000|FG001|COMPLETED|Overall Study||22
10652692|NCT02186652|11812999|FG000|NOT COMPLETED|Overall Study||2
10652693|NCT02186652|11813000|FG001|NOT COMPLETED|Overall Study||0
10652694|NCT02186665|11813015|FG000|STARTED|Overall Study||8
10652695|NCT02186665|11813016|FG001|STARTED|Overall Study||11
10604793|NCT01864291|11762083|FG000|STARTED|Overall Study||9
10604794|NCT01864291|11762083|FG000|COMPLETED|Overall Study|7/9 subjects had a minimum of one year followup since enrollment.|7
10604795|NCT01864291|11762083|FG000|NOT COMPLETED|Overall Study||2
10604796|NCT01864434|11762089|FG000|STARTED|Overall Study||25
10604797|NCT01864434|11762090|FG001|STARTED|Overall Study||25
10604798|NCT01864434|11762089|FG000|COMPLETED|Overall Study||25
10604799|NCT01864434|11762090|FG001|COMPLETED|Overall Study||25
10604800|NCT01864434|11762089|FG000|NOT COMPLETED|Overall Study||0
10604801|NCT01864434|11762090|FG001|NOT COMPLETED|Overall Study||0
10604802|NCT01864525|11762098|FG000|STARTED|Overall Study||10
10604803|NCT01864525|11762099|FG001|STARTED|Overall Study||7
10604804|NCT01864525|11762098|FG000|COMPLETED|Overall Study||9
10604805|NCT01864525|11762099|FG001|COMPLETED|Overall Study||7
10604806|NCT01864525|11762098|FG000|NOT COMPLETED|Overall Study||1
10604807|NCT01864525|11762099|FG001|NOT COMPLETED|Overall Study||0
10604808|NCT01864538|11762105|FG000|STARTED|Overall Study||11
10604809|NCT01864538|11762105|FG000|COMPLETED|Overall Study||0
10604810|NCT01864538|11762105|FG000|NOT COMPLETED|Overall Study||11
10604811|NCT01864564|11762111|FG000|STARTED|Overall Study||480
10604812|NCT01864564|11762112|FG001|STARTED|Overall Study||482
10604813|NCT01864564|11762111|FG000|COMPLETED|Overall Study||443
10604814|NCT01864564|11762112|FG001|COMPLETED|Overall Study||387
10604815|NCT01864564|11762111|FG000|NOT COMPLETED|Overall Study||37
10604816|NCT01864564|11762112|FG001|NOT COMPLETED|Overall Study||95
10604817|NCT01865084|11762121|FG000|STARTED|Double Blind Period (DB)||116
10604818|NCT01865084|11762122|FG001|STARTED|Double Blind Period (DB)||102
10604819|NCT01865084|11762123|FG002|STARTED|Double Blind Period (DB)||113
10604820|NCT01865084|11762121|FG000|Received at Least One Dose of Study Drug|Double Blind Period (DB)||116
10604821|NCT01865084|11762122|FG001|Received at Least One Dose of Study Drug|Double Blind Period (DB)||102
10604822|NCT01865084|11762123|FG002|Received at Least One Dose of Study Drug|Double Blind Period (DB)||112
10604823|NCT01865084|11762121|FG000|COMPLETED|Double Blind Period (DB)||111
10604824|NCT01865084|11762122|FG001|COMPLETED|Double Blind Period (DB)|One participant stopped therapy during the DB period but remained in the study for follow-up.|98
10604825|NCT01865084|11762123|FG002|COMPLETED|Double Blind Period (DB)||107
10704172|NCT02589665|11868640|FG004|NOT COMPLETED|Maintenance Period||13
10704173|NCT02589665|11868641|FG005|NOT COMPLETED|Maintenance Period||47
10704174|NCT02589665|11868642|FG006|NOT COMPLETED|Maintenance Period||46
10704175|NCT02589665|11868643|FG007|NOT COMPLETED|Maintenance Period||0
10704176|NCT02589665|11868644|FG008|NOT COMPLETED|Maintenance Period||0
10704177|NCT02589665|11868645|FG009|NOT COMPLETED|Maintenance Period||0
10704178|NCT02589665|11868636|FG000|STARTED|Induction Extension Period||0
10704179|NCT02589665|11868637|FG001|STARTED|Induction Extension Period||0
10704180|NCT02589665|11868638|FG002|STARTED|Induction Extension Period||0
10704181|NCT02589665|11868639|FG003|STARTED|Induction Extension Period||0
10704182|NCT02589665|11868640|FG004|STARTED|Induction Extension Period||0
10604826|NCT01865084|11762121|FG000|NOT COMPLETED|Double Blind Period (DB)||5
10604827|NCT01865084|11762122|FG001|NOT COMPLETED|Double Blind Period (DB)||4
10604828|NCT01865084|11762123|FG002|NOT COMPLETED|Double Blind Period (DB)||6
10604829|NCT01865084|11762121|FG000|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|0
10604830|NCT01865084|11762122|FG001|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|150
10604831|NCT01865084|11762123|FG002|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|165
10604832|NCT01865084|11762121|FG000|COMPLETED|Open Label Extension (OLE) Period||0
10604833|NCT01865084|11762122|FG001|COMPLETED|Open Label Extension (OLE) Period||139
10604834|NCT01865084|11762123|FG002|COMPLETED|Open Label Extension (OLE) Period||158
10604835|NCT01865084|11762121|FG000|NOT COMPLETED|Open Label Extension (OLE) Period||0
10604836|NCT01865084|11762122|FG001|NOT COMPLETED|Open Label Extension (OLE) Period||11
10604837|NCT01865084|11762123|FG002|NOT COMPLETED|Open Label Extension (OLE) Period||7
10604838|NCT01865448|11762137|FG000|STARTED|Overall Study||17
10604839|NCT01865448|11762138|FG001|STARTED|Overall Study||17
10604840|NCT01865448|11762137|FG000|COMPLETED|Overall Study||15
10604841|NCT01865448|11762138|FG001|COMPLETED|Overall Study||14
10604842|NCT01865448|11762137|FG000|NOT COMPLETED|Overall Study||2
10604843|NCT01865448|11762138|FG001|NOT COMPLETED|Overall Study||3
10604844|NCT01865487|11762151|FG000|STARTED|Overall Study||15
10604845|NCT01865487|11762152|FG001|STARTED|Overall Study||15
10604846|NCT01865487|11762153|FG002|STARTED|Overall Study||15
10604847|NCT01865487|11762154|FG003|STARTED|Overall Study||5
10604848|NCT01865487|11762155|FG004|STARTED|Overall Study||12
10604849|NCT01865487|11762156|FG005|STARTED|Overall Study||4
10604850|NCT01865487|11762157|FG006|STARTED|Overall Study||12
10604851|NCT01865487|11762158|FG007|STARTED|Overall Study||4
10604852|NCT01865487|11762159|FG008|STARTED|Overall Study||12
10604853|NCT01865487|11762160|FG009|STARTED|Overall Study||4
10604854|NCT01865487|11762151|FG000|COMPLETED|Overall Study||15
10604855|NCT01865487|11762152|FG001|COMPLETED|Overall Study||15
10604856|NCT01865487|11762153|FG002|COMPLETED|Overall Study||15
10704183|NCT02589665|11868641|FG005|STARTED|Induction Extension Period||0
10704184|NCT02589665|11868642|FG006|STARTED|Induction Extension Period||0
10604857|NCT01865487|11762154|FG003|COMPLETED|Overall Study||4
10604858|NCT01865487|11762155|FG004|COMPLETED|Overall Study||11
10604859|NCT01865487|11762156|FG005|COMPLETED|Overall Study||4
10604860|NCT01865487|11762157|FG006|COMPLETED|Overall Study||11
10604861|NCT01865487|11762158|FG007|COMPLETED|Overall Study||4
10604862|NCT01865487|11762159|FG008|COMPLETED|Overall Study||12
10604863|NCT01865487|11762160|FG009|COMPLETED|Overall Study||4
10604864|NCT01865487|11762151|FG000|NOT COMPLETED|Overall Study||0
10604865|NCT01865487|11762152|FG001|NOT COMPLETED|Overall Study||0
10604866|NCT01865487|11762153|FG002|NOT COMPLETED|Overall Study||0
10604867|NCT01865487|11762154|FG003|NOT COMPLETED|Overall Study||1
10604868|NCT01865487|11762155|FG004|NOT COMPLETED|Overall Study||1
10604869|NCT01865487|11762156|FG005|NOT COMPLETED|Overall Study||0
10604870|NCT01865487|11762157|FG006|NOT COMPLETED|Overall Study||1
10604871|NCT01865487|11762158|FG007|NOT COMPLETED|Overall Study||0
10604872|NCT01865487|11762159|FG008|NOT COMPLETED|Overall Study||0
10604873|NCT01865487|11762160|FG009|NOT COMPLETED|Overall Study||0
10604874|NCT01865552|11762194|FG000|STARTED|Period 1||23
10604875|NCT01865552|11762195|FG001|STARTED|Period 1||23
10604876|NCT01865552|11762196|FG002|STARTED|Period 1||23
10604877|NCT01865552|11762197|FG003|STARTED|Period 1||23
10604878|NCT01865552|11762198|FG004|STARTED|Period 1||23
10604879|NCT01865552|11762199|FG005|STARTED|Period 1||23
10604880|NCT01865552|11762194|FG000|Discontinued From Period 1|Period 1||1
10604881|NCT01865552|11762195|FG001|Discontinued From Period 1|Period 1||0
10604882|NCT01865552|11762196|FG002|Discontinued From Period 1|Period 1||0
10604883|NCT01865552|11762197|FG003|Discontinued From Period 1|Period 1||1
10604884|NCT01865552|11762198|FG004|Discontinued From Period 1|Period 1||3
10604885|NCT01865552|11762199|FG005|Discontinued From Period 1|Period 1||1
10604886|NCT01865552|11762194|FG000|COMPLETED|Period 1||22
10604887|NCT01865552|11762195|FG001|COMPLETED|Period 1||23
10604888|NCT01865552|11762196|FG002|COMPLETED|Period 1||23
10604889|NCT01865552|11762197|FG003|COMPLETED|Period 1||22
10604890|NCT01865552|11762198|FG004|COMPLETED|Period 1||20
10604891|NCT01865552|11762199|FG005|COMPLETED|Period 1||22
10604892|NCT01865552|11762194|FG000|NOT COMPLETED|Period 1||1
10604893|NCT01865552|11762195|FG001|NOT COMPLETED|Period 1||0
10704185|NCT02589665|11868643|FG007|STARTED|Induction Extension Period||32
10704186|NCT02589665|11868644|FG008|STARTED|Induction Extension Period||96
10704187|NCT02589665|11868645|FG009|STARTED|Induction Extension Period||0
10704188|NCT02589665|11868636|FG000|COMPLETED|Induction Extension Period||0
10704189|NCT02589665|11868637|FG001|COMPLETED|Induction Extension Period||0
10604894|NCT01865552|11762196|FG002|NOT COMPLETED|Period 1||0
10604895|NCT01865552|11762197|FG003|NOT COMPLETED|Period 1||1
10604896|NCT01865552|11762198|FG004|NOT COMPLETED|Period 1||3
10604897|NCT01865552|11762199|FG005|NOT COMPLETED|Period 1||1
10604898|NCT01865552|11762194|FG000|STARTED|Period 2||22
10604899|NCT01865552|11762195|FG001|STARTED|Period 2||23
10604900|NCT01865552|11762196|FG002|STARTED|Period 2||23
10604901|NCT01865552|11762197|FG003|STARTED|Period 2||22
10604902|NCT01865552|11762198|FG004|STARTED|Period 2||20
10604903|NCT01865552|11762199|FG005|STARTED|Period 2||22
10604904|NCT01865552|11762194|FG000|COMPLETED|Period 2||22
10604905|NCT01865552|11762195|FG001|COMPLETED|Period 2||23
10604906|NCT01865552|11762196|FG002|COMPLETED|Period 2||23
10604907|NCT01865552|11762197|FG003|COMPLETED|Period 2||22
10604908|NCT01865552|11762198|FG004|COMPLETED|Period 2||20
10604909|NCT01865552|11762199|FG005|COMPLETED|Period 2||22
10604910|NCT01865552|11762194|FG000|NOT COMPLETED|Period 2||0
10604911|NCT01865552|11762195|FG001|NOT COMPLETED|Period 2||0
10604912|NCT01865552|11762196|FG002|NOT COMPLETED|Period 2||0
10604913|NCT01865552|11762197|FG003|NOT COMPLETED|Period 2||0
10604914|NCT01865552|11762198|FG004|NOT COMPLETED|Period 2||0
10604915|NCT01865552|11762199|FG005|NOT COMPLETED|Period 2||0
10604916|NCT01865708|11762213|FG000|STARTED|Overall Study||10
10604917|NCT01865708|11762213|FG000|COMPLETED|Overall Study||10
10604918|NCT01865708|11762213|FG000|NOT COMPLETED|Overall Study||0
10604919|NCT01865747|11762219|FG000|STARTED|Overall Study (ITT)||330
10604920|NCT01865747|11762220|FG001|STARTED|Overall Study (ITT)||328
10604921|NCT01865747|11762219|FG000|COMPLETED|Overall Study (ITT)|One subject randomized to everolimus arm received cabozantinib discontd due to clin. deterioration|132
10604922|NCT01865747|11762220|FG001|COMPLETED|Overall Study (ITT)|Five subjects were randomized but not treated|73
10604923|NCT01865747|11762219|FG000|NOT COMPLETED|Overall Study (ITT)||198
10604924|NCT01865747|11762220|FG001|NOT COMPLETED|Overall Study (ITT)||255
10604925|NCT01865747|11762219|FG000|STARTED|Primary Intent to Treat (PITT)||187
10604926|NCT01865747|11762220|FG001|STARTED|Primary Intent to Treat (PITT)|Three subjects in the everolimus arm were randomized but not treated.|188
10604927|NCT01865747|11762219|FG000|COMPLETED|Primary Intent to Treat (PITT)||56
10604928|NCT01865747|11762220|FG001|COMPLETED|Primary Intent to Treat (PITT)||36
10604929|NCT01865747|11762219|FG000|NOT COMPLETED|Primary Intent to Treat (PITT)||131
10604930|NCT01865747|11762220|FG001|NOT COMPLETED|Primary Intent to Treat (PITT)||152
10604934|NCT01866098|11762233|FG000|STARTED|Overall Study||51
10604935|NCT01866098|11762234|FG001|STARTED|Overall Study||47
10604936|NCT01866098|11762235|FG002|STARTED|Overall Study||46
10704190|NCT02589665|11868638|FG002|COMPLETED|Induction Extension Period||0
10604937|NCT01866098|11762233|FG000|COMPLETED|Overall Study||32
10604938|NCT01866098|11762234|FG001|COMPLETED|Overall Study||20
10604939|NCT01866098|11762235|FG002|COMPLETED|Overall Study||25
10604940|NCT01866098|11762233|FG000|NOT COMPLETED|Overall Study||19
10604941|NCT01866098|11762234|FG001|NOT COMPLETED|Overall Study||27
10604942|NCT01866098|11762235|FG002|NOT COMPLETED|Overall Study||21
10604943|NCT01866150|11762243|FG000|STARTED|Overall Study||450
10604944|NCT01866150|11762243|FG000|COMPLETED|Overall Study||450
10604945|NCT01866150|11762243|FG000|NOT COMPLETED|Overall Study||0
10604946|NCT01866163|11762252|FG000|STARTED|Overall Study||323
10604947|NCT01866163|11762253|FG001|STARTED|Overall Study||103
10604948|NCT01866163|11762252|FG000|COMPLETED|Overall Study||313
10604949|NCT01866163|11762253|FG001|COMPLETED|Overall Study||99
10604950|NCT01866163|11762252|FG000|NOT COMPLETED|Overall Study||10
10604951|NCT01866163|11762253|FG001|NOT COMPLETED|Overall Study||4
10604952|NCT01866293|11762259|FG000|STARTED|Overall Study||11
10604953|NCT01866293|11762259|FG000|COMPLETED|Overall Study||9
10604954|NCT01866293|11762259|FG000|NOT COMPLETED|Overall Study||2
10604955|NCT01866306|11762270|FG000|STARTED|Overall Study||6
10604956|NCT01866306|11762271|FG001|STARTED|Overall Study||6
10604957|NCT01866306|11762272|FG002|STARTED|Overall Study||6
10604958|NCT01866306|11762273|FG003|STARTED|Overall Study||6
10604959|NCT01866306|11762274|FG004|STARTED|Overall Study||6
10604960|NCT01866306|11762275|FG005|STARTED|Overall Study||6
10604961|NCT01866306|11762276|FG006|STARTED|Overall Study||23
10604962|NCT01866306|11762270|FG000|COMPLETED|Overall Study||6
10604963|NCT01866306|11762271|FG001|COMPLETED|Overall Study||6
10604964|NCT01866306|11762272|FG002|COMPLETED|Overall Study||6
10604965|NCT01866306|11762273|FG003|COMPLETED|Overall Study||6
10604966|NCT01866306|11762274|FG004|COMPLETED|Overall Study||6
10604967|NCT01866306|11762275|FG005|COMPLETED|Overall Study||6
10604968|NCT01866306|11762276|FG006|COMPLETED|Overall Study||23
10604969|NCT01866306|11762270|FG000|NOT COMPLETED|Overall Study||0
10604970|NCT01866306|11762271|FG001|NOT COMPLETED|Overall Study||0
10604971|NCT01866306|11762272|FG002|NOT COMPLETED|Overall Study||0
10604972|NCT01866306|11762273|FG003|NOT COMPLETED|Overall Study||0
10604973|NCT01866306|11762274|FG004|NOT COMPLETED|Overall Study||0
10604974|NCT01866306|11762275|FG005|NOT COMPLETED|Overall Study||0
10604975|NCT01866306|11762276|FG006|NOT COMPLETED|Overall Study||0
10604976|NCT01866319|11762295|FG000|STARTED|Overall Study||278
10604977|NCT01866319|11762296|FG001|STARTED|Overall Study||279
10604978|NCT01866319|11762297|FG002|STARTED|Overall Study||277
10604979|NCT01866319|11762295|FG000|Treated|Overall Study||256
10604980|NCT01866319|11762296|FG001|Treated|Overall Study||278
10604981|NCT01866319|11762297|FG002|Treated|Overall Study||277
10604982|NCT01866319|11762295|FG000|COMPLETED|Overall Study||71
10604983|NCT01866319|11762296|FG001|COMPLETED|Overall Study||101
10604984|NCT01866319|11762297|FG002|COMPLETED|Overall Study||97
10604985|NCT01866319|11762295|FG000|NOT COMPLETED|Overall Study||207
10604986|NCT01866319|11762296|FG001|NOT COMPLETED|Overall Study||178
10604987|NCT01866319|11762297|FG002|NOT COMPLETED|Overall Study||180
10604988|NCT01866410|11762305|FG000|STARTED|Overall Study||37
10604989|NCT01866410|11762305|FG000|COMPLETED|Overall Study||37
10604990|NCT01866410|11762305|FG000|NOT COMPLETED|Overall Study||0
10604991|NCT01866423|11762312|FG000|STARTED|Overall Study||4
10604992|NCT01866423|11762312|FG000|COMPLETED|Overall Study||0
10604993|NCT01866423|11762312|FG000|NOT COMPLETED|Overall Study||4
10604994|NCT01866592|11762316|FG000|STARTED|Overall Study||81
10604995|NCT01866592|11762316|FG000|COMPLETED|Overall Study||58
10604996|NCT01866592|11762316|FG000|NOT COMPLETED|Overall Study||23
10604997|NCT01866826|11762320|FG000|STARTED|Phase I -Initial Randomization - 4 Weeks||23
10604998|NCT01866826|11762321|FG001|STARTED|Phase I -Initial Randomization - 4 Weeks||23
10604999|NCT01866826|11762320|FG000|COMPLETED|Phase I -Initial Randomization - 4 Weeks||22
10605000|NCT01866826|11762321|FG001|COMPLETED|Phase I -Initial Randomization - 4 Weeks||23
10605001|NCT01866826|11762320|FG000|NOT COMPLETED|Phase I -Initial Randomization - 4 Weeks||1
10605002|NCT01866826|11762321|FG001|NOT COMPLETED|Phase I -Initial Randomization - 4 Weeks||0
10605003|NCT01866826|11762320|FG000|STARTED|Wash-Out Period - 4 -6 Weeks||22
10605004|NCT01866826|11762321|FG001|STARTED|Wash-Out Period - 4 -6 Weeks||23
10605005|NCT01866826|11762320|FG000|COMPLETED|Wash-Out Period - 4 -6 Weeks||22
10605006|NCT01866826|11762321|FG001|COMPLETED|Wash-Out Period - 4 -6 Weeks||20
10605007|NCT01866826|11762320|FG000|NOT COMPLETED|Wash-Out Period - 4 -6 Weeks||0
10605008|NCT01866826|11762321|FG001|NOT COMPLETED|Wash-Out Period - 4 -6 Weeks||3
10605009|NCT01866826|11762320|FG000|STARTED|Second Intervention - 4 Weeks||22
10605010|NCT01866826|11762321|FG001|STARTED|Second Intervention - 4 Weeks||20
10605011|NCT01866826|11762320|FG000|COMPLETED|Second Intervention - 4 Weeks||22
10605012|NCT01866826|11762321|FG001|COMPLETED|Second Intervention - 4 Weeks||20
10605013|NCT01866826|11762320|FG000|NOT COMPLETED|Second Intervention - 4 Weeks||0
10605014|NCT01866826|11762321|FG001|NOT COMPLETED|Second Intervention - 4 Weeks||0
10605015|NCT01866839|11762327|FG000|STARTED|Overall Study||40
10605016|NCT01866839|11762327|FG000|COMPLETED|Overall Study||30
10605017|NCT01866839|11762327|FG000|NOT COMPLETED|Overall Study||10
10605018|NCT01866917|11762333|FG000|STARTED|Overall Study||17
10605019|NCT01866917|11762334|FG001|STARTED|Overall Study||18
10605020|NCT01866917|11762333|FG000|COMPLETED|Overall Study||13
10605021|NCT01866917|11762334|FG001|COMPLETED|Overall Study||12
10605022|NCT01866917|11762333|FG000|NOT COMPLETED|Overall Study||4
10605023|NCT01866917|11762334|FG001|NOT COMPLETED|Overall Study||6
10605024|NCT01866943|11762342|FG000|STARTED|Overall Study||19
10605025|NCT01866943|11762343|FG001|STARTED|Overall Study||22
10605026|NCT01866943|11762342|FG000|COMPLETED|Overall Study|Unknown - the only spreadsheet available is de-identified and blinded.|0
10605027|NCT01866943|11762343|FG001|COMPLETED|Overall Study|Unknown - the only spreadsheet available is de-identified and blinded.|0
10605028|NCT01866943|11762342|FG000|NOT COMPLETED|Overall Study||19
10605029|NCT01866943|11762343|FG001|NOT COMPLETED|Overall Study||22
10605030|NCT01867008|11762352|FG000|STARTED|Overall Study||55
10605031|NCT01867008|11762352|FG000|COMPLETED|Overall Study||54
10605032|NCT01867008|11762352|FG000|NOT COMPLETED|Overall Study||1
10605033|NCT01867021|11762358|FG000|STARTED|Overall Study||1452
10605034|NCT01867021|11762359|FG001|STARTED|Overall Study||1450
10605035|NCT01867021|11762358|FG000|COMPLETED|Overall Study||1450
10605036|NCT01867021|11762359|FG001|COMPLETED|Overall Study||1440
10605037|NCT01867021|11762358|FG000|NOT COMPLETED|Overall Study||2
10605038|NCT01867021|11762359|FG001|NOT COMPLETED|Overall Study||10
10605039|NCT01867047|11762372|FG000|STARTED|Overall Study||31
10605040|NCT01867047|11762373|FG001|STARTED|Overall Study||28
10605041|NCT01867047|11762372|FG000|COMPLETED|Overall Study||23
10605042|NCT01867047|11762373|FG001|COMPLETED|Overall Study||23
10605043|NCT01867047|11762372|FG000|NOT COMPLETED|Overall Study||8
10605044|NCT01867047|11762373|FG001|NOT COMPLETED|Overall Study||5
10605045|NCT01867086|11762383|FG000|STARTED|Overall Study||1
10605046|NCT01867086|11762383|FG000|COMPLETED|Overall Study|"Completed means subject had been given all manufactured doses."|0
10605047|NCT01867086|11762383|FG000|NOT COMPLETED|Overall Study||1
10605048|NCT01867164|11762389|FG000|STARTED|Overall Study||81
10605049|NCT01867164|11762390|FG001|STARTED|Overall Study||79
10605050|NCT01867164|11762389|FG000|COMPLETED|Overall Study||81
10808699|NCT03850496|11970656|FG000|COMPLETED|Overall Study||25
10808700|NCT03850496|11970657|FG001|COMPLETED|Overall Study||24
10808701|NCT03850496|11970658|FG002|COMPLETED|Overall Study||21
10808702|NCT03850496|11970656|FG000|NOT COMPLETED|Overall Study||1
10808703|NCT03850496|11970657|FG001|NOT COMPLETED|Overall Study||1
10605051|NCT01867164|11762390|FG001|COMPLETED|Overall Study||79
10605052|NCT01867164|11762389|FG000|NOT COMPLETED|Overall Study||0
10605053|NCT01867164|11762390|FG001|NOT COMPLETED|Overall Study||0
10605054|NCT01867216|11762403|FG000|STARTED|Overall Study||16
10605055|NCT01867216|11762404|FG001|STARTED|Overall Study||8
10605056|NCT01867216|11762405|FG002|STARTED|Overall Study||8
10605057|NCT01867216|11762406|FG003|STARTED|Overall Study||8
10605058|NCT01867216|11762407|FG004|STARTED|Overall Study||9
10605059|NCT01867216|11762408|FG005|STARTED|Overall Study||8
10704191|NCT02589665|11868639|FG003|COMPLETED|Induction Extension Period||0
10704192|NCT02589665|11868640|FG004|COMPLETED|Induction Extension Period||0
10704193|NCT02589665|11868641|FG005|COMPLETED|Induction Extension Period||0
10605060|NCT01867216|11762409|FG006|STARTED|Overall Study||9
10605061|NCT01867216|11762403|FG000|Received Study Drug|Overall Study||14
10605062|NCT01867216|11762404|FG001|Received Study Drug|Overall Study||8
10605063|NCT01867216|11762405|FG002|Received Study Drug|Overall Study||8
10605064|NCT01867216|11762406|FG003|Received Study Drug|Overall Study||8
10605065|NCT01867216|11762407|FG004|Received Study Drug|Overall Study||9
10605066|NCT01867216|11762408|FG005|Received Study Drug|Overall Study||8
10605067|NCT01867216|11762409|FG006|Received Study Drug|Overall Study||9
10605068|NCT01867216|11762403|FG000|COMPLETED|Overall Study||12
10605069|NCT01867216|11762404|FG001|COMPLETED|Overall Study||8
10605070|NCT01867216|11762405|FG002|COMPLETED|Overall Study||8
10605071|NCT01867216|11762406|FG003|COMPLETED|Overall Study||8
10605072|NCT01867216|11762407|FG004|COMPLETED|Overall Study||8
10605073|NCT01867216|11762408|FG005|COMPLETED|Overall Study||8
10605074|NCT01867216|11762409|FG006|COMPLETED|Overall Study||8
10605075|NCT01867216|11762403|FG000|NOT COMPLETED|Overall Study||4
10605076|NCT01867216|11762404|FG001|NOT COMPLETED|Overall Study||0
10605077|NCT01867216|11762405|FG002|NOT COMPLETED|Overall Study||0
10605078|NCT01867216|11762406|FG003|NOT COMPLETED|Overall Study||0
10605079|NCT01867216|11762407|FG004|NOT COMPLETED|Overall Study||1
10605080|NCT01867216|11762408|FG005|NOT COMPLETED|Overall Study||0
10605081|NCT01867216|11762409|FG006|NOT COMPLETED|Overall Study||1
10605082|NCT01867294|11762435|FG000|STARTED|Overall Study||9
10605083|NCT01867294|11762436|FG001|STARTED|Overall Study||10
10605084|NCT01867294|11762437|FG002|STARTED|Overall Study||0
10605085|NCT01867294|11762438|FG003|STARTED|Overall Study||0
10605086|NCT01867294|11762435|FG000|COMPLETED|Overall Study||8
10605087|NCT01867294|11762436|FG001|COMPLETED|Overall Study||9
10605088|NCT01867294|11762437|FG002|COMPLETED|Overall Study||0
10605089|NCT01867294|11762438|FG003|COMPLETED|Overall Study||0
10605090|NCT01867294|11762435|FG000|NOT COMPLETED|Overall Study||1
10605091|NCT01867294|11762436|FG001|NOT COMPLETED|Overall Study||1
10605092|NCT01867294|11762437|FG002|NOT COMPLETED|Overall Study||0
10605093|NCT01867294|11762438|FG003|NOT COMPLETED|Overall Study||0
10605094|NCT01867307|11762448|FG000|STARTED|Overall Study|Started are the treated patients|18
10605095|NCT01867307|11762449|FG001|STARTED|Overall Study|Started are the treated patients|19
10605096|NCT01867307|11762448|FG000|COMPLETED|Overall Study||15
10605097|NCT01867307|11762449|FG001|COMPLETED|Overall Study||16
10704194|NCT02589665|11868642|FG006|COMPLETED|Induction Extension Period||0
10704195|NCT02589665|11868643|FG007|COMPLETED|Induction Extension Period||30
10704196|NCT02589665|11868644|FG008|COMPLETED|Induction Extension Period||84
10704197|NCT02589665|11868645|FG009|COMPLETED|Induction Extension Period||0
10808704|NCT03850496|11970658|FG002|NOT COMPLETED|Overall Study||4
10808705|NCT03848949|11970668|FG000|STARTED|Overall Study||54
10808706|NCT03848949|11970669|FG001|STARTED|Overall Study||53
10605098|NCT01867307|11762448|FG000|NOT COMPLETED|Overall Study||3
10605099|NCT01867307|11762449|FG001|NOT COMPLETED|Overall Study||3
10605100|NCT01867424|11762457|FG000|STARTED|Overall Study||12
10605101|NCT01867424|11762458|FG001|STARTED|Overall Study||12
10605102|NCT01867424|11762457|FG000|COMPLETED|Overall Study||10
10605103|NCT01867424|11762458|FG001|COMPLETED|Overall Study||11
10605104|NCT01867424|11762457|FG000|NOT COMPLETED|Overall Study||2
10605105|NCT01867424|11762458|FG001|NOT COMPLETED|Overall Study||1
10605106|NCT01867515|11762467|FG000|STARTED|Overall Study||13
10605107|NCT01867515|11762468|FG001|STARTED|Overall Study||12
10605108|NCT01867515|11762469|FG002|STARTED|Overall Study||25
10605109|NCT01867515|11762467|FG000|COMPLETED|Overall Study||13
10605110|NCT01867515|11762468|FG001|COMPLETED|Overall Study||11
10605111|NCT01867515|11762469|FG002|COMPLETED|Overall Study||14
10605112|NCT01867515|11762467|FG000|NOT COMPLETED|Overall Study||0
10605113|NCT01867515|11762468|FG001|NOT COMPLETED|Overall Study||1
10605114|NCT01867515|11762469|FG002|NOT COMPLETED|Overall Study||11
10605121|NCT01867632|11762488|FG000|STARTED|Overall Study||65
10605122|NCT01867632|11762489|FG001|STARTED|Overall Study||66
10605123|NCT01867632|11762488|FG000|COMPLETED|Overall Study||65
10605124|NCT01867632|11762489|FG001|COMPLETED|Overall Study||66
10605125|NCT01867632|11762488|FG000|NOT COMPLETED|Overall Study||0
10605126|NCT01867632|11762489|FG001|NOT COMPLETED|Overall Study||0
10605127|NCT01867658|11762495|FG000|STARTED|Overall Study||112
10605128|NCT01867658|11762495|FG000|COMPLETED|Overall Study||103
10605129|NCT01867658|11762495|FG000|NOT COMPLETED|Overall Study||9
10605130|NCT01867671|11762501|FG000|STARTED|Overall Study||96
10605131|NCT01867671|11762502|FG001|STARTED|Overall Study||50
10605132|NCT01867671|11762501|FG000|COMPLETED|Overall Study||67
10605133|NCT01867671|11762502|FG001|COMPLETED|Overall Study||22
10605134|NCT01867671|11762501|FG000|NOT COMPLETED|Overall Study||29
10605135|NCT01867671|11762502|FG001|NOT COMPLETED|Overall Study||28
10605136|NCT01867710|11762512|FG000|STARTED|Overall Study||41
10605137|NCT01867710|11762513|FG001|STARTED|Overall Study||41
10605138|NCT01867710|11762514|FG002|STARTED|Overall Study||40
10605139|NCT01867710|11762515|FG003|STARTED|Overall Study||42
10605140|NCT01867710|11762512|FG000|Treated|Overall Study||41
10605141|NCT01867710|11762513|FG001|Treated|Overall Study||41
10605142|NCT01867710|11762514|FG002|Treated|Overall Study||39
10605143|NCT01867710|11762515|FG003|Treated|Overall Study||42
10605144|NCT01867710|11762512|FG000|COMPLETED|Overall Study||0
10605145|NCT01867710|11762513|FG001|COMPLETED|Overall Study||0
10605146|NCT01867710|11762514|FG002|COMPLETED|Overall Study||0
10605147|NCT01867710|11762515|FG003|COMPLETED|Overall Study||0
10605148|NCT01867710|11762512|FG000|NOT COMPLETED|Overall Study||41
10605149|NCT01867710|11762513|FG001|NOT COMPLETED|Overall Study||41
10605150|NCT01867710|11762514|FG002|NOT COMPLETED|Overall Study||40
10605151|NCT01867710|11762515|FG003|NOT COMPLETED|Overall Study||42
10605152|NCT01868009|11762525|FG000|STARTED|Period 1 (5-9 Days)||143
10605153|NCT01868009|11762526|FG001|STARTED|Period 1 (5-9 Days)||144
10605154|NCT01868009|11762525|FG000|COMPLETED|Period 1 (5-9 Days)||143
10605155|NCT01868009|11762526|FG001|COMPLETED|Period 1 (5-9 Days)||142
10605156|NCT01868009|11762525|FG000|NOT COMPLETED|Period 1 (5-9 Days)||0
10605157|NCT01868009|11762526|FG001|NOT COMPLETED|Period 1 (5-9 Days)||2
10605158|NCT01868009|11762525|FG000|STARTED|Period 2 (5-9 Days)||143
10605159|NCT01868009|11762526|FG001|STARTED|Period 2 (5-9 Days)||142
10605160|NCT01868009|11762525|FG000|COMPLETED|Period 2 (5-9 Days)||141
10605161|NCT01868009|11762526|FG001|COMPLETED|Period 2 (5-9 Days)||142
10605162|NCT01868009|11762525|FG000|NOT COMPLETED|Period 2 (5-9 Days)||2
10605163|NCT01868009|11762526|FG001|NOT COMPLETED|Period 2 (5-9 Days)||0
10605164|NCT01868022|11762541|FG000|STARTED|Overall Study||3
10605165|NCT01868022|11762542|FG001|STARTED|Overall Study||3
10605166|NCT01868022|11762543|FG002|STARTED|Overall Study||14
10605167|NCT01868022|11762544|FG003|STARTED|Overall Study||3
10605168|NCT01868022|11762545|FG004|STARTED|Overall Study||3
10605169|NCT01868022|11762546|FG005|STARTED|Overall Study||3
10605170|NCT01868022|11762547|FG006|STARTED|Overall Study||3
10605171|NCT01868022|11762548|FG007|STARTED|Overall Study||25
10605172|NCT01868022|11762549|FG008|STARTED|Overall Study||8
10605173|NCT01868022|11762541|FG000|COMPLETED|Overall Study||3
10605174|NCT01868022|11762542|FG001|COMPLETED|Overall Study||3
10605175|NCT01868022|11762543|FG002|COMPLETED|Overall Study||13
10605176|NCT01868022|11762544|FG003|COMPLETED|Overall Study||2
10605177|NCT01868022|11762545|FG004|COMPLETED|Overall Study||1
10605178|NCT01868022|11762546|FG005|COMPLETED|Overall Study||2
10605179|NCT01868022|11762547|FG006|COMPLETED|Overall Study||3
10605180|NCT01868022|11762548|FG007|COMPLETED|Overall Study||16
10605181|NCT01868022|11762549|FG008|COMPLETED|Overall Study||6
10605182|NCT01868022|11762541|FG000|NOT COMPLETED|Overall Study||0
10605183|NCT01868022|11762542|FG001|NOT COMPLETED|Overall Study||0
10605184|NCT01868022|11762543|FG002|NOT COMPLETED|Overall Study||1
10605185|NCT01868022|11762544|FG003|NOT COMPLETED|Overall Study||1
10605186|NCT01868022|11762545|FG004|NOT COMPLETED|Overall Study||2
10605187|NCT01868022|11762546|FG005|NOT COMPLETED|Overall Study||1
10605188|NCT01868022|11762547|FG006|NOT COMPLETED|Overall Study||0
10605189|NCT01868022|11762548|FG007|NOT COMPLETED|Overall Study||9
10605190|NCT01868022|11762549|FG008|NOT COMPLETED|Overall Study||2
10605191|NCT01868035|11762575|FG000|STARTED|Overall Study||15
10605192|NCT01868035|11762575|FG000|COMPLETED|Overall Study|These participants completed 10 years of follow-up.|8
10605193|NCT01868035|11762575|FG000|NOT COMPLETED|Overall Study||7
10605194|NCT01868074|11762581|FG000|STARTED|Overall Study||36
10605195|NCT01868074|11762582|FG001|STARTED|Overall Study||36
10605196|NCT01868074|11762581|FG000|COMPLETED|Overall Study||29
10605197|NCT01868074|11762582|FG001|COMPLETED|Overall Study||32
10605198|NCT01868074|11762581|FG000|NOT COMPLETED|Overall Study||7
10605199|NCT01868074|11762582|FG001|NOT COMPLETED|Overall Study||4
10605200|NCT01868165|11762588|FG000|STARTED|Overall Study||337
10605201|NCT01868165|11762588|FG000|COMPLETED|Overall Study||292
10605202|NCT01868165|11762588|FG000|NOT COMPLETED|Overall Study||45
10605203|NCT01868243|11762594|FG000|STARTED|Overall Study||15
10605204|NCT01868243|11762595|FG001|STARTED|Overall Study||12
10605205|NCT01868243|11762594|FG000|COMPLETED|Overall Study||15
10605206|NCT01868243|11762595|FG001|COMPLETED|Overall Study||11
10605207|NCT01868243|11762594|FG000|NOT COMPLETED|Overall Study||0
10605208|NCT01868243|11762595|FG001|NOT COMPLETED|Overall Study||1
10605209|NCT01868334|11762605|FG000|STARTED|Year 1 RCCT Study||13186
10605210|NCT01868334|11762606|FG001|STARTED|Year 1 RCCT Study||17185
10605211|NCT01868334|11762607|FG002|STARTED|Year 1 RCCT Study||19274
10605212|NCT01868334|11762608|FG003|STARTED|Year 1 RCCT Study||20904
10605213|NCT01868334|11762605|FG000|COMPLETED|Year 1 RCCT Study||13186
10605214|NCT01868334|11762606|FG001|COMPLETED|Year 1 RCCT Study||17185
10605215|NCT01868334|11762607|FG002|COMPLETED|Year 1 RCCT Study||19274
10605216|NCT01868334|11762608|FG003|COMPLETED|Year 1 RCCT Study||20904
10605217|NCT01868334|11762605|FG000|NOT COMPLETED|Year 1 RCCT Study||0
10605218|NCT01868334|11762606|FG001|NOT COMPLETED|Year 1 RCCT Study||0
10605219|NCT01868334|11762607|FG002|NOT COMPLETED|Year 1 RCCT Study||0
10605220|NCT01868334|11762608|FG003|NOT COMPLETED|Year 1 RCCT Study||0
10605221|NCT01868334|11762605|FG000|STARTED|Year 2 Pre-post Study|Reflects: control sites from Year 1 (N=8) and Year 1 Intervention sites who continued in Y2 (N=4)|22324
10605222|NCT01868334|11762606|FG001|STARTED|Year 2 Pre-post Study|Reflects: the six Year 1 Intervention sites who chose not to actively engage Year 2|8047
10605223|NCT01868334|11762607|FG002|STARTED|Year 2 Pre-post Study|Reflects: Year 1 Control sites who became active in the intervention during Year 2|20904
10605224|NCT01868334|11762608|FG003|STARTED|Year 2 Pre-post Study|Reflects: Year 1 Intervention sites who chose not to actively engage Year 2|19274
10605225|NCT01868334|11762605|FG000|COMPLETED|Year 2 Pre-post Study||22324
10605226|NCT01868334|11762606|FG001|COMPLETED|Year 2 Pre-post Study||8047
10605227|NCT01868334|11762607|FG002|COMPLETED|Year 2 Pre-post Study||20904
10605228|NCT01868334|11762608|FG003|COMPLETED|Year 2 Pre-post Study||19274
10605229|NCT01868334|11762605|FG000|NOT COMPLETED|Year 2 Pre-post Study||0
10605230|NCT01868334|11762606|FG001|NOT COMPLETED|Year 2 Pre-post Study||0
10605231|NCT01868334|11762607|FG002|NOT COMPLETED|Year 2 Pre-post Study||0
10605232|NCT01868334|11762608|FG003|NOT COMPLETED|Year 2 Pre-post Study||0
10605233|NCT01868425|11762648|FG000|STARTED|Overall Study||55
10605234|NCT01868425|11762649|FG001|STARTED|Overall Study||57
10605235|NCT01868425|11762648|FG000|COMPLETED|Overall Study||55
10605236|NCT01868425|11762649|FG001|COMPLETED|Overall Study||57
10605237|NCT01868425|11762648|FG000|NOT COMPLETED|Overall Study||0
10605238|NCT01868425|11762649|FG001|NOT COMPLETED|Overall Study||0
10605239|NCT01868477|11762657|FG000|STARTED|Overall Study||12
10605240|NCT01868477|11762658|FG001|STARTED|Overall Study||11
10605241|NCT01868477|11762657|FG000|Switched to EPO+DFX|Overall Study||5
10605242|NCT01868477|11762658|FG001|Switched to EPO+DFX|Overall Study||0
10605243|NCT01868477|11762657|FG000|Not Switched to EPO+DFX|Overall Study||7
10605244|NCT01868477|11762658|FG001|Not Switched to EPO+DFX|Overall Study||0
10605245|NCT01868477|11762657|FG000|COMPLETED|Overall Study||8
10605246|NCT01868477|11762658|FG001|COMPLETED|Overall Study||6
10605247|NCT01868477|11762657|FG000|NOT COMPLETED|Overall Study||4
10605248|NCT01868477|11762658|FG001|NOT COMPLETED|Overall Study||5
10605249|NCT01868503|11762671|FG000|STARTED|Overall Study||7
10605250|NCT01868503|11762671|FG000|COMPLETED|Overall Study||5
10605251|NCT01868503|11762671|FG000|NOT COMPLETED|Overall Study||2
10605252|NCT01868542|11762679|FG000|STARTED|Overall Study||23
10605253|NCT01868542|11762680|FG001|STARTED|Overall Study||23
10605254|NCT01868542|11762679|FG000|COMPLETED|Overall Study||23
10605255|NCT01868542|11762680|FG001|COMPLETED|Overall Study||21
10605256|NCT01868542|11762679|FG000|NOT COMPLETED|Overall Study||0
10605257|NCT01868542|11762680|FG001|NOT COMPLETED|Overall Study||2
10605258|NCT01868594|11762688|FG000|STARTED|Overall Study||76
10605259|NCT01868594|11762689|FG001|STARTED|Overall Study||75
10605260|NCT01868594|11762688|FG000|COMPLETED|Overall Study||72
10605261|NCT01868594|11762689|FG001|COMPLETED|Overall Study||72
10605262|NCT01868594|11762688|FG000|NOT COMPLETED|Overall Study||4
10605263|NCT01868594|11762689|FG001|NOT COMPLETED|Overall Study||3
10605264|NCT01868633|11762699|FG000|STARTED|Overall Study||26
10605265|NCT01868633|11762700|FG001|STARTED|Overall Study||26
10605266|NCT01868633|11762699|FG000|COMPLETED|Overall Study||26
10605267|NCT01868633|11762700|FG001|COMPLETED|Overall Study||26
10605268|NCT01868633|11762699|FG000|NOT COMPLETED|Overall Study||0
10605269|NCT01868633|11762700|FG001|NOT COMPLETED|Overall Study||0
10605270|NCT01868646|11762708|FG000|STARTED|Overall Study||76
10605271|NCT01868646|11762709|FG001|STARTED|Overall Study||72
10605272|NCT01868646|11762708|FG000|COMPLETED|Overall Study||73
10605273|NCT01868646|11762709|FG001|COMPLETED|Overall Study||67
10605274|NCT01868646|11762708|FG000|NOT COMPLETED|Overall Study||3
10605275|NCT01868646|11762709|FG001|NOT COMPLETED|Overall Study||5
10605276|NCT01868776|11762717|FG000|STARTED|Overall Study||50
10605277|NCT01868776|11762718|FG001|STARTED|Overall Study||50
10605278|NCT01868776|11762717|FG000|COMPLETED|Overall Study||50
10605279|NCT01868776|11762718|FG001|COMPLETED|Overall Study||50
10605280|NCT01868776|11762717|FG000|NOT COMPLETED|Overall Study||0
10605281|NCT01868776|11762718|FG001|NOT COMPLETED|Overall Study||0
10605282|NCT01868789|11762726|FG000|STARTED|Overall Study||9
10605283|NCT01868789|11762727|FG001|STARTED|Overall Study||14
10605284|NCT01868789|11762726|FG000|COMPLETED|Overall Study||7
10605285|NCT01868789|11762727|FG001|COMPLETED|Overall Study||12
10605286|NCT01868789|11762726|FG000|NOT COMPLETED|Overall Study||2
10605287|NCT01868789|11762727|FG001|NOT COMPLETED|Overall Study||2
10605288|NCT01868893|11762733|FG000|STARTED|Overall Study||20
10605289|NCT01868893|11762733|FG000|COMPLETED|Overall Study||0
10605290|NCT01868893|11762733|FG000|NOT COMPLETED|Overall Study||20
10605291|NCT01868997|11762741|FG000|STARTED|Overall Study|randomized and treated|45
10605292|NCT01868997|11762742|FG001|STARTED|Overall Study|randomized and treated|42
10605293|NCT01868997|11762741|FG000|COMPLETED|Overall Study||38
10605294|NCT01868997|11762742|FG001|COMPLETED|Overall Study||36
10605295|NCT01868997|11762741|FG000|NOT COMPLETED|Overall Study||7
10605296|NCT01868997|11762742|FG001|NOT COMPLETED|Overall Study||6
10605297|NCT01869075|11762754|FG000|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
10605298|NCT01869075|11762755|FG001|STARTED|Phase 0 (Baseline)||418
10605299|NCT01869075|11762756|FG002|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
10605300|NCT01869075|11762757|FG003|STARTED|Phase 0 (Baseline)||416
10605301|NCT01869075|11762758|FG004|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
10605302|NCT01869075|11762759|FG005|STARTED|Phase 0 (Baseline)||341
10605303|NCT01869075|11762754|FG000|COMPLETED|Phase 0 (Baseline)||0
10605304|NCT01869075|11762755|FG001|COMPLETED|Phase 0 (Baseline)||418
10605305|NCT01869075|11762756|FG002|COMPLETED|Phase 0 (Baseline)||0
10605306|NCT01869075|11762757|FG003|COMPLETED|Phase 0 (Baseline)||416
10605307|NCT01869075|11762758|FG004|COMPLETED|Phase 0 (Baseline)||0
10605308|NCT01869075|11762759|FG005|COMPLETED|Phase 0 (Baseline)||341
10605309|NCT01869075|11762754|FG000|NOT COMPLETED|Phase 0 (Baseline)||0
10605310|NCT01869075|11762755|FG001|NOT COMPLETED|Phase 0 (Baseline)||0
10605311|NCT01869075|11762756|FG002|NOT COMPLETED|Phase 0 (Baseline)||0
10605312|NCT01869075|11762757|FG003|NOT COMPLETED|Phase 0 (Baseline)||0
10605313|NCT01869075|11762758|FG004|NOT COMPLETED|Phase 0 (Baseline)||0
10605314|NCT01869075|11762759|FG005|NOT COMPLETED|Phase 0 (Baseline)||0
10605315|NCT01869075|11762754|FG000|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|45
10605316|NCT01869075|11762755|FG001|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|75
10605317|NCT01869075|11762756|FG002|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|45
10605318|NCT01869075|11762757|FG003|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|75
10605319|NCT01869075|11762758|FG004|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|30
10605320|NCT01869075|11762759|FG005|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|90
10605321|NCT01869075|11762754|FG000|COMPLETED|Phase 1||45
10605322|NCT01869075|11762755|FG001|COMPLETED|Phase 1||75
10605323|NCT01869075|11762756|FG002|COMPLETED|Phase 1||45
10605324|NCT01869075|11762757|FG003|COMPLETED|Phase 1||75
10605325|NCT01869075|11762758|FG004|COMPLETED|Phase 1||30
10605326|NCT01869075|11762759|FG005|COMPLETED|Phase 1||90
10605327|NCT01869075|11762754|FG000|NOT COMPLETED|Phase 1||0
10605328|NCT01869075|11762755|FG001|NOT COMPLETED|Phase 1||0
10605329|NCT01869075|11762756|FG002|NOT COMPLETED|Phase 1||0
10605330|NCT01869075|11762757|FG003|NOT COMPLETED|Phase 1||0
10605331|NCT01869075|11762758|FG004|NOT COMPLETED|Phase 1||0
10605332|NCT01869075|11762759|FG005|NOT COMPLETED|Phase 1||0
10605333|NCT01869075|11762754|FG000|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|90
10605334|NCT01869075|11762755|FG001|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|30
10605335|NCT01869075|11762756|FG002|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|75
10605336|NCT01869075|11762757|FG003|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|45
10605337|NCT01869075|11762758|FG004|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|75
10605338|NCT01869075|11762759|FG005|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|45
10605339|NCT01869075|11762754|FG000|COMPLETED|Phase 2||90
10605340|NCT01869075|11762755|FG001|COMPLETED|Phase 2||30
10605341|NCT01869075|11762756|FG002|COMPLETED|Phase 2||75
10605342|NCT01869075|11762757|FG003|COMPLETED|Phase 2||45
10605343|NCT01869075|11762758|FG004|COMPLETED|Phase 2||75
10605344|NCT01869075|11762759|FG005|COMPLETED|Phase 2||45
10605345|NCT01869075|11762754|FG000|NOT COMPLETED|Phase 2||0
10605346|NCT01869075|11762755|FG001|NOT COMPLETED|Phase 2||0
10605347|NCT01869075|11762756|FG002|NOT COMPLETED|Phase 2||0
10605348|NCT01869075|11762757|FG003|NOT COMPLETED|Phase 2||0
10605349|NCT01869075|11762758|FG004|NOT COMPLETED|Phase 2||0
10605350|NCT01869075|11762759|FG005|NOT COMPLETED|Phase 2||0
10605351|NCT01869192|11762775|FG000|STARTED|Preoperative Chemotherapy to Surgery||37
10605500|NCT01870596|11762956|FG001|STARTED|Overall Study||18
10605352|NCT01869192|11762776|FG001|STARTED|Preoperative Chemotherapy to Surgery||35
10605353|NCT01869192|11762775|FG000|COMPLETED|Preoperative Chemotherapy to Surgery||35
10605354|NCT01869192|11762776|FG001|COMPLETED|Preoperative Chemotherapy to Surgery|one never got treatment on study|34
10605355|NCT01869192|11762775|FG000|NOT COMPLETED|Preoperative Chemotherapy to Surgery||2
10605356|NCT01869192|11762776|FG001|NOT COMPLETED|Preoperative Chemotherapy to Surgery||1
10605357|NCT01869192|11762775|FG000|STARTED|Postoperative Chemotherapy|3 did not start postop chemotherapy|32
10605358|NCT01869192|11762776|FG001|STARTED|Postoperative Chemotherapy||33
10605359|NCT01869192|11762775|FG000|COMPLETED|Postoperative Chemotherapy||32
10605360|NCT01869192|11762776|FG001|COMPLETED|Postoperative Chemotherapy||31
10605361|NCT01869192|11762775|FG000|NOT COMPLETED|Postoperative Chemotherapy||0
10605362|NCT01869192|11762776|FG001|NOT COMPLETED|Postoperative Chemotherapy||2
10605363|NCT01869348|11762784|FG000|STARTED|Overall Study||20
10605364|NCT01869348|11762785|FG001|STARTED|Overall Study||20
10605365|NCT01869348|11762784|FG000|COMPLETED|Overall Study||19
10605366|NCT01869348|11762785|FG001|COMPLETED|Overall Study||19
10605367|NCT01869348|11762784|FG000|NOT COMPLETED|Overall Study||1
10605368|NCT01869348|11762785|FG001|NOT COMPLETED|Overall Study||1
10605369|NCT01869374|11762793|FG000|STARTED|Overall Study||9
10605370|NCT01869374|11762794|FG001|STARTED|Overall Study||9
10605371|NCT01869374|11762793|FG000|COMPLETED|Overall Study||9
10605372|NCT01869374|11762794|FG001|COMPLETED|Overall Study||8
10605373|NCT01869374|11762793|FG000|NOT COMPLETED|Overall Study||0
10605374|NCT01869374|11762794|FG001|NOT COMPLETED|Overall Study||1
10605375|NCT01869439|11762800|FG000|STARTED|Overall Study||40
10605376|NCT01869439|11762800|FG000|COMPLETED|Overall Study||40
10605377|NCT01869439|11762800|FG000|NOT COMPLETED|Overall Study||0
10605378|NCT01869634|11762806|FG000|STARTED|Overall Study||20
10605379|NCT01869634|11762807|FG001|STARTED|Overall Study||17
10605380|NCT01869634|11762806|FG000|COMPLETED|Overall Study||18
10605381|NCT01869634|11762807|FG001|COMPLETED|Overall Study||17
10605382|NCT01869634|11762806|FG000|NOT COMPLETED|Overall Study||2
10605383|NCT01869634|11762807|FG001|NOT COMPLETED|Overall Study||0
10605384|NCT01869647|11762816|FG000|STARTED|Overall Study||66
10605385|NCT01869647|11762817|FG001|STARTED|Overall Study||136
10605386|NCT01869647|11762818|FG002|STARTED|Overall Study||62
10605387|NCT01869647|11762816|FG000|COMPLETED|Overall Study||65
10605388|NCT01869647|11762817|FG001|COMPLETED|Overall Study||130
10605389|NCT01869647|11762818|FG002|COMPLETED|Overall Study||62
10605390|NCT01869647|11762816|FG000|NOT COMPLETED|Overall Study||1
10605391|NCT01869647|11762817|FG001|NOT COMPLETED|Overall Study||6
10605392|NCT01869647|11762818|FG002|NOT COMPLETED|Overall Study||0
10605393|NCT01869686|11762826|FG000|STARTED|Overall Study||12
10605394|NCT01869686|11762826|FG000|COMPLETED|Overall Study||12
10605395|NCT01869686|11762826|FG000|NOT COMPLETED|Overall Study||0
10605396|NCT01869699|11762832|FG000|STARTED|Overall Study||21
10605397|NCT01869699|11762833|FG001|STARTED|Overall Study||20
10605398|NCT01869699|11762832|FG000|COMPLETED|Overall Study||20
10605399|NCT01869699|11762833|FG001|COMPLETED|Overall Study||20
10605400|NCT01869699|11762832|FG000|NOT COMPLETED|Overall Study||1
10605401|NCT01869699|11762833|FG001|NOT COMPLETED|Overall Study||0
10605402|NCT01869725|11762839|FG000|STARTED|Overall Study||68
10605403|NCT01869725|11762839|FG000|COMPLETED|Overall Study||64
10605404|NCT01869725|11762839|FG000|NOT COMPLETED|Overall Study||4
10605405|NCT01869764|11762845|FG000|STARTED|Overall Study||28
10605406|NCT01869764|11762846|FG001|STARTED|Overall Study||29
10605407|NCT01869764|11762845|FG000|COMPLETED|Overall Study||28
10605408|NCT01869764|11762846|FG001|COMPLETED|Overall Study||27
10605409|NCT01869764|11762845|FG000|NOT COMPLETED|Overall Study||0
10605410|NCT01869764|11762846|FG001|NOT COMPLETED|Overall Study||2
10605411|NCT01869777|11762852|FG000|STARTED|Overall Study||102
10605412|NCT01869777|11762852|FG000|COMPLETED|Overall Study||101
10605413|NCT01869777|11762852|FG000|NOT COMPLETED|Overall Study||1
10605414|NCT01869959|11762860|FG000|STARTED|Randomization Period||0
10605415|NCT01869959|11762861|FG001|STARTED|Randomization Period||0
10605416|NCT01869959|11762862|FG002|STARTED|Randomization Period||0
10605417|NCT01869959|11762863|FG003|STARTED|Randomization Period||0
10605418|NCT01869959|11762864|FG004|STARTED|Randomization Period||47
10605419|NCT01869959|11762860|FG000|COMPLETED|Randomization Period||0
10605420|NCT01869959|11762861|FG001|COMPLETED|Randomization Period||0
10605421|NCT01869959|11762862|FG002|COMPLETED|Randomization Period||0
10605422|NCT01869959|11762863|FG003|COMPLETED|Randomization Period||0
10605423|NCT01869959|11762864|FG004|COMPLETED|Randomization Period|One participant discontinued after randomization but did not receive study drug.|46
10605424|NCT01869959|11762860|FG000|NOT COMPLETED|Randomization Period||0
10605425|NCT01869959|11762861|FG001|NOT COMPLETED|Randomization Period||0
10605426|NCT01869959|11762862|FG002|NOT COMPLETED|Randomization Period||0
10605427|NCT01869959|11762863|FG003|NOT COMPLETED|Randomization Period||0
10605428|NCT01869959|11762864|FG004|NOT COMPLETED|Randomization Period||1
10605429|NCT01869959|11762860|FG000|STARTED|Treatment Period||11
10605430|NCT01869959|11762861|FG001|STARTED|Treatment Period||10
10605431|NCT01869959|11762862|FG002|STARTED|Treatment Period||15
10605432|NCT01869959|11762863|FG003|STARTED|Treatment Period||10
10605433|NCT01869959|11762864|FG004|STARTED|Treatment Period|Participants were randomized to treatment groups for the Treatment Period.|0
10605434|NCT01869959|11762860|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||11
10605435|NCT01869959|11762861|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||10
10605436|NCT01869959|11762862|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||15
10605437|NCT01869959|11762863|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||10
10605438|NCT01869959|11762864|FG004|Received at Least 1 Dose of Study Drug|Treatment Period||0
10605439|NCT01869959|11762860|FG000|COMPLETED|Treatment Period||10
10457029|NCT01008618|11604755|FG001|NOT COMPLETED|Period 2 (Double-Blind Period)||36
10457030|NCT01008618|11604756|FG002|NOT COMPLETED|Period 2 (Double-Blind Period)||38
10457031|NCT01008696|11604767|FG000|STARTED|Overall Study||108
10457032|NCT01008696|11604768|FG001|STARTED|Overall Study||109
10457033|NCT01008696|11604767|FG000|COMPLETED|Overall Study||91
10457034|NCT01008696|11604768|FG001|COMPLETED|Overall Study||92
10457035|NCT01008696|11604767|FG000|NOT COMPLETED|Overall Study||17
10457036|NCT01008696|11604768|FG001|NOT COMPLETED|Overall Study||17
10457037|NCT01008722|11604777|FG000|STARTED|Overall Study|Based on Power Calculations to see 20% outcome improvement by adding FIRM-guided ablation to PVI|36
10605440|NCT01869959|11762861|FG001|COMPLETED|Treatment Period||8
10605441|NCT01869959|11762862|FG002|COMPLETED|Treatment Period||12
10605442|NCT01869959|11762863|FG003|COMPLETED|Treatment Period||8
10605443|NCT01869959|11762864|FG004|COMPLETED|Treatment Period||0
10605444|NCT01869959|11762860|FG000|NOT COMPLETED|Treatment Period||1
10605445|NCT01869959|11762861|FG001|NOT COMPLETED|Treatment Period||2
10605446|NCT01869959|11762862|FG002|NOT COMPLETED|Treatment Period||3
10605447|NCT01869959|11762863|FG003|NOT COMPLETED|Treatment Period||2
10605448|NCT01869959|11762864|FG004|NOT COMPLETED|Treatment Period||0
10605449|NCT01870076|11762878|FG000|STARTED|Overall Study||10
10605450|NCT01870076|11762879|FG001|STARTED|Overall Study||12
10605451|NCT01870076|11762880|FG002|STARTED|Overall Study||8
10605452|NCT01870076|11762881|FG003|STARTED|Overall Study||11
10605453|NCT01870076|11762878|FG000|COMPLETED|Overall Study||9
10605454|NCT01870076|11762879|FG001|COMPLETED|Overall Study||12
10605455|NCT01870076|11762880|FG002|COMPLETED|Overall Study||7
10605456|NCT01870076|11762881|FG003|COMPLETED|Overall Study||11
10605457|NCT01870076|11762878|FG000|NOT COMPLETED|Overall Study||1
10605458|NCT01870076|11762879|FG001|NOT COMPLETED|Overall Study||0
10605459|NCT01870076|11762880|FG002|NOT COMPLETED|Overall Study||1
10605460|NCT01870076|11762881|FG003|NOT COMPLETED|Overall Study||0
10605461|NCT01870297|11762898|FG000|STARTED|Overall Study||11
10605462|NCT01870297|11762899|FG001|STARTED|Overall Study||15
10605463|NCT01870297|11762900|FG002|STARTED|Overall Study||8
10605464|NCT01870297|11762901|FG003|STARTED|Overall Study||9
10605465|NCT01870297|11762902|FG004|STARTED|Overall Study||10
10605466|NCT01870297|11762903|FG005|STARTED|Overall Study||9
10605467|NCT01870297|11762904|FG006|STARTED|Overall Study||10
10605468|NCT01870297|11762898|FG000|COMPLETED|Overall Study||11
10457038|NCT01008722|11604778|FG001|STARTED|Overall Study|Based on Power Calculations to see 20% outcome improvement by adding FIRM-guided ablation to PVI|71
10457039|NCT01008722|11604777|FG000|COMPLETED|Overall Study||36
10457040|NCT01008722|11604778|FG001|COMPLETED|Overall Study||71
10457041|NCT01008722|11604777|FG000|NOT COMPLETED|Overall Study||0
10457042|NCT01008722|11604778|FG001|NOT COMPLETED|Overall Study||0
10457043|NCT01008748|11604784|FG000|STARTED|Overall Study||200
10457044|NCT01008748|11604784|FG000|Baseline|Overall Study||188
10457045|NCT01008748|11604784|FG000|Week 0|Overall Study||182
10457046|NCT01008748|11604784|FG000|Week 3|Overall Study||168
10457047|NCT01008748|11604784|FG000|Week 26|Overall Study||119
10457048|NCT01008748|11604784|FG000|COMPLETED|Overall Study||119
10457049|NCT01008748|11604784|FG000|NOT COMPLETED|Overall Study||81
10457050|NCT01008904|11604788|FG000|STARTED|Overall Study||29
10457051|NCT01008904|11604788|FG000|COMPLETED|Overall Study||25
10457052|NCT01008904|11604788|FG000|NOT COMPLETED|Overall Study||4
10457053|NCT01008943|11604792|FG000|STARTED|Overall Study||16
10457054|NCT01008943|11604792|FG000|COMPLETED|Overall Study||15
10457055|NCT01008943|11604792|FG000|NOT COMPLETED|Overall Study||1
10605469|NCT01870297|11762899|FG001|COMPLETED|Overall Study||8
10605470|NCT01870297|11762900|FG002|COMPLETED|Overall Study||7
10605471|NCT01870297|11762901|FG003|COMPLETED|Overall Study||9
10605472|NCT01870297|11762902|FG004|COMPLETED|Overall Study||7
10605473|NCT01870297|11762903|FG005|COMPLETED|Overall Study||8
10605474|NCT01870297|11762904|FG006|COMPLETED|Overall Study||8
10605475|NCT01870297|11762898|FG000|NOT COMPLETED|Overall Study||0
10605476|NCT01870297|11762899|FG001|NOT COMPLETED|Overall Study||7
10605477|NCT01870297|11762900|FG002|NOT COMPLETED|Overall Study||1
10605478|NCT01870297|11762901|FG003|NOT COMPLETED|Overall Study||0
10605479|NCT01870297|11762902|FG004|NOT COMPLETED|Overall Study||3
10605480|NCT01870297|11762903|FG005|NOT COMPLETED|Overall Study||1
10605481|NCT01870297|11762904|FG006|NOT COMPLETED|Overall Study||2
10605482|NCT01870388|11762931|FG000|STARTED|Overall Study||8
10605483|NCT01870388|11762932|FG001|STARTED|Overall Study||8
10605484|NCT01870388|11762931|FG000|Received 1 Dose of Study Drug|Overall Study||8
10605485|NCT01870388|11762932|FG001|Received 1 Dose of Study Drug|Overall Study||8
10605486|NCT01870388|11762931|FG000|COMPLETED|Overall Study||8
10457056|NCT01008969|11604796|FG000|STARTED|Overall Study||10
10605487|NCT01870388|11762932|FG001|COMPLETED|Overall Study||8
10605488|NCT01870388|11762931|FG000|NOT COMPLETED|Overall Study||0
10605489|NCT01870388|11762932|FG001|NOT COMPLETED|Overall Study||0
10605490|NCT01870583|11762943|FG000|STARTED|Overall Study||467
10605491|NCT01870583|11762944|FG001|STARTED|Overall Study||474
10605492|NCT01870583|11762945|FG002|STARTED|Overall Study||463
10605493|NCT01870583|11762943|FG000|COMPLETED|Overall Study||456
10605494|NCT01870583|11762944|FG001|COMPLETED|Overall Study||456
10605495|NCT01870583|11762945|FG002|COMPLETED|Overall Study||455
10605496|NCT01870583|11762943|FG000|NOT COMPLETED|Overall Study||11
10605497|NCT01870583|11762944|FG001|NOT COMPLETED|Overall Study||18
10605498|NCT01870583|11762945|FG002|NOT COMPLETED|Overall Study||8
10605499|NCT01870596|11762955|FG000|STARTED|Overall Study||14
10605501|NCT01870596|11762955|FG000|COMPLETED|Overall Study||14
10605502|NCT01870596|11762956|FG001|COMPLETED|Overall Study||18
10704198|NCT02589665|11868636|FG000|NOT COMPLETED|Induction Extension Period||0
10704199|NCT02589665|11868637|FG001|NOT COMPLETED|Induction Extension Period||0
10704200|NCT02589665|11868638|FG002|NOT COMPLETED|Induction Extension Period||0
10704201|NCT02589665|11868639|FG003|NOT COMPLETED|Induction Extension Period||0
10704202|NCT02589665|11868640|FG004|NOT COMPLETED|Induction Extension Period||0
10704203|NCT02589665|11868641|FG005|NOT COMPLETED|Induction Extension Period||0
10605503|NCT01870596|11762955|FG000|NOT COMPLETED|Overall Study||0
10605504|NCT01870596|11762956|FG001|NOT COMPLETED|Overall Study||0
10605505|NCT01870726|11762969|FG000|STARTED|Overall Study||5
10605506|NCT01870726|11762970|FG001|STARTED|Overall Study||6
10605507|NCT01870726|11762971|FG002|STARTED|Overall Study||4
10605508|NCT01870726|11762972|FG003|STARTED|Overall Study||6
10605509|NCT01870726|11762973|FG004|STARTED|Overall Study||7
10605510|NCT01870726|11762974|FG005|STARTED|Overall Study||5
10605511|NCT01870726|11762975|FG006|STARTED|Overall Study||10
10605512|NCT01870726|11762969|FG000|COMPLETED|Overall Study||0
10605513|NCT01870726|11762970|FG001|COMPLETED|Overall Study||0
10605514|NCT01870726|11762971|FG002|COMPLETED|Overall Study||0
10605515|NCT01870726|11762972|FG003|COMPLETED|Overall Study||0
10605516|NCT01870726|11762973|FG004|COMPLETED|Overall Study||0
10605517|NCT01870726|11762974|FG005|COMPLETED|Overall Study||0
10605518|NCT01870726|11762975|FG006|COMPLETED|Overall Study||0
10605519|NCT01870726|11762969|FG000|NOT COMPLETED|Overall Study||5
10605520|NCT01870726|11762970|FG001|NOT COMPLETED|Overall Study||6
10605521|NCT01870726|11762971|FG002|NOT COMPLETED|Overall Study||4
10605522|NCT01870726|11762972|FG003|NOT COMPLETED|Overall Study||6
10605523|NCT01870726|11762973|FG004|NOT COMPLETED|Overall Study||7
10605524|NCT01870726|11762974|FG005|NOT COMPLETED|Overall Study||5
10605525|NCT01870726|11762975|FG006|NOT COMPLETED|Overall Study||10
10605526|NCT01870739|11763002|FG000|STARTED|Single Drug Treatment (12 Weeks)|"Start = Safety/Pharmacokinetic/Pharmacodynamic analysis set"|57
10605527|NCT01870739|11763003|FG001|STARTED|Single Drug Treatment (12 Weeks)||57
10605528|NCT01870739|11763002|FG000|Initiation Dose Completed|Single Drug Treatment (12 Weeks)||57
10605529|NCT01870739|11763003|FG001|Initiation Dose Completed|Single Drug Treatment (12 Weeks)||56
10605530|NCT01870739|11763002|FG000|Maintenance Dose Started|Single Drug Treatment (12 Weeks)||57
10605531|NCT01870739|11763003|FG001|Maintenance Dose Started|Single Drug Treatment (12 Weeks)||56
10605532|NCT01870739|11763002|FG000|COMPLETED|Single Drug Treatment (12 Weeks)|"Completed indicates maintenance dose complete"|54
10605533|NCT01870739|11763003|FG001|COMPLETED|Single Drug Treatment (12 Weeks)||53
10605534|NCT01870739|11763002|FG000|NOT COMPLETED|Single Drug Treatment (12 Weeks)||3
10605535|NCT01870739|11763003|FG001|NOT COMPLETED|Single Drug Treatment (12 Weeks)||4
10605536|NCT01870739|11763002|FG000|STARTED|Add-on Period (40 Weeks)||54
10605537|NCT01870739|11763003|FG001|STARTED|Add-on Period (40 Weeks)||53
10605538|NCT01870739|11763002|FG000|COMPLETED|Add-on Period (40 Weeks)||51
10605539|NCT01870739|11763003|FG001|COMPLETED|Add-on Period (40 Weeks)||51
10605540|NCT01870739|11763002|FG000|NOT COMPLETED|Add-on Period (40 Weeks)||3
10605541|NCT01870739|11763003|FG001|NOT COMPLETED|Add-on Period (40 Weeks)||2
10605542|NCT01870778|11763021|FG000|STARTED|Overall Study||3274
10605543|NCT01870778|11763022|FG001|STARTED|Overall Study||3271
10605544|NCT01870778|11763021|FG000|Safety Set|Overall Study||3257
10605545|NCT01870778|11763022|FG001|Safety Set|Overall Study||3248
10605546|NCT01870778|11763021|FG000|Full Analysis Set|Overall Study||3274
10605547|NCT01870778|11763022|FG001|Full Analysis Set|Overall Study||3271
10605548|NCT01870778|11763021|FG000|Biomarker Analysis Set|Overall Study||521
10605549|NCT01870778|11763022|FG001|Biomarker Analysis Set|Overall Study||510
10605550|NCT01870778|11763021|FG000|COMPLETED|Overall Study||3266
10605551|NCT01870778|11763022|FG001|COMPLETED|Overall Study||3262
10605552|NCT01870778|11763021|FG000|NOT COMPLETED|Overall Study||8
10605553|NCT01870778|11763022|FG001|NOT COMPLETED|Overall Study||9
10605554|NCT01870843|11763028|FG000|STARTED|Overall Study||261
10605555|NCT01870843|11763028|FG000|COMPLETED|Overall Study||208
10605556|NCT01870843|11763028|FG000|NOT COMPLETED|Overall Study||53
10605557|NCT01870856|11763034|FG000|STARTED|Overall Study||25
10605558|NCT01870856|11763035|FG001|STARTED|Overall Study||27
10605559|NCT01870856|11763034|FG000|COMPLETED|Overall Study||25
10605560|NCT01870856|11763035|FG001|COMPLETED|Overall Study||27
10605561|NCT01870856|11763034|FG000|NOT COMPLETED|Overall Study||0
10605562|NCT01870856|11763035|FG001|NOT COMPLETED|Overall Study||0
10605563|NCT01870869|11763047|FG000|STARTED|Overall Study||288
10605564|NCT01870869|11763048|FG001|STARTED|Overall Study||206
10605565|NCT01870869|11763049|FG002|STARTED|Overall Study||1222
10605566|NCT01870869|11763050|FG003|STARTED|Overall Study||235
10605567|NCT01870869|11763047|FG000|COMPLETED|Overall Study||260
10605568|NCT01870869|11763048|FG001|COMPLETED|Overall Study||192
10605569|NCT01870869|11763049|FG002|COMPLETED|Overall Study||1092
10605570|NCT01870869|11763050|FG003|COMPLETED|Overall Study||205
10605571|NCT01870869|11763047|FG000|NOT COMPLETED|Overall Study||28
10605572|NCT01870869|11763048|FG001|NOT COMPLETED|Overall Study||14
10605573|NCT01870869|11763049|FG002|NOT COMPLETED|Overall Study||130
10605574|NCT01870869|11763050|FG003|NOT COMPLETED|Overall Study||30
10605575|NCT01870921|11763060|FG000|STARTED|Overall Study||2004
10605576|NCT01870921|11763060|FG000|COMPLETED|Overall Study||1914
10605577|NCT01870921|11763060|FG000|NOT COMPLETED|Overall Study||90
10605578|NCT01870973|11763066|FG000|STARTED|Overall Study||56
10605579|NCT01870973|11763067|FG001|STARTED|Overall Study||52
10605580|NCT01870973|11763066|FG000|COMPLETED|Overall Study||46
10605581|NCT01870973|11763067|FG001|COMPLETED|Overall Study||49
10605582|NCT01870973|11763066|FG000|NOT COMPLETED|Overall Study||10
10605583|NCT01870973|11763067|FG001|NOT COMPLETED|Overall Study||3
10605584|NCT01870999|11763076|FG000|STARTED|Overall Study||14
10605585|NCT01870999|11763077|FG001|STARTED|Overall Study||16
10605586|NCT01870999|11763078|FG002|STARTED|Overall Study||11
10605587|NCT01870999|11763076|FG000|Safety Population; Received Study Drug|Overall Study||14
10605588|NCT01870999|11763077|FG001|Safety Population; Received Study Drug|Overall Study||15
10605589|NCT01870999|11763078|FG002|Safety Population; Received Study Drug|Overall Study||10
10605590|NCT01870999|11763076|FG000|COMPLETED|Overall Study||10
10605591|NCT01870999|11763077|FG001|COMPLETED|Overall Study||8
10605592|NCT01870999|11763078|FG002|COMPLETED|Overall Study||4
10605593|NCT01870999|11763076|FG000|NOT COMPLETED|Overall Study||4
10605594|NCT01870999|11763077|FG001|NOT COMPLETED|Overall Study||8
10605595|NCT01870999|11763078|FG002|NOT COMPLETED|Overall Study||7
10605596|NCT01871077|11763086|FG000|STARTED|Overall Study||30
10605597|NCT01871077|11763086|FG000|COMPLETED|Overall Study||30
10605598|NCT01871077|11763086|FG000|NOT COMPLETED|Overall Study||0
10605599|NCT01871090|11763092|FG000|STARTED|Overall Study||35
10605600|NCT01871090|11763093|FG001|STARTED|Overall Study||48
10605601|NCT01871090|11763092|FG000|COMPLETED|Overall Study||33
10605602|NCT01871090|11763093|FG001|COMPLETED|Overall Study||25
10605603|NCT01871090|11763092|FG000|NOT COMPLETED|Overall Study||2
10605604|NCT01871090|11763093|FG001|NOT COMPLETED|Overall Study||23
10605605|NCT01871142|11763099|FG000|STARTED|Overall Study||12
10605606|NCT01871142|11763099|FG000|Received Placebo + Normoixa|Overall Study||11
10605607|NCT01871142|11763099|FG000|Received Placebo + Hypoxia|Overall Study||12
10605608|NCT01871142|11763099|FG000|Received 1000mg Aes 103+ Hypoxia|Overall Study||11
10605609|NCT01871142|11763099|FG000|Received 3000mg Aes-103 + Hypoxia|Overall Study||12
10605610|NCT01871142|11763099|FG000|COMPLETED|Overall Study||11
10605611|NCT01871142|11763099|FG000|NOT COMPLETED|Overall Study||1
10605612|NCT01871285|11763115|FG000|STARTED|First Intervention (1 Day)||18
10605613|NCT01871285|11763116|FG001|STARTED|First Intervention (1 Day)||15
10605614|NCT01871285|11763117|FG002|STARTED|First Intervention (1 Day)||4
10605615|NCT01871285|11763118|FG003|STARTED|First Intervention (1 Day)||2
10605616|NCT01871285|11763115|FG000|COMPLETED|First Intervention (1 Day)||17
10605617|NCT01871285|11763116|FG001|COMPLETED|First Intervention (1 Day)||14
10605618|NCT01871285|11763117|FG002|COMPLETED|First Intervention (1 Day)||3
10605619|NCT01871285|11763118|FG003|COMPLETED|First Intervention (1 Day)||2
10605620|NCT01871285|11763115|FG000|NOT COMPLETED|First Intervention (1 Day)||1
10605621|NCT01871285|11763116|FG001|NOT COMPLETED|First Intervention (1 Day)||1
10605622|NCT01871285|11763117|FG002|NOT COMPLETED|First Intervention (1 Day)||1
10605623|NCT01871285|11763118|FG003|NOT COMPLETED|First Intervention (1 Day)||0
10605624|NCT01871285|11763115|FG000|STARTED|Second Intervention (1 Day)||17
10605625|NCT01871285|11763116|FG001|STARTED|Second Intervention (1 Day)||14
10605626|NCT01871285|11763117|FG002|STARTED|Second Intervention (1 Day)||3
10605627|NCT01871285|11763118|FG003|STARTED|Second Intervention (1 Day)||2
10605628|NCT01871285|11763115|FG000|COMPLETED|Second Intervention (1 Day)||17
10605629|NCT01871285|11763116|FG001|COMPLETED|Second Intervention (1 Day)||14
10605630|NCT01871285|11763117|FG002|COMPLETED|Second Intervention (1 Day)||3
10605631|NCT01871285|11763118|FG003|COMPLETED|Second Intervention (1 Day)||2
10605632|NCT01871285|11763115|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10605633|NCT01871285|11763116|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10605634|NCT01871285|11763117|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
10605635|NCT01871285|11763118|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
10605636|NCT01871402|11763130|FG000|STARTED|Overall Study||110
10605637|NCT01871402|11763131|FG001|STARTED|Overall Study||111
10605638|NCT01871402|11763130|FG000|COMPLETED|Overall Study||109
10605639|NCT01871402|11763131|FG001|COMPLETED|Overall Study||108
10605640|NCT01871402|11763130|FG000|NOT COMPLETED|Overall Study||1
10605641|NCT01871402|11763131|FG001|NOT COMPLETED|Overall Study||3
10605642|NCT01871441|11763137|FG000|STARTED|Overall Study||4
10605643|NCT01871441|11763137|FG000|COMPLETED|Overall Study||4
10704204|NCT02589665|11868642|FG006|NOT COMPLETED|Induction Extension Period||0
10704205|NCT02589665|11868643|FG007|NOT COMPLETED|Induction Extension Period||2
10704206|NCT02589665|11868644|FG008|NOT COMPLETED|Induction Extension Period||12
10704207|NCT02589665|11868645|FG009|NOT COMPLETED|Induction Extension Period||0
10704208|NCT02589665|11868636|FG000|STARTED|Maintenance Extension Period||0
10704209|NCT02589665|11868637|FG001|STARTED|Maintenance Extension Period||0
10605644|NCT01871441|11763137|FG000|NOT COMPLETED|Overall Study||0
10605645|NCT01871506|11763144|FG000|STARTED|Overall Study||150
10605646|NCT01871506|11763145|FG001|STARTED|Overall Study||153
10605647|NCT01871506|11763144|FG000|COMPLETED|Overall Study||150
10605648|NCT01871506|11763145|FG001|COMPLETED|Overall Study||153
10704210|NCT02589665|11868638|FG002|STARTED|Maintenance Extension Period||0
10605649|NCT01871506|11763144|FG000|NOT COMPLETED|Overall Study||0
10605650|NCT01871506|11763145|FG001|NOT COMPLETED|Overall Study||0
10605651|NCT01871519|11763164|FG000|STARTED|Overall Study||350
10605652|NCT01871519|11763164|FG000|COMPLETED|Overall Study||260
10605653|NCT01871519|11763164|FG000|NOT COMPLETED|Overall Study||90
10605654|NCT01871532|11763171|FG000|STARTED|Overall Study||12
10605655|NCT01871532|11763172|FG001|STARTED|Overall Study||12
10605656|NCT01871532|11763171|FG000|Subjects Received hCG Treatment|Overall Study||11
10605657|NCT01871532|11763172|FG001|Subjects Received hCG Treatment|Overall Study||9
10704211|NCT02589665|11868639|FG003|STARTED|Maintenance Extension Period||0
10605658|NCT01871532|11763171|FG000|COMPLETED|Overall Study||11
10605659|NCT01871532|11763172|FG001|COMPLETED|Overall Study||10
10605660|NCT01871532|11763171|FG000|NOT COMPLETED|Overall Study||1
10605661|NCT01871532|11763172|FG001|NOT COMPLETED|Overall Study||2
10605662|NCT01871545|11763180|FG000|STARTED|Overall Study||73
10605663|NCT01871545|11763181|FG001|STARTED|Overall Study||11
10605664|NCT01871545|11763180|FG000|COMPLETED|Overall Study||56
10605665|NCT01871545|11763181|FG001|COMPLETED|Overall Study||8
10605666|NCT01871545|11763180|FG000|NOT COMPLETED|Overall Study||17
10605667|NCT01871545|11763181|FG001|NOT COMPLETED|Overall Study||3
10605668|NCT01871558|11763192|FG000|STARTED|Overall Study||21
10605669|NCT01871558|11763193|FG001|STARTED|Overall Study||21
10605670|NCT01871558|11763192|FG000|COMPLETED|Overall Study||18
10333834|NCT00335972|11470083|FG000|COMPLETED|Overall Study||71
10333835|NCT00335972|11470084|FG001|COMPLETED|Overall Study||68
10333836|NCT00335972|11470083|FG000|NOT COMPLETED|Overall Study||0
10333837|NCT00335972|11470084|FG001|NOT COMPLETED|Overall Study||3
10808707|NCT03848949|11970668|FG000|COMPLETED|Overall Study||49
10808708|NCT03848949|11970669|FG001|COMPLETED|Overall Study||46
10808709|NCT03848949|11970668|FG000|NOT COMPLETED|Overall Study||5
10808710|NCT03848949|11970669|FG001|NOT COMPLETED|Overall Study||7
10808711|NCT03849690|11970675|FG000|STARTED|Period 1 (3 Days)||12
10605671|NCT01871558|11763193|FG001|COMPLETED|Overall Study||19
10605672|NCT01871558|11763192|FG000|NOT COMPLETED|Overall Study||3
10605673|NCT01871558|11763193|FG001|NOT COMPLETED|Overall Study||2
10605674|NCT01871805|11763205|FG000|STARTED|Phase I||7
10605675|NCT01871805|11763206|FG001|STARTED|Phase I||7
10605676|NCT01871805|11763207|FG002|STARTED|Phase I||13
10605677|NCT01871805|11763208|FG003|STARTED|Phase I||7
10605678|NCT01871805|11763209|FG004|STARTED|Phase I||13
10605679|NCT01871805|11763210|FG005|STARTED|Phase I||0
10605680|NCT01871805|11763205|FG000|COMPLETED|Phase I||0
10605681|NCT01871805|11763206|FG001|COMPLETED|Phase I||0
10605682|NCT01871805|11763207|FG002|COMPLETED|Phase I||0
10605683|NCT01871805|11763208|FG003|COMPLETED|Phase I||0
10605684|NCT01871805|11763209|FG004|COMPLETED|Phase I||0
10605685|NCT01871805|11763210|FG005|COMPLETED|Phase I||0
10605686|NCT01871805|11763205|FG000|NOT COMPLETED|Phase I||7
10605687|NCT01871805|11763206|FG001|NOT COMPLETED|Phase I||7
10605688|NCT01871805|11763207|FG002|NOT COMPLETED|Phase I||13
10605689|NCT01871805|11763208|FG003|NOT COMPLETED|Phase I||7
10605690|NCT01871805|11763209|FG004|NOT COMPLETED|Phase I||13
10605691|NCT01871805|11763210|FG005|NOT COMPLETED|Phase I||0
10605692|NCT01871805|11763205|FG000|STARTED|Phase II||0
10605693|NCT01871805|11763206|FG001|STARTED|Phase II||0
10605694|NCT01871805|11763207|FG002|STARTED|Phase II||0
10605695|NCT01871805|11763208|FG003|STARTED|Phase II||0
10605696|NCT01871805|11763209|FG004|STARTED|Phase II||0
10605697|NCT01871805|11763210|FG005|STARTED|Phase II||87
10605698|NCT01871805|11763205|FG000|COMPLETED|Phase II||0
10605699|NCT01871805|11763206|FG001|COMPLETED|Phase II||0
10605700|NCT01871805|11763207|FG002|COMPLETED|Phase II||0
10605701|NCT01871805|11763208|FG003|COMPLETED|Phase II||0
10605702|NCT01871805|11763209|FG004|COMPLETED|Phase II||0
10605703|NCT01871805|11763210|FG005|COMPLETED|Phase II||0
10605704|NCT01871805|11763205|FG000|NOT COMPLETED|Phase II||0
10605705|NCT01871805|11763206|FG001|NOT COMPLETED|Phase II||0
10605706|NCT01871805|11763207|FG002|NOT COMPLETED|Phase II||0
10605707|NCT01871805|11763208|FG003|NOT COMPLETED|Phase II||0
10605708|NCT01871805|11763209|FG004|NOT COMPLETED|Phase II||0
10605709|NCT01871805|11763210|FG005|NOT COMPLETED|Phase II||87
10605710|NCT01871870|11763241|FG000|STARTED|Overall Study||20
10605711|NCT01871870|11763241|FG000|COMPLETED|Overall Study||11
10605712|NCT01871870|11763241|FG000|NOT COMPLETED|Overall Study||9
10605713|NCT01872078|11763249|FG000|STARTED|Overall Study||16
10605714|NCT01872078|11763250|FG001|STARTED|Overall Study||15
10605715|NCT01872078|11763251|FG002|STARTED|Overall Study||17
10605716|NCT01872078|11763252|FG003|STARTED|Overall Study||17
10605717|NCT01872078|11763249|FG000|COMPLETED|Overall Study||16
10605718|NCT01872078|11763250|FG001|COMPLETED|Overall Study||15
10605719|NCT01872078|11763251|FG002|COMPLETED|Overall Study||14
10605720|NCT01872078|11763252|FG003|COMPLETED|Overall Study||15
10605721|NCT01872078|11763249|FG000|NOT COMPLETED|Overall Study||0
10605722|NCT01872078|11763250|FG001|NOT COMPLETED|Overall Study||0
10605723|NCT01872078|11763251|FG002|NOT COMPLETED|Overall Study||3
10605724|NCT01872078|11763252|FG003|NOT COMPLETED|Overall Study||2
10605725|NCT01872325|11763264|FG000|STARTED|Overall Study||689
10605726|NCT01872325|11763265|FG001|STARTED|Overall Study||387
10605727|NCT01872325|11763264|FG000|COMPLETED|Overall Study||689
10605728|NCT01872325|11763265|FG001|COMPLETED|Overall Study||387
10605729|NCT01872325|11763264|FG000|NOT COMPLETED|Overall Study||0
10605730|NCT01872325|11763265|FG001|NOT COMPLETED|Overall Study||0
10652696|NCT02186665|11813015|FG000|COMPLETED|Overall Study||8
10652697|NCT02186665|11813016|FG001|COMPLETED|Overall Study||10
10808712|NCT03849690|11970675|FG000|COMPLETED|Period 1 (3 Days)||12
10652698|NCT02186665|11813015|FG000|NOT COMPLETED|Overall Study||0
10652699|NCT02186665|11813016|FG001|NOT COMPLETED|Overall Study||1
10333844|NCT00336232|11470099|FG000|STARTED|Baseline (200mcg Daily)||59
10652700|NCT02186795|11813024|FG000|STARTED|Overall Study||24
10652701|NCT02186795|11813025|FG001|STARTED|Overall Study||24
10652702|NCT02186795|11813024|FG000|COMPLETED|Overall Study||24
10652703|NCT02186795|11813025|FG001|COMPLETED|Overall Study||24
10652704|NCT02186795|11813024|FG000|NOT COMPLETED|Overall Study||0
10652705|NCT02186795|11813025|FG001|NOT COMPLETED|Overall Study||0
10652706|NCT02186808|11813031|FG000|STARTED|Overall Study||80
10652707|NCT02186808|11813031|FG000|COMPLETED|Overall Study||67
10652708|NCT02186808|11813031|FG000|NOT COMPLETED|Overall Study||13
10605731|NCT01872338|11763273|FG000|STARTED|Overall Study||66
10605732|NCT01872338|11763274|FG001|STARTED|Overall Study||69
10605733|NCT01872338|11763273|FG000|COMPLETED|Overall Study||46
10605734|NCT01872338|11763274|FG001|COMPLETED|Overall Study||69
10605735|NCT01872338|11763273|FG000|NOT COMPLETED|Overall Study||20
10605736|NCT01872338|11763274|FG001|NOT COMPLETED|Overall Study||0
10605737|NCT01872611|11763282|FG000|STARTED|Overall Study||301
10605738|NCT01872611|11763283|FG001|STARTED|Overall Study||304
10605739|NCT01872611|11763282|FG000|Randomized|Overall Study||301
10605740|NCT01872611|11763283|FG001|Randomized|Overall Study||304
10605741|NCT01872611|11763282|FG000|Treated (Safety Analysis Set)|Overall Study||293
10605742|NCT01872611|11763283|FG001|Treated (Safety Analysis Set)|Overall Study||295
10605743|NCT01872611|11763282|FG000|Full Analysis Set|Overall Study||289
10605744|NCT01872611|11763283|FG001|Full Analysis Set|Overall Study||293
10605745|NCT01872611|11763282|FG000|COMPLETED|Overall Study||277
10605746|NCT01872611|11763283|FG001|COMPLETED|Overall Study||292
10605747|NCT01872611|11763282|FG000|NOT COMPLETED|Overall Study||24
10605748|NCT01872611|11763283|FG001|NOT COMPLETED|Overall Study||12
10605749|NCT01872689|11763295|FG000|STARTED|Double-Blind/Placebo-Controlled Period||76
10605750|NCT01872689|11763296|FG001|STARTED|Double-Blind/Placebo-Controlled Period||78
10605751|NCT01872689|11763297|FG002|STARTED|Double-Blind/Placebo-Controlled Period||177
10605752|NCT01872689|11763298|FG003|STARTED|Double-Blind/Placebo-Controlled Period||174
10605753|NCT01872689|11763295|FG000|COMPLETED|Double-Blind/Placebo-Controlled Period||56
10605754|NCT01872689|11763296|FG001|COMPLETED|Double-Blind/Placebo-Controlled Period||58
10605755|NCT01872689|11763297|FG002|COMPLETED|Double-Blind/Placebo-Controlled Period||129
10605756|NCT01872689|11763298|FG003|COMPLETED|Double-Blind/Placebo-Controlled Period||136
10605757|NCT01872689|11763295|FG000|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||20
10605758|NCT01872689|11763296|FG001|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||20
10605759|NCT01872689|11763297|FG002|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||48
10605760|NCT01872689|11763298|FG003|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||38
10605761|NCT01872689|11763295|FG000|STARTED|Open-Label Period (Only For Monotherapy)|Of the 56 participants who completed Period 1, only 52 started Period 2.|52
10605762|NCT01872689|11763296|FG001|STARTED|Open-Label Period (Only For Monotherapy)|Of the 58 participants who completed Period 1, only 56 started Period 2.|56
10605763|NCT01872689|11763297|FG002|STARTED|Open-Label Period (Only For Monotherapy)|As per study design, Period 2 was not intended for this arm.|0
10605764|NCT01872689|11763298|FG003|STARTED|Open-Label Period (Only For Monotherapy)|As per study design, Period 2 was not intended for this arm.|0
10605765|NCT01872689|11763295|FG000|COMPLETED|Open-Label Period (Only For Monotherapy)||31
10605766|NCT01872689|11763296|FG001|COMPLETED|Open-Label Period (Only For Monotherapy)||33
10605767|NCT01872689|11763297|FG002|COMPLETED|Open-Label Period (Only For Monotherapy)||0
10605768|NCT01872689|11763298|FG003|COMPLETED|Open-Label Period (Only For Monotherapy)||0
10605769|NCT01872689|11763295|FG000|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||21
10605770|NCT01872689|11763296|FG001|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||23
10605771|NCT01872689|11763297|FG002|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||0
10605772|NCT01872689|11763298|FG003|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||0
10605776|NCT01872819|11763325|FG000|STARTED|Overall Study||14
10605777|NCT01872819|11763325|FG000|COMPLETED|Overall Study||14
10605778|NCT01872819|11763325|FG000|NOT COMPLETED|Overall Study||0
10605779|NCT01872910|11763336|FG000|STARTED|Overall Study||30
10605780|NCT01872910|11763337|FG001|STARTED|Overall Study||31
10605781|NCT01872910|11763338|FG002|STARTED|Overall Study||30
10605782|NCT01872910|11763339|FG003|STARTED|Overall Study||15
10605783|NCT01872910|11763340|FG004|STARTED|Overall Study||15
10605784|NCT01872910|11763341|FG005|STARTED|Overall Study||3
10605785|NCT01872910|11763336|FG000|Received Any Study Drug|Overall Study||30
10605786|NCT01872910|11763337|FG001|Received Any Study Drug|Overall Study||31
10605787|NCT01872910|11763338|FG002|Received Any Study Drug|Overall Study||30
10605788|NCT01872910|11763339|FG003|Received Any Study Drug|Overall Study||15
10605789|NCT01872910|11763340|FG004|Received Any Study Drug|Overall Study||15
10605790|NCT01872910|11763341|FG005|Received Any Study Drug|Overall Study||3
10605791|NCT01872910|11763336|FG000|COMPLETED|Overall Study||28
10605792|NCT01872910|11763337|FG001|COMPLETED|Overall Study||31
10605793|NCT01872910|11763338|FG002|COMPLETED|Overall Study||28
10605794|NCT01872910|11763339|FG003|COMPLETED|Overall Study||15
10605795|NCT01872910|11763340|FG004|COMPLETED|Overall Study||15
10605796|NCT01872910|11763341|FG005|COMPLETED|Overall Study||3
10605797|NCT01872910|11763336|FG000|NOT COMPLETED|Overall Study||2
10605798|NCT01872910|11763337|FG001|NOT COMPLETED|Overall Study||0
10605799|NCT01872910|11763338|FG002|NOT COMPLETED|Overall Study||2
10605800|NCT01872910|11763339|FG003|NOT COMPLETED|Overall Study||0
10605801|NCT01872910|11763340|FG004|NOT COMPLETED|Overall Study||0
10605802|NCT01872910|11763341|FG005|NOT COMPLETED|Overall Study||0
10605803|NCT01873287|11763356|FG000|STARTED|Overall Study||2006
10605804|NCT01873287|11763357|FG001|STARTED|Overall Study||1057
10605805|NCT01873287|11763356|FG000|COMPLETED|Overall Study||1701
10605806|NCT01873287|11763357|FG001|COMPLETED|Overall Study||883
10605807|NCT01873287|11763356|FG000|NOT COMPLETED|Overall Study||305
10605808|NCT01873287|11763357|FG001|NOT COMPLETED|Overall Study||174
10605809|NCT01873417|11763365|FG000|STARTED|Overall Study||237
10605810|NCT01873417|11763365|FG000|Safety Population|Overall Study|Participants who received at least 1 dose of dimethyl fumarate (DMF), recorded in diary data.|233
10605811|NCT01873417|11763365|FG000|COMPLETED|Overall Study||202
10605812|NCT01873417|11763365|FG000|NOT COMPLETED|Overall Study||35
10605813|NCT01873495|11763369|FG000|STARTED|Overall Study||7
10605814|NCT01873495|11763369|FG000|COMPLETED|Overall Study||0
10605815|NCT01873495|11763369|FG000|NOT COMPLETED|Overall Study||7
10605816|NCT01873586|11763373|FG000|STARTED|Overall Study||29
10605817|NCT01873586|11763373|FG000|COMPLETED|Overall Study||26
10605818|NCT01873586|11763373|FG000|NOT COMPLETED|Overall Study||3
10605819|NCT01873729|11763380|FG000|STARTED|Overall Study||3
10605820|NCT01873729|11763380|FG000|COMPLETED|Overall Study||2
10605821|NCT01873729|11763380|FG000|NOT COMPLETED|Overall Study||1
10605822|NCT01873742|11763386|FG000|STARTED|Overall Study||165
10605823|NCT01873742|11763387|FG001|STARTED|Overall Study||163
10605824|NCT01873742|11763386|FG000|COMPLETED|Overall Study||97
10605825|NCT01873742|11763387|FG001|COMPLETED|Overall Study||87
10605826|NCT01873742|11763386|FG000|NOT COMPLETED|Overall Study||68
10605827|NCT01873742|11763387|FG001|NOT COMPLETED|Overall Study||76
10605828|NCT01873846|11763393|FG000|STARTED|Overall Study||400
10605829|NCT01873846|11763393|FG000|Eligble Participants Dispensed Lenses|Overall Study||396
10605830|NCT01873846|11763393|FG000|COMPLETED|Overall Study||388
10605831|NCT01873846|11763393|FG000|NOT COMPLETED|Overall Study||12
10605832|NCT01873859|11763399|FG000|STARTED|Overall Study||83
10605833|NCT01873859|11763400|FG001|STARTED|Overall Study||83
10605834|NCT01873859|11763399|FG000|COMPLETED|Overall Study||83
10605835|NCT01873859|11763400|FG001|COMPLETED|Overall Study||79
10605836|NCT01873859|11763399|FG000|NOT COMPLETED|Overall Study||0
10605837|NCT01873859|11763400|FG001|NOT COMPLETED|Overall Study||4
10605838|NCT01873950|11763407|FG000|STARTED|Period 1||5
10605839|NCT01873950|11763408|FG001|STARTED|Period 1||4
10605840|NCT01873950|11763409|FG002|STARTED|Period 1||5
10605841|NCT01873950|11763410|FG003|STARTED|Period 1||4
10605842|NCT01873950|11763411|FG004|STARTED|Period 1||4
10605843|NCT01873950|11763407|FG000|COMPLETED|Period 1||5
10605844|NCT01873950|11763408|FG001|COMPLETED|Period 1||4
10605845|NCT01873950|11763409|FG002|COMPLETED|Period 1||5
10605846|NCT01873950|11763410|FG003|COMPLETED|Period 1||4
10605847|NCT01873950|11763411|FG004|COMPLETED|Period 1||4
10605848|NCT01873950|11763407|FG000|NOT COMPLETED|Period 1||0
10605849|NCT01873950|11763408|FG001|NOT COMPLETED|Period 1||0
10605850|NCT01873950|11763409|FG002|NOT COMPLETED|Period 1||0
10605851|NCT01873950|11763410|FG003|NOT COMPLETED|Period 1||0
10605852|NCT01873950|11763411|FG004|NOT COMPLETED|Period 1||0
10605853|NCT01873950|11763407|FG000|STARTED|Period 2||5
10605854|NCT01873950|11763408|FG001|STARTED|Period 2||4
10605855|NCT01873950|11763409|FG002|STARTED|Period 2||4
10605856|NCT01873950|11763410|FG003|STARTED|Period 2||4
10605857|NCT01873950|11763411|FG004|STARTED|Period 2||5
10605858|NCT01873950|11763407|FG000|COMPLETED|Period 2||5
10605859|NCT01873950|11763408|FG001|COMPLETED|Period 2||4
10605860|NCT01873950|11763409|FG002|COMPLETED|Period 2||4
10605861|NCT01873950|11763410|FG003|COMPLETED|Period 2||4
10605862|NCT01873950|11763411|FG004|COMPLETED|Period 2||5
10605863|NCT01873950|11763407|FG000|NOT COMPLETED|Period 2||0
10605864|NCT01873950|11763408|FG001|NOT COMPLETED|Period 2||0
10605865|NCT01873950|11763409|FG002|NOT COMPLETED|Period 2||0
10605866|NCT01873950|11763410|FG003|NOT COMPLETED|Period 2||0
10605867|NCT01873950|11763411|FG004|NOT COMPLETED|Period 2||0
10605868|NCT01873950|11763407|FG000|STARTED|Period 3||4
10605869|NCT01873950|11763408|FG001|STARTED|Period 3||4
10605870|NCT01873950|11763409|FG002|STARTED|Period 3||5
10605871|NCT01873950|11763410|FG003|STARTED|Period 3||5
10605872|NCT01873950|11763411|FG004|STARTED|Period 3||4
10605873|NCT01873950|11763407|FG000|COMPLETED|Period 3||4
10605874|NCT01873950|11763408|FG001|COMPLETED|Period 3||4
10605875|NCT01873950|11763409|FG002|COMPLETED|Period 3||5
10605876|NCT01873950|11763410|FG003|COMPLETED|Period 3||5
10605877|NCT01873950|11763411|FG004|COMPLETED|Period 3||4
10605878|NCT01873950|11763407|FG000|NOT COMPLETED|Period 3||0
10605879|NCT01873950|11763408|FG001|NOT COMPLETED|Period 3||0
10605880|NCT01873950|11763409|FG002|NOT COMPLETED|Period 3||0
10605881|NCT01873950|11763410|FG003|NOT COMPLETED|Period 3||0
10605882|NCT01873950|11763411|FG004|NOT COMPLETED|Period 3||0
10605883|NCT01873950|11763407|FG000|STARTED|Period 4||4
10605884|NCT01873950|11763408|FG001|STARTED|Period 4||5
10605885|NCT01873950|11763409|FG002|STARTED|Period 4||4
10605886|NCT01873950|11763410|FG003|STARTED|Period 4||4
10605887|NCT01873950|11763411|FG004|STARTED|Period 4||5
10605888|NCT01873950|11763407|FG000|COMPLETED|Period 4||4
10605889|NCT01873950|11763408|FG001|COMPLETED|Period 4||5
10605890|NCT01873950|11763409|FG002|COMPLETED|Period 4||4
10605891|NCT01873950|11763410|FG003|COMPLETED|Period 4||4
10605892|NCT01873950|11763411|FG004|COMPLETED|Period 4||5
10605893|NCT01873950|11763407|FG000|NOT COMPLETED|Period 4||0
10605894|NCT01873950|11763408|FG001|NOT COMPLETED|Period 4||0
10605895|NCT01873950|11763409|FG002|NOT COMPLETED|Period 4||0
10605896|NCT01873950|11763410|FG003|NOT COMPLETED|Period 4||0
10605897|NCT01873950|11763411|FG004|NOT COMPLETED|Period 4||0
10605898|NCT01873950|11763407|FG000|STARTED|Period 5||4
10605899|NCT01873950|11763408|FG001|STARTED|Period 5||5
10605900|NCT01873950|11763409|FG002|STARTED|Period 5||4
10605901|NCT01873950|11763410|FG003|STARTED|Period 5||4
10605902|NCT01873950|11763411|FG004|STARTED|Period 5||4
10605903|NCT01873950|11763407|FG000|COMPLETED|Period 5||4
10605904|NCT01873950|11763408|FG001|COMPLETED|Period 5||5
10605905|NCT01873950|11763409|FG002|COMPLETED|Period 5||4
10605906|NCT01873950|11763410|FG003|COMPLETED|Period 5||3
10605907|NCT01873950|11763411|FG004|COMPLETED|Period 5||4
10605908|NCT01873950|11763407|FG000|NOT COMPLETED|Period 5||0
10605909|NCT01873950|11763408|FG001|NOT COMPLETED|Period 5||0
10605910|NCT01873950|11763409|FG002|NOT COMPLETED|Period 5||0
10605911|NCT01873950|11763410|FG003|NOT COMPLETED|Period 5||1
10605912|NCT01873950|11763411|FG004|NOT COMPLETED|Period 5||0
10605913|NCT01873989|11763427|FG000|STARTED|Overall Study||8
10605914|NCT01873989|11763428|FG001|STARTED|Overall Study||7
10605915|NCT01873989|11763427|FG000|COMPLETED|Overall Study||7
10605916|NCT01873989|11763428|FG001|COMPLETED|Overall Study||6
10605917|NCT01873989|11763427|FG000|NOT COMPLETED|Overall Study||1
10605918|NCT01873989|11763428|FG001|NOT COMPLETED|Overall Study||1
10605919|NCT01874054|11763434|FG000|STARTED|Overall Study||55
10605920|NCT01874054|11763434|FG000|Completed ≥2 Cycles of Combo Treatment|Overall Study||53
10605921|NCT01874054|11763434|FG000|Completed 16 Cycles of BV Treatment|Overall Study||17
10605922|NCT01874054|11763434|FG000|COMPLETED|Overall Study||0
10605923|NCT01874054|11763434|FG000|NOT COMPLETED|Overall Study||55
10605924|NCT01874119|11763438|FG000|STARTED|First Intervention (6 Days)||8
10605925|NCT01874119|11763439|FG001|STARTED|First Intervention (6 Days)||5
10605926|NCT01874119|11763438|FG000|COMPLETED|First Intervention (6 Days)||7
10605927|NCT01874119|11763439|FG001|COMPLETED|First Intervention (6 Days)||5
10605928|NCT01874119|11763438|FG000|NOT COMPLETED|First Intervention (6 Days)||1
10605929|NCT01874119|11763439|FG001|NOT COMPLETED|First Intervention (6 Days)||0
10605930|NCT01874119|11763438|FG000|STARTED|Washout (7 Days)||7
10605931|NCT01874119|11763439|FG001|STARTED|Washout (7 Days)||5
10605932|NCT01874119|11763438|FG000|COMPLETED|Washout (7 Days)||4
10605933|NCT01874119|11763439|FG001|COMPLETED|Washout (7 Days)||3
10605934|NCT01874119|11763438|FG000|NOT COMPLETED|Washout (7 Days)||3
10605935|NCT01874119|11763439|FG001|NOT COMPLETED|Washout (7 Days)||2
10605936|NCT01874119|11763438|FG000|STARTED|Second Intervention (6 Days)||4
10605937|NCT01874119|11763439|FG001|STARTED|Second Intervention (6 Days)||3
10605938|NCT01874119|11763438|FG000|COMPLETED|Second Intervention (6 Days)||4
10605939|NCT01874119|11763439|FG001|COMPLETED|Second Intervention (6 Days)||3
10605940|NCT01874119|11763438|FG000|NOT COMPLETED|Second Intervention (6 Days)||0
10605941|NCT01874119|11763439|FG001|NOT COMPLETED|Second Intervention (6 Days)||0
10605942|NCT01874132|11763448|FG000|STARTED|Overall Study||22
10605943|NCT01874132|11763449|FG001|STARTED|Overall Study||22
10605944|NCT01874132|11763450|FG002|STARTED|Overall Study||22
10605945|NCT01874132|11763448|FG000|COMPLETED|Overall Study||18
10605946|NCT01874132|11763449|FG001|COMPLETED|Overall Study||18
10605947|NCT01874132|11763450|FG002|COMPLETED|Overall Study||19
10605948|NCT01874132|11763448|FG000|NOT COMPLETED|Overall Study||4
10605949|NCT01874132|11763449|FG001|NOT COMPLETED|Overall Study||4
10605950|NCT01874132|11763450|FG002|NOT COMPLETED|Overall Study||3
10605951|NCT01874145|11763460|FG000|STARTED|Core Period||101
10605952|NCT01874145|11763461|FG001|STARTED|Core Period||108
10605953|NCT01874145|11763460|FG000|Full Analysis Set|Core Period||100
10605954|NCT01874145|11763461|FG001|Full Analysis Set|Core Period||108
10605955|NCT01874145|11763460|FG000|COMPLETED|Core Period||98
10605956|NCT01874145|11763461|FG001|COMPLETED|Core Period||101
10605957|NCT01874145|11763460|FG000|NOT COMPLETED|Core Period||3
10605958|NCT01874145|11763461|FG001|NOT COMPLETED|Core Period||7
10605959|NCT01874145|11763460|FG000|STARTED|Extension Period|Switchers|97
10605960|NCT01874145|11763461|FG001|STARTED|Extension Period|Non-Switchers|101
10605961|NCT01874145|11763460|FG000|Full Analysis Set|Extension Period||95
10605962|NCT01874145|11763461|FG001|Full Analysis Set|Extension Period||101
10605963|NCT01874145|11763460|FG000|COMPLETED|Extension Period||91
10605964|NCT01874145|11763461|FG001|COMPLETED|Extension Period||97
10605965|NCT01874145|11763460|FG000|NOT COMPLETED|Extension Period||6
10605966|NCT01874145|11763461|FG001|NOT COMPLETED|Extension Period||4
10605967|NCT01874262|11763473|FG000|STARTED|Overall Study||91
10605968|NCT01874262|11763474|FG001|STARTED|Overall Study||83
10605969|NCT01874262|11763473|FG000|Not Correctly Randomised|Overall Study||2
10605970|NCT01874262|11763474|FG001|Not Correctly Randomised|Overall Study||0
10605971|NCT01874262|11763473|FG000|Not Included Due to Tehnical Issues|Overall Study||3
10605972|NCT01874262|11763474|FG001|Not Included Due to Tehnical Issues|Overall Study||3
10605973|NCT01874262|11763473|FG000|COMPLETED|Overall Study||86
10605974|NCT01874262|11763474|FG001|COMPLETED|Overall Study||80
10605975|NCT01874262|11763473|FG000|NOT COMPLETED|Overall Study||5
10605976|NCT01874262|11763474|FG001|NOT COMPLETED|Overall Study||3
10605977|NCT01874275|11763482|FG000|STARTED|Overall Study||4
10605978|NCT01874275|11763483|FG001|STARTED|Overall Study||2
10605979|NCT01874275|11763482|FG000|COMPLETED|Overall Study||3
10605980|NCT01874275|11763483|FG001|COMPLETED|Overall Study||2
10605981|NCT01874275|11763482|FG000|NOT COMPLETED|Overall Study||1
10605982|NCT01874275|11763483|FG001|NOT COMPLETED|Overall Study||0
10605983|NCT01874288|11763500|FG000|STARTED|Overall Study||3
10605984|NCT01874288|11763501|FG001|STARTED|Overall Study||3
10605985|NCT01874288|11763502|FG002|STARTED|Overall Study||9
10605986|NCT01874288|11763503|FG003|STARTED|Overall Study||7
10605987|NCT01874288|11763504|FG004|STARTED|Overall Study||2
10605988|NCT01874288|11763500|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
10605989|NCT01874288|11763501|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
10605990|NCT01874288|11763502|FG002|Received at Least 1 Dose of Study Drug|Overall Study||9
10605991|NCT01874288|11763503|FG003|Received at Least 1 Dose of Study Drug|Overall Study||7
10605992|NCT01874288|11763504|FG004|Received at Least 1 Dose of Study Drug|Overall Study||2
10605993|NCT01874288|11763500|FG000|COMPLETED|Overall Study||0
10605994|NCT01874288|11763501|FG001|COMPLETED|Overall Study||3
10605995|NCT01874288|11763502|FG002|COMPLETED|Overall Study||4
10605996|NCT01874288|11763503|FG003|COMPLETED|Overall Study||0
10605997|NCT01874288|11763504|FG004|COMPLETED|Overall Study||0
10605998|NCT01874288|11763500|FG000|NOT COMPLETED|Overall Study||3
10605999|NCT01874288|11763501|FG001|NOT COMPLETED|Overall Study||0
10606000|NCT01874288|11763502|FG002|NOT COMPLETED|Overall Study||5
10606001|NCT01874288|11763503|FG003|NOT COMPLETED|Overall Study||7
10606002|NCT01874288|11763504|FG004|NOT COMPLETED|Overall Study||2
10606003|NCT01874340|11763521|FG000|STARTED|Overall Study||6
10606004|NCT01874340|11763522|FG001|STARTED|Overall Study||8
10606005|NCT01874340|11763523|FG002|STARTED|Overall Study||8
10606006|NCT01874340|11763524|FG003|STARTED|Overall Study||6
10606007|NCT01874340|11763521|FG000|COMPLETED|Overall Study||0
10606008|NCT01874340|11763522|FG001|COMPLETED|Overall Study||0
10606009|NCT01874340|11763523|FG002|COMPLETED|Overall Study||0
10606010|NCT01874340|11763524|FG003|COMPLETED|Overall Study||1
10606011|NCT01874340|11763521|FG000|NOT COMPLETED|Overall Study||6
10606012|NCT01874340|11763522|FG001|NOT COMPLETED|Overall Study||8
10606013|NCT01874340|11763523|FG002|NOT COMPLETED|Overall Study||8
10606014|NCT01874340|11763524|FG003|NOT COMPLETED|Overall Study||5
10606015|NCT01874392|11763534|FG000|STARTED|Overall Study||9
10606016|NCT01874392|11763534|FG000|COMPLETED|Overall Study||9
10606017|NCT01874392|11763534|FG000|NOT COMPLETED|Overall Study||0
10606018|NCT01874431|11763546|FG000|STARTED|Overall Study||96
10606019|NCT01874431|11763547|FG001|STARTED|Overall Study||92
10606020|NCT01874431|11763548|FG002|STARTED|Overall Study||100
10606021|NCT01874431|11763549|FG003|STARTED|Overall Study||98
10606022|NCT01874431|11763550|FG004|STARTED|Overall Study||98
10606023|NCT01874431|11763551|FG005|STARTED|Overall Study||125
10606024|NCT01874431|11763552|FG006|STARTED|Overall Study||120
10606025|NCT01874431|11763553|FG007|STARTED|Overall Study||94
10606026|NCT01874431|11763546|FG000|Participants Received Treatment|Overall Study||96
10606027|NCT01874431|11763547|FG001|Participants Received Treatment|Overall Study||92
10606028|NCT01874431|11763548|FG002|Participants Received Treatment|Overall Study||100
10606029|NCT01874431|11763549|FG003|Participants Received Treatment|Overall Study||97
10606030|NCT01874431|11763550|FG004|Participants Received Treatment|Overall Study||98
10606031|NCT01874431|11763551|FG005|Participants Received Treatment|Overall Study||125
10606032|NCT01874431|11763552|FG006|Participants Received Treatment|Overall Study||119
10606033|NCT01874431|11763553|FG007|Participants Received Treatment|Overall Study||94
10606034|NCT01874431|11763546|FG000|COMPLETED|Overall Study||90
10606035|NCT01874431|11763547|FG001|COMPLETED|Overall Study||87
10606036|NCT01874431|11763548|FG002|COMPLETED|Overall Study||90
10606037|NCT01874431|11763549|FG003|COMPLETED|Overall Study||91
10606038|NCT01874431|11763550|FG004|COMPLETED|Overall Study||90
10606039|NCT01874431|11763551|FG005|COMPLETED|Overall Study||114
10606040|NCT01874431|11763552|FG006|COMPLETED|Overall Study||112
10606041|NCT01874431|11763553|FG007|COMPLETED|Overall Study||90
10606042|NCT01874431|11763546|FG000|NOT COMPLETED|Overall Study||6
10606043|NCT01874431|11763547|FG001|NOT COMPLETED|Overall Study||5
10606044|NCT01874431|11763548|FG002|NOT COMPLETED|Overall Study||10
10606045|NCT01874431|11763549|FG003|NOT COMPLETED|Overall Study||7
10606046|NCT01874431|11763550|FG004|NOT COMPLETED|Overall Study||8
10606047|NCT01874431|11763551|FG005|NOT COMPLETED|Overall Study||11
10606048|NCT01874431|11763552|FG006|NOT COMPLETED|Overall Study||8
10606049|NCT01874431|11763553|FG007|NOT COMPLETED|Overall Study||4
10606050|NCT01874535|11763573|FG000|STARTED|Overall Study||207
10606051|NCT01874535|11763574|FG001|STARTED|Overall Study||201
10606052|NCT01874535|11763573|FG000|COMPLETED|Overall Study||152
10606053|NCT01874535|11763574|FG001|COMPLETED|Overall Study||157
10606054|NCT01874535|11763573|FG000|NOT COMPLETED|Overall Study||55
10606055|NCT01874535|11763574|FG001|NOT COMPLETED|Overall Study||44
10606056|NCT01874665|11763582|FG000|STARTED|Overall Study||30
10606057|NCT01874665|11763583|FG001|STARTED|Overall Study||15
10606058|NCT01874665|11763582|FG000|COMPLETED|Overall Study||0
10606059|NCT01874665|11763583|FG001|COMPLETED|Overall Study||0
10606060|NCT01874665|11763582|FG000|NOT COMPLETED|Overall Study||30
10606061|NCT01874665|11763583|FG001|NOT COMPLETED|Overall Study||15
10606062|NCT01874756|11763594|FG000|STARTED|Overall Study||29
10606063|NCT01874756|11763595|FG001|STARTED|Overall Study||10
10606064|NCT01874756|11763596|FG002|STARTED|Overall Study||29
10704212|NCT02589665|11868640|FG004|STARTED|Maintenance Extension Period||0
10704213|NCT02589665|11868641|FG005|STARTED|Maintenance Extension Period||0
10704214|NCT02589665|11868642|FG006|STARTED|Maintenance Extension Period||0
10606065|NCT01874756|11763597|FG003|STARTED|Overall Study||27
10606066|NCT01874756|11763594|FG000|COMPLETED|Overall Study||28
10606067|NCT01874756|11763595|FG001|COMPLETED|Overall Study||10
10606068|NCT01874756|11763596|FG002|COMPLETED|Overall Study||27
10606069|NCT01874756|11763597|FG003|COMPLETED|Overall Study||21
10606070|NCT01874756|11763594|FG000|NOT COMPLETED|Overall Study||1
10606071|NCT01874756|11763595|FG001|NOT COMPLETED|Overall Study||0
10606072|NCT01874756|11763596|FG002|NOT COMPLETED|Overall Study||2
10606073|NCT01874756|11763597|FG003|NOT COMPLETED|Overall Study||6
10606074|NCT01874951|11763609|FG000|STARTED|Overall Study||6
10606075|NCT01874951|11763610|FG001|STARTED|Overall Study||6
10606076|NCT01874951|11763609|FG000|COMPLETED|Overall Study||6
10606077|NCT01874951|11763610|FG001|COMPLETED|Overall Study||6
10606078|NCT01874951|11763609|FG000|NOT COMPLETED|Overall Study||0
10606079|NCT01874951|11763610|FG001|NOT COMPLETED|Overall Study||0
10606080|NCT01875159|11763621|FG000|STARTED|Overall Study||45
10606081|NCT01875159|11763622|FG001|STARTED|Overall Study||53
10606082|NCT01875159|11763621|FG000|COMPLETED|Overall Study||42
10606083|NCT01875159|11763622|FG001|COMPLETED|Overall Study||53
10606084|NCT01875159|11763621|FG000|NOT COMPLETED|Overall Study||3
10606085|NCT01875159|11763622|FG001|NOT COMPLETED|Overall Study||0
10606086|NCT01875237|11763630|FG000|STARTED|Overall Study||2
10606087|NCT01875237|11763631|FG001|STARTED|Overall Study||1
10606088|NCT01875237|11763630|FG000|COMPLETED|Overall Study||0
10606089|NCT01875237|11763631|FG001|COMPLETED|Overall Study||1
10606090|NCT01875237|11763630|FG000|NOT COMPLETED|Overall Study||2
10606091|NCT01875237|11763631|FG001|NOT COMPLETED|Overall Study||0
10606092|NCT01875250|11763641|FG000|STARTED|Overall Study||19
10606093|NCT01875250|11763642|FG001|STARTED|Overall Study||19
10606094|NCT01875250|11763641|FG000|COMPLETED|Overall Study||17
10606095|NCT01875250|11763642|FG001|COMPLETED|Overall Study||19
10606096|NCT01875250|11763641|FG000|NOT COMPLETED|Overall Study||2
10606097|NCT01875250|11763642|FG001|NOT COMPLETED|Overall Study||0
10606098|NCT01875367|11763652|FG000|STARTED|Overall Study||81
10606099|NCT01875367|11763653|FG001|STARTED|Overall Study||85
10606100|NCT01875367|11763652|FG000|COMPLETED|Overall Study||76
10606101|NCT01875367|11763653|FG001|COMPLETED|Overall Study||83
10606102|NCT01875367|11763652|FG000|NOT COMPLETED|Overall Study||5
10606103|NCT01875367|11763653|FG001|NOT COMPLETED|Overall Study||2
10606104|NCT01875445|11763665|FG000|STARTED|Overall Study||19
10606105|NCT01875445|11763666|FG001|STARTED|Overall Study||19
10606106|NCT01875445|11763665|FG000|COMPLETED|Overall Study||12
10606107|NCT01875445|11763666|FG001|COMPLETED|Overall Study||19
10606108|NCT01875445|11763665|FG000|NOT COMPLETED|Overall Study||7
10606109|NCT01875445|11763666|FG001|NOT COMPLETED|Overall Study||0
10704215|NCT02589665|11868643|FG007|STARTED|Maintenance Extension Period||0
10704216|NCT02589665|11868644|FG008|STARTED|Maintenance Extension Period||0
10704217|NCT02589665|11868645|FG009|STARTED|Maintenance Extension Period||68
10704218|NCT02589665|11868636|FG000|COMPLETED|Maintenance Extension Period||0
10704219|NCT02589665|11868637|FG001|COMPLETED|Maintenance Extension Period||0
10704220|NCT02589665|11868638|FG002|COMPLETED|Maintenance Extension Period||0
10704221|NCT02589665|11868639|FG003|COMPLETED|Maintenance Extension Period||0
10704222|NCT02589665|11868640|FG004|COMPLETED|Maintenance Extension Period||0
10704223|NCT02589665|11868641|FG005|COMPLETED|Maintenance Extension Period||0
10704224|NCT02589665|11868642|FG006|COMPLETED|Maintenance Extension Period||0
10704225|NCT02589665|11868643|FG007|COMPLETED|Maintenance Extension Period||0
10704226|NCT02589665|11868644|FG008|COMPLETED|Maintenance Extension Period||0
10704227|NCT02589665|11868645|FG009|COMPLETED|Maintenance Extension Period||0
10704228|NCT02589665|11868636|FG000|NOT COMPLETED|Maintenance Extension Period||0
10704229|NCT02589665|11868637|FG001|NOT COMPLETED|Maintenance Extension Period||0
10704230|NCT02589665|11868638|FG002|NOT COMPLETED|Maintenance Extension Period||0
10704231|NCT02589665|11868639|FG003|NOT COMPLETED|Maintenance Extension Period||0
10704232|NCT02589665|11868640|FG004|NOT COMPLETED|Maintenance Extension Period||0
10704233|NCT02589665|11868641|FG005|NOT COMPLETED|Maintenance Extension Period||0
10704234|NCT02589665|11868642|FG006|NOT COMPLETED|Maintenance Extension Period||0
10704235|NCT02589665|11868643|FG007|NOT COMPLETED|Maintenance Extension Period||0
10704236|NCT02589665|11868644|FG008|NOT COMPLETED|Maintenance Extension Period||0
10704237|NCT02589665|11868645|FG009|NOT COMPLETED|Maintenance Extension Period||68
10704238|NCT02589808|11868669|FG000|STARTED|Overall Study||76
10704239|NCT02589808|11868669|FG000|COMPLETED|Overall Study||76
10704240|NCT02589808|11868669|FG000|NOT COMPLETED|Overall Study||0
10704241|NCT02589847|11868675|FG000|STARTED|Overall Study||162
10704242|NCT02589847|11868676|FG001|STARTED|Overall Study||110
10704243|NCT02589847|11868675|FG000|Safety Population|Overall Study||149
10704244|NCT02589847|11868676|FG001|Safety Population|Overall Study||0
10704245|NCT02589847|11868675|FG000|Full Analysis Set (FAS)|Overall Study||149
10704246|NCT02589847|11868676|FG001|Full Analysis Set (FAS)|Overall Study||104
10704247|NCT02589847|11868675|FG000|Evaluable|Overall Study||142
10704248|NCT02589847|11868676|FG001|Evaluable|Overall Study||75
10704249|NCT02589847|11868675|FG000|COMPLETED|Overall Study||107
10704250|NCT02589847|11868676|FG001|COMPLETED|Overall Study||39
10704251|NCT02589847|11868675|FG000|NOT COMPLETED|Overall Study||55
10704252|NCT02589847|11868676|FG001|NOT COMPLETED|Overall Study||71
10704253|NCT02589977|11868686|FG000|STARTED|Overall Study||23
10704254|NCT02589977|11868687|FG001|STARTED|Overall Study||20
10704255|NCT02589977|11868688|FG002|STARTED|Overall Study||12
10704256|NCT02589977|11868686|FG000|COMPLETED|Overall Study||17
10704257|NCT02589977|11868687|FG001|COMPLETED|Overall Study||15
10704258|NCT02589977|11868688|FG002|COMPLETED|Overall Study||8
10704259|NCT02589977|11868686|FG000|NOT COMPLETED|Overall Study||6
10704260|NCT02589977|11868687|FG001|NOT COMPLETED|Overall Study||5
10704261|NCT02589977|11868688|FG002|NOT COMPLETED|Overall Study||4
10704262|NCT02590003|11868698|FG000|STARTED|Overall Study||1
10606110|NCT01875471|11763674|FG000|STARTED|Overall Study||137
10606111|NCT01875471|11763675|FG001|STARTED|Overall Study||138
10606112|NCT01875471|11763674|FG000|Completed Per Protocol|Overall Study||127
10606113|NCT01875471|11763675|FG001|Completed Per Protocol|Overall Study||123
10606114|NCT01875471|11763674|FG000|COMPLETED|Overall Study||136
10606115|NCT01875471|11763675|FG001|COMPLETED|Overall Study||137
10606116|NCT01875471|11763674|FG000|NOT COMPLETED|Overall Study||1
10606117|NCT01875471|11763675|FG001|NOT COMPLETED|Overall Study||1
10606118|NCT01875510|11763683|FG000|STARTED|Overall Study||40
10606119|NCT01875510|11763684|FG001|STARTED|Overall Study||40
10606120|NCT01875510|11763683|FG000|COMPLETED|Overall Study||40
10606121|NCT01875510|11763684|FG001|COMPLETED|Overall Study||40
10606122|NCT01875510|11763683|FG000|NOT COMPLETED|Overall Study||0
10606123|NCT01875510|11763684|FG001|NOT COMPLETED|Overall Study||0
10606124|NCT01875731|11763692|FG000|STARTED|Overall Study||34
10606125|NCT01875731|11763693|FG001|STARTED|Overall Study||32
10606126|NCT01875731|11763692|FG000|COMPLETED|Overall Study||33
10606127|NCT01875731|11763693|FG001|COMPLETED|Overall Study||32
10606128|NCT01875731|11763692|FG000|NOT COMPLETED|Overall Study||1
10606129|NCT01875731|11763693|FG001|NOT COMPLETED|Overall Study||0
10606130|NCT01875783|11763699|FG000|STARTED|Overall Study||385
10606131|NCT01875783|11763699|FG000|COMPLETED|Overall Study||385
10606132|NCT01875783|11763699|FG000|NOT COMPLETED|Overall Study||0
10606133|NCT01875848|11763707|FG000|STARTED|Overall Study|3 patients were enrolled in the Buprenorphine arm of the study|3
10606134|NCT01875848|11763708|FG001|STARTED|Overall Study|4 patients were enrolled in the opioid dose escalation arm of the study|4
10704263|NCT02590003|11868699|FG001|STARTED|Overall Study||2
10704264|NCT02590003|11868698|FG000|COMPLETED|Overall Study||0
10704265|NCT02590003|11868699|FG001|COMPLETED|Overall Study||0
10704266|NCT02590003|11868698|FG000|NOT COMPLETED|Overall Study||1
10704267|NCT02590003|11868699|FG001|NOT COMPLETED|Overall Study||2
10704268|NCT02590354|11868705|FG000|STARTED|Phase 1||114
10704269|NCT02590354|11868705|FG000|COMPLETED|Phase 1||16
10704270|NCT02590354|11868705|FG000|NOT COMPLETED|Phase 1||98
10704271|NCT02590354|11868705|FG000|STARTED|Phase 2 - Treatment Interruption||16
10704272|NCT02590354|11868705|FG000|COMPLETED|Phase 2 - Treatment Interruption||14
10704273|NCT02590354|11868705|FG000|NOT COMPLETED|Phase 2 - Treatment Interruption||2
10704274|NCT02590406|11868712|FG000|STARTED|Overall Study||25
10704275|NCT02590406|11868713|FG001|STARTED|Overall Study||25
10704276|NCT02590406|11868712|FG000|COMPLETED|Overall Study||24
10704277|NCT02590406|11868713|FG001|COMPLETED|Overall Study||24
10704278|NCT02590406|11868712|FG000|NOT COMPLETED|Overall Study||1
10704279|NCT02590406|11868713|FG001|NOT COMPLETED|Overall Study||1
10704280|NCT02590432|11868721|FG000|STARTED|Open-label Treatment Period||508
10704281|NCT02590432|11868722|FG001|STARTED|Open-label Treatment Period||318
10704282|NCT02590432|11868723|FG002|STARTED|Open-label Treatment Period||0
10704283|NCT02590432|11868724|FG003|STARTED|Open-label Treatment Period||0
10704284|NCT02590432|11868725|FG004|STARTED|Open-label Treatment Period||0
10704285|NCT02590432|11868726|FG005|STARTED|Open-label Treatment Period||0
10704286|NCT02590432|11868727|FG006|STARTED|Open-label Treatment Period||0
10704287|NCT02590432|11868728|FG007|STARTED|Open-label Treatment Period||0
10704288|NCT02590432|11868729|FG008|STARTED|Open-label Treatment Period||0
10704289|NCT02590432|11868721|FG000|COMPLETED|Open-label Treatment Period|Participants were not randomized to Double-blind Treatment Period.|276
10704290|NCT02590432|11868722|FG001|COMPLETED|Open-label Treatment Period|Participants were not randomized to Double-blind Treatment Period.|166
10704291|NCT02590432|11868723|FG002|COMPLETED|Open-label Treatment Period||0
10704292|NCT02590432|11868724|FG003|COMPLETED|Open-label Treatment Period||0
10704293|NCT02590432|11868725|FG004|COMPLETED|Open-label Treatment Period||0
10704294|NCT02590432|11868726|FG005|COMPLETED|Open-label Treatment Period||0
10704295|NCT02590432|11868727|FG006|COMPLETED|Open-label Treatment Period||0
10704296|NCT02590432|11868728|FG007|COMPLETED|Open-label Treatment Period||0
10704297|NCT02590432|11868729|FG008|COMPLETED|Open-label Treatment Period||0
10704298|NCT02590432|11868721|FG000|NOT COMPLETED|Open-label Treatment Period||232
10704299|NCT02590432|11868722|FG001|NOT COMPLETED|Open-label Treatment Period||152
10704300|NCT02590432|11868723|FG002|NOT COMPLETED|Open-label Treatment Period||0
10704301|NCT02590432|11868724|FG003|NOT COMPLETED|Open-label Treatment Period||0
10704302|NCT02590432|11868725|FG004|NOT COMPLETED|Open-label Treatment Period||0
10704303|NCT02590432|11868726|FG005|NOT COMPLETED|Open-label Treatment Period||0
10704304|NCT02590432|11868727|FG006|NOT COMPLETED|Open-label Treatment Period||0
10704305|NCT02590432|11868728|FG007|NOT COMPLETED|Open-label Treatment Period||0
10704306|NCT02590432|11868729|FG008|NOT COMPLETED|Open-label Treatment Period||0
10704307|NCT02590432|11868721|FG000|STARTED|Double-blind Treatment Period||0
10704308|NCT02590432|11868722|FG001|STARTED|Double-blind Treatment Period||0
10704309|NCT02590432|11868723|FG002|STARTED|Double-blind Treatment Period||18
10704310|NCT02590432|11868724|FG003|STARTED|Double-blind Treatment Period||18
10704311|NCT02590432|11868725|FG004|STARTED|Double-blind Treatment Period||16
10704312|NCT02590432|11868726|FG005|STARTED|Double-blind Treatment Period||32
10704313|NCT02590432|11868727|FG006|STARTED|Double-blind Treatment Period||30
10704314|NCT02590432|11868728|FG007|STARTED|Double-blind Treatment Period||0
10704315|NCT02590432|11868729|FG008|STARTED|Double-blind Treatment Period||0
10704316|NCT02590432|11868721|FG000|COMPLETED|Double-blind Treatment Period||0
10704317|NCT02590432|11868722|FG001|COMPLETED|Double-blind Treatment Period||0
10704318|NCT02590432|11868723|FG002|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|1
10713914|NCT02683668|11879478|FG000|COMPLETED|Period 1||44
10606135|NCT01875848|11763707|FG000|COMPLETED|Overall Study|1 patient completed the Buprenorphine arm of the study. 2 patients withdrew|1
10652709|NCT02186821|11813035|FG000|STARTED|Overall Study||47
10606136|NCT01875848|11763708|FG001|COMPLETED|Overall Study|4 patients completed the opioid dose escalation arm of the study|4
10606137|NCT01875848|11763707|FG000|NOT COMPLETED|Overall Study||2
10606138|NCT01875848|11763708|FG001|NOT COMPLETED|Overall Study||0
10606139|NCT01875861|11763716|FG000|STARTED|Pre-implementation||4779
10606140|NCT01875861|11763717|FG001|STARTED|Pre-implementation||3714
10606141|NCT01875861|11763716|FG000|COMPLETED|Pre-implementation||4779
10704319|NCT02590432|11868724|FG003|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|3
10704320|NCT02590432|11868725|FG004|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|7
10704321|NCT02590432|11868726|FG005|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|6
10704322|NCT02590432|11868727|FG006|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|9
10704323|NCT02590432|11868728|FG007|COMPLETED|Double-blind Treatment Period||0
10704324|NCT02590432|11868729|FG008|COMPLETED|Double-blind Treatment Period||0
10704325|NCT02590432|11868721|FG000|NOT COMPLETED|Double-blind Treatment Period||0
10704326|NCT02590432|11868722|FG001|NOT COMPLETED|Double-blind Treatment Period||0
10704327|NCT02590432|11868723|FG002|NOT COMPLETED|Double-blind Treatment Period||17
10704328|NCT02590432|11868724|FG003|NOT COMPLETED|Double-blind Treatment Period||15
10704329|NCT02590432|11868725|FG004|NOT COMPLETED|Double-blind Treatment Period||9
10704330|NCT02590432|11868726|FG005|NOT COMPLETED|Double-blind Treatment Period||26
10704331|NCT02590432|11868727|FG006|NOT COMPLETED|Double-blind Treatment Period||21
10704332|NCT02590432|11868728|FG007|NOT COMPLETED|Double-blind Treatment Period||0
10704333|NCT02590432|11868729|FG008|NOT COMPLETED|Double-blind Treatment Period||0
10704334|NCT02590432|11868721|FG000|STARTED|Dose-reduced Open Label Treatment Period||0
10704335|NCT02590432|11868722|FG001|STARTED|Dose-reduced Open Label Treatment Period||0
10704336|NCT02590432|11868723|FG002|STARTED|Dose-reduced Open Label Treatment Period||0
10704337|NCT02590432|11868724|FG003|STARTED|Dose-reduced Open Label Treatment Period||0
10704338|NCT02590432|11868725|FG004|STARTED|Dose-reduced Open Label Treatment Period||0
10704339|NCT02590432|11868726|FG005|STARTED|Dose-reduced Open Label Treatment Period||0
10704340|NCT02590432|11868727|FG006|STARTED|Dose-reduced Open Label Treatment Period||0
10704341|NCT02590432|11868728|FG007|STARTED|Dose-reduced Open Label Treatment Period||31
10704342|NCT02590432|11868729|FG008|STARTED|Dose-reduced Open Label Treatment Period||26
10704343|NCT02590432|11868721|FG000|COMPLETED|Dose-reduced Open Label Treatment Period||0
10704344|NCT02590432|11868722|FG001|COMPLETED|Dose-reduced Open Label Treatment Period||0
10606142|NCT01875861|11763717|FG001|COMPLETED|Pre-implementation||3714
10606143|NCT01875861|11763716|FG000|NOT COMPLETED|Pre-implementation||0
10606144|NCT01875861|11763717|FG001|NOT COMPLETED|Pre-implementation||0
10606145|NCT01875861|11763716|FG000|STARTED|Implementation||4546
10606146|NCT01875861|11763717|FG001|STARTED|Implementation||3444
10606147|NCT01875861|11763716|FG000|COMPLETED|Implementation||4546
10606148|NCT01875861|11763717|FG001|COMPLETED|Implementation||3444
10606149|NCT01875861|11763716|FG000|NOT COMPLETED|Implementation||0
10606150|NCT01875861|11763717|FG001|NOT COMPLETED|Implementation||0
10606151|NCT01875861|11763716|FG000|STARTED|Sustainability||4306
10606152|NCT01875861|11763717|FG001|STARTED|Sustainability||3444
10606153|NCT01875861|11763716|FG000|COMPLETED|Sustainability||4306
10606154|NCT01875861|11763717|FG001|COMPLETED|Sustainability||3444
10606155|NCT01875861|11763716|FG000|NOT COMPLETED|Sustainability||0
10606156|NCT01875861|11763717|FG001|NOT COMPLETED|Sustainability||0
10606157|NCT01875874|11763724|FG000|STARTED|Overall Study||8
10606158|NCT01875874|11763724|FG000|COMPLETED|Overall Study||5
10606159|NCT01875874|11763724|FG000|NOT COMPLETED|Overall Study||3
10606160|NCT01875978|11763731|FG000|STARTED|Study 4weeks||20
10606161|NCT01875978|11763732|FG001|STARTED|Study 4weeks||20
10606162|NCT01875978|11763731|FG000|COMPLETED|Study 4weeks||20
10606163|NCT01875978|11763732|FG001|COMPLETED|Study 4weeks||20
10606164|NCT01875978|11763731|FG000|NOT COMPLETED|Study 4weeks||0
10606165|NCT01875978|11763732|FG001|NOT COMPLETED|Study 4weeks||0
10606166|NCT01875978|11763731|FG000|STARTED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
10606167|NCT01875978|11763732|FG001|STARTED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
10606168|NCT01875978|11763731|FG000|COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
10606169|NCT01875978|11763732|FG001|COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
10606170|NCT01875978|11763731|FG000|NOT COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||0
10606171|NCT01875978|11763732|FG001|NOT COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||0
10606172|NCT01875991|11763742|FG000|STARTED|Overall Study||108
10606173|NCT01875991|11763743|FG001|STARTED|Overall Study||109
10606174|NCT01875991|11763742|FG000|Received Etanercept in Period 1|Overall Study||108
10606175|NCT01875991|11763743|FG001|Received Etanercept in Period 1|Overall Study||108
10606176|NCT01875991|11763742|FG000|Received Etanercept in Period 2|Overall Study||102
10606177|NCT01875991|11763743|FG001|Received Etanercept in Period 2|Overall Study||103
10606178|NCT01875991|11763742|FG000|COMPLETED|Overall Study||101
10606179|NCT01875991|11763743|FG001|COMPLETED|Overall Study||103
10606180|NCT01875991|11763742|FG000|NOT COMPLETED|Overall Study||7
10606181|NCT01875991|11763743|FG001|NOT COMPLETED|Overall Study||6
10606182|NCT01876043|11763752|FG000|STARTED|Overall Study||24
10606183|NCT01876043|11763752|FG000|Interim Analysis Population|Overall Study||17
10606184|NCT01876043|11763752|FG000|COMPLETED|Overall Study||22
10606185|NCT01876043|11763752|FG000|NOT COMPLETED|Overall Study||2
10606186|NCT01876082|11763758|FG000|STARTED|Overall Study||48
10606187|NCT01876082|11763759|FG001|STARTED|Overall Study||24
10606188|NCT01876082|11763758|FG000|Safety Population|Overall Study||48
10606189|NCT01876082|11763759|FG001|Safety Population|Overall Study|2 patients did not start control treatment|22
10606190|NCT01876082|11763758|FG000|COMPLETED|Overall Study||46
10606191|NCT01876082|11763759|FG001|COMPLETED|Overall Study||20
10606192|NCT01876082|11763758|FG000|NOT COMPLETED|Overall Study||2
10606193|NCT01876082|11763759|FG001|NOT COMPLETED|Overall Study||4
10606194|NCT01876212|11763767|FG000|STARTED|Overall Study||9
10606195|NCT01876212|11763768|FG001|STARTED|Overall Study||6
10606196|NCT01876212|11763767|FG000|COMPLETED|Overall Study||9
10606197|NCT01876212|11763768|FG001|COMPLETED|Overall Study||6
10606198|NCT01876212|11763767|FG000|NOT COMPLETED|Overall Study||0
10606199|NCT01876212|11763768|FG001|NOT COMPLETED|Overall Study||0
10606200|NCT01876251|11763777|FG000|STARTED|Overall Study||15
10606201|NCT01876251|11763778|FG001|STARTED|Overall Study||3
10606202|NCT01876251|11763779|FG002|STARTED|Overall Study||11
10606203|NCT01876251|11763777|FG000|COMPLETED|Overall Study||0
10606204|NCT01876251|11763778|FG001|COMPLETED|Overall Study||0
10606205|NCT01876251|11763779|FG002|COMPLETED|Overall Study||0
10606206|NCT01876251|11763777|FG000|NOT COMPLETED|Overall Study||15
10606207|NCT01876251|11763778|FG001|NOT COMPLETED|Overall Study||3
10606208|NCT01876251|11763779|FG002|NOT COMPLETED|Overall Study||11
10606209|NCT01876329|11763791|FG000|STARTED|Overall Study||45
10606210|NCT01876329|11763792|FG001|STARTED|Overall Study||36
10606211|NCT01876329|11763793|FG002|STARTED|Overall Study||44
10606212|NCT01876329|11763791|FG000|COMPLETED|Overall Study||45
10606213|NCT01876329|11763792|FG001|COMPLETED|Overall Study||36
10606214|NCT01876329|11763793|FG002|COMPLETED|Overall Study||44
10606215|NCT01876329|11763791|FG000|NOT COMPLETED|Overall Study||0
10606216|NCT01876329|11763792|FG001|NOT COMPLETED|Overall Study||0
10606217|NCT01876329|11763793|FG002|NOT COMPLETED|Overall Study||0
10606218|NCT01876368|11763803|FG000|STARTED|Overall Study||188
10606219|NCT01876368|11763804|FG001|STARTED|Overall Study||188
10606220|NCT01876368|11763803|FG000|Full Analysis Set (FAS)|Overall Study||188
10606221|NCT01876368|11763804|FG001|Full Analysis Set (FAS)|Overall Study|One patient was not included in the SAF and FAS due to mis-randomization.|187
10606222|NCT01876368|11763803|FG000|Safety Set (SAF)|Overall Study||188
10606223|NCT01876368|11763804|FG001|Safety Set (SAF)|Overall Study||187
10606224|NCT01876368|11763803|FG000|COMPLETED|Overall Study||179
10606225|NCT01876368|11763804|FG001|COMPLETED|Overall Study||175
10606226|NCT01876368|11763803|FG000|NOT COMPLETED|Overall Study||9
10606227|NCT01876368|11763804|FG001|NOT COMPLETED|Overall Study||13
10606228|NCT01876381|11763810|FG000|STARTED|Overall Study||23
10606229|NCT01876381|11763810|FG000|COMPLETED|Overall Study||16
10606230|NCT01876381|11763810|FG000|NOT COMPLETED|Overall Study||7
10606231|NCT01876420|11763814|FG000|STARTED|Overall Study||60
10606232|NCT01876420|11763814|FG000|COMPLETED|Overall Study||59
10606233|NCT01876420|11763814|FG000|NOT COMPLETED|Overall Study||1
10606234|NCT01876446|11763820|FG000|STARTED|Overall Study||20
10606235|NCT01876446|11763821|FG001|STARTED|Overall Study||18
10606236|NCT01876446|11763820|FG000|COMPLETED|Overall Study||18
10606237|NCT01876446|11763821|FG001|COMPLETED|Overall Study||12
10606238|NCT01876446|11763820|FG000|NOT COMPLETED|Overall Study||2
10606239|NCT01876446|11763821|FG001|NOT COMPLETED|Overall Study||6
10606240|NCT01876485|11763829|FG000|STARTED|Overall Study||140
10606241|NCT01876485|11763830|FG001|STARTED|Overall Study||140
10606242|NCT01876485|11763829|FG000|Post-Intervention|Overall Study||125
10606243|NCT01876485|11763830|FG001|Post-Intervention|Overall Study||129
10606244|NCT01876485|11763829|FG000|Maintenance|Overall Study||116
10606245|NCT01876485|11763830|FG001|Maintenance|Overall Study||114
10606246|NCT01876485|11763829|FG000|COMPLETED|Overall Study||116
10606247|NCT01876485|11763830|FG001|COMPLETED|Overall Study||114
10606248|NCT01876485|11763829|FG000|NOT COMPLETED|Overall Study||24
10606249|NCT01876485|11763830|FG001|NOT COMPLETED|Overall Study||26
10606250|NCT01876511|11763839|FG000|STARTED|Overall Study||41
10606251|NCT01876511|11763840|FG001|STARTED|Overall Study||25
10606252|NCT01876511|11763841|FG002|STARTED|Overall Study||47
10606253|NCT01876511|11763839|FG000|Stages 1 and 2|Overall Study||24
10606254|NCT01876511|11763840|FG001|Stages 1 and 2|Overall Study||25
10606255|NCT01876511|11763841|FG002|Stages 1 and 2|Overall Study||21
10606256|NCT01876511|11763839|FG000|COMPLETED|Overall Study||18
10606257|NCT01876511|11763840|FG001|COMPLETED|Overall Study||0
10606258|NCT01876511|11763841|FG002|COMPLETED|Overall Study||16
10606259|NCT01876511|11763839|FG000|NOT COMPLETED|Overall Study||23
10606260|NCT01876511|11763840|FG001|NOT COMPLETED|Overall Study||25
10606261|NCT01876511|11763841|FG002|NOT COMPLETED|Overall Study||31
10606262|NCT01876706|11763851|FG000|STARTED|Overall Study||51
10606263|NCT01876706|11763851|FG000|1 Month|Overall Study||51
10704345|NCT02590432|11868723|FG002|COMPLETED|Dose-reduced Open Label Treatment Period||0
10704346|NCT02590432|11868724|FG003|COMPLETED|Dose-reduced Open Label Treatment Period||0
10704347|NCT02590432|11868725|FG004|COMPLETED|Dose-reduced Open Label Treatment Period||0
10606264|NCT01876706|11763851|FG000|3 Months|Overall Study||51
10606265|NCT01876706|11763851|FG000|6 Months|Overall Study||46
10606266|NCT01876706|11763851|FG000|12 Months|Overall Study||42
10606267|NCT01876706|11763851|FG000|24 Months|Overall Study||35
10606268|NCT01876706|11763851|FG000|36 Months|Overall Study||32
10606269|NCT01876706|11763851|FG000|48 Months|Overall Study||31
10606270|NCT01876706|11763851|FG000|60 Months|Overall Study||26
10606271|NCT01876706|11763851|FG000|COMPLETED|Overall Study||26
10606272|NCT01876706|11763851|FG000|NOT COMPLETED|Overall Study||25
10606273|NCT01876732|11763855|FG000|STARTED|Overall Study||132
10606274|NCT01876732|11763855|FG000|COMPLETED|Overall Study||57
10606275|NCT01876732|11763855|FG000|NOT COMPLETED|Overall Study||75
10606276|NCT01876784|11763862|FG000|STARTED|Overall Study||119
10606277|NCT01876784|11763863|FG001|STARTED|Overall Study||119
10606278|NCT01876784|11763862|FG000|Treated|Overall Study||117
10606279|NCT01876784|11763863|FG001|Treated|Overall Study||118
10606280|NCT01876784|11763862|FG000|COMPLETED|Overall Study||0
10606281|NCT01876784|11763863|FG001|COMPLETED|Overall Study||0
10606282|NCT01876784|11763862|FG000|NOT COMPLETED|Overall Study||119
10606283|NCT01876784|11763863|FG001|NOT COMPLETED|Overall Study||119
10606284|NCT01876810|11763869|FG000|STARTED|Overall Study||14
10606285|NCT01876810|11763870|FG001|STARTED|Overall Study||14
10606286|NCT01876810|11763869|FG000|COMPLETED|Overall Study||14
10606287|NCT01876810|11763870|FG001|COMPLETED|Overall Study||13
10606288|NCT01876810|11763869|FG000|NOT COMPLETED|Overall Study||0
10606289|NCT01876810|11763870|FG001|NOT COMPLETED|Overall Study||1
10606290|NCT01876823|11763879|FG000|STARTED|Overall Study||35
10606291|NCT01876823|11763879|FG000|COMPLETED|Overall Study||26
10606292|NCT01876823|11763879|FG000|NOT COMPLETED|Overall Study||9
10606293|NCT01876901|11763885|FG000|STARTED|Overall Study||65
10606294|NCT01876901|11763886|FG001|STARTED|Overall Study||59
10606295|NCT01876901|11763885|FG000|COMPLETED|Overall Study||48
10606296|NCT01876901|11763886|FG001|COMPLETED|Overall Study||52
10606297|NCT01876901|11763885|FG000|NOT COMPLETED|Overall Study||17
10606298|NCT01876901|11763886|FG001|NOT COMPLETED|Overall Study||7
10606299|NCT01876979|11763895|FG000|STARTED|Overall Study||2
10606300|NCT01876979|11763896|FG001|STARTED|Overall Study||3
10606301|NCT01876979|11763895|FG000|COMPLETED|Overall Study||0
10606302|NCT01876979|11763896|FG001|COMPLETED|Overall Study||0
10606303|NCT01876979|11763895|FG000|NOT COMPLETED|Overall Study||2
10606304|NCT01876979|11763896|FG001|NOT COMPLETED|Overall Study||3
10606305|NCT01876992|11763904|FG000|STARTED|Overall Study||5
10606306|NCT01876992|11763905|FG001|STARTED|Overall Study||5
10606307|NCT01876992|11763904|FG000|COMPLETED|Overall Study||5
10606308|NCT01876992|11763905|FG001|COMPLETED|Overall Study||5
10606309|NCT01876992|11763904|FG000|NOT COMPLETED|Overall Study||0
10606310|NCT01876992|11763905|FG001|NOT COMPLETED|Overall Study||0
10606311|NCT01877083|11763912|FG000|STARTED|Treatment Phase||25
10606312|NCT01877083|11763912|FG000|COMPLETED|Treatment Phase||5
10606313|NCT01877083|11763912|FG000|NOT COMPLETED|Treatment Phase||20
10606314|NCT01877083|11763912|FG000|STARTED|Extension Phase||5
10606315|NCT01877083|11763912|FG000|COMPLETED|Extension Phase||0
10704348|NCT02590432|11868726|FG005|COMPLETED|Dose-reduced Open Label Treatment Period||0
10606316|NCT01877083|11763912|FG000|NOT COMPLETED|Extension Phase||5
10606317|NCT01877148|11763918|FG000|STARTED|Overall Study||6
10606318|NCT01877148|11763919|FG001|STARTED|Overall Study||6
10606319|NCT01877148|11763918|FG000|COMPLETED|Overall Study||5
10704349|NCT02590432|11868727|FG006|COMPLETED|Dose-reduced Open Label Treatment Period||0
10606320|NCT01877148|11763919|FG001|COMPLETED|Overall Study||5
10606321|NCT01877148|11763918|FG000|NOT COMPLETED|Overall Study||1
10606322|NCT01877148|11763919|FG001|NOT COMPLETED|Overall Study||1
10606323|NCT01877161|11763925|FG000|STARTED|First Session of Stimulation||12
10606324|NCT01877161|11763925|FG000|COMPLETED|First Session of Stimulation||12
10606325|NCT01877161|11763925|FG000|NOT COMPLETED|First Session of Stimulation||0
10606326|NCT01877161|11763925|FG000|STARTED|Washout (at Least 3 Days)||12
10606327|NCT01877161|11763925|FG000|COMPLETED|Washout (at Least 3 Days)||12
10606328|NCT01877161|11763925|FG000|NOT COMPLETED|Washout (at Least 3 Days)||0
10606329|NCT01877161|11763925|FG000|STARTED|Second Session of Stimulation||12
10606330|NCT01877161|11763925|FG000|COMPLETED|Second Session of Stimulation||12
10606331|NCT01877161|11763925|FG000|NOT COMPLETED|Second Session of Stimulation||0
10606332|NCT01877161|11763925|FG000|STARTED|Washout (at Least 3 Days)||12
10606333|NCT01877161|11763925|FG000|COMPLETED|Washout (at Least 3 Days)||12
10606334|NCT01877161|11763925|FG000|NOT COMPLETED|Washout (at Least 3 Days)||0
10606335|NCT01877161|11763925|FG000|STARTED|Third Session of Stimulation||12
10606336|NCT01877161|11763925|FG000|COMPLETED|Third Session of Stimulation||12
10606337|NCT01877161|11763925|FG000|NOT COMPLETED|Third Session of Stimulation||0
10606338|NCT01877187|11763933|FG000|STARTED|Overall Study|21 HCC, 18 non-HCC|39
10606339|NCT01877187|11763933|FG000|Completed 30 Day f/u|Overall Study|18 HCC, 17 non-HCC|35
10606340|NCT01877187|11763933|FG000|Completed 90 Day f/u|Overall Study|11 HCC, 9 non-HCC|20
10606341|NCT01877187|11763933|FG000|COMPLETED|Overall Study|10 HCC, 7 non-HCC|17
10606342|NCT01877187|11763933|FG000|NOT COMPLETED|Overall Study||22
10606343|NCT01877239|11763940|FG000|STARTED|Overall Study||111
10606344|NCT01877239|11763940|FG000|Treated|Overall Study||76
10606345|NCT01877239|11763940|FG000|COMPLETED|Overall Study||61
10606346|NCT01877239|11763940|FG000|NOT COMPLETED|Overall Study||50
10606347|NCT01877265|11763944|FG000|STARTED|Treatment Period 1||3
10606348|NCT01877265|11763945|FG001|STARTED|Treatment Period 1||3
10606349|NCT01877265|11763946|FG002|STARTED|Treatment Period 1||3
10606350|NCT01877265|11763947|FG003|STARTED|Treatment Period 1||3
10606351|NCT01877265|11763948|FG004|STARTED|Treatment Period 1||3
10606352|NCT01877265|11763949|FG005|STARTED|Treatment Period 1||3
10606353|NCT01877265|11763944|FG000|Received at Least One Dose of Study Drug|Treatment Period 1||3
10606354|NCT01877265|11763945|FG001|Received at Least One Dose of Study Drug|Treatment Period 1||3
10606355|NCT01877265|11763946|FG002|Received at Least One Dose of Study Drug|Treatment Period 1||3
10606356|NCT01877265|11763947|FG003|Received at Least One Dose of Study Drug|Treatment Period 1||3
10606357|NCT01877265|11763948|FG004|Received at Least One Dose of Study Drug|Treatment Period 1||3
10606358|NCT01877265|11763949|FG005|Received at Least One Dose of Study Drug|Treatment Period 1||3
10606359|NCT01877265|11763944|FG000|COMPLETED|Treatment Period 1||3
10606360|NCT01877265|11763945|FG001|COMPLETED|Treatment Period 1||3
10606361|NCT01877265|11763946|FG002|COMPLETED|Treatment Period 1||2
10606362|NCT01877265|11763947|FG003|COMPLETED|Treatment Period 1||3
10606363|NCT01877265|11763948|FG004|COMPLETED|Treatment Period 1||3
10606364|NCT01877265|11763949|FG005|COMPLETED|Treatment Period 1||3
10606365|NCT01877265|11763944|FG000|NOT COMPLETED|Treatment Period 1||0
10606366|NCT01877265|11763945|FG001|NOT COMPLETED|Treatment Period 1||0
10606367|NCT01877265|11763946|FG002|NOT COMPLETED|Treatment Period 1||1
10606368|NCT01877265|11763947|FG003|NOT COMPLETED|Treatment Period 1||0
10606369|NCT01877265|11763948|FG004|NOT COMPLETED|Treatment Period 1||0
10606370|NCT01877265|11763949|FG005|NOT COMPLETED|Treatment Period 1||0
10606371|NCT01877265|11763944|FG000|STARTED|Washout Period 1 (at Least 14 Days)||3
10606372|NCT01877265|11763945|FG001|STARTED|Washout Period 1 (at Least 14 Days)||3
10606373|NCT01877265|11763946|FG002|STARTED|Washout Period 1 (at Least 14 Days)||2
10606374|NCT01877265|11763947|FG003|STARTED|Washout Period 1 (at Least 14 Days)||3
10606375|NCT01877265|11763948|FG004|STARTED|Washout Period 1 (at Least 14 Days)||3
10606376|NCT01877265|11763949|FG005|STARTED|Washout Period 1 (at Least 14 Days)||3
10606377|NCT01877265|11763944|FG000|COMPLETED|Washout Period 1 (at Least 14 Days)||3
10606378|NCT01877265|11763945|FG001|COMPLETED|Washout Period 1 (at Least 14 Days)||3
10606379|NCT01877265|11763946|FG002|COMPLETED|Washout Period 1 (at Least 14 Days)||2
10606380|NCT01877265|11763947|FG003|COMPLETED|Washout Period 1 (at Least 14 Days)||3
10606381|NCT01877265|11763948|FG004|COMPLETED|Washout Period 1 (at Least 14 Days)||3
10606382|NCT01877265|11763949|FG005|COMPLETED|Washout Period 1 (at Least 14 Days)||3
10606383|NCT01877265|11763944|FG000|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
10606384|NCT01877265|11763945|FG001|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
10606385|NCT01877265|11763946|FG002|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
10606386|NCT01877265|11763947|FG003|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
10606387|NCT01877265|11763948|FG004|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
10606388|NCT01877265|11763949|FG005|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
10606389|NCT01877265|11763944|FG000|STARTED|Treatment Period 2||3
10606390|NCT01877265|11763945|FG001|STARTED|Treatment Period 2||3
10606391|NCT01877265|11763946|FG002|STARTED|Treatment Period 2||2
10606392|NCT01877265|11763947|FG003|STARTED|Treatment Period 2||3
10606393|NCT01877265|11763948|FG004|STARTED|Treatment Period 2||3
10606394|NCT01877265|11763949|FG005|STARTED|Treatment Period 2||3
10606395|NCT01877265|11763944|FG000|Received at Least One Dose of Study Drug|Treatment Period 2||3
10606396|NCT01877265|11763945|FG001|Received at Least One Dose of Study Drug|Treatment Period 2||3
10606397|NCT01877265|11763946|FG002|Received at Least One Dose of Study Drug|Treatment Period 2||2
10606398|NCT01877265|11763947|FG003|Received at Least One Dose of Study Drug|Treatment Period 2||3
10606399|NCT01877265|11763948|FG004|Received at Least One Dose of Study Drug|Treatment Period 2||3
10606400|NCT01877265|11763949|FG005|Received at Least One Dose of Study Drug|Treatment Period 2||3
10606401|NCT01877265|11763944|FG000|COMPLETED|Treatment Period 2||3
10606402|NCT01877265|11763945|FG001|COMPLETED|Treatment Period 2||3
10606403|NCT01877265|11763946|FG002|COMPLETED|Treatment Period 2||2
10606404|NCT01877265|11763947|FG003|COMPLETED|Treatment Period 2||3
10606405|NCT01877265|11763948|FG004|COMPLETED|Treatment Period 2||3
10606406|NCT01877265|11763949|FG005|COMPLETED|Treatment Period 2||3
10606407|NCT01877265|11763944|FG000|NOT COMPLETED|Treatment Period 2||0
10606408|NCT01877265|11763945|FG001|NOT COMPLETED|Treatment Period 2||0
10606409|NCT01877265|11763946|FG002|NOT COMPLETED|Treatment Period 2||0
10606410|NCT01877265|11763947|FG003|NOT COMPLETED|Treatment Period 2||0
10606411|NCT01877265|11763948|FG004|NOT COMPLETED|Treatment Period 2||0
10606412|NCT01877265|11763949|FG005|NOT COMPLETED|Treatment Period 2||0
10606413|NCT01877265|11763944|FG000|STARTED|Washout Period 2 (at Least 14 Days)||3
10606414|NCT01877265|11763945|FG001|STARTED|Washout Period 2 (at Least 14 Days)||3
10606415|NCT01877265|11763946|FG002|STARTED|Washout Period 2 (at Least 14 Days)||2
10606416|NCT01877265|11763947|FG003|STARTED|Washout Period 2 (at Least 14 Days)||3
10606417|NCT01877265|11763948|FG004|STARTED|Washout Period 2 (at Least 14 Days)||3
10606418|NCT01877265|11763949|FG005|STARTED|Washout Period 2 (at Least 14 Days)||3
10606419|NCT01877265|11763944|FG000|COMPLETED|Washout Period 2 (at Least 14 Days)||3
10606420|NCT01877265|11763945|FG001|COMPLETED|Washout Period 2 (at Least 14 Days)||3
10606421|NCT01877265|11763946|FG002|COMPLETED|Washout Period 2 (at Least 14 Days)||2
10606422|NCT01877265|11763947|FG003|COMPLETED|Washout Period 2 (at Least 14 Days)||3
10606423|NCT01877265|11763948|FG004|COMPLETED|Washout Period 2 (at Least 14 Days)||3
10606424|NCT01877265|11763949|FG005|COMPLETED|Washout Period 2 (at Least 14 Days)||2
10606425|NCT01877265|11763944|FG000|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
10606426|NCT01877265|11763945|FG001|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
10606427|NCT01877265|11763946|FG002|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
10606428|NCT01877265|11763947|FG003|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
10606429|NCT01877265|11763948|FG004|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
10606430|NCT01877265|11763949|FG005|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||1
10606431|NCT01877265|11763944|FG000|STARTED|Treatment Period 3||3
10606432|NCT01877265|11763945|FG001|STARTED|Treatment Period 3||3
10606433|NCT01877265|11763946|FG002|STARTED|Treatment Period 3||2
10606434|NCT01877265|11763947|FG003|STARTED|Treatment Period 3||3
10606435|NCT01877265|11763948|FG004|STARTED|Treatment Period 3||3
10606436|NCT01877265|11763949|FG005|STARTED|Treatment Period 3||2
10606437|NCT01877265|11763944|FG000|Received at Least One Dose of Study Drug|Treatment Period 3||3
10606438|NCT01877265|11763945|FG001|Received at Least One Dose of Study Drug|Treatment Period 3||3
10606439|NCT01877265|11763946|FG002|Received at Least One Dose of Study Drug|Treatment Period 3||2
10606440|NCT01877265|11763947|FG003|Received at Least One Dose of Study Drug|Treatment Period 3||3
10606441|NCT01877265|11763948|FG004|Received at Least One Dose of Study Drug|Treatment Period 3||3
10606442|NCT01877265|11763949|FG005|Received at Least One Dose of Study Drug|Treatment Period 3||2
10606443|NCT01877265|11763944|FG000|COMPLETED|Treatment Period 3||2
10606444|NCT01877265|11763945|FG001|COMPLETED|Treatment Period 3||3
10606445|NCT01877265|11763946|FG002|COMPLETED|Treatment Period 3||2
10606446|NCT01877265|11763947|FG003|COMPLETED|Treatment Period 3||3
10606447|NCT01877265|11763948|FG004|COMPLETED|Treatment Period 3||3
10606448|NCT01877265|11763949|FG005|COMPLETED|Treatment Period 3||2
10606449|NCT01877265|11763944|FG000|NOT COMPLETED|Treatment Period 3||1
10606450|NCT01877265|11763945|FG001|NOT COMPLETED|Treatment Period 3||0
10606451|NCT01877265|11763946|FG002|NOT COMPLETED|Treatment Period 3||0
10606452|NCT01877265|11763947|FG003|NOT COMPLETED|Treatment Period 3||0
10606453|NCT01877265|11763948|FG004|NOT COMPLETED|Treatment Period 3||0
10606454|NCT01877265|11763949|FG005|NOT COMPLETED|Treatment Period 3||0
10606455|NCT01877278|11763962|FG000|STARTED|Overall Study||33
10606456|NCT01877278|11763963|FG001|STARTED|Overall Study||33
10606457|NCT01877278|11763962|FG000|COMPLETED|Overall Study||30
10606458|NCT01877278|11763963|FG001|COMPLETED|Overall Study||30
10606459|NCT01877278|11763962|FG000|NOT COMPLETED|Overall Study||3
10606460|NCT01877278|11763963|FG001|NOT COMPLETED|Overall Study||3
10606461|NCT01877408|11763971|FG000|STARTED|Overall Study||50
10606462|NCT01877408|11763972|FG001|STARTED|Overall Study||100
10606463|NCT01877408|11763971|FG000|COMPLETED|Overall Study|Completed follow up visit 28 days after procedure|50
10606464|NCT01877408|11763972|FG001|COMPLETED|Overall Study|Completed follow up visit 28 days after procedure|98
10606465|NCT01877408|11763971|FG000|NOT COMPLETED|Overall Study||0
10606466|NCT01877408|11763972|FG001|NOT COMPLETED|Overall Study||2
10606467|NCT01877421|11764011|FG000|STARTED|Phase 1||2
10606468|NCT01877421|11764012|FG001|STARTED|Phase 1||1
10606469|NCT01877421|11764013|FG002|STARTED|Phase 1||4
10606470|NCT01877421|11764014|FG003|STARTED|Phase 1||2
10606471|NCT01877421|11764015|FG004|STARTED|Phase 1||4
10606472|NCT01877421|11764016|FG005|STARTED|Phase 1||2
10606473|NCT01877421|11764017|FG006|STARTED|Phase 1||4
10606474|NCT01877421|11764018|FG007|STARTED|Phase 1||2
10606475|NCT01877421|11764019|FG008|STARTED|Phase 1||7
10606476|NCT01877421|11764020|FG009|STARTED|Phase 1||3
10606477|NCT01877421|11764021|FG010|STARTED|Phase 1||7
10606478|NCT01877421|11764022|FG011|STARTED|Phase 1||3
10606479|NCT01877421|11764023|FG012|STARTED|Phase 1||7
10606480|NCT01877421|11764024|FG013|STARTED|Phase 1||3
10606481|NCT01877421|11764025|FG014|STARTED|Phase 1||7
10606482|NCT01877421|11764026|FG015|STARTED|Phase 1||3
10606483|NCT01877421|11764027|FG016|STARTED|Phase 1||7
10606484|NCT01877421|11764028|FG017|STARTED|Phase 1||3
10606485|NCT01877421|11764011|FG000|COMPLETED|Phase 1||2
10606486|NCT01877421|11764012|FG001|COMPLETED|Phase 1||1
10606487|NCT01877421|11764013|FG002|COMPLETED|Phase 1||4
10606488|NCT01877421|11764014|FG003|COMPLETED|Phase 1||2
10606489|NCT01877421|11764015|FG004|COMPLETED|Phase 1||4
10606490|NCT01877421|11764016|FG005|COMPLETED|Phase 1||2
10606491|NCT01877421|11764017|FG006|COMPLETED|Phase 1||4
10606492|NCT01877421|11764018|FG007|COMPLETED|Phase 1||2
10606493|NCT01877421|11764019|FG008|COMPLETED|Phase 1||7
10606494|NCT01877421|11764020|FG009|COMPLETED|Phase 1||3
10606495|NCT01877421|11764021|FG010|COMPLETED|Phase 1||7
10606496|NCT01877421|11764022|FG011|COMPLETED|Phase 1||3
10606497|NCT01877421|11764023|FG012|COMPLETED|Phase 1||7
10606498|NCT01877421|11764024|FG013|COMPLETED|Phase 1||3
10606499|NCT01877421|11764025|FG014|COMPLETED|Phase 1||7
10606500|NCT01877421|11764026|FG015|COMPLETED|Phase 1||3
10606501|NCT01877421|11764027|FG016|COMPLETED|Phase 1||7
10606502|NCT01877421|11764028|FG017|COMPLETED|Phase 1||3
10606503|NCT01877421|11764011|FG000|NOT COMPLETED|Phase 1||0
10606504|NCT01877421|11764012|FG001|NOT COMPLETED|Phase 1||0
10606505|NCT01877421|11764013|FG002|NOT COMPLETED|Phase 1||0
10606506|NCT01877421|11764014|FG003|NOT COMPLETED|Phase 1||0
10606507|NCT01877421|11764015|FG004|NOT COMPLETED|Phase 1||0
10606508|NCT01877421|11764016|FG005|NOT COMPLETED|Phase 1||0
10606509|NCT01877421|11764017|FG006|NOT COMPLETED|Phase 1||0
10606510|NCT01877421|11764018|FG007|NOT COMPLETED|Phase 1||0
10606511|NCT01877421|11764019|FG008|NOT COMPLETED|Phase 1||0
10606512|NCT01877421|11764020|FG009|NOT COMPLETED|Phase 1||0
10606513|NCT01877421|11764021|FG010|NOT COMPLETED|Phase 1||0
10606514|NCT01877421|11764022|FG011|NOT COMPLETED|Phase 1||0
10606515|NCT01877421|11764023|FG012|NOT COMPLETED|Phase 1||0
10606516|NCT01877421|11764024|FG013|NOT COMPLETED|Phase 1||0
10606517|NCT01877421|11764025|FG014|NOT COMPLETED|Phase 1||0
10606518|NCT01877421|11764026|FG015|NOT COMPLETED|Phase 1||0
10606519|NCT01877421|11764027|FG016|NOT COMPLETED|Phase 1||0
10606520|NCT01877421|11764028|FG017|NOT COMPLETED|Phase 1||0
10606521|NCT01877421|11764011|FG000|STARTED|Phase 2||0
10606522|NCT01877421|11764012|FG001|STARTED|Phase 2||0
10606523|NCT01877421|11764013|FG002|STARTED|Phase 2||4
10606524|NCT01877421|11764014|FG003|STARTED|Phase 2||2
10606525|NCT01877421|11764015|FG004|STARTED|Phase 2||7
10606526|NCT01877421|11764016|FG005|STARTED|Phase 2||3
10606527|NCT01877421|11764017|FG006|STARTED|Phase 2||7
10606528|NCT01877421|11764018|FG007|STARTED|Phase 2||2
10606529|NCT01877421|11764019|FG008|STARTED|Phase 2||6
10606530|NCT01877421|11764020|FG009|STARTED|Phase 2||3
10606531|NCT01877421|11764021|FG010|STARTED|Phase 2||7
10606532|NCT01877421|11764022|FG011|STARTED|Phase 2||3
10606533|NCT01877421|11764023|FG012|STARTED|Phase 2||7
10606534|NCT01877421|11764024|FG013|STARTED|Phase 2||3
10606535|NCT01877421|11764025|FG014|STARTED|Phase 2||7
10606536|NCT01877421|11764026|FG015|STARTED|Phase 2||3
10606537|NCT01877421|11764027|FG016|STARTED|Phase 2||0
10606538|NCT01877421|11764028|FG017|STARTED|Phase 2||0
10606539|NCT01877421|11764011|FG000|COMPLETED|Phase 2||0
10606540|NCT01877421|11764012|FG001|COMPLETED|Phase 2||0
10606541|NCT01877421|11764013|FG002|COMPLETED|Phase 2||4
10606542|NCT01877421|11764014|FG003|COMPLETED|Phase 2||2
10606543|NCT01877421|11764015|FG004|COMPLETED|Phase 2||7
10606544|NCT01877421|11764016|FG005|COMPLETED|Phase 2||3
10606545|NCT01877421|11764017|FG006|COMPLETED|Phase 2||6
10606546|NCT01877421|11764018|FG007|COMPLETED|Phase 2||2
10606547|NCT01877421|11764019|FG008|COMPLETED|Phase 2||5
10606548|NCT01877421|11764020|FG009|COMPLETED|Phase 2||3
10606549|NCT01877421|11764021|FG010|COMPLETED|Phase 2||5
10606550|NCT01877421|11764022|FG011|COMPLETED|Phase 2||3
10606551|NCT01877421|11764023|FG012|COMPLETED|Phase 2||6
10606552|NCT01877421|11764024|FG013|COMPLETED|Phase 2||3
10606553|NCT01877421|11764025|FG014|COMPLETED|Phase 2||7
10606554|NCT01877421|11764026|FG015|COMPLETED|Phase 2||2
10606555|NCT01877421|11764027|FG016|COMPLETED|Phase 2||0
10606556|NCT01877421|11764028|FG017|COMPLETED|Phase 2||0
10606557|NCT01877421|11764011|FG000|NOT COMPLETED|Phase 2||0
10606558|NCT01877421|11764012|FG001|NOT COMPLETED|Phase 2||0
10606559|NCT01877421|11764013|FG002|NOT COMPLETED|Phase 2||0
10606560|NCT01877421|11764014|FG003|NOT COMPLETED|Phase 2||0
10606561|NCT01877421|11764015|FG004|NOT COMPLETED|Phase 2||0
10606562|NCT01877421|11764016|FG005|NOT COMPLETED|Phase 2||0
10606563|NCT01877421|11764017|FG006|NOT COMPLETED|Phase 2||1
10606564|NCT01877421|11764018|FG007|NOT COMPLETED|Phase 2||0
10606565|NCT01877421|11764019|FG008|NOT COMPLETED|Phase 2||1
10606566|NCT01877421|11764020|FG009|NOT COMPLETED|Phase 2||0
10606567|NCT01877421|11764021|FG010|NOT COMPLETED|Phase 2||2
10606568|NCT01877421|11764022|FG011|NOT COMPLETED|Phase 2||0
10606569|NCT01877421|11764023|FG012|NOT COMPLETED|Phase 2||1
10606570|NCT01877421|11764024|FG013|NOT COMPLETED|Phase 2||0
10606571|NCT01877421|11764025|FG014|NOT COMPLETED|Phase 2||0
10606572|NCT01877421|11764026|FG015|NOT COMPLETED|Phase 2||1
10606573|NCT01877421|11764027|FG016|NOT COMPLETED|Phase 2||0
10606574|NCT01877421|11764028|FG017|NOT COMPLETED|Phase 2||0
10606575|NCT01877538|11764108|FG000|STARTED|Overall Study||7
10606576|NCT01877538|11764108|FG000|COMPLETED|Overall Study||7
10606577|NCT01877538|11764108|FG000|NOT COMPLETED|Overall Study||0
10606578|NCT01877551|11764114|FG000|STARTED|Overall Study||13
10606579|NCT01877551|11764115|FG001|STARTED|Overall Study||14
10606580|NCT01877551|11764114|FG000|COMPLETED|Overall Study||13
10606581|NCT01877551|11764115|FG001|COMPLETED|Overall Study||13
10606582|NCT01877551|11764114|FG000|NOT COMPLETED|Overall Study||0
10606583|NCT01877551|11764115|FG001|NOT COMPLETED|Overall Study||1
10606584|NCT01877642|11764123|FG000|STARTED|Overall Study||4
10606585|NCT01877642|11764124|FG001|STARTED|Overall Study||3
10606586|NCT01877642|11764125|FG002|STARTED|Overall Study||3
10606587|NCT01877642|11764126|FG003|STARTED|Overall Study||3
10606588|NCT01877642|11764127|FG004|STARTED|Overall Study||3
10606589|NCT01877642|11764128|FG005|STARTED|Overall Study||3
10606590|NCT01877642|11764129|FG006|STARTED|Overall Study||3
10606591|NCT01877642|11764123|FG000|COMPLETED|Overall Study||4
10606592|NCT01877642|11764124|FG001|COMPLETED|Overall Study||3
10606593|NCT01877642|11764125|FG002|COMPLETED|Overall Study||3
10606594|NCT01877642|11764126|FG003|COMPLETED|Overall Study||3
10606595|NCT01877642|11764127|FG004|COMPLETED|Overall Study||3
10606596|NCT01877642|11764128|FG005|COMPLETED|Overall Study||3
10606597|NCT01877642|11764129|FG006|COMPLETED|Overall Study||3
10606598|NCT01877642|11764123|FG000|NOT COMPLETED|Overall Study||0
10606599|NCT01877642|11764124|FG001|NOT COMPLETED|Overall Study||0
10606600|NCT01877642|11764125|FG002|NOT COMPLETED|Overall Study||0
10606601|NCT01877642|11764126|FG003|NOT COMPLETED|Overall Study||0
10606602|NCT01877642|11764127|FG004|NOT COMPLETED|Overall Study||0
10606603|NCT01877642|11764128|FG005|NOT COMPLETED|Overall Study||0
10606604|NCT01877642|11764129|FG006|NOT COMPLETED|Overall Study||0
10606605|NCT01877668|11764143|FG000|STARTED|Overall Study|Received treatment|107
10606606|NCT01877668|11764144|FG001|STARTED|Overall Study|Received treatment|104
10606607|NCT01877668|11764145|FG002|STARTED|Overall Study|Received treatment|106
10606608|NCT01877668|11764146|FG003|STARTED|Overall Study|Received treatment|52
10606609|NCT01877668|11764147|FG004|STARTED|Overall Study|Received treatment|53
10704350|NCT02590432|11868728|FG007|COMPLETED|Dose-reduced Open Label Treatment Period||13
10704351|NCT02590432|11868729|FG008|COMPLETED|Dose-reduced Open Label Treatment Period||8
10704352|NCT02590432|11868721|FG000|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
10704353|NCT02590432|11868722|FG001|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
10606610|NCT01877668|11764143|FG000|COMPLETED|Overall Study||96
10606611|NCT01877668|11764144|FG001|COMPLETED|Overall Study||96
10606612|NCT01877668|11764145|FG002|COMPLETED|Overall Study||94
10606613|NCT01877668|11764146|FG003|COMPLETED|Overall Study||44
10606614|NCT01877668|11764147|FG004|COMPLETED|Overall Study||43
10606615|NCT01877668|11764143|FG000|NOT COMPLETED|Overall Study||11
10606616|NCT01877668|11764144|FG001|NOT COMPLETED|Overall Study||8
10606617|NCT01877668|11764145|FG002|NOT COMPLETED|Overall Study||12
10606618|NCT01877668|11764146|FG003|NOT COMPLETED|Overall Study||8
10606619|NCT01877668|11764147|FG004|NOT COMPLETED|Overall Study||10
10606620|NCT01877720|11764163|FG000|STARTED|Overall Study||8
10606621|NCT01877720|11764164|FG001|STARTED|Overall Study||8
10606622|NCT01877720|11764163|FG000|1st Intervention|Overall Study||7
10606623|NCT01877720|11764164|FG001|1st Intervention|Overall Study||8
10606624|NCT01877720|11764163|FG000|2nd Intervention|Overall Study||7
10606625|NCT01877720|11764164|FG001|2nd Intervention|Overall Study||8
10606626|NCT01877720|11764163|FG000|COMPLETED|Overall Study||7
10606627|NCT01877720|11764164|FG001|COMPLETED|Overall Study||8
10606628|NCT01877720|11764163|FG000|NOT COMPLETED|Overall Study||1
10606629|NCT01877720|11764164|FG001|NOT COMPLETED|Overall Study||0
10606630|NCT01877915|11764172|FG000|STARTED|Overall Study||2507
10606631|NCT01877915|11764173|FG001|STARTED|Overall Study||2515
10606632|NCT01877915|11764172|FG000|COMPLETED|Overall Study||2453
10606633|NCT01877915|11764173|FG001|COMPLETED|Overall Study||2447
10606634|NCT01877915|11764172|FG000|NOT COMPLETED|Overall Study||54
10606635|NCT01877915|11764173|FG001|NOT COMPLETED|Overall Study||68
10606636|NCT01877941|11764179|FG000|STARTED|Overall Study||39
10606637|NCT01877941|11764179|FG000|COMPLETED|Overall Study||39
10606638|NCT01877941|11764179|FG000|NOT COMPLETED|Overall Study||0
10606639|NCT01878006|11764184|FG000|STARTED|Study Session 1||5
10606640|NCT01878006|11764185|FG001|STARTED|Study Session 1||5
10606641|NCT01878006|11764184|FG000|COMPLETED|Study Session 1||5
10606642|NCT01878006|11764185|FG001|COMPLETED|Study Session 1||5
10606643|NCT01878006|11764184|FG000|NOT COMPLETED|Study Session 1||0
10606644|NCT01878006|11764185|FG001|NOT COMPLETED|Study Session 1||0
10606645|NCT01878006|11764184|FG000|STARTED|Study Session 2||5
10606646|NCT01878006|11764185|FG001|STARTED|Study Session 2||5
10606647|NCT01878006|11764184|FG000|COMPLETED|Study Session 2||5
10606648|NCT01878006|11764185|FG001|COMPLETED|Study Session 2||5
10606649|NCT01878006|11764184|FG000|NOT COMPLETED|Study Session 2||0
10606650|NCT01878006|11764185|FG001|NOT COMPLETED|Study Session 2||0
10606651|NCT01878084|11764191|FG000|STARTED|Overall Study||9
10606652|NCT01878084|11764191|FG000|Test(Received TAMP Bioglass) s|Overall Study||7
10606653|NCT01878084|11764191|FG000|Control (Sockets Were Left Empty)|Overall Study||7
10606654|NCT01878084|11764191|FG000|COMPLETED|Overall Study||7
10606655|NCT01878084|11764191|FG000|NOT COMPLETED|Overall Study||2
10606656|NCT01878097|11764198|FG000|STARTED|Baseline|number of students in 13 intervention schools completing anonymous surveys with non missing data|10725
10606657|NCT01878097|11764199|FG001|STARTED|Baseline|number of students in 13 control schools completing anonymous surveys with non missing data|10081
10606658|NCT01878097|11764198|FG000|COMPLETED|Baseline|Anonymous surveys so only last year data provided as annual completed.|8228
10606659|NCT01878097|11764199|FG001|COMPLETED|Baseline|Anonymous surveys; sum of all completed surveys.|8281
10606660|NCT01878097|11764198|FG000|NOT COMPLETED|Baseline||2497
10606661|NCT01878097|11764199|FG001|NOT COMPLETED|Baseline||1800
10606662|NCT01878097|11764198|FG000|STARTED|Implementation Year 1||11742
10606663|NCT01878097|11764199|FG001|STARTED|Implementation Year 1||9866
10606664|NCT01878097|11764198|FG000|COMPLETED|Implementation Year 1||8540
10606665|NCT01878097|11764199|FG001|COMPLETED|Implementation Year 1||7317
10606666|NCT01878097|11764198|FG000|NOT COMPLETED|Implementation Year 1||3202
10606667|NCT01878097|11764199|FG001|NOT COMPLETED|Implementation Year 1||2549
10606668|NCT01878097|11764198|FG000|STARTED|Implementation Year 2||11567
10606669|NCT01878097|11764199|FG001|STARTED|Implementation Year 2||9611
10606670|NCT01878097|11764198|FG000|COMPLETED|Implementation Year 2||8286
10606671|NCT01878097|11764199|FG001|COMPLETED|Implementation Year 2||6770
10606672|NCT01878097|11764198|FG000|NOT COMPLETED|Implementation Year 2||3281
10606673|NCT01878097|11764199|FG001|NOT COMPLETED|Implementation Year 2||2841
10606674|NCT01878097|11764198|FG000|STARTED|Implementation Year 3||10540
10606675|NCT01878097|11764199|FG001|STARTED|Implementation Year 3||9750
10606676|NCT01878097|11764198|FG000|COMPLETED|Implementation Year 3||7046
10606677|NCT01878097|11764199|FG001|COMPLETED|Implementation Year 3||6770
10606678|NCT01878097|11764198|FG000|NOT COMPLETED|Implementation Year 3||3494
10606679|NCT01878097|11764199|FG001|NOT COMPLETED|Implementation Year 3||2980
10606680|NCT01878097|11764198|FG000|STARTED|Implementation Year 4||10585
10606681|NCT01878097|11764199|FG001|STARTED|Implementation Year 4||9614
10606682|NCT01878097|11764198|FG000|COMPLETED|Implementation Year 4||6981
10606683|NCT01878097|11764199|FG001|COMPLETED|Implementation Year 4||6607
10606684|NCT01878097|11764198|FG000|NOT COMPLETED|Implementation Year 4||3604
10606685|NCT01878097|11764199|FG001|NOT COMPLETED|Implementation Year 4||3007
10606686|NCT01878149|11764207|FG000|STARTED|Overall Study||21
10606687|NCT01878149|11764208|FG001|STARTED|Overall Study||17
10606688|NCT01878149|11764207|FG000|COMPLETED|Overall Study||19
10606689|NCT01878149|11764208|FG001|COMPLETED|Overall Study||15
10606690|NCT01878149|11764207|FG000|NOT COMPLETED|Overall Study||2
10606691|NCT01878149|11764208|FG001|NOT COMPLETED|Overall Study||2
10606692|NCT01878175|11764214|FG000|STARTED|Overall Study||15
10606693|NCT01878175|11764214|FG000|COMPLETED|Overall Study||13
10606694|NCT01878175|11764214|FG000|NOT COMPLETED|Overall Study||2
10606695|NCT01878214|11764221|FG000|STARTED|Overall Study||223
10606696|NCT01878214|11764222|FG001|STARTED|Overall Study||219
10606697|NCT01878214|11764221|FG000|COMPLETED|Overall Study||170
10606698|NCT01878214|11764222|FG001|COMPLETED|Overall Study||175
10606699|NCT01878214|11764221|FG000|NOT COMPLETED|Overall Study||53
10606700|NCT01878214|11764222|FG001|NOT COMPLETED|Overall Study||44
10606701|NCT01878253|11764228|FG000|STARTED|Overall Study||95
10606702|NCT01878253|11764228|FG000|Pre-Operative|Overall Study||95
10606703|NCT01878253|11764228|FG000|6 Weeks|Overall Study||95
10606704|NCT01878253|11764228|FG000|6 Months|Overall Study||90
10606705|NCT01878253|11764228|FG000|1 Year|Overall Study||88
10606706|NCT01878253|11764228|FG000|2 Year|Overall Study||86
10606707|NCT01878253|11764228|FG000|COMPLETED|Overall Study||86
10606708|NCT01878253|11764228|FG000|NOT COMPLETED|Overall Study||9
10606709|NCT01878292|11764240|FG000|STARTED|Randomized||174
10606710|NCT01878292|11764241|FG001|STARTED|Randomized||175
10606711|NCT01878292|11764242|FG002|STARTED|Randomized||180
10606712|NCT01878292|11764240|FG000|COMPLETED|Randomized||171
10606713|NCT01878292|11764241|FG001|COMPLETED|Randomized||175
10606714|NCT01878292|11764242|FG002|COMPLETED|Randomized||180
10606715|NCT01878292|11764240|FG000|NOT COMPLETED|Randomized||3
10606716|NCT01878292|11764241|FG001|NOT COMPLETED|Randomized||0
10606717|NCT01878292|11764242|FG002|NOT COMPLETED|Randomized||0
10808713|NCT03849690|11970675|FG000|NOT COMPLETED|Period 1 (3 Days)||0
10808714|NCT03849690|11970675|FG000|STARTED|Washout Period (at Least 4 Days)||12
10606718|NCT01878292|11764240|FG000|STARTED|Double-blind Treatment Period||171
10606719|NCT01878292|11764241|FG001|STARTED|Double-blind Treatment Period||175
10606720|NCT01878292|11764242|FG002|STARTED|Double-blind Treatment Period||180
10808715|NCT03849690|11970675|FG000|COMPLETED|Washout Period (at Least 4 Days)||12
10808716|NCT03849690|11970675|FG000|NOT COMPLETED|Washout Period (at Least 4 Days)||0
10808717|NCT03849690|11970675|FG000|STARTED|Period 2 (6 Days)||12
10808718|NCT03849690|11970675|FG000|COMPLETED|Period 2 (6 Days)||12
10606721|NCT01878292|11764240|FG000|COMPLETED|Double-blind Treatment Period||142
10606722|NCT01878292|11764241|FG001|COMPLETED|Double-blind Treatment Period||149
10606723|NCT01878292|11764242|FG002|COMPLETED|Double-blind Treatment Period||161
10606724|NCT01878292|11764240|FG000|NOT COMPLETED|Double-blind Treatment Period||29
10606725|NCT01878292|11764241|FG001|NOT COMPLETED|Double-blind Treatment Period||26
10606726|NCT01878292|11764242|FG002|NOT COMPLETED|Double-blind Treatment Period||19
10606727|NCT01878292|11764240|FG000|STARTED|Double-blind Down-Taper Period||127
10606728|NCT01878292|11764241|FG001|STARTED|Double-blind Down-Taper Period||140
10606729|NCT01878292|11764242|FG002|STARTED|Double-blind Down-Taper Period||146
10606730|NCT01878292|11764240|FG000|COMPLETED|Double-blind Down-Taper Period||122
10606731|NCT01878292|11764241|FG001|COMPLETED|Double-blind Down-Taper Period||132
10808719|NCT03849690|11970675|FG000|NOT COMPLETED|Period 2 (6 Days)||0
10808720|NCT03845933|11970686|FG000|STARTED|Overall Study||131
10808721|NCT03845933|11970687|FG001|STARTED|Overall Study||131
10808722|NCT03845933|11970686|FG000|COMPLETED|Overall Study||131
10808723|NCT03845933|11970687|FG001|COMPLETED|Overall Study||131
10808724|NCT03845933|11970686|FG000|NOT COMPLETED|Overall Study||0
10808725|NCT03845933|11970687|FG001|NOT COMPLETED|Overall Study||0
10808726|NCT03844945|11970697|FG000|STARTED|Overall Study||55
10808727|NCT03844945|11970698|FG001|STARTED|Overall Study||54
10808728|NCT03844945|11970699|FG002|STARTED|Overall Study||51
10808729|NCT03844945|11970700|FG003|STARTED|Overall Study||55
10808730|NCT03844945|11970697|FG000|COMPLETED|Overall Study||54
10606732|NCT01878292|11764242|FG002|COMPLETED|Double-blind Down-Taper Period||142
10606733|NCT01878292|11764240|FG000|NOT COMPLETED|Double-blind Down-Taper Period||5
10606734|NCT01878292|11764241|FG001|NOT COMPLETED|Double-blind Down-Taper Period||8
10606735|NCT01878292|11764242|FG002|NOT COMPLETED|Double-blind Down-Taper Period||4
10606736|NCT01878383|11764252|FG000|STARTED|Overall Study||50
10606737|NCT01878383|11764253|FG001|STARTED|Overall Study||12500
10606738|NCT01878383|11764252|FG000|COMPLETED|Overall Study||50
10606739|NCT01878383|11764253|FG001|COMPLETED|Overall Study||11001
10606740|NCT01878383|11764252|FG000|NOT COMPLETED|Overall Study||0
10606741|NCT01878383|11764253|FG001|NOT COMPLETED|Overall Study||1499
10606742|NCT01878526|11764261|FG000|STARTED|Overall Study||40
10606743|NCT01878526|11764262|FG001|STARTED|Overall Study||40
10606744|NCT01878526|11764261|FG000|COMPLETED|Overall Study||37
10606745|NCT01878526|11764262|FG001|COMPLETED|Overall Study||38
10606746|NCT01878526|11764261|FG000|NOT COMPLETED|Overall Study||3
10606747|NCT01878526|11764262|FG001|NOT COMPLETED|Overall Study||2
10606748|NCT01878604|11764269|FG000|STARTED|Overall Study||5
10606749|NCT01878604|11764269|FG000|COMPLETED|Overall Study||5
10606750|NCT01878604|11764269|FG000|NOT COMPLETED|Overall Study||0
10606751|NCT01878656|11764276|FG000|STARTED|Overall Study||72
10606752|NCT01878656|11764277|FG001|STARTED|Overall Study||72
10606753|NCT01878656|11764276|FG000|COMPLETED|Overall Study||72
10606754|NCT01878656|11764277|FG001|COMPLETED|Overall Study||72
10606755|NCT01878656|11764276|FG000|NOT COMPLETED|Overall Study||0
10606756|NCT01878656|11764277|FG001|NOT COMPLETED|Overall Study||0
10606757|NCT01878799|11764285|FG000|STARTED|Overall Study||37
10606758|NCT01878799|11764286|FG001|STARTED|Overall Study||13
10606759|NCT01878799|11764285|FG000|COMPLETED|Overall Study||36
10606760|NCT01878799|11764286|FG001|COMPLETED|Overall Study||13
10606761|NCT01878799|11764285|FG000|NOT COMPLETED|Overall Study||1
10606762|NCT01878799|11764286|FG001|NOT COMPLETED|Overall Study||0
10606763|NCT01878812|11764294|FG000|STARTED|Overall Study||60
10606764|NCT01878812|11764295|FG001|STARTED|Overall Study||57
10606765|NCT01878812|11764294|FG000|COMPLETED|Overall Study||60
10606766|NCT01878812|11764295|FG001|COMPLETED|Overall Study||57
10606767|NCT01878812|11764294|FG000|NOT COMPLETED|Overall Study||0
10606768|NCT01878812|11764295|FG001|NOT COMPLETED|Overall Study||0
10606769|NCT01878825|11764303|FG000|STARTED|Overall Study||60
10606770|NCT01878825|11764304|FG001|STARTED|Overall Study||60
10606771|NCT01878825|11764303|FG000|COMPLETED|Overall Study||60
10606772|NCT01878825|11764304|FG001|COMPLETED|Overall Study||60
10606773|NCT01878825|11764303|FG000|NOT COMPLETED|Overall Study||0
10606774|NCT01878825|11764304|FG001|NOT COMPLETED|Overall Study||0
10606775|NCT01878890|11764323|FG000|STARTED|Overall Study||5
10606776|NCT01878890|11764324|FG001|STARTED|Overall Study||11
10606777|NCT01878890|11764325|FG002|STARTED|Overall Study||4
10606778|NCT01878890|11764326|FG003|STARTED|Overall Study||5
10606779|NCT01878890|11764323|FG000|COMPLETED|Overall Study||5
10606780|NCT01878890|11764324|FG001|COMPLETED|Overall Study||10
10606781|NCT01878890|11764325|FG002|COMPLETED|Overall Study||4
10606782|NCT01878890|11764326|FG003|COMPLETED|Overall Study||5
10606783|NCT01878890|11764323|FG000|NOT COMPLETED|Overall Study||0
10606784|NCT01878890|11764324|FG001|NOT COMPLETED|Overall Study||1
10606785|NCT01878890|11764325|FG002|NOT COMPLETED|Overall Study||0
10606786|NCT01878890|11764326|FG003|NOT COMPLETED|Overall Study||0
10606787|NCT01879059|11764337|FG000|STARTED|Overall Study||13
10606788|NCT01879059|11764337|FG000|COMPLETED|Overall Study||13
10606789|NCT01879059|11764337|FG000|NOT COMPLETED|Overall Study||0
10808731|NCT03844945|11970698|FG001|COMPLETED|Overall Study||53
10606790|NCT01879072|11764341|FG000|STARTED|Overall Study||1860
10606791|NCT01879072|11764341|FG000|COMPLETED|Overall Study||1709
10606792|NCT01879072|11764341|FG000|NOT COMPLETED|Overall Study||151
10606793|NCT01879176|11764347|FG000|STARTED|Overall Study||24
10808732|NCT03844945|11970699|FG002|COMPLETED|Overall Study||46
10808733|NCT03844945|11970700|FG003|COMPLETED|Overall Study||54
10808734|NCT03844945|11970697|FG000|NOT COMPLETED|Overall Study||1
10606794|NCT01879176|11764348|FG001|STARTED|Overall Study||22
10606795|NCT01879176|11764347|FG000|COMPLETED|Overall Study||16
10606796|NCT01879176|11764348|FG001|COMPLETED|Overall Study||16
10606797|NCT01879176|11764347|FG000|NOT COMPLETED|Overall Study||8
10606798|NCT01879176|11764348|FG001|NOT COMPLETED|Overall Study||6
10606799|NCT01879319|11764356|FG000|STARTED|Overall Study||82
10606800|NCT01879319|11764357|FG001|STARTED|Overall Study||82
10606801|NCT01879319|11764356|FG000|Received Treatment|Overall Study||82
10606802|NCT01879319|11764357|FG001|Received Treatment|Overall Study||82
10606803|NCT01879319|11764356|FG000|COMPLETED|Overall Study||80
10606804|NCT01879319|11764357|FG001|COMPLETED|Overall Study||77
10606805|NCT01879319|11764356|FG000|NOT COMPLETED|Overall Study||2
10606806|NCT01879319|11764357|FG001|NOT COMPLETED|Overall Study||5
10606807|NCT01879332|11764366|FG000|STARTED|Overall Study||6
10606808|NCT01879332|11764367|FG001|STARTED|Overall Study||6
10606809|NCT01879332|11764368|FG002|STARTED|Overall Study||4
10606810|NCT01879332|11764366|FG000|COMPLETED|Overall Study||0
10606811|NCT01879332|11764367|FG001|COMPLETED|Overall Study||0
10606812|NCT01879332|11764368|FG002|COMPLETED|Overall Study||0
10606813|NCT01879332|11764366|FG000|NOT COMPLETED|Overall Study||6
10606814|NCT01879332|11764367|FG001|NOT COMPLETED|Overall Study||6
10606815|NCT01879332|11764368|FG002|NOT COMPLETED|Overall Study||4
10652710|NCT02186821|11813035|FG000|COMPLETED|Overall Study||0
10652711|NCT02186821|11813035|FG000|NOT COMPLETED|Overall Study||47
10652712|NCT02186873|11813041|FG000|STARTED|Overall Study||103
10652713|NCT02186873|11813042|FG001|STARTED|Overall Study||105
10652714|NCT02186873|11813041|FG000|End of Control Period|Overall Study|Participants taking placebo crossed over to golimumab|99
10652715|NCT02186873|11813042|FG001|End of Control Period|Overall Study|Participants continued to receive golimumab|105
10652716|NCT02186873|11813041|FG000|COMPLETED|Overall Study||94
10652717|NCT02186873|11813042|FG001|COMPLETED|Overall Study||97
10652718|NCT02186873|11813041|FG000|NOT COMPLETED|Overall Study||9
10652719|NCT02186873|11813042|FG001|NOT COMPLETED|Overall Study||8
10652720|NCT02186938|11813051|FG000|STARTED|Overall Study|2012|47
10652721|NCT02186938|11813052|FG001|STARTED|Overall Study||47
10652722|NCT02186938|11813051|FG000|COMPLETED|Overall Study||38
10652723|NCT02186938|11813052|FG001|COMPLETED|Overall Study||44
10652724|NCT02186938|11813051|FG000|NOT COMPLETED|Overall Study||9
10652725|NCT02186938|11813052|FG001|NOT COMPLETED|Overall Study||3
10652726|NCT02187016|11813062|FG000|STARTED|Overall Study||80
10652727|NCT02187016|11813063|FG001|STARTED|Overall Study||80
10652728|NCT02187016|11813064|FG002|STARTED|Overall Study||79
10652729|NCT02187016|11813065|FG003|STARTED|Overall Study||51
10652730|NCT02187016|11813062|FG000|COMPLETED|Overall Study||79
10652731|NCT02187016|11813063|FG001|COMPLETED|Overall Study||78
10652732|NCT02187016|11813064|FG002|COMPLETED|Overall Study||78
10652733|NCT02187016|11813065|FG003|COMPLETED|Overall Study||51
10652734|NCT02187016|11813062|FG000|NOT COMPLETED|Overall Study||1
10652735|NCT02187016|11813063|FG001|NOT COMPLETED|Overall Study||2
10652736|NCT02187016|11813064|FG002|NOT COMPLETED|Overall Study||1
10652737|NCT02187016|11813065|FG003|NOT COMPLETED|Overall Study||0
10652738|NCT02187029|11813079|FG000|STARTED|Overall Study||7
10652739|NCT02187029|11813080|FG001|STARTED|Overall Study||3
10652740|NCT02187029|11813081|FG002|STARTED|Overall Study||11
10652741|NCT02187029|11813082|FG003|STARTED|Overall Study||9
10652742|NCT02187029|11813079|FG000|COMPLETED|Overall Study||6
10652743|NCT02187029|11813080|FG001|COMPLETED|Overall Study||2
10652744|NCT02187029|11813081|FG002|COMPLETED|Overall Study||0
10652745|NCT02187029|11813082|FG003|COMPLETED|Overall Study||6
10652746|NCT02187029|11813079|FG000|NOT COMPLETED|Overall Study||1
10652747|NCT02187029|11813080|FG001|NOT COMPLETED|Overall Study||1
10652748|NCT02187029|11813081|FG002|NOT COMPLETED|Overall Study||11
10652749|NCT02187029|11813082|FG003|NOT COMPLETED|Overall Study||3
10652750|NCT02187042|11813094|FG000|STARTED|Overall Study||42
10652751|NCT02187042|11813095|FG001|STARTED|Overall Study||27
10652752|NCT02187042|11813094|FG000|COMPLETED|Overall Study||29
10652753|NCT02187042|11813095|FG001|COMPLETED|Overall Study||13
10652754|NCT02187042|11813094|FG000|NOT COMPLETED|Overall Study||13
10652755|NCT02187042|11813095|FG001|NOT COMPLETED|Overall Study||14
10652756|NCT02187055|11813105|FG000|STARTED|Overall Study|Treated|384
10652757|NCT02187055|11813106|FG001|STARTED|Overall Study|Treated|376
10652758|NCT02187055|11813107|FG002|STARTED|Overall Study|Treated|386
10652759|NCT02187055|11813105|FG000|COMPLETED|Overall Study||315
10652760|NCT02187055|11813106|FG001|COMPLETED|Overall Study||303
10652761|NCT02187055|11813107|FG002|COMPLETED|Overall Study||312
10652762|NCT02187055|11813105|FG000|NOT COMPLETED|Overall Study||69
10652763|NCT02187055|11813106|FG001|NOT COMPLETED|Overall Study||73
10652764|NCT02187055|11813107|FG002|NOT COMPLETED|Overall Study||74
10652765|NCT02187159|11813119|FG000|STARTED|Overall Study||318
10652766|NCT02187159|11813120|FG001|STARTED|Overall Study||317
10652767|NCT02187159|11813121|FG002|STARTED|Overall Study||318
10652768|NCT02187159|11813122|FG003|STARTED|Overall Study||317
10652769|NCT02187159|11813119|FG000|COMPLETED|Overall Study||249
10652770|NCT02187159|11813120|FG001|COMPLETED|Overall Study||238
10652771|NCT02187159|11813121|FG002|COMPLETED|Overall Study||241
10652772|NCT02187159|11813122|FG003|COMPLETED|Overall Study||221
10652773|NCT02187159|11813119|FG000|NOT COMPLETED|Overall Study||69
10652774|NCT02187159|11813120|FG001|NOT COMPLETED|Overall Study||79
10652775|NCT02187159|11813121|FG002|NOT COMPLETED|Overall Study||77
10652776|NCT02187159|11813122|FG003|NOT COMPLETED|Overall Study||96
10652777|NCT02187172|11813134|FG000|STARTED|Overall Study||22
10652778|NCT02187172|11813135|FG001|STARTED|Overall Study||21
10652779|NCT02187172|11813134|FG000|RCT Phase Completed|Overall Study||22
10606816|NCT01879345|11764379|FG000|STARTED|Single-dose Period||6
10606817|NCT01879345|11764380|FG001|STARTED|Single-dose Period||6
10606818|NCT01879345|11764381|FG002|STARTED|Single-dose Period||6
10606819|NCT01879345|11764379|FG000|COMPLETED|Single-dose Period||6
10606820|NCT01879345|11764380|FG001|COMPLETED|Single-dose Period||6
10606821|NCT01879345|11764381|FG002|COMPLETED|Single-dose Period||6
10606822|NCT01879345|11764379|FG000|NOT COMPLETED|Single-dose Period||0
10606823|NCT01879345|11764380|FG001|NOT COMPLETED|Single-dose Period||0
10606824|NCT01879345|11764381|FG002|NOT COMPLETED|Single-dose Period||0
10606825|NCT01879345|11764379|FG000|STARTED|7-day Multiple-dose Period||6
10606826|NCT01879345|11764380|FG001|STARTED|7-day Multiple-dose Period||6
10606827|NCT01879345|11764381|FG002|STARTED|7-day Multiple-dose Period||6
10606828|NCT01879345|11764379|FG000|COMPLETED|7-day Multiple-dose Period||6
10606829|NCT01879345|11764380|FG001|COMPLETED|7-day Multiple-dose Period||6
10606830|NCT01879345|11764381|FG002|COMPLETED|7-day Multiple-dose Period||6
10606831|NCT01879345|11764379|FG000|NOT COMPLETED|7-day Multiple-dose Period||0
10606832|NCT01879345|11764380|FG001|NOT COMPLETED|7-day Multiple-dose Period||0
10606833|NCT01879345|11764381|FG002|NOT COMPLETED|7-day Multiple-dose Period||0
10606834|NCT01879371|11764397|FG000|STARTED|Overall Study||6
10606835|NCT01879371|11764398|FG001|STARTED|Overall Study||6
10606836|NCT01879371|11764399|FG002|STARTED|Overall Study||6
10606837|NCT01879371|11764400|FG003|STARTED|Overall Study||6
10704354|NCT02590432|11868723|FG002|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
10704355|NCT02590432|11868724|FG003|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
10704356|NCT02590432|11868725|FG004|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
10606838|NCT01879371|11764401|FG004|STARTED|Overall Study||6
10606839|NCT01879371|11764402|FG005|STARTED|Overall Study||6
10606840|NCT01879371|11764397|FG000|COMPLETED|Overall Study||6
10606841|NCT01879371|11764398|FG001|COMPLETED|Overall Study||6
10606842|NCT01879371|11764399|FG002|COMPLETED|Overall Study||6
10606843|NCT01879371|11764400|FG003|COMPLETED|Overall Study||6
10606844|NCT01879371|11764401|FG004|COMPLETED|Overall Study||6
10606845|NCT01879371|11764402|FG005|COMPLETED|Overall Study||6
10606846|NCT01879371|11764397|FG000|NOT COMPLETED|Overall Study||0
10606847|NCT01879371|11764398|FG001|NOT COMPLETED|Overall Study||0
10606848|NCT01879371|11764399|FG002|NOT COMPLETED|Overall Study||0
10606849|NCT01879371|11764400|FG003|NOT COMPLETED|Overall Study||0
10606850|NCT01879371|11764401|FG004|NOT COMPLETED|Overall Study||0
10606851|NCT01879371|11764402|FG005|NOT COMPLETED|Overall Study||0
10606852|NCT01879410|11764412|FG000|STARTED|Overall Study||350
10606853|NCT01879410|11764413|FG001|STARTED|Overall Study||350
10606854|NCT01879410|11764412|FG000|Intent-to-Treat Population|Overall Study||349
10606855|NCT01879410|11764413|FG001|Intent-to-Treat Population|Overall Study||348
10606856|NCT01879410|11764412|FG000|COMPLETED|Overall Study||326
10606857|NCT01879410|11764413|FG001|COMPLETED|Overall Study||312
10606858|NCT01879410|11764412|FG000|NOT COMPLETED|Overall Study||24
10606859|NCT01879410|11764413|FG001|NOT COMPLETED|Overall Study||38
10606860|NCT01879540|11764419|FG000|STARTED|Overall Study||63
10606861|NCT01879540|11764419|FG000|COMPLETED|Overall Study||63
10606862|NCT01879540|11764419|FG000|NOT COMPLETED|Overall Study||0
10606863|NCT01879553|11764425|FG000|STARTED|Overall Study||63
10606864|NCT01879553|11764426|FG001|STARTED|Overall Study||63
10606865|NCT01879553|11764425|FG000|COMPLETED|Overall Study||62
10606866|NCT01879553|11764426|FG001|COMPLETED|Overall Study||63
10606867|NCT01879553|11764425|FG000|NOT COMPLETED|Overall Study||1
10606868|NCT01879553|11764426|FG001|NOT COMPLETED|Overall Study||0
10606869|NCT01879579|11764435|FG000|STARTED|Overall Study||33
10606870|NCT01879579|11764436|FG001|STARTED|Overall Study||28
10606871|NCT01879579|11764435|FG000|COMPLETED|Overall Study||28
10606872|NCT01879579|11764436|FG001|COMPLETED|Overall Study||26
10606873|NCT01879579|11764435|FG000|NOT COMPLETED|Overall Study||5
10606874|NCT01879579|11764436|FG001|NOT COMPLETED|Overall Study||2
10606875|NCT01879618|11764445|FG000|STARTED|Overall Study||152
10606876|NCT01879618|11764445|FG000|COMPLETED|Overall Study||131
10606877|NCT01879618|11764445|FG000|NOT COMPLETED|Overall Study||21
10606878|NCT01879683|11764449|FG000|STARTED|Overall Study||10
10606879|NCT01879683|11764449|FG000|COMPLETED|Overall Study||9
10606880|NCT01879683|11764449|FG000|NOT COMPLETED|Overall Study||1
10606881|NCT01879722|11764463|FG000|STARTED|Overall Study||7
10606882|NCT01879722|11764464|FG001|STARTED|Overall Study||8
10606883|NCT01879722|11764465|FG002|STARTED|Overall Study||7
10606884|NCT01879722|11764466|FG003|STARTED|Overall Study||8
10606885|NCT01879722|11764467|FG004|STARTED|Overall Study||8
10606886|NCT01879722|11764468|FG005|STARTED|Overall Study||9
10606887|NCT01879722|11764469|FG006|STARTED|Overall Study||8
10606888|NCT01879722|11764470|FG007|STARTED|Overall Study||8
10606889|NCT01879722|11764471|FG008|STARTED|Overall Study||8
10606890|NCT01879722|11764472|FG009|STARTED|Overall Study||6
10606891|NCT01879722|11764463|FG000|COMPLETED|Overall Study||7
10606892|NCT01879722|11764464|FG001|COMPLETED|Overall Study||7
10606893|NCT01879722|11764465|FG002|COMPLETED|Overall Study||7
10606894|NCT01879722|11764466|FG003|COMPLETED|Overall Study||7
10606895|NCT01879722|11764467|FG004|COMPLETED|Overall Study||7
10606896|NCT01879722|11764468|FG005|COMPLETED|Overall Study||9
10606897|NCT01879722|11764469|FG006|COMPLETED|Overall Study||8
10606898|NCT01879722|11764470|FG007|COMPLETED|Overall Study||7
10606899|NCT01879722|11764471|FG008|COMPLETED|Overall Study||6
10606900|NCT01879722|11764472|FG009|COMPLETED|Overall Study||6
10606901|NCT01879722|11764463|FG000|NOT COMPLETED|Overall Study||0
10606902|NCT01879722|11764464|FG001|NOT COMPLETED|Overall Study||1
10606903|NCT01879722|11764465|FG002|NOT COMPLETED|Overall Study||0
10606904|NCT01879722|11764466|FG003|NOT COMPLETED|Overall Study||1
10606905|NCT01879722|11764467|FG004|NOT COMPLETED|Overall Study||1
10606906|NCT01879722|11764468|FG005|NOT COMPLETED|Overall Study||0
10606907|NCT01879722|11764469|FG006|NOT COMPLETED|Overall Study||0
10606908|NCT01879722|11764470|FG007|NOT COMPLETED|Overall Study||1
10606909|NCT01879722|11764471|FG008|NOT COMPLETED|Overall Study||2
10606910|NCT01879722|11764472|FG009|NOT COMPLETED|Overall Study||0
10652780|NCT02187172|11813135|FG001|RCT Phase Completed|Overall Study||19
10652781|NCT02187172|11813134|FG000|COMPLETED|Overall Study||19
10652782|NCT02187172|11813135|FG001|COMPLETED|Overall Study||15
10652783|NCT02187172|11813134|FG000|NOT COMPLETED|Overall Study||3
10652784|NCT02187172|11813135|FG001|NOT COMPLETED|Overall Study||6
10652785|NCT02187471|11813147|FG000|STARTED|Overall Study||325
10652786|NCT02187471|11813148|FG001|STARTED|Overall Study||324
10652787|NCT02187471|11813149|FG002|STARTED|Overall Study||326
10652788|NCT02187471|11813150|FG003|STARTED|Overall Study||326
10652789|NCT02187471|11813147|FG000|COMPLETED|Overall Study||249
10652790|NCT02187471|11813148|FG001|COMPLETED|Overall Study||242
10652791|NCT02187471|11813149|FG002|COMPLETED|Overall Study||240
10652792|NCT02187471|11813150|FG003|COMPLETED|Overall Study||246
10652793|NCT02187471|11813147|FG000|NOT COMPLETED|Overall Study||76
10652794|NCT02187471|11813148|FG001|NOT COMPLETED|Overall Study||82
10652795|NCT02187471|11813149|FG002|NOT COMPLETED|Overall Study||86
10652796|NCT02187471|11813150|FG003|NOT COMPLETED|Overall Study||80
10652797|NCT02187744|11813163|FG000|STARTED|Study|Received treatment|113
10652798|NCT02187744|11813164|FG001|STARTED|Study|Received treatment|112
10652799|NCT02187744|11813163|FG000|COMPLETED|Study||109
10652800|NCT02187744|11813164|FG001|COMPLETED|Study||106
10652801|NCT02187744|11813163|FG000|NOT COMPLETED|Study||4
10652802|NCT02187744|11813164|FG001|NOT COMPLETED|Study||6
10652803|NCT02187744|11813163|FG000|STARTED|Treatment||113
10652804|NCT02187744|11813164|FG001|STARTED|Treatment||112
10652805|NCT02187744|11813163|FG000|COMPLETED|Treatment||109
10652806|NCT02187744|11813164|FG001|COMPLETED|Treatment||107
10652807|NCT02187744|11813163|FG000|NOT COMPLETED|Treatment||4
10652808|NCT02187744|11813164|FG001|NOT COMPLETED|Treatment||5
10652809|NCT02187783|11813170|FG000|STARTED|Overall Study||106
10652810|NCT02187783|11813170|FG000|Patients With Solid Tumors|Overall Study||105
10652811|NCT02187783|11813170|FG000|COMPLETED|Overall Study||0
10652812|NCT02187783|11813170|FG000|NOT COMPLETED|Overall Study||106
10652813|NCT02187809|11813174|FG000|STARTED|Overall Study||3
10652814|NCT02187809|11813174|FG000|Treated|Overall Study||1
10704357|NCT02590432|11868726|FG005|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
10704358|NCT02590432|11868727|FG006|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
10704359|NCT02590432|11868728|FG007|NOT COMPLETED|Dose-reduced Open Label Treatment Period||18
10704360|NCT02590432|11868729|FG008|NOT COMPLETED|Dose-reduced Open Label Treatment Period||18
10704361|NCT02590562|11868741|FG000|STARTED|Overall Study||808
10652815|NCT02187809|11813174|FG000|COMPLETED|Overall Study||0
10652816|NCT02187809|11813174|FG000|NOT COMPLETED|Overall Study||3
10652817|NCT02187861|11813182|FG000|STARTED|Overall Study||9
10652818|NCT02187861|11813183|FG001|STARTED|Overall Study||52
10652819|NCT02187861|11813184|FG002|STARTED|Overall Study||51
10652820|NCT02187861|11813185|FG003|STARTED|Overall Study||51
10652821|NCT02187861|11813182|FG000|Treated|Overall Study||9
10652822|NCT02187861|11813183|FG001|Treated|Overall Study||52
10652823|NCT02187861|11813184|FG002|Treated|Overall Study||49
10652824|NCT02187861|11813185|FG003|Treated|Overall Study||50
10652825|NCT02187861|11813182|FG000|COMPLETED|Overall Study||3
10652826|NCT02187861|11813183|FG001|COMPLETED|Overall Study||4
10652827|NCT02187861|11813184|FG002|COMPLETED|Overall Study||19
10652828|NCT02187861|11813185|FG003|COMPLETED|Overall Study||19
10652829|NCT02187861|11813182|FG000|NOT COMPLETED|Overall Study||6
10652830|NCT02187861|11813183|FG001|NOT COMPLETED|Overall Study||48
10652831|NCT02187861|11813184|FG002|NOT COMPLETED|Overall Study||32
10652832|NCT02187861|11813185|FG003|NOT COMPLETED|Overall Study||32
10652833|NCT02187887|11813197|FG000|STARTED|Overall Study||393
10704362|NCT02590562|11868741|FG000|COMPLETED|Overall Study||802
10704363|NCT02590562|11868741|FG000|NOT COMPLETED|Overall Study||6
10704364|NCT02590588|11868751|FG000|STARTED|Overall Study||1
10652834|NCT02187887|11813198|FG001|STARTED|Overall Study||400
10652835|NCT02187887|11813197|FG000|COMPLETED|Overall Study||388
10652836|NCT02187887|11813198|FG001|COMPLETED|Overall Study||396
10652837|NCT02187887|11813197|FG000|NOT COMPLETED|Overall Study||5
10652838|NCT02187887|11813198|FG001|NOT COMPLETED|Overall Study||4
10652839|NCT02188160|11813206|FG000|STARTED|Overall Study||73
10652840|NCT02188160|11813207|FG001|STARTED|Overall Study||77
10652841|NCT02188160|11813206|FG000|COMPLETED|Overall Study||72
10652842|NCT02188160|11813207|FG001|COMPLETED|Overall Study||76
10652843|NCT02188160|11813206|FG000|NOT COMPLETED|Overall Study||1
10652844|NCT02188160|11813207|FG001|NOT COMPLETED|Overall Study||1
10652845|NCT02188303|11813221|FG000|STARTED|Overall Study||6
10652846|NCT02188303|11813222|FG001|STARTED|Overall Study||6
10652847|NCT02188303|11813223|FG002|STARTED|Overall Study||6
10652848|NCT02188303|11813224|FG003|STARTED|Overall Study||6
10652849|NCT02188303|11813225|FG004|STARTED|Overall Study||4
10652850|NCT02188303|11813226|FG005|STARTED|Overall Study||12
10652851|NCT02188303|11813227|FG006|STARTED|Overall Study||2
10652852|NCT02188303|11813228|FG007|STARTED|Overall Study||6
10652853|NCT02188303|11813221|FG000|COMPLETED|Overall Study||6
10652854|NCT02188303|11813222|FG001|COMPLETED|Overall Study||6
10652855|NCT02188303|11813223|FG002|COMPLETED|Overall Study||6
10652856|NCT02188303|11813224|FG003|COMPLETED|Overall Study||6
10652857|NCT02188303|11813225|FG004|COMPLETED|Overall Study||4
10606911|NCT04838054|11764499|FG000|STARTED|Overall Study||29
10606912|NCT04838054|11764500|FG001|STARTED|Overall Study||28
10606913|NCT04838054|11764499|FG000|COMPLETED|Overall Study||27
10606914|NCT04838054|11764500|FG001|COMPLETED|Overall Study||28
10606915|NCT04838054|11764499|FG000|NOT COMPLETED|Overall Study||2
10606916|NCT04838054|11764500|FG001|NOT COMPLETED|Overall Study||0
10606917|NCT04495829|11764506|FG000|STARTED|Overall Study||70
10606918|NCT04495829|11764506|FG000|COMPLETED|Overall Study||65
10606919|NCT04495829|11764506|FG000|NOT COMPLETED|Overall Study||5
10606920|NCT03861052|11764514|FG000|STARTED|Overall Study||159
10606921|NCT03861052|11764515|FG001|STARTED|Overall Study||158
10606922|NCT03861052|11764516|FG002|STARTED|Overall Study||160
10606923|NCT03861052|11764517|FG003|STARTED|Overall Study||159
10606924|NCT03861052|11764514|FG000|Received at Least One Dose of Study Drug|Overall Study||159
10606925|NCT03861052|11764515|FG001|Received at Least One Dose of Study Drug|Overall Study||158
10606926|NCT03861052|11764516|FG002|Received at Least One Dose of Study Drug|Overall Study||160
10606927|NCT03861052|11764517|FG003|Received at Least One Dose of Study Drug|Overall Study||159
10606928|NCT03861052|11764514|FG000|COMPLETED|Overall Study||155
10606929|NCT03861052|11764515|FG001|COMPLETED|Overall Study||151
10606930|NCT03861052|11764516|FG002|COMPLETED|Overall Study||155
10606931|NCT03861052|11764517|FG003|COMPLETED|Overall Study||154
10606932|NCT03861052|11764514|FG000|NOT COMPLETED|Overall Study||4
10606933|NCT03861052|11764515|FG001|NOT COMPLETED|Overall Study||7
10606934|NCT03861052|11764516|FG002|NOT COMPLETED|Overall Study||5
10606935|NCT03861052|11764517|FG003|NOT COMPLETED|Overall Study||5
10606936|NCT03846453|11764534|FG000|STARTED|Placebo Run-in (14 Days)||1108
10606937|NCT03846453|11764535|FG001|STARTED|Placebo Run-in (14 Days)|Participants in this group were randomized after they completed the placebo run-in period.|0
10606938|NCT03846453|11764536|FG002|STARTED|Placebo Run-in (14 Days)|Participants in this group were randomized after they completed the placebo run-in period.|0
10606939|NCT03846453|11764534|FG000|COMPLETED|Placebo Run-in (14 Days)||637
10606940|NCT03846453|11764535|FG001|COMPLETED|Placebo Run-in (14 Days)||0
10606941|NCT03846453|11764536|FG002|COMPLETED|Placebo Run-in (14 Days)||0
10606942|NCT03846453|11764534|FG000|NOT COMPLETED|Placebo Run-in (14 Days)||471
10606943|NCT03846453|11764535|FG001|NOT COMPLETED|Placebo Run-in (14 Days)||0
10606944|NCT03846453|11764536|FG002|NOT COMPLETED|Placebo Run-in (14 Days)||0
10606945|NCT03846453|11764534|FG000|STARTED|Randomized Treatment Period (Days 57±3)|All participants who completed the placebo run-in period and qualified were randomized to either 0.25% HL036 Ophthalmic Solution group or placebo group.|0
10606946|NCT03846453|11764535|FG001|STARTED|Randomized Treatment Period (Days 57±3)||318
10704365|NCT02590588|11868751|FG000|COMPLETED|Overall Study||0
10704366|NCT02590588|11868751|FG000|NOT COMPLETED|Overall Study||1
10704367|NCT02590939|11868757|FG000|STARTED|Overall Study||52
10704368|NCT02590939|11868758|FG001|STARTED|Overall Study||54
10704369|NCT02590939|11868757|FG000|COMPLETED|Overall Study||47
10704370|NCT02590939|11868758|FG001|COMPLETED|Overall Study||52
10704371|NCT02590939|11868757|FG000|NOT COMPLETED|Overall Study||5
10704372|NCT02590939|11868758|FG001|NOT COMPLETED|Overall Study||2
10704373|NCT02591056|11868764|FG000|STARTED|Overall Study||27
10704374|NCT02591056|11868764|FG000|COMPLETED|Overall Study||27
10704375|NCT02591056|11868764|FG000|NOT COMPLETED|Overall Study||0
10704376|NCT02591238|11868772|FG000|STARTED|Overall Study||16
10704377|NCT02591238|11868773|FG001|STARTED|Overall Study||17
10704378|NCT02591238|11868774|FG002|STARTED|Overall Study||17
10704379|NCT02591238|11868775|FG003|STARTED|Overall Study||18
10704380|NCT02591238|11868772|FG000|COMPLETED|Overall Study||15
10704381|NCT02591238|11868773|FG001|COMPLETED|Overall Study||16
10704382|NCT02591238|11868774|FG002|COMPLETED|Overall Study||17
10704383|NCT02591238|11868775|FG003|COMPLETED|Overall Study||15
10704384|NCT02591238|11868772|FG000|NOT COMPLETED|Overall Study||1
10704385|NCT02591238|11868773|FG001|NOT COMPLETED|Overall Study||1
10704386|NCT02591238|11868774|FG002|NOT COMPLETED|Overall Study||0
10704387|NCT02591238|11868775|FG003|NOT COMPLETED|Overall Study||3
10704388|NCT02591290|11868785|FG000|STARTED|Overall Study||60
10704389|NCT02591290|11868785|FG000|Vaccinated Dose 1|Overall Study||60
10704390|NCT02591290|11868785|FG000|Vaccinated Dose 2|Overall Study||58
10704391|NCT02591290|11868785|FG000|COMPLETED|Overall Study||58
10704392|NCT02591290|11868785|FG000|NOT COMPLETED|Overall Study||2
10704393|NCT02591511|11868791|FG000|STARTED|Overall Study||30
10704394|NCT02591511|11868792|FG001|STARTED|Overall Study||33
10704395|NCT02591511|11868791|FG000|COMPLETED|Overall Study||30
10704396|NCT02591511|11868792|FG001|COMPLETED|Overall Study||33
10704397|NCT02591511|11868791|FG000|NOT COMPLETED|Overall Study||0
10704398|NCT02591511|11868792|FG001|NOT COMPLETED|Overall Study||0
10704399|NCT02591537|11868800|FG000|STARTED|Overall Study||8
10704400|NCT02591537|11868801|FG001|STARTED|Overall Study||8
10704401|NCT02591537|11868800|FG000|COMPLETED|Overall Study||8
10704402|NCT02591537|11868801|FG001|COMPLETED|Overall Study||8
10704403|NCT02591537|11868800|FG000|NOT COMPLETED|Overall Study||0
10704404|NCT02591537|11868801|FG001|NOT COMPLETED|Overall Study||0
10606947|NCT03846453|11764536|FG002|STARTED|Randomized Treatment Period (Days 57±3)||319
10606948|NCT03846453|11764534|FG000|COMPLETED|Randomized Treatment Period (Days 57±3)||0
10606949|NCT03846453|11764535|FG001|COMPLETED|Randomized Treatment Period (Days 57±3)||291
10606950|NCT03846453|11764536|FG002|COMPLETED|Randomized Treatment Period (Days 57±3)||294
10606951|NCT03846453|11764534|FG000|NOT COMPLETED|Randomized Treatment Period (Days 57±3)||0
10606952|NCT03846453|11764535|FG001|NOT COMPLETED|Randomized Treatment Period (Days 57±3)||27
10704405|NCT02592018|11868808|FG000|STARTED|Overall Study||15
10704406|NCT02592018|11868808|FG000|COMPLETED|Overall Study||13
10606953|NCT03846453|11764536|FG002|NOT COMPLETED|Randomized Treatment Period (Days 57±3)||25
10652858|NCT02188303|11813226|FG005|COMPLETED|Overall Study||10
10704407|NCT02592018|11868808|FG000|NOT COMPLETED|Overall Study||2
10704408|NCT02592421|11868814|FG000|STARTED|Study 1||20
10704409|NCT02592421|11868815|FG001|STARTED|Study 1||10
10704410|NCT02592421|11868814|FG000|COMPLETED|Study 1||20
10704411|NCT02592421|11868815|FG001|COMPLETED|Study 1||10
10652859|NCT02188303|11813227|FG006|COMPLETED|Overall Study|Protocol-defined dose termination criteria met, dosing stopped on Day 5 and study was terminated.|0
10652860|NCT02188303|11813228|FG007|COMPLETED|Overall Study|Protocol-defined dose termination criteria met, dosing stopped on Day 5 and study was terminated.|0
10652861|NCT02188303|11813221|FG000|NOT COMPLETED|Overall Study||0
10652862|NCT02188303|11813222|FG001|NOT COMPLETED|Overall Study||0
10652863|NCT02188303|11813223|FG002|NOT COMPLETED|Overall Study||0
10652864|NCT02188303|11813224|FG003|NOT COMPLETED|Overall Study||0
10652865|NCT02188303|11813225|FG004|NOT COMPLETED|Overall Study||0
10652866|NCT02188303|11813226|FG005|NOT COMPLETED|Overall Study||2
10652867|NCT02188303|11813227|FG006|NOT COMPLETED|Overall Study||2
10652868|NCT02188303|11813228|FG007|NOT COMPLETED|Overall Study||6
10652869|NCT02188459|11813254|FG000|STARTED|Overall Study||64
10652870|NCT02188459|11813255|FG001|STARTED|Overall Study||65
10652871|NCT02188459|11813254|FG000|COMPLETED|Overall Study||61
10652872|NCT02188459|11813255|FG001|COMPLETED|Overall Study||58
10652873|NCT02188459|11813254|FG000|NOT COMPLETED|Overall Study||3
10652874|NCT02188459|11813255|FG001|NOT COMPLETED|Overall Study||7
10652875|NCT02188485|11813267|FG000|STARTED|Overall Study||32
10652876|NCT02188485|11813268|FG001|STARTED|Overall Study||30
10652877|NCT02188485|11813267|FG000|COMPLETED|Overall Study||30
10652878|NCT02188485|11813268|FG001|COMPLETED|Overall Study||27
10652879|NCT02188485|11813267|FG000|NOT COMPLETED|Overall Study||2
10652880|NCT02188485|11813268|FG001|NOT COMPLETED|Overall Study||3
10652881|NCT02188576|11813276|FG000|STARTED|Overall Study||32
10652882|NCT02188576|11813277|FG001|STARTED|Overall Study||34
10652883|NCT02188576|11813276|FG000|COMPLETED|Overall Study||32
10652884|NCT02188576|11813277|FG001|COMPLETED|Overall Study||34
10652885|NCT02188576|11813276|FG000|NOT COMPLETED|Overall Study||0
10652886|NCT02188576|11813277|FG001|NOT COMPLETED|Overall Study||0
10652887|NCT02188589|11813283|FG000|STARTED|Overall Study||30
10652888|NCT02188589|11813283|FG000|6 Months|Overall Study||30
10652889|NCT02188589|11813283|FG000|12 Months|Overall Study||30
10652890|NCT02188589|11813283|FG000|24 Months|Overall Study||25
10652891|NCT02188589|11813283|FG000|COMPLETED|Overall Study||25
10652892|NCT02188589|11813283|FG000|NOT COMPLETED|Overall Study||5
10652893|NCT02188719|11813292|FG000|STARTED|Overall Study||6
10652894|NCT02188719|11813293|FG001|STARTED|Overall Study||9
10652895|NCT02188719|11813294|FG002|STARTED|Overall Study||0
10652896|NCT02188719|11813295|FG003|STARTED|Overall Study||0
10652897|NCT02188719|11813292|FG000|COMPLETED|Overall Study||6
10652898|NCT02188719|11813293|FG001|COMPLETED|Overall Study||8
10652899|NCT02188719|11813294|FG002|COMPLETED|Overall Study||0
10652900|NCT02188719|11813295|FG003|COMPLETED|Overall Study||0
10652901|NCT02188719|11813292|FG000|NOT COMPLETED|Overall Study||0
10652902|NCT02188719|11813293|FG001|NOT COMPLETED|Overall Study||1
10652903|NCT02188719|11813294|FG002|NOT COMPLETED|Overall Study||0
10652904|NCT02188719|11813295|FG003|NOT COMPLETED|Overall Study||0
10652905|NCT02188784|11813305|FG000|STARTED|Overall Study||111
10652906|NCT02188784|11813306|FG001|STARTED|Overall Study||114
10652907|NCT02188784|11813305|FG000|COMPLETED|Overall Study|Patients completing the protocol excluding death, lost to follow-up and withdrawn consent.|102
10652908|NCT02188784|11813306|FG001|COMPLETED|Overall Study|Patients completing the protocol excluding death, lost to follow-up and withdrawn consent.|101
10652909|NCT02188784|11813305|FG000|NOT COMPLETED|Overall Study||9
10652910|NCT02188784|11813306|FG001|NOT COMPLETED|Overall Study||13
10652911|NCT02188849|11813314|FG000|STARTED|Overall Study||25
10652912|NCT02188849|11813315|FG001|STARTED|Overall Study||25
10652913|NCT02188849|11813314|FG000|COMPLETED|Overall Study||22
10652914|NCT02188849|11813315|FG001|COMPLETED|Overall Study||17
10652915|NCT02188849|11813314|FG000|NOT COMPLETED|Overall Study||3
10652916|NCT02188849|11813315|FG001|NOT COMPLETED|Overall Study||8
10652917|NCT02189122|11813323|FG000|STARTED|Overall Study||18
10652918|NCT02189122|11813324|FG001|STARTED|Overall Study||18
10652919|NCT02189122|11813323|FG000|COMPLETED|Overall Study||18
10652920|NCT02189122|11813324|FG001|COMPLETED|Overall Study||18
10652921|NCT02189122|11813323|FG000|NOT COMPLETED|Overall Study||0
10652922|NCT02189122|11813324|FG001|NOT COMPLETED|Overall Study||0
10652923|NCT02189161|11813332|FG000|STARTED|Overall Study||10
10652924|NCT02189161|11813332|FG000|COMPLETED|Overall Study||10
10652925|NCT02189161|11813332|FG000|NOT COMPLETED|Overall Study||0
10652926|NCT02189213|11813338|FG000|STARTED|Overall Study||13
10652927|NCT02189213|11813339|FG001|STARTED|Overall Study||1
10652928|NCT02189213|11813338|FG000|COMPLETED|Overall Study||7
10704412|NCT02592421|11868814|FG000|NOT COMPLETED|Study 1||0
10704413|NCT02592421|11868815|FG001|NOT COMPLETED|Study 1||0
10652929|NCT02189213|11813339|FG001|COMPLETED|Overall Study||1
10652930|NCT02189213|11813338|FG000|NOT COMPLETED|Overall Study||6
10652931|NCT02189213|11813339|FG001|NOT COMPLETED|Overall Study||0
10652932|NCT02189252|11813349|FG000|STARTED|Period 1 (Visit 4b, Week 4)||4
10652933|NCT02189252|11813350|FG001|STARTED|Period 1 (Visit 4b, Week 4)||4
10652934|NCT02189252|11813351|FG002|STARTED|Period 1 (Visit 4b, Week 4)||3
10652935|NCT02189252|11813352|FG003|STARTED|Period 1 (Visit 4b, Week 4)||4
10652936|NCT02189252|11813349|FG000|COMPLETED|Period 1 (Visit 4b, Week 4)||4
10704414|NCT02592421|11868814|FG000|STARTED|Study 2: Glucose Clamp Conditions||20
10606954|NCT03605862|11764546|FG000|STARTED|Overall Study||872
10606955|NCT03605862|11764547|FG001|STARTED|Overall Study||884
10606956|NCT03605862|11764546|FG000|COMPLETED|Overall Study||844
10606957|NCT03605862|11764547|FG001|COMPLETED|Overall Study||858
10606958|NCT03605862|11764546|FG000|NOT COMPLETED|Overall Study||28
10606959|NCT03605862|11764547|FG001|NOT COMPLETED|Overall Study||26
10606960|NCT03541252|11764554|FG000|STARTED|Overall Study||20
10606961|NCT03541252|11764554|FG000|COMPLETED|Overall Study||19
10606962|NCT03541252|11764554|FG000|NOT COMPLETED|Overall Study||1
10606963|NCT03401112|11764563|FG000|STARTED|Overall Study||15
10606964|NCT03401112|11764564|FG001|STARTED|Overall Study||26
10606965|NCT03401112|11764565|FG002|STARTED|Overall Study||22
10606966|NCT03401112|11764566|FG003|STARTED|Overall Study||27
10606967|NCT03401112|11764567|FG004|STARTED|Overall Study||10
10606968|NCT03401112|11764563|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12
10606969|NCT03401112|11764564|FG001|Received at Least 1 Dose of Study Drug|Overall Study||26
10606970|NCT03401112|11764565|FG002|Received at Least 1 Dose of Study Drug|Overall Study||20
10606971|NCT03401112|11764566|FG003|Received at Least 1 Dose of Study Drug|Overall Study||25
10606972|NCT03401112|11764567|FG004|Received at Least 1 Dose of Study Drug|Overall Study||10
10606973|NCT03401112|11764563|FG000|COMPLETED|Overall Study||10
10606974|NCT03401112|11764564|FG001|COMPLETED|Overall Study||19
10606975|NCT03401112|11764565|FG002|COMPLETED|Overall Study||11
10606976|NCT03401112|11764566|FG003|COMPLETED|Overall Study||21
10606977|NCT03401112|11764567|FG004|COMPLETED|Overall Study||10
10606978|NCT03401112|11764563|FG000|NOT COMPLETED|Overall Study||5
10606979|NCT03401112|11764564|FG001|NOT COMPLETED|Overall Study||7
10606980|NCT03401112|11764565|FG002|NOT COMPLETED|Overall Study||11
10606981|NCT03401112|11764566|FG003|NOT COMPLETED|Overall Study||6
10606982|NCT03401112|11764567|FG004|NOT COMPLETED|Overall Study||0
10606983|NCT03362112|11764594|FG000|STARTED|Overall Study||1713
10606984|NCT03362112|11764594|FG000|COMPLETED|Overall Study||1622
10606985|NCT03362112|11764594|FG000|NOT COMPLETED|Overall Study||91
10606986|NCT03158298|11764598|FG000|STARTED|Overall Study||82
10606987|NCT03158298|11764598|FG000|COMPLETED|Overall Study||82
10606988|NCT03158298|11764598|FG000|NOT COMPLETED|Overall Study||0
10606989|NCT03041701|11764605|FG000|STARTED|Ph I: Dose Level 1 and 2 Dose Escalation||7
10606990|NCT03041701|11764606|FG001|STARTED|Ph I: Dose Level 1 and 2 Dose Escalation||6
10606991|NCT03041701|11764607|FG002|STARTED|Ph I: Dose Level 1 and 2 Dose Escalation||0
10606992|NCT03041701|11764605|FG000|COMPLETED|Ph I: Dose Level 1 and 2 Dose Escalation||6
10606993|NCT03041701|11764606|FG001|COMPLETED|Ph I: Dose Level 1 and 2 Dose Escalation||5
10606994|NCT03041701|11764607|FG002|COMPLETED|Ph I: Dose Level 1 and 2 Dose Escalation||0
10606995|NCT03041701|11764605|FG000|NOT COMPLETED|Ph I: Dose Level 1 and 2 Dose Escalation||1
10606996|NCT03041701|11764606|FG001|NOT COMPLETED|Ph I: Dose Level 1 and 2 Dose Escalation||1
10606997|NCT03041701|11764607|FG002|NOT COMPLETED|Ph I: Dose Level 1 and 2 Dose Escalation||0
10606998|NCT03041701|11764605|FG000|STARTED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0
10606999|NCT03041701|11764606|FG001|STARTED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0
10607000|NCT03041701|11764607|FG002|STARTED|Ph 2:Dose Level 1 Maximum Tolerated Dose||1
10607001|NCT03041701|11764605|FG000|COMPLETED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0
10607002|NCT03041701|11764606|FG001|COMPLETED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0
10607003|NCT03041701|11764607|FG002|COMPLETED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0
10607004|NCT03041701|11764605|FG000|NOT COMPLETED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0
10607005|NCT03041701|11764606|FG001|NOT COMPLETED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0
10607006|NCT03041701|11764607|FG002|NOT COMPLETED|Ph 2:Dose Level 1 Maximum Tolerated Dose||1
10607007|NCT03000179|11764618|FG000|STARTED|Overall Study||8
10607008|NCT03000179|11764618|FG000|COMPLETED|Overall Study||6
10607009|NCT03000179|11764618|FG000|NOT COMPLETED|Overall Study||2
10607010|NCT02876835|11764624|FG000|STARTED|Run-in Period: Placebo (Week-4 to Day 1)||1937
10607011|NCT02876835|11764625|FG001|STARTED|Run-in Period: Placebo (Week-4 to Day 1)||1935
10607012|NCT02876835|11764624|FG000|COMPLETED|Run-in Period: Placebo (Week-4 to Day 1)||1937
10607013|NCT02876835|11764625|FG001|COMPLETED|Run-in Period: Placebo (Week-4 to Day 1)||1935
10607014|NCT02876835|11764624|FG000|NOT COMPLETED|Run-in Period: Placebo (Week-4 to Day 1)||0
10607015|NCT02876835|11764625|FG001|NOT COMPLETED|Run-in Period: Placebo (Week-4 to Day 1)||0
10607016|NCT02876835|11764624|FG000|STARTED|Treatment Period (51.1 Month)||1937
10607017|NCT02876835|11764625|FG001|STARTED|Treatment Period (51.1 Month)||1935
10607018|NCT02876835|11764624|FG000|COMPLETED|Treatment Period (51.1 Month)||1873
10607019|NCT02876835|11764625|FG001|COMPLETED|Treatment Period (51.1 Month)||1870
10607020|NCT02876835|11764624|FG000|NOT COMPLETED|Treatment Period (51.1 Month)||64
10607021|NCT02876835|11764625|FG001|NOT COMPLETED|Treatment Period (51.1 Month)||65
10808735|NCT03844945|11970698|FG001|NOT COMPLETED|Overall Study||1
10808736|NCT03844945|11970699|FG002|NOT COMPLETED|Overall Study||5
10808737|NCT03844945|11970700|FG003|NOT COMPLETED|Overall Study||1
10808738|NCT03844321|11970712|FG000|STARTED|Overall Study||2220
10808739|NCT03844321|11970713|FG001|STARTED|Overall Study||2192
10808740|NCT03844321|11970712|FG000|COMPLETED|Overall Study||579
10808741|NCT03844321|11970713|FG001|COMPLETED|Overall Study||533
10808742|NCT03844321|11970712|FG000|NOT COMPLETED|Overall Study||1641
10808743|NCT03844321|11970713|FG001|NOT COMPLETED|Overall Study||1659
10808744|NCT03843632|11970723|FG000|STARTED|Overall Study||50
10808745|NCT03843632|11970724|FG001|STARTED|Overall Study||30
10808746|NCT03843632|11970725|FG002|STARTED|Overall Study||33
10808747|NCT03843632|11970726|FG003|STARTED|Overall Study||37
10808748|NCT03843632|11970723|FG000|Vaccination 1|Overall Study||50
10808749|NCT03843632|11970724|FG001|Vaccination 1|Overall Study||30
10808750|NCT03843632|11970725|FG002|Vaccination 1|Overall Study||33
10808751|NCT03843632|11970726|FG003|Vaccination 1|Overall Study||37
10808752|NCT03843632|11970723|FG000|Vaccination 2|Overall Study||49
10808753|NCT03843632|11970724|FG001|Vaccination 2|Overall Study||30
10808754|NCT03843632|11970725|FG002|Vaccination 2|Overall Study||0
10808755|NCT03843632|11970726|FG003|Vaccination 2|Overall Study||0
10808756|NCT03843632|11970723|FG000|COMPLETED|Overall Study||49
10652937|NCT02189252|11813350|FG001|COMPLETED|Period 1 (Visit 4b, Week 4)||2
10652938|NCT02189252|11813351|FG002|COMPLETED|Period 1 (Visit 4b, Week 4)||3
10652939|NCT02189252|11813352|FG003|COMPLETED|Period 1 (Visit 4b, Week 4)||4
10652940|NCT02189252|11813349|FG000|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
10652941|NCT02189252|11813350|FG001|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||2
10652942|NCT02189252|11813351|FG002|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
10652943|NCT02189252|11813352|FG003|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
10652944|NCT02189252|11813349|FG000|STARTED|Period 2 (Visit6b, Week 12)||4
10652945|NCT02189252|11813350|FG001|STARTED|Period 2 (Visit6b, Week 12)||2
10652946|NCT02189252|11813351|FG002|STARTED|Period 2 (Visit6b, Week 12)||3
10652947|NCT02189252|11813352|FG003|STARTED|Period 2 (Visit6b, Week 12)||4
10652948|NCT02189252|11813349|FG000|COMPLETED|Period 2 (Visit6b, Week 12)||4
10652949|NCT02189252|11813350|FG001|COMPLETED|Period 2 (Visit6b, Week 12)||2
10652950|NCT02189252|11813351|FG002|COMPLETED|Period 2 (Visit6b, Week 12)||3
10652951|NCT02189252|11813352|FG003|COMPLETED|Period 2 (Visit6b, Week 12)||4
10652952|NCT02189252|11813349|FG000|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
10652953|NCT02189252|11813350|FG001|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
10652954|NCT02189252|11813351|FG002|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
10652955|NCT02189252|11813352|FG003|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
10652956|NCT02189317|11813365|FG000|STARTED|Overall Study||16
10652957|NCT02189317|11813366|FG001|STARTED|Overall Study||16
10652958|NCT02189317|11813365|FG000|COMPLETED|Overall Study||16
10652959|NCT02189317|11813366|FG001|COMPLETED|Overall Study||16
10652960|NCT02189317|11813365|FG000|NOT COMPLETED|Overall Study||0
10652961|NCT02189317|11813366|FG001|NOT COMPLETED|Overall Study||0
10652962|NCT02189382|11813374|FG000|STARTED|Overall Study||35
10652963|NCT02189382|11813375|FG001|STARTED|Overall Study||35
10652964|NCT02189382|11813374|FG000|COMPLETED|Overall Study||35
10652965|NCT02189382|11813375|FG001|COMPLETED|Overall Study||35
10652966|NCT02189382|11813374|FG000|NOT COMPLETED|Overall Study||0
10652967|NCT02189382|11813375|FG001|NOT COMPLETED|Overall Study||0
10652968|NCT02189473|11813383|FG000|STARTED|Overall Study||101
10652969|NCT02189473|11813384|FG001|STARTED|Overall Study||102
10652970|NCT02189473|11813383|FG000|COMPLETED|Overall Study||78
10652971|NCT02189473|11813384|FG001|COMPLETED|Overall Study||77
10652972|NCT02189473|11813383|FG000|NOT COMPLETED|Overall Study||23
10652973|NCT02189473|11813384|FG001|NOT COMPLETED|Overall Study||25
10652974|NCT02189629|11813390|FG000|STARTED|Overall Study||453
10652975|NCT02189629|11813390|FG000|COMPLETED|Overall Study||348
10652976|NCT02189629|11813390|FG000|NOT COMPLETED|Overall Study||105
10652977|NCT02189668|11813396|FG000|STARTED|Overall Study||5
10652978|NCT02189668|11813397|FG001|STARTED|Overall Study||9
10652979|NCT02189668|11813396|FG000|COMPLETED|Overall Study||5
10652980|NCT02189668|11813397|FG001|COMPLETED|Overall Study||9
10652981|NCT02189668|11813396|FG000|NOT COMPLETED|Overall Study||0
10652982|NCT02189668|11813397|FG001|NOT COMPLETED|Overall Study||0
10652983|NCT02189759|11813407|FG000|STARTED|Overall Study||102
10652984|NCT02189759|11813408|FG001|STARTED|Overall Study||101
10652985|NCT02189759|11813409|FG002|STARTED|Overall Study||83
10652986|NCT02189759|11813410|FG003|STARTED|Overall Study||89
10652987|NCT02189759|11813407|FG000|COMPLETED|Overall Study||102
10652988|NCT02189759|11813408|FG001|COMPLETED|Overall Study||101
10652989|NCT02189759|11813409|FG002|COMPLETED|Overall Study||81
10652990|NCT02189759|11813410|FG003|COMPLETED|Overall Study||84
10652991|NCT02189759|11813407|FG000|NOT COMPLETED|Overall Study||0
10652992|NCT02189759|11813408|FG001|NOT COMPLETED|Overall Study||0
10652993|NCT02189759|11813409|FG002|NOT COMPLETED|Overall Study||2
10652994|NCT02189759|11813410|FG003|NOT COMPLETED|Overall Study||5
10652995|NCT02189837|11813426|FG000|STARTED|Overall Study||22
10652996|NCT02189837|11813427|FG001|STARTED|Overall Study||23
10652997|NCT02189837|11813428|FG002|STARTED|Overall Study||23
10652998|NCT02189837|11813429|FG003|STARTED|Overall Study||21
10652999|NCT02189837|11813426|FG000|Received Treatment|Overall Study||21
10653000|NCT02189837|11813427|FG001|Received Treatment|Overall Study||22
10653001|NCT02189837|11813428|FG002|Received Treatment|Overall Study||22
10653002|NCT02189837|11813429|FG003|Received Treatment|Overall Study||20
10653003|NCT02189837|11813426|FG000|COMPLETED|Overall Study||20
10653004|NCT02189837|11813427|FG001|COMPLETED|Overall Study||22
10653005|NCT02189837|11813428|FG002|COMPLETED|Overall Study||20
10653006|NCT02189837|11813429|FG003|COMPLETED|Overall Study||19
10653007|NCT02189837|11813426|FG000|NOT COMPLETED|Overall Study||2
10653008|NCT02189837|11813427|FG001|NOT COMPLETED|Overall Study||1
10653009|NCT02189837|11813428|FG002|NOT COMPLETED|Overall Study||3
10653010|NCT02189837|11813429|FG003|NOT COMPLETED|Overall Study||2
10653011|NCT02189850|11813441|FG000|STARTED|Overall Study||16
10653012|NCT02189850|11813442|FG001|STARTED|Overall Study||13
10653013|NCT02189850|11813441|FG000|COMPLETED|Overall Study||14
10653014|NCT02189850|11813442|FG001|COMPLETED|Overall Study||11
10653015|NCT02189850|11813441|FG000|NOT COMPLETED|Overall Study||2
10653016|NCT02189850|11813442|FG001|NOT COMPLETED|Overall Study||2
10653017|NCT02189863|11813448|FG000|STARTED|First 2 Weeks||12
10653018|NCT02189863|11813449|FG001|STARTED|First 2 Weeks||15
10653019|NCT02189863|11813448|FG000|COMPLETED|First 2 Weeks||8
10607047|NCT02482389|11764645|FG000|STARTED|Overall Study||3
10607048|NCT02482389|11764645|FG000|COMPLETED|Overall Study||3
10607049|NCT02482389|11764645|FG000|NOT COMPLETED|Overall Study||0
10607050|NCT02232282|11764651|FG000|STARTED|Overall Study||10
10607051|NCT02232282|11764652|FG001|STARTED|Overall Study||12
10607052|NCT02232282|11764651|FG000|COMPLETED|Overall Study||10
10607053|NCT02232282|11764652|FG001|COMPLETED|Overall Study||11
10607054|NCT02232282|11764651|FG000|NOT COMPLETED|Overall Study||0
10607055|NCT02232282|11764652|FG001|NOT COMPLETED|Overall Study||1
10607056|NCT01492361|11764664|FG000|STARTED|Overall Study||4089
10607057|NCT01492361|11764665|FG001|STARTED|Overall Study||4090
10607058|NCT01492361|11764664|FG000|Completed Final Visit|Overall Study||3419
10607059|NCT01492361|11764665|FG001|Completed Final Visit|Overall Study||3335
10607060|NCT01492361|11764664|FG000|Death Before Final Visit|Overall Study||265
10607061|NCT01492361|11764665|FG001|Death Before Final Visit|Overall Study||295
10607062|NCT01492361|11764664|FG000|COMPLETED|Overall Study||3684
10607063|NCT01492361|11764665|FG001|COMPLETED|Overall Study||3630
10607064|NCT01492361|11764664|FG000|NOT COMPLETED|Overall Study||405
10607065|NCT01492361|11764665|FG001|NOT COMPLETED|Overall Study||460
10607066|NCT01296711|11764679|FG000|STARTED|Overall Study||20
10607067|NCT01296711|11764680|FG001|STARTED|Overall Study||20
10607068|NCT01296711|11764681|FG002|STARTED|Overall Study||21
10607069|NCT01296711|11764682|FG003|STARTED|Overall Study||20
10607070|NCT01296711|11764683|FG004|STARTED|Overall Study||17
10607071|NCT01296711|11764684|FG005|STARTED|Overall Study||16
10607072|NCT01296711|11764685|FG006|STARTED|Overall Study||40
10607073|NCT01296711|11764686|FG007|STARTED|Overall Study||36
10607074|NCT01296711|11764679|FG000|COMPLETED|Overall Study||4
10607075|NCT01296711|11764680|FG001|COMPLETED|Overall Study||12
10607076|NCT01296711|11764681|FG002|COMPLETED|Overall Study||8
10607077|NCT01296711|11764682|FG003|COMPLETED|Overall Study||7
10607078|NCT01296711|11764683|FG004|COMPLETED|Overall Study||7
10607079|NCT01296711|11764684|FG005|COMPLETED|Overall Study||5
10607080|NCT01296711|11764685|FG006|COMPLETED|Overall Study||9
10607081|NCT01296711|11764686|FG007|COMPLETED|Overall Study||15
10607082|NCT01296711|11764679|FG000|NOT COMPLETED|Overall Study||16
10607083|NCT01296711|11764680|FG001|NOT COMPLETED|Overall Study||8
10607084|NCT01296711|11764681|FG002|NOT COMPLETED|Overall Study||13
10607085|NCT01296711|11764682|FG003|NOT COMPLETED|Overall Study||13
10607086|NCT01296711|11764683|FG004|NOT COMPLETED|Overall Study||10
10607087|NCT01296711|11764684|FG005|NOT COMPLETED|Overall Study||11
10607088|NCT01296711|11764685|FG006|NOT COMPLETED|Overall Study||31
10607089|NCT01296711|11764686|FG007|NOT COMPLETED|Overall Study||21
10607090|NCT00084656|11764707|FG000|STARTED|Overall Study||25
10607091|NCT00084656|11764708|FG001|STARTED|Overall Study||25
10607092|NCT00084656|11764709|FG002|STARTED|Overall Study||26
10607093|NCT00084656|11764707|FG000|COMPLETED|Overall Study||0
10607094|NCT00084656|11764708|FG001|COMPLETED|Overall Study||0
10607095|NCT00084656|11764709|FG002|COMPLETED|Overall Study||0
10607096|NCT00084656|11764707|FG000|NOT COMPLETED|Overall Study||25
10607097|NCT00084656|11764708|FG001|NOT COMPLETED|Overall Study||25
10607098|NCT00084656|11764709|FG002|NOT COMPLETED|Overall Study||26
10607099|NCT01879735|11764721|FG000|STARTED|Overall Study||6
10607100|NCT01879735|11764722|FG001|STARTED|Overall Study||16
10607101|NCT01879735|11764721|FG000|COMPLETED|Overall Study||6
10607102|NCT01879735|11764722|FG001|COMPLETED|Overall Study||16
10607103|NCT01879735|11764721|FG000|NOT COMPLETED|Overall Study||0
10607104|NCT01879735|11764722|FG001|NOT COMPLETED|Overall Study||0
10607105|NCT01879800|11764730|FG000|STARTED|Overall Study||14
10607106|NCT01879800|11764731|FG001|STARTED|Overall Study||30
10607107|NCT01879800|11764730|FG000|COMPLETED|Overall Study||14
10607108|NCT01879800|11764731|FG001|COMPLETED|Overall Study||26
10607109|NCT01879800|11764730|FG000|NOT COMPLETED|Overall Study||0
10607110|NCT01879800|11764731|FG001|NOT COMPLETED|Overall Study||4
10607111|NCT01879826|11764739|FG000|STARTED|Overall Study||41
10607112|NCT01879826|11764740|FG001|STARTED|Overall Study||40
10607113|NCT01879826|11764739|FG000|COMPLETED|Overall Study||41
10607114|NCT01879826|11764740|FG001|COMPLETED|Overall Study||40
10607115|NCT01879826|11764739|FG000|NOT COMPLETED|Overall Study||0
10607116|NCT01879826|11764740|FG001|NOT COMPLETED|Overall Study||0
10607117|NCT01879852|11764748|FG000|STARTED|Overall Study||14
10607118|NCT01879852|11764749|FG001|STARTED|Overall Study||13
10607119|NCT01879852|11764748|FG000|COMPLETED|Overall Study||12
10607120|NCT01879852|11764749|FG001|COMPLETED|Overall Study||13
10607121|NCT01879852|11764748|FG000|NOT COMPLETED|Overall Study||2
10607122|NCT01879852|11764749|FG001|NOT COMPLETED|Overall Study||0
10607123|NCT01880047|11764759|FG000|STARTED|Weeks 0-2||17
10607124|NCT01880047|11764760|FG001|STARTED|Weeks 0-2||9
10607125|NCT01880047|11764761|FG002|STARTED|Weeks 0-2||5
10607126|NCT01880047|11764762|FG003|STARTED|Weeks 0-2||3
10607127|NCT01880047|11764759|FG000|COMPLETED|Weeks 0-2||17
10607128|NCT01880047|11764760|FG001|COMPLETED|Weeks 0-2||8
10607129|NCT01880047|11764761|FG002|COMPLETED|Weeks 0-2||4
10607130|NCT01880047|11764762|FG003|COMPLETED|Weeks 0-2||2
10607131|NCT01880047|11764759|FG000|NOT COMPLETED|Weeks 0-2||0
10607132|NCT01880047|11764760|FG001|NOT COMPLETED|Weeks 0-2||1
10607133|NCT01880047|11764761|FG002|NOT COMPLETED|Weeks 0-2||1
10607134|NCT01880047|11764762|FG003|NOT COMPLETED|Weeks 0-2||1
10607135|NCT01880047|11764759|FG000|STARTED|Weeks 3-4||17
10607136|NCT01880047|11764760|FG001|STARTED|Weeks 3-4||8
10607137|NCT01880047|11764761|FG002|STARTED|Weeks 3-4||4
10607138|NCT01880047|11764762|FG003|STARTED|Weeks 3-4||2
10607139|NCT01880047|11764759|FG000|COMPLETED|Weeks 3-4||17
10607140|NCT01880047|11764760|FG001|COMPLETED|Weeks 3-4||7
10607141|NCT01880047|11764761|FG002|COMPLETED|Weeks 3-4||4
10607142|NCT01880047|11764762|FG003|COMPLETED|Weeks 3-4||2
10607143|NCT01880047|11764759|FG000|NOT COMPLETED|Weeks 3-4||0
10607144|NCT01880047|11764760|FG001|NOT COMPLETED|Weeks 3-4||1
10607145|NCT01880047|11764761|FG002|NOT COMPLETED|Weeks 3-4||0
10607146|NCT01880047|11764762|FG003|NOT COMPLETED|Weeks 3-4||0
10607147|NCT01880047|11764759|FG000|STARTED|Weeks 5-8||17
10607148|NCT01880047|11764760|FG001|STARTED|Weeks 5-8||7
10607149|NCT01880047|11764761|FG002|STARTED|Weeks 5-8||4
10607150|NCT01880047|11764762|FG003|STARTED|Weeks 5-8||2
10607151|NCT01880047|11764759|FG000|COMPLETED|Weeks 5-8||15
10607152|NCT01880047|11764760|FG001|COMPLETED|Weeks 5-8||6
10607153|NCT01880047|11764761|FG002|COMPLETED|Weeks 5-8||4
10607154|NCT01880047|11764762|FG003|COMPLETED|Weeks 5-8||2
10607155|NCT01880047|11764759|FG000|NOT COMPLETED|Weeks 5-8||2
10607156|NCT01880047|11764760|FG001|NOT COMPLETED|Weeks 5-8||1
10607157|NCT01880047|11764761|FG002|NOT COMPLETED|Weeks 5-8||0
10607158|NCT01880047|11764762|FG003|NOT COMPLETED|Weeks 5-8||0
10607159|NCT01880047|11764759|FG000|STARTED|Extension Phase - 18 Months|15 subjects went into extension phase, were followed for variable periods of time|15
10607160|NCT01880047|11764760|FG001|STARTED|Extension Phase - 18 Months|6 subjects went into extension phase, were followed for variable periods of time|6
10607161|NCT01880047|11764761|FG002|STARTED|Extension Phase - 18 Months|4 subjects went into extension phase, were followed for variable periods of time|4
10607162|NCT01880047|11764762|FG003|STARTED|Extension Phase - 18 Months|2 subjects went into extension phase, were followed for variable periods of time|2
10607163|NCT01880047|11764759|FG000|COMPLETED|Extension Phase - 18 Months||6
10607164|NCT01880047|11764760|FG001|COMPLETED|Extension Phase - 18 Months||3
10607165|NCT01880047|11764761|FG002|COMPLETED|Extension Phase - 18 Months||3
10607166|NCT01880047|11764762|FG003|COMPLETED|Extension Phase - 18 Months||0
10607167|NCT01880047|11764759|FG000|NOT COMPLETED|Extension Phase - 18 Months||9
10607168|NCT01880047|11764760|FG001|NOT COMPLETED|Extension Phase - 18 Months||3
10607169|NCT01880047|11764761|FG002|NOT COMPLETED|Extension Phase - 18 Months||1
10607170|NCT01880047|11764762|FG003|NOT COMPLETED|Extension Phase - 18 Months||2
10607171|NCT01880073|11764779|FG000|STARTED|Overall Study||24
10607172|NCT01880073|11764779|FG000|COMPLETED|Overall Study||24
10607173|NCT01880073|11764779|FG000|NOT COMPLETED|Overall Study||0
10607174|NCT01880086|11764785|FG000|STARTED|Overall Study||6
10607175|NCT01880086|11764786|FG001|STARTED|Overall Study||7
10607176|NCT01880086|11764785|FG000|COMPLETED|Overall Study||5
10607177|NCT01880086|11764786|FG001|COMPLETED|Overall Study||6
10607178|NCT01880086|11764785|FG000|NOT COMPLETED|Overall Study||1
10607179|NCT01880086|11764786|FG001|NOT COMPLETED|Overall Study||1
10607180|NCT01880099|11764795|FG000|STARTED|Overall Study||17
10607181|NCT01880099|11764796|FG001|STARTED|Overall Study||21
10607182|NCT01880099|11764797|FG002|STARTED|Overall Study||22
10607183|NCT01880099|11764795|FG000|COMPLETED|Overall Study||9
10607184|NCT01880099|11764796|FG001|COMPLETED|Overall Study||11
10607185|NCT01880099|11764797|FG002|COMPLETED|Overall Study||15
10607186|NCT01880099|11764795|FG000|NOT COMPLETED|Overall Study||8
10607187|NCT01880099|11764796|FG001|NOT COMPLETED|Overall Study||10
10607188|NCT01880099|11764797|FG002|NOT COMPLETED|Overall Study||7
10607189|NCT01880320|11764808|FG000|STARTED|Overall Study||217
10607190|NCT01880320|11764809|FG001|STARTED|Overall Study||217
10607191|NCT01880320|11764810|FG002|STARTED|Overall Study||69
10607192|NCT01880320|11764808|FG000|COMPLETED|Overall Study||197
10607193|NCT01880320|11764809|FG001|COMPLETED|Overall Study||192
10607194|NCT01880320|11764810|FG002|COMPLETED|Overall Study||61
10607195|NCT01880320|11764808|FG000|NOT COMPLETED|Overall Study||20
10607196|NCT01880320|11764809|FG001|NOT COMPLETED|Overall Study||25
10607197|NCT01880320|11764810|FG002|NOT COMPLETED|Overall Study||8
10607198|NCT01880424|11764820|FG000|STARTED|Overall Study||417
10607199|NCT01880424|11764821|FG001|STARTED|Overall Study||422
10607200|NCT01880424|11764820|FG000|COMPLETED|Overall Study||384
10607201|NCT01880424|11764821|FG001|COMPLETED|Overall Study||367
10607202|NCT01880424|11764820|FG000|NOT COMPLETED|Overall Study||33
10607203|NCT01880424|11764821|FG001|NOT COMPLETED|Overall Study||55
10607204|NCT01880437|11764830|FG000|STARTED|Overall Study||15
10607205|NCT01880437|11764831|FG001|STARTED|Overall Study||4
10607206|NCT01880437|11764832|FG002|STARTED|Overall Study||19
10607207|NCT01880437|11764830|FG000|COMPLETED|Overall Study||0
10607208|NCT01880437|11764831|FG001|COMPLETED|Overall Study||0
10607209|NCT01880437|11764832|FG002|COMPLETED|Overall Study||0
10607210|NCT01880437|11764830|FG000|NOT COMPLETED|Overall Study||15
10607211|NCT01880437|11764831|FG001|NOT COMPLETED|Overall Study||4
10607212|NCT01880437|11764832|FG002|NOT COMPLETED|Overall Study||19
10607213|NCT01880515|11764844|FG000|STARTED|Overall Study||53
10607214|NCT01880515|11764845|FG001|STARTED|Overall Study||54
10607215|NCT01880515|11764844|FG000|COMPLETED|Overall Study||45
10607216|NCT01880515|11764845|FG001|COMPLETED|Overall Study||45
10607217|NCT01880515|11764844|FG000|NOT COMPLETED|Overall Study||8
10607218|NCT01880515|11764845|FG001|NOT COMPLETED|Overall Study||9
10607219|NCT01880528|11764854|FG000|STARTED|Overall Study||12
10607220|NCT01880528|11764855|FG001|STARTED|Overall Study||11
10607221|NCT01880528|11764854|FG000|COMPLETED|Overall Study||11
10607222|NCT01880528|11764855|FG001|COMPLETED|Overall Study||10
10607223|NCT01880528|11764854|FG000|NOT COMPLETED|Overall Study||1
10607224|NCT01880528|11764855|FG001|NOT COMPLETED|Overall Study||1
10607225|NCT01880554|11764861|FG000|STARTED|Overall Study|Patients enrolled in the study|68
10607226|NCT01880554|11764861|FG000|Population Eligible|Overall Study||58
10607227|NCT01880554|11764861|FG000|Population Eligible and Assessable|Overall Study||54
10607228|NCT01880554|11764861|FG000|COMPLETED|Overall Study|Patients eligible and assessable according to two-stage Simon's design (primary outcome)|52
10607229|NCT01880554|11764861|FG000|NOT COMPLETED|Overall Study||16
10607230|NCT01880593|11764868|FG000|STARTED|Overall Study||18
10607231|NCT01880593|11764869|FG001|STARTED|Overall Study||16
10607232|NCT01880593|11764868|FG000|COMPLETED|Overall Study||10
10607233|NCT01880593|11764869|FG001|COMPLETED|Overall Study||10
10607234|NCT01880593|11764868|FG000|NOT COMPLETED|Overall Study||8
10607235|NCT01880593|11764869|FG001|NOT COMPLETED|Overall Study||6
10607236|NCT01880697|11764877|FG000|STARTED|Overall Study||63
10607237|NCT01880697|11764878|FG001|STARTED|Overall Study||63
10607238|NCT01880697|11764877|FG000|COMPLETED|Overall Study||63
10607239|NCT01880697|11764878|FG001|COMPLETED|Overall Study||62
10607240|NCT01880697|11764877|FG000|NOT COMPLETED|Overall Study||0
10607241|NCT01880697|11764878|FG001|NOT COMPLETED|Overall Study||1
10607242|NCT01880723|11764886|FG000|STARTED|Overall Study||16
10607243|NCT01880723|11764887|FG001|STARTED|Overall Study||16
10607244|NCT01880723|11764886|FG000|COMPLETED|Overall Study||16
10607245|NCT01880723|11764887|FG001|COMPLETED|Overall Study||16
10607246|NCT01880723|11764886|FG000|NOT COMPLETED|Overall Study||0
10607247|NCT01880723|11764887|FG001|NOT COMPLETED|Overall Study||0
10607248|NCT01880736|11764897|FG000|STARTED|Overall Study||114
10607249|NCT01880736|11764898|FG001|STARTED|Overall Study||115
10607250|NCT01880736|11764899|FG002|STARTED|Overall Study||115
10607251|NCT01880736|11764900|FG003|STARTED|Overall Study||114
10607252|NCT01880736|11764897|FG000|COMPLETED|Overall Study||113
10607253|NCT01880736|11764898|FG001|COMPLETED|Overall Study||113
10607254|NCT01880736|11764899|FG002|COMPLETED|Overall Study||114
10607255|NCT01880736|11764900|FG003|COMPLETED|Overall Study||108
10607256|NCT01880736|11764897|FG000|NOT COMPLETED|Overall Study||1
10607257|NCT01880736|11764898|FG001|NOT COMPLETED|Overall Study||2
10607258|NCT01880736|11764899|FG002|NOT COMPLETED|Overall Study||1
10607259|NCT01880736|11764900|FG003|NOT COMPLETED|Overall Study||6
10607260|NCT01880840|11764912|FG000|STARTED|Overall Study||95
10607261|NCT01880840|11764913|FG001|STARTED|Overall Study||96
10607262|NCT01880840|11764912|FG000|COMPLETED|Overall Study||87
10607263|NCT01880840|11764913|FG001|COMPLETED|Overall Study||91
10607264|NCT01880840|11764912|FG000|NOT COMPLETED|Overall Study||8
10607265|NCT01880840|11764913|FG001|NOT COMPLETED|Overall Study||5
10607266|NCT01881009|11764921|FG000|STARTED|Inpatient Safety Testing (22 Hours)||16
10607267|NCT01881009|11764922|FG001|STARTED|Inpatient Safety Testing (22 Hours)||0
10607268|NCT01881009|11764921|FG000|COMPLETED|Inpatient Safety Testing (22 Hours)||16
10607269|NCT01881009|11764922|FG001|COMPLETED|Inpatient Safety Testing (22 Hours)||0
10607270|NCT01881009|11764921|FG000|NOT COMPLETED|Inpatient Safety Testing (22 Hours)||0
10607271|NCT01881009|11764922|FG001|NOT COMPLETED|Inpatient Safety Testing (22 Hours)||0
10607272|NCT01881009|11764921|FG000|STARTED|Summer Camp Session (6 Days)||0
10607273|NCT01881009|11764922|FG001|STARTED|Summer Camp Session (6 Days)||22
10607274|NCT01881009|11764921|FG000|COMPLETED|Summer Camp Session (6 Days)||0
10607275|NCT01881009|11764922|FG001|COMPLETED|Summer Camp Session (6 Days)||21
10607276|NCT01881009|11764921|FG000|NOT COMPLETED|Summer Camp Session (6 Days)||0
10607277|NCT01881009|11764922|FG001|NOT COMPLETED|Summer Camp Session (6 Days)||1
10607278|NCT01881087|11764932|FG000|STARTED|Overall Study||60
10704415|NCT02592421|11868815|FG001|STARTED|Study 2: Glucose Clamp Conditions||10
10704416|NCT02592421|11868814|FG000|COMPLETED|Study 2: Glucose Clamp Conditions||20
10704417|NCT02592421|11868815|FG001|COMPLETED|Study 2: Glucose Clamp Conditions||10
10704418|NCT02592421|11868814|FG000|NOT COMPLETED|Study 2: Glucose Clamp Conditions||0
10704419|NCT02592421|11868815|FG001|NOT COMPLETED|Study 2: Glucose Clamp Conditions||0
10704420|NCT02592421|11868814|FG000|STARTED|Study 3: Pancreatic Clamp Conditions||20
10704421|NCT02592421|11868815|FG001|STARTED|Study 3: Pancreatic Clamp Conditions||10
10704422|NCT02592421|11868814|FG000|COMPLETED|Study 3: Pancreatic Clamp Conditions||20
10704423|NCT02592421|11868815|FG001|COMPLETED|Study 3: Pancreatic Clamp Conditions||10
10704424|NCT02592421|11868814|FG000|NOT COMPLETED|Study 3: Pancreatic Clamp Conditions||0
10704425|NCT02592421|11868815|FG001|NOT COMPLETED|Study 3: Pancreatic Clamp Conditions||0
10704426|NCT02592434|11868821|FG000|STARTED|Open-Label Phase (18 Weeks)||225
10704427|NCT02592434|11868822|FG001|STARTED|Open-Label Phase (18 Weeks)||0
10704428|NCT02592434|11868823|FG002|STARTED|Open-Label Phase (18 Weeks)||0
10704429|NCT02592434|11868821|FG000|Treated|Open-Label Phase (18 Weeks)||225
10607279|NCT01881087|11764933|FG001|STARTED|Overall Study||61
10607280|NCT01881087|11764934|FG002|STARTED|Overall Study||62
10607281|NCT01881087|11764932|FG000|COMPLETED|Overall Study||59
10704430|NCT02592434|11868822|FG001|Treated|Open-Label Phase (18 Weeks)||0
10607282|NCT01881087|11764933|FG001|COMPLETED|Overall Study||61
10607283|NCT01881087|11764934|FG002|COMPLETED|Overall Study||60
10607284|NCT01881087|11764932|FG000|NOT COMPLETED|Overall Study||1
10607285|NCT01881087|11764933|FG001|NOT COMPLETED|Overall Study||0
10607286|NCT01881087|11764934|FG002|NOT COMPLETED|Overall Study||2
10607287|NCT01881113|11764944|FG000|STARTED|Overall Study||51
10607288|NCT01881113|11764945|FG001|STARTED|Overall Study||50
10607289|NCT01881113|11764944|FG000|COMPLETED|Overall Study||43
10607290|NCT01881113|11764945|FG001|COMPLETED|Overall Study||44
10607291|NCT01881113|11764944|FG000|NOT COMPLETED|Overall Study||8
10607292|NCT01881113|11764945|FG001|NOT COMPLETED|Overall Study||6
10607293|NCT01881126|11764953|FG000|STARTED|Overall Study||47
10607294|NCT01881126|11764954|FG001|STARTED|Overall Study||46
10607295|NCT01881126|11764953|FG000|COMPLETED|Overall Study||46
10607296|NCT01881126|11764954|FG001|COMPLETED|Overall Study||44
10607297|NCT01881126|11764953|FG000|NOT COMPLETED|Overall Study||1
10607298|NCT01881126|11764954|FG001|NOT COMPLETED|Overall Study||2
10607299|NCT01881230|11764963|FG000|STARTED|Overall Study||61
10607300|NCT01881230|11764964|FG001|STARTED|Overall Study||64
10607301|NCT01881230|11764965|FG002|STARTED|Overall Study||66
10607302|NCT01881230|11764963|FG000|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of Investigational Product (IP)|60
10607303|NCT01881230|11764964|FG001|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of IP|64
10607304|NCT01881230|11764965|FG002|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of IP|64
10607305|NCT01881230|11764963|FG000|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|60
10607306|NCT01881230|11764964|FG001|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|64
10607307|NCT01881230|11764965|FG002|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|64
10607308|NCT01881230|11764963|FG000|COMPLETED|Overall Study|Not applicable according to the study design|0
10607309|NCT01881230|11764964|FG001|COMPLETED|Overall Study|Not applicable according to the study design|0
10607310|NCT01881230|11764965|FG002|COMPLETED|Overall Study|Not applicable according to the study design|0
10607311|NCT01881230|11764963|FG000|NOT COMPLETED|Overall Study||61
10607312|NCT01881230|11764964|FG001|NOT COMPLETED|Overall Study||64
10607313|NCT01881230|11764965|FG002|NOT COMPLETED|Overall Study||66
10607314|NCT01881373|11764976|FG000|STARTED|Baseline|Cross-sectional sample|1517
10607315|NCT01881373|11764977|FG001|STARTED|Baseline|Cross-sectional sample|1491
10607316|NCT01881373|11764978|FG002|STARTED|Baseline|Cross-sectional sample|1321
10607317|NCT01881373|11764976|FG000|COMPLETED|Baseline|Cross-sectional sample|1517
10607318|NCT01881373|11764977|FG001|COMPLETED|Baseline|Cross-sectional sample|1491
10607319|NCT01881373|11764978|FG002|COMPLETED|Baseline|Cross-sectional sample|1321
10607320|NCT01881373|11764976|FG000|NOT COMPLETED|Baseline||0
10607321|NCT01881373|11764977|FG001|NOT COMPLETED|Baseline||0
10607322|NCT01881373|11764978|FG002|NOT COMPLETED|Baseline||0
10607323|NCT01881373|11764976|FG000|STARTED|24 Months|Cross-sectional sample, independent of sample at baseline|1342
10607324|NCT01881373|11764977|FG001|STARTED|24 Months|Cross-sectional sample, independent of sample at baseline|1295
10607325|NCT01881373|11764978|FG002|STARTED|24 Months|Cross-sectional sample, independent of sample at baseline|1405
10607326|NCT01881373|11764976|FG000|COMPLETED|24 Months|Cross-sectional sample, independent of sample at baseline|1342
10607327|NCT01881373|11764977|FG001|COMPLETED|24 Months|Cross-sectional sample, independent of sample at baseline|1295
10607328|NCT01881373|11764978|FG002|COMPLETED|24 Months|Cross-sectional sample, independent of sample at baseline|1405
10607329|NCT01881373|11764976|FG000|NOT COMPLETED|24 Months||0
10607330|NCT01881373|11764977|FG001|NOT COMPLETED|24 Months||0
10607331|NCT01881373|11764978|FG002|NOT COMPLETED|24 Months||0
10607332|NCT01881412|11764992|FG000|STARTED|Overall Study||59
10607333|NCT01881412|11764993|FG001|STARTED|Overall Study||59
10607334|NCT01881412|11764992|FG000|COMPLETED|Overall Study||49
10607335|NCT01881412|11764993|FG001|COMPLETED|Overall Study||57
10607336|NCT01881412|11764992|FG000|NOT COMPLETED|Overall Study||10
10607337|NCT01881412|11764993|FG001|NOT COMPLETED|Overall Study||2
10607338|NCT01881620|11764999|FG000|STARTED|Overall Study||109
10607339|NCT01881620|11764999|FG000|COMPLETED|Overall Study|Eligible patients with PET-CT scanner performed AND interpretation of 2 pairs of observors available|105
10607340|NCT01881620|11764999|FG000|NOT COMPLETED|Overall Study||4
10607341|NCT01881737|11765003|FG000|STARTED|Overall Study|This is a pilot study|15
10607342|NCT01881737|11765003|FG000|Number Screened|Overall Study||15
10607343|NCT01881737|11765003|FG000|COMPLETED|Overall Study||10
10607344|NCT01881737|11765003|FG000|NOT COMPLETED|Overall Study||5
10607345|NCT01881750|11765011|FG000|STARTED|Overall Study||27
10607346|NCT01881750|11765012|FG001|STARTED|Overall Study||26
10607347|NCT01881750|11765011|FG000|COMPLETED|Overall Study||25
10607348|NCT01881750|11765012|FG001|COMPLETED|Overall Study||22
10607349|NCT01881750|11765011|FG000|NOT COMPLETED|Overall Study||2
10607350|NCT01881750|11765012|FG001|NOT COMPLETED|Overall Study||4
10607351|NCT01881776|11765023|FG000|STARTED|Overall Study||24
10607352|NCT01881776|11765024|FG001|STARTED|Overall Study||24
10607353|NCT01881776|11765025|FG002|STARTED|Overall Study||22
10607354|NCT01881776|11765023|FG000|COMPLETED|Overall Study||23
10607355|NCT01881776|11765024|FG001|COMPLETED|Overall Study||20
10607356|NCT01881776|11765025|FG002|COMPLETED|Overall Study||20
10607357|NCT01881776|11765023|FG000|NOT COMPLETED|Overall Study||1
10607358|NCT01881776|11765024|FG001|NOT COMPLETED|Overall Study||4
10607359|NCT01881776|11765025|FG002|NOT COMPLETED|Overall Study||2
10607360|NCT01881789|11765039|FG000|STARTED|Overall Study||3
10607361|NCT01881789|11765040|FG001|STARTED|Overall Study||7
10607362|NCT01881789|11765041|FG002|STARTED|Overall Study||3
10607363|NCT01881789|11765042|FG003|STARTED|Overall Study||3
10607364|NCT01881789|11765043|FG004|STARTED|Overall Study||2
10607365|NCT01881789|11765044|FG005|STARTED|Overall Study||3
10607366|NCT01881789|11765039|FG000|COMPLETED|Overall Study||0
10607367|NCT01881789|11765040|FG001|COMPLETED|Overall Study||0
10607368|NCT01881789|11765041|FG002|COMPLETED|Overall Study||0
10607369|NCT01881789|11765042|FG003|COMPLETED|Overall Study||0
10607370|NCT01881789|11765043|FG004|COMPLETED|Overall Study||0
10607371|NCT01881789|11765044|FG005|COMPLETED|Overall Study||0
10607372|NCT01881789|11765039|FG000|NOT COMPLETED|Overall Study||3
10607373|NCT01881789|11765040|FG001|NOT COMPLETED|Overall Study||7
10607374|NCT01881789|11765041|FG002|NOT COMPLETED|Overall Study||3
10607375|NCT01881789|11765042|FG003|NOT COMPLETED|Overall Study||3
10607376|NCT01881789|11765043|FG004|NOT COMPLETED|Overall Study||2
10607377|NCT01881789|11765044|FG005|NOT COMPLETED|Overall Study||3
10607378|NCT01881828|11765061|FG000|STARTED|Overall Study|23 excluded at randomization from enrollment|71
10607379|NCT01881828|11765062|FG001|STARTED|Overall Study|23 excluded from randomization from enrollment|69
10607380|NCT01881828|11765061|FG000|COMPLETED|Overall Study||71
10607381|NCT01881828|11765062|FG001|COMPLETED|Overall Study||69
10607382|NCT01881828|11765061|FG000|NOT COMPLETED|Overall Study||0
10607383|NCT01881828|11765062|FG001|NOT COMPLETED|Overall Study||0
10607384|NCT01881867|11765070|FG000|STARTED|Overall Study||26
10607385|NCT01881867|11765071|FG001|STARTED|Overall Study||28
10808757|NCT03843632|11970724|FG001|COMPLETED|Overall Study||30
10808758|NCT03843632|11970725|FG002|COMPLETED|Overall Study||33
10808759|NCT03843632|11970726|FG003|COMPLETED|Overall Study||37
10808760|NCT03843632|11970723|FG000|NOT COMPLETED|Overall Study||1
10808761|NCT03843632|11970724|FG001|NOT COMPLETED|Overall Study||0
10808762|NCT03843632|11970725|FG002|NOT COMPLETED|Overall Study||0
10808763|NCT03843632|11970726|FG003|NOT COMPLETED|Overall Study||0
10808764|NCT03840811|11970739|FG000|STARTED|Overall Study||9
10808765|NCT03840811|11970740|FG001|STARTED|Overall Study||6
10808766|NCT03840811|11970741|FG002|STARTED|Overall Study||12
10808767|NCT03840811|11970739|FG000|COMPLETED|Overall Study||9
10607386|NCT01881867|11765070|FG000|COMPLETED|Overall Study||14
10607387|NCT01881867|11765071|FG001|COMPLETED|Overall Study||15
10607388|NCT01881867|11765070|FG000|NOT COMPLETED|Overall Study||12
10607389|NCT01881867|11765071|FG001|NOT COMPLETED|Overall Study||13
10607390|NCT01882062|11765079|FG000|STARTED|Overall Study|16th of may 2013|10
10607391|NCT01882062|11765079|FG000|COMPLETED|Overall Study|18th of july 2013|10
10607392|NCT01882062|11765079|FG000|NOT COMPLETED|Overall Study||0
10607393|NCT01882088|11765083|FG000|STARTED|Overall Study|35 patients were provided with psyllium in 5.0 sachets, 3 sachets per day for 10 days|35
10607394|NCT01882088|11765083|FG000|COMPLETED|Overall Study||30
10607395|NCT01882088|11765083|FG000|NOT COMPLETED|Overall Study||5
10607396|NCT01882257|11765090|FG000|STARTED|Study Origination to Beginning Therapy||11
10607397|NCT01882257|11765091|FG001|STARTED|Study Origination to Beginning Therapy||40
10607398|NCT01882257|11765092|FG002|STARTED|Study Origination to Beginning Therapy||23
10607399|NCT01882257|11765090|FG000|Started Therapy Using Device|Study Origination to Beginning Therapy||11
10607400|NCT01882257|11765091|FG001|Started Therapy Using Device|Study Origination to Beginning Therapy|Of the 40 who were given the device, 2 chose not to begin the actual therapy|38
10607401|NCT01882257|11765092|FG002|Started Therapy Using Device|Study Origination to Beginning Therapy|Of the 23 who were given the device, 1 chose not to begin the actual therapy|22
10607402|NCT01882257|11765090|FG000|COMPLETED|Study Origination to Beginning Therapy||11
10607403|NCT01882257|11765091|FG001|COMPLETED|Study Origination to Beginning Therapy||38
10607404|NCT01882257|11765092|FG002|COMPLETED|Study Origination to Beginning Therapy||22
10607405|NCT01882257|11765090|FG000|NOT COMPLETED|Study Origination to Beginning Therapy||0
10607406|NCT01882257|11765091|FG001|NOT COMPLETED|Study Origination to Beginning Therapy||2
10607407|NCT01882257|11765092|FG002|NOT COMPLETED|Study Origination to Beginning Therapy||1
10607408|NCT01882257|11765090|FG000|STARTED|Therapy Portion of Study (12 Months)||11
10607409|NCT01882257|11765091|FG001|STARTED|Therapy Portion of Study (12 Months)||38
10607410|NCT01882257|11765092|FG002|STARTED|Therapy Portion of Study (12 Months)||22
10607411|NCT01882257|11765090|FG000|COMPLETED|Therapy Portion of Study (12 Months)||11
10607412|NCT01882257|11765091|FG001|COMPLETED|Therapy Portion of Study (12 Months)||27
10607413|NCT01882257|11765092|FG002|COMPLETED|Therapy Portion of Study (12 Months)||18
10607414|NCT01882257|11765090|FG000|NOT COMPLETED|Therapy Portion of Study (12 Months)||0
10607415|NCT01882257|11765091|FG001|NOT COMPLETED|Therapy Portion of Study (12 Months)||11
10607416|NCT01882257|11765092|FG002|NOT COMPLETED|Therapy Portion of Study (12 Months)||4
10607417|NCT01882413|11765099|FG000|STARTED|Overall Study||204
10607418|NCT01882413|11765099|FG000|COMPLETED|Overall Study||204
10607419|NCT01882413|11765099|FG000|NOT COMPLETED|Overall Study||0
10607420|NCT01882439|11765107|FG000|STARTED|Overall Study|Received treatment|131
10607421|NCT01882439|11765108|FG001|STARTED|Overall Study|Received treatment|132
10607422|NCT01882439|11765109|FG002|STARTED|Overall Study|Received treatment|66
10607423|NCT01882439|11765110|FG003|STARTED|Overall Study|Received treatment|65
10607424|NCT01882439|11765107|FG000|COMPLETED|Overall Study||122
10607425|NCT01882439|11765108|FG001|COMPLETED|Overall Study||111
10607426|NCT01882439|11765109|FG002|COMPLETED|Overall Study||56
10607427|NCT01882439|11765110|FG003|COMPLETED|Overall Study||56
10607428|NCT01882439|11765107|FG000|NOT COMPLETED|Overall Study||9
10607429|NCT01882439|11765108|FG001|NOT COMPLETED|Overall Study||21
10607430|NCT01882439|11765109|FG002|NOT COMPLETED|Overall Study||10
10607431|NCT01882439|11765110|FG003|NOT COMPLETED|Overall Study||9
10607432|NCT01882465|11765125|FG000|STARTED|Period 1||6
10808768|NCT03840811|11970740|FG001|COMPLETED|Overall Study||6
10808769|NCT03840811|11970741|FG002|COMPLETED|Overall Study||11
10808770|NCT03840811|11970739|FG000|NOT COMPLETED|Overall Study||0
10808771|NCT03840811|11970740|FG001|NOT COMPLETED|Overall Study||0
10607433|NCT01882465|11765126|FG001|STARTED|Period 1||6
10607434|NCT01882465|11765127|FG002|STARTED|Period 1||5
10607435|NCT01882465|11765128|FG003|STARTED|Period 1||6
10607436|NCT01882465|11765129|FG004|STARTED|Period 1||5
10607437|NCT01882465|11765130|FG005|STARTED|Period 1||5
10607438|NCT01882465|11765131|FG006|STARTED|Period 1||1
10607439|NCT01882465|11765125|FG000|COMPLETED|Period 1||6
10607440|NCT01882465|11765126|FG001|COMPLETED|Period 1||6
10607441|NCT01882465|11765127|FG002|COMPLETED|Period 1||5
10607442|NCT01882465|11765128|FG003|COMPLETED|Period 1||5
10607443|NCT01882465|11765129|FG004|COMPLETED|Period 1||5
10607444|NCT01882465|11765130|FG005|COMPLETED|Period 1||5
10607445|NCT01882465|11765131|FG006|COMPLETED|Period 1||0
10607446|NCT01882465|11765125|FG000|NOT COMPLETED|Period 1||0
10607447|NCT01882465|11765126|FG001|NOT COMPLETED|Period 1||0
10607448|NCT01882465|11765127|FG002|NOT COMPLETED|Period 1||0
10607449|NCT01882465|11765128|FG003|NOT COMPLETED|Period 1||1
10607450|NCT01882465|11765129|FG004|NOT COMPLETED|Period 1||0
10607451|NCT01882465|11765130|FG005|NOT COMPLETED|Period 1||0
10607452|NCT01882465|11765131|FG006|NOT COMPLETED|Period 1||1
10607453|NCT01882465|11765125|FG000|STARTED|Period 2||6
10607454|NCT01882465|11765126|FG001|STARTED|Period 2||6
10607455|NCT01882465|11765127|FG002|STARTED|Period 2||5
10607456|NCT01882465|11765128|FG003|STARTED|Period 2||5
10607457|NCT01882465|11765129|FG004|STARTED|Period 2||5
10607458|NCT01882465|11765130|FG005|STARTED|Period 2||5
10607459|NCT01882465|11765131|FG006|STARTED|Period 2||0
10607460|NCT01882465|11765125|FG000|COMPLETED|Period 2||6
10607461|NCT01882465|11765126|FG001|COMPLETED|Period 2||6
10607462|NCT01882465|11765127|FG002|COMPLETED|Period 2||5
10607463|NCT01882465|11765128|FG003|COMPLETED|Period 2||5
10607464|NCT01882465|11765129|FG004|COMPLETED|Period 2||4
10607465|NCT01882465|11765130|FG005|COMPLETED|Period 2||5
10607466|NCT01882465|11765131|FG006|COMPLETED|Period 2||0
10607467|NCT01882465|11765125|FG000|NOT COMPLETED|Period 2||0
10607468|NCT01882465|11765126|FG001|NOT COMPLETED|Period 2||0
10607469|NCT01882465|11765127|FG002|NOT COMPLETED|Period 2||0
10607470|NCT01882465|11765128|FG003|NOT COMPLETED|Period 2||0
10607471|NCT01882465|11765129|FG004|NOT COMPLETED|Period 2||1
10607472|NCT01882465|11765130|FG005|NOT COMPLETED|Period 2||0
10607473|NCT01882465|11765131|FG006|NOT COMPLETED|Period 2||0
10607474|NCT01882465|11765125|FG000|STARTED|Period 3||6
10607475|NCT01882465|11765126|FG001|STARTED|Period 3||6
10607476|NCT01882465|11765127|FG002|STARTED|Period 3||5
10607477|NCT01882465|11765128|FG003|STARTED|Period 3||5
10607478|NCT01882465|11765129|FG004|STARTED|Period 3||4
10607479|NCT01882465|11765130|FG005|STARTED|Period 3||5
10607480|NCT01882465|11765131|FG006|STARTED|Period 3||0
10607481|NCT01882465|11765125|FG000|COMPLETED|Period 3||6
10607482|NCT01882465|11765126|FG001|COMPLETED|Period 3||6
10607483|NCT01882465|11765127|FG002|COMPLETED|Period 3||5
10607484|NCT01882465|11765128|FG003|COMPLETED|Period 3||5
10607485|NCT01882465|11765129|FG004|COMPLETED|Period 3||4
10607486|NCT01882465|11765130|FG005|COMPLETED|Period 3||5
10607487|NCT01882465|11765131|FG006|COMPLETED|Period 3||0
10607488|NCT01882465|11765125|FG000|NOT COMPLETED|Period 3||0
10607489|NCT01882465|11765126|FG001|NOT COMPLETED|Period 3||0
10607490|NCT01882465|11765127|FG002|NOT COMPLETED|Period 3||0
10607491|NCT01882465|11765128|FG003|NOT COMPLETED|Period 3||0
10607492|NCT01882465|11765129|FG004|NOT COMPLETED|Period 3||0
10607493|NCT01882465|11765130|FG005|NOT COMPLETED|Period 3||0
10607494|NCT01882465|11765131|FG006|NOT COMPLETED|Period 3||0
10653020|NCT02189863|11813449|FG001|COMPLETED|First 2 Weeks||13
10653021|NCT02189863|11813448|FG000|NOT COMPLETED|First 2 Weeks||4
10653022|NCT02189863|11813449|FG001|NOT COMPLETED|First 2 Weeks||2
10653023|NCT02189863|11813448|FG000|STARTED|Second 2 Weeks||8
10653024|NCT02189863|11813449|FG001|STARTED|Second 2 Weeks||13
10653025|NCT02189863|11813448|FG000|COMPLETED|Second 2 Weeks||8
10653026|NCT02189863|11813449|FG001|COMPLETED|Second 2 Weeks||13
10653027|NCT02189863|11813448|FG000|NOT COMPLETED|Second 2 Weeks||0
10653028|NCT02189863|11813449|FG001|NOT COMPLETED|Second 2 Weeks||0
10653029|NCT02189889|11813460|FG000|STARTED|Overall Study||2
10653030|NCT02189889|11813461|FG001|STARTED|Overall Study||3
10653031|NCT02189889|11813460|FG000|COMPLETED|Overall Study||2
10653032|NCT02189889|11813461|FG001|COMPLETED|Overall Study||3
10653033|NCT02189889|11813460|FG000|NOT COMPLETED|Overall Study||0
10653034|NCT02189889|11813461|FG001|NOT COMPLETED|Overall Study||0
10653035|NCT02189915|11813467|FG000|STARTED|Overall Study||14
10653036|NCT02189915|11813467|FG000|COMPLETED|Overall Study||11
10653037|NCT02189915|11813467|FG000|NOT COMPLETED|Overall Study||3
10653038|NCT02189941|11813471|FG000|STARTED|Overall Study||4
10653039|NCT02189941|11813472|FG001|STARTED|Overall Study||4
10653040|NCT02189941|11813473|FG002|STARTED|Overall Study||3
10653041|NCT02189941|11813471|FG000|COMPLETED|Overall Study||4
10653042|NCT02189941|11813472|FG001|COMPLETED|Overall Study||4
10653043|NCT02189941|11813473|FG002|COMPLETED|Overall Study||2
10653044|NCT02189941|11813471|FG000|NOT COMPLETED|Overall Study||0
10653045|NCT02189941|11813472|FG001|NOT COMPLETED|Overall Study||0
10653046|NCT02189941|11813473|FG002|NOT COMPLETED|Overall Study||1
10653047|NCT02189954|11813483|FG000|STARTED|Overall Study||45
10653048|NCT02189954|11813484|FG001|STARTED|Overall Study||45
10653049|NCT02189954|11813483|FG000|COMPLETED|Overall Study||45
10653050|NCT02189954|11813484|FG001|COMPLETED|Overall Study||45
10653051|NCT02189954|11813483|FG000|NOT COMPLETED|Overall Study||0
10653052|NCT02189954|11813484|FG001|NOT COMPLETED|Overall Study||0
10653053|NCT02190045|11813492|FG000|STARTED|Overall Study||15
10653054|NCT02190045|11813493|FG001|STARTED|Overall Study||15
10653055|NCT02190045|11813492|FG000|COMPLETED|Overall Study||12
10607495|NCT01882543|11765141|FG000|STARTED|Overall Study||37
10607496|NCT01882543|11765142|FG001|STARTED|Overall Study||32
10607497|NCT01882543|11765141|FG000|COMPLETED|Overall Study||33
10607498|NCT01882543|11765142|FG001|COMPLETED|Overall Study||29
10607499|NCT01882543|11765141|FG000|NOT COMPLETED|Overall Study||4
10607500|NCT01882543|11765142|FG001|NOT COMPLETED|Overall Study||3
10607501|NCT01882647|11765151|FG000|STARTED|Overall Study||110
10607502|NCT01882647|11765152|FG001|STARTED|Overall Study||112
10607503|NCT01882647|11765151|FG000|COMPLETED|Overall Study||108
10607504|NCT01882647|11765152|FG001|COMPLETED|Overall Study||106
10607505|NCT01882647|11765151|FG000|NOT COMPLETED|Overall Study||2
10607506|NCT01882647|11765152|FG001|NOT COMPLETED|Overall Study||6
10607507|NCT01882725|11765158|FG000|STARTED|Overall Study||14
10607508|NCT01882725|11765158|FG000|COMPLETED|Overall Study||14
10607509|NCT01882725|11765158|FG000|NOT COMPLETED|Overall Study||0
10607510|NCT01882764|11765164|FG000|STARTED|Overall Study||47
10607511|NCT01882764|11765165|FG001|STARTED|Overall Study||19
10607512|NCT01882764|11765164|FG000|COMPLETED|Overall Study||0
10607513|NCT01882764|11765165|FG001|COMPLETED|Overall Study||1
10607514|NCT01882764|11765164|FG000|NOT COMPLETED|Overall Study||47
10607515|NCT01882764|11765165|FG001|NOT COMPLETED|Overall Study||18
10607516|NCT01882803|11765171|FG000|STARTED|Overall Study||129
10607517|NCT01882803|11765171|FG000|COMPLETED|Overall Study|Subject received treatment in 28-day cycles until disease progression or unacceptable toxicity.|35
10607518|NCT01882803|11765171|FG000|NOT COMPLETED|Overall Study||94
10607519|NCT01882829|11765176|FG000|STARTED|Overall Study||20
10607520|NCT01882829|11765176|FG000|COMPLETED|Overall Study||14
10607521|NCT01882829|11765176|FG000|NOT COMPLETED|Overall Study||6
10607522|NCT01882868|11765180|FG000|STARTED|Overall Study||62
10607523|NCT01882868|11765180|FG000|COMPLETED|Overall Study||62
10607524|NCT01882868|11765180|FG000|NOT COMPLETED|Overall Study||0
10607525|NCT01882907|11765186|FG000|STARTED|Overall Study||117
10607526|NCT01882907|11765187|FG001|STARTED|Overall Study||111
10607527|NCT01882907|11765186|FG000|COMPLETED|Overall Study||103
10607528|NCT01882907|11765187|FG001|COMPLETED|Overall Study||83
10607529|NCT01882907|11765186|FG000|NOT COMPLETED|Overall Study||14
10607530|NCT01882907|11765187|FG001|NOT COMPLETED|Overall Study||28
10607531|NCT01882985|11765195|FG000|STARTED|Overall Study||14
10607532|NCT01882985|11765195|FG000|COMPLETED|Overall Study||12
10607533|NCT01882985|11765195|FG000|NOT COMPLETED|Overall Study||2
10607534|NCT01883141|11765199|FG000|STARTED|Overall Study||31
10607535|NCT01883141|11765199|FG000|Passing Eligibility|Overall Study||30
10607536|NCT01883141|11765199|FG000|EP Study Performed|Overall Study||30
10607537|NCT01883141|11765199|FG000|Usable EP Data|Overall Study||26
10607538|NCT01883141|11765199|FG000|BiV Pacing-Distal|Overall Study||24
10607539|NCT01883141|11765199|FG000|BiV Pacing-Mid|Overall Study||25
10607540|NCT01883141|11765199|FG000|BiV Pacing-Standard Therapy|Overall Study||26
10607541|NCT01883141|11765199|FG000|Multispot-pacing|Overall Study||24
10607542|NCT01883141|11765199|FG000|BiV Pacing-Anterior|Overall Study||23
10607543|NCT01883141|11765199|FG000|Biv Pacing-Posterior|Overall Study||22
10607544|NCT01883141|11765199|FG000|Multivein|Overall Study||23
10607545|NCT01883141|11765199|FG000|COMPLETED|Overall Study|Exit form with exit reason available|31
10607546|NCT01883141|11765199|FG000|NOT COMPLETED|Overall Study||0
10607547|NCT01883362|11765205|FG000|STARTED|Treatment||30
10607548|NCT01883362|11765206|FG001|STARTED|Treatment||30
10607549|NCT01883362|11765205|FG000|COMPLETED|Treatment||14
10607550|NCT01883362|11765206|FG001|COMPLETED|Treatment||16
10607551|NCT01883362|11765205|FG000|NOT COMPLETED|Treatment||16
10607552|NCT01883362|11765206|FG001|NOT COMPLETED|Treatment||14
10607553|NCT01883362|11765205|FG000|STARTED|Post Treatment Follow-up||26
10607554|NCT01883362|11765206|FG001|STARTED|Post Treatment Follow-up||27
10607555|NCT01883362|11765205|FG000|COMPLETED|Post Treatment Follow-up||10
10607556|NCT01883362|11765206|FG001|COMPLETED|Post Treatment Follow-up||13
10607557|NCT01883362|11765205|FG000|NOT COMPLETED|Post Treatment Follow-up||16
10607558|NCT01883362|11765206|FG001|NOT COMPLETED|Post Treatment Follow-up||14
10607559|NCT01883427|11765218|FG000|STARTED|Overall Study||20
10607560|NCT01883427|11765219|FG001|STARTED|Overall Study||20
10607561|NCT01883427|11765218|FG000|COMPLETED|Overall Study||20
10607562|NCT01883427|11765219|FG001|COMPLETED|Overall Study||20
10607563|NCT01883427|11765218|FG000|NOT COMPLETED|Overall Study||0
10607564|NCT01883427|11765219|FG001|NOT COMPLETED|Overall Study||0
10607565|NCT01883440|11765227|FG000|STARTED|Overall Study||45
10607566|NCT01883440|11765228|FG001|STARTED|Overall Study||45
10607567|NCT01883440|11765227|FG000|COMPLETED|Overall Study||42
10607568|NCT01883440|11765228|FG001|COMPLETED|Overall Study||45
10607569|NCT01883440|11765227|FG000|NOT COMPLETED|Overall Study||3
10607570|NCT01883440|11765228|FG001|NOT COMPLETED|Overall Study||0
10607571|NCT01883453|11765237|FG000|STARTED|Overall Study||73
10607572|NCT01883453|11765238|FG001|STARTED|Overall Study||73
10607573|NCT01883453|11765237|FG000|COMPLETED|Overall Study||48
10607574|NCT01883453|11765238|FG001|COMPLETED|Overall Study||50
10607575|NCT01883453|11765237|FG000|NOT COMPLETED|Overall Study||25
10607576|NCT01883453|11765238|FG001|NOT COMPLETED|Overall Study||23
10607577|NCT01883492|11765246|FG000|STARTED|Overall Study||75
10607578|NCT01883492|11765247|FG001|STARTED|Overall Study||78
10607579|NCT01883492|11765246|FG000|COMPLETED|Overall Study||62
10607580|NCT01883492|11765247|FG001|COMPLETED|Overall Study||67
10607581|NCT01883492|11765246|FG000|NOT COMPLETED|Overall Study||13
10607582|NCT01883492|11765247|FG001|NOT COMPLETED|Overall Study||11
10607583|NCT01883635|11765255|FG000|STARTED|Overall Study||24
10607584|NCT01883635|11765256|FG001|STARTED|Overall Study||20
10607585|NCT01883635|11765255|FG000|COMPLETED|Overall Study||20
10607586|NCT01883635|11765256|FG001|COMPLETED|Overall Study||20
10607587|NCT01883635|11765255|FG000|NOT COMPLETED|Overall Study||4
10607588|NCT01883635|11765256|FG001|NOT COMPLETED|Overall Study||0
10607589|NCT01883856|11765266|FG000|STARTED|Overall Study||26
10607590|NCT01883856|11765267|FG001|STARTED|Overall Study||26
10607591|NCT01883856|11765266|FG000|COMPLETED|Overall Study||26
10607592|NCT01883856|11765267|FG001|COMPLETED|Overall Study||26
10607593|NCT01883856|11765266|FG000|NOT COMPLETED|Overall Study||0
10607594|NCT01883856|11765267|FG001|NOT COMPLETED|Overall Study||0
10607595|NCT01883895|11765273|FG000|STARTED|Overall Study||34
10607596|NCT01883895|11765273|FG000|COMPLETED|Overall Study||32
10607597|NCT01883895|11765273|FG000|NOT COMPLETED|Overall Study||2
10607598|NCT01883986|11765279|FG000|STARTED|Overall Study|Allocated to intervention arm|20
10607599|NCT01883986|11765280|FG001|STARTED|Overall Study|Allocated to usual care arm|20
10607600|NCT01883986|11765279|FG000|Did Not Complete Study|Overall Study||3
10607601|NCT01883986|11765280|FG001|Did Not Complete Study|Overall Study|Did not completed study|1
10607602|NCT01883986|11765279|FG000|COMPLETED|Overall Study|Received allocated intervention|17
10607603|NCT01883986|11765280|FG001|COMPLETED|Overall Study|Completed study|19
10704431|NCT02592434|11868823|FG002|Treated|Open-Label Phase (18 Weeks)||0
10704432|NCT02592434|11868821|FG000|COMPLETED|Open-Label Phase (18 Weeks)||185
10704433|NCT02592434|11868822|FG001|COMPLETED|Open-Label Phase (18 Weeks)||0
10704434|NCT02592434|11868823|FG002|COMPLETED|Open-Label Phase (18 Weeks)||0
10607604|NCT01883986|11765279|FG000|NOT COMPLETED|Overall Study||3
10607605|NCT01883986|11765280|FG001|NOT COMPLETED|Overall Study||1
10607606|NCT01883999|11765286|FG000|STARTED|Overall Study||64
10607607|NCT01883999|11765286|FG000|COMPLETED|Overall Study||61
10607608|NCT01883999|11765286|FG000|NOT COMPLETED|Overall Study||3
10607609|NCT01884025|11765292|FG000|STARTED|Overall Study||13
10607610|NCT01884025|11765293|FG001|STARTED|Overall Study||14
10607611|NCT01884025|11765292|FG000|COMPLETED|Overall Study||10
10607612|NCT01884025|11765293|FG001|COMPLETED|Overall Study||10
10607613|NCT01884025|11765292|FG000|NOT COMPLETED|Overall Study||3
10607614|NCT01884025|11765293|FG001|NOT COMPLETED|Overall Study||4
10607615|NCT01884064|11765301|FG000|STARTED|Overall Study||12
10607616|NCT01884064|11765302|FG001|STARTED|Overall Study||5
10607617|NCT01884064|11765301|FG000|COMPLETED|Overall Study||12
10607618|NCT01884064|11765302|FG001|COMPLETED|Overall Study||5
10607619|NCT01884064|11765301|FG000|NOT COMPLETED|Overall Study||0
10607620|NCT01884064|11765302|FG001|NOT COMPLETED|Overall Study||0
10607621|NCT01884311|11765308|FG000|STARTED|Overall Study||38
10607622|NCT01884311|11765308|FG000|COMPLETED|Overall Study||33
10607623|NCT01884311|11765308|FG000|NOT COMPLETED|Overall Study||5
10607624|NCT01884337|11765317|FG000|STARTED|Treatment||326
10607625|NCT01884337|11765318|FG001|STARTED|Treatment||172
10607626|NCT01884337|11765317|FG000|Continuing Into Follow-up Period|Treatment||324
10607627|NCT01884337|11765318|FG001|Continuing Into Follow-up Period|Treatment||171
10607628|NCT01884337|11765317|FG000|COMPLETED|Treatment||322
10607629|NCT01884337|11765318|FG001|COMPLETED|Treatment||170
10607630|NCT01884337|11765317|FG000|NOT COMPLETED|Treatment||4
10607631|NCT01884337|11765318|FG001|NOT COMPLETED|Treatment||2
10607632|NCT01884337|11765317|FG000|STARTED|Follow-up Period||324
10607633|NCT01884337|11765318|FG001|STARTED|Follow-up Period||171
10607634|NCT01884337|11765317|FG000|COMPLETED|Follow-up Period||323
10607635|NCT01884337|11765318|FG001|COMPLETED|Follow-up Period||170
10607636|NCT01884337|11765317|FG000|NOT COMPLETED|Follow-up Period||1
10607637|NCT01884337|11765318|FG001|NOT COMPLETED|Follow-up Period||1
10607638|NCT01884350|11765326|FG000|STARTED|Primary Efficacy Analysis Set (24 Weeks)||583
10607639|NCT01884350|11765327|FG001|STARTED|Primary Efficacy Analysis Set (24 Weeks)||579
10607640|NCT01884350|11765328|FG002|STARTED|Primary Efficacy Analysis Set (24 Weeks)|Participants were not randomized to this arm until after initial 24-week period|0
10607641|NCT01884350|11765326|FG000|Safety Analysis Set|Primary Efficacy Analysis Set (24 Weeks)||604
10607642|NCT01884350|11765327|FG001|Safety Analysis Set|Primary Efficacy Analysis Set (24 Weeks)||558
10607643|NCT01884350|11765328|FG002|Safety Analysis Set|Primary Efficacy Analysis Set (24 Weeks)||0
10607644|NCT01884350|11765326|FG000|COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||529
10607645|NCT01884350|11765327|FG001|COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||525
10607646|NCT01884350|11765328|FG002|COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||0
10607647|NCT01884350|11765326|FG000|NOT COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||54
10607648|NCT01884350|11765327|FG001|NOT COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||54
10607649|NCT01884350|11765328|FG002|NOT COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||0
10607650|NCT01884350|11765326|FG000|STARTED|Primary Efficacy Analysis Set (48 Weeks)||583
10607651|NCT01884350|11765327|FG001|STARTED|Primary Efficacy Analysis Set (48 Weeks)|After 24 weeks participants were randomized to continue AEP or stop AEP and revert to SOC.|263
10607652|NCT01884350|11765328|FG002|STARTED|Primary Efficacy Analysis Set (48 Weeks)|After 24 weeks participants were randomized to continue AEP or stop AEP and revert to SOC.|261
10607653|NCT01884350|11765326|FG000|Safety Analysis Set|Primary Efficacy Analysis Set (48 Weeks)||604
10607654|NCT01884350|11765327|FG001|Safety Analysis Set|Primary Efficacy Analysis Set (48 Weeks)||308
10607655|NCT01884350|11765328|FG002|Safety Analysis Set|Primary Efficacy Analysis Set (48 Weeks)||223
10607656|NCT01884350|11765326|FG000|COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||503
10607657|NCT01884350|11765327|FG001|COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||250
10607658|NCT01884350|11765328|FG002|COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||250
10607659|NCT01884350|11765326|FG000|NOT COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||80
10704435|NCT02592434|11868821|FG000|NOT COMPLETED|Open-Label Phase (18 Weeks)||40
10607660|NCT01884350|11765327|FG001|NOT COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||13
10607661|NCT01884350|11765328|FG002|NOT COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||11
10607662|NCT01884519|11765340|FG000|STARTED|Overall Study||60
10607663|NCT01884519|11765341|FG001|STARTED|Overall Study||60
10607664|NCT01884519|11765340|FG000|COMPLETED|Overall Study||60
10607665|NCT01884519|11765341|FG001|COMPLETED|Overall Study||60
10607666|NCT01884519|11765340|FG000|NOT COMPLETED|Overall Study||0
10607667|NCT01884519|11765341|FG001|NOT COMPLETED|Overall Study||0
10607668|NCT01884545|11765359|FG000|STARTED|Overall Study||50
10607669|NCT01884545|11765360|FG001|STARTED|Overall Study||49
10607670|NCT01884545|11765361|FG002|STARTED|Overall Study||49
10607671|NCT01884545|11765362|FG003|STARTED|Overall Study||52
10607672|NCT01884545|11765359|FG000|COMPLETED|Overall Study||37
10607673|NCT01884545|11765360|FG001|COMPLETED|Overall Study||31
10607674|NCT01884545|11765361|FG002|COMPLETED|Overall Study||35
10607675|NCT01884545|11765362|FG003|COMPLETED|Overall Study||43
10607676|NCT01884545|11765359|FG000|NOT COMPLETED|Overall Study||13
10607677|NCT01884545|11765360|FG001|NOT COMPLETED|Overall Study||18
10607678|NCT01884545|11765361|FG002|NOT COMPLETED|Overall Study||14
10607679|NCT01884545|11765362|FG003|NOT COMPLETED|Overall Study||9
10607680|NCT01884571|11765372|FG000|STARTED|Overall Study||31
10607681|NCT01884571|11765372|FG000|COMPLETED|Overall Study||23
10607682|NCT01884571|11765372|FG000|NOT COMPLETED|Overall Study||8
10607683|NCT01884597|11765379|FG000|STARTED|Overall Study||5
10607684|NCT01884597|11765380|FG001|STARTED|Overall Study||3
10607685|NCT01884597|11765381|FG002|STARTED|Overall Study||16
10607686|NCT01884597|11765379|FG000|COMPLETED|Overall Study||4
10607687|NCT01884597|11765380|FG001|COMPLETED|Overall Study||2
10607688|NCT01884597|11765381|FG002|COMPLETED|Overall Study||15
10607689|NCT01884597|11765379|FG000|NOT COMPLETED|Overall Study||1
10607690|NCT01884597|11765380|FG001|NOT COMPLETED|Overall Study||1
10607691|NCT01884597|11765381|FG002|NOT COMPLETED|Overall Study||1
10607692|NCT01884675|11765397|FG000|STARTED|Overall Study||16
10607693|NCT01884675|11765398|FG001|STARTED|Overall Study||17
10607694|NCT01884675|11765397|FG000|COMPLETED|Overall Study||13
10607695|NCT01884675|11765398|FG001|COMPLETED|Overall Study||15
10607696|NCT01884675|11765397|FG000|NOT COMPLETED|Overall Study||3
10607697|NCT01884675|11765398|FG001|NOT COMPLETED|Overall Study||2
10607698|NCT01884688|11765406|FG000|STARTED|Overall Study||3
10607699|NCT01884688|11765406|FG000|COMPLETED|Overall Study||1
10607700|NCT01884688|11765406|FG000|NOT COMPLETED|Overall Study||2
10607701|NCT01884844|11765412|FG000|STARTED|Overall Study||16
10607702|NCT01884844|11765413|FG001|STARTED|Overall Study||17
10607703|NCT01884844|11765412|FG000|COMPLETED|Overall Study||13
10607704|NCT01884844|11765413|FG001|COMPLETED|Overall Study||12
10607705|NCT01884844|11765412|FG000|NOT COMPLETED|Overall Study||3
10607706|NCT01884844|11765413|FG001|NOT COMPLETED|Overall Study||5
10607707|NCT01885000|11765421|FG000|STARTED|Overall Study||48
10607708|NCT01885000|11765422|FG001|STARTED|Overall Study||44
10607709|NCT01885000|11765421|FG000|COMPLETED|Overall Study||46
10607710|NCT01885000|11765422|FG001|COMPLETED|Overall Study||42
10607711|NCT01885000|11765421|FG000|NOT COMPLETED|Overall Study||2
10607712|NCT01885000|11765422|FG001|NOT COMPLETED|Overall Study||2
10607713|NCT01885104|11765430|FG000|STARTED|Overall Study||31
10607714|NCT01885104|11765431|FG001|STARTED|Overall Study||34
10607715|NCT01885104|11765430|FG000|COMPLETED|Overall Study||29
10607716|NCT01885104|11765431|FG001|COMPLETED|Overall Study||33
10607717|NCT01885104|11765430|FG000|NOT COMPLETED|Overall Study||2
10607718|NCT01885104|11765431|FG001|NOT COMPLETED|Overall Study||1
10607719|NCT01885117|11765439|FG000|STARTED|Overall Study||61
10607720|NCT01885117|11765440|FG001|STARTED|Overall Study||64
10607721|NCT01885117|11765439|FG000|COMPLETED|Overall Study||61
10607722|NCT01885117|11765440|FG001|COMPLETED|Overall Study||64
10607723|NCT01885117|11765439|FG000|NOT COMPLETED|Overall Study||0
10607724|NCT01885117|11765440|FG001|NOT COMPLETED|Overall Study||0
10607725|NCT01885182|11765448|FG000|STARTED|Overall Study||117
10607726|NCT01885182|11765449|FG001|STARTED|Overall Study||115
10607727|NCT01885182|11765448|FG000|Safety Population|Overall Study||114
10607728|NCT01885182|11765449|FG001|Safety Population|Overall Study||111
10607729|NCT01885182|11765448|FG000|FAP Population|Overall Study||107
10607730|NCT01885182|11765449|FG001|FAP Population|Overall Study||106
10607731|NCT01885182|11765448|FG000|COMPLETED|Overall Study||83
10607732|NCT01885182|11765449|FG001|COMPLETED|Overall Study||93
10607733|NCT01885182|11765448|FG000|NOT COMPLETED|Overall Study||34
10607734|NCT01885182|11765449|FG001|NOT COMPLETED|Overall Study||22
10607735|NCT01885195|11765457|FG000|STARTED|Overall Study||110
10607736|NCT01885195|11765457|FG000|COMPLETED|Overall Study||0
10607737|NCT01885195|11765457|FG000|NOT COMPLETED|Overall Study||110
10607738|NCT01885208|11765463|FG000|STARTED|Overall Study||406
10607739|NCT01885208|11765464|FG001|STARTED|Overall Study||407
10704436|NCT02592434|11868822|FG001|NOT COMPLETED|Open-Label Phase (18 Weeks)||0
10704437|NCT02592434|11868823|FG002|NOT COMPLETED|Open-Label Phase (18 Weeks)||0
10704438|NCT02592434|11868821|FG000|STARTED|Double Blind Phase (26 Weeks)||0
10607740|NCT01885208|11765463|FG000|Exposed|Overall Study||404
10607741|NCT01885208|11765464|FG001|Exposed|Overall Study||405
10607742|NCT01885208|11765463|FG000|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|82
10607743|NCT01885208|11765464|FG001|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|85
10607744|NCT01885208|11765463|FG000|COMPLETED|Overall Study||374
10607745|NCT01885208|11765464|FG001|COMPLETED|Overall Study||369
10607746|NCT01885208|11765463|FG000|NOT COMPLETED|Overall Study||32
10607747|NCT01885208|11765464|FG001|NOT COMPLETED|Overall Study||38
10607748|NCT01885559|11765472|FG000|STARTED|Overall Study||242
10607749|NCT01885559|11765473|FG001|STARTED|Overall Study||244
10607750|NCT01885559|11765472|FG000|COMPLETED|Overall Study||218
10607751|NCT01885559|11765473|FG001|COMPLETED|Overall Study||208
10607752|NCT01885559|11765472|FG000|NOT COMPLETED|Overall Study||24
10607753|NCT01885559|11765473|FG001|NOT COMPLETED|Overall Study||36
10607754|NCT01885871|11765479|FG000|STARTED|Overall Study||20
10607755|NCT01885871|11765479|FG000|COMPLETED|Overall Study||20
10607756|NCT01885871|11765479|FG000|NOT COMPLETED|Overall Study||0
10607757|NCT01885897|11765489|FG000|STARTED|Overall Study||6
10607758|NCT01885897|11765490|FG001|STARTED|Overall Study||3
10607759|NCT01885897|11765491|FG002|STARTED|Overall Study||4
10607760|NCT01885897|11765492|FG003|STARTED|Overall Study||3
10607761|NCT01885897|11765493|FG004|STARTED|Overall Study||8
10607762|NCT01885897|11765494|FG005|STARTED|Overall Study||9
10607763|NCT01885897|11765489|FG000|COMPLETED|Overall Study||6
10607764|NCT01885897|11765490|FG001|COMPLETED|Overall Study||3
10607765|NCT01885897|11765491|FG002|COMPLETED|Overall Study||4
10607766|NCT01885897|11765492|FG003|COMPLETED|Overall Study||3
10607767|NCT01885897|11765493|FG004|COMPLETED|Overall Study||8
10607768|NCT01885897|11765494|FG005|COMPLETED|Overall Study||9
10607769|NCT01885897|11765489|FG000|NOT COMPLETED|Overall Study||0
10607770|NCT01885897|11765490|FG001|NOT COMPLETED|Overall Study||0
10607771|NCT01885897|11765491|FG002|NOT COMPLETED|Overall Study||0
10607772|NCT01885897|11765492|FG003|NOT COMPLETED|Overall Study||0
10607773|NCT01885897|11765493|FG004|NOT COMPLETED|Overall Study||0
10607774|NCT01885897|11765494|FG005|NOT COMPLETED|Overall Study||0
10607775|NCT01885910|11765508|FG000|STARTED|Overall Study||32
10607776|NCT01885910|11765508|FG000|COMPLETED|Overall Study||24
10607777|NCT01885910|11765508|FG000|NOT COMPLETED|Overall Study||8
10607778|NCT01885936|11765516|FG000|STARTED|Overall Study||8
10607779|NCT01885936|11765517|FG001|STARTED|Overall Study||5
10607780|NCT01885936|11765516|FG000|COMPLETED|Overall Study||7
10607781|NCT01885936|11765517|FG001|COMPLETED|Overall Study||5
10607782|NCT01885936|11765516|FG000|NOT COMPLETED|Overall Study||1
10607783|NCT01885936|11765517|FG001|NOT COMPLETED|Overall Study||0
10607784|NCT01886105|11765523|FG000|STARTED|Overall Study||4
10607785|NCT01886105|11765523|FG000|COMPLETED|Overall Study||1
10607786|NCT01886105|11765523|FG000|NOT COMPLETED|Overall Study||3
10607787|NCT01886235|11765528|FG000|STARTED|Overall Study||10
10607788|NCT01886235|11765528|FG000|COMPLETED|Overall Study||10
10607789|NCT01886235|11765528|FG000|NOT COMPLETED|Overall Study||0
10607790|NCT01886287|11765532|FG000|STARTED|Overall Study||2
10607791|NCT01886287|11765532|FG000|COMPLETED|Overall Study||0
10607792|NCT01886287|11765532|FG000|NOT COMPLETED|Overall Study||2
10607793|NCT01886300|11765536|FG000|STARTED|Overall Study||16
10607794|NCT01886300|11765536|FG000|COMPLETED|Overall Study||0
10607795|NCT01886300|11765536|FG000|NOT COMPLETED|Overall Study||16
10607796|NCT01886313|11765542|FG000|STARTED|Overall Study||6
10607797|NCT01886313|11765543|FG001|STARTED|Overall Study||5
10607798|NCT01886313|11765542|FG000|COMPLETED|Overall Study||5
10607799|NCT01886313|11765543|FG001|COMPLETED|Overall Study||4
10607800|NCT01886313|11765542|FG000|NOT COMPLETED|Overall Study||1
10607801|NCT01886313|11765543|FG001|NOT COMPLETED|Overall Study||1
10607802|NCT01886378|11765549|FG000|STARTED|Overall Study||29
10607803|NCT01886378|11765549|FG000|Completed 24 Weeks of UX007 Treatment|Overall Study||25
10607804|NCT01886378|11765549|FG000|COMPLETED|Overall Study||24
10607805|NCT01886378|11765549|FG000|NOT COMPLETED|Overall Study||5
10607806|NCT01886690|11765555|FG000|STARTED|Overall Study||75
10607807|NCT01886690|11765556|FG001|STARTED|Overall Study||73
10607808|NCT01886690|11765555|FG000|COMPLETED|Overall Study||75
10607809|NCT01886690|11765556|FG001|COMPLETED|Overall Study||71
10607810|NCT01886690|11765555|FG000|NOT COMPLETED|Overall Study||0
10607811|NCT01886690|11765556|FG001|NOT COMPLETED|Overall Study||2
10607812|NCT01886716|11765566|FG000|STARTED|Week 1||24
10607813|NCT01886716|11765567|FG001|STARTED|Week 1||20
10607814|NCT01886716|11765568|FG002|STARTED|Week 1||22
10607815|NCT01886716|11765569|FG003|STARTED|Week 1||20
10607816|NCT01886716|11765566|FG000|COMPLETED|Week 1||24
10607817|NCT01886716|11765567|FG001|COMPLETED|Week 1||20
10607818|NCT01886716|11765568|FG002|COMPLETED|Week 1||20
10607819|NCT01886716|11765569|FG003|COMPLETED|Week 1||18
10607820|NCT01886716|11765566|FG000|NOT COMPLETED|Week 1||0
10607821|NCT01886716|11765567|FG001|NOT COMPLETED|Week 1||0
10607822|NCT01886716|11765568|FG002|NOT COMPLETED|Week 1||2
10607823|NCT01886716|11765569|FG003|NOT COMPLETED|Week 1||2
10607824|NCT01886716|11765566|FG000|STARTED|Week 2||24
10607825|NCT01886716|11765567|FG001|STARTED|Week 2||20
10607826|NCT01886716|11765568|FG002|STARTED|Week 2||20
10607827|NCT01886716|11765569|FG003|STARTED|Week 2||18
10607828|NCT01886716|11765566|FG000|COMPLETED|Week 2||21
10607829|NCT01886716|11765567|FG001|COMPLETED|Week 2||18
10607830|NCT01886716|11765568|FG002|COMPLETED|Week 2||19
10607831|NCT01886716|11765569|FG003|COMPLETED|Week 2||15
10607832|NCT01886716|11765566|FG000|NOT COMPLETED|Week 2||3
10607833|NCT01886716|11765567|FG001|NOT COMPLETED|Week 2||2
10607834|NCT01886716|11765568|FG002|NOT COMPLETED|Week 2||1
10607835|NCT01886716|11765569|FG003|NOT COMPLETED|Week 2||3
10607836|NCT01886716|11765566|FG000|STARTED|Week 3||21
10607837|NCT01886716|11765567|FG001|STARTED|Week 3||18
10607838|NCT01886716|11765568|FG002|STARTED|Week 3||19
10607839|NCT01886716|11765569|FG003|STARTED|Week 3||15
10607840|NCT01886716|11765566|FG000|COMPLETED|Week 3||20
10607841|NCT01886716|11765567|FG001|COMPLETED|Week 3||17
10607842|NCT01886716|11765568|FG002|COMPLETED|Week 3||19
10607843|NCT01886716|11765569|FG003|COMPLETED|Week 3||14
10607844|NCT01886716|11765566|FG000|NOT COMPLETED|Week 3||1
10607845|NCT01886716|11765567|FG001|NOT COMPLETED|Week 3||1
10607846|NCT01886716|11765568|FG002|NOT COMPLETED|Week 3||0
10607847|NCT01886716|11765569|FG003|NOT COMPLETED|Week 3||1
10607848|NCT01886716|11765566|FG000|STARTED|Week 4||20
10607849|NCT01886716|11765567|FG001|STARTED|Week 4||17
10607850|NCT01886716|11765568|FG002|STARTED|Week 4||19
10607851|NCT01886716|11765569|FG003|STARTED|Week 4||14
10607852|NCT01886716|11765566|FG000|COMPLETED|Week 4||20
10607853|NCT01886716|11765567|FG001|COMPLETED|Week 4||17
10607854|NCT01886716|11765568|FG002|COMPLETED|Week 4||19
10607855|NCT01886716|11765569|FG003|COMPLETED|Week 4||14
10607856|NCT01886716|11765566|FG000|NOT COMPLETED|Week 4||0
10607857|NCT01886716|11765567|FG001|NOT COMPLETED|Week 4||0
10607858|NCT01886716|11765568|FG002|NOT COMPLETED|Week 4||0
10607859|NCT01886716|11765569|FG003|NOT COMPLETED|Week 4||0
10607860|NCT01886716|11765566|FG000|STARTED|1-Week Post Follow-Up||20
10607861|NCT01886716|11765567|FG001|STARTED|1-Week Post Follow-Up||17
10607862|NCT01886716|11765568|FG002|STARTED|1-Week Post Follow-Up||19
10607863|NCT01886716|11765569|FG003|STARTED|1-Week Post Follow-Up||14
10607864|NCT01886716|11765566|FG000|COMPLETED|1-Week Post Follow-Up||20
10607865|NCT01886716|11765567|FG001|COMPLETED|1-Week Post Follow-Up||17
10607866|NCT01886716|11765568|FG002|COMPLETED|1-Week Post Follow-Up||19
10607867|NCT01886716|11765569|FG003|COMPLETED|1-Week Post Follow-Up||14
10607868|NCT01886716|11765566|FG000|NOT COMPLETED|1-Week Post Follow-Up||0
10607869|NCT01886716|11765567|FG001|NOT COMPLETED|1-Week Post Follow-Up||0
10607870|NCT01886716|11765568|FG002|NOT COMPLETED|1-Week Post Follow-Up||0
10607871|NCT01886716|11765569|FG003|NOT COMPLETED|1-Week Post Follow-Up||0
10607872|NCT01886716|11765566|FG000|STARTED|1-Month Post Follow-Up||20
10607873|NCT01886716|11765567|FG001|STARTED|1-Month Post Follow-Up||17
10607874|NCT01886716|11765568|FG002|STARTED|1-Month Post Follow-Up||19
10607875|NCT01886716|11765569|FG003|STARTED|1-Month Post Follow-Up||14
10607876|NCT01886716|11765566|FG000|COMPLETED|1-Month Post Follow-Up||20
10607877|NCT01886716|11765567|FG001|COMPLETED|1-Month Post Follow-Up||17
10607878|NCT01886716|11765568|FG002|COMPLETED|1-Month Post Follow-Up||19
10607879|NCT01886716|11765569|FG003|COMPLETED|1-Month Post Follow-Up||14
10607880|NCT01886716|11765566|FG000|NOT COMPLETED|1-Month Post Follow-Up||0
10607881|NCT01886716|11765567|FG001|NOT COMPLETED|1-Month Post Follow-Up||0
10607882|NCT01886716|11765568|FG002|NOT COMPLETED|1-Month Post Follow-Up||0
10607883|NCT01886716|11765569|FG003|NOT COMPLETED|1-Month Post Follow-Up||0
10607884|NCT01886781|11765581|FG000|STARTED|Overall Study||54
10607885|NCT01886781|11765582|FG001|STARTED|Overall Study||27
10607886|NCT01886781|11765581|FG000|COMPLETED|Overall Study||40
10607887|NCT01886781|11765582|FG001|COMPLETED|Overall Study||25
10607888|NCT01886781|11765581|FG000|NOT COMPLETED|Overall Study||14
10607889|NCT01886781|11765582|FG001|NOT COMPLETED|Overall Study||2
10607890|NCT01886807|11765591|FG000|STARTED|Overall Study||164
10607891|NCT01886807|11765592|FG001|STARTED|Overall Study||155
10704439|NCT02592434|11868822|FG001|STARTED|Double Blind Phase (26 Weeks)|Only those participants who completed OL phase, achieved at least a JIA ACR 30 response in OL phase.|88
10704440|NCT02592434|11868823|FG002|STARTED|Double Blind Phase (26 Weeks)|Only those participants who completed OL phase,achieved at least a JIA ACR 30 response in OL phase.|85
10704441|NCT02592434|11868821|FG000|Treated|Double Blind Phase (26 Weeks)||0
10704442|NCT02592434|11868822|FG001|Treated|Double Blind Phase (26 Weeks)||88
10704443|NCT02592434|11868823|FG002|Treated|Double Blind Phase (26 Weeks)||85
10704444|NCT02592434|11868821|FG000|COMPLETED|Double Blind Phase (26 Weeks)||0
10704445|NCT02592434|11868822|FG001|COMPLETED|Double Blind Phase (26 Weeks)||61
10607892|NCT01886807|11765593|FG002|STARTED|Overall Study||163
10607893|NCT01886807|11765591|FG000|COMPLETED|Overall Study||159
10607894|NCT01886807|11765592|FG001|COMPLETED|Overall Study||145
10607895|NCT01886807|11765593|FG002|COMPLETED|Overall Study||153
10607896|NCT01886807|11765591|FG000|NOT COMPLETED|Overall Study||5
10704446|NCT02592434|11868823|FG002|COMPLETED|Double Blind Phase (26 Weeks)||38
10607897|NCT01886807|11765592|FG001|NOT COMPLETED|Overall Study||10
10607898|NCT01886807|11765593|FG002|NOT COMPLETED|Overall Study||10
10607899|NCT01886833|11765604|FG000|STARTED|Overall Study||420
10607900|NCT01886833|11765604|FG000|COMPLETED|Overall Study||216
10607901|NCT01886833|11765604|FG000|NOT COMPLETED|Overall Study||204
10607902|NCT01886937|11765613|FG000|STARTED|Overall Study||7
10607903|NCT01886937|11765614|FG001|STARTED|Overall Study||6
10607904|NCT01886937|11765613|FG000|COMPLETED|Overall Study||7
10607905|NCT01886937|11765614|FG001|COMPLETED|Overall Study||6
10607906|NCT01886937|11765613|FG000|NOT COMPLETED|Overall Study||0
10607907|NCT01886937|11765614|FG001|NOT COMPLETED|Overall Study||0
10607908|NCT01887132|11765620|FG000|STARTED|Overall Study||4
10607909|NCT01887132|11765620|FG000|COMPLETED|Overall Study||4
10607910|NCT01887132|11765620|FG000|NOT COMPLETED|Overall Study||0
10607911|NCT01887171|11765626|FG000|STARTED|Overall Study||43
10607912|NCT01887171|11765627|FG001|STARTED|Overall Study||43
10607913|NCT01887171|11765626|FG000|COMPLETED|Overall Study||43
10607914|NCT01887171|11765627|FG001|COMPLETED|Overall Study||43
10607915|NCT01887171|11765626|FG000|NOT COMPLETED|Overall Study||0
10607916|NCT01887171|11765627|FG001|NOT COMPLETED|Overall Study||0
10607917|NCT01887210|11765635|FG000|STARTED|Overall Study||33
10607918|NCT01887210|11765636|FG001|STARTED|Overall Study||33
10607919|NCT01887210|11765635|FG000|COMPLETED|Overall Study||32
10607920|NCT01887210|11765636|FG001|COMPLETED|Overall Study||29
10607921|NCT01887210|11765635|FG000|NOT COMPLETED|Overall Study||1
10607922|NCT01887210|11765636|FG001|NOT COMPLETED|Overall Study||4
10607923|NCT01887327|11765645|FG000|STARTED|Overall Study||30
10607924|NCT01887327|11765646|FG001|STARTED|Overall Study||31
10607925|NCT01887327|11765647|FG002|STARTED|Overall Study||30
10607926|NCT01887327|11765645|FG000|COMPLETED|Overall Study||29
10607927|NCT01887327|11765646|FG001|COMPLETED|Overall Study||27
10607928|NCT01887327|11765647|FG002|COMPLETED|Overall Study||27
10607929|NCT01887327|11765645|FG000|NOT COMPLETED|Overall Study||1
10607930|NCT01887327|11765646|FG001|NOT COMPLETED|Overall Study||4
10607931|NCT01887327|11765647|FG002|NOT COMPLETED|Overall Study||3
10607932|NCT01887353|11765658|FG000|STARTED|Overall Study||4
10607933|NCT01887353|11765659|FG001|STARTED|Overall Study||4
10607934|NCT01887353|11765658|FG000|COMPLETED|Overall Study|Study was stopped early because of difficulty recruiting.|0
10607935|NCT01887353|11765659|FG001|COMPLETED|Overall Study|Study was stopped early because of difficulty recruiting.|1
10607936|NCT01887353|11765658|FG000|NOT COMPLETED|Overall Study||4
10607937|NCT01887353|11765659|FG001|NOT COMPLETED|Overall Study||3
10607938|NCT01887418|11765668|FG000|STARTED|Overall Study||15
10607939|NCT01887418|11765669|FG001|STARTED|Overall Study||14
10607940|NCT01887418|11765670|FG002|STARTED|Overall Study||10
10607941|NCT01887418|11765668|FG000|COMPLETED|Overall Study||15
10607942|NCT01887418|11765669|FG001|COMPLETED|Overall Study||14
10607943|NCT01887418|11765670|FG002|COMPLETED|Overall Study||9
10607944|NCT01887418|11765668|FG000|NOT COMPLETED|Overall Study||0
10607945|NCT01887418|11765669|FG001|NOT COMPLETED|Overall Study||0
10607946|NCT01887418|11765670|FG002|NOT COMPLETED|Overall Study||1
10607947|NCT01887470|11765682|FG000|STARTED|Overall Study||10
10607948|NCT01887470|11765683|FG001|STARTED|Overall Study||10
10607949|NCT01887470|11765684|FG002|STARTED|Overall Study||10
10607950|NCT01887470|11765685|FG003|STARTED|Overall Study||10
10607951|NCT01887470|11765682|FG000|COMPLETED|Overall Study||10
10607952|NCT01887470|11765683|FG001|COMPLETED|Overall Study||10
10607953|NCT01887470|11765684|FG002|COMPLETED|Overall Study||10
10607954|NCT01887470|11765685|FG003|COMPLETED|Overall Study||10
10607955|NCT01887470|11765682|FG000|NOT COMPLETED|Overall Study||0
10607956|NCT01887470|11765683|FG001|NOT COMPLETED|Overall Study||0
10607957|NCT01887470|11765684|FG002|NOT COMPLETED|Overall Study||0
10607958|NCT01887470|11765685|FG003|NOT COMPLETED|Overall Study||0
10607959|NCT01887587|11765695|FG000|STARTED|Overall Study||5
10607960|NCT01887587|11765695|FG000|COMPLETED|Overall Study||5
10607961|NCT01887587|11765695|FG000|NOT COMPLETED|Overall Study||0
10607962|NCT01887600|11765702|FG000|STARTED|Overall Study||391
10607963|NCT01887600|11765703|FG001|STARTED|Overall Study||203
10607964|NCT01887600|11765702|FG000|Treatment Received|Overall Study||391
10607965|NCT01887600|11765703|FG001|Treatment Received|Overall Study||203
10607966|NCT01887600|11765702|FG000|COMPLETED|Overall Study||245
10607967|NCT01887600|11765703|FG001|COMPLETED|Overall Study||89
10607968|NCT01887600|11765702|FG000|NOT COMPLETED|Overall Study||146
10607969|NCT01887600|11765703|FG001|NOT COMPLETED|Overall Study||114
10607970|NCT01887678|11765712|FG000|STARTED|Overall Study||119
10607971|NCT01887678|11765713|FG001|STARTED|Overall Study||113
10607972|NCT01887678|11765712|FG000|COMPLETED|Overall Study||102
10607973|NCT01887678|11765713|FG001|COMPLETED|Overall Study||85
10607974|NCT01887678|11765712|FG000|NOT COMPLETED|Overall Study||17
10607975|NCT01887678|11765713|FG001|NOT COMPLETED|Overall Study||28
10607976|NCT01887717|11765721|FG000|STARTED|Overall Study||17
10607977|NCT01887717|11765722|FG001|STARTED|Overall Study||19
10607978|NCT01887717|11765721|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
10607979|NCT01887717|11765722|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16
10607980|NCT01887717|11765721|FG000|COMPLETED|Overall Study||11
10607981|NCT01887717|11765722|FG001|COMPLETED|Overall Study||8
10607982|NCT01887717|11765721|FG000|NOT COMPLETED|Overall Study||6
10607983|NCT01887717|11765722|FG001|NOT COMPLETED|Overall Study||11
10607984|NCT01887990|11765732|FG000|STARTED|Overall Study||7
10607985|NCT01887990|11765733|FG001|STARTED|Overall Study||7
10607986|NCT01887990|11765734|FG002|STARTED|Overall Study||2
10607987|NCT01887990|11765735|FG003|STARTED|Overall Study||2
10607988|NCT01887990|11765732|FG000|COMPLETED|Overall Study||7
10607989|NCT01887990|11765733|FG001|COMPLETED|Overall Study||7
10607990|NCT01887990|11765734|FG002|COMPLETED|Overall Study||2
10607991|NCT01887990|11765735|FG003|COMPLETED|Overall Study||2
10607992|NCT01887990|11765732|FG000|NOT COMPLETED|Overall Study||0
10607993|NCT01887990|11765733|FG001|NOT COMPLETED|Overall Study||0
10607994|NCT01887990|11765734|FG002|NOT COMPLETED|Overall Study||0
10607995|NCT01887990|11765735|FG003|NOT COMPLETED|Overall Study||0
10607996|NCT01888003|11765750|FG000|STARTED|Overall Study||5
10607997|NCT01888003|11765751|FG001|STARTED|Overall Study||6
10607998|NCT01888003|11765752|FG002|STARTED|Overall Study||40
10607999|NCT01888003|11765750|FG000|COMPLETED|Overall Study||0
10608000|NCT01888003|11765751|FG001|COMPLETED|Overall Study||0
10608001|NCT01888003|11765752|FG002|COMPLETED|Overall Study||0
10608002|NCT01888003|11765750|FG000|NOT COMPLETED|Overall Study||5
10608003|NCT01888003|11765751|FG001|NOT COMPLETED|Overall Study||6
10608004|NCT01888003|11765752|FG002|NOT COMPLETED|Overall Study||40
10608005|NCT01888367|11765763|FG000|STARTED|Overall Study||296
10608006|NCT01888367|11765764|FG001|STARTED|Overall Study||71
10608007|NCT01888367|11765765|FG002|STARTED|Overall Study||78
10608008|NCT01888367|11765763|FG000|COMPLETED|Overall Study||288
10608009|NCT01888367|11765764|FG001|COMPLETED|Overall Study||66
10608010|NCT01888367|11765765|FG002|COMPLETED|Overall Study||73
10608011|NCT01888367|11765763|FG000|NOT COMPLETED|Overall Study||8
10608012|NCT01888367|11765764|FG001|NOT COMPLETED|Overall Study||5
10608013|NCT01888367|11765765|FG002|NOT COMPLETED|Overall Study||5
10608014|NCT01888432|11765775|FG000|STARTED|12-month Analysis (FAS)||142
10608015|NCT01888432|11765776|FG001|STARTED|12-month Analysis (FAS)||142
10608016|NCT01888432|11765775|FG000|COMPLETED|12-month Analysis (FAS)||131
10608017|NCT01888432|11765776|FG001|COMPLETED|12-month Analysis (FAS)||133
10608018|NCT01888432|11765775|FG000|NOT COMPLETED|12-month Analysis (FAS)||11
10608019|NCT01888432|11765776|FG001|NOT COMPLETED|12-month Analysis (FAS)||9
10608020|NCT01888432|11765775|FG000|STARTED|24-month Analysis (FAS)||142
10608021|NCT01888432|11765776|FG001|STARTED|24-month Analysis (FAS)||142
10608022|NCT01888432|11765775|FG000|COMPLETED|24-month Analysis (FAS)||125
10608023|NCT01888432|11765776|FG001|COMPLETED|24-month Analysis (FAS)||125
10608024|NCT01888432|11765775|FG000|NOT COMPLETED|24-month Analysis (FAS)||17
10608025|NCT01888432|11765776|FG001|NOT COMPLETED|24-month Analysis (FAS)||17
10608026|NCT01888432|11765775|FG000|STARTED|36-month Analysis (Extension)||13
10608027|NCT01888432|11765776|FG001|STARTED|36-month Analysis (Extension)||5
10608028|NCT01888432|11765775|FG000|COMPLETED|36-month Analysis (Extension)||12
10608029|NCT01888432|11765776|FG001|COMPLETED|36-month Analysis (Extension)||5
10608030|NCT01888432|11765775|FG000|NOT COMPLETED|36-month Analysis (Extension)||1
10608031|NCT01888432|11765776|FG001|NOT COMPLETED|36-month Analysis (Extension)||0
10608032|NCT01888484|11765784|FG000|STARTED|Overall Study||12
10608033|NCT01888484|11765785|FG001|STARTED|Overall Study||14
10608034|NCT01888484|11765786|FG002|STARTED|Overall Study||12
10608035|NCT01888484|11765787|FG003|STARTED|Overall Study||37
10608036|NCT01888484|11765784|FG000|COMPLETED|Overall Study||12
10608037|NCT01888484|11765785|FG001|COMPLETED|Overall Study||14
10608038|NCT01888484|11765786|FG002|COMPLETED|Overall Study||8
10608039|NCT01888484|11765787|FG003|COMPLETED|Overall Study||34
10608040|NCT01888484|11765784|FG000|NOT COMPLETED|Overall Study||0
10608041|NCT01888484|11765785|FG001|NOT COMPLETED|Overall Study||0
10608042|NCT01888484|11765786|FG002|NOT COMPLETED|Overall Study||4
10608043|NCT01888484|11765787|FG003|NOT COMPLETED|Overall Study||3
10608044|NCT01888497|11765792|FG000|STARTED|First Intervention Period||13
10608045|NCT01888497|11765793|FG001|STARTED|First Intervention Period||14
10608046|NCT01888497|11765794|FG002|STARTED|First Intervention Period||15
10608047|NCT01888497|11765795|FG003|STARTED|First Intervention Period||17
10608048|NCT01888497|11765792|FG000|COMPLETED|First Intervention Period||13
10608049|NCT01888497|11765793|FG001|COMPLETED|First Intervention Period||14
10608050|NCT01888497|11765794|FG002|COMPLETED|First Intervention Period||15
10608051|NCT01888497|11765795|FG003|COMPLETED|First Intervention Period||17
10608052|NCT01888497|11765792|FG000|NOT COMPLETED|First Intervention Period||0
10608053|NCT01888497|11765793|FG001|NOT COMPLETED|First Intervention Period||0
10608054|NCT01888497|11765794|FG002|NOT COMPLETED|First Intervention Period||0
10608055|NCT01888497|11765795|FG003|NOT COMPLETED|First Intervention Period||0
10608056|NCT01888497|11765792|FG000|STARTED|Washout Period 1||13
10608057|NCT01888497|11765793|FG001|STARTED|Washout Period 1||14
10608058|NCT01888497|11765794|FG002|STARTED|Washout Period 1||15
10608059|NCT01888497|11765795|FG003|STARTED|Washout Period 1||17
10608060|NCT01888497|11765792|FG000|COMPLETED|Washout Period 1||13
10608061|NCT01888497|11765793|FG001|COMPLETED|Washout Period 1||14
10608062|NCT01888497|11765794|FG002|COMPLETED|Washout Period 1||14
10608063|NCT01888497|11765795|FG003|COMPLETED|Washout Period 1||16
10608064|NCT01888497|11765792|FG000|NOT COMPLETED|Washout Period 1||0
10608065|NCT01888497|11765793|FG001|NOT COMPLETED|Washout Period 1||0
10608066|NCT01888497|11765794|FG002|NOT COMPLETED|Washout Period 1||1
10608067|NCT01888497|11765795|FG003|NOT COMPLETED|Washout Period 1||1
10608068|NCT01888497|11765792|FG000|STARTED|Second Intervention Period||13
10608069|NCT01888497|11765793|FG001|STARTED|Second Intervention Period||14
10608070|NCT01888497|11765794|FG002|STARTED|Second Intervention Period||14
10608071|NCT01888497|11765795|FG003|STARTED|Second Intervention Period||16
10608072|NCT01888497|11765792|FG000|COMPLETED|Second Intervention Period||13
10608073|NCT01888497|11765793|FG001|COMPLETED|Second Intervention Period||14
10608074|NCT01888497|11765794|FG002|COMPLETED|Second Intervention Period||14
10608075|NCT01888497|11765795|FG003|COMPLETED|Second Intervention Period||16
10608076|NCT01888497|11765792|FG000|NOT COMPLETED|Second Intervention Period||0
10608077|NCT01888497|11765793|FG001|NOT COMPLETED|Second Intervention Period||0
10608078|NCT01888497|11765794|FG002|NOT COMPLETED|Second Intervention Period||0
10608079|NCT01888497|11765795|FG003|NOT COMPLETED|Second Intervention Period||0
10608080|NCT01888497|11765792|FG000|STARTED|Washout Period 2||13
10704447|NCT02592434|11868821|FG000|NOT COMPLETED|Double Blind Phase (26 Weeks)||0
10704448|NCT02592434|11868822|FG001|NOT COMPLETED|Double Blind Phase (26 Weeks)||27
10704449|NCT02592434|11868823|FG002|NOT COMPLETED|Double Blind Phase (26 Weeks)||47
10704450|NCT02592447|11868833|FG000|STARTED|Overall Study||29
10704451|NCT02592447|11868834|FG001|STARTED|Overall Study||15
10704452|NCT02592447|11868833|FG000|COMPLETED|Overall Study||27
10704453|NCT02592447|11868834|FG001|COMPLETED|Overall Study||14
10704454|NCT02592447|11868833|FG000|NOT COMPLETED|Overall Study||2
10704455|NCT02592447|11868834|FG001|NOT COMPLETED|Overall Study||1
10704456|NCT02592486|11868842|FG000|STARTED|Overall Study||81
10704457|NCT02592486|11868843|FG001|STARTED|Overall Study||81
10704458|NCT02592486|11868842|FG000|COMPLETED|Overall Study||81
10704459|NCT02592486|11868843|FG001|COMPLETED|Overall Study||76
10704460|NCT02592486|11868842|FG000|NOT COMPLETED|Overall Study||0
10704461|NCT02592486|11868843|FG001|NOT COMPLETED|Overall Study||5
10704462|NCT02592629|11868852|FG000|STARTED|Overall Study||5
10704463|NCT02592629|11868853|FG001|STARTED|Overall Study||9
10704464|NCT02592629|11868854|FG002|STARTED|Overall Study||5
10704465|NCT02592629|11868852|FG000|COMPLETED|Overall Study||5
10704466|NCT02592629|11868853|FG001|COMPLETED|Overall Study||9
10608081|NCT01888497|11765793|FG001|STARTED|Washout Period 2||14
10704467|NCT02592629|11868854|FG002|COMPLETED|Overall Study||5
10704468|NCT02592629|11868852|FG000|NOT COMPLETED|Overall Study||0
10704469|NCT02592629|11868853|FG001|NOT COMPLETED|Overall Study||0
10608082|NCT01888497|11765794|FG002|STARTED|Washout Period 2||14
10608083|NCT01888497|11765795|FG003|STARTED|Washout Period 2||16
10608084|NCT01888497|11765792|FG000|COMPLETED|Washout Period 2||13
10608085|NCT01888497|11765793|FG001|COMPLETED|Washout Period 2||14
10608086|NCT01888497|11765794|FG002|COMPLETED|Washout Period 2||14
10704470|NCT02592629|11868854|FG002|NOT COMPLETED|Overall Study||0
10704471|NCT02592655|11868864|FG000|STARTED|First Tourniquet, Left Thigh.||19
10704472|NCT02592655|11868864|FG000|ATS (Pneumatic)|First Tourniquet, Left Thigh.||5
10704473|NCT02592655|11868864|FG000|Windlass Tourniquet|First Tourniquet, Left Thigh.||7
10704474|NCT02592655|11868864|FG000|Tourniquet Tape 10 cm Width|First Tourniquet, Left Thigh.||5
10713915|NCT02683668|11879479|FG001|COMPLETED|Period 1||0
10608087|NCT01888497|11765795|FG003|COMPLETED|Washout Period 2||14
10608088|NCT01888497|11765792|FG000|NOT COMPLETED|Washout Period 2||0
10608089|NCT01888497|11765793|FG001|NOT COMPLETED|Washout Period 2||0
10608090|NCT01888497|11765794|FG002|NOT COMPLETED|Washout Period 2||0
10608091|NCT01888497|11765795|FG003|NOT COMPLETED|Washout Period 2||2
10608092|NCT01888497|11765792|FG000|STARTED|Third Intervention Period||13
10608093|NCT01888497|11765793|FG001|STARTED|Third Intervention Period||14
10608094|NCT01888497|11765794|FG002|STARTED|Third Intervention Period||14
10608095|NCT01888497|11765795|FG003|STARTED|Third Intervention Period||14
10608096|NCT01888497|11765792|FG000|COMPLETED|Third Intervention Period||13
10608097|NCT01888497|11765793|FG001|COMPLETED|Third Intervention Period||14
10608098|NCT01888497|11765794|FG002|COMPLETED|Third Intervention Period||14
10608099|NCT01888497|11765795|FG003|COMPLETED|Third Intervention Period||14
10608100|NCT01888497|11765792|FG000|NOT COMPLETED|Third Intervention Period||0
10608101|NCT01888497|11765793|FG001|NOT COMPLETED|Third Intervention Period||0
10608102|NCT01888497|11765794|FG002|NOT COMPLETED|Third Intervention Period||0
10608103|NCT01888497|11765795|FG003|NOT COMPLETED|Third Intervention Period||0
10608104|NCT01888497|11765792|FG000|STARTED|Washout Period 3||13
10608105|NCT01888497|11765793|FG001|STARTED|Washout Period 3||14
10608106|NCT01888497|11765794|FG002|STARTED|Washout Period 3||14
10608107|NCT01888497|11765795|FG003|STARTED|Washout Period 3||14
10608108|NCT01888497|11765792|FG000|COMPLETED|Washout Period 3||13
10608109|NCT01888497|11765793|FG001|COMPLETED|Washout Period 3||14
10608110|NCT01888497|11765794|FG002|COMPLETED|Washout Period 3||14
10608111|NCT01888497|11765795|FG003|COMPLETED|Washout Period 3||14
10608112|NCT01888497|11765792|FG000|NOT COMPLETED|Washout Period 3||0
10608113|NCT01888497|11765793|FG001|NOT COMPLETED|Washout Period 3||0
10608114|NCT01888497|11765794|FG002|NOT COMPLETED|Washout Period 3||0
10608115|NCT01888497|11765795|FG003|NOT COMPLETED|Washout Period 3||0
10608116|NCT01888497|11765792|FG000|STARTED|Fourth Intervention Period||13
10608117|NCT01888497|11765793|FG001|STARTED|Fourth Intervention Period||14
10608118|NCT01888497|11765794|FG002|STARTED|Fourth Intervention Period||14
10608119|NCT01888497|11765795|FG003|STARTED|Fourth Intervention Period||14
10608120|NCT01888497|11765792|FG000|COMPLETED|Fourth Intervention Period||13
10608121|NCT01888497|11765793|FG001|COMPLETED|Fourth Intervention Period||14
10608122|NCT01888497|11765794|FG002|COMPLETED|Fourth Intervention Period||14
10608123|NCT01888497|11765795|FG003|COMPLETED|Fourth Intervention Period||14
10608124|NCT01888497|11765792|FG000|NOT COMPLETED|Fourth Intervention Period||0
10608125|NCT01888497|11765793|FG001|NOT COMPLETED|Fourth Intervention Period||0
10608126|NCT01888497|11765794|FG002|NOT COMPLETED|Fourth Intervention Period||0
10608127|NCT01888497|11765795|FG003|NOT COMPLETED|Fourth Intervention Period||0
10608128|NCT01888640|11765808|FG000|STARTED|Overall Study||103
10608129|NCT01888640|11765809|FG001|STARTED|Overall Study||99
10608130|NCT01888640|11765810|FG002|STARTED|Overall Study||99
10608131|NCT01888640|11765808|FG000|COMPLETED|Overall Study||76
10608132|NCT01888640|11765809|FG001|COMPLETED|Overall Study||68
10608133|NCT01888640|11765810|FG002|COMPLETED|Overall Study||94
10608134|NCT01888640|11765808|FG000|NOT COMPLETED|Overall Study||27
10608135|NCT01888640|11765809|FG001|NOT COMPLETED|Overall Study||31
10608136|NCT01888640|11765810|FG002|NOT COMPLETED|Overall Study||5
10608137|NCT01888874|11765828|FG000|STARTED|Period 1 (Baseline up to Week 12)||86
10608138|NCT01888874|11765829|FG001|STARTED|Period 1 (Baseline up to Week 12)||82
10608139|NCT01888874|11765830|FG002|STARTED|Period 1 (Baseline up to Week 12)||85
10608140|NCT01888874|11765831|FG003|STARTED|Period 1 (Baseline up to Week 12)||86
10608141|NCT01888874|11765832|FG004|STARTED|Period 1 (Baseline up to Week 12)||86
10608142|NCT01888874|11765833|FG005|STARTED|Period 1 (Baseline up to Week 12)||85
10608143|NCT01888874|11765834|FG006|STARTED|Period 1 (Baseline up to Week 12)||84
10608144|NCT01888874|11765828|FG000|COMPLETED|Period 1 (Baseline up to Week 12)||83
10608145|NCT01888874|11765829|FG001|COMPLETED|Period 1 (Baseline up to Week 12)||76
10608146|NCT01888874|11765830|FG002|COMPLETED|Period 1 (Baseline up to Week 12)||78
10608147|NCT01888874|11765831|FG003|COMPLETED|Period 1 (Baseline up to Week 12)||80
10608148|NCT01888874|11765832|FG004|COMPLETED|Period 1 (Baseline up to Week 12)||77
10608149|NCT01888874|11765833|FG005|COMPLETED|Period 1 (Baseline up to Week 12)||80
10608150|NCT01888874|11765834|FG006|COMPLETED|Period 1 (Baseline up to Week 12)||83
10608151|NCT01888874|11765828|FG000|NOT COMPLETED|Period 1 (Baseline up to Week 12)||3
10608152|NCT01888874|11765829|FG001|NOT COMPLETED|Period 1 (Baseline up to Week 12)||6
10608153|NCT01888874|11765830|FG002|NOT COMPLETED|Period 1 (Baseline up to Week 12)||7
10608154|NCT01888874|11765831|FG003|NOT COMPLETED|Period 1 (Baseline up to Week 12)||6
10608155|NCT01888874|11765832|FG004|NOT COMPLETED|Period 1 (Baseline up to Week 12)||9
10608156|NCT01888874|11765833|FG005|NOT COMPLETED|Period 1 (Baseline up to Week 12)||5
10608157|NCT01888874|11765834|FG006|NOT COMPLETED|Period 1 (Baseline up to Week 12)||1
10608158|NCT01888874|11765828|FG000|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from Placebo group moved to 100 mg QD(15 participants) and 50 mg BID(15 participants).|53
10608159|NCT01888874|11765829|FG001|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from 50 mg QD group moved to 100 mg QD group (19 participants).|57
10608160|NCT01888874|11765830|FG002|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from Placebo(15 participants) and 50 mg QD (19 participants) moved to 100 mg QD group.|112
10608161|NCT01888874|11765831|FG003|STARTED|Period 2 (Week 13 to Week 24)||80
10608162|NCT01888874|11765832|FG004|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from 25 mg BID group moved to 50 mg BID group (17 participants).|60
10608163|NCT01888874|11765833|FG005|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from Placebo(15 participants) and 25 mg BID(17 participants) moved to 50 mg BID group.|112
10608164|NCT01888874|11765834|FG006|STARTED|Period 2 (Week 13 to Week 24)||83
10608165|NCT01888874|11765828|FG000|COMPLETED|Period 2 (Week 13 to Week 24)||50
10608166|NCT01888874|11765829|FG001|COMPLETED|Period 2 (Week 13 to Week 24)||55
10608167|NCT01888874|11765830|FG002|COMPLETED|Period 2 (Week 13 to Week 24)||104
10608168|NCT01888874|11765831|FG003|COMPLETED|Period 2 (Week 13 to Week 24)||78
10608169|NCT01888874|11765832|FG004|COMPLETED|Period 2 (Week 13 to Week 24)||57
10608170|NCT01888874|11765833|FG005|COMPLETED|Period 2 (Week 13 to Week 24)||109
10608171|NCT01888874|11765834|FG006|COMPLETED|Period 2 (Week 13 to Week 24)||80
10608172|NCT01888874|11765828|FG000|NOT COMPLETED|Period 2 (Week 13 to Week 24)||3
10608173|NCT01888874|11765829|FG001|NOT COMPLETED|Period 2 (Week 13 to Week 24)||2
10608174|NCT01888874|11765830|FG002|NOT COMPLETED|Period 2 (Week 13 to Week 24)||8
10608175|NCT01888874|11765831|FG003|NOT COMPLETED|Period 2 (Week 13 to Week 24)||2
10608176|NCT01888874|11765832|FG004|NOT COMPLETED|Period 2 (Week 13 to Week 24)||3
10608177|NCT01888874|11765833|FG005|NOT COMPLETED|Period 2 (Week 13 to Week 24)||3
10608178|NCT01888874|11765834|FG006|NOT COMPLETED|Period 2 (Week 13 to Week 24)||3
10608179|NCT01888900|11765853|FG000|STARTED|Overall Study||22
10608180|NCT01888900|11765854|FG001|STARTED|Overall Study||13
10608181|NCT01888900|11765853|FG000|COMPLETED|Overall Study||22
10608182|NCT01888900|11765854|FG001|COMPLETED|Overall Study||11
10608183|NCT01888900|11765853|FG000|NOT COMPLETED|Overall Study||0
10608184|NCT01888900|11765854|FG001|NOT COMPLETED|Overall Study||2
10608185|NCT01888952|11765862|FG000|STARTED|Overall Study||10
10608186|NCT01888952|11765862|FG000|COMPLETED|Overall Study||10
10608187|NCT01888952|11765862|FG000|NOT COMPLETED|Overall Study||0
10608188|NCT01888965|11765866|FG000|STARTED|Overall Study||9
10608189|NCT01888965|11765866|FG000|COMPLETED|Overall Study||0
10608190|NCT01888965|11765866|FG000|NOT COMPLETED|Overall Study||9
10608191|NCT01889069|11765872|FG000|STARTED|Overall Study||158
10608192|NCT01889069|11765872|FG000|COMPLETED|Overall Study||113
10608193|NCT01889069|11765872|FG000|NOT COMPLETED|Overall Study||45
10608194|NCT01889251|11765884|FG000|STARTED|Overall Study||115
10608195|NCT01889251|11765885|FG001|STARTED|Overall Study||57
10608196|NCT01889251|11765884|FG000|COMPLETED|Overall Study||114
10608197|NCT01889251|11765885|FG001|COMPLETED|Overall Study||57
10608198|NCT01889251|11765884|FG000|NOT COMPLETED|Overall Study||1
10608199|NCT01889251|11765885|FG001|NOT COMPLETED|Overall Study||0
10608200|NCT01889355|11765891|FG000|STARTED|Overall Study||115
10608201|NCT01889355|11765891|FG000|COMPLETED|Overall Study||113
10608202|NCT01889355|11765891|FG000|NOT COMPLETED|Overall Study||2
10608203|NCT01889563|11765897|FG000|STARTED|Overall Study||17
10608204|NCT01889563|11765898|FG001|STARTED|Overall Study||15
10608205|NCT01889563|11765897|FG000|COMPLETED|Overall Study||10
10608206|NCT01889563|11765898|FG001|COMPLETED|Overall Study||10
10608207|NCT01889563|11765897|FG000|NOT COMPLETED|Overall Study||7
10608208|NCT01889563|11765898|FG001|NOT COMPLETED|Overall Study||5
10608209|NCT01889602|11765907|FG000|STARTED|First Intervention||20
10608210|NCT01889602|11765908|FG001|STARTED|First Intervention||20
10608211|NCT01889602|11765909|FG002|STARTED|First Intervention||20
10608212|NCT01889602|11765907|FG000|COMPLETED|First Intervention||19
10608213|NCT01889602|11765908|FG001|COMPLETED|First Intervention||17
10608214|NCT01889602|11765909|FG002|COMPLETED|First Intervention||18
10608215|NCT01889602|11765907|FG000|NOT COMPLETED|First Intervention||1
10608216|NCT01889602|11765908|FG001|NOT COMPLETED|First Intervention||3
10608217|NCT01889602|11765909|FG002|NOT COMPLETED|First Intervention||2
10608218|NCT01889602|11765907|FG000|STARTED|First Washout Period of at Least 2 Weeks||19
10608219|NCT01889602|11765908|FG001|STARTED|First Washout Period of at Least 2 Weeks||17
10608220|NCT01889602|11765909|FG002|STARTED|First Washout Period of at Least 2 Weeks||18
10608221|NCT01889602|11765907|FG000|COMPLETED|First Washout Period of at Least 2 Weeks||19
10608222|NCT01889602|11765908|FG001|COMPLETED|First Washout Period of at Least 2 Weeks||17
10608223|NCT01889602|11765909|FG002|COMPLETED|First Washout Period of at Least 2 Weeks||18
10608224|NCT01889602|11765907|FG000|NOT COMPLETED|First Washout Period of at Least 2 Weeks||0
10608225|NCT01889602|11765908|FG001|NOT COMPLETED|First Washout Period of at Least 2 Weeks||0
10608226|NCT01889602|11765909|FG002|NOT COMPLETED|First Washout Period of at Least 2 Weeks||0
10608227|NCT01889602|11765907|FG000|STARTED|Second Intervention||19
10608228|NCT01889602|11765908|FG001|STARTED|Second Intervention||17
10608229|NCT01889602|11765909|FG002|STARTED|Second Intervention||18
10608230|NCT01889602|11765907|FG000|COMPLETED|Second Intervention||18
10608231|NCT01889602|11765908|FG001|COMPLETED|Second Intervention||17
10608232|NCT01889602|11765909|FG002|COMPLETED|Second Intervention||16
10608233|NCT01889602|11765907|FG000|NOT COMPLETED|Second Intervention||1
10704475|NCT02592655|11868864|FG000|Tourniquet Tape 5 cm Width|First Tourniquet, Left Thigh.||2
10704476|NCT02592655|11868864|FG000|COMPLETED|First Tourniquet, Left Thigh.||19
10704477|NCT02592655|11868864|FG000|NOT COMPLETED|First Tourniquet, Left Thigh.||0
10704478|NCT02592655|11868864|FG000|STARTED|Second Tourniquet Right Thigh.||19
10704479|NCT02592655|11868864|FG000|ATS (Pneumatic)|Second Tourniquet Right Thigh.||5
10704480|NCT02592655|11868864|FG000|Windlass Tourniquet|Second Tourniquet Right Thigh.||8
10704481|NCT02592655|11868864|FG000|Tourniquet Tape 10 cm Width|Second Tourniquet Right Thigh.||5
10704482|NCT02592655|11868864|FG000|Tourniquet Tape 5 cm Width|Second Tourniquet Right Thigh.||1
10704483|NCT02592655|11868864|FG000|COMPLETED|Second Tourniquet Right Thigh.||19
10704484|NCT02592655|11868864|FG000|NOT COMPLETED|Second Tourniquet Right Thigh.||0
10704485|NCT02592655|11868864|FG000|STARTED|Third Tourniquet, Left Thigh.||19
10704486|NCT02592655|11868864|FG000|ATS (Pneumatic)|Third Tourniquet, Left Thigh.||8
10608234|NCT01889602|11765908|FG001|NOT COMPLETED|Second Intervention||0
10608235|NCT01889602|11765909|FG002|NOT COMPLETED|Second Intervention||2
10608236|NCT01889602|11765907|FG000|STARTED|Second Washout Period of at Least 2 Week||18
10608237|NCT01889602|11765908|FG001|STARTED|Second Washout Period of at Least 2 Week||17
10608238|NCT01889602|11765909|FG002|STARTED|Second Washout Period of at Least 2 Week||16
10608239|NCT01889602|11765907|FG000|COMPLETED|Second Washout Period of at Least 2 Week||18
10608240|NCT01889602|11765908|FG001|COMPLETED|Second Washout Period of at Least 2 Week||17
10608241|NCT01889602|11765909|FG002|COMPLETED|Second Washout Period of at Least 2 Week||16
10608242|NCT01889602|11765907|FG000|NOT COMPLETED|Second Washout Period of at Least 2 Week||0
10608243|NCT01889602|11765908|FG001|NOT COMPLETED|Second Washout Period of at Least 2 Week||0
10608244|NCT01889602|11765909|FG002|NOT COMPLETED|Second Washout Period of at Least 2 Week||0
10608245|NCT01889602|11765907|FG000|STARTED|Third Intervention||18
10608246|NCT01889602|11765908|FG001|STARTED|Third Intervention||17
10608247|NCT01889602|11765909|FG002|STARTED|Third Intervention||16
10608248|NCT01889602|11765907|FG000|COMPLETED|Third Intervention||15
10608249|NCT01889602|11765908|FG001|COMPLETED|Third Intervention||15
10608250|NCT01889602|11765909|FG002|COMPLETED|Third Intervention||16
10608251|NCT01889602|11765907|FG000|NOT COMPLETED|Third Intervention||3
10608252|NCT01889602|11765908|FG001|NOT COMPLETED|Third Intervention||2
10608253|NCT01889602|11765909|FG002|NOT COMPLETED|Third Intervention||0
10608254|NCT01889602|11765907|FG000|STARTED|Third Washout Period of at Least 2 Weeks||15
10608255|NCT01889602|11765908|FG001|STARTED|Third Washout Period of at Least 2 Weeks||15
10608256|NCT01889602|11765909|FG002|STARTED|Third Washout Period of at Least 2 Weeks||16
10608257|NCT01889602|11765907|FG000|COMPLETED|Third Washout Period of at Least 2 Weeks||15
10608258|NCT01889602|11765908|FG001|COMPLETED|Third Washout Period of at Least 2 Weeks||15
10608259|NCT01889602|11765909|FG002|COMPLETED|Third Washout Period of at Least 2 Weeks||16
10608260|NCT01889602|11765907|FG000|NOT COMPLETED|Third Washout Period of at Least 2 Weeks||0
10608261|NCT01889602|11765908|FG001|NOT COMPLETED|Third Washout Period of at Least 2 Weeks||0
10608262|NCT01889602|11765909|FG002|NOT COMPLETED|Third Washout Period of at Least 2 Weeks||0
10608263|NCT01889667|11765928|FG000|STARTED|Overall Study||10
10608264|NCT01889667|11765929|FG001|STARTED|Overall Study||10
10608265|NCT01889667|11765930|FG002|STARTED|Overall Study||10
10608266|NCT01889667|11765928|FG000|COMPLETED|Overall Study||10
10808772|NCT03840811|11970741|FG002|NOT COMPLETED|Overall Study||1
10808773|NCT03837028|11970753|FG000|STARTED|Overall Study||35
10808774|NCT03837028|11970754|FG001|STARTED|Overall Study||34
10608267|NCT01889667|11765929|FG001|COMPLETED|Overall Study||10
10608268|NCT01889667|11765930|FG002|COMPLETED|Overall Study||10
10608269|NCT01889667|11765928|FG000|NOT COMPLETED|Overall Study||0
10608270|NCT01889667|11765929|FG001|NOT COMPLETED|Overall Study||0
10608271|NCT01889667|11765930|FG002|NOT COMPLETED|Overall Study||0
10608272|NCT01889797|11765942|FG000|STARTED|Overall Study||16
10608273|NCT01889797|11765943|FG001|STARTED|Overall Study||16
10608274|NCT01889797|11765942|FG000|COMPLETED|Overall Study||16
10608275|NCT01889797|11765943|FG001|COMPLETED|Overall Study||16
10608276|NCT01889797|11765942|FG000|NOT COMPLETED|Overall Study||0
10608277|NCT01889797|11765943|FG001|NOT COMPLETED|Overall Study||0
10608278|NCT01889862|11765949|FG000|STARTED|Part 1 (Up to 13 Weeks)||86
10608279|NCT01889862|11765950|FG001|STARTED|Part 1 (Up to 13 Weeks)||0
10608280|NCT01889862|11765951|FG002|STARTED|Part 1 (Up to 13 Weeks)||78
10608281|NCT01889862|11765952|FG003|STARTED|Part 1 (Up to 13 Weeks)||0
10608282|NCT01889862|11765953|FG004|STARTED|Part 1 (Up to 13 Weeks)||0
10608283|NCT01889862|11765949|FG000|COMPLETED|Part 1 (Up to 13 Weeks)|Out of 164, total 12 subjects have not completed Part 1.|74
10608284|NCT01889862|11765950|FG001|COMPLETED|Part 1 (Up to 13 Weeks)||0
10608285|NCT01889862|11765951|FG002|COMPLETED|Part 1 (Up to 13 Weeks)||78
10608286|NCT01889862|11765952|FG003|COMPLETED|Part 1 (Up to 13 Weeks)||0
10608287|NCT01889862|11765953|FG004|COMPLETED|Part 1 (Up to 13 Weeks)||0
10608288|NCT01889862|11765949|FG000|NOT COMPLETED|Part 1 (Up to 13 Weeks)||12
10608289|NCT01889862|11765950|FG001|NOT COMPLETED|Part 1 (Up to 13 Weeks)||0
10608290|NCT01889862|11765951|FG002|NOT COMPLETED|Part 1 (Up to 13 Weeks)||0
10608291|NCT01889862|11765952|FG003|NOT COMPLETED|Part 1 (Up to 13 Weeks)||0
10608292|NCT01889862|11765953|FG004|NOT COMPLETED|Part 1 (Up to 13 Weeks)||0
10608293|NCT01889862|11765949|FG000|STARTED|Part 2 (8 Weeks)|Subjects ≥20% reduction in blood Phe from naïve baseline levels are randomized in Part 2.|34
10608294|NCT01889862|11765950|FG001|STARTED|Part 2 (8 Weeks)|Subjects ≥20% reduction in blood Phe from naïve baseline levels are randomized in Part 2.|15
10608295|NCT01889862|11765951|FG002|STARTED|Part 2 (8 Weeks)|Subjects ≥20% reduction in blood Phe from naïve baseline levels are randomized in Part 2.|32
10608296|NCT01889862|11765952|FG003|STARTED|Part 2 (8 Weeks)|Subjects ≥20% reduction in blood Phe from naïve baseline levels are randomized in Part 2.|14
10608297|NCT01889862|11765953|FG004|STARTED|Part 2 (8 Weeks)||0
10608298|NCT01889862|11765949|FG000|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||29
10608299|NCT01889862|11765950|FG001|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||14
10608300|NCT01889862|11765951|FG002|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||29
10608301|NCT01889862|11765952|FG003|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||14
10608302|NCT01889862|11765953|FG004|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||0
10608303|NCT01889862|11765949|FG000|COMPLETED|Part 2 (8 Weeks)||34
10608304|NCT01889862|11765950|FG001|COMPLETED|Part 2 (8 Weeks)||15
10608305|NCT01889862|11765951|FG002|COMPLETED|Part 2 (8 Weeks)||31
10608306|NCT01889862|11765952|FG003|COMPLETED|Part 2 (8 Weeks)||14
10608307|NCT01889862|11765953|FG004|COMPLETED|Part 2 (8 Weeks)||0
10608308|NCT01889862|11765949|FG000|NOT COMPLETED|Part 2 (8 Weeks)||0
10608309|NCT01889862|11765950|FG001|NOT COMPLETED|Part 2 (8 Weeks)||0
10608310|NCT01889862|11765951|FG002|NOT COMPLETED|Part 2 (8 Weeks)||1
10608311|NCT01889862|11765952|FG003|NOT COMPLETED|Part 2 (8 Weeks)||0
10608312|NCT01889862|11765953|FG004|NOT COMPLETED|Part 2 (8 Weeks)||0
10608313|NCT01889862|11765949|FG000|STARTED|Part 3A/B (6 Week)|Subjects switch from placebo to active 20mg/kg.|48
10608314|NCT01889862|11765950|FG001|STARTED|Part 3A/B (6 Week)|Subjects switch from placebo to active 20mg/kg.|0
10808775|NCT03837028|11970755|FG002|STARTED|Overall Study||33
10608315|NCT01889862|11765951|FG002|STARTED|Part 3A/B (6 Week)|Subjects switch from placebo to active 40mg/kg.|41
10608316|NCT01889862|11765952|FG003|STARTED|Part 3A/B (6 Week)|Subjects switch from placebo to active 40mg/kg.|0
10608317|NCT01889862|11765953|FG004|STARTED|Part 3A/B (6 Week)||0
10608318|NCT01889862|11765949|FG000|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||34
10608319|NCT01889862|11765950|FG001|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||0
10608320|NCT01889862|11765951|FG002|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||26
10608321|NCT01889862|11765952|FG003|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||0
10608322|NCT01889862|11765953|FG004|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||0
10608323|NCT01889862|11765949|FG000|COMPLETED|Part 3A/B (6 Week)||48
10608324|NCT01889862|11765950|FG001|COMPLETED|Part 3A/B (6 Week)||0
10608325|NCT01889862|11765951|FG002|COMPLETED|Part 3A/B (6 Week)||41
10608326|NCT01889862|11765952|FG003|COMPLETED|Part 3A/B (6 Week)||0
10608327|NCT01889862|11765953|FG004|COMPLETED|Part 3A/B (6 Week)||0
10608328|NCT01889862|11765949|FG000|NOT COMPLETED|Part 3A/B (6 Week)||0
10608329|NCT01889862|11765950|FG001|NOT COMPLETED|Part 3A/B (6 Week)||0
10608330|NCT01889862|11765951|FG002|NOT COMPLETED|Part 3A/B (6 Week)||0
10608331|NCT01889862|11765952|FG003|NOT COMPLETED|Part 3A/B (6 Week)||0
10608332|NCT01889862|11765953|FG004|NOT COMPLETED|Part 3A/B (6 Week)||0
10608333|NCT01889862|11765949|FG000|STARTED|Part 4 (Up to 274 Weeks)|51, 57, 5 and 89 subjects from 165-301, 165-302 Part 1, 2 & 3 entered 165-302 Part 4 respectively.|0
10608334|NCT01889862|11765950|FG001|STARTED|Part 4 (Up to 274 Weeks)||0
10608335|NCT01889862|11765951|FG002|STARTED|Part 4 (Up to 274 Weeks)|51, 57, 5 and 89 subjects from 165-301, 165-302 Part 1, 2 & 3 entered 165-302 Part 4 respectively.|0
10608336|NCT01889862|11765952|FG003|STARTED|Part 4 (Up to 274 Weeks)||0
10608337|NCT01889862|11765953|FG004|STARTED|Part 4 (Up to 274 Weeks)|Total of 202 subjects from 165-301, Part 1, 2, 3 entered Part 4 to receive dose of up to 60mg/kg.|202
10608338|NCT01889862|11765949|FG000|COMPLETED|Part 4 (Up to 274 Weeks)||0
10608339|NCT01889862|11765950|FG001|COMPLETED|Part 4 (Up to 274 Weeks)||0
10608340|NCT01889862|11765951|FG002|COMPLETED|Part 4 (Up to 274 Weeks)||0
10608341|NCT01889862|11765952|FG003|COMPLETED|Part 4 (Up to 274 Weeks)||0
10608342|NCT01889862|11765953|FG004|COMPLETED|Part 4 (Up to 274 Weeks)||172
10608343|NCT01889862|11765949|FG000|NOT COMPLETED|Part 4 (Up to 274 Weeks)||0
10608344|NCT01889862|11765950|FG001|NOT COMPLETED|Part 4 (Up to 274 Weeks)||0
10608345|NCT01889862|11765951|FG002|NOT COMPLETED|Part 4 (Up to 274 Weeks)||0
10608346|NCT01889862|11765952|FG003|NOT COMPLETED|Part 4 (Up to 274 Weeks)||0
10608347|NCT01889862|11765953|FG004|NOT COMPLETED|Part 4 (Up to 274 Weeks)||30
10608348|NCT01890031|11765983|FG000|STARTED|Overall Study||50
10608349|NCT01890031|11765984|FG001|STARTED|Overall Study||50
10608350|NCT01890031|11765985|FG002|STARTED|Overall Study||12
10608351|NCT01890031|11765986|FG003|STARTED|Overall Study||11
10608352|NCT01890031|11765987|FG004|STARTED|Overall Study||8
10608353|NCT01890031|11765983|FG000|COMPLETED|Overall Study||50
10608354|NCT01890031|11765984|FG001|COMPLETED|Overall Study||50
10608355|NCT01890031|11765985|FG002|COMPLETED|Overall Study||12
10608356|NCT01890031|11765986|FG003|COMPLETED|Overall Study||11
10608357|NCT01890031|11765987|FG004|COMPLETED|Overall Study||8
10608358|NCT01890031|11765983|FG000|NOT COMPLETED|Overall Study||0
10608359|NCT01890031|11765984|FG001|NOT COMPLETED|Overall Study||0
10608360|NCT01890031|11765985|FG002|NOT COMPLETED|Overall Study||0
10608361|NCT01890031|11765986|FG003|NOT COMPLETED|Overall Study||0
10608362|NCT01890031|11765987|FG004|NOT COMPLETED|Overall Study||0
10608363|NCT01890109|11766001|FG000|STARTED|Overall Study||52
10608364|NCT01890109|11766002|FG001|STARTED|Overall Study||51
10608365|NCT01890109|11766001|FG000|Received Study Treatment|Overall Study||52
10608366|NCT01890109|11766002|FG001|Received Study Treatment|Overall Study||50
10608367|NCT01890109|11766001|FG000|COMPLETED|Overall Study||51
10608368|NCT01890109|11766002|FG001|COMPLETED|Overall Study||46
10608369|NCT01890109|11766001|FG000|NOT COMPLETED|Overall Study||1
10608370|NCT01890109|11766002|FG001|NOT COMPLETED|Overall Study||5
10608371|NCT01890122|11766013|FG000|STARTED|Overall Study|Started = Enrolled set which included all participants who signed informed consent.|162
10608372|NCT01890122|11766014|FG001|STARTED|Overall Study||163
10608373|NCT01890122|11766015|FG002|STARTED|Overall Study||159
10608374|NCT01890122|11766016|FG003|STARTED|Overall Study||163
10608375|NCT01890122|11766013|FG000|Treated|Overall Study|Treated = Randomized participants who received at least one dose of study drug.|161
10608376|NCT01890122|11766014|FG001|Treated|Overall Study||162
10608377|NCT01890122|11766015|FG002|Treated|Overall Study||159
10608378|NCT01890122|11766016|FG003|Treated|Overall Study||163
10608379|NCT01890122|11766013|FG000|COMPLETED|Overall Study||135
10608380|NCT01890122|11766014|FG001|COMPLETED|Overall Study||126
10608381|NCT01890122|11766015|FG002|COMPLETED|Overall Study||146
10608382|NCT01890122|11766016|FG003|COMPLETED|Overall Study||104
10608383|NCT01890122|11766013|FG000|NOT COMPLETED|Overall Study||27
10608384|NCT01890122|11766014|FG001|NOT COMPLETED|Overall Study||37
10608385|NCT01890122|11766015|FG002|NOT COMPLETED|Overall Study||13
10608386|NCT01890122|11766016|FG003|NOT COMPLETED|Overall Study||59
10608387|NCT01890148|11766026|FG000|STARTED|Overall Study||5
10608388|NCT01890148|11766026|FG000|COMPLETED|Overall Study||4
10608389|NCT01890148|11766026|FG000|NOT COMPLETED|Overall Study||1
10608390|NCT01890226|11766032|FG000|STARTED|Overall Study||155
10608391|NCT01890226|11766033|FG001|STARTED|Overall Study||156
10608392|NCT01890226|11766032|FG000|COMPLETED|Overall Study||155
10608393|NCT01890226|11766033|FG001|COMPLETED|Overall Study||156
10608394|NCT01890226|11766032|FG000|NOT COMPLETED|Overall Study||0
10608395|NCT01890226|11766033|FG001|NOT COMPLETED|Overall Study||0
10608396|NCT01890265|11766045|FG000|STARTED|Overall Study||50
10608397|NCT01890265|11766046|FG001|STARTED|Overall Study||53
10608398|NCT01890265|11766047|FG002|STARTED|Overall Study||24
10608399|NCT01890265|11766048|FG003|STARTED|Overall Study||12
10608400|NCT01890265|11766049|FG004|STARTED|Overall Study||15
10608401|NCT01890265|11766050|FG005|STARTED|Overall Study||6
10608402|NCT01890265|11766045|FG000|Safety Population|Overall Study||50
10608403|NCT01890265|11766046|FG001|Safety Population|Overall Study||53
10608404|NCT01890265|11766047|FG002|Safety Population|Overall Study||24
10608405|NCT01890265|11766048|FG003|Safety Population|Overall Study||12
10608406|NCT01890265|11766049|FG004|Safety Population|Overall Study||15
10608407|NCT01890265|11766050|FG005|Safety Population|Overall Study||6
10608408|NCT01890265|11766045|FG000|Intent-to-Treat (ITT) Population|Overall Study||50
10608409|NCT01890265|11766046|FG001|Intent-to-Treat (ITT) Population|Overall Study||51
10608410|NCT01890265|11766047|FG002|Intent-to-Treat (ITT) Population|Overall Study||24
10608411|NCT01890265|11766048|FG003|Intent-to-Treat (ITT) Population|Overall Study||12
10608412|NCT01890265|11766049|FG004|Intent-to-Treat (ITT) Population|Overall Study||15
10608413|NCT01890265|11766050|FG005|Intent-to-Treat (ITT) Population|Overall Study||6
10608414|NCT01890265|11766045|FG000|COMPLETED|Overall Study||40
10608415|NCT01890265|11766046|FG001|COMPLETED|Overall Study||40
10608416|NCT01890265|11766047|FG002|COMPLETED|Overall Study||20
10608417|NCT01890265|11766048|FG003|COMPLETED|Overall Study||12
10608418|NCT01890265|11766049|FG004|COMPLETED|Overall Study||13
10608419|NCT01890265|11766050|FG005|COMPLETED|Overall Study||6
10608420|NCT01890265|11766045|FG000|NOT COMPLETED|Overall Study||10
10608421|NCT01890265|11766046|FG001|NOT COMPLETED|Overall Study||13
10608422|NCT01890265|11766047|FG002|NOT COMPLETED|Overall Study||4
10608423|NCT01890265|11766048|FG003|NOT COMPLETED|Overall Study||0
10608424|NCT01890265|11766049|FG004|NOT COMPLETED|Overall Study||2
10608425|NCT01890265|11766050|FG005|NOT COMPLETED|Overall Study||0
10608426|NCT01890343|11766063|FG000|STARTED|Overall Study||8
10608427|NCT01890343|11766064|FG001|STARTED|Overall Study||10
10608428|NCT01890343|11766065|FG002|STARTED|Overall Study||10
10608429|NCT01890343|11766063|FG000|COMPLETED|Overall Study||8
10608430|NCT01890343|11766064|FG001|COMPLETED|Overall Study||10
10608431|NCT01890343|11766065|FG002|COMPLETED|Overall Study||10
10608432|NCT01890343|11766063|FG000|NOT COMPLETED|Overall Study||0
10608433|NCT01890343|11766064|FG001|NOT COMPLETED|Overall Study||0
10608434|NCT01890343|11766065|FG002|NOT COMPLETED|Overall Study||0
10608435|NCT01890421|11766073|FG000|STARTED|Overall Study||426
10608436|NCT01890421|11766073|FG000|COMPLETED|Overall Study||415
10608437|NCT01890421|11766073|FG000|NOT COMPLETED|Overall Study||11
10608438|NCT01890434|11766077|FG000|STARTED|Overall Study||478
10608439|NCT01890434|11766077|FG000|Evaluated for Efficacy|Overall Study||389
10608440|NCT01890434|11766077|FG000|COMPLETED|Overall Study||458
10608441|NCT01890434|11766077|FG000|NOT COMPLETED|Overall Study||20
10608442|NCT01890473|11766083|FG000|STARTED|Overall Study||111
10608443|NCT01890473|11766084|FG001|STARTED|Overall Study||113
10608444|NCT01890473|11766083|FG000|COMPLETED|Overall Study||109
10608445|NCT01890473|11766084|FG001|COMPLETED|Overall Study||113
10608446|NCT01890473|11766083|FG000|NOT COMPLETED|Overall Study||2
10608447|NCT01890473|11766084|FG001|NOT COMPLETED|Overall Study||0
10608448|NCT01890512|11766092|FG000|STARTED|Overall Study||20
10608449|NCT01890512|11766092|FG000|COMPLETED|Overall Study||17
10608450|NCT01890512|11766092|FG000|NOT COMPLETED|Overall Study||3
10608451|NCT01890642|11766099|FG000|STARTED|Overall Study||56
10608452|NCT01890642|11766100|FG001|STARTED|Overall Study||53
10608453|NCT01890642|11766101|FG002|STARTED|Overall Study||96
10608454|NCT01890642|11766099|FG000|COMPLETED|Overall Study||56
10608455|NCT01890642|11766100|FG001|COMPLETED|Overall Study||53
10608456|NCT01890642|11766101|FG002|COMPLETED|Overall Study||96
10608457|NCT01890642|11766099|FG000|NOT COMPLETED|Overall Study||0
10608458|NCT01890642|11766100|FG001|NOT COMPLETED|Overall Study||0
10608459|NCT01890642|11766101|FG002|NOT COMPLETED|Overall Study||0
10608460|NCT01890707|11766111|FG000|STARTED|Overall Study||11
10608461|NCT01890707|11766112|FG001|STARTED|Overall Study||8
10608462|NCT01890707|11766111|FG000|COMPLETED|Overall Study||10
10608463|NCT01890707|11766112|FG001|COMPLETED|Overall Study||7
10608464|NCT01890707|11766111|FG000|NOT COMPLETED|Overall Study||1
10608465|NCT01890707|11766112|FG001|NOT COMPLETED|Overall Study||1
10608466|NCT01890746|11766120|FG000|STARTED|Overall Study||74
10608467|NCT01890746|11766121|FG001|STARTED|Overall Study||74
10608468|NCT01890746|11766120|FG000|COMPLETED|Overall Study||22
10608469|NCT01890746|11766121|FG001|COMPLETED|Overall Study||33
10608470|NCT01890746|11766120|FG000|NOT COMPLETED|Overall Study||52
10608471|NCT01890746|11766121|FG001|NOT COMPLETED|Overall Study||41
10608472|NCT01890785|11766133|FG000|STARTED|First Intervention||5
10608473|NCT01890785|11766134|FG001|STARTED|First Intervention||5
10608474|NCT01890785|11766135|FG002|STARTED|First Intervention||5
10608475|NCT01890785|11766136|FG003|STARTED|First Intervention||5
10608476|NCT01890785|11766137|FG004|STARTED|First Intervention||5
10608477|NCT01890785|11766138|FG005|STARTED|First Intervention||5
10608478|NCT01890785|11766133|FG000|COMPLETED|First Intervention||5
10608479|NCT01890785|11766134|FG001|COMPLETED|First Intervention||5
10608480|NCT01890785|11766135|FG002|COMPLETED|First Intervention||5
10608481|NCT01890785|11766136|FG003|COMPLETED|First Intervention||5
10608482|NCT01890785|11766137|FG004|COMPLETED|First Intervention||5
10608483|NCT01890785|11766138|FG005|COMPLETED|First Intervention||5
10608484|NCT01890785|11766133|FG000|NOT COMPLETED|First Intervention||0
10608485|NCT01890785|11766134|FG001|NOT COMPLETED|First Intervention||0
10608486|NCT01890785|11766135|FG002|NOT COMPLETED|First Intervention||0
10608487|NCT01890785|11766136|FG003|NOT COMPLETED|First Intervention||0
10608488|NCT01890785|11766137|FG004|NOT COMPLETED|First Intervention||0
10608489|NCT01890785|11766138|FG005|NOT COMPLETED|First Intervention||0
10608490|NCT01890785|11766133|FG000|STARTED|Second Intervention||5
10608491|NCT01890785|11766134|FG001|STARTED|Second Intervention||5
10608492|NCT01890785|11766135|FG002|STARTED|Second Intervention||5
10608493|NCT01890785|11766136|FG003|STARTED|Second Intervention||5
10608494|NCT01890785|11766137|FG004|STARTED|Second Intervention||5
10608495|NCT01890785|11766138|FG005|STARTED|Second Intervention||5
10608496|NCT01890785|11766133|FG000|COMPLETED|Second Intervention||5
10608497|NCT01890785|11766134|FG001|COMPLETED|Second Intervention||5
10608498|NCT01890785|11766135|FG002|COMPLETED|Second Intervention||5
10608499|NCT01890785|11766136|FG003|COMPLETED|Second Intervention||5
10608500|NCT01890785|11766137|FG004|COMPLETED|Second Intervention||5
10608501|NCT01890785|11766138|FG005|COMPLETED|Second Intervention||5
10608502|NCT01890785|11766133|FG000|NOT COMPLETED|Second Intervention||0
10608503|NCT01890785|11766134|FG001|NOT COMPLETED|Second Intervention||0
10608504|NCT01890785|11766135|FG002|NOT COMPLETED|Second Intervention||0
10608505|NCT01890785|11766136|FG003|NOT COMPLETED|Second Intervention||0
10608506|NCT01890785|11766137|FG004|NOT COMPLETED|Second Intervention||0
10608507|NCT01890785|11766138|FG005|NOT COMPLETED|Second Intervention||0
10608508|NCT01890785|11766133|FG000|STARTED|Third Intervention||5
10608509|NCT01890785|11766134|FG001|STARTED|Third Intervention||5
10608510|NCT01890785|11766135|FG002|STARTED|Third Intervention||5
10608511|NCT01890785|11766136|FG003|STARTED|Third Intervention||5
10608512|NCT01890785|11766137|FG004|STARTED|Third Intervention||5
10608513|NCT01890785|11766138|FG005|STARTED|Third Intervention||5
10608514|NCT01890785|11766133|FG000|COMPLETED|Third Intervention||5
10608515|NCT01890785|11766134|FG001|COMPLETED|Third Intervention||4
10608516|NCT01890785|11766135|FG002|COMPLETED|Third Intervention||5
10608517|NCT01890785|11766136|FG003|COMPLETED|Third Intervention||5
10608518|NCT01890785|11766137|FG004|COMPLETED|Third Intervention||5
10608519|NCT01890785|11766138|FG005|COMPLETED|Third Intervention||5
10608520|NCT01890785|11766133|FG000|NOT COMPLETED|Third Intervention||0
10608521|NCT01890785|11766134|FG001|NOT COMPLETED|Third Intervention||1
10608522|NCT01890785|11766135|FG002|NOT COMPLETED|Third Intervention||0
10608523|NCT01890785|11766136|FG003|NOT COMPLETED|Third Intervention||0
10608524|NCT01890785|11766137|FG004|NOT COMPLETED|Third Intervention||0
10608525|NCT01890785|11766138|FG005|NOT COMPLETED|Third Intervention||0
10653056|NCT02190045|11813493|FG001|COMPLETED|Overall Study||15
10653057|NCT02190045|11813492|FG000|NOT COMPLETED|Overall Study||3
10653058|NCT02190045|11813493|FG001|NOT COMPLETED|Overall Study||0
10653059|NCT02190279|11813502|FG000|STARTED|Overall Study||16
10653060|NCT02190279|11813503|FG001|STARTED|Overall Study||69
10653061|NCT02190279|11813504|FG002|STARTED|Overall Study||31
10653062|NCT02190279|11813502|FG000|COMPLETED|Overall Study||13
10653063|NCT02190279|11813503|FG001|COMPLETED|Overall Study||69
10653064|NCT02190279|11813504|FG002|COMPLETED|Overall Study||28
10653065|NCT02190279|11813502|FG000|NOT COMPLETED|Overall Study||3
10653066|NCT02190279|11813503|FG001|NOT COMPLETED|Overall Study||0
10653067|NCT02190279|11813504|FG002|NOT COMPLETED|Overall Study||3
10653068|NCT02190435|11813516|FG000|STARTED|Overall Study||41
10653069|NCT02190435|11813517|FG001|STARTED|Overall Study||24
10653070|NCT02190435|11813516|FG000|COMPLETED|Overall Study||26
10653071|NCT02190435|11813517|FG001|COMPLETED|Overall Study||24
10653072|NCT02190435|11813516|FG000|NOT COMPLETED|Overall Study||15
10653073|NCT02190435|11813517|FG001|NOT COMPLETED|Overall Study||0
10653074|NCT02190552|11813523|FG000|STARTED|Overall Study||40
10653075|NCT02190552|11813523|FG000|COMPLETED|Overall Study||36
10653076|NCT02190552|11813523|FG000|NOT COMPLETED|Overall Study||4
10653077|NCT02190591|11813530|FG000|STARTED|Overall Study||102
10653078|NCT02190591|11813531|FG001|STARTED|Overall Study||102
10653079|NCT02190591|11813530|FG000|COMPLETED|Overall Study||100
10653080|NCT02190591|11813531|FG001|COMPLETED|Overall Study||91
10653081|NCT02190591|11813530|FG000|NOT COMPLETED|Overall Study||2
10653082|NCT02190591|11813531|FG001|NOT COMPLETED|Overall Study||11
10653083|NCT02190604|11813556|FG000|STARTED|Part 1 and 2 (Healthy Volunteers)||6
10653084|NCT02190604|11813557|FG001|STARTED|Part 1 and 2 (Healthy Volunteers)||6
10653085|NCT02190604|11813558|FG002|STARTED|Part 1 and 2 (Healthy Volunteers)||6
10653086|NCT02190604|11813559|FG003|STARTED|Part 1 and 2 (Healthy Volunteers)||6
10653087|NCT02190604|11813560|FG004|STARTED|Part 1 and 2 (Healthy Volunteers)||6
10653088|NCT02190604|11813561|FG005|STARTED|Part 1 and 2 (Healthy Volunteers)||6
10653089|NCT02190604|11813562|FG006|STARTED|Part 1 and 2 (Healthy Volunteers)||6
10653090|NCT02190604|11813563|FG007|STARTED|Part 1 and 2 (Healthy Volunteers)||6
10653091|NCT02190604|11813564|FG008|STARTED|Part 1 and 2 (Healthy Volunteers)||16
10608526|NCT01890915|11766149|FG000|STARTED|Overall Study||11
10608527|NCT01890915|11766150|FG001|STARTED|Overall Study||10
10608528|NCT01890915|11766149|FG000|COMPLETED|Overall Study||8
10608529|NCT01890915|11766150|FG001|COMPLETED|Overall Study||9
10608530|NCT01890915|11766149|FG000|NOT COMPLETED|Overall Study||3
10608531|NCT01890915|11766150|FG001|NOT COMPLETED|Overall Study||1
10608538|NCT01890967|11766171|FG000|STARTED|Overall Study||88
10608539|NCT01890967|11766172|FG001|STARTED|Overall Study||88
10608540|NCT01890967|11766173|FG002|STARTED|Overall Study||88
10608541|NCT01890967|11766174|FG003|STARTED|Overall Study||88
10608542|NCT01890967|11766175|FG004|STARTED|Overall Study||87
10608543|NCT01890967|11766176|FG005|STARTED|Overall Study||88
10608544|NCT01890967|11766171|FG000|Received at Least One Dose of Study Drug|Overall Study||87
10608545|NCT01890967|11766172|FG001|Received at Least One Dose of Study Drug|Overall Study||87
10608714|NCT01892020|11766352|FG000|COMPLETED|Period 2||77
10608546|NCT01890967|11766173|FG002|Received at Least One Dose of Study Drug|Overall Study||86
10608547|NCT01890967|11766174|FG003|Received at Least One Dose of Study Drug|Overall Study||86
10608548|NCT01890967|11766175|FG004|Received at Least One Dose of Study Drug|Overall Study||86
10608549|NCT01890967|11766176|FG005|Received at Least One Dose of Study Drug|Overall Study||87
10608550|NCT01890967|11766171|FG000|COMPLETED|Overall Study||78
10608551|NCT01890967|11766172|FG001|COMPLETED|Overall Study||77
10608552|NCT01890967|11766173|FG002|COMPLETED|Overall Study||78
10608553|NCT01890967|11766174|FG003|COMPLETED|Overall Study||77
10608554|NCT01890967|11766175|FG004|COMPLETED|Overall Study||77
10608555|NCT01890967|11766176|FG005|COMPLETED|Overall Study||75
10608556|NCT01890967|11766171|FG000|NOT COMPLETED|Overall Study||10
10608557|NCT01890967|11766172|FG001|NOT COMPLETED|Overall Study||11
10608558|NCT01890967|11766173|FG002|NOT COMPLETED|Overall Study||10
10608559|NCT01890967|11766174|FG003|NOT COMPLETED|Overall Study||11
10608560|NCT01890967|11766175|FG004|NOT COMPLETED|Overall Study||10
10608561|NCT01890967|11766176|FG005|NOT COMPLETED|Overall Study||13
10608562|NCT01891305|11766199|FG000|STARTED|Overall Study||12
10608563|NCT01891305|11766200|FG001|STARTED|Overall Study||12
10608564|NCT01891305|11766201|FG002|STARTED|Overall Study||14
10608565|NCT01891305|11766202|FG003|STARTED|Overall Study||12
10608566|NCT01891305|11766199|FG000|COMPLETED|Overall Study||9
10608567|NCT01891305|11766200|FG001|COMPLETED|Overall Study||11
10608568|NCT01891305|11766201|FG002|COMPLETED|Overall Study||11
10608569|NCT01891305|11766202|FG003|COMPLETED|Overall Study||12
10608570|NCT01891305|11766199|FG000|NOT COMPLETED|Overall Study||3
10608571|NCT01891305|11766200|FG001|NOT COMPLETED|Overall Study||1
10608572|NCT01891305|11766201|FG002|NOT COMPLETED|Overall Study||3
10608573|NCT01891305|11766202|FG003|NOT COMPLETED|Overall Study||0
10608574|NCT01891331|11766216|FG000|STARTED|Overall Study||14
10608575|NCT01891331|11766217|FG001|STARTED|Overall Study||12
10608576|NCT01891331|11766218|FG002|STARTED|Overall Study||14
10608577|NCT01891331|11766219|FG003|STARTED|Overall Study||15
10608578|NCT01891331|11766216|FG000|COMPLETED|Overall Study||12
10608579|NCT01891331|11766217|FG001|COMPLETED|Overall Study||10
10608580|NCT01891331|11766218|FG002|COMPLETED|Overall Study||13
10608581|NCT01891331|11766219|FG003|COMPLETED|Overall Study||13
10608582|NCT01891331|11766216|FG000|NOT COMPLETED|Overall Study||2
10608583|NCT01891331|11766217|FG001|NOT COMPLETED|Overall Study||2
10608584|NCT01891331|11766218|FG002|NOT COMPLETED|Overall Study||1
10608585|NCT01891331|11766219|FG003|NOT COMPLETED|Overall Study||2
10608586|NCT01891357|11766229|FG000|STARTED|Overall Study||64
10608587|NCT01891357|11766229|FG000|COMPLETED|Overall Study||61
10608588|NCT01891357|11766229|FG000|NOT COMPLETED|Overall Study||3
10608589|NCT01891669|11766243|FG000|STARTED|Overall Study||2
10608590|NCT01891669|11766244|FG001|STARTED|Overall Study||2
10608591|NCT01891669|11766245|FG002|STARTED|Overall Study||2
10608592|NCT01891669|11766246|FG003|STARTED|Overall Study||2
10608593|NCT01891669|11766247|FG004|STARTED|Overall Study||2
10608594|NCT01891669|11766248|FG005|STARTED|Overall Study||2
10608595|NCT01891669|11766249|FG006|STARTED|Overall Study||2
10608596|NCT01891669|11766250|FG007|STARTED|Overall Study||6
10608597|NCT01891669|11766251|FG008|STARTED|Overall Study||3
10608598|NCT01891669|11766252|FG009|STARTED|Overall Study||3
10608599|NCT01891669|11766243|FG000|COMPLETED|Overall Study||0
10608600|NCT01891669|11766244|FG001|COMPLETED|Overall Study||1
10608601|NCT01891669|11766245|FG002|COMPLETED|Overall Study||2
10608602|NCT01891669|11766246|FG003|COMPLETED|Overall Study||2
10608603|NCT01891669|11766247|FG004|COMPLETED|Overall Study||2
10608604|NCT01891669|11766248|FG005|COMPLETED|Overall Study||2
10608605|NCT01891669|11766249|FG006|COMPLETED|Overall Study||1
10608606|NCT01891669|11766250|FG007|COMPLETED|Overall Study||2
10608607|NCT01891669|11766251|FG008|COMPLETED|Overall Study||2
10608608|NCT01891669|11766252|FG009|COMPLETED|Overall Study||1
10608609|NCT01891669|11766243|FG000|NOT COMPLETED|Overall Study||2
10608610|NCT01891669|11766244|FG001|NOT COMPLETED|Overall Study||1
10608611|NCT01891669|11766245|FG002|NOT COMPLETED|Overall Study||0
10608612|NCT01891669|11766246|FG003|NOT COMPLETED|Overall Study||0
10608613|NCT01891669|11766247|FG004|NOT COMPLETED|Overall Study||0
10608614|NCT01891669|11766248|FG005|NOT COMPLETED|Overall Study||0
10608615|NCT01891669|11766249|FG006|NOT COMPLETED|Overall Study||1
10608616|NCT01891669|11766250|FG007|NOT COMPLETED|Overall Study||4
10608617|NCT01891669|11766251|FG008|NOT COMPLETED|Overall Study||1
10608618|NCT01891669|11766252|FG009|NOT COMPLETED|Overall Study||2
10608619|NCT01891721|11766286|FG000|STARTED|Overall Study||39
10608620|NCT01891721|11766287|FG001|STARTED|Overall Study||40
10608621|NCT01891721|11766288|FG002|STARTED|Overall Study||20
10608622|NCT01891721|11766286|FG000|COMPLETED|Overall Study||29
10608623|NCT01891721|11766287|FG001|COMPLETED|Overall Study||35
10608624|NCT01891721|11766288|FG002|COMPLETED|Overall Study||19
10608625|NCT01891721|11766286|FG000|NOT COMPLETED|Overall Study||10
10608626|NCT01891721|11766287|FG001|NOT COMPLETED|Overall Study||5
10608627|NCT01891721|11766288|FG002|NOT COMPLETED|Overall Study||1
10608628|NCT01891734|11766298|FG000|STARTED|Overall Study||17
10608629|NCT01891734|11766299|FG001|STARTED|Overall Study||16
10608630|NCT01891734|11766298|FG000|COMPLETED|Overall Study||14
10608631|NCT01891734|11766299|FG001|COMPLETED|Overall Study||13
10608632|NCT01891734|11766298|FG000|NOT COMPLETED|Overall Study||3
10608633|NCT01891734|11766299|FG001|NOT COMPLETED|Overall Study||3
10608634|NCT01891864|11766309|FG000|STARTED|Treatment Period 1||264
10608635|NCT01891864|11766310|FG001|STARTED|Treatment Period 1||267
10608636|NCT01891864|11766311|FG002|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
10608637|NCT01891864|11766312|FG003|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
10608638|NCT01891864|11766313|FG004|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
10608639|NCT01891864|11766314|FG005|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
10608640|NCT01891864|11766309|FG000|COMPLETED|Treatment Period 1|6 patients discontinued after completion of Treatment Period 1 and did NOT start Treatment Period 2|256
10608641|NCT01891864|11766310|FG001|COMPLETED|Treatment Period 1|8 patients discontinued after completion of Treatment Period 1 and did NOT start Treatment Period 2|255
10608642|NCT01891864|11766311|FG002|COMPLETED|Treatment Period 1||0
10608643|NCT01891864|11766312|FG003|COMPLETED|Treatment Period 1||0
10608644|NCT01891864|11766313|FG004|COMPLETED|Treatment Period 1||0
10608645|NCT01891864|11766314|FG005|COMPLETED|Treatment Period 1||0
10608646|NCT01891864|11766309|FG000|NOT COMPLETED|Treatment Period 1||8
10608647|NCT01891864|11766310|FG001|NOT COMPLETED|Treatment Period 1||12
10608648|NCT01891864|11766311|FG002|NOT COMPLETED|Treatment Period 1||0
10608649|NCT01891864|11766312|FG003|NOT COMPLETED|Treatment Period 1||0
10608650|NCT01891864|11766313|FG004|NOT COMPLETED|Treatment Period 1||0
10608651|NCT01891864|11766314|FG005|NOT COMPLETED|Treatment Period 1||0
10608652|NCT01891864|11766309|FG000|STARTED|Treatment Period 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
10608653|NCT01891864|11766310|FG001|STARTED|Treatment Period 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
10608654|NCT01891864|11766311|FG002|STARTED|Treatment Period 2|"Part of the patients re-randomized from GP2015 Etanercept treatment arm in Treatment Period 1"|150
10608655|NCT01891864|11766312|FG003|STARTED|Treatment Period 2|"Part of the patients re-randomized from Enbrel ® Etanercept treatment arm in Treatment Period 1"|151
10608656|NCT01891864|11766313|FG004|STARTED|Treatment Period 2|"Part of the patients re-randomized from GP2015 Etanercept treatment arm in Treatment Period 1"|100
10608657|NCT01891864|11766314|FG005|STARTED|Treatment Period 2|"Part of the patients re-randomized from Enbrel ® Etanercept treatment arm in Treatment Period 1"|96
10608658|NCT01891864|11766309|FG000|COMPLETED|Treatment Period 2||0
10608659|NCT01891864|11766310|FG001|COMPLETED|Treatment Period 2||0
10608660|NCT01891864|11766311|FG002|COMPLETED|Treatment Period 2||143
10608661|NCT01891864|11766312|FG003|COMPLETED|Treatment Period 2||142
10608662|NCT01891864|11766313|FG004|COMPLETED|Treatment Period 2||96
10608663|NCT01891864|11766314|FG005|COMPLETED|Treatment Period 2||91
10608664|NCT01891864|11766309|FG000|NOT COMPLETED|Treatment Period 2||0
10608665|NCT01891864|11766310|FG001|NOT COMPLETED|Treatment Period 2||0
10608666|NCT01891864|11766311|FG002|NOT COMPLETED|Treatment Period 2||7
10608667|NCT01891864|11766312|FG003|NOT COMPLETED|Treatment Period 2||9
10608668|NCT01891864|11766313|FG004|NOT COMPLETED|Treatment Period 2||4
10608669|NCT01891864|11766314|FG005|NOT COMPLETED|Treatment Period 2||5
10608670|NCT01891864|11766309|FG000|STARTED|Extension Period||0
10608671|NCT01891864|11766310|FG001|STARTED|Extension Period||0
10608672|NCT01891864|11766311|FG002|STARTED|Extension Period|2 patients withdrew consent 1 patient lost to FU between Treatment Period 2 and the Extension period|140
10608673|NCT01891864|11766312|FG003|STARTED|Extension Period||142
10608674|NCT01891864|11766313|FG004|STARTED|Extension Period|1 patient discontinued between Treatment Period 2 and Extension Period due to lack of efficacy|95
10608675|NCT01891864|11766314|FG005|STARTED|Extension Period|1 patient discontinued between Treatment Period 2 and Extension Period due to an adverse event|90
10608676|NCT01891864|11766309|FG000|COMPLETED|Extension Period||0
10608677|NCT01891864|11766310|FG001|COMPLETED|Extension Period||0
10608678|NCT01891864|11766311|FG002|COMPLETED|Extension Period||132
10608679|NCT01891864|11766312|FG003|COMPLETED|Extension Period||137
10608680|NCT01891864|11766313|FG004|COMPLETED|Extension Period||88
10608681|NCT01891864|11766314|FG005|COMPLETED|Extension Period||90
10608682|NCT01891864|11766309|FG000|NOT COMPLETED|Extension Period||0
10608683|NCT01891864|11766310|FG001|NOT COMPLETED|Extension Period||0
10608684|NCT01891864|11766311|FG002|NOT COMPLETED|Extension Period||8
10608685|NCT01891864|11766312|FG003|NOT COMPLETED|Extension Period||5
10608686|NCT01891864|11766313|FG004|NOT COMPLETED|Extension Period||7
10608687|NCT01891864|11766314|FG005|NOT COMPLETED|Extension Period||0
10608688|NCT01891890|11766329|FG000|STARTED|Overall Study||24
10608689|NCT01891890|11766330|FG001|STARTED|Overall Study||27
10608690|NCT01891890|11766331|FG002|STARTED|Overall Study||21
10608691|NCT01891890|11766329|FG000|COMPLETED|Overall Study||17
10608692|NCT01891890|11766330|FG001|COMPLETED|Overall Study||24
10608693|NCT01891890|11766331|FG002|COMPLETED|Overall Study||14
10608694|NCT01891890|11766329|FG000|NOT COMPLETED|Overall Study||7
10608695|NCT01891890|11766330|FG001|NOT COMPLETED|Overall Study||3
10608696|NCT01891890|11766331|FG002|NOT COMPLETED|Overall Study||7
10608697|NCT01891968|11766339|FG000|STARTED|Overall Study||15
10608698|NCT01891968|11766339|FG000|COMPLETED|Overall Study||15
10608699|NCT01891968|11766339|FG000|NOT COMPLETED|Overall Study||0
10608700|NCT01892007|11766345|FG000|STARTED|Overall Study||27
10608701|NCT01892007|11766346|FG001|STARTED|Overall Study||30
10608702|NCT01892007|11766345|FG000|COMPLETED|Overall Study||27
10608703|NCT01892007|11766346|FG001|COMPLETED|Overall Study||30
10608704|NCT01892007|11766345|FG000|NOT COMPLETED|Overall Study||0
10608705|NCT01892007|11766346|FG001|NOT COMPLETED|Overall Study||0
10608706|NCT01892020|11766352|FG000|STARTED|Period 1||81
10608707|NCT01892020|11766353|FG001|STARTED|Period 1||80
10608708|NCT01892020|11766352|FG000|COMPLETED|Period 1||78
10608709|NCT01892020|11766353|FG001|COMPLETED|Period 1||74
10608710|NCT01892020|11766352|FG000|NOT COMPLETED|Period 1||3
10608711|NCT01892020|11766353|FG001|NOT COMPLETED|Period 1||6
10608712|NCT01892020|11766352|FG000|STARTED|Period 2||78
10608713|NCT01892020|11766353|FG001|STARTED|Period 2||74
10608715|NCT01892020|11766353|FG001|COMPLETED|Period 2||74
10608716|NCT01892020|11766352|FG000|NOT COMPLETED|Period 2||1
10608717|NCT01892020|11766353|FG001|NOT COMPLETED|Period 2||0
10608718|NCT01892163|11766361|FG000|STARTED|Overall Study||50
10608719|NCT01892163|11766362|FG001|STARTED|Overall Study||50
10608720|NCT01892163|11766361|FG000|COMPLETED|Overall Study||48
10608721|NCT01892163|11766362|FG001|COMPLETED|Overall Study||49
10608722|NCT01892163|11766361|FG000|NOT COMPLETED|Overall Study||2
10608723|NCT01892163|11766362|FG001|NOT COMPLETED|Overall Study||1
10608724|NCT01892189|11766377|FG000|STARTED|First Intervention Period (1 Day)||3
10608725|NCT01892189|11766378|FG001|STARTED|First Intervention Period (1 Day)||3
10608726|NCT01892189|11766379|FG002|STARTED|First Intervention Period (1 Day)||3
10608727|NCT01892189|11766380|FG003|STARTED|First Intervention Period (1 Day)||3
10608728|NCT01892189|11766381|FG004|STARTED|First Intervention Period (1 Day)||3
10608729|NCT01892189|11766382|FG005|STARTED|First Intervention Period (1 Day)||3
10608730|NCT01892189|11766383|FG006|STARTED|First Intervention Period (1 Day)||3
10608731|NCT01892189|11766384|FG007|STARTED|First Intervention Period (1 Day)||3
10608732|NCT01892189|11766385|FG008|STARTED|First Intervention Period (1 Day)||3
10608733|NCT01892189|11766377|FG000|COMPLETED|First Intervention Period (1 Day)||3
10608734|NCT01892189|11766378|FG001|COMPLETED|First Intervention Period (1 Day)||3
10608735|NCT01892189|11766379|FG002|COMPLETED|First Intervention Period (1 Day)||3
10608736|NCT01892189|11766380|FG003|COMPLETED|First Intervention Period (1 Day)||3
10608737|NCT01892189|11766381|FG004|COMPLETED|First Intervention Period (1 Day)||3
10608738|NCT01892189|11766382|FG005|COMPLETED|First Intervention Period (1 Day)||3
10608739|NCT01892189|11766383|FG006|COMPLETED|First Intervention Period (1 Day)||3
10608740|NCT01892189|11766384|FG007|COMPLETED|First Intervention Period (1 Day)||3
10608741|NCT01892189|11766385|FG008|COMPLETED|First Intervention Period (1 Day)||3
10608742|NCT01892189|11766377|FG000|NOT COMPLETED|First Intervention Period (1 Day)||0
10608743|NCT01892189|11766378|FG001|NOT COMPLETED|First Intervention Period (1 Day)||0
10608744|NCT01892189|11766379|FG002|NOT COMPLETED|First Intervention Period (1 Day)||0
10608745|NCT01892189|11766380|FG003|NOT COMPLETED|First Intervention Period (1 Day)||0
10608746|NCT01892189|11766381|FG004|NOT COMPLETED|First Intervention Period (1 Day)||0
10608747|NCT01892189|11766382|FG005|NOT COMPLETED|First Intervention Period (1 Day)||0
10608748|NCT01892189|11766383|FG006|NOT COMPLETED|First Intervention Period (1 Day)||0
10608749|NCT01892189|11766384|FG007|NOT COMPLETED|First Intervention Period (1 Day)||0
10608750|NCT01892189|11766385|FG008|NOT COMPLETED|First Intervention Period (1 Day)||0
10608751|NCT01892189|11766377|FG000|STARTED|Washout Period 1 (7 Days)||3
10608752|NCT01892189|11766378|FG001|STARTED|Washout Period 1 (7 Days)||3
10608753|NCT01892189|11766379|FG002|STARTED|Washout Period 1 (7 Days)||3
10608754|NCT01892189|11766380|FG003|STARTED|Washout Period 1 (7 Days)||3
10608755|NCT01892189|11766381|FG004|STARTED|Washout Period 1 (7 Days)||3
10608756|NCT01892189|11766382|FG005|STARTED|Washout Period 1 (7 Days)||3
10608757|NCT01892189|11766383|FG006|STARTED|Washout Period 1 (7 Days)||3
10608758|NCT01892189|11766384|FG007|STARTED|Washout Period 1 (7 Days)||3
10608759|NCT01892189|11766385|FG008|STARTED|Washout Period 1 (7 Days)||3
10608760|NCT01892189|11766377|FG000|COMPLETED|Washout Period 1 (7 Days)||3
10608761|NCT01892189|11766378|FG001|COMPLETED|Washout Period 1 (7 Days)||3
10608762|NCT01892189|11766379|FG002|COMPLETED|Washout Period 1 (7 Days)||1
10608763|NCT01892189|11766380|FG003|COMPLETED|Washout Period 1 (7 Days)||2
10608764|NCT01892189|11766381|FG004|COMPLETED|Washout Period 1 (7 Days)||3
10608765|NCT01892189|11766382|FG005|COMPLETED|Washout Period 1 (7 Days)||2
10608766|NCT01892189|11766383|FG006|COMPLETED|Washout Period 1 (7 Days)||2
10608767|NCT01892189|11766384|FG007|COMPLETED|Washout Period 1 (7 Days)||3
10608768|NCT01892189|11766385|FG008|COMPLETED|Washout Period 1 (7 Days)||1
10608769|NCT01892189|11766377|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
10608770|NCT01892189|11766378|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
10608771|NCT01892189|11766379|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||2
10608772|NCT01892189|11766380|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||1
10608773|NCT01892189|11766381|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
10608774|NCT01892189|11766382|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||1
10608775|NCT01892189|11766383|FG006|NOT COMPLETED|Washout Period 1 (7 Days)||1
10608776|NCT01892189|11766384|FG007|NOT COMPLETED|Washout Period 1 (7 Days)||0
10608777|NCT01892189|11766385|FG008|NOT COMPLETED|Washout Period 1 (7 Days)||2
10608778|NCT01892189|11766377|FG000|STARTED|Second Intervention Period (1 Day)||3
10608779|NCT01892189|11766378|FG001|STARTED|Second Intervention Period (1 Day)||3
10608780|NCT01892189|11766379|FG002|STARTED|Second Intervention Period (1 Day)||1
10608781|NCT01892189|11766380|FG003|STARTED|Second Intervention Period (1 Day)||2
10608782|NCT01892189|11766381|FG004|STARTED|Second Intervention Period (1 Day)||3
10608783|NCT01892189|11766382|FG005|STARTED|Second Intervention Period (1 Day)||2
10608784|NCT01892189|11766383|FG006|STARTED|Second Intervention Period (1 Day)||2
10608785|NCT01892189|11766384|FG007|STARTED|Second Intervention Period (1 Day)||3
10608786|NCT01892189|11766385|FG008|STARTED|Second Intervention Period (1 Day)||1
10608787|NCT01892189|11766377|FG000|COMPLETED|Second Intervention Period (1 Day)||3
10608788|NCT01892189|11766378|FG001|COMPLETED|Second Intervention Period (1 Day)||3
10608789|NCT01892189|11766379|FG002|COMPLETED|Second Intervention Period (1 Day)||1
10608790|NCT01892189|11766380|FG003|COMPLETED|Second Intervention Period (1 Day)||2
10608791|NCT01892189|11766381|FG004|COMPLETED|Second Intervention Period (1 Day)||3
10608792|NCT01892189|11766382|FG005|COMPLETED|Second Intervention Period (1 Day)||2
10608793|NCT01892189|11766383|FG006|COMPLETED|Second Intervention Period (1 Day)||2
10608794|NCT01892189|11766384|FG007|COMPLETED|Second Intervention Period (1 Day)||3
10608795|NCT01892189|11766385|FG008|COMPLETED|Second Intervention Period (1 Day)||1
10608796|NCT01892189|11766377|FG000|NOT COMPLETED|Second Intervention Period (1 Day)||0
10608797|NCT01892189|11766378|FG001|NOT COMPLETED|Second Intervention Period (1 Day)||0
10608798|NCT01892189|11766379|FG002|NOT COMPLETED|Second Intervention Period (1 Day)||0
10608799|NCT01892189|11766380|FG003|NOT COMPLETED|Second Intervention Period (1 Day)||0
10608800|NCT01892189|11766381|FG004|NOT COMPLETED|Second Intervention Period (1 Day)||0
10608801|NCT01892189|11766382|FG005|NOT COMPLETED|Second Intervention Period (1 Day)||0
10608802|NCT01892189|11766383|FG006|NOT COMPLETED|Second Intervention Period (1 Day)||0
10608803|NCT01892189|11766384|FG007|NOT COMPLETED|Second Intervention Period (1 Day)||0
10608804|NCT01892189|11766385|FG008|NOT COMPLETED|Second Intervention Period (1 Day)||0
10608805|NCT01892189|11766377|FG000|STARTED|Washout Period 2 (7 Days)||3
10608806|NCT01892189|11766378|FG001|STARTED|Washout Period 2 (7 Days)||3
10608807|NCT01892189|11766379|FG002|STARTED|Washout Period 2 (7 Days)||1
10608808|NCT01892189|11766380|FG003|STARTED|Washout Period 2 (7 Days)||2
10608809|NCT01892189|11766381|FG004|STARTED|Washout Period 2 (7 Days)||3
10608810|NCT01892189|11766382|FG005|STARTED|Washout Period 2 (7 Days)||2
10608811|NCT01892189|11766383|FG006|STARTED|Washout Period 2 (7 Days)||2
10608812|NCT01892189|11766384|FG007|STARTED|Washout Period 2 (7 Days)||3
10608813|NCT01892189|11766385|FG008|STARTED|Washout Period 2 (7 Days)||1
10608814|NCT01892189|11766377|FG000|COMPLETED|Washout Period 2 (7 Days)||3
10608815|NCT01892189|11766378|FG001|COMPLETED|Washout Period 2 (7 Days)||3
10608816|NCT01892189|11766379|FG002|COMPLETED|Washout Period 2 (7 Days)||1
10608817|NCT01892189|11766380|FG003|COMPLETED|Washout Period 2 (7 Days)||2
10608818|NCT01892189|11766381|FG004|COMPLETED|Washout Period 2 (7 Days)||3
10608819|NCT01892189|11766382|FG005|COMPLETED|Washout Period 2 (7 Days)||2
10608820|NCT01892189|11766383|FG006|COMPLETED|Washout Period 2 (7 Days)||2
10608821|NCT01892189|11766384|FG007|COMPLETED|Washout Period 2 (7 Days)||3
10608822|NCT01892189|11766385|FG008|COMPLETED|Washout Period 2 (7 Days)||1
10608823|NCT01892189|11766377|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
10608824|NCT01892189|11766378|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
10608825|NCT01892189|11766379|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
10608826|NCT01892189|11766380|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
10608827|NCT01892189|11766381|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
10608828|NCT01892189|11766382|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
10608829|NCT01892189|11766383|FG006|NOT COMPLETED|Washout Period 2 (7 Days)||0
10608830|NCT01892189|11766384|FG007|NOT COMPLETED|Washout Period 2 (7 Days)||0
10608831|NCT01892189|11766385|FG008|NOT COMPLETED|Washout Period 2 (7 Days)||0
10608832|NCT01892189|11766377|FG000|STARTED|Third Intervention Period (1 Day)||3
10608833|NCT01892189|11766378|FG001|STARTED|Third Intervention Period (1 Day)||3
10608834|NCT01892189|11766379|FG002|STARTED|Third Intervention Period (1 Day)||1
10608835|NCT01892189|11766380|FG003|STARTED|Third Intervention Period (1 Day)||2
10608836|NCT01892189|11766381|FG004|STARTED|Third Intervention Period (1 Day)||3
10608837|NCT01892189|11766382|FG005|STARTED|Third Intervention Period (1 Day)||2
10608838|NCT01892189|11766383|FG006|STARTED|Third Intervention Period (1 Day)||2
10608839|NCT01892189|11766384|FG007|STARTED|Third Intervention Period (1 Day)||3
10608840|NCT01892189|11766385|FG008|STARTED|Third Intervention Period (1 Day)||1
10608841|NCT01892189|11766377|FG000|COMPLETED|Third Intervention Period (1 Day)||3
10608842|NCT01892189|11766378|FG001|COMPLETED|Third Intervention Period (1 Day)||3
10608843|NCT01892189|11766379|FG002|COMPLETED|Third Intervention Period (1 Day)||1
10608844|NCT01892189|11766380|FG003|COMPLETED|Third Intervention Period (1 Day)||2
10608845|NCT01892189|11766381|FG004|COMPLETED|Third Intervention Period (1 Day)||3
10608846|NCT01892189|11766382|FG005|COMPLETED|Third Intervention Period (1 Day)||2
10608847|NCT01892189|11766383|FG006|COMPLETED|Third Intervention Period (1 Day)||2
10608848|NCT01892189|11766384|FG007|COMPLETED|Third Intervention Period (1 Day)||3
10608849|NCT01892189|11766385|FG008|COMPLETED|Third Intervention Period (1 Day)||1
10608850|NCT01892189|11766377|FG000|NOT COMPLETED|Third Intervention Period (1 Day)||0
10608851|NCT01892189|11766378|FG001|NOT COMPLETED|Third Intervention Period (1 Day)||0
10608852|NCT01892189|11766379|FG002|NOT COMPLETED|Third Intervention Period (1 Day)||0
10608853|NCT01892189|11766380|FG003|NOT COMPLETED|Third Intervention Period (1 Day)||0
10608854|NCT01892189|11766381|FG004|NOT COMPLETED|Third Intervention Period (1 Day)||0
10608855|NCT01892189|11766382|FG005|NOT COMPLETED|Third Intervention Period (1 Day)||0
10608856|NCT01892189|11766383|FG006|NOT COMPLETED|Third Intervention Period (1 Day)||0
10608857|NCT01892189|11766384|FG007|NOT COMPLETED|Third Intervention Period (1 Day)||0
10608858|NCT01892189|11766385|FG008|NOT COMPLETED|Third Intervention Period (1 Day)||0
10608859|NCT01892267|11766402|FG000|STARTED|Overall Study||9
10608860|NCT01892267|11766403|FG001|STARTED|Overall Study||10
10608861|NCT01892267|11766402|FG000|COMPLETED|Overall Study||9
10608862|NCT01892267|11766403|FG001|COMPLETED|Overall Study||10
10608863|NCT01892267|11766402|FG000|NOT COMPLETED|Overall Study||0
10608864|NCT01892267|11766403|FG001|NOT COMPLETED|Overall Study||0
10608865|NCT01892293|11766409|FG000|STARTED|Overall Study||6
10608866|NCT01892293|11766409|FG000|Received T-cell|Overall Study||2
10608867|NCT01892293|11766409|FG000|COMPLETED|Overall Study||2
10608868|NCT01892293|11766409|FG000|NOT COMPLETED|Overall Study||4
10608869|NCT01892306|11766415|FG000|STARTED|Overall Study||13
10608870|NCT01892306|11766416|FG001|STARTED|Overall Study||16
10608871|NCT01892306|11766415|FG000|COMPLETED|Overall Study||8
10608872|NCT01892306|11766416|FG001|COMPLETED|Overall Study||10
10608873|NCT01892306|11766415|FG000|NOT COMPLETED|Overall Study||5
10608874|NCT01892306|11766416|FG001|NOT COMPLETED|Overall Study||6
10608875|NCT01892345|11766424|FG000|STARTED|Overall Study||96
10608876|NCT01892345|11766425|FG001|STARTED|Overall Study||47
10608877|NCT01892345|11766424|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||96
10608878|NCT01892345|11766425|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||47
10608879|NCT01892345|11766424|FG000|COMPLETED|Overall Study||80
10608880|NCT01892345|11766425|FG001|COMPLETED|Overall Study||44
10608881|NCT01892345|11766424|FG000|NOT COMPLETED|Overall Study||16
10608882|NCT01892345|11766425|FG001|NOT COMPLETED|Overall Study||3
10608883|NCT01892436|11766435|FG000|STARTED|Overall Study||147
10608884|NCT01892436|11766436|FG001|STARTED|Overall Study||161
10608885|NCT01892436|11766437|FG002|STARTED|Overall Study||74
10608886|NCT01892436|11766438|FG003|STARTED|Overall Study||75
10608887|NCT01892436|11766435|FG000|COMPLETED|Overall Study||124
10608888|NCT01892436|11766436|FG001|COMPLETED|Overall Study||132
10608889|NCT01892436|11766437|FG002|COMPLETED|Overall Study||63
10608890|NCT01892436|11766438|FG003|COMPLETED|Overall Study||61
10608891|NCT01892436|11766435|FG000|NOT COMPLETED|Overall Study||23
10608892|NCT01892436|11766436|FG001|NOT COMPLETED|Overall Study||29
10608893|NCT01892436|11766437|FG002|NOT COMPLETED|Overall Study||11
10608894|NCT01892436|11766438|FG003|NOT COMPLETED|Overall Study||14
10608895|NCT01892501|11766448|FG000|STARTED|Overall Study||75
10608896|NCT01892501|11766448|FG000|Group A : Biopsy Surgically Possible|Overall Study||72
10608897|NCT01892501|11766448|FG000|Group B : Biopsy Not Surgically Possible|Overall Study||3
10608898|NCT01892501|11766448|FG000|COMPLETED|Overall Study||47
10608899|NCT01892501|11766448|FG000|NOT COMPLETED|Overall Study||28
10608900|NCT01892540|11766455|FG000|STARTED|Overall Study||15
10608901|NCT01892540|11766456|FG001|STARTED|Overall Study||0
10608902|NCT01892540|11766457|FG002|STARTED|Overall Study||28
10608903|NCT01892540|11766455|FG000|COMPLETED|Overall Study||15
10608904|NCT01892540|11766456|FG001|COMPLETED|Overall Study||0
10608905|NCT01892540|11766457|FG002|COMPLETED|Overall Study||25
10608906|NCT01892540|11766455|FG000|NOT COMPLETED|Overall Study||0
10608907|NCT01892540|11766456|FG001|NOT COMPLETED|Overall Study||0
10608908|NCT01892540|11766457|FG002|NOT COMPLETED|Overall Study||3
10608912|NCT01892709|11766481|FG000|STARTED|Overall Study||215
10608913|NCT01892709|11766481|FG000|COMPLETED|Overall Study||215
10608914|NCT01892709|11766481|FG000|NOT COMPLETED|Overall Study||0
10608915|NCT01892865|11766491|FG000|STARTED|Overall Study|107 operative days scheduled with the Historical Means method were included|356
10608916|NCT01892865|11766492|FG001|STARTED|Overall Study|100 operative days scheduled with the Predictive Modeling System method were included|379
10608917|NCT01892865|11766491|FG000|COMPLETED|Overall Study||356
10608918|NCT01892865|11766492|FG001|COMPLETED|Overall Study||379
10704487|NCT02592655|11868864|FG000|Windlass Tourniquet|Third Tourniquet, Left Thigh.||4
10704488|NCT02592655|11868864|FG000|Tourniquet Tape 10 cm Width|Third Tourniquet, Left Thigh.||6
10704489|NCT02592655|11868864|FG000|Tourniquet Tape 5 cm Width|Third Tourniquet, Left Thigh.||1
10704490|NCT02592655|11868864|FG000|COMPLETED|Third Tourniquet, Left Thigh.||19
10704491|NCT02592655|11868864|FG000|NOT COMPLETED|Third Tourniquet, Left Thigh.||0
10713916|NCT02683668|11879480|FG002|COMPLETED|Period 1||0
10608919|NCT01892865|11766491|FG000|NOT COMPLETED|Overall Study||0
10608920|NCT01892865|11766492|FG001|NOT COMPLETED|Overall Study||0
10608921|NCT01893203|11766498|FG000|STARTED|Overall Study||14
10608922|NCT01893203|11766498|FG000|COMPLETED|Overall Study||13
10608923|NCT01893203|11766498|FG000|NOT COMPLETED|Overall Study||1
10608924|NCT01893281|11766502|FG000|STARTED|Overall Study||78
10608925|NCT01893281|11766502|FG000|Received at Least 1 Dose of Study Drug|Overall Study||78
10608926|NCT01893281|11766502|FG000|COMPLETED|Overall Study||75
10608927|NCT01893281|11766502|FG000|NOT COMPLETED|Overall Study||3
10608928|NCT01893346|11766510|FG000|STARTED|Overall Study||11
10608929|NCT01893346|11766511|FG001|STARTED|Overall Study||8
10608930|NCT01893346|11766512|FG002|STARTED|Overall Study||8
10608931|NCT01893346|11766513|FG003|STARTED|Overall Study||8
10608932|NCT01893346|11766510|FG000|Patients Who Received Full Infusion|Overall Study||8
10608933|NCT01893346|11766511|FG001|Patients Who Received Full Infusion|Overall Study||8
10608934|NCT01893346|11766512|FG002|Patients Who Received Full Infusion|Overall Study||8
10608935|NCT01893346|11766513|FG003|Patients Who Received Full Infusion|Overall Study||8
10608936|NCT01893346|11766510|FG000|COMPLETED|Overall Study||8
10608937|NCT01893346|11766511|FG001|COMPLETED|Overall Study||7
10608938|NCT01893346|11766512|FG002|COMPLETED|Overall Study||8
10608939|NCT01893346|11766513|FG003|COMPLETED|Overall Study||8
10608940|NCT01893346|11766510|FG000|NOT COMPLETED|Overall Study||3
10608941|NCT01893346|11766511|FG001|NOT COMPLETED|Overall Study||1
10608942|NCT01893346|11766512|FG002|NOT COMPLETED|Overall Study||0
10608943|NCT01893346|11766513|FG003|NOT COMPLETED|Overall Study||0
10608944|NCT01893372|11766525|FG000|STARTED|Overall Study||7
10608945|NCT01893372|11766526|FG001|STARTED|Overall Study||22
10608946|NCT01893372|11766525|FG000|COMPLETED|Overall Study||7
10608947|NCT01893372|11766526|FG001|COMPLETED|Overall Study||22
10608948|NCT01893372|11766525|FG000|NOT COMPLETED|Overall Study||0
10608949|NCT01893372|11766526|FG001|NOT COMPLETED|Overall Study||0
10608950|NCT01893411|11766535|FG000|STARTED|Overall Study||156
10608951|NCT01893411|11766536|FG001|STARTED|Overall Study||77
10608952|NCT01893411|11766537|FG002|STARTED|Overall Study||78
10608953|NCT01893411|11766535|FG000|COMPLETED|Overall Study||139
10608954|NCT01893411|11766536|FG001|COMPLETED|Overall Study||70
10608955|NCT01893411|11766537|FG002|COMPLETED|Overall Study||69
10608956|NCT01893411|11766535|FG000|NOT COMPLETED|Overall Study||17
10608957|NCT01893411|11766536|FG001|NOT COMPLETED|Overall Study||7
10608958|NCT01893411|11766537|FG002|NOT COMPLETED|Overall Study||9
10608962|NCT01893632|11766551|FG000|STARTED|Overall Study||1
10608963|NCT01893632|11766552|FG001|STARTED|Overall Study||1
10608964|NCT01893632|11766551|FG000|COMPLETED|Overall Study||1
10608965|NCT01893632|11766552|FG001|COMPLETED|Overall Study||1
10608966|NCT01893632|11766551|FG000|NOT COMPLETED|Overall Study||0
10608967|NCT01893632|11766552|FG001|NOT COMPLETED|Overall Study||0
10608968|NCT01893801|11766558|FG000|STARTED|Overall Study||25
10608969|NCT01893801|11766558|FG000|COMPLETED|Overall Study||25
10608970|NCT01893801|11766558|FG000|NOT COMPLETED|Overall Study||0
10608971|NCT01893827|11766566|FG000|STARTED|Overall Study||117
10608972|NCT01893827|11766567|FG001|STARTED|Overall Study||120
10608973|NCT01893827|11766566|FG000|COMPLETED|Overall Study||98
10608974|NCT01893827|11766567|FG001|COMPLETED|Overall Study||94
10608975|NCT01893827|11766566|FG000|NOT COMPLETED|Overall Study||19
10608976|NCT01893827|11766567|FG001|NOT COMPLETED|Overall Study||26
10608977|NCT01893879|11766575|FG000|STARTED|Overall Study||7
10608978|NCT01893879|11766576|FG001|STARTED|Overall Study||7
10608979|NCT01893879|11766575|FG000|COMPLETED|Overall Study||5
10608980|NCT01893879|11766576|FG001|COMPLETED|Overall Study||4
10608981|NCT01893879|11766575|FG000|NOT COMPLETED|Overall Study||2
10608982|NCT01893879|11766576|FG001|NOT COMPLETED|Overall Study||3
10608983|NCT01893905|11766584|FG000|STARTED|Overall Study||80
10608984|NCT01893905|11766585|FG001|STARTED|Overall Study||78
10608985|NCT01893905|11766584|FG000|COMPLETED|Overall Study||55
10608986|NCT01893905|11766585|FG001|COMPLETED|Overall Study||64
10608987|NCT01893905|11766584|FG000|NOT COMPLETED|Overall Study||25
10608988|NCT01893905|11766585|FG001|NOT COMPLETED|Overall Study||14
10608989|NCT01893983|11766593|FG000|STARTED|Overall Study||140
10608990|NCT01893983|11766594|FG001|STARTED|Overall Study||140
10608991|NCT01893983|11766593|FG000|COMPLETED|Overall Study||130
10608992|NCT01893983|11766594|FG001|COMPLETED|Overall Study||134
10608993|NCT01893983|11766593|FG000|NOT COMPLETED|Overall Study||10
10608994|NCT01893983|11766594|FG001|NOT COMPLETED|Overall Study||6
10608995|NCT01894022|11766602|FG000|STARTED|Overall Study||9
10608996|NCT01894022|11766603|FG001|STARTED|Overall Study||10
10608997|NCT01894022|11766602|FG000|COMPLETED|Overall Study||0
10608998|NCT01894022|11766603|FG001|COMPLETED|Overall Study||0
10608999|NCT01894022|11766602|FG000|NOT COMPLETED|Overall Study||9
10609000|NCT01894022|11766603|FG001|NOT COMPLETED|Overall Study||10
10609001|NCT01894087|11766612|FG000|STARTED|Overall Study||102
10609002|NCT01894087|11766613|FG001|STARTED|Overall Study||102
10609003|NCT01894087|11766612|FG000|COMPLETED|Overall Study||96
10609004|NCT01894087|11766613|FG001|COMPLETED|Overall Study||102
10609005|NCT01894087|11766612|FG000|NOT COMPLETED|Overall Study||6
10609006|NCT01894087|11766613|FG001|NOT COMPLETED|Overall Study||0
10609007|NCT01894100|11766621|FG000|STARTED|Overall Study||15
10609008|NCT01894100|11766622|FG001|STARTED|Overall Study||15
10609009|NCT01894100|11766621|FG000|COMPLETED|Overall Study||12
10609010|NCT01894100|11766622|FG001|COMPLETED|Overall Study||14
10609011|NCT01894100|11766621|FG000|NOT COMPLETED|Overall Study||3
10609012|NCT01894100|11766622|FG001|NOT COMPLETED|Overall Study||1
10609013|NCT01894152|11766628|FG000|STARTED|Overall Study||2002
10609014|NCT01894152|11766628|FG000|COMPLETED|Overall Study||1851
10609015|NCT01894152|11766628|FG000|NOT COMPLETED|Overall Study||151
10609016|NCT01894178|11766634|FG000|STARTED|Overall Study||30
10609017|NCT01894178|11766635|FG001|STARTED|Overall Study||30
10609018|NCT01894178|11766634|FG000|COMPLETED|Overall Study||30
10609019|NCT01894178|11766635|FG001|COMPLETED|Overall Study||30
10609020|NCT01894178|11766634|FG000|NOT COMPLETED|Overall Study||0
10609021|NCT01894178|11766635|FG001|NOT COMPLETED|Overall Study||0
10609022|NCT01894230|11766643|FG000|STARTED|Overall Study||83
10609023|NCT01894230|11766644|FG001|STARTED|Overall Study||76
10609024|NCT01894230|11766643|FG000|COMPLETED|Overall Study||76
10609025|NCT01894230|11766644|FG001|COMPLETED|Overall Study||69
10609026|NCT01894230|11766643|FG000|NOT COMPLETED|Overall Study||7
10609027|NCT01894230|11766644|FG001|NOT COMPLETED|Overall Study||7
10609028|NCT01894243|11766653|FG000|STARTED|Overall Study||13
10609029|NCT01894243|11766654|FG001|STARTED|Overall Study||10
10609030|NCT01894243|11766655|FG002|STARTED|Overall Study||8
10609031|NCT01894243|11766653|FG000|Completed Treatment in Part A|Overall Study||13
10609032|NCT01894243|11766654|FG001|Completed Treatment in Part A|Overall Study||10
10609033|NCT01894243|11766655|FG002|Completed Treatment in Part A|Overall Study||8
10609034|NCT01894243|11766653|FG000|Ongoing Into Part B|Overall Study||13
10609035|NCT01894243|11766654|FG001|Ongoing Into Part B|Overall Study||10
10609036|NCT01894243|11766655|FG002|Ongoing Into Part B|Overall Study||8
10609037|NCT01894243|11766653|FG000|COMPLETED|Overall Study||0
10609038|NCT01894243|11766654|FG001|COMPLETED|Overall Study||0
10609039|NCT01894243|11766655|FG002|COMPLETED|Overall Study||0
10609040|NCT01894243|11766653|FG000|NOT COMPLETED|Overall Study||13
10609041|NCT01894243|11766654|FG001|NOT COMPLETED|Overall Study||10
10609042|NCT01894243|11766655|FG002|NOT COMPLETED|Overall Study||8
10609043|NCT01894256|11766673|FG000|STARTED|Part A||15
10609044|NCT01894256|11766674|FG001|STARTED|Part A||15
10609045|NCT01894256|11766675|FG002|STARTED|Part A||14
10609046|NCT01894256|11766673|FG000|COMPLETED|Part A||15
10609047|NCT01894256|11766674|FG001|COMPLETED|Part A||14
10609048|NCT01894256|11766675|FG002|COMPLETED|Part A||14
10609049|NCT01894256|11766673|FG000|NOT COMPLETED|Part A||0
10609050|NCT01894256|11766674|FG001|NOT COMPLETED|Part A||1
10609051|NCT01894256|11766675|FG002|NOT COMPLETED|Part A||0
10609052|NCT01894256|11766673|FG000|STARTED|Part B||15
10609053|NCT01894256|11766674|FG001|STARTED|Part B||14
10609054|NCT01894256|11766675|FG002|STARTED|Part B||14
10609055|NCT01894256|11766673|FG000|COMPLETED|Part B||0
10609056|NCT01894256|11766674|FG001|COMPLETED|Part B||0
10609057|NCT01894256|11766675|FG002|COMPLETED|Part B||0
10609058|NCT01894256|11766673|FG000|NOT COMPLETED|Part B||15
10609059|NCT01894256|11766674|FG001|NOT COMPLETED|Part B||14
10609060|NCT01894256|11766675|FG002|NOT COMPLETED|Part B||14
10609061|NCT01894477|11766688|FG000|STARTED|Overall Study||35
10609062|NCT01894477|11766689|FG001|STARTED|Overall Study||67
10609063|NCT01894477|11766688|FG000|COMPLETED|Overall Study||35
10609064|NCT01894477|11766689|FG001|COMPLETED|Overall Study||65
10609065|NCT01894477|11766688|FG000|NOT COMPLETED|Overall Study||0
10609066|NCT01894477|11766689|FG001|NOT COMPLETED|Overall Study||2
10609067|NCT01894503|11766695|FG000|STARTED|Overall Study||5
10609068|NCT01894503|11766695|FG000|COMPLETED|Overall Study||5
10609069|NCT01894503|11766695|FG000|NOT COMPLETED|Overall Study||0
10609070|NCT01894516|11766704|FG000|STARTED|Period 1 (Baseline up to Week 12)||72
10609071|NCT01894516|11766705|FG001|STARTED|Period 1 (Baseline up to Week 12)||72
10609072|NCT01894516|11766706|FG002|STARTED|Period 1 (Baseline up to Week 12)||70
10609073|NCT01894516|11766707|FG003|STARTED|Period 1 (Baseline up to Week 12)||69
10609074|NCT01894516|11766704|FG000|COMPLETED|Period 1 (Baseline up to Week 12)||65
10609075|NCT01894516|11766705|FG001|COMPLETED|Period 1 (Baseline up to Week 12)||67
10609076|NCT01894516|11766706|FG002|COMPLETED|Period 1 (Baseline up to Week 12)||67
10609077|NCT01894516|11766707|FG003|COMPLETED|Period 1 (Baseline up to Week 12)||66
10609078|NCT01894516|11766704|FG000|NOT COMPLETED|Period 1 (Baseline up to Week 12)||7
10609079|NCT01894516|11766705|FG001|NOT COMPLETED|Period 1 (Baseline up to Week 12)||5
10609080|NCT01894516|11766706|FG002|NOT COMPLETED|Period 1 (Baseline up to Week 12)||3
10609081|NCT01894516|11766707|FG003|NOT COMPLETED|Period 1 (Baseline up to Week 12)||3
10609082|NCT01894516|11766704|FG000|STARTED|Period 2 (Week 13 to Week 24)|All participants from Placebo moved to 100 mg QD (65 participants) group.|0
10609083|NCT01894516|11766705|FG001|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from 50 mg QD group moved to 100 mg QD group (15 participants).|52
10609084|NCT01894516|11766706|FG002|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from Placebo(65 participants) and 50 mg QD (15 participants) moved to 100 mg QD group.|147
10609085|NCT01894516|11766707|FG003|STARTED|Period 2 (Week 13 to Week 24)||66
10609086|NCT01894516|11766704|FG000|COMPLETED|Period 2 (Week 13 to Week 24)||0
10609087|NCT01894516|11766705|FG001|COMPLETED|Period 2 (Week 13 to Week 24)||50
10609088|NCT01894516|11766706|FG002|COMPLETED|Period 2 (Week 13 to Week 24)||142
10609089|NCT01894516|11766707|FG003|COMPLETED|Period 2 (Week 13 to Week 24)||65
10609090|NCT01894516|11766704|FG000|NOT COMPLETED|Period 2 (Week 13 to Week 24)||0
10609091|NCT01894516|11766705|FG001|NOT COMPLETED|Period 2 (Week 13 to Week 24)||2
10609092|NCT01894516|11766706|FG002|NOT COMPLETED|Period 2 (Week 13 to Week 24)||5
10609093|NCT01894516|11766707|FG003|NOT COMPLETED|Period 2 (Week 13 to Week 24)||1
10609094|NCT01894555|11766721|FG000|STARTED|Overall Study||33
10609095|NCT01894555|11766721|FG000|COMPLETED|Overall Study||33
10609096|NCT01894555|11766721|FG000|NOT COMPLETED|Overall Study||0
10609097|NCT01894568|11766727|FG000|STARTED|Overall Study||192
10609098|NCT01894568|11766728|FG001|STARTED|Overall Study||196
10609099|NCT01894568|11766727|FG000|Received at Least 1 Dose of Study Drug|Overall Study||192
10609100|NCT01894568|11766728|FG001|Received at Least 1 Dose of Study Drug|Overall Study||196
10609101|NCT01894568|11766727|FG000|COMPLETED|Overall Study||182
10609102|NCT01894568|11766728|FG001|COMPLETED|Overall Study||186
10609103|NCT01894568|11766727|FG000|NOT COMPLETED|Overall Study||10
10609104|NCT01894568|11766728|FG001|NOT COMPLETED|Overall Study||10
10609105|NCT01894581|11766737|FG000|STARTED|Overall Study||20
10609106|NCT01894581|11766738|FG001|STARTED|Overall Study||19
10609107|NCT01894581|11766737|FG000|COMPLETED|Overall Study||15
10609108|NCT01894581|11766738|FG001|COMPLETED|Overall Study||12
10609109|NCT01894581|11766737|FG000|NOT COMPLETED|Overall Study||5
10609110|NCT01894581|11766738|FG001|NOT COMPLETED|Overall Study||7
10609111|NCT01894607|11766744|FG000|STARTED|Overall Study||11
10609112|NCT01894607|11766744|FG000|COMPLETED|Overall Study||10
10609113|NCT01894607|11766744|FG000|NOT COMPLETED|Overall Study||1
10609114|NCT01894620|11766750|FG000|STARTED|Overall Study||6
10609115|NCT01894620|11766751|FG001|STARTED|Overall Study||5
10609116|NCT01894620|11766750|FG000|COMPLETED|Overall Study||6
10609117|NCT01894620|11766751|FG001|COMPLETED|Overall Study||4
10609118|NCT01894620|11766750|FG000|NOT COMPLETED|Overall Study||0
10609119|NCT01894620|11766751|FG001|NOT COMPLETED|Overall Study||1
10609120|NCT01894672|11766759|FG000|STARTED|Overall Study||7
10609121|NCT01894672|11766759|FG000|COMPLETED|Overall Study||7
10609122|NCT01894672|11766759|FG000|NOT COMPLETED|Overall Study||0
10609123|NCT01894776|11766764|FG000|STARTED|Overall Study||15
10609124|NCT01894776|11766764|FG000|COMPLETED|Overall Study||14
10609125|NCT01894776|11766764|FG000|NOT COMPLETED|Overall Study||1
10609126|NCT01894841|11766770|FG000|STARTED|Overall Study||52
10609127|NCT01894841|11766771|FG001|STARTED|Overall Study||53
10609128|NCT01894841|11766770|FG000|COMPLETED|Overall Study||34
10609129|NCT01894841|11766771|FG001|COMPLETED|Overall Study||44
10609130|NCT01894841|11766770|FG000|NOT COMPLETED|Overall Study||18
10609131|NCT01894841|11766771|FG001|NOT COMPLETED|Overall Study||9
10609132|NCT01894906|11766783|FG000|STARTED|Overall Study||6
10609133|NCT01894906|11766784|FG001|STARTED|Overall Study||6
10609134|NCT01894906|11766783|FG000|Treatment A|Overall Study||6
10609135|NCT01894906|11766784|FG001|Treatment A|Overall Study||6
10609136|NCT01894906|11766783|FG000|Treatment B|Overall Study||6
10609137|NCT01894906|11766784|FG001|Treatment B|Overall Study||6
10609138|NCT01894906|11766783|FG000|Treatment C|Overall Study||6
10609139|NCT01894906|11766784|FG001|Treatment C|Overall Study||6
10609140|NCT01894906|11766783|FG000|Treatment D|Overall Study||6
10609141|NCT01894906|11766784|FG001|Treatment D|Overall Study||6
10609142|NCT01894906|11766783|FG000|Treatment E|Overall Study||6
10609143|NCT01894906|11766784|FG001|Treatment E|Overall Study||6
10609144|NCT01894906|11766783|FG000|Treatment F|Overall Study||6
10609145|NCT01894906|11766784|FG001|Treatment F|Overall Study||6
10609146|NCT01894906|11766783|FG000|COMPLETED|Overall Study||6
10609147|NCT01894906|11766784|FG001|COMPLETED|Overall Study||6
10609148|NCT01894906|11766783|FG000|NOT COMPLETED|Overall Study||0
10609149|NCT01894906|11766784|FG001|NOT COMPLETED|Overall Study||0
10609150|NCT01894919|11766815|FG000|STARTED|Overall Study||98
10609151|NCT01894919|11766816|FG001|STARTED|Overall Study||47
10609152|NCT01894919|11766817|FG002|STARTED|Overall Study||89
10609153|NCT01894919|11766818|FG003|STARTED|Overall Study||43
10609154|NCT01894919|11766819|FG004|STARTED|Overall Study||81
10609155|NCT01894919|11766820|FG005|STARTED|Overall Study||39
10609156|NCT01894919|11766821|FG006|STARTED|Overall Study||32
10609157|NCT01894919|11766822|FG007|STARTED|Overall Study||36
10609158|NCT01894919|11766823|FG008|STARTED|Overall Study||91
10609159|NCT01894919|11766824|FG009|STARTED|Overall Study||90
10609160|NCT01894919|11766825|FG010|STARTED|Overall Study||100
10609161|NCT01894919|11766826|FG011|STARTED|Overall Study||55
10609162|NCT01894919|11766827|FG012|STARTED|Overall Study||50
10609163|NCT01894919|11766815|FG000|COMPLETED|Overall Study||96
10609164|NCT01894919|11766816|FG001|COMPLETED|Overall Study||47
10609165|NCT01894919|11766817|FG002|COMPLETED|Overall Study||89
10609166|NCT01894919|11766818|FG003|COMPLETED|Overall Study||43
10609167|NCT01894919|11766819|FG004|COMPLETED|Overall Study||78
10609168|NCT01894919|11766820|FG005|COMPLETED|Overall Study||39
10609169|NCT01894919|11766821|FG006|COMPLETED|Overall Study||32
10609170|NCT01894919|11766822|FG007|COMPLETED|Overall Study||36
10609171|NCT01894919|11766823|FG008|COMPLETED|Overall Study||91
10609172|NCT01894919|11766824|FG009|COMPLETED|Overall Study||89
10609173|NCT01894919|11766825|FG010|COMPLETED|Overall Study||98
10609174|NCT01894919|11766826|FG011|COMPLETED|Overall Study||55
10609175|NCT01894919|11766827|FG012|COMPLETED|Overall Study||50
10609176|NCT01894919|11766815|FG000|NOT COMPLETED|Overall Study||2
10609177|NCT01894919|11766816|FG001|NOT COMPLETED|Overall Study||0
10609178|NCT01894919|11766817|FG002|NOT COMPLETED|Overall Study||0
10609179|NCT01894919|11766818|FG003|NOT COMPLETED|Overall Study||0
10609180|NCT01894919|11766819|FG004|NOT COMPLETED|Overall Study||3
10609181|NCT01894919|11766820|FG005|NOT COMPLETED|Overall Study||0
10609182|NCT01894919|11766821|FG006|NOT COMPLETED|Overall Study||0
10609183|NCT01894919|11766822|FG007|NOT COMPLETED|Overall Study||0
10609184|NCT01894919|11766823|FG008|NOT COMPLETED|Overall Study||0
10609185|NCT01894919|11766824|FG009|NOT COMPLETED|Overall Study||1
10609186|NCT01894919|11766825|FG010|NOT COMPLETED|Overall Study||2
10609187|NCT01894919|11766826|FG011|NOT COMPLETED|Overall Study||0
10609188|NCT01894919|11766827|FG012|NOT COMPLETED|Overall Study||0
10609189|NCT01894984|11766871|FG000|STARTED|Overall Study||396
10609190|NCT01894984|11766872|FG001|STARTED|Overall Study||244
10609191|NCT01894984|11766871|FG000|COMPLETED|Overall Study||82
10609192|NCT01894984|11766872|FG001|COMPLETED|Overall Study||69
10609193|NCT01894984|11766871|FG000|NOT COMPLETED|Overall Study||314
10609194|NCT01894984|11766872|FG001|NOT COMPLETED|Overall Study||175
10609195|NCT01895036|11766878|FG000|STARTED|Overall Study||6
10609196|NCT01895036|11766878|FG000|COMPLETED|Overall Study||6
10609197|NCT01895036|11766878|FG000|NOT COMPLETED|Overall Study||0
10609198|NCT01895062|11766884|FG000|STARTED|Overall Study||30
10609199|NCT01895062|11766885|FG001|STARTED|Overall Study||24
10609200|NCT01895062|11766884|FG000|COMPLETED|Overall Study||30
10609201|NCT01895062|11766885|FG001|COMPLETED|Overall Study||24
10609202|NCT01895062|11766884|FG000|NOT COMPLETED|Overall Study||0
10609203|NCT01895062|11766885|FG001|NOT COMPLETED|Overall Study||0
10609204|NCT01895088|11766891|FG000|STARTED|Overall Study|1 subject consented for monitoring after device removal (not included in cohort), per FDA request.|271
10609205|NCT01895088|11766891|FG000|COMPLETED|Overall Study||253
10609206|NCT01895088|11766891|FG000|NOT COMPLETED|Overall Study||18
10609207|NCT01895101|11766898|FG000|STARTED|Overall Study||250
10609208|NCT01895101|11766899|FG001|STARTED|Overall Study||250
10609209|NCT01895101|11766900|FG002|STARTED|Overall Study||250
10609210|NCT01895101|11766898|FG000|COMPLETED|Overall Study||249
10609211|NCT01895101|11766899|FG001|COMPLETED|Overall Study||245
10609212|NCT01895101|11766900|FG002|COMPLETED|Overall Study||245
10609213|NCT01895101|11766898|FG000|NOT COMPLETED|Overall Study||1
10609214|NCT01895101|11766899|FG001|NOT COMPLETED|Overall Study||5
10609215|NCT01895101|11766900|FG002|NOT COMPLETED|Overall Study||5
10609216|NCT01895127|11766910|FG000|STARTED|Screening||4
10609217|NCT01895127|11766911|FG001|STARTED|Screening||7
10609218|NCT01895127|11766910|FG000|COMPLETED|Screening|One subject was found to be pregnant at screening so was withdrawn from the study prior to treatment|4
10609219|NCT01895127|11766911|FG001|COMPLETED|Screening||7
10609220|NCT01895127|11766910|FG000|NOT COMPLETED|Screening||0
10609221|NCT01895127|11766911|FG001|NOT COMPLETED|Screening||0
10609222|NCT01895127|11766910|FG000|STARTED|Treatment Period (Week 0-Month 3)||3
10609223|NCT01895127|11766911|FG001|STARTED|Treatment Period (Week 0-Month 3)||7
10609224|NCT01895127|11766910|FG000|COMPLETED|Treatment Period (Week 0-Month 3)||3
10609225|NCT01895127|11766911|FG001|COMPLETED|Treatment Period (Week 0-Month 3)||7
10609226|NCT01895127|11766910|FG000|NOT COMPLETED|Treatment Period (Week 0-Month 3)||0
10609227|NCT01895127|11766911|FG001|NOT COMPLETED|Treatment Period (Week 0-Month 3)||0
10609228|NCT01895127|11766910|FG000|STARTED|Month 3 Follow-up & Biopsy||3
10609229|NCT01895127|11766911|FG001|STARTED|Month 3 Follow-up & Biopsy||7
10609230|NCT01895127|11766910|FG000|COMPLETED|Month 3 Follow-up & Biopsy||3
10609231|NCT01895127|11766911|FG001|COMPLETED|Month 3 Follow-up & Biopsy||7
10609232|NCT01895127|11766910|FG000|NOT COMPLETED|Month 3 Follow-up & Biopsy||0
10609233|NCT01895127|11766911|FG001|NOT COMPLETED|Month 3 Follow-up & Biopsy||0
10609234|NCT01895127|11766910|FG000|STARTED|Long Term Follow-up (Month 3-12)||3
10609235|NCT01895127|11766911|FG001|STARTED|Long Term Follow-up (Month 3-12)||7
10609236|NCT01895127|11766910|FG000|COMPLETED|Long Term Follow-up (Month 3-12)||1
10609237|NCT01895127|11766911|FG001|COMPLETED|Long Term Follow-up (Month 3-12)||4
10609238|NCT01895127|11766910|FG000|NOT COMPLETED|Long Term Follow-up (Month 3-12)||2
10609239|NCT01895127|11766911|FG001|NOT COMPLETED|Long Term Follow-up (Month 3-12)||3
10609240|NCT01895270|11766920|FG000|STARTED|Study Medications Induction (W1-4)||11
10609241|NCT01895270|11766921|FG001|STARTED|Study Medications Induction (W1-4)||14
10609242|NCT01895270|11766920|FG000|COMPLETED|Study Medications Induction (W1-4)||5
10609243|NCT01895270|11766921|FG001|COMPLETED|Study Medications Induction (W1-4)||8
10609244|NCT01895270|11766920|FG000|NOT COMPLETED|Study Medications Induction (W1-4)||6
10609245|NCT01895270|11766921|FG001|NOT COMPLETED|Study Medications Induction (W1-4)||6
10609246|NCT01895270|11766920|FG000|STARTED|Buprenorphine Taper (W5 to W6D3)||5
10609247|NCT01895270|11766921|FG001|STARTED|Buprenorphine Taper (W5 to W6D3)|1 subject missed meds prior to bup taper so did not start this phase|7
10609248|NCT01895270|11766920|FG000|COMPLETED|Buprenorphine Taper (W5 to W6D3)||2
10609249|NCT01895270|11766921|FG001|COMPLETED|Buprenorphine Taper (W5 to W6D3)||2
10609250|NCT01895270|11766920|FG000|NOT COMPLETED|Buprenorphine Taper (W5 to W6D3)||3
10609251|NCT01895270|11766921|FG001|NOT COMPLETED|Buprenorphine Taper (W5 to W6D3)||5
10704492|NCT02592655|11868864|FG000|STARTED|Fourth Tourniquet Right Thigh.|Only the first 4 participants received all four interventions.|4
10704493|NCT02592655|11868864|FG000|ATS (Pneumatic)|Fourth Tourniquet Right Thigh.||1
10704494|NCT02592655|11868864|FG000|Windlass Tourniquet|Fourth Tourniquet Right Thigh.||0
10704495|NCT02592655|11868864|FG000|Tourniquet Tape 10 cm Width|Fourth Tourniquet Right Thigh.||3
10704496|NCT02592655|11868864|FG000|Tourniquet Tape 5 cm Width|Fourth Tourniquet Right Thigh.||0
10704497|NCT02592655|11868864|FG000|COMPLETED|Fourth Tourniquet Right Thigh.||4
10704498|NCT02592655|11868864|FG000|NOT COMPLETED|Fourth Tourniquet Right Thigh.||0
10704499|NCT02592798|11868881|FG000|STARTED|Double-Blind Period 1 (DB1)||17
10704500|NCT02592798|11868882|FG001|STARTED|Double-Blind Period 1 (DB1)||19
10704501|NCT02592798|11868881|FG000|COMPLETED|Double-Blind Period 1 (DB1)||14
10704502|NCT02592798|11868882|FG001|COMPLETED|Double-Blind Period 1 (DB1)||13
10704503|NCT02592798|11868881|FG000|NOT COMPLETED|Double-Blind Period 1 (DB1)||3
10704504|NCT02592798|11868882|FG001|NOT COMPLETED|Double-Blind Period 1 (DB1)||6
10704505|NCT02592798|11868881|FG000|STARTED|Transition From DB1 to DB2||14
10609252|NCT01895270|11766920|FG000|STARTED|Isradipine Taper (W7-8)||2
10609253|NCT01895270|11766921|FG001|STARTED|Isradipine Taper (W7-8)||2
10609254|NCT01895270|11766920|FG000|COMPLETED|Isradipine Taper (W7-8)||2
10609255|NCT01895270|11766921|FG001|COMPLETED|Isradipine Taper (W7-8)||0
10609256|NCT01895270|11766920|FG000|NOT COMPLETED|Isradipine Taper (W7-8)||0
10609257|NCT01895270|11766921|FG001|NOT COMPLETED|Isradipine Taper (W7-8)||2
10609258|NCT01895309|11766929|FG000|STARTED|Overall Study||299
10609259|NCT01895309|11766930|FG001|STARTED|Overall Study||297
10609260|NCT01895309|11766929|FG000|COMPLETED|Overall Study||259
10609261|NCT01895309|11766930|FG001|COMPLETED|Overall Study||246
10609262|NCT01895309|11766929|FG000|NOT COMPLETED|Overall Study||40
10609263|NCT01895309|11766930|FG001|NOT COMPLETED|Overall Study||51
10609264|NCT01895322|11766940|FG000|STARTED|Overall Study||20
10609265|NCT01895322|11766940|FG000|COMPLETED|Overall Study||7
10609266|NCT01895322|11766940|FG000|NOT COMPLETED|Overall Study||13
10609267|NCT01895335|11766945|FG000|STARTED|Overall Study||1001
10609268|NCT01895335|11766945|FG000|Treated|Overall Study||1000
10609269|NCT01895335|11766945|FG000|COMPLETED|Overall Study||786
10609270|NCT01895335|11766945|FG000|NOT COMPLETED|Overall Study||215
10609271|NCT01895361|11766952|FG000|STARTED|Overall Study||67
10609272|NCT01895361|11766953|FG001|STARTED|Overall Study||66
10609273|NCT01895361|11766954|FG002|STARTED|Overall Study||65
10609274|NCT01895361|11766952|FG000|COMPLETED|Overall Study||43
10609275|NCT01895361|11766953|FG001|COMPLETED|Overall Study||45
10609276|NCT01895361|11766954|FG002|COMPLETED|Overall Study||41
10609277|NCT01895361|11766952|FG000|NOT COMPLETED|Overall Study||24
10609278|NCT01895361|11766953|FG001|NOT COMPLETED|Overall Study||21
10609279|NCT01895361|11766954|FG002|NOT COMPLETED|Overall Study||24
10609280|NCT01895452|11766964|FG000|STARTED|Overall Study||65
10609281|NCT01895452|11766965|FG001|STARTED|Overall Study||226
10704506|NCT02592798|11868882|FG001|STARTED|Transition From DB1 to DB2||13
10704507|NCT02592798|11868881|FG000|COMPLETED|Transition From DB1 to DB2||11
10704508|NCT02592798|11868882|FG001|COMPLETED|Transition From DB1 to DB2||11
10704509|NCT02592798|11868881|FG000|NOT COMPLETED|Transition From DB1 to DB2||3
10609282|NCT01895452|11766964|FG000|COMPLETED|Overall Study||61
10609283|NCT01895452|11766965|FG001|COMPLETED|Overall Study||198
10609284|NCT01895452|11766964|FG000|NOT COMPLETED|Overall Study||4
10609285|NCT01895452|11766965|FG001|NOT COMPLETED|Overall Study||28
10609286|NCT01895543|11766971|FG000|STARTED|Overall Study||411
10609287|NCT01895543|11766971|FG000|Safety Analysis Set|Overall Study|Set included all enrolled patients who took at least one dose of Investigational Medicinal Product.|409
10609288|NCT01895543|11766971|FG000|Per Protocol Analysis Set|Overall Study|Set included all enrolled patients who had no major protocol deviations.|380
10609289|NCT01895543|11766971|FG000|COMPLETED|Overall Study||282
10609290|NCT01895543|11766971|FG000|NOT COMPLETED|Overall Study||129
10609291|NCT01895608|11766979|FG000|STARTED|Overall Study||10
10609292|NCT01895608|11766980|FG001|STARTED|Overall Study||7
10609293|NCT01895608|11766981|FG002|STARTED|Overall Study||11
10609294|NCT01895608|11766982|FG003|STARTED|Overall Study||6
10609295|NCT01895608|11766979|FG000|COMPLETED|Overall Study||10
10609296|NCT01895608|11766980|FG001|COMPLETED|Overall Study||6
10609297|NCT01895608|11766981|FG002|COMPLETED|Overall Study||8
10609298|NCT01895608|11766982|FG003|COMPLETED|Overall Study||6
10609299|NCT01895608|11766979|FG000|NOT COMPLETED|Overall Study||0
10609300|NCT01895608|11766980|FG001|NOT COMPLETED|Overall Study||1
10609301|NCT01895608|11766981|FG002|NOT COMPLETED|Overall Study||3
10609302|NCT01895608|11766982|FG003|NOT COMPLETED|Overall Study||0
10609303|NCT01895634|11766992|FG000|STARTED|Overall Study||49
10609304|NCT01895634|11766992|FG000|COMPLETED|Overall Study||46
10609305|NCT01895634|11766992|FG000|NOT COMPLETED|Overall Study||3
10609306|NCT01895647|11766999|FG000|STARTED|Overall Study||8
10609307|NCT01895647|11767000|FG001|STARTED|Overall Study||10
10609308|NCT01895647|11767001|FG002|STARTED|Overall Study||7
10609309|NCT01895647|11766999|FG000|COMPLETED|Overall Study||8
10609310|NCT01895647|11767000|FG001|COMPLETED|Overall Study||10
10609311|NCT01895647|11767001|FG002|COMPLETED|Overall Study||7
10609312|NCT01895647|11766999|FG000|NOT COMPLETED|Overall Study||0
10609313|NCT01895647|11767000|FG001|NOT COMPLETED|Overall Study||0
10609314|NCT01895647|11767001|FG002|NOT COMPLETED|Overall Study||0
10609315|NCT01895777|11767011|FG000|STARTED|Overall Study||177
10609316|NCT01895777|11767012|FG001|STARTED|Overall Study||90
10609317|NCT01895777|11767011|FG000|Treated|Overall Study||176
10609318|NCT01895777|11767012|FG001|Treated|Overall Study||90
10609319|NCT01895777|11767011|FG000|COMPLETED|Overall Study||168
10609320|NCT01895777|11767012|FG001|COMPLETED|Overall Study||85
10609321|NCT01895777|11767011|FG000|NOT COMPLETED|Overall Study||9
10609322|NCT01895777|11767012|FG001|NOT COMPLETED|Overall Study||5
10609323|NCT01895855|11767023|FG000|STARTED|Overall Study||95
10609324|NCT01895855|11767024|FG001|STARTED|Overall Study||102
10609325|NCT01895855|11767023|FG000|COMPLETED|Overall Study||95
10609326|NCT01895855|11767024|FG001|COMPLETED|Overall Study||102
10609327|NCT01895855|11767023|FG000|NOT COMPLETED|Overall Study||0
10609328|NCT01895855|11767024|FG001|NOT COMPLETED|Overall Study||0
10609329|NCT01895946|11767036|FG000|STARTED|Overall Study||18
10609330|NCT01895946|11767037|FG001|STARTED|Overall Study||12
10609331|NCT01895946|11767036|FG000|COMPLETED|Overall Study||18
10609332|NCT01895946|11767037|FG001|COMPLETED|Overall Study||12
10609333|NCT01895946|11767036|FG000|NOT COMPLETED|Overall Study||0
10609334|NCT01895946|11767037|FG001|NOT COMPLETED|Overall Study||0
10609335|NCT01895972|11767043|FG000|STARTED|Overall Study||130
10609336|NCT01895972|11767043|FG000|COMPLETED|Overall Study||121
10609337|NCT01895972|11767043|FG000|NOT COMPLETED|Overall Study||9
10609338|NCT01896050|11767049|FG000|STARTED|Overall Study||93
10609339|NCT01896050|11767050|FG001|STARTED|Overall Study||22
10609340|NCT01896050|11767049|FG000|COMPLETED|Overall Study|This includes only patients who remained on the same aromatase inhibitor medication for 12 months|55
10609341|NCT01896050|11767050|FG001|COMPLETED|Overall Study||20
10609342|NCT01896050|11767049|FG000|NOT COMPLETED|Overall Study||38
10609343|NCT01896050|11767050|FG001|NOT COMPLETED|Overall Study||2
10609344|NCT01896115|11767060|FG000|STARTED|Overall Study||16
10609345|NCT01896115|11767061|FG001|STARTED|Overall Study||24
10609346|NCT01896115|11767060|FG000|Phase 1 Short PW|Overall Study||15
10609347|NCT01896115|11767061|FG001|Phase 1 Short PW|Overall Study||0
10609348|NCT01896115|11767060|FG000|Phase 1 Conventional PW|Overall Study||15
10609349|NCT01896115|11767061|FG001|Phase 1 Conventional PW|Overall Study||0
10609350|NCT01896115|11767060|FG000|Phase 1 Dorsal Steering|Overall Study||15
10704510|NCT02592798|11868882|FG001|NOT COMPLETED|Transition From DB1 to DB2||2
10609351|NCT01896115|11767061|FG001|Phase 1 Dorsal Steering|Overall Study||0
10609352|NCT01896115|11767060|FG000|Phase 1 Ventral Steering|Overall Study||15
10609353|NCT01896115|11767061|FG001|Phase 1 Ventral Steering|Overall Study||0
10609354|NCT01896115|11767060|FG000|Phase 2 Single Contact|Overall Study||0
10609355|NCT01896115|11767061|FG001|Phase 2 Single Contact|Overall Study||24
10609356|NCT01896115|11767060|FG000|Phase 2 Steering|Overall Study||0
10609357|NCT01896115|11767061|FG001|Phase 2 Steering|Overall Study||24
10609358|NCT01896115|11767060|FG000|COMPLETED|Overall Study||15
10609359|NCT01896115|11767061|FG001|COMPLETED|Overall Study||24
10609360|NCT01896115|11767060|FG000|NOT COMPLETED|Overall Study||1
10609361|NCT01896115|11767061|FG001|NOT COMPLETED|Overall Study||0
10609362|NCT01896128|11767074|FG000|STARTED|Overall Study||8
10609363|NCT01896128|11767075|FG001|STARTED|Overall Study||11
10609364|NCT01896128|11767074|FG000|COMPLETED|Overall Study||5
10609365|NCT01896128|11767075|FG001|COMPLETED|Overall Study||8
10609366|NCT01896128|11767074|FG000|NOT COMPLETED|Overall Study||3
10609367|NCT01896128|11767075|FG001|NOT COMPLETED|Overall Study||3
10609368|NCT01896193|11767085|FG000|STARTED|Overall Study||62
10609369|NCT01896193|11767086|FG001|STARTED|Overall Study||65
10609370|NCT01896193|11767085|FG000|COMPLETED|Overall Study||41
10609371|NCT01896193|11767086|FG001|COMPLETED|Overall Study||53
10609372|NCT01896193|11767085|FG000|NOT COMPLETED|Overall Study||21
10609373|NCT01896193|11767086|FG001|NOT COMPLETED|Overall Study||12
10609374|NCT01896206|11767094|FG000|STARTED|Overall Study||21
10609375|NCT01896206|11767094|FG000|COMPLETED|Overall Study||21
10609376|NCT01896206|11767094|FG000|NOT COMPLETED|Overall Study||0
10609377|NCT01896232|11767100|FG000|STARTED|Overall Study||343
10609378|NCT01896232|11767101|FG001|STARTED|Overall Study||340
10609379|NCT01896232|11767100|FG000|Received Treatment|Overall Study||341
10609380|NCT01896232|11767101|FG001|Received Treatment|Overall Study||338
10609381|NCT01896232|11767100|FG000|COMPLETED|Overall Study||294
10609382|NCT01896232|11767101|FG001|COMPLETED|Overall Study||287
10609383|NCT01896232|11767100|FG000|NOT COMPLETED|Overall Study||49
10609384|NCT01896232|11767101|FG001|NOT COMPLETED|Overall Study||53
10609385|NCT01896271|11767107|FG000|STARTED|Overall Study||30
10609386|NCT01896271|11767107|FG000|COMPLETED|Overall Study||20
10609387|NCT01896271|11767107|FG000|NOT COMPLETED|Overall Study||10
10609388|NCT01896297|11767111|FG000|STARTED|Overall Study||60
10609389|NCT01896297|11767111|FG000|COMPLETED|Overall Study||59
10609390|NCT01896297|11767111|FG000|NOT COMPLETED|Overall Study||1
10609391|NCT01896544|11767118|FG000|STARTED|Overall Study||10
10609392|NCT01896544|11767119|FG001|STARTED|Overall Study||10
10609393|NCT01896544|11767120|FG002|STARTED|Overall Study||10
10609394|NCT01896544|11767118|FG000|COMPLETED|Overall Study||10
10609395|NCT01896544|11767119|FG001|COMPLETED|Overall Study||10
10609396|NCT01896544|11767120|FG002|COMPLETED|Overall Study||10
10609397|NCT01896544|11767118|FG000|NOT COMPLETED|Overall Study||0
10609398|NCT01896544|11767119|FG001|NOT COMPLETED|Overall Study||0
10609399|NCT01896544|11767120|FG002|NOT COMPLETED|Overall Study||0
10609400|NCT01896557|11767133|FG000|STARTED|Clopidogrel Alone||44
10609401|NCT01896557|11767134|FG001|STARTED|Clopidogrel Alone||48
10609402|NCT01896557|11767133|FG000|COMPLETED|Clopidogrel Alone||43
10609403|NCT01896557|11767134|FG001|COMPLETED|Clopidogrel Alone||48
10609404|NCT01896557|11767133|FG000|NOT COMPLETED|Clopidogrel Alone||1
10609405|NCT01896557|11767134|FG001|NOT COMPLETED|Clopidogrel Alone||0
10609406|NCT01896557|11767133|FG000|STARTED|Clopidogrel + GI Protector||43
10609407|NCT01896557|11767134|FG001|STARTED|Clopidogrel + GI Protector||48
10609408|NCT01896557|11767133|FG000|COMPLETED|Clopidogrel + GI Protector||41
10609409|NCT01896557|11767134|FG001|COMPLETED|Clopidogrel + GI Protector||44
10609410|NCT01896557|11767133|FG000|NOT COMPLETED|Clopidogrel + GI Protector||2
10609411|NCT01896557|11767134|FG001|NOT COMPLETED|Clopidogrel + GI Protector||4
10609412|NCT01896687|11767142|FG000|STARTED|Overall Study||15
10609413|NCT01896687|11767143|FG001|STARTED|Overall Study||15
10609414|NCT01896687|11767142|FG000|COMPLETED|Overall Study||15
10609415|NCT01896687|11767143|FG001|COMPLETED|Overall Study||15
10609416|NCT01896687|11767142|FG000|NOT COMPLETED|Overall Study||0
10609417|NCT01896687|11767143|FG001|NOT COMPLETED|Overall Study||0
10609418|NCT01896700|11767151|FG000|STARTED|Overall Study||12
10609419|NCT01896700|11767152|FG001|STARTED|Overall Study||12
10609420|NCT01896700|11767151|FG000|COMPLETED|Overall Study||8
10609421|NCT01896700|11767152|FG001|COMPLETED|Overall Study||6
10609422|NCT01896700|11767151|FG000|NOT COMPLETED|Overall Study||4
10609423|NCT01896700|11767152|FG001|NOT COMPLETED|Overall Study||6
10609424|NCT01896726|11767158|FG000|STARTED|Treatment Period 1 (Days 1-22)||20
10609425|NCT01896726|11767158|FG000|Received Microgynon|Treatment Period 1 (Days 1-22)||20
10609426|NCT01896726|11767158|FG000|COMPLETED|Treatment Period 1 (Days 1-22)||20
10609427|NCT01896726|11767158|FG000|NOT COMPLETED|Treatment Period 1 (Days 1-22)||0
10609428|NCT01896726|11767158|FG000|STARTED|Treatment Period 2 (Days 23-31)||20
10609429|NCT01896726|11767158|FG000|Received at Least 1 Dose of Baricitinib|Treatment Period 2 (Days 23-31)||20
10609430|NCT01896726|11767158|FG000|Received Microgynon|Treatment Period 2 (Days 23-31)||18
10609431|NCT01896726|11767158|FG000|COMPLETED|Treatment Period 2 (Days 23-31)||18
10609432|NCT01896726|11767158|FG000|NOT COMPLETED|Treatment Period 2 (Days 23-31)||2
10609433|NCT01896856|11767171|FG000|STARTED|Overall Study||6
10609434|NCT01896856|11767172|FG001|STARTED|Overall Study||3
10609435|NCT01896856|11767173|FG002|STARTED|Overall Study||7
10609436|NCT01896856|11767174|FG003|STARTED|Overall Study||6
10609437|NCT01896856|11767175|FG004|STARTED|Overall Study||62
10609438|NCT01896856|11767176|FG005|STARTED|Overall Study||34
10609439|NCT01896856|11767171|FG000|COMPLETED|Overall Study||6
10609440|NCT01896856|11767172|FG001|COMPLETED|Overall Study||3
10609441|NCT01896856|11767173|FG002|COMPLETED|Overall Study||6
10609442|NCT01896856|11767174|FG003|COMPLETED|Overall Study||6
10609443|NCT01896856|11767175|FG004|COMPLETED|Overall Study||62
10609444|NCT01896856|11767176|FG005|COMPLETED|Overall Study||34
10609445|NCT01896856|11767171|FG000|NOT COMPLETED|Overall Study||0
10609446|NCT01896856|11767172|FG001|NOT COMPLETED|Overall Study||0
10609447|NCT01896856|11767173|FG002|NOT COMPLETED|Overall Study||1
10609448|NCT01896856|11767174|FG003|NOT COMPLETED|Overall Study||0
10609449|NCT01896856|11767175|FG004|NOT COMPLETED|Overall Study||0
10609450|NCT01896856|11767176|FG005|NOT COMPLETED|Overall Study||0
10609451|NCT01896869|11767193|FG000|STARTED|Overall Study||41
10609452|NCT01896869|11767194|FG001|STARTED|Overall Study||42
10609453|NCT01896869|11767193|FG000|COMPLETED|Overall Study||40
10609454|NCT01896869|11767194|FG001|COMPLETED|Overall Study||36
10609455|NCT01896869|11767193|FG000|NOT COMPLETED|Overall Study||1
10609456|NCT01896869|11767194|FG001|NOT COMPLETED|Overall Study||6
10609457|NCT01896895|11767205|FG000|STARTED|Double-blind MP||20
10609458|NCT01896895|11767206|FG001|STARTED|Double-blind MP||22
10609459|NCT01896895|11767207|FG002|STARTED|Double-blind MP||19
10609460|NCT01896895|11767208|FG003|STARTED|Double-blind MP||0
10704511|NCT02592798|11868881|FG000|STARTED|Double-Blind Period 2 (DB2)||11
10704512|NCT02592798|11868882|FG001|STARTED|Double-Blind Period 2 (DB2)||11
10704513|NCT02592798|11868881|FG000|COMPLETED|Double-Blind Period 2 (DB2)||6
10704514|NCT02592798|11868882|FG001|COMPLETED|Double-Blind Period 2 (DB2)||9
10609461|NCT01896895|11767205|FG000|COMPLETED|Double-blind MP||19
10609462|NCT01896895|11767206|FG001|COMPLETED|Double-blind MP||20
10609463|NCT01896895|11767207|FG002|COMPLETED|Double-blind MP||16
10609464|NCT01896895|11767208|FG003|COMPLETED|Double-blind MP||0
10609465|NCT01896895|11767205|FG000|NOT COMPLETED|Double-blind MP||1
10609466|NCT01896895|11767206|FG001|NOT COMPLETED|Double-blind MP||2
10609467|NCT01896895|11767207|FG002|NOT COMPLETED|Double-blind MP||3
10609468|NCT01896895|11767208|FG003|NOT COMPLETED|Double-blind MP||0
10609469|NCT01896895|11767205|FG000|STARTED|OLEX Period||0
10609470|NCT01896895|11767206|FG001|STARTED|OLEX Period||0
10609471|NCT01896895|11767207|FG002|STARTED|OLEX Period||0
10609472|NCT01896895|11767208|FG003|STARTED|OLEX Period|Not all participants who completed double-blind MP fulfilled the inclusion criteria for OLEX period.|39
10609473|NCT01896895|11767205|FG000|COMPLETED|OLEX Period||0
10609474|NCT01896895|11767206|FG001|COMPLETED|OLEX Period||0
10609475|NCT01896895|11767207|FG002|COMPLETED|OLEX Period||0
10609476|NCT01896895|11767208|FG003|COMPLETED|OLEX Period||39
10609477|NCT01896895|11767205|FG000|NOT COMPLETED|OLEX Period||0
10609478|NCT01896895|11767206|FG001|NOT COMPLETED|OLEX Period||0
10609479|NCT01896895|11767207|FG002|NOT COMPLETED|OLEX Period||0
10609480|NCT01896895|11767208|FG003|NOT COMPLETED|OLEX Period||0
10609481|NCT01896921|11767217|FG000|STARTED|Overall Study||7
10609482|NCT01896921|11767217|FG000|COMPLETED|Overall Study||5
10609483|NCT01896921|11767217|FG000|NOT COMPLETED|Overall Study||2
10609484|NCT01896934|11767221|FG000|STARTED|Overall Study||21
10609485|NCT01896934|11767221|FG000|COMPLETED|Overall Study||19
10609486|NCT01896934|11767221|FG000|NOT COMPLETED|Overall Study||2
10609487|NCT01896986|11767227|FG000|STARTED|Overall Study||14
10609488|NCT01896986|11767228|FG001|STARTED|Overall Study||23
10609489|NCT01896986|11767227|FG000|COMPLETED|Overall Study||0
10609490|NCT01896986|11767228|FG001|COMPLETED|Overall Study||0
10609491|NCT01896986|11767227|FG000|NOT COMPLETED|Overall Study||14
10609492|NCT01896986|11767228|FG001|NOT COMPLETED|Overall Study||23
10609493|NCT01897025|11767236|FG000|STARTED|Overall Study||10
10609494|NCT01897025|11767237|FG001|STARTED|Overall Study||9
10609495|NCT01897025|11767236|FG000|COMPLETED|Overall Study||10
10609496|NCT01897025|11767237|FG001|COMPLETED|Overall Study||9
10609497|NCT01897025|11767236|FG000|NOT COMPLETED|Overall Study||0
10609498|NCT01897025|11767237|FG001|NOT COMPLETED|Overall Study||0
10609499|NCT01897077|11767245|FG000|STARTED|Overall Study||0
10609500|NCT01897077|11767246|FG001|STARTED|Overall Study||5
10609501|NCT01897077|11767245|FG000|COMPLETED|Overall Study||0
10609502|NCT01897077|11767246|FG001|COMPLETED|Overall Study||5
10609503|NCT01897077|11767245|FG000|NOT COMPLETED|Overall Study||0
10609504|NCT01897077|11767246|FG001|NOT COMPLETED|Overall Study||0
10653092|NCT02190604|11813565|FG009|STARTED|Part 1 and 2 (Healthy Volunteers)||6
10653093|NCT02190604|11813566|FG010|STARTED|Part 1 and 2 (Healthy Volunteers)||6
10653094|NCT02190604|11813567|FG011|STARTED|Part 1 and 2 (Healthy Volunteers)||6
10653095|NCT02190604|11813568|FG012|STARTED|Part 1 and 2 (Healthy Volunteers)||6
10653096|NCT02190604|11813569|FG013|STARTED|Part 1 and 2 (Healthy Volunteers)||6
10653097|NCT02190604|11813570|FG014|STARTED|Part 1 and 2 (Healthy Volunteers)||10
10653098|NCT02190604|11813571|FG015|STARTED|Part 1 and 2 (Healthy Volunteers)||0
10653099|NCT02190604|11813572|FG016|STARTED|Part 1 and 2 (Healthy Volunteers)||0
10653100|NCT02190604|11813573|FG017|STARTED|Part 1 and 2 (Healthy Volunteers)||0
10653101|NCT02190604|11813574|FG018|STARTED|Part 1 and 2 (Healthy Volunteers)||0
10653102|NCT02190604|11813556|FG000|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
10653103|NCT02190604|11813557|FG001|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
10653104|NCT02190604|11813558|FG002|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
10653105|NCT02190604|11813559|FG003|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
10653106|NCT02190604|11813560|FG004|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
10653107|NCT02190604|11813561|FG005|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
10653108|NCT02190604|11813562|FG006|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
10653109|NCT02190604|11813563|FG007|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
10653110|NCT02190604|11813564|FG008|COMPLETED|Part 1 and 2 (Healthy Volunteers)||16
10653111|NCT02190604|11813565|FG009|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
10653112|NCT02190604|11813566|FG010|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
10653113|NCT02190604|11813567|FG011|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
10653114|NCT02190604|11813568|FG012|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
10653115|NCT02190604|11813569|FG013|COMPLETED|Part 1 and 2 (Healthy Volunteers)||5
10704515|NCT02592798|11868881|FG000|NOT COMPLETED|Double-Blind Period 2 (DB2)||5
10609505|NCT01897233|11767252|FG000|STARTED|Part A (14 Days)||10
10609506|NCT01897233|11767252|FG000|Part A Cohort 1 (6 to 8 Years)|Part A (14 Days)||5
10609507|NCT01897233|11767252|FG000|Part A Cohort 2 (9 to 11 Years)|Part A (14 Days)||5
10609508|NCT01897233|11767252|FG000|COMPLETED|Part A (14 Days)||10
10609509|NCT01897233|11767252|FG000|NOT COMPLETED|Part A (14 Days)||0
10609510|NCT01897233|11767252|FG000|STARTED|Part B (24 Weeks)|6 participants from Part A also participated in Part B of the study.|58
10609511|NCT01897233|11767252|FG000|COMPLETED|Part B (24 Weeks)||54
10609512|NCT01897233|11767252|FG000|NOT COMPLETED|Part B (24 Weeks)||4
10609513|NCT01897285|11767260|FG000|STARTED|Overall Study|All 20 participants received original AND test adhesive dressings on upper arms and lower back.|20
10609514|NCT01897285|11767260|FG000|COMPLETED|Overall Study||20
10609515|NCT01897285|11767260|FG000|NOT COMPLETED|Overall Study||0
10609516|NCT01897402|11767268|FG000|STARTED|Overall Study||265
10609517|NCT01897402|11767269|FG001|STARTED|Overall Study||260
10609518|NCT01897402|11767268|FG000|COMPLETED|Overall Study||246
10609519|NCT01897402|11767269|FG001|COMPLETED|Overall Study||244
10609520|NCT01897402|11767268|FG000|NOT COMPLETED|Overall Study||19
10609521|NCT01897402|11767269|FG001|NOT COMPLETED|Overall Study||16
10609522|NCT01897493|11767281|FG000|STARTED|Period 1 (Day 1 Through Day 6 Predose)||16
10609523|NCT01897493|11767281|FG000|Received at Least 1 Dose of Study Drug|Period 1 (Day 1 Through Day 6 Predose)||16
10609524|NCT01897493|11767281|FG000|COMPLETED|Period 1 (Day 1 Through Day 6 Predose)||15
10609525|NCT01897493|11767281|FG000|NOT COMPLETED|Period 1 (Day 1 Through Day 6 Predose)||1
10609526|NCT01897493|11767281|FG000|STARTED|Period 2 (Day 6 Postdose Through Day 20)||15
10609527|NCT01897493|11767281|FG000|Received at Least 1 Dose of Study Drug|Period 2 (Day 6 Postdose Through Day 20)||15
10609528|NCT01897493|11767281|FG000|COMPLETED|Period 2 (Day 6 Postdose Through Day 20)||15
10609529|NCT01897493|11767281|FG000|NOT COMPLETED|Period 2 (Day 6 Postdose Through Day 20)||0
10609530|NCT01897532|11767290|FG000|STARTED|Discontinuation From Treatment||3492
10609531|NCT01897532|11767291|FG001|STARTED|Discontinuation From Treatment||3499
10609532|NCT01897532|11767290|FG000|Treated|Discontinuation From Treatment||3485
10609533|NCT01897532|11767291|FG001|Treated|Discontinuation From Treatment||3494
10609534|NCT01897532|11767290|FG000|COMPLETED|Discontinuation From Treatment||2530
10609535|NCT01897532|11767291|FG001|COMPLETED|Discontinuation From Treatment||2660
10609536|NCT01897532|11767290|FG000|NOT COMPLETED|Discontinuation From Treatment||962
10609537|NCT01897532|11767291|FG001|NOT COMPLETED|Discontinuation From Treatment||839
10609538|NCT01897532|11767290|FG000|STARTED|Discontinuation From Trial||3492
10609539|NCT01897532|11767291|FG001|STARTED|Discontinuation From Trial||3499
10609540|NCT01897532|11767290|FG000|Treated|Discontinuation From Trial||3485
10609541|NCT01897532|11767291|FG001|Treated|Discontinuation From Trial||3494
10609542|NCT01897532|11767290|FG000|COMPLETED|Discontinuation From Trial||3430
10609543|NCT01897532|11767291|FG001|COMPLETED|Discontinuation From Trial||3458
10609544|NCT01897532|11767290|FG000|NOT COMPLETED|Discontinuation From Trial||62
10609545|NCT01897532|11767291|FG001|NOT COMPLETED|Discontinuation From Trial||41
10609546|NCT01897714|11767303|FG000|STARTED|Phase I (Dose Escalation)||4
10609547|NCT01897714|11767304|FG001|STARTED|Phase I (Dose Escalation)||7
10609548|NCT01897714|11767305|FG002|STARTED|Phase I (Dose Escalation)||6
10609549|NCT01897714|11767306|FG003|STARTED|Phase I (Dose Escalation)||6
10609550|NCT01897714|11767307|FG004|STARTED|Phase I (Dose Escalation)||0
10609551|NCT01897714|11767308|FG005|STARTED|Phase I (Dose Escalation)||0
10609552|NCT01897714|11767303|FG000|COMPLETED|Phase I (Dose Escalation)||1
10609553|NCT01897714|11767304|FG001|COMPLETED|Phase I (Dose Escalation)||0
10609554|NCT01897714|11767305|FG002|COMPLETED|Phase I (Dose Escalation)||1
10609555|NCT01897714|11767306|FG003|COMPLETED|Phase I (Dose Escalation)||0
10609556|NCT01897714|11767307|FG004|COMPLETED|Phase I (Dose Escalation)||0
10609557|NCT01897714|11767308|FG005|COMPLETED|Phase I (Dose Escalation)||0
10609558|NCT01897714|11767303|FG000|NOT COMPLETED|Phase I (Dose Escalation)||3
10609559|NCT01897714|11767304|FG001|NOT COMPLETED|Phase I (Dose Escalation)||7
10609560|NCT01897714|11767305|FG002|NOT COMPLETED|Phase I (Dose Escalation)||5
10609561|NCT01897714|11767306|FG003|NOT COMPLETED|Phase I (Dose Escalation)||6
10609562|NCT01897714|11767307|FG004|NOT COMPLETED|Phase I (Dose Escalation)||0
10609563|NCT01897714|11767308|FG005|NOT COMPLETED|Phase I (Dose Escalation)||0
10609564|NCT01897714|11767303|FG000|STARTED|Phase II (MTD)||0
10609565|NCT01897714|11767304|FG001|STARTED|Phase II (MTD)||0
10609566|NCT01897714|11767305|FG002|STARTED|Phase II (MTD)||0
10609567|NCT01897714|11767306|FG003|STARTED|Phase II (MTD)||0
10609568|NCT01897714|11767307|FG004|STARTED|Phase II (MTD)|6 patients were entered from the Phase I: Melflufen 40 mg + Dexamethasone arm.|45
10609569|NCT01897714|11767308|FG005|STARTED|Phase II (MTD)||13
10609570|NCT01897714|11767303|FG000|COMPLETED|Phase II (MTD)||0
10609571|NCT01897714|11767304|FG001|COMPLETED|Phase II (MTD)||0
10609572|NCT01897714|11767305|FG002|COMPLETED|Phase II (MTD)||0
10609573|NCT01897714|11767306|FG003|COMPLETED|Phase II (MTD)||0
10609574|NCT01897714|11767307|FG004|COMPLETED|Phase II (MTD)||15
10609575|NCT01897714|11767308|FG005|COMPLETED|Phase II (MTD)||2
10609576|NCT01897714|11767303|FG000|NOT COMPLETED|Phase II (MTD)||0
10609577|NCT01897714|11767304|FG001|NOT COMPLETED|Phase II (MTD)||0
10609578|NCT01897714|11767305|FG002|NOT COMPLETED|Phase II (MTD)||0
10609579|NCT01897714|11767306|FG003|NOT COMPLETED|Phase II (MTD)||0
10609580|NCT01897714|11767307|FG004|NOT COMPLETED|Phase II (MTD)||30
10609581|NCT01897714|11767308|FG005|NOT COMPLETED|Phase II (MTD)||11
10609582|NCT01897727|11767326|FG000|STARTED|Overall Study||8
10609583|NCT01897727|11767327|FG001|STARTED|Overall Study||9
10609584|NCT01897727|11767326|FG000|COMPLETED|Overall Study||8
10609585|NCT01897727|11767327|FG001|COMPLETED|Overall Study||8
10609586|NCT01897727|11767326|FG000|NOT COMPLETED|Overall Study||0
10609587|NCT01897727|11767327|FG001|NOT COMPLETED|Overall Study||1
10609588|NCT01897766|11767333|FG000|STARTED|Overall Study||482
10609589|NCT01897766|11767333|FG000|COMPLETED|Overall Study||482
10609590|NCT01897766|11767333|FG000|NOT COMPLETED|Overall Study||0
10609591|NCT01897792|11767339|FG000|STARTED|Overall Study||6
10609592|NCT01897792|11767340|FG001|STARTED|Overall Study||5
10609593|NCT01897792|11767339|FG000|COMPLETED|Overall Study||6
10609594|NCT01897792|11767340|FG001|COMPLETED|Overall Study||5
10609595|NCT01897792|11767339|FG000|NOT COMPLETED|Overall Study||0
10609596|NCT01897792|11767340|FG001|NOT COMPLETED|Overall Study||0
10609597|NCT01897896|11767352|FG000|STARTED|Overall Study||82
10609598|NCT01897896|11767353|FG001|STARTED|Overall Study||37
10609599|NCT01897896|11767352|FG000|COMPLETED|Overall Study||56
10609600|NCT01897896|11767353|FG001|COMPLETED|Overall Study||25
10609601|NCT01897896|11767352|FG000|NOT COMPLETED|Overall Study||26
10609602|NCT01897896|11767353|FG001|NOT COMPLETED|Overall Study||12
10609603|NCT01898013|11767363|FG000|STARTED|Visit 3 (Randomization Visit)||45
10609604|NCT01898013|11767364|FG001|STARTED|Visit 3 (Randomization Visit)||49
10609605|NCT01898013|11767363|FG000|COMPLETED|Visit 3 (Randomization Visit)||45
10609606|NCT01898013|11767364|FG001|COMPLETED|Visit 3 (Randomization Visit)||49
10609607|NCT01898013|11767363|FG000|NOT COMPLETED|Visit 3 (Randomization Visit)||0
10609608|NCT01898013|11767364|FG001|NOT COMPLETED|Visit 3 (Randomization Visit)||0
10609609|NCT01898013|11767363|FG000|STARTED|Visit 4||45
10609610|NCT01898013|11767364|FG001|STARTED|Visit 4||49
10609611|NCT01898013|11767363|FG000|COMPLETED|Visit 4||45
10609612|NCT01898013|11767364|FG001|COMPLETED|Visit 4||48
10609613|NCT01898013|11767363|FG000|NOT COMPLETED|Visit 4||0
10609614|NCT01898013|11767364|FG001|NOT COMPLETED|Visit 4||1
10609615|NCT01898013|11767363|FG000|STARTED|Visit 5||45
10609616|NCT01898013|11767364|FG001|STARTED|Visit 5||48
10609617|NCT01898013|11767363|FG000|COMPLETED|Visit 5||44
10609618|NCT01898013|11767364|FG001|COMPLETED|Visit 5||47
10609619|NCT01898013|11767363|FG000|NOT COMPLETED|Visit 5||1
10609620|NCT01898013|11767364|FG001|NOT COMPLETED|Visit 5||1
10609621|NCT01898013|11767363|FG000|STARTED|Visit 6||44
10609622|NCT01898013|11767364|FG001|STARTED|Visit 6||47
10609623|NCT01898013|11767363|FG000|COMPLETED|Visit 6||41
10609624|NCT01898013|11767364|FG001|COMPLETED|Visit 6||42
10609625|NCT01898013|11767363|FG000|NOT COMPLETED|Visit 6||3
10609626|NCT01898013|11767364|FG001|NOT COMPLETED|Visit 6||5
10609627|NCT01898078|11767372|FG000|STARTED|Overall Study||13
10609628|NCT01898078|11767373|FG001|STARTED|Overall Study||13
10609629|NCT01898078|11767372|FG000|COMPLETED|Overall Study|Completed treatment|7
10609630|NCT01898078|11767373|FG001|COMPLETED|Overall Study|Completed treatment|5
10609631|NCT01898078|11767372|FG000|NOT COMPLETED|Overall Study||6
10609632|NCT01898078|11767373|FG001|NOT COMPLETED|Overall Study||8
10609633|NCT01898091|11767383|FG000|STARTED|Overall Study|Allocated to intervention. All allocated received intervention.|25
10609634|NCT01898091|11767384|FG001|STARTED|Overall Study|Allocated to intervention. All allocated received intervention.|25
10609635|NCT01898091|11767383|FG000|COMPLETED|Overall Study||23
10609636|NCT01898091|11767384|FG001|COMPLETED|Overall Study||19
10609637|NCT01898091|11767383|FG000|NOT COMPLETED|Overall Study||2
10609638|NCT01898091|11767384|FG001|NOT COMPLETED|Overall Study||6
10609639|NCT01898130|11767390|FG000|STARTED|Treatment||27
10609640|NCT01898130|11767390|FG000|Reached 1st Response/2 Cycles|Treatment||24
10704516|NCT02592798|11868882|FG001|NOT COMPLETED|Double-Blind Period 2 (DB2)||2
10704517|NCT02592798|11868881|FG000|STARTED|Transition From DB2 to OLE||6
10704518|NCT02592798|11868882|FG001|STARTED|Transition From DB2 to OLE||9
10704519|NCT02592798|11868881|FG000|COMPLETED|Transition From DB2 to OLE||5
10704520|NCT02592798|11868882|FG001|COMPLETED|Transition From DB2 to OLE||9
10704521|NCT02592798|11868881|FG000|NOT COMPLETED|Transition From DB2 to OLE||1
10704522|NCT02592798|11868882|FG001|NOT COMPLETED|Transition From DB2 to OLE||0
10704523|NCT02592798|11868881|FG000|STARTED|Open Label Period (OLE)||10
10704524|NCT02592798|11868882|FG001|STARTED|Open Label Period (OLE)||13
10704525|NCT02592798|11868881|FG000|COMPLETED|Open Label Period (OLE)||6
10704526|NCT02592798|11868882|FG001|COMPLETED|Open Label Period (OLE)||4
10704527|NCT02592798|11868881|FG000|NOT COMPLETED|Open Label Period (OLE)||4
10704528|NCT02592798|11868882|FG001|NOT COMPLETED|Open Label Period (OLE)||9
10704529|NCT02592876|11868897|FG000|STARTED|Overall Study||41
10609641|NCT01898130|11767390|FG000|Went on to Start Cycle 3|Treatment||21
10609642|NCT01898130|11767390|FG000|COMPLETED|Treatment||21
10609643|NCT01898130|11767390|FG000|NOT COMPLETED|Treatment||6
10609644|NCT01898130|11767390|FG000|STARTED|Follow up Until PD or Death|All patients treated on study go into follow up period for survival data.|27
10609645|NCT01898130|11767390|FG000|COMPLETED|Follow up Until PD or Death||26
10609646|NCT01898130|11767390|FG000|NOT COMPLETED|Follow up Until PD or Death||1
10609647|NCT01898195|11767397|FG000|STARTED|Varenicline Adherence||53
10609648|NCT01898195|11767398|FG001|STARTED|Varenicline Adherence||54
10704530|NCT02592876|11868898|FG001|STARTED|Overall Study||40
10609649|NCT01898195|11767399|FG002|STARTED|Varenicline Adherence||51
10609650|NCT01898195|11767397|FG000|COMPLETED|Varenicline Adherence||18
10609651|NCT01898195|11767398|FG001|COMPLETED|Varenicline Adherence||16
10609652|NCT01898195|11767399|FG002|COMPLETED|Varenicline Adherence||15
10609653|NCT01898195|11767397|FG000|NOT COMPLETED|Varenicline Adherence||35
10704531|NCT02592876|11868897|FG000|Received Study Drug|Overall Study||40
10609654|NCT01898195|11767398|FG001|NOT COMPLETED|Varenicline Adherence||38
10609655|NCT01898195|11767399|FG002|NOT COMPLETED|Varenicline Adherence||36
10609656|NCT01898195|11767397|FG000|STARTED|Smoking Abstinence||53
10609657|NCT01898195|11767398|FG001|STARTED|Smoking Abstinence||54
10609658|NCT01898195|11767399|FG002|STARTED|Smoking Abstinence||51
10609659|NCT01898195|11767397|FG000|COMPLETED|Smoking Abstinence||18
10609660|NCT01898195|11767398|FG001|COMPLETED|Smoking Abstinence||16
10457057|NCT01008969|11604796|FG000|COMPLETED|Overall Study||10
10457058|NCT01008969|11604796|FG000|NOT COMPLETED|Overall Study||0
10457059|NCT01008995|11604802|FG000|STARTED|Controlled Period||162
10457060|NCT01008995|11604803|FG001|STARTED|Controlled Period||160
10457061|NCT01008995|11604804|FG002|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
10457062|NCT01008995|11604805|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
10609661|NCT01898195|11767399|FG002|COMPLETED|Smoking Abstinence||15
10609662|NCT01898195|11767397|FG000|NOT COMPLETED|Smoking Abstinence||35
10609663|NCT01898195|11767398|FG001|NOT COMPLETED|Smoking Abstinence||38
10609664|NCT01898195|11767399|FG002|NOT COMPLETED|Smoking Abstinence||36
10609665|NCT01898208|11767410|FG000|STARTED|Overall Study||247
10609666|NCT01898208|11767411|FG001|STARTED|Overall Study||247
10609667|NCT01898208|11767412|FG002|STARTED|Overall Study||249
10609668|NCT01898208|11767410|FG000|COMPLETED|Overall Study||207
10609669|NCT01898208|11767411|FG001|COMPLETED|Overall Study||198
10609670|NCT01898208|11767412|FG002|COMPLETED|Overall Study||212
10609671|NCT01898208|11767410|FG000|NOT COMPLETED|Overall Study||40
10609672|NCT01898208|11767411|FG001|NOT COMPLETED|Overall Study||49
10609673|NCT01898208|11767412|FG002|NOT COMPLETED|Overall Study||37
10704532|NCT02592876|11868898|FG001|Received Study Drug|Overall Study||40
10704533|NCT02592876|11868897|FG000|Completed Treatment|Overall Study||34
10704534|NCT02592876|11868898|FG001|Completed Treatment|Overall Study||32
10704535|NCT02592876|11868897|FG000|COMPLETED|Overall Study||0
10704536|NCT02592876|11868898|FG001|COMPLETED|Overall Study||0
10704537|NCT02592876|11868897|FG000|NOT COMPLETED|Overall Study||41
10808776|NCT03837028|11970756|FG003|STARTED|Overall Study||25
10808777|NCT03837028|11970753|FG000|COMPLETED|Overall Study||19
10808778|NCT03837028|11970754|FG001|COMPLETED|Overall Study||23
10808779|NCT03837028|11970755|FG002|COMPLETED|Overall Study||20
10808780|NCT03837028|11970756|FG003|COMPLETED|Overall Study||18
10609674|NCT01898286|11767420|FG000|STARTED|Overall Study||38
10609675|NCT01898286|11767420|FG000|COMPLETED|Overall Study|"For this study completed is defined as completing the Early Termination visit"|35
10609676|NCT01898286|11767420|FG000|NOT COMPLETED|Overall Study||3
10609677|NCT01898299|11767426|FG000|STARTED|Post Treatment (One Week)||47
10609678|NCT01898299|11767427|FG001|STARTED|Post Treatment (One Week)||42
10609679|NCT01898299|11767426|FG000|COMPLETED|Post Treatment (One Week)||47
10609680|NCT01898299|11767427|FG001|COMPLETED|Post Treatment (One Week)||42
10609681|NCT01898299|11767426|FG000|NOT COMPLETED|Post Treatment (One Week)||0
10609682|NCT01898299|11767427|FG001|NOT COMPLETED|Post Treatment (One Week)||0
10609683|NCT01898299|11767426|FG000|STARTED|Post Treatment (One Month)||47
10609684|NCT01898299|11767427|FG001|STARTED|Post Treatment (One Month)||42
10609685|NCT01898299|11767426|FG000|COMPLETED|Post Treatment (One Month)||44
10609686|NCT01898299|11767427|FG001|COMPLETED|Post Treatment (One Month)||38
10609687|NCT01898299|11767426|FG000|NOT COMPLETED|Post Treatment (One Month)||3
10609688|NCT01898299|11767427|FG001|NOT COMPLETED|Post Treatment (One Month)||4
10609689|NCT01898403|11767433|FG000|STARTED|Overall Study||50
10609690|NCT01898403|11767433|FG000|COMPLETED|Overall Study||50
10609691|NCT01898403|11767433|FG000|NOT COMPLETED|Overall Study||0
10609692|NCT01898429|11767439|FG000|STARTED|Phase 1||5
10609693|NCT01898429|11767440|FG001|STARTED|Phase 1||0
10609694|NCT01898429|11767441|FG002|STARTED|Phase 1||0
10609695|NCT01898429|11767439|FG000|COMPLETED|Phase 1||5
10609696|NCT01898429|11767440|FG001|COMPLETED|Phase 1||0
10609697|NCT01898429|11767441|FG002|COMPLETED|Phase 1||0
10609698|NCT01898429|11767439|FG000|NOT COMPLETED|Phase 1||0
10609699|NCT01898429|11767440|FG001|NOT COMPLETED|Phase 1||0
10609700|NCT01898429|11767441|FG002|NOT COMPLETED|Phase 1||0
10609701|NCT01898429|11767439|FG000|STARTED|Phase 2||0
10609702|NCT01898429|11767440|FG001|STARTED|Phase 2||5
10609703|NCT01898429|11767441|FG002|STARTED|Phase 2||0
10609704|NCT01898429|11767439|FG000|COMPLETED|Phase 2||0
10609705|NCT01898429|11767440|FG001|COMPLETED|Phase 2||5
10609706|NCT01898429|11767441|FG002|COMPLETED|Phase 2||0
10609707|NCT01898429|11767439|FG000|NOT COMPLETED|Phase 2||0
10609708|NCT01898429|11767440|FG001|NOT COMPLETED|Phase 2||0
10609709|NCT01898429|11767441|FG002|NOT COMPLETED|Phase 2||0
10609710|NCT01898429|11767439|FG000|STARTED|Phase 3||0
10609711|NCT01898429|11767440|FG001|STARTED|Phase 3||0
10704538|NCT02592876|11868898|FG001|NOT COMPLETED|Overall Study||40
10704539|NCT02593006|11868907|FG000|STARTED|Overall Study||257
10704540|NCT02593006|11868908|FG001|STARTED|Overall Study||100
10808781|NCT03837028|11970753|FG000|NOT COMPLETED|Overall Study||16
10808782|NCT03837028|11970754|FG001|NOT COMPLETED|Overall Study||11
10808783|NCT03837028|11970755|FG002|NOT COMPLETED|Overall Study||13
10808784|NCT03837028|11970756|FG003|NOT COMPLETED|Overall Study||7
10808785|NCT03825939|11970769|FG000|STARTED|Overall Study||18
10808786|NCT03825939|11970770|FG001|STARTED|Overall Study||20
10609712|NCT01898429|11767441|FG002|STARTED|Phase 3||5
10609713|NCT01898429|11767439|FG000|COMPLETED|Phase 3||0
10609714|NCT01898429|11767440|FG001|COMPLETED|Phase 3||0
10609715|NCT01898429|11767441|FG002|COMPLETED|Phase 3||5
10609716|NCT01898429|11767439|FG000|NOT COMPLETED|Phase 3||0
10609717|NCT01898429|11767440|FG001|NOT COMPLETED|Phase 3||0
10609718|NCT01898429|11767441|FG002|NOT COMPLETED|Phase 3||0
10609719|NCT01898442|11767448|FG000|STARTED|Overall Study||17
10609720|NCT01898442|11767449|FG001|STARTED|Overall Study||17
10609721|NCT01898442|11767450|FG002|STARTED|Overall Study||18
10609722|NCT01898442|11767448|FG000|COMPLETED|Overall Study||16
10609723|NCT01898442|11767449|FG001|COMPLETED|Overall Study||15
10609724|NCT01898442|11767450|FG002|COMPLETED|Overall Study||15
10609725|NCT01898442|11767448|FG000|NOT COMPLETED|Overall Study||1
10609726|NCT01898442|11767449|FG001|NOT COMPLETED|Overall Study||2
10609727|NCT01898442|11767450|FG002|NOT COMPLETED|Overall Study||3
10609728|NCT01898598|11767460|FG000|STARTED|Overall Study||12
10609729|NCT01898598|11767461|FG001|STARTED|Overall Study||6
10609730|NCT01898598|11767460|FG000|Treated|Overall Study||11
10609731|NCT01898598|11767461|FG001|Treated|Overall Study||5
10609732|NCT01898598|11767460|FG000|COMPLETED|Overall Study||8
10609733|NCT01898598|11767461|FG001|COMPLETED|Overall Study||4
10609734|NCT01898598|11767460|FG000|NOT COMPLETED|Overall Study||4
10609735|NCT01898598|11767461|FG001|NOT COMPLETED|Overall Study||2
10609736|NCT01898611|11767469|FG000|STARTED|Overall Study||5
10609737|NCT01898611|11767470|FG001|STARTED|Overall Study||11
10609738|NCT01898611|11767469|FG000|COMPLETED|Overall Study||5
10609739|NCT01898611|11767470|FG001|COMPLETED|Overall Study||10
10609740|NCT01898611|11767469|FG000|NOT COMPLETED|Overall Study||0
10609741|NCT01898611|11767470|FG001|NOT COMPLETED|Overall Study||1
10609742|NCT01898689|11767478|FG000|STARTED|Overall Study||10
10609743|NCT01898689|11767479|FG001|STARTED|Overall Study||14
10609744|NCT01898689|11767478|FG000|COMPLETED|Overall Study||10
10609745|NCT01898689|11767479|FG001|COMPLETED|Overall Study||14
10609746|NCT01898689|11767478|FG000|NOT COMPLETED|Overall Study||0
10609747|NCT01898689|11767479|FG001|NOT COMPLETED|Overall Study||0
10609748|NCT01898754|11767489|FG000|STARTED|Overall Study||494
10609749|NCT01898754|11767490|FG001|STARTED|Overall Study||497
10609750|NCT01898754|11767489|FG000|COMPLETED|Overall Study||400
10609751|NCT01898754|11767490|FG001|COMPLETED|Overall Study||403
10609752|NCT01898754|11767489|FG000|NOT COMPLETED|Overall Study||94
10609753|NCT01898754|11767490|FG001|NOT COMPLETED|Overall Study||94
10609754|NCT01898806|11767496|FG000|STARTED|Overall Study||11
10609755|NCT01898806|11767496|FG000|COMPLETED|Overall Study||8
10609756|NCT01898806|11767496|FG000|NOT COMPLETED|Overall Study||3
10609757|NCT01898884|11767505|FG000|STARTED|Single Dose Period||8
10609758|NCT01898884|11767506|FG001|STARTED|Single Dose Period||6
10609759|NCT01898884|11767507|FG002|STARTED|Single Dose Period||6
10609760|NCT01898884|11767508|FG003|STARTED|Single Dose Period||6
10609761|NCT01898884|11767509|FG004|STARTED|Single Dose Period||6
10609762|NCT01898884|11767510|FG005|STARTED|Single Dose Period||0
10609763|NCT01898884|11767511|FG006|STARTED|Single Dose Period||0
10609764|NCT01898884|11767512|FG007|STARTED|Single Dose Period||0
10609765|NCT01898884|11767513|FG008|STARTED|Single Dose Period||0
10609766|NCT01898884|11767505|FG000|COMPLETED|Single Dose Period||8
10609767|NCT01898884|11767506|FG001|COMPLETED|Single Dose Period||6
10609768|NCT01898884|11767507|FG002|COMPLETED|Single Dose Period||6
10609769|NCT01898884|11767508|FG003|COMPLETED|Single Dose Period||6
10609770|NCT01898884|11767509|FG004|COMPLETED|Single Dose Period||6
10609771|NCT01898884|11767510|FG005|COMPLETED|Single Dose Period||0
10609772|NCT01898884|11767511|FG006|COMPLETED|Single Dose Period||0
10609773|NCT01898884|11767512|FG007|COMPLETED|Single Dose Period||0
10609774|NCT01898884|11767513|FG008|COMPLETED|Single Dose Period||0
10609775|NCT01898884|11767505|FG000|NOT COMPLETED|Single Dose Period||0
10609776|NCT01898884|11767506|FG001|NOT COMPLETED|Single Dose Period||0
10609777|NCT01898884|11767507|FG002|NOT COMPLETED|Single Dose Period||0
10609778|NCT01898884|11767508|FG003|NOT COMPLETED|Single Dose Period||0
10609779|NCT01898884|11767509|FG004|NOT COMPLETED|Single Dose Period||0
10609780|NCT01898884|11767510|FG005|NOT COMPLETED|Single Dose Period||0
10609781|NCT01898884|11767511|FG006|NOT COMPLETED|Single Dose Period||0
10609782|NCT01898884|11767512|FG007|NOT COMPLETED|Single Dose Period||0
10609783|NCT01898884|11767513|FG008|NOT COMPLETED|Single Dose Period||0
10609784|NCT01898884|11767505|FG000|STARTED|Multiple Dose Period||0
10609785|NCT01898884|11767506|FG001|STARTED|Multiple Dose Period||0
10609786|NCT01898884|11767507|FG002|STARTED|Multiple Dose Period||0
10609787|NCT01898884|11767508|FG003|STARTED|Multiple Dose Period||0
10609788|NCT01898884|11767509|FG004|STARTED|Multiple Dose Period||0
10609789|NCT01898884|11767510|FG005|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
10609790|NCT01898884|11767511|FG006|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
10609791|NCT01898884|11767512|FG007|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
10609792|NCT01898884|11767513|FG008|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
10609793|NCT01898884|11767505|FG000|Treated|Multiple Dose Period||0
10609794|NCT01898884|11767506|FG001|Treated|Multiple Dose Period||0
10609795|NCT01898884|11767507|FG002|Treated|Multiple Dose Period||0
10609796|NCT01898884|11767508|FG003|Treated|Multiple Dose Period||0
10609797|NCT01898884|11767509|FG004|Treated|Multiple Dose Period||0
10609798|NCT01898884|11767510|FG005|Treated|Multiple Dose Period||6
10609799|NCT01898884|11767511|FG006|Treated|Multiple Dose Period||6
10609800|NCT01898884|11767512|FG007|Treated|Multiple Dose Period||6
10609801|NCT01898884|11767513|FG008|Treated|Multiple Dose Period||5
10609802|NCT01898884|11767505|FG000|COMPLETED|Multiple Dose Period||0
10609803|NCT01898884|11767506|FG001|COMPLETED|Multiple Dose Period||0
10609804|NCT01898884|11767507|FG002|COMPLETED|Multiple Dose Period||0
10609805|NCT01898884|11767508|FG003|COMPLETED|Multiple Dose Period||0
10609806|NCT01898884|11767509|FG004|COMPLETED|Multiple Dose Period||0
10609807|NCT01898884|11767510|FG005|COMPLETED|Multiple Dose Period||6
10609808|NCT01898884|11767511|FG006|COMPLETED|Multiple Dose Period||5
10609809|NCT01898884|11767512|FG007|COMPLETED|Multiple Dose Period||6
10609810|NCT01898884|11767513|FG008|COMPLETED|Multiple Dose Period||5
10609811|NCT01898884|11767505|FG000|NOT COMPLETED|Multiple Dose Period||0
10609812|NCT01898884|11767506|FG001|NOT COMPLETED|Multiple Dose Period||0
10609813|NCT01898884|11767507|FG002|NOT COMPLETED|Multiple Dose Period||0
10609814|NCT01898884|11767508|FG003|NOT COMPLETED|Multiple Dose Period||0
10609815|NCT01898884|11767509|FG004|NOT COMPLETED|Multiple Dose Period||0
10609816|NCT01898884|11767510|FG005|NOT COMPLETED|Multiple Dose Period||0
10609817|NCT01898884|11767511|FG006|NOT COMPLETED|Multiple Dose Period||1
10609818|NCT01898884|11767512|FG007|NOT COMPLETED|Multiple Dose Period||0
10609819|NCT01898884|11767513|FG008|NOT COMPLETED|Multiple Dose Period||1
10609820|NCT01898923|11767551|FG000|STARTED|Overall Study||122
10609821|NCT01898923|11767552|FG001|STARTED|Overall Study||114
10609822|NCT01898923|11767551|FG000|COMPLETED|Overall Study||106
10609823|NCT01898923|11767552|FG001|COMPLETED|Overall Study||93
10609824|NCT01898923|11767551|FG000|NOT COMPLETED|Overall Study||16
10609825|NCT01898923|11767552|FG001|NOT COMPLETED|Overall Study||21
10609826|NCT01899053|11767572|FG000|STARTED|Overall Study||7
10609827|NCT01899053|11767573|FG001|STARTED|Overall Study||3
10609828|NCT01899053|11767574|FG002|STARTED|Overall Study||7
10609829|NCT01899053|11767575|FG003|STARTED|Overall Study||3
10609830|NCT01899053|11767576|FG004|STARTED|Overall Study||6
10609831|NCT01899053|11767577|FG005|STARTED|Overall Study||3
10609832|NCT01899053|11767578|FG006|STARTED|Overall Study||3
10609833|NCT01899053|11767579|FG007|STARTED|Overall Study||3
10609834|NCT01899053|11767580|FG008|STARTED|Overall Study||6
10609835|NCT01899053|11767581|FG009|STARTED|Overall Study||3
10609836|NCT01899053|11767582|FG010|STARTED|Overall Study||16
10609837|NCT01899053|11767583|FG011|STARTED|Overall Study||7
10609838|NCT01899053|11767584|FG012|STARTED|Overall Study||14
10609839|NCT01899053|11767585|FG013|STARTED|Overall Study||20
10609840|NCT01899053|11767572|FG000|COMPLETED|Overall Study||0
10609841|NCT01899053|11767573|FG001|COMPLETED|Overall Study||0
10609842|NCT01899053|11767574|FG002|COMPLETED|Overall Study||0
10609843|NCT01899053|11767575|FG003|COMPLETED|Overall Study||0
10609844|NCT01899053|11767576|FG004|COMPLETED|Overall Study||0
10609845|NCT01899053|11767577|FG005|COMPLETED|Overall Study||0
10609846|NCT01899053|11767578|FG006|COMPLETED|Overall Study||0
10609847|NCT01899053|11767579|FG007|COMPLETED|Overall Study||0
10609848|NCT01899053|11767580|FG008|COMPLETED|Overall Study||0
10609849|NCT01899053|11767581|FG009|COMPLETED|Overall Study||0
10609850|NCT01899053|11767582|FG010|COMPLETED|Overall Study||0
10609851|NCT01899053|11767583|FG011|COMPLETED|Overall Study||0
10609852|NCT01899053|11767584|FG012|COMPLETED|Overall Study||0
10609853|NCT01899053|11767585|FG013|COMPLETED|Overall Study||0
10609854|NCT01899053|11767572|FG000|NOT COMPLETED|Overall Study||7
10609855|NCT01899053|11767573|FG001|NOT COMPLETED|Overall Study||3
10609856|NCT01899053|11767574|FG002|NOT COMPLETED|Overall Study||7
10609857|NCT01899053|11767575|FG003|NOT COMPLETED|Overall Study||3
10609858|NCT01899053|11767576|FG004|NOT COMPLETED|Overall Study||6
10609859|NCT01899053|11767577|FG005|NOT COMPLETED|Overall Study||3
10609860|NCT01899053|11767578|FG006|NOT COMPLETED|Overall Study||3
10609861|NCT01899053|11767579|FG007|NOT COMPLETED|Overall Study||3
10609862|NCT01899053|11767580|FG008|NOT COMPLETED|Overall Study||6
10609863|NCT01899053|11767581|FG009|NOT COMPLETED|Overall Study||3
10609864|NCT01899053|11767582|FG010|NOT COMPLETED|Overall Study||16
10704541|NCT02593006|11868909|FG002|STARTED|Overall Study||43
10704542|NCT02593006|11868907|FG000|COMPLETED|Overall Study||250
10704543|NCT02593006|11868908|FG001|COMPLETED|Overall Study||93
10704544|NCT02593006|11868909|FG002|COMPLETED|Overall Study||38
10704545|NCT02593006|11868907|FG000|NOT COMPLETED|Overall Study||7
10609865|NCT01899053|11767583|FG011|NOT COMPLETED|Overall Study||7
10609866|NCT01899053|11767584|FG012|NOT COMPLETED|Overall Study||14
10609867|NCT01899053|11767585|FG013|NOT COMPLETED|Overall Study||20
10609868|NCT01899300|11767617|FG000|STARTED|Overall Study||1
10609869|NCT01899300|11767618|FG001|STARTED|Overall Study||0
10609870|NCT01899300|11767617|FG000|COMPLETED|Overall Study||1
10609871|NCT01899300|11767618|FG001|COMPLETED|Overall Study||0
10609872|NCT01899300|11767617|FG000|NOT COMPLETED|Overall Study||0
10609873|NCT01899300|11767618|FG001|NOT COMPLETED|Overall Study||0
10609874|NCT01899677|11767626|FG000|STARTED|Overall Study||35
10609875|NCT01899677|11767627|FG001|STARTED|Overall Study||35
10609876|NCT01899677|11767626|FG000|COMPLETED|Overall Study||25
10609877|NCT01899677|11767627|FG001|COMPLETED|Overall Study||28
10609878|NCT01899677|11767626|FG000|NOT COMPLETED|Overall Study||10
10609879|NCT01899677|11767627|FG001|NOT COMPLETED|Overall Study||7
10704546|NCT02593006|11868908|FG001|NOT COMPLETED|Overall Study||7
10704547|NCT02593006|11868909|FG002|NOT COMPLETED|Overall Study||5
10609880|NCT01899742|11767635|FG000|STARTED|Overall Study||247
10609881|NCT01899742|11767636|FG001|STARTED|Overall Study||247
10609882|NCT01899742|11767635|FG000|COMPLETED|Overall Study||230
10609883|NCT01899742|11767636|FG001|COMPLETED|Overall Study||231
10609884|NCT01899742|11767635|FG000|NOT COMPLETED|Overall Study||17
10609885|NCT01899742|11767636|FG001|NOT COMPLETED|Overall Study||16
10609886|NCT01899768|11767642|FG000|STARTED|Part A||16
10609887|NCT01899768|11767642|FG000|COMPLETED|Part A||13
10609888|NCT01899768|11767642|FG000|NOT COMPLETED|Part A||3
10609889|NCT01899768|11767642|FG000|STARTED|Part B||13
10609890|NCT01899768|11767642|FG000|COMPLETED|Part B||11
10609891|NCT01899768|11767642|FG000|NOT COMPLETED|Part B||2
10609892|NCT01899768|11767642|FG000|STARTED|Part C||11
10609893|NCT01899768|11767642|FG000|COMPLETED|Part C||11
10609894|NCT01899768|11767642|FG000|NOT COMPLETED|Part C||0
10609895|NCT01899911|11767650|FG000|STARTED|Overall Study||12
10609896|NCT01899911|11767650|FG000|COMPLETED|Overall Study||12
10609897|NCT01899911|11767650|FG000|NOT COMPLETED|Overall Study||0
10609898|NCT01900054|11767654|FG000|STARTED|Overall Study||58
10609899|NCT01900054|11767654|FG000|COMPLETED|Overall Study||56
10609900|NCT01900054|11767654|FG000|NOT COMPLETED|Overall Study||2
10609901|NCT01900067|11767660|FG000|STARTED|Overall Study||134
10609902|NCT01900067|11767661|FG001|STARTED|Overall Study||137
10609903|NCT01900067|11767660|FG000|COMPLETED|Overall Study||122
10609904|NCT01900067|11767661|FG001|COMPLETED|Overall Study||124
10609905|NCT01900067|11767660|FG000|NOT COMPLETED|Overall Study||12
10609906|NCT01900067|11767661|FG001|NOT COMPLETED|Overall Study||13
10609907|NCT01900249|11767670|FG000|STARTED|Overall Study||67
10609908|NCT01900249|11767671|FG001|STARTED|Overall Study||68
10609909|NCT01900249|11767672|FG002|STARTED|Overall Study||69
10609910|NCT01900249|11767670|FG000|COMPLETED|Overall Study||64
10609911|NCT01900249|11767671|FG001|COMPLETED|Overall Study||63
10609912|NCT01900249|11767672|FG002|COMPLETED|Overall Study||65
10609913|NCT01900249|11767670|FG000|NOT COMPLETED|Overall Study||3
10609914|NCT01900249|11767671|FG001|NOT COMPLETED|Overall Study||5
10609915|NCT01900249|11767672|FG002|NOT COMPLETED|Overall Study||4
10609916|NCT01900314|11767682|FG000|STARTED|Overall Study||20
10609917|NCT01900314|11767683|FG001|STARTED|Overall Study||20
10609918|NCT01900314|11767682|FG000|Completed MRI#1|Overall Study|2 withdrew consent prior to MRI, 1 had MRI technical failure|17
10609919|NCT01900314|11767683|FG001|Completed MRI#1|Overall Study|2 withdrew consent, 1 patient was unable to tolerate MRI|17
10609920|NCT01900314|11767682|FG000|COMPLETED|Overall Study|1 patient had MRI, then moved away after 5 TMS treatments|16
10609998|NCT01900899|11767767|FG001|STARTED|Overall Study||25
10609921|NCT01900314|11767683|FG001|COMPLETED|Overall Study|1 patient had 4 TMS Tx, but missed too many for protocol requirements,|16
10609922|NCT01900314|11767682|FG000|NOT COMPLETED|Overall Study||4
10609923|NCT01900314|11767683|FG001|NOT COMPLETED|Overall Study||4
10609924|NCT01900392|11767693|FG000|STARTED|Overall Study||39
10609925|NCT01900392|11767694|FG001|STARTED|Overall Study||75
10609926|NCT01900392|11767695|FG002|STARTED|Overall Study||77
10609927|NCT01900392|11767693|FG000|COMPLETED|Overall Study||38
10609928|NCT01900392|11767694|FG001|COMPLETED|Overall Study||74
10609929|NCT01900392|11767695|FG002|COMPLETED|Overall Study||77
10609930|NCT01900392|11767693|FG000|NOT COMPLETED|Overall Study||1
10609931|NCT01900392|11767694|FG001|NOT COMPLETED|Overall Study||1
10609932|NCT01900392|11767695|FG002|NOT COMPLETED|Overall Study||0
10609933|NCT01900431|11767705|FG000|STARTED|Principal Treatment Period (Part A)||20
10609934|NCT01900431|11767706|FG001|STARTED|Principal Treatment Period (Part A)||38
10609935|NCT01900431|11767707|FG002|STARTED|Principal Treatment Period (Part A)||0
10653116|NCT02190604|11813570|FG014|COMPLETED|Part 1 and 2 (Healthy Volunteers)||8
10609936|NCT01900431|11767705|FG000|COMPLETED|Principal Treatment Period (Part A)|8 responders entered Part B and 5 non-responders entered Part C.|13
10609937|NCT01900431|11767706|FG001|COMPLETED|Principal Treatment Period (Part A)|22 responders entered Part B, 5 non-responders entered Part C, 1 discontinued the study.|28
10609938|NCT01900431|11767707|FG002|COMPLETED|Principal Treatment Period (Part A)||0
10609939|NCT01900431|11767705|FG000|NOT COMPLETED|Principal Treatment Period (Part A)||7
10609940|NCT01900431|11767706|FG001|NOT COMPLETED|Principal Treatment Period (Part A)||10
10609941|NCT01900431|11767707|FG002|NOT COMPLETED|Principal Treatment Period (Part A)||0
10609942|NCT01900431|11767705|FG000|STARTED|Extended Treatment Period (Part B)||8
10609943|NCT01900431|11767706|FG001|STARTED|Extended Treatment Period (Part B)||22
10609944|NCT01900431|11767707|FG002|STARTED|Extended Treatment Period (Part B)||0
10609945|NCT01900431|11767705|FG000|COMPLETED|Extended Treatment Period (Part B)||7
10609946|NCT01900431|11767706|FG001|COMPLETED|Extended Treatment Period (Part B)||12
10609947|NCT01900431|11767707|FG002|COMPLETED|Extended Treatment Period (Part B)||0
10609948|NCT01900431|11767705|FG000|NOT COMPLETED|Extended Treatment Period (Part B)||1
10609949|NCT01900431|11767706|FG001|NOT COMPLETED|Extended Treatment Period (Part B)||10
10609950|NCT01900431|11767707|FG002|NOT COMPLETED|Extended Treatment Period (Part B)||0
10609951|NCT01900431|11767705|FG000|STARTED|Open-Label Treatment Period (Part C)||0
10609952|NCT01900431|11767706|FG001|STARTED|Open-Label Treatment Period (Part C)||0
10609953|NCT01900431|11767707|FG002|STARTED|Open-Label Treatment Period (Part C)|10 non-responders (5 Placebo, 5 Sarilumab) & 11 non-completers (6 Placebo, 5 Sarilumab) from Part A.|21
10609954|NCT01900431|11767705|FG000|COMPLETED|Open-Label Treatment Period (Part C)||0
10609955|NCT01900431|11767706|FG001|COMPLETED|Open-Label Treatment Period (Part C)||0
10609956|NCT01900431|11767707|FG002|COMPLETED|Open-Label Treatment Period (Part C)||13
10609957|NCT01900431|11767705|FG000|NOT COMPLETED|Open-Label Treatment Period (Part C)||0
10609958|NCT01900431|11767706|FG001|NOT COMPLETED|Open-Label Treatment Period (Part C)||0
10609959|NCT01900431|11767707|FG002|NOT COMPLETED|Open-Label Treatment Period (Part C)||8
10609960|NCT01900561|11767717|FG000|STARTED|Overall Study||278
10609961|NCT01900561|11767718|FG001|STARTED|Overall Study||278
10609962|NCT01900561|11767717|FG000|COMPLETED|Overall Study||261
10609963|NCT01900561|11767718|FG001|COMPLETED|Overall Study||269
10609964|NCT01900561|11767717|FG000|NOT COMPLETED|Overall Study||17
10609965|NCT01900561|11767718|FG001|NOT COMPLETED|Overall Study||9
10609966|NCT01900652|11767726|FG000|STARTED|Overall Study||83
10609967|NCT01900652|11767727|FG001|STARTED|Overall Study||28
10609968|NCT01900652|11767726|FG000|Post-Erlotinib Progression Tumor Sample|Overall Study||66
10609969|NCT01900652|11767727|FG001|Post-Erlotinib Progression Tumor Sample|Overall Study||23
10609970|NCT01900652|11767726|FG000|COMPLETED|Overall Study||75
10609971|NCT01900652|11767727|FG001|COMPLETED|Overall Study||25
10609972|NCT01900652|11767726|FG000|NOT COMPLETED|Overall Study||8
10609973|NCT01900652|11767727|FG001|NOT COMPLETED|Overall Study||3
10609974|NCT01900665|11767740|FG000|STARTED|Placebo Controlled Period||1057
10609975|NCT01900665|11767741|FG001|STARTED|Placebo Controlled Period||1072
10609976|NCT01900665|11767740|FG000|Received at Least 1 Dose of Study Drug|Placebo Controlled Period||1054
10609977|NCT01900665|11767741|FG001|Received at Least 1 Dose of Study Drug|Placebo Controlled Period||1067
10609978|NCT01900665|11767740|FG000|COMPLETED|Placebo Controlled Period||914
10609979|NCT01900665|11767741|FG001|COMPLETED|Placebo Controlled Period||908
10609980|NCT01900665|11767740|FG000|NOT COMPLETED|Placebo Controlled Period||143
10609981|NCT01900665|11767741|FG001|NOT COMPLETED|Placebo Controlled Period||164
10609982|NCT01900665|11767740|FG000|STARTED|Open Label Period|Patients from Placebo Controlled Period were not required to enter into Open Label Period.|881
10609983|NCT01900665|11767741|FG001|STARTED|Open Label Period|Patients from Placebo Controlled Period were not required to enter into Open Label Period.|859
10609984|NCT01900665|11767740|FG000|COMPLETED|Open Label Period||0
10609985|NCT01900665|11767741|FG001|COMPLETED|Open Label Period||0
10609986|NCT01900665|11767740|FG000|NOT COMPLETED|Open Label Period||881
10609987|NCT01900665|11767741|FG001|NOT COMPLETED|Open Label Period||859
10609988|NCT01900704|11767753|FG000|STARTED|Overall Study||270
10609989|NCT01900704|11767754|FG001|STARTED|Overall Study||270
10609990|NCT01900704|11767755|FG002|STARTED|Overall Study||270
10609991|NCT01900704|11767753|FG000|COMPLETED|Overall Study||229
10609992|NCT01900704|11767754|FG001|COMPLETED|Overall Study||235
10609993|NCT01900704|11767755|FG002|COMPLETED|Overall Study||237
10609994|NCT01900704|11767753|FG000|NOT COMPLETED|Overall Study||41
10609995|NCT01900704|11767754|FG001|NOT COMPLETED|Overall Study||35
10609996|NCT01900704|11767755|FG002|NOT COMPLETED|Overall Study||33
10609997|NCT01900899|11767766|FG000|STARTED|Overall Study||159
10609999|NCT01900899|11767766|FG000|COMPLETED|Overall Study||150
10610000|NCT01900899|11767767|FG001|COMPLETED|Overall Study||24
10610001|NCT01900899|11767766|FG000|NOT COMPLETED|Overall Study||9
10610002|NCT01900899|11767767|FG001|NOT COMPLETED|Overall Study||1
10610003|NCT01901055|11767775|FG000|STARTED|Randomization But Not Titrated||49
10610004|NCT01901055|11767776|FG001|STARTED|Randomization But Not Titrated||49
10610005|NCT01901055|11767775|FG000|COMPLETED|Randomization But Not Titrated||48
10704548|NCT02593032|11868920|FG000|STARTED|Overall Study||17
10704549|NCT02593032|11868921|FG001|STARTED|Overall Study||33
10704550|NCT02593032|11868920|FG000|COMPLETED|Overall Study||17
10704551|NCT02593032|11868921|FG001|COMPLETED|Overall Study||33
10704552|NCT02593032|11868920|FG000|NOT COMPLETED|Overall Study||0
10704553|NCT02593032|11868921|FG001|NOT COMPLETED|Overall Study||0
10704554|NCT02593097|11868929|FG000|STARTED|First Intervention (12 Weeks)||14
10704555|NCT02593097|11868930|FG001|STARTED|First Intervention (12 Weeks)||20
10610006|NCT01901055|11767776|FG001|COMPLETED|Randomization But Not Titrated||47
10610007|NCT01901055|11767775|FG000|NOT COMPLETED|Randomization But Not Titrated||1
10610008|NCT01901055|11767776|FG001|NOT COMPLETED|Randomization But Not Titrated||2
10610009|NCT01901055|11767775|FG000|STARTED|Started Protocol to Week 6||48
10610010|NCT01901055|11767776|FG001|STARTED|Started Protocol to Week 6||47
10610011|NCT01901055|11767775|FG000|COMPLETED|Started Protocol to Week 6||45
10610012|NCT01901055|11767776|FG001|COMPLETED|Started Protocol to Week 6||43
10610013|NCT01901055|11767775|FG000|NOT COMPLETED|Started Protocol to Week 6||3
10610014|NCT01901055|11767776|FG001|NOT COMPLETED|Started Protocol to Week 6||4
10610015|NCT01901055|11767775|FG000|STARTED|Week 12 Assessment||45
10610016|NCT01901055|11767776|FG001|STARTED|Week 12 Assessment||43
10610017|NCT01901055|11767775|FG000|COMPLETED|Week 12 Assessment||44
10610018|NCT01901055|11767776|FG001|COMPLETED|Week 12 Assessment||39
10610019|NCT01901055|11767775|FG000|NOT COMPLETED|Week 12 Assessment||1
10610020|NCT01901055|11767776|FG001|NOT COMPLETED|Week 12 Assessment||4
10610021|NCT01901055|11767775|FG000|STARTED|Week 24||44
10610022|NCT01901055|11767776|FG001|STARTED|Week 24||39
10610023|NCT01901055|11767775|FG000|COMPLETED|Week 24||30
10610024|NCT01901055|11767776|FG001|COMPLETED|Week 24||20
10610025|NCT01901055|11767775|FG000|NOT COMPLETED|Week 24||14
10610026|NCT01901055|11767776|FG001|NOT COMPLETED|Week 24||19
10610027|NCT01901055|11767775|FG000|STARTED|Week 36||30
10610028|NCT01901055|11767776|FG001|STARTED|Week 36||20
10610029|NCT01901055|11767775|FG000|COMPLETED|Week 36||30
10610030|NCT01901055|11767776|FG001|COMPLETED|Week 36||15
10610031|NCT01901055|11767775|FG000|NOT COMPLETED|Week 36||0
10610032|NCT01901055|11767776|FG001|NOT COMPLETED|Week 36||5
10610033|NCT01901146|11767787|FG000|STARTED|Neoadjuvant Phase||364
10610034|NCT01901146|11767788|FG001|STARTED|Neoadjuvant Phase||361
10610035|NCT01901146|11767789|FG002|STARTED|Neoadjuvant Phase||0
10610036|NCT01901146|11767790|FG003|STARTED|Neoadjuvant Phase||0
10610037|NCT01901146|11767791|FG004|STARTED|Neoadjuvant Phase||0
10610038|NCT01901146|11767787|FG000|COMPLETED|Neoadjuvant Phase|Indicates participants who completed surgery|358
10610039|NCT01901146|11767788|FG001|COMPLETED|Neoadjuvant Phase|Indicates participants who completed surgery|347
10610040|NCT01901146|11767789|FG002|COMPLETED|Neoadjuvant Phase||0
10610041|NCT01901146|11767790|FG003|COMPLETED|Neoadjuvant Phase||0
10610042|NCT01901146|11767791|FG004|COMPLETED|Neoadjuvant Phase||0
10610043|NCT01901146|11767787|FG000|NOT COMPLETED|Neoadjuvant Phase||6
10610044|NCT01901146|11767788|FG001|NOT COMPLETED|Neoadjuvant Phase||14
10610045|NCT01901146|11767789|FG002|NOT COMPLETED|Neoadjuvant Phase||0
10610046|NCT01901146|11767790|FG003|NOT COMPLETED|Neoadjuvant Phase||0
10610047|NCT01901146|11767791|FG004|NOT COMPLETED|Neoadjuvant Phase||0
10610048|NCT01901146|11767787|FG000|STARTED|Adjuvant Phase||0
10610049|NCT01901146|11767788|FG001|STARTED|Adjuvant Phase||0
10610050|NCT01901146|11767789|FG002|STARTED|Adjuvant Phase|Nine participants discontinued the study after surgery but before entering adjuvant phase.|349
10610051|NCT01901146|11767790|FG003|STARTED|Adjuvant Phase|Two participants discontinued the study after surgery but before entering adjuvant phase.|171
10610052|NCT01901146|11767791|FG004|STARTED|Adjuvant Phase|Three participants discontinued the study after surgery but before entering adjuvant phase.|171
10610053|NCT01901146|11767787|FG000|COMPLETED|Adjuvant Phase||0
10610054|NCT01901146|11767788|FG001|COMPLETED|Adjuvant Phase||0
10610055|NCT01901146|11767789|FG002|COMPLETED|Adjuvant Phase||323
10610056|NCT01901146|11767790|FG003|COMPLETED|Adjuvant Phase||164
10610057|NCT01901146|11767791|FG004|COMPLETED|Adjuvant Phase||157
10610058|NCT01901146|11767787|FG000|NOT COMPLETED|Adjuvant Phase||0
10610059|NCT01901146|11767788|FG001|NOT COMPLETED|Adjuvant Phase||0
10610060|NCT01901146|11767789|FG002|NOT COMPLETED|Adjuvant Phase||26
10610061|NCT01901146|11767790|FG003|NOT COMPLETED|Adjuvant Phase||7
10610062|NCT01901146|11767791|FG004|NOT COMPLETED|Adjuvant Phase||14
10610063|NCT01901185|11767800|FG000|STARTED|Overall Study||77
10610064|NCT01901185|11767800|FG000|Received Etanercept With Autoinjector A|Overall Study||75
10610065|NCT01901185|11767800|FG000|COMPLETED|Overall Study||75
10610066|NCT01901185|11767800|FG000|NOT COMPLETED|Overall Study||2
10610067|NCT01901211|11767806|FG000|STARTED|First Ten-week Period||6
10610068|NCT01901211|11767807|FG001|STARTED|First Ten-week Period||5
10610069|NCT01901211|11767806|FG000|COMPLETED|First Ten-week Period||6
10610070|NCT01901211|11767807|FG001|COMPLETED|First Ten-week Period||5
10610071|NCT01901211|11767806|FG000|NOT COMPLETED|First Ten-week Period||0
10610072|NCT01901211|11767807|FG001|NOT COMPLETED|First Ten-week Period||0
10610073|NCT01901211|11767806|FG000|STARTED|Washout (6 Weeks)||6
10610074|NCT01901211|11767807|FG001|STARTED|Washout (6 Weeks)||5
10610075|NCT01901211|11767806|FG000|COMPLETED|Washout (6 Weeks)||6
10610076|NCT01901211|11767807|FG001|COMPLETED|Washout (6 Weeks)||5
10610077|NCT01901211|11767806|FG000|NOT COMPLETED|Washout (6 Weeks)||0
10610078|NCT01901211|11767807|FG001|NOT COMPLETED|Washout (6 Weeks)||0
10610079|NCT01901211|11767806|FG000|STARTED|Second Ten-week Period||6
10610080|NCT01901211|11767807|FG001|STARTED|Second Ten-week Period||5
10610081|NCT01901211|11767806|FG000|COMPLETED|Second Ten-week Period||6
10610082|NCT01901211|11767807|FG001|COMPLETED|Second Ten-week Period||5
10610083|NCT01901211|11767806|FG000|NOT COMPLETED|Second Ten-week Period||0
10610084|NCT01901211|11767807|FG001|NOT COMPLETED|Second Ten-week Period||0
10610085|NCT01901250|11767815|FG000|STARTED|Overall Study||260
10610086|NCT01901250|11767816|FG001|STARTED|Overall Study||265
10610087|NCT01901250|11767815|FG000|End of Kidergarten|Overall Study||215
10610088|NCT01901250|11767816|FG001|End of Kidergarten|Overall Study||212
10610089|NCT01901250|11767815|FG000|Start of 1st Grade|Overall Study||173
10610090|NCT01901250|11767816|FG001|Start of 1st Grade|Overall Study||176
10610091|NCT01901250|11767815|FG000|End of 1st Grade|Overall Study||143
10610092|NCT01901250|11767816|FG001|End of 1st Grade|Overall Study||151
10610093|NCT01901250|11767815|FG000|COMPLETED|Overall Study||122
10610094|NCT01901250|11767816|FG001|COMPLETED|Overall Study||139
10610095|NCT01901250|11767815|FG000|NOT COMPLETED|Overall Study||138
10610096|NCT01901250|11767816|FG001|NOT COMPLETED|Overall Study||126
10704556|NCT02593097|11868929|FG000|Received Intervention|First Intervention (12 Weeks)||14
10610097|NCT01901302|11767824|FG000|STARTED|Overall Study||31
10610098|NCT01901302|11767825|FG001|STARTED|Overall Study||30
10610099|NCT01901302|11767824|FG000|Received at Least 1 Dose of Study Drug|Overall Study||31
10610100|NCT01901302|11767825|FG001|Received at Least 1 Dose of Study Drug|Overall Study||30
10610101|NCT01901302|11767824|FG000|COMPLETED|Overall Study||4
10610102|NCT01901302|11767825|FG001|COMPLETED|Overall Study||7
10610103|NCT01901302|11767824|FG000|NOT COMPLETED|Overall Study||27
10610104|NCT01901302|11767825|FG001|NOT COMPLETED|Overall Study||23
10610105|NCT01901328|11767833|FG000|STARTED|Overall Study||26
10610106|NCT01901328|11767834|FG001|STARTED|Overall Study||23
10610107|NCT01901328|11767833|FG000|Received at Least 1 Dose of Study Drug|Overall Study||26
10610108|NCT01901328|11767834|FG001|Received at Least 1 Dose of Study Drug|Overall Study||23
10610109|NCT01901328|11767833|FG000|COMPLETED|Overall Study||4
10610110|NCT01901328|11767834|FG001|COMPLETED|Overall Study||2
10610111|NCT01901328|11767833|FG000|NOT COMPLETED|Overall Study||22
10610112|NCT01901328|11767834|FG001|NOT COMPLETED|Overall Study||21
10610113|NCT01901341|11767843|FG000|STARTED|Overall Study||22
10610114|NCT01901341|11767844|FG001|STARTED|Overall Study||22
10610115|NCT01901341|11767843|FG000|Received at Least 1 Dose of Study Drug|Overall Study||22
10610116|NCT01901341|11767844|FG001|Received at Least 1 Dose of Study Drug|Overall Study||22
10610117|NCT01901341|11767843|FG000|COMPLETED|Overall Study||2
10610118|NCT01901341|11767844|FG001|COMPLETED|Overall Study||1
10610119|NCT01901341|11767843|FG000|NOT COMPLETED|Overall Study||20
10610120|NCT01901341|11767844|FG001|NOT COMPLETED|Overall Study||21
10610121|NCT01901393|11767853|FG000|STARTED|Overall Study||51
10610122|NCT01901393|11767854|FG001|STARTED|Overall Study||49
10610123|NCT01901393|11767853|FG000|COMPLETED|Overall Study||50
10610124|NCT01901393|11767854|FG001|COMPLETED|Overall Study||49
10610125|NCT01901393|11767853|FG000|NOT COMPLETED|Overall Study||1
10610126|NCT01901393|11767854|FG001|NOT COMPLETED|Overall Study||0
10610127|NCT01901419|11767862|FG000|STARTED|Overall Study||40
10610128|NCT01901419|11767863|FG001|STARTED|Overall Study||40
10610129|NCT01901419|11767862|FG000|COMPLETED|Overall Study||32
10610130|NCT01901419|11767863|FG001|COMPLETED|Overall Study||31
10610131|NCT01901419|11767862|FG000|NOT COMPLETED|Overall Study||8
10610132|NCT01901419|11767863|FG001|NOT COMPLETED|Overall Study||9
10610133|NCT01901575|11767869|FG000|STARTED|Overall Study|enrolled patients with PVC's present prior to sedation with remifentanil IVPCA|16
10610134|NCT01901575|11767869|FG000|COMPLETED|Overall Study||16
10610135|NCT01901575|11767869|FG000|NOT COMPLETED|Overall Study||0
10610136|NCT01901588|11767876|FG000|STARTED|Overall Study||32
10610137|NCT01901588|11767877|FG001|STARTED|Overall Study||31
10610138|NCT01901588|11767876|FG000|COMPLETED|Overall Study||32
10610139|NCT01901588|11767877|FG001|COMPLETED|Overall Study||31
10610140|NCT01901588|11767876|FG000|NOT COMPLETED|Overall Study||0
10610141|NCT01901588|11767877|FG001|NOT COMPLETED|Overall Study||0
10610142|NCT01901614|11767885|FG000|STARTED|Overall Study||3
10610143|NCT01901614|11767886|FG001|STARTED|Overall Study||2
10610144|NCT01901614|11767885|FG000|COMPLETED|Overall Study||1
10610145|NCT01901614|11767886|FG001|COMPLETED|Overall Study||1
10610146|NCT01901614|11767885|FG000|NOT COMPLETED|Overall Study||2
10610147|NCT01901614|11767886|FG001|NOT COMPLETED|Overall Study||1
10610148|NCT01901653|11767905|FG000|STARTED|Overall Study||3
10610149|NCT01901653|11767906|FG001|STARTED|Overall Study||1
10610150|NCT01901653|11767907|FG002|STARTED|Overall Study||11
10610151|NCT01901653|11767908|FG003|STARTED|Overall Study||3
10610152|NCT01901653|11767909|FG004|STARTED|Overall Study||2
10610153|NCT01901653|11767910|FG005|STARTED|Overall Study||3
10610154|NCT01901653|11767911|FG006|STARTED|Overall Study||7
10610155|NCT01901653|11767912|FG007|STARTED|Overall Study||10
10610156|NCT01901653|11767913|FG008|STARTED|Overall Study||1
10610157|NCT01901653|11767914|FG009|STARTED|Overall Study||18
10610158|NCT01901653|11767915|FG010|STARTED|Overall Study||2
10610159|NCT01901653|11767916|FG011|STARTED|Overall Study||16
10610160|NCT01901653|11767917|FG012|STARTED|Overall Study||5
10610161|NCT01901653|11767905|FG000|COMPLETED|Overall Study||0
10610162|NCT01901653|11767906|FG001|COMPLETED|Overall Study||0
10610163|NCT01901653|11767907|FG002|COMPLETED|Overall Study||0
10610164|NCT01901653|11767908|FG003|COMPLETED|Overall Study||0
10704557|NCT02593097|11868930|FG001|Received Intervention|First Intervention (12 Weeks)||20
10610165|NCT01901653|11767909|FG004|COMPLETED|Overall Study||0
10610166|NCT01901653|11767910|FG005|COMPLETED|Overall Study||0
10610167|NCT01901653|11767911|FG006|COMPLETED|Overall Study||0
10610168|NCT01901653|11767912|FG007|COMPLETED|Overall Study||0
10610169|NCT01901653|11767913|FG008|COMPLETED|Overall Study||0
10610170|NCT01901653|11767914|FG009|COMPLETED|Overall Study||0
10610171|NCT01901653|11767915|FG010|COMPLETED|Overall Study||0
10610172|NCT01901653|11767916|FG011|COMPLETED|Overall Study||0
10610173|NCT01901653|11767917|FG012|COMPLETED|Overall Study||0
10610174|NCT01901653|11767905|FG000|NOT COMPLETED|Overall Study||3
10610175|NCT01901653|11767906|FG001|NOT COMPLETED|Overall Study||1
10610176|NCT01901653|11767907|FG002|NOT COMPLETED|Overall Study||11
10610177|NCT01901653|11767908|FG003|NOT COMPLETED|Overall Study||3
10610178|NCT01901653|11767909|FG004|NOT COMPLETED|Overall Study||2
10610179|NCT01901653|11767910|FG005|NOT COMPLETED|Overall Study||3
10610180|NCT01901653|11767911|FG006|NOT COMPLETED|Overall Study||7
10610181|NCT01901653|11767912|FG007|NOT COMPLETED|Overall Study||10
10610182|NCT01901653|11767913|FG008|NOT COMPLETED|Overall Study||1
10610183|NCT01901653|11767914|FG009|NOT COMPLETED|Overall Study||18
10610184|NCT01901653|11767915|FG010|NOT COMPLETED|Overall Study||2
10610185|NCT01901653|11767916|FG011|NOT COMPLETED|Overall Study||16
10610186|NCT01901653|11767917|FG012|NOT COMPLETED|Overall Study||5
10610187|NCT01901809|11767947|FG000|STARTED|Overall Study||19
10610188|NCT01901809|11767948|FG001|STARTED|Overall Study||23
10610189|NCT01901809|11767949|FG002|STARTED|Overall Study||24
10610190|NCT01901809|11767950|FG003|STARTED|Overall Study||24
10610191|NCT01901809|11767947|FG000|COMPLETED|Overall Study||19
10610192|NCT01901809|11767948|FG001|COMPLETED|Overall Study||23
10610193|NCT01901809|11767949|FG002|COMPLETED|Overall Study||21
10610194|NCT01901809|11767950|FG003|COMPLETED|Overall Study||22
10610195|NCT01901809|11767947|FG000|NOT COMPLETED|Overall Study||0
10610196|NCT01901809|11767948|FG001|NOT COMPLETED|Overall Study||0
10610197|NCT01901809|11767949|FG002|NOT COMPLETED|Overall Study||3
10610198|NCT01901809|11767950|FG003|NOT COMPLETED|Overall Study||2
10610199|NCT01901848|11767966|FG000|STARTED|Randomized and Treated||25
10610200|NCT01901848|11767967|FG001|STARTED|Randomized and Treated||25
10610201|NCT01901848|11767966|FG000|COMPLETED|Randomized and Treated|Ten cases were practice cases used to establish fidelity to CPT, and were removed from analyses.|22
10610202|NCT01901848|11767967|FG001|COMPLETED|Randomized and Treated||19
10610203|NCT01901848|11767966|FG000|NOT COMPLETED|Randomized and Treated||3
10610204|NCT01901848|11767967|FG001|NOT COMPLETED|Randomized and Treated||6
10610205|NCT01901848|11767966|FG000|STARTED|Removed From Analyses||22
10610206|NCT01901848|11767967|FG001|STARTED|Removed From Analyses||19
10610207|NCT01901848|11767966|FG000|COMPLETED|Removed From Analyses||12
10610208|NCT01901848|11767967|FG001|COMPLETED|Removed From Analyses||19
10610209|NCT01901848|11767966|FG000|NOT COMPLETED|Removed From Analyses||10
10610210|NCT01901848|11767967|FG001|NOT COMPLETED|Removed From Analyses||0
10610211|NCT01901874|11767973|FG000|STARTED|Procedure||312
10610212|NCT01901874|11767973|FG000|COMPLETED|Procedure||312
10610213|NCT01901874|11767973|FG000|NOT COMPLETED|Procedure||0
10610214|NCT01901874|11767973|FG000|STARTED|Screening Committee Retrospective Review||312
10610215|NCT01901874|11767973|FG000|COMPLETED|Screening Committee Retrospective Review||265
10610216|NCT01901874|11767973|FG000|NOT COMPLETED|Screening Committee Retrospective Review||47
10610217|NCT01901874|11767973|FG000|STARTED|30-Day MAE Evaluation||265
10610218|NCT01901874|11767973|FG000|COMPLETED|30-Day MAE Evaluation||264
10610219|NCT01901874|11767973|FG000|NOT COMPLETED|30-Day MAE Evaluation||1
10610220|NCT01901874|11767973|FG000|STARTED|1-Year (365-Day) MAE Evaluation||264
10610221|NCT01901874|11767973|FG000|COMPLETED|1-Year (365-Day) MAE Evaluation||244
10610222|NCT01901874|11767973|FG000|NOT COMPLETED|1-Year (365-Day) MAE Evaluation||20
10610223|NCT01902004|11767979|FG000|STARTED|Overall Study||48
10610224|NCT01902004|11767980|FG001|STARTED|Overall Study||47
10610225|NCT01902004|11767979|FG000|COMPLETED|Overall Study||33
10610226|NCT01902004|11767980|FG001|COMPLETED|Overall Study||29
10610227|NCT01902004|11767979|FG000|NOT COMPLETED|Overall Study||15
10610228|NCT01902004|11767980|FG001|NOT COMPLETED|Overall Study||18
10610229|NCT01902134|11767992|FG000|STARTED|Overall Study||159
10610230|NCT01902134|11767993|FG001|STARTED|Overall Study||161
10610231|NCT01902134|11767994|FG002|STARTED|Overall Study||160
10610232|NCT01902134|11767995|FG003|STARTED|Overall Study||54
10610233|NCT01902134|11767996|FG004|STARTED|Overall Study||53
10610234|NCT01902134|11767997|FG005|STARTED|Overall Study||54
10610235|NCT01902134|11767992|FG000|Single-dose Phase|Overall Study||159
10610236|NCT01902134|11767993|FG001|Single-dose Phase|Overall Study||161
10610237|NCT01902134|11767994|FG002|Single-dose Phase|Overall Study||160
10610238|NCT01902134|11767995|FG003|Single-dose Phase|Overall Study||54
10610239|NCT01902134|11767996|FG004|Single-dose Phase|Overall Study||53
10610240|NCT01902134|11767997|FG005|Single-dose Phase|Overall Study||54
10610241|NCT01902134|11767992|FG000|Multiple-dose Phase|Overall Study||159
10610242|NCT01902134|11767993|FG001|Multiple-dose Phase|Overall Study||160
10610243|NCT01902134|11767994|FG002|Multiple-dose Phase|Overall Study||160
10610244|NCT01902134|11767995|FG003|Multiple-dose Phase|Overall Study||54
10610245|NCT01902134|11767996|FG004|Multiple-dose Phase|Overall Study||53
10610246|NCT01902134|11767997|FG005|Multiple-dose Phase|Overall Study||52
10610247|NCT01902134|11767992|FG000|COMPLETED|Overall Study||151
10610248|NCT01902134|11767993|FG001|COMPLETED|Overall Study||150
10610249|NCT01902134|11767994|FG002|COMPLETED|Overall Study||145
10610250|NCT01902134|11767995|FG003|COMPLETED|Overall Study||52
10610251|NCT01902134|11767996|FG004|COMPLETED|Overall Study||46
10610252|NCT01902134|11767997|FG005|COMPLETED|Overall Study||45
10610253|NCT01902134|11767992|FG000|NOT COMPLETED|Overall Study||8
10610254|NCT01902134|11767993|FG001|NOT COMPLETED|Overall Study||11
10610255|NCT01902134|11767994|FG002|NOT COMPLETED|Overall Study||15
10610256|NCT01902134|11767995|FG003|NOT COMPLETED|Overall Study||2
10610257|NCT01902134|11767996|FG004|NOT COMPLETED|Overall Study||7
10610258|NCT01902134|11767997|FG005|NOT COMPLETED|Overall Study||9
10610259|NCT01902303|11768015|FG000|STARTED|Overall Study|Allocated to placebo|77
10610260|NCT01902303|11768016|FG001|STARTED|Overall Study|Allocated to active treatment|81
10610261|NCT01902303|11768015|FG000|Number of Participants|Overall Study|Number of randomized participants who developed a cold sore and used the assigned treatment.|56
10610262|NCT01902303|11768016|FG001|Number of Participants|Overall Study|Number of randomized participants who developed a cold sore and used the assigned treatment.|62
10610263|NCT01902303|11768015|FG000|COMPLETED|Overall Study|21 not treated - did not use placebo medication as they did not develop cold sore|54
10610264|NCT01902303|11768016|FG001|COMPLETED|Overall Study|19 not treated /did not use medication as they did not develop a cold sore|57
10610265|NCT01902303|11768015|FG000|NOT COMPLETED|Overall Study||23
10610266|NCT01902303|11768016|FG001|NOT COMPLETED|Overall Study||24
10610267|NCT01902459|11768026|FG000|STARTED|Overall Study||75
10610268|NCT01902459|11768027|FG001|STARTED|Overall Study||75
10610269|NCT01902459|11768026|FG000|COMPLETED|Overall Study||75
10610270|NCT01902459|11768027|FG001|COMPLETED|Overall Study||75
10610271|NCT01902459|11768026|FG000|NOT COMPLETED|Overall Study||0
10610272|NCT01902459|11768027|FG001|NOT COMPLETED|Overall Study||0
10610273|NCT01902628|11768033|FG000|STARTED|Overall Study||437
10610274|NCT01902628|11768033|FG000|COMPLETED|Overall Study||354
10610275|NCT01902628|11768033|FG000|NOT COMPLETED|Overall Study||83
10610276|NCT01902758|11768039|FG000|STARTED|Overall Study||14
10610277|NCT01902758|11768040|FG001|STARTED|Overall Study||14
10610278|NCT01902758|11768039|FG000|COMPLETED|Overall Study||14
10610279|NCT01902758|11768040|FG001|COMPLETED|Overall Study||14
10610280|NCT01902758|11768039|FG000|NOT COMPLETED|Overall Study||0
10610281|NCT01902758|11768040|FG001|NOT COMPLETED|Overall Study||0
10610282|NCT01902901|11768048|FG000|STARTED|Overall Study||180
10610283|NCT01902901|11768049|FG001|STARTED|Overall Study||203
10610284|NCT01902901|11768048|FG000|COMPLETED|Overall Study||180
10610285|NCT01902901|11768049|FG001|COMPLETED|Overall Study||201
10610286|NCT01902901|11768048|FG000|NOT COMPLETED|Overall Study||0
10610287|NCT01902901|11768049|FG001|NOT COMPLETED|Overall Study||2
10610288|NCT01902953|11768055|FG000|STARTED|Overall Study||16
10610289|NCT01902953|11768055|FG000|COMPLETED|Overall Study||16
10610290|NCT01902953|11768055|FG000|NOT COMPLETED|Overall Study||0
10610291|NCT01903005|11768061|FG000|STARTED|Overall Study|Primary study OX219-006 (n=475); Primary study OX219-007 (n=190)|665
10610292|NCT01903005|11768061|FG000|COMPLETED|Overall Study|Primary study OX219-006 (n=194); Primary study OX219-007 (n=98)|292
10610293|NCT01903005|11768061|FG000|NOT COMPLETED|Overall Study||373
10610294|NCT01903031|11768069|FG000|STARTED|Overall Study||27
10610295|NCT01903031|11768070|FG001|STARTED|Overall Study||28
10610296|NCT01903031|11768071|FG002|STARTED|Overall Study||29
10610297|NCT01903031|11768069|FG000|COMPLETED|Overall Study||25
10610298|NCT01903031|11768070|FG001|COMPLETED|Overall Study||25
10610299|NCT01903031|11768071|FG002|COMPLETED|Overall Study||24
10610300|NCT01903031|11768069|FG000|NOT COMPLETED|Overall Study||2
10610301|NCT01903031|11768070|FG001|NOT COMPLETED|Overall Study||3
10610302|NCT01903031|11768071|FG002|NOT COMPLETED|Overall Study||5
10610303|NCT01903148|11768084|FG000|STARTED|Overall Study||441
10610304|NCT01903148|11768084|FG000|COMPLETED|Overall Study||441
10610305|NCT01903148|11768084|FG000|NOT COMPLETED|Overall Study||0
10610306|NCT01903187|11768092|FG000|STARTED|Procedure||2
10610307|NCT01903187|11768093|FG001|STARTED|Procedure||2
10610308|NCT01903187|11768092|FG000|COMPLETED|Procedure||2
10610309|NCT01903187|11768093|FG001|COMPLETED|Procedure||2
10610310|NCT01903187|11768092|FG000|NOT COMPLETED|Procedure||0
10610311|NCT01903187|11768093|FG001|NOT COMPLETED|Procedure||0
10610312|NCT01903187|11768092|FG000|STARTED|1 Month||2
10610313|NCT01903187|11768093|FG001|STARTED|1 Month||2
10610314|NCT01903187|11768092|FG000|COMPLETED|1 Month||2
10610315|NCT01903187|11768093|FG001|COMPLETED|1 Month||2
10610316|NCT01903187|11768092|FG000|NOT COMPLETED|1 Month||0
10610317|NCT01903187|11768093|FG001|NOT COMPLETED|1 Month||0
10610318|NCT01903187|11768092|FG000|STARTED|3 Month||2
10610319|NCT01903187|11768093|FG001|STARTED|3 Month||0
10610320|NCT01903187|11768092|FG000|COMPLETED|3 Month||2
10610321|NCT01903187|11768093|FG001|COMPLETED|3 Month||0
10610322|NCT01903187|11768092|FG000|NOT COMPLETED|3 Month||0
10610323|NCT01903187|11768093|FG001|NOT COMPLETED|3 Month||0
10610324|NCT01903187|11768092|FG000|STARTED|6 Month||2
10610325|NCT01903187|11768093|FG001|STARTED|6 Month||0
10610326|NCT01903187|11768092|FG000|COMPLETED|6 Month||2
10610327|NCT01903187|11768093|FG001|COMPLETED|6 Month||0
10610328|NCT01903187|11768092|FG000|NOT COMPLETED|6 Month||0
10610329|NCT01903187|11768093|FG001|NOT COMPLETED|6 Month||0
10610330|NCT01903187|11768092|FG000|STARTED|12 Month||2
10610331|NCT01903187|11768093|FG001|STARTED|12 Month||0
10610332|NCT01903187|11768092|FG000|COMPLETED|12 Month||2
10610333|NCT01903187|11768093|FG001|COMPLETED|12 Month||0
10610334|NCT01903187|11768092|FG000|NOT COMPLETED|12 Month||0
10610335|NCT01903187|11768093|FG001|NOT COMPLETED|12 Month||0
10610336|NCT01903252|11768102|FG000|STARTED|Double-Blind Induction||409
10610337|NCT01903252|11768103|FG001|STARTED|Double-Blind Induction||408
10610338|NCT01903252|11768104|FG002|STARTED|Double-Blind Induction||0
10610339|NCT01903252|11768105|FG003|STARTED|Double-Blind Induction||0
10610340|NCT01903252|11768106|FG004|STARTED|Double-Blind Induction||0
10610341|NCT01903252|11768107|FG005|STARTED|Double-Blind Induction||0
10610342|NCT01903252|11768102|FG000|COMPLETED|Double-Blind Induction||370
10610343|NCT01903252|11768103|FG001|COMPLETED|Double-Blind Induction||367
10610344|NCT01903252|11768104|FG002|COMPLETED|Double-Blind Induction||0
10610345|NCT01903252|11768105|FG003|COMPLETED|Double-Blind Induction||0
10610346|NCT01903252|11768106|FG004|COMPLETED|Double-Blind Induction||0
10610347|NCT01903252|11768107|FG005|COMPLETED|Double-Blind Induction||0
10610348|NCT01903252|11768102|FG000|NOT COMPLETED|Double-Blind Induction||39
10610349|NCT01903252|11768103|FG001|NOT COMPLETED|Double-Blind Induction||41
10610350|NCT01903252|11768104|FG002|NOT COMPLETED|Double-Blind Induction||0
10610351|NCT01903252|11768105|FG003|NOT COMPLETED|Double-Blind Induction||0
10610352|NCT01903252|11768106|FG004|NOT COMPLETED|Double-Blind Induction||0
10610353|NCT01903252|11768107|FG005|NOT COMPLETED|Double-Blind Induction||0
10610354|NCT01903252|11768102|FG000|STARTED|Extended Induction, Open-Label||0
10654519|NCT02203071|11815307|FG001|STARTED|Overall Study||6
10610355|NCT01903252|11768103|FG001|STARTED|Extended Induction, Open-Label|This treatment arm was only used in Period 1, double-blind induction phase.|0
10610356|NCT01903252|11768104|FG002|STARTED|Extended Induction, Open-Label|The subjects in this phase were non-responders at week 8 and discontinued the double-blind phase.|243
10610357|NCT01903252|11768105|FG003|STARTED|Extended Induction, Open-Label||0
10610358|NCT01903252|11768106|FG004|STARTED|Extended Induction, Open-Label||0
10610359|NCT01903252|11768107|FG005|STARTED|Extended Induction, Open-Label||0
10610360|NCT01903252|11768102|FG000|COMPLETED|Extended Induction, Open-Label||0
10610361|NCT01903252|11768103|FG001|COMPLETED|Extended Induction, Open-Label||0
10610362|NCT01903252|11768104|FG002|COMPLETED|Extended Induction, Open-Label||220
10610363|NCT01903252|11768105|FG003|COMPLETED|Extended Induction, Open-Label||0
10610364|NCT01903252|11768106|FG004|COMPLETED|Extended Induction, Open-Label||0
10610365|NCT01903252|11768107|FG005|COMPLETED|Extended Induction, Open-Label||0
10610366|NCT01903252|11768102|FG000|NOT COMPLETED|Extended Induction, Open-Label||0
10610367|NCT01903252|11768103|FG001|NOT COMPLETED|Extended Induction, Open-Label||0
10610368|NCT01903252|11768104|FG002|NOT COMPLETED|Extended Induction, Open-Label||23
10610369|NCT01903252|11768105|FG003|NOT COMPLETED|Extended Induction, Open-Label||0
10610370|NCT01903252|11768106|FG004|NOT COMPLETED|Extended Induction, Open-Label||0
10610371|NCT01903252|11768107|FG005|NOT COMPLETED|Extended Induction, Open-Label||0
10610372|NCT01903252|11768102|FG000|STARTED|Maintenance, Open-Label||0
10610373|NCT01903252|11768103|FG001|STARTED|Maintenance, Open-Label||0
10610374|NCT01903252|11768104|FG002|STARTED|Maintenance, Open-Label|Period 2 (extended induction) is completed, subjects are newly allocated to Period 3, maintenance.|0
10610375|NCT01903252|11768105|FG003|STARTED|Maintenance, Open-Label|This is period 3, Open-Label Maintenance following on from period 1, the double-blind induction.|202
10610376|NCT01903252|11768106|FG004|STARTED|Maintenance, Open-Label|This is period 3, Open-Label Maintenance following on from period 1, the double-blind induction.|274
10610377|NCT01903252|11768107|FG005|STARTED|Maintenance, Open-Label|This is period 3, Open-Label Maintenance following on from period 1, the double-blind induction.|199
10610378|NCT01903252|11768102|FG000|COMPLETED|Maintenance, Open-Label||0
10610379|NCT01903252|11768103|FG001|COMPLETED|Maintenance, Open-Label||0
10610380|NCT01903252|11768104|FG002|COMPLETED|Maintenance, Open-Label||0
10610381|NCT01903252|11768105|FG003|COMPLETED|Maintenance, Open-Label||196
10610382|NCT01903252|11768106|FG004|COMPLETED|Maintenance, Open-Label||253
10610383|NCT01903252|11768107|FG005|COMPLETED|Maintenance, Open-Label||181
10610384|NCT01903252|11768102|FG000|NOT COMPLETED|Maintenance, Open-Label||0
10610385|NCT01903252|11768103|FG001|NOT COMPLETED|Maintenance, Open-Label||0
10610386|NCT01903252|11768104|FG002|NOT COMPLETED|Maintenance, Open-Label||0
10610387|NCT01903252|11768105|FG003|NOT COMPLETED|Maintenance, Open-Label||6
10610388|NCT01903252|11768106|FG004|NOT COMPLETED|Maintenance, Open-Label||21
10610389|NCT01903252|11768107|FG005|NOT COMPLETED|Maintenance, Open-Label||18
10610390|NCT01903265|11768127|FG000|STARTED|Overall Study||103
10610391|NCT01903265|11768128|FG001|STARTED|Overall Study||102
10610392|NCT01903265|11768127|FG000|COMPLETED|Overall Study||89
10610393|NCT01903265|11768128|FG001|COMPLETED|Overall Study||85
10610394|NCT01903265|11768127|FG000|NOT COMPLETED|Overall Study||14
10610395|NCT01903265|11768128|FG001|NOT COMPLETED|Overall Study||17
10610396|NCT01903356|11768134|FG000|STARTED|Overall Study||724
10610397|NCT01903356|11768134|FG000|COMPLETED|Overall Study||709
10610398|NCT01903356|11768134|FG000|NOT COMPLETED|Overall Study||15
10610399|NCT01903434|11768138|FG000|STARTED|Treatment Period 1||30
10610400|NCT01903434|11768139|FG001|STARTED|Treatment Period 1||30
10610401|NCT01903434|11768138|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||30
10610402|NCT01903434|11768139|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1||30
10610403|NCT01903434|11768138|FG000|COMPLETED|Treatment Period 1||30
10610404|NCT01903434|11768139|FG001|COMPLETED|Treatment Period 1||30
10610405|NCT01903434|11768138|FG000|NOT COMPLETED|Treatment Period 1||0
10610406|NCT01903434|11768139|FG001|NOT COMPLETED|Treatment Period 1||0
10610407|NCT01903434|11768138|FG000|STARTED|Washout Period 1 (at Least 14 Days)||30
10610408|NCT01903434|11768139|FG001|STARTED|Washout Period 1 (at Least 14 Days)||30
10610409|NCT01903434|11768138|FG000|COMPLETED|Washout Period 1 (at Least 14 Days)||29
10610410|NCT01903434|11768139|FG001|COMPLETED|Washout Period 1 (at Least 14 Days)||28
10610411|NCT01903434|11768138|FG000|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||1
10610412|NCT01903434|11768139|FG001|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||2
10610413|NCT01903434|11768138|FG000|STARTED|Treatment Period 2||29
10610414|NCT01903434|11768139|FG001|STARTED|Treatment Period 2||28
10610415|NCT01903434|11768138|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 2||29
10610416|NCT01903434|11768139|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 2||28
10610417|NCT01903434|11768138|FG000|COMPLETED|Treatment Period 2||29
10610418|NCT01903434|11768139|FG001|COMPLETED|Treatment Period 2||28
10610419|NCT01903434|11768138|FG000|NOT COMPLETED|Treatment Period 2||0
10610420|NCT01903434|11768139|FG001|NOT COMPLETED|Treatment Period 2||0
10610421|NCT01903434|11768138|FG000|STARTED|Washout Period 1 (at Least 14 Days)||29
10610422|NCT01903434|11768139|FG001|STARTED|Washout Period 1 (at Least 14 Days)||28
10610423|NCT01903434|11768138|FG000|COMPLETED|Washout Period 1 (at Least 14 Days)||29
10610424|NCT01903434|11768139|FG001|COMPLETED|Washout Period 1 (at Least 14 Days)||28
10610425|NCT01903434|11768138|FG000|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
10704558|NCT02593097|11868929|FG000|COMPLETED|First Intervention (12 Weeks)||12
10704559|NCT02593097|11868930|FG001|COMPLETED|First Intervention (12 Weeks)||16
10704560|NCT02593097|11868929|FG000|NOT COMPLETED|First Intervention (12 Weeks)||2
10610426|NCT01903434|11768139|FG001|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
10610427|NCT01903434|11768138|FG000|STARTED|Treatment Period 3||29
10610428|NCT01903434|11768139|FG001|STARTED|Treatment Period 3||28
10610429|NCT01903434|11768138|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 3||29
10610430|NCT01903434|11768139|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 3||28
10610431|NCT01903434|11768138|FG000|COMPLETED|Treatment Period 3||29
10610432|NCT01903434|11768139|FG001|COMPLETED|Treatment Period 3||28
10610433|NCT01903434|11768138|FG000|NOT COMPLETED|Treatment Period 3||0
10610434|NCT01903434|11768139|FG001|NOT COMPLETED|Treatment Period 3||0
10610435|NCT01903460|11768149|FG000|STARTED|Overall Study||6
10610436|NCT01903460|11768150|FG001|STARTED|Overall Study||8
10610437|NCT01903460|11768151|FG002|STARTED|Overall Study||3
10610438|NCT01903460|11768152|FG003|STARTED|Overall Study||3
10610439|NCT01903460|11768149|FG000|COMPLETED|Overall Study||6
10610440|NCT01903460|11768150|FG001|COMPLETED|Overall Study||8
10457063|NCT01008995|11604802|FG000|COMPLETED|Controlled Period||159
10457064|NCT01008995|11604803|FG001|COMPLETED|Controlled Period||157
10457065|NCT01008995|11604804|FG002|COMPLETED|Controlled Period||0
10457066|NCT01008995|11604805|FG003|COMPLETED|Controlled Period||0
10808787|NCT03825939|11970771|FG002|STARTED|Overall Study||14
10808788|NCT03825939|11970769|FG000|COMPLETED|Overall Study||18
10808789|NCT03825939|11970770|FG001|COMPLETED|Overall Study||20
10808790|NCT03825939|11970771|FG002|COMPLETED|Overall Study||14
10808791|NCT03825939|11970769|FG000|NOT COMPLETED|Overall Study||0
10808792|NCT03825939|11970770|FG001|NOT COMPLETED|Overall Study||0
10808793|NCT03825939|11970771|FG002|NOT COMPLETED|Overall Study||0
10808794|NCT03817775|11970781|FG000|STARTED|Overall Study||22
10808795|NCT03817775|11970782|FG001|STARTED|Overall Study||54
10808796|NCT03817775|11970781|FG000|COMPLETED|Overall Study||22
10808797|NCT03817775|11970782|FG001|COMPLETED|Overall Study||54
10808798|NCT03817775|11970781|FG000|NOT COMPLETED|Overall Study||0
10808799|NCT03817775|11970782|FG001|NOT COMPLETED|Overall Study||0
10808800|NCT03843372|11970790|FG000|STARTED|Overall Study||14
10808801|NCT03843372|11970791|FG001|STARTED|Overall Study||18
10808802|NCT03843372|11970790|FG000|COMPLETED|Overall Study||12
10808803|NCT03843372|11970791|FG001|COMPLETED|Overall Study||16
10808804|NCT03843372|11970790|FG000|NOT COMPLETED|Overall Study||2
10808805|NCT03843372|11970791|FG001|NOT COMPLETED|Overall Study||2
10808806|NCT03841331|11970799|FG000|STARTED|Overall Study||117
10808807|NCT03841331|11970800|FG001|STARTED|Overall Study||116
10610441|NCT01903460|11768151|FG002|COMPLETED|Overall Study||3
10610442|NCT01903460|11768152|FG003|COMPLETED|Overall Study||2
10610443|NCT01903460|11768149|FG000|NOT COMPLETED|Overall Study||0
10610444|NCT01903460|11768150|FG001|NOT COMPLETED|Overall Study||0
10610445|NCT01903460|11768151|FG002|NOT COMPLETED|Overall Study||0
10610446|NCT01903460|11768152|FG003|NOT COMPLETED|Overall Study||1
10610447|NCT01903525|11768163|FG000|STARTED|Overall Study||20
10610448|NCT01903525|11768164|FG001|STARTED|Overall Study||20
10610449|NCT01903525|11768163|FG000|COMPLETED|Overall Study||15
10610450|NCT01903525|11768164|FG001|COMPLETED|Overall Study||10
10610451|NCT01903525|11768163|FG000|NOT COMPLETED|Overall Study||5
10610452|NCT01903525|11768164|FG001|NOT COMPLETED|Overall Study||10
10610453|NCT01903564|11768172|FG000|STARTED|Overall Study||10
10610454|NCT01903564|11768173|FG001|STARTED|Overall Study||29
10610455|NCT01903564|11768172|FG000|COMPLETED|Overall Study||10
10610456|NCT01903564|11768173|FG001|COMPLETED|Overall Study||29
10610457|NCT01903564|11768172|FG000|NOT COMPLETED|Overall Study||0
10610458|NCT01903564|11768173|FG001|NOT COMPLETED|Overall Study||0
10610459|NCT01903720|11768179|FG000|STARTED|Overall Study||71
10610460|NCT01903720|11768179|FG000|COMPLETED|Overall Study||59
10610461|NCT01903720|11768179|FG000|NOT COMPLETED|Overall Study||12
10704561|NCT02593097|11868930|FG001|NOT COMPLETED|First Intervention (12 Weeks)||4
10704562|NCT02593097|11868929|FG000|STARTED|Washout (4 Weeks)||12
10704563|NCT02593097|11868930|FG001|STARTED|Washout (4 Weeks)||16
10704564|NCT02593097|11868929|FG000|COMPLETED|Washout (4 Weeks)||12
10704565|NCT02593097|11868930|FG001|COMPLETED|Washout (4 Weeks)||16
10704566|NCT02593097|11868929|FG000|NOT COMPLETED|Washout (4 Weeks)||0
10704567|NCT02593097|11868930|FG001|NOT COMPLETED|Washout (4 Weeks)||0
10704568|NCT02593097|11868929|FG000|STARTED|Second Intervention (12 Weeks)||12
10808808|NCT03841331|11970799|FG000|COMPLETED|Overall Study||108
10457067|NCT01008995|11604802|FG000|NOT COMPLETED|Controlled Period||3
10808809|NCT03841331|11970800|FG001|COMPLETED|Overall Study||106
10808810|NCT03841331|11970799|FG000|NOT COMPLETED|Overall Study||9
10808811|NCT03841331|11970800|FG001|NOT COMPLETED|Overall Study||10
10610490|NCT01903798|11768214|FG000|STARTED|Overall Study||2
10610491|NCT01903798|11768215|FG001|STARTED|Overall Study||0
10610492|NCT01903798|11768216|FG002|STARTED|Overall Study||1
10610493|NCT01903798|11768217|FG003|STARTED|Overall Study||1
10610494|NCT01903798|11768214|FG000|COMPLETED|Overall Study||2
10610495|NCT01903798|11768215|FG001|COMPLETED|Overall Study||0
10610496|NCT01903798|11768216|FG002|COMPLETED|Overall Study||1
10610497|NCT01903798|11768217|FG003|COMPLETED|Overall Study||1
10610498|NCT01903798|11768214|FG000|NOT COMPLETED|Overall Study||0
10610499|NCT01903798|11768215|FG001|NOT COMPLETED|Overall Study||0
10610500|NCT01903798|11768216|FG002|NOT COMPLETED|Overall Study||0
10610501|NCT01903798|11768217|FG003|NOT COMPLETED|Overall Study||0
10610502|NCT01903811|11768229|FG000|STARTED|Overall Study||72
10610503|NCT01903811|11768230|FG001|STARTED|Overall Study||71
10610504|NCT01903811|11768229|FG000|Crossover to Arm II|Overall Study|Following disease progression on Arm I. Note: these patients are also counted in 'Completed'.|16
10610505|NCT01903811|11768230|FG001|Crossover to Arm II|Overall Study||0
10610506|NCT01903811|11768229|FG000|COMPLETED|Overall Study||64
10610507|NCT01903811|11768230|FG001|COMPLETED|Overall Study||57
10610508|NCT01903811|11768229|FG000|NOT COMPLETED|Overall Study||8
10610509|NCT01903811|11768230|FG001|NOT COMPLETED|Overall Study||14
10610510|NCT01903837|11768243|FG000|STARTED|Part A||75
10610511|NCT01903837|11768244|FG001|STARTED|Part A||80
10610512|NCT01903837|11768245|FG002|STARTED|Part A||86
10610513|NCT01903837|11768246|FG003|STARTED|Part A||68
10610514|NCT01903837|11768243|FG000|COMPLETED|Part A||56
10610515|NCT01903837|11768244|FG001|COMPLETED|Part A||52
10610516|NCT01903837|11768245|FG002|COMPLETED|Part A||58
10610517|NCT01903837|11768246|FG003|COMPLETED|Part A||55
10610518|NCT01903837|11768243|FG000|NOT COMPLETED|Part A||19
10610519|NCT01903837|11768244|FG001|NOT COMPLETED|Part A||28
10610520|NCT01903837|11768245|FG002|NOT COMPLETED|Part A||28
10610521|NCT01903837|11768246|FG003|NOT COMPLETED|Part A||13
10610522|NCT01903837|11768243|FG000|STARTED|Part B||54
10610523|NCT01903837|11768244|FG001|STARTED|Part B||52
10610524|NCT01903837|11768245|FG002|STARTED|Part B||57
10610525|NCT01903837|11768246|FG003|STARTED|Part B||55
10610526|NCT01903837|11768243|FG000|COMPLETED|Part B||45
10610527|NCT01903837|11768244|FG001|COMPLETED|Part B||46
10610528|NCT01903837|11768245|FG002|COMPLETED|Part B||52
10610529|NCT01903837|11768246|FG003|COMPLETED|Part B||44
10610530|NCT01903837|11768243|FG000|NOT COMPLETED|Part B||9
10610531|NCT01903837|11768244|FG001|NOT COMPLETED|Part B||6
10610532|NCT01903837|11768245|FG002|NOT COMPLETED|Part B||5
10610533|NCT01903837|11768246|FG003|NOT COMPLETED|Part B||11
10610534|NCT01903863|11768279|FG000|STARTED|Overall Study||15
10610535|NCT01903863|11768280|FG001|STARTED|Overall Study||16
10610536|NCT01903863|11768279|FG000|COMPLETED|Overall Study||13
10610537|NCT01903863|11768280|FG001|COMPLETED|Overall Study||16
10610538|NCT01903863|11768279|FG000|NOT COMPLETED|Overall Study||2
10610539|NCT01903863|11768280|FG001|NOT COMPLETED|Overall Study||0
10610540|NCT01903876|11768288|FG000|STARTED|Baseline to Post-Intervention Period||367
10610541|NCT01903876|11768289|FG001|STARTED|Baseline to Post-Intervention Period||376
10610542|NCT01903876|11768288|FG000|COMPLETED|Baseline to Post-Intervention Period||183
10610543|NCT01903876|11768289|FG001|COMPLETED|Baseline to Post-Intervention Period||268
10610544|NCT01903876|11768288|FG000|NOT COMPLETED|Baseline to Post-Intervention Period||184
10610545|NCT01903876|11768289|FG001|NOT COMPLETED|Baseline to Post-Intervention Period||108
10610546|NCT01903876|11768288|FG000|STARTED|Six-Month Follow-up Period||183
10610547|NCT01903876|11768289|FG001|STARTED|Six-Month Follow-up Period||268
10610548|NCT01903876|11768288|FG000|COMPLETED|Six-Month Follow-up Period||92
10610549|NCT01903876|11768289|FG001|COMPLETED|Six-Month Follow-up Period||123
10610550|NCT01903876|11768288|FG000|NOT COMPLETED|Six-Month Follow-up Period||91
10610551|NCT01903876|11768289|FG001|NOT COMPLETED|Six-Month Follow-up Period||145
10610552|NCT01903993|11768297|FG000|STARTED|Overall Study||143
10610553|NCT01903993|11768298|FG001|STARTED|Overall Study||144
10610554|NCT01903993|11768297|FG000|Received Treatment|Overall Study||135
10610555|NCT01903993|11768298|FG001|Received Treatment|Overall Study||142
10610556|NCT01903993|11768297|FG000|COMPLETED|Overall Study||0
10610557|NCT01903993|11768298|FG001|COMPLETED|Overall Study||0
10610558|NCT01903993|11768297|FG000|NOT COMPLETED|Overall Study||143
10610559|NCT01903993|11768298|FG001|NOT COMPLETED|Overall Study||144
10610560|NCT01904019|11768305|FG000|STARTED|Pre-operative||95
10610561|NCT01904019|11768305|FG000|COMPLETED|Pre-operative||95
10610562|NCT01904019|11768305|FG000|NOT COMPLETED|Pre-operative||0
10610563|NCT01904019|11768305|FG000|STARTED|1 Year Follow-up||95
10610564|NCT01904019|11768305|FG000|COMPLETED|1 Year Follow-up||86
10610565|NCT01904019|11768305|FG000|NOT COMPLETED|1 Year Follow-up||9
10610566|NCT01904019|11768305|FG000|STARTED|3 Year Follow-up||86
10610567|NCT01904019|11768305|FG000|COMPLETED|3 Year Follow-up||71
10610568|NCT01904019|11768305|FG000|NOT COMPLETED|3 Year Follow-up||15
10610569|NCT01904019|11768305|FG000|STARTED|5 Year Follow-up||71
10610570|NCT01904019|11768305|FG000|COMPLETED|5 Year Follow-up||65
10610571|NCT01904019|11768305|FG000|NOT COMPLETED|5 Year Follow-up||6
10610572|NCT01904058|11768313|FG000|STARTED|Overall Study||21
10610573|NCT01904058|11768314|FG001|STARTED|Overall Study||21
10610574|NCT01904058|11768315|FG002|STARTED|Overall Study||11
10610575|NCT01904058|11768316|FG003|STARTED|Overall Study||13
10610576|NCT01904058|11768313|FG000|COMPLETED|Overall Study||18
10610577|NCT01904058|11768314|FG001|COMPLETED|Overall Study||21
10610578|NCT01904058|11768315|FG002|COMPLETED|Overall Study||10
10610579|NCT01904058|11768316|FG003|COMPLETED|Overall Study||12
10610580|NCT01904058|11768313|FG000|NOT COMPLETED|Overall Study||3
10704569|NCT02593097|11868930|FG001|STARTED|Second Intervention (12 Weeks)||16
10704570|NCT02593097|11868929|FG000|COMPLETED|Second Intervention (12 Weeks)||9
10704571|NCT02593097|11868930|FG001|COMPLETED|Second Intervention (12 Weeks)||15
10610581|NCT01904058|11768314|FG001|NOT COMPLETED|Overall Study||0
10610582|NCT01904058|11768315|FG002|NOT COMPLETED|Overall Study||1
10610583|NCT01904058|11768316|FG003|NOT COMPLETED|Overall Study||1
10610584|NCT01904071|11768335|FG000|STARTED|Overall Study||24
10610585|NCT01904071|11768336|FG001|STARTED|Overall Study||20
10610586|NCT01904071|11768337|FG002|STARTED|Overall Study||20
10610587|NCT01904071|11768335|FG000|COMPLETED|Overall Study||24
10610588|NCT01904071|11768336|FG001|COMPLETED|Overall Study||20
10610589|NCT01904071|11768337|FG002|COMPLETED|Overall Study||20
10610590|NCT01904071|11768335|FG000|NOT COMPLETED|Overall Study||0
10610591|NCT01904071|11768336|FG001|NOT COMPLETED|Overall Study||0
10610592|NCT01904071|11768337|FG002|NOT COMPLETED|Overall Study||0
10610593|NCT01904149|11768351|FG000|STARTED|Overall Study||152
10610594|NCT01904149|11768352|FG001|STARTED|Overall Study||151
10610595|NCT01904149|11768353|FG002|STARTED|Overall Study||150
10610596|NCT01904149|11768354|FG003|STARTED|Overall Study||51
10610597|NCT01904149|11768355|FG004|STARTED|Overall Study||51
10610598|NCT01904149|11768356|FG005|STARTED|Overall Study||51
10610599|NCT01904149|11768351|FG000|Single-dose Phase|Overall Study||152
10610600|NCT01904149|11768352|FG001|Single-dose Phase|Overall Study||151
10704572|NCT02593097|11868929|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||3
10610601|NCT01904149|11768353|FG002|Single-dose Phase|Overall Study||150
10610602|NCT01904149|11768354|FG003|Single-dose Phase|Overall Study||51
10610603|NCT01904149|11768355|FG004|Single-dose Phase|Overall Study||51
10610604|NCT01904149|11768356|FG005|Single-dose Phase|Overall Study||51
10610605|NCT01904149|11768351|FG000|Multiple-dose Phase|Overall Study||150
10610606|NCT01904149|11768352|FG001|Multiple-dose Phase|Overall Study||146
10610607|NCT01904149|11768353|FG002|Multiple-dose Phase|Overall Study||149
10610608|NCT01904149|11768354|FG003|Multiple-dose Phase|Overall Study||48
10610609|NCT01904149|11768355|FG004|Multiple-dose Phase|Overall Study||48
10610610|NCT01904149|11768356|FG005|Multiple-dose Phase|Overall Study||49
10610611|NCT01904149|11768351|FG000|COMPLETED|Overall Study||147
10610612|NCT01904149|11768352|FG001|COMPLETED|Overall Study||140
10610613|NCT01904149|11768353|FG002|COMPLETED|Overall Study||148
10610614|NCT01904149|11768354|FG003|COMPLETED|Overall Study||47
10610615|NCT01904149|11768355|FG004|COMPLETED|Overall Study||46
10610616|NCT01904149|11768356|FG005|COMPLETED|Overall Study||48
10610617|NCT01904149|11768351|FG000|NOT COMPLETED|Overall Study||5
10610618|NCT01904149|11768352|FG001|NOT COMPLETED|Overall Study||11
10610619|NCT01904149|11768353|FG002|NOT COMPLETED|Overall Study||2
10610620|NCT01904149|11768354|FG003|NOT COMPLETED|Overall Study||4
10610621|NCT01904149|11768355|FG004|NOT COMPLETED|Overall Study||5
10610622|NCT01904149|11768356|FG005|NOT COMPLETED|Overall Study||3
10610623|NCT01904383|11768372|FG000|STARTED|Overall Study||4057
10610624|NCT01904383|11768372|FG000|Treated|Overall Study||3940
10610625|NCT01904383|11768372|FG000|COMPLETED|Overall Study||2283
10610626|NCT01904383|11768372|FG000|NOT COMPLETED|Overall Study||1774
10610627|NCT01904448|11768376|FG000|STARTED|Overall Study||5
10610628|NCT01904448|11768376|FG000|COMPLETED|Overall Study||5
10610629|NCT01904448|11768376|FG000|NOT COMPLETED|Overall Study||0
10704573|NCT02593097|11868930|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||1
10704574|NCT02593149|11868938|FG000|STARTED|Run-In||340
10704575|NCT02593149|11868939|FG001|STARTED|Run-In||361
10704576|NCT02593149|11868938|FG000|COMPLETED|Run-In||304
10704577|NCT02593149|11868939|FG001|COMPLETED|Run-In||323
10704578|NCT02593149|11868938|FG000|NOT COMPLETED|Run-In||36
10610630|NCT01904526|11768381|FG000|STARTED|Overall Study||5
10610631|NCT01904526|11768381|FG000|COMPLETED|Overall Study||5
10610632|NCT01904526|11768381|FG000|NOT COMPLETED|Overall Study||0
10610633|NCT01904604|11768392|FG000|STARTED|Overall Study||25
10610634|NCT01904604|11768393|FG001|STARTED|Overall Study||25
10610635|NCT01904604|11768394|FG002|STARTED|Overall Study||25
10610636|NCT01904604|11768392|FG000|Completed Week 52 OFC|Overall Study||22
10704579|NCT02593149|11868939|FG001|NOT COMPLETED|Run-In||38
10704580|NCT02593149|11868938|FG000|STARTED|Intervention||942
10704581|NCT02593149|11868939|FG001|STARTED|Intervention||960
10704582|NCT02593149|11868938|FG000|COMPLETED|Intervention||826
10704583|NCT02593149|11868939|FG001|COMPLETED|Intervention||845
10704584|NCT02593149|11868938|FG000|NOT COMPLETED|Intervention||116
10610637|NCT01904604|11768393|FG001|Completed Week 52 OFC|Overall Study||21
10610638|NCT01904604|11768394|FG002|Completed Week 52 OFC|Overall Study||25
10653117|NCT02190604|11813571|FG015|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
10704585|NCT02593149|11868939|FG001|NOT COMPLETED|Intervention||115
10610639|NCT01904604|11768392|FG000|Began Crossover Treatment|Overall Study|2 participants who completed the Week 52 OFC did not crossover; 1 passed the OFC and 1 relocated.|20
10610640|NCT01904604|11768393|FG001|Began Crossover Treatment|Overall Study||21
10610641|NCT01904604|11768394|FG002|Began Crossover Treatment|Overall Study|Per protocol, this treatment group did not crossover.|0
10610642|NCT01904604|11768392|FG000|Completed Week 130 OFC|Overall Study||18
10610643|NCT01904604|11768393|FG001|Completed Week 130 OFC|Overall Study||18
10610644|NCT01904604|11768394|FG002|Completed Week 130 OFC|Overall Study||23
10610645|NCT01904604|11768392|FG000|COMPLETED|Overall Study|COMPLETED: Completed the Week 130 Oral Food Challenge (OFC).|18
10610646|NCT01904604|11768393|FG001|COMPLETED|Overall Study|COMPLETED: Completed the Week 130 Oral Food Challenge (OFC).|18
10610647|NCT01904604|11768394|FG002|COMPLETED|Overall Study|COMPLETED: Completed the Week 130 Oral Food Challenge (OFC).|23
10610648|NCT01904604|11768392|FG000|NOT COMPLETED|Overall Study||7
10610649|NCT01904604|11768393|FG001|NOT COMPLETED|Overall Study||7
10610650|NCT01904604|11768394|FG002|NOT COMPLETED|Overall Study||2
10610651|NCT01904721|11768412|FG000|STARTED|Overall Study||13
10610652|NCT01904721|11768413|FG001|STARTED|Overall Study||13
10610653|NCT01904721|11768414|FG002|STARTED|Overall Study||12
10610654|NCT01904721|11768415|FG003|STARTED|Overall Study||12
10610655|NCT01904721|11768416|FG004|STARTED|Overall Study||65
10610656|NCT01904721|11768417|FG005|STARTED|Overall Study||65
10610657|NCT01904721|11768418|FG006|STARTED|Overall Study||64
10610658|NCT01904721|11768412|FG000|COMPLETED|Overall Study||13
10610659|NCT01904721|11768413|FG001|COMPLETED|Overall Study||13
10610660|NCT01904721|11768414|FG002|COMPLETED|Overall Study||11
10610661|NCT01904721|11768415|FG003|COMPLETED|Overall Study||11
10610662|NCT01904721|11768416|FG004|COMPLETED|Overall Study||57
10610663|NCT01904721|11768417|FG005|COMPLETED|Overall Study||56
10610664|NCT01904721|11768418|FG006|COMPLETED|Overall Study||57
10610665|NCT01904721|11768412|FG000|NOT COMPLETED|Overall Study||0
10610666|NCT01904721|11768413|FG001|NOT COMPLETED|Overall Study||0
10610667|NCT01904721|11768414|FG002|NOT COMPLETED|Overall Study||1
10610668|NCT01904721|11768415|FG003|NOT COMPLETED|Overall Study||1
10610669|NCT01904721|11768416|FG004|NOT COMPLETED|Overall Study||8
10610670|NCT01904721|11768417|FG005|NOT COMPLETED|Overall Study||9
10610671|NCT01904721|11768418|FG006|NOT COMPLETED|Overall Study||7
10610672|NCT01904760|11768432|FG000|STARTED|Overall Study||40
10610673|NCT01904760|11768433|FG001|STARTED|Overall Study||40
10610674|NCT01904760|11768432|FG000|COMPLETED|Overall Study||39
10610675|NCT01904760|11768433|FG001|COMPLETED|Overall Study||40
10610676|NCT01904760|11768432|FG000|NOT COMPLETED|Overall Study||1
10610677|NCT01904760|11768433|FG001|NOT COMPLETED|Overall Study||0
10610678|NCT01904773|11768439|FG000|STARTED|Screen||28
10610679|NCT01904773|11768440|FG001|STARTED|Screen||0
10610680|NCT01904773|11768441|FG002|STARTED|Screen||0
10610681|NCT01904773|11768442|FG003|STARTED|Screen||0
10610682|NCT01904773|11768443|FG004|STARTED|Screen||0
10610683|NCT01904773|11768444|FG005|STARTED|Screen||0
10610684|NCT01904773|11768445|FG006|STARTED|Screen||0
10610685|NCT01904773|11768446|FG007|STARTED|Screen||0
10610686|NCT01904773|11768447|FG008|STARTED|Screen||0
10610687|NCT01904773|11768439|FG000|COMPLETED|Screen||24
10610688|NCT01904773|11768440|FG001|COMPLETED|Screen||0
10704586|NCT02593305|11868948|FG000|STARTED|Baseline 1||7
10704587|NCT02593305|11868949|FG001|STARTED|Baseline 1||6
10704588|NCT02593305|11868950|FG002|STARTED|Baseline 1||10
10610689|NCT01904773|11768441|FG002|COMPLETED|Screen||0
10610690|NCT01904773|11768442|FG003|COMPLETED|Screen||0
10610691|NCT01904773|11768443|FG004|COMPLETED|Screen||0
10610692|NCT01904773|11768444|FG005|COMPLETED|Screen||0
10610693|NCT01904773|11768445|FG006|COMPLETED|Screen||0
10610694|NCT01904773|11768446|FG007|COMPLETED|Screen||0
10610695|NCT01904773|11768447|FG008|COMPLETED|Screen||0
10610696|NCT01904773|11768439|FG000|NOT COMPLETED|Screen||4
10610697|NCT01904773|11768440|FG001|NOT COMPLETED|Screen||0
10610698|NCT01904773|11768441|FG002|NOT COMPLETED|Screen||0
10610699|NCT01904773|11768442|FG003|NOT COMPLETED|Screen||0
10610700|NCT01904773|11768443|FG004|NOT COMPLETED|Screen||0
10610701|NCT01904773|11768444|FG005|NOT COMPLETED|Screen||0
10610702|NCT01904773|11768445|FG006|NOT COMPLETED|Screen||0
10610703|NCT01904773|11768446|FG007|NOT COMPLETED|Screen||0
10610704|NCT01904773|11768447|FG008|NOT COMPLETED|Screen||0
10610705|NCT01904773|11768439|FG000|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||24
10610706|NCT01904773|11768440|FG001|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10610707|NCT01904773|11768441|FG002|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10610708|NCT01904773|11768442|FG003|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10610709|NCT01904773|11768443|FG004|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10610710|NCT01904773|11768444|FG005|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10610711|NCT01904773|11768445|FG006|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10610712|NCT01904773|11768446|FG007|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10610713|NCT01904773|11768447|FG008|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10610714|NCT01904773|11768439|FG000|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||24
10610715|NCT01904773|11768440|FG001|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10610716|NCT01904773|11768441|FG002|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10610717|NCT01904773|11768442|FG003|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10610718|NCT01904773|11768443|FG004|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10610719|NCT01904773|11768444|FG005|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10610720|NCT01904773|11768445|FG006|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10704589|NCT02593305|11868948|FG000|COMPLETED|Baseline 1||7
10704590|NCT02593305|11868949|FG001|COMPLETED|Baseline 1||6
10610721|NCT01904773|11768446|FG007|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10610722|NCT01904773|11768447|FG008|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10610723|NCT01904773|11768439|FG000|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10610724|NCT01904773|11768440|FG001|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10610725|NCT01904773|11768441|FG002|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10610726|NCT01904773|11768442|FG003|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10610727|NCT01904773|11768443|FG004|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10610728|NCT01904773|11768444|FG005|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10610729|NCT01904773|11768445|FG006|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10610730|NCT01904773|11768446|FG007|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10610731|NCT01904773|11768447|FG008|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
10610732|NCT01904773|11768439|FG000|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||24
10610733|NCT01904773|11768440|FG001|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10610734|NCT01904773|11768441|FG002|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10610735|NCT01904773|11768442|FG003|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10610736|NCT01904773|11768443|FG004|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10610737|NCT01904773|11768444|FG005|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10610738|NCT01904773|11768445|FG006|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10610739|NCT01904773|11768446|FG007|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10610888|NCT01904773|11768442|FG003|STARTED|Third Intervention||2
10610740|NCT01904773|11768447|FG008|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10610741|NCT01904773|11768439|FG000|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||20
10610742|NCT01904773|11768440|FG001|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10610743|NCT01904773|11768441|FG002|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10610744|NCT01904773|11768442|FG003|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10610745|NCT01904773|11768443|FG004|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10610746|NCT01904773|11768444|FG005|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10610747|NCT01904773|11768445|FG006|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10610748|NCT01904773|11768446|FG007|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10610749|NCT01904773|11768447|FG008|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10610750|NCT01904773|11768439|FG000|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||4
10610751|NCT01904773|11768440|FG001|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10610752|NCT01904773|11768441|FG002|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10610753|NCT01904773|11768442|FG003|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10610754|NCT01904773|11768443|FG004|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10610755|NCT01904773|11768444|FG005|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10610756|NCT01904773|11768445|FG006|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10610757|NCT01904773|11768446|FG007|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10610758|NCT01904773|11768447|FG008|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10610759|NCT01904773|11768439|FG000|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||23
10610760|NCT01904773|11768440|FG001|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10610761|NCT01904773|11768441|FG002|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10610762|NCT01904773|11768442|FG003|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10610763|NCT01904773|11768443|FG004|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10610764|NCT01904773|11768444|FG005|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10610765|NCT01904773|11768445|FG006|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10610766|NCT01904773|11768446|FG007|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10610767|NCT01904773|11768447|FG008|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10610768|NCT01904773|11768439|FG000|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||1
10610769|NCT01904773|11768440|FG001|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10610770|NCT01904773|11768441|FG002|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10610771|NCT01904773|11768442|FG003|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10610772|NCT01904773|11768443|FG004|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10610773|NCT01904773|11768444|FG005|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10610774|NCT01904773|11768445|FG006|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10610775|NCT01904773|11768446|FG007|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10610776|NCT01904773|11768447|FG008|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
10610777|NCT01904773|11768439|FG000|STARTED|First Intervention||0
10610778|NCT01904773|11768440|FG001|STARTED|First Intervention||2
10610779|NCT01904773|11768441|FG002|STARTED|First Intervention||1
10610780|NCT01904773|11768442|FG003|STARTED|First Intervention||2
10610781|NCT01904773|11768443|FG004|STARTED|First Intervention||3
10610782|NCT01904773|11768444|FG005|STARTED|First Intervention||4
10610783|NCT01904773|11768445|FG006|STARTED|First Intervention||4
10610784|NCT01904773|11768446|FG007|STARTED|First Intervention||3
10610785|NCT01904773|11768447|FG008|STARTED|First Intervention||4
10610786|NCT01904773|11768439|FG000|COMPLETED|First Intervention||0
10610787|NCT01904773|11768440|FG001|COMPLETED|First Intervention||2
10610788|NCT01904773|11768441|FG002|COMPLETED|First Intervention||1
10610789|NCT01904773|11768442|FG003|COMPLETED|First Intervention||2
10610790|NCT01904773|11768443|FG004|COMPLETED|First Intervention||3
10610791|NCT01904773|11768444|FG005|COMPLETED|First Intervention||4
10610792|NCT01904773|11768445|FG006|COMPLETED|First Intervention||3
10610793|NCT01904773|11768446|FG007|COMPLETED|First Intervention||3
10610794|NCT01904773|11768447|FG008|COMPLETED|First Intervention||4
10610795|NCT01904773|11768439|FG000|NOT COMPLETED|First Intervention||0
10610796|NCT01904773|11768440|FG001|NOT COMPLETED|First Intervention||0
10610797|NCT01904773|11768441|FG002|NOT COMPLETED|First Intervention||0
10610798|NCT01904773|11768442|FG003|NOT COMPLETED|First Intervention||0
10610799|NCT01904773|11768443|FG004|NOT COMPLETED|First Intervention||0
10610800|NCT01904773|11768444|FG005|NOT COMPLETED|First Intervention||0
10610801|NCT01904773|11768445|FG006|NOT COMPLETED|First Intervention||1
10610802|NCT01904773|11768446|FG007|NOT COMPLETED|First Intervention||0
10610803|NCT01904773|11768447|FG008|NOT COMPLETED|First Intervention||0
10610804|NCT01904773|11768439|FG000|STARTED|Placebo Washout First Intervention||0
10610805|NCT01904773|11768440|FG001|STARTED|Placebo Washout First Intervention||2
10610806|NCT01904773|11768441|FG002|STARTED|Placebo Washout First Intervention||1
10610807|NCT01904773|11768442|FG003|STARTED|Placebo Washout First Intervention||2
10610808|NCT01904773|11768443|FG004|STARTED|Placebo Washout First Intervention||3
10610809|NCT01904773|11768444|FG005|STARTED|Placebo Washout First Intervention||4
10610810|NCT01904773|11768445|FG006|STARTED|Placebo Washout First Intervention||3
10610811|NCT01904773|11768446|FG007|STARTED|Placebo Washout First Intervention||3
10610812|NCT01904773|11768447|FG008|STARTED|Placebo Washout First Intervention||4
10610813|NCT01904773|11768439|FG000|COMPLETED|Placebo Washout First Intervention||0
10610814|NCT01904773|11768440|FG001|COMPLETED|Placebo Washout First Intervention||1
10610815|NCT01904773|11768441|FG002|COMPLETED|Placebo Washout First Intervention||1
10610816|NCT01904773|11768442|FG003|COMPLETED|Placebo Washout First Intervention||2
10610817|NCT01904773|11768443|FG004|COMPLETED|Placebo Washout First Intervention||3
10610818|NCT01904773|11768444|FG005|COMPLETED|Placebo Washout First Intervention||4
10610819|NCT01904773|11768445|FG006|COMPLETED|Placebo Washout First Intervention||3
10610820|NCT01904773|11768446|FG007|COMPLETED|Placebo Washout First Intervention||3
10610821|NCT01904773|11768447|FG008|COMPLETED|Placebo Washout First Intervention||4
10610822|NCT01904773|11768439|FG000|NOT COMPLETED|Placebo Washout First Intervention||0
10610823|NCT01904773|11768440|FG001|NOT COMPLETED|Placebo Washout First Intervention||1
10610824|NCT01904773|11768441|FG002|NOT COMPLETED|Placebo Washout First Intervention||0
10610825|NCT01904773|11768442|FG003|NOT COMPLETED|Placebo Washout First Intervention||0
10610826|NCT01904773|11768443|FG004|NOT COMPLETED|Placebo Washout First Intervention||0
10610827|NCT01904773|11768444|FG005|NOT COMPLETED|Placebo Washout First Intervention||0
10610828|NCT01904773|11768445|FG006|NOT COMPLETED|Placebo Washout First Intervention||0
10610829|NCT01904773|11768446|FG007|NOT COMPLETED|Placebo Washout First Intervention||0
10610830|NCT01904773|11768447|FG008|NOT COMPLETED|Placebo Washout First Intervention||0
10610831|NCT01904773|11768439|FG000|STARTED|Second Intervention||0
10610832|NCT01904773|11768440|FG001|STARTED|Second Intervention||1
10610833|NCT01904773|11768441|FG002|STARTED|Second Intervention||1
10610834|NCT01904773|11768442|FG003|STARTED|Second Intervention||2
10610835|NCT01904773|11768443|FG004|STARTED|Second Intervention||3
10610836|NCT01904773|11768444|FG005|STARTED|Second Intervention||4
10610837|NCT01904773|11768445|FG006|STARTED|Second Intervention||3
10610838|NCT01904773|11768446|FG007|STARTED|Second Intervention||3
10610839|NCT01904773|11768447|FG008|STARTED|Second Intervention||4
10610840|NCT01904773|11768439|FG000|COMPLETED|Second Intervention||0
10610841|NCT01904773|11768440|FG001|COMPLETED|Second Intervention||1
10610842|NCT01904773|11768441|FG002|COMPLETED|Second Intervention||1
10610843|NCT01904773|11768442|FG003|COMPLETED|Second Intervention||2
10610844|NCT01904773|11768443|FG004|COMPLETED|Second Intervention||3
10610845|NCT01904773|11768444|FG005|COMPLETED|Second Intervention||4
10610846|NCT01904773|11768445|FG006|COMPLETED|Second Intervention||3
10610847|NCT01904773|11768446|FG007|COMPLETED|Second Intervention||3
10610848|NCT01904773|11768447|FG008|COMPLETED|Second Intervention||4
10610849|NCT01904773|11768439|FG000|NOT COMPLETED|Second Intervention||0
10610850|NCT01904773|11768440|FG001|NOT COMPLETED|Second Intervention||0
10610851|NCT01904773|11768441|FG002|NOT COMPLETED|Second Intervention||0
10610852|NCT01904773|11768442|FG003|NOT COMPLETED|Second Intervention||0
10610853|NCT01904773|11768443|FG004|NOT COMPLETED|Second Intervention||0
10610854|NCT01904773|11768444|FG005|NOT COMPLETED|Second Intervention||0
10610855|NCT01904773|11768445|FG006|NOT COMPLETED|Second Intervention||0
10610856|NCT01904773|11768446|FG007|NOT COMPLETED|Second Intervention||0
10610857|NCT01904773|11768447|FG008|NOT COMPLETED|Second Intervention||0
10610858|NCT01904773|11768439|FG000|STARTED|Placebo Washout Second Intervention||0
10610859|NCT01904773|11768440|FG001|STARTED|Placebo Washout Second Intervention||1
10610860|NCT01904773|11768441|FG002|STARTED|Placebo Washout Second Intervention||1
10610861|NCT01904773|11768442|FG003|STARTED|Placebo Washout Second Intervention||2
10610862|NCT01904773|11768443|FG004|STARTED|Placebo Washout Second Intervention||3
10610863|NCT01904773|11768444|FG005|STARTED|Placebo Washout Second Intervention||4
10610864|NCT01904773|11768445|FG006|STARTED|Placebo Washout Second Intervention||3
10610865|NCT01904773|11768446|FG007|STARTED|Placebo Washout Second Intervention||3
10610866|NCT01904773|11768447|FG008|STARTED|Placebo Washout Second Intervention||4
10610867|NCT01904773|11768439|FG000|COMPLETED|Placebo Washout Second Intervention||0
10610868|NCT01904773|11768440|FG001|COMPLETED|Placebo Washout Second Intervention||1
10610869|NCT01904773|11768441|FG002|COMPLETED|Placebo Washout Second Intervention||1
10610870|NCT01904773|11768442|FG003|COMPLETED|Placebo Washout Second Intervention||2
10610871|NCT01904773|11768443|FG004|COMPLETED|Placebo Washout Second Intervention||3
10610872|NCT01904773|11768444|FG005|COMPLETED|Placebo Washout Second Intervention||4
10610873|NCT01904773|11768445|FG006|COMPLETED|Placebo Washout Second Intervention||3
10610874|NCT01904773|11768446|FG007|COMPLETED|Placebo Washout Second Intervention||3
10704591|NCT02593305|11868950|FG002|COMPLETED|Baseline 1||10
10704592|NCT02593305|11868948|FG000|NOT COMPLETED|Baseline 1||0
10704593|NCT02593305|11868949|FG001|NOT COMPLETED|Baseline 1||0
10704594|NCT02593305|11868950|FG002|NOT COMPLETED|Baseline 1||0
10704595|NCT02593305|11868948|FG000|STARTED|Post 1||7
10704596|NCT02593305|11868949|FG001|STARTED|Post 1||6
10704597|NCT02593305|11868950|FG002|STARTED|Post 1||10
10704598|NCT02593305|11868948|FG000|COMPLETED|Post 1||7
10704599|NCT02593305|11868949|FG001|COMPLETED|Post 1||6
10610875|NCT01904773|11768447|FG008|COMPLETED|Placebo Washout Second Intervention||4
10610876|NCT01904773|11768439|FG000|NOT COMPLETED|Placebo Washout Second Intervention||0
10610877|NCT01904773|11768440|FG001|NOT COMPLETED|Placebo Washout Second Intervention||0
10610878|NCT01904773|11768441|FG002|NOT COMPLETED|Placebo Washout Second Intervention||0
10610879|NCT01904773|11768442|FG003|NOT COMPLETED|Placebo Washout Second Intervention||0
10610880|NCT01904773|11768443|FG004|NOT COMPLETED|Placebo Washout Second Intervention||0
10610881|NCT01904773|11768444|FG005|NOT COMPLETED|Placebo Washout Second Intervention||0
10610882|NCT01904773|11768445|FG006|NOT COMPLETED|Placebo Washout Second Intervention||0
10610883|NCT01904773|11768446|FG007|NOT COMPLETED|Placebo Washout Second Intervention||0
10610884|NCT01904773|11768447|FG008|NOT COMPLETED|Placebo Washout Second Intervention||0
10610885|NCT01904773|11768439|FG000|STARTED|Third Intervention||0
10610886|NCT01904773|11768440|FG001|STARTED|Third Intervention||1
10610887|NCT01904773|11768441|FG002|STARTED|Third Intervention||1
10610889|NCT01904773|11768443|FG004|STARTED|Third Intervention||3
10610890|NCT01904773|11768444|FG005|STARTED|Third Intervention||4
10610891|NCT01904773|11768445|FG006|STARTED|Third Intervention||3
10610892|NCT01904773|11768446|FG007|STARTED|Third Intervention||3
10610893|NCT01904773|11768447|FG008|STARTED|Third Intervention||4
10610894|NCT01904773|11768439|FG000|COMPLETED|Third Intervention||0
10610895|NCT01904773|11768440|FG001|COMPLETED|Third Intervention||1
10610896|NCT01904773|11768441|FG002|COMPLETED|Third Intervention||1
10610897|NCT01904773|11768442|FG003|COMPLETED|Third Intervention||2
10610898|NCT01904773|11768443|FG004|COMPLETED|Third Intervention||3
10610899|NCT01904773|11768444|FG005|COMPLETED|Third Intervention||4
10610900|NCT01904773|11768445|FG006|COMPLETED|Third Intervention||3
10610901|NCT01904773|11768446|FG007|COMPLETED|Third Intervention||3
10610902|NCT01904773|11768447|FG008|COMPLETED|Third Intervention||4
10610903|NCT01904773|11768439|FG000|NOT COMPLETED|Third Intervention||0
10610904|NCT01904773|11768440|FG001|NOT COMPLETED|Third Intervention||0
10610905|NCT01904773|11768441|FG002|NOT COMPLETED|Third Intervention||0
10610906|NCT01904773|11768442|FG003|NOT COMPLETED|Third Intervention||0
10610907|NCT01904773|11768443|FG004|NOT COMPLETED|Third Intervention||0
10610908|NCT01904773|11768444|FG005|NOT COMPLETED|Third Intervention||0
10610909|NCT01904773|11768445|FG006|NOT COMPLETED|Third Intervention||0
10610910|NCT01904773|11768446|FG007|NOT COMPLETED|Third Intervention||0
10610911|NCT01904773|11768447|FG008|NOT COMPLETED|Third Intervention||0
10610912|NCT01904773|11768439|FG000|STARTED|Placebo Washout Third Intervention||0
10610913|NCT01904773|11768440|FG001|STARTED|Placebo Washout Third Intervention||1
10704600|NCT02593305|11868950|FG002|COMPLETED|Post 1||0
10610914|NCT01904773|11768441|FG002|STARTED|Placebo Washout Third Intervention||1
10610915|NCT01904773|11768442|FG003|STARTED|Placebo Washout Third Intervention||2
10610916|NCT01904773|11768443|FG004|STARTED|Placebo Washout Third Intervention||3
10610917|NCT01904773|11768444|FG005|STARTED|Placebo Washout Third Intervention||4
10610918|NCT01904773|11768445|FG006|STARTED|Placebo Washout Third Intervention||3
10610919|NCT01904773|11768446|FG007|STARTED|Placebo Washout Third Intervention||3
10704601|NCT02593305|11868948|FG000|NOT COMPLETED|Post 1||0
10704602|NCT02593305|11868949|FG001|NOT COMPLETED|Post 1||0
10610920|NCT01904773|11768447|FG008|STARTED|Placebo Washout Third Intervention||4
10610921|NCT01904773|11768439|FG000|COMPLETED|Placebo Washout Third Intervention||0
10610922|NCT01904773|11768440|FG001|COMPLETED|Placebo Washout Third Intervention||1
10610923|NCT01904773|11768441|FG002|COMPLETED|Placebo Washout Third Intervention||1
10704603|NCT02593305|11868950|FG002|NOT COMPLETED|Post 1||10
10704604|NCT02593305|11868948|FG000|STARTED|Baseline 2||7
10704605|NCT02593305|11868949|FG001|STARTED|Baseline 2||6
10704606|NCT02593305|11868950|FG002|STARTED|Baseline 2||0
10610924|NCT01904773|11768442|FG003|COMPLETED|Placebo Washout Third Intervention||2
10610925|NCT01904773|11768443|FG004|COMPLETED|Placebo Washout Third Intervention||3
10610926|NCT01904773|11768444|FG005|COMPLETED|Placebo Washout Third Intervention||4
10610927|NCT01904773|11768445|FG006|COMPLETED|Placebo Washout Third Intervention||3
10610928|NCT01904773|11768446|FG007|COMPLETED|Placebo Washout Third Intervention||3
10610929|NCT01904773|11768447|FG008|COMPLETED|Placebo Washout Third Intervention||4
10610930|NCT01904773|11768439|FG000|NOT COMPLETED|Placebo Washout Third Intervention||0
10610931|NCT01904773|11768440|FG001|NOT COMPLETED|Placebo Washout Third Intervention||0
10610932|NCT01904773|11768441|FG002|NOT COMPLETED|Placebo Washout Third Intervention||0
10610933|NCT01904773|11768442|FG003|NOT COMPLETED|Placebo Washout Third Intervention||0
10610934|NCT01904773|11768443|FG004|NOT COMPLETED|Placebo Washout Third Intervention||0
10610935|NCT01904773|11768444|FG005|NOT COMPLETED|Placebo Washout Third Intervention||0
10610936|NCT01904773|11768445|FG006|NOT COMPLETED|Placebo Washout Third Intervention||0
10610937|NCT01904773|11768446|FG007|NOT COMPLETED|Placebo Washout Third Intervention||0
10610938|NCT01904773|11768447|FG008|NOT COMPLETED|Placebo Washout Third Intervention||0
10610939|NCT01904773|11768439|FG000|STARTED|Fourth Intervention||0
10610940|NCT01904773|11768440|FG001|STARTED|Fourth Intervention||1
10610941|NCT01904773|11768441|FG002|STARTED|Fourth Intervention||1
10610942|NCT01904773|11768442|FG003|STARTED|Fourth Intervention||2
10610943|NCT01904773|11768443|FG004|STARTED|Fourth Intervention||3
10610944|NCT01904773|11768444|FG005|STARTED|Fourth Intervention||4
10610945|NCT01904773|11768445|FG006|STARTED|Fourth Intervention||3
10610946|NCT01904773|11768446|FG007|STARTED|Fourth Intervention||3
10610947|NCT01904773|11768447|FG008|STARTED|Fourth Intervention||4
10610948|NCT01904773|11768439|FG000|COMPLETED|Fourth Intervention||0
10610949|NCT01904773|11768440|FG001|COMPLETED|Fourth Intervention||1
10610950|NCT01904773|11768441|FG002|COMPLETED|Fourth Intervention||1
10610951|NCT01904773|11768442|FG003|COMPLETED|Fourth Intervention||2
10610952|NCT01904773|11768443|FG004|COMPLETED|Fourth Intervention||3
10610953|NCT01904773|11768444|FG005|COMPLETED|Fourth Intervention||4
10610954|NCT01904773|11768445|FG006|COMPLETED|Fourth Intervention||3
10610955|NCT01904773|11768446|FG007|COMPLETED|Fourth Intervention||3
10610956|NCT01904773|11768447|FG008|COMPLETED|Fourth Intervention||4
10610957|NCT01904773|11768439|FG000|NOT COMPLETED|Fourth Intervention||0
10610958|NCT01904773|11768440|FG001|NOT COMPLETED|Fourth Intervention||0
10610959|NCT01904773|11768441|FG002|NOT COMPLETED|Fourth Intervention||0
10610960|NCT01904773|11768442|FG003|NOT COMPLETED|Fourth Intervention||0
10610961|NCT01904773|11768443|FG004|NOT COMPLETED|Fourth Intervention||0
10610962|NCT01904773|11768444|FG005|NOT COMPLETED|Fourth Intervention||0
10610963|NCT01904773|11768445|FG006|NOT COMPLETED|Fourth Intervention||0
10610964|NCT01904773|11768446|FG007|NOT COMPLETED|Fourth Intervention||0
10610965|NCT01904773|11768447|FG008|NOT COMPLETED|Fourth Intervention||0
10610966|NCT01904773|11768439|FG000|STARTED|Placebo Washout Fourth Intervention||0
10610967|NCT01904773|11768440|FG001|STARTED|Placebo Washout Fourth Intervention||1
10610968|NCT01904773|11768441|FG002|STARTED|Placebo Washout Fourth Intervention||1
10610969|NCT01904773|11768442|FG003|STARTED|Placebo Washout Fourth Intervention||2
10610970|NCT01904773|11768443|FG004|STARTED|Placebo Washout Fourth Intervention||3
10610971|NCT01904773|11768444|FG005|STARTED|Placebo Washout Fourth Intervention||4
10610972|NCT01904773|11768445|FG006|STARTED|Placebo Washout Fourth Intervention||3
10610973|NCT01904773|11768446|FG007|STARTED|Placebo Washout Fourth Intervention||3
10610974|NCT01904773|11768447|FG008|STARTED|Placebo Washout Fourth Intervention||4
10610975|NCT01904773|11768439|FG000|COMPLETED|Placebo Washout Fourth Intervention||0
10610976|NCT01904773|11768440|FG001|COMPLETED|Placebo Washout Fourth Intervention||1
10610977|NCT01904773|11768441|FG002|COMPLETED|Placebo Washout Fourth Intervention||1
10610978|NCT01904773|11768442|FG003|COMPLETED|Placebo Washout Fourth Intervention||2
10610979|NCT01904773|11768443|FG004|COMPLETED|Placebo Washout Fourth Intervention||3
10610980|NCT01904773|11768444|FG005|COMPLETED|Placebo Washout Fourth Intervention||4
10610981|NCT01904773|11768445|FG006|COMPLETED|Placebo Washout Fourth Intervention||3
10610982|NCT01904773|11768446|FG007|COMPLETED|Placebo Washout Fourth Intervention||3
10610983|NCT01904773|11768447|FG008|COMPLETED|Placebo Washout Fourth Intervention||4
10610984|NCT01904773|11768439|FG000|NOT COMPLETED|Placebo Washout Fourth Intervention||0
10610985|NCT01904773|11768440|FG001|NOT COMPLETED|Placebo Washout Fourth Intervention||0
10610986|NCT01904773|11768441|FG002|NOT COMPLETED|Placebo Washout Fourth Intervention||0
10610987|NCT01904773|11768442|FG003|NOT COMPLETED|Placebo Washout Fourth Intervention||0
10610988|NCT01904773|11768443|FG004|NOT COMPLETED|Placebo Washout Fourth Intervention||0
10610989|NCT01904773|11768444|FG005|NOT COMPLETED|Placebo Washout Fourth Intervention||0
10610990|NCT01904773|11768445|FG006|NOT COMPLETED|Placebo Washout Fourth Intervention||0
10610991|NCT01904773|11768446|FG007|NOT COMPLETED|Placebo Washout Fourth Intervention||0
10704607|NCT02593305|11868948|FG000|COMPLETED|Baseline 2||7
10704608|NCT02593305|11868949|FG001|COMPLETED|Baseline 2||6
10610992|NCT01904773|11768447|FG008|NOT COMPLETED|Placebo Washout Fourth Intervention||0
10610993|NCT01904773|11768439|FG000|STARTED|Fifth Intervention||0
10610994|NCT01904773|11768440|FG001|STARTED|Fifth Intervention||1
10610995|NCT01904773|11768441|FG002|STARTED|Fifth Intervention||1
10610996|NCT01904773|11768442|FG003|STARTED|Fifth Intervention||2
10610997|NCT01904773|11768443|FG004|STARTED|Fifth Intervention||3
10610998|NCT01904773|11768444|FG005|STARTED|Fifth Intervention||4
10610999|NCT01904773|11768445|FG006|STARTED|Fifth Intervention||3
10704609|NCT02593305|11868950|FG002|COMPLETED|Baseline 2||0
10611000|NCT01904773|11768446|FG007|STARTED|Fifth Intervention||3
10611001|NCT01904773|11768447|FG008|STARTED|Fifth Intervention||4
10611002|NCT01904773|11768439|FG000|COMPLETED|Fifth Intervention||0
10611003|NCT01904773|11768440|FG001|COMPLETED|Fifth Intervention||1
10611004|NCT01904773|11768441|FG002|COMPLETED|Fifth Intervention||1
10611005|NCT01904773|11768442|FG003|COMPLETED|Fifth Intervention||2
10611006|NCT01904773|11768443|FG004|COMPLETED|Fifth Intervention||3
10611007|NCT01904773|11768444|FG005|COMPLETED|Fifth Intervention||4
10611008|NCT01904773|11768445|FG006|COMPLETED|Fifth Intervention||3
10611009|NCT01904773|11768446|FG007|COMPLETED|Fifth Intervention||2
10611010|NCT01904773|11768447|FG008|COMPLETED|Fifth Intervention||4
10611011|NCT01904773|11768439|FG000|NOT COMPLETED|Fifth Intervention||0
10611012|NCT01904773|11768440|FG001|NOT COMPLETED|Fifth Intervention||0
10611013|NCT01904773|11768441|FG002|NOT COMPLETED|Fifth Intervention||0
10611014|NCT01904773|11768442|FG003|NOT COMPLETED|Fifth Intervention||0
10611015|NCT01904773|11768443|FG004|NOT COMPLETED|Fifth Intervention||0
10611016|NCT01904773|11768444|FG005|NOT COMPLETED|Fifth Intervention||0
10611017|NCT01904773|11768445|FG006|NOT COMPLETED|Fifth Intervention||0
10611018|NCT01904773|11768446|FG007|NOT COMPLETED|Fifth Intervention||1
10611019|NCT01904773|11768447|FG008|NOT COMPLETED|Fifth Intervention||0
10611020|NCT01904773|11768439|FG000|STARTED|Placebo Washout Fifth Intervention||0
10611021|NCT01904773|11768440|FG001|STARTED|Placebo Washout Fifth Intervention||1
10611022|NCT01904773|11768441|FG002|STARTED|Placebo Washout Fifth Intervention||1
10611023|NCT01904773|11768442|FG003|STARTED|Placebo Washout Fifth Intervention||2
10611024|NCT01904773|11768443|FG004|STARTED|Placebo Washout Fifth Intervention||3
10611025|NCT01904773|11768444|FG005|STARTED|Placebo Washout Fifth Intervention||4
10611026|NCT01904773|11768445|FG006|STARTED|Placebo Washout Fifth Intervention||3
10611027|NCT01904773|11768446|FG007|STARTED|Placebo Washout Fifth Intervention||2
10611028|NCT01904773|11768447|FG008|STARTED|Placebo Washout Fifth Intervention||4
10611029|NCT01904773|11768439|FG000|COMPLETED|Placebo Washout Fifth Intervention||0
10611030|NCT01904773|11768440|FG001|COMPLETED|Placebo Washout Fifth Intervention||0
10611031|NCT01904773|11768441|FG002|COMPLETED|Placebo Washout Fifth Intervention||1
10611032|NCT01904773|11768442|FG003|COMPLETED|Placebo Washout Fifth Intervention||2
10611033|NCT01904773|11768443|FG004|COMPLETED|Placebo Washout Fifth Intervention||3
10611034|NCT01904773|11768444|FG005|COMPLETED|Placebo Washout Fifth Intervention||4
10611035|NCT01904773|11768445|FG006|COMPLETED|Placebo Washout Fifth Intervention||3
10611036|NCT01904773|11768446|FG007|COMPLETED|Placebo Washout Fifth Intervention||2
10611037|NCT01904773|11768447|FG008|COMPLETED|Placebo Washout Fifth Intervention||4
10611038|NCT01904773|11768439|FG000|NOT COMPLETED|Placebo Washout Fifth Intervention||0
10611039|NCT01904773|11768440|FG001|NOT COMPLETED|Placebo Washout Fifth Intervention||1
10611040|NCT01904773|11768441|FG002|NOT COMPLETED|Placebo Washout Fifth Intervention||0
10611041|NCT01904773|11768442|FG003|NOT COMPLETED|Placebo Washout Fifth Intervention||0
10611042|NCT01904773|11768443|FG004|NOT COMPLETED|Placebo Washout Fifth Intervention||0
10611043|NCT01904773|11768444|FG005|NOT COMPLETED|Placebo Washout Fifth Intervention||0
10611044|NCT01904773|11768445|FG006|NOT COMPLETED|Placebo Washout Fifth Intervention||0
10611045|NCT01904773|11768446|FG007|NOT COMPLETED|Placebo Washout Fifth Intervention||0
10611046|NCT01904773|11768447|FG008|NOT COMPLETED|Placebo Washout Fifth Intervention||0
10611047|NCT01904773|11768439|FG000|STARTED|Sixth Intervention||0
10611048|NCT01904773|11768440|FG001|STARTED|Sixth Intervention||0
10611049|NCT01904773|11768441|FG002|STARTED|Sixth Intervention||1
10611050|NCT01904773|11768442|FG003|STARTED|Sixth Intervention||2
10611051|NCT01904773|11768443|FG004|STARTED|Sixth Intervention||3
10611052|NCT01904773|11768444|FG005|STARTED|Sixth Intervention||4
10611053|NCT01904773|11768445|FG006|STARTED|Sixth Intervention||3
10611054|NCT01904773|11768446|FG007|STARTED|Sixth Intervention||2
10611055|NCT01904773|11768447|FG008|STARTED|Sixth Intervention||4
10611056|NCT01904773|11768439|FG000|COMPLETED|Sixth Intervention||0
10611057|NCT01904773|11768440|FG001|COMPLETED|Sixth Intervention||0
10611058|NCT01904773|11768441|FG002|COMPLETED|Sixth Intervention||1
10611059|NCT01904773|11768442|FG003|COMPLETED|Sixth Intervention||2
10611060|NCT01904773|11768443|FG004|COMPLETED|Sixth Intervention||3
10611061|NCT01904773|11768444|FG005|COMPLETED|Sixth Intervention||4
10611062|NCT01904773|11768445|FG006|COMPLETED|Sixth Intervention||3
10611063|NCT01904773|11768446|FG007|COMPLETED|Sixth Intervention||2
10611064|NCT01904773|11768447|FG008|COMPLETED|Sixth Intervention||4
10611065|NCT01904773|11768439|FG000|NOT COMPLETED|Sixth Intervention||0
10611066|NCT01904773|11768440|FG001|NOT COMPLETED|Sixth Intervention||0
10611067|NCT01904773|11768441|FG002|NOT COMPLETED|Sixth Intervention||0
10611068|NCT01904773|11768442|FG003|NOT COMPLETED|Sixth Intervention||0
10611069|NCT01904773|11768443|FG004|NOT COMPLETED|Sixth Intervention||0
10611070|NCT01904773|11768444|FG005|NOT COMPLETED|Sixth Intervention||0
10611071|NCT01904773|11768445|FG006|NOT COMPLETED|Sixth Intervention||0
10611072|NCT01904773|11768446|FG007|NOT COMPLETED|Sixth Intervention||0
10611073|NCT01904773|11768447|FG008|NOT COMPLETED|Sixth Intervention||0
10653118|NCT02190604|11813572|FG016|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
10653119|NCT02190604|11813573|FG017|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
10653120|NCT02190604|11813574|FG018|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
10653121|NCT02190604|11813556|FG000|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
10653122|NCT02190604|11813557|FG001|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
10653123|NCT02190604|11813558|FG002|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
10653124|NCT02190604|11813559|FG003|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
10611074|NCT01904864|11768461|FG000|STARTED|Overall Study||40
10611075|NCT01904864|11768462|FG001|STARTED|Overall Study||40
10611076|NCT01904864|11768461|FG000|COMPLETED|Overall Study||31
10611077|NCT01904864|11768462|FG001|COMPLETED|Overall Study||28
10611078|NCT01904864|11768461|FG000|NOT COMPLETED|Overall Study||9
10611079|NCT01904864|11768462|FG001|NOT COMPLETED|Overall Study||12
10611080|NCT01905241|11768468|FG000|STARTED|Overall Study||20
10611081|NCT01905241|11768468|FG000|COMPLETED|Overall Study||20
10611082|NCT01905241|11768468|FG000|NOT COMPLETED|Overall Study||0
10611083|NCT01905254|11768472|FG000|STARTED|Overall Study||34
10611084|NCT01905254|11768472|FG000|COMPLETED|Overall Study||34
10611085|NCT01905254|11768472|FG000|NOT COMPLETED|Overall Study||0
10611086|NCT01905267|11768478|FG000|STARTED|Overall Study||17
10611087|NCT01905267|11768479|FG001|STARTED|Overall Study||16
10611088|NCT01905267|11768478|FG000|COMPLETED|Overall Study||15
10611089|NCT01905267|11768479|FG001|COMPLETED|Overall Study||14
10611090|NCT01905267|11768478|FG000|NOT COMPLETED|Overall Study||2
10611091|NCT01905267|11768479|FG001|NOT COMPLETED|Overall Study||2
10611092|NCT01905423|11768490|FG000|STARTED|Overall Study||4456
10611093|NCT01905423|11768491|FG001|STARTED|Overall Study||3297
10611094|NCT01905423|11768492|FG002|STARTED|Overall Study||4111
10611095|NCT01905423|11768493|FG003|STARTED|Overall Study||2757
10611096|NCT01905423|11768494|FG004|STARTED|Overall Study||2487
10611097|NCT01905423|11768490|FG000|Baseline|Overall Study||1443
10611098|NCT01905423|11768491|FG001|Baseline|Overall Study||722
10611099|NCT01905423|11768492|FG002|Baseline|Overall Study||1033
10611100|NCT01905423|11768493|FG003|Baseline|Overall Study||1482
10611101|NCT01905423|11768494|FG004|Baseline|Overall Study||1326
10611102|NCT01905423|11768490|FG000|Year 1 Follow-up|Overall Study||994
10611103|NCT01905423|11768491|FG001|Year 1 Follow-up|Overall Study||846
10611104|NCT01905423|11768492|FG002|Year 1 Follow-up|Overall Study||1007
10611105|NCT01905423|11768493|FG003|Year 1 Follow-up|Overall Study||1275
10611106|NCT01905423|11768494|FG004|Year 1 Follow-up|Overall Study||1161
10611107|NCT01905423|11768490|FG000|Year 2 Follow-up|Overall Study||1114
10611108|NCT01905423|11768491|FG001|Year 2 Follow-up|Overall Study||858
10611109|NCT01905423|11768492|FG002|Year 2 Follow-up|Overall Study||1043
10611110|NCT01905423|11768493|FG003|Year 2 Follow-up|Overall Study||0
10611111|NCT01905423|11768494|FG004|Year 2 Follow-up|Overall Study||0
10611112|NCT01905423|11768490|FG000|Year 3 Follow-up|Overall Study||905
10611113|NCT01905423|11768491|FG001|Year 3 Follow-up|Overall Study||871
10611114|NCT01905423|11768492|FG002|Year 3 Follow-up|Overall Study||1028
10611115|NCT01905423|11768493|FG003|Year 3 Follow-up|Overall Study||0
10611116|NCT01905423|11768494|FG004|Year 3 Follow-up|Overall Study||0
10611117|NCT01905423|11768490|FG000|COMPLETED|Overall Study||4456
10611118|NCT01905423|11768491|FG001|COMPLETED|Overall Study||3297
10611119|NCT01905423|11768492|FG002|COMPLETED|Overall Study||4111
10611120|NCT01905423|11768493|FG003|COMPLETED|Overall Study||2757
10611121|NCT01905423|11768494|FG004|COMPLETED|Overall Study||2487
10611122|NCT01905423|11768490|FG000|NOT COMPLETED|Overall Study||0
10611123|NCT01905423|11768491|FG001|NOT COMPLETED|Overall Study||0
10611124|NCT01905423|11768492|FG002|NOT COMPLETED|Overall Study||0
10611125|NCT01905423|11768493|FG003|NOT COMPLETED|Overall Study||0
10611126|NCT01905423|11768494|FG004|NOT COMPLETED|Overall Study||0
10611127|NCT01905540|11768510|FG000|STARTED|Period 1||7
10611128|NCT01905540|11768511|FG001|STARTED|Period 1||7
10611129|NCT01905540|11768512|FG002|STARTED|Period 1||7
10611130|NCT01905540|11768513|FG003|STARTED|Period 1||7
10611131|NCT01905540|11768510|FG000|COMPLETED|Period 1||7
10611132|NCT01905540|11768511|FG001|COMPLETED|Period 1||7
10611133|NCT01905540|11768512|FG002|COMPLETED|Period 1||7
10611134|NCT01905540|11768513|FG003|COMPLETED|Period 1||7
10611135|NCT01905540|11768510|FG000|NOT COMPLETED|Period 1||0
10611136|NCT01905540|11768511|FG001|NOT COMPLETED|Period 1||0
10611137|NCT01905540|11768512|FG002|NOT COMPLETED|Period 1||0
10611138|NCT01905540|11768513|FG003|NOT COMPLETED|Period 1||0
10611139|NCT01905540|11768510|FG000|STARTED|Period 2||7
10611140|NCT01905540|11768511|FG001|STARTED|Period 2||7
10611141|NCT01905540|11768512|FG002|STARTED|Period 2||7
10611142|NCT01905540|11768513|FG003|STARTED|Period 2||7
10611143|NCT01905540|11768510|FG000|COMPLETED|Period 2||7
10611144|NCT01905540|11768511|FG001|COMPLETED|Period 2||7
10611145|NCT01905540|11768512|FG002|COMPLETED|Period 2||7
10611146|NCT01905540|11768513|FG003|COMPLETED|Period 2||7
10611147|NCT01905540|11768510|FG000|NOT COMPLETED|Period 2||0
10611148|NCT01905540|11768511|FG001|NOT COMPLETED|Period 2||0
10611149|NCT01905540|11768512|FG002|NOT COMPLETED|Period 2||0
10611150|NCT01905540|11768513|FG003|NOT COMPLETED|Period 2||0
10611151|NCT01905540|11768510|FG000|STARTED|Period 3||7
10611152|NCT01905540|11768511|FG001|STARTED|Period 3||7
10611153|NCT01905540|11768512|FG002|STARTED|Period 3||7
10611154|NCT01905540|11768513|FG003|STARTED|Period 3||7
10611155|NCT01905540|11768510|FG000|COMPLETED|Period 3||6
10611156|NCT01905540|11768511|FG001|COMPLETED|Period 3||7
10611157|NCT01905540|11768512|FG002|COMPLETED|Period 3||6
10611158|NCT01905540|11768513|FG003|COMPLETED|Period 3||6
10611159|NCT01905540|11768510|FG000|NOT COMPLETED|Period 3||1
10611160|NCT01905540|11768511|FG001|NOT COMPLETED|Period 3||0
10611161|NCT01905540|11768512|FG002|NOT COMPLETED|Period 3||1
10611162|NCT01905540|11768513|FG003|NOT COMPLETED|Period 3||1
10611163|NCT01905553|11768525|FG000|STARTED|Period 1||5
10611164|NCT01905553|11768526|FG001|STARTED|Period 1||4
10611165|NCT01905553|11768525|FG000|COMPLETED|Period 1||5
10611166|NCT01905553|11768526|FG001|COMPLETED|Period 1||4
10611167|NCT01905553|11768525|FG000|NOT COMPLETED|Period 1||0
10611168|NCT01905553|11768526|FG001|NOT COMPLETED|Period 1||0
10611169|NCT01905553|11768525|FG000|STARTED|Period 2||5
10611170|NCT01905553|11768526|FG001|STARTED|Period 2||4
10611171|NCT01905553|11768525|FG000|COMPLETED|Period 2||4
10611172|NCT01905553|11768526|FG001|COMPLETED|Period 2||4
10611173|NCT01905553|11768525|FG000|NOT COMPLETED|Period 2||1
10611174|NCT01905553|11768526|FG001|NOT COMPLETED|Period 2||0
10611175|NCT01905592|11768534|FG000|STARTED|Overall Study||71
10611176|NCT01905592|11768535|FG001|STARTED|Overall Study||135
10611177|NCT01905592|11768534|FG000|COMPLETED|Overall Study||0
10611178|NCT01905592|11768535|FG001|COMPLETED|Overall Study||0
10611179|NCT01905592|11768534|FG000|NOT COMPLETED|Overall Study||71
10611180|NCT01905592|11768535|FG001|NOT COMPLETED|Overall Study||135
10611181|NCT01905657|11768544|FG000|STARTED|Overall Study||345
10611182|NCT01905657|11768545|FG001|STARTED|Overall Study||346
10611183|NCT01905657|11768546|FG002|STARTED|Overall Study||343
10611184|NCT01905657|11768544|FG000|Treated|Overall Study||339
10611185|NCT01905657|11768545|FG001|Treated|Overall Study||343
10611186|NCT01905657|11768546|FG002|Treated|Overall Study||309
10611187|NCT01905657|11768544|FG000|Received Second Course of Pembrolizumab|Overall Study||14
10611188|NCT01905657|11768545|FG001|Received Second Course of Pembrolizumab|Overall Study||7
10611189|NCT01905657|11768546|FG002|Received Second Course of Pembrolizumab|Overall Study||0
10611190|NCT01905657|11768544|FG000|Switched Over to Pembrolizumab|Overall Study||0
10611191|NCT01905657|11768545|FG001|Switched Over to Pembrolizumab|Overall Study||0
10611192|NCT01905657|11768546|FG002|Switched Over to Pembrolizumab|Overall Study||8
10611193|NCT01905657|11768544|FG000|COMPLETED|Overall Study||142
10611194|NCT01905657|11768545|FG001|COMPLETED|Overall Study||159
10611195|NCT01905657|11768546|FG002|COMPLETED|Overall Study||143
10611196|NCT01905657|11768544|FG000|NOT COMPLETED|Overall Study||203
10611197|NCT01905657|11768545|FG001|NOT COMPLETED|Overall Study||187
10611198|NCT01905657|11768546|FG002|NOT COMPLETED|Overall Study||200
10611199|NCT01905683|11768557|FG000|STARTED|Overall Study||370
10611200|NCT01905683|11768557|FG000|COMPLETED|Overall Study||319
10611201|NCT01905683|11768557|FG000|NOT COMPLETED|Overall Study||51
10611202|NCT01905943|11768561|FG000|STARTED|Overall Study||972
10611203|NCT01905943|11768561|FG000|COMPLETED|Overall Study|All patients provide reason at final analysis|658
10611204|NCT01905943|11768561|FG000|NOT COMPLETED|Overall Study||314
10611205|NCT01905956|11768582|FG000|STARTED|Overall Study|Randomized|60
10611206|NCT01905956|11768583|FG001|STARTED|Overall Study|Randomized|59
10704610|NCT02593305|11868948|FG000|NOT COMPLETED|Baseline 2||0
10704611|NCT02593305|11868949|FG001|NOT COMPLETED|Baseline 2||0
10704612|NCT02593305|11868950|FG002|NOT COMPLETED|Baseline 2||0
10704613|NCT02593305|11868948|FG000|STARTED|Post 2||7
10704614|NCT02593305|11868949|FG001|STARTED|Post 2||6
10611207|NCT01905956|11768582|FG000|Intention-to-treat Population|Overall Study|Intention-to-treat population|57
10611208|NCT01905956|11768583|FG001|Intention-to-treat Population|Overall Study|Intention-to-treat population|54
10611209|NCT01905956|11768582|FG000|COMPLETED|Overall Study|Per-protocol population|54
10611210|NCT01905956|11768583|FG001|COMPLETED|Overall Study|Per-protocol population|48
10611211|NCT01905956|11768582|FG000|NOT COMPLETED|Overall Study||6
10611212|NCT01905956|11768583|FG001|NOT COMPLETED|Overall Study||11
10611213|NCT01906008|11768591|FG000|STARTED|Overall Study||59
10611214|NCT01906008|11768592|FG001|STARTED|Overall Study||61
10611215|NCT01906008|11768591|FG000|COMPLETED|Overall Study||32
10611216|NCT01906008|11768592|FG001|COMPLETED|Overall Study||34
10611217|NCT01906008|11768591|FG000|NOT COMPLETED|Overall Study||27
10611218|NCT01906008|11768592|FG001|NOT COMPLETED|Overall Study||27
10611219|NCT01906346|11768598|FG000|STARTED|Overall Study||9
10611220|NCT01906346|11768598|FG000|COMPLETED|Overall Study||8
10611221|NCT01906346|11768598|FG000|NOT COMPLETED|Overall Study||1
10611222|NCT01906372|11768604|FG000|STARTED|Overall Study||12
10611223|NCT01906372|11768604|FG000|Visit 7: Treatment Phase Completed|Overall Study||10
10611224|NCT01906372|11768604|FG000|Visit 10: Follow up Phase Completed|Overall Study||8
10611225|NCT01906372|11768604|FG000|COMPLETED|Overall Study||10
10611226|NCT01906372|11768604|FG000|NOT COMPLETED|Overall Study||2
10611227|NCT01906476|11768611|FG000|STARTED|Overall Study||157
10611228|NCT01906476|11768612|FG001|STARTED|Overall Study||155
10611229|NCT01906476|11768611|FG000|COMPLETED|Overall Study||140
10611230|NCT01906476|11768612|FG001|COMPLETED|Overall Study||139
10611231|NCT01906476|11768611|FG000|NOT COMPLETED|Overall Study||17
10704615|NCT02593305|11868950|FG002|STARTED|Post 2||0
10704616|NCT02593305|11868948|FG000|COMPLETED|Post 2||7
10704617|NCT02593305|11868949|FG001|COMPLETED|Post 2||6
10704618|NCT02593305|11868950|FG002|COMPLETED|Post 2||0
10704619|NCT02593305|11868948|FG000|NOT COMPLETED|Post 2||0
10704620|NCT02593305|11868949|FG001|NOT COMPLETED|Post 2||0
10704621|NCT02593305|11868950|FG002|NOT COMPLETED|Post 2||0
10704622|NCT02593318|11868961|FG000|STARTED|Overall Study||16
10704623|NCT02593318|11868962|FG001|STARTED|Overall Study||16
10611232|NCT01906476|11768612|FG001|NOT COMPLETED|Overall Study||16
10611233|NCT01906515|11768620|FG000|STARTED|Overall Study||45
10611234|NCT01906515|11768621|FG001|STARTED|Overall Study||61
10611235|NCT01906515|11768620|FG000|COMPLETED|Overall Study||45
10611236|NCT01906515|11768621|FG001|COMPLETED|Overall Study||61
10611237|NCT01906515|11768620|FG000|NOT COMPLETED|Overall Study||0
10611238|NCT01906515|11768621|FG001|NOT COMPLETED|Overall Study||0
10611239|NCT01906658|11768632|FG000|STARTED|Overall Study||11
10611240|NCT01906658|11768633|FG001|STARTED|Overall Study||11
10704624|NCT02593318|11868961|FG000|COMPLETED|Overall Study||15
10704625|NCT02593318|11868962|FG001|COMPLETED|Overall Study||15
10611241|NCT01906658|11768634|FG002|STARTED|Overall Study||10
10611242|NCT01906658|11768635|FG003|STARTED|Overall Study||11
10704626|NCT02593318|11868961|FG000|NOT COMPLETED|Overall Study||1
10704627|NCT02593318|11868962|FG001|NOT COMPLETED|Overall Study||1
10704628|NCT02593396|11868976|FG000|STARTED|Overall Study||40
10611243|NCT01906658|11768632|FG000|COMPLETED|Overall Study||9
10611244|NCT01906658|11768633|FG001|COMPLETED|Overall Study||10
10611245|NCT01906658|11768634|FG002|COMPLETED|Overall Study||7
10611246|NCT01906658|11768635|FG003|COMPLETED|Overall Study||11
10611247|NCT01906658|11768632|FG000|NOT COMPLETED|Overall Study||2
10611248|NCT01906658|11768633|FG001|NOT COMPLETED|Overall Study||1
10611249|NCT01906658|11768634|FG002|NOT COMPLETED|Overall Study||3
10611250|NCT01906658|11768635|FG003|NOT COMPLETED|Overall Study||0
10611251|NCT01906866|11768647|FG000|STARTED|Overall Study||60
10611252|NCT01906866|11768648|FG001|STARTED|Overall Study||65
10611253|NCT01906866|11768647|FG000|COMPLETED|Overall Study||51
10611254|NCT01906866|11768648|FG001|COMPLETED|Overall Study||44
10611255|NCT01906866|11768647|FG000|NOT COMPLETED|Overall Study||9
10611256|NCT01906866|11768648|FG001|NOT COMPLETED|Overall Study||21
10611257|NCT01907087|11768657|FG000|STARTED|Overall Study||24
10611258|NCT01907087|11768657|FG000|COMPLETED|Overall Study||23
10611259|NCT01907087|11768657|FG000|NOT COMPLETED|Overall Study||1
10611260|NCT01907100|11768665|FG000|STARTED|Overall Study||43
10611261|NCT01907100|11768666|FG001|STARTED|Overall Study||44
10611262|NCT01907100|11768667|FG002|STARTED|Overall Study||229
10611263|NCT01907100|11768668|FG003|STARTED|Overall Study||229
10611264|NCT01907100|11768665|FG000|Treated Patients|Overall Study||41
10611265|NCT01907100|11768666|FG001|Treated Patients|Overall Study||44
10611266|NCT01907100|11768667|FG002|Treated Patients|Overall Study||228
10611267|NCT01907100|11768668|FG003|Treated Patients|Overall Study||227
10611268|NCT01907100|11768665|FG000|COMPLETED|Overall Study||1
10611269|NCT01907100|11768666|FG001|COMPLETED|Overall Study||4
10611270|NCT01907100|11768667|FG002|COMPLETED|Overall Study||82
10611271|NCT01907100|11768668|FG003|COMPLETED|Overall Study||83
10611272|NCT01907100|11768665|FG000|NOT COMPLETED|Overall Study||42
10704629|NCT02593396|11868977|FG001|STARTED|Overall Study||40
10704630|NCT02593396|11868976|FG000|At Least Done One Efficacy Assessment|Overall Study||36
10611273|NCT01907100|11768666|FG001|NOT COMPLETED|Overall Study||40
10611274|NCT01907100|11768667|FG002|NOT COMPLETED|Overall Study||147
10611275|NCT01907100|11768668|FG003|NOT COMPLETED|Overall Study||146
10611276|NCT01907113|11768681|FG000|STARTED|Overall Study||8
10611277|NCT01907113|11768682|FG001|STARTED|Overall Study||9
10611278|NCT01907113|11768683|FG002|STARTED|Overall Study||7
10611279|NCT01907113|11768684|FG003|STARTED|Overall Study||8
10611280|NCT01907113|11768685|FG004|STARTED|Overall Study||8
10611281|NCT01907113|11768681|FG000|COMPLETED|Overall Study||8
10611282|NCT01907113|11768682|FG001|COMPLETED|Overall Study||9
10611283|NCT01907113|11768683|FG002|COMPLETED|Overall Study||7
10611284|NCT01907113|11768684|FG003|COMPLETED|Overall Study||8
10611285|NCT01907113|11768685|FG004|COMPLETED|Overall Study||8
10611286|NCT01907113|11768681|FG000|NOT COMPLETED|Overall Study||0
10611287|NCT01907113|11768682|FG001|NOT COMPLETED|Overall Study||0
10611288|NCT01907113|11768683|FG002|NOT COMPLETED|Overall Study||0
10611289|NCT01907113|11768684|FG003|NOT COMPLETED|Overall Study||0
10611290|NCT01907113|11768685|FG004|NOT COMPLETED|Overall Study||0
10611291|NCT01907217|11768699|FG000|STARTED|Overall Study||69
10611292|NCT01907217|11768700|FG001|STARTED|Overall Study||69
10611293|NCT01907217|11768699|FG000|COMPLETED|Overall Study||69
10611294|NCT01907217|11768700|FG001|COMPLETED|Overall Study||67
10611295|NCT01907217|11768699|FG000|NOT COMPLETED|Overall Study||0
10611296|NCT01907217|11768700|FG001|NOT COMPLETED|Overall Study||2
10611297|NCT01907269|11768710|FG000|STARTED|6 Month Outcome Measures Post-interventi||1342
10611298|NCT01907269|11768711|FG001|STARTED|6 Month Outcome Measures Post-interventi||1342
10611299|NCT01907269|11768710|FG000|COMPLETED|6 Month Outcome Measures Post-interventi||953
10611300|NCT01907269|11768711|FG001|COMPLETED|6 Month Outcome Measures Post-interventi||1053
10611301|NCT01907269|11768710|FG000|NOT COMPLETED|6 Month Outcome Measures Post-interventi||389
10611302|NCT01907269|11768711|FG001|NOT COMPLETED|6 Month Outcome Measures Post-interventi||289
10611303|NCT01907269|11768710|FG000|STARTED|18 Month Outcome Measures Post-intervent||1178
10611304|NCT01907269|11768711|FG001|STARTED|18 Month Outcome Measures Post-intervent||1250
10611305|NCT01907269|11768710|FG000|COMPLETED|18 Month Outcome Measures Post-intervent||859
10611306|NCT01907269|11768711|FG001|COMPLETED|18 Month Outcome Measures Post-intervent||970
10611307|NCT01907269|11768710|FG000|NOT COMPLETED|18 Month Outcome Measures Post-intervent||319
10611308|NCT01907269|11768711|FG001|NOT COMPLETED|18 Month Outcome Measures Post-intervent||280
10611309|NCT01907321|11768717|FG000|STARTED|Overall Study||14
10611310|NCT01907321|11768717|FG000|COMPLETED|Overall Study||12
10611311|NCT01907321|11768717|FG000|NOT COMPLETED|Overall Study||2
10611312|NCT01907334|11768721|FG000|STARTED|Overall Study||6
10611313|NCT01907334|11768722|FG001|STARTED|Overall Study||4
10611314|NCT01907334|11768721|FG000|COMPLETED|Overall Study||6
10704631|NCT02593396|11868977|FG001|At Least Done One Efficacy Assessment|Overall Study||36
10611315|NCT01907334|11768722|FG001|COMPLETED|Overall Study||4
10611316|NCT01907334|11768721|FG000|NOT COMPLETED|Overall Study||0
10704632|NCT02593396|11868976|FG000|COMPLETED|Overall Study||25
10611317|NCT01907334|11768722|FG001|NOT COMPLETED|Overall Study||0
10611318|NCT01907490|11768727|FG000|STARTED|Overall Study||38
10611319|NCT01907490|11768727|FG000|COMPLETED|Overall Study||38
10611320|NCT01907490|11768727|FG000|NOT COMPLETED|Overall Study||0
10611321|NCT01907516|11768734|FG000|STARTED|First Intervention (3 Weeks)||50
10611322|NCT01907516|11768735|FG001|STARTED|First Intervention (3 Weeks)||50
10611323|NCT01907516|11768734|FG000|COMPLETED|First Intervention (3 Weeks)||40
10611324|NCT01907516|11768735|FG001|COMPLETED|First Intervention (3 Weeks)||34
10611325|NCT01907516|11768734|FG000|NOT COMPLETED|First Intervention (3 Weeks)||10
10611326|NCT01907516|11768735|FG001|NOT COMPLETED|First Intervention (3 Weeks)||16
10611327|NCT01907516|11768734|FG000|STARTED|Second Intervention (3 Weeks)||40
10704633|NCT02593396|11868977|FG001|COMPLETED|Overall Study||26
10704634|NCT02593396|11868976|FG000|NOT COMPLETED|Overall Study||15
10704635|NCT02593396|11868977|FG001|NOT COMPLETED|Overall Study||14
10704636|NCT02593539|11868983|FG000|STARTED|Overall Study||5
10704637|NCT02593539|11868983|FG000|COMPLETED|Overall Study||4
10704638|NCT02593539|11868983|FG000|NOT COMPLETED|Overall Study||1
10611328|NCT01907516|11768735|FG001|STARTED|Second Intervention (3 Weeks)||34
10611329|NCT01907516|11768734|FG000|COMPLETED|Second Intervention (3 Weeks)||40
10611330|NCT01907516|11768735|FG001|COMPLETED|Second Intervention (3 Weeks)||34
10611331|NCT01907516|11768734|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
10704639|NCT02593630|11868990|FG000|STARTED|Overall Study||54
10704640|NCT02593630|11868990|FG000|COMPLETED|Overall Study||53
10704641|NCT02593630|11868990|FG000|NOT COMPLETED|Overall Study||1
10704642|NCT02593773|11868995|FG000|STARTED|Overall Study||86
10704643|NCT02593773|11868995|FG000|COMPLETED|Overall Study||51
10611332|NCT01907516|11768735|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
10611333|NCT01907607|11768742|FG000|STARTED|Overall Study||29
10611334|NCT01907607|11768742|FG000|COMPLETED|Overall Study||29
10611335|NCT01907607|11768742|FG000|NOT COMPLETED|Overall Study||0
10611336|NCT01907737|11768746|FG000|STARTED|Overall Study||22
10611337|NCT01907737|11768746|FG000|COMPLETED|Overall Study||21
10611338|NCT01907737|11768746|FG000|NOT COMPLETED|Overall Study||1
10611339|NCT01907815|11768758|FG000|STARTED|Overall Study||17
10611340|NCT01907815|11768759|FG001|STARTED|Overall Study||7
10611341|NCT01907815|11768758|FG000|COMPLETED|Overall Study||16
10611342|NCT01907815|11768759|FG001|COMPLETED|Overall Study||7
10611343|NCT01907815|11768758|FG000|NOT COMPLETED|Overall Study||1
10611344|NCT01907815|11768759|FG001|NOT COMPLETED|Overall Study||0
10611345|NCT01907828|11768769|FG000|STARTED|Overall Study||39
10611346|NCT01907828|11768770|FG001|STARTED|Overall Study||22
10611347|NCT01907828|11768769|FG000|Underwent Procedure|Overall Study||39
10611348|NCT01907828|11768770|FG001|Underwent Procedure|Overall Study|2 participants terminated early|20
10611349|NCT01907828|11768769|FG000|1-month Follow-up|Overall Study|2 participants terminated early|37
10611350|NCT01907828|11768770|FG001|1-month Follow-up|Overall Study|3 participants terminated early|17
10611351|NCT01907828|11768769|FG000|3-month Follow-up|Overall Study|1 participant terminated early|36
10611352|NCT01907828|11768770|FG001|3-month Follow-up|Overall Study|1 participant terminated early|16
10611353|NCT01907828|11768769|FG000|6-month Follow-up|Overall Study|1 participant terminated early|35
10611354|NCT01907828|11768770|FG001|6-month Follow-up|Overall Study||16
10611355|NCT01907828|11768769|FG000|12-month Follow-up|Overall Study|1 participant terminated early|34
10611356|NCT01907828|11768770|FG001|12-month Follow-up|Overall Study||16
10611357|NCT01907828|11768769|FG000|24-month Follow-up|Overall Study|2 participants terminated early|32
10611358|NCT01907828|11768770|FG001|24-month Follow-up|Overall Study||16
10611359|NCT01907828|11768769|FG000|COMPLETED|Overall Study||32
10611360|NCT01907828|11768770|FG001|COMPLETED|Overall Study||16
10611361|NCT01907828|11768769|FG000|NOT COMPLETED|Overall Study||7
10611362|NCT01907828|11768770|FG001|NOT COMPLETED|Overall Study||6
10611363|NCT01907854|11768778|FG000|STARTED|Overall Study||203
10611364|NCT01907854|11768779|FG001|STARTED|Overall Study||204
10611365|NCT01907854|11768778|FG000|Exposed|Overall Study|One subject in lira arm was not exposed (Reason: withdrawal by subject)|202
10611366|NCT01907854|11768779|FG001|Exposed|Overall Study||204
10611367|NCT01907854|11768778|FG000|COMPLETED|Overall Study||187
10611368|NCT01907854|11768779|FG001|COMPLETED|Overall Study||191
10611369|NCT01907854|11768778|FG000|NOT COMPLETED|Overall Study||16
10611370|NCT01907854|11768779|FG001|NOT COMPLETED|Overall Study||13
10611371|NCT01907906|11768787|FG000|STARTED|Overall Study||16
10611372|NCT01907906|11768788|FG001|STARTED|Overall Study||13
10611373|NCT01907906|11768787|FG000|COMPLETED|Overall Study||12
10611374|NCT01907906|11768788|FG001|COMPLETED|Overall Study||12
10611375|NCT01907906|11768787|FG000|NOT COMPLETED|Overall Study||4
10611376|NCT01907906|11768788|FG001|NOT COMPLETED|Overall Study||1
10611377|NCT01908062|11768798|FG000|STARTED|Overall Study||26
10611378|NCT01908062|11768799|FG001|STARTED|Overall Study||25
10611379|NCT01908062|11768798|FG000|COMPLETED|Overall Study||24
10611380|NCT01908062|11768799|FG001|COMPLETED|Overall Study||22
10611381|NCT01908062|11768798|FG000|NOT COMPLETED|Overall Study||2
10611382|NCT01908062|11768799|FG001|NOT COMPLETED|Overall Study||3
10611383|NCT01908101|11768808|FG000|STARTED|Overall Study||68
10611384|NCT01908101|11768808|FG000|COMPLETED|Overall Study||59
10611385|NCT01908101|11768808|FG000|NOT COMPLETED|Overall Study||9
10611386|NCT01908127|11768814|FG000|STARTED|Overall Study||23
10611387|NCT01908127|11768815|FG001|STARTED|Overall Study||23
10611388|NCT01908127|11768814|FG000|COMPLETED|Overall Study||22
10611389|NCT01908127|11768815|FG001|COMPLETED|Overall Study||23
10611390|NCT01908127|11768814|FG000|NOT COMPLETED|Overall Study||1
10611391|NCT01908127|11768815|FG001|NOT COMPLETED|Overall Study||0
10611392|NCT01908140|11768823|FG000|STARTED|Overall Study||468
10611393|NCT01908140|11768824|FG001|STARTED|Overall Study||465
10611394|NCT01908140|11768823|FG000|COMPLETED|Overall Study||402
10611395|NCT01908140|11768824|FG001|COMPLETED|Overall Study||386
10611396|NCT01908140|11768823|FG000|NOT COMPLETED|Overall Study||66
10611397|NCT01908140|11768824|FG001|NOT COMPLETED|Overall Study||79
10704644|NCT02593773|11868995|FG000|NOT COMPLETED|Overall Study||35
10704645|NCT02593825|11869001|FG000|STARTED|Intervention||67
10704646|NCT02593825|11869002|FG001|STARTED|Intervention||67
10611398|NCT01908205|11768832|FG000|STARTED|Overall Study||30
10611399|NCT01908205|11768833|FG001|STARTED|Overall Study||30
10611400|NCT01908205|11768832|FG000|COMPLETED|Overall Study||25
10611401|NCT01908205|11768833|FG001|COMPLETED|Overall Study||29
10611402|NCT01908205|11768832|FG000|NOT COMPLETED|Overall Study||5
10611403|NCT01908205|11768833|FG001|NOT COMPLETED|Overall Study||1
10611404|NCT01908426|11768854|FG000|STARTED|Overall Study||470
10611405|NCT01908426|11768855|FG001|STARTED|Overall Study||237
10611406|NCT01908426|11768854|FG000|COMPLETED|Overall Study||73
10611407|NCT01908426|11768855|FG001|COMPLETED|Overall Study||26
10611408|NCT01908426|11768854|FG000|NOT COMPLETED|Overall Study||397
10611409|NCT01908426|11768855|FG001|NOT COMPLETED|Overall Study||211
10611410|NCT01908530|11768864|FG000|STARTED|Overall Study||8
10611411|NCT01908530|11768865|FG001|STARTED|Overall Study||8
10611412|NCT01908530|11768866|FG002|STARTED|Overall Study||10
10611413|NCT01908530|11768864|FG000|COMPLETED|Overall Study||8
10611414|NCT01908530|11768865|FG001|COMPLETED|Overall Study||8
10611415|NCT01908530|11768866|FG002|COMPLETED|Overall Study||10
10611416|NCT01908530|11768864|FG000|NOT COMPLETED|Overall Study||0
10611417|NCT01908530|11768865|FG001|NOT COMPLETED|Overall Study||0
10611418|NCT01908530|11768866|FG002|NOT COMPLETED|Overall Study||0
10611419|NCT01908582|11768877|FG000|STARTED|Period 1||26
10611420|NCT01908582|11768877|FG000|Received at Least One Dose of Study Drug|Period 1||26
10611421|NCT01908582|11768877|FG000|COMPLETED|Period 1||26
10611422|NCT01908582|11768877|FG000|NOT COMPLETED|Period 1||0
10611423|NCT01908582|11768877|FG000|STARTED|Period 2||26
10611424|NCT01908582|11768877|FG000|COMPLETED|Period 2||24
10611425|NCT01908582|11768877|FG000|NOT COMPLETED|Period 2||2
10611426|NCT01908634|11768884|FG000|STARTED|Milk-based Strawberry Beverage With Meal||10
10611427|NCT01908634|11768884|FG000|COMPLETED|Milk-based Strawberry Beverage With Meal||10
10611428|NCT01908634|11768884|FG000|NOT COMPLETED|Milk-based Strawberry Beverage With Meal||0
10611429|NCT01908634|11768884|FG000|STARTED|Water-based Strawberry Beverage Wit Meal||10
10611430|NCT01908634|11768884|FG000|COMPLETED|Water-based Strawberry Beverage Wit Meal||9
10611431|NCT01908634|11768884|FG000|NOT COMPLETED|Water-based Strawberry Beverage Wit Meal||1
10611432|NCT01908634|11768884|FG000|STARTED|Milk-based Strawberry Beverage w/o Meal||9
10611433|NCT01908634|11768884|FG000|COMPLETED|Milk-based Strawberry Beverage w/o Meal||4
10611434|NCT01908634|11768884|FG000|NOT COMPLETED|Milk-based Strawberry Beverage w/o Meal||5
10611435|NCT01908634|11768884|FG000|STARTED|Water-based Strawberry Beverage w/o Meal||4
10611436|NCT01908634|11768884|FG000|COMPLETED|Water-based Strawberry Beverage w/o Meal||4
10611437|NCT01908634|11768884|FG000|NOT COMPLETED|Water-based Strawberry Beverage w/o Meal||0
10611438|NCT01908699|11768894|FG000|STARTED|Overall Study||137
10611439|NCT01908699|11768895|FG001|STARTED|Overall Study||136
10611440|NCT01908699|11768894|FG000|Received at Least 1 Dose of Study Drug|Overall Study||136
10611441|NCT01908699|11768895|FG001|Received at Least 1 Dose of Study Drug|Overall Study||135
10611442|NCT01908699|11768894|FG000|COMPLETED|Overall Study||62
10611443|NCT01908699|11768895|FG001|COMPLETED|Overall Study||58
10611444|NCT01908699|11768894|FG000|NOT COMPLETED|Overall Study||75
10611445|NCT01908699|11768895|FG001|NOT COMPLETED|Overall Study||78
10611446|NCT01908751|11768905|FG000|STARTED|Overall Study||22
10611447|NCT01908751|11768906|FG001|STARTED|Overall Study||23
10611448|NCT01908751|11768907|FG002|STARTED|Overall Study||21
10611449|NCT01908751|11768908|FG003|STARTED|Overall Study||20
10611450|NCT01908751|11768905|FG000|COMPLETED|Overall Study||17
10611451|NCT01908751|11768906|FG001|COMPLETED|Overall Study||18
10611452|NCT01908751|11768907|FG002|COMPLETED|Overall Study||16
10611453|NCT01908751|11768908|FG003|COMPLETED|Overall Study||16
10611454|NCT01908751|11768905|FG000|NOT COMPLETED|Overall Study||5
10611455|NCT01908751|11768906|FG001|NOT COMPLETED|Overall Study||5
10611456|NCT01908751|11768907|FG002|NOT COMPLETED|Overall Study||5
10611457|NCT01908751|11768908|FG003|NOT COMPLETED|Overall Study||4
10611458|NCT01908803|11768920|FG000|STARTED|Overall Study||46
10611459|NCT01908803|11768921|FG001|STARTED|Overall Study||24
10611460|NCT01908803|11768920|FG000|Treated|Overall Study|Two randomized subjects discontinued prior to receiving investigational product.|44
10611461|NCT01908803|11768921|FG001|Treated|Overall Study||24
10611462|NCT01908803|11768920|FG000|COMPLETED|Overall Study||42
10611463|NCT01908803|11768921|FG001|COMPLETED|Overall Study||23
10611464|NCT01908803|11768920|FG000|NOT COMPLETED|Overall Study||4
10611465|NCT01908803|11768921|FG001|NOT COMPLETED|Overall Study||1
10611466|NCT01908816|11768932|FG000|STARTED|Overall Study||93
10611467|NCT01908816|11768933|FG001|STARTED|Overall Study||84
10611468|NCT01908816|11768934|FG002|STARTED|Overall Study||58
10611469|NCT01908816|11768935|FG003|STARTED|Overall Study||35
10611470|NCT01908816|11768932|FG000|COMPLETED|Overall Study||0
10611471|NCT01908816|11768933|FG001|COMPLETED|Overall Study||0
10611472|NCT01908816|11768934|FG002|COMPLETED|Overall Study||0
10611473|NCT01908816|11768935|FG003|COMPLETED|Overall Study||0
10611474|NCT01908816|11768932|FG000|NOT COMPLETED|Overall Study||93
10611475|NCT01908816|11768933|FG001|NOT COMPLETED|Overall Study||84
10611476|NCT01908816|11768934|FG002|NOT COMPLETED|Overall Study||58
10611477|NCT01908816|11768935|FG003|NOT COMPLETED|Overall Study||35
10611478|NCT01908829|11768951|FG000|STARTED|Overall Study||727
10611479|NCT01908829|11768952|FG001|STARTED|Overall Study||728
10611480|NCT01908829|11768953|FG002|STARTED|Overall Study||719
10611481|NCT01908829|11768951|FG000|Treated With Double-blind Drug|Overall Study||725
10611482|NCT01908829|11768952|FG001|Treated With Double-blind Drug|Overall Study||728
10611483|NCT01908829|11768953|FG002|Treated With Double-blind Drug|Overall Study||719
10611484|NCT01908829|11768951|FG000|COMPLETED|Overall Study||678
10611485|NCT01908829|11768952|FG001|COMPLETED|Overall Study||679
10611486|NCT01908829|11768953|FG002|COMPLETED|Overall Study||680
10611487|NCT01908829|11768951|FG000|NOT COMPLETED|Overall Study||49
10611488|NCT01908829|11768952|FG001|NOT COMPLETED|Overall Study||49
10611489|NCT01908829|11768953|FG002|NOT COMPLETED|Overall Study||39
10611490|NCT01908842|11768963|FG000|STARTED|Induction||383
10611491|NCT01908842|11768964|FG001|STARTED|Induction||375
10611492|NCT01908842|11768963|FG000|COMPLETED|Induction||357
10611493|NCT01908842|11768964|FG001|COMPLETED|Induction||344
10611494|NCT01908842|11768963|FG000|NOT COMPLETED|Induction||26
10611495|NCT01908842|11768964|FG001|NOT COMPLETED|Induction||31
10611496|NCT01908842|11768963|FG000|STARTED|Switch to Other BNX Formulation (Day 15)||357
10611497|NCT01908842|11768964|FG001|STARTED|Switch to Other BNX Formulation (Day 15)||344
10611498|NCT01908842|11768963|FG000|COMPLETED|Switch to Other BNX Formulation (Day 15)||287
10611499|NCT01908842|11768964|FG001|COMPLETED|Switch to Other BNX Formulation (Day 15)||279
10611500|NCT01908842|11768963|FG000|NOT COMPLETED|Switch to Other BNX Formulation (Day 15)||70
10611501|NCT01908842|11768964|FG001|NOT COMPLETED|Switch to Other BNX Formulation (Day 15)||65
10611502|NCT01908842|11768963|FG000|STARTED|Day 22: Film (Col 1); Tablets (Col 2)||287
10611503|NCT01908842|11768964|FG001|STARTED|Day 22: Film (Col 1); Tablets (Col 2)||279
10611504|NCT01908842|11768963|FG000|COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||262
10611505|NCT01908842|11768964|FG001|COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||262
10611506|NCT01908842|11768963|FG000|NOT COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||25
10611507|NCT01908842|11768964|FG001|NOT COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||17
10611508|NCT01908907|11768972|FG000|STARTED|Overall Study||31
10611509|NCT01908907|11768973|FG001|STARTED|Overall Study||29
10611510|NCT01908907|11768972|FG000|COMPLETED|Overall Study||29
10611511|NCT01908907|11768973|FG001|COMPLETED|Overall Study||29
10611512|NCT01908907|11768972|FG000|NOT COMPLETED|Overall Study||2
10611513|NCT01908907|11768973|FG001|NOT COMPLETED|Overall Study||0
10611514|NCT01908972|11768985|FG000|STARTED|Overall Study||17
10611515|NCT01908972|11768986|FG001|STARTED|Overall Study||17
10611516|NCT01908972|11768985|FG000|COMPLETED|Overall Study||15
10611517|NCT01908972|11768986|FG001|COMPLETED|Overall Study||17
10611518|NCT01908972|11768985|FG000|NOT COMPLETED|Overall Study||2
10611519|NCT01908972|11768986|FG001|NOT COMPLETED|Overall Study||0
10611520|NCT01909011|11768994|FG000|STARTED|Overall Study||7
10611521|NCT01909011|11768995|FG001|STARTED|Overall Study||9
10611522|NCT01909011|11768994|FG000|COMPLETED|Overall Study||7
10611523|NCT01909011|11768995|FG001|COMPLETED|Overall Study||9
10611524|NCT01909011|11768994|FG000|NOT COMPLETED|Overall Study||0
10611525|NCT01909011|11768995|FG001|NOT COMPLETED|Overall Study||0
10611526|NCT01909141|11769003|FG000|STARTED|Overall Study||50
10611527|NCT01909141|11769004|FG001|STARTED|Overall Study||50
10611528|NCT01909141|11769003|FG000|COMPLETED|Overall Study||50
10611529|NCT01909141|11769004|FG001|COMPLETED|Overall Study||50
10611530|NCT01909141|11769003|FG000|NOT COMPLETED|Overall Study||0
10611531|NCT01909141|11769004|FG001|NOT COMPLETED|Overall Study||0
10611532|NCT01909154|11769012|FG000|STARTED|Overall Study||12
10611533|NCT01909154|11769012|FG000|COMPLETED|Overall Study||12
10611534|NCT01909154|11769012|FG000|NOT COMPLETED|Overall Study||0
10611535|NCT01909180|11769016|FG000|STARTED|Overall Study||49
10611536|NCT01909180|11769016|FG000|COMPLETED|Overall Study||49
10611537|NCT01909180|11769016|FG000|NOT COMPLETED|Overall Study||0
10611538|NCT01909336|11769025|FG000|STARTED|Overall Study||53
10611539|NCT01909336|11769026|FG001|STARTED|Overall Study||53
10611540|NCT01909336|11769027|FG002|STARTED|Overall Study||55
10611541|NCT01909336|11769025|FG000|COMPLETED|Overall Study||49
10611542|NCT01909336|11769026|FG001|COMPLETED|Overall Study||50
10611543|NCT01909336|11769027|FG002|COMPLETED|Overall Study||52
10611544|NCT01909336|11769025|FG000|NOT COMPLETED|Overall Study||4
10611545|NCT01909336|11769026|FG001|NOT COMPLETED|Overall Study||3
10611546|NCT01909336|11769027|FG002|NOT COMPLETED|Overall Study||3
10611547|NCT01909466|11769035|FG000|STARTED|Overall Study||68
10611548|NCT01909466|11769036|FG001|STARTED|Overall Study||73
10611549|NCT01909466|11769035|FG000|COMPLETED|Overall Study||46
10611550|NCT01909466|11769036|FG001|COMPLETED|Overall Study||50
10611551|NCT01909466|11769035|FG000|NOT COMPLETED|Overall Study||22
10611552|NCT01909466|11769036|FG001|NOT COMPLETED|Overall Study||23
10611553|NCT01909674|11769042|FG000|STARTED|Overall Study||12
10611554|NCT01909674|11769043|FG001|STARTED|Overall Study||9
10611555|NCT01909674|11769042|FG000|COMPLETED|Overall Study||7
10611556|NCT01909674|11769043|FG001|COMPLETED|Overall Study||7
10611557|NCT01909674|11769042|FG000|NOT COMPLETED|Overall Study||5
10611558|NCT01909674|11769043|FG001|NOT COMPLETED|Overall Study||2
10611562|NCT01909778|11769074|FG000|STARTED|Overall Study||2
10611563|NCT01909778|11769074|FG000|COMPLETED|Overall Study||1
10611564|NCT01909778|11769074|FG000|NOT COMPLETED|Overall Study||1
10611565|NCT01909791|11769083|FG000|STARTED|Overall Study||226
10611566|NCT01909791|11769084|FG001|STARTED|Overall Study||240
10611567|NCT01909791|11769085|FG002|STARTED|Overall Study||236
10611568|NCT01909791|11769083|FG000|COMPLETED|Overall Study||205
10611569|NCT01909791|11769084|FG001|COMPLETED|Overall Study||212
10611570|NCT01909791|11769085|FG002|COMPLETED|Overall Study||208
10611571|NCT01909791|11769083|FG000|NOT COMPLETED|Overall Study||21
10611572|NCT01909791|11769084|FG001|NOT COMPLETED|Overall Study||28
10611573|NCT01909791|11769085|FG002|NOT COMPLETED|Overall Study||28
10611574|NCT01909804|11769110|FG000|STARTED|Overall Study||26
10611575|NCT01909804|11769111|FG001|STARTED|Overall Study||28
10611576|NCT01909804|11769112|FG002|STARTED|Overall Study||27
10611577|NCT01909804|11769113|FG003|STARTED|Overall Study||26
10611578|NCT01909804|11769114|FG004|STARTED|Overall Study||26
10611579|NCT01909804|11769115|FG005|STARTED|Overall Study||25
10611580|NCT01909804|11769116|FG006|STARTED|Overall Study||27
10611581|NCT01909804|11769117|FG007|STARTED|Overall Study||26
10611582|NCT01909804|11769118|FG008|STARTED|Overall Study||27
10611583|NCT01909804|11769119|FG009|STARTED|Overall Study||29
10611584|NCT01909804|11769120|FG010|STARTED|Overall Study||27
10611585|NCT01909804|11769121|FG011|STARTED|Overall Study||29
10611586|NCT01909804|11769110|FG000|COMPLETED|Overall Study||22
10611587|NCT01909804|11769111|FG001|COMPLETED|Overall Study||27
10611588|NCT01909804|11769112|FG002|COMPLETED|Overall Study||27
10611589|NCT01909804|11769113|FG003|COMPLETED|Overall Study||26
10611590|NCT01909804|11769114|FG004|COMPLETED|Overall Study||18
10611591|NCT01909804|11769115|FG005|COMPLETED|Overall Study||21
10611592|NCT01909804|11769116|FG006|COMPLETED|Overall Study||25
10611593|NCT01909804|11769117|FG007|COMPLETED|Overall Study||25
10611594|NCT01909804|11769118|FG008|COMPLETED|Overall Study||27
10611595|NCT01909804|11769119|FG009|COMPLETED|Overall Study||28
10611596|NCT01909804|11769120|FG010|COMPLETED|Overall Study||26
10611597|NCT01909804|11769121|FG011|COMPLETED|Overall Study||26
10611598|NCT01909804|11769110|FG000|NOT COMPLETED|Overall Study||4
10611599|NCT01909804|11769111|FG001|NOT COMPLETED|Overall Study||1
10611600|NCT01909804|11769112|FG002|NOT COMPLETED|Overall Study||0
10611601|NCT01909804|11769113|FG003|NOT COMPLETED|Overall Study||0
10611602|NCT01909804|11769114|FG004|NOT COMPLETED|Overall Study||8
10611603|NCT01909804|11769115|FG005|NOT COMPLETED|Overall Study||4
10611604|NCT01909804|11769116|FG006|NOT COMPLETED|Overall Study||2
10611605|NCT01909804|11769117|FG007|NOT COMPLETED|Overall Study||1
10611606|NCT01909804|11769118|FG008|NOT COMPLETED|Overall Study||0
10611607|NCT01909804|11769119|FG009|NOT COMPLETED|Overall Study||1
10611608|NCT01909804|11769120|FG010|NOT COMPLETED|Overall Study||1
10611609|NCT01909804|11769121|FG011|NOT COMPLETED|Overall Study||3
10611610|NCT01909973|11769145|FG000|STARTED|Overall Study||8
10611611|NCT01909973|11769146|FG001|STARTED|Overall Study||7
10611612|NCT01909973|11769145|FG000|COMPLETED|Overall Study||7
10611613|NCT01909973|11769146|FG001|COMPLETED|Overall Study||7
10611614|NCT01909973|11769145|FG000|NOT COMPLETED|Overall Study||1
10611615|NCT01909973|11769146|FG001|NOT COMPLETED|Overall Study||0
10611616|NCT01910064|11769152|FG000|STARTED|Overall Study||436
10611617|NCT01910064|11769152|FG000|COMPLETED|Overall Study||391
10611618|NCT01910064|11769152|FG000|NOT COMPLETED|Overall Study||45
10611619|NCT01910116|11769158|FG000|STARTED|Overall Study||110
10611620|NCT01910116|11769159|FG001|STARTED|Overall Study||110
10611621|NCT01910116|11769158|FG000|Week 4|Overall Study||106
10611622|NCT01910116|11769159|FG001|Week 4|Overall Study||102
10611623|NCT01910116|11769158|FG000|Week 8|Overall Study||98
10611624|NCT01910116|11769159|FG001|Week 8|Overall Study||99
10611625|NCT01910116|11769158|FG000|Week 12|Overall Study||97
10611626|NCT01910116|11769159|FG001|Week 12|Overall Study||96
10611627|NCT01910116|11769158|FG000|Week 16|Overall Study||96
10611628|NCT01910116|11769159|FG001|Week 16|Overall Study||94
10611629|NCT01910116|11769158|FG000|COMPLETED|Overall Study||96
10611630|NCT01910116|11769159|FG001|COMPLETED|Overall Study||94
10611631|NCT01910116|11769158|FG000|NOT COMPLETED|Overall Study||14
10611632|NCT01910116|11769159|FG001|NOT COMPLETED|Overall Study||16
10611633|NCT01910129|11769167|FG000|STARTED|Run-in Period Phase 1||0
10611634|NCT01910129|11769168|FG001|STARTED|Run-in Period Phase 1||0
10611635|NCT01910129|11769169|FG002|STARTED|Run-in Period Phase 1||13
10611636|NCT01910129|11769167|FG000|COMPLETED|Run-in Period Phase 1||0
10611637|NCT01910129|11769168|FG001|COMPLETED|Run-in Period Phase 1||0
10611638|NCT01910129|11769169|FG002|COMPLETED|Run-in Period Phase 1||13
10611639|NCT01910129|11769167|FG000|NOT COMPLETED|Run-in Period Phase 1||0
10611640|NCT01910129|11769168|FG001|NOT COMPLETED|Run-in Period Phase 1||0
10611641|NCT01910129|11769169|FG002|NOT COMPLETED|Run-in Period Phase 1||0
10611642|NCT01910129|11769167|FG000|STARTED|Randomized Phase 2||7
10611643|NCT01910129|11769168|FG001|STARTED|Randomized Phase 2||6
10611644|NCT01910129|11769169|FG002|STARTED|Randomized Phase 2||0
10611645|NCT01910129|11769167|FG000|COMPLETED|Randomized Phase 2||5
10611646|NCT01910129|11769168|FG001|COMPLETED|Randomized Phase 2||5
10611647|NCT01910129|11769169|FG002|COMPLETED|Randomized Phase 2||0
10611648|NCT01910129|11769167|FG000|NOT COMPLETED|Randomized Phase 2||2
10611649|NCT01910129|11769168|FG001|NOT COMPLETED|Randomized Phase 2||1
10611650|NCT01910129|11769169|FG002|NOT COMPLETED|Randomized Phase 2||0
10611651|NCT01910129|11769167|FG000|STARTED|Randomized Phase 3||5
10611652|NCT01910129|11769168|FG001|STARTED|Randomized Phase 3||5
10611653|NCT01910129|11769169|FG002|STARTED|Randomized Phase 3||0
10611654|NCT01910129|11769167|FG000|COMPLETED|Randomized Phase 3||5
10611655|NCT01910129|11769168|FG001|COMPLETED|Randomized Phase 3||4
10611656|NCT01910129|11769169|FG002|COMPLETED|Randomized Phase 3||0
10611657|NCT01910129|11769167|FG000|NOT COMPLETED|Randomized Phase 3||0
10611658|NCT01910129|11769168|FG001|NOT COMPLETED|Randomized Phase 3||1
10611659|NCT01910129|11769169|FG002|NOT COMPLETED|Randomized Phase 3||0
10611660|NCT01910181|11769187|FG000|STARTED|Overall Study||46
10611661|NCT01910181|11769187|FG000|PK Cohort|Overall Study||20
10611662|NCT01910181|11769187|FG000|Expansion Cohort|Overall Study||26
10611663|NCT01910181|11769187|FG000|COMPLETED|Overall Study||0
10611664|NCT01910181|11769187|FG000|NOT COMPLETED|Overall Study||46
10611665|NCT01910298|11769194|FG000|STARTED|Overall Study||76
10611666|NCT01910298|11769195|FG001|STARTED|Overall Study||55
10611667|NCT01910298|11769194|FG000|Safety Set|Overall Study||76
10611668|NCT01910298|11769195|FG001|Safety Set|Overall Study|4 participants did not have first surgery date and were not included in Safety Set.|51
10611669|NCT01910298|11769194|FG000|COMPLETED|Overall Study||71
10611670|NCT01910298|11769195|FG001|COMPLETED|Overall Study||23
10611671|NCT01910298|11769194|FG000|NOT COMPLETED|Overall Study||5
10611672|NCT01910298|11769195|FG001|NOT COMPLETED|Overall Study||32
10611673|NCT01910311|11769201|FG000|STARTED|Period 1 (Days 1-2)||18
10611674|NCT01910311|11769201|FG000|Received Baricitinib|Period 1 (Days 1-2)||18
10611675|NCT01910311|11769201|FG000|COMPLETED|Period 1 (Days 1-2)||18
10611676|NCT01910311|11769201|FG000|NOT COMPLETED|Period 1 (Days 1-2)||0
10611677|NCT01910311|11769201|FG000|STARTED|Period 2 (Days 3-32)||18
10611678|NCT01910311|11769201|FG000|Received Baricitinib|Period 2 (Days 3-32)||18
10611679|NCT01910311|11769201|FG000|Received At Least 1 Dose of Rifampicin|Period 2 (Days 3-32)||18
10611680|NCT01910311|11769201|FG000|COMPLETED|Period 2 (Days 3-32)||18
10611681|NCT01910311|11769201|FG000|NOT COMPLETED|Period 2 (Days 3-32)||0
10611682|NCT01910519|11769211|FG000|STARTED|Overall Study||35
10611683|NCT01910519|11769212|FG001|STARTED|Overall Study||15
10611684|NCT01910519|11769211|FG000|COMPLETED|Overall Study||31
10611685|NCT01910519|11769212|FG001|COMPLETED|Overall Study||15
10611686|NCT01910519|11769211|FG000|NOT COMPLETED|Overall Study||4
10611687|NCT01910519|11769212|FG001|NOT COMPLETED|Overall Study||0
10611688|NCT01910636|11769220|FG000|STARTED|Overall Study||90
10611689|NCT01910636|11769221|FG001|STARTED|Overall Study||63
10611690|NCT01910636|11769220|FG000|COMPLETED|Overall Study||90
10611691|NCT01910636|11769221|FG001|COMPLETED|Overall Study||63
10611692|NCT01910636|11769220|FG000|NOT COMPLETED|Overall Study||0
10611693|NCT01910636|11769221|FG001|NOT COMPLETED|Overall Study||0
10611694|NCT01910688|11769227|FG000|STARTED|Overall Study||25
10611695|NCT01910688|11769227|FG000|3.5month|Overall Study||25
10611696|NCT01910688|11769227|FG000|2nd RFA Treatment|Overall Study||22
10611697|NCT01910688|11769227|FG000|7.5months|Overall Study||24
10611698|NCT01910688|11769227|FG000|3rd RFA Treatment|Overall Study||18
10611699|NCT01910688|11769227|FG000|12months|Overall Study||22
10611700|NCT01910688|11769227|FG000|COMPLETED|Overall Study||20
10611701|NCT01910688|11769227|FG000|NOT COMPLETED|Overall Study||5
10611702|NCT01910792|11769233|FG000|STARTED|Overall Study||9
10611703|NCT01910792|11769234|FG001|STARTED|Overall Study||10
10611704|NCT01910792|11769233|FG000|COMPLETED|Overall Study||9
10611705|NCT01910792|11769234|FG001|COMPLETED|Overall Study||10
10611706|NCT01910792|11769233|FG000|NOT COMPLETED|Overall Study||0
10611707|NCT01910792|11769234|FG001|NOT COMPLETED|Overall Study||0
10611708|NCT01910831|11769240|FG000|STARTED|Overall Study||20
10611709|NCT01910831|11769240|FG000|COMPLETED|Overall Study||19
10611710|NCT01910831|11769240|FG000|NOT COMPLETED|Overall Study||1
10611711|NCT01911065|11769247|FG000|STARTED|Overall Study||45
10611712|NCT01911065|11769248|FG001|STARTED|Overall Study||9
10611713|NCT01911065|11769247|FG000|COMPLETED|Overall Study||45
10611714|NCT01911065|11769248|FG001|COMPLETED|Overall Study||9
10611715|NCT01911065|11769247|FG000|NOT COMPLETED|Overall Study||0
10611716|NCT01911065|11769248|FG001|NOT COMPLETED|Overall Study||0
10611717|NCT01911169|11769256|FG000|STARTED|Overall Study||6
10611718|NCT01911169|11769257|FG001|STARTED|Overall Study||3
10611719|NCT01911169|11769256|FG000|COMPLETED|Overall Study||6
10611720|NCT01911169|11769257|FG001|COMPLETED|Overall Study||3
10611721|NCT01911169|11769256|FG000|NOT COMPLETED|Overall Study||0
10611722|NCT01911169|11769257|FG001|NOT COMPLETED|Overall Study||0
10611723|NCT01911221|11769263|FG000|STARTED|Overall Study||13
10611724|NCT01911221|11769263|FG000|COMPLETED|Overall Study||13
10611725|NCT01911221|11769263|FG000|NOT COMPLETED|Overall Study||0
10611726|NCT01911260|11769271|FG000|STARTED|Supplementation Period||50
10611727|NCT01911260|11769272|FG001|STARTED|Supplementation Period||50
10611728|NCT01911260|11769273|FG002|STARTED|Supplementation Period||49
10611729|NCT01911260|11769274|FG003|STARTED|Supplementation Period||50
10611730|NCT01911260|11769271|FG000|COMPLETED|Supplementation Period||40
10611731|NCT01911260|11769272|FG001|COMPLETED|Supplementation Period||38
10611732|NCT01911260|11769273|FG002|COMPLETED|Supplementation Period||39
10611733|NCT01911260|11769274|FG003|COMPLETED|Supplementation Period||42
10611734|NCT01911260|11769271|FG000|NOT COMPLETED|Supplementation Period||10
10611735|NCT01911260|11769272|FG001|NOT COMPLETED|Supplementation Period||12
10611736|NCT01911260|11769273|FG002|NOT COMPLETED|Supplementation Period||10
10611737|NCT01911260|11769274|FG003|NOT COMPLETED|Supplementation Period||8
10611738|NCT01911260|11769271|FG000|STARTED|Follow-up Period||40
10611739|NCT01911260|11769272|FG001|STARTED|Follow-up Period||38
10611740|NCT01911260|11769273|FG002|STARTED|Follow-up Period||39
10611741|NCT01911260|11769274|FG003|STARTED|Follow-up Period||42
10611742|NCT01911260|11769271|FG000|COMPLETED|Follow-up Period||27
10611743|NCT01911260|11769272|FG001|COMPLETED|Follow-up Period||18
10611744|NCT01911260|11769273|FG002|COMPLETED|Follow-up Period||24
10611745|NCT01911260|11769274|FG003|COMPLETED|Follow-up Period||30
10611746|NCT01911260|11769271|FG000|NOT COMPLETED|Follow-up Period||13
10611747|NCT01911260|11769272|FG001|NOT COMPLETED|Follow-up Period||20
10611748|NCT01911260|11769273|FG002|NOT COMPLETED|Follow-up Period||15
10611749|NCT01911260|11769274|FG003|NOT COMPLETED|Follow-up Period||12
10611750|NCT01911273|11769286|FG000|STARTED|Overall Study||1
10611751|NCT01911273|11769287|FG001|STARTED|Overall Study||2
10611752|NCT01911273|11769286|FG000|COMPLETED|Overall Study||0
10611753|NCT01911273|11769287|FG001|COMPLETED|Overall Study||0
10611754|NCT01911273|11769286|FG000|NOT COMPLETED|Overall Study||1
10611755|NCT01911273|11769287|FG001|NOT COMPLETED|Overall Study||2
10611756|NCT01911351|11769295|FG000|STARTED|Overall Study||39
10611757|NCT01911351|11769296|FG001|STARTED|Overall Study||43
10611758|NCT01911351|11769295|FG000|COMPLETED|Overall Study||39
10611759|NCT01911351|11769296|FG001|COMPLETED|Overall Study||43
10611760|NCT01911351|11769295|FG000|NOT COMPLETED|Overall Study||0
10611761|NCT01911351|11769296|FG001|NOT COMPLETED|Overall Study||0
10611762|NCT01911390|11769306|FG000|STARTED|Overall Study||10
10611763|NCT01911390|11769307|FG001|STARTED|Overall Study||10
10611764|NCT01911390|11769308|FG002|STARTED|Overall Study||10
10611765|NCT01911390|11769309|FG003|STARTED|Overall Study||11
10611766|NCT01911390|11769306|FG000|COMPLETED|Overall Study||9
10611767|NCT01911390|11769307|FG001|COMPLETED|Overall Study||10
10611768|NCT01911390|11769308|FG002|COMPLETED|Overall Study||9
10611769|NCT01911390|11769309|FG003|COMPLETED|Overall Study||10
10611770|NCT01911390|11769306|FG000|NOT COMPLETED|Overall Study||1
10611771|NCT01911390|11769307|FG001|NOT COMPLETED|Overall Study||0
10611772|NCT01911390|11769308|FG002|NOT COMPLETED|Overall Study||1
10611773|NCT01911390|11769309|FG003|NOT COMPLETED|Overall Study||1
10611774|NCT01911403|11769321|FG000|STARTED|Overall Study||61
10611775|NCT01911403|11769322|FG001|STARTED|Overall Study||62
10611776|NCT01911403|11769321|FG000|COMPLETED|Overall Study||52
10611777|NCT01911403|11769322|FG001|COMPLETED|Overall Study||59
10611778|NCT01911403|11769321|FG000|NOT COMPLETED|Overall Study||9
10611779|NCT01911403|11769322|FG001|NOT COMPLETED|Overall Study||3
10611780|NCT01911429|11769331|FG000|STARTED|Overall Study||108
10611781|NCT01911429|11769332|FG001|STARTED|Overall Study|Subjects received lurasidone 40/mg day from Days 1-3, and 80mg/day from days 4 to Week 6 visit|106
10611782|NCT01911429|11769333|FG002|STARTED|Overall Study|one subject randomized to Placebo group was never dosed for study medication, making the total 112|113
10611783|NCT01911429|11769331|FG000|COMPLETED|Overall Study||96
10611784|NCT01911429|11769332|FG001|COMPLETED|Overall Study||96
10611785|NCT01911429|11769333|FG002|COMPLETED|Overall Study||93
10611786|NCT01911429|11769331|FG000|NOT COMPLETED|Overall Study||12
10611787|NCT01911429|11769332|FG001|NOT COMPLETED|Overall Study||10
10611788|NCT01911429|11769333|FG002|NOT COMPLETED|Overall Study||20
10611789|NCT01911442|11769344|FG000|STARTED|Overall Study||49
10611790|NCT01911442|11769345|FG001|STARTED|Overall Study||51
10611791|NCT01911442|11769346|FG002|STARTED|Overall Study||50
10611792|NCT01911442|11769344|FG000|COMPLETED|Overall Study||43
10611793|NCT01911442|11769345|FG001|COMPLETED|Overall Study||47
10611794|NCT01911442|11769346|FG002|COMPLETED|Overall Study||38
10611795|NCT01911442|11769344|FG000|NOT COMPLETED|Overall Study||6
10611796|NCT01911442|11769345|FG001|NOT COMPLETED|Overall Study||4
10611797|NCT01911442|11769346|FG002|NOT COMPLETED|Overall Study||12
10611798|NCT01911546|11769358|FG000|STARTED|Overall Study||20
10611799|NCT01911546|11769358|FG000|COMPLETED|Overall Study||14
10611800|NCT01911546|11769358|FG000|NOT COMPLETED|Overall Study||6
10611801|NCT01911689|11769364|FG000|STARTED|Overall Study||117
10611802|NCT01911689|11769365|FG001|STARTED|Overall Study||51
10611803|NCT01911689|11769364|FG000|COMPLETED|Overall Study||117
10611804|NCT01911689|11769365|FG001|COMPLETED|Overall Study||51
10611805|NCT01911689|11769364|FG000|NOT COMPLETED|Overall Study||0
10611806|NCT01911689|11769365|FG001|NOT COMPLETED|Overall Study||0
10611807|NCT01911780|11769380|FG000|STARTED|Double-blind Period (8 Weeks)||68
10611808|NCT01911780|11769381|FG001|STARTED|Double-blind Period (8 Weeks)||64
10704647|NCT02593825|11869001|FG000|COMPLETED|Intervention||57
10704648|NCT02593825|11869002|FG001|COMPLETED|Intervention||55
10704649|NCT02593825|11869001|FG000|NOT COMPLETED|Intervention||10
10704650|NCT02593825|11869002|FG001|NOT COMPLETED|Intervention||12
10704651|NCT02593825|11869001|FG000|STARTED|Follow-up||57
10704652|NCT02593825|11869002|FG001|STARTED|Follow-up||55
10704653|NCT02593825|11869001|FG000|COMPLETED|Follow-up||57
10704654|NCT02593825|11869002|FG001|COMPLETED|Follow-up||55
10704655|NCT02593825|11869001|FG000|NOT COMPLETED|Follow-up||0
10704656|NCT02593825|11869002|FG001|NOT COMPLETED|Follow-up||0
10704657|NCT02593864|11869010|FG000|STARTED|Overall Study||25
10704658|NCT02593864|11869010|FG000|COMPLETED|Overall Study||19
10704659|NCT02593864|11869010|FG000|NOT COMPLETED|Overall Study||6
10713741|NCT02681094|11879232|FG000|Participants Completed Treatment Period|2 - Enrolled Participants Set||281
10713742|NCT02681094|11879233|FG001|Participants Completed Treatment Period|2 - Enrolled Participants Set|A participant was randomized but did not receive treatment due to screen failure.|284
10713743|NCT02681094|11879234|FG002|Participants Completed Treatment Period|2 - Enrolled Participants Set|A participant was randomized but did not receive treatment due to screen failure.|289
10713744|NCT02681094|11879232|FG000|COMPLETED|2 - Enrolled Participants Set||261
10713745|NCT02681094|11879233|FG001|COMPLETED|2 - Enrolled Participants Set||261
10713746|NCT02681094|11879234|FG002|COMPLETED|2 - Enrolled Participants Set||248
10713747|NCT02681094|11879232|FG000|NOT COMPLETED|2 - Enrolled Participants Set||40
10713748|NCT02681094|11879233|FG001|NOT COMPLETED|2 - Enrolled Participants Set||41
10713749|NCT02681094|11879234|FG002|NOT COMPLETED|2 - Enrolled Participants Set||54
10713750|NCT02681172|11879243|FG000|STARTED|Overall Study||218
10713751|NCT02681172|11879243|FG000|Safety Analysis Set|Overall Study||205
10713752|NCT02681172|11879243|FG000|Full Analysis Set|Overall Study||205
10713753|NCT02681172|11879243|FG000|Per Protocol Set|Overall Study||205
10713754|NCT02681172|11879243|FG000|COMPLETED|Overall Study||205
10713755|NCT02681172|11879243|FG000|NOT COMPLETED|Overall Study||13
10713756|NCT02681458|11879249|FG000|STARTED|Overall Study||718
10713757|NCT02681458|11879250|FG001|STARTED|Overall Study||718
10713758|NCT02681458|11879249|FG000|COMPLETED|Overall Study||73
10713759|NCT02681458|11879250|FG001|COMPLETED|Overall Study||62
10713760|NCT02681458|11879249|FG000|NOT COMPLETED|Overall Study||645
10713761|NCT02681458|11879250|FG001|NOT COMPLETED|Overall Study||656
10713917|NCT02683668|11879478|FG000|NOT COMPLETED|Period 1||0
10713918|NCT02683668|11879479|FG001|NOT COMPLETED|Period 1||0
10713919|NCT02683668|11879480|FG002|NOT COMPLETED|Period 1||0
10713920|NCT02683668|11879478|FG000|STARTED|Period 2||0
10713921|NCT02683668|11879479|FG001|STARTED|Period 2||44
10713922|NCT02683668|11879480|FG002|STARTED|Period 2||0
10713923|NCT02683668|11879478|FG000|COMPLETED|Period 2||0
10713924|NCT02683668|11879479|FG001|COMPLETED|Period 2||43
10713925|NCT02683668|11879480|FG002|COMPLETED|Period 2||0
10713926|NCT02683668|11879478|FG000|NOT COMPLETED|Period 2||0
10713927|NCT02683668|11879479|FG001|NOT COMPLETED|Period 2||1
10713928|NCT02683668|11879480|FG002|NOT COMPLETED|Period 2||0
10713929|NCT02683668|11879478|FG000|STARTED|Period 3||0
10713930|NCT02683668|11879479|FG001|STARTED|Period 3||0
10713931|NCT02683668|11879480|FG002|STARTED|Period 3||43
10713932|NCT02683668|11879478|FG000|COMPLETED|Period 3||0
10713933|NCT02683668|11879479|FG001|COMPLETED|Period 3||0
10713934|NCT02683668|11879480|FG002|COMPLETED|Period 3||43
10611809|NCT01911780|11769380|FG000|COMPLETED|Double-blind Period (8 Weeks)||65
10611810|NCT01911780|11769381|FG001|COMPLETED|Double-blind Period (8 Weeks)||61
10611811|NCT01911780|11769380|FG000|NOT COMPLETED|Double-blind Period (8 Weeks)||3
10611812|NCT01911780|11769381|FG001|NOT COMPLETED|Double-blind Period (8 Weeks)||3
10611813|NCT01911780|11769380|FG000|STARTED|Extension Period (52 Weeks)||65
10611814|NCT01911780|11769381|FG001|STARTED|Extension Period (52 Weeks)||61
10611815|NCT01911780|11769380|FG000|COMPLETED|Extension Period (52 Weeks)||61
10611816|NCT01911780|11769381|FG001|COMPLETED|Extension Period (52 Weeks)||58
10611817|NCT01911780|11769380|FG000|NOT COMPLETED|Extension Period (52 Weeks)||4
10611818|NCT01911780|11769381|FG001|NOT COMPLETED|Extension Period (52 Weeks)||3
10611819|NCT01911819|11769394|FG000|STARTED|Overall Study||10
10611820|NCT01911819|11769395|FG001|STARTED|Overall Study|One of 10 sinuses was replaced to another sinus due to infection.|11
10611821|NCT01911819|11769396|FG002|STARTED|Overall Study||10
10611822|NCT01911819|11769394|FG000|COMPLETED|Overall Study||9
10611823|NCT01911819|11769395|FG001|COMPLETED|Overall Study||9
10611824|NCT01911819|11769396|FG002|COMPLETED|Overall Study||10
10611825|NCT01911819|11769394|FG000|NOT COMPLETED|Overall Study||1
10611826|NCT01911819|11769395|FG001|NOT COMPLETED|Overall Study||2
10611827|NCT01911819|11769396|FG002|NOT COMPLETED|Overall Study||0
10611828|NCT01911845|11769404|FG000|STARTED|Overall Study||38
10611829|NCT01911845|11769404|FG000|Completed Study Drug|Overall Study||37
10611830|NCT01911845|11769404|FG000|COMPLETED|Overall Study||32
10611831|NCT01911845|11769404|FG000|NOT COMPLETED|Overall Study||6
10611832|NCT01911910|11769412|FG000|STARTED|Overall Study||197
10713935|NCT02683668|11879478|FG000|NOT COMPLETED|Period 3||0
10713936|NCT02683668|11879479|FG001|NOT COMPLETED|Period 3||0
10713937|NCT02683668|11879480|FG002|NOT COMPLETED|Period 3||0
10713938|NCT02683707|11879488|FG000|STARTED|Overall Study||105
10713939|NCT02683707|11879489|FG001|STARTED|Overall Study||107
10713940|NCT02683707|11879488|FG000|COMPLETED|Overall Study||105
10713941|NCT02683707|11879489|FG001|COMPLETED|Overall Study||107
10713942|NCT02683707|11879488|FG000|NOT COMPLETED|Overall Study||0
10713943|NCT02683707|11879489|FG001|NOT COMPLETED|Overall Study||0
10713944|NCT02683746|11879497|FG000|STARTED|Overall Study||154
10713945|NCT02683746|11879498|FG001|STARTED|Overall Study||154
10611833|NCT01911910|11769413|FG001|STARTED|Overall Study||205
10611834|NCT01911910|11769412|FG000|COMPLETED|Overall Study||184
10611835|NCT01911910|11769413|FG001|COMPLETED|Overall Study||194
10611836|NCT01911910|11769412|FG000|NOT COMPLETED|Overall Study||13
10611837|NCT01911910|11769413|FG001|NOT COMPLETED|Overall Study||11
10611838|NCT01912222|11769422|FG000|STARTED|Part A: Pharmacokinetic Period||13
10611839|NCT01912222|11769423|FG001|STARTED|Part A: Pharmacokinetic Period||15
10611840|NCT01912222|11769424|FG002|STARTED|Part A: Pharmacokinetic Period||20
10611841|NCT01912222|11769422|FG000|COMPLETED|Part A: Pharmacokinetic Period||12
10611842|NCT01912222|11769423|FG001|COMPLETED|Part A: Pharmacokinetic Period||13
10611843|NCT01912222|11769424|FG002|COMPLETED|Part A: Pharmacokinetic Period||18
10611844|NCT01912222|11769422|FG000|NOT COMPLETED|Part A: Pharmacokinetic Period||1
10611845|NCT01912222|11769423|FG001|NOT COMPLETED|Part A: Pharmacokinetic Period||2
10611846|NCT01912222|11769424|FG002|NOT COMPLETED|Part A: Pharmacokinetic Period||2
10611847|NCT01912222|11769422|FG000|STARTED|Part B: Treatment Period||13
10611848|NCT01912222|11769423|FG001|STARTED|Part B: Treatment Period||15
10611849|NCT01912222|11769424|FG002|STARTED|Part B: Treatment Period||20
10611850|NCT01912222|11769422|FG000|COMPLETED|Part B: Treatment Period||0
10611851|NCT01912222|11769423|FG001|COMPLETED|Part B: Treatment Period||0
10611852|NCT01912222|11769424|FG002|COMPLETED|Part B: Treatment Period||0
10611853|NCT01912222|11769422|FG000|NOT COMPLETED|Part B: Treatment Period||13
10611854|NCT01912222|11769423|FG001|NOT COMPLETED|Part B: Treatment Period||15
10611855|NCT01912222|11769424|FG002|NOT COMPLETED|Part B: Treatment Period||20
10611856|NCT01912274|11769433|FG000|STARTED|Overall Study||50
10611857|NCT01912274|11769433|FG000|COMPLETED|Overall Study||50
10611858|NCT01912274|11769433|FG000|NOT COMPLETED|Overall Study||0
10611859|NCT01912287|11769440|FG000|STARTED|Overall Study||93
10611860|NCT01912287|11769441|FG001|STARTED|Overall Study||90
10611861|NCT01912287|11769442|FG002|STARTED|Overall Study||43
10611862|NCT01912287|11769440|FG000|COMPLETED|Overall Study||60
10611863|NCT01912287|11769441|FG001|COMPLETED|Overall Study||67
10611864|NCT01912287|11769442|FG002|COMPLETED|Overall Study||28
10611865|NCT01912287|11769440|FG000|NOT COMPLETED|Overall Study||33
10611866|NCT01912287|11769441|FG001|NOT COMPLETED|Overall Study||23
10611867|NCT01912287|11769442|FG002|NOT COMPLETED|Overall Study||15
10611868|NCT01912339|11769452|FG000|STARTED|Blinded (0 to 3 Months)||136
10611869|NCT01912339|11769453|FG001|STARTED|Blinded (0 to 3 Months)||61
10611870|NCT01912339|11769454|FG002|STARTED|Blinded (0 to 3 Months)||0
10611871|NCT01912339|11769452|FG000|COMPLETED|Blinded (0 to 3 Months)||134
10611872|NCT01912339|11769453|FG001|COMPLETED|Blinded (0 to 3 Months)||61
10611873|NCT01912339|11769454|FG002|COMPLETED|Blinded (0 to 3 Months)||0
10611874|NCT01912339|11769452|FG000|NOT COMPLETED|Blinded (0 to 3 Months)||2
10611875|NCT01912339|11769453|FG001|NOT COMPLETED|Blinded (0 to 3 Months)||0
10611876|NCT01912339|11769454|FG002|NOT COMPLETED|Blinded (0 to 3 Months)||0
10611877|NCT01912339|11769452|FG000|STARTED|Unblinded (3 to 6 Months/Crossover)||134
10611878|NCT01912339|11769453|FG001|STARTED|Unblinded (3 to 6 Months/Crossover)||61
10611879|NCT01912339|11769454|FG002|STARTED|Unblinded (3 to 6 Months/Crossover)||0
10611880|NCT01912339|11769452|FG000|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Still in study|133
10611881|NCT01912339|11769453|FG001|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Of the 61 subjects, there were 53 crossover subjects and 8 that completed their study participation.|61
10611882|NCT01912339|11769454|FG002|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Still in study|0
10611883|NCT01912339|11769452|FG000|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||1
10611884|NCT01912339|11769453|FG001|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||0
10611885|NCT01912339|11769454|FG002|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||0
10611886|NCT01912339|11769452|FG000|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)||133
10611887|NCT01912339|11769453|FG001|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)|All subjects for the control group either completed study or crossed over.|0
10611888|NCT01912339|11769454|FG002|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)|Control subjects that have crossed over.|53
10611889|NCT01912339|11769452|FG000|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
10611890|NCT01912339|11769453|FG001|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
10611891|NCT01912339|11769454|FG002|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
10611892|NCT01912339|11769452|FG000|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||133
10611893|NCT01912339|11769453|FG001|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
10611894|NCT01912339|11769454|FG002|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||53
10611895|NCT01912352|11769460|FG000|STARTED|Overall Study||83
10611896|NCT01912352|11769460|FG000|COMPLETED|Overall Study||78
10611897|NCT01912352|11769460|FG000|NOT COMPLETED|Overall Study||5
10611898|NCT01912456|11769466|FG000|STARTED|Period 1||22
10611899|NCT01912456|11769467|FG001|STARTED|Period 1||23
10611900|NCT01912456|11769468|FG002|STARTED|Period 1||23
10611901|NCT01912456|11769469|FG003|STARTED|Period 1||22
10611902|NCT01912456|11769466|FG000|COMPLETED|Period 1||20
10611903|NCT01912456|11769467|FG001|COMPLETED|Period 1||22
10611904|NCT01912456|11769468|FG002|COMPLETED|Period 1||21
10611905|NCT01912456|11769469|FG003|COMPLETED|Period 1||19
10611906|NCT01912456|11769466|FG000|NOT COMPLETED|Period 1||2
10611907|NCT01912456|11769467|FG001|NOT COMPLETED|Period 1||1
10611908|NCT01912456|11769468|FG002|NOT COMPLETED|Period 1||2
10611909|NCT01912456|11769469|FG003|NOT COMPLETED|Period 1||3
10611910|NCT01912456|11769466|FG000|STARTED|Period 2||20
10611911|NCT01912456|11769467|FG001|STARTED|Period 2||22
10611912|NCT01912456|11769468|FG002|STARTED|Period 2||21
10611913|NCT01912456|11769469|FG003|STARTED|Period 2||19
10611914|NCT01912456|11769466|FG000|COMPLETED|Period 2||20
10611915|NCT01912456|11769467|FG001|COMPLETED|Period 2||20
10611916|NCT01912456|11769468|FG002|COMPLETED|Period 2||21
10611917|NCT01912456|11769469|FG003|COMPLETED|Period 2||18
10611918|NCT01912456|11769466|FG000|NOT COMPLETED|Period 2||0
10611919|NCT01912456|11769467|FG001|NOT COMPLETED|Period 2||2
10611920|NCT01912456|11769468|FG002|NOT COMPLETED|Period 2||0
10611921|NCT01912456|11769469|FG003|NOT COMPLETED|Period 2||1
10611922|NCT01912495|11769479|FG000|STARTED|Overall Study|8 patients had only screening visit, total enrollment: 65|57
10611923|NCT01912495|11769479|FG000|COMPLETED|Overall Study||57
10611924|NCT01912495|11769479|FG000|NOT COMPLETED|Overall Study||0
10611925|NCT01912599|11769488|FG000|STARTED|Overall Study||20
10611926|NCT01912599|11769489|FG001|STARTED|Overall Study||16
10611927|NCT01912599|11769488|FG000|COMPLETED|Overall Study||20
10611928|NCT01912599|11769489|FG001|COMPLETED|Overall Study||15
10611929|NCT01912599|11769488|FG000|NOT COMPLETED|Overall Study||0
10611930|NCT01912599|11769489|FG001|NOT COMPLETED|Overall Study||1
10611931|NCT01912612|11769497|FG000|STARTED|Overall Study||36
10611932|NCT01912612|11769498|FG001|STARTED|Overall Study||40
10611933|NCT01912612|11769499|FG002|STARTED|Overall Study||3
10611934|NCT01912612|11769497|FG000|COMPLETED|Overall Study||31
10611935|NCT01912612|11769498|FG001|COMPLETED|Overall Study||40
10611936|NCT01912612|11769499|FG002|COMPLETED|Overall Study||0
10611937|NCT01912612|11769497|FG000|NOT COMPLETED|Overall Study||5
10611938|NCT01912612|11769498|FG001|NOT COMPLETED|Overall Study||0
10611939|NCT01912612|11769499|FG002|NOT COMPLETED|Overall Study||3
10611940|NCT01912716|11769507|FG000|STARTED|Overall Study|receipt of 1st dose of indomethacin|522
10611941|NCT01912716|11769508|FG001|STARTED|Overall Study||515
10611942|NCT01912716|11769507|FG000|Receipt of 2nd Dose|Overall Study||511
10611943|NCT01912716|11769508|FG001|Receipt of 2nd Dose|Overall Study||503
10611944|NCT01912716|11769507|FG000|5-day Follow-up|Overall Study||522
10611945|NCT01912716|11769508|FG001|5-day Follow-up|Overall Study||515
10611946|NCT01912716|11769507|FG000|3-day Follow-up|Overall Study||521
10611947|NCT01912716|11769508|FG001|3-day Follow-up|Overall Study||513
10611948|NCT01912716|11769507|FG000|COMPLETED|Overall Study||522
10611949|NCT01912716|11769508|FG001|COMPLETED|Overall Study||515
10611950|NCT01912716|11769507|FG000|NOT COMPLETED|Overall Study||0
10611951|NCT01912716|11769508|FG001|NOT COMPLETED|Overall Study||0
10653125|NCT02190604|11813560|FG004|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
10653126|NCT02190604|11813561|FG005|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
10653127|NCT02190604|11813562|FG006|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
10653128|NCT02190604|11813563|FG007|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
10653129|NCT02190604|11813564|FG008|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
10653130|NCT02190604|11813565|FG009|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
10653131|NCT02190604|11813566|FG010|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
10653132|NCT02190604|11813567|FG011|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
10653133|NCT02190604|11813568|FG012|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
10653134|NCT02190604|11813569|FG013|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||1
10653135|NCT02190604|11813570|FG014|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||2
10653136|NCT02190604|11813571|FG015|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
10653137|NCT02190604|11813572|FG016|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
10653138|NCT02190604|11813573|FG017|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
10653139|NCT02190604|11813574|FG018|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
10653140|NCT02190604|11813556|FG000|STARTED|Part 3 (Patients)||0
10653141|NCT02190604|11813557|FG001|STARTED|Part 3 (Patients)||0
10653142|NCT02190604|11813558|FG002|STARTED|Part 3 (Patients)||0
10653143|NCT02190604|11813559|FG003|STARTED|Part 3 (Patients)||0
10653144|NCT02190604|11813560|FG004|STARTED|Part 3 (Patients)||0
10653145|NCT02190604|11813561|FG005|STARTED|Part 3 (Patients)||0
10653146|NCT02190604|11813562|FG006|STARTED|Part 3 (Patients)||0
10653147|NCT02190604|11813563|FG007|STARTED|Part 3 (Patients)||0
10653148|NCT02190604|11813564|FG008|STARTED|Part 3 (Patients)||0
10653149|NCT02190604|11813565|FG009|STARTED|Part 3 (Patients)||0
10653150|NCT02190604|11813566|FG010|STARTED|Part 3 (Patients)||0
10653151|NCT02190604|11813567|FG011|STARTED|Part 3 (Patients)||0
10653152|NCT02190604|11813568|FG012|STARTED|Part 3 (Patients)||0
10653153|NCT02190604|11813569|FG013|STARTED|Part 3 (Patients)||0
10653154|NCT02190604|11813570|FG014|STARTED|Part 3 (Patients)||0
10653155|NCT02190604|11813571|FG015|STARTED|Part 3 (Patients)||6
10653156|NCT02190604|11813572|FG016|STARTED|Part 3 (Patients)||12
10653157|NCT02190604|11813573|FG017|STARTED|Part 3 (Patients)||19
10653158|NCT02190604|11813574|FG018|STARTED|Part 3 (Patients)||12
10653159|NCT02190604|11813556|FG000|COMPLETED|Part 3 (Patients)||0
10653160|NCT02190604|11813557|FG001|COMPLETED|Part 3 (Patients)||0
10653161|NCT02190604|11813558|FG002|COMPLETED|Part 3 (Patients)||0
10653162|NCT02190604|11813559|FG003|COMPLETED|Part 3 (Patients)||0
10653163|NCT02190604|11813560|FG004|COMPLETED|Part 3 (Patients)||0
10653164|NCT02190604|11813561|FG005|COMPLETED|Part 3 (Patients)||0
10653165|NCT02190604|11813562|FG006|COMPLETED|Part 3 (Patients)||0
10653166|NCT02190604|11813563|FG007|COMPLETED|Part 3 (Patients)||0
10653167|NCT02190604|11813564|FG008|COMPLETED|Part 3 (Patients)||0
10653168|NCT02190604|11813565|FG009|COMPLETED|Part 3 (Patients)||0
10653169|NCT02190604|11813566|FG010|COMPLETED|Part 3 (Patients)||0
10653170|NCT02190604|11813567|FG011|COMPLETED|Part 3 (Patients)||0
10653171|NCT02190604|11813568|FG012|COMPLETED|Part 3 (Patients)||0
10653172|NCT02190604|11813569|FG013|COMPLETED|Part 3 (Patients)||0
10653173|NCT02190604|11813570|FG014|COMPLETED|Part 3 (Patients)||0
10653174|NCT02190604|11813571|FG015|COMPLETED|Part 3 (Patients)||6
10653175|NCT02190604|11813572|FG016|COMPLETED|Part 3 (Patients)||12
10653176|NCT02190604|11813573|FG017|COMPLETED|Part 3 (Patients)||19
10611952|NCT01912729|11769518|FG000|STARTED|Overall Study||20
10611953|NCT01912729|11769519|FG001|STARTED|Overall Study||20
10611954|NCT01912729|11769518|FG000|COMPLETED|Overall Study||20
10611955|NCT01912729|11769519|FG001|COMPLETED|Overall Study||19
10611956|NCT01912729|11769518|FG000|NOT COMPLETED|Overall Study||0
10611957|NCT01912729|11769519|FG001|NOT COMPLETED|Overall Study||1
10611958|NCT01912768|11769527|FG000|STARTED|Overall Study||239
10611959|NCT01912768|11769528|FG001|STARTED|Overall Study||113
10611960|NCT01912768|11769527|FG000|COMPLETED|Overall Study||229
10611961|NCT01912768|11769528|FG001|COMPLETED|Overall Study||109
10611962|NCT01912768|11769527|FG000|NOT COMPLETED|Overall Study||10
10611963|NCT01912768|11769528|FG001|NOT COMPLETED|Overall Study||4
10611964|NCT01912781|11769537|FG000|STARTED|Overall Study||71
10611965|NCT01912781|11769538|FG001|STARTED|Overall Study||35
10611966|NCT01912781|11769537|FG000|COMPLETED|Overall Study||69
10611967|NCT01912781|11769538|FG001|COMPLETED|Overall Study||35
10611968|NCT01912781|11769537|FG000|NOT COMPLETED|Overall Study||2
10611969|NCT01912781|11769538|FG001|NOT COMPLETED|Overall Study||0
10611970|NCT01912807|11769547|FG000|STARTED|Overall Study|Enrolment phase: Recruiting of participants started December 11, 2013|150
10611971|NCT01912807|11769548|FG001|STARTED|Overall Study|Enrolment phase: Recruitment of participants started December 11, 2013|150
10611972|NCT01912807|11769547|FG000|Randomized|Overall Study||144
10611973|NCT01912807|11769548|FG001|Randomized|Overall Study||146
10611974|NCT01912807|11769547|FG000|COMPLETED|Overall Study|"n=108 completed study and immediate follow up~n=36 participants were lost to follow up at 24 hr"|108
10611975|NCT01912807|11769548|FG001|COMPLETED|Overall Study|"n=109 completed study and immediate follow up~n=37 participants were lost to follow up at 24 hr"|109
10611976|NCT01912807|11769547|FG000|NOT COMPLETED|Overall Study||42
10611977|NCT01912807|11769548|FG001|NOT COMPLETED|Overall Study||41
10611978|NCT01912872|11769558|FG000|STARTED|Overall Study||16
10611979|NCT01912872|11769559|FG001|STARTED|Overall Study||17
10611980|NCT01912872|11769560|FG002|STARTED|Overall Study||40
10611981|NCT01912872|11769561|FG003|STARTED|Overall Study||39
10611982|NCT01912872|11769558|FG000|Completed Study Treatment at Month 12|Overall Study||11
10611983|NCT01912872|11769559|FG001|Completed Study Treatment at Month 12|Overall Study||13
10611984|NCT01912872|11769560|FG002|Completed Study Treatment at Month 12|Overall Study||30
10611985|NCT01912872|11769561|FG003|Completed Study Treatment at Month 12|Overall Study||27
10611986|NCT01912872|11769558|FG000|Discontinued Treatment Prior to Month 12|Overall Study||5
10611987|NCT01912872|11769559|FG001|Discontinued Treatment Prior to Month 12|Overall Study||4
10611988|NCT01912872|11769560|FG002|Discontinued Treatment Prior to Month 12|Overall Study||10
10611989|NCT01912872|11769561|FG003|Discontinued Treatment Prior to Month 12|Overall Study||11
10611990|NCT01912872|11769558|FG000|COMPLETED|Overall Study||11
10611991|NCT01912872|11769559|FG001|COMPLETED|Overall Study||13
10611992|NCT01912872|11769560|FG002|COMPLETED|Overall Study||30
10611993|NCT01912872|11769561|FG003|COMPLETED|Overall Study||27
10611994|NCT01912872|11769558|FG000|NOT COMPLETED|Overall Study||5
10611995|NCT01912872|11769559|FG001|NOT COMPLETED|Overall Study||4
10611996|NCT01912872|11769560|FG002|NOT COMPLETED|Overall Study||10
10611997|NCT01912872|11769561|FG003|NOT COMPLETED|Overall Study||12
10611998|NCT01912963|11769575|FG000|STARTED|Overall Study||6
10611999|NCT01912963|11769576|FG001|STARTED|Overall Study||19
10612000|NCT01912963|11769577|FG002|STARTED|Overall Study||7
10612001|NCT01912963|11769575|FG000|COMPLETED|Overall Study||0
10612002|NCT01912963|11769576|FG001|COMPLETED|Overall Study||0
10612003|NCT01912963|11769577|FG002|COMPLETED|Overall Study||0
10612004|NCT01912963|11769575|FG000|NOT COMPLETED|Overall Study||6
10612005|NCT01912963|11769576|FG001|NOT COMPLETED|Overall Study||19
10612006|NCT01912963|11769577|FG002|NOT COMPLETED|Overall Study||7
10612007|NCT01913041|11769585|FG000|STARTED|Overall Study||869
10612008|NCT01913041|11769585|FG000|COMPLETED|Overall Study||830
10612009|NCT01913041|11769585|FG000|NOT COMPLETED|Overall Study||39
10612010|NCT01913314|11769589|FG000|STARTED|Overall Study||6
10612011|NCT01913314|11769589|FG000|Received Study Drug|Overall Study||6
10612012|NCT01913314|11769589|FG000|COMPLETED|Overall Study||6
10612013|NCT01913314|11769589|FG000|NOT COMPLETED|Overall Study||0
10612014|NCT01913340|11769595|FG000|STARTED|Overall Study|22 (92%) received all 5 doses, 1 (4%) received 4 doses, and 1 (4%) only received 1 dose.|24
10612015|NCT01913340|11769596|FG001|STARTED|Overall Study||26
10612016|NCT01913340|11769595|FG000|COMPLETED|Overall Study||21
10612017|NCT01913340|11769596|FG001|COMPLETED|Overall Study||20
10612018|NCT01913340|11769595|FG000|NOT COMPLETED|Overall Study||3
10612019|NCT01913340|11769596|FG001|NOT COMPLETED|Overall Study||6
10612020|NCT01913353|11769604|FG000|STARTED|Overall Study||221
10612021|NCT01913353|11769605|FG001|STARTED|Overall Study||219
10612022|NCT01913353|11769604|FG000|COMPLETED|Overall Study||189
10612023|NCT01913353|11769605|FG001|COMPLETED|Overall Study||204
10612024|NCT01913353|11769604|FG000|NOT COMPLETED|Overall Study||32
10612025|NCT01913353|11769605|FG001|NOT COMPLETED|Overall Study||15
10612026|NCT01913405|11769618|FG000|STARTED|Overall Study||22
10612027|NCT01913405|11769618|FG000|COMPLETED|Overall Study||20
10612028|NCT01913405|11769618|FG000|NOT COMPLETED|Overall Study||2
10612029|NCT01913470|11769637|FG000|STARTED|Overall Study||5
10612030|NCT01913470|11769638|FG001|STARTED|Overall Study||7
10612031|NCT01913470|11769637|FG000|COMPLETED|Overall Study||5
10612032|NCT01913470|11769638|FG001|COMPLETED|Overall Study||4
10612033|NCT01913470|11769637|FG000|NOT COMPLETED|Overall Study||0
10612034|NCT01913470|11769638|FG001|NOT COMPLETED|Overall Study||3
10612035|NCT01913483|11769647|FG000|STARTED|Overall Study||367
10612036|NCT01913483|11769648|FG001|STARTED|Overall Study||365
10612037|NCT01913483|11769647|FG000|Received at Least 1 Dose of Study Drug|Overall Study||335
10612038|NCT01913483|11769648|FG001|Received at Least 1 Dose of Study Drug|Overall Study||321
10612039|NCT01913483|11769647|FG000|COMPLETED|Overall Study||346
10612040|NCT01913483|11769648|FG001|COMPLETED|Overall Study||343
10612041|NCT01913483|11769647|FG000|NOT COMPLETED|Overall Study||21
10612042|NCT01913483|11769648|FG001|NOT COMPLETED|Overall Study||22
10612043|NCT01913535|11769659|FG000|STARTED|Phase 1 (Days 0-2)||2
10704660|NCT04142242|11869020|FG000|STARTED|Overall Study||139
10704661|NCT04142242|11869021|FG001|STARTED|Overall Study||176
10612044|NCT01913535|11769660|FG001|STARTED|Phase 1 (Days 0-2)||2
10612045|NCT01913535|11769661|FG002|STARTED|Phase 1 (Days 0-2)||1
10612046|NCT01913535|11769662|FG003|STARTED|Phase 1 (Days 0-2)||2
10612047|NCT01913535|11769663|FG004|STARTED|Phase 1 (Days 0-2)||1
10612048|NCT01913535|11769659|FG000|COMPLETED|Phase 1 (Days 0-2)||2
10612049|NCT01913535|11769660|FG001|COMPLETED|Phase 1 (Days 0-2)||2
10612050|NCT01913535|11769661|FG002|COMPLETED|Phase 1 (Days 0-2)||1
10612051|NCT01913535|11769662|FG003|COMPLETED|Phase 1 (Days 0-2)||2
10612052|NCT01913535|11769663|FG004|COMPLETED|Phase 1 (Days 0-2)||1
10612053|NCT01913535|11769659|FG000|NOT COMPLETED|Phase 1 (Days 0-2)||0
10612054|NCT01913535|11769660|FG001|NOT COMPLETED|Phase 1 (Days 0-2)||0
10612055|NCT01913535|11769661|FG002|NOT COMPLETED|Phase 1 (Days 0-2)||0
10612056|NCT01913535|11769662|FG003|NOT COMPLETED|Phase 1 (Days 0-2)||0
10612057|NCT01913535|11769663|FG004|NOT COMPLETED|Phase 1 (Days 0-2)||0
10612058|NCT01913535|11769659|FG000|STARTED|Phase 2 (Days 3-5)||2
10612059|NCT01913535|11769660|FG001|STARTED|Phase 2 (Days 3-5)||2
10612060|NCT01913535|11769661|FG002|STARTED|Phase 2 (Days 3-5)||1
10612061|NCT01913535|11769662|FG003|STARTED|Phase 2 (Days 3-5)||2
10612062|NCT01913535|11769663|FG004|STARTED|Phase 2 (Days 3-5)||1
10612063|NCT01913535|11769659|FG000|COMPLETED|Phase 2 (Days 3-5)||2
10612064|NCT01913535|11769660|FG001|COMPLETED|Phase 2 (Days 3-5)||2
10704662|NCT04142242|11869022|FG002|STARTED|Overall Study||31
10612065|NCT01913535|11769661|FG002|COMPLETED|Phase 2 (Days 3-5)||1
10612066|NCT01913535|11769662|FG003|COMPLETED|Phase 2 (Days 3-5)||2
10612067|NCT01913535|11769663|FG004|COMPLETED|Phase 2 (Days 3-5)||1
10612068|NCT01913535|11769659|FG000|NOT COMPLETED|Phase 2 (Days 3-5)||0
10612069|NCT01913535|11769660|FG001|NOT COMPLETED|Phase 2 (Days 3-5)||0
10612070|NCT01913535|11769661|FG002|NOT COMPLETED|Phase 2 (Days 3-5)||0
10612071|NCT01913535|11769662|FG003|NOT COMPLETED|Phase 2 (Days 3-5)||0
10612072|NCT01913535|11769663|FG004|NOT COMPLETED|Phase 2 (Days 3-5)||0
10612073|NCT01913600|11769676|FG000|STARTED|Overall Study||56
10612074|NCT01913600|11769676|FG000|COMPLETED|Overall Study||55
10612075|NCT01913600|11769676|FG000|NOT COMPLETED|Overall Study||1
10612076|NCT01913639|11769680|FG000|STARTED|Overall Study||39
10612077|NCT01913639|11769680|FG000|COMPLETED|Overall Study||36
10612078|NCT01913639|11769680|FG000|NOT COMPLETED|Overall Study||3
10612079|NCT01914003|11769686|FG000|STARTED|Overall Study||27
10612080|NCT01914003|11769687|FG001|STARTED|Overall Study||26
10612081|NCT01914003|11769686|FG000|COMPLETED|Overall Study|Number of subjects who completed through study and qualify as evaluable|19
10612082|NCT01914003|11769687|FG001|COMPLETED|Overall Study|Number of subjects who completed through study and qualify as evaluable|14
10612083|NCT01914003|11769686|FG000|NOT COMPLETED|Overall Study||8
10612084|NCT01914003|11769687|FG001|NOT COMPLETED|Overall Study||12
10612085|NCT01914159|11769693|FG000|STARTED|Overall Study||24
10612086|NCT01914159|11769693|FG000|COMPLETED|Overall Study||21
10612087|NCT01914159|11769693|FG000|NOT COMPLETED|Overall Study||3
10612088|NCT01914393|11769700|FG000|STARTED|Overall Study||271
10612089|NCT01914393|11769701|FG001|STARTED|Overall Study||125
10612090|NCT01914393|11769702|FG002|STARTED|Overall Study||306
10612091|NCT01914393|11769700|FG000|COMPLETED|Overall Study||156
10612092|NCT01914393|11769701|FG001|COMPLETED|Overall Study||54
10612093|NCT01914393|11769702|FG002|COMPLETED|Overall Study||168
10612094|NCT01914393|11769700|FG000|NOT COMPLETED|Overall Study||115
10612095|NCT01914393|11769701|FG001|NOT COMPLETED|Overall Study||71
10612096|NCT01914393|11769702|FG002|NOT COMPLETED|Overall Study||138
10612097|NCT01914510|11769714|FG000|STARTED|Overall Study||40
10612098|NCT01914510|11769714|FG000|COMPLETED|Overall Study||38
10612099|NCT01914510|11769714|FG000|NOT COMPLETED|Overall Study||2
10612100|NCT01914666|11769722|FG000|STARTED|Treatment Period||68
10612101|NCT01914666|11769723|FG001|STARTED|Treatment Period||42
10612102|NCT01914666|11769724|FG002|STARTED|Treatment Period||41
10612103|NCT01914666|11769722|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||68
10612104|NCT01914666|11769723|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||42
10612105|NCT01914666|11769724|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||41
10704663|NCT04142242|11869023|FG003|STARTED|Overall Study||39
10612106|NCT01914666|11769722|FG000|COMPLETED|Treatment Period||55
10612107|NCT01914666|11769723|FG001|COMPLETED|Treatment Period||36
10612108|NCT01914666|11769724|FG002|COMPLETED|Treatment Period||33
10704664|NCT04142242|11869024|FG004|STARTED|Overall Study||26
10612109|NCT01914666|11769722|FG000|NOT COMPLETED|Treatment Period||13
10612110|NCT01914666|11769723|FG001|NOT COMPLETED|Treatment Period||6
10612111|NCT01914666|11769724|FG002|NOT COMPLETED|Treatment Period||8
10612112|NCT01914666|11769722|FG000|STARTED|Tapering Period|4 Pts who discontinued, and 55 Pts who completed Treatment Period entered Tapering Period.|59
10612113|NCT01914666|11769723|FG001|STARTED|Tapering Period|3 Pts who discontinued, and 36 Pts who completed Treatment Period entered Tapering Period.|39
10612114|NCT01914666|11769724|FG002|STARTED|Tapering Period|7 Pts who discontinued, and 33 Pts who completed Treatment Period entered Tapering Period.|40
10612115|NCT01914666|11769722|FG000|COMPLETED|Tapering Period||59
10612116|NCT01914666|11769723|FG001|COMPLETED|Tapering Period||39
10612117|NCT01914666|11769724|FG002|COMPLETED|Tapering Period||40
10612118|NCT01914666|11769722|FG000|NOT COMPLETED|Tapering Period||0
10612119|NCT01914666|11769723|FG001|NOT COMPLETED|Tapering Period||0
10612120|NCT01914666|11769724|FG002|NOT COMPLETED|Tapering Period||0
10612121|NCT01914679|11769730|FG000|STARTED|Overall Study||17
10612122|NCT01914679|11769730|FG000|Began 12 Week Actual RINCE Treatment|Overall Study||17
10612123|NCT01914679|11769730|FG000|COMPLETED|Overall Study||12
10612124|NCT01914679|11769730|FG000|NOT COMPLETED|Overall Study||5
10612125|NCT01914757|11769737|FG000|STARTED|Overall Study||425
10612126|NCT01914757|11769738|FG001|STARTED|Overall Study||441
10612127|NCT01914757|11769739|FG002|STARTED|Overall Study||440
10612128|NCT01914757|11769737|FG000|COMPLETED|Overall Study||389
10612129|NCT01914757|11769738|FG001|COMPLETED|Overall Study||390
10612130|NCT01914757|11769739|FG002|COMPLETED|Overall Study||402
10612131|NCT01914757|11769737|FG000|NOT COMPLETED|Overall Study||36
10612132|NCT01914757|11769738|FG001|NOT COMPLETED|Overall Study||51
10612133|NCT01914757|11769739|FG002|NOT COMPLETED|Overall Study||38
10612134|NCT01914926|11769749|FG000|STARTED|Overall Study||29
10612135|NCT01914926|11769750|FG001|STARTED|Overall Study||25
10612136|NCT01914926|11769749|FG000|COMPLETED|Overall Study||28
10612137|NCT01914926|11769750|FG001|COMPLETED|Overall Study||24
10612138|NCT01914926|11769749|FG000|NOT COMPLETED|Overall Study||1
10612139|NCT01914926|11769750|FG001|NOT COMPLETED|Overall Study||1
10612140|NCT01915095|11769763|FG000|STARTED|Overall Study||10
10612141|NCT01915095|11769764|FG001|STARTED|Overall Study||10
10612142|NCT01915095|11769765|FG002|STARTED|Overall Study||5
10612143|NCT01915095|11769766|FG003|STARTED|Overall Study||8
10612144|NCT01915095|11769767|FG004|STARTED|Overall Study||9
10612145|NCT01915095|11769763|FG000|SCI|Overall Study||5
10612146|NCT01915095|11769764|FG001|SCI|Overall Study||5
10612147|NCT01915095|11769765|FG002|SCI|Overall Study||5
10612148|NCT01915095|11769766|FG003|SCI|Overall Study||8
10612149|NCT01915095|11769767|FG004|SCI|Overall Study||9
10612150|NCT01915095|11769763|FG000|Control|Overall Study||5
10612151|NCT01915095|11769764|FG001|Control|Overall Study||5
10612152|NCT01915095|11769765|FG002|Control|Overall Study||0
10612153|NCT01915095|11769766|FG003|Control|Overall Study||0
10612154|NCT01915095|11769767|FG004|Control|Overall Study||0
10612155|NCT01915095|11769763|FG000|COMPLETED|Overall Study||10
10612156|NCT01915095|11769764|FG001|COMPLETED|Overall Study||10
10612157|NCT01915095|11769765|FG002|COMPLETED|Overall Study||5
10612158|NCT01915095|11769766|FG003|COMPLETED|Overall Study||4
10612159|NCT01915095|11769767|FG004|COMPLETED|Overall Study||3
10612160|NCT01915095|11769763|FG000|NOT COMPLETED|Overall Study||0
10612161|NCT01915095|11769764|FG001|NOT COMPLETED|Overall Study||0
10612162|NCT01915095|11769765|FG002|NOT COMPLETED|Overall Study||0
10612163|NCT01915095|11769766|FG003|NOT COMPLETED|Overall Study||4
10612164|NCT01915095|11769767|FG004|NOT COMPLETED|Overall Study||6
10612165|NCT01915108|11769792|FG000|STARTED|Overall Study||32
10612166|NCT01915108|11769793|FG001|STARTED|Overall Study||32
10612167|NCT01915108|11769794|FG002|STARTED|Overall Study||32
10612168|NCT01915108|11769795|FG003|STARTED|Overall Study||32
10612169|NCT01915108|11769792|FG000|COMPLETED|Overall Study|two patients were excluded from the study|30
10612170|NCT01915108|11769793|FG001|COMPLETED|Overall Study|three patients were excluded from the study|29
10612171|NCT01915108|11769794|FG002|COMPLETED|Overall Study|one patients were excluded from the study|31
10612172|NCT01915108|11769795|FG003|COMPLETED|Overall Study|two patients were excluded from the study|30
10612173|NCT01915108|11769792|FG000|NOT COMPLETED|Overall Study||2
10612174|NCT01915108|11769793|FG001|NOT COMPLETED|Overall Study||3
10612175|NCT01915108|11769794|FG002|NOT COMPLETED|Overall Study||1
10612176|NCT01915108|11769795|FG003|NOT COMPLETED|Overall Study||2
10612177|NCT01915173|11769809|FG000|STARTED|Overall Study||6
10612178|NCT01915173|11769810|FG001|STARTED|Overall Study||6
10612179|NCT01915173|11769811|FG002|STARTED|Overall Study||6
10612180|NCT01915173|11769812|FG003|STARTED|Overall Study||6
10612181|NCT01915173|11769809|FG000|COMPLETED|Overall Study||6
10612182|NCT01915173|11769810|FG001|COMPLETED|Overall Study||6
10612183|NCT01915173|11769811|FG002|COMPLETED|Overall Study||6
10612184|NCT01915173|11769812|FG003|COMPLETED|Overall Study||6
10612185|NCT01915173|11769809|FG000|NOT COMPLETED|Overall Study||0
10612186|NCT01915173|11769810|FG001|NOT COMPLETED|Overall Study||0
10612187|NCT01915173|11769811|FG002|NOT COMPLETED|Overall Study||0
10612188|NCT01915173|11769812|FG003|NOT COMPLETED|Overall Study||0
10612189|NCT01915303|11769822|FG000|STARTED|Core Phase||68
10612190|NCT01915303|11769822|FG000|COMPLETED|Core Phase||52
10612191|NCT01915303|11769822|FG000|NOT COMPLETED|Core Phase||16
10612192|NCT01915303|11769822|FG000|STARTED|Extension Phase||29
10612193|NCT01915303|11769822|FG000|COMPLETED|Extension Phase||12
10612194|NCT01915303|11769822|FG000|NOT COMPLETED|Extension Phase||17
10612195|NCT01915563|11769828|FG000|STARTED|Overall Study||243
10612196|NCT01915563|11769829|FG001|STARTED|Overall Study||227
10612197|NCT01915563|11769828|FG000|COMPLETED|Overall Study||243
10612198|NCT01915563|11769829|FG001|COMPLETED|Overall Study||227
10612199|NCT01915563|11769828|FG000|NOT COMPLETED|Overall Study||0
10612200|NCT01915563|11769829|FG001|NOT COMPLETED|Overall Study||0
10612201|NCT01915732|11769837|FG000|STARTED|Overall Study||500
10612202|NCT01915732|11769838|FG001|STARTED|Overall Study||516
10612203|NCT01915732|11769837|FG000|COMPLETED|Overall Study||430
10612204|NCT01915732|11769838|FG001|COMPLETED|Overall Study||445
10612205|NCT01915732|11769837|FG000|NOT COMPLETED|Overall Study||70
10612206|NCT01915732|11769838|FG001|NOT COMPLETED|Overall Study||71
10612207|NCT01915771|11769844|FG000|STARTED|Day 1||15
10612208|NCT01915771|11769844|FG000|COMPLETED|Day 1||14
10612209|NCT01915771|11769844|FG000|NOT COMPLETED|Day 1||1
10612210|NCT01915771|11769844|FG000|STARTED|Day 15||14
10612211|NCT01915771|11769844|FG000|COMPLETED|Day 15||13
10612212|NCT01915771|11769844|FG000|NOT COMPLETED|Day 15||1
10612213|NCT01915823|11769854|FG000|STARTED|Overall Study||173
10612214|NCT01915823|11769855|FG001|STARTED|Overall Study||175
10612215|NCT01915823|11769854|FG000|COMPLETED|Overall Study||171
10612216|NCT01915823|11769855|FG001|COMPLETED|Overall Study||173
10612217|NCT01915823|11769854|FG000|NOT COMPLETED|Overall Study||2
10612218|NCT01915823|11769855|FG001|NOT COMPLETED|Overall Study||2
10612219|NCT01915849|11769865|FG000|STARTED|Treatment Period 1 (4 Days)||5
10612220|NCT01915849|11769866|FG001|STARTED|Treatment Period 1 (4 Days)||3
10612221|NCT01915849|11769867|FG002|STARTED|Treatment Period 1 (4 Days)||3
10612222|NCT01915849|11769868|FG003|STARTED|Treatment Period 1 (4 Days)||3
10612223|NCT01915849|11769865|FG000|COMPLETED|Treatment Period 1 (4 Days)||3
10612224|NCT01915849|11769866|FG001|COMPLETED|Treatment Period 1 (4 Days)||3
10612225|NCT01915849|11769867|FG002|COMPLETED|Treatment Period 1 (4 Days)||3
10612226|NCT01915849|11769868|FG003|COMPLETED|Treatment Period 1 (4 Days)||3
10612227|NCT01915849|11769865|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||2
10612228|NCT01915849|11769866|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||0
10612229|NCT01915849|11769867|FG002|NOT COMPLETED|Treatment Period 1 (4 Days)||0
10612230|NCT01915849|11769868|FG003|NOT COMPLETED|Treatment Period 1 (4 Days)||0
10612231|NCT01915849|11769865|FG000|STARTED|Treatment Period 2 (4 Days)||3
10612232|NCT01915849|11769866|FG001|STARTED|Treatment Period 2 (4 Days)||3
10612233|NCT01915849|11769867|FG002|STARTED|Treatment Period 2 (4 Days)||3
10612234|NCT01915849|11769868|FG003|STARTED|Treatment Period 2 (4 Days)||3
10612235|NCT01915849|11769865|FG000|COMPLETED|Treatment Period 2 (4 Days)||3
10612236|NCT01915849|11769866|FG001|COMPLETED|Treatment Period 2 (4 Days)||3
10612237|NCT01915849|11769867|FG002|COMPLETED|Treatment Period 2 (4 Days)||3
10612238|NCT01915849|11769868|FG003|COMPLETED|Treatment Period 2 (4 Days)||3
10612239|NCT01915849|11769865|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0
10612240|NCT01915849|11769866|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0
10612241|NCT01915849|11769867|FG002|NOT COMPLETED|Treatment Period 2 (4 Days)||0
10612242|NCT01915849|11769868|FG003|NOT COMPLETED|Treatment Period 2 (4 Days)||0
10612243|NCT01915849|11769865|FG000|STARTED|Treatment Period 3 (4 Days)||3
10612244|NCT01915849|11769866|FG001|STARTED|Treatment Period 3 (4 Days)||3
10704665|NCT04142242|11869025|FG005|STARTED|Overall Study||60
10704666|NCT04142242|11869020|FG000|Vaccinated|Overall Study||138
10704667|NCT04142242|11869021|FG001|Vaccinated|Overall Study||175
10704668|NCT04142242|11869022|FG002|Vaccinated|Overall Study||0
10457068|NCT01008995|11604803|FG001|NOT COMPLETED|Controlled Period||3
10612245|NCT01915849|11769867|FG002|STARTED|Treatment Period 3 (4 Days)||3
10612246|NCT01915849|11769868|FG003|STARTED|Treatment Period 3 (4 Days)||3
10612247|NCT01915849|11769865|FG000|COMPLETED|Treatment Period 3 (4 Days)||3
10612248|NCT01915849|11769866|FG001|COMPLETED|Treatment Period 3 (4 Days)||3
10612249|NCT01915849|11769867|FG002|COMPLETED|Treatment Period 3 (4 Days)||3
10612250|NCT01915849|11769868|FG003|COMPLETED|Treatment Period 3 (4 Days)||3
10612251|NCT01915849|11769865|FG000|NOT COMPLETED|Treatment Period 3 (4 Days)||0
10612252|NCT01915849|11769866|FG001|NOT COMPLETED|Treatment Period 3 (4 Days)||0
10612253|NCT01915849|11769867|FG002|NOT COMPLETED|Treatment Period 3 (4 Days)||0
10612254|NCT01915849|11769868|FG003|NOT COMPLETED|Treatment Period 3 (4 Days)||0
10612255|NCT01915849|11769865|FG000|STARTED|Treatment Period 4 (4 Days)||3
10612256|NCT01915849|11769866|FG001|STARTED|Treatment Period 4 (4 Days)||3
10612257|NCT01915849|11769867|FG002|STARTED|Treatment Period 4 (4 Days)||3
10612258|NCT01915849|11769868|FG003|STARTED|Treatment Period 4 (4 Days)||3
10612259|NCT01915849|11769865|FG000|COMPLETED|Treatment Period 4 (4 Days)||3
10704669|NCT04142242|11869023|FG003|Vaccinated|Overall Study||0
10612260|NCT01915849|11769866|FG001|COMPLETED|Treatment Period 4 (4 Days)||3
10612261|NCT01915849|11769867|FG002|COMPLETED|Treatment Period 4 (4 Days)||3
10612262|NCT01915849|11769868|FG003|COMPLETED|Treatment Period 4 (4 Days)||3
10612263|NCT01915849|11769865|FG000|NOT COMPLETED|Treatment Period 4 (4 Days)||0
10612264|NCT01915849|11769866|FG001|NOT COMPLETED|Treatment Period 4 (4 Days)||0
10612265|NCT01915849|11769867|FG002|NOT COMPLETED|Treatment Period 4 (4 Days)||0
10612266|NCT01915849|11769868|FG003|NOT COMPLETED|Treatment Period 4 (4 Days)||0
10612267|NCT01915914|11769878|FG000|STARTED|Acute Phase||123
10612268|NCT01915914|11769879|FG001|STARTED|Acute Phase||0
10612269|NCT01915914|11769880|FG002|STARTED|Acute Phase||0
10612270|NCT01915914|11769881|FG003|STARTED|Acute Phase||0
10612271|NCT01915914|11769878|FG000|Completed-Not Entered Maintenance Phase|Acute Phase||4
10612272|NCT01915914|11769879|FG001|Completed-Not Entered Maintenance Phase|Acute Phase||0
10612273|NCT01915914|11769880|FG002|Completed-Not Entered Maintenance Phase|Acute Phase||0
10612274|NCT01915914|11769881|FG003|Completed-Not Entered Maintenance Phase|Acute Phase||0
10612275|NCT01915914|11769878|FG000|COMPLETED|Acute Phase||111
10612276|NCT01915914|11769879|FG001|COMPLETED|Acute Phase||0
10612277|NCT01915914|11769880|FG002|COMPLETED|Acute Phase||0
10612278|NCT01915914|11769881|FG003|COMPLETED|Acute Phase||0
10612279|NCT01915914|11769878|FG000|NOT COMPLETED|Acute Phase||12
10612280|NCT01915914|11769879|FG001|NOT COMPLETED|Acute Phase||0
10612281|NCT01915914|11769880|FG002|NOT COMPLETED|Acute Phase||0
10612282|NCT01915914|11769881|FG003|NOT COMPLETED|Acute Phase||0
10612283|NCT01915914|11769878|FG000|STARTED|Maintenance Phase||0
10612284|NCT01915914|11769879|FG001|STARTED|Maintenance Phase||54
10612285|NCT01915914|11769880|FG002|STARTED|Maintenance Phase||53
10612286|NCT01915914|11769881|FG003|STARTED|Maintenance Phase||0
10612287|NCT01915914|11769878|FG000|COMPLETED|Maintenance Phase||0
10612288|NCT01915914|11769879|FG001|COMPLETED|Maintenance Phase||48
10612289|NCT01915914|11769880|FG002|COMPLETED|Maintenance Phase||51
10612290|NCT01915914|11769881|FG003|COMPLETED|Maintenance Phase||0
10612291|NCT01915914|11769878|FG000|NOT COMPLETED|Maintenance Phase||0
10612292|NCT01915914|11769879|FG001|NOT COMPLETED|Maintenance Phase||6
10612293|NCT01915914|11769880|FG002|NOT COMPLETED|Maintenance Phase||2
10612294|NCT01915914|11769881|FG003|NOT COMPLETED|Maintenance Phase||0
10612295|NCT01915914|11769878|FG000|STARTED|Follow-up Phase||0
10612296|NCT01915914|11769879|FG001|STARTED|Follow-up Phase||0
10612297|NCT01915914|11769880|FG002|STARTED|Follow-up Phase||0
10612298|NCT01915914|11769881|FG003|STARTED|Follow-up Phase||66
10612299|NCT01915914|11769878|FG000|COMPLETED|Follow-up Phase||0
10612300|NCT01915914|11769879|FG001|COMPLETED|Follow-up Phase||0
10612301|NCT01915914|11769880|FG002|COMPLETED|Follow-up Phase||0
10612302|NCT01915914|11769881|FG003|COMPLETED|Follow-up Phase||64
10612303|NCT01915914|11769878|FG000|NOT COMPLETED|Follow-up Phase||0
10612304|NCT01915914|11769879|FG001|NOT COMPLETED|Follow-up Phase||0
10612305|NCT01915914|11769880|FG002|NOT COMPLETED|Follow-up Phase||0
10612306|NCT01915914|11769881|FG003|NOT COMPLETED|Follow-up Phase||2
10612307|NCT01915940|11769901|FG000|STARTED|Pre-randomization Washout Period||169
10612308|NCT01915940|11769902|FG001|STARTED|Pre-randomization Washout Period||0
10612309|NCT01915940|11769903|FG002|STARTED|Pre-randomization Washout Period||0
10612310|NCT01915940|11769901|FG000|COMPLETED|Pre-randomization Washout Period||130
10612311|NCT01915940|11769902|FG001|COMPLETED|Pre-randomization Washout Period||0
10612312|NCT01915940|11769903|FG002|COMPLETED|Pre-randomization Washout Period||0
10612313|NCT01915940|11769901|FG000|NOT COMPLETED|Pre-randomization Washout Period||39
10612314|NCT01915940|11769902|FG001|NOT COMPLETED|Pre-randomization Washout Period||0
10612315|NCT01915940|11769903|FG002|NOT COMPLETED|Pre-randomization Washout Period||0
10612316|NCT01915940|11769901|FG000|STARTED|Treatment Period||0
10612317|NCT01915940|11769902|FG001|STARTED|Treatment Period||64
10612318|NCT01915940|11769903|FG002|STARTED|Treatment Period||66
10612319|NCT01915940|11769901|FG000|COMPLETED|Treatment Period||0
10612320|NCT01915940|11769902|FG001|COMPLETED|Treatment Period||53
10612321|NCT01915940|11769903|FG002|COMPLETED|Treatment Period||62
10612322|NCT01915940|11769901|FG000|NOT COMPLETED|Treatment Period||0
10612323|NCT01915940|11769902|FG001|NOT COMPLETED|Treatment Period||11
10612324|NCT01915940|11769903|FG002|NOT COMPLETED|Treatment Period||4
10612325|NCT01916109|11769909|FG000|STARTED|Overall Study||4
10612326|NCT01916109|11769909|FG000|COMPLETED|Overall Study||3
10612327|NCT01916109|11769909|FG000|NOT COMPLETED|Overall Study||1
10612328|NCT01916226|11769917|FG000|STARTED|Overall Study||170
10612329|NCT01916226|11769918|FG001|STARTED|Overall Study||170
10612330|NCT01916226|11769919|FG002|STARTED|Overall Study||171
10612331|NCT01916226|11769920|FG003|STARTED|Overall Study||171
10612332|NCT01916226|11769917|FG000|COMPLETED|Overall Study||169
10612333|NCT01916226|11769918|FG001|COMPLETED|Overall Study||169
10612334|NCT01916226|11769919|FG002|COMPLETED|Overall Study||168
10612335|NCT01916226|11769920|FG003|COMPLETED|Overall Study||167
10612336|NCT01916226|11769917|FG000|NOT COMPLETED|Overall Study||1
10612337|NCT01916226|11769918|FG001|NOT COMPLETED|Overall Study||1
10612338|NCT01916226|11769919|FG002|NOT COMPLETED|Overall Study||3
10612339|NCT01916226|11769920|FG003|NOT COMPLETED|Overall Study||4
10612340|NCT01916304|11769931|FG000|STARTED|Overall Study||101
10612341|NCT01916304|11769931|FG000|Safety Set|Overall Study||101
10612342|NCT01916304|11769931|FG000|Intent-to-Treat Set|Overall Study||84
10612343|NCT01916304|11769931|FG000|COMPLETED|Overall Study||84
10612344|NCT01916304|11769931|FG000|NOT COMPLETED|Overall Study||17
10612345|NCT01916629|11769937|FG000|STARTED|Overall Study||7
10612346|NCT01916629|11769938|FG001|STARTED|Overall Study||5
10612347|NCT01916629|11769937|FG000|COMPLETED|Overall Study||7
10612348|NCT01916629|11769938|FG001|COMPLETED|Overall Study||5
10612349|NCT01916629|11769937|FG000|NOT COMPLETED|Overall Study||0
10612350|NCT01916629|11769938|FG001|NOT COMPLETED|Overall Study||0
10612351|NCT01916655|11769947|FG000|STARTED|Overall Study||131
10612352|NCT01916655|11769948|FG001|STARTED|Overall Study||109
10612353|NCT01916655|11769949|FG002|STARTED|Overall Study||120
10612354|NCT01916655|11769947|FG000|COMPLETED|Overall Study||116
10612355|NCT01916655|11769948|FG001|COMPLETED|Overall Study||89
10612356|NCT01916655|11769949|FG002|COMPLETED|Overall Study||91
10612357|NCT01916655|11769947|FG000|NOT COMPLETED|Overall Study||15
10612358|NCT01916655|11769948|FG001|NOT COMPLETED|Overall Study||20
10612359|NCT01916655|11769949|FG002|NOT COMPLETED|Overall Study||29
10612360|NCT01916681|11769961|FG000|STARTED|Overall Study||123
10612361|NCT01916681|11769962|FG001|STARTED|Overall Study||120
10612362|NCT01916681|11769963|FG002|STARTED|Overall Study||123
10612363|NCT01916681|11769964|FG003|STARTED|Overall Study||125
10612364|NCT01916681|11769961|FG000|COMPLETED|Overall Study||123
10612365|NCT01916681|11769962|FG001|COMPLETED|Overall Study||120
10612366|NCT01916681|11769963|FG002|COMPLETED|Overall Study||123
10612367|NCT01916681|11769964|FG003|COMPLETED|Overall Study||125
10612368|NCT01916681|11769961|FG000|NOT COMPLETED|Overall Study||0
10612369|NCT01916681|11769962|FG001|NOT COMPLETED|Overall Study||0
10612370|NCT01916681|11769963|FG002|NOT COMPLETED|Overall Study||0
10612371|NCT01916681|11769964|FG003|NOT COMPLETED|Overall Study||0
10612372|NCT01916824|11769977|FG000|STARTED|Overall Study||24
10612373|NCT01916824|11769978|FG001|STARTED|Overall Study||29
10612374|NCT01916824|11769977|FG000|COMPLETED|Overall Study||17
10612375|NCT01916824|11769978|FG001|COMPLETED|Overall Study||20
10612376|NCT01916824|11769977|FG000|NOT COMPLETED|Overall Study||7
10612377|NCT01916824|11769978|FG001|NOT COMPLETED|Overall Study||9
10612378|NCT01916928|11769984|FG000|STARTED|Overall Study||50
10612379|NCT01916928|11769984|FG000|COMPLETED|Overall Study||50
10612380|NCT01916928|11769984|FG000|NOT COMPLETED|Overall Study||0
10612381|NCT01916941|11769990|FG000|STARTED|Overall Study||18
10612382|NCT01916941|11769991|FG001|STARTED|Overall Study||18
10612383|NCT01916941|11769990|FG000|COMPLETED|Overall Study||13
10612384|NCT01916941|11769991|FG001|COMPLETED|Overall Study||14
10612385|NCT01916941|11769990|FG000|NOT COMPLETED|Overall Study||5
10612386|NCT01916941|11769991|FG001|NOT COMPLETED|Overall Study||4
10612387|NCT01917006|11770004|FG000|STARTED|Randomized-treatment Period||5
10612388|NCT01917006|11770005|FG001|STARTED|Randomized-treatment Period||7
10612389|NCT01917006|11770006|FG002|STARTED|Randomized-treatment Period||8
10612390|NCT01917006|11770007|FG003|STARTED|Randomized-treatment Period||8
10612391|NCT01917006|11770008|FG004|STARTED|Randomized-treatment Period||8
10612392|NCT01917006|11770009|FG005|STARTED|Randomized-treatment Period||8
10612393|NCT01917006|11770010|FG006|STARTED|Randomized-treatment Period||15
10612394|NCT01917006|11770011|FG007|STARTED|Randomized-treatment Period||0
10612395|NCT01917006|11770004|FG000|COMPLETED|Randomized-treatment Period||3
10612396|NCT01917006|11770005|FG001|COMPLETED|Randomized-treatment Period||7
10612397|NCT01917006|11770006|FG002|COMPLETED|Randomized-treatment Period||8
10612398|NCT01917006|11770007|FG003|COMPLETED|Randomized-treatment Period||7
10612399|NCT01917006|11770008|FG004|COMPLETED|Randomized-treatment Period||8
10612400|NCT01917006|11770009|FG005|COMPLETED|Randomized-treatment Period||7
10612401|NCT01917006|11770010|FG006|COMPLETED|Randomized-treatment Period||14
10612402|NCT01917006|11770011|FG007|COMPLETED|Randomized-treatment Period||0
10612403|NCT01917006|11770004|FG000|NOT COMPLETED|Randomized-treatment Period||2
10612404|NCT01917006|11770005|FG001|NOT COMPLETED|Randomized-treatment Period||0
10612405|NCT01917006|11770006|FG002|NOT COMPLETED|Randomized-treatment Period||0
10612406|NCT01917006|11770007|FG003|NOT COMPLETED|Randomized-treatment Period||1
10612407|NCT01917006|11770008|FG004|NOT COMPLETED|Randomized-treatment Period||0
10612408|NCT01917006|11770009|FG005|NOT COMPLETED|Randomized-treatment Period||1
10612409|NCT01917006|11770010|FG006|NOT COMPLETED|Randomized-treatment Period||1
10612410|NCT01917006|11770011|FG007|NOT COMPLETED|Randomized-treatment Period||0
10612411|NCT01917006|11770004|FG000|STARTED|Open-label Period||0
10612412|NCT01917006|11770005|FG001|STARTED|Open-label Period||0
10612413|NCT01917006|11770006|FG002|STARTED|Open-label Period||0
10612414|NCT01917006|11770007|FG003|STARTED|Open-label Period||0
10612415|NCT01917006|11770008|FG004|STARTED|Open-label Period||0
10612416|NCT01917006|11770009|FG005|STARTED|Open-label Period||0
10612417|NCT01917006|11770010|FG006|STARTED|Open-label Period||0
10612418|NCT01917006|11770011|FG007|STARTED|Open-label Period||8
10612419|NCT01917006|11770004|FG000|COMPLETED|Open-label Period||0
10612420|NCT01917006|11770005|FG001|COMPLETED|Open-label Period||0
10612421|NCT01917006|11770006|FG002|COMPLETED|Open-label Period||0
10612422|NCT01917006|11770007|FG003|COMPLETED|Open-label Period||0
10612423|NCT01917006|11770008|FG004|COMPLETED|Open-label Period||0
10612424|NCT01917006|11770009|FG005|COMPLETED|Open-label Period||0
10612425|NCT01917006|11770010|FG006|COMPLETED|Open-label Period||0
10612426|NCT01917006|11770011|FG007|COMPLETED|Open-label Period||6
10612427|NCT01917006|11770004|FG000|NOT COMPLETED|Open-label Period||0
10612428|NCT01917006|11770005|FG001|NOT COMPLETED|Open-label Period||0
10612429|NCT01917006|11770006|FG002|NOT COMPLETED|Open-label Period||0
10612430|NCT01917006|11770007|FG003|NOT COMPLETED|Open-label Period||0
10612431|NCT01917006|11770008|FG004|NOT COMPLETED|Open-label Period||0
10612432|NCT01917006|11770009|FG005|NOT COMPLETED|Open-label Period||0
10612433|NCT01917006|11770010|FG006|NOT COMPLETED|Open-label Period||0
10612434|NCT01917006|11770011|FG007|NOT COMPLETED|Open-label Period||2
10612435|NCT01917084|11770028|FG000|STARTED|Overall Study||20
10612436|NCT01917084|11770028|FG000|COMPLETED|Overall Study||19
10612437|NCT01917084|11770028|FG000|NOT COMPLETED|Overall Study||1
10612438|NCT01917136|11770032|FG000|STARTED|Overall Study||21
10612439|NCT01917136|11770032|FG000|COMPLETED|Overall Study||21
10612440|NCT01917136|11770032|FG000|NOT COMPLETED|Overall Study||0
10612441|NCT01917188|11770039|FG000|STARTED|Overall Study||29
10612442|NCT01917188|11770040|FG001|STARTED|Overall Study||23
10612443|NCT01917188|11770041|FG002|STARTED|Overall Study||20
10612444|NCT01917188|11770039|FG000|COMPLETED|Overall Study||17
10612445|NCT01917188|11770040|FG001|COMPLETED|Overall Study||17
10612446|NCT01917188|11770041|FG002|COMPLETED|Overall Study||11
10612447|NCT01917188|11770039|FG000|NOT COMPLETED|Overall Study||12
10612448|NCT01917188|11770040|FG001|NOT COMPLETED|Overall Study||6
10612449|NCT01917188|11770041|FG002|NOT COMPLETED|Overall Study||9
10612450|NCT01917214|11770049|FG000|STARTED|Overall Study||212
10612451|NCT01917214|11770049|FG000|COMPLETED|Overall Study||212
10612452|NCT01917214|11770049|FG000|NOT COMPLETED|Overall Study||0
10612453|NCT01917344|11770054|FG000|STARTED|Overall Study||10
10612454|NCT01917344|11770054|FG000|COMPLETED|Overall Study||9
10612455|NCT01917344|11770054|FG000|NOT COMPLETED|Overall Study||1
10612456|NCT01917513|11770060|FG000|STARTED|Overall Study||502
10612457|NCT01917513|11770061|FG001|STARTED|Overall Study||498
10612458|NCT01917513|11770060|FG000|COMPLETED|Overall Study||407
10612459|NCT01917513|11770061|FG001|COMPLETED|Overall Study||396
10612460|NCT01917513|11770060|FG000|NOT COMPLETED|Overall Study||95
10612461|NCT01917513|11770061|FG001|NOT COMPLETED|Overall Study||102
10612462|NCT01917526|11770069|FG000|STARTED|Overall Study||250
10612463|NCT01917526|11770070|FG001|STARTED|Overall Study||250
10612464|NCT01917526|11770069|FG000|COMPLETED|Overall Study|One patient in oxygen mask received oxygen cannula|249
10612465|NCT01917526|11770070|FG001|COMPLETED|Overall Study|1 patient in oxygen cannula group receive oxygen mask|249
10612466|NCT01917526|11770069|FG000|NOT COMPLETED|Overall Study||1
10612467|NCT01917526|11770070|FG001|NOT COMPLETED|Overall Study||1
10612468|NCT01917656|11770078|FG000|STARTED|Overall Study||172
10612469|NCT01917656|11770079|FG001|STARTED|Overall Study||171
10612470|NCT01917656|11770078|FG000|Exposed|Overall Study|1 subject was withdrawn prior to exposure to trial products|171
10612471|NCT01917656|11770079|FG001|Exposed|Overall Study|1 subject was withdrawn prior to exposure to first SU dose after randomisation|170
10612472|NCT01917656|11770078|FG000|Exposed During Ramadan (Fasting)|Overall Study||152
10612473|NCT01917656|11770079|FG001|Exposed During Ramadan (Fasting)|Overall Study||163
10612474|NCT01917656|11770078|FG000|COMPLETED|Overall Study||146
10612475|NCT01917656|11770079|FG001|COMPLETED|Overall Study||147
10612476|NCT01917656|11770078|FG000|NOT COMPLETED|Overall Study||26
10704670|NCT04142242|11869024|FG004|Vaccinated|Overall Study||0
10704671|NCT04142242|11869025|FG005|Vaccinated|Overall Study||0
10704672|NCT04142242|11869020|FG000|Full Analysis Set (FAS)|Overall Study||138
10704673|NCT04142242|11869021|FG001|Full Analysis Set (FAS)|Overall Study||175
10612477|NCT01917656|11770079|FG001|NOT COMPLETED|Overall Study||24
10612478|NCT01917682|11770085|FG000|STARTED|Overall Study||754
10612479|NCT01917682|11770085|FG000|COMPLETED|Overall Study||754
10612480|NCT01917682|11770085|FG000|NOT COMPLETED|Overall Study||0
10612481|NCT01917747|11770092|FG000|STARTED|Overall Study||60
10612482|NCT01917747|11770093|FG001|STARTED|Overall Study||46
10612483|NCT01917747|11770092|FG000|COMPLETED|Overall Study||41
10612484|NCT01917747|11770093|FG001|COMPLETED|Overall Study||35
10612485|NCT01917747|11770092|FG000|NOT COMPLETED|Overall Study||19
10612486|NCT01917747|11770093|FG001|NOT COMPLETED|Overall Study||11
10612487|NCT01917773|11770103|FG000|STARTED|Overall Study||13
10612488|NCT01917773|11770103|FG000|COMPLETED|Overall Study||13
10612489|NCT01917773|11770103|FG000|NOT COMPLETED|Overall Study||0
10612490|NCT01917812|11770112|FG000|STARTED|Overall Study||16
10612491|NCT01917812|11770113|FG001|STARTED|Overall Study||16
10612492|NCT01917812|11770114|FG002|STARTED|Overall Study||16
10612493|NCT01917812|11770112|FG000|COMPLETED|Overall Study||15
10612494|NCT01917812|11770113|FG001|COMPLETED|Overall Study||16
10612495|NCT01917812|11770114|FG002|COMPLETED|Overall Study||16
10612496|NCT01917812|11770112|FG000|NOT COMPLETED|Overall Study||1
10612497|NCT01917812|11770113|FG001|NOT COMPLETED|Overall Study||0
10612498|NCT01917812|11770114|FG002|NOT COMPLETED|Overall Study||0
10612499|NCT01917968|11770124|FG000|STARTED|Overall Study||225
10612500|NCT01917968|11770125|FG001|STARTED|Overall Study||485
10612501|NCT01917968|11770124|FG000|COMPLETED|Overall Study||171
10612502|NCT01917968|11770125|FG001|COMPLETED|Overall Study||401
10612503|NCT01917968|11770124|FG000|NOT COMPLETED|Overall Study||54
10612504|NCT01917968|11770125|FG001|NOT COMPLETED|Overall Study||84
10612505|NCT01918072|11770138|FG000|STARTED|Controlled Trial Step One - Six Months||11
10612506|NCT01918072|11770139|FG001|STARTED|Controlled Trial Step One - Six Months||0
10612507|NCT01918072|11770140|FG002|STARTED|Controlled Trial Step One - Six Months||0
10612508|NCT01918072|11770138|FG000|Intervention|Controlled Trial Step One - Six Months||1
10612509|NCT01918072|11770139|FG001|Intervention|Controlled Trial Step One - Six Months||0
10612510|NCT01918072|11770140|FG002|Intervention|Controlled Trial Step One - Six Months||0
10612511|NCT01918072|11770138|FG000|Control|Controlled Trial Step One - Six Months||10
10612512|NCT01918072|11770139|FG001|Control|Controlled Trial Step One - Six Months||0
10612513|NCT01918072|11770140|FG002|Control|Controlled Trial Step One - Six Months||0
10612514|NCT01918072|11770138|FG000|COMPLETED|Controlled Trial Step One - Six Months||11
10612515|NCT01918072|11770139|FG001|COMPLETED|Controlled Trial Step One - Six Months||0
10612516|NCT01918072|11770140|FG002|COMPLETED|Controlled Trial Step One - Six Months||0
10612517|NCT01918072|11770138|FG000|NOT COMPLETED|Controlled Trial Step One - Six Months||0
10612518|NCT01918072|11770139|FG001|NOT COMPLETED|Controlled Trial Step One - Six Months||0
10612519|NCT01918072|11770140|FG002|NOT COMPLETED|Controlled Trial Step One - Six Months||0
10612520|NCT01918072|11770138|FG000|STARTED|Controlled Trial Step Two - Six Months||11
10612521|NCT01918072|11770139|FG001|STARTED|Controlled Trial Step Two - Six Months||0
10612522|NCT01918072|11770140|FG002|STARTED|Controlled Trial Step Two - Six Months||0
10612523|NCT01918072|11770138|FG000|Intervention|Controlled Trial Step Two - Six Months||7
10612524|NCT01918072|11770139|FG001|Intervention|Controlled Trial Step Two - Six Months||0
10612525|NCT01918072|11770140|FG002|Intervention|Controlled Trial Step Two - Six Months||0
10612526|NCT01918072|11770138|FG000|Control|Controlled Trial Step Two - Six Months||4
10612527|NCT01918072|11770139|FG001|Control|Controlled Trial Step Two - Six Months||0
10612528|NCT01918072|11770140|FG002|Control|Controlled Trial Step Two - Six Months||0
10612529|NCT01918072|11770138|FG000|COMPLETED|Controlled Trial Step Two - Six Months||11
10612530|NCT01918072|11770139|FG001|COMPLETED|Controlled Trial Step Two - Six Months||0
10612531|NCT01918072|11770140|FG002|COMPLETED|Controlled Trial Step Two - Six Months||0
10612532|NCT01918072|11770138|FG000|NOT COMPLETED|Controlled Trial Step Two - Six Months||0
10612533|NCT01918072|11770139|FG001|NOT COMPLETED|Controlled Trial Step Two - Six Months||0
10612534|NCT01918072|11770140|FG002|NOT COMPLETED|Controlled Trial Step Two - Six Months||0
10612535|NCT01918072|11770138|FG000|STARTED|Controlled Trial Step Three - Six Months||11
10612536|NCT01918072|11770139|FG001|STARTED|Controlled Trial Step Three - Six Months||0
10612537|NCT01918072|11770140|FG002|STARTED|Controlled Trial Step Three - Six Months||0
10612538|NCT01918072|11770138|FG000|Intervention|Controlled Trial Step Three - Six Months||9
10612539|NCT01918072|11770139|FG001|Intervention|Controlled Trial Step Three - Six Months||0
10612540|NCT01918072|11770140|FG002|Intervention|Controlled Trial Step Three - Six Months||0
10612541|NCT01918072|11770138|FG000|Control|Controlled Trial Step Three - Six Months||2
10612542|NCT01918072|11770139|FG001|Control|Controlled Trial Step Three - Six Months||0
10612543|NCT01918072|11770140|FG002|Control|Controlled Trial Step Three - Six Months||0
10612544|NCT01918072|11770138|FG000|COMPLETED|Controlled Trial Step Three - Six Months||11
10612545|NCT01918072|11770139|FG001|COMPLETED|Controlled Trial Step Three - Six Months||0
10612546|NCT01918072|11770140|FG002|COMPLETED|Controlled Trial Step Three - Six Months||0
10612547|NCT01918072|11770138|FG000|NOT COMPLETED|Controlled Trial Step Three - Six Months||0
10612548|NCT01918072|11770139|FG001|NOT COMPLETED|Controlled Trial Step Three - Six Months||0
10612549|NCT01918072|11770140|FG002|NOT COMPLETED|Controlled Trial Step Three - Six Months||0
10612550|NCT01918072|11770138|FG000|STARTED|Controlled Trial Step Four - Six Months||11
10612551|NCT01918072|11770139|FG001|STARTED|Controlled Trial Step Four - Six Months||0
10612552|NCT01918072|11770140|FG002|STARTED|Controlled Trial Step Four - Six Months||0
10612553|NCT01918072|11770138|FG000|Intervention|Controlled Trial Step Four - Six Months||11
10612554|NCT01918072|11770139|FG001|Intervention|Controlled Trial Step Four - Six Months||0
10612555|NCT01918072|11770140|FG002|Intervention|Controlled Trial Step Four - Six Months||0
10612556|NCT01918072|11770138|FG000|Control|Controlled Trial Step Four - Six Months||0
10612557|NCT01918072|11770139|FG001|Control|Controlled Trial Step Four - Six Months||0
10612558|NCT01918072|11770140|FG002|Control|Controlled Trial Step Four - Six Months||0
10612559|NCT01918072|11770138|FG000|COMPLETED|Controlled Trial Step Four - Six Months||11
10612560|NCT01918072|11770139|FG001|COMPLETED|Controlled Trial Step Four - Six Months||0
10612561|NCT01918072|11770140|FG002|COMPLETED|Controlled Trial Step Four - Six Months||0
10612562|NCT01918072|11770138|FG000|NOT COMPLETED|Controlled Trial Step Four - Six Months||0
10612563|NCT01918072|11770139|FG001|NOT COMPLETED|Controlled Trial Step Four - Six Months||0
10612564|NCT01918072|11770140|FG002|NOT COMPLETED|Controlled Trial Step Four - Six Months||0
10612565|NCT01918072|11770138|FG000|STARTED|Controlled Trial Step Five - Four Months||11
10612566|NCT01918072|11770139|FG001|STARTED|Controlled Trial Step Five - Four Months||0
10612567|NCT01918072|11770140|FG002|STARTED|Controlled Trial Step Five - Four Months||0
10612568|NCT01918072|11770138|FG000|Intervention|Controlled Trial Step Five - Four Months||11
10612569|NCT01918072|11770139|FG001|Intervention|Controlled Trial Step Five - Four Months||0
10612570|NCT01918072|11770140|FG002|Intervention|Controlled Trial Step Five - Four Months||0
10612571|NCT01918072|11770138|FG000|Control|Controlled Trial Step Five - Four Months||0
10612572|NCT01918072|11770139|FG001|Control|Controlled Trial Step Five - Four Months||0
10612573|NCT01918072|11770140|FG002|Control|Controlled Trial Step Five - Four Months||0
10612574|NCT01918072|11770138|FG000|COMPLETED|Controlled Trial Step Five - Four Months||11
10612575|NCT01918072|11770139|FG001|COMPLETED|Controlled Trial Step Five - Four Months||0
10612576|NCT01918072|11770140|FG002|COMPLETED|Controlled Trial Step Five - Four Months||0
10612577|NCT01918072|11770138|FG000|NOT COMPLETED|Controlled Trial Step Five - Four Months||0
10612578|NCT01918072|11770139|FG001|NOT COMPLETED|Controlled Trial Step Five - Four Months||0
10612579|NCT01918072|11770140|FG002|NOT COMPLETED|Controlled Trial Step Five - Four Months||0
10612580|NCT01918072|11770138|FG000|STARTED|E-consult Assessment Period||0
10612581|NCT01918072|11770139|FG001|STARTED|E-consult Assessment Period||42
10612582|NCT01918072|11770140|FG002|STARTED|E-consult Assessment Period||0
10612583|NCT01918072|11770138|FG000|COMPLETED|E-consult Assessment Period||0
10612584|NCT01918072|11770139|FG001|COMPLETED|E-consult Assessment Period||42
10612585|NCT01918072|11770140|FG002|COMPLETED|E-consult Assessment Period||0
10612586|NCT01918072|11770138|FG000|NOT COMPLETED|E-consult Assessment Period||0
10612587|NCT01918072|11770139|FG001|NOT COMPLETED|E-consult Assessment Period||0
10612588|NCT01918072|11770140|FG002|NOT COMPLETED|E-consult Assessment Period||0
10612589|NCT01918072|11770138|FG000|STARTED|Quality Assessment Period||0
10612590|NCT01918072|11770139|FG001|STARTED|Quality Assessment Period||0
10612591|NCT01918072|11770140|FG002|STARTED|Quality Assessment Period||202
10612592|NCT01918072|11770138|FG000|COMPLETED|Quality Assessment Period||0
10612593|NCT01918072|11770139|FG001|COMPLETED|Quality Assessment Period||0
10612594|NCT01918072|11770140|FG002|COMPLETED|Quality Assessment Period||202
10612595|NCT01918072|11770138|FG000|NOT COMPLETED|Quality Assessment Period||0
10612596|NCT01918072|11770139|FG001|NOT COMPLETED|Quality Assessment Period||0
10612597|NCT01918072|11770140|FG002|NOT COMPLETED|Quality Assessment Period||0
10612598|NCT01918085|11770152|FG000|STARTED|Test Period 1: Strata Strip||10
10612599|NCT01918085|11770153|FG001|STARTED|Test Period 1: Strata Strip||12
10612600|NCT01918085|11770152|FG000|COMPLETED|Test Period 1: Strata Strip||10
10612601|NCT01918085|11770153|FG001|COMPLETED|Test Period 1: Strata Strip||11
10612602|NCT01918085|11770152|FG000|NOT COMPLETED|Test Period 1: Strata Strip||0
10612603|NCT01918085|11770153|FG001|NOT COMPLETED|Test Period 1: Strata Strip||1
10612604|NCT01918085|11770152|FG000|STARTED|Test Period 1: Hydrocolloid Strip||10
10612605|NCT01918085|11770153|FG001|STARTED|Test Period 1: Hydrocolloid Strip||11
10612606|NCT01918085|11770152|FG000|COMPLETED|Test Period 1: Hydrocolloid Strip||10
10612607|NCT01918085|11770153|FG001|COMPLETED|Test Period 1: Hydrocolloid Strip||11
10612608|NCT01918085|11770152|FG000|NOT COMPLETED|Test Period 1: Hydrocolloid Strip||0
10612609|NCT01918085|11770153|FG001|NOT COMPLETED|Test Period 1: Hydrocolloid Strip||0
10612610|NCT01918085|11770152|FG000|STARTED|Test Period 2: Strata Strip||10
10612611|NCT01918085|11770153|FG001|STARTED|Test Period 2: Strata Strip||11
10612612|NCT01918085|11770152|FG000|COMPLETED|Test Period 2: Strata Strip||10
10612613|NCT01918085|11770153|FG001|COMPLETED|Test Period 2: Strata Strip||11
10612614|NCT01918085|11770152|FG000|NOT COMPLETED|Test Period 2: Strata Strip||0
10612615|NCT01918085|11770153|FG001|NOT COMPLETED|Test Period 2: Strata Strip||0
10612616|NCT01918085|11770152|FG000|STARTED|Test Period 2: Hydrocolloid Strip||10
10612617|NCT01918085|11770153|FG001|STARTED|Test Period 2: Hydrocolloid Strip||11
10612618|NCT01918085|11770152|FG000|COMPLETED|Test Period 2: Hydrocolloid Strip||10
10612619|NCT01918085|11770153|FG001|COMPLETED|Test Period 2: Hydrocolloid Strip||11
10612620|NCT01918085|11770152|FG000|NOT COMPLETED|Test Period 2: Hydrocolloid Strip||0
10612621|NCT01918085|11770153|FG001|NOT COMPLETED|Test Period 2: Hydrocolloid Strip||0
10612622|NCT01918189|11770161|FG000|STARTED|Overall Study||59
10612623|NCT01918189|11770161|FG000|Completed Baseline Assessment|Overall Study||58
10612624|NCT01918189|11770161|FG000|Completed Follow-up Assessment|Overall Study||41
10612625|NCT01918189|11770161|FG000|COMPLETED|Overall Study||41
10612626|NCT01918189|11770161|FG000|NOT COMPLETED|Overall Study||18
10612627|NCT01918306|11770168|FG000|STARTED|Overall Study||6
10612628|NCT01918306|11770169|FG001|STARTED|Overall Study|No patients enrolled|0
10612629|NCT01918306|11770170|FG002|STARTED|Overall Study|1 participant Crossed-over to ARM 2|2
10612630|NCT01918306|11770171|FG003|STARTED|Overall Study||3
10612631|NCT01918306|11770168|FG000|COMPLETED|Overall Study||0
10612632|NCT01918306|11770169|FG001|COMPLETED|Overall Study||0
10612633|NCT01918306|11770170|FG002|COMPLETED|Overall Study||0
10612634|NCT01918306|11770171|FG003|COMPLETED|Overall Study||0
10612635|NCT01918306|11770168|FG000|NOT COMPLETED|Overall Study||6
10612636|NCT01918306|11770169|FG001|NOT COMPLETED|Overall Study||0
10612637|NCT01918306|11770170|FG002|NOT COMPLETED|Overall Study||2
10612638|NCT01918306|11770171|FG003|NOT COMPLETED|Overall Study||3
10612639|NCT01918332|11770195|FG000|STARTED|Overall Study||43
10612640|NCT01918332|11770196|FG001|STARTED|Overall Study||41
10612641|NCT01918332|11770197|FG002|STARTED|Overall Study||39
10612642|NCT01918332|11770198|FG003|STARTED|Overall Study||45
10612643|NCT01918332|11770195|FG000|COMPLETED|Overall Study||35
10612644|NCT01918332|11770196|FG001|COMPLETED|Overall Study||36
10612645|NCT01918332|11770197|FG002|COMPLETED|Overall Study||30
10612646|NCT01918332|11770198|FG003|COMPLETED|Overall Study||38
10612647|NCT01918332|11770195|FG000|NOT COMPLETED|Overall Study||8
10612648|NCT01918332|11770196|FG001|NOT COMPLETED|Overall Study||5
10612649|NCT01918332|11770197|FG002|NOT COMPLETED|Overall Study||9
10612650|NCT01918332|11770198|FG003|NOT COMPLETED|Overall Study||7
10612651|NCT01918371|11770210|FG000|STARTED|Overall Study||166
10612652|NCT01918371|11770211|FG001|STARTED|Overall Study||157
10612653|NCT01918371|11770210|FG000|Participants With Complete Data|Overall Study||165
10612654|NCT01918371|11770211|FG001|Participants With Complete Data|Overall Study||156
10612655|NCT01918371|11770210|FG000|COMPLETED|Overall Study||165
10612656|NCT01918371|11770211|FG001|COMPLETED|Overall Study||156
10612657|NCT01918371|11770210|FG000|NOT COMPLETED|Overall Study||1
10612658|NCT01918371|11770211|FG001|NOT COMPLETED|Overall Study||1
10612659|NCT01918761|11770217|FG000|STARTED|Overall Study||5
10612660|NCT01918761|11770217|FG000|COMPLETED|Overall Study||5
10612661|NCT01918761|11770217|FG000|NOT COMPLETED|Overall Study||0
10612662|NCT01918774|11770221|FG000|STARTED|Overall Study||57
10612663|NCT01918774|11770221|FG000|COMPLETED|Overall Study||52
10612664|NCT01918774|11770221|FG000|NOT COMPLETED|Overall Study||5
10612665|NCT01918800|11770227|FG000|STARTED|Overall Study||109
10612666|NCT01918800|11770228|FG001|STARTED|Overall Study||109
10612667|NCT01918800|11770227|FG000|COMPLETED|Overall Study||100
10612668|NCT01918800|11770228|FG001|COMPLETED|Overall Study||104
10612669|NCT01918800|11770227|FG000|NOT COMPLETED|Overall Study||9
10612670|NCT01918800|11770228|FG001|NOT COMPLETED|Overall Study||5
10612671|NCT01919112|11770237|FG000|STARTED|Primary Analysis-day 5 of Intervention||14
10612672|NCT01919112|11770238|FG001|STARTED|Primary Analysis-day 5 of Intervention||13
10612673|NCT01919112|11770239|FG002|STARTED|Primary Analysis-day 5 of Intervention||15
10612674|NCT01919112|11770237|FG000|COMPLETED|Primary Analysis-day 5 of Intervention||14
10612675|NCT01919112|11770238|FG001|COMPLETED|Primary Analysis-day 5 of Intervention||13
10612676|NCT01919112|11770239|FG002|COMPLETED|Primary Analysis-day 5 of Intervention||15
10612677|NCT01919112|11770237|FG000|NOT COMPLETED|Primary Analysis-day 5 of Intervention||0
10612678|NCT01919112|11770238|FG001|NOT COMPLETED|Primary Analysis-day 5 of Intervention||0
10612679|NCT01919112|11770239|FG002|NOT COMPLETED|Primary Analysis-day 5 of Intervention||0
10612680|NCT01919112|11770237|FG000|STARTED|Secondary Analysis-day 30||14
10612681|NCT01919112|11770238|FG001|STARTED|Secondary Analysis-day 30||13
10612682|NCT01919112|11770239|FG002|STARTED|Secondary Analysis-day 30||15
10612683|NCT01919112|11770237|FG000|COMPLETED|Secondary Analysis-day 30||12
10612684|NCT01919112|11770238|FG001|COMPLETED|Secondary Analysis-day 30||12
10612685|NCT01919112|11770239|FG002|COMPLETED|Secondary Analysis-day 30||14
10612686|NCT01919112|11770237|FG000|NOT COMPLETED|Secondary Analysis-day 30||2
10612687|NCT01919112|11770238|FG001|NOT COMPLETED|Secondary Analysis-day 30||1
10612688|NCT01919112|11770239|FG002|NOT COMPLETED|Secondary Analysis-day 30||1
10612689|NCT01919164|11770252|FG000|STARTED|Overall Study||108
10612690|NCT01919164|11770253|FG001|STARTED|Overall Study||110
10704674|NCT04142242|11869022|FG002|Full Analysis Set (FAS)|Overall Study||31
10704675|NCT04142242|11869023|FG003|Full Analysis Set (FAS)|Overall Study||39
10612691|NCT01919164|11770254|FG002|STARTED|Overall Study||111
10612692|NCT01919164|11770255|FG003|STARTED|Overall Study||110
10612693|NCT01919164|11770256|FG004|STARTED|Overall Study||110
10612694|NCT01919164|11770252|FG000|Safety Analysis Set|Overall Study||107
10612695|NCT01919164|11770253|FG001|Safety Analysis Set|Overall Study|1 participant assigned to Placebo arm who inadvertently received 30 mcg was included in this arm.|109
10612696|NCT01919164|11770254|FG002|Safety Analysis Set|Overall Study||111
10612697|NCT01919164|11770255|FG003|Safety Analysis Set|Overall Study|1 participant in Sprifermin2 Cycles arm who inadvertently received 100 mcg was included in this arm.|111
10612698|NCT01919164|11770256|FG004|Safety Analysis Set|Overall Study||109
10612699|NCT01919164|11770252|FG000|COMPLETED|Overall Study||65
10612700|NCT01919164|11770253|FG001|COMPLETED|Overall Study||80
10612701|NCT01919164|11770254|FG002|COMPLETED|Overall Study||74
10612702|NCT01919164|11770255|FG003|COMPLETED|Overall Study||82
10612703|NCT01919164|11770256|FG004|COMPLETED|Overall Study||77
10612704|NCT01919164|11770252|FG000|NOT COMPLETED|Overall Study||43
10612705|NCT01919164|11770253|FG001|NOT COMPLETED|Overall Study||30
10612706|NCT01919164|11770254|FG002|NOT COMPLETED|Overall Study||37
10612707|NCT01919164|11770255|FG003|NOT COMPLETED|Overall Study||28
10612708|NCT01919164|11770256|FG004|NOT COMPLETED|Overall Study||33
10612709|NCT01919190|11770270|FG000|STARTED|Overall Study|Met eligibility criteria|33
10612710|NCT01919190|11770271|FG001|STARTED|Overall Study|Met eligibility criteria|34
10612711|NCT01919190|11770270|FG000|COMPLETED|Overall Study||30
10612712|NCT01919190|11770271|FG001|COMPLETED|Overall Study||34
10612713|NCT01919190|11770270|FG000|NOT COMPLETED|Overall Study||3
10612714|NCT01919190|11770271|FG001|NOT COMPLETED|Overall Study||0
10612715|NCT01919216|11770281|FG000|STARTED|Overall Study||28
10612716|NCT01919216|11770282|FG001|STARTED|Overall Study||21
10612717|NCT01919216|11770283|FG002|STARTED|Overall Study||5
10612718|NCT01919216|11770281|FG000|COMPLETED|Overall Study||26
10612719|NCT01919216|11770282|FG001|COMPLETED|Overall Study||20
10612720|NCT01919216|11770283|FG002|COMPLETED|Overall Study||4
10612721|NCT01919216|11770281|FG000|NOT COMPLETED|Overall Study||2
10612722|NCT01919216|11770282|FG001|NOT COMPLETED|Overall Study||1
10612723|NCT01919216|11770283|FG002|NOT COMPLETED|Overall Study||1
10612724|NCT01919229|11770294|FG000|STARTED|Overall Study||4
10612725|NCT01919229|11770295|FG001|STARTED|Overall Study||6
10612726|NCT01919229|11770296|FG002|STARTED|Overall Study||4
10612727|NCT01919229|11770294|FG000|COMPLETED|Overall Study||4
10612728|NCT01919229|11770295|FG001|COMPLETED|Overall Study||6
10612729|NCT01919229|11770296|FG002|COMPLETED|Overall Study||3
10612730|NCT01919229|11770294|FG000|NOT COMPLETED|Overall Study||0
10612731|NCT01919229|11770295|FG001|NOT COMPLETED|Overall Study||0
10612732|NCT01919229|11770296|FG002|NOT COMPLETED|Overall Study||1
10612733|NCT01919307|11770304|FG000|STARTED|Overall Study||29
10612734|NCT01919307|11770304|FG000|COMPLETED|Overall Study||20
10612735|NCT01919307|11770304|FG000|NOT COMPLETED|Overall Study||9
10612736|NCT01919398|11770311|FG000|STARTED|Overall Study||3
10612737|NCT01919398|11770312|FG001|STARTED|Overall Study||3
10333845|NCT00336232|11470099|FG000|COMPLETED|Baseline (200mcg Daily)||42
10333846|NCT00336232|11470099|FG000|NOT COMPLETED|Baseline (200mcg Daily)||17
10333847|NCT00336232|11470099|FG000|STARTED|Low Vitamin K (10mcg Daily)||42
10333848|NCT00336232|11470099|FG000|COMPLETED|Low Vitamin K (10mcg Daily)||42
10704676|NCT04142242|11869024|FG004|Full Analysis Set (FAS)|Overall Study||26
10333849|NCT00336232|11470099|FG000|NOT COMPLETED|Low Vitamin K (10mcg Daily)||0
10612738|NCT01919398|11770313|FG002|STARTED|Overall Study||13
10704677|NCT04142242|11869025|FG005|Full Analysis Set (FAS)|Overall Study||59
10333850|NCT00336232|11470099|FG000|STARTED|High Vitamin K (500mcg Daily)||42
10333851|NCT00336232|11470099|FG000|COMPLETED|High Vitamin K (500mcg Daily)||42
10612739|NCT01919398|11770311|FG000|Received at Least One Dose of Study Drug|Overall Study||3
10612740|NCT01919398|11770312|FG001|Received at Least One Dose of Study Drug|Overall Study||3
10612741|NCT01919398|11770313|FG002|Received at Least One Dose of Study Drug|Overall Study||13
10612742|NCT01919398|11770311|FG000|COMPLETED|Overall Study||3
10612743|NCT01919398|11770312|FG001|COMPLETED|Overall Study||3
10612744|NCT01919398|11770313|FG002|COMPLETED|Overall Study||9
10612745|NCT01919398|11770311|FG000|NOT COMPLETED|Overall Study||0
10612746|NCT01919398|11770312|FG001|NOT COMPLETED|Overall Study||0
10612747|NCT01919398|11770313|FG002|NOT COMPLETED|Overall Study||4
10612748|NCT01919411|11770323|FG000|STARTED|Overall Study||43
10704678|NCT04142242|11869020|FG000|Safety Analysis Set (SAfAS)|Overall Study|1 MenACYW Conjugate vaccine-primed participant was erroneously assigned by Investigator to Group 1 but per planned analysis was counted in Group 2 for safety analysis.|151
10704679|NCT04142242|11869021|FG001|Safety Analysis Set (SAfAS)|Overall Study|14 Menomune-primed participants were erroneously assigned by Investigator to Group 2 but per planned analysis they were counted in Group 1 for safety analysis.|162
10704680|NCT04142242|11869022|FG002|Safety Analysis Set (SAfAS)|Overall Study||0
10704681|NCT04142242|11869023|FG003|Safety Analysis Set (SAfAS)|Overall Study||0
10704682|NCT04142242|11869024|FG004|Safety Analysis Set (SAfAS)|Overall Study||0
10612749|NCT01919411|11770324|FG001|STARTED|Overall Study||46
10612750|NCT01919411|11770323|FG000|COMPLETED|Overall Study||38
10612751|NCT01919411|11770324|FG001|COMPLETED|Overall Study||41
10612752|NCT01919411|11770323|FG000|NOT COMPLETED|Overall Study||5
10612753|NCT01919411|11770324|FG001|NOT COMPLETED|Overall Study||5
10612754|NCT01919450|11770334|FG000|STARTED|Overall Study||20
10612755|NCT01919450|11770335|FG001|STARTED|Overall Study||20
10612756|NCT01919450|11770336|FG002|STARTED|Overall Study||20
10612757|NCT01919450|11770337|FG003|STARTED|Overall Study||20
10612758|NCT01919450|11770334|FG000|COMPLETED|Overall Study||20
10612759|NCT01919450|11770335|FG001|COMPLETED|Overall Study||20
10612760|NCT01919450|11770336|FG002|COMPLETED|Overall Study||20
10612761|NCT01919450|11770337|FG003|COMPLETED|Overall Study||19
10612762|NCT01919450|11770334|FG000|NOT COMPLETED|Overall Study||0
10612763|NCT01919450|11770335|FG001|NOT COMPLETED|Overall Study||0
10612764|NCT01919450|11770336|FG002|NOT COMPLETED|Overall Study||0
10612765|NCT01919450|11770337|FG003|NOT COMPLETED|Overall Study||1
10612766|NCT01919489|11770349|FG000|STARTED|Overall Study||136
10612767|NCT01919489|11770350|FG001|STARTED|Overall Study||137
10612768|NCT01919489|11770349|FG000|COMPLETED|Overall Study||80
10612769|NCT01919489|11770350|FG001|COMPLETED|Overall Study||93
10612770|NCT01919489|11770349|FG000|NOT COMPLETED|Overall Study||56
10612771|NCT01919489|11770350|FG001|NOT COMPLETED|Overall Study||44
10612772|NCT01919606|11770358|FG000|STARTED|Overall Study||1
10612773|NCT01919606|11770359|FG001|STARTED|Overall Study||0
10612774|NCT01919606|11770358|FG000|COMPLETED|Overall Study||1
10612775|NCT01919606|11770359|FG001|COMPLETED|Overall Study||0
10612776|NCT01919606|11770358|FG000|NOT COMPLETED|Overall Study||0
10612777|NCT01919606|11770359|FG001|NOT COMPLETED|Overall Study||0
10612778|NCT01919697|11770367|FG000|STARTED|Overall Study||224
10612779|NCT01919697|11770368|FG001|STARTED|Overall Study||2146
10612780|NCT01919697|11770367|FG000|COMPLETED|Overall Study||171
10612781|NCT01919697|11770368|FG001|COMPLETED|Overall Study||1761
10612782|NCT01919697|11770367|FG000|NOT COMPLETED|Overall Study||53
10612783|NCT01919697|11770368|FG001|NOT COMPLETED|Overall Study||385
10612784|NCT01919723|11770377|FG000|STARTED|Overall Study||35
10612785|NCT01919723|11770378|FG001|STARTED|Overall Study||35
10612786|NCT01919723|11770377|FG000|COMPLETED|Overall Study||33
10612787|NCT01919723|11770378|FG001|COMPLETED|Overall Study||33
10612788|NCT01919723|11770377|FG000|NOT COMPLETED|Overall Study||2
10612789|NCT01919723|11770378|FG001|NOT COMPLETED|Overall Study||2
10612790|NCT01919801|11770386|FG000|STARTED|Overall Study||61
10612791|NCT01919801|11770387|FG001|STARTED|Overall Study||60
10612792|NCT01919801|11770386|FG000|COMPLETED|Overall Study||60
10612793|NCT01919801|11770387|FG001|COMPLETED|Overall Study||57
10612794|NCT01919801|11770386|FG000|NOT COMPLETED|Overall Study||1
10612795|NCT01919801|11770387|FG001|NOT COMPLETED|Overall Study||3
10612796|NCT01919814|11770393|FG000|STARTED|Overall Study||30
10612797|NCT01919814|11770394|FG001|STARTED|Overall Study||30
10612798|NCT01919814|11770393|FG000|COMPLETED|Overall Study||27
10612799|NCT01919814|11770394|FG001|COMPLETED|Overall Study||30
10612800|NCT01919814|11770393|FG000|NOT COMPLETED|Overall Study||3
10612801|NCT01919814|11770394|FG001|NOT COMPLETED|Overall Study||0
10612802|NCT01919970|11770402|FG000|STARTED|Overall Study||14
10612803|NCT01919970|11770403|FG001|STARTED|Overall Study||18
10612804|NCT01919970|11770402|FG000|COMPLETED|Overall Study||11
10612805|NCT01919970|11770403|FG001|COMPLETED|Overall Study||18
10612806|NCT01919970|11770402|FG000|NOT COMPLETED|Overall Study||3
10612807|NCT01919970|11770403|FG001|NOT COMPLETED|Overall Study||0
10612808|NCT01919996|11770409|FG000|STARTED|Overall Study||8
10612809|NCT01919996|11770409|FG000|COMPLETED|Overall Study||8
10612810|NCT01919996|11770409|FG000|NOT COMPLETED|Overall Study||0
10704683|NCT04142242|11869025|FG005|Safety Analysis Set (SAfAS)|Overall Study||0
10704684|NCT04142242|11869020|FG000|COMPLETED|Overall Study||138
10704685|NCT04142242|11869021|FG001|COMPLETED|Overall Study||175
10612891|NCT01920152|11770517|FG000|STARTED|Overall Study||19
10612892|NCT01920152|11770518|FG001|STARTED|Overall Study||15
10612893|NCT01920152|11770517|FG000|COMPLETED|Overall Study||18
10612894|NCT01920152|11770518|FG001|COMPLETED|Overall Study||13
10612895|NCT01920152|11770517|FG000|NOT COMPLETED|Overall Study||1
10612896|NCT01920152|11770518|FG001|NOT COMPLETED|Overall Study||2
10612897|NCT01920178|11770526|FG000|STARTED|Overall Study||5
10612898|NCT01920178|11770527|FG001|STARTED|Overall Study||2
10612899|NCT01920178|11770526|FG000|COMPLETED|Overall Study||3
10612900|NCT01920178|11770527|FG001|COMPLETED|Overall Study||1
10612901|NCT01920178|11770526|FG000|NOT COMPLETED|Overall Study||2
10612902|NCT01920178|11770527|FG001|NOT COMPLETED|Overall Study||1
10612903|NCT01920282|11770536|FG000|STARTED|Overall Study||15
10612904|NCT01920282|11770537|FG001|STARTED|Overall Study||15
10612905|NCT01920282|11770538|FG002|STARTED|Overall Study||15
10612906|NCT01920282|11770536|FG000|COMPLETED|Overall Study||15
10612907|NCT01920282|11770537|FG001|COMPLETED|Overall Study||15
10612908|NCT01920282|11770538|FG002|COMPLETED|Overall Study||15
10612909|NCT01920282|11770536|FG000|NOT COMPLETED|Overall Study||0
10612910|NCT01920282|11770537|FG001|NOT COMPLETED|Overall Study||0
10612911|NCT01920282|11770538|FG002|NOT COMPLETED|Overall Study||0
10612912|NCT01920477|11770548|FG000|STARTED|Overall Study||17
10612913|NCT01920477|11770549|FG001|STARTED|Overall Study||18
10612914|NCT01920477|11770548|FG000|Requiried Individualized Follow-up|Overall Study||1
10612915|NCT01920477|11770549|FG001|Requiried Individualized Follow-up|Overall Study||0
10612916|NCT01920477|11770548|FG000|COMPLETED|Overall Study||2
10612917|NCT01920477|11770549|FG001|COMPLETED|Overall Study||1
10612918|NCT01920477|11770548|FG000|NOT COMPLETED|Overall Study||15
10612919|NCT01920477|11770549|FG001|NOT COMPLETED|Overall Study||17
10612920|NCT01920555|11770560|FG000|STARTED|Overall Study||18
10612921|NCT01920555|11770561|FG001|STARTED|Overall Study||20
10612922|NCT01920555|11770562|FG002|STARTED|Overall Study||22
10612923|NCT01920555|11770563|FG003|STARTED|Overall Study||20
10612924|NCT01920555|11770564|FG004|STARTED|Overall Study||19
10612925|NCT01920555|11770560|FG000|COMPLETED|Overall Study||14
10612926|NCT01920555|11770561|FG001|COMPLETED|Overall Study||16
10612927|NCT01920555|11770562|FG002|COMPLETED|Overall Study||21
10612928|NCT01920555|11770563|FG003|COMPLETED|Overall Study||17
10704686|NCT04142242|11869022|FG002|COMPLETED|Overall Study||0
10704687|NCT04142242|11869023|FG003|COMPLETED|Overall Study||0
10612929|NCT01920555|11770564|FG004|COMPLETED|Overall Study||18
10612930|NCT01920555|11770560|FG000|NOT COMPLETED|Overall Study||4
10612931|NCT01920555|11770561|FG001|NOT COMPLETED|Overall Study||4
10612932|NCT01920555|11770562|FG002|NOT COMPLETED|Overall Study||1
10612933|NCT01920555|11770563|FG003|NOT COMPLETED|Overall Study||3
10612934|NCT01920555|11770564|FG004|NOT COMPLETED|Overall Study||1
10612935|NCT01920568|11770578|FG000|STARTED|Overall Study||326
10612936|NCT01920568|11770579|FG001|STARTED|Overall Study||159
10612937|NCT01920568|11770578|FG000|COMPLETED|Overall Study||175
10612938|NCT01920568|11770579|FG001|COMPLETED|Overall Study||75
10612939|NCT01920568|11770578|FG000|NOT COMPLETED|Overall Study||151
10612940|NCT01920568|11770579|FG001|NOT COMPLETED|Overall Study||84
10612941|NCT01920594|11770588|FG000|STARTED|Overall Study||27
10612942|NCT01920594|11770589|FG001|STARTED|Overall Study||28
10612943|NCT01920594|11770588|FG000|COMPLETED|Overall Study||20
10612944|NCT01920594|11770589|FG001|COMPLETED|Overall Study||25
10612945|NCT01920594|11770588|FG000|NOT COMPLETED|Overall Study||7
10612946|NCT01920594|11770589|FG001|NOT COMPLETED|Overall Study||3
10612947|NCT01920711|11770597|FG000|STARTED|Overall Study||2419
10612948|NCT01920711|11770598|FG001|STARTED|Overall Study||2403
10612949|NCT01920711|11770597|FG000|COMPLETED|Overall Study||2055
10612950|NCT01920711|11770598|FG001|COMPLETED|Overall Study||2030
10612951|NCT01920711|11770597|FG000|NOT COMPLETED|Overall Study||364
10612952|NCT01920711|11770598|FG001|NOT COMPLETED|Overall Study||373
10612953|NCT01920802|11770608|FG000|STARTED|Overall Study||11
10612954|NCT01920802|11770609|FG001|STARTED|Overall Study||9
10612955|NCT01920802|11770610|FG002|STARTED|Overall Study||11
10612956|NCT01920802|11770608|FG000|COMPLETED|Overall Study||7
10612957|NCT01920802|11770609|FG001|COMPLETED|Overall Study||7
10612958|NCT01920802|11770610|FG002|COMPLETED|Overall Study||10
10612959|NCT01920802|11770608|FG000|NOT COMPLETED|Overall Study||4
10612960|NCT01920802|11770609|FG001|NOT COMPLETED|Overall Study||2
10612961|NCT01920802|11770610|FG002|NOT COMPLETED|Overall Study||1
10612962|NCT01920854|11770625|FG000|STARTED|Overall Study||12
10612963|NCT01920854|11770626|FG001|STARTED|Overall Study||6
10612964|NCT01920854|11770627|FG002|STARTED|Overall Study||6
10612965|NCT01920854|11770628|FG003|STARTED|Overall Study||6
10612966|NCT01920854|11770629|FG004|STARTED|Overall Study||6
10612967|NCT01920854|11770630|FG005|STARTED|Overall Study||6
10612968|NCT01920854|11770631|FG006|STARTED|Overall Study||6
10612969|NCT01920854|11770625|FG000|COMPLETED|Overall Study||11
10612970|NCT01920854|11770626|FG001|COMPLETED|Overall Study||6
10612971|NCT01920854|11770627|FG002|COMPLETED|Overall Study||6
10612972|NCT01920854|11770628|FG003|COMPLETED|Overall Study||6
10612973|NCT01920854|11770629|FG004|COMPLETED|Overall Study||5
10612974|NCT01920854|11770630|FG005|COMPLETED|Overall Study||6
10612975|NCT01920854|11770631|FG006|COMPLETED|Overall Study||5
10612976|NCT01920854|11770625|FG000|NOT COMPLETED|Overall Study||1
10612977|NCT01920854|11770626|FG001|NOT COMPLETED|Overall Study||0
10612978|NCT01920854|11770627|FG002|NOT COMPLETED|Overall Study||0
10612979|NCT01920854|11770628|FG003|NOT COMPLETED|Overall Study||0
10612980|NCT01920854|11770629|FG004|NOT COMPLETED|Overall Study||1
10612981|NCT01920854|11770630|FG005|NOT COMPLETED|Overall Study||0
10612982|NCT01920854|11770631|FG006|NOT COMPLETED|Overall Study||1
10612983|NCT01920893|11770668|FG000|STARTED|Overall Study||30
10612984|NCT01920893|11770669|FG001|STARTED|Overall Study||30
10612985|NCT01920893|11770668|FG000|Treated (Safety Population)|Overall Study||30
10612986|NCT01920893|11770669|FG001|Treated (Safety Population)|Overall Study||30
10612987|NCT01920893|11770668|FG000|COMPLETED|Overall Study||23
10612988|NCT01920893|11770669|FG001|COMPLETED|Overall Study||28
10612989|NCT01920893|11770668|FG000|NOT COMPLETED|Overall Study||7
10612990|NCT01920893|11770669|FG001|NOT COMPLETED|Overall Study||2
10612991|NCT01920958|11770676|FG000|STARTED|Overall Study||233
10612992|NCT01920958|11770676|FG000|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|228
10612993|NCT01920958|11770676|FG000|NOT COMPLETED|Overall Study||5
10612994|NCT01921101|11770682|FG000|STARTED|Overall Study||40
10612995|NCT01921101|11770683|FG001|STARTED|Overall Study||38
10612996|NCT01921101|11770682|FG000|COMPLETED|Overall Study||24
10612997|NCT01921101|11770683|FG001|COMPLETED|Overall Study||32
10612998|NCT01921101|11770682|FG000|NOT COMPLETED|Overall Study||16
10612999|NCT01921101|11770683|FG001|NOT COMPLETED|Overall Study||6
10613000|NCT01921179|11770691|FG000|STARTED|5 Week Randomized GOALS vs EDU Training||24
10613001|NCT01921179|11770692|FG001|STARTED|5 Week Randomized GOALS vs EDU Training||22
10613002|NCT01921179|11770691|FG000|COMPLETED|5 Week Randomized GOALS vs EDU Training||21
10613003|NCT01921179|11770692|FG001|COMPLETED|5 Week Randomized GOALS vs EDU Training||19
10613004|NCT01921179|11770691|FG000|NOT COMPLETED|5 Week Randomized GOALS vs EDU Training||3
10613005|NCT01921179|11770692|FG001|NOT COMPLETED|5 Week Randomized GOALS vs EDU Training||3
10613006|NCT01921179|11770691|FG000|STARTED|Long Term Follow-up After GOALS Training||34
10613007|NCT01921179|11770692|FG001|STARTED|Long Term Follow-up After GOALS Training|13 out of 19 participants who completed EDU, also completed GOALS training|0
10613008|NCT01921179|11770691|FG000|COMPLETED|Long Term Follow-up After GOALS Training||32
10613009|NCT01921179|11770692|FG001|COMPLETED|Long Term Follow-up After GOALS Training||0
10613010|NCT01921179|11770691|FG000|NOT COMPLETED|Long Term Follow-up After GOALS Training||2
10613011|NCT01921179|11770692|FG001|NOT COMPLETED|Long Term Follow-up After GOALS Training||0
10613012|NCT01921205|11770701|FG000|STARTED|Overall Study||172
10613013|NCT01921205|11770702|FG001|STARTED|Overall Study||171
10613014|NCT01921205|11770701|FG000|COMPLETED|Overall Study||151
10613015|NCT01921205|11770702|FG001|COMPLETED|Overall Study||151
10613016|NCT01921205|11770701|FG000|NOT COMPLETED|Overall Study||21
10613017|NCT01921205|11770702|FG001|NOT COMPLETED|Overall Study||20
10653177|NCT02190604|11813574|FG018|COMPLETED|Part 3 (Patients)||12
10613018|NCT01921257|11770708|FG000|STARTED|Overall Study||16
10613019|NCT01921257|11770708|FG000|Placebo run-in|Overall Study||16
10613020|NCT01921257|11770708|FG000|Active Treatment|Overall Study||13
10613021|NCT01921257|11770708|FG000|COMPLETED|Overall Study||13
10613022|NCT01921257|11770708|FG000|NOT COMPLETED|Overall Study||3
10613023|NCT01921270|11770713|FG000|STARTED|Overall Study||18
10613024|NCT01921270|11770713|FG000|COMPLETED|Overall Study||17
10613025|NCT01921270|11770713|FG000|NOT COMPLETED|Overall Study||1
10613026|NCT01921296|11770717|FG000|STARTED|Overall Study||2
10613027|NCT01921296|11770717|FG000|COMPLETED|Overall Study||2
10613028|NCT01921296|11770717|FG000|NOT COMPLETED|Overall Study||0
10613029|NCT01921322|11770723|FG000|STARTED|Overall Study||57
10613030|NCT01921322|11770724|FG001|STARTED|Overall Study||61
10613031|NCT01921322|11770723|FG000|COMPLETED|Overall Study||42
10613032|NCT01921322|11770724|FG001|COMPLETED|Overall Study||44
10613033|NCT01921322|11770723|FG000|NOT COMPLETED|Overall Study||15
10613034|NCT01921322|11770724|FG001|NOT COMPLETED|Overall Study||17
10613035|NCT01921348|11770732|FG000|STARTED|Overall Study||9
10613036|NCT01921348|11770733|FG001|STARTED|Overall Study||9
10613037|NCT01921348|11770732|FG000|COMPLETED|Overall Study||8
10613038|NCT01921348|11770733|FG001|COMPLETED|Overall Study||7
10613039|NCT01921348|11770732|FG000|NOT COMPLETED|Overall Study||1
10613040|NCT01921348|11770733|FG001|NOT COMPLETED|Overall Study||2
10613041|NCT01921387|11770739|FG000|STARTED|Overall Study||20
10613042|NCT01921387|11770739|FG000|COMPLETED|Overall Study||19
10613043|NCT01921387|11770739|FG000|NOT COMPLETED|Overall Study||1
10613044|NCT01921452|11770743|FG000|STARTED|Overall Study||283
10613045|NCT01921452|11770743|FG000|COMPLETED|Overall Study||283
10613046|NCT01921452|11770743|FG000|NOT COMPLETED|Overall Study||0
10613047|NCT01921517|11770750|FG000|STARTED|Overall Study||42
10613048|NCT01921517|11770751|FG001|STARTED|Overall Study||38
10613049|NCT01921517|11770750|FG000|COMPLETED|Overall Study||27
10613050|NCT01921517|11770751|FG001|COMPLETED|Overall Study||29
10613051|NCT01921517|11770750|FG000|NOT COMPLETED|Overall Study||15
10613052|NCT01921517|11770751|FG001|NOT COMPLETED|Overall Study||9
10613053|NCT01921634|11770757|FG000|STARTED|Overall Study||300
10613054|NCT01921634|11770757|FG000|COMPLETED|Overall Study||300
10613055|NCT01921634|11770757|FG000|NOT COMPLETED|Overall Study||0
10613056|NCT01921751|11770765|FG000|STARTED|Overall Study||4
10613057|NCT01921751|11770766|FG001|STARTED|Overall Study||4
10613058|NCT01921751|11770767|FG002|STARTED|Overall Study||5
10613059|NCT01921751|11770765|FG000|COMPLETED|Overall Study|All randomized patients are reported here.|4
10613060|NCT01921751|11770766|FG001|COMPLETED|Overall Study|All randomized patients are reported here.|4
10613061|NCT01921751|11770767|FG002|COMPLETED|Overall Study|All randomized patients are reported here.|5
10613062|NCT01921751|11770765|FG000|NOT COMPLETED|Overall Study||0
10613063|NCT01921751|11770766|FG001|NOT COMPLETED|Overall Study||0
10613064|NCT01921751|11770767|FG002|NOT COMPLETED|Overall Study||0
10613065|NCT01921829|11770778|FG000|STARTED|Overall Study||10
10613066|NCT01921829|11770779|FG001|STARTED|Overall Study||9
10613067|NCT01921829|11770778|FG000|COMPLETED|Overall Study||10
10613068|NCT01921829|11770779|FG001|COMPLETED|Overall Study||8
10613069|NCT01921829|11770778|FG000|NOT COMPLETED|Overall Study||0
10613070|NCT01921829|11770779|FG001|NOT COMPLETED|Overall Study||1
10613071|NCT01921894|11770788|FG000|STARTED|Overall Study||8
10613072|NCT01921894|11770789|FG001|STARTED|Overall Study||8
10613073|NCT01921894|11770790|FG002|STARTED|Overall Study||8
10613074|NCT01921894|11770788|FG000|COMPLETED|Overall Study||8
10613075|NCT01921894|11770789|FG001|COMPLETED|Overall Study||8
10613076|NCT01921894|11770790|FG002|COMPLETED|Overall Study||8
10613077|NCT01921894|11770788|FG000|NOT COMPLETED|Overall Study||0
10613078|NCT01921894|11770789|FG001|NOT COMPLETED|Overall Study||0
10613079|NCT01921894|11770790|FG002|NOT COMPLETED|Overall Study||0
10613080|NCT01922011|11770812|FG000|STARTED|Overall Study|Randomized participants|75
10613081|NCT01922011|11770813|FG001|STARTED|Overall Study|Randomized participants|74
10613082|NCT01922011|11770812|FG000|Treated|Overall Study|Treated Participants|73
10613083|NCT01922011|11770813|FG001|Treated|Overall Study|Treated Participants|73
10613084|NCT01922011|11770812|FG000|Treatment Actually Received|Overall Study|One participant intended for treatment with Vancomycin or Nafcillin was treated with Daptomycin|74
10613085|NCT01922011|11770813|FG001|Treatment Actually Received|Overall Study|One participant intended for treatment with Vancomycin or Nafcillin was treated with Daptomycin|72
10613086|NCT01922011|11770812|FG000|COMPLETED|Overall Study||69
10613087|NCT01922011|11770813|FG001|COMPLETED|Overall Study||69
10613088|NCT01922011|11770812|FG000|NOT COMPLETED|Overall Study||6
10613089|NCT01922011|11770813|FG001|NOT COMPLETED|Overall Study||5
10613090|NCT01922024|11770827|FG000|STARTED|Overall Study||1653
10613091|NCT01922024|11770828|FG001|STARTED|Overall Study||471
10613092|NCT01922024|11770827|FG000|COMPLETED|Overall Study||1653
10613093|NCT01922024|11770828|FG001|COMPLETED|Overall Study||471
10613094|NCT01922024|11770827|FG000|NOT COMPLETED|Overall Study||0
10613095|NCT01922024|11770828|FG001|NOT COMPLETED|Overall Study||0
10613096|NCT01922037|11770836|FG000|STARTED|Overall Study||69
10613097|NCT01922037|11770837|FG001|STARTED|Overall Study||737
10613098|NCT01922037|11770836|FG000|Treated|Overall Study||69
10613099|NCT01922037|11770837|FG001|Treated|Overall Study||732
10613100|NCT01922037|11770836|FG000|COMPLETED|Overall Study||59
10613101|NCT01922037|11770837|FG001|COMPLETED|Overall Study||563
10613102|NCT01922037|11770836|FG000|NOT COMPLETED|Overall Study||10
10613103|NCT01922037|11770837|FG001|NOT COMPLETED|Overall Study||174
10613104|NCT01922050|11770859|FG000|STARTED|Part 1 Open-label, Dose-escalation Phase||3
10613105|NCT01922050|11770860|FG001|STARTED|Part 1 Open-label, Dose-escalation Phase||3
10613106|NCT01922050|11770861|FG002|STARTED|Part 1 Open-label, Dose-escalation Phase||6
10613107|NCT01922050|11770862|FG003|STARTED|Part 1 Open-label, Dose-escalation Phase||6
10613108|NCT01922050|11770863|FG004|STARTED|Part 1 Open-label, Dose-escalation Phase||17
10613109|NCT01922050|11770864|FG005|STARTED|Part 1 Open-label, Dose-escalation Phase||18
10613110|NCT01922050|11770865|FG006|STARTED|Part 1 Open-label, Dose-escalation Phase||3
10613111|NCT01922050|11770866|FG007|STARTED|Part 1 Open-label, Dose-escalation Phase||3
10613112|NCT01922050|11770867|FG008|STARTED|Part 1 Open-label, Dose-escalation Phase||6
10613113|NCT01922050|11770868|FG009|STARTED|Part 1 Open-label, Dose-escalation Phase||12
10613114|NCT01922050|11770869|FG010|STARTED|Part 1 Open-label, Dose-escalation Phase||0
10613115|NCT01922050|11770870|FG011|STARTED|Part 1 Open-label, Dose-escalation Phase||0
10613116|NCT01922050|11770871|FG012|STARTED|Part 1 Open-label, Dose-escalation Phase||0
10613117|NCT01922050|11770872|FG013|STARTED|Part 1 Open-label, Dose-escalation Phase||0
10613118|NCT01922050|11770859|FG000|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
10613119|NCT01922050|11770860|FG001|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
10613120|NCT01922050|11770861|FG002|COMPLETED|Part 1 Open-label, Dose-escalation Phase||6
10613121|NCT01922050|11770862|FG003|COMPLETED|Part 1 Open-label, Dose-escalation Phase||6
10613122|NCT01922050|11770863|FG004|COMPLETED|Part 1 Open-label, Dose-escalation Phase||17
10613123|NCT01922050|11770864|FG005|COMPLETED|Part 1 Open-label, Dose-escalation Phase||18
10613124|NCT01922050|11770865|FG006|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
10613125|NCT01922050|11770866|FG007|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
10613126|NCT01922050|11770867|FG008|COMPLETED|Part 1 Open-label, Dose-escalation Phase||6
10613127|NCT01922050|11770868|FG009|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
10613128|NCT01922050|11770869|FG010|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10613129|NCT01922050|11770870|FG011|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10613130|NCT01922050|11770871|FG012|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10613131|NCT01922050|11770872|FG013|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10613132|NCT01922050|11770859|FG000|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10613133|NCT01922050|11770860|FG001|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10613134|NCT01922050|11770861|FG002|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10613135|NCT01922050|11770862|FG003|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10613136|NCT01922050|11770863|FG004|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10613137|NCT01922050|11770864|FG005|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10613138|NCT01922050|11770865|FG006|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10613139|NCT01922050|11770866|FG007|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10613140|NCT01922050|11770867|FG008|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10613141|NCT01922050|11770868|FG009|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10613142|NCT01922050|11770869|FG010|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10613143|NCT01922050|11770870|FG011|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10613144|NCT01922050|11770871|FG012|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10613145|NCT01922050|11770872|FG013|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10613146|NCT01922050|11770859|FG000|STARTED|Part 2 Double-blind Phase||0
10613147|NCT01922050|11770860|FG001|STARTED|Part 2 Double-blind Phase||0
10613148|NCT01922050|11770861|FG002|STARTED|Part 2 Double-blind Phase||0
10613149|NCT01922050|11770862|FG003|STARTED|Part 2 Double-blind Phase||0
10613150|NCT01922050|11770863|FG004|STARTED|Part 2 Double-blind Phase||0
10613151|NCT01922050|11770864|FG005|STARTED|Part 2 Double-blind Phase||0
10613152|NCT01922050|11770865|FG006|STARTED|Part 2 Double-blind Phase||0
10613153|NCT01922050|11770866|FG007|STARTED|Part 2 Double-blind Phase||0
10613154|NCT01922050|11770867|FG008|STARTED|Part 2 Double-blind Phase||0
10613155|NCT01922050|11770868|FG009|STARTED|Part 2 Double-blind Phase||0
10613156|NCT01922050|11770869|FG010|STARTED|Part 2 Double-blind Phase||62
10613157|NCT01922050|11770870|FG011|STARTED|Part 2 Double-blind Phase||60
10613158|NCT01922050|11770871|FG012|STARTED|Part 2 Double-blind Phase||62
10613159|NCT01922050|11770872|FG013|STARTED|Part 2 Double-blind Phase||59
10613160|NCT01922050|11770859|FG000|COMPLETED|Part 2 Double-blind Phase||0
10613161|NCT01922050|11770860|FG001|COMPLETED|Part 2 Double-blind Phase||0
10613162|NCT01922050|11770861|FG002|COMPLETED|Part 2 Double-blind Phase||0
10613163|NCT01922050|11770862|FG003|COMPLETED|Part 2 Double-blind Phase||0
10613164|NCT01922050|11770863|FG004|COMPLETED|Part 2 Double-blind Phase||0
10613165|NCT01922050|11770864|FG005|COMPLETED|Part 2 Double-blind Phase||0
10613166|NCT01922050|11770865|FG006|COMPLETED|Part 2 Double-blind Phase||0
10613167|NCT01922050|11770866|FG007|COMPLETED|Part 2 Double-blind Phase||0
10613168|NCT01922050|11770867|FG008|COMPLETED|Part 2 Double-blind Phase||0
10613169|NCT01922050|11770868|FG009|COMPLETED|Part 2 Double-blind Phase||0
10613170|NCT01922050|11770869|FG010|COMPLETED|Part 2 Double-blind Phase||61
10613171|NCT01922050|11770870|FG011|COMPLETED|Part 2 Double-blind Phase||58
10613172|NCT01922050|11770871|FG012|COMPLETED|Part 2 Double-blind Phase||62
10613173|NCT01922050|11770872|FG013|COMPLETED|Part 2 Double-blind Phase||56
10613174|NCT01922050|11770859|FG000|NOT COMPLETED|Part 2 Double-blind Phase||0
10613175|NCT01922050|11770860|FG001|NOT COMPLETED|Part 2 Double-blind Phase||0
10613176|NCT01922050|11770861|FG002|NOT COMPLETED|Part 2 Double-blind Phase||0
10613177|NCT01922050|11770862|FG003|NOT COMPLETED|Part 2 Double-blind Phase||0
10613178|NCT01922050|11770863|FG004|NOT COMPLETED|Part 2 Double-blind Phase||0
10613179|NCT01922050|11770864|FG005|NOT COMPLETED|Part 2 Double-blind Phase||0
10613180|NCT01922050|11770865|FG006|NOT COMPLETED|Part 2 Double-blind Phase||0
10613181|NCT01922050|11770866|FG007|NOT COMPLETED|Part 2 Double-blind Phase||0
10613182|NCT01922050|11770867|FG008|NOT COMPLETED|Part 2 Double-blind Phase||0
10613183|NCT01922050|11770868|FG009|NOT COMPLETED|Part 2 Double-blind Phase||0
10613184|NCT01922050|11770869|FG010|NOT COMPLETED|Part 2 Double-blind Phase||1
10613185|NCT01922050|11770870|FG011|NOT COMPLETED|Part 2 Double-blind Phase||2
10613186|NCT01922050|11770871|FG012|NOT COMPLETED|Part 2 Double-blind Phase||0
10613187|NCT01922050|11770872|FG013|NOT COMPLETED|Part 2 Double-blind Phase||3
10613188|NCT01922089|11770904|FG000|STARTED|Overall Study||247
10613189|NCT01922089|11770905|FG001|STARTED|Overall Study||251
10613190|NCT01922089|11770904|FG000|Safety Set|Overall Study||246
10613191|NCT01922089|11770905|FG001|Safety Set|Overall Study||251
10613192|NCT01922089|11770904|FG000|COMPLETED|Overall Study||208
10613193|NCT01922089|11770905|FG001|COMPLETED|Overall Study||221
10613194|NCT01922089|11770904|FG000|NOT COMPLETED|Overall Study||39
10613195|NCT01922089|11770905|FG001|NOT COMPLETED|Overall Study||30
10613196|NCT01922102|11770914|FG000|STARTED|Overall Study||182
10613197|NCT01922102|11770915|FG001|STARTED|Overall Study||184
10613198|NCT01922102|11770916|FG002|STARTED|Overall Study||91
10613199|NCT01922102|11770914|FG000|COMPLETED|Overall Study||173
10613200|NCT01922102|11770915|FG001|COMPLETED|Overall Study||175
10613201|NCT01922102|11770916|FG002|COMPLETED|Overall Study||83
10613202|NCT01922102|11770914|FG000|NOT COMPLETED|Overall Study||9
10613203|NCT01922102|11770915|FG001|NOT COMPLETED|Overall Study||9
10613204|NCT01922102|11770916|FG002|NOT COMPLETED|Overall Study||8
10613205|NCT01922115|11770930|FG000|STARTED|Overall Study||28
10613206|NCT01922115|11770931|FG001|STARTED|Overall Study||31
10613207|NCT01922115|11770930|FG000|COMPLETED|Overall Study||21
10613208|NCT01922115|11770931|FG001|COMPLETED|Overall Study||24
10613209|NCT01922115|11770930|FG000|NOT COMPLETED|Overall Study||7
10613210|NCT01922115|11770931|FG001|NOT COMPLETED|Overall Study||7
10613211|NCT01922219|11770937|FG000|STARTED|Overall Study||37
10613212|NCT01922219|11770937|FG000|COMPLETED|Overall Study||28
10613213|NCT01922219|11770937|FG000|NOT COMPLETED|Overall Study||9
10613214|NCT01922258|11770943|FG000|STARTED|Overall Study||133
10613215|NCT01922258|11770944|FG001|STARTED|Overall Study||137
10613216|NCT01922258|11770943|FG000|COMPLETED|Overall Study||117
10613217|NCT01922258|11770944|FG001|COMPLETED|Overall Study||121
10613218|NCT01922258|11770943|FG000|NOT COMPLETED|Overall Study||16
10613219|NCT01922258|11770944|FG001|NOT COMPLETED|Overall Study||16
10613220|NCT01922271|11770952|FG000|STARTED|PERIOD 1||76
10613221|NCT01922271|11770953|FG001|STARTED|PERIOD 1||76
10613222|NCT01922271|11770952|FG000|COMPLETED|PERIOD 1||76
10613223|NCT01922271|11770953|FG001|COMPLETED|PERIOD 1||76
10613224|NCT01922271|11770952|FG000|NOT COMPLETED|PERIOD 1||0
10613225|NCT01922271|11770953|FG001|NOT COMPLETED|PERIOD 1||0
10613226|NCT01922271|11770952|FG000|STARTED|WASHOUT Period||76
10613227|NCT01922271|11770953|FG001|STARTED|WASHOUT Period||76
10613228|NCT01922271|11770952|FG000|COMPLETED|WASHOUT Period||75
10613229|NCT01922271|11770953|FG001|COMPLETED|WASHOUT Period||76
10613230|NCT01922271|11770952|FG000|NOT COMPLETED|WASHOUT Period||1
10613231|NCT01922271|11770953|FG001|NOT COMPLETED|WASHOUT Period||0
10613232|NCT01922271|11770952|FG000|STARTED|PERIOD 2||75
10613233|NCT01922271|11770953|FG001|STARTED|PERIOD 2||76
10613234|NCT01922271|11770952|FG000|COMPLETED|PERIOD 2||75
10613235|NCT01922271|11770953|FG001|COMPLETED|PERIOD 2||76
10613236|NCT01922271|11770952|FG000|NOT COMPLETED|PERIOD 2||0
10613237|NCT01922271|11770953|FG001|NOT COMPLETED|PERIOD 2||0
10613238|NCT01922336|11770962|FG000|STARTED|Overall Study||53
10613239|NCT01922336|11770963|FG001|STARTED|Overall Study||53
10613240|NCT01922336|11770964|FG002|STARTED|Overall Study||53
10613241|NCT01922336|11770962|FG000|COMPLETED|Overall Study||53
10613242|NCT01922336|11770963|FG001|COMPLETED|Overall Study||53
10613243|NCT01922336|11770964|FG002|COMPLETED|Overall Study||53
10613244|NCT01922336|11770962|FG000|NOT COMPLETED|Overall Study||0
10613245|NCT01922336|11770963|FG001|NOT COMPLETED|Overall Study||0
10613246|NCT01922336|11770964|FG002|NOT COMPLETED|Overall Study||0
10613247|NCT01922349|11770976|FG000|STARTED|Single Rising Dose (SRD) Period||25
10613248|NCT01922349|11770977|FG001|STARTED|Single Rising Dose (SRD) Period||27
10613249|NCT01922349|11770978|FG002|STARTED|Single Rising Dose (SRD) Period||18
10613250|NCT01922349|11770979|FG003|STARTED|Single Rising Dose (SRD) Period||27
10613251|NCT01922349|11770976|FG000|COMPLETED|Single Rising Dose (SRD) Period||25
10613252|NCT01922349|11770977|FG001|COMPLETED|Single Rising Dose (SRD) Period||27
10613253|NCT01922349|11770978|FG002|COMPLETED|Single Rising Dose (SRD) Period||18
10613254|NCT01922349|11770979|FG003|COMPLETED|Single Rising Dose (SRD) Period||27
10613255|NCT01922349|11770976|FG000|NOT COMPLETED|Single Rising Dose (SRD) Period||0
10613256|NCT01922349|11770977|FG001|NOT COMPLETED|Single Rising Dose (SRD) Period||0
10613257|NCT01922349|11770978|FG002|NOT COMPLETED|Single Rising Dose (SRD) Period||0
10613258|NCT01922349|11770979|FG003|NOT COMPLETED|Single Rising Dose (SRD) Period||0
10613259|NCT01922349|11770976|FG000|STARTED|Multiple Rising Dose (MRD) Period|One subject discontinued the trial after the SRD period due to non-compliance with the protocol.|24
10613260|NCT01922349|11770977|FG001|STARTED|Multiple Rising Dose (MRD) Period||27
10613261|NCT01922349|11770978|FG002|STARTED|Multiple Rising Dose (MRD) Period||18
10613262|NCT01922349|11770979|FG003|STARTED|Multiple Rising Dose (MRD) Period||27
10613263|NCT01922349|11770976|FG000|COMPLETED|Multiple Rising Dose (MRD) Period||24
10613264|NCT01922349|11770977|FG001|COMPLETED|Multiple Rising Dose (MRD) Period||27
10613265|NCT01922349|11770978|FG002|COMPLETED|Multiple Rising Dose (MRD) Period||18
10613266|NCT01922349|11770979|FG003|COMPLETED|Multiple Rising Dose (MRD) Period||26
10613267|NCT01922349|11770976|FG000|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
10613268|NCT01922349|11770977|FG001|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
10613269|NCT01922349|11770978|FG002|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
10613270|NCT01922349|11770979|FG003|NOT COMPLETED|Multiple Rising Dose (MRD) Period||1
10613271|NCT01922739|11771015|FG000|STARTED|Titration/Adjustment Period||182
10704688|NCT04142242|11869024|FG004|COMPLETED|Overall Study||26
10704689|NCT04142242|11869025|FG005|COMPLETED|Overall Study||59
10704690|NCT04142242|11869020|FG000|NOT COMPLETED|Overall Study||1
10704691|NCT04142242|11869021|FG001|NOT COMPLETED|Overall Study||1
10704692|NCT04142242|11869022|FG002|NOT COMPLETED|Overall Study||31
10704693|NCT04142242|11869023|FG003|NOT COMPLETED|Overall Study||39
10704694|NCT04142242|11869024|FG004|NOT COMPLETED|Overall Study||0
10704695|NCT04142242|11869025|FG005|NOT COMPLETED|Overall Study||1
10704696|NCT04087122|11869038|FG000|STARTED|Overall Study||20
10704697|NCT04087122|11869038|FG000|COMPLETED|Overall Study||20
10704698|NCT04087122|11869038|FG000|NOT COMPLETED|Overall Study||0
10704699|NCT03990389|11869046|FG000|STARTED|Overall Study||15
10704700|NCT03990389|11869047|FG001|STARTED|Overall Study||16
10704701|NCT03990389|11869046|FG000|COMPLETED|Overall Study||12
10704702|NCT03990389|11869047|FG001|COMPLETED|Overall Study||16
10704703|NCT03990389|11869046|FG000|NOT COMPLETED|Overall Study||3
10704704|NCT03990389|11869047|FG001|NOT COMPLETED|Overall Study||0
10613272|NCT01922739|11771015|FG000|Safety Analysis Set|Titration/Adjustment Period||182
10613273|NCT01922739|11771015|FG000|COMPLETED|Titration/Adjustment Period||170
10613274|NCT01922739|11771015|FG000|NOT COMPLETED|Titration/Adjustment Period||12
10704705|NCT03939312|11869053|FG000|STARTED|OL Treatment Period (40 Weeks)||685
10704706|NCT03939312|11869053|FG000|COMPLETED|OL Treatment Period (40 Weeks)||511
10704707|NCT03939312|11869053|FG000|NOT COMPLETED|OL Treatment Period (40 Weeks)||174
10704708|NCT03939312|11869053|FG000|STARTED|Safety Follow-up 4 Weeks (Up to Week 44)|Out of 685 participants, 640 participants who received treatment including 511 participants who completed the treatment entered safety follow-up period.|640
10613317|NCT01923181|11771071|FG002|STARTED|Overall Study||69
10704709|NCT03939312|11869053|FG000|COMPLETED|Safety Follow-up 4 Weeks (Up to Week 44)||624
10704710|NCT03939312|11869053|FG000|NOT COMPLETED|Safety Follow-up 4 Weeks (Up to Week 44)||16
10704711|NCT03934541|11869063|FG000|STARTED|Overall Study||5
10704712|NCT03934541|11869064|FG001|STARTED|Overall Study||15
10704713|NCT03934541|11869065|FG002|STARTED|Overall Study||1
10704714|NCT03934541|11869066|FG003|STARTED|Overall Study||3
10704715|NCT03934541|11869063|FG000|COMPLETED|Overall Study||5
10704716|NCT03934541|11869064|FG001|COMPLETED|Overall Study||14
10704717|NCT03934541|11869065|FG002|COMPLETED|Overall Study||1
10704718|NCT03934541|11869066|FG003|COMPLETED|Overall Study||3
10704719|NCT03934541|11869063|FG000|NOT COMPLETED|Overall Study||0
10704720|NCT03934541|11869064|FG001|NOT COMPLETED|Overall Study||1
10704721|NCT03934541|11869065|FG002|NOT COMPLETED|Overall Study||0
10704722|NCT03934541|11869066|FG003|NOT COMPLETED|Overall Study||0
10704723|NCT03895034|11869076|FG000|STARTED|Overall Study||66
10704724|NCT03895034|11869076|FG000|COMPLETED|Overall Study||64
10704725|NCT03895034|11869076|FG000|NOT COMPLETED|Overall Study||2
10704726|NCT03870477|11869080|FG000|STARTED|Overall Study||1
10704727|NCT03870477|11869080|FG000|COMPLETED|Overall Study||0
10704728|NCT03870477|11869080|FG000|NOT COMPLETED|Overall Study||1
10713762|NCT02681510|11879256|FG000|STARTED|Overall Study||36
10713763|NCT02681510|11879256|FG000|COMPLETED|Overall Study||26
10713764|NCT02681510|11879256|FG000|NOT COMPLETED|Overall Study||10
10713765|NCT02681523|11879260|FG000|STARTED|Overall Study||8
10704729|NCT03351244|11869087|FG000|STARTED|Overall Study||89
10704730|NCT03351244|11869088|FG001|STARTED|Overall Study||88
10704731|NCT03351244|11869089|FG002|STARTED|Overall Study||87
10704732|NCT03351244|11869087|FG000|COMPLETED|Overall Study||62
10704733|NCT03351244|11869088|FG001|COMPLETED|Overall Study||48
10704734|NCT03351244|11869089|FG002|COMPLETED|Overall Study||53
10613275|NCT01922739|11771015|FG000|STARTED|Open-label Treatment Period||170
10613276|NCT01922739|11771015|FG000|Treatment SAS and FAS|Open-label Treatment Period|SAS = safety analysis set FAS = full analysis set|170
10613277|NCT01922739|11771015|FG000|COMPLETED|Open-label Treatment Period||136
10613278|NCT01922739|11771015|FG000|NOT COMPLETED|Open-label Treatment Period||34
10613279|NCT01922934|11771033|FG000|STARTED|Eligible Patients||428
10613280|NCT01922934|11771034|FG001|STARTED|Eligible Patients||4302
10613281|NCT01922934|11771033|FG000|COMPLETED|Eligible Patients|375 patients determined eligible after original random selection from DHHA data warehouse.|375
10613282|NCT01922934|11771034|FG001|COMPLETED|Eligible Patients|81 patients did not meet inclusion criteria as they were 80 years or older. 7 patients had died.|4214
10613283|NCT01922934|11771033|FG000|NOT COMPLETED|Eligible Patients||53
10613284|NCT01922934|11771034|FG001|NOT COMPLETED|Eligible Patients||88
10613285|NCT01922934|11771033|FG000|STARTED|Visit 0 - Patient Contacted & Consented||375
10613286|NCT01922934|11771034|FG001|STARTED|Visit 0 - Patient Contacted & Consented|Control group patients were not contacted or offered intervention|4214
10613287|NCT01922934|11771033|FG000|COMPLETED|Visit 0 - Patient Contacted & Consented|reflects number of patients that were contacted and agreed to attend Visit 0|140
10613288|NCT01922934|11771034|FG001|COMPLETED|Visit 0 - Patient Contacted & Consented||4214
10613289|NCT01922934|11771033|FG000|NOT COMPLETED|Visit 0 - Patient Contacted & Consented||235
10613290|NCT01922934|11771034|FG001|NOT COMPLETED|Visit 0 - Patient Contacted & Consented||0
10613291|NCT01922934|11771033|FG000|STARTED|Visit 1- Weight Measured|21 patients did not return for Visit 1 to receive tool or have weight measured.|140
10613292|NCT01922934|11771034|FG001|STARTED|Visit 1- Weight Measured||4214
10613293|NCT01922934|11771033|FG000|COMPLETED|Visit 1- Weight Measured|Patients first received tool and were weighed at Visit 1|119
10613294|NCT01922934|11771034|FG001|COMPLETED|Visit 1- Weight Measured|1284 patients did not have any weights recorded in EMR during study timeframe|2930
10613295|NCT01922934|11771033|FG000|NOT COMPLETED|Visit 1- Weight Measured||21
10613296|NCT01922934|11771034|FG001|NOT COMPLETED|Visit 1- Weight Measured||1284
10613297|NCT01922934|11771033|FG000|STARTED|Visit 12 / Final Visits||119
10613298|NCT01922934|11771034|FG001|STARTED|Visit 12 / Final Visits||2930
10613299|NCT01922934|11771033|FG000|COMPLETED|Visit 12 / Final Visits|6 patients did not return for final visit and weight measure|113
10613300|NCT01922934|11771034|FG001|COMPLETED|Visit 12 / Final Visits|290 patients did not have a second weight recorded at one year (+/- 6months) of first weight|2640
10613301|NCT01922934|11771033|FG000|NOT COMPLETED|Visit 12 / Final Visits||6
10613302|NCT01922934|11771034|FG001|NOT COMPLETED|Visit 12 / Final Visits||290
10613303|NCT01922986|11771044|FG000|STARTED|Overall Study||2
10613304|NCT01922986|11771045|FG001|STARTED|Overall Study||2
10613305|NCT01922986|11771044|FG000|COMPLETED|Overall Study||2
10613306|NCT01922986|11771045|FG001|COMPLETED|Overall Study||2
10613307|NCT01922986|11771044|FG000|NOT COMPLETED|Overall Study||0
10613308|NCT01922986|11771045|FG001|NOT COMPLETED|Overall Study||0
10613309|NCT01923129|11771053|FG000|STARTED|Overall Study||71
10613310|NCT01923129|11771054|FG001|STARTED|Overall Study||71
10613311|NCT01923129|11771053|FG000|COMPLETED|Overall Study||71
10613312|NCT01923129|11771054|FG001|COMPLETED|Overall Study||71
10613313|NCT01923129|11771053|FG000|NOT COMPLETED|Overall Study||0
10613314|NCT01923129|11771054|FG001|NOT COMPLETED|Overall Study||0
10704735|NCT03351244|11869087|FG000|NOT COMPLETED|Overall Study||27
10704736|NCT03351244|11869088|FG001|NOT COMPLETED|Overall Study||40
10704737|NCT03351244|11869089|FG002|NOT COMPLETED|Overall Study||34
10613315|NCT01923181|11771069|FG000|STARTED|Overall Study||70
10613316|NCT01923181|11771070|FG001|STARTED|Overall Study||70
10613318|NCT01923181|11771072|FG003|STARTED|Overall Study||70
10613319|NCT01923181|11771073|FG004|STARTED|Overall Study||71
10613320|NCT01923181|11771074|FG005|STARTED|Overall Study||70
10613321|NCT01923181|11771075|FG006|STARTED|Overall Study||70
10613322|NCT01923181|11771076|FG007|STARTED|Overall Study||69
10613323|NCT01923181|11771077|FG008|STARTED|Overall Study||71
10613324|NCT01923181|11771069|FG000|Full Analysis Set (FAS)|Overall Study||70
10613325|NCT01923181|11771070|FG001|Full Analysis Set (FAS)|Overall Study||70
10613326|NCT01923181|11771071|FG002|Full Analysis Set (FAS)|Overall Study||69
10613327|NCT01923181|11771072|FG003|Full Analysis Set (FAS)|Overall Study||70
10613328|NCT01923181|11771073|FG004|Full Analysis Set (FAS)|Overall Study||71
10613329|NCT01923181|11771074|FG005|Full Analysis Set (FAS)|Overall Study||70
10613330|NCT01923181|11771075|FG006|Full Analysis Set (FAS)|Overall Study||70
10613331|NCT01923181|11771076|FG007|Full Analysis Set (FAS)|Overall Study||69
10613332|NCT01923181|11771077|FG008|Full Analysis Set (FAS)|Overall Study||71
10613333|NCT01923181|11771069|FG000|Safety Analysis Set (SAS)|Overall Study||70
10613334|NCT01923181|11771070|FG001|Safety Analysis Set (SAS)|Overall Study||70
10613335|NCT01923181|11771071|FG002|Safety Analysis Set (SAS)|Overall Study||69
10613336|NCT01923181|11771072|FG003|Safety Analysis Set (SAS)|Overall Study||70
10613337|NCT01923181|11771073|FG004|Safety Analysis Set (SAS)|Overall Study||71
10613338|NCT01923181|11771074|FG005|Safety Analysis Set (SAS)|Overall Study||70
10613339|NCT01923181|11771075|FG006|Safety Analysis Set (SAS)|Overall Study||70
10613340|NCT01923181|11771076|FG007|Safety Analysis Set (SAS)|Overall Study||69
10613341|NCT01923181|11771077|FG008|Safety Analysis Set (SAS)|Overall Study||71
10613342|NCT01923181|11771069|FG000|COMPLETED|Overall Study||67
10613343|NCT01923181|11771070|FG001|COMPLETED|Overall Study||64
10704744|NCT03084666|11869110|FG000|STARTED|Overall Study||20
10613344|NCT01923181|11771071|FG002|COMPLETED|Overall Study||67
10613345|NCT01923181|11771072|FG003|COMPLETED|Overall Study||65
10613346|NCT01923181|11771073|FG004|COMPLETED|Overall Study||63
10613347|NCT01923181|11771074|FG005|COMPLETED|Overall Study||66
10613348|NCT01923181|11771075|FG006|COMPLETED|Overall Study||62
10613349|NCT01923181|11771076|FG007|COMPLETED|Overall Study||61
10613350|NCT01923181|11771077|FG008|COMPLETED|Overall Study||68
10613351|NCT01923181|11771069|FG000|NOT COMPLETED|Overall Study||3
10613352|NCT01923181|11771070|FG001|NOT COMPLETED|Overall Study||6
10613353|NCT01923181|11771071|FG002|NOT COMPLETED|Overall Study||2
10613354|NCT01923181|11771072|FG003|NOT COMPLETED|Overall Study||5
10613355|NCT01923181|11771073|FG004|NOT COMPLETED|Overall Study||8
10613356|NCT01923181|11771074|FG005|NOT COMPLETED|Overall Study||4
10613357|NCT01923181|11771075|FG006|NOT COMPLETED|Overall Study||8
10613358|NCT01923181|11771076|FG007|NOT COMPLETED|Overall Study||8
10613359|NCT01923181|11771077|FG008|NOT COMPLETED|Overall Study||3
10613360|NCT01923285|11771102|FG000|STARTED|Overall Study||76
10613361|NCT01923285|11771103|FG001|STARTED|Overall Study||76
10613362|NCT01923285|11771102|FG000|Modified Intent-to-treat|Overall Study||73
10613363|NCT01923285|11771103|FG001|Modified Intent-to-treat|Overall Study||73
10613364|NCT01923285|11771102|FG000|COMPLETED|Overall Study||69
10613365|NCT01923285|11771103|FG001|COMPLETED|Overall Study||70
10613366|NCT01923285|11771102|FG000|NOT COMPLETED|Overall Study||7
10613367|NCT01923285|11771103|FG001|NOT COMPLETED|Overall Study||6
10613368|NCT01923311|11771111|FG000|STARTED|Overall Study||17
10613369|NCT01923311|11771112|FG001|STARTED|Overall Study||14
10613370|NCT01923311|11771111|FG000|COMPLETED|Overall Study||0
10613371|NCT01923311|11771112|FG001|COMPLETED|Overall Study||13
10613372|NCT01923311|11771111|FG000|NOT COMPLETED|Overall Study||17
10613373|NCT01923311|11771112|FG001|NOT COMPLETED|Overall Study||1
10613374|NCT01923363|11771119|FG000|STARTED|Overall Study||29
10613375|NCT01923363|11771119|FG000|COMPLETED|Overall Study||28
10613376|NCT01923363|11771119|FG000|NOT COMPLETED|Overall Study||1
10613377|NCT01923389|11771125|FG000|STARTED|Overall Study||2
10613378|NCT01923389|11771126|FG001|STARTED|Overall Study||2
10613379|NCT01923389|11771125|FG000|COMPLETED|Overall Study||1
10613380|NCT01923389|11771126|FG001|COMPLETED|Overall Study||2
10613381|NCT01923389|11771125|FG000|NOT COMPLETED|Overall Study||1
10613382|NCT01923389|11771126|FG001|NOT COMPLETED|Overall Study||0
10613383|NCT01923428|11771137|FG000|STARTED|Overall Study||88
10613384|NCT01923428|11771138|FG001|STARTED|Overall Study||89
10613385|NCT01923428|11771139|FG002|STARTED|Overall Study||89
10613386|NCT01923428|11771140|FG003|STARTED|Overall Study||90
10613387|NCT01923428|11771137|FG000|COMPLETED|Overall Study||69
10613388|NCT01923428|11771138|FG001|COMPLETED|Overall Study||77
10613389|NCT01923428|11771139|FG002|COMPLETED|Overall Study||78
10613390|NCT01923428|11771140|FG003|COMPLETED|Overall Study||80
10613391|NCT01923428|11771137|FG000|NOT COMPLETED|Overall Study||19
10613392|NCT01923428|11771138|FG001|NOT COMPLETED|Overall Study||12
10613393|NCT01923428|11771139|FG002|NOT COMPLETED|Overall Study||11
10613394|NCT01923428|11771140|FG003|NOT COMPLETED|Overall Study||10
10613395|NCT01923467|11771150|FG000|STARTED|Overall Study|Offered stop smoking program|767
10613396|NCT01923467|11771150|FG000|Baseline Completed, Enrolled|Overall Study||288
10613397|NCT01923467|11771150|FG000|COMPLETED|Overall Study|Completed 3-month follow up survey|226
10613398|NCT01923467|11771150|FG000|NOT COMPLETED|Overall Study||541
10613399|NCT01923740|11771156|FG000|STARTED|Overall Study||227
10613400|NCT01923740|11771157|FG001|STARTED|Overall Study||232
10613401|NCT01923740|11771156|FG000|COMPLETED|Overall Study||221
10613402|NCT01923740|11771157|FG001|COMPLETED|Overall Study||223
10613403|NCT01923740|11771156|FG000|NOT COMPLETED|Overall Study||6
10613404|NCT01923740|11771157|FG001|NOT COMPLETED|Overall Study||9
10613405|NCT01923805|11771165|FG000|STARTED|Overall Study|early termination|3
10613406|NCT01923805|11771166|FG001|STARTED|Overall Study|early termination|5
10613407|NCT01923805|11771165|FG000|COMPLETED|Overall Study||0
10613408|NCT01923805|11771166|FG001|COMPLETED|Overall Study||0
10613409|NCT01923805|11771165|FG000|NOT COMPLETED|Overall Study||3
10613410|NCT01923805|11771166|FG001|NOT COMPLETED|Overall Study||5
10704745|NCT03084666|11869111|FG001|STARTED|Overall Study||20
10704746|NCT03084666|11869110|FG000|COMPLETED|Overall Study||20
10704747|NCT03084666|11869111|FG001|COMPLETED|Overall Study||20
10704748|NCT03084666|11869110|FG000|NOT COMPLETED|Overall Study||0
10704749|NCT03084666|11869111|FG001|NOT COMPLETED|Overall Study||0
10704750|NCT02982954|11869121|FG000|STARTED|Treatment Period||106
10704751|NCT02982954|11869122|FG001|STARTED|Treatment Period||52
10613411|NCT01923896|11771174|FG000|STARTED|Overall Study||8
10613412|NCT01923896|11771175|FG001|STARTED|Overall Study||8
10613413|NCT01923896|11771174|FG000|COMPLETED|Overall Study||7
10613414|NCT01923896|11771175|FG001|COMPLETED|Overall Study||8
10613415|NCT01923896|11771174|FG000|NOT COMPLETED|Overall Study||1
10613416|NCT01923896|11771175|FG001|NOT COMPLETED|Overall Study||0
10613417|NCT01923961|11771184|FG000|STARTED|First Intervention||3
10613418|NCT01923961|11771185|FG001|STARTED|First Intervention||3
10613419|NCT01923961|11771186|FG002|STARTED|First Intervention||2
10704752|NCT02982954|11869123|FG002|STARTED|Treatment Period||28
10704753|NCT02982954|11869124|FG003|STARTED|Treatment Period||25
10613420|NCT01923961|11771184|FG000|COMPLETED|First Intervention||3
10613421|NCT01923961|11771185|FG001|COMPLETED|First Intervention||3
10613422|NCT01923961|11771186|FG002|COMPLETED|First Intervention||2
10613423|NCT01923961|11771184|FG000|NOT COMPLETED|First Intervention||0
10613424|NCT01923961|11771185|FG001|NOT COMPLETED|First Intervention||0
10613425|NCT01923961|11771186|FG002|NOT COMPLETED|First Intervention||0
10613426|NCT01923961|11771184|FG000|STARTED|Washout (1 Week)||3
10704754|NCT02982954|11869121|FG000|COMPLETED|Treatment Period||0
10704755|NCT02982954|11869122|FG001|COMPLETED|Treatment Period||0
10704756|NCT02982954|11869123|FG002|COMPLETED|Treatment Period||0
10704757|NCT02982954|11869124|FG003|COMPLETED|Treatment Period||0
10613427|NCT01923961|11771185|FG001|STARTED|Washout (1 Week)||3
10613428|NCT01923961|11771186|FG002|STARTED|Washout (1 Week)||2
10613429|NCT01923961|11771184|FG000|COMPLETED|Washout (1 Week)||3
10613430|NCT01923961|11771185|FG001|COMPLETED|Washout (1 Week)||3
10613431|NCT01923961|11771186|FG002|COMPLETED|Washout (1 Week)||2
10613432|NCT01923961|11771184|FG000|NOT COMPLETED|Washout (1 Week)||0
10613433|NCT01923961|11771185|FG001|NOT COMPLETED|Washout (1 Week)||0
10613434|NCT01923961|11771186|FG002|NOT COMPLETED|Washout (1 Week)||0
10613435|NCT01923961|11771184|FG000|STARTED|Second Intervention||3
10613436|NCT01923961|11771185|FG001|STARTED|Second Intervention||3
10613437|NCT01923961|11771186|FG002|STARTED|Second Intervention||2
10613438|NCT01923961|11771184|FG000|COMPLETED|Second Intervention||3
10808812|NCT03840278|11970806|FG000|STARTED|Overall Study||5
10808813|NCT03840278|11970807|FG001|STARTED|Overall Study||5
10613439|NCT01923961|11771185|FG001|COMPLETED|Second Intervention||3
10613440|NCT01923961|11771186|FG002|COMPLETED|Second Intervention||2
10613441|NCT01923961|11771184|FG000|NOT COMPLETED|Second Intervention||0
10613442|NCT01923961|11771185|FG001|NOT COMPLETED|Second Intervention||0
10613443|NCT01923961|11771186|FG002|NOT COMPLETED|Second Intervention||0
10613444|NCT01923961|11771184|FG000|STARTED|Washout (1 Week)||3
10613445|NCT01923961|11771185|FG001|STARTED|Washout (1 Week)||3
10613446|NCT01923961|11771186|FG002|STARTED|Washout (1 Week)||2
10613447|NCT01923961|11771184|FG000|COMPLETED|Washout (1 Week)||3
10613448|NCT01923961|11771185|FG001|COMPLETED|Washout (1 Week)||3
10613449|NCT01923961|11771186|FG002|COMPLETED|Washout (1 Week)||2
10613450|NCT01923961|11771184|FG000|NOT COMPLETED|Washout (1 Week)||0
10613451|NCT01923961|11771185|FG001|NOT COMPLETED|Washout (1 Week)||0
10613452|NCT01923961|11771186|FG002|NOT COMPLETED|Washout (1 Week)||0
10613453|NCT01923961|11771184|FG000|STARTED|Third Intervention||3
10613454|NCT01923961|11771185|FG001|STARTED|Third Intervention||3
10613455|NCT01923961|11771186|FG002|STARTED|Third Intervention||2
10613456|NCT01923961|11771184|FG000|COMPLETED|Third Intervention||3
10613457|NCT01923961|11771185|FG001|COMPLETED|Third Intervention||3
10613458|NCT01923961|11771186|FG002|COMPLETED|Third Intervention||2
10613459|NCT01923961|11771184|FG000|NOT COMPLETED|Third Intervention||0
10613460|NCT01923961|11771185|FG001|NOT COMPLETED|Third Intervention||0
10613461|NCT01923961|11771186|FG002|NOT COMPLETED|Third Intervention||0
10613462|NCT01924169|11771194|FG000|STARTED|Overall Study||3
10613463|NCT01924169|11771194|FG000|COMPLETED|Overall Study||3
10613464|NCT01924169|11771194|FG000|NOT COMPLETED|Overall Study||0
10613465|NCT01924182|11771200|FG000|STARTED|Overall Study||3
10613466|NCT01924182|11771201|FG001|STARTED|Overall Study||0
10613467|NCT01924182|11771200|FG000|COMPLETED|Overall Study||2
10613468|NCT01924182|11771201|FG001|COMPLETED|Overall Study||0
10613469|NCT01924182|11771200|FG000|NOT COMPLETED|Overall Study||1
10613470|NCT01924182|11771201|FG001|NOT COMPLETED|Overall Study||0
10613471|NCT01924299|11771209|FG000|STARTED|Period 1||18
10613472|NCT01924299|11771210|FG001|STARTED|Period 1||18
10613473|NCT01924299|11771209|FG000|Received Baricitinib|Period 1||18
10613474|NCT01924299|11771210|FG001|Received Baricitinib|Period 1||18
10613475|NCT01924299|11771209|FG000|COMPLETED|Period 1||18
10613476|NCT01924299|11771210|FG001|COMPLETED|Period 1||18
10613477|NCT01924299|11771209|FG000|NOT COMPLETED|Period 1||0
10613478|NCT01924299|11771210|FG001|NOT COMPLETED|Period 1||0
10613479|NCT01924299|11771209|FG000|STARTED|Period 2||18
10613480|NCT01924299|11771210|FG001|STARTED|Period 2||18
10613481|NCT01924299|11771209|FG000|Received at Least 1 Dose of Study Drug|Period 2||18
10613482|NCT01924299|11771210|FG001|Received at Least 1 Dose of Study Drug|Period 2||18
10613483|NCT01924299|11771209|FG000|Received Baricitinib|Period 2||17
10613484|NCT01924299|11771210|FG001|Received Baricitinib|Period 2||17
10613485|NCT01924299|11771209|FG000|COMPLETED|Period 2||17
10613486|NCT01924299|11771210|FG001|COMPLETED|Period 2||17
10613487|NCT01924299|11771209|FG000|NOT COMPLETED|Period 2||1
10613488|NCT01924299|11771210|FG001|NOT COMPLETED|Period 2||1
10613489|NCT01924364|11771222|FG000|STARTED|Overall Study||7
10613490|NCT01924364|11771222|FG000|COMPLETED|Overall Study||4
10613491|NCT01924364|11771222|FG000|NOT COMPLETED|Overall Study||3
10613492|NCT01924390|11771239|FG000|STARTED|Overall Study||22
10613493|NCT01924390|11771240|FG001|STARTED|Overall Study||22
10613494|NCT01924390|11771239|FG000|COMPLETED|Overall Study||21
10613495|NCT01924390|11771240|FG001|COMPLETED|Overall Study||21
10613496|NCT01924390|11771239|FG000|NOT COMPLETED|Overall Study||1
10704758|NCT02982954|11869121|FG000|NOT COMPLETED|Treatment Period||106
10704759|NCT02982954|11869122|FG001|NOT COMPLETED|Treatment Period||52
10704760|NCT02982954|11869123|FG002|NOT COMPLETED|Treatment Period||28
10808814|NCT03840278|11970806|FG000|COMPLETED|Overall Study||5
10808815|NCT03840278|11970807|FG001|COMPLETED|Overall Study||5
10613497|NCT01924390|11771240|FG001|NOT COMPLETED|Overall Study||1
10613498|NCT01924429|11771248|FG000|STARTED|Period 1 - First Intervention (4 Weeks)||17
10613499|NCT01924429|11771249|FG001|STARTED|Period 1 - First Intervention (4 Weeks)||13
10613500|NCT01924429|11771248|FG000|COMPLETED|Period 1 - First Intervention (4 Weeks)||17
10613501|NCT01924429|11771249|FG001|COMPLETED|Period 1 - First Intervention (4 Weeks)||13
10613502|NCT01924429|11771248|FG000|NOT COMPLETED|Period 1 - First Intervention (4 Weeks)||0
10613503|NCT01924429|11771249|FG001|NOT COMPLETED|Period 1 - First Intervention (4 Weeks)||0
10613504|NCT01924429|11771248|FG000|STARTED|Washout Period (2 Weeks)||17
10613505|NCT01924429|11771249|FG001|STARTED|Washout Period (2 Weeks)||13
10613506|NCT01924429|11771248|FG000|COMPLETED|Washout Period (2 Weeks)||14
10613507|NCT01924429|11771249|FG001|COMPLETED|Washout Period (2 Weeks)||11
10613508|NCT01924429|11771248|FG000|NOT COMPLETED|Washout Period (2 Weeks)||3
10613509|NCT01924429|11771249|FG001|NOT COMPLETED|Washout Period (2 Weeks)||2
10613510|NCT01924429|11771248|FG000|STARTED|Period 2 - Second Intervention (4 Weeks)||14
10613511|NCT01924429|11771249|FG001|STARTED|Period 2 - Second Intervention (4 Weeks)||11
10613512|NCT01924429|11771248|FG000|COMPLETED|Period 2 - Second Intervention (4 Weeks)||14
10613513|NCT01924429|11771249|FG001|COMPLETED|Period 2 - Second Intervention (4 Weeks)||11
10613514|NCT01924429|11771248|FG000|NOT COMPLETED|Period 2 - Second Intervention (4 Weeks)||0
10613515|NCT01924429|11771249|FG001|NOT COMPLETED|Period 2 - Second Intervention (4 Weeks)||0
10613516|NCT01924442|11771259|FG000|STARTED|Overall Study||1099
10613517|NCT01924442|11771260|FG001|STARTED|Overall Study||1104
10613518|NCT01924442|11771259|FG000|COMPLETED|Overall Study||1059
10613519|NCT01924442|11771260|FG001|COMPLETED|Overall Study||967
10613520|NCT01924442|11771259|FG000|NOT COMPLETED|Overall Study||40
10613521|NCT01924442|11771260|FG001|NOT COMPLETED|Overall Study||137
10613522|NCT01924559|11771266|FG000|STARTED|Overall Study|All 37 participants were scored under the same six scenarios, resulting in 222 observations.|37
10613523|NCT01924559|11771266|FG000|COMPLETED|Overall Study|The order in which subjects started scenarios (in biohazard gear vs street clothing) was randomized|37
10613524|NCT01924559|11771266|FG000|NOT COMPLETED|Overall Study||0
10613525|NCT01924689|11771286|FG000|STARTED|Overall Study||3
10613526|NCT01924689|11771287|FG001|STARTED|Overall Study||3
10613527|NCT01924689|11771288|FG002|STARTED|Overall Study||4
10613528|NCT01924689|11771289|FG003|STARTED|Overall Study||6
10613529|NCT01924689|11771290|FG004|STARTED|Overall Study||6
10613530|NCT01924689|11771291|FG005|STARTED|Overall Study||2
10613531|NCT01924689|11771286|FG000|COMPLETED|Overall Study||0
10613532|NCT01924689|11771287|FG001|COMPLETED|Overall Study||0
10613533|NCT01924689|11771288|FG002|COMPLETED|Overall Study||0
10613534|NCT01924689|11771289|FG003|COMPLETED|Overall Study||0
10613535|NCT01924689|11771290|FG004|COMPLETED|Overall Study||0
10613536|NCT01924689|11771291|FG005|COMPLETED|Overall Study||0
10613537|NCT01924689|11771286|FG000|NOT COMPLETED|Overall Study||3
10613538|NCT01924689|11771287|FG001|NOT COMPLETED|Overall Study||3
10613539|NCT01924689|11771288|FG002|NOT COMPLETED|Overall Study||4
10613540|NCT01924689|11771289|FG003|NOT COMPLETED|Overall Study||6
10613541|NCT01924689|11771290|FG004|NOT COMPLETED|Overall Study||6
10613542|NCT01924689|11771291|FG005|NOT COMPLETED|Overall Study||2
10613543|NCT01924754|11771312|FG000|STARTED|Overall Study||50
10613544|NCT01924754|11771313|FG001|STARTED|Overall Study||50
10613545|NCT01924754|11771314|FG002|STARTED|Overall Study||50
10613546|NCT01924754|11771312|FG000|COMPLETED|Overall Study||49
10613547|NCT01924754|11771313|FG001|COMPLETED|Overall Study||47
10613548|NCT01924754|11771314|FG002|COMPLETED|Overall Study||47
10613549|NCT01924754|11771312|FG000|NOT COMPLETED|Overall Study||1
10613550|NCT01924754|11771313|FG001|NOT COMPLETED|Overall Study||3
10613551|NCT01924754|11771314|FG002|NOT COMPLETED|Overall Study||3
10613552|NCT01924767|11771330|FG000|STARTED|Overall Study||12
10613553|NCT01924767|11771331|FG001|STARTED|Overall Study||9
10613554|NCT01924767|11771332|FG002|STARTED|Overall Study||9
10613555|NCT01924767|11771333|FG003|STARTED|Overall Study||9
10613556|NCT01924767|11771334|FG004|STARTED|Overall Study||9
10613557|NCT01924767|11771330|FG000|COMPLETED|Overall Study||11
10613558|NCT01924767|11771331|FG001|COMPLETED|Overall Study||9
10613559|NCT01924767|11771332|FG002|COMPLETED|Overall Study||8
10613560|NCT01924767|11771333|FG003|COMPLETED|Overall Study||9
10613561|NCT01924767|11771334|FG004|COMPLETED|Overall Study||9
10613562|NCT01924767|11771330|FG000|NOT COMPLETED|Overall Study||1
10613563|NCT01924767|11771331|FG001|NOT COMPLETED|Overall Study||0
10613564|NCT01924767|11771332|FG002|NOT COMPLETED|Overall Study||1
10613565|NCT01924767|11771333|FG003|NOT COMPLETED|Overall Study||0
10613566|NCT01924767|11771334|FG004|NOT COMPLETED|Overall Study||0
10613567|NCT01924806|11771353|FG000|STARTED|Overall Study||5
10613568|NCT01924806|11771354|FG001|STARTED|Overall Study||4
10613569|NCT01924806|11771353|FG000|COMPLETED|Overall Study||3
10613570|NCT01924806|11771354|FG001|COMPLETED|Overall Study||3
10613571|NCT01924806|11771353|FG000|NOT COMPLETED|Overall Study||2
10613572|NCT01924806|11771354|FG001|NOT COMPLETED|Overall Study||1
10613573|NCT01924845|11771360|FG000|STARTED|Overall Study||24
10613574|NCT01924845|11771360|FG000|COMPLETED|Overall Study||18
10613575|NCT01924845|11771360|FG000|NOT COMPLETED|Overall Study||6
10613576|NCT01924871|11771366|FG000|STARTED|Overall Study||31
10613577|NCT01924871|11771367|FG001|STARTED|Overall Study||31
10613578|NCT01924871|11771366|FG000|COMPLETED|Overall Study||25
10613579|NCT01924871|11771367|FG001|COMPLETED|Overall Study||29
10613580|NCT01924871|11771366|FG000|NOT COMPLETED|Overall Study||6
10613581|NCT01924871|11771367|FG001|NOT COMPLETED|Overall Study||2
10613582|NCT01924949|11771373|FG000|STARTED|Overall Study||5
10613583|NCT01924949|11771373|FG000|COMPLETED|Overall Study||5
10613584|NCT01924949|11771373|FG000|NOT COMPLETED|Overall Study||0
10613585|NCT01924975|11771379|FG000|STARTED|Overall Study||51
10613586|NCT01924975|11771380|FG001|STARTED|Overall Study||51
10613587|NCT01924975|11771379|FG000|COMPLETED|Overall Study||51
10613588|NCT01924975|11771380|FG001|COMPLETED|Overall Study||51
10613589|NCT01924975|11771379|FG000|NOT COMPLETED|Overall Study||0
10613590|NCT01924975|11771380|FG001|NOT COMPLETED|Overall Study||0
10613591|NCT01924988|11771386|FG000|STARTED|Overall Study||15
10613592|NCT01924988|11771386|FG000|COMPLETED|Overall Study||15
10613593|NCT01924988|11771386|FG000|NOT COMPLETED|Overall Study||0
10613594|NCT01925014|11771395|FG000|STARTED|Overall Study||1535
10613595|NCT01925014|11771396|FG001|STARTED|Overall Study||1539
10613596|NCT01925014|11771395|FG000|COMPLETED|Overall Study||1526
10613597|NCT01925014|11771396|FG001|COMPLETED|Overall Study||1520
10613598|NCT01925014|11771395|FG000|NOT COMPLETED|Overall Study||9
10613599|NCT01925014|11771396|FG001|NOT COMPLETED|Overall Study||19
10613600|NCT01925144|11771402|FG000|STARTED|Period 1 (Day 1 Through Predose Day 3)||30
10613601|NCT01925144|11771402|FG000|Received Baricitinib|Period 1 (Day 1 Through Predose Day 3)||30
10613602|NCT01925144|11771402|FG000|COMPLETED|Period 1 (Day 1 Through Predose Day 3)||30
10613603|NCT01925144|11771402|FG000|NOT COMPLETED|Period 1 (Day 1 Through Predose Day 3)||0
10613604|NCT01925144|11771402|FG000|STARTED|Period 2 (At Dosing Day 3 Through Day12)||30
10613605|NCT01925144|11771402|FG000|Received Baricitinib|Period 2 (At Dosing Day 3 Through Day12)||30
10613606|NCT01925144|11771402|FG000|Received 8 Doses of Omeprazole|Period 2 (At Dosing Day 3 Through Day12)||30
10613607|NCT01925144|11771402|FG000|COMPLETED|Period 2 (At Dosing Day 3 Through Day12)||30
10613608|NCT01925144|11771402|FG000|NOT COMPLETED|Period 2 (At Dosing Day 3 Through Day12)||0
10613609|NCT01925170|11771409|FG000|STARTED|Overall Study||1638
10613610|NCT01925170|11771409|FG000|COMPLETED|Overall Study||1585
10613611|NCT01925170|11771409|FG000|NOT COMPLETED|Overall Study||53
10613612|NCT01925183|11771417|FG000|STARTED|Overall Study||3
10613613|NCT01925183|11771418|FG001|STARTED|Overall Study||3
10613614|NCT01925183|11771417|FG000|COMPLETED|Overall Study||2
10613615|NCT01925183|11771418|FG001|COMPLETED|Overall Study||3
10613616|NCT01925183|11771417|FG000|NOT COMPLETED|Overall Study||1
10613617|NCT01925183|11771418|FG001|NOT COMPLETED|Overall Study||0
10613618|NCT01925209|11771428|FG000|STARTED|Treatment Epoch||63
10613619|NCT01925209|11771429|FG001|STARTED|Treatment Epoch||63
10613620|NCT01925209|11771430|FG002|STARTED|Treatment Epoch||63
10613621|NCT01925209|11771431|FG003|STARTED|Treatment Epoch||62
10613622|NCT01925209|11771428|FG000|Full Analysis Set|Treatment Epoch||63
10613623|NCT01925209|11771429|FG001|Full Analysis Set|Treatment Epoch||63
10613624|NCT01925209|11771430|FG002|Full Analysis Set|Treatment Epoch||63
10613625|NCT01925209|11771431|FG003|Full Analysis Set|Treatment Epoch||62
10613626|NCT01925209|11771428|FG000|COMPLETED|Treatment Epoch||54
10613627|NCT01925209|11771429|FG001|COMPLETED|Treatment Epoch||55
10613628|NCT01925209|11771430|FG002|COMPLETED|Treatment Epoch||56
10613629|NCT01925209|11771431|FG003|COMPLETED|Treatment Epoch||57
10613630|NCT01925209|11771428|FG000|NOT COMPLETED|Treatment Epoch||9
10613631|NCT01925209|11771429|FG001|NOT COMPLETED|Treatment Epoch||8
10613632|NCT01925209|11771430|FG002|NOT COMPLETED|Treatment Epoch||7
10613633|NCT01925209|11771431|FG003|NOT COMPLETED|Treatment Epoch||5
10613634|NCT01925209|11771428|FG000|STARTED|Maintenance Treatment Epoch||49
10613635|NCT01925209|11771429|FG001|STARTED|Maintenance Treatment Epoch||46
10613636|NCT01925209|11771430|FG002|STARTED|Maintenance Treatment Epoch||52
10613637|NCT01925209|11771431|FG003|STARTED|Maintenance Treatment Epoch||50
10613638|NCT01925209|11771428|FG000|COMPLETED|Maintenance Treatment Epoch||49
10613639|NCT01925209|11771429|FG001|COMPLETED|Maintenance Treatment Epoch||45
10613640|NCT01925209|11771430|FG002|COMPLETED|Maintenance Treatment Epoch||50
10613641|NCT01925209|11771431|FG003|COMPLETED|Maintenance Treatment Epoch||48
10613642|NCT01925209|11771428|FG000|NOT COMPLETED|Maintenance Treatment Epoch||0
10613643|NCT01925209|11771429|FG001|NOT COMPLETED|Maintenance Treatment Epoch||1
10613644|NCT01925209|11771430|FG002|NOT COMPLETED|Maintenance Treatment Epoch||2
10613645|NCT01925209|11771431|FG003|NOT COMPLETED|Maintenance Treatment Epoch||2
10613646|NCT01925209|11771428|FG000|STARTED|Follow-up||57
10613647|NCT01925209|11771429|FG001|STARTED|Follow-up||61
10613648|NCT01925209|11771430|FG002|STARTED|Follow-up||56
10613649|NCT01925209|11771431|FG003|STARTED|Follow-up||58
10613650|NCT01925209|11771428|FG000|COMPLETED|Follow-up||56
10613651|NCT01925209|11771429|FG001|COMPLETED|Follow-up||55
10613652|NCT01925209|11771430|FG002|COMPLETED|Follow-up||55
10613653|NCT01925209|11771431|FG003|COMPLETED|Follow-up||54
10613654|NCT01925209|11771428|FG000|NOT COMPLETED|Follow-up||1
10613655|NCT01925209|11771429|FG001|NOT COMPLETED|Follow-up||6
10613656|NCT01925209|11771430|FG002|NOT COMPLETED|Follow-up||1
10613657|NCT01925209|11771431|FG003|NOT COMPLETED|Follow-up||4
10613658|NCT01925274|11771444|FG000|STARTED|Overall Study||7
10613659|NCT01925274|11771445|FG001|STARTED|Overall Study||6
10613660|NCT01925274|11771446|FG002|STARTED|Overall Study||6
10613661|NCT01925274|11771444|FG000|COMPLETED|Overall Study||0
10613662|NCT01925274|11771445|FG001|COMPLETED|Overall Study||0
10613663|NCT01925274|11771446|FG002|COMPLETED|Overall Study||0
10613664|NCT01925274|11771444|FG000|NOT COMPLETED|Overall Study||7
10613665|NCT01925274|11771445|FG001|NOT COMPLETED|Overall Study||6
10613666|NCT01925274|11771446|FG002|NOT COMPLETED|Overall Study||6
10613667|NCT01925339|11771458|FG000|STARTED|Overall Study||20
10613668|NCT01925339|11771459|FG001|STARTED|Overall Study||20
10613669|NCT01925339|11771458|FG000|COMPLETED|Overall Study||18
10613670|NCT01925339|11771459|FG001|COMPLETED|Overall Study||20
10613671|NCT01925339|11771458|FG000|NOT COMPLETED|Overall Study||2
10613672|NCT01925339|11771459|FG001|NOT COMPLETED|Overall Study||0
10613673|NCT01925404|11771469|FG000|STARTED|Overall Study|"The primary outcome of this study is at the level of a park.~The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users"|
10613674|NCT01925404|11771470|FG001|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users|
10613675|NCT01925404|11771471|FG002|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users|
10613676|NCT01925404|11771472|FG003|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users|
10613677|NCT01925404|11771469|FG000|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|
10613678|NCT01925404|11771470|FG001|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|
10613679|NCT01925404|11771471|FG002|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|
10613680|NCT01925404|11771472|FG003|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|
10613681|NCT01925404|11771469|FG000|NOT COMPLETED|Overall Study||
10613682|NCT01925404|11771470|FG001|NOT COMPLETED|Overall Study||
10613683|NCT01925404|11771471|FG002|NOT COMPLETED|Overall Study||
10613684|NCT01925404|11771472|FG003|NOT COMPLETED|Overall Study||
10613685|NCT01925417|11771482|FG000|STARTED|Overall Study||34
10613686|NCT01925417|11771482|FG000|COMPLETED|Overall Study||31
10613687|NCT01925417|11771482|FG000|NOT COMPLETED|Overall Study||3
10613688|NCT01925469|11771489|FG000|STARTED|Overall Study||15
10613689|NCT01925469|11771490|FG001|STARTED|Overall Study||15
10613690|NCT01925469|11771489|FG000|COMPLETED|Overall Study||14
10613691|NCT01925469|11771490|FG001|COMPLETED|Overall Study||15
10613692|NCT01925469|11771489|FG000|NOT COMPLETED|Overall Study||1
10613693|NCT01925469|11771490|FG001|NOT COMPLETED|Overall Study||0
10613694|NCT01925612|11771501|FG000|STARTED|Overall Study||29
10613695|NCT01925612|11771502|FG001|STARTED|Overall Study||22
10613696|NCT01925612|11771503|FG002|STARTED|Overall Study||11
10613697|NCT01925612|11771504|FG003|STARTED|Overall Study||11
10613698|NCT01925612|11771505|FG004|STARTED|Overall Study||12
10613699|NCT01925612|11771501|FG000|COMPLETED|Overall Study||25
10613700|NCT01925612|11771502|FG001|COMPLETED|Overall Study||18
10613701|NCT01925612|11771503|FG002|COMPLETED|Overall Study||10
10613702|NCT01925612|11771504|FG003|COMPLETED|Overall Study||10
10613703|NCT01925612|11771505|FG004|COMPLETED|Overall Study||10
10613704|NCT01925612|11771501|FG000|NOT COMPLETED|Overall Study||4
10613705|NCT01925612|11771502|FG001|NOT COMPLETED|Overall Study||4
10613706|NCT01925612|11771503|FG002|NOT COMPLETED|Overall Study||1
10613707|NCT01925612|11771504|FG003|NOT COMPLETED|Overall Study||1
10613708|NCT01925612|11771505|FG004|NOT COMPLETED|Overall Study||2
10613709|NCT01925677|11771517|FG000|STARTED|Overall Study||3
10613710|NCT01925677|11771517|FG000|COMPLETED|Overall Study||3
10613711|NCT01925677|11771517|FG000|NOT COMPLETED|Overall Study||0
10613712|NCT01925703|11771521|FG000|STARTED|Overall Study||13
10613713|NCT01925703|11771521|FG000|Dosing Regimen Completed|Overall Study||12
10613714|NCT01925703|11771521|FG000|Full Iron Repletion Achieved|Overall Study||11
10613715|NCT01925703|11771521|FG000|Follow-up Completed|Overall Study||9
10613716|NCT01925703|11771521|FG000|COMPLETED|Overall Study||9
10613717|NCT01925703|11771521|FG000|NOT COMPLETED|Overall Study||4
10613718|NCT01925768|11771527|FG000|STARTED|Placebo-controlled Phase (Week 0 - 24)||109
10613719|NCT01925768|11771528|FG001|STARTED|Placebo-controlled Phase (Week 0 - 24)||110
10613720|NCT01925768|11771527|FG000|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||109
10613721|NCT01925768|11771528|FG001|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||109
10613722|NCT01925768|11771527|FG000|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||101
10613723|NCT01925768|11771528|FG001|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||91
10613724|NCT01925768|11771527|FG000|Escaped Early (EE)|Placebo-controlled Phase (Week 0 - 24)||35
10613725|NCT01925768|11771528|FG001|Escaped Early (EE)|Placebo-controlled Phase (Week 0 - 24)||13
10613726|NCT01925768|11771527|FG000|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|3 participants who completed Week 24 did not enter the active treatment phase|98
10613727|NCT01925768|11771528|FG001|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|2 participants who completed Week 24 did not enter the active treatment phase|87
10613728|NCT01925768|11771527|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||11
10613729|NCT01925768|11771528|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||23
10613730|NCT01925768|11771527|FG000|STARTED|ActiveTreatment/Extension (Weeks 24-104)||95
10613731|NCT01925768|11771528|FG001|STARTED|ActiveTreatment/Extension (Weeks 24-104)||85
10613732|NCT01925768|11771527|FG000|COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||75
10613733|NCT01925768|11771528|FG001|COMPLETED|ActiveTreatment/Extension (Weeks 24-104)|Completed Apremilast treatment at Week 104|67
10613734|NCT01925768|11771527|FG000|NOT COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||20
10613735|NCT01925768|11771528|FG001|NOT COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||18
10613736|NCT01925781|11771540|FG000|STARTED|Overall Study||5
10613737|NCT01925781|11771541|FG001|STARTED|Overall Study||5
10613738|NCT01925781|11771540|FG000|COMPLETED|Overall Study||3
10613739|NCT01925781|11771541|FG001|COMPLETED|Overall Study||1
10613740|NCT01925781|11771540|FG000|NOT COMPLETED|Overall Study||2
10613741|NCT01925781|11771541|FG001|NOT COMPLETED|Overall Study||4
10613742|NCT01925950|11771549|FG000|STARTED|Part 1||1
10613743|NCT01925950|11771550|FG001|STARTED|Part 1||1
10613744|NCT01925950|11771549|FG000|COMPLETED|Part 1||1
10613745|NCT01925950|11771550|FG001|COMPLETED|Part 1||1
10613746|NCT01925950|11771549|FG000|NOT COMPLETED|Part 1||0
10613747|NCT01925950|11771550|FG001|NOT COMPLETED|Part 1||0
10613748|NCT01925950|11771549|FG000|STARTED|Part 2||1
10613749|NCT01925950|11771550|FG001|STARTED|Part 2|The 1 orBec subject completed Part 1 but did not meet the criteria of a CR to continue to Part 2|0
10613750|NCT01925950|11771549|FG000|COMPLETED|Part 2||0
10613751|NCT01925950|11771550|FG001|COMPLETED|Part 2||0
10613752|NCT01925950|11771549|FG000|NOT COMPLETED|Part 2||1
10613753|NCT01925950|11771550|FG001|NOT COMPLETED|Part 2||0
10613754|NCT01925989|11771558|FG000|STARTED|Period 1||7
10613755|NCT01925989|11771559|FG001|STARTED|Period 1||8
10613756|NCT01925989|11771560|FG002|STARTED|Period 1||12
10613757|NCT01925989|11771558|FG000|Received at Least 1 Dose of Study Drug|Period 1||7
10613758|NCT01925989|11771559|FG001|Received at Least 1 Dose of Study Drug|Period 1||8
10613759|NCT01925989|11771560|FG002|Received at Least 1 Dose of Study Drug|Period 1||0
10613760|NCT01925989|11771558|FG000|COMPLETED|Period 1||6
10613761|NCT01925989|11771559|FG001|COMPLETED|Period 1||6
10613762|NCT01925989|11771560|FG002|COMPLETED|Period 1||12
10613763|NCT01925989|11771558|FG000|NOT COMPLETED|Period 1||1
10613764|NCT01925989|11771559|FG001|NOT COMPLETED|Period 1||2
10613765|NCT01925989|11771560|FG002|NOT COMPLETED|Period 1||0
10613766|NCT01925989|11771558|FG000|STARTED|Period 2||6
10613767|NCT01925989|11771559|FG001|STARTED|Period 2||6
10613768|NCT01925989|11771560|FG002|STARTED|Period 2||12
10613769|NCT01925989|11771558|FG000|COMPLETED|Period 2||6
10613770|NCT01925989|11771559|FG001|COMPLETED|Period 2||6
10613771|NCT01925989|11771560|FG002|COMPLETED|Period 2||12
10613772|NCT01925989|11771558|FG000|NOT COMPLETED|Period 2||0
10613773|NCT01925989|11771559|FG001|NOT COMPLETED|Period 2||0
10613774|NCT01925989|11771560|FG002|NOT COMPLETED|Period 2||0
10613775|NCT01926015|11771574|FG000|STARTED|Overall Study|Participants who passed all entry criteria and who were randomized into the study|96
10613776|NCT01926015|11771575|FG001|STARTED|Overall Study|Participants who passed all entry criteria and who were randomized into the study|96
10613777|NCT01926015|11771574|FG000|Received >=1 Vaccination|Overall Study||94
10613778|NCT01926015|11771575|FG001|Received >=1 Vaccination|Overall Study||96
10613779|NCT01926015|11771574|FG000|COMPLETED|Overall Study||94
10613780|NCT01926015|11771575|FG001|COMPLETED|Overall Study||95
10613781|NCT01926015|11771574|FG000|NOT COMPLETED|Overall Study||2
10613782|NCT01926015|11771575|FG001|NOT COMPLETED|Overall Study||1
10613783|NCT01926028|11771584|FG000|STARTED|Overall Study||85
10613784|NCT01926028|11771585|FG001|STARTED|Overall Study||89
10613785|NCT01926028|11771586|FG002|STARTED|Overall Study||14
10613786|NCT01926028|11771584|FG000|COMPLETED|Overall Study||64
10613787|NCT01926028|11771585|FG001|COMPLETED|Overall Study||67
10613788|NCT01926028|11771586|FG002|COMPLETED|Overall Study||12
10613789|NCT01926028|11771584|FG000|NOT COMPLETED|Overall Study||21
10613790|NCT01926028|11771585|FG001|NOT COMPLETED|Overall Study||22
10613791|NCT01926028|11771586|FG002|NOT COMPLETED|Overall Study||2
10613792|NCT01926119|11771595|FG000|STARTED|Overall Study||4
10613793|NCT01926119|11771595|FG000|COMPLETED|Overall Study||3
10613794|NCT01926119|11771595|FG000|NOT COMPLETED|Overall Study||1
10613795|NCT01926444|11771603|FG000|STARTED|Overall Study||56
10613796|NCT01926444|11771604|FG001|STARTED|Overall Study||52
10613797|NCT01926444|11771605|FG002|STARTED|Overall Study||57
10613798|NCT01926444|11771606|FG003|STARTED|Overall Study||103
10613799|NCT01926444|11771603|FG000|COMPLETED|Overall Study||56
10613800|NCT01926444|11771604|FG001|COMPLETED|Overall Study||52
10613801|NCT01926444|11771605|FG002|COMPLETED|Overall Study||53
10613802|NCT01926444|11771606|FG003|COMPLETED|Overall Study||101
10613803|NCT01926444|11771603|FG000|NOT COMPLETED|Overall Study||0
10613804|NCT01926444|11771604|FG001|NOT COMPLETED|Overall Study||0
10613805|NCT01926444|11771605|FG002|NOT COMPLETED|Overall Study||4
10613806|NCT01926444|11771606|FG003|NOT COMPLETED|Overall Study||2
10613807|NCT01926496|11771618|FG000|STARTED|Overall Study||240
10613808|NCT01926496|11771619|FG001|STARTED|Overall Study||245
10613809|NCT01926496|11771618|FG000|COMPLETED|Overall Study||203
10613810|NCT01926496|11771619|FG001|COMPLETED|Overall Study||197
10613811|NCT01926496|11771618|FG000|NOT COMPLETED|Overall Study||37
10613812|NCT01926496|11771619|FG001|NOT COMPLETED|Overall Study||48
10613813|NCT01926509|11771633|FG000|STARTED|Overall Study||6
10613814|NCT01926509|11771634|FG001|STARTED|Overall Study||6
10613815|NCT01926509|11771635|FG002|STARTED|Overall Study||5
10613816|NCT01926509|11771636|FG003|STARTED|Overall Study||6
10613817|NCT01926509|11771633|FG000|COMPLETED|Overall Study||5
10613818|NCT01926509|11771634|FG001|COMPLETED|Overall Study||6
10613819|NCT01926509|11771635|FG002|COMPLETED|Overall Study||5
10613820|NCT01926509|11771636|FG003|COMPLETED|Overall Study||6
10613821|NCT01926509|11771633|FG000|NOT COMPLETED|Overall Study||1
10613822|NCT01926509|11771634|FG001|NOT COMPLETED|Overall Study||0
10613823|NCT01926509|11771635|FG002|NOT COMPLETED|Overall Study||0
10613824|NCT01926509|11771636|FG003|NOT COMPLETED|Overall Study||0
10613825|NCT01926626|11771646|FG000|STARTED|Overall Study||38
10613826|NCT01926626|11771646|FG000|Received Moclobemide|Overall Study||37
10613827|NCT01926626|11771646|FG000|COMPLETED|Overall Study||16
10613828|NCT01926626|11771646|FG000|NOT COMPLETED|Overall Study||22
10613829|NCT01926782|11771656|FG000|STARTED|Overall Study||157
10613830|NCT01926782|11771657|FG001|STARTED|Overall Study||78
10613831|NCT01926782|11771658|FG002|STARTED|Overall Study||312
10613832|NCT01926782|11771659|FG003|STARTED|Overall Study||73
10613833|NCT01926782|11771660|FG004|STARTED|Overall Study||37
10613834|NCT01926782|11771661|FG005|STARTED|Overall Study||146
10613835|NCT01926782|11771656|FG000|Treated|Overall Study||157
10613836|NCT01926782|11771657|FG001|Treated|Overall Study||78
10613837|NCT01926782|11771658|FG002|Treated|Overall Study||312
10613838|NCT01926782|11771659|FG003|Treated|Overall Study||72
10613839|NCT01926782|11771660|FG004|Treated|Overall Study||37
10613840|NCT01926782|11771661|FG005|Treated|Overall Study||146
10613841|NCT01926782|11771656|FG000|Completed 24 Weeks Treatment Period|Overall Study||137
10613842|NCT01926782|11771657|FG001|Completed 24 Weeks Treatment Period|Overall Study||68
10613843|NCT01926782|11771658|FG002|Completed 24 Weeks Treatment Period|Overall Study||285
10613844|NCT01926782|11771659|FG003|Completed 24 Weeks Treatment Period|Overall Study||58
10613845|NCT01926782|11771660|FG004|Completed 24 Weeks Treatment Period|Overall Study||31
10613846|NCT01926782|11771661|FG005|Completed 24 Weeks Treatment Period|Overall Study||120
10613847|NCT01926782|11771656|FG000|COMPLETED|Overall Study||129
10613848|NCT01926782|11771657|FG001|COMPLETED|Overall Study||65
10613849|NCT01926782|11771658|FG002|COMPLETED|Overall Study||272
10613850|NCT01926782|11771659|FG003|COMPLETED|Overall Study||53
10613851|NCT01926782|11771660|FG004|COMPLETED|Overall Study||29
10613852|NCT01926782|11771661|FG005|COMPLETED|Overall Study||105
10613853|NCT01926782|11771656|FG000|NOT COMPLETED|Overall Study||28
10613854|NCT01926782|11771657|FG001|NOT COMPLETED|Overall Study||13
10613855|NCT01926782|11771658|FG002|NOT COMPLETED|Overall Study||40
10613856|NCT01926782|11771659|FG003|NOT COMPLETED|Overall Study||20
10613857|NCT01926782|11771660|FG004|NOT COMPLETED|Overall Study||8
10613858|NCT01926782|11771661|FG005|NOT COMPLETED|Overall Study||41
10613859|NCT01926886|11771676|FG000|STARTED|Overall Study||102
10653178|NCT02190604|11813556|FG000|NOT COMPLETED|Part 3 (Patients)||0
10613860|NCT01926886|11771677|FG001|STARTED|Overall Study|HCPs were not enrolled in the study. No baseline data were collected for these participants.|21
10613861|NCT01926886|11771676|FG000|Received at Least 1 Dose of Study Drug|Overall Study||101
10613862|NCT01926886|11771677|FG001|Received at Least 1 Dose of Study Drug|Overall Study|Partcipants were HCPs included for polling purposes. HCPs were not enrolled in the study.|0
10613863|NCT01926886|11771676|FG000|COMPLETED|Overall Study||70
10613864|NCT01926886|11771677|FG001|COMPLETED|Overall Study|Partcipants were HCPs included for polling purposes. HCPs were not enrolled in the study.|21
10613865|NCT01926886|11771676|FG000|NOT COMPLETED|Overall Study||32
10613866|NCT01926886|11771677|FG001|NOT COMPLETED|Overall Study||0
10613867|NCT01926977|11771685|FG000|STARTED|Overall Study||47
10613868|NCT01926977|11771686|FG001|STARTED|Overall Study||53
10613869|NCT01926977|11771685|FG000|COMPLETED|Overall Study||47
10613870|NCT01926977|11771686|FG001|COMPLETED|Overall Study||53
10613871|NCT01926977|11771685|FG000|NOT COMPLETED|Overall Study||0
10613872|NCT01926977|11771686|FG001|NOT COMPLETED|Overall Study||0
10613873|NCT01927055|11771695|FG000|STARTED|Open-label||61
10613874|NCT01927055|11771696|FG001|STARTED|Open-label||0
10613875|NCT01927055|11771697|FG002|STARTED|Open-label||0
10613876|NCT01927055|11771695|FG000|COMPLETED|Open-label||45
10613877|NCT01927055|11771696|FG001|COMPLETED|Open-label||0
10613878|NCT01927055|11771697|FG002|COMPLETED|Open-label||0
10613879|NCT01927055|11771695|FG000|NOT COMPLETED|Open-label||16
10613880|NCT01927055|11771696|FG001|NOT COMPLETED|Open-label||0
10613881|NCT01927055|11771697|FG002|NOT COMPLETED|Open-label||0
10613882|NCT01927055|11771695|FG000|STARTED|Double-Blind||0
10613883|NCT01927055|11771696|FG001|STARTED|Double-Blind||22
10613884|NCT01927055|11771697|FG002|STARTED|Double-Blind||23
10613885|NCT01927055|11771695|FG000|COMPLETED|Double-Blind||0
10613886|NCT01927055|11771696|FG001|COMPLETED|Double-Blind||11
10613887|NCT01927055|11771697|FG002|COMPLETED|Double-Blind||10
10613888|NCT01927055|11771695|FG000|NOT COMPLETED|Double-Blind||0
10613889|NCT01927055|11771696|FG001|NOT COMPLETED|Double-Blind||11
10613890|NCT01927055|11771697|FG002|NOT COMPLETED|Double-Blind||13
10613891|NCT01927120|11771704|FG000|STARTED|Overall Study||20
10613892|NCT01927120|11771704|FG000|COMPLETED|Overall Study||10
10613893|NCT01927120|11771704|FG000|NOT COMPLETED|Overall Study||10
10613894|NCT01927341|11771713|FG000|STARTED|Phase 1b||10
10613895|NCT01927341|11771714|FG001|STARTED|Phase 1b||0
10613896|NCT01927341|11771715|FG002|STARTED|Phase 1b||0
10613897|NCT01927341|11771716|FG003|STARTED|Phase 1b||0
10613898|NCT01927341|11771717|FG004|STARTED|Phase 1b||0
10613899|NCT01927341|11771713|FG000|COMPLETED|Phase 1b||0
10613900|NCT01927341|11771714|FG001|COMPLETED|Phase 1b||0
10613901|NCT01927341|11771715|FG002|COMPLETED|Phase 1b||0
10613902|NCT01927341|11771716|FG003|COMPLETED|Phase 1b||0
10613903|NCT01927341|11771717|FG004|COMPLETED|Phase 1b||0
10613904|NCT01927341|11771713|FG000|NOT COMPLETED|Phase 1b||10
10613905|NCT01927341|11771714|FG001|NOT COMPLETED|Phase 1b||0
10613906|NCT01927341|11771715|FG002|NOT COMPLETED|Phase 1b||0
10613907|NCT01927341|11771716|FG003|NOT COMPLETED|Phase 1b||0
10613908|NCT01927341|11771717|FG004|NOT COMPLETED|Phase 1b||0
10613909|NCT01927341|11771713|FG000|STARTED|Phase 2||0
10613910|NCT01927341|11771714|FG001|STARTED|Phase 2|Participants of phase 2 enrolled after enrollment of participants of phase 1b.|15
10613911|NCT01927341|11771715|FG002|STARTED|Phase 2|Participants of phase 2 enrolled after enrollment of participants of phase 1b.|5
10613912|NCT01927341|11771716|FG003|STARTED|Phase 2|Participants of phase 2 enrolled after enrollment of participants of phase 1b.|15
10613913|NCT01927341|11771717|FG004|STARTED|Phase 2|Participants of phase 2 enrolled after enrollment of participants of phase 1b.|8
10613914|NCT01927341|11771713|FG000|COMPLETED|Phase 2||0
10613915|NCT01927341|11771714|FG001|COMPLETED|Phase 2||0
10613916|NCT01927341|11771715|FG002|COMPLETED|Phase 2||0
10613917|NCT01927341|11771716|FG003|COMPLETED|Phase 2||0
10613918|NCT01927341|11771717|FG004|COMPLETED|Phase 2||0
10613919|NCT01927341|11771713|FG000|NOT COMPLETED|Phase 2||0
10613920|NCT01927341|11771714|FG001|NOT COMPLETED|Phase 2||15
10613921|NCT01927341|11771715|FG002|NOT COMPLETED|Phase 2||5
10613922|NCT01927341|11771716|FG003|NOT COMPLETED|Phase 2||15
10613923|NCT01927341|11771717|FG004|NOT COMPLETED|Phase 2||8
10613924|NCT01927367|11771735|FG000|STARTED|Overall Study||597
10613925|NCT01927367|11771736|FG001|STARTED|Overall Study||548
10613926|NCT01927367|11771735|FG000|COMPLETED|Overall Study||590
10613927|NCT01927367|11771736|FG001|COMPLETED|Overall Study||543
10613928|NCT01927367|11771735|FG000|NOT COMPLETED|Overall Study||7
10613929|NCT01927367|11771736|FG001|NOT COMPLETED|Overall Study||5
10613930|NCT01927497|11771744|FG000|STARTED|Overall Study||50
10613931|NCT01927497|11771745|FG001|STARTED|Overall Study||54
10613932|NCT01927497|11771744|FG000|COMPLETED|Overall Study||48
10613933|NCT01927497|11771745|FG001|COMPLETED|Overall Study||53
10613934|NCT01927497|11771744|FG000|NOT COMPLETED|Overall Study||2
10613935|NCT01927497|11771745|FG001|NOT COMPLETED|Overall Study||1
10613936|NCT01927562|11771751|FG000|STARTED|Overall Study||57
10613937|NCT01927562|11771751|FG000|COMPLETED|Overall Study|5 at M24, 2 at M30,12 at M36 due to two protocol changes moving followups from M24 to M30 to M36|19
10613938|NCT01927562|11771751|FG000|NOT COMPLETED|Overall Study||38
10613939|NCT01927575|11771755|FG000|STARTED|Overall Study||1
10613940|NCT01927575|11771755|FG000|COMPLETED|Overall Study||1
10613941|NCT01927575|11771755|FG000|NOT COMPLETED|Overall Study||0
10613942|NCT01927627|11771763|FG000|STARTED|Overall Study||42
10613943|NCT01927627|11771763|FG000|COMPLETED|Overall Study||37
10613944|NCT01927627|11771763|FG000|NOT COMPLETED|Overall Study||5
10613945|NCT01927718|11771767|FG000|STARTED|Overall Study||10
10613946|NCT01927718|11771767|FG000|COMPLETED|Overall Study||10
10613947|NCT01927718|11771767|FG000|NOT COMPLETED|Overall Study||0
10613948|NCT01927757|11771771|FG000|STARTED|Overall Study||90
10613949|NCT01927757|11771771|FG000|Received Etanercept|Overall Study||88
10613950|NCT01927757|11771771|FG000|COMPLETED|Overall Study||67
10613951|NCT01927757|11771771|FG000|NOT COMPLETED|Overall Study||23
10613952|NCT01927861|11771781|FG000|STARTED|Pivotal Phase (104 Weeks)||25
10613953|NCT01927861|11771782|FG001|STARTED|Pivotal Phase (104 Weeks)||26
10613954|NCT01927861|11771781|FG000|COMPLETED|Pivotal Phase (104 Weeks)||25
10613955|NCT01927861|11771782|FG001|COMPLETED|Pivotal Phase (104 Weeks)||26
10613956|NCT01927861|11771781|FG000|NOT COMPLETED|Pivotal Phase (104 Weeks)||0
10613957|NCT01927861|11771782|FG001|NOT COMPLETED|Pivotal Phase (104 Weeks)||0
10613958|NCT01927861|11771781|FG000|STARTED|Extension Phase (104 Weeks)||25
10613959|NCT01927861|11771782|FG001|STARTED|Extension Phase (104 Weeks)||26
10613960|NCT01927861|11771781|FG000|COMPLETED|Extension Phase (104 Weeks)||25
10613961|NCT01927861|11771782|FG001|COMPLETED|Extension Phase (104 Weeks)||23
10613962|NCT01927861|11771781|FG000|NOT COMPLETED|Extension Phase (104 Weeks)||0
10613963|NCT01927861|11771782|FG001|NOT COMPLETED|Extension Phase (104 Weeks)||3
10613964|NCT01927861|11771781|FG000|STARTED|Extended Treatment Phase (26 Weeks)|15 participants agreed to continue the treatment for 26 weeks in the extended treatment phase.|15
10613965|NCT01927861|11771782|FG001|STARTED|Extended Treatment Phase (26 Weeks)|14 participants agreed to continue the treatment for 26 weeks in the extended treatment phase.|14
10613966|NCT01927861|11771781|FG000|COMPLETED|Extended Treatment Phase (26 Weeks)||15
10613967|NCT01927861|11771782|FG001|COMPLETED|Extended Treatment Phase (26 Weeks)||14
10613968|NCT01927861|11771781|FG000|NOT COMPLETED|Extended Treatment Phase (26 Weeks)||0
10613969|NCT01927861|11771782|FG001|NOT COMPLETED|Extended Treatment Phase (26 Weeks)||0
10613970|NCT01927887|11771788|FG000|STARTED|Overall Study||12
10613971|NCT01927887|11771788|FG000|COMPLETED|Overall Study||12
10613972|NCT01927887|11771788|FG000|NOT COMPLETED|Overall Study||0
10613973|NCT01928030|11771793|FG000|STARTED|Overall Study||3
10613974|NCT01928030|11771794|FG001|STARTED|Overall Study||0
10613975|NCT01928030|11771795|FG002|STARTED|Overall Study||0
10613976|NCT01928030|11771793|FG000|COMPLETED|Overall Study||3
10613977|NCT01928030|11771794|FG001|COMPLETED|Overall Study||0
10613978|NCT01928030|11771795|FG002|COMPLETED|Overall Study||0
10613979|NCT01928030|11771793|FG000|NOT COMPLETED|Overall Study||0
10613980|NCT01928030|11771794|FG001|NOT COMPLETED|Overall Study||0
10613981|NCT01928030|11771795|FG002|NOT COMPLETED|Overall Study||0
10613982|NCT01928186|11771802|FG000|STARTED|Overall Study||28
10613983|NCT01928186|11771802|FG000|COMPLETED|Overall Study||28
10613984|NCT01928186|11771802|FG000|NOT COMPLETED|Overall Study||0
10613985|NCT01928199|11771808|FG000|STARTED|Overall Study||32
10613986|NCT01928199|11771809|FG001|STARTED|Overall Study||29
10613987|NCT01928199|11771808|FG000|COMPLETED|Overall Study||32
10613988|NCT01928199|11771809|FG001|COMPLETED|Overall Study||29
10613989|NCT01928199|11771808|FG000|NOT COMPLETED|Overall Study||0
10613990|NCT01928199|11771809|FG001|NOT COMPLETED|Overall Study||0
10613991|NCT01928225|11771817|FG000|STARTED|Overall Study||90
10613992|NCT01928225|11771818|FG001|STARTED|Overall Study||90
10613993|NCT01928225|11771817|FG000|COMPLETED|Overall Study||87
10613994|NCT01928225|11771818|FG001|COMPLETED|Overall Study||87
10613995|NCT01928225|11771817|FG000|NOT COMPLETED|Overall Study||3
10613996|NCT01928225|11771818|FG001|NOT COMPLETED|Overall Study||3
10613997|NCT01928290|11771827|FG000|STARTED|Overall Study||41
10613998|NCT01928290|11771828|FG001|STARTED|Overall Study||26
10613999|NCT01928290|11771827|FG000|COMPLETED|Overall Study||41
10614000|NCT01928290|11771828|FG001|COMPLETED|Overall Study||26
10614001|NCT01928290|11771827|FG000|NOT COMPLETED|Overall Study||0
10614002|NCT01928290|11771828|FG001|NOT COMPLETED|Overall Study||0
10653179|NCT02190604|11813557|FG001|NOT COMPLETED|Part 3 (Patients)||0
10653180|NCT02190604|11813558|FG002|NOT COMPLETED|Part 3 (Patients)||0
10653181|NCT02190604|11813559|FG003|NOT COMPLETED|Part 3 (Patients)||0
10653182|NCT02190604|11813560|FG004|NOT COMPLETED|Part 3 (Patients)||0
10653183|NCT02190604|11813561|FG005|NOT COMPLETED|Part 3 (Patients)||0
10653184|NCT02190604|11813562|FG006|NOT COMPLETED|Part 3 (Patients)||0
10653185|NCT02190604|11813563|FG007|NOT COMPLETED|Part 3 (Patients)||0
10653186|NCT02190604|11813564|FG008|NOT COMPLETED|Part 3 (Patients)||0
10653187|NCT02190604|11813565|FG009|NOT COMPLETED|Part 3 (Patients)||0
10653188|NCT02190604|11813566|FG010|NOT COMPLETED|Part 3 (Patients)||0
10653189|NCT02190604|11813567|FG011|NOT COMPLETED|Part 3 (Patients)||0
10653190|NCT02190604|11813568|FG012|NOT COMPLETED|Part 3 (Patients)||0
10653191|NCT02190604|11813569|FG013|NOT COMPLETED|Part 3 (Patients)||0
10614003|NCT01928329|11771836|FG000|STARTED|Overall Study||40
10614004|NCT01928329|11771837|FG001|STARTED|Overall Study||39
10614005|NCT01928329|11771836|FG000|COMPLETED|Overall Study||28
10614006|NCT01928329|11771837|FG001|COMPLETED|Overall Study||25
10614007|NCT01928329|11771836|FG000|NOT COMPLETED|Overall Study||12
10614008|NCT01928329|11771837|FG001|NOT COMPLETED|Overall Study||14
10614009|NCT01928381|11771843|FG000|STARTED|Screening for Pain Training||143
10614010|NCT01928381|11771844|FG001|STARTED|Screening for Pain Training||0
10614011|NCT01928381|11771845|FG002|STARTED|Screening for Pain Training||0
10614012|NCT01928381|11771846|FG003|STARTED|Screening for Pain Training||0
10614013|NCT01928381|11771847|FG004|STARTED|Screening for Pain Training||0
10614014|NCT01928381|11771848|FG005|STARTED|Screening for Pain Training||0
10614015|NCT01928381|11771849|FG006|STARTED|Screening for Pain Training||0
10614016|NCT01928381|11771843|FG000|COMPLETED|Screening for Pain Training||83
10614017|NCT01928381|11771844|FG001|COMPLETED|Screening for Pain Training||0
10614018|NCT01928381|11771845|FG002|COMPLETED|Screening for Pain Training||0
10614019|NCT01928381|11771846|FG003|COMPLETED|Screening for Pain Training||0
10614020|NCT01928381|11771847|FG004|COMPLETED|Screening for Pain Training||0
10614021|NCT01928381|11771848|FG005|COMPLETED|Screening for Pain Training||0
10614022|NCT01928381|11771849|FG006|COMPLETED|Screening for Pain Training||0
10614023|NCT01928381|11771843|FG000|NOT COMPLETED|Screening for Pain Training||60
10614024|NCT01928381|11771844|FG001|NOT COMPLETED|Screening for Pain Training||0
10614025|NCT01928381|11771845|FG002|NOT COMPLETED|Screening for Pain Training||0
10614026|NCT01928381|11771846|FG003|NOT COMPLETED|Screening for Pain Training||0
10614027|NCT01928381|11771847|FG004|NOT COMPLETED|Screening for Pain Training||0
10614028|NCT01928381|11771848|FG005|NOT COMPLETED|Screening for Pain Training||0
10614029|NCT01928381|11771849|FG006|NOT COMPLETED|Screening for Pain Training||0
10614030|NCT01928381|11771843|FG000|STARTED|Part 1 - Pain Training||83
10614031|NCT01928381|11771844|FG001|STARTED|Part 1 - Pain Training||0
10614032|NCT01928381|11771845|FG002|STARTED|Part 1 - Pain Training||0
10614033|NCT01928381|11771846|FG003|STARTED|Part 1 - Pain Training||0
10614034|NCT01928381|11771847|FG004|STARTED|Part 1 - Pain Training||0
10614035|NCT01928381|11771848|FG005|STARTED|Part 1 - Pain Training||0
10614036|NCT01928381|11771849|FG006|STARTED|Part 1 - Pain Training||0
10614037|NCT01928381|11771843|FG000|COMPLETED|Part 1 - Pain Training||48
10614038|NCT01928381|11771844|FG001|COMPLETED|Part 1 - Pain Training||0
10614039|NCT01928381|11771845|FG002|COMPLETED|Part 1 - Pain Training||0
10614040|NCT01928381|11771846|FG003|COMPLETED|Part 1 - Pain Training||0
10614041|NCT01928381|11771847|FG004|COMPLETED|Part 1 - Pain Training||0
10614042|NCT01928381|11771848|FG005|COMPLETED|Part 1 - Pain Training||0
10614043|NCT01928381|11771849|FG006|COMPLETED|Part 1 - Pain Training||0
10614044|NCT01928381|11771843|FG000|NOT COMPLETED|Part 1 - Pain Training||35
10614045|NCT01928381|11771844|FG001|NOT COMPLETED|Part 1 - Pain Training||0
10614046|NCT01928381|11771845|FG002|NOT COMPLETED|Part 1 - Pain Training||0
10614047|NCT01928381|11771846|FG003|NOT COMPLETED|Part 1 - Pain Training||0
10614048|NCT01928381|11771847|FG004|NOT COMPLETED|Part 1 - Pain Training||0
10614049|NCT01928381|11771848|FG005|NOT COMPLETED|Part 1 - Pain Training||0
10614050|NCT01928381|11771849|FG006|NOT COMPLETED|Part 1 - Pain Training||0
10614051|NCT01928381|11771843|FG000|STARTED|Placebo run-in & Part 2 Eligibility||48
10614052|NCT01928381|11771844|FG001|STARTED|Placebo run-in & Part 2 Eligibility||0
10614053|NCT01928381|11771845|FG002|STARTED|Placebo run-in & Part 2 Eligibility||0
10614054|NCT01928381|11771846|FG003|STARTED|Placebo run-in & Part 2 Eligibility||0
10614055|NCT01928381|11771847|FG004|STARTED|Placebo run-in & Part 2 Eligibility||0
10614056|NCT01928381|11771848|FG005|STARTED|Placebo run-in & Part 2 Eligibility||0
10614057|NCT01928381|11771849|FG006|STARTED|Placebo run-in & Part 2 Eligibility||0
10614058|NCT01928381|11771843|FG000|COMPLETED|Placebo run-in & Part 2 Eligibility||34
10614059|NCT01928381|11771844|FG001|COMPLETED|Placebo run-in & Part 2 Eligibility||0
10614060|NCT01928381|11771845|FG002|COMPLETED|Placebo run-in & Part 2 Eligibility||0
10614061|NCT01928381|11771846|FG003|COMPLETED|Placebo run-in & Part 2 Eligibility||0
10614062|NCT01928381|11771847|FG004|COMPLETED|Placebo run-in & Part 2 Eligibility||0
10614063|NCT01928381|11771848|FG005|COMPLETED|Placebo run-in & Part 2 Eligibility||0
10614064|NCT01928381|11771849|FG006|COMPLETED|Placebo run-in & Part 2 Eligibility||0
10614065|NCT01928381|11771843|FG000|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||14
10614066|NCT01928381|11771844|FG001|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
10614067|NCT01928381|11771845|FG002|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
10614068|NCT01928381|11771846|FG003|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
10614069|NCT01928381|11771847|FG004|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
10614070|NCT01928381|11771848|FG005|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
10614071|NCT01928381|11771849|FG006|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
10614072|NCT01928381|11771843|FG000|STARTED|Part 2 - First Intervention||0
10614073|NCT01928381|11771844|FG001|STARTED|Part 2 - First Intervention||6
10614074|NCT01928381|11771845|FG002|STARTED|Part 2 - First Intervention||6
10614075|NCT01928381|11771846|FG003|STARTED|Part 2 - First Intervention||6
10614076|NCT01928381|11771847|FG004|STARTED|Part 2 - First Intervention||4
10614077|NCT01928381|11771848|FG005|STARTED|Part 2 - First Intervention||6
10614078|NCT01928381|11771849|FG006|STARTED|Part 2 - First Intervention||6
10614079|NCT01928381|11771843|FG000|COMPLETED|Part 2 - First Intervention||0
10614080|NCT01928381|11771844|FG001|COMPLETED|Part 2 - First Intervention||6
10614081|NCT01928381|11771845|FG002|COMPLETED|Part 2 - First Intervention||4
10614082|NCT01928381|11771846|FG003|COMPLETED|Part 2 - First Intervention||5
10614083|NCT01928381|11771847|FG004|COMPLETED|Part 2 - First Intervention||4
10614084|NCT01928381|11771848|FG005|COMPLETED|Part 2 - First Intervention||5
10614085|NCT01928381|11771849|FG006|COMPLETED|Part 2 - First Intervention||5
10614086|NCT01928381|11771843|FG000|NOT COMPLETED|Part 2 - First Intervention||0
10614087|NCT01928381|11771844|FG001|NOT COMPLETED|Part 2 - First Intervention||0
10614088|NCT01928381|11771845|FG002|NOT COMPLETED|Part 2 - First Intervention||2
10614089|NCT01928381|11771846|FG003|NOT COMPLETED|Part 2 - First Intervention||1
10614090|NCT01928381|11771847|FG004|NOT COMPLETED|Part 2 - First Intervention||0
10614091|NCT01928381|11771848|FG005|NOT COMPLETED|Part 2 - First Intervention||1
10614092|NCT01928381|11771849|FG006|NOT COMPLETED|Part 2 - First Intervention||1
10614093|NCT01928381|11771843|FG000|STARTED|Washout First Intervention||0
10614094|NCT01928381|11771844|FG001|STARTED|Washout First Intervention||6
10614095|NCT01928381|11771845|FG002|STARTED|Washout First Intervention||4
10614096|NCT01928381|11771846|FG003|STARTED|Washout First Intervention||5
10614097|NCT01928381|11771847|FG004|STARTED|Washout First Intervention||4
10614098|NCT01928381|11771848|FG005|STARTED|Washout First Intervention||5
10614099|NCT01928381|11771849|FG006|STARTED|Washout First Intervention||5
10614100|NCT01928381|11771843|FG000|COMPLETED|Washout First Intervention||0
10614101|NCT01928381|11771844|FG001|COMPLETED|Washout First Intervention||6
10614102|NCT01928381|11771845|FG002|COMPLETED|Washout First Intervention||4
10614103|NCT01928381|11771846|FG003|COMPLETED|Washout First Intervention||5
10614104|NCT01928381|11771847|FG004|COMPLETED|Washout First Intervention||3
10614105|NCT01928381|11771848|FG005|COMPLETED|Washout First Intervention||5
10614106|NCT01928381|11771849|FG006|COMPLETED|Washout First Intervention||5
10614107|NCT01928381|11771843|FG000|NOT COMPLETED|Washout First Intervention||0
10614108|NCT01928381|11771844|FG001|NOT COMPLETED|Washout First Intervention||0
10614109|NCT01928381|11771845|FG002|NOT COMPLETED|Washout First Intervention||0
10614110|NCT01928381|11771846|FG003|NOT COMPLETED|Washout First Intervention||0
10614111|NCT01928381|11771847|FG004|NOT COMPLETED|Washout First Intervention||1
10614112|NCT01928381|11771848|FG005|NOT COMPLETED|Washout First Intervention||0
10614113|NCT01928381|11771849|FG006|NOT COMPLETED|Washout First Intervention||0
10614114|NCT01928381|11771843|FG000|STARTED|Part 2 - Second Intervention||0
10614115|NCT01928381|11771844|FG001|STARTED|Part 2 - Second Intervention||6
10614116|NCT01928381|11771845|FG002|STARTED|Part 2 - Second Intervention||4
10614117|NCT01928381|11771846|FG003|STARTED|Part 2 - Second Intervention||5
10614118|NCT01928381|11771847|FG004|STARTED|Part 2 - Second Intervention||3
10614119|NCT01928381|11771848|FG005|STARTED|Part 2 - Second Intervention||5
10614120|NCT01928381|11771849|FG006|STARTED|Part 2 - Second Intervention||5
10614121|NCT01928381|11771843|FG000|COMPLETED|Part 2 - Second Intervention||0
10614122|NCT01928381|11771844|FG001|COMPLETED|Part 2 - Second Intervention||5
10614123|NCT01928381|11771845|FG002|COMPLETED|Part 2 - Second Intervention||4
10614124|NCT01928381|11771846|FG003|COMPLETED|Part 2 - Second Intervention||4
10614125|NCT01928381|11771847|FG004|COMPLETED|Part 2 - Second Intervention||3
10614126|NCT01928381|11771848|FG005|COMPLETED|Part 2 - Second Intervention||5
10614127|NCT01928381|11771849|FG006|COMPLETED|Part 2 - Second Intervention||5
10614128|NCT01928381|11771843|FG000|NOT COMPLETED|Part 2 - Second Intervention||0
10614129|NCT01928381|11771844|FG001|NOT COMPLETED|Part 2 - Second Intervention||1
10614130|NCT01928381|11771845|FG002|NOT COMPLETED|Part 2 - Second Intervention||0
10614131|NCT01928381|11771846|FG003|NOT COMPLETED|Part 2 - Second Intervention||1
10614132|NCT01928381|11771847|FG004|NOT COMPLETED|Part 2 - Second Intervention||0
10614133|NCT01928381|11771848|FG005|NOT COMPLETED|Part 2 - Second Intervention||0
10614134|NCT01928381|11771849|FG006|NOT COMPLETED|Part 2 - Second Intervention||0
10614135|NCT01928381|11771843|FG000|STARTED|Washout Second Intervention||0
10614136|NCT01928381|11771844|FG001|STARTED|Washout Second Intervention||5
10614137|NCT01928381|11771845|FG002|STARTED|Washout Second Intervention||4
10614138|NCT01928381|11771846|FG003|STARTED|Washout Second Intervention||4
10614139|NCT01928381|11771847|FG004|STARTED|Washout Second Intervention||3
10614140|NCT01928381|11771848|FG005|STARTED|Washout Second Intervention||5
10614141|NCT01928381|11771849|FG006|STARTED|Washout Second Intervention||5
10614142|NCT01928381|11771843|FG000|COMPLETED|Washout Second Intervention||0
10614143|NCT01928381|11771844|FG001|COMPLETED|Washout Second Intervention||5
10614144|NCT01928381|11771845|FG002|COMPLETED|Washout Second Intervention||4
10614145|NCT01928381|11771846|FG003|COMPLETED|Washout Second Intervention||4
10614146|NCT01928381|11771847|FG004|COMPLETED|Washout Second Intervention||3
10614147|NCT01928381|11771848|FG005|COMPLETED|Washout Second Intervention||5
10614148|NCT01928381|11771849|FG006|COMPLETED|Washout Second Intervention||5
10614149|NCT01928381|11771843|FG000|NOT COMPLETED|Washout Second Intervention||0
10614150|NCT01928381|11771844|FG001|NOT COMPLETED|Washout Second Intervention||0
10614151|NCT01928381|11771845|FG002|NOT COMPLETED|Washout Second Intervention||0
10614152|NCT01928381|11771846|FG003|NOT COMPLETED|Washout Second Intervention||0
10614153|NCT01928381|11771847|FG004|NOT COMPLETED|Washout Second Intervention||0
10614154|NCT01928381|11771848|FG005|NOT COMPLETED|Washout Second Intervention||0
10614155|NCT01928381|11771849|FG006|NOT COMPLETED|Washout Second Intervention||0
10614156|NCT01928381|11771843|FG000|STARTED|Part 2 - Third Intervention||0
10614157|NCT01928381|11771844|FG001|STARTED|Part 2 - Third Intervention||5
10614158|NCT01928381|11771845|FG002|STARTED|Part 2 - Third Intervention||4
10614159|NCT01928381|11771846|FG003|STARTED|Part 2 - Third Intervention||4
10614160|NCT01928381|11771847|FG004|STARTED|Part 2 - Third Intervention||3
10614161|NCT01928381|11771848|FG005|STARTED|Part 2 - Third Intervention||5
10614162|NCT01928381|11771849|FG006|STARTED|Part 2 - Third Intervention||5
10614163|NCT01928381|11771843|FG000|COMPLETED|Part 2 - Third Intervention||0
10614164|NCT01928381|11771844|FG001|COMPLETED|Part 2 - Third Intervention||5
10614165|NCT01928381|11771845|FG002|COMPLETED|Part 2 - Third Intervention||4
10614166|NCT01928381|11771846|FG003|COMPLETED|Part 2 - Third Intervention||4
10614167|NCT01928381|11771847|FG004|COMPLETED|Part 2 - Third Intervention||3
10614168|NCT01928381|11771848|FG005|COMPLETED|Part 2 - Third Intervention||5
10614169|NCT01928381|11771849|FG006|COMPLETED|Part 2 - Third Intervention||5
10614170|NCT01928381|11771843|FG000|NOT COMPLETED|Part 2 - Third Intervention||0
10614171|NCT01928381|11771844|FG001|NOT COMPLETED|Part 2 - Third Intervention||0
10614172|NCT01928381|11771845|FG002|NOT COMPLETED|Part 2 - Third Intervention||0
10614173|NCT01928381|11771846|FG003|NOT COMPLETED|Part 2 - Third Intervention||0
10614174|NCT01928381|11771847|FG004|NOT COMPLETED|Part 2 - Third Intervention||0
10614175|NCT01928381|11771848|FG005|NOT COMPLETED|Part 2 - Third Intervention||0
10614176|NCT01928381|11771849|FG006|NOT COMPLETED|Part 2 - Third Intervention||0
10614177|NCT01928381|11771843|FG000|STARTED|Part 2 - Post Third Intervention||0
10614178|NCT01928381|11771844|FG001|STARTED|Part 2 - Post Third Intervention||5
10614179|NCT01928381|11771845|FG002|STARTED|Part 2 - Post Third Intervention||4
10614180|NCT01928381|11771846|FG003|STARTED|Part 2 - Post Third Intervention||4
10614181|NCT01928381|11771847|FG004|STARTED|Part 2 - Post Third Intervention||3
10614182|NCT01928381|11771848|FG005|STARTED|Part 2 - Post Third Intervention||5
10614183|NCT01928381|11771849|FG006|STARTED|Part 2 - Post Third Intervention||5
10614184|NCT01928381|11771843|FG000|COMPLETED|Part 2 - Post Third Intervention||0
10614185|NCT01928381|11771844|FG001|COMPLETED|Part 2 - Post Third Intervention||5
10614186|NCT01928381|11771845|FG002|COMPLETED|Part 2 - Post Third Intervention||3
10614187|NCT01928381|11771846|FG003|COMPLETED|Part 2 - Post Third Intervention||4
10614188|NCT01928381|11771847|FG004|COMPLETED|Part 2 - Post Third Intervention||3
10614189|NCT01928381|11771848|FG005|COMPLETED|Part 2 - Post Third Intervention||5
10614190|NCT01928381|11771849|FG006|COMPLETED|Part 2 - Post Third Intervention||5
10614191|NCT01928381|11771843|FG000|NOT COMPLETED|Part 2 - Post Third Intervention||0
10614192|NCT01928381|11771844|FG001|NOT COMPLETED|Part 2 - Post Third Intervention||0
10614193|NCT01928381|11771845|FG002|NOT COMPLETED|Part 2 - Post Third Intervention||1
10614194|NCT01928381|11771846|FG003|NOT COMPLETED|Part 2 - Post Third Intervention||0
10614195|NCT01928381|11771847|FG004|NOT COMPLETED|Part 2 - Post Third Intervention||0
10614196|NCT01928381|11771848|FG005|NOT COMPLETED|Part 2 - Post Third Intervention||0
10614197|NCT01928381|11771849|FG006|NOT COMPLETED|Part 2 - Post Third Intervention||0
10614198|NCT01928433|11771862|FG000|STARTED|Overall Study||76
10614199|NCT01928433|11771863|FG001|STARTED|Overall Study||75
10614200|NCT01928433|11771864|FG002|STARTED|Overall Study||74
10614201|NCT01928433|11771862|FG000|COMPLETED|Overall Study||56
10614202|NCT01928433|11771863|FG001|COMPLETED|Overall Study||54
10614203|NCT01928433|11771864|FG002|COMPLETED|Overall Study||46
10614204|NCT01928433|11771862|FG000|NOT COMPLETED|Overall Study||20
10614205|NCT01928433|11771863|FG001|NOT COMPLETED|Overall Study||21
10614206|NCT01928433|11771864|FG002|NOT COMPLETED|Overall Study||28
10614207|NCT01928446|11771877|FG000|STARTED|Overall Study||255
10614208|NCT01928446|11771878|FG001|STARTED|Overall Study||264
10614209|NCT01928446|11771877|FG000|COMPLETED|Overall Study|39 subjects stopped study drug but continued with followup|144
10614210|NCT01928446|11771878|FG001|COMPLETED|Overall Study|23 subjects stopped study drug but continued with followup|125
10614211|NCT01928446|11771877|FG000|NOT COMPLETED|Overall Study||111
10614212|NCT01928446|11771878|FG001|NOT COMPLETED|Overall Study||139
10614213|NCT01928472|11771890|FG000|STARTED|Overall Study||98
10614214|NCT01928472|11771891|FG001|STARTED|Overall Study||104
10614215|NCT01928472|11771892|FG002|STARTED|Overall Study||98
10614216|NCT01928472|11771893|FG003|STARTED|Overall Study||102
10614217|NCT01928472|11771890|FG000|COMPLETED|Overall Study||90
10614218|NCT01928472|11771891|FG001|COMPLETED|Overall Study||96
10614219|NCT01928472|11771892|FG002|COMPLETED|Overall Study||91
10614220|NCT01928472|11771893|FG003|COMPLETED|Overall Study||100
10614221|NCT01928472|11771890|FG000|NOT COMPLETED|Overall Study||8
10614222|NCT01928472|11771891|FG001|NOT COMPLETED|Overall Study||8
10614223|NCT01928472|11771892|FG002|NOT COMPLETED|Overall Study||7
10614224|NCT01928472|11771893|FG003|NOT COMPLETED|Overall Study||2
10614225|NCT01928485|11771906|FG000|STARTED|Overall Study||4
10614226|NCT01928485|11771907|FG001|STARTED|Overall Study||2
10614227|NCT01928485|11771906|FG000|COMPLETED|Overall Study||4
10614228|NCT01928485|11771907|FG001|COMPLETED|Overall Study||1
10614229|NCT01928485|11771906|FG000|NOT COMPLETED|Overall Study||0
10614230|NCT01928485|11771907|FG001|NOT COMPLETED|Overall Study||1
10614231|NCT01928524|11771920|FG000|STARTED|Overall Study||3
10614232|NCT01928524|11771921|FG001|STARTED|Overall Study||3
10614233|NCT01928524|11771922|FG002|STARTED|Overall Study||6
10614234|NCT01928524|11771923|FG003|STARTED|Overall Study||6
10614235|NCT01928524|11771924|FG004|STARTED|Overall Study||3
10614236|NCT01928524|11771925|FG005|STARTED|Overall Study||8
10614237|NCT01928524|11771926|FG006|STARTED|Overall Study||5
10614238|NCT01928524|11771920|FG000|COMPLETED|Overall Study||3
10614239|NCT01928524|11771921|FG001|COMPLETED|Overall Study||3
10614240|NCT01928524|11771922|FG002|COMPLETED|Overall Study||6
10614241|NCT01928524|11771923|FG003|COMPLETED|Overall Study||6
10614242|NCT01928524|11771924|FG004|COMPLETED|Overall Study||3
10614243|NCT01928524|11771925|FG005|COMPLETED|Overall Study||8
10614244|NCT01928524|11771926|FG006|COMPLETED|Overall Study||5
10614245|NCT01928524|11771920|FG000|NOT COMPLETED|Overall Study||0
10614246|NCT01928524|11771921|FG001|NOT COMPLETED|Overall Study||0
10614247|NCT01928524|11771922|FG002|NOT COMPLETED|Overall Study||0
10614248|NCT01928524|11771923|FG003|NOT COMPLETED|Overall Study||0
10614249|NCT01928524|11771924|FG004|NOT COMPLETED|Overall Study||0
10614250|NCT01928524|11771925|FG005|NOT COMPLETED|Overall Study||0
10614251|NCT01928524|11771926|FG006|NOT COMPLETED|Overall Study||0
10614252|NCT01928680|11771942|FG000|STARTED|Overall Study||33
10614253|NCT01928680|11771942|FG000|COMPLETED|Overall Study||33
10614254|NCT01928680|11771942|FG000|NOT COMPLETED|Overall Study||0
10614255|NCT01928693|11771949|FG000|STARTED|Overall Study||0
10614256|NCT01928693|11771950|FG001|STARTED|Overall Study||1
10614257|NCT01928693|11771951|FG002|STARTED|Overall Study||1
10614258|NCT01928693|11771949|FG000|COMPLETED|Overall Study||0
10614259|NCT01928693|11771950|FG001|COMPLETED|Overall Study||1
10614260|NCT01928693|11771951|FG002|COMPLETED|Overall Study||1
10614261|NCT01928693|11771949|FG000|NOT COMPLETED|Overall Study||0
10614262|NCT01928693|11771950|FG001|NOT COMPLETED|Overall Study||0
10614263|NCT01928693|11771951|FG002|NOT COMPLETED|Overall Study||0
10614264|NCT01928719|11771961|FG000|STARTED|Overall Study||122
10614265|NCT01928719|11771962|FG001|STARTED|Overall Study||123
10614266|NCT01928719|11771961|FG000|COMPLETED|Overall Study||70
10614267|NCT01928719|11771962|FG001|COMPLETED|Overall Study||104
10614268|NCT01928719|11771961|FG000|NOT COMPLETED|Overall Study||52
10614269|NCT01928719|11771962|FG001|NOT COMPLETED|Overall Study||19
10614270|NCT01928758|11771972|FG000|STARTED|Overall Study||94
10614271|NCT01928758|11771973|FG001|STARTED|Overall Study||94
10614272|NCT01928758|11771972|FG000|COMPLETED|Overall Study||69
10614273|NCT01928758|11771973|FG001|COMPLETED|Overall Study||74
10614274|NCT01928758|11771972|FG000|NOT COMPLETED|Overall Study||25
10614275|NCT01928758|11771973|FG001|NOT COMPLETED|Overall Study||20
10614276|NCT01928771|11771983|FG000|STARTED|Overall Study||400
10614277|NCT01928771|11771984|FG001|STARTED|Overall Study||398
10704761|NCT02982954|11869124|FG003|NOT COMPLETED|Treatment Period||25
10704762|NCT02982954|11869121|FG000|STARTED|Continuing in Study||106
10704763|NCT02982954|11869122|FG001|STARTED|Continuing in Study||52
10704764|NCT02982954|11869123|FG002|STARTED|Continuing in Study||28
10704765|NCT02982954|11869124|FG003|STARTED|Continuing in Study||25
10704766|NCT02982954|11869121|FG000|COMPLETED|Continuing in Study||52
10704767|NCT02982954|11869122|FG001|COMPLETED|Continuing in Study||19
10704768|NCT02982954|11869123|FG002|COMPLETED|Continuing in Study||17
10704769|NCT02982954|11869124|FG003|COMPLETED|Continuing in Study||7
10614278|NCT01928771|11771985|FG002|STARTED|Overall Study||407
10614279|NCT01928771|11771983|FG000|Received Treatment|Overall Study||399
10614280|NCT01928771|11771984|FG001|Received Treatment|Overall Study||398
10614281|NCT01928771|11771985|FG002|Received Treatment|Overall Study||407
10614282|NCT01928771|11771983|FG000|COMPLETED|Overall Study||354
10614283|NCT01928771|11771984|FG001|COMPLETED|Overall Study||358
10614284|NCT01928771|11771985|FG002|COMPLETED|Overall Study||367
10614285|NCT01928771|11771983|FG000|NOT COMPLETED|Overall Study||46
10614286|NCT01928771|11771984|FG001|NOT COMPLETED|Overall Study||40
10614287|NCT01928771|11771985|FG002|NOT COMPLETED|Overall Study||40
10614288|NCT01928797|11771995|FG000|STARTED|Overall Study||30
10614289|NCT01928797|11771996|FG001|STARTED|Overall Study||30
10614290|NCT01928797|11771995|FG000|COMPLETED|Overall Study||30
10614291|NCT01928797|11771996|FG001|COMPLETED|Overall Study||30
10614292|NCT01928797|11771995|FG000|NOT COMPLETED|Overall Study||0
10614293|NCT01928797|11771996|FG001|NOT COMPLETED|Overall Study||0
10614294|NCT01928849|11772006|FG000|STARTED|Overall Study||66
10614295|NCT01928849|11772007|FG001|STARTED|Overall Study||62
10614296|NCT01928849|11772006|FG000|COMPLETED|Overall Study||52
10614297|NCT01928849|11772007|FG001|COMPLETED|Overall Study||55
10614298|NCT01928849|11772006|FG000|NOT COMPLETED|Overall Study||14
10614299|NCT01928849|11772007|FG001|NOT COMPLETED|Overall Study||7
10614300|NCT01928862|11772018|FG000|STARTED|Overall Study||16
10614301|NCT01928862|11772019|FG001|STARTED|Overall Study||16
10614302|NCT01928862|11772020|FG002|STARTED|Overall Study||16
10614303|NCT01928862|11772021|FG003|STARTED|Overall Study||16
10614304|NCT01928862|11772022|FG004|STARTED|Overall Study||14
10614305|NCT01928862|11772018|FG000|COMPLETED|Overall Study||15
10614306|NCT01928862|11772019|FG001|COMPLETED|Overall Study||16
10614307|NCT01928862|11772020|FG002|COMPLETED|Overall Study||16
10614308|NCT01928862|11772021|FG003|COMPLETED|Overall Study||16
10614309|NCT01928862|11772022|FG004|COMPLETED|Overall Study||13
10614310|NCT01928862|11772018|FG000|NOT COMPLETED|Overall Study||1
10614311|NCT01928862|11772019|FG001|NOT COMPLETED|Overall Study||0
10614312|NCT01928862|11772020|FG002|NOT COMPLETED|Overall Study||0
10614313|NCT01928862|11772021|FG003|NOT COMPLETED|Overall Study||0
10614314|NCT01928862|11772022|FG004|NOT COMPLETED|Overall Study||1
10614315|NCT01928927|11772037|FG000|STARTED|Overall Study||29
10614316|NCT01928927|11772038|FG001|STARTED|Overall Study||15
10614317|NCT01928927|11772037|FG000|COMPLETED|Overall Study||27
10614318|NCT01928927|11772038|FG001|COMPLETED|Overall Study||14
10614319|NCT01928927|11772037|FG000|NOT COMPLETED|Overall Study||2
10614320|NCT01928927|11772038|FG001|NOT COMPLETED|Overall Study||1
10614321|NCT01928940|11772050|FG000|STARTED|Overall Study||6
10614322|NCT01928940|11772051|FG001|STARTED|Overall Study||6
10614323|NCT01928940|11772050|FG000|COMPLETED|Overall Study||6
10614324|NCT01928940|11772051|FG001|COMPLETED|Overall Study||5
10614325|NCT01928940|11772050|FG000|NOT COMPLETED|Overall Study||0
10614326|NCT01928940|11772051|FG001|NOT COMPLETED|Overall Study||1
10614327|NCT01929018|11772060|FG000|STARTED|Overall Study||19
10614328|NCT01929018|11772061|FG001|STARTED|Overall Study||19
10614329|NCT01929018|11772060|FG000|COMPLETED|Overall Study||18
10614330|NCT01929018|11772061|FG001|COMPLETED|Overall Study||18
10614331|NCT01929018|11772060|FG000|NOT COMPLETED|Overall Study||1
10614332|NCT01929018|11772061|FG001|NOT COMPLETED|Overall Study||1
10614333|NCT01929031|11772071|FG000|STARTED|Overall Study||213
10704770|NCT02982954|11869121|FG000|NOT COMPLETED|Continuing in Study||54
10614334|NCT01929031|11772072|FG001|STARTED|Overall Study||209
10704771|NCT02982954|11869122|FG001|NOT COMPLETED|Continuing in Study||33
10704772|NCT02982954|11869123|FG002|NOT COMPLETED|Continuing in Study||11
10614335|NCT01929031|11772073|FG002|STARTED|Overall Study||35
10614336|NCT01929031|11772074|FG003|STARTED|Overall Study||35
10614337|NCT01929031|11772075|FG004|STARTED|Overall Study||34
10614338|NCT01929031|11772076|FG005|STARTED|Overall Study||36
10614339|NCT01929031|11772071|FG000|COMPLETED|Overall Study||209
10614340|NCT01929031|11772072|FG001|COMPLETED|Overall Study||207
10614341|NCT01929031|11772073|FG002|COMPLETED|Overall Study||34
10614342|NCT01929031|11772074|FG003|COMPLETED|Overall Study||35
10614343|NCT01929031|11772075|FG004|COMPLETED|Overall Study||33
10614344|NCT01929031|11772076|FG005|COMPLETED|Overall Study||35
10614345|NCT01929031|11772071|FG000|NOT COMPLETED|Overall Study||4
10614346|NCT01929031|11772072|FG001|NOT COMPLETED|Overall Study||2
10614347|NCT01929031|11772073|FG002|NOT COMPLETED|Overall Study||1
10614348|NCT01929031|11772074|FG003|NOT COMPLETED|Overall Study||0
10614349|NCT01929031|11772075|FG004|NOT COMPLETED|Overall Study||1
10614350|NCT01929031|11772076|FG005|NOT COMPLETED|Overall Study||1
10614351|NCT01929044|11772088|FG000|STARTED|Overall Study||153
10614352|NCT01929044|11772089|FG001|STARTED|Overall Study||146
10614353|NCT01929044|11772088|FG000|COMPLETED|Overall Study||142
10614354|NCT01929044|11772089|FG001|COMPLETED|Overall Study||129
10614355|NCT01929044|11772088|FG000|NOT COMPLETED|Overall Study||11
10614356|NCT01929044|11772089|FG001|NOT COMPLETED|Overall Study||17
10614357|NCT01929057|11772097|FG000|STARTED|Overall Study||31
10614358|NCT01929057|11772098|FG001|STARTED|Overall Study||3
10614359|NCT01929057|11772097|FG000|COMPLETED|Overall Study||31
10614360|NCT01929057|11772098|FG001|COMPLETED|Overall Study||3
10614361|NCT01929057|11772097|FG000|NOT COMPLETED|Overall Study||0
10614362|NCT01929057|11772098|FG001|NOT COMPLETED|Overall Study||0
10614363|NCT01929083|11772106|FG000|STARTED|Intervention 1|Number of patients randomized to receive progesterone first|10
10614364|NCT01929083|11772107|FG001|STARTED|Intervention 1||9
10614365|NCT01929083|11772106|FG000|Returned for 1st Ibutilide Administratio|Intervention 1||7
10614366|NCT01929083|11772107|FG001|Returned for 1st Ibutilide Administratio|Intervention 1||9
10614367|NCT01929083|11772106|FG000|COMPLETED|Intervention 1||7
10614368|NCT01929083|11772107|FG001|COMPLETED|Intervention 1||9
10614369|NCT01929083|11772106|FG000|NOT COMPLETED|Intervention 1||3
10614370|NCT01929083|11772107|FG001|NOT COMPLETED|Intervention 1||0
10614371|NCT01929083|11772106|FG000|STARTED|Intervention 2||7
10614372|NCT01929083|11772107|FG001|STARTED|Intervention 2||9
10614373|NCT01929083|11772106|FG000|Returned for 2nd Ibutilide Administratio|Intervention 2||7
10614374|NCT01929083|11772107|FG001|Returned for 2nd Ibutilide Administratio|Intervention 2||8
10614375|NCT01929083|11772106|FG000|COMPLETED|Intervention 2||7
10614376|NCT01929083|11772107|FG001|COMPLETED|Intervention 2||8
10614377|NCT01929083|11772106|FG000|NOT COMPLETED|Intervention 2||0
10614378|NCT01929083|11772107|FG001|NOT COMPLETED|Intervention 2||1
10614379|NCT01929109|11772118|FG000|STARTED|Period 1 (All Groups)||14
10614380|NCT01929109|11772119|FG001|STARTED|Period 1 (All Groups)||8
10614381|NCT01929109|11772120|FG002|STARTED|Period 1 (All Groups)||9
10614382|NCT01929109|11772121|FG003|STARTED|Period 1 (All Groups)||8
10614383|NCT01929109|11772122|FG004|STARTED|Period 1 (All Groups)||8
10614384|NCT01929109|11772118|FG000|COMPLETED|Period 1 (All Groups)||14
10614385|NCT01929109|11772119|FG001|COMPLETED|Period 1 (All Groups)||8
10614386|NCT01929109|11772120|FG002|COMPLETED|Period 1 (All Groups)||8
10614387|NCT01929109|11772121|FG003|COMPLETED|Period 1 (All Groups)||8
10614388|NCT01929109|11772122|FG004|COMPLETED|Period 1 (All Groups)||8
10614389|NCT01929109|11772118|FG000|NOT COMPLETED|Period 1 (All Groups)||0
10614390|NCT01929109|11772119|FG001|NOT COMPLETED|Period 1 (All Groups)||0
10614391|NCT01929109|11772120|FG002|NOT COMPLETED|Period 1 (All Groups)||1
10614392|NCT01929109|11772121|FG003|NOT COMPLETED|Period 1 (All Groups)||0
10614393|NCT01929109|11772122|FG004|NOT COMPLETED|Period 1 (All Groups)||0
10614394|NCT01929109|11772118|FG000|STARTED|Period 2 (End Stage Renal Disease Only)||0
10614395|NCT01929109|11772119|FG001|STARTED|Period 2 (End Stage Renal Disease Only)||0
10614396|NCT01929109|11772120|FG002|STARTED|Period 2 (End Stage Renal Disease Only)||0
10614397|NCT01929109|11772121|FG003|STARTED|Period 2 (End Stage Renal Disease Only)||0
10614398|NCT01929109|11772122|FG004|STARTED|Period 2 (End Stage Renal Disease Only)||8
10614399|NCT01929109|11772118|FG000|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
10614400|NCT01929109|11772119|FG001|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
10614401|NCT01929109|11772120|FG002|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
10614402|NCT01929109|11772121|FG003|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
10614403|NCT01929109|11772122|FG004|COMPLETED|Period 2 (End Stage Renal Disease Only)||8
10614404|NCT01929109|11772118|FG000|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
10614405|NCT01929109|11772119|FG001|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
10614406|NCT01929109|11772120|FG002|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
10614407|NCT01929109|11772121|FG003|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
10614408|NCT01929109|11772122|FG004|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
10614409|NCT01929135|11772139|FG000|STARTED|Overall Study||19
10614410|NCT01929135|11772140|FG001|STARTED|Overall Study||19
10614411|NCT01929135|11772139|FG000|COMPLETED|Overall Study||18
10614412|NCT01929135|11772140|FG001|COMPLETED|Overall Study||18
10614413|NCT01929135|11772139|FG000|NOT COMPLETED|Overall Study||1
10614414|NCT01929135|11772140|FG001|NOT COMPLETED|Overall Study||1
10614415|NCT01929226|11772150|FG000|STARTED|Overall Study||210
10614416|NCT01929226|11772151|FG001|STARTED|Overall Study||70
10704773|NCT02982954|11869124|FG003|NOT COMPLETED|Continuing in Study||18
10614417|NCT01929226|11772150|FG000|COMPLETED|Overall Study||205
10614418|NCT01929226|11772151|FG001|COMPLETED|Overall Study||69
10614419|NCT01929226|11772150|FG000|NOT COMPLETED|Overall Study||5
10614420|NCT01929226|11772151|FG001|NOT COMPLETED|Overall Study||1
10614421|NCT01929291|11772158|FG000|STARTED|Overall Study||672
10614422|NCT01929291|11772158|FG000|COMPLETED|Overall Study||672
10614423|NCT01929291|11772158|FG000|NOT COMPLETED|Overall Study||0
10614424|NCT01929317|11772164|FG000|STARTED|Dose Increase Effect Verification Phase||61
10614425|NCT01929317|11772165|FG001|STARTED|Dose Increase Effect Verification Phase||20
10614426|NCT01929317|11772164|FG000|COMPLETED|Dose Increase Effect Verification Phase||52
10614427|NCT01929317|11772165|FG001|COMPLETED|Dose Increase Effect Verification Phase||19
10614428|NCT01929317|11772164|FG000|NOT COMPLETED|Dose Increase Effect Verification Phase||9
10614429|NCT01929317|11772165|FG001|NOT COMPLETED|Dose Increase Effect Verification Phase||1
10614430|NCT01929317|11772164|FG000|STARTED|Long-term Phase||44
10614431|NCT01929317|11772165|FG001|STARTED|Long-term Phase||18
10614432|NCT01929317|11772164|FG000|COMPLETED|Long-term Phase||25
10614433|NCT01929317|11772165|FG001|COMPLETED|Long-term Phase||14
10614434|NCT01929317|11772164|FG000|NOT COMPLETED|Long-term Phase||19
10614435|NCT01929317|11772165|FG001|NOT COMPLETED|Long-term Phase||4
10614436|NCT01929343|11772180|FG000|STARTED|Overall Study||12
10614437|NCT01929343|11772181|FG001|STARTED|Overall Study||9
10704798|NCT02727699|11869171|FG000|STARTED|Overall Study||91
10704799|NCT02727699|11869172|FG001|STARTED|Overall Study||94
10704800|NCT02727699|11869171|FG000|COMPLETED|Overall Study||82
10704801|NCT02727699|11869172|FG001|COMPLETED|Overall Study||89
10704802|NCT02727699|11869171|FG000|NOT COMPLETED|Overall Study||9
10704803|NCT02727699|11869172|FG001|NOT COMPLETED|Overall Study||5
10704804|NCT02429375|11869181|FG000|STARTED|Overall Study||3
10614438|NCT01929343|11772182|FG002|STARTED|Overall Study||12
10614439|NCT01929343|11772180|FG000|COMPLETED|Overall Study||11
10614440|NCT01929343|11772181|FG001|COMPLETED|Overall Study||7
10614441|NCT01929343|11772182|FG002|COMPLETED|Overall Study||12
10614442|NCT01929343|11772180|FG000|NOT COMPLETED|Overall Study||1
10614443|NCT01929343|11772181|FG001|NOT COMPLETED|Overall Study||2
10614444|NCT01929343|11772182|FG002|NOT COMPLETED|Overall Study||0
10614445|NCT01929395|11772193|FG000|STARTED|Overall Study||19
10614446|NCT01929395|11772194|FG001|STARTED|Overall Study||70
10614447|NCT01929395|11772195|FG002|STARTED|Overall Study||70
10614448|NCT01929395|11772193|FG000|COMPLETED|Overall Study||18
10614449|NCT01929395|11772194|FG001|COMPLETED|Overall Study||69
10614450|NCT01929395|11772195|FG002|COMPLETED|Overall Study||69
10614451|NCT01929395|11772193|FG000|NOT COMPLETED|Overall Study||1
10614452|NCT01929395|11772194|FG001|NOT COMPLETED|Overall Study||1
10614453|NCT01929395|11772195|FG002|NOT COMPLETED|Overall Study||1
10614454|NCT01929408|11772203|FG000|STARTED|Overall Study||703
10614455|NCT01929408|11772203|FG000|COMPLETED|Overall Study||695
10614456|NCT01929408|11772203|FG000|NOT COMPLETED|Overall Study||8
10614457|NCT01929460|11772209|FG000|STARTED|Overall Study||13
10614458|NCT01929460|11772210|FG001|STARTED|Overall Study||13
10614459|NCT01929460|11772209|FG000|COMPLETED|Overall Study||13
10614460|NCT01929460|11772210|FG001|COMPLETED|Overall Study||13
10614461|NCT01929460|11772209|FG000|NOT COMPLETED|Overall Study||0
10614462|NCT01929460|11772210|FG001|NOT COMPLETED|Overall Study||0
10614463|NCT01929473|11772216|FG000|STARTED|Overall Study|0 day|3830
10614464|NCT01929473|11772216|FG000|365 Day|Overall Study||3589
10614465|NCT01929473|11772216|FG000|COMPLETED|Overall Study||3243
10704805|NCT02429375|11869182|FG001|STARTED|Overall Study||3
10704806|NCT02429375|11869183|FG002|STARTED|Overall Study||1
10704807|NCT02429375|11869181|FG000|COMPLETED|Overall Study||3
10704808|NCT02429375|11869182|FG001|COMPLETED|Overall Study||3
10704809|NCT02429375|11869183|FG002|COMPLETED|Overall Study||1
10614466|NCT01929473|11772216|FG000|NOT COMPLETED|Overall Study||587
10614467|NCT01929642|11772220|FG000|STARTED|Overall Study||3
10704810|NCT02429375|11869181|FG000|NOT COMPLETED|Overall Study||0
10614468|NCT01929642|11772220|FG000|COMPLETED|Overall Study||1
10614469|NCT01929642|11772220|FG000|NOT COMPLETED|Overall Study||2
10614470|NCT01929681|11772228|FG000|STARTED|Overall Study||28
10614471|NCT01929681|11772229|FG001|STARTED|Overall Study||25
10614472|NCT01929681|11772228|FG000|COMPLETED|Overall Study||26
10614473|NCT01929681|11772229|FG001|COMPLETED|Overall Study||24
10614474|NCT01929681|11772228|FG000|NOT COMPLETED|Overall Study||2
10614475|NCT01929681|11772229|FG001|NOT COMPLETED|Overall Study||1
10614476|NCT01929707|11772235|FG000|STARTED|Intervention Period 1||6
10614477|NCT01929707|11772236|FG001|STARTED|Intervention Period 1||8
10614478|NCT01929707|11772237|FG002|STARTED|Intervention Period 1||12
10614479|NCT01929707|11772238|FG003|STARTED|Intervention Period 1||10
10614480|NCT01929707|11772239|FG004|STARTED|Intervention Period 1||0
10614481|NCT01929707|11772240|FG005|STARTED|Intervention Period 1||0
10614482|NCT01929707|11772241|FG006|STARTED|Intervention Period 1||0
10614483|NCT01929707|11772242|FG007|STARTED|Intervention Period 1||0
10614484|NCT01929707|11772235|FG000|Received at Least 1 Dose of Study Drug|Intervention Period 1||6
10614485|NCT01929707|11772236|FG001|Received at Least 1 Dose of Study Drug|Intervention Period 1||8
10614486|NCT01929707|11772237|FG002|Received at Least 1 Dose of Study Drug|Intervention Period 1||12
10614487|NCT01929707|11772238|FG003|Received at Least 1 Dose of Study Drug|Intervention Period 1||10
10614488|NCT01929707|11772239|FG004|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
10614489|NCT01929707|11772240|FG005|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
10614490|NCT01929707|11772241|FG006|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
10614491|NCT01929707|11772242|FG007|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
10614492|NCT01929707|11772235|FG000|COMPLETED|Intervention Period 1||6
10614493|NCT01929707|11772236|FG001|COMPLETED|Intervention Period 1||8
10614494|NCT01929707|11772237|FG002|COMPLETED|Intervention Period 1||12
10614495|NCT01929707|11772238|FG003|COMPLETED|Intervention Period 1|Two discontinued participants were replaced in Period 2|7
10614496|NCT01929707|11772239|FG004|COMPLETED|Intervention Period 1||0
10614497|NCT01929707|11772240|FG005|COMPLETED|Intervention Period 1||0
10614498|NCT01929707|11772241|FG006|COMPLETED|Intervention Period 1||0
10614499|NCT01929707|11772242|FG007|COMPLETED|Intervention Period 1||0
10614500|NCT01929707|11772235|FG000|NOT COMPLETED|Intervention Period 1||0
10614501|NCT01929707|11772236|FG001|NOT COMPLETED|Intervention Period 1||0
10614502|NCT01929707|11772237|FG002|NOT COMPLETED|Intervention Period 1||0
10614503|NCT01929707|11772238|FG003|NOT COMPLETED|Intervention Period 1||3
10614504|NCT01929707|11772239|FG004|NOT COMPLETED|Intervention Period 1||0
10614505|NCT01929707|11772240|FG005|NOT COMPLETED|Intervention Period 1||0
10614506|NCT01929707|11772241|FG006|NOT COMPLETED|Intervention Period 1||0
10614507|NCT01929707|11772242|FG007|NOT COMPLETED|Intervention Period 1||0
10614508|NCT01929707|11772235|FG000|STARTED|Washout Period ≥7 Days||6
10614509|NCT01929707|11772236|FG001|STARTED|Washout Period ≥7 Days||8
10614510|NCT01929707|11772237|FG002|STARTED|Washout Period ≥7 Days||12
10614511|NCT01929707|11772238|FG003|STARTED|Washout Period ≥7 Days||7
10614512|NCT01929707|11772239|FG004|STARTED|Washout Period ≥7 Days||0
10614513|NCT01929707|11772240|FG005|STARTED|Washout Period ≥7 Days||0
10614514|NCT01929707|11772241|FG006|STARTED|Washout Period ≥7 Days||0
10614515|NCT01929707|11772242|FG007|STARTED|Washout Period ≥7 Days||0
10614516|NCT01929707|11772235|FG000|COMPLETED|Washout Period ≥7 Days||6
10614517|NCT01929707|11772236|FG001|COMPLETED|Washout Period ≥7 Days||8
10614518|NCT01929707|11772237|FG002|COMPLETED|Washout Period ≥7 Days||12
10614519|NCT01929707|11772238|FG003|COMPLETED|Washout Period ≥7 Days||7
10614520|NCT01929707|11772239|FG004|COMPLETED|Washout Period ≥7 Days||0
10614521|NCT01929707|11772240|FG005|COMPLETED|Washout Period ≥7 Days||0
10614522|NCT01929707|11772241|FG006|COMPLETED|Washout Period ≥7 Days||0
10614523|NCT01929707|11772242|FG007|COMPLETED|Washout Period ≥7 Days||0
10614524|NCT01929707|11772235|FG000|NOT COMPLETED|Washout Period ≥7 Days||0
10614525|NCT01929707|11772236|FG001|NOT COMPLETED|Washout Period ≥7 Days||0
10614526|NCT01929707|11772237|FG002|NOT COMPLETED|Washout Period ≥7 Days||0
10614527|NCT01929707|11772238|FG003|NOT COMPLETED|Washout Period ≥7 Days||0
10614528|NCT01929707|11772239|FG004|NOT COMPLETED|Washout Period ≥7 Days||0
10614529|NCT01929707|11772240|FG005|NOT COMPLETED|Washout Period ≥7 Days||0
10614530|NCT01929707|11772241|FG006|NOT COMPLETED|Washout Period ≥7 Days||0
10614531|NCT01929707|11772242|FG007|NOT COMPLETED|Washout Period ≥7 Days||0
10614532|NCT01929707|11772235|FG000|STARTED|Intervention Period 2|Incomplete-crossover design|0
10614533|NCT01929707|11772236|FG001|STARTED|Intervention Period 2|Incomplete-crossover design|0
10614534|NCT01929707|11772237|FG002|STARTED|Intervention Period 2|Incomplete-crossover design|0
10614535|NCT01929707|11772238|FG003|STARTED|Intervention Period 2|Incomplete-crossover design|5
10614536|NCT01929707|11772239|FG004|STARTED|Intervention Period 2|Incomplete-crossover design|6
10614537|NCT01929707|11772240|FG005|STARTED|Intervention Period 2|Incomplete-crossover design|8
10614538|NCT01929707|11772241|FG006|STARTED|Intervention Period 2|Incomplete-crossover design|12
10614539|NCT01929707|11772242|FG007|STARTED|Intervention Period 2|Incomplete-crossover design|4
10614540|NCT01929707|11772235|FG000|COMPLETED|Intervention Period 2||0
10614541|NCT01929707|11772236|FG001|COMPLETED|Intervention Period 2||0
10614542|NCT01929707|11772237|FG002|COMPLETED|Intervention Period 2||0
10614543|NCT01929707|11772238|FG003|COMPLETED|Intervention Period 2||5
10614544|NCT01929707|11772239|FG004|COMPLETED|Intervention Period 2||6
10614545|NCT01929707|11772240|FG005|COMPLETED|Intervention Period 2||6
10614546|NCT01929707|11772241|FG006|COMPLETED|Intervention Period 2||12
10614547|NCT01929707|11772242|FG007|COMPLETED|Intervention Period 2||4
10614548|NCT01929707|11772235|FG000|NOT COMPLETED|Intervention Period 2||0
10614549|NCT01929707|11772236|FG001|NOT COMPLETED|Intervention Period 2||0
10614550|NCT01929707|11772237|FG002|NOT COMPLETED|Intervention Period 2||0
10614551|NCT01929707|11772238|FG003|NOT COMPLETED|Intervention Period 2||0
10614552|NCT01929707|11772239|FG004|NOT COMPLETED|Intervention Period 2||0
10614553|NCT01929707|11772240|FG005|NOT COMPLETED|Intervention Period 2||2
10614554|NCT01929707|11772241|FG006|NOT COMPLETED|Intervention Period 2||0
10614555|NCT01929707|11772242|FG007|NOT COMPLETED|Intervention Period 2||0
10614556|NCT01929759|11772263|FG000|STARTED|Overall Study||10
10614557|NCT01929759|11772263|FG000|COMPLETED|Overall Study||10
10614558|NCT01929759|11772263|FG000|NOT COMPLETED|Overall Study||0
10614559|NCT01929863|11772267|FG000|STARTED|Period 1:Intervention Period 1 (7 Days)||7
10614560|NCT01929863|11772268|FG001|STARTED|Period 1:Intervention Period 1 (7 Days)||8
10614561|NCT01929863|11772267|FG000|COMPLETED|Period 1:Intervention Period 1 (7 Days)||6
10614562|NCT01929863|11772268|FG001|COMPLETED|Period 1:Intervention Period 1 (7 Days)||7
10614563|NCT01929863|11772267|FG000|NOT COMPLETED|Period 1:Intervention Period 1 (7 Days)||1
10614564|NCT01929863|11772268|FG001|NOT COMPLETED|Period 1:Intervention Period 1 (7 Days)||1
10614565|NCT01929863|11772267|FG000|STARTED|Period 2:Washout Period (13-15 Days)||6
10614566|NCT01929863|11772268|FG001|STARTED|Period 2:Washout Period (13-15 Days)||7
10614567|NCT01929863|11772267|FG000|COMPLETED|Period 2:Washout Period (13-15 Days)||6
10614568|NCT01929863|11772268|FG001|COMPLETED|Period 2:Washout Period (13-15 Days)||7
10614569|NCT01929863|11772267|FG000|NOT COMPLETED|Period 2:Washout Period (13-15 Days)||0
10614570|NCT01929863|11772268|FG001|NOT COMPLETED|Period 2:Washout Period (13-15 Days)||0
10614571|NCT01929863|11772267|FG000|STARTED|Period 3:Intervention Period 2 (7 Days)||6
10614572|NCT01929863|11772268|FG001|STARTED|Period 3:Intervention Period 2 (7 Days)||7
10614573|NCT01929863|11772267|FG000|COMPLETED|Period 3:Intervention Period 2 (7 Days)||6
10614574|NCT01929863|11772268|FG001|COMPLETED|Period 3:Intervention Period 2 (7 Days)||6
10614575|NCT01929863|11772267|FG000|NOT COMPLETED|Period 3:Intervention Period 2 (7 Days)||0
10614576|NCT01929863|11772268|FG001|NOT COMPLETED|Period 3:Intervention Period 2 (7 Days)||1
10614577|NCT01929863|11772267|FG000|STARTED|Period 4:Follow-up-Metformin (7-10 Days)||6
10614578|NCT01929863|11772268|FG001|STARTED|Period 4:Follow-up-Metformin (7-10 Days)||6
10614579|NCT01929863|11772267|FG000|COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||0
10614580|NCT01929863|11772268|FG001|COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||0
10614581|NCT01929863|11772267|FG000|NOT COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||6
10614582|NCT01929863|11772268|FG001|NOT COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||6
10614583|NCT01929876|11772279|FG000|STARTED|Period 1||16
10614584|NCT01929876|11772279|FG000|COMPLETED|Period 1||16
10614585|NCT01929876|11772279|FG000|NOT COMPLETED|Period 1||0
10614586|NCT01929876|11772279|FG000|STARTED|Period 2||16
10614587|NCT01929876|11772279|FG000|COMPLETED|Period 2||15
10614588|NCT01929876|11772279|FG000|NOT COMPLETED|Period 2||1
10614589|NCT01929889|11772283|FG000|STARTED|Overall Study|Target enrollment goal was 20 completed subjects.|8
10614590|NCT01929889|11772283|FG000|COMPLETED|Overall Study|3 subjects completed the study.|3
10614591|NCT01929889|11772283|FG000|NOT COMPLETED|Overall Study||5
10614592|NCT01929980|11772287|FG000|STARTED|Overall Study||4
10614593|NCT01929980|11772287|FG000|COMPLETED|Overall Study||3
10614594|NCT01929980|11772287|FG000|NOT COMPLETED|Overall Study||1
10614595|NCT01929993|11772293|FG000|STARTED|Overall Study||82
10614596|NCT01929993|11772294|FG001|STARTED|Overall Study||82
10614597|NCT01929993|11772293|FG000|COMPLETED|Overall Study||52
10614598|NCT01929993|11772294|FG001|COMPLETED|Overall Study||54
10614599|NCT01929993|11772293|FG000|NOT COMPLETED|Overall Study||30
10614600|NCT01929993|11772294|FG001|NOT COMPLETED|Overall Study||28
10614601|NCT01930045|11772300|FG000|STARTED|Part 1 - Period 1||3
10614602|NCT01930045|11772301|FG001|STARTED|Part 1 - Period 1||3
10614603|NCT01930045|11772302|FG002|STARTED|Part 1 - Period 1||3
10614604|NCT01930045|11772303|FG003|STARTED|Part 1 - Period 1||3
10614605|NCT01930045|11772304|FG004|STARTED|Part 1 - Period 1||3
10614606|NCT01930045|11772305|FG005|STARTED|Part 1 - Period 1||3
10614607|NCT01930045|11772300|FG000|COMPLETED|Part 1 - Period 1||3
10614608|NCT01930045|11772301|FG001|COMPLETED|Part 1 - Period 1||3
10614609|NCT01930045|11772302|FG002|COMPLETED|Part 1 - Period 1||3
10614610|NCT01930045|11772303|FG003|COMPLETED|Part 1 - Period 1||3
10614611|NCT01930045|11772304|FG004|COMPLETED|Part 1 - Period 1||3
10614612|NCT01930045|11772305|FG005|COMPLETED|Part 1 - Period 1||3
10614613|NCT01930045|11772300|FG000|NOT COMPLETED|Part 1 - Period 1||0
10614614|NCT01930045|11772301|FG001|NOT COMPLETED|Part 1 - Period 1||0
10614615|NCT01930045|11772302|FG002|NOT COMPLETED|Part 1 - Period 1||0
10614616|NCT01930045|11772303|FG003|NOT COMPLETED|Part 1 - Period 1||0
10614617|NCT01930045|11772304|FG004|NOT COMPLETED|Part 1 - Period 1||0
10614618|NCT01930045|11772305|FG005|NOT COMPLETED|Part 1 - Period 1||0
10614619|NCT01930045|11772300|FG000|STARTED|Part 1 - Period 2||3
10614620|NCT01930045|11772301|FG001|STARTED|Part 1 - Period 2||3
10614621|NCT01930045|11772302|FG002|STARTED|Part 1 - Period 2||3
10614622|NCT01930045|11772303|FG003|STARTED|Part 1 - Period 2||3
10614623|NCT01930045|11772304|FG004|STARTED|Part 1 - Period 2||3
10614624|NCT01930045|11772305|FG005|STARTED|Part 1 - Period 2||3
10614625|NCT01930045|11772300|FG000|COMPLETED|Part 1 - Period 2||3
10614626|NCT01930045|11772301|FG001|COMPLETED|Part 1 - Period 2||3
10614627|NCT01930045|11772302|FG002|COMPLETED|Part 1 - Period 2||3
10614628|NCT01930045|11772303|FG003|COMPLETED|Part 1 - Period 2||3
10614629|NCT01930045|11772304|FG004|COMPLETED|Part 1 - Period 2||3
10614630|NCT01930045|11772305|FG005|COMPLETED|Part 1 - Period 2||3
10614631|NCT01930045|11772300|FG000|NOT COMPLETED|Part 1 - Period 2||0
10614632|NCT01930045|11772301|FG001|NOT COMPLETED|Part 1 - Period 2||0
10614633|NCT01930045|11772302|FG002|NOT COMPLETED|Part 1 - Period 2||0
10614634|NCT01930045|11772303|FG003|NOT COMPLETED|Part 1 - Period 2||0
10614635|NCT01930045|11772304|FG004|NOT COMPLETED|Part 1 - Period 2||0
10614636|NCT01930045|11772305|FG005|NOT COMPLETED|Part 1 - Period 2||0
10614637|NCT01930045|11772300|FG000|STARTED|Part 1 - Period 3||3
10614638|NCT01930045|11772301|FG001|STARTED|Part 1 - Period 3||3
10614639|NCT01930045|11772302|FG002|STARTED|Part 1 - Period 3|One participant missed treatment during Period 3 only.|2
10614640|NCT01930045|11772303|FG003|STARTED|Part 1 - Period 3||3
10614641|NCT01930045|11772304|FG004|STARTED|Part 1 - Period 3||3
10614642|NCT01930045|11772305|FG005|STARTED|Part 1 - Period 3||3
10614643|NCT01930045|11772300|FG000|COMPLETED|Part 1 - Period 3||3
10614644|NCT01930045|11772301|FG001|COMPLETED|Part 1 - Period 3||3
10614645|NCT01930045|11772302|FG002|COMPLETED|Part 1 - Period 3||2
10614646|NCT01930045|11772303|FG003|COMPLETED|Part 1 - Period 3||3
10614647|NCT01930045|11772304|FG004|COMPLETED|Part 1 - Period 3||3
10614648|NCT01930045|11772305|FG005|COMPLETED|Part 1 - Period 3||3
10614649|NCT01930045|11772300|FG000|NOT COMPLETED|Part 1 - Period 3||0
10614650|NCT01930045|11772301|FG001|NOT COMPLETED|Part 1 - Period 3||0
10614651|NCT01930045|11772302|FG002|NOT COMPLETED|Part 1 - Period 3||0
10614652|NCT01930045|11772303|FG003|NOT COMPLETED|Part 1 - Period 3||0
10614653|NCT01930045|11772304|FG004|NOT COMPLETED|Part 1 - Period 3||0
10614654|NCT01930045|11772305|FG005|NOT COMPLETED|Part 1 - Period 3||0
10614655|NCT01930045|11772300|FG000|STARTED|Pause (up to 37 Days)||3
10614656|NCT01930045|11772301|FG001|STARTED|Pause (up to 37 Days)||3
10614657|NCT01930045|11772302|FG002|STARTED|Pause (up to 37 Days)|The participant who missed treatment in Period 3, resumed the study|3
10614658|NCT01930045|11772303|FG003|STARTED|Pause (up to 37 Days)||3
10614659|NCT01930045|11772304|FG004|STARTED|Pause (up to 37 Days)||3
10614660|NCT01930045|11772305|FG005|STARTED|Pause (up to 37 Days)||3
10614661|NCT01930045|11772300|FG000|COMPLETED|Pause (up to 37 Days)||3
10614662|NCT01930045|11772301|FG001|COMPLETED|Pause (up to 37 Days)||3
10614663|NCT01930045|11772302|FG002|COMPLETED|Pause (up to 37 Days)||3
10614664|NCT01930045|11772303|FG003|COMPLETED|Pause (up to 37 Days)||3
10614665|NCT01930045|11772304|FG004|COMPLETED|Pause (up to 37 Days)||3
10614666|NCT01930045|11772305|FG005|COMPLETED|Pause (up to 37 Days)||1
10614667|NCT01930045|11772300|FG000|NOT COMPLETED|Pause (up to 37 Days)||0
10614668|NCT01930045|11772301|FG001|NOT COMPLETED|Pause (up to 37 Days)||0
10614669|NCT01930045|11772302|FG002|NOT COMPLETED|Pause (up to 37 Days)||0
10614670|NCT01930045|11772303|FG003|NOT COMPLETED|Pause (up to 37 Days)||0
10614671|NCT01930045|11772304|FG004|NOT COMPLETED|Pause (up to 37 Days)||0
10614672|NCT01930045|11772305|FG005|NOT COMPLETED|Pause (up to 37 Days)||2
10614673|NCT01930045|11772300|FG000|STARTED|Part 2 - Period 4||3
10614674|NCT01930045|11772301|FG001|STARTED|Part 2 - Period 4||3
10614675|NCT01930045|11772302|FG002|STARTED|Part 2 - Period 4||3
10614676|NCT01930045|11772303|FG003|STARTED|Part 2 - Period 4||3
10614677|NCT01930045|11772304|FG004|STARTED|Part 2 - Period 4||3
10614678|NCT01930045|11772305|FG005|STARTED|Part 2 - Period 4||1
10614679|NCT01930045|11772300|FG000|COMPLETED|Part 2 - Period 4||3
10614680|NCT01930045|11772301|FG001|COMPLETED|Part 2 - Period 4||3
10614681|NCT01930045|11772302|FG002|COMPLETED|Part 2 - Period 4||3
10614682|NCT01930045|11772303|FG003|COMPLETED|Part 2 - Period 4||3
10614683|NCT01930045|11772304|FG004|COMPLETED|Part 2 - Period 4||3
10614684|NCT01930045|11772305|FG005|COMPLETED|Part 2 - Period 4||1
10614685|NCT01930045|11772300|FG000|NOT COMPLETED|Part 2 - Period 4||0
10614686|NCT01930045|11772301|FG001|NOT COMPLETED|Part 2 - Period 4||0
10614687|NCT01930045|11772302|FG002|NOT COMPLETED|Part 2 - Period 4||0
10614688|NCT01930045|11772303|FG003|NOT COMPLETED|Part 2 - Period 4||0
10614689|NCT01930045|11772304|FG004|NOT COMPLETED|Part 2 - Period 4||0
10614690|NCT01930045|11772305|FG005|NOT COMPLETED|Part 2 - Period 4||0
10614691|NCT01930045|11772300|FG000|STARTED|Part 2 - Period 5||3
10614692|NCT01930045|11772301|FG001|STARTED|Part 2 - Period 5||3
10614693|NCT01930045|11772302|FG002|STARTED|Part 2 - Period 5||3
10614694|NCT01930045|11772303|FG003|STARTED|Part 2 - Period 5||3
10614695|NCT01930045|11772304|FG004|STARTED|Part 2 - Period 5||3
10614696|NCT01930045|11772305|FG005|STARTED|Part 2 - Period 5||1
10614697|NCT01930045|11772300|FG000|COMPLETED|Part 2 - Period 5||3
10614698|NCT01930045|11772301|FG001|COMPLETED|Part 2 - Period 5||3
10614699|NCT01930045|11772302|FG002|COMPLETED|Part 2 - Period 5||3
10614700|NCT01930045|11772303|FG003|COMPLETED|Part 2 - Period 5||3
10614701|NCT01930045|11772304|FG004|COMPLETED|Part 2 - Period 5||3
10614702|NCT01930045|11772305|FG005|COMPLETED|Part 2 - Period 5||1
10614703|NCT01930045|11772300|FG000|NOT COMPLETED|Part 2 - Period 5||0
10614704|NCT01930045|11772301|FG001|NOT COMPLETED|Part 2 - Period 5||0
10614705|NCT01930045|11772302|FG002|NOT COMPLETED|Part 2 - Period 5||0
10614706|NCT01930045|11772303|FG003|NOT COMPLETED|Part 2 - Period 5||0
10614707|NCT01930045|11772304|FG004|NOT COMPLETED|Part 2 - Period 5||0
10614708|NCT01930045|11772305|FG005|NOT COMPLETED|Part 2 - Period 5||0
10614709|NCT01930058|11772320|FG000|STARTED|Overall Study||3
10614710|NCT01930058|11772321|FG001|STARTED|Overall Study||3
10614711|NCT01930058|11772322|FG002|STARTED|Overall Study||3
10614712|NCT01930058|11772320|FG000|COMPLETED|Overall Study||3
10614713|NCT01930058|11772321|FG001|COMPLETED|Overall Study||3
10614714|NCT01930058|11772322|FG002|COMPLETED|Overall Study||3
10614715|NCT01930058|11772320|FG000|NOT COMPLETED|Overall Study||0
10614716|NCT01930058|11772321|FG001|NOT COMPLETED|Overall Study||0
10614717|NCT01930058|11772322|FG002|NOT COMPLETED|Overall Study||0
10614718|NCT01930162|11772329|FG000|STARTED|Overall Study||9
10614719|NCT01930162|11772329|FG000|COMPLETED|Overall Study||4
10614720|NCT01930162|11772329|FG000|NOT COMPLETED|Overall Study||5
10614721|NCT01930175|11772337|FG000|STARTED|Core Study||7
10614722|NCT01930175|11772338|FG001|STARTED|Core Study||2
10614723|NCT01930175|11772339|FG002|STARTED|Core Study||4
10614724|NCT01930175|11772337|FG000|Safety Analysis Set|Core Study||7
10614725|NCT01930175|11772338|FG001|Safety Analysis Set|Core Study||2
10614726|NCT01930175|11772339|FG002|Safety Analysis Set|Core Study||4
10614727|NCT01930175|11772337|FG000|Pharmacokinetics (PK) Analysis Set|Core Study||7
10614728|NCT01930175|11772338|FG001|Pharmacokinetics (PK) Analysis Set|Core Study||2
10614729|NCT01930175|11772339|FG002|Pharmacokinetics (PK) Analysis Set|Core Study|Placebo patients were excluded from the PK analyses|0
10614730|NCT01930175|11772337|FG000|COMPLETED|Core Study||7
10614731|NCT01930175|11772338|FG001|COMPLETED|Core Study||1
10614732|NCT01930175|11772339|FG002|COMPLETED|Core Study||3
10614733|NCT01930175|11772337|FG000|NOT COMPLETED|Core Study||0
10614734|NCT01930175|11772338|FG001|NOT COMPLETED|Core Study||1
10614735|NCT01930175|11772339|FG002|NOT COMPLETED|Core Study||1
10704811|NCT02429375|11869182|FG001|NOT COMPLETED|Overall Study||0
10704812|NCT02429375|11869183|FG002|NOT COMPLETED|Overall Study||0
10704813|NCT02230254|11869192|FG000|STARTED|Overall Study||101
10704814|NCT02230254|11869192|FG000|COMPLETED|Overall Study||98
10704815|NCT02230254|11869192|FG000|NOT COMPLETED|Overall Study||3
10614736|NCT01930175|11772337|FG000|STARTED|Open Label VAY736 10 mg/kg at Week 24|Only patients originally randomized to Placebo were allowed to enter this Period.|0
10614737|NCT01930175|11772338|FG001|STARTED|Open Label VAY736 10 mg/kg at Week 24|Only patients originally randomized to Placebo were allowed to enter this Period.|0
10614738|NCT01930175|11772339|FG002|STARTED|Open Label VAY736 10 mg/kg at Week 24|Only patients originally randomized to Placebo were allowed to enter this Period.|3
10614739|NCT01930175|11772337|FG000|COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
10614740|NCT01930175|11772338|FG001|COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
10614741|NCT01930175|11772339|FG002|COMPLETED|Open Label VAY736 10 mg/kg at Week 24||3
10614742|NCT01930175|11772337|FG000|NOT COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
10614743|NCT01930175|11772338|FG001|NOT COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
10614744|NCT01930175|11772339|FG002|NOT COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
10614745|NCT01930188|11772351|FG000|STARTED|Overall Study||409
10614746|NCT01930188|11772352|FG001|STARTED|Overall Study||409
10614747|NCT01930188|11772353|FG002|STARTED|Overall Study||407
10614748|NCT01930188|11772351|FG000|Premature Discontinuation of Treatment|Overall Study|Subjects prematurely discontinued treatment were allowed to continue participation in the trial.|53
10614749|NCT01930188|11772352|FG001|Premature Discontinuation of Treatment|Overall Study|Subjects prematurely discontinued treatment were allowed to continue participation in the trial.|61
10614750|NCT01930188|11772353|FG002|Premature Discontinuation of Treatment|Overall Study|Subjects prematurely discontinued treatment were allowed to continue participation in the trial.|32
10614751|NCT01930188|11772351|FG000|COMPLETED|Overall Study||387
10614752|NCT01930188|11772352|FG001|COMPLETED|Overall Study||388
10614753|NCT01930188|11772353|FG002|COMPLETED|Overall Study||388
10614754|NCT01930188|11772351|FG000|NOT COMPLETED|Overall Study||22
10614755|NCT01930188|11772352|FG001|NOT COMPLETED|Overall Study||21
10614756|NCT01930188|11772353|FG002|NOT COMPLETED|Overall Study||19
10614757|NCT01930214|11772365|FG000|STARTED|Overall Study||100
10614758|NCT01930214|11772366|FG001|STARTED|Overall Study||117
10614759|NCT01930214|11772367|FG002|STARTED|Overall Study||133
10614760|NCT01930214|11772365|FG000|COMPLETED|Overall Study||80
10614761|NCT01930214|11772366|FG001|COMPLETED|Overall Study||96
10614762|NCT01930214|11772367|FG002|COMPLETED|Overall Study||108
10614763|NCT01930214|11772365|FG000|NOT COMPLETED|Overall Study||20
10614764|NCT01930214|11772366|FG001|NOT COMPLETED|Overall Study||21
10614765|NCT01930214|11772367|FG002|NOT COMPLETED|Overall Study||25
10614766|NCT01930435|11772375|FG000|STARTED|Overall Study||20
10614767|NCT01930435|11772375|FG000|COMPLETED|Overall Study||20
10614768|NCT01930435|11772375|FG000|NOT COMPLETED|Overall Study||0
10614769|NCT01930487|11772380|FG000|STARTED|First Intervention (30 Days)||21
10614770|NCT01930487|11772381|FG001|STARTED|First Intervention (30 Days)||25
10614771|NCT01930487|11772380|FG000|COMPLETED|First Intervention (30 Days)||19
10614772|NCT01930487|11772381|FG001|COMPLETED|First Intervention (30 Days)||23
10614773|NCT01930487|11772380|FG000|NOT COMPLETED|First Intervention (30 Days)||2
10614774|NCT01930487|11772381|FG001|NOT COMPLETED|First Intervention (30 Days)||2
10614775|NCT01930487|11772380|FG000|STARTED|Washout Period (3 Weeks)||19
10614776|NCT01930487|11772381|FG001|STARTED|Washout Period (3 Weeks)||23
10614777|NCT01930487|11772380|FG000|COMPLETED|Washout Period (3 Weeks)||19
10614778|NCT01930487|11772381|FG001|COMPLETED|Washout Period (3 Weeks)||23
10614779|NCT01930487|11772380|FG000|NOT COMPLETED|Washout Period (3 Weeks)||0
10614780|NCT01930487|11772381|FG001|NOT COMPLETED|Washout Period (3 Weeks)||0
10614781|NCT01930487|11772380|FG000|STARTED|Second Intervention (30 Days)||19
10614782|NCT01930487|11772381|FG001|STARTED|Second Intervention (30 Days)||23
10614783|NCT01930487|11772380|FG000|COMPLETED|Second Intervention (30 Days)||19
10614784|NCT01930487|11772381|FG001|COMPLETED|Second Intervention (30 Days)||23
10614785|NCT01930487|11772380|FG000|NOT COMPLETED|Second Intervention (30 Days)||0
10614786|NCT01930487|11772381|FG001|NOT COMPLETED|Second Intervention (30 Days)||0
10614787|NCT01930643|11772389|FG000|STARTED|Overall Study||7
10614788|NCT01930643|11772390|FG001|STARTED|Overall Study||6
10614789|NCT01930643|11772389|FG000|COMPLETED|Overall Study||7
10614790|NCT01930643|11772390|FG001|COMPLETED|Overall Study||6
10614791|NCT01930643|11772389|FG000|NOT COMPLETED|Overall Study||0
10614792|NCT01930643|11772390|FG001|NOT COMPLETED|Overall Study||0
10614793|NCT01930747|11772399|FG000|STARTED|Overall Study||16
10614794|NCT01930747|11772400|FG001|STARTED|Overall Study||14
10614795|NCT01930747|11772401|FG002|STARTED|Overall Study||12
10614796|NCT01930747|11772399|FG000|COMPLETED|Overall Study||16
10614797|NCT01930747|11772400|FG001|COMPLETED|Overall Study||14
10614798|NCT01930747|11772401|FG002|COMPLETED|Overall Study||12
10614799|NCT01930747|11772399|FG000|NOT COMPLETED|Overall Study||0
10614800|NCT01930747|11772400|FG001|NOT COMPLETED|Overall Study||0
10614801|NCT01930747|11772401|FG002|NOT COMPLETED|Overall Study||0
10614802|NCT01930799|11772409|FG000|STARTED|Overall Study||120
10614803|NCT01930799|11772409|FG000|COMPLETED|Overall Study||112
10614804|NCT01930799|11772409|FG000|NOT COMPLETED|Overall Study||8
10614805|NCT01930890|11772417|FG000|STARTED|Overall Study||14
10614806|NCT01930890|11772418|FG001|STARTED|Overall Study||33
10614807|NCT01930890|11772419|FG002|STARTED|Overall Study||13
10614808|NCT01930890|11772420|FG003|STARTED|Overall Study||27
10614809|NCT01930890|11772417|FG000|COMPLETED|Overall Study||0
10614810|NCT01930890|11772418|FG001|COMPLETED|Overall Study||0
10614811|NCT01930890|11772419|FG002|COMPLETED|Overall Study||0
10614812|NCT01930890|11772420|FG003|COMPLETED|Overall Study||0
10614813|NCT01930890|11772417|FG000|NOT COMPLETED|Overall Study||14
10614814|NCT01930890|11772418|FG001|NOT COMPLETED|Overall Study||33
10614815|NCT01930890|11772419|FG002|NOT COMPLETED|Overall Study||13
10614816|NCT01930890|11772420|FG003|NOT COMPLETED|Overall Study||27
10614817|NCT01931059|11772432|FG000|STARTED|Day 1||6
10614818|NCT01931059|11772433|FG001|STARTED|Day 1||5
10614819|NCT01931059|11772432|FG000|COMPLETED|Day 1||6
10614820|NCT01931059|11772433|FG001|COMPLETED|Day 1||4
10614821|NCT01931059|11772432|FG000|NOT COMPLETED|Day 1||0
10614822|NCT01931059|11772433|FG001|NOT COMPLETED|Day 1||1
10614823|NCT01931059|11772432|FG000|STARTED|Day2||6
10614824|NCT01931059|11772433|FG001|STARTED|Day2||4
10614825|NCT01931059|11772432|FG000|COMPLETED|Day2||6
10614826|NCT01931059|11772433|FG001|COMPLETED|Day2||4
10614827|NCT01931059|11772432|FG000|NOT COMPLETED|Day2||0
10614828|NCT01931059|11772433|FG001|NOT COMPLETED|Day2||0
10614829|NCT01931059|11772432|FG000|STARTED|Day3||6
10614830|NCT01931059|11772433|FG001|STARTED|Day3||4
10614831|NCT01931059|11772432|FG000|COMPLETED|Day3||5
10614832|NCT01931059|11772433|FG001|COMPLETED|Day3||4
10614833|NCT01931059|11772432|FG000|NOT COMPLETED|Day3||1
10614834|NCT01931059|11772433|FG001|NOT COMPLETED|Day3||0
10614835|NCT01931150|11772447|FG000|STARTED|Overall Study||5
10614836|NCT01931150|11772448|FG001|STARTED|Overall Study||6
10614837|NCT01931150|11772447|FG000|COMPLETED|Overall Study||4
10614838|NCT01931150|11772448|FG001|COMPLETED|Overall Study||4
10614839|NCT01931150|11772447|FG000|NOT COMPLETED|Overall Study||1
10614840|NCT01931150|11772448|FG001|NOT COMPLETED|Overall Study||2
10614841|NCT01931163|11772454|FG000|STARTED|Overall Study||22
10614842|NCT01931163|11772454|FG000|COMPLETED|Overall Study||22
10614843|NCT01931163|11772454|FG000|NOT COMPLETED|Overall Study||0
10614844|NCT01931202|11772461|FG000|STARTED|Overall Study||8
10614845|NCT01931202|11772462|FG001|STARTED|Overall Study||51
10614846|NCT01931202|11772463|FG002|STARTED|Overall Study||49
10614847|NCT01931202|11772461|FG000|COMPLETED|Overall Study||8
10614848|NCT01931202|11772462|FG001|COMPLETED|Overall Study||46
10614849|NCT01931202|11772463|FG002|COMPLETED|Overall Study||45
10614850|NCT01931202|11772461|FG000|NOT COMPLETED|Overall Study||0
10614851|NCT01931202|11772462|FG001|NOT COMPLETED|Overall Study||5
10614852|NCT01931202|11772463|FG002|NOT COMPLETED|Overall Study||4
10614853|NCT01931397|11772474|FG000|STARTED|Overall Study||30
10614854|NCT01931397|11772474|FG000|COMPLETED|Overall Study||19
10614855|NCT01931397|11772474|FG000|NOT COMPLETED|Overall Study||11
10614856|NCT01931462|11772482|FG000|STARTED|Overall Study||2
10614857|NCT01931462|11772482|FG000|COMPLETED|Overall Study||1
10614858|NCT01931462|11772482|FG000|NOT COMPLETED|Overall Study||1
10614859|NCT01931475|11772488|FG000|STARTED|Period 1: Double-Blind Treatment Phase||205
10614860|NCT01931475|11772489|FG001|STARTED|Period 1: Double-Blind Treatment Phase||202
10614861|NCT01931475|11772488|FG000|Received at Least 1 Dose of Study Drug|Period 1: Double-Blind Treatment Phase||199
10614862|NCT01931475|11772489|FG001|Received at Least 1 Dose of Study Drug|Period 1: Double-Blind Treatment Phase||198
10614863|NCT01931475|11772488|FG000|COMPLETED|Period 1: Double-Blind Treatment Phase||166
10614864|NCT01931475|11772489|FG001|COMPLETED|Period 1: Double-Blind Treatment Phase||176
10614865|NCT01931475|11772488|FG000|NOT COMPLETED|Period 1: Double-Blind Treatment Phase||39
10614866|NCT01931475|11772489|FG001|NOT COMPLETED|Period 1: Double-Blind Treatment Phase||26
10614867|NCT01931475|11772488|FG000|STARTED|Period 2: Extension Treatment Phase||166
10614868|NCT01931475|11772489|FG001|STARTED|Period 2: Extension Treatment Phase||176
10614869|NCT01931475|11772488|FG000|Received at Least 1 Dose of Study Drug|Period 2: Extension Treatment Phase||166
10614870|NCT01931475|11772489|FG001|Received at Least 1 Dose of Study Drug|Period 2: Extension Treatment Phase||175
10614871|NCT01931475|11772488|FG000|COMPLETED|Period 2: Extension Treatment Phase||162
10614872|NCT01931475|11772489|FG001|COMPLETED|Period 2: Extension Treatment Phase||157
10614873|NCT01931475|11772488|FG000|NOT COMPLETED|Period 2: Extension Treatment Phase||4
10614874|NCT01931475|11772489|FG001|NOT COMPLETED|Period 2: Extension Treatment Phase||19
10614875|NCT01931527|11772502|FG000|STARTED|Overall Study||16
10614876|NCT01931527|11772503|FG001|STARTED|Overall Study||15
10614877|NCT01931527|11772502|FG000|COMPLETED|Overall Study||16
10614878|NCT01931527|11772503|FG001|COMPLETED|Overall Study||15
10614879|NCT01931527|11772502|FG000|NOT COMPLETED|Overall Study||0
10614880|NCT01931527|11772503|FG001|NOT COMPLETED|Overall Study||0
10614881|NCT01931566|11772516|FG000|STARTED|Overall Study||433
10614882|NCT01931566|11772517|FG001|STARTED|Overall Study||1516
10614883|NCT01931566|11772518|FG002|STARTED|Overall Study||1545
10614884|NCT01931566|11772516|FG000|Treated|Overall Study||427
10614885|NCT01931566|11772517|FG001|Treated|Overall Study||1507
10614886|NCT01931566|11772518|FG002|Treated|Overall Study||1531
10614887|NCT01931566|11772516|FG000|COMPLETED|Overall Study||4
10614888|NCT01931566|11772517|FG001|COMPLETED|Overall Study||40
10614889|NCT01931566|11772518|FG002|COMPLETED|Overall Study||39
10614890|NCT01931566|11772516|FG000|NOT COMPLETED|Overall Study||429
10614891|NCT01931566|11772517|FG001|NOT COMPLETED|Overall Study||1476
10614892|NCT01931566|11772518|FG002|NOT COMPLETED|Overall Study||1506
10614893|NCT01931670|11772530|FG000|STARTED|Treatment Period||360
10614894|NCT01931670|11772531|FG001|STARTED|Treatment Period||226
10614895|NCT01931670|11772532|FG002|STARTED|Treatment Period||229
10614896|NCT01931670|11772530|FG000|COMPLETED|Treatment Period||270
10614897|NCT01931670|11772531|FG001|COMPLETED|Treatment Period||178
10614898|NCT01931670|11772532|FG002|COMPLETED|Treatment Period||184
10614899|NCT01931670|11772530|FG000|NOT COMPLETED|Treatment Period||90
10614900|NCT01931670|11772531|FG001|NOT COMPLETED|Treatment Period||48
10614901|NCT01931670|11772532|FG002|NOT COMPLETED|Treatment Period||45
10614902|NCT01931670|11772530|FG000|STARTED|Post-Treatment Follow-Up (PTFU) Period||61
10614903|NCT01931670|11772531|FG001|STARTED|Post-Treatment Follow-Up (PTFU) Period||40
10614904|NCT01931670|11772532|FG002|STARTED|Post-Treatment Follow-Up (PTFU) Period||54
10614905|NCT01931670|11772530|FG000|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||42
10614906|NCT01931670|11772531|FG001|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||24
10614907|NCT01931670|11772532|FG002|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||18
10614908|NCT01931670|11772530|FG000|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||0
10614909|NCT01931670|11772531|FG001|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||4
10614910|NCT01931670|11772532|FG002|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||15
10614911|NCT01931670|11772530|FG000|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||42
10614912|NCT01931670|11772531|FG001|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||28
10614913|NCT01931670|11772532|FG002|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||33
10614914|NCT01931670|11772530|FG000|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||19
10614915|NCT01931670|11772531|FG001|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||12
10614916|NCT01931670|11772532|FG002|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||21
10614917|NCT01931735|11772544|FG000|STARTED|Randomized Phase||4
10614918|NCT01931735|11772545|FG001|STARTED|Randomized Phase||3
10614919|NCT01931735|11772546|FG002|STARTED|Randomized Phase||9
10614920|NCT01931735|11772547|FG003|STARTED|Randomized Phase||0
10614921|NCT01931735|11772544|FG000|COMPLETED|Randomized Phase||2
10614922|NCT01931735|11772545|FG001|COMPLETED|Randomized Phase||1
10614923|NCT01931735|11772546|FG002|COMPLETED|Randomized Phase||4
10614924|NCT01931735|11772547|FG003|COMPLETED|Randomized Phase||0
10614925|NCT01931735|11772544|FG000|NOT COMPLETED|Randomized Phase||2
10614926|NCT01931735|11772545|FG001|NOT COMPLETED|Randomized Phase||2
10614927|NCT01931735|11772546|FG002|NOT COMPLETED|Randomized Phase||5
10614928|NCT01931735|11772547|FG003|NOT COMPLETED|Randomized Phase||0
10614929|NCT01931735|11772544|FG000|STARTED|Observational Non-Randomized Phase|Participants continued from the randomized phase|2
10614930|NCT01931735|11772545|FG001|STARTED|Observational Non-Randomized Phase|Participants continued from the randomized phase|1
10614931|NCT01931735|11772546|FG002|STARTED|Observational Non-Randomized Phase||0
10704831|NCT01891396|11869226|FG000|STARTED|Overall Study||149
10704832|NCT01891396|11869227|FG001|STARTED|Overall Study||150
10704833|NCT01891396|11869228|FG002|STARTED|Overall Study||69
10704834|NCT01891396|11869226|FG000|Received Study Injection|Overall Study||149
10704835|NCT01891396|11869227|FG001|Received Study Injection|Overall Study||150
10704836|NCT01891396|11869228|FG002|Received Study Injection|Overall Study||69
10614932|NCT01931735|11772547|FG003|STARTED|Observational Non-Randomized Phase|Participants recruited post-amendment|11
10614933|NCT01931735|11772544|FG000|COMPLETED|Observational Non-Randomized Phase||2
10704837|NCT01891396|11869226|FG000|COMPLETED|Overall Study||145
10704838|NCT01891396|11869227|FG001|COMPLETED|Overall Study||145
10704839|NCT01891396|11869228|FG002|COMPLETED|Overall Study||66
10704840|NCT01891396|11869226|FG000|NOT COMPLETED|Overall Study||4
10704841|NCT01891396|11869227|FG001|NOT COMPLETED|Overall Study||5
10704842|NCT01891396|11869228|FG002|NOT COMPLETED|Overall Study||3
10713766|NCT02681523|11879260|FG000|COMPLETED|Overall Study||6
10713767|NCT02681523|11879260|FG000|NOT COMPLETED|Overall Study||2
10713768|NCT02681757|11879266|FG000|STARTED|Overall Study||47
10713769|NCT02681757|11879267|FG001|STARTED|Overall Study||49
10614934|NCT01931735|11772545|FG001|COMPLETED|Observational Non-Randomized Phase||1
10614935|NCT01931735|11772546|FG002|COMPLETED|Observational Non-Randomized Phase||0
10614936|NCT01931735|11772547|FG003|COMPLETED|Observational Non-Randomized Phase||9
10614937|NCT01931735|11772544|FG000|NOT COMPLETED|Observational Non-Randomized Phase||0
10614938|NCT01931735|11772545|FG001|NOT COMPLETED|Observational Non-Randomized Phase||0
10614939|NCT01931735|11772546|FG002|NOT COMPLETED|Observational Non-Randomized Phase||0
10614940|NCT01931735|11772547|FG003|NOT COMPLETED|Observational Non-Randomized Phase||2
10614941|NCT01931839|11772564|FG000|STARTED|Overall Study||335
10614942|NCT01931839|11772565|FG001|STARTED|Overall Study||178
10614943|NCT01931839|11772566|FG002|STARTED|Overall Study||340
10614944|NCT01931839|11772567|FG003|STARTED|Overall Study||176
10614945|NCT01931839|11772568|FG004|STARTED|Overall Study||19
10614946|NCT01931839|11772569|FG005|STARTED|Overall Study||55
10614947|NCT01931839|11772570|FG006|STARTED|Overall Study||60
10614948|NCT01931839|11772564|FG000|Full Analysis Set (As Randomized)|Overall Study||334
10614949|NCT01931839|11772565|FG001|Full Analysis Set (As Randomized)|Overall Study||179
10614950|NCT01931839|11772566|FG002|Full Analysis Set (As Randomized)|Overall Study||340
10614951|NCT01931839|11772567|FG003|Full Analysis Set (As Randomized)|Overall Study||176
10614952|NCT01931839|11772568|FG004|Full Analysis Set (As Randomized)|Overall Study||19
10614953|NCT01931839|11772569|FG005|Full Analysis Set (As Randomized)|Overall Study||55
10614954|NCT01931839|11772570|FG006|Full Analysis Set (As Randomized)|Overall Study||60
10614955|NCT01931839|11772564|FG000|Safety Analysis Set (As Dosed)|Overall Study||335
10614956|NCT01931839|11772565|FG001|Safety Analysis Set (As Dosed)|Overall Study||178
10614957|NCT01931839|11772566|FG002|Safety Analysis Set (As Dosed)|Overall Study||340
10614958|NCT01931839|11772567|FG003|Safety Analysis Set (As Dosed)|Overall Study||176
10614959|NCT01931839|11772568|FG004|Safety Analysis Set (As Dosed)|Overall Study||19
10614960|NCT01931839|11772569|FG005|Safety Analysis Set (As Dosed)|Overall Study||55
10614961|NCT01931839|11772570|FG006|Safety Analysis Set (As Dosed)|Overall Study||60
10614962|NCT01931839|11772564|FG000|COMPLETED|Overall Study||294
10614963|NCT01931839|11772565|FG001|COMPLETED|Overall Study||152
10614964|NCT01931839|11772566|FG002|COMPLETED|Overall Study||301
10614965|NCT01931839|11772567|FG003|COMPLETED|Overall Study||162
10614966|NCT01931839|11772568|FG004|COMPLETED|Overall Study||18
10614967|NCT01931839|11772569|FG005|COMPLETED|Overall Study||50
10614968|NCT01931839|11772570|FG006|COMPLETED|Overall Study||56
10614969|NCT01931839|11772564|FG000|NOT COMPLETED|Overall Study||41
10614970|NCT01931839|11772565|FG001|NOT COMPLETED|Overall Study||26
10614971|NCT01931839|11772566|FG002|NOT COMPLETED|Overall Study||39
10614972|NCT01931839|11772567|FG003|NOT COMPLETED|Overall Study||14
10614973|NCT01931839|11772568|FG004|NOT COMPLETED|Overall Study||1
10614974|NCT01931839|11772569|FG005|NOT COMPLETED|Overall Study||5
10614975|NCT01931839|11772570|FG006|NOT COMPLETED|Overall Study||4
10614976|NCT01931865|11772590|FG000|STARTED|Overall Study||12
10614977|NCT01931865|11772590|FG000|COMPLETED|Overall Study||8
10614978|NCT01931865|11772590|FG000|NOT COMPLETED|Overall Study||4
10614979|NCT01931878|11772595|FG000|STARTED|First Intervention||10
10614980|NCT01931878|11772596|FG001|STARTED|First Intervention||14
10614981|NCT01931878|11772595|FG000|COMPLETED|First Intervention||9
10614982|NCT01931878|11772596|FG001|COMPLETED|First Intervention||14
10614983|NCT01931878|11772595|FG000|NOT COMPLETED|First Intervention||1
10614984|NCT01931878|11772596|FG001|NOT COMPLETED|First Intervention||0
10614985|NCT01931878|11772595|FG000|STARTED|Second Intervention (After 3 Months)||9
10614986|NCT01931878|11772596|FG001|STARTED|Second Intervention (After 3 Months)||14
10614987|NCT01931878|11772595|FG000|COMPLETED|Second Intervention (After 3 Months)||9
10614988|NCT01931878|11772596|FG001|COMPLETED|Second Intervention (After 3 Months)||12
10614989|NCT01931878|11772595|FG000|NOT COMPLETED|Second Intervention (After 3 Months)||0
10614990|NCT01931878|11772596|FG001|NOT COMPLETED|Second Intervention (After 3 Months)||2
10614991|NCT01931956|11772610|FG000|STARTED|Overall Study||59
10614992|NCT01931956|11772611|FG001|STARTED|Overall Study||7
10614993|NCT01931956|11772612|FG002|STARTED|Overall Study||628
10614994|NCT01931956|11772613|FG003|STARTED|Overall Study||271
10614995|NCT01931956|11772610|FG000|COMPLETED|Overall Study||8
10614996|NCT01931956|11772611|FG001|COMPLETED|Overall Study||0
10614997|NCT01931956|11772612|FG002|COMPLETED|Overall Study||141
10614998|NCT01931956|11772613|FG003|COMPLETED|Overall Study||138
10614999|NCT01931956|11772610|FG000|NOT COMPLETED|Overall Study||51
10615000|NCT01931956|11772611|FG001|NOT COMPLETED|Overall Study||7
10615001|NCT01931956|11772612|FG002|NOT COMPLETED|Overall Study||487
10615002|NCT01931956|11772613|FG003|NOT COMPLETED|Overall Study||133
10713770|NCT02681757|11879266|FG000|COMPLETED|Overall Study||47
10713771|NCT02681757|11879267|FG001|COMPLETED|Overall Study||49
10615003|NCT01931995|11772638|FG000|STARTED|First Intervention (1 Day)||23
10615004|NCT01931995|11772639|FG001|STARTED|First Intervention (1 Day)||22
10615005|NCT01931995|11772638|FG000|COMPLETED|First Intervention (1 Day)||19
10615006|NCT01931995|11772639|FG001|COMPLETED|First Intervention (1 Day)||18
10615007|NCT01931995|11772638|FG000|NOT COMPLETED|First Intervention (1 Day)||4
10615008|NCT01931995|11772639|FG001|NOT COMPLETED|First Intervention (1 Day)||4
10615009|NCT01931995|11772638|FG000|STARTED|Washout (at Least 6 Days)||19
10615010|NCT01931995|11772639|FG001|STARTED|Washout (at Least 6 Days)||18
10615011|NCT01931995|11772638|FG000|COMPLETED|Washout (at Least 6 Days)||19
10615012|NCT01931995|11772639|FG001|COMPLETED|Washout (at Least 6 Days)||18
10615013|NCT01931995|11772638|FG000|NOT COMPLETED|Washout (at Least 6 Days)||0
10615014|NCT01931995|11772639|FG001|NOT COMPLETED|Washout (at Least 6 Days)||0
10615015|NCT01931995|11772638|FG000|STARTED|Second Intervention (1 Day)||18
10615016|NCT01931995|11772639|FG001|STARTED|Second Intervention (1 Day)||19
10615017|NCT01931995|11772638|FG000|COMPLETED|Second Intervention (1 Day)||18
10615018|NCT01931995|11772639|FG001|COMPLETED|Second Intervention (1 Day)||19
10615019|NCT01931995|11772638|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10615020|NCT01931995|11772639|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10615021|NCT01932060|11772647|FG000|STARTED|Overall Study||27
10615022|NCT01932060|11772648|FG001|STARTED|Overall Study||24
10615023|NCT01932060|11772647|FG000|COMPLETED|Overall Study||27
10615024|NCT01932060|11772648|FG001|COMPLETED|Overall Study||24
10615025|NCT01932060|11772647|FG000|NOT COMPLETED|Overall Study||0
10615026|NCT01932060|11772648|FG001|NOT COMPLETED|Overall Study||0
10615027|NCT01932112|11772654|FG000|STARTED|Overall Study||378
10615028|NCT01932112|11772654|FG000|COMPLETED|Overall Study||378
10615029|NCT01932112|11772654|FG000|NOT COMPLETED|Overall Study||0
10615030|NCT01932164|11772658|FG000|STARTED|Overall Study|It was performed the selection of 5 patients to participate of these study (08/2013)|5
10704843|NCT01525901|11869244|FG000|STARTED|Period 1: 12 Weeks||5
10704844|NCT01525901|11869245|FG001|STARTED|Period 1: 12 Weeks||4
10704845|NCT01525901|11869246|FG002|STARTED|Period 1: 12 Weeks||5
10704846|NCT01525901|11869247|FG003|STARTED|Period 1: 12 Weeks||5
10704847|NCT01525901|11869244|FG000|COMPLETED|Period 1: 12 Weeks||5
10704848|NCT01525901|11869245|FG001|COMPLETED|Period 1: 12 Weeks||4
10615031|NCT01932164|11772658|FG000|Cleft Lip and Palate|Overall Study|It was performed de extraction of deciduous teeth of 5 cleft lip/palate patients (09/2013)|5
10615032|NCT01932164|11772658|FG000|Cleft Lip and Palate|Overall Study|Dental pulp was obtained from teeth of 5 different patients (09/2013)|5
10615033|NCT01932164|11772658|FG000|Cleft Lip and Palate|Overall Study|Mesenchymal stem cell obtained from dental pulp of 5patients was obtained, caractherized and frozen|5
10615034|NCT01932164|11772658|FG000|Cleft Lip and Palate|Overall Study|Alveolar bone graft surgeries were did using their dental pulp stem cells with biomaterial|5
10615035|NCT01932164|11772658|FG000|Cleft Lip and Palate|Overall Study|The surgeries were performed between december 2013 and june 2014.|5
10615036|NCT01932164|11772658|FG000|COMPLETED|Overall Study|In all 5 patients we observed bone formation closing the alveolar cleft after 6 months|5
10615037|NCT01932164|11772658|FG000|NOT COMPLETED|Overall Study||0
10615038|NCT01932242|11772664|FG000|STARTED|Overall Study||35
10615039|NCT01932242|11772665|FG001|STARTED|Overall Study||35
10615040|NCT01932242|11772664|FG000|COMPLETED|Overall Study||30
10615041|NCT01932242|11772665|FG001|COMPLETED|Overall Study||30
10615042|NCT01932242|11772664|FG000|NOT COMPLETED|Overall Study||5
10615043|NCT01932242|11772665|FG001|NOT COMPLETED|Overall Study||5
10615044|NCT01932294|11772671|FG000|STARTED|Overall Study||171
10615045|NCT01932294|11772671|FG000|COMPLETED|Overall Study||72
10615046|NCT01932294|11772671|FG000|NOT COMPLETED|Overall Study||99
10615047|NCT01932437|11772678|FG000|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||1
10615048|NCT01932437|11772679|FG001|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||3
10615049|NCT01932437|11772680|FG002|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
10615050|NCT01932437|11772681|FG003|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
10615051|NCT01932437|11772682|FG004|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
10615052|NCT01932437|11772683|FG005|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
10615053|NCT01932437|11772678|FG000|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||1
10615054|NCT01932437|11772679|FG001|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||3
10615055|NCT01932437|11772680|FG002|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
10615056|NCT01932437|11772681|FG003|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
10615057|NCT01932437|11772682|FG004|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
10615058|NCT01932437|11772683|FG005|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
10615059|NCT01932437|11772678|FG000|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
10615060|NCT01932437|11772679|FG001|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
10615061|NCT01932437|11772680|FG002|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
10615062|NCT01932437|11772681|FG003|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
10615063|NCT01932437|11772682|FG004|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
10615064|NCT01932437|11772683|FG005|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
10615065|NCT01932437|11772678|FG000|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||2
10615066|NCT01932437|11772679|FG001|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
10615067|NCT01932437|11772680|FG002|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||6
10615068|NCT01932437|11772681|FG003|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
10615069|NCT01932437|11772682|FG004|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
10615070|NCT01932437|11772683|FG005|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
10615071|NCT01932437|11772678|FG000|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||2
10615072|NCT01932437|11772679|FG001|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
10615073|NCT01932437|11772680|FG002|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||6
10615074|NCT01932437|11772681|FG003|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
10615075|NCT01932437|11772682|FG004|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
10615076|NCT01932437|11772683|FG005|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
10615077|NCT01932437|11772678|FG000|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
10615078|NCT01932437|11772679|FG001|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
10615079|NCT01932437|11772680|FG002|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
10615080|NCT01932437|11772681|FG003|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
10615081|NCT01932437|11772682|FG004|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
10615082|NCT01932437|11772683|FG005|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
10615083|NCT01932437|11772678|FG000|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||2
10615084|NCT01932437|11772679|FG001|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
10615085|NCT01932437|11772680|FG002|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
10615086|NCT01932437|11772681|FG003|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||6
10615087|NCT01932437|11772682|FG004|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
10615088|NCT01932437|11772683|FG005|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
10615089|NCT01932437|11772678|FG000|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||2
10615090|NCT01932437|11772679|FG001|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
10615091|NCT01932437|11772680|FG002|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
10615092|NCT01932437|11772681|FG003|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||6
10615093|NCT01932437|11772682|FG004|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
10615094|NCT01932437|11772683|FG005|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
10615095|NCT01932437|11772678|FG000|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
10615096|NCT01932437|11772679|FG001|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
10615097|NCT01932437|11772680|FG002|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
10615098|NCT01932437|11772681|FG003|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
10615099|NCT01932437|11772682|FG004|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
10615100|NCT01932437|11772683|FG005|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
10615101|NCT01932437|11772678|FG000|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||2
10615102|NCT01932437|11772679|FG001|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
10615103|NCT01932437|11772680|FG002|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
10615104|NCT01932437|11772681|FG003|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
10615105|NCT01932437|11772682|FG004|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||6
10615106|NCT01932437|11772683|FG005|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
10615107|NCT01932437|11772678|FG000|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||2
10615108|NCT01932437|11772679|FG001|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
10615109|NCT01932437|11772680|FG002|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
10615110|NCT01932437|11772681|FG003|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
10615111|NCT01932437|11772682|FG004|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||6
10615112|NCT01932437|11772683|FG005|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
10615113|NCT01932437|11772678|FG000|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
10615114|NCT01932437|11772679|FG001|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
10615115|NCT01932437|11772680|FG002|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
10615116|NCT01932437|11772681|FG003|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
10615117|NCT01932437|11772682|FG004|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
10615118|NCT01932437|11772683|FG005|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
10615119|NCT01932437|11772678|FG000|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||2
10615120|NCT01932437|11772679|FG001|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
10615121|NCT01932437|11772680|FG002|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
10615122|NCT01932437|11772681|FG003|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
10615123|NCT01932437|11772682|FG004|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
10615124|NCT01932437|11772683|FG005|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||6
10615125|NCT01932437|11772678|FG000|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||2
10615126|NCT01932437|11772679|FG001|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
10615127|NCT01932437|11772680|FG002|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
10615128|NCT01932437|11772681|FG003|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
10615129|NCT01932437|11772682|FG004|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
10615130|NCT01932437|11772683|FG005|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||5
10615131|NCT01932437|11772678|FG000|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
10615132|NCT01932437|11772679|FG001|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
10615133|NCT01932437|11772680|FG002|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
10615134|NCT01932437|11772681|FG003|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
10615135|NCT01932437|11772682|FG004|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
10615136|NCT01932437|11772683|FG005|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||1
10615137|NCT01932606|11772706|FG000|STARTED|Overall Study||14
10615138|NCT01932606|11772707|FG001|STARTED|Overall Study||14
10615139|NCT01932606|11772706|FG000|COMPLETED|Overall Study||14
10615140|NCT01932606|11772707|FG001|COMPLETED|Overall Study||14
10615141|NCT01932606|11772706|FG000|NOT COMPLETED|Overall Study||0
10615142|NCT01932606|11772707|FG001|NOT COMPLETED|Overall Study||0
10615143|NCT01932697|11772715|FG000|STARTED|Overall Study||38
10615144|NCT01932697|11772716|FG001|STARTED|Overall Study||43
10615145|NCT01932697|11772715|FG000|COMPLETED|Overall Study||36
10615146|NCT01932697|11772716|FG001|COMPLETED|Overall Study||43
10615147|NCT01932697|11772715|FG000|NOT COMPLETED|Overall Study||2
10615148|NCT01932697|11772716|FG001|NOT COMPLETED|Overall Study||0
10615149|NCT01932762|11772728|FG000|STARTED|Overall Study||30
10615150|NCT01932762|11772729|FG001|STARTED|Overall Study||30
10615151|NCT01932762|11772730|FG002|STARTED|Overall Study||19
10615152|NCT01932762|11772731|FG003|STARTED|Overall Study||19
10615153|NCT01932762|11772728|FG000|COMPLETED|Overall Study||24
10615154|NCT01932762|11772729|FG001|COMPLETED|Overall Study||28
10615155|NCT01932762|11772730|FG002|COMPLETED|Overall Study||19
10615156|NCT01932762|11772731|FG003|COMPLETED|Overall Study||18
10615157|NCT01932762|11772728|FG000|NOT COMPLETED|Overall Study||6
10615158|NCT01932762|11772729|FG001|NOT COMPLETED|Overall Study||2
10615159|NCT01932762|11772730|FG002|NOT COMPLETED|Overall Study||0
10615160|NCT01932762|11772731|FG003|NOT COMPLETED|Overall Study||1
10615161|NCT01932788|11772743|FG000|STARTED|Overall Study||173
10615162|NCT01932788|11772744|FG001|STARTED|Overall Study||169
10615163|NCT01932788|11772743|FG000|COMPLETED|Overall Study||135
10615164|NCT01932788|11772744|FG001|COMPLETED|Overall Study||118
10615165|NCT01932788|11772743|FG000|NOT COMPLETED|Overall Study||38
10615166|NCT01932788|11772744|FG001|NOT COMPLETED|Overall Study||51
10615167|NCT01932970|11772750|FG000|STARTED|Overall Study|Includes all participants who enrolled into the washout period.|158
10615168|NCT01932970|11772750|FG000|Received Treatment|Overall Study|Includes participants who completed the washout period and received etelcalcetide|148
10615169|NCT01932970|11772750|FG000|COMPLETED|Overall Study||140
10615170|NCT01932970|11772750|FG000|NOT COMPLETED|Overall Study||18
10615171|NCT01932996|11772756|FG000|STARTED|Overall Study||172
10615172|NCT01932996|11772757|FG001|STARTED|Overall Study||180
10615173|NCT01932996|11772756|FG000|COMPLETED|Overall Study||170
10615174|NCT01932996|11772757|FG001|COMPLETED|Overall Study||180
10615175|NCT01932996|11772756|FG000|NOT COMPLETED|Overall Study||2
10615176|NCT01932996|11772757|FG001|NOT COMPLETED|Overall Study||0
10615177|NCT01933048|11772765|FG000|STARTED|Overall Study||548
10615178|NCT01933048|11772766|FG001|STARTED|Overall Study||529
10615179|NCT01933048|11772765|FG000|COMPLETED|Overall Study||523
10615180|NCT01933048|11772766|FG001|COMPLETED|Overall Study||501
10615181|NCT01933048|11772765|FG000|NOT COMPLETED|Overall Study||25
10615182|NCT01933048|11772766|FG001|NOT COMPLETED|Overall Study||28
10615183|NCT01933113|11772775|FG000|STARTED|Overall Study||3
10615184|NCT01933113|11772775|FG000|COMPLETED|Overall Study||2
10615185|NCT01933113|11772775|FG000|NOT COMPLETED|Overall Study||1
10615186|NCT01933217|11772781|FG000|STARTED|Randomization (4 Weeks)||12
10615187|NCT01933217|11772782|FG001|STARTED|Randomization (4 Weeks)||14
10615188|NCT01933217|11772781|FG000|COMPLETED|Randomization (4 Weeks)||10
10615189|NCT01933217|11772782|FG001|COMPLETED|Randomization (4 Weeks)||10
10615190|NCT01933217|11772781|FG000|NOT COMPLETED|Randomization (4 Weeks)||2
10615191|NCT01933217|11772782|FG001|NOT COMPLETED|Randomization (4 Weeks)||4
10615192|NCT01933217|11772781|FG000|STARTED|Crossover (4 Weeks)||10
10615193|NCT01933217|11772782|FG001|STARTED|Crossover (4 Weeks)||10
10615194|NCT01933217|11772781|FG000|COMPLETED|Crossover (4 Weeks)||10
10615195|NCT01933217|11772782|FG001|COMPLETED|Crossover (4 Weeks)||10
10615196|NCT01933217|11772781|FG000|NOT COMPLETED|Crossover (4 Weeks)||0
10615197|NCT01933217|11772782|FG001|NOT COMPLETED|Crossover (4 Weeks)||0
10615198|NCT01933230|11772790|FG000|STARTED|Overall Study||2
10615199|NCT01933230|11772790|FG000|COMPLETED|Overall Study||2
10615200|NCT01933230|11772790|FG000|NOT COMPLETED|Overall Study||0
10615201|NCT01933243|11772796|FG000|STARTED|Overall Study||12
10615202|NCT01933243|11772797|FG001|STARTED|Overall Study||12
10615203|NCT01933243|11772796|FG000|COMPLETED|Overall Study||10
10615204|NCT01933243|11772797|FG001|COMPLETED|Overall Study||8
10615205|NCT01933243|11772796|FG000|NOT COMPLETED|Overall Study||2
10615206|NCT01933243|11772797|FG001|NOT COMPLETED|Overall Study||4
10615207|NCT01933334|11772805|FG000|STARTED|Overall Study||32
10615208|NCT01933334|11772806|FG001|STARTED|Overall Study||31
10615209|NCT01933334|11772805|FG000|COMPLETED|Overall Study||27
10615210|NCT01933334|11772806|FG001|COMPLETED|Overall Study||29
10615211|NCT01933334|11772805|FG000|NOT COMPLETED|Overall Study||5
10615212|NCT01933334|11772806|FG001|NOT COMPLETED|Overall Study||2
10615213|NCT01933399|11772815|FG000|STARTED|Overall Study||29
10615214|NCT01933399|11772816|FG001|STARTED|Overall Study||32
10615215|NCT01933399|11772817|FG002|STARTED|Overall Study||37
10615216|NCT01933399|11772815|FG000|COMPLETED|Overall Study||29
10615217|NCT01933399|11772816|FG001|COMPLETED|Overall Study||32
10615218|NCT01933399|11772817|FG002|COMPLETED|Overall Study||37
10615219|NCT01933399|11772815|FG000|NOT COMPLETED|Overall Study||0
10615220|NCT01933399|11772816|FG001|NOT COMPLETED|Overall Study||0
10615221|NCT01933399|11772817|FG002|NOT COMPLETED|Overall Study||0
10615222|NCT01933425|11772825|FG000|STARTED|Overall Study||7
10615223|NCT01933425|11772826|FG001|STARTED|Overall Study||7
10615224|NCT01933425|11772825|FG000|COMPLETED|Overall Study||7
10615225|NCT01933425|11772826|FG001|COMPLETED|Overall Study||7
10615226|NCT01933425|11772825|FG000|NOT COMPLETED|Overall Study||0
10615227|NCT01933425|11772826|FG001|NOT COMPLETED|Overall Study||0
10615228|NCT01933464|11772836|FG000|STARTED|Overall Study||5
10615229|NCT01933464|11772837|FG001|STARTED|Overall Study||5
10615230|NCT01933464|11772836|FG000|COMPLETED|Overall Study||5
10615231|NCT01933464|11772837|FG001|COMPLETED|Overall Study||5
10615232|NCT01933464|11772836|FG000|NOT COMPLETED|Overall Study||0
10615233|NCT01933464|11772837|FG001|NOT COMPLETED|Overall Study||0
10615234|NCT01933594|11772849|FG000|STARTED|Overall Study||12
10615235|NCT01933594|11772850|FG001|STARTED|Overall Study||12
10615236|NCT01933594|11772851|FG002|STARTED|Overall Study||12
10615237|NCT01933594|11772852|FG003|STARTED|Overall Study||7
10615238|NCT01933594|11772853|FG004|STARTED|Overall Study||13
10615239|NCT01933594|11772854|FG005|STARTED|Overall Study||3
10615240|NCT01933594|11772849|FG000|COMPLETED|Overall Study||11
10615241|NCT01933594|11772850|FG001|COMPLETED|Overall Study||12
10615242|NCT01933594|11772851|FG002|COMPLETED|Overall Study||12
10615243|NCT01933594|11772852|FG003|COMPLETED|Overall Study||7
10615244|NCT01933594|11772853|FG004|COMPLETED|Overall Study||11
10615245|NCT01933594|11772854|FG005|COMPLETED|Overall Study||3
10615246|NCT01933594|11772849|FG000|NOT COMPLETED|Overall Study||1
10615247|NCT01933594|11772850|FG001|NOT COMPLETED|Overall Study||0
10615248|NCT01933594|11772851|FG002|NOT COMPLETED|Overall Study||0
10615249|NCT01933594|11772852|FG003|NOT COMPLETED|Overall Study||0
10615250|NCT01933594|11772853|FG004|NOT COMPLETED|Overall Study||2
10615251|NCT01933594|11772854|FG005|NOT COMPLETED|Overall Study||0
10615252|NCT01933672|11772872|FG000|STARTED|Metformin Run-in Period||43
10615253|NCT01933672|11772873|FG001|STARTED|Metformin Run-in Period||0
10615254|NCT01933672|11772874|FG002|STARTED|Metformin Run-in Period||0
10615255|NCT01933672|11772875|FG003|STARTED|Metformin Run-in Period||0
10615256|NCT01933672|11772876|FG004|STARTED|Metformin Run-in Period||0
10615257|NCT01933672|11772877|FG005|STARTED|Metformin Run-in Period||0
10615258|NCT01933672|11772878|FG006|STARTED|Metformin Run-in Period||0
10615259|NCT01933672|11772872|FG000|Received Treatment|Metformin Run-in Period||43
10615260|NCT01933672|11772873|FG001|Received Treatment|Metformin Run-in Period||0
10615261|NCT01933672|11772874|FG002|Received Treatment|Metformin Run-in Period||0
10615262|NCT01933672|11772875|FG003|Received Treatment|Metformin Run-in Period||0
10615263|NCT01933672|11772876|FG004|Received Treatment|Metformin Run-in Period||0
10615264|NCT01933672|11772877|FG005|Received Treatment|Metformin Run-in Period||0
10615265|NCT01933672|11772878|FG006|Received Treatment|Metformin Run-in Period||0
10615266|NCT01933672|11772872|FG000|COMPLETED|Metformin Run-in Period||33
10615267|NCT01933672|11772873|FG001|COMPLETED|Metformin Run-in Period||0
10615268|NCT01933672|11772874|FG002|COMPLETED|Metformin Run-in Period||0
10615269|NCT01933672|11772875|FG003|COMPLETED|Metformin Run-in Period||0
10615270|NCT01933672|11772876|FG004|COMPLETED|Metformin Run-in Period||0
10615271|NCT01933672|11772877|FG005|COMPLETED|Metformin Run-in Period||0
10615272|NCT01933672|11772878|FG006|COMPLETED|Metformin Run-in Period||0
10615273|NCT01933672|11772872|FG000|NOT COMPLETED|Metformin Run-in Period||10
10615274|NCT01933672|11772873|FG001|NOT COMPLETED|Metformin Run-in Period||0
10615275|NCT01933672|11772874|FG002|NOT COMPLETED|Metformin Run-in Period||0
10615276|NCT01933672|11772875|FG003|NOT COMPLETED|Metformin Run-in Period||0
10615277|NCT01933672|11772876|FG004|NOT COMPLETED|Metformin Run-in Period||0
10615278|NCT01933672|11772877|FG005|NOT COMPLETED|Metformin Run-in Period||0
10615279|NCT01933672|11772878|FG006|NOT COMPLETED|Metformin Run-in Period||0
10615280|NCT01933672|11772872|FG000|STARTED|First Intervention Period (12-16 Days)||0
10615281|NCT01933672|11772873|FG001|STARTED|First Intervention Period (12-16 Days)||7
10615282|NCT01933672|11772874|FG002|STARTED|First Intervention Period (12-16 Days)||3
10615283|NCT01933672|11772875|FG003|STARTED|First Intervention Period (12-16 Days)||5
10615284|NCT01933672|11772876|FG004|STARTED|First Intervention Period (12-16 Days)||7
10615285|NCT01933672|11772877|FG005|STARTED|First Intervention Period (12-16 Days)||5
10615286|NCT01933672|11772878|FG006|STARTED|First Intervention Period (12-16 Days)||6
10615287|NCT01933672|11772872|FG000|COMPLETED|First Intervention Period (12-16 Days)||0
10615288|NCT01933672|11772873|FG001|COMPLETED|First Intervention Period (12-16 Days)||7
10615289|NCT01933672|11772874|FG002|COMPLETED|First Intervention Period (12-16 Days)||2
10615290|NCT01933672|11772875|FG003|COMPLETED|First Intervention Period (12-16 Days)||5
10615291|NCT01933672|11772876|FG004|COMPLETED|First Intervention Period (12-16 Days)||6
10615292|NCT01933672|11772877|FG005|COMPLETED|First Intervention Period (12-16 Days)||4
10615293|NCT01933672|11772878|FG006|COMPLETED|First Intervention Period (12-16 Days)||6
10615294|NCT01933672|11772872|FG000|NOT COMPLETED|First Intervention Period (12-16 Days)||0
10615295|NCT01933672|11772873|FG001|NOT COMPLETED|First Intervention Period (12-16 Days)||0
10615296|NCT01933672|11772874|FG002|NOT COMPLETED|First Intervention Period (12-16 Days)||1
10615297|NCT01933672|11772875|FG003|NOT COMPLETED|First Intervention Period (12-16 Days)||0
10615298|NCT01933672|11772876|FG004|NOT COMPLETED|First Intervention Period (12-16 Days)||1
10615299|NCT01933672|11772877|FG005|NOT COMPLETED|First Intervention Period (12-16 Days)||1
10615300|NCT01933672|11772878|FG006|NOT COMPLETED|First Intervention Period (12-16 Days)||0
10615301|NCT01933672|11772872|FG000|STARTED|First Washout Period (7-14 Days)||0
10615302|NCT01933672|11772873|FG001|STARTED|First Washout Period (7-14 Days)||7
10615303|NCT01933672|11772874|FG002|STARTED|First Washout Period (7-14 Days)||2
10615304|NCT01933672|11772875|FG003|STARTED|First Washout Period (7-14 Days)||5
10615305|NCT01933672|11772876|FG004|STARTED|First Washout Period (7-14 Days)||6
10615306|NCT01933672|11772877|FG005|STARTED|First Washout Period (7-14 Days)||4
10615307|NCT01933672|11772878|FG006|STARTED|First Washout Period (7-14 Days)||6
10615308|NCT01933672|11772872|FG000|COMPLETED|First Washout Period (7-14 Days)||0
10615309|NCT01933672|11772873|FG001|COMPLETED|First Washout Period (7-14 Days)||7
10615310|NCT01933672|11772874|FG002|COMPLETED|First Washout Period (7-14 Days)||2
10615311|NCT01933672|11772875|FG003|COMPLETED|First Washout Period (7-14 Days)||5
10615312|NCT01933672|11772876|FG004|COMPLETED|First Washout Period (7-14 Days)||6
10615313|NCT01933672|11772877|FG005|COMPLETED|First Washout Period (7-14 Days)||4
10615314|NCT01933672|11772878|FG006|COMPLETED|First Washout Period (7-14 Days)||6
10615315|NCT01933672|11772872|FG000|NOT COMPLETED|First Washout Period (7-14 Days)||0
10615316|NCT01933672|11772873|FG001|NOT COMPLETED|First Washout Period (7-14 Days)||0
10615317|NCT01933672|11772874|FG002|NOT COMPLETED|First Washout Period (7-14 Days)||0
10615318|NCT01933672|11772875|FG003|NOT COMPLETED|First Washout Period (7-14 Days)||0
10615319|NCT01933672|11772876|FG004|NOT COMPLETED|First Washout Period (7-14 Days)||0
10615320|NCT01933672|11772877|FG005|NOT COMPLETED|First Washout Period (7-14 Days)||0
10615321|NCT01933672|11772878|FG006|NOT COMPLETED|First Washout Period (7-14 Days)||0
10615322|NCT01933672|11772872|FG000|STARTED|Second Intervention Period (12-16 Days)||0
10615323|NCT01933672|11772873|FG001|STARTED|Second Intervention Period (12-16 Days)||7
10615324|NCT01933672|11772874|FG002|STARTED|Second Intervention Period (12-16 Days)||2
10615325|NCT01933672|11772875|FG003|STARTED|Second Intervention Period (12-16 Days)||5
10615326|NCT01933672|11772876|FG004|STARTED|Second Intervention Period (12-16 Days)||6
10615327|NCT01933672|11772877|FG005|STARTED|Second Intervention Period (12-16 Days)||4
10704849|NCT01525901|11869246|FG002|COMPLETED|Period 1: 12 Weeks||5
10704850|NCT01525901|11869247|FG003|COMPLETED|Period 1: 12 Weeks||5
10704851|NCT01525901|11869244|FG000|NOT COMPLETED|Period 1: 12 Weeks||0
10704852|NCT01525901|11869245|FG001|NOT COMPLETED|Period 1: 12 Weeks||0
10704853|NCT01525901|11869246|FG002|NOT COMPLETED|Period 1: 12 Weeks||0
10615328|NCT01933672|11772878|FG006|STARTED|Second Intervention Period (12-16 Days)||6
10615329|NCT01933672|11772872|FG000|COMPLETED|Second Intervention Period (12-16 Days)||0
10615330|NCT01933672|11772873|FG001|COMPLETED|Second Intervention Period (12-16 Days)||6
10615331|NCT01933672|11772874|FG002|COMPLETED|Second Intervention Period (12-16 Days)||1
10615332|NCT01933672|11772875|FG003|COMPLETED|Second Intervention Period (12-16 Days)||5
10615333|NCT01933672|11772876|FG004|COMPLETED|Second Intervention Period (12-16 Days)||6
10615334|NCT01933672|11772877|FG005|COMPLETED|Second Intervention Period (12-16 Days)||4
10615335|NCT01933672|11772878|FG006|COMPLETED|Second Intervention Period (12-16 Days)||6
10615336|NCT01933672|11772872|FG000|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
10615337|NCT01933672|11772873|FG001|NOT COMPLETED|Second Intervention Period (12-16 Days)||1
10615338|NCT01933672|11772874|FG002|NOT COMPLETED|Second Intervention Period (12-16 Days)||1
10615339|NCT01933672|11772875|FG003|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
10615340|NCT01933672|11772876|FG004|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
10615341|NCT01933672|11772877|FG005|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
10615342|NCT01933672|11772878|FG006|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
10615343|NCT01933672|11772872|FG000|STARTED|Second Washout Period (7-14 Days)||0
10615344|NCT01933672|11772873|FG001|STARTED|Second Washout Period (7-14 Days)||6
10615345|NCT01933672|11772874|FG002|STARTED|Second Washout Period (7-14 Days)||1
10615346|NCT01933672|11772875|FG003|STARTED|Second Washout Period (7-14 Days)||5
10615347|NCT01933672|11772876|FG004|STARTED|Second Washout Period (7-14 Days)||6
10615348|NCT01933672|11772877|FG005|STARTED|Second Washout Period (7-14 Days)||4
10615349|NCT01933672|11772878|FG006|STARTED|Second Washout Period (7-14 Days)||6
10615350|NCT01933672|11772872|FG000|COMPLETED|Second Washout Period (7-14 Days)||0
10615351|NCT01933672|11772873|FG001|COMPLETED|Second Washout Period (7-14 Days)||6
10615352|NCT01933672|11772874|FG002|COMPLETED|Second Washout Period (7-14 Days)||1
10615353|NCT01933672|11772875|FG003|COMPLETED|Second Washout Period (7-14 Days)||5
10615354|NCT01933672|11772876|FG004|COMPLETED|Second Washout Period (7-14 Days)||6
10615355|NCT01933672|11772877|FG005|COMPLETED|Second Washout Period (7-14 Days)||4
10615356|NCT01933672|11772878|FG006|COMPLETED|Second Washout Period (7-14 Days)||6
10615357|NCT01933672|11772872|FG000|NOT COMPLETED|Second Washout Period (7-14 Days)||0
10615358|NCT01933672|11772873|FG001|NOT COMPLETED|Second Washout Period (7-14 Days)||0
10615359|NCT01933672|11772874|FG002|NOT COMPLETED|Second Washout Period (7-14 Days)||0
10615360|NCT01933672|11772875|FG003|NOT COMPLETED|Second Washout Period (7-14 Days)||0
10615361|NCT01933672|11772876|FG004|NOT COMPLETED|Second Washout Period (7-14 Days)||0
10615362|NCT01933672|11772877|FG005|NOT COMPLETED|Second Washout Period (7-14 Days)||0
10615363|NCT01933672|11772878|FG006|NOT COMPLETED|Second Washout Period (7-14 Days)||0
10615364|NCT01933672|11772872|FG000|STARTED|Third Intervention Period (12-16 Days)||0
10615365|NCT01933672|11772873|FG001|STARTED|Third Intervention Period (12-16 Days)||6
10615366|NCT01933672|11772874|FG002|STARTED|Third Intervention Period (12-16 Days)||1
10615367|NCT01933672|11772875|FG003|STARTED|Third Intervention Period (12-16 Days)||5
10615368|NCT01933672|11772876|FG004|STARTED|Third Intervention Period (12-16 Days)||6
10615369|NCT01933672|11772877|FG005|STARTED|Third Intervention Period (12-16 Days)||4
10615370|NCT01933672|11772878|FG006|STARTED|Third Intervention Period (12-16 Days)||6
10615371|NCT01933672|11772872|FG000|COMPLETED|Third Intervention Period (12-16 Days)||0
10615372|NCT01933672|11772873|FG001|COMPLETED|Third Intervention Period (12-16 Days)||5
10615373|NCT01933672|11772874|FG002|COMPLETED|Third Intervention Period (12-16 Days)||1
10615374|NCT01933672|11772875|FG003|COMPLETED|Third Intervention Period (12-16 Days)||4
10615375|NCT01933672|11772876|FG004|COMPLETED|Third Intervention Period (12-16 Days)||6
10615376|NCT01933672|11772877|FG005|COMPLETED|Third Intervention Period (12-16 Days)||4
10615377|NCT01933672|11772878|FG006|COMPLETED|Third Intervention Period (12-16 Days)||6
10615378|NCT01933672|11772872|FG000|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
10615379|NCT01933672|11772873|FG001|NOT COMPLETED|Third Intervention Period (12-16 Days)||1
10615380|NCT01933672|11772874|FG002|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
10615381|NCT01933672|11772875|FG003|NOT COMPLETED|Third Intervention Period (12-16 Days)||1
10615382|NCT01933672|11772876|FG004|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
10615383|NCT01933672|11772877|FG005|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
10615384|NCT01933672|11772878|FG006|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
10615385|NCT01933776|11772893|FG000|STARTED|Overall Study||20
10615386|NCT01933776|11772894|FG001|STARTED|Overall Study||20
10615387|NCT01933776|11772893|FG000|COMPLETED|Overall Study||20
10615388|NCT01933776|11772894|FG001|COMPLETED|Overall Study||20
10615389|NCT01933776|11772893|FG000|NOT COMPLETED|Overall Study||0
10615390|NCT01933776|11772894|FG001|NOT COMPLETED|Overall Study||0
10615391|NCT01933789|11772909|FG000|STARTED|Overall Study||65
10615392|NCT01933789|11772910|FG001|STARTED|Overall Study||67
10615393|NCT01933789|11772911|FG002|STARTED|Overall Study||2
10615394|NCT01933789|11772912|FG003|STARTED|Overall Study||2
10615395|NCT01933789|11772913|FG004|STARTED|Overall Study||249
10615396|NCT01933789|11772914|FG005|STARTED|Overall Study||288
10615397|NCT01933789|11772915|FG006|STARTED|Overall Study||58
10615398|NCT01933789|11772916|FG007|STARTED|Overall Study||61
10615399|NCT01933789|11772917|FG008|STARTED|Overall Study||25
10615400|NCT01933789|11772909|FG000|Had Target Visit|Overall Study|Had target visit(s) completed before clinician or patient withdrawal|61
10615401|NCT01933789|11772910|FG001|Had Target Visit|Overall Study|Had target visit(s) completed before clinician or patient withdrawal|65
10615402|NCT01933789|11772911|FG002|Had Target Visit|Overall Study||2
10615403|NCT01933789|11772912|FG003|Had Target Visit|Overall Study||2
10615404|NCT01933789|11772913|FG004|Had Target Visit|Overall Study||228
10615405|NCT01933789|11772914|FG005|Had Target Visit|Overall Study||266
10615406|NCT01933789|11772915|FG006|Had Target Visit|Overall Study||0
10615407|NCT01933789|11772916|FG007|Had Target Visit|Overall Study||0
10615408|NCT01933789|11772917|FG008|Had Target Visit|Overall Study||0
10615409|NCT01933789|11772909|FG000|Completed After-visit Survey|Overall Study|Number reflects individual clinicians who returned surveys for up to 6 enrolled patients|57
10615410|NCT01933789|11772910|FG001|Completed After-visit Survey|Overall Study|Number reflects individual clinicians who returned surveys for up to 6 enrolled patients|64
10615411|NCT01933789|11772911|FG002|Completed After-visit Survey|Overall Study|Number reflects individual IP Team members who returned surveys for up to 6 enrolled patients|2
10615412|NCT01933789|11772912|FG003|Completed After-visit Survey|Overall Study|Number reflects individual IP Team members who returned surveys for up to 6 enrolled patients|1
10615413|NCT01933789|11772913|FG004|Completed After-visit Survey|Overall Study||0
10615414|NCT01933789|11772914|FG005|Completed After-visit Survey|Overall Study||0
10615415|NCT01933789|11772915|FG006|Completed After-visit Survey|Overall Study||0
10615416|NCT01933789|11772916|FG007|Completed After-visit Survey|Overall Study||0
10615417|NCT01933789|11772917|FG008|Completed After-visit Survey|Overall Study||0
10615418|NCT01933789|11772909|FG000|Completed 2-Week Survey|Overall Study||0
10615419|NCT01933789|11772910|FG001|Completed 2-Week Survey|Overall Study||0
10615420|NCT01933789|11772911|FG002|Completed 2-Week Survey|Overall Study||0
10615421|NCT01933789|11772912|FG003|Completed 2-Week Survey|Overall Study||0
10615422|NCT01933789|11772913|FG004|Completed 2-Week Survey|Overall Study||184
10615423|NCT01933789|11772914|FG005|Completed 2-Week Survey|Overall Study||215
10615424|NCT01933789|11772915|FG006|Completed 2-Week Survey|Overall Study||0
10615425|NCT01933789|11772916|FG007|Completed 2-Week Survey|Overall Study||0
10615426|NCT01933789|11772917|FG008|Completed 2-Week Survey|Overall Study||0
10615427|NCT01933789|11772909|FG000|Completed 3-Month Survey|Overall Study||0
10615428|NCT01933789|11772910|FG001|Completed 3-Month Survey|Overall Study||0
10615429|NCT01933789|11772911|FG002|Completed 3-Month Survey|Overall Study||0
10615430|NCT01933789|11772912|FG003|Completed 3-Month Survey|Overall Study||0
10615431|NCT01933789|11772913|FG004|Completed 3-Month Survey|Overall Study||176
10615432|NCT01933789|11772914|FG005|Completed 3-Month Survey|Overall Study||211
10615433|NCT01933789|11772915|FG006|Completed 3-Month Survey|Overall Study||37
10615434|NCT01933789|11772916|FG007|Completed 3-Month Survey|Overall Study||43
10615435|NCT01933789|11772917|FG008|Completed 3-Month Survey|Overall Study||0
10615436|NCT01933789|11772909|FG000|Completed 6-Month Survey|Overall Study||0
10615437|NCT01933789|11772910|FG001|Completed 6-Month Survey|Overall Study||0
10615438|NCT01933789|11772911|FG002|Completed 6-Month Survey|Overall Study||0
10615439|NCT01933789|11772912|FG003|Completed 6-Month Survey|Overall Study||0
10615440|NCT01933789|11772913|FG004|Completed 6-Month Survey|Overall Study||160
10615441|NCT01933789|11772914|FG005|Completed 6-Month Survey|Overall Study||188
10615442|NCT01933789|11772915|FG006|Completed 6-Month Survey|Overall Study||35
10615443|NCT01933789|11772916|FG007|Completed 6-Month Survey|Overall Study||40
10615444|NCT01933789|11772917|FG008|Completed 6-Month Survey|Overall Study||0
10615445|NCT01933789|11772909|FG000|Qualitative Interviews|Overall Study||0
10615446|NCT01933789|11772910|FG001|Qualitative Interviews|Overall Study||0
10615447|NCT01933789|11772911|FG002|Qualitative Interviews|Overall Study||0
10615448|NCT01933789|11772912|FG003|Qualitative Interviews|Overall Study||0
10615449|NCT01933789|11772913|FG004|Qualitative Interviews|Overall Study||0
10615450|NCT01933789|11772914|FG005|Qualitative Interviews|Overall Study||0
10615451|NCT01933789|11772915|FG006|Qualitative Interviews|Overall Study||0
10615452|NCT01933789|11772916|FG007|Qualitative Interviews|Overall Study||0
10615453|NCT01933789|11772917|FG008|Qualitative Interviews|Overall Study||25
10615454|NCT01933789|11772909|FG000|COMPLETED|Overall Study||59
10615455|NCT01933789|11772910|FG001|COMPLETED|Overall Study||66
10615456|NCT01933789|11772911|FG002|COMPLETED|Overall Study||2
10615457|NCT01933789|11772912|FG003|COMPLETED|Overall Study||1
10615458|NCT01933789|11772913|FG004|COMPLETED|Overall Study||190
10615459|NCT01933789|11772914|FG005|COMPLETED|Overall Study||221
10615460|NCT01933789|11772915|FG006|COMPLETED|Overall Study||43
10615461|NCT01933789|11772916|FG007|COMPLETED|Overall Study||47
10615462|NCT01933789|11772917|FG008|COMPLETED|Overall Study||25
10615463|NCT01933789|11772909|FG000|NOT COMPLETED|Overall Study||6
10615464|NCT01933789|11772910|FG001|NOT COMPLETED|Overall Study||1
10615465|NCT01933789|11772911|FG002|NOT COMPLETED|Overall Study||0
10615466|NCT01933789|11772912|FG003|NOT COMPLETED|Overall Study||1
10615467|NCT01933789|11772913|FG004|NOT COMPLETED|Overall Study||59
10615468|NCT01933789|11772914|FG005|NOT COMPLETED|Overall Study||67
10615469|NCT01933789|11772915|FG006|NOT COMPLETED|Overall Study||15
10615470|NCT01933789|11772916|FG007|NOT COMPLETED|Overall Study||14
10615471|NCT01933789|11772917|FG008|NOT COMPLETED|Overall Study||0
10615472|NCT01933880|11772939|FG000|STARTED|Overall Study||153
10615473|NCT01933880|11772940|FG001|STARTED|Overall Study||41
10615474|NCT01933880|11772939|FG000|COMPLETED|Overall Study||123
10615475|NCT01933880|11772940|FG001|COMPLETED|Overall Study||40
10615476|NCT01933880|11772939|FG000|NOT COMPLETED|Overall Study||30
10615477|NCT01933880|11772940|FG001|NOT COMPLETED|Overall Study||1
10615478|NCT01933919|11772953|FG000|STARTED|Double-blind Placebo-controlled Phase||19
10615479|NCT01933919|11772954|FG001|STARTED|Double-blind Placebo-controlled Phase||19
10615480|NCT01933919|11772953|FG000|Received Study Drug|Double-blind Placebo-controlled Phase||19
10615481|NCT01933919|11772954|FG001|Received Study Drug|Double-blind Placebo-controlled Phase||19
10615482|NCT01933919|11772953|FG000|COMPLETED|Double-blind Placebo-controlled Phase||19
10615483|NCT01933919|11772954|FG001|COMPLETED|Double-blind Placebo-controlled Phase||15
10615484|NCT01933919|11772953|FG000|NOT COMPLETED|Double-blind Placebo-controlled Phase||0
10615485|NCT01933919|11772954|FG001|NOT COMPLETED|Double-blind Placebo-controlled Phase||4
10615486|NCT01933919|11772953|FG000|STARTED|Open-label Long-term Phase||19
10615487|NCT01933919|11772954|FG001|STARTED|Open-label Long-term Phase||15
10615488|NCT01933919|11772953|FG000|COMPLETED|Open-label Long-term Phase||12
10615489|NCT01933919|11772954|FG001|COMPLETED|Open-label Long-term Phase||9
10615490|NCT01933919|11772953|FG000|NOT COMPLETED|Open-label Long-term Phase||7
10615491|NCT01933919|11772954|FG001|NOT COMPLETED|Open-label Long-term Phase||6
10615492|NCT01933984|11772974|FG000|STARTED|Overall Study||26
10615493|NCT01933984|11772975|FG001|STARTED|Overall Study||25
10615494|NCT01933984|11772974|FG000|COMPLETED|Overall Study||26
10615495|NCT01933984|11772975|FG001|COMPLETED|Overall Study||25
10615496|NCT01933984|11772974|FG000|NOT COMPLETED|Overall Study||0
10615497|NCT01933984|11772975|FG001|NOT COMPLETED|Overall Study||0
10615498|NCT01934010|11772988|FG000|STARTED|Overall Study||114
10615499|NCT01934010|11772989|FG001|STARTED|Overall Study||67
10615500|NCT01934010|11772990|FG002|STARTED|Overall Study||76
10615501|NCT01934010|11772988|FG000|COMPLETED|Overall Study||91
10615502|NCT01934010|11772989|FG001|COMPLETED|Overall Study||56
10615503|NCT01934010|11772990|FG002|COMPLETED|Overall Study||74
10615504|NCT01934010|11772988|FG000|NOT COMPLETED|Overall Study||23
10615505|NCT01934010|11772989|FG001|NOT COMPLETED|Overall Study||11
10615506|NCT01934010|11772990|FG002|NOT COMPLETED|Overall Study||2
10615507|NCT01934140|11773009|FG000|STARTED|Persistence Phase (Year 6-10)||235
10615508|NCT01934140|11773010|FG001|STARTED|Persistence Phase (Year 6-10)||76
10615509|NCT01934140|11773009|FG000|COMPLETED|Persistence Phase (Year 6-10)|Participants completed all persistence phase visits|152
10615510|NCT01934140|11773010|FG001|COMPLETED|Persistence Phase (Year 6-10)|Participants completed all persistence phase visits|51
10615511|NCT01934140|11773009|FG000|NOT COMPLETED|Persistence Phase (Year 6-10)||83
10615512|NCT01934140|11773010|FG001|NOT COMPLETED|Persistence Phase (Year 6-10)||25
10615513|NCT01934140|11773009|FG000|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent, were enrolled in booster phase.|164
10615514|NCT01934140|11773010|FG001|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent, were enrolled in booster phase.|56
10615515|NCT01934140|11773009|FG000|Vaccinated|Booster Phase (6 Months)||164
10615516|NCT01934140|11773010|FG001|Vaccinated|Booster Phase (6 Months)||56
10615517|NCT01934140|11773009|FG000|COMPLETED|Booster Phase (6 Months)||159
10615518|NCT01934140|11773010|FG001|COMPLETED|Booster Phase (6 Months)||53
10615519|NCT01934140|11773009|FG000|NOT COMPLETED|Booster Phase (6 Months)||5
10615520|NCT01934140|11773010|FG001|NOT COMPLETED|Booster Phase (6 Months)||3
10615521|NCT01934192|11773022|FG000|STARTED|Overall Study||40
10615522|NCT01934192|11773023|FG001|STARTED|Overall Study||44
10615523|NCT01934192|11773024|FG002|STARTED|Overall Study||4
10615524|NCT01934192|11773025|FG003|STARTED|Overall Study||4
10615525|NCT01934192|11773022|FG000|COMPLETED|Overall Study||31
10615526|NCT01934192|11773023|FG001|COMPLETED|Overall Study||37
10615527|NCT01934192|11773024|FG002|COMPLETED|Overall Study||3
10615528|NCT01934192|11773025|FG003|COMPLETED|Overall Study||3
10615529|NCT01934192|11773022|FG000|NOT COMPLETED|Overall Study||9
10615530|NCT01934192|11773023|FG001|NOT COMPLETED|Overall Study||7
10615531|NCT01934192|11773024|FG002|NOT COMPLETED|Overall Study||1
10615532|NCT01934192|11773025|FG003|NOT COMPLETED|Overall Study||1
10653192|NCT02190604|11813570|FG014|NOT COMPLETED|Part 3 (Patients)||0
10653193|NCT02190604|11813571|FG015|NOT COMPLETED|Part 3 (Patients)||0
10653194|NCT02190604|11813572|FG016|NOT COMPLETED|Part 3 (Patients)||0
10653195|NCT02190604|11813573|FG017|NOT COMPLETED|Part 3 (Patients)||0
10653196|NCT02190604|11813574|FG018|NOT COMPLETED|Part 3 (Patients)||0
10653197|NCT02190747|11813634|FG000|STARTED|Overall Study||21
10653198|NCT02190747|11813635|FG001|STARTED|Overall Study||9
10653199|NCT02190747|11813636|FG002|STARTED|Overall Study||10
10653200|NCT02190747|11813634|FG000|COMPLETED|Overall Study||21
10653201|NCT02190747|11813635|FG001|COMPLETED|Overall Study||9
10653202|NCT02190747|11813636|FG002|COMPLETED|Overall Study||10
10653203|NCT02190747|11813634|FG000|NOT COMPLETED|Overall Study||0
10653204|NCT02190747|11813635|FG001|NOT COMPLETED|Overall Study||0
10653205|NCT02190747|11813636|FG002|NOT COMPLETED|Overall Study||0
10653206|NCT02190903|11813646|FG000|STARTED|Overall Study||6
10653207|NCT02190903|11813647|FG001|STARTED|Overall Study||6
10653208|NCT02190903|11813646|FG000|COMPLETED|Overall Study||6
10653209|NCT02190903|11813647|FG001|COMPLETED|Overall Study||6
10653210|NCT02190903|11813646|FG000|NOT COMPLETED|Overall Study||0
10653211|NCT02190903|11813647|FG001|NOT COMPLETED|Overall Study||0
10653212|NCT02191033|11813655|FG000|STARTED|Overall Study||20
10653213|NCT02191033|11813656|FG001|STARTED|Overall Study||20
10653214|NCT02191033|11813655|FG000|COMPLETED|Overall Study||18
10653215|NCT02191033|11813656|FG001|COMPLETED|Overall Study||19
10615533|NCT01934218|11773048|FG000|STARTED|Double-blind Phase||404
10615534|NCT01934218|11773049|FG001|STARTED|Double-blind Phase||410
10615535|NCT01934218|11773048|FG000|Analyzed Participants|Double-blind Phase||402
10615536|NCT01934218|11773049|FG001|Analyzed Participants|Double-blind Phase||407
10615537|NCT01934218|11773048|FG000|COMPLETED|Double-blind Phase||356
10615538|NCT01934218|11773049|FG001|COMPLETED|Double-blind Phase||356
10615539|NCT01934218|11773048|FG000|NOT COMPLETED|Double-blind Phase||48
10615540|NCT01934218|11773049|FG001|NOT COMPLETED|Double-blind Phase||54
10615541|NCT01934218|11773048|FG000|STARTED|Open-Label Phase||316
10615542|NCT01934218|11773049|FG001|STARTED|Open-Label Phase||328
10615543|NCT01934218|11773048|FG000|COMPLETED|Open-Label Phase||290
10615544|NCT01934218|11773049|FG001|COMPLETED|Open-Label Phase||304
10615545|NCT01934218|11773048|FG000|NOT COMPLETED|Open-Label Phase||26
10615546|NCT01934218|11773049|FG001|NOT COMPLETED|Open-Label Phase||24
10615547|NCT01934231|11773055|FG000|STARTED|Overall Study||27
10615548|NCT01934231|11773055|FG000|COMPLETED|Overall Study||27
10615549|NCT01934231|11773055|FG000|NOT COMPLETED|Overall Study||0
10615550|NCT01934335|11773061|FG000|STARTED|Overall Study||7
10615551|NCT01934335|11773062|FG001|STARTED|Overall Study||5
10615552|NCT01934335|11773061|FG000|COMPLETED|Overall Study||6
10615553|NCT01934335|11773062|FG001|COMPLETED|Overall Study||4
10615554|NCT01934335|11773061|FG000|NOT COMPLETED|Overall Study||1
10615555|NCT01934335|11773062|FG001|NOT COMPLETED|Overall Study||1
10615556|NCT01934517|11773068|FG000|STARTED|Overall Study||25
10615557|NCT01934517|11773068|FG000|COMPLETED|Overall Study||25
10615558|NCT01934517|11773068|FG000|NOT COMPLETED|Overall Study||0
10615559|NCT01934556|11773079|FG000|STARTED|Overall Study||30
10615560|NCT01934556|11773080|FG001|STARTED|Overall Study||60
10615561|NCT01934556|11773081|FG002|STARTED|Overall Study||60
10615562|NCT01934556|11773079|FG000|COMPLETED|Overall Study||25
10615563|NCT01934556|11773080|FG001|COMPLETED|Overall Study||44
10615564|NCT01934556|11773081|FG002|COMPLETED|Overall Study||50
10615565|NCT01934556|11773079|FG000|NOT COMPLETED|Overall Study||5
10615566|NCT01934556|11773080|FG001|NOT COMPLETED|Overall Study||16
10615567|NCT01934556|11773081|FG002|NOT COMPLETED|Overall Study||10
10615568|NCT01934582|11773089|FG000|STARTED|Overall Study||13
10615569|NCT01934582|11773089|FG000|COMPLETED|Overall Study||13
10615570|NCT01934582|11773089|FG000|NOT COMPLETED|Overall Study||0
10615571|NCT01934790|11773095|FG000|STARTED|Treatment|Eligible for treatment|45
10615572|NCT01934790|11773095|FG000|Participants Received Study Treatment|Treatment||44
10615573|NCT01934790|11773095|FG000|COMPLETED|Treatment||29
10615574|NCT01934790|11773095|FG000|NOT COMPLETED|Treatment||16
10615575|NCT01934790|11773095|FG000|STARTED|Active Follow up||34
10615576|NCT01934790|11773095|FG000|COMPLETED|Active Follow up||10
10615577|NCT01934790|11773095|FG000|NOT COMPLETED|Active Follow up||24
10615578|NCT01934790|11773095|FG000|STARTED|Long Term Follow up||12
10615579|NCT01934790|11773095|FG000|COMPLETED|Long Term Follow up||12
10615580|NCT01934790|11773095|FG000|NOT COMPLETED|Long Term Follow up||0
10615581|NCT01934894|11773101|FG000|STARTED|Overall Study||6
10615582|NCT01934894|11773102|FG001|STARTED|Overall Study||5
10615583|NCT01934894|11773101|FG000|COMPLETED|Overall Study||0
10615584|NCT01934894|11773102|FG001|COMPLETED|Overall Study||0
10615585|NCT01934894|11773101|FG000|NOT COMPLETED|Overall Study||6
10615586|NCT01934894|11773102|FG001|NOT COMPLETED|Overall Study||5
10615587|NCT01934972|11773113|FG000|STARTED|Overall Study||13
10615588|NCT01934972|11773114|FG001|STARTED|Overall Study||11
10615589|NCT01934972|11773113|FG000|COMPLETED|Overall Study||4
10615590|NCT01934972|11773114|FG001|COMPLETED|Overall Study||5
10615591|NCT01934972|11773113|FG000|NOT COMPLETED|Overall Study||9
10615592|NCT01934972|11773114|FG001|NOT COMPLETED|Overall Study||6
10615593|NCT01935180|11773122|FG000|STARTED|Overall Study||573
10615594|NCT01935180|11773123|FG001|STARTED|Overall Study||575
10615595|NCT01935180|11773122|FG000|COMPLETED|Overall Study||552
10615596|NCT01935180|11773123|FG001|COMPLETED|Overall Study||561
10615597|NCT01935180|11773122|FG000|NOT COMPLETED|Overall Study||21
10615598|NCT01935180|11773123|FG001|NOT COMPLETED|Overall Study||14
10615599|NCT01935622|11773132|FG000|STARTED|Overall Study||3
10615600|NCT01935622|11773133|FG001|STARTED|Overall Study||3
10615601|NCT01935622|11773134|FG002|STARTED|Overall Study||4
10615602|NCT01935622|11773132|FG000|COMPLETED|Overall Study||1
10615603|NCT01935622|11773133|FG001|COMPLETED|Overall Study||1
10615604|NCT01935622|11773134|FG002|COMPLETED|Overall Study||4
10615605|NCT01935622|11773132|FG000|NOT COMPLETED|Overall Study||2
10615606|NCT01935622|11773133|FG001|NOT COMPLETED|Overall Study||2
10615607|NCT01935622|11773134|FG002|NOT COMPLETED|Overall Study||0
10615608|NCT01935700|11773144|FG000|STARTED|Overall Study||14
10615609|NCT01935700|11773145|FG001|STARTED|Overall Study||86
10615610|NCT01935700|11773144|FG000|COMPLETED|Overall Study||9
10615611|NCT01935700|11773145|FG001|COMPLETED|Overall Study||86
10615612|NCT01935700|11773144|FG000|NOT COMPLETED|Overall Study||5
10615613|NCT01935700|11773145|FG001|NOT COMPLETED|Overall Study||0
10615614|NCT01935791|11773153|FG000|STARTED|Period 1||4
10615615|NCT01935791|11773154|FG001|STARTED|Period 1||4
10615616|NCT01935791|11773155|FG002|STARTED|Period 1||3
10615617|NCT01935791|11773156|FG003|STARTED|Period 1||0
10615618|NCT01935791|11773157|FG004|STARTED|Period 1||0
10615619|NCT01935791|11773158|FG005|STARTED|Period 1||0
10615620|NCT01935791|11773159|FG006|STARTED|Period 1||0
10615621|NCT01935791|11773160|FG007|STARTED|Period 1||0
10615622|NCT01935791|11773161|FG008|STARTED|Period 1||0
10615623|NCT01935791|11773153|FG000|COMPLETED|Period 1||4
10615624|NCT01935791|11773154|FG001|COMPLETED|Period 1||4
10615625|NCT01935791|11773155|FG002|COMPLETED|Period 1||3
10615626|NCT01935791|11773156|FG003|COMPLETED|Period 1||0
10615627|NCT01935791|11773157|FG004|COMPLETED|Period 1||0
10615628|NCT01935791|11773158|FG005|COMPLETED|Period 1||0
10615629|NCT01935791|11773159|FG006|COMPLETED|Period 1||0
10615630|NCT01935791|11773160|FG007|COMPLETED|Period 1||0
10615631|NCT01935791|11773161|FG008|COMPLETED|Period 1||0
10615632|NCT01935791|11773153|FG000|NOT COMPLETED|Period 1||0
10615633|NCT01935791|11773154|FG001|NOT COMPLETED|Period 1||0
10615634|NCT01935791|11773155|FG002|NOT COMPLETED|Period 1||0
10615635|NCT01935791|11773156|FG003|NOT COMPLETED|Period 1||0
10615636|NCT01935791|11773157|FG004|NOT COMPLETED|Period 1||0
10615637|NCT01935791|11773158|FG005|NOT COMPLETED|Period 1||0
10615638|NCT01935791|11773159|FG006|NOT COMPLETED|Period 1||0
10615639|NCT01935791|11773160|FG007|NOT COMPLETED|Period 1||0
10615640|NCT01935791|11773161|FG008|NOT COMPLETED|Period 1||0
10615641|NCT01935791|11773153|FG000|STARTED|Period 2||0
10615642|NCT01935791|11773154|FG001|STARTED|Period 2||0
10615643|NCT01935791|11773155|FG002|STARTED|Period 2||0
10615644|NCT01935791|11773156|FG003|STARTED|Period 2||2
10615645|NCT01935791|11773157|FG004|STARTED|Period 2||3
10615646|NCT01935791|11773158|FG005|STARTED|Period 2||1
10615647|NCT01935791|11773159|FG006|STARTED|Period 2||1
10615648|NCT01935791|11773160|FG007|STARTED|Period 2||3
10615649|NCT01935791|11773161|FG008|STARTED|Period 2||1
10615650|NCT01935791|11773153|FG000|COMPLETED|Period 2||0
10615651|NCT01935791|11773154|FG001|COMPLETED|Period 2||0
10615652|NCT01935791|11773155|FG002|COMPLETED|Period 2||0
10615653|NCT01935791|11773156|FG003|COMPLETED|Period 2||2
10615654|NCT01935791|11773157|FG004|COMPLETED|Period 2||3
10615655|NCT01935791|11773158|FG005|COMPLETED|Period 2||1
10615656|NCT01935791|11773159|FG006|COMPLETED|Period 2||1
10615657|NCT01935791|11773160|FG007|COMPLETED|Period 2||3
10615658|NCT01935791|11773161|FG008|COMPLETED|Period 2||1
10615659|NCT01935791|11773153|FG000|NOT COMPLETED|Period 2||0
10615660|NCT01935791|11773154|FG001|NOT COMPLETED|Period 2||0
10615661|NCT01935791|11773155|FG002|NOT COMPLETED|Period 2||0
10615662|NCT01935791|11773156|FG003|NOT COMPLETED|Period 2||0
10615663|NCT01935791|11773157|FG004|NOT COMPLETED|Period 2||0
10615664|NCT01935791|11773158|FG005|NOT COMPLETED|Period 2||0
10615665|NCT01935791|11773159|FG006|NOT COMPLETED|Period 2||0
10615666|NCT01935791|11773160|FG007|NOT COMPLETED|Period 2||0
10615667|NCT01935791|11773161|FG008|NOT COMPLETED|Period 2||0
10615668|NCT01936181|11773177|FG000|STARTED|Randomised, Double-blind||291
10615669|NCT01936181|11773178|FG001|STARTED|Randomised, Double-blind||293
10615670|NCT01936181|11773179|FG002|STARTED|Randomised, Double-blind||0
10615671|NCT01936181|11773180|FG003|STARTED|Randomised, Double-blind||0
10615672|NCT01936181|11773177|FG000|COMPLETED|Randomised, Double-blind||227
10615673|NCT01936181|11773178|FG001|COMPLETED|Randomised, Double-blind||225
10615674|NCT01936181|11773179|FG002|COMPLETED|Randomised, Double-blind||0
10615675|NCT01936181|11773180|FG003|COMPLETED|Randomised, Double-blind||0
10615676|NCT01936181|11773177|FG000|NOT COMPLETED|Randomised, Double-blind||64
10615677|NCT01936181|11773178|FG001|NOT COMPLETED|Randomised, Double-blind||68
10615678|NCT01936181|11773179|FG002|NOT COMPLETED|Randomised, Double-blind||0
10615679|NCT01936181|11773180|FG003|NOT COMPLETED|Randomised, Double-blind||0
10615680|NCT01936181|11773177|FG000|STARTED|Transition-extension||201
10615681|NCT01936181|11773178|FG001|STARTED|Transition-extension||0
10615682|NCT01936181|11773179|FG002|STARTED|Transition-extension||94
10615683|NCT01936181|11773180|FG003|STARTED|Transition-extension||101
10615684|NCT01936181|11773177|FG000|COMPLETED|Transition-extension||186
10615685|NCT01936181|11773178|FG001|COMPLETED|Transition-extension||0
10615686|NCT01936181|11773179|FG002|COMPLETED|Transition-extension||88
10615687|NCT01936181|11773180|FG003|COMPLETED|Transition-extension||96
10615688|NCT01936181|11773177|FG000|NOT COMPLETED|Transition-extension||15
10615689|NCT01936181|11773178|FG001|NOT COMPLETED|Transition-extension||0
10615690|NCT01936181|11773179|FG002|NOT COMPLETED|Transition-extension||6
10615691|NCT01936181|11773180|FG003|NOT COMPLETED|Transition-extension||5
10615692|NCT01936259|11773193|FG000|STARTED|Overall Study||130
10615693|NCT01936259|11773194|FG001|STARTED|Overall Study||131
10615694|NCT01936259|11773193|FG000|COMPLETED|Overall Study||118
10615695|NCT01936259|11773194|FG001|COMPLETED|Overall Study||111
10615696|NCT01936259|11773193|FG000|NOT COMPLETED|Overall Study||12
10615697|NCT01936259|11773194|FG001|NOT COMPLETED|Overall Study||20
10615698|NCT01936324|11773203|FG000|STARTED|Overall Study||6
10615699|NCT01936324|11773204|FG001|STARTED|Overall Study||53
10615700|NCT01936324|11773205|FG002|STARTED|Overall Study||55
10615701|NCT01936324|11773203|FG000|COMPLETED|Overall Study||6
10615702|NCT01936324|11773204|FG001|COMPLETED|Overall Study||47
10615703|NCT01936324|11773205|FG002|COMPLETED|Overall Study||50
10615704|NCT01936324|11773203|FG000|NOT COMPLETED|Overall Study||0
10615705|NCT01936324|11773204|FG001|NOT COMPLETED|Overall Study||6
10615706|NCT01936324|11773205|FG002|NOT COMPLETED|Overall Study||5
10615707|NCT01936363|11773214|FG000|STARTED|Overall Study||32
10615708|NCT01936363|11773215|FG001|STARTED|Overall Study||33
10615709|NCT01936363|11773214|FG000|COMPLETED|Overall Study||32
10615710|NCT01936363|11773215|FG001|COMPLETED|Overall Study||33
10615711|NCT01936363|11773214|FG000|NOT COMPLETED|Overall Study||0
10615712|NCT01936363|11773215|FG001|NOT COMPLETED|Overall Study||0
10615713|NCT01936389|11773223|FG000|STARTED|Overall Study||5
10615714|NCT01936389|11773224|FG001|STARTED|Overall Study||5
10615715|NCT01936389|11773223|FG000|COMPLETED|Overall Study||4
10615716|NCT01936389|11773224|FG001|COMPLETED|Overall Study||5
10615717|NCT01936389|11773223|FG000|NOT COMPLETED|Overall Study||1
10615718|NCT01936389|11773224|FG001|NOT COMPLETED|Overall Study||0
10615719|NCT01936467|11773232|FG000|STARTED|Overall Study||60
10615720|NCT01936467|11773233|FG001|STARTED|Overall Study||61
10615721|NCT01936467|11773232|FG000|COMPLETED|Overall Study||60
10615722|NCT01936467|11773233|FG001|COMPLETED|Overall Study||61
10615723|NCT01936467|11773232|FG000|NOT COMPLETED|Overall Study||0
10615724|NCT01936467|11773233|FG001|NOT COMPLETED|Overall Study||0
10615725|NCT01936519|11773245|FG000|STARTED|Overall Study||12
10615726|NCT01936519|11773246|FG001|STARTED|Overall Study||12
10615727|NCT01936519|11773245|FG000|COMPLETED|Overall Study||11
10615728|NCT01936519|11773246|FG001|COMPLETED|Overall Study||8
10615729|NCT01936519|11773245|FG000|NOT COMPLETED|Overall Study||1
10615730|NCT01936519|11773246|FG001|NOT COMPLETED|Overall Study||4
10615731|NCT01936623|11773257|FG000|STARTED|Overall Study||40
10615732|NCT01936623|11773258|FG001|STARTED|Overall Study||40
10615733|NCT01936623|11773257|FG000|COMPLETED|Overall Study||40
10615734|NCT01936623|11773258|FG001|COMPLETED|Overall Study||35
10615735|NCT01936623|11773257|FG000|NOT COMPLETED|Overall Study||0
10615736|NCT01936623|11773258|FG001|NOT COMPLETED|Overall Study||5
10615737|NCT01936649|11773264|FG000|STARTED|Overall Study||63
10615738|NCT01936649|11773264|FG000|Treated|Overall Study||51
10615739|NCT01936649|11773264|FG000|COMPLETED|Overall Study||50
10615740|NCT01936649|11773264|FG000|NOT COMPLETED|Overall Study||13
10615741|NCT01936662|11773270|FG000|STARTED|Overall Study||42
10615742|NCT01936662|11773271|FG001|STARTED|Overall Study||42
10615743|NCT01936662|11773270|FG000|COMPLETED|Overall Study||42
10615744|NCT01936662|11773271|FG001|COMPLETED|Overall Study||42
10615745|NCT01936662|11773270|FG000|NOT COMPLETED|Overall Study||0
10615746|NCT01936662|11773271|FG001|NOT COMPLETED|Overall Study||0
10615747|NCT01936844|11773281|FG000|STARTED|Overall Study||15
10615748|NCT01936844|11773282|FG001|STARTED|Overall Study||15
10615749|NCT01936844|11773281|FG000|COMPLETED|Overall Study||9
10615750|NCT01936844|11773282|FG001|COMPLETED|Overall Study||8
10615751|NCT01936844|11773281|FG000|NOT COMPLETED|Overall Study||6
10615752|NCT01936844|11773282|FG001|NOT COMPLETED|Overall Study||7
10615753|NCT01936870|11773288|FG000|STARTED|Overall Study||2492
10615754|NCT01936870|11773288|FG000|COMPLETED|Overall Study||2303
10615755|NCT01936870|11773288|FG000|NOT COMPLETED|Overall Study||189
10615756|NCT01936896|11773292|FG000|STARTED|Overall Study||10
10615757|NCT01936896|11773292|FG000|COMPLETED|Overall Study||10
10615758|NCT01936896|11773292|FG000|NOT COMPLETED|Overall Study||0
10615759|NCT01936909|11773299|FG000|STARTED|Overall Study||20
10615760|NCT01936909|11773300|FG001|STARTED|Overall Study||20
10615761|NCT01936909|11773301|FG002|STARTED|Overall Study||20
10615762|NCT01936909|11773299|FG000|COMPLETED|Overall Study||10
10615763|NCT01936909|11773300|FG001|COMPLETED|Overall Study||12
10615764|NCT01936909|11773301|FG002|COMPLETED|Overall Study||14
10615765|NCT01936909|11773299|FG000|NOT COMPLETED|Overall Study||10
10615766|NCT01936909|11773300|FG001|NOT COMPLETED|Overall Study||8
10615767|NCT01936909|11773301|FG002|NOT COMPLETED|Overall Study||6
10615768|NCT01936948|11773313|FG000|STARTED|Overall Study||227
10615769|NCT01936948|11773314|FG001|STARTED|Overall Study||231
10615770|NCT01936948|11773315|FG002|STARTED|Overall Study||237
10615771|NCT01936948|11773316|FG003|STARTED|Overall Study||233
10615772|NCT01936948|11773313|FG000|Crossover|Overall Study||31
10615773|NCT01936948|11773314|FG001|Crossover|Overall Study||27
10615774|NCT01936948|11773315|FG002|Crossover|Overall Study||22
10615775|NCT01936948|11773316|FG003|Crossover|Overall Study||25
10615776|NCT01936948|11773313|FG000|COMPLETED|Overall Study||227
10615777|NCT01936948|11773314|FG001|COMPLETED|Overall Study||228
10615778|NCT01936948|11773315|FG002|COMPLETED|Overall Study||234
10615779|NCT01936948|11773316|FG003|COMPLETED|Overall Study||230
10615780|NCT01936948|11773313|FG000|NOT COMPLETED|Overall Study||0
10615781|NCT01936948|11773314|FG001|NOT COMPLETED|Overall Study||3
10615782|NCT01936948|11773315|FG002|NOT COMPLETED|Overall Study||3
10615783|NCT01936948|11773316|FG003|NOT COMPLETED|Overall Study||3
10615784|NCT01937026|11773324|FG000|STARTED|Period 1 (Day 1 Through Predose Day 3)||18
10615785|NCT01937026|11773324|FG000|Received Baricitinib|Period 1 (Day 1 Through Predose Day 3)||18
10615786|NCT01937026|11773324|FG000|COMPLETED|Period 1 (Day 1 Through Predose Day 3)||18
10615787|NCT01937026|11773324|FG000|NOT COMPLETED|Period 1 (Day 1 Through Predose Day 3)||0
10615788|NCT01937026|11773324|FG000|STARTED|Period 2 (At Dosing Day 3 Through Day 8)||18
10615789|NCT01937026|11773324|FG000|Received Baricitinib|Period 2 (At Dosing Day 3 Through Day 8)||18
10615790|NCT01937026|11773324|FG000|Received Probenecid on Days 3 Through 7|Period 2 (At Dosing Day 3 Through Day 8)||18
10615791|NCT01937026|11773324|FG000|COMPLETED|Period 2 (At Dosing Day 3 Through Day 8)||18
10615792|NCT01937026|11773324|FG000|NOT COMPLETED|Period 2 (At Dosing Day 3 Through Day 8)||0
10615793|NCT01937117|11773331|FG000|STARTED|Overall Study||88
10615794|NCT01937117|11773331|FG000|COMPLETED|Overall Study||75
10615795|NCT01937117|11773331|FG000|NOT COMPLETED|Overall Study||13
10615796|NCT01937130|11773339|FG000|STARTED|Overall Study||5
10615797|NCT01937130|11773340|FG001|STARTED|Overall Study||7
10615798|NCT01937130|11773341|FG002|STARTED|Overall Study||5
10615799|NCT01937130|11773342|FG003|STARTED|Overall Study||4
10615800|NCT01937130|11773339|FG000|COMPLETED|Overall Study||0
10615801|NCT01937130|11773340|FG001|COMPLETED|Overall Study||3
10615802|NCT01937130|11773341|FG002|COMPLETED|Overall Study||2
10615803|NCT01937130|11773342|FG003|COMPLETED|Overall Study||2
10615804|NCT01937130|11773339|FG000|NOT COMPLETED|Overall Study||5
10615805|NCT01937130|11773340|FG001|NOT COMPLETED|Overall Study||4
10615806|NCT01937130|11773341|FG002|NOT COMPLETED|Overall Study||3
10615807|NCT01937130|11773342|FG003|NOT COMPLETED|Overall Study||2
10615808|NCT01937195|11773352|FG000|STARTED|Overall Study||95
10615809|NCT01937195|11773352|FG000|COMPLETED|Overall Study||95
10615810|NCT01937195|11773352|FG000|NOT COMPLETED|Overall Study||0
10615811|NCT01937260|11773358|FG000|STARTED|Overall Study||21
10615812|NCT01937260|11773359|FG001|STARTED|Overall Study||10
10615813|NCT01937260|11773358|FG000|COMPLETED|Overall Study||20
10615814|NCT01937260|11773359|FG001|COMPLETED|Overall Study||10
10615815|NCT01937260|11773358|FG000|NOT COMPLETED|Overall Study||1
10615816|NCT01937260|11773359|FG001|NOT COMPLETED|Overall Study||0
10615817|NCT01937299|11773367|FG000|STARTED|Overall Study||117
10615818|NCT01937299|11773368|FG001|STARTED|Overall Study||116
10615819|NCT01937299|11773367|FG000|COMPLETED|Overall Study||103
10615820|NCT01937299|11773368|FG001|COMPLETED|Overall Study||112
10615821|NCT01937299|11773367|FG000|NOT COMPLETED|Overall Study||14
10615822|NCT01937299|11773368|FG001|NOT COMPLETED|Overall Study||4
10615823|NCT01937312|11773377|FG000|STARTED|Overall Study||94
10615824|NCT01937312|11773378|FG001|STARTED|Overall Study||95
10615825|NCT01937312|11773377|FG000|Treated|Overall Study||93
10615826|NCT01937312|11773378|FG001|Treated|Overall Study||95
10615827|NCT01937312|11773377|FG000|COMPLETED|Overall Study||83
10615828|NCT01937312|11773378|FG001|COMPLETED|Overall Study||92
10615829|NCT01937312|11773377|FG000|NOT COMPLETED|Overall Study||11
10615830|NCT01937312|11773378|FG001|NOT COMPLETED|Overall Study||3
10615831|NCT01937351|11773387|FG000|STARTED|Overall Study||134
10615832|NCT01937351|11773388|FG001|STARTED|Overall Study||28
10615833|NCT01937351|11773387|FG000|Treated w Study Device|Overall Study||130
10615834|NCT01937351|11773388|FG001|Treated w Study Device|Overall Study||28
10615835|NCT01937351|11773387|FG000|30-Day Follow-up|Overall Study||128
10615836|NCT01937351|11773388|FG001|30-Day Follow-up|Overall Study||27
10615837|NCT01937351|11773387|FG000|6-Month Follow-up|Overall Study||125
10615838|NCT01937351|11773388|FG001|6-Month Follow-up|Overall Study||26
10615839|NCT01937351|11773387|FG000|COMPLETED|Overall Study||125
10615840|NCT01937351|11773388|FG001|COMPLETED|Overall Study||26
10615841|NCT01937351|11773387|FG000|NOT COMPLETED|Overall Study||9
10615842|NCT01937351|11773388|FG001|NOT COMPLETED|Overall Study||2
10615843|NCT01937364|11773395|FG000|STARTED|Overall Study||9
10615844|NCT01937364|11773396|FG001|STARTED|Overall Study||8
10615845|NCT01937364|11773395|FG000|COMPLETED|Overall Study||7
10615846|NCT01937364|11773396|FG001|COMPLETED|Overall Study||7
10615847|NCT01937364|11773395|FG000|NOT COMPLETED|Overall Study||2
10615848|NCT01937364|11773396|FG001|NOT COMPLETED|Overall Study||1
10615849|NCT01937390|11773402|FG000|STARTED|Overall Study||585
10615850|NCT01937390|11773402|FG000|COMPLETED|Overall Study||550
10615851|NCT01937390|11773402|FG000|NOT COMPLETED|Overall Study||35
10615852|NCT01937520|11773408|FG000|STARTED|Overall Study||11
10615853|NCT01937520|11773409|FG001|STARTED|Overall Study||9
10615854|NCT01937520|11773408|FG000|COMPLETED|Overall Study||11
10615855|NCT01937520|11773409|FG001|COMPLETED|Overall Study||9
10615856|NCT01937520|11773408|FG000|NOT COMPLETED|Overall Study||0
10615857|NCT01937520|11773409|FG001|NOT COMPLETED|Overall Study||0
10615858|NCT01937559|11773419|FG000|STARTED|Overall Study||61
10615859|NCT01937559|11773420|FG001|STARTED|Overall Study||61
10615860|NCT01937559|11773421|FG002|STARTED|Overall Study||66
10615861|NCT01937559|11773419|FG000|COMPLETED|Overall Study||50
10615862|NCT01937559|11773420|FG001|COMPLETED|Overall Study||50
10615863|NCT01937559|11773421|FG002|COMPLETED|Overall Study||66
10615864|NCT01937559|11773419|FG000|NOT COMPLETED|Overall Study||11
10615865|NCT01937559|11773420|FG001|NOT COMPLETED|Overall Study||11
10615866|NCT01937559|11773421|FG002|NOT COMPLETED|Overall Study||0
10615867|NCT01937598|11773433|FG000|STARTED|Overall Study||8
10615868|NCT01937598|11773434|FG001|STARTED|Overall Study||8
10615869|NCT01937598|11773433|FG000|COMPLETED|Overall Study||8
10615870|NCT01937598|11773434|FG001|COMPLETED|Overall Study||8
10615871|NCT01937598|11773433|FG000|NOT COMPLETED|Overall Study||0
10615872|NCT01937598|11773434|FG001|NOT COMPLETED|Overall Study||0
10615873|NCT01937624|11773440|FG000|STARTED|Overall Study||51
10615874|NCT01937624|11773440|FG000|COMPLETED|Overall Study||51
10615875|NCT01937624|11773440|FG000|NOT COMPLETED|Overall Study||0
10615876|NCT01937715|11773449|FG000|STARTED|Overall Study||3
10615877|NCT01937715|11773450|FG001|STARTED|Overall Study||4
10615878|NCT01937715|11773451|FG002|STARTED|Overall Study||3
10615879|NCT01937715|11773452|FG003|STARTED|Overall Study||5
10615880|NCT01937715|11773453|FG004|STARTED|Overall Study||3
10615881|NCT01937715|11773449|FG000|COMPLETED|Overall Study||3
10615882|NCT01937715|11773450|FG001|COMPLETED|Overall Study||3
10615883|NCT01937715|11773451|FG002|COMPLETED|Overall Study||3
10615884|NCT01937715|11773452|FG003|COMPLETED|Overall Study||1
10615885|NCT01937715|11773453|FG004|COMPLETED|Overall Study||1
10615886|NCT01937715|11773449|FG000|NOT COMPLETED|Overall Study||0
10615887|NCT01937715|11773450|FG001|NOT COMPLETED|Overall Study||1
10615888|NCT01937715|11773451|FG002|NOT COMPLETED|Overall Study||0
10615889|NCT01937715|11773452|FG003|NOT COMPLETED|Overall Study||4
10615890|NCT01937715|11773453|FG004|NOT COMPLETED|Overall Study||2
10615891|NCT01937871|11773468|FG000|STARTED|Overall Study||361
10615892|NCT01937871|11773469|FG001|STARTED|Overall Study||363
10615893|NCT01937871|11773470|FG002|STARTED|Overall Study||185
10615894|NCT01937871|11773468|FG000|Received at Least One Dose of Study Drug|Overall Study||361
10615895|NCT01937871|11773469|FG001|Received at Least One Dose of Study Drug|Overall Study||362
10615896|NCT01937871|11773470|FG002|Received at Least One Dose of Study Drug|Overall Study||185
10615897|NCT01937871|11773468|FG000|COMPLETED|Overall Study||337
10615898|NCT01937871|11773469|FG001|COMPLETED|Overall Study||346
10615899|NCT01937871|11773470|FG002|COMPLETED|Overall Study||174
10615900|NCT01937871|11773468|FG000|NOT COMPLETED|Overall Study||24
10615901|NCT01937871|11773469|FG001|NOT COMPLETED|Overall Study||17
10615902|NCT01937871|11773470|FG002|NOT COMPLETED|Overall Study||11
10615903|NCT01937884|11773483|FG000|STARTED|Overall Study||7
10615904|NCT01937884|11773484|FG001|STARTED|Overall Study||11
10615905|NCT01937884|11773483|FG000|COMPLETED|Overall Study||6
10615906|NCT01937884|11773484|FG001|COMPLETED|Overall Study||11
10704854|NCT01525901|11869247|FG003|NOT COMPLETED|Period 1: 12 Weeks||0
10704855|NCT01525901|11869244|FG000|STARTED|Washout 4 Weeks||5
10704856|NCT01525901|11869245|FG001|STARTED|Washout 4 Weeks||4
10704857|NCT01525901|11869246|FG002|STARTED|Washout 4 Weeks||5
10704858|NCT01525901|11869247|FG003|STARTED|Washout 4 Weeks||5
10704859|NCT01525901|11869244|FG000|COMPLETED|Washout 4 Weeks||5
10704860|NCT01525901|11869245|FG001|COMPLETED|Washout 4 Weeks||4
10704861|NCT01525901|11869246|FG002|COMPLETED|Washout 4 Weeks||5
10704862|NCT01525901|11869247|FG003|COMPLETED|Washout 4 Weeks||5
10704863|NCT01525901|11869244|FG000|NOT COMPLETED|Washout 4 Weeks||0
10704864|NCT01525901|11869245|FG001|NOT COMPLETED|Washout 4 Weeks||0
10704865|NCT01525901|11869246|FG002|NOT COMPLETED|Washout 4 Weeks||0
10615907|NCT01937884|11773483|FG000|NOT COMPLETED|Overall Study||1
10615908|NCT01937884|11773484|FG001|NOT COMPLETED|Overall Study||0
10615909|NCT01937975|11773495|FG000|STARTED|Overall Study||8
10615910|NCT01937975|11773496|FG001|STARTED|Overall Study||8
10615911|NCT01937975|11773497|FG002|STARTED|Overall Study||8
10615912|NCT01937975|11773495|FG000|COMPLETED|Overall Study||8
10615913|NCT01937975|11773496|FG001|COMPLETED|Overall Study||8
10615914|NCT01937975|11773497|FG002|COMPLETED|Overall Study||8
10615915|NCT01937975|11773495|FG000|NOT COMPLETED|Overall Study||0
10615916|NCT01937975|11773496|FG001|NOT COMPLETED|Overall Study||0
10615917|NCT01937975|11773497|FG002|NOT COMPLETED|Overall Study||0
10615918|NCT01938040|11773511|FG000|STARTED|Overall Study||28
10615919|NCT01938040|11773512|FG001|STARTED|Overall Study||27
10615920|NCT01938040|11773511|FG000|Plasma Analysis|Overall Study|complete set of blood samples could not be obtained|24
10615921|NCT01938040|11773512|FG001|Plasma Analysis|Overall Study|complete set of blood samples could not be obtained|25
10615922|NCT01938040|11773511|FG000|Behavior Metrics|Overall Study||28
10615923|NCT01938040|11773512|FG001|Behavior Metrics|Overall Study||27
10615924|NCT01938040|11773511|FG000|COMPLETED|Overall Study||28
10615925|NCT01938040|11773512|FG001|COMPLETED|Overall Study||27
10615926|NCT01938040|11773511|FG000|NOT COMPLETED|Overall Study||0
10704866|NCT01525901|11869247|FG003|NOT COMPLETED|Washout 4 Weeks||0
10704867|NCT01525901|11869244|FG000|STARTED|Period 2: 12 Weeks||5
10615927|NCT01938040|11773512|FG001|NOT COMPLETED|Overall Study||0
10615928|NCT01938066|11773526|FG000|STARTED|Overall Study||15
10615929|NCT01938066|11773527|FG001|STARTED|Overall Study||15
10615930|NCT01938066|11773526|FG000|COMPLETED|Overall Study||14
10615931|NCT01938066|11773527|FG001|COMPLETED|Overall Study||13
10615932|NCT01938066|11773526|FG000|NOT COMPLETED|Overall Study||1
10615933|NCT01938066|11773527|FG001|NOT COMPLETED|Overall Study||2
10615934|NCT01938079|11773535|FG000|STARTED|Overall Study||10
10615935|NCT01938079|11773536|FG001|STARTED|Overall Study||10
10615936|NCT01938079|11773535|FG000|COMPLETED|Overall Study||10
10615937|NCT01938079|11773536|FG001|COMPLETED|Overall Study||10
10615938|NCT01938079|11773535|FG000|NOT COMPLETED|Overall Study||0
10615939|NCT01938079|11773536|FG001|NOT COMPLETED|Overall Study||0
10615940|NCT01938170|11773542|FG000|STARTED|Overall Study||41
10615941|NCT01938170|11773542|FG000|COMPLETED|Overall Study||41
10615942|NCT01938170|11773542|FG000|NOT COMPLETED|Overall Study||0
10615943|NCT01938378|11773549|FG000|STARTED|Overall Study||41
10615944|NCT01938378|11773549|FG000|COMPLETED|Overall Study||41
10615945|NCT01938378|11773549|FG000|NOT COMPLETED|Overall Study||0
10704868|NCT01525901|11869245|FG001|STARTED|Period 2: 12 Weeks||4
10704869|NCT01525901|11869246|FG002|STARTED|Period 2: 12 Weeks||5
10457069|NCT01008995|11604804|FG002|NOT COMPLETED|Controlled Period||0
10457070|NCT01008995|11604805|FG003|NOT COMPLETED|Controlled Period||0
10457071|NCT01008995|11604802|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
10457072|NCT01008995|11604803|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
10457073|NCT01008995|11604804|FG002|STARTED|After Controlled Period|1 placebo participant discontinued after completing the CP and did not receive ustekinumab 45 mg.|158
10457074|NCT01008995|11604805|FG003|STARTED|After Controlled Period|2 participants discontinued in CP, had follow-up, and are among frequent and serious adverse events.|157
10457075|NCT01008995|11604802|FG000|COMPLETED|After Controlled Period||0
10457076|NCT01008995|11604803|FG001|COMPLETED|After Controlled Period||0
10457077|NCT01008995|11604804|FG002|COMPLETED|After Controlled Period||156
10457078|NCT01008995|11604805|FG003|COMPLETED|After Controlled Period||156
10457079|NCT01008995|11604802|FG000|NOT COMPLETED|After Controlled Period||0
10457080|NCT01008995|11604803|FG001|NOT COMPLETED|After Controlled Period||0
10457081|NCT01008995|11604804|FG002|NOT COMPLETED|After Controlled Period||2
10457082|NCT01008995|11604805|FG003|NOT COMPLETED|After Controlled Period||1
10457083|NCT01009034|11604813|FG000|STARTED|Overall Study||14
10457084|NCT01009034|11604813|FG000|COMPLETED|Overall Study||10
10457085|NCT01009034|11604813|FG000|NOT COMPLETED|Overall Study||4
10457086|NCT01009047|11604819|FG000|STARTED|Overall Study||113
10615946|NCT01938391|11773567|FG000|STARTED|Baseline||25
10615947|NCT01938391|11773567|FG000|COMPLETED|Baseline||25
10615948|NCT01938391|11773567|FG000|NOT COMPLETED|Baseline||0
10615949|NCT01938391|11773567|FG000|STARTED|2 Week Follow up||25
10615950|NCT01938391|11773567|FG000|COMPLETED|2 Week Follow up||25
10615951|NCT01938391|11773567|FG000|NOT COMPLETED|2 Week Follow up||0
10615952|NCT01938391|11773567|FG000|STARTED|6 Month Follow up||25
10615953|NCT01938391|11773567|FG000|COMPLETED|6 Month Follow up||24
10615954|NCT01938391|11773567|FG000|NOT COMPLETED|6 Month Follow up||1
10615955|NCT01938391|11773567|FG000|STARTED|12 Month Follow up||24
10615956|NCT01938391|11773567|FG000|COMPLETED|12 Month Follow up||22
10615957|NCT01938391|11773567|FG000|NOT COMPLETED|12 Month Follow up||2
10615958|NCT01938430|11773585|FG000|STARTED|Overall Study||30
10615959|NCT01938430|11773586|FG001|STARTED|Overall Study||29
10615960|NCT01938430|11773587|FG002|STARTED|Overall Study||23
10704870|NCT01525901|11869247|FG003|STARTED|Period 2: 12 Weeks||5
10704871|NCT01525901|11869244|FG000|COMPLETED|Period 2: 12 Weeks||5
10704872|NCT01525901|11869245|FG001|COMPLETED|Period 2: 12 Weeks||3
10615961|NCT01938430|11773588|FG003|STARTED|Overall Study||26
10615962|NCT01938430|11773589|FG004|STARTED|Overall Study||55
10615963|NCT01938430|11773590|FG005|STARTED|Overall Study||56
10615964|NCT01938430|11773591|FG006|STARTED|Overall Study||26
10615965|NCT01938430|11773592|FG007|STARTED|Overall Study||25
10615966|NCT01938430|11773593|FG008|STARTED|Overall Study||26
10615967|NCT01938430|11773594|FG009|STARTED|Overall Study||26
10615968|NCT01938430|11773595|FG010|STARTED|Overall Study||6
10615969|NCT01938430|11773596|FG011|STARTED|Overall Study||4
10615970|NCT01938430|11773597|FG012|STARTED|Overall Study||4
10615971|NCT01938430|11773598|FG013|STARTED|Overall Study||3
10615972|NCT01938430|11773585|FG000|COMPLETED|Overall Study||26
10615973|NCT01938430|11773586|FG001|COMPLETED|Overall Study||26
10615974|NCT01938430|11773587|FG002|COMPLETED|Overall Study||18
10615975|NCT01938430|11773588|FG003|COMPLETED|Overall Study||24
10615976|NCT01938430|11773589|FG004|COMPLETED|Overall Study||55
10615977|NCT01938430|11773590|FG005|COMPLETED|Overall Study||55
10615978|NCT01938430|11773591|FG006|COMPLETED|Overall Study||24
10615979|NCT01938430|11773592|FG007|COMPLETED|Overall Study||24
10615980|NCT01938430|11773593|FG008|COMPLETED|Overall Study||22
10615981|NCT01938430|11773594|FG009|COMPLETED|Overall Study||23
10615982|NCT01938430|11773595|FG010|COMPLETED|Overall Study||3
10615983|NCT01938430|11773596|FG011|COMPLETED|Overall Study||3
10615984|NCT01938430|11773597|FG012|COMPLETED|Overall Study||4
10615985|NCT01938430|11773598|FG013|COMPLETED|Overall Study||2
10615986|NCT01938430|11773585|FG000|NOT COMPLETED|Overall Study||4
10615987|NCT01938430|11773586|FG001|NOT COMPLETED|Overall Study||3
10615988|NCT01938430|11773587|FG002|NOT COMPLETED|Overall Study||5
10615989|NCT01938430|11773588|FG003|NOT COMPLETED|Overall Study||2
10615990|NCT01938430|11773589|FG004|NOT COMPLETED|Overall Study||0
10615991|NCT01938430|11773590|FG005|NOT COMPLETED|Overall Study||1
10615992|NCT01938430|11773591|FG006|NOT COMPLETED|Overall Study||2
10615993|NCT01938430|11773592|FG007|NOT COMPLETED|Overall Study||1
10615994|NCT01938430|11773593|FG008|NOT COMPLETED|Overall Study||4
10615995|NCT01938430|11773594|FG009|NOT COMPLETED|Overall Study||3
10615996|NCT01938430|11773595|FG010|NOT COMPLETED|Overall Study||3
10615997|NCT01938430|11773596|FG011|NOT COMPLETED|Overall Study||1
10615998|NCT01938430|11773597|FG012|NOT COMPLETED|Overall Study||0
10615999|NCT01938430|11773598|FG013|NOT COMPLETED|Overall Study||1
10616000|NCT01938573|11773653|FG000|STARTED|Overall Study||15
10616001|NCT01938573|11773654|FG001|STARTED|Overall Study||6
10616002|NCT01938573|11773653|FG000|COMPLETED|Overall Study||13
10616003|NCT01938573|11773654|FG001|COMPLETED|Overall Study||6
10616004|NCT01938573|11773653|FG000|NOT COMPLETED|Overall Study||2
10616005|NCT01938573|11773654|FG001|NOT COMPLETED|Overall Study||0
10616006|NCT01938625|11773661|FG000|STARTED|Overall Study||10
10616007|NCT01938625|11773662|FG001|STARTED|Overall Study||25
10616008|NCT01938625|11773661|FG000|COMPLETED|Overall Study||10
10616009|NCT01938625|11773662|FG001|COMPLETED|Overall Study||23
10616010|NCT01938625|11773661|FG000|NOT COMPLETED|Overall Study||0
10616011|NCT01938625|11773662|FG001|NOT COMPLETED|Overall Study||2
10616012|NCT01938664|11773670|FG000|STARTED|Overall Study||20
10616013|NCT01938664|11773671|FG001|STARTED|Overall Study||10
10616014|NCT01938664|11773670|FG000|COMPLETED|Overall Study||5
10616015|NCT01938664|11773671|FG001|COMPLETED|Overall Study||0
10616016|NCT01938664|11773670|FG000|NOT COMPLETED|Overall Study||15
10616017|NCT01938664|11773671|FG001|NOT COMPLETED|Overall Study||10
10616018|NCT01938846|11773680|FG000|STARTED|Overall Study||41
10616019|NCT01938846|11773681|FG001|STARTED|Overall Study||25
10616020|NCT01938846|11773682|FG002|STARTED|Overall Study||24
10616021|NCT01938846|11773680|FG000|COMPLETED|Overall Study||0
10616022|NCT01938846|11773681|FG001|COMPLETED|Overall Study||0
10616023|NCT01938846|11773682|FG002|COMPLETED|Overall Study||0
10616024|NCT01938846|11773680|FG000|NOT COMPLETED|Overall Study||41
10616025|NCT01938846|11773681|FG001|NOT COMPLETED|Overall Study||25
10616026|NCT01938846|11773682|FG002|NOT COMPLETED|Overall Study||24
10616027|NCT01938989|11773723|FG000|STARTED|Overall Study||77
10616028|NCT01938989|11773724|FG001|STARTED|Overall Study||77
10616029|NCT01938989|11773723|FG000|COMPLETED|Overall Study||77
10616030|NCT01938989|11773724|FG001|COMPLETED|Overall Study||77
10616031|NCT01938989|11773723|FG000|NOT COMPLETED|Overall Study||0
10616032|NCT01938989|11773724|FG001|NOT COMPLETED|Overall Study||0
10616033|NCT01939002|11773732|FG000|STARTED|Overall Study||103
10616034|NCT01939002|11773733|FG001|STARTED|Overall Study||98
10616035|NCT01939002|11773732|FG000|COMPLETED|Overall Study||84
10616036|NCT01939002|11773733|FG001|COMPLETED|Overall Study||80
10616037|NCT01939002|11773732|FG000|NOT COMPLETED|Overall Study||19
10616038|NCT01939002|11773733|FG001|NOT COMPLETED|Overall Study||18
10616039|NCT01939028|11773744|FG000|STARTED|Overall Study||58
10616040|NCT01939028|11773744|FG000|COMPLETED|Overall Study||46
10616041|NCT01939028|11773744|FG000|NOT COMPLETED|Overall Study||12
10616042|NCT01939145|11773750|FG000|STARTED|Overall Study||49
10616043|NCT01939145|11773751|FG001|STARTED|Overall Study||51
10616044|NCT01939145|11773750|FG000|COMPLETED|Overall Study||47
10616045|NCT01939145|11773751|FG001|COMPLETED|Overall Study||44
10616046|NCT01939145|11773750|FG000|NOT COMPLETED|Overall Study||2
10616047|NCT01939145|11773751|FG001|NOT COMPLETED|Overall Study||7
10616048|NCT01939158|11773761|FG000|STARTED|Overall Study||203
10616049|NCT01939158|11773762|FG001|STARTED|Overall Study||198
10616050|NCT01939158|11773763|FG002|STARTED|Overall Study||201
10616051|NCT01939158|11773764|FG003|STARTED|Overall Study||201
10616052|NCT01939158|11773761|FG000|Vaccinated|Overall Study||203
10616053|NCT01939158|11773762|FG001|Vaccinated|Overall Study||197
10616054|NCT01939158|11773763|FG002|Vaccinated|Overall Study||201
10616055|NCT01939158|11773764|FG003|Vaccinated|Overall Study||201
10616056|NCT01939158|11773761|FG000|COMPLETED|Overall Study||156
10616057|NCT01939158|11773762|FG001|COMPLETED|Overall Study||146
10616058|NCT01939158|11773763|FG002|COMPLETED|Overall Study||160
10616059|NCT01939158|11773764|FG003|COMPLETED|Overall Study||157
10616060|NCT01939158|11773761|FG000|NOT COMPLETED|Overall Study||47
10616061|NCT01939158|11773762|FG001|NOT COMPLETED|Overall Study||52
10616062|NCT01939158|11773763|FG002|NOT COMPLETED|Overall Study||41
10616063|NCT01939158|11773764|FG003|NOT COMPLETED|Overall Study||44
10616064|NCT01939197|11773785|FG000|STARTED|Overall Study||31
10616065|NCT01939197|11773786|FG001|STARTED|Overall Study||32
10616066|NCT01939197|11773787|FG002|STARTED|Overall Study||10
10616067|NCT01939197|11773788|FG003|STARTED|Overall Study||12
10616068|NCT01939197|11773789|FG004|STARTED|Overall Study||200
10616069|NCT01939197|11773790|FG005|STARTED|Overall Study||5
10616070|NCT01939197|11773791|FG006|STARTED|Overall Study||28
10616071|NCT01939197|11773785|FG000|COMPLETED|Overall Study||30
10616072|NCT01939197|11773786|FG001|COMPLETED|Overall Study||31
10616073|NCT01939197|11773787|FG002|COMPLETED|Overall Study||10
10616074|NCT01939197|11773788|FG003|COMPLETED|Overall Study||11
10616075|NCT01939197|11773789|FG004|COMPLETED|Overall Study||196
10616076|NCT01939197|11773790|FG005|COMPLETED|Overall Study||4
10616077|NCT01939197|11773791|FG006|COMPLETED|Overall Study||26
10616078|NCT01939197|11773785|FG000|NOT COMPLETED|Overall Study||1
10616079|NCT01939197|11773786|FG001|NOT COMPLETED|Overall Study||1
10616080|NCT01939197|11773787|FG002|NOT COMPLETED|Overall Study||0
10616081|NCT01939197|11773788|FG003|NOT COMPLETED|Overall Study||1
10616082|NCT01939197|11773789|FG004|NOT COMPLETED|Overall Study||4
10616083|NCT01939197|11773790|FG005|NOT COMPLETED|Overall Study||1
10616084|NCT01939197|11773791|FG006|NOT COMPLETED|Overall Study||2
10616085|NCT01939288|11773823|FG000|STARTED|Overall Study||5
10616086|NCT01939288|11773824|FG001|STARTED|Overall Study||5
10616087|NCT01939288|11773823|FG000|COMPLETED|Overall Study||5
10616088|NCT01939288|11773824|FG001|COMPLETED|Overall Study||5
10616089|NCT01939288|11773823|FG000|NOT COMPLETED|Overall Study||0
10616090|NCT01939288|11773824|FG001|NOT COMPLETED|Overall Study||0
10616091|NCT01939301|11773831|FG000|STARTED|Overall Study||39
10616092|NCT01939301|11773832|FG001|STARTED|Overall Study||39
10616093|NCT01939301|11773831|FG000|COMPLETED|Overall Study||38
10616094|NCT01939301|11773832|FG001|COMPLETED|Overall Study||38
10616095|NCT01939301|11773831|FG000|NOT COMPLETED|Overall Study||1
10616096|NCT01939301|11773832|FG001|NOT COMPLETED|Overall Study||1
10616097|NCT01939314|11773840|FG000|STARTED|Overall Study||45
10616098|NCT01939314|11773841|FG001|STARTED|Overall Study||48
10616099|NCT01939314|11773840|FG000|15 Minute Endpoint|Overall Study||41
10616100|NCT01939314|11773841|FG001|15 Minute Endpoint|Overall Study||46
10616101|NCT01939314|11773840|FG000|24 Hour Endpoint|Overall Study||36
10616102|NCT01939314|11773841|FG001|24 Hour Endpoint|Overall Study||40
10616103|NCT01939314|11773840|FG000|COMPLETED|Overall Study||36
10616104|NCT01939314|11773841|FG001|COMPLETED|Overall Study||40
10616105|NCT01939314|11773840|FG000|NOT COMPLETED|Overall Study||9
10616106|NCT01939314|11773841|FG001|NOT COMPLETED|Overall Study||8
10616107|NCT01939353|11773849|FG000|STARTED|Placebo Run-in (1 Week)||45
10616108|NCT01939353|11773849|FG000|COMPLETED|Placebo Run-in (1 Week)||41
10616109|NCT01939353|11773849|FG000|NOT COMPLETED|Placebo Run-in (1 Week)||4
10616110|NCT01939353|11773849|FG000|STARTED|CTN SR Treatment Phase (4 Weeks)||41
10616111|NCT01939353|11773849|FG000|COMPLETED|CTN SR Treatment Phase (4 Weeks)||37
10616112|NCT01939353|11773849|FG000|NOT COMPLETED|CTN SR Treatment Phase (4 Weeks)||4
10616113|NCT01939366|11773858|FG000|STARTED|Overall Study||66
10616114|NCT01939366|11773859|FG001|STARTED|Overall Study||64
10616115|NCT01939366|11773860|FG002|STARTED|Overall Study||65
10616116|NCT01939366|11773861|FG003|STARTED|Overall Study||68
10616117|NCT01939366|11773862|FG004|STARTED|Overall Study||66
10616118|NCT01939366|11773858|FG000|Allocated Set Excl. Non-compliant Sites|Overall Study||64
10616119|NCT01939366|11773859|FG001|Allocated Set Excl. Non-compliant Sites|Overall Study||61
10616120|NCT01939366|11773860|FG002|Allocated Set Excl. Non-compliant Sites|Overall Study||63
10616121|NCT01939366|11773861|FG003|Allocated Set Excl. Non-compliant Sites|Overall Study||65
10616122|NCT01939366|11773862|FG004|Allocated Set Excl. Non-compliant Sites|Overall Study||63
10616123|NCT01939366|11773858|FG000|Safety Set|Overall Study||64
10616124|NCT01939366|11773859|FG001|Safety Set|Overall Study||61
10616125|NCT01939366|11773860|FG002|Safety Set|Overall Study||62
10616126|NCT01939366|11773861|FG003|Safety Set|Overall Study||65
10616127|NCT01939366|11773862|FG004|Safety Set|Overall Study||62
10616128|NCT01939366|11773858|FG000|Full Analysis Set|Overall Study||64
10616129|NCT01939366|11773859|FG001|Full Analysis Set|Overall Study||60
10616130|NCT01939366|11773860|FG002|Full Analysis Set|Overall Study||61
10616131|NCT01939366|11773861|FG003|Full Analysis Set|Overall Study||65
10616132|NCT01939366|11773862|FG004|Full Analysis Set|Overall Study||62
10616133|NCT01939366|11773858|FG000|Per Protocol Set|Overall Study||58
10616134|NCT01939366|11773859|FG001|Per Protocol Set|Overall Study||55
10616135|NCT01939366|11773860|FG002|Per Protocol Set|Overall Study||50
10616136|NCT01939366|11773861|FG003|Per Protocol Set|Overall Study||51
10616137|NCT01939366|11773862|FG004|Per Protocol Set|Overall Study||49
10616138|NCT01939366|11773858|FG000|COMPLETED|Overall Study||52
10616139|NCT01939366|11773859|FG001|COMPLETED|Overall Study||41
10616140|NCT01939366|11773860|FG002|COMPLETED|Overall Study||27
10616141|NCT01939366|11773861|FG003|COMPLETED|Overall Study||51
10616142|NCT01939366|11773862|FG004|COMPLETED|Overall Study||48
10616143|NCT01939366|11773858|FG000|NOT COMPLETED|Overall Study||14
10616144|NCT01939366|11773859|FG001|NOT COMPLETED|Overall Study||23
10616145|NCT01939366|11773860|FG002|NOT COMPLETED|Overall Study||38
10616146|NCT01939366|11773861|FG003|NOT COMPLETED|Overall Study||17
10616147|NCT01939366|11773862|FG004|NOT COMPLETED|Overall Study||18
10616148|NCT01939405|11773876|FG000|STARTED|Overall Study||30
10616149|NCT01939405|11773877|FG001|STARTED|Overall Study||30
10616150|NCT01939405|11773876|FG000|COMPLETED|Overall Study||27
10616151|NCT01939405|11773877|FG001|COMPLETED|Overall Study||28
10616152|NCT01939405|11773876|FG000|NOT COMPLETED|Overall Study||3
10616153|NCT01939405|11773877|FG001|NOT COMPLETED|Overall Study||2
10616154|NCT01939496|11773886|FG000|STARTED|Overall Study||56
10616155|NCT01939496|11773887|FG001|STARTED|Overall Study||57
10616156|NCT01939496|11773888|FG002|STARTED|Overall Study||56
10616157|NCT01939496|11773886|FG000|COMPLETED|Overall Study||47
10616158|NCT01939496|11773887|FG001|COMPLETED|Overall Study||54
10616159|NCT01939496|11773888|FG002|COMPLETED|Overall Study||54
10616160|NCT01939496|11773886|FG000|NOT COMPLETED|Overall Study||9
10616161|NCT01939496|11773887|FG001|NOT COMPLETED|Overall Study||3
10616162|NCT01939496|11773888|FG002|NOT COMPLETED|Overall Study||2
10616163|NCT01939548|11773899|FG000|STARTED|Overall Study||78
10616164|NCT01939548|11773900|FG001|STARTED|Overall Study||82
10616165|NCT01939548|11773901|FG002|STARTED|Overall Study||80
10616166|NCT01939548|11773899|FG000|COMPLETED|Overall Study||41
10616167|NCT01939548|11773900|FG001|COMPLETED|Overall Study||33
10616168|NCT01939548|11773901|FG002|COMPLETED|Overall Study||50
10616169|NCT01939548|11773899|FG000|NOT COMPLETED|Overall Study||37
10616170|NCT01939548|11773900|FG001|NOT COMPLETED|Overall Study||49
10616171|NCT01939548|11773901|FG002|NOT COMPLETED|Overall Study||30
10616172|NCT01939899|11773914|FG000|STARTED|Lead-in Dose Finding Phase||3
10616173|NCT01939899|11773915|FG001|STARTED|Lead-in Dose Finding Phase||7
10616174|NCT01939899|11773916|FG002|STARTED|Lead-in Dose Finding Phase||6
10616175|NCT01939899|11773917|FG003|STARTED|Lead-in Dose Finding Phase||0
10616176|NCT01939899|11773918|FG004|STARTED|Lead-in Dose Finding Phase||0
10616177|NCT01939899|11773914|FG000|COMPLETED|Lead-in Dose Finding Phase||1
10616178|NCT01939899|11773915|FG001|COMPLETED|Lead-in Dose Finding Phase||0
10616179|NCT01939899|11773916|FG002|COMPLETED|Lead-in Dose Finding Phase||1
10616180|NCT01939899|11773917|FG003|COMPLETED|Lead-in Dose Finding Phase||0
10616181|NCT01939899|11773918|FG004|COMPLETED|Lead-in Dose Finding Phase||0
10616182|NCT01939899|11773914|FG000|NOT COMPLETED|Lead-in Dose Finding Phase||2
10616183|NCT01939899|11773915|FG001|NOT COMPLETED|Lead-in Dose Finding Phase||7
10616184|NCT01939899|11773916|FG002|NOT COMPLETED|Lead-in Dose Finding Phase||5
10616185|NCT01939899|11773917|FG003|NOT COMPLETED|Lead-in Dose Finding Phase||0
10616186|NCT01939899|11773918|FG004|NOT COMPLETED|Lead-in Dose Finding Phase||0
10616187|NCT01939899|11773914|FG000|STARTED|Phase 2||0
10616188|NCT01939899|11773915|FG001|STARTED|Phase 2||0
10704873|NCT01525901|11869246|FG002|COMPLETED|Period 2: 12 Weeks||5
10704874|NCT01525901|11869247|FG003|COMPLETED|Period 2: 12 Weeks||5
10616189|NCT01939899|11773916|FG002|STARTED|Phase 2||0
10616190|NCT01939899|11773917|FG003|STARTED|Phase 2||12
10616191|NCT01939899|11773918|FG004|STARTED|Phase 2||1
10616192|NCT01939899|11773914|FG000|COMPLETED|Phase 2||0
10616193|NCT01939899|11773915|FG001|COMPLETED|Phase 2||0
10616194|NCT01939899|11773916|FG002|COMPLETED|Phase 2||0
10616195|NCT01939899|11773917|FG003|COMPLETED|Phase 2||1
10616196|NCT01939899|11773918|FG004|COMPLETED|Phase 2||0
10616197|NCT01939899|11773914|FG000|NOT COMPLETED|Phase 2||0
10616198|NCT01939899|11773915|FG001|NOT COMPLETED|Phase 2||0
10616199|NCT01939899|11773916|FG002|NOT COMPLETED|Phase 2||0
10616200|NCT01939899|11773917|FG003|NOT COMPLETED|Phase 2||11
10616201|NCT01939899|11773918|FG004|NOT COMPLETED|Phase 2||1
10616202|NCT01939938|11773936|FG000|STARTED|Overall Study||10
10616203|NCT01939938|11773936|FG000|COMPLETED|Overall Study||10
10616204|NCT01939938|11773936|FG000|NOT COMPLETED|Overall Study||0
10616205|NCT01939977|11773944|FG000|STARTED|Overall Study||46
10616206|NCT01939977|11773945|FG001|STARTED|Overall Study|48 patients randomized but 1 did not meet inclusion criteria. 47 patients analyzed.|48
10616207|NCT01939977|11773944|FG000|COMPLETED|Overall Study||37
10704875|NCT01525901|11869244|FG000|NOT COMPLETED|Period 2: 12 Weeks||0
10616208|NCT01939977|11773945|FG001|COMPLETED|Overall Study||41
10616209|NCT01939977|11773944|FG000|NOT COMPLETED|Overall Study||9
10616210|NCT01939977|11773945|FG001|NOT COMPLETED|Overall Study||7
10616211|NCT01940120|11773951|FG000|STARTED|Overall Study||78
10616212|NCT01940120|11773951|FG000|COMPLETED|Overall Study||30
10616213|NCT01940120|11773951|FG000|NOT COMPLETED|Overall Study||48
10616214|NCT01940146|11773960|FG000|STARTED|Overall Study||56
10616215|NCT01940146|11773961|FG001|STARTED|Overall Study||55
10616216|NCT01940146|11773962|FG002|STARTED|Overall Study||56
10616217|NCT01940146|11773963|FG003|STARTED|Overall Study||55
10616218|NCT01940146|11773960|FG000|COMPLETED|Overall Study||55
10616219|NCT01940146|11773961|FG001|COMPLETED|Overall Study||55
10616220|NCT01940146|11773962|FG002|COMPLETED|Overall Study||55
10616221|NCT01940146|11773963|FG003|COMPLETED|Overall Study||53
10616222|NCT01940146|11773960|FG000|NOT COMPLETED|Overall Study||1
10616223|NCT01940146|11773961|FG001|NOT COMPLETED|Overall Study||0
10616224|NCT01940146|11773962|FG002|NOT COMPLETED|Overall Study||1
10616225|NCT01940146|11773963|FG003|NOT COMPLETED|Overall Study||2
10616226|NCT01940276|11773975|FG000|STARTED|Overall Study||50
10616227|NCT01940276|11773976|FG001|STARTED|Overall Study||50
10616228|NCT01940276|11773975|FG000|COMPLETED|Overall Study||50
10616229|NCT01940276|11773976|FG001|COMPLETED|Overall Study||50
10616230|NCT01940276|11773975|FG000|NOT COMPLETED|Overall Study||0
10616231|NCT01940276|11773976|FG001|NOT COMPLETED|Overall Study||0
10616232|NCT01940354|11773984|FG000|STARTED|Overall Study||110
10616233|NCT01940354|11773985|FG001|STARTED|Overall Study||110
10616234|NCT01940354|11773984|FG000|COMPLETED|Overall Study||106
10616235|NCT01940354|11773985|FG001|COMPLETED|Overall Study||108
10616236|NCT01940354|11773984|FG000|NOT COMPLETED|Overall Study||4
10616237|NCT01940354|11773985|FG001|NOT COMPLETED|Overall Study||2
10616238|NCT01940484|11773991|FG000|STARTED|Overall Study||98
10616239|NCT01940484|11773991|FG000|COMPLETED|Overall Study||88
10616240|NCT01940484|11773991|FG000|NOT COMPLETED|Overall Study||10
10616241|NCT01940497|11773997|FG000|STARTED|Overall Study||121
10616242|NCT01940497|11773998|FG001|STARTED|Overall Study||119
10616243|NCT01940497|11773997|FG000|Treated|Overall Study||115
10616244|NCT01940497|11773998|FG001|Treated|Overall Study||113
10616245|NCT01940497|11773997|FG000|Treated: Adjuvant|Overall Study||95
10616246|NCT01940497|11773998|FG001|Treated: Adjuvant|Overall Study||92
10616247|NCT01940497|11773997|FG000|Treated: Neoadjuvant|Overall Study||20
10616248|NCT01940497|11773998|FG001|Treated: Neoadjuvant|Overall Study||21
10616249|NCT01940497|11773997|FG000|COMPLETED|Overall Study||100
10616250|NCT01940497|11773998|FG001|COMPLETED|Overall Study||101
10616251|NCT01940497|11773997|FG000|NOT COMPLETED|Overall Study||21
10616252|NCT01940497|11773998|FG001|NOT COMPLETED|Overall Study||18
10616253|NCT01940510|11774015|FG000|STARTED|Overall Study||24
10616254|NCT01940510|11774015|FG000|COMPLETED|Overall Study||24
10616255|NCT01940510|11774015|FG000|NOT COMPLETED|Overall Study||0
10616256|NCT01940523|11774024|FG000|STARTED|Overall Study||320
10616257|NCT01940523|11774025|FG001|STARTED|Overall Study||320
10616258|NCT01940523|11774024|FG000|COMPLETED|Overall Study||320
10616259|NCT01940523|11774025|FG001|COMPLETED|Overall Study||320
10616260|NCT01940523|11774024|FG000|NOT COMPLETED|Overall Study||0
10616261|NCT01940523|11774025|FG001|NOT COMPLETED|Overall Study||0
10616262|NCT01940705|11774037|FG000|STARTED|Overall Study||66
10616263|NCT01940705|11774038|FG001|STARTED|Overall Study||67
10616264|NCT01940705|11774039|FG002|STARTED|Overall Study||69
10616265|NCT01940705|11774040|FG003|STARTED|Overall Study||67
10616266|NCT01940705|11774037|FG000|COMPLETED|Overall Study||62
10616267|NCT01940705|11774038|FG001|COMPLETED|Overall Study||59
10616268|NCT01940705|11774039|FG002|COMPLETED|Overall Study||61
10616269|NCT01940705|11774040|FG003|COMPLETED|Overall Study||63
10616270|NCT01940705|11774037|FG000|NOT COMPLETED|Overall Study||4
10616271|NCT01940705|11774038|FG001|NOT COMPLETED|Overall Study||8
10616272|NCT01940705|11774039|FG002|NOT COMPLETED|Overall Study||8
10616273|NCT01940705|11774040|FG003|NOT COMPLETED|Overall Study||4
10616274|NCT01940887|11774055|FG000|STARTED|Year 1||322
10616275|NCT01940887|11774056|FG001|STARTED|Year 1||320
10616276|NCT01940887|11774055|FG000|COMPLETED|Year 1||283
10616277|NCT01940887|11774056|FG001|COMPLETED|Year 1||297
10616278|NCT01940887|11774055|FG000|NOT COMPLETED|Year 1||39
10616279|NCT01940887|11774056|FG001|NOT COMPLETED|Year 1||23
10616280|NCT01940887|11774055|FG000|STARTED|Year 2||283
10616281|NCT01940887|11774056|FG001|STARTED|Year 2||297
10616282|NCT01940887|11774055|FG000|COMPLETED|Year 2||66
10616283|NCT01940887|11774056|FG001|COMPLETED|Year 2||75
10616284|NCT01940887|11774055|FG000|NOT COMPLETED|Year 2||217
10616285|NCT01940887|11774056|FG001|NOT COMPLETED|Year 2||222
10616286|NCT01940900|11774064|FG000|STARTED|Overall Study||311
10616287|NCT01940900|11774065|FG001|STARTED|Overall Study||315
10616288|NCT01940900|11774064|FG000|COMPLETED|Overall Study||282
10616289|NCT01940900|11774065|FG001|COMPLETED|Overall Study||284
10616290|NCT01940900|11774064|FG000|NOT COMPLETED|Overall Study||29
10616291|NCT01940900|11774065|FG001|NOT COMPLETED|Overall Study||31
10616292|NCT01940939|11774073|FG000|STARTED|Overall Study||35
10616293|NCT01940939|11774074|FG001|STARTED|Overall Study||35
10616294|NCT01940939|11774073|FG000|COMPLETED|Overall Study||33
10616295|NCT01940939|11774074|FG001|COMPLETED|Overall Study||27
10616296|NCT01940939|11774073|FG000|NOT COMPLETED|Overall Study||2
10616297|NCT01940939|11774074|FG001|NOT COMPLETED|Overall Study||8
10616298|NCT01941030|11774082|FG000|STARTED|Overall Study||25
10616299|NCT01941030|11774083|FG001|STARTED|Overall Study||26
10616300|NCT01941030|11774082|FG000|COMPLETED|Overall Study||12
10616301|NCT01941030|11774083|FG001|COMPLETED|Overall Study||13
10616302|NCT01941030|11774082|FG000|NOT COMPLETED|Overall Study||13
10616303|NCT01941030|11774083|FG001|NOT COMPLETED|Overall Study||13
10616304|NCT01941095|11774089|FG000|STARTED|Overall Study||97
10616305|NCT01941095|11774089|FG000|COMPLETED|Overall Study||41
10616306|NCT01941095|11774089|FG000|NOT COMPLETED|Overall Study||56
10616307|NCT01941186|11774096|FG000|STARTED|Randomization/Allocation to Study Group||31
10616308|NCT01941186|11774097|FG001|STARTED|Randomization/Allocation to Study Group||33
10616309|NCT01941186|11774096|FG000|COMPLETED|Randomization/Allocation to Study Group||31
10616310|NCT01941186|11774097|FG001|COMPLETED|Randomization/Allocation to Study Group||33
10616311|NCT01941186|11774096|FG000|NOT COMPLETED|Randomization/Allocation to Study Group||0
10616312|NCT01941186|11774097|FG001|NOT COMPLETED|Randomization/Allocation to Study Group||0
10616313|NCT01941186|11774096|FG000|STARTED|Follow-up||31
10616314|NCT01941186|11774097|FG001|STARTED|Follow-up||33
10616315|NCT01941186|11774096|FG000|COMPLETED|Follow-up||30
10704876|NCT01525901|11869245|FG001|NOT COMPLETED|Period 2: 12 Weeks||1
10704877|NCT01525901|11869246|FG002|NOT COMPLETED|Period 2: 12 Weeks||0
10704878|NCT01525901|11869247|FG003|NOT COMPLETED|Period 2: 12 Weeks||0
10704879|NCT01354431|11869260|FG000|STARTED|Pre-Treatment Period||60
10704880|NCT01354431|11869261|FG001|STARTED|Pre-Treatment Period||54
10704881|NCT01354431|11869262|FG002|STARTED|Pre-Treatment Period||54
10704882|NCT01354431|11869260|FG000|COMPLETED|Pre-Treatment Period||59
10616316|NCT01941186|11774097|FG001|COMPLETED|Follow-up||33
10616317|NCT01941186|11774096|FG000|NOT COMPLETED|Follow-up||1
10616318|NCT01941186|11774097|FG001|NOT COMPLETED|Follow-up||0
10616319|NCT01941472|11774116|FG000|STARTED|Overall Study||40
10616320|NCT01941472|11774116|FG000|COMPLETED|Overall Study||40
10616321|NCT01941472|11774116|FG000|NOT COMPLETED|Overall Study||0
10616322|NCT01941485|11774120|FG000|STARTED|Overall Study||59
10616323|NCT01941485|11774120|FG000|COMPLETED|Overall Study||59
10616324|NCT01941485|11774120|FG000|NOT COMPLETED|Overall Study||0
10616325|NCT01941498|11774142|FG000|STARTED|Overall Study||97
10616326|NCT01941498|11774142|FG000|COMPLETED|Overall Study||96
10616327|NCT01941498|11774142|FG000|NOT COMPLETED|Overall Study||1
10616328|NCT01941537|11774163|FG000|STARTED|Overall Study||40
10616329|NCT01941537|11774164|FG001|STARTED|Overall Study||20
10616330|NCT01941537|11774163|FG000|COMPLETED|Overall Study||36
10616331|NCT01941537|11774164|FG001|COMPLETED|Overall Study||17
10616332|NCT01941537|11774163|FG000|NOT COMPLETED|Overall Study||4
10616333|NCT01941537|11774164|FG001|NOT COMPLETED|Overall Study||3
10616334|NCT01941628|11774173|FG000|STARTED|Overall Study||46
10616335|NCT01941628|11774174|FG001|STARTED|Overall Study||45
10616336|NCT01941628|11774173|FG000|COMPLETED|Overall Study||45
10616337|NCT01941628|11774174|FG001|COMPLETED|Overall Study||45
10616338|NCT01941628|11774173|FG000|NOT COMPLETED|Overall Study||1
10616339|NCT01941628|11774174|FG001|NOT COMPLETED|Overall Study||0
10616340|NCT01941745|11774184|FG000|STARTED|Overall Study||22
10616341|NCT01941745|11774185|FG001|STARTED|Overall Study||22
10616342|NCT01941745|11774186|FG002|STARTED|Overall Study||21
10616343|NCT01941745|11774187|FG003|STARTED|Overall Study||23
10616344|NCT01941745|11774184|FG000|COMPLETED|Overall Study||22
10616345|NCT01941745|11774185|FG001|COMPLETED|Overall Study||22
10616346|NCT01941745|11774186|FG002|COMPLETED|Overall Study||21
10616347|NCT01941745|11774187|FG003|COMPLETED|Overall Study||23
10616348|NCT01941745|11774184|FG000|NOT COMPLETED|Overall Study||0
10616349|NCT01941745|11774185|FG001|NOT COMPLETED|Overall Study||0
10616350|NCT01941745|11774186|FG002|NOT COMPLETED|Overall Study||0
10616351|NCT01941745|11774187|FG003|NOT COMPLETED|Overall Study||0
10616352|NCT01941927|11774202|FG000|STARTED|Overall Study||10
10616353|NCT01941927|11774203|FG001|STARTED|Overall Study||10
10616354|NCT01941927|11774202|FG000|COMPLETED|Overall Study||10
10616355|NCT01941927|11774203|FG001|COMPLETED|Overall Study||10
10616356|NCT01941927|11774202|FG000|NOT COMPLETED|Overall Study||0
10616357|NCT01941927|11774203|FG001|NOT COMPLETED|Overall Study||0
10616358|NCT01941940|11774209|FG000|STARTED|Overall Study||227
10616359|NCT01941940|11774209|FG000|COMPLETED|Overall Study||194
10616360|NCT01941940|11774209|FG000|NOT COMPLETED|Overall Study||33
10616361|NCT01942148|11774213|FG000|STARTED|Overall Study||68
10616362|NCT01942148|11774213|FG000|COMPLETED|Overall Study||41
10704883|NCT01354431|11869261|FG001|COMPLETED|Pre-Treatment Period||54
10704884|NCT01354431|11869262|FG002|COMPLETED|Pre-Treatment Period||54
10704885|NCT01354431|11869260|FG000|NOT COMPLETED|Pre-Treatment Period||1
10704886|NCT01354431|11869261|FG001|NOT COMPLETED|Pre-Treatment Period||0
10704887|NCT01354431|11869262|FG002|NOT COMPLETED|Pre-Treatment Period||0
10704888|NCT01354431|11869260|FG000|STARTED|Treatment Period||59
10704889|NCT01354431|11869261|FG001|STARTED|Treatment Period||54
10704890|NCT01354431|11869262|FG002|STARTED|Treatment Period||54
10704891|NCT01354431|11869260|FG000|COMPLETED|Treatment Period||0
10704892|NCT01354431|11869261|FG001|COMPLETED|Treatment Period||0
10704893|NCT01354431|11869262|FG002|COMPLETED|Treatment Period||0
10704894|NCT01354431|11869260|FG000|NOT COMPLETED|Treatment Period||59
10704895|NCT01354431|11869261|FG001|NOT COMPLETED|Treatment Period||54
10704896|NCT01354431|11869262|FG002|NOT COMPLETED|Treatment Period||54
10704897|NCT01003691|11869274|FG000|STARTED|Overall Study||6
10704898|NCT01003691|11869275|FG001|STARTED|Overall Study||6
10704899|NCT01003691|11869276|FG002|STARTED|Overall Study||6
10704900|NCT01003691|11869277|FG003|STARTED|Overall Study||6
10616363|NCT01942148|11774213|FG000|NOT COMPLETED|Overall Study||27
10616364|NCT01942161|11774220|FG000|STARTED|Overall Study||35
10616365|NCT01942161|11774221|FG001|STARTED|Overall Study||30
10616366|NCT01942161|11774222|FG002|STARTED|Overall Study||41
10616367|NCT01942161|11774220|FG000|COMPLETED|Overall Study||27
10616368|NCT01942161|11774221|FG001|COMPLETED|Overall Study||24
10616369|NCT01942161|11774222|FG002|COMPLETED|Overall Study||35
10616370|NCT01942161|11774220|FG000|NOT COMPLETED|Overall Study||8
10616371|NCT01942161|11774221|FG001|NOT COMPLETED|Overall Study||6
10616372|NCT01942161|11774222|FG002|NOT COMPLETED|Overall Study||6
10704901|NCT01003691|11869274|FG000|COMPLETED|Overall Study||6
10704902|NCT01003691|11869275|FG001|COMPLETED|Overall Study||6
10704903|NCT01003691|11869276|FG002|COMPLETED|Overall Study||6
10704904|NCT01003691|11869277|FG003|COMPLETED|Overall Study||5
10616373|NCT01942486|11774230|FG000|STARTED|Overall Study||35
10616374|NCT01942486|11774230|FG000|COMPLETED|Overall Study||8
10616375|NCT01942486|11774230|FG000|NOT COMPLETED|Overall Study||27
10653216|NCT02191033|11813655|FG000|NOT COMPLETED|Overall Study||2
10653217|NCT02191033|11813656|FG001|NOT COMPLETED|Overall Study||1
10654520|NCT02203071|11815306|FG000|COMPLETED|Overall Study||10
10654521|NCT02203071|11815307|FG001|COMPLETED|Overall Study||5
10654522|NCT02203071|11815306|FG000|NOT COMPLETED|Overall Study||3
10654523|NCT02203071|11815307|FG001|NOT COMPLETED|Overall Study||1
10654524|NCT02203149|11815318|FG000|STARTED|Part 1||31
10654525|NCT02203149|11815319|FG001|STARTED|Part 1||32
10654526|NCT02203149|11815320|FG002|STARTED|Part 1||0
10654527|NCT02203149|11815321|FG003|STARTED|Part 1||0
10654528|NCT02203149|11815322|FG004|STARTED|Part 1||0
10654529|NCT02203149|11815318|FG000|COMPLETED|Part 1||31
10654530|NCT02203149|11815319|FG001|COMPLETED|Part 1||31
10654531|NCT02203149|11815320|FG002|COMPLETED|Part 1||0
10654532|NCT02203149|11815321|FG003|COMPLETED|Part 1||0
10654533|NCT02203149|11815322|FG004|COMPLETED|Part 1||0
10654534|NCT02203149|11815318|FG000|NOT COMPLETED|Part 1||0
10654535|NCT02203149|11815319|FG001|NOT COMPLETED|Part 1||1
10654536|NCT02203149|11815320|FG002|NOT COMPLETED|Part 1||0
10654537|NCT02203149|11815321|FG003|NOT COMPLETED|Part 1||0
10654538|NCT02203149|11815322|FG004|NOT COMPLETED|Part 1||0
10654539|NCT02203149|11815318|FG000|STARTED|Part 2|Participants of Part 1 did not enter Part 2|0
10654540|NCT02203149|11815319|FG001|STARTED|Part 2|Participants of Part 1 did not enter Part 2|0
10654541|NCT02203149|11815320|FG002|STARTED|Part 2||227
10654542|NCT02203149|11815321|FG003|STARTED|Part 2||74
10654543|NCT02203149|11815322|FG004|STARTED|Part 2||35
10654544|NCT02203149|11815318|FG000|Started Deferred Active Treatment|Part 2||0
10654545|NCT02203149|11815319|FG001|Started Deferred Active Treatment|Part 2||0
10654546|NCT02203149|11815320|FG002|Started Deferred Active Treatment|Part 2||0
10654547|NCT02203149|11815321|FG003|Started Deferred Active Treatment|Part 2|1 participant in Deferred Treatment Arm receiving Placebo did not receive Deferred Active Treatment.|73
10654548|NCT02203149|11815322|FG004|Started Deferred Active Treatment|Part 2||0
10654549|NCT02203149|11815318|FG000|COMPLETED|Part 2||0
10654550|NCT02203149|11815319|FG001|COMPLETED|Part 2||0
10654551|NCT02203149|11815320|FG002|COMPLETED|Part 2||226
10654552|NCT02203149|11815321|FG003|COMPLETED|Part 2||71
10654553|NCT02203149|11815322|FG004|COMPLETED|Part 2||34
10654554|NCT02203149|11815318|FG000|NOT COMPLETED|Part 2||0
10654555|NCT02203149|11815319|FG001|NOT COMPLETED|Part 2||0
10654556|NCT02203149|11815320|FG002|NOT COMPLETED|Part 2||1
10654557|NCT02203149|11815321|FG003|NOT COMPLETED|Part 2||3
10654558|NCT02203149|11815322|FG004|NOT COMPLETED|Part 2||1
10654559|NCT02203162|11815344|FG000|STARTED|Overall Study||30
10654560|NCT02203162|11815344|FG000|COMPLETED|Overall Study||30
10654561|NCT02203162|11815344|FG000|NOT COMPLETED|Overall Study||0
10654562|NCT02203331|11815354|FG000|STARTED|Overall Study||52
10654563|NCT02203331|11815355|FG001|STARTED|Overall Study||53
10654564|NCT02203331|11815356|FG002|STARTED|Overall Study||55
10654565|NCT02203331|11815357|FG003|STARTED|Overall Study||53
10654566|NCT02203331|11815358|FG004|STARTED|Overall Study||53
10654567|NCT02203331|11815359|FG005|STARTED|Overall Study||53
10654568|NCT02203331|11815354|FG000|Treated|Overall Study||49
10654569|NCT02203331|11815355|FG001|Treated|Overall Study||50
10654570|NCT02203331|11815356|FG002|Treated|Overall Study||54
10654571|NCT02203331|11815357|FG003|Treated|Overall Study||49
10654572|NCT02203331|11815358|FG004|Treated|Overall Study||50
10654573|NCT02203331|11815359|FG005|Treated|Overall Study||53
10654574|NCT02203331|11815354|FG000|COMPLETED|Overall Study||45
10654575|NCT02203331|11815355|FG001|COMPLETED|Overall Study||39
10654576|NCT02203331|11815356|FG002|COMPLETED|Overall Study||50
10654577|NCT02203331|11815357|FG003|COMPLETED|Overall Study||46
10654578|NCT02203331|11815358|FG004|COMPLETED|Overall Study||46
10654579|NCT02203331|11815359|FG005|COMPLETED|Overall Study||46
10654580|NCT02203331|11815354|FG000|NOT COMPLETED|Overall Study||7
10654581|NCT02203331|11815355|FG001|NOT COMPLETED|Overall Study||14
10654582|NCT02203331|11815356|FG002|NOT COMPLETED|Overall Study||5
10654583|NCT02203331|11815357|FG003|NOT COMPLETED|Overall Study||7
10654584|NCT02203331|11815358|FG004|NOT COMPLETED|Overall Study||7
10654585|NCT02203331|11815359|FG005|NOT COMPLETED|Overall Study||7
10654586|NCT02203357|11815376|FG000|STARTED|Overall Study||117
10654587|NCT02203357|11815377|FG001|STARTED|Overall Study||111
10654588|NCT02203357|11815378|FG002|STARTED|Overall Study||125
10654589|NCT02203357|11815376|FG000|mon7/2/3|Overall Study||114
10654590|NCT02203357|11815377|FG001|mon7/2/3|Overall Study||110
10654591|NCT02203357|11815378|FG002|mon7/2/3|Overall Study||124
10654592|NCT02203357|11815376|FG000|mon12|Overall Study||113
10654593|NCT02203357|11815377|FG001|mon12|Overall Study||101
10654594|NCT02203357|11815378|FG002|mon12|Overall Study||122
10654595|NCT02203357|11815376|FG000|mon24|Overall Study||59
10654596|NCT02203357|11815377|FG001|mon24|Overall Study||45
10654597|NCT02203357|11815378|FG002|mon24|Overall Study||55
10654598|NCT02203357|11815376|FG000|COMPLETED|Overall Study||59
10654599|NCT02203357|11815377|FG001|COMPLETED|Overall Study||45
10654600|NCT02203357|11815378|FG002|COMPLETED|Overall Study||55
10654601|NCT02203357|11815376|FG000|NOT COMPLETED|Overall Study||58
10654602|NCT02203357|11815377|FG001|NOT COMPLETED|Overall Study||66
10654603|NCT02203357|11815378|FG002|NOT COMPLETED|Overall Study||70
10654604|NCT02203565|11815389|FG000|STARTED|Overall Study||20
10654605|NCT02203565|11815389|FG000|COMPLETED|Overall Study||19
10654606|NCT02203565|11815389|FG000|NOT COMPLETED|Overall Study||1
10654607|NCT02203578|11815393|FG000|STARTED|Overall Study||1
10654608|NCT02203578|11815393|FG000|COMPLETED|Overall Study||1
10616376|NCT01942590|11774236|FG000|STARTED|Overall Study||8
10616377|NCT01942590|11774237|FG001|STARTED|Overall Study||5
10616378|NCT01942590|11774236|FG000|COMPLETED|Overall Study||7
10616379|NCT01942590|11774237|FG001|COMPLETED|Overall Study||4
10616380|NCT01942590|11774236|FG000|NOT COMPLETED|Overall Study||1
10616381|NCT01942590|11774237|FG001|NOT COMPLETED|Overall Study||1
10616382|NCT01942668|11774249|FG000|STARTED|Overall Study||418
10616383|NCT01942668|11774250|FG001|STARTED|Overall Study||426
10616384|NCT01942668|11774251|FG002|STARTED|Overall Study||422
10616385|NCT01942668|11774252|FG003|STARTED|Overall Study||427
10616386|NCT01942668|11774253|FG004|STARTED|Overall Study||152
10616387|NCT01942668|11774249|FG000|COMPLETED|Overall Study||284
10616388|NCT01942668|11774250|FG001|COMPLETED|Overall Study||305
10616389|NCT01942668|11774251|FG002|COMPLETED|Overall Study||312
10616390|NCT01942668|11774252|FG003|COMPLETED|Overall Study||281
10616391|NCT01942668|11774253|FG004|COMPLETED|Overall Study||93
10616392|NCT01942668|11774249|FG000|NOT COMPLETED|Overall Study||134
10616393|NCT01942668|11774250|FG001|NOT COMPLETED|Overall Study||121
10616394|NCT01942668|11774251|FG002|NOT COMPLETED|Overall Study||110
10616395|NCT01942668|11774252|FG003|NOT COMPLETED|Overall Study||146
10616396|NCT01942668|11774253|FG004|NOT COMPLETED|Overall Study||59
10616403|NCT01942707|11774281|FG000|STARTED|Overall Study||23
10616404|NCT01942707|11774282|FG001|STARTED|Overall Study||23
10616405|NCT01942707|11774281|FG000|COMPLETED|Overall Study||23
10616406|NCT01942707|11774282|FG001|COMPLETED|Overall Study||23
10616407|NCT01942707|11774281|FG000|NOT COMPLETED|Overall Study||0
10616408|NCT01942707|11774282|FG001|NOT COMPLETED|Overall Study||0
10616409|NCT01942720|11774288|FG000|STARTED|Overall Study||74
10616410|NCT01942720|11774288|FG000|COMPLETED|Overall Study||53
10616411|NCT01942720|11774288|FG000|NOT COMPLETED|Overall Study||21
10616412|NCT01942733|11774292|FG000|STARTED|Overall Study||44
10616413|NCT01942733|11774292|FG000|COMPLETED|Overall Study||41
10616414|NCT01942733|11774292|FG000|NOT COMPLETED|Overall Study||3
10616415|NCT01942785|11774296|FG000|STARTED|Overall Study||54
10616416|NCT01942785|11774296|FG000|COMPLETED|Overall Study||50
10616417|NCT01942785|11774296|FG000|NOT COMPLETED|Overall Study||4
10616418|NCT01942993|11774302|FG000|STARTED|Overall Study||3
10616419|NCT01942993|11774302|FG000|COMPLETED|Overall Study||1
10616420|NCT01942993|11774302|FG000|NOT COMPLETED|Overall Study||2
10616421|NCT01943110|11774306|FG000|STARTED|Overall Study||30
10616422|NCT01943110|11774306|FG000|COMPLETED|Overall Study||30
10616423|NCT01943110|11774306|FG000|NOT COMPLETED|Overall Study||0
10616424|NCT01943227|11774324|FG000|STARTED|Overall Study||10
10616425|NCT01943227|11774325|FG001|STARTED|Overall Study||10
10616426|NCT01943227|11774324|FG000|COMPLETED|Overall Study||10
10616427|NCT01943227|11774325|FG001|COMPLETED|Overall Study||10
10616428|NCT01943227|11774324|FG000|NOT COMPLETED|Overall Study||0
10616429|NCT01943227|11774325|FG001|NOT COMPLETED|Overall Study||0
10616430|NCT01943292|11774334|FG000|STARTED|Overall Study||3
10616431|NCT01943292|11774335|FG001|STARTED|Overall Study||3
10616432|NCT01943292|11774336|FG002|STARTED|Overall Study||3
10616433|NCT01943292|11774334|FG000|Completed Cycle 1|Overall Study||3
10616434|NCT01943292|11774335|FG001|Completed Cycle 1|Overall Study||3
10616435|NCT01943292|11774336|FG002|Completed Cycle 1|Overall Study||3
10616436|NCT01943292|11774334|FG000|Completed Treatment|Overall Study||3
10616437|NCT01943292|11774335|FG001|Completed Treatment|Overall Study||3
10616438|NCT01943292|11774336|FG002|Completed Treatment|Overall Study||3
10616439|NCT01943292|11774334|FG000|Completed Follow-Up|Overall Study||2
10616440|NCT01943292|11774335|FG001|Completed Follow-Up|Overall Study||3
10616441|NCT01943292|11774336|FG002|Completed Follow-Up|Overall Study||3
10616442|NCT01943292|11774334|FG000|COMPLETED|Overall Study||2
10616443|NCT01943292|11774335|FG001|COMPLETED|Overall Study||3
10616444|NCT01943292|11774336|FG002|COMPLETED|Overall Study||3
10616445|NCT01943292|11774334|FG000|NOT COMPLETED|Overall Study||1
10616446|NCT01943292|11774335|FG001|NOT COMPLETED|Overall Study||0
10616447|NCT01943292|11774336|FG002|NOT COMPLETED|Overall Study||0
10616448|NCT01943344|11774344|FG000|STARTED|Overall Study||12
10616449|NCT01943344|11774344|FG000|COMPLETED|Overall Study||9
10616450|NCT01943344|11774344|FG000|NOT COMPLETED|Overall Study||3
10616451|NCT01943435|11774353|FG000|STARTED|Baseline Eligibility and Randomization||88
10616452|NCT01943435|11774354|FG001|STARTED|Baseline Eligibility and Randomization||84
10808816|NCT03840278|11970806|FG000|NOT COMPLETED|Overall Study||0
10808817|NCT03840278|11970807|FG001|NOT COMPLETED|Overall Study||0
10808818|NCT03840135|11970815|FG000|STARTED|Overall Study||86
10808819|NCT03840135|11970816|FG001|STARTED|Overall Study||86
10616453|NCT01943435|11774355|FG002|STARTED|Baseline Eligibility and Randomization||87
10616454|NCT01943435|11774353|FG000|COMPLETED|Baseline Eligibility and Randomization||84
10616455|NCT01943435|11774354|FG001|COMPLETED|Baseline Eligibility and Randomization||72
10616456|NCT01943435|11774355|FG002|COMPLETED|Baseline Eligibility and Randomization||84
10616457|NCT01943435|11774353|FG000|NOT COMPLETED|Baseline Eligibility and Randomization||4
10616458|NCT01943435|11774354|FG001|NOT COMPLETED|Baseline Eligibility and Randomization||12
10616459|NCT01943435|11774355|FG002|NOT COMPLETED|Baseline Eligibility and Randomization||3
10616460|NCT01943435|11774353|FG000|STARTED|Intervention Period||84
10616461|NCT01943435|11774354|FG001|STARTED|Intervention Period||72
10616462|NCT01943435|11774355|FG002|STARTED|Intervention Period||84
10616463|NCT01943435|11774353|FG000|COMPLETED|Intervention Period||81
10616464|NCT01943435|11774354|FG001|COMPLETED|Intervention Period||69
10616465|NCT01943435|11774355|FG002|COMPLETED|Intervention Period||80
10616466|NCT01943435|11774353|FG000|NOT COMPLETED|Intervention Period||3
10616467|NCT01943435|11774354|FG001|NOT COMPLETED|Intervention Period||3
10616468|NCT01943435|11774355|FG002|NOT COMPLETED|Intervention Period||4
10616469|NCT01943435|11774353|FG000|STARTED|2 Month Follow up||81
10616470|NCT01943435|11774354|FG001|STARTED|2 Month Follow up||69
10616471|NCT01943435|11774355|FG002|STARTED|2 Month Follow up||80
10616472|NCT01943435|11774353|FG000|COMPLETED|2 Month Follow up||79
10616473|NCT01943435|11774354|FG001|COMPLETED|2 Month Follow up||66
10616474|NCT01943435|11774355|FG002|COMPLETED|2 Month Follow up||80
10616475|NCT01943435|11774353|FG000|NOT COMPLETED|2 Month Follow up||2
10616476|NCT01943435|11774354|FG001|NOT COMPLETED|2 Month Follow up||3
10616477|NCT01943435|11774355|FG002|NOT COMPLETED|2 Month Follow up||0
10616478|NCT01943435|11774353|FG000|STARTED|6 Month Follow up||79
10616479|NCT01943435|11774354|FG001|STARTED|6 Month Follow up||66
10616480|NCT01943435|11774355|FG002|STARTED|6 Month Follow up||80
10616481|NCT01943435|11774353|FG000|COMPLETED|6 Month Follow up||67
10616482|NCT01943435|11774354|FG001|COMPLETED|6 Month Follow up||59
10616483|NCT01943435|11774355|FG002|COMPLETED|6 Month Follow up||65
10616484|NCT01943435|11774353|FG000|NOT COMPLETED|6 Month Follow up||12
10616485|NCT01943435|11774354|FG001|NOT COMPLETED|6 Month Follow up||7
10616486|NCT01943435|11774355|FG002|NOT COMPLETED|6 Month Follow up||15
10616487|NCT01943461|11774367|FG000|STARTED|Overall Study||5
10616488|NCT01943461|11774368|FG001|STARTED|Overall Study||6
10616489|NCT01943461|11774369|FG002|STARTED|Overall Study||6
10616490|NCT01943461|11774370|FG003|STARTED|Overall Study||40
10616491|NCT01943461|11774367|FG000|COMPLETED|Overall Study||5
10616492|NCT01943461|11774368|FG001|COMPLETED|Overall Study||6
10616493|NCT01943461|11774369|FG002|COMPLETED|Overall Study||6
10616494|NCT01943461|11774370|FG003|COMPLETED|Overall Study||40
10616495|NCT01943461|11774367|FG000|NOT COMPLETED|Overall Study||0
10616496|NCT01943461|11774368|FG001|NOT COMPLETED|Overall Study||0
10616497|NCT01943461|11774369|FG002|NOT COMPLETED|Overall Study||0
10616498|NCT01943461|11774370|FG003|NOT COMPLETED|Overall Study||0
10616499|NCT01943474|11774382|FG000|STARTED|Overall Study||123
10616500|NCT01943474|11774383|FG001|STARTED|Overall Study||125
10616501|NCT01943474|11774382|FG000|COMPLETED|Overall Study||123
10616502|NCT01943474|11774383|FG001|COMPLETED|Overall Study||125
10616503|NCT01943474|11774382|FG000|NOT COMPLETED|Overall Study||0
10616504|NCT01943474|11774383|FG001|NOT COMPLETED|Overall Study||0
10616505|NCT01943539|11774389|FG000|STARTED|Overall Study||44
10616506|NCT01943539|11774390|FG001|STARTED|Overall Study||40
10616507|NCT01943539|11774389|FG000|COMPLETED|Overall Study||40
10616508|NCT01943539|11774390|FG001|COMPLETED|Overall Study||40
10616509|NCT01943539|11774389|FG000|NOT COMPLETED|Overall Study||4
10616510|NCT01943539|11774390|FG001|NOT COMPLETED|Overall Study||0
10616511|NCT01943552|11774399|FG000|STARTED|Overall Study|One patient was randomised to the placebo group, but received nebulized ipratropium bromide.|96
10616512|NCT01943552|11774400|FG001|STARTED|Overall Study||94
10616513|NCT01943552|11774399|FG000|COMPLETED|Overall Study||71
10616514|NCT01943552|11774400|FG001|COMPLETED|Overall Study||69
10616515|NCT01943552|11774399|FG000|NOT COMPLETED|Overall Study||25
10616516|NCT01943552|11774400|FG001|NOT COMPLETED|Overall Study||25
10616517|NCT01943565|11774409|FG000|STARTED|Overall Study||11
10616518|NCT01943565|11774410|FG001|STARTED|Overall Study||9
10616519|NCT01943565|11774411|FG002|STARTED|Overall Study||9
10616520|NCT01943565|11774409|FG000|COMPLETED|Overall Study||11
10616521|NCT01943565|11774410|FG001|COMPLETED|Overall Study||9
10616522|NCT01943565|11774411|FG002|COMPLETED|Overall Study||9
10616523|NCT01943565|11774409|FG000|NOT COMPLETED|Overall Study||0
10616524|NCT01943565|11774410|FG001|NOT COMPLETED|Overall Study||0
10616525|NCT01943565|11774411|FG002|NOT COMPLETED|Overall Study||0
10616526|NCT01943591|11774421|FG000|STARTED|Overall Study||104
10616527|NCT01943591|11774422|FG001|STARTED|Overall Study||106
10616528|NCT01943591|11774421|FG000|COMPLETED|Overall Study||99
10616529|NCT01943591|11774422|FG001|COMPLETED|Overall Study||95
10616530|NCT01943591|11774421|FG000|NOT COMPLETED|Overall Study||5
10616531|NCT01943591|11774422|FG001|NOT COMPLETED|Overall Study||11
10616532|NCT01943799|11774432|FG000|STARTED|Overall Study||27
10616533|NCT01943799|11774433|FG001|STARTED|Overall Study||50
10616534|NCT01943799|11774434|FG002|STARTED|Overall Study|1 participant was randomized to OAV + GS-4774 2 YU but received OAV + GS-4774 10 YU.|51
10616535|NCT01943799|11774435|FG003|STARTED|Overall Study||50
10616536|NCT01943799|11774432|FG000|COMPLETED|Overall Study||22
10616537|NCT01943799|11774433|FG001|COMPLETED|Overall Study||47
10616538|NCT01943799|11774434|FG002|COMPLETED|Overall Study||49
10616539|NCT01943799|11774435|FG003|COMPLETED|Overall Study||50
10616540|NCT01943799|11774432|FG000|NOT COMPLETED|Overall Study||5
10616541|NCT01943799|11774433|FG001|NOT COMPLETED|Overall Study||3
10616542|NCT01943799|11774434|FG002|NOT COMPLETED|Overall Study||2
10616543|NCT01943799|11774435|FG003|NOT COMPLETED|Overall Study||0
10616544|NCT01943851|11774463|FG000|STARTED|Part 1 (Up to 86.9 Weeks)||1
10616545|NCT01943851|11774464|FG001|STARTED|Part 1 (Up to 86.9 Weeks)||1
10616546|NCT01943851|11774465|FG002|STARTED|Part 1 (Up to 86.9 Weeks)||1
10616547|NCT01943851|11774466|FG003|STARTED|Part 1 (Up to 86.9 Weeks)||5
10616548|NCT01943851|11774467|FG004|STARTED|Part 1 (Up to 86.9 Weeks)||1
10616549|NCT01943851|11774468|FG005|STARTED|Part 1 (Up to 86.9 Weeks)||4
10616550|NCT01943851|11774469|FG006|STARTED|Part 1 (Up to 86.9 Weeks)||8
10616551|NCT01943851|11774470|FG007|STARTED|Part 1 (Up to 86.9 Weeks)||18
10616552|NCT01943851|11774471|FG008|STARTED|Part 1 (Up to 86.9 Weeks)||3
10616553|NCT01943851|11774472|FG009|STARTED|Part 1 (Up to 86.9 Weeks)||8
10616554|NCT01943851|11774473|FG010|STARTED|Part 1 (Up to 86.9 Weeks)||1
10616555|NCT01943851|11774474|FG011|STARTED|Part 1 (Up to 86.9 Weeks)||7
10616556|NCT01943851|11774475|FG012|STARTED|Part 1 (Up to 86.9 Weeks)||7
10616557|NCT01943851|11774476|FG013|STARTED|Part 1 (Up to 86.9 Weeks)||16
10616558|NCT01943851|11774477|FG014|STARTED|Part 1 (Up to 86.9 Weeks)||6
10616559|NCT01943851|11774478|FG015|STARTED|Part 1 (Up to 86.9 Weeks)||0
10616560|NCT01943851|11774479|FG016|STARTED|Part 1 (Up to 86.9 Weeks)||0
10616561|NCT01943851|11774480|FG017|STARTED|Part 1 (Up to 86.9 Weeks)||0
10616562|NCT01943851|11774463|FG000|COMPLETED|Part 1 (Up to 86.9 Weeks)||1
10616563|NCT01943851|11774464|FG001|COMPLETED|Part 1 (Up to 86.9 Weeks)||1
10616564|NCT01943851|11774465|FG002|COMPLETED|Part 1 (Up to 86.9 Weeks)||1
10616565|NCT01943851|11774466|FG003|COMPLETED|Part 1 (Up to 86.9 Weeks)||4
10616566|NCT01943851|11774467|FG004|COMPLETED|Part 1 (Up to 86.9 Weeks)||0
10704905|NCT01003691|11869274|FG000|NOT COMPLETED|Overall Study||0
10704906|NCT01003691|11869275|FG001|NOT COMPLETED|Overall Study||0
10704907|NCT01003691|11869276|FG002|NOT COMPLETED|Overall Study||0
10704908|NCT01003691|11869277|FG003|NOT COMPLETED|Overall Study||1
10704909|NCT02593903|11869290|FG000|STARTED|Overall Study||35
10616567|NCT01943851|11774468|FG005|COMPLETED|Part 1 (Up to 86.9 Weeks)||4
10616568|NCT01943851|11774469|FG006|COMPLETED|Part 1 (Up to 86.9 Weeks)||7
10616569|NCT01943851|11774470|FG007|COMPLETED|Part 1 (Up to 86.9 Weeks)||16
10616570|NCT01943851|11774471|FG008|COMPLETED|Part 1 (Up to 86.9 Weeks)||2
10616571|NCT01943851|11774472|FG009|COMPLETED|Part 1 (Up to 86.9 Weeks)||8
10616572|NCT01943851|11774473|FG010|COMPLETED|Part 1 (Up to 86.9 Weeks)||1
10616573|NCT01943851|11774474|FG011|COMPLETED|Part 1 (Up to 86.9 Weeks)||7
10616574|NCT01943851|11774475|FG012|COMPLETED|Part 1 (Up to 86.9 Weeks)||7
10616575|NCT01943851|11774476|FG013|COMPLETED|Part 1 (Up to 86.9 Weeks)||15
10616576|NCT01943851|11774477|FG014|COMPLETED|Part 1 (Up to 86.9 Weeks)||6
10616577|NCT01943851|11774478|FG015|COMPLETED|Part 1 (Up to 86.9 Weeks)||0
10616578|NCT01943851|11774479|FG016|COMPLETED|Part 1 (Up to 86.9 Weeks)||0
10616579|NCT01943851|11774480|FG017|COMPLETED|Part 1 (Up to 86.9 Weeks)||0
10616580|NCT01943851|11774463|FG000|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
10616581|NCT01943851|11774464|FG001|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
10616582|NCT01943851|11774465|FG002|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
10616583|NCT01943851|11774466|FG003|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1
10616584|NCT01943851|11774467|FG004|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1
10616585|NCT01943851|11774468|FG005|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
10616586|NCT01943851|11774469|FG006|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1
10616587|NCT01943851|11774470|FG007|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||2
10616588|NCT01943851|11774471|FG008|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1
10616589|NCT01943851|11774472|FG009|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
10616590|NCT01943851|11774473|FG010|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
10616591|NCT01943851|11774474|FG011|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
10616592|NCT01943851|11774475|FG012|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
10616593|NCT01943851|11774476|FG013|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1
10616594|NCT01943851|11774477|FG014|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
10616595|NCT01943851|11774478|FG015|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
10616596|NCT01943851|11774479|FG016|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
10616597|NCT01943851|11774480|FG017|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
10616598|NCT01943851|11774463|FG000|STARTED|Part 2 (Up to 36.4 Weeks)||0
10616599|NCT01943851|11774464|FG001|STARTED|Part 2 (Up to 36.4 Weeks)||0
10616600|NCT01943851|11774465|FG002|STARTED|Part 2 (Up to 36.4 Weeks)||0
10616601|NCT01943851|11774466|FG003|STARTED|Part 2 (Up to 36.4 Weeks)||0
10616602|NCT01943851|11774467|FG004|STARTED|Part 2 (Up to 36.4 Weeks)||0
10616603|NCT01943851|11774468|FG005|STARTED|Part 2 (Up to 36.4 Weeks)||0
10616604|NCT01943851|11774469|FG006|STARTED|Part 2 (Up to 36.4 Weeks)||0
10616605|NCT01943851|11774470|FG007|STARTED|Part 2 (Up to 36.4 Weeks)||0
10616606|NCT01943851|11774471|FG008|STARTED|Part 2 (Up to 36.4 Weeks)||0
10616607|NCT01943851|11774472|FG009|STARTED|Part 2 (Up to 36.4 Weeks)||0
10616608|NCT01943851|11774473|FG010|STARTED|Part 2 (Up to 36.4 Weeks)||0
10616609|NCT01943851|11774474|FG011|STARTED|Part 2 (Up to 36.4 Weeks)||0
10616610|NCT01943851|11774475|FG012|STARTED|Part 2 (Up to 36.4 Weeks)||0
10616611|NCT01943851|11774476|FG013|STARTED|Part 2 (Up to 36.4 Weeks)||0
10616612|NCT01943851|11774477|FG014|STARTED|Part 2 (Up to 36.4 Weeks)||0
10616613|NCT01943851|11774478|FG015|STARTED|Part 2 (Up to 36.4 Weeks)||7
10616614|NCT01943851|11774479|FG016|STARTED|Part 2 (Up to 36.4 Weeks)||16
10616615|NCT01943851|11774480|FG017|STARTED|Part 2 (Up to 36.4 Weeks)||1
10616616|NCT01943851|11774463|FG000|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10616617|NCT01943851|11774464|FG001|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10616618|NCT01943851|11774465|FG002|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10616619|NCT01943851|11774466|FG003|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10704910|NCT02593903|11869291|FG001|STARTED|Overall Study||32
10616620|NCT01943851|11774467|FG004|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10616621|NCT01943851|11774468|FG005|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10616622|NCT01943851|11774469|FG006|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10616623|NCT01943851|11774470|FG007|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10616624|NCT01943851|11774471|FG008|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10616625|NCT01943851|11774472|FG009|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10616626|NCT01943851|11774473|FG010|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10616627|NCT01943851|11774474|FG011|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10616628|NCT01943851|11774475|FG012|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10616629|NCT01943851|11774476|FG013|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10616630|NCT01943851|11774477|FG014|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10616631|NCT01943851|11774478|FG015|COMPLETED|Part 2 (Up to 36.4 Weeks)||1
10616632|NCT01943851|11774479|FG016|COMPLETED|Part 2 (Up to 36.4 Weeks)||13
10616633|NCT01943851|11774480|FG017|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10616634|NCT01943851|11774463|FG000|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10616635|NCT01943851|11774464|FG001|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10704911|NCT02593903|11869290|FG000|COMPLETED|Overall Study||35
10704912|NCT02593903|11869291|FG001|COMPLETED|Overall Study||31
10704913|NCT02593903|11869290|FG000|NOT COMPLETED|Overall Study||0
10704914|NCT02593903|11869291|FG001|NOT COMPLETED|Overall Study||1
10704915|NCT02594098|11869299|FG000|STARTED|Overall Study||27
10616636|NCT01943851|11774465|FG002|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10616637|NCT01943851|11774466|FG003|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10616638|NCT01943851|11774467|FG004|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10616639|NCT01943851|11774468|FG005|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10616640|NCT01943851|11774469|FG006|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10616641|NCT01943851|11774470|FG007|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10616642|NCT01943851|11774471|FG008|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10616643|NCT01943851|11774472|FG009|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10616644|NCT01943851|11774473|FG010|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10616645|NCT01943851|11774474|FG011|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10616646|NCT01943851|11774475|FG012|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10616647|NCT01943851|11774476|FG013|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10616648|NCT01943851|11774477|FG014|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
10616649|NCT01943851|11774478|FG015|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||6
10616650|NCT01943851|11774479|FG016|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||3
10616651|NCT01943851|11774480|FG017|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||1
10616652|NCT01943864|11774521|FG000|STARTED|Overall Study||20
10616653|NCT01943864|11774521|FG000|COMPLETED|Overall Study|Death or 1 year from randomization after progression was considered completion; 20 participants died|20
10616654|NCT01943864|11774521|FG000|NOT COMPLETED|Overall Study||0
10616655|NCT01943916|11774525|FG000|STARTED|Overall Study||2105
10616656|NCT01943916|11774525|FG000|COMPLETED|Overall Study||1739
10616657|NCT01943916|11774525|FG000|NOT COMPLETED|Overall Study||366
10616658|NCT01944046|11774536|FG000|STARTED|Randomized to DB||146
10616659|NCT01944046|11774537|FG001|STARTED|Randomized to DB||144
10616660|NCT01944046|11774536|FG000|COMPLETED|Randomized to DB||125
10616661|NCT01944046|11774537|FG001|COMPLETED|Randomized to DB||125
10616662|NCT01944046|11774536|FG000|NOT COMPLETED|Randomized to DB||21
10616663|NCT01944046|11774537|FG001|NOT COMPLETED|Randomized to DB||19
10616664|NCT01944046|11774536|FG000|STARTED|Open Label Eligible and Consented||124
10616665|NCT01944046|11774537|FG001|STARTED|Open Label Eligible and Consented||124
10616666|NCT01944046|11774536|FG000|COMPLETED|Open Label Eligible and Consented||110
10616667|NCT01944046|11774537|FG001|COMPLETED|Open Label Eligible and Consented||116
10616668|NCT01944046|11774536|FG000|NOT COMPLETED|Open Label Eligible and Consented||14
10616669|NCT01944046|11774537|FG001|NOT COMPLETED|Open Label Eligible and Consented||8
10616670|NCT01944098|11774549|FG000|STARTED|Overall Study||10
10616671|NCT01944098|11774550|FG001|STARTED|Overall Study||10
10616672|NCT01944098|11774549|FG000|COMPLETED|Overall Study||9
10616673|NCT01944098|11774550|FG001|COMPLETED|Overall Study||10
10616674|NCT01944098|11774549|FG000|NOT COMPLETED|Overall Study||1
10616675|NCT01944098|11774550|FG001|NOT COMPLETED|Overall Study||0
10616676|NCT01944293|11774558|FG000|STARTED|Overall Study||7
10616677|NCT01944293|11774559|FG001|STARTED|Overall Study||9
10616678|NCT01944293|11774558|FG000|COMPLETED|Overall Study||7
10616679|NCT01944293|11774559|FG001|COMPLETED|Overall Study||9
10616680|NCT01944293|11774558|FG000|NOT COMPLETED|Overall Study||0
10616681|NCT01944293|11774559|FG001|NOT COMPLETED|Overall Study||0
10616682|NCT01944319|11774567|FG000|STARTED|Overall Study||40
10616683|NCT01944319|11774568|FG001|STARTED|Overall Study||39
10616684|NCT01944319|11774567|FG000|COMPLETED|Overall Study||40
10616685|NCT01944319|11774568|FG001|COMPLETED|Overall Study||39
10616686|NCT01944319|11774567|FG000|NOT COMPLETED|Overall Study||0
10616687|NCT01944319|11774568|FG001|NOT COMPLETED|Overall Study||0
10616688|NCT01944345|11774575|FG000|STARTED|Overall Study||69
10616689|NCT01944345|11774575|FG000|COMPLETED|Overall Study||69
10616690|NCT01944345|11774575|FG000|NOT COMPLETED|Overall Study||0
10616691|NCT01944371|11774582|FG000|STARTED|Overall Study||10
10616692|NCT01944371|11774583|FG001|STARTED|Overall Study||10
10616693|NCT01944371|11774584|FG002|STARTED|Overall Study||10
10616694|NCT01944371|11774582|FG000|COMPLETED|Overall Study||10
10616695|NCT01944371|11774583|FG001|COMPLETED|Overall Study||10
10616696|NCT01944371|11774584|FG002|COMPLETED|Overall Study||10
10616697|NCT01944371|11774582|FG000|NOT COMPLETED|Overall Study||0
10616698|NCT01944371|11774583|FG001|NOT COMPLETED|Overall Study||0
10616699|NCT01944371|11774584|FG002|NOT COMPLETED|Overall Study||0
10616700|NCT01944423|11774594|FG000|STARTED|Overall Study||27
10616701|NCT01944423|11774595|FG001|STARTED|Overall Study||26
10616702|NCT01944423|11774594|FG000|End of Treatment|Overall Study||21
10616703|NCT01944423|11774595|FG001|End of Treatment|Overall Study||20
10616704|NCT01944423|11774594|FG000|1-month Follow-up|Overall Study||22
10616705|NCT01944423|11774595|FG001|1-month Follow-up|Overall Study||19
10616706|NCT01944423|11774594|FG000|4-month Follow-up|Overall Study||19
10616707|NCT01944423|11774595|FG001|4-month Follow-up|Overall Study||16
10616708|NCT01944423|11774594|FG000|COMPLETED|Overall Study|6-month follow-up|19
10704916|NCT02594098|11869300|FG001|STARTED|Overall Study||14
10616709|NCT01944423|11774595|FG001|COMPLETED|Overall Study|6-month follow-up|17
10616710|NCT01944423|11774594|FG000|NOT COMPLETED|Overall Study||8
10616711|NCT01944423|11774595|FG001|NOT COMPLETED|Overall Study||9
10616712|NCT01944462|11774601|FG000|STARTED|PPPP Educational Program||203
10616713|NCT01944462|11774601|FG000|Baseline|PPPP Educational Program||203
10616714|NCT01944462|11774601|FG000|Post-Test|PPPP Educational Program||187
10616715|NCT01944462|11774601|FG000|3 Month Follow-Up|PPPP Educational Program||143
10616716|NCT01944462|11774601|FG000|COMPLETED|PPPP Educational Program||143
10616717|NCT01944462|11774601|FG000|NOT COMPLETED|PPPP Educational Program||60
10616718|NCT01944462|11774601|FG000|STARTED|Optional Vaccination||20
10616719|NCT01944462|11774601|FG000|COMPLETED|Optional Vaccination||20
10616720|NCT01944462|11774601|FG000|NOT COMPLETED|Optional Vaccination||0
10616721|NCT01944631|11774608|FG000|STARTED|Overall Study||100
10616722|NCT01944631|11774609|FG001|STARTED|Overall Study||100
10616723|NCT01944631|11774608|FG000|COMPLETED|Overall Study||96
10616724|NCT01944631|11774609|FG001|COMPLETED|Overall Study||98
10616725|NCT01944631|11774608|FG000|NOT COMPLETED|Overall Study||4
10616726|NCT01944631|11774609|FG001|NOT COMPLETED|Overall Study||2
10616727|NCT01944644|11774617|FG000|STARTED|Overall Study||34
10616728|NCT01944644|11774618|FG001|STARTED|Overall Study||32
10616729|NCT01944644|11774617|FG000|COMPLETED|Overall Study||34
10616730|NCT01944644|11774618|FG001|COMPLETED|Overall Study||32
10616731|NCT01944644|11774617|FG000|NOT COMPLETED|Overall Study||0
10616732|NCT01944644|11774618|FG001|NOT COMPLETED|Overall Study||0
10616733|NCT01944670|11774624|FG000|STARTED|Overall Study||26
10616734|NCT01944670|11774624|FG000|COMPLETED|Overall Study||24
10616735|NCT01944670|11774624|FG000|NOT COMPLETED|Overall Study||2
10616736|NCT01944722|11774630|FG000|STARTED|Overall Study||33858
10616737|NCT01944722|11774630|FG000|COMPLETED|Overall Study||24343
10616738|NCT01944722|11774630|FG000|NOT COMPLETED|Overall Study||9515
10616739|NCT01944774|11774642|FG000|STARTED|Overall Study||69
10616740|NCT01944774|11774643|FG001|STARTED|Overall Study||68
10616741|NCT01944774|11774644|FG002|STARTED|Overall Study||70
10616742|NCT01944774|11774642|FG000|Received Treatment|Overall Study||68
10616743|NCT01944774|11774643|FG001|Received Treatment|Overall Study||67
10616744|NCT01944774|11774644|FG002|Received Treatment|Overall Study||70
10616745|NCT01944774|11774642|FG000|COMPLETED|Overall Study||63
10616746|NCT01944774|11774643|FG001|COMPLETED|Overall Study||60
10616747|NCT01944774|11774644|FG002|COMPLETED|Overall Study||62
10616748|NCT01944774|11774642|FG000|NOT COMPLETED|Overall Study||6
10616749|NCT01944774|11774643|FG001|NOT COMPLETED|Overall Study||8
10616750|NCT01944774|11774644|FG002|NOT COMPLETED|Overall Study||8
10616751|NCT01944839|11774657|FG000|STARTED|Overall Study||309
10616752|NCT01944839|11774658|FG001|STARTED|Overall Study||310
10616753|NCT01944839|11774657|FG000|COMPLETED|Overall Study||287
10616754|NCT01944839|11774658|FG001|COMPLETED|Overall Study||282
10616755|NCT01944839|11774657|FG000|NOT COMPLETED|Overall Study||22
10616756|NCT01944839|11774658|FG001|NOT COMPLETED|Overall Study||28
10616757|NCT01944878|11774666|FG000|STARTED|Overall Study||127
10616758|NCT01944878|11774667|FG001|STARTED|Overall Study||328
10616759|NCT01944878|11774666|FG000|COMPLETED|Overall Study||127
10616760|NCT01944878|11774667|FG001|COMPLETED|Overall Study||328
10616761|NCT01944878|11774666|FG000|NOT COMPLETED|Overall Study||0
10616762|NCT01944878|11774667|FG001|NOT COMPLETED|Overall Study||0
10616763|NCT01944930|11774677|FG000|STARTED|Overall Study||12
10704917|NCT02594098|11869299|FG000|COMPLETED|Overall Study||1
10704918|NCT02594098|11869300|FG001|COMPLETED|Overall Study||1
10704919|NCT02594098|11869299|FG000|NOT COMPLETED|Overall Study||26
10704920|NCT02594098|11869300|FG001|NOT COMPLETED|Overall Study||13
10333852|NCT00336232|11470099|FG000|NOT COMPLETED|High Vitamin K (500mcg Daily)||0
10616764|NCT01944930|11774678|FG001|STARTED|Overall Study||11
10616765|NCT01944930|11774677|FG000|COMPLETED|Overall Study||10
10616766|NCT01944930|11774678|FG001|COMPLETED|Overall Study||10
10616767|NCT01944930|11774677|FG000|NOT COMPLETED|Overall Study||2
10616768|NCT01944930|11774678|FG001|NOT COMPLETED|Overall Study||1
10616769|NCT01944969|11774684|FG000|STARTED|Overall Study||26
10616770|NCT01944969|11774684|FG000|COMPLETED|Overall Study||0
10616771|NCT01944969|11774684|FG000|NOT COMPLETED|Overall Study||26
10616772|NCT01945034|11774693|FG000|STARTED|Overall Study||67
10616773|NCT01945034|11774694|FG001|STARTED|Overall Study||85
10616774|NCT01945034|11774695|FG002|STARTED|Overall Study||152
10616775|NCT01945034|11774693|FG000|COMPLETED|Overall Study||66
10616776|NCT01945034|11774694|FG001|COMPLETED|Overall Study||80
10616777|NCT01945034|11774695|FG002|COMPLETED|Overall Study||145
10616778|NCT01945034|11774693|FG000|NOT COMPLETED|Overall Study||1
10616779|NCT01945034|11774694|FG001|NOT COMPLETED|Overall Study||5
10616780|NCT01945034|11774695|FG002|NOT COMPLETED|Overall Study||7
10616781|NCT01945086|11774706|FG000|STARTED|Overall Study||27
10616782|NCT01945086|11774707|FG001|STARTED|Overall Study||24
10616783|NCT01945086|11774708|FG002|STARTED|Overall Study||28
10616784|NCT01945086|11774706|FG000|COMPLETED|Overall Study||26
10616785|NCT01945086|11774707|FG001|COMPLETED|Overall Study||24
10616786|NCT01945086|11774708|FG002|COMPLETED|Overall Study||26
10616787|NCT01945086|11774706|FG000|NOT COMPLETED|Overall Study||1
10616788|NCT01945086|11774707|FG001|NOT COMPLETED|Overall Study||0
10333853|NCT00336284|11470105|FG000|STARTED|Overall Study||977
10333854|NCT00336284|11470106|FG001|STARTED|Overall Study||473
10616789|NCT01945086|11774708|FG002|NOT COMPLETED|Overall Study||2
10616790|NCT01945112|11774716|FG000|STARTED|Overall Study|total number of sites where tape was applied|77
10653218|NCT02191046|11813664|FG000|STARTED|Overall Study||41
10333855|NCT00336284|11470105|FG000|COMPLETED|Overall Study||741
10333856|NCT00336284|11470106|FG001|COMPLETED|Overall Study||322
10333857|NCT00336284|11470105|FG000|NOT COMPLETED|Overall Study||236
10333858|NCT00336284|11470106|FG001|NOT COMPLETED|Overall Study||151
10333859|NCT00336323|11470117|FG000|STARTED|Overall Study||19
10333860|NCT00336323|11470118|FG001|STARTED|Overall Study||22
10616791|NCT01945112|11774717|FG001|STARTED|Overall Study|total number of sites where tape was applied|51
10616792|NCT01945112|11774716|FG000|COMPLETED|Overall Study||77
10616793|NCT01945112|11774717|FG001|COMPLETED|Overall Study||51
10616794|NCT01945112|11774716|FG000|NOT COMPLETED|Overall Study||0
10616795|NCT01945112|11774717|FG001|NOT COMPLETED|Overall Study||0
10616796|NCT01945138|11774724|FG000|STARTED|Overall Study||7
10616797|NCT01945138|11774725|FG001|STARTED|Overall Study||7
10616798|NCT01945138|11774724|FG000|COMPLETED|Overall Study||7
10616799|NCT01945138|11774725|FG001|COMPLETED|Overall Study||7
10616800|NCT01945138|11774724|FG000|NOT COMPLETED|Overall Study||0
10616801|NCT01945138|11774725|FG001|NOT COMPLETED|Overall Study||0
10616802|NCT01945216|11774734|FG000|STARTED|Overall Study||3317
10616803|NCT01945216|11774734|FG000|COMPLETED|Overall Study||3218
10616804|NCT01945216|11774734|FG000|NOT COMPLETED|Overall Study||99
10616805|NCT01945242|11774744|FG000|STARTED|Overall Study||1251
10616806|NCT01945242|11774745|FG001|STARTED|Overall Study||123
10616807|NCT01945242|11774744|FG000|COMPLETED|Overall Study||1248
10616808|NCT01945242|11774745|FG001|COMPLETED|Overall Study||120
10616809|NCT01945242|11774744|FG000|NOT COMPLETED|Overall Study||3
10616810|NCT01945242|11774745|FG001|NOT COMPLETED|Overall Study||3
10616811|NCT01945281|11774754|FG000|STARTED|Overall Study||34
10616812|NCT01945281|11774755|FG001|STARTED|Overall Study||17
10616813|NCT01945281|11774754|FG000|Treated|Overall Study||33
10616814|NCT01945281|11774755|FG001|Treated|Overall Study||16
10616815|NCT01945281|11774754|FG000|COMPLETED|Overall Study||28
10616816|NCT01945281|11774755|FG001|COMPLETED|Overall Study||13
10616817|NCT01945281|11774754|FG000|NOT COMPLETED|Overall Study||6
10616818|NCT01945281|11774755|FG001|NOT COMPLETED|Overall Study||4
10616819|NCT01945294|11774764|FG000|STARTED|Period 1: 12-Week PR + BOC Lead-In||257
10616820|NCT01945294|11774765|FG001|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
10616821|NCT01945294|11774766|FG002|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
10616822|NCT01945294|11774767|FG003|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
10616823|NCT01945294|11774764|FG000|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||236
10616824|NCT01945294|11774765|FG001|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
10616825|NCT01945294|11774766|FG002|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
10616826|NCT01945294|11774767|FG003|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
10616827|NCT01945294|11774764|FG000|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||21
10616828|NCT01945294|11774765|FG001|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
10616829|NCT01945294|11774766|FG002|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
10616830|NCT01945294|11774767|FG003|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
10616831|NCT01945294|11774764|FG000|STARTED|Period 2: BOC+ PR Treatment & Follow-up|Participants were assigned to 1 of the 3 arms after upon the 12-week BOC + PR lead-in.|0
10616832|NCT01945294|11774765|FG001|STARTED|Period 2: BOC+ PR Treatment & Follow-up||102
10616833|NCT01945294|11774766|FG002|STARTED|Period 2: BOC+ PR Treatment & Follow-up||105
10616834|NCT01945294|11774767|FG003|STARTED|Period 2: BOC+ PR Treatment & Follow-up||29
10616835|NCT01945294|11774764|FG000|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||0
10616836|NCT01945294|11774765|FG001|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||97
10616837|NCT01945294|11774766|FG002|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||97
10616838|NCT01945294|11774767|FG003|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||23
10616839|NCT01945294|11774764|FG000|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||0
10616840|NCT01945294|11774765|FG001|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||5
10616841|NCT01945294|11774766|FG002|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||8
10616842|NCT01945294|11774767|FG003|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||6
10616843|NCT01945489|11774778|FG000|STARTED|Cycle 1||129
10616844|NCT01945489|11774779|FG001|STARTED|Cycle 1||125
10616845|NCT01945489|11774778|FG000|COMPLETED|Cycle 1||116
10616846|NCT01945489|11774779|FG001|COMPLETED|Cycle 1||121
10616847|NCT01945489|11774778|FG000|NOT COMPLETED|Cycle 1||13
10616848|NCT01945489|11774779|FG001|NOT COMPLETED|Cycle 1||4
10616849|NCT01945489|11774778|FG000|STARTED|Cycle 2|Not all participants participated in Cycle 2.|88
10616850|NCT01945489|11774779|FG001|STARTED|Cycle 2||107
10616851|NCT01945489|11774778|FG000|COMPLETED|Cycle 2||87
10616852|NCT01945489|11774779|FG001|COMPLETED|Cycle 2||106
10616853|NCT01945489|11774778|FG000|NOT COMPLETED|Cycle 2||1
10616854|NCT01945489|11774779|FG001|NOT COMPLETED|Cycle 2||1
10616855|NCT01945580|11774788|FG000|STARTED|Overall Study||228
10616856|NCT01945580|11774789|FG001|STARTED|Overall Study||485
10616857|NCT01945580|11774788|FG000|COMPLETED|Overall Study||176
10616858|NCT01945580|11774789|FG001|COMPLETED|Overall Study||401
10616859|NCT01945580|11774788|FG000|NOT COMPLETED|Overall Study||52
10616860|NCT01945580|11774789|FG001|NOT COMPLETED|Overall Study||84
10616861|NCT01945593|11774803|FG000|STARTED|Overall Study||3
10616862|NCT01945593|11774804|FG001|STARTED|Overall Study||64
10616863|NCT01945593|11774805|FG002|STARTED|Overall Study||26
10616864|NCT01945593|11774806|FG003|STARTED|Overall Study||125
10616865|NCT01945593|11774803|FG000|COMPLETED|Overall Study||3
10616866|NCT01945593|11774804|FG001|COMPLETED|Overall Study||56
10616867|NCT01945593|11774805|FG002|COMPLETED|Overall Study||23
10616868|NCT01945593|11774806|FG003|COMPLETED|Overall Study||105
10616869|NCT01945593|11774803|FG000|NOT COMPLETED|Overall Study||0
10616870|NCT01945593|11774804|FG001|NOT COMPLETED|Overall Study||8
10616871|NCT01945593|11774805|FG002|NOT COMPLETED|Overall Study||3
10616872|NCT01945593|11774806|FG003|NOT COMPLETED|Overall Study||20
10616873|NCT01945710|11774828|FG000|STARTED|Overall Study||7
10616874|NCT01945710|11774829|FG001|STARTED|Overall Study||6
10616875|NCT01945710|11774830|FG002|STARTED|Overall Study||7
10616876|NCT01945710|11774831|FG003|STARTED|Overall Study||3
10616877|NCT01945710|11774832|FG004|STARTED|Overall Study||9
10616878|NCT01945710|11774833|FG005|STARTED|Overall Study||3
10616879|NCT01945710|11774834|FG006|STARTED|Overall Study||23
10616880|NCT01945710|11774828|FG000|COMPLETED|Overall Study||0
10616881|NCT01945710|11774829|FG001|COMPLETED|Overall Study||0
10616882|NCT01945710|11774830|FG002|COMPLETED|Overall Study||0
10616883|NCT01945710|11774831|FG003|COMPLETED|Overall Study||0
10616884|NCT01945710|11774832|FG004|COMPLETED|Overall Study||0
10616885|NCT01945710|11774833|FG005|COMPLETED|Overall Study||0
10616886|NCT01945710|11774834|FG006|COMPLETED|Overall Study||0
10616887|NCT01945710|11774828|FG000|NOT COMPLETED|Overall Study||7
10616888|NCT01945710|11774829|FG001|NOT COMPLETED|Overall Study||6
10616889|NCT01945710|11774830|FG002|NOT COMPLETED|Overall Study||7
10616890|NCT01945710|11774831|FG003|NOT COMPLETED|Overall Study||3
10616891|NCT01945710|11774832|FG004|NOT COMPLETED|Overall Study||9
10616892|NCT01945710|11774833|FG005|NOT COMPLETED|Overall Study||3
10616893|NCT01945710|11774834|FG006|NOT COMPLETED|Overall Study||23
10616894|NCT01945866|11774854|FG000|STARTED|Overall Study||65
10616895|NCT01945866|11774855|FG001|STARTED|Overall Study||64
10616896|NCT01945866|11774854|FG000|COMPLETED|Overall Study||63
10616897|NCT01945866|11774855|FG001|COMPLETED|Overall Study||64
10616898|NCT01945866|11774854|FG000|NOT COMPLETED|Overall Study||2
10616899|NCT01945866|11774855|FG001|NOT COMPLETED|Overall Study||0
10616900|NCT01945944|11774864|FG000|STARTED|Overall Study||9
10616901|NCT01945944|11774865|FG001|STARTED|Overall Study||9
10616902|NCT01945944|11774864|FG000|COMPLETED|Overall Study||8
10616903|NCT01945944|11774865|FG001|COMPLETED|Overall Study||6
10616904|NCT01945944|11774864|FG000|NOT COMPLETED|Overall Study||1
10616905|NCT01945944|11774865|FG001|NOT COMPLETED|Overall Study||3
10616906|NCT01945970|11774873|FG000|STARTED|Overall Study||5
10616907|NCT01945970|11774874|FG001|STARTED|Overall Study||5
10616908|NCT01945970|11774875|FG002|STARTED|Overall Study||5
10616909|NCT01945970|11774876|FG003|STARTED|Overall Study||5
10616910|NCT01945970|11774877|FG004|STARTED|Overall Study||5
10616911|NCT01945970|11774878|FG005|STARTED|Overall Study||5
10616912|NCT01945970|11774873|FG000|COMPLETED|Overall Study||5
10616913|NCT01945970|11774874|FG001|COMPLETED|Overall Study||5
10616914|NCT01945970|11774875|FG002|COMPLETED|Overall Study||5
10616915|NCT01945970|11774876|FG003|COMPLETED|Overall Study||5
10616916|NCT01945970|11774877|FG004|COMPLETED|Overall Study||5
10616917|NCT01945970|11774878|FG005|COMPLETED|Overall Study||5
10616918|NCT01945970|11774873|FG000|NOT COMPLETED|Overall Study||0
10616919|NCT01945970|11774874|FG001|NOT COMPLETED|Overall Study||0
10616920|NCT01945970|11774875|FG002|NOT COMPLETED|Overall Study||0
10616921|NCT01945970|11774876|FG003|NOT COMPLETED|Overall Study||0
10616922|NCT01945970|11774877|FG004|NOT COMPLETED|Overall Study||0
10616923|NCT01945970|11774878|FG005|NOT COMPLETED|Overall Study||0
10616924|NCT01945996|11774890|FG000|STARTED|Overall Study||22
10616925|NCT01945996|11774891|FG001|STARTED|Overall Study||22
10616926|NCT01945996|11774890|FG000|COMPLETED|Overall Study||19
10616927|NCT01945996|11774891|FG001|COMPLETED|Overall Study||17
10616928|NCT01945996|11774890|FG000|NOT COMPLETED|Overall Study||3
10616929|NCT01945996|11774891|FG001|NOT COMPLETED|Overall Study||5
10616930|NCT01946126|11774901|FG000|STARTED|Overall Study||184
10616931|NCT01946126|11774902|FG001|STARTED|Overall Study||275
10616932|NCT01946126|11774901|FG000|COMPLETED|Overall Study||184
10616933|NCT01946126|11774902|FG001|COMPLETED|Overall Study||275
10616934|NCT01946126|11774901|FG000|NOT COMPLETED|Overall Study||0
10616935|NCT01946126|11774902|FG001|NOT COMPLETED|Overall Study||0
10616936|NCT01946152|11774912|FG000|STARTED|Overall Study||3
10616937|NCT01946152|11774913|FG001|STARTED|Overall Study||3
10616938|NCT01946152|11774914|FG002|STARTED|Overall Study||6
10616939|NCT01946152|11774915|FG003|STARTED|Overall Study||8
10616940|NCT01946152|11774912|FG000|COMPLETED|Overall Study||2
10616941|NCT01946152|11774913|FG001|COMPLETED|Overall Study||0
10616942|NCT01946152|11774914|FG002|COMPLETED|Overall Study||0
10616943|NCT01946152|11774915|FG003|COMPLETED|Overall Study||0
10616944|NCT01946152|11774912|FG000|NOT COMPLETED|Overall Study||1
10616945|NCT01946152|11774913|FG001|NOT COMPLETED|Overall Study||3
10616946|NCT01946152|11774914|FG002|NOT COMPLETED|Overall Study||6
10616947|NCT01946152|11774915|FG003|NOT COMPLETED|Overall Study||8
10616948|NCT01946165|11774929|FG000|STARTED|Overall Study||45
10616949|NCT01946165|11774930|FG001|STARTED|Overall Study||23
10616950|NCT01946165|11774929|FG000|COMPLETED|Overall Study||43
10616951|NCT01946165|11774930|FG001|COMPLETED|Overall Study||21
10616952|NCT01946165|11774929|FG000|NOT COMPLETED|Overall Study||2
10616953|NCT01946165|11774930|FG001|NOT COMPLETED|Overall Study||2
10616954|NCT01946178|11774937|FG000|STARTED|Overall Study||73
10616955|NCT01946178|11774937|FG000|COMPLETED|Overall Study||71
10616956|NCT01946178|11774937|FG000|NOT COMPLETED|Overall Study||2
10616957|NCT01946191|11774947|FG000|STARTED|Allocation||98
10616958|NCT01946191|11774948|FG001|STARTED|Allocation||96
10616959|NCT01946191|11774947|FG000|COMPLETED|Allocation||97
10616960|NCT01946191|11774948|FG001|COMPLETED|Allocation||95
10616961|NCT01946191|11774947|FG000|NOT COMPLETED|Allocation||1
10616962|NCT01946191|11774948|FG001|NOT COMPLETED|Allocation||1
10616963|NCT01946191|11774947|FG000|STARTED|Follow-Up, 24-mo Endpoint||97
10616964|NCT01946191|11774948|FG001|STARTED|Follow-Up, 24-mo Endpoint||95
10616965|NCT01946191|11774947|FG000|COMPLETED|Follow-Up, 24-mo Endpoint||80
10616966|NCT01946191|11774948|FG001|COMPLETED|Follow-Up, 24-mo Endpoint||77
10616967|NCT01946191|11774947|FG000|NOT COMPLETED|Follow-Up, 24-mo Endpoint||17
10616968|NCT01946191|11774948|FG001|NOT COMPLETED|Follow-Up, 24-mo Endpoint||18
10616969|NCT01946191|11774947|FG000|STARTED|Primary Outcome Analysis||98
10616970|NCT01946191|11774948|FG001|STARTED|Primary Outcome Analysis||95
10616971|NCT01946191|11774947|FG000|COMPLETED|Primary Outcome Analysis|Weight data at 24 months|80
10616972|NCT01946191|11774948|FG001|COMPLETED|Primary Outcome Analysis|Weight data at 24 months|77
10616973|NCT01946191|11774947|FG000|NOT COMPLETED|Primary Outcome Analysis||18
10616974|NCT01946191|11774948|FG001|NOT COMPLETED|Primary Outcome Analysis||18
10616975|NCT01946243|11774955|FG000|STARTED|Overall Study||96
10616976|NCT01946243|11774955|FG000|COMPLETED|Overall Study||96
10616977|NCT01946243|11774955|FG000|NOT COMPLETED|Overall Study||0
10616978|NCT01946282|11774964|FG000|STARTED|Year 1||6565
10616979|NCT01946282|11774965|FG001|STARTED|Year 1||1000
10616980|NCT01946282|11774966|FG002|STARTED|Year 1||1000
10616981|NCT01946282|11774964|FG000|COMPLETED|Year 1||2379
10616982|NCT01946282|11774965|FG001|COMPLETED|Year 1||392
10616983|NCT01946282|11774966|FG002|COMPLETED|Year 1||346
10616984|NCT01946282|11774964|FG000|NOT COMPLETED|Year 1||4186
10616985|NCT01946282|11774965|FG001|NOT COMPLETED|Year 1||608
10616986|NCT01946282|11774966|FG002|NOT COMPLETED|Year 1||654
10616987|NCT01946282|11774964|FG000|STARTED|Year 2|Patients are those with Year 1 negative FIT results, or no longer met inclusion criteria.|2051
10616988|NCT01946282|11774965|FG001|STARTED|Year 2|Patients are those with Year 1 negative FIT results, or no longer met inclusion criteria.|341
10616989|NCT01946282|11774966|FG002|STARTED|Year 2|Patients are those with Year 1 negative FIT results, or no longer met inclusion criteria.|299
10616990|NCT01946282|11774964|FG000|COMPLETED|Year 2||1248
10616991|NCT01946282|11774965|FG001|COMPLETED|Year 2||210
10616992|NCT01946282|11774966|FG002|COMPLETED|Year 2||184
10616993|NCT01946282|11774964|FG000|NOT COMPLETED|Year 2||803
10616994|NCT01946282|11774965|FG001|NOT COMPLETED|Year 2||131
10616995|NCT01946282|11774966|FG002|NOT COMPLETED|Year 2||115
10616996|NCT01946282|11774964|FG000|STARTED|Year 3|Patients are those with Year 2 negative FIT results, or no longer met inclusion criteria.|1144
10616997|NCT01946282|11774965|FG001|STARTED|Year 3|Patients are those with Year 2 negative FIT results, or no longer met inclusion criteria.|184
10616998|NCT01946282|11774966|FG002|STARTED|Year 3|Patients are those with Year 2 negative FIT results, or no longer met inclusion criteria.|170
10616999|NCT01946282|11774964|FG000|COMPLETED|Year 3||856
10617000|NCT01946282|11774965|FG001|COMPLETED|Year 3||141
10617001|NCT01946282|11774966|FG002|COMPLETED|Year 3||140
10617002|NCT01946282|11774964|FG000|NOT COMPLETED|Year 3||288
10617003|NCT01946282|11774965|FG001|NOT COMPLETED|Year 3||43
10617004|NCT01946282|11774966|FG002|NOT COMPLETED|Year 3||30
10617005|NCT01946412|11774976|FG000|STARTED|Overall Study||33
10617006|NCT01946412|11774976|FG000|COMPLETED|Overall Study||28
10617007|NCT01946412|11774976|FG000|NOT COMPLETED|Overall Study||5
10617008|NCT01946425|11774984|FG000|STARTED|Overall Study||30
10617009|NCT01946425|11774985|FG001|STARTED|Overall Study||30
10617010|NCT01946425|11774984|FG000|COMPLETED|Overall Study||28
10617011|NCT01946425|11774985|FG001|COMPLETED|Overall Study||30
10617012|NCT01946425|11774984|FG000|NOT COMPLETED|Overall Study||2
10617013|NCT01946425|11774985|FG001|NOT COMPLETED|Overall Study||0
10617014|NCT01946438|11774996|FG000|STARTED|Overall Study||52
10617015|NCT01946438|11774997|FG001|STARTED|Overall Study||52
10617016|NCT01946438|11774998|FG002|STARTED|Overall Study||52
10617017|NCT01946438|11774999|FG003|STARTED|Overall Study||52
10617018|NCT01946438|11774996|FG000|COMPLETED|Overall Study||50
10617019|NCT01946438|11774997|FG001|COMPLETED|Overall Study||52
10617020|NCT01946438|11774998|FG002|COMPLETED|Overall Study||51
10617021|NCT01946438|11774999|FG003|COMPLETED|Overall Study||51
10617022|NCT01946438|11774996|FG000|NOT COMPLETED|Overall Study||2
10617023|NCT01946438|11774997|FG001|NOT COMPLETED|Overall Study||0
10704927|NCT02594163|11869319|FG000|STARTED|Treatment Period||12
10704928|NCT02594163|11869320|FG001|STARTED|Treatment Period||13
10704929|NCT02594163|11869319|FG000|COMPLETED|Treatment Period||5
10617024|NCT01946438|11774998|FG002|NOT COMPLETED|Overall Study||1
10617025|NCT01946438|11774999|FG003|NOT COMPLETED|Overall Study||1
10617044|NCT01946802|11775027|FG000|STARTED|Overall Study||44
10617045|NCT01946802|11775027|FG000|COMPLETED|Overall Study||39
10617046|NCT01946802|11775027|FG000|NOT COMPLETED|Overall Study||5
10617047|NCT01946880|11775033|FG000|STARTED|Overall Study||50
10617048|NCT01946880|11775034|FG001|STARTED|Overall Study||52
10617049|NCT01946880|11775033|FG000|COMPLETED|Overall Study||43
10617050|NCT01946880|11775034|FG001|COMPLETED|Overall Study||49
10617051|NCT01946880|11775033|FG000|NOT COMPLETED|Overall Study||7
10617052|NCT01946880|11775034|FG001|NOT COMPLETED|Overall Study||3
10617053|NCT01947127|11775042|FG000|STARTED|Overall Study||166
10617054|NCT01947127|11775043|FG001|STARTED|Overall Study||292
10617055|NCT01947127|11775042|FG000|COMPLETED|Overall Study||143
10617056|NCT01947127|11775043|FG001|COMPLETED|Overall Study||249
10617057|NCT01947127|11775042|FG000|NOT COMPLETED|Overall Study||23
10617058|NCT01947127|11775043|FG001|NOT COMPLETED|Overall Study||43
10617059|NCT01947153|11775049|FG000|STARTED|Test Period 1||18
10617060|NCT01947153|11775050|FG001|STARTED|Test Period 1||18
10617061|NCT01947153|11775049|FG000|COMPLETED|Test Period 1||18
10617062|NCT01947153|11775050|FG001|COMPLETED|Test Period 1||18
10617063|NCT01947153|11775049|FG000|NOT COMPLETED|Test Period 1||0
10617064|NCT01947153|11775050|FG001|NOT COMPLETED|Test Period 1||0
10617065|NCT01947153|11775049|FG000|STARTED|Test Period 2||18
10617066|NCT01947153|11775050|FG001|STARTED|Test Period 2||18
10617067|NCT01947153|11775049|FG000|COMPLETED|Test Period 2||18
10617068|NCT01947153|11775050|FG001|COMPLETED|Test Period 2||18
10617069|NCT01947153|11775049|FG000|NOT COMPLETED|Test Period 2||0
10617070|NCT01947153|11775050|FG001|NOT COMPLETED|Test Period 2||0
10617071|NCT01947283|11775063|FG000|STARTED|Overall Study||89
10617072|NCT01947283|11775064|FG001|STARTED|Overall Study||68
10617073|NCT01947283|11775065|FG002|STARTED|Overall Study||83
10617074|NCT01947283|11775066|FG003|STARTED|Overall Study||72
10617075|NCT01947283|11775067|FG004|STARTED|Overall Study||95
10617076|NCT01947283|11775068|FG005|STARTED|Overall Study||34
10617077|NCT01947283|11775069|FG006|STARTED|Overall Study||40
10617078|NCT01947283|11775063|FG000|Baseline Assessment|Overall Study||89
10617079|NCT01947283|11775064|FG001|Baseline Assessment|Overall Study||68
10617080|NCT01947283|11775065|FG002|Baseline Assessment|Overall Study||83
10617081|NCT01947283|11775066|FG003|Baseline Assessment|Overall Study||72
10617082|NCT01947283|11775067|FG004|Baseline Assessment|Overall Study||0
10617083|NCT01947283|11775068|FG005|Baseline Assessment|Overall Study||34
10617084|NCT01947283|11775069|FG006|Baseline Assessment|Overall Study||40
10617085|NCT01947283|11775063|FG000|Follow-up Assessment|Overall Study||64
10617086|NCT01947283|11775064|FG001|Follow-up Assessment|Overall Study||51
10617087|NCT01947283|11775065|FG002|Follow-up Assessment|Overall Study||65
10617088|NCT01947283|11775066|FG003|Follow-up Assessment|Overall Study||59
10617089|NCT01947283|11775067|FG004|Follow-up Assessment|Overall Study||0
10617090|NCT01947283|11775068|FG005|Follow-up Assessment|Overall Study||27
10617091|NCT01947283|11775069|FG006|Follow-up Assessment|Overall Study||36
10617092|NCT01947283|11775063|FG000|Clinical Recording|Overall Study||65
10617093|NCT01947283|11775064|FG001|Clinical Recording|Overall Study||54
10617094|NCT01947283|11775065|FG002|Clinical Recording|Overall Study||68
10617095|NCT01947283|11775066|FG003|Clinical Recording|Overall Study||57
10617096|NCT01947283|11775067|FG004|Clinical Recording|Overall Study||0
10617097|NCT01947283|11775068|FG005|Clinical Recording|Overall Study||0
10617098|NCT01947283|11775069|FG006|Clinical Recording|Overall Study||0
10617099|NCT01947283|11775063|FG000|End-of-Intervention Assessment|Overall Study||74
10617100|NCT01947283|11775064|FG001|End-of-Intervention Assessment|Overall Study||53
10617101|NCT01947283|11775065|FG002|End-of-Intervention Assessment|Overall Study||73
10617102|NCT01947283|11775066|FG003|End-of-Intervention Assessment|Overall Study||66
10617103|NCT01947283|11775067|FG004|End-of-Intervention Assessment|Overall Study||0
10617104|NCT01947283|11775068|FG005|End-of-Intervention Assessment|Overall Study||32
10617105|NCT01947283|11775069|FG006|End-of-Intervention Assessment|Overall Study||33
10617106|NCT01947283|11775063|FG000|In Analysis|Overall Study||89
10617107|NCT01947283|11775064|FG001|In Analysis|Overall Study||68
10617108|NCT01947283|11775065|FG002|In Analysis|Overall Study||83
10617109|NCT01947283|11775066|FG003|In Analysis|Overall Study||72
10617110|NCT01947283|11775067|FG004|In Analysis|Overall Study||95
10617111|NCT01947283|11775068|FG005|In Analysis|Overall Study||30
10617112|NCT01947283|11775069|FG006|In Analysis|Overall Study||38
10617113|NCT01947283|11775063|FG000|Completed NRCT Baseline Assessment|Overall Study||0
10617114|NCT01947283|11775064|FG001|Completed NRCT Baseline Assessment|Overall Study||0
10617115|NCT01947283|11775065|FG002|Completed NRCT Baseline Assessment|Overall Study||0
10617116|NCT01947283|11775066|FG003|Completed NRCT Baseline Assessment|Overall Study||0
10617117|NCT01947283|11775067|FG004|Completed NRCT Baseline Assessment|Overall Study||95
10617118|NCT01947283|11775068|FG005|Completed NRCT Baseline Assessment|Overall Study||0
10617119|NCT01947283|11775069|FG006|Completed NRCT Baseline Assessment|Overall Study||0
10617120|NCT01947283|11775063|FG000|COMPLETED|Overall Study||60
10617121|NCT01947283|11775064|FG001|COMPLETED|Overall Study||45
10617122|NCT01947283|11775065|FG002|COMPLETED|Overall Study||62
10617123|NCT01947283|11775066|FG003|COMPLETED|Overall Study||55
10617124|NCT01947283|11775067|FG004|COMPLETED|Overall Study||95
10617125|NCT01947283|11775068|FG005|COMPLETED|Overall Study||27
10617126|NCT01947283|11775069|FG006|COMPLETED|Overall Study||32
10617127|NCT01947283|11775063|FG000|NOT COMPLETED|Overall Study||29
10617128|NCT01947283|11775064|FG001|NOT COMPLETED|Overall Study||23
10617129|NCT01947283|11775065|FG002|NOT COMPLETED|Overall Study||21
10617130|NCT01947283|11775066|FG003|NOT COMPLETED|Overall Study||17
10617131|NCT01947283|11775067|FG004|NOT COMPLETED|Overall Study||0
10617132|NCT01947283|11775068|FG005|NOT COMPLETED|Overall Study||7
10617133|NCT01947283|11775069|FG006|NOT COMPLETED|Overall Study||8
10617134|NCT01947335|11775088|FG000|STARTED|Overall Study||42
10617135|NCT01947335|11775089|FG001|STARTED|Overall Study||41
10617136|NCT01947335|11775088|FG000|COMPLETED|Overall Study||42
10617137|NCT01947335|11775089|FG001|COMPLETED|Overall Study||41
10617138|NCT01947335|11775088|FG000|NOT COMPLETED|Overall Study||0
10617139|NCT01947335|11775089|FG001|NOT COMPLETED|Overall Study||0
10617140|NCT01947491|11775099|FG000|STARTED|Overall Study||174
10617141|NCT01947491|11775100|FG001|STARTED|Overall Study||87
10617142|NCT01947491|11775101|FG002|STARTED|Overall Study||90
10617143|NCT01947491|11775102|FG003|STARTED|Overall Study||43
10617144|NCT01947491|11775099|FG000|COMPLETED|Overall Study||166
10617145|NCT01947491|11775100|FG001|COMPLETED|Overall Study||81
10617146|NCT01947491|11775101|FG002|COMPLETED|Overall Study||88
10617147|NCT01947491|11775102|FG003|COMPLETED|Overall Study||38
10617148|NCT01947491|11775099|FG000|NOT COMPLETED|Overall Study||8
10617149|NCT01947491|11775100|FG001|NOT COMPLETED|Overall Study||6
10617150|NCT01947491|11775101|FG002|NOT COMPLETED|Overall Study||2
10617151|NCT01947491|11775102|FG003|NOT COMPLETED|Overall Study||5
10617152|NCT01947517|11775114|FG000|STARTED|Overall Study||26
10617153|NCT01947517|11775115|FG001|STARTED|Overall Study||26
10617154|NCT01947517|11775114|FG000|COMPLETED|Overall Study||25
10617155|NCT01947517|11775115|FG001|COMPLETED|Overall Study||25
10617156|NCT01947517|11775114|FG000|NOT COMPLETED|Overall Study||1
10617157|NCT01947517|11775115|FG001|NOT COMPLETED|Overall Study||1
10617158|NCT01947582|11775121|FG000|STARTED|Overall Study||2
10617159|NCT01947582|11775121|FG000|COMPLETED|Overall Study||1
10617160|NCT01947582|11775121|FG000|NOT COMPLETED|Overall Study||1
10617161|NCT01947647|11775127|FG000|STARTED|Treatment Phase||46
10617162|NCT01947647|11775128|FG001|STARTED|Treatment Phase||47
10617163|NCT01947647|11775127|FG000|COMPLETED|Treatment Phase||29
10617164|NCT01947647|11775128|FG001|COMPLETED|Treatment Phase||21
10617165|NCT01947647|11775127|FG000|NOT COMPLETED|Treatment Phase||17
10617166|NCT01947647|11775128|FG001|NOT COMPLETED|Treatment Phase||26
10617167|NCT01947647|11775127|FG000|STARTED|6-month Followup Phase||29
10617168|NCT01947647|11775128|FG001|STARTED|6-month Followup Phase||21
10617169|NCT01947647|11775127|FG000|COMPLETED|6-month Followup Phase||20
10617170|NCT01947647|11775128|FG001|COMPLETED|6-month Followup Phase||13
10617171|NCT01947647|11775127|FG000|NOT COMPLETED|6-month Followup Phase||9
10617172|NCT01947647|11775128|FG001|NOT COMPLETED|6-month Followup Phase||8
10617173|NCT01947816|11775134|FG000|STARTED|Overall Study||1593
10617174|NCT01947816|11775134|FG000|COMPLETED|Overall Study||1523
10617175|NCT01947816|11775134|FG000|NOT COMPLETED|Overall Study||70
10617176|NCT01947855|11775141|FG000|STARTED|Overall Study||21
10617177|NCT01947855|11775142|FG001|STARTED|Overall Study||20
10617178|NCT01947855|11775143|FG002|STARTED|Overall Study||19
10617179|NCT01947855|11775141|FG000|COMPLETED|Overall Study||20
10617180|NCT01947855|11775142|FG001|COMPLETED|Overall Study||20
10617181|NCT01947855|11775143|FG002|COMPLETED|Overall Study||19
10617182|NCT01947855|11775141|FG000|NOT COMPLETED|Overall Study||1
10617183|NCT01947855|11775142|FG001|NOT COMPLETED|Overall Study||0
10617184|NCT01947855|11775143|FG002|NOT COMPLETED|Overall Study||0
10617185|NCT01947894|11775154|FG000|STARTED|Overall Study||247
10617186|NCT01947894|11775155|FG001|STARTED|Overall Study||42
10617187|NCT01947894|11775156|FG002|STARTED|Overall Study||88
10617188|NCT01947894|11775154|FG000|Treated|Overall Study||246
10617189|NCT01947894|11775155|FG001|Treated|Overall Study||41
10617190|NCT01947894|11775156|FG002|Treated|Overall Study||87
10617191|NCT01947894|11775154|FG000|COMPLETED|Overall Study||160
10617192|NCT01947894|11775155|FG001|COMPLETED|Overall Study||24
10617193|NCT01947894|11775156|FG002|COMPLETED|Overall Study||61
10617194|NCT01947894|11775154|FG000|NOT COMPLETED|Overall Study||87
10617195|NCT01947894|11775155|FG001|NOT COMPLETED|Overall Study||18
10617196|NCT01947894|11775156|FG002|NOT COMPLETED|Overall Study||27
10704930|NCT02594163|11869320|FG001|COMPLETED|Treatment Period||1
10617197|NCT01947907|11775168|FG000|STARTED|Overall Study||12
10617198|NCT01947907|11775169|FG001|STARTED|Overall Study||14
10617199|NCT01947907|11775170|FG002|STARTED|Overall Study||14
10617200|NCT01947907|11775171|FG003|STARTED|Overall Study||13
10617201|NCT01947907|11775168|FG000|COMPLETED|Overall Study||12
10617202|NCT01947907|11775169|FG001|COMPLETED|Overall Study||14
10704931|NCT02594163|11869319|FG000|NOT COMPLETED|Treatment Period||7
10617203|NCT01947907|11775170|FG002|COMPLETED|Overall Study||14
10617204|NCT01947907|11775171|FG003|COMPLETED|Overall Study||13
10617205|NCT01947907|11775168|FG000|NOT COMPLETED|Overall Study||0
10617206|NCT01947907|11775169|FG001|NOT COMPLETED|Overall Study||0
10617207|NCT01947907|11775170|FG002|NOT COMPLETED|Overall Study||0
10617208|NCT01947907|11775171|FG003|NOT COMPLETED|Overall Study||0
10617209|NCT01947946|11775184|FG000|STARTED|Overall Study||3
10617210|NCT01947946|11775185|FG001|STARTED|Overall Study||5
10617211|NCT01947946|11775186|FG002|STARTED|Overall Study||5
10617212|NCT01947946|11775184|FG000|COMPLETED|Overall Study|Study Stopped|0
10617213|NCT01947946|11775185|FG001|COMPLETED|Overall Study||0
10617214|NCT01947946|11775186|FG002|COMPLETED|Overall Study||0
10617215|NCT01947946|11775184|FG000|NOT COMPLETED|Overall Study||3
10617216|NCT01947946|11775185|FG001|NOT COMPLETED|Overall Study||5
10617217|NCT01947946|11775186|FG002|NOT COMPLETED|Overall Study||5
10617218|NCT01948050|11775196|FG000|STARTED|Overall Study||16
10617219|NCT01948050|11775197|FG001|STARTED|Overall Study||8
10617220|NCT01948050|11775196|FG000|COMPLETED|Overall Study||16
10617221|NCT01948050|11775197|FG001|COMPLETED|Overall Study||7
10617222|NCT01948050|11775196|FG000|NOT COMPLETED|Overall Study||0
10617223|NCT01948050|11775197|FG001|NOT COMPLETED|Overall Study||1
10617224|NCT01948063|11775205|FG000|STARTED|Overall Study||20
10617225|NCT01948063|11775206|FG001|STARTED|Overall Study||21
10617226|NCT01948063|11775205|FG000|COMPLETED|Overall Study||19
10617227|NCT01948063|11775206|FG001|COMPLETED|Overall Study||19
10617228|NCT01948063|11775205|FG000|NOT COMPLETED|Overall Study||1
10617229|NCT01948063|11775206|FG001|NOT COMPLETED|Overall Study||2
10617230|NCT01948076|11775214|FG000|STARTED|Overall Study||20
10617231|NCT01948076|11775215|FG001|STARTED|Overall Study||20
10617232|NCT01948076|11775214|FG000|COMPLETED|Overall Study||20
10617233|NCT01948076|11775215|FG001|COMPLETED|Overall Study||19
10617234|NCT01948076|11775214|FG000|NOT COMPLETED|Overall Study||0
10617235|NCT01948076|11775215|FG001|NOT COMPLETED|Overall Study||1
10617236|NCT01948141|11775223|FG000|STARTED|Overall Study||6
10617237|NCT01948141|11775223|FG000|COMPLETED|Overall Study||6
10617238|NCT01948141|11775223|FG000|NOT COMPLETED|Overall Study||0
10617239|NCT01948193|11775227|FG000|STARTED|Overall Study||177
10617240|NCT01948193|11775227|FG000|COMPLETED|Overall Study||168
10617241|NCT01948193|11775227|FG000|NOT COMPLETED|Overall Study||9
10617242|NCT01948258|11775232|FG000|STARTED|Overall Study||395
10617243|NCT01948258|11775232|FG000|COMPLETED|Overall Study||233
10617244|NCT01948258|11775232|FG000|NOT COMPLETED|Overall Study||162
10617245|NCT01948310|11775238|FG000|STARTED|Overall Study||19
10617246|NCT01948310|11775239|FG001|STARTED|Overall Study||18
10617247|NCT01948310|11775238|FG000|COMPLETED|Overall Study||16
10617248|NCT01948310|11775239|FG001|COMPLETED|Overall Study||13
10617249|NCT01948310|11775238|FG000|NOT COMPLETED|Overall Study||3
10617250|NCT01948310|11775239|FG001|NOT COMPLETED|Overall Study||5
10617251|NCT01948375|11775247|FG000|STARTED|Overall Study||30
10617252|NCT01948375|11775248|FG001|STARTED|Overall Study||30
10617253|NCT01948375|11775247|FG000|COMPLETED|Overall Study||30
10617254|NCT01948375|11775248|FG001|COMPLETED|Overall Study||30
10617255|NCT01948375|11775247|FG000|NOT COMPLETED|Overall Study||0
10617256|NCT01948375|11775248|FG001|NOT COMPLETED|Overall Study||0
10617257|NCT01948388|11775258|FG000|STARTED|Overall Study||10
10617258|NCT01948388|11775259|FG001|STARTED|Overall Study||10
10617259|NCT01948388|11775258|FG000|COMPLETED|Overall Study||8
10617260|NCT01948388|11775259|FG001|COMPLETED|Overall Study||9
10617261|NCT01948388|11775258|FG000|NOT COMPLETED|Overall Study||2
10617262|NCT01948388|11775259|FG001|NOT COMPLETED|Overall Study||1
10617263|NCT01948427|11775272|FG000|STARTED|Overall Study||49
10617264|NCT01948427|11775273|FG001|STARTED|Overall Study||89
10617265|NCT01948427|11775274|FG002|STARTED|Overall Study||4
10617266|NCT01948427|11775275|FG003|STARTED|Overall Study||1
10617267|NCT01948427|11775276|FG004|STARTED|Overall Study||60
10617268|NCT01948427|11775272|FG000|COMPLETED|Overall Study||42
10617269|NCT01948427|11775273|FG001|COMPLETED|Overall Study||72
10617270|NCT01948427|11775274|FG002|COMPLETED|Overall Study||4
10617271|NCT01948427|11775275|FG003|COMPLETED|Overall Study||1
10617272|NCT01948427|11775276|FG004|COMPLETED|Overall Study||46
10617273|NCT01948427|11775272|FG000|NOT COMPLETED|Overall Study||7
10617274|NCT01948427|11775273|FG001|NOT COMPLETED|Overall Study||17
10617275|NCT01948427|11775274|FG002|NOT COMPLETED|Overall Study||0
10617276|NCT01948427|11775275|FG003|NOT COMPLETED|Overall Study||0
10617277|NCT01948427|11775276|FG004|NOT COMPLETED|Overall Study||14
10617278|NCT01948518|11775293|FG000|STARTED|Overall Study||15
10617279|NCT01948518|11775293|FG000|COMPLETED|Overall Study||15
10617280|NCT01948518|11775293|FG000|NOT COMPLETED|Overall Study||0
10617281|NCT01948739|11775297|FG000|STARTED|Overall Study||18
10617282|NCT01948739|11775297|FG000|Received Intervention|Overall Study||10
10617283|NCT01948739|11775297|FG000|COMPLETED|Overall Study||10
10617284|NCT01948739|11775297|FG000|NOT COMPLETED|Overall Study||8
10617285|NCT01948791|11775301|FG000|STARTED|Overall Study||222
10617286|NCT01948791|11775301|FG000|COMPLETED|Overall Study||151
10617287|NCT01948791|11775301|FG000|NOT COMPLETED|Overall Study||71
10617288|NCT01948830|11775307|FG000|STARTED|Overall Study||323
10617289|NCT01948830|11775308|FG001|STARTED|Overall Study||327
10617290|NCT01948830|11775307|FG000|Safety Set|Overall Study||323
10617291|NCT01948830|11775308|FG001|Safety Set|Overall Study||326
10617292|NCT01948830|11775307|FG000|COMPLETED|Overall Study||290
10617293|NCT01948830|11775308|FG001|COMPLETED|Overall Study||295
10617294|NCT01948830|11775307|FG000|NOT COMPLETED|Overall Study||33
10617295|NCT01948830|11775308|FG001|NOT COMPLETED|Overall Study||32
10617296|NCT01948908|11775317|FG000|STARTED|Overall Study||33
10617297|NCT01948908|11775318|FG001|STARTED|Overall Study||33
10617298|NCT01948908|11775319|FG002|STARTED|Overall Study||33
10617299|NCT01948908|11775317|FG000|COMPLETED|Overall Study||32
10617300|NCT01948908|11775318|FG001|COMPLETED|Overall Study||33
10617301|NCT01948908|11775319|FG002|COMPLETED|Overall Study||31
10617302|NCT01948908|11775317|FG000|NOT COMPLETED|Overall Study||1
10617303|NCT01948908|11775318|FG001|NOT COMPLETED|Overall Study||0
10617304|NCT01948908|11775319|FG002|NOT COMPLETED|Overall Study||2
10617305|NCT01948947|11775329|FG000|STARTED|Overall Study||14
10617306|NCT01948947|11775330|FG001|STARTED|Overall Study||15
10617307|NCT01948947|11775329|FG000|COMPLETED|Overall Study||14
10617308|NCT01948947|11775330|FG001|COMPLETED|Overall Study||15
10617309|NCT01948947|11775329|FG000|NOT COMPLETED|Overall Study||0
10617310|NCT01948947|11775330|FG001|NOT COMPLETED|Overall Study||0
10617311|NCT01948986|11775341|FG000|STARTED|Overall Study||6
10617312|NCT01948986|11775342|FG001|STARTED|Overall Study||8
10617313|NCT01948986|11775343|FG002|STARTED|Overall Study||8
10617314|NCT01948986|11775344|FG003|STARTED|Overall Study||6
10617315|NCT01948986|11775345|FG004|STARTED|Overall Study||8
10617316|NCT01948986|11775341|FG000|COMPLETED|Overall Study||6
10617317|NCT01948986|11775342|FG001|COMPLETED|Overall Study||8
10617318|NCT01948986|11775343|FG002|COMPLETED|Overall Study||8
10617319|NCT01948986|11775344|FG003|COMPLETED|Overall Study||6
10617320|NCT01948986|11775345|FG004|COMPLETED|Overall Study||8
10617321|NCT01948986|11775341|FG000|NOT COMPLETED|Overall Study||0
10617322|NCT01948986|11775342|FG001|NOT COMPLETED|Overall Study||0
10617323|NCT01948986|11775343|FG002|NOT COMPLETED|Overall Study||0
10617324|NCT01948986|11775344|FG003|NOT COMPLETED|Overall Study||0
10617325|NCT01948986|11775345|FG004|NOT COMPLETED|Overall Study||0
10617326|NCT01949051|11775357|FG000|STARTED|Treatment Period 1 (7 Days)||13
10617327|NCT01949051|11775358|FG001|STARTED|Treatment Period 1 (7 Days)||13
10617328|NCT01949051|11775359|FG002|STARTED|Treatment Period 1 (7 Days)||13
10617329|NCT01949051|11775360|FG003|STARTED|Treatment Period 1 (7 Days)||13
10617330|NCT01949051|11775361|FG004|STARTED|Treatment Period 1 (7 Days)||13
10617331|NCT01949051|11775362|FG005|STARTED|Treatment Period 1 (7 Days)||13
10617332|NCT01949051|11775357|FG000|COMPLETED|Treatment Period 1 (7 Days)||11
10617333|NCT01949051|11775358|FG001|COMPLETED|Treatment Period 1 (7 Days)||13
10617334|NCT01949051|11775359|FG002|COMPLETED|Treatment Period 1 (7 Days)||13
10617335|NCT01949051|11775360|FG003|COMPLETED|Treatment Period 1 (7 Days)||12
10617336|NCT01949051|11775361|FG004|COMPLETED|Treatment Period 1 (7 Days)||13
10617337|NCT01949051|11775362|FG005|COMPLETED|Treatment Period 1 (7 Days)||13
10617338|NCT01949051|11775357|FG000|NOT COMPLETED|Treatment Period 1 (7 Days)||2
10617339|NCT01949051|11775358|FG001|NOT COMPLETED|Treatment Period 1 (7 Days)||0
10617340|NCT01949051|11775359|FG002|NOT COMPLETED|Treatment Period 1 (7 Days)||0
10617341|NCT01949051|11775360|FG003|NOT COMPLETED|Treatment Period 1 (7 Days)||1
10617342|NCT01949051|11775361|FG004|NOT COMPLETED|Treatment Period 1 (7 Days)||0
10617343|NCT01949051|11775362|FG005|NOT COMPLETED|Treatment Period 1 (7 Days)||0
10617344|NCT01949051|11775357|FG000|STARTED|Washout Period 1 (14 to 20 Days)||11
10617345|NCT01949051|11775358|FG001|STARTED|Washout Period 1 (14 to 20 Days)||13
10617346|NCT01949051|11775359|FG002|STARTED|Washout Period 1 (14 to 20 Days)||13
10617347|NCT01949051|11775360|FG003|STARTED|Washout Period 1 (14 to 20 Days)||12
10617348|NCT01949051|11775361|FG004|STARTED|Washout Period 1 (14 to 20 Days)||13
10617349|NCT01949051|11775362|FG005|STARTED|Washout Period 1 (14 to 20 Days)||13
10617350|NCT01949051|11775357|FG000|COMPLETED|Washout Period 1 (14 to 20 Days)||11
10617351|NCT01949051|11775358|FG001|COMPLETED|Washout Period 1 (14 to 20 Days)||13
10617352|NCT01949051|11775359|FG002|COMPLETED|Washout Period 1 (14 to 20 Days)||13
10617353|NCT01949051|11775360|FG003|COMPLETED|Washout Period 1 (14 to 20 Days)||12
10617354|NCT01949051|11775361|FG004|COMPLETED|Washout Period 1 (14 to 20 Days)||13
10617355|NCT01949051|11775362|FG005|COMPLETED|Washout Period 1 (14 to 20 Days)||13
10617356|NCT01949051|11775357|FG000|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
10617357|NCT01949051|11775358|FG001|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
10617358|NCT01949051|11775359|FG002|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
10617359|NCT01949051|11775360|FG003|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
10617360|NCT01949051|11775361|FG004|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
10617361|NCT01949051|11775362|FG005|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
10617362|NCT01949051|11775357|FG000|STARTED|Treatment Period 2 (7 Days)||11
10617363|NCT01949051|11775358|FG001|STARTED|Treatment Period 2 (7 Days)||13
10617364|NCT01949051|11775359|FG002|STARTED|Treatment Period 2 (7 Days)||13
10617365|NCT01949051|11775360|FG003|STARTED|Treatment Period 2 (7 Days)||12
10617366|NCT01949051|11775361|FG004|STARTED|Treatment Period 2 (7 Days)||13
10617367|NCT01949051|11775362|FG005|STARTED|Treatment Period 2 (7 Days)||13
10617368|NCT01949051|11775357|FG000|COMPLETED|Treatment Period 2 (7 Days)||11
10617369|NCT01949051|11775358|FG001|COMPLETED|Treatment Period 2 (7 Days)||12
10617370|NCT01949051|11775359|FG002|COMPLETED|Treatment Period 2 (7 Days)||12
10617371|NCT01949051|11775360|FG003|COMPLETED|Treatment Period 2 (7 Days)||12
10617372|NCT01949051|11775361|FG004|COMPLETED|Treatment Period 2 (7 Days)||13
10617373|NCT01949051|11775362|FG005|COMPLETED|Treatment Period 2 (7 Days)||12
10617374|NCT01949051|11775357|FG000|NOT COMPLETED|Treatment Period 2 (7 Days)||0
10617375|NCT01949051|11775358|FG001|NOT COMPLETED|Treatment Period 2 (7 Days)||1
10617376|NCT01949051|11775359|FG002|NOT COMPLETED|Treatment Period 2 (7 Days)||1
10617377|NCT01949051|11775360|FG003|NOT COMPLETED|Treatment Period 2 (7 Days)||0
10617378|NCT01949051|11775361|FG004|NOT COMPLETED|Treatment Period 2 (7 Days)||0
10617379|NCT01949051|11775362|FG005|NOT COMPLETED|Treatment Period 2 (7 Days)||1
10617380|NCT01949051|11775357|FG000|STARTED|Washout Period 2 (14 to 20 Days)||11
10617381|NCT01949051|11775358|FG001|STARTED|Washout Period 2 (14 to 20 Days)||12
10617382|NCT01949051|11775359|FG002|STARTED|Washout Period 2 (14 to 20 Days)||12
10457087|NCT01009047|11604820|FG001|STARTED|Overall Study||115
10457088|NCT01009047|11604819|FG000|COMPLETED|Overall Study||85
10617383|NCT01949051|11775360|FG003|STARTED|Washout Period 2 (14 to 20 Days)||12
10617384|NCT01949051|11775361|FG004|STARTED|Washout Period 2 (14 to 20 Days)||13
10617385|NCT01949051|11775362|FG005|STARTED|Washout Period 2 (14 to 20 Days)||12
10617386|NCT01949051|11775357|FG000|COMPLETED|Washout Period 2 (14 to 20 Days)||11
10617387|NCT01949051|11775358|FG001|COMPLETED|Washout Period 2 (14 to 20 Days)||12
10457089|NCT01009047|11604820|FG001|COMPLETED|Overall Study||89
10457090|NCT01009047|11604819|FG000|NOT COMPLETED|Overall Study||28
10617388|NCT01949051|11775359|FG002|COMPLETED|Washout Period 2 (14 to 20 Days)||12
10617389|NCT01949051|11775360|FG003|COMPLETED|Washout Period 2 (14 to 20 Days)||12
10617390|NCT01949051|11775361|FG004|COMPLETED|Washout Period 2 (14 to 20 Days)||13
10617391|NCT01949051|11775362|FG005|COMPLETED|Washout Period 2 (14 to 20 Days)||12
10617392|NCT01949051|11775357|FG000|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
10617393|NCT01949051|11775358|FG001|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
10617394|NCT01949051|11775359|FG002|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
10617395|NCT01949051|11775360|FG003|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
10617396|NCT01949051|11775361|FG004|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
10617397|NCT01949051|11775362|FG005|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
10617398|NCT01949051|11775357|FG000|STARTED|Treatment Period 3 (7 Days)||11
10617399|NCT01949051|11775358|FG001|STARTED|Treatment Period 3 (7 Days)||12
10617400|NCT01949051|11775359|FG002|STARTED|Treatment Period 3 (7 Days)||12
10617401|NCT01949051|11775360|FG003|STARTED|Treatment Period 3 (7 Days)||12
10617402|NCT01949051|11775361|FG004|STARTED|Treatment Period 3 (7 Days)||13
10617403|NCT01949051|11775362|FG005|STARTED|Treatment Period 3 (7 Days)||12
10617404|NCT01949051|11775357|FG000|COMPLETED|Treatment Period 3 (7 Days)||11
10617405|NCT01949051|11775358|FG001|COMPLETED|Treatment Period 3 (7 Days)||12
10617406|NCT01949051|11775359|FG002|COMPLETED|Treatment Period 3 (7 Days)||12
10617407|NCT01949051|11775360|FG003|COMPLETED|Treatment Period 3 (7 Days)||12
10617408|NCT01949051|11775361|FG004|COMPLETED|Treatment Period 3 (7 Days)||13
10617409|NCT01949051|11775362|FG005|COMPLETED|Treatment Period 3 (7 Days)||12
10617410|NCT01949051|11775357|FG000|NOT COMPLETED|Treatment Period 3 (7 Days)||0
10617411|NCT01949051|11775358|FG001|NOT COMPLETED|Treatment Period 3 (7 Days)||0
10617412|NCT01949051|11775359|FG002|NOT COMPLETED|Treatment Period 3 (7 Days)||0
10617413|NCT01949051|11775360|FG003|NOT COMPLETED|Treatment Period 3 (7 Days)||0
10617414|NCT01949051|11775361|FG004|NOT COMPLETED|Treatment Period 3 (7 Days)||0
10617415|NCT01949051|11775362|FG005|NOT COMPLETED|Treatment Period 3 (7 Days)||0
10653219|NCT02191046|11813665|FG001|STARTED|Overall Study||39
10653220|NCT02191046|11813664|FG000|COMPLETED|Overall Study|exclude 5 patients because low compliance|36
10653221|NCT02191046|11813665|FG001|COMPLETED|Overall Study|exclude 1 patient because low compliance|38
10653222|NCT02191046|11813664|FG000|NOT COMPLETED|Overall Study||5
10653223|NCT02191046|11813665|FG001|NOT COMPLETED|Overall Study||1
10653224|NCT02191137|11813671|FG000|STARTED|Treatment||75
10653225|NCT02191137|11813671|FG000|COMPLETED|Treatment||65
10653226|NCT02191137|11813671|FG000|NOT COMPLETED|Treatment||10
10653227|NCT02191137|11813671|FG000|STARTED|Follow-up||65
10653228|NCT02191137|11813671|FG000|COMPLETED|Follow-up||60
10653229|NCT02191137|11813671|FG000|NOT COMPLETED|Follow-up||5
10653230|NCT02191267|11813678|FG000|STARTED|Overall Study||20
10653231|NCT02191267|11813679|FG001|STARTED|Overall Study||6
10653232|NCT02191267|11813680|FG002|STARTED|Overall Study||4
10653233|NCT02191267|11813678|FG000|COMPLETED|Overall Study||19
10653234|NCT02191267|11813679|FG001|COMPLETED|Overall Study||6
10653235|NCT02191267|11813680|FG002|COMPLETED|Overall Study||4
10653236|NCT02191267|11813678|FG000|NOT COMPLETED|Overall Study||1
10653237|NCT02191267|11813679|FG001|NOT COMPLETED|Overall Study||0
10653238|NCT02191267|11813680|FG002|NOT COMPLETED|Overall Study||0
10653239|NCT02191397|11813690|FG000|STARTED|Overall Study||266
10653240|NCT02191397|11813691|FG001|STARTED|Overall Study||268
10653241|NCT02191397|11813690|FG000|COMPLETED|Overall Study||183
10653242|NCT02191397|11813691|FG001|COMPLETED|Overall Study||198
10653243|NCT02191397|11813690|FG000|NOT COMPLETED|Overall Study||83
10653244|NCT02191397|11813691|FG001|NOT COMPLETED|Overall Study||70
10653245|NCT02191579|11813699|FG000|STARTED|Treatment 1||140
10653246|NCT02191579|11813700|FG001|STARTED|Treatment 1||142
10653247|NCT02191579|11813699|FG000|COMPLETED|Treatment 1||113
10653248|NCT02191579|11813700|FG001|COMPLETED|Treatment 1||84
10653249|NCT02191579|11813699|FG000|NOT COMPLETED|Treatment 1||27
10653250|NCT02191579|11813700|FG001|NOT COMPLETED|Treatment 1||58
10653251|NCT02191579|11813699|FG000|STARTED|Treatment 2||0
10653252|NCT02191579|11813700|FG001|STARTED|Treatment 2||80
10653253|NCT02191579|11813699|FG000|COMPLETED|Treatment 2||0
10653254|NCT02191579|11813700|FG001|COMPLETED|Treatment 2||55
10653255|NCT02191579|11813699|FG000|NOT COMPLETED|Treatment 2||0
10653256|NCT02191579|11813700|FG001|NOT COMPLETED|Treatment 2||25
10653257|NCT02191605|11813711|FG000|STARTED|Overall Study||15
10653258|NCT02191605|11813712|FG001|STARTED|Overall Study||15
10653259|NCT02191605|11813713|FG002|STARTED|Overall Study||15
10653260|NCT02191605|11813714|FG003|STARTED|Overall Study||8
10653261|NCT02191605|11813715|FG004|STARTED|Overall Study||7
10653262|NCT02191605|11813711|FG000|Completed Intervention Portion|Overall Study||15
10653263|NCT02191605|11813712|FG001|Completed Intervention Portion|Overall Study||15
10653264|NCT02191605|11813713|FG002|Completed Intervention Portion|Overall Study||15
10653265|NCT02191605|11813714|FG003|Completed Intervention Portion|Overall Study||8
10653266|NCT02191605|11813715|FG004|Completed Intervention Portion|Overall Study||7
10653267|NCT02191605|11813711|FG000|COMPLETED|Overall Study||6
10653268|NCT02191605|11813712|FG001|COMPLETED|Overall Study||11
10653269|NCT02191605|11813713|FG002|COMPLETED|Overall Study||8
10653270|NCT02191605|11813714|FG003|COMPLETED|Overall Study||5
10653271|NCT02191605|11813715|FG004|COMPLETED|Overall Study||3
10653272|NCT02191605|11813711|FG000|NOT COMPLETED|Overall Study||9
10653273|NCT02191605|11813712|FG001|NOT COMPLETED|Overall Study||4
10653274|NCT02191605|11813713|FG002|NOT COMPLETED|Overall Study||7
10653275|NCT02191605|11813714|FG003|NOT COMPLETED|Overall Study||3
10653276|NCT02191605|11813715|FG004|NOT COMPLETED|Overall Study||4
10653277|NCT02191618|11813727|FG000|STARTED|Overall Study||150
10653278|NCT02191618|11813727|FG000|COMPLETED|Overall Study||143
10653279|NCT02191618|11813727|FG000|NOT COMPLETED|Overall Study||7
10617416|NCT01949090|11775375|FG000|STARTED|Overall Study||60
10617417|NCT01949090|11775376|FG001|STARTED|Overall Study||60
10617418|NCT01949090|11775377|FG002|STARTED|Overall Study||60
10617419|NCT01949090|11775378|FG003|STARTED|Overall Study||60
10617420|NCT01949090|11775379|FG004|STARTED|Overall Study||120
10617421|NCT01949090|11775375|FG000|COMPLETED|Overall Study||56
10617422|NCT01949090|11775376|FG001|COMPLETED|Overall Study||58
10617423|NCT01949090|11775377|FG002|COMPLETED|Overall Study||58
10617424|NCT01949090|11775378|FG003|COMPLETED|Overall Study||59
10617425|NCT01949090|11775379|FG004|COMPLETED|Overall Study||116
10617426|NCT01949090|11775375|FG000|NOT COMPLETED|Overall Study||4
10617427|NCT01949090|11775376|FG001|NOT COMPLETED|Overall Study||2
10617428|NCT01949090|11775377|FG002|NOT COMPLETED|Overall Study||2
10617429|NCT01949090|11775378|FG003|NOT COMPLETED|Overall Study||1
10617430|NCT01949090|11775379|FG004|NOT COMPLETED|Overall Study||4
10617431|NCT01949116|11775394|FG000|STARTED|Overall Study||86
10617432|NCT01949116|11775395|FG001|STARTED|Overall Study||90
10617433|NCT01949116|11775394|FG000|COMPLETED|Overall Study||78
10617434|NCT01949116|11775395|FG001|COMPLETED|Overall Study||84
10617435|NCT01949116|11775394|FG000|NOT COMPLETED|Overall Study||8
10617436|NCT01949116|11775395|FG001|NOT COMPLETED|Overall Study||6
10617437|NCT01949142|11775407|FG000|STARTED|Overall Study||179
10617438|NCT01949142|11775408|FG001|STARTED|Overall Study||87
10617439|NCT01949142|11775407|FG000|COMPLETED|Overall Study||176
10617440|NCT01949142|11775408|FG001|COMPLETED|Overall Study||86
10617441|NCT01949142|11775407|FG000|NOT COMPLETED|Overall Study||3
10617442|NCT01949142|11775408|FG001|NOT COMPLETED|Overall Study||1
10617443|NCT01949155|11775417|FG000|STARTED|Overall Study||178
10617444|NCT01949155|11775418|FG001|STARTED|Overall Study||88
10617445|NCT01949155|11775417|FG000|COMPLETED|Overall Study||176
10617446|NCT01949155|11775418|FG001|COMPLETED|Overall Study||88
10617447|NCT01949155|11775417|FG000|NOT COMPLETED|Overall Study||2
10617448|NCT01949155|11775418|FG001|NOT COMPLETED|Overall Study||0
10617455|NCT01949389|11775434|FG000|STARTED|Overall Study||51
10617456|NCT01949389|11775434|FG000|COMPLETED|Overall Study||51
10617457|NCT01949389|11775434|FG000|NOT COMPLETED|Overall Study||0
10617458|NCT01949480|11775440|FG000|STARTED|Overall Study||20
10617459|NCT01949480|11775441|FG001|STARTED|Overall Study||22
10617460|NCT01949480|11775440|FG000|COMPLETED|Overall Study||15
10617461|NCT01949480|11775441|FG001|COMPLETED|Overall Study||14
10617462|NCT01949480|11775440|FG000|NOT COMPLETED|Overall Study||5
10617463|NCT01949480|11775441|FG001|NOT COMPLETED|Overall Study||8
10617464|NCT01949532|11775449|FG000|STARTED|Overall Study||15
10617465|NCT01949532|11775450|FG001|STARTED|Overall Study||11
10617466|NCT01949532|11775449|FG000|COMPLETED|Overall Study||12
10617467|NCT01949532|11775450|FG001|COMPLETED|Overall Study||8
10617468|NCT01949532|11775449|FG000|NOT COMPLETED|Overall Study||3
10617469|NCT01949532|11775450|FG001|NOT COMPLETED|Overall Study||3
10617470|NCT01949545|11775460|FG000|STARTED|Overall Study||11
10617471|NCT01949545|11775461|FG001|STARTED|Overall Study||17
10617472|NCT01949545|11775462|FG002|STARTED|Overall Study||14
10617473|NCT01949545|11775463|FG003|STARTED|Overall Study||4
10617474|NCT01949545|11775460|FG000|COMPLETED|Overall Study||11
10617475|NCT01949545|11775461|FG001|COMPLETED|Overall Study||17
10617476|NCT01949545|11775462|FG002|COMPLETED|Overall Study||14
10617477|NCT01949545|11775463|FG003|COMPLETED|Overall Study||4
10617478|NCT01949545|11775460|FG000|NOT COMPLETED|Overall Study||0
10617479|NCT01949545|11775461|FG001|NOT COMPLETED|Overall Study||0
10617480|NCT01949545|11775462|FG002|NOT COMPLETED|Overall Study||0
10617481|NCT01949545|11775463|FG003|NOT COMPLETED|Overall Study||0
10617488|NCT01949779|11775482|FG000|STARTED|Overall Study||81
10617489|NCT01949779|11775482|FG000|COMPLETED|Overall Study||79
10617490|NCT01949779|11775482|FG000|NOT COMPLETED|Overall Study||2
10617491|NCT01949844|11775486|FG000|STARTED|Overall Study||44
10617492|NCT01949844|11775486|FG000|COMPLETED|Overall Study||44
10617493|NCT01949844|11775486|FG000|NOT COMPLETED|Overall Study||0
10617494|NCT01949870|11775490|FG000|STARTED|Overall Study||6
10617495|NCT01949870|11775490|FG000|Received Treatment|Overall Study||4
10617496|NCT01949870|11775490|FG000|COMPLETED|Overall Study||0
10617497|NCT01949870|11775490|FG000|NOT COMPLETED|Overall Study||6
10617498|NCT01950013|11775497|FG000|STARTED|Overall Study||15
10617499|NCT01950013|11775498|FG001|STARTED|Overall Study||15
10617500|NCT01950013|11775499|FG002|STARTED|Overall Study||15
10617501|NCT01950013|11775497|FG000|COMPLETED|Overall Study||15
10617502|NCT01950013|11775498|FG001|COMPLETED|Overall Study||13
10617503|NCT01950013|11775499|FG002|COMPLETED|Overall Study||15
10617504|NCT01950013|11775497|FG000|NOT COMPLETED|Overall Study||0
10617505|NCT01950013|11775498|FG001|NOT COMPLETED|Overall Study||2
10617506|NCT01950013|11775499|FG002|NOT COMPLETED|Overall Study||0
10617507|NCT01950039|11775509|FG000|STARTED|Overall Study||15
10617508|NCT01950039|11775510|FG001|STARTED|Overall Study||13
10617509|NCT01950039|11775509|FG000|Study Drug Initiated|Overall Study||14
10617510|NCT01950039|11775510|FG001|Study Drug Initiated|Overall Study||13
10617511|NCT01950039|11775509|FG000|Completed Clamp|Overall Study||13
10617512|NCT01950039|11775510|FG001|Completed Clamp|Overall Study||12
10617513|NCT01950039|11775509|FG000|Completed MRI|Overall Study||13
10617514|NCT01950039|11775510|FG001|Completed MRI|Overall Study||12
10617515|NCT01950039|11775509|FG000|Completed Endothelial Evaluation|Overall Study||14
10617516|NCT01950039|11775510|FG001|Completed Endothelial Evaluation|Overall Study||12
10617517|NCT01950039|11775509|FG000|COMPLETED|Overall Study||14
10617518|NCT01950039|11775510|FG001|COMPLETED|Overall Study||13
10617519|NCT01950039|11775509|FG000|NOT COMPLETED|Overall Study||1
10617520|NCT01950039|11775510|FG001|NOT COMPLETED|Overall Study||0
10617521|NCT01950078|11775518|FG000|STARTED|Overall Study||1025
10617522|NCT01950078|11775519|FG001|STARTED|Overall Study||508
10617523|NCT01950078|11775518|FG000|COMPLETED|Overall Study||1005
10617524|NCT01950078|11775519|FG001|COMPLETED|Overall Study||496
10617525|NCT01950078|11775518|FG000|NOT COMPLETED|Overall Study||20
10617526|NCT01950078|11775519|FG001|NOT COMPLETED|Overall Study||12
10617527|NCT01950169|11775528|FG000|STARTED|Overall Study||28
10617528|NCT01950169|11775529|FG001|STARTED|Overall Study||26
10617529|NCT01950169|11775530|FG002|STARTED|Overall Study||25
10617530|NCT01950169|11775528|FG000|COMPLETED|Overall Study||25
10617531|NCT01950169|11775529|FG001|COMPLETED|Overall Study||18
10617532|NCT01950169|11775530|FG002|COMPLETED|Overall Study||24
10617533|NCT01950169|11775528|FG000|NOT COMPLETED|Overall Study||3
10617534|NCT01950169|11775529|FG001|NOT COMPLETED|Overall Study||8
10617535|NCT01950169|11775530|FG002|NOT COMPLETED|Overall Study||1
10617536|NCT01950260|11775541|FG000|STARTED|Overall Study||30
10617537|NCT01950260|11775542|FG001|STARTED|Overall Study||31
10617538|NCT01950260|11775541|FG000|COMPLETED|Overall Study||30
10617539|NCT01950260|11775542|FG001|COMPLETED|Overall Study||31
10617540|NCT01950260|11775541|FG000|NOT COMPLETED|Overall Study||0
10617541|NCT01950260|11775542|FG001|NOT COMPLETED|Overall Study||0
10617542|NCT01950273|11775550|FG000|STARTED|Overall Study||49
10617543|NCT01950273|11775551|FG001|STARTED|Overall Study||46
10617544|NCT01950273|11775550|FG000|COMPLETED|Overall Study||45
10617545|NCT01950273|11775551|FG001|COMPLETED|Overall Study||46
10617546|NCT01950273|11775550|FG000|NOT COMPLETED|Overall Study||4
10617547|NCT01950273|11775551|FG001|NOT COMPLETED|Overall Study||0
10617548|NCT01950299|11775560|FG000|STARTED|Overall Study||33
10617549|NCT01950299|11775561|FG001|STARTED|Overall Study||31
10617550|NCT01950299|11775562|FG002|STARTED|Overall Study||35
10617551|NCT01950299|11775560|FG000|COMPLETED|Overall Study||22
10617552|NCT01950299|11775561|FG001|COMPLETED|Overall Study||27
10617553|NCT01950299|11775562|FG002|COMPLETED|Overall Study||28
10617554|NCT01950299|11775560|FG000|NOT COMPLETED|Overall Study||11
10617555|NCT01950299|11775561|FG001|NOT COMPLETED|Overall Study||4
10617556|NCT01950299|11775562|FG002|NOT COMPLETED|Overall Study||7
10617557|NCT01950364|11775572|FG000|STARTED|Overall Study||10
10617558|NCT01950364|11775573|FG001|STARTED|Overall Study||10
10617559|NCT01950364|11775572|FG000|COMPLETED|Overall Study||0
10617560|NCT01950364|11775573|FG001|COMPLETED|Overall Study||0
10617561|NCT01950364|11775572|FG000|NOT COMPLETED|Overall Study||10
10617562|NCT01950364|11775573|FG001|NOT COMPLETED|Overall Study||10
10617563|NCT01950663|11775579|FG000|STARTED|Overall Study||468
10617564|NCT01950663|11775579|FG000|COMPLETED|Overall Study||467
10617565|NCT01950663|11775579|FG000|NOT COMPLETED|Overall Study||1
10617566|NCT01950741|11775583|FG000|STARTED|Overall Study||48
10617567|NCT01950741|11775583|FG000|COMPLETED|Overall Study||45
10617568|NCT01950741|11775583|FG000|NOT COMPLETED|Overall Study||3
10617569|NCT01950780|11775587|FG000|STARTED|Overall Study||12
10617570|NCT01950780|11775587|FG000|COMPLETED|Overall Study||12
10617571|NCT01950780|11775587|FG000|NOT COMPLETED|Overall Study||0
10617572|NCT01950819|11775594|FG000|STARTED|Overall Study||1022
10617573|NCT01950819|11775595|FG001|STARTED|Overall Study||1015
10617574|NCT01950819|11775594|FG000|COMPLETED|Overall Study||893
10617575|NCT01950819|11775595|FG001|COMPLETED|Overall Study||881
10617576|NCT01950819|11775594|FG000|NOT COMPLETED|Overall Study||129
10617577|NCT01950819|11775595|FG001|NOT COMPLETED|Overall Study||134
10617578|NCT01951066|11775601|FG000|STARTED|First Intervention (Baseline to Week 16)||10
10617579|NCT01951066|11775602|FG001|STARTED|First Intervention (Baseline to Week 16)||10
10617580|NCT01951066|11775601|FG000|COMPLETED|First Intervention (Baseline to Week 16)||10
10617581|NCT01951066|11775602|FG001|COMPLETED|First Intervention (Baseline to Week 16)||10
10617582|NCT01951066|11775601|FG000|NOT COMPLETED|First Intervention (Baseline to Week 16)||0
10617583|NCT01951066|11775602|FG001|NOT COMPLETED|First Intervention (Baseline to Week 16)||0
10617584|NCT01951066|11775601|FG000|STARTED|Second Intervention (Week 16 to Week 32)||10
10617585|NCT01951066|11775602|FG001|STARTED|Second Intervention (Week 16 to Week 32)||10
10617586|NCT01951066|11775601|FG000|COMPLETED|Second Intervention (Week 16 to Week 32)||10
10617587|NCT01951066|11775602|FG001|COMPLETED|Second Intervention (Week 16 to Week 32)||10
10617588|NCT01951066|11775601|FG000|NOT COMPLETED|Second Intervention (Week 16 to Week 32)||0
10617589|NCT01951066|11775602|FG001|NOT COMPLETED|Second Intervention (Week 16 to Week 32)||0
10617590|NCT01951092|11775607|FG000|STARTED|Overall Study||32
10617591|NCT01951092|11775607|FG000|COMPLETED|Overall Study||20
10617592|NCT01951092|11775607|FG000|NOT COMPLETED|Overall Study||12
10617593|NCT01951105|11775614|FG000|STARTED|Overall Study||11
10617594|NCT01951105|11775615|FG001|STARTED|Overall Study||31
10617595|NCT01951105|11775616|FG002|STARTED|Overall Study||30
10617596|NCT01951105|11775614|FG000|Completed 12 Weeks Treatment|Overall Study||10
10617597|NCT01951105|11775615|FG001|Completed 12 Weeks Treatment|Overall Study||24
10617598|NCT01951105|11775616|FG002|Completed 12 Weeks Treatment|Overall Study||28
10617599|NCT01951105|11775614|FG000|COMPLETED|Overall Study||10
10617600|NCT01951105|11775615|FG001|COMPLETED|Overall Study||21
10617601|NCT01951105|11775616|FG002|COMPLETED|Overall Study||28
10617602|NCT01951105|11775614|FG000|NOT COMPLETED|Overall Study||1
10617603|NCT01951105|11775615|FG001|NOT COMPLETED|Overall Study||10
10617604|NCT01951105|11775616|FG002|NOT COMPLETED|Overall Study||2
10617605|NCT01951118|11775630|FG000|STARTED|Overall Study||121
10617606|NCT01951118|11775630|FG000|COMPLETED|Overall Study||94
10617607|NCT01951118|11775630|FG000|NOT COMPLETED|Overall Study||27
10617608|NCT01951157|11775642|FG000|STARTED|Overall Study||22
10617609|NCT01951157|11775643|FG001|STARTED|Overall Study||22
10617610|NCT01951157|11775644|FG002|STARTED|Overall Study||25
10617611|NCT01951157|11775642|FG000|COMPLETED|Overall Study||0
10617612|NCT01951157|11775643|FG001|COMPLETED|Overall Study||0
10617613|NCT01951157|11775644|FG002|COMPLETED|Overall Study||0
10617614|NCT01951157|11775642|FG000|NOT COMPLETED|Overall Study||22
10617615|NCT01951157|11775643|FG001|NOT COMPLETED|Overall Study||22
10617616|NCT01951157|11775644|FG002|NOT COMPLETED|Overall Study||25
10617617|NCT01951170|11775653|FG000|STARTED|Overall Study||52
10617618|NCT01951170|11775653|FG000|COMPLETED|Overall Study||51
10617619|NCT01951170|11775653|FG000|NOT COMPLETED|Overall Study||1
10617620|NCT01951261|11775659|FG000|STARTED|Overall Study||58
10617621|NCT01951261|11775660|FG001|STARTED|Overall Study||58
10617622|NCT01951261|11775659|FG000|Discontinued|Overall Study|"2-readmission when was at home~1-monitor failure~1-new home hospitalitation 4-missing~1-death"|9
10617623|NCT01951261|11775660|FG001|Discontinued|Overall Study|"2-readmission when was at home~1-new home hospitalitation 3-missing"|6
10617624|NCT01951261|11775659|FG000|COMPLETED|Overall Study||49
10617625|NCT01951261|11775660|FG001|COMPLETED|Overall Study||52
10617626|NCT01951261|11775659|FG000|NOT COMPLETED|Overall Study||9
10617627|NCT01951261|11775660|FG001|NOT COMPLETED|Overall Study||6
10617628|NCT01951326|11775668|FG000|STARTED|Overall Study||166
10617629|NCT01951326|11775669|FG001|STARTED|Overall Study||165
10617630|NCT01951326|11775668|FG000|COMPLETED|Overall Study||87
10617631|NCT01951326|11775669|FG001|COMPLETED|Overall Study||87
10617632|NCT01951326|11775668|FG000|NOT COMPLETED|Overall Study||79
10617633|NCT01951326|11775669|FG001|NOT COMPLETED|Overall Study||78
10617634|NCT01951339|11775678|FG000|STARTED|Overall Study||15
10617635|NCT01951339|11775679|FG001|STARTED|Overall Study||15
10617636|NCT01951339|11775678|FG000|COMPLETED|Overall Study||13
10617637|NCT01951339|11775679|FG001|COMPLETED|Overall Study||14
10617638|NCT01951339|11775678|FG000|NOT COMPLETED|Overall Study||2
10617639|NCT01951339|11775679|FG001|NOT COMPLETED|Overall Study||1
10617640|NCT01951352|11775685|FG000|STARTED|Overall Study||10
10617641|NCT01951352|11775685|FG000|COMPLETED|Overall Study||10
10617642|NCT01951352|11775685|FG000|NOT COMPLETED|Overall Study||0
10617643|NCT01951391|11775691|FG000|STARTED|Overall Study||5
10617644|NCT01951391|11775692|FG001|STARTED|Overall Study||5
10617645|NCT01951391|11775691|FG000|COMPLETED|Overall Study||5
10617646|NCT01951391|11775692|FG001|COMPLETED|Overall Study||5
10617647|NCT01951391|11775691|FG000|NOT COMPLETED|Overall Study||0
10617648|NCT01951391|11775692|FG001|NOT COMPLETED|Overall Study||0
10617652|NCT01951573|11775708|FG000|STARTED|Period 1, First 9 Hours of Wear||17
10617653|NCT01951573|11775709|FG001|STARTED|Period 1, First 9 Hours of Wear||17
10617654|NCT01951573|11775708|FG000|COMPLETED|Period 1, First 9 Hours of Wear||17
10617655|NCT01951573|11775709|FG001|COMPLETED|Period 1, First 9 Hours of Wear||17
10617656|NCT01951573|11775708|FG000|NOT COMPLETED|Period 1, First 9 Hours of Wear||0
10617657|NCT01951573|11775709|FG001|NOT COMPLETED|Period 1, First 9 Hours of Wear||0
10617658|NCT01951573|11775708|FG000|STARTED|Washout Period||17
10617659|NCT01951573|11775709|FG001|STARTED|Washout Period||17
10617660|NCT01951573|11775708|FG000|COMPLETED|Washout Period||17
10617661|NCT01951573|11775709|FG001|COMPLETED|Washout Period||16
10617662|NCT01951573|11775708|FG000|NOT COMPLETED|Washout Period||0
10617663|NCT01951573|11775709|FG001|NOT COMPLETED|Washout Period||1
10617664|NCT01951573|11775708|FG000|STARTED|Period 2, Second 9 Hours of Wear||17
10617665|NCT01951573|11775709|FG001|STARTED|Period 2, Second 9 Hours of Wear||16
10617666|NCT01951573|11775708|FG000|COMPLETED|Period 2, Second 9 Hours of Wear||17
10617667|NCT01951573|11775709|FG001|COMPLETED|Period 2, Second 9 Hours of Wear||16
10617668|NCT01951573|11775708|FG000|NOT COMPLETED|Period 2, Second 9 Hours of Wear||0
10617669|NCT01951573|11775709|FG001|NOT COMPLETED|Period 2, Second 9 Hours of Wear||0
10617670|NCT01951586|11775717|FG000|STARTED|Overall Study||78
10617671|NCT01951586|11775718|FG001|STARTED|Overall Study||148
10617672|NCT01951586|11775717|FG000|Received Study Drug|Overall Study||76
10617673|NCT01951586|11775718|FG001|Received Study Drug|Overall Study||145
10617674|NCT01951586|11775717|FG000|COMPLETED|Overall Study||0
10617675|NCT01951586|11775718|FG001|COMPLETED|Overall Study||0
10617676|NCT01951586|11775717|FG000|NOT COMPLETED|Overall Study||78
10617677|NCT01951586|11775718|FG001|NOT COMPLETED|Overall Study||148
10617678|NCT01951625|11775730|FG000|STARTED|Treatment Period||92
10617679|NCT01951625|11775731|FG001|STARTED|Treatment Period||91
10617680|NCT01951625|11775732|FG002|STARTED|Treatment Period||91
10617681|NCT01951625|11775733|FG003|STARTED|Treatment Period||91
10617682|NCT01951625|11775734|FG004|STARTED|Treatment Period||91
10617683|NCT01951625|11775730|FG000|COMPLETED|Treatment Period||73
10617684|NCT01951625|11775731|FG001|COMPLETED|Treatment Period||70
10617685|NCT01951625|11775732|FG002|COMPLETED|Treatment Period||76
10617686|NCT01951625|11775733|FG003|COMPLETED|Treatment Period||69
10617687|NCT01951625|11775734|FG004|COMPLETED|Treatment Period||74
10617688|NCT01951625|11775730|FG000|NOT COMPLETED|Treatment Period||19
10617689|NCT01951625|11775731|FG001|NOT COMPLETED|Treatment Period||21
10617690|NCT01951625|11775732|FG002|NOT COMPLETED|Treatment Period||15
10617691|NCT01951625|11775733|FG003|NOT COMPLETED|Treatment Period||22
10617692|NCT01951625|11775734|FG004|NOT COMPLETED|Treatment Period||17
10617693|NCT01951625|11775730|FG000|STARTED|Follow Up Period||87
10617694|NCT01951625|11775731|FG001|STARTED|Follow Up Period||88
10617695|NCT01951625|11775732|FG002|STARTED|Follow Up Period||88
10617696|NCT01951625|11775733|FG003|STARTED|Follow Up Period||87
10617697|NCT01951625|11775734|FG004|STARTED|Follow Up Period||88
10617698|NCT01951625|11775730|FG000|COMPLETED|Follow Up Period||79
10617699|NCT01951625|11775731|FG001|COMPLETED|Follow Up Period||79
10617700|NCT01951625|11775732|FG002|COMPLETED|Follow Up Period||84
10617701|NCT01951625|11775733|FG003|COMPLETED|Follow Up Period||76
10617702|NCT01951625|11775734|FG004|COMPLETED|Follow Up Period||78
10617703|NCT01951625|11775730|FG000|NOT COMPLETED|Follow Up Period||8
10704932|NCT02594163|11869320|FG001|NOT COMPLETED|Treatment Period||12
10704933|NCT02594163|11869319|FG000|STARTED|Follow-up Period|All participants were to be followed after treatment|12
10704934|NCT02594163|11869320|FG001|STARTED|Follow-up Period|All participants were to be followed after treatment|13
10617704|NCT01951625|11775731|FG001|NOT COMPLETED|Follow Up Period||9
10617705|NCT01951625|11775732|FG002|NOT COMPLETED|Follow Up Period||4
10617706|NCT01951625|11775733|FG003|NOT COMPLETED|Follow Up Period||11
10617707|NCT01951625|11775734|FG004|NOT COMPLETED|Follow Up Period||10
10617708|NCT01951638|11775752|FG000|STARTED|Treatment Period||93
10617709|NCT01951638|11775753|FG001|STARTED|Treatment Period||96
10617710|NCT01951638|11775754|FG002|STARTED|Treatment Period||96
10617711|NCT01951638|11775755|FG003|STARTED|Treatment Period||96
10617712|NCT01951638|11775756|FG004|STARTED|Treatment Period||96
10617713|NCT01951638|11775752|FG000|COMPLETED|Treatment Period||80
10617714|NCT01951638|11775753|FG001|COMPLETED|Treatment Period||82
10617715|NCT01951638|11775754|FG002|COMPLETED|Treatment Period||83
10617716|NCT01951638|11775755|FG003|COMPLETED|Treatment Period||80
10617717|NCT01951638|11775756|FG004|COMPLETED|Treatment Period||86
10617718|NCT01951638|11775752|FG000|NOT COMPLETED|Treatment Period||13
10617719|NCT01951638|11775753|FG001|NOT COMPLETED|Treatment Period||14
10617720|NCT01951638|11775754|FG002|NOT COMPLETED|Treatment Period||13
10617721|NCT01951638|11775755|FG003|NOT COMPLETED|Treatment Period||16
10808820|NCT03840135|11970815|FG000|COMPLETED|Overall Study||79
10808821|NCT03840135|11970816|FG001|COMPLETED|Overall Study||85
10617722|NCT01951638|11775756|FG004|NOT COMPLETED|Treatment Period||10
10617723|NCT01951638|11775752|FG000|STARTED|Follow-up Period||89
10617724|NCT01951638|11775753|FG001|STARTED|Follow-up Period||95
10617725|NCT01951638|11775754|FG002|STARTED|Follow-up Period||95
10617726|NCT01951638|11775755|FG003|STARTED|Follow-up Period||88
10617727|NCT01951638|11775756|FG004|STARTED|Follow-up Period||94
10617728|NCT01951638|11775752|FG000|COMPLETED|Follow-up Period||87
10617729|NCT01951638|11775753|FG001|COMPLETED|Follow-up Period||86
10617730|NCT01951638|11775754|FG002|COMPLETED|Follow-up Period||90
10617731|NCT01951638|11775755|FG003|COMPLETED|Follow-up Period||80
10617732|NCT01951638|11775756|FG004|COMPLETED|Follow-up Period||89
10617733|NCT01951638|11775752|FG000|NOT COMPLETED|Follow-up Period||2
10617734|NCT01951638|11775753|FG001|NOT COMPLETED|Follow-up Period||9
10617735|NCT01951638|11775754|FG002|NOT COMPLETED|Follow-up Period||5
10617736|NCT01951638|11775755|FG003|NOT COMPLETED|Follow-up Period||8
10617737|NCT01951638|11775756|FG004|NOT COMPLETED|Follow-up Period||5
10617738|NCT01951651|11775770|FG000|STARTED|Overall Study||12
10617739|NCT01951651|11775771|FG001|STARTED|Overall Study||12
10617740|NCT01951651|11775770|FG000|COMPLETED|Overall Study||8
10617741|NCT01951651|11775771|FG001|COMPLETED|Overall Study||10
10617742|NCT01951651|11775770|FG000|NOT COMPLETED|Overall Study||4
10617743|NCT01951651|11775771|FG001|NOT COMPLETED|Overall Study||2
10617744|NCT01951703|11775779|FG000|STARTED|First Intervention||64
10617745|NCT01951703|11775780|FG001|STARTED|First Intervention||63
10617746|NCT01951703|11775779|FG000|COMPLETED|First Intervention||61
10704935|NCT02594163|11869319|FG000|COMPLETED|Follow-up Period||1
10704936|NCT02594163|11869320|FG001|COMPLETED|Follow-up Period||1
10704937|NCT02594163|11869319|FG000|NOT COMPLETED|Follow-up Period||11
10704938|NCT02594163|11869320|FG001|NOT COMPLETED|Follow-up Period||12
10808822|NCT03840135|11970815|FG000|NOT COMPLETED|Overall Study||7
10617747|NCT01951703|11775780|FG001|COMPLETED|First Intervention||62
10617748|NCT01951703|11775779|FG000|NOT COMPLETED|First Intervention||3
10617749|NCT01951703|11775780|FG001|NOT COMPLETED|First Intervention||1
10617750|NCT01951703|11775779|FG000|STARTED|Second Intervention||61
10617751|NCT01951703|11775780|FG001|STARTED|Second Intervention||62
10617752|NCT01951703|11775779|FG000|COMPLETED|Second Intervention||61
10617753|NCT01951703|11775780|FG001|COMPLETED|Second Intervention||60
10617754|NCT01951703|11775779|FG000|NOT COMPLETED|Second Intervention||0
10617755|NCT01951703|11775780|FG001|NOT COMPLETED|Second Intervention||2
10617756|NCT01951768|11775789|FG000|STARTED|Overall Study||43
10617757|NCT01951768|11775790|FG001|STARTED|Overall Study||45
10617758|NCT01951768|11775789|FG000|COMPLETED|Overall Study|43 patients|43
10617759|NCT01951768|11775790|FG001|COMPLETED|Overall Study|45 patients|45
10617760|NCT01951768|11775789|FG000|NOT COMPLETED|Overall Study||0
10617761|NCT01951768|11775790|FG001|NOT COMPLETED|Overall Study||0
10617762|NCT01951820|11775798|FG000|STARTED|Overall Study||34
10704939|NCT02594644|11869328|FG000|STARTED|Overall Study||16
10617763|NCT01951820|11775799|FG001|STARTED|Overall Study||30
10617764|NCT01951820|11775798|FG000|COMPLETED|Overall Study||34
10617765|NCT01951820|11775799|FG001|COMPLETED|Overall Study||30
10617766|NCT01951820|11775798|FG000|NOT COMPLETED|Overall Study||0
10617767|NCT01951820|11775799|FG001|NOT COMPLETED|Overall Study||0
10617768|NCT01951950|11775807|FG000|STARTED|Overall Study||26
10617769|NCT01951950|11775808|FG001|STARTED|Overall Study||26
10617770|NCT01951950|11775807|FG000|COMPLETED|Overall Study||20
10617771|NCT01951950|11775808|FG001|COMPLETED|Overall Study||20
10617772|NCT01951950|11775807|FG000|NOT COMPLETED|Overall Study||6
10617773|NCT01951950|11775808|FG001|NOT COMPLETED|Overall Study||6
10617774|NCT01951963|11775816|FG000|STARTED|Overall Study||31
10617775|NCT01951963|11775817|FG001|STARTED|Overall Study||32
10617776|NCT01951963|11775816|FG000|COMPLETED|Overall Study||31
10617777|NCT01951963|11775817|FG001|COMPLETED|Overall Study||32
10617778|NCT01951963|11775816|FG000|NOT COMPLETED|Overall Study||0
10617779|NCT01951963|11775817|FG001|NOT COMPLETED|Overall Study||0
10617780|NCT01952015|11775827|FG000|STARTED|Induction||12
10617781|NCT01952015|11775827|FG000|COMPLETED|Induction||11
10617782|NCT01952015|11775827|FG000|NOT COMPLETED|Induction||1
10704940|NCT02594644|11869329|FG001|STARTED|Overall Study||16
10704941|NCT02594644|11869328|FG000|COMPLETED|Overall Study||16
10704942|NCT02594644|11869329|FG001|COMPLETED|Overall Study||15
10617783|NCT01952015|11775827|FG000|STARTED|Maintenance||11
10617784|NCT01952015|11775827|FG000|COMPLETED|Maintenance||9
10617785|NCT01952015|11775827|FG000|NOT COMPLETED|Maintenance||2
10617786|NCT01952015|11775827|FG000|STARTED|Treatment Period 3||9
10617787|NCT01952015|11775827|FG000|COMPLETED|Treatment Period 3||0
10617788|NCT01952015|11775827|FG000|NOT COMPLETED|Treatment Period 3||9
10617789|NCT01952041|11775845|FG000|STARTED|Overall Study||62
10617790|NCT01952041|11775846|FG001|STARTED|Overall Study||64
10617791|NCT01952041|11775845|FG000|COMPLETED|Overall Study||45
10617792|NCT01952041|11775846|FG001|COMPLETED|Overall Study||43
10617793|NCT01952041|11775845|FG000|NOT COMPLETED|Overall Study||17
10617794|NCT01952041|11775846|FG001|NOT COMPLETED|Overall Study||21
10617795|NCT01952054|11775852|FG000|STARTED|Overall Study||6
10617796|NCT01952054|11775852|FG000|COMPLETED|Overall Study||5
10617797|NCT01952054|11775852|FG000|NOT COMPLETED|Overall Study||1
10617798|NCT01952080|11775860|FG000|STARTED|Overall Study||5
10617799|NCT01952080|11775861|FG001|STARTED|Overall Study||8
10617800|NCT01952080|11775862|FG002|STARTED|Overall Study||14
10617801|NCT01952080|11775863|FG003|STARTED|Overall Study||15
10617802|NCT01952080|11775860|FG000|Treated|Overall Study||5
10617803|NCT01952080|11775861|FG001|Treated|Overall Study||8
10617804|NCT01952080|11775862|FG002|Treated|Overall Study||14
10617805|NCT01952080|11775863|FG003|Treated|Overall Study||15
10617806|NCT01952080|11775860|FG000|COMPLETED|Overall Study||5
10617807|NCT01952080|11775861|FG001|COMPLETED|Overall Study||7
10617808|NCT01952080|11775862|FG002|COMPLETED|Overall Study||14
10617809|NCT01952080|11775863|FG003|COMPLETED|Overall Study||14
10617810|NCT01952080|11775860|FG000|NOT COMPLETED|Overall Study||0
10617811|NCT01952080|11775861|FG001|NOT COMPLETED|Overall Study||1
10617812|NCT01952080|11775862|FG002|NOT COMPLETED|Overall Study||0
10617813|NCT01952080|11775863|FG003|NOT COMPLETED|Overall Study||1
10617814|NCT01952145|11775875|FG000|STARTED|Overall Study||278
10617815|NCT01952145|11775876|FG001|STARTED|Overall Study||279
10617816|NCT01952145|11775875|FG000|COMPLETED|Overall Study||250
10617817|NCT01952145|11775876|FG001|COMPLETED|Overall Study||265
10704943|NCT02594644|11869328|FG000|NOT COMPLETED|Overall Study||0
10617818|NCT01952145|11775875|FG000|NOT COMPLETED|Overall Study||28
10617819|NCT01952145|11775876|FG001|NOT COMPLETED|Overall Study||14
10617820|NCT01952301|11775882|FG000|STARTED|Overall Study|We designed and implemented a single-blind, randomized, controlled, split-mouth study of 30 subjects|30
10617821|NCT01952301|11775882|FG000|COMPLETED|Overall Study||30
10617822|NCT01952301|11775882|FG000|NOT COMPLETED|Overall Study||0
10617823|NCT01952366|11775888|FG000|STARTED|Overall Study||169
10617824|NCT01952366|11775888|FG000|COMPLETED|Overall Study||138
10617825|NCT01952366|11775888|FG000|NOT COMPLETED|Overall Study||31
10617826|NCT01952418|11775897|FG000|STARTED|Overall Study||910
10617827|NCT01952418|11775898|FG001|STARTED|Overall Study||895
10617828|NCT01952418|11775897|FG000|COMPLETED|Overall Study||910
10617829|NCT01952418|11775898|FG001|COMPLETED|Overall Study||895
10617830|NCT01952418|11775897|FG000|NOT COMPLETED|Overall Study||0
10617831|NCT01952418|11775898|FG001|NOT COMPLETED|Overall Study||0
10617832|NCT01952444|11775906|FG000|STARTED|Overall Study||20
10617833|NCT01952444|11775907|FG001|STARTED|Overall Study||20
10617834|NCT01952444|11775906|FG000|COMPLETED|Overall Study||20
10617835|NCT01952444|11775907|FG001|COMPLETED|Overall Study||19
10617836|NCT01952444|11775906|FG000|NOT COMPLETED|Overall Study||0
10704944|NCT02594644|11869329|FG001|NOT COMPLETED|Overall Study||1
10617837|NCT01952444|11775907|FG001|NOT COMPLETED|Overall Study||1
10617838|NCT01952470|11775920|FG000|STARTED|Overall Study||16
10617839|NCT01952470|11775921|FG001|STARTED|Overall Study||16
10617840|NCT01952470|11775920|FG000|ITT Analysis|Overall Study||16
10617841|NCT01952470|11775921|FG001|ITT Analysis|Overall Study||16
10617842|NCT01952470|11775920|FG000|Discontinued Intervention|Overall Study||2
10617843|NCT01952470|11775921|FG001|Discontinued Intervention|Overall Study||1
10617844|NCT01952470|11775920|FG000|Death|Overall Study||1
10617845|NCT01952470|11775921|FG001|Death|Overall Study||1
10617846|NCT01952470|11775920|FG000|Missing Baseline LCI 2% Data.|Overall Study||0
10617847|NCT01952470|11775921|FG001|Missing Baseline LCI 2% Data.|Overall Study||2
10617848|NCT01952470|11775920|FG000|Missing 1+3 Month LCI 2% Data.|Overall Study||2
10617849|NCT01952470|11775921|FG001|Missing 1+3 Month LCI 2% Data.|Overall Study||1
10617850|NCT01952470|11775920|FG000|Missing 3 Month LCI 2% Data.|Overall Study||1
10617851|NCT01952470|11775921|FG001|Missing 3 Month LCI 2% Data.|Overall Study||0
10617852|NCT01952470|11775920|FG000|COMPLETED|Overall Study||13
10617853|NCT01952470|11775921|FG001|COMPLETED|Overall Study||13
10617854|NCT01952470|11775920|FG000|NOT COMPLETED|Overall Study||3
10617855|NCT01952470|11775921|FG001|NOT COMPLETED|Overall Study||3
10617856|NCT01952600|11775930|FG000|STARTED|Overall Study||80
10617857|NCT01952600|11775931|FG001|STARTED|Overall Study||90
10617858|NCT01952600|11775932|FG002|STARTED|Overall Study||45
10617859|NCT01952600|11775930|FG000|COMPLETED|Overall Study||65
10617860|NCT01952600|11775931|FG001|COMPLETED|Overall Study||77
10617861|NCT01952600|11775932|FG002|COMPLETED|Overall Study||38
10617862|NCT01952600|11775930|FG000|NOT COMPLETED|Overall Study||15
10617863|NCT01952600|11775931|FG001|NOT COMPLETED|Overall Study||13
10617864|NCT01952600|11775932|FG002|NOT COMPLETED|Overall Study||7
10617865|NCT01952665|11775942|FG000|STARTED|Overall Study||37
10617866|NCT01952665|11775943|FG001|STARTED|Overall Study||26
10617867|NCT01952665|11775942|FG000|COMPLETED|Overall Study||31
10617868|NCT01952665|11775943|FG001|COMPLETED|Overall Study||20
10617869|NCT01952665|11775942|FG000|NOT COMPLETED|Overall Study||6
10617870|NCT01952665|11775943|FG001|NOT COMPLETED|Overall Study||6
10617871|NCT01952678|11775954|FG000|STARTED|Overall Study||102
10617872|NCT01952678|11775955|FG001|STARTED|Overall Study||102
10617873|NCT01952678|11775954|FG000|COMPLETED|Overall Study||102
10617874|NCT01952678|11775955|FG001|COMPLETED|Overall Study||102
10617875|NCT01952678|11775954|FG000|NOT COMPLETED|Overall Study||0
10617876|NCT01952678|11775955|FG001|NOT COMPLETED|Overall Study||0
10617877|NCT01952691|11775971|FG000|STARTED|Overall Study||22
10617878|NCT01952691|11775971|FG000|COMPLETED|Overall Study||20
10617879|NCT01952691|11775971|FG000|NOT COMPLETED|Overall Study||2
10617880|NCT01952834|11775975|FG000|STARTED|Overall Study||21
10617881|NCT01952834|11775975|FG000|COMPLETED|Overall Study||20
10617882|NCT01952834|11775975|FG000|NOT COMPLETED|Overall Study||1
10617883|NCT01953003|11775982|FG000|STARTED|Overall Study||56
10617884|NCT01953003|11775983|FG001|STARTED|Overall Study||56
10617885|NCT01953003|11775982|FG000|COMPLETED|Overall Study||0
10617886|NCT01953003|11775983|FG001|COMPLETED|Overall Study||1
10617887|NCT01953003|11775982|FG000|NOT COMPLETED|Overall Study||56
10617888|NCT01953003|11775983|FG001|NOT COMPLETED|Overall Study||55
10617889|NCT01953081|11775991|FG000|STARTED|Overall Study||7
10617890|NCT01953081|11775992|FG001|STARTED|Overall Study||6
10617891|NCT01953081|11775991|FG000|COMPLETED|Overall Study||5
10617892|NCT01953081|11775992|FG001|COMPLETED|Overall Study||3
10617893|NCT01953081|11775991|FG000|NOT COMPLETED|Overall Study||2
10617894|NCT01953081|11775992|FG001|NOT COMPLETED|Overall Study||3
10617895|NCT01953211|11775998|FG000|STARTED|Overall Study|completed prior to clinical trials submission|64
10617896|NCT01953211|11775998|FG000|COMPLETED|Overall Study|completed prior to clinical trials submission|64
10617897|NCT01953211|11775998|FG000|NOT COMPLETED|Overall Study||0
10617898|NCT01953224|11776006|FG000|STARTED|Overall Study||20
10617899|NCT01953224|11776007|FG001|STARTED|Overall Study||20
10617900|NCT01953224|11776006|FG000|COMPLETED|Overall Study||18
10617901|NCT01953224|11776007|FG001|COMPLETED|Overall Study||17
10617902|NCT01953224|11776006|FG000|NOT COMPLETED|Overall Study||2
10617903|NCT01953224|11776007|FG001|NOT COMPLETED|Overall Study||3
10617904|NCT01953237|11776015|FG000|STARTED|Overall Study||10
10617905|NCT01953237|11776016|FG001|STARTED|Overall Study||21
10617906|NCT01953237|11776015|FG000|COMPLETED|Overall Study||10
10617907|NCT01953237|11776016|FG001|COMPLETED|Overall Study||21
10617908|NCT01953237|11776015|FG000|NOT COMPLETED|Overall Study||0
10617909|NCT01953237|11776016|FG001|NOT COMPLETED|Overall Study||0
10617910|NCT01953328|11776030|FG000|STARTED|Overall Study||49
10617911|NCT01953328|11776031|FG001|STARTED|Overall Study||50
10617912|NCT01953328|11776032|FG002|STARTED|Overall Study||50
10617913|NCT01953328|11776033|FG003|STARTED|Overall Study||50
10617914|NCT01953328|11776034|FG004|STARTED|Overall Study||52
10617915|NCT01953328|11776035|FG005|STARTED|Overall Study||51
10617916|NCT01953328|11776036|FG006|STARTED|Overall Study||51
10617917|NCT01953328|11776037|FG007|STARTED|Overall Study||51
10617918|NCT01953328|11776030|FG000|Received Treatment|Overall Study||49
10617919|NCT01953328|11776031|FG001|Received Treatment|Overall Study||50
10617920|NCT01953328|11776032|FG002|Received Treatment|Overall Study||50
10617921|NCT01953328|11776033|FG003|Received Treatment|Overall Study||50
10617922|NCT01953328|11776034|FG004|Received Treatment|Overall Study||52
10617923|NCT01953328|11776035|FG005|Received Treatment|Overall Study||51
10617924|NCT01953328|11776036|FG006|Received Treatment|Overall Study||51
10617925|NCT01953328|11776037|FG007|Received Treatment|Overall Study||51
10617926|NCT01953328|11776030|FG000|COMPLETED|Overall Study||49
10617927|NCT01953328|11776031|FG001|COMPLETED|Overall Study||50
10617928|NCT01953328|11776032|FG002|COMPLETED|Overall Study||50
10617929|NCT01953328|11776033|FG003|COMPLETED|Overall Study||50
10617930|NCT01953328|11776034|FG004|COMPLETED|Overall Study||50
10617931|NCT01953328|11776035|FG005|COMPLETED|Overall Study||51
10617932|NCT01953328|11776036|FG006|COMPLETED|Overall Study||51
10617933|NCT01953328|11776037|FG007|COMPLETED|Overall Study||51
10617934|NCT01953328|11776030|FG000|NOT COMPLETED|Overall Study||0
10617935|NCT01953328|11776031|FG001|NOT COMPLETED|Overall Study||0
10617936|NCT01953328|11776032|FG002|NOT COMPLETED|Overall Study||0
10617937|NCT01953328|11776033|FG003|NOT COMPLETED|Overall Study||0
10617938|NCT01953328|11776034|FG004|NOT COMPLETED|Overall Study||2
10617939|NCT01953328|11776035|FG005|NOT COMPLETED|Overall Study||0
10617940|NCT01953328|11776036|FG006|NOT COMPLETED|Overall Study||0
10617941|NCT01953328|11776037|FG007|NOT COMPLETED|Overall Study||0
10617942|NCT01953354|11776057|FG000|STARTED|Overall Study||9
10617943|NCT01953354|11776058|FG001|STARTED|Overall Study||7
10617944|NCT01953354|11776057|FG000|COMPLETED|Overall Study||8
10617945|NCT01953354|11776058|FG001|COMPLETED|Overall Study||5
10617946|NCT01953354|11776057|FG000|NOT COMPLETED|Overall Study||1
10617947|NCT01953354|11776058|FG001|NOT COMPLETED|Overall Study||2
10617948|NCT01953432|11776066|FG000|STARTED|Overall Study||22
10617949|NCT01953432|11776067|FG001|STARTED|Overall Study||21
10617950|NCT01953432|11776066|FG000|COMPLETED|Overall Study||8
10617951|NCT01953432|11776067|FG001|COMPLETED|Overall Study||6
10617952|NCT01953432|11776066|FG000|NOT COMPLETED|Overall Study||14
10617953|NCT01953432|11776067|FG001|NOT COMPLETED|Overall Study||15
10617954|NCT01953575|11776076|FG000|STARTED|Overall Study||10
10617955|NCT01953575|11776077|FG001|STARTED|Overall Study||10
10617956|NCT01953575|11776078|FG002|STARTED|Overall Study||10
10617957|NCT01953575|11776076|FG000|COMPLETED|Overall Study||10
10617958|NCT01953575|11776077|FG001|COMPLETED|Overall Study||10
10617959|NCT01953575|11776078|FG002|COMPLETED|Overall Study||10
10617960|NCT01953575|11776076|FG000|NOT COMPLETED|Overall Study||0
10617961|NCT01953575|11776077|FG001|NOT COMPLETED|Overall Study||0
10617962|NCT01953575|11776078|FG002|NOT COMPLETED|Overall Study||0
10617963|NCT01953601|11776089|FG000|STARTED|Part 1 (Base Study)||485
10617964|NCT01953601|11776090|FG001|STARTED|Part 1 (Base Study)||484
10617965|NCT01953601|11776091|FG002|STARTED|Part 1 (Base Study)||485
10617966|NCT01953601|11776089|FG000|Treated|Part 1 (Base Study)||483
10617967|NCT01953601|11776090|FG001|Treated|Part 1 (Base Study)||484
10617968|NCT01953601|11776091|FG002|Treated|Part 1 (Base Study)||484
10617969|NCT01953601|11776089|FG000|COMPLETED|Part 1 (Base Study)||234
10617970|NCT01953601|11776090|FG001|COMPLETED|Part 1 (Base Study)||231
10617971|NCT01953601|11776091|FG002|COMPLETED|Part 1 (Base Study)||239
10617972|NCT01953601|11776089|FG000|NOT COMPLETED|Part 1 (Base Study)||251
10617973|NCT01953601|11776090|FG001|NOT COMPLETED|Part 1 (Base Study)||253
10617974|NCT01953601|11776091|FG002|NOT COMPLETED|Part 1 (Base Study)||246
10617975|NCT01953601|11776089|FG000|STARTED|Part 2 (Extension Study)|Number started refers only to participants completing Part 1, volunteering to continue to Part 2.|198
10617976|NCT01953601|11776090|FG001|STARTED|Part 2 (Extension Study)|Number started refers only to participants completing Part 1, volunteering to continue to Part 2.|191
10617977|NCT01953601|11776091|FG002|STARTED|Part 2 (Extension Study)|Number started refers only to participants completing Part 1, volunteering to continue to Part 2.|204
10617978|NCT01953601|11776089|FG000|Treated|Part 2 (Extension Study)||197
10617979|NCT01953601|11776090|FG001|Treated|Part 2 (Extension Study)||191
10617980|NCT01953601|11776091|FG002|Treated|Part 2 (Extension Study)||204
10617981|NCT01953601|11776089|FG000|COMPLETED|Part 2 (Extension Study)||0
10617982|NCT01953601|11776090|FG001|COMPLETED|Part 2 (Extension Study)||0
10617983|NCT01953601|11776091|FG002|COMPLETED|Part 2 (Extension Study)||0
10617984|NCT01953601|11776089|FG000|NOT COMPLETED|Part 2 (Extension Study)||198
10617985|NCT01953601|11776090|FG001|NOT COMPLETED|Part 2 (Extension Study)||191
10617986|NCT01953601|11776091|FG002|NOT COMPLETED|Part 2 (Extension Study)||204
10617987|NCT01953692|11776111|FG000|STARTED|Overall Study||28
10617988|NCT01953692|11776112|FG001|STARTED|Overall Study||30
10617989|NCT01953692|11776113|FG002|STARTED|Overall Study||31
10617990|NCT01953692|11776114|FG003|STARTED|Overall Study||21
10617991|NCT01953692|11776115|FG004|STARTED|Overall Study||4
10617992|NCT01953692|11776116|FG005|STARTED|Overall Study||22
10617993|NCT01953692|11776117|FG006|STARTED|Overall Study||42
10617994|NCT01953692|11776118|FG007|STARTED|Overall Study||13
10617995|NCT01953692|11776119|FG008|STARTED|Overall Study||6
10617996|NCT01953692|11776111|FG000|COMPLETED|Overall Study||1
10617997|NCT01953692|11776112|FG001|COMPLETED|Overall Study||5
10617998|NCT01953692|11776113|FG002|COMPLETED|Overall Study||11
10617999|NCT01953692|11776114|FG003|COMPLETED|Overall Study||7
10618000|NCT01953692|11776115|FG004|COMPLETED|Overall Study||1
10618001|NCT01953692|11776116|FG005|COMPLETED|Overall Study||4
10618002|NCT01953692|11776117|FG006|COMPLETED|Overall Study||10
10618003|NCT01953692|11776118|FG007|COMPLETED|Overall Study||3
10618004|NCT01953692|11776119|FG008|COMPLETED|Overall Study||1
10618005|NCT01953692|11776111|FG000|NOT COMPLETED|Overall Study||27
10618006|NCT01953692|11776112|FG001|NOT COMPLETED|Overall Study||25
10618007|NCT01953692|11776113|FG002|NOT COMPLETED|Overall Study||20
10618008|NCT01953692|11776114|FG003|NOT COMPLETED|Overall Study||14
10618009|NCT01953692|11776115|FG004|NOT COMPLETED|Overall Study||3
10618010|NCT01953692|11776116|FG005|NOT COMPLETED|Overall Study||18
10618011|NCT01953692|11776117|FG006|NOT COMPLETED|Overall Study||32
10618012|NCT01953692|11776118|FG007|NOT COMPLETED|Overall Study||10
10618013|NCT01953692|11776119|FG008|NOT COMPLETED|Overall Study||5
10618014|NCT01953783|11776149|FG000|STARTED|Overall Study||7
10618015|NCT01953783|11776149|FG000|COMPLETED|Overall Study||5
10618016|NCT01953783|11776149|FG000|NOT COMPLETED|Overall Study||2
10618017|NCT01953874|11776155|FG000|STARTED|Overall Study||65
10618018|NCT01953874|11776156|FG001|STARTED|Overall Study||61
10618019|NCT01953874|11776155|FG000|COMPLETED|Overall Study||65
10618020|NCT01953874|11776156|FG001|COMPLETED|Overall Study||61
10618021|NCT01953874|11776155|FG000|NOT COMPLETED|Overall Study||0
10618022|NCT01953874|11776156|FG001|NOT COMPLETED|Overall Study||0
10618023|NCT01953913|11776163|FG000|STARTED|Overall Study||542
10618024|NCT01953913|11776163|FG000|Treated|Overall Study||541
10618025|NCT01953913|11776163|FG000|COMPLETED|Overall Study||0
10618026|NCT01953913|11776163|FG000|NOT COMPLETED|Overall Study||542
10618027|NCT01954017|11776170|FG000|STARTED|Overall Study||36
10618028|NCT01954017|11776171|FG001|STARTED|Overall Study||33
10618029|NCT01954017|11776172|FG002|STARTED|Overall Study||34
10618030|NCT01954017|11776170|FG000|COMPLETED|Overall Study||31
10618031|NCT01954017|11776171|FG001|COMPLETED|Overall Study||25
10618032|NCT01954017|11776172|FG002|COMPLETED|Overall Study||21
10618033|NCT01954017|11776170|FG000|NOT COMPLETED|Overall Study||5
10618034|NCT01954017|11776171|FG001|NOT COMPLETED|Overall Study||8
10618035|NCT01954017|11776172|FG002|NOT COMPLETED|Overall Study||13
10618036|NCT01954056|11776208|FG000|STARTED|Birth to 60 Days of Life||6
10618037|NCT01954056|11776209|FG001|STARTED|Birth to 60 Days of Life||6
10618038|NCT01954056|11776208|FG000|COMPLETED|Birth to 60 Days of Life||6
10618039|NCT01954056|11776209|FG001|COMPLETED|Birth to 60 Days of Life||6
10618040|NCT01954056|11776208|FG000|NOT COMPLETED|Birth to 60 Days of Life||0
10618041|NCT01954056|11776209|FG001|NOT COMPLETED|Birth to 60 Days of Life||0
10618042|NCT01954056|11776208|FG000|STARTED|Birth to 22-26 Mos. Corrected GA||6
10618043|NCT01954056|11776209|FG001|STARTED|Birth to 22-26 Mos. Corrected GA||6
10618044|NCT01954056|11776208|FG000|COMPLETED|Birth to 22-26 Mos. Corrected GA||5
10618045|NCT01954056|11776209|FG001|COMPLETED|Birth to 22-26 Mos. Corrected GA||6
10618046|NCT01954056|11776208|FG000|NOT COMPLETED|Birth to 22-26 Mos. Corrected GA||1
10618047|NCT01954056|11776209|FG001|NOT COMPLETED|Birth to 22-26 Mos. Corrected GA||0
10618048|NCT01954082|11776217|FG000|STARTED|Overall Study||317
10618049|NCT01954082|11776218|FG001|STARTED|Overall Study||321
10618050|NCT01954082|11776217|FG000|Treated|Overall Study|The 4 participants who were not treated either died (3) or withdrew before treatment start (1).|313
10618051|NCT01954082|11776218|FG001|Treated|Overall Study|The 2 participants who were not treated died before treatment start.|319
10618052|NCT01954082|11776217|FG000|COMPLETED|Overall Study|There were 22 infants that received more doses than intended per protocol.|249
10618053|NCT01954082|11776218|FG001|COMPLETED|Overall Study|There were 27 infants that received more doses than intended per protocol.|264
10618054|NCT01954082|11776217|FG000|NOT COMPLETED|Overall Study||68
10618055|NCT01954082|11776218|FG001|NOT COMPLETED|Overall Study||57
10618056|NCT01954121|11776226|FG000|STARTED|Overall Study||220
10618057|NCT01954121|11776227|FG001|STARTED|Overall Study||216
10618058|NCT01954121|11776226|FG000|COMPLETED|Overall Study||93
10618059|NCT01954121|11776227|FG001|COMPLETED|Overall Study||125
10618060|NCT01954121|11776226|FG000|NOT COMPLETED|Overall Study||127
10618061|NCT01954121|11776227|FG001|NOT COMPLETED|Overall Study||91
10618062|NCT01954251|11776235|FG000|STARTED|Overall Study||413
10618063|NCT01954251|11776236|FG001|STARTED|Overall Study||415
10618064|NCT01954251|11776235|FG000|COMPLETED|Overall Study||400
10618065|NCT01954251|11776236|FG001|COMPLETED|Overall Study||396
10618066|NCT01954251|11776235|FG000|NOT COMPLETED|Overall Study||13
10618067|NCT01954251|11776236|FG001|NOT COMPLETED|Overall Study||19
10618068|NCT01954264|11776243|FG000|STARTED|Overall Study||2421
10618069|NCT01954264|11776243|FG000|COMPLETED|Overall Study||2421
10618070|NCT01954264|11776243|FG000|NOT COMPLETED|Overall Study||0
10618071|NCT01954342|11776264|FG000|STARTED|Overall Study||36
10618072|NCT01954342|11776265|FG001|STARTED|Overall Study||8
10618073|NCT01954342|11776266|FG002|STARTED|Overall Study||10
10618074|NCT01954342|11776267|FG003|STARTED|Overall Study||18
10618075|NCT01954342|11776264|FG000|COMPLETED|Overall Study||36
10618076|NCT01954342|11776265|FG001|COMPLETED|Overall Study||8
10618077|NCT01954342|11776266|FG002|COMPLETED|Overall Study||10
10618078|NCT01954342|11776267|FG003|COMPLETED|Overall Study||0
10618079|NCT01954342|11776264|FG000|NOT COMPLETED|Overall Study||0
10618080|NCT01954342|11776265|FG001|NOT COMPLETED|Overall Study||0
10618081|NCT01954342|11776266|FG002|NOT COMPLETED|Overall Study||0
10618082|NCT01954342|11776267|FG003|NOT COMPLETED|Overall Study||18
10618083|NCT01954394|11776279|FG000|STARTED|Overall Study|Enrolled|331
10618084|NCT01954394|11776280|FG001|STARTED|Overall Study|Enrolled|655
10618085|NCT01954394|11776279|FG000|Treated|Overall Study|Safety population|330
10618086|NCT01954394|11776280|FG001|Treated|Overall Study|Safety population|655
10618087|NCT01954394|11776279|FG000|COMPLETED|Overall Study||301
10618088|NCT01954394|11776280|FG001|COMPLETED|Overall Study||598
10618089|NCT01954394|11776279|FG000|NOT COMPLETED|Overall Study||30
10618090|NCT01954394|11776280|FG001|NOT COMPLETED|Overall Study||57
10618091|NCT01954628|11776290|FG000|STARTED|Overall Study||200
10618092|NCT01954628|11776291|FG001|STARTED|Overall Study||200
10618093|NCT01954628|11776290|FG000|Full Analysis Set (FAS)|Overall Study||200
10618094|NCT01954628|11776291|FG001|Full Analysis Set (FAS)|Overall Study||198
10618095|NCT01954628|11776290|FG000|Safety Set|Overall Study||200
10618096|NCT01954628|11776291|FG001|Safety Set|Overall Study||200
10618097|NCT01954628|11776290|FG000|Pharmacokinetic Population|Overall Study||181
10618098|NCT01954628|11776291|FG001|Pharmacokinetic Population|Overall Study||0
10618099|NCT01954628|11776290|FG000|US 6 Month Ophthalmology Safety Visit|Overall Study||37
10618100|NCT01954628|11776291|FG001|US 6 Month Ophthalmology Safety Visit|Overall Study||32
10618101|NCT01954628|11776290|FG000|COMPLETED|Overall Study||169
10618102|NCT01954628|11776291|FG001|COMPLETED|Overall Study||173
10618103|NCT01954628|11776290|FG000|NOT COMPLETED|Overall Study||31
10618104|NCT01954628|11776291|FG001|NOT COMPLETED|Overall Study||27
10618105|NCT01954745|11776301|FG000|STARTED|Overall Study||19
10618106|NCT01954745|11776301|FG000|COMPLETED|Overall Study||0
10618107|NCT01954745|11776301|FG000|NOT COMPLETED|Overall Study||19
10618108|NCT01954771|11776308|FG000|STARTED|Overall Study||29
10618109|NCT01954771|11776309|FG001|STARTED|Overall Study||32
10618110|NCT01954771|11776310|FG002|STARTED|Overall Study||28
10618111|NCT01954771|11776308|FG000|COMPLETED|Overall Study||22
10618112|NCT01954771|11776309|FG001|COMPLETED|Overall Study||29
10618113|NCT01954771|11776310|FG002|COMPLETED|Overall Study||25
10618114|NCT01954771|11776308|FG000|NOT COMPLETED|Overall Study||7
10618115|NCT01954771|11776309|FG001|NOT COMPLETED|Overall Study||3
10618116|NCT01954771|11776310|FG002|NOT COMPLETED|Overall Study||3
10618117|NCT01954927|11776323|FG000|STARTED|Overall Study||45
10618118|NCT01954927|11776324|FG001|STARTED|Overall Study||45
10618119|NCT01954927|11776323|FG000|COMPLETED|Overall Study||42
10618120|NCT01954927|11776324|FG001|COMPLETED|Overall Study||44
10618121|NCT01954927|11776323|FG000|NOT COMPLETED|Overall Study||3
10618122|NCT01954927|11776324|FG001|NOT COMPLETED|Overall Study||1
10618123|NCT01955005|11776332|FG000|STARTED|Overall Study||30
10618124|NCT01955005|11776333|FG001|STARTED|Overall Study||30
10618125|NCT01955005|11776332|FG000|COMPLETED|Overall Study||27
10618126|NCT01955005|11776333|FG001|COMPLETED|Overall Study||25
10618127|NCT01955005|11776332|FG000|NOT COMPLETED|Overall Study||3
10618128|NCT01955005|11776333|FG001|NOT COMPLETED|Overall Study||5
10618129|NCT01955044|11776342|FG000|STARTED|Overall Study||10
10618130|NCT01955044|11776343|FG001|STARTED|Overall Study||10
10618131|NCT01955044|11776344|FG002|STARTED|Overall Study||10
10618132|NCT01955044|11776342|FG000|COMPLETED|Overall Study||9
10618133|NCT01955044|11776343|FG001|COMPLETED|Overall Study||9
10618134|NCT01955044|11776344|FG002|COMPLETED|Overall Study||10
10618135|NCT01955044|11776342|FG000|NOT COMPLETED|Overall Study||1
10618136|NCT01955044|11776343|FG001|NOT COMPLETED|Overall Study||1
10618137|NCT01955044|11776344|FG002|NOT COMPLETED|Overall Study||0
10618138|NCT01955083|11776354|FG000|STARTED|Overall Study||15
10618139|NCT01955083|11776355|FG001|STARTED|Overall Study||15
10618140|NCT01955083|11776354|FG000|COMPLETED|Overall Study||14
10618141|NCT01955083|11776355|FG001|COMPLETED|Overall Study||14
10618142|NCT01955083|11776354|FG000|NOT COMPLETED|Overall Study||1
10618143|NCT01955083|11776355|FG001|NOT COMPLETED|Overall Study||1
10618144|NCT01955122|11776387|FG000|STARTED|Overall Study|"Excluded (n = 5)~Included in analysis (n = 59)"|64
10618145|NCT01955122|11776388|FG001|STARTED|Overall Study|"Excluded (n = 5)~Included in analysis (n = 57)"|62
10618146|NCT01955122|11776387|FG000|No.Patients Enrolled|Overall Study||64
10618147|NCT01955122|11776388|FG001|No.Patients Enrolled|Overall Study||62
10618148|NCT01955122|11776387|FG000|No. Patients Completed Double Procedure|Overall Study||59
10618149|NCT01955122|11776388|FG001|No. Patients Completed Double Procedure|Overall Study||57
10618150|NCT01955122|11776387|FG000|COMPLETED|Overall Study||59
10618151|NCT01955122|11776388|FG001|COMPLETED|Overall Study||57
10618152|NCT01955122|11776387|FG000|NOT COMPLETED|Overall Study||5
10618153|NCT01955122|11776388|FG001|NOT COMPLETED|Overall Study||5
10618154|NCT01955161|11776403|FG000|STARTED|Overall Study||310
10618155|NCT01955161|11776404|FG001|STARTED|Overall Study||313
10618156|NCT01955161|11776405|FG002|STARTED|Overall Study||310
10618157|NCT01955161|11776403|FG000|Treated|Overall Study||308
10618158|NCT01955161|11776404|FG001|Treated|Overall Study||313
10618159|NCT01955161|11776405|FG002|Treated|Overall Study||309
10618160|NCT01955161|11776403|FG000|COMPLETED|Overall Study||283
10618161|NCT01955161|11776404|FG001|COMPLETED|Overall Study||288
10618162|NCT01955161|11776405|FG002|COMPLETED|Overall Study||275
10618163|NCT01955161|11776403|FG000|NOT COMPLETED|Overall Study||27
10618164|NCT01955161|11776404|FG001|NOT COMPLETED|Overall Study||25
10618165|NCT01955161|11776405|FG002|NOT COMPLETED|Overall Study||35
10618166|NCT01955369|11776413|FG000|STARTED|Overall Study||200
10618167|NCT01955369|11776413|FG000|COMPLETED|Overall Study||200
10618168|NCT01955369|11776413|FG000|NOT COMPLETED|Overall Study||0
10618169|NCT01955382|11776419|FG000|STARTED|Overall Study||35
10618170|NCT01955382|11776420|FG001|STARTED|Overall Study||35
10618171|NCT01955382|11776419|FG000|COMPLETED|Overall Study||35
10618172|NCT01955382|11776420|FG001|COMPLETED|Overall Study||35
10618173|NCT01955382|11776419|FG000|NOT COMPLETED|Overall Study||0
10618174|NCT01955382|11776420|FG001|NOT COMPLETED|Overall Study||0
10618175|NCT01955434|11776427|FG000|STARTED|Overall Study||25
10618176|NCT01955434|11776427|FG000|COMPLETED|Overall Study||25
10618177|NCT01955434|11776427|FG000|NOT COMPLETED|Overall Study||0
10618178|NCT01955473|11776436|FG000|STARTED|Overall Study||3
10618179|NCT01955473|11776437|FG001|STARTED|Overall Study||6
10618180|NCT01955473|11776438|FG002|STARTED|Overall Study||6
10618181|NCT01955473|11776439|FG003|STARTED|Overall Study||6
10618182|NCT01955473|11776440|FG004|STARTED|Overall Study||30
10618183|NCT01955473|11776436|FG000|COMPLETED|Overall Study||3
10618184|NCT01955473|11776437|FG001|COMPLETED|Overall Study||6
10618185|NCT01955473|11776438|FG002|COMPLETED|Overall Study||6
10618186|NCT01955473|11776439|FG003|COMPLETED|Overall Study||6
10618187|NCT01955473|11776440|FG004|COMPLETED|Overall Study||30
10618188|NCT01955473|11776436|FG000|NOT COMPLETED|Overall Study||0
10618189|NCT01955473|11776437|FG001|NOT COMPLETED|Overall Study||0
10618190|NCT01955473|11776438|FG002|NOT COMPLETED|Overall Study||0
10618191|NCT01955473|11776439|FG003|NOT COMPLETED|Overall Study||0
10618192|NCT01955473|11776440|FG004|NOT COMPLETED|Overall Study||0
10618193|NCT01955564|11776463|FG000|STARTED|Overall Study||18
10618194|NCT01955564|11776464|FG001|STARTED|Overall Study||6
10618195|NCT01955564|11776465|FG002|STARTED|Overall Study||6
10618196|NCT01955564|11776466|FG003|STARTED|Overall Study||6
10618197|NCT01955564|11776467|FG004|STARTED|Overall Study||6
10618198|NCT01955564|11776468|FG005|STARTED|Overall Study||6
10618199|NCT01955564|11776469|FG006|STARTED|Overall Study||6
10618200|NCT01955564|11776463|FG000|COMPLETED|Overall Study||18
10618201|NCT01955564|11776464|FG001|COMPLETED|Overall Study||6
10618202|NCT01955564|11776465|FG002|COMPLETED|Overall Study||6
10618203|NCT01955564|11776466|FG003|COMPLETED|Overall Study||6
10618204|NCT01955564|11776467|FG004|COMPLETED|Overall Study||6
10618205|NCT01955564|11776468|FG005|COMPLETED|Overall Study||6
10618206|NCT01955564|11776469|FG006|COMPLETED|Overall Study||6
10618207|NCT01955564|11776463|FG000|NOT COMPLETED|Overall Study||0
10618208|NCT01955564|11776464|FG001|NOT COMPLETED|Overall Study||0
10618209|NCT01955564|11776465|FG002|NOT COMPLETED|Overall Study||0
10618210|NCT01955564|11776466|FG003|NOT COMPLETED|Overall Study||0
10618211|NCT01955564|11776467|FG004|NOT COMPLETED|Overall Study||0
10618212|NCT01955564|11776468|FG005|NOT COMPLETED|Overall Study||0
10618213|NCT01955564|11776469|FG006|NOT COMPLETED|Overall Study||0
10618214|NCT01955629|11776491|FG000|STARTED|Overall Study||4
10618215|NCT01955629|11776491|FG000|COMPLETED|Overall Study|1 participant with DP and 3 with unacceptable toxicity were considered completed as per protocol.|4
10618216|NCT01955629|11776491|FG000|NOT COMPLETED|Overall Study||0
10618217|NCT01955707|11776497|FG000|STARTED|Overall Study||82
10618218|NCT01955707|11776498|FG001|STARTED|Overall Study||79
10618219|NCT01955707|11776497|FG000|Withdrew Prior to Dosing|Overall Study||0
10618220|NCT01955707|11776498|FG001|Withdrew Prior to Dosing|Overall Study||1
10618221|NCT01955707|11776497|FG000|Dosed|Overall Study||82
10618222|NCT01955707|11776498|FG001|Dosed|Overall Study||78
10618223|NCT01955707|11776497|FG000|Received Total Volume of Study Drug|Overall Study||82
10618224|NCT01955707|11776498|FG001|Received Total Volume of Study Drug|Overall Study||77
10618225|NCT01955707|11776497|FG000|COMPLETED|Overall Study||62
10618226|NCT01955707|11776498|FG001|COMPLETED|Overall Study||57
10618227|NCT01955707|11776497|FG000|NOT COMPLETED|Overall Study||20
10618228|NCT01955707|11776498|FG001|NOT COMPLETED|Overall Study||22
10653280|NCT02191865|11813734|FG000|STARTED|Overall Study||8
10653281|NCT02191865|11813735|FG001|STARTED|Overall Study||8
10653282|NCT02191865|11813736|FG002|STARTED|Overall Study||17
10653283|NCT02191865|11813734|FG000|COMPLETED|Overall Study||8
10653284|NCT02191865|11813735|FG001|COMPLETED|Overall Study||8
10653285|NCT02191865|11813736|FG002|COMPLETED|Overall Study||17
10653286|NCT02191865|11813734|FG000|NOT COMPLETED|Overall Study||0
10653287|NCT02191865|11813735|FG001|NOT COMPLETED|Overall Study||0
10653288|NCT02191865|11813736|FG002|NOT COMPLETED|Overall Study||0
10653289|NCT02192099|11813747|FG000|STARTED|Overall Study||61
10653290|NCT02192099|11813747|FG000|COMPLETED|Overall Study||0
10653291|NCT02192099|11813747|FG000|NOT COMPLETED|Overall Study||61
10653292|NCT02192164|11813751|FG000|STARTED|Overall Study||126
10653293|NCT02192164|11813751|FG000|Etanercept Treated Population|Overall Study||112
10653294|NCT02192164|11813751|FG000|COMPLETED|Overall Study||112
10653295|NCT02192164|11813751|FG000|NOT COMPLETED|Overall Study||14
10653296|NCT02192190|11813764|FG000|STARTED|Overall Study||76
10653297|NCT02192190|11813765|FG001|STARTED|Overall Study||39
10653298|NCT02192190|11813766|FG002|STARTED|Overall Study||38
10653299|NCT02192190|11813767|FG003|STARTED|Overall Study||38
10653300|NCT02192190|11813768|FG004|STARTED|Overall Study||39
10653301|NCT02192190|11813769|FG005|STARTED|Overall Study||38
10653302|NCT02192190|11813764|FG000|Received at Least 1 Dose of Study Drug|Overall Study||76
10653303|NCT02192190|11813765|FG001|Received at Least 1 Dose of Study Drug|Overall Study||39
10653304|NCT02192190|11813766|FG002|Received at Least 1 Dose of Study Drug|Overall Study||38
10653305|NCT02192190|11813767|FG003|Received at Least 1 Dose of Study Drug|Overall Study||38
10653306|NCT02192190|11813768|FG004|Received at Least 1 Dose of Study Drug|Overall Study||38
10653307|NCT02192190|11813769|FG005|Received at Least 1 Dose of Study Drug|Overall Study||37
10653308|NCT02192190|11813764|FG000|COMPLETED|Overall Study||22
10653309|NCT02192190|11813765|FG001|COMPLETED|Overall Study||10
10653310|NCT02192190|11813766|FG002|COMPLETED|Overall Study||13
10653311|NCT02192190|11813767|FG003|COMPLETED|Overall Study||12
10653312|NCT02192190|11813768|FG004|COMPLETED|Overall Study||9
10653313|NCT02192190|11813769|FG005|COMPLETED|Overall Study||9
10653314|NCT02192190|11813764|FG000|NOT COMPLETED|Overall Study||54
10653315|NCT02192190|11813765|FG001|NOT COMPLETED|Overall Study||29
10653316|NCT02192190|11813766|FG002|NOT COMPLETED|Overall Study||25
10653317|NCT02192190|11813767|FG003|NOT COMPLETED|Overall Study||26
10653318|NCT02192190|11813768|FG004|NOT COMPLETED|Overall Study||30
10653319|NCT02192190|11813769|FG005|NOT COMPLETED|Overall Study||29
10653320|NCT02192307|11813786|FG000|STARTED|Overall Study||30
10653321|NCT02192307|11813787|FG001|STARTED|Overall Study||30
10653322|NCT02192307|11813786|FG000|COMPLETED|Overall Study||30
10653323|NCT02192307|11813787|FG001|COMPLETED|Overall Study||30
10653324|NCT02192307|11813786|FG000|NOT COMPLETED|Overall Study||0
10653325|NCT02192307|11813787|FG001|NOT COMPLETED|Overall Study||0
10618229|NCT01955720|11776504|FG000|STARTED|Overall Study||13
10618230|NCT01955720|11776505|FG001|STARTED|Overall Study||13
10618231|NCT01955720|11776506|FG002|STARTED|Overall Study||3
10618232|NCT01955720|11776507|FG003|STARTED|Overall Study||3
10618233|NCT01955720|11776508|FG004|STARTED|Overall Study||7
10618234|NCT01955720|11776509|FG005|STARTED|Overall Study||7
10618235|NCT01955720|11776504|FG000|Healthy Subjects Aged 45-64|Overall Study||3
10618236|NCT01955720|11776505|FG001|Healthy Subjects Aged 45-64|Overall Study||3
10618237|NCT01955720|11776506|FG002|Healthy Subjects Aged 45-64|Overall Study||3
10618238|NCT01955720|11776507|FG003|Healthy Subjects Aged 45-64|Overall Study||3
10618239|NCT01955720|11776508|FG004|Healthy Subjects Aged 45-64|Overall Study||0
10618240|NCT01955720|11776509|FG005|Healthy Subjects Aged 45-64|Overall Study||0
10618241|NCT01955720|11776504|FG000|Healthy Subjects Aged 65-80|Overall Study||4
10618242|NCT01955720|11776505|FG001|Healthy Subjects Aged 65-80|Overall Study||4
10618243|NCT01955720|11776506|FG002|Healthy Subjects Aged 65-80|Overall Study||0
10618244|NCT01955720|11776507|FG003|Healthy Subjects Aged 65-80|Overall Study||0
10618245|NCT01955720|11776508|FG004|Healthy Subjects Aged 65-80|Overall Study||4
10704945|NCT02594826|11869347|FG000|STARTED|Overall Study||347
10704946|NCT02594826|11869348|FG001|STARTED|Overall Study||358
10704947|NCT02594826|11869347|FG000|COMPLETED|Overall Study||290
10704948|NCT02594826|11869348|FG001|COMPLETED|Overall Study||298
10704949|NCT02594826|11869347|FG000|NOT COMPLETED|Overall Study||57
10704950|NCT02594826|11869348|FG001|NOT COMPLETED|Overall Study||60
10618246|NCT01955720|11776509|FG005|Healthy Subjects Aged 65-80|Overall Study||4
10618247|NCT01955720|11776504|FG000|Subjects With Mild Renal Impairment|Overall Study||3
10618248|NCT01955720|11776505|FG001|Subjects With Mild Renal Impairment|Overall Study||3
10618249|NCT01955720|11776506|FG002|Subjects With Mild Renal Impairment|Overall Study||0
10618250|NCT01955720|11776507|FG003|Subjects With Mild Renal Impairment|Overall Study||0
10618251|NCT01955720|11776508|FG004|Subjects With Mild Renal Impairment|Overall Study||3
10618252|NCT01955720|11776509|FG005|Subjects With Mild Renal Impairment|Overall Study||3
10618253|NCT01955720|11776504|FG000|Subjects With Moderate Renal Impairment|Overall Study||3
10618254|NCT01955720|11776505|FG001|Subjects With Moderate Renal Impairment|Overall Study||3
10618255|NCT01955720|11776506|FG002|Subjects With Moderate Renal Impairment|Overall Study||0
10618256|NCT01955720|11776507|FG003|Subjects With Moderate Renal Impairment|Overall Study||0
10618257|NCT01955720|11776508|FG004|Subjects With Moderate Renal Impairment|Overall Study||0
10618258|NCT01955720|11776509|FG005|Subjects With Moderate Renal Impairment|Overall Study||0
10618259|NCT01955720|11776504|FG000|COMPLETED|Overall Study||13
10618260|NCT01955720|11776505|FG001|COMPLETED|Overall Study||13
10618261|NCT01955720|11776506|FG002|COMPLETED|Overall Study||3
10618262|NCT01955720|11776507|FG003|COMPLETED|Overall Study||3
10618263|NCT01955720|11776508|FG004|COMPLETED|Overall Study||7
10618264|NCT01955720|11776509|FG005|COMPLETED|Overall Study||7
10618265|NCT01955720|11776504|FG000|NOT COMPLETED|Overall Study||0
10618266|NCT01955720|11776505|FG001|NOT COMPLETED|Overall Study||0
10618267|NCT01955720|11776506|FG002|NOT COMPLETED|Overall Study||0
10618268|NCT01955720|11776507|FG003|NOT COMPLETED|Overall Study||0
10618269|NCT01955720|11776508|FG004|NOT COMPLETED|Overall Study||0
10618270|NCT01955720|11776509|FG005|NOT COMPLETED|Overall Study||0
10618271|NCT01955733|11776558|FG000|STARTED|Period 1||33
10618272|NCT01955733|11776559|FG001|STARTED|Period 1||29
10618273|NCT01955733|11776560|FG002|STARTED|Period 1||29
10618274|NCT01955733|11776558|FG000|COMPLETED|Period 1||32
10618275|NCT01955733|11776559|FG001|COMPLETED|Period 1||29
10618276|NCT01955733|11776560|FG002|COMPLETED|Period 1||29
10618277|NCT01955733|11776558|FG000|NOT COMPLETED|Period 1||1
10618278|NCT01955733|11776559|FG001|NOT COMPLETED|Period 1||0
10618279|NCT01955733|11776560|FG002|NOT COMPLETED|Period 1||0
10618280|NCT01955733|11776558|FG000|STARTED|Period 2||32
10704951|NCT02595008|11869356|FG000|STARTED|Overall Study||20
10704952|NCT02595008|11869357|FG001|STARTED|Overall Study||4
10704953|NCT02595008|11869356|FG000|COMPLETED|Overall Study||19
10618281|NCT01955733|11776559|FG001|STARTED|Period 2||29
10618282|NCT01955733|11776560|FG002|STARTED|Period 2||29
10618283|NCT01955733|11776558|FG000|COMPLETED|Period 2||20
10618284|NCT01955733|11776559|FG001|COMPLETED|Period 2||10
10618285|NCT01955733|11776560|FG002|COMPLETED|Period 2||8
10618286|NCT01955733|11776558|FG000|NOT COMPLETED|Period 2||12
10618287|NCT01955733|11776559|FG001|NOT COMPLETED|Period 2||19
10618288|NCT01955733|11776560|FG002|NOT COMPLETED|Period 2||21
10618289|NCT01955837|11776570|FG000|STARTED|Overall Study||271
10618290|NCT01955837|11776571|FG001|STARTED|Overall Study||135
10618291|NCT01955837|11776570|FG000|COMPLETED|Overall Study||271
10618292|NCT01955837|11776571|FG001|COMPLETED|Overall Study||135
10618293|NCT01955837|11776570|FG000|NOT COMPLETED|Overall Study||0
10618294|NCT01955837|11776571|FG001|NOT COMPLETED|Overall Study||0
10618295|NCT01955954|11776577|FG000|STARTED|Overall Study||69
10618296|NCT01955954|11776577|FG000|Received Treatment|Overall Study||66
10618297|NCT01955954|11776577|FG000|Completed Treatment|Overall Study||53
10618298|NCT01955954|11776577|FG000|Completed Post-treatment Assessement|Overall Study||48
10704954|NCT02595008|11869357|FG001|COMPLETED|Overall Study||4
10618299|NCT01955954|11776577|FG000|Completed 2-month Assessment|Overall Study|Primary endpoint|46
10618300|NCT01955954|11776577|FG000|Completed 6-month Assessement|Overall Study||42
10618301|NCT01955954|11776577|FG000|COMPLETED|Overall Study|12-months|33
10618302|NCT01955954|11776577|FG000|NOT COMPLETED|Overall Study||36
10618303|NCT01956032|11776581|FG000|STARTED|Overall Study||15
10618304|NCT01956032|11776581|FG000|COMPLETED|Overall Study||15
10618305|NCT01956032|11776581|FG000|NOT COMPLETED|Overall Study||0
10618306|NCT01956071|11776585|FG000|STARTED|Overall Study||44
10618307|NCT01956071|11776585|FG000|COMPLETED|Overall Study||44
10618308|NCT01956071|11776585|FG000|NOT COMPLETED|Overall Study||0
10618309|NCT01956097|11776592|FG000|STARTED|Overall Study||30
10618310|NCT01956097|11776593|FG001|STARTED|Overall Study||30
10618311|NCT01956097|11776594|FG002|STARTED|Overall Study||15
10618312|NCT01956097|11776592|FG000|COMPLETED|Overall Study||24
10618313|NCT01956097|11776593|FG001|COMPLETED|Overall Study||28
10618314|NCT01956097|11776594|FG002|COMPLETED|Overall Study||15
10618315|NCT01956097|11776592|FG000|NOT COMPLETED|Overall Study||6
10618316|NCT01956097|11776593|FG001|NOT COMPLETED|Overall Study||2
10618317|NCT01956097|11776594|FG002|NOT COMPLETED|Overall Study||0
10618318|NCT01956123|11776604|FG000|STARTED|COS Cycle 2||252
10618319|NCT01956123|11776605|FG001|STARTED|COS Cycle 2||261
10618320|NCT01956123|11776606|FG002|STARTED|COS Cycle 2||0
10618321|NCT01956123|11776607|FG003|STARTED|COS Cycle 2||0
10618322|NCT01956123|11776604|FG000|COMPLETED|COS Cycle 2||238
10618323|NCT01956123|11776605|FG001|COMPLETED|COS Cycle 2||254
10618324|NCT01956123|11776606|FG002|COMPLETED|COS Cycle 2||0
10618325|NCT01956123|11776607|FG003|COMPLETED|COS Cycle 2||0
10618326|NCT01956123|11776604|FG000|NOT COMPLETED|COS Cycle 2||14
10618327|NCT01956123|11776605|FG001|NOT COMPLETED|COS Cycle 2||7
10618328|NCT01956123|11776606|FG002|NOT COMPLETED|COS Cycle 2||0
10618329|NCT01956123|11776607|FG003|NOT COMPLETED|COS Cycle 2||0
10618330|NCT01956123|11776604|FG000|STARTED|COS Cycle 3||0
10618331|NCT01956123|11776605|FG001|STARTED|COS Cycle 3||0
10618332|NCT01956123|11776606|FG002|STARTED|COS Cycle 3|Subjects in COS cycle 2 who failed to achieve an ongoing pregnancy could undergo COS cycle 3|95
10618333|NCT01956123|11776607|FG003|STARTED|COS Cycle 3|Subjects in COS cycle 2 who failed to achieve an ongoing pregnancy could undergo COS cycle 3|93
10618334|NCT01956123|11776604|FG000|COMPLETED|COS Cycle 3||0
10618335|NCT01956123|11776605|FG001|COMPLETED|COS Cycle 3||0
10618336|NCT01956123|11776606|FG002|COMPLETED|COS Cycle 3||89
10618337|NCT01956123|11776607|FG003|COMPLETED|COS Cycle 3||91
10618338|NCT01956123|11776604|FG000|NOT COMPLETED|COS Cycle 3||0
10618339|NCT01956123|11776605|FG001|NOT COMPLETED|COS Cycle 3||0
10618340|NCT01956123|11776606|FG002|NOT COMPLETED|COS Cycle 3||6
10618341|NCT01956123|11776607|FG003|NOT COMPLETED|COS Cycle 3||2
10618342|NCT01956240|11776620|FG000|STARTED|Overall Study||48
10618343|NCT01956240|11776621|FG001|STARTED|Overall Study||49
10618344|NCT01956240|11776620|FG000|COMPLETED|Overall Study||25
10618345|NCT01956240|11776621|FG001|COMPLETED|Overall Study||25
10618346|NCT01956240|11776620|FG000|NOT COMPLETED|Overall Study||23
10618347|NCT01956240|11776621|FG001|NOT COMPLETED|Overall Study||24
10618348|NCT01956279|11776629|FG000|STARTED|Overall Study||82
10618349|NCT01956279|11776630|FG001|STARTED|Overall Study||88
10618350|NCT01956279|11776629|FG000|COMPLETED|Overall Study||68
10618351|NCT01956279|11776630|FG001|COMPLETED|Overall Study||74
10618352|NCT01956279|11776629|FG000|NOT COMPLETED|Overall Study||14
10618353|NCT01956279|11776630|FG001|NOT COMPLETED|Overall Study||14
10618354|NCT01956435|11776636|FG000|STARTED|Overall Study||3
10618355|NCT01956435|11776637|FG001|STARTED|Overall Study||3
10618356|NCT01956435|11776636|FG000|COMPLETED|Overall Study||3
10618357|NCT01956435|11776637|FG001|COMPLETED|Overall Study||3
10618358|NCT01956435|11776636|FG000|NOT COMPLETED|Overall Study||0
10618359|NCT01956435|11776637|FG001|NOT COMPLETED|Overall Study||0
10618360|NCT01956773|11776646|FG000|STARTED|Overall Study||2520
10618361|NCT01956773|11776647|FG001|STARTED|Overall Study||100
10618362|NCT01956773|11776646|FG000|COMPLETED|Overall Study||1892
10618363|NCT01956773|11776647|FG001|COMPLETED|Overall Study||99
10618364|NCT01956773|11776646|FG000|NOT COMPLETED|Overall Study||628
10618365|NCT01956773|11776647|FG001|NOT COMPLETED|Overall Study||1
10618366|NCT01957085|11776653|FG000|STARTED|Overall Study|Per Institutional Review Board requirements, exact dates are not to be reported|366
10618367|NCT01957085|11776653|FG000|COMPLETED|Overall Study|Per Institutional Review Board, exact dates are not to be reported|366
10618368|NCT01957085|11776653|FG000|NOT COMPLETED|Overall Study||0
10618369|NCT01957111|11776660|FG000|STARTED|Overall Study||16
10618370|NCT01957111|11776661|FG001|STARTED|Overall Study||16
10618371|NCT01957111|11776660|FG000|COMPLETED|Overall Study||15
10618372|NCT01957111|11776661|FG001|COMPLETED|Overall Study||15
10618373|NCT01957111|11776660|FG000|NOT COMPLETED|Overall Study||1
10618374|NCT01957111|11776661|FG001|NOT COMPLETED|Overall Study||1
10618375|NCT01957137|11776667|FG000|STARTED|Randomized Portion||30
10618376|NCT01957137|11776667|FG000|Continuous Stimulation|Randomized Portion|Subjects received continuous stimulation for approximately 4 weeks.|29
10618377|NCT01957137|11776667|FG000|Cycling Parameter #1|Randomized Portion|Subjects received Cycling Parameter #1 for approximately 4 weeks.|30
10618378|NCT01957137|11776667|FG000|Cycling Parameter #2|Randomized Portion|Subjects received Cycling Parameter #2 for approximately 4 weeks.|28
10618379|NCT01957137|11776667|FG000|Cycling Parameter #3|Randomized Portion|Subjects received Cycling Parameter #3 for approximately 4 weeks.|28
10618380|NCT01957137|11776667|FG000|COMPLETED|Randomized Portion||28
10618381|NCT01957137|11776667|FG000|NOT COMPLETED|Randomized Portion||2
10618382|NCT01957137|11776667|FG000|STARTED|No Stimulation|Following randomized portion, all subjects went through no stimulation for approximately 4 weeks.|28
10618383|NCT01957137|11776667|FG000|COMPLETED|No Stimulation||28
10618384|NCT01957137|11776667|FG000|NOT COMPLETED|No Stimulation||0
10618385|NCT01957150|11776681|FG000|STARTED|Overall Study||142
10618386|NCT01957150|11776682|FG001|STARTED|Overall Study||141
10618387|NCT01957150|11776681|FG000|COMPLETED|Overall Study||87
10618388|NCT01957150|11776682|FG001|COMPLETED|Overall Study||83
10618389|NCT01957150|11776681|FG000|NOT COMPLETED|Overall Study||55
10618390|NCT01957150|11776682|FG001|NOT COMPLETED|Overall Study||58
10618391|NCT01957163|11776691|FG000|STARTED|Overall Study||206
10618392|NCT01957163|11776692|FG001|STARTED|Overall Study||206
10618393|NCT01957163|11776693|FG002|STARTED|Overall Study||207
10618394|NCT01957163|11776691|FG000|COMPLETED|Overall Study||191
10618395|NCT01957163|11776692|FG001|COMPLETED|Overall Study||195
10618396|NCT01957163|11776693|FG002|COMPLETED|Overall Study||189
10618397|NCT01957163|11776691|FG000|NOT COMPLETED|Overall Study||15
10618398|NCT01957163|11776692|FG001|NOT COMPLETED|Overall Study||11
10618399|NCT01957163|11776693|FG002|NOT COMPLETED|Overall Study||18
10618400|NCT01957202|11776701|FG000|STARTED|Treatment Period 1 (8 Days)||3
10618401|NCT01957202|11776702|FG001|STARTED|Treatment Period 1 (8 Days)||6
10618402|NCT01957202|11776703|FG002|STARTED|Treatment Period 1 (8 Days)||6
10618403|NCT01957202|11776704|FG003|STARTED|Treatment Period 1 (8 Days)||3
10618404|NCT01957202|11776705|FG004|STARTED|Treatment Period 1 (8 Days)||3
10618405|NCT01957202|11776706|FG005|STARTED|Treatment Period 1 (8 Days)||2
10618406|NCT01957202|11776707|FG006|STARTED|Treatment Period 1 (8 Days)||3
10618407|NCT01957202|11776708|FG007|STARTED|Treatment Period 1 (8 Days)||3
10618408|NCT01957202|11776709|FG008|STARTED|Treatment Period 1 (8 Days)||3
10618409|NCT01957202|11776710|FG009|STARTED|Treatment Period 1 (8 Days)||6
10618410|NCT01957202|11776711|FG010|STARTED|Treatment Period 1 (8 Days)||3
10618411|NCT01957202|11776712|FG011|STARTED|Treatment Period 1 (8 Days)||6
10618412|NCT01957202|11776713|FG012|STARTED|Treatment Period 1 (8 Days)||3
10618413|NCT01957202|11776714|FG013|STARTED|Treatment Period 1 (8 Days)||3
10618414|NCT01957202|11776715|FG014|STARTED|Treatment Period 1 (8 Days)||6
10618415|NCT01957202|11776716|FG015|STARTED|Treatment Period 1 (8 Days)||3
10618416|NCT01957202|11776717|FG016|STARTED|Treatment Period 1 (8 Days)||6
10618417|NCT01957202|11776718|FG017|STARTED|Treatment Period 1 (8 Days)||3
10618418|NCT01957202|11776701|FG000|COMPLETED|Treatment Period 1 (8 Days)||3
10618419|NCT01957202|11776702|FG001|COMPLETED|Treatment Period 1 (8 Days)||6
10618420|NCT01957202|11776703|FG002|COMPLETED|Treatment Period 1 (8 Days)||6
10618421|NCT01957202|11776704|FG003|COMPLETED|Treatment Period 1 (8 Days)||3
10618422|NCT01957202|11776705|FG004|COMPLETED|Treatment Period 1 (8 Days)||3
10618423|NCT01957202|11776706|FG005|COMPLETED|Treatment Period 1 (8 Days)||2
10618424|NCT01957202|11776707|FG006|COMPLETED|Treatment Period 1 (8 Days)||3
10618425|NCT01957202|11776708|FG007|COMPLETED|Treatment Period 1 (8 Days)||3
10618426|NCT01957202|11776709|FG008|COMPLETED|Treatment Period 1 (8 Days)||3
10618427|NCT01957202|11776710|FG009|COMPLETED|Treatment Period 1 (8 Days)||6
10618428|NCT01957202|11776711|FG010|COMPLETED|Treatment Period 1 (8 Days)||3
10618429|NCT01957202|11776712|FG011|COMPLETED|Treatment Period 1 (8 Days)||6
10618430|NCT01957202|11776713|FG012|COMPLETED|Treatment Period 1 (8 Days)||3
10618431|NCT01957202|11776714|FG013|COMPLETED|Treatment Period 1 (8 Days)||3
10618432|NCT01957202|11776715|FG014|COMPLETED|Treatment Period 1 (8 Days)||6
10618433|NCT01957202|11776716|FG015|COMPLETED|Treatment Period 1 (8 Days)||3
10618434|NCT01957202|11776717|FG016|COMPLETED|Treatment Period 1 (8 Days)||6
10618435|NCT01957202|11776718|FG017|COMPLETED|Treatment Period 1 (8 Days)||3
10618436|NCT01957202|11776701|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10618437|NCT01957202|11776702|FG001|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10618438|NCT01957202|11776703|FG002|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10618439|NCT01957202|11776704|FG003|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10618440|NCT01957202|11776705|FG004|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10618441|NCT01957202|11776706|FG005|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10618442|NCT01957202|11776707|FG006|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10618443|NCT01957202|11776708|FG007|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10618444|NCT01957202|11776709|FG008|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10618445|NCT01957202|11776710|FG009|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10618446|NCT01957202|11776711|FG010|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10618447|NCT01957202|11776712|FG011|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10618448|NCT01957202|11776713|FG012|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10618449|NCT01957202|11776714|FG013|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10618450|NCT01957202|11776715|FG014|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10618451|NCT01957202|11776716|FG015|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10618452|NCT01957202|11776717|FG016|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10618453|NCT01957202|11776718|FG017|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10618454|NCT01957202|11776701|FG000|STARTED|Washout Period 1 (14 to 28 Days)||3
10618455|NCT01957202|11776702|FG001|STARTED|Washout Period 1 (14 to 28 Days)||6
10618456|NCT01957202|11776703|FG002|STARTED|Washout Period 1 (14 to 28 Days)||6
10618457|NCT01957202|11776704|FG003|STARTED|Washout Period 1 (14 to 28 Days)||3
10618458|NCT01957202|11776705|FG004|STARTED|Washout Period 1 (14 to 28 Days)||3
10618459|NCT01957202|11776706|FG005|STARTED|Washout Period 1 (14 to 28 Days)||2
10618460|NCT01957202|11776707|FG006|STARTED|Washout Period 1 (14 to 28 Days)||3
10618461|NCT01957202|11776708|FG007|STARTED|Washout Period 1 (14 to 28 Days)||3
10618462|NCT01957202|11776709|FG008|STARTED|Washout Period 1 (14 to 28 Days)||3
10618463|NCT01957202|11776710|FG009|STARTED|Washout Period 1 (14 to 28 Days)||6
10618464|NCT01957202|11776711|FG010|STARTED|Washout Period 1 (14 to 28 Days)||3
10618465|NCT01957202|11776712|FG011|STARTED|Washout Period 1 (14 to 28 Days)||6
10618466|NCT01957202|11776713|FG012|STARTED|Washout Period 1 (14 to 28 Days)||3
10618467|NCT01957202|11776714|FG013|STARTED|Washout Period 1 (14 to 28 Days)||3
10618468|NCT01957202|11776715|FG014|STARTED|Washout Period 1 (14 to 28 Days)||6
10618469|NCT01957202|11776716|FG015|STARTED|Washout Period 1 (14 to 28 Days)||3
10618470|NCT01957202|11776717|FG016|STARTED|Washout Period 1 (14 to 28 Days)||6
10618471|NCT01957202|11776718|FG017|STARTED|Washout Period 1 (14 to 28 Days)||3
10618472|NCT01957202|11776701|FG000|COMPLETED|Washout Period 1 (14 to 28 Days)||3
10618473|NCT01957202|11776702|FG001|COMPLETED|Washout Period 1 (14 to 28 Days)||6
10618474|NCT01957202|11776703|FG002|COMPLETED|Washout Period 1 (14 to 28 Days)||6
10618475|NCT01957202|11776704|FG003|COMPLETED|Washout Period 1 (14 to 28 Days)||3
10618476|NCT01957202|11776705|FG004|COMPLETED|Washout Period 1 (14 to 28 Days)||3
10618477|NCT01957202|11776706|FG005|COMPLETED|Washout Period 1 (14 to 28 Days)||2
10618478|NCT01957202|11776707|FG006|COMPLETED|Washout Period 1 (14 to 28 Days)||3
10618479|NCT01957202|11776708|FG007|COMPLETED|Washout Period 1 (14 to 28 Days)||3
10618480|NCT01957202|11776709|FG008|COMPLETED|Washout Period 1 (14 to 28 Days)||3
10618481|NCT01957202|11776710|FG009|COMPLETED|Washout Period 1 (14 to 28 Days)||6
10618482|NCT01957202|11776711|FG010|COMPLETED|Washout Period 1 (14 to 28 Days)||3
10618483|NCT01957202|11776712|FG011|COMPLETED|Washout Period 1 (14 to 28 Days)||6
10618484|NCT01957202|11776713|FG012|COMPLETED|Washout Period 1 (14 to 28 Days)||3
10618485|NCT01957202|11776714|FG013|COMPLETED|Washout Period 1 (14 to 28 Days)||3
10618486|NCT01957202|11776715|FG014|COMPLETED|Washout Period 1 (14 to 28 Days)||6
10618487|NCT01957202|11776716|FG015|COMPLETED|Washout Period 1 (14 to 28 Days)||3
10618488|NCT01957202|11776717|FG016|COMPLETED|Washout Period 1 (14 to 28 Days)||6
10618489|NCT01957202|11776718|FG017|COMPLETED|Washout Period 1 (14 to 28 Days)||3
10618490|NCT01957202|11776701|FG000|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
10618491|NCT01957202|11776702|FG001|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
10618492|NCT01957202|11776703|FG002|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
10618493|NCT01957202|11776704|FG003|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
10618494|NCT01957202|11776705|FG004|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
10618495|NCT01957202|11776706|FG005|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
10618496|NCT01957202|11776707|FG006|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
10618497|NCT01957202|11776708|FG007|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
10618498|NCT01957202|11776709|FG008|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
10618499|NCT01957202|11776710|FG009|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
10618500|NCT01957202|11776711|FG010|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
10618501|NCT01957202|11776712|FG011|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
10618502|NCT01957202|11776713|FG012|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
10618503|NCT01957202|11776714|FG013|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
10618504|NCT01957202|11776715|FG014|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
10618505|NCT01957202|11776716|FG015|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
10618506|NCT01957202|11776717|FG016|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
10618507|NCT01957202|11776718|FG017|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
10618508|NCT01957202|11776701|FG000|STARTED|Treatment Period 2 (8 Days)||3
10618509|NCT01957202|11776702|FG001|STARTED|Treatment Period 2 (8 Days)||6
10618510|NCT01957202|11776703|FG002|STARTED|Treatment Period 2 (8 Days)||6
10618511|NCT01957202|11776704|FG003|STARTED|Treatment Period 2 (8 Days)||3
10618512|NCT01957202|11776705|FG004|STARTED|Treatment Period 2 (8 Days)||3
10618513|NCT01957202|11776706|FG005|STARTED|Treatment Period 2 (8 Days)||2
10618514|NCT01957202|11776707|FG006|STARTED|Treatment Period 2 (8 Days)||3
10618515|NCT01957202|11776708|FG007|STARTED|Treatment Period 2 (8 Days)||3
10618516|NCT01957202|11776709|FG008|STARTED|Treatment Period 2 (8 Days)||3
10618517|NCT01957202|11776710|FG009|STARTED|Treatment Period 2 (8 Days)||6
10618518|NCT01957202|11776711|FG010|STARTED|Treatment Period 2 (8 Days)||3
10618519|NCT01957202|11776712|FG011|STARTED|Treatment Period 2 (8 Days)||6
10618520|NCT01957202|11776713|FG012|STARTED|Treatment Period 2 (8 Days)||3
10618521|NCT01957202|11776714|FG013|STARTED|Treatment Period 2 (8 Days)||3
10618522|NCT01957202|11776715|FG014|STARTED|Treatment Period 2 (8 Days)||6
10618523|NCT01957202|11776716|FG015|STARTED|Treatment Period 2 (8 Days)||3
10618524|NCT01957202|11776717|FG016|STARTED|Treatment Period 2 (8 Days)||6
10618525|NCT01957202|11776718|FG017|STARTED|Treatment Period 2 (8 Days)||3
10618526|NCT01957202|11776701|FG000|COMPLETED|Treatment Period 2 (8 Days)||3
10618527|NCT01957202|11776702|FG001|COMPLETED|Treatment Period 2 (8 Days)||5
10618528|NCT01957202|11776703|FG002|COMPLETED|Treatment Period 2 (8 Days)||6
10618529|NCT01957202|11776704|FG003|COMPLETED|Treatment Period 2 (8 Days)||3
10618530|NCT01957202|11776705|FG004|COMPLETED|Treatment Period 2 (8 Days)||3
10618531|NCT01957202|11776706|FG005|COMPLETED|Treatment Period 2 (8 Days)||2
10618532|NCT01957202|11776707|FG006|COMPLETED|Treatment Period 2 (8 Days)||3
10618533|NCT01957202|11776708|FG007|COMPLETED|Treatment Period 2 (8 Days)||3
10618534|NCT01957202|11776709|FG008|COMPLETED|Treatment Period 2 (8 Days)||3
10618535|NCT01957202|11776710|FG009|COMPLETED|Treatment Period 2 (8 Days)||6
10618536|NCT01957202|11776711|FG010|COMPLETED|Treatment Period 2 (8 Days)||3
10618537|NCT01957202|11776712|FG011|COMPLETED|Treatment Period 2 (8 Days)||6
10618538|NCT01957202|11776713|FG012|COMPLETED|Treatment Period 2 (8 Days)||3
10618539|NCT01957202|11776714|FG013|COMPLETED|Treatment Period 2 (8 Days)||3
10618540|NCT01957202|11776715|FG014|COMPLETED|Treatment Period 2 (8 Days)||6
10618541|NCT01957202|11776716|FG015|COMPLETED|Treatment Period 2 (8 Days)||3
10618542|NCT01957202|11776717|FG016|COMPLETED|Treatment Period 2 (8 Days)||5
10618543|NCT01957202|11776718|FG017|COMPLETED|Treatment Period 2 (8 Days)||3
10618544|NCT01957202|11776701|FG000|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10618545|NCT01957202|11776702|FG001|NOT COMPLETED|Treatment Period 2 (8 Days)||1
10618546|NCT01957202|11776703|FG002|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10618547|NCT01957202|11776704|FG003|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10618548|NCT01957202|11776705|FG004|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10618549|NCT01957202|11776706|FG005|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10618550|NCT01957202|11776707|FG006|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10618551|NCT01957202|11776708|FG007|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10618552|NCT01957202|11776709|FG008|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10618553|NCT01957202|11776710|FG009|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10618554|NCT01957202|11776711|FG010|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10618555|NCT01957202|11776712|FG011|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10618556|NCT01957202|11776713|FG012|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10618557|NCT01957202|11776714|FG013|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10618558|NCT01957202|11776715|FG014|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10618559|NCT01957202|11776716|FG015|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10618560|NCT01957202|11776717|FG016|NOT COMPLETED|Treatment Period 2 (8 Days)||1
10618561|NCT01957202|11776718|FG017|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10618562|NCT01957202|11776701|FG000|STARTED|Washout Period 2 (14 to 28 Days)||3
10618563|NCT01957202|11776702|FG001|STARTED|Washout Period 2 (14 to 28 Days)||5
10618564|NCT01957202|11776703|FG002|STARTED|Washout Period 2 (14 to 28 Days)||6
10618565|NCT01957202|11776704|FG003|STARTED|Washout Period 2 (14 to 28 Days)||3
10618566|NCT01957202|11776705|FG004|STARTED|Washout Period 2 (14 to 28 Days)||3
10618567|NCT01957202|11776706|FG005|STARTED|Washout Period 2 (14 to 28 Days)||2
10618568|NCT01957202|11776707|FG006|STARTED|Washout Period 2 (14 to 28 Days)||3
10618569|NCT01957202|11776708|FG007|STARTED|Washout Period 2 (14 to 28 Days)||3
10618570|NCT01957202|11776709|FG008|STARTED|Washout Period 2 (14 to 28 Days)||3
10618571|NCT01957202|11776710|FG009|STARTED|Washout Period 2 (14 to 28 Days)||6
10618572|NCT01957202|11776711|FG010|STARTED|Washout Period 2 (14 to 28 Days)||3
10618573|NCT01957202|11776712|FG011|STARTED|Washout Period 2 (14 to 28 Days)||6
10618574|NCT01957202|11776713|FG012|STARTED|Washout Period 2 (14 to 28 Days)||3
10618575|NCT01957202|11776714|FG013|STARTED|Washout Period 2 (14 to 28 Days)||3
10618576|NCT01957202|11776715|FG014|STARTED|Washout Period 2 (14 to 28 Days)||6
10618577|NCT01957202|11776716|FG015|STARTED|Washout Period 2 (14 to 28 Days)||3
10618578|NCT01957202|11776717|FG016|STARTED|Washout Period 2 (14 to 28 Days)||5
10618579|NCT01957202|11776718|FG017|STARTED|Washout Period 2 (14 to 28 Days)||3
10618580|NCT01957202|11776701|FG000|COMPLETED|Washout Period 2 (14 to 28 Days)||3
10618581|NCT01957202|11776702|FG001|COMPLETED|Washout Period 2 (14 to 28 Days)||5
10618582|NCT01957202|11776703|FG002|COMPLETED|Washout Period 2 (14 to 28 Days)||6
10618583|NCT01957202|11776704|FG003|COMPLETED|Washout Period 2 (14 to 28 Days)||3
10618584|NCT01957202|11776705|FG004|COMPLETED|Washout Period 2 (14 to 28 Days)||3
10618585|NCT01957202|11776706|FG005|COMPLETED|Washout Period 2 (14 to 28 Days)||2
10618586|NCT01957202|11776707|FG006|COMPLETED|Washout Period 2 (14 to 28 Days)||3
10618587|NCT01957202|11776708|FG007|COMPLETED|Washout Period 2 (14 to 28 Days)||3
10618667|NCT01957202|11776716|FG015|NOT COMPLETED|Treatment Period 3 (8 Days)||0
10618588|NCT01957202|11776709|FG008|COMPLETED|Washout Period 2 (14 to 28 Days)||3
10618589|NCT01957202|11776710|FG009|COMPLETED|Washout Period 2 (14 to 28 Days)||6
10618590|NCT01957202|11776711|FG010|COMPLETED|Washout Period 2 (14 to 28 Days)||3
10618591|NCT01957202|11776712|FG011|COMPLETED|Washout Period 2 (14 to 28 Days)||6
10618592|NCT01957202|11776713|FG012|COMPLETED|Washout Period 2 (14 to 28 Days)||3
10618593|NCT01957202|11776714|FG013|COMPLETED|Washout Period 2 (14 to 28 Days)||3
10618594|NCT01957202|11776715|FG014|COMPLETED|Washout Period 2 (14 to 28 Days)||6
10618595|NCT01957202|11776716|FG015|COMPLETED|Washout Period 2 (14 to 28 Days)||3
10618596|NCT01957202|11776717|FG016|COMPLETED|Washout Period 2 (14 to 28 Days)||5
10618597|NCT01957202|11776718|FG017|COMPLETED|Washout Period 2 (14 to 28 Days)||3
10618598|NCT01957202|11776701|FG000|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
10618599|NCT01957202|11776702|FG001|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
10618600|NCT01957202|11776703|FG002|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
10618601|NCT01957202|11776704|FG003|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
10618602|NCT01957202|11776705|FG004|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
10618603|NCT01957202|11776706|FG005|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
10618604|NCT01957202|11776707|FG006|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
10618605|NCT01957202|11776708|FG007|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
10618606|NCT01957202|11776709|FG008|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
10618607|NCT01957202|11776710|FG009|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
10618608|NCT01957202|11776711|FG010|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
10618609|NCT01957202|11776712|FG011|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
10618610|NCT01957202|11776713|FG012|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
10618611|NCT01957202|11776714|FG013|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
10618612|NCT01957202|11776715|FG014|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
10618613|NCT01957202|11776716|FG015|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
10618614|NCT01957202|11776717|FG016|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
10618615|NCT01957202|11776718|FG017|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
10618616|NCT01957202|11776701|FG000|STARTED|Treatment Period 3 (8 Days)||3
10618617|NCT01957202|11776702|FG001|STARTED|Treatment Period 3 (8 Days)||5
10618618|NCT01957202|11776703|FG002|STARTED|Treatment Period 3 (8 Days)||6
10618619|NCT01957202|11776704|FG003|STARTED|Treatment Period 3 (8 Days)||3
10618620|NCT01957202|11776705|FG004|STARTED|Treatment Period 3 (8 Days)||3
10618621|NCT01957202|11776706|FG005|STARTED|Treatment Period 3 (8 Days)||2
10618622|NCT01957202|11776707|FG006|STARTED|Treatment Period 3 (8 Days)||3
10618623|NCT01957202|11776708|FG007|STARTED|Treatment Period 3 (8 Days)||3
10618624|NCT01957202|11776709|FG008|STARTED|Treatment Period 3 (8 Days)||3
10618625|NCT01957202|11776710|FG009|STARTED|Treatment Period 3 (8 Days)||6
10618626|NCT01957202|11776711|FG010|STARTED|Treatment Period 3 (8 Days)||3
10618627|NCT01957202|11776712|FG011|STARTED|Treatment Period 3 (8 Days)||6
10618628|NCT01957202|11776713|FG012|STARTED|Treatment Period 3 (8 Days)||3
10618629|NCT01957202|11776714|FG013|STARTED|Treatment Period 3 (8 Days)||3
10618630|NCT01957202|11776715|FG014|STARTED|Treatment Period 3 (8 Days)||6
10618631|NCT01957202|11776716|FG015|STARTED|Treatment Period 3 (8 Days)||3
10618632|NCT01957202|11776717|FG016|STARTED|Treatment Period 3 (8 Days)||5
10618633|NCT01957202|11776718|FG017|STARTED|Treatment Period 3 (8 Days)||3
10618634|NCT01957202|11776701|FG000|COMPLETED|Treatment Period 3 (8 Days)||3
10618635|NCT01957202|11776702|FG001|COMPLETED|Treatment Period 3 (8 Days)||5
10618636|NCT01957202|11776703|FG002|COMPLETED|Treatment Period 3 (8 Days)||6
10618637|NCT01957202|11776704|FG003|COMPLETED|Treatment Period 3 (8 Days)||3
10618638|NCT01957202|11776705|FG004|COMPLETED|Treatment Period 3 (8 Days)||3
10618639|NCT01957202|11776706|FG005|COMPLETED|Treatment Period 3 (8 Days)||2
10618640|NCT01957202|11776707|FG006|COMPLETED|Treatment Period 3 (8 Days)||3
10618641|NCT01957202|11776708|FG007|COMPLETED|Treatment Period 3 (8 Days)||3
10618642|NCT01957202|11776709|FG008|COMPLETED|Treatment Period 3 (8 Days)||3
10618643|NCT01957202|11776710|FG009|COMPLETED|Treatment Period 3 (8 Days)||6
10618644|NCT01957202|11776711|FG010|COMPLETED|Treatment Period 3 (8 Days)||3
10618645|NCT01957202|11776712|FG011|COMPLETED|Treatment Period 3 (8 Days)||6
10618646|NCT01957202|11776713|FG012|COMPLETED|Treatment Period 3 (8 Days)||3
10618647|NCT01957202|11776714|FG013|COMPLETED|Treatment Period 3 (8 Days)||3
10618648|NCT01957202|11776715|FG014|COMPLETED|Treatment Period 3 (8 Days)||6
10618649|NCT01957202|11776716|FG015|COMPLETED|Treatment Period 3 (8 Days)||3
10618650|NCT01957202|11776717|FG016|COMPLETED|Treatment Period 3 (8 Days)||4
10618651|NCT01957202|11776718|FG017|COMPLETED|Treatment Period 3 (8 Days)||3
10618652|NCT01957202|11776701|FG000|NOT COMPLETED|Treatment Period 3 (8 Days)||0
10618653|NCT01957202|11776702|FG001|NOT COMPLETED|Treatment Period 3 (8 Days)||0
10618654|NCT01957202|11776703|FG002|NOT COMPLETED|Treatment Period 3 (8 Days)||0
10618655|NCT01957202|11776704|FG003|NOT COMPLETED|Treatment Period 3 (8 Days)||0
10618656|NCT01957202|11776705|FG004|NOT COMPLETED|Treatment Period 3 (8 Days)||0
10618657|NCT01957202|11776706|FG005|NOT COMPLETED|Treatment Period 3 (8 Days)||0
10618658|NCT01957202|11776707|FG006|NOT COMPLETED|Treatment Period 3 (8 Days)||0
10618659|NCT01957202|11776708|FG007|NOT COMPLETED|Treatment Period 3 (8 Days)||0
10618660|NCT01957202|11776709|FG008|NOT COMPLETED|Treatment Period 3 (8 Days)||0
10618661|NCT01957202|11776710|FG009|NOT COMPLETED|Treatment Period 3 (8 Days)||0
10618662|NCT01957202|11776711|FG010|NOT COMPLETED|Treatment Period 3 (8 Days)||0
10618663|NCT01957202|11776712|FG011|NOT COMPLETED|Treatment Period 3 (8 Days)||0
10618664|NCT01957202|11776713|FG012|NOT COMPLETED|Treatment Period 3 (8 Days)||0
10618665|NCT01957202|11776714|FG013|NOT COMPLETED|Treatment Period 3 (8 Days)||0
10618666|NCT01957202|11776715|FG014|NOT COMPLETED|Treatment Period 3 (8 Days)||0
10618668|NCT01957202|11776717|FG016|NOT COMPLETED|Treatment Period 3 (8 Days)||1
10618669|NCT01957202|11776718|FG017|NOT COMPLETED|Treatment Period 3 (8 Days)||0
10618670|NCT01957215|11776730|FG000|STARTED|Overall Study||135
10618671|NCT01957215|11776731|FG001|STARTED|Overall Study||135
10618672|NCT01957215|11776730|FG000|COMPLETED|Overall Study||122
10618673|NCT01957215|11776731|FG001|COMPLETED|Overall Study||123
10618674|NCT01957215|11776730|FG000|NOT COMPLETED|Overall Study||13
10618675|NCT01957215|11776731|FG001|NOT COMPLETED|Overall Study||12
10618676|NCT01957384|11776741|FG000|STARTED|Test Period 1 (14 Days)||4
10618677|NCT01957384|11776742|FG001|STARTED|Test Period 1 (14 Days)||4
10618678|NCT01957384|11776743|FG002|STARTED|Test Period 1 (14 Days)||4
10618679|NCT01957384|11776744|FG003|STARTED|Test Period 1 (14 Days)||4
10618680|NCT01957384|11776745|FG004|STARTED|Test Period 1 (14 Days)||3
10618681|NCT01957384|11776746|FG005|STARTED|Test Period 1 (14 Days)||3
10618682|NCT01957384|11776741|FG000|COMPLETED|Test Period 1 (14 Days)||4
10618683|NCT01957384|11776742|FG001|COMPLETED|Test Period 1 (14 Days)||4
10618684|NCT01957384|11776743|FG002|COMPLETED|Test Period 1 (14 Days)||4
10618685|NCT01957384|11776744|FG003|COMPLETED|Test Period 1 (14 Days)||4
10618686|NCT01957384|11776745|FG004|COMPLETED|Test Period 1 (14 Days)||3
10618687|NCT01957384|11776746|FG005|COMPLETED|Test Period 1 (14 Days)||3
10618688|NCT01957384|11776741|FG000|NOT COMPLETED|Test Period 1 (14 Days)||0
10618689|NCT01957384|11776742|FG001|NOT COMPLETED|Test Period 1 (14 Days)||0
10618690|NCT01957384|11776743|FG002|NOT COMPLETED|Test Period 1 (14 Days)||0
10618691|NCT01957384|11776744|FG003|NOT COMPLETED|Test Period 1 (14 Days)||0
10618692|NCT01957384|11776745|FG004|NOT COMPLETED|Test Period 1 (14 Days)||0
10618693|NCT01957384|11776746|FG005|NOT COMPLETED|Test Period 1 (14 Days)||0
10618694|NCT01957384|11776741|FG000|STARTED|Test Period 2 (14 Days)||4
10618695|NCT01957384|11776742|FG001|STARTED|Test Period 2 (14 Days)||4
10618696|NCT01957384|11776743|FG002|STARTED|Test Period 2 (14 Days)||4
10618697|NCT01957384|11776744|FG003|STARTED|Test Period 2 (14 Days)||4
10618698|NCT01957384|11776745|FG004|STARTED|Test Period 2 (14 Days)||3
10618699|NCT01957384|11776746|FG005|STARTED|Test Period 2 (14 Days)||3
10618700|NCT01957384|11776741|FG000|COMPLETED|Test Period 2 (14 Days)||4
10618701|NCT01957384|11776742|FG001|COMPLETED|Test Period 2 (14 Days)||4
10618702|NCT01957384|11776743|FG002|COMPLETED|Test Period 2 (14 Days)||4
10618703|NCT01957384|11776744|FG003|COMPLETED|Test Period 2 (14 Days)||4
10618704|NCT01957384|11776745|FG004|COMPLETED|Test Period 2 (14 Days)||3
10618705|NCT01957384|11776746|FG005|COMPLETED|Test Period 2 (14 Days)||3
10618706|NCT01957384|11776741|FG000|NOT COMPLETED|Test Period 2 (14 Days)||0
10618707|NCT01957384|11776742|FG001|NOT COMPLETED|Test Period 2 (14 Days)||0
10618708|NCT01957384|11776743|FG002|NOT COMPLETED|Test Period 2 (14 Days)||0
10618709|NCT01957384|11776744|FG003|NOT COMPLETED|Test Period 2 (14 Days)||0
10618710|NCT01957384|11776745|FG004|NOT COMPLETED|Test Period 2 (14 Days)||0
10618711|NCT01957384|11776746|FG005|NOT COMPLETED|Test Period 2 (14 Days)||0
10618712|NCT01957384|11776741|FG000|STARTED|Test Period 3 (14 Days)||4
10618713|NCT01957384|11776742|FG001|STARTED|Test Period 3 (14 Days)||4
10618714|NCT01957384|11776743|FG002|STARTED|Test Period 3 (14 Days)||4
10618715|NCT01957384|11776744|FG003|STARTED|Test Period 3 (14 Days)||4
10618716|NCT01957384|11776745|FG004|STARTED|Test Period 3 (14 Days)||3
10618717|NCT01957384|11776746|FG005|STARTED|Test Period 3 (14 Days)||3
10618718|NCT01957384|11776741|FG000|COMPLETED|Test Period 3 (14 Days)||4
10618719|NCT01957384|11776742|FG001|COMPLETED|Test Period 3 (14 Days)||4
10618720|NCT01957384|11776743|FG002|COMPLETED|Test Period 3 (14 Days)||4
10618721|NCT01957384|11776744|FG003|COMPLETED|Test Period 3 (14 Days)||4
10618722|NCT01957384|11776745|FG004|COMPLETED|Test Period 3 (14 Days)||3
10618723|NCT01957384|11776746|FG005|COMPLETED|Test Period 3 (14 Days)||3
10618724|NCT01957384|11776741|FG000|NOT COMPLETED|Test Period 3 (14 Days)||0
10618725|NCT01957384|11776742|FG001|NOT COMPLETED|Test Period 3 (14 Days)||0
10618726|NCT01957384|11776743|FG002|NOT COMPLETED|Test Period 3 (14 Days)||0
10618727|NCT01957384|11776744|FG003|NOT COMPLETED|Test Period 3 (14 Days)||0
10618728|NCT01957384|11776745|FG004|NOT COMPLETED|Test Period 3 (14 Days)||0
10618729|NCT01957384|11776746|FG005|NOT COMPLETED|Test Period 3 (14 Days)||0
10618730|NCT01957397|11776754|FG000|STARTED|Baseline Own Product||13
10618731|NCT01957397|11776755|FG001|STARTED|Baseline Own Product||13
10618732|NCT01957397|11776754|FG000|COMPLETED|Baseline Own Product||13
10618733|NCT01957397|11776755|FG001|COMPLETED|Baseline Own Product||13
10618734|NCT01957397|11776754|FG000|NOT COMPLETED|Baseline Own Product||0
10618735|NCT01957397|11776755|FG001|NOT COMPLETED|Baseline Own Product||0
10618736|NCT01957397|11776754|FG000|STARTED|Test Period 1||13
10618737|NCT01957397|11776755|FG001|STARTED|Test Period 1||13
10618738|NCT01957397|11776754|FG000|COMPLETED|Test Period 1||11
10618739|NCT01957397|11776755|FG001|COMPLETED|Test Period 1||12
10618740|NCT01957397|11776754|FG000|NOT COMPLETED|Test Period 1||2
10618741|NCT01957397|11776755|FG001|NOT COMPLETED|Test Period 1||1
10618742|NCT01957397|11776754|FG000|STARTED|Test Period 2||11
10618743|NCT01957397|11776755|FG001|STARTED|Test Period 2||12
10618744|NCT01957397|11776754|FG000|COMPLETED|Test Period 2||11
10618745|NCT01957397|11776755|FG001|COMPLETED|Test Period 2||11
10618746|NCT01957397|11776754|FG000|NOT COMPLETED|Test Period 2||0
10618747|NCT01957397|11776755|FG001|NOT COMPLETED|Test Period 2||1
10618748|NCT01957397|11776754|FG000|STARTED|Test Period 3||11
10618749|NCT01957397|11776755|FG001|STARTED|Test Period 3||11
10618750|NCT01957397|11776754|FG000|COMPLETED|Test Period 3||9
10618751|NCT01957397|11776755|FG001|COMPLETED|Test Period 3||9
10618752|NCT01957397|11776754|FG000|NOT COMPLETED|Test Period 3||2
10618753|NCT01957397|11776755|FG001|NOT COMPLETED|Test Period 3||2
10618754|NCT01957410|11776765|FG000|STARTED|Open Label||13
10618755|NCT01957410|11776765|FG000|COMPLETED|Open Label||13
10618756|NCT01957410|11776765|FG000|NOT COMPLETED|Open Label||0
10618757|NCT01957410|11776765|FG000|STARTED|Optional Open Label||13
10618758|NCT01957410|11776765|FG000|COMPLETED|Optional Open Label||13
10618759|NCT01957410|11776765|FG000|NOT COMPLETED|Optional Open Label||0
10618760|NCT01957462|11776769|FG000|STARTED|Test Period 1||16
10618761|NCT01957462|11776770|FG001|STARTED|Test Period 1||15
10618762|NCT01957462|11776769|FG000|COMPLETED|Test Period 1||14
10618763|NCT01957462|11776770|FG001|COMPLETED|Test Period 1||15
10618764|NCT01957462|11776769|FG000|NOT COMPLETED|Test Period 1||2
10618765|NCT01957462|11776770|FG001|NOT COMPLETED|Test Period 1||0
10618766|NCT01957462|11776769|FG000|STARTED|Test Period 2||14
10618767|NCT01957462|11776770|FG001|STARTED|Test Period 2||15
10618768|NCT01957462|11776769|FG000|COMPLETED|Test Period 2||14
10618769|NCT01957462|11776770|FG001|COMPLETED|Test Period 2||15
10618770|NCT01957462|11776769|FG000|NOT COMPLETED|Test Period 2||0
10618771|NCT01957462|11776770|FG001|NOT COMPLETED|Test Period 2||0
10618772|NCT01957475|11776776|FG000|STARTED|Test Period 1||10
10618773|NCT01957475|11776777|FG001|STARTED|Test Period 1||10
10618774|NCT01957475|11776776|FG000|COMPLETED|Test Period 1||8
10618775|NCT01957475|11776777|FG001|COMPLETED|Test Period 1||9
10618776|NCT01957475|11776776|FG000|NOT COMPLETED|Test Period 1||2
10618777|NCT01957475|11776777|FG001|NOT COMPLETED|Test Period 1||1
10618778|NCT01957475|11776776|FG000|STARTED|Test Period 2||9
10618779|NCT01957475|11776777|FG001|STARTED|Test Period 2||8
10618780|NCT01957475|11776776|FG000|COMPLETED|Test Period 2||8
10618781|NCT01957475|11776777|FG001|COMPLETED|Test Period 2||8
10618782|NCT01957475|11776776|FG000|NOT COMPLETED|Test Period 2||1
10618783|NCT01957475|11776777|FG001|NOT COMPLETED|Test Period 2||0
10618784|NCT01957488|11776783|FG000|STARTED|Test Period 1 (2 Weeks)||30
10618785|NCT01957488|11776784|FG001|STARTED|Test Period 1 (2 Weeks)||31
10618786|NCT01957488|11776785|FG002|STARTED|Test Period 1 (2 Weeks)||30
10618787|NCT01957488|11776786|FG003|STARTED|Test Period 1 (2 Weeks)||32
10618788|NCT01957488|11776787|FG004|STARTED|Test Period 1 (2 Weeks)||30
10618789|NCT01957488|11776788|FG005|STARTED|Test Period 1 (2 Weeks)||30
10618790|NCT01957488|11776783|FG000|COMPLETED|Test Period 1 (2 Weeks)||27
10618791|NCT01957488|11776784|FG001|COMPLETED|Test Period 1 (2 Weeks)||28
10618792|NCT01957488|11776785|FG002|COMPLETED|Test Period 1 (2 Weeks)||26
10618793|NCT01957488|11776786|FG003|COMPLETED|Test Period 1 (2 Weeks)||29
10618794|NCT01957488|11776787|FG004|COMPLETED|Test Period 1 (2 Weeks)||27
10618795|NCT01957488|11776788|FG005|COMPLETED|Test Period 1 (2 Weeks)||24
10618796|NCT01957488|11776783|FG000|NOT COMPLETED|Test Period 1 (2 Weeks)||3
10618797|NCT01957488|11776784|FG001|NOT COMPLETED|Test Period 1 (2 Weeks)||3
10618798|NCT01957488|11776785|FG002|NOT COMPLETED|Test Period 1 (2 Weeks)||4
10618799|NCT01957488|11776786|FG003|NOT COMPLETED|Test Period 1 (2 Weeks)||3
10618800|NCT01957488|11776787|FG004|NOT COMPLETED|Test Period 1 (2 Weeks)||3
10618801|NCT01957488|11776788|FG005|NOT COMPLETED|Test Period 1 (2 Weeks)||6
10618802|NCT01957488|11776783|FG000|STARTED|Test Period 2 (2 Weeks)||27
10618803|NCT01957488|11776784|FG001|STARTED|Test Period 2 (2 Weeks)||28
10618804|NCT01957488|11776785|FG002|STARTED|Test Period 2 (2 Weeks)||26
10618805|NCT01957488|11776786|FG003|STARTED|Test Period 2 (2 Weeks)||29
10618806|NCT01957488|11776787|FG004|STARTED|Test Period 2 (2 Weeks)||27
10618807|NCT01957488|11776788|FG005|STARTED|Test Period 2 (2 Weeks)||24
10618808|NCT01957488|11776783|FG000|COMPLETED|Test Period 2 (2 Weeks)||24
10618809|NCT01957488|11776784|FG001|COMPLETED|Test Period 2 (2 Weeks)||27
10618810|NCT01957488|11776785|FG002|COMPLETED|Test Period 2 (2 Weeks)||25
10618811|NCT01957488|11776786|FG003|COMPLETED|Test Period 2 (2 Weeks)||28
10618812|NCT01957488|11776787|FG004|COMPLETED|Test Period 2 (2 Weeks)||25
10618813|NCT01957488|11776788|FG005|COMPLETED|Test Period 2 (2 Weeks)||23
10618814|NCT01957488|11776783|FG000|NOT COMPLETED|Test Period 2 (2 Weeks)||3
10618815|NCT01957488|11776784|FG001|NOT COMPLETED|Test Period 2 (2 Weeks)||1
10618816|NCT01957488|11776785|FG002|NOT COMPLETED|Test Period 2 (2 Weeks)||1
10618817|NCT01957488|11776786|FG003|NOT COMPLETED|Test Period 2 (2 Weeks)||1
10618818|NCT01957488|11776787|FG004|NOT COMPLETED|Test Period 2 (2 Weeks)||2
10618819|NCT01957488|11776788|FG005|NOT COMPLETED|Test Period 2 (2 Weeks)||1
10618820|NCT01957488|11776783|FG000|STARTED|Test Period 3 (2 Weeks)||24
10618821|NCT01957488|11776784|FG001|STARTED|Test Period 3 (2 Weeks)||27
10618822|NCT01957488|11776785|FG002|STARTED|Test Period 3 (2 Weeks)||25
10618823|NCT01957488|11776786|FG003|STARTED|Test Period 3 (2 Weeks)||28
10618824|NCT01957488|11776787|FG004|STARTED|Test Period 3 (2 Weeks)||25
10618825|NCT01957488|11776788|FG005|STARTED|Test Period 3 (2 Weeks)||23
10618826|NCT01957488|11776783|FG000|COMPLETED|Test Period 3 (2 Weeks)||23
10618827|NCT01957488|11776784|FG001|COMPLETED|Test Period 3 (2 Weeks)||26
10618828|NCT01957488|11776785|FG002|COMPLETED|Test Period 3 (2 Weeks)||25
10618829|NCT01957488|11776786|FG003|COMPLETED|Test Period 3 (2 Weeks)||28
10618830|NCT01957488|11776787|FG004|COMPLETED|Test Period 3 (2 Weeks)||25
10618831|NCT01957488|11776788|FG005|COMPLETED|Test Period 3 (2 Weeks)||23
10618832|NCT01957488|11776783|FG000|NOT COMPLETED|Test Period 3 (2 Weeks)||1
10618833|NCT01957488|11776784|FG001|NOT COMPLETED|Test Period 3 (2 Weeks)||1
10618834|NCT01957488|11776785|FG002|NOT COMPLETED|Test Period 3 (2 Weeks)||0
10618835|NCT01957488|11776786|FG003|NOT COMPLETED|Test Period 3 (2 Weeks)||0
10618836|NCT01957488|11776787|FG004|NOT COMPLETED|Test Period 3 (2 Weeks)||0
10618837|NCT01957488|11776788|FG005|NOT COMPLETED|Test Period 3 (2 Weeks)||0
10618838|NCT01957553|11776796|FG000|STARTED|Test Period 1 (21 +- 1 Days)||61
10618839|NCT01957553|11776797|FG001|STARTED|Test Period 1 (21 +- 1 Days)||66
10618840|NCT01957553|11776796|FG000|COMPLETED|Test Period 1 (21 +- 1 Days)||54
10618841|NCT01957553|11776797|FG001|COMPLETED|Test Period 1 (21 +- 1 Days)||63
10618842|NCT01957553|11776796|FG000|NOT COMPLETED|Test Period 1 (21 +- 1 Days)||7
10618843|NCT01957553|11776797|FG001|NOT COMPLETED|Test Period 1 (21 +- 1 Days)||3
10618844|NCT01957553|11776796|FG000|STARTED|Test Period 2 (21 +- 1 Days)||54
10618845|NCT01957553|11776797|FG001|STARTED|Test Period 2 (21 +- 1 Days)||63
10618846|NCT01957553|11776796|FG000|COMPLETED|Test Period 2 (21 +- 1 Days)||51
10618847|NCT01957553|11776797|FG001|COMPLETED|Test Period 2 (21 +- 1 Days)||56
10618848|NCT01957553|11776796|FG000|NOT COMPLETED|Test Period 2 (21 +- 1 Days)||3
10618849|NCT01957553|11776797|FG001|NOT COMPLETED|Test Period 2 (21 +- 1 Days)||7
10618850|NCT01957579|11776807|FG000|STARTED|Overall Study||3
10618851|NCT01957579|11776808|FG001|STARTED|Overall Study||7
10618852|NCT01957579|11776809|FG002|STARTED|Overall Study||4
10618853|NCT01957579|11776810|FG003|STARTED|Overall Study||6
10618854|NCT01957579|11776807|FG000|COMPLETED|Overall Study||3
10618855|NCT01957579|11776808|FG001|COMPLETED|Overall Study||6
10618856|NCT01957579|11776809|FG002|COMPLETED|Overall Study||2
10618857|NCT01957579|11776810|FG003|COMPLETED|Overall Study||6
10618858|NCT01957579|11776807|FG000|NOT COMPLETED|Overall Study||0
10618859|NCT01957579|11776808|FG001|NOT COMPLETED|Overall Study||1
10618860|NCT01957579|11776809|FG002|NOT COMPLETED|Overall Study||2
10618861|NCT01957579|11776810|FG003|NOT COMPLETED|Overall Study||0
10618862|NCT01957644|11776842|FG000|STARTED|Overall Study||6
10618863|NCT01957644|11776843|FG001|STARTED|Overall Study||6
10618864|NCT01957644|11776844|FG002|STARTED|Overall Study||1
10618865|NCT01957644|11776845|FG003|STARTED|Overall Study||2
10618866|NCT01957644|11776846|FG004|STARTED|Overall Study||1
10618867|NCT01957644|11776842|FG000|COMPLETED|Overall Study||0
10618868|NCT01957644|11776843|FG001|COMPLETED|Overall Study||0
10618869|NCT01957644|11776844|FG002|COMPLETED|Overall Study||0
10618870|NCT01957644|11776845|FG003|COMPLETED|Overall Study||0
10618871|NCT01957644|11776846|FG004|COMPLETED|Overall Study||0
10618872|NCT01957644|11776842|FG000|NOT COMPLETED|Overall Study||6
10618873|NCT01957644|11776843|FG001|NOT COMPLETED|Overall Study||6
10618874|NCT01957644|11776844|FG002|NOT COMPLETED|Overall Study||1
10618875|NCT01957644|11776845|FG003|NOT COMPLETED|Overall Study||2
10618876|NCT01957644|11776846|FG004|NOT COMPLETED|Overall Study||1
10618877|NCT01957657|11776860|FG000|STARTED|Overall Study||4
10618878|NCT01957657|11776860|FG000|COMPLETED|Overall Study||4
10618879|NCT01957657|11776860|FG000|NOT COMPLETED|Overall Study||0
10618880|NCT01957709|11776864|FG000|STARTED|Overall Study||8
10618881|NCT01957709|11776864|FG000|COMPLETED|Overall Study||7
10618882|NCT01957709|11776864|FG000|NOT COMPLETED|Overall Study||1
10618883|NCT01957761|11776868|FG000|STARTED|Overall Study||189
10618884|NCT01957761|11776868|FG000|COMPLETED|Overall Study||189
10618885|NCT01957761|11776868|FG000|NOT COMPLETED|Overall Study||0
10618886|NCT01957787|11776872|FG000|STARTED|Overall Study|Participant who was withdrawn prior to study treatment was not included in Number of Index Tumors.|131
10618887|NCT01957787|11776872|FG000|Intent-to-Treat (ITT) Population|Overall Study||130
10618888|NCT01957787|11776872|FG000|Modified ITT (mITT) Population|Overall Study||128
10618889|NCT01957787|11776872|FG000|COMPLETED|Overall Study||95
10618890|NCT01957787|11776872|FG000|NOT COMPLETED|Overall Study||36
10618891|NCT01957865|11776879|FG000|STARTED|Overall Study||21
10618892|NCT01957865|11776880|FG001|STARTED|Overall Study||20
10618893|NCT01957865|11776881|FG002|STARTED|Overall Study||22
10618894|NCT01957865|11776879|FG000|COMPLETED|Overall Study||21
10618895|NCT01957865|11776880|FG001|COMPLETED|Overall Study||18
10618896|NCT01957865|11776881|FG002|COMPLETED|Overall Study||19
10618897|NCT01957865|11776879|FG000|NOT COMPLETED|Overall Study||0
10618898|NCT01957865|11776880|FG001|NOT COMPLETED|Overall Study||2
10618899|NCT01957865|11776881|FG002|NOT COMPLETED|Overall Study||3
10618900|NCT01957930|11776893|FG000|STARTED|Overall Study||35
10618901|NCT01957930|11776894|FG001|STARTED|Overall Study||37
10704955|NCT02595008|11869356|FG000|NOT COMPLETED|Overall Study||1
10704956|NCT02595008|11869357|FG001|NOT COMPLETED|Overall Study||0
10704957|NCT02595073|11869365|FG000|STARTED|Overall Study||61
10704958|NCT02595073|11869366|FG001|STARTED|Overall Study||63
10704959|NCT02595073|11869365|FG000|COMPLETED|Overall Study||59
10704960|NCT02595073|11869366|FG001|COMPLETED|Overall Study||62
10704961|NCT02595073|11869365|FG000|NOT COMPLETED|Overall Study||2
10704962|NCT02595073|11869366|FG001|NOT COMPLETED|Overall Study||1
10704963|NCT02595398|11869374|FG000|STARTED|Overall Study||96
10618902|NCT01957930|11776895|FG002|STARTED|Overall Study||19
10618903|NCT01957930|11776893|FG000|COMPLETED|Overall Study||35
10618904|NCT01957930|11776894|FG001|COMPLETED|Overall Study||37
10618905|NCT01957930|11776895|FG002|COMPLETED|Overall Study||19
10618906|NCT01957930|11776893|FG000|NOT COMPLETED|Overall Study||0
10618907|NCT01957930|11776894|FG001|NOT COMPLETED|Overall Study||0
10618908|NCT01957930|11776895|FG002|NOT COMPLETED|Overall Study||0
10618909|NCT01958008|11776906|FG000|STARTED|Overall Study||21
10618910|NCT01958008|11776907|FG001|STARTED|Overall Study||21
10618911|NCT01958008|11776908|FG002|STARTED|Overall Study||21
10618912|NCT01958008|11776909|FG003|STARTED|Overall Study||21
10618913|NCT01958008|11776906|FG000|COMPLETED|Overall Study||20
10618914|NCT01958008|11776907|FG001|COMPLETED|Overall Study||21
10618915|NCT01958008|11776908|FG002|COMPLETED|Overall Study||20
10618916|NCT01958008|11776909|FG003|COMPLETED|Overall Study||21
10618917|NCT01958008|11776906|FG000|NOT COMPLETED|Overall Study||1
10618918|NCT01958008|11776907|FG001|NOT COMPLETED|Overall Study||0
10618919|NCT01958008|11776908|FG002|NOT COMPLETED|Overall Study||1
10618920|NCT01958008|11776909|FG003|NOT COMPLETED|Overall Study||0
10618921|NCT01958060|11776928|FG000|STARTED|Overall Study||10
10618922|NCT01958060|11776929|FG001|STARTED|Overall Study||6
10618923|NCT01958060|11776930|FG002|STARTED|Overall Study||6
10618924|NCT01958060|11776931|FG003|STARTED|Overall Study||5
10618925|NCT01958060|11776932|FG004|STARTED|Overall Study||7
10618926|NCT01958060|11776933|FG005|STARTED|Overall Study||1
10618927|NCT01958060|11776928|FG000|COMPLETED|Overall Study||8
10618928|NCT01958060|11776929|FG001|COMPLETED|Overall Study||6
10618929|NCT01958060|11776930|FG002|COMPLETED|Overall Study||6
10618930|NCT01958060|11776931|FG003|COMPLETED|Overall Study||5
10618931|NCT01958060|11776932|FG004|COMPLETED|Overall Study|One subject in the 50 mg iv dose group did not receive complete dose of trial medication.|6
10618932|NCT01958060|11776933|FG005|COMPLETED|Overall Study|One subject in the 100 mg iv dose group did not receive complete dose of trial medication.|1
10618933|NCT01958060|11776928|FG000|NOT COMPLETED|Overall Study||2
10618934|NCT01958060|11776929|FG001|NOT COMPLETED|Overall Study||0
10618935|NCT01958060|11776930|FG002|NOT COMPLETED|Overall Study||0
10618936|NCT01958060|11776931|FG003|NOT COMPLETED|Overall Study||0
10618937|NCT01958060|11776932|FG004|NOT COMPLETED|Overall Study||1
10618938|NCT01958060|11776933|FG005|NOT COMPLETED|Overall Study||0
10618939|NCT01958073|11776954|FG000|STARTED|Randomized Period||9
10618940|NCT01958073|11776955|FG001|STARTED|Randomized Period||9
10618941|NCT01958073|11776956|FG002|STARTED|Randomized Period||17
10618942|NCT01958073|11776957|FG003|STARTED|Randomized Period||0
10618943|NCT01958073|11776958|FG004|STARTED|Randomized Period||0
10618944|NCT01958073|11776954|FG000|COMPLETED|Randomized Period||7
10618945|NCT01958073|11776955|FG001|COMPLETED|Randomized Period||8
10618946|NCT01958073|11776956|FG002|COMPLETED|Randomized Period||11
10618947|NCT01958073|11776957|FG003|COMPLETED|Randomized Period||0
10618948|NCT01958073|11776958|FG004|COMPLETED|Randomized Period||0
10704964|NCT02595398|11869375|FG001|STARTED|Overall Study||64
10704965|NCT02595398|11869374|FG000|Intention-to-Treat (ITT) Population|Overall Study||96
10704966|NCT02595398|11869375|FG001|Intention-to-Treat (ITT) Population|Overall Study||64
10618949|NCT01958073|11776954|FG000|NOT COMPLETED|Randomized Period||2
10618950|NCT01958073|11776955|FG001|NOT COMPLETED|Randomized Period||1
10618951|NCT01958073|11776956|FG002|NOT COMPLETED|Randomized Period||6
10618952|NCT01958073|11776957|FG003|NOT COMPLETED|Randomized Period||0
10618953|NCT01958073|11776958|FG004|NOT COMPLETED|Randomized Period||0
10618954|NCT01958073|11776954|FG000|STARTED|Open Label Period||0
10618955|NCT01958073|11776955|FG001|STARTED|Open Label Period||0
10618956|NCT01958073|11776956|FG002|STARTED|Open Label Period||0
10618957|NCT01958073|11776957|FG003|STARTED|Open Label Period||5
10704967|NCT02595398|11869374|FG000|Safety Population|Overall Study||96
10704968|NCT02595398|11869375|FG001|Safety Population|Overall Study||64
10704969|NCT02595398|11869374|FG000|COMPLETED|Overall Study||92
10618958|NCT01958073|11776958|FG004|STARTED|Open Label Period||17
10618959|NCT01958073|11776954|FG000|COMPLETED|Open Label Period||0
10618960|NCT01958073|11776955|FG001|COMPLETED|Open Label Period||0
10618961|NCT01958073|11776956|FG002|COMPLETED|Open Label Period||0
10618962|NCT01958073|11776957|FG003|COMPLETED|Open Label Period||5
10618963|NCT01958073|11776958|FG004|COMPLETED|Open Label Period||17
10618964|NCT01958073|11776954|FG000|NOT COMPLETED|Open Label Period||0
10618965|NCT01958073|11776955|FG001|NOT COMPLETED|Open Label Period||0
10618966|NCT01958073|11776956|FG002|NOT COMPLETED|Open Label Period||0
10618967|NCT01958073|11776957|FG003|NOT COMPLETED|Open Label Period||0
10618968|NCT01958073|11776958|FG004|NOT COMPLETED|Open Label Period||0
10618969|NCT01958112|11776974|FG000|STARTED|Overall Study||14
10618970|NCT01958112|11776974|FG000|COMPLETED|Overall Study||14
10618971|NCT01958112|11776974|FG000|NOT COMPLETED|Overall Study||0
10618972|NCT01958125|11776980|FG000|STARTED|Overall Study||50
10618973|NCT01958125|11776981|FG001|STARTED|Overall Study||52
10618974|NCT01958125|11776980|FG000|COMPLETED|Overall Study||48
10618975|NCT01958125|11776981|FG001|COMPLETED|Overall Study||44
10618976|NCT01958125|11776980|FG000|NOT COMPLETED|Overall Study||2
10618977|NCT01958125|11776981|FG001|NOT COMPLETED|Overall Study||8
10618978|NCT01958164|11776989|FG000|STARTED|Overall Study|Randomised and treated|6
10618979|NCT01958164|11776990|FG001|STARTED|Overall Study|Randomised and treated|10
10618980|NCT01958164|11776989|FG000|COMPLETED|Overall Study||4
10618981|NCT01958164|11776990|FG001|COMPLETED|Overall Study||5
10618982|NCT01958164|11776989|FG000|NOT COMPLETED|Overall Study||2
10618983|NCT01958164|11776990|FG001|NOT COMPLETED|Overall Study||5
10618984|NCT01958281|11776999|FG000|STARTED|Overall Study||10
10618985|NCT01958281|11777000|FG001|STARTED|Overall Study||10
10618986|NCT01958281|11777001|FG002|STARTED|Overall Study||18
10618987|NCT01958281|11776999|FG000|COMPLETED|Overall Study||4
10618988|NCT01958281|11777000|FG001|COMPLETED|Overall Study||6
10618989|NCT01958281|11777001|FG002|COMPLETED|Overall Study||18
10618990|NCT01958281|11776999|FG000|NOT COMPLETED|Overall Study||6
10618991|NCT01958281|11777000|FG001|NOT COMPLETED|Overall Study||4
10618992|NCT01958281|11777001|FG002|NOT COMPLETED|Overall Study||0
10618993|NCT01958294|11777010|FG000|STARTED|Overall Study||12
10618994|NCT01958294|11777010|FG000|COMPLETED|Overall Study||10
10618995|NCT01958294|11777010|FG000|NOT COMPLETED|Overall Study||2
10618996|NCT01958320|11777016|FG000|STARTED|Overall Study||104
10618997|NCT01958320|11777017|FG001|STARTED|Overall Study||98
10618998|NCT01958320|11777016|FG000|COMPLETED|Overall Study||104
10618999|NCT01958320|11777017|FG001|COMPLETED|Overall Study||98
10619000|NCT01958320|11777016|FG000|NOT COMPLETED|Overall Study||0
10619001|NCT01958320|11777017|FG001|NOT COMPLETED|Overall Study||0
10619002|NCT01958346|11777027|FG000|STARTED|Overall Study||39
10619003|NCT01958346|11777028|FG001|STARTED|Overall Study||39
10619004|NCT01958346|11777027|FG000|COMPLETED|Overall Study||39
10619005|NCT01958346|11777028|FG001|COMPLETED|Overall Study||39
10619006|NCT01958346|11777027|FG000|NOT COMPLETED|Overall Study||0
10619007|NCT01958346|11777028|FG001|NOT COMPLETED|Overall Study||0
10619008|NCT01958437|11777036|FG000|STARTED|Overall Study||11
10619009|NCT01958437|11777037|FG001|STARTED|Overall Study||11
10619010|NCT01958437|11777038|FG002|STARTED|Overall Study||11
10619011|NCT01958437|11777039|FG003|STARTED|Overall Study||11
10619012|NCT01958437|11777036|FG000|COMPLETED|Overall Study||11
10619013|NCT01958437|11777037|FG001|COMPLETED|Overall Study||11
10619014|NCT01958437|11777038|FG002|COMPLETED|Overall Study||10
10619015|NCT01958437|11777039|FG003|COMPLETED|Overall Study||10
10619016|NCT01958437|11777036|FG000|NOT COMPLETED|Overall Study||0
10619017|NCT01958437|11777037|FG001|NOT COMPLETED|Overall Study||0
10619018|NCT01958437|11777038|FG002|NOT COMPLETED|Overall Study||1
10619019|NCT01958437|11777039|FG003|NOT COMPLETED|Overall Study||1
10619020|NCT01958476|11777058|FG000|STARTED|Overall Study||59
10619021|NCT01958476|11777059|FG001|STARTED|Overall Study||58
10619022|NCT01958476|11777058|FG000|COMPLETED|Overall Study||58
10619023|NCT01958476|11777059|FG001|COMPLETED|Overall Study||58
10619024|NCT01958476|11777058|FG000|NOT COMPLETED|Overall Study||1
10619025|NCT01958476|11777059|FG001|NOT COMPLETED|Overall Study||0
10619026|NCT01958489|11777065|FG000|STARTED|Period 1||24
10619027|NCT01958489|11777066|FG001|STARTED|Period 1||0
10619028|NCT01958489|11777065|FG000|Received at Least 1 Dose of Study Drug|Period 1||24
10619029|NCT01958489|11777066|FG001|Received at Least 1 Dose of Study Drug|Period 1||0
10619030|NCT01958489|11777065|FG000|COMPLETED|Period 1||24
10619031|NCT01958489|11777066|FG001|COMPLETED|Period 1||0
10619032|NCT01958489|11777065|FG000|NOT COMPLETED|Period 1||0
10619033|NCT01958489|11777066|FG001|NOT COMPLETED|Period 1||0
10619034|NCT01958489|11777065|FG000|STARTED|Period 2|Participants who completed Period 1 treatment crossed over to Period 2 treatment|0
10619035|NCT01958489|11777066|FG001|STARTED|Period 2|Participants who started Period 2 treatment crossed over from Period 1 treatment|24
10619036|NCT01958489|11777065|FG000|Received at Least 1 Dose of Study Drug|Period 2||0
10333861|NCT00336323|11470119|FG002|STARTED|Overall Study||24
10333862|NCT00336323|11470120|FG003|STARTED|Overall Study||22
10333863|NCT00336323|11470121|FG004|STARTED|Overall Study||22
10333864|NCT00336323|11470117|FG000|3 Week Visit|Overall Study||18
10333865|NCT00336323|11470118|FG001|3 Week Visit|Overall Study||21
10333866|NCT00336323|11470119|FG002|3 Week Visit|Overall Study||24
10619037|NCT01958489|11777066|FG001|Received at Least 1 Dose of Study Drug|Period 2||24
10619038|NCT01958489|11777065|FG000|COMPLETED|Period 2||0
10619039|NCT01958489|11777066|FG001|COMPLETED|Period 2||23
10619040|NCT01958489|11777065|FG000|NOT COMPLETED|Period 2||0
10619041|NCT01958489|11777066|FG001|NOT COMPLETED|Period 2||1
10619042|NCT01958606|11777079|FG000|STARTED|Overall Study||13
10619043|NCT01958606|11777080|FG001|STARTED|Overall Study||5
10619044|NCT01958606|11777079|FG000|COMPLETED|Overall Study||11
10619045|NCT01958606|11777080|FG001|COMPLETED|Overall Study||5
10619046|NCT01958606|11777079|FG000|NOT COMPLETED|Overall Study||2
10619047|NCT01958606|11777080|FG001|NOT COMPLETED|Overall Study||0
10619048|NCT01958619|11777090|FG000|STARTED|Overall Study||15
10619049|NCT01958619|11777091|FG001|STARTED|Overall Study||14
10619050|NCT01958619|11777092|FG002|STARTED|Overall Study||14
10619051|NCT01958619|11777093|FG003|STARTED|Overall Study||12
10619052|NCT01958619|11777090|FG000|COMPLETED|Overall Study||13
10619053|NCT01958619|11777091|FG001|COMPLETED|Overall Study||14
10619054|NCT01958619|11777092|FG002|COMPLETED|Overall Study||13
10619055|NCT01958619|11777093|FG003|COMPLETED|Overall Study||12
10619056|NCT01958619|11777090|FG000|NOT COMPLETED|Overall Study||2
10619057|NCT01958619|11777091|FG001|NOT COMPLETED|Overall Study||0
10619058|NCT01958619|11777092|FG002|NOT COMPLETED|Overall Study||1
10619059|NCT01958619|11777093|FG003|NOT COMPLETED|Overall Study||0
10619060|NCT01958645|11777106|FG000|STARTED|Overall Study||4
10619061|NCT01958645|11777107|FG001|STARTED|Overall Study||4
10619062|NCT01958645|11777108|FG002|STARTED|Overall Study||4
10619063|NCT01958645|11777106|FG000|COMPLETED|Overall Study||4
10619064|NCT01958645|11777107|FG001|COMPLETED|Overall Study||4
10619065|NCT01958645|11777108|FG002|COMPLETED|Overall Study||4
10619066|NCT01958645|11777106|FG000|NOT COMPLETED|Overall Study||0
10619067|NCT01958645|11777107|FG001|NOT COMPLETED|Overall Study||0
10619068|NCT01958645|11777108|FG002|NOT COMPLETED|Overall Study||0
10619069|NCT01958671|11777121|FG000|STARTED|Overall Study||156
10619070|NCT01958671|11777122|FG001|STARTED|Overall Study||152
10619071|NCT01958671|11777123|FG002|STARTED|Overall Study||153
10619072|NCT01958671|11777121|FG000|COMPLETED|Overall Study||137
10619073|NCT01958671|11777122|FG001|COMPLETED|Overall Study||128
10619074|NCT01958671|11777123|FG002|COMPLETED|Overall Study||121
10619075|NCT01958671|11777121|FG000|NOT COMPLETED|Overall Study||19
10619076|NCT01958671|11777122|FG001|NOT COMPLETED|Overall Study||24
10619077|NCT01958671|11777123|FG002|NOT COMPLETED|Overall Study||32
10619078|NCT01958788|11777135|FG000|STARTED|Overall Study||7
10619079|NCT01958788|11777135|FG000|COMPLETED|Overall Study||7
10619080|NCT01958788|11777135|FG000|NOT COMPLETED|Overall Study||0
10619081|NCT01958827|11777139|FG000|STARTED|Overall Study||28
10619082|NCT01958827|11777139|FG000|COMPLETED|Overall Study||18
10619083|NCT01958827|11777139|FG000|NOT COMPLETED|Overall Study||10
10619084|NCT01958918|11777145|FG000|STARTED|Overall Study||356
10619085|NCT01958918|11777146|FG001|STARTED|Overall Study||356
10619086|NCT01958918|11777145|FG000|Full Analysis Set|Overall Study||353
10619087|NCT01958918|11777146|FG001|Full Analysis Set|Overall Study||354
10619088|NCT01958918|11777145|FG000|COMPLETED|Overall Study||313
10619089|NCT01958918|11777146|FG001|COMPLETED|Overall Study||314
10619090|NCT01958918|11777145|FG000|NOT COMPLETED|Overall Study||43
10619091|NCT01958918|11777146|FG001|NOT COMPLETED|Overall Study||42
10619092|NCT01959035|11777152|FG000|STARTED|Overall Study||88
10619093|NCT01959035|11777152|FG000|COMPLETED|Overall Study||77
10619094|NCT01959035|11777152|FG000|NOT COMPLETED|Overall Study||11
10619095|NCT01959048|11777156|FG000|STARTED|Overall Study||3
10619096|NCT01959048|11777156|FG000|COMPLETED|Overall Study||3
10619097|NCT01959048|11777156|FG000|NOT COMPLETED|Overall Study||0
10619098|NCT01959113|11777160|FG000|STARTED|Overall Study||5
10619099|NCT01959113|11777160|FG000|COMPLETED|Overall Study||5
10619100|NCT01959113|11777160|FG000|NOT COMPLETED|Overall Study||0
10619101|NCT01959165|11777170|FG000|STARTED|Overall Study||13
10619102|NCT01959165|11777171|FG001|STARTED|Overall Study|1 patient discontinued the study without any treatment out of 11 patients.|11
10619103|NCT01959165|11777172|FG002|STARTED|Overall Study||12
10619104|NCT01959165|11777173|FG003|STARTED|Overall Study||9
10619105|NCT01959165|11777170|FG000|COMPLETED|Overall Study||12
10619106|NCT01959165|11777171|FG001|COMPLETED|Overall Study||10
10619107|NCT01959165|11777172|FG002|COMPLETED|Overall Study||12
10619108|NCT01959165|11777173|FG003|COMPLETED|Overall Study||7
10619109|NCT01959165|11777170|FG000|NOT COMPLETED|Overall Study||1
10619110|NCT01959165|11777171|FG001|NOT COMPLETED|Overall Study||1
10619111|NCT01959165|11777172|FG002|NOT COMPLETED|Overall Study||0
10619112|NCT01959165|11777173|FG003|NOT COMPLETED|Overall Study||2
10704970|NCT02595398|11869375|FG001|COMPLETED|Overall Study||63
10619113|NCT01959178|11777183|FG000|STARTED|Overall Study||73
10619114|NCT01959178|11777184|FG001|STARTED|Overall Study||73
10619115|NCT01959178|11777183|FG000|COMPLETED|Overall Study||71
10619116|NCT01959178|11777184|FG001|COMPLETED|Overall Study||71
10619117|NCT01959178|11777183|FG000|NOT COMPLETED|Overall Study||2
10619118|NCT01959178|11777184|FG001|NOT COMPLETED|Overall Study||2
10619119|NCT01959230|11777192|FG000|STARTED|Overall Study||40
10619120|NCT01959230|11777193|FG001|STARTED|Overall Study||20
10619121|NCT01959230|11777192|FG000|Received at Least 1 Dose of Study Drug|Overall Study||40
10619122|NCT01959230|11777193|FG001|Received at Least 1 Dose of Study Drug|Overall Study||20
10619123|NCT01959230|11777192|FG000|COMPLETED|Overall Study||36
10619124|NCT01959230|11777193|FG001|COMPLETED|Overall Study||19
10619125|NCT01959230|11777192|FG000|NOT COMPLETED|Overall Study||4
10619126|NCT01959230|11777193|FG001|NOT COMPLETED|Overall Study||1
10619127|NCT01959243|11777201|FG000|STARTED|Overall Study||337
10619128|NCT01959243|11777202|FG001|STARTED|Overall Study||170
10619129|NCT01959243|11777201|FG000|Received at Least 1 Dose of Study Drug|Overall Study||337
10619130|NCT01959243|11777202|FG001|Received at Least 1 Dose of Study Drug|Overall Study||170
10619131|NCT01959243|11777201|FG000|COMPLETED|Overall Study||324
10619132|NCT01959243|11777202|FG001|COMPLETED|Overall Study||166
10619133|NCT01959243|11777201|FG000|NOT COMPLETED|Overall Study||13
10619134|NCT01959243|11777202|FG001|NOT COMPLETED|Overall Study||4
10619135|NCT01959334|11777210|FG000|STARTED|First Dose||26
10619136|NCT01959334|11777211|FG001|STARTED|First Dose||49
10619137|NCT01959334|11777210|FG000|COMPLETED|First Dose|Each Dosing Period separated by at least 7 calendar days.|26
10619138|NCT01959334|11777211|FG001|COMPLETED|First Dose|Each Dosing Period is separated by at least 7 calendar days.|49
10619139|NCT01959334|11777210|FG000|NOT COMPLETED|First Dose||0
10619140|NCT01959334|11777211|FG001|NOT COMPLETED|First Dose||0
10619141|NCT01959334|11777210|FG000|STARTED|Second Dose||26
10619142|NCT01959334|11777211|FG001|STARTED|Second Dose||49
10619143|NCT01959334|11777210|FG000|COMPLETED|Second Dose||25
10619144|NCT01959334|11777211|FG001|COMPLETED|Second Dose||49
10619145|NCT01959334|11777210|FG000|NOT COMPLETED|Second Dose||1
10619146|NCT01959334|11777211|FG001|NOT COMPLETED|Second Dose||0
10619147|NCT01959334|11777210|FG000|STARTED|Third Dose||25
10619148|NCT01959334|11777211|FG001|STARTED|Third Dose||49
10619149|NCT01959334|11777210|FG000|COMPLETED|Third Dose||25
10619150|NCT01959334|11777211|FG001|COMPLETED|Third Dose||48
10619151|NCT01959334|11777210|FG000|NOT COMPLETED|Third Dose||0
10619152|NCT01959334|11777211|FG001|NOT COMPLETED|Third Dose||1
10619153|NCT01959347|11777219|FG000|STARTED|Overall Study||238
10619154|NCT01959347|11777220|FG001|STARTED|Overall Study||242
10619155|NCT01959347|11777219|FG000|COMPLETED|Overall Study||229
10619156|NCT01959347|11777220|FG001|COMPLETED|Overall Study||235
10619157|NCT01959347|11777219|FG000|NOT COMPLETED|Overall Study||9
10619158|NCT01959347|11777220|FG001|NOT COMPLETED|Overall Study||7
10619159|NCT01959412|11777226|FG000|STARTED|Overall Study||15
10619160|NCT01959412|11777227|FG001|STARTED|Overall Study||15
10619161|NCT01959412|11777228|FG002|STARTED|Overall Study||15
10619162|NCT01959412|11777229|FG003|STARTED|Overall Study||15
10619163|NCT01959412|11777230|FG004|STARTED|Overall Study||16
10619164|NCT01959412|11777231|FG005|STARTED|Overall Study||15
10619165|NCT01959412|11777226|FG000|COMPLETED|Overall Study||14
10619166|NCT01959412|11777227|FG001|COMPLETED|Overall Study||14
10619167|NCT01959412|11777228|FG002|COMPLETED|Overall Study||15
10619168|NCT01959412|11777229|FG003|COMPLETED|Overall Study||13
10619169|NCT01959412|11777230|FG004|COMPLETED|Overall Study||13
10619170|NCT01959412|11777231|FG005|COMPLETED|Overall Study||15
10619171|NCT01959412|11777226|FG000|NOT COMPLETED|Overall Study||1
10619172|NCT01959412|11777227|FG001|NOT COMPLETED|Overall Study||1
10619173|NCT01959412|11777228|FG002|NOT COMPLETED|Overall Study||0
10619174|NCT01959412|11777229|FG003|NOT COMPLETED|Overall Study||2
10619175|NCT01959412|11777230|FG004|NOT COMPLETED|Overall Study||3
10619176|NCT01959412|11777231|FG005|NOT COMPLETED|Overall Study||0
10619177|NCT01959425|11777247|FG000|STARTED|Overall Study||32
10619178|NCT01959425|11777248|FG001|STARTED|Overall Study||31
10619179|NCT01959425|11777247|FG000|COMPLETED|Overall Study||20
10619180|NCT01959425|11777248|FG001|COMPLETED|Overall Study||23
10619181|NCT01959425|11777247|FG000|NOT COMPLETED|Overall Study||12
10619182|NCT01959425|11777248|FG001|NOT COMPLETED|Overall Study||8
10619183|NCT01959490|11777257|FG000|STARTED|Overall Study||5
10619184|NCT01959490|11777258|FG001|STARTED|Overall Study||6
10619185|NCT01959490|11777259|FG002|STARTED|Overall Study||5
10619186|NCT01959490|11777257|FG000|COMPLETED|Overall Study||5
10619187|NCT01959490|11777258|FG001|COMPLETED|Overall Study||6
10619188|NCT01959490|11777259|FG002|COMPLETED|Overall Study||5
10619189|NCT01959490|11777257|FG000|NOT COMPLETED|Overall Study||0
10619190|NCT01959490|11777258|FG001|NOT COMPLETED|Overall Study||0
10619191|NCT01959490|11777259|FG002|NOT COMPLETED|Overall Study||0
10619192|NCT01959503|11777269|FG000|STARTED|Overall Study||107
10619193|NCT01959503|11777270|FG001|STARTED|Overall Study||51
10619194|NCT01959503|11777269|FG000|COMPLETED|Overall Study||104
10619195|NCT01959503|11777270|FG001|COMPLETED|Overall Study||49
10619196|NCT01959503|11777269|FG000|NOT COMPLETED|Overall Study||3
10619197|NCT01959503|11777270|FG001|NOT COMPLETED|Overall Study||2
10619198|NCT01959516|11777276|FG000|STARTED|Epoch 1||63
10619199|NCT01959516|11777277|FG001|STARTED|Epoch 1||63
10619200|NCT01959516|11777276|FG000|Safety Population|Epoch 1||62
10619201|NCT01959516|11777277|FG001|Safety Population|Epoch 1||62
10619202|NCT01959516|11777276|FG000|ITT Population|Epoch 1||62
10619203|NCT01959516|11777277|FG001|ITT Population|Epoch 1||62
10619204|NCT01959516|11777276|FG000|COMPLETED|Epoch 1||53
10619205|NCT01959516|11777277|FG001|COMPLETED|Epoch 1||58
10619206|NCT01959516|11777276|FG000|NOT COMPLETED|Epoch 1||10
10619207|NCT01959516|11777277|FG001|NOT COMPLETED|Epoch 1||5
10619208|NCT01959516|11777276|FG000|STARTED|Epoch 2||63
10619209|NCT01959516|11777277|FG001|STARTED|Epoch 2||63
10619210|NCT01959516|11777276|FG000|COMPLETED|Epoch 2||61
10619211|NCT01959516|11777277|FG001|COMPLETED|Epoch 2||62
10619212|NCT01959516|11777276|FG000|NOT COMPLETED|Epoch 2||2
10619213|NCT01959516|11777277|FG001|NOT COMPLETED|Epoch 2||1
10619214|NCT01959529|11777285|FG000|STARTED|Overall Study||3818
10619215|NCT01959529|11777286|FG001|STARTED|Overall Study||3819
10619216|NCT01959529|11777285|FG000|Exposed|Overall Study||3809
10619217|NCT01959529|11777286|FG001|Exposed|Overall Study||3806
10619218|NCT01959529|11777285|FG000|COMPLETED|Overall Study||3742
10619219|NCT01959529|11777286|FG001|COMPLETED|Overall Study||3747
10619220|NCT01959529|11777285|FG000|NOT COMPLETED|Overall Study||76
10619221|NCT01959529|11777286|FG001|NOT COMPLETED|Overall Study||72
10619222|NCT01959542|11777292|FG000|STARTED|Overall Study||15
10619223|NCT01959542|11777292|FG000|Evaluable at Visit 1|Overall Study||12
10619224|NCT01959542|11777292|FG000|Evaluable at Visit 2|Overall Study||12
10619225|NCT01959542|11777292|FG000|COMPLETED|Overall Study||12
10619226|NCT01959542|11777292|FG000|NOT COMPLETED|Overall Study||3
10619227|NCT01959581|11777297|FG000|STARTED|Overall Study||30
10619228|NCT01959581|11777297|FG000|COMPLETED|Overall Study||25
10619229|NCT01959581|11777297|FG000|NOT COMPLETED|Overall Study||5
10619230|NCT01959607|11777303|FG000|STARTED|Washout Period of 1 Day (Day 0)||22
10619231|NCT01959607|11777304|FG001|STARTED|Washout Period of 1 Day (Day 0)||22
10619232|NCT01959607|11777305|FG002|STARTED|Washout Period of 1 Day (Day 0)||9
10619233|NCT01959607|11777306|FG003|STARTED|Washout Period of 1 Day (Day 0)||9
10619234|NCT01959607|11777303|FG000|COMPLETED|Washout Period of 1 Day (Day 0)||22
10619235|NCT01959607|11777304|FG001|COMPLETED|Washout Period of 1 Day (Day 0)||22
10619236|NCT01959607|11777305|FG002|COMPLETED|Washout Period of 1 Day (Day 0)||9
10619237|NCT01959607|11777306|FG003|COMPLETED|Washout Period of 1 Day (Day 0)||9
10619238|NCT01959607|11777303|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
10619239|NCT01959607|11777304|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
10619240|NCT01959607|11777305|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
10619241|NCT01959607|11777306|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
10619242|NCT01959607|11777303|FG000|STARTED|First Intervention (Day 1)||22
10619243|NCT01959607|11777304|FG001|STARTED|First Intervention (Day 1)||22
10619244|NCT01959607|11777305|FG002|STARTED|First Intervention (Day 1)||9
10619245|NCT01959607|11777306|FG003|STARTED|First Intervention (Day 1)||9
10619246|NCT01959607|11777303|FG000|COMPLETED|First Intervention (Day 1)||21
10619247|NCT01959607|11777304|FG001|COMPLETED|First Intervention (Day 1)||21
10619248|NCT01959607|11777305|FG002|COMPLETED|First Intervention (Day 1)||9
10619249|NCT01959607|11777306|FG003|COMPLETED|First Intervention (Day 1)||9
10619250|NCT01959607|11777303|FG000|NOT COMPLETED|First Intervention (Day 1)||1
10619251|NCT01959607|11777304|FG001|NOT COMPLETED|First Intervention (Day 1)||1
10619252|NCT01959607|11777305|FG002|NOT COMPLETED|First Intervention (Day 1)||0
10619253|NCT01959607|11777306|FG003|NOT COMPLETED|First Intervention (Day 1)||0
10619254|NCT01959607|11777303|FG000|STARTED|Washout Period of 1 Day (Day 2)||21
10619255|NCT01959607|11777304|FG001|STARTED|Washout Period of 1 Day (Day 2)||21
10619256|NCT01959607|11777305|FG002|STARTED|Washout Period of 1 Day (Day 2)||9
10619257|NCT01959607|11777306|FG003|STARTED|Washout Period of 1 Day (Day 2)||9
10619258|NCT01959607|11777303|FG000|COMPLETED|Washout Period of 1 Day (Day 2)||21
10619259|NCT01959607|11777304|FG001|COMPLETED|Washout Period of 1 Day (Day 2)||21
10619260|NCT01959607|11777305|FG002|COMPLETED|Washout Period of 1 Day (Day 2)||9
10619261|NCT01959607|11777306|FG003|COMPLETED|Washout Period of 1 Day (Day 2)||9
10619262|NCT01959607|11777303|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
10704971|NCT02595398|11869374|FG000|NOT COMPLETED|Overall Study||4
10704972|NCT02595398|11869375|FG001|NOT COMPLETED|Overall Study||1
10704973|NCT02595437|11869381|FG000|STARTED|Triferic Via IV||22
10704974|NCT02595437|11869381|FG000|COMPLETED|Triferic Via IV||21
10704975|NCT02595437|11869381|FG000|NOT COMPLETED|Triferic Via IV||1
10704976|NCT02595437|11869381|FG000|STARTED|Triferic Via Hemodialysate||21
10704977|NCT02595437|11869381|FG000|COMPLETED|Triferic Via Hemodialysate||21
10704978|NCT02595437|11869381|FG000|NOT COMPLETED|Triferic Via Hemodialysate||0
10704979|NCT02595450|11869393|FG000|STARTED|Overall Study||299
10704980|NCT02595450|11869393|FG000|Treated|Overall Study||291
10704981|NCT02595450|11869393|FG000|COMPLETED|Overall Study||218
10704982|NCT02595450|11869393|FG000|NOT COMPLETED|Overall Study||81
10704983|NCT02595502|11869397|FG000|STARTED|Period 1||143
10704984|NCT02595502|11869398|FG001|STARTED|Period 1||142
10704985|NCT02595502|11869397|FG000|COMPLETED|Period 1||142
10704986|NCT02595502|11869398|FG001|COMPLETED|Period 1||140
10704987|NCT02595502|11869397|FG000|NOT COMPLETED|Period 1||1
10704988|NCT02595502|11869398|FG001|NOT COMPLETED|Period 1||2
10619263|NCT01959607|11777304|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
10619264|NCT01959607|11777305|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
10619265|NCT01959607|11777306|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
10619266|NCT01959607|11777303|FG000|STARTED|Second Intervention (Day 3)||21
10704989|NCT02595502|11869397|FG000|STARTED|Period 2||142
10704990|NCT02595502|11869398|FG001|STARTED|Period 2||140
10704991|NCT02595502|11869397|FG000|COMPLETED|Period 2||141
10704992|NCT02595502|11869398|FG001|COMPLETED|Period 2||138
10704993|NCT02595502|11869397|FG000|NOT COMPLETED|Period 2||1
10619267|NCT01959607|11777304|FG001|STARTED|Second Intervention (Day 3)||21
10619268|NCT01959607|11777305|FG002|STARTED|Second Intervention (Day 3)||9
10619269|NCT01959607|11777306|FG003|STARTED|Second Intervention (Day 3)||9
10619270|NCT01959607|11777303|FG000|COMPLETED|Second Intervention (Day 3)||21
10619271|NCT01959607|11777304|FG001|COMPLETED|Second Intervention (Day 3)||21
10704994|NCT02595502|11869398|FG001|NOT COMPLETED|Period 2||2
10704995|NCT02595502|11869397|FG000|STARTED|Period 3||141
10704996|NCT02595502|11869398|FG001|STARTED|Period 3||138
10619272|NCT01959607|11777305|FG002|COMPLETED|Second Intervention (Day 3)||9
10619273|NCT01959607|11777306|FG003|COMPLETED|Second Intervention (Day 3)||9
10619274|NCT01959607|11777303|FG000|NOT COMPLETED|Second Intervention (Day 3)||0
10619275|NCT01959607|11777304|FG001|NOT COMPLETED|Second Intervention (Day 3)||0
10704997|NCT02595502|11869397|FG000|COMPLETED|Period 3||140
10704998|NCT02595502|11869398|FG001|COMPLETED|Period 3||136
10704999|NCT02595502|11869397|FG000|NOT COMPLETED|Period 3||1
10705000|NCT02595502|11869398|FG001|NOT COMPLETED|Period 3||2
10705001|NCT02595528|11869408|FG000|STARTED|Overall Study||41
10705002|NCT02595528|11869409|FG001|STARTED|Overall Study||40
10705003|NCT02595528|11869410|FG002|STARTED|Overall Study||42
10619276|NCT01959607|11777305|FG002|NOT COMPLETED|Second Intervention (Day 3)||0
10619277|NCT01959607|11777306|FG003|NOT COMPLETED|Second Intervention (Day 3)||0
10619278|NCT01959672|11777315|FG000|STARTED|Overall Study||11
10619279|NCT01959672|11777315|FG000|COMPLETED|Overall Study||10
10619280|NCT01959672|11777315|FG000|NOT COMPLETED|Overall Study||1
10619281|NCT01959685|11777322|FG000|STARTED|Overall Study||9
10619282|NCT01959685|11777322|FG000|COMPLETED|Overall Study||9
10619283|NCT01959685|11777322|FG000|NOT COMPLETED|Overall Study||0
10619305|NCT01959841|11777359|FG000|STARTED|Overall Study||252
10619306|NCT01959841|11777360|FG001|STARTED|Overall Study||250
10619307|NCT01959841|11777361|FG002|STARTED|Overall Study||249
10619308|NCT01959841|11777359|FG000|Full Analysis Set Included|Overall Study||247
10705004|NCT02595528|11869411|FG003|STARTED|Overall Study||40
10705005|NCT02595528|11869408|FG000|COMPLETED|Overall Study||39
10705006|NCT02595528|11869409|FG001|COMPLETED|Overall Study||37
10705007|NCT02595528|11869410|FG002|COMPLETED|Overall Study||41
10705008|NCT02595528|11869411|FG003|COMPLETED|Overall Study||36
10705009|NCT02595528|11869408|FG000|NOT COMPLETED|Overall Study||2
10705010|NCT02595528|11869409|FG001|NOT COMPLETED|Overall Study||3
10705011|NCT02595528|11869410|FG002|NOT COMPLETED|Overall Study||1
10705012|NCT02595528|11869411|FG003|NOT COMPLETED|Overall Study||4
10705013|NCT02595567|11869421|FG000|STARTED|Overall Study||25
10705014|NCT02595567|11869421|FG000|COMPLETED|Overall Study||25
10619309|NCT01959841|11777360|FG001|Full Analysis Set Included|Overall Study||243
10619310|NCT01959841|11777361|FG002|Full Analysis Set Included|Overall Study||245
10619311|NCT01959841|11777359|FG000|Full Analysis Set Excluded|Overall Study||5
10619312|NCT01959841|11777360|FG001|Full Analysis Set Excluded|Overall Study||7
10619313|NCT01959841|11777361|FG002|Full Analysis Set Excluded|Overall Study||4
10619314|NCT01959841|11777359|FG000|Reason FAS Excluding 1|Overall Study||5
10619315|NCT01959841|11777360|FG001|Reason FAS Excluding 1|Overall Study||5
10619316|NCT01959841|11777361|FG002|Reason FAS Excluding 1|Overall Study||4
10619317|NCT01959841|11777359|FG000|Reason FAS Excluding 2|Overall Study||0
10619318|NCT01959841|11777360|FG001|Reason FAS Excluding 2|Overall Study||1
10619319|NCT01959841|11777361|FG002|Reason FAS Excluding 2|Overall Study||0
10619320|NCT01959841|11777359|FG000|Reason FAS Excluding 3|Overall Study||0
10619321|NCT01959841|11777360|FG001|Reason FAS Excluding 3|Overall Study||1
10619322|NCT01959841|11777361|FG002|Reason FAS Excluding 3|Overall Study||0
10619323|NCT01959841|11777359|FG000|COMPLETED|Overall Study||209
10619324|NCT01959841|11777360|FG001|COMPLETED|Overall Study||193
10619325|NCT01959841|11777361|FG002|COMPLETED|Overall Study||206
10619326|NCT01959841|11777359|FG000|NOT COMPLETED|Overall Study||43
10619327|NCT01959841|11777360|FG001|NOT COMPLETED|Overall Study||57
10619328|NCT01959841|11777361|FG002|NOT COMPLETED|Overall Study||43
10619329|NCT01959880|11777373|FG000|STARTED|Overall Study||1132
10619330|NCT01959880|11777374|FG001|STARTED|Overall Study||369
10619331|NCT01959880|11777375|FG002|STARTED|Overall Study||209
10619332|NCT01959880|11777376|FG003|STARTED|Overall Study||181
10619333|NCT01959880|11777373|FG000|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
10619334|NCT01959880|11777374|FG001|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
10705015|NCT02595567|11869421|FG000|NOT COMPLETED|Overall Study||0
10619335|NCT01959880|11777375|FG002|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|1
10619422|NCT01960400|11777489|FG000|STARTED|Overall Study||11
10619336|NCT01959880|11777376|FG003|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
10619337|NCT01959880|11777373|FG000|NOT COMPLETED|Overall Study||1132
10619338|NCT01959880|11777374|FG001|NOT COMPLETED|Overall Study||369
10619339|NCT01959880|11777375|FG002|NOT COMPLETED|Overall Study||208
10619340|NCT01959880|11777376|FG003|NOT COMPLETED|Overall Study||181
10619341|NCT01959919|11777386|FG000|STARTED|Overall Study||86
10705016|NCT02595684|11869427|FG000|STARTED|Overall Study||9
10705017|NCT02595684|11869428|FG001|STARTED|Overall Study||9
10619342|NCT01959919|11777386|FG000|COMPLETED|Overall Study||84
10619343|NCT01959919|11777386|FG000|NOT COMPLETED|Overall Study||2
10619344|NCT01959932|11777393|FG000|STARTED|Overall Study||80
10619345|NCT01959932|11777394|FG001|STARTED|Overall Study||41
10619346|NCT01959932|11777395|FG002|STARTED|Overall Study||39
10619347|NCT01959932|11777393|FG000|COMPLETED|Overall Study||79
10619348|NCT01959932|11777394|FG001|COMPLETED|Overall Study||41
10619349|NCT01959932|11777395|FG002|COMPLETED|Overall Study||39
10619350|NCT01959932|11777393|FG000|NOT COMPLETED|Overall Study||1
10619351|NCT01959932|11777394|FG001|NOT COMPLETED|Overall Study||0
10619352|NCT01959932|11777395|FG002|NOT COMPLETED|Overall Study||0
10619353|NCT01959945|11777408|FG000|STARTED|Overall Study||80
10619354|NCT01959945|11777409|FG001|STARTED|Overall Study||78
10619355|NCT01959945|11777410|FG002|STARTED|Overall Study||28
10619356|NCT01959945|11777411|FG003|STARTED|Overall Study||31
10619357|NCT01959945|11777408|FG000|COMPLETED|Overall Study||76
10619358|NCT01959945|11777409|FG001|COMPLETED|Overall Study||75
10619359|NCT01959945|11777410|FG002|COMPLETED|Overall Study||9
10619360|NCT01959945|11777411|FG003|COMPLETED|Overall Study||15
10619361|NCT01959945|11777408|FG000|NOT COMPLETED|Overall Study||4
10619362|NCT01959945|11777409|FG001|NOT COMPLETED|Overall Study||3
10619363|NCT01959945|11777410|FG002|NOT COMPLETED|Overall Study||19
10619364|NCT01959945|11777411|FG003|NOT COMPLETED|Overall Study||16
10619365|NCT01960075|11777426|FG000|STARTED|Overall Study||149
10619366|NCT01960075|11777427|FG001|STARTED|Overall Study||149
10619367|NCT01960075|11777428|FG002|STARTED|Overall Study||180
10619368|NCT01960075|11777426|FG000|COMPLETED|Overall Study||141
10619369|NCT01960075|11777427|FG001|COMPLETED|Overall Study||146
10619370|NCT01960075|11777428|FG002|COMPLETED|Overall Study||173
10619371|NCT01960075|11777426|FG000|NOT COMPLETED|Overall Study||8
10619372|NCT01960075|11777427|FG001|NOT COMPLETED|Overall Study||3
10619373|NCT01960075|11777428|FG002|NOT COMPLETED|Overall Study||7
10619374|NCT01960114|11777438|FG000|STARTED|Overall Study||134
10619375|NCT01960114|11777439|FG001|STARTED|Overall Study||269
10619376|NCT01960114|11777438|FG000|COMPLETED|Overall Study||133
10619377|NCT01960114|11777439|FG001|COMPLETED|Overall Study||268
10619378|NCT01960114|11777438|FG000|NOT COMPLETED|Overall Study||1
10619379|NCT01960114|11777439|FG001|NOT COMPLETED|Overall Study||1
10619380|NCT01960140|11777445|FG000|STARTED|Period 1 (Days 1-2)||40
10619381|NCT01960140|11777445|FG000|Received Simvastatin|Period 1 (Days 1-2)||40
10619382|NCT01960140|11777445|FG000|COMPLETED|Period 1 (Days 1-2)||40
10619383|NCT01960140|11777445|FG000|NOT COMPLETED|Period 1 (Days 1-2)||0
10619384|NCT01960140|11777445|FG000|STARTED|Period 2 (Days 3-18)||40
10619385|NCT01960140|11777445|FG000|Received At Least 1 Dose of Baricitinib|Period 2 (Days 3-18)||40
10619386|NCT01960140|11777445|FG000|Received Simvastatin|Period 2 (Days 3-18)||38
10619387|NCT01960140|11777445|FG000|COMPLETED|Period 2 (Days 3-18)||38
10619388|NCT01960140|11777445|FG000|NOT COMPLETED|Period 2 (Days 3-18)||2
10619389|NCT01960257|11777453|FG000|STARTED|Stage 1 (1-3 Weeks)||77
10619390|NCT01960257|11777454|FG001|STARTED|Stage 1 (1-3 Weeks)||0
10619391|NCT01960257|11777455|FG002|STARTED|Stage 1 (1-3 Weeks)||0
10619392|NCT01960257|11777453|FG000|COMPLETED|Stage 1 (1-3 Weeks)||61
10619393|NCT01960257|11777454|FG001|COMPLETED|Stage 1 (1-3 Weeks)||0
10619394|NCT01960257|11777455|FG002|COMPLETED|Stage 1 (1-3 Weeks)||0
10619395|NCT01960257|11777453|FG000|NOT COMPLETED|Stage 1 (1-3 Weeks)||16
10619396|NCT01960257|11777454|FG001|NOT COMPLETED|Stage 1 (1-3 Weeks)||0
10619397|NCT01960257|11777455|FG002|NOT COMPLETED|Stage 1 (1-3 Weeks)||0
10619398|NCT01960257|11777453|FG000|STARTED|Stage 2(1-4 Months, Not to Exceed 12wks)||0
10619399|NCT01960257|11777454|FG001|STARTED|Stage 2(1-4 Months, Not to Exceed 12wks)||41
10619400|NCT01960257|11777455|FG002|STARTED|Stage 2(1-4 Months, Not to Exceed 12wks)||20
10619401|NCT01960257|11777453|FG000|COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||0
10619402|NCT01960257|11777454|FG001|COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||41
10619403|NCT01960257|11777455|FG002|COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||20
10619404|NCT01960257|11777453|FG000|NOT COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||0
10619405|NCT01960257|11777454|FG001|NOT COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||0
10619406|NCT01960257|11777455|FG002|NOT COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||0
10619407|NCT01960296|11777467|FG000|STARTED|Overall Study||23
10619408|NCT01960296|11777468|FG001|STARTED|Overall Study||25
10619409|NCT01960296|11777467|FG000|COMPLETED|Overall Study||21
10619410|NCT01960296|11777468|FG001|COMPLETED|Overall Study||22
10619411|NCT01960296|11777467|FG000|NOT COMPLETED|Overall Study||2
10619412|NCT01960296|11777468|FG001|NOT COMPLETED|Overall Study||3
10619413|NCT01960348|11777476|FG000|STARTED|Overall Study||148
10619414|NCT01960348|11777477|FG001|STARTED|Overall Study||77
10619415|NCT01960348|11777476|FG000|COMPLETED|Overall Study||138
10619416|NCT01960348|11777477|FG001|COMPLETED|Overall Study||55
10619417|NCT01960348|11777476|FG000|NOT COMPLETED|Overall Study||10
10619418|NCT01960348|11777477|FG001|NOT COMPLETED|Overall Study||22
10619419|NCT01960387|11777483|FG000|STARTED|Overall Study||2
10619420|NCT01960387|11777483|FG000|COMPLETED|Overall Study||2
10619421|NCT01960387|11777483|FG000|NOT COMPLETED|Overall Study||0
10619423|NCT01960400|11777490|FG001|STARTED|Overall Study||11
10619424|NCT01960400|11777489|FG000|COMPLETED|Overall Study||11
10619425|NCT01960400|11777490|FG001|COMPLETED|Overall Study||11
10619426|NCT01960400|11777489|FG000|NOT COMPLETED|Overall Study||0
10619427|NCT01960400|11777490|FG001|NOT COMPLETED|Overall Study||0
10619428|NCT01960413|11777498|FG000|STARTED|Overall Study||24
10619429|NCT01960413|11777499|FG001|STARTED|Overall Study||22
10619430|NCT01960413|11777498|FG000|COMPLETED|Overall Study||20
10619431|NCT01960413|11777499|FG001|COMPLETED|Overall Study||21
10619432|NCT01960413|11777498|FG000|NOT COMPLETED|Overall Study||4
10619433|NCT01960413|11777499|FG001|NOT COMPLETED|Overall Study||1
10619434|NCT01960465|11777507|FG000|STARTED|Overall Study||138
10619435|NCT01960465|11777508|FG001|STARTED|Overall Study||82
10619436|NCT01960465|11777507|FG000|COMPLETED|Overall Study||118
10619437|NCT01960465|11777508|FG001|COMPLETED|Overall Study||73
10619438|NCT01960465|11777507|FG000|NOT COMPLETED|Overall Study||20
10619439|NCT01960465|11777508|FG001|NOT COMPLETED|Overall Study||9
10619440|NCT01960725|11777516|FG000|STARTED|Overall Study||33
10619441|NCT01960725|11777517|FG001|STARTED|Overall Study||33
10619442|NCT01960725|11777516|FG000|Received First Vaccine|Overall Study||33
10619443|NCT01960725|11777517|FG001|Received First Vaccine|Overall Study||33
10619444|NCT01960725|11777516|FG000|Recieved Second Vaccine|Overall Study||33
10619445|NCT01960725|11777517|FG001|Recieved Second Vaccine|Overall Study||33
10619446|NCT01960725|11777516|FG000|Received Third Vaccine|Overall Study||32
10619447|NCT01960725|11777517|FG001|Received Third Vaccine|Overall Study||32
10619448|NCT01960725|11777516|FG000|COMPLETED|Overall Study||27
10619449|NCT01960725|11777517|FG001|COMPLETED|Overall Study||28
10619450|NCT01960725|11777516|FG000|NOT COMPLETED|Overall Study||6
10619451|NCT01960725|11777517|FG001|NOT COMPLETED|Overall Study||5
10619452|NCT01960790|11777523|FG000|STARTED|Overall Study||473
10619453|NCT01960790|11777523|FG000|COMPLETED|Overall Study||462
10619454|NCT01960790|11777523|FG000|NOT COMPLETED|Overall Study||11
10619455|NCT01960816|11777527|FG000|STARTED|Overall Study||33
10619456|NCT01960816|11777527|FG000|COMPLETED|Overall Study||32
10619457|NCT01960816|11777527|FG000|NOT COMPLETED|Overall Study||1
10619458|NCT01960842|11777531|FG000|STARTED|Overall Study||31
10619459|NCT01960842|11777531|FG000|COMPLETED|Overall Study||28
10619460|NCT01960842|11777531|FG000|NOT COMPLETED|Overall Study||3
10619461|NCT01960855|11777540|FG000|STARTED|Overall Study||56
10619462|NCT01960855|11777541|FG001|STARTED|Overall Study||55
10619463|NCT01960855|11777542|FG002|STARTED|Overall Study||55
10619464|NCT01960855|11777543|FG003|STARTED|Overall Study||55
10619465|NCT01960855|11777544|FG004|STARTED|Overall Study||55
10619466|NCT01960855|11777540|FG000|COMPLETED|Overall Study||45
10619467|NCT01960855|11777541|FG001|COMPLETED|Overall Study||51
10619468|NCT01960855|11777542|FG002|COMPLETED|Overall Study||46
10619469|NCT01960855|11777543|FG003|COMPLETED|Overall Study||51
10619470|NCT01960855|11777544|FG004|COMPLETED|Overall Study||50
10619471|NCT01960855|11777540|FG000|NOT COMPLETED|Overall Study||11
10619472|NCT01960855|11777541|FG001|NOT COMPLETED|Overall Study||4
10619473|NCT01960855|11777542|FG002|NOT COMPLETED|Overall Study||9
10619474|NCT01960855|11777543|FG003|NOT COMPLETED|Overall Study||4
10619475|NCT01960855|11777544|FG004|NOT COMPLETED|Overall Study||5
10619476|NCT01960907|11777558|FG000|STARTED|Overall Study||158
10619477|NCT01960907|11777559|FG001|STARTED|Overall Study||154
10619478|NCT01960907|11777558|FG000|COMPLETED|Overall Study||122
10619479|NCT01960907|11777559|FG001|COMPLETED|Overall Study||109
10619480|NCT01960907|11777558|FG000|NOT COMPLETED|Overall Study||36
10619481|NCT01960907|11777559|FG001|NOT COMPLETED|Overall Study||45
10619482|NCT01960998|11777570|FG000|STARTED|Overall Study||101
10619483|NCT01960998|11777571|FG001|STARTED|Overall Study||96
10619484|NCT01960998|11777570|FG000|COMPLETED|Overall Study||90
10619485|NCT01960998|11777571|FG001|COMPLETED|Overall Study||85
10619486|NCT01960998|11777570|FG000|NOT COMPLETED|Overall Study||11
10619487|NCT01960998|11777571|FG001|NOT COMPLETED|Overall Study||11
10619488|NCT01961089|11777579|FG000|STARTED|Overall Study||40
10619489|NCT01961089|11777579|FG000|COMPLETED|Overall Study||40
10619490|NCT01961089|11777579|FG000|NOT COMPLETED|Overall Study||0
10619491|NCT01961115|11777586|FG000|STARTED|Overall Study||2
10619492|NCT01961115|11777587|FG001|STARTED|Overall Study||0
10619493|NCT01961115|11777588|FG002|STARTED|Overall Study||9
10619494|NCT01961115|11777586|FG000|COMPLETED|Overall Study||0
10619495|NCT01961115|11777587|FG001|COMPLETED|Overall Study||0
10619496|NCT01961115|11777588|FG002|COMPLETED|Overall Study||5
10619497|NCT01961115|11777586|FG000|NOT COMPLETED|Overall Study||2
10619498|NCT01961115|11777587|FG001|NOT COMPLETED|Overall Study||0
10619499|NCT01961115|11777588|FG002|NOT COMPLETED|Overall Study||4
10619500|NCT01961167|11777596|FG000|STARTED|Overall Study||27
10619501|NCT01961167|11777596|FG000|COMPLETED|Overall Study||27
10619502|NCT01961167|11777596|FG000|NOT COMPLETED|Overall Study||0
10653326|NCT02192541|11813795|FG000|STARTED|Overall Study||2
10653327|NCT02192541|11813796|FG001|STARTED|Overall Study||3
10653328|NCT02192541|11813795|FG000|Treated|Overall Study||2
10705018|NCT02595684|11869427|FG000|COMPLETED|Overall Study||9
10705019|NCT02595684|11869428|FG001|COMPLETED|Overall Study||9
10705020|NCT02595684|11869427|FG000|NOT COMPLETED|Overall Study||0
10705021|NCT02595684|11869428|FG001|NOT COMPLETED|Overall Study||0
10653329|NCT02192541|11813796|FG001|Treated|Overall Study||3
10653330|NCT02192541|11813795|FG000|Evaluable for Response|Overall Study||1
10653331|NCT02192541|11813796|FG001|Evaluable for Response|Overall Study||3
10653332|NCT02192541|11813795|FG000|COMPLETED|Overall Study||2
10653333|NCT02192541|11813796|FG001|COMPLETED|Overall Study||3
10653334|NCT02192541|11813795|FG000|NOT COMPLETED|Overall Study||0
10653335|NCT02192541|11813796|FG001|NOT COMPLETED|Overall Study||0
10653336|NCT02192606|11813805|FG000|STARTED|Overall Study||29
10653337|NCT02192606|11813806|FG001|STARTED|Overall Study||28
10653338|NCT02192606|11813805|FG000|COMPLETED|Overall Study||27
10653339|NCT02192606|11813806|FG001|COMPLETED|Overall Study||24
10653340|NCT02192606|11813805|FG000|NOT COMPLETED|Overall Study||2
10705022|NCT02595723|11869437|FG000|STARTED|First Intervention (4 Days)||8
10619503|NCT01961271|11777600|FG000|STARTED|Overall Study||114
10619504|NCT01961271|11777600|FG000|COMPLETED|Overall Study||64
10619505|NCT01961271|11777600|FG000|NOT COMPLETED|Overall Study||50
10619506|NCT01961297|11777606|FG000|STARTED|Overall Study||30
10619507|NCT01961297|11777607|FG001|STARTED|Overall Study||23
10619508|NCT01961297|11777606|FG000|COMPLETED|Overall Study||28
10619509|NCT01961297|11777607|FG001|COMPLETED|Overall Study||22
10619510|NCT01961297|11777606|FG000|NOT COMPLETED|Overall Study||2
10619511|NCT01961297|11777607|FG001|NOT COMPLETED|Overall Study||1
10619512|NCT01961323|11777613|FG000|STARTED|Overall Study||70
10619513|NCT01961323|11777613|FG000|COMPLETED|Overall Study||21
10619514|NCT01961323|11777613|FG000|NOT COMPLETED|Overall Study||49
10619515|NCT01961349|11777620|FG000|STARTED|Overall Study||54
10619516|NCT01961349|11777621|FG001|STARTED|Overall Study||107
10619517|NCT01961349|11777622|FG002|STARTED|Overall Study||111
10619518|NCT01961349|11777620|FG000|COMPLETED|Overall Study||51
10619519|NCT01961349|11777621|FG001|COMPLETED|Overall Study||101
10619520|NCT01961349|11777622|FG002|COMPLETED|Overall Study||109
10619521|NCT01961349|11777620|FG000|NOT COMPLETED|Overall Study||3
10619522|NCT01961349|11777621|FG001|NOT COMPLETED|Overall Study||6
10619523|NCT01961349|11777622|FG002|NOT COMPLETED|Overall Study||2
10619524|NCT01961362|11777630|FG000|STARTED|Overall Study||19
10619525|NCT01961362|11777630|FG000|COMPLETED|Overall Study||19
10619526|NCT01961362|11777630|FG000|NOT COMPLETED|Overall Study||0
10619527|NCT01961544|11777634|FG000|STARTED|Overall Study||101
10619528|NCT01961544|11777634|FG000|COMPLETED|Overall Study||88
10619529|NCT01961544|11777634|FG000|NOT COMPLETED|Overall Study||13
10619530|NCT01961609|11777640|FG000|STARTED|Initiation||119
10619531|NCT01961609|11777641|FG001|STARTED|Initiation||116
10619532|NCT01961609|11777642|FG002|STARTED|Initiation||0
10619533|NCT01961609|11777643|FG003|STARTED|Initiation||0
10619534|NCT01961609|11777640|FG000|Safety Set|Initiation||118
10619535|NCT01961609|11777641|FG001|Safety Set|Initiation||115
10619536|NCT01961609|11777642|FG002|Safety Set|Initiation||0
10619537|NCT01961609|11777643|FG003|Safety Set|Initiation||0
10619538|NCT01961609|11777640|FG000|Full Analysis Set|Initiation||118
10619539|NCT01961609|11777641|FG001|Full Analysis Set|Initiation||115
10619540|NCT01961609|11777642|FG002|Full Analysis Set|Initiation||0
10619541|NCT01961609|11777643|FG003|Full Analysis Set|Initiation||0
10619542|NCT01961609|11777640|FG000|COMPLETED|Initiation||107
10619543|NCT01961609|11777641|FG001|COMPLETED|Initiation||103
10619544|NCT01961609|11777642|FG002|COMPLETED|Initiation||0
10619545|NCT01961609|11777643|FG003|COMPLETED|Initiation||0
10619546|NCT01961609|11777640|FG000|NOT COMPLETED|Initiation||12
10619547|NCT01961609|11777641|FG001|NOT COMPLETED|Initiation||13
10619548|NCT01961609|11777642|FG002|NOT COMPLETED|Initiation||0
10619549|NCT01961609|11777643|FG003|NOT COMPLETED|Initiation||0
10619550|NCT01961609|11777640|FG000|STARTED|Maintenance 1 (Weeks 17 - 48)||107
10619551|NCT01961609|11777641|FG001|STARTED|Maintenance 1 (Weeks 17 - 48)||66
10619552|NCT01961609|11777642|FG002|STARTED|Maintenance 1 (Weeks 17 - 48)||37
10619553|NCT01961609|11777643|FG003|STARTED|Maintenance 1 (Weeks 17 - 48)||0
10619554|NCT01961609|11777640|FG000|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||107
10619555|NCT01961609|11777641|FG001|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||66
10619556|NCT01961609|11777642|FG002|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||37
10619557|NCT01961609|11777643|FG003|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||0
10619558|NCT01961609|11777640|FG000|Safety Set|Maintenance 1 (Weeks 17 - 48)||107
10619559|NCT01961609|11777641|FG001|Safety Set|Maintenance 1 (Weeks 17 - 48)||66
10619560|NCT01961609|11777642|FG002|Safety Set|Maintenance 1 (Weeks 17 - 48)||37
10619561|NCT01961609|11777643|FG003|Safety Set|Maintenance 1 (Weeks 17 - 48)||0
10619562|NCT01961609|11777640|FG000|COMPLETED|Maintenance 1 (Weeks 17 - 48)||84
10333867|NCT00336323|11470120|FG003|3 Week Visit|Overall Study||22
10333868|NCT00336323|11470121|FG004|3 Week Visit|Overall Study|Laser given late at six weeks for one patient|20
10333869|NCT00336323|11470117|FG000|6 Week Visit|Overall Study||18
10333870|NCT00336323|11470118|FG001|6 Week Visit|Overall Study||22
10333871|NCT00336323|11470119|FG002|6 Week Visit|Overall Study||24
10333872|NCT00336323|11470120|FG003|6 Week Visit|Overall Study||22
10333873|NCT00336323|11470121|FG004|6 Week Visit|Overall Study|1 patient was dropped - injection was given late at 9 wks for one patient|20
10619563|NCT01961609|11777641|FG001|COMPLETED|Maintenance 1 (Weeks 17 - 48)||55
10619564|NCT01961609|11777642|FG002|COMPLETED|Maintenance 1 (Weeks 17 - 48)||18
10619565|NCT01961609|11777643|FG003|COMPLETED|Maintenance 1 (Weeks 17 - 48)||0
10619566|NCT01961609|11777640|FG000|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||23
10333874|NCT00336323|11470117|FG000|9 Week Visit|Overall Study||18
10333875|NCT00336323|11470118|FG001|9 Week Visit|Overall Study||21
10619567|NCT01961609|11777641|FG001|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||11
10619568|NCT01961609|11777642|FG002|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||19
10619569|NCT01961609|11777643|FG003|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||0
10619570|NCT01961609|11777640|FG000|STARTED|Maintanence 2 (Weeks 49 - 72)||83
10619571|NCT01961609|11777641|FG001|STARTED|Maintanence 2 (Weeks 49 - 72)||31
10619572|NCT01961609|11777642|FG002|STARTED|Maintanence 2 (Weeks 49 - 72)||16
10619573|NCT01961609|11777643|FG003|STARTED|Maintanence 2 (Weeks 49 - 72)||24
10619574|NCT01961609|11777640|FG000|Safety Set|Maintanence 2 (Weeks 49 - 72)||83
10619575|NCT01961609|11777641|FG001|Safety Set|Maintanence 2 (Weeks 49 - 72)||31
10619576|NCT01961609|11777642|FG002|Safety Set|Maintanence 2 (Weeks 49 - 72)||16
10619577|NCT01961609|11777643|FG003|Safety Set|Maintanence 2 (Weeks 49 - 72)||24
10619578|NCT01961609|11777640|FG000|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||83
10619579|NCT01961609|11777641|FG001|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||31
10619580|NCT01961609|11777642|FG002|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||16
10619581|NCT01961609|11777643|FG003|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||24
10619582|NCT01961609|11777640|FG000|COMPLETED|Maintanence 2 (Weeks 49 - 72)||71
10619583|NCT01961609|11777641|FG001|COMPLETED|Maintanence 2 (Weeks 49 - 72)||25
10619584|NCT01961609|11777642|FG002|COMPLETED|Maintanence 2 (Weeks 49 - 72)||12
10619585|NCT01961609|11777643|FG003|COMPLETED|Maintanence 2 (Weeks 49 - 72)||17
10619586|NCT01961609|11777640|FG000|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||12
10619587|NCT01961609|11777641|FG001|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||6
10619588|NCT01961609|11777642|FG002|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||4
10619589|NCT01961609|11777643|FG003|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||7
10619590|NCT01961687|11777660|FG000|STARTED|Overall Study||121
10619591|NCT01961687|11777660|FG000|COMPLETED|Overall Study||60
10619592|NCT01961687|11777660|FG000|NOT COMPLETED|Overall Study||61
10619593|NCT01961882|11777666|FG000|STARTED|Overall Study||69
10619594|NCT01961882|11777667|FG001|STARTED|Overall Study||65
10619595|NCT01961882|11777666|FG000|COMPLETED|Overall Study||19
10619596|NCT01961882|11777667|FG001|COMPLETED|Overall Study||23
10619597|NCT01961882|11777666|FG000|NOT COMPLETED|Overall Study||50
10619598|NCT01961882|11777667|FG001|NOT COMPLETED|Overall Study||42
10619599|NCT01961921|11777673|FG000|STARTED|Overall Study||27
10619600|NCT01961921|11777673|FG000|COMPLETED|Overall Study||25
10619601|NCT01961921|11777673|FG000|NOT COMPLETED|Overall Study||2
10619602|NCT01962025|11777679|FG000|STARTED|Overall Study||8
10619603|NCT01962025|11777680|FG001|STARTED|Overall Study||6
10619604|NCT01962025|11777679|FG000|COMPLETED|Overall Study||8
10619605|NCT01962025|11777680|FG001|COMPLETED|Overall Study||6
10619606|NCT01962025|11777679|FG000|NOT COMPLETED|Overall Study||0
10619607|NCT01962025|11777680|FG001|NOT COMPLETED|Overall Study||0
10619608|NCT01962103|11777697|FG000|STARTED|Phase 1||16
10619609|NCT01962103|11777698|FG001|STARTED|Phase 1||8
10619610|NCT01962103|11777699|FG002|STARTED|Phase 1||14
10619611|NCT01962103|11777700|FG003|STARTED|Phase 1||11
10619612|NCT01962103|11777701|FG004|STARTED|Phase 1||8
10619613|NCT01962103|11777702|FG005|STARTED|Phase 1||7
10619614|NCT01962103|11777703|FG006|STARTED|Phase 1||0
10619615|NCT01962103|11777704|FG007|STARTED|Phase 1||0
10619616|NCT01962103|11777705|FG008|STARTED|Phase 1||0
10619617|NCT01962103|11777697|FG000|COMPLETED|Phase 1||0
10619618|NCT01962103|11777698|FG001|COMPLETED|Phase 1||0
10808823|NCT03840135|11970816|FG001|NOT COMPLETED|Overall Study||1
10808824|NCT03839641|11970828|FG000|STARTED|Overall Study||5
10808825|NCT03839641|11970829|FG001|STARTED|Overall Study||5
10808826|NCT03839641|11970828|FG000|COMPLETED|Overall Study||4
10808827|NCT03839641|11970829|FG001|COMPLETED|Overall Study||4
10808828|NCT03839641|11970828|FG000|NOT COMPLETED|Overall Study||1
10808829|NCT03839641|11970829|FG001|NOT COMPLETED|Overall Study||1
10808830|NCT03839212|11970837|FG000|STARTED|Overall Study||18
10808831|NCT03839212|11970837|FG000|COMPLETED|Overall Study||14
10808832|NCT03839212|11970837|FG000|NOT COMPLETED|Overall Study||4
10808833|NCT03839355|11970843|FG000|STARTED|Overall Study||18
10808834|NCT03839355|11970844|FG001|STARTED|Overall Study||16
10808835|NCT03839355|11970843|FG000|COMPLETED|Overall Study||17
10808836|NCT03839355|11970844|FG001|COMPLETED|Overall Study||16
10808837|NCT03839355|11970843|FG000|NOT COMPLETED|Overall Study||1
10808838|NCT03839355|11970844|FG001|NOT COMPLETED|Overall Study||0
10808839|NCT03838874|11970852|FG000|STARTED|Overall Study||80
10808840|NCT03838874|11970853|FG001|STARTED|Overall Study||74
10808841|NCT03838874|11970852|FG000|COMPLETED|Overall Study||80
10808842|NCT03838874|11970853|FG001|COMPLETED|Overall Study||74
10808843|NCT03838874|11970852|FG000|NOT COMPLETED|Overall Study||0
10808844|NCT03838874|11970853|FG001|NOT COMPLETED|Overall Study||0
10808845|NCT03838731|11970861|FG000|STARTED|Overall Study||27
10808846|NCT03838731|11970862|FG001|STARTED|Overall Study||29
10808847|NCT03838731|11970861|FG000|COMPLETED|Overall Study||26
10808848|NCT03838731|11970862|FG001|COMPLETED|Overall Study||28
10808849|NCT03838731|11970861|FG000|NOT COMPLETED|Overall Study||1
10808850|NCT03838731|11970862|FG001|NOT COMPLETED|Overall Study||1
10811199|NCT03774433|11972917|FG000|COMPLETED|Overall Study|Participants who completed at least 12 EMAs for inclusion in data analysis|100
10811200|NCT03774433|11972917|FG000|NOT COMPLETED|Overall Study||14
10811201|NCT03771560|11972921|FG000|STARTED|Overall Study||18
10811202|NCT03771560|11972921|FG000|COMPLETED|Overall Study||12
10811203|NCT03771560|11972921|FG000|NOT COMPLETED|Overall Study||6
10619619|NCT01962103|11777699|FG002|COMPLETED|Phase 1||0
10619620|NCT01962103|11777700|FG003|COMPLETED|Phase 1||0
10619621|NCT01962103|11777701|FG004|COMPLETED|Phase 1||0
10619622|NCT01962103|11777702|FG005|COMPLETED|Phase 1||0
10619623|NCT01962103|11777703|FG006|COMPLETED|Phase 1||0
10619624|NCT01962103|11777704|FG007|COMPLETED|Phase 1||0
10619625|NCT01962103|11777705|FG008|COMPLETED|Phase 1||0
10619626|NCT01962103|11777697|FG000|NOT COMPLETED|Phase 1||16
10811204|NCT03770091|11972928|FG000|STARTED|Overall Study||15
10811205|NCT03770091|11972929|FG001|STARTED|Overall Study||13
10811206|NCT03770091|11972930|FG002|STARTED|Overall Study||12
10811207|NCT03770091|11972928|FG000|COMPLETED|Overall Study||15
10811208|NCT03770091|11972929|FG001|COMPLETED|Overall Study||13
10619663|NCT01962207|11777730|FG001|STARTED|Persistence Phase (5 Years)||23
10808851|NCT03838198|11970870|FG000|STARTED|Phase 1: Safety Plan (SP) vs. SP w/Texts|Because it was a SMART trial, no participants were allocated to receive booster calls until Phase 2.|0
10808852|NCT03838198|11970871|FG001|STARTED|Phase 1: Safety Plan (SP) vs. SP w/Texts||40
10808853|NCT03838198|11970872|FG002|STARTED|Phase 1: Safety Plan (SP) vs. SP w/Texts|Because it was a SMART trial, no participants were allocated to receive booster calls until Phase 2.|0
10808854|NCT03838198|11970873|FG003|STARTED|Phase 1: Safety Plan (SP) vs. SP w/Texts||40
10808855|NCT03838198|11970870|FG000|COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0
10808856|NCT03838198|11970871|FG001|COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||40
10808857|NCT03838198|11970872|FG002|COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0
10808858|NCT03838198|11970873|FG003|COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||40
10808859|NCT03838198|11970870|FG000|NOT COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0
10808860|NCT03838198|11970871|FG001|NOT COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0
10808861|NCT03838198|11970872|FG002|NOT COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0
10808862|NCT03838198|11970873|FG003|NOT COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0
10808863|NCT03838198|11970870|FG000|STARTED|Phase 2: Added Booster Call or Not|These participants continued with Phase 1 intervention (Safety plan and text) with added booster call.|18
10808864|NCT03838198|11970871|FG001|STARTED|Phase 2: Added Booster Call or Not|These participants continued with Phase 1 intervention (Safety plan and text) with no added booster call.|22
10808865|NCT03838198|11970872|FG002|STARTED|Phase 2: Added Booster Call or Not|These participants continued with Phase 1 intervention (Safety plan only) with added booster call.|18
10808866|NCT03838198|11970873|FG003|STARTED|Phase 2: Added Booster Call or Not|These participants continued with Phase 1 intervention (Safety plan only) with no added booster call in Phase 2|22
10808867|NCT03838198|11970870|FG000|COMPLETED|Phase 2: Added Booster Call or Not|All 18 completed the safety plan; but only 14 had both parent and adolescent completing the call; 1 had parent only; 1 had adolescent only; 2 were unable to be reached.|18
10808868|NCT03838198|11970871|FG001|COMPLETED|Phase 2: Added Booster Call or Not||0
10808869|NCT03838198|11970872|FG002|COMPLETED|Phase 2: Added Booster Call or Not|Of the 17 who completed the safety plan, only 15 had both parent and adolescent completing the call; 1 had parent only; 1 was unable to be reached.|17
10808870|NCT03838198|11970873|FG003|COMPLETED|Phase 2: Added Booster Call or Not||0
10808871|NCT03838198|11970870|FG000|NOT COMPLETED|Phase 2: Added Booster Call or Not||0
10808872|NCT03838198|11970871|FG001|NOT COMPLETED|Phase 2: Added Booster Call or Not||22
10808873|NCT03838198|11970872|FG002|NOT COMPLETED|Phase 2: Added Booster Call or Not||1
10808874|NCT03838198|11970873|FG003|NOT COMPLETED|Phase 2: Added Booster Call or Not||22
10808875|NCT03838198|11970870|FG000|STARTED|1 Month Follow up Period||18
10808876|NCT03838198|11970871|FG001|STARTED|1 Month Follow up Period|All participants from Phase 1 and 2 were followed unless they withdrew.|22
10808877|NCT03838198|11970872|FG002|STARTED|1 Month Follow up Period||17
10808878|NCT03838198|11970873|FG003|STARTED|1 Month Follow up Period|All participants from Phase 1 and 2 were followed unless they withdrew.|22
10808879|NCT03838198|11970870|FG000|Adolescent Surveys Completed|1 Month Follow up Period||16
10808880|NCT03838198|11970871|FG001|Adolescent Surveys Completed|1 Month Follow up Period||22
10808881|NCT03838198|11970872|FG002|Adolescent Surveys Completed|1 Month Follow up Period||16
10808882|NCT03838198|11970873|FG003|Adolescent Surveys Completed|1 Month Follow up Period||22
10808883|NCT03838198|11970870|FG000|COMPLETED|1 Month Follow up Period||16
10808884|NCT03838198|11970871|FG001|COMPLETED|1 Month Follow up Period||22
10808885|NCT03838198|11970872|FG002|COMPLETED|1 Month Follow up Period||16
10808886|NCT03838198|11970873|FG003|COMPLETED|1 Month Follow up Period||21
10808887|NCT03838198|11970870|FG000|NOT COMPLETED|1 Month Follow up Period||2
10808888|NCT03838198|11970871|FG001|NOT COMPLETED|1 Month Follow up Period||0
10619627|NCT01962103|11777698|FG001|NOT COMPLETED|Phase 1||8
10619628|NCT01962103|11777699|FG002|NOT COMPLETED|Phase 1||14
10619629|NCT01962103|11777700|FG003|NOT COMPLETED|Phase 1||11
10619630|NCT01962103|11777701|FG004|NOT COMPLETED|Phase 1||8
10619631|NCT01962103|11777702|FG005|NOT COMPLETED|Phase 1||7
10619632|NCT01962103|11777703|FG006|NOT COMPLETED|Phase 1||0
10619633|NCT01962103|11777704|FG007|NOT COMPLETED|Phase 1||0
10619634|NCT01962103|11777705|FG008|NOT COMPLETED|Phase 1||0
10619635|NCT01962103|11777697|FG000|STARTED|Phase 2||0
10619636|NCT01962103|11777698|FG001|STARTED|Phase 2||0
10619637|NCT01962103|11777699|FG002|STARTED|Phase 2||0
10619638|NCT01962103|11777700|FG003|STARTED|Phase 2||0
10619639|NCT01962103|11777701|FG004|STARTED|Phase 2||0
10619640|NCT01962103|11777702|FG005|STARTED|Phase 2||0
10619641|NCT01962103|11777703|FG006|STARTED|Phase 2||14
10619642|NCT01962103|11777704|FG007|STARTED|Phase 2||14
10619643|NCT01962103|11777705|FG008|STARTED|Phase 2||14
10619644|NCT01962103|11777697|FG000|COMPLETED|Phase 2||0
10619645|NCT01962103|11777698|FG001|COMPLETED|Phase 2||0
10619646|NCT01962103|11777699|FG002|COMPLETED|Phase 2||0
10619647|NCT01962103|11777700|FG003|COMPLETED|Phase 2||0
10619648|NCT01962103|11777701|FG004|COMPLETED|Phase 2||0
10619649|NCT01962103|11777702|FG005|COMPLETED|Phase 2||0
10619650|NCT01962103|11777703|FG006|COMPLETED|Phase 2|completed treatment|0
10619651|NCT01962103|11777704|FG007|COMPLETED|Phase 2|completed treatment|0
10619652|NCT01962103|11777705|FG008|COMPLETED|Phase 2|completed treatment|0
10619653|NCT01962103|11777697|FG000|NOT COMPLETED|Phase 2||0
10619654|NCT01962103|11777698|FG001|NOT COMPLETED|Phase 2||0
10619655|NCT01962103|11777699|FG002|NOT COMPLETED|Phase 2||0
10619656|NCT01962103|11777700|FG003|NOT COMPLETED|Phase 2||0
10619657|NCT01962103|11777701|FG004|NOT COMPLETED|Phase 2||0
10619658|NCT01962103|11777702|FG005|NOT COMPLETED|Phase 2||0
10619659|NCT01962103|11777703|FG006|NOT COMPLETED|Phase 2||14
10619660|NCT01962103|11777704|FG007|NOT COMPLETED|Phase 2||14
10619661|NCT01962103|11777705|FG008|NOT COMPLETED|Phase 2||14
10619662|NCT01962207|11777729|FG000|STARTED|Persistence Phase (5 Years)||76
10619664|NCT01962207|11777731|FG002|STARTED|Persistence Phase (5 Years)||115
10619665|NCT01962207|11777732|FG003|STARTED|Persistence Phase (5 Years)||29
10619666|NCT01962207|11777729|FG000|COMPLETED|Persistence Phase (5 Years)||47
10619667|NCT01962207|11777730|FG001|COMPLETED|Persistence Phase (5 Years)||10
10619668|NCT01962207|11777731|FG002|COMPLETED|Persistence Phase (5 Years)||71
10619669|NCT01962207|11777732|FG003|COMPLETED|Persistence Phase (5 Years)||17
10619670|NCT01962207|11777729|FG000|NOT COMPLETED|Persistence Phase (5 Years)||29
10619671|NCT01962207|11777730|FG001|NOT COMPLETED|Persistence Phase (5 Years)||13
10619672|NCT01962207|11777731|FG002|NOT COMPLETED|Persistence Phase (5 Years)||44
10619673|NCT01962207|11777732|FG003|NOT COMPLETED|Persistence Phase (5 Years)||12
10619674|NCT01962207|11777729|FG000|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|67
10619675|NCT01962207|11777730|FG001|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|16
10619676|NCT01962207|11777731|FG002|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|77
10619677|NCT01962207|11777732|FG003|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|21
10619678|NCT01962207|11777729|FG000|COMPLETED|Booster Phase (6 Months)||67
10619679|NCT01962207|11777730|FG001|COMPLETED|Booster Phase (6 Months)||16
10619680|NCT01962207|11777731|FG002|COMPLETED|Booster Phase (6 Months)||77
10619681|NCT01962207|11777732|FG003|COMPLETED|Booster Phase (6 Months)||21
10619682|NCT01962207|11777729|FG000|NOT COMPLETED|Booster Phase (6 Months)||0
10619683|NCT01962207|11777730|FG001|NOT COMPLETED|Booster Phase (6 Months)||0
10619684|NCT01962207|11777731|FG002|NOT COMPLETED|Booster Phase (6 Months)||0
10619685|NCT01962207|11777732|FG003|NOT COMPLETED|Booster Phase (6 Months)||0
10619686|NCT01962298|11777751|FG000|STARTED|Overall Study||15
10619687|NCT01962298|11777752|FG001|STARTED|Overall Study||15
10619688|NCT01962298|11777753|FG002|STARTED|Overall Study||15
10619689|NCT01962298|11777754|FG003|STARTED|Overall Study||15
10619690|NCT01962298|11777755|FG004|STARTED|Overall Study||15
10619691|NCT01962298|11777751|FG000|Received Intervention|Overall Study|1 subject did not receive the planned intervention and received a different one for clinical reasons|14
10619692|NCT01962298|11777752|FG001|Received Intervention|Overall Study||15
10619693|NCT01962298|11777753|FG002|Received Intervention|Overall Study||15
10619694|NCT01962298|11777754|FG003|Received Intervention|Overall Study||15
10619695|NCT01962298|11777755|FG004|Received Intervention|Overall Study||15
10619696|NCT01962298|11777751|FG000|COMPLETED|Overall Study||12
10619697|NCT01962298|11777752|FG001|COMPLETED|Overall Study||11
10619698|NCT01962298|11777753|FG002|COMPLETED|Overall Study||10
10619699|NCT01962298|11777754|FG003|COMPLETED|Overall Study||13
10619700|NCT01962298|11777755|FG004|COMPLETED|Overall Study||9
10619701|NCT01962298|11777751|FG000|NOT COMPLETED|Overall Study||3
10619702|NCT01962298|11777752|FG001|NOT COMPLETED|Overall Study||4
10619703|NCT01962298|11777753|FG002|NOT COMPLETED|Overall Study||5
10619704|NCT01962298|11777754|FG003|NOT COMPLETED|Overall Study||2
10619705|NCT01962298|11777755|FG004|NOT COMPLETED|Overall Study||6
10619706|NCT01962428|11777769|FG000|STARTED|Overall Study||139
10619707|NCT01962428|11777770|FG001|STARTED|Overall Study||139
10619708|NCT01962428|11777769|FG000|COMPLETED|Overall Study||129
10619709|NCT01962428|11777770|FG001|COMPLETED|Overall Study||133
10619710|NCT01962428|11777769|FG000|NOT COMPLETED|Overall Study||10
10619711|NCT01962428|11777770|FG001|NOT COMPLETED|Overall Study||6
10619712|NCT01962441|11777779|FG000|STARTED|Randomized Period||200
10619713|NCT01962441|11777780|FG001|STARTED|Randomized Period||201
10619714|NCT01962441|11777781|FG002|STARTED|Randomized Period||200
10619715|NCT01962441|11777779|FG000|COMPLETED|Randomized Period||190
10619716|NCT01962441|11777780|FG001|COMPLETED|Randomized Period||190
10619717|NCT01962441|11777781|FG002|COMPLETED|Randomized Period||189
10619718|NCT01962441|11777779|FG000|NOT COMPLETED|Randomized Period||10
10619719|NCT01962441|11777780|FG001|NOT COMPLETED|Randomized Period||11
10619720|NCT01962441|11777781|FG002|NOT COMPLETED|Randomized Period||11
10619721|NCT01962441|11777779|FG000|STARTED|Retreatment Substudy|20 participants who experienced virologic failure enrolled into the Retreatment Substudy.|20
10619722|NCT01962441|11777780|FG001|STARTED|Retreatment Substudy|10 participants who experienced virologic failure enrolled into the Retreatment Substudy.|10
10619723|NCT01962441|11777781|FG002|STARTED|Retreatment Substudy|Participants in the SOF+RBV+Peg-IFN group were not eligible to enroll in the Retreatment Substudy.|0
10619724|NCT01962441|11777779|FG000|COMPLETED|Retreatment Substudy||18
10619725|NCT01962441|11777780|FG001|COMPLETED|Retreatment Substudy||10
10619726|NCT01962441|11777781|FG002|COMPLETED|Retreatment Substudy||0
10619727|NCT01962441|11777779|FG000|NOT COMPLETED|Retreatment Substudy||2
10619728|NCT01962441|11777780|FG001|NOT COMPLETED|Retreatment Substudy||0
10619729|NCT01962441|11777781|FG002|NOT COMPLETED|Retreatment Substudy||0
10619730|NCT01962493|11777792|FG000|STARTED|Overall Study||78
10619731|NCT01962493|11777793|FG001|STARTED|Overall Study||82
10619732|NCT01962493|11777792|FG000|COMPLETED|Overall Study||73
10619733|NCT01962493|11777793|FG001|COMPLETED|Overall Study||77
10619734|NCT01962493|11777792|FG000|NOT COMPLETED|Overall Study||5
10619735|NCT01962493|11777793|FG001|NOT COMPLETED|Overall Study||5
10619736|NCT01962558|11777801|FG000|STARTED|Overall Study||16
10619737|NCT01962558|11777802|FG001|STARTED|Overall Study||14
10619738|NCT01962558|11777801|FG000|Acute Study|Overall Study||16
10619739|NCT01962558|11777802|FG001|Acute Study|Overall Study||14
10619740|NCT01962558|11777801|FG000|12-Weeks|Overall Study||16
10619741|NCT01962558|11777802|FG001|12-Weeks|Overall Study||14
10619742|NCT01962558|11777801|FG000|COMPLETED|Overall Study||16
10619743|NCT01962558|11777802|FG001|COMPLETED|Overall Study||14
10619744|NCT01962558|11777801|FG000|NOT COMPLETED|Overall Study||0
10619745|NCT01962558|11777802|FG001|NOT COMPLETED|Overall Study||0
10619746|NCT01962688|11777810|FG000|STARTED|Overall Study||19
10619747|NCT01962688|11777811|FG001|STARTED|Overall Study||18
10619748|NCT01962688|11777810|FG000|COMPLETED|Overall Study||19
10619749|NCT01962688|11777811|FG001|COMPLETED|Overall Study||18
10619750|NCT01962688|11777810|FG000|NOT COMPLETED|Overall Study||0
10619751|NCT01962688|11777811|FG001|NOT COMPLETED|Overall Study||0
10619752|NCT01962714|11777819|FG000|STARTED|Overall Study||91
10619753|NCT01962714|11777820|FG001|STARTED|Overall Study||93
10619754|NCT01962714|11777819|FG000|Immediate Post-treatment Assessment|Overall Study||63
10619755|NCT01962714|11777820|FG001|Immediate Post-treatment Assessment|Overall Study||57
10619756|NCT01962714|11777819|FG000|3-month Follow-up|Overall Study||58
10619757|NCT01962714|11777820|FG001|3-month Follow-up|Overall Study||56
10619758|NCT01962714|11777819|FG000|COMPLETED|Overall Study||61
10619759|NCT01962714|11777820|FG001|COMPLETED|Overall Study||60
10619760|NCT01962714|11777819|FG000|NOT COMPLETED|Overall Study||30
10619761|NCT01962714|11777820|FG001|NOT COMPLETED|Overall Study||33
10619762|NCT01962870|11777828|FG000|STARTED|Overall Study||13
10619763|NCT01962870|11777829|FG001|STARTED|Overall Study||17
10619764|NCT01962870|11777828|FG000|COMPLETED|Overall Study||13
10619765|NCT01962870|11777829|FG001|COMPLETED|Overall Study||17
10619766|NCT01962870|11777828|FG000|NOT COMPLETED|Overall Study||0
10619767|NCT01962870|11777829|FG001|NOT COMPLETED|Overall Study||0
10619768|NCT01962896|11777835|FG000|STARTED|Overall Study||4
10619769|NCT01962896|11777835|FG000|COMPLETED|Overall Study||0
10619770|NCT01962896|11777835|FG000|NOT COMPLETED|Overall Study||4
10457091|NCT01009047|11604820|FG001|NOT COMPLETED|Overall Study||26
10457092|NCT01009060|11604828|FG000|STARTED|Overall Study||25
10457093|NCT01009060|11604829|FG001|STARTED|Overall Study||25
10457094|NCT01009060|11604828|FG000|COMPLETED|Overall Study||21
10619771|NCT01962922|11777842|FG000|STARTED|PK Portion Day 7||27
10619772|NCT01962922|11777843|FG001|STARTED|PK Portion Day 7||23
10619773|NCT01962922|11777842|FG000|COMPLETED|PK Portion Day 7||23
10619774|NCT01962922|11777843|FG001|COMPLETED|PK Portion Day 7||23
10619775|NCT01962922|11777842|FG000|NOT COMPLETED|PK Portion Day 7||4
10619776|NCT01962922|11777843|FG001|NOT COMPLETED|PK Portion Day 7||0
10619777|NCT01962922|11777842|FG000|STARTED|PK Portion Day 14||23
10705023|NCT02595723|11869438|FG001|STARTED|First Intervention (4 Days)||6
10705024|NCT02595723|11869439|FG002|STARTED|First Intervention (4 Days)||7
10619778|NCT01962922|11777843|FG001|STARTED|PK Portion Day 14||23
10619779|NCT01962922|11777842|FG000|COMPLETED|PK Portion Day 14||23
10619780|NCT01962922|11777843|FG001|COMPLETED|PK Portion Day 14||23
10619781|NCT01962922|11777842|FG000|NOT COMPLETED|PK Portion Day 14||0
10619782|NCT01962922|11777843|FG001|NOT COMPLETED|PK Portion Day 14||0
10619783|NCT01962922|11777842|FG000|STARTED|PK Portion Day 21||23
10705025|NCT02595723|11869437|FG000|COMPLETED|First Intervention (4 Days)||8
10705026|NCT02595723|11869438|FG001|COMPLETED|First Intervention (4 Days)||6
10457095|NCT01009060|11604829|FG001|COMPLETED|Overall Study||20
10619784|NCT01962922|11777843|FG001|STARTED|PK Portion Day 21||23
10705027|NCT02595723|11869439|FG002|COMPLETED|First Intervention (4 Days)||7
10333876|NCT00336323|11470119|FG002|9 Week Visit|Overall Study||23
10333877|NCT00336323|11470120|FG003|9 Week Visit|Overall Study||21
10333878|NCT00336323|11470121|FG004|9 Week Visit|Overall Study||19
10333879|NCT00336323|11470117|FG000|12 Week Visit|Overall Study||19
10333880|NCT00336323|11470118|FG001|12 Week Visit|Overall Study||21
10333881|NCT00336323|11470119|FG002|12 Week Visit|Overall Study||24
10619785|NCT01962922|11777842|FG000|COMPLETED|PK Portion Day 21||23
10619786|NCT01962922|11777843|FG001|COMPLETED|PK Portion Day 21||23
10619787|NCT01962922|11777842|FG000|NOT COMPLETED|PK Portion Day 21||0
10619788|NCT01962922|11777843|FG001|NOT COMPLETED|PK Portion Day 21||0
10619789|NCT01962922|11777842|FG000|STARTED|Extendion Portion (up to Month 6)||23
10619790|NCT01962922|11777843|FG001|STARTED|Extendion Portion (up to Month 6)||23
10619791|NCT01962922|11777842|FG000|COMPLETED|Extendion Portion (up to Month 6)||18
10619792|NCT01962922|11777843|FG001|COMPLETED|Extendion Portion (up to Month 6)||20
10619793|NCT01962922|11777842|FG000|NOT COMPLETED|Extendion Portion (up to Month 6)||5
10619794|NCT01962922|11777843|FG001|NOT COMPLETED|Extendion Portion (up to Month 6)||3
10333882|NCT00336323|11470120|FG003|12 Week Visit|Overall Study||22
10333883|NCT00336323|11470121|FG004|12 Week Visit|Overall Study|1 patient was dropped from study|20
10333884|NCT00336323|11470117|FG000|18 Week Visit|Overall Study||19
10333885|NCT00336323|11470118|FG001|18 Week Visit|Overall Study||22
10333886|NCT00336323|11470119|FG002|18 Week Visit|Overall Study||23
10333887|NCT00336323|11470120|FG003|18 Week Visit|Overall Study||21
10333888|NCT00336323|11470121|FG004|18 Week Visit|Overall Study|1 patient was dropped from the study|18
10333889|NCT00336323|11470117|FG000|24 Week Visit|Overall Study||18
10333890|NCT00336323|11470118|FG001|24 Week Visit|Overall Study|1 patient was dropped from the study|20
10619795|NCT01962961|11777852|FG000|STARTED|Overall Study||9
10619796|NCT01962961|11777853|FG001|STARTED|Overall Study||8
10619797|NCT01962961|11777854|FG002|STARTED|Overall Study||7
10619798|NCT01962961|11777852|FG000|COMPLETED|Overall Study||9
10619799|NCT01962961|11777853|FG001|COMPLETED|Overall Study||7
10619800|NCT01962961|11777854|FG002|COMPLETED|Overall Study||6
10619801|NCT01962961|11777852|FG000|NOT COMPLETED|Overall Study||0
10619802|NCT01962961|11777853|FG001|NOT COMPLETED|Overall Study||1
10619803|NCT01962961|11777854|FG002|NOT COMPLETED|Overall Study||1
10619804|NCT01962987|11777865|FG000|STARTED|Overall Study||190
10619805|NCT01962987|11777866|FG001|STARTED|Overall Study||191
10619806|NCT01962987|11777867|FG002|STARTED|Overall Study||95
10619807|NCT01962987|11777865|FG000|COMPLETED|Overall Study||160
10619808|NCT01962987|11777866|FG001|COMPLETED|Overall Study||163
10619809|NCT01962987|11777867|FG002|COMPLETED|Overall Study||83
10619810|NCT01962987|11777865|FG000|NOT COMPLETED|Overall Study||30
10619811|NCT01962987|11777866|FG001|NOT COMPLETED|Overall Study||28
10619812|NCT01962987|11777867|FG002|NOT COMPLETED|Overall Study||12
10619813|NCT01963078|11777879|FG000|STARTED|Overall Study||9
10619814|NCT01963078|11777880|FG001|STARTED|Overall Study||10
10619815|NCT01963078|11777881|FG002|STARTED|Overall Study||10
10619816|NCT01963078|11777882|FG003|STARTED|Overall Study||9
10619817|NCT01963078|11777879|FG000|COMPLETED|Overall Study||8
10619818|NCT01963078|11777880|FG001|COMPLETED|Overall Study||9
10619819|NCT01963078|11777881|FG002|COMPLETED|Overall Study||9
10619820|NCT01963078|11777882|FG003|COMPLETED|Overall Study||7
10619821|NCT01963078|11777879|FG000|NOT COMPLETED|Overall Study||1
10619822|NCT01963078|11777880|FG001|NOT COMPLETED|Overall Study||1
10619823|NCT01963078|11777881|FG002|NOT COMPLETED|Overall Study||1
10619824|NCT01963078|11777882|FG003|NOT COMPLETED|Overall Study||2
10619825|NCT01963091|11777894|FG000|STARTED|Overall Study||17
10619826|NCT01963091|11777895|FG001|STARTED|Overall Study||16
10619827|NCT01963091|11777894|FG000|COMPLETED|Overall Study||17
10619828|NCT01963091|11777895|FG001|COMPLETED|Overall Study||16
10619829|NCT01963091|11777894|FG000|NOT COMPLETED|Overall Study||0
10619830|NCT01963091|11777895|FG001|NOT COMPLETED|Overall Study||0
10619831|NCT01963117|11777901|FG000|STARTED|Overall Study||11
10619832|NCT01963117|11777901|FG000|COMPLETED|Overall Study||10
10619833|NCT01963117|11777901|FG000|NOT COMPLETED|Overall Study||1
10619834|NCT01963143|11777908|FG000|STARTED|Overall Study||14
10619835|NCT01963143|11777909|FG001|STARTED|Overall Study||19
10619836|NCT01963143|11777910|FG002|STARTED|Overall Study||15
10619837|NCT01963143|11777908|FG000|COMPLETED|Overall Study||14
10619838|NCT01963143|11777909|FG001|COMPLETED|Overall Study||18
10619839|NCT01963143|11777910|FG002|COMPLETED|Overall Study||14
10619840|NCT01963143|11777908|FG000|NOT COMPLETED|Overall Study||0
10619841|NCT01963143|11777909|FG001|NOT COMPLETED|Overall Study||1
10619842|NCT01963143|11777910|FG002|NOT COMPLETED|Overall Study||1
10619843|NCT01963169|11777919|FG000|STARTED|Overall Study||301
10619844|NCT01963169|11777920|FG001|STARTED|Overall Study||302
10619845|NCT01963169|11777921|FG002|STARTED|Overall Study||263
10619846|NCT01963169|11777919|FG000|COMPLETED|Overall Study||242
10619847|NCT01963169|11777920|FG001|COMPLETED|Overall Study||220
10619848|NCT01963169|11777921|FG002|COMPLETED|Overall Study||237
10333891|NCT00336323|11470119|FG002|24 Week Visit|Overall Study|1 patient was dropped from the study|22
10619849|NCT01963169|11777919|FG000|NOT COMPLETED|Overall Study||59
10619850|NCT01963169|11777920|FG001|NOT COMPLETED|Overall Study||82
10619851|NCT01963169|11777921|FG002|NOT COMPLETED|Overall Study||26
10619852|NCT01963234|11777932|FG000|STARTED|Overall Study||268
10619853|NCT01963234|11777933|FG001|STARTED|Overall Study||171
10619854|NCT01963234|11777932|FG000|COMPLETED|Overall Study||207
10619855|NCT01963234|11777933|FG001|COMPLETED|Overall Study||171
10619856|NCT01963234|11777932|FG000|NOT COMPLETED|Overall Study||61
10619857|NCT01963234|11777933|FG001|NOT COMPLETED|Overall Study||0
10619858|NCT01963260|11777955|FG000|STARTED|Overall Study||6
10619859|NCT01963260|11777956|FG001|STARTED|Overall Study||6
10619860|NCT01963260|11777957|FG002|STARTED|Overall Study||6
10619861|NCT01963260|11777958|FG003|STARTED|Overall Study||6
10619862|NCT01963260|11777959|FG004|STARTED|Overall Study||6
10619863|NCT01963260|11777960|FG005|STARTED|Overall Study||10
10619864|NCT01963260|11777961|FG006|STARTED|Overall Study||3
10619865|NCT01963260|11777962|FG007|STARTED|Overall Study||2
10619866|NCT01963260|11777963|FG008|STARTED|Overall Study||1
10619867|NCT01963260|11777964|FG009|STARTED|Overall Study||4
10619868|NCT01963260|11777955|FG000|Treated|Overall Study||6
10619869|NCT01963260|11777956|FG001|Treated|Overall Study||6
10619870|NCT01963260|11777957|FG002|Treated|Overall Study||6
10619871|NCT01963260|11777958|FG003|Treated|Overall Study||6
10619872|NCT01963260|11777959|FG004|Treated|Overall Study||6
10619873|NCT01963260|11777960|FG005|Treated|Overall Study||10
10619874|NCT01963260|11777961|FG006|Treated|Overall Study||3
10619875|NCT01963260|11777962|FG007|Treated|Overall Study||2
10619876|NCT01963260|11777963|FG008|Treated|Overall Study||1
10619877|NCT01963260|11777964|FG009|Treated|Overall Study||4
10619878|NCT01963260|11777955|FG000|COMPLETED|Overall Study||4
10619879|NCT01963260|11777956|FG001|COMPLETED|Overall Study||6
10619880|NCT01963260|11777957|FG002|COMPLETED|Overall Study||6
10619881|NCT01963260|11777958|FG003|COMPLETED|Overall Study||5
10619882|NCT01963260|11777959|FG004|COMPLETED|Overall Study||4
10619883|NCT01963260|11777960|FG005|COMPLETED|Overall Study||10
10619884|NCT01963260|11777961|FG006|COMPLETED|Overall Study||3
10619885|NCT01963260|11777962|FG007|COMPLETED|Overall Study||2
10619886|NCT01963260|11777963|FG008|COMPLETED|Overall Study||1
10619887|NCT01963260|11777964|FG009|COMPLETED|Overall Study||4
10619888|NCT01963260|11777955|FG000|NOT COMPLETED|Overall Study||2
10619889|NCT01963260|11777956|FG001|NOT COMPLETED|Overall Study||0
10619890|NCT01963260|11777957|FG002|NOT COMPLETED|Overall Study||0
10619891|NCT01963260|11777958|FG003|NOT COMPLETED|Overall Study||1
10619892|NCT01963260|11777959|FG004|NOT COMPLETED|Overall Study||2
10619893|NCT01963260|11777960|FG005|NOT COMPLETED|Overall Study||0
10619894|NCT01963260|11777961|FG006|NOT COMPLETED|Overall Study||0
10619895|NCT01963260|11777962|FG007|NOT COMPLETED|Overall Study||0
10619896|NCT01963260|11777963|FG008|NOT COMPLETED|Overall Study||0
10619897|NCT01963260|11777964|FG009|NOT COMPLETED|Overall Study||0
10619898|NCT01963403|11777995|FG000|STARTED|Overall Study||13
10619899|NCT01963403|11777996|FG001|STARTED|Overall Study||13
10619900|NCT01963403|11777995|FG000|COMPLETED|Overall Study|Follow-up over three months|11
10619901|NCT01963403|11777996|FG001|COMPLETED|Overall Study|Follow-up over three months|9
10619902|NCT01963403|11777995|FG000|NOT COMPLETED|Overall Study||2
10619903|NCT01963403|11777996|FG001|NOT COMPLETED|Overall Study||4
10619904|NCT01963481|11778004|FG000|STARTED|Overall Study||23
10619905|NCT01963481|11778004|FG000|COMPLETED|Overall Study||23
10619906|NCT01963481|11778004|FG000|NOT COMPLETED|Overall Study||0
10619907|NCT01963611|11778013|FG000|STARTED|Overall Study||51
10619908|NCT01963611|11778014|FG001|STARTED|Overall Study||49
10619909|NCT01963611|11778015|FG002|STARTED|Overall Study||52
10619910|NCT01963611|11778016|FG003|STARTED|Overall Study||52
10619911|NCT01963611|11778017|FG004|STARTED|Overall Study||51
10619912|NCT01963611|11778013|FG000|Safety Analysis Set|Overall Study||51
10619913|NCT01963611|11778014|FG001|Safety Analysis Set|Overall Study||49
10619914|NCT01963611|11778015|FG002|Safety Analysis Set|Overall Study||52
10619915|NCT01963611|11778016|FG003|Safety Analysis Set|Overall Study||52
10619916|NCT01963611|11778017|FG004|Safety Analysis Set|Overall Study||50
10619917|NCT01963611|11778013|FG000|COMPLETED|Overall Study||0
10619918|NCT01963611|11778014|FG001|COMPLETED|Overall Study||0
10619919|NCT01963611|11778015|FG002|COMPLETED|Overall Study||0
10619920|NCT01963611|11778016|FG003|COMPLETED|Overall Study||0
10619921|NCT01963611|11778017|FG004|COMPLETED|Overall Study||0
10619922|NCT01963611|11778013|FG000|NOT COMPLETED|Overall Study||51
10619923|NCT01963611|11778014|FG001|NOT COMPLETED|Overall Study||49
10619924|NCT01963611|11778015|FG002|NOT COMPLETED|Overall Study||52
10619925|NCT01963611|11778016|FG003|NOT COMPLETED|Overall Study||52
10619926|NCT01963611|11778017|FG004|NOT COMPLETED|Overall Study||51
10619927|NCT01963676|11778032|FG000|STARTED|Overall Study||14
10619928|NCT01963676|11778033|FG001|STARTED|Overall Study||13
10619929|NCT01963676|11778032|FG000|COMPLETED|Overall Study||13
10619930|NCT01963676|11778033|FG001|COMPLETED|Overall Study||13
10619931|NCT01963676|11778032|FG000|NOT COMPLETED|Overall Study||1
10619932|NCT01963676|11778033|FG001|NOT COMPLETED|Overall Study||0
10619933|NCT01963767|11778041|FG000|STARTED|Overall Study||58
10619934|NCT01963767|11778042|FG001|STARTED|Overall Study||55
10619935|NCT01963767|11778041|FG000|COMPLETED|Overall Study||52
10619936|NCT01963767|11778042|FG001|COMPLETED|Overall Study||53
10619937|NCT01963767|11778041|FG000|NOT COMPLETED|Overall Study||6
10619938|NCT01963767|11778042|FG001|NOT COMPLETED|Overall Study||2
10619939|NCT01963793|11778048|FG000|STARTED|Overall Study||20
10619940|NCT01963793|11778048|FG000|COMPLETED|Overall Study||20
10619941|NCT01963793|11778048|FG000|NOT COMPLETED|Overall Study||0
10619942|NCT01963845|11778065|FG000|STARTED|Overall Study||25
10619943|NCT01963845|11778066|FG001|STARTED|Overall Study||25
10619944|NCT01963845|11778065|FG000|COMPLETED|Overall Study||25
10619945|NCT01963845|11778066|FG001|COMPLETED|Overall Study||25
10619946|NCT01963845|11778065|FG000|NOT COMPLETED|Overall Study||0
10619947|NCT01963845|11778066|FG001|NOT COMPLETED|Overall Study||0
10619948|NCT01963923|11778074|FG000|STARTED|3 Weeks Post-surgery||20
10619949|NCT01963923|11778075|FG001|STARTED|3 Weeks Post-surgery||20
10619950|NCT01963923|11778074|FG000|COMPLETED|3 Weeks Post-surgery||12
10619951|NCT01963923|11778075|FG001|COMPLETED|3 Weeks Post-surgery||10
10619952|NCT01963923|11778074|FG000|NOT COMPLETED|3 Weeks Post-surgery||8
10619953|NCT01963923|11778075|FG001|NOT COMPLETED|3 Weeks Post-surgery||10
10619954|NCT01963923|11778074|FG000|STARTED|3 Months Post-surgery||12
10619955|NCT01963923|11778075|FG001|STARTED|3 Months Post-surgery||10
10619956|NCT01963923|11778074|FG000|COMPLETED|3 Months Post-surgery||10
10619957|NCT01963923|11778075|FG001|COMPLETED|3 Months Post-surgery||9
10619958|NCT01963923|11778074|FG000|NOT COMPLETED|3 Months Post-surgery||2
10619959|NCT01963923|11778075|FG001|NOT COMPLETED|3 Months Post-surgery||1
10619960|NCT01964092|11778090|FG000|STARTED|Overall Study||229
10619961|NCT01964092|11778091|FG001|STARTED|Overall Study||181
10619962|NCT01964092|11778090|FG000|COMPLETED|Overall Study||227
10619963|NCT01964092|11778091|FG001|COMPLETED|Overall Study||181
10619964|NCT01964092|11778090|FG000|NOT COMPLETED|Overall Study||2
10619965|NCT01964092|11778091|FG001|NOT COMPLETED|Overall Study||0
10619966|NCT01964105|11778100|FG000|STARTED|Overall Study||15
10619967|NCT01964105|11778101|FG001|STARTED|Overall Study||75
10619968|NCT01964105|11778102|FG002|STARTED|Overall Study||10
10619969|NCT01964105|11778100|FG000|COMPLETED|Overall Study||13
10619970|NCT01964105|11778101|FG001|COMPLETED|Overall Study||62
10619971|NCT01964105|11778102|FG002|COMPLETED|Overall Study||10
10619972|NCT01964105|11778100|FG000|NOT COMPLETED|Overall Study||2
10619973|NCT01964105|11778101|FG001|NOT COMPLETED|Overall Study||13
10619974|NCT01964105|11778102|FG002|NOT COMPLETED|Overall Study||0
10619975|NCT01964222|11778112|FG000|STARTED|Overall Study||101
10619976|NCT01964222|11778113|FG001|STARTED|Overall Study||100
10619977|NCT01964222|11778112|FG000|COMPLETED|Overall Study||86
10619978|NCT01964222|11778113|FG001|COMPLETED|Overall Study||89
10619979|NCT01964222|11778112|FG000|NOT COMPLETED|Overall Study||15
10619980|NCT01964222|11778113|FG001|NOT COMPLETED|Overall Study||11
10619981|NCT01964300|11778121|FG000|STARTED|Overall Study||7
10619982|NCT01964300|11778122|FG001|STARTED|Overall Study||12
10619983|NCT01964300|11778121|FG000|COMPLETED|Overall Study||1
10619984|NCT01964300|11778122|FG001|COMPLETED|Overall Study||1
10619985|NCT01964300|11778121|FG000|NOT COMPLETED|Overall Study||6
10619986|NCT01964300|11778122|FG001|NOT COMPLETED|Overall Study||11
10619987|NCT01964326|11778128|FG000|STARTED|Overall Study||1311
10619988|NCT01964326|11778128|FG000|COMPLETED|Overall Study||1014
10619989|NCT01964326|11778128|FG000|NOT COMPLETED|Overall Study||297
10619990|NCT01964352|11778136|FG000|STARTED|Overall Study||204
10619991|NCT01964352|11778137|FG001|STARTED|Overall Study||203
10619992|NCT01964352|11778138|FG002|STARTED|Overall Study||202
10619993|NCT01964352|11778139|FG003|STARTED|Overall Study||203
10619994|NCT01964352|11778136|FG000|COMPLETED|Overall Study||178
10619995|NCT01964352|11778137|FG001|COMPLETED|Overall Study||192
10619996|NCT01964352|11778138|FG002|COMPLETED|Overall Study||196
10619997|NCT01964352|11778139|FG003|COMPLETED|Overall Study||195
10619998|NCT01964352|11778136|FG000|NOT COMPLETED|Overall Study||26
10619999|NCT01964352|11778137|FG001|NOT COMPLETED|Overall Study||11
10620000|NCT01964352|11778138|FG002|NOT COMPLETED|Overall Study||6
10620001|NCT01964352|11778139|FG003|NOT COMPLETED|Overall Study||8
10620002|NCT01964378|11778151|FG000|STARTED|Overall Study||66
10620003|NCT01964378|11778152|FG001|STARTED|Overall Study||66
10620004|NCT01964378|11778151|FG000|Participants Treated (Safety Set)|Overall Study||65
10620005|NCT01964378|11778152|FG001|Participants Treated (Safety Set)|Overall Study|"4 Participants died during treatment, hereof 2 with withdrawal... as primary reason for discont."|61
10620006|NCT01964378|11778151|FG000|COMPLETED|Overall Study||41
10620007|NCT01964378|11778152|FG001|COMPLETED|Overall Study||45
10705028|NCT02595723|11869437|FG000|NOT COMPLETED|First Intervention (4 Days)||0
10705029|NCT02595723|11869438|FG001|NOT COMPLETED|First Intervention (4 Days)||0
10705030|NCT02595723|11869439|FG002|NOT COMPLETED|First Intervention (4 Days)||0
10705031|NCT02595723|11869437|FG000|STARTED|First Washout (21 Days)||8
10705032|NCT02595723|11869438|FG001|STARTED|First Washout (21 Days)||6
10705033|NCT02595723|11869439|FG002|STARTED|First Washout (21 Days)||7
10620008|NCT01964378|11778151|FG000|NOT COMPLETED|Overall Study||25
10620009|NCT01964378|11778152|FG001|NOT COMPLETED|Overall Study||21
10620018|NCT01964521|11778167|FG000|STARTED|Overall Study||24
10620019|NCT01964521|11778167|FG000|COMPLETED|Overall Study||20
10620020|NCT01964521|11778167|FG000|NOT COMPLETED|Overall Study||4
10620021|NCT01964547|11778174|FG000|STARTED|Overall Study||62
10620022|NCT01964547|11778175|FG001|STARTED|Overall Study||59
10620023|NCT01964547|11778174|FG000|COMPLETED|Overall Study||50
10620024|NCT01964547|11778175|FG001|COMPLETED|Overall Study||48
10620025|NCT01964547|11778174|FG000|NOT COMPLETED|Overall Study||12
10620026|NCT01964547|11778175|FG001|NOT COMPLETED|Overall Study||11
10620027|NCT01964716|11778183|FG000|STARTED|Overall Study||250
10620028|NCT01964716|11778184|FG001|STARTED|Overall Study||250
10620029|NCT01964716|11778183|FG000|Vaccinated Dose 1|Overall Study||250
10620030|NCT01964716|11778184|FG001|Vaccinated Dose 1|Overall Study||250
10620031|NCT01964716|11778183|FG000|Vaccinated Dose 2|Overall Study||249
10620032|NCT01964716|11778184|FG001|Vaccinated Dose 2|Overall Study||248
10620033|NCT01964716|11778183|FG000|Vaccinated Dose 3|Overall Study||247
10620034|NCT01964716|11778184|FG001|Vaccinated Dose 3|Overall Study||244
10705034|NCT02595723|11869437|FG000|COMPLETED|First Washout (21 Days)||6
10620035|NCT01964716|11778183|FG000|COMPLETED|Overall Study||245
10620036|NCT01964716|11778184|FG001|COMPLETED|Overall Study||244
10620037|NCT01964716|11778183|FG000|NOT COMPLETED|Overall Study||5
10620038|NCT01964716|11778184|FG001|NOT COMPLETED|Overall Study||6
10620039|NCT01964755|11778198|FG000|STARTED|Overall Study||6
10620040|NCT01964755|11778198|FG000|Cycle 2|Overall Study||5
10620041|NCT01964755|11778198|FG000|Cycle 3|Overall Study||4
10620042|NCT01964755|11778198|FG000|Cycle 4|Overall Study||4
10620043|NCT01964755|11778198|FG000|Cycle 5|Overall Study||4
10620044|NCT01964755|11778198|FG000|COMPLETED|Overall Study||4
10620045|NCT01964755|11778198|FG000|NOT COMPLETED|Overall Study||2
10620046|NCT01964898|11778204|FG000|STARTED|Overall Study||31
10620047|NCT01964898|11778205|FG001|STARTED|Overall Study||33
10620048|NCT01964898|11778204|FG000|12 Week Assessment|Overall Study||25
10620049|NCT01964898|11778205|FG001|12 Week Assessment|Overall Study||30
10705035|NCT02595723|11869438|FG001|COMPLETED|First Washout (21 Days)||6
10705036|NCT02595723|11869439|FG002|COMPLETED|First Washout (21 Days)||7
10705037|NCT02595723|11869437|FG000|NOT COMPLETED|First Washout (21 Days)||2
10705038|NCT02595723|11869438|FG001|NOT COMPLETED|First Washout (21 Days)||0
10705039|NCT02595723|11869439|FG002|NOT COMPLETED|First Washout (21 Days)||0
10705040|NCT02595723|11869437|FG000|STARTED|Second Intervention (4 Days)||6
10705041|NCT02595723|11869438|FG001|STARTED|Second Intervention (4 Days)||6
10705042|NCT02595723|11869439|FG002|STARTED|Second Intervention (4 Days)||7
10705043|NCT02595723|11869437|FG000|COMPLETED|Second Intervention (4 Days)||6
10705044|NCT02595723|11869438|FG001|COMPLETED|Second Intervention (4 Days)||6
10705045|NCT02595723|11869439|FG002|COMPLETED|Second Intervention (4 Days)||7
10705046|NCT02595723|11869437|FG000|NOT COMPLETED|Second Intervention (4 Days)||0
10705047|NCT02595723|11869438|FG001|NOT COMPLETED|Second Intervention (4 Days)||0
10705048|NCT02595723|11869439|FG002|NOT COMPLETED|Second Intervention (4 Days)||0
10705049|NCT02595723|11869437|FG000|STARTED|Second Washout (21 Days)||6
10705050|NCT02595723|11869438|FG001|STARTED|Second Washout (21 Days)||6
10705051|NCT02595723|11869439|FG002|STARTED|Second Washout (21 Days)||7
10705052|NCT02595723|11869437|FG000|COMPLETED|Second Washout (21 Days)||6
10705053|NCT02595723|11869438|FG001|COMPLETED|Second Washout (21 Days)||5
10705054|NCT02595723|11869439|FG002|COMPLETED|Second Washout (21 Days)||7
10705055|NCT02595723|11869437|FG000|NOT COMPLETED|Second Washout (21 Days)||0
10705056|NCT02595723|11869438|FG001|NOT COMPLETED|Second Washout (21 Days)||1
10705057|NCT02595723|11869439|FG002|NOT COMPLETED|Second Washout (21 Days)||0
10705058|NCT02595723|11869437|FG000|STARTED|Third Intervention (4 Days)||6
10705059|NCT02595723|11869438|FG001|STARTED|Third Intervention (4 Days)||5
10705060|NCT02595723|11869439|FG002|STARTED|Third Intervention (4 Days)||7
10620050|NCT01964898|11778204|FG000|COMPLETED|Overall Study||24
10620051|NCT01964898|11778205|FG001|COMPLETED|Overall Study||26
10620052|NCT01964898|11778204|FG000|NOT COMPLETED|Overall Study||7
10620053|NCT01964898|11778205|FG001|NOT COMPLETED|Overall Study||7
10620054|NCT01964924|11778211|FG000|STARTED|Trametinib Monotherapy||37
10620055|NCT01964924|11778212|FG001|STARTED|Trametinib Monotherapy||0
10620056|NCT01964924|11778211|FG000|COMPLETED|Trametinib Monotherapy||18
10620057|NCT01964924|11778212|FG001|COMPLETED|Trametinib Monotherapy||0
10620058|NCT01964924|11778211|FG000|NOT COMPLETED|Trametinib Monotherapy||19
10620059|NCT01964924|11778212|FG001|NOT COMPLETED|Trametinib Monotherapy||0
10620060|NCT01964924|11778211|FG000|STARTED|Trametinib + GSK2141||0
10620061|NCT01964924|11778212|FG001|STARTED|Trametinib + GSK2141|Progressed in Part 1 and therefore initiated combination treatment in Part 2|19
10620062|NCT01964924|11778211|FG000|COMPLETED|Trametinib + GSK2141||0
10620063|NCT01964924|11778212|FG001|COMPLETED|Trametinib + GSK2141||19
10620064|NCT01964924|11778211|FG000|NOT COMPLETED|Trametinib + GSK2141||0
10620065|NCT01964924|11778212|FG001|NOT COMPLETED|Trametinib + GSK2141||0
10620066|NCT01964950|11778223|FG000|STARTED|Overall Study|Data reports overall population,since data not collected separately per arm as specified in protocol|1101
10620067|NCT01964950|11778223|FG000|COMPLETED|Overall Study||1076
10620068|NCT01964950|11778223|FG000|NOT COMPLETED|Overall Study||25
10620069|NCT01964963|11778230|FG000|STARTED|Overall Study||19192
10620070|NCT01964963|11778230|FG000|COMPLETED|Overall Study||18249
10620071|NCT01964963|11778230|FG000|NOT COMPLETED|Overall Study||943
10620072|NCT01964976|11778236|FG000|STARTED|Overall Study|Data reports overall population,since data not collected separately per arm as specified in protocol|1096
10620073|NCT01964976|11778236|FG000|COMPLETED|Overall Study||1065
10620074|NCT01964976|11778236|FG000|NOT COMPLETED|Overall Study||31
10620075|NCT01965002|11778243|FG000|STARTED|Overall Study||5
10620076|NCT01965002|11778243|FG000|COMPLETED|Overall Study||5
10620077|NCT01965002|11778243|FG000|NOT COMPLETED|Overall Study||0
10620078|NCT01965067|11778251|FG000|STARTED|Overall Study||30
10620079|NCT01965067|11778252|FG001|STARTED|Overall Study||30
10620080|NCT01965067|11778251|FG000|COMPLETED|Overall Study||30
10620081|NCT01965067|11778252|FG001|COMPLETED|Overall Study||30
10620082|NCT01965067|11778251|FG000|NOT COMPLETED|Overall Study||0
10620083|NCT01965067|11778252|FG001|NOT COMPLETED|Overall Study||0
10620084|NCT01965158|11778260|FG000|STARTED|Overall Study|Includes 1 participant enrolled at 2 different sites simultaneously|274
10620085|NCT01965158|11778261|FG001|STARTED|Overall Study|Includes 1 participant enrolled at 2 different sites simultaneously|273
10620086|NCT01965158|11778260|FG000|Received Treatment|Overall Study||272
10620087|NCT01965158|11778261|FG001|Received Treatment|Overall Study||273
10620088|NCT01965158|11778260|FG000|COMPLETED|Overall Study||233
10620089|NCT01965158|11778261|FG001|COMPLETED|Overall Study||238
10705061|NCT02595723|11869437|FG000|COMPLETED|Third Intervention (4 Days)||6
10705062|NCT02595723|11869438|FG001|COMPLETED|Third Intervention (4 Days)||5
10620090|NCT01965158|11778260|FG000|NOT COMPLETED|Overall Study||41
10620091|NCT01965158|11778261|FG001|NOT COMPLETED|Overall Study||35
10620092|NCT01965262|11778267|FG000|STARTED|First Intervention (7 Days)||15
10620093|NCT01965262|11778268|FG001|STARTED|First Intervention (7 Days)||15
10620094|NCT01965262|11778267|FG000|COMPLETED|First Intervention (7 Days)||15
10620095|NCT01965262|11778268|FG001|COMPLETED|First Intervention (7 Days)||15
10620096|NCT01965262|11778267|FG000|NOT COMPLETED|First Intervention (7 Days)||0
10620097|NCT01965262|11778268|FG001|NOT COMPLETED|First Intervention (7 Days)||0
10620098|NCT01965262|11778267|FG000|STARTED|Second Intervention (7 Days)||15
10620099|NCT01965262|11778268|FG001|STARTED|Second Intervention (7 Days)||15
10620100|NCT01965262|11778267|FG000|COMPLETED|Second Intervention (7 Days)||14
10620101|NCT01965262|11778268|FG001|COMPLETED|Second Intervention (7 Days)||5
10620102|NCT01965262|11778267|FG000|NOT COMPLETED|Second Intervention (7 Days)||1
10620103|NCT01965262|11778268|FG001|NOT COMPLETED|Second Intervention (7 Days)||10
10620104|NCT01965288|11778276|FG000|STARTED|Overall Study||30
10620105|NCT01965288|11778277|FG001|STARTED|Overall Study||30
10620106|NCT01965288|11778276|FG000|COMPLETED|Overall Study||30
10620107|NCT01965288|11778277|FG001|COMPLETED|Overall Study||30
10620108|NCT01965288|11778276|FG000|NOT COMPLETED|Overall Study||0
10620109|NCT01965288|11778277|FG001|NOT COMPLETED|Overall Study||0
10620110|NCT01965327|11778295|FG000|STARTED|Overall Study||12
10620111|NCT01965327|11778295|FG000|COMPLETED|Overall Study|Prior to completion, 2 subjects were withdrawn by the PI for failure to adhere to study protocol.|10
10620112|NCT01965327|11778295|FG000|NOT COMPLETED|Overall Study||2
10620113|NCT01965366|11778301|FG000|STARTED|Overall Study||13
10620114|NCT01965366|11778302|FG001|STARTED|Overall Study||14
10620115|NCT01965366|11778301|FG000|COMPLETED|Overall Study||3
10620116|NCT01965366|11778302|FG001|COMPLETED|Overall Study||9
10620117|NCT01965366|11778301|FG000|NOT COMPLETED|Overall Study||10
10620118|NCT01965366|11778302|FG001|NOT COMPLETED|Overall Study||5
10620119|NCT01965431|11778308|FG000|STARTED|Overall Study|Started are actually Treated subjects|8
10620120|NCT01965431|11778309|FG001|STARTED|Overall Study||8
10620121|NCT01965431|11778310|FG002|STARTED|Overall Study||8
10620122|NCT01965431|11778311|FG003|STARTED|Overall Study||8
10620123|NCT01965431|11778312|FG004|STARTED|Overall Study||8
10620124|NCT01965431|11778313|FG005|STARTED|Overall Study||8
10620125|NCT01965431|11778308|FG000|COMPLETED|Overall Study||2
10620126|NCT01965431|11778309|FG001|COMPLETED|Overall Study||2
10620127|NCT01965431|11778310|FG002|COMPLETED|Overall Study||2
10620128|NCT01965431|11778311|FG003|COMPLETED|Overall Study||2
10620129|NCT01965431|11778312|FG004|COMPLETED|Overall Study||2
10620130|NCT01965431|11778313|FG005|COMPLETED|Overall Study||2
10620131|NCT01965431|11778308|FG000|NOT COMPLETED|Overall Study||6
10620132|NCT01965431|11778309|FG001|NOT COMPLETED|Overall Study||6
10620133|NCT01965431|11778310|FG002|NOT COMPLETED|Overall Study||6
10620134|NCT01965431|11778311|FG003|NOT COMPLETED|Overall Study||6
10620135|NCT01965431|11778312|FG004|NOT COMPLETED|Overall Study||6
10620136|NCT01965431|11778313|FG005|NOT COMPLETED|Overall Study||6
10620137|NCT01965535|11778325|FG000|STARTED|Overall Study||78
10620138|NCT01965535|11778326|FG001|STARTED|Overall Study||77
10620139|NCT01965535|11778325|FG000|COMPLETED|Overall Study||76
10620140|NCT01965535|11778326|FG001|COMPLETED|Overall Study||76
10620141|NCT01965535|11778325|FG000|NOT COMPLETED|Overall Study||2
10620142|NCT01965535|11778326|FG001|NOT COMPLETED|Overall Study||1
10620143|NCT01965561|11778332|FG000|STARTED|Overall Study||10
10620144|NCT01965561|11778332|FG000|COMPLETED|Overall Study||10
10620145|NCT01965561|11778332|FG000|NOT COMPLETED|Overall Study||0
10620146|NCT01965600|11778339|FG000|STARTED|First Intervention||6
10620147|NCT01965600|11778340|FG001|STARTED|First Intervention||8
10620148|NCT01965600|11778341|FG002|STARTED|First Intervention||5
10620149|NCT01965600|11778342|FG003|STARTED|First Intervention||4
10620150|NCT01965600|11778339|FG000|Received at Least One Dose of Drug|First Intervention||6
10620151|NCT01965600|11778340|FG001|Received at Least One Dose of Drug|First Intervention||8
10620152|NCT01965600|11778341|FG002|Received at Least One Dose of Drug|First Intervention||5
10620153|NCT01965600|11778342|FG003|Received at Least One Dose of Drug|First Intervention||4
10620154|NCT01965600|11778339|FG000|COMPLETED|First Intervention||6
10620155|NCT01965600|11778340|FG001|COMPLETED|First Intervention||8
10620156|NCT01965600|11778341|FG002|COMPLETED|First Intervention||5
10620157|NCT01965600|11778342|FG003|COMPLETED|First Intervention||4
10620158|NCT01965600|11778339|FG000|NOT COMPLETED|First Intervention||0
10620159|NCT01965600|11778340|FG001|NOT COMPLETED|First Intervention||0
10620160|NCT01965600|11778341|FG002|NOT COMPLETED|First Intervention||0
10620161|NCT01965600|11778342|FG003|NOT COMPLETED|First Intervention||0
10620162|NCT01965600|11778339|FG000|STARTED|Washout Period of Approximately 15 Days||6
10620163|NCT01965600|11778340|FG001|STARTED|Washout Period of Approximately 15 Days||8
10620164|NCT01965600|11778341|FG002|STARTED|Washout Period of Approximately 15 Days||5
10620165|NCT01965600|11778342|FG003|STARTED|Washout Period of Approximately 15 Days||4
10620166|NCT01965600|11778339|FG000|COMPLETED|Washout Period of Approximately 15 Days||4
10620167|NCT01965600|11778340|FG001|COMPLETED|Washout Period of Approximately 15 Days||4
10620168|NCT01965600|11778341|FG002|COMPLETED|Washout Period of Approximately 15 Days||3
10620169|NCT01965600|11778342|FG003|COMPLETED|Washout Period of Approximately 15 Days||2
10620170|NCT01965600|11778339|FG000|NOT COMPLETED|Washout Period of Approximately 15 Days||2
10620171|NCT01965600|11778340|FG001|NOT COMPLETED|Washout Period of Approximately 15 Days||4
10620172|NCT01965600|11778341|FG002|NOT COMPLETED|Washout Period of Approximately 15 Days||2
10620173|NCT01965600|11778342|FG003|NOT COMPLETED|Washout Period of Approximately 15 Days||2
10620174|NCT01965600|11778339|FG000|STARTED|Second Intervention||4
10620175|NCT01965600|11778340|FG001|STARTED|Second Intervention||4
10620176|NCT01965600|11778341|FG002|STARTED|Second Intervention||3
10620177|NCT01965600|11778342|FG003|STARTED|Second Intervention||2
10620178|NCT01965600|11778339|FG000|COMPLETED|Second Intervention||4
10620179|NCT01965600|11778340|FG001|COMPLETED|Second Intervention||4
10620180|NCT01965600|11778341|FG002|COMPLETED|Second Intervention||1
10620181|NCT01965600|11778342|FG003|COMPLETED|Second Intervention||0
10620182|NCT01965600|11778339|FG000|NOT COMPLETED|Second Intervention||0
10620183|NCT01965600|11778340|FG001|NOT COMPLETED|Second Intervention||0
10620184|NCT01965600|11778341|FG002|NOT COMPLETED|Second Intervention||2
10620185|NCT01965600|11778342|FG003|NOT COMPLETED|Second Intervention||2
10620186|NCT01965652|11778352|FG000|STARTED|Overall Study|Includes two participants who each enrolled at two different sites|623
10620187|NCT01965652|11778353|FG001|STARTED|Overall Study|Includes three participants who each enrolled at two different sites|623
10620188|NCT01965652|11778352|FG000|Received Treatment|Overall Study||622
10620189|NCT01965652|11778353|FG001|Received Treatment|Overall Study||623
10620190|NCT01965652|11778352|FG000|COMPLETED|Overall Study||413
10620191|NCT01965652|11778353|FG001|COMPLETED|Overall Study||413
10620192|NCT01965652|11778352|FG000|NOT COMPLETED|Overall Study||210
10620193|NCT01965652|11778353|FG001|NOT COMPLETED|Overall Study||210
10620194|NCT01965665|11778359|FG000|STARTED|Overall Study||20
10620195|NCT01965665|11778359|FG000|COMPLETED|Overall Study||19
10620196|NCT01965665|11778359|FG000|NOT COMPLETED|Overall Study||1
10620197|NCT01965756|11778365|FG000|STARTED|Overall Study||10
10620198|NCT01965756|11778366|FG001|STARTED|Overall Study||10
10620199|NCT01965756|11778365|FG000|COMPLETED|Overall Study||10
10620200|NCT01965756|11778366|FG001|COMPLETED|Overall Study||10
10620201|NCT01965756|11778365|FG000|NOT COMPLETED|Overall Study||0
10620202|NCT01965756|11778366|FG001|NOT COMPLETED|Overall Study||0
10620203|NCT01965834|11778376|FG000|STARTED|Overall Study||6
10620204|NCT01965834|11778376|FG000|COMPLETED|Overall Study||2
10620205|NCT01965834|11778376|FG000|NOT COMPLETED|Overall Study||4
10620206|NCT01965860|11778383|FG000|STARTED|Overall Study||11
10620207|NCT01965860|11778384|FG001|STARTED|Overall Study||10
10620208|NCT01965860|11778385|FG002|STARTED|Overall Study||11
10620209|NCT01965860|11778383|FG000|COMPLETED|Overall Study||9
10620210|NCT01965860|11778384|FG001|COMPLETED|Overall Study||10
10620211|NCT01965860|11778385|FG002|COMPLETED|Overall Study||10
10620212|NCT01965860|11778383|FG000|NOT COMPLETED|Overall Study||2
10620213|NCT01965860|11778384|FG001|NOT COMPLETED|Overall Study||0
10620214|NCT01965860|11778385|FG002|NOT COMPLETED|Overall Study||1
10620215|NCT01965899|11778393|FG000|STARTED|Overall Study||151
10620216|NCT01965899|11778393|FG000|COMPLETED|Overall Study||145
10620217|NCT01965899|11778393|FG000|NOT COMPLETED|Overall Study||6
10620218|NCT01965938|11778400|FG000|STARTED|Overall Study||21
10620219|NCT01965938|11778401|FG001|STARTED|Overall Study||20
10620220|NCT01965938|11778400|FG000|COMPLETED|Overall Study||20
10620221|NCT01965938|11778401|FG001|COMPLETED|Overall Study||20
10620222|NCT01965938|11778400|FG000|NOT COMPLETED|Overall Study||1
10620223|NCT01965938|11778401|FG001|NOT COMPLETED|Overall Study||0
10620224|NCT01966003|11778411|FG000|STARTED|Overall Study||328
10620225|NCT01966003|11778412|FG001|STARTED|Overall Study||314
10620226|NCT01966003|11778411|FG000|Received Study Drug|Overall Study||324
10620227|NCT01966003|11778412|FG001|Received Study Drug|Overall Study||309
10620228|NCT01966003|11778411|FG000|COMPLETED|Overall Study||58
10620229|NCT01966003|11778412|FG001|COMPLETED|Overall Study||44
10620230|NCT01966003|11778411|FG000|NOT COMPLETED|Overall Study||270
10620231|NCT01966003|11778412|FG001|NOT COMPLETED|Overall Study||270
10620232|NCT01966042|11778418|FG000|STARTED|Overall Study||13
10620233|NCT01966042|11778418|FG000|COMPLETED|Overall Study||11
10620234|NCT01966042|11778418|FG000|NOT COMPLETED|Overall Study||2
10620235|NCT01966068|11778424|FG000|STARTED|Overall Study||294
10620236|NCT01966068|11778424|FG000|Used the MyAsthma Portal at Least Once|Overall Study||237
10620237|NCT01966068|11778424|FG000|Use the MyAsthma Portal More Than Once|Overall Study||156
10620238|NCT01966068|11778424|FG000|COMPLETED|Overall Study||156
10620239|NCT01966068|11778424|FG000|NOT COMPLETED|Overall Study||138
10620240|NCT01966107|11778431|FG000|STARTED|Overall Study||1812
10620241|NCT01966107|11778432|FG001|STARTED|Overall Study||1818
10705063|NCT02595723|11869439|FG002|COMPLETED|Third Intervention (4 Days)||7
10705064|NCT02595723|11869437|FG000|NOT COMPLETED|Third Intervention (4 Days)||0
10620242|NCT01966107|11778431|FG000|Full Analysis Set|Overall Study||1791
10620243|NCT01966107|11778432|FG001|Full Analysis Set|Overall Study||1798
10620244|NCT01966107|11778431|FG000|COMPLETED|Overall Study||1010
10705065|NCT02595723|11869438|FG001|NOT COMPLETED|Third Intervention (4 Days)||0
10620245|NCT01966107|11778432|FG001|COMPLETED|Overall Study||937
10620246|NCT01966107|11778431|FG000|NOT COMPLETED|Overall Study||802
10620247|NCT01966107|11778432|FG001|NOT COMPLETED|Overall Study||881
10620248|NCT01966120|11778440|FG000|STARTED|Overall Study||55
10620249|NCT01966120|11778441|FG001|STARTED|Overall Study||32
10620250|NCT01966120|11778440|FG000|COMPLETED|Overall Study||54
10620251|NCT01966120|11778441|FG001|COMPLETED|Overall Study||26
10620252|NCT01966120|11778440|FG000|NOT COMPLETED|Overall Study||1
10620253|NCT01966120|11778441|FG001|NOT COMPLETED|Overall Study||6
10620254|NCT01966159|11778449|FG000|STARTED|Overall Study||205
10620255|NCT01966159|11778450|FG001|STARTED|Overall Study||207
10620256|NCT01966159|11778449|FG000|COMPLETED|Overall Study||205
10620257|NCT01966159|11778450|FG001|COMPLETED|Overall Study||207
10620258|NCT01966159|11778449|FG000|NOT COMPLETED|Overall Study||0
10620259|NCT01966159|11778450|FG001|NOT COMPLETED|Overall Study||0
10620260|NCT01966354|11778459|FG000|STARTED|Overall Study||75
10620261|NCT01966354|11778460|FG001|STARTED|Overall Study||73
10620262|NCT01966354|11778461|FG002|STARTED|Overall Study||72
10620263|NCT01966354|11778459|FG000|COMPLETED|Overall Study||75
10620264|NCT01966354|11778460|FG001|COMPLETED|Overall Study||73
10620265|NCT01966354|11778461|FG002|COMPLETED|Overall Study||72
10620266|NCT01966354|11778459|FG000|NOT COMPLETED|Overall Study||0
10620267|NCT01966354|11778460|FG001|NOT COMPLETED|Overall Study||0
10620268|NCT01966354|11778461|FG002|NOT COMPLETED|Overall Study||0
10620269|NCT01966380|11778469|FG000|STARTED|Overall Study||3
10620270|NCT01966380|11778470|FG001|STARTED|Overall Study||3
10620271|NCT01966380|11778469|FG000|COMPLETED|Overall Study||3
10620272|NCT01966380|11778470|FG001|COMPLETED|Overall Study||2
10620273|NCT01966380|11778469|FG000|NOT COMPLETED|Overall Study||0
10620274|NCT01966380|11778470|FG001|NOT COMPLETED|Overall Study||1
10705066|NCT02595723|11869439|FG002|NOT COMPLETED|Third Intervention (4 Days)||0
10705067|NCT02595749|11869449|FG000|STARTED|Overall Study||45
10705068|NCT02595749|11869450|FG001|STARTED|Overall Study||38
10620275|NCT01966419|11778478|FG000|STARTED|Overall Study||115
10620276|NCT01966419|11778479|FG001|STARTED|Overall Study||116
10620277|NCT01966419|11778478|FG000|Intent to Treat Population (ITT)T)115|Overall Study||115
10620278|NCT01966419|11778479|FG001|Intent to Treat Population (ITT)T)115|Overall Study||116
10620279|NCT01966419|11778478|FG000|Safety Analysis Set (SAS)|Overall Study||112
10620280|NCT01966419|11778479|FG001|Safety Analysis Set (SAS)|Overall Study||114
10620281|NCT01966419|11778478|FG000|COMPLETED|Overall Study||74
10620282|NCT01966419|11778479|FG001|COMPLETED|Overall Study||80
10620283|NCT01966419|11778478|FG000|NOT COMPLETED|Overall Study||41
10620284|NCT01966419|11778479|FG001|NOT COMPLETED|Overall Study||36
10620285|NCT01966432|11778488|FG000|STARTED|Overall Study||10
10620286|NCT01966432|11778489|FG001|STARTED|Overall Study||34
10620287|NCT01966432|11778490|FG002|STARTED|Overall Study||54
10620288|NCT01966432|11778488|FG000|COMPLETED|Overall Study||5
10620289|NCT01966432|11778489|FG001|COMPLETED|Overall Study||21
10620290|NCT01966432|11778490|FG002|COMPLETED|Overall Study||28
10620291|NCT01966432|11778488|FG000|NOT COMPLETED|Overall Study||5
10620292|NCT01966432|11778489|FG001|NOT COMPLETED|Overall Study||13
10620293|NCT01966432|11778490|FG002|NOT COMPLETED|Overall Study||26
10620294|NCT01966445|11778506|FG000|STARTED|Part1 (Median Exposure of 6.143 Weeks)||1
10620295|NCT01966445|11778507|FG001|STARTED|Part1 (Median Exposure of 6.143 Weeks)||3
10620296|NCT01966445|11778508|FG002|STARTED|Part1 (Median Exposure of 6.143 Weeks)||2
10620297|NCT01966445|11778509|FG003|STARTED|Part1 (Median Exposure of 6.143 Weeks)||5
10620298|NCT01966445|11778510|FG004|STARTED|Part1 (Median Exposure of 6.143 Weeks)||4
10620299|NCT01966445|11778511|FG005|STARTED|Part1 (Median Exposure of 6.143 Weeks)||5
10620300|NCT01966445|11778512|FG006|STARTED|Part1 (Median Exposure of 6.143 Weeks)||0
10620301|NCT01966445|11778506|FG000|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
10620302|NCT01966445|11778507|FG001|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
10620303|NCT01966445|11778508|FG002|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
10620387|NCT01967121|11778641|FG000|STARTED|Overall Study||25
10620304|NCT01966445|11778509|FG003|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||2
10620305|NCT01966445|11778510|FG004|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
10620306|NCT01966445|11778511|FG005|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||4
10620307|NCT01966445|11778512|FG006|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||0
10620308|NCT01966445|11778506|FG000|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||0
10620309|NCT01966445|11778507|FG001|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||2
10620310|NCT01966445|11778508|FG002|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
10620311|NCT01966445|11778509|FG003|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||3
10620312|NCT01966445|11778510|FG004|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||3
10620313|NCT01966445|11778511|FG005|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
10620314|NCT01966445|11778512|FG006|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||0
10620315|NCT01966445|11778506|FG000|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
10620316|NCT01966445|11778507|FG001|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
10620317|NCT01966445|11778508|FG002|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
10620318|NCT01966445|11778509|FG003|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
10620319|NCT01966445|11778510|FG004|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
10620320|NCT01966445|11778511|FG005|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
10620321|NCT01966445|11778512|FG006|STARTED|Part2 (Median Exposure of 7.143 Weeks)||9
10620322|NCT01966445|11778506|FG000|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
10620323|NCT01966445|11778507|FG001|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
10620324|NCT01966445|11778508|FG002|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
10620325|NCT01966445|11778509|FG003|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
10620326|NCT01966445|11778510|FG004|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
10620327|NCT01966445|11778511|FG005|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
10620328|NCT01966445|11778512|FG006|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||4
10620329|NCT01966445|11778506|FG000|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
10620330|NCT01966445|11778507|FG001|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
10620331|NCT01966445|11778508|FG002|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
10705069|NCT02595749|11869449|FG000|COMPLETED|Overall Study||33
10705070|NCT02595749|11869450|FG001|COMPLETED|Overall Study||31
10620332|NCT01966445|11778509|FG003|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
10620333|NCT01966445|11778510|FG004|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
10620334|NCT01966445|11778511|FG005|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
10620335|NCT01966445|11778512|FG006|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||5
10620336|NCT01966458|11778530|FG000|STARTED|Overall Study||308
10620337|NCT01966458|11778531|FG001|STARTED|Overall Study||157
10620338|NCT01966458|11778530|FG000|COMPLETED|Overall Study||304
10620339|NCT01966458|11778531|FG001|COMPLETED|Overall Study||155
10620340|NCT01966458|11778530|FG000|NOT COMPLETED|Overall Study||4
10620341|NCT01966458|11778531|FG001|NOT COMPLETED|Overall Study||2
10620342|NCT01966718|11778537|FG000|STARTED|Overall Study||8
10620343|NCT01966718|11778537|FG000|COMPLETED|Overall Study||8
10620344|NCT01966718|11778537|FG000|NOT COMPLETED|Overall Study||0
10620345|NCT01966770|11778543|FG000|STARTED|Overall Study||20
10620346|NCT01966770|11778543|FG000|COMPLETED|Overall Study||20
10620347|NCT01966770|11778543|FG000|NOT COMPLETED|Overall Study||0
10620348|NCT01966796|11778581|FG000|STARTED|Overall Study||15
10620349|NCT01966796|11778582|FG001|STARTED|Overall Study||51
10620350|NCT01966796|11778583|FG002|STARTED|Overall Study||195
10620351|NCT01966796|11778584|FG003|STARTED|Overall Study||269
10620352|NCT01966796|11778581|FG000|COMPLETED|Overall Study||15
10620353|NCT01966796|11778582|FG001|COMPLETED|Overall Study||51
10620354|NCT01966796|11778583|FG002|COMPLETED|Overall Study||195
10620355|NCT01966796|11778584|FG003|COMPLETED|Overall Study||269
10620356|NCT01966796|11778581|FG000|NOT COMPLETED|Overall Study||0
10620357|NCT01966796|11778582|FG001|NOT COMPLETED|Overall Study||0
10620358|NCT01966796|11778583|FG002|NOT COMPLETED|Overall Study||0
10620359|NCT01966796|11778584|FG003|NOT COMPLETED|Overall Study||0
10620360|NCT01966809|11778598|FG000|STARTED|Overall Study||1
10620361|NCT01966809|11778598|FG000|COMPLETED|Overall Study||1
10620362|NCT01966809|11778598|FG000|NOT COMPLETED|Overall Study||0
10620363|NCT01966900|11778604|FG000|STARTED|Overall Study||8
10620364|NCT01966900|11778605|FG001|STARTED|Overall Study||6
10620365|NCT01966900|11778604|FG000|COMPLETED|Overall Study||6
10620366|NCT01966900|11778605|FG001|COMPLETED|Overall Study||6
10620367|NCT01966900|11778604|FG000|NOT COMPLETED|Overall Study||2
10620368|NCT01966900|11778605|FG001|NOT COMPLETED|Overall Study||0
10620369|NCT01966926|11778613|FG000|STARTED|Overall Study||15
10620370|NCT01966926|11778614|FG001|STARTED|Overall Study||15
10620371|NCT01966926|11778613|FG000|COMPLETED|Overall Study||15
10620372|NCT01966926|11778614|FG001|COMPLETED|Overall Study||15
10620373|NCT01966926|11778613|FG000|NOT COMPLETED|Overall Study||0
10620374|NCT01966926|11778614|FG001|NOT COMPLETED|Overall Study||0
10620375|NCT01966978|11778622|FG000|STARTED|Overall Study||61
10620376|NCT01966978|11778623|FG001|STARTED|Overall Study||59
10620377|NCT01966978|11778622|FG000|COMPLETED|Overall Study||44
10620378|NCT01966978|11778623|FG001|COMPLETED|Overall Study||46
10620379|NCT01966978|11778622|FG000|NOT COMPLETED|Overall Study||17
10620380|NCT01966978|11778623|FG001|NOT COMPLETED|Overall Study||13
10620381|NCT01967069|11778631|FG000|STARTED|Overall Study||182
10620382|NCT01967069|11778632|FG001|STARTED|Overall Study||95
10620383|NCT01967069|11778631|FG000|COMPLETED|Overall Study||174
10620384|NCT01967069|11778632|FG001|COMPLETED|Overall Study||87
10620385|NCT01967069|11778631|FG000|NOT COMPLETED|Overall Study||8
10620386|NCT01967069|11778632|FG001|NOT COMPLETED|Overall Study||8
10620388|NCT01967121|11778642|FG001|STARTED|Overall Study||25
10620389|NCT01967121|11778643|FG002|STARTED|Overall Study||25
10620390|NCT01967121|11778641|FG000|COMPLETED|Overall Study||25
10620391|NCT01967121|11778642|FG001|COMPLETED|Overall Study||25
10620392|NCT01967121|11778643|FG002|COMPLETED|Overall Study||25
10808889|NCT03838198|11970872|FG002|NOT COMPLETED|1 Month Follow up Period||1
10808890|NCT03838198|11970873|FG003|NOT COMPLETED|1 Month Follow up Period||1
10808891|NCT03838198|11970870|FG000|STARTED|3 Month Follow up Period||18
10808892|NCT03838198|11970871|FG001|STARTED|3 Month Follow up Period||22
10808893|NCT03838198|11970872|FG002|STARTED|3 Month Follow up Period||17
10620393|NCT01967121|11778641|FG000|NOT COMPLETED|Overall Study||0
10620394|NCT01967121|11778642|FG001|NOT COMPLETED|Overall Study||0
10620395|NCT01967121|11778643|FG002|NOT COMPLETED|Overall Study||0
10620396|NCT01967134|11778654|FG000|STARTED|Overall Study||8
10620397|NCT01967134|11778655|FG001|STARTED|Overall Study||8
10620398|NCT01967134|11778656|FG002|STARTED|Overall Study||9
10808894|NCT03838198|11970873|FG003|STARTED|3 Month Follow up Period||22
10811209|NCT03770091|11972930|FG002|COMPLETED|Overall Study||12
10620399|NCT01967134|11778654|FG000|COMPLETED|Overall Study||8
10620400|NCT01967134|11778655|FG001|COMPLETED|Overall Study||7
10620401|NCT01967134|11778656|FG002|COMPLETED|Overall Study||9
10620402|NCT01967134|11778654|FG000|NOT COMPLETED|Overall Study||0
10620403|NCT01967134|11778655|FG001|NOT COMPLETED|Overall Study||1
10620404|NCT01967134|11778656|FG002|NOT COMPLETED|Overall Study||0
10620405|NCT01967147|11778666|FG000|STARTED|Overall Study||112
10620406|NCT01967147|11778667|FG001|STARTED|Overall Study||102
10620407|NCT01967147|11778666|FG000|COMPLETED|Overall Study||99
10620408|NCT01967147|11778667|FG001|COMPLETED|Overall Study||82
10620409|NCT01967147|11778666|FG000|NOT COMPLETED|Overall Study||13
10620410|NCT01967147|11778667|FG001|NOT COMPLETED|Overall Study||20
10620411|NCT01967173|11778682|FG000|STARTED|Overall Study||69
10620412|NCT01967173|11778683|FG001|STARTED|Overall Study||69
10620413|NCT01967173|11778684|FG002|STARTED|Overall Study||71
10620414|NCT01967173|11778685|FG003|STARTED|Overall Study||71
10620415|NCT01967173|11778686|FG004|STARTED|Overall Study||73
10620416|NCT01967173|11778687|FG005|STARTED|Overall Study||72
10620417|NCT01967173|11778688|FG006|STARTED|Overall Study||75
10620418|NCT01967173|11778689|FG007|STARTED|Overall Study||74
10620419|NCT01967173|11778682|FG000|Completed 1st Period|Overall Study||58
10620420|NCT01967173|11778683|FG001|Completed 1st Period|Overall Study||60
10620421|NCT01967173|11778684|FG002|Completed 1st Period|Overall Study||67
10620422|NCT01967173|11778685|FG003|Completed 1st Period|Overall Study||65
10620423|NCT01967173|11778686|FG004|Completed 1st Period|Overall Study||64
10620424|NCT01967173|11778687|FG005|Completed 1st Period|Overall Study||62
10620425|NCT01967173|11778688|FG006|Completed 1st Period|Overall Study||67
10620426|NCT01967173|11778689|FG007|Completed 1st Period|Overall Study||69
10620427|NCT01967173|11778682|FG000|Completed 2nd Period|Overall Study||52
10620428|NCT01967173|11778683|FG001|Completed 2nd Period|Overall Study||58
10620429|NCT01967173|11778684|FG002|Completed 2nd Period|Overall Study||63
10620430|NCT01967173|11778685|FG003|Completed 2nd Period|Overall Study||62
10620431|NCT01967173|11778686|FG004|Completed 2nd Period|Overall Study||63
10620432|NCT01967173|11778687|FG005|Completed 2nd Period|Overall Study||57
10620433|NCT01967173|11778688|FG006|Completed 2nd Period|Overall Study||63
10620434|NCT01967173|11778689|FG007|Completed 2nd Period|Overall Study||61
10620435|NCT01967173|11778682|FG000|Completed 3rd Period|Overall Study||48
10620436|NCT01967173|11778683|FG001|Completed 3rd Period|Overall Study||54
10620437|NCT01967173|11778684|FG002|Completed 3rd Period|Overall Study||60
10620438|NCT01967173|11778685|FG003|Completed 3rd Period|Overall Study||61
10620439|NCT01967173|11778686|FG004|Completed 3rd Period|Overall Study||59
10620440|NCT01967173|11778687|FG005|Completed 3rd Period|Overall Study||56
10620441|NCT01967173|11778688|FG006|Completed 3rd Period|Overall Study||59
10620442|NCT01967173|11778689|FG007|Completed 3rd Period|Overall Study||56
10620443|NCT01967173|11778682|FG000|Completed 4th Period|Overall Study||45
10620444|NCT01967173|11778683|FG001|Completed 4th Period|Overall Study||52
10620445|NCT01967173|11778684|FG002|Completed 4th Period|Overall Study||55
10620446|NCT01967173|11778685|FG003|Completed 4th Period|Overall Study||57
10620447|NCT01967173|11778686|FG004|Completed 4th Period|Overall Study||56
10620448|NCT01967173|11778687|FG005|Completed 4th Period|Overall Study||49
10620449|NCT01967173|11778688|FG006|Completed 4th Period|Overall Study||57
10620450|NCT01967173|11778689|FG007|Completed 4th Period|Overall Study||50
10620451|NCT01967173|11778682|FG000|COMPLETED|Overall Study||45
10620452|NCT01967173|11778683|FG001|COMPLETED|Overall Study||52
10620453|NCT01967173|11778684|FG002|COMPLETED|Overall Study||55
10620454|NCT01967173|11778685|FG003|COMPLETED|Overall Study||57
10620455|NCT01967173|11778686|FG004|COMPLETED|Overall Study||56
10620456|NCT01967173|11778687|FG005|COMPLETED|Overall Study||49
10620457|NCT01967173|11778688|FG006|COMPLETED|Overall Study||57
10620458|NCT01967173|11778689|FG007|COMPLETED|Overall Study||50
10620459|NCT01967173|11778682|FG000|NOT COMPLETED|Overall Study||24
10620460|NCT01967173|11778683|FG001|NOT COMPLETED|Overall Study||17
10620461|NCT01967173|11778684|FG002|NOT COMPLETED|Overall Study||16
10620462|NCT01967173|11778685|FG003|NOT COMPLETED|Overall Study||14
10620463|NCT01967173|11778686|FG004|NOT COMPLETED|Overall Study||17
10620464|NCT01967173|11778687|FG005|NOT COMPLETED|Overall Study||23
10620465|NCT01967173|11778688|FG006|NOT COMPLETED|Overall Study||18
10620466|NCT01967173|11778689|FG007|NOT COMPLETED|Overall Study||24
10620467|NCT01967225|11778705|FG000|STARTED|Overall Study||84
10620468|NCT01967225|11778706|FG001|STARTED|Overall Study||41
10620469|NCT01967225|11778705|FG000|Participants Received Treatment|Overall Study||83
10620470|NCT01967225|11778706|FG001|Participants Received Treatment|Overall Study||41
10620471|NCT01967225|11778705|FG000|COMPLETED|Overall Study||72
10620472|NCT01967225|11778706|FG001|COMPLETED|Overall Study||38
10620473|NCT01967225|11778705|FG000|NOT COMPLETED|Overall Study||12
10620474|NCT01967225|11778706|FG001|NOT COMPLETED|Overall Study||3
10653341|NCT02192606|11813806|FG001|NOT COMPLETED|Overall Study||4
10653342|NCT02192684|11813814|FG000|STARTED|Overall Study||30
10808895|NCT03838198|11970870|FG000|Adolescent Survey Completed|3 Month Follow up Period||16
10808896|NCT03838198|11970871|FG001|Adolescent Survey Completed|3 Month Follow up Period||21
10808897|NCT03838198|11970872|FG002|Adolescent Survey Completed|3 Month Follow up Period||15
10808898|NCT03838198|11970873|FG003|Adolescent Survey Completed|3 Month Follow up Period||21
10808899|NCT03838198|11970870|FG000|COMPLETED|3 Month Follow up Period||15
10808900|NCT03838198|11970871|FG001|COMPLETED|3 Month Follow up Period||19
10808901|NCT03838198|11970872|FG002|COMPLETED|3 Month Follow up Period||14
10808902|NCT03838198|11970873|FG003|COMPLETED|3 Month Follow up Period||18
10808903|NCT03838198|11970870|FG000|NOT COMPLETED|3 Month Follow up Period||3
10808904|NCT03838198|11970871|FG001|NOT COMPLETED|3 Month Follow up Period||3
10808905|NCT03838198|11970872|FG002|NOT COMPLETED|3 Month Follow up Period||3
10653343|NCT02192684|11813815|FG001|STARTED|Overall Study||15
10653344|NCT02192684|11813814|FG000|COMPLETED|Overall Study||30
10653345|NCT02192684|11813815|FG001|COMPLETED|Overall Study||15
10653346|NCT02192684|11813814|FG000|NOT COMPLETED|Overall Study||0
10653347|NCT02192684|11813815|FG001|NOT COMPLETED|Overall Study||0
10653348|NCT02192814|11813821|FG000|STARTED|Overall Study||9
10653349|NCT02192814|11813821|FG000|COMPLETED|Overall Study||9
10653350|NCT02192814|11813821|FG000|NOT COMPLETED|Overall Study||0
10653351|NCT02192879|11813828|FG000|STARTED|Overall Study||3
10653352|NCT02192879|11813829|FG001|STARTED|Overall Study||4
10653353|NCT02192879|11813830|FG002|STARTED|Overall Study||3
10653354|NCT02192879|11813828|FG000|COMPLETED|Overall Study||3
10653355|NCT02192879|11813829|FG001|COMPLETED|Overall Study||4
10653356|NCT02192879|11813830|FG002|COMPLETED|Overall Study||3
10620475|NCT01967277|11778716|FG000|STARTED|Overall Study||22
10620476|NCT01967277|11778717|FG001|STARTED|Overall Study||22
10620477|NCT01967277|11778716|FG000|COMPLETED|Overall Study||21
10620478|NCT01967277|11778717|FG001|COMPLETED|Overall Study||19
10620479|NCT01967277|11778716|FG000|NOT COMPLETED|Overall Study||1
10620480|NCT01967277|11778717|FG001|NOT COMPLETED|Overall Study||3
10620481|NCT01967342|11778726|FG000|STARTED|Overall Study||98
10620482|NCT01967342|11778727|FG001|STARTED|Overall Study||95
10620483|NCT01967342|11778728|FG002|STARTED|Overall Study||97
10620484|NCT01967342|11778726|FG000|5-week Follow-up|Overall Study||83
10620485|NCT01967342|11778727|FG001|5-week Follow-up|Overall Study||78
10620486|NCT01967342|11778728|FG002|5-week Follow-up|Overall Study||76
10620487|NCT01967342|11778726|FG000|10-week Follow-up|Overall Study||78
10620488|NCT01967342|11778727|FG001|10-week Follow-up|Overall Study||83
10620489|NCT01967342|11778728|FG002|10-week Follow-up|Overall Study||80
10620490|NCT01967342|11778726|FG000|COMPLETED|Overall Study||71
10620491|NCT01967342|11778727|FG001|COMPLETED|Overall Study||70
10620492|NCT01967342|11778728|FG002|COMPLETED|Overall Study||68
10620493|NCT01967342|11778726|FG000|NOT COMPLETED|Overall Study||27
10620494|NCT01967342|11778727|FG001|NOT COMPLETED|Overall Study||25
10620495|NCT01967342|11778728|FG002|NOT COMPLETED|Overall Study||29
10620496|NCT01967433|11778738|FG000|STARTED|Overall Study||61
10620497|NCT01967433|11778739|FG001|STARTED|Overall Study||59
10620498|NCT01967433|11778738|FG000|COMPLETED|Overall Study||61
10620499|NCT01967433|11778739|FG001|COMPLETED|Overall Study||58
10620500|NCT01967433|11778738|FG000|NOT COMPLETED|Overall Study||0
10620501|NCT01967433|11778739|FG001|NOT COMPLETED|Overall Study||1
10620502|NCT01967537|11778751|FG000|STARTED|Overall Study||341
10620503|NCT01967537|11778751|FG000|COMPLETED|Overall Study||281
10620504|NCT01967537|11778751|FG000|NOT COMPLETED|Overall Study||60
10620505|NCT01967550|11778757|FG000|STARTED|Overall Study||153
10620506|NCT01967550|11778758|FG001|STARTED|Overall Study||151
10620507|NCT01967550|11778757|FG000|COMPLETED|Overall Study||148
10620508|NCT01967550|11778758|FG001|COMPLETED|Overall Study||149
10620509|NCT01967550|11778757|FG000|NOT COMPLETED|Overall Study||5
10620510|NCT01967550|11778758|FG001|NOT COMPLETED|Overall Study||2
10620511|NCT01967576|11778764|FG000|STARTED|Overall Study||14
10620512|NCT01967576|11778764|FG000|COMPLETED|Overall Study||7
10620513|NCT01967576|11778764|FG000|NOT COMPLETED|Overall Study||7
10620514|NCT01967628|11778770|FG000|STARTED|Overall Study||48
10620515|NCT01967628|11778771|FG001|STARTED|Overall Study||50
10620516|NCT01967628|11778770|FG000|COMPLETED|Overall Study||21
10620517|NCT01967628|11778771|FG001|COMPLETED|Overall Study||19
10620518|NCT01967628|11778770|FG000|NOT COMPLETED|Overall Study||27
10620519|NCT01967628|11778771|FG001|NOT COMPLETED|Overall Study||31
10620520|NCT01967641|11778777|FG000|STARTED|Randomized||51
10620521|NCT01967641|11778777|FG000|COMPLETED|Randomized|Completed week 12|43
10620522|NCT01967641|11778777|FG000|NOT COMPLETED|Randomized||8
10620523|NCT01967641|11778777|FG000|STARTED|Admission to Inpatient Phase||43
10620524|NCT01967641|11778777|FG000|COMPLETED|Admission to Inpatient Phase|Completed 7 week inpatient phase|31
10620525|NCT01967641|11778777|FG000|NOT COMPLETED|Admission to Inpatient Phase||12
10620526|NCT01967641|11778777|FG000|STARTED|12-week Outpatient Phase||31
10620527|NCT01967641|11778777|FG000|COMPLETED|12-week Outpatient Phase|Completed week 12 of outpatient phase|18
10620528|NCT01967641|11778777|FG000|NOT COMPLETED|12-week Outpatient Phase||13
10620529|NCT01967706|11778784|FG000|STARTED|Washout Period of 1 Day (Day 0)||22
10620530|NCT01967706|11778785|FG001|STARTED|Washout Period of 1 Day (Day 0)||22
10620531|NCT01967706|11778786|FG002|STARTED|Washout Period of 1 Day (Day 0)||9
10620532|NCT01967706|11778787|FG003|STARTED|Washout Period of 1 Day (Day 0)||9
10620533|NCT01967706|11778784|FG000|COMPLETED|Washout Period of 1 Day (Day 0)||22
10620534|NCT01967706|11778785|FG001|COMPLETED|Washout Period of 1 Day (Day 0)||22
10620535|NCT01967706|11778786|FG002|COMPLETED|Washout Period of 1 Day (Day 0)||9
10620536|NCT01967706|11778787|FG003|COMPLETED|Washout Period of 1 Day (Day 0)||9
10620537|NCT01967706|11778784|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
10620538|NCT01967706|11778785|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
10620539|NCT01967706|11778786|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
10620540|NCT01967706|11778787|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
10620541|NCT01967706|11778784|FG000|STARTED|First Intervention (Day 1)||22
10620542|NCT01967706|11778785|FG001|STARTED|First Intervention (Day 1)||22
10620543|NCT01967706|11778786|FG002|STARTED|First Intervention (Day 1)||9
10620544|NCT01967706|11778787|FG003|STARTED|First Intervention (Day 1)||9
10620545|NCT01967706|11778784|FG000|COMPLETED|First Intervention (Day 1)||21
10620546|NCT01967706|11778785|FG001|COMPLETED|First Intervention (Day 1)||22
10620547|NCT01967706|11778786|FG002|COMPLETED|First Intervention (Day 1)||9
10620548|NCT01967706|11778787|FG003|COMPLETED|First Intervention (Day 1)||9
10620549|NCT01967706|11778784|FG000|NOT COMPLETED|First Intervention (Day 1)||1
10620550|NCT01967706|11778785|FG001|NOT COMPLETED|First Intervention (Day 1)||0
10620551|NCT01967706|11778786|FG002|NOT COMPLETED|First Intervention (Day 1)||0
10620552|NCT01967706|11778787|FG003|NOT COMPLETED|First Intervention (Day 1)||0
10620553|NCT01967706|11778784|FG000|STARTED|Washout Period of 1 Day (Day 2)||21
10620554|NCT01967706|11778785|FG001|STARTED|Washout Period of 1 Day (Day 2)||22
10620555|NCT01967706|11778786|FG002|STARTED|Washout Period of 1 Day (Day 2)||9
10620556|NCT01967706|11778787|FG003|STARTED|Washout Period of 1 Day (Day 2)||9
10620557|NCT01967706|11778784|FG000|COMPLETED|Washout Period of 1 Day (Day 2)||21
10620558|NCT01967706|11778785|FG001|COMPLETED|Washout Period of 1 Day (Day 2)||22
10620559|NCT01967706|11778786|FG002|COMPLETED|Washout Period of 1 Day (Day 2)||9
10620560|NCT01967706|11778787|FG003|COMPLETED|Washout Period of 1 Day (Day 2)||9
10620561|NCT01967706|11778784|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
10620562|NCT01967706|11778785|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
10620563|NCT01967706|11778786|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
10620564|NCT01967706|11778787|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
10620565|NCT01967706|11778784|FG000|STARTED|Second Intervention (Day 3)||21
10620566|NCT01967706|11778785|FG001|STARTED|Second Intervention (Day 3)||22
10620567|NCT01967706|11778786|FG002|STARTED|Second Intervention (Day 3)||9
10620568|NCT01967706|11778787|FG003|STARTED|Second Intervention (Day 3)||9
10620569|NCT01967706|11778784|FG000|COMPLETED|Second Intervention (Day 3)||21
10620570|NCT01967706|11778785|FG001|COMPLETED|Second Intervention (Day 3)||22
10620571|NCT01967706|11778786|FG002|COMPLETED|Second Intervention (Day 3)||9
10620572|NCT01967706|11778787|FG003|COMPLETED|Second Intervention (Day 3)||9
10620573|NCT01967706|11778784|FG000|NOT COMPLETED|Second Intervention (Day 3)||0
10620574|NCT01967706|11778785|FG001|NOT COMPLETED|Second Intervention (Day 3)||0
10620575|NCT01967706|11778786|FG002|NOT COMPLETED|Second Intervention (Day 3)||0
10620576|NCT01967706|11778787|FG003|NOT COMPLETED|Second Intervention (Day 3)||0
10620577|NCT01967719|11778798|FG000|STARTED|Washout Period of 1 Day (Day 0)||22
10620578|NCT01967719|11778799|FG001|STARTED|Washout Period of 1 Day (Day 0)||22
10620579|NCT01967719|11778800|FG002|STARTED|Washout Period of 1 Day (Day 0)||9
10620580|NCT01967719|11778801|FG003|STARTED|Washout Period of 1 Day (Day 0)||9
10620581|NCT01967719|11778798|FG000|COMPLETED|Washout Period of 1 Day (Day 0)||22
10620582|NCT01967719|11778799|FG001|COMPLETED|Washout Period of 1 Day (Day 0)||22
10620583|NCT01967719|11778800|FG002|COMPLETED|Washout Period of 1 Day (Day 0)||9
10620584|NCT01967719|11778801|FG003|COMPLETED|Washout Period of 1 Day (Day 0)||9
10620585|NCT01967719|11778798|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
10620586|NCT01967719|11778799|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
10620587|NCT01967719|11778800|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
10620588|NCT01967719|11778801|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
10620589|NCT01967719|11778798|FG000|STARTED|First Intervention (Day 1)||22
10620590|NCT01967719|11778799|FG001|STARTED|First Intervention (Day 1)||22
10620591|NCT01967719|11778800|FG002|STARTED|First Intervention (Day 1)||9
10620592|NCT01967719|11778801|FG003|STARTED|First Intervention (Day 1)||9
10620593|NCT01967719|11778798|FG000|COMPLETED|First Intervention (Day 1)||22
10620594|NCT01967719|11778799|FG001|COMPLETED|First Intervention (Day 1)||21
10620595|NCT01967719|11778800|FG002|COMPLETED|First Intervention (Day 1)||9
10620596|NCT01967719|11778801|FG003|COMPLETED|First Intervention (Day 1)||8
10620597|NCT01967719|11778798|FG000|NOT COMPLETED|First Intervention (Day 1)||0
10620598|NCT01967719|11778799|FG001|NOT COMPLETED|First Intervention (Day 1)||1
10620599|NCT01967719|11778800|FG002|NOT COMPLETED|First Intervention (Day 1)||0
10620600|NCT01967719|11778801|FG003|NOT COMPLETED|First Intervention (Day 1)||1
10620601|NCT01967719|11778798|FG000|STARTED|Washout Period of 1 Day (Day 2)||22
10620602|NCT01967719|11778799|FG001|STARTED|Washout Period of 1 Day (Day 2)||21
10620603|NCT01967719|11778800|FG002|STARTED|Washout Period of 1 Day (Day 2)||9
10620604|NCT01967719|11778801|FG003|STARTED|Washout Period of 1 Day (Day 2)||8
10620605|NCT01967719|11778798|FG000|COMPLETED|Washout Period of 1 Day (Day 2)||22
10620606|NCT01967719|11778799|FG001|COMPLETED|Washout Period of 1 Day (Day 2)||21
10620607|NCT01967719|11778800|FG002|COMPLETED|Washout Period of 1 Day (Day 2)||9
10620608|NCT01967719|11778801|FG003|COMPLETED|Washout Period of 1 Day (Day 2)||8
10620609|NCT01967719|11778798|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
10620610|NCT01967719|11778799|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
10620611|NCT01967719|11778800|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
10620612|NCT01967719|11778801|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
10620613|NCT01967719|11778798|FG000|STARTED|Second Intervention (Day 3)||22
10620614|NCT01967719|11778799|FG001|STARTED|Second Intervention (Day 3)||21
10620615|NCT01967719|11778800|FG002|STARTED|Second Intervention (Day 3)||9
10620616|NCT01967719|11778801|FG003|STARTED|Second Intervention (Day 3)||8
10620617|NCT01967719|11778798|FG000|COMPLETED|Second Intervention (Day 3)||22
10620618|NCT01967719|11778799|FG001|COMPLETED|Second Intervention (Day 3)||20
10620619|NCT01967719|11778800|FG002|COMPLETED|Second Intervention (Day 3)||9
10620620|NCT01967719|11778801|FG003|COMPLETED|Second Intervention (Day 3)||8
10620621|NCT01967719|11778798|FG000|NOT COMPLETED|Second Intervention (Day 3)||0
10620622|NCT01967719|11778799|FG001|NOT COMPLETED|Second Intervention (Day 3)||1
10620623|NCT01967719|11778800|FG002|NOT COMPLETED|Second Intervention (Day 3)||0
10620624|NCT01967719|11778801|FG003|NOT COMPLETED|Second Intervention (Day 3)||0
10620625|NCT01967732|11778813|FG000|STARTED|Washout Period of 1 Day (Day 0)||22
10620626|NCT01967732|11778814|FG001|STARTED|Washout Period of 1 Day (Day 0)||22
10620627|NCT01967732|11778815|FG002|STARTED|Washout Period of 1 Day (Day 0)||9
10620628|NCT01967732|11778816|FG003|STARTED|Washout Period of 1 Day (Day 0)||9
10620629|NCT01967732|11778813|FG000|COMPLETED|Washout Period of 1 Day (Day 0)||22
10620630|NCT01967732|11778814|FG001|COMPLETED|Washout Period of 1 Day (Day 0)||21
10620631|NCT01967732|11778815|FG002|COMPLETED|Washout Period of 1 Day (Day 0)||9
10620632|NCT01967732|11778816|FG003|COMPLETED|Washout Period of 1 Day (Day 0)||9
10620633|NCT01967732|11778813|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
10620634|NCT01967732|11778814|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 0)||1
10620635|NCT01967732|11778815|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
10620636|NCT01967732|11778816|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
10620637|NCT01967732|11778813|FG000|STARTED|First Intervention (Day 1)||22
10620638|NCT01967732|11778814|FG001|STARTED|First Intervention (Day 1)||21
10620639|NCT01967732|11778815|FG002|STARTED|First Intervention (Day 1)||9
10620640|NCT01967732|11778816|FG003|STARTED|First Intervention (Day 1)||9
10620641|NCT01967732|11778813|FG000|COMPLETED|First Intervention (Day 1)||22
10620642|NCT01967732|11778814|FG001|COMPLETED|First Intervention (Day 1)|Subject discontinued from the study prior to product use|20
10620643|NCT01967732|11778815|FG002|COMPLETED|First Intervention (Day 1)||9
10620644|NCT01967732|11778816|FG003|COMPLETED|First Intervention (Day 1)||9
10620645|NCT01967732|11778813|FG000|NOT COMPLETED|First Intervention (Day 1)||0
10620646|NCT01967732|11778814|FG001|NOT COMPLETED|First Intervention (Day 1)||1
10620647|NCT01967732|11778815|FG002|NOT COMPLETED|First Intervention (Day 1)||0
10620648|NCT01967732|11778816|FG003|NOT COMPLETED|First Intervention (Day 1)||0
10620649|NCT01967732|11778813|FG000|STARTED|Washout Period of 1 Day (Day 2)||22
10620650|NCT01967732|11778814|FG001|STARTED|Washout Period of 1 Day (Day 2)||20
10620651|NCT01967732|11778815|FG002|STARTED|Washout Period of 1 Day (Day 2)||9
10620652|NCT01967732|11778816|FG003|STARTED|Washout Period of 1 Day (Day 2)||9
10620653|NCT01967732|11778813|FG000|COMPLETED|Washout Period of 1 Day (Day 2)||22
10620654|NCT01967732|11778814|FG001|COMPLETED|Washout Period of 1 Day (Day 2)||20
10620655|NCT01967732|11778815|FG002|COMPLETED|Washout Period of 1 Day (Day 2)||9
10620656|NCT01967732|11778816|FG003|COMPLETED|Washout Period of 1 Day (Day 2)||9
10620657|NCT01967732|11778813|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
10620658|NCT01967732|11778814|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
10620659|NCT01967732|11778815|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
10620660|NCT01967732|11778816|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
10620661|NCT01967732|11778813|FG000|STARTED|Second Intervention (Day 3)||22
10620662|NCT01967732|11778814|FG001|STARTED|Second Intervention (Day 3)||20
10620663|NCT01967732|11778815|FG002|STARTED|Second Intervention (Day 3)||9
10620664|NCT01967732|11778816|FG003|STARTED|Second Intervention (Day 3)||9
10620665|NCT01967732|11778813|FG000|COMPLETED|Second Intervention (Day 3)||22
10620666|NCT01967732|11778814|FG001|COMPLETED|Second Intervention (Day 3)||20
10620667|NCT01967732|11778815|FG002|COMPLETED|Second Intervention (Day 3)||9
10620668|NCT01967732|11778816|FG003|COMPLETED|Second Intervention (Day 3)||9
10620669|NCT01967732|11778813|FG000|NOT COMPLETED|Second Intervention (Day 3)||0
10620670|NCT01967732|11778814|FG001|NOT COMPLETED|Second Intervention (Day 3)||0
10620671|NCT01967732|11778815|FG002|NOT COMPLETED|Second Intervention (Day 3)||0
10620672|NCT01967732|11778816|FG003|NOT COMPLETED|Second Intervention (Day 3)||0
10620673|NCT01967784|11778824|FG000|STARTED|Overall Study||100
10620674|NCT01967784|11778824|FG000|COMPLETED|Overall Study||100
10620675|NCT01967784|11778824|FG000|NOT COMPLETED|Overall Study||0
10620676|NCT01967836|11778828|FG000|STARTED|Overall Study||20
10620677|NCT01967836|11778828|FG000|COMPLETED|Overall Study||11
10620678|NCT01967836|11778828|FG000|NOT COMPLETED|Overall Study||9
10620679|NCT01967862|11778833|FG000|STARTED|Overall Study||54
10620680|NCT01967862|11778833|FG000|COMPLETED|Overall Study||54
10620681|NCT01967862|11778833|FG000|NOT COMPLETED|Overall Study||0
10620682|NCT01967888|11778839|FG000|STARTED|Overall Study||52
10620683|NCT01967888|11778840|FG001|STARTED|Overall Study||52
10620684|NCT01967888|11778839|FG000|COMPLETED|Overall Study||42
10620685|NCT01967888|11778840|FG001|COMPLETED|Overall Study||45
10620686|NCT01967888|11778839|FG000|NOT COMPLETED|Overall Study||10
10620687|NCT01967888|11778840|FG001|NOT COMPLETED|Overall Study||7
10620688|NCT01967940|11778849|FG000|STARTED|Part 1||12
10620689|NCT01967940|11778850|FG001|STARTED|Part 1||28
10620690|NCT01967940|11778851|FG002|STARTED|Part 1||15
10620691|NCT01967940|11778852|FG003|STARTED|Part 1||0
10620692|NCT01967940|11778849|FG000|COMPLETED|Part 1||12
10620693|NCT01967940|11778850|FG001|COMPLETED|Part 1||28
10620694|NCT01967940|11778851|FG002|COMPLETED|Part 1||15
10620695|NCT01967940|11778852|FG003|COMPLETED|Part 1||0
10620696|NCT01967940|11778849|FG000|NOT COMPLETED|Part 1||0
10620697|NCT01967940|11778850|FG001|NOT COMPLETED|Part 1||0
10620698|NCT01967940|11778851|FG002|NOT COMPLETED|Part 1||0
10620699|NCT01967940|11778852|FG003|NOT COMPLETED|Part 1||0
10620700|NCT01967940|11778849|FG000|STARTED|Part 2|4 participants completed Part 1 and did not enter Part 2; 8 participants moved to the Part 2 group|0
10620701|NCT01967940|11778850|FG001|STARTED|Part 2|12 participants completed Part 1 and did not enter Part 2; 16 participants moved to the Part 2 group|0
10620702|NCT01967940|11778851|FG002|STARTED|Part 2|1 participant completed Part 1 and did not enter Part 2; 14 participants moved to the Part 2 group|0
10620703|NCT01967940|11778852|FG003|STARTED|Part 2|38 participants from the Part 1 groups moved to this Part 2 E/C/F/TAF + ATV group|38
10620704|NCT01967940|11778849|FG000|COMPLETED|Part 2||0
10620705|NCT01967940|11778850|FG001|COMPLETED|Part 2||0
10620706|NCT01967940|11778851|FG002|COMPLETED|Part 2||0
10620707|NCT01967940|11778852|FG003|COMPLETED|Part 2||35
10620708|NCT01967940|11778849|FG000|NOT COMPLETED|Part 2||0
10620709|NCT01967940|11778850|FG001|NOT COMPLETED|Part 2||0
10620710|NCT01967940|11778851|FG002|NOT COMPLETED|Part 2||0
10620711|NCT01967940|11778852|FG003|NOT COMPLETED|Part 2||3
10620712|NCT01968031|11778865|FG000|STARTED|Overall Study||204
10620713|NCT01968031|11778866|FG001|STARTED|Overall Study||202
10620714|NCT01968031|11778867|FG002|STARTED|Overall Study||207
10620715|NCT01968031|11778865|FG000|Completed Week 2|Overall Study||197
10620716|NCT01968031|11778866|FG001|Completed Week 2|Overall Study||190
10620717|NCT01968031|11778867|FG002|Completed Week 2|Overall Study||199
10620718|NCT01968031|11778865|FG000|Completed Week 6|Overall Study||191
10620719|NCT01968031|11778866|FG001|Completed Week 6|Overall Study||183
10620720|NCT01968031|11778867|FG002|Completed Week 6|Overall Study||187
10620721|NCT01968031|11778865|FG000|Completed Week 10|Overall Study||187
10620722|NCT01968031|11778866|FG001|Completed Week 10|Overall Study||181
10620723|NCT01968031|11778867|FG002|Completed Week 10|Overall Study||181
10620724|NCT01968031|11778865|FG000|COMPLETED|Overall Study||186
10620725|NCT01968031|11778866|FG001|COMPLETED|Overall Study||182
10620726|NCT01968031|11778867|FG002|COMPLETED|Overall Study||178
10620727|NCT01968031|11778865|FG000|NOT COMPLETED|Overall Study||18
10620728|NCT01968031|11778866|FG001|NOT COMPLETED|Overall Study||20
10620729|NCT01968031|11778867|FG002|NOT COMPLETED|Overall Study||29
10620730|NCT01968057|11778875|FG000|STARTED|Period 1 (Day 1 to Predosing Day 4)||18
10620731|NCT01968057|11778875|FG000|Received Baricitinib|Period 1 (Day 1 to Predosing Day 4)||18
10620732|NCT01968057|11778875|FG000|COMPLETED|Period 1 (Day 1 to Predosing Day 4)||18
10620733|NCT01968057|11778875|FG000|NOT COMPLETED|Period 1 (Day 1 to Predosing Day 4)||0
10620734|NCT01968057|11778875|FG000|STARTED|Period 2 (At Dosing Day 4 to Day 7)||18
10620735|NCT01968057|11778875|FG000|Received Baricitinib + Ciclosporin|Period 2 (At Dosing Day 4 to Day 7)||18
10620736|NCT01968057|11778875|FG000|COMPLETED|Period 2 (At Dosing Day 4 to Day 7)||18
10620737|NCT01968057|11778875|FG000|NOT COMPLETED|Period 2 (At Dosing Day 4 to Day 7)||0
10620738|NCT01968070|11778899|FG000|STARTED|Period 1||4
10620739|NCT01968070|11778900|FG001|STARTED|Period 1||4
10620740|NCT01968070|11778901|FG002|STARTED|Period 1||4
10620741|NCT01968070|11778902|FG003|STARTED|Period 1||4
10620742|NCT01968070|11778903|FG004|STARTED|Period 1||4
10620743|NCT01968070|11778904|FG005|STARTED|Period 1||4
10620744|NCT01968070|11778905|FG006|STARTED|Period 1||10
10620745|NCT01968070|11778906|FG007|STARTED|Period 1||2
10620746|NCT01968070|11778907|FG008|STARTED|Period 1||2
10620747|NCT01968070|11778908|FG009|STARTED|Period 1||9
10620748|NCT01968070|11778909|FG010|STARTED|Period 1||2
10620749|NCT01968070|11778910|FG011|STARTED|Period 1||2
10620750|NCT01968070|11778911|FG012|STARTED|Period 1||9
10620751|NCT01968070|11778912|FG013|STARTED|Period 1||2
10620752|NCT01968070|11778913|FG014|STARTED|Period 1||2
10620753|NCT01968070|11778914|FG015|STARTED|Period 1||9
10620754|NCT01968070|11778915|FG016|STARTED|Period 1||2
10620755|NCT01968070|11778916|FG017|STARTED|Period 1||2
10620756|NCT01968070|11778899|FG000|COMPLETED|Period 1||4
10620757|NCT01968070|11778900|FG001|COMPLETED|Period 1||3
10620758|NCT01968070|11778901|FG002|COMPLETED|Period 1||4
10620759|NCT01968070|11778902|FG003|COMPLETED|Period 1||2
10620760|NCT01968070|11778903|FG004|COMPLETED|Period 1||3
10620761|NCT01968070|11778904|FG005|COMPLETED|Period 1||4
10620762|NCT01968070|11778905|FG006|COMPLETED|Period 1||8
10620763|NCT01968070|11778906|FG007|COMPLETED|Period 1||2
10620764|NCT01968070|11778907|FG008|COMPLETED|Period 1||2
10620765|NCT01968070|11778908|FG009|COMPLETED|Period 1||9
10620766|NCT01968070|11778909|FG010|COMPLETED|Period 1||2
10620767|NCT01968070|11778910|FG011|COMPLETED|Period 1||1
10620768|NCT01968070|11778911|FG012|COMPLETED|Period 1||9
10620769|NCT01968070|11778912|FG013|COMPLETED|Period 1||2
10620770|NCT01968070|11778913|FG014|COMPLETED|Period 1||2
10620771|NCT01968070|11778914|FG015|COMPLETED|Period 1||8
10620772|NCT01968070|11778915|FG016|COMPLETED|Period 1||2
10620773|NCT01968070|11778916|FG017|COMPLETED|Period 1||2
10620774|NCT01968070|11778899|FG000|NOT COMPLETED|Period 1||0
10620775|NCT01968070|11778900|FG001|NOT COMPLETED|Period 1||1
10620776|NCT01968070|11778901|FG002|NOT COMPLETED|Period 1||0
10620777|NCT01968070|11778902|FG003|NOT COMPLETED|Period 1||2
10620778|NCT01968070|11778903|FG004|NOT COMPLETED|Period 1||1
10620779|NCT01968070|11778904|FG005|NOT COMPLETED|Period 1||0
10620780|NCT01968070|11778905|FG006|NOT COMPLETED|Period 1||2
10620781|NCT01968070|11778906|FG007|NOT COMPLETED|Period 1||0
10620782|NCT01968070|11778907|FG008|NOT COMPLETED|Period 1||0
10620783|NCT01968070|11778908|FG009|NOT COMPLETED|Period 1||0
10620784|NCT01968070|11778909|FG010|NOT COMPLETED|Period 1||0
10620785|NCT01968070|11778910|FG011|NOT COMPLETED|Period 1||1
10620786|NCT01968070|11778911|FG012|NOT COMPLETED|Period 1||0
10620787|NCT01968070|11778912|FG013|NOT COMPLETED|Period 1||0
10620788|NCT01968070|11778913|FG014|NOT COMPLETED|Period 1||0
10620789|NCT01968070|11778914|FG015|NOT COMPLETED|Period 1||1
10620790|NCT01968070|11778915|FG016|NOT COMPLETED|Period 1||0
10620791|NCT01968070|11778916|FG017|NOT COMPLETED|Period 1||0
10620792|NCT01968070|11778899|FG000|STARTED|Period 2||4
10620793|NCT01968070|11778900|FG001|STARTED|Period 2|1 participant was added to replace the participant who discontinued the period 1.|4
10620794|NCT01968070|11778901|FG002|STARTED|Period 2||4
10620795|NCT01968070|11778902|FG003|STARTED|Period 2|2 participants were added to replace the 2 participants who discontinued the period 1.|4
10620796|NCT01968070|11778903|FG004|STARTED|Period 2||3
10620797|NCT01968070|11778904|FG005|STARTED|Period 2||4
10620798|NCT01968070|11778905|FG006|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
10620799|NCT01968070|11778906|FG007|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
10620800|NCT01968070|11778907|FG008|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
10620801|NCT01968070|11778908|FG009|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
10620802|NCT01968070|11778909|FG010|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
10620803|NCT01968070|11778910|FG011|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
10620804|NCT01968070|11778911|FG012|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
10620805|NCT01968070|11778912|FG013|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
10620806|NCT01968070|11778913|FG014|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
10620807|NCT01968070|11778914|FG015|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
10620808|NCT01968070|11778915|FG016|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
10620809|NCT01968070|11778916|FG017|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
10620810|NCT01968070|11778899|FG000|COMPLETED|Period 2||4
10620811|NCT01968070|11778900|FG001|COMPLETED|Period 2||4
10620812|NCT01968070|11778901|FG002|COMPLETED|Period 2||4
10620813|NCT01968070|11778902|FG003|COMPLETED|Period 2||4
10620814|NCT01968070|11778903|FG004|COMPLETED|Period 2||2
10620815|NCT01968070|11778904|FG005|COMPLETED|Period 2||4
10620816|NCT01968070|11778905|FG006|COMPLETED|Period 2||0
10620817|NCT01968070|11778906|FG007|COMPLETED|Period 2||0
10620818|NCT01968070|11778907|FG008|COMPLETED|Period 2||0
10620819|NCT01968070|11778908|FG009|COMPLETED|Period 2||0
10620820|NCT01968070|11778909|FG010|COMPLETED|Period 2||0
10620821|NCT01968070|11778910|FG011|COMPLETED|Period 2||0
10620822|NCT01968070|11778911|FG012|COMPLETED|Period 2||0
10620823|NCT01968070|11778912|FG013|COMPLETED|Period 2||0
10620824|NCT01968070|11778913|FG014|COMPLETED|Period 2||0
10620825|NCT01968070|11778914|FG015|COMPLETED|Period 2||0
10620826|NCT01968070|11778915|FG016|COMPLETED|Period 2||0
10620827|NCT01968070|11778916|FG017|COMPLETED|Period 2||0
10620828|NCT01968070|11778899|FG000|NOT COMPLETED|Period 2||0
10620829|NCT01968070|11778900|FG001|NOT COMPLETED|Period 2||0
10620830|NCT01968070|11778901|FG002|NOT COMPLETED|Period 2||0
10620831|NCT01968070|11778902|FG003|NOT COMPLETED|Period 2||0
10620832|NCT01968070|11778903|FG004|NOT COMPLETED|Period 2||1
10620833|NCT01968070|11778904|FG005|NOT COMPLETED|Period 2||0
10620834|NCT01968070|11778905|FG006|NOT COMPLETED|Period 2||0
10620835|NCT01968070|11778906|FG007|NOT COMPLETED|Period 2||0
10620836|NCT01968070|11778907|FG008|NOT COMPLETED|Period 2||0
10620837|NCT01968070|11778908|FG009|NOT COMPLETED|Period 2||0
10620838|NCT01968070|11778909|FG010|NOT COMPLETED|Period 2||0
10620839|NCT01968070|11778910|FG011|NOT COMPLETED|Period 2||0
10620840|NCT01968070|11778911|FG012|NOT COMPLETED|Period 2||0
10620841|NCT01968070|11778912|FG013|NOT COMPLETED|Period 2||0
10620842|NCT01968070|11778913|FG014|NOT COMPLETED|Period 2||0
10620843|NCT01968070|11778914|FG015|NOT COMPLETED|Period 2||0
10620844|NCT01968070|11778915|FG016|NOT COMPLETED|Period 2||0
10620845|NCT01968070|11778916|FG017|NOT COMPLETED|Period 2||0
10620846|NCT01968070|11778899|FG000|STARTED|Period 3||4
10620847|NCT01968070|11778900|FG001|STARTED|Period 3||4
10620848|NCT01968070|11778901|FG002|STARTED|Period 3||4
10620849|NCT01968070|11778902|FG003|STARTED|Period 3||4
10620850|NCT01968070|11778903|FG004|STARTED|Period 3||3
10620851|NCT01968070|11778904|FG005|STARTED|Period 3||4
10620852|NCT01968070|11778905|FG006|STARTED|Period 3||0
10620853|NCT01968070|11778906|FG007|STARTED|Period 3||0
10620854|NCT01968070|11778907|FG008|STARTED|Period 3||0
10620855|NCT01968070|11778908|FG009|STARTED|Period 3||0
10620856|NCT01968070|11778909|FG010|STARTED|Period 3||0
10620857|NCT01968070|11778910|FG011|STARTED|Period 3||0
10620858|NCT01968070|11778911|FG012|STARTED|Period 3||0
10620859|NCT01968070|11778912|FG013|STARTED|Period 3||0
10620860|NCT01968070|11778913|FG014|STARTED|Period 3||0
10620861|NCT01968070|11778914|FG015|STARTED|Period 3||0
10620862|NCT01968070|11778915|FG016|STARTED|Period 3||0
10620863|NCT01968070|11778916|FG017|STARTED|Period 3||0
10620864|NCT01968070|11778899|FG000|COMPLETED|Period 3||4
10620865|NCT01968070|11778900|FG001|COMPLETED|Period 3||4
10620866|NCT01968070|11778901|FG002|COMPLETED|Period 3||4
10620867|NCT01968070|11778902|FG003|COMPLETED|Period 3||4
10620868|NCT01968070|11778903|FG004|COMPLETED|Period 3||3
10620869|NCT01968070|11778904|FG005|COMPLETED|Period 3||4
10620870|NCT01968070|11778905|FG006|COMPLETED|Period 3||0
10620871|NCT01968070|11778906|FG007|COMPLETED|Period 3||0
10620872|NCT01968070|11778907|FG008|COMPLETED|Period 3||0
10620873|NCT01968070|11778908|FG009|COMPLETED|Period 3||0
10620874|NCT01968070|11778909|FG010|COMPLETED|Period 3||0
10620875|NCT01968070|11778910|FG011|COMPLETED|Period 3||0
10620876|NCT01968070|11778911|FG012|COMPLETED|Period 3||0
10620877|NCT01968070|11778912|FG013|COMPLETED|Period 3||0
10620878|NCT01968070|11778913|FG014|COMPLETED|Period 3||0
10620879|NCT01968070|11778914|FG015|COMPLETED|Period 3||0
10620880|NCT01968070|11778915|FG016|COMPLETED|Period 3||0
10620881|NCT01968070|11778916|FG017|COMPLETED|Period 3||0
10620882|NCT01968070|11778899|FG000|NOT COMPLETED|Period 3||0
10620883|NCT01968070|11778900|FG001|NOT COMPLETED|Period 3||0
10620884|NCT01968070|11778901|FG002|NOT COMPLETED|Period 3||0
10620885|NCT01968070|11778902|FG003|NOT COMPLETED|Period 3||0
10620886|NCT01968070|11778903|FG004|NOT COMPLETED|Period 3||0
10620887|NCT01968070|11778904|FG005|NOT COMPLETED|Period 3||0
10620888|NCT01968070|11778905|FG006|NOT COMPLETED|Period 3||0
10620889|NCT01968070|11778906|FG007|NOT COMPLETED|Period 3||0
10620890|NCT01968070|11778907|FG008|NOT COMPLETED|Period 3||0
10620891|NCT01968070|11778908|FG009|NOT COMPLETED|Period 3||0
10620892|NCT01968070|11778909|FG010|NOT COMPLETED|Period 3||0
10620893|NCT01968070|11778910|FG011|NOT COMPLETED|Period 3||0
10620894|NCT01968070|11778911|FG012|NOT COMPLETED|Period 3||0
10620895|NCT01968070|11778912|FG013|NOT COMPLETED|Period 3||0
10620896|NCT01968070|11778913|FG014|NOT COMPLETED|Period 3||0
10620897|NCT01968070|11778914|FG015|NOT COMPLETED|Period 3||0
10620898|NCT01968070|11778915|FG016|NOT COMPLETED|Period 3||0
10620899|NCT01968070|11778916|FG017|NOT COMPLETED|Period 3||0
10620900|NCT01968135|11778956|FG000|STARTED|Overall Study||16
10620901|NCT01968135|11778957|FG001|STARTED|Overall Study||16
10620902|NCT01968135|11778956|FG000|COMPLETED|Overall Study||16
10620903|NCT01968135|11778957|FG001|COMPLETED|Overall Study||16
10620904|NCT01968135|11778956|FG000|NOT COMPLETED|Overall Study||0
10620905|NCT01968135|11778957|FG001|NOT COMPLETED|Overall Study||0
10620906|NCT01968317|11778965|FG000|STARTED|Overall Study||76
10620907|NCT01968317|11778966|FG001|STARTED|Overall Study||74
10620908|NCT01968317|11778965|FG000|COMPLETED|Overall Study||76
10620909|NCT01968317|11778966|FG001|COMPLETED|Overall Study||74
10620910|NCT01968317|11778965|FG000|NOT COMPLETED|Overall Study||0
10620911|NCT01968317|11778966|FG001|NOT COMPLETED|Overall Study||0
10620912|NCT01968356|11778980|FG000|STARTED|Overall Study||101
10620913|NCT01968356|11778981|FG001|STARTED|Overall Study||93
10620914|NCT01968356|11778982|FG002|STARTED|Overall Study||96
10620915|NCT01968356|11778983|FG003|STARTED|Overall Study||32
10620916|NCT01968356|11778984|FG004|STARTED|Overall Study||97
10620917|NCT01968356|11778985|FG005|STARTED|Overall Study||99
10620918|NCT01968356|11778986|FG006|STARTED|Overall Study||97
10620919|NCT01968356|11778987|FG007|STARTED|Overall Study||31
10620920|NCT01968356|11778980|FG000|COMPLETED|Overall Study||101
10620921|NCT01968356|11778981|FG001|COMPLETED|Overall Study||93
10620922|NCT01968356|11778982|FG002|COMPLETED|Overall Study||96
10620923|NCT01968356|11778983|FG003|COMPLETED|Overall Study||32
10620924|NCT01968356|11778984|FG004|COMPLETED|Overall Study||97
10620925|NCT01968356|11778985|FG005|COMPLETED|Overall Study||99
10620926|NCT01968356|11778986|FG006|COMPLETED|Overall Study||97
10620927|NCT01968356|11778987|FG007|COMPLETED|Overall Study||31
10620928|NCT01968356|11778980|FG000|NOT COMPLETED|Overall Study||0
10620929|NCT01968356|11778981|FG001|NOT COMPLETED|Overall Study||0
10620930|NCT01968356|11778982|FG002|NOT COMPLETED|Overall Study||0
10620931|NCT01968356|11778983|FG003|NOT COMPLETED|Overall Study||0
10620932|NCT01968356|11778984|FG004|NOT COMPLETED|Overall Study||0
10620933|NCT01968356|11778985|FG005|NOT COMPLETED|Overall Study||0
10620934|NCT01968356|11778986|FG006|NOT COMPLETED|Overall Study||0
10620935|NCT01968356|11778987|FG007|NOT COMPLETED|Overall Study||0
10620936|NCT01968382|11779016|FG000|STARTED|Overall Study||18
10620937|NCT01968382|11779017|FG001|STARTED|Overall Study||19
10620938|NCT01968382|11779018|FG002|STARTED|Overall Study||20
10620939|NCT01968382|11779016|FG000|COMPLETED|Overall Study||18
10620940|NCT01968382|11779017|FG001|COMPLETED|Overall Study||19
10620941|NCT01968382|11779018|FG002|COMPLETED|Overall Study||20
10620942|NCT01968382|11779016|FG000|NOT COMPLETED|Overall Study||0
10620943|NCT01968382|11779017|FG001|NOT COMPLETED|Overall Study||0
10620944|NCT01968382|11779018|FG002|NOT COMPLETED|Overall Study||0
10620945|NCT01968421|11779028|FG000|STARTED|Overall Study|March 1, 2015 was the date for recruiting patients|99
10620946|NCT01968421|11779029|FG001|STARTED|Overall Study|March 1, 2015 was the date for recruiting controls|97
10620947|NCT01968421|11779028|FG000|Starting Trial|Overall Study||99
10620948|NCT01968421|11779029|FG001|Starting Trial|Overall Study||97
10620949|NCT01968421|11779028|FG000|COMPLETED|Overall Study|Nov. 23, 2018 is the date for completing the trial|99
10620950|NCT01968421|11779029|FG001|COMPLETED|Overall Study|Nov. 23, 2018 is the date for completing the trial|97
10620951|NCT01968421|11779028|FG000|NOT COMPLETED|Overall Study||0
10620952|NCT01968421|11779029|FG001|NOT COMPLETED|Overall Study||0
10620953|NCT01968434|11779037|FG000|STARTED|Overall Study||78
10620954|NCT01968434|11779038|FG001|STARTED|Overall Study||72
10620955|NCT01968434|11779037|FG000|COMPLETED|Overall Study||75
10620956|NCT01968434|11779038|FG001|COMPLETED|Overall Study||66
10620957|NCT01968434|11779037|FG000|NOT COMPLETED|Overall Study||3
10620958|NCT01968434|11779038|FG001|NOT COMPLETED|Overall Study||6
10620959|NCT01968447|11779046|FG000|STARTED|Overall Study||20
10620960|NCT01968447|11779047|FG001|STARTED|Overall Study||20
10620961|NCT01968447|11779046|FG000|COMPLETED|Overall Study||20
10620962|NCT01968447|11779047|FG001|COMPLETED|Overall Study||20
10620963|NCT01968447|11779046|FG000|NOT COMPLETED|Overall Study||0
10620964|NCT01968447|11779047|FG001|NOT COMPLETED|Overall Study||0
10620965|NCT01968551|11779056|FG000|STARTED|Open Label Phase (48 Weeks)||22
10620966|NCT01968551|11779057|FG001|STARTED|Open Label Phase (48 Weeks)||90
10620967|NCT01968551|11779058|FG002|STARTED|Open Label Phase (48 Weeks)||46
10620968|NCT01968551|11779056|FG000|COMPLETED|Open Label Phase (48 Weeks)||20
10620969|NCT01968551|11779057|FG001|COMPLETED|Open Label Phase (48 Weeks)||87
10620970|NCT01968551|11779058|FG002|COMPLETED|Open Label Phase (48 Weeks)||41
10620971|NCT01968551|11779056|FG000|NOT COMPLETED|Open Label Phase (48 Weeks)||2
10620972|NCT01968551|11779057|FG001|NOT COMPLETED|Open Label Phase (48 Weeks)||3
10620973|NCT01968551|11779058|FG002|NOT COMPLETED|Open Label Phase (48 Weeks)||5
10620974|NCT01968551|11779056|FG000|STARTED|Extension Phase||20
10620975|NCT01968551|11779057|FG001|STARTED|Extension Phase||87
10620976|NCT01968551|11779058|FG002|STARTED|Extension Phase|7 participant completed the Open-Label Phase, but did not enter in the Extension Phase|34
10620977|NCT01968551|11779056|FG000|COMPLETED|Extension Phase||19
10620978|NCT01968551|11779057|FG001|COMPLETED|Extension Phase||86
10620979|NCT01968551|11779058|FG002|COMPLETED|Extension Phase||30
10620980|NCT01968551|11779056|FG000|NOT COMPLETED|Extension Phase||1
10620981|NCT01968551|11779057|FG001|NOT COMPLETED|Extension Phase||1
10620982|NCT01968551|11779058|FG002|NOT COMPLETED|Extension Phase||4
10620983|NCT01968694|11779072|FG000|STARTED|Visit 1 (1 Day)||10
10620984|NCT01968694|11779073|FG001|STARTED|Visit 1 (1 Day)||9
10620985|NCT01968694|11779072|FG000|COMPLETED|Visit 1 (1 Day)||10
10620986|NCT01968694|11779073|FG001|COMPLETED|Visit 1 (1 Day)||9
10620987|NCT01968694|11779072|FG000|NOT COMPLETED|Visit 1 (1 Day)||0
10620988|NCT01968694|11779073|FG001|NOT COMPLETED|Visit 1 (1 Day)||0
10620989|NCT01968694|11779072|FG000|STARTED|Washout (1 Month)||10
10620990|NCT01968694|11779073|FG001|STARTED|Washout (1 Month)||9
10620991|NCT01968694|11779072|FG000|COMPLETED|Washout (1 Month)||10
10620992|NCT01968694|11779073|FG001|COMPLETED|Washout (1 Month)||8
10620993|NCT01968694|11779072|FG000|NOT COMPLETED|Washout (1 Month)||0
10620994|NCT01968694|11779073|FG001|NOT COMPLETED|Washout (1 Month)||1
10620995|NCT01968694|11779072|FG000|STARTED|Visit 2 (1 Day)||10
10620996|NCT01968694|11779073|FG001|STARTED|Visit 2 (1 Day)||8
10620997|NCT01968694|11779072|FG000|COMPLETED|Visit 2 (1 Day)||10
10620998|NCT01968694|11779073|FG001|COMPLETED|Visit 2 (1 Day)||8
10620999|NCT01968694|11779072|FG000|NOT COMPLETED|Visit 2 (1 Day)||0
10621000|NCT01968694|11779073|FG001|NOT COMPLETED|Visit 2 (1 Day)||0
10621001|NCT01968707|11779089|FG000|STARTED|Overall Study||247
10621002|NCT01968707|11779090|FG001|STARTED|Overall Study||74
10621003|NCT01968707|11779091|FG002|STARTED|Overall Study||246
10621004|NCT01968707|11779092|FG003|STARTED|Overall Study||245
10621005|NCT01968707|11779093|FG004|STARTED|Overall Study||236
10621006|NCT01968707|11779094|FG005|STARTED|Overall Study||70
10621007|NCT01968707|11779095|FG006|STARTED|Overall Study||238
10621008|NCT01968707|11779096|FG007|STARTED|Overall Study||238
10621009|NCT01968707|11779089|FG000|COMPLETED|Overall Study||198
10621010|NCT01968707|11779090|FG001|COMPLETED|Overall Study||62
10621011|NCT01968707|11779091|FG002|COMPLETED|Overall Study||205
10621012|NCT01968707|11779092|FG003|COMPLETED|Overall Study||201
10621013|NCT01968707|11779093|FG004|COMPLETED|Overall Study||200
10621014|NCT01968707|11779094|FG005|COMPLETED|Overall Study||59
10621015|NCT01968707|11779095|FG006|COMPLETED|Overall Study||204
10621016|NCT01968707|11779096|FG007|COMPLETED|Overall Study||203
10621017|NCT01968707|11779089|FG000|NOT COMPLETED|Overall Study||49
10621018|NCT01968707|11779090|FG001|NOT COMPLETED|Overall Study||12
10621019|NCT01968707|11779091|FG002|NOT COMPLETED|Overall Study||41
10621020|NCT01968707|11779092|FG003|NOT COMPLETED|Overall Study||44
10621021|NCT01968707|11779093|FG004|NOT COMPLETED|Overall Study||36
10621022|NCT01968707|11779094|FG005|NOT COMPLETED|Overall Study||11
10621023|NCT01968707|11779095|FG006|NOT COMPLETED|Overall Study||34
10621024|NCT01968707|11779096|FG007|NOT COMPLETED|Overall Study||35
10621025|NCT01968811|11779129|FG000|STARTED|Overall Study||10
10621026|NCT01968811|11779129|FG000|COMPLETED|Overall Study||5
10621027|NCT01968811|11779129|FG000|NOT COMPLETED|Overall Study||5
10621028|NCT01968954|11779135|FG000|STARTED|Overall Study||354
10621029|NCT01968954|11779136|FG001|STARTED|Overall Study||357
10621030|NCT01968954|11779135|FG000|Treated|Overall Study||353
10621031|NCT01968954|11779136|FG001|Treated|Overall Study||356
10621032|NCT01968954|11779135|FG000|COMPLETED|Overall Study||314
10621033|NCT01968954|11779136|FG001|COMPLETED|Overall Study||314
10621034|NCT01968954|11779135|FG000|NOT COMPLETED|Overall Study||40
10621035|NCT01968954|11779136|FG001|NOT COMPLETED|Overall Study||43
10621036|NCT01968967|11779145|FG000|STARTED|Treatment Period||1071
10621037|NCT01968967|11779146|FG001|STARTED|Treatment Period||1068
10621038|NCT01968967|11779147|FG002|STARTED|Treatment Period||0
10621039|NCT01968967|11779148|FG003|STARTED|Treatment Period||0
10621040|NCT01968967|11779149|FG004|STARTED|Treatment Period||0
10621041|NCT01968967|11779145|FG000|Treated|Treatment Period||1065
10621042|NCT01968967|11779146|FG001|Treated|Treatment Period||1063
10621043|NCT01968967|11779147|FG002|Treated|Treatment Period||0
10621044|NCT01968967|11779148|FG003|Treated|Treatment Period||0
10621045|NCT01968967|11779149|FG004|Treated|Treatment Period||0
10621046|NCT01968967|11779145|FG000|COMPLETED|Treatment Period||925
10621047|NCT01968967|11779146|FG001|COMPLETED|Treatment Period||934
10621048|NCT01968967|11779147|FG002|COMPLETED|Treatment Period||0
10621049|NCT01968967|11779148|FG003|COMPLETED|Treatment Period||0
10621050|NCT01968967|11779149|FG004|COMPLETED|Treatment Period||0
10621051|NCT01968967|11779145|FG000|NOT COMPLETED|Treatment Period||146
10621052|NCT01968967|11779146|FG001|NOT COMPLETED|Treatment Period||134
10621053|NCT01968967|11779147|FG002|NOT COMPLETED|Treatment Period||0
10621054|NCT01968967|11779148|FG003|NOT COMPLETED|Treatment Period||0
10621055|NCT01968967|11779149|FG004|NOT COMPLETED|Treatment Period||0
10621056|NCT01968967|11779145|FG000|STARTED|Extension Period||0
10621057|NCT01968967|11779146|FG001|STARTED|Extension Period||0
10621058|NCT01968967|11779147|FG002|STARTED|Extension Period||47
10621059|NCT01968967|11779148|FG003|STARTED|Extension Period||19
10621060|NCT01968967|11779149|FG004|STARTED|Extension Period||39
10621061|NCT01968967|11779145|FG000|COMPLETED|Extension Period||0
10621062|NCT01968967|11779146|FG001|COMPLETED|Extension Period||0
10621063|NCT01968967|11779147|FG002|COMPLETED|Extension Period||45
10621064|NCT01968967|11779148|FG003|COMPLETED|Extension Period||19
10621065|NCT01968967|11779149|FG004|COMPLETED|Extension Period||34
10621066|NCT01968967|11779145|FG000|NOT COMPLETED|Extension Period||0
10621067|NCT01968967|11779146|FG001|NOT COMPLETED|Extension Period||0
10621068|NCT01968967|11779147|FG002|NOT COMPLETED|Extension Period||2
10621069|NCT01968967|11779148|FG003|NOT COMPLETED|Extension Period||0
10621070|NCT01968967|11779149|FG004|NOT COMPLETED|Extension Period||5
10621071|NCT01968980|11779165|FG000|STARTED|Overall Study||185
10621072|NCT01968980|11779166|FG001|STARTED|Overall Study||185
10621073|NCT01968980|11779165|FG000|COMPLETED|Overall Study||169
10621074|NCT01968980|11779166|FG001|COMPLETED|Overall Study||171
10621075|NCT01968980|11779165|FG000|NOT COMPLETED|Overall Study||16
10621076|NCT01968980|11779166|FG001|NOT COMPLETED|Overall Study||14
10621077|NCT01969058|11779175|FG000|STARTED|Overall Study||50
10621078|NCT01969058|11779176|FG001|STARTED|Overall Study||26
10621079|NCT01969058|11779175|FG000|COMPLETED|Overall Study||47
10621080|NCT01969058|11779176|FG001|COMPLETED|Overall Study||26
10621081|NCT01969058|11779175|FG000|NOT COMPLETED|Overall Study||3
10621082|NCT01969058|11779176|FG001|NOT COMPLETED|Overall Study||0
10621083|NCT01969084|11779184|FG000|STARTED|Overall Study||19
10621084|NCT01969084|11779185|FG001|STARTED|Overall Study||22
10621085|NCT01969084|11779184|FG000|COMPLETED|Overall Study||19
10621086|NCT01969084|11779185|FG001|COMPLETED|Overall Study|One subject withdrew due to unrelated serious adverse event|21
10621087|NCT01969084|11779184|FG000|NOT COMPLETED|Overall Study||0
10621088|NCT01969084|11779185|FG001|NOT COMPLETED|Overall Study||1
10621089|NCT01969162|11779195|FG000|STARTED|Overall Study||35
10621090|NCT01969162|11779195|FG000|COMPLETED|Overall Study||35
10621091|NCT01969162|11779195|FG000|NOT COMPLETED|Overall Study||0
10621092|NCT01969201|11779201|FG000|STARTED|Overall Study||352
10621093|NCT01969201|11779202|FG001|STARTED|Overall Study||358
10621094|NCT01969201|11779201|FG000|COMPLETED|Overall Study||307
10621095|NCT01969201|11779202|FG001|COMPLETED|Overall Study||313
10705071|NCT02595749|11869449|FG000|NOT COMPLETED|Overall Study||12
10705072|NCT02595749|11869450|FG001|NOT COMPLETED|Overall Study||7
10705073|NCT02595970|11869456|FG000|STARTED|Overall Study||120
10705074|NCT02595970|11869456|FG000|COMPLETED|Overall Study|Out of 100 patients who completed treatment period 2, 20 patients completed the extension period.|100
10621096|NCT01969201|11779201|FG000|NOT COMPLETED|Overall Study||45
10621097|NCT01969201|11779202|FG001|NOT COMPLETED|Overall Study||45
10621098|NCT01969214|11779208|FG000|STARTED|Overall Study||101
10621099|NCT01969214|11779208|FG000|COMPLETED|Overall Study||86
10621100|NCT01969214|11779208|FG000|NOT COMPLETED|Overall Study||15
10621101|NCT01969240|11779214|FG000|STARTED|Overall Study||451
10621102|NCT01969240|11779215|FG001|STARTED|Overall Study||447
10621103|NCT01969240|11779214|FG000|COMPLETED|Overall Study||451
10621104|NCT01969240|11779215|FG001|COMPLETED|Overall Study||447
10621105|NCT01969240|11779214|FG000|NOT COMPLETED|Overall Study||0
10621106|NCT01969240|11779215|FG001|NOT COMPLETED|Overall Study||0
10621107|NCT01969435|11779223|FG000|STARTED|Overall Study||50
10621108|NCT01969435|11779223|FG000|COMPLETED|Overall Study||50
10621109|NCT01969435|11779223|FG000|NOT COMPLETED|Overall Study||0
10621110|NCT01969448|11779230|FG000|STARTED|Overall Study||55
10621111|NCT01969448|11779231|FG001|STARTED|Overall Study||24
10621112|NCT01969448|11779232|FG002|STARTED|Overall Study||0
10621113|NCT01969448|11779230|FG000|COMPLETED|Overall Study||55
10621114|NCT01969448|11779231|FG001|COMPLETED|Overall Study||24
10621115|NCT01969448|11779232|FG002|COMPLETED|Overall Study||0
10621116|NCT01969448|11779230|FG000|NOT COMPLETED|Overall Study||0
10621117|NCT01969448|11779231|FG001|NOT COMPLETED|Overall Study||0
10621118|NCT01969448|11779232|FG002|NOT COMPLETED|Overall Study||0
10621119|NCT01969500|11779242|FG000|STARTED|Overall Study||25
10621120|NCT01969500|11779243|FG001|STARTED|Overall Study||26
10621121|NCT01969500|11779242|FG000|COMPLETED|Overall Study||24
10621122|NCT01969500|11779243|FG001|COMPLETED|Overall Study||24
10621123|NCT01969500|11779242|FG000|NOT COMPLETED|Overall Study||1
10621124|NCT01969500|11779243|FG001|NOT COMPLETED|Overall Study||2
10621125|NCT01969539|11779249|FG000|STARTED|Overall Study||11
10621126|NCT01969539|11779249|FG000|COMPLETED|Overall Study||11
10621127|NCT01969539|11779249|FG000|NOT COMPLETED|Overall Study||0
10621128|NCT01969708|11779255|FG000|STARTED|Overall Study||180
10621129|NCT01969708|11779256|FG001|STARTED|Overall Study||182
10621130|NCT01969708|11779255|FG000|COMPLETED|Overall Study||175
10621131|NCT01969708|11779256|FG001|COMPLETED|Overall Study||173
10621132|NCT01969708|11779255|FG000|NOT COMPLETED|Overall Study||5
10621133|NCT01969708|11779256|FG001|NOT COMPLETED|Overall Study||9
10621134|NCT01969721|11779262|FG000|STARTED|Overall Study||58
10621135|NCT01969721|11779263|FG001|STARTED|Overall Study||69
10621136|NCT01969721|11779264|FG002|STARTED|Overall Study||50
10621137|NCT01969721|11779265|FG003|STARTED|Overall Study||52
10621138|NCT01969721|11779262|FG000|COMPLETED|Overall Study||54
10621139|NCT01969721|11779263|FG001|COMPLETED|Overall Study||57
10621140|NCT01969721|11779264|FG002|COMPLETED|Overall Study||45
10621141|NCT01969721|11779265|FG003|COMPLETED|Overall Study||46
10621142|NCT01969721|11779262|FG000|NOT COMPLETED|Overall Study||4
10621143|NCT01969721|11779263|FG001|NOT COMPLETED|Overall Study||12
10621144|NCT01969721|11779264|FG002|NOT COMPLETED|Overall Study||5
10621145|NCT01969721|11779265|FG003|NOT COMPLETED|Overall Study||6
10621146|NCT01969747|11779279|FG000|STARTED|Overall Study||19
10621147|NCT01969747|11779280|FG001|STARTED|Overall Study||19
10621148|NCT01969747|11779281|FG002|STARTED|Overall Study||19
10621149|NCT01969747|11779282|FG003|STARTED|Overall Study||18
10621150|NCT01969747|11779279|FG000|COMPLETED|Overall Study||19
10621151|NCT01969747|11779280|FG001|COMPLETED|Overall Study||19
10621152|NCT01969747|11779281|FG002|COMPLETED|Overall Study||19
10621153|NCT01969747|11779282|FG003|COMPLETED|Overall Study||18
10621154|NCT01969747|11779279|FG000|NOT COMPLETED|Overall Study||0
10621155|NCT01969747|11779280|FG001|NOT COMPLETED|Overall Study||0
10621156|NCT01969747|11779281|FG002|NOT COMPLETED|Overall Study||0
10621157|NCT01969747|11779282|FG003|NOT COMPLETED|Overall Study||0
10621158|NCT01969799|11779294|FG000|STARTED|Overall Study||71
10621159|NCT01969799|11779295|FG001|STARTED|Overall Study||72
10621160|NCT01969799|11779294|FG000|COMPLETED|Overall Study||54
10621161|NCT01969799|11779295|FG001|COMPLETED|Overall Study||58
10621162|NCT01969799|11779294|FG000|NOT COMPLETED|Overall Study||17
10621163|NCT01969799|11779295|FG001|NOT COMPLETED|Overall Study||14
10621164|NCT01969851|11779304|FG000|STARTED|Overall Study||10
10621165|NCT01969851|11779305|FG001|STARTED|Overall Study||24
10621166|NCT01969851|11779306|FG002|STARTED|Overall Study||21
10621167|NCT01969851|11779304|FG000|COMPLETED|Overall Study||9
10621168|NCT01969851|11779305|FG001|COMPLETED|Overall Study||21
10621169|NCT01969851|11779306|FG002|COMPLETED|Overall Study||14
10621170|NCT01969851|11779304|FG000|NOT COMPLETED|Overall Study||1
10621171|NCT01969851|11779305|FG001|NOT COMPLETED|Overall Study||3
10705075|NCT02595970|11869456|FG000|NOT COMPLETED|Overall Study||20
10621172|NCT01969851|11779306|FG002|NOT COMPLETED|Overall Study||7
10621173|NCT01969916|11779314|FG000|STARTED|Overall Study||150
10621174|NCT01969916|11779314|FG000|COMPLETED|Overall Study||105
10621175|NCT01969916|11779314|FG000|NOT COMPLETED|Overall Study||45
10621176|NCT01970007|11779318|FG000|STARTED|Overall Study||243
10621177|NCT01970007|11779318|FG000|COMPLETED|Overall Study||188
10621178|NCT01970007|11779318|FG000|NOT COMPLETED|Overall Study||55
10621179|NCT01970176|11779324|FG000|STARTED|Overall Study||14
10621180|NCT01970176|11779325|FG001|STARTED|Overall Study||6
10621181|NCT01970176|11779324|FG000|COMPLETED|Overall Study||14
10621182|NCT01970176|11779325|FG001|COMPLETED|Overall Study||6
10621183|NCT01970176|11779324|FG000|NOT COMPLETED|Overall Study||0
10621184|NCT01970176|11779325|FG001|NOT COMPLETED|Overall Study||0
10621185|NCT01970241|11779333|FG000|STARTED|Overall Study||46
10621186|NCT01970241|11779334|FG001|STARTED|Overall Study||39
10621187|NCT01970241|11779333|FG000|COMPLETED|Overall Study||29
10621188|NCT01970241|11779334|FG001|COMPLETED|Overall Study||31
10621189|NCT01970241|11779333|FG000|NOT COMPLETED|Overall Study||17
10621190|NCT01970241|11779334|FG001|NOT COMPLETED|Overall Study||8
10621191|NCT01970371|11779345|FG000|STARTED|Overall Study||18
10621192|NCT01970371|11779346|FG001|STARTED|Overall Study||21
10621193|NCT01970371|11779347|FG002|STARTED|Overall Study||30
10621194|NCT01970371|11779345|FG000|COMPLETED|Overall Study||10
10621195|NCT01970371|11779346|FG001|COMPLETED|Overall Study||8
10621196|NCT01970371|11779347|FG002|COMPLETED|Overall Study||17
10621197|NCT01970371|11779345|FG000|NOT COMPLETED|Overall Study||8
10621198|NCT01970371|11779346|FG001|NOT COMPLETED|Overall Study||13
10621199|NCT01970371|11779347|FG002|NOT COMPLETED|Overall Study||13
10621200|NCT01970397|11779359|FG000|STARTED|Overall Study||69
10621201|NCT01970397|11779360|FG001|STARTED|Overall Study||69
10621202|NCT01970397|11779359|FG000|COMPLETED|Overall Study||67
10621203|NCT01970397|11779360|FG001|COMPLETED|Overall Study||64
10621204|NCT01970397|11779359|FG000|NOT COMPLETED|Overall Study||2
10621205|NCT01970397|11779360|FG001|NOT COMPLETED|Overall Study||5
10621206|NCT01970475|11779368|FG000|STARTED|Overall Study||264
10621207|NCT01970475|11779369|FG001|STARTED|Overall Study||262
10621208|NCT01970475|11779368|FG000|COMPLETED|Overall Study||243
10621209|NCT01970475|11779369|FG001|COMPLETED|Overall Study||251
10621210|NCT01970475|11779368|FG000|NOT COMPLETED|Overall Study||21
10621211|NCT01970475|11779369|FG001|NOT COMPLETED|Overall Study||11
10621212|NCT01970488|11779377|FG000|STARTED|Part 1: Through Week 16||175
10621213|NCT01970488|11779378|FG001|STARTED|Part 1: Through Week 16||175
10621214|NCT01970488|11779379|FG002|STARTED|Part 1: Through Week 16||0
10621215|NCT01970488|11779380|FG003|STARTED|Part 1: Through Week 16||0
10621216|NCT01970488|11779381|FG004|STARTED|Part 1: Through Week 16||0
10621217|NCT01970488|11779377|FG000|Received Treatment|Part 1: Through Week 16||174
10621218|NCT01970488|11779378|FG001|Received Treatment|Part 1: Through Week 16||173
10621219|NCT01970488|11779379|FG002|Received Treatment|Part 1: Through Week 16||0
10621220|NCT01970488|11779380|FG003|Received Treatment|Part 1: Through Week 16||0
10621221|NCT01970488|11779381|FG004|Received Treatment|Part 1: Through Week 16||0
10621222|NCT01970488|11779377|FG000|COMPLETED|Part 1: Through Week 16||164
10621223|NCT01970488|11779378|FG001|COMPLETED|Part 1: Through Week 16||162
10621224|NCT01970488|11779379|FG002|COMPLETED|Part 1: Through Week 16||0
10621225|NCT01970488|11779380|FG003|COMPLETED|Part 1: Through Week 16||0
10621226|NCT01970488|11779381|FG004|COMPLETED|Part 1: Through Week 16||0
10621227|NCT01970488|11779377|FG000|NOT COMPLETED|Part 1: Through Week 16||11
10621228|NCT01970488|11779378|FG001|NOT COMPLETED|Part 1: Through Week 16||13
10621229|NCT01970488|11779379|FG002|NOT COMPLETED|Part 1: Through Week 16||0
10621230|NCT01970488|11779380|FG003|NOT COMPLETED|Part 1: Through Week 16||0
10621231|NCT01970488|11779381|FG004|NOT COMPLETED|Part 1: Through Week 16||0
10621232|NCT01970488|11779377|FG000|STARTED|Part 2: Post Week 16||0
10621233|NCT01970488|11779378|FG001|STARTED|Part 2: Post Week 16||0
10621234|NCT01970488|11779379|FG002|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|152
10621235|NCT01970488|11779380|FG003|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|79
10621236|NCT01970488|11779381|FG004|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|77
10621237|NCT01970488|11779377|FG000|COMPLETED|Part 2: Post Week 16||0
10621238|NCT01970488|11779378|FG001|COMPLETED|Part 2: Post Week 16||0
10621239|NCT01970488|11779379|FG002|COMPLETED|Part 2: Post Week 16||135
10621240|NCT01970488|11779380|FG003|COMPLETED|Part 2: Post Week 16||71
10621241|NCT01970488|11779381|FG004|COMPLETED|Part 2: Post Week 16||69
10621242|NCT01970488|11779377|FG000|NOT COMPLETED|Part 2: Post Week 16||0
10621243|NCT01970488|11779378|FG001|NOT COMPLETED|Part 2: Post Week 16||0
10621244|NCT01970488|11779379|FG002|NOT COMPLETED|Part 2: Post Week 16||17
10621245|NCT01970488|11779380|FG003|NOT COMPLETED|Part 2: Post Week 16||8
10621246|NCT01970488|11779381|FG004|NOT COMPLETED|Part 2: Post Week 16||8
10621247|NCT01970527|11779398|FG000|STARTED|Pre-treatment/Baseline||9
10621248|NCT01970527|11779399|FG001|STARTED|Pre-treatment/Baseline||14
10621249|NCT01970527|11779398|FG000|COMPLETED|Pre-treatment/Baseline||8
10621250|NCT01970527|11779399|FG001|COMPLETED|Pre-treatment/Baseline||14
10621251|NCT01970527|11779398|FG000|NOT COMPLETED|Pre-treatment/Baseline||1
10621252|NCT01970527|11779399|FG001|NOT COMPLETED|Pre-treatment/Baseline||0
10621253|NCT01970527|11779398|FG000|STARTED|Treatment||8
10621254|NCT01970527|11779399|FG001|STARTED|Treatment||14
10705076|NCT02595983|11869460|FG000|STARTED|Overall Study||12
10705077|NCT02595983|11869460|FG000|COMPLETED|Overall Study||8
10705078|NCT02595983|11869460|FG000|NOT COMPLETED|Overall Study||4
10705079|NCT02596009|11869465|FG000|STARTED|Overall Study||14
10705080|NCT02596009|11869466|FG001|STARTED|Overall Study||16
10705081|NCT02596009|11869467|FG002|STARTED|Overall Study||16
10705082|NCT02596009|11869468|FG003|STARTED|Overall Study||16
10705083|NCT02596009|11869469|FG004|STARTED|Overall Study||18
10621255|NCT01970527|11779398|FG000|COMPLETED|Treatment||8
10621256|NCT01970527|11779399|FG001|COMPLETED|Treatment||11
10621257|NCT01970527|11779398|FG000|NOT COMPLETED|Treatment||0
10621258|NCT01970527|11779399|FG001|NOT COMPLETED|Treatment||3
10621259|NCT01970527|11779398|FG000|STARTED|Follow-up Clinic Visit||8
10621260|NCT01970527|11779399|FG001|STARTED|Follow-up Clinic Visit||11
10621261|NCT01970527|11779398|FG000|COMPLETED|Follow-up Clinic Visit||7
10621262|NCT01970527|11779399|FG001|COMPLETED|Follow-up Clinic Visit||8
10621263|NCT01970527|11779398|FG000|NOT COMPLETED|Follow-up Clinic Visit||1
10621264|NCT01970527|11779399|FG001|NOT COMPLETED|Follow-up Clinic Visit||3
10621265|NCT01970540|11779411|FG000|STARTED|Overall Study||73
10621266|NCT01970540|11779412|FG001|STARTED|Overall Study||28
10621267|NCT01970540|11779413|FG002|STARTED|Overall Study||19
10621268|NCT01970540|11779411|FG000|COMPLETED|Overall Study||0
10621269|NCT01970540|11779412|FG001|COMPLETED|Overall Study||0
10621270|NCT01970540|11779413|FG002|COMPLETED|Overall Study||0
10621271|NCT01970540|11779411|FG000|NOT COMPLETED|Overall Study||73
10621272|NCT01970540|11779412|FG001|NOT COMPLETED|Overall Study||28
10621273|NCT01970540|11779413|FG002|NOT COMPLETED|Overall Study||19
10621274|NCT01970592|11779432|FG000|STARTED|Overall Study|Completed all training sessions|56
10621275|NCT01970592|11779432|FG000|COMPLETED|Overall Study||50
10621276|NCT01970592|11779432|FG000|NOT COMPLETED|Overall Study||6
10621277|NCT01970787|11779436|FG000|STARTED|Overall Study||22
10621278|NCT01970787|11779436|FG000|COMPLETED|Overall Study||21
10621279|NCT01970787|11779436|FG000|NOT COMPLETED|Overall Study||1
10621280|NCT01970878|11779444|FG000|STARTED|Overall Study||290
10621281|NCT01970878|11779445|FG001|STARTED|Overall Study|218 subjects were reported in the CSR, 1 had no completion status|218
10621282|NCT01970878|11779446|FG002|STARTED|Overall Study||213
10621283|NCT01970878|11779447|FG003|STARTED|Overall Study||171
10621284|NCT01970878|11779444|FG000|COMPLETED|Overall Study||253
10621285|NCT01970878|11779445|FG001|COMPLETED|Overall Study||191
10621286|NCT01970878|11779446|FG002|COMPLETED|Overall Study||187
10621287|NCT01970878|11779447|FG003|COMPLETED|Overall Study||147
10621288|NCT01970878|11779444|FG000|NOT COMPLETED|Overall Study||37
10621289|NCT01970878|11779445|FG001|NOT COMPLETED|Overall Study||27
10621290|NCT01970878|11779446|FG002|NOT COMPLETED|Overall Study||26
10621291|NCT01970878|11779447|FG003|NOT COMPLETED|Overall Study||24
10621292|NCT01970943|11779457|FG000|STARTED|Overall Study||11
10621293|NCT01970943|11779458|FG001|STARTED|Overall Study||12
10621294|NCT01970943|11779457|FG000|COMPLETED|Overall Study||8
10621295|NCT01970943|11779458|FG001|COMPLETED|Overall Study||11
10621296|NCT01970943|11779457|FG000|NOT COMPLETED|Overall Study||3
10621297|NCT01970943|11779458|FG001|NOT COMPLETED|Overall Study||1
10621298|NCT01970982|11779467|FG000|STARTED|Overall Study||80
10621299|NCT01970982|11779468|FG001|STARTED|Overall Study||40
10621300|NCT01970982|11779469|FG002|STARTED|Overall Study||40
10621301|NCT01970982|11779467|FG000|COMPLETED|Overall Study||80
10621302|NCT01970982|11779468|FG001|COMPLETED|Overall Study||40
10621303|NCT01970982|11779469|FG002|COMPLETED|Overall Study||38
10621304|NCT01970982|11779467|FG000|NOT COMPLETED|Overall Study||0
10621305|NCT01970982|11779468|FG001|NOT COMPLETED|Overall Study||0
10621306|NCT01970982|11779469|FG002|NOT COMPLETED|Overall Study||2
10621307|NCT01970995|11779481|FG000|STARTED|Confinement Period (Population at Day 5)||78
10621308|NCT01970995|11779482|FG001|STARTED|Confinement Period (Population at Day 5)||42
10621309|NCT01970995|11779483|FG002|STARTED|Confinement Period (Population at Day 5)||40
10621310|NCT01970995|11779481|FG000|COMPLETED|Confinement Period (Population at Day 5)||77
10621311|NCT01970995|11779482|FG001|COMPLETED|Confinement Period (Population at Day 5)||41
10621312|NCT01970995|11779483|FG002|COMPLETED|Confinement Period (Population at Day 5)||39
10621313|NCT01970995|11779481|FG000|NOT COMPLETED|Confinement Period (Population at Day 5)||1
10621314|NCT01970995|11779482|FG001|NOT COMPLETED|Confinement Period (Population at Day 5)||1
10621315|NCT01970995|11779483|FG002|NOT COMPLETED|Confinement Period (Population at Day 5)||1
10621316|NCT01970995|11779481|FG000|STARTED|End of Study (Population at Day 90)||77
10621317|NCT01970995|11779482|FG001|STARTED|End of Study (Population at Day 90)||41
10621318|NCT01970995|11779483|FG002|STARTED|End of Study (Population at Day 90)||39
10705084|NCT02596009|11869470|FG005|STARTED|Overall Study||17
10705085|NCT02596009|11869465|FG000|COMPLETED|Overall Study||14
10705086|NCT02596009|11869466|FG001|COMPLETED|Overall Study||15
10621319|NCT01970995|11779481|FG000|COMPLETED|End of Study (Population at Day 90)||76
10621320|NCT01970995|11779482|FG001|COMPLETED|End of Study (Population at Day 90)||41
10621321|NCT01970995|11779483|FG002|COMPLETED|End of Study (Population at Day 90)||38
10621322|NCT01970995|11779481|FG000|NOT COMPLETED|End of Study (Population at Day 90)||1
10621323|NCT01970995|11779482|FG001|NOT COMPLETED|End of Study (Population at Day 90)||0
10621324|NCT01970995|11779483|FG002|NOT COMPLETED|End of Study (Population at Day 90)||1
10621325|NCT01971086|11779491|FG000|STARTED|Overall Study||300
10621326|NCT01971086|11779491|FG000|COMPLETED|Overall Study||300
10621327|NCT01971086|11779491|FG000|NOT COMPLETED|Overall Study||0
10705087|NCT02596009|11869467|FG002|COMPLETED|Overall Study||16
10705088|NCT02596009|11869468|FG003|COMPLETED|Overall Study||16
10705089|NCT02596009|11869469|FG004|COMPLETED|Overall Study||18
10621328|NCT01971203|11779498|FG000|STARTED|Overall Study||26
10621329|NCT01971203|11779499|FG001|STARTED|Overall Study||29
10621330|NCT01971203|11779498|FG000|COMPLETED|Overall Study||17
10621331|NCT01971203|11779499|FG001|COMPLETED|Overall Study||21
10621332|NCT01971203|11779498|FG000|NOT COMPLETED|Overall Study||9
10621333|NCT01971203|11779499|FG001|NOT COMPLETED|Overall Study||8
10621334|NCT01971255|11779507|FG000|STARTED|Overall Study||32
10621335|NCT01971255|11779508|FG001|STARTED|Overall Study||42
10621336|NCT01971255|11779507|FG000|COMPLETED|Overall Study||31
10621337|NCT01971255|11779508|FG001|COMPLETED|Overall Study||40
10621338|NCT01971255|11779507|FG000|NOT COMPLETED|Overall Study||1
10621339|NCT01971255|11779508|FG001|NOT COMPLETED|Overall Study||2
10621340|NCT01971346|11779514|FG000|STARTED|Overall Study|Four subjects signed the informed consent and terminated the study before beginning.|50
10621341|NCT01971346|11779514|FG000|COMPLETED|Overall Study||42
10621342|NCT01971346|11779514|FG000|NOT COMPLETED|Overall Study||8
10621343|NCT01971385|11779529|FG000|STARTED|Overall Study||17
10621344|NCT01971385|11779530|FG001|STARTED|Overall Study||18
10621345|NCT01971385|11779531|FG002|STARTED|Overall Study||19
10621346|NCT01971385|11779529|FG000|COMPLETED|Overall Study||14
10621347|NCT01971385|11779530|FG001|COMPLETED|Overall Study||13
10621348|NCT01971385|11779531|FG002|COMPLETED|Overall Study||15
10621349|NCT01971385|11779529|FG000|NOT COMPLETED|Overall Study||3
10621350|NCT01971385|11779530|FG001|NOT COMPLETED|Overall Study||5
10621351|NCT01971385|11779531|FG002|NOT COMPLETED|Overall Study||4
10621352|NCT01971463|11779538|FG000|STARTED|Overall Study||81
10621353|NCT01971463|11779538|FG000|COMPLETED|Overall Study||81
10621354|NCT01971463|11779538|FG000|NOT COMPLETED|Overall Study||0
10621355|NCT01971476|11779545|FG000|STARTED|Cohort 1: 2 to <12 Years||3
10621356|NCT01971476|11779546|FG001|STARTED|Cohort 1: 2 to <12 Years||3
10621357|NCT01971476|11779547|FG002|STARTED|Cohort 1: 2 to <12 Years||6
10621358|NCT01971476|11779545|FG000|COMPLETED|Cohort 1: 2 to <12 Years||0
10621359|NCT01971476|11779546|FG001|COMPLETED|Cohort 1: 2 to <12 Years||0
10621360|NCT01971476|11779547|FG002|COMPLETED|Cohort 1: 2 to <12 Years||0
10621361|NCT01971476|11779545|FG000|NOT COMPLETED|Cohort 1: 2 to <12 Years||3
10621362|NCT01971476|11779546|FG001|NOT COMPLETED|Cohort 1: 2 to <12 Years||3
10621363|NCT01971476|11779547|FG002|NOT COMPLETED|Cohort 1: 2 to <12 Years||6
10621364|NCT01971476|11779545|FG000|STARTED|Cohort 2: 12 to <18 Years||6
10621365|NCT01971476|11779546|FG001|STARTED|Cohort 2: 12 to <18 Years||4
10621366|NCT01971476|11779547|FG002|STARTED|Cohort 2: 12 to <18 Years||0
10621367|NCT01971476|11779545|FG000|COMPLETED|Cohort 2: 12 to <18 Years||0
10621368|NCT01971476|11779546|FG001|COMPLETED|Cohort 2: 12 to <18 Years||0
10621369|NCT01971476|11779547|FG002|COMPLETED|Cohort 2: 12 to <18 Years||0
10621370|NCT01971476|11779545|FG000|NOT COMPLETED|Cohort 2: 12 to <18 Years||6
10621371|NCT01971476|11779546|FG001|NOT COMPLETED|Cohort 2: 12 to <18 Years||4
10621372|NCT01971476|11779547|FG002|NOT COMPLETED|Cohort 2: 12 to <18 Years||0
10621373|NCT01971554|11779568|FG000|STARTED|Overall Study||9
10621374|NCT01971554|11779569|FG001|STARTED|Overall Study||18
10621375|NCT01971554|11779570|FG002|STARTED|Overall Study||18
10621376|NCT01971554|11779571|FG003|STARTED|Overall Study||18
10621377|NCT01971554|11779568|FG000|COMPLETED|Overall Study||8
10621378|NCT01971554|11779569|FG001|COMPLETED|Overall Study||18
10621379|NCT01971554|11779570|FG002|COMPLETED|Overall Study||18
10621380|NCT01971554|11779571|FG003|COMPLETED|Overall Study||18
10621381|NCT01971554|11779568|FG000|NOT COMPLETED|Overall Study||1
10621382|NCT01971554|11779569|FG001|NOT COMPLETED|Overall Study||0
10621383|NCT01971554|11779570|FG002|NOT COMPLETED|Overall Study||0
10621384|NCT01971554|11779571|FG003|NOT COMPLETED|Overall Study||0
10621385|NCT01971567|11779583|FG000|STARTED|Overall Study||56
10621386|NCT01971567|11779584|FG001|STARTED|Overall Study||51
10621387|NCT01971567|11779583|FG000|COMPLETED|Overall Study||52
10621388|NCT01971567|11779584|FG001|COMPLETED|Overall Study||49
10621389|NCT01971567|11779583|FG000|NOT COMPLETED|Overall Study||4
10621390|NCT01971567|11779584|FG001|NOT COMPLETED|Overall Study||2
10621391|NCT01971580|11779592|FG000|STARTED|Overall Study||14
10621392|NCT01971580|11779593|FG001|STARTED|Overall Study||14
10621393|NCT01971580|11779592|FG000|COMPLETED|Overall Study||10
10621394|NCT01971580|11779593|FG001|COMPLETED|Overall Study||9
10621395|NCT01971580|11779592|FG000|NOT COMPLETED|Overall Study||4
10621396|NCT01971580|11779593|FG001|NOT COMPLETED|Overall Study||5
10621397|NCT01971593|11779601|FG000|STARTED|Overall Study||14
10621398|NCT01971593|11779602|FG001|STARTED|Overall Study||12
10621399|NCT01971593|11779601|FG000|COMPLETED|Overall Study||9
10621400|NCT01971593|11779602|FG001|COMPLETED|Overall Study||8
10705090|NCT02596009|11869470|FG005|COMPLETED|Overall Study||17
10705091|NCT02596009|11869465|FG000|NOT COMPLETED|Overall Study||0
10621401|NCT01971593|11779601|FG000|NOT COMPLETED|Overall Study||5
10621402|NCT01971593|11779602|FG001|NOT COMPLETED|Overall Study||4
10621403|NCT01971645|11779609|FG000|STARTED|Overall Study||25
10621404|NCT01971645|11779610|FG001|STARTED|Overall Study||27
10621405|NCT01971645|11779611|FG002|STARTED|Overall Study||25
10621406|NCT01971645|11779609|FG000|COMPLETED|Overall Study||23
10705092|NCT02596009|11869466|FG001|NOT COMPLETED|Overall Study||1
10621407|NCT01971645|11779610|FG001|COMPLETED|Overall Study||27
10621408|NCT01971645|11779611|FG002|COMPLETED|Overall Study||23
10621409|NCT01971645|11779609|FG000|NOT COMPLETED|Overall Study||2
10621410|NCT01971645|11779610|FG001|NOT COMPLETED|Overall Study||0
10621411|NCT01971645|11779611|FG002|NOT COMPLETED|Overall Study||2
10621412|NCT01971723|11779621|FG000|STARTED|Overall Study||16
10621413|NCT01971723|11779622|FG001|STARTED|Overall Study||16
10621414|NCT01971723|11779621|FG000|COMPLETED|Overall Study||14
10621415|NCT01971723|11779622|FG001|COMPLETED|Overall Study||13
10621416|NCT01971723|11779621|FG000|NOT COMPLETED|Overall Study||2
10621417|NCT01971723|11779622|FG001|NOT COMPLETED|Overall Study||3
10621418|NCT01972061|11779631|FG000|STARTED|Overall Study||1
10621419|NCT01972061|11779632|FG001|STARTED|Overall Study||23
10621420|NCT01972061|11779633|FG002|STARTED|Overall Study||20
10705093|NCT02596009|11869467|FG002|NOT COMPLETED|Overall Study||0
10705094|NCT02596009|11869468|FG003|NOT COMPLETED|Overall Study||0
10705095|NCT02596009|11869469|FG004|NOT COMPLETED|Overall Study||0
10705096|NCT02596009|11869470|FG005|NOT COMPLETED|Overall Study||0
10705097|NCT02596022|11869478|FG000|STARTED|Overall Study||10
10705098|NCT02596022|11869479|FG001|STARTED|Overall Study||8
10705099|NCT02596022|11869478|FG000|COMPLETED|Overall Study||10
10705100|NCT02596022|11869479|FG001|COMPLETED|Overall Study||8
10705101|NCT02596022|11869478|FG000|NOT COMPLETED|Overall Study||0
10705102|NCT02596022|11869479|FG001|NOT COMPLETED|Overall Study||0
10705103|NCT02596230|11869490|FG000|STARTED|Objective 1, One Visit During 14 Days||3714
10705104|NCT02596230|11869491|FG001|STARTED|Objective 1, One Visit During 14 Days||1006
10705105|NCT02596230|11869492|FG002|STARTED|Objective 1, One Visit During 14 Days||0
10705106|NCT02596230|11869493|FG003|STARTED|Objective 1, One Visit During 14 Days||1375
10705107|NCT02596230|11869494|FG004|STARTED|Objective 1, One Visit During 14 Days||0
10705108|NCT02596230|11869490|FG000|COMPLETED|Objective 1, One Visit During 14 Days||3714
10705109|NCT02596230|11869491|FG001|COMPLETED|Objective 1, One Visit During 14 Days||1006
10705110|NCT02596230|11869492|FG002|COMPLETED|Objective 1, One Visit During 14 Days||0
10621421|NCT01972061|11779631|FG000|COMPLETED|Overall Study||1
10621422|NCT01972061|11779632|FG001|COMPLETED|Overall Study||23
10621423|NCT01972061|11779633|FG002|COMPLETED|Overall Study||20
10621424|NCT01972061|11779631|FG000|NOT COMPLETED|Overall Study||0
10621425|NCT01972061|11779632|FG001|NOT COMPLETED|Overall Study||0
10621426|NCT01972061|11779633|FG002|NOT COMPLETED|Overall Study||0
10621427|NCT01972074|11779644|FG000|STARTED|Overall Study||22
10621428|NCT01972074|11779645|FG001|STARTED|Overall Study||21
10621429|NCT01972074|11779646|FG002|STARTED|Overall Study||18
10621430|NCT01972074|11779644|FG000|COMPLETED|Overall Study||16
10621431|NCT01972074|11779645|FG001|COMPLETED|Overall Study||17
10621432|NCT01972074|11779646|FG002|COMPLETED|Overall Study||15
10621433|NCT01972074|11779644|FG000|NOT COMPLETED|Overall Study||6
10621434|NCT01972074|11779645|FG001|NOT COMPLETED|Overall Study||4
10621435|NCT01972074|11779646|FG002|NOT COMPLETED|Overall Study||3
10621436|NCT01972152|11779653|FG000|STARTED|First Treatment Visit||5
10621437|NCT01972152|11779654|FG001|STARTED|First Treatment Visit||5
10621438|NCT01972152|11779655|FG002|STARTED|First Treatment Visit||5
10621439|NCT01972152|11779656|FG003|STARTED|First Treatment Visit||5
10621440|NCT01972152|11779657|FG004|STARTED|First Treatment Visit||5
10621441|NCT01972152|11779658|FG005|STARTED|First Treatment Visit||5
10621442|NCT01972152|11779653|FG000|COMPLETED|First Treatment Visit||5
10621443|NCT01972152|11779654|FG001|COMPLETED|First Treatment Visit||4
10621444|NCT01972152|11779655|FG002|COMPLETED|First Treatment Visit||5
10621445|NCT01972152|11779656|FG003|COMPLETED|First Treatment Visit||5
10621446|NCT01972152|11779657|FG004|COMPLETED|First Treatment Visit||5
10621447|NCT01972152|11779658|FG005|COMPLETED|First Treatment Visit||5
10621448|NCT01972152|11779653|FG000|NOT COMPLETED|First Treatment Visit||0
10621449|NCT01972152|11779654|FG001|NOT COMPLETED|First Treatment Visit||1
10621450|NCT01972152|11779655|FG002|NOT COMPLETED|First Treatment Visit||0
10621451|NCT01972152|11779656|FG003|NOT COMPLETED|First Treatment Visit||0
10621452|NCT01972152|11779657|FG004|NOT COMPLETED|First Treatment Visit||0
10621453|NCT01972152|11779658|FG005|NOT COMPLETED|First Treatment Visit||0
10621454|NCT01972152|11779653|FG000|STARTED|Second Treatment Visit||5
10621455|NCT01972152|11779654|FG001|STARTED|Second Treatment Visit||4
10621456|NCT01972152|11779655|FG002|STARTED|Second Treatment Visit||5
10621457|NCT01972152|11779656|FG003|STARTED|Second Treatment Visit||5
10621458|NCT01972152|11779657|FG004|STARTED|Second Treatment Visit||5
10621459|NCT01972152|11779658|FG005|STARTED|Second Treatment Visit||5
10621460|NCT01972152|11779653|FG000|COMPLETED|Second Treatment Visit||5
10621461|NCT01972152|11779654|FG001|COMPLETED|Second Treatment Visit||3
10621462|NCT01972152|11779655|FG002|COMPLETED|Second Treatment Visit||5
10621463|NCT01972152|11779656|FG003|COMPLETED|Second Treatment Visit||5
10621464|NCT01972152|11779657|FG004|COMPLETED|Second Treatment Visit||5
10621465|NCT01972152|11779658|FG005|COMPLETED|Second Treatment Visit||5
10621466|NCT01972152|11779653|FG000|NOT COMPLETED|Second Treatment Visit||0
10621467|NCT01972152|11779654|FG001|NOT COMPLETED|Second Treatment Visit||1
10621468|NCT01972152|11779655|FG002|NOT COMPLETED|Second Treatment Visit||0
10621469|NCT01972152|11779656|FG003|NOT COMPLETED|Second Treatment Visit||0
10621470|NCT01972152|11779657|FG004|NOT COMPLETED|Second Treatment Visit||0
10621471|NCT01972152|11779658|FG005|NOT COMPLETED|Second Treatment Visit||0
10621472|NCT01972152|11779653|FG000|STARTED|Third Treatment Visit||5
10705111|NCT02596230|11869493|FG003|COMPLETED|Objective 1, One Visit During 14 Days||1375
10705112|NCT02596230|11869494|FG004|COMPLETED|Objective 1, One Visit During 14 Days||0
10705113|NCT02596230|11869490|FG000|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
10705114|NCT02596230|11869491|FG001|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
10621473|NCT01972152|11779654|FG001|STARTED|Third Treatment Visit||3
10621474|NCT01972152|11779655|FG002|STARTED|Third Treatment Visit||5
10621475|NCT01972152|11779656|FG003|STARTED|Third Treatment Visit||5
10621476|NCT01972152|11779657|FG004|STARTED|Third Treatment Visit||5
10705115|NCT02596230|11869492|FG002|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
10705116|NCT02596230|11869493|FG003|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
10621477|NCT01972152|11779658|FG005|STARTED|Third Treatment Visit||5
10621478|NCT01972152|11779653|FG000|COMPLETED|Third Treatment Visit||5
10621479|NCT01972152|11779654|FG001|COMPLETED|Third Treatment Visit||3
10621480|NCT01972152|11779655|FG002|COMPLETED|Third Treatment Visit||5
10621481|NCT01972152|11779656|FG003|COMPLETED|Third Treatment Visit||5
10621482|NCT01972152|11779657|FG004|COMPLETED|Third Treatment Visit||5
10621483|NCT01972152|11779658|FG005|COMPLETED|Third Treatment Visit||5
10621484|NCT01972152|11779653|FG000|NOT COMPLETED|Third Treatment Visit||0
10621485|NCT01972152|11779654|FG001|NOT COMPLETED|Third Treatment Visit||0
10621486|NCT01972152|11779655|FG002|NOT COMPLETED|Third Treatment Visit||0
10621487|NCT01972152|11779656|FG003|NOT COMPLETED|Third Treatment Visit||0
10621488|NCT01972152|11779657|FG004|NOT COMPLETED|Third Treatment Visit||0
10621489|NCT01972152|11779658|FG005|NOT COMPLETED|Third Treatment Visit||0
10621490|NCT01972204|11779671|FG000|STARTED|Overall Study||62
10621491|NCT01972204|11779672|FG001|STARTED|Overall Study||63
10621492|NCT01972204|11779671|FG000|COMPLETED|Overall Study||58
10621493|NCT01972204|11779672|FG001|COMPLETED|Overall Study||59
10621494|NCT01972204|11779671|FG000|NOT COMPLETED|Overall Study||4
10621495|NCT01972204|11779672|FG001|NOT COMPLETED|Overall Study||4
10621496|NCT01972282|11779678|FG000|STARTED|Overall Study||1020
10621497|NCT01972282|11779678|FG000|COMPLETED|Overall Study||1005
10621498|NCT01972282|11779678|FG000|NOT COMPLETED|Overall Study||15
10621505|NCT01972438|11779695|FG000|STARTED|Baseline-Month 3 Crossover Period|Two participants never started IP: one died and one did not meet the inclusion criteria|9
10621506|NCT01972438|11779696|FG001|STARTED|Baseline-Month 3 Crossover Period|One participant never started IP, as unable to donate blood for preparation of ASEDs|9
10621507|NCT01972438|11779695|FG000|COMPLETED|Baseline-Month 3 Crossover Period||6
10621508|NCT01972438|11779696|FG001|COMPLETED|Baseline-Month 3 Crossover Period||6
10621509|NCT01972438|11779695|FG000|NOT COMPLETED|Baseline-Month 3 Crossover Period||3
10621510|NCT01972438|11779696|FG001|NOT COMPLETED|Baseline-Month 3 Crossover Period||3
10621511|NCT01972438|11779695|FG000|STARTED|Months 3-6 Crossover Period||6
10621512|NCT01972438|11779696|FG001|STARTED|Months 3-6 Crossover Period|Two participants who missed Month 3 visit completed this pd but one who completed Month 3 didn't|7
10621513|NCT01972438|11779695|FG000|COMPLETED|Months 3-6 Crossover Period||6
10621514|NCT01972438|11779696|FG001|COMPLETED|Months 3-6 Crossover Period||6
10621515|NCT01972438|11779695|FG000|NOT COMPLETED|Months 3-6 Crossover Period||0
10621516|NCT01972438|11779696|FG001|NOT COMPLETED|Months 3-6 Crossover Period||1
10621517|NCT01972438|11779695|FG000|STARTED|Months 6-12 Study Period||6
10621518|NCT01972438|11779696|FG001|STARTED|Months 6-12 Study Period||6
10621519|NCT01972438|11779695|FG000|COMPLETED|Months 6-12 Study Period||3
10621520|NCT01972438|11779696|FG001|COMPLETED|Months 6-12 Study Period||4
10621521|NCT01972438|11779695|FG000|NOT COMPLETED|Months 6-12 Study Period||3
10621522|NCT01972438|11779696|FG001|NOT COMPLETED|Months 6-12 Study Period||2
10621523|NCT01972438|11779695|FG000|STARTED|Post Month 12 Study Period||3
10621524|NCT01972438|11779696|FG001|STARTED|Post Month 12 Study Period||4
10621525|NCT01972438|11779695|FG000|COMPLETED|Post Month 12 Study Period||0
10621526|NCT01972438|11779696|FG001|COMPLETED|Post Month 12 Study Period||0
10621527|NCT01972438|11779695|FG000|NOT COMPLETED|Post Month 12 Study Period||3
10621528|NCT01972438|11779696|FG001|NOT COMPLETED|Post Month 12 Study Period||4
10621529|NCT01972464|11779706|FG000|STARTED|Treatment Period (Week 1 Through Week 8)||19
10621530|NCT01972464|11779707|FG001|STARTED|Treatment Period (Week 1 Through Week 8)||22
10621531|NCT01972464|11779706|FG000|COMPLETED|Treatment Period (Week 1 Through Week 8)||16
10621532|NCT01972464|11779707|FG001|COMPLETED|Treatment Period (Week 1 Through Week 8)||18
10621533|NCT01972464|11779706|FG000|NOT COMPLETED|Treatment Period (Week 1 Through Week 8)||3
10621534|NCT01972464|11779707|FG001|NOT COMPLETED|Treatment Period (Week 1 Through Week 8)||4
10621535|NCT01972464|11779706|FG000|STARTED|3-Month Follow-Up (Week 20)||16
10621536|NCT01972464|11779707|FG001|STARTED|3-Month Follow-Up (Week 20)||18
10621537|NCT01972464|11779706|FG000|COMPLETED|3-Month Follow-Up (Week 20)||15
10621538|NCT01972464|11779707|FG001|COMPLETED|3-Month Follow-Up (Week 20)||17
10621539|NCT01972464|11779706|FG000|NOT COMPLETED|3-Month Follow-Up (Week 20)||1
10621540|NCT01972464|11779707|FG001|NOT COMPLETED|3-Month Follow-Up (Week 20)||1
10621541|NCT01972516|11779716|FG000|STARTED|Overall Study||3
10621542|NCT01972516|11779717|FG001|STARTED|Overall Study||1
10621543|NCT01972516|11779716|FG000|COMPLETED|Overall Study||3
10621544|NCT01972516|11779717|FG001|COMPLETED|Overall Study||1
10621545|NCT01972516|11779716|FG000|NOT COMPLETED|Overall Study||0
10621546|NCT01972516|11779717|FG001|NOT COMPLETED|Overall Study||0
10621547|NCT01972529|11779727|FG000|STARTED|Overall Study||48
10621548|NCT01972529|11779728|FG001|STARTED|Overall Study||90
10621549|NCT01972529|11779729|FG002|STARTED|Overall Study||34
10621550|NCT01972529|11779730|FG003|STARTED|Overall Study||59
10621551|NCT01972529|11779727|FG000|COMPLETED|Overall Study||46
10705117|NCT02596230|11869494|FG004|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
10705118|NCT02596230|11869490|FG000|STARTED|Screening Period for Objective 2||3714
10705119|NCT02596230|11869491|FG001|STARTED|Screening Period for Objective 2||1006
10621552|NCT01972529|11779728|FG001|COMPLETED|Overall Study||85
10621553|NCT01972529|11779729|FG002|COMPLETED|Overall Study||32
10621554|NCT01972529|11779730|FG003|COMPLETED|Overall Study||55
10621555|NCT01972529|11779727|FG000|NOT COMPLETED|Overall Study||2
10621556|NCT01972529|11779728|FG001|NOT COMPLETED|Overall Study||5
10621557|NCT01972529|11779729|FG002|NOT COMPLETED|Overall Study||2
10621558|NCT01972529|11779730|FG003|NOT COMPLETED|Overall Study||4
10621559|NCT01972568|11779744|FG000|STARTED|Overall Study||102
10621560|NCT01972568|11779745|FG001|STARTED|Overall Study||104
10621561|NCT01972568|11779746|FG002|STARTED|Overall Study||100
10621562|NCT01972568|11779744|FG000|COMPLETED|Overall Study||86
10621563|NCT01972568|11779745|FG001|COMPLETED|Overall Study||92
10621564|NCT01972568|11779746|FG002|COMPLETED|Overall Study||84
10621565|NCT01972568|11779744|FG000|NOT COMPLETED|Overall Study||16
10621566|NCT01972568|11779745|FG001|NOT COMPLETED|Overall Study||12
10621567|NCT01972568|11779746|FG002|NOT COMPLETED|Overall Study||16
10621568|NCT01972659|11779756|FG000|STARTED|Overall Study||40
10621569|NCT01972659|11779757|FG001|STARTED|Overall Study||40
10621570|NCT01972659|11779756|FG000|COMPLETED|Overall Study||36
10621571|NCT01972659|11779757|FG001|COMPLETED|Overall Study||37
10621572|NCT01972659|11779756|FG000|NOT COMPLETED|Overall Study||4
10621573|NCT01972659|11779757|FG001|NOT COMPLETED|Overall Study||3
10621574|NCT01972724|11779766|FG000|STARTED|Double-Blind||19
10705120|NCT02596230|11869492|FG002|STARTED|Screening Period for Objective 2|Participants entering the study after the completion of objective 1.|910
10705121|NCT02596230|11869493|FG003|STARTED|Screening Period for Objective 2||1375
10705122|NCT02596230|11869494|FG004|STARTED|Screening Period for Objective 2|Participants entering the study after the completion of objective 1.|792
10621575|NCT01972724|11779767|FG001|STARTED|Double-Blind||18
10621576|NCT01972724|11779768|FG002|STARTED|Double-Blind||0
10621577|NCT01972724|11779766|FG000|Intent-to-treat:Received Study Drug|Double-Blind||17
10621578|NCT01972724|11779767|FG001|Intent-to-treat:Received Study Drug|Double-Blind||17
10621579|NCT01972724|11779768|FG002|Intent-to-treat:Received Study Drug|Double-Blind||0
10621580|NCT01972724|11779766|FG000|COMPLETED|Double-Blind||10
10621581|NCT01972724|11779767|FG001|COMPLETED|Double-Blind||9
10621582|NCT01972724|11779768|FG002|COMPLETED|Double-Blind||0
10621583|NCT01972724|11779766|FG000|NOT COMPLETED|Double-Blind||9
10621584|NCT01972724|11779767|FG001|NOT COMPLETED|Double-Blind||9
10621585|NCT01972724|11779768|FG002|NOT COMPLETED|Double-Blind||0
10621586|NCT01972724|11779766|FG000|STARTED|Open-Label||0
10621587|NCT01972724|11779767|FG001|STARTED|Open-Label||0
10621588|NCT01972724|11779768|FG002|STARTED|Open-Label||77
10621589|NCT01972724|11779766|FG000|COMPLETED|Open-Label||0
10621590|NCT01972724|11779767|FG001|COMPLETED|Open-Label||0
10621591|NCT01972724|11779768|FG002|COMPLETED|Open-Label||72
10621592|NCT01972724|11779766|FG000|NOT COMPLETED|Open-Label||0
10621593|NCT01972724|11779767|FG001|NOT COMPLETED|Open-Label||0
10621594|NCT01972724|11779768|FG002|NOT COMPLETED|Open-Label||5
10621595|NCT01972776|11779782|FG000|STARTED|Part 1||6
10621596|NCT01972776|11779783|FG001|STARTED|Part 1||6
10621597|NCT01972776|11779784|FG002|STARTED|Part 1||8
10621598|NCT01972776|11779785|FG003|STARTED|Part 1||7
10621599|NCT01972776|11779786|FG004|STARTED|Part 1||0
10621600|NCT01972776|11779787|FG005|STARTED|Part 1||0
10621601|NCT01972776|11779782|FG000|COMPLETED|Part 1||6
10621602|NCT01972776|11779783|FG001|COMPLETED|Part 1||6
10621603|NCT01972776|11779784|FG002|COMPLETED|Part 1||6
10621604|NCT01972776|11779785|FG003|COMPLETED|Part 1||6
10621605|NCT01972776|11779786|FG004|COMPLETED|Part 1||0
10621606|NCT01972776|11779787|FG005|COMPLETED|Part 1||0
10621607|NCT01972776|11779782|FG000|NOT COMPLETED|Part 1||0
10621608|NCT01972776|11779783|FG001|NOT COMPLETED|Part 1||0
10621609|NCT01972776|11779784|FG002|NOT COMPLETED|Part 1||2
10621610|NCT01972776|11779785|FG003|NOT COMPLETED|Part 1||1
10621611|NCT01972776|11779786|FG004|NOT COMPLETED|Part 1||0
10621612|NCT01972776|11779787|FG005|NOT COMPLETED|Part 1||0
10621613|NCT01972776|11779782|FG000|STARTED|Part 2||0
10621614|NCT01972776|11779783|FG001|STARTED|Part 2||0
10621615|NCT01972776|11779784|FG002|STARTED|Part 2||0
10621616|NCT01972776|11779785|FG003|STARTED|Part 2||0
10621617|NCT01972776|11779786|FG004|STARTED|Part 2||14
10621618|NCT01972776|11779787|FG005|STARTED|Part 2||7
10621619|NCT01972776|11779782|FG000|COMPLETED|Part 2||0
10621620|NCT01972776|11779783|FG001|COMPLETED|Part 2||0
10621621|NCT01972776|11779784|FG002|COMPLETED|Part 2||0
10621622|NCT01972776|11779785|FG003|COMPLETED|Part 2||0
10621623|NCT01972776|11779786|FG004|COMPLETED|Part 2||1
10621624|NCT01972776|11779787|FG005|COMPLETED|Part 2||0
10621625|NCT01972776|11779782|FG000|NOT COMPLETED|Part 2||0
10621626|NCT01972776|11779783|FG001|NOT COMPLETED|Part 2||0
10621627|NCT01972776|11779784|FG002|NOT COMPLETED|Part 2||0
10621628|NCT01972776|11779785|FG003|NOT COMPLETED|Part 2||0
10621629|NCT01972776|11779786|FG004|NOT COMPLETED|Part 2||13
10621630|NCT01972776|11779787|FG005|NOT COMPLETED|Part 2||7
10621631|NCT01972789|11779803|FG000|STARTED|Overall Study||174
10621632|NCT01972789|11779804|FG001|STARTED|Overall Study||175
10621633|NCT01972789|11779803|FG000|COMPLETED|Overall Study||134
10621634|NCT01972789|11779804|FG001|COMPLETED|Overall Study||145
10621635|NCT01972789|11779803|FG000|NOT COMPLETED|Overall Study||40
10621636|NCT01972789|11779804|FG001|NOT COMPLETED|Overall Study||30
10621637|NCT01972841|11779816|FG000|STARTED|Overall Study||447
10621638|NCT01972841|11779817|FG001|STARTED|Overall Study||441
10621639|NCT01972841|11779818|FG002|STARTED|Overall Study||437
10621640|NCT01972841|11779819|FG003|STARTED|Overall Study||434
10621641|NCT01972841|11779820|FG004|STARTED|Overall Study||885
10621642|NCT01972841|11779821|FG005|STARTED|Overall Study||883
10621643|NCT01972841|11779816|FG000|COMPLETED|Overall Study||404
10621644|NCT01972841|11779817|FG001|COMPLETED|Overall Study||397
10621645|NCT01972841|11779818|FG002|COMPLETED|Overall Study||387
10621646|NCT01972841|11779819|FG003|COMPLETED|Overall Study||397
10621647|NCT01972841|11779820|FG004|COMPLETED|Overall Study||802
10621648|NCT01972841|11779821|FG005|COMPLETED|Overall Study||798
10621649|NCT01972841|11779816|FG000|NOT COMPLETED|Overall Study||43
10621650|NCT01972841|11779817|FG001|NOT COMPLETED|Overall Study||44
10621651|NCT01972841|11779818|FG002|NOT COMPLETED|Overall Study||50
10621652|NCT01972841|11779819|FG003|NOT COMPLETED|Overall Study||37
10621653|NCT01972841|11779820|FG004|NOT COMPLETED|Overall Study||83
10621654|NCT01972841|11779821|FG005|NOT COMPLETED|Overall Study||85
10621655|NCT01973036|11779837|FG000|STARTED|Overall Study||108
10621656|NCT01973036|11779838|FG001|STARTED|Overall Study||93
10621657|NCT01973036|11779837|FG000|Received Assigned Intervention|Overall Study||113
10621658|NCT01973036|11779838|FG001|Received Assigned Intervention|Overall Study||88
10621659|NCT01973036|11779837|FG000|COMPLETED|Overall Study||108
10621660|NCT01973036|11779838|FG001|COMPLETED|Overall Study||93
10621661|NCT01973036|11779837|FG000|NOT COMPLETED|Overall Study||0
10621662|NCT01973036|11779838|FG001|NOT COMPLETED|Overall Study||0
10621663|NCT01973205|11779847|FG000|STARTED|Overall Study||453
10621664|NCT01973205|11779848|FG001|STARTED|Overall Study||447
10621665|NCT01973205|11779847|FG000|COMPLETED|Overall Study||423
10621666|NCT01973205|11779848|FG001|COMPLETED|Overall Study||425
10621667|NCT01973205|11779847|FG000|NOT COMPLETED|Overall Study||30
10621668|NCT01973205|11779848|FG001|NOT COMPLETED|Overall Study||22
10621669|NCT01973218|11779856|FG000|STARTED|Overall Study||176
10621670|NCT01973218|11779857|FG001|STARTED|Overall Study||88
10621671|NCT01973218|11779856|FG000|COMPLETED|Overall Study||174
10621672|NCT01973218|11779857|FG001|COMPLETED|Overall Study||88
10621673|NCT01973218|11779856|FG000|NOT COMPLETED|Overall Study||2
10621674|NCT01973218|11779857|FG001|NOT COMPLETED|Overall Study||0
10621675|NCT01973231|11779867|FG000|STARTED|Overall Study||202
10621676|NCT01973231|11779868|FG001|STARTED|Overall Study||202
10621677|NCT01973231|11779867|FG000|COMPLETED|Overall Study||191
10621678|NCT01973231|11779868|FG001|COMPLETED|Overall Study||190
10621679|NCT01973231|11779867|FG000|NOT COMPLETED|Overall Study||11
10621680|NCT01973231|11779868|FG001|NOT COMPLETED|Overall Study||12
10621681|NCT01973283|11779874|FG000|STARTED|Overall Study||100
10621682|NCT01973283|11779874|FG000|COMPLETED|Overall Study||96
10621683|NCT01973283|11779874|FG000|NOT COMPLETED|Overall Study||4
10621684|NCT01973335|11779884|FG000|STARTED|Overall Study||9
10621685|NCT01973335|11779885|FG001|STARTED|Overall Study||7
10621686|NCT01973335|11779886|FG002|STARTED|Overall Study||9
10621687|NCT01973335|11779887|FG003|STARTED|Overall Study||9
10621688|NCT01973335|11779884|FG000|COMPLETED|Overall Study||9
10621689|NCT01973335|11779885|FG001|COMPLETED|Overall Study||7
10621690|NCT01973335|11779886|FG002|COMPLETED|Overall Study||9
10621691|NCT01973335|11779887|FG003|COMPLETED|Overall Study||9
10621692|NCT01973335|11779884|FG000|NOT COMPLETED|Overall Study||0
10621693|NCT01973335|11779885|FG001|NOT COMPLETED|Overall Study||0
10621694|NCT01973335|11779886|FG002|NOT COMPLETED|Overall Study||0
10621695|NCT01973335|11779887|FG003|NOT COMPLETED|Overall Study||0
10621696|NCT01973348|11779901|FG000|STARTED|Overall Study||27
10621697|NCT01973348|11779902|FG001|STARTED|Overall Study||18
10621698|NCT01973348|11779903|FG002|STARTED|Overall Study||0
10621699|NCT01973348|11779904|FG003|STARTED|Overall Study||0
10621700|NCT01973348|11779901|FG000|COMPLETED|Overall Study||19
10621701|NCT01973348|11779902|FG001|COMPLETED|Overall Study||15
10621702|NCT01973348|11779903|FG002|COMPLETED|Overall Study||0
10621703|NCT01973348|11779904|FG003|COMPLETED|Overall Study||0
10621704|NCT01973348|11779901|FG000|NOT COMPLETED|Overall Study||8
10621705|NCT01973348|11779902|FG001|NOT COMPLETED|Overall Study||3
10621706|NCT01973348|11779903|FG002|NOT COMPLETED|Overall Study||0
10621707|NCT01973348|11779904|FG003|NOT COMPLETED|Overall Study||0
10653357|NCT02192879|11813828|FG000|NOT COMPLETED|Overall Study||0
10653358|NCT02192879|11813829|FG001|NOT COMPLETED|Overall Study||0
10653359|NCT02192879|11813830|FG002|NOT COMPLETED|Overall Study||0
10653360|NCT02192905|11813838|FG000|STARTED|Overall Study||43
10653361|NCT02192905|11813838|FG000|COMPLETED|Overall Study|Reporting a minimum of current weight at 16-week follow-up|42
10653362|NCT02192905|11813838|FG000|NOT COMPLETED|Overall Study||1
10653363|NCT02192970|11813845|FG000|STARTED|Overall Study||101
10653364|NCT02192970|11813846|FG001|STARTED|Overall Study||195
10653365|NCT02192970|11813845|FG000|COMPLETED|Overall Study||95
10653366|NCT02192970|11813846|FG001|COMPLETED|Overall Study||195
10653367|NCT02192970|11813845|FG000|NOT COMPLETED|Overall Study||6
10653368|NCT02192970|11813846|FG001|NOT COMPLETED|Overall Study||0
10653369|NCT02193074|11813854|FG000|STARTED|Overall Study|Randomized and received double-blind treatment.|41
10653370|NCT02193074|11813855|FG001|STARTED|Overall Study|Randomized and received double-blind treatment.|80
10653371|NCT02193074|11813854|FG000|Completed During Follow-Up Period|Overall Study||11
10653372|NCT02193074|11813855|FG001|Completed During Follow-Up Period|Overall Study||26
10653373|NCT02193074|11813854|FG000|Completed Due to Early Study Termination|Overall Study||13
10653374|NCT02193074|11813855|FG001|Completed Due to Early Study Termination|Overall Study||39
10653375|NCT02193074|11813854|FG000|COMPLETED|Overall Study||24
10653376|NCT02193074|11813855|FG001|COMPLETED|Overall Study||65
10653377|NCT02193074|11813854|FG000|NOT COMPLETED|Overall Study||17
10653378|NCT02193074|11813855|FG001|NOT COMPLETED|Overall Study||15
10653379|NCT02193087|11813865|FG000|STARTED|Overall Study||199
10653380|NCT02193087|11813866|FG001|STARTED|Overall Study||100
10653381|NCT02193087|11813867|FG002|STARTED|Overall Study||100
10653382|NCT02193087|11813868|FG003|STARTED|Overall Study||603
10653383|NCT02193087|11813865|FG000|Received Vaccination|Overall Study||197
10621708|NCT01973387|11779916|FG000|STARTED|Overall Study||106
10621709|NCT01973387|11779917|FG001|STARTED|Overall Study||54
10621710|NCT01973387|11779916|FG000|Treated|Overall Study||104
10621711|NCT01973387|11779917|FG001|Treated|Overall Study||52
10621712|NCT01973387|11779916|FG000|COMPLETED|Overall Study||0
10621713|NCT01973387|11779917|FG001|COMPLETED|Overall Study||36
10621714|NCT01973387|11779916|FG000|NOT COMPLETED|Overall Study||106
10621715|NCT01973387|11779917|FG001|NOT COMPLETED|Overall Study||18
10621716|NCT01973413|11779925|FG000|STARTED|Overall Study||12
10621717|NCT01973413|11779926|FG001|STARTED|Overall Study||20
10705123|NCT02596230|11869490|FG000|COMPLETED|Screening Period for Objective 2||0
10705124|NCT02596230|11869491|FG001|COMPLETED|Screening Period for Objective 2||778
10705125|NCT02596230|11869492|FG002|COMPLETED|Screening Period for Objective 2||910
10705126|NCT02596230|11869493|FG003|COMPLETED|Screening Period for Objective 2||529
10705127|NCT02596230|11869494|FG004|COMPLETED|Screening Period for Objective 2||792
10705128|NCT02596230|11869490|FG000|NOT COMPLETED|Screening Period for Objective 2||3714
10705129|NCT02596230|11869491|FG001|NOT COMPLETED|Screening Period for Objective 2||228
10705130|NCT02596230|11869492|FG002|NOT COMPLETED|Screening Period for Objective 2||0
10705131|NCT02596230|11869493|FG003|NOT COMPLETED|Screening Period for Objective 2||846
10705132|NCT02596230|11869494|FG004|NOT COMPLETED|Screening Period for Objective 2||0
10705133|NCT02596230|11869490|FG000|STARTED|Objective 2, One Year||0
10705134|NCT02596230|11869491|FG001|STARTED|Objective 2, One Year||778
10705135|NCT02596230|11869492|FG002|STARTED|Objective 2, One Year||910
10705136|NCT02596230|11869493|FG003|STARTED|Objective 2, One Year||529
10621718|NCT01973413|11779925|FG000|COMPLETED|Overall Study||11
10621719|NCT01973413|11779926|FG001|COMPLETED|Overall Study||20
10621720|NCT01973413|11779925|FG000|NOT COMPLETED|Overall Study||1
10621721|NCT01973413|11779926|FG001|NOT COMPLETED|Overall Study||0
10621722|NCT01973439|11779933|FG000|STARTED|Overall Study||23
10621723|NCT01973439|11779933|FG000|Two Evaluable PK Days|Overall Study|18 Children had two evaluable PK days|18
10621724|NCT01973439|11779933|FG000|One Evaluable PK Day Only|Overall Study|5 children had only one evaluable PK day.|5
10621725|NCT01973439|11779933|FG000|COMPLETED|Overall Study||18
10621726|NCT01973439|11779933|FG000|NOT COMPLETED|Overall Study||5
10621727|NCT01973491|11779937|FG000|STARTED|Baseline Control Period (8 Weeks)||37
10621728|NCT01973491|11779937|FG000|COMPLETED|Baseline Control Period (8 Weeks)||19
10621729|NCT01973491|11779937|FG000|NOT COMPLETED|Baseline Control Period (8 Weeks)||18
10621730|NCT01973491|11779937|FG000|STARTED|Titration Period(4 Weeks)||19
10621731|NCT01973491|11779937|FG000|COMPLETED|Titration Period(4 Weeks)||19
10621732|NCT01973491|11779937|FG000|NOT COMPLETED|Titration Period(4 Weeks)||0
10621733|NCT01973491|11779937|FG000|STARTED|Treatment Period (16 Weeks)||19
10621734|NCT01973491|11779937|FG000|COMPLETED|Treatment Period (16 Weeks)||18
10621735|NCT01973491|11779937|FG000|NOT COMPLETED|Treatment Period (16 Weeks)||1
10621736|NCT01973569|11779944|FG000|STARTED|Overall Study||228
10621737|NCT01973569|11779945|FG001|STARTED|Overall Study||225
10621738|NCT01973569|11779946|FG002|STARTED|Overall Study||226
10621739|NCT01973569|11779944|FG000|Received Study Drug|Overall Study||222
10621740|NCT01973569|11779945|FG001|Received Study Drug|Overall Study||222
10621741|NCT01973569|11779946|FG002|Received Study Drug|Overall Study||223
10621742|NCT01973569|11779944|FG000|Did Not Receive Study Drug|Overall Study||6
10621743|NCT01973569|11779945|FG001|Did Not Receive Study Drug|Overall Study||3
10621744|NCT01973569|11779946|FG002|Did Not Receive Study Drug|Overall Study||3
10621745|NCT01973569|11779944|FG000|Discontinued Study Treatment|Overall Study||23
10621746|NCT01973569|11779945|FG001|Discontinued Study Treatment|Overall Study||22
10621747|NCT01973569|11779946|FG002|Discontinued Study Treatment|Overall Study||15
10621748|NCT01973569|11779944|FG000|Discontinued Study|Overall Study||23
10621749|NCT01973569|11779945|FG001|Discontinued Study|Overall Study||22
10621750|NCT01973569|11779946|FG002|Discontinued Study|Overall Study||15
10621751|NCT01973569|11779944|FG000|COMPLETED|Overall Study||199
10621752|NCT01973569|11779945|FG001|COMPLETED|Overall Study||200
10621753|NCT01973569|11779946|FG002|COMPLETED|Overall Study||208
10621754|NCT01973569|11779944|FG000|NOT COMPLETED|Overall Study||29
10621755|NCT01973569|11779945|FG001|NOT COMPLETED|Overall Study||25
10621756|NCT01973569|11779946|FG002|NOT COMPLETED|Overall Study||18
10621757|NCT01973595|11779958|FG000|STARTED|Intervention Phase 1||15
10621758|NCT01973595|11779959|FG001|STARTED|Intervention Phase 1||14
10621759|NCT01973595|11779960|FG002|STARTED|Intervention Phase 1||15
10621760|NCT01973595|11779961|FG003|STARTED|Intervention Phase 1||14
10621761|NCT01973595|11779958|FG000|COMPLETED|Intervention Phase 1||15
10621762|NCT01973595|11779959|FG001|COMPLETED|Intervention Phase 1||14
10621763|NCT01973595|11779960|FG002|COMPLETED|Intervention Phase 1||15
10621764|NCT01973595|11779961|FG003|COMPLETED|Intervention Phase 1||14
10621765|NCT01973595|11779958|FG000|NOT COMPLETED|Intervention Phase 1||0
10621766|NCT01973595|11779959|FG001|NOT COMPLETED|Intervention Phase 1||0
10621767|NCT01973595|11779960|FG002|NOT COMPLETED|Intervention Phase 1||0
10621768|NCT01973595|11779961|FG003|NOT COMPLETED|Intervention Phase 1||0
10621769|NCT01973595|11779958|FG000|STARTED|Washout||15
10621770|NCT01973595|11779959|FG001|STARTED|Washout||14
10621771|NCT01973595|11779960|FG002|STARTED|Washout||15
10621772|NCT01973595|11779961|FG003|STARTED|Washout||14
10621773|NCT01973595|11779958|FG000|COMPLETED|Washout||14
10621774|NCT01973595|11779959|FG001|COMPLETED|Washout||14
10621775|NCT01973595|11779960|FG002|COMPLETED|Washout||14
10621776|NCT01973595|11779961|FG003|COMPLETED|Washout||14
10705137|NCT02596230|11869494|FG004|STARTED|Objective 2, One Year||792
10705138|NCT02596230|11869490|FG000|COMPLETED|Objective 2, One Year||0
10705139|NCT02596230|11869491|FG001|COMPLETED|Objective 2, One Year||710
10621777|NCT01973595|11779958|FG000|NOT COMPLETED|Washout||1
10621778|NCT01973595|11779959|FG001|NOT COMPLETED|Washout||0
10621779|NCT01973595|11779960|FG002|NOT COMPLETED|Washout||1
10621780|NCT01973595|11779961|FG003|NOT COMPLETED|Washout||0
10621781|NCT01973595|11779958|FG000|STARTED|Intervention Phase 2||14
10621782|NCT01973595|11779959|FG001|STARTED|Intervention Phase 2||14
10621783|NCT01973595|11779960|FG002|STARTED|Intervention Phase 2||14
10621784|NCT01973595|11779961|FG003|STARTED|Intervention Phase 2||14
10621785|NCT01973595|11779958|FG000|COMPLETED|Intervention Phase 2||14
10621786|NCT01973595|11779959|FG001|COMPLETED|Intervention Phase 2||14
10621787|NCT01973595|11779960|FG002|COMPLETED|Intervention Phase 2||14
10621788|NCT01973595|11779961|FG003|COMPLETED|Intervention Phase 2||14
10621789|NCT01973595|11779958|FG000|NOT COMPLETED|Intervention Phase 2||0
10621790|NCT01973595|11779959|FG001|NOT COMPLETED|Intervention Phase 2||0
10621791|NCT01973595|11779960|FG002|NOT COMPLETED|Intervention Phase 2||0
10621792|NCT01973595|11779961|FG003|NOT COMPLETED|Intervention Phase 2||0
10621793|NCT01973608|11779976|FG000|STARTED|Overall Study||2
10621794|NCT01973608|11779977|FG001|STARTED|Overall Study||2
10621795|NCT01973608|11779978|FG002|STARTED|Overall Study||6
10621796|NCT01973608|11779979|FG003|STARTED|Overall Study||2
10621797|NCT01973608|11779976|FG000|COMPLETED|Overall Study||2
10621798|NCT01973608|11779977|FG001|COMPLETED|Overall Study||2
10621799|NCT01973608|11779978|FG002|COMPLETED|Overall Study||6
10621800|NCT01973608|11779979|FG003|COMPLETED|Overall Study||2
10621801|NCT01973608|11779976|FG000|NOT COMPLETED|Overall Study||0
10621802|NCT01973608|11779977|FG001|NOT COMPLETED|Overall Study||0
10621803|NCT01973608|11779978|FG002|NOT COMPLETED|Overall Study||0
10621804|NCT01973608|11779979|FG003|NOT COMPLETED|Overall Study||0
10621805|NCT01973777|11779993|FG000|STARTED|Overall Study|January 2014|51
10621806|NCT01973777|11779993|FG000|One Year Follow-up|Overall Study||44
10621807|NCT01973777|11779993|FG000|COMPLETED|Overall Study||44
10621808|NCT01973777|11779993|FG000|NOT COMPLETED|Overall Study||7
10621809|NCT01973972|11779999|FG000|STARTED|Overall Study||127
10621810|NCT01973972|11780000|FG001|STARTED|Overall Study||136
10621811|NCT01973972|11779999|FG000|COMPLETED|Overall Study||109
10621812|NCT01973972|11780000|FG001|COMPLETED|Overall Study||117
10621813|NCT01973972|11779999|FG000|NOT COMPLETED|Overall Study||18
10621814|NCT01973972|11780000|FG001|NOT COMPLETED|Overall Study||19
10621815|NCT01973998|11780008|FG000|STARTED|Overall Study||33
10621816|NCT01973998|11780009|FG001|STARTED|Overall Study||35
10621817|NCT01973998|11780008|FG000|COMPLETED|Overall Study||31
10621818|NCT01973998|11780009|FG001|COMPLETED|Overall Study||33
10621819|NCT01973998|11780008|FG000|NOT COMPLETED|Overall Study||2
10621820|NCT01973998|11780009|FG001|NOT COMPLETED|Overall Study||2
10621821|NCT01974050|11780015|FG000|STARTED|Overall Study||166
10621822|NCT01974050|11780015|FG000|COMPLETED|Overall Study||141
10621823|NCT01974050|11780015|FG000|NOT COMPLETED|Overall Study||25
10621824|NCT01974089|11780021|FG000|STARTED|Overall Study||53
10621825|NCT01974089|11780022|FG001|STARTED|Overall Study||101
10621826|NCT01974089|11780021|FG000|COMPLETED|Overall Study||53
10621827|NCT01974089|11780022|FG001|COMPLETED|Overall Study||101
10621828|NCT01974089|11780021|FG000|NOT COMPLETED|Overall Study||0
10621829|NCT01974089|11780022|FG001|NOT COMPLETED|Overall Study||0
10621830|NCT01974102|11780032|FG000|STARTED|Overall Study||22
10621831|NCT01974102|11780033|FG001|STARTED|Overall Study||20
10621832|NCT01974102|11780032|FG000|COMPLETED|Overall Study||15
10621833|NCT01974102|11780033|FG001|COMPLETED|Overall Study||19
10621834|NCT01974102|11780032|FG000|NOT COMPLETED|Overall Study||7
10621835|NCT01974102|11780033|FG001|NOT COMPLETED|Overall Study||1
10621836|NCT01974141|11780043|FG000|STARTED|Overall Study||1044
10621837|NCT01974141|11780044|FG001|STARTED|Overall Study||1058
10621838|NCT01974141|11780043|FG000|COMPLETED|Overall Study||948
10621839|NCT01974141|11780044|FG001|COMPLETED|Overall Study||976
10621840|NCT01974141|11780043|FG000|NOT COMPLETED|Overall Study||96
10621841|NCT01974141|11780044|FG001|NOT COMPLETED|Overall Study||82
10621842|NCT01974245|11780052|FG000|STARTED|Overall Study||27
10621843|NCT01974245|11780053|FG001|STARTED|Overall Study||28
10621844|NCT01974245|11780052|FG000|COMPLETED|Overall Study||18
10621845|NCT01974245|11780053|FG001|COMPLETED|Overall Study||20
10621846|NCT01974245|11780052|FG000|NOT COMPLETED|Overall Study||9
10621847|NCT01974245|11780053|FG001|NOT COMPLETED|Overall Study||8
10621848|NCT01974323|11780061|FG000|STARTED|Overall Study||1118
10621849|NCT01974323|11780062|FG001|STARTED|Overall Study||1120
10621850|NCT01974323|11780061|FG000|COMPLETED|Overall Study||1026
10621851|NCT01974323|11780062|FG001|COMPLETED|Overall Study||1027
10621852|NCT01974323|11780061|FG000|NOT COMPLETED|Overall Study||92
10621853|NCT01974323|11780062|FG001|NOT COMPLETED|Overall Study||93
10621854|NCT01974687|11780093|FG000|STARTED|Overall Study||6
10705140|NCT02596230|11869492|FG002|COMPLETED|Objective 2, One Year||812
10621855|NCT01974687|11780094|FG001|STARTED|Overall Study||6
10621856|NCT01974687|11780095|FG002|STARTED|Overall Study||6
10621857|NCT01974687|11780096|FG003|STARTED|Overall Study||6
10621858|NCT01974687|11780097|FG004|STARTED|Overall Study||2
10621859|NCT01974687|11780098|FG005|STARTED|Overall Study||6
10621860|NCT01974687|11780099|FG006|STARTED|Overall Study||3
10621861|NCT01974687|11780100|FG007|STARTED|Overall Study||3
10621862|NCT01974687|11780101|FG008|STARTED|Overall Study||3
10621863|NCT01974687|11780102|FG009|STARTED|Overall Study||3
10621864|NCT01974687|11780103|FG010|STARTED|Overall Study||3
10621865|NCT01974687|11780104|FG011|STARTED|Overall Study||13
10621866|NCT01974687|11780105|FG012|STARTED|Overall Study||13
10621867|NCT01974687|11780106|FG013|STARTED|Overall Study||10
10621868|NCT01974687|11780107|FG014|STARTED|Overall Study||19
10705141|NCT02596230|11869493|FG003|COMPLETED|Objective 2, One Year||471
10705142|NCT02596230|11869494|FG004|COMPLETED|Objective 2, One Year||714
10705143|NCT02596230|11869490|FG000|NOT COMPLETED|Objective 2, One Year||0
10705144|NCT02596230|11869491|FG001|NOT COMPLETED|Objective 2, One Year||68
10621869|NCT01974687|11780108|FG015|STARTED|Overall Study||9
10621870|NCT01974687|11780109|FG016|STARTED|Overall Study||9
10621871|NCT01974687|11780110|FG017|STARTED|Overall Study||11
10621872|NCT01974687|11780111|FG018|STARTED|Overall Study||9
10621873|NCT01974687|11780112|FG019|STARTED|Overall Study||3
10621874|NCT01974687|11780113|FG020|STARTED|Overall Study||3
10621875|NCT01974687|11780114|FG021|STARTED|Overall Study||8
10621876|NCT01974687|11780115|FG022|STARTED|Overall Study||8
10621877|NCT01974687|11780116|FG023|STARTED|Overall Study||6
10621878|NCT01974687|11780117|FG024|STARTED|Overall Study||10
10621879|NCT01974687|11780093|FG000|Treated|Overall Study||6
10621880|NCT01974687|11780094|FG001|Treated|Overall Study||6
10621881|NCT01974687|11780095|FG002|Treated|Overall Study||6
10621882|NCT01974687|11780096|FG003|Treated|Overall Study||6
10621883|NCT01974687|11780097|FG004|Treated|Overall Study||2
10621884|NCT01974687|11780098|FG005|Treated|Overall Study||6
10621885|NCT01974687|11780099|FG006|Treated|Overall Study||3
10621886|NCT01974687|11780100|FG007|Treated|Overall Study||3
10621887|NCT01974687|11780101|FG008|Treated|Overall Study||3
10621888|NCT01974687|11780102|FG009|Treated|Overall Study||3
10621889|NCT01974687|11780103|FG010|Treated|Overall Study||3
10621890|NCT01974687|11780104|FG011|Treated|Overall Study|2 participants discontinued prior to receiving study drug|11
10621891|NCT01974687|11780105|FG012|Treated|Overall Study|3 participants discontinued prior to receiving study drug|10
10621892|NCT01974687|11780106|FG013|Treated|Overall Study|2 participants discontinued prior to receiving study drug|8
10621893|NCT01974687|11780107|FG014|Treated|Overall Study|1 participant discontinued prior to receiving study drug|18
10621894|NCT01974687|11780108|FG015|Treated|Overall Study|1 participant discontinued prior to receiving study drug|8
10621895|NCT01974687|11780109|FG016|Treated|Overall Study|1 participant discontinued prior to receiving study drug|8
10621896|NCT01974687|11780110|FG017|Treated|Overall Study|3 participants discontinued prior to receiving study drug|8
10621897|NCT01974687|11780111|FG018|Treated|Overall Study||9
10621898|NCT01974687|11780112|FG019|Treated|Overall Study||3
10621899|NCT01974687|11780113|FG020|Treated|Overall Study||3
10705145|NCT02596230|11869492|FG002|NOT COMPLETED|Objective 2, One Year||98
10705146|NCT02596230|11869493|FG003|NOT COMPLETED|Objective 2, One Year||58
10705147|NCT02596230|11869494|FG004|NOT COMPLETED|Objective 2, One Year||78
10621900|NCT01974687|11780114|FG021|Treated|Overall Study||8
10621901|NCT01974687|11780115|FG022|Treated|Overall Study||8
10621902|NCT01974687|11780116|FG023|Treated|Overall Study||6
10621903|NCT01974687|11780117|FG024|Treated|Overall Study||10
10621904|NCT01974687|11780093|FG000|COMPLETED|Overall Study||6
10621905|NCT01974687|11780094|FG001|COMPLETED|Overall Study||6
10621906|NCT01974687|11780095|FG002|COMPLETED|Overall Study||6
10621907|NCT01974687|11780096|FG003|COMPLETED|Overall Study||6
10621908|NCT01974687|11780097|FG004|COMPLETED|Overall Study||2
10621909|NCT01974687|11780098|FG005|COMPLETED|Overall Study||6
10621910|NCT01974687|11780099|FG006|COMPLETED|Overall Study||3
10621911|NCT01974687|11780100|FG007|COMPLETED|Overall Study||3
10621912|NCT01974687|11780101|FG008|COMPLETED|Overall Study||3
10621913|NCT01974687|11780102|FG009|COMPLETED|Overall Study||3
10621914|NCT01974687|11780103|FG010|COMPLETED|Overall Study||3
10621915|NCT01974687|11780104|FG011|COMPLETED|Overall Study||11
10621916|NCT01974687|11780105|FG012|COMPLETED|Overall Study||10
10621917|NCT01974687|11780106|FG013|COMPLETED|Overall Study||8
10621918|NCT01974687|11780107|FG014|COMPLETED|Overall Study||18
10621919|NCT01974687|11780108|FG015|COMPLETED|Overall Study||8
10621920|NCT01974687|11780109|FG016|COMPLETED|Overall Study||8
10621921|NCT01974687|11780110|FG017|COMPLETED|Overall Study||8
10621922|NCT01974687|11780111|FG018|COMPLETED|Overall Study||9
10621923|NCT01974687|11780112|FG019|COMPLETED|Overall Study||3
10621924|NCT01974687|11780113|FG020|COMPLETED|Overall Study||3
10621925|NCT01974687|11780114|FG021|COMPLETED|Overall Study||8
10621926|NCT01974687|11780115|FG022|COMPLETED|Overall Study||8
10621927|NCT01974687|11780116|FG023|COMPLETED|Overall Study||6
10621928|NCT01974687|11780117|FG024|COMPLETED|Overall Study||10
10621929|NCT01974687|11780093|FG000|NOT COMPLETED|Overall Study||0
10621930|NCT01974687|11780094|FG001|NOT COMPLETED|Overall Study||0
10621931|NCT01974687|11780095|FG002|NOT COMPLETED|Overall Study||0
10621932|NCT01974687|11780096|FG003|NOT COMPLETED|Overall Study||0
10621933|NCT01974687|11780097|FG004|NOT COMPLETED|Overall Study||0
10621934|NCT01974687|11780098|FG005|NOT COMPLETED|Overall Study||0
10621935|NCT01974687|11780099|FG006|NOT COMPLETED|Overall Study||0
10705148|NCT02596321|11869506|FG000|STARTED|Overall Study||56
10621936|NCT01974687|11780100|FG007|NOT COMPLETED|Overall Study||0
10621937|NCT01974687|11780101|FG008|NOT COMPLETED|Overall Study||0
10621938|NCT01974687|11780102|FG009|NOT COMPLETED|Overall Study||0
10621939|NCT01974687|11780103|FG010|NOT COMPLETED|Overall Study||0
10621940|NCT01974687|11780104|FG011|NOT COMPLETED|Overall Study||2
10621941|NCT01974687|11780105|FG012|NOT COMPLETED|Overall Study||3
10621942|NCT01974687|11780106|FG013|NOT COMPLETED|Overall Study||2
10621943|NCT01974687|11780107|FG014|NOT COMPLETED|Overall Study||1
10621944|NCT01974687|11780108|FG015|NOT COMPLETED|Overall Study||1
10621945|NCT01974687|11780109|FG016|NOT COMPLETED|Overall Study||1
10621946|NCT01974687|11780110|FG017|NOT COMPLETED|Overall Study||3
10621947|NCT01974687|11780111|FG018|NOT COMPLETED|Overall Study||0
10705149|NCT02596321|11869507|FG001|STARTED|Overall Study||56
10705150|NCT02596321|11869506|FG000|COMPLETED|Overall Study||53
10621948|NCT01974687|11780112|FG019|NOT COMPLETED|Overall Study||0
10621949|NCT01974687|11780113|FG020|NOT COMPLETED|Overall Study||0
10621950|NCT01974687|11780114|FG021|NOT COMPLETED|Overall Study||0
10621951|NCT01974687|11780115|FG022|NOT COMPLETED|Overall Study||0
10621952|NCT01974687|11780116|FG023|NOT COMPLETED|Overall Study||0
10621953|NCT01974687|11780117|FG024|NOT COMPLETED|Overall Study||0
10621954|NCT01974700|11780199|FG000|STARTED|Overall Study||5
10621955|NCT01974700|11780200|FG001|STARTED|Overall Study||3
10621956|NCT01974700|11780199|FG000|COMPLETED|Overall Study||5
10621957|NCT01974700|11780200|FG001|COMPLETED|Overall Study||3
10621958|NCT01974700|11780199|FG000|NOT COMPLETED|Overall Study||0
10621959|NCT01974700|11780200|FG001|NOT COMPLETED|Overall Study||0
10621960|NCT01974752|11780208|FG000|STARTED|Overall Study||97
10621961|NCT01974752|11780209|FG001|STARTED|Overall Study||32
10621962|NCT01974752|11780208|FG000|COMPLETED|Overall Study||60
10621963|NCT01974752|11780209|FG001|COMPLETED|Overall Study||17
10621964|NCT01974752|11780208|FG000|NOT COMPLETED|Overall Study||37
10621965|NCT01974752|11780209|FG001|NOT COMPLETED|Overall Study||15
10621966|NCT01974817|11780215|FG000|STARTED|Overall Study||25
10621967|NCT01974817|11780215|FG000|COMPLETED|Overall Study||17
10621968|NCT01974817|11780215|FG000|NOT COMPLETED|Overall Study||8
10621969|NCT01974895|11780221|FG000|STARTED|Overall Study||158
10621970|NCT01974895|11780222|FG001|STARTED|Overall Study||156
10621971|NCT01974895|11780221|FG000|COMPLETED|Overall Study||143
10621972|NCT01974895|11780222|FG001|COMPLETED|Overall Study||141
10621973|NCT01974895|11780221|FG000|NOT COMPLETED|Overall Study||15
10621974|NCT01974895|11780222|FG001|NOT COMPLETED|Overall Study||15
10621975|NCT01975090|11780228|FG000|STARTED|Overall Study||129
10621976|NCT01975090|11780228|FG000|6-month Follow-up|Overall Study||117
10621977|NCT01975090|11780228|FG000|COMPLETED|Overall Study||117
10621978|NCT01975090|11780228|FG000|NOT COMPLETED|Overall Study||12
10621979|NCT01975220|11780241|FG000|STARTED|Test Period 1||12
10621980|NCT01975220|11780242|FG001|STARTED|Test Period 1||12
10621981|NCT01975220|11780243|FG002|STARTED|Test Period 1||12
10621982|NCT01975220|11780244|FG003|STARTED|Test Period 1||12
10621983|NCT01975220|11780245|FG004|STARTED|Test Period 1||12
10621984|NCT01975220|11780246|FG005|STARTED|Test Period 1||12
10621985|NCT01975220|11780241|FG000|COMPLETED|Test Period 1||12
10621986|NCT01975220|11780242|FG001|COMPLETED|Test Period 1||11
10621987|NCT01975220|11780243|FG002|COMPLETED|Test Period 1||12
10621988|NCT01975220|11780244|FG003|COMPLETED|Test Period 1||12
10621989|NCT01975220|11780245|FG004|COMPLETED|Test Period 1||12
10621990|NCT01975220|11780246|FG005|COMPLETED|Test Period 1||12
10621991|NCT01975220|11780241|FG000|NOT COMPLETED|Test Period 1||0
10621992|NCT01975220|11780242|FG001|NOT COMPLETED|Test Period 1||1
10621993|NCT01975220|11780243|FG002|NOT COMPLETED|Test Period 1||0
10621994|NCT01975220|11780244|FG003|NOT COMPLETED|Test Period 1||0
10621995|NCT01975220|11780245|FG004|NOT COMPLETED|Test Period 1||0
10621996|NCT01975220|11780246|FG005|NOT COMPLETED|Test Period 1||0
10621997|NCT01975220|11780241|FG000|STARTED|Test Period 2||12
10621998|NCT01975220|11780242|FG001|STARTED|Test Period 2||11
10621999|NCT01975220|11780243|FG002|STARTED|Test Period 2||12
10622000|NCT01975220|11780244|FG003|STARTED|Test Period 2||12
10622001|NCT01975220|11780245|FG004|STARTED|Test Period 2||12
10622002|NCT01975220|11780246|FG005|STARTED|Test Period 2||12
10622003|NCT01975220|11780241|FG000|COMPLETED|Test Period 2||12
10622004|NCT01975220|11780242|FG001|COMPLETED|Test Period 2||11
10622005|NCT01975220|11780243|FG002|COMPLETED|Test Period 2||12
10622006|NCT01975220|11780244|FG003|COMPLETED|Test Period 2||12
10622007|NCT01975220|11780245|FG004|COMPLETED|Test Period 2||12
10622008|NCT01975220|11780246|FG005|COMPLETED|Test Period 2||12
10622009|NCT01975220|11780241|FG000|NOT COMPLETED|Test Period 2||0
10622010|NCT01975220|11780242|FG001|NOT COMPLETED|Test Period 2||0
10622011|NCT01975220|11780243|FG002|NOT COMPLETED|Test Period 2||0
10622012|NCT01975220|11780244|FG003|NOT COMPLETED|Test Period 2||0
10622013|NCT01975220|11780245|FG004|NOT COMPLETED|Test Period 2||0
10622014|NCT01975220|11780246|FG005|NOT COMPLETED|Test Period 2||0
10622015|NCT01975246|11780263|FG000|STARTED|Overall Study||149
10622016|NCT01975246|11780264|FG001|STARTED|Overall Study||160
10622017|NCT01975246|11780263|FG000|COMPLETED|Overall Study||145
10622018|NCT01975246|11780264|FG001|COMPLETED|Overall Study||158
10622019|NCT01975246|11780263|FG000|NOT COMPLETED|Overall Study||4
10622020|NCT01975246|11780264|FG001|NOT COMPLETED|Overall Study||2
10622021|NCT01975285|11780272|FG000|STARTED|Overall Study||30
10622022|NCT01975285|11780273|FG001|STARTED|Overall Study||30
10622023|NCT01975285|11780272|FG000|COMPLETED|Overall Study||28
10622024|NCT01975285|11780273|FG001|COMPLETED|Overall Study||28
10622025|NCT01975285|11780272|FG000|NOT COMPLETED|Overall Study||2
10622026|NCT01975285|11780273|FG001|NOT COMPLETED|Overall Study||2
10622027|NCT01975376|11780281|FG000|STARTED|Overall Study||8390
10622028|NCT01975376|11780282|FG001|STARTED|Overall Study||8394
10622029|NCT01975376|11780281|FG000|Treated|Overall Study||8374
10622030|NCT01975376|11780282|FG001|Treated|Overall Study||8386
10622031|NCT01975376|11780281|FG000|COMPLETED|Overall Study||8164
10622032|NCT01975376|11780282|FG001|COMPLETED|Overall Study||8177
10622033|NCT01975376|11780281|FG000|NOT COMPLETED|Overall Study||226
10622034|NCT01975376|11780282|FG001|NOT COMPLETED|Overall Study||217
10622035|NCT01975389|11780290|FG000|STARTED|Overall Study||5283
10622036|NCT01975389|11780291|FG001|STARTED|Overall Study||5281
10622037|NCT01975389|11780290|FG000|Treated|Overall Study||5279
10622038|NCT01975389|11780291|FG001|Treated|Overall Study||5276
10622039|NCT01975389|11780290|FG000|COMPLETED|Overall Study||5031
10622040|NCT01975389|11780291|FG001|COMPLETED|Overall Study||5045
10622041|NCT01975389|11780290|FG000|NOT COMPLETED|Overall Study||252
10622042|NCT01975389|11780291|FG001|NOT COMPLETED|Overall Study||236
10622043|NCT01975428|11780299|FG000|STARTED|Overall Study||85
10622044|NCT01975428|11780300|FG001|STARTED|Overall Study||97
10622045|NCT01975428|11780299|FG000|COMPLETED|Overall Study||65
10622046|NCT01975428|11780300|FG001|COMPLETED|Overall Study||83
10622047|NCT01975428|11780299|FG000|NOT COMPLETED|Overall Study||20
10622048|NCT01975428|11780300|FG001|NOT COMPLETED|Overall Study||14
10622049|NCT01975519|11780308|FG000|STARTED|Overall Study||3
10622050|NCT01975519|11780309|FG001|STARTED|Overall Study||108
10622051|NCT01975519|11780308|FG000|Phase 1b|Overall Study||3
10622052|NCT01975519|11780309|FG001|Phase 1b|Overall Study||23
10622053|NCT01975519|11780308|FG000|Phase 2a Soft Tissue Sarcoma|Overall Study||0
10622054|NCT01975519|11780309|FG001|Phase 2a Soft Tissue Sarcoma|Overall Study||63
10622055|NCT01975519|11780308|FG000|Phase 2a Angiosarcoma Cohort|Overall Study||0
10622056|NCT01975519|11780309|FG001|Phase 2a Angiosarcoma Cohort|Overall Study||22
10622057|NCT01975519|11780308|FG000|COMPLETED|Overall Study||3
10622058|NCT01975519|11780309|FG001|COMPLETED|Overall Study||108
10622059|NCT01975519|11780308|FG000|NOT COMPLETED|Overall Study||0
10622060|NCT01975519|11780309|FG001|NOT COMPLETED|Overall Study||0
10622061|NCT01975675|11780327|FG000|STARTED|Overall Study||83
10622062|NCT01975675|11780328|FG001|STARTED|Overall Study||83
10622063|NCT01975675|11780329|FG002|STARTED|Overall Study||88
10622064|NCT01975675|11780330|FG003|STARTED|Overall Study||87
10622065|NCT01975675|11780327|FG000|COMPLETED|Overall Study||83
10622066|NCT01975675|11780328|FG001|COMPLETED|Overall Study||82
10622067|NCT01975675|11780329|FG002|COMPLETED|Overall Study||88
10622068|NCT01975675|11780330|FG003|COMPLETED|Overall Study||87
10622069|NCT01975675|11780327|FG000|NOT COMPLETED|Overall Study||0
10622070|NCT01975675|11780328|FG001|NOT COMPLETED|Overall Study||1
10622071|NCT01975675|11780329|FG002|NOT COMPLETED|Overall Study||0
10622072|NCT01975675|11780330|FG003|NOT COMPLETED|Overall Study||0
10622073|NCT01975701|11780340|FG000|STARTED|Overall Study||26
10622074|NCT01975701|11780340|FG000|COMPLETED|Overall Study||1
10622075|NCT01975701|11780340|FG000|NOT COMPLETED|Overall Study||25
10622076|NCT01975831|11780353|FG000|STARTED|Overall Study||3
10622077|NCT01975831|11780354|FG001|STARTED|Overall Study||11
10622078|NCT01975831|11780355|FG002|STARTED|Overall Study||4
10622079|NCT01975831|11780356|FG003|STARTED|Overall Study||4
10622080|NCT01975831|11780357|FG004|STARTED|Overall Study||19
10622081|NCT01975831|11780358|FG005|STARTED|Overall Study||16
10622082|NCT01975831|11780359|FG006|STARTED|Overall Study||16
10622083|NCT01975831|11780360|FG007|STARTED|Overall Study||16
10622084|NCT01975831|11780361|FG008|STARTED|Overall Study||15
10622085|NCT01975831|11780353|FG000|COMPLETED|Overall Study||0
10622086|NCT01975831|11780354|FG001|COMPLETED|Overall Study||2
10622087|NCT01975831|11780355|FG002|COMPLETED|Overall Study||0
10622088|NCT01975831|11780356|FG003|COMPLETED|Overall Study||0
10622089|NCT01975831|11780357|FG004|COMPLETED|Overall Study||1
10622090|NCT01975831|11780358|FG005|COMPLETED|Overall Study||2
10622091|NCT01975831|11780359|FG006|COMPLETED|Overall Study||0
10622092|NCT01975831|11780360|FG007|COMPLETED|Overall Study||1
10622093|NCT01975831|11780361|FG008|COMPLETED|Overall Study||3
10622094|NCT01975831|11780353|FG000|NOT COMPLETED|Overall Study||3
10622095|NCT01975831|11780354|FG001|NOT COMPLETED|Overall Study||9
10622096|NCT01975831|11780355|FG002|NOT COMPLETED|Overall Study||4
10622097|NCT01975831|11780356|FG003|NOT COMPLETED|Overall Study||4
10622098|NCT01975831|11780357|FG004|NOT COMPLETED|Overall Study||18
10622099|NCT01975831|11780358|FG005|NOT COMPLETED|Overall Study||14
10622100|NCT01975831|11780359|FG006|NOT COMPLETED|Overall Study||16
10622101|NCT01975831|11780360|FG007|NOT COMPLETED|Overall Study||15
10622102|NCT01975831|11780361|FG008|NOT COMPLETED|Overall Study||12
10622103|NCT01975909|11780383|FG000|STARTED|Overall Study||10
10622104|NCT01975909|11780384|FG001|STARTED|Overall Study||10
10622105|NCT01975909|11780383|FG000|COMPLETED|Overall Study||10
10622106|NCT01975909|11780384|FG001|COMPLETED|Overall Study||10
10622107|NCT01975909|11780383|FG000|NOT COMPLETED|Overall Study||0
10622108|NCT01975909|11780384|FG001|NOT COMPLETED|Overall Study||0
10622109|NCT01975922|11780392|FG000|STARTED|Overall Study||45
10622110|NCT01975922|11780393|FG001|STARTED|Overall Study||52
10622111|NCT01975922|11780392|FG000|COMPLETED|Overall Study||45
10622112|NCT01975922|11780393|FG001|COMPLETED|Overall Study||43
10622113|NCT01975922|11780392|FG000|NOT COMPLETED|Overall Study||0
10622114|NCT01975922|11780393|FG001|NOT COMPLETED|Overall Study||9
10622115|NCT01975935|11780401|FG000|STARTED|Overall Study||21
10622116|NCT01975935|11780402|FG001|STARTED|Overall Study||21
10622117|NCT01975935|11780401|FG000|COMPLETED|Overall Study||18
10622118|NCT01975935|11780402|FG001|COMPLETED|Overall Study||20
10622119|NCT01975935|11780401|FG000|NOT COMPLETED|Overall Study||3
10622120|NCT01975935|11780402|FG001|NOT COMPLETED|Overall Study||1
10622121|NCT01975948|11780412|FG000|STARTED|Overall Study||56
10622122|NCT01975948|11780413|FG001|STARTED|Overall Study||55
10622123|NCT01975948|11780414|FG002|STARTED|Overall Study||72
10622124|NCT01975948|11780415|FG003|STARTED|Overall Study||57
10622125|NCT01975948|11780412|FG000|COMPLETED|Overall Study||39
10622126|NCT01975948|11780413|FG001|COMPLETED|Overall Study||34
10622127|NCT01975948|11780414|FG002|COMPLETED|Overall Study||65
10622128|NCT01975948|11780415|FG003|COMPLETED|Overall Study||51
10622129|NCT01975948|11780412|FG000|NOT COMPLETED|Overall Study||17
10622130|NCT01975948|11780413|FG001|NOT COMPLETED|Overall Study||21
10622131|NCT01975948|11780414|FG002|NOT COMPLETED|Overall Study||7
10622132|NCT01975948|11780415|FG003|NOT COMPLETED|Overall Study||6
10622133|NCT01975974|11780425|FG000|STARTED|Overall Study||100
10622134|NCT01975974|11780425|FG000|COMPLETED|Overall Study||100
10622135|NCT01975974|11780425|FG000|NOT COMPLETED|Overall Study||0
10622136|NCT01976104|11780433|FG000|STARTED|Overall Study||43
10622137|NCT01976104|11780434|FG001|STARTED|Overall Study||70
10622138|NCT01976104|11780435|FG002|STARTED|Overall Study||33
10622139|NCT01976104|11780436|FG003|STARTED|Overall Study||58
10622140|NCT01976104|11780433|FG000|COMPLETED|Overall Study||37
10622141|NCT01976104|11780434|FG001|COMPLETED|Overall Study||68
10622142|NCT01976104|11780435|FG002|COMPLETED|Overall Study||31
10622143|NCT01976104|11780436|FG003|COMPLETED|Overall Study||55
10622144|NCT01976104|11780433|FG000|NOT COMPLETED|Overall Study||6
10622145|NCT01976104|11780434|FG001|NOT COMPLETED|Overall Study||2
10622146|NCT01976104|11780435|FG002|NOT COMPLETED|Overall Study||2
10622147|NCT01976104|11780436|FG003|NOT COMPLETED|Overall Study||3
10622148|NCT01976299|11780449|FG000|STARTED|Overall Study||292
10622149|NCT01976299|11780450|FG001|STARTED|Overall Study||286
10622150|NCT01976299|11780449|FG000|Completed Procedure|Overall Study||283
10622151|NCT01976299|11780450|FG001|Completed Procedure|Overall Study||284
10622152|NCT01976299|11780449|FG000|COMPLETED|Overall Study|9 subjects did not proceed onto procedure in this arm.|269
10622153|NCT01976299|11780450|FG001|COMPLETED|Overall Study|2 subjects did not proceed onto procedure in this arm.|280
10622154|NCT01976299|11780449|FG000|NOT COMPLETED|Overall Study||23
10622155|NCT01976299|11780450|FG001|NOT COMPLETED|Overall Study||6
10622156|NCT01976312|11780458|FG000|STARTED|Overall Study||190
10622157|NCT01976312|11780459|FG001|STARTED|Overall Study||62
10622158|NCT01976312|11780458|FG000|Completed 3 Months|Overall Study||186
10622159|NCT01976312|11780459|FG001|Completed 3 Months|Overall Study||60
10622160|NCT01976312|11780458|FG000|Discontinued Study Prior to 3 Months|Overall Study||4
10622161|NCT01976312|11780459|FG001|Discontinued Study Prior to 3 Months|Overall Study||2
10622162|NCT01976312|11780458|FG000|COMPLETED|Overall Study|Completed study at 12 months|173
10622163|NCT01976312|11780459|FG001|COMPLETED|Overall Study|Completed study at 12 months|53
10622164|NCT01976312|11780458|FG000|NOT COMPLETED|Overall Study||17
10622165|NCT01976312|11780459|FG001|NOT COMPLETED|Overall Study||9
10622166|NCT01976338|11780468|FG000|STARTED|Overall Study||190
10622167|NCT01976338|11780469|FG001|STARTED|Overall Study||93
10622168|NCT01976338|11780468|FG000|Completed 6 Months|Overall Study||185
10622169|NCT01976338|11780469|FG001|Completed 6 Months|Overall Study||91
10622170|NCT01976338|11780468|FG000|Discontinued Study Prior to 6 Months|Overall Study||5
10622171|NCT01976338|11780469|FG001|Discontinued Study Prior to 6 Months|Overall Study||2
10622172|NCT01976338|11780468|FG000|COMPLETED|Overall Study|12 months|177
10622173|NCT01976338|11780469|FG001|COMPLETED|Overall Study|12 months|89
10622174|NCT01976338|11780468|FG000|NOT COMPLETED|Overall Study||13
10622175|NCT01976338|11780469|FG001|NOT COMPLETED|Overall Study||4
10622176|NCT01976364|11780476|FG000|STARTED|Main Study (36 Months)||686
10622177|NCT01976364|11780477|FG001|STARTED|Main Study (36 Months)||0
10622178|NCT01976364|11780478|FG002|STARTED|Main Study (36 Months)||0
10622179|NCT01976364|11780476|FG000|COMPLETED|Main Study (36 Months)||465
10622180|NCT01976364|11780477|FG001|COMPLETED|Main Study (36 Months)||0
10622181|NCT01976364|11780478|FG002|COMPLETED|Main Study (36 Months)||0
10622182|NCT01976364|11780476|FG000|NOT COMPLETED|Main Study (36 Months)||221
10622183|NCT01976364|11780477|FG001|NOT COMPLETED|Main Study (36 Months)||0
10622184|NCT01976364|11780478|FG002|NOT COMPLETED|Main Study (36 Months)||0
10622185|NCT01976364|11780476|FG000|STARTED|Sub-study (12 Months)||0
10622186|NCT01976364|11780477|FG001|STARTED|Sub-study (12 Months)|Participants from main study who consented to take part in sub-study, continued into sub-study.|89
10622187|NCT01976364|11780478|FG002|STARTED|Sub-study (12 Months)|Participants from main study who consented to take part in sub-study, continued into sub-study.|90
10622188|NCT01976364|11780476|FG000|COMPLETED|Sub-study (12 Months)||0
10622189|NCT01976364|11780477|FG001|COMPLETED|Sub-study (12 Months)||83
10622190|NCT01976364|11780478|FG002|COMPLETED|Sub-study (12 Months)||85
10622191|NCT01976364|11780476|FG000|NOT COMPLETED|Sub-study (12 Months)||0
10622192|NCT01976364|11780477|FG001|NOT COMPLETED|Sub-study (12 Months)||6
10622193|NCT01976364|11780478|FG002|NOT COMPLETED|Sub-study (12 Months)||5
10622194|NCT01976390|11780489|FG000|STARTED|Overall Study||41
10622195|NCT01976390|11780490|FG001|STARTED|Overall Study||19
10622196|NCT01976390|11780489|FG000|COMPLETED|Overall Study||41
10622197|NCT01976390|11780490|FG001|COMPLETED|Overall Study||19
10622198|NCT01976390|11780489|FG000|NOT COMPLETED|Overall Study||0
10622199|NCT01976390|11780490|FG001|NOT COMPLETED|Overall Study||0
10622200|NCT01976416|11780498|FG000|STARTED|Overall Study||104
10622201|NCT01976416|11780499|FG001|STARTED|Overall Study||104
10622202|NCT01976416|11780498|FG000|COMPLETED|Overall Study||102
10622203|NCT01976416|11780499|FG001|COMPLETED|Overall Study||102
10622204|NCT01976416|11780498|FG000|NOT COMPLETED|Overall Study||2
10622205|NCT01976416|11780499|FG001|NOT COMPLETED|Overall Study||2
10622206|NCT01976442|11780507|FG000|STARTED|Overall Study||69
10622207|NCT01976442|11780508|FG001|STARTED|Overall Study||31
10622208|NCT01976442|11780507|FG000|COMPLETED|Overall Study||69
10622209|NCT01976442|11780508|FG001|COMPLETED|Overall Study||31
10622210|NCT01976442|11780507|FG000|NOT COMPLETED|Overall Study||0
10622211|NCT01976442|11780508|FG001|NOT COMPLETED|Overall Study||0
10622212|NCT01976507|11780514|FG000|STARTED|Overall Study||101
10622213|NCT01976507|11780514|FG000|Received Initial Dose of Dabigatran|Overall Study||100
10622214|NCT01976507|11780514|FG000|COMPLETED|Overall Study||94
10622215|NCT01976507|11780514|FG000|NOT COMPLETED|Overall Study||7
10622216|NCT01976572|11780518|FG000|STARTED|Overall Study||6
10622217|NCT01976572|11780519|FG001|STARTED|Overall Study||6
10622218|NCT01976572|11780520|FG002|STARTED|Overall Study||6
10622219|NCT01976572|11780518|FG000|COMPLETED|Overall Study||6
10622220|NCT01976572|11780519|FG001|COMPLETED|Overall Study||6
10622221|NCT01976572|11780520|FG002|COMPLETED|Overall Study||6
10622222|NCT01976572|11780518|FG000|NOT COMPLETED|Overall Study||0
10622223|NCT01976572|11780519|FG001|NOT COMPLETED|Overall Study||0
10622224|NCT01976572|11780520|FG002|NOT COMPLETED|Overall Study||0
10457096|NCT01009060|11604828|FG000|NOT COMPLETED|Overall Study||4
10457097|NCT01009060|11604829|FG001|NOT COMPLETED|Overall Study||5
10457098|NCT01009086|11604842|FG000|STARTED|Overall Study||206
10457099|NCT01009086|11604843|FG001|STARTED|Overall Study||205
10457100|NCT01009086|11604844|FG002|STARTED|Overall Study||204
10457101|NCT01009086|11604842|FG000|COMPLETED|Overall Study||162
10457102|NCT01009086|11604843|FG001|COMPLETED|Overall Study||158
10457103|NCT01009086|11604844|FG002|COMPLETED|Overall Study||170
10457104|NCT01009086|11604842|FG000|NOT COMPLETED|Overall Study||44
10457105|NCT01009086|11604843|FG001|NOT COMPLETED|Overall Study||47
10457106|NCT01009086|11604844|FG002|NOT COMPLETED|Overall Study||34
10457107|NCT01009099|11604859|FG000|STARTED|Overall Study||58
10457108|NCT01009099|11604860|FG001|STARTED|Overall Study||61
10457109|NCT01009099|11604859|FG000|COMPLETED|Overall Study||53
10457110|NCT01009099|11604860|FG001|COMPLETED|Overall Study||57
10457111|NCT01009099|11604859|FG000|NOT COMPLETED|Overall Study||5
10457112|NCT01009099|11604860|FG001|NOT COMPLETED|Overall Study||4
10457113|NCT01009138|11604868|FG000|STARTED|Overall Study||106
10457114|NCT01009138|11604869|FG001|STARTED|Overall Study||108
10457115|NCT01009138|11604868|FG000|COMPLETED|Overall Study||93
10457116|NCT01009138|11604869|FG001|COMPLETED|Overall Study||88
10457117|NCT01009138|11604868|FG000|NOT COMPLETED|Overall Study||13
10457118|NCT01009138|11604869|FG001|NOT COMPLETED|Overall Study||20
10457119|NCT01009203|11604875|FG000|STARTED|Overall Study||13
10457120|NCT01009203|11604875|FG000|Received Treatment|Overall Study|One patient withdrew consent before treatment started.|12
10457121|NCT01009203|11604875|FG000|COMPLETED|Overall Study||6
10457122|NCT01009203|11604875|FG000|NOT COMPLETED|Overall Study||7
10457123|NCT01009281|11604879|FG000|STARTED|Overall Study||7
10457124|NCT01009281|11604879|FG000|COMPLETED|Overall Study||0
10457125|NCT01009281|11604879|FG000|NOT COMPLETED|Overall Study||7
10457126|NCT01009333|11604883|FG000|STARTED|Week 1||2
10457127|NCT01009333|11604884|FG001|STARTED|Week 1||3
10457128|NCT01009333|11604885|FG002|STARTED|Week 1||2
10457129|NCT01009333|11604886|FG003|STARTED|Week 1||2
10457130|NCT01009333|11604887|FG004|STARTED|Week 1||2
10457131|NCT01009333|11604888|FG005|STARTED|Week 1||2
10457132|NCT01009333|11604883|FG000|COMPLETED|Week 1||2
10457133|NCT01009333|11604884|FG001|COMPLETED|Week 1|1 participant did not progress to the second period due to a protocol violation.|3
10457134|NCT01009333|11604885|FG002|COMPLETED|Week 1||2
10457135|NCT01009333|11604886|FG003|COMPLETED|Week 1||2
10457136|NCT01009333|11604887|FG004|COMPLETED|Week 1||2
10457137|NCT01009333|11604888|FG005|COMPLETED|Week 1||2
10457138|NCT01009333|11604883|FG000|NOT COMPLETED|Week 1||0
10457139|NCT01009333|11604884|FG001|NOT COMPLETED|Week 1||0
10457140|NCT01009333|11604885|FG002|NOT COMPLETED|Week 1||0
10457141|NCT01009333|11604886|FG003|NOT COMPLETED|Week 1||0
10457142|NCT01009333|11604887|FG004|NOT COMPLETED|Week 1||0
10457143|NCT01009333|11604888|FG005|NOT COMPLETED|Week 1||0
10457144|NCT01009333|11604883|FG000|STARTED|Week 2||2
10457145|NCT01009333|11604884|FG001|STARTED|Week 2||2
10457146|NCT01009333|11604885|FG002|STARTED|Week 2||2
10457147|NCT01009333|11604886|FG003|STARTED|Week 2||2
10457148|NCT01009333|11604887|FG004|STARTED|Week 2||2
10457149|NCT01009333|11604888|FG005|STARTED|Week 2||2
10457150|NCT01009333|11604883|FG000|COMPLETED|Week 2||2
10457151|NCT01009333|11604884|FG001|COMPLETED|Week 2||2
10457152|NCT01009333|11604885|FG002|COMPLETED|Week 2||2
10457153|NCT01009333|11604886|FG003|COMPLETED|Week 2||2
10457154|NCT01009333|11604887|FG004|COMPLETED|Week 2||2
10457155|NCT01009333|11604888|FG005|COMPLETED|Week 2||2
10457156|NCT01009333|11604883|FG000|NOT COMPLETED|Week 2||0
10457157|NCT01009333|11604884|FG001|NOT COMPLETED|Week 2||0
10457158|NCT01009333|11604885|FG002|NOT COMPLETED|Week 2||0
10457159|NCT01009333|11604886|FG003|NOT COMPLETED|Week 2||0
10457160|NCT01009333|11604887|FG004|NOT COMPLETED|Week 2||0
10457161|NCT01009333|11604888|FG005|NOT COMPLETED|Week 2||0
10457162|NCT01009333|11604883|FG000|STARTED|Week 3||2
10457163|NCT01009333|11604884|FG001|STARTED|Week 3||2
10457164|NCT01009333|11604885|FG002|STARTED|Week 3||2
10457165|NCT01009333|11604886|FG003|STARTED|Week 3||2
10457166|NCT01009333|11604887|FG004|STARTED|Week 3||2
10457167|NCT01009333|11604888|FG005|STARTED|Week 3||2
10457168|NCT01009333|11604883|FG000|COMPLETED|Week 3||2
10457169|NCT01009333|11604884|FG001|COMPLETED|Week 3||2
10457170|NCT01009333|11604885|FG002|COMPLETED|Week 3||2
10457171|NCT01009333|11604886|FG003|COMPLETED|Week 3||2
10457172|NCT01009333|11604887|FG004|COMPLETED|Week 3||2
10457173|NCT01009333|11604888|FG005|COMPLETED|Week 3||2
10457174|NCT01009333|11604883|FG000|NOT COMPLETED|Week 3||0
10457175|NCT01009333|11604884|FG001|NOT COMPLETED|Week 3||0
10622225|NCT01976624|11780529|FG000|STARTED|Overall Study||756
10622226|NCT01976624|11780529|FG000|COMPLETED|Overall Study||742
10622227|NCT01976624|11780529|FG000|NOT COMPLETED|Overall Study||14
10622228|NCT01976650|11780533|FG000|STARTED|Overall Study||724
10622229|NCT01976650|11780533|FG000|COMPLETED|Overall Study||718
10622230|NCT01976650|11780533|FG000|NOT COMPLETED|Overall Study||6
10622231|NCT01976663|11780537|FG000|STARTED|Overall Study||126
10622232|NCT01976663|11780537|FG000|Received Touch-up Treatment|Overall Study||63
10622233|NCT01976663|11780537|FG000|Received Asymmetry Correction|Overall Study||45
10622234|NCT01976663|11780537|FG000|Received Repeat Treatment|Overall Study||85
10622235|NCT01976663|11780537|FG000|COMPLETED|Overall Study||84
10622236|NCT01976663|11780537|FG000|NOT COMPLETED|Overall Study||42
10622237|NCT01976728|11780549|FG000|STARTED|Overall Study||10
10622238|NCT01976728|11780550|FG001|STARTED|Overall Study||9
10622239|NCT01976728|11780551|FG002|STARTED|Overall Study||10
10622240|NCT01976728|11780552|FG003|STARTED|Overall Study||10
10622241|NCT01976728|11780549|FG000|Dosed|Overall Study||10
10622242|NCT01976728|11780550|FG001|Dosed|Overall Study||9
10622243|NCT01976728|11780551|FG002|Dosed|Overall Study||10
10622244|NCT01976728|11780552|FG003|Dosed|Overall Study||10
10622245|NCT01976728|11780549|FG000|COMPLETED|Overall Study||9
10622246|NCT01976728|11780550|FG001|COMPLETED|Overall Study||9
10622247|NCT01976728|11780551|FG002|COMPLETED|Overall Study||10
10622248|NCT01976728|11780552|FG003|COMPLETED|Overall Study||10
10622249|NCT01976728|11780549|FG000|NOT COMPLETED|Overall Study||1
10622250|NCT01976728|11780550|FG001|NOT COMPLETED|Overall Study||0
10622251|NCT01976728|11780551|FG002|NOT COMPLETED|Overall Study||0
10622252|NCT01976728|11780552|FG003|NOT COMPLETED|Overall Study||0
10622253|NCT01976741|11780588|FG000|STARTED|Overall Study||4
10622254|NCT01976741|11780589|FG001|STARTED|Overall Study||4
10622255|NCT01976741|11780590|FG002|STARTED|Overall Study||4
10622256|NCT01976741|11780591|FG003|STARTED|Overall Study||3
10705151|NCT02596321|11869507|FG001|COMPLETED|Overall Study||56
10705152|NCT02596321|11869506|FG000|NOT COMPLETED|Overall Study||3
10705153|NCT02596321|11869507|FG001|NOT COMPLETED|Overall Study||0
10705154|NCT02596451|11869516|FG000|STARTED|Overall Study||385
10705155|NCT02596451|11869517|FG001|STARTED|Overall Study||392
10705156|NCT02596451|11869518|FG002|STARTED|Overall Study||387
10622257|NCT01976741|11780592|FG004|STARTED|Overall Study||4
10622258|NCT01976741|11780593|FG005|STARTED|Overall Study||4
10622259|NCT01976741|11780594|FG006|STARTED|Overall Study||23
10622260|NCT01976741|11780595|FG007|STARTED|Overall Study||74
10622261|NCT01976741|11780596|FG008|STARTED|Overall Study||8
10622262|NCT01976741|11780597|FG009|STARTED|Overall Study||40
10622263|NCT01976741|11780588|FG000|COMPLETED|Overall Study||3
10622264|NCT01976741|11780589|FG001|COMPLETED|Overall Study||4
10622265|NCT01976741|11780590|FG002|COMPLETED|Overall Study||1
10622266|NCT01976741|11780591|FG003|COMPLETED|Overall Study||2
10622267|NCT01976741|11780592|FG004|COMPLETED|Overall Study||4
10705157|NCT02596451|11869516|FG000|COMPLETED|Overall Study||381
10705158|NCT02596451|11869517|FG001|COMPLETED|Overall Study||374
10705159|NCT02596451|11869518|FG002|COMPLETED|Overall Study||373
10705160|NCT02596451|11869516|FG000|NOT COMPLETED|Overall Study||4
10705161|NCT02596451|11869517|FG001|NOT COMPLETED|Overall Study||18
10705162|NCT02596451|11869518|FG002|NOT COMPLETED|Overall Study||14
10705163|NCT02596620|11869527|FG000|STARTED|Overall Study|Started from 1st October 2013|82
10705164|NCT02596620|11869528|FG001|STARTED|Overall Study|Started from 1st October 2013|82
10705165|NCT02596620|11869527|FG000|COMPLETED|Overall Study|Completed on 30th September 2015|81
10622268|NCT01976741|11780593|FG005|COMPLETED|Overall Study||4
10622269|NCT01976741|11780594|FG006|COMPLETED|Overall Study||19
10622270|NCT01976741|11780595|FG007|COMPLETED|Overall Study||62
10622271|NCT01976741|11780596|FG008|COMPLETED|Overall Study||7
10622272|NCT01976741|11780597|FG009|COMPLETED|Overall Study||36
10622273|NCT01976741|11780588|FG000|NOT COMPLETED|Overall Study||1
10622274|NCT01976741|11780589|FG001|NOT COMPLETED|Overall Study||0
10622275|NCT01976741|11780590|FG002|NOT COMPLETED|Overall Study||3
10622276|NCT01976741|11780591|FG003|NOT COMPLETED|Overall Study||1
10622277|NCT01976741|11780592|FG004|NOT COMPLETED|Overall Study||0
10622278|NCT01976741|11780593|FG005|NOT COMPLETED|Overall Study||0
10622279|NCT01976741|11780594|FG006|NOT COMPLETED|Overall Study||4
10622280|NCT01976741|11780595|FG007|NOT COMPLETED|Overall Study||12
10622281|NCT01976741|11780596|FG008|NOT COMPLETED|Overall Study||1
10622282|NCT01976741|11780597|FG009|NOT COMPLETED|Overall Study||4
10622283|NCT01976806|11780633|FG000|STARTED|Overall Study||27
10622284|NCT01976806|11780634|FG001|STARTED|Overall Study||28
10622285|NCT01976806|11780633|FG000|COMPLETED|Overall Study||24
10622286|NCT01976806|11780634|FG001|COMPLETED|Overall Study||22
10705166|NCT02596620|11869528|FG001|COMPLETED|Overall Study|Completed on 30th September 2015|81
10705167|NCT02596620|11869527|FG000|NOT COMPLETED|Overall Study||1
10705168|NCT02596620|11869528|FG001|NOT COMPLETED|Overall Study||1
10705169|NCT02596711|11869537|FG000|STARTED|Overall Study||9
10705170|NCT02596711|11869538|FG001|STARTED|Overall Study||8
10705171|NCT02596711|11869539|FG002|STARTED|Overall Study||8
10705172|NCT02596711|11869537|FG000|Visit 2|Overall Study||9
10622287|NCT01976806|11780633|FG000|NOT COMPLETED|Overall Study||3
10622288|NCT01976806|11780634|FG001|NOT COMPLETED|Overall Study||6
10622289|NCT01976819|11780640|FG000|STARTED|Overall Study||16
10622290|NCT01976819|11780640|FG000|COMPLETED|Overall Study||11
10622291|NCT01976819|11780640|FG000|NOT COMPLETED|Overall Study||5
10622292|NCT01976845|11780652|FG000|STARTED|Overall Study||48
10622293|NCT01976845|11780653|FG001|STARTED|Overall Study||48
10622294|NCT01976845|11780654|FG002|STARTED|Overall Study||43
10622295|NCT01976845|11780652|FG000|COMPLETED|Overall Study||40
10622296|NCT01976845|11780653|FG001|COMPLETED|Overall Study||40
10622297|NCT01976845|11780654|FG002|COMPLETED|Overall Study||40
10705173|NCT02596711|11869538|FG001|Visit 2|Overall Study||7
10705174|NCT02596711|11869539|FG002|Visit 2|Overall Study||6
10705175|NCT02596711|11869537|FG000|Visit 3|Overall Study||7
10705176|NCT02596711|11869538|FG001|Visit 3|Overall Study||8
10622298|NCT01976845|11780652|FG000|NOT COMPLETED|Overall Study||8
10622299|NCT01976845|11780653|FG001|NOT COMPLETED|Overall Study||8
10622300|NCT01976845|11780654|FG002|NOT COMPLETED|Overall Study||3
10622301|NCT01976871|11780662|FG000|STARTED|Overall Study||21
10622302|NCT01976871|11780662|FG000|COMPLETED|Overall Study||20
10622303|NCT01976871|11780662|FG000|NOT COMPLETED|Overall Study||1
10622304|NCT01976975|11780668|FG000|STARTED|Overall Study||226
10622305|NCT01976975|11780669|FG001|STARTED|Overall Study||44
10622306|NCT01976975|11780668|FG000|COMPLETED|Overall Study||79
10622307|NCT01976975|11780669|FG001|COMPLETED|Overall Study||32
10622308|NCT01976975|11780668|FG000|NOT COMPLETED|Overall Study||147
10622309|NCT01976975|11780669|FG001|NOT COMPLETED|Overall Study||12
10622310|NCT01976988|11780677|FG000|STARTED|Overall Study||208
10622311|NCT01976988|11780678|FG001|STARTED|Overall Study||202
10622312|NCT01976988|11780677|FG000|COMPLETED|Overall Study||192
10622313|NCT01976988|11780678|FG001|COMPLETED|Overall Study||184
10622314|NCT01976988|11780677|FG000|NOT COMPLETED|Overall Study||16
10622315|NCT01976988|11780678|FG001|NOT COMPLETED|Overall Study||18
10622316|NCT01977040|11780686|FG000|STARTED|Overall Study||68
10622317|NCT01977040|11780686|FG000|COMPLETED|Overall Study||66
10622318|NCT01977040|11780686|FG000|NOT COMPLETED|Overall Study||2
10622319|NCT01977092|11780696|FG000|STARTED|Overall Study||149
10622320|NCT01977092|11780697|FG001|STARTED|Overall Study||181
10622321|NCT01977092|11780696|FG000|COMPLETED|Overall Study||118
10622322|NCT01977092|11780697|FG001|COMPLETED|Overall Study||151
10622323|NCT01977092|11780696|FG000|NOT COMPLETED|Overall Study||31
10622324|NCT01977092|11780697|FG001|NOT COMPLETED|Overall Study||30
10622325|NCT01977222|11780703|FG000|STARTED|Overall Study||12
10622326|NCT01977222|11780703|FG000|COMPLETED|Overall Study||11
10622327|NCT01977222|11780703|FG000|NOT COMPLETED|Overall Study||1
10622328|NCT01977352|11780709|FG000|STARTED|Overall Study||21
10622329|NCT01977352|11780710|FG001|STARTED|Overall Study||21
10622330|NCT01977352|11780709|FG000|COMPLETED|Overall Study||20
10622331|NCT01977352|11780710|FG001|COMPLETED|Overall Study||19
10622332|NCT01977352|11780709|FG000|NOT COMPLETED|Overall Study||1
10622333|NCT01977352|11780710|FG001|NOT COMPLETED|Overall Study||2
10622334|NCT01977456|11780716|FG000|STARTED|Overall Study||27
10622335|NCT01977456|11780716|FG000|COMPLETED|Overall Study||22
10622336|NCT01977456|11780716|FG000|NOT COMPLETED|Overall Study||5
10622337|NCT01977482|11780726|FG000|STARTED|Overall Study||39
10622338|NCT01977482|11780727|FG001|STARTED|Overall Study||39
10622339|NCT01977482|11780728|FG002|STARTED|Overall Study||40
10622340|NCT01977482|11780729|FG003|STARTED|Overall Study||39
10622341|NCT01977482|11780730|FG004|STARTED|Overall Study||40
10622342|NCT01977482|11780731|FG005|STARTED|Overall Study||19
10622343|NCT01977482|11780726|FG000|COMPLETED|Overall Study||36
10622344|NCT01977482|11780727|FG001|COMPLETED|Overall Study||30
10622345|NCT01977482|11780728|FG002|COMPLETED|Overall Study||35
10622346|NCT01977482|11780729|FG003|COMPLETED|Overall Study||35
10622347|NCT01977482|11780730|FG004|COMPLETED|Overall Study||37
10622348|NCT01977482|11780731|FG005|COMPLETED|Overall Study||14
10622349|NCT01977482|11780726|FG000|NOT COMPLETED|Overall Study||3
10622350|NCT01977482|11780727|FG001|NOT COMPLETED|Overall Study||9
10622351|NCT01977482|11780728|FG002|NOT COMPLETED|Overall Study||5
10622352|NCT01977482|11780729|FG003|NOT COMPLETED|Overall Study||4
10622353|NCT01977482|11780730|FG004|NOT COMPLETED|Overall Study||3
10622354|NCT01977482|11780731|FG005|NOT COMPLETED|Overall Study||5
10622355|NCT01977547|11780752|FG000|STARTED|Overall Study||768
10622356|NCT01977547|11780753|FG001|STARTED|Overall Study||770
10622357|NCT01977547|11780752|FG000|COMPLETED|Overall Study||728
10622358|NCT01977547|11780753|FG001|COMPLETED|Overall Study||733
10622359|NCT01977547|11780752|FG000|NOT COMPLETED|Overall Study||40
10622360|NCT01977547|11780753|FG001|NOT COMPLETED|Overall Study||37
10622361|NCT01977573|11780763|FG000|STARTED|Overall Study||136
10622362|NCT01977573|11780764|FG001|STARTED|Overall Study||44
10622363|NCT01977573|11780765|FG002|STARTED|Overall Study||36
10622364|NCT01977573|11780766|FG003|STARTED|Overall Study||36
10622365|NCT01977573|11780763|FG000|COMPLETED|Overall Study||116
10622366|NCT01977573|11780764|FG001|COMPLETED|Overall Study||41
10622367|NCT01977573|11780765|FG002|COMPLETED|Overall Study||32
10622368|NCT01977573|11780766|FG003|COMPLETED|Overall Study||33
10622369|NCT01977573|11780763|FG000|NOT COMPLETED|Overall Study||20
10622370|NCT01977573|11780764|FG001|NOT COMPLETED|Overall Study||3
10622371|NCT01977573|11780765|FG002|NOT COMPLETED|Overall Study||4
10622372|NCT01977573|11780766|FG003|NOT COMPLETED|Overall Study||3
10622373|NCT01977599|11780779|FG000|STARTED|Overall Study||1118
10622374|NCT01977599|11780780|FG001|STARTED|Overall Study||1122
10622375|NCT01977599|11780779|FG000|COMPLETED|Overall Study||1118
10622376|NCT01977599|11780780|FG001|COMPLETED|Overall Study||1122
10622377|NCT01977599|11780779|FG000|NOT COMPLETED|Overall Study||0
10622378|NCT01977599|11780780|FG001|NOT COMPLETED|Overall Study||0
10622379|NCT01977612|11780788|FG000|STARTED|Overall Study||85
10622380|NCT01977612|11780789|FG001|STARTED|Overall Study||80
10622381|NCT01977612|11780788|FG000|COMPLETED|Overall Study||84
10622382|NCT01977612|11780789|FG001|COMPLETED|Overall Study||79
10622383|NCT01977612|11780788|FG000|NOT COMPLETED|Overall Study||1
10622384|NCT01977612|11780789|FG001|NOT COMPLETED|Overall Study||1
10622385|NCT01977625|11780795|FG000|STARTED|First Intervention (4 Weeks)||11
10622386|NCT01977625|11780796|FG001|STARTED|First Intervention (4 Weeks)||7
10622387|NCT01977625|11780795|FG000|COMPLETED|First Intervention (4 Weeks)||8
10622388|NCT01977625|11780796|FG001|COMPLETED|First Intervention (4 Weeks)||7
10622389|NCT01977625|11780795|FG000|NOT COMPLETED|First Intervention (4 Weeks)||3
10622390|NCT01977625|11780796|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
10622391|NCT01977625|11780795|FG000|STARTED|Washout (2 Weeks)||8
10622392|NCT01977625|11780796|FG001|STARTED|Washout (2 Weeks)||7
10622393|NCT01977625|11780795|FG000|COMPLETED|Washout (2 Weeks)||8
10622394|NCT01977625|11780796|FG001|COMPLETED|Washout (2 Weeks)||7
10622395|NCT01977625|11780795|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10622396|NCT01977625|11780796|FG001|NOT COMPLETED|Washout (2 Weeks)||0
10622397|NCT01977625|11780795|FG000|STARTED|Second Intervention (4 Weeks)||8
10622398|NCT01977625|11780796|FG001|STARTED|Second Intervention (4 Weeks)||7
10622399|NCT01977625|11780795|FG000|COMPLETED|Second Intervention (4 Weeks)||7
10622400|NCT01977625|11780796|FG001|COMPLETED|Second Intervention (4 Weeks)||7
10622401|NCT01977625|11780795|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1
10622402|NCT01977625|11780796|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
10622403|NCT01977651|11780804|FG000|STARTED|4 Month Treatment Period||423
10622404|NCT01977651|11780804|FG000|COMPLETED|4 Month Treatment Period||322
10622405|NCT01977651|11780804|FG000|NOT COMPLETED|4 Month Treatment Period||101
10622406|NCT01977651|11780804|FG000|STARTED|1 Year Extension Period|Participants who benefited from enzalutamide treatment continued in the 1 year extension period|287
10622407|NCT01977651|11780804|FG000|COMPLETED|1 Year Extension Period||157
10622408|NCT01977651|11780804|FG000|NOT COMPLETED|1 Year Extension Period||130
10622409|NCT01977651|11780804|FG000|STARTED|Post 1 Year Extension Period|Participants who benefited from enzalutamide treatment continued in the post 1 year extension period|145
10622410|NCT01977651|11780804|FG000|COMPLETED|Post 1 Year Extension Period||1
10622411|NCT01977651|11780804|FG000|NOT COMPLETED|Post 1 Year Extension Period||144
10622412|NCT01977677|11780811|FG000|STARTED|Overall Study||3
10622413|NCT01977677|11780812|FG001|STARTED|Overall Study||6
10622414|NCT01977677|11780813|FG002|STARTED|Overall Study||21
10622415|NCT01977677|11780811|FG000|COMPLETED|Overall Study||3
10622416|NCT01977677|11780812|FG001|COMPLETED|Overall Study||6
10622417|NCT01977677|11780813|FG002|COMPLETED|Overall Study||20
10622418|NCT01977677|11780811|FG000|NOT COMPLETED|Overall Study||0
10622419|NCT01977677|11780812|FG001|NOT COMPLETED|Overall Study||0
10622420|NCT01977677|11780813|FG002|NOT COMPLETED|Overall Study||1
10622421|NCT01977690|11780823|FG000|STARTED|Overall Study||15
10622422|NCT01977690|11780824|FG001|STARTED|Overall Study||15
10622423|NCT01977690|11780823|FG000|COMPLETED|Overall Study||15
10622424|NCT01977690|11780824|FG001|COMPLETED|Overall Study||11
10622425|NCT01977690|11780823|FG000|NOT COMPLETED|Overall Study||0
10622426|NCT01977690|11780824|FG001|NOT COMPLETED|Overall Study||4
10622427|NCT01977781|11780832|FG000|STARTED|Overall Study||24
10622428|NCT01977781|11780833|FG001|STARTED|Overall Study||16
10622429|NCT01977781|11780832|FG000|COMPLETED|Overall Study||18
10622430|NCT01977781|11780833|FG001|COMPLETED|Overall Study||15
10622431|NCT01977781|11780832|FG000|NOT COMPLETED|Overall Study||6
10622432|NCT01977781|11780833|FG001|NOT COMPLETED|Overall Study||1
10622433|NCT01977794|11780841|FG000|STARTED|Overall Study||100
10622434|NCT01977794|11780842|FG001|STARTED|Overall Study||100
10622435|NCT01977794|11780841|FG000|COMPLETED|Overall Study||92
10622436|NCT01977794|11780842|FG001|COMPLETED|Overall Study||94
10622437|NCT01977794|11780841|FG000|NOT COMPLETED|Overall Study||8
10622438|NCT01977794|11780842|FG001|NOT COMPLETED|Overall Study||6
10622439|NCT01977820|11780850|FG000|STARTED|Overall Study||1
10622440|NCT01977820|11780851|FG001|STARTED|Overall Study||1
10622441|NCT01977820|11780850|FG000|COMPLETED|Overall Study||0
10622442|NCT01977820|11780851|FG001|COMPLETED|Overall Study||0
10622443|NCT01977820|11780850|FG000|NOT COMPLETED|Overall Study||1
10622444|NCT01977820|11780851|FG001|NOT COMPLETED|Overall Study||1
10622445|NCT01977846|11780859|FG000|STARTED|Total Study - Retrospective||251
10622446|NCT01977846|11780860|FG001|STARTED|Total Study - Retrospective||0
10622447|NCT01977846|11780859|FG000|COMPLETED|Total Study - Retrospective||251
10622448|NCT01977846|11780860|FG001|COMPLETED|Total Study - Retrospective||0
10622449|NCT01977846|11780859|FG000|NOT COMPLETED|Total Study - Retrospective||0
10622450|NCT01977846|11780860|FG001|NOT COMPLETED|Total Study - Retrospective||0
10622451|NCT01977846|11780859|FG000|STARTED|Total Study - Prospective||0
10622452|NCT01977846|11780860|FG001|STARTED|Total Study - Prospective||259
10705177|NCT02596711|11869539|FG002|Visit 3|Overall Study||6
10705178|NCT02596711|11869537|FG000|3 Month Follow-up|Overall Study||8
10705179|NCT02596711|11869538|FG001|3 Month Follow-up|Overall Study||6
10622453|NCT01977846|11780859|FG000|COMPLETED|Total Study - Prospective||0
10622454|NCT01977846|11780860|FG001|COMPLETED|Total Study - Prospective||230
10622455|NCT01977846|11780859|FG000|NOT COMPLETED|Total Study - Prospective||0
10622456|NCT01977846|11780860|FG001|NOT COMPLETED|Total Study - Prospective||29
10622457|NCT01977898|11780869|FG000|STARTED|Overall Study||28
10622458|NCT01977898|11780870|FG001|STARTED|Overall Study||35
10622459|NCT01977898|11780869|FG000|COMPLETED|Overall Study||27
10622460|NCT01977898|11780870|FG001|COMPLETED|Overall Study||34
10622461|NCT01977898|11780869|FG000|NOT COMPLETED|Overall Study||1
10622462|NCT01977898|11780870|FG001|NOT COMPLETED|Overall Study||1
10622463|NCT01977937|11780878|FG000|STARTED|Overall Study||27
10622464|NCT01977937|11780879|FG001|STARTED|Overall Study||28
10622465|NCT01977937|11780878|FG000|COMPLETED|Overall Study||24
10622466|NCT01977937|11780879|FG001|COMPLETED|Overall Study||26
10622467|NCT01977937|11780878|FG000|NOT COMPLETED|Overall Study||3
10622468|NCT01977937|11780879|FG001|NOT COMPLETED|Overall Study||2
10705180|NCT02596711|11869539|FG002|3 Month Follow-up|Overall Study||6
10622469|NCT01978093|11780887|FG000|STARTED|Overall Study||297
10622470|NCT01978093|11780888|FG001|STARTED|Overall Study||303
10622471|NCT01978093|11780887|FG000|COMPLETED|Overall Study||232
10705181|NCT02596711|11869537|FG000|6 Month Follow-up|Overall Study||8
10622472|NCT01978093|11780888|FG001|COMPLETED|Overall Study||230
10622473|NCT01978093|11780887|FG000|NOT COMPLETED|Overall Study||65
10622474|NCT01978093|11780888|FG001|NOT COMPLETED|Overall Study||73
10622475|NCT01978119|11780897|FG000|STARTED|Treatment Period 1 (12 Weeks)||40
10622476|NCT01978119|11780898|FG001|STARTED|Treatment Period 1 (12 Weeks)||42
10622477|NCT01978119|11780897|FG000|COMPLETED|Treatment Period 1 (12 Weeks)||38
10622478|NCT01978119|11780898|FG001|COMPLETED|Treatment Period 1 (12 Weeks)||42
10622479|NCT01978119|11780897|FG000|NOT COMPLETED|Treatment Period 1 (12 Weeks)||2
10622480|NCT01978119|11780898|FG001|NOT COMPLETED|Treatment Period 1 (12 Weeks)||0
10622481|NCT01978119|11780897|FG000|STARTED|Washout Period 1 (3 Weeks)||38
10622482|NCT01978119|11780898|FG001|STARTED|Washout Period 1 (3 Weeks)||42
10622483|NCT01978119|11780897|FG000|COMPLETED|Washout Period 1 (3 Weeks)||38
10622484|NCT01978119|11780898|FG001|COMPLETED|Washout Period 1 (3 Weeks)||42
10622485|NCT01978119|11780897|FG000|NOT COMPLETED|Washout Period 1 (3 Weeks)||0
10622486|NCT01978119|11780898|FG001|NOT COMPLETED|Washout Period 1 (3 Weeks)||0
10622487|NCT01978119|11780897|FG000|STARTED|Treatment Period 2 (12 Weeks)||38
10622488|NCT01978119|11780898|FG001|STARTED|Treatment Period 2 (12 Weeks)||42
10622489|NCT01978119|11780897|FG000|COMPLETED|Treatment Period 2 (12 Weeks)||38
10622490|NCT01978119|11780898|FG001|COMPLETED|Treatment Period 2 (12 Weeks)||40
10622491|NCT01978119|11780897|FG000|NOT COMPLETED|Treatment Period 2 (12 Weeks)||0
10622492|NCT01978119|11780898|FG001|NOT COMPLETED|Treatment Period 2 (12 Weeks)||2
10622493|NCT01978145|11780904|FG000|STARTED|Treatment Period 1||214
10622494|NCT01978145|11780905|FG001|STARTED|Treatment Period 1||212
10622495|NCT01978145|11780904|FG000|COMPLETED|Treatment Period 1||205
10622496|NCT01978145|11780905|FG001|COMPLETED|Treatment Period 1||196
10622497|NCT01978145|11780904|FG000|NOT COMPLETED|Treatment Period 1||9
10622498|NCT01978145|11780905|FG001|NOT COMPLETED|Treatment Period 1||16
10622499|NCT01978145|11780904|FG000|STARTED|Washout Period 1||205
10622500|NCT01978145|11780905|FG001|STARTED|Washout Period 1||196
10622501|NCT01978145|11780904|FG000|COMPLETED|Washout Period 1||204
10622502|NCT01978145|11780905|FG001|COMPLETED|Washout Period 1||193
10622503|NCT01978145|11780904|FG000|NOT COMPLETED|Washout Period 1||1
10622504|NCT01978145|11780905|FG001|NOT COMPLETED|Washout Period 1||3
10808906|NCT03838198|11970873|FG003|NOT COMPLETED|3 Month Follow up Period||4
10808907|NCT03831451|11970886|FG000|STARTED|Overall Study||74
10808908|NCT03831451|11970887|FG001|STARTED|Overall Study||55
10808909|NCT03831451|11970886|FG000|COMPLETED|Overall Study||74
10808910|NCT03831451|11970887|FG001|COMPLETED|Overall Study||55
10808911|NCT03831451|11970886|FG000|NOT COMPLETED|Overall Study||0
10808912|NCT03831451|11970887|FG001|NOT COMPLETED|Overall Study||0
10808913|NCT03822078|11970899|FG000|STARTED|Overall Study||12
10808914|NCT03822078|11970900|FG001|STARTED|Overall Study||6
10808915|NCT03822078|11970901|FG002|STARTED|Overall Study||6
10808916|NCT03822078|11970902|FG003|STARTED|Overall Study||8
10808917|NCT03822078|11970903|FG004|STARTED|Overall Study||7
10808918|NCT03822078|11970904|FG005|STARTED|Overall Study||6
10808919|NCT03822078|11970899|FG000|Received Study Drug|Overall Study||10
10808920|NCT03822078|11970900|FG001|Received Study Drug|Overall Study||6
10808921|NCT03822078|11970901|FG002|Received Study Drug|Overall Study||6
10808922|NCT03822078|11970902|FG003|Received Study Drug|Overall Study||6
10808923|NCT03822078|11970903|FG004|Received Study Drug|Overall Study||6
10808924|NCT03822078|11970904|FG005|Received Study Drug|Overall Study||6
10808925|NCT03822078|11970899|FG000|COMPLETED|Overall Study||10
10808926|NCT03822078|11970900|FG001|COMPLETED|Overall Study||6
10808927|NCT03822078|11970901|FG002|COMPLETED|Overall Study||6
10808928|NCT03822078|11970902|FG003|COMPLETED|Overall Study||6
10808929|NCT03822078|11970903|FG004|COMPLETED|Overall Study||6
10808930|NCT03822078|11970904|FG005|COMPLETED|Overall Study||6
10808931|NCT03822078|11970899|FG000|NOT COMPLETED|Overall Study||2
10808932|NCT03822078|11970900|FG001|NOT COMPLETED|Overall Study||0
10808933|NCT03822078|11970901|FG002|NOT COMPLETED|Overall Study||0
10808934|NCT03822078|11970902|FG003|NOT COMPLETED|Overall Study||2
10808935|NCT03822078|11970903|FG004|NOT COMPLETED|Overall Study||1
10808936|NCT03822078|11970904|FG005|NOT COMPLETED|Overall Study||0
10808937|NCT03815240|11970924|FG000|STARTED|Intervention no Dressing||2
10808938|NCT03815240|11970925|FG001|STARTED|Intervention no Dressing||1
10808939|NCT03815240|11970926|FG002|STARTED|Intervention no Dressing||1
10808940|NCT03815240|11970927|FG003|STARTED|Intervention no Dressing||2
10808941|NCT03815240|11970928|FG004|STARTED|Intervention no Dressing||1
10808942|NCT03815240|11970929|FG005|STARTED|Intervention no Dressing||2
10808943|NCT03815240|11970930|FG006|STARTED|Intervention no Dressing||1
10808944|NCT03815240|11970931|FG007|STARTED|Intervention no Dressing||1
10808945|NCT03815240|11970932|FG008|STARTED|Intervention no Dressing||1
10808946|NCT03815240|11970924|FG000|COMPLETED|Intervention no Dressing||2
10622505|NCT01978145|11780904|FG000|STARTED|Treatment Period 2||204
10622506|NCT01978145|11780905|FG001|STARTED|Treatment Period 2||193
10622507|NCT01978145|11780904|FG000|COMPLETED|Treatment Period 2||185
10622508|NCT01978145|11780905|FG001|COMPLETED|Treatment Period 2||179
10622509|NCT01978145|11780904|FG000|NOT COMPLETED|Treatment Period 2||19
10622510|NCT01978145|11780905|FG001|NOT COMPLETED|Treatment Period 2||14
10622511|NCT01978184|11780913|FG000|STARTED|Overall Study||43
10808947|NCT03815240|11970925|FG001|COMPLETED|Intervention no Dressing||1
10808948|NCT03815240|11970926|FG002|COMPLETED|Intervention no Dressing||1
10808949|NCT03815240|11970927|FG003|COMPLETED|Intervention no Dressing||2
10808950|NCT03815240|11970928|FG004|COMPLETED|Intervention no Dressing||1
10808951|NCT03815240|11970929|FG005|COMPLETED|Intervention no Dressing||2
10622512|NCT01978184|11780914|FG001|STARTED|Overall Study||61
10808952|NCT03815240|11970930|FG006|COMPLETED|Intervention no Dressing||1
10808953|NCT03815240|11970931|FG007|COMPLETED|Intervention no Dressing||1
10808954|NCT03815240|11970932|FG008|COMPLETED|Intervention no Dressing||1
10808955|NCT03815240|11970924|FG000|NOT COMPLETED|Intervention no Dressing||0
10808956|NCT03815240|11970925|FG001|NOT COMPLETED|Intervention no Dressing||0
10808957|NCT03815240|11970926|FG002|NOT COMPLETED|Intervention no Dressing||0
10808958|NCT03815240|11970927|FG003|NOT COMPLETED|Intervention no Dressing||0
10808959|NCT03815240|11970928|FG004|NOT COMPLETED|Intervention no Dressing||0
10808960|NCT03815240|11970929|FG005|NOT COMPLETED|Intervention no Dressing||0
10808961|NCT03815240|11970930|FG006|NOT COMPLETED|Intervention no Dressing||0
10808962|NCT03815240|11970931|FG007|NOT COMPLETED|Intervention no Dressing||0
10808963|NCT03815240|11970932|FG008|NOT COMPLETED|Intervention no Dressing||0
10808964|NCT03815240|11970924|FG000|STARTED|Intervention Mepilex Dressing||2
10808965|NCT03815240|11970925|FG001|STARTED|Intervention Mepilex Dressing||1
10808966|NCT03815240|11970926|FG002|STARTED|Intervention Mepilex Dressing||1
10808967|NCT03815240|11970927|FG003|STARTED|Intervention Mepilex Dressing||2
10808968|NCT03815240|11970928|FG004|STARTED|Intervention Mepilex Dressing||1
10808969|NCT03815240|11970929|FG005|STARTED|Intervention Mepilex Dressing||2
10808970|NCT03815240|11970930|FG006|STARTED|Intervention Mepilex Dressing||1
10622513|NCT01978184|11780913|FG000|COMPLETED|Overall Study||30
10622514|NCT01978184|11780914|FG001|COMPLETED|Overall Study||41
10622515|NCT01978184|11780913|FG000|NOT COMPLETED|Overall Study||13
10622516|NCT01978184|11780914|FG001|NOT COMPLETED|Overall Study||20
10622517|NCT01978236|11780920|FG000|STARTED|Overall Study||6
10622518|NCT01978236|11780920|FG000|COMPLETED|Overall Study||4
10622519|NCT01978236|11780920|FG000|NOT COMPLETED|Overall Study||2
10622520|NCT01978262|11780924|FG000|STARTED|Overall Study||103
10622521|NCT01978262|11780924|FG000|COMPLETED|Overall Study||92
10622522|NCT01978262|11780924|FG000|NOT COMPLETED|Overall Study||11
10622523|NCT01978314|11780934|FG000|STARTED|Overall Study||8
10622524|NCT01978314|11780935|FG001|STARTED|Overall Study||8
10622525|NCT01978314|11780936|FG002|STARTED|Overall Study||8
10622526|NCT01978314|11780937|FG003|STARTED|Overall Study||1
10622527|NCT01978314|11780938|FG004|STARTED|Overall Study||8
10622528|NCT01978314|11780934|FG000|COMPLETED|Overall Study||8
10622529|NCT01978314|11780935|FG001|COMPLETED|Overall Study||8
10622530|NCT01978314|11780936|FG002|COMPLETED|Overall Study||8
10622531|NCT01978314|11780937|FG003|COMPLETED|Overall Study||1
10622532|NCT01978314|11780938|FG004|COMPLETED|Overall Study||8
10622533|NCT01978314|11780934|FG000|NOT COMPLETED|Overall Study||0
10622534|NCT01978314|11780935|FG001|NOT COMPLETED|Overall Study||0
10622535|NCT01978314|11780936|FG002|NOT COMPLETED|Overall Study||0
10622536|NCT01978314|11780937|FG003|NOT COMPLETED|Overall Study||0
10622537|NCT01978314|11780938|FG004|NOT COMPLETED|Overall Study||0
10622538|NCT01978509|11780964|FG000|STARTED|Overall Study||10
10622539|NCT01978509|11780965|FG001|STARTED|Overall Study||13
10622540|NCT01978509|11780966|FG002|STARTED|Overall Study||9
10622541|NCT01978509|11780964|FG000|COMPLETED|Overall Study||8
10622542|NCT01978509|11780965|FG001|COMPLETED|Overall Study||8
10622543|NCT01978509|11780966|FG002|COMPLETED|Overall Study||9
10622544|NCT01978509|11780964|FG000|NOT COMPLETED|Overall Study||2
10622545|NCT01978509|11780965|FG001|NOT COMPLETED|Overall Study||5
10622546|NCT01978509|11780966|FG002|NOT COMPLETED|Overall Study||0
10622547|NCT01978600|11780976|FG000|STARTED|Overall Study||44
10622548|NCT01978600|11780977|FG001|STARTED|Overall Study||42
10622549|NCT01978600|11780976|FG000|COMPLETED|Overall Study||44
10622550|NCT01978600|11780977|FG001|COMPLETED|Overall Study||42
10622551|NCT01978600|11780976|FG000|NOT COMPLETED|Overall Study||0
10622552|NCT01978600|11780977|FG001|NOT COMPLETED|Overall Study||0
10622553|NCT01978743|11780983|FG000|STARTED|Overall Study||10
10622554|NCT01978743|11780983|FG000|COMPLETED|Overall Study||10
10622555|NCT01978743|11780983|FG000|NOT COMPLETED|Overall Study||0
10622556|NCT01978912|11780992|FG000|STARTED|Overall Study||6
10622557|NCT01978912|11780993|FG001|STARTED|Overall Study||6
10622558|NCT01978912|11780994|FG002|STARTED|Overall Study||6
10622559|NCT01978912|11780995|FG003|STARTED|Overall Study||6
10622560|NCT01978912|11780992|FG000|COMPLETED|Overall Study||3
10622561|NCT01978912|11780993|FG001|COMPLETED|Overall Study||3
10622562|NCT01978912|11780994|FG002|COMPLETED|Overall Study||3
10622563|NCT01978912|11780995|FG003|COMPLETED|Overall Study||3
10622564|NCT01978912|11780992|FG000|NOT COMPLETED|Overall Study||3
10622565|NCT01978912|11780993|FG001|NOT COMPLETED|Overall Study||3
10622566|NCT01978912|11780994|FG002|NOT COMPLETED|Overall Study||3
10622567|NCT01978912|11780995|FG003|NOT COMPLETED|Overall Study||3
10622568|NCT01979016|11781007|FG000|STARTED|Overall Study||27
10622569|NCT01979016|11781008|FG001|STARTED|Overall Study||27
10622570|NCT01979016|11781007|FG000|COMPLETED|Overall Study||25
10622571|NCT01979016|11781008|FG001|COMPLETED|Overall Study||26
10622572|NCT01979016|11781007|FG000|NOT COMPLETED|Overall Study||2
10622573|NCT01979016|11781008|FG001|NOT COMPLETED|Overall Study||1
10622574|NCT01979029|11781016|FG000|STARTED|Overall Study||29
10622575|NCT01979029|11781017|FG001|STARTED|Overall Study||28
10622576|NCT01979029|11781016|FG000|COMPLETED|Overall Study||29
10808971|NCT03815240|11970931|FG007|STARTED|Intervention Mepilex Dressing||1
10808972|NCT03815240|11970932|FG008|STARTED|Intervention Mepilex Dressing||1
10622577|NCT01979029|11781017|FG001|COMPLETED|Overall Study||28
10622578|NCT01979029|11781016|FG000|NOT COMPLETED|Overall Study||0
10622579|NCT01979029|11781017|FG001|NOT COMPLETED|Overall Study||0
10622580|NCT01979133|11781023|FG000|STARTED|Overall Study||10
10622581|NCT01979133|11781023|FG000|COMPLETED|Overall Study||7
10622582|NCT01979133|11781023|FG000|NOT COMPLETED|Overall Study||3
10622583|NCT01979159|11781040|FG000|STARTED|Overall Study||4
10622584|NCT01979159|11781040|FG000|COMPLETED|Overall Study||4
10622585|NCT01979159|11781040|FG000|NOT COMPLETED|Overall Study||0
10622586|NCT01979185|11781048|FG000|STARTED|Period 1||15
10622587|NCT01979185|11781049|FG001|STARTED|Period 1||15
10622588|NCT01979185|11781048|FG000|COMPLETED|Period 1||15
10622589|NCT01979185|11781049|FG001|COMPLETED|Period 1||15
10622590|NCT01979185|11781048|FG000|NOT COMPLETED|Period 1||0
10622591|NCT01979185|11781049|FG001|NOT COMPLETED|Period 1||0
10622592|NCT01979185|11781048|FG000|STARTED|Period 2||15
10622593|NCT01979185|11781049|FG001|STARTED|Period 2||15
10622594|NCT01979185|11781048|FG000|COMPLETED|Period 2||15
10622595|NCT01979185|11781049|FG001|COMPLETED|Period 2|1 subject discontinued due to a positive drug test prior to receiving Simvastatin alone in Period 2.|14
10622596|NCT01979185|11781048|FG000|NOT COMPLETED|Period 2||0
10622597|NCT01979185|11781049|FG001|NOT COMPLETED|Period 2||1
10622598|NCT01979276|11781055|FG000|STARTED|Overall Study||2
10622599|NCT01979276|11781055|FG000|COMPLETED|Overall Study||2
10622600|NCT01979276|11781055|FG000|NOT COMPLETED|Overall Study||0
10622601|NCT01979445|11781061|FG000|STARTED|Overall Study||3
10622602|NCT01979445|11781062|FG001|STARTED|Overall Study||3
10622603|NCT01979445|11781063|FG002|STARTED|Overall Study||6
10622604|NCT01979445|11781064|FG003|STARTED|Overall Study||3
10622605|NCT01979445|11781061|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
10622606|NCT01979445|11781062|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
10622607|NCT01979445|11781063|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
10622608|NCT01979445|11781064|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
10622609|NCT01979445|11781061|FG000|ITT Population|Overall Study||3
10622610|NCT01979445|11781062|FG001|ITT Population|Overall Study||3
10622611|NCT01979445|11781063|FG002|ITT Population|Overall Study||6
10622612|NCT01979445|11781064|FG003|ITT Population|Overall Study||3
10622613|NCT01979445|11781061|FG000|COMPLETED|Overall Study||3
10622614|NCT01979445|11781062|FG001|COMPLETED|Overall Study||3
10622615|NCT01979445|11781063|FG002|COMPLETED|Overall Study||6
10622616|NCT01979445|11781064|FG003|COMPLETED|Overall Study||3
10622617|NCT01979445|11781061|FG000|NOT COMPLETED|Overall Study||0
10622618|NCT01979445|11781062|FG001|NOT COMPLETED|Overall Study||0
10622619|NCT01979445|11781063|FG002|NOT COMPLETED|Overall Study||0
10622620|NCT01979445|11781064|FG003|NOT COMPLETED|Overall Study||0
10333892|NCT00336323|11470120|FG003|24 Week Visit|Overall Study||22
10333893|NCT00336323|11470121|FG004|24 Week Visit|Overall Study||19
10333894|NCT00336323|11470117|FG000|COMPLETED|Overall Study||19
10333895|NCT00336323|11470118|FG001|COMPLETED|Overall Study||21
10333896|NCT00336323|11470119|FG002|COMPLETED|Overall Study||23
10333897|NCT00336323|11470120|FG003|COMPLETED|Overall Study||22
10333898|NCT00336323|11470121|FG004|COMPLETED|Overall Study||19
10333899|NCT00336323|11470117|FG000|NOT COMPLETED|Overall Study||0
10622621|NCT01979523|11781084|FG000|STARTED|Overall Study||21
10622622|NCT01979523|11781085|FG001|STARTED|Overall Study||21
10622623|NCT01979523|11781084|FG000|COMPLETED|Overall Study||20
10622624|NCT01979523|11781085|FG001|COMPLETED|Overall Study||21
10622625|NCT01979523|11781084|FG000|NOT COMPLETED|Overall Study||1
10622626|NCT01979523|11781085|FG001|NOT COMPLETED|Overall Study||0
10622627|NCT01979614|11781094|FG000|STARTED|Overall Study||30
10622628|NCT01979614|11781095|FG001|STARTED|Overall Study||28
10622629|NCT01979614|11781094|FG000|Safety Analysis Set|Overall Study||30
10622630|NCT01979614|11781095|FG001|Safety Analysis Set|Overall Study||28
10622631|NCT01979614|11781094|FG000|PK Analysis Set|Overall Study||30
10622632|NCT01979614|11781095|FG001|PK Analysis Set|Overall Study||0
10622633|NCT01979614|11781094|FG000|PD Analysis Set|Overall Study||25
10622634|NCT01979614|11781095|FG001|PD Analysis Set|Overall Study||26
10622635|NCT01979614|11781094|FG000|COMPLETED|Overall Study||29
10622636|NCT01979614|11781095|FG001|COMPLETED|Overall Study||27
10622637|NCT01979614|11781094|FG000|NOT COMPLETED|Overall Study||1
10622638|NCT01979614|11781095|FG001|NOT COMPLETED|Overall Study||1
10622639|NCT01979835|11781101|FG000|STARTED|Primary Outcome SA Measurment||1030
10622640|NCT01979835|11781101|FG000|COMPLETED|Primary Outcome SA Measurment||1012
10622641|NCT01979835|11781101|FG000|NOT COMPLETED|Primary Outcome SA Measurment||18
10622642|NCT01979835|11781101|FG000|STARTED|Follow-up||1012
10622643|NCT01979835|11781101|FG000|COMPLETED|Follow-up||980
10622644|NCT01979835|11781101|FG000|NOT COMPLETED|Follow-up||32
10622645|NCT01979952|11781107|FG000|STARTED|Overall Study||56
10622646|NCT01979952|11781108|FG001|STARTED|Overall Study||57
10622647|NCT01979952|11781107|FG000|COMPLETED|Overall Study||48
10622648|NCT01979952|11781108|FG001|COMPLETED|Overall Study||51
10622649|NCT01979952|11781107|FG000|NOT COMPLETED|Overall Study||8
10622650|NCT01979952|11781108|FG001|NOT COMPLETED|Overall Study||6
10653384|NCT02193087|11813866|FG001|Received Vaccination|Overall Study||97
10653385|NCT02193087|11813867|FG002|Received Vaccination|Overall Study||100
10653386|NCT02193087|11813868|FG003|Received Vaccination|Overall Study||602
10653387|NCT02193087|11813865|FG000|COMPLETED|Overall Study||162
10653388|NCT02193087|11813866|FG001|COMPLETED|Overall Study||86
10653389|NCT02193087|11813867|FG002|COMPLETED|Overall Study||93
10653390|NCT02193087|11813868|FG003|COMPLETED|Overall Study||524
10653391|NCT02193087|11813865|FG000|NOT COMPLETED|Overall Study||37
10653392|NCT02193087|11813866|FG001|NOT COMPLETED|Overall Study||14
10333900|NCT00336323|11470118|FG001|NOT COMPLETED|Overall Study||1
10333901|NCT00336323|11470119|FG002|NOT COMPLETED|Overall Study||1
10653393|NCT02193087|11813867|FG002|NOT COMPLETED|Overall Study||7
10653394|NCT02193087|11813868|FG003|NOT COMPLETED|Overall Study||79
10622651|NCT01980056|11781117|FG000|STARTED|Overall Study||4
10622652|NCT01980056|11781118|FG001|STARTED|Overall Study||4
10622653|NCT01980056|11781119|FG002|STARTED|Overall Study||2
10622654|NCT01980056|11781117|FG000|COMPLETED|Overall Study||3
10622655|NCT01980056|11781118|FG001|COMPLETED|Overall Study||3
10622656|NCT01980056|11781119|FG002|COMPLETED|Overall Study||2
10622657|NCT01980056|11781117|FG000|NOT COMPLETED|Overall Study||1
10622658|NCT01980056|11781118|FG001|NOT COMPLETED|Overall Study||1
10622659|NCT01980056|11781119|FG002|NOT COMPLETED|Overall Study||0
10622660|NCT01980095|11781133|FG000|STARTED|Overall Study|Protocol planned for 90 patients, protocol amendment increase up to 120 patients.|78
10622661|NCT01980095|11781134|FG001|STARTED|Overall Study|Protocol planned for 90 patients, protocol amendment increase up to 120 patients.|41
10622662|NCT01980095|11781133|FG000|Treated|Overall Study|Of 78 patients randomized, 1 patient erroneously randomized and not treated|77
10622663|NCT01980095|11781134|FG001|Treated|Overall Study||41
10622664|NCT01980095|11781133|FG000|COMPLETED|Overall Study||63
10622665|NCT01980095|11781134|FG001|COMPLETED|Overall Study||30
10622666|NCT01980095|11781133|FG000|NOT COMPLETED|Overall Study||15
10622667|NCT01980095|11781134|FG001|NOT COMPLETED|Overall Study||11
10622668|NCT01980485|11781144|FG000|STARTED|Overall Study||120
10622669|NCT01980485|11781145|FG001|STARTED|Overall Study||105
10622670|NCT01980485|11781144|FG000|COMPLETED|Overall Study||84
10622671|NCT01980485|11781145|FG001|COMPLETED|Overall Study||80
10622672|NCT01980485|11781144|FG000|NOT COMPLETED|Overall Study||36
10622673|NCT01980485|11781145|FG001|NOT COMPLETED|Overall Study||25
10622674|NCT01980524|11781153|FG000|STARTED|Study Day 1||4
10622675|NCT01980524|11781154|FG001|STARTED|Study Day 1||4
10622676|NCT01980524|11781153|FG000|COMPLETED|Study Day 1||4
10622677|NCT01980524|11781154|FG001|COMPLETED|Study Day 1||4
10622678|NCT01980524|11781153|FG000|NOT COMPLETED|Study Day 1||0
10622679|NCT01980524|11781154|FG001|NOT COMPLETED|Study Day 1||0
10622680|NCT01980524|11781153|FG000|STARTED|Washout (at Least 2 Weeks)||4
10622681|NCT01980524|11781154|FG001|STARTED|Washout (at Least 2 Weeks)||4
10622682|NCT01980524|11781153|FG000|COMPLETED|Washout (at Least 2 Weeks)||4
10622683|NCT01980524|11781154|FG001|COMPLETED|Washout (at Least 2 Weeks)||4
10622684|NCT01980524|11781153|FG000|NOT COMPLETED|Washout (at Least 2 Weeks)||0
10622685|NCT01980524|11781154|FG001|NOT COMPLETED|Washout (at Least 2 Weeks)||0
10622686|NCT01980524|11781153|FG000|STARTED|Study Day 2||4
10622687|NCT01980524|11781154|FG001|STARTED|Study Day 2||4
10622688|NCT01980524|11781153|FG000|COMPLETED|Study Day 2||4
10622689|NCT01980524|11781154|FG001|COMPLETED|Study Day 2||4
10622690|NCT01980524|11781153|FG000|NOT COMPLETED|Study Day 2||0
10622691|NCT01980524|11781154|FG001|NOT COMPLETED|Study Day 2||0
10622692|NCT01980589|11781163|FG000|STARTED|Overall Study||3
10622693|NCT01980589|11781164|FG001|STARTED|Overall Study||3
10622694|NCT01980589|11781165|FG002|STARTED|Overall Study||16
10622695|NCT01980589|11781163|FG000|COMPLETED|Overall Study||3
10622696|NCT01980589|11781164|FG001|COMPLETED|Overall Study||3
10622697|NCT01980589|11781165|FG002|COMPLETED|Overall Study||16
10622698|NCT01980589|11781163|FG000|NOT COMPLETED|Overall Study||0
10622699|NCT01980589|11781164|FG001|NOT COMPLETED|Overall Study||0
10622700|NCT01980589|11781165|FG002|NOT COMPLETED|Overall Study||0
10622701|NCT01980628|11781173|FG000|STARTED|Overall Study|Total number of patients enrolled to the study and received study treatment|63
10622702|NCT01980628|11781173|FG000|COMPLETED|Overall Study|Participants who remain on treatment at Final Analysis.|0
10622703|NCT01980628|11781173|FG000|NOT COMPLETED|Overall Study||63
10622704|NCT01980654|11781180|FG000|STARTED|Overall Study||60
10622705|NCT01980654|11781181|FG001|STARTED|Overall Study||20
10622706|NCT01980654|11781180|FG000|COMPLETED|Overall Study||60
10622707|NCT01980654|11781181|FG001|COMPLETED|Overall Study||20
10622708|NCT01980654|11781180|FG000|NOT COMPLETED|Overall Study||0
10622709|NCT01980654|11781181|FG001|NOT COMPLETED|Overall Study||0
10622710|NCT01980706|11781190|FG000|STARTED|Overall Study||40
10622711|NCT01980706|11781191|FG001|STARTED|Overall Study||43
10622712|NCT01980706|11781192|FG002|STARTED|Overall Study||37
10622713|NCT01980706|11781190|FG000|COMPLETED|Overall Study||23
10622714|NCT01980706|11781191|FG001|COMPLETED|Overall Study||26
10622715|NCT01980706|11781192|FG002|COMPLETED|Overall Study||24
10622716|NCT01980706|11781190|FG000|NOT COMPLETED|Overall Study||17
10622717|NCT01980706|11781191|FG001|NOT COMPLETED|Overall Study||17
10622718|NCT01980706|11781192|FG002|NOT COMPLETED|Overall Study||13
10622719|NCT01980771|11781202|FG000|STARTED|Overall Study||436
10622720|NCT01980771|11781203|FG001|STARTED|Overall Study||424
10622721|NCT01980771|11781202|FG000|COMPLETED|Overall Study||352
10622722|NCT01980771|11781203|FG001|COMPLETED|Overall Study||305
10622723|NCT01980771|11781202|FG000|NOT COMPLETED|Overall Study||84
10622724|NCT01980771|11781203|FG001|NOT COMPLETED|Overall Study||119
10622725|NCT01980888|11781211|FG000|STARTED|Overall Study||157
10622726|NCT01980888|11781212|FG001|STARTED|Overall Study||154
10622727|NCT01980888|11781211|FG000|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|13
10622728|NCT01980888|11781212|FG001|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|21
10622729|NCT01980888|11781211|FG000|NOT COMPLETED|Overall Study||144
10622730|NCT01980888|11781212|FG001|NOT COMPLETED|Overall Study||133
10622731|NCT01980914|11781218|FG000|STARTED|Overall Study||11
10622732|NCT01980914|11781218|FG000|COMPLETED|Overall Study||11
10622733|NCT01980914|11781218|FG000|NOT COMPLETED|Overall Study||0
10622734|NCT01980992|11781225|FG000|STARTED|52 Weeks Blinded Study Treatment||23
10622735|NCT01980992|11781226|FG001|STARTED|52 Weeks Blinded Study Treatment||23
10622736|NCT01980992|11781225|FG000|COMPLETED|52 Weeks Blinded Study Treatment||21
10622737|NCT01980992|11781226|FG001|COMPLETED|52 Weeks Blinded Study Treatment||19
10622738|NCT01980992|11781225|FG000|NOT COMPLETED|52 Weeks Blinded Study Treatment||2
10622739|NCT01980992|11781226|FG001|NOT COMPLETED|52 Weeks Blinded Study Treatment||4
10622740|NCT01980992|11781225|FG000|STARTED|52 Weeks Open Label Active Wheat OIT||21
10622741|NCT01980992|11781226|FG001|STARTED|52 Weeks Open Label Active Wheat OIT||19
10622742|NCT01980992|11781225|FG000|COMPLETED|52 Weeks Open Label Active Wheat OIT||18
10622743|NCT01980992|11781226|FG001|COMPLETED|52 Weeks Open Label Active Wheat OIT||18
10622744|NCT01980992|11781225|FG000|NOT COMPLETED|52 Weeks Open Label Active Wheat OIT||3
10622745|NCT01980992|11781226|FG001|NOT COMPLETED|52 Weeks Open Label Active Wheat OIT||1
10622746|NCT01981057|11781241|FG000|STARTED|Overall Study||50
10622747|NCT01981057|11781242|FG001|STARTED|Overall Study||50
10622748|NCT01981057|11781241|FG000|COMPLETED|Overall Study||50
10622749|NCT01981057|11781242|FG001|COMPLETED|Overall Study||50
10622750|NCT01981057|11781241|FG000|NOT COMPLETED|Overall Study||0
10622751|NCT01981057|11781242|FG001|NOT COMPLETED|Overall Study||0
10622752|NCT01981109|11781248|FG000|STARTED|Overall Study||225
10622753|NCT01981109|11781248|FG000|COMPLETED|Overall Study||1
10622754|NCT01981109|11781248|FG000|NOT COMPLETED|Overall Study||224
10622755|NCT01981122|11781255|FG000|STARTED|Overall Study||25
10622756|NCT01981122|11781256|FG001|STARTED|Overall Study||27
10622757|NCT01981122|11781255|FG000|COMPLETED|Overall Study||11
10622758|NCT01981122|11781256|FG001|COMPLETED|Overall Study||7
10622759|NCT01981122|11781255|FG000|NOT COMPLETED|Overall Study||14
10622760|NCT01981122|11781256|FG001|NOT COMPLETED|Overall Study||20
10622761|NCT01981187|11781262|FG000|STARTED|Overall Study||12
10622762|NCT01981187|11781262|FG000|COMPLETED|Overall Study||0
10622763|NCT01981187|11781262|FG000|NOT COMPLETED|Overall Study||12
10622764|NCT01981356|11781268|FG000|STARTED|Overall Study||12
10622765|NCT01981356|11781269|FG001|STARTED|Overall Study||6
10622766|NCT01981356|11781268|FG000|COMPLETED|Overall Study||5
10622767|NCT01981356|11781269|FG001|COMPLETED|Overall Study||4
10622768|NCT01981356|11781268|FG000|NOT COMPLETED|Overall Study||7
10622769|NCT01981356|11781269|FG001|NOT COMPLETED|Overall Study||2
10622770|NCT01981473|11781279|FG000|STARTED|Overall Study||202
10622771|NCT01981473|11781280|FG001|STARTED|Overall Study||199
10622772|NCT01981473|11781281|FG002|STARTED|Overall Study||204
10622773|NCT01981473|11781279|FG000|COMPLETED|Overall Study||200
10622774|NCT01981473|11781280|FG001|COMPLETED|Overall Study||199
10622775|NCT01981473|11781281|FG002|COMPLETED|Overall Study||196
10622776|NCT01981473|11781279|FG000|NOT COMPLETED|Overall Study||2
10622777|NCT01981473|11781280|FG001|NOT COMPLETED|Overall Study||0
10622778|NCT01981473|11781281|FG002|NOT COMPLETED|Overall Study||8
10622779|NCT01981564|11781294|FG000|STARTED|Overall Study||107
10622780|NCT01981564|11781295|FG001|STARTED|Overall Study||115
10622781|NCT01981564|11781294|FG000|COMPLETED|Overall Study||98
10622782|NCT01981564|11781295|FG001|COMPLETED|Overall Study||106
10622783|NCT01981564|11781294|FG000|NOT COMPLETED|Overall Study||9
10622784|NCT01981564|11781295|FG001|NOT COMPLETED|Overall Study||9
10622785|NCT01981590|11781302|FG000|STARTED|Overall Study||15
10622786|NCT01981590|11781302|FG000|COMPLETED|Overall Study||15
10622787|NCT01981590|11781302|FG000|NOT COMPLETED|Overall Study||0
10622788|NCT01981616|11781309|FG000|STARTED|Overall Study||64
10622789|NCT01981616|11781310|FG001|STARTED|Overall Study||63
10622790|NCT01981616|11781309|FG000|COMPLETED|Overall Study||63
10622791|NCT01981616|11781310|FG001|COMPLETED|Overall Study||62
10622792|NCT01981616|11781309|FG000|NOT COMPLETED|Overall Study||1
10622793|NCT01981616|11781310|FG001|NOT COMPLETED|Overall Study||1
10622794|NCT01981759|11781318|FG000|STARTED|Overall Study||28
10622795|NCT01981759|11781319|FG001|STARTED|Overall Study||30
10622796|NCT01981759|11781318|FG000|Baseline (Week 1)|Overall Study||28
10622797|NCT01981759|11781319|FG001|Baseline (Week 1)|Overall Study||30
10622798|NCT01981759|11781318|FG000|Randomization (Week 3)|Overall Study||28
10622799|NCT01981759|11781319|FG001|Randomization (Week 3)|Overall Study||30
10622800|NCT01981759|11781318|FG000|Completed Week 12|Overall Study||22
10622801|NCT01981759|11781319|FG001|Completed Week 12|Overall Study||22
10622802|NCT01981759|11781318|FG000|COMPLETED|Overall Study||21
10622803|NCT01981759|11781319|FG001|COMPLETED|Overall Study||19
10622804|NCT01981759|11781318|FG000|NOT COMPLETED|Overall Study||7
10622805|NCT01981759|11781319|FG001|NOT COMPLETED|Overall Study||11
10622806|NCT01981772|11781327|FG000|STARTED|Overall Study||45
10622807|NCT01981772|11781328|FG001|STARTED|Overall Study||43
10622808|NCT01981772|11781327|FG000|COMPLETED|Overall Study||45
10622809|NCT01981772|11781328|FG001|COMPLETED|Overall Study||43
10705182|NCT02596711|11869538|FG001|6 Month Follow-up|Overall Study||6
10622810|NCT01981772|11781327|FG000|NOT COMPLETED|Overall Study||0
10622811|NCT01981772|11781328|FG001|NOT COMPLETED|Overall Study||0
10622812|NCT01981863|11781336|FG000|STARTED|Overall Study||20
10622813|NCT01981863|11781337|FG001|STARTED|Overall Study||20
10622814|NCT01981863|11781336|FG000|COMPLETED|Overall Study||20
10622815|NCT01981863|11781337|FG001|COMPLETED|Overall Study||20
10622816|NCT01981863|11781336|FG000|NOT COMPLETED|Overall Study||0
10622817|NCT01981863|11781337|FG001|NOT COMPLETED|Overall Study||0
10622818|NCT01981954|11781343|FG000|STARTED|Titration Period||23
10622819|NCT01981954|11781343|FG000|Treated|Titration Period||23
10622820|NCT01981954|11781343|FG000|COMPLETED|Titration Period||22
10622821|NCT01981954|11781343|FG000|NOT COMPLETED|Titration Period||1
10622822|NCT01981954|11781343|FG000|STARTED|Fixed-Dose Assessment Period||22
10622823|NCT01981954|11781343|FG000|Treated|Fixed-Dose Assessment Period||22
10622824|NCT01981954|11781343|FG000|COMPLETED|Fixed-Dose Assessment Period||21
10622825|NCT01981954|11781343|FG000|NOT COMPLETED|Fixed-Dose Assessment Period||1
10622826|NCT01981967|11781349|FG000|STARTED|Overall Study||6851
10622827|NCT01981967|11781350|FG001|STARTED|Overall Study||3149
10622828|NCT01981967|11781349|FG000|COMPLETED|Overall Study||6851
10622829|NCT01981967|11781350|FG001|COMPLETED|Overall Study||3149
10622830|NCT01981967|11781349|FG000|NOT COMPLETED|Overall Study||0
10622831|NCT01981967|11781350|FG001|NOT COMPLETED|Overall Study||0
10622832|NCT01982123|11781356|FG000|STARTED|Overall Study||12
10622833|NCT01982123|11781356|FG000|COMPLETED|Overall Study||12
10622834|NCT01982123|11781356|FG000|NOT COMPLETED|Overall Study||0
10622835|NCT01982240|11781363|FG000|STARTED|Overall Study||452
10622836|NCT01982240|11781364|FG001|STARTED|Overall Study||453
10622837|NCT01982240|11781365|FG002|STARTED|Overall Study||441
10622838|NCT01982240|11781363|FG000|COMPLETED|Overall Study||385
10622839|NCT01982240|11781364|FG001|COMPLETED|Overall Study||384
10622840|NCT01982240|11781365|FG002|COMPLETED|Overall Study||371
10622841|NCT01982240|11781363|FG000|NOT COMPLETED|Overall Study||67
10622842|NCT01982240|11781364|FG001|NOT COMPLETED|Overall Study||69
10622843|NCT01982240|11781365|FG002|NOT COMPLETED|Overall Study||70
10622844|NCT01982292|11781379|FG000|STARTED|Overall Study|"Started indicates Randomized set"|215
10622845|NCT01982292|11781380|FG001|STARTED|Overall Study||108
10622846|NCT01982292|11781379|FG000|Full Analaysis Set (FAS)|Overall Study|FAS excludes mis-randomized patients|213
10622847|NCT01982292|11781380|FG001|Full Analaysis Set (FAS)|Overall Study||108
10622848|NCT01982292|11781379|FG000|Safety Set|Overall Study||212
10622849|NCT01982292|11781380|FG001|Safety Set|Overall Study||108
10622850|NCT01982292|11781379|FG000|COMPLETED|Overall Study||203
10622851|NCT01982292|11781380|FG001|COMPLETED|Overall Study||107
10622852|NCT01982292|11781379|FG000|NOT COMPLETED|Overall Study||12
10622853|NCT01982292|11781380|FG001|NOT COMPLETED|Overall Study||1
10622854|NCT01982331|11781388|FG000|STARTED|Received Vaccination 1||28
10622855|NCT01982331|11781389|FG001|STARTED|Received Vaccination 1||10
10622856|NCT01982331|11781388|FG000|COMPLETED|Received Vaccination 1||28
10622857|NCT01982331|11781389|FG001|COMPLETED|Received Vaccination 1||10
10622858|NCT01982331|11781388|FG000|NOT COMPLETED|Received Vaccination 1||0
10622859|NCT01982331|11781389|FG001|NOT COMPLETED|Received Vaccination 1||0
10622860|NCT01982331|11781388|FG000|STARTED|Received Vaccination 2||28
10622861|NCT01982331|11781389|FG001|STARTED|Received Vaccination 2||10
10622862|NCT01982331|11781388|FG000|COMPLETED|Received Vaccination 2||27
10622863|NCT01982331|11781389|FG001|COMPLETED|Received Vaccination 2||7
10622864|NCT01982331|11781388|FG000|NOT COMPLETED|Received Vaccination 2||1
10622865|NCT01982331|11781389|FG001|NOT COMPLETED|Received Vaccination 2||3
10622866|NCT01982331|11781388|FG000|STARTED|Completed Study (Day 112)||27
10622867|NCT01982331|11781389|FG001|STARTED|Completed Study (Day 112)||7
10622868|NCT01982331|11781388|FG000|COMPLETED|Completed Study (Day 112)||25
10622869|NCT01982331|11781389|FG001|COMPLETED|Completed Study (Day 112)||7
10622870|NCT01982331|11781388|FG000|NOT COMPLETED|Completed Study (Day 112)||2
10622871|NCT01982331|11781389|FG001|NOT COMPLETED|Completed Study (Day 112)||0
10622872|NCT01982435|11781397|FG000|STARTED|Overall Study||15
10622873|NCT01982435|11781398|FG001|STARTED|Overall Study||12
10622874|NCT01982435|11781397|FG000|COMPLETED|Overall Study||14
10622875|NCT01982435|11781398|FG001|COMPLETED|Overall Study||12
10622876|NCT01982435|11781397|FG000|NOT COMPLETED|Overall Study||1
10622877|NCT01982435|11781398|FG001|NOT COMPLETED|Overall Study||0
10622878|NCT01982539|11781404|FG000|STARTED|Overall Study||25
10622879|NCT01982539|11781404|FG000|COMPLETED|Overall Study||25
10622880|NCT01982539|11781404|FG000|NOT COMPLETED|Overall Study||0
10622881|NCT01982643|11781408|FG000|STARTED|Overall Study||49
10622882|NCT01982643|11781408|FG000|COMPLETED|Overall Study||37
10622883|NCT01982643|11781408|FG000|NOT COMPLETED|Overall Study||12
10622884|NCT01982682|11781412|FG000|STARTED|Overall Study||41
10622885|NCT01982682|11781412|FG000|COMPLETED|Overall Study||40
10622886|NCT01982682|11781412|FG000|NOT COMPLETED|Overall Study||1
10622887|NCT01982695|11781419|FG000|STARTED|Overall Study||12
10622888|NCT01982695|11781420|FG001|STARTED|Overall Study||11
10622889|NCT01982695|11781419|FG000|COMPLETED|Overall Study||12
10622890|NCT01982695|11781420|FG001|COMPLETED|Overall Study||10
10622891|NCT01982695|11781419|FG000|NOT COMPLETED|Overall Study||0
10622892|NCT01982695|11781420|FG001|NOT COMPLETED|Overall Study||1
10622893|NCT01982773|11781428|FG000|STARTED|Overall Study||58
10622894|NCT01982773|11781429|FG001|STARTED|Overall Study||60
10622895|NCT01982773|11781428|FG000|COMPLETED|Overall Study||50
10622896|NCT01982773|11781429|FG001|COMPLETED|Overall Study||56
10622897|NCT01982773|11781428|FG000|NOT COMPLETED|Overall Study||8
10622898|NCT01982773|11781429|FG001|NOT COMPLETED|Overall Study||4
10622899|NCT01982786|11781437|FG000|STARTED|Overall Study||29
10622900|NCT01982786|11781438|FG001|STARTED|Overall Study||28
10622901|NCT01982786|11781437|FG000|COMPLETED|Overall Study||29
10622902|NCT01982786|11781438|FG001|COMPLETED|Overall Study||28
10622903|NCT01982786|11781437|FG000|NOT COMPLETED|Overall Study||0
10622904|NCT01982786|11781438|FG001|NOT COMPLETED|Overall Study||0
10622905|NCT01982812|11781446|FG000|STARTED|Overall Study||23
10622906|NCT01982812|11781447|FG001|STARTED|Overall Study||21
10622907|NCT01982812|11781446|FG000|COMPLETED|Overall Study||22
10622908|NCT01982812|11781447|FG001|COMPLETED|Overall Study||11
10622909|NCT01982812|11781446|FG000|NOT COMPLETED|Overall Study||1
10622910|NCT01982812|11781447|FG001|NOT COMPLETED|Overall Study||10
10622911|NCT01982942|11781455|FG000|STARTED|Overall Study||129
10622912|NCT01982942|11781456|FG001|STARTED|Overall Study||126
10622913|NCT01982942|11781455|FG000|COMPLETED|Overall Study||108
10622914|NCT01982942|11781456|FG001|COMPLETED|Overall Study||112
10622915|NCT01982942|11781455|FG000|NOT COMPLETED|Overall Study||21
10622916|NCT01982942|11781456|FG001|NOT COMPLETED|Overall Study||14
10622937|NCT01982968|11781486|FG000|STARTED|Overall Study||29
10622938|NCT01982968|11781487|FG001|STARTED|Overall Study||29
10622939|NCT01982968|11781486|FG000|COMPLETED|Overall Study||21
10622940|NCT01982968|11781487|FG001|COMPLETED|Overall Study||27
10622941|NCT01982968|11781486|FG000|NOT COMPLETED|Overall Study||8
10622942|NCT01982968|11781487|FG001|NOT COMPLETED|Overall Study||2
10622943|NCT01983020|11781497|FG000|STARTED|Overall Study||12
10622944|NCT01983020|11781498|FG001|STARTED|Overall Study||11
10622945|NCT01983020|11781499|FG002|STARTED|Overall Study||12
10622946|NCT01983020|11781500|FG003|STARTED|Overall Study||11
10622947|NCT01983020|11781497|FG000|COMPLETED|Overall Study||12
10622948|NCT01983020|11781498|FG001|COMPLETED|Overall Study||11
10622949|NCT01983020|11781499|FG002|COMPLETED|Overall Study||12
10622950|NCT01983020|11781500|FG003|COMPLETED|Overall Study||11
10622951|NCT01983020|11781497|FG000|NOT COMPLETED|Overall Study||0
10622952|NCT01983020|11781498|FG001|NOT COMPLETED|Overall Study||0
10622953|NCT01983020|11781499|FG002|NOT COMPLETED|Overall Study||0
10622954|NCT01983020|11781500|FG003|NOT COMPLETED|Overall Study||0
10622955|NCT01983111|11781512|FG000|STARTED|Overall Study||70
10622956|NCT01983111|11781513|FG001|STARTED|Overall Study||66
10622957|NCT01983111|11781512|FG000|COMPLETED|Overall Study||58
10622958|NCT01983111|11781513|FG001|COMPLETED|Overall Study||59
10622959|NCT01983111|11781512|FG000|NOT COMPLETED|Overall Study||12
10622960|NCT01983111|11781513|FG001|NOT COMPLETED|Overall Study||7
10622961|NCT01983228|11781521|FG000|STARTED|Overall Study||249
10622962|NCT01983228|11781522|FG001|STARTED|Overall Study||251
10622963|NCT01983228|11781521|FG000|COMPLETED|Overall Study||211
10622964|NCT01983228|11781522|FG001|COMPLETED|Overall Study||189
10622965|NCT01983228|11781521|FG000|NOT COMPLETED|Overall Study||38
10622966|NCT01983228|11781522|FG001|NOT COMPLETED|Overall Study||62
10622967|NCT01983254|11781532|FG000|STARTED|Overall Study|86 patients, 39 caregivers|125
10622968|NCT01983254|11781533|FG001|STARTED|Overall Study|89 patients, 47 caregivers|136
10622969|NCT01983254|11781532|FG000|Interview 1|Overall Study|86 patients, 39 caregivers|125
10622970|NCT01983254|11781533|FG001|Interview 1|Overall Study|89 patients, 47 caregivers|136
10622971|NCT01983254|11781532|FG000|Interview 2|Overall Study|65 patients, 30 caregivers|95
10622972|NCT01983254|11781533|FG001|Interview 2|Overall Study|71 patients, 39 caregivers|110
10622973|NCT01983254|11781532|FG000|Interview 3|Overall Study|62 patients, 29 caregivers|91
10622974|NCT01983254|11781533|FG001|Interview 3|Overall Study|69 patients, 37 caregivers|106
10622975|NCT01983254|11781532|FG000|COMPLETED|Overall Study|62 patients, 29 caregivers|91
10622976|NCT01983254|11781533|FG001|COMPLETED|Overall Study|69 patients, 37 caregivers|106
10622977|NCT01983254|11781532|FG000|NOT COMPLETED|Overall Study||34
10622978|NCT01983254|11781533|FG001|NOT COMPLETED|Overall Study||30
10622979|NCT01983293|11781541|FG000|STARTED|Overall Study||161
10622980|NCT01983293|11781542|FG001|STARTED|Overall Study||81
10622981|NCT01983293|11781541|FG000|COMPLETED|Overall Study||128
10622982|NCT01983293|11781542|FG001|COMPLETED|Overall Study||62
10622983|NCT01983293|11781541|FG000|NOT COMPLETED|Overall Study||33
10622984|NCT01983293|11781542|FG001|NOT COMPLETED|Overall Study||19
10622985|NCT01983566|11781552|FG000|STARTED|Test Period 1||4
10622986|NCT01983566|11781553|FG001|STARTED|Test Period 1||4
10622987|NCT01983566|11781554|FG002|STARTED|Test Period 1||4
10622988|NCT01983566|11781555|FG003|STARTED|Test Period 1||4
10622989|NCT01983566|11781552|FG000|COMPLETED|Test Period 1||4
10622990|NCT01983566|11781553|FG001|COMPLETED|Test Period 1||4
10622991|NCT01983566|11781554|FG002|COMPLETED|Test Period 1||4
10622992|NCT01983566|11781555|FG003|COMPLETED|Test Period 1||4
10622993|NCT01983566|11781552|FG000|NOT COMPLETED|Test Period 1||0
10622994|NCT01983566|11781553|FG001|NOT COMPLETED|Test Period 1||0
10622995|NCT01983566|11781554|FG002|NOT COMPLETED|Test Period 1||0
10622996|NCT01983566|11781555|FG003|NOT COMPLETED|Test Period 1||0
10622997|NCT01983566|11781552|FG000|STARTED|Wash-Out 1||4
10622998|NCT01983566|11781553|FG001|STARTED|Wash-Out 1||4
10622999|NCT01983566|11781554|FG002|STARTED|Wash-Out 1||4
10623000|NCT01983566|11781555|FG003|STARTED|Wash-Out 1||4
10623001|NCT01983566|11781552|FG000|COMPLETED|Wash-Out 1||4
10623002|NCT01983566|11781553|FG001|COMPLETED|Wash-Out 1||4
10623003|NCT01983566|11781554|FG002|COMPLETED|Wash-Out 1||4
10623004|NCT01983566|11781555|FG003|COMPLETED|Wash-Out 1||4
10623005|NCT01983566|11781552|FG000|NOT COMPLETED|Wash-Out 1||0
10623006|NCT01983566|11781553|FG001|NOT COMPLETED|Wash-Out 1||0
10623007|NCT01983566|11781554|FG002|NOT COMPLETED|Wash-Out 1||0
10623008|NCT01983566|11781555|FG003|NOT COMPLETED|Wash-Out 1||0
10623009|NCT01983566|11781552|FG000|STARTED|Test Period 2||4
10623010|NCT01983566|11781553|FG001|STARTED|Test Period 2||4
10623011|NCT01983566|11781554|FG002|STARTED|Test Period 2||4
10623012|NCT01983566|11781555|FG003|STARTED|Test Period 2||4
10623013|NCT01983566|11781552|FG000|COMPLETED|Test Period 2||4
10623014|NCT01983566|11781553|FG001|COMPLETED|Test Period 2||4
10623015|NCT01983566|11781554|FG002|COMPLETED|Test Period 2||4
10623016|NCT01983566|11781555|FG003|COMPLETED|Test Period 2||4
10623017|NCT01983566|11781552|FG000|NOT COMPLETED|Test Period 2||0
10623018|NCT01983566|11781553|FG001|NOT COMPLETED|Test Period 2||0
10623019|NCT01983566|11781554|FG002|NOT COMPLETED|Test Period 2||0
10623020|NCT01983566|11781555|FG003|NOT COMPLETED|Test Period 2||0
10623021|NCT01983566|11781552|FG000|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|2
10623022|NCT01983566|11781553|FG001|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|3
10623023|NCT01983566|11781554|FG002|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|2
10623024|NCT01983566|11781555|FG003|STARTED|Wash-Out 2||4
10623025|NCT01983566|11781552|FG000|COMPLETED|Wash-Out 2||2
10623026|NCT01983566|11781553|FG001|COMPLETED|Wash-Out 2||3
10623027|NCT01983566|11781554|FG002|COMPLETED|Wash-Out 2||2
10623028|NCT01983566|11781555|FG003|COMPLETED|Wash-Out 2||4
10623029|NCT01983566|11781552|FG000|NOT COMPLETED|Wash-Out 2||0
10623030|NCT01983566|11781553|FG001|NOT COMPLETED|Wash-Out 2||0
10623031|NCT01983566|11781554|FG002|NOT COMPLETED|Wash-Out 2||0
10623032|NCT01983566|11781555|FG003|NOT COMPLETED|Wash-Out 2||0
10623033|NCT01983566|11781552|FG000|STARTED|Test Period 3||2
10623034|NCT01983566|11781553|FG001|STARTED|Test Period 3||3
10623035|NCT01983566|11781554|FG002|STARTED|Test Period 3||2
10623036|NCT01983566|11781555|FG003|STARTED|Test Period 3||4
10623037|NCT01983566|11781552|FG000|COMPLETED|Test Period 3||2
10623038|NCT01983566|11781553|FG001|COMPLETED|Test Period 3||3
10623039|NCT01983566|11781554|FG002|COMPLETED|Test Period 3||2
10623040|NCT01983566|11781555|FG003|COMPLETED|Test Period 3||4
10623041|NCT01983566|11781552|FG000|NOT COMPLETED|Test Period 3||0
10623042|NCT01983566|11781553|FG001|NOT COMPLETED|Test Period 3||0
10623043|NCT01983566|11781554|FG002|NOT COMPLETED|Test Period 3||0
10623044|NCT01983566|11781555|FG003|NOT COMPLETED|Test Period 3||0
10623045|NCT01983566|11781552|FG000|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
10623046|NCT01983566|11781553|FG001|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
10623047|NCT01983566|11781554|FG002|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
10623048|NCT01983566|11781555|FG003|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
10623049|NCT01983566|11781552|FG000|COMPLETED|Wash-Out 3||0
10623050|NCT01983566|11781553|FG001|COMPLETED|Wash-Out 3||0
10623051|NCT01983566|11781554|FG002|COMPLETED|Wash-Out 3||0
10623052|NCT01983566|11781555|FG003|COMPLETED|Wash-Out 3||0
10623053|NCT01983566|11781552|FG000|NOT COMPLETED|Wash-Out 3||0
10623054|NCT01983566|11781553|FG001|NOT COMPLETED|Wash-Out 3||0
10623055|NCT01983566|11781554|FG002|NOT COMPLETED|Wash-Out 3||0
10623056|NCT01983566|11781555|FG003|NOT COMPLETED|Wash-Out 3||0
10623057|NCT01983566|11781552|FG000|STARTED|Test Period 4||0
10623058|NCT01983566|11781553|FG001|STARTED|Test Period 4||0
10623059|NCT01983566|11781554|FG002|STARTED|Test Period 4||0
10623060|NCT01983566|11781555|FG003|STARTED|Test Period 4||0
10623061|NCT01983566|11781552|FG000|COMPLETED|Test Period 4||0
10623062|NCT01983566|11781553|FG001|COMPLETED|Test Period 4||0
10623063|NCT01983566|11781554|FG002|COMPLETED|Test Period 4||0
10623064|NCT01983566|11781555|FG003|COMPLETED|Test Period 4||0
10623065|NCT01983566|11781552|FG000|NOT COMPLETED|Test Period 4||0
10623066|NCT01983566|11781553|FG001|NOT COMPLETED|Test Period 4||0
10623067|NCT01983566|11781554|FG002|NOT COMPLETED|Test Period 4||0
10623068|NCT01983566|11781555|FG003|NOT COMPLETED|Test Period 4||0
10623069|NCT01983683|11781568|FG000|STARTED|Overall Study||298
10623070|NCT01983683|11781569|FG001|STARTED|Overall Study||311
10623071|NCT01983683|11781568|FG000|COMPLETED|Overall Study||260
10623072|NCT01983683|11781569|FG001|COMPLETED|Overall Study||260
10623073|NCT01983683|11781568|FG000|NOT COMPLETED|Overall Study||38
10623074|NCT01983683|11781569|FG001|NOT COMPLETED|Overall Study||51
10623075|NCT01983787|11781575|FG000|STARTED|Overall Study||10
10623076|NCT01983787|11781575|FG000|COMPLETED|Overall Study||10
10623077|NCT01983787|11781575|FG000|NOT COMPLETED|Overall Study||0
10623078|NCT01983826|11781600|FG000|STARTED|Overall Study||13
10623079|NCT01983826|11781601|FG001|STARTED|Overall Study||8
10623080|NCT01983826|11781600|FG000|COMPLETED|Overall Study||13
10623081|NCT01983826|11781601|FG001|COMPLETED|Overall Study||8
10623082|NCT01983826|11781600|FG000|NOT COMPLETED|Overall Study||0
10623083|NCT01983826|11781601|FG001|NOT COMPLETED|Overall Study||0
10623084|NCT01983839|11781611|FG000|STARTED|Overall Study||18
10623085|NCT01983839|11781611|FG000|COMPLETED|Overall Study||18
10623086|NCT01983839|11781611|FG000|NOT COMPLETED|Overall Study||0
10623087|NCT01983878|11781615|FG000|STARTED|Overall Study||36
10623088|NCT01983878|11781615|FG000|Received At Least One Dose of Study Drug|Overall Study||36
10623089|NCT01983878|11781615|FG000|COMPLETED|Overall Study||36
10623090|NCT01983878|11781615|FG000|NOT COMPLETED|Overall Study||0
10623091|NCT01983930|11781622|FG000|STARTED|Overall Study||41
10623092|NCT01983930|11781623|FG001|STARTED|Overall Study||38
10623093|NCT01983930|11781622|FG000|COMPLETED|Overall Study||32
10623094|NCT01983930|11781623|FG001|COMPLETED|Overall Study||29
10623095|NCT01983930|11781622|FG000|NOT COMPLETED|Overall Study||9
10623096|NCT01983930|11781623|FG001|NOT COMPLETED|Overall Study||9
10623097|NCT01983969|11781633|FG000|STARTED|Overall Study||37
10623098|NCT01983969|11781634|FG001|STARTED|Overall Study||19
10623099|NCT01983969|11781635|FG002|STARTED|Overall Study||5
10623100|NCT01983969|11781633|FG000|COMPLETED|Overall Study||37
10623101|NCT01983969|11781634|FG001|COMPLETED|Overall Study||18
10623102|NCT01983969|11781635|FG002|COMPLETED|Overall Study||5
10623103|NCT01983969|11781633|FG000|NOT COMPLETED|Overall Study||0
10623104|NCT01983969|11781634|FG001|NOT COMPLETED|Overall Study||1
10623105|NCT01983969|11781635|FG002|NOT COMPLETED|Overall Study||0
10623106|NCT01984164|11781649|FG000|STARTED|Overall Study||87
10623107|NCT01984164|11781650|FG001|STARTED|Overall Study||89
10623108|NCT01984164|11781649|FG000|COMPLETED|Overall Study||77
10623109|NCT01984164|11781650|FG001|COMPLETED|Overall Study||64
10623110|NCT01984164|11781649|FG000|NOT COMPLETED|Overall Study||10
10623111|NCT01984164|11781650|FG001|NOT COMPLETED|Overall Study||25
10623112|NCT01984229|11781658|FG000|STARTED|Period 1||6
10705183|NCT02596711|11869539|FG002|6 Month Follow-up|Overall Study||5
10623113|NCT01984229|11781659|FG001|STARTED|Period 1||17
10623114|NCT01984229|11781658|FG000|COMPLETED|Period 1||6
10623115|NCT01984229|11781659|FG001|COMPLETED|Period 1||17
10623116|NCT01984229|11781658|FG000|NOT COMPLETED|Period 1||0
10623117|NCT01984229|11781659|FG001|NOT COMPLETED|Period 1||0
10623118|NCT01984229|11781658|FG000|STARTED|Period 2||6
10623119|NCT01984229|11781659|FG001|STARTED|Period 2||17
10623120|NCT01984229|11781658|FG000|COMPLETED|Period 2||6
10623121|NCT01984229|11781659|FG001|COMPLETED|Period 2||17
10623122|NCT01984229|11781658|FG000|NOT COMPLETED|Period 2||0
10623123|NCT01984229|11781659|FG001|NOT COMPLETED|Period 2||0
10623124|NCT01984229|11781658|FG000|STARTED|Period 3||6
10623125|NCT01984229|11781659|FG001|STARTED|Period 3||17
10623126|NCT01984229|11781658|FG000|COMPLETED|Period 3||6
10623127|NCT01984229|11781659|FG001|COMPLETED|Period 3||17
10623128|NCT01984229|11781658|FG000|NOT COMPLETED|Period 3||0
10623129|NCT01984229|11781659|FG001|NOT COMPLETED|Period 3||0
10623130|NCT01984229|11781658|FG000|STARTED|Safety Follow-up Period||6
10623131|NCT01984229|11781659|FG001|STARTED|Safety Follow-up Period||17
10623132|NCT01984229|11781658|FG000|COMPLETED|Safety Follow-up Period||4
10623133|NCT01984229|11781659|FG001|COMPLETED|Safety Follow-up Period||16
10623134|NCT01984229|11781658|FG000|NOT COMPLETED|Safety Follow-up Period||2
10623135|NCT01984229|11781659|FG001|NOT COMPLETED|Safety Follow-up Period||1
10623136|NCT01984242|11781674|FG000|STARTED|Overall Study||101
10623137|NCT01984242|11781675|FG001|STARTED|Overall Study||103
10623138|NCT01984242|11781676|FG002|STARTED|Overall Study||101
10623139|NCT01984242|11781674|FG000|Treated|Overall Study||101
10623140|NCT01984242|11781675|FG001|Treated|Overall Study||103
10623141|NCT01984242|11781676|FG002|Treated|Overall Study||100
10623142|NCT01984242|11781674|FG000|COMPLETED|Overall Study||0
10623143|NCT01984242|11781675|FG001|COMPLETED|Overall Study||0
10623144|NCT01984242|11781676|FG002|COMPLETED|Overall Study||0
10623145|NCT01984242|11781674|FG000|NOT COMPLETED|Overall Study||101
10623146|NCT01984242|11781675|FG001|NOT COMPLETED|Overall Study||103
10623147|NCT01984242|11781676|FG002|NOT COMPLETED|Overall Study||101
10623148|NCT01984294|11781695|FG000|STARTED|Overall Study||35
10623149|NCT01984294|11781696|FG001|STARTED|Overall Study||32
10623150|NCT01984294|11781697|FG002|STARTED|Overall Study||34
10623151|NCT01984294|11781695|FG000|COMPLETED|Overall Study||31
10623152|NCT01984294|11781696|FG001|COMPLETED|Overall Study||29
10623153|NCT01984294|11781697|FG002|COMPLETED|Overall Study||27
10623154|NCT01984294|11781695|FG000|NOT COMPLETED|Overall Study||4
10623155|NCT01984294|11781696|FG001|NOT COMPLETED|Overall Study||3
10623156|NCT01984294|11781697|FG002|NOT COMPLETED|Overall Study||7
10623157|NCT01984398|11781707|FG000|STARTED|Treatment Period 1||4
10623158|NCT01984398|11781708|FG001|STARTED|Treatment Period 1||4
10623159|NCT01984398|11781709|FG002|STARTED|Treatment Period 1||4
10623160|NCT01984398|11781710|FG003|STARTED|Treatment Period 1||4
10623161|NCT01984398|11781707|FG000|COMPLETED|Treatment Period 1||4
10623162|NCT01984398|11781708|FG001|COMPLETED|Treatment Period 1||4
10623163|NCT01984398|11781709|FG002|COMPLETED|Treatment Period 1||4
10623164|NCT01984398|11781710|FG003|COMPLETED|Treatment Period 1||4
10623165|NCT01984398|11781707|FG000|NOT COMPLETED|Treatment Period 1||0
10623166|NCT01984398|11781708|FG001|NOT COMPLETED|Treatment Period 1||0
10623167|NCT01984398|11781709|FG002|NOT COMPLETED|Treatment Period 1||0
10623168|NCT01984398|11781710|FG003|NOT COMPLETED|Treatment Period 1||0
10623169|NCT01984398|11781707|FG000|STARTED|Washout Period of 5 to 7 Days||4
10623170|NCT01984398|11781708|FG001|STARTED|Washout Period of 5 to 7 Days||4
10623171|NCT01984398|11781709|FG002|STARTED|Washout Period of 5 to 7 Days||4
10623172|NCT01984398|11781710|FG003|STARTED|Washout Period of 5 to 7 Days||4
10623173|NCT01984398|11781707|FG000|COMPLETED|Washout Period of 5 to 7 Days||4
10623174|NCT01984398|11781708|FG001|COMPLETED|Washout Period of 5 to 7 Days||4
10623175|NCT01984398|11781709|FG002|COMPLETED|Washout Period of 5 to 7 Days||4
10705184|NCT02596711|11869537|FG000|COMPLETED|Overall Study||8
10623176|NCT01984398|11781710|FG003|COMPLETED|Washout Period of 5 to 7 Days||4
10623177|NCT01984398|11781707|FG000|NOT COMPLETED|Washout Period of 5 to 7 Days||0
10623178|NCT01984398|11781708|FG001|NOT COMPLETED|Washout Period of 5 to 7 Days||0
10623179|NCT01984398|11781709|FG002|NOT COMPLETED|Washout Period of 5 to 7 Days||0
10623180|NCT01984398|11781710|FG003|NOT COMPLETED|Washout Period of 5 to 7 Days||0
10705185|NCT02596711|11869538|FG001|COMPLETED|Overall Study||6
10705186|NCT02596711|11869539|FG002|COMPLETED|Overall Study||5
10705187|NCT02596711|11869537|FG000|NOT COMPLETED|Overall Study||1
10623181|NCT01984398|11781707|FG000|STARTED|Treatment Period 2||4
10623182|NCT01984398|11781708|FG001|STARTED|Treatment Period 2||4
10623183|NCT01984398|11781709|FG002|STARTED|Treatment Period 2||4
10623184|NCT01984398|11781710|FG003|STARTED|Treatment Period 2||4
10623185|NCT01984398|11781707|FG000|COMPLETED|Treatment Period 2||4
10623186|NCT01984398|11781708|FG001|COMPLETED|Treatment Period 2||4
10623187|NCT01984398|11781709|FG002|COMPLETED|Treatment Period 2||4
10623188|NCT01984398|11781710|FG003|COMPLETED|Treatment Period 2||4
10623189|NCT01984398|11781707|FG000|NOT COMPLETED|Treatment Period 2||0
10623190|NCT01984398|11781708|FG001|NOT COMPLETED|Treatment Period 2||0
10623191|NCT01984398|11781709|FG002|NOT COMPLETED|Treatment Period 2||0
10623192|NCT01984398|11781710|FG003|NOT COMPLETED|Treatment Period 2||0
10623193|NCT01984424|11781722|FG000|STARTED|Overall Study||73
10623194|NCT01984424|11781723|FG001|STARTED|Overall Study||145
10623195|NCT01984424|11781722|FG000|COMPLETED|Overall Study||70
10623196|NCT01984424|11781723|FG001|COMPLETED|Overall Study||138
10623197|NCT01984424|11781722|FG000|NOT COMPLETED|Overall Study||3
10705188|NCT02596711|11869538|FG001|NOT COMPLETED|Overall Study||2
10705189|NCT02596711|11869539|FG002|NOT COMPLETED|Overall Study||3
10705190|NCT02596750|11869549|FG000|STARTED|Baseline||21
10705191|NCT02596750|11869550|FG001|STARTED|Baseline||21
10705192|NCT02596750|11869549|FG000|COMPLETED|Baseline||21
10705193|NCT02596750|11869550|FG001|COMPLETED|Baseline||21
10705194|NCT02596750|11869549|FG000|NOT COMPLETED|Baseline||0
10623198|NCT01984424|11781723|FG001|NOT COMPLETED|Overall Study||7
10623199|NCT01984515|11781729|FG000|STARTED|Overall Study||59
10623200|NCT01984515|11781729|FG000|Received CBT Session|Overall Study||40
10623201|NCT01984515|11781729|FG000|COMPLETED|Overall Study||40
10623202|NCT01984515|11781729|FG000|NOT COMPLETED|Overall Study||19
10623203|NCT01984684|11781735|FG000|STARTED|Overall Study||423
10623204|NCT01984684|11781736|FG001|STARTED|Overall Study||427
10623205|NCT01984684|11781735|FG000|COMPLETED|Overall Study||366
10623206|NCT01984684|11781736|FG001|COMPLETED|Overall Study||368
10623207|NCT01984684|11781735|FG000|NOT COMPLETED|Overall Study||57
10623208|NCT01984684|11781736|FG001|NOT COMPLETED|Overall Study||59
10623209|NCT01984697|11781747|FG000|STARTED|Overall Study||301
10623210|NCT01984697|11781748|FG001|STARTED|Overall Study||301
10623211|NCT01984697|11781749|FG002|STARTED|Overall Study||301
10623212|NCT01984697|11781750|FG003|STARTED|Overall Study||301
10623213|NCT01984697|11781751|FG004|STARTED|Overall Study||314
10623214|NCT01984697|11781747|FG000|Vaccination 1|Overall Study||301
10623215|NCT01984697|11781748|FG001|Vaccination 1|Overall Study||301
10623216|NCT01984697|11781749|FG002|Vaccination 1|Overall Study||300
10623217|NCT01984697|11781750|FG003|Vaccination 1|Overall Study||300
10623218|NCT01984697|11781751|FG004|Vaccination 1|Overall Study||314
10623219|NCT01984697|11781747|FG000|Vaccination 2|Overall Study||293
10623220|NCT01984697|11781748|FG001|Vaccination 2|Overall Study||296
10623221|NCT01984697|11781749|FG002|Vaccination 2|Overall Study||291
10623222|NCT01984697|11781750|FG003|Vaccination 2|Overall Study||298
10623223|NCT01984697|11781751|FG004|Vaccination 2|Overall Study||313
10623224|NCT01984697|11781747|FG000|Vaccination 3|Overall Study||0
10623225|NCT01984697|11781748|FG001|Vaccination 3|Overall Study||0
10623226|NCT01984697|11781749|FG002|Vaccination 3|Overall Study||0
10623227|NCT01984697|11781750|FG003|Vaccination 3|Overall Study||293
10623228|NCT01984697|11781751|FG004|Vaccination 3|Overall Study||311
10623229|NCT01984697|11781747|FG000|Month 36 Vaccination|Overall Study||270
10623230|NCT01984697|11781748|FG001|Month 36 Vaccination|Overall Study||281
10623231|NCT01984697|11781749|FG002|Month 36 Vaccination|Overall Study||280
10623232|NCT01984697|11781750|FG003|Month 36 Vaccination|Overall Study||9
10623233|NCT01984697|11781751|FG004|Month 36 Vaccination|Overall Study||31
10623234|NCT01984697|11781747|FG000|COMPLETED|Overall Study||258
10623235|NCT01984697|11781748|FG001|COMPLETED|Overall Study||270
10623236|NCT01984697|11781749|FG002|COMPLETED|Overall Study||272
10623237|NCT01984697|11781750|FG003|COMPLETED|Overall Study||280
10623238|NCT01984697|11781751|FG004|COMPLETED|Overall Study||279
10623239|NCT01984697|11781747|FG000|NOT COMPLETED|Overall Study||43
10623240|NCT01984697|11781748|FG001|NOT COMPLETED|Overall Study||31
10623241|NCT01984697|11781749|FG002|NOT COMPLETED|Overall Study||29
10623242|NCT01984697|11781750|FG003|NOT COMPLETED|Overall Study||21
10623243|NCT01984697|11781751|FG004|NOT COMPLETED|Overall Study||35
10623244|NCT01984892|11781763|FG000|STARTED|Overall Study||8
10623245|NCT01984892|11781763|FG000|COMPLETED|Overall Study|1 completed all study visits up until the termination of the study, last study visit not done.|1
10623246|NCT01984892|11781763|FG000|NOT COMPLETED|Overall Study||7
10623247|NCT01985126|11781769|FG000|STARTED|Overall Study||18
10623248|NCT01985126|11781770|FG001|STARTED|Overall Study||106
10705195|NCT02596750|11869550|FG001|NOT COMPLETED|Baseline||0
10705196|NCT02596750|11869549|FG000|STARTED|2 Minutes||21
10705197|NCT02596750|11869550|FG001|STARTED|2 Minutes||21
10705198|NCT02596750|11869549|FG000|COMPLETED|2 Minutes||21
10623249|NCT01985126|11781769|FG000|COMPLETED|Overall Study||0
10623250|NCT01985126|11781770|FG001|COMPLETED|Overall Study||0
10623251|NCT01985126|11781769|FG000|NOT COMPLETED|Overall Study||18
10623252|NCT01985126|11781770|FG001|NOT COMPLETED|Overall Study||106
10623253|NCT01985321|11781778|FG000|STARTED|Overall Study|This is Treatment Eligible Subjects only|90
10623254|NCT01985321|11781779|FG001|STARTED|Overall Study|This is treatment eligible subjects only|83
10623255|NCT01985321|11781778|FG000|COMPLETED|Overall Study||79
10623256|NCT01985321|11781779|FG001|COMPLETED|Overall Study||78
10623257|NCT01985321|11781778|FG000|NOT COMPLETED|Overall Study||11
10623258|NCT01985321|11781779|FG001|NOT COMPLETED|Overall Study||5
10623259|NCT01985334|11781793|FG000|STARTED|Overall Study||130
10623260|NCT01985334|11781794|FG001|STARTED|Overall Study||387
10623261|NCT01985334|11781795|FG002|STARTED|Overall Study||420
10623262|NCT01985334|11781796|FG003|STARTED|Overall Study||1262
10623263|NCT01985334|11781797|FG004|STARTED|Overall Study||274
10623264|NCT01985334|11781798|FG005|STARTED|Overall Study||822
10623265|NCT01985334|11781799|FG006|STARTED|Overall Study||274
10623266|NCT01985334|11781800|FG007|STARTED|Overall Study||820
10623267|NCT01985334|11781793|FG000|The Intention-to-treat (ITT) Population|Overall Study||122
10623268|NCT01985334|11781794|FG001|The Intention-to-treat (ITT) Population|Overall Study||369
10623269|NCT01985334|11781795|FG002|The Intention-to-treat (ITT) Population|Overall Study||420
10623270|NCT01985334|11781796|FG003|The Intention-to-treat (ITT) Population|Overall Study||1254
10623271|NCT01985334|11781797|FG004|The Intention-to-treat (ITT) Population|Overall Study||269
10623272|NCT01985334|11781798|FG005|The Intention-to-treat (ITT) Population|Overall Study||811
10623273|NCT01985334|11781799|FG006|The Intention-to-treat (ITT) Population|Overall Study||268
10623274|NCT01985334|11781800|FG007|The Intention-to-treat (ITT) Population|Overall Study||811
10623275|NCT01985334|11781793|FG000|COMPLETED|Overall Study||107
10623276|NCT01985334|11781794|FG001|COMPLETED|Overall Study||303
10623277|NCT01985334|11781795|FG002|COMPLETED|Overall Study||367
10623278|NCT01985334|11781796|FG003|COMPLETED|Overall Study||1033
10623279|NCT01985334|11781797|FG004|COMPLETED|Overall Study||234
10623280|NCT01985334|11781798|FG005|COMPLETED|Overall Study||666
10623281|NCT01985334|11781799|FG006|COMPLETED|Overall Study||237
10623282|NCT01985334|11781800|FG007|COMPLETED|Overall Study||699
10623283|NCT01985334|11781793|FG000|NOT COMPLETED|Overall Study||23
10623284|NCT01985334|11781794|FG001|NOT COMPLETED|Overall Study||84
10623285|NCT01985334|11781795|FG002|NOT COMPLETED|Overall Study||53
10623286|NCT01985334|11781796|FG003|NOT COMPLETED|Overall Study||229
10623287|NCT01985334|11781797|FG004|NOT COMPLETED|Overall Study||40
10623288|NCT01985334|11781798|FG005|NOT COMPLETED|Overall Study||156
10623289|NCT01985334|11781799|FG006|NOT COMPLETED|Overall Study||37
10623290|NCT01985334|11781800|FG007|NOT COMPLETED|Overall Study||121
10623291|NCT01985360|11781834|FG000|STARTED|Overall Study||388
10623292|NCT01985360|11781835|FG001|STARTED|Overall Study||389
10623293|NCT01985360|11781834|FG000|COMPLETED|Overall Study||379
10623294|NCT01985360|11781835|FG001|COMPLETED|Overall Study||386
10623295|NCT01985360|11781834|FG000|NOT COMPLETED|Overall Study||9
10623296|NCT01985360|11781835|FG001|NOT COMPLETED|Overall Study||3
10623297|NCT01985425|11781843|FG000|STARTED|Overall Study||49
10623298|NCT01985425|11781844|FG001|STARTED|Overall Study||51
10623299|NCT01985425|11781843|FG000|COMPLETED|Overall Study||49
10623300|NCT01985425|11781844|FG001|COMPLETED|Overall Study||51
10623301|NCT01985425|11781843|FG000|NOT COMPLETED|Overall Study||0
10623302|NCT01985425|11781844|FG001|NOT COMPLETED|Overall Study||0
10623303|NCT01985542|11781852|FG000|STARTED|Overall Study||7
10623304|NCT01985542|11781853|FG001|STARTED|Overall Study||9
10623305|NCT01985542|11781852|FG000|COMPLETED|Overall Study||3
10623306|NCT01985542|11781853|FG001|COMPLETED|Overall Study||3
10623307|NCT01985542|11781852|FG000|NOT COMPLETED|Overall Study||4
10623308|NCT01985542|11781853|FG001|NOT COMPLETED|Overall Study||6
10623309|NCT01985581|11781862|FG000|STARTED|First Intervention||25
10623310|NCT01985581|11781863|FG001|STARTED|First Intervention||25
10623311|NCT01985581|11781862|FG000|COMPLETED|First Intervention||22
10623312|NCT01985581|11781863|FG001|COMPLETED|First Intervention||23
10623313|NCT01985581|11781862|FG000|NOT COMPLETED|First Intervention||3
10623314|NCT01985581|11781863|FG001|NOT COMPLETED|First Intervention||2
10623315|NCT01985581|11781862|FG000|STARTED|Second Intervention||22
10623316|NCT01985581|11781863|FG001|STARTED|Second Intervention||23
10623317|NCT01985581|11781862|FG000|COMPLETED|Second Intervention||20
10623318|NCT01985581|11781863|FG001|COMPLETED|Second Intervention||19
10623319|NCT01985581|11781862|FG000|NOT COMPLETED|Second Intervention||2
10623320|NCT01985581|11781863|FG001|NOT COMPLETED|Second Intervention||4
10623321|NCT01985685|11781882|FG000|STARTED|Overall Study||27
10623322|NCT01985685|11781883|FG001|STARTED|Overall Study||29
10623323|NCT01985685|11781882|FG000|COMPLETED|Overall Study||27
10623324|NCT01985685|11781883|FG001|COMPLETED|Overall Study||29
10623325|NCT01985685|11781882|FG000|NOT COMPLETED|Overall Study||0
10623326|NCT01985685|11781883|FG001|NOT COMPLETED|Overall Study||0
10623327|NCT01985763|11781889|FG000|STARTED|Overall Study||13
10623328|NCT01985763|11781889|FG000|COMPLETED|Overall Study||13
10623329|NCT01985763|11781889|FG000|NOT COMPLETED|Overall Study||0
10623330|NCT01985932|11781894|FG000|STARTED|Overall Study||15
10623331|NCT01985932|11781894|FG000|COMPLETED|Overall Study||15
10623332|NCT01985932|11781894|FG000|NOT COMPLETED|Overall Study||0
10623333|NCT01985958|11781898|FG000|STARTED|Overall Study||4
10623334|NCT01985958|11781898|FG000|COMPLETED|Overall Study||3
10623335|NCT01985958|11781898|FG000|NOT COMPLETED|Overall Study||1
10623336|NCT01985971|11781902|FG000|STARTED|Overall Study||2
10623337|NCT01985971|11781902|FG000|COMPLETED|Overall Study||1
10623338|NCT01985971|11781902|FG000|NOT COMPLETED|Overall Study||1
10623339|NCT01986010|11781923|FG000|STARTED|Overall Study||13
10623340|NCT01986010|11781924|FG001|STARTED|Overall Study||14
10623341|NCT01986010|11781925|FG002|STARTED|Overall Study||14
10623342|NCT01986010|11781926|FG003|STARTED|Overall Study||10
10623343|NCT01986010|11781927|FG004|STARTED|Overall Study||11
10623344|NCT01986010|11781928|FG005|STARTED|Overall Study||19
10623345|NCT01986010|11781929|FG006|STARTED|Overall Study||10
10623346|NCT01986010|11781930|FG007|STARTED|Overall Study||4
10623347|NCT01986010|11781931|FG008|STARTED|Overall Study||12
10623348|NCT01986010|11781932|FG009|STARTED|Overall Study||10
10623349|NCT01986010|11781933|FG010|STARTED|Overall Study||10
10623350|NCT01986010|11781934|FG011|STARTED|Overall Study||11
10623351|NCT01986010|11781935|FG012|STARTED|Overall Study||10
10623352|NCT01986010|11781936|FG013|STARTED|Overall Study||11
10623353|NCT01986010|11781937|FG014|STARTED|Overall Study||16
10623354|NCT01986010|11781938|FG015|STARTED|Overall Study||11
10623355|NCT01986010|11781939|FG016|STARTED|Overall Study||4
10623356|NCT01986010|11781923|FG000|Vaccination 1|Overall Study||13
10623357|NCT01986010|11781924|FG001|Vaccination 1|Overall Study||14
10623358|NCT01986010|11781925|FG002|Vaccination 1|Overall Study||14
10623359|NCT01986010|11781926|FG003|Vaccination 1|Overall Study||10
10623360|NCT01986010|11781927|FG004|Vaccination 1|Overall Study||11
10623361|NCT01986010|11781928|FG005|Vaccination 1|Overall Study||19
10623362|NCT01986010|11781929|FG006|Vaccination 1|Overall Study||10
10623363|NCT01986010|11781930|FG007|Vaccination 1|Overall Study||4
10623364|NCT01986010|11781931|FG008|Vaccination 1|Overall Study||12
10623365|NCT01986010|11781932|FG009|Vaccination 1|Overall Study||10
10623366|NCT01986010|11781933|FG010|Vaccination 1|Overall Study||10
10623367|NCT01986010|11781934|FG011|Vaccination 1|Overall Study||11
10623368|NCT01986010|11781935|FG012|Vaccination 1|Overall Study||10
10623369|NCT01986010|11781936|FG013|Vaccination 1|Overall Study||11
10623370|NCT01986010|11781937|FG014|Vaccination 1|Overall Study||16
10623371|NCT01986010|11781938|FG015|Vaccination 1|Overall Study||11
10623372|NCT01986010|11781939|FG016|Vaccination 1|Overall Study||4
10623373|NCT01986010|11781923|FG000|Vaccination 2|Overall Study||12
10623374|NCT01986010|11781924|FG001|Vaccination 2|Overall Study||13
10623375|NCT01986010|11781925|FG002|Vaccination 2|Overall Study||12
10623376|NCT01986010|11781926|FG003|Vaccination 2|Overall Study||10
10623377|NCT01986010|11781927|FG004|Vaccination 2|Overall Study||9
10623378|NCT01986010|11781928|FG005|Vaccination 2|Overall Study||19
10623379|NCT01986010|11781929|FG006|Vaccination 2|Overall Study||10
10623380|NCT01986010|11781930|FG007|Vaccination 2|Overall Study||4
10623381|NCT01986010|11781931|FG008|Vaccination 2|Overall Study||11
10623382|NCT01986010|11781932|FG009|Vaccination 2|Overall Study||10
10623383|NCT01986010|11781933|FG010|Vaccination 2|Overall Study||10
10623384|NCT01986010|11781934|FG011|Vaccination 2|Overall Study||10
10623385|NCT01986010|11781935|FG012|Vaccination 2|Overall Study||10
10623386|NCT01986010|11781936|FG013|Vaccination 2|Overall Study||9
10623387|NCT01986010|11781937|FG014|Vaccination 2|Overall Study||16
10623388|NCT01986010|11781938|FG015|Vaccination 2|Overall Study||10
10623389|NCT01986010|11781939|FG016|Vaccination 2|Overall Study||4
10623390|NCT01986010|11781923|FG000|Vaccination 3|Overall Study||10
10623391|NCT01986010|11781924|FG001|Vaccination 3|Overall Study||10
10623392|NCT01986010|11781925|FG002|Vaccination 3|Overall Study||9
10623393|NCT01986010|11781926|FG003|Vaccination 3|Overall Study||10
10623394|NCT01986010|11781927|FG004|Vaccination 3|Overall Study||9
10623395|NCT01986010|11781928|FG005|Vaccination 3|Overall Study||15
10623396|NCT01986010|11781929|FG006|Vaccination 3|Overall Study||10
10705199|NCT02596750|11869550|FG001|COMPLETED|2 Minutes||21
10705200|NCT02596750|11869549|FG000|NOT COMPLETED|2 Minutes||0
10705201|NCT02596750|11869550|FG001|NOT COMPLETED|2 Minutes||0
10623397|NCT01986010|11781930|FG007|Vaccination 3|Overall Study||4
10623398|NCT01986010|11781931|FG008|Vaccination 3|Overall Study||10
10623399|NCT01986010|11781932|FG009|Vaccination 3|Overall Study||10
10623400|NCT01986010|11781933|FG010|Vaccination 3|Overall Study||10
10623401|NCT01986010|11781934|FG011|Vaccination 3|Overall Study||8
10623402|NCT01986010|11781935|FG012|Vaccination 3|Overall Study||10
10705202|NCT02596750|11869549|FG000|STARTED|5 Minutes||21
10705203|NCT02596750|11869550|FG001|STARTED|5 Minutes||21
10705204|NCT02596750|11869549|FG000|COMPLETED|5 Minutes||21
10705205|NCT02596750|11869550|FG001|COMPLETED|5 Minutes||21
10705206|NCT02596750|11869549|FG000|NOT COMPLETED|5 Minutes||0
10623403|NCT01986010|11781936|FG013|Vaccination 3|Overall Study||9
10623404|NCT01986010|11781937|FG014|Vaccination 3|Overall Study||13
10623405|NCT01986010|11781938|FG015|Vaccination 3|Overall Study||10
10623406|NCT01986010|11781939|FG016|Vaccination 3|Overall Study||4
10623407|NCT01986010|11781923|FG000|COMPLETED|Overall Study||7
10623408|NCT01986010|11781924|FG001|COMPLETED|Overall Study||6
10623409|NCT01986010|11781925|FG002|COMPLETED|Overall Study||7
10623410|NCT01986010|11781926|FG003|COMPLETED|Overall Study||8
10623411|NCT01986010|11781927|FG004|COMPLETED|Overall Study||6
10623412|NCT01986010|11781928|FG005|COMPLETED|Overall Study||11
10623413|NCT01986010|11781929|FG006|COMPLETED|Overall Study||10
10623414|NCT01986010|11781930|FG007|COMPLETED|Overall Study||4
10623415|NCT01986010|11781931|FG008|COMPLETED|Overall Study||6
10623416|NCT01986010|11781932|FG009|COMPLETED|Overall Study||7
10623417|NCT01986010|11781933|FG010|COMPLETED|Overall Study||3
10623418|NCT01986010|11781934|FG011|COMPLETED|Overall Study||1
10705207|NCT02596750|11869550|FG001|NOT COMPLETED|5 Minutes||0
10705208|NCT02596750|11869549|FG000|STARTED|10 Minutes||21
10705209|NCT02596750|11869550|FG001|STARTED|10 Minutes||21
10705210|NCT02596750|11869549|FG000|COMPLETED|10 Minutes||21
10705211|NCT02596750|11869550|FG001|COMPLETED|10 Minutes||21
10705212|NCT02596750|11869549|FG000|NOT COMPLETED|10 Minutes||0
10705213|NCT02596750|11869550|FG001|NOT COMPLETED|10 Minutes||0
10623419|NCT01986010|11781935|FG012|COMPLETED|Overall Study||0
10623420|NCT01986010|11781936|FG013|COMPLETED|Overall Study||0
10623421|NCT01986010|11781937|FG014|COMPLETED|Overall Study||6
10623422|NCT01986010|11781938|FG015|COMPLETED|Overall Study||0
10623423|NCT01986010|11781939|FG016|COMPLETED|Overall Study||0
10623424|NCT01986010|11781923|FG000|NOT COMPLETED|Overall Study||6
10623425|NCT01986010|11781924|FG001|NOT COMPLETED|Overall Study||8
10623426|NCT01986010|11781925|FG002|NOT COMPLETED|Overall Study||7
10623427|NCT01986010|11781926|FG003|NOT COMPLETED|Overall Study||2
10623428|NCT01986010|11781927|FG004|NOT COMPLETED|Overall Study||5
10623429|NCT01986010|11781928|FG005|NOT COMPLETED|Overall Study||8
10623430|NCT01986010|11781929|FG006|NOT COMPLETED|Overall Study||0
10623431|NCT01986010|11781930|FG007|NOT COMPLETED|Overall Study||0
10623432|NCT01986010|11781931|FG008|NOT COMPLETED|Overall Study||6
10623433|NCT01986010|11781932|FG009|NOT COMPLETED|Overall Study||3
10623434|NCT01986010|11781933|FG010|NOT COMPLETED|Overall Study||7
10623435|NCT01986010|11781934|FG011|NOT COMPLETED|Overall Study||10
10623436|NCT01986010|11781935|FG012|NOT COMPLETED|Overall Study||10
10623437|NCT01986010|11781936|FG013|NOT COMPLETED|Overall Study||11
10623438|NCT01986010|11781937|FG014|NOT COMPLETED|Overall Study||10
10623439|NCT01986010|11781938|FG015|NOT COMPLETED|Overall Study||11
10623440|NCT01986010|11781939|FG016|NOT COMPLETED|Overall Study||4
10623441|NCT01986062|11781987|FG000|STARTED|Overall Study||47
10623442|NCT01986062|11781988|FG001|STARTED|Overall Study||50
10623443|NCT01986062|11781987|FG000|COMPLETED|Overall Study||46
10623444|NCT01986062|11781988|FG001|COMPLETED|Overall Study||49
10623445|NCT01986062|11781987|FG000|NOT COMPLETED|Overall Study||1
10623446|NCT01986062|11781988|FG001|NOT COMPLETED|Overall Study||1
10623447|NCT01986140|11781996|FG000|STARTED|Overall Study||157
10623448|NCT01986140|11781997|FG001|STARTED|Overall Study||79
10623449|NCT01986140|11781996|FG000|COMPLETED|Overall Study||122
10623450|NCT01986140|11781997|FG001|COMPLETED|Overall Study||51
10623451|NCT01986140|11781996|FG000|NOT COMPLETED|Overall Study||35
10623452|NCT01986140|11781997|FG001|NOT COMPLETED|Overall Study||28
10623453|NCT01986231|11782003|FG000|STARTED|Overall Study||12
10623454|NCT01986231|11782003|FG000|COMPLETED|Overall Study||11
10623455|NCT01986231|11782003|FG000|NOT COMPLETED|Overall Study||1
10623456|NCT01986348|11782011|FG000|STARTED|Overall Study||8
10623457|NCT01986348|11782012|FG001|STARTED|Overall Study||24
10623458|NCT01986348|11782013|FG002|STARTED|Overall Study||14
10623459|NCT01986348|11782014|FG003|STARTED|Overall Study||30
10623460|NCT01986348|11782011|FG000|COMPLETED|Overall Study||0
10623461|NCT01986348|11782012|FG001|COMPLETED|Overall Study||0
10623462|NCT01986348|11782013|FG002|COMPLETED|Overall Study||0
10623463|NCT01986348|11782014|FG003|COMPLETED|Overall Study||0
10623464|NCT01986348|11782011|FG000|NOT COMPLETED|Overall Study||8
10623465|NCT01986348|11782012|FG001|NOT COMPLETED|Overall Study||24
10623466|NCT01986348|11782013|FG002|NOT COMPLETED|Overall Study||14
10623467|NCT01986348|11782014|FG003|NOT COMPLETED|Overall Study||30
10623468|NCT01986361|11782029|FG000|STARTED|Overall Study||101
10623469|NCT01986361|11782030|FG001|STARTED|Overall Study||21
10623470|NCT01986361|11782029|FG000|COMPLETED|Overall Study||101
10623471|NCT01986361|11782030|FG001|COMPLETED|Overall Study||21
10623472|NCT01986361|11782029|FG000|NOT COMPLETED|Overall Study||0
10623473|NCT01986361|11782030|FG001|NOT COMPLETED|Overall Study||0
10623474|NCT01986647|11782040|FG000|STARTED|Overall Study||152
10623475|NCT01986647|11782041|FG001|STARTED|Overall Study||146
10623476|NCT01986647|11782042|FG002|STARTED|Overall Study||49
10623477|NCT01986647|11782043|FG003|STARTED|Overall Study||77
10623478|NCT01986647|11782040|FG000|COMPLETED|Overall Study||142
10623479|NCT01986647|11782041|FG001|COMPLETED|Overall Study||139
10623480|NCT01986647|11782042|FG002|COMPLETED|Overall Study||37
10623481|NCT01986647|11782043|FG003|COMPLETED|Overall Study||66
10623482|NCT01986647|11782040|FG000|NOT COMPLETED|Overall Study||10
10623483|NCT01986647|11782041|FG001|NOT COMPLETED|Overall Study||7
10623484|NCT01986647|11782042|FG002|NOT COMPLETED|Overall Study||12
10623485|NCT01986647|11782043|FG003|NOT COMPLETED|Overall Study||11
10623486|NCT01986686|11782059|FG000|STARTED|Overall Study||81
10623487|NCT01986686|11782060|FG001|STARTED|Overall Study||26
10623488|NCT01986686|11782059|FG000|COMPLETED|Overall Study||81
10623489|NCT01986686|11782060|FG001|COMPLETED|Overall Study||26
10623490|NCT01986686|11782059|FG000|NOT COMPLETED|Overall Study||0
10623491|NCT01986686|11782060|FG001|NOT COMPLETED|Overall Study||0
10623492|NCT01986790|11782069|FG000|STARTED|Overall Study||91
10623493|NCT01986790|11782070|FG001|STARTED|Overall Study||154
10623494|NCT01986790|11782071|FG002|STARTED|Overall Study||98
10623495|NCT01986790|11782069|FG000|COMPLETED|Overall Study||91
10623496|NCT01986790|11782070|FG001|COMPLETED|Overall Study||154
10623497|NCT01986790|11782071|FG002|COMPLETED|Overall Study||98
10623498|NCT01986790|11782069|FG000|NOT COMPLETED|Overall Study||0
10623499|NCT01986790|11782070|FG001|NOT COMPLETED|Overall Study||0
10623500|NCT01986790|11782071|FG002|NOT COMPLETED|Overall Study||0
10623501|NCT01986829|11782079|FG000|STARTED|Overall Study||9
10623502|NCT01986829|11782079|FG000|COMPLETED|Overall Study||8
10623503|NCT01986829|11782079|FG000|NOT COMPLETED|Overall Study||1
10623504|NCT01986855|11782089|FG000|STARTED|Overall Study||158
10623505|NCT01986855|11782090|FG001|STARTED|Overall Study||156
10623506|NCT01986855|11782091|FG002|STARTED|Overall Study||154
10705214|NCT02596750|11869549|FG000|STARTED|30 Minutes||21
10623507|NCT01986855|11782089|FG000|Treated|Overall Study||158
10623508|NCT01986855|11782090|FG001|Treated|Overall Study||155
10623509|NCT01986855|11782091|FG002|Treated|Overall Study||154
10623510|NCT01986855|11782089|FG000|COMPLETED|Overall Study||145
10623511|NCT01986855|11782090|FG001|COMPLETED|Overall Study||142
10623512|NCT01986855|11782091|FG002|COMPLETED|Overall Study||143
10623513|NCT01986855|11782089|FG000|NOT COMPLETED|Overall Study||13
10623514|NCT01986855|11782090|FG001|NOT COMPLETED|Overall Study||14
10623515|NCT01986855|11782091|FG002|NOT COMPLETED|Overall Study||11
10623537|NCT01986907|11782135|FG000|STARTED|Overall Study||936
10623538|NCT01986907|11782135|FG000|COMPLETED|Overall Study||774
10623539|NCT01986907|11782135|FG000|NOT COMPLETED|Overall Study||162
10623540|NCT01986920|11782142|FG000|STARTED|A- 101 25%||35
10623541|NCT01986920|11782143|FG001|STARTED|A- 101 25%||0
10623542|NCT01986920|11782144|FG002|STARTED|A- 101 25%||0
10623543|NCT01986920|11782145|FG003|STARTED|A- 101 25%||0
10623544|NCT01986920|11782142|FG000|COMPLETED|A- 101 25%||34
10623545|NCT01986920|11782143|FG001|COMPLETED|A- 101 25%||0
10623546|NCT01986920|11782144|FG002|COMPLETED|A- 101 25%||0
10623547|NCT01986920|11782145|FG003|COMPLETED|A- 101 25%||0
10623548|NCT01986920|11782142|FG000|NOT COMPLETED|A- 101 25%||1
10623549|NCT01986920|11782143|FG001|NOT COMPLETED|A- 101 25%||0
10623550|NCT01986920|11782144|FG002|NOT COMPLETED|A- 101 25%||0
10623551|NCT01986920|11782145|FG003|NOT COMPLETED|A- 101 25%||0
10623552|NCT01986920|11782142|FG000|STARTED|A-101 32.5%||0
10623553|NCT01986920|11782143|FG001|STARTED|A-101 32.5%||35
10623554|NCT01986920|11782144|FG002|STARTED|A-101 32.5%||0
10623555|NCT01986920|11782145|FG003|STARTED|A-101 32.5%||0
10623556|NCT01986920|11782142|FG000|COMPLETED|A-101 32.5%||0
10623557|NCT01986920|11782143|FG001|COMPLETED|A-101 32.5%||34
10623558|NCT01986920|11782144|FG002|COMPLETED|A-101 32.5%||0
10623559|NCT01986920|11782145|FG003|COMPLETED|A-101 32.5%||0
10623560|NCT01986920|11782142|FG000|NOT COMPLETED|A-101 32.5%||0
10623561|NCT01986920|11782143|FG001|NOT COMPLETED|A-101 32.5%||1
10623562|NCT01986920|11782144|FG002|NOT COMPLETED|A-101 32.5%||0
10623563|NCT01986920|11782145|FG003|NOT COMPLETED|A-101 32.5%||0
10623564|NCT01986920|11782142|FG000|STARTED|A-101 40%||0
10623565|NCT01986920|11782143|FG001|STARTED|A-101 40%||0
10623566|NCT01986920|11782144|FG002|STARTED|A-101 40%||35
10623567|NCT01986920|11782145|FG003|STARTED|A-101 40%||0
10623568|NCT01986920|11782142|FG000|COMPLETED|A-101 40%||0
10623569|NCT01986920|11782143|FG001|COMPLETED|A-101 40%||0
10623570|NCT01986920|11782144|FG002|COMPLETED|A-101 40%||34
10623571|NCT01986920|11782145|FG003|COMPLETED|A-101 40%||0
10623572|NCT01986920|11782142|FG000|NOT COMPLETED|A-101 40%||0
10623573|NCT01986920|11782143|FG001|NOT COMPLETED|A-101 40%||0
10623574|NCT01986920|11782144|FG002|NOT COMPLETED|A-101 40%||1
10623575|NCT01986920|11782145|FG003|NOT COMPLETED|A-101 40%||0
10623576|NCT01986920|11782142|FG000|STARTED|Placebo||0
10623577|NCT01986920|11782143|FG001|STARTED|Placebo||0
10623578|NCT01986920|11782144|FG002|STARTED|Placebo||0
10623579|NCT01986920|11782145|FG003|STARTED|Placebo||35
10623580|NCT01986920|11782142|FG000|COMPLETED|Placebo||0
10623581|NCT01986920|11782143|FG001|COMPLETED|Placebo||0
10623582|NCT01986920|11782144|FG002|COMPLETED|Placebo||0
10623583|NCT01986920|11782145|FG003|COMPLETED|Placebo||34
10623584|NCT01986920|11782142|FG000|NOT COMPLETED|Placebo||0
10623585|NCT01986920|11782143|FG001|NOT COMPLETED|Placebo||0
10623586|NCT01986920|11782144|FG002|NOT COMPLETED|Placebo||0
10623587|NCT01986920|11782145|FG003|NOT COMPLETED|Placebo||1
10623588|NCT01986946|11782157|FG000|STARTED|Overall Study||5
10623589|NCT01986946|11782158|FG001|STARTED|Overall Study||9
10623590|NCT01986946|11782157|FG000|COMPLETED|Overall Study||5
10623591|NCT01986946|11782158|FG001|COMPLETED|Overall Study||9
10623592|NCT01986946|11782157|FG000|NOT COMPLETED|Overall Study||0
10623593|NCT01986946|11782158|FG001|NOT COMPLETED|Overall Study||0
10623594|NCT01986985|11782164|FG000|STARTED|Overall Study||58
10623595|NCT01986985|11782164|FG000|COMPLETED|Overall Study||51
10623596|NCT01986985|11782164|FG000|NOT COMPLETED|Overall Study||7
10623597|NCT01987089|11782170|FG000|STARTED|Overall Study||31
10623598|NCT01987089|11782171|FG001|STARTED|Overall Study||32
10623599|NCT01987089|11782170|FG000|COMPLETED|Overall Study||30
10623600|NCT01987089|11782171|FG001|COMPLETED|Overall Study||28
10623601|NCT01987089|11782170|FG000|NOT COMPLETED|Overall Study||1
10623602|NCT01987089|11782171|FG001|NOT COMPLETED|Overall Study||4
10623603|NCT01987102|11782179|FG000|STARTED|2 Courses of HDMTX With SOC Rescue||8
10623604|NCT01987102|11782180|FG001|STARTED|2 Courses of HDMTX With SOC Rescue||10
10623605|NCT01987102|11782179|FG000|COMPLETED|2 Courses of HDMTX With SOC Rescue||4
10623606|NCT01987102|11782180|FG001|COMPLETED|2 Courses of HDMTX With SOC Rescue||4
10623607|NCT01987102|11782179|FG000|NOT COMPLETED|2 Courses of HDMTX With SOC Rescue||4
10623608|NCT01987102|11782180|FG001|NOT COMPLETED|2 Courses of HDMTX With SOC Rescue||6
10623609|NCT01987102|11782179|FG000|STARTED|2 Courses of HDMTX With MOD Rescue||4
10623610|NCT01987102|11782180|FG001|STARTED|2 Courses of HDMTX With MOD Rescue||4
10623611|NCT01987102|11782179|FG000|COMPLETED|2 Courses of HDMTX With MOD Rescue||4
10623612|NCT01987102|11782180|FG001|COMPLETED|2 Courses of HDMTX With MOD Rescue||3
10623613|NCT01987102|11782179|FG000|NOT COMPLETED|2 Courses of HDMTX With MOD Rescue||0
10623614|NCT01987102|11782180|FG001|NOT COMPLETED|2 Courses of HDMTX With MOD Rescue||1
10623615|NCT01987219|11782193|FG000|STARTED|Overall Study||2
10623616|NCT01987219|11782194|FG001|STARTED|Overall Study||2
10623617|NCT01987219|11782195|FG002|STARTED|Overall Study||7
10623618|NCT01987219|11782196|FG003|STARTED|Overall Study||2
10623619|NCT01987219|11782197|FG004|STARTED|Overall Study||1
10623620|NCT01987219|11782198|FG005|STARTED|Overall Study||1
10623621|NCT01987219|11782193|FG000|COMPLETED|Overall Study||2
10623622|NCT01987219|11782194|FG001|COMPLETED|Overall Study||2
10623623|NCT01987219|11782195|FG002|COMPLETED|Overall Study||6
10623624|NCT01987219|11782196|FG003|COMPLETED|Overall Study||2
10623625|NCT01987219|11782197|FG004|COMPLETED|Overall Study||1
10623626|NCT01987219|11782198|FG005|COMPLETED|Overall Study||1
10623627|NCT01987219|11782193|FG000|NOT COMPLETED|Overall Study||0
10623628|NCT01987219|11782194|FG001|NOT COMPLETED|Overall Study||0
10623629|NCT01987219|11782195|FG002|NOT COMPLETED|Overall Study||1
10623630|NCT01987219|11782196|FG003|NOT COMPLETED|Overall Study||0
10623631|NCT01987219|11782197|FG004|NOT COMPLETED|Overall Study||0
10623632|NCT01987219|11782198|FG005|NOT COMPLETED|Overall Study||0
10623633|NCT01987232|11782211|FG000|STARTED|Overall Study||5
10623634|NCT01987232|11782212|FG001|STARTED|Overall Study||3
10623635|NCT01987232|11782213|FG002|STARTED|Overall Study||3
10623636|NCT01987232|11782214|FG003|STARTED|Overall Study||15
10623637|NCT01987232|11782215|FG004|STARTED|Overall Study||6
10623638|NCT01987232|11782211|FG000|COMPLETED|Overall Study||5
10623639|NCT01987232|11782212|FG001|COMPLETED|Overall Study||3
10623640|NCT01987232|11782213|FG002|COMPLETED|Overall Study||3
10623641|NCT01987232|11782214|FG003|COMPLETED|Overall Study||14
10623642|NCT01987232|11782215|FG004|COMPLETED|Overall Study||6
10623643|NCT01987232|11782211|FG000|NOT COMPLETED|Overall Study||0
10623644|NCT01987232|11782212|FG001|NOT COMPLETED|Overall Study||0
10623645|NCT01987232|11782213|FG002|NOT COMPLETED|Overall Study||0
10623646|NCT01987232|11782214|FG003|NOT COMPLETED|Overall Study||1
10623647|NCT01987232|11782215|FG004|NOT COMPLETED|Overall Study||0
10623648|NCT01987349|11782237|FG000|STARTED|Overall Study||6
10623649|NCT01987349|11782238|FG001|STARTED|Overall Study||6
10623650|NCT01987349|11782239|FG002|STARTED|Overall Study||8
10623651|NCT01987349|11782240|FG003|STARTED|Overall Study||6
10623652|NCT01987349|11782241|FG004|STARTED|Overall Study||6
10623653|NCT01987349|11782242|FG005|STARTED|Overall Study||6
10623654|NCT01987349|11782243|FG006|STARTED|Overall Study||10
10623655|NCT01987349|11782244|FG007|STARTED|Overall Study||25
10623656|NCT01987349|11782237|FG000|COMPLETED|Overall Study||6
10623657|NCT01987349|11782238|FG001|COMPLETED|Overall Study||6
10623658|NCT01987349|11782239|FG002|COMPLETED|Overall Study||8
10623659|NCT01987349|11782240|FG003|COMPLETED|Overall Study||6
10623660|NCT01987349|11782241|FG004|COMPLETED|Overall Study||6
10623661|NCT01987349|11782242|FG005|COMPLETED|Overall Study||6
10623662|NCT01987349|11782243|FG006|COMPLETED|Overall Study||10
10705215|NCT02596750|11869550|FG001|STARTED|30 Minutes||21
10705216|NCT02596750|11869549|FG000|COMPLETED|30 Minutes||21
10705217|NCT02596750|11869550|FG001|COMPLETED|30 Minutes||21
10705218|NCT02596750|11869549|FG000|NOT COMPLETED|30 Minutes||0
10623663|NCT01987349|11782244|FG007|COMPLETED|Overall Study||24
10623664|NCT01987349|11782237|FG000|NOT COMPLETED|Overall Study||0
10623665|NCT01987349|11782238|FG001|NOT COMPLETED|Overall Study||0
10623666|NCT01987349|11782239|FG002|NOT COMPLETED|Overall Study||0
10623667|NCT01987349|11782240|FG003|NOT COMPLETED|Overall Study||0
10623668|NCT01987349|11782241|FG004|NOT COMPLETED|Overall Study||0
10623669|NCT01987349|11782242|FG005|NOT COMPLETED|Overall Study||0
10623670|NCT01987349|11782243|FG006|NOT COMPLETED|Overall Study||0
10623671|NCT01987349|11782244|FG007|NOT COMPLETED|Overall Study||1
10623672|NCT01987401|11782269|FG000|STARTED|Overall Study||591
10623673|NCT01987401|11782270|FG001|STARTED|Overall Study||591
10623674|NCT01987401|11782271|FG002|STARTED|Overall Study||60
10623675|NCT01987401|11782269|FG000|COMPLETED|Overall Study||137
10623676|NCT01987401|11782270|FG001|COMPLETED|Overall Study||121
10623677|NCT01987401|11782271|FG002|COMPLETED|Overall Study||16
10623678|NCT01987401|11782269|FG000|NOT COMPLETED|Overall Study||454
10623679|NCT01987401|11782270|FG001|NOT COMPLETED|Overall Study||470
10623680|NCT01987401|11782271|FG002|NOT COMPLETED|Overall Study||44
10623681|NCT01987414|11782281|FG000|STARTED|Overall Study||10
10705219|NCT02596750|11869550|FG001|NOT COMPLETED|30 Minutes||0
10705220|NCT02596854|11869557|FG000|STARTED|Overall Study||117
10623682|NCT01987414|11782282|FG001|STARTED|Overall Study||8
10623683|NCT01987414|11782281|FG000|COMPLETED|Overall Study||8
10623684|NCT01987414|11782282|FG001|COMPLETED|Overall Study||6
10623685|NCT01987414|11782281|FG000|NOT COMPLETED|Overall Study||2
10623686|NCT01987414|11782282|FG001|NOT COMPLETED|Overall Study||2
10623687|NCT01987427|11782291|FG000|STARTED|Overall Study||78
10623688|NCT01987427|11782292|FG001|STARTED|Overall Study||78
10623689|NCT01987427|11782293|FG002|STARTED|Overall Study||79
10623690|NCT01987427|11782291|FG000|COMPLETED|Overall Study||64
10623691|NCT01987427|11782292|FG001|COMPLETED|Overall Study||68
10623692|NCT01987427|11782293|FG002|COMPLETED|Overall Study||59
10623693|NCT01987427|11782291|FG000|NOT COMPLETED|Overall Study||14
10623694|NCT01987427|11782292|FG001|NOT COMPLETED|Overall Study||10
10623695|NCT01987427|11782293|FG002|NOT COMPLETED|Overall Study||20
10653395|NCT02193152|11813885|FG000|STARTED|Overall Study||16
10653396|NCT02193152|11813885|FG000|COMPLETED|Overall Study||16
10653397|NCT02193152|11813885|FG000|NOT COMPLETED|Overall Study||0
10653398|NCT02193165|11813892|FG000|STARTED|4 Week Product Use||40
10653399|NCT02193165|11813893|FG001|STARTED|4 Week Product Use||40
10653400|NCT02193165|11813894|FG002|STARTED|4 Week Product Use||40
10653401|NCT02193165|11813892|FG000|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
10653402|NCT02193165|11813893|FG001|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
10653403|NCT02193165|11813894|FG002|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
10653404|NCT02193165|11813892|FG000|NOT COMPLETED|4 Week Product Use||1
10653405|NCT02193165|11813893|FG001|NOT COMPLETED|4 Week Product Use||1
10653406|NCT02193165|11813894|FG002|NOT COMPLETED|4 Week Product Use||1
10653407|NCT02193165|11813892|FG000|STARTED|6 Week Product Use||39
10653408|NCT02193165|11813893|FG001|STARTED|6 Week Product Use||39
10653409|NCT02193165|11813894|FG002|STARTED|6 Week Product Use||39
10653410|NCT02193165|11813892|FG000|COMPLETED|6 Week Product Use||39
10653411|NCT02193165|11813893|FG001|COMPLETED|6 Week Product Use|1 subject failed to keep appointment time and didn't return to clinical site.|38
10653412|NCT02193165|11813894|FG002|COMPLETED|6 Week Product Use||39
10653413|NCT02193165|11813892|FG000|NOT COMPLETED|6 Week Product Use||0
10653414|NCT02193165|11813893|FG001|NOT COMPLETED|6 Week Product Use||1
10653415|NCT02193165|11813894|FG002|NOT COMPLETED|6 Week Product Use||0
10653416|NCT02193178|11813902|FG000|STARTED|Overall Study||15
10653417|NCT02193178|11813902|FG000|COMPLETED|Overall Study||13
10653418|NCT02193178|11813902|FG000|NOT COMPLETED|Overall Study||2
10653419|NCT02193347|11813920|FG000|STARTED|Overall Study||24
10653420|NCT02193347|11813920|FG000|COMPLETED|Overall Study||24
10653421|NCT02193347|11813920|FG000|NOT COMPLETED|Overall Study||0
10653422|NCT02193490|11813926|FG000|STARTED|Overall Study||25
10653423|NCT02193490|11813927|FG001|STARTED|Overall Study||22
10653424|NCT02193490|11813926|FG000|COMPLETED|Overall Study||21
10653425|NCT02193490|11813927|FG001|COMPLETED|Overall Study||20
10653426|NCT02193490|11813926|FG000|NOT COMPLETED|Overall Study||4
10653427|NCT02193490|11813927|FG001|NOT COMPLETED|Overall Study||2
10653428|NCT02193776|11813937|FG000|STARTED|Overall Study||59
10653429|NCT02193776|11813938|FG001|STARTED|Overall Study||60
10653430|NCT02193776|11813939|FG002|STARTED|Overall Study||61
10653431|NCT02193776|11813940|FG003|STARTED|Overall Study||60
10653432|NCT02193776|11813937|FG000|Completed Day 70 Follow-up|Overall Study||54
10653433|NCT02193776|11813938|FG001|Completed Day 70 Follow-up|Overall Study||56
10653434|NCT02193776|11813939|FG002|Completed Day 70 Follow-up|Overall Study||60
10653435|NCT02193776|11813940|FG003|Completed Day 70 Follow-up|Overall Study||60
10653436|NCT02193776|11813937|FG000|Completed Day 140 Follow-up|Overall Study||52
10653437|NCT02193776|11813938|FG001|Completed Day 140 Follow-up|Overall Study||52
10653438|NCT02193776|11813939|FG002|Completed Day 140 Follow-up|Overall Study||58
10653439|NCT02193776|11813940|FG003|Completed Day 140 Follow-up|Overall Study||58
10653440|NCT02193776|11813937|FG000|COMPLETED|Overall Study||51
10653441|NCT02193776|11813938|FG001|COMPLETED|Overall Study||53
10653442|NCT02193776|11813939|FG002|COMPLETED|Overall Study||59
10653443|NCT02193776|11813940|FG003|COMPLETED|Overall Study||58
10653444|NCT02193776|11813937|FG000|NOT COMPLETED|Overall Study||8
10653445|NCT02193776|11813938|FG001|NOT COMPLETED|Overall Study||7
10653446|NCT02193776|11813939|FG002|NOT COMPLETED|Overall Study||2
10653447|NCT02193776|11813940|FG003|NOT COMPLETED|Overall Study||2
10653448|NCT02193815|11813950|FG000|STARTED|Overall Study||15
10653449|NCT02193815|11813950|FG000|COMPLETED|Overall Study||15
10653450|NCT02193815|11813950|FG000|NOT COMPLETED|Overall Study||0
10653451|NCT02193828|11813968|FG000|STARTED|Overall Study||18
10653452|NCT02193828|11813969|FG001|STARTED|Overall Study||18
10653453|NCT02193828|11813970|FG002|STARTED|Overall Study||23
10653454|NCT02193828|11813971|FG003|STARTED|Overall Study||17
10653455|NCT02193828|11813968|FG000|COMPLETED|Overall Study||18
10653456|NCT02193828|11813969|FG001|COMPLETED|Overall Study||18
10653457|NCT02193828|11813970|FG002|COMPLETED|Overall Study||22
10653458|NCT02193828|11813971|FG003|COMPLETED|Overall Study||16
10653459|NCT02193828|11813968|FG000|NOT COMPLETED|Overall Study||0
10653460|NCT02193828|11813969|FG001|NOT COMPLETED|Overall Study||0
10653461|NCT02193828|11813970|FG002|NOT COMPLETED|Overall Study||1
10653462|NCT02193828|11813971|FG003|NOT COMPLETED|Overall Study||1
10653463|NCT02193880|11813981|FG000|STARTED|Overall Study||7
10653464|NCT02193880|11813981|FG000|COMPLETED|Overall Study||4
10653465|NCT02193880|11813981|FG000|NOT COMPLETED|Overall Study||3
10653466|NCT02194062|11813988|FG000|STARTED|Overall Study||10
10653467|NCT02194062|11813989|FG001|STARTED|Overall Study||10
10653468|NCT02194062|11813990|FG002|STARTED|Overall Study||12
10623696|NCT01987453|11782304|FG000|STARTED|Overall Study||51
10623697|NCT01987453|11782305|FG001|STARTED|Overall Study||41
10623698|NCT01987453|11782306|FG002|STARTED|Overall Study||8
10623699|NCT01987453|11782304|FG000|COMPLETED|Overall Study||50
10623700|NCT01987453|11782305|FG001|COMPLETED|Overall Study||29
10623701|NCT01987453|11782306|FG002|COMPLETED|Overall Study||7
10623702|NCT01987453|11782304|FG000|NOT COMPLETED|Overall Study||1
10623703|NCT01987453|11782305|FG001|NOT COMPLETED|Overall Study||12
10623704|NCT01987453|11782306|FG002|NOT COMPLETED|Overall Study||1
10623705|NCT01987479|11782318|FG000|STARTED|Overall Study||150
10623706|NCT01987479|11782318|FG000|COMPLETED|Overall Study||133
10623707|NCT01987479|11782318|FG000|NOT COMPLETED|Overall Study||17
10623708|NCT01987505|11782324|FG000|STARTED|Overall Study||140
10623709|NCT01987505|11782324|FG000|COMPLETED|Overall Study||106
10623710|NCT01987505|11782324|FG000|NOT COMPLETED|Overall Study||34
10623711|NCT01987557|11782333|FG000|STARTED|Overall Study||16
10623712|NCT01987557|11782334|FG001|STARTED|Overall Study||16
10623713|NCT01987557|11782335|FG002|STARTED|Overall Study||16
10623714|NCT01987557|11782333|FG000|COMPLETED|Overall Study||13
10623715|NCT01987557|11782334|FG001|COMPLETED|Overall Study||13
10623716|NCT01987557|11782335|FG002|COMPLETED|Overall Study||13
10623717|NCT01987557|11782333|FG000|NOT COMPLETED|Overall Study||3
10623718|NCT01987557|11782334|FG001|NOT COMPLETED|Overall Study||3
10623719|NCT01987557|11782335|FG002|NOT COMPLETED|Overall Study||3
10623720|NCT01987583|11782345|FG000|STARTED|Overall Study||40
10623721|NCT01987583|11782346|FG001|STARTED|Overall Study||40
10623722|NCT01987583|11782345|FG000|COMPLETED|Overall Study||37
10623723|NCT01987583|11782346|FG001|COMPLETED|Overall Study||38
10623724|NCT01987583|11782345|FG000|NOT COMPLETED|Overall Study||3
10623725|NCT01987583|11782346|FG001|NOT COMPLETED|Overall Study||2
10623726|NCT01987596|11782354|FG000|STARTED|Overall Study||12
10623727|NCT01987596|11782355|FG001|STARTED|Overall Study||11
10623728|NCT01987596|11782354|FG000|COMPLETED|Overall Study||11
10623729|NCT01987596|11782355|FG001|COMPLETED|Overall Study||10
10623730|NCT01987596|11782354|FG000|NOT COMPLETED|Overall Study||1
10623731|NCT01987596|11782355|FG001|NOT COMPLETED|Overall Study||1
10623732|NCT01987609|11782367|FG000|STARTED|Overall Study|one arm on one patient|7
10623733|NCT01987609|11782367|FG000|Hylenex Injected in Arm|Overall Study||6
10623734|NCT01987609|11782367|FG000|Normal Saline Injected in Arm|Overall Study||6
10623735|NCT01987609|11782367|FG000|COMPLETED|Overall Study||6
10623736|NCT01987609|11782367|FG000|NOT COMPLETED|Overall Study||1
10623737|NCT01987752|11782381|FG000|STARTED|Overall Study||732
10623738|NCT01987752|11782381|FG000|COMPLETED|Overall Study||732
10623739|NCT01987752|11782381|FG000|NOT COMPLETED|Overall Study||0
10623740|NCT01987765|11782385|FG000|STARTED|Overall Study||847
10623741|NCT01987765|11782385|FG000|COMPLETED|Overall Study||745
10623742|NCT01987765|11782385|FG000|NOT COMPLETED|Overall Study||102
10623743|NCT01987817|11782391|FG000|STARTED|Overall Study||29
10623744|NCT01987817|11782392|FG001|STARTED|Overall Study||27
10623745|NCT01987817|11782391|FG000|COMPLETED|Overall Study||23
10623746|NCT01987817|11782392|FG001|COMPLETED|Overall Study||26
10623747|NCT01987817|11782391|FG000|NOT COMPLETED|Overall Study||6
10623748|NCT01987817|11782392|FG001|NOT COMPLETED|Overall Study||1
10623749|NCT01987830|11782399|FG000|STARTED|Overall Study||13
10623750|NCT01987830|11782399|FG000|COMPLETED|Overall Study||12
10623751|NCT01987830|11782399|FG000|NOT COMPLETED|Overall Study||1
10623752|NCT01987895|11782405|FG000|STARTED|Overall Study||306
10623753|NCT01987895|11782406|FG001|STARTED|Overall Study||326
10623754|NCT01987895|11782405|FG000|COMPLETED|Overall Study||276
10623755|NCT01987895|11782406|FG001|COMPLETED|Overall Study||296
10623756|NCT01987895|11782405|FG000|NOT COMPLETED|Overall Study||30
10623757|NCT01987895|11782406|FG001|NOT COMPLETED|Overall Study||30
10623758|NCT01987908|11782412|FG000|STARTED|Placebo Lead-in Period||23
10623759|NCT01987908|11782413|FG001|STARTED|Placebo Lead-in Period||0
10623760|NCT01987908|11782414|FG002|STARTED|Placebo Lead-in Period||0
10623761|NCT01987908|11782412|FG000|COMPLETED|Placebo Lead-in Period||14
10623762|NCT01987908|11782413|FG001|COMPLETED|Placebo Lead-in Period||0
10623763|NCT01987908|11782414|FG002|COMPLETED|Placebo Lead-in Period||0
10623764|NCT01987908|11782412|FG000|NOT COMPLETED|Placebo Lead-in Period||9
10623765|NCT01987908|11782413|FG001|NOT COMPLETED|Placebo Lead-in Period||0
10623766|NCT01987908|11782414|FG002|NOT COMPLETED|Placebo Lead-in Period||0
10623767|NCT01987908|11782412|FG000|STARTED|Treatment Period||0
10623768|NCT01987908|11782413|FG001|STARTED|Treatment Period||11
10623769|NCT01987908|11782414|FG002|STARTED|Treatment Period||3
10623770|NCT01987908|11782412|FG000|COMPLETED|Treatment Period||0
10623771|NCT01987908|11782413|FG001|COMPLETED|Treatment Period||10
10623772|NCT01987908|11782414|FG002|COMPLETED|Treatment Period||2
10623773|NCT01987908|11782412|FG000|NOT COMPLETED|Treatment Period||0
10623774|NCT01987908|11782413|FG001|NOT COMPLETED|Treatment Period||1
10623775|NCT01987908|11782414|FG002|NOT COMPLETED|Treatment Period||1
10623776|NCT01987908|11782412|FG000|STARTED|Post-Treatment Observation Period||0
10623777|NCT01987908|11782413|FG001|STARTED|Post-Treatment Observation Period||10
10623778|NCT01987908|11782414|FG002|STARTED|Post-Treatment Observation Period||2
10623779|NCT01987908|11782412|FG000|COMPLETED|Post-Treatment Observation Period||0
10623780|NCT01987908|11782413|FG001|COMPLETED|Post-Treatment Observation Period||7
10623781|NCT01987908|11782414|FG002|COMPLETED|Post-Treatment Observation Period||2
10623782|NCT01987908|11782412|FG000|NOT COMPLETED|Post-Treatment Observation Period||0
10623783|NCT01987908|11782413|FG001|NOT COMPLETED|Post-Treatment Observation Period||3
10623784|NCT01987908|11782414|FG002|NOT COMPLETED|Post-Treatment Observation Period||0
10623785|NCT01987960|11782440|FG000|STARTED|Period 1||417
10623786|NCT01987960|11782441|FG001|STARTED|Period 1||0
10623787|NCT01987960|11782442|FG002|STARTED|Period 1||0
10623788|NCT01987960|11782443|FG003|STARTED|Period 1||0
10623789|NCT01987960|11782440|FG000|COMPLETED|Period 1||231
10623790|NCT01987960|11782441|FG001|COMPLETED|Period 1||0
10623791|NCT01987960|11782442|FG002|COMPLETED|Period 1||0
10623792|NCT01987960|11782443|FG003|COMPLETED|Period 1||0
10623793|NCT01987960|11782440|FG000|NOT COMPLETED|Period 1||186
10623794|NCT01987960|11782441|FG001|NOT COMPLETED|Period 1||0
10623795|NCT01987960|11782442|FG002|NOT COMPLETED|Period 1||0
10623796|NCT01987960|11782443|FG003|NOT COMPLETED|Period 1||0
10623797|NCT01987960|11782440|FG000|STARTED|Period 2||0
10623798|NCT01987960|11782441|FG001|STARTED|Period 2||17
10623799|NCT01987960|11782442|FG002|STARTED|Period 2||23
10623800|NCT01987960|11782443|FG003|STARTED|Period 2||0
10623801|NCT01987960|11782440|FG000|COMPLETED|Period 2||0
10623802|NCT01987960|11782441|FG001|COMPLETED|Period 2||12
10623803|NCT01987960|11782442|FG002|COMPLETED|Period 2||14
10623804|NCT01987960|11782443|FG003|COMPLETED|Period 2||0
10623805|NCT01987960|11782440|FG000|NOT COMPLETED|Period 2||0
10623806|NCT01987960|11782441|FG001|NOT COMPLETED|Period 2||5
10623807|NCT01987960|11782442|FG002|NOT COMPLETED|Period 2||9
10623808|NCT01987960|11782443|FG003|NOT COMPLETED|Period 2||0
10623809|NCT01987960|11782440|FG000|STARTED|Period 3||0
10623810|NCT01987960|11782441|FG001|STARTED|Period 3||0
10623811|NCT01987960|11782442|FG002|STARTED|Period 3||0
10623812|NCT01987960|11782443|FG003|STARTED|Period 3||190
10623813|NCT01987960|11782440|FG000|COMPLETED|Period 3||0
10623814|NCT01987960|11782441|FG001|COMPLETED|Period 3||0
10623815|NCT01987960|11782442|FG002|COMPLETED|Period 3||0
10623816|NCT01987960|11782443|FG003|COMPLETED|Period 3||119
10623817|NCT01987960|11782440|FG000|NOT COMPLETED|Period 3||0
10623818|NCT01987960|11782441|FG001|NOT COMPLETED|Period 3||0
10623819|NCT01987960|11782442|FG002|NOT COMPLETED|Period 3||0
10623820|NCT01987960|11782443|FG003|NOT COMPLETED|Period 3||71
10623821|NCT01987986|11782457|FG000|STARTED|Overall Study||43
10623822|NCT01987986|11782458|FG001|STARTED|Overall Study||43
10623823|NCT01987986|11782459|FG002|STARTED|Overall Study||40
10623824|NCT01987986|11782460|FG003|STARTED|Overall Study||24
10623825|NCT01987986|11782457|FG000|COMPLETED|Overall Study||41
10623826|NCT01987986|11782458|FG001|COMPLETED|Overall Study||43
10623827|NCT01987986|11782459|FG002|COMPLETED|Overall Study||38
10623828|NCT01987986|11782460|FG003|COMPLETED|Overall Study||24
10623829|NCT01987986|11782457|FG000|NOT COMPLETED|Overall Study||2
10623830|NCT01987986|11782458|FG001|NOT COMPLETED|Overall Study||0
10623831|NCT01987986|11782459|FG002|NOT COMPLETED|Overall Study||2
10623832|NCT01987986|11782460|FG003|NOT COMPLETED|Overall Study||0
10623833|NCT01988012|11782470|FG000|STARTED|Overall Study||100
10623834|NCT01988012|11782470|FG000|COMPLETED|Overall Study||85
10623835|NCT01988012|11782470|FG000|NOT COMPLETED|Overall Study||15
10623836|NCT01988090|11782476|FG000|STARTED|Start Treament After Randomization||46
10623837|NCT01988090|11782477|FG001|STARTED|Start Treament After Randomization||47
10623838|NCT01988090|11782476|FG000|COMPLETED|Start Treament After Randomization||44
10623839|NCT01988090|11782477|FG001|COMPLETED|Start Treament After Randomization||43
10623840|NCT01988090|11782476|FG000|NOT COMPLETED|Start Treament After Randomization||2
10623841|NCT01988090|11782477|FG001|NOT COMPLETED|Start Treament After Randomization||4
10623842|NCT01988090|11782476|FG000|STARTED|Complete Study After Start||44
10623843|NCT01988090|11782477|FG001|STARTED|Complete Study After Start||43
10623844|NCT01988090|11782476|FG000|COMPLETED|Complete Study After Start||41
10623845|NCT01988090|11782477|FG001|COMPLETED|Complete Study After Start||42
10623846|NCT01988090|11782476|FG000|NOT COMPLETED|Complete Study After Start||3
10623847|NCT01988090|11782477|FG001|NOT COMPLETED|Complete Study After Start||1
10623848|NCT01988103|11782486|FG000|STARTED|Placebo-Controlled Phase Week 0-16||84
10623849|NCT01988103|11782487|FG001|STARTED|Placebo-Controlled Phase Week 0-16||85
10623850|NCT01988103|11782488|FG002|STARTED|Placebo-Controlled Phase Week 0-16||85
10623851|NCT01988103|11782489|FG003|STARTED|Placebo-Controlled Phase Week 0-16||0
10623852|NCT01988103|11782490|FG004|STARTED|Placebo-Controlled Phase Week 0-16||0
10623853|NCT01988103|11782486|FG000|COMPLETED|Placebo-Controlled Phase Week 0-16||72
10623854|NCT01988103|11782487|FG001|COMPLETED|Placebo-Controlled Phase Week 0-16||69
10623855|NCT01988103|11782488|FG002|COMPLETED|Placebo-Controlled Phase Week 0-16||76
10623856|NCT01988103|11782489|FG003|COMPLETED|Placebo-Controlled Phase Week 0-16||0
10623857|NCT01988103|11782490|FG004|COMPLETED|Placebo-Controlled Phase Week 0-16||0
10623858|NCT01988103|11782486|FG000|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||12
10623859|NCT01988103|11782487|FG001|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||16
10623860|NCT01988103|11782488|FG002|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||9
10623861|NCT01988103|11782489|FG003|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||0
10623862|NCT01988103|11782490|FG004|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||0
10623863|NCT01988103|11782486|FG000|STARTED|Active Treatment Phase (Weeks 16-68)||0
10623864|NCT01988103|11782487|FG001|STARTED|Active Treatment Phase (Weeks 16-68)||69
10623865|NCT01988103|11782488|FG002|STARTED|Active Treatment Phase (Weeks 16-68)||76
10623866|NCT01988103|11782489|FG003|STARTED|Active Treatment Phase (Weeks 16-68)||36
10623867|NCT01988103|11782490|FG004|STARTED|Active Treatment Phase (Weeks 16-68)||35
10623868|NCT01988103|11782486|FG000|COMPLETED|Active Treatment Phase (Weeks 16-68)||0
10623953|NCT01989130|11782592|FG001|COMPLETED|Overall Study||27
10623869|NCT01988103|11782487|FG001|COMPLETED|Active Treatment Phase (Weeks 16-68)||56
10623870|NCT01988103|11782488|FG002|COMPLETED|Active Treatment Phase (Weeks 16-68)||65
10623871|NCT01988103|11782489|FG003|COMPLETED|Active Treatment Phase (Weeks 16-68)||33
10623872|NCT01988103|11782490|FG004|COMPLETED|Active Treatment Phase (Weeks 16-68)||30
10623873|NCT01988103|11782486|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||0
10623874|NCT01988103|11782487|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||13
10623875|NCT01988103|11782488|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||11
10623876|NCT01988103|11782489|FG003|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||3
10623877|NCT01988103|11782490|FG004|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||5
10623878|NCT01988103|11782486|FG000|STARTED|Observational Follow-up Phase||12
10623879|NCT01988103|11782487|FG001|STARTED|Observational Follow-up Phase||82
10623880|NCT01988103|11782488|FG002|STARTED|Observational Follow-up Phase||83
10623881|NCT01988103|11782489|FG003|STARTED|Observational Follow-up Phase||36
10623882|NCT01988103|11782490|FG004|STARTED|Observational Follow-up Phase||33
10623883|NCT01988103|11782486|FG000|COMPLETED|Observational Follow-up Phase||12
10623884|NCT01988103|11782487|FG001|COMPLETED|Observational Follow-up Phase||79
10623885|NCT01988103|11782488|FG002|COMPLETED|Observational Follow-up Phase||82
10623886|NCT01988103|11782489|FG003|COMPLETED|Observational Follow-up Phase||36
10623887|NCT01988103|11782490|FG004|COMPLETED|Observational Follow-up Phase||33
10623888|NCT01988103|11782486|FG000|NOT COMPLETED|Observational Follow-up Phase||0
10623889|NCT01988103|11782487|FG001|NOT COMPLETED|Observational Follow-up Phase||3
10623890|NCT01988103|11782488|FG002|NOT COMPLETED|Observational Follow-up Phase||1
10623891|NCT01988103|11782489|FG003|NOT COMPLETED|Observational Follow-up Phase||0
10623892|NCT01988103|11782490|FG004|NOT COMPLETED|Observational Follow-up Phase||0
10623893|NCT01988129|11782507|FG000|STARTED|Overall Study|Intervention participant data obtained from department. Individuals not enrolled for primary aim.|601
10623894|NCT01988129|11782508|FG001|STARTED|Overall Study|Control participant data obtained from department. Individuals were not enrolled.|588
10623895|NCT01988129|11782507|FG000|Attended Education Session|Overall Study||542
10623896|NCT01988129|11782508|FG001|Attended Education Session|Overall Study||18
10623897|NCT01988129|11782507|FG000|Screened for Sleep Disorders|Overall Study||416
10623898|NCT01988129|11782508|FG001|Screened for Sleep Disorders|Overall Study||15
10623899|NCT01988129|11782507|FG000|Completed 1-year Follow-up Survey|Overall Study||100
10623900|NCT01988129|11782508|FG001|Completed 1-year Follow-up Survey|Overall Study||4
10623901|NCT01988129|11782507|FG000|COMPLETED|Overall Study||601
10623902|NCT01988129|11782508|FG001|COMPLETED|Overall Study||588
10623903|NCT01988129|11782507|FG000|NOT COMPLETED|Overall Study||0
10623904|NCT01988129|11782508|FG001|NOT COMPLETED|Overall Study||0
10623905|NCT01988246|11782519|FG000|STARTED|Overall Study||15
10623906|NCT01988246|11782520|FG001|STARTED|Overall Study||15
10623907|NCT01988246|11782519|FG000|COMPLETED|Overall Study||14
10623908|NCT01988246|11782520|FG001|COMPLETED|Overall Study||15
10623909|NCT01988246|11782519|FG000|NOT COMPLETED|Overall Study||1
10623910|NCT01988246|11782520|FG001|NOT COMPLETED|Overall Study||0
10623911|NCT01988376|11782528|FG000|STARTED|Overall Study||129
10623912|NCT01988376|11782529|FG001|STARTED|Overall Study||129
10623913|NCT01988376|11782528|FG000|COMPLETED|Overall Study||129
10623914|NCT01988376|11782529|FG001|COMPLETED|Overall Study||129
10623915|NCT01988376|11782528|FG000|NOT COMPLETED|Overall Study||0
10623916|NCT01988376|11782529|FG001|NOT COMPLETED|Overall Study||0
10623917|NCT01988402|11782537|FG000|STARTED|Overall Study||16
10623918|NCT01988402|11782538|FG001|STARTED|Overall Study||19
10623919|NCT01988402|11782537|FG000|COMPLETED|Overall Study||14
10623920|NCT01988402|11782538|FG001|COMPLETED|Overall Study||17
10623921|NCT01988402|11782537|FG000|NOT COMPLETED|Overall Study||2
10623922|NCT01988402|11782538|FG001|NOT COMPLETED|Overall Study||2
10623923|NCT01988415|11782544|FG000|STARTED|Overall Study|52 eyes of 26 subjects (paired-eyes: commercial and investigational software)|26
10623924|NCT01988415|11782544|FG000|COMPLETED|Overall Study||26
10623925|NCT01988415|11782544|FG000|NOT COMPLETED|Overall Study||0
10623926|NCT01988662|11782552|FG000|STARTED|Overall Study||104
10623927|NCT01988662|11782553|FG001|STARTED|Overall Study||101
10623928|NCT01988662|11782552|FG000|COMPLETED|Overall Study||100
10623929|NCT01988662|11782553|FG001|COMPLETED|Overall Study||99
10623930|NCT01988662|11782552|FG000|NOT COMPLETED|Overall Study||4
10623931|NCT01988662|11782553|FG001|NOT COMPLETED|Overall Study||2
10623932|NCT01988779|11782562|FG000|STARTED|Overall Study||12
10623933|NCT01988779|11782563|FG001|STARTED|Overall Study||13
10623934|NCT01988779|11782562|FG000|COMPLETED|Overall Study||9
10623935|NCT01988779|11782563|FG001|COMPLETED|Overall Study||11
10623936|NCT01988779|11782562|FG000|NOT COMPLETED|Overall Study||3
10623937|NCT01988779|11782563|FG001|NOT COMPLETED|Overall Study||2
10623938|NCT01988857|11782569|FG000|STARTED|Overall Study||300
10623939|NCT01988857|11782569|FG000|COMPLETED|Overall Study||300
10623940|NCT01988857|11782569|FG000|NOT COMPLETED|Overall Study||0
10623941|NCT01988922|11782576|FG000|STARTED|Overall Study||10
10623942|NCT01988922|11782577|FG001|STARTED|Overall Study||10
10623943|NCT01988922|11782578|FG002|STARTED|Overall Study||10
10623944|NCT01988922|11782576|FG000|COMPLETED|Overall Study||10
10623945|NCT01988922|11782577|FG001|COMPLETED|Overall Study||10
10623946|NCT01988922|11782578|FG002|COMPLETED|Overall Study||10
10623947|NCT01988922|11782576|FG000|NOT COMPLETED|Overall Study||0
10623948|NCT01988922|11782577|FG001|NOT COMPLETED|Overall Study||0
10623949|NCT01988922|11782578|FG002|NOT COMPLETED|Overall Study||0
10623950|NCT01989130|11782591|FG000|STARTED|Overall Study||43
10623951|NCT01989130|11782592|FG001|STARTED|Overall Study||27
10623952|NCT01989130|11782591|FG000|COMPLETED|Overall Study||43
10623954|NCT01989130|11782591|FG000|NOT COMPLETED|Overall Study||0
10623955|NCT01989130|11782592|FG001|NOT COMPLETED|Overall Study||0
10623956|NCT01989156|11782601|FG000|STARTED|Confinement Period (Population at Day 5)||80
10623957|NCT01989156|11782602|FG001|STARTED|Confinement Period (Population at Day 5)||41
10623958|NCT01989156|11782603|FG002|STARTED|Confinement Period (Population at Day 5)||39
10623959|NCT01989156|11782601|FG000|COMPLETED|Confinement Period (Population at Day 5)||80
10623960|NCT01989156|11782602|FG001|COMPLETED|Confinement Period (Population at Day 5)||40
10623961|NCT01989156|11782603|FG002|COMPLETED|Confinement Period (Population at Day 5)||34
10623962|NCT01989156|11782601|FG000|NOT COMPLETED|Confinement Period (Population at Day 5)||0
10623963|NCT01989156|11782602|FG001|NOT COMPLETED|Confinement Period (Population at Day 5)||1
10623964|NCT01989156|11782603|FG002|NOT COMPLETED|Confinement Period (Population at Day 5)||5
10623965|NCT01989156|11782601|FG000|STARTED|End of Study (Population at Day 90)||80
10623966|NCT01989156|11782602|FG001|STARTED|End of Study (Population at Day 90)||40
10623967|NCT01989156|11782603|FG002|STARTED|End of Study (Population at Day 90)||34
10623968|NCT01989156|11782601|FG000|COMPLETED|End of Study (Population at Day 90)||73
10623969|NCT01989156|11782602|FG001|COMPLETED|End of Study (Population at Day 90)||35
10623970|NCT01989156|11782603|FG002|COMPLETED|End of Study (Population at Day 90)||31
10623971|NCT01989156|11782601|FG000|NOT COMPLETED|End of Study (Population at Day 90)||7
10623972|NCT01989156|11782602|FG001|NOT COMPLETED|End of Study (Population at Day 90)||5
10623973|NCT01989156|11782603|FG002|NOT COMPLETED|End of Study (Population at Day 90)||3
10623974|NCT01989169|11782613|FG000|STARTED|Period 1||15
10623975|NCT01989169|11782614|FG001|STARTED|Period 1||15
10623976|NCT01989169|11782613|FG000|COMPLETED|Period 1||15
10623977|NCT01989169|11782614|FG001|COMPLETED|Period 1||15
10623978|NCT01989169|11782613|FG000|NOT COMPLETED|Period 1||0
10623979|NCT01989169|11782614|FG001|NOT COMPLETED|Period 1||0
10623980|NCT01989169|11782613|FG000|STARTED|Period 2||15
10623981|NCT01989169|11782614|FG001|STARTED|Period 2||15
10623982|NCT01989169|11782613|FG000|COMPLETED|Period 2||15
10623983|NCT01989169|11782614|FG001|COMPLETED|Period 2||14
10623984|NCT01989169|11782613|FG000|NOT COMPLETED|Period 2||0
10623985|NCT01989169|11782614|FG001|NOT COMPLETED|Period 2||1
10623986|NCT01989195|11782620|FG000|STARTED|Overall Study||6
10623987|NCT01989195|11782620|FG000|COMPLETED|Overall Study||6
10623988|NCT01989195|11782620|FG000|NOT COMPLETED|Overall Study||0
10623989|NCT01989208|11782629|FG000|STARTED|200 mg (7 Days)||4
10623990|NCT01989208|11782630|FG001|STARTED|200 mg (7 Days)||12
10623991|NCT01989208|11782629|FG000|COMPLETED|200 mg (7 Days)||4
10623992|NCT01989208|11782630|FG001|COMPLETED|200 mg (7 Days)||11
10623993|NCT01989208|11782629|FG000|NOT COMPLETED|200 mg (7 Days)||0
10623994|NCT01989208|11782630|FG001|NOT COMPLETED|200 mg (7 Days)||1
10623995|NCT01989208|11782629|FG000|STARTED|400 mg (7 Days)||4
10623996|NCT01989208|11782630|FG001|STARTED|400 mg (7 Days)||11
10623997|NCT01989208|11782629|FG000|COMPLETED|400 mg (7 Days)||4
10623998|NCT01989208|11782630|FG001|COMPLETED|400 mg (7 Days)||11
10623999|NCT01989208|11782629|FG000|NOT COMPLETED|400 mg (7 Days)||0
10624000|NCT01989208|11782630|FG001|NOT COMPLETED|400 mg (7 Days)||0
10624001|NCT01989208|11782629|FG000|STARTED|800 mg (7 Days)||4
10624002|NCT01989208|11782630|FG001|STARTED|800 mg (7 Days)||11
10624003|NCT01989208|11782629|FG000|COMPLETED|800 mg (7 Days)||4
10624004|NCT01989208|11782630|FG001|COMPLETED|800 mg (7 Days)||11
10624005|NCT01989208|11782629|FG000|NOT COMPLETED|800 mg (7 Days)||0
10624006|NCT01989208|11782630|FG001|NOT COMPLETED|800 mg (7 Days)||0
10624007|NCT01989221|11782648|FG000|STARTED|Overall Study||14
10624008|NCT01989221|11782648|FG000|COMPLETED|Overall Study||14
10624009|NCT01989221|11782648|FG000|NOT COMPLETED|Overall Study||0
10624010|NCT01989455|11782657|FG000|STARTED|Overall Study||14
10624011|NCT01989455|11782658|FG001|STARTED|Overall Study||14
10624012|NCT01989455|11782659|FG002|STARTED|Overall Study||14
10624013|NCT01989455|11782660|FG003|STARTED|Overall Study||14
10624014|NCT01989455|11782661|FG004|STARTED|Overall Study||8
10624015|NCT01989455|11782657|FG000|COMPLETED|Overall Study||14
10624016|NCT01989455|11782658|FG001|COMPLETED|Overall Study||12
10624017|NCT01989455|11782659|FG002|COMPLETED|Overall Study||13
10624018|NCT01989455|11782660|FG003|COMPLETED|Overall Study||14
10624019|NCT01989455|11782661|FG004|COMPLETED|Overall Study||7
10624020|NCT01989455|11782657|FG000|NOT COMPLETED|Overall Study||0
10624021|NCT01989455|11782658|FG001|NOT COMPLETED|Overall Study||2
10624022|NCT01989455|11782659|FG002|NOT COMPLETED|Overall Study||1
10624023|NCT01989455|11782660|FG003|NOT COMPLETED|Overall Study||0
10624024|NCT01989455|11782661|FG004|NOT COMPLETED|Overall Study||1
10624025|NCT01989468|11782680|FG000|STARTED|Overall Study||138
10624026|NCT01989468|11782681|FG001|STARTED|Overall Study||139
10624027|NCT01989468|11782682|FG002|STARTED|Overall Study||64
10624028|NCT01989468|11782683|FG003|STARTED|Overall Study||65
10624029|NCT01989468|11782684|FG004|STARTED|Overall Study||8
10624030|NCT01989468|11782680|FG000|COMPLETED|Overall Study||91
10624031|NCT01989468|11782681|FG001|COMPLETED|Overall Study||102
10624032|NCT01989468|11782682|FG002|COMPLETED|Overall Study||45
10624033|NCT01989468|11782683|FG003|COMPLETED|Overall Study||49
10624034|NCT01989468|11782684|FG004|COMPLETED|Overall Study||0
10624035|NCT01989468|11782680|FG000|NOT COMPLETED|Overall Study||47
10624036|NCT01989468|11782681|FG001|NOT COMPLETED|Overall Study||37
10624037|NCT01989468|11782682|FG002|NOT COMPLETED|Overall Study||19
10624038|NCT01989468|11782683|FG003|NOT COMPLETED|Overall Study||16
10624039|NCT01989468|11782684|FG004|NOT COMPLETED|Overall Study||8
10624040|NCT01989546|11782697|FG000|STARTED|Overall Study||9
10624041|NCT01989546|11782697|FG000|COMPLETED|Overall Study||0
10624042|NCT01989546|11782697|FG000|NOT COMPLETED|Overall Study||9
10624043|NCT01989572|11782707|FG000|STARTED|Overall Study||109
10624044|NCT01989572|11782708|FG001|STARTED|Overall Study||111
10624045|NCT01989572|11782709|FG002|STARTED|Overall Study||109
10624046|NCT01989572|11782710|FG003|STARTED|Overall Study||107
10624047|NCT01989572|11782711|FG004|STARTED|Overall Study||190
10624048|NCT01989572|11782712|FG005|STARTED|Overall Study||189
10624049|NCT01989572|11782707|FG000|Treated|Overall Study||104
10624050|NCT01989572|11782708|FG001|Treated|Overall Study||110
10624051|NCT01989572|11782709|FG002|Treated|Overall Study||107
10624052|NCT01989572|11782710|FG003|Treated|Overall Study||104
10624053|NCT01989572|11782711|FG004|Treated|Overall Study||186
10624054|NCT01989572|11782712|FG005|Treated|Overall Study||171
10624055|NCT01989572|11782707|FG000|COMPLETED|Overall Study||54
10624056|NCT01989572|11782708|FG001|COMPLETED|Overall Study||53
10624057|NCT01989572|11782709|FG002|COMPLETED|Overall Study||47
10624058|NCT01989572|11782710|FG003|COMPLETED|Overall Study||56
10624059|NCT01989572|11782711|FG004|COMPLETED|Overall Study||92
10624060|NCT01989572|11782712|FG005|COMPLETED|Overall Study||79
10624061|NCT01989572|11782707|FG000|NOT COMPLETED|Overall Study||55
10624062|NCT01989572|11782708|FG001|NOT COMPLETED|Overall Study||58
10624063|NCT01989572|11782709|FG002|NOT COMPLETED|Overall Study||62
10624064|NCT01989572|11782710|FG003|NOT COMPLETED|Overall Study||51
10624065|NCT01989572|11782711|FG004|NOT COMPLETED|Overall Study||98
10624066|NCT01989572|11782712|FG005|NOT COMPLETED|Overall Study||110
10624067|NCT01989689|11782732|FG000|STARTED|Baseline||11
10624068|NCT01989689|11782733|FG001|STARTED|Baseline||13
10624069|NCT01989689|11782732|FG000|COMPLETED|Baseline||11
10624070|NCT01989689|11782733|FG001|COMPLETED|Baseline||13
10624071|NCT01989689|11782732|FG000|NOT COMPLETED|Baseline||0
10624072|NCT01989689|11782733|FG001|NOT COMPLETED|Baseline||0
10624073|NCT01989689|11782732|FG000|STARTED|Treatment Period 1 ( 3 Months)||11
10624074|NCT01989689|11782733|FG001|STARTED|Treatment Period 1 ( 3 Months)||13
10624075|NCT01989689|11782732|FG000|COMPLETED|Treatment Period 1 ( 3 Months)||11
10624076|NCT01989689|11782733|FG001|COMPLETED|Treatment Period 1 ( 3 Months)||10
10624077|NCT01989689|11782732|FG000|NOT COMPLETED|Treatment Period 1 ( 3 Months)||0
10624078|NCT01989689|11782733|FG001|NOT COMPLETED|Treatment Period 1 ( 3 Months)||3
10624079|NCT01989689|11782732|FG000|STARTED|Treatment Period ( 3 Months)||11
10624080|NCT01989689|11782733|FG001|STARTED|Treatment Period ( 3 Months)||10
10624081|NCT01989689|11782732|FG000|COMPLETED|Treatment Period ( 3 Months)||11
10624082|NCT01989689|11782733|FG001|COMPLETED|Treatment Period ( 3 Months)||10
10624083|NCT01989689|11782732|FG000|NOT COMPLETED|Treatment Period ( 3 Months)||0
10624084|NCT01989689|11782733|FG001|NOT COMPLETED|Treatment Period ( 3 Months)||0
10624085|NCT01989754|11782743|FG000|STARTED|Overall Study||2905
10624086|NCT01989754|11782744|FG001|STARTED|Overall Study||2907
10624087|NCT01989754|11782743|FG000|Treated|Overall Study||2903
10624088|NCT01989754|11782744|FG001|Treated|Overall Study||2904
10624089|NCT01989754|11782743|FG000|COMPLETED|Overall Study|Participants who died are included in this category.|2866
10624090|NCT01989754|11782744|FG001|COMPLETED|Overall Study|Participants who died are included in this category.|2872
10624091|NCT01989754|11782743|FG000|NOT COMPLETED|Overall Study||39
10624092|NCT01989754|11782744|FG001|NOT COMPLETED|Overall Study||35
10624093|NCT01989793|11782752|FG000|STARTED|Overall Study||18
10624094|NCT01989793|11782753|FG001|STARTED|Overall Study||19
10624095|NCT01989793|11782752|FG000|COMPLETED|Overall Study||10
10624096|NCT01989793|11782753|FG001|COMPLETED|Overall Study||15
10624097|NCT01989793|11782752|FG000|NOT COMPLETED|Overall Study||8
10624098|NCT01989793|11782753|FG001|NOT COMPLETED|Overall Study||4
10624099|NCT01989910|11782761|FG000|STARTED|Overall Study||53
10624100|NCT01989910|11782762|FG001|STARTED|Overall Study||54
10624101|NCT01989910|11782761|FG000|COMPLETED|Overall Study||51
10624102|NCT01989910|11782762|FG001|COMPLETED|Overall Study||54
10624103|NCT01989910|11782761|FG000|NOT COMPLETED|Overall Study||2
10624104|NCT01989910|11782762|FG001|NOT COMPLETED|Overall Study||0
10624105|NCT01989975|11782768|FG000|STARTED|Overall Study||40
10624106|NCT01989975|11782768|FG000|COMPLETED|Overall Study||40
10624107|NCT01989975|11782768|FG000|NOT COMPLETED|Overall Study||0
10624108|NCT01990261|11782772|FG000|STARTED|Overall Study||33
10624109|NCT01990261|11782772|FG000|Treated|Overall Study||29
10624110|NCT01990261|11782772|FG000|COMPLETED|Overall Study||8
10624111|NCT01990261|11782772|FG000|NOT COMPLETED|Overall Study||25
10624112|NCT01990300|11782776|FG000|STARTED|Overall Study||3281
10624113|NCT01990300|11782776|FG000|COMPLETED|Overall Study||3139
10624114|NCT01990300|11782776|FG000|NOT COMPLETED|Overall Study||142
10624115|NCT01990313|11782780|FG000|STARTED|Overall Study||15
10624116|NCT01990313|11782780|FG000|COMPLETED|Overall Study||14
10624117|NCT01990313|11782780|FG000|NOT COMPLETED|Overall Study||1
10624118|NCT01990339|11782784|FG000|STARTED|Overall Study||14965
10624119|NCT01990339|11782784|FG000|COMPLETED|Overall Study||12653
10624120|NCT01990339|11782784|FG000|NOT COMPLETED|Overall Study||2312
10624121|NCT01990495|11782790|FG000|STARTED|Overall Study||18
10624122|NCT01990495|11782791|FG001|STARTED|Overall Study||19
10624123|NCT01990495|11782790|FG000|COMPLETED|Overall Study||13
10624124|NCT01990495|11782791|FG001|COMPLETED|Overall Study||15
10624125|NCT01990495|11782790|FG000|NOT COMPLETED|Overall Study||5
10624126|NCT01990495|11782791|FG001|NOT COMPLETED|Overall Study||4
10624127|NCT01990534|11782799|FG000|STARTED|Overall Study||60
10624128|NCT01990534|11782799|FG000|COMPLETED|Overall Study||25
10624129|NCT01990534|11782799|FG000|NOT COMPLETED|Overall Study||35
10624130|NCT01990560|11782803|FG000|STARTED|Overall Study||8
10624131|NCT01990560|11782803|FG000|COMPLETED|Overall Study||7
10624132|NCT01990560|11782803|FG000|NOT COMPLETED|Overall Study||1
10624133|NCT01990573|11782810|FG000|STARTED|Overall Study||20
10624134|NCT01990573|11782811|FG001|STARTED|Overall Study||14
10624135|NCT01990573|11782812|FG002|STARTED|Overall Study||17
10624136|NCT01990573|11782810|FG000|COMPLETED|Overall Study||20
10624137|NCT01990573|11782811|FG001|COMPLETED|Overall Study||14
10624138|NCT01990573|11782812|FG002|COMPLETED|Overall Study||16
10624139|NCT01990573|11782810|FG000|NOT COMPLETED|Overall Study||0
10624140|NCT01990573|11782811|FG001|NOT COMPLETED|Overall Study||0
10624141|NCT01990573|11782812|FG002|NOT COMPLETED|Overall Study||1
10624142|NCT01990612|11782822|FG000|STARTED|Overall Study||3044
10624143|NCT01990612|11782823|FG001|STARTED|Overall Study||3062
10624144|NCT01990612|11782822|FG000|COMPLETED|Overall Study||3037
10624145|NCT01990612|11782823|FG001|COMPLETED|Overall Study||3059
10624146|NCT01990612|11782822|FG000|NOT COMPLETED|Overall Study||7
10624147|NCT01990612|11782823|FG001|NOT COMPLETED|Overall Study||3
10624148|NCT01990664|11782831|FG000|STARTED|Overall Study||102
10624149|NCT01990664|11782832|FG001|STARTED|Overall Study||90
10624150|NCT01990664|11782831|FG000|COMPLETED|Overall Study||95
10624151|NCT01990664|11782832|FG001|COMPLETED|Overall Study||79
10624152|NCT01990664|11782831|FG000|NOT COMPLETED|Overall Study||7
10624153|NCT01990664|11782832|FG001|NOT COMPLETED|Overall Study||11
10624154|NCT01990677|11782840|FG000|STARTED|Overall Study||12
10624155|NCT01990677|11782841|FG001|STARTED|Overall Study||6
10624156|NCT01990677|11782840|FG000|COMPLETED|Overall Study||10
10624157|NCT01990677|11782841|FG001|COMPLETED|Overall Study||5
10624158|NCT01990677|11782840|FG000|NOT COMPLETED|Overall Study||2
10624159|NCT01990677|11782841|FG001|NOT COMPLETED|Overall Study||1
10624160|NCT01990703|11782849|FG000|STARTED|Overall Study||147
10624161|NCT01990703|11782850|FG001|STARTED|Overall Study||138
10624162|NCT01990703|11782849|FG000|COMPLETED|Overall Study||108
10624163|NCT01990703|11782850|FG001|COMPLETED|Overall Study||93
10624164|NCT01990703|11782849|FG000|NOT COMPLETED|Overall Study||39
10624165|NCT01990703|11782850|FG001|NOT COMPLETED|Overall Study||45
10624166|NCT01990742|11782858|FG000|STARTED|Overall Study|This is a facility-level intervention, access to individual level records occurred via MDS data only|3259
10624167|NCT01990742|11782859|FG001|STARTED|Overall Study|This is a facility-level control , access to individual participants occurred only via MDS records.|4331
10624168|NCT01990742|11782858|FG000|COMPLETED|Overall Study|Fourteen facilities completed the intervention.|2852
10624169|NCT01990742|11782859|FG001|COMPLETED|Overall Study|Eleven nursing homes completed the control group /usual care allocation.|2978
10624170|NCT01990742|11782858|FG000|NOT COMPLETED|Overall Study||407
10624171|NCT01990742|11782859|FG001|NOT COMPLETED|Overall Study||1353
10624172|NCT01990768|11782868|FG000|STARTED|Intervention Started||345
10624173|NCT01990768|11782869|FG001|STARTED|Intervention Started||345
10624174|NCT01990768|11782870|FG002|STARTED|Intervention Started||373
10624175|NCT01990768|11782868|FG000|COMPLETED|Intervention Started||309
10624176|NCT01990768|11782869|FG001|COMPLETED|Intervention Started||312
10624177|NCT01990768|11782870|FG002|COMPLETED|Intervention Started||346
10624178|NCT01990768|11782868|FG000|NOT COMPLETED|Intervention Started||36
10624179|NCT01990768|11782869|FG001|NOT COMPLETED|Intervention Started||33
10624180|NCT01990768|11782870|FG002|NOT COMPLETED|Intervention Started||27
10624181|NCT01990768|11782868|FG000|STARTED|Prehospital Study Drug Infusion||309
10624182|NCT01990768|11782869|FG001|STARTED|Prehospital Study Drug Infusion||312
10624183|NCT01990768|11782870|FG002|STARTED|Prehospital Study Drug Infusion||346
10624184|NCT01990768|11782868|FG000|COMPLETED|Prehospital Study Drug Infusion||290
10624185|NCT01990768|11782869|FG001|COMPLETED|Prehospital Study Drug Infusion||285
10624186|NCT01990768|11782870|FG002|COMPLETED|Prehospital Study Drug Infusion||327
10624187|NCT01990768|11782868|FG000|NOT COMPLETED|Prehospital Study Drug Infusion||19
10624188|NCT01990768|11782869|FG001|NOT COMPLETED|Prehospital Study Drug Infusion||27
10624189|NCT01990768|11782870|FG002|NOT COMPLETED|Prehospital Study Drug Infusion||19
10624190|NCT01990768|11782868|FG000|STARTED|In-Hospital Study Drug Infusion||309
10624191|NCT01990768|11782869|FG001|STARTED|In-Hospital Study Drug Infusion||312
10624192|NCT01990768|11782870|FG002|STARTED|In-Hospital Study Drug Infusion||346
10624193|NCT01990768|11782868|FG000|COMPLETED|In-Hospital Study Drug Infusion||214
10624194|NCT01990768|11782869|FG001|COMPLETED|In-Hospital Study Drug Infusion||229
10624195|NCT01990768|11782870|FG002|COMPLETED|In-Hospital Study Drug Infusion||266
10624196|NCT01990768|11782868|FG000|NOT COMPLETED|In-Hospital Study Drug Infusion||95
10624197|NCT01990768|11782869|FG001|NOT COMPLETED|In-Hospital Study Drug Infusion||83
10624198|NCT01990768|11782870|FG002|NOT COMPLETED|In-Hospital Study Drug Infusion||80
10624199|NCT01990768|11782868|FG000|STARTED|6-Month Follow-up||309
10624200|NCT01990768|11782869|FG001|STARTED|6-Month Follow-up||312
10624201|NCT01990768|11782870|FG002|STARTED|6-Month Follow-up||346
10624202|NCT01990768|11782868|FG000|COMPLETED|6-Month Follow-up||270
10624203|NCT01990768|11782869|FG001|COMPLETED|6-Month Follow-up||261
10624204|NCT01990768|11782870|FG002|COMPLETED|6-Month Follow-up||288
10624205|NCT01990768|11782868|FG000|NOT COMPLETED|6-Month Follow-up||39
10624206|NCT01990768|11782869|FG001|NOT COMPLETED|6-Month Follow-up||51
10624207|NCT01990768|11782870|FG002|NOT COMPLETED|6-Month Follow-up||58
10624208|NCT01990794|11782879|FG000|STARTED|Overall Study||13
10624209|NCT01990794|11782879|FG000|One Month Into Study|Overall Study||10
10624210|NCT01990794|11782879|FG000|COMPLETED|Overall Study||10
10624211|NCT01990794|11782879|FG000|NOT COMPLETED|Overall Study||3
10624212|NCT01990820|11782968|FG000|STARTED|Overall Study||13
10624213|NCT01990820|11782969|FG001|STARTED|Overall Study||12
10624214|NCT01990820|11782968|FG000|COMPLETED|Overall Study||13
10624215|NCT01990820|11782969|FG001|COMPLETED|Overall Study||12
10624216|NCT01990820|11782968|FG000|NOT COMPLETED|Overall Study||0
10624217|NCT01990820|11782969|FG001|NOT COMPLETED|Overall Study||0
10624218|NCT01990859|11782975|FG000|STARTED|Treatment (4 Doses Over 12 Weeks)||20
10624219|NCT01990859|11782975|FG000|COMPLETED|Treatment (4 Doses Over 12 Weeks)||15
10624220|NCT01990859|11782975|FG000|NOT COMPLETED|Treatment (4 Doses Over 12 Weeks)||5
10624221|NCT01990859|11782975|FG000|STARTED|Week 12 to Week 24 Post Dosing Follow Up|All were entered into follow-up whether dosing was completed or not.|20
10624222|NCT01990859|11782975|FG000|COMPLETED|Week 12 to Week 24 Post Dosing Follow Up||3
10624223|NCT01990859|11782975|FG000|NOT COMPLETED|Week 12 to Week 24 Post Dosing Follow Up||17
10624224|NCT01990859|11782975|FG000|STARTED|90 Day Follow Up for All Participants|All entered into 90 day follow-up whether treatment and/or post dose follow up was completed or not.|20
10624225|NCT01990859|11782975|FG000|COMPLETED|90 Day Follow Up for All Participants||20
10624226|NCT01990859|11782975|FG000|NOT COMPLETED|90 Day Follow Up for All Participants||0
10624227|NCT01990898|11782980|FG000|STARTED|Overall Study||26
10624228|NCT01990898|11782980|FG000|3 Months|Overall Study||22
10624229|NCT01990898|11782980|FG000|COMPLETED|Overall Study||22
10624230|NCT01990898|11782980|FG000|NOT COMPLETED|Overall Study||4
10624231|NCT01990950|11782984|FG000|STARTED|Overall Study||21
10624232|NCT01990950|11782984|FG000|COMPLETED|Overall Study||10
10624233|NCT01990950|11782984|FG000|NOT COMPLETED|Overall Study||11
10624234|NCT01991197|11782990|FG000|STARTED|Overall Study||9
10624235|NCT01991197|11782991|FG001|STARTED|Overall Study||11
10624236|NCT01991197|11782990|FG000|COMPLETED|Overall Study||6
10624237|NCT01991197|11782991|FG001|COMPLETED|Overall Study||8
10624238|NCT01991197|11782990|FG000|NOT COMPLETED|Overall Study||3
10624239|NCT01991197|11782991|FG001|NOT COMPLETED|Overall Study||3
10624240|NCT01991314|11783004|FG000|STARTED|Overall Study||45
10624241|NCT01991314|11783005|FG001|STARTED|Overall Study||43
10624242|NCT01991314|11783004|FG000|COMPLETED|Overall Study||34
10624243|NCT01991314|11783005|FG001|COMPLETED|Overall Study||32
10624244|NCT01991314|11783004|FG000|NOT COMPLETED|Overall Study||11
10624245|NCT01991314|11783005|FG001|NOT COMPLETED|Overall Study||11
10624246|NCT01991470|11783011|FG000|STARTED|Enlite 1 Period||161
10624247|NCT01991470|11783011|FG000|COMPLETED|Enlite 1 Period||141
10624248|NCT01991470|11783011|FG000|NOT COMPLETED|Enlite 1 Period||20
10624249|NCT01991470|11783011|FG000|STARTED|Enlite 3 Period|Additional 25 subjects who participated only Enlite 3 phase|158
10624250|NCT01991470|11783011|FG000|COMPLETED|Enlite 3 Period||146
10624251|NCT01991470|11783011|FG000|NOT COMPLETED|Enlite 3 Period||12
10624252|NCT01991483|11783027|FG000|STARTED|Dose Level: Placebo||7
10624253|NCT01991483|11783028|FG001|STARTED|Dose Level: Placebo||0
10624254|NCT01991483|11783029|FG002|STARTED|Dose Level: Placebo||0
10624255|NCT01991483|11783030|FG003|STARTED|Dose Level: Placebo||0
10624256|NCT01991483|11783027|FG000|Received at Least One Dose of Study Drug|Dose Level: Placebo||7
10624257|NCT01991483|11783028|FG001|Received at Least One Dose of Study Drug|Dose Level: Placebo||0
10624258|NCT01991483|11783029|FG002|Received at Least One Dose of Study Drug|Dose Level: Placebo||0
10624259|NCT01991483|11783030|FG003|Received at Least One Dose of Study Drug|Dose Level: Placebo||0
10624260|NCT01991483|11783027|FG000|COMPLETED|Dose Level: Placebo||7
10624261|NCT01991483|11783028|FG001|COMPLETED|Dose Level: Placebo||0
10624262|NCT01991483|11783029|FG002|COMPLETED|Dose Level: Placebo||0
10624263|NCT01991483|11783030|FG003|COMPLETED|Dose Level: Placebo||0
10624264|NCT01991483|11783027|FG000|NOT COMPLETED|Dose Level: Placebo||0
10624265|NCT01991483|11783028|FG001|NOT COMPLETED|Dose Level: Placebo||0
10624266|NCT01991483|11783029|FG002|NOT COMPLETED|Dose Level: Placebo||0
10624267|NCT01991483|11783030|FG003|NOT COMPLETED|Dose Level: Placebo||0
10624268|NCT01991483|11783027|FG000|STARTED|Dose Level 300 mg|Multiple periods were added for each dose level to represent dose escalation.|0
10624269|NCT01991483|11783028|FG001|STARTED|Dose Level 300 mg|Multiple periods were added for each dose level to represent dose escalation.|6
10624270|NCT01991483|11783029|FG002|STARTED|Dose Level 300 mg||0
10624271|NCT01991483|11783030|FG003|STARTED|Dose Level 300 mg||0
10624272|NCT01991483|11783027|FG000|Received at Least One Dose of Study Drug|Dose Level 300 mg||0
10624273|NCT01991483|11783028|FG001|Received at Least One Dose of Study Drug|Dose Level 300 mg||6
10624274|NCT01991483|11783029|FG002|Received at Least One Dose of Study Drug|Dose Level 300 mg||0
10624275|NCT01991483|11783030|FG003|Received at Least One Dose of Study Drug|Dose Level 300 mg||0
10624276|NCT01991483|11783027|FG000|COMPLETED|Dose Level 300 mg||0
10624277|NCT01991483|11783028|FG001|COMPLETED|Dose Level 300 mg||6
10624278|NCT01991483|11783029|FG002|COMPLETED|Dose Level 300 mg||0
10624279|NCT01991483|11783030|FG003|COMPLETED|Dose Level 300 mg||0
10624280|NCT01991483|11783027|FG000|NOT COMPLETED|Dose Level 300 mg||0
10624281|NCT01991483|11783028|FG001|NOT COMPLETED|Dose Level 300 mg||0
10624282|NCT01991483|11783029|FG002|NOT COMPLETED|Dose Level 300 mg||0
10624283|NCT01991483|11783030|FG003|NOT COMPLETED|Dose Level 300 mg||0
10624284|NCT01991483|11783027|FG000|STARTED|Dose Level 600 mg||0
10624285|NCT01991483|11783028|FG001|STARTED|Dose Level 600 mg|Multiple periods were added for each dose level to represent dose escalation.|0
10624286|NCT01991483|11783029|FG002|STARTED|Dose Level 600 mg|Multiple periods were added for each dose level to represent dose escalation.|11
10624287|NCT01991483|11783030|FG003|STARTED|Dose Level 600 mg||0
10624288|NCT01991483|11783027|FG000|Receive at Least One Dose of Study Drug|Dose Level 600 mg||0
10624289|NCT01991483|11783028|FG001|Receive at Least One Dose of Study Drug|Dose Level 600 mg||0
10624290|NCT01991483|11783029|FG002|Receive at Least One Dose of Study Drug|Dose Level 600 mg||11
10624291|NCT01991483|11783030|FG003|Receive at Least One Dose of Study Drug|Dose Level 600 mg||0
10624292|NCT01991483|11783027|FG000|COMPLETED|Dose Level 600 mg||0
10624293|NCT01991483|11783028|FG001|COMPLETED|Dose Level 600 mg||0
10624294|NCT01991483|11783029|FG002|COMPLETED|Dose Level 600 mg||9
10624295|NCT01991483|11783030|FG003|COMPLETED|Dose Level 600 mg||0
10624296|NCT01991483|11783027|FG000|NOT COMPLETED|Dose Level 600 mg||0
10624297|NCT01991483|11783028|FG001|NOT COMPLETED|Dose Level 600 mg||0
10624298|NCT01991483|11783029|FG002|NOT COMPLETED|Dose Level 600 mg||2
10624299|NCT01991483|11783030|FG003|NOT COMPLETED|Dose Level 600 mg||0
10624300|NCT01991483|11783027|FG000|STARTED|Dose Level 1000 mg||0
10624301|NCT01991483|11783028|FG001|STARTED|Dose Level 1000 mg||0
10624302|NCT01991483|11783029|FG002|STARTED|Dose Level 1000 mg|Multiple periods were added for each dose level to represent dose escalation.|0
10624303|NCT01991483|11783030|FG003|STARTED|Dose Level 1000 mg|Multiple periods were added for each dose level to represent dose escalation.|4
10624304|NCT01991483|11783027|FG000|Received at Least One Dose of Study Drug|Dose Level 1000 mg||0
10624305|NCT01991483|11783028|FG001|Received at Least One Dose of Study Drug|Dose Level 1000 mg||0
10624306|NCT01991483|11783029|FG002|Received at Least One Dose of Study Drug|Dose Level 1000 mg||0
10624307|NCT01991483|11783030|FG003|Received at Least One Dose of Study Drug|Dose Level 1000 mg||4
10624308|NCT01991483|11783027|FG000|COMPLETED|Dose Level 1000 mg||0
10624309|NCT01991483|11783028|FG001|COMPLETED|Dose Level 1000 mg||0
10624310|NCT01991483|11783029|FG002|COMPLETED|Dose Level 1000 mg||0
10624311|NCT01991483|11783030|FG003|COMPLETED|Dose Level 1000 mg||3
10624312|NCT01991483|11783027|FG000|NOT COMPLETED|Dose Level 1000 mg||0
10624313|NCT01991483|11783028|FG001|NOT COMPLETED|Dose Level 1000 mg||0
10624314|NCT01991483|11783029|FG002|NOT COMPLETED|Dose Level 1000 mg||0
10624315|NCT01991483|11783030|FG003|NOT COMPLETED|Dose Level 1000 mg||1
10624316|NCT01991522|11783045|FG000|STARTED|Overall Study||16
10624317|NCT01991522|11783046|FG001|STARTED|Overall Study||17
10624318|NCT01991522|11783045|FG000|COMPLETED|Overall Study||16
10624319|NCT01991522|11783046|FG001|COMPLETED|Overall Study||17
10624320|NCT01991522|11783045|FG000|NOT COMPLETED|Overall Study||0
10705221|NCT02596854|11869557|FG000|COMPLETED|Overall Study||109
10705222|NCT02596854|11869557|FG000|NOT COMPLETED|Overall Study||8
10624321|NCT01991522|11783046|FG001|NOT COMPLETED|Overall Study||0
10624322|NCT01991548|11783052|FG000|STARTED|Overall Study||40
10624323|NCT01991548|11783052|FG000|COMPLETED|Overall Study||39
10624324|NCT01991548|11783052|FG000|NOT COMPLETED|Overall Study||1
10624325|NCT01991743|11783060|FG000|STARTED|Overall Study||60
10624326|NCT01991743|11783061|FG001|STARTED|Overall Study||60
10624327|NCT01991743|11783062|FG002|STARTED|Overall Study||60
10624328|NCT01991743|11783063|FG003|STARTED|Overall Study||60
10624329|NCT01991743|11783060|FG000|COMPLETED|Overall Study||60
10624330|NCT01991743|11783061|FG001|COMPLETED|Overall Study||60
10624331|NCT01991743|11783062|FG002|COMPLETED|Overall Study||59
10624332|NCT01991743|11783063|FG003|COMPLETED|Overall Study||60
10624333|NCT01991743|11783060|FG000|NOT COMPLETED|Overall Study||0
10624334|NCT01991743|11783061|FG001|NOT COMPLETED|Overall Study||0
10624335|NCT01991743|11783062|FG002|NOT COMPLETED|Overall Study||1
10624336|NCT01991743|11783063|FG003|NOT COMPLETED|Overall Study||0
10624337|NCT01991795|11783075|FG000|STARTED|Overall Study||9645
10624338|NCT01991795|11783076|FG001|STARTED|Overall Study||9626
10624339|NCT01991795|11783075|FG000|COMPLETED|Overall Study||9496
10624340|NCT01991795|11783076|FG001|COMPLETED|Overall Study||9503
10624341|NCT01991795|11783075|FG000|NOT COMPLETED|Overall Study||149
10624342|NCT01991795|11783076|FG001|NOT COMPLETED|Overall Study||123
10624343|NCT01991808|11783082|FG000|STARTED|Overall Study||16
10624344|NCT01991808|11783082|FG000|COMPLETED|Overall Study||16
10624345|NCT01991808|11783082|FG000|NOT COMPLETED|Overall Study||0
10624346|NCT01991821|11783088|FG000|STARTED|Overall Study||169
10624347|NCT01991821|11783089|FG001|STARTED|Overall Study||178
10624348|NCT01991821|11783088|FG000|COMPLETED|Overall Study||6
10624349|NCT01991821|11783089|FG001|COMPLETED|Overall Study||11
10624350|NCT01991821|11783088|FG000|NOT COMPLETED|Overall Study||163
10705223|NCT02596867|11869561|FG000|STARTED|Overall Study||2
10705224|NCT02596867|11869561|FG000|2 Patients Prospectively Recruited|Overall Study||2
10624351|NCT01991821|11783089|FG001|NOT COMPLETED|Overall Study||167
10624352|NCT01991860|11783099|FG000|STARTED|Overall Study||176
10624353|NCT01991860|11783100|FG001|STARTED|Overall Study||166
10705225|NCT02596867|11869561|FG000|COMPLETED|Overall Study||2
10624354|NCT01991860|11783099|FG000|COMPLETED|Overall Study||172
10624355|NCT01991860|11783100|FG001|COMPLETED|Overall Study||164
10624356|NCT01991860|11783099|FG000|NOT COMPLETED|Overall Study||4
10624357|NCT01991860|11783100|FG001|NOT COMPLETED|Overall Study||2
10624364|NCT01991990|11783112|FG000|STARTED|Overall Study||6
10624365|NCT01991990|11783113|FG001|STARTED|Overall Study||12
10624366|NCT01991990|11783112|FG000|COMPLETED|Overall Study||6
10624367|NCT01991990|11783113|FG001|COMPLETED|Overall Study||12
10624368|NCT01991990|11783112|FG000|NOT COMPLETED|Overall Study||0
10624369|NCT01991990|11783113|FG001|NOT COMPLETED|Overall Study||0
10624370|NCT01992016|11783125|FG000|STARTED|Overall Study||4
10624371|NCT01992016|11783126|FG001|STARTED|Overall Study||7
10624372|NCT01992016|11783125|FG000|COMPLETED|Overall Study||4
10624373|NCT01992016|11783126|FG001|COMPLETED|Overall Study||7
10624374|NCT01992016|11783125|FG000|NOT COMPLETED|Overall Study||0
10624375|NCT01992016|11783126|FG001|NOT COMPLETED|Overall Study||0
10624376|NCT01992094|11783135|FG000|STARTED|Overall Study||1335
10624377|NCT01992094|11783136|FG001|STARTED|Overall Study||676
10624378|NCT01992094|11783137|FG002|STARTED|Overall Study||669
10624379|NCT01992094|11783135|FG000|COMPLETED|Overall Study||1285
10624380|NCT01992094|11783136|FG001|COMPLETED|Overall Study||652
10624381|NCT01992094|11783137|FG002|COMPLETED|Overall Study||648
10624382|NCT01992094|11783135|FG000|NOT COMPLETED|Overall Study||50
10624383|NCT01992094|11783136|FG001|NOT COMPLETED|Overall Study||24
10624384|NCT01992094|11783137|FG002|NOT COMPLETED|Overall Study||21
10624385|NCT01992107|11783164|FG000|STARTED|Overall Study||1159
10624386|NCT01992107|11783165|FG001|STARTED|Overall Study||593
10624387|NCT01992107|11783166|FG002|STARTED|Overall Study||581
10624388|NCT01992107|11783164|FG000|COMPLETED|Overall Study||1091
10624389|NCT01992107|11783165|FG001|COMPLETED|Overall Study||560
10624390|NCT01992107|11783166|FG002|COMPLETED|Overall Study||545
10624391|NCT01992107|11783164|FG000|NOT COMPLETED|Overall Study||68
10624392|NCT01992107|11783165|FG001|NOT COMPLETED|Overall Study||33
10624393|NCT01992107|11783166|FG002|NOT COMPLETED|Overall Study||36
10624394|NCT01992159|11783195|FG000|STARTED|Overall Study||63
10624395|NCT01992159|11783196|FG001|STARTED|Overall Study||63
10624396|NCT01992159|11783197|FG002|STARTED|Overall Study||63
10624397|NCT01992159|11783198|FG003|STARTED|Overall Study||63
10624398|NCT01992159|11783195|FG000|Received Treatment|Overall Study||63
10624399|NCT01992159|11783196|FG001|Received Treatment|Overall Study||63
10624400|NCT01992159|11783197|FG002|Received Treatment|Overall Study||63
10624401|NCT01992159|11783198|FG003|Received Treatment|Overall Study||63
10624402|NCT01992159|11783195|FG000|Completed First 12 Months of Study|Overall Study||59
10624403|NCT01992159|11783196|FG001|Completed First 12 Months of Study|Overall Study||56
10624404|NCT01992159|11783197|FG002|Completed First 12 Months of Study|Overall Study||63
10624405|NCT01992159|11783198|FG003|Completed First 12 Months of Study|Overall Study||59
10624406|NCT01992159|11783195|FG000|COMPLETED|Overall Study||59
10624407|NCT01992159|11783196|FG001|COMPLETED|Overall Study||55
10624408|NCT01992159|11783197|FG002|COMPLETED|Overall Study||62
10624409|NCT01992159|11783198|FG003|COMPLETED|Overall Study||59
10624410|NCT01992159|11783195|FG000|NOT COMPLETED|Overall Study||4
10624411|NCT01992159|11783196|FG001|NOT COMPLETED|Overall Study||8
10624412|NCT01992159|11783197|FG002|NOT COMPLETED|Overall Study||1
10624413|NCT01992159|11783198|FG003|NOT COMPLETED|Overall Study||4
10624414|NCT01992172|11783210|FG000|STARTED|Overall Study||7
10624415|NCT01992172|11783211|FG001|STARTED|Overall Study||0
10624416|NCT01992172|11783210|FG000|COMPLETED|Overall Study||7
10624417|NCT01992172|11783211|FG001|COMPLETED|Overall Study||0
10624418|NCT01992172|11783210|FG000|NOT COMPLETED|Overall Study||0
10624419|NCT01992172|11783211|FG001|NOT COMPLETED|Overall Study||0
10624420|NCT01992185|11783219|FG000|STARTED|Overall Study||7
10624421|NCT01992185|11783220|FG001|STARTED|Overall Study||8
10624422|NCT01992185|11783219|FG000|COMPLETED|Overall Study||7
10624423|NCT01992185|11783220|FG001|COMPLETED|Overall Study||8
10624424|NCT01992185|11783219|FG000|NOT COMPLETED|Overall Study||0
10624425|NCT01992185|11783220|FG001|NOT COMPLETED|Overall Study||0
10624426|NCT01992354|11783226|FG000|STARTED|Overall Study||4
10624427|NCT01992354|11783226|FG000|COMPLETED|Overall Study||4
10624428|NCT01992354|11783226|FG000|NOT COMPLETED|Overall Study||0
10624429|NCT01992380|11783234|FG000|STARTED|Overall Study||6
10624430|NCT01992380|11783235|FG001|STARTED|Overall Study||8
10624431|NCT01992380|11783236|FG002|STARTED|Overall Study||10
10624432|NCT01992380|11783234|FG000|COMPLETED|Overall Study||6
10624433|NCT01992380|11783235|FG001|COMPLETED|Overall Study||8
10624434|NCT01992380|11783236|FG002|COMPLETED|Overall Study||10
10624435|NCT01992380|11783234|FG000|NOT COMPLETED|Overall Study||0
10624436|NCT01992380|11783235|FG001|NOT COMPLETED|Overall Study||0
10624437|NCT01992380|11783236|FG002|NOT COMPLETED|Overall Study||0
10624438|NCT01992523|11783244|FG000|STARTED|Overall Study||41
10624439|NCT01992523|11783245|FG001|STARTED|Overall Study||41
10624440|NCT01992523|11783244|FG000|COMPLETED|Overall Study||41
10624441|NCT01992523|11783245|FG001|COMPLETED|Overall Study||41
10624442|NCT01992523|11783244|FG000|NOT COMPLETED|Overall Study||0
10624443|NCT01992523|11783245|FG001|NOT COMPLETED|Overall Study||0
10624444|NCT01992536|11783263|FG000|STARTED|Overall Study||26
10624445|NCT01992536|11783264|FG001|STARTED|Overall Study||25
10808973|NCT03815240|11970924|FG000|COMPLETED|Intervention Mepilex Dressing||2
10705226|NCT02596867|11869561|FG000|NOT COMPLETED|Overall Study||0
10705227|NCT02596893|11869570|FG000|STARTED|Overall Double-Blind Period Weeks 0-52||174
10705228|NCT02596893|11869571|FG001|STARTED|Overall Double-Blind Period Weeks 0-52||176
10808974|NCT03815240|11970925|FG001|COMPLETED|Intervention Mepilex Dressing||1
10808975|NCT03815240|11970926|FG002|COMPLETED|Intervention Mepilex Dressing||1
10808976|NCT03815240|11970927|FG003|COMPLETED|Intervention Mepilex Dressing||2
10808977|NCT03815240|11970928|FG004|COMPLETED|Intervention Mepilex Dressing||1
10624446|NCT01992536|11783265|FG002|STARTED|Overall Study||17
10624447|NCT01992536|11783266|FG003|STARTED|Overall Study||24
10624448|NCT01992536|11783267|FG004|STARTED|Overall Study||11
10624449|NCT01992536|11783268|FG005|STARTED|Overall Study||21
10624450|NCT01992536|11783269|FG006|STARTED|Overall Study||7
10624451|NCT01992536|11783270|FG007|STARTED|Overall Study||21
10624452|NCT01992536|11783271|FG008|STARTED|Overall Study||19
10624453|NCT01992536|11783272|FG009|STARTED|Overall Study||19
10624454|NCT01992536|11783263|FG000|COMPLETED|Overall Study||22
10624455|NCT01992536|11783264|FG001|COMPLETED|Overall Study||22
10624456|NCT01992536|11783265|FG002|COMPLETED|Overall Study||16
10624457|NCT01992536|11783266|FG003|COMPLETED|Overall Study||22
10624458|NCT01992536|11783267|FG004|COMPLETED|Overall Study||11
10624459|NCT01992536|11783268|FG005|COMPLETED|Overall Study||20
10705229|NCT02596893|11869572|FG002|STARTED|Overall Double-Blind Period Weeks 0-52||176
10705230|NCT02596893|11869573|FG003|STARTED|Overall Double-Blind Period Weeks 0-52||175
10705231|NCT02596893|11869570|FG000|COMPLETED|Overall Double-Blind Period Weeks 0-52||10
10705232|NCT02596893|11869571|FG001|COMPLETED|Overall Double-Blind Period Weeks 0-52||8
10705233|NCT02596893|11869572|FG002|COMPLETED|Overall Double-Blind Period Weeks 0-52||14
10705234|NCT02596893|11869573|FG003|COMPLETED|Overall Double-Blind Period Weeks 0-52||9
10705235|NCT02596893|11869570|FG000|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||164
10705236|NCT02596893|11869571|FG001|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||168
10705237|NCT02596893|11869572|FG002|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||162
10705238|NCT02596893|11869573|FG003|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||166
10705239|NCT02596893|11869570|FG000|STARTED|Follow-Up Period Weeks 0 to 52||57
10705240|NCT02596893|11869571|FG001|STARTED|Follow-Up Period Weeks 0 to 52||51
10705241|NCT02596893|11869572|FG002|STARTED|Follow-Up Period Weeks 0 to 52||56
10705242|NCT02596893|11869573|FG003|STARTED|Follow-Up Period Weeks 0 to 52||47
10705243|NCT02596893|11869570|FG000|COMPLETED|Follow-Up Period Weeks 0 to 52||57
10705244|NCT02596893|11869571|FG001|COMPLETED|Follow-Up Period Weeks 0 to 52||51
10705245|NCT02596893|11869572|FG002|COMPLETED|Follow-Up Period Weeks 0 to 52||56
10705246|NCT02596893|11869573|FG003|COMPLETED|Follow-Up Period Weeks 0 to 52||47
10705247|NCT02596893|11869570|FG000|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
10705248|NCT02596893|11869571|FG001|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
10705249|NCT02596893|11869572|FG002|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
10705250|NCT02596893|11869573|FG003|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
10705251|NCT02596906|11869585|FG000|STARTED|Overall Study||12
10705252|NCT02596906|11869586|FG001|STARTED|Overall Study||10
10705253|NCT02596906|11869585|FG000|COMPLETED|Overall Study||8
10705254|NCT02596906|11869586|FG001|COMPLETED|Overall Study||7
10705255|NCT02596906|11869585|FG000|NOT COMPLETED|Overall Study||4
10705256|NCT02596906|11869586|FG001|NOT COMPLETED|Overall Study||3
10705257|NCT02596945|11869592|FG000|STARTED|Overall Study||223
10705258|NCT02596945|11869592|FG000|Treated|Overall Study||220
10705259|NCT02596945|11869592|FG000|COMPLETED|Overall Study||167
10705260|NCT02596945|11869592|FG000|NOT COMPLETED|Overall Study||56
10705261|NCT02596958|11869596|FG000|STARTED|Overall Study||996
10705262|NCT02596958|11869596|FG000|COMPLETED|Overall Study||0
10705263|NCT02596958|11869596|FG000|NOT COMPLETED|Overall Study||996
10705264|NCT02596971|11869603|FG000|STARTED|Overall Study||42
10705265|NCT02596971|11869604|FG001|STARTED|Overall Study||7
10705266|NCT02596971|11869605|FG002|STARTED|Overall Study||42
10705267|NCT02596971|11869603|FG000|COMPLETED|Overall Study||32
10705268|NCT02596971|11869604|FG001|COMPLETED|Overall Study||5
10705269|NCT02596971|11869605|FG002|COMPLETED|Overall Study||33
10808978|NCT03815240|11970929|FG005|COMPLETED|Intervention Mepilex Dressing||2
10808979|NCT03815240|11970930|FG006|COMPLETED|Intervention Mepilex Dressing||1
10808980|NCT03815240|11970931|FG007|COMPLETED|Intervention Mepilex Dressing||1
10808981|NCT03815240|11970932|FG008|COMPLETED|Intervention Mepilex Dressing||1
10808982|NCT03815240|11970924|FG000|NOT COMPLETED|Intervention Mepilex Dressing||0
10808983|NCT03815240|11970925|FG001|NOT COMPLETED|Intervention Mepilex Dressing||0
10808984|NCT03815240|11970926|FG002|NOT COMPLETED|Intervention Mepilex Dressing||0
10808985|NCT03815240|11970927|FG003|NOT COMPLETED|Intervention Mepilex Dressing||0
10808986|NCT03815240|11970928|FG004|NOT COMPLETED|Intervention Mepilex Dressing||0
10624460|NCT01992536|11783269|FG006|COMPLETED|Overall Study||0
10705270|NCT02596971|11869603|FG000|NOT COMPLETED|Overall Study||10
10808987|NCT03815240|11970929|FG005|NOT COMPLETED|Intervention Mepilex Dressing||0
10624461|NCT01992536|11783270|FG007|COMPLETED|Overall Study||21
10624462|NCT01992536|11783271|FG008|COMPLETED|Overall Study||18
10624463|NCT01992536|11783272|FG009|COMPLETED|Overall Study||18
10624464|NCT01992536|11783263|FG000|NOT COMPLETED|Overall Study||4
10624465|NCT01992536|11783264|FG001|NOT COMPLETED|Overall Study||3
10624466|NCT01992536|11783265|FG002|NOT COMPLETED|Overall Study||1
10624467|NCT01992536|11783266|FG003|NOT COMPLETED|Overall Study||2
10624468|NCT01992536|11783267|FG004|NOT COMPLETED|Overall Study||0
10624469|NCT01992536|11783268|FG005|NOT COMPLETED|Overall Study||1
10624470|NCT01992536|11783269|FG006|NOT COMPLETED|Overall Study||7
10624471|NCT01992536|11783270|FG007|NOT COMPLETED|Overall Study||0
10624472|NCT01992536|11783271|FG008|NOT COMPLETED|Overall Study||1
10624473|NCT01992536|11783272|FG009|NOT COMPLETED|Overall Study||1
10624474|NCT01992549|11783314|FG000|STARTED|Overall Study||48
10624475|NCT01992549|11783314|FG000|SAF Population|Overall Study||48
10624476|NCT01992549|11783314|FG000|ITT Population|Overall Study||47
10624477|NCT01992549|11783314|FG000|PROPH Population|Overall Study||47
10624478|NCT01992549|11783314|FG000|BLEED Population|Overall Study||29
10624479|NCT01992549|11783314|FG000|SURG Population|Overall Study||3
10624480|NCT01992549|11783314|FG000|COMPLETED|Overall Study||44
10624481|NCT01992549|11783314|FG000|NOT COMPLETED|Overall Study||4
10624482|NCT01992757|11783324|FG000|STARTED|Overall Study||51
10624483|NCT01992757|11783324|FG000|COMPLETED|Overall Study||49
10624484|NCT01992757|11783324|FG000|NOT COMPLETED|Overall Study||2
10624485|NCT01992874|11783329|FG000|STARTED|Part A||21
10624486|NCT01992874|11783330|FG001|STARTED|Part A||17
10624487|NCT01992874|11783331|FG002|STARTED|Part A||0
10624488|NCT01992874|11783329|FG000|COMPLETED|Part A||21
10624489|NCT01992874|11783330|FG001|COMPLETED|Part A||17
10624490|NCT01992874|11783331|FG002|COMPLETED|Part A||0
10624491|NCT01992874|11783329|FG000|NOT COMPLETED|Part A||0
10624492|NCT01992874|11783330|FG001|NOT COMPLETED|Part A||0
10624493|NCT01992874|11783331|FG002|NOT COMPLETED|Part A||0
10624494|NCT01992874|11783329|FG000|STARTED|Part B||0
10624495|NCT01992874|11783330|FG001|STARTED|Part B||0
10624496|NCT01992874|11783331|FG002|STARTED|Part B||38
10624497|NCT01992874|11783329|FG000|COMPLETED|Part B||0
10624498|NCT01992874|11783330|FG001|COMPLETED|Part B||0
10624499|NCT01992874|11783331|FG002|COMPLETED|Part B||38
10624500|NCT01992874|11783329|FG000|NOT COMPLETED|Part B||0
10624501|NCT01992874|11783330|FG001|NOT COMPLETED|Part B||0
10624502|NCT01992874|11783331|FG002|NOT COMPLETED|Part B||0
10624503|NCT01993017|11783344|FG000|STARTED|Overall Study||499
10624504|NCT01993017|11783345|FG001|STARTED|Overall Study||501
10624505|NCT01993017|11783346|FG002|STARTED|Overall Study||500
10624506|NCT01993017|11783344|FG000|COMPLETED|Overall Study||393
10624507|NCT01993017|11783345|FG001|COMPLETED|Overall Study||411
10624508|NCT01993017|11783346|FG002|COMPLETED|Overall Study||421
10624509|NCT01993017|11783344|FG000|NOT COMPLETED|Overall Study||106
10624510|NCT01993017|11783345|FG001|NOT COMPLETED|Overall Study||90
10624511|NCT01993017|11783346|FG002|NOT COMPLETED|Overall Study||79
10624512|NCT01993030|11783357|FG000|STARTED|Overall Study||36
10624513|NCT01993030|11783358|FG001|STARTED|Overall Study||35
10624514|NCT01993030|11783357|FG000|COMPLETED|Overall Study||36
10624515|NCT01993030|11783358|FG001|COMPLETED|Overall Study||31
10624516|NCT01993030|11783357|FG000|NOT COMPLETED|Overall Study||0
10624517|NCT01993030|11783358|FG001|NOT COMPLETED|Overall Study||4
10624518|NCT01993108|11783366|FG000|STARTED|Overall Study||11
10624519|NCT01993108|11783367|FG001|STARTED|Overall Study||12
10624520|NCT01993108|11783366|FG000|COMPLETED|Overall Study||11
10624521|NCT01993108|11783367|FG001|COMPLETED|Overall Study||12
10624522|NCT01993108|11783366|FG000|NOT COMPLETED|Overall Study||0
10624523|NCT01993108|11783367|FG001|NOT COMPLETED|Overall Study||0
10624524|NCT01993186|11783387|FG000|STARTED|Double-Blind Placebo-Controlled Period||25
10624525|NCT01993186|11783388|FG001|STARTED|Double-Blind Placebo-Controlled Period||11
10624526|NCT01993186|11783387|FG000|COMPLETED|Double-Blind Placebo-Controlled Period||23
10624527|NCT01993186|11783388|FG001|COMPLETED|Double-Blind Placebo-Controlled Period||11
10624528|NCT01993186|11783387|FG000|NOT COMPLETED|Double-Blind Placebo-Controlled Period||2
10624529|NCT01993186|11783388|FG001|NOT COMPLETED|Double-Blind Placebo-Controlled Period||0
10624530|NCT01993186|11783387|FG000|STARTED|Open-Label Extension Period||23
10624531|NCT01993186|11783388|FG001|STARTED|Open-Label Extension Period||11
10624532|NCT01993186|11783387|FG000|COMPLETED|Open-Label Extension Period||16
10624533|NCT01993186|11783388|FG001|COMPLETED|Open-Label Extension Period||5
10624534|NCT01993186|11783387|FG000|NOT COMPLETED|Open-Label Extension Period||7
10624535|NCT01993186|11783388|FG001|NOT COMPLETED|Open-Label Extension Period||6
10624536|NCT01993238|11783395|FG000|STARTED|Overall Study||11
10624537|NCT01993238|11783395|FG000|COMPLETED|Overall Study||11
10624538|NCT01993238|11783395|FG000|NOT COMPLETED|Overall Study||0
10624539|NCT01993329|11783405|FG000|STARTED|Period 1||3
10624540|NCT01993329|11783406|FG001|STARTED|Period 1||4
10624541|NCT01993329|11783407|FG002|STARTED|Period 1||3
10624542|NCT01993329|11783408|FG003|STARTED|Period 1||3
10624543|NCT01993329|11783409|FG004|STARTED|Period 1||3
10624544|NCT01993329|11783410|FG005|STARTED|Period 1||4
10624545|NCT01993329|11783405|FG000|COMPLETED|Period 1||3
10624546|NCT01993329|11783406|FG001|COMPLETED|Period 1||4
10624547|NCT01993329|11783407|FG002|COMPLETED|Period 1||3
10624548|NCT01993329|11783408|FG003|COMPLETED|Period 1||3
10624549|NCT01993329|11783409|FG004|COMPLETED|Period 1||3
10624550|NCT01993329|11783410|FG005|COMPLETED|Period 1||4
10624551|NCT01993329|11783405|FG000|NOT COMPLETED|Period 1||0
10624552|NCT01993329|11783406|FG001|NOT COMPLETED|Period 1||0
10624553|NCT01993329|11783407|FG002|NOT COMPLETED|Period 1||0
10624554|NCT01993329|11783408|FG003|NOT COMPLETED|Period 1||0
10624555|NCT01993329|11783409|FG004|NOT COMPLETED|Period 1||0
10624556|NCT01993329|11783410|FG005|NOT COMPLETED|Period 1||0
10624557|NCT01993329|11783405|FG000|STARTED|Wash-out||3
10624558|NCT01993329|11783406|FG001|STARTED|Wash-out||4
10624559|NCT01993329|11783407|FG002|STARTED|Wash-out||3
10624560|NCT01993329|11783408|FG003|STARTED|Wash-out||3
10624561|NCT01993329|11783409|FG004|STARTED|Wash-out||3
10624562|NCT01993329|11783410|FG005|STARTED|Wash-out||4
10624563|NCT01993329|11783405|FG000|COMPLETED|Wash-out||3
10624564|NCT01993329|11783406|FG001|COMPLETED|Wash-out||4
10624565|NCT01993329|11783407|FG002|COMPLETED|Wash-out||3
10624566|NCT01993329|11783408|FG003|COMPLETED|Wash-out||3
10624567|NCT01993329|11783409|FG004|COMPLETED|Wash-out||3
10624568|NCT01993329|11783410|FG005|COMPLETED|Wash-out||4
10624569|NCT01993329|11783405|FG000|NOT COMPLETED|Wash-out||0
10624570|NCT01993329|11783406|FG001|NOT COMPLETED|Wash-out||0
10624571|NCT01993329|11783407|FG002|NOT COMPLETED|Wash-out||0
10624572|NCT01993329|11783408|FG003|NOT COMPLETED|Wash-out||0
10624573|NCT01993329|11783409|FG004|NOT COMPLETED|Wash-out||0
10624574|NCT01993329|11783410|FG005|NOT COMPLETED|Wash-out||0
10624575|NCT01993329|11783405|FG000|STARTED|Period 2||3
10624576|NCT01993329|11783406|FG001|STARTED|Period 2||4
10624577|NCT01993329|11783407|FG002|STARTED|Period 2||3
10624578|NCT01993329|11783408|FG003|STARTED|Period 2||3
10624579|NCT01993329|11783409|FG004|STARTED|Period 2||3
10624580|NCT01993329|11783410|FG005|STARTED|Period 2||4
10624581|NCT01993329|11783405|FG000|COMPLETED|Period 2||3
10624582|NCT01993329|11783406|FG001|COMPLETED|Period 2||4
10624583|NCT01993329|11783407|FG002|COMPLETED|Period 2||3
10624584|NCT01993329|11783408|FG003|COMPLETED|Period 2||3
10624585|NCT01993329|11783409|FG004|COMPLETED|Period 2||3
10624586|NCT01993329|11783410|FG005|COMPLETED|Period 2||3
10624587|NCT01993329|11783405|FG000|NOT COMPLETED|Period 2||0
10624588|NCT01993329|11783406|FG001|NOT COMPLETED|Period 2||0
10624589|NCT01993329|11783407|FG002|NOT COMPLETED|Period 2||0
10624590|NCT01993329|11783408|FG003|NOT COMPLETED|Period 2||0
10624591|NCT01993329|11783409|FG004|NOT COMPLETED|Period 2||0
10624592|NCT01993329|11783410|FG005|NOT COMPLETED|Period 2||1
10624593|NCT01993329|11783405|FG000|STARTED|Wash-out||3
10624594|NCT01993329|11783406|FG001|STARTED|Wash-out||4
10624595|NCT01993329|11783407|FG002|STARTED|Wash-out||3
10624596|NCT01993329|11783408|FG003|STARTED|Wash-out||3
10624597|NCT01993329|11783409|FG004|STARTED|Wash-out||3
10624598|NCT01993329|11783410|FG005|STARTED|Wash-out||3
10624599|NCT01993329|11783405|FG000|COMPLETED|Wash-out||3
10624600|NCT01993329|11783406|FG001|COMPLETED|Wash-out||3
10624601|NCT01993329|11783407|FG002|COMPLETED|Wash-out||3
10624602|NCT01993329|11783408|FG003|COMPLETED|Wash-out||3
10624603|NCT01993329|11783409|FG004|COMPLETED|Wash-out||3
10624604|NCT01993329|11783410|FG005|COMPLETED|Wash-out||3
10624605|NCT01993329|11783405|FG000|NOT COMPLETED|Wash-out||0
10624606|NCT01993329|11783406|FG001|NOT COMPLETED|Wash-out||1
10624607|NCT01993329|11783407|FG002|NOT COMPLETED|Wash-out||0
10624608|NCT01993329|11783408|FG003|NOT COMPLETED|Wash-out||0
10624609|NCT01993329|11783409|FG004|NOT COMPLETED|Wash-out||0
10624610|NCT01993329|11783410|FG005|NOT COMPLETED|Wash-out||0
10624611|NCT01993329|11783405|FG000|STARTED|Period 3||3
10624612|NCT01993329|11783406|FG001|STARTED|Period 3||3
10624613|NCT01993329|11783407|FG002|STARTED|Period 3||3
10624614|NCT01993329|11783408|FG003|STARTED|Period 3||3
10624615|NCT01993329|11783409|FG004|STARTED|Period 3||3
10624616|NCT01993329|11783410|FG005|STARTED|Period 3||3
10624617|NCT01993329|11783405|FG000|COMPLETED|Period 3||3
10624618|NCT01993329|11783406|FG001|COMPLETED|Period 3||3
10624619|NCT01993329|11783407|FG002|COMPLETED|Period 3||3
10624620|NCT01993329|11783408|FG003|COMPLETED|Period 3||3
10624621|NCT01993329|11783409|FG004|COMPLETED|Period 3||3
10624622|NCT01993329|11783410|FG005|COMPLETED|Period 3||3
10624623|NCT01993329|11783405|FG000|NOT COMPLETED|Period 3||0
10624624|NCT01993329|11783406|FG001|NOT COMPLETED|Period 3||0
10624625|NCT01993329|11783407|FG002|NOT COMPLETED|Period 3||0
10624626|NCT01993329|11783408|FG003|NOT COMPLETED|Period 3||0
10624627|NCT01993329|11783409|FG004|NOT COMPLETED|Period 3||0
10624628|NCT01993329|11783410|FG005|NOT COMPLETED|Period 3||0
10624629|NCT01993615|11783424|FG000|STARTED|Overall Study||40
10624630|NCT01993615|11783425|FG001|STARTED|Overall Study||40
10624631|NCT01993615|11783424|FG000|COMPLETED|Overall Study||39
10624632|NCT01993615|11783425|FG001|COMPLETED|Overall Study||40
10624633|NCT01993615|11783424|FG000|NOT COMPLETED|Overall Study||1
10624634|NCT01993615|11783425|FG001|NOT COMPLETED|Overall Study||0
10624635|NCT01993667|11783433|FG000|STARTED|Overall Study||64
10624636|NCT01993667|11783434|FG001|STARTED|Overall Study||66
10624637|NCT01993667|11783433|FG000|COMPLETED|Overall Study||43
10624638|NCT01993667|11783434|FG001|COMPLETED|Overall Study||47
10624639|NCT01993667|11783433|FG000|NOT COMPLETED|Overall Study||21
10624640|NCT01993667|11783434|FG001|NOT COMPLETED|Overall Study||19
10624641|NCT01993823|11783442|FG000|STARTED|Overall Study||95
10624642|NCT01993823|11783443|FG001|STARTED|Overall Study||95
10624643|NCT01993823|11783442|FG000|COMPLETED|Overall Study||88
10624644|NCT01993823|11783443|FG001|COMPLETED|Overall Study||79
10624645|NCT01993823|11783442|FG000|NOT COMPLETED|Overall Study||7
10624646|NCT01993823|11783443|FG001|NOT COMPLETED|Overall Study||16
10624647|NCT01993836|11783452|FG000|STARTED|Overall Study|This represents the number of enrolled patients who completed baseline cognitive testing|72
10624648|NCT01993836|11783453|FG001|STARTED|Overall Study||68
10624649|NCT01993836|11783454|FG002|STARTED|Overall Study||51
10624650|NCT01993836|11783452|FG000|COMPLETED|Overall Study||55
10624651|NCT01993836|11783453|FG001|COMPLETED|Overall Study||55
10624652|NCT01993836|11783454|FG002|COMPLETED|Overall Study||46
10624653|NCT01993836|11783452|FG000|NOT COMPLETED|Overall Study||17
10624654|NCT01993836|11783453|FG001|NOT COMPLETED|Overall Study||13
10624655|NCT01993836|11783454|FG002|NOT COMPLETED|Overall Study||5
10624656|NCT01993849|11783464|FG000|STARTED|Overall Study||12
10624657|NCT01993849|11783465|FG001|STARTED|Overall Study||11
10624658|NCT01993849|11783464|FG000|COMPLETED|Overall Study||9
10624659|NCT01993849|11783465|FG001|COMPLETED|Overall Study||9
10624660|NCT01993849|11783464|FG000|NOT COMPLETED|Overall Study||3
10624661|NCT01993849|11783465|FG001|NOT COMPLETED|Overall Study||2
10624662|NCT01993875|11783475|FG000|STARTED|Overall Study||82
10624663|NCT01993875|11783476|FG001|STARTED|Overall Study||82
10624664|NCT01993875|11783475|FG000|COMPLETED|Overall Study||75
10624665|NCT01993875|11783476|FG001|COMPLETED|Overall Study||76
10624666|NCT01993875|11783475|FG000|NOT COMPLETED|Overall Study||7
10624667|NCT01993875|11783476|FG001|NOT COMPLETED|Overall Study||6
10624668|NCT01993888|11783485|FG000|STARTED|Overall Study||50
10624669|NCT01993888|11783486|FG001|STARTED|Overall Study||52
10624670|NCT01993888|11783485|FG000|COMPLETED|Overall Study||48
10624671|NCT01993888|11783486|FG001|COMPLETED|Overall Study||49
10624672|NCT01993888|11783485|FG000|NOT COMPLETED|Overall Study||2
10624673|NCT01993888|11783486|FG001|NOT COMPLETED|Overall Study||3
10653469|NCT02194062|11813988|FG000|COMPLETED|Overall Study||8
10653470|NCT02194062|11813989|FG001|COMPLETED|Overall Study||8
10653471|NCT02194062|11813990|FG002|COMPLETED|Overall Study||7
10653472|NCT02194062|11813988|FG000|NOT COMPLETED|Overall Study||2
10653473|NCT02194062|11813989|FG001|NOT COMPLETED|Overall Study||2
10653474|NCT02194062|11813990|FG002|NOT COMPLETED|Overall Study||5
10653475|NCT02194088|11814000|FG000|STARTED|Overall Study||75
10653476|NCT02194088|11814001|FG001|STARTED|Overall Study||25
10653477|NCT02194088|11814000|FG000|COMPLETED|Overall Study||75
10653478|NCT02194088|11814001|FG001|COMPLETED|Overall Study||25
10653479|NCT02194088|11814000|FG000|NOT COMPLETED|Overall Study||0
10653480|NCT02194088|11814001|FG001|NOT COMPLETED|Overall Study||0
10653481|NCT02194439|11814009|FG000|STARTED|Overall Study||415
10653482|NCT02194439|11814009|FG000|COMPLETED|Overall Study||415
10653483|NCT02194439|11814009|FG000|NOT COMPLETED|Overall Study||0
10653484|NCT02194465|11814020|FG000|STARTED|Overall Study||51
10653485|NCT02194465|11814021|FG001|STARTED|Overall Study||50
10653486|NCT02194465|11814022|FG002|STARTED|Overall Study||52
10653487|NCT02194465|11814023|FG003|STARTED|Overall Study||49
10653488|NCT02194465|11814024|FG004|STARTED|Overall Study||51
10653489|NCT02194465|11814025|FG005|STARTED|Overall Study||25
10653490|NCT02194465|11814026|FG006|STARTED|Overall Study||26
10653491|NCT02194465|11814020|FG000|Received at Least 1 Dose of Study Drug|Overall Study||51
10653492|NCT02194465|11814021|FG001|Received at Least 1 Dose of Study Drug|Overall Study||50
10653493|NCT02194465|11814022|FG002|Received at Least 1 Dose of Study Drug|Overall Study||51
10653494|NCT02194465|11814023|FG003|Received at Least 1 Dose of Study Drug|Overall Study||49
10653495|NCT02194465|11814024|FG004|Received at Least 1 Dose of Study Drug|Overall Study||51
10653496|NCT02194465|11814025|FG005|Received at Least 1 Dose of Study Drug|Overall Study||25
10653497|NCT02194465|11814026|FG006|Received at Least 1 Dose of Study Drug|Overall Study||26
10653498|NCT02194465|11814020|FG000|COMPLETED|Overall Study||42
10653499|NCT02194465|11814021|FG001|COMPLETED|Overall Study||43
10653500|NCT02194465|11814022|FG002|COMPLETED|Overall Study||44
10653501|NCT02194465|11814023|FG003|COMPLETED|Overall Study||41
10653502|NCT02194465|11814024|FG004|COMPLETED|Overall Study||42
10653503|NCT02194465|11814025|FG005|COMPLETED|Overall Study||21
10653504|NCT02194465|11814026|FG006|COMPLETED|Overall Study||24
10653505|NCT02194465|11814020|FG000|NOT COMPLETED|Overall Study||9
10653506|NCT02194465|11814021|FG001|NOT COMPLETED|Overall Study||7
10653507|NCT02194465|11814022|FG002|NOT COMPLETED|Overall Study||8
10653508|NCT02194465|11814023|FG003|NOT COMPLETED|Overall Study||8
10653509|NCT02194465|11814024|FG004|NOT COMPLETED|Overall Study||9
10653510|NCT02194465|11814025|FG005|NOT COMPLETED|Overall Study||4
10653511|NCT02194465|11814026|FG006|NOT COMPLETED|Overall Study||2
10653512|NCT02194621|11814049|FG000|STARTED|Overall Study||43
10653513|NCT02194621|11814050|FG001|STARTED|Overall Study||42
10653514|NCT02194621|11814051|FG002|STARTED|Overall Study||43
10653515|NCT02194621|11814049|FG000|COMPLETED|Overall Study||37
10653516|NCT02194621|11814050|FG001|COMPLETED|Overall Study||36
10653517|NCT02194621|11814051|FG002|COMPLETED|Overall Study||34
10653518|NCT02194621|11814049|FG000|NOT COMPLETED|Overall Study||6
10653519|NCT02194621|11814050|FG001|NOT COMPLETED|Overall Study||6
10653520|NCT02194621|11814051|FG002|NOT COMPLETED|Overall Study||9
10653521|NCT02194699|11814061|FG000|STARTED|Randomised||428
10653522|NCT02194699|11814062|FG001|STARTED|Randomised||428
10653523|NCT02194699|11814061|FG000|COMPLETED|Randomised||420
10653524|NCT02194699|11814062|FG001|COMPLETED|Randomised||417
10653525|NCT02194699|11814061|FG000|NOT COMPLETED|Randomised||8
10653526|NCT02194699|11814062|FG001|NOT COMPLETED|Randomised||11
10653527|NCT02194699|11814061|FG000|STARTED|With Potential to Receive 52 Weeks of IP|Includes all patients randomised with the potential to receive 52 weeks of IP and receiving any IP.|420
10654609|NCT02203578|11815393|FG000|NOT COMPLETED|Overall Study||0
10654610|NCT02203591|11815405|FG000|STARTED|Overall Study||343
10624674|NCT01993927|11783492|FG000|STARTED|Overall Study||742
10624675|NCT01993927|11783492|FG000|COMPLETED|Overall Study||713
10624676|NCT01993927|11783492|FG000|NOT COMPLETED|Overall Study||29
10624677|NCT01993940|11783498|FG000|STARTED|Overall Study|Includes one participant who enrolled at two different sites|277
10624678|NCT01993940|11783499|FG001|STARTED|Overall Study|Includes two participants who each enrolled at two different sites|276
10624679|NCT01993940|11783498|FG000|Received Treatment|Overall Study||272
10624680|NCT01993940|11783499|FG001|Received Treatment|Overall Study||276
10624681|NCT01993940|11783498|FG000|COMPLETED|Overall Study||237
10624682|NCT01993940|11783499|FG001|COMPLETED|Overall Study||232
10624683|NCT01993940|11783498|FG000|NOT COMPLETED|Overall Study||40
10624684|NCT01993940|11783499|FG001|NOT COMPLETED|Overall Study||44
10624685|NCT01994109|11783508|FG000|STARTED|Double-blind Phase (Part A)||63
10624686|NCT01994109|11783509|FG001|STARTED|Double-blind Phase (Part A)||64
10624687|NCT01994109|11783510|FG002|STARTED|Double-blind Phase (Part A)||60
10624688|NCT01994109|11783511|FG003|STARTED|Double-blind Phase (Part A)||0
10624689|NCT01994109|11783508|FG000|COMPLETED|Double-blind Phase (Part A)||62
10624690|NCT01994109|11783509|FG001|COMPLETED|Double-blind Phase (Part A)||61
10624691|NCT01994109|11783510|FG002|COMPLETED|Double-blind Phase (Part A)||53
10624692|NCT01994109|11783511|FG003|COMPLETED|Double-blind Phase (Part A)||0
10624693|NCT01994109|11783508|FG000|NOT COMPLETED|Double-blind Phase (Part A)||1
10624694|NCT01994109|11783509|FG001|NOT COMPLETED|Double-blind Phase (Part A)||3
10624695|NCT01994109|11783510|FG002|NOT COMPLETED|Double-blind Phase (Part A)||7
10624696|NCT01994109|11783511|FG003|NOT COMPLETED|Double-blind Phase (Part A)||0
10624697|NCT01994109|11783508|FG000|STARTED|Open-label Phase (Part B)||0
10624698|NCT01994109|11783509|FG001|STARTED|Open-label Phase (Part B)||0
10624699|NCT01994109|11783510|FG002|STARTED|Open-label Phase (Part B)|No placebo group in Part B.|0
10624700|NCT01994109|11783511|FG003|STARTED|Open-label Phase (Part B)|61 from 2500 U group, 57 from 3500 U group, 52 from Placebo group continued to Part B|170
10624701|NCT01994109|11783508|FG000|COMPLETED|Open-label Phase (Part B)||0
10624702|NCT01994109|11783509|FG001|COMPLETED|Open-label Phase (Part B)||0
10624703|NCT01994109|11783510|FG002|COMPLETED|Open-label Phase (Part B)|No placebo group in Part B.|0
10624704|NCT01994109|11783511|FG003|COMPLETED|Open-label Phase (Part B)||128
10624705|NCT01994109|11783508|FG000|NOT COMPLETED|Open-label Phase (Part B)||0
10624706|NCT01994109|11783509|FG001|NOT COMPLETED|Open-label Phase (Part B)||0
10624707|NCT01994109|11783510|FG002|NOT COMPLETED|Open-label Phase (Part B)||0
10624708|NCT01994109|11783511|FG003|NOT COMPLETED|Open-label Phase (Part B)||42
10624709|NCT01994226|11783523|FG000|STARTED|Overall Study||199
10624710|NCT01994226|11783524|FG001|STARTED|Overall Study||200
10624711|NCT01994226|11783523|FG000|COMPLETED|Overall Study||180
10624712|NCT01994226|11783524|FG001|COMPLETED|Overall Study||179
10624713|NCT01994226|11783523|FG000|NOT COMPLETED|Overall Study||19
10624714|NCT01994226|11783524|FG001|NOT COMPLETED|Overall Study||21
10624715|NCT01994291|11783533|FG000|STARTED|Overall Study||99
10624716|NCT01994291|11783534|FG001|STARTED|Overall Study||43
10624717|NCT01994291|11783535|FG002|STARTED|Overall Study||56
10624718|NCT01994291|11783533|FG000|Received Treatment|Overall Study||99
10624719|NCT01994291|11783534|FG001|Received Treatment|Overall Study||43
10624720|NCT01994291|11783535|FG002|Received Treatment|Overall Study||56
10624721|NCT01994291|11783533|FG000|COMPLETED|Overall Study||84
10624722|NCT01994291|11783534|FG001|COMPLETED|Overall Study||36
10624723|NCT01994291|11783535|FG002|COMPLETED|Overall Study||47
10624724|NCT01994291|11783533|FG000|NOT COMPLETED|Overall Study||15
10624725|NCT01994291|11783534|FG001|NOT COMPLETED|Overall Study||7
10624726|NCT01994291|11783535|FG002|NOT COMPLETED|Overall Study||9
10624727|NCT01994395|11783546|FG000|STARTED|Overall Study||26
10705271|NCT02596971|11869604|FG001|NOT COMPLETED|Overall Study||2
10705272|NCT02596971|11869605|FG002|NOT COMPLETED|Overall Study||9
10705273|NCT02597049|11869619|FG000|STARTED|Overall Study||142
10705274|NCT02597049|11869620|FG001|STARTED|Overall Study||142
10705275|NCT02597049|11869621|FG002|STARTED|Overall Study||140
10705276|NCT02597049|11869619|FG000|Received at Least One Dose of Study Drug|Overall Study||142
10705277|NCT02597049|11869620|FG001|Received at Least One Dose of Study Drug|Overall Study||141
10705278|NCT02597049|11869621|FG002|Received at Least One Dose of Study Drug|Overall Study||140
10705279|NCT02597049|11869619|FG000|COMPLETED|Overall Study||135
10705280|NCT02597049|11869620|FG001|COMPLETED|Overall Study||137
10705281|NCT02597049|11869621|FG002|COMPLETED|Overall Study||137
10624728|NCT01994395|11783547|FG001|STARTED|Overall Study||27
10624729|NCT01994395|11783546|FG000|COMPLETED|Overall Study||25
10624730|NCT01994395|11783547|FG001|COMPLETED|Overall Study||25
10624731|NCT01994395|11783546|FG000|NOT COMPLETED|Overall Study||1
10624732|NCT01994395|11783547|FG001|NOT COMPLETED|Overall Study||2
10624733|NCT01994486|11783553|FG000|STARTED|Overall Study||20
10624734|NCT01994486|11783553|FG000|COMPLETED|Overall Study||20
10624735|NCT01994486|11783553|FG000|NOT COMPLETED|Overall Study||0
10624736|NCT01994538|11783561|FG000|STARTED|Overall Study||136
10624737|NCT01994538|11783562|FG001|STARTED|Overall Study||136
10624738|NCT01994538|11783561|FG000|COMPLETED|Overall Study||136
10624739|NCT01994538|11783562|FG001|COMPLETED|Overall Study||136
10624740|NCT01994538|11783561|FG000|NOT COMPLETED|Overall Study||0
10624741|NCT01994538|11783562|FG001|NOT COMPLETED|Overall Study||0
10624742|NCT01994590|11783568|FG000|STARTED|Overall Study||4
10624743|NCT01994590|11783568|FG000|COMPLETED|Overall Study||2
10624744|NCT01994590|11783568|FG000|NOT COMPLETED|Overall Study||2
10624745|NCT01994629|11783574|FG000|STARTED|Overall Study||100
10624746|NCT01994629|11783575|FG001|STARTED|Overall Study||102
10624747|NCT01994629|11783574|FG000|COMPLETED|Overall Study||99
10624748|NCT01994629|11783575|FG001|COMPLETED|Overall Study||99
10624749|NCT01994629|11783574|FG000|NOT COMPLETED|Overall Study||1
10624750|NCT01994629|11783575|FG001|NOT COMPLETED|Overall Study||3
10624751|NCT01994720|11783583|FG000|STARTED|Overall Study||6589
10624752|NCT01994720|11783584|FG001|STARTED|Overall Study||6610
10624753|NCT01994720|11783583|FG000|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the Study Closure Visit|6543
10624754|NCT01994720|11783584|FG001|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the Study Closure Visit|6554
10624755|NCT01994720|11783583|FG000|NOT COMPLETED|Overall Study||46
10624756|NCT01994720|11783584|FG001|NOT COMPLETED|Overall Study||56
10624757|NCT01994746|11783590|FG000|STARTED|First Visit||39
10624758|NCT01994746|11783591|FG001|STARTED|First Visit||38
10624759|NCT01994746|11783590|FG000|Received At Least 1 Dose|First Visit||39
10624760|NCT01994746|11783591|FG001|Received At Least 1 Dose|First Visit||38
10624761|NCT01994746|11783590|FG000|COMPLETED|First Visit||39
10624762|NCT01994746|11783591|FG001|COMPLETED|First Visit||38
10624763|NCT01994746|11783590|FG000|NOT COMPLETED|First Visit||0
10624764|NCT01994746|11783591|FG001|NOT COMPLETED|First Visit||0
10624765|NCT01994746|11783590|FG000|STARTED|Second Visit|One participant requested to withdraw after completing the first dosing visit.|38
10624766|NCT01994746|11783591|FG001|STARTED|Second Visit||38
10624767|NCT01994746|11783590|FG000|Completed Both Dosing Visits|Second Visit||38
10624768|NCT01994746|11783591|FG001|Completed Both Dosing Visits|Second Visit||38
10624769|NCT01994746|11783590|FG000|COMPLETED|Second Visit||38
10624770|NCT01994746|11783591|FG001|COMPLETED|Second Visit||38
10624771|NCT01994746|11783590|FG000|NOT COMPLETED|Second Visit||0
10624772|NCT01994746|11783591|FG001|NOT COMPLETED|Second Visit||0
10624773|NCT01994785|11783601|FG000|STARTED|Overall Study||109
10624774|NCT01994785|11783602|FG001|STARTED|Overall Study||109
10624775|NCT01994785|11783603|FG002|STARTED|Overall Study||117
10624776|NCT01994785|11783604|FG003|STARTED|Overall Study||117
10624777|NCT01994785|11783601|FG000|COMPLETED|Overall Study||101
10624778|NCT01994785|11783602|FG001|COMPLETED|Overall Study||108
10624779|NCT01994785|11783603|FG002|COMPLETED|Overall Study||117
10624780|NCT01994785|11783604|FG003|COMPLETED|Overall Study||114
10705282|NCT02597049|11869619|FG000|NOT COMPLETED|Overall Study||7
10705283|NCT02597049|11869620|FG001|NOT COMPLETED|Overall Study||5
10624781|NCT01994785|11783601|FG000|NOT COMPLETED|Overall Study||8
10624782|NCT01994785|11783602|FG001|NOT COMPLETED|Overall Study||1
10624783|NCT01994785|11783603|FG002|NOT COMPLETED|Overall Study||0
10624784|NCT01994785|11783604|FG003|NOT COMPLETED|Overall Study||3
10624785|NCT01994837|11783614|FG000|STARTED|Overall Study||32
10624786|NCT01994837|11783614|FG000|Treated|Overall Study||32
10624787|NCT01994837|11783614|FG000|COMPLETED|Overall Study||0
10624788|NCT01994837|11783614|FG000|NOT COMPLETED|Overall Study||32
10624789|NCT01994850|11783618|FG000|STARTED|Overall Study||32
10624790|NCT01994850|11783618|FG000|COMPLETED|Overall Study||30
10624791|NCT01994850|11783618|FG000|NOT COMPLETED|Overall Study||2
10624792|NCT01994863|11783622|FG000|STARTED|Period 1||11
10624793|NCT01994863|11783623|FG001|STARTED|Period 1||12
10624794|NCT01994863|11783622|FG000|COMPLETED|Period 1||4
10624795|NCT01994863|11783623|FG001|COMPLETED|Period 1||9
10624796|NCT01994863|11783622|FG000|NOT COMPLETED|Period 1||7
10624797|NCT01994863|11783623|FG001|NOT COMPLETED|Period 1||3
10624798|NCT01994863|11783622|FG000|STARTED|Period 2||8
10624799|NCT01994863|11783623|FG001|STARTED|Period 2||9
10624800|NCT01994863|11783622|FG000|COMPLETED|Period 2||7
10624801|NCT01994863|11783623|FG001|COMPLETED|Period 2||5
10624802|NCT01994863|11783622|FG000|NOT COMPLETED|Period 2||1
10624803|NCT01994863|11783623|FG001|NOT COMPLETED|Period 2||4
10333902|NCT00336323|11470120|FG003|NOT COMPLETED|Overall Study||0
10333903|NCT00336323|11470121|FG004|NOT COMPLETED|Overall Study||3
10333904|NCT00336479|11470141|FG000|STARTED|Overall Study||75
10333905|NCT00336479|11470142|FG001|STARTED|Overall Study||79
10333906|NCT00336479|11470143|FG002|STARTED|Overall Study||79
10333907|NCT00336479|11470144|FG003|STARTED|Overall Study||17
10624804|NCT01994876|11783629|FG000|STARTED|Baseline - Own Product||9
10624805|NCT01994876|11783630|FG001|STARTED|Baseline - Own Product||9
10624806|NCT01994876|11783629|FG000|COMPLETED|Baseline - Own Product||9
10624807|NCT01994876|11783630|FG001|COMPLETED|Baseline - Own Product||9
10624808|NCT01994876|11783629|FG000|NOT COMPLETED|Baseline - Own Product||0
10624809|NCT01994876|11783630|FG001|NOT COMPLETED|Baseline - Own Product||0
10624810|NCT01994876|11783629|FG000|STARTED|Test Period 1||9
10624811|NCT01994876|11783630|FG001|STARTED|Test Period 1||9
10624812|NCT01994876|11783629|FG000|COMPLETED|Test Period 1||9
10624813|NCT01994876|11783630|FG001|COMPLETED|Test Period 1||7
10624814|NCT01994876|11783629|FG000|NOT COMPLETED|Test Period 1||0
10624815|NCT01994876|11783630|FG001|NOT COMPLETED|Test Period 1||2
10624816|NCT01994876|11783629|FG000|STARTED|Test Period 2||9
10624817|NCT01994876|11783630|FG001|STARTED|Test Period 2||7
10624818|NCT01994876|11783629|FG000|COMPLETED|Test Period 2||8
10624819|NCT01994876|11783630|FG001|COMPLETED|Test Period 2||6
10624820|NCT01994876|11783629|FG000|NOT COMPLETED|Test Period 2||1
10624821|NCT01994876|11783630|FG001|NOT COMPLETED|Test Period 2||1
10624822|NCT01994889|11783641|FG000|STARTED|Overall Study||88
10624823|NCT01994889|11783642|FG001|STARTED|Overall Study||176
10624824|NCT01994889|11783643|FG002|STARTED|Overall Study||177
10624825|NCT01994889|11783641|FG000|COMPLETED|Overall Study||60
10624826|NCT01994889|11783642|FG001|COMPLETED|Overall Study||113
10624827|NCT01994889|11783643|FG002|COMPLETED|Overall Study||85
10624828|NCT01994889|11783641|FG000|NOT COMPLETED|Overall Study||28
10624829|NCT01994889|11783642|FG001|NOT COMPLETED|Overall Study||63
10624830|NCT01994889|11783643|FG002|NOT COMPLETED|Overall Study||92
10624831|NCT01994902|11783650|FG000|STARTED|Test Period 1||63
10624832|NCT01994902|11783651|FG001|STARTED|Test Period 1|Randomisation mistake:a subject randomised to SenSura Convex Light but tested Coloplast test product|64
10624833|NCT01994902|11783650|FG000|COMPLETED|Test Period 1||57
10624834|NCT01994902|11783651|FG001|COMPLETED|Test Period 1|The subject testing Coloplast test product discontinued due to device deficiency with adverse event|61
10624835|NCT01994902|11783650|FG000|NOT COMPLETED|Test Period 1||6
10624836|NCT01994902|11783651|FG001|NOT COMPLETED|Test Period 1||3
10624837|NCT01994902|11783650|FG000|STARTED|Test Period 2||57
10624838|NCT01994902|11783651|FG001|STARTED|Test Period 2||61
10624839|NCT01994902|11783650|FG000|COMPLETED|Test Period 2||57
10705284|NCT02597049|11869621|FG002|NOT COMPLETED|Overall Study||3
10705285|NCT02597101|11869631|FG000|STARTED|Overall Study||4
10705286|NCT02597101|11869632|FG001|STARTED|Overall Study||5
10705287|NCT02597101|11869631|FG000|COMPLETED|Overall Study||4
10808988|NCT03815240|11970930|FG006|NOT COMPLETED|Intervention Mepilex Dressing||0
10705288|NCT02597101|11869632|FG001|COMPLETED|Overall Study||5
10624840|NCT01994902|11783651|FG001|COMPLETED|Test Period 2||55
10624841|NCT01994902|11783650|FG000|NOT COMPLETED|Test Period 2||0
10624842|NCT01994902|11783651|FG001|NOT COMPLETED|Test Period 2||6
10624843|NCT01994954|11783659|FG000|STARTED|Overall Study||99
10624844|NCT01994954|11783660|FG001|STARTED|Overall Study||97
10624845|NCT01994954|11783659|FG000|COMPLETED|Overall Study||74
10624846|NCT01994954|11783660|FG001|COMPLETED|Overall Study||67
10624847|NCT01994954|11783659|FG000|NOT COMPLETED|Overall Study||25
10624848|NCT01994954|11783660|FG001|NOT COMPLETED|Overall Study||30
10624849|NCT01994993|11783677|FG000|STARTED|Overall Study||63
10624850|NCT01994993|11783678|FG001|STARTED|Overall Study||47
10624851|NCT01994993|11783679|FG002|STARTED|Overall Study||70
10624852|NCT01994993|11783680|FG003|STARTED|Overall Study||55
10624853|NCT01994993|11783681|FG004|STARTED|Overall Study||24
10624854|NCT01994993|11783677|FG000|COMPLETED|Overall Study||28
10624855|NCT01994993|11783678|FG001|COMPLETED|Overall Study||12
10624856|NCT01994993|11783679|FG002|COMPLETED|Overall Study||23
10705289|NCT02597101|11869631|FG000|NOT COMPLETED|Overall Study||0
10705290|NCT02597101|11869632|FG001|NOT COMPLETED|Overall Study||0
10624857|NCT01994993|11783680|FG003|COMPLETED|Overall Study||9
10624858|NCT01994993|11783681|FG004|COMPLETED|Overall Study||22
10624859|NCT01994993|11783677|FG000|NOT COMPLETED|Overall Study||35
10624860|NCT01994993|11783678|FG001|NOT COMPLETED|Overall Study||35
10624861|NCT01994993|11783679|FG002|NOT COMPLETED|Overall Study||47
10624862|NCT01994993|11783680|FG003|NOT COMPLETED|Overall Study||46
10624863|NCT01994993|11783681|FG004|NOT COMPLETED|Overall Study||2
10624864|NCT01995045|11783695|FG000|STARTED|Overall Study||29
10624865|NCT01995045|11783696|FG001|STARTED|Overall Study||28
10624866|NCT01995045|11783695|FG000|COMPLETED|Overall Study||29
10624867|NCT01995045|11783696|FG001|COMPLETED|Overall Study||28
10624868|NCT01995045|11783695|FG000|NOT COMPLETED|Overall Study||0
10624869|NCT01995045|11783696|FG001|NOT COMPLETED|Overall Study||0
10624870|NCT01995071|11783714|FG000|STARTED|Overall Study||8
10624871|NCT01995071|11783715|FG001|STARTED|Overall Study||8
10624872|NCT01995071|11783716|FG002|STARTED|Overall Study||9
10624873|NCT01995071|11783717|FG003|STARTED|Overall Study||8
10624874|NCT01995071|11783718|FG004|STARTED|Overall Study||8
10624875|NCT01995071|11783719|FG005|STARTED|Overall Study||8
10624876|NCT01995071|11783720|FG006|STARTED|Overall Study||8
10624877|NCT01995071|11783721|FG007|STARTED|Overall Study||8
10624878|NCT01995071|11783722|FG008|STARTED|Overall Study||8
10624879|NCT01995071|11783723|FG009|STARTED|Overall Study||8
10624880|NCT01995071|11783724|FG010|STARTED|Overall Study||8
10624881|NCT01995071|11783725|FG011|STARTED|Overall Study||0
10624882|NCT01995071|11783714|FG000|COMPLETED|Overall Study||7
10624883|NCT01995071|11783715|FG001|COMPLETED|Overall Study||8
10624884|NCT01995071|11783716|FG002|COMPLETED|Overall Study||8
10624885|NCT01995071|11783717|FG003|COMPLETED|Overall Study||8
10624886|NCT01995071|11783718|FG004|COMPLETED|Overall Study||7
10624887|NCT01995071|11783719|FG005|COMPLETED|Overall Study||8
10624888|NCT01995071|11783720|FG006|COMPLETED|Overall Study||7
10624889|NCT01995071|11783721|FG007|COMPLETED|Overall Study||6
10624890|NCT01995071|11783722|FG008|COMPLETED|Overall Study||7
10624891|NCT01995071|11783723|FG009|COMPLETED|Overall Study||8
10624892|NCT01995071|11783724|FG010|COMPLETED|Overall Study||7
10624893|NCT01995071|11783725|FG011|COMPLETED|Overall Study||0
10624894|NCT01995071|11783714|FG000|NOT COMPLETED|Overall Study||1
10624895|NCT01995071|11783715|FG001|NOT COMPLETED|Overall Study||0
10624896|NCT01995071|11783716|FG002|NOT COMPLETED|Overall Study||1
10624897|NCT01995071|11783717|FG003|NOT COMPLETED|Overall Study||0
10624898|NCT01995071|11783718|FG004|NOT COMPLETED|Overall Study||1
10624899|NCT01995071|11783719|FG005|NOT COMPLETED|Overall Study||0
10624900|NCT01995071|11783720|FG006|NOT COMPLETED|Overall Study||1
10624901|NCT01995071|11783721|FG007|NOT COMPLETED|Overall Study||2
10624902|NCT01995071|11783722|FG008|NOT COMPLETED|Overall Study||1
10624903|NCT01995071|11783723|FG009|NOT COMPLETED|Overall Study||0
10624904|NCT01995071|11783724|FG010|NOT COMPLETED|Overall Study||1
10624905|NCT01995071|11783725|FG011|NOT COMPLETED|Overall Study||0
10624906|NCT01995123|11783759|FG000|STARTED|Overall Study||63
10624907|NCT01995123|11783760|FG001|STARTED|Overall Study||61
10624908|NCT01995123|11783759|FG000|COMPLETED|Overall Study||45
10624909|NCT01995123|11783760|FG001|COMPLETED|Overall Study||46
10624910|NCT01995123|11783759|FG000|NOT COMPLETED|Overall Study||18
10624911|NCT01995123|11783760|FG001|NOT COMPLETED|Overall Study||15
10624912|NCT01995136|11783766|FG000|STARTED|Overall Study||32
10624913|NCT01995136|11783766|FG000|COMPLETED|Overall Study||31
10624914|NCT01995136|11783766|FG000|NOT COMPLETED|Overall Study||1
10624915|NCT01995201|11783772|FG000|STARTED|From Baseline Until Week 24||74
10624916|NCT01995201|11783773|FG001|STARTED|From Baseline Until Week 24||327
10624917|NCT01995201|11783774|FG002|STARTED|From Baseline Until Week 24||0
10624918|NCT01995201|11783775|FG003|STARTED|From Baseline Until Week 24||0
10624919|NCT01995201|11783776|FG004|STARTED|From Baseline Until Week 24||0
10624920|NCT01995201|11783777|FG005|STARTED|From Baseline Until Week 24||0
10624921|NCT01995201|11783778|FG006|STARTED|From Baseline Until Week 24||0
10624922|NCT01995201|11783772|FG000|COMPLETED|From Baseline Until Week 24||64
10624923|NCT01995201|11783773|FG001|COMPLETED|From Baseline Until Week 24||281
10624924|NCT01995201|11783774|FG002|COMPLETED|From Baseline Until Week 24||0
10624925|NCT01995201|11783775|FG003|COMPLETED|From Baseline Until Week 24||0
10624926|NCT01995201|11783776|FG004|COMPLETED|From Baseline Until Week 24||0
10624927|NCT01995201|11783777|FG005|COMPLETED|From Baseline Until Week 24||0
10624928|NCT01995201|11783778|FG006|COMPLETED|From Baseline Until Week 24||0
10624929|NCT01995201|11783772|FG000|NOT COMPLETED|From Baseline Until Week 24||10
10624930|NCT01995201|11783773|FG001|NOT COMPLETED|From Baseline Until Week 24||46
10624931|NCT01995201|11783774|FG002|NOT COMPLETED|From Baseline Until Week 24||0
10624932|NCT01995201|11783775|FG003|NOT COMPLETED|From Baseline Until Week 24||0
10624933|NCT01995201|11783776|FG004|NOT COMPLETED|From Baseline Until Week 24||0
10624934|NCT01995201|11783777|FG005|NOT COMPLETED|From Baseline Until Week 24||0
10624935|NCT01995201|11783778|FG006|NOT COMPLETED|From Baseline Until Week 24||0
10624936|NCT01995201|11783772|FG000|STARTED|From Week 24 Until Week 48||0
10624937|NCT01995201|11783773|FG001|STARTED|From Week 24 Until Week 48||0
10624938|NCT01995201|11783774|FG002|STARTED|From Week 24 Until Week 48||89
10624939|NCT01995201|11783775|FG003|STARTED|From Week 24 Until Week 48||90
10624940|NCT01995201|11783776|FG004|STARTED|From Week 24 Until Week 48||95
10624941|NCT01995201|11783777|FG005|STARTED|From Week 24 Until Week 48||67
10624942|NCT01995201|11783778|FG006|STARTED|From Week 24 Until Week 48||2
10624943|NCT01995201|11783772|FG000|COMPLETED|From Week 24 Until Week 48||0
10624944|NCT01995201|11783773|FG001|COMPLETED|From Week 24 Until Week 48||0
10624945|NCT01995201|11783774|FG002|COMPLETED|From Week 24 Until Week 48||84
10624946|NCT01995201|11783775|FG003|COMPLETED|From Week 24 Until Week 48||89
10624947|NCT01995201|11783776|FG004|COMPLETED|From Week 24 Until Week 48||89
10705291|NCT02597127|11869646|FG000|STARTED|Overall Study||60
10705292|NCT02597127|11869647|FG001|STARTED|Overall Study||62
10705293|NCT02597127|11869648|FG002|STARTED|Overall Study||66
10624948|NCT01995201|11783777|FG005|COMPLETED|From Week 24 Until Week 48||59
10624949|NCT01995201|11783778|FG006|COMPLETED|From Week 24 Until Week 48||0
10624950|NCT01995201|11783772|FG000|NOT COMPLETED|From Week 24 Until Week 48||0
10624951|NCT01995201|11783773|FG001|NOT COMPLETED|From Week 24 Until Week 48||0
10624952|NCT01995201|11783774|FG002|NOT COMPLETED|From Week 24 Until Week 48||5
10624953|NCT01995201|11783775|FG003|NOT COMPLETED|From Week 24 Until Week 48||1
10624954|NCT01995201|11783776|FG004|NOT COMPLETED|From Week 24 Until Week 48||6
10624955|NCT01995201|11783777|FG005|NOT COMPLETED|From Week 24 Until Week 48||8
10624956|NCT01995201|11783778|FG006|NOT COMPLETED|From Week 24 Until Week 48||2
10624957|NCT01995266|11783799|FG000|STARTED|Overall Study||159
10624958|NCT01995266|11783799|FG000|COMPLETED|Overall Study||150
10624959|NCT01995266|11783799|FG000|NOT COMPLETED|Overall Study||9
10624960|NCT01995357|11783803|FG000|STARTED|Period 1||4
10624961|NCT01995357|11783804|FG001|STARTED|Period 1||3
10624962|NCT01995357|11783805|FG002|STARTED|Period 1||4
10624963|NCT01995357|11783806|FG003|STARTED|Period 1||3
10624964|NCT01995357|11783807|FG004|STARTED|Period 1||4
10624965|NCT01995357|11783808|FG005|STARTED|Period 1||4
10624966|NCT01995357|11783803|FG000|COMPLETED|Period 1||4
10624967|NCT01995357|11783804|FG001|COMPLETED|Period 1||3
10624968|NCT01995357|11783805|FG002|COMPLETED|Period 1||4
10624969|NCT01995357|11783806|FG003|COMPLETED|Period 1||3
10624970|NCT01995357|11783807|FG004|COMPLETED|Period 1||4
10624971|NCT01995357|11783808|FG005|COMPLETED|Period 1||4
10624972|NCT01995357|11783803|FG000|NOT COMPLETED|Period 1||0
10624973|NCT01995357|11783804|FG001|NOT COMPLETED|Period 1||0
10624974|NCT01995357|11783805|FG002|NOT COMPLETED|Period 1||0
10624975|NCT01995357|11783806|FG003|NOT COMPLETED|Period 1||0
10624976|NCT01995357|11783807|FG004|NOT COMPLETED|Period 1||0
10624977|NCT01995357|11783808|FG005|NOT COMPLETED|Period 1||0
10624978|NCT01995357|11783803|FG000|STARTED|Period 2||4
10624979|NCT01995357|11783804|FG001|STARTED|Period 2||3
10624980|NCT01995357|11783805|FG002|STARTED|Period 2||4
10705294|NCT02597127|11869649|FG003|STARTED|Overall Study||65
10705295|NCT02597127|11869650|FG004|STARTED|Overall Study||62
10705296|NCT02597127|11869651|FG005|STARTED|Overall Study||63
10705297|NCT02597127|11869652|FG006|STARTED|Overall Study||61
10705298|NCT02597127|11869653|FG007|STARTED|Overall Study||62
10705299|NCT02597127|11869646|FG000|Treated|Overall Study||60
10624981|NCT01995357|11783806|FG003|STARTED|Period 2||3
10624982|NCT01995357|11783807|FG004|STARTED|Period 2||4
10624983|NCT01995357|11783808|FG005|STARTED|Period 2||4
10624984|NCT01995357|11783803|FG000|COMPLETED|Period 2||4
10624985|NCT01995357|11783804|FG001|COMPLETED|Period 2||3
10624986|NCT01995357|11783805|FG002|COMPLETED|Period 2||4
10624987|NCT01995357|11783806|FG003|COMPLETED|Period 2||3
10624988|NCT01995357|11783807|FG004|COMPLETED|Period 2||4
10624989|NCT01995357|11783808|FG005|COMPLETED|Period 2||4
10624990|NCT01995357|11783803|FG000|NOT COMPLETED|Period 2||0
10624991|NCT01995357|11783804|FG001|NOT COMPLETED|Period 2||0
10624992|NCT01995357|11783805|FG002|NOT COMPLETED|Period 2||0
10624993|NCT01995357|11783806|FG003|NOT COMPLETED|Period 2||0
10624994|NCT01995357|11783807|FG004|NOT COMPLETED|Period 2||0
10624995|NCT01995357|11783808|FG005|NOT COMPLETED|Period 2||0
10624996|NCT01995357|11783803|FG000|STARTED|Period 3||4
10624997|NCT01995357|11783804|FG001|STARTED|Period 3||3
10624998|NCT01995357|11783805|FG002|STARTED|Period 3||4
10624999|NCT01995357|11783806|FG003|STARTED|Period 3||3
10625000|NCT01995357|11783807|FG004|STARTED|Period 3||4
10625001|NCT01995357|11783808|FG005|STARTED|Period 3||4
10625002|NCT01995357|11783803|FG000|COMPLETED|Period 3||4
10705300|NCT02597127|11869647|FG001|Treated|Overall Study||61
10705301|NCT02597127|11869648|FG002|Treated|Overall Study||65
10705302|NCT02597127|11869649|FG003|Treated|Overall Study||65
10705303|NCT02597127|11869650|FG004|Treated|Overall Study||61
10625003|NCT01995357|11783804|FG001|COMPLETED|Period 3||3
10625004|NCT01995357|11783805|FG002|COMPLETED|Period 3||4
10625005|NCT01995357|11783806|FG003|COMPLETED|Period 3||3
10625006|NCT01995357|11783807|FG004|COMPLETED|Period 3||4
10625007|NCT01995357|11783808|FG005|COMPLETED|Period 3||4
10625008|NCT01995357|11783803|FG000|NOT COMPLETED|Period 3||0
10625009|NCT01995357|11783804|FG001|NOT COMPLETED|Period 3||0
10625010|NCT01995357|11783805|FG002|NOT COMPLETED|Period 3||0
10705304|NCT02597127|11869651|FG005|Treated|Overall Study||62
10705305|NCT02597127|11869652|FG006|Treated|Overall Study||61
10625011|NCT01995357|11783806|FG003|NOT COMPLETED|Period 3||0
10625012|NCT01995357|11783807|FG004|NOT COMPLETED|Period 3||0
10625013|NCT01995357|11783808|FG005|NOT COMPLETED|Period 3||0
10625014|NCT01995357|11783803|FG000|STARTED|Period 4||4
10625015|NCT01995357|11783804|FG001|STARTED|Period 4||3
10625016|NCT01995357|11783805|FG002|STARTED|Period 4|The subject who did not complete period 5, erroneously used product A when B should have been used.|4
10625017|NCT01995357|11783806|FG003|STARTED|Period 4||3
10625018|NCT01995357|11783807|FG004|STARTED|Period 4||4
10705306|NCT02597127|11869653|FG007|Treated|Overall Study||62
10705307|NCT02597127|11869646|FG000|COMPLETED|Overall Study||59
10625019|NCT01995357|11783808|FG005|STARTED|Period 4||4
10625020|NCT01995357|11783803|FG000|COMPLETED|Period 4||4
10625021|NCT01995357|11783804|FG001|COMPLETED|Period 4||3
10625022|NCT01995357|11783805|FG002|COMPLETED|Period 4||4
10625023|NCT01995357|11783806|FG003|COMPLETED|Period 4||3
10625024|NCT01995357|11783807|FG004|COMPLETED|Period 4||4
10625025|NCT01995357|11783808|FG005|COMPLETED|Period 4||4
10625026|NCT01995357|11783803|FG000|NOT COMPLETED|Period 4||0
10625027|NCT01995357|11783804|FG001|NOT COMPLETED|Period 4||0
10625028|NCT01995357|11783805|FG002|NOT COMPLETED|Period 4||0
10625029|NCT01995357|11783806|FG003|NOT COMPLETED|Period 4||0
10625030|NCT01995357|11783807|FG004|NOT COMPLETED|Period 4||0
10625031|NCT01995357|11783808|FG005|NOT COMPLETED|Period 4||0
10625032|NCT01995357|11783803|FG000|STARTED|Period 5|The two discontinued subjects tested zero planned B products in period 5.|4
10625033|NCT01995357|11783804|FG001|STARTED|Period 5||3
10625034|NCT01995357|11783805|FG002|STARTED|Period 5||4
10625035|NCT01995357|11783806|FG003|STARTED|Period 5||3
10625036|NCT01995357|11783807|FG004|STARTED|Period 5|1 subject terminated due to an adverse event. Subject counted as completed as some B products tested|4
10625037|NCT01995357|11783808|FG005|STARTED|Period 5||4
10625038|NCT01995357|11783803|FG000|COMPLETED|Period 5||2
10625039|NCT01995357|11783804|FG001|COMPLETED|Period 5||3
10625040|NCT01995357|11783805|FG002|COMPLETED|Period 5||3
10625041|NCT01995357|11783806|FG003|COMPLETED|Period 5||3
10625042|NCT01995357|11783807|FG004|COMPLETED|Period 5||4
10625043|NCT01995357|11783808|FG005|COMPLETED|Period 5||4
10625044|NCT01995357|11783803|FG000|NOT COMPLETED|Period 5||2
10625045|NCT01995357|11783804|FG001|NOT COMPLETED|Period 5||0
10625046|NCT01995357|11783805|FG002|NOT COMPLETED|Period 5||1
10625047|NCT01995357|11783806|FG003|NOT COMPLETED|Period 5||0
10625048|NCT01995357|11783807|FG004|NOT COMPLETED|Period 5||0
10625049|NCT01995357|11783808|FG005|NOT COMPLETED|Period 5||0
10625050|NCT01995461|11783824|FG000|STARTED|Overall Study||26
10625051|NCT01995461|11783824|FG000|COMPLETED|Overall Study||21
10625052|NCT01995461|11783824|FG000|NOT COMPLETED|Overall Study||5
10625053|NCT01995487|11783830|FG000|STARTED|Overall Study||958
10625054|NCT01995487|11783831|FG001|STARTED|Overall Study||961
10625055|NCT01995487|11783830|FG000|COMPLETED|Overall Study||884
10705308|NCT02597127|11869647|FG001|COMPLETED|Overall Study||59
10705309|NCT02597127|11869648|FG002|COMPLETED|Overall Study||58
10705310|NCT02597127|11869649|FG003|COMPLETED|Overall Study||60
10705311|NCT02597127|11869650|FG004|COMPLETED|Overall Study||57
10705312|NCT02597127|11869651|FG005|COMPLETED|Overall Study||59
10705313|NCT02597127|11869652|FG006|COMPLETED|Overall Study||57
10625056|NCT01995487|11783831|FG001|COMPLETED|Overall Study||878
10625057|NCT01995487|11783830|FG000|NOT COMPLETED|Overall Study||74
10625058|NCT01995487|11783831|FG001|NOT COMPLETED|Overall Study||83
10625059|NCT01995513|11783837|FG000|STARTED|Open Label Treatment Period||509
10625060|NCT01995513|11783838|FG001|STARTED|Open Label Treatment Period||0
10625061|NCT01995513|11783839|FG002|STARTED|Open Label Treatment Period||0
10625062|NCT01995513|11783837|FG000|COMPLETED|Open Label Treatment Period||251
10625063|NCT01995513|11783838|FG001|COMPLETED|Open Label Treatment Period||0
10625064|NCT01995513|11783839|FG002|COMPLETED|Open Label Treatment Period||0
10625065|NCT01995513|11783837|FG000|NOT COMPLETED|Open Label Treatment Period||258
10625066|NCT01995513|11783838|FG001|NOT COMPLETED|Open Label Treatment Period||0
10625067|NCT01995513|11783839|FG002|NOT COMPLETED|Open Label Treatment Period||0
10625068|NCT01995513|11783837|FG000|STARTED|Double Blind Treatment Period||0
10625069|NCT01995513|11783838|FG001|STARTED|Double Blind Treatment Period||126
10625070|NCT01995513|11783839|FG002|STARTED|Double Blind Treatment Period||125
10625071|NCT01995513|11783837|FG000|Treated|Double Blind Treatment Period||0
10625072|NCT01995513|11783838|FG001|Treated|Double Blind Treatment Period||125
10625073|NCT01995513|11783839|FG002|Treated|Double Blind Treatment Period||124
10625074|NCT01995513|11783837|FG000|COMPLETED|Double Blind Treatment Period||0
10625075|NCT01995513|11783838|FG001|COMPLETED|Double Blind Treatment Period||0
10625076|NCT01995513|11783839|FG002|COMPLETED|Double Blind Treatment Period||0
10705314|NCT02597127|11869653|FG007|COMPLETED|Overall Study||60
10705315|NCT02597127|11869646|FG000|NOT COMPLETED|Overall Study||1
10705316|NCT02597127|11869647|FG001|NOT COMPLETED|Overall Study||3
10625077|NCT01995513|11783837|FG000|NOT COMPLETED|Double Blind Treatment Period||0
10625078|NCT01995513|11783838|FG001|NOT COMPLETED|Double Blind Treatment Period||126
10625079|NCT01995513|11783839|FG002|NOT COMPLETED|Double Blind Treatment Period||125
10625080|NCT01995526|11783849|FG000|STARTED|Overall Study||11
10625081|NCT01995526|11783849|FG000|Received One Dose of Study Drug|Overall Study||11
10625082|NCT01995526|11783849|FG000|COMPLETED|Overall Study||10
10625083|NCT01995526|11783849|FG000|NOT COMPLETED|Overall Study||1
10625084|NCT01995539|11783853|FG000|STARTED|Overall Study||181
10625085|NCT01995539|11783853|FG000|COMPLETED|Overall Study||148
10625086|NCT01995539|11783853|FG000|NOT COMPLETED|Overall Study||33
10625087|NCT01995552|11783857|FG000|STARTED|Overall Study|There were 249 patients were included for Baseline cohort and 233 in analysis cohort|250
10625088|NCT01995552|11783857|FG000|COMPLETED|Overall Study|There were 233 patients who were eligible for primary objective analysis|233
10625089|NCT01995552|11783857|FG000|NOT COMPLETED|Overall Study||17
10625090|NCT01995825|11783865|FG000|STARTED|Overall Study||18
10625091|NCT01995825|11783866|FG001|STARTED|Overall Study||17
10625092|NCT01995825|11783865|FG000|COMPLETED|Overall Study||17
10625093|NCT01995825|11783866|FG001|COMPLETED|Overall Study||17
10625094|NCT01995825|11783865|FG000|NOT COMPLETED|Overall Study||1
10705317|NCT02597127|11869648|FG002|NOT COMPLETED|Overall Study||8
10705318|NCT02597127|11869649|FG003|NOT COMPLETED|Overall Study||5
10705319|NCT02597127|11869650|FG004|NOT COMPLETED|Overall Study||5
10705320|NCT02597127|11869651|FG005|NOT COMPLETED|Overall Study||4
10705321|NCT02597127|11869652|FG006|NOT COMPLETED|Overall Study||4
10705322|NCT02597127|11869653|FG007|NOT COMPLETED|Overall Study||2
10705323|NCT02597452|11869692|FG000|STARTED|Overall Study||516
10705324|NCT02597452|11869692|FG000|COMPLETED|Overall Study||486
10705325|NCT02597452|11869692|FG000|NOT COMPLETED|Overall Study||30
10625095|NCT01995825|11783866|FG001|NOT COMPLETED|Overall Study||0
10625096|NCT01995838|11783879|FG000|STARTED|Overall Study||56
10625097|NCT01995838|11783880|FG001|STARTED|Overall Study||32
10625098|NCT01995838|11783881|FG002|STARTED|Overall Study||27
10625099|NCT01995838|11783882|FG003|STARTED|Overall Study||38
10625100|NCT01995838|11783883|FG004|STARTED|Overall Study||32
10625101|NCT01995838|11783884|FG005|STARTED|Overall Study||56
10625102|NCT01995838|11783885|FG006|STARTED|Overall Study||50
10625103|NCT01995838|11783879|FG000|COMPLETED|Overall Study||51
10625104|NCT01995838|11783880|FG001|COMPLETED|Overall Study||30
10625105|NCT01995838|11783881|FG002|COMPLETED|Overall Study||27
10625106|NCT01995838|11783882|FG003|COMPLETED|Overall Study||36
10625107|NCT01995838|11783883|FG004|COMPLETED|Overall Study||30
10625108|NCT01995838|11783884|FG005|COMPLETED|Overall Study||54
10625109|NCT01995838|11783885|FG006|COMPLETED|Overall Study||45
10625110|NCT01995838|11783879|FG000|NOT COMPLETED|Overall Study||5
10625111|NCT01995838|11783880|FG001|NOT COMPLETED|Overall Study||2
10625112|NCT01995838|11783881|FG002|NOT COMPLETED|Overall Study||0
10625113|NCT01995838|11783882|FG003|NOT COMPLETED|Overall Study||2
10625114|NCT01995838|11783883|FG004|NOT COMPLETED|Overall Study||2
10625115|NCT01995838|11783884|FG005|NOT COMPLETED|Overall Study||2
10625116|NCT01995838|11783885|FG006|NOT COMPLETED|Overall Study||5
10625117|NCT01996033|11783902|FG000|STARTED|Overall Study||25
10625118|NCT01996033|11783902|FG000|COMPLETED|Overall Study||16
10625119|NCT01996033|11783902|FG000|NOT COMPLETED|Overall Study||9
10625120|NCT01996241|11783908|FG000|STARTED|Overall Study||1164
10625121|NCT01996241|11783909|FG001|STARTED|Overall Study||1111
10625122|NCT01996241|11783908|FG000|COMPLETED|Overall Study||912
10625123|NCT01996241|11783909|FG001|COMPLETED|Overall Study||876
10625124|NCT01996241|11783908|FG000|NOT COMPLETED|Overall Study||252
10625125|NCT01996241|11783909|FG001|NOT COMPLETED|Overall Study||235
10625126|NCT01996254|11783919|FG000|STARTED|Overall Study||5
10625127|NCT01996254|11783920|FG001|STARTED|Overall Study||14
10625128|NCT01996254|11783921|FG002|STARTED|Overall Study||14
10625129|NCT01996254|11783919|FG000|Safety Set|Overall Study||5
10625130|NCT01996254|11783920|FG001|Safety Set|Overall Study||14
10625131|NCT01996254|11783921|FG002|Safety Set|Overall Study||14
10625132|NCT01996254|11783919|FG000|Full Analysis Set|Overall Study||0
10625133|NCT01996254|11783920|FG001|Full Analysis Set|Overall Study||12
10625134|NCT01996254|11783921|FG002|Full Analysis Set|Overall Study||14
10625135|NCT01996254|11783919|FG000|Long Term Analysis Set|Overall Study||0
10625136|NCT01996254|11783920|FG001|Long Term Analysis Set|Overall Study||12
10625137|NCT01996254|11783921|FG002|Long Term Analysis Set|Overall Study||14
10625138|NCT01996254|11783919|FG000|Per Protocol Set|Overall Study||0
10625139|NCT01996254|11783920|FG001|Per Protocol Set|Overall Study||10
10625140|NCT01996254|11783921|FG002|Per Protocol Set|Overall Study||13
10625141|NCT01996254|11783919|FG000|COMPLETED|Overall Study||4
10625142|NCT01996254|11783920|FG001|COMPLETED|Overall Study||9
10625143|NCT01996254|11783921|FG002|COMPLETED|Overall Study||6
10625144|NCT01996254|11783919|FG000|NOT COMPLETED|Overall Study||1
10625145|NCT01996254|11783920|FG001|NOT COMPLETED|Overall Study||5
10625146|NCT01996254|11783921|FG002|NOT COMPLETED|Overall Study||8
10625147|NCT01996319|11783933|FG000|STARTED|Overall Study||96
10625148|NCT01996319|11783934|FG001|STARTED|Overall Study||98
10625149|NCT01996319|11783933|FG000|COMPLETED|Overall Study||88
10625150|NCT01996319|11783934|FG001|COMPLETED|Overall Study||95
10625151|NCT01996319|11783933|FG000|NOT COMPLETED|Overall Study||8
10625152|NCT01996319|11783934|FG001|NOT COMPLETED|Overall Study||3
10625153|NCT01996332|11783940|FG000|STARTED|Overall Study||1805
10625154|NCT01996332|11783940|FG000|COMPLETED|Overall Study||0
10625155|NCT01996332|11783940|FG000|NOT COMPLETED|Overall Study||1805
10625156|NCT01996592|11783944|FG000|STARTED|Overall Study||575
10625157|NCT01996592|11783944|FG000|COMPLETED|Overall Study||530
10625158|NCT01996592|11783944|FG000|NOT COMPLETED|Overall Study||45
10625159|NCT01996644|11783955|FG000|STARTED|Overall Study||20
10625160|NCT01996644|11783956|FG001|STARTED|Overall Study||16
10625161|NCT01996644|11783955|FG000|COMPLETED|Overall Study||20
10625162|NCT01996644|11783956|FG001|COMPLETED|Overall Study||16
10625163|NCT01996644|11783955|FG000|NOT COMPLETED|Overall Study||0
10625164|NCT01996644|11783956|FG001|NOT COMPLETED|Overall Study||0
10625165|NCT01996657|11783968|FG000|STARTED|Overall Study||250
10625166|NCT01996657|11783969|FG001|STARTED|Overall Study||250
10625167|NCT01996657|11783970|FG002|STARTED|Overall Study||248
10625168|NCT01996657|11783968|FG000|COMPLETED|Overall Study||237
10625169|NCT01996657|11783969|FG001|COMPLETED|Overall Study||239
10625170|NCT01996657|11783970|FG002|COMPLETED|Overall Study||234
10625171|NCT01996657|11783968|FG000|NOT COMPLETED|Overall Study||13
10705326|NCT02597478|11869698|FG000|STARTED|Overall Study||16
10625172|NCT01996657|11783969|FG001|NOT COMPLETED|Overall Study||11
10625173|NCT01996657|11783970|FG002|NOT COMPLETED|Overall Study||14
10625174|NCT01996709|11783980|FG000|STARTED|Overall Study||66
10625175|NCT01996709|11783981|FG001|STARTED|Overall Study||68
10625176|NCT01996709|11783980|FG000|COMPLETED|Overall Study||61
10625177|NCT01996709|11783981|FG001|COMPLETED|Overall Study||67
10625178|NCT01996709|11783980|FG000|NOT COMPLETED|Overall Study||5
10705327|NCT02597478|11869699|FG001|STARTED|Overall Study||18
10625179|NCT01996709|11783981|FG001|NOT COMPLETED|Overall Study||1
10625180|NCT01996748|11783993|FG000|STARTED|Overall Study||66
10625181|NCT01996748|11783994|FG001|STARTED|Overall Study||69
10625182|NCT01996748|11783993|FG000|COMPLETED|Overall Study||58
10625183|NCT01996748|11783994|FG001|COMPLETED|Overall Study||63
10625184|NCT01996748|11783993|FG000|NOT COMPLETED|Overall Study||8
10625185|NCT01996748|11783994|FG001|NOT COMPLETED|Overall Study||6
10625186|NCT01996813|11784004|FG000|STARTED|Overall Study||23
10625187|NCT01996813|11784005|FG001|STARTED|Overall Study||24
10625188|NCT01996813|11784004|FG000|COMPLETED|Overall Study||23
10625189|NCT01996813|11784005|FG001|COMPLETED|Overall Study||24
10625190|NCT01996813|11784004|FG000|NOT COMPLETED|Overall Study||0
10625191|NCT01996813|11784005|FG001|NOT COMPLETED|Overall Study||0
10625192|NCT01996826|11784013|FG000|STARTED|Overall Study||39
10625193|NCT01996826|11784014|FG001|STARTED|Overall Study||36
10625194|NCT01996826|11784013|FG000|COMPLETED|Overall Study||32
10625195|NCT01996826|11784014|FG001|COMPLETED|Overall Study||33
10625196|NCT01996826|11784013|FG000|NOT COMPLETED|Overall Study||7
10625197|NCT01996826|11784014|FG001|NOT COMPLETED|Overall Study||3
10625198|NCT01996839|11784023|FG000|STARTED|Overall Study||172
10625199|NCT01996839|11784024|FG001|STARTED|Overall Study||171
10625200|NCT01996839|11784025|FG002|STARTED|Overall Study||171
10625201|NCT01996839|11784023|FG000|COMPLETED|Overall Study||80
10625202|NCT01996839|11784024|FG001|COMPLETED|Overall Study||133
10625203|NCT01996839|11784025|FG002|COMPLETED|Overall Study||139
10625204|NCT01996839|11784023|FG000|NOT COMPLETED|Overall Study||92
10625205|NCT01996839|11784024|FG001|NOT COMPLETED|Overall Study||38
10625206|NCT01996839|11784025|FG002|NOT COMPLETED|Overall Study||32
10625207|NCT01996904|11784035|FG000|STARTED|Overall Study||139
10625208|NCT01996904|11784036|FG001|STARTED|Overall Study||117
10625209|NCT01996904|11784035|FG000|COMPLETED|Overall Study||101
10625210|NCT01996904|11784036|FG001|COMPLETED|Overall Study||90
10625211|NCT01996904|11784035|FG000|NOT COMPLETED|Overall Study||38
10625212|NCT01996904|11784036|FG001|NOT COMPLETED|Overall Study||27
10625213|NCT01996917|11784042|FG000|STARTED|Overall Study||21
10625214|NCT01996917|11784042|FG000|COMPLETED|Overall Study||21
10625215|NCT01996917|11784042|FG000|NOT COMPLETED|Overall Study||0
10625216|NCT01996943|11784049|FG000|STARTED|Overall Study||50
10625217|NCT01996943|11784050|FG001|STARTED|Overall Study||50
10625218|NCT01996943|11784049|FG000|COMPLETED|Overall Study||50
10625219|NCT01996943|11784050|FG001|COMPLETED|Overall Study||50
10625220|NCT01996943|11784049|FG000|NOT COMPLETED|Overall Study||0
10625221|NCT01996943|11784050|FG001|NOT COMPLETED|Overall Study||0
10625222|NCT01997125|11784056|FG000|STARTED|Overall Study||1
10625223|NCT01997125|11784056|FG000|COMPLETED|Overall Study||1
10625224|NCT01997125|11784056|FG000|NOT COMPLETED|Overall Study||0
10625225|NCT01997216|11784060|FG000|STARTED|First 9 Hours||18
10625226|NCT01997216|11784061|FG001|STARTED|First 9 Hours||21
10625227|NCT01997216|11784060|FG000|COMPLETED|First 9 Hours||18
10625228|NCT01997216|11784061|FG001|COMPLETED|First 9 Hours||21
10625229|NCT01997216|11784060|FG000|NOT COMPLETED|First 9 Hours||0
10625230|NCT01997216|11784061|FG001|NOT COMPLETED|First 9 Hours||0
10625231|NCT01997216|11784060|FG000|STARTED|Second 9 Hours|One participant was not exposed to Pair 1 due to product unavailability, but was exposed to Pair 2.|19
10625232|NCT01997216|11784061|FG001|STARTED|Second 9 Hours||21
10625233|NCT01997216|11784060|FG000|COMPLETED|Second 9 Hours||19
10625234|NCT01997216|11784061|FG001|COMPLETED|Second 9 Hours||21
10625235|NCT01997216|11784060|FG000|NOT COMPLETED|Second 9 Hours||0
10625236|NCT01997216|11784061|FG001|NOT COMPLETED|Second 9 Hours||0
10625237|NCT01997229|11784069|FG000|STARTED|Overall Study||62
10625238|NCT01997229|11784070|FG001|STARTED|Overall Study||63
10625239|NCT01997229|11784069|FG000|COMPLETED|Overall Study||57
10625240|NCT01997229|11784070|FG001|COMPLETED|Overall Study||61
10625241|NCT01997229|11784069|FG000|NOT COMPLETED|Overall Study||5
10625242|NCT01997229|11784070|FG001|NOT COMPLETED|Overall Study||2
10625243|NCT01997281|11784078|FG000|STARTED|Overall Study||7
10625244|NCT01997281|11784079|FG001|STARTED|Overall Study||7
10625245|NCT01997281|11784078|FG000|Withdrawal|Overall Study||1
10625246|NCT01997281|11784079|FG001|Withdrawal|Overall Study||0
10625247|NCT01997281|11784078|FG000|COMPLETED|Overall Study||6
10625248|NCT01997281|11784079|FG001|COMPLETED|Overall Study||7
10625249|NCT01997281|11784078|FG000|NOT COMPLETED|Overall Study||1
10625250|NCT01997281|11784079|FG001|NOT COMPLETED|Overall Study||0
10625251|NCT01997333|11784087|FG000|STARTED|Randomization and Treatment||109
10625252|NCT01997333|11784088|FG001|STARTED|Randomization and Treatment||218
10625253|NCT01997333|11784087|FG000|COMPLETED|Randomization and Treatment||6
10625254|NCT01997333|11784088|FG001|COMPLETED|Randomization and Treatment||15
10625255|NCT01997333|11784087|FG000|NOT COMPLETED|Randomization and Treatment||103
10625256|NCT01997333|11784088|FG001|NOT COMPLETED|Randomization and Treatment||203
10625257|NCT01997333|11784087|FG000|STARTED|Survival Follow up||92
10625258|NCT01997333|11784088|FG001|STARTED|Survival Follow up||213
10625259|NCT01997333|11784087|FG000|COMPLETED|Survival Follow up||76
10625260|NCT01997333|11784088|FG001|COMPLETED|Survival Follow up||199
10625261|NCT01997333|11784087|FG000|NOT COMPLETED|Survival Follow up||16
10625262|NCT01997333|11784088|FG001|NOT COMPLETED|Survival Follow up||14
10625263|NCT01997398|11784096|FG000|STARTED|Overall Study||35
10625264|NCT01997398|11784096|FG000|COMPLETED|Overall Study|One patient took PD meds 3 hours prior to 6 mo. UPDRS testing and was excluded from the analysis.|34
10625265|NCT01997398|11784096|FG000|NOT COMPLETED|Overall Study||1
10625266|NCT01997411|11784110|FG000|STARTED|Overall Study||6
10625267|NCT01997411|11784111|FG001|STARTED|Overall Study||6
10625268|NCT01997411|11784112|FG002|STARTED|Overall Study||6
10625269|NCT01997411|11784113|FG003|STARTED|Overall Study||6
10625270|NCT01997411|11784114|FG004|STARTED|Overall Study||6
10625271|NCT01997411|11784115|FG005|STARTED|Overall Study||6
10625272|NCT01997411|11784116|FG006|STARTED|Overall Study||6
10625273|NCT01997411|11784117|FG007|STARTED|Overall Study||6
10625274|NCT01997411|11784110|FG000|COMPLETED|Overall Study||6
10625275|NCT01997411|11784111|FG001|COMPLETED|Overall Study||6
10625276|NCT01997411|11784112|FG002|COMPLETED|Overall Study||6
10625277|NCT01997411|11784113|FG003|COMPLETED|Overall Study||6
10625278|NCT01997411|11784114|FG004|COMPLETED|Overall Study||6
10625279|NCT01997411|11784115|FG005|COMPLETED|Overall Study||5
10625280|NCT01997411|11784116|FG006|COMPLETED|Overall Study||6
10625281|NCT01997411|11784117|FG007|COMPLETED|Overall Study||6
10625282|NCT01997411|11784110|FG000|NOT COMPLETED|Overall Study||0
10625283|NCT01997411|11784111|FG001|NOT COMPLETED|Overall Study||0
10625284|NCT01997411|11784112|FG002|NOT COMPLETED|Overall Study||0
10625285|NCT01997411|11784113|FG003|NOT COMPLETED|Overall Study||0
10625286|NCT01997411|11784114|FG004|NOT COMPLETED|Overall Study||0
10625287|NCT01997411|11784115|FG005|NOT COMPLETED|Overall Study||1
10625288|NCT01997411|11784116|FG006|NOT COMPLETED|Overall Study||0
10625289|NCT01997411|11784117|FG007|NOT COMPLETED|Overall Study||0
10625290|NCT01997437|11784135|FG000|STARTED|Overall Study||6
10625291|NCT01997437|11784135|FG000|COMPLETED|Overall Study||6
10625292|NCT01997437|11784135|FG000|NOT COMPLETED|Overall Study||0
10625293|NCT01997515|11784141|FG000|STARTED|Overall Study||40
10625294|NCT01997515|11784142|FG001|STARTED|Overall Study||40
10625295|NCT01997515|11784141|FG000|COMPLETED|Overall Study||36
10625296|NCT01997515|11784142|FG001|COMPLETED|Overall Study||35
10625297|NCT01997515|11784141|FG000|NOT COMPLETED|Overall Study||4
10625298|NCT01997515|11784142|FG001|NOT COMPLETED|Overall Study||5
10625299|NCT01997723|11784148|FG000|STARTED|Overall Study||75
10625300|NCT01997723|11784148|FG000|COMPLETED|Overall Study||75
10625301|NCT01997723|11784148|FG000|NOT COMPLETED|Overall Study||0
10625302|NCT01997892|11784152|FG000|STARTED|Overall Study||1027
10625303|NCT01997892|11784152|FG000|Received Darbepoetin Alfa|Overall Study||987
10625304|NCT01997892|11784152|FG000|COMPLETED|Overall Study||959
10625305|NCT01997892|11784152|FG000|NOT COMPLETED|Overall Study||68
10625306|NCT01997905|11784161|FG000|STARTED|Overall Study||13
10625307|NCT01997905|11784161|FG000|Baseline Completed|Overall Study||11
10625308|NCT01997905|11784161|FG000|COMPLETED|Overall Study||10
10625309|NCT01997905|11784161|FG000|NOT COMPLETED|Overall Study||3
10625310|NCT01998243|11784167|FG000|STARTED|Overall Study||42
10625311|NCT01998243|11784168|FG001|STARTED|Overall Study||39
10625312|NCT01998243|11784167|FG000|COMPLETED|Overall Study||34
10625313|NCT01998243|11784168|FG001|COMPLETED|Overall Study||32
10625314|NCT01998243|11784167|FG000|NOT COMPLETED|Overall Study||8
10625315|NCT01998243|11784168|FG001|NOT COMPLETED|Overall Study||7
10625316|NCT01998269|11784176|FG000|STARTED|Overall Study||193
10625317|NCT01998269|11784176|FG000|COMPLETED|Overall Study||193
10625318|NCT01998269|11784176|FG000|NOT COMPLETED|Overall Study||0
10625319|NCT01998360|11784182|FG000|STARTED|Overall Study||50
10625320|NCT01998360|11784183|FG001|STARTED|Overall Study||50
10625321|NCT01998360|11784182|FG000|COMPLETED|Overall Study||50
10625322|NCT01998360|11784183|FG001|COMPLETED|Overall Study||50
10625323|NCT01998360|11784182|FG000|NOT COMPLETED|Overall Study||0
10625324|NCT01998360|11784183|FG001|NOT COMPLETED|Overall Study||0
10625325|NCT01998399|11784191|FG000|STARTED|Overall Study||12
10625326|NCT01998399|11784192|FG001|STARTED|Overall Study||13
10625327|NCT01998399|11784191|FG000|COMPLETED|Overall Study||4
10625328|NCT01998399|11784192|FG001|COMPLETED|Overall Study||4
10625329|NCT01998399|11784191|FG000|NOT COMPLETED|Overall Study||8
10625330|NCT01998399|11784192|FG001|NOT COMPLETED|Overall Study||9
10625331|NCT01998438|11784201|FG000|STARTED|Overall Study||319
10625332|NCT01998438|11784202|FG001|STARTED|Overall Study||318
10625333|NCT01998438|11784203|FG002|STARTED|Overall Study||318
10625334|NCT01998438|11784201|FG000|COMPLETED|Overall Study||319
10625335|NCT01998438|11784202|FG001|COMPLETED|Overall Study||318
10625336|NCT01998438|11784203|FG002|COMPLETED|Overall Study||318
10625337|NCT01998438|11784201|FG000|NOT COMPLETED|Overall Study||0
10625338|NCT01998438|11784202|FG001|NOT COMPLETED|Overall Study||0
10625339|NCT01998438|11784203|FG002|NOT COMPLETED|Overall Study||0
10625340|NCT01998477|11784213|FG000|STARTED|Overall Study||282
10625341|NCT01998477|11784214|FG001|STARTED|Overall Study||148
10625342|NCT01998477|11784213|FG000|COMPLETED|Overall Study||272
10625343|NCT01998477|11784214|FG001|COMPLETED|Overall Study||143
10625344|NCT01998477|11784213|FG000|NOT COMPLETED|Overall Study||10
10625345|NCT01998477|11784214|FG001|NOT COMPLETED|Overall Study||5
10625346|NCT01998581|11784247|FG000|STARTED|Overall Study||169
10625347|NCT01998581|11784248|FG001|STARTED|Overall Study||56
10625348|NCT01998581|11784247|FG000|COMPLETED|Overall Study||123
10625349|NCT01998581|11784248|FG001|COMPLETED|Overall Study||44
10625350|NCT01998581|11784247|FG000|NOT COMPLETED|Overall Study||46
10625351|NCT01998581|11784248|FG001|NOT COMPLETED|Overall Study||12
10625352|NCT01998633|11784257|FG000|STARTED|Overall Study||47
10625353|NCT01998633|11784257|FG000|COMPLETED|Overall Study||46
10625354|NCT01998633|11784257|FG000|NOT COMPLETED|Overall Study||1
10625355|NCT01998737|11784267|FG000|STARTED|Overall Study||911
10625356|NCT01998737|11784268|FG001|STARTED|Overall Study||100
10625357|NCT01998737|11784267|FG000|COMPLETED|Overall Study||888
10625358|NCT01998737|11784268|FG001|COMPLETED|Overall Study||100
10625359|NCT01998737|11784267|FG000|NOT COMPLETED|Overall Study||23
10625360|NCT01998737|11784268|FG001|NOT COMPLETED|Overall Study||0
10625361|NCT01998880|11784276|FG000|STARTED|Overall Study||233
10625362|NCT01998880|11784277|FG001|STARTED|Overall Study||118
10625363|NCT01998880|11784276|FG000|Received Study Drug|Overall Study||230
10625364|NCT01998880|11784277|FG001|Received Study Drug|Overall Study||116
10625365|NCT01998880|11784276|FG000|COMPLETED|Overall Study|Completed=Completed treatment.|205
10625366|NCT01998880|11784277|FG001|COMPLETED|Overall Study||78
10625367|NCT01998880|11784276|FG000|NOT COMPLETED|Overall Study||28
10625368|NCT01998880|11784277|FG001|NOT COMPLETED|Overall Study||40
10625369|NCT01998893|11784283|FG000|STARTED|Overall Study||38
10625370|NCT01998893|11784283|FG000|1st Treatment Cycle Completed Until PD|Overall Study|Progressive disease (PD)|30
10625371|NCT01998893|11784283|FG000|2nd Treatment Cycle Started|Overall Study||5
10625372|NCT01998893|11784283|FG000|2nd Treatment Cycle Completed Until PD|Overall Study||3
10625373|NCT01998893|11784283|FG000|COMPLETED|Overall Study||21
10625374|NCT01998893|11784283|FG000|NOT COMPLETED|Overall Study||17
10625375|NCT01998906|11784290|FG000|STARTED|Overall Study||115
10625376|NCT01998906|11784291|FG001|STARTED|Overall Study||116
10625377|NCT01998906|11784292|FG002|STARTED|Overall Study||99
10625378|NCT01998906|11784290|FG000|COMPLETED|Overall Study||1
10625379|NCT01998906|11784291|FG001|COMPLETED|Overall Study||2
10625380|NCT01998906|11784292|FG002|COMPLETED|Overall Study||1
10625381|NCT01998906|11784290|FG000|NOT COMPLETED|Overall Study||114
10625382|NCT01998906|11784291|FG001|NOT COMPLETED|Overall Study||114
10625383|NCT01998906|11784292|FG002|NOT COMPLETED|Overall Study||98
10625384|NCT01998919|11784305|FG000|STARTED|Overall Study||79
10625385|NCT01998919|11784306|FG001|STARTED|Overall Study||74
10625386|NCT01998919|11784305|FG000|Randomized|Overall Study|1 participant randomized to erlotinib didn't receive study drug; analyzed in placebo for safety|78
10625387|NCT01998919|11784306|FG001|Randomized|Overall Study|One participant withdrew consent prior to 1st dose and was excluded from safety analysis population.|76
10625388|NCT01998919|11784305|FG000|COMPLETED|Overall Study||37
10625389|NCT01998919|11784306|FG001|COMPLETED|Overall Study||39
10625390|NCT01998919|11784305|FG000|NOT COMPLETED|Overall Study||42
10625391|NCT01998919|11784306|FG001|NOT COMPLETED|Overall Study||35
10625392|NCT01998958|11784319|FG000|STARTED|Period 1 (Panel A and B)||33
10625393|NCT01998958|11784320|FG001|STARTED|Period 1 (Panel A and B)||11
10625394|NCT01998958|11784321|FG002|STARTED|Period 1 (Panel A and B)||11
10625395|NCT01998958|11784322|FG003|STARTED|Period 1 (Panel A and B)||12
10625396|NCT01998958|11784323|FG004|STARTED|Period 1 (Panel A and B)||21
10625397|NCT01998958|11784324|FG005|STARTED|Period 1 (Panel A and B)||11
10625398|NCT01998958|11784325|FG006|STARTED|Period 1 (Panel A and B)||9
10625399|NCT01998958|11784326|FG007|STARTED|Period 1 (Panel A and B)||0
10625400|NCT01998958|11784327|FG008|STARTED|Period 1 (Panel A and B)||0
10625401|NCT01998958|11784328|FG009|STARTED|Period 1 (Panel A and B)||0
10625402|NCT01998958|11784329|FG010|STARTED|Period 1 (Panel A and B)||0
10625403|NCT01998958|11784330|FG011|STARTED|Period 1 (Panel A and B)||0
10625404|NCT01998958|11784331|FG012|STARTED|Period 1 (Panel A and B)||0
10625405|NCT01998958|11784332|FG013|STARTED|Period 1 (Panel A and B)||0
10625406|NCT01998958|11784333|FG014|STARTED|Period 1 (Panel A and B)||0
10625407|NCT01998958|11784334|FG015|STARTED|Period 1 (Panel A and B)||0
10625408|NCT01998958|11784335|FG016|STARTED|Period 1 (Panel A and B)||0
10625409|NCT01998958|11784336|FG017|STARTED|Period 1 (Panel A and B)||0
10625410|NCT01998958|11784337|FG018|STARTED|Period 1 (Panel A and B)||0
10625411|NCT01998958|11784338|FG019|STARTED|Period 1 (Panel A and B)||0
10625412|NCT01998958|11784339|FG020|STARTED|Period 1 (Panel A and B)||0
10625413|NCT01998958|11784340|FG021|STARTED|Period 1 (Panel A and B)||0
10625414|NCT01998958|11784341|FG022|STARTED|Period 1 (Panel A and B)||0
10625415|NCT01998958|11784342|FG023|STARTED|Period 1 (Panel A and B)||0
10625416|NCT01998958|11784343|FG024|STARTED|Period 1 (Panel A and B)||0
10625417|NCT01998958|11784344|FG025|STARTED|Period 1 (Panel A and B)||0
10625418|NCT01998958|11784345|FG026|STARTED|Period 1 (Panel A and B)||0
10625419|NCT01998958|11784346|FG027|STARTED|Period 1 (Panel A and B)||0
10625420|NCT01998958|11784347|FG028|STARTED|Period 1 (Panel A and B)||0
10625421|NCT01998958|11784348|FG029|STARTED|Period 1 (Panel A and B)||0
10625422|NCT01998958|11784349|FG030|STARTED|Period 1 (Panel A and B)||0
10625423|NCT01998958|11784350|FG031|STARTED|Period 1 (Panel A and B)||0
10625424|NCT01998958|11784319|FG000|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||9
10625425|NCT01998958|11784320|FG001|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10625426|NCT01998958|11784321|FG002|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10625427|NCT01998958|11784322|FG003|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10625428|NCT01998958|11784323|FG004|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10625429|NCT01998958|11784324|FG005|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10625430|NCT01998958|11784325|FG006|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10625431|NCT01998958|11784326|FG007|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10625432|NCT01998958|11784327|FG008|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10625433|NCT01998958|11784328|FG009|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10625434|NCT01998958|11784329|FG010|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10625435|NCT01998958|11784330|FG011|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10625436|NCT01998958|11784331|FG012|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10625437|NCT01998958|11784332|FG013|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10625438|NCT01998958|11784333|FG014|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10625439|NCT01998958|11784334|FG015|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10625440|NCT01998958|11784335|FG016|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10625441|NCT01998958|11784336|FG017|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10625442|NCT01998958|11784337|FG018|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10625443|NCT01998958|11784338|FG019|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10625444|NCT01998958|11784339|FG020|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10625445|NCT01998958|11784340|FG021|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10625446|NCT01998958|11784341|FG022|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10625447|NCT01998958|11784342|FG023|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10625448|NCT01998958|11784343|FG024|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10625449|NCT01998958|11784344|FG025|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10625450|NCT01998958|11784345|FG026|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10625451|NCT01998958|11784346|FG027|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10625452|NCT01998958|11784347|FG028|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10625453|NCT01998958|11784348|FG029|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10625454|NCT01998958|11784349|FG030|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10625455|NCT01998958|11784350|FG031|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
10625456|NCT01998958|11784319|FG000|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||8
10625457|NCT01998958|11784320|FG001|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10625458|NCT01998958|11784321|FG002|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10625459|NCT01998958|11784322|FG003|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10625460|NCT01998958|11784323|FG004|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10625461|NCT01998958|11784324|FG005|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10625462|NCT01998958|11784325|FG006|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10625463|NCT01998958|11784326|FG007|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10625464|NCT01998958|11784327|FG008|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10625465|NCT01998958|11784328|FG009|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10625466|NCT01998958|11784329|FG010|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10625467|NCT01998958|11784330|FG011|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10625468|NCT01998958|11784331|FG012|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10625469|NCT01998958|11784332|FG013|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10625470|NCT01998958|11784333|FG014|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10625471|NCT01998958|11784334|FG015|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10625472|NCT01998958|11784335|FG016|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10625473|NCT01998958|11784336|FG017|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10625474|NCT01998958|11784337|FG018|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10625475|NCT01998958|11784338|FG019|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10625476|NCT01998958|11784339|FG020|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10625477|NCT01998958|11784340|FG021|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10625478|NCT01998958|11784341|FG022|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10625479|NCT01998958|11784342|FG023|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10625480|NCT01998958|11784343|FG024|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10625481|NCT01998958|11784344|FG025|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10625482|NCT01998958|11784345|FG026|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10625483|NCT01998958|11784346|FG027|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10625484|NCT01998958|11784347|FG028|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10625485|NCT01998958|11784348|FG029|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10625486|NCT01998958|11784349|FG030|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10625487|NCT01998958|11784350|FG031|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10625488|NCT01998958|11784319|FG000|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||5
10625489|NCT01998958|11784320|FG001|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10625490|NCT01998958|11784321|FG002|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10625491|NCT01998958|11784322|FG003|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10625492|NCT01998958|11784323|FG004|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10625493|NCT01998958|11784324|FG005|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10625494|NCT01998958|11784325|FG006|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10625495|NCT01998958|11784326|FG007|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10625496|NCT01998958|11784327|FG008|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10625497|NCT01998958|11784328|FG009|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10625498|NCT01998958|11784329|FG010|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10625499|NCT01998958|11784330|FG011|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10625500|NCT01998958|11784331|FG012|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10625501|NCT01998958|11784332|FG013|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10625502|NCT01998958|11784333|FG014|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10625503|NCT01998958|11784334|FG015|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10625504|NCT01998958|11784335|FG016|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10625505|NCT01998958|11784336|FG017|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10625506|NCT01998958|11784337|FG018|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10625507|NCT01998958|11784338|FG019|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10625508|NCT01998958|11784339|FG020|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10625509|NCT01998958|11784340|FG021|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10625510|NCT01998958|11784341|FG022|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10625511|NCT01998958|11784342|FG023|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10625512|NCT01998958|11784343|FG024|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10625513|NCT01998958|11784344|FG025|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10625514|NCT01998958|11784345|FG026|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10625515|NCT01998958|11784346|FG027|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10625516|NCT01998958|11784347|FG028|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10625517|NCT01998958|11784348|FG029|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10625518|NCT01998958|11784349|FG030|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10625519|NCT01998958|11784350|FG031|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10625520|NCT01998958|11784319|FG000|COMPLETED|Period 1 (Panel A and B)||32
10625521|NCT01998958|11784320|FG001|COMPLETED|Period 1 (Panel A and B)||8
10625522|NCT01998958|11784321|FG002|COMPLETED|Period 1 (Panel A and B)||11
10625523|NCT01998958|11784322|FG003|COMPLETED|Period 1 (Panel A and B)||12
10625524|NCT01998958|11784323|FG004|COMPLETED|Period 1 (Panel A and B)||21
10625525|NCT01998958|11784324|FG005|COMPLETED|Period 1 (Panel A and B)||11
10625526|NCT01998958|11784325|FG006|COMPLETED|Period 1 (Panel A and B)||9
10625527|NCT01998958|11784326|FG007|COMPLETED|Period 1 (Panel A and B)||0
10625528|NCT01998958|11784327|FG008|COMPLETED|Period 1 (Panel A and B)||0
10625529|NCT01998958|11784328|FG009|COMPLETED|Period 1 (Panel A and B)||0
10625530|NCT01998958|11784329|FG010|COMPLETED|Period 1 (Panel A and B)||0
10625531|NCT01998958|11784330|FG011|COMPLETED|Period 1 (Panel A and B)||0
10625532|NCT01998958|11784331|FG012|COMPLETED|Period 1 (Panel A and B)||0
10625533|NCT01998958|11784332|FG013|COMPLETED|Period 1 (Panel A and B)||0
10625534|NCT01998958|11784333|FG014|COMPLETED|Period 1 (Panel A and B)||0
10625535|NCT01998958|11784334|FG015|COMPLETED|Period 1 (Panel A and B)||0
10625536|NCT01998958|11784335|FG016|COMPLETED|Period 1 (Panel A and B)||0
10625537|NCT01998958|11784336|FG017|COMPLETED|Period 1 (Panel A and B)||0
10625538|NCT01998958|11784337|FG018|COMPLETED|Period 1 (Panel A and B)||0
10625539|NCT01998958|11784338|FG019|COMPLETED|Period 1 (Panel A and B)||0
10625540|NCT01998958|11784339|FG020|COMPLETED|Period 1 (Panel A and B)||0
10625541|NCT01998958|11784340|FG021|COMPLETED|Period 1 (Panel A and B)||0
10625542|NCT01998958|11784341|FG022|COMPLETED|Period 1 (Panel A and B)||0
10625543|NCT01998958|11784342|FG023|COMPLETED|Period 1 (Panel A and B)||0
10625544|NCT01998958|11784343|FG024|COMPLETED|Period 1 (Panel A and B)||0
10625545|NCT01998958|11784344|FG025|COMPLETED|Period 1 (Panel A and B)||0
10625546|NCT01998958|11784345|FG026|COMPLETED|Period 1 (Panel A and B)||0
10625547|NCT01998958|11784346|FG027|COMPLETED|Period 1 (Panel A and B)||0
10625548|NCT01998958|11784347|FG028|COMPLETED|Period 1 (Panel A and B)||0
10625549|NCT01998958|11784348|FG029|COMPLETED|Period 1 (Panel A and B)||0
10625550|NCT01998958|11784349|FG030|COMPLETED|Period 1 (Panel A and B)||0
10625551|NCT01998958|11784350|FG031|COMPLETED|Period 1 (Panel A and B)||0
10625552|NCT01998958|11784319|FG000|NOT COMPLETED|Period 1 (Panel A and B)||1
10625553|NCT01998958|11784320|FG001|NOT COMPLETED|Period 1 (Panel A and B)||3
10625554|NCT01998958|11784321|FG002|NOT COMPLETED|Period 1 (Panel A and B)||0
10625555|NCT01998958|11784322|FG003|NOT COMPLETED|Period 1 (Panel A and B)||0
10625556|NCT01998958|11784323|FG004|NOT COMPLETED|Period 1 (Panel A and B)||0
10625557|NCT01998958|11784324|FG005|NOT COMPLETED|Period 1 (Panel A and B)||0
10625558|NCT01998958|11784325|FG006|NOT COMPLETED|Period 1 (Panel A and B)||0
10625559|NCT01998958|11784326|FG007|NOT COMPLETED|Period 1 (Panel A and B)||0
10625560|NCT01998958|11784327|FG008|NOT COMPLETED|Period 1 (Panel A and B)||0
10625561|NCT01998958|11784328|FG009|NOT COMPLETED|Period 1 (Panel A and B)||0
10625562|NCT01998958|11784329|FG010|NOT COMPLETED|Period 1 (Panel A and B)||0
10625563|NCT01998958|11784330|FG011|NOT COMPLETED|Period 1 (Panel A and B)||0
10625564|NCT01998958|11784331|FG012|NOT COMPLETED|Period 1 (Panel A and B)||0
10625565|NCT01998958|11784332|FG013|NOT COMPLETED|Period 1 (Panel A and B)||0
10625566|NCT01998958|11784333|FG014|NOT COMPLETED|Period 1 (Panel A and B)||0
10625567|NCT01998958|11784334|FG015|NOT COMPLETED|Period 1 (Panel A and B)||0
10625568|NCT01998958|11784335|FG016|NOT COMPLETED|Period 1 (Panel A and B)||0
10625569|NCT01998958|11784336|FG017|NOT COMPLETED|Period 1 (Panel A and B)||0
10625570|NCT01998958|11784337|FG018|NOT COMPLETED|Period 1 (Panel A and B)||0
10625571|NCT01998958|11784338|FG019|NOT COMPLETED|Period 1 (Panel A and B)||0
10625572|NCT01998958|11784339|FG020|NOT COMPLETED|Period 1 (Panel A and B)||0
10625573|NCT01998958|11784340|FG021|NOT COMPLETED|Period 1 (Panel A and B)||0
10625574|NCT01998958|11784341|FG022|NOT COMPLETED|Period 1 (Panel A and B)||0
10625575|NCT01998958|11784342|FG023|NOT COMPLETED|Period 1 (Panel A and B)||0
10625576|NCT01998958|11784343|FG024|NOT COMPLETED|Period 1 (Panel A and B)||0
10625577|NCT01998958|11784344|FG025|NOT COMPLETED|Period 1 (Panel A and B)||0
10625578|NCT01998958|11784345|FG026|NOT COMPLETED|Period 1 (Panel A and B)||0
10625579|NCT01998958|11784346|FG027|NOT COMPLETED|Period 1 (Panel A and B)||0
10625580|NCT01998958|11784347|FG028|NOT COMPLETED|Period 1 (Panel A and B)||0
10625581|NCT01998958|11784348|FG029|NOT COMPLETED|Period 1 (Panel A and B)||0
10625582|NCT01998958|11784349|FG030|NOT COMPLETED|Period 1 (Panel A and B)||0
10625583|NCT01998958|11784350|FG031|NOT COMPLETED|Period 1 (Panel A and B)||0
10625584|NCT01998958|11784319|FG000|STARTED|Period 2 (Panel A and B)||0
10625585|NCT01998958|11784320|FG001|STARTED|Period 2 (Panel A and B)||0
10625586|NCT01998958|11784321|FG002|STARTED|Period 2 (Panel A and B)||0
10625587|NCT01998958|11784322|FG003|STARTED|Period 2 (Panel A and B)||0
10625588|NCT01998958|11784323|FG004|STARTED|Period 2 (Panel A and B)||0
10625589|NCT01998958|11784324|FG005|STARTED|Period 2 (Panel A and B)||0
10625590|NCT01998958|11784325|FG006|STARTED|Period 2 (Panel A and B)||0
10625591|NCT01998958|11784326|FG007|STARTED|Period 2 (Panel A and B)||6
10625592|NCT01998958|11784327|FG008|STARTED|Period 2 (Panel A and B)||4
10625593|NCT01998958|11784328|FG009|STARTED|Period 2 (Panel A and B)||8
10625594|NCT01998958|11784329|FG010|STARTED|Period 2 (Panel A and B)||9
10625595|NCT01998958|11784330|FG011|STARTED|Period 2 (Panel A and B)||5
10625596|NCT01998958|11784331|FG012|STARTED|Period 2 (Panel A and B)||8
10625597|NCT01998958|11784332|FG013|STARTED|Period 2 (Panel A and B)||11
10625598|NCT01998958|11784333|FG014|STARTED|Period 2 (Panel A and B)||12
10625599|NCT01998958|11784334|FG015|STARTED|Period 2 (Panel A and B)||5
10625600|NCT01998958|11784335|FG016|STARTED|Period 2 (Panel A and B)||8
10625601|NCT01998958|11784336|FG017|STARTED|Period 2 (Panel A and B)||5
10625602|NCT01998958|11784337|FG018|STARTED|Period 2 (Panel A and B)||3
10625603|NCT01998958|11784338|FG019|STARTED|Period 2 (Panel A and B)||11
10625604|NCT01998958|11784339|FG020|STARTED|Period 2 (Panel A and B)||9
10625605|NCT01998958|11784340|FG021|STARTED|Period 2 (Panel A and B)||0
10625606|NCT01998958|11784341|FG022|STARTED|Period 2 (Panel A and B)||0
10625607|NCT01998958|11784342|FG023|STARTED|Period 2 (Panel A and B)||0
10625608|NCT01998958|11784343|FG024|STARTED|Period 2 (Panel A and B)||0
10625609|NCT01998958|11784344|FG025|STARTED|Period 2 (Panel A and B)||0
10625610|NCT01998958|11784345|FG026|STARTED|Period 2 (Panel A and B)||0
10625611|NCT01998958|11784346|FG027|STARTED|Period 2 (Panel A and B)||0
10625612|NCT01998958|11784347|FG028|STARTED|Period 2 (Panel A and B)||0
10625613|NCT01998958|11784348|FG029|STARTED|Period 2 (Panel A and B)||0
10625614|NCT01998958|11784349|FG030|STARTED|Period 2 (Panel A and B)||0
10625615|NCT01998958|11784350|FG031|STARTED|Period 2 (Panel A and B)||0
10625616|NCT01998958|11784319|FG000|COMPLETED|Period 2 (Panel A and B)||0
10625617|NCT01998958|11784320|FG001|COMPLETED|Period 2 (Panel A and B)||0
10625618|NCT01998958|11784321|FG002|COMPLETED|Period 2 (Panel A and B)||0
10625619|NCT01998958|11784322|FG003|COMPLETED|Period 2 (Panel A and B)||0
10625620|NCT01998958|11784323|FG004|COMPLETED|Period 2 (Panel A and B)||0
10625621|NCT01998958|11784324|FG005|COMPLETED|Period 2 (Panel A and B)||0
10625622|NCT01998958|11784325|FG006|COMPLETED|Period 2 (Panel A and B)||0
10625623|NCT01998958|11784326|FG007|COMPLETED|Period 2 (Panel A and B)||6
10625624|NCT01998958|11784327|FG008|COMPLETED|Period 2 (Panel A and B)||4
10625625|NCT01998958|11784328|FG009|COMPLETED|Period 2 (Panel A and B)||8
10625626|NCT01998958|11784329|FG010|COMPLETED|Period 2 (Panel A and B)||8
10625627|NCT01998958|11784330|FG011|COMPLETED|Period 2 (Panel A and B)||5
10625628|NCT01998958|11784331|FG012|COMPLETED|Period 2 (Panel A and B)||8
10625629|NCT01998958|11784332|FG013|COMPLETED|Period 2 (Panel A and B)||11
10625630|NCT01998958|11784333|FG014|COMPLETED|Period 2 (Panel A and B)||10
10625631|NCT01998958|11784334|FG015|COMPLETED|Period 2 (Panel A and B)||5
10625632|NCT01998958|11784335|FG016|COMPLETED|Period 2 (Panel A and B)||8
10625633|NCT01998958|11784336|FG017|COMPLETED|Period 2 (Panel A and B)||5
10625634|NCT01998958|11784337|FG018|COMPLETED|Period 2 (Panel A and B)||2
10625635|NCT01998958|11784338|FG019|COMPLETED|Period 2 (Panel A and B)||11
10625636|NCT01998958|11784339|FG020|COMPLETED|Period 2 (Panel A and B)||9
10625637|NCT01998958|11784340|FG021|COMPLETED|Period 2 (Panel A and B)||0
10625638|NCT01998958|11784341|FG022|COMPLETED|Period 2 (Panel A and B)||0
10625639|NCT01998958|11784342|FG023|COMPLETED|Period 2 (Panel A and B)||0
10625640|NCT01998958|11784343|FG024|COMPLETED|Period 2 (Panel A and B)||0
10625641|NCT01998958|11784344|FG025|COMPLETED|Period 2 (Panel A and B)||0
10625642|NCT01998958|11784345|FG026|COMPLETED|Period 2 (Panel A and B)||0
10625643|NCT01998958|11784346|FG027|COMPLETED|Period 2 (Panel A and B)||0
10625644|NCT01998958|11784347|FG028|COMPLETED|Period 2 (Panel A and B)||0
10625645|NCT01998958|11784348|FG029|COMPLETED|Period 2 (Panel A and B)||0
10625646|NCT01998958|11784349|FG030|COMPLETED|Period 2 (Panel A and B)||0
10625647|NCT01998958|11784350|FG031|COMPLETED|Period 2 (Panel A and B)||0
10625648|NCT01998958|11784319|FG000|NOT COMPLETED|Period 2 (Panel A and B)||0
10625649|NCT01998958|11784320|FG001|NOT COMPLETED|Period 2 (Panel A and B)||0
10625650|NCT01998958|11784321|FG002|NOT COMPLETED|Period 2 (Panel A and B)||0
10625651|NCT01998958|11784322|FG003|NOT COMPLETED|Period 2 (Panel A and B)||0
10625652|NCT01998958|11784323|FG004|NOT COMPLETED|Period 2 (Panel A and B)||0
10625653|NCT01998958|11784324|FG005|NOT COMPLETED|Period 2 (Panel A and B)||0
10625654|NCT01998958|11784325|FG006|NOT COMPLETED|Period 2 (Panel A and B)||0
10625655|NCT01998958|11784326|FG007|NOT COMPLETED|Period 2 (Panel A and B)||0
10625656|NCT01998958|11784327|FG008|NOT COMPLETED|Period 2 (Panel A and B)||0
10625657|NCT01998958|11784328|FG009|NOT COMPLETED|Period 2 (Panel A and B)||0
10625658|NCT01998958|11784329|FG010|NOT COMPLETED|Period 2 (Panel A and B)||1
10625659|NCT01998958|11784330|FG011|NOT COMPLETED|Period 2 (Panel A and B)||0
10625660|NCT01998958|11784331|FG012|NOT COMPLETED|Period 2 (Panel A and B)||0
10625661|NCT01998958|11784332|FG013|NOT COMPLETED|Period 2 (Panel A and B)||0
10625662|NCT01998958|11784333|FG014|NOT COMPLETED|Period 2 (Panel A and B)||2
10625663|NCT01998958|11784334|FG015|NOT COMPLETED|Period 2 (Panel A and B)||0
10625664|NCT01998958|11784335|FG016|NOT COMPLETED|Period 2 (Panel A and B)||0
10625665|NCT01998958|11784336|FG017|NOT COMPLETED|Period 2 (Panel A and B)||0
10625666|NCT01998958|11784337|FG018|NOT COMPLETED|Period 2 (Panel A and B)||1
10625667|NCT01998958|11784338|FG019|NOT COMPLETED|Period 2 (Panel A and B)||0
10625668|NCT01998958|11784339|FG020|NOT COMPLETED|Period 2 (Panel A and B)||0
10625669|NCT01998958|11784340|FG021|NOT COMPLETED|Period 2 (Panel A and B)||0
10625670|NCT01998958|11784341|FG022|NOT COMPLETED|Period 2 (Panel A and B)||0
10625671|NCT01998958|11784342|FG023|NOT COMPLETED|Period 2 (Panel A and B)||0
10625672|NCT01998958|11784343|FG024|NOT COMPLETED|Period 2 (Panel A and B)||0
10625673|NCT01998958|11784344|FG025|NOT COMPLETED|Period 2 (Panel A and B)||0
10625674|NCT01998958|11784345|FG026|NOT COMPLETED|Period 2 (Panel A and B)||0
10625675|NCT01998958|11784346|FG027|NOT COMPLETED|Period 2 (Panel A and B)||0
10625676|NCT01998958|11784347|FG028|NOT COMPLETED|Period 2 (Panel A and B)||0
10625677|NCT01998958|11784348|FG029|NOT COMPLETED|Period 2 (Panel A and B)||0
10625678|NCT01998958|11784349|FG030|NOT COMPLETED|Period 2 (Panel A and B)||0
10625679|NCT01998958|11784350|FG031|NOT COMPLETED|Period 2 (Panel A and B)||0
10625680|NCT01998958|11784319|FG000|STARTED|Open Label Phase (Optional)||0
10625681|NCT01998958|11784320|FG001|STARTED|Open Label Phase (Optional)||0
10625682|NCT01998958|11784321|FG002|STARTED|Open Label Phase (Optional)||0
10625683|NCT01998958|11784322|FG003|STARTED|Open Label Phase (Optional)||0
10625684|NCT01998958|11784323|FG004|STARTED|Open Label Phase (Optional)||0
10625685|NCT01998958|11784324|FG005|STARTED|Open Label Phase (Optional)||0
10625686|NCT01998958|11784325|FG006|STARTED|Open Label Phase (Optional)||0
10625687|NCT01998958|11784326|FG007|STARTED|Open Label Phase (Optional)||0
10625688|NCT01998958|11784327|FG008|STARTED|Open Label Phase (Optional)||0
10625689|NCT01998958|11784328|FG009|STARTED|Open Label Phase (Optional)||0
10625690|NCT01998958|11784329|FG010|STARTED|Open Label Phase (Optional)||0
10625691|NCT01998958|11784330|FG011|STARTED|Open Label Phase (Optional)||0
10625692|NCT01998958|11784331|FG012|STARTED|Open Label Phase (Optional)||0
10625693|NCT01998958|11784332|FG013|STARTED|Open Label Phase (Optional)||0
10625694|NCT01998958|11784333|FG014|STARTED|Open Label Phase (Optional)||0
10625695|NCT01998958|11784334|FG015|STARTED|Open Label Phase (Optional)||0
10625696|NCT01998958|11784335|FG016|STARTED|Open Label Phase (Optional)||0
10625697|NCT01998958|11784336|FG017|STARTED|Open Label Phase (Optional)||0
10625698|NCT01998958|11784337|FG018|STARTED|Open Label Phase (Optional)||0
10625699|NCT01998958|11784338|FG019|STARTED|Open Label Phase (Optional)||0
10625700|NCT01998958|11784339|FG020|STARTED|Open Label Phase (Optional)||0
10625701|NCT01998958|11784340|FG021|STARTED|Open Label Phase (Optional)||10
10705328|NCT02597478|11869698|FG000|COMPLETED|Overall Study||13
10625702|NCT01998958|11784341|FG022|STARTED|Open Label Phase (Optional)||20
10625703|NCT01998958|11784342|FG023|STARTED|Open Label Phase (Optional)||27
10625704|NCT01998958|11784343|FG024|STARTED|Open Label Phase (Optional)||13
10625705|NCT01998958|11784344|FG025|STARTED|Open Label Phase (Optional)||7
10625706|NCT01998958|11784345|FG026|STARTED|Open Label Phase (Optional)||19
10625707|NCT01998958|11784346|FG027|STARTED|Open Label Phase (Optional)||0
10625708|NCT01998958|11784347|FG028|STARTED|Open Label Phase (Optional)||0
10625709|NCT01998958|11784348|FG029|STARTED|Open Label Phase (Optional)||0
10625710|NCT01998958|11784349|FG030|STARTED|Open Label Phase (Optional)||0
10625711|NCT01998958|11784350|FG031|STARTED|Open Label Phase (Optional)||0
10625712|NCT01998958|11784319|FG000|COMPLETED|Open Label Phase (Optional)||0
10625713|NCT01998958|11784320|FG001|COMPLETED|Open Label Phase (Optional)||0
10625714|NCT01998958|11784321|FG002|COMPLETED|Open Label Phase (Optional)||0
10625715|NCT01998958|11784322|FG003|COMPLETED|Open Label Phase (Optional)||0
10625716|NCT01998958|11784323|FG004|COMPLETED|Open Label Phase (Optional)||0
10625717|NCT01998958|11784324|FG005|COMPLETED|Open Label Phase (Optional)||0
10625718|NCT01998958|11784325|FG006|COMPLETED|Open Label Phase (Optional)||0
10625719|NCT01998958|11784326|FG007|COMPLETED|Open Label Phase (Optional)||0
10625720|NCT01998958|11784327|FG008|COMPLETED|Open Label Phase (Optional)||0
10625721|NCT01998958|11784328|FG009|COMPLETED|Open Label Phase (Optional)||0
10625722|NCT01998958|11784329|FG010|COMPLETED|Open Label Phase (Optional)||0
10625723|NCT01998958|11784330|FG011|COMPLETED|Open Label Phase (Optional)||0
10625724|NCT01998958|11784331|FG012|COMPLETED|Open Label Phase (Optional)||0
10705329|NCT02597478|11869699|FG001|COMPLETED|Overall Study||17
10625725|NCT01998958|11784332|FG013|COMPLETED|Open Label Phase (Optional)||0
10625726|NCT01998958|11784333|FG014|COMPLETED|Open Label Phase (Optional)||0
10625727|NCT01998958|11784334|FG015|COMPLETED|Open Label Phase (Optional)||0
10625728|NCT01998958|11784335|FG016|COMPLETED|Open Label Phase (Optional)||0
10625729|NCT01998958|11784336|FG017|COMPLETED|Open Label Phase (Optional)||0
10625730|NCT01998958|11784337|FG018|COMPLETED|Open Label Phase (Optional)||0
10625731|NCT01998958|11784338|FG019|COMPLETED|Open Label Phase (Optional)||0
10625732|NCT01998958|11784339|FG020|COMPLETED|Open Label Phase (Optional)||0
10625733|NCT01998958|11784340|FG021|COMPLETED|Open Label Phase (Optional)||7
10625734|NCT01998958|11784341|FG022|COMPLETED|Open Label Phase (Optional)||11
10625735|NCT01998958|11784342|FG023|COMPLETED|Open Label Phase (Optional)||23
10625736|NCT01998958|11784343|FG024|COMPLETED|Open Label Phase (Optional)||13
10625737|NCT01998958|11784344|FG025|COMPLETED|Open Label Phase (Optional)||7
10625738|NCT01998958|11784345|FG026|COMPLETED|Open Label Phase (Optional)||19
10625739|NCT01998958|11784346|FG027|COMPLETED|Open Label Phase (Optional)||0
10625740|NCT01998958|11784347|FG028|COMPLETED|Open Label Phase (Optional)||0
10625741|NCT01998958|11784348|FG029|COMPLETED|Open Label Phase (Optional)||0
10625742|NCT01998958|11784349|FG030|COMPLETED|Open Label Phase (Optional)||0
10625743|NCT01998958|11784350|FG031|COMPLETED|Open Label Phase (Optional)||0
10625744|NCT01998958|11784319|FG000|NOT COMPLETED|Open Label Phase (Optional)||0
10625745|NCT01998958|11784320|FG001|NOT COMPLETED|Open Label Phase (Optional)||0
10625746|NCT01998958|11784321|FG002|NOT COMPLETED|Open Label Phase (Optional)||0
10625747|NCT01998958|11784322|FG003|NOT COMPLETED|Open Label Phase (Optional)||0
10625748|NCT01998958|11784323|FG004|NOT COMPLETED|Open Label Phase (Optional)||0
10625749|NCT01998958|11784324|FG005|NOT COMPLETED|Open Label Phase (Optional)||0
10625750|NCT01998958|11784325|FG006|NOT COMPLETED|Open Label Phase (Optional)||0
10625751|NCT01998958|11784326|FG007|NOT COMPLETED|Open Label Phase (Optional)||0
10625752|NCT01998958|11784327|FG008|NOT COMPLETED|Open Label Phase (Optional)||0
10625753|NCT01998958|11784328|FG009|NOT COMPLETED|Open Label Phase (Optional)||0
10625754|NCT01998958|11784329|FG010|NOT COMPLETED|Open Label Phase (Optional)||0
10625755|NCT01998958|11784330|FG011|NOT COMPLETED|Open Label Phase (Optional)||0
10625756|NCT01998958|11784331|FG012|NOT COMPLETED|Open Label Phase (Optional)||0
10625757|NCT01998958|11784332|FG013|NOT COMPLETED|Open Label Phase (Optional)||0
10625758|NCT01998958|11784333|FG014|NOT COMPLETED|Open Label Phase (Optional)||0
10625759|NCT01998958|11784334|FG015|NOT COMPLETED|Open Label Phase (Optional)||0
10625760|NCT01998958|11784335|FG016|NOT COMPLETED|Open Label Phase (Optional)||0
10625761|NCT01998958|11784336|FG017|NOT COMPLETED|Open Label Phase (Optional)||0
10625762|NCT01998958|11784337|FG018|NOT COMPLETED|Open Label Phase (Optional)||0
10625763|NCT01998958|11784338|FG019|NOT COMPLETED|Open Label Phase (Optional)||0
10625764|NCT01998958|11784339|FG020|NOT COMPLETED|Open Label Phase (Optional)||0
10625765|NCT01998958|11784340|FG021|NOT COMPLETED|Open Label Phase (Optional)||3
10625766|NCT01998958|11784341|FG022|NOT COMPLETED|Open Label Phase (Optional)||9
10625767|NCT01998958|11784342|FG023|NOT COMPLETED|Open Label Phase (Optional)||4
10625768|NCT01998958|11784343|FG024|NOT COMPLETED|Open Label Phase (Optional)||0
10625769|NCT01998958|11784344|FG025|NOT COMPLETED|Open Label Phase (Optional)||0
10625770|NCT01998958|11784345|FG026|NOT COMPLETED|Open Label Phase (Optional)||0
10625771|NCT01998958|11784346|FG027|NOT COMPLETED|Open Label Phase (Optional)||0
10625772|NCT01998958|11784347|FG028|NOT COMPLETED|Open Label Phase (Optional)||0
10625773|NCT01998958|11784348|FG029|NOT COMPLETED|Open Label Phase (Optional)||0
10625774|NCT01998958|11784349|FG030|NOT COMPLETED|Open Label Phase (Optional)||0
10625775|NCT01998958|11784350|FG031|NOT COMPLETED|Open Label Phase (Optional)||0
10625776|NCT01998958|11784319|FG000|STARTED|Follow-up Phase||0
10625777|NCT01998958|11784320|FG001|STARTED|Follow-up Phase||0
10625778|NCT01998958|11784321|FG002|STARTED|Follow-up Phase||0
10625779|NCT01998958|11784322|FG003|STARTED|Follow-up Phase||0
10625780|NCT01998958|11784323|FG004|STARTED|Follow-up Phase||0
10625781|NCT01998958|11784324|FG005|STARTED|Follow-up Phase||0
10625782|NCT01998958|11784325|FG006|STARTED|Follow-up Phase||0
10625783|NCT01998958|11784326|FG007|STARTED|Follow-up Phase||0
10625784|NCT01998958|11784327|FG008|STARTED|Follow-up Phase||0
10625785|NCT01998958|11784328|FG009|STARTED|Follow-up Phase||0
10625786|NCT01998958|11784329|FG010|STARTED|Follow-up Phase||0
10625787|NCT01998958|11784330|FG011|STARTED|Follow-up Phase||0
10625788|NCT01998958|11784331|FG012|STARTED|Follow-up Phase||0
10625789|NCT01998958|11784332|FG013|STARTED|Follow-up Phase||0
10625790|NCT01998958|11784333|FG014|STARTED|Follow-up Phase||0
10625791|NCT01998958|11784334|FG015|STARTED|Follow-up Phase||0
10625792|NCT01998958|11784335|FG016|STARTED|Follow-up Phase||0
10625793|NCT01998958|11784336|FG017|STARTED|Follow-up Phase||0
10625794|NCT01998958|11784337|FG018|STARTED|Follow-up Phase||0
10625795|NCT01998958|11784338|FG019|STARTED|Follow-up Phase||0
10625796|NCT01998958|11784339|FG020|STARTED|Follow-up Phase||0
10625797|NCT01998958|11784340|FG021|STARTED|Follow-up Phase||0
10625798|NCT01998958|11784341|FG022|STARTED|Follow-up Phase||0
10625799|NCT01998958|11784342|FG023|STARTED|Follow-up Phase||0
10625800|NCT01998958|11784343|FG024|STARTED|Follow-up Phase||0
10625801|NCT01998958|11784344|FG025|STARTED|Follow-up Phase||0
10625802|NCT01998958|11784345|FG026|STARTED|Follow-up Phase||0
10625803|NCT01998958|11784346|FG027|STARTED|Follow-up Phase||1
10625804|NCT01998958|11784347|FG028|STARTED|Follow-up Phase||4
10625805|NCT01998958|11784348|FG029|STARTED|Follow-up Phase||12
10625806|NCT01998958|11784349|FG030|STARTED|Follow-up Phase||39
10625807|NCT01998958|11784350|FG031|STARTED|Follow-up Phase||42
10625808|NCT01998958|11784319|FG000|COMPLETED|Follow-up Phase||0
10625809|NCT01998958|11784320|FG001|COMPLETED|Follow-up Phase||0
10625810|NCT01998958|11784321|FG002|COMPLETED|Follow-up Phase||0
10625811|NCT01998958|11784322|FG003|COMPLETED|Follow-up Phase||0
10625812|NCT01998958|11784323|FG004|COMPLETED|Follow-up Phase||0
10625813|NCT01998958|11784324|FG005|COMPLETED|Follow-up Phase||0
10625814|NCT01998958|11784325|FG006|COMPLETED|Follow-up Phase||0
10625815|NCT01998958|11784326|FG007|COMPLETED|Follow-up Phase||0
10625816|NCT01998958|11784327|FG008|COMPLETED|Follow-up Phase||0
10625817|NCT01998958|11784328|FG009|COMPLETED|Follow-up Phase||0
10625818|NCT01998958|11784329|FG010|COMPLETED|Follow-up Phase||0
10625819|NCT01998958|11784330|FG011|COMPLETED|Follow-up Phase||0
10625820|NCT01998958|11784331|FG012|COMPLETED|Follow-up Phase||0
10625821|NCT01998958|11784332|FG013|COMPLETED|Follow-up Phase||0
10625822|NCT01998958|11784333|FG014|COMPLETED|Follow-up Phase||0
10625823|NCT01998958|11784334|FG015|COMPLETED|Follow-up Phase||0
10625824|NCT01998958|11784335|FG016|COMPLETED|Follow-up Phase||0
10625825|NCT01998958|11784336|FG017|COMPLETED|Follow-up Phase||0
10625826|NCT01998958|11784337|FG018|COMPLETED|Follow-up Phase||0
10625827|NCT01998958|11784338|FG019|COMPLETED|Follow-up Phase||0
10625828|NCT01998958|11784339|FG020|COMPLETED|Follow-up Phase||0
10625829|NCT01998958|11784340|FG021|COMPLETED|Follow-up Phase||0
10625830|NCT01998958|11784341|FG022|COMPLETED|Follow-up Phase||0
10625831|NCT01998958|11784342|FG023|COMPLETED|Follow-up Phase||0
10625832|NCT01998958|11784343|FG024|COMPLETED|Follow-up Phase||0
10625833|NCT01998958|11784344|FG025|COMPLETED|Follow-up Phase||0
10625834|NCT01998958|11784345|FG026|COMPLETED|Follow-up Phase||0
10625835|NCT01998958|11784346|FG027|COMPLETED|Follow-up Phase||1
10625836|NCT01998958|11784347|FG028|COMPLETED|Follow-up Phase||4
10625837|NCT01998958|11784348|FG029|COMPLETED|Follow-up Phase||12
10625838|NCT01998958|11784349|FG030|COMPLETED|Follow-up Phase||39
10625839|NCT01998958|11784350|FG031|COMPLETED|Follow-up Phase||42
10625840|NCT01998958|11784319|FG000|NOT COMPLETED|Follow-up Phase||0
10625841|NCT01998958|11784320|FG001|NOT COMPLETED|Follow-up Phase||0
10625842|NCT01998958|11784321|FG002|NOT COMPLETED|Follow-up Phase||0
10625843|NCT01998958|11784322|FG003|NOT COMPLETED|Follow-up Phase||0
10625844|NCT01998958|11784323|FG004|NOT COMPLETED|Follow-up Phase||0
10625845|NCT01998958|11784324|FG005|NOT COMPLETED|Follow-up Phase||0
10625846|NCT01998958|11784325|FG006|NOT COMPLETED|Follow-up Phase||0
10625847|NCT01998958|11784326|FG007|NOT COMPLETED|Follow-up Phase||0
10625848|NCT01998958|11784327|FG008|NOT COMPLETED|Follow-up Phase||0
10625849|NCT01998958|11784328|FG009|NOT COMPLETED|Follow-up Phase||0
10625850|NCT01998958|11784329|FG010|NOT COMPLETED|Follow-up Phase||0
10625851|NCT01998958|11784330|FG011|NOT COMPLETED|Follow-up Phase||0
10625852|NCT01998958|11784331|FG012|NOT COMPLETED|Follow-up Phase||0
10625853|NCT01998958|11784332|FG013|NOT COMPLETED|Follow-up Phase||0
10625854|NCT01998958|11784333|FG014|NOT COMPLETED|Follow-up Phase||0
10808989|NCT03815240|11970931|FG007|NOT COMPLETED|Intervention Mepilex Dressing||0
10808990|NCT03815240|11970932|FG008|NOT COMPLETED|Intervention Mepilex Dressing||0
10808991|NCT03815240|11970924|FG000|STARTED|Intervention Allevyn Dressing||2
10808992|NCT03815240|11970925|FG001|STARTED|Intervention Allevyn Dressing||1
10808993|NCT03815240|11970926|FG002|STARTED|Intervention Allevyn Dressing||1
10808994|NCT03815240|11970927|FG003|STARTED|Intervention Allevyn Dressing||2
10808995|NCT03815240|11970928|FG004|STARTED|Intervention Allevyn Dressing||1
10808996|NCT03815240|11970929|FG005|STARTED|Intervention Allevyn Dressing||2
10808997|NCT03815240|11970930|FG006|STARTED|Intervention Allevyn Dressing||1
10625855|NCT01998958|11784334|FG015|NOT COMPLETED|Follow-up Phase||0
10625856|NCT01998958|11784335|FG016|NOT COMPLETED|Follow-up Phase||0
10625857|NCT01998958|11784336|FG017|NOT COMPLETED|Follow-up Phase||0
10625858|NCT01998958|11784337|FG018|NOT COMPLETED|Follow-up Phase||0
10625859|NCT01998958|11784338|FG019|NOT COMPLETED|Follow-up Phase||0
10625860|NCT01998958|11784339|FG020|NOT COMPLETED|Follow-up Phase||0
10625861|NCT01998958|11784340|FG021|NOT COMPLETED|Follow-up Phase||0
10625862|NCT01998958|11784341|FG022|NOT COMPLETED|Follow-up Phase||0
10625863|NCT01998958|11784342|FG023|NOT COMPLETED|Follow-up Phase||0
10625864|NCT01998958|11784343|FG024|NOT COMPLETED|Follow-up Phase||0
10625865|NCT01998958|11784344|FG025|NOT COMPLETED|Follow-up Phase||0
10625866|NCT01998958|11784345|FG026|NOT COMPLETED|Follow-up Phase||0
10625867|NCT01998958|11784346|FG027|NOT COMPLETED|Follow-up Phase||0
10625868|NCT01998958|11784347|FG028|NOT COMPLETED|Follow-up Phase||0
10625869|NCT01998958|11784348|FG029|NOT COMPLETED|Follow-up Phase||0
10625870|NCT01998958|11784349|FG030|NOT COMPLETED|Follow-up Phase||0
10625871|NCT01998958|11784350|FG031|NOT COMPLETED|Follow-up Phase||0
10625872|NCT01998984|11784404|FG000|STARTED|Overall Study||55
10625873|NCT01998984|11784405|FG001|STARTED|Overall Study||59
10625874|NCT01998984|11784406|FG002|STARTED|Overall Study||49
10625875|NCT01998984|11784407|FG003|STARTED|Overall Study||61
10625876|NCT01998984|11784404|FG000|COMPLETED|Overall Study||55
10625877|NCT01998984|11784405|FG001|COMPLETED|Overall Study||58
10625878|NCT01998984|11784406|FG002|COMPLETED|Overall Study||48
10625879|NCT01998984|11784407|FG003|COMPLETED|Overall Study||58
10625880|NCT01998984|11784404|FG000|NOT COMPLETED|Overall Study||0
10625881|NCT01998984|11784405|FG001|NOT COMPLETED|Overall Study||1
10625882|NCT01998984|11784406|FG002|NOT COMPLETED|Overall Study||1
10625883|NCT01998984|11784407|FG003|NOT COMPLETED|Overall Study||3
10625884|NCT01999114|11784422|FG000|STARTED|Overall Study||66
10625885|NCT01999114|11784423|FG001|STARTED|Overall Study||66
10625886|NCT01999114|11784424|FG002|STARTED|Overall Study||66
10625887|NCT01999114|11784425|FG003|STARTED|Overall Study||65
10625888|NCT01999114|11784426|FG004|STARTED|Overall Study||65
10625889|NCT01999114|11784422|FG000|COMPLETED|Overall Study||58
10625890|NCT01999114|11784423|FG001|COMPLETED|Overall Study||59
10625891|NCT01999114|11784424|FG002|COMPLETED|Overall Study||61
10625892|NCT01999114|11784425|FG003|COMPLETED|Overall Study||62
10625893|NCT01999114|11784426|FG004|COMPLETED|Overall Study||61
10625894|NCT01999114|11784422|FG000|NOT COMPLETED|Overall Study||8
10625895|NCT01999114|11784423|FG001|NOT COMPLETED|Overall Study||7
10625896|NCT01999114|11784424|FG002|NOT COMPLETED|Overall Study||5
10625897|NCT01999114|11784425|FG003|NOT COMPLETED|Overall Study||3
10625898|NCT01999114|11784426|FG004|NOT COMPLETED|Overall Study||4
10625899|NCT01999192|11784456|FG000|STARTED|Main Phase I||83
10625900|NCT01999192|11784457|FG001|STARTED|Main Phase I||80
10625901|NCT01999192|11784458|FG002|STARTED|Main Phase I||78
10625902|NCT01999192|11784459|FG003|STARTED|Main Phase I||80
10625903|NCT01999192|11784456|FG000|COMPLETED|Main Phase I||72
10625904|NCT01999192|11784457|FG001|COMPLETED|Main Phase I||70
10625905|NCT01999192|11784458|FG002|COMPLETED|Main Phase I||70
10625906|NCT01999192|11784459|FG003|COMPLETED|Main Phase I||72
10625907|NCT01999192|11784456|FG000|NOT COMPLETED|Main Phase I||11
10625908|NCT01999192|11784457|FG001|NOT COMPLETED|Main Phase I||10
10625909|NCT01999192|11784458|FG002|NOT COMPLETED|Main Phase I||8
10625910|NCT01999192|11784459|FG003|NOT COMPLETED|Main Phase I||8
10625911|NCT01999192|11784456|FG000|STARTED|Main Phase II|Non-responders were switched to higher dose Level after Main Phase 1, started = completed -switched.|64
10625912|NCT01999192|11784457|FG001|STARTED|Main Phase II|started Patient = completed patients + switched patients (non-responder) from other arms.|75
10625913|NCT01999192|11784458|FG002|STARTED|Main Phase II|started Patient = completed patients + switched patients (non-responder) from other arms.|98
10625914|NCT01999192|11784459|FG003|STARTED|Main Phase II|non-responders were switched to higher dose Level after Main Phase 1, started = completed -switched|44
10625915|NCT01999192|11784456|FG000|COMPLETED|Main Phase II||55
10625916|NCT01999192|11784457|FG001|COMPLETED|Main Phase II||66
10625917|NCT01999192|11784458|FG002|COMPLETED|Main Phase II||76
10625918|NCT01999192|11784459|FG003|COMPLETED|Main Phase II||43
10625919|NCT01999192|11784456|FG000|NOT COMPLETED|Main Phase II||9
10625920|NCT01999192|11784457|FG001|NOT COMPLETED|Main Phase II||9
10625921|NCT01999192|11784458|FG002|NOT COMPLETED|Main Phase II||22
10625922|NCT01999192|11784459|FG003|NOT COMPLETED|Main Phase II||1
10625923|NCT01999192|11784456|FG000|STARTED|Extension Phase|Some patients terminated or were switched to higher dose Level after Main Phase 2.|54
10625924|NCT01999192|11784457|FG001|STARTED|Extension Phase|Some patients terminated or were switched to higher dose Level after Main Phase 2.|56
10625925|NCT01999192|11784458|FG002|STARTED|Extension Phase|Some patients terminated after Main Phase 2.|68
10625926|NCT01999192|11784459|FG003|STARTED|Extension Phase|No Placebo arm for Extension Phase, all patients terminated or were switched to tregalizumab Groups.|0
10625927|NCT01999192|11784456|FG000|COMPLETED|Extension Phase||41
10625928|NCT01999192|11784457|FG001|COMPLETED|Extension Phase||38
10625929|NCT01999192|11784458|FG002|COMPLETED|Extension Phase||44
10625930|NCT01999192|11784459|FG003|COMPLETED|Extension Phase||0
10625931|NCT01999192|11784456|FG000|NOT COMPLETED|Extension Phase||13
10625932|NCT01999192|11784457|FG001|NOT COMPLETED|Extension Phase||18
10625933|NCT01999192|11784458|FG002|NOT COMPLETED|Extension Phase||24
10625934|NCT01999192|11784459|FG003|NOT COMPLETED|Extension Phase||0
10625935|NCT01999218|11784472|FG000|STARTED|Overall Study||448
10625936|NCT01999218|11784473|FG001|STARTED|Overall Study||441
10625937|NCT01999218|11784474|FG002|STARTED|Overall Study||437
10625938|NCT01999218|11784472|FG000|Treated|Overall Study||448
10625939|NCT01999218|11784473|FG001|Treated|Overall Study||440
10625940|NCT01999218|11784474|FG002|Treated|Overall Study||437
10625941|NCT01999218|11784472|FG000|Site Issue|Overall Study||445
10625942|NCT01999218|11784473|FG001|Site Issue|Overall Study||435
10625943|NCT01999218|11784474|FG002|Site Issue|Overall Study||435
10625944|NCT01999218|11784472|FG000|COMPLETED|Overall Study||339
10625945|NCT01999218|11784473|FG001|COMPLETED|Overall Study||340
10625946|NCT01999218|11784474|FG002|COMPLETED|Overall Study||327
10625947|NCT01999218|11784472|FG000|NOT COMPLETED|Overall Study||109
10625948|NCT01999218|11784473|FG001|NOT COMPLETED|Overall Study||101
10625949|NCT01999218|11784474|FG002|NOT COMPLETED|Overall Study||110
10625950|NCT01999231|11784486|FG000|STARTED|Overall Study||6
10625951|NCT01999231|11784487|FG001|STARTED|Overall Study||6
10625952|NCT01999231|11784488|FG002|STARTED|Overall Study||6
10625953|NCT01999231|11784489|FG003|STARTED|Overall Study||6
10625954|NCT01999231|11784486|FG000|COMPLETED|Overall Study||6
10625955|NCT01999231|11784487|FG001|COMPLETED|Overall Study||6
10625956|NCT01999231|11784488|FG002|COMPLETED|Overall Study||6
10625957|NCT01999231|11784489|FG003|COMPLETED|Overall Study||6
10625958|NCT01999231|11784486|FG000|NOT COMPLETED|Overall Study||0
10625959|NCT01999231|11784487|FG001|NOT COMPLETED|Overall Study||0
10625960|NCT01999231|11784488|FG002|NOT COMPLETED|Overall Study||0
10625961|NCT01999231|11784489|FG003|NOT COMPLETED|Overall Study||0
10625962|NCT01999322|11784503|FG000|STARTED|Overall Study||25
10625963|NCT01999322|11784504|FG001|STARTED|Overall Study||12
10625964|NCT01999322|11784503|FG000|COMPLETED|Overall Study||24
10625965|NCT01999322|11784504|FG001|COMPLETED|Overall Study||12
10625966|NCT01999322|11784503|FG000|NOT COMPLETED|Overall Study||1
10625967|NCT01999322|11784504|FG001|NOT COMPLETED|Overall Study||0
10625968|NCT01999335|11784515|FG000|STARTED|Overall Study||3
10625969|NCT01999335|11784516|FG001|STARTED|Overall Study||1
10625970|NCT01999335|11784517|FG002|STARTED|Overall Study||7
10625971|NCT01999335|11784518|FG003|STARTED|Overall Study||10
10625972|NCT01999335|11784519|FG004|STARTED|Overall Study||12
10625973|NCT01999335|11784515|FG000|Received Study Treatment|Overall Study||3
10625974|NCT01999335|11784516|FG001|Received Study Treatment|Overall Study||1
10625975|NCT01999335|11784517|FG002|Received Study Treatment|Overall Study||7
10625976|NCT01999335|11784518|FG003|Received Study Treatment|Overall Study||10
10625977|NCT01999335|11784519|FG004|Received Study Treatment|Overall Study||10
10625978|NCT01999335|11784515|FG000|COMPLETED|Overall Study||3
10625979|NCT01999335|11784516|FG001|COMPLETED|Overall Study||1
10625980|NCT01999335|11784517|FG002|COMPLETED|Overall Study||7
10625981|NCT01999335|11784518|FG003|COMPLETED|Overall Study||10
10625982|NCT01999335|11784519|FG004|COMPLETED|Overall Study||10
10625983|NCT01999335|11784515|FG000|NOT COMPLETED|Overall Study||0
10625984|NCT01999335|11784516|FG001|NOT COMPLETED|Overall Study||0
10625985|NCT01999335|11784517|FG002|NOT COMPLETED|Overall Study||0
10625986|NCT01999335|11784518|FG003|NOT COMPLETED|Overall Study||0
10625987|NCT01999335|11784519|FG004|NOT COMPLETED|Overall Study||2
10625988|NCT01999348|11784534|FG000|STARTED|Overall Study||1553
10625989|NCT01999348|11784534|FG000|COMPLETED|Overall Study||1433
10705330|NCT02597478|11869698|FG000|NOT COMPLETED|Overall Study||3
10705331|NCT02597478|11869699|FG001|NOT COMPLETED|Overall Study||1
10705332|NCT02597543|11869707|FG000|STARTED|Overall Study||6
10625990|NCT01999348|11784534|FG000|NOT COMPLETED|Overall Study||120
10625991|NCT01999400|11784538|FG000|STARTED|First Intervention (1 Day)||6
10625992|NCT01999400|11784539|FG001|STARTED|First Intervention (1 Day)||6
10625993|NCT01999400|11784540|FG002|STARTED|First Intervention (1 Day)||5
10625994|NCT01999400|11784541|FG003|STARTED|First Intervention (1 Day)||5
10625995|NCT01999400|11784542|FG004|STARTED|First Intervention (1 Day)||4
10625996|NCT01999400|11784543|FG005|STARTED|First Intervention (1 Day)||4
10625997|NCT01999400|11784538|FG000|COMPLETED|First Intervention (1 Day)||4
10625998|NCT01999400|11784539|FG001|COMPLETED|First Intervention (1 Day)||4
10625999|NCT01999400|11784540|FG002|COMPLETED|First Intervention (1 Day)||3
10626000|NCT01999400|11784541|FG003|COMPLETED|First Intervention (1 Day)||2
10626001|NCT01999400|11784542|FG004|COMPLETED|First Intervention (1 Day)||4
10626002|NCT01999400|11784543|FG005|COMPLETED|First Intervention (1 Day)||3
10626003|NCT01999400|11784538|FG000|NOT COMPLETED|First Intervention (1 Day)||2
10626004|NCT01999400|11784539|FG001|NOT COMPLETED|First Intervention (1 Day)||2
10626005|NCT01999400|11784540|FG002|NOT COMPLETED|First Intervention (1 Day)||2
10626006|NCT01999400|11784541|FG003|NOT COMPLETED|First Intervention (1 Day)||3
10626007|NCT01999400|11784542|FG004|NOT COMPLETED|First Intervention (1 Day)||0
10626008|NCT01999400|11784543|FG005|NOT COMPLETED|First Intervention (1 Day)||1
10626009|NCT01999400|11784538|FG000|STARTED|Washout (10 Days)||5
10626010|NCT01999400|11784539|FG001|STARTED|Washout (10 Days)||4
10626011|NCT01999400|11784540|FG002|STARTED|Washout (10 Days)||3
10626012|NCT01999400|11784541|FG003|STARTED|Washout (10 Days)||2
10626013|NCT01999400|11784542|FG004|STARTED|Washout (10 Days)||3
10626014|NCT01999400|11784543|FG005|STARTED|Washout (10 Days)||3
10626015|NCT01999400|11784538|FG000|COMPLETED|Washout (10 Days)||5
10626016|NCT01999400|11784539|FG001|COMPLETED|Washout (10 Days)||4
10626017|NCT01999400|11784540|FG002|COMPLETED|Washout (10 Days)||3
10626018|NCT01999400|11784541|FG003|COMPLETED|Washout (10 Days)||2
10626019|NCT01999400|11784542|FG004|COMPLETED|Washout (10 Days)||3
10626020|NCT01999400|11784543|FG005|COMPLETED|Washout (10 Days)||3
10626021|NCT01999400|11784538|FG000|NOT COMPLETED|Washout (10 Days)||0
10626022|NCT01999400|11784539|FG001|NOT COMPLETED|Washout (10 Days)||0
10626023|NCT01999400|11784540|FG002|NOT COMPLETED|Washout (10 Days)||0
10626024|NCT01999400|11784541|FG003|NOT COMPLETED|Washout (10 Days)||0
10626025|NCT01999400|11784542|FG004|NOT COMPLETED|Washout (10 Days)||0
10626026|NCT01999400|11784543|FG005|NOT COMPLETED|Washout (10 Days)||0
10626027|NCT01999400|11784538|FG000|STARTED|Second Intervention (1 Day)||5
10626028|NCT01999400|11784539|FG001|STARTED|Second Intervention (1 Day)||4
10626029|NCT01999400|11784540|FG002|STARTED|Second Intervention (1 Day)||3
10626030|NCT01999400|11784541|FG003|STARTED|Second Intervention (1 Day)||2
10626031|NCT01999400|11784542|FG004|STARTED|Second Intervention (1 Day)||3
10626032|NCT01999400|11784543|FG005|STARTED|Second Intervention (1 Day)||3
10626033|NCT01999400|11784538|FG000|COMPLETED|Second Intervention (1 Day)||5
10626034|NCT01999400|11784539|FG001|COMPLETED|Second Intervention (1 Day)||4
10626035|NCT01999400|11784540|FG002|COMPLETED|Second Intervention (1 Day)||3
10626036|NCT01999400|11784541|FG003|COMPLETED|Second Intervention (1 Day)||2
10626037|NCT01999400|11784542|FG004|COMPLETED|Second Intervention (1 Day)||3
10626038|NCT01999400|11784543|FG005|COMPLETED|Second Intervention (1 Day)||3
10626039|NCT01999400|11784538|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10626040|NCT01999400|11784539|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10626041|NCT01999400|11784540|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
10626042|NCT01999400|11784541|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
10626043|NCT01999400|11784542|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
10626044|NCT01999400|11784543|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
10626045|NCT01999400|11784538|FG000|STARTED|Washout (10 Days)||2
10626046|NCT01999400|11784539|FG001|STARTED|Washout (10 Days)||0
10626047|NCT01999400|11784540|FG002|STARTED|Washout (10 Days)||1
10626048|NCT01999400|11784541|FG003|STARTED|Washout (10 Days)||1
10626049|NCT01999400|11784542|FG004|STARTED|Washout (10 Days)||1
10626050|NCT01999400|11784543|FG005|STARTED|Washout (10 Days)||1
10626051|NCT01999400|11784538|FG000|COMPLETED|Washout (10 Days)||2
10626052|NCT01999400|11784539|FG001|COMPLETED|Washout (10 Days)||0
10626053|NCT01999400|11784540|FG002|COMPLETED|Washout (10 Days)||1
10626054|NCT01999400|11784541|FG003|COMPLETED|Washout (10 Days)||1
10626055|NCT01999400|11784542|FG004|COMPLETED|Washout (10 Days)||1
10626056|NCT01999400|11784543|FG005|COMPLETED|Washout (10 Days)||1
10626057|NCT01999400|11784538|FG000|NOT COMPLETED|Washout (10 Days)||0
10626058|NCT01999400|11784539|FG001|NOT COMPLETED|Washout (10 Days)||0
10626059|NCT01999400|11784540|FG002|NOT COMPLETED|Washout (10 Days)||0
10626060|NCT01999400|11784541|FG003|NOT COMPLETED|Washout (10 Days)||0
10626061|NCT01999400|11784542|FG004|NOT COMPLETED|Washout (10 Days)||0
10626062|NCT01999400|11784543|FG005|NOT COMPLETED|Washout (10 Days)||0
10626063|NCT01999400|11784538|FG000|STARTED|Third Intervention (1 Day)||2
10626064|NCT01999400|11784539|FG001|STARTED|Third Intervention (1 Day)||0
10626065|NCT01999400|11784540|FG002|STARTED|Third Intervention (1 Day)||1
10626066|NCT01999400|11784541|FG003|STARTED|Third Intervention (1 Day)||1
10626067|NCT01999400|11784542|FG004|STARTED|Third Intervention (1 Day)||1
10626068|NCT01999400|11784543|FG005|STARTED|Third Intervention (1 Day)||1
10626069|NCT01999400|11784538|FG000|COMPLETED|Third Intervention (1 Day)||2
10626070|NCT01999400|11784539|FG001|COMPLETED|Third Intervention (1 Day)||0
10626071|NCT01999400|11784540|FG002|COMPLETED|Third Intervention (1 Day)||1
10626072|NCT01999400|11784541|FG003|COMPLETED|Third Intervention (1 Day)||1
10626073|NCT01999400|11784542|FG004|COMPLETED|Third Intervention (1 Day)||1
10626074|NCT01999400|11784543|FG005|COMPLETED|Third Intervention (1 Day)||0
10626075|NCT01999400|11784538|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
10626076|NCT01999400|11784539|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
10626077|NCT01999400|11784540|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
10626078|NCT01999400|11784541|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
10626079|NCT01999400|11784542|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
10626080|NCT01999400|11784543|FG005|NOT COMPLETED|Third Intervention (1 Day)||1
10626081|NCT01999400|11784538|FG000|STARTED|Washout (10 Days)||1
10626082|NCT01999400|11784539|FG001|STARTED|Washout (10 Days)||0
10626083|NCT01999400|11784540|FG002|STARTED|Washout (10 Days)||1
10626084|NCT01999400|11784541|FG003|STARTED|Washout (10 Days)||0
10626085|NCT01999400|11784542|FG004|STARTED|Washout (10 Days)||0
10626086|NCT01999400|11784543|FG005|STARTED|Washout (10 Days)||0
10626087|NCT01999400|11784538|FG000|COMPLETED|Washout (10 Days)||1
10626088|NCT01999400|11784539|FG001|COMPLETED|Washout (10 Days)||0
10626089|NCT01999400|11784540|FG002|COMPLETED|Washout (10 Days)||1
10626090|NCT01999400|11784541|FG003|COMPLETED|Washout (10 Days)||0
10626091|NCT01999400|11784542|FG004|COMPLETED|Washout (10 Days)||0
10626092|NCT01999400|11784543|FG005|COMPLETED|Washout (10 Days)||0
10626093|NCT01999400|11784538|FG000|NOT COMPLETED|Washout (10 Days)||0
10626094|NCT01999400|11784539|FG001|NOT COMPLETED|Washout (10 Days)||0
10626095|NCT01999400|11784540|FG002|NOT COMPLETED|Washout (10 Days)||0
10626096|NCT01999400|11784541|FG003|NOT COMPLETED|Washout (10 Days)||0
10626097|NCT01999400|11784542|FG004|NOT COMPLETED|Washout (10 Days)||0
10626098|NCT01999400|11784543|FG005|NOT COMPLETED|Washout (10 Days)||0
10626099|NCT01999400|11784538|FG000|STARTED|Fourth Intervention (1 Day)||1
10626100|NCT01999400|11784539|FG001|STARTED|Fourth Intervention (1 Day)||0
10626101|NCT01999400|11784540|FG002|STARTED|Fourth Intervention (1 Day)||1
10626102|NCT01999400|11784541|FG003|STARTED|Fourth Intervention (1 Day)||0
10626103|NCT01999400|11784542|FG004|STARTED|Fourth Intervention (1 Day)||0
10626104|NCT01999400|11784543|FG005|STARTED|Fourth Intervention (1 Day)||0
10626105|NCT01999400|11784538|FG000|COMPLETED|Fourth Intervention (1 Day)||1
10626106|NCT01999400|11784539|FG001|COMPLETED|Fourth Intervention (1 Day)||0
10626107|NCT01999400|11784540|FG002|COMPLETED|Fourth Intervention (1 Day)||1
10626108|NCT01999400|11784541|FG003|COMPLETED|Fourth Intervention (1 Day)||0
10626109|NCT01999400|11784542|FG004|COMPLETED|Fourth Intervention (1 Day)||0
10626110|NCT01999400|11784543|FG005|COMPLETED|Fourth Intervention (1 Day)||0
10626111|NCT01999400|11784538|FG000|NOT COMPLETED|Fourth Intervention (1 Day)||0
10626112|NCT01999400|11784539|FG001|NOT COMPLETED|Fourth Intervention (1 Day)||0
10626113|NCT01999400|11784540|FG002|NOT COMPLETED|Fourth Intervention (1 Day)||0
10626114|NCT01999400|11784541|FG003|NOT COMPLETED|Fourth Intervention (1 Day)||0
10626115|NCT01999400|11784542|FG004|NOT COMPLETED|Fourth Intervention (1 Day)||0
10626116|NCT01999400|11784543|FG005|NOT COMPLETED|Fourth Intervention (1 Day)||0
10626117|NCT01999465|11784555|FG000|STARTED|Overall Study||10
10626118|NCT01999465|11784556|FG001|STARTED|Overall Study||10
10626119|NCT01999465|11784555|FG000|COMPLETED|Overall Study||10
10626120|NCT01999465|11784556|FG001|COMPLETED|Overall Study||7
10626121|NCT01999465|11784555|FG000|NOT COMPLETED|Overall Study||0
10626122|NCT01999465|11784556|FG001|NOT COMPLETED|Overall Study||3
10626123|NCT01999517|11784564|FG000|STARTED|Overall Study||68
10626124|NCT01999517|11784565|FG001|STARTED|Overall Study||54
10626125|NCT01999517|11784564|FG000|COMPLETED|Overall Study||68
10626126|NCT01999517|11784565|FG001|COMPLETED|Overall Study||54
10626127|NCT01999517|11784564|FG000|NOT COMPLETED|Overall Study||0
10626128|NCT01999517|11784565|FG001|NOT COMPLETED|Overall Study||0
10626129|NCT01999530|11784571|FG000|STARTED|Overall Study||20
10626130|NCT01999530|11784571|FG000|COMPLETED|Overall Study||7
10626131|NCT01999530|11784571|FG000|NOT COMPLETED|Overall Study||13
10626132|NCT01999777|11784577|FG000|STARTED|Overall Study||31
10626133|NCT01999777|11784578|FG001|STARTED|Overall Study||31
10626134|NCT01999777|11784577|FG000|COMPLETED|Overall Study||31
10626135|NCT01999777|11784578|FG001|COMPLETED|Overall Study||31
10626136|NCT01999777|11784577|FG000|NOT COMPLETED|Overall Study||0
10626137|NCT01999777|11784578|FG001|NOT COMPLETED|Overall Study||0
10626138|NCT01999868|11784587|FG000|STARTED|Lead-in Phase (Week 0 - 12)||45
10626139|NCT01999868|11784588|FG001|STARTED|Lead-in Phase (Week 0 - 12)||46
10626140|NCT01999868|11784589|FG002|STARTED|Lead-in Phase (Week 0 - 12)||17
10626141|NCT01999868|11784587|FG000|COMPLETED|Lead-in Phase (Week 0 - 12)||45
10626142|NCT01999868|11784588|FG001|COMPLETED|Lead-in Phase (Week 0 - 12)||46
10626143|NCT01999868|11784589|FG002|COMPLETED|Lead-in Phase (Week 0 - 12)||12
10626144|NCT01999868|11784587|FG000|NOT COMPLETED|Lead-in Phase (Week 0 - 12)||0
10626145|NCT01999868|11784588|FG001|NOT COMPLETED|Lead-in Phase (Week 0 - 12)||0
10626146|NCT01999868|11784589|FG002|NOT COMPLETED|Lead-in Phase (Week 0 - 12)||5
10626147|NCT01999868|11784587|FG000|STARTED|Blinded Treatment Phase (Week 12 - 40)||45
10626148|NCT01999868|11784588|FG001|STARTED|Blinded Treatment Phase (Week 12 - 40)||46
10626149|NCT01999868|11784589|FG002|STARTED|Blinded Treatment Phase (Week 12 - 40)|Participants didn't meet eligibility requirements for randomization or withdrew prior to Week 12.|0
10626150|NCT01999868|11784587|FG000|COMPLETED|Blinded Treatment Phase (Week 12 - 40)||27
10626151|NCT01999868|11784588|FG001|COMPLETED|Blinded Treatment Phase (Week 12 - 40)||35
10626152|NCT01999868|11784589|FG002|COMPLETED|Blinded Treatment Phase (Week 12 - 40)||0
10626153|NCT01999868|11784587|FG000|NOT COMPLETED|Blinded Treatment Phase (Week 12 - 40)||18
10626154|NCT01999868|11784588|FG001|NOT COMPLETED|Blinded Treatment Phase (Week 12 - 40)||11
10626155|NCT01999868|11784589|FG002|NOT COMPLETED|Blinded Treatment Phase (Week 12 - 40)||0
10626156|NCT01999868|11784587|FG000|STARTED|Blinded Observation Phase (Week 40 - 88)||27
10626157|NCT01999868|11784588|FG001|STARTED|Blinded Observation Phase (Week 40 - 88)||35
10626158|NCT01999868|11784589|FG002|STARTED|Blinded Observation Phase (Week 40 - 88)||0
10626159|NCT01999868|11784587|FG000|COMPLETED|Blinded Observation Phase (Week 40 - 88)||4
10626160|NCT01999868|11784588|FG001|COMPLETED|Blinded Observation Phase (Week 40 - 88)||6
10626161|NCT01999868|11784589|FG002|COMPLETED|Blinded Observation Phase (Week 40 - 88)||0
10626162|NCT01999868|11784587|FG000|NOT COMPLETED|Blinded Observation Phase (Week 40 - 88)||23
10626163|NCT01999868|11784588|FG001|NOT COMPLETED|Blinded Observation Phase (Week 40 - 88)||29
10626164|NCT01999868|11784589|FG002|NOT COMPLETED|Blinded Observation Phase (Week 40 - 88)||0
10626165|NCT01999894|11784597|FG000|STARTED|Overall Study||102
10626166|NCT01999894|11784597|FG000|COMPLETED|Overall Study||66
10626167|NCT01999894|11784597|FG000|NOT COMPLETED|Overall Study||36
10626168|NCT01999920|11784604|FG000|STARTED|Overall Study||13
10626169|NCT01999920|11784605|FG001|STARTED|Overall Study||11
10626170|NCT01999920|11784604|FG000|COMPLETED|Overall Study||7
10626171|NCT01999920|11784605|FG001|COMPLETED|Overall Study||9
10626172|NCT01999920|11784604|FG000|NOT COMPLETED|Overall Study||6
10626173|NCT01999920|11784605|FG001|NOT COMPLETED|Overall Study||2
10626174|NCT01999946|11784614|FG000|STARTED|Overall Study||61
10626175|NCT01999946|11784615|FG001|STARTED|Overall Study||58
10626176|NCT01999946|11784616|FG002|STARTED|Overall Study||79
10626177|NCT01999946|11784614|FG000|COMPLETED|Overall Study||59
10626178|NCT01999946|11784615|FG001|COMPLETED|Overall Study||56
10626179|NCT01999946|11784616|FG002|COMPLETED|Overall Study||0
10626180|NCT01999946|11784614|FG000|NOT COMPLETED|Overall Study||2
10626181|NCT01999946|11784615|FG001|NOT COMPLETED|Overall Study||2
10626182|NCT01999946|11784616|FG002|NOT COMPLETED|Overall Study||79
10626183|NCT01999972|11784629|FG000|STARTED|Dose Escalation Part||5
10626184|NCT01999972|11784630|FG001|STARTED|Dose Escalation Part||3
10626185|NCT01999972|11784631|FG002|STARTED|Dose Escalation Part||5
10626186|NCT01999972|11784632|FG003|STARTED|Dose Escalation Part||11
10626187|NCT01999972|11784633|FG004|STARTED|Dose Escalation Part||0
10626188|NCT01999972|11784634|FG005|STARTED|Dose Escalation Part||0
10626189|NCT01999972|11784629|FG000|Treated|Dose Escalation Part||5
10626190|NCT01999972|11784630|FG001|Treated|Dose Escalation Part||3
10626191|NCT01999972|11784631|FG002|Treated|Dose Escalation Part||4
10626192|NCT01999972|11784632|FG003|Treated|Dose Escalation Part||10
10626193|NCT01999972|11784633|FG004|Treated|Dose Escalation Part||0
10626194|NCT01999972|11784634|FG005|Treated|Dose Escalation Part||0
10626195|NCT01999972|11784629|FG000|COMPLETED|Dose Escalation Part||0
10626196|NCT01999972|11784630|FG001|COMPLETED|Dose Escalation Part||0
10626197|NCT01999972|11784631|FG002|COMPLETED|Dose Escalation Part||0
10626198|NCT01999972|11784632|FG003|COMPLETED|Dose Escalation Part||0
10626199|NCT01999972|11784633|FG004|COMPLETED|Dose Escalation Part||0
10626200|NCT01999972|11784634|FG005|COMPLETED|Dose Escalation Part||0
10626201|NCT01999972|11784629|FG000|NOT COMPLETED|Dose Escalation Part||5
10626202|NCT01999972|11784630|FG001|NOT COMPLETED|Dose Escalation Part||3
10626203|NCT01999972|11784631|FG002|NOT COMPLETED|Dose Escalation Part||5
10626204|NCT01999972|11784632|FG003|NOT COMPLETED|Dose Escalation Part||11
10626205|NCT01999972|11784633|FG004|NOT COMPLETED|Dose Escalation Part||0
10626206|NCT01999972|11784634|FG005|NOT COMPLETED|Dose Escalation Part||0
10626207|NCT01999972|11784629|FG000|STARTED|Dose Expansion Part||0
10626208|NCT01999972|11784630|FG001|STARTED|Dose Expansion Part||0
10626209|NCT01999972|11784631|FG002|STARTED|Dose Expansion Part||0
10626210|NCT01999972|11784632|FG003|STARTED|Dose Expansion Part||0
10626211|NCT01999972|11784633|FG004|STARTED|Dose Expansion Part||21
10626212|NCT01999972|11784634|FG005|STARTED|Dose Expansion Part||7
10626213|NCT01999972|11784629|FG000|Treated|Dose Expansion Part||0
10626214|NCT01999972|11784630|FG001|Treated|Dose Expansion Part||0
10626215|NCT01999972|11784631|FG002|Treated|Dose Expansion Part||0
10626216|NCT01999972|11784632|FG003|Treated|Dose Expansion Part||0
10626217|NCT01999972|11784633|FG004|Treated|Dose Expansion Part||21
10626218|NCT01999972|11784634|FG005|Treated|Dose Expansion Part||7
10626219|NCT01999972|11784629|FG000|COMPLETED|Dose Expansion Part||0
10626220|NCT01999972|11784630|FG001|COMPLETED|Dose Expansion Part||0
10626221|NCT01999972|11784631|FG002|COMPLETED|Dose Expansion Part||0
10626222|NCT01999972|11784632|FG003|COMPLETED|Dose Expansion Part||0
10626223|NCT01999972|11784633|FG004|COMPLETED|Dose Expansion Part||0
10626224|NCT01999972|11784634|FG005|COMPLETED|Dose Expansion Part||0
10626225|NCT01999972|11784629|FG000|NOT COMPLETED|Dose Expansion Part||0
10626226|NCT01999972|11784630|FG001|NOT COMPLETED|Dose Expansion Part||0
10626227|NCT01999972|11784631|FG002|NOT COMPLETED|Dose Expansion Part||0
10626228|NCT01999972|11784632|FG003|NOT COMPLETED|Dose Expansion Part||0
10626229|NCT01999972|11784633|FG004|NOT COMPLETED|Dose Expansion Part||21
10626230|NCT01999972|11784634|FG005|NOT COMPLETED|Dose Expansion Part||7
10626231|NCT01999985|11784650|FG000|STARTED|Overall Study||8
10626232|NCT01999985|11784651|FG001|STARTED|Overall Study||3
10626233|NCT01999985|11784652|FG002|STARTED|Overall Study||14
10626234|NCT01999985|11784650|FG000|COMPLETED|Overall Study||8
10626235|NCT01999985|11784651|FG001|COMPLETED|Overall Study||3
10626236|NCT01999985|11784652|FG002|COMPLETED|Overall Study||14
10626237|NCT01999985|11784650|FG000|NOT COMPLETED|Overall Study||0
10626238|NCT01999985|11784651|FG001|NOT COMPLETED|Overall Study||0
10626239|NCT01999985|11784652|FG002|NOT COMPLETED|Overall Study||0
10626240|NCT02000154|11784658|FG000|STARTED|Overall Study||1
10626241|NCT02000154|11784658|FG000|COMPLETED|Overall Study||1
10626242|NCT02000154|11784658|FG000|NOT COMPLETED|Overall Study||0
10626243|NCT02000180|11784664|FG000|STARTED|Overall Study||18
10626244|NCT02000180|11784665|FG001|STARTED|Overall Study||19
10626245|NCT02000180|11784664|FG000|COMPLETED|Overall Study||18
10626246|NCT02000180|11784665|FG001|COMPLETED|Overall Study||19
10626247|NCT02000180|11784664|FG000|NOT COMPLETED|Overall Study||0
10626248|NCT02000180|11784665|FG001|NOT COMPLETED|Overall Study||0
10626249|NCT02000440|11784671|FG000|STARTED|Overall Study||17
10626250|NCT02000440|11784671|FG000|COMPLETED|Overall Study||13
10626251|NCT02000440|11784671|FG000|NOT COMPLETED|Overall Study||4
10653528|NCT02194699|11814062|FG001|STARTED|With Potential to Receive 52 Weeks of IP|Includes all patients randomised with the potential to receive 52 weeks of IP and receiving any IP.|417
10653529|NCT02194699|11814061|FG000|COMPLETED|With Potential to Receive 52 Weeks of IP||370
10653530|NCT02194699|11814062|FG001|COMPLETED|With Potential to Receive 52 Weeks of IP||365
10653531|NCT02194699|11814061|FG000|NOT COMPLETED|With Potential to Receive 52 Weeks of IP||50
10653532|NCT02194699|11814062|FG001|NOT COMPLETED|With Potential to Receive 52 Weeks of IP||52
10653533|NCT02194933|11814078|FG000|STARTED|Overall Study||19
10653534|NCT02194933|11814079|FG001|STARTED|Overall Study||19
10653535|NCT02194933|11814078|FG000|COMPLETED|Overall Study||16
10653536|NCT02194933|11814079|FG001|COMPLETED|Overall Study||10
10653537|NCT02194933|11814078|FG000|NOT COMPLETED|Overall Study||3
10653538|NCT02194933|11814079|FG001|NOT COMPLETED|Overall Study||9
10653539|NCT02194985|11814087|FG000|STARTED|Overall Study||84
10653540|NCT02194985|11814087|FG000|Received at Least 1 Dose of Study Drug|Overall Study||84
10653541|NCT02194985|11814087|FG000|COMPLETED|Overall Study||73
10653542|NCT02194985|11814087|FG000|NOT COMPLETED|Overall Study||11
10653543|NCT02194998|11814095|FG000|STARTED|On-HCV Treatment||21
10653544|NCT02194998|11814096|FG001|STARTED|On-HCV Treatment||6
10653545|NCT02194998|11814097|FG002|STARTED|On-HCV Treatment||15
10653546|NCT02194998|11814098|FG003|STARTED|On-HCV Treatment||4
10653547|NCT02194998|11814095|FG000|COMPLETED|On-HCV Treatment||21
10653548|NCT02194998|11814096|FG001|COMPLETED|On-HCV Treatment||5
10653549|NCT02194998|11814097|FG002|COMPLETED|On-HCV Treatment||15
10653550|NCT02194998|11814098|FG003|COMPLETED|On-HCV Treatment||4
10653551|NCT02194998|11814095|FG000|NOT COMPLETED|On-HCV Treatment||0
10653552|NCT02194998|11814096|FG001|NOT COMPLETED|On-HCV Treatment||1
10653553|NCT02194998|11814097|FG002|NOT COMPLETED|On-HCV Treatment||0
10653554|NCT02194998|11814098|FG003|NOT COMPLETED|On-HCV Treatment||0
10653555|NCT02194998|11814095|FG000|STARTED|Post-HCV Treatment Follow-Up||21
10653556|NCT02194998|11814096|FG001|STARTED|Post-HCV Treatment Follow-Up||5
10653557|NCT02194998|11814097|FG002|STARTED|Post-HCV Treatment Follow-Up||15
10653558|NCT02194998|11814098|FG003|STARTED|Post-HCV Treatment Follow-Up||4
10653559|NCT02194998|11814095|FG000|COMPLETED|Post-HCV Treatment Follow-Up||20
10653560|NCT02194998|11814096|FG001|COMPLETED|Post-HCV Treatment Follow-Up||5
10653561|NCT02194998|11814097|FG002|COMPLETED|Post-HCV Treatment Follow-Up||14
10653562|NCT02194998|11814098|FG003|COMPLETED|Post-HCV Treatment Follow-Up||4
10653563|NCT02194998|11814095|FG000|NOT COMPLETED|Post-HCV Treatment Follow-Up||1
10653564|NCT02194998|11814096|FG001|NOT COMPLETED|Post-HCV Treatment Follow-Up||0
10653565|NCT02194998|11814097|FG002|NOT COMPLETED|Post-HCV Treatment Follow-Up||1
10653566|NCT02194998|11814098|FG003|NOT COMPLETED|Post-HCV Treatment Follow-Up||0
10653567|NCT02195011|11814110|FG000|STARTED|Overall Study||25
10653568|NCT02195011|11814111|FG001|STARTED|Overall Study||1
10653569|NCT02195011|11814110|FG000|COMPLETED|Overall Study||0
10653570|NCT02195011|11814111|FG001|COMPLETED|Overall Study||0
10653571|NCT02195011|11814110|FG000|NOT COMPLETED|Overall Study||25
10653572|NCT02195011|11814111|FG001|NOT COMPLETED|Overall Study||1
10653573|NCT02195232|11814119|FG000|STARTED|Overall Study|patients consented|32
10653574|NCT02195232|11814120|FG001|STARTED|Overall Study|patients consented|32
10653575|NCT02195232|11814119|FG000|COMPLETED|Overall Study|Evaluated for VTE and safety|28
10653576|NCT02195232|11814120|FG001|COMPLETED|Overall Study|Evaluated for VTE and safety|29
10653577|NCT02195232|11814119|FG000|NOT COMPLETED|Overall Study||4
10653578|NCT02195232|11814120|FG001|NOT COMPLETED|Overall Study||3
10653579|NCT02195310|11814132|FG000|STARTED|Overall Study||173
10653580|NCT02195310|11814133|FG001|STARTED|Overall Study||169
10705333|NCT02597543|11869708|FG001|STARTED|Overall Study||8
10653581|NCT02195310|11814132|FG000|COMPLETED|Overall Study||153
10653582|NCT02195310|11814133|FG001|COMPLETED|Overall Study||153
10653583|NCT02195310|11814132|FG000|NOT COMPLETED|Overall Study||20
10653584|NCT02195310|11814133|FG001|NOT COMPLETED|Overall Study||16
10653585|NCT02195349|11814150|FG000|STARTED|Overall Study||14
10653586|NCT02195349|11814151|FG001|STARTED|Overall Study||1
10653587|NCT02195349|11814152|FG002|STARTED|Overall Study||1
10653588|NCT02195349|11814153|FG003|STARTED|Overall Study||6
10653589|NCT02195349|11814154|FG004|STARTED|Overall Study||6
10653590|NCT02195349|11814155|FG005|STARTED|Overall Study||6
10653591|NCT02195349|11814156|FG006|STARTED|Overall Study||6
10653592|NCT02195349|11814157|FG007|STARTED|Overall Study||9
10653593|NCT02195349|11814158|FG008|STARTED|Overall Study||6
10626252|NCT02000531|11784677|FG000|STARTED|Overall Study||21
10626253|NCT02000531|11784678|FG001|STARTED|Overall Study||24
10626254|NCT02000531|11784677|FG000|Safety Population|Overall Study||21
10626255|NCT02000531|11784678|FG001|Safety Population|Overall Study||24
10626256|NCT02000531|11784677|FG000|COMPLETED|Overall Study||17
10626257|NCT02000531|11784678|FG001|COMPLETED|Overall Study||16
10626258|NCT02000531|11784677|FG000|NOT COMPLETED|Overall Study||4
10626259|NCT02000531|11784678|FG001|NOT COMPLETED|Overall Study||8
10626260|NCT02000583|11784686|FG000|STARTED|Overall Study||78
10626261|NCT02000583|11784687|FG001|STARTED|Overall Study||39
10626262|NCT02000583|11784686|FG000|COMPLETED|Overall Study||75
10626263|NCT02000583|11784687|FG001|COMPLETED|Overall Study||34
10626264|NCT02000583|11784686|FG000|NOT COMPLETED|Overall Study||3
10626265|NCT02000583|11784687|FG001|NOT COMPLETED|Overall Study||5
10626266|NCT02000752|11784695|FG000|STARTED|Overall Study||60
10626267|NCT02000752|11784696|FG001|STARTED|Overall Study||60
10626268|NCT02000752|11784695|FG000|COMPLETED|Overall Study||29
10626269|NCT02000752|11784696|FG001|COMPLETED|Overall Study||47
10626270|NCT02000752|11784695|FG000|NOT COMPLETED|Overall Study||31
10626271|NCT02000752|11784696|FG001|NOT COMPLETED|Overall Study||13
10626272|NCT02000817|11784706|FG000|STARTED|Overall Study||6
10626273|NCT02000817|11784707|FG001|STARTED|Overall Study||9
10626274|NCT02000817|11784708|FG002|STARTED|Overall Study||8
10626275|NCT02000817|11784709|FG003|STARTED|Overall Study||7
10626276|NCT02000817|11784706|FG000|COMPLETED|Overall Study||4
10626277|NCT02000817|11784707|FG001|COMPLETED|Overall Study||8
10626278|NCT02000817|11784708|FG002|COMPLETED|Overall Study||7
10626279|NCT02000817|11784709|FG003|COMPLETED|Overall Study||7
10626280|NCT02000817|11784706|FG000|NOT COMPLETED|Overall Study||2
10626281|NCT02000817|11784707|FG001|NOT COMPLETED|Overall Study||1
10626282|NCT02000817|11784708|FG002|NOT COMPLETED|Overall Study||1
10626283|NCT02000817|11784709|FG003|NOT COMPLETED|Overall Study||0
10626284|NCT02000908|11784724|FG000|STARTED|Overall Study||30
10626285|NCT02000908|11784725|FG001|STARTED|Overall Study||40
10626286|NCT02000908|11784724|FG000|COMPLETED|Overall Study||28
10626287|NCT02000908|11784725|FG001|COMPLETED|Overall Study||36
10626288|NCT02000908|11784724|FG000|NOT COMPLETED|Overall Study||2
10626289|NCT02000908|11784725|FG001|NOT COMPLETED|Overall Study||4
10626290|NCT02000921|11784734|FG000|STARTED|Overall Study||27
10626291|NCT02000921|11784735|FG001|STARTED|Overall Study||53
10808998|NCT03815240|11970931|FG007|STARTED|Intervention Allevyn Dressing||1
10808999|NCT03815240|11970932|FG008|STARTED|Intervention Allevyn Dressing||1
10809000|NCT03815240|11970924|FG000|COMPLETED|Intervention Allevyn Dressing||2
10809001|NCT03815240|11970925|FG001|COMPLETED|Intervention Allevyn Dressing||1
10626292|NCT02000921|11784736|FG002|STARTED|Overall Study||56
10626293|NCT02000921|11784734|FG000|COMPLETED|Overall Study||22
10626294|NCT02000921|11784735|FG001|COMPLETED|Overall Study||37
10626295|NCT02000921|11784736|FG002|COMPLETED|Overall Study||46
10626296|NCT02000921|11784734|FG000|NOT COMPLETED|Overall Study||5
10626297|NCT02000921|11784735|FG001|NOT COMPLETED|Overall Study||16
10626298|NCT02000921|11784736|FG002|NOT COMPLETED|Overall Study||10
10626299|NCT02000973|11784748|FG000|STARTED|Overall Study||20
10626300|NCT02000973|11784749|FG001|STARTED|Overall Study||20
10626301|NCT02000973|11784750|FG002|STARTED|Overall Study||20
10626302|NCT02000973|11784751|FG003|STARTED|Overall Study||20
10626303|NCT02000973|11784748|FG000|COMPLETED|Overall Study||20
10626304|NCT02000973|11784749|FG001|COMPLETED|Overall Study||20
10626305|NCT02000973|11784750|FG002|COMPLETED|Overall Study||20
10626306|NCT02000973|11784751|FG003|COMPLETED|Overall Study||20
10626307|NCT02000973|11784748|FG000|NOT COMPLETED|Overall Study||0
10626308|NCT02000973|11784749|FG001|NOT COMPLETED|Overall Study||0
10626309|NCT02000973|11784750|FG002|NOT COMPLETED|Overall Study||0
10626310|NCT02000973|11784751|FG003|NOT COMPLETED|Overall Study||0
10626311|NCT02001051|11784763|FG000|STARTED|Overall Study||2
10626312|NCT02001051|11784764|FG001|STARTED|Overall Study||2
10626313|NCT02001051|11784763|FG000|COMPLETED|Overall Study||2
10626314|NCT02001051|11784764|FG001|COMPLETED|Overall Study||1
10626315|NCT02001051|11784763|FG000|NOT COMPLETED|Overall Study||0
10626316|NCT02001051|11784764|FG001|NOT COMPLETED|Overall Study||1
10626317|NCT02001064|11784772|FG000|STARTED|Overall Study||30
10626318|NCT02001064|11784773|FG001|STARTED|Overall Study||30
10626319|NCT02001064|11784772|FG000|COMPLETED|Overall Study||28
10626320|NCT02001064|11784773|FG001|COMPLETED|Overall Study||29
10626321|NCT02001064|11784772|FG000|NOT COMPLETED|Overall Study||2
10626322|NCT02001064|11784773|FG001|NOT COMPLETED|Overall Study||1
10626323|NCT02001181|11784781|FG000|STARTED|Overall Study||35
10626324|NCT02001181|11784782|FG001|STARTED|Overall Study||34
10626325|NCT02001181|11784781|FG000|COMPLETED|Overall Study||34
10626326|NCT02001181|11784782|FG001|COMPLETED|Overall Study||31
10626327|NCT02001181|11784781|FG000|NOT COMPLETED|Overall Study||1
10626328|NCT02001181|11784782|FG001|NOT COMPLETED|Overall Study||3
10626329|NCT02001194|11784792|FG000|STARTED|Intervention Period (13 Weeks)|17 teams|68
10626330|NCT02001194|11784793|FG001|STARTED|Intervention Period (13 Weeks)|20 teams|80
10626331|NCT02001194|11784794|FG002|STARTED|Intervention Period (13 Weeks)|19 teams|76
10626332|NCT02001194|11784795|FG003|STARTED|Intervention Period (13 Weeks)|20 teams|80
10626333|NCT02001194|11784792|FG000|COMPLETED|Intervention Period (13 Weeks)|16 teams|67
10626334|NCT02001194|11784793|FG001|COMPLETED|Intervention Period (13 Weeks)|20 teams|80
10626335|NCT02001194|11784794|FG002|COMPLETED|Intervention Period (13 Weeks)|19 teams|74
10626336|NCT02001194|11784795|FG003|COMPLETED|Intervention Period (13 Weeks)|20 teams|78
10626337|NCT02001194|11784792|FG000|NOT COMPLETED|Intervention Period (13 Weeks)||1
10626338|NCT02001194|11784793|FG001|NOT COMPLETED|Intervention Period (13 Weeks)||0
10626339|NCT02001194|11784794|FG002|NOT COMPLETED|Intervention Period (13 Weeks)||2
10626340|NCT02001194|11784795|FG003|NOT COMPLETED|Intervention Period (13 Weeks)||2
10626341|NCT02001194|11784792|FG000|STARTED|Follow-Up Period (13 Weeks)||67
10626342|NCT02001194|11784793|FG001|STARTED|Follow-Up Period (13 Weeks)||80
10626343|NCT02001194|11784794|FG002|STARTED|Follow-Up Period (13 Weeks)||74
10626344|NCT02001194|11784795|FG003|STARTED|Follow-Up Period (13 Weeks)||78
10626345|NCT02001194|11784792|FG000|COMPLETED|Follow-Up Period (13 Weeks)||64
10626346|NCT02001194|11784793|FG001|COMPLETED|Follow-Up Period (13 Weeks)||78
10626347|NCT02001194|11784794|FG002|COMPLETED|Follow-Up Period (13 Weeks)||73
10626348|NCT02001194|11784795|FG003|COMPLETED|Follow-Up Period (13 Weeks)||78
10626349|NCT02001194|11784792|FG000|NOT COMPLETED|Follow-Up Period (13 Weeks)||3
10626350|NCT02001194|11784793|FG001|NOT COMPLETED|Follow-Up Period (13 Weeks)||2
10626351|NCT02001194|11784794|FG002|NOT COMPLETED|Follow-Up Period (13 Weeks)||1
10626352|NCT02001194|11784795|FG003|NOT COMPLETED|Follow-Up Period (13 Weeks)||0
10626353|NCT02001558|11784807|FG000|STARTED|Overall Study||32
10626354|NCT02001558|11784808|FG001|STARTED|Overall Study||33
10626355|NCT02001558|11784807|FG000|COMPLETED|Overall Study||24
10626356|NCT02001558|11784808|FG001|COMPLETED|Overall Study||19
10626357|NCT02001558|11784807|FG000|NOT COMPLETED|Overall Study||8
10626358|NCT02001558|11784808|FG001|NOT COMPLETED|Overall Study||14
10626359|NCT02001688|11784817|FG000|STARTED|Overall Study||12
10626360|NCT02001688|11784818|FG001|STARTED|Overall Study||12
10626361|NCT02001688|11784819|FG002|STARTED|Overall Study||12
10626362|NCT02001688|11784817|FG000|COMPLETED|Overall Study||12
10626363|NCT02001688|11784818|FG001|COMPLETED|Overall Study||11
10626364|NCT02001688|11784819|FG002|COMPLETED|Overall Study||11
10626365|NCT02001688|11784817|FG000|NOT COMPLETED|Overall Study||0
10626366|NCT02001688|11784818|FG001|NOT COMPLETED|Overall Study||1
10626367|NCT02001688|11784819|FG002|NOT COMPLETED|Overall Study||1
10626368|NCT02001714|11784830|FG000|STARTED|Overall Study||232
10626369|NCT02001714|11784831|FG001|STARTED|Overall Study||231
10626370|NCT02001714|11784830|FG000|COMPLETED|Overall Study||210
10626371|NCT02001714|11784831|FG001|COMPLETED|Overall Study||219
10626372|NCT02001714|11784830|FG000|NOT COMPLETED|Overall Study||22
10626373|NCT02001714|11784831|FG001|NOT COMPLETED|Overall Study||12
10626374|NCT02001987|11784837|FG000|STARTED|Core Study Period (24 Weeks)||139
10626375|NCT02001987|11784837|FG000|COMPLETED|Core Study Period (24 Weeks)||116
10626376|NCT02001987|11784837|FG000|NOT COMPLETED|Core Study Period (24 Weeks)||23
10626377|NCT02001987|11784837|FG000|STARTED|LTE Period (52 Weeks)||116
10626378|NCT02001987|11784837|FG000|COMPLETED|LTE Period (52 Weeks)||107
10626379|NCT02001987|11784837|FG000|NOT COMPLETED|LTE Period (52 Weeks)||9
10626380|NCT02002091|11784848|FG000|STARTED|Screening||122
10626381|NCT02002091|11784849|FG001|STARTED|Screening||205
10626382|NCT02002091|11784848|FG000|COMPLETED|Screening||109
10626383|NCT02002091|11784849|FG001|COMPLETED|Screening||191
10626384|NCT02002091|11784848|FG000|NOT COMPLETED|Screening||13
10626385|NCT02002091|11784849|FG001|NOT COMPLETED|Screening||14
10626386|NCT02002091|11784848|FG000|STARTED|One Year Follow up||109
10626387|NCT02002091|11784849|FG001|STARTED|One Year Follow up||191
10626388|NCT02002091|11784848|FG000|COMPLETED|One Year Follow up||109
10705334|NCT02597543|11869707|FG000|COMPLETED|Overall Study||6
10705335|NCT02597543|11869708|FG001|COMPLETED|Overall Study||8
10705336|NCT02597543|11869707|FG000|NOT COMPLETED|Overall Study||0
10626389|NCT02002091|11784849|FG001|COMPLETED|One Year Follow up||191
10626390|NCT02002091|11784848|FG000|NOT COMPLETED|One Year Follow up||0
10626391|NCT02002091|11784849|FG001|NOT COMPLETED|One Year Follow up||0
10333908|NCT00336479|11470141|FG000|COMPLETED|Overall Study||38
10333909|NCT00336479|11470142|FG001|COMPLETED|Overall Study||54
10333910|NCT00336479|11470143|FG002|COMPLETED|Overall Study||53
10333911|NCT00336479|11470144|FG003|COMPLETED|Overall Study||13
10333912|NCT00336479|11470141|FG000|NOT COMPLETED|Overall Study||37
10333913|NCT00336479|11470142|FG001|NOT COMPLETED|Overall Study||25
10333914|NCT00336479|11470143|FG002|NOT COMPLETED|Overall Study||26
10333915|NCT00336479|11470144|FG003|NOT COMPLETED|Overall Study||4
10705337|NCT02597543|11869708|FG001|NOT COMPLETED|Overall Study||0
10705338|NCT02597582|11869716|FG000|STARTED|Overall Study||21
10333916|NCT00336492|11470158|FG000|STARTED|Overall Study||15
10626398|NCT02002208|11784895|FG000|STARTED|Overall Study||69
10626399|NCT02002208|11784896|FG001|STARTED|Overall Study||70
10626400|NCT02002208|11784895|FG000|COMPLETED|Overall Study||32
10626401|NCT02002208|11784896|FG001|COMPLETED|Overall Study||30
10626402|NCT02002208|11784895|FG000|NOT COMPLETED|Overall Study||37
10333917|NCT00336492|11470159|FG001|STARTED|Overall Study||22
10333918|NCT00336492|11470160|FG002|STARTED|Overall Study||23
10626403|NCT02002208|11784896|FG001|NOT COMPLETED|Overall Study||40
10626404|NCT02002221|11784904|FG000|STARTED|Overall Study||78
10626405|NCT02002221|11784905|FG001|STARTED|Overall Study||78
10626406|NCT02002221|11784904|FG000|COMPLETED|Overall Study||76
10705339|NCT02597582|11869717|FG001|STARTED|Overall Study||20
10626407|NCT02002221|11784905|FG001|COMPLETED|Overall Study||75
10626408|NCT02002221|11784904|FG000|NOT COMPLETED|Overall Study||2
10626409|NCT02002221|11784905|FG001|NOT COMPLETED|Overall Study||3
10626410|NCT02002494|11784911|FG000|STARTED|Overall Study||27
10626411|NCT02002494|11784911|FG000|COMPLETED|Overall Study||27
10626412|NCT02002494|11784911|FG000|NOT COMPLETED|Overall Study||0
10626413|NCT02002533|11784928|FG000|STARTED|Overall Study||34
10626414|NCT02002533|11784929|FG001|STARTED|Overall Study||37
10626415|NCT02002533|11784928|FG000|COMPLETED|Overall Study||28
10626416|NCT02002533|11784929|FG001|COMPLETED|Overall Study||19
10626417|NCT02002533|11784928|FG000|NOT COMPLETED|Overall Study||6
10626418|NCT02002533|11784929|FG001|NOT COMPLETED|Overall Study||18
10626419|NCT02002650|11784938|FG000|STARTED|Overall Study||1297
10626420|NCT02002650|11784939|FG001|STARTED|Overall Study||1303
10626421|NCT02002650|11784938|FG000|COMPLETED|Overall Study||1297
10626422|NCT02002650|11784939|FG001|COMPLETED|Overall Study||1303
10626423|NCT02002650|11784938|FG000|NOT COMPLETED|Overall Study||0
10626424|NCT02002650|11784939|FG001|NOT COMPLETED|Overall Study||0
10626425|NCT02002689|11784946|FG000|STARTED|Overall Study||10
10626426|NCT02002689|11784946|FG000|COMPLETED|Overall Study||0
10626427|NCT02002689|11784946|FG000|NOT COMPLETED|Overall Study||10
10626428|NCT02002702|11784953|FG000|STARTED|Overall Study||16
10626429|NCT02002702|11784954|FG001|STARTED|Overall Study||15
10626430|NCT02002702|11784955|FG002|STARTED|Overall Study||15
10626431|NCT02002702|11784953|FG000|COMPLETED|Overall Study||16
10626432|NCT02002702|11784954|FG001|COMPLETED|Overall Study||15
10626433|NCT02002702|11784955|FG002|COMPLETED|Overall Study||15
10626434|NCT02002702|11784953|FG000|NOT COMPLETED|Overall Study||0
10626435|NCT02002702|11784954|FG001|NOT COMPLETED|Overall Study||0
10626436|NCT02002702|11784955|FG002|NOT COMPLETED|Overall Study||0
10626437|NCT02002767|11784965|FG000|STARTED|Overall Study||9
10626438|NCT02002767|11784966|FG001|STARTED|Overall Study||10
10626439|NCT02002767|11784965|FG000|COMPLETED|Overall Study||9
10626440|NCT02002767|11784966|FG001|COMPLETED|Overall Study||10
10626441|NCT02002767|11784965|FG000|NOT COMPLETED|Overall Study||0
10626442|NCT02002767|11784966|FG001|NOT COMPLETED|Overall Study||0
10626443|NCT02002832|11784974|FG000|STARTED|Overall Study||194
10626444|NCT02002832|11784975|FG001|STARTED|Overall Study||194
10626445|NCT02002832|11784974|FG000|COMPLETED|Overall Study||166
10626446|NCT02002832|11784975|FG001|COMPLETED|Overall Study||168
10626447|NCT02002832|11784974|FG000|NOT COMPLETED|Overall Study||28
10626448|NCT02002832|11784975|FG001|NOT COMPLETED|Overall Study||26
10626449|NCT02002871|11784982|FG000|STARTED|Overall Study||21
10626450|NCT02002871|11784982|FG000|COMPLETED|Overall Study||20
10626451|NCT02002871|11784982|FG000|NOT COMPLETED|Overall Study||1
10626452|NCT02002884|11784990|FG000|STARTED|Main Period (MP)||87
10626453|NCT02002884|11784991|FG001|STARTED|Main Period (MP)||88
10626454|NCT02002884|11784992|FG002|STARTED|Main Period (MP)||176
10626455|NCT02002884|11784993|FG003|STARTED|Main Period (MP)||0
10626456|NCT02002884|11784990|FG000|Treated|Main Period (MP)||87
10626457|NCT02002884|11784991|FG001|Treated|Main Period (MP)||87
10626458|NCT02002884|11784992|FG002|Treated|Main Period (MP)||176
10626459|NCT02002884|11784993|FG003|Treated|Main Period (MP)||0
10626460|NCT02002884|11784990|FG000|COMPLETED|Main Period (MP)||81
10626461|NCT02002884|11784991|FG001|COMPLETED|Main Period (MP)||82
10626462|NCT02002884|11784992|FG002|COMPLETED|Main Period (MP)||168
10626463|NCT02002884|11784993|FG003|COMPLETED|Main Period (MP)||0
10626464|NCT02002884|11784990|FG000|NOT COMPLETED|Main Period (MP)||6
10626465|NCT02002884|11784991|FG001|NOT COMPLETED|Main Period (MP)||6
10626466|NCT02002884|11784992|FG002|NOT COMPLETED|Main Period (MP)||8
10626467|NCT02002884|11784993|FG003|NOT COMPLETED|Main Period (MP)||0
10626468|NCT02002884|11784990|FG000|STARTED|Open-Label Extension Period (OLEX)||0
10626469|NCT02002884|11784991|FG001|STARTED|Open-Label Extension Period (OLEX)||0
10626470|NCT02002884|11784992|FG002|STARTED|Open-Label Extension Period (OLEX)||0
10626471|NCT02002884|11784993|FG003|STARTED|Open-Label Extension Period (OLEX)||331
10626472|NCT02002884|11784990|FG000|COMPLETED|Open-Label Extension Period (OLEX)||0
10626473|NCT02002884|11784991|FG001|COMPLETED|Open-Label Extension Period (OLEX)||0
10626474|NCT02002884|11784992|FG002|COMPLETED|Open-Label Extension Period (OLEX)||0
10626475|NCT02002884|11784993|FG003|COMPLETED|Open-Label Extension Period (OLEX)||281
10626476|NCT02002884|11784990|FG000|NOT COMPLETED|Open-Label Extension Period (OLEX)||0
10626477|NCT02002884|11784991|FG001|NOT COMPLETED|Open-Label Extension Period (OLEX)||0
10626478|NCT02002884|11784992|FG002|NOT COMPLETED|Open-Label Extension Period (OLEX)||0
10626479|NCT02002884|11784993|FG003|NOT COMPLETED|Open-Label Extension Period (OLEX)||50
10626480|NCT02002936|11785003|FG000|STARTED|Overall Study||1
10626481|NCT02002936|11785003|FG000|COMPLETED|Overall Study||1
10626482|NCT02002936|11785003|FG000|NOT COMPLETED|Overall Study||0
10626483|NCT02002975|11785007|FG000|STARTED|Overall Study||18223
10626484|NCT02002975|11785007|FG000|COMPLETED|Overall Study||17651
10626485|NCT02002975|11785007|FG000|NOT COMPLETED|Overall Study||572
10626486|NCT02003014|11785011|FG000|STARTED|Overall Study||899
10626487|NCT02003014|11785011|FG000|COMPLETED|Overall Study||880
10626488|NCT02003014|11785011|FG000|NOT COMPLETED|Overall Study||19
10626489|NCT02003053|11785017|FG000|STARTED|Overall Study||4
10626490|NCT02003053|11785018|FG001|STARTED|Overall Study||3
10626491|NCT02003053|11785017|FG000|COMPLETED|Overall Study||4
10626492|NCT02003053|11785018|FG001|COMPLETED|Overall Study||3
10626493|NCT02003053|11785017|FG000|NOT COMPLETED|Overall Study||0
10626494|NCT02003053|11785018|FG001|NOT COMPLETED|Overall Study||0
10626495|NCT02003183|11785026|FG000|STARTED|Overall Study||7
10626496|NCT02003183|11785027|FG001|STARTED|Overall Study||17
10626497|NCT02003183|11785026|FG000|COMPLETED|Overall Study||7
10626498|NCT02003183|11785027|FG001|COMPLETED|Overall Study||15
10626499|NCT02003183|11785026|FG000|NOT COMPLETED|Overall Study||0
10626500|NCT02003183|11785027|FG001|NOT COMPLETED|Overall Study||2
10626501|NCT02003352|11785033|FG000|STARTED|Overall Study||98
10626502|NCT02003352|11785033|FG000|COMPLETED|Overall Study||98
10626503|NCT02003352|11785033|FG000|NOT COMPLETED|Overall Study||0
10626504|NCT02003365|11785040|FG000|STARTED|Overall Study||10
10626505|NCT02003365|11785041|FG001|STARTED|Overall Study||30
10626506|NCT02003365|11785042|FG002|STARTED|Overall Study||10
10626507|NCT02003365|11785040|FG000|COMPLETED|Overall Study||10
10626508|NCT02003365|11785041|FG001|COMPLETED|Overall Study||30
10626509|NCT02003365|11785042|FG002|COMPLETED|Overall Study||9
10626510|NCT02003365|11785040|FG000|NOT COMPLETED|Overall Study||0
10626511|NCT02003365|11785041|FG001|NOT COMPLETED|Overall Study||0
10626512|NCT02003365|11785042|FG002|NOT COMPLETED|Overall Study||1
10626513|NCT02003391|11785052|FG000|STARTED|Overall Study||81
10626514|NCT02003391|11785053|FG001|STARTED|Overall Study||75
10626515|NCT02003391|11785052|FG000|Safety Population|Overall Study||81
10626516|NCT02003391|11785053|FG001|Safety Population|Overall Study||75
10626517|NCT02003391|11785052|FG000|Intent to Treat Population|Overall Study||78
10626518|NCT02003391|11785053|FG001|Intent to Treat Population|Overall Study||73
10626519|NCT02003391|11785052|FG000|COMPLETED|Overall Study||78
10626520|NCT02003391|11785053|FG001|COMPLETED|Overall Study||73
10626521|NCT02003391|11785052|FG000|NOT COMPLETED|Overall Study||3
10626522|NCT02003391|11785053|FG001|NOT COMPLETED|Overall Study||2
10626523|NCT02003404|11785059|FG000|STARTED|Overall Study||17
10626524|NCT02003404|11785059|FG000|COMPLETED|Overall Study||17
10626525|NCT02003404|11785059|FG000|NOT COMPLETED|Overall Study||0
10626526|NCT02003508|11785067|FG000|STARTED|Overall Study||179
10626527|NCT02003508|11785068|FG001|STARTED|Overall Study||166
10626528|NCT02003508|11785067|FG000|COMPLETED|Overall Study||179
10626529|NCT02003508|11785068|FG001|COMPLETED|Overall Study||166
10626530|NCT02003508|11785067|FG000|NOT COMPLETED|Overall Study||0
10626531|NCT02003508|11785068|FG001|NOT COMPLETED|Overall Study||0
10626532|NCT02003534|11785074|FG000|STARTED|Overall Study||376
10626533|NCT02003534|11785074|FG000|COMPLETED|Overall Study||329
10626534|NCT02003534|11785074|FG000|NOT COMPLETED|Overall Study||47
10626535|NCT02003573|11785081|FG000|STARTED|Overall Study|Started are treated patients|3
10626536|NCT02003573|11785082|FG001|STARTED|Overall Study|Started are treated patients|4
10626537|NCT02003573|11785083|FG002|STARTED|Overall Study|Started are treated patients|6
10626538|NCT02003573|11785081|FG000|COMPLETED|Overall Study||0
10626539|NCT02003573|11785082|FG001|COMPLETED|Overall Study||0
10626540|NCT02003573|11785083|FG002|COMPLETED|Overall Study||0
10626541|NCT02003573|11785081|FG000|NOT COMPLETED|Overall Study||3
10626542|NCT02003573|11785082|FG001|NOT COMPLETED|Overall Study||4
10626543|NCT02003573|11785083|FG002|NOT COMPLETED|Overall Study||6
10626544|NCT02003625|11785095|FG000|STARTED|Overall Study||15
10626545|NCT02003625|11785096|FG001|STARTED|Overall Study||15
10626546|NCT02003625|11785095|FG000|Received Transplant|Overall Study||14
10626547|NCT02003625|11785096|FG001|Received Transplant|Overall Study||12
10626548|NCT02003625|11785095|FG000|COMPLETED|Overall Study||14
10626549|NCT02003625|11785096|FG001|COMPLETED|Overall Study||12
10626550|NCT02003625|11785095|FG000|NOT COMPLETED|Overall Study||1
10626551|NCT02003625|11785096|FG001|NOT COMPLETED|Overall Study||3
10626552|NCT02003638|11785104|FG000|STARTED|Overall Study||6
10626553|NCT02003638|11785105|FG001|STARTED|Overall Study||3
10626554|NCT02003638|11785104|FG000|COMPLETED|Overall Study|1 withdrew after developing bacterial pharyngitis. Not considered treatment-emergent.|5
10626555|NCT02003638|11785105|FG001|COMPLETED|Overall Study||3
10626556|NCT02003638|11785104|FG000|NOT COMPLETED|Overall Study||1
10626557|NCT02003638|11785105|FG001|NOT COMPLETED|Overall Study||0
10626558|NCT02003898|11785111|FG000|STARTED|Overall Study||372
10626559|NCT02003898|11785111|FG000|COMPLETED|Overall Study||305
10626560|NCT02003898|11785111|FG000|NOT COMPLETED|Overall Study||67
10626561|NCT02003911|11785117|FG000|STARTED|Overall Study||80
10626562|NCT02003911|11785118|FG001|STARTED|Overall Study||79
10626563|NCT02003911|11785117|FG000|COMPLETED|Overall Study||78
10626564|NCT02003911|11785118|FG001|COMPLETED|Overall Study||72
10626565|NCT02003911|11785117|FG000|NOT COMPLETED|Overall Study||2
10626566|NCT02003911|11785118|FG001|NOT COMPLETED|Overall Study||7
10626567|NCT02003963|11785126|FG000|STARTED|Overall Study||22
10626568|NCT02003963|11785127|FG001|STARTED|Overall Study||19
10626569|NCT02003963|11785126|FG000|COMPLETED|Overall Study|2 participants dropped out: 1 due to lack of interest and 1 due to a mental health hospitalization.|20
10626570|NCT02003963|11785127|FG001|COMPLETED|Overall Study|1 participant was removed from analysis for completing final visit outside of visit window.|18
10626571|NCT02003963|11785126|FG000|NOT COMPLETED|Overall Study||2
10626572|NCT02003963|11785127|FG001|NOT COMPLETED|Overall Study||1
10626573|NCT02004093|11785137|FG000|STARTED|Overall Study|Includes 1 participant who was randomized to chemotherapy group but received pertuzumab+chemotherapy|75
10626574|NCT02004093|11785138|FG001|STARTED|Overall Study||74
10626575|NCT02004093|11785137|FG000|COMPLETED|Overall Study||1
10626576|NCT02004093|11785138|FG001|COMPLETED|Overall Study||1
10626577|NCT02004093|11785137|FG000|NOT COMPLETED|Overall Study||74
10626578|NCT02004093|11785138|FG001|NOT COMPLETED|Overall Study||73
10626579|NCT02004132|11785147|FG000|STARTED|Overall Study||12
10626580|NCT02004132|11785147|FG000|Received Study Drug|Overall Study||12
10626581|NCT02004132|11785147|FG000|COMPLETED|Overall Study||12
10626582|NCT02004132|11785147|FG000|NOT COMPLETED|Overall Study||0
10626583|NCT02004158|11785151|FG000|STARTED|Overall Study||23
10626584|NCT02004158|11785151|FG000|COMPLETED|Overall Study||20
10626585|NCT02004158|11785151|FG000|NOT COMPLETED|Overall Study||3
10626586|NCT02004236|11785160|FG000|STARTED|Overall Study||75
10626587|NCT02004236|11785161|FG001|STARTED|Overall Study||75
10626588|NCT02004236|11785162|FG002|STARTED|Overall Study||75
10626589|NCT02004236|11785160|FG000|COMPLETED|Overall Study||75
10626590|NCT02004236|11785161|FG001|COMPLETED|Overall Study||75
10626591|NCT02004236|11785162|FG002|COMPLETED|Overall Study|Leave the group because the parents does't find any clinical improvement.|59
10626592|NCT02004236|11785160|FG000|NOT COMPLETED|Overall Study||0
10626593|NCT02004236|11785161|FG001|NOT COMPLETED|Overall Study||0
10626594|NCT02004236|11785162|FG002|NOT COMPLETED|Overall Study||16
10626595|NCT02004262|11785177|FG000|STARTED|Overall Study||73
10626596|NCT02004262|11785178|FG001|STARTED|Overall Study||68
10626597|NCT02004262|11785179|FG002|STARTED|Overall Study||72
10626598|NCT02004262|11785180|FG003|STARTED|Overall Study||29
10626599|NCT02004262|11785181|FG004|STARTED|Overall Study||31
10626600|NCT02004262|11785182|FG005|STARTED|Overall Study||30
10626601|NCT02004262|11785177|FG000|Treated|Overall Study||68
10626602|NCT02004262|11785178|FG001|Treated|Overall Study||58
10626603|NCT02004262|11785179|FG002|Treated|Overall Study||43
10626604|NCT02004262|11785180|FG003|Treated|Overall Study||26
10626605|NCT02004262|11785181|FG004|Treated|Overall Study||29
10626606|NCT02004262|11785182|FG005|Treated|Overall Study||11
10626607|NCT02004262|11785177|FG000|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
10626608|NCT02004262|11785178|FG001|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
10626609|NCT02004262|11785179|FG002|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
10626610|NCT02004262|11785180|FG003|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
10626611|NCT02004262|11785181|FG004|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
10626612|NCT02004262|11785182|FG005|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
10626613|NCT02004262|11785177|FG000|NOT COMPLETED|Overall Study||73
10626614|NCT02004262|11785178|FG001|NOT COMPLETED|Overall Study||68
10626615|NCT02004262|11785179|FG002|NOT COMPLETED|Overall Study||72
10626616|NCT02004262|11785180|FG003|NOT COMPLETED|Overall Study||29
10626617|NCT02004262|11785181|FG004|NOT COMPLETED|Overall Study||31
10626618|NCT02004262|11785182|FG005|NOT COMPLETED|Overall Study||30
10626619|NCT02004288|11785198|FG000|STARTED|Overall Study||15
10626620|NCT02004288|11785199|FG001|STARTED|Overall Study||16
10626621|NCT02004288|11785198|FG000|COMPLETED|Overall Study||14
10626622|NCT02004288|11785199|FG001|COMPLETED|Overall Study||15
10626623|NCT02004288|11785198|FG000|NOT COMPLETED|Overall Study||1
10626624|NCT02004288|11785199|FG001|NOT COMPLETED|Overall Study||1
10626625|NCT02004353|11785205|FG000|STARTED|Overall Study||1518
10626626|NCT02004353|11785205|FG000|COMPLETED|Overall Study||184
10626627|NCT02004353|11785205|FG000|NOT COMPLETED|Overall Study||1334
10626628|NCT02004366|11785214|FG000|STARTED|In-hospital||128
10626629|NCT02004366|11785215|FG001|STARTED|In-hospital||122
10626630|NCT02004366|11785216|FG002|STARTED|In-hospital||0
10626631|NCT02004366|11785217|FG003|STARTED|In-hospital||0
10626632|NCT02004366|11785218|FG004|STARTED|In-hospital||0
10626633|NCT02004366|11785214|FG000|COMPLETED|In-hospital||128
10626634|NCT02004366|11785215|FG001|COMPLETED|In-hospital||122
10626635|NCT02004366|11785216|FG002|COMPLETED|In-hospital||0
10626636|NCT02004366|11785217|FG003|COMPLETED|In-hospital||0
10626637|NCT02004366|11785218|FG004|COMPLETED|In-hospital||0
10626638|NCT02004366|11785214|FG000|NOT COMPLETED|In-hospital||0
10626639|NCT02004366|11785215|FG001|NOT COMPLETED|In-hospital||0
10626640|NCT02004366|11785216|FG002|NOT COMPLETED|In-hospital||0
10626641|NCT02004366|11785217|FG003|NOT COMPLETED|In-hospital||0
10626642|NCT02004366|11785218|FG004|NOT COMPLETED|In-hospital||0
10626643|NCT02004366|11785214|FG000|STARTED|On Discharge||0
10626644|NCT02004366|11785215|FG001|STARTED|On Discharge||0
10626645|NCT02004366|11785216|FG002|STARTED|On Discharge||92
10626646|NCT02004366|11785217|FG003|STARTED|On Discharge||93
10626647|NCT02004366|11785218|FG004|STARTED|On Discharge||39
10626648|NCT02004366|11785214|FG000|COMPLETED|On Discharge||0
10705340|NCT02597582|11869716|FG000|COMPLETED|Overall Study||21
10705341|NCT02597582|11869717|FG001|COMPLETED|Overall Study||20
10705342|NCT02597582|11869716|FG000|NOT COMPLETED|Overall Study||0
10705343|NCT02597582|11869717|FG001|NOT COMPLETED|Overall Study||0
10705344|NCT02597673|11869729|FG000|STARTED|Overall Study||34
10705345|NCT02597673|11869730|FG001|STARTED|Overall Study||33
10705346|NCT02597673|11869731|FG002|STARTED|Overall Study||33
10705347|NCT02597673|11869732|FG003|STARTED|Overall Study||30
10705348|NCT02597673|11869729|FG000|COMPLETED|Overall Study||31
10705349|NCT02597673|11869730|FG001|COMPLETED|Overall Study||27
10626649|NCT02004366|11785215|FG001|COMPLETED|On Discharge||0
10626650|NCT02004366|11785216|FG002|COMPLETED|On Discharge||92
10626651|NCT02004366|11785217|FG003|COMPLETED|On Discharge||93
10626652|NCT02004366|11785218|FG004|COMPLETED|On Discharge||39
10626653|NCT02004366|11785214|FG000|NOT COMPLETED|On Discharge||0
10626654|NCT02004366|11785215|FG001|NOT COMPLETED|On Discharge||0
10626655|NCT02004366|11785216|FG002|NOT COMPLETED|On Discharge||0
10626656|NCT02004366|11785217|FG003|NOT COMPLETED|On Discharge||0
10626657|NCT02004366|11785218|FG004|NOT COMPLETED|On Discharge||0
10626658|NCT02004613|11785233|FG000|STARTED|Overall Study||400
10626659|NCT02004613|11785234|FG001|STARTED|Overall Study||398
10626660|NCT02004613|11785233|FG000|COMPLETED|Overall Study||398
10626661|NCT02004613|11785234|FG001|COMPLETED|Overall Study||396
10626662|NCT02004613|11785233|FG000|NOT COMPLETED|Overall Study||2
10626663|NCT02004613|11785234|FG001|NOT COMPLETED|Overall Study||2
10626664|NCT02004847|11785242|FG000|STARTED|Overall Study||24
10626665|NCT02004847|11785243|FG001|STARTED|Overall Study||23
10626666|NCT02004847|11785242|FG000|COMPLETED|Overall Study||23
10626667|NCT02004847|11785243|FG001|COMPLETED|Overall Study||22
10626668|NCT02004847|11785242|FG000|NOT COMPLETED|Overall Study||1
10626669|NCT02004847|11785243|FG001|NOT COMPLETED|Overall Study||1
10626670|NCT02004873|11785258|FG000|STARTED|Overall Study|Micra Implant Attempt|725
10626671|NCT02004873|11785258|FG000|Micra Implant Success|Overall Study||719
10626672|NCT02004873|11785258|FG000|COMPLETED|Overall Study|6-Month Follow-up|301
10626673|NCT02004873|11785258|FG000|NOT COMPLETED|Overall Study||424
10626674|NCT02004886|11785269|FG000|STARTED|Overall Study||19
10705350|NCT02597673|11869731|FG002|COMPLETED|Overall Study||28
10705351|NCT02597673|11869732|FG003|COMPLETED|Overall Study||25
10705352|NCT02597673|11869729|FG000|NOT COMPLETED|Overall Study||3
10705353|NCT02597673|11869730|FG001|NOT COMPLETED|Overall Study||6
10626675|NCT02004886|11785270|FG001|STARTED|Overall Study||18
10626676|NCT02004886|11785271|FG002|STARTED|Overall Study||18
10626677|NCT02004886|11785272|FG003|STARTED|Overall Study||19
10705354|NCT02597673|11869731|FG002|NOT COMPLETED|Overall Study||5
10626678|NCT02004886|11785269|FG000|COMPLETED|Overall Study||18
10626679|NCT02004886|11785270|FG001|COMPLETED|Overall Study||17
10626680|NCT02004886|11785271|FG002|COMPLETED|Overall Study||18
10626681|NCT02004886|11785272|FG003|COMPLETED|Overall Study||19
10626682|NCT02004886|11785269|FG000|NOT COMPLETED|Overall Study||1
10626683|NCT02004886|11785270|FG001|NOT COMPLETED|Overall Study||1
10626684|NCT02004886|11785271|FG002|NOT COMPLETED|Overall Study||0
10626685|NCT02004886|11785272|FG003|NOT COMPLETED|Overall Study||0
10626686|NCT02004977|11785284|FG000|STARTED|Overall Study||463
10626687|NCT02004977|11785285|FG001|STARTED|Overall Study||441
10626688|NCT02004977|11785284|FG000|COMPLETED|Overall Study||409
10626689|NCT02004977|11785285|FG001|COMPLETED|Overall Study||436
10626690|NCT02004977|11785284|FG000|NOT COMPLETED|Overall Study||54
10626691|NCT02004977|11785285|FG001|NOT COMPLETED|Overall Study||5
10626692|NCT02004990|11785291|FG000|STARTED|Overall Study||12
10626693|NCT02004990|11785291|FG000|COMPLETED|Overall Study||12
10626694|NCT02004990|11785291|FG000|NOT COMPLETED|Overall Study||0
10626695|NCT02005016|11785295|FG000|STARTED|Overall Study||46
10626696|NCT02005016|11785295|FG000|COMPLETED|Overall Study||44
10626697|NCT02005016|11785295|FG000|NOT COMPLETED|Overall Study||2
10626698|NCT02005029|11785301|FG000|STARTED|First Intervention (1 Day)||5
10626699|NCT02005029|11785302|FG001|STARTED|First Intervention (1 Day)||5
10626700|NCT02005029|11785301|FG000|COMPLETED|First Intervention (1 Day)||4
10626701|NCT02005029|11785302|FG001|COMPLETED|First Intervention (1 Day)||5
10626702|NCT02005029|11785301|FG000|NOT COMPLETED|First Intervention (1 Day)||1
10626703|NCT02005029|11785302|FG001|NOT COMPLETED|First Intervention (1 Day)||0
10626704|NCT02005029|11785301|FG000|STARTED|Washout (2 Weeks)||4
10626705|NCT02005029|11785302|FG001|STARTED|Washout (2 Weeks)||5
10626706|NCT02005029|11785301|FG000|COMPLETED|Washout (2 Weeks)||4
10626707|NCT02005029|11785302|FG001|COMPLETED|Washout (2 Weeks)||5
10626708|NCT02005029|11785301|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10626709|NCT02005029|11785302|FG001|NOT COMPLETED|Washout (2 Weeks)||0
10626710|NCT02005029|11785301|FG000|STARTED|Second Intervention (1 Day)||4
10626711|NCT02005029|11785302|FG001|STARTED|Second Intervention (1 Day)||5
10626712|NCT02005029|11785301|FG000|COMPLETED|Second Intervention (1 Day)||4
10626713|NCT02005029|11785302|FG001|COMPLETED|Second Intervention (1 Day)||5
10626714|NCT02005029|11785301|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10626715|NCT02005029|11785302|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10626716|NCT02005211|11785333|FG000|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
10626717|NCT02005211|11785334|FG001|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
10626718|NCT02005211|11785335|FG002|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
10626719|NCT02005211|11785336|FG003|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
10626720|NCT02005211|11785337|FG004|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
10626721|NCT02005211|11785338|FG005|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
10626722|NCT02005211|11785339|FG006|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
10626723|NCT02005211|11785333|FG000|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
10626724|NCT02005211|11785334|FG001|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
10626725|NCT02005211|11785335|FG002|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
10626726|NCT02005211|11785336|FG003|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
10626727|NCT02005211|11785337|FG004|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
10626728|NCT02005211|11785338|FG005|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
10626729|NCT02005211|11785339|FG006|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
10626730|NCT02005211|11785333|FG000|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
10626731|NCT02005211|11785334|FG001|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
10626732|NCT02005211|11785335|FG002|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
10626733|NCT02005211|11785336|FG003|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
10626734|NCT02005211|11785337|FG004|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
10626735|NCT02005211|11785338|FG005|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
10626736|NCT02005211|11785339|FG006|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
10626737|NCT02005211|11785333|FG000|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
10626738|NCT02005211|11785334|FG001|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
10626739|NCT02005211|11785335|FG002|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
10626740|NCT02005211|11785336|FG003|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
10705355|NCT02597673|11869732|FG003|NOT COMPLETED|Overall Study||5
10705356|NCT02597712|11869745|FG000|STARTED|Overall Study||13
10705357|NCT02597712|11869746|FG001|STARTED|Overall Study||11
10705358|NCT02597712|11869745|FG000|COMPLETED|Overall Study||10
10705359|NCT02597712|11869746|FG001|COMPLETED|Overall Study||10
10626741|NCT02005211|11785337|FG004|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
10626742|NCT02005211|11785338|FG005|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
10626743|NCT02005211|11785339|FG006|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||4
10626744|NCT02005211|11785333|FG000|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
10626745|NCT02005211|11785334|FG001|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
10626746|NCT02005211|11785335|FG002|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
10626747|NCT02005211|11785336|FG003|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
10626748|NCT02005211|11785337|FG004|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||5
10626749|NCT02005211|11785338|FG005|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
10626750|NCT02005211|11785339|FG006|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||4
10626751|NCT02005211|11785333|FG000|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
10626752|NCT02005211|11785334|FG001|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
10626753|NCT02005211|11785335|FG002|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
10626754|NCT02005211|11785336|FG003|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
10626755|NCT02005211|11785337|FG004|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||1
10705360|NCT02597712|11869745|FG000|NOT COMPLETED|Overall Study||3
10705361|NCT02597712|11869746|FG001|NOT COMPLETED|Overall Study||1
10705362|NCT02597855|11869754|FG000|STARTED|Overall Study||18
10626756|NCT02005211|11785338|FG005|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
10626757|NCT02005211|11785339|FG006|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
10626758|NCT02005250|11785364|FG000|STARTED|Overall Study||61
10626759|NCT02005250|11785365|FG001|STARTED|Overall Study||32
10626760|NCT02005250|11785364|FG000|COMPLETED|Overall Study||46
10626761|NCT02005250|11785365|FG001|COMPLETED|Overall Study||27
10626762|NCT02005250|11785364|FG000|NOT COMPLETED|Overall Study||15
10626763|NCT02005250|11785365|FG001|NOT COMPLETED|Overall Study||5
10626764|NCT02005276|11785375|FG000|STARTED|Overall Study||65
10626765|NCT02005276|11785376|FG001|STARTED|Overall Study||41
10626766|NCT02005276|11785377|FG002|STARTED|Overall Study||59
10626767|NCT02005276|11785378|FG003|STARTED|Overall Study||44
10626768|NCT02005276|11785375|FG000|Completed Intervention|Overall Study||61
10626769|NCT02005276|11785376|FG001|Completed Intervention|Overall Study||39
10626770|NCT02005276|11785377|FG002|Completed Intervention|Overall Study||56
10626771|NCT02005276|11785378|FG003|Completed Intervention|Overall Study||42
10626772|NCT02005276|11785375|FG000|COMPLETED|Overall Study||60
10626773|NCT02005276|11785376|FG001|COMPLETED|Overall Study||39
10626774|NCT02005276|11785377|FG002|COMPLETED|Overall Study||56
10626775|NCT02005276|11785378|FG003|COMPLETED|Overall Study||41
10626776|NCT02005276|11785375|FG000|NOT COMPLETED|Overall Study||5
10626777|NCT02005276|11785376|FG001|NOT COMPLETED|Overall Study||2
10626778|NCT02005276|11785377|FG002|NOT COMPLETED|Overall Study||3
10626779|NCT02005276|11785378|FG003|NOT COMPLETED|Overall Study||3
10626780|NCT02005354|11785392|FG000|STARTED|Overall Study||35
10626781|NCT02005354|11785393|FG001|STARTED|Overall Study||35
10626782|NCT02005354|11785392|FG000|COMPLETED|Overall Study||35
10626783|NCT02005354|11785393|FG001|COMPLETED|Overall Study||35
10626784|NCT02005354|11785392|FG000|NOT COMPLETED|Overall Study||0
10626785|NCT02005354|11785393|FG001|NOT COMPLETED|Overall Study||0
10626786|NCT02005393|11785399|FG000|STARTED|Overall Study||20
10626787|NCT02005393|11785399|FG000|COMPLETED|Overall Study||20
10626788|NCT02005393|11785399|FG000|NOT COMPLETED|Overall Study||0
10626789|NCT02005484|11785403|FG000|STARTED|Overall Study||6
10626790|NCT02005484|11785403|FG000|COMPLETED|Overall Study||2
10626791|NCT02005484|11785403|FG000|NOT COMPLETED|Overall Study||4
10626792|NCT02005510|11785409|FG000|STARTED|Randomized (Round 1)|Excludes 163 determined to be ineligible post-randomization due to delays in data warehouse update.|8120
10626793|NCT02005510|11785410|FG001|STARTED|Randomized (Round 1)|Excludes 196 determined to be ineligible post-randomization due to delays in data warehouse update.|8111
10626794|NCT02005510|11785409|FG000|COMPLETED|Randomized (Round 1)||8120
10626795|NCT02005510|11785410|FG001|COMPLETED|Randomized (Round 1)||8111
10626796|NCT02005510|11785409|FG000|NOT COMPLETED|Randomized (Round 1)||0
10626797|NCT02005510|11785410|FG001|NOT COMPLETED|Randomized (Round 1)||0
10626798|NCT02005510|11785409|FG000|STARTED|Rerandomized (Round 2)|Excludes 10 determined to be ineligible post-randomization due to delays in data warehouse update.|1631
10626799|NCT02005510|11785410|FG001|STARTED|Rerandomized (Round 2)|Excludes 5 determined to be ineligible post-randomization due to delays in data warehouse update.|1585
10626800|NCT02005510|11785409|FG000|COMPLETED|Rerandomized (Round 2)||1631
10626801|NCT02005510|11785410|FG001|COMPLETED|Rerandomized (Round 2)||1585
10626802|NCT02005510|11785409|FG000|NOT COMPLETED|Rerandomized (Round 2)||0
10626803|NCT02005510|11785410|FG001|NOT COMPLETED|Rerandomized (Round 2)||0
10626804|NCT02005510|11785409|FG000|STARTED|Rerandomized (Round 3)|Excludes 5 determined to be ineligible post-randomization due to delays in data warehouse update.|209
10626805|NCT02005510|11785410|FG001|STARTED|Rerandomized (Round 3)||195
10626806|NCT02005510|11785409|FG000|COMPLETED|Rerandomized (Round 3)||209
10626807|NCT02005510|11785410|FG001|COMPLETED|Rerandomized (Round 3)||195
10626808|NCT02005510|11785409|FG000|NOT COMPLETED|Rerandomized (Round 3)||0
10626809|NCT02005510|11785410|FG001|NOT COMPLETED|Rerandomized (Round 3)||0
10626810|NCT02005536|11785416|FG000|STARTED|Overall Study||60
10626811|NCT02005536|11785416|FG000|COMPLETED|Overall Study||60
10626812|NCT02005536|11785416|FG000|NOT COMPLETED|Overall Study||0
10626813|NCT02005549|11785420|FG000|STARTED|Overall Study||18
10626814|NCT02005549|11785420|FG000|COMPLETED|Overall Study||18
10626815|NCT02005549|11785420|FG000|NOT COMPLETED|Overall Study||0
10626816|NCT02005562|11785426|FG000|STARTED|Overall Study||127
10809002|NCT03815240|11970926|FG002|COMPLETED|Intervention Allevyn Dressing||1
10809003|NCT03815240|11970927|FG003|COMPLETED|Intervention Allevyn Dressing||2
10809004|NCT03815240|11970928|FG004|COMPLETED|Intervention Allevyn Dressing||1
10809005|NCT03815240|11970929|FG005|COMPLETED|Intervention Allevyn Dressing||2
10809006|NCT03815240|11970930|FG006|COMPLETED|Intervention Allevyn Dressing||1
10809007|NCT03815240|11970931|FG007|COMPLETED|Intervention Allevyn Dressing||1
10809008|NCT03815240|11970932|FG008|COMPLETED|Intervention Allevyn Dressing||1
10809009|NCT03815240|11970924|FG000|NOT COMPLETED|Intervention Allevyn Dressing||0
10809010|NCT03815240|11970925|FG001|NOT COMPLETED|Intervention Allevyn Dressing||0
10809011|NCT03815240|11970926|FG002|NOT COMPLETED|Intervention Allevyn Dressing||0
10809012|NCT03815240|11970927|FG003|NOT COMPLETED|Intervention Allevyn Dressing||0
10809013|NCT03815240|11970928|FG004|NOT COMPLETED|Intervention Allevyn Dressing||0
10626817|NCT02005562|11785427|FG001|STARTED|Overall Study||125
10626818|NCT02005562|11785426|FG000|Transplanted|Overall Study||126
10626819|NCT02005562|11785427|FG001|Transplanted|Overall Study||121
10626820|NCT02005562|11785426|FG000|COMPLETED|Overall Study||115
10626821|NCT02005562|11785427|FG001|COMPLETED|Overall Study||110
10626822|NCT02005562|11785426|FG000|NOT COMPLETED|Overall Study||12
10626823|NCT02005562|11785427|FG001|NOT COMPLETED|Overall Study||15
10626824|NCT02005601|11785435|FG000|STARTED|Overall Study||53
10626825|NCT02005601|11785436|FG001|STARTED|Overall Study||53
10809014|NCT03815240|11970929|FG005|NOT COMPLETED|Intervention Allevyn Dressing||0
10809015|NCT03815240|11970930|FG006|NOT COMPLETED|Intervention Allevyn Dressing||0
10809016|NCT03815240|11970931|FG007|NOT COMPLETED|Intervention Allevyn Dressing||0
10809017|NCT03815240|11970932|FG008|NOT COMPLETED|Intervention Allevyn Dressing||0
10809018|NCT03815240|11970924|FG000|STARTED|Intervention Optifoam Dressing||2
10809019|NCT03815240|11970925|FG001|STARTED|Intervention Optifoam Dressing||1
10809020|NCT03815240|11970926|FG002|STARTED|Intervention Optifoam Dressing||1
10809021|NCT03815240|11970927|FG003|STARTED|Intervention Optifoam Dressing||2
10809022|NCT03815240|11970928|FG004|STARTED|Intervention Optifoam Dressing||1
10809023|NCT03815240|11970929|FG005|STARTED|Intervention Optifoam Dressing||2
10809024|NCT03815240|11970930|FG006|STARTED|Intervention Optifoam Dressing||1
10809025|NCT03815240|11970931|FG007|STARTED|Intervention Optifoam Dressing||1
10809026|NCT03815240|11970932|FG008|STARTED|Intervention Optifoam Dressing||1
10809027|NCT03815240|11970924|FG000|COMPLETED|Intervention Optifoam Dressing||2
10809028|NCT03815240|11970925|FG001|COMPLETED|Intervention Optifoam Dressing||1
10809029|NCT03815240|11970926|FG002|COMPLETED|Intervention Optifoam Dressing||1
10809030|NCT03815240|11970927|FG003|COMPLETED|Intervention Optifoam Dressing||2
10809031|NCT03815240|11970928|FG004|COMPLETED|Intervention Optifoam Dressing||1
10809032|NCT03815240|11970929|FG005|COMPLETED|Intervention Optifoam Dressing||2
10809033|NCT03815240|11970930|FG006|COMPLETED|Intervention Optifoam Dressing||1
10809034|NCT03815240|11970931|FG007|COMPLETED|Intervention Optifoam Dressing||1
10809035|NCT03815240|11970932|FG008|COMPLETED|Intervention Optifoam Dressing||1
10809036|NCT03815240|11970924|FG000|NOT COMPLETED|Intervention Optifoam Dressing||0
10809037|NCT03815240|11970925|FG001|NOT COMPLETED|Intervention Optifoam Dressing||0
10809038|NCT03815240|11970926|FG002|NOT COMPLETED|Intervention Optifoam Dressing||0
10809039|NCT03815240|11970927|FG003|NOT COMPLETED|Intervention Optifoam Dressing||0
10809040|NCT03815240|11970928|FG004|NOT COMPLETED|Intervention Optifoam Dressing||0
10809041|NCT03815240|11970929|FG005|NOT COMPLETED|Intervention Optifoam Dressing||0
10809042|NCT03815240|11970930|FG006|NOT COMPLETED|Intervention Optifoam Dressing||0
10809043|NCT03815240|11970931|FG007|NOT COMPLETED|Intervention Optifoam Dressing||0
10809044|NCT03815240|11970932|FG008|NOT COMPLETED|Intervention Optifoam Dressing||0
10809045|NCT03836859|11970950|FG000|STARTED|Overall Study||20
10809046|NCT03836859|11970951|FG001|STARTED|Overall Study||10
10809047|NCT03836859|11970950|FG000|COMPLETED|Overall Study||20
10809048|NCT03836859|11970951|FG001|COMPLETED|Overall Study||10
10809049|NCT03836859|11970950|FG000|NOT COMPLETED|Overall Study||0
10809050|NCT03836859|11970951|FG001|NOT COMPLETED|Overall Study||0
10809051|NCT03835078|11970957|FG000|STARTED|Overall Study||39
10809052|NCT03835078|11970957|FG000|COMPLETED|Overall Study||39
10809053|NCT03835078|11970957|FG000|NOT COMPLETED|Overall Study||0
10809054|NCT03834025|11970970|FG000|STARTED|Sent Recruitment Letter (Phase 1)||4150
10809055|NCT03834025|11970971|FG001|STARTED|Sent Recruitment Letter (Phase 1)||3871
10809056|NCT03834025|11970972|FG002|STARTED|Sent Recruitment Letter (Phase 1)||4121
10809057|NCT03834025|11970973|FG003|STARTED|Sent Recruitment Letter (Phase 1)||3693
10809058|NCT03834025|11970974|FG004|STARTED|Sent Recruitment Letter (Phase 1)||0
10809059|NCT03834025|11970975|FG005|STARTED|Sent Recruitment Letter (Phase 1)||0
10809060|NCT03834025|11970976|FG006|STARTED|Sent Recruitment Letter (Phase 1)||0
10809061|NCT03834025|11970970|FG000|Sent Letter|Sent Recruitment Letter (Phase 1)||4150
10809062|NCT03834025|11970971|FG001|Sent Letter|Sent Recruitment Letter (Phase 1)||3871
10809063|NCT03834025|11970972|FG002|Sent Letter|Sent Recruitment Letter (Phase 1)||4121
10809064|NCT03834025|11970973|FG003|Sent Letter|Sent Recruitment Letter (Phase 1)||3693
10809065|NCT03834025|11970974|FG004|Sent Letter|Sent Recruitment Letter (Phase 1)||0
10809066|NCT03834025|11970975|FG005|Sent Letter|Sent Recruitment Letter (Phase 1)||0
10809067|NCT03834025|11970976|FG006|Sent Letter|Sent Recruitment Letter (Phase 1)||0
10809068|NCT03834025|11970970|FG000|Responded to Letter|Sent Recruitment Letter (Phase 1)||36
10809069|NCT03834025|11970971|FG001|Responded to Letter|Sent Recruitment Letter (Phase 1)||36
10809070|NCT03834025|11970972|FG002|Responded to Letter|Sent Recruitment Letter (Phase 1)||44
10809071|NCT03834025|11970973|FG003|Responded to Letter|Sent Recruitment Letter (Phase 1)||44
10809072|NCT03834025|11970974|FG004|Responded to Letter|Sent Recruitment Letter (Phase 1)||0
10809073|NCT03834025|11970975|FG005|Responded to Letter|Sent Recruitment Letter (Phase 1)||0
10809074|NCT03834025|11970976|FG006|Responded to Letter|Sent Recruitment Letter (Phase 1)||0
10809075|NCT03834025|11970970|FG000|COMPLETED|Sent Recruitment Letter (Phase 1)||36
10809076|NCT03834025|11970971|FG001|COMPLETED|Sent Recruitment Letter (Phase 1)||36
10809077|NCT03834025|11970972|FG002|COMPLETED|Sent Recruitment Letter (Phase 1)||44
10809078|NCT03834025|11970973|FG003|COMPLETED|Sent Recruitment Letter (Phase 1)||44
10809079|NCT03834025|11970974|FG004|COMPLETED|Sent Recruitment Letter (Phase 1)||0
10809080|NCT03834025|11970975|FG005|COMPLETED|Sent Recruitment Letter (Phase 1)||0
10809081|NCT03834025|11970976|FG006|COMPLETED|Sent Recruitment Letter (Phase 1)||0
10809082|NCT03834025|11970970|FG000|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||4114
10809083|NCT03834025|11970971|FG001|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||3835
10809084|NCT03834025|11970972|FG002|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||4077
10809085|NCT03834025|11970973|FG003|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||3649
10809086|NCT03834025|11970974|FG004|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||0
10809087|NCT03834025|11970975|FG005|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||0
10809088|NCT03834025|11970976|FG006|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||0
10809089|NCT03834025|11970970|FG000|STARTED|Randomized to Payment Condition(Phase 2)||0
10809090|NCT03834025|11970971|FG001|STARTED|Randomized to Payment Condition(Phase 2)||0
10809091|NCT03834025|11970972|FG002|STARTED|Randomized to Payment Condition(Phase 2)||0
10809092|NCT03834025|11970973|FG003|STARTED|Randomized to Payment Condition(Phase 2)||0
10809093|NCT03834025|11970974|FG004|STARTED|Randomized to Payment Condition(Phase 2)||24
10809094|NCT03834025|11970975|FG005|STARTED|Randomized to Payment Condition(Phase 2)||21
10809095|NCT03834025|11970976|FG006|STARTED|Randomized to Payment Condition(Phase 2)||28
10809096|NCT03834025|11970970|FG000|COMPLETED|Randomized to Payment Condition(Phase 2)||0
10809097|NCT03834025|11970971|FG001|COMPLETED|Randomized to Payment Condition(Phase 2)||0
10809098|NCT03834025|11970972|FG002|COMPLETED|Randomized to Payment Condition(Phase 2)||0
10809099|NCT03834025|11970973|FG003|COMPLETED|Randomized to Payment Condition(Phase 2)||0
10809100|NCT03834025|11970974|FG004|COMPLETED|Randomized to Payment Condition(Phase 2)||24
10809101|NCT03834025|11970975|FG005|COMPLETED|Randomized to Payment Condition(Phase 2)||21
10809102|NCT03834025|11970976|FG006|COMPLETED|Randomized to Payment Condition(Phase 2)||27
10809103|NCT03834025|11970970|FG000|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0
10809104|NCT03834025|11970971|FG001|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0
10809105|NCT03834025|11970972|FG002|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0
10809106|NCT03834025|11970973|FG003|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0
10809107|NCT03834025|11970974|FG004|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0
10809108|NCT03834025|11970975|FG005|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0
10809109|NCT03834025|11970976|FG006|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||1
10809110|NCT03836677|11970992|FG000|STARTED|Period 1||13
10809111|NCT03836677|11970993|FG001|STARTED|Period 1||10
10809112|NCT03836677|11970992|FG000|COMPLETED|Period 1||13
10626826|NCT02005601|11785435|FG000|COMPLETED|Overall Study||53
10626827|NCT02005601|11785436|FG001|COMPLETED|Overall Study||53
10626828|NCT02005601|11785435|FG000|NOT COMPLETED|Overall Study||0
10626829|NCT02005601|11785436|FG001|NOT COMPLETED|Overall Study||0
10626830|NCT02005627|11785444|FG000|STARTED|Overall Study||23
10626831|NCT02005627|11785445|FG001|STARTED|Overall Study||23
10626832|NCT02005627|11785444|FG000|COMPLETED|Overall Study||21
10626833|NCT02005627|11785445|FG001|COMPLETED|Overall Study||19
10626834|NCT02005627|11785444|FG000|NOT COMPLETED|Overall Study||2
10626835|NCT02005627|11785445|FG001|NOT COMPLETED|Overall Study||4
10626836|NCT02005666|11785455|FG000|STARTED|Overall Study||338
10626837|NCT02005666|11785456|FG001|STARTED|Overall Study||343
10626838|NCT02005666|11785457|FG002|STARTED|Overall Study||169
10626839|NCT02005666|11785455|FG000|COMPLETED|Overall Study||311
10626840|NCT02005666|11785456|FG001|COMPLETED|Overall Study||299
10626841|NCT02005666|11785457|FG002|COMPLETED|Overall Study||160
10626842|NCT02005666|11785455|FG000|NOT COMPLETED|Overall Study||27
10626843|NCT02005666|11785456|FG001|NOT COMPLETED|Overall Study||44
10626844|NCT02005666|11785457|FG002|NOT COMPLETED|Overall Study||9
10626845|NCT02005692|11785465|FG000|STARTED|Overall Study||70
10626846|NCT02005692|11785465|FG000|COMPLETED|Overall Study||63
10626847|NCT02005692|11785465|FG000|NOT COMPLETED|Overall Study||7
10626848|NCT02005887|11785472|FG000|STARTED|Overall Study||26
10626849|NCT02005887|11785473|FG001|STARTED|Overall Study||25
10626850|NCT02005887|11785472|FG000|COMPLETED|Overall Study||26
10626851|NCT02005887|11785473|FG001|COMPLETED|Overall Study||23
10626852|NCT02005887|11785472|FG000|NOT COMPLETED|Overall Study||0
10626853|NCT02005887|11785473|FG001|NOT COMPLETED|Overall Study||2
10626854|NCT02006056|11785481|FG000|STARTED|Overall Study||26
10626855|NCT02006056|11785482|FG001|STARTED|Overall Study||4
10626856|NCT02006056|11785481|FG000|COMPLETED|Overall Study||26
10626857|NCT02006056|11785482|FG001|COMPLETED|Overall Study||4
10626858|NCT02006056|11785481|FG000|NOT COMPLETED|Overall Study||0
10626859|NCT02006056|11785482|FG001|NOT COMPLETED|Overall Study||0
10626860|NCT02006108|11785488|FG000|STARTED|Overall Study||21
10626861|NCT02006108|11785488|FG000|MR Imaging|Overall Study||19
10626862|NCT02006108|11785488|FG000|COMPLETED|Overall Study||19
10626863|NCT02006108|11785488|FG000|NOT COMPLETED|Overall Study||2
10626864|NCT02006121|11785494|FG000|STARTED|Double Blind Phase||54
10626865|NCT02006121|11785495|FG001|STARTED|Double Blind Phase||53
10626866|NCT02006121|11785494|FG000|COMPLETED|Double Blind Phase|Early switching to open label: 1 for lack of efficacy, 1 could not tolerate 3 mg/hour minimum rate|42
10626867|NCT02006121|11785495|FG001|COMPLETED|Double Blind Phase|16 placebo-treated patients early switched to open label phase due to lack of efficacy|29
10626868|NCT02006121|11785494|FG000|NOT COMPLETED|Double Blind Phase||12
10626869|NCT02006121|11785495|FG001|NOT COMPLETED|Double Blind Phase||24
10626870|NCT02006121|11785494|FG000|STARTED|Open Label Phase|From Apo: 38 completers and 2 early switched; From Placebo: 28 completers and 16 early switched|84
10626871|NCT02006121|11785495|FG001|STARTED|Open Label Phase|No patients received placebo in the open label phase|0
10626872|NCT02006121|11785494|FG000|COMPLETED|Open Label Phase|30 who continued on apomorphine from blinded phase, 29 who switched to apomorphine from placebo|59
10626873|NCT02006121|11785495|FG001|COMPLETED|Open Label Phase||0
10626874|NCT02006121|11785494|FG000|NOT COMPLETED|Open Label Phase||25
10626875|NCT02006121|11785495|FG001|NOT COMPLETED|Open Label Phase||0
10626876|NCT02006160|11785507|FG000|STARTED|Overall Study||45
10626877|NCT02006160|11785508|FG001|STARTED|Overall Study||16
10626878|NCT02006160|11785507|FG000|COMPLETED|Overall Study||41
10626879|NCT02006160|11785508|FG001|COMPLETED|Overall Study||16
10626880|NCT02006160|11785507|FG000|NOT COMPLETED|Overall Study||4
10626881|NCT02006160|11785508|FG001|NOT COMPLETED|Overall Study||0
10626882|NCT02006264|11785516|FG000|STARTED|Overall Study||15
10626883|NCT02006264|11785517|FG001|STARTED|Overall Study||15
10626884|NCT02006264|11785516|FG000|COMPLETED|Overall Study||14
10626885|NCT02006264|11785517|FG001|COMPLETED|Overall Study||15
10626886|NCT02006264|11785516|FG000|NOT COMPLETED|Overall Study||1
10626887|NCT02006264|11785517|FG001|NOT COMPLETED|Overall Study||0
10626888|NCT02006342|11785525|FG000|STARTED|Overall Study||20
10626889|NCT02006342|11785526|FG001|STARTED|Overall Study||20
10626890|NCT02006342|11785525|FG000|COMPLETED|Overall Study||19
10626891|NCT02006342|11785526|FG001|COMPLETED|Overall Study||20
10809113|NCT03836677|11970993|FG001|COMPLETED|Period 1||9
10626892|NCT02006342|11785525|FG000|NOT COMPLETED|Overall Study||1
10626893|NCT02006342|11785526|FG001|NOT COMPLETED|Overall Study||0
10626894|NCT02006420|11785534|FG000|STARTED|Overall Study||24
10626895|NCT02006420|11785535|FG001|STARTED|Overall Study||21
10626896|NCT02006420|11785534|FG000|COMPLETED|Overall Study||24
10626897|NCT02006420|11785535|FG001|COMPLETED|Overall Study||21
10626898|NCT02006420|11785534|FG000|NOT COMPLETED|Overall Study||0
10626899|NCT02006420|11785535|FG001|NOT COMPLETED|Overall Study||0
10626900|NCT02006472|11785552|FG000|STARTED|Period 1 (Through Week 26)||82
10626901|NCT02006472|11785553|FG001|STARTED|Period 1 (Through Week 26)||81
10626902|NCT02006472|11785554|FG002|STARTED|Period 1 (Through Week 26)||82
10626903|NCT02006472|11785555|FG003|STARTED|Period 1 (Through Week 26)||81
10626904|NCT02006472|11785556|FG004|STARTED|Period 1 (Through Week 26)||82
10626905|NCT02006472|11785552|FG000|ITT|Period 1 (Through Week 26)||82
10626906|NCT02006472|11785553|FG001|ITT|Period 1 (Through Week 26)||81
10626907|NCT02006472|11785554|FG002|ITT|Period 1 (Through Week 26)||82
10626908|NCT02006472|11785555|FG003|ITT|Period 1 (Through Week 26)||81
10626909|NCT02006472|11785556|FG004|ITT|Period 1 (Through Week 26)||82
10626910|NCT02006472|11785552|FG000|FAS|Period 1 (Through Week 26)||81
10626911|NCT02006472|11785553|FG001|FAS|Period 1 (Through Week 26)||75
10626912|NCT02006472|11785554|FG002|FAS|Period 1 (Through Week 26)||79
10626913|NCT02006472|11785555|FG003|FAS|Period 1 (Through Week 26)||81
10626914|NCT02006472|11785556|FG004|FAS|Period 1 (Through Week 26)||81
10626915|NCT02006472|11785552|FG000|Safety Set|Period 1 (Through Week 26)||82
10626916|NCT02006472|11785553|FG001|Safety Set|Period 1 (Through Week 26)||81
10626917|NCT02006472|11785554|FG002|Safety Set|Period 1 (Through Week 26)||82
10626918|NCT02006472|11785555|FG003|Safety Set|Period 1 (Through Week 26)||81
10626919|NCT02006472|11785556|FG004|Safety Set|Period 1 (Through Week 26)||82
10626920|NCT02006472|11785552|FG000|COMPLETED|Period 1 (Through Week 26)||70
10626921|NCT02006472|11785553|FG001|COMPLETED|Period 1 (Through Week 26)||59
10626922|NCT02006472|11785554|FG002|COMPLETED|Period 1 (Through Week 26)||65
10626923|NCT02006472|11785555|FG003|COMPLETED|Period 1 (Through Week 26)||67
10626924|NCT02006472|11785556|FG004|COMPLETED|Period 1 (Through Week 26)||62
10626925|NCT02006472|11785552|FG000|NOT COMPLETED|Period 1 (Through Week 26)||12
10626926|NCT02006472|11785553|FG001|NOT COMPLETED|Period 1 (Through Week 26)||22
10626927|NCT02006472|11785554|FG002|NOT COMPLETED|Period 1 (Through Week 26)||17
10626928|NCT02006472|11785555|FG003|NOT COMPLETED|Period 1 (Through Week 26)||14
10626929|NCT02006472|11785556|FG004|NOT COMPLETED|Period 1 (Through Week 26)||20
10626930|NCT02006472|11785552|FG000|STARTED|Period 2 (Through Week 52)||57
10626931|NCT02006472|11785553|FG001|STARTED|Period 2 (Through Week 52)||49
10626932|NCT02006472|11785554|FG002|STARTED|Period 2 (Through Week 52)||54
10626933|NCT02006472|11785555|FG003|STARTED|Period 2 (Through Week 52)||56
10626934|NCT02006472|11785556|FG004|STARTED|Period 2 (Through Week 52)||46
10626935|NCT02006472|11785552|FG000|Started Treatment in Period 2|Period 2 (Through Week 52)||57
10626936|NCT02006472|11785553|FG001|Started Treatment in Period 2|Period 2 (Through Week 52)||49
10626937|NCT02006472|11785554|FG002|Started Treatment in Period 2|Period 2 (Through Week 52)||52
10626938|NCT02006472|11785555|FG003|Started Treatment in Period 2|Period 2 (Through Week 52)||56
10626939|NCT02006472|11785556|FG004|Started Treatment in Period 2|Period 2 (Through Week 52)||46
10626940|NCT02006472|11785552|FG000|COMPLETED|Period 2 (Through Week 52)||52
10626941|NCT02006472|11785553|FG001|COMPLETED|Period 2 (Through Week 52)||43
10626942|NCT02006472|11785554|FG002|COMPLETED|Period 2 (Through Week 52)||44
10626943|NCT02006472|11785555|FG003|COMPLETED|Period 2 (Through Week 52)||53
10626944|NCT02006472|11785556|FG004|COMPLETED|Period 2 (Through Week 52)||44
10626945|NCT02006472|11785552|FG000|NOT COMPLETED|Period 2 (Through Week 52)||5
10626946|NCT02006472|11785553|FG001|NOT COMPLETED|Period 2 (Through Week 52)||6
10626947|NCT02006472|11785554|FG002|NOT COMPLETED|Period 2 (Through Week 52)||10
10626948|NCT02006472|11785555|FG003|NOT COMPLETED|Period 2 (Through Week 52)||3
10626949|NCT02006472|11785556|FG004|NOT COMPLETED|Period 2 (Through Week 52)||2
10626950|NCT02006576|11785576|FG000|STARTED|Overall Study||35
10626951|NCT02006576|11785577|FG001|STARTED|Overall Study||51
10626952|NCT02006576|11785578|FG002|STARTED|Overall Study||32
10626953|NCT02006576|11785576|FG000|COMPLETED|Overall Study||17
10626954|NCT02006576|11785577|FG001|COMPLETED|Overall Study||44
10626955|NCT02006576|11785578|FG002|COMPLETED|Overall Study||15
10626956|NCT02006576|11785576|FG000|NOT COMPLETED|Overall Study||18
10626957|NCT02006576|11785577|FG001|NOT COMPLETED|Overall Study||7
10626958|NCT02006576|11785578|FG002|NOT COMPLETED|Overall Study||17
10626969|NCT02006641|11785598|FG000|STARTED|Overall Study||284
10626970|NCT02006641|11785599|FG001|STARTED|Overall Study||290
10626971|NCT02006641|11785600|FG002|STARTED|Overall Study||284
10626972|NCT02006641|11785598|FG000|Treated|Overall Study||282
10626973|NCT02006641|11785599|FG001|Treated|Overall Study||285
10626974|NCT02006641|11785600|FG002|Treated|Overall Study||281
10626975|NCT02006641|11785598|FG000|COMPLETED|Overall Study||258
10626976|NCT02006641|11785599|FG001|COMPLETED|Overall Study||257
10626977|NCT02006641|11785600|FG002|COMPLETED|Overall Study||248
10626978|NCT02006641|11785598|FG000|NOT COMPLETED|Overall Study||26
10626979|NCT02006641|11785599|FG001|NOT COMPLETED|Overall Study||33
10626980|NCT02006641|11785600|FG002|NOT COMPLETED|Overall Study||36
10626981|NCT02006654|11785610|FG000|STARTED|Overall Study||369
10626982|NCT02006654|11785611|FG001|STARTED|Overall Study||365
10626983|NCT02006654|11785610|FG000|Treated|Overall Study||365
10626984|NCT02006654|11785611|FG001|Treated|Overall Study||363
10626985|NCT02006654|11785610|FG000|COMPLETED|Overall Study||324
10626986|NCT02006654|11785611|FG001|COMPLETED|Overall Study||321
10626987|NCT02006654|11785610|FG000|NOT COMPLETED|Overall Study||45
10626988|NCT02006654|11785611|FG001|NOT COMPLETED|Overall Study||44
10626989|NCT02006667|11785618|FG000|STARTED|Overall Study||13
10626990|NCT02006667|11785618|FG000|COMPLETED|Overall Study||7
10626991|NCT02006667|11785618|FG000|NOT COMPLETED|Overall Study||6
10626992|NCT02006693|11785624|FG000|STARTED|Overall Study||112
10626993|NCT02006693|11785625|FG001|STARTED|Overall Study||87
10626994|NCT02006693|11785624|FG000|COMPLETED|Overall Study||84
10626995|NCT02006693|11785625|FG001|COMPLETED|Overall Study||74
10626996|NCT02006693|11785624|FG000|NOT COMPLETED|Overall Study||28
10626997|NCT02006693|11785625|FG001|NOT COMPLETED|Overall Study||13
10626998|NCT02006706|11785631|FG000|STARTED|Overall Study||15
10626999|NCT02006706|11785631|FG000|COMPLETED|Overall Study||14
10627000|NCT02006706|11785631|FG000|NOT COMPLETED|Overall Study||1
10627001|NCT02006719|11785637|FG000|STARTED|Overall Study||237
10627002|NCT02006719|11785638|FG001|STARTED|Overall Study||85
10627003|NCT02006719|11785637|FG000|COMPLETED|Overall Study||219
10627004|NCT02006719|11785638|FG001|COMPLETED|Overall Study||80
10627005|NCT02006719|11785637|FG000|NOT COMPLETED|Overall Study||18
10627006|NCT02006719|11785638|FG001|NOT COMPLETED|Overall Study||5
10627007|NCT02006732|11785648|FG000|STARTED|Overall Study||202
10627008|NCT02006732|11785649|FG001|STARTED|Overall Study||203
10627009|NCT02006732|11785650|FG002|STARTED|Overall Study||202
10627010|NCT02006732|11785651|FG003|STARTED|Overall Study||202
10627011|NCT02006732|11785648|FG000|COMPLETED|Overall Study||182
10627012|NCT02006732|11785649|FG001|COMPLETED|Overall Study||191
10627013|NCT02006732|11785650|FG002|COMPLETED|Overall Study||193
10627014|NCT02006732|11785651|FG003|COMPLETED|Overall Study||198
10627015|NCT02006732|11785648|FG000|NOT COMPLETED|Overall Study||20
10627016|NCT02006732|11785649|FG001|NOT COMPLETED|Overall Study||12
10627017|NCT02006732|11785650|FG002|NOT COMPLETED|Overall Study||9
10627018|NCT02006732|11785651|FG003|NOT COMPLETED|Overall Study||4
10627019|NCT02006758|11785661|FG000|STARTED|Overall Study|Total number of enrolled participants|68
10627020|NCT02006758|11785661|FG000|Underwent Renal Denervation|Overall Study|Underwent renal denervation|67
10627021|NCT02006758|11785661|FG000|1-month Follow up|Overall Study|1-month follow up completed|66
10627022|NCT02006758|11785661|FG000|6-month Follow up|Overall Study|6-month follow up completed|60
10627023|NCT02006758|11785661|FG000|12-month Follow up|Overall Study|12-month follow up completed|55
10627024|NCT02006758|11785661|FG000|COMPLETED|Overall Study||55
10627025|NCT02006758|11785661|FG000|NOT COMPLETED|Overall Study||13
10627026|NCT02006836|11785669|FG000|STARTED|Case-control Period: Month 1- Month 6||20
10627027|NCT02006836|11785670|FG001|STARTED|Case-control Period: Month 1- Month 6||20
10627028|NCT02006836|11785671|FG002|STARTED|Case-control Period: Month 1- Month 6||0
10627029|NCT02006836|11785669|FG000|COMPLETED|Case-control Period: Month 1- Month 6||20
10627030|NCT02006836|11785670|FG001|COMPLETED|Case-control Period: Month 1- Month 6||20
10627031|NCT02006836|11785671|FG002|COMPLETED|Case-control Period: Month 1- Month 6||0
10627032|NCT02006836|11785669|FG000|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
10627033|NCT02006836|11785670|FG001|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
10627034|NCT02006836|11785671|FG002|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
10627035|NCT02006836|11785669|FG000|STARTED|Self-control Period: Month 7-month 12||0
10627036|NCT02006836|11785670|FG001|STARTED|Self-control Period: Month 7-month 12||0
10627037|NCT02006836|11785671|FG002|STARTED|Self-control Period: Month 7-month 12||19
10627038|NCT02006836|11785669|FG000|COMPLETED|Self-control Period: Month 7-month 12||0
10627039|NCT02006836|11785670|FG001|COMPLETED|Self-control Period: Month 7-month 12||0
10627040|NCT02006836|11785671|FG002|COMPLETED|Self-control Period: Month 7-month 12||19
10627041|NCT02006836|11785669|FG000|NOT COMPLETED|Self-control Period: Month 7-month 12||0
10627042|NCT02006836|11785670|FG001|NOT COMPLETED|Self-control Period: Month 7-month 12||0
10627043|NCT02006836|11785671|FG002|NOT COMPLETED|Self-control Period: Month 7-month 12||0
10627044|NCT02006888|11785684|FG000|STARTED|Overall Study||158
10627045|NCT02006888|11785685|FG001|STARTED|Overall Study||156
10627046|NCT02006888|11785686|FG002|STARTED|Overall Study||80
10627047|NCT02006888|11785684|FG000|COMPLETED|Overall Study||122
10627048|NCT02006888|11785685|FG001|COMPLETED|Overall Study||122
10627049|NCT02006888|11785686|FG002|COMPLETED|Overall Study||58
10627050|NCT02006888|11785684|FG000|NOT COMPLETED|Overall Study||36
10627051|NCT02006888|11785685|FG001|NOT COMPLETED|Overall Study||34
10627052|NCT02006888|11785686|FG002|NOT COMPLETED|Overall Study||22
10627053|NCT02006979|11785696|FG000|STARTED|Overall Study||14
10627054|NCT02006979|11785697|FG001|STARTED|Overall Study||13
10627055|NCT02006979|11785696|FG000|COMPLETED|Overall Study||13
10627056|NCT02006979|11785697|FG001|COMPLETED|Overall Study||11
10627057|NCT02006979|11785696|FG000|NOT COMPLETED|Overall Study||1
10627058|NCT02006979|11785697|FG001|NOT COMPLETED|Overall Study||2
10627059|NCT02007070|11785703|FG000|STARTED|Overall Study||38
10627060|NCT02007070|11785703|FG000|COMPLETED|Overall Study|Completed 2 years of treatment.|5
10627061|NCT02007070|11785703|FG000|NOT COMPLETED|Overall Study||33
10627062|NCT02007096|11785709|FG000|STARTED|Overall Study||63
10627063|NCT02007096|11785710|FG001|STARTED|Overall Study||64
10627064|NCT02007096|11785709|FG000|COMPLETED|Overall Study||52
10627065|NCT02007096|11785710|FG001|COMPLETED|Overall Study||48
10627066|NCT02007096|11785709|FG000|NOT COMPLETED|Overall Study||11
10627067|NCT02007096|11785710|FG001|NOT COMPLETED|Overall Study||16
10627068|NCT02007109|11785716|FG000|STARTED|Overall Study||193
10627069|NCT02007109|11785716|FG000|PACU Analysis|Overall Study||184
10627070|NCT02007109|11785716|FG000|COMPLETED|Overall Study||82
10627071|NCT02007109|11785716|FG000|NOT COMPLETED|Overall Study||111
10627072|NCT02007200|11785723|FG000|STARTED|Overall Study||55
10627073|NCT02007200|11785723|FG000|COMPLETED|Overall Study||55
10627074|NCT02007200|11785723|FG000|NOT COMPLETED|Overall Study||0
10627075|NCT02007252|11785729|FG000|STARTED|Overall Study||31
10627076|NCT02007252|11785730|FG001|STARTED|Overall Study||33
10627077|NCT02007252|11785729|FG000|Safety Analysis Set|Overall Study||31
10627078|NCT02007252|11785730|FG001|Safety Analysis Set|Overall Study||33
10627079|NCT02007252|11785729|FG000|Pharmacodynamic Analysis Set|Overall Study||31
10627080|NCT02007252|11785730|FG001|Pharmacodynamic Analysis Set|Overall Study||33
10627081|NCT02007252|11785729|FG000|COMPLETED|Overall Study||20
10627082|NCT02007252|11785730|FG001|COMPLETED|Overall Study||22
10627083|NCT02007252|11785729|FG000|NOT COMPLETED|Overall Study||11
10627084|NCT02007252|11785730|FG001|NOT COMPLETED|Overall Study||11
10627085|NCT02007278|11785738|FG000|STARTED|Overall Study||20
10627086|NCT02007278|11785739|FG001|STARTED|Overall Study||20
10627087|NCT02007278|11785738|FG000|COMPLETED|Overall Study||18
10627088|NCT02007278|11785739|FG001|COMPLETED|Overall Study||17
10627089|NCT02007278|11785738|FG000|NOT COMPLETED|Overall Study||2
10627090|NCT02007278|11785739|FG001|NOT COMPLETED|Overall Study||3
10627091|NCT02007291|11785745|FG000|STARTED|Overall Study||48
10627092|NCT02007291|11785746|FG001|STARTED|Overall Study||23
10627093|NCT02007291|11785745|FG000|COMPLETED|Overall Study||48
10627094|NCT02007291|11785746|FG001|COMPLETED|Overall Study||23
10627095|NCT02007291|11785745|FG000|NOT COMPLETED|Overall Study||0
10627096|NCT02007291|11785746|FG001|NOT COMPLETED|Overall Study||0
10627097|NCT02007369|11785755|FG000|STARTED|Overall Study||42
10627098|NCT02007369|11785756|FG001|STARTED|Overall Study||40
10627099|NCT02007369|11785757|FG002|STARTED|Overall Study||54
10627100|NCT02007369|11785755|FG000|COMPLETED|Overall Study||42
10627101|NCT02007369|11785756|FG001|COMPLETED|Overall Study||40
10627102|NCT02007369|11785757|FG002|COMPLETED|Overall Study||54
10627103|NCT02007369|11785755|FG000|NOT COMPLETED|Overall Study||0
10627104|NCT02007369|11785756|FG001|NOT COMPLETED|Overall Study||0
10627105|NCT02007369|11785757|FG002|NOT COMPLETED|Overall Study||0
10627106|NCT02007434|11785773|FG000|STARTED|Overall Study||17
10627107|NCT02007434|11785774|FG001|STARTED|Overall Study||4
10627108|NCT02007434|11785775|FG002|STARTED|Overall Study||17
10627109|NCT02007434|11785776|FG003|STARTED|Overall Study||4
10627110|NCT02007434|11785777|FG004|STARTED|Overall Study||16
10627111|NCT02007434|11785778|FG005|STARTED|Overall Study||4
10627112|NCT02007434|11785779|FG006|STARTED|Overall Study||18
10627113|NCT02007434|11785780|FG007|STARTED|Overall Study||4
10627114|NCT02007434|11785773|FG000|Received Treatment|Overall Study||17
10627115|NCT02007434|11785774|FG001|Received Treatment|Overall Study||3
10627116|NCT02007434|11785775|FG002|Received Treatment|Overall Study||17
10627117|NCT02007434|11785776|FG003|Received Treatment|Overall Study||4
10627118|NCT02007434|11785777|FG004|Received Treatment|Overall Study||16
10627119|NCT02007434|11785778|FG005|Received Treatment|Overall Study||4
10627120|NCT02007434|11785779|FG006|Received Treatment|Overall Study||18
10627121|NCT02007434|11785780|FG007|Received Treatment|Overall Study||4
10627122|NCT02007434|11785773|FG000|COMPLETED|Overall Study||16
10627123|NCT02007434|11785774|FG001|COMPLETED|Overall Study||3
10627124|NCT02007434|11785775|FG002|COMPLETED|Overall Study||16
10627125|NCT02007434|11785776|FG003|COMPLETED|Overall Study||4
10627126|NCT02007434|11785777|FG004|COMPLETED|Overall Study||16
10627127|NCT02007434|11785778|FG005|COMPLETED|Overall Study||4
10627128|NCT02007434|11785779|FG006|COMPLETED|Overall Study||18
10627129|NCT02007434|11785780|FG007|COMPLETED|Overall Study||4
10627130|NCT02007434|11785773|FG000|NOT COMPLETED|Overall Study||1
10627131|NCT02007434|11785774|FG001|NOT COMPLETED|Overall Study||1
10627132|NCT02007434|11785775|FG002|NOT COMPLETED|Overall Study||1
10627133|NCT02007434|11785776|FG003|NOT COMPLETED|Overall Study||0
10627134|NCT02007434|11785777|FG004|NOT COMPLETED|Overall Study||0
10627135|NCT02007434|11785778|FG005|NOT COMPLETED|Overall Study||0
10627136|NCT02007434|11785779|FG006|NOT COMPLETED|Overall Study||0
10627137|NCT02007434|11785780|FG007|NOT COMPLETED|Overall Study||0
10627138|NCT02007577|11785801|FG000|STARTED|Overall Study||27
10627139|NCT02007577|11785802|FG001|STARTED|Overall Study||14
10627140|NCT02007577|11785801|FG000|COMPLETED|Overall Study||26
10627141|NCT02007577|11785802|FG001|COMPLETED|Overall Study||13
10627142|NCT02007577|11785801|FG000|NOT COMPLETED|Overall Study||1
10627143|NCT02007577|11785802|FG001|NOT COMPLETED|Overall Study||1
10627144|NCT02007720|11785810|FG000|STARTED|Overall Study||436
10627145|NCT02007720|11785811|FG001|STARTED|Overall Study||440
10627146|NCT02007720|11785810|FG000|Full Analysis Set|Overall Study||433
10627147|NCT02007720|11785811|FG001|Full Analysis Set|Overall Study||437
10627148|NCT02007720|11785810|FG000|Safety Set|Overall Study||426
10627149|NCT02007720|11785811|FG001|Safety Set|Overall Study||432
10627150|NCT02007720|11785810|FG000|COMPLETED|Overall Study||354
10627151|NCT02007720|11785811|FG001|COMPLETED|Overall Study||368
10627152|NCT02007720|11785810|FG000|NOT COMPLETED|Overall Study||82
10627153|NCT02007720|11785811|FG001|NOT COMPLETED|Overall Study||72
10627154|NCT02007863|11785818|FG000|STARTED|Overall Study||2
10627155|NCT02007863|11785818|FG000|COMPLETED|Overall Study||2
10705363|NCT02597855|11869755|FG001|STARTED|Overall Study||14
10705364|NCT02597855|11869754|FG000|COMPLETED|Overall Study||16
10705365|NCT02597855|11869755|FG001|COMPLETED|Overall Study||13
10705366|NCT02597855|11869754|FG000|NOT COMPLETED|Overall Study||2
10627156|NCT02007863|11785818|FG000|NOT COMPLETED|Overall Study||0
10627157|NCT02007954|11785822|FG000|STARTED|Overall Study|A total of 32 participants were consented, with 8 patients screened out prior to treatment.|24
10627158|NCT02007954|11785822|FG000|Completed First TACE|Overall Study||24
10627159|NCT02007954|11785822|FG000|Completed First Clinical and Imaging|Overall Study|1 patient exited prior to first imaging follow-up due to unrelated serious adverse event and death|23
10627160|NCT02007954|11785822|FG000|COMPLETED|Overall Study||17
10627161|NCT02007954|11785822|FG000|NOT COMPLETED|Overall Study||7
10627162|NCT02008149|11785829|FG000|STARTED|Overall Study||7
10627163|NCT02008149|11785830|FG001|STARTED|Overall Study||1
10627164|NCT02008149|11785831|FG002|STARTED|Overall Study||1
10627165|NCT02008149|11785829|FG000|COMPLETED|Overall Study||4
10627166|NCT02008149|11785830|FG001|COMPLETED|Overall Study||0
10627167|NCT02008149|11785831|FG002|COMPLETED|Overall Study||1
10627168|NCT02008149|11785829|FG000|NOT COMPLETED|Overall Study||3
10627169|NCT02008149|11785830|FG001|NOT COMPLETED|Overall Study||1
10627170|NCT02008149|11785831|FG002|NOT COMPLETED|Overall Study||0
10627171|NCT02008227|11785841|FG000|STARTED|Overall Study||612
10627172|NCT02008227|11785842|FG001|STARTED|Overall Study||613
10627173|NCT02008227|11785841|FG000|Treated|Overall Study||579
10627174|NCT02008227|11785842|FG001|Treated|Overall Study||608
10627175|NCT02008227|11785841|FG000|COMPLETED|Overall Study||0
10627176|NCT02008227|11785842|FG001|COMPLETED|Overall Study||0
10627177|NCT02008227|11785841|FG000|NOT COMPLETED|Overall Study||612
10627178|NCT02008227|11785842|FG001|NOT COMPLETED|Overall Study||613
10627179|NCT02008318|11785851|FG000|STARTED|Overall Study||41
10627180|NCT02008318|11785852|FG001|STARTED|Overall Study||2
10627181|NCT02008318|11785851|FG000|Received At Least 1 Dose of Study Drug|Overall Study||41
10627182|NCT02008318|11785852|FG001|Received At Least 1 Dose of Study Drug|Overall Study||2
10627183|NCT02008318|11785851|FG000|COMPLETED|Overall Study||29
10627184|NCT02008318|11785852|FG001|COMPLETED|Overall Study||1
10627185|NCT02008318|11785851|FG000|NOT COMPLETED|Overall Study||12
10627186|NCT02008318|11785852|FG001|NOT COMPLETED|Overall Study||1
10627187|NCT02008526|11785864|FG000|STARTED|Overall Study||94
10627188|NCT02008526|11785865|FG001|STARTED|Overall Study||99
10627189|NCT02008526|11785866|FG002|STARTED|Overall Study||93
10627190|NCT02008526|11785864|FG000|COMPLETED|Overall Study||86
10627191|NCT02008526|11785865|FG001|COMPLETED|Overall Study||85
10627192|NCT02008526|11785866|FG002|COMPLETED|Overall Study||84
10627193|NCT02008526|11785864|FG000|NOT COMPLETED|Overall Study||8
10627194|NCT02008526|11785865|FG001|NOT COMPLETED|Overall Study||14
10627195|NCT02008526|11785866|FG002|NOT COMPLETED|Overall Study||9
10705367|NCT02597855|11869755|FG001|NOT COMPLETED|Overall Study||1
10705368|NCT02597907|11869763|FG000|STARTED|Overall Study||44
10705369|NCT02597907|11869764|FG001|STARTED|Overall Study||44
10627196|NCT02008565|11785878|FG000|STARTED|Overall Study||86
10627197|NCT02008565|11785879|FG001|STARTED|Overall Study||84
10627198|NCT02008565|11785880|FG002|STARTED|Overall Study||88
10627199|NCT02008565|11785881|FG003|STARTED|Overall Study||42
10627200|NCT02008565|11785878|FG000|COMPLETED|Overall Study||85
10627201|NCT02008565|11785879|FG001|COMPLETED|Overall Study||83
10627202|NCT02008565|11785880|FG002|COMPLETED|Overall Study||86
10627203|NCT02008565|11785881|FG003|COMPLETED|Overall Study||42
10627204|NCT02008565|11785878|FG000|NOT COMPLETED|Overall Study||1
10627205|NCT02008565|11785879|FG001|NOT COMPLETED|Overall Study||1
10627206|NCT02008565|11785880|FG002|NOT COMPLETED|Overall Study||2
10627207|NCT02008565|11785881|FG003|NOT COMPLETED|Overall Study||0
10627208|NCT02008617|11785895|FG000|STARTED|Overall Study||8
10627209|NCT02008617|11785896|FG001|STARTED|Overall Study||10
10627210|NCT02008617|11785895|FG000|COMPLETED|Overall Study||8
10627211|NCT02008617|11785896|FG001|COMPLETED|Overall Study||10
10627212|NCT02008617|11785895|FG000|NOT COMPLETED|Overall Study||0
10627213|NCT02008617|11785896|FG001|NOT COMPLETED|Overall Study||0
10627214|NCT02008682|11785904|FG000|STARTED|Overall Study||184
10627215|NCT02008682|11785905|FG001|STARTED|Overall Study||184
10627216|NCT02008682|11785904|FG000|Exposed|Overall Study|1 subject withdrawn before exposure to trial product|183
10627217|NCT02008682|11785905|FG001|Exposed|Overall Study||184
10627218|NCT02008682|11785904|FG000|COMPLETED|Overall Study|Completed without discontinuation of trial product|157
10627219|NCT02008682|11785905|FG001|COMPLETED|Overall Study|Completed without discontinuation of trial product|170
10627220|NCT02008682|11785904|FG000|NOT COMPLETED|Overall Study||27
10627221|NCT02008682|11785905|FG001|NOT COMPLETED|Overall Study||14
10627222|NCT02008773|11785915|FG000|STARTED|Overall Study||40
10627223|NCT02008773|11785916|FG001|STARTED|Overall Study||34
10627224|NCT02008773|11785917|FG002|STARTED|Overall Study||46
10627225|NCT02008773|11785918|FG003|STARTED|Overall Study||50
10627226|NCT02008773|11785915|FG000|COMPLETED|Overall Study||27
10627227|NCT02008773|11785916|FG001|COMPLETED|Overall Study||25
10627228|NCT02008773|11785917|FG002|COMPLETED|Overall Study||32
10627229|NCT02008773|11785918|FG003|COMPLETED|Overall Study||38
10627230|NCT02008773|11785915|FG000|NOT COMPLETED|Overall Study||13
10627231|NCT02008773|11785916|FG001|NOT COMPLETED|Overall Study||9
10627232|NCT02008773|11785917|FG002|NOT COMPLETED|Overall Study||14
10627233|NCT02008773|11785918|FG003|NOT COMPLETED|Overall Study||12
10627234|NCT02008877|11785926|FG000|STARTED|Overall Study||3
10627235|NCT02008877|11785927|FG001|STARTED|Overall Study||7
10627236|NCT02008877|11785928|FG002|STARTED|Overall Study||10
10627237|NCT02008877|11785926|FG000|COMPLETED|Overall Study||3
10627238|NCT02008877|11785927|FG001|COMPLETED|Overall Study||6
10627239|NCT02008877|11785928|FG002|COMPLETED|Overall Study||10
10627240|NCT02008877|11785926|FG000|NOT COMPLETED|Overall Study||0
10627241|NCT02008877|11785927|FG001|NOT COMPLETED|Overall Study||1
10627242|NCT02008877|11785928|FG002|NOT COMPLETED|Overall Study||0
10627243|NCT02008890|11785940|FG000|STARTED|Period 1||80
10627244|NCT02008890|11785941|FG001|STARTED|Period 1||79
10627245|NCT02008890|11785942|FG002|STARTED|Period 1||78
10627246|NCT02008890|11785943|FG003|STARTED|Period 1||0
10627247|NCT02008890|11785944|FG004|STARTED|Period 1||0
10627248|NCT02008890|11785940|FG000|COMPLETED|Period 1||65
10627249|NCT02008890|11785941|FG001|COMPLETED|Period 1||64
10627250|NCT02008890|11785942|FG002|COMPLETED|Period 1||66
10627251|NCT02008890|11785943|FG003|COMPLETED|Period 1||0
10627252|NCT02008890|11785944|FG004|COMPLETED|Period 1||0
10627253|NCT02008890|11785940|FG000|NOT COMPLETED|Period 1||15
10627254|NCT02008890|11785941|FG001|NOT COMPLETED|Period 1||15
10627255|NCT02008890|11785942|FG002|NOT COMPLETED|Period 1||12
10627256|NCT02008890|11785943|FG003|NOT COMPLETED|Period 1||0
10627257|NCT02008890|11785944|FG004|NOT COMPLETED|Period 1||0
10627258|NCT02008890|11785940|FG000|STARTED|Period 2||65
10627259|NCT02008890|11785941|FG001|STARTED|Period 2||64
10627260|NCT02008890|11785942|FG002|STARTED|Period 2||10
10627261|NCT02008890|11785943|FG003|STARTED|Period 2||27
10627262|NCT02008890|11785944|FG004|STARTED|Period 2||28
10627263|NCT02008890|11785940|FG000|COMPLETED|Period 2||38
10627264|NCT02008890|11785941|FG001|COMPLETED|Period 2||49
10627265|NCT02008890|11785942|FG002|COMPLETED|Period 2||9
10627266|NCT02008890|11785943|FG003|COMPLETED|Period 2||13
10627267|NCT02008890|11785944|FG004|COMPLETED|Period 2||20
10627268|NCT02008890|11785940|FG000|NOT COMPLETED|Period 2||27
10627269|NCT02008890|11785941|FG001|NOT COMPLETED|Period 2||15
10627270|NCT02008890|11785942|FG002|NOT COMPLETED|Period 2||1
10627271|NCT02008890|11785943|FG003|NOT COMPLETED|Period 2||14
10627272|NCT02008890|11785944|FG004|NOT COMPLETED|Period 2||8
10627273|NCT02008890|11785940|FG000|STARTED|Extension Period||31
10627274|NCT02008890|11785941|FG001|STARTED|Extension Period||36
10627275|NCT02008890|11785942|FG002|STARTED|Extension Period||0
10627276|NCT02008890|11785943|FG003|STARTED|Extension Period||10
10627277|NCT02008890|11785944|FG004|STARTED|Extension Period||17
10627278|NCT02008890|11785940|FG000|COMPLETED|Extension Period||26
10627279|NCT02008890|11785941|FG001|COMPLETED|Extension Period||31
10627280|NCT02008890|11785942|FG002|COMPLETED|Extension Period||0
10627281|NCT02008890|11785943|FG003|COMPLETED|Extension Period||6
10627282|NCT02008890|11785944|FG004|COMPLETED|Extension Period||13
10627283|NCT02008890|11785940|FG000|NOT COMPLETED|Extension Period||5
10627284|NCT02008890|11785941|FG001|NOT COMPLETED|Extension Period||5
10627285|NCT02008890|11785942|FG002|NOT COMPLETED|Extension Period||0
10627286|NCT02008890|11785943|FG003|NOT COMPLETED|Extension Period||4
10627287|NCT02008890|11785944|FG004|NOT COMPLETED|Extension Period||4
10627288|NCT02008916|11785962|FG000|STARTED|Primary Assessment (up to Week 16)||74
10627289|NCT02008916|11785963|FG001|STARTED|Primary Assessment (up to Week 16)||76
10653594|NCT02195349|11814159|FG009|STARTED|Overall Study||6
10705370|NCT02597907|11869763|FG000|COMPLETED|Overall Study||44
10705371|NCT02597907|11869764|FG001|COMPLETED|Overall Study||44
10705372|NCT02597907|11869763|FG000|NOT COMPLETED|Overall Study||0
10705373|NCT02597907|11869764|FG001|NOT COMPLETED|Overall Study||0
10705374|NCT02597920|11869773|FG000|STARTED|Overall Study|Information about study termination is not available for 1 subject.|585
10705375|NCT02597920|11869774|FG001|STARTED|Overall Study||1159
10705376|NCT02597920|11869775|FG002|STARTED|Overall Study||78
10705377|NCT02597920|11869773|FG000|COMPLETED|Overall Study||544
10705378|NCT02597920|11869774|FG001|COMPLETED|Overall Study||1075
10705379|NCT02597920|11869775|FG002|COMPLETED|Overall Study||72
10705380|NCT02597920|11869773|FG000|NOT COMPLETED|Overall Study||41
10705381|NCT02597920|11869774|FG001|NOT COMPLETED|Overall Study||84
10705382|NCT02597920|11869775|FG002|NOT COMPLETED|Overall Study||6
10705383|NCT02597933|11869787|FG000|STARTED|Overall Study|Started are randomised|290
10705384|NCT02597933|11869788|FG001|STARTED|Overall Study|Started are randomised|290
10705385|NCT02597933|11869787|FG000|Treated Patients|Overall Study||288
10705386|NCT02597933|11869788|FG001|Treated Patients|Overall Study||288
10705387|NCT02597933|11869787|FG000|COMPLETED|Overall Study||252
10705388|NCT02597933|11869788|FG001|COMPLETED|Overall Study||239
10627290|NCT02008916|11785964|FG002|STARTED|Primary Assessment (up to Week 16)||76
10627291|NCT02008916|11785962|FG000|FAS|Primary Assessment (up to Week 16)||74
10627292|NCT02008916|11785963|FG001|FAS|Primary Assessment (up to Week 16)||76
10627293|NCT02008916|11785964|FG002|FAS|Primary Assessment (up to Week 16)||76
10627294|NCT02008916|11785962|FG000|Safety Set|Primary Assessment (up to Week 16)||74
10627295|NCT02008916|11785963|FG001|Safety Set|Primary Assessment (up to Week 16)||76
10627296|NCT02008916|11785964|FG002|Safety Set|Primary Assessment (up to Week 16)||75
10627297|NCT02008916|11785962|FG000|COMPLETED|Primary Assessment (up to Week 16)||74
10627298|NCT02008916|11785963|FG001|COMPLETED|Primary Assessment (up to Week 16)||75
10627299|NCT02008916|11785964|FG002|COMPLETED|Primary Assessment (up to Week 16)||73
10627300|NCT02008916|11785962|FG000|NOT COMPLETED|Primary Assessment (up to Week 16)||0
10627301|NCT02008916|11785963|FG001|NOT COMPLETED|Primary Assessment (up to Week 16)||1
10627302|NCT02008916|11785964|FG002|NOT COMPLETED|Primary Assessment (up to Week 16)||3
10627303|NCT02008916|11785962|FG000|STARTED|Week 16 - 156||74
10627304|NCT02008916|11785963|FG001|STARTED|Week 16 - 156||75
10627305|NCT02008916|11785964|FG002|STARTED|Week 16 - 156||73
10627306|NCT02008916|11785962|FG000|COMPLETED|Week 16 - 156||55
10627307|NCT02008916|11785963|FG001|COMPLETED|Week 16 - 156||62
10627308|NCT02008916|11785964|FG002|COMPLETED|Week 16 - 156||63
10627309|NCT02008916|11785962|FG000|NOT COMPLETED|Week 16 - 156||19
10627310|NCT02008916|11785963|FG001|NOT COMPLETED|Week 16 - 156||13
10627311|NCT02008916|11785964|FG002|NOT COMPLETED|Week 16 - 156||10
10627312|NCT02008942|11785973|FG000|STARTED|First Intervention||27
10627313|NCT02008942|11785974|FG001|STARTED|First Intervention||30
10627314|NCT02008942|11785973|FG000|COMPLETED|First Intervention||27
10627315|NCT02008942|11785974|FG001|COMPLETED|First Intervention||30
10627316|NCT02008942|11785973|FG000|NOT COMPLETED|First Intervention||0
10627317|NCT02008942|11785974|FG001|NOT COMPLETED|First Intervention||0
10627318|NCT02008942|11785973|FG000|STARTED|Second Intervention||26
10627319|NCT02008942|11785974|FG001|STARTED|Second Intervention||30
10627320|NCT02008942|11785973|FG000|COMPLETED|Second Intervention||25
10627321|NCT02008942|11785974|FG001|COMPLETED|Second Intervention||30
10627322|NCT02008942|11785973|FG000|NOT COMPLETED|Second Intervention||1
10627323|NCT02008942|11785974|FG001|NOT COMPLETED|Second Intervention||0
10627324|NCT02009046|11785982|FG000|STARTED|Overall Study||1025
10627325|NCT02009046|11785983|FG001|STARTED|Overall Study||884
10705389|NCT02597933|11869787|FG000|NOT COMPLETED|Overall Study||38
10705390|NCT02597933|11869788|FG001|NOT COMPLETED|Overall Study||51
10627326|NCT02009046|11785982|FG000|SEI Curriculum Only|Overall Study||461
10627327|NCT02009046|11785983|FG001|SEI Curriculum Only|Overall Study||0
10627328|NCT02009046|11785982|FG000|SEI Curriculum + 3 SchoolWide Components|Overall Study||544
10627329|NCT02009046|11785983|FG001|SEI Curriculum + 3 SchoolWide Components|Overall Study||0
10705391|NCT02597946|11869794|FG000|STARTED|Overall Study||18
10627330|NCT02009046|11785982|FG000|Ctrl Curriculum Only|Overall Study||0
10627331|NCT02009046|11785983|FG001|Ctrl Curriculum Only|Overall Study||456
10627332|NCT02009046|11785982|FG000|Ctrl Curriculm +1 SchoolWide Component|Overall Study||0
10627333|NCT02009046|11785983|FG001|Ctrl Curriculm +1 SchoolWide Component|Overall Study||428
10627334|NCT02009046|11785982|FG000|COMPLETED|Overall Study||769
10627335|NCT02009046|11785983|FG001|COMPLETED|Overall Study||678
10627336|NCT02009046|11785982|FG000|NOT COMPLETED|Overall Study||256
10627337|NCT02009046|11785983|FG001|NOT COMPLETED|Overall Study||206
10627338|NCT02009163|11785997|FG000|STARTED|Open-label Period (Non-randomized)||418
10627339|NCT02009163|11785998|FG001|STARTED|Open-label Period (Non-randomized)||0
10627340|NCT02009163|11785999|FG002|STARTED|Open-label Period (Non-randomized)||0
10627341|NCT02009163|11785997|FG000|COMPLETED|Open-label Period (Non-randomized)||275
10627342|NCT02009163|11785998|FG001|COMPLETED|Open-label Period (Non-randomized)||0
10627343|NCT02009163|11785999|FG002|COMPLETED|Open-label Period (Non-randomized)||0
10627344|NCT02009163|11785997|FG000|NOT COMPLETED|Open-label Period (Non-randomized)||143
10627345|NCT02009163|11785998|FG001|NOT COMPLETED|Open-label Period (Non-randomized)||0
10627346|NCT02009163|11785999|FG002|NOT COMPLETED|Open-label Period (Non-randomized)||0
10627347|NCT02009163|11785997|FG000|STARTED|Randomized-withdrawal Period|The open-label treatment group is not an arm of the randomized-withdrawal period.|0
10627348|NCT02009163|11785998|FG001|STARTED|Randomized-withdrawal Period|The total who started the Placebo and SPD489 arms equals those who completed the open-label period.|138
10627349|NCT02009163|11785999|FG002|STARTED|Randomized-withdrawal Period|The total who started the Placebo and SPD489 arms equals those who completed the open-label period.|137
10627350|NCT02009163|11785997|FG000|COMPLETED|Randomized-withdrawal Period||0
10627351|NCT02009163|11785998|FG001|COMPLETED|Randomized-withdrawal Period||50
10627352|NCT02009163|11785999|FG002|COMPLETED|Randomized-withdrawal Period||102
10627353|NCT02009163|11785997|FG000|NOT COMPLETED|Randomized-withdrawal Period||0
10627354|NCT02009163|11785998|FG001|NOT COMPLETED|Randomized-withdrawal Period||88
10627355|NCT02009163|11785999|FG002|NOT COMPLETED|Randomized-withdrawal Period||35
10627356|NCT02009332|11786015|FG000|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||3
10627357|NCT02009332|11786016|FG001|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0
10627358|NCT02009332|11786017|FG002|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0
10627359|NCT02009332|11786018|FG003|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0
10627360|NCT02009332|11786019|FG004|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0
10627361|NCT02009332|11786020|FG005|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0
10627362|NCT02009332|11786015|FG000|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)|Cohort 1 completed 6-week treatment.|3
10627363|NCT02009332|11786016|FG001|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
10627364|NCT02009332|11786017|FG002|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
10627365|NCT02009332|11786018|FG003|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
10627366|NCT02009332|11786019|FG004|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
10627367|NCT02009332|11786020|FG005|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
10627368|NCT02009332|11786015|FG000|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
10627369|NCT02009332|11786016|FG001|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
10627370|NCT02009332|11786017|FG002|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
10627371|NCT02009332|11786018|FG003|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
10627372|NCT02009332|11786019|FG004|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
10627373|NCT02009332|11786020|FG005|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
10627374|NCT02009332|11786015|FG000|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
10627375|NCT02009332|11786016|FG001|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||4
10627376|NCT02009332|11786017|FG002|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||1
10627377|NCT02009332|11786018|FG003|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
10627378|NCT02009332|11786019|FG004|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
10627379|NCT02009332|11786020|FG005|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
10627380|NCT02009332|11786015|FG000|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
10627381|NCT02009332|11786016|FG001|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)|Cohort 2 completed 6-week treatment.|3
10627382|NCT02009332|11786017|FG002|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)|Cohort 2b stopped due to lack of enrollment.|1
10627383|NCT02009332|11786018|FG003|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
10627384|NCT02009332|11786019|FG004|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
10627385|NCT02009332|11786020|FG005|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
10627386|NCT02009332|11786015|FG000|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
10627387|NCT02009332|11786016|FG001|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||1
10627388|NCT02009332|11786017|FG002|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
10627389|NCT02009332|11786018|FG003|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
10627390|NCT02009332|11786019|FG004|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
10627391|NCT02009332|11786020|FG005|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
10627392|NCT02009332|11786015|FG000|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0
10627393|NCT02009332|11786016|FG001|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0
10627394|NCT02009332|11786017|FG002|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0
10627395|NCT02009332|11786018|FG003|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||3
10627396|NCT02009332|11786019|FG004|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0
10627397|NCT02009332|11786020|FG005|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0
10627398|NCT02009332|11786015|FG000|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
10627399|NCT02009332|11786016|FG001|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
10627400|NCT02009332|11786017|FG002|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
10627401|NCT02009332|11786018|FG003|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)|Cohort 3 completed 6-week treatment.|3
10627402|NCT02009332|11786019|FG004|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
10627403|NCT02009332|11786020|FG005|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
10627404|NCT02009332|11786015|FG000|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
10627405|NCT02009332|11786016|FG001|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
10627406|NCT02009332|11786017|FG002|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
10627407|NCT02009332|11786018|FG003|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
10627408|NCT02009332|11786019|FG004|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
10627409|NCT02009332|11786020|FG005|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
10627410|NCT02009332|11786015|FG000|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0
10627411|NCT02009332|11786016|FG001|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0
10627412|NCT02009332|11786017|FG002|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0
10627413|NCT02009332|11786018|FG003|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0
10627414|NCT02009332|11786019|FG004|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||4
10627415|NCT02009332|11786020|FG005|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0
10627416|NCT02009332|11786015|FG000|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
10627417|NCT02009332|11786016|FG001|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
10627418|NCT02009332|11786017|FG002|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
10627419|NCT02009332|11786018|FG003|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
10627420|NCT02009332|11786019|FG004|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)|Cohort 4 completed 6-week treatment.|3
10627421|NCT02009332|11786020|FG005|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
10627422|NCT02009332|11786015|FG000|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
10627423|NCT02009332|11786016|FG001|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
10627424|NCT02009332|11786017|FG002|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
10627425|NCT02009332|11786018|FG003|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
10627426|NCT02009332|11786019|FG004|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||1
10627427|NCT02009332|11786020|FG005|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
10627428|NCT02009332|11786015|FG000|STARTED|Phase 2 (Weeks 206-252)||0
10627429|NCT02009332|11786016|FG001|STARTED|Phase 2 (Weeks 206-252)||0
10627430|NCT02009332|11786017|FG002|STARTED|Phase 2 (Weeks 206-252)||0
10627431|NCT02009332|11786018|FG003|STARTED|Phase 2 (Weeks 206-252)||0
10627432|NCT02009332|11786019|FG004|STARTED|Phase 2 (Weeks 206-252)||0
10627433|NCT02009332|11786020|FG005|STARTED|Phase 2 (Weeks 206-252)||6
10627434|NCT02009332|11786015|FG000|COMPLETED|Phase 2 (Weeks 206-252)||0
10627435|NCT02009332|11786016|FG001|COMPLETED|Phase 2 (Weeks 206-252)||0
10627436|NCT02009332|11786017|FG002|COMPLETED|Phase 2 (Weeks 206-252)||0
10627437|NCT02009332|11786018|FG003|COMPLETED|Phase 2 (Weeks 206-252)||0
10627438|NCT02009332|11786019|FG004|COMPLETED|Phase 2 (Weeks 206-252)||0
10627439|NCT02009332|11786020|FG005|COMPLETED|Phase 2 (Weeks 206-252)|Phase 2 stopped due to lack of efficacy.|5
10627440|NCT02009332|11786015|FG000|NOT COMPLETED|Phase 2 (Weeks 206-252)||0
10627441|NCT02009332|11786016|FG001|NOT COMPLETED|Phase 2 (Weeks 206-252)||0
10627442|NCT02009332|11786017|FG002|NOT COMPLETED|Phase 2 (Weeks 206-252)||0
10627443|NCT02009332|11786018|FG003|NOT COMPLETED|Phase 2 (Weeks 206-252)||0
10627444|NCT02009332|11786019|FG004|NOT COMPLETED|Phase 2 (Weeks 206-252)||0
10627445|NCT02009332|11786020|FG005|NOT COMPLETED|Phase 2 (Weeks 206-252)||1
10627446|NCT02009397|11786034|FG000|STARTED|Overall Study||26
10627447|NCT02009397|11786034|FG000|COMPLETED|Overall Study||6
10627448|NCT02009397|11786034|FG000|NOT COMPLETED|Overall Study||20
10627449|NCT02009501|11786040|FG000|STARTED|Overall Study||9
10627450|NCT02009501|11786041|FG001|STARTED|Overall Study||11
10627451|NCT02009501|11786040|FG000|COMPLETED|Overall Study||9
10627452|NCT02009501|11786041|FG001|COMPLETED|Overall Study||11
10627453|NCT02009501|11786040|FG000|NOT COMPLETED|Overall Study||0
10627454|NCT02009501|11786041|FG001|NOT COMPLETED|Overall Study||0
10627455|NCT02009696|11786047|FG000|STARTED|Overall Study||221
10627456|NCT02009696|11786047|FG000|COMPLETED|Overall Study||219
10705392|NCT02597946|11869794|FG000|COMPLETED|Overall Study||0
10705393|NCT02597946|11869794|FG000|NOT COMPLETED|Overall Study||18
10705394|NCT02598076|11869800|FG000|STARTED|Overall Study||31
10705395|NCT02598076|11869801|FG001|STARTED|Overall Study||29
10627457|NCT02009696|11786047|FG000|NOT COMPLETED|Overall Study||2
10627458|NCT02009722|11786053|FG000|STARTED|Overall Study||41
10627459|NCT02009722|11786054|FG001|STARTED|Overall Study||43
10627460|NCT02009722|11786053|FG000|Received Intervention|Overall Study||41
10627461|NCT02009722|11786054|FG001|Received Intervention|Overall Study||42
10627462|NCT02009722|11786053|FG000|COMPLETED|Overall Study||40
10627463|NCT02009722|11786054|FG001|COMPLETED|Overall Study||40
10627464|NCT02009722|11786053|FG000|NOT COMPLETED|Overall Study||1
10627465|NCT02009722|11786054|FG001|NOT COMPLETED|Overall Study||3
10627466|NCT02009865|11786062|FG000|STARTED|Overall Study||81
10627467|NCT02009865|11786063|FG001|STARTED|Overall Study||81
10627468|NCT02009865|11786062|FG000|COMPLETED|Overall Study||80
10627469|NCT02009865|11786063|FG001|COMPLETED|Overall Study||76
10627470|NCT02009865|11786062|FG000|NOT COMPLETED|Overall Study||1
10627471|NCT02009865|11786063|FG001|NOT COMPLETED|Overall Study||5
10627472|NCT02009878|11786072|FG000|STARTED|Overall Study||10
10627473|NCT02009878|11786073|FG001|STARTED|Overall Study||11
10627474|NCT02009878|11786074|FG002|STARTED|Overall Study||9
10627475|NCT02009878|11786072|FG000|COMPLETED|Overall Study||10
10627476|NCT02009878|11786073|FG001|COMPLETED|Overall Study||10
10627477|NCT02009878|11786074|FG002|COMPLETED|Overall Study||9
10627478|NCT02009878|11786072|FG000|NOT COMPLETED|Overall Study||0
10627479|NCT02009878|11786073|FG001|NOT COMPLETED|Overall Study||1
10627480|NCT02009878|11786074|FG002|NOT COMPLETED|Overall Study||0
10627481|NCT02009930|11786082|FG000|STARTED|Overall Study|5 withdrawn|112
10627482|NCT02009930|11786082|FG000|COMPLETED|Overall Study||107
10627483|NCT02009930|11786082|FG000|NOT COMPLETED|Overall Study||5
10627484|NCT02010021|11786095|FG000|STARTED|Overall Study||10
10627485|NCT02010021|11786096|FG001|STARTED|Overall Study||7
10627486|NCT02010021|11786095|FG000|COMPLETED|Overall Study||10
10627487|NCT02010021|11786096|FG001|COMPLETED|Overall Study||7
10705396|NCT02598076|11869800|FG000|COMPLETED|Overall Study||29
10705397|NCT02598076|11869801|FG001|COMPLETED|Overall Study||26
10705398|NCT02598076|11869800|FG000|NOT COMPLETED|Overall Study||2
10705399|NCT02598076|11869801|FG001|NOT COMPLETED|Overall Study||3
10627488|NCT02010021|11786095|FG000|NOT COMPLETED|Overall Study||0
10627489|NCT02010021|11786096|FG001|NOT COMPLETED|Overall Study||0
10627490|NCT02010151|11786104|FG000|STARTED|Overall Study|January 2013 to December 2017|1498
10627491|NCT02010151|11786105|FG001|STARTED|Overall Study|January 2013 to December 2017|1696
10627492|NCT02010151|11786104|FG000|COMPLETED|Overall Study|Text message (TM) sent: 0|1498
10705400|NCT02598089|11869809|FG000|STARTED|Overall Study||30
10705401|NCT02598089|11869810|FG001|STARTED|Overall Study||30
10627493|NCT02010151|11786105|FG001|COMPLETED|Overall Study|TM sent: 598|1696
10627494|NCT02010151|11786104|FG000|NOT COMPLETED|Overall Study||0
10627495|NCT02010151|11786105|FG001|NOT COMPLETED|Overall Study||0
10627496|NCT02010203|11786116|FG000|STARTED|Overall Study||10
10627497|NCT02010203|11786117|FG001|STARTED|Overall Study||26
10627498|NCT02010203|11786118|FG002|STARTED|Overall Study||26
10627499|NCT02010203|11786119|FG003|STARTED|Overall Study||26
10627500|NCT02010203|11786120|FG004|STARTED|Overall Study||16
10627501|NCT02010203|11786116|FG000|COMPLETED|Overall Study||10
10627502|NCT02010203|11786117|FG001|COMPLETED|Overall Study||17
10627503|NCT02010203|11786118|FG002|COMPLETED|Overall Study||16
10627504|NCT02010203|11786119|FG003|COMPLETED|Overall Study||23
10627505|NCT02010203|11786120|FG004|COMPLETED|Overall Study||3
10627506|NCT02010203|11786116|FG000|NOT COMPLETED|Overall Study||0
10627507|NCT02010203|11786117|FG001|NOT COMPLETED|Overall Study||9
10627508|NCT02010203|11786118|FG002|NOT COMPLETED|Overall Study||10
10627509|NCT02010203|11786119|FG003|NOT COMPLETED|Overall Study||3
10627510|NCT02010203|11786120|FG004|NOT COMPLETED|Overall Study||13
10627511|NCT02010216|11786132|FG000|STARTED|Overall Study||23
10627512|NCT02010216|11786132|FG000|COMPLETED|Overall Study||23
10627513|NCT02010216|11786132|FG000|NOT COMPLETED|Overall Study||0
10627514|NCT02010255|11786150|FG000|STARTED|Overall Study||28
10627515|NCT02010255|11786151|FG001|STARTED|Overall Study||28
10627516|NCT02010255|11786152|FG002|STARTED|Overall Study||25
10627517|NCT02010255|11786153|FG003|STARTED|Overall Study||26
10627518|NCT02010255|11786154|FG004|STARTED|Overall Study||52
10627519|NCT02010255|11786155|FG005|STARTED|Overall Study||49
10627520|NCT02010255|11786156|FG006|STARTED|Overall Study||34
10627521|NCT02010255|11786157|FG007|STARTED|Overall Study||33
10627522|NCT02010255|11786158|FG008|STARTED|Overall Study||22
10627523|NCT02010255|11786159|FG009|STARTED|Overall Study||23
10627524|NCT02010255|11786160|FG010|STARTED|Overall Study||3
10627525|NCT02010255|11786161|FG011|STARTED|Overall Study||5
10627526|NCT02010255|11786162|FG012|STARTED|Overall Study||3
10627527|NCT02010255|11786163|FG013|STARTED|Overall Study||3
10627528|NCT02010255|11786150|FG000|COMPLETED|Overall Study||22
10627529|NCT02010255|11786151|FG001|COMPLETED|Overall Study||26
10627530|NCT02010255|11786152|FG002|COMPLETED|Overall Study||18
10627531|NCT02010255|11786153|FG003|COMPLETED|Overall Study||20
10627532|NCT02010255|11786154|FG004|COMPLETED|Overall Study||48
10627533|NCT02010255|11786155|FG005|COMPLETED|Overall Study||49
10627534|NCT02010255|11786156|FG006|COMPLETED|Overall Study||33
10627535|NCT02010255|11786157|FG007|COMPLETED|Overall Study||32
10627536|NCT02010255|11786158|FG008|COMPLETED|Overall Study||21
10627537|NCT02010255|11786159|FG009|COMPLETED|Overall Study||23
10627538|NCT02010255|11786160|FG010|COMPLETED|Overall Study||1
10627539|NCT02010255|11786161|FG011|COMPLETED|Overall Study||4
10627540|NCT02010255|11786162|FG012|COMPLETED|Overall Study||3
10627541|NCT02010255|11786163|FG013|COMPLETED|Overall Study||2
10627542|NCT02010255|11786150|FG000|NOT COMPLETED|Overall Study||6
10627543|NCT02010255|11786151|FG001|NOT COMPLETED|Overall Study||2
10627544|NCT02010255|11786152|FG002|NOT COMPLETED|Overall Study||7
10627545|NCT02010255|11786153|FG003|NOT COMPLETED|Overall Study||6
10627546|NCT02010255|11786154|FG004|NOT COMPLETED|Overall Study||4
10627547|NCT02010255|11786155|FG005|NOT COMPLETED|Overall Study||0
10627548|NCT02010255|11786156|FG006|NOT COMPLETED|Overall Study||1
10627549|NCT02010255|11786157|FG007|NOT COMPLETED|Overall Study||1
10627550|NCT02010255|11786158|FG008|NOT COMPLETED|Overall Study||1
10627551|NCT02010255|11786159|FG009|NOT COMPLETED|Overall Study||0
10627552|NCT02010255|11786160|FG010|NOT COMPLETED|Overall Study||2
10627553|NCT02010255|11786161|FG011|NOT COMPLETED|Overall Study||1
10705402|NCT02598089|11869809|FG000|COMPLETED|Overall Study||30
10705403|NCT02598089|11869810|FG001|COMPLETED|Overall Study||30
10705404|NCT02598089|11869809|FG000|NOT COMPLETED|Overall Study||0
10705405|NCT02598089|11869810|FG001|NOT COMPLETED|Overall Study||0
10809114|NCT03836677|11970992|FG000|NOT COMPLETED|Period 1||0
10627554|NCT02010255|11786162|FG012|NOT COMPLETED|Overall Study||0
10627555|NCT02010255|11786163|FG013|NOT COMPLETED|Overall Study||1
10627556|NCT02010359|11786220|FG000|STARTED|Overall Study||15
10627557|NCT02010359|11786221|FG001|STARTED|Overall Study||14
10627558|NCT02010359|11786220|FG000|COMPLETED|Overall Study||13
10627559|NCT02010359|11786221|FG001|COMPLETED|Overall Study||12
10627560|NCT02010359|11786220|FG000|NOT COMPLETED|Overall Study||2
10627561|NCT02010359|11786221|FG001|NOT COMPLETED|Overall Study||2
10627562|NCT02010567|11786232|FG000|STARTED|Overall Study||3
10627563|NCT02010567|11786233|FG001|STARTED|Overall Study||6
10627564|NCT02010567|11786234|FG002|STARTED|Overall Study||14
10627565|NCT02010567|11786235|FG003|STARTED|Overall Study||3
10627566|NCT02010567|11786236|FG004|STARTED|Overall Study||6
10627567|NCT02010567|11786232|FG000|COMPLETED|Overall Study||3
10627568|NCT02010567|11786233|FG001|COMPLETED|Overall Study||6
10705406|NCT02598128|11869823|FG000|STARTED|Period A: Days -7 to -1||34
10627569|NCT02010567|11786234|FG002|COMPLETED|Overall Study||13
10627570|NCT02010567|11786235|FG003|COMPLETED|Overall Study||3
10627571|NCT02010567|11786236|FG004|COMPLETED|Overall Study||5
10627572|NCT02010567|11786232|FG000|NOT COMPLETED|Overall Study||0
10705407|NCT02598128|11869824|FG001|STARTED|Period A: Days -7 to -1||0
10627573|NCT02010567|11786233|FG001|NOT COMPLETED|Overall Study||0
10627574|NCT02010567|11786234|FG002|NOT COMPLETED|Overall Study||1
10627575|NCT02010567|11786235|FG003|NOT COMPLETED|Overall Study||0
10627576|NCT02010567|11786236|FG004|NOT COMPLETED|Overall Study||1
10705408|NCT02598128|11869825|FG002|STARTED|Period A: Days -7 to -1||0
10809115|NCT03836677|11970993|FG001|NOT COMPLETED|Period 1||1
10627577|NCT02010632|11786246|FG000|STARTED|First Intervention (7 Days)||16
10627578|NCT02010632|11786247|FG001|STARTED|First Intervention (7 Days)||16
10627579|NCT02010632|11786246|FG000|COMPLETED|First Intervention (7 Days)||16
10627580|NCT02010632|11786247|FG001|COMPLETED|First Intervention (7 Days)||16
10627581|NCT02010632|11786246|FG000|NOT COMPLETED|First Intervention (7 Days)||0
10627582|NCT02010632|11786247|FG001|NOT COMPLETED|First Intervention (7 Days)||0
10627583|NCT02010632|11786246|FG000|STARTED|Wash Out Period (14 Days)||16
10627584|NCT02010632|11786247|FG001|STARTED|Wash Out Period (14 Days)||16
10627585|NCT02010632|11786246|FG000|COMPLETED|Wash Out Period (14 Days)||16
10627586|NCT02010632|11786247|FG001|COMPLETED|Wash Out Period (14 Days)||16
10627587|NCT02010632|11786246|FG000|NOT COMPLETED|Wash Out Period (14 Days)||0
10627588|NCT02010632|11786247|FG001|NOT COMPLETED|Wash Out Period (14 Days)||0
10627589|NCT02010632|11786246|FG000|STARTED|Second Intervention (7 Days)||16
10627590|NCT02010632|11786247|FG001|STARTED|Second Intervention (7 Days)||16
10627591|NCT02010632|11786246|FG000|COMPLETED|Second Intervention (7 Days)||15
10627592|NCT02010632|11786247|FG001|COMPLETED|Second Intervention (7 Days)||16
10627593|NCT02010632|11786246|FG000|NOT COMPLETED|Second Intervention (7 Days)||1
10627594|NCT02010632|11786247|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
10627595|NCT02010645|11786253|FG000|STARTED|Overall Study||6
10627596|NCT02010645|11786253|FG000|COMPLETED|Overall Study||6
10627597|NCT02010645|11786253|FG000|NOT COMPLETED|Overall Study||0
10627598|NCT02010684|11786259|FG000|STARTED|Overall Study||39
10627599|NCT02010684|11786260|FG001|STARTED|Overall Study||82
10627600|NCT02010684|11786259|FG000|COMPLETED|Overall Study||27
10627601|NCT02010684|11786260|FG001|COMPLETED|Overall Study||59
10627602|NCT02010684|11786259|FG000|NOT COMPLETED|Overall Study||12
10627603|NCT02010684|11786260|FG001|NOT COMPLETED|Overall Study||23
10627604|NCT02010697|11786269|FG000|STARTED|Overall Study||1044
10627605|NCT02010697|11786270|FG001|STARTED|Overall Study||1038
10627606|NCT02010697|11786271|FG002|STARTED|Overall Study||1043
10627607|NCT02010697|11786269|FG000|COMPLETED|Overall Study||1044
10627608|NCT02010697|11786270|FG001|COMPLETED|Overall Study||1038
10627609|NCT02010697|11786271|FG002|COMPLETED|Overall Study||1043
10627610|NCT02010697|11786269|FG000|NOT COMPLETED|Overall Study||0
10627611|NCT02010697|11786270|FG001|NOT COMPLETED|Overall Study||0
10627612|NCT02010697|11786271|FG002|NOT COMPLETED|Overall Study||0
10627613|NCT02010775|11786284|FG000|STARTED|Overall Study||38
10627614|NCT02010775|11786285|FG001|STARTED|Overall Study||38
10627615|NCT02010775|11786286|FG002|STARTED|Overall Study||37
10627616|NCT02010775|11786287|FG003|STARTED|Overall Study||37
10627617|NCT02010775|11786288|FG004|STARTED|Overall Study||37
10627618|NCT02010775|11786284|FG000|COMPLETED|Overall Study||33
10627619|NCT02010775|11786285|FG001|COMPLETED|Overall Study||35
10627620|NCT02010775|11786286|FG002|COMPLETED|Overall Study||34
10627621|NCT02010775|11786287|FG003|COMPLETED|Overall Study||34
10627622|NCT02010775|11786288|FG004|COMPLETED|Overall Study||31
10627623|NCT02010775|11786284|FG000|NOT COMPLETED|Overall Study||5
10627624|NCT02010775|11786285|FG001|NOT COMPLETED|Overall Study||3
10627625|NCT02010775|11786286|FG002|NOT COMPLETED|Overall Study||3
10627626|NCT02010775|11786287|FG003|NOT COMPLETED|Overall Study||3
10627627|NCT02010775|11786288|FG004|NOT COMPLETED|Overall Study||6
10627628|NCT02010996|11786302|FG000|STARTED|Overall Study||36
10627629|NCT02010996|11786303|FG001|STARTED|Overall Study||36
10627630|NCT02010996|11786302|FG000|COMPLETED|Overall Study||36
10627631|NCT02010996|11786303|FG001|COMPLETED|Overall Study||36
10627632|NCT02010996|11786302|FG000|NOT COMPLETED|Overall Study||0
10627633|NCT02010996|11786303|FG001|NOT COMPLETED|Overall Study||0
10627634|NCT02011113|11786313|FG000|STARTED|Overall Study||36
10627635|NCT02011113|11786313|FG000|COMPLETED|Overall Study|Completed = participants with progressive disease were considered as completed.|0
10627636|NCT02011113|11786313|FG000|NOT COMPLETED|Overall Study||36
10627637|NCT02011386|11786318|FG000|STARTED|Overall Study||53
10627638|NCT02011386|11786318|FG000|COMPLETED|Overall Study||48
10627639|NCT02011386|11786318|FG000|NOT COMPLETED|Overall Study||5
10627640|NCT02011464|11786324|FG000|STARTED|Overall Study||10
10627641|NCT02011464|11786325|FG001|STARTED|Overall Study||10
10627642|NCT02011464|11786324|FG000|COMPLETED|Overall Study||10
10627643|NCT02011464|11786325|FG001|COMPLETED|Overall Study||10
10627644|NCT02011464|11786324|FG000|NOT COMPLETED|Overall Study||0
10627645|NCT02011464|11786325|FG001|NOT COMPLETED|Overall Study||0
10627646|NCT02011490|11786346|FG000|STARTED|Part 1||8
10627647|NCT02011490|11786347|FG001|STARTED|Part 1||8
10627648|NCT02011490|11786348|FG002|STARTED|Part 1||8
10627649|NCT02011490|11786349|FG003|STARTED|Part 1||0
10627650|NCT02011490|11786350|FG004|STARTED|Part 1||0
10627651|NCT02011490|11786351|FG005|STARTED|Part 1||0
10627652|NCT02011490|11786346|FG000|COMPLETED|Part 1||8
10627653|NCT02011490|11786347|FG001|COMPLETED|Part 1||8
10627654|NCT02011490|11786348|FG002|COMPLETED|Part 1||8
10627655|NCT02011490|11786349|FG003|COMPLETED|Part 1||0
10627656|NCT02011490|11786350|FG004|COMPLETED|Part 1||0
10627657|NCT02011490|11786351|FG005|COMPLETED|Part 1||0
10627658|NCT02011490|11786346|FG000|NOT COMPLETED|Part 1||0
10627659|NCT02011490|11786347|FG001|NOT COMPLETED|Part 1||0
10627660|NCT02011490|11786348|FG002|NOT COMPLETED|Part 1||0
10627661|NCT02011490|11786349|FG003|NOT COMPLETED|Part 1||0
10627662|NCT02011490|11786350|FG004|NOT COMPLETED|Part 1||0
10627663|NCT02011490|11786351|FG005|NOT COMPLETED|Part 1||0
10627664|NCT02011490|11786346|FG000|STARTED|Part 2||0
10627665|NCT02011490|11786347|FG001|STARTED|Part 2||0
10627666|NCT02011490|11786348|FG002|STARTED|Part 2||0
10627667|NCT02011490|11786349|FG003|STARTED|Part 2|4 had also participated in Part 1 (all in severe group)|6
10627668|NCT02011490|11786350|FG004|STARTED|Part 2|3 had also participated in Part 1 (2 in moderate, 1 in severe groups)|6
10627669|NCT02011490|11786351|FG005|STARTED|Part 2|2 had also participated in Part 1 (both in healthy group)|6
10627670|NCT02011490|11786346|FG000|COMPLETED|Part 2||0
10627671|NCT02011490|11786347|FG001|COMPLETED|Part 2||0
10627672|NCT02011490|11786348|FG002|COMPLETED|Part 2||0
10627673|NCT02011490|11786349|FG003|COMPLETED|Part 2||6
10627674|NCT02011490|11786350|FG004|COMPLETED|Part 2||6
10627675|NCT02011490|11786351|FG005|COMPLETED|Part 2||6
10627676|NCT02011490|11786346|FG000|NOT COMPLETED|Part 2||0
10627677|NCT02011490|11786347|FG001|NOT COMPLETED|Part 2||0
10627678|NCT02011490|11786348|FG002|NOT COMPLETED|Part 2||0
10627679|NCT02011490|11786349|FG003|NOT COMPLETED|Part 2||0
10627680|NCT02011490|11786350|FG004|NOT COMPLETED|Part 2||0
10627681|NCT02011490|11786351|FG005|NOT COMPLETED|Part 2||0
10627682|NCT02011516|11786367|FG000|STARTED|Overall Study||8
10627683|NCT02011516|11786368|FG001|STARTED|Overall Study||8
10627684|NCT02011516|11786367|FG000|COMPLETED|Overall Study||4
10627685|NCT02011516|11786368|FG001|COMPLETED|Overall Study||6
10627686|NCT02011516|11786367|FG000|NOT COMPLETED|Overall Study||4
10627687|NCT02011516|11786368|FG001|NOT COMPLETED|Overall Study||2
10627688|NCT02011893|11786374|FG000|STARTED|Enrollment to Randomization||173
10627689|NCT02011893|11786375|FG001|STARTED|Enrollment to Randomization||0
10627690|NCT02011893|11786376|FG002|STARTED|Enrollment to Randomization||0
10627691|NCT02011893|11786374|FG000|Baseline|Enrollment to Randomization||141
10627692|NCT02011893|11786375|FG001|Baseline|Enrollment to Randomization||0
10627693|NCT02011893|11786376|FG002|Baseline|Enrollment to Randomization||0
10627694|NCT02011893|11786374|FG000|Trial Stimulation Implant|Enrollment to Randomization||121
10627695|NCT02011893|11786375|FG001|Trial Stimulation Implant|Enrollment to Randomization||0
10627696|NCT02011893|11786376|FG002|Trial Stimulation Implant|Enrollment to Randomization||0
10627697|NCT02011893|11786374|FG000|Permanent Stimulation Implant|Enrollment to Randomization||101
10627698|NCT02011893|11786375|FG001|Permanent Stimulation Implant|Enrollment to Randomization||0
10627699|NCT02011893|11786376|FG002|Permanent Stimulation Implant|Enrollment to Randomization||0
10627700|NCT02011893|11786374|FG000|Randomization|Enrollment to Randomization||100
10627701|NCT02011893|11786375|FG001|Randomization|Enrollment to Randomization||0
10627702|NCT02011893|11786376|FG002|Randomization|Enrollment to Randomization||0
10627703|NCT02011893|11786374|FG000|COMPLETED|Enrollment to Randomization||100
10627704|NCT02011893|11786375|FG001|COMPLETED|Enrollment to Randomization||0
10627705|NCT02011893|11786376|FG002|COMPLETED|Enrollment to Randomization||0
10627706|NCT02011893|11786374|FG000|NOT COMPLETED|Enrollment to Randomization||73
10627707|NCT02011893|11786375|FG001|NOT COMPLETED|Enrollment to Randomization||0
10627708|NCT02011893|11786376|FG002|NOT COMPLETED|Enrollment to Randomization||0
10627709|NCT02011893|11786374|FG000|STARTED|Period 1 (Randomization to 12 Weeks)||0
10627710|NCT02011893|11786375|FG001|STARTED|Period 1 (Randomization to 12 Weeks)||45
10627711|NCT02011893|11786376|FG002|STARTED|Period 1 (Randomization to 12 Weeks)||55
10627712|NCT02011893|11786374|FG000|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||0
10627713|NCT02011893|11786375|FG001|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||45
10627714|NCT02011893|11786376|FG002|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||52
10627715|NCT02011893|11786374|FG000|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||0
10627716|NCT02011893|11786375|FG001|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||45
10627717|NCT02011893|11786376|FG002|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||52
10627718|NCT02011893|11786374|FG000|COMPLETED|Period 1 (Randomization to 12 Weeks)||0
10627719|NCT02011893|11786375|FG001|COMPLETED|Period 1 (Randomization to 12 Weeks)||45
10627720|NCT02011893|11786376|FG002|COMPLETED|Period 1 (Randomization to 12 Weeks)||52
10627721|NCT02011893|11786374|FG000|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||0
10627722|NCT02011893|11786375|FG001|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||0
10627723|NCT02011893|11786376|FG002|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||3
10627724|NCT02011893|11786374|FG000|STARTED|Period 2 (12 Weeks to 24 Weeks)||0
10627725|NCT02011893|11786375|FG001|STARTED|Period 2 (12 Weeks to 24 Weeks)||45
10627726|NCT02011893|11786376|FG002|STARTED|Period 2 (12 Weeks to 24 Weeks)||52
10627727|NCT02011893|11786374|FG000|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||0
10627728|NCT02011893|11786375|FG001|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||44
10627729|NCT02011893|11786376|FG002|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||51
10627730|NCT02011893|11786374|FG000|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||0
10627731|NCT02011893|11786375|FG001|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||45
10627732|NCT02011893|11786376|FG002|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||51
10627733|NCT02011893|11786374|FG000|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
10627734|NCT02011893|11786375|FG001|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||45
10627735|NCT02011893|11786376|FG002|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||51
10627736|NCT02011893|11786374|FG000|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
10627737|NCT02011893|11786375|FG001|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
10627738|NCT02011893|11786376|FG002|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||1
10627739|NCT02011945|11786384|FG000|STARTED|Overall Study||2
10627740|NCT02011945|11786385|FG001|STARTED|Overall Study||13
10627741|NCT02011945|11786386|FG002|STARTED|Overall Study||16
10627742|NCT02011945|11786384|FG000|COMPLETED|Overall Study||0
10627743|NCT02011945|11786385|FG001|COMPLETED|Overall Study||3
10627744|NCT02011945|11786386|FG002|COMPLETED|Overall Study||6
10627745|NCT02011945|11786384|FG000|NOT COMPLETED|Overall Study||2
10627746|NCT02011945|11786385|FG001|NOT COMPLETED|Overall Study||10
10627747|NCT02011945|11786386|FG002|NOT COMPLETED|Overall Study||10
10627748|NCT02012192|11786396|FG000|STARTED|Overall Study||90
10627749|NCT02012192|11786397|FG001|STARTED|Overall Study||43
10627750|NCT02012192|11786396|FG000|COMPLETED|Overall Study||63
10627751|NCT02012192|11786397|FG001|COMPLETED|Overall Study||43
10627752|NCT02012192|11786396|FG000|NOT COMPLETED|Overall Study||27
10627753|NCT02012192|11786397|FG001|NOT COMPLETED|Overall Study||0
10627754|NCT02012218|11786408|FG000|STARTED|Overall Study||12
10627755|NCT02012218|11786409|FG001|STARTED|Overall Study||11
10627756|NCT02012218|11786410|FG002|STARTED|Overall Study||13
10627757|NCT02012218|11786411|FG003|STARTED|Overall Study||19
10627758|NCT02012218|11786412|FG004|STARTED|Overall Study||6
10627759|NCT02012218|11786408|FG000|COMPLETED|Overall Study||8
10627760|NCT02012218|11786409|FG001|COMPLETED|Overall Study||10
10627761|NCT02012218|11786410|FG002|COMPLETED|Overall Study||11
10627762|NCT02012218|11786411|FG003|COMPLETED|Overall Study||17
10627763|NCT02012218|11786412|FG004|COMPLETED|Overall Study||5
10627764|NCT02012218|11786408|FG000|NOT COMPLETED|Overall Study||4
10627765|NCT02012218|11786409|FG001|NOT COMPLETED|Overall Study||1
10627766|NCT02012218|11786410|FG002|NOT COMPLETED|Overall Study||2
10627767|NCT02012218|11786411|FG003|NOT COMPLETED|Overall Study||2
10627768|NCT02012218|11786412|FG004|NOT COMPLETED|Overall Study||1
10627769|NCT02012283|11786426|FG000|STARTED|First Intervention||10
10627770|NCT02012283|11786427|FG001|STARTED|First Intervention||10
10627771|NCT02012283|11786426|FG000|COMPLETED|First Intervention||10
10627772|NCT02012283|11786427|FG001|COMPLETED|First Intervention||10
10627773|NCT02012283|11786426|FG000|NOT COMPLETED|First Intervention||0
10627774|NCT02012283|11786427|FG001|NOT COMPLETED|First Intervention||0
10627775|NCT02012283|11786426|FG000|STARTED|Second Intervention||10
10627776|NCT02012283|11786427|FG001|STARTED|Second Intervention||10
10627777|NCT02012283|11786426|FG000|COMPLETED|Second Intervention||10
10627778|NCT02012283|11786427|FG001|COMPLETED|Second Intervention||10
10627779|NCT02012283|11786426|FG000|NOT COMPLETED|Second Intervention||0
10627780|NCT02012283|11786427|FG001|NOT COMPLETED|Second Intervention||0
10627781|NCT02012283|11786426|FG000|STARTED|Third Intervention||10
10627782|NCT02012283|11786427|FG001|STARTED|Third Intervention||10
10627783|NCT02012283|11786426|FG000|COMPLETED|Third Intervention||10
10627784|NCT02012283|11786427|FG001|COMPLETED|Third Intervention||10
10627785|NCT02012283|11786426|FG000|NOT COMPLETED|Third Intervention||0
10627786|NCT02012283|11786427|FG001|NOT COMPLETED|Third Intervention||0
10627787|NCT02012348|11786441|FG000|STARTED|Overall Study||10
10627788|NCT02012348|11786442|FG001|STARTED|Overall Study||10
10627789|NCT02012348|11786443|FG002|STARTED|Overall Study||10
10627790|NCT02012348|11786441|FG000|COMPLETED|Overall Study||10
10627791|NCT02012348|11786442|FG001|COMPLETED|Overall Study||10
10627792|NCT02012348|11786443|FG002|COMPLETED|Overall Study||10
10627793|NCT02012348|11786441|FG000|NOT COMPLETED|Overall Study||0
10627794|NCT02012348|11786442|FG001|NOT COMPLETED|Overall Study||0
10627795|NCT02012348|11786443|FG002|NOT COMPLETED|Overall Study||0
10627796|NCT02012452|11786453|FG000|STARTED|Overall Study||7
10627797|NCT02012452|11786454|FG001|STARTED|Overall Study||2
10627798|NCT02012452|11786453|FG000|COMPLETED|Overall Study||1
10627799|NCT02012452|11786454|FG001|COMPLETED|Overall Study||1
10627800|NCT02012452|11786453|FG000|NOT COMPLETED|Overall Study||6
10627801|NCT02012452|11786454|FG001|NOT COMPLETED|Overall Study||1
10627802|NCT02012491|11786462|FG000|STARTED|Overall Study||151
10627803|NCT02012491|11786463|FG001|STARTED|Overall Study||149
10627804|NCT02012491|11786462|FG000|COMPLETED|Overall Study||149
10627805|NCT02012491|11786463|FG001|COMPLETED|Overall Study||148
10627806|NCT02012491|11786462|FG000|NOT COMPLETED|Overall Study||2
10627807|NCT02012491|11786463|FG001|NOT COMPLETED|Overall Study||1
10627808|NCT02012582|11786473|FG000|STARTED|Overall Study||8
10627809|NCT02012582|11786474|FG001|STARTED|Overall Study||8
10627810|NCT02012582|11786475|FG002|STARTED|Overall Study||8
10627811|NCT02012582|11786476|FG003|STARTED|Overall Study||8
10627812|NCT02012582|11786473|FG000|COMPLETED|Overall Study||8
10627813|NCT02012582|11786474|FG001|COMPLETED|Overall Study||8
10627814|NCT02012582|11786475|FG002|COMPLETED|Overall Study||8
10627815|NCT02012582|11786476|FG003|COMPLETED|Overall Study||7
10627816|NCT02012582|11786473|FG000|NOT COMPLETED|Overall Study||0
10627817|NCT02012582|11786474|FG001|NOT COMPLETED|Overall Study||0
10627818|NCT02012582|11786475|FG002|NOT COMPLETED|Overall Study||0
10627819|NCT02012582|11786476|FG003|NOT COMPLETED|Overall Study||1
10627820|NCT02012621|11786486|FG000|STARTED|Overall Study||807
10627821|NCT02012621|11786486|FG000|Visit 1 Completed|Overall Study||807
10627822|NCT02012621|11786486|FG000|Visit 2 Completed|Overall Study||688
10627823|NCT02012621|11786486|FG000|Visit 3 Completed|Overall Study||444
10627824|NCT02012621|11786486|FG000|COMPLETED|Overall Study||807
10627825|NCT02012621|11786486|FG000|NOT COMPLETED|Overall Study||0
10627826|NCT02012686|11786492|FG000|STARTED|Overall Study||50
10627827|NCT02012686|11786493|FG001|STARTED|Overall Study||50
10627828|NCT02012686|11786492|FG000|COMPLETED|Overall Study||50
10627829|NCT02012686|11786493|FG001|COMPLETED|Overall Study||48
10627830|NCT02012686|11786492|FG000|NOT COMPLETED|Overall Study||0
10627831|NCT02012686|11786493|FG001|NOT COMPLETED|Overall Study||2
10627832|NCT02012959|11786499|FG000|STARTED|Treatment Phase A||9
10627833|NCT02012959|11786500|FG001|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
10627834|NCT02012959|11786501|FG002|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
10627835|NCT02012959|11786502|FG003|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
10627836|NCT02012959|11786503|FG004|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
10627837|NCT02012959|11786499|FG000|Received At Least 1 Dose of Study Drug|Treatment Phase A||9
10627838|NCT02012959|11786500|FG001|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
10627839|NCT02012959|11786501|FG002|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
10627840|NCT02012959|11786502|FG003|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
10627841|NCT02012959|11786503|FG004|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
10627842|NCT02012959|11786499|FG000|COMPLETED|Treatment Phase A||7
10627843|NCT02012959|11786500|FG001|COMPLETED|Treatment Phase A||0
10627844|NCT02012959|11786501|FG002|COMPLETED|Treatment Phase A||0
10627845|NCT02012959|11786502|FG003|COMPLETED|Treatment Phase A||0
10627846|NCT02012959|11786503|FG004|COMPLETED|Treatment Phase A||0
10627847|NCT02012959|11786499|FG000|NOT COMPLETED|Treatment Phase A||2
10627848|NCT02012959|11786500|FG001|NOT COMPLETED|Treatment Phase A||0
10627849|NCT02012959|11786501|FG002|NOT COMPLETED|Treatment Phase A||0
10627850|NCT02012959|11786502|FG003|NOT COMPLETED|Treatment Phase A||0
10627851|NCT02012959|11786503|FG004|NOT COMPLETED|Treatment Phase A||0
10627852|NCT02012959|11786499|FG000|STARTED|Treatment Phase B|Zero participants noted because participants had completed Phase A|0
10627853|NCT02012959|11786500|FG001|STARTED|Treatment Phase B|Participants in this group continued treatment with the study drug|2
10627854|NCT02012959|11786501|FG002|STARTED|Treatment Phase B|Participants in this group did not receive additional study drug after Phase A|3
10627855|NCT02012959|11786502|FG003|STARTED|Treatment Phase B|Participants in this group could continue study drug treatment, per the investigator's discretion|1
10627856|NCT02012959|11786503|FG004|STARTED|Treatment Phase B|Participants in this group could receive the investigator's preferred standard of care|1
10627857|NCT02012959|11786499|FG000|Received At Least 1 Dose of Study Drug|Treatment Phase B||0
10627858|NCT02012959|11786500|FG001|Received At Least 1 Dose of Study Drug|Treatment Phase B||2
10627859|NCT02012959|11786501|FG002|Received At Least 1 Dose of Study Drug|Treatment Phase B||3
10627860|NCT02012959|11786502|FG003|Received At Least 1 Dose of Study Drug|Treatment Phase B||1
10627861|NCT02012959|11786503|FG004|Received At Least 1 Dose of Study Drug|Treatment Phase B||1
10627862|NCT02012959|11786499|FG000|COMPLETED|Treatment Phase B||0
10627863|NCT02012959|11786500|FG001|COMPLETED|Treatment Phase B||2
10627864|NCT02012959|11786501|FG002|COMPLETED|Treatment Phase B||3
10627865|NCT02012959|11786502|FG003|COMPLETED|Treatment Phase B||1
10627866|NCT02012959|11786503|FG004|COMPLETED|Treatment Phase B||1
10627867|NCT02012959|11786499|FG000|NOT COMPLETED|Treatment Phase B||0
10627868|NCT02012959|11786500|FG001|NOT COMPLETED|Treatment Phase B||0
10627869|NCT02012959|11786501|FG002|NOT COMPLETED|Treatment Phase B||0
10627870|NCT02012959|11786502|FG003|NOT COMPLETED|Treatment Phase B||0
10627871|NCT02012959|11786503|FG004|NOT COMPLETED|Treatment Phase B||0
10627872|NCT02013037|11786513|FG000|STARTED|Overall Study||36
10627873|NCT02013037|11786513|FG000|COMPLETED|Overall Study||20
10627874|NCT02013037|11786513|FG000|NOT COMPLETED|Overall Study||16
10627875|NCT02013050|11786522|FG000|STARTED|Overall Study||42
10627876|NCT02013050|11786523|FG001|STARTED|Overall Study||41
10627877|NCT02013050|11786524|FG002|STARTED|Overall Study||3
10627878|NCT02013050|11786525|FG003|STARTED|Overall Study||23
10627879|NCT02013050|11786522|FG000|COMPLETED|Overall Study||38
10627880|NCT02013050|11786523|FG001|COMPLETED|Overall Study||36
10627881|NCT02013050|11786524|FG002|COMPLETED|Overall Study||3
10627882|NCT02013050|11786525|FG003|COMPLETED|Overall Study||19
10627883|NCT02013050|11786522|FG000|NOT COMPLETED|Overall Study||4
10627884|NCT02013050|11786523|FG001|NOT COMPLETED|Overall Study||5
10627885|NCT02013050|11786524|FG002|NOT COMPLETED|Overall Study||0
10627886|NCT02013050|11786525|FG003|NOT COMPLETED|Overall Study||4
10627887|NCT02013180|11786537|FG000|STARTED|Overall Study||119
10627888|NCT02013180|11786538|FG001|STARTED|Overall Study||361
10627889|NCT02013180|11786537|FG000|COMPLETED|Overall Study||119
10627890|NCT02013180|11786538|FG001|COMPLETED|Overall Study||361
10627891|NCT02013180|11786537|FG000|NOT COMPLETED|Overall Study||0
10627892|NCT02013180|11786538|FG001|NOT COMPLETED|Overall Study||0
10627893|NCT02013206|11786546|FG000|STARTED|Overall Study||29
10627894|NCT02013206|11786547|FG001|STARTED|Overall Study||23
10627895|NCT02013206|11786546|FG000|Received Study Drug|Overall Study||26
10627896|NCT02013206|11786547|FG001|Received Study Drug|Overall Study||23
10627897|NCT02013206|11786546|FG000|COMPLETED|Overall Study|3 Patients were on-going at clinical cut-off. Not Completed=patients who discontinued treatment.|2
10627898|NCT02013206|11786547|FG001|COMPLETED|Overall Study||1
10627899|NCT02013206|11786546|FG000|NOT COMPLETED|Overall Study||27
10627900|NCT02013206|11786547|FG001|NOT COMPLETED|Overall Study||22
10627901|NCT02013245|11786557|FG000|STARTED|Overall Study||9
10627902|NCT02013245|11786558|FG001|STARTED|Overall Study||9
10627903|NCT02013245|11786559|FG002|STARTED|Overall Study||9
10627904|NCT02013245|11786560|FG003|STARTED|Overall Study||9
10627905|NCT02013245|11786557|FG000|COMPLETED|Overall Study||9
10627906|NCT02013245|11786558|FG001|COMPLETED|Overall Study||8
10627907|NCT02013245|11786559|FG002|COMPLETED|Overall Study||9
10627908|NCT02013245|11786560|FG003|COMPLETED|Overall Study||9
10627909|NCT02013245|11786557|FG000|NOT COMPLETED|Overall Study||0
10627910|NCT02013245|11786558|FG001|NOT COMPLETED|Overall Study||1
10627911|NCT02013245|11786559|FG002|NOT COMPLETED|Overall Study||0
10627912|NCT02013245|11786560|FG003|NOT COMPLETED|Overall Study||0
10627913|NCT02013375|11786570|FG000|STARTED|Overall Study||2
10627914|NCT02013375|11786570|FG000|COMPLETED|Overall Study||0
10627915|NCT02013375|11786570|FG000|NOT COMPLETED|Overall Study||2
10627916|NCT02013388|11786583|FG000|STARTED|Overall Study||9
10627917|NCT02013388|11786584|FG001|STARTED|Overall Study||6
10627918|NCT02013388|11786585|FG002|STARTED|Overall Study||6
10627919|NCT02013388|11786586|FG003|STARTED|Overall Study||6
10627920|NCT02013388|11786587|FG004|STARTED|Overall Study||6
10627921|NCT02013388|11786588|FG005|STARTED|Overall Study||6
10627922|NCT02013388|11786589|FG006|STARTED|Overall Study||6
10627923|NCT02013388|11786590|FG007|STARTED|Overall Study||4
10627924|NCT02013388|11786583|FG000|COMPLETED|Overall Study||8
10627925|NCT02013388|11786584|FG001|COMPLETED|Overall Study||6
10627926|NCT02013388|11786585|FG002|COMPLETED|Overall Study||6
10627927|NCT02013388|11786586|FG003|COMPLETED|Overall Study||6
10627928|NCT02013388|11786587|FG004|COMPLETED|Overall Study||5
10627929|NCT02013388|11786588|FG005|COMPLETED|Overall Study||6
10627930|NCT02013388|11786589|FG006|COMPLETED|Overall Study||6
10627931|NCT02013388|11786590|FG007|COMPLETED|Overall Study||4
10627932|NCT02013388|11786583|FG000|NOT COMPLETED|Overall Study||1
10627933|NCT02013388|11786584|FG001|NOT COMPLETED|Overall Study||0
10627934|NCT02013388|11786585|FG002|NOT COMPLETED|Overall Study||0
10627935|NCT02013388|11786586|FG003|NOT COMPLETED|Overall Study||0
10627936|NCT02013388|11786587|FG004|NOT COMPLETED|Overall Study||1
10627937|NCT02013388|11786588|FG005|NOT COMPLETED|Overall Study||0
10627938|NCT02013388|11786589|FG006|NOT COMPLETED|Overall Study||0
10627939|NCT02013388|11786590|FG007|NOT COMPLETED|Overall Study||0
10627940|NCT02013531|11786612|FG000|STARTED|Overall Study||37
10627941|NCT02013531|11786612|FG000|COMPLETED|Overall Study||32
10627942|NCT02013531|11786612|FG000|NOT COMPLETED|Overall Study||5
10627943|NCT02013544|11786618|FG000|STARTED|Overall Study||182
10627944|NCT02013544|11786619|FG001|STARTED|Overall Study||376
10627945|NCT02013544|11786618|FG000|Safety Population|Overall Study||180
10627946|NCT02013544|11786619|FG001|Safety Population|Overall Study||374
10627947|NCT02013544|11786618|FG000|ITT Population|Overall Study||157
10627948|NCT02013544|11786619|FG001|ITT Population|Overall Study||325
10627949|NCT02013544|11786618|FG000|COMPLETED|Overall Study||171
10627950|NCT02013544|11786619|FG001|COMPLETED|Overall Study||356
10627951|NCT02013544|11786618|FG000|NOT COMPLETED|Overall Study||11
10627952|NCT02013544|11786619|FG001|NOT COMPLETED|Overall Study||20
10627953|NCT02013609|11786625|FG000|STARTED|Overall Study|One participant out of 48 participants enrolled had discontinued before receiving study medication.|47
10627954|NCT02013609|11786625|FG000|COMPLETED|Overall Study||29
10627955|NCT02013609|11786625|FG000|NOT COMPLETED|Overall Study||18
10627956|NCT02013622|11786629|FG000|STARTED|Overall Study||49
10627957|NCT02013622|11786629|FG000|COMPLETED|Overall Study||25
10627958|NCT02013622|11786629|FG000|NOT COMPLETED|Overall Study||24
10627959|NCT02013674|11786635|FG000|STARTED|Overall Study||15
10627960|NCT02013674|11786636|FG001|STARTED|Overall Study||15
10627961|NCT02013674|11786635|FG000|COMPLETED|Overall Study||14
10627962|NCT02013674|11786636|FG001|COMPLETED|Overall Study||14
10627963|NCT02013674|11786635|FG000|NOT COMPLETED|Overall Study||1
10627964|NCT02013674|11786636|FG001|NOT COMPLETED|Overall Study||1
10627965|NCT02013687|11786646|FG000|STARTED|Overall Study||6
10627966|NCT02013687|11786647|FG001|STARTED|Overall Study||6
10627967|NCT02013687|11786648|FG002|STARTED|Overall Study||16
10627968|NCT02013687|11786649|FG003|STARTED|Overall Study||16
10627969|NCT02013687|11786646|FG000|COMPLETED|Overall Study||6
10627970|NCT02013687|11786647|FG001|COMPLETED|Overall Study||6
10627971|NCT02013687|11786648|FG002|COMPLETED|Overall Study||14
10627972|NCT02013687|11786649|FG003|COMPLETED|Overall Study||14
10627973|NCT02013687|11786646|FG000|NOT COMPLETED|Overall Study||0
10627974|NCT02013687|11786647|FG001|NOT COMPLETED|Overall Study||0
10627975|NCT02013687|11786648|FG002|NOT COMPLETED|Overall Study||2
10627976|NCT02013687|11786649|FG003|NOT COMPLETED|Overall Study||2
10627977|NCT02013765|11786663|FG000|STARTED|Overall Study||5
10627978|NCT02013765|11786663|FG000|COMPLETED|Overall Study||4
10627979|NCT02013765|11786663|FG000|NOT COMPLETED|Overall Study||1
10627980|NCT02013778|11786667|FG000|STARTED|Overall Study||8
10627981|NCT02013778|11786667|FG000|COMPLETED|Overall Study||1
10627982|NCT02013778|11786667|FG000|NOT COMPLETED|Overall Study||7
10627983|NCT02013791|11786680|FG000|STARTED|Period 1||8
10627984|NCT02013791|11786681|FG001|STARTED|Period 1||8
10627985|NCT02013791|11786682|FG002|STARTED|Period 1||4
10627986|NCT02013791|11786683|FG003|STARTED|Period 1||8
10627987|NCT02013791|11786684|FG004|STARTED|Period 1||4
10627988|NCT02013791|11786685|FG005|STARTED|Period 1||8
10627989|NCT02013791|11786686|FG006|STARTED|Period 1||4
10627990|NCT02013791|11786687|FG007|STARTED|Period 1||8
10627991|NCT02013791|11786688|FG008|STARTED|Period 1||3
10627992|NCT02013791|11786680|FG000|COMPLETED|Period 1||8
10627993|NCT02013791|11786681|FG001|COMPLETED|Period 1||6
10627994|NCT02013791|11786682|FG002|COMPLETED|Period 1||4
10627995|NCT02013791|11786683|FG003|COMPLETED|Period 1||7
10627996|NCT02013791|11786684|FG004|COMPLETED|Period 1||4
10627997|NCT02013791|11786685|FG005|COMPLETED|Period 1||8
10627998|NCT02013791|11786686|FG006|COMPLETED|Period 1||3
10627999|NCT02013791|11786687|FG007|COMPLETED|Period 1||7
10628000|NCT02013791|11786688|FG008|COMPLETED|Period 1||3
10628001|NCT02013791|11786680|FG000|NOT COMPLETED|Period 1||0
10628002|NCT02013791|11786681|FG001|NOT COMPLETED|Period 1||2
10628003|NCT02013791|11786682|FG002|NOT COMPLETED|Period 1||0
10628004|NCT02013791|11786683|FG003|NOT COMPLETED|Period 1||1
10628005|NCT02013791|11786684|FG004|NOT COMPLETED|Period 1||0
10628006|NCT02013791|11786685|FG005|NOT COMPLETED|Period 1||0
10628007|NCT02013791|11786686|FG006|NOT COMPLETED|Period 1||1
10628008|NCT02013791|11786687|FG007|NOT COMPLETED|Period 1||1
10628009|NCT02013791|11786688|FG008|NOT COMPLETED|Period 1||0
10628010|NCT02013791|11786680|FG000|STARTED|Period 2||0
10628011|NCT02013791|11786681|FG001|STARTED|Period 2||0
10628012|NCT02013791|11786682|FG002|STARTED|Period 2||2
10628013|NCT02013791|11786683|FG003|STARTED|Period 2||0
10628014|NCT02013791|11786684|FG004|STARTED|Period 2||0
10628015|NCT02013791|11786685|FG005|STARTED|Period 2||0
10628016|NCT02013791|11786686|FG006|STARTED|Period 2||3
10628017|NCT02013791|11786687|FG007|STARTED|Period 2||0
10628018|NCT02013791|11786688|FG008|STARTED|Period 2||0
10628019|NCT02013791|11786680|FG000|COMPLETED|Period 2||0
10628020|NCT02013791|11786681|FG001|COMPLETED|Period 2||0
10628021|NCT02013791|11786682|FG002|COMPLETED|Period 2||2
10628022|NCT02013791|11786683|FG003|COMPLETED|Period 2||0
10628023|NCT02013791|11786684|FG004|COMPLETED|Period 2||0
10628024|NCT02013791|11786685|FG005|COMPLETED|Period 2||0
10628025|NCT02013791|11786686|FG006|COMPLETED|Period 2||3
10628026|NCT02013791|11786687|FG007|COMPLETED|Period 2||0
10628027|NCT02013791|11786688|FG008|COMPLETED|Period 2||0
10628028|NCT02013791|11786680|FG000|NOT COMPLETED|Period 2||0
10628029|NCT02013791|11786681|FG001|NOT COMPLETED|Period 2||0
10628030|NCT02013791|11786682|FG002|NOT COMPLETED|Period 2||0
10628031|NCT02013791|11786683|FG003|NOT COMPLETED|Period 2||0
10628032|NCT02013791|11786684|FG004|NOT COMPLETED|Period 2||0
10628033|NCT02013791|11786685|FG005|NOT COMPLETED|Period 2||0
10628034|NCT02013791|11786686|FG006|NOT COMPLETED|Period 2||0
10628035|NCT02013791|11786687|FG007|NOT COMPLETED|Period 2||0
10628036|NCT02013791|11786688|FG008|NOT COMPLETED|Period 2||0
10628037|NCT02013817|11786709|FG000|STARTED|Overall Study||43
10628038|NCT02013817|11786709|FG000|COMPLETED|Overall Study||16
10628039|NCT02013817|11786709|FG000|NOT COMPLETED|Overall Study||27
10628040|NCT02013830|11786713|FG000|STARTED|Overall Study||45
10628041|NCT02013830|11786713|FG000|COMPLETED|Overall Study||15
10628042|NCT02013830|11786713|FG000|NOT COMPLETED|Overall Study||30
10628043|NCT02014051|11786717|FG000|STARTED|Overall Study||3
10628044|NCT02014051|11786718|FG001|STARTED|Overall Study||6
10628045|NCT02014051|11786717|FG000|COMPLETED|Overall Study||2
10628046|NCT02014051|11786718|FG001|COMPLETED|Overall Study||5
10628047|NCT02014051|11786717|FG000|NOT COMPLETED|Overall Study||1
10628048|NCT02014051|11786718|FG001|NOT COMPLETED|Overall Study||1
10628049|NCT02014116|11786734|FG000|STARTED|Overall Study||3
10628050|NCT02014116|11786735|FG001|STARTED|Overall Study||4
10628051|NCT02014116|11786736|FG002|STARTED|Overall Study||3
10628052|NCT02014116|11786737|FG003|STARTED|Overall Study||7
10628053|NCT02014116|11786738|FG004|STARTED|Overall Study||2
10628054|NCT02014116|11786739|FG005|STARTED|Overall Study||16
10628055|NCT02014116|11786740|FG006|STARTED|Overall Study||1
10628056|NCT02014116|11786741|FG007|STARTED|Overall Study||5
10628057|NCT02014116|11786742|FG008|STARTED|Overall Study||10
10628058|NCT02014116|11786734|FG000|Received at Least One Dose of Study Drug|Overall Study||3
10628059|NCT02014116|11786735|FG001|Received at Least One Dose of Study Drug|Overall Study||4
10628060|NCT02014116|11786736|FG002|Received at Least One Dose of Study Drug|Overall Study||3
10628061|NCT02014116|11786737|FG003|Received at Least One Dose of Study Drug|Overall Study||7
10628062|NCT02014116|11786738|FG004|Received at Least One Dose of Study Drug|Overall Study||2
10628063|NCT02014116|11786739|FG005|Received at Least One Dose of Study Drug|Overall Study||16
10628064|NCT02014116|11786740|FG006|Received at Least One Dose of Study Drug|Overall Study||1
10628065|NCT02014116|11786741|FG007|Received at Least One Dose of Study Drug|Overall Study||5
10628066|NCT02014116|11786742|FG008|Received at Least One Dose of Study Drug|Overall Study||10
10628067|NCT02014116|11786734|FG000|COMPLETED|Overall Study||0
10628068|NCT02014116|11786735|FG001|COMPLETED|Overall Study||0
10628069|NCT02014116|11786736|FG002|COMPLETED|Overall Study||0
10628070|NCT02014116|11786737|FG003|COMPLETED|Overall Study||0
10628071|NCT02014116|11786738|FG004|COMPLETED|Overall Study||0
10628072|NCT02014116|11786739|FG005|COMPLETED|Overall Study||0
10628073|NCT02014116|11786740|FG006|COMPLETED|Overall Study||0
10628074|NCT02014116|11786741|FG007|COMPLETED|Overall Study||0
10628075|NCT02014116|11786742|FG008|COMPLETED|Overall Study||0
10628076|NCT02014116|11786734|FG000|NOT COMPLETED|Overall Study||3
10628077|NCT02014116|11786735|FG001|NOT COMPLETED|Overall Study||4
10628078|NCT02014116|11786736|FG002|NOT COMPLETED|Overall Study||3
10628079|NCT02014116|11786737|FG003|NOT COMPLETED|Overall Study||7
10628080|NCT02014116|11786738|FG004|NOT COMPLETED|Overall Study||2
10628081|NCT02014116|11786739|FG005|NOT COMPLETED|Overall Study||16
10628082|NCT02014116|11786740|FG006|NOT COMPLETED|Overall Study||1
10628083|NCT02014116|11786741|FG007|NOT COMPLETED|Overall Study||5
10628084|NCT02014116|11786742|FG008|NOT COMPLETED|Overall Study||10
10628085|NCT02014129|11786768|FG000|STARTED|Overall Study||3
10628086|NCT02014129|11786769|FG001|STARTED|Overall Study||3
10628087|NCT02014129|11786770|FG002|STARTED|Overall Study||6
10628088|NCT02014129|11786768|FG000|Received at Least One Dose of Study Drug|Overall Study||3
10628089|NCT02014129|11786769|FG001|Received at Least One Dose of Study Drug|Overall Study||3
10628090|NCT02014129|11786770|FG002|Received at Least One Dose of Study Drug|Overall Study||6
10628091|NCT02014129|11786768|FG000|COMPLETED|Overall Study||3
10628092|NCT02014129|11786769|FG001|COMPLETED|Overall Study||3
10628093|NCT02014129|11786770|FG002|COMPLETED|Overall Study||6
10628094|NCT02014129|11786768|FG000|NOT COMPLETED|Overall Study||0
10628095|NCT02014129|11786769|FG001|NOT COMPLETED|Overall Study||0
10628096|NCT02014129|11786770|FG002|NOT COMPLETED|Overall Study||0
10628097|NCT02014272|11786778|FG000|STARTED|Intervention Period 1||14
10628098|NCT02014272|11786779|FG001|STARTED|Intervention Period 1||14
10628099|NCT02014272|11786778|FG000|COMPLETED|Intervention Period 1||13
10628100|NCT02014272|11786779|FG001|COMPLETED|Intervention Period 1||13
10628101|NCT02014272|11786778|FG000|NOT COMPLETED|Intervention Period 1||1
10628102|NCT02014272|11786779|FG001|NOT COMPLETED|Intervention Period 1||1
10628103|NCT02014272|11786778|FG000|STARTED|Washout Period 1 (7 Days)||13
10628104|NCT02014272|11786779|FG001|STARTED|Washout Period 1 (7 Days)||13
10628105|NCT02014272|11786778|FG000|COMPLETED|Washout Period 1 (7 Days)||13
10628106|NCT02014272|11786779|FG001|COMPLETED|Washout Period 1 (7 Days)||13
10628107|NCT02014272|11786778|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
10628108|NCT02014272|11786779|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
10628109|NCT02014272|11786778|FG000|STARTED|Intervention Period 2||13
10628110|NCT02014272|11786779|FG001|STARTED|Intervention Period 2||13
10628111|NCT02014272|11786778|FG000|COMPLETED|Intervention Period 2||13
10628112|NCT02014272|11786779|FG001|COMPLETED|Intervention Period 2||13
10628113|NCT02014272|11786778|FG000|NOT COMPLETED|Intervention Period 2||0
10628114|NCT02014272|11786779|FG001|NOT COMPLETED|Intervention Period 2||0
10628115|NCT02014363|11786788|FG000|STARTED|Overall Study||55
10628116|NCT02014363|11786789|FG001|STARTED|Overall Study||54
10628117|NCT02014363|11786790|FG002|STARTED|Overall Study||55
10628118|NCT02014363|11786788|FG000|COMPLETED|Overall Study||38
10628119|NCT02014363|11786789|FG001|COMPLETED|Overall Study||35
10628120|NCT02014363|11786790|FG002|COMPLETED|Overall Study||31
10628121|NCT02014363|11786788|FG000|NOT COMPLETED|Overall Study||17
10628122|NCT02014363|11786789|FG001|NOT COMPLETED|Overall Study||19
10628123|NCT02014363|11786790|FG002|NOT COMPLETED|Overall Study||24
10628124|NCT02014376|11786801|FG000|STARTED|Overall Study||15
10628125|NCT02014376|11786802|FG001|STARTED|Overall Study||16
10628126|NCT02014376|11786803|FG002|STARTED|Overall Study||17
10628127|NCT02014376|11786801|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
10628128|NCT02014376|11786802|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16
10628129|NCT02014376|11786803|FG002|Received at Least 1 Dose of Study Drug|Overall Study||17
10628130|NCT02014376|11786801|FG000|COMPLETED|Overall Study||12
10628131|NCT02014376|11786802|FG001|COMPLETED|Overall Study||15
10628132|NCT02014376|11786803|FG002|COMPLETED|Overall Study||17
10628133|NCT02014376|11786801|FG000|NOT COMPLETED|Overall Study||3
10628134|NCT02014376|11786802|FG001|NOT COMPLETED|Overall Study||1
10628135|NCT02014376|11786803|FG002|NOT COMPLETED|Overall Study||0
10628136|NCT02014402|11786815|FG000|STARTED|Overall Study||31
10628137|NCT02014402|11786816|FG001|STARTED|Overall Study||30
10628138|NCT02014402|11786817|FG002|STARTED|Overall Study||35
10628139|NCT02014402|11786818|FG003|STARTED|Overall Study||85
10628140|NCT02014402|11786815|FG000|Human Thrombin|Overall Study||20
10628141|NCT02014402|11786816|FG001|Human Thrombin|Overall Study||20
10628142|NCT02014402|11786817|FG002|Human Thrombin|Overall Study||23
10628143|NCT02014402|11786818|FG003|Human Thrombin|Overall Study||57
10628144|NCT02014402|11786815|FG000|Bovine Thrombin|Overall Study||11
10628145|NCT02014402|11786816|FG001|Bovine Thrombin|Overall Study||10
10628146|NCT02014402|11786817|FG002|Bovine Thrombin|Overall Study||12
10628147|NCT02014402|11786818|FG003|Bovine Thrombin|Overall Study||28
10628148|NCT02014402|11786815|FG000|COMPLETED|Overall Study||29
10628149|NCT02014402|11786816|FG001|COMPLETED|Overall Study||27
10628150|NCT02014402|11786817|FG002|COMPLETED|Overall Study||32
10628151|NCT02014402|11786818|FG003|COMPLETED|Overall Study||82
10628152|NCT02014402|11786815|FG000|NOT COMPLETED|Overall Study||2
10628153|NCT02014402|11786816|FG001|NOT COMPLETED|Overall Study||3
10628154|NCT02014402|11786817|FG002|NOT COMPLETED|Overall Study||3
10628155|NCT02014402|11786818|FG003|NOT COMPLETED|Overall Study||3
10628156|NCT02014441|11786835|FG000|STARTED|Overall Study||61
10628157|NCT02014441|11786835|FG000|Received Treatment|Overall Study||60
10628158|NCT02014441|11786835|FG000|COMPLETED|Overall Study||49
10628159|NCT02014441|11786835|FG000|NOT COMPLETED|Overall Study||12
10628160|NCT02014467|11786843|FG000|STARTED|Overall Study||365
10628161|NCT02014467|11786844|FG001|STARTED|Overall Study||119
10628162|NCT02014467|11786843|FG000|COMPLETED|Overall Study||340
10628163|NCT02014467|11786844|FG001|COMPLETED|Overall Study||112
10628164|NCT02014467|11786843|FG000|NOT COMPLETED|Overall Study||25
10628165|NCT02014467|11786844|FG001|NOT COMPLETED|Overall Study||7
10628166|NCT02014480|11786850|FG000|STARTED|Treatment Period 1 (14 Days)||35
10628167|NCT02014480|11786851|FG001|STARTED|Treatment Period 1 (14 Days)||35
10628168|NCT02014480|11786852|FG002|STARTED|Treatment Period 1 (14 Days)||34
10628169|NCT02014480|11786853|FG003|STARTED|Treatment Period 1 (14 Days)||34
10628170|NCT02014480|11786854|FG004|STARTED|Treatment Period 1 (14 Days)||35
10628171|NCT02014480|11786855|FG005|STARTED|Treatment Period 1 (14 Days)|One participant randomized to Sequence 6 actually received UMEC in Treatment Periods 2 and 3.|34
10628172|NCT02014480|11786850|FG000|COMPLETED|Treatment Period 1 (14 Days)||35
10628173|NCT02014480|11786851|FG001|COMPLETED|Treatment Period 1 (14 Days)||34
10628174|NCT02014480|11786852|FG002|COMPLETED|Treatment Period 1 (14 Days)||33
10628175|NCT02014480|11786853|FG003|COMPLETED|Treatment Period 1 (14 Days)||32
10628176|NCT02014480|11786854|FG004|COMPLETED|Treatment Period 1 (14 Days)||34
10628177|NCT02014480|11786855|FG005|COMPLETED|Treatment Period 1 (14 Days)||34
10628178|NCT02014480|11786850|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||0
10628179|NCT02014480|11786851|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||1
10628180|NCT02014480|11786852|FG002|NOT COMPLETED|Treatment Period 1 (14 Days)||1
10628181|NCT02014480|11786853|FG003|NOT COMPLETED|Treatment Period 1 (14 Days)||2
10628182|NCT02014480|11786854|FG004|NOT COMPLETED|Treatment Period 1 (14 Days)||1
10628183|NCT02014480|11786855|FG005|NOT COMPLETED|Treatment Period 1 (14 Days)||0
10628184|NCT02014480|11786850|FG000|STARTED|Washout Period 1 (10 to 14 Days)||35
10628185|NCT02014480|11786851|FG001|STARTED|Washout Period 1 (10 to 14 Days)||34
10628186|NCT02014480|11786852|FG002|STARTED|Washout Period 1 (10 to 14 Days)||33
10628187|NCT02014480|11786853|FG003|STARTED|Washout Period 1 (10 to 14 Days)||32
10628188|NCT02014480|11786854|FG004|STARTED|Washout Period 1 (10 to 14 Days)||34
10628189|NCT02014480|11786855|FG005|STARTED|Washout Period 1 (10 to 14 Days)||34
10628190|NCT02014480|11786850|FG000|COMPLETED|Washout Period 1 (10 to 14 Days)||35
10628191|NCT02014480|11786851|FG001|COMPLETED|Washout Period 1 (10 to 14 Days)||34
10628192|NCT02014480|11786852|FG002|COMPLETED|Washout Period 1 (10 to 14 Days)||32
10628193|NCT02014480|11786853|FG003|COMPLETED|Washout Period 1 (10 to 14 Days)||32
10628194|NCT02014480|11786854|FG004|COMPLETED|Washout Period 1 (10 to 14 Days)||34
10628195|NCT02014480|11786855|FG005|COMPLETED|Washout Period 1 (10 to 14 Days)||34
10628196|NCT02014480|11786850|FG000|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
10628197|NCT02014480|11786851|FG001|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
10628198|NCT02014480|11786852|FG002|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
10628199|NCT02014480|11786853|FG003|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
10628200|NCT02014480|11786854|FG004|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
10628201|NCT02014480|11786855|FG005|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
10628202|NCT02014480|11786850|FG000|STARTED|Treatment Period 2 (14 Days)||35
10628203|NCT02014480|11786851|FG001|STARTED|Treatment Period 2 (14 Days)||34
10628204|NCT02014480|11786852|FG002|STARTED|Treatment Period 2 (14 Days)||32
10628205|NCT02014480|11786853|FG003|STARTED|Treatment Period 2 (14 Days)||32
10628206|NCT02014480|11786854|FG004|STARTED|Treatment Period 2 (14 Days)||34
10628207|NCT02014480|11786855|FG005|STARTED|Treatment Period 2 (14 Days)||34
10628208|NCT02014480|11786850|FG000|COMPLETED|Treatment Period 2 (14 Days)||34
10628209|NCT02014480|11786851|FG001|COMPLETED|Treatment Period 2 (14 Days)||33
10628210|NCT02014480|11786852|FG002|COMPLETED|Treatment Period 2 (14 Days)||30
10628211|NCT02014480|11786853|FG003|COMPLETED|Treatment Period 2 (14 Days)||31
10628212|NCT02014480|11786854|FG004|COMPLETED|Treatment Period 2 (14 Days)||34
10628213|NCT02014480|11786855|FG005|COMPLETED|Treatment Period 2 (14 Days)||34
10628214|NCT02014480|11786850|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||1
10628215|NCT02014480|11786851|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||1
10628216|NCT02014480|11786852|FG002|NOT COMPLETED|Treatment Period 2 (14 Days)||2
10628217|NCT02014480|11786853|FG003|NOT COMPLETED|Treatment Period 2 (14 Days)||1
10628218|NCT02014480|11786854|FG004|NOT COMPLETED|Treatment Period 2 (14 Days)||0
10628219|NCT02014480|11786855|FG005|NOT COMPLETED|Treatment Period 2 (14 Days)||0
10628220|NCT02014480|11786850|FG000|STARTED|Washout Period 2 (10 to 14 Days)||34
10628221|NCT02014480|11786851|FG001|STARTED|Washout Period 2 (10 to 14 Days)||33
10628222|NCT02014480|11786852|FG002|STARTED|Washout Period 2 (10 to 14 Days)||30
10628223|NCT02014480|11786853|FG003|STARTED|Washout Period 2 (10 to 14 Days)||31
10628224|NCT02014480|11786854|FG004|STARTED|Washout Period 2 (10 to 14 Days)||34
10628225|NCT02014480|11786855|FG005|STARTED|Washout Period 2 (10 to 14 Days)||34
10628226|NCT02014480|11786850|FG000|COMPLETED|Washout Period 2 (10 to 14 Days)||34
10628227|NCT02014480|11786851|FG001|COMPLETED|Washout Period 2 (10 to 14 Days)||33
10628228|NCT02014480|11786852|FG002|COMPLETED|Washout Period 2 (10 to 14 Days)||30
10628229|NCT02014480|11786853|FG003|COMPLETED|Washout Period 2 (10 to 14 Days)||31
10628230|NCT02014480|11786854|FG004|COMPLETED|Washout Period 2 (10 to 14 Days)||34
10628231|NCT02014480|11786855|FG005|COMPLETED|Washout Period 2 (10 to 14 Days)||34
10628232|NCT02014480|11786850|FG000|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
10628233|NCT02014480|11786851|FG001|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
10628234|NCT02014480|11786852|FG002|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
10628235|NCT02014480|11786853|FG003|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
10628236|NCT02014480|11786854|FG004|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
10628237|NCT02014480|11786855|FG005|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
10628238|NCT02014480|11786850|FG000|STARTED|Treatment Period 3 (14 Days)||34
10628239|NCT02014480|11786851|FG001|STARTED|Treatment Period 3 (14 Days)||33
10628240|NCT02014480|11786852|FG002|STARTED|Treatment Period 3 (14 Days)||30
10628241|NCT02014480|11786853|FG003|STARTED|Treatment Period 3 (14 Days)||31
10628242|NCT02014480|11786854|FG004|STARTED|Treatment Period 3 (14 Days)||34
10628243|NCT02014480|11786855|FG005|STARTED|Treatment Period 3 (14 Days)||34
10628244|NCT02014480|11786850|FG000|COMPLETED|Treatment Period 3 (14 Days)||34
10628245|NCT02014480|11786851|FG001|COMPLETED|Treatment Period 3 (14 Days)||32
10628246|NCT02014480|11786852|FG002|COMPLETED|Treatment Period 3 (14 Days)||29
10628247|NCT02014480|11786853|FG003|COMPLETED|Treatment Period 3 (14 Days)||31
10628248|NCT02014480|11786854|FG004|COMPLETED|Treatment Period 3 (14 Days)||34
10628249|NCT02014480|11786855|FG005|COMPLETED|Treatment Period 3 (14 Days)||32
10628250|NCT02014480|11786850|FG000|NOT COMPLETED|Treatment Period 3 (14 Days)||0
10628251|NCT02014480|11786851|FG001|NOT COMPLETED|Treatment Period 3 (14 Days)||1
10628252|NCT02014480|11786852|FG002|NOT COMPLETED|Treatment Period 3 (14 Days)||1
10628253|NCT02014480|11786853|FG003|NOT COMPLETED|Treatment Period 3 (14 Days)||0
10628254|NCT02014480|11786854|FG004|NOT COMPLETED|Treatment Period 3 (14 Days)||0
10628255|NCT02014480|11786855|FG005|NOT COMPLETED|Treatment Period 3 (14 Days)||2
10628256|NCT02014519|11786863|FG000|STARTED|Overall Study||2000
10628257|NCT02014519|11786863|FG000|COMPLETED|Overall Study||2000
10628258|NCT02014519|11786863|FG000|NOT COMPLETED|Overall Study||0
10628259|NCT02014584|11786877|FG000|STARTED|Double-Blind Period (24 Weeks)||59
10628260|NCT02014584|11786878|FG001|STARTED|Double-Blind Period (24 Weeks)||58
10628261|NCT02014584|11786879|FG002|STARTED|Double-Blind Period (24 Weeks)||0
10628262|NCT02014584|11786880|FG003|STARTED|Double-Blind Period (24 Weeks)||0
10628263|NCT02014584|11786881|FG004|STARTED|Double-Blind Period (24 Weeks)||0
10628264|NCT02014584|11786882|FG005|STARTED|Double-Blind Period (24 Weeks)||0
10628265|NCT02014584|11786877|FG000|COMPLETED|Double-Blind Period (24 Weeks)||57
10628266|NCT02014584|11786878|FG001|COMPLETED|Double-Blind Period (24 Weeks)||52
10628267|NCT02014584|11786879|FG002|COMPLETED|Double-Blind Period (24 Weeks)||0
10628268|NCT02014584|11786880|FG003|COMPLETED|Double-Blind Period (24 Weeks)||0
10628269|NCT02014584|11786881|FG004|COMPLETED|Double-Blind Period (24 Weeks)||0
10628270|NCT02014584|11786882|FG005|COMPLETED|Double-Blind Period (24 Weeks)||0
10628271|NCT02014584|11786877|FG000|NOT COMPLETED|Double-Blind Period (24 Weeks)||2
10628272|NCT02014584|11786878|FG001|NOT COMPLETED|Double-Blind Period (24 Weeks)||6
10628273|NCT02014584|11786879|FG002|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
10628274|NCT02014584|11786880|FG003|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
10628275|NCT02014584|11786881|FG004|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
10628276|NCT02014584|11786882|FG005|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
10628277|NCT02014584|11786877|FG000|STARTED|Open-Label Period (24 Weeks)||0
10628278|NCT02014584|11786878|FG001|STARTED|Open-Label Period (24 Weeks)||0
10628279|NCT02014584|11786879|FG002|STARTED|Open-Label Period (24 Weeks)||49
10628280|NCT02014584|11786880|FG003|STARTED|Open-Label Period (24 Weeks)||48
10628281|NCT02014584|11786881|FG004|STARTED|Open-Label Period (24 Weeks)||0
10628282|NCT02014584|11786882|FG005|STARTED|Open-Label Period (24 Weeks)||0
10628283|NCT02014584|11786877|FG000|COMPLETED|Open-Label Period (24 Weeks)||0
10628284|NCT02014584|11786878|FG001|COMPLETED|Open-Label Period (24 Weeks)||0
10628285|NCT02014584|11786879|FG002|COMPLETED|Open-Label Period (24 Weeks)||44
10628286|NCT02014584|11786880|FG003|COMPLETED|Open-Label Period (24 Weeks)||47
10628287|NCT02014584|11786881|FG004|COMPLETED|Open-Label Period (24 Weeks)||0
10628288|NCT02014584|11786882|FG005|COMPLETED|Open-Label Period (24 Weeks)||0
10628289|NCT02014584|11786877|FG000|NOT COMPLETED|Open-Label Period (24 Weeks)||0
10628290|NCT02014584|11786878|FG001|NOT COMPLETED|Open-Label Period (24 Weeks)||0
10628291|NCT02014584|11786879|FG002|NOT COMPLETED|Open-Label Period (24 Weeks)||5
10628292|NCT02014584|11786880|FG003|NOT COMPLETED|Open-Label Period (24 Weeks)||1
10628293|NCT02014584|11786881|FG004|NOT COMPLETED|Open-Label Period (24 Weeks)||0
10628294|NCT02014584|11786882|FG005|NOT COMPLETED|Open-Label Period (24 Weeks)||0
10628295|NCT02014584|11786877|FG000|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
10628296|NCT02014584|11786878|FG001|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
10628297|NCT02014584|11786879|FG002|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
10628298|NCT02014584|11786880|FG003|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
10628299|NCT02014584|11786881|FG004|STARTED|Target Follow-up (F/U) Period (24 Weeks)||3
10628300|NCT02014584|11786882|FG005|STARTED|Target Follow-up (F/U) Period (24 Weeks)||2
10628301|NCT02014584|11786877|FG000|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
10628302|NCT02014584|11786878|FG001|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
10628303|NCT02014584|11786879|FG002|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
10628304|NCT02014584|11786880|FG003|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
10628305|NCT02014584|11786881|FG004|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||2
10628306|NCT02014584|11786882|FG005|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||2
10628307|NCT02014584|11786877|FG000|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
10628308|NCT02014584|11786878|FG001|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
10628309|NCT02014584|11786879|FG002|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
10628310|NCT02014584|11786880|FG003|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
10628311|NCT02014584|11786881|FG004|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||1
10628312|NCT02014584|11786882|FG005|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
10628313|NCT02014597|11786896|FG000|STARTED|Overall Study||12
10628314|NCT02014597|11786897|FG001|STARTED|Overall Study||11
10628315|NCT02014597|11786896|FG000|COMPLETED|Overall Study||10
10628316|NCT02014597|11786897|FG001|COMPLETED|Overall Study||10
10628317|NCT02014597|11786896|FG000|NOT COMPLETED|Overall Study||2
10628318|NCT02014597|11786897|FG001|NOT COMPLETED|Overall Study||1
10628319|NCT02014740|11786905|FG000|STARTED|Overall Study||55
10628320|NCT02014740|11786906|FG001|STARTED|Overall Study||45
10628321|NCT02014740|11786905|FG000|COMPLETED|Overall Study||49
10628322|NCT02014740|11786906|FG001|COMPLETED|Overall Study||40
10628323|NCT02014740|11786905|FG000|NOT COMPLETED|Overall Study||6
10628324|NCT02014740|11786906|FG001|NOT COMPLETED|Overall Study||5
10628325|NCT02015039|11786914|FG000|STARTED|Overall Study||6
10628326|NCT02015039|11786915|FG001|STARTED|Overall Study||7
10628327|NCT02015039|11786914|FG000|COMPLETED|Overall Study||6
10628328|NCT02015039|11786915|FG001|COMPLETED|Overall Study||6
10628329|NCT02015039|11786914|FG000|NOT COMPLETED|Overall Study||0
10628330|NCT02015039|11786915|FG001|NOT COMPLETED|Overall Study||1
10628331|NCT02015065|11786924|FG000|STARTED|Overall Study||2
10628332|NCT02015065|11786925|FG001|STARTED|Overall Study||5
10628333|NCT02015065|11786926|FG002|STARTED|Overall Study||2
10628334|NCT02015065|11786924|FG000|COMPLETED|Overall Study||1
10628335|NCT02015065|11786925|FG001|COMPLETED|Overall Study||3
10628336|NCT02015065|11786926|FG002|COMPLETED|Overall Study||1
10628337|NCT02015065|11786924|FG000|NOT COMPLETED|Overall Study||1
10628338|NCT02015065|11786925|FG001|NOT COMPLETED|Overall Study||2
10628339|NCT02015065|11786926|FG002|NOT COMPLETED|Overall Study||1
10628340|NCT02015104|11786936|FG000|STARTED|Overall Study||16
10628341|NCT02015104|11786937|FG001|STARTED|Overall Study||16
10628342|NCT02015104|11786936|FG000|COMPLETED|Overall Study||15
10628343|NCT02015104|11786937|FG001|COMPLETED|Overall Study||15
10628344|NCT02015104|11786936|FG000|NOT COMPLETED|Overall Study||1
10628345|NCT02015104|11786937|FG001|NOT COMPLETED|Overall Study||1
10628346|NCT02015195|11786953|FG000|STARTED|Overall Study||16
10628347|NCT02015195|11786954|FG001|STARTED|Overall Study||16
10628348|NCT02015195|11786955|FG002|STARTED|Overall Study||16
10628349|NCT02015195|11786956|FG003|STARTED|Overall Study||1
10628350|NCT02015195|11786957|FG004|STARTED|Overall Study||16
10628351|NCT02015195|11786958|FG005|STARTED|Overall Study||16
10628352|NCT02015195|11786959|FG006|STARTED|Overall Study||16
10628353|NCT02015195|11786953|FG000|COMPLETED|Overall Study||16
10628354|NCT02015195|11786954|FG001|COMPLETED|Overall Study||16
10628355|NCT02015195|11786955|FG002|COMPLETED|Overall Study||16
10628356|NCT02015195|11786956|FG003|COMPLETED|Overall Study||0
10628357|NCT02015195|11786957|FG004|COMPLETED|Overall Study||16
10628358|NCT02015195|11786958|FG005|COMPLETED|Overall Study||16
10628359|NCT02015195|11786959|FG006|COMPLETED|Overall Study||16
10628360|NCT02015195|11786953|FG000|NOT COMPLETED|Overall Study||0
10628361|NCT02015195|11786954|FG001|NOT COMPLETED|Overall Study||0
10628362|NCT02015195|11786955|FG002|NOT COMPLETED|Overall Study||0
10628363|NCT02015195|11786956|FG003|NOT COMPLETED|Overall Study||1
10628364|NCT02015195|11786957|FG004|NOT COMPLETED|Overall Study||0
10628365|NCT02015195|11786958|FG005|NOT COMPLETED|Overall Study||0
10628366|NCT02015195|11786959|FG006|NOT COMPLETED|Overall Study||0
10628367|NCT02015221|11786976|FG000|STARTED|Overall Study||41
10628368|NCT02015221|11786977|FG001|STARTED|Overall Study||40
10628369|NCT02015221|11786976|FG000|COMPLETED|Overall Study||32
10628370|NCT02015221|11786977|FG001|COMPLETED|Overall Study||34
10628371|NCT02015221|11786976|FG000|NOT COMPLETED|Overall Study||9
10628372|NCT02015221|11786977|FG001|NOT COMPLETED|Overall Study||6
10628373|NCT02015234|11786985|FG000|STARTED|Overall Study||79
10628374|NCT02015234|11786986|FG001|STARTED|Overall Study||79
10628375|NCT02015234|11786985|FG000|COMPLETED|Overall Study||43
10628376|NCT02015234|11786986|FG001|COMPLETED|Overall Study||54
10705409|NCT02598128|11869826|FG003|STARTED|Period A: Days -7 to -1||0
10705410|NCT02598128|11869823|FG000|COMPLETED|Period A: Days -7 to -1||33
10705411|NCT02598128|11869824|FG001|COMPLETED|Period A: Days -7 to -1||0
10705412|NCT02598128|11869825|FG002|COMPLETED|Period A: Days -7 to -1||0
10705413|NCT02598128|11869826|FG003|COMPLETED|Period A: Days -7 to -1||0
10705414|NCT02598128|11869823|FG000|NOT COMPLETED|Period A: Days -7 to -1||1
10705415|NCT02598128|11869824|FG001|NOT COMPLETED|Period A: Days -7 to -1||0
10705416|NCT02598128|11869825|FG002|NOT COMPLETED|Period A: Days -7 to -1||0
10628377|NCT02015234|11786985|FG000|NOT COMPLETED|Overall Study||36
10628378|NCT02015234|11786986|FG001|NOT COMPLETED|Overall Study||25
10653595|NCT02195349|11814160|FG010|STARTED|Overall Study||6
10653596|NCT02195349|11814150|FG000|COMPLETED|Overall Study||14
10653597|NCT02195349|11814151|FG001|COMPLETED|Overall Study||1
10653598|NCT02195349|11814152|FG002|COMPLETED|Overall Study||1
10653599|NCT02195349|11814153|FG003|COMPLETED|Overall Study||6
10653600|NCT02195349|11814154|FG004|COMPLETED|Overall Study||6
10653601|NCT02195349|11814155|FG005|COMPLETED|Overall Study||6
10653602|NCT02195349|11814156|FG006|COMPLETED|Overall Study||6
10653603|NCT02195349|11814157|FG007|COMPLETED|Overall Study||9
10653604|NCT02195349|11814158|FG008|COMPLETED|Overall Study||6
10653605|NCT02195349|11814159|FG009|COMPLETED|Overall Study||6
10653606|NCT02195349|11814160|FG010|COMPLETED|Overall Study||6
10653607|NCT02195349|11814150|FG000|NOT COMPLETED|Overall Study||0
10653608|NCT02195349|11814151|FG001|NOT COMPLETED|Overall Study||0
10653609|NCT02195349|11814152|FG002|NOT COMPLETED|Overall Study||0
10653610|NCT02195349|11814153|FG003|NOT COMPLETED|Overall Study||0
10653611|NCT02195349|11814154|FG004|NOT COMPLETED|Overall Study||0
10653612|NCT02195349|11814155|FG005|NOT COMPLETED|Overall Study||0
10653613|NCT02195349|11814156|FG006|NOT COMPLETED|Overall Study||0
10653614|NCT02195349|11814157|FG007|NOT COMPLETED|Overall Study||0
10653615|NCT02195349|11814158|FG008|NOT COMPLETED|Overall Study||0
10653616|NCT02195349|11814159|FG009|NOT COMPLETED|Overall Study||0
10653617|NCT02195349|11814160|FG010|NOT COMPLETED|Overall Study||0
10653618|NCT02195414|11814200|FG000|STARTED|Overall Study||31
10653619|NCT02195414|11814200|FG000|Primary Endpoint|Overall Study||31
10653620|NCT02195414|11814200|FG000|COMPLETED|Overall Study||31
10653621|NCT02195414|11814200|FG000|NOT COMPLETED|Overall Study||0
10653622|NCT02195427|11814206|FG000|STARTED|Overall Study||73
10653623|NCT02195427|11814207|FG001|STARTED|Overall Study||74
10653624|NCT02195427|11814206|FG000|N Patients at W24 (Primary Outcome)|Overall Study||67
10653625|NCT02195427|11814207|FG001|N Patients at W24 (Primary Outcome)|Overall Study||62
10653626|NCT02195427|11814206|FG000|N Patients at W36|Overall Study||65
10653627|NCT02195427|11814207|FG001|N Patients at W36|Overall Study||59
10653628|NCT02195427|11814206|FG000|N Patients at W52|Overall Study||63
10653629|NCT02195427|11814207|FG001|N Patients at W52|Overall Study||56
10653630|NCT02195427|11814206|FG000|COMPLETED|Overall Study||47
10653631|NCT02195427|11814207|FG001|COMPLETED|Overall Study||47
10653632|NCT02195427|11814206|FG000|NOT COMPLETED|Overall Study||26
10653633|NCT02195427|11814207|FG001|NOT COMPLETED|Overall Study||27
10653634|NCT02195518|11814217|FG000|STARTED|Overall Study||213
10653635|NCT02195518|11814217|FG000|COMPLETED|Overall Study||204
10653636|NCT02195518|11814217|FG000|NOT COMPLETED|Overall Study||9
10653637|NCT02195531|11814224|FG000|STARTED|Overall Study||64
10653638|NCT02195531|11814225|FG001|STARTED|Overall Study||49
10653639|NCT02195531|11814226|FG002|STARTED|Overall Study||56
10653640|NCT02195531|11814224|FG000|COMPLETED|Overall Study||63
10653641|NCT02195531|11814225|FG001|COMPLETED|Overall Study||48
10653642|NCT02195531|11814226|FG002|COMPLETED|Overall Study||55
10653643|NCT02195531|11814224|FG000|NOT COMPLETED|Overall Study||1
10705417|NCT02598128|11869826|FG003|NOT COMPLETED|Period A: Days -7 to -1||0
10653644|NCT02195531|11814225|FG001|NOT COMPLETED|Overall Study||1
10653645|NCT02195531|11814226|FG002|NOT COMPLETED|Overall Study||1
10653646|NCT02195583|11814234|FG000|STARTED|Overall Study||62
10653647|NCT02195583|11814234|FG000|Sodium Fluoride (1150 Ppm)|Overall Study|Discontinuations: 1 due to other reason in Period 5|57
10653648|NCT02195583|11814234|FG000|Sodium Fluoride (0 Ppm)|Overall Study||59
10653649|NCT02195583|11814234|FG000|Sodium Fluoride (1426 Ppm) + Zinc Base A|Overall Study|Discontinuations: 1 withdrawal of consent in Period 3 and 1 withdrawal of consent in Period 4|58
10653650|NCT02195583|11814234|FG000|Sodium Fluoride (250 Ppm)|Overall Study||55
10653651|NCT02195583|11814234|FG000|Sodium Fluoride (1426 Ppm)|Overall Study|Discontinuation:1 lost to follow up, 1 withdrawal of consent in Period 2, 1 other reason in Period 5|59
10653652|NCT02195583|11814234|FG000|Sodium Fluoride (1426 Ppm) + Zinc Base B|Overall Study|Discontinuations: 1 withdrawal of consent in Period 2;1 adverse event each in Period 3 and Period 4|60
10653653|NCT02195583|11814234|FG000|COMPLETED|Overall Study||53
10653654|NCT02195583|11814234|FG000|NOT COMPLETED|Overall Study||9
10653655|NCT02195622|11814251|FG000|STARTED|Overall Study||37
10653656|NCT02195622|11814252|FG001|STARTED|Overall Study||37
10653657|NCT02195622|11814251|FG000|COMPLETED|Overall Study||37
10653658|NCT02195622|11814252|FG001|COMPLETED|Overall Study||37
10653659|NCT02195622|11814251|FG000|NOT COMPLETED|Overall Study||0
10653660|NCT02195622|11814252|FG001|NOT COMPLETED|Overall Study||0
10705418|NCT02598128|11869823|FG000|STARTED|Period B: Days 1 to 11||0
10628379|NCT02015390|11786996|FG000|STARTED|Overall Study||9
10628380|NCT02015390|11786997|FG001|STARTED|Overall Study||7
10628381|NCT02015390|11786996|FG000|COMPLETED|Overall Study||8
10628382|NCT02015390|11786997|FG001|COMPLETED|Overall Study||3
10628383|NCT02015390|11786996|FG000|NOT COMPLETED|Overall Study||1
10628384|NCT02015390|11786997|FG001|NOT COMPLETED|Overall Study||4
10628385|NCT02015442|11787004|FG000|STARTED|First Intervention (7 Days)||5
10628386|NCT02015442|11787005|FG001|STARTED|First Intervention (7 Days)||4
10628387|NCT02015442|11787004|FG000|COMPLETED|First Intervention (7 Days)||5
10628388|NCT02015442|11787005|FG001|COMPLETED|First Intervention (7 Days)||4
10628389|NCT02015442|11787004|FG000|NOT COMPLETED|First Intervention (7 Days)||0
10628390|NCT02015442|11787005|FG001|NOT COMPLETED|First Intervention (7 Days)||0
10628391|NCT02015442|11787004|FG000|STARTED|Wash-out (4 Weeks)||5
10628392|NCT02015442|11787005|FG001|STARTED|Wash-out (4 Weeks)||4
10628393|NCT02015442|11787004|FG000|COMPLETED|Wash-out (4 Weeks)||5
10628394|NCT02015442|11787005|FG001|COMPLETED|Wash-out (4 Weeks)||4
10628395|NCT02015442|11787004|FG000|NOT COMPLETED|Wash-out (4 Weeks)||0
10628396|NCT02015442|11787005|FG001|NOT COMPLETED|Wash-out (4 Weeks)||0
10628397|NCT02015442|11787004|FG000|STARTED|Second Intervention (7 Days)||5
10628398|NCT02015442|11787005|FG001|STARTED|Second Intervention (7 Days)||4
10628399|NCT02015442|11787004|FG000|COMPLETED|Second Intervention (7 Days)||5
10628400|NCT02015442|11787005|FG001|COMPLETED|Second Intervention (7 Days)||4
10628401|NCT02015442|11787004|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
10628402|NCT02015442|11787005|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
10628403|NCT02015481|11787011|FG000|STARTED|Overall Study||25
10628404|NCT02015481|11787011|FG000|COMPLETED|Overall Study||24
10628405|NCT02015481|11787011|FG000|NOT COMPLETED|Overall Study||1
10628406|NCT02015520|11787020|FG000|STARTED|Overall Study||40
10628407|NCT02015520|11787021|FG001|STARTED|Overall Study||21
10628408|NCT02015520|11787022|FG002|STARTED|Overall Study||42
10628409|NCT02015520|11787023|FG003|STARTED|Overall Study||40
10628410|NCT02015520|11787020|FG000|COMPLETED|Overall Study||35
10628411|NCT02015520|11787021|FG001|COMPLETED|Overall Study||17
10628412|NCT02015520|11787022|FG002|COMPLETED|Overall Study||35
10628413|NCT02015520|11787023|FG003|COMPLETED|Overall Study||36
10628414|NCT02015520|11787020|FG000|NOT COMPLETED|Overall Study||5
10628415|NCT02015520|11787021|FG001|NOT COMPLETED|Overall Study||4
10628416|NCT02015520|11787022|FG002|NOT COMPLETED|Overall Study||7
10628417|NCT02015520|11787023|FG003|NOT COMPLETED|Overall Study||4
10628418|NCT02015546|11787036|FG000|STARTED|Overall Study||23
10628419|NCT02015546|11787037|FG001|STARTED|Overall Study||21
10628420|NCT02015546|11787038|FG002|STARTED|Overall Study||26
10628421|NCT02015546|11787036|FG000|COMPLETED|Overall Study||20
10628422|NCT02015546|11787037|FG001|COMPLETED|Overall Study||19
10628423|NCT02015546|11787038|FG002|COMPLETED|Overall Study||22
10628424|NCT02015546|11787036|FG000|NOT COMPLETED|Overall Study||3
10628425|NCT02015546|11787037|FG001|NOT COMPLETED|Overall Study||2
10628426|NCT02015546|11787038|FG002|NOT COMPLETED|Overall Study||4
10628427|NCT02015637|11787048|FG000|STARTED|Overall Study||306
10628428|NCT02015637|11787049|FG001|STARTED|Overall Study||154
10628429|NCT02015637|11787048|FG000|COMPLETED|Overall Study||298
10628430|NCT02015637|11787049|FG001|COMPLETED|Overall Study||149
10628431|NCT02015637|11787048|FG000|NOT COMPLETED|Overall Study||8
10628432|NCT02015637|11787049|FG001|NOT COMPLETED|Overall Study||5
10628433|NCT02015676|11787058|FG000|STARTED|Overall Study||15
10628434|NCT02015676|11787059|FG001|STARTED|Overall Study||48
10628435|NCT02015676|11787060|FG002|STARTED|Overall Study||6
10628436|NCT02015676|11787058|FG000|COMPLETED|Overall Study||6
10628437|NCT02015676|11787059|FG001|COMPLETED|Overall Study||14
10628438|NCT02015676|11787060|FG002|COMPLETED|Overall Study||3
10628439|NCT02015676|11787058|FG000|NOT COMPLETED|Overall Study||9
10628440|NCT02015676|11787059|FG001|NOT COMPLETED|Overall Study||34
10628441|NCT02015676|11787060|FG002|NOT COMPLETED|Overall Study||3
10628442|NCT02015754|11787064|FG000|STARTED|Overall Study|17 participants were consented, but 3 participants were screened out prior to treatment|14
10628443|NCT02015754|11787064|FG000|Completed First TACE|Overall Study||14
10628444|NCT02015754|11787064|FG000|Completed First Clinical and Imaging|Overall Study|1 patient exited prior to follow-up|13
10628445|NCT02015754|11787064|FG000|COMPLETED|Overall Study||3
10628446|NCT02015754|11787064|FG000|NOT COMPLETED|Overall Study||11
10628447|NCT02015793|11787070|FG000|STARTED|Overall Study||15
10628448|NCT02015793|11787071|FG001|STARTED|Overall Study||15
10628449|NCT02015793|11787070|FG000|Completed Double-Blind Period|Overall Study||14
10628450|NCT02015793|11787071|FG001|Completed Double-Blind Period|Overall Study||14
10628451|NCT02015793|11787070|FG000|Entered Open-label Extension Period|Overall Study||13
10628452|NCT02015793|11787071|FG001|Entered Open-label Extension Period|Overall Study||14
10628453|NCT02015793|11787070|FG000|COMPLETED|Overall Study||11
10628454|NCT02015793|11787071|FG001|COMPLETED|Overall Study||11
10628455|NCT02015793|11787070|FG000|NOT COMPLETED|Overall Study||4
10628456|NCT02015793|11787071|FG001|NOT COMPLETED|Overall Study||4
10628457|NCT02015819|11787087|FG000|STARTED|Overall Study||3
10628458|NCT02015819|11787088|FG001|STARTED|Overall Study||3
10628459|NCT02015819|11787089|FG002|STARTED|Overall Study||3
10628460|NCT02015819|11787090|FG003|STARTED|Overall Study||7
10628461|NCT02015819|11787087|FG000|COMPLETED|Overall Study||3
10628462|NCT02015819|11787088|FG001|COMPLETED|Overall Study||3
10628463|NCT02015819|11787089|FG002|COMPLETED|Overall Study||3
10628464|NCT02015819|11787090|FG003|COMPLETED|Overall Study||6
10628465|NCT02015819|11787087|FG000|NOT COMPLETED|Overall Study||0
10628466|NCT02015819|11787088|FG001|NOT COMPLETED|Overall Study||0
10628467|NCT02015819|11787089|FG002|NOT COMPLETED|Overall Study||0
10628468|NCT02015819|11787090|FG003|NOT COMPLETED|Overall Study||1
10628469|NCT02016105|11787106|FG000|STARTED|TREATMENT PERIOD 1||231
10628470|NCT02016105|11787107|FG001|STARTED|TREATMENT PERIOD 1||234
10628471|NCT02016105|11787108|FG002|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
10628472|NCT02016105|11787109|FG003|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
10628473|NCT02016105|11787110|FG004|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
10628474|NCT02016105|11787111|FG005|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
10628475|NCT02016105|11787106|FG000|COMPLETED|TREATMENT PERIOD 1|12 patients did not proceed into Treatment Period 2|201
10628476|NCT02016105|11787107|FG001|COMPLETED|TREATMENT PERIOD 1|11 patients did not proceed into Treatment Period 2|201
10628477|NCT02016105|11787108|FG002|COMPLETED|TREATMENT PERIOD 1||0
10628478|NCT02016105|11787109|FG003|COMPLETED|TREATMENT PERIOD 1||0
10628479|NCT02016105|11787110|FG004|COMPLETED|TREATMENT PERIOD 1||0
10628480|NCT02016105|11787111|FG005|COMPLETED|TREATMENT PERIOD 1||0
10628481|NCT02016105|11787106|FG000|NOT COMPLETED|TREATMENT PERIOD 1||30
10628482|NCT02016105|11787107|FG001|NOT COMPLETED|TREATMENT PERIOD 1||33
10628483|NCT02016105|11787108|FG002|NOT COMPLETED|TREATMENT PERIOD 1||0
10628484|NCT02016105|11787109|FG003|NOT COMPLETED|TREATMENT PERIOD 1||0
10628485|NCT02016105|11787110|FG004|NOT COMPLETED|TREATMENT PERIOD 1||0
10628486|NCT02016105|11787111|FG005|NOT COMPLETED|TREATMENT PERIOD 1||0
10628487|NCT02016105|11787106|FG000|STARTED|TREATMENT PERIOD 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
10628488|NCT02016105|11787107|FG001|STARTED|TREATMENT PERIOD 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
10628489|NCT02016105|11787108|FG002|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from Humira ® adalimumab treatment arm in Treatment Period 1"|63
10628490|NCT02016105|11787109|FG003|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from Humira ® adalimumab treatment arm in Treatment Period 1"|127
10628491|NCT02016105|11787110|FG004|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from GP2017 adalimumab treatment arm in Treatment Period 1"|63
10628492|NCT02016105|11787111|FG005|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from GP2017 adalimumab treatment arm in Treatment Period 1"|126
10628493|NCT02016105|11787106|FG000|COMPLETED|TREATMENT PERIOD 2||0
10628494|NCT02016105|11787107|FG001|COMPLETED|TREATMENT PERIOD 2||0
10628495|NCT02016105|11787108|FG002|COMPLETED|TREATMENT PERIOD 2||57
10628496|NCT02016105|11787109|FG003|COMPLETED|TREATMENT PERIOD 2||116
10628497|NCT02016105|11787110|FG004|COMPLETED|TREATMENT PERIOD 2||59
10628498|NCT02016105|11787111|FG005|COMPLETED|TREATMENT PERIOD 2||112
10628499|NCT02016105|11787106|FG000|NOT COMPLETED|TREATMENT PERIOD 2||0
10628500|NCT02016105|11787107|FG001|NOT COMPLETED|TREATMENT PERIOD 2||0
10628501|NCT02016105|11787108|FG002|NOT COMPLETED|TREATMENT PERIOD 2||6
10628502|NCT02016105|11787109|FG003|NOT COMPLETED|TREATMENT PERIOD 2||11
10628503|NCT02016105|11787110|FG004|NOT COMPLETED|TREATMENT PERIOD 2||4
10628504|NCT02016105|11787111|FG005|NOT COMPLETED|TREATMENT PERIOD 2||14
10628505|NCT02016105|11787106|FG000|STARTED|EXTENSION PERIOD||0
10628506|NCT02016105|11787107|FG001|STARTED|EXTENSION PERIOD||0
10628507|NCT02016105|11787108|FG002|STARTED|EXTENSION PERIOD|5 patients did not proceed from Treatment Period 2 into Extension Period|52
10628508|NCT02016105|11787109|FG003|STARTED|EXTENSION PERIOD|7 patients did not proceed from Treatment Period 2 into Extension Period|109
10628509|NCT02016105|11787110|FG004|STARTED|EXTENSION PERIOD|3 patients did not proceed from Treatment Period 2 into Extension Period|56
10628510|NCT02016105|11787111|FG005|STARTED|EXTENSION PERIOD|6 patients did not proceed from Treatment Period 2 into Extension Period|106
10628511|NCT02016105|11787106|FG000|COMPLETED|EXTENSION PERIOD||0
10628512|NCT02016105|11787107|FG001|COMPLETED|EXTENSION PERIOD||0
10628513|NCT02016105|11787108|FG002|COMPLETED|EXTENSION PERIOD||47
10628514|NCT02016105|11787109|FG003|COMPLETED|EXTENSION PERIOD||104
10628515|NCT02016105|11787110|FG004|COMPLETED|EXTENSION PERIOD||50
10628516|NCT02016105|11787111|FG005|COMPLETED|EXTENSION PERIOD||100
10628517|NCT02016105|11787106|FG000|NOT COMPLETED|EXTENSION PERIOD||0
10628518|NCT02016105|11787107|FG001|NOT COMPLETED|EXTENSION PERIOD||0
10628519|NCT02016105|11787108|FG002|NOT COMPLETED|EXTENSION PERIOD||5
10628520|NCT02016105|11787109|FG003|NOT COMPLETED|EXTENSION PERIOD||5
10628521|NCT02016105|11787110|FG004|NOT COMPLETED|EXTENSION PERIOD||6
10628522|NCT02016105|11787111|FG005|NOT COMPLETED|EXTENSION PERIOD||6
10628523|NCT02016170|11787128|FG000|STARTED|Overall Study||27
10628524|NCT02016170|11787129|FG001|STARTED|Overall Study||28
10628525|NCT02016170|11787130|FG002|STARTED|Overall Study||27
10628526|NCT02016170|11787128|FG000|COMPLETED|Overall Study||25
10628527|NCT02016170|11787129|FG001|COMPLETED|Overall Study||27
10628528|NCT02016170|11787130|FG002|COMPLETED|Overall Study||27
10628529|NCT02016170|11787128|FG000|NOT COMPLETED|Overall Study||2
10628530|NCT02016170|11787129|FG001|NOT COMPLETED|Overall Study||1
10628531|NCT02016170|11787130|FG002|NOT COMPLETED|Overall Study||0
10628532|NCT02016183|11787137|FG000|STARTED|Overall Study||3222
10628533|NCT02016183|11787137|FG000|COMPLETED|Overall Study||3157
10628534|NCT02016183|11787137|FG000|NOT COMPLETED|Overall Study||65
10628535|NCT02016235|11787144|FG000|STARTED|Overall Study||10
10628536|NCT02016235|11787145|FG001|STARTED|Overall Study||10
10628537|NCT02016235|11787146|FG002|STARTED|Overall Study||10
10628538|NCT02016235|11787144|FG000|COMPLETED|Overall Study||10
10628539|NCT02016235|11787145|FG001|COMPLETED|Overall Study||10
10628540|NCT02016235|11787146|FG002|COMPLETED|Overall Study||10
10628541|NCT02016235|11787144|FG000|NOT COMPLETED|Overall Study||0
10628542|NCT02016235|11787145|FG001|NOT COMPLETED|Overall Study||0
10628543|NCT02016235|11787146|FG002|NOT COMPLETED|Overall Study||0
10628544|NCT02016300|11787156|FG000|STARTED|Overall Study||12
10628545|NCT02016300|11787157|FG001|STARTED|Overall Study||12
10628546|NCT02016300|11787156|FG000|COMPLETED|Overall Study||12
10628547|NCT02016300|11787157|FG001|COMPLETED|Overall Study||9
10628548|NCT02016300|11787156|FG000|NOT COMPLETED|Overall Study||0
10628549|NCT02016300|11787157|FG001|NOT COMPLETED|Overall Study||3
10628550|NCT02016482|11787165|FG000|STARTED|Period A||108
10628551|NCT02016482|11787166|FG001|STARTED|Period A||109
10628552|NCT02016482|11787165|FG000|COMPLETED|Period A|56 participants early escaped to the end of Period A and 38 continued to the end of Period A.|94
10628553|NCT02016482|11787166|FG001|COMPLETED|Period A|8 participants early escaped to the end of Period A and 86 continued to the end of Period A.|94
10628554|NCT02016482|11787165|FG000|NOT COMPLETED|Period A||14
10628555|NCT02016482|11787166|FG001|NOT COMPLETED|Period A||15
10628556|NCT02016482|11787165|FG000|STARTED|Period B||94
10628557|NCT02016482|11787166|FG001|STARTED|Period B||94
10628558|NCT02016482|11787165|FG000|COMPLETED|Period B||81
10628559|NCT02016482|11787166|FG001|COMPLETED|Period B||87
10628560|NCT02016482|11787165|FG000|NOT COMPLETED|Period B||13
10628561|NCT02016482|11787166|FG001|NOT COMPLETED|Period B||7
10628562|NCT02016560|11787180|FG000|STARTED|Exploratory Phase||16
10628563|NCT02016560|11787181|FG001|STARTED|Exploratory Phase||58
10628564|NCT02016560|11787182|FG002|STARTED|Exploratory Phase||98
10628565|NCT02016560|11787183|FG003|STARTED|Exploratory Phase||51
10628566|NCT02016560|11787184|FG004|STARTED|Exploratory Phase||0
10628567|NCT02016560|11787185|FG005|STARTED|Exploratory Phase||0
10628568|NCT02016560|11787180|FG000|COMPLETED|Exploratory Phase||16
10628569|NCT02016560|11787181|FG001|COMPLETED|Exploratory Phase||54
10628570|NCT02016560|11787182|FG002|COMPLETED|Exploratory Phase||62
10628571|NCT02016560|11787183|FG003|COMPLETED|Exploratory Phase||35
10628572|NCT02016560|11787184|FG004|COMPLETED|Exploratory Phase||0
10628573|NCT02016560|11787185|FG005|COMPLETED|Exploratory Phase||0
10628574|NCT02016560|11787180|FG000|NOT COMPLETED|Exploratory Phase||0
10628575|NCT02016560|11787181|FG001|NOT COMPLETED|Exploratory Phase||4
10628576|NCT02016560|11787182|FG002|NOT COMPLETED|Exploratory Phase||36
10628577|NCT02016560|11787183|FG003|NOT COMPLETED|Exploratory Phase||16
10628578|NCT02016560|11787184|FG004|NOT COMPLETED|Exploratory Phase||0
10628579|NCT02016560|11787185|FG005|NOT COMPLETED|Exploratory Phase||0
10628580|NCT02016560|11787180|FG000|STARTED|Confirmatory Phase||0
10628581|NCT02016560|11787181|FG001|STARTED|Confirmatory Phase||0
10628582|NCT02016560|11787182|FG002|STARTED|Confirmatory Phase||0
10628583|NCT02016560|11787183|FG003|STARTED|Confirmatory Phase||0
10628584|NCT02016560|11787184|FG004|STARTED|Confirmatory Phase||98
10628585|NCT02016560|11787185|FG005|STARTED|Confirmatory Phase||62
10628586|NCT02016560|11787180|FG000|COMPLETED|Confirmatory Phase||0
10628587|NCT02016560|11787181|FG001|COMPLETED|Confirmatory Phase||0
10628588|NCT02016560|11787182|FG002|COMPLETED|Confirmatory Phase||0
10628589|NCT02016560|11787183|FG003|COMPLETED|Confirmatory Phase||0
10628590|NCT02016560|11787184|FG004|COMPLETED|Confirmatory Phase||76
10628591|NCT02016560|11787185|FG005|COMPLETED|Confirmatory Phase||35
10628592|NCT02016560|11787180|FG000|NOT COMPLETED|Confirmatory Phase||0
10628593|NCT02016560|11787181|FG001|NOT COMPLETED|Confirmatory Phase||0
10628594|NCT02016560|11787182|FG002|NOT COMPLETED|Confirmatory Phase||0
10628595|NCT02016560|11787183|FG003|NOT COMPLETED|Confirmatory Phase||0
10628596|NCT02016560|11787184|FG004|NOT COMPLETED|Confirmatory Phase||22
10628597|NCT02016560|11787185|FG005|NOT COMPLETED|Confirmatory Phase||27
10628598|NCT02016612|11787211|FG000|STARTED|Overall Study||25
10628599|NCT02016612|11787212|FG001|STARTED|Overall Study||25
10628600|NCT02016612|11787213|FG002|STARTED|Overall Study||26
10628601|NCT02016612|11787214|FG003|STARTED|Overall Study||61
10628602|NCT02016612|11787211|FG000|COMPLETED|Overall Study||25
10628603|NCT02016612|11787212|FG001|COMPLETED|Overall Study||25
10628604|NCT02016612|11787213|FG002|COMPLETED|Overall Study||26
10628605|NCT02016612|11787214|FG003|COMPLETED|Overall Study||61
10628606|NCT02016612|11787211|FG000|NOT COMPLETED|Overall Study||0
10628607|NCT02016612|11787212|FG001|NOT COMPLETED|Overall Study||0
10628608|NCT02016612|11787213|FG002|NOT COMPLETED|Overall Study||0
10333919|NCT00336492|11470158|FG000|COMPLETED|Overall Study||0
10628609|NCT02016612|11787214|FG003|NOT COMPLETED|Overall Study||0
10628610|NCT02016625|11787226|FG000|STARTED|Cyclo or Tac (Single Dose, Day 1)||16
10628611|NCT02016625|11787227|FG001|STARTED|Cyclo or Tac (Single Dose, Day 1)||16
10628612|NCT02016625|11787226|FG000|COMPLETED|Cyclo or Tac (Single Dose, Day 1)||16
10628613|NCT02016625|11787227|FG001|COMPLETED|Cyclo or Tac (Single Dose, Day 1)||15
10628614|NCT02016625|11787226|FG000|NOT COMPLETED|Cyclo or Tac (Single Dose, Day 1)||0
10628615|NCT02016625|11787227|FG001|NOT COMPLETED|Cyclo or Tac (Single Dose, Day 1)||1
10628616|NCT02016625|11787226|FG000|STARTED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||16
10628617|NCT02016625|11787227|FG001|STARTED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||15
10628618|NCT02016625|11787226|FG000|COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||13
10628619|NCT02016625|11787227|FG001|COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||15
10628620|NCT02016625|11787226|FG000|NOT COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||3
10628621|NCT02016625|11787227|FG001|NOT COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||0
10628622|NCT02016690|11787243|FG000|STARTED|Overall Study||312
10628623|NCT02016690|11787243|FG000|Treated|Overall Study||312
10628624|NCT02016690|11787243|FG000|Safety Analysis Set (SAS)|Overall Study||304
10628625|NCT02016690|11787243|FG000|COMPLETED|Overall Study|(Effectiveness analysis set)|288
10628626|NCT02016690|11787243|FG000|NOT COMPLETED|Overall Study||24
10628627|NCT02016716|11787250|FG000|STARTED|Overall Study||53
10628628|NCT02016716|11787251|FG001|STARTED|Overall Study||118
10628629|NCT02016716|11787252|FG002|STARTED|Overall Study||123
10628630|NCT02016716|11787250|FG000|Received Study Treatment|Overall Study||53
10628631|NCT02016716|11787251|FG001|Received Study Treatment|Overall Study||118
10628632|NCT02016716|11787252|FG002|Received Study Treatment|Overall Study||123
10628633|NCT02016716|11787250|FG000|COMPLETED|Overall Study||47
10628634|NCT02016716|11787251|FG001|COMPLETED|Overall Study||110
10628635|NCT02016716|11787252|FG002|COMPLETED|Overall Study||117
10628636|NCT02016716|11787250|FG000|NOT COMPLETED|Overall Study||6
10628637|NCT02016716|11787251|FG001|NOT COMPLETED|Overall Study||8
10628638|NCT02016716|11787252|FG002|NOT COMPLETED|Overall Study||6
10628639|NCT02016755|11787261|FG000|STARTED|Overall Study||10
10628640|NCT02016755|11787261|FG000|Completed Month 18 Clinic Visit|Overall Study||5
10628641|NCT02016755|11787261|FG000|Completed Month 36 LTFU Questionnaire|Overall Study||3
10628642|NCT02016755|11787261|FG000|COMPLETED|Overall Study||3
10628643|NCT02016755|11787261|FG000|NOT COMPLETED|Overall Study||7
10628644|NCT02016885|11787270|FG000|STARTED|Overall Study||38
10628645|NCT02016885|11787271|FG001|STARTED|Overall Study||40
10628646|NCT02016885|11787272|FG002|STARTED|Overall Study||40
10628647|NCT02016885|11787273|FG003|STARTED|Overall Study||40
10628648|NCT02016885|11787274|FG004|STARTED|Overall Study||40
10628649|NCT02016885|11787270|FG000|COMPLETED|Overall Study||34
10628650|NCT02016885|11787271|FG001|COMPLETED|Overall Study||36
10628651|NCT02016885|11787272|FG002|COMPLETED|Overall Study||39
10628652|NCT02016885|11787273|FG003|COMPLETED|Overall Study||30
10628653|NCT02016885|11787274|FG004|COMPLETED|Overall Study||39
10628654|NCT02016885|11787270|FG000|NOT COMPLETED|Overall Study||4
10628655|NCT02016885|11787271|FG001|NOT COMPLETED|Overall Study||4
10628656|NCT02016885|11787272|FG002|NOT COMPLETED|Overall Study||1
10628657|NCT02016885|11787273|FG003|NOT COMPLETED|Overall Study||10
10628658|NCT02016885|11787274|FG004|NOT COMPLETED|Overall Study||1
10628659|NCT02016898|11787288|FG000|STARTED|Overall Study||50
10333920|NCT00336492|11470159|FG001|COMPLETED|Overall Study||18
10333921|NCT00336492|11470160|FG002|COMPLETED|Overall Study||12
10333922|NCT00336492|11470158|FG000|NOT COMPLETED|Overall Study||15
10333923|NCT00336492|11470159|FG001|NOT COMPLETED|Overall Study||4
10333924|NCT00336492|11470160|FG002|NOT COMPLETED|Overall Study||11
10628660|NCT02016898|11787289|FG001|STARTED|Overall Study||45
10628661|NCT02016898|11787288|FG000|COMPLETED|Overall Study||45
10628662|NCT02016898|11787289|FG001|COMPLETED|Overall Study||40
10628663|NCT02016898|11787288|FG000|NOT COMPLETED|Overall Study||5
10628664|NCT02016898|11787289|FG001|NOT COMPLETED|Overall Study||5
10628665|NCT02016963|11787295|FG000|STARTED|Overall Study||20
10628666|NCT02016963|11787295|FG000|COMPLETED|Overall Study||20
10628667|NCT02016963|11787295|FG000|NOT COMPLETED|Overall Study||0
10628668|NCT02017015|11787300|FG000|STARTED|Overall Study||83
10628669|NCT02017015|11787300|FG000|Safety Population|Overall Study||83
10628670|NCT02017015|11787300|FG000|COMPLETED|Overall Study|Completed = Participants remaining on treatment at the time of the data cut-off of 01 Jun 2015|14
10628671|NCT02017015|11787300|FG000|NOT COMPLETED|Overall Study||69
10628672|NCT02017093|11787307|FG000|STARTED|Overall Study||4
10628673|NCT02017093|11787308|FG001|STARTED|Overall Study||3
10628674|NCT02017093|11787307|FG000|COMPLETED|Overall Study||4
10628675|NCT02017093|11787308|FG001|COMPLETED|Overall Study||3
10628676|NCT02017093|11787307|FG000|NOT COMPLETED|Overall Study||0
10628677|NCT02017093|11787308|FG001|NOT COMPLETED|Overall Study||0
10628678|NCT02017171|11787318|FG000|STARTED|Overall Study||267
10628679|NCT02017171|11787319|FG001|STARTED|Overall Study||263
10628680|NCT02017171|11787318|FG000|COMPLETED|Overall Study||205
10628681|NCT02017171|11787319|FG001|COMPLETED|Overall Study||217
10628682|NCT02017171|11787318|FG000|NOT COMPLETED|Overall Study||62
10628683|NCT02017171|11787319|FG001|NOT COMPLETED|Overall Study||46
10628684|NCT02017210|11787329|FG000|STARTED|Overall Study||17
10628685|NCT02017210|11787330|FG001|STARTED|Overall Study||20
10628686|NCT02017210|11787331|FG002|STARTED|Overall Study||20
10628687|NCT02017210|11787329|FG000|COMPLETED|Overall Study||17
10628688|NCT02017210|11787330|FG001|COMPLETED|Overall Study||20
10628689|NCT02017210|11787331|FG002|COMPLETED|Overall Study||20
10628690|NCT02017210|11787329|FG000|NOT COMPLETED|Overall Study||0
10628691|NCT02017210|11787330|FG001|NOT COMPLETED|Overall Study||0
10628692|NCT02017210|11787331|FG002|NOT COMPLETED|Overall Study||0
10628693|NCT02017223|11787342|FG000|STARTED|Overall Study||12
10628694|NCT02017223|11787342|FG000|COMPLETED|Overall Study||10
10628695|NCT02017223|11787342|FG000|NOT COMPLETED|Overall Study||2
10628696|NCT02017327|11787349|FG000|STARTED|Overall Study||122
10628697|NCT02017327|11787350|FG001|STARTED|Overall Study||125
10628698|NCT02017327|11787351|FG002|STARTED|Overall Study||132
10628699|NCT02017327|11787349|FG000|COMPLETED|Overall Study||106
10628700|NCT02017327|11787350|FG001|COMPLETED|Overall Study||113
10628701|NCT02017327|11787351|FG002|COMPLETED|Overall Study||117
10628702|NCT02017327|11787349|FG000|NOT COMPLETED|Overall Study||16
10628703|NCT02017327|11787350|FG001|NOT COMPLETED|Overall Study||12
10628704|NCT02017327|11787351|FG002|NOT COMPLETED|Overall Study||15
10628705|NCT02017444|11787361|FG000|STARTED|Overall Study||14
10628706|NCT02017444|11787362|FG001|STARTED|Overall Study||17
10628707|NCT02017444|11787361|FG000|COMPLETED|Overall Study||12
10628708|NCT02017444|11787362|FG001|COMPLETED|Overall Study|NB: One participant did not complete primary outcome.|17
10628709|NCT02017444|11787361|FG000|NOT COMPLETED|Overall Study||2
10628710|NCT02017444|11787362|FG001|NOT COMPLETED|Overall Study||0
10628711|NCT02017535|11787372|FG000|STARTED|Overall Study||9
10628712|NCT02017535|11787373|FG001|STARTED|Overall Study||3
10628713|NCT02017535|11787374|FG002|STARTED|Overall Study||2
10628714|NCT02017535|11787375|FG003|STARTED|Overall Study||1
10628715|NCT02017535|11787372|FG000|COMPLETED|Overall Study||8
10628716|NCT02017535|11787373|FG001|COMPLETED|Overall Study||3
10628717|NCT02017535|11787374|FG002|COMPLETED|Overall Study||2
10628718|NCT02017535|11787375|FG003|COMPLETED|Overall Study||1
10628719|NCT02017535|11787372|FG000|NOT COMPLETED|Overall Study||1
10628720|NCT02017535|11787373|FG001|NOT COMPLETED|Overall Study||0
10628721|NCT02017535|11787374|FG002|NOT COMPLETED|Overall Study||0
10628722|NCT02017535|11787375|FG003|NOT COMPLETED|Overall Study||0
10628723|NCT02017574|11787387|FG000|STARTED|Overall Study||12
10628724|NCT02017574|11787388|FG001|STARTED|Overall Study||12
10628725|NCT02017574|11787387|FG000|COMPLETED|Overall Study||12
10628726|NCT02017574|11787388|FG001|COMPLETED|Overall Study||12
10628727|NCT02017574|11787387|FG000|NOT COMPLETED|Overall Study||0
10628728|NCT02017574|11787388|FG001|NOT COMPLETED|Overall Study||0
10628729|NCT02017860|11787394|FG000|STARTED|Overall Study||4
10628730|NCT02017860|11787394|FG000|COMPLETED|Overall Study||2
10628731|NCT02017860|11787394|FG000|NOT COMPLETED|Overall Study||2
10628732|NCT02017899|11787404|FG000|STARTED|Overall Study||8
10628733|NCT02017899|11787405|FG001|STARTED|Overall Study||9
10628734|NCT02017899|11787406|FG002|STARTED|Overall Study||8
10628735|NCT02017899|11787407|FG003|STARTED|Overall Study||8
10628736|NCT02017899|11787408|FG004|STARTED|Overall Study||9
10628737|NCT02017899|11787409|FG005|STARTED|Overall Study||8
10628738|NCT02017899|11787404|FG000|COMPLETED|Overall Study||8
10628739|NCT02017899|11787405|FG001|COMPLETED|Overall Study||9
10628740|NCT02017899|11787406|FG002|COMPLETED|Overall Study||8
10628741|NCT02017899|11787407|FG003|COMPLETED|Overall Study||7
10628742|NCT02017899|11787408|FG004|COMPLETED|Overall Study||8
10628743|NCT02017899|11787409|FG005|COMPLETED|Overall Study||8
10628744|NCT02017899|11787404|FG000|NOT COMPLETED|Overall Study||0
10628745|NCT02017899|11787405|FG001|NOT COMPLETED|Overall Study||0
10628746|NCT02017899|11787406|FG002|NOT COMPLETED|Overall Study||0
10628747|NCT02017899|11787407|FG003|NOT COMPLETED|Overall Study||1
10628748|NCT02017899|11787408|FG004|NOT COMPLETED|Overall Study||1
10628749|NCT02017899|11787409|FG005|NOT COMPLETED|Overall Study||0
10628750|NCT02018042|11787423|FG000|STARTED|Overall Study||15
10628751|NCT02018042|11787423|FG000|COMPLETED|Overall Study||14
10628752|NCT02018042|11787423|FG000|NOT COMPLETED|Overall Study||1
10628753|NCT02018107|11787427|FG000|STARTED|Overall Study||27
10628754|NCT02018107|11787427|FG000|COMPLETED|Overall Study||27
10628755|NCT02018107|11787427|FG000|NOT COMPLETED|Overall Study||0
10628756|NCT02018315|11787431|FG000|STARTED|Overall Study||14
10628757|NCT02018315|11787431|FG000|COMPLETED|Overall Study||14
10628758|NCT02018315|11787431|FG000|NOT COMPLETED|Overall Study||0
10628759|NCT02018445|11787435|FG000|STARTED|Overall Study||36
10628760|NCT02018445|11787435|FG000|COMPLETED|Overall Study||29
10628761|NCT02018445|11787435|FG000|NOT COMPLETED|Overall Study||7
10628762|NCT02018458|11787442|FG000|STARTED|Overall Study||10
10628763|NCT02018458|11787442|FG000|COMPLETED|Overall Study||6
10628764|NCT02018458|11787442|FG000|NOT COMPLETED|Overall Study||4
10628765|NCT02018562|11787448|FG000|STARTED|Overall Study||25
10628766|NCT02018562|11787449|FG001|STARTED|Overall Study||25
10628767|NCT02018562|11787448|FG000|COMPLETED|Overall Study||22
10628768|NCT02018562|11787449|FG001|COMPLETED|Overall Study||25
10628769|NCT02018562|11787448|FG000|NOT COMPLETED|Overall Study||3
10628770|NCT02018562|11787449|FG001|NOT COMPLETED|Overall Study||0
10628771|NCT02018627|11787457|FG000|STARTED|Overall Study||7
10628772|NCT02018627|11787458|FG001|STARTED|Overall Study||6
10628773|NCT02018627|11787457|FG000|COMPLETED|Overall Study||7
10628774|NCT02018627|11787458|FG001|COMPLETED|Overall Study||6
10628775|NCT02018627|11787457|FG000|NOT COMPLETED|Overall Study||0
10628776|NCT02018627|11787458|FG001|NOT COMPLETED|Overall Study||0
10628777|NCT02018653|11787466|FG000|STARTED|Overall Study||1
10628778|NCT02018653|11787467|FG001|STARTED|Overall Study||1
10628779|NCT02018653|11787466|FG000|COMPLETED|Overall Study||1
10628780|NCT02018653|11787467|FG001|COMPLETED|Overall Study||0
10628781|NCT02018653|11787466|FG000|NOT COMPLETED|Overall Study||0
10628782|NCT02018653|11787467|FG001|NOT COMPLETED|Overall Study||1
10628783|NCT02018809|11787477|FG000|STARTED|Overall Study||50
10628784|NCT02018809|11787478|FG001|STARTED|Overall Study||50
10628785|NCT02018809|11787479|FG002|STARTED|Overall Study||50
10628786|NCT02018809|11787480|FG003|STARTED|Overall Study||50
10628787|NCT02018809|11787477|FG000|COMPLETED|Overall Study||50
10628788|NCT02018809|11787478|FG001|COMPLETED|Overall Study||50
10628789|NCT02018809|11787479|FG002|COMPLETED|Overall Study||50
10628790|NCT02018809|11787480|FG003|COMPLETED|Overall Study||50
10628791|NCT02018809|11787477|FG000|NOT COMPLETED|Overall Study||0
10628792|NCT02018809|11787478|FG001|NOT COMPLETED|Overall Study||0
10628793|NCT02018809|11787479|FG002|NOT COMPLETED|Overall Study||0
10628794|NCT02018809|11787480|FG003|NOT COMPLETED|Overall Study||0
10628795|NCT02018822|11787492|FG000|STARTED|Overall Study||50
10628796|NCT02018822|11787493|FG001|STARTED|Overall Study||50
10628797|NCT02018822|11787494|FG002|STARTED|Overall Study||35
10628798|NCT02018822|11787492|FG000|COMPLETED|Overall Study||44
10628799|NCT02018822|11787493|FG001|COMPLETED|Overall Study||42
10628800|NCT02018822|11787494|FG002|COMPLETED|Overall Study||29
10628801|NCT02018822|11787492|FG000|NOT COMPLETED|Overall Study||6
10628802|NCT02018822|11787493|FG001|NOT COMPLETED|Overall Study||8
10628803|NCT02018822|11787494|FG002|NOT COMPLETED|Overall Study||6
10628804|NCT02018887|11787513|FG000|STARTED|Part A: Cohorts 1-2: Period 1||9
10628805|NCT02018887|11787514|FG001|STARTED|Part A: Cohorts 1-2: Period 1||9
10628806|NCT02018887|11787515|FG002|STARTED|Part A: Cohorts 1-2: Period 1|Placebo was not administered in this period.|0
10628807|NCT02018887|11787516|FG003|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
10628808|NCT02018887|11787517|FG004|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
10628809|NCT02018887|11787518|FG005|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
10628810|NCT02018887|11787519|FG006|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
10628811|NCT02018887|11787520|FG007|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
10628812|NCT02018887|11787521|FG008|STARTED|Part A: Cohorts 1-2: Period 1|Placebo was not administered in this period.|0
10628813|NCT02018887|11787522|FG009|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
10628814|NCT02018887|11787523|FG010|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
10628815|NCT02018887|11787513|FG000|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||9
10628816|NCT02018887|11787514|FG001|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||9
10628817|NCT02018887|11787515|FG002|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
10628818|NCT02018887|11787516|FG003|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
10628819|NCT02018887|11787517|FG004|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
10628820|NCT02018887|11787518|FG005|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
10628821|NCT02018887|11787519|FG006|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
10628822|NCT02018887|11787520|FG007|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
10628823|NCT02018887|11787521|FG008|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
10628824|NCT02018887|11787522|FG009|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
10628825|NCT02018887|11787523|FG010|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
10628826|NCT02018887|11787513|FG000|COMPLETED|Part A: Cohorts 1-2: Period 1||9
10628827|NCT02018887|11787514|FG001|COMPLETED|Part A: Cohorts 1-2: Period 1||9
10628828|NCT02018887|11787515|FG002|COMPLETED|Part A: Cohorts 1-2: Period 1||0
10628829|NCT02018887|11787516|FG003|COMPLETED|Part A: Cohorts 1-2: Period 1||0
10628830|NCT02018887|11787517|FG004|COMPLETED|Part A: Cohorts 1-2: Period 1||0
10628831|NCT02018887|11787518|FG005|COMPLETED|Part A: Cohorts 1-2: Period 1||0
10628832|NCT02018887|11787519|FG006|COMPLETED|Part A: Cohorts 1-2: Period 1||0
10628833|NCT02018887|11787520|FG007|COMPLETED|Part A: Cohorts 1-2: Period 1||0
10628834|NCT02018887|11787521|FG008|COMPLETED|Part A: Cohorts 1-2: Period 1||0
10628835|NCT02018887|11787522|FG009|COMPLETED|Part A: Cohorts 1-2: Period 1||0
10628836|NCT02018887|11787523|FG010|COMPLETED|Part A: Cohorts 1-2: Period 1||0
10628837|NCT02018887|11787513|FG000|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
10628838|NCT02018887|11787514|FG001|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
10628839|NCT02018887|11787515|FG002|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
10628840|NCT02018887|11787516|FG003|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
10628841|NCT02018887|11787517|FG004|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
10628842|NCT02018887|11787518|FG005|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
10628843|NCT02018887|11787519|FG006|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
10628844|NCT02018887|11787520|FG007|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
10628845|NCT02018887|11787521|FG008|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
10628846|NCT02018887|11787522|FG009|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
10628847|NCT02018887|11787523|FG010|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
10628848|NCT02018887|11787513|FG000|STARTED|Part A: Cohorts 1-2: Period 2||9
10628849|NCT02018887|11787514|FG001|STARTED|Part A: Cohorts 1-2: Period 2||9
10628850|NCT02018887|11787515|FG002|STARTED|Part A: Cohorts 1-2: Period 2|Placebo was not administered in this period.|0
10628851|NCT02018887|11787516|FG003|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
10628852|NCT02018887|11787517|FG004|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
10628853|NCT02018887|11787518|FG005|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
10628854|NCT02018887|11787519|FG006|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
10628855|NCT02018887|11787520|FG007|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
10628856|NCT02018887|11787521|FG008|STARTED|Part A: Cohorts 1-2: Period 2|Placebo was not administered in this period.|0
10628857|NCT02018887|11787522|FG009|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
10628858|NCT02018887|11787523|FG010|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
10628859|NCT02018887|11787513|FG000|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||9
10628860|NCT02018887|11787514|FG001|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||9
10628861|NCT02018887|11787515|FG002|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
10628862|NCT02018887|11787516|FG003|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
10628863|NCT02018887|11787517|FG004|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
10628864|NCT02018887|11787518|FG005|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
10628865|NCT02018887|11787519|FG006|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
10628866|NCT02018887|11787520|FG007|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
10628867|NCT02018887|11787521|FG008|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
10628868|NCT02018887|11787522|FG009|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
10628869|NCT02018887|11787523|FG010|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
10628870|NCT02018887|11787513|FG000|COMPLETED|Part A: Cohorts 1-2: Period 2||9
10628871|NCT02018887|11787514|FG001|COMPLETED|Part A: Cohorts 1-2: Period 2||9
10628872|NCT02018887|11787515|FG002|COMPLETED|Part A: Cohorts 1-2: Period 2||0
10628873|NCT02018887|11787516|FG003|COMPLETED|Part A: Cohorts 1-2: Period 2||0
10628874|NCT02018887|11787517|FG004|COMPLETED|Part A: Cohorts 1-2: Period 2||0
10628875|NCT02018887|11787518|FG005|COMPLETED|Part A: Cohorts 1-2: Period 2||0
10628876|NCT02018887|11787519|FG006|COMPLETED|Part A: Cohorts 1-2: Period 2||0
10628877|NCT02018887|11787520|FG007|COMPLETED|Part A: Cohorts 1-2: Period 2||0
10628878|NCT02018887|11787521|FG008|COMPLETED|Part A: Cohorts 1-2: Period 2||0
10628879|NCT02018887|11787522|FG009|COMPLETED|Part A: Cohorts 1-2: Period 2||0
10628880|NCT02018887|11787523|FG010|COMPLETED|Part A: Cohorts 1-2: Period 2||0
10628881|NCT02018887|11787513|FG000|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
10628882|NCT02018887|11787514|FG001|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
10628883|NCT02018887|11787515|FG002|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
10628884|NCT02018887|11787516|FG003|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
10628885|NCT02018887|11787517|FG004|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
10628886|NCT02018887|11787518|FG005|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
10628887|NCT02018887|11787519|FG006|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
10628888|NCT02018887|11787520|FG007|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
10628889|NCT02018887|11787521|FG008|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
10628890|NCT02018887|11787522|FG009|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
10628891|NCT02018887|11787523|FG010|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
10628892|NCT02018887|11787513|FG000|STARTED|Part A: Cohorts 1-2: Period 3||9
10628893|NCT02018887|11787514|FG001|STARTED|Part A: Cohorts 1-2: Period 3||9
10628894|NCT02018887|11787515|FG002|STARTED|Part A: Cohorts 1-2: Period 3|Placebo was not administered in this period.|0
10628895|NCT02018887|11787516|FG003|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
10628896|NCT02018887|11787517|FG004|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
10628897|NCT02018887|11787518|FG005|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
10628898|NCT02018887|11787519|FG006|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
10628899|NCT02018887|11787520|FG007|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
10653661|NCT02195687|11814260|FG000|STARTED|Overall Study||316
10628900|NCT02018887|11787521|FG008|STARTED|Part A: Cohorts 1-2: Period 3|Placebo was not administered in this period.|0
10628901|NCT02018887|11787522|FG009|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
10628902|NCT02018887|11787523|FG010|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
10628903|NCT02018887|11787513|FG000|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||8
10628904|NCT02018887|11787514|FG001|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||9
10628905|NCT02018887|11787515|FG002|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
10628906|NCT02018887|11787516|FG003|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
10628907|NCT02018887|11787517|FG004|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
10628908|NCT02018887|11787518|FG005|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
10628909|NCT02018887|11787519|FG006|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
10628910|NCT02018887|11787520|FG007|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
10628911|NCT02018887|11787521|FG008|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
10628912|NCT02018887|11787522|FG009|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
10628913|NCT02018887|11787523|FG010|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
10628914|NCT02018887|11787513|FG000|COMPLETED|Part A: Cohorts 1-2: Period 3||8
10628915|NCT02018887|11787514|FG001|COMPLETED|Part A: Cohorts 1-2: Period 3||9
10628916|NCT02018887|11787515|FG002|COMPLETED|Part A: Cohorts 1-2: Period 3||0
10628917|NCT02018887|11787516|FG003|COMPLETED|Part A: Cohorts 1-2: Period 3||0
10628918|NCT02018887|11787517|FG004|COMPLETED|Part A: Cohorts 1-2: Period 3||0
10628919|NCT02018887|11787518|FG005|COMPLETED|Part A: Cohorts 1-2: Period 3||0
10628920|NCT02018887|11787519|FG006|COMPLETED|Part A: Cohorts 1-2: Period 3||0
10628921|NCT02018887|11787520|FG007|COMPLETED|Part A: Cohorts 1-2: Period 3||0
10628922|NCT02018887|11787521|FG008|COMPLETED|Part A: Cohorts 1-2: Period 3||0
10628923|NCT02018887|11787522|FG009|COMPLETED|Part A: Cohorts 1-2: Period 3||0
10628924|NCT02018887|11787523|FG010|COMPLETED|Part A: Cohorts 1-2: Period 3||0
10628925|NCT02018887|11787513|FG000|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||1
10628926|NCT02018887|11787514|FG001|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
10628927|NCT02018887|11787515|FG002|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
10628928|NCT02018887|11787516|FG003|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
10628929|NCT02018887|11787517|FG004|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
10628930|NCT02018887|11787518|FG005|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
10628931|NCT02018887|11787519|FG006|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
10628932|NCT02018887|11787520|FG007|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
10628933|NCT02018887|11787521|FG008|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
10628934|NCT02018887|11787522|FG009|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
10628935|NCT02018887|11787523|FG010|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
10628936|NCT02018887|11787513|FG000|STARTED|Part B: Cohorts 3-7 Overall|Column for Part A data only.|0
10628937|NCT02018887|11787514|FG001|STARTED|Part B: Cohorts 3-7 Overall|Column for Part A data only.|0
10628938|NCT02018887|11787515|FG002|STARTED|Part B: Cohorts 3-7 Overall||15
10628939|NCT02018887|11787516|FG003|STARTED|Part B: Cohorts 3-7 Overall||9
10628940|NCT02018887|11787517|FG004|STARTED|Part B: Cohorts 3-7 Overall||9
10628941|NCT02018887|11787518|FG005|STARTED|Part B: Cohorts 3-7 Overall||9
10628942|NCT02018887|11787519|FG006|STARTED|Part B: Cohorts 3-7 Overall||9
10628943|NCT02018887|11787520|FG007|STARTED|Part B: Cohorts 3-7 Overall||9
10628944|NCT02018887|11787521|FG008|STARTED|Part B: Cohorts 3-7 Overall|Placebo was not administered in this period.|0
10628945|NCT02018887|11787522|FG009|STARTED|Part B: Cohorts 3-7 Overall|This dose was not administered in this period.|0
10628946|NCT02018887|11787523|FG010|STARTED|Part B: Cohorts 3-7 Overall|This dose was not administered in this period.|0
10628947|NCT02018887|11787513|FG000|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
10628948|NCT02018887|11787514|FG001|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
10628949|NCT02018887|11787515|FG002|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||15
10628950|NCT02018887|11787516|FG003|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
10628951|NCT02018887|11787517|FG004|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
10628952|NCT02018887|11787518|FG005|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
10628953|NCT02018887|11787519|FG006|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
10628954|NCT02018887|11787520|FG007|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
10628955|NCT02018887|11787521|FG008|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
10628956|NCT02018887|11787522|FG009|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
10628957|NCT02018887|11787523|FG010|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
10628958|NCT02018887|11787513|FG000|COMPLETED|Part B: Cohorts 3-7 Overall||0
10628959|NCT02018887|11787514|FG001|COMPLETED|Part B: Cohorts 3-7 Overall||0
10628960|NCT02018887|11787515|FG002|COMPLETED|Part B: Cohorts 3-7 Overall||15
10628961|NCT02018887|11787516|FG003|COMPLETED|Part B: Cohorts 3-7 Overall||9
10628962|NCT02018887|11787517|FG004|COMPLETED|Part B: Cohorts 3-7 Overall||8
10628963|NCT02018887|11787518|FG005|COMPLETED|Part B: Cohorts 3-7 Overall||9
10628964|NCT02018887|11787519|FG006|COMPLETED|Part B: Cohorts 3-7 Overall||8
10628965|NCT02018887|11787520|FG007|COMPLETED|Part B: Cohorts 3-7 Overall||5
10628966|NCT02018887|11787521|FG008|COMPLETED|Part B: Cohorts 3-7 Overall||0
10628967|NCT02018887|11787522|FG009|COMPLETED|Part B: Cohorts 3-7 Overall||0
10628968|NCT02018887|11787523|FG010|COMPLETED|Part B: Cohorts 3-7 Overall||0
10705419|NCT02598128|11869824|FG001|STARTED|Period B: Days 1 to 11||17
10705420|NCT02598128|11869825|FG002|STARTED|Period B: Days 1 to 11||16
10628969|NCT02018887|11787513|FG000|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
10628970|NCT02018887|11787514|FG001|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
10628971|NCT02018887|11787515|FG002|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
10628972|NCT02018887|11787516|FG003|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
10628973|NCT02018887|11787517|FG004|NOT COMPLETED|Part B: Cohorts 3-7 Overall||1
10628974|NCT02018887|11787518|FG005|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
10628975|NCT02018887|11787519|FG006|NOT COMPLETED|Part B: Cohorts 3-7 Overall||1
10628976|NCT02018887|11787520|FG007|NOT COMPLETED|Part B: Cohorts 3-7 Overall||4
10628977|NCT02018887|11787521|FG008|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
10628978|NCT02018887|11787522|FG009|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
10628979|NCT02018887|11787523|FG010|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
10628980|NCT02018887|11787513|FG000|STARTED|Part C: Cohort 8 Overall||0
10628981|NCT02018887|11787514|FG001|STARTED|Part C: Cohort 8 Overall||0
10628982|NCT02018887|11787515|FG002|STARTED|Part C: Cohort 8 Overall|Placebo was not administered in this period.|0
10628983|NCT02018887|11787516|FG003|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
10628984|NCT02018887|11787517|FG004|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
10628985|NCT02018887|11787518|FG005|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
10628986|NCT02018887|11787519|FG006|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
10628987|NCT02018887|11787520|FG007|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
10628988|NCT02018887|11787521|FG008|STARTED|Part C: Cohort 8 Overall||10
10628989|NCT02018887|11787522|FG009|STARTED|Part C: Cohort 8 Overall||4
10628990|NCT02018887|11787523|FG010|STARTED|Part C: Cohort 8 Overall||7
10628991|NCT02018887|11787513|FG000|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
10628992|NCT02018887|11787514|FG001|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
10628993|NCT02018887|11787515|FG002|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
10628994|NCT02018887|11787516|FG003|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
10628995|NCT02018887|11787517|FG004|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
10628996|NCT02018887|11787518|FG005|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
10628997|NCT02018887|11787519|FG006|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
10628998|NCT02018887|11787520|FG007|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
10628999|NCT02018887|11787521|FG008|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||10
10629000|NCT02018887|11787522|FG009|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||4
10629001|NCT02018887|11787523|FG010|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||7
10629002|NCT02018887|11787513|FG000|COMPLETED|Part C: Cohort 8 Overall||0
10629003|NCT02018887|11787514|FG001|COMPLETED|Part C: Cohort 8 Overall||0
10629004|NCT02018887|11787515|FG002|COMPLETED|Part C: Cohort 8 Overall||0
10629005|NCT02018887|11787516|FG003|COMPLETED|Part C: Cohort 8 Overall||0
10629006|NCT02018887|11787517|FG004|COMPLETED|Part C: Cohort 8 Overall||0
10629007|NCT02018887|11787518|FG005|COMPLETED|Part C: Cohort 8 Overall||0
10629008|NCT02018887|11787519|FG006|COMPLETED|Part C: Cohort 8 Overall||0
10629009|NCT02018887|11787520|FG007|COMPLETED|Part C: Cohort 8 Overall||0
10629010|NCT02018887|11787521|FG008|COMPLETED|Part C: Cohort 8 Overall||7
10629011|NCT02018887|11787522|FG009|COMPLETED|Part C: Cohort 8 Overall||1
10629012|NCT02018887|11787523|FG010|COMPLETED|Part C: Cohort 8 Overall||6
10629013|NCT02018887|11787513|FG000|NOT COMPLETED|Part C: Cohort 8 Overall||0
10629014|NCT02018887|11787514|FG001|NOT COMPLETED|Part C: Cohort 8 Overall||0
10629015|NCT02018887|11787515|FG002|NOT COMPLETED|Part C: Cohort 8 Overall||0
10629016|NCT02018887|11787516|FG003|NOT COMPLETED|Part C: Cohort 8 Overall||0
10629017|NCT02018887|11787517|FG004|NOT COMPLETED|Part C: Cohort 8 Overall||0
10629018|NCT02018887|11787518|FG005|NOT COMPLETED|Part C: Cohort 8 Overall||0
10629019|NCT02018887|11787519|FG006|NOT COMPLETED|Part C: Cohort 8 Overall||0
10629020|NCT02018887|11787520|FG007|NOT COMPLETED|Part C: Cohort 8 Overall||0
10629021|NCT02018887|11787521|FG008|NOT COMPLETED|Part C: Cohort 8 Overall||3
10629022|NCT02018887|11787522|FG009|NOT COMPLETED|Part C: Cohort 8 Overall||3
10629023|NCT02018887|11787523|FG010|NOT COMPLETED|Part C: Cohort 8 Overall||1
10629024|NCT02019069|11787589|FG000|STARTED|Overall Study||11
10629025|NCT02019069|11787589|FG000|COMPLETED|Overall Study||11
10629026|NCT02019069|11787589|FG000|NOT COMPLETED|Overall Study||0
10629027|NCT02019108|11787595|FG000|STARTED|Overall Study||40
10629028|NCT02019108|11787596|FG001|STARTED|Overall Study||39
10629029|NCT02019108|11787595|FG000|Baseline (Week 0)|Overall Study||40
10629030|NCT02019108|11787596|FG001|Baseline (Week 0)|Overall Study||39
10629031|NCT02019108|11787595|FG000|Follow-up (Week 17)|Overall Study||38
10629032|NCT02019108|11787596|FG001|Follow-up (Week 17)|Overall Study||36
10629033|NCT02019108|11787595|FG000|Retention (Week 21)|Overall Study||35
10629034|NCT02019108|11787596|FG001|Retention (Week 21)|Overall Study||32
10629035|NCT02019108|11787595|FG000|COMPLETED|Overall Study||35
10629036|NCT02019108|11787596|FG001|COMPLETED|Overall Study||32
10629037|NCT02019108|11787595|FG000|NOT COMPLETED|Overall Study||5
10629038|NCT02019108|11787596|FG001|NOT COMPLETED|Overall Study||7
10629039|NCT02019264|11787604|FG000|STARTED|Overall Study||6000
10629040|NCT02019264|11787605|FG001|STARTED|Overall Study||6000
10629041|NCT02019264|11787604|FG000|Safety Analysis Set|Overall Study||5992
10629042|NCT02019264|11787605|FG001|Safety Analysis Set|Overall Study||5995
10705421|NCT02598128|11869826|FG003|STARTED|Period B: Days 1 to 11||0
10629043|NCT02019264|11787604|FG000|COMPLETED|Overall Study||5752
10629044|NCT02019264|11787605|FG001|COMPLETED|Overall Study||5793
10629045|NCT02019264|11787604|FG000|NOT COMPLETED|Overall Study||248
10629046|NCT02019264|11787605|FG001|NOT COMPLETED|Overall Study||207
10629047|NCT02019277|11787611|FG000|STARTED|Overall Study||50
10629048|NCT02019277|11787611|FG000|COMPLETED|Overall Study||38
10629049|NCT02019277|11787611|FG000|NOT COMPLETED|Overall Study||12
10629050|NCT02019420|11787617|FG000|STARTED|Overall Study||366
10629051|NCT02019420|11787618|FG001|STARTED|Overall Study||360
10629052|NCT02019420|11787617|FG000|Treated|Overall Study||361
10629053|NCT02019420|11787618|FG001|Treated|Overall Study||357
10629054|NCT02019420|11787617|FG000|COMPLETED|Overall Study||258
10629055|NCT02019420|11787618|FG001|COMPLETED|Overall Study||254
10629056|NCT02019420|11787617|FG000|NOT COMPLETED|Overall Study||108
10629057|NCT02019420|11787618|FG001|NOT COMPLETED|Overall Study||106
10629058|NCT02019472|11787627|FG000|STARTED|Overall Study||186
10629059|NCT02019472|11787628|FG001|STARTED|Overall Study||186
10629060|NCT02019472|11787629|FG002|STARTED|Overall Study||187
10629061|NCT02019472|11787627|FG000|COMPLETED|Overall Study||149
10629062|NCT02019472|11787628|FG001|COMPLETED|Overall Study||134
10629063|NCT02019472|11787629|FG002|COMPLETED|Overall Study||145
10629064|NCT02019472|11787627|FG000|NOT COMPLETED|Overall Study||37
10629065|NCT02019472|11787628|FG001|NOT COMPLETED|Overall Study||52
10629066|NCT02019472|11787629|FG002|NOT COMPLETED|Overall Study||42
10629067|NCT02019550|11787643|FG000|STARTED|Treatment Period 1 (4 Weeks)||46
10629068|NCT02019550|11787644|FG001|STARTED|Treatment Period 1 (4 Weeks)||51
10629069|NCT02019550|11787643|FG000|COMPLETED|Treatment Period 1 (4 Weeks)||46
10629070|NCT02019550|11787644|FG001|COMPLETED|Treatment Period 1 (4 Weeks)||50
10629071|NCT02019550|11787643|FG000|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
10629072|NCT02019550|11787644|FG001|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
10629073|NCT02019550|11787643|FG000|STARTED|Treatment Period 2 (4 Weeks)||46
10629074|NCT02019550|11787644|FG001|STARTED|Treatment Period 2 (4 Weeks)||50
10629075|NCT02019550|11787643|FG000|COMPLETED|Treatment Period 2 (4 Weeks)||46
10629076|NCT02019550|11787644|FG001|COMPLETED|Treatment Period 2 (4 Weeks)||50
10629077|NCT02019550|11787643|FG000|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
10629078|NCT02019550|11787644|FG001|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
10629079|NCT02019563|11787654|FG000|STARTED|Overall Study|100 incisors were treated in the MTA/FS pulpotomy group|40
10629161|NCT02019927|11787742|FG004|STARTED|Overall Study||10
10629080|NCT02019563|11787655|FG001|STARTED|Overall Study|72 incisors were treated in the RCT group|30
10629081|NCT02019563|11787654|FG000|COMPLETED|Overall Study|100 incisors were treated in the MTA/FS pulpotomy group|40
10629082|NCT02019563|11787655|FG001|COMPLETED|Overall Study|72 incisors were treated in the RCT group|30
10629083|NCT02019563|11787654|FG000|NOT COMPLETED|Overall Study||0
10629084|NCT02019563|11787655|FG001|NOT COMPLETED|Overall Study||0
10629085|NCT02019602|11787665|FG000|STARTED|Screening Period||21
10629086|NCT02019602|11787666|FG001|STARTED|Screening Period||16
10629087|NCT02019602|11787665|FG000|COMPLETED|Screening Period||16
10629088|NCT02019602|11787666|FG001|COMPLETED|Screening Period||16
10629089|NCT02019602|11787665|FG000|NOT COMPLETED|Screening Period||5
10629090|NCT02019602|11787666|FG001|NOT COMPLETED|Screening Period||0
10629091|NCT02019602|11787665|FG000|STARTED|Sampling Period||16
10629092|NCT02019602|11787666|FG001|STARTED|Sampling Period||16
10629093|NCT02019602|11787665|FG000|COMPLETED|Sampling Period||16
10629094|NCT02019602|11787666|FG001|COMPLETED|Sampling Period||16
10629095|NCT02019602|11787665|FG000|NOT COMPLETED|Sampling Period||0
10629096|NCT02019602|11787666|FG001|NOT COMPLETED|Sampling Period||0
10629097|NCT02019667|11787673|FG000|STARTED|First Intervention (6 Months)||10
10705422|NCT02598128|11869823|FG000|COMPLETED|Period B: Days 1 to 11||0
10705423|NCT02598128|11869824|FG001|COMPLETED|Period B: Days 1 to 11||17
10629098|NCT02019667|11787674|FG001|STARTED|First Intervention (6 Months)||9
10629099|NCT02019667|11787673|FG000|COMPLETED|First Intervention (6 Months)||10
10629100|NCT02019667|11787674|FG001|COMPLETED|First Intervention (6 Months)||8
10629101|NCT02019667|11787673|FG000|NOT COMPLETED|First Intervention (6 Months)||0
10629102|NCT02019667|11787674|FG001|NOT COMPLETED|First Intervention (6 Months)||1
10629103|NCT02019667|11787673|FG000|STARTED|Washout Period (9 Weeks)||10
10629104|NCT02019667|11787674|FG001|STARTED|Washout Period (9 Weeks)||8
10629105|NCT02019667|11787673|FG000|COMPLETED|Washout Period (9 Weeks)||10
10629106|NCT02019667|11787674|FG001|COMPLETED|Washout Period (9 Weeks)||8
10629107|NCT02019667|11787673|FG000|NOT COMPLETED|Washout Period (9 Weeks)||0
10629108|NCT02019667|11787674|FG001|NOT COMPLETED|Washout Period (9 Weeks)||0
10629109|NCT02019667|11787673|FG000|STARTED|2nd Intervention (6 Months)||10
10629110|NCT02019667|11787674|FG001|STARTED|2nd Intervention (6 Months)||8
10629111|NCT02019667|11787673|FG000|COMPLETED|2nd Intervention (6 Months)||10
10629112|NCT02019667|11787674|FG001|COMPLETED|2nd Intervention (6 Months)||6
10629113|NCT02019667|11787673|FG000|NOT COMPLETED|2nd Intervention (6 Months)||0
10629114|NCT02019667|11787674|FG001|NOT COMPLETED|2nd Intervention (6 Months)||2
10629115|NCT02019667|11787673|FG000|STARTED|Washout Period (9 Weeks)||10
10629116|NCT02019667|11787674|FG001|STARTED|Washout Period (9 Weeks)||6
10629117|NCT02019667|11787673|FG000|COMPLETED|Washout Period (9 Weeks)||10
10629118|NCT02019667|11787674|FG001|COMPLETED|Washout Period (9 Weeks)||6
10629119|NCT02019667|11787673|FG000|NOT COMPLETED|Washout Period (9 Weeks)||0
10629120|NCT02019667|11787674|FG001|NOT COMPLETED|Washout Period (9 Weeks)||0
10629121|NCT02019719|11787687|FG000|STARTED|Overall Study||19
10629122|NCT02019719|11787688|FG001|STARTED|Overall Study||19
10629123|NCT02019719|11787689|FG002|STARTED|Overall Study||20
10629124|NCT02019719|11787690|FG003|STARTED|Overall Study||19
10629125|NCT02019719|11787691|FG004|STARTED|Overall Study||20
10629126|NCT02019719|11787687|FG000|COMPLETED|Overall Study||13
10629127|NCT02019719|11787688|FG001|COMPLETED|Overall Study||18
10629128|NCT02019719|11787689|FG002|COMPLETED|Overall Study||20
10629129|NCT02019719|11787690|FG003|COMPLETED|Overall Study||17
10629130|NCT02019719|11787691|FG004|COMPLETED|Overall Study||18
10629131|NCT02019719|11787687|FG000|NOT COMPLETED|Overall Study||6
10629132|NCT02019719|11787688|FG001|NOT COMPLETED|Overall Study||1
10629133|NCT02019719|11787689|FG002|NOT COMPLETED|Overall Study||0
10629134|NCT02019719|11787690|FG003|NOT COMPLETED|Overall Study||2
10629135|NCT02019719|11787691|FG004|NOT COMPLETED|Overall Study||2
10629136|NCT02019758|11787712|FG000|STARTED|Overall Study|64 received intervention; 1 did not receive intervention|65
10629137|NCT02019758|11787713|FG001|STARTED|Overall Study|63 received intervention; 1 did not receive intervention|64
10629138|NCT02019758|11787712|FG000|Received Intervention|Overall Study||64
10629139|NCT02019758|11787713|FG001|Received Intervention|Overall Study||63
10629140|NCT02019758|11787712|FG000|Did Not Receive Intervention|Overall Study||1
10629141|NCT02019758|11787713|FG001|Did Not Receive Intervention|Overall Study||1
10629142|NCT02019758|11787712|FG000|Lost to Follow-up|Overall Study|8 were lost to follow-up and did not undergo week 8 endoscopy or other outcome assessments|8
10629143|NCT02019758|11787713|FG001|Lost to Follow-up|Overall Study|8 were lost to follow-up and did not undergo week 8 endoscopy or other outcome assessments|8
10629144|NCT02019758|11787712|FG000|COMPLETED|Overall Study||56
10629145|NCT02019758|11787713|FG001|COMPLETED|Overall Study|8 were lost to follow-up and did not undergo week 8 endoscopy or other outcome assessments|55
10629146|NCT02019758|11787712|FG000|NOT COMPLETED|Overall Study||9
10629147|NCT02019758|11787713|FG001|NOT COMPLETED|Overall Study||9
10629148|NCT02019888|11787722|FG000|STARTED|Overall Study||148
10629149|NCT02019888|11787723|FG001|STARTED|Overall Study||113
10629150|NCT02019888|11787724|FG002|STARTED|Overall Study||59
10629151|NCT02019888|11787722|FG000|COMPLETED|Overall Study||108
10629152|NCT02019888|11787723|FG001|COMPLETED|Overall Study||83
10629153|NCT02019888|11787724|FG002|COMPLETED|Overall Study||54
10629154|NCT02019888|11787722|FG000|NOT COMPLETED|Overall Study||40
10629155|NCT02019888|11787723|FG001|NOT COMPLETED|Overall Study||30
10629156|NCT02019888|11787724|FG002|NOT COMPLETED|Overall Study||5
10629157|NCT02019927|11787738|FG000|STARTED|Overall Study||46
10629158|NCT02019927|11787739|FG001|STARTED|Overall Study||23
10629159|NCT02019927|11787740|FG002|STARTED|Overall Study||9
10629160|NCT02019927|11787741|FG003|STARTED|Overall Study||5
10629162|NCT02019927|11787743|FG005|STARTED|Overall Study||4
10629163|NCT02019927|11787738|FG000|COMPLETED|Overall Study||44
10629164|NCT02019927|11787739|FG001|COMPLETED|Overall Study||19
10629165|NCT02019927|11787740|FG002|COMPLETED|Overall Study||8
10629166|NCT02019927|11787741|FG003|COMPLETED|Overall Study||3
10629167|NCT02019927|11787742|FG004|COMPLETED|Overall Study||7
10629168|NCT02019927|11787743|FG005|COMPLETED|Overall Study||3
10629169|NCT02019927|11787738|FG000|NOT COMPLETED|Overall Study||2
10629170|NCT02019927|11787739|FG001|NOT COMPLETED|Overall Study||4
10629171|NCT02019927|11787740|FG002|NOT COMPLETED|Overall Study||1
10629172|NCT02019927|11787741|FG003|NOT COMPLETED|Overall Study||2
10629173|NCT02019927|11787742|FG004|NOT COMPLETED|Overall Study||3
10629174|NCT02019927|11787743|FG005|NOT COMPLETED|Overall Study||1
10629175|NCT02019940|11787761|FG000|STARTED|Overall Study||18
10629176|NCT02019940|11787761|FG000|COMPLETED|Overall Study||8
10629177|NCT02019940|11787761|FG000|NOT COMPLETED|Overall Study||10
10629178|NCT02019979|11787765|FG000|STARTED|Overall Study||14
10629179|NCT02019979|11787765|FG000|COMPLETED|Overall Study||0
10629180|NCT02019979|11787765|FG000|NOT COMPLETED|Overall Study||14
10629181|NCT02020018|11787771|FG000|STARTED|Overall Study||272
10629182|NCT02020018|11787772|FG001|STARTED|Overall Study||1597
10629183|NCT02020018|11787771|FG000|COMPLETED|Overall Study||272
10629184|NCT02020018|11787772|FG001|COMPLETED|Overall Study||1597
10629185|NCT02020018|11787771|FG000|NOT COMPLETED|Overall Study||0
10629186|NCT02020018|11787772|FG001|NOT COMPLETED|Overall Study||0
10629187|NCT02020031|11787780|FG000|STARTED|Overall Study||11
10629188|NCT02020031|11787781|FG001|STARTED|Overall Study||11
10629189|NCT02020031|11787780|FG000|COMPLETED|Overall Study||10
10629190|NCT02020031|11787781|FG001|COMPLETED|Overall Study||10
10629191|NCT02020031|11787780|FG000|NOT COMPLETED|Overall Study||1
10629192|NCT02020031|11787781|FG001|NOT COMPLETED|Overall Study||1
10629193|NCT02020135|11787789|FG000|STARTED|Overall Study||9
10629194|NCT02020135|11787789|FG000|COMPLETED|Overall Study||0
10705424|NCT02598128|11869825|FG002|COMPLETED|Period B: Days 1 to 11||16
10705425|NCT02598128|11869826|FG003|COMPLETED|Period B: Days 1 to 11||0
10705426|NCT02598128|11869823|FG000|NOT COMPLETED|Period B: Days 1 to 11||0
10629195|NCT02020135|11787789|FG000|NOT COMPLETED|Overall Study||9
10629196|NCT02020252|11787795|FG000|STARTED|Overall Study||120
10629197|NCT02020252|11787795|FG000|COMPLETED|Overall Study||120
10629198|NCT02020252|11787795|FG000|NOT COMPLETED|Overall Study||0
10629199|NCT02020278|11787799|FG000|STARTED|Core Safety Follow-up Component||3
10629200|NCT02020278|11787799|FG000|COMPLETED|Core Safety Follow-up Component||3
10629201|NCT02020278|11787799|FG000|NOT COMPLETED|Core Safety Follow-up Component||0
10629202|NCT02020278|11787799|FG000|STARTED|Optional Tolvaptan Treatment Component||0
10629203|NCT02020278|11787799|FG000|COMPLETED|Optional Tolvaptan Treatment Component||0
10629204|NCT02020278|11787799|FG000|NOT COMPLETED|Optional Tolvaptan Treatment Component||0
10629205|NCT02020304|11787807|FG000|STARTED|Overall Study||30
10629206|NCT02020304|11787808|FG001|STARTED|Overall Study||28
10629207|NCT02020304|11787807|FG000|COMPLETED|Overall Study||27
10629208|NCT02020304|11787808|FG001|COMPLETED|Overall Study||26
10629209|NCT02020304|11787807|FG000|NOT COMPLETED|Overall Study||3
10629210|NCT02020304|11787808|FG001|NOT COMPLETED|Overall Study||2
10629211|NCT02020369|11787816|FG000|STARTED|Overall Study||14
10629212|NCT02020369|11787817|FG001|STARTED|Overall Study||13
10629213|NCT02020369|11787816|FG000|COMPLETED|Overall Study||11
10629214|NCT02020369|11787817|FG001|COMPLETED|Overall Study||11
10629215|NCT02020369|11787816|FG000|NOT COMPLETED|Overall Study||3
10629216|NCT02020369|11787817|FG001|NOT COMPLETED|Overall Study||2
10629217|NCT02020408|11787826|FG000|STARTED|Overall Study||88
10629218|NCT02020408|11787826|FG000|COMPLETED|Overall Study||85
10629219|NCT02020408|11787826|FG000|NOT COMPLETED|Overall Study||3
10629220|NCT02020512|11787836|FG000|STARTED|Overall Study||87
10629221|NCT02020512|11787836|FG000|COMPLETED|Overall Study||79
10629222|NCT02020512|11787836|FG000|NOT COMPLETED|Overall Study||8
10629223|NCT02020577|11787842|FG000|STARTED|Overall Study||3
10629224|NCT02020577|11787843|FG001|STARTED|Overall Study||55
10629225|NCT02020577|11787842|FG000|COMPLETED|Overall Study||0
10629226|NCT02020577|11787843|FG001|COMPLETED|Overall Study||0
10629227|NCT02020577|11787842|FG000|NOT COMPLETED|Overall Study||3
10705427|NCT02598128|11869824|FG001|NOT COMPLETED|Period B: Days 1 to 11||0
10705428|NCT02598128|11869825|FG002|NOT COMPLETED|Period B: Days 1 to 11||0
10705429|NCT02598128|11869826|FG003|NOT COMPLETED|Period B: Days 1 to 11||0
10705430|NCT02598128|11869823|FG000|STARTED|Period C: Days 12 to 20||0
10705431|NCT02598128|11869824|FG001|STARTED|Period C: Days 12 to 20||0
10705432|NCT02598128|11869825|FG002|STARTED|Period C: Days 12 to 20||0
10705433|NCT02598128|11869826|FG003|STARTED|Period C: Days 12 to 20||33
10705434|NCT02598128|11869823|FG000|COMPLETED|Period C: Days 12 to 20||0
10705435|NCT02598128|11869824|FG001|COMPLETED|Period C: Days 12 to 20||0
10705436|NCT02598128|11869825|FG002|COMPLETED|Period C: Days 12 to 20||0
10705437|NCT02598128|11869826|FG003|COMPLETED|Period C: Days 12 to 20||33
10629228|NCT02020577|11787843|FG001|NOT COMPLETED|Overall Study||55
10629229|NCT02020590|11787851|FG000|STARTED|Overall Study||22
10629230|NCT02020590|11787851|FG000|COMPLETED|Overall Study||22
10629231|NCT02020590|11787851|FG000|NOT COMPLETED|Overall Study||0
10629232|NCT02020616|11787862|FG000|STARTED|Overall Study||10
10629233|NCT02020616|11787863|FG001|STARTED|Overall Study||8
10629234|NCT02020616|11787864|FG002|STARTED|Overall Study||8
10629235|NCT02020616|11787865|FG003|STARTED|Overall Study||8
10629236|NCT02020616|11787866|FG004|STARTED|Overall Study||8
10629237|NCT02020616|11787867|FG005|STARTED|Overall Study||8
10629238|NCT02020616|11787868|FG006|STARTED|Overall Study||10
10629239|NCT02020616|11787862|FG000|Received at Least One Dose of Study Drug|Overall Study||10
10629240|NCT02020616|11787863|FG001|Received at Least One Dose of Study Drug|Overall Study||8
10705438|NCT02598128|11869823|FG000|NOT COMPLETED|Period C: Days 12 to 20||0
10629241|NCT02020616|11787864|FG002|Received at Least One Dose of Study Drug|Overall Study||8
10629242|NCT02020616|11787865|FG003|Received at Least One Dose of Study Drug|Overall Study||7
10629243|NCT02020616|11787866|FG004|Received at Least One Dose of Study Drug|Overall Study||8
10629244|NCT02020616|11787867|FG005|Received at Least One Dose of Study Drug|Overall Study||8
10629245|NCT02020616|11787868|FG006|Received at Least One Dose of Study Drug|Overall Study||10
10629246|NCT02020616|11787862|FG000|COMPLETED|Overall Study||10
10629247|NCT02020616|11787863|FG001|COMPLETED|Overall Study||7
10629248|NCT02020616|11787864|FG002|COMPLETED|Overall Study||6
10629249|NCT02020616|11787865|FG003|COMPLETED|Overall Study||6
10629250|NCT02020616|11787866|FG004|COMPLETED|Overall Study||6
10629251|NCT02020616|11787867|FG005|COMPLETED|Overall Study||3
10629252|NCT02020616|11787868|FG006|COMPLETED|Overall Study||6
10629253|NCT02020616|11787862|FG000|NOT COMPLETED|Overall Study||0
10629254|NCT02020616|11787863|FG001|NOT COMPLETED|Overall Study||1
10629255|NCT02020616|11787864|FG002|NOT COMPLETED|Overall Study||2
10629256|NCT02020616|11787865|FG003|NOT COMPLETED|Overall Study||2
10629257|NCT02020616|11787866|FG004|NOT COMPLETED|Overall Study||2
10629258|NCT02020616|11787867|FG005|NOT COMPLETED|Overall Study||5
10629259|NCT02020616|11787868|FG006|NOT COMPLETED|Overall Study||4
10629260|NCT02020785|11787900|FG000|STARTED|First Intervention (3 Weeks)||15
10629261|NCT02020785|11787901|FG001|STARTED|First Intervention (3 Weeks)||16
10629262|NCT02020785|11787900|FG000|COMPLETED|First Intervention (3 Weeks)||15
10629263|NCT02020785|11787901|FG001|COMPLETED|First Intervention (3 Weeks)||16
10629264|NCT02020785|11787900|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0
10629265|NCT02020785|11787901|FG001|NOT COMPLETED|First Intervention (3 Weeks)||0
10629266|NCT02020785|11787900|FG000|STARTED|Second Intervention (3 Weeks)||15
10629267|NCT02020785|11787901|FG001|STARTED|Second Intervention (3 Weeks)||16
10629268|NCT02020785|11787900|FG000|COMPLETED|Second Intervention (3 Weeks)||15
10629269|NCT02020785|11787901|FG001|COMPLETED|Second Intervention (3 Weeks)||16
10629270|NCT02020785|11787900|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
10629271|NCT02020785|11787901|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
10629272|NCT02020863|11787907|FG000|STARTED|Overall Study||40
10629273|NCT02020863|11787907|FG000|COMPLETED|Overall Study||35
10629274|NCT02020863|11787907|FG000|NOT COMPLETED|Overall Study||5
10629275|NCT02020889|11787913|FG000|STARTED|Overall Study||68
10629276|NCT02020889|11787914|FG001|STARTED|Overall Study||68
10629277|NCT02020889|11787913|FG000|COMPLETED|Overall Study||61
10629278|NCT02020889|11787914|FG001|COMPLETED|Overall Study||65
10629279|NCT02020889|11787913|FG000|NOT COMPLETED|Overall Study||7
10629280|NCT02020889|11787914|FG001|NOT COMPLETED|Overall Study||3
10629281|NCT02020941|11787920|FG000|STARTED|Overall Study||10
10629282|NCT02020941|11787920|FG000|COMPLETED|Overall Study||2
10629283|NCT02020941|11787920|FG000|NOT COMPLETED|Overall Study||8
10629284|NCT02020967|11787926|FG000|STARTED|Overall Study||367
10629285|NCT02020967|11787926|FG000|Examined Participants|Overall Study||329
10629286|NCT02020967|11787926|FG000|COMPLETED|Overall Study||316
10629287|NCT02020967|11787926|FG000|NOT COMPLETED|Overall Study||51
10629288|NCT02021292|11787934|FG000|STARTED|Overall Study||40
10629289|NCT02021292|11787935|FG001|STARTED|Overall Study||40
10629290|NCT02021292|11787934|FG000|COMPLETED|Overall Study||40
10629291|NCT02021292|11787935|FG001|COMPLETED|Overall Study||37
10629292|NCT02021292|11787934|FG000|NOT COMPLETED|Overall Study||0
10629293|NCT02021292|11787935|FG001|NOT COMPLETED|Overall Study||3
10629294|NCT02021318|11787945|FG000|STARTED|Overall Study||323
10629295|NCT02021318|11787946|FG001|STARTED|Overall Study||293
10629296|NCT02021318|11787945|FG000|COMPLETED|Overall Study||250
10629297|NCT02021318|11787946|FG001|COMPLETED|Overall Study||230
10629298|NCT02021318|11787945|FG000|NOT COMPLETED|Overall Study||73
10629299|NCT02021318|11787946|FG001|NOT COMPLETED|Overall Study||63
10629300|NCT02021331|11787955|FG000|STARTED|Overall Study||2
10629301|NCT02021331|11787956|FG001|STARTED|Overall Study||3
10629302|NCT02021331|11787955|FG000|COMPLETED|Overall Study||2
10629303|NCT02021331|11787956|FG001|COMPLETED|Overall Study||1
10629304|NCT02021331|11787955|FG000|NOT COMPLETED|Overall Study||0
10629305|NCT02021331|11787956|FG001|NOT COMPLETED|Overall Study||2
10629306|NCT02021461|11787962|FG000|STARTED|Overall Study||38
10629307|NCT02021461|11787962|FG000|COMPLETED|Overall Study||38
10629308|NCT02021461|11787962|FG000|NOT COMPLETED|Overall Study||0
10629309|NCT02021565|11787970|FG000|STARTED|Baseline Through Intervention||72
10629310|NCT02021565|11787971|FG001|STARTED|Baseline Through Intervention||54
10629311|NCT02021565|11787970|FG000|Caregivers|Baseline Through Intervention||36
10629312|NCT02021565|11787971|FG001|Caregivers|Baseline Through Intervention||27
10629313|NCT02021565|11787970|FG000|Care Recipients|Baseline Through Intervention||36
10629314|NCT02021565|11787971|FG001|Care Recipients|Baseline Through Intervention||27
10629315|NCT02021565|11787970|FG000|COMPLETED|Baseline Through Intervention||60
10629316|NCT02021565|11787971|FG001|COMPLETED|Baseline Through Intervention||36
10629317|NCT02021565|11787970|FG000|NOT COMPLETED|Baseline Through Intervention||12
10629318|NCT02021565|11787971|FG001|NOT COMPLETED|Baseline Through Intervention||18
10629319|NCT02021565|11787970|FG000|STARTED|3-month Follow-up||60
10629320|NCT02021565|11787971|FG001|STARTED|3-month Follow-up||36
10629321|NCT02021565|11787970|FG000|Caregivers|3-month Follow-up||30
10629322|NCT02021565|11787971|FG001|Caregivers|3-month Follow-up||18
10629323|NCT02021565|11787970|FG000|Care Recipients|3-month Follow-up||30
10629324|NCT02021565|11787971|FG001|Care Recipients|3-month Follow-up||18
10629325|NCT02021565|11787970|FG000|COMPLETED|3-month Follow-up||50
10629326|NCT02021565|11787971|FG001|COMPLETED|3-month Follow-up||34
10629327|NCT02021565|11787970|FG000|NOT COMPLETED|3-month Follow-up||10
10629328|NCT02021565|11787971|FG001|NOT COMPLETED|3-month Follow-up||2
10629329|NCT02021643|11787985|FG000|STARTED|Overall Study||156
10629330|NCT02021643|11787986|FG001|STARTED|Overall Study||290
10629331|NCT02021643|11787987|FG002|STARTED|Overall Study||11
10629332|NCT02021643|11787988|FG003|STARTED|Overall Study||230
10629333|NCT02021643|11787985|FG000|COMPLETED|Overall Study||147
10629334|NCT02021643|11787986|FG001|COMPLETED|Overall Study||280
10629335|NCT02021643|11787987|FG002|COMPLETED|Overall Study||11
10629336|NCT02021643|11787988|FG003|COMPLETED|Overall Study||218
10629337|NCT02021643|11787985|FG000|NOT COMPLETED|Overall Study||9
10629338|NCT02021643|11787986|FG001|NOT COMPLETED|Overall Study||10
10629339|NCT02021643|11787987|FG002|NOT COMPLETED|Overall Study||0
10629340|NCT02021643|11787988|FG003|NOT COMPLETED|Overall Study||12
10629341|NCT02021656|11788004|FG000|STARTED|Overall Study||384
10629342|NCT02021656|11788004|FG000|COMPLETED|Overall Study||378
10629343|NCT02021656|11788004|FG000|NOT COMPLETED|Overall Study||6
10629344|NCT02021669|11788014|FG000|STARTED|Overall Study||71
10629345|NCT02021669|11788015|FG001|STARTED|Overall Study||73
10629346|NCT02021669|11788014|FG000|COMPLETED|Overall Study||64
10629347|NCT02021669|11788015|FG001|COMPLETED|Overall Study||70
10629348|NCT02021669|11788014|FG000|NOT COMPLETED|Overall Study||7
10629349|NCT02021669|11788015|FG001|NOT COMPLETED|Overall Study||3
10629350|NCT02021929|11788023|FG000|STARTED|Overall Study||16
10629351|NCT02021929|11788024|FG001|STARTED|Overall Study||12
10629352|NCT02021929|11788023|FG000|COMPLETED|Overall Study||14
10629353|NCT02021929|11788024|FG001|COMPLETED|Overall Study||11
10629354|NCT02021929|11788023|FG000|NOT COMPLETED|Overall Study||2
10629355|NCT02021929|11788024|FG001|NOT COMPLETED|Overall Study||1
10629356|NCT02021942|11788030|FG000|STARTED|Overall Study||16
10629357|NCT02021942|11788030|FG000|COMPLETED|Overall Study||16
10629358|NCT02021942|11788030|FG000|NOT COMPLETED|Overall Study||0
10629359|NCT02021955|11788037|FG000|STARTED|Step 0|Provider attrition=2; Provider addition=3; Patient discharges=14|210
10629360|NCT02021955|11788038|FG001|STARTED|Step 0|Provider attrition=0; Provider addition=0; Patient discharges=0|0
10629361|NCT02021955|11788037|FG000|COMPLETED|Step 0||210
10629362|NCT02021955|11788038|FG001|COMPLETED|Step 0||0
10629363|NCT02021955|11788037|FG000|NOT COMPLETED|Step 0||0
10629364|NCT02021955|11788038|FG001|NOT COMPLETED|Step 0||0
10629365|NCT02021955|11788037|FG000|STARTED|Step 1|Provider attrition=20; Provider addition=2; Patient discharges=14|193
10629366|NCT02021955|11788038|FG001|STARTED|Step 1|Provider attrition=7; Provider addition=0; Patient discharges: 0|18
10629367|NCT02021955|11788037|FG000|COMPLETED|Step 1||193
10629368|NCT02021955|11788038|FG001|COMPLETED|Step 1||18
10629369|NCT02021955|11788037|FG000|NOT COMPLETED|Step 1||0
10629370|NCT02021955|11788038|FG001|NOT COMPLETED|Step 1||0
10629371|NCT02021955|11788037|FG000|STARTED|Step 2|Provider attrition=5; Provider addition=21; Patient discharges=12|165
10629372|NCT02021955|11788038|FG001|STARTED|Step 2|Provider attrition=2; Provider addition=5; Patient discharges=2|21
10629373|NCT02021955|11788037|FG000|COMPLETED|Step 2||165
10629374|NCT02021955|11788038|FG001|COMPLETED|Step 2||21
10629375|NCT02021955|11788037|FG000|NOT COMPLETED|Step 2||0
10629376|NCT02021955|11788038|FG001|NOT COMPLETED|Step 2||0
10629377|NCT02021955|11788037|FG000|STARTED|Step 3|Provider attrition=2; Provider addition=4; Patient discharges=5|175
10629378|NCT02021955|11788038|FG001|STARTED|Step 3|Provider attrition=0; Provider addition=3; Patient discharges=3|30
10629379|NCT02021955|11788037|FG000|COMPLETED|Step 3||175
10629380|NCT02021955|11788038|FG001|COMPLETED|Step 3||30
10629381|NCT02021955|11788037|FG000|NOT COMPLETED|Step 3||0
10629382|NCT02021955|11788038|FG001|NOT COMPLETED|Step 3||0
10629383|NCT02021955|11788037|FG000|STARTED|Step 4|Provider attrition=0; Provider addition=3; Patient discharges: 13|173
10629384|NCT02021955|11788038|FG001|STARTED|Step 4|Provider attrition=0; Provider addition=1; Patient discharges=0|37
10629385|NCT02021955|11788037|FG000|COMPLETED|Step 4||173
10629386|NCT02021955|11788038|FG001|COMPLETED|Step 4||37
10629387|NCT02021955|11788037|FG000|NOT COMPLETED|Step 4||0
10629388|NCT02021955|11788038|FG001|NOT COMPLETED|Step 4||0
10629389|NCT02021955|11788037|FG000|STARTED|Step 5|Provider attrition=3; Provider addition=0; Patient discharges=11|174
10629390|NCT02021955|11788038|FG001|STARTED|Step 5|Provider attrition=0; Provider addition=0; Patient discharges=2|40
10629391|NCT02021955|11788037|FG000|COMPLETED|Step 5||174
10629392|NCT02021955|11788038|FG001|COMPLETED|Step 5||40
10629393|NCT02021955|11788037|FG000|NOT COMPLETED|Step 5||0
10629394|NCT02021955|11788038|FG001|NOT COMPLETED|Step 5||0
10629395|NCT02021955|11788037|FG000|STARTED|Step 6|Provider attrition=0; Provider addition=2; Patient discharges=6|158
10629396|NCT02021955|11788038|FG001|STARTED|Step 6|Provider attrition=0; Provider addition=1; Patient discharges=1|53
10629397|NCT02021955|11788037|FG000|COMPLETED|Step 6||158
10629398|NCT02021955|11788038|FG001|COMPLETED|Step 6||53
10629399|NCT02021955|11788037|FG000|NOT COMPLETED|Step 6||0
10629400|NCT02021955|11788038|FG001|NOT COMPLETED|Step 6||0
10629401|NCT02021955|11788037|FG000|STARTED|Step 7|Provider attrition=0; Provider addition=2; Patient discharges=13|157
10629402|NCT02021955|11788038|FG001|STARTED|Step 7|Provider attrition=0; Provider addition=1; Patient discharges=2|57
10629403|NCT02021955|11788037|FG000|COMPLETED|Step 7||157
10629404|NCT02021955|11788038|FG001|COMPLETED|Step 7||57
10629405|NCT02021955|11788037|FG000|NOT COMPLETED|Step 7||0
10629406|NCT02021955|11788038|FG001|NOT COMPLETED|Step 7||0
10629407|NCT02021955|11788037|FG000|STARTED|Step 8|Provider attrition=1; Provider addition=0; Patient discharges=9|144
10653662|NCT02195687|11814261|FG001|STARTED|Overall Study||101
10629408|NCT02021955|11788038|FG001|STARTED|Step 8|Provider attrition=0; Provider addition=0; Patient discharges=11|73
10629409|NCT02021955|11788037|FG000|COMPLETED|Step 8||144
10629410|NCT02021955|11788038|FG001|COMPLETED|Step 8||73
10629411|NCT02021955|11788037|FG000|NOT COMPLETED|Step 8||0
10629412|NCT02021955|11788038|FG001|NOT COMPLETED|Step 8||0
10629413|NCT02021955|11788037|FG000|STARTED|Step 9|Provider attrition=2; Provider addition=1; Patient discharges=9|139
10629414|NCT02021955|11788038|FG001|STARTED|Step 9|Provider attrition=1; Provider addition=0; Patient discharges=8|77
10629415|NCT02021955|11788037|FG000|COMPLETED|Step 9||139
10629416|NCT02021955|11788038|FG001|COMPLETED|Step 9||77
10629417|NCT02021955|11788037|FG000|NOT COMPLETED|Step 9||0
10629418|NCT02021955|11788038|FG001|NOT COMPLETED|Step 9||0
10629419|NCT02021955|11788037|FG000|STARTED|Step 10|Provider attrition=0; Provider addition=1; Patient discharges: 8|135
10629420|NCT02021955|11788038|FG001|STARTED|Step 10|Provider attrition=1; Provider addition=0; Patient discharges=5|79
10629421|NCT02021955|11788037|FG000|COMPLETED|Step 10||135
10629422|NCT02021955|11788038|FG001|COMPLETED|Step 10||79
10629423|NCT02021955|11788037|FG000|NOT COMPLETED|Step 10||0
10629424|NCT02021955|11788038|FG001|NOT COMPLETED|Step 10||0
10629425|NCT02021955|11788037|FG000|STARTED|Step 11|Provider attrition=1; Provider addition=0; Patient discharges=11|126
10629426|NCT02021955|11788038|FG001|STARTED|Step 11|Provider attrition=2; Provider addition=2; Patient discharges=7|88
10629427|NCT02021955|11788037|FG000|COMPLETED|Step 11||126
10629428|NCT02021955|11788038|FG001|COMPLETED|Step 11||88
10629429|NCT02021955|11788037|FG000|NOT COMPLETED|Step 11||0
10629430|NCT02021955|11788038|FG001|NOT COMPLETED|Step 11||0
10629431|NCT02021955|11788037|FG000|STARTED|Step 12|Provider attrition=1; Provider addition=0; Patient discharges=3|123
10629432|NCT02021955|11788038|FG001|STARTED|Step 12|Provider attrition=0; Provider addition=2; Patient discharges=1|90
10629433|NCT02021955|11788037|FG000|COMPLETED|Step 12||123
10629434|NCT02021955|11788038|FG001|COMPLETED|Step 12||90
10629435|NCT02021955|11788037|FG000|NOT COMPLETED|Step 12||0
10629436|NCT02021955|11788038|FG001|NOT COMPLETED|Step 12||0
10629437|NCT02021955|11788037|FG000|STARTED|Step 13|Provider attrition=10; Provider addition=0; Patient discharges=4|118
10629438|NCT02021955|11788038|FG001|STARTED|Step 13|Provider attrition=4; Provider addition=0; Patient discharges=5|96
10629439|NCT02021955|11788037|FG000|COMPLETED|Step 13||118
10629440|NCT02021955|11788038|FG001|COMPLETED|Step 13||96
10629441|NCT02021955|11788037|FG000|NOT COMPLETED|Step 13||0
10629442|NCT02021955|11788038|FG001|NOT COMPLETED|Step 13||0
10629443|NCT02021955|11788037|FG000|STARTED|Step 14|Provider attrition=1; Provider addition=9; Patient discharges=7|105
10629444|NCT02021955|11788038|FG001|STARTED|Step 14|Provider attrition=7; Provider addition=11; Patient discharges=3|95
10629445|NCT02021955|11788037|FG000|COMPLETED|Step 14||105
10629446|NCT02021955|11788038|FG001|COMPLETED|Step 14||95
10629447|NCT02021955|11788037|FG000|NOT COMPLETED|Step 14||0
10629448|NCT02021955|11788038|FG001|NOT COMPLETED|Step 14||0
10629449|NCT02021955|11788037|FG000|STARTED|Step 15|Provider attrition=0; Provider addition=0; Patient discharges=4|110
10629450|NCT02021955|11788038|FG001|STARTED|Step 15|Provider attrition=0; Provider addition=5; Patient discharges=5|102
10629451|NCT02021955|11788037|FG000|COMPLETED|Step 15||110
10629452|NCT02021955|11788038|FG001|COMPLETED|Step 15||102
10629453|NCT02021955|11788037|FG000|NOT COMPLETED|Step 15||0
10629454|NCT02021955|11788038|FG001|NOT COMPLETED|Step 15||0
10629455|NCT02021955|11788037|FG000|STARTED|Step 16|Provider attrition=0; Provider addition=0; Patient discharges=2|103
10629456|NCT02021955|11788038|FG001|STARTED|Step 16|Provider attrition=0; Provider addition=3; Patient discharges=3|114
10629457|NCT02021955|11788037|FG000|COMPLETED|Step 16||103
10629458|NCT02021955|11788038|FG001|COMPLETED|Step 16||114
10629459|NCT02021955|11788037|FG000|NOT COMPLETED|Step 16||0
10629460|NCT02021955|11788038|FG001|NOT COMPLETED|Step 16||0
10629461|NCT02021955|11788037|FG000|STARTED|Step 17|Provider attrition=0; Provider addition=0; Patient discharges=8|99
10629462|NCT02021955|11788038|FG001|STARTED|Step 17|Provider attrition=0; Provider addition=0; Patient discharges=3|121
10629463|NCT02021955|11788037|FG000|COMPLETED|Step 17||99
10629464|NCT02021955|11788038|FG001|COMPLETED|Step 17||121
10629465|NCT02021955|11788037|FG000|NOT COMPLETED|Step 17||0
10629466|NCT02021955|11788038|FG001|NOT COMPLETED|Step 17||0
10629467|NCT02021955|11788037|FG000|STARTED|Step 18|Provider attrition=0; Provider addition=0; Patient discharges=6|96
10629468|NCT02021955|11788038|FG001|STARTED|Step 18|Provider attrition=0; Provider addition=0; Patient discharges=7|124
10629469|NCT02021955|11788037|FG000|COMPLETED|Step 18||96
10629470|NCT02021955|11788038|FG001|COMPLETED|Step 18||124
10629471|NCT02021955|11788037|FG000|NOT COMPLETED|Step 18||0
10629472|NCT02021955|11788038|FG001|NOT COMPLETED|Step 18||0
10629473|NCT02021955|11788037|FG000|STARTED|Step 19|Provider attrition=0; Provider addition=0; Patient discharges=5|94
10629474|NCT02021955|11788038|FG001|STARTED|Step 19|Provider attrition=0; Provider addition=0; Patient discharges=9|126
10629475|NCT02021955|11788037|FG000|COMPLETED|Step 19||94
10629476|NCT02021955|11788038|FG001|COMPLETED|Step 19||126
10629477|NCT02021955|11788037|FG000|NOT COMPLETED|Step 19||0
10629478|NCT02021955|11788038|FG001|NOT COMPLETED|Step 19||0
10629479|NCT02021955|11788037|FG000|STARTED|Step 20|Provider attrition=0; Provider addition=1; Patient discharges=9|92
10629480|NCT02021955|11788038|FG001|STARTED|Step 20|Provider attrition=0; Provider addition=1; Patient discharges=9|128
10629481|NCT02021955|11788037|FG000|COMPLETED|Step 20||92
10629482|NCT02021955|11788038|FG001|COMPLETED|Step 20||128
10629483|NCT02021955|11788037|FG000|NOT COMPLETED|Step 20||0
10629484|NCT02021955|11788038|FG001|NOT COMPLETED|Step 20||0
10629485|NCT02021955|11788037|FG000|STARTED|Step 21|Provider attrition=0; Provider addition=7; Patient discharges=1|88
10629486|NCT02021955|11788038|FG001|STARTED|Step 21|Provider attrition=0; Provider addition=12; Patient discharges=9|134
10629487|NCT02021955|11788037|FG000|COMPLETED|Step 21||88
10629488|NCT02021955|11788038|FG001|COMPLETED|Step 21||134
10629489|NCT02021955|11788037|FG000|NOT COMPLETED|Step 21||0
10629490|NCT02021955|11788038|FG001|NOT COMPLETED|Step 21||0
10629491|NCT02021955|11788037|FG000|STARTED|Step 22|Provider attrition=0; Provider addition=0; Patient discharges=8|89
10629492|NCT02021955|11788038|FG001|STARTED|Step 22|Provider attrition=0; Provider addition=3; Patient discharges=8|152
10629493|NCT02021955|11788037|FG000|COMPLETED|Step 22||89
10629494|NCT02021955|11788038|FG001|COMPLETED|Step 22||152
10629495|NCT02021955|11788037|FG000|NOT COMPLETED|Step 22||0
10629496|NCT02021955|11788038|FG001|NOT COMPLETED|Step 22||0
10629497|NCT02021955|11788037|FG000|STARTED|Step 23|Provider attrition=0; Provider addition=1; Patient discharges=3|69
10629498|NCT02021955|11788038|FG001|STARTED|Step 23|Provider attrition=0; Provider addition=0; Patient discharges=7|175
10629499|NCT02021955|11788037|FG000|COMPLETED|Step 23||69
10629500|NCT02021955|11788038|FG001|COMPLETED|Step 23||175
10629501|NCT02021955|11788037|FG000|NOT COMPLETED|Step 23||0
10629502|NCT02021955|11788038|FG001|NOT COMPLETED|Step 23||0
10629503|NCT02021955|11788037|FG000|STARTED|Step 24|Provider attrition=0; Provider addition=0; Patient discharges=4|62
10629504|NCT02021955|11788038|FG001|STARTED|Step 24|Provider attrition=1; Provider addition=1; Patient discharges=8|183
10629505|NCT02021955|11788037|FG000|COMPLETED|Step 24||62
10629506|NCT02021955|11788038|FG001|COMPLETED|Step 24||183
10629507|NCT02021955|11788037|FG000|NOT COMPLETED|Step 24||0
10629508|NCT02021955|11788038|FG001|NOT COMPLETED|Step 24||0
10629509|NCT02021955|11788037|FG000|STARTED|Step 25|Provider attrition=0; Provider addition=1; Patient discharges=0|37
10629510|NCT02021955|11788038|FG001|STARTED|Step 25|Provider attrition=1; Provider addition=0; Patient discharges=5|208
10629511|NCT02021955|11788037|FG000|COMPLETED|Step 25||37
10629512|NCT02021955|11788038|FG001|COMPLETED|Step 25||208
10629513|NCT02021955|11788037|FG000|NOT COMPLETED|Step 25||0
10629514|NCT02021955|11788038|FG001|NOT COMPLETED|Step 25||0
10629515|NCT02021955|11788037|FG000|STARTED|Step 26|Provider attrition=0; Provider addition=0; Patient discharges=2|30
10629516|NCT02021955|11788038|FG001|STARTED|Step 26|Provider attrition=0; Provider addition=23; Patient discharges=9|215
10629517|NCT02021955|11788037|FG000|COMPLETED|Step 26||30
10629518|NCT02021955|11788038|FG001|COMPLETED|Step 26||215
10629519|NCT02021955|11788037|FG000|NOT COMPLETED|Step 26||0
10629520|NCT02021955|11788038|FG001|NOT COMPLETED|Step 26||0
10629521|NCT02021955|11788037|FG000|STARTED|Step 27|Provider attrition=1; Provider addition=1; Patient discharges=0|25
10629522|NCT02021955|11788038|FG001|STARTED|Step 27|Provider attrition=1; Provider addition=4; Patient discharges=4|243
10629523|NCT02021955|11788037|FG000|COMPLETED|Step 27||25
10629524|NCT02021955|11788038|FG001|COMPLETED|Step 27||243
10629525|NCT02021955|11788037|FG000|NOT COMPLETED|Step 27||0
10629526|NCT02021955|11788038|FG001|NOT COMPLETED|Step 27||0
10629527|NCT02021955|11788037|FG000|STARTED|Step 28|Provider attrition=0; Provider addition=2; Patient discharges=0|15
10629528|NCT02021955|11788038|FG001|STARTED|Step 28|Provider attrition=3; Provider addition=6; Patient discharges=6|256
10629529|NCT02021955|11788037|FG000|COMPLETED|Step 28||15
10629530|NCT02021955|11788038|FG001|COMPLETED|Step 28||256
10629531|NCT02021955|11788037|FG000|NOT COMPLETED|Step 28||0
10629532|NCT02021955|11788038|FG001|NOT COMPLETED|Step 28||0
10629533|NCT02021955|11788037|FG000|STARTED|Step 29|Provider attrition=0; Provider addition=0; Patient discharges=0|10
10629534|NCT02021955|11788038|FG001|STARTED|Step 29|Provider attrition=1; Provider addition=2; Patient discharges=8|266
10629535|NCT02021955|11788037|FG000|COMPLETED|Step 29||10
10629536|NCT02021955|11788038|FG001|COMPLETED|Step 29||266
10629537|NCT02021955|11788037|FG000|NOT COMPLETED|Step 29||0
10629538|NCT02021955|11788038|FG001|NOT COMPLETED|Step 29||0
10629539|NCT02021955|11788037|FG000|STARTED|Step 30|Provider attrition=0; Provider addition=0; Patient discharges=0|0
10629540|NCT02021955|11788038|FG001|STARTED|Step 30|Provider attrition=0; Provider addition=1; Patient discharges=11|277
10629541|NCT02021955|11788037|FG000|COMPLETED|Step 30||0
10629542|NCT02021955|11788038|FG001|COMPLETED|Step 30||277
10629543|NCT02021955|11788037|FG000|NOT COMPLETED|Step 30||0
10629544|NCT02021955|11788038|FG001|NOT COMPLETED|Step 30||0
10629545|NCT02022007|11788047|FG000|STARTED|Overall Study||13
10629546|NCT02022007|11788048|FG001|STARTED|Overall Study||12
10629547|NCT02022007|11788049|FG002|STARTED|Overall Study||13
10629548|NCT02022007|11788047|FG000|COMPLETED|Overall Study||12
10629549|NCT02022007|11788048|FG001|COMPLETED|Overall Study||11
10629550|NCT02022007|11788049|FG002|COMPLETED|Overall Study||11
10629551|NCT02022007|11788047|FG000|NOT COMPLETED|Overall Study||1
10629552|NCT02022007|11788048|FG001|NOT COMPLETED|Overall Study||1
10629553|NCT02022007|11788049|FG002|NOT COMPLETED|Overall Study||2
10629554|NCT02022020|11788057|FG000|STARTED|Overall Study||220
10629555|NCT02022020|11788057|FG000|COMPLETED|Overall Study||220
10629556|NCT02022020|11788057|FG000|NOT COMPLETED|Overall Study||0
10629557|NCT02022085|11788061|FG000|STARTED|Overall Study||54
10629558|NCT02022085|11788061|FG000|COMPLETED|Overall Study||53
10629559|NCT02022085|11788061|FG000|NOT COMPLETED|Overall Study||1
10629560|NCT02022111|11788067|FG000|STARTED|Overall Study||196
10629561|NCT02022111|11788068|FG001|STARTED|Overall Study||208
10629562|NCT02022111|11788067|FG000|COMPLETED|Overall Study||186
10629563|NCT02022111|11788068|FG001|COMPLETED|Overall Study||193
10629564|NCT02022111|11788067|FG000|NOT COMPLETED|Overall Study||10
10629565|NCT02022111|11788068|FG001|NOT COMPLETED|Overall Study||15
10629566|NCT02022657|11788076|FG000|STARTED|Overall Study||10
10629567|NCT02022657|11788077|FG001|STARTED|Overall Study||8
10629568|NCT02022657|11788078|FG002|STARTED|Overall Study||9
10629569|NCT02022657|11788079|FG003|STARTED|Overall Study||8
10629570|NCT02022657|11788080|FG004|STARTED|Overall Study||8
10629571|NCT02022657|11788081|FG005|STARTED|Overall Study||9
10629572|NCT02022657|11788076|FG000|COMPLETED|Overall Study||8
10629573|NCT02022657|11788077|FG001|COMPLETED|Overall Study||8
10629574|NCT02022657|11788078|FG002|COMPLETED|Overall Study||8
10629575|NCT02022657|11788079|FG003|COMPLETED|Overall Study||8
10629576|NCT02022657|11788080|FG004|COMPLETED|Overall Study||8
10629577|NCT02022657|11788081|FG005|COMPLETED|Overall Study||8
10629578|NCT02022657|11788076|FG000|NOT COMPLETED|Overall Study||2
10629579|NCT02022657|11788077|FG001|NOT COMPLETED|Overall Study||0
10629580|NCT02022657|11788078|FG002|NOT COMPLETED|Overall Study||1
10629581|NCT02022657|11788079|FG003|NOT COMPLETED|Overall Study||0
10629582|NCT02022657|11788080|FG004|NOT COMPLETED|Overall Study||0
10629583|NCT02022657|11788081|FG005|NOT COMPLETED|Overall Study||1
10629584|NCT02022670|11788090|FG000|STARTED|Overall Study||11
10809116|NCT03836677|11970992|FG000|STARTED|Washout||13
10705439|NCT02598128|11869824|FG001|NOT COMPLETED|Period C: Days 12 to 20||0
10705440|NCT02598128|11869825|FG002|NOT COMPLETED|Period C: Days 12 to 20||0
10705441|NCT02598128|11869826|FG003|NOT COMPLETED|Period C: Days 12 to 20||0
10705442|NCT02598193|11869838|FG000|STARTED|Overall Study||89
10705443|NCT02598193|11869838|FG000|COMPLETED|Overall Study||73
10629585|NCT02022670|11788091|FG001|STARTED|Overall Study||10
10629586|NCT02022670|11788092|FG002|STARTED|Overall Study||12
10629587|NCT02022670|11788090|FG000|COMPLETED|Overall Study||10
10629588|NCT02022670|11788091|FG001|COMPLETED|Overall Study||10
10629589|NCT02022670|11788092|FG002|COMPLETED|Overall Study||11
10629590|NCT02022670|11788090|FG000|NOT COMPLETED|Overall Study||1
10629591|NCT02022670|11788091|FG001|NOT COMPLETED|Overall Study||0
10629592|NCT02022670|11788092|FG002|NOT COMPLETED|Overall Study||1
10629593|NCT02022735|11788101|FG000|STARTED|Overall Study||22
10629594|NCT02022735|11788101|FG000|COMPLETED|Overall Study||22
10629595|NCT02022735|11788101|FG000|NOT COMPLETED|Overall Study||0
10629596|NCT02022748|11788113|FG000|STARTED|Overall Study||8
10629597|NCT02022748|11788114|FG001|STARTED|Overall Study||6
10629598|NCT02022748|11788115|FG002|STARTED|Overall Study||13
10629599|NCT02022748|11788113|FG000|Subject Who Started Treatment|Overall Study||8
10629600|NCT02022748|11788114|FG001|Subject Who Started Treatment|Overall Study||6
10629601|NCT02022748|11788115|FG002|Subject Who Started Treatment|Overall Study||13
10629602|NCT02022748|11788113|FG000|Subjects Who Completed Treatment|Overall Study||7
10629603|NCT02022748|11788114|FG001|Subjects Who Completed Treatment|Overall Study||4
10629604|NCT02022748|11788115|FG002|Subjects Who Completed Treatment|Overall Study||13
10629605|NCT02022748|11788113|FG000|COMPLETED|Overall Study||7
10629606|NCT02022748|11788114|FG001|COMPLETED|Overall Study||4
10629607|NCT02022748|11788115|FG002|COMPLETED|Overall Study||13
10629608|NCT02022748|11788113|FG000|NOT COMPLETED|Overall Study||1
10629609|NCT02022748|11788114|FG001|NOT COMPLETED|Overall Study||2
10629610|NCT02022748|11788115|FG002|NOT COMPLETED|Overall Study||0
10629611|NCT02022826|11788123|FG000|STARTED|Overall Study||167
10629612|NCT02022826|11788123|FG000|COMPLETED|Overall Study||139
10629613|NCT02022826|11788123|FG000|NOT COMPLETED|Overall Study||28
10653663|NCT02195687|11814260|FG000|COMPLETED|Overall Study||311
10653664|NCT02195687|11814261|FG001|COMPLETED|Overall Study||99
10653665|NCT02195687|11814260|FG000|NOT COMPLETED|Overall Study||5
10653666|NCT02195687|11814261|FG001|NOT COMPLETED|Overall Study||2
10653667|NCT02195700|11814269|FG000|STARTED|Overall Study||58
10653668|NCT02195700|11814270|FG001|STARTED|Overall Study||59
10653669|NCT02195700|11814269|FG000|Safety and ITT Populations|Overall Study||58
10653670|NCT02195700|11814270|FG001|Safety and ITT Populations|Overall Study||59
10653671|NCT02195700|11814269|FG000|Modified ITT Population|Overall Study|ITT who received study drug and >=1 centrally read post-baseline AIMS from weeks 2, 4, 6, 9, or 12|56
10653672|NCT02195700|11814270|FG001|Modified ITT Population|Overall Study|ITT who received study drug and >=1 centrally read post-baseline AIMS from weeks 2, 4, 6, 9, or 12|57
10653673|NCT02195700|11814269|FG000|Maintenance Period|Overall Study||53
10653674|NCT02195700|11814270|FG001|Maintenance Period|Overall Study||54
10653675|NCT02195700|11814269|FG000|COMPLETED|Overall Study||52
10705444|NCT02598193|11869838|FG000|NOT COMPLETED|Overall Study||16
10705445|NCT02598297|11869844|FG000|STARTED|Overall Study|One subject in the ruxolitinib arm was not treated with the study drug|25
10705446|NCT02598297|11869845|FG001|STARTED|Overall Study||24
10705447|NCT02598297|11869844|FG000|Not Treted Wit Study Drug|Overall Study||1
10705448|NCT02598297|11869845|FG001|Not Treted Wit Study Drug|Overall Study||0
10809117|NCT03836677|11970993|FG001|STARTED|Washout||9
10653676|NCT02195700|11814270|FG001|COMPLETED|Overall Study||52
10653677|NCT02195700|11814269|FG000|NOT COMPLETED|Overall Study||6
10705449|NCT02598297|11869844|FG000|Subjects Followed for Survival|Overall Study||1
10705450|NCT02598297|11869845|FG001|Subjects Followed for Survival|Overall Study||0
10705451|NCT02598297|11869844|FG000|COMPLETED|Overall Study||0
10653678|NCT02195700|11814270|FG001|NOT COMPLETED|Overall Study||7
10653679|NCT02195713|11814278|FG000|STARTED|Overall Study||10
10653680|NCT02195713|11814279|FG001|STARTED|Overall Study||10
10653681|NCT02195713|11814278|FG000|COMPLETED|Overall Study||10
10653682|NCT02195713|11814279|FG001|COMPLETED|Overall Study||10
10653683|NCT02195713|11814278|FG000|NOT COMPLETED|Overall Study||0
10653684|NCT02195713|11814279|FG001|NOT COMPLETED|Overall Study||0
10653685|NCT02195869|11814285|FG000|STARTED|Overall Study|Phase 1b: 6 patients, 420 mg, no DLT observed. Phase 2: 42 patients, 420 mg|42
10629614|NCT02023099|11788130|FG000|STARTED|Overall Study||215
10629615|NCT02023099|11788131|FG001|STARTED|Overall Study||106
10629616|NCT02023099|11788132|FG002|STARTED|Overall Study||42
10629617|NCT02023099|11788130|FG000|COMPLETED|Overall Study||212
10629618|NCT02023099|11788131|FG001|COMPLETED|Overall Study||106
10629619|NCT02023099|11788132|FG002|COMPLETED|Overall Study||39
10629620|NCT02023099|11788130|FG000|NOT COMPLETED|Overall Study||3
10629621|NCT02023099|11788131|FG001|NOT COMPLETED|Overall Study||0
10629622|NCT02023099|11788132|FG002|NOT COMPLETED|Overall Study||3
10629623|NCT02023112|11788142|FG000|STARTED|Overall Study||85
10629624|NCT02023112|11788143|FG001|STARTED|Overall Study||86
10629625|NCT02023112|11788142|FG000|COMPLETED|Overall Study||83
10629626|NCT02023112|11788143|FG001|COMPLETED|Overall Study||85
10629627|NCT02023112|11788142|FG000|NOT COMPLETED|Overall Study||2
10629628|NCT02023112|11788143|FG001|NOT COMPLETED|Overall Study||1
10629629|NCT02023125|11788153|FG000|STARTED|Period 1||9
10629630|NCT02023125|11788154|FG001|STARTED|Period 1||9
10629631|NCT02023125|11788155|FG002|STARTED|Period 1||24
10629632|NCT02023125|11788153|FG000|COMPLETED|Period 1||9
10629633|NCT02023125|11788154|FG001|COMPLETED|Period 1||9
10629634|NCT02023125|11788155|FG002|COMPLETED|Period 1||24
10629635|NCT02023125|11788153|FG000|NOT COMPLETED|Period 1||0
10629636|NCT02023125|11788154|FG001|NOT COMPLETED|Period 1||0
10629637|NCT02023125|11788155|FG002|NOT COMPLETED|Period 1||0
10629638|NCT02023125|11788153|FG000|STARTED|Washout Period||9
10629639|NCT02023125|11788154|FG001|STARTED|Washout Period||9
10629640|NCT02023125|11788155|FG002|STARTED|Washout Period||24
10629641|NCT02023125|11788153|FG000|COMPLETED|Washout Period||9
10629642|NCT02023125|11788154|FG001|COMPLETED|Washout Period||9
10629643|NCT02023125|11788155|FG002|COMPLETED|Washout Period||24
10629644|NCT02023125|11788153|FG000|NOT COMPLETED|Washout Period||0
10629645|NCT02023125|11788154|FG001|NOT COMPLETED|Washout Period||0
10629646|NCT02023125|11788155|FG002|NOT COMPLETED|Washout Period||0
10629647|NCT02023125|11788153|FG000|STARTED|Period 2||9
10629648|NCT02023125|11788154|FG001|STARTED|Period 2||9
10629649|NCT02023125|11788155|FG002|STARTED|Period 2||24
10629650|NCT02023125|11788153|FG000|COMPLETED|Period 2||9
10629651|NCT02023125|11788154|FG001|COMPLETED|Period 2||9
10629652|NCT02023125|11788155|FG002|COMPLETED|Period 2||24
10629653|NCT02023125|11788153|FG000|NOT COMPLETED|Period 2||0
10629654|NCT02023125|11788154|FG001|NOT COMPLETED|Period 2||0
10629655|NCT02023125|11788155|FG002|NOT COMPLETED|Period 2||0
10629656|NCT02023151|11788167|FG000|STARTED|Overall Study||17
10629657|NCT02023151|11788167|FG000|COMPLETED|Overall Study||13
10629658|NCT02023151|11788167|FG000|NOT COMPLETED|Overall Study||4
10629659|NCT02023242|11788173|FG000|STARTED|Overall Study||75
10629660|NCT02023242|11788174|FG001|STARTED|Overall Study||77
10629661|NCT02023242|11788173|FG000|COMPLETED|Overall Study||72
10629662|NCT02023242|11788174|FG001|COMPLETED|Overall Study||75
10629663|NCT02023242|11788173|FG000|NOT COMPLETED|Overall Study||3
10629664|NCT02023242|11788174|FG001|NOT COMPLETED|Overall Study||2
10629665|NCT02023268|11788182|FG000|STARTED|Overall Study||52
10629666|NCT02023268|11788183|FG001|STARTED|Overall Study||53
10629667|NCT02023268|11788182|FG000|COMPLETED|Overall Study||52
10629668|NCT02023268|11788183|FG001|COMPLETED|Overall Study||49
10629669|NCT02023268|11788182|FG000|NOT COMPLETED|Overall Study||0
10629670|NCT02023268|11788183|FG001|NOT COMPLETED|Overall Study||4
10629671|NCT02023411|11788191|FG000|STARTED|Overall Study||10
10629672|NCT02023411|11788192|FG001|STARTED|Overall Study||10
10629673|NCT02023411|11788191|FG000|COMPLETED|Overall Study||10
10629674|NCT02023411|11788192|FG001|COMPLETED|Overall Study||10
10629675|NCT02023411|11788191|FG000|NOT COMPLETED|Overall Study||0
10629676|NCT02023411|11788192|FG001|NOT COMPLETED|Overall Study||0
10629677|NCT02023515|11788201|FG000|STARTED|Overall Study||24
10629678|NCT02023515|11788202|FG001|STARTED|Overall Study||25
10629679|NCT02023515|11788201|FG000|COMPLETED|Overall Study||23
10629680|NCT02023515|11788202|FG001|COMPLETED|Overall Study||22
10629681|NCT02023515|11788201|FG000|NOT COMPLETED|Overall Study||1
10629682|NCT02023515|11788202|FG001|NOT COMPLETED|Overall Study||3
10629683|NCT02023697|11788211|FG000|STARTED|Treatment Period||130
10629684|NCT02023697|11788212|FG001|STARTED|Treatment Period||130
10629685|NCT02023697|11788213|FG002|STARTED|Treatment Period||131
10629686|NCT02023697|11788211|FG000|Received Treatment|Treatment Period||125
10629687|NCT02023697|11788212|FG001|Received Treatment|Treatment Period||124
10629688|NCT02023697|11788213|FG002|Received Treatment|Treatment Period||121
10629689|NCT02023697|11788211|FG000|COMPLETED|Treatment Period||84
10629690|NCT02023697|11788212|FG001|COMPLETED|Treatment Period||67
10629691|NCT02023697|11788213|FG002|COMPLETED|Treatment Period||29
10629692|NCT02023697|11788211|FG000|NOT COMPLETED|Treatment Period||46
10629693|NCT02023697|11788212|FG001|NOT COMPLETED|Treatment Period||63
10629694|NCT02023697|11788213|FG002|NOT COMPLETED|Treatment Period||102
10629695|NCT02023697|11788211|FG000|STARTED|Active Follow-up Period|Not all participants in ITT entered active follow-up.|120
10629696|NCT02023697|11788212|FG001|STARTED|Active Follow-up Period|Not all participants in ITT entered active follow-up.|120
10629697|NCT02023697|11788213|FG002|STARTED|Active Follow-up Period|Not all participants in ITT entered active follow-up.|116
10629698|NCT02023697|11788211|FG000|COMPLETED|Active Follow-up Period||28
10629699|NCT02023697|11788212|FG001|COMPLETED|Active Follow-up Period||21
10629700|NCT02023697|11788213|FG002|COMPLETED|Active Follow-up Period||17
10629701|NCT02023697|11788211|FG000|NOT COMPLETED|Active Follow-up Period||92
10629702|NCT02023697|11788212|FG001|NOT COMPLETED|Active Follow-up Period||99
10629703|NCT02023697|11788213|FG002|NOT COMPLETED|Active Follow-up Period||99
10629704|NCT02023697|11788211|FG000|STARTED|Long-term Follow-up Period||28
10629705|NCT02023697|11788212|FG001|STARTED|Long-term Follow-up Period||21
10629706|NCT02023697|11788213|FG002|STARTED|Long-term Follow-up Period||17
10629707|NCT02023697|11788211|FG000|COMPLETED|Long-term Follow-up Period||0
10629708|NCT02023697|11788212|FG001|COMPLETED|Long-term Follow-up Period||0
10629709|NCT02023697|11788213|FG002|COMPLETED|Long-term Follow-up Period||0
10629710|NCT02023697|11788211|FG000|NOT COMPLETED|Long-term Follow-up Period||28
10629711|NCT02023697|11788212|FG001|NOT COMPLETED|Long-term Follow-up Period||21
10629712|NCT02023697|11788213|FG002|NOT COMPLETED|Long-term Follow-up Period||17
10629713|NCT02023801|11788228|FG000|STARTED|Overall Study|Treatment Attempted|24
10629714|NCT02023801|11788228|FG000|Treated|Overall Study|Treatment Completed|24
10629715|NCT02023801|11788228|FG000|COMPLETED|Overall Study|Completed 12 Month Follow-up|24
10629716|NCT02023801|11788228|FG000|NOT COMPLETED|Overall Study||0
10629717|NCT02023866|11788232|FG000|STARTED|Overall Study||36
10629718|NCT02023866|11788232|FG000|COMPLETED|Overall Study||30
10629719|NCT02023866|11788232|FG000|NOT COMPLETED|Overall Study||6
10629720|NCT02023879|11788239|FG000|STARTED|Period 1: 24-Week Double-blind Treatment||58
10629721|NCT02023879|11788240|FG001|STARTED|Period 1: 24-Week Double-blind Treatment||116
10629722|NCT02023879|11788241|FG002|STARTED|Period 1: 24-Week Double-blind Treatment||59
10629723|NCT02023879|11788239|FG000|Treated|Period 1: 24-Week Double-blind Treatment||58
10629724|NCT02023879|11788240|FG001|Treated|Period 1: 24-Week Double-blind Treatment||115
10629725|NCT02023879|11788241|FG002|Treated|Period 1: 24-Week Double-blind Treatment||58
10629726|NCT02023879|11788239|FG000|COMPLETED|Period 1: 24-Week Double-blind Treatment||54
10629727|NCT02023879|11788240|FG001|COMPLETED|Period 1: 24-Week Double-blind Treatment||107
10629728|NCT02023879|11788241|FG002|COMPLETED|Period 1: 24-Week Double-blind Treatment||50
10629729|NCT02023879|11788239|FG000|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||4
10629730|NCT02023879|11788240|FG001|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||9
10629731|NCT02023879|11788241|FG002|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||9
10629732|NCT02023879|11788239|FG000|STARTED|Extension Open Label Treatment|The open-label extension period was optional for participants who completed the double-blind period.|51
10629733|NCT02023879|11788240|FG001|STARTED|Extension Open Label Treatment|The open-label extension period was optional for participants who completed the double-blind period.|106
10629734|NCT02023879|11788241|FG002|STARTED|Extension Open Label Treatment|The open-label extension period was optional for participants who completed the double-blind period.|48
10629735|NCT02023879|11788239|FG000|COMPLETED|Extension Open Label Treatment||46
10629736|NCT02023879|11788240|FG001|COMPLETED|Extension Open Label Treatment||89
10629737|NCT02023879|11788241|FG002|COMPLETED|Extension Open Label Treatment||43
10629738|NCT02023879|11788239|FG000|NOT COMPLETED|Extension Open Label Treatment||5
10629739|NCT02023879|11788240|FG001|NOT COMPLETED|Extension Open Label Treatment||17
10629740|NCT02023879|11788241|FG002|NOT COMPLETED|Extension Open Label Treatment||5
10629741|NCT02023918|11788256|FG000|STARTED|Overall Study||6
10629742|NCT02023918|11788256|FG000|COMPLETED|Overall Study||6
10629743|NCT02023918|11788256|FG000|NOT COMPLETED|Overall Study||0
10629744|NCT02023944|11788262|FG000|STARTED|Overall Study||25
10629745|NCT02023944|11788263|FG001|STARTED|Overall Study||25
10629746|NCT02023944|11788262|FG000|COMPLETED|Overall Study||25
10629747|NCT02023944|11788263|FG001|COMPLETED|Overall Study||24
10629748|NCT02023944|11788262|FG000|NOT COMPLETED|Overall Study||0
10629749|NCT02023944|11788263|FG001|NOT COMPLETED|Overall Study||1
10629750|NCT02023983|11788272|FG000|STARTED|Overall Study||76
10629751|NCT02023983|11788273|FG001|STARTED|Overall Study||75
10629752|NCT02023983|11788272|FG000|COMPLETED|Overall Study||76
10629753|NCT02023983|11788273|FG001|COMPLETED|Overall Study||75
10629754|NCT02023983|11788272|FG000|NOT COMPLETED|Overall Study||0
10629755|NCT02023983|11788273|FG001|NOT COMPLETED|Overall Study||0
10629762|NCT02024165|11788289|FG000|STARTED|Overall Study||71
10629763|NCT02024165|11788289|FG000|COMPLETED|Overall Study||71
10629764|NCT02024165|11788289|FG000|NOT COMPLETED|Overall Study||0
10629765|NCT02024204|11788296|FG000|STARTED|Overall Study||49
10629766|NCT02024204|11788297|FG001|STARTED|Overall Study||11
10629767|NCT02024204|11788296|FG000|COMPLETED|Overall Study||49
10629768|NCT02024204|11788297|FG001|COMPLETED|Overall Study||11
10629769|NCT02024204|11788296|FG000|NOT COMPLETED|Overall Study||0
10629770|NCT02024204|11788297|FG001|NOT COMPLETED|Overall Study||0
10629771|NCT02024386|11788306|FG000|STARTED|Overall Study||6
10629772|NCT02024386|11788307|FG001|STARTED|Overall Study||11
10629773|NCT02024386|11788308|FG002|STARTED|Overall Study||5
10629774|NCT02024386|11788306|FG000|COMPLETED|Overall Study||6
10629775|NCT02024386|11788307|FG001|COMPLETED|Overall Study||11
10629776|NCT02024386|11788308|FG002|COMPLETED|Overall Study||5
10629777|NCT02024386|11788306|FG000|NOT COMPLETED|Overall Study||0
10629778|NCT02024386|11788307|FG001|NOT COMPLETED|Overall Study||0
10629779|NCT02024386|11788308|FG002|NOT COMPLETED|Overall Study||0
10629780|NCT02024477|11788319|FG000|STARTED|Overall Study||21
10629781|NCT02024477|11788320|FG001|STARTED|Overall Study||21
10629782|NCT02024477|11788319|FG000|COMPLETED|Overall Study||21
10629783|NCT02024477|11788320|FG001|COMPLETED|Overall Study||21
10629784|NCT02024477|11788319|FG000|NOT COMPLETED|Overall Study||0
10629785|NCT02024477|11788320|FG001|NOT COMPLETED|Overall Study||0
10629786|NCT02024646|11788329|FG000|STARTED|Overall Study||163
10629787|NCT02024646|11788330|FG001|STARTED|Overall Study||160
10629788|NCT02024646|11788331|FG002|STARTED|Overall Study||161
10629789|NCT02024646|11788329|FG000|COMPLETED|Overall Study||131
10629790|NCT02024646|11788330|FG001|COMPLETED|Overall Study||135
10629791|NCT02024646|11788331|FG002|COMPLETED|Overall Study||133
10629792|NCT02024646|11788329|FG000|NOT COMPLETED|Overall Study||32
10629793|NCT02024646|11788330|FG001|NOT COMPLETED|Overall Study||25
10629794|NCT02024646|11788331|FG002|NOT COMPLETED|Overall Study||28
10629795|NCT02024698|11788339|FG000|STARTED|First Intervention (7 Days)||16
10629796|NCT02024698|11788340|FG001|STARTED|First Intervention (7 Days)||27
10629797|NCT02024698|11788339|FG000|COMPLETED|First Intervention (7 Days)||16
10629798|NCT02024698|11788340|FG001|COMPLETED|First Intervention (7 Days)||26
10629799|NCT02024698|11788339|FG000|NOT COMPLETED|First Intervention (7 Days)||0
10629800|NCT02024698|11788340|FG001|NOT COMPLETED|First Intervention (7 Days)||1
10629801|NCT02024698|11788339|FG000|STARTED|Second Intervention (7 Days)||16
10629802|NCT02024698|11788340|FG001|STARTED|Second Intervention (7 Days)||26
10629803|NCT02024698|11788339|FG000|Received Etafilcon A Twice|Second Intervention (7 Days)||1
10629804|NCT02024698|11788340|FG001|Received Etafilcon A Twice|Second Intervention (7 Days)||0
10629805|NCT02024698|11788339|FG000|COMPLETED|Second Intervention (7 Days)||16
10629806|NCT02024698|11788340|FG001|COMPLETED|Second Intervention (7 Days)||26
10629807|NCT02024698|11788339|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
10629808|NCT02024698|11788340|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
10629809|NCT02024711|11788348|FG000|STARTED|Overall Study||130
10629810|NCT02024711|11788349|FG001|STARTED|Overall Study||132
10629811|NCT02024711|11788348|FG000|COMPLETED|Overall Study||129
10629812|NCT02024711|11788349|FG001|COMPLETED|Overall Study||128
10629813|NCT02024711|11788348|FG000|NOT COMPLETED|Overall Study||1
10629814|NCT02024711|11788349|FG001|NOT COMPLETED|Overall Study||4
10629815|NCT02024724|11788357|FG000|STARTED|Overall Study||30
10629816|NCT02024724|11788358|FG001|STARTED|Overall Study||30
10629817|NCT02024724|11788357|FG000|COMPLETED|Overall Study||29
10629818|NCT02024724|11788358|FG001|COMPLETED|Overall Study||30
10629819|NCT02024724|11788357|FG000|NOT COMPLETED|Overall Study||1
10629820|NCT02024724|11788358|FG001|NOT COMPLETED|Overall Study||0
10629821|NCT02024750|11788366|FG000|STARTED|Overall Study||106
10629822|NCT02024750|11788367|FG001|STARTED|Overall Study||108
10629823|NCT02024750|11788366|FG000|COMPLETED|Overall Study||104
10629824|NCT02024750|11788367|FG001|COMPLETED|Overall Study||107
10629825|NCT02024750|11788366|FG000|NOT COMPLETED|Overall Study||2
10629826|NCT02024750|11788367|FG001|NOT COMPLETED|Overall Study||1
10629827|NCT02024867|11788375|FG000|STARTED|Overall Study||134
10629828|NCT02024867|11788376|FG001|STARTED|Overall Study||131
10629829|NCT02024867|11788375|FG000|COMPLETED|Overall Study||125
10629830|NCT02024867|11788376|FG001|COMPLETED|Overall Study||124
10629831|NCT02024867|11788375|FG000|NOT COMPLETED|Overall Study||9
10629832|NCT02024867|11788376|FG001|NOT COMPLETED|Overall Study||7
10629833|NCT02024932|11788388|FG000|STARTED|Overall Study||2
10629834|NCT02024932|11788389|FG001|STARTED|Overall Study||4
10629835|NCT02024932|11788390|FG002|STARTED|Overall Study||2
10629836|NCT02024932|11788391|FG003|STARTED|Overall Study||2
10629837|NCT02024932|11788392|FG004|STARTED|Overall Study||18
10629838|NCT02024932|11788393|FG005|STARTED|Overall Study||9
10629839|NCT02024932|11788388|FG000|Safety Analysis Set|Overall Study||2
10629840|NCT02024932|11788389|FG001|Safety Analysis Set|Overall Study||4
10629841|NCT02024932|11788390|FG002|Safety Analysis Set|Overall Study||2
10629842|NCT02024932|11788391|FG003|Safety Analysis Set|Overall Study||2
10629843|NCT02024932|11788392|FG004|Safety Analysis Set|Overall Study||18
10629844|NCT02024932|11788393|FG005|Safety Analysis Set|Overall Study||9
10629845|NCT02024932|11788388|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||2
10629846|NCT02024932|11788389|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||4
10629847|NCT02024932|11788390|FG002|Pharmacokinetic (PK) Analysis Set|Overall Study||0
10629848|NCT02024932|11788391|FG003|Pharmacokinetic (PK) Analysis Set|Overall Study||2
10629849|NCT02024932|11788392|FG004|Pharmacokinetic (PK) Analysis Set|Overall Study||18
10629850|NCT02024932|11788393|FG005|Pharmacokinetic (PK) Analysis Set|Overall Study||0
10629851|NCT02024932|11788388|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||2
10629852|NCT02024932|11788389|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||4
10629853|NCT02024932|11788390|FG002|Pharmacodynamic (PD) Analysis Set|Overall Study||2
10629854|NCT02024932|11788391|FG003|Pharmacodynamic (PD) Analysis Set|Overall Study||2
10629855|NCT02024932|11788392|FG004|Pharmacodynamic (PD) Analysis Set|Overall Study||18
10629856|NCT02024932|11788393|FG005|Pharmacodynamic (PD) Analysis Set|Overall Study||9
10629857|NCT02024932|11788388|FG000|COMPLETED|Overall Study||0
10629858|NCT02024932|11788389|FG001|COMPLETED|Overall Study||1
10629859|NCT02024932|11788390|FG002|COMPLETED|Overall Study||2
10629860|NCT02024932|11788391|FG003|COMPLETED|Overall Study||0
10629861|NCT02024932|11788392|FG004|COMPLETED|Overall Study||16
10629862|NCT02024932|11788393|FG005|COMPLETED|Overall Study||9
10629863|NCT02024932|11788388|FG000|NOT COMPLETED|Overall Study||2
10629864|NCT02024932|11788389|FG001|NOT COMPLETED|Overall Study||3
10629865|NCT02024932|11788390|FG002|NOT COMPLETED|Overall Study||0
10629866|NCT02024932|11788391|FG003|NOT COMPLETED|Overall Study||2
10629867|NCT02024932|11788392|FG004|NOT COMPLETED|Overall Study||2
10629868|NCT02024932|11788393|FG005|NOT COMPLETED|Overall Study||0
10629869|NCT02024971|11788413|FG000|STARTED|Overall Study||1103
10629870|NCT02024971|11788413|FG000|Safety Analysis Set|Overall Study|All participants with available data who were enrolled prior to Day 15 of the start of treatment.|1067
10653686|NCT02195869|11814285|FG000|All-Treated Population|Overall Study||42
10629871|NCT02024971|11788413|FG000|COMPLETED|Overall Study|Including 162 patients with missing efficacy data at two or more time points.|1067
10629872|NCT02024971|11788413|FG000|NOT COMPLETED|Overall Study||36
10629873|NCT02025075|11788419|FG000|STARTED|Overall Study||16
10629874|NCT02025075|11788420|FG001|STARTED|Overall Study||21
10629875|NCT02025075|11788419|FG000|COMPLETED|Overall Study||16
10629876|NCT02025075|11788420|FG001|COMPLETED|Overall Study||19
10629877|NCT02025075|11788419|FG000|NOT COMPLETED|Overall Study||0
10629878|NCT02025075|11788420|FG001|NOT COMPLETED|Overall Study||2
10629879|NCT02025179|11788435|FG000|STARTED|Overall Study||8
10629880|NCT02025179|11788436|FG001|STARTED|Overall Study||9
10629881|NCT02025179|11788437|FG002|STARTED|Overall Study||8
10629882|NCT02025179|11788435|FG000|COMPLETED|Overall Study||8
10629883|NCT02025179|11788436|FG001|COMPLETED|Overall Study||9
10629884|NCT02025179|11788437|FG002|COMPLETED|Overall Study||7
10629885|NCT02025179|11788435|FG000|NOT COMPLETED|Overall Study||0
10629886|NCT02025179|11788436|FG001|NOT COMPLETED|Overall Study||0
10629887|NCT02025179|11788437|FG002|NOT COMPLETED|Overall Study||1
10629888|NCT02025205|11788447|FG000|STARTED|Overall Study||43
10629889|NCT02025205|11788448|FG001|STARTED|Overall Study||50
10629890|NCT02025205|11788447|FG000|COMPLETED|Overall Study||40
10629891|NCT02025205|11788448|FG001|COMPLETED|Overall Study||47
10629892|NCT02025205|11788447|FG000|NOT COMPLETED|Overall Study||3
10629893|NCT02025205|11788448|FG001|NOT COMPLETED|Overall Study||3
10629894|NCT02025426|11788456|FG000|STARTED|Overall Study||9
10629895|NCT02025426|11788457|FG001|STARTED|Overall Study||4
10629896|NCT02025426|11788456|FG000|COMPLETED|Overall Study||9
10629897|NCT02025426|11788457|FG001|COMPLETED|Overall Study||4
10629898|NCT02025426|11788456|FG000|NOT COMPLETED|Overall Study||0
10629899|NCT02025426|11788457|FG001|NOT COMPLETED|Overall Study||0
10629900|NCT02025439|11788465|FG000|STARTED|Overall Study||2
10629901|NCT02025439|11788466|FG001|STARTED|Overall Study||2
10629902|NCT02025439|11788465|FG000|COMPLETED|Overall Study||2
10629903|NCT02025439|11788466|FG001|COMPLETED|Overall Study||2
10629904|NCT02025439|11788465|FG000|NOT COMPLETED|Overall Study||0
10629905|NCT02025439|11788466|FG001|NOT COMPLETED|Overall Study||0
10629906|NCT02025530|11788476|FG000|STARTED|Overall Study||296
10629907|NCT02025530|11788477|FG001|STARTED|Overall Study||734
10629908|NCT02025530|11788476|FG000|COMPLETED|Overall Study||291
10629909|NCT02025530|11788477|FG001|COMPLETED|Overall Study||733
10629910|NCT02025530|11788476|FG000|NOT COMPLETED|Overall Study||5
10629911|NCT02025530|11788477|FG001|NOT COMPLETED|Overall Study||1
10629912|NCT02025621|11788485|FG000|STARTED|Overall Study||442
10629913|NCT02025621|11788486|FG001|STARTED|Overall Study||440
10629914|NCT02025621|11788485|FG000|COMPLETED|Overall Study||428
10629915|NCT02025621|11788486|FG001|COMPLETED|Overall Study||421
10629916|NCT02025621|11788485|FG000|NOT COMPLETED|Overall Study||14
10629917|NCT02025621|11788486|FG001|NOT COMPLETED|Overall Study||19
10629918|NCT02025634|11788494|FG000|STARTED|Overall Study||65
10629919|NCT02025634|11788495|FG001|STARTED|Overall Study||54
10629920|NCT02025634|11788494|FG000|COMPLETED|Overall Study||65
10629921|NCT02025634|11788495|FG001|COMPLETED|Overall Study||54
10629922|NCT02025634|11788494|FG000|NOT COMPLETED|Overall Study||0
10629923|NCT02025634|11788495|FG001|NOT COMPLETED|Overall Study||0
10629924|NCT02025647|11788501|FG000|STARTED|Overall Study||139
10629925|NCT02025647|11788501|FG000|Session 1 (Narrative Module)|Overall Study||139
10629926|NCT02025647|11788501|FG000|Immediate Retest (Rating Module: 5 Min)|Overall Study|"27 did not generate IRS~15 technology issues or administered wrong session"|97
10629927|NCT02025647|11788501|FG000|Session 2 (Narrative Module: 24-48 Hrs)|Overall Study|"19 lost to follow up or technology issues~3 administered wrong session"|117
10629928|NCT02025647|11788501|FG000|Session 3 (Rating Module: 30-45 Days)|Overall Study|"27 did not generate IRS~36 lost to follow up"|76
10629929|NCT02025647|11788501|FG000|COMPLETED|Overall Study||139
10629930|NCT02025647|11788501|FG000|NOT COMPLETED|Overall Study||0
10629931|NCT02025725|11788507|FG000|STARTED|Overall Study||102
10629932|NCT02025725|11788508|FG001|STARTED|Overall Study||103
10629933|NCT02025725|11788507|FG000|COMPLETED|Overall Study||91
10629934|NCT02025725|11788508|FG001|COMPLETED|Overall Study||99
10629935|NCT02025725|11788507|FG000|NOT COMPLETED|Overall Study||11
10629936|NCT02025725|11788508|FG001|NOT COMPLETED|Overall Study||4
10629937|NCT02025751|11788518|FG000|STARTED|Overall Study||26
10629938|NCT02025751|11788519|FG001|STARTED|Overall Study||27
10629939|NCT02025751|11788518|FG000|COMPLETED|Overall Study||25
10629940|NCT02025751|11788519|FG001|COMPLETED|Overall Study||24
10629941|NCT02025751|11788518|FG000|NOT COMPLETED|Overall Study||1
10629942|NCT02025751|11788519|FG001|NOT COMPLETED|Overall Study||3
10629943|NCT02025829|11788527|FG000|STARTED|Overall Study||3
10629944|NCT02025829|11788528|FG001|STARTED|Overall Study||11
10629945|NCT02025829|11788527|FG000|COMPLETED|Overall Study||3
10629946|NCT02025829|11788528|FG001|COMPLETED|Overall Study||11
10629947|NCT02025829|11788527|FG000|NOT COMPLETED|Overall Study||0
10629948|NCT02025829|11788528|FG001|NOT COMPLETED|Overall Study||0
10629949|NCT02025907|11788537|FG000|STARTED|Overall Study|Participant flow is presented for safety population.|108
10629950|NCT02025907|11788538|FG001|STARTED|Overall Study|Participant flow is presented for safety population.|108
10629951|NCT02025907|11788537|FG000|COMPLETED|Overall Study||81
10629952|NCT02025907|11788538|FG001|COMPLETED|Overall Study||96
10629953|NCT02025907|11788537|FG000|NOT COMPLETED|Overall Study||27
10629954|NCT02025907|11788538|FG001|NOT COMPLETED|Overall Study||12
10629955|NCT02025985|11788549|FG000|STARTED|Overall Study||25
10629956|NCT02025985|11788550|FG001|STARTED|Overall Study||23
10629957|NCT02025985|11788551|FG002|STARTED|Overall Study||25
10629958|NCT02025985|11788552|FG003|STARTED|Overall Study||21
10629959|NCT02025985|11788553|FG004|STARTED|Overall Study||20
10629960|NCT02025985|11788549|FG000|Modified Intent-to-treat(mITT)Population|Overall Study||23
10629961|NCT02025985|11788550|FG001|Modified Intent-to-treat(mITT)Population|Overall Study||22
10629962|NCT02025985|11788551|FG002|Modified Intent-to-treat(mITT)Population|Overall Study||25
10629963|NCT02025985|11788552|FG003|Modified Intent-to-treat(mITT)Population|Overall Study||21
10629964|NCT02025985|11788553|FG004|Modified Intent-to-treat(mITT)Population|Overall Study||20
10629965|NCT02025985|11788549|FG000|COMPLETED|Overall Study||0
10629966|NCT02025985|11788550|FG001|COMPLETED|Overall Study||0
10629967|NCT02025985|11788551|FG002|COMPLETED|Overall Study||0
10629968|NCT02025985|11788552|FG003|COMPLETED|Overall Study||0
10629969|NCT02025985|11788553|FG004|COMPLETED|Overall Study||0
10629970|NCT02025985|11788549|FG000|NOT COMPLETED|Overall Study||25
10629971|NCT02025985|11788550|FG001|NOT COMPLETED|Overall Study||23
10629972|NCT02025985|11788551|FG002|NOT COMPLETED|Overall Study||25
10629973|NCT02025985|11788552|FG003|NOT COMPLETED|Overall Study||21
10629974|NCT02025985|11788553|FG004|NOT COMPLETED|Overall Study||20
10629975|NCT02026011|11788569|FG000|STARTED|Allocation 1 (First Set of Medication)||46
10629976|NCT02026011|11788570|FG001|STARTED|Allocation 1 (First Set of Medication)||41
10629977|NCT02026011|11788569|FG000|COMPLETED|Allocation 1 (First Set of Medication)||38
10629978|NCT02026011|11788570|FG001|COMPLETED|Allocation 1 (First Set of Medication)||39
10629979|NCT02026011|11788569|FG000|NOT COMPLETED|Allocation 1 (First Set of Medication)||8
10629980|NCT02026011|11788570|FG001|NOT COMPLETED|Allocation 1 (First Set of Medication)||2
10629981|NCT02026011|11788569|FG000|STARTED|Allocation 2 (Second Set of Medication)||38
10629982|NCT02026011|11788570|FG001|STARTED|Allocation 2 (Second Set of Medication)||37
10629983|NCT02026011|11788569|FG000|COMPLETED|Allocation 2 (Second Set of Medication)||37
10629984|NCT02026011|11788570|FG001|COMPLETED|Allocation 2 (Second Set of Medication)||35
10629985|NCT02026011|11788569|FG000|NOT COMPLETED|Allocation 2 (Second Set of Medication)||1
10629986|NCT02026011|11788570|FG001|NOT COMPLETED|Allocation 2 (Second Set of Medication)||2
10629987|NCT02026063|11788581|FG000|STARTED|Overall Study||22
10629988|NCT02026063|11788582|FG001|STARTED|Overall Study||102
10629989|NCT02026063|11788581|FG000|COMPLETED|Overall Study||13
10629990|NCT02026063|11788582|FG001|COMPLETED|Overall Study||53
10629991|NCT02026063|11788581|FG000|NOT COMPLETED|Overall Study||9
10629992|NCT02026063|11788582|FG001|NOT COMPLETED|Overall Study||49
10629993|NCT02026141|11788591|FG000|STARTED|Overall Study||20
10629994|NCT02026141|11788592|FG001|STARTED|Overall Study||20
10629995|NCT02026141|11788591|FG000|COMPLETED|Overall Study||20
10629996|NCT02026141|11788592|FG001|COMPLETED|Overall Study||19
10629997|NCT02026141|11788591|FG000|NOT COMPLETED|Overall Study||0
10629998|NCT02026141|11788592|FG001|NOT COMPLETED|Overall Study||1
10629999|NCT02026193|11788600|FG000|STARTED|Overall Study||3
10630000|NCT02026193|11788601|FG001|STARTED|Overall Study||8
10630001|NCT02026193|11788600|FG000|COMPLETED|Overall Study||3
10630002|NCT02026193|11788601|FG001|COMPLETED|Overall Study||8
10630003|NCT02026193|11788600|FG000|NOT COMPLETED|Overall Study||0
10630004|NCT02026193|11788601|FG001|NOT COMPLETED|Overall Study||0
10630005|NCT02026206|11788609|FG000|STARTED|Overall Study||44
10630006|NCT02026206|11788610|FG001|STARTED|Overall Study||44
10809118|NCT03836677|11970992|FG000|COMPLETED|Washout||13
10809119|NCT03836677|11970993|FG001|COMPLETED|Washout||9
10809120|NCT03836677|11970992|FG000|NOT COMPLETED|Washout||0
10630007|NCT02026206|11788609|FG000|COMPLETED|Overall Study||40
10630008|NCT02026206|11788610|FG001|COMPLETED|Overall Study||36
10630009|NCT02026206|11788609|FG000|NOT COMPLETED|Overall Study||4
10630010|NCT02026206|11788610|FG001|NOT COMPLETED|Overall Study||8
10630011|NCT02026258|11788618|FG000|STARTED|Randomized||20
10630012|NCT02026258|11788619|FG001|STARTED|Randomized||21
10630013|NCT02026258|11788618|FG000|COMPLETED|Randomized||16
10630014|NCT02026258|11788619|FG001|COMPLETED|Randomized||19
10630015|NCT02026258|11788618|FG000|NOT COMPLETED|Randomized||4
10630016|NCT02026258|11788619|FG001|NOT COMPLETED|Randomized||2
10630017|NCT02026258|11788618|FG000|STARTED|Recieved Allocated Intervention||16
10630018|NCT02026258|11788619|FG001|STARTED|Recieved Allocated Intervention||19
10630019|NCT02026258|11788618|FG000|COMPLETED|Recieved Allocated Intervention||15
10630020|NCT02026258|11788619|FG001|COMPLETED|Recieved Allocated Intervention||17
10630021|NCT02026258|11788618|FG000|NOT COMPLETED|Recieved Allocated Intervention||1
10809121|NCT03836677|11970993|FG001|NOT COMPLETED|Washout||0
10809122|NCT03836677|11970992|FG000|STARTED|Period 2||13
10809123|NCT03836677|11970993|FG001|STARTED|Period 2||9
10809124|NCT03836677|11970992|FG000|COMPLETED|Period 2||12
10809125|NCT03836677|11970993|FG001|COMPLETED|Period 2||9
10809126|NCT03836677|11970992|FG000|NOT COMPLETED|Period 2||1
10809127|NCT03836677|11970993|FG001|NOT COMPLETED|Period 2||0
10809128|NCT03836989|11971001|FG000|STARTED|Overall Study||4
10630022|NCT02026258|11788619|FG001|NOT COMPLETED|Recieved Allocated Intervention||2
10630023|NCT02026297|11788628|FG000|STARTED|Overall Study||7
10630024|NCT02026297|11788629|FG001|STARTED|Overall Study||13
10630025|NCT02026297|11788628|FG000|COMPLETED|Overall Study||7
10630026|NCT02026297|11788629|FG001|COMPLETED|Overall Study||13
10630027|NCT02026297|11788628|FG000|NOT COMPLETED|Overall Study||0
10809129|NCT03836989|11971002|FG001|STARTED|Overall Study||0
10809130|NCT03836989|11971001|FG000|Subjects > 60 Years Old With Complete Paralysis|Overall Study||1
10809131|NCT03836989|11971002|FG001|Subjects > 60 Years Old With Complete Paralysis|Overall Study||0
10811210|NCT03770091|11972928|FG000|NOT COMPLETED|Overall Study||0
10630028|NCT02026297|11788629|FG001|NOT COMPLETED|Overall Study||0
10630029|NCT02026453|11788638|FG000|STARTED|Overall Study||101
10630030|NCT02026453|11788639|FG001|STARTED|Overall Study||103
10630031|NCT02026453|11788640|FG002|STARTED|Overall Study||102
10630032|NCT02026453|11788638|FG000|COMPLETED|Overall Study||95
10630033|NCT02026453|11788639|FG001|COMPLETED|Overall Study||94
10630034|NCT02026453|11788640|FG002|COMPLETED|Overall Study||89
10630035|NCT02026453|11788638|FG000|NOT COMPLETED|Overall Study||6
10630036|NCT02026453|11788639|FG001|NOT COMPLETED|Overall Study||9
10630037|NCT02026453|11788640|FG002|NOT COMPLETED|Overall Study||13
10630038|NCT02026687|11788650|FG000|STARTED|Overall Study||40
10630039|NCT02026687|11788651|FG001|STARTED|Overall Study||40
10630040|NCT02026687|11788650|FG000|COMPLETED|Overall Study||39
10630041|NCT02026687|11788651|FG001|COMPLETED|Overall Study||38
10630042|NCT02026687|11788650|FG000|NOT COMPLETED|Overall Study||1
10630043|NCT02026687|11788651|FG001|NOT COMPLETED|Overall Study||2
10630044|NCT02027025|11788660|FG000|STARTED|Overall Study||48
10630045|NCT02027025|11788661|FG001|STARTED|Overall Study||47
10630046|NCT02027025|11788662|FG002|STARTED|Overall Study||47
10630047|NCT02027025|11788660|FG000|COMPLETED|Overall Study||47
10630048|NCT02027025|11788661|FG001|COMPLETED|Overall Study||42
10630049|NCT02027025|11788662|FG002|COMPLETED|Overall Study||46
10630050|NCT02027025|11788660|FG000|NOT COMPLETED|Overall Study||1
10630051|NCT02027025|11788661|FG001|NOT COMPLETED|Overall Study||5
10630052|NCT02027025|11788662|FG002|NOT COMPLETED|Overall Study||1
10630053|NCT02027311|11788683|FG000|STARTED|Overall Study||33
10630054|NCT02027311|11788684|FG001|STARTED|Overall Study||35
10630055|NCT02027311|11788683|FG000|COMPLETED|Overall Study|1 case was dropped due to hypotension and 2 were desaturation.|30
10630056|NCT02027311|11788684|FG001|COMPLETED|Overall Study|1 cases was dropped due to tachycardia and 1 were desaturation.|33
10630057|NCT02027311|11788683|FG000|NOT COMPLETED|Overall Study||3
10630058|NCT02027311|11788684|FG001|NOT COMPLETED|Overall Study||2
10630059|NCT02027376|11788692|FG000|STARTED|Overall Study||5
10705452|NCT02598297|11869845|FG001|COMPLETED|Overall Study||0
10705453|NCT02598297|11869844|FG000|NOT COMPLETED|Overall Study||25
10705454|NCT02598297|11869845|FG001|NOT COMPLETED|Overall Study||24
10705455|NCT02598934|11869853|FG000|STARTED|Overall Study||154
10705456|NCT02598934|11869854|FG001|STARTED|Overall Study||154
10705457|NCT02598934|11869853|FG000|COMPLETED|Overall Study||135
10630060|NCT02027376|11788693|FG001|STARTED|Overall Study||4
10630061|NCT02027376|11788694|FG002|STARTED|Overall Study||3
10630062|NCT02027376|11788692|FG000|COMPLETED|Overall Study||4
10630063|NCT02027376|11788693|FG001|COMPLETED|Overall Study||4
10630064|NCT02027376|11788694|FG002|COMPLETED|Overall Study||3
10630065|NCT02027376|11788692|FG000|NOT COMPLETED|Overall Study||1
10630066|NCT02027376|11788693|FG001|NOT COMPLETED|Overall Study||0
10630067|NCT02027376|11788694|FG002|NOT COMPLETED|Overall Study||0
10705458|NCT02598934|11869854|FG001|COMPLETED|Overall Study||132
10705459|NCT02598934|11869853|FG000|NOT COMPLETED|Overall Study||19
10705460|NCT02598934|11869854|FG001|NOT COMPLETED|Overall Study||22
10705461|NCT02599129|11869862|FG000|STARTED|Overall Study||7
10705462|NCT02599129|11869863|FG001|STARTED|Overall Study||4
10705463|NCT02599129|11869862|FG000|COMPLETED|Overall Study||2
10705464|NCT02599129|11869863|FG001|COMPLETED|Overall Study||1
10705465|NCT02599129|11869862|FG000|NOT COMPLETED|Overall Study||5
10630068|NCT02027402|11788706|FG000|STARTED|Overall Study||98
10630069|NCT02027402|11788707|FG001|STARTED|Overall Study||100
10630070|NCT02027402|11788706|FG000|COMPLETED|Overall Study||94
10630071|NCT02027402|11788707|FG001|COMPLETED|Overall Study||99
10630072|NCT02027402|11788706|FG000|NOT COMPLETED|Overall Study||4
10630073|NCT02027402|11788707|FG001|NOT COMPLETED|Overall Study||1
10630074|NCT02027428|11788717|FG000|STARTED|Induction||427
10630075|NCT02027428|11788718|FG001|STARTED|Induction||0
10630076|NCT02027428|11788719|FG002|STARTED|Induction||0
10705466|NCT02599129|11869863|FG001|NOT COMPLETED|Overall Study||3
10705467|NCT02599194|11869869|FG000|STARTED|Overall Study||7
10705468|NCT02599194|11869869|FG000|COMPLETED|Overall Study||7
10705469|NCT02599194|11869869|FG000|NOT COMPLETED|Overall Study||0
10705470|NCT02599402|11869875|FG000|STARTED|Overall Study||533
10705471|NCT02599402|11869875|FG000|COMPLETED|Overall Study||0
10705472|NCT02599402|11869875|FG000|NOT COMPLETED|Overall Study||533
10705473|NCT02599441|11869905|FG000|STARTED|Overall Study||9
10630077|NCT02027428|11788717|FG000|Received Study Drug|Induction||420
10630078|NCT02027428|11788718|FG001|Received Study Drug|Induction||0
10630079|NCT02027428|11788719|FG002|Received Study Drug|Induction||0
10630080|NCT02027428|11788717|FG000|COMPLETED|Induction|If radiologically CR, PR or SD after 4 cycles of treatment, participants continue on to Maintenance.|202
10630081|NCT02027428|11788718|FG001|COMPLETED|Induction||0
10630082|NCT02027428|11788719|FG002|COMPLETED|Induction||0
10630083|NCT02027428|11788717|FG000|NOT COMPLETED|Induction||225
10630084|NCT02027428|11788718|FG001|NOT COMPLETED|Induction||0
10630085|NCT02027428|11788719|FG002|NOT COMPLETED|Induction||0
10630086|NCT02027428|11788717|FG000|STARTED|Maintenance||0
10630087|NCT02027428|11788718|FG001|STARTED|Maintenance||136
10630088|NCT02027428|11788719|FG002|STARTED|Maintenance||66
10705474|NCT02599441|11869905|FG000|COMPLETED|Overall Study||9
10705475|NCT02599441|11869905|FG000|NOT COMPLETED|Overall Study||0
10705476|NCT02599649|11869913|FG000|STARTED|Overall Study||2
10630089|NCT02027428|11788717|FG000|COMPLETED|Maintenance||0
10630090|NCT02027428|11788718|FG001|COMPLETED|Maintenance||12
10630091|NCT02027428|11788719|FG002|COMPLETED|Maintenance||6
10630092|NCT02027428|11788717|FG000|NOT COMPLETED|Maintenance||0
10630093|NCT02027428|11788718|FG001|NOT COMPLETED|Maintenance||124
10630094|NCT02027428|11788719|FG002|NOT COMPLETED|Maintenance||60
10630095|NCT02027428|11788717|FG000|STARTED|Survival Follow-up||0
10630096|NCT02027428|11788718|FG001|STARTED|Survival Follow-up|Participants are not taking study intervention but are on appropriate standard of care.|117
10630097|NCT02027428|11788719|FG002|STARTED|Survival Follow-up|Participants are not taking study intervention but are on appropriate standard of care.|55
10630098|NCT02027428|11788717|FG000|COMPLETED|Survival Follow-up||0
10630099|NCT02027428|11788718|FG001|COMPLETED|Survival Follow-up||38
10630100|NCT02027428|11788719|FG002|COMPLETED|Survival Follow-up||9
10630101|NCT02027428|11788717|FG000|NOT COMPLETED|Survival Follow-up||0
10630102|NCT02027428|11788718|FG001|NOT COMPLETED|Survival Follow-up||79
10630103|NCT02027428|11788719|FG002|NOT COMPLETED|Survival Follow-up||46
10630104|NCT02027545|11788744|FG000|STARTED|Overall Study||261
10630105|NCT02027545|11788745|FG001|STARTED|Overall Study||175
10630106|NCT02027545|11788744|FG000|COMPLETED|Overall Study||259
10630107|NCT02027545|11788745|FG001|COMPLETED|Overall Study||173
10630108|NCT02027545|11788744|FG000|NOT COMPLETED|Overall Study||2
10630109|NCT02027545|11788745|FG001|NOT COMPLETED|Overall Study||2
10630110|NCT02027558|11788753|FG000|STARTED|Overall Study||62
10630111|NCT02027558|11788754|FG001|STARTED|Overall Study||63
10630112|NCT02027558|11788753|FG000|Post-treatment|Overall Study||49
10630113|NCT02027558|11788754|FG001|Post-treatment|Overall Study||60
10630114|NCT02027558|11788753|FG000|3-month Follow-up|Overall Study||53
10630115|NCT02027558|11788754|FG001|3-month Follow-up|Overall Study||58
10630116|NCT02027558|11788753|FG000|6-month Follow-up|Overall Study||53
10630117|NCT02027558|11788754|FG001|6-month Follow-up|Overall Study||61
10630118|NCT02027558|11788753|FG000|COMPLETED|Overall Study||53
10630119|NCT02027558|11788754|FG001|COMPLETED|Overall Study||61
10630120|NCT02027558|11788753|FG000|NOT COMPLETED|Overall Study||9
10630121|NCT02027558|11788754|FG001|NOT COMPLETED|Overall Study||2
10630122|NCT02027623|11788764|FG000|STARTED|Overall Study||77
10630123|NCT02027623|11788765|FG001|STARTED|Overall Study||77
10630124|NCT02027623|11788764|FG000|COMPLETED|Overall Study||68
10630125|NCT02027623|11788765|FG001|COMPLETED|Overall Study||65
10630126|NCT02027623|11788764|FG000|NOT COMPLETED|Overall Study||9
10630127|NCT02027623|11788765|FG001|NOT COMPLETED|Overall Study||12
10630128|NCT02027701|11788772|FG000|STARTED|Overall Study||82
10630129|NCT02027701|11788772|FG000|COMPLETED|Overall Study||66
10630130|NCT02027701|11788772|FG000|NOT COMPLETED|Overall Study||16
10630131|NCT02027844|11788781|FG000|STARTED|Overall Study||39
10630132|NCT02027844|11788782|FG001|STARTED|Overall Study||39
10630133|NCT02027844|11788783|FG002|STARTED|Overall Study||39
10630134|NCT02027844|11788781|FG000|COMPLETED|Overall Study||34
10705477|NCT02599649|11869914|FG001|STARTED|Overall Study||0
10705478|NCT02599649|11869915|FG002|STARTED|Overall Study||8
10333925|NCT00336505|11470170|FG000|STARTED|Overall Study|All subjects who were randomized and dosed.|291
10333926|NCT00336505|11470171|FG001|STARTED|Overall Study|All subjects who were randomized and dosed.|291
10333927|NCT00336505|11470170|FG000|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|254
10705479|NCT02599649|11869916|FG003|STARTED|Overall Study||0
10705480|NCT02599649|11869913|FG000|COMPLETED|Overall Study||2
10705481|NCT02599649|11869914|FG001|COMPLETED|Overall Study||0
10333928|NCT00336505|11470171|FG001|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|264
10333929|NCT00336505|11470170|FG000|NOT COMPLETED|Overall Study||37
10333930|NCT00336505|11470171|FG001|NOT COMPLETED|Overall Study||27
10333931|NCT00336544|11470179|FG000|STARTED|Overall Study|All subjects who were randomized and dosed.|261
10333932|NCT00336544|11470180|FG001|STARTED|Overall Study|All subjects who were randomized and dosed.|260
10333933|NCT00336544|11470179|FG000|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|242
10333934|NCT00336544|11470180|FG001|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|238
10333935|NCT00336544|11470179|FG000|NOT COMPLETED|Overall Study||19
10333936|NCT00336544|11470180|FG001|NOT COMPLETED|Overall Study||22
10333937|NCT00336583|11470186|FG000|STARTED|Overall Study||27
10333938|NCT00336583|11470186|FG000|COMPLETED|Overall Study||25
10333939|NCT00336583|11470186|FG000|NOT COMPLETED|Overall Study||2
10333940|NCT00336700|11470190|FG000|STARTED|Overall Study||25
10333941|NCT00336700|11470190|FG000|COMPLETED|Overall Study||25
10333942|NCT00336700|11470190|FG000|NOT COMPLETED|Overall Study||0
10333943|NCT00336817|11470196|FG000|STARTED|Overall Study||15
10333944|NCT00336817|11470197|FG001|STARTED|Overall Study||15
10333945|NCT00336817|11470196|FG000|COMPLETED|Overall Study||14
10333946|NCT00336817|11470197|FG001|COMPLETED|Overall Study||13
10333947|NCT00336817|11470196|FG000|NOT COMPLETED|Overall Study||1
10333948|NCT00336817|11470197|FG001|NOT COMPLETED|Overall Study||2
10333949|NCT00336856|11470205|FG000|STARTED|Overall Study|Number of patients consented and registered for the study|35
10333950|NCT00336856|11470205|FG000|COMPLETED|Overall Study||31
10705482|NCT02599649|11869915|FG002|COMPLETED|Overall Study||8
10705483|NCT02599649|11869916|FG003|COMPLETED|Overall Study||0
10705484|NCT02599649|11869913|FG000|NOT COMPLETED|Overall Study||0
10705485|NCT02599649|11869914|FG001|NOT COMPLETED|Overall Study||0
10705486|NCT02599649|11869915|FG002|NOT COMPLETED|Overall Study||0
10705487|NCT02599649|11869916|FG003|NOT COMPLETED|Overall Study||0
10333951|NCT00336856|11470205|FG000|NOT COMPLETED|Overall Study||4
10333952|NCT00336895|11470209|FG000|STARTED|Overall Study||30
10333953|NCT00336895|11470209|FG000|COMPLETED|Overall Study||26
10333954|NCT00336895|11470209|FG000|NOT COMPLETED|Overall Study||4
10333955|NCT00337077|11470216|FG000|STARTED|Overall Study||43
10705488|NCT02599688|11869926|FG000|STARTED|Overall Study||18
10705489|NCT02599688|11869926|FG000|COMPLETED|Overall Study||14
10630135|NCT02027844|11788782|FG001|COMPLETED|Overall Study||33
10630136|NCT02027844|11788783|FG002|COMPLETED|Overall Study||37
10630137|NCT02027844|11788781|FG000|NOT COMPLETED|Overall Study||5
10630138|NCT02027844|11788782|FG001|NOT COMPLETED|Overall Study||6
10630139|NCT02027844|11788783|FG002|NOT COMPLETED|Overall Study||2
10630140|NCT02027883|11788793|FG000|STARTED|Overall Study||50
10630141|NCT02027883|11788794|FG001|STARTED|Overall Study||50
10630142|NCT02027883|11788793|FG000|COMPLETED|Overall Study||50
10630143|NCT02027883|11788794|FG001|COMPLETED|Overall Study||50
10630144|NCT02027883|11788793|FG000|NOT COMPLETED|Overall Study||0
10630145|NCT02027883|11788794|FG001|NOT COMPLETED|Overall Study||0
10630146|NCT02028065|11788807|FG000|STARTED|Randomization Through Start Treatment|Randomized|76
10630147|NCT02028065|11788808|FG001|STARTED|Randomization Through Start Treatment|Randomized|154
10630148|NCT02028065|11788809|FG002|STARTED|Randomization Through Start Treatment|Randomized|152
10630149|NCT02028065|11788807|FG000|COMPLETED|Randomization Through Start Treatment||75
10630150|NCT02028065|11788808|FG001|COMPLETED|Randomization Through Start Treatment||151
10630151|NCT02028065|11788809|FG002|COMPLETED|Randomization Through Start Treatment||149
10630152|NCT02028065|11788807|FG000|NOT COMPLETED|Randomization Through Start Treatment||1
10630153|NCT02028065|11788808|FG001|NOT COMPLETED|Randomization Through Start Treatment||3
10630154|NCT02028065|11788809|FG002|NOT COMPLETED|Randomization Through Start Treatment||3
10630155|NCT02028065|11788807|FG000|STARTED|Treatment Through Study Completion|Includes 1 participant randomized to sugammadex 16 mg/kg who actually received placebo|76
10630156|NCT02028065|11788808|FG001|STARTED|Treatment Through Study Completion||151
10630157|NCT02028065|11788809|FG002|STARTED|Treatment Through Study Completion|Does not include the 1 participant randomized to sugammadex 16 mg/kg who actually received placebo|148
10630158|NCT02028065|11788807|FG000|Received First Dose|Treatment Through Study Completion||76
10630159|NCT02028065|11788808|FG001|Received First Dose|Treatment Through Study Completion||151
10630160|NCT02028065|11788809|FG002|Received First Dose|Treatment Through Study Completion||148
10630161|NCT02028065|11788807|FG000|Received Second Dose|Treatment Through Study Completion||69
10630162|NCT02028065|11788808|FG001|Received Second Dose|Treatment Through Study Completion||140
10630163|NCT02028065|11788809|FG002|Received Second Dose|Treatment Through Study Completion||138
10630164|NCT02028065|11788807|FG000|Received Third Dose|Treatment Through Study Completion||64
10630165|NCT02028065|11788808|FG001|Received Third Dose|Treatment Through Study Completion||136
10630166|NCT02028065|11788809|FG002|Received Third Dose|Treatment Through Study Completion||134
10630167|NCT02028065|11788807|FG000|COMPLETED|Treatment Through Study Completion||64
10630168|NCT02028065|11788808|FG001|COMPLETED|Treatment Through Study Completion||136
10630169|NCT02028065|11788809|FG002|COMPLETED|Treatment Through Study Completion||134
10630170|NCT02028065|11788807|FG000|NOT COMPLETED|Treatment Through Study Completion||12
10630171|NCT02028065|11788808|FG001|NOT COMPLETED|Treatment Through Study Completion||15
10630172|NCT02028065|11788809|FG002|NOT COMPLETED|Treatment Through Study Completion||14
10630173|NCT02028169|11788817|FG000|STARTED|Overall Study||120
10630174|NCT02028169|11788817|FG000|COMPLETED|Overall Study||92
10630175|NCT02028169|11788817|FG000|NOT COMPLETED|Overall Study||28
10630176|NCT02028182|11788821|FG000|STARTED|Overall Study||22
10630177|NCT02028182|11788821|FG000|COMPLETED|Overall Study||20
10630178|NCT02028182|11788821|FG000|NOT COMPLETED|Overall Study||2
10630179|NCT02028208|11788829|FG000|STARTED|Overall Study||21
10630180|NCT02028208|11788830|FG001|STARTED|Overall Study||13
10630181|NCT02028208|11788831|FG002|STARTED|Overall Study||22
10630182|NCT02028208|11788829|FG000|COMPLETED|Overall Study||21
10630183|NCT02028208|11788830|FG001|COMPLETED|Overall Study||13
10630184|NCT02028208|11788831|FG002|COMPLETED|Overall Study||21
10630185|NCT02028208|11788829|FG000|NOT COMPLETED|Overall Study||0
10630186|NCT02028208|11788830|FG001|NOT COMPLETED|Overall Study||0
10630187|NCT02028208|11788831|FG002|NOT COMPLETED|Overall Study||1
10809132|NCT03836989|11971001|FG000|Subjects > 60 Years Old With Incomplete Paralysis|Overall Study||1
10809133|NCT03836989|11971002|FG001|Subjects > 60 Years Old With Incomplete Paralysis|Overall Study||0
10705490|NCT02599688|11869926|FG000|NOT COMPLETED|Overall Study||4
10705491|NCT02599766|11869930|FG000|STARTED|Overall Study||22
10705492|NCT02599766|11869930|FG000|COMPLETED|Overall Study||19
10705493|NCT02599766|11869930|FG000|NOT COMPLETED|Overall Study||3
10705494|NCT02599961|11869938|FG000|STARTED|Overall Study||15
10705495|NCT02599961|11869938|FG000|COMPLETED|Overall Study||0
10705496|NCT02599961|11869938|FG000|NOT COMPLETED|Overall Study||15
10705497|NCT02600325|11869942|FG000|STARTED|Overall Study||80
10705498|NCT02600325|11869942|FG000|COMPLETED|Overall Study||80
10705499|NCT02600325|11869942|FG000|NOT COMPLETED|Overall Study||0
10705500|NCT02600351|11869950|FG000|STARTED|Overall Study||17
10705501|NCT02600351|11869951|FG001|STARTED|Overall Study||17
10705502|NCT02600351|11869952|FG002|STARTED|Overall Study||26
10705503|NCT02600351|11869953|FG003|STARTED|Overall Study||27
10705504|NCT02600351|11869950|FG000|COMPLETED|Overall Study||12
10705505|NCT02600351|11869951|FG001|COMPLETED|Overall Study||17
10705506|NCT02600351|11869952|FG002|COMPLETED|Overall Study||20
10705507|NCT02600351|11869953|FG003|COMPLETED|Overall Study||22
10705508|NCT02600351|11869950|FG000|NOT COMPLETED|Overall Study||5
10705509|NCT02600351|11869951|FG001|NOT COMPLETED|Overall Study||0
10705510|NCT02600351|11869952|FG002|NOT COMPLETED|Overall Study||6
10705511|NCT02600351|11869953|FG003|NOT COMPLETED|Overall Study||5
10705512|NCT02600403|11869968|FG000|STARTED|Overall Study||44
10705513|NCT02600403|11869969|FG001|STARTED|Overall Study||6
10705514|NCT02600403|11869970|FG002|STARTED|Overall Study||11
10705515|NCT02600403|11869968|FG000|COMPLETED|Overall Study||44
10705516|NCT02600403|11869969|FG001|COMPLETED|Overall Study||6
10705517|NCT02600403|11869970|FG002|COMPLETED|Overall Study||11
10809134|NCT03836989|11971001|FG000|Subject < 60 Years Old + Complete Paralysis < 15 Days Duration|Overall Study||1
10809135|NCT03836989|11971002|FG001|Subject < 60 Years Old + Complete Paralysis < 15 Days Duration|Overall Study||0
10630194|NCT02028247|11788851|FG000|STARTED|Overall Study||77
10630195|NCT02028247|11788852|FG001|STARTED|Overall Study||71
10630196|NCT02028247|11788853|FG002|STARTED|Overall Study||19
10630197|NCT02028247|11788851|FG000|COMPLETED|Overall Study||67
10630198|NCT02028247|11788852|FG001|COMPLETED|Overall Study||59
10630199|NCT02028247|11788853|FG002|COMPLETED|Overall Study||15
10630200|NCT02028247|11788851|FG000|NOT COMPLETED|Overall Study||10
10630201|NCT02028247|11788852|FG001|NOT COMPLETED|Overall Study||12
10630202|NCT02028247|11788853|FG002|NOT COMPLETED|Overall Study||4
10630203|NCT02028325|11788861|FG000|STARTED|Overall Study||136
10630204|NCT02028325|11788861|FG000|COMPLETED|Overall Study||126
10630205|NCT02028325|11788861|FG000|NOT COMPLETED|Overall Study||10
10630206|NCT02028676|11788874|FG000|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|606
10630207|NCT02028676|11788875|FG001|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|600
10630208|NCT02028676|11788876|FG002|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
10630209|NCT02028676|11788877|FG003|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
10630210|NCT02028676|11788878|FG004|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
10630211|NCT02028676|11788879|FG005|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
10630212|NCT02028676|11788880|FG006|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
10630213|NCT02028676|11788881|FG007|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
10630214|NCT02028676|11788882|FG008|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
10630215|NCT02028676|11788874|FG000|COMPLETED|Initial Enrolment: CDM vs LCM||606
10630216|NCT02028676|11788875|FG001|COMPLETED|Initial Enrolment: CDM vs LCM||600
10630217|NCT02028676|11788876|FG002|COMPLETED|Initial Enrolment: CDM vs LCM||0
10630218|NCT02028676|11788877|FG003|COMPLETED|Initial Enrolment: CDM vs LCM||0
10630219|NCT02028676|11788878|FG004|COMPLETED|Initial Enrolment: CDM vs LCM||0
10630220|NCT02028676|11788879|FG005|COMPLETED|Initial Enrolment: CDM vs LCM||0
10630221|NCT02028676|11788880|FG006|COMPLETED|Initial Enrolment: CDM vs LCM||0
10630222|NCT02028676|11788881|FG007|COMPLETED|Initial Enrolment: CDM vs LCM||0
10630223|NCT02028676|11788882|FG008|COMPLETED|Initial Enrolment: CDM vs LCM||0
10630224|NCT02028676|11788874|FG000|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
10630225|NCT02028676|11788875|FG001|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
10630226|NCT02028676|11788876|FG002|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
10630227|NCT02028676|11788877|FG003|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
10630228|NCT02028676|11788878|FG004|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
10630229|NCT02028676|11788879|FG005|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
10630230|NCT02028676|11788880|FG006|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
10630231|NCT02028676|11788881|FG007|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
10630232|NCT02028676|11788882|FG008|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
10630233|NCT02028676|11788874|FG000|STARTED|Initial Enrolment: Induction ART||0
10630234|NCT02028676|11788875|FG001|STARTED|Initial Enrolment: Induction ART||0
10630235|NCT02028676|11788876|FG002|STARTED|Initial Enrolment: Induction ART||397
10630236|NCT02028676|11788877|FG003|STARTED|Initial Enrolment: Induction ART||404
10630237|NCT02028676|11788878|FG004|STARTED|Initial Enrolment: Induction ART||405
10630238|NCT02028676|11788879|FG005|STARTED|Initial Enrolment: Induction ART||0
10630239|NCT02028676|11788880|FG006|STARTED|Initial Enrolment: Induction ART||0
10630240|NCT02028676|11788881|FG007|STARTED|Initial Enrolment: Induction ART||0
10630241|NCT02028676|11788882|FG008|STARTED|Initial Enrolment: Induction ART||0
10630242|NCT02028676|11788874|FG000|COMPLETED|Initial Enrolment: Induction ART||0
10630243|NCT02028676|11788875|FG001|COMPLETED|Initial Enrolment: Induction ART||0
10630244|NCT02028676|11788876|FG002|COMPLETED|Initial Enrolment: Induction ART||397
10630245|NCT02028676|11788877|FG003|COMPLETED|Initial Enrolment: Induction ART||404
10630246|NCT02028676|11788878|FG004|COMPLETED|Initial Enrolment: Induction ART||405
10630247|NCT02028676|11788879|FG005|COMPLETED|Initial Enrolment: Induction ART||0
10630248|NCT02028676|11788880|FG006|COMPLETED|Initial Enrolment: Induction ART||0
10630249|NCT02028676|11788881|FG007|COMPLETED|Initial Enrolment: Induction ART||0
10630250|NCT02028676|11788882|FG008|COMPLETED|Initial Enrolment: Induction ART||0
10630251|NCT02028676|11788874|FG000|NOT COMPLETED|Initial Enrolment: Induction ART||0
10630252|NCT02028676|11788875|FG001|NOT COMPLETED|Initial Enrolment: Induction ART||0
10630253|NCT02028676|11788876|FG002|NOT COMPLETED|Initial Enrolment: Induction ART||0
10630254|NCT02028676|11788877|FG003|NOT COMPLETED|Initial Enrolment: Induction ART||0
10630255|NCT02028676|11788878|FG004|NOT COMPLETED|Initial Enrolment: Induction ART||0
10630256|NCT02028676|11788879|FG005|NOT COMPLETED|Initial Enrolment: Induction ART||0
10630257|NCT02028676|11788880|FG006|NOT COMPLETED|Initial Enrolment: Induction ART||0
10630258|NCT02028676|11788881|FG007|NOT COMPLETED|Initial Enrolment: Induction ART||0
10630259|NCT02028676|11788882|FG008|NOT COMPLETED|Initial Enrolment: Induction ART||0
10630260|NCT02028676|11788874|FG000|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
10653687|NCT02195869|11814285|FG000|COMPLETED|Overall Study||0
10630261|NCT02028676|11788875|FG001|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
10630262|NCT02028676|11788876|FG002|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
10630263|NCT02028676|11788877|FG003|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
10630264|NCT02028676|11788878|FG004|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
10630265|NCT02028676|11788879|FG005|STARTED|Subsequent Once vs Twice Daily ABC+3TC||336
10630266|NCT02028676|11788880|FG006|STARTED|Subsequent Once vs Twice Daily ABC+3TC||333
10630267|NCT02028676|11788881|FG007|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
10630268|NCT02028676|11788882|FG008|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
10630269|NCT02028676|11788874|FG000|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
10630270|NCT02028676|11788875|FG001|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
10630271|NCT02028676|11788876|FG002|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
10630272|NCT02028676|11788877|FG003|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
10630273|NCT02028676|11788878|FG004|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
10630274|NCT02028676|11788879|FG005|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||336
10630275|NCT02028676|11788880|FG006|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||333
10630358|NCT02028780|11788951|FG008|COMPLETED|Observation Phase||9
10630276|NCT02028676|11788881|FG007|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
10630277|NCT02028676|11788882|FG008|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
10630278|NCT02028676|11788874|FG000|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
10630279|NCT02028676|11788875|FG001|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
10630280|NCT02028676|11788876|FG002|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
10630281|NCT02028676|11788877|FG003|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
10630282|NCT02028676|11788878|FG004|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
10630283|NCT02028676|11788879|FG005|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
10630284|NCT02028676|11788880|FG006|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
10630285|NCT02028676|11788881|FG007|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
10630286|NCT02028676|11788882|FG008|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
10630287|NCT02028676|11788874|FG000|STARTED|Subsequent Cotrimoxazole Randomization||0
10630288|NCT02028676|11788875|FG001|STARTED|Subsequent Cotrimoxazole Randomization||0
10630289|NCT02028676|11788876|FG002|STARTED|Subsequent Cotrimoxazole Randomization||0
10630290|NCT02028676|11788877|FG003|STARTED|Subsequent Cotrimoxazole Randomization||0
10630291|NCT02028676|11788878|FG004|STARTED|Subsequent Cotrimoxazole Randomization||0
10630292|NCT02028676|11788879|FG005|STARTED|Subsequent Cotrimoxazole Randomization||0
10630293|NCT02028676|11788880|FG006|STARTED|Subsequent Cotrimoxazole Randomization||0
10630294|NCT02028676|11788881|FG007|STARTED|Subsequent Cotrimoxazole Randomization||376
10630295|NCT02028676|11788882|FG008|STARTED|Subsequent Cotrimoxazole Randomization||382
10630296|NCT02028676|11788874|FG000|COMPLETED|Subsequent Cotrimoxazole Randomization||0
10630297|NCT02028676|11788875|FG001|COMPLETED|Subsequent Cotrimoxazole Randomization||0
10630298|NCT02028676|11788876|FG002|COMPLETED|Subsequent Cotrimoxazole Randomization||0
10630299|NCT02028676|11788877|FG003|COMPLETED|Subsequent Cotrimoxazole Randomization||0
10630300|NCT02028676|11788878|FG004|COMPLETED|Subsequent Cotrimoxazole Randomization||0
10630301|NCT02028676|11788879|FG005|COMPLETED|Subsequent Cotrimoxazole Randomization||0
10630302|NCT02028676|11788880|FG006|COMPLETED|Subsequent Cotrimoxazole Randomization||0
10630303|NCT02028676|11788881|FG007|COMPLETED|Subsequent Cotrimoxazole Randomization||376
10630304|NCT02028676|11788882|FG008|COMPLETED|Subsequent Cotrimoxazole Randomization||382
10630305|NCT02028676|11788874|FG000|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
10630306|NCT02028676|11788875|FG001|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
10630307|NCT02028676|11788876|FG002|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
10630308|NCT02028676|11788877|FG003|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
10630309|NCT02028676|11788878|FG004|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
10630310|NCT02028676|11788879|FG005|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
10630311|NCT02028676|11788880|FG006|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
10630312|NCT02028676|11788881|FG007|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
10630313|NCT02028676|11788882|FG008|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
10630314|NCT02028715|11788908|FG000|STARTED|Overall Study||34
10630315|NCT02028715|11788909|FG001|STARTED|Overall Study||34
10630316|NCT02028715|11788908|FG000|COMPLETED|Overall Study||29
10630317|NCT02028715|11788909|FG001|COMPLETED|Overall Study||30
10630318|NCT02028715|11788908|FG000|NOT COMPLETED|Overall Study||5
10630319|NCT02028715|11788909|FG001|NOT COMPLETED|Overall Study||4
10630320|NCT02028754|11788917|FG000|STARTED|Overall Study||90
10630321|NCT02028754|11788918|FG001|STARTED|Overall Study||90
10630322|NCT02028754|11788917|FG000|COMPLETED|Overall Study||83
10630323|NCT02028754|11788918|FG001|COMPLETED|Overall Study||82
10630324|NCT02028754|11788917|FG000|NOT COMPLETED|Overall Study||7
10630325|NCT02028754|11788918|FG001|NOT COMPLETED|Overall Study||8
10630326|NCT02028767|11788924|FG000|STARTED|Treatment Period 1||16
10630327|NCT02028767|11788925|FG001|STARTED|Treatment Period 1||16
10630328|NCT02028767|11788924|FG000|COMPLETED|Treatment Period 1||16
10630329|NCT02028767|11788925|FG001|COMPLETED|Treatment Period 1||16
10630330|NCT02028767|11788924|FG000|NOT COMPLETED|Treatment Period 1||0
10630331|NCT02028767|11788925|FG001|NOT COMPLETED|Treatment Period 1||0
10630332|NCT02028767|11788924|FG000|STARTED|Treatment Period 2||16
10630333|NCT02028767|11788925|FG001|STARTED|Treatment Period 2||16
10630334|NCT02028767|11788924|FG000|COMPLETED|Treatment Period 2||14
10630335|NCT02028767|11788925|FG001|COMPLETED|Treatment Period 2||16
10630336|NCT02028767|11788924|FG000|NOT COMPLETED|Treatment Period 2||2
10630337|NCT02028767|11788925|FG001|NOT COMPLETED|Treatment Period 2||0
10630338|NCT02028780|11788943|FG000|STARTED|Observation Phase||6
10630339|NCT02028780|11788944|FG001|STARTED|Observation Phase||2
10630340|NCT02028780|11788945|FG002|STARTED|Observation Phase||6
10630341|NCT02028780|11788946|FG003|STARTED|Observation Phase||6
10630342|NCT02028780|11788947|FG004|STARTED|Observation Phase||6
10630343|NCT02028780|11788948|FG005|STARTED|Observation Phase||6
10630344|NCT02028780|11788949|FG006|STARTED|Observation Phase||9
10630345|NCT02028780|11788950|FG007|STARTED|Observation Phase||3
10630346|NCT02028780|11788951|FG008|STARTED|Observation Phase||9
10630347|NCT02028780|11788952|FG009|STARTED|Observation Phase||9
10630348|NCT02028780|11788953|FG010|STARTED|Observation Phase||9
10630349|NCT02028780|11788954|FG011|STARTED|Observation Phase||9
10630350|NCT02028780|11788943|FG000|COMPLETED|Observation Phase||6
10630351|NCT02028780|11788944|FG001|COMPLETED|Observation Phase||2
10630352|NCT02028780|11788945|FG002|COMPLETED|Observation Phase||6
10630353|NCT02028780|11788946|FG003|COMPLETED|Observation Phase||6
10630354|NCT02028780|11788947|FG004|COMPLETED|Observation Phase||6
10630355|NCT02028780|11788948|FG005|COMPLETED|Observation Phase||6
10630356|NCT02028780|11788949|FG006|COMPLETED|Observation Phase||9
10630357|NCT02028780|11788950|FG007|COMPLETED|Observation Phase||3
10630359|NCT02028780|11788952|FG009|COMPLETED|Observation Phase||9
10630360|NCT02028780|11788953|FG010|COMPLETED|Observation Phase||9
10630361|NCT02028780|11788954|FG011|COMPLETED|Observation Phase||9
10630362|NCT02028780|11788943|FG000|NOT COMPLETED|Observation Phase||0
10630363|NCT02028780|11788944|FG001|NOT COMPLETED|Observation Phase||0
10630364|NCT02028780|11788945|FG002|NOT COMPLETED|Observation Phase||0
10630365|NCT02028780|11788946|FG003|NOT COMPLETED|Observation Phase||0
10630366|NCT02028780|11788947|FG004|NOT COMPLETED|Observation Phase||0
10630367|NCT02028780|11788948|FG005|NOT COMPLETED|Observation Phase||0
10630368|NCT02028780|11788949|FG006|NOT COMPLETED|Observation Phase||0
10630369|NCT02028780|11788950|FG007|NOT COMPLETED|Observation Phase||0
10630370|NCT02028780|11788951|FG008|NOT COMPLETED|Observation Phase||0
10630371|NCT02028780|11788952|FG009|NOT COMPLETED|Observation Phase||0
10630372|NCT02028780|11788953|FG010|NOT COMPLETED|Observation Phase||0
10630373|NCT02028780|11788954|FG011|NOT COMPLETED|Observation Phase||0
10630374|NCT02028780|11788943|FG000|STARTED|Follow up Phase||6
10630375|NCT02028780|11788944|FG001|STARTED|Follow up Phase||2
10630376|NCT02028780|11788945|FG002|STARTED|Follow up Phase||6
10630377|NCT02028780|11788946|FG003|STARTED|Follow up Phase||6
10630378|NCT02028780|11788947|FG004|STARTED|Follow up Phase||6
10630379|NCT02028780|11788948|FG005|STARTED|Follow up Phase||6
10630380|NCT02028780|11788949|FG006|STARTED|Follow up Phase||9
10630381|NCT02028780|11788950|FG007|STARTED|Follow up Phase||3
10630382|NCT02028780|11788951|FG008|STARTED|Follow up Phase||9
10630383|NCT02028780|11788952|FG009|STARTED|Follow up Phase||9
10630384|NCT02028780|11788953|FG010|STARTED|Follow up Phase||9
10630385|NCT02028780|11788954|FG011|STARTED|Follow up Phase||9
10630386|NCT02028780|11788943|FG000|COMPLETED|Follow up Phase||6
10630387|NCT02028780|11788944|FG001|COMPLETED|Follow up Phase||2
10630388|NCT02028780|11788945|FG002|COMPLETED|Follow up Phase||6
10630389|NCT02028780|11788946|FG003|COMPLETED|Follow up Phase||6
10630390|NCT02028780|11788947|FG004|COMPLETED|Follow up Phase||6
10630391|NCT02028780|11788948|FG005|COMPLETED|Follow up Phase||6
10630392|NCT02028780|11788949|FG006|COMPLETED|Follow up Phase||9
10630393|NCT02028780|11788950|FG007|COMPLETED|Follow up Phase||3
10630394|NCT02028780|11788951|FG008|COMPLETED|Follow up Phase||9
10630395|NCT02028780|11788952|FG009|COMPLETED|Follow up Phase||9
10630396|NCT02028780|11788953|FG010|COMPLETED|Follow up Phase||9
10630397|NCT02028780|11788954|FG011|COMPLETED|Follow up Phase||9
10630398|NCT02028780|11788943|FG000|NOT COMPLETED|Follow up Phase||0
10630399|NCT02028780|11788944|FG001|NOT COMPLETED|Follow up Phase||0
10630400|NCT02028780|11788945|FG002|NOT COMPLETED|Follow up Phase||0
10630401|NCT02028780|11788946|FG003|NOT COMPLETED|Follow up Phase||0
10630402|NCT02028780|11788947|FG004|NOT COMPLETED|Follow up Phase||0
10630403|NCT02028780|11788948|FG005|NOT COMPLETED|Follow up Phase||0
10630404|NCT02028780|11788949|FG006|NOT COMPLETED|Follow up Phase||0
10630405|NCT02028780|11788950|FG007|NOT COMPLETED|Follow up Phase||0
10630406|NCT02028780|11788951|FG008|NOT COMPLETED|Follow up Phase||0
10630407|NCT02028780|11788952|FG009|NOT COMPLETED|Follow up Phase||0
10630408|NCT02028780|11788953|FG010|NOT COMPLETED|Follow up Phase||0
10630409|NCT02028780|11788954|FG011|NOT COMPLETED|Follow up Phase||0
10630410|NCT02028871|11789000|FG000|STARTED|Overall Study||14
10630411|NCT02028871|11789001|FG001|STARTED|Overall Study||12
10630412|NCT02028871|11789000|FG000|COMPLETED|Overall Study||10
10630413|NCT02028871|11789001|FG001|COMPLETED|Overall Study||9
10630414|NCT02028871|11789000|FG000|NOT COMPLETED|Overall Study||4
10630415|NCT02028871|11789001|FG001|NOT COMPLETED|Overall Study||3
10630416|NCT02029040|11789012|FG000|STARTED|Overall Study||27
10630417|NCT02029040|11789013|FG001|STARTED|Overall Study||25
10630418|NCT02029040|11789012|FG000|COMPLETED|Overall Study||27
10630419|NCT02029040|11789013|FG001|COMPLETED|Overall Study||25
10630420|NCT02029040|11789012|FG000|NOT COMPLETED|Overall Study||0
10630421|NCT02029040|11789013|FG001|NOT COMPLETED|Overall Study||0
10630422|NCT02029196|11789021|FG000|STARTED|Overall Study||306
10630423|NCT02029196|11789022|FG001|STARTED|Overall Study||102
10630424|NCT02029196|11789021|FG000|COMPLETED|Overall Study||286
10630425|NCT02029196|11789022|FG001|COMPLETED|Overall Study||101
10630426|NCT02029196|11789021|FG000|NOT COMPLETED|Overall Study||20
10630427|NCT02029196|11789022|FG001|NOT COMPLETED|Overall Study||1
10630428|NCT02029235|11789030|FG000|STARTED|Overall Study||34
10630429|NCT02029235|11789031|FG001|STARTED|Overall Study||31
10630430|NCT02029235|11789030|FG000|COMPLETED|Overall Study||30
10630431|NCT02029235|11789031|FG001|COMPLETED|Overall Study||30
10630432|NCT02029235|11789030|FG000|NOT COMPLETED|Overall Study||4
10630433|NCT02029235|11789031|FG001|NOT COMPLETED|Overall Study||1
10630434|NCT02029274|11789041|FG000|STARTED|Overall Study||5
10630435|NCT02029274|11789042|FG001|STARTED|Overall Study||4
10630436|NCT02029274|11789043|FG002|STARTED|Overall Study||4
10630437|NCT02029274|11789044|FG003|STARTED|Overall Study||4
10630438|NCT02029274|11789041|FG000|Fixed Dose Period 2|Overall Study||5
10630439|NCT02029274|11789042|FG001|Fixed Dose Period 2|Overall Study||4
10630440|NCT02029274|11789043|FG002|Fixed Dose Period 2|Overall Study||4
10630441|NCT02029274|11789044|FG003|Fixed Dose Period 2|Overall Study||4
10630442|NCT02029274|11789041|FG000|COMPLETED|Overall Study||4
10630443|NCT02029274|11789042|FG001|COMPLETED|Overall Study||4
10630444|NCT02029274|11789043|FG002|COMPLETED|Overall Study||2
10630445|NCT02029274|11789044|FG003|COMPLETED|Overall Study||2
10630446|NCT02029274|11789041|FG000|NOT COMPLETED|Overall Study||1
10630447|NCT02029274|11789042|FG001|NOT COMPLETED|Overall Study||0
10630448|NCT02029274|11789043|FG002|NOT COMPLETED|Overall Study||2
10630449|NCT02029274|11789044|FG003|NOT COMPLETED|Overall Study||2
10630450|NCT02029417|11789058|FG000|STARTED|Overall Study||2
10630451|NCT02029417|11789058|FG000|COMPLETED|Overall Study||0
10630452|NCT02029417|11789058|FG000|NOT COMPLETED|Overall Study||2
10630453|NCT02029495|11789065|FG000|STARTED|Overall Study||159
10630454|NCT02029495|11789066|FG001|STARTED|Overall Study||158
10630455|NCT02029495|11789067|FG002|STARTED|Overall Study||161
10630456|NCT02029495|11789065|FG000|COMPLETED|Overall Study||158
10630457|NCT02029495|11789066|FG001|COMPLETED|Overall Study||158
10630458|NCT02029495|11789067|FG002|COMPLETED|Overall Study||159
10630459|NCT02029495|11789065|FG000|NOT COMPLETED|Overall Study||1
10630460|NCT02029495|11789066|FG001|NOT COMPLETED|Overall Study||0
10630461|NCT02029495|11789067|FG002|NOT COMPLETED|Overall Study||2
10630462|NCT02029521|11789077|FG000|STARTED|Overall Study||24
10630463|NCT02029521|11789078|FG001|STARTED|Overall Study||23
10630464|NCT02029521|11789077|FG000|COMPLETED|Overall Study||22
10630465|NCT02029521|11789078|FG001|COMPLETED|Overall Study||22
10630466|NCT02029521|11789077|FG000|NOT COMPLETED|Overall Study||2
10630467|NCT02029521|11789078|FG001|NOT COMPLETED|Overall Study||1
10630468|NCT02029638|11789090|FG000|STARTED|Overall Study||2
10630469|NCT02029638|11789091|FG001|STARTED|Overall Study||1
10630470|NCT02029638|11789092|FG002|STARTED|Overall Study||1
10630471|NCT02029638|11789090|FG000|COMPLETED|Overall Study||0
10630472|NCT02029638|11789091|FG001|COMPLETED|Overall Study||1
10630473|NCT02029638|11789092|FG002|COMPLETED|Overall Study||0
10630474|NCT02029638|11789090|FG000|NOT COMPLETED|Overall Study||2
10630475|NCT02029638|11789091|FG001|NOT COMPLETED|Overall Study||0
10630476|NCT02029638|11789092|FG002|NOT COMPLETED|Overall Study||1
10630477|NCT02029703|11789102|FG000|STARTED|Overall Study||20
10630478|NCT02029703|11789103|FG001|STARTED|Overall Study||22
10630479|NCT02029703|11789102|FG000|COMPLETED|Overall Study||20
10630480|NCT02029703|11789103|FG001|COMPLETED|Overall Study||22
10630481|NCT02029703|11789102|FG000|NOT COMPLETED|Overall Study||0
10630482|NCT02029703|11789103|FG001|NOT COMPLETED|Overall Study||0
10630483|NCT02029755|11789112|FG000|STARTED|Overall Study||36
10630484|NCT02029755|11789113|FG001|STARTED|Overall Study||36
10630485|NCT02029755|11789114|FG002|STARTED|Overall Study||36
10630486|NCT02029755|11789112|FG000|COMPLETED|Overall Study||36
10630487|NCT02029755|11789113|FG001|COMPLETED|Overall Study||36
10630488|NCT02029755|11789114|FG002|COMPLETED|Overall Study||36
10630489|NCT02029755|11789112|FG000|NOT COMPLETED|Overall Study||0
10630490|NCT02029755|11789113|FG001|NOT COMPLETED|Overall Study||0
10630491|NCT02029755|11789114|FG002|NOT COMPLETED|Overall Study||0
10630492|NCT02029872|11789124|FG000|STARTED|Overall Study||9
10630493|NCT02029872|11789125|FG001|STARTED|Overall Study||9
10630494|NCT02029872|11789124|FG000|COMPLETED|Overall Study||7
10630495|NCT02029872|11789125|FG001|COMPLETED|Overall Study||6
10630496|NCT02029872|11789124|FG000|NOT COMPLETED|Overall Study||2
10630497|NCT02029872|11789125|FG001|NOT COMPLETED|Overall Study||3
10630498|NCT02029911|11789131|FG000|STARTED|Overall Study|Treatment Attempted|60
10630499|NCT02029911|11789131|FG000|Treated|Overall Study|Treatment Completed|60
10630500|NCT02029911|11789131|FG000|COMPLETED|Overall Study|Completed 12 Month Follow-up|60
10630501|NCT02029911|11789131|FG000|NOT COMPLETED|Overall Study||0
10630502|NCT02029976|11789137|FG000|STARTED|YR-1 Post Intervention vs Baseline||132
10630503|NCT02029976|11789138|FG001|STARTED|YR-1 Post Intervention vs Baseline||132
10630504|NCT02029976|11789137|FG000|COMPLETED|YR-1 Post Intervention vs Baseline||120
10630505|NCT02029976|11789138|FG001|COMPLETED|YR-1 Post Intervention vs Baseline||124
10630506|NCT02029976|11789137|FG000|NOT COMPLETED|YR-1 Post Intervention vs Baseline||12
10630507|NCT02029976|11789138|FG001|NOT COMPLETED|YR-1 Post Intervention vs Baseline||8
10630508|NCT02029976|11789137|FG000|STARTED|YR-2 Follow Up vs Baseline|Attrition at end of year 2 was calculated based on baseline enrollment|132
10630509|NCT02029976|11789138|FG001|STARTED|YR-2 Follow Up vs Baseline|Attrition at end of year 2 was calculated based on baseline enrollment|132
10630510|NCT02029976|11789137|FG000|COMPLETED|YR-2 Follow Up vs Baseline||122
10630511|NCT02029976|11789138|FG001|COMPLETED|YR-2 Follow Up vs Baseline||124
10630512|NCT02029976|11789137|FG000|NOT COMPLETED|YR-2 Follow Up vs Baseline||10
10630513|NCT02029976|11789138|FG001|NOT COMPLETED|YR-2 Follow Up vs Baseline||8
10630514|NCT02029989|11789146|FG000|STARTED|Overall Study|A subject was given the same ID# as withdrawn subject (ID # counted twice) causing N=61 discrepancy.|61
10630515|NCT02029989|11789147|FG001|STARTED|Overall Study||60
10630516|NCT02029989|11789146|FG000|COMPLETED|Overall Study||45
10630517|NCT02029989|11789147|FG001|COMPLETED|Overall Study||49
10630518|NCT02029989|11789146|FG000|NOT COMPLETED|Overall Study||16
10630519|NCT02029989|11789147|FG001|NOT COMPLETED|Overall Study||11
10630520|NCT02030002|11789153|FG000|STARTED|Enrollment||49
10630521|NCT02030002|11789153|FG000|COMPLETED|Enrollment||44
10630522|NCT02030002|11789153|FG000|NOT COMPLETED|Enrollment||5
10630523|NCT02030002|11789153|FG000|STARTED|APC Flash-Free Adhesive Coated Appliance||44
10630524|NCT02030002|11789153|FG000|COMPLETED|APC Flash-Free Adhesive Coated Appliance||44
10630525|NCT02030002|11789153|FG000|NOT COMPLETED|APC Flash-Free Adhesive Coated Appliance||0
10630526|NCT02030002|11789153|FG000|STARTED|APC II Adhesive Coated Appliance System||44
10630527|NCT02030002|11789153|FG000|COMPLETED|APC II Adhesive Coated Appliance System||44
10630528|NCT02030002|11789153|FG000|NOT COMPLETED|APC II Adhesive Coated Appliance System||0
10630529|NCT02030002|11789153|FG000|STARTED|Follow-up||44
10630530|NCT02030002|11789153|FG000|COMPLETED|Follow-up||42
10630531|NCT02030002|11789153|FG000|NOT COMPLETED|Follow-up||2
10630532|NCT02030041|11789162|FG000|STARTED|Overall Study||11
10630533|NCT02030041|11789163|FG001|STARTED|Overall Study||11
10630534|NCT02030041|11789164|FG002|STARTED|Overall Study||11
10630535|NCT02030041|11789162|FG000|COMPLETED|Overall Study||9
10630536|NCT02030041|11789163|FG001|COMPLETED|Overall Study||9
10630537|NCT02030041|11789164|FG002|COMPLETED|Overall Study||10
10630538|NCT02030041|11789162|FG000|NOT COMPLETED|Overall Study||2
10630539|NCT02030041|11789163|FG001|NOT COMPLETED|Overall Study||2
10630540|NCT02030041|11789164|FG002|NOT COMPLETED|Overall Study||1
10630541|NCT02030080|11789176|FG000|STARTED|Overall Study|25 teams|100
10630542|NCT02030080|11789177|FG001|STARTED|Overall Study|16 teams|64
10630543|NCT02030080|11789178|FG002|STARTED|Overall Study|20 teams|80
10630544|NCT02030080|11789179|FG003|STARTED|Overall Study|11 teams|44
10630545|NCT02030080|11789176|FG000|COMPLETED|Overall Study||100
10630546|NCT02030080|11789177|FG001|COMPLETED|Overall Study||64
10630547|NCT02030080|11789178|FG002|COMPLETED|Overall Study||80
10630548|NCT02030080|11789179|FG003|COMPLETED|Overall Study||42
10630549|NCT02030080|11789176|FG000|NOT COMPLETED|Overall Study||0
10630550|NCT02030080|11789177|FG001|NOT COMPLETED|Overall Study||0
10630551|NCT02030080|11789178|FG002|NOT COMPLETED|Overall Study||0
10630552|NCT02030080|11789179|FG003|NOT COMPLETED|Overall Study||2
10630553|NCT02030119|11789193|FG000|STARTED|Overall Study||70
10630554|NCT02030119|11789194|FG001|STARTED|Overall Study||70
10630555|NCT02030119|11789195|FG002|STARTED|Overall Study||71
10630556|NCT02030119|11789196|FG003|STARTED|Overall Study||70
10630557|NCT02030119|11789193|FG000|COMPLETED|Overall Study||67
10630558|NCT02030119|11789194|FG001|COMPLETED|Overall Study||68
10630559|NCT02030119|11789195|FG002|COMPLETED|Overall Study||65
10630560|NCT02030119|11789196|FG003|COMPLETED|Overall Study||67
10630561|NCT02030119|11789193|FG000|NOT COMPLETED|Overall Study||3
10630562|NCT02030119|11789194|FG001|NOT COMPLETED|Overall Study||2
10630563|NCT02030119|11789195|FG002|NOT COMPLETED|Overall Study||6
10630564|NCT02030119|11789196|FG003|NOT COMPLETED|Overall Study||3
10630565|NCT02030288|11789208|FG000|STARTED|Overall Study||89
10630566|NCT02030288|11789209|FG001|STARTED|Overall Study||89
10630567|NCT02030288|11789208|FG000|COMPLETED|Overall Study||89
10630568|NCT02030288|11789209|FG001|COMPLETED|Overall Study||89
10630569|NCT02030288|11789208|FG000|NOT COMPLETED|Overall Study||0
10630570|NCT02030288|11789209|FG001|NOT COMPLETED|Overall Study||0
10630571|NCT02030405|11789219|FG000|STARTED|Overall Study||4
10630572|NCT02030405|11789219|FG000|COMPLETED|Overall Study||2
10630573|NCT02030405|11789219|FG000|NOT COMPLETED|Overall Study||2
10630574|NCT02030535|11789224|FG000|STARTED|Treatment Period 1 (1 Day)||53
10630575|NCT02030535|11789224|FG000|COMPLETED|Treatment Period 1 (1 Day)||53
10630576|NCT02030535|11789224|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0
10630577|NCT02030535|11789224|FG000|STARTED|Washout Period 1 (21 Days)||53
10630578|NCT02030535|11789224|FG000|COMPLETED|Washout Period 1 (21 Days)||52
10630579|NCT02030535|11789224|FG000|NOT COMPLETED|Washout Period 1 (21 Days)||1
10630580|NCT02030535|11789224|FG000|STARTED|Treatment Period 2 (1 Day)||52
10630581|NCT02030535|11789224|FG000|COMPLETED|Treatment Period 2 (1 Day)||52
10630582|NCT02030535|11789224|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0
10630583|NCT02030535|11789224|FG000|STARTED|Washout Period 2 (21 Days)||52
10630584|NCT02030535|11789224|FG000|COMPLETED|Washout Period 2 (21 Days)||52
10630585|NCT02030535|11789224|FG000|NOT COMPLETED|Washout Period 2 (21 Days)||0
10630586|NCT02030535|11789224|FG000|STARTED|Treatment Period 3 (1 Day)||52
10630587|NCT02030535|11789224|FG000|COMPLETED|Treatment Period 3 (1 Day)||52
10630588|NCT02030535|11789224|FG000|NOT COMPLETED|Treatment Period 3 (1 Day)||0
10630589|NCT02030574|11789238|FG000|STARTED|Overall Study||2
10630590|NCT02030574|11789238|FG000|COMPLETED|Overall Study||2
10630591|NCT02030574|11789238|FG000|NOT COMPLETED|Overall Study||0
10630592|NCT02030600|11789244|FG000|STARTED|Treatment Period 1||361
10630593|NCT02030600|11789245|FG001|STARTED|Treatment Period 1||360
10630594|NCT02030600|11789244|FG000|Exposed|Treatment Period 1||356
10630595|NCT02030600|11789245|FG001|Exposed|Treatment Period 1||357
10630596|NCT02030600|11789244|FG000|COMPLETED|Treatment Period 1||308
10630597|NCT02030600|11789245|FG001|COMPLETED|Treatment Period 1||315
10630598|NCT02030600|11789244|FG000|NOT COMPLETED|Treatment Period 1||53
10630599|NCT02030600|11789245|FG001|NOT COMPLETED|Treatment Period 1||45
10630600|NCT02030600|11789244|FG000|STARTED|Treatment Period 2||308
10630601|NCT02030600|11789245|FG001|STARTED|Treatment Period 2||315
10630602|NCT02030600|11789244|FG000|COMPLETED|Treatment Period 2||283
10630603|NCT02030600|11789245|FG001|COMPLETED|Treatment Period 2||297
10630604|NCT02030600|11789244|FG000|NOT COMPLETED|Treatment Period 2||25
10630605|NCT02030600|11789245|FG001|NOT COMPLETED|Treatment Period 2||18
10630606|NCT02030821|11789257|FG000|STARTED|Overall Study||48
10630607|NCT02030821|11789258|FG001|STARTED|Overall Study||46
10630608|NCT02030821|11789259|FG002|STARTED|Overall Study||78
10630609|NCT02030821|11789260|FG003|STARTED|Overall Study||74
10630610|NCT02030821|11789257|FG000|COMPLETED|Overall Study||46
10630611|NCT02030821|11789258|FG001|COMPLETED|Overall Study||44
10630612|NCT02030821|11789259|FG002|COMPLETED|Overall Study||73
10630613|NCT02030821|11789260|FG003|COMPLETED|Overall Study||72
10630614|NCT02030821|11789257|FG000|NOT COMPLETED|Overall Study||2
10705518|NCT02600403|11869968|FG000|NOT COMPLETED|Overall Study||0
10705519|NCT02600403|11869969|FG001|NOT COMPLETED|Overall Study||0
10705520|NCT02600403|11869970|FG002|NOT COMPLETED|Overall Study||0
10630615|NCT02030821|11789258|FG001|NOT COMPLETED|Overall Study||2
10630616|NCT02030821|11789259|FG002|NOT COMPLETED|Overall Study||5
10630617|NCT02030821|11789260|FG003|NOT COMPLETED|Overall Study||2
10630618|NCT02030834|11789273|FG000|STARTED|Overall Study||50
10630619|NCT02030834|11789274|FG001|STARTED|Overall Study||3
10630620|NCT02030834|11789275|FG002|STARTED|Overall Study||10
10630621|NCT02030834|11789273|FG000|COMPLETED|Overall Study||39
10630622|NCT02030834|11789274|FG001|COMPLETED|Overall Study||3
10630623|NCT02030834|11789275|FG002|COMPLETED|Overall Study||7
10630624|NCT02030834|11789273|FG000|NOT COMPLETED|Overall Study||11
10630625|NCT02030834|11789274|FG001|NOT COMPLETED|Overall Study||0
10630626|NCT02030834|11789275|FG002|NOT COMPLETED|Overall Study||3
10653688|NCT02195869|11814285|FG000|NOT COMPLETED|Overall Study||42
10653689|NCT02195895|11814292|FG000|STARTED|Overall Study||17
10653690|NCT02195895|11814292|FG000|COMPLETED|Overall Study||17
10653691|NCT02195895|11814292|FG000|NOT COMPLETED|Overall Study||0
10653692|NCT02195921|11814300|FG000|STARTED|Overall Study||40
10653693|NCT02195921|11814301|FG001|STARTED|Overall Study||40
10653694|NCT02195921|11814302|FG002|STARTED|Overall Study||40
10653695|NCT02195921|11814303|FG003|STARTED|Overall Study||40
10653696|NCT02195921|11814300|FG000|COMPLETED|Overall Study||39
10653697|NCT02195921|11814301|FG001|COMPLETED|Overall Study||39
10653698|NCT02195921|11814302|FG002|COMPLETED|Overall Study||39
10653699|NCT02195921|11814303|FG003|COMPLETED|Overall Study||40
10653700|NCT02195921|11814300|FG000|NOT COMPLETED|Overall Study||1
10653701|NCT02195921|11814301|FG001|NOT COMPLETED|Overall Study||1
10653702|NCT02195921|11814302|FG002|NOT COMPLETED|Overall Study||1
10653703|NCT02195921|11814303|FG003|NOT COMPLETED|Overall Study||0
10653704|NCT02196038|11814320|FG000|STARTED|Overall Study||174
10653705|NCT02196038|11814321|FG001|STARTED|Overall Study||175
10653706|NCT02196038|11814320|FG000|COMPLETED|Overall Study||157
10653707|NCT02196038|11814321|FG001|COMPLETED|Overall Study||153
10653708|NCT02196038|11814320|FG000|NOT COMPLETED|Overall Study||17
10653709|NCT02196038|11814321|FG001|NOT COMPLETED|Overall Study||22
10653710|NCT02196077|11814327|FG000|STARTED|Overall Study||180
10653711|NCT02196077|11814327|FG000|BFF MDI 320/9.6 μg|Overall Study||155
10653712|NCT02196077|11814327|FG000|BFF MDI 160/9.6 μg|Overall Study||106
10653713|NCT02196077|11814327|FG000|BFF MDI 80/9.6 μg|Overall Study||103
10653714|NCT02196077|11814327|FG000|BD MDI 320 μg|Overall Study||108
10653715|NCT02196077|11814327|FG000|FF MDI 9.6 μg|Overall Study||157
10653716|NCT02196077|11814327|FG000|COMPLETED|Overall Study||133
10653717|NCT02196077|11814327|FG000|NOT COMPLETED|Overall Study||47
10653718|NCT02196168|11814341|FG000|STARTED|Overall Study||6
10653719|NCT02196168|11814342|FG001|STARTED|Overall Study||0
10653720|NCT02196168|11814341|FG000|COMPLETED|Overall Study||6
10653721|NCT02196168|11814342|FG001|COMPLETED|Overall Study||0
10653722|NCT02196168|11814341|FG000|NOT COMPLETED|Overall Study||0
10653723|NCT02196168|11814342|FG001|NOT COMPLETED|Overall Study||0
10653724|NCT02196259|11814351|FG000|STARTED|Overall Study||3
10653725|NCT02196259|11814352|FG001|STARTED|Overall Study||7
10653726|NCT02196259|11814353|FG002|STARTED|Overall Study||3
10653727|NCT02196259|11814351|FG000|COMPLETED|Overall Study||3
10653728|NCT02196259|11814352|FG001|COMPLETED|Overall Study||4
10653729|NCT02196259|11814353|FG002|COMPLETED|Overall Study||2
10653730|NCT02196259|11814351|FG000|NOT COMPLETED|Overall Study||0
10653731|NCT02196259|11814352|FG001|NOT COMPLETED|Overall Study||3
10653732|NCT02196259|11814353|FG002|NOT COMPLETED|Overall Study||1
10653733|NCT02196324|11814362|FG000|STARTED|Overall Study||63
10653734|NCT02196324|11814363|FG001|STARTED|Overall Study||65
10653735|NCT02196324|11814362|FG000|COMPLETED|Overall Study||48
10653736|NCT02196324|11814363|FG001|COMPLETED|Overall Study||57
10653737|NCT02196324|11814362|FG000|NOT COMPLETED|Overall Study||15
10653738|NCT02196324|11814363|FG001|NOT COMPLETED|Overall Study||8
10653739|NCT02196506|11814371|FG000|STARTED|Phase A||837
10653740|NCT02196506|11814372|FG001|STARTED|Phase A||0
10653741|NCT02196506|11814373|FG002|STARTED|Phase A||0
10653742|NCT02196506|11814374|FG003|STARTED|Phase A||0
10653743|NCT02196506|11814371|FG000|COMPLETED|Phase A||716
10653744|NCT02196506|11814372|FG001|COMPLETED|Phase A||0
10653745|NCT02196506|11814373|FG002|COMPLETED|Phase A||0
10653746|NCT02196506|11814374|FG003|COMPLETED|Phase A||0
10705521|NCT02600559|11869981|FG000|STARTED|Overall Study||501
10705522|NCT02600559|11869981|FG000|COMPLETED|Overall Study||478
10653747|NCT02196506|11814371|FG000|NOT COMPLETED|Phase A||121
10653748|NCT02196506|11814372|FG001|NOT COMPLETED|Phase A||0
10653749|NCT02196506|11814373|FG002|NOT COMPLETED|Phase A||0
10653750|NCT02196506|11814374|FG003|NOT COMPLETED|Phase A||0
10653751|NCT02196506|11814371|FG000|STARTED|Phase B||0
10653752|NCT02196506|11814372|FG001|STARTED|Phase B||192
10653753|NCT02196506|11814373|FG002|STARTED|Phase B||202
10653754|NCT02196506|11814374|FG003|STARTED|Phase B||0
10653755|NCT02196506|11814371|FG000|COMPLETED|Phase B||0
10705523|NCT02600559|11869981|FG000|NOT COMPLETED|Overall Study||23
10630627|NCT02030847|11789283|FG000|STARTED|Overall Study||42
10630628|NCT02030847|11789283|FG000|COMPLETED|Overall Study||5
10630629|NCT02030847|11789283|FG000|NOT COMPLETED|Overall Study||37
10630630|NCT02030886|11789290|FG000|STARTED|Overall Study||14
10630631|NCT02030886|11789291|FG001|STARTED|Overall Study||6
10630632|NCT02030886|11789290|FG000|COMPLETED|Overall Study||14
10630633|NCT02030886|11789291|FG001|COMPLETED|Overall Study||6
10630634|NCT02030886|11789290|FG000|NOT COMPLETED|Overall Study||0
10630635|NCT02030886|11789291|FG001|NOT COMPLETED|Overall Study||0
10630636|NCT02031146|11789301|FG000|STARTED|Overall Study||11
10630637|NCT02031146|11789302|FG001|STARTED|Overall Study||3
10630638|NCT02031146|11789303|FG002|STARTED|Overall Study||18
10630639|NCT02031146|11789304|FG003|STARTED|Overall Study||148
10630640|NCT02031146|11789305|FG004|STARTED|Overall Study||42
10630641|NCT02031146|11789306|FG005|STARTED|Overall Study||4
10630642|NCT02031146|11789307|FG006|STARTED|Overall Study||5
10630643|NCT02031146|11789301|FG000|Considered in Analysis|Overall Study||11
10630644|NCT02031146|11789302|FG001|Considered in Analysis|Overall Study||3
10630645|NCT02031146|11789303|FG002|Considered in Analysis|Overall Study||18
10630646|NCT02031146|11789304|FG003|Considered in Analysis|Overall Study||48
10630647|NCT02031146|11789305|FG004|Considered in Analysis|Overall Study||16
10630648|NCT02031146|11789306|FG005|Considered in Analysis|Overall Study||0
10630649|NCT02031146|11789307|FG006|Considered in Analysis|Overall Study||0
10630650|NCT02031146|11789301|FG000|COMPLETED|Overall Study||11
10630651|NCT02031146|11789302|FG001|COMPLETED|Overall Study||3
10630652|NCT02031146|11789303|FG002|COMPLETED|Overall Study||18
10630653|NCT02031146|11789304|FG003|COMPLETED|Overall Study||48
10630654|NCT02031146|11789305|FG004|COMPLETED|Overall Study||16
10630655|NCT02031146|11789306|FG005|COMPLETED|Overall Study||0
10630656|NCT02031146|11789307|FG006|COMPLETED|Overall Study||0
10630657|NCT02031146|11789301|FG000|NOT COMPLETED|Overall Study||0
10630658|NCT02031146|11789302|FG001|NOT COMPLETED|Overall Study||0
10630659|NCT02031146|11789303|FG002|NOT COMPLETED|Overall Study||0
10630660|NCT02031146|11789304|FG003|NOT COMPLETED|Overall Study||100
10630661|NCT02031146|11789305|FG004|NOT COMPLETED|Overall Study||26
10630662|NCT02031146|11789306|FG005|NOT COMPLETED|Overall Study||4
10630663|NCT02031146|11789307|FG006|NOT COMPLETED|Overall Study||5
10630664|NCT02031237|11789319|FG000|STARTED|Overall Study||14
10630665|NCT02031237|11789320|FG001|STARTED|Overall Study||35
10630666|NCT02031237|11789321|FG002|STARTED|Overall Study||3
10630667|NCT02031237|11789319|FG000|COMPLETED|Overall Study||9
10630668|NCT02031237|11789320|FG001|COMPLETED|Overall Study||21
10630669|NCT02031237|11789321|FG002|COMPLETED|Overall Study||0
10630670|NCT02031237|11789319|FG000|NOT COMPLETED|Overall Study||5
10630671|NCT02031237|11789320|FG001|NOT COMPLETED|Overall Study||14
10630672|NCT02031237|11789321|FG002|NOT COMPLETED|Overall Study||3
10630673|NCT02031276|11789331|FG000|STARTED|Period 1 Double-blind IV||39
10630674|NCT02031276|11789332|FG001|STARTED|Period 1 Double-blind IV||41
10630675|NCT02031276|11789333|FG002|STARTED|Period 1 Double-blind IV||41
10630676|NCT02031276|11789331|FG000|COMPLETED|Period 1 Double-blind IV||33
10630677|NCT02031276|11789332|FG001|COMPLETED|Period 1 Double-blind IV||35
10630678|NCT02031276|11789333|FG002|COMPLETED|Period 1 Double-blind IV||40
10630679|NCT02031276|11789331|FG000|NOT COMPLETED|Period 1 Double-blind IV||6
10630680|NCT02031276|11789332|FG001|NOT COMPLETED|Period 1 Double-blind IV||6
10630681|NCT02031276|11789333|FG002|NOT COMPLETED|Period 1 Double-blind IV||1
10630682|NCT02031276|11789331|FG000|STARTED|Period 2 Open-label Risankizumab IV||33
10630683|NCT02031276|11789332|FG001|STARTED|Period 2 Open-label Risankizumab IV||35
10630684|NCT02031276|11789333|FG002|STARTED|Period 2 Open-label Risankizumab IV|1 participant did not enter Period 2 (declined open-label treatment in Period 2)|39
10630685|NCT02031276|11789331|FG000|COMPLETED|Period 2 Open-label Risankizumab IV||29
10630686|NCT02031276|11789332|FG001|COMPLETED|Period 2 Open-label Risankizumab IV||33
10630687|NCT02031276|11789333|FG002|COMPLETED|Period 2 Open-label Risankizumab IV||38
10630688|NCT02031276|11789331|FG000|NOT COMPLETED|Period 2 Open-label Risankizumab IV||4
10630689|NCT02031276|11789332|FG001|NOT COMPLETED|Period 2 Open-label Risankizumab IV||2
10630690|NCT02031276|11789333|FG002|NOT COMPLETED|Period 2 Open-label Risankizumab IV||1
10630691|NCT02031276|11789331|FG000|STARTED|Period 3 Open-label Risankizumab SC|10 participants did not enter period 3 (not in clinical remission)|19
10630692|NCT02031276|11789332|FG001|STARTED|Period 3 Open-label Risankizumab SC|11 participants did not enter period 3 (not in clinical remission)|22
10630693|NCT02031276|11789333|FG002|STARTED|Period 3 Open-label Risankizumab SC|17 participants did not enter period 3 (not in clinical remission)|21
10630694|NCT02031276|11789331|FG000|COMPLETED|Period 3 Open-label Risankizumab SC||16
10630695|NCT02031276|11789332|FG001|COMPLETED|Period 3 Open-label Risankizumab SC||19
10630696|NCT02031276|11789333|FG002|COMPLETED|Period 3 Open-label Risankizumab SC||19
10630697|NCT02031276|11789331|FG000|NOT COMPLETED|Period 3 Open-label Risankizumab SC||3
10630698|NCT02031276|11789332|FG001|NOT COMPLETED|Period 3 Open-label Risankizumab SC||3
10630699|NCT02031276|11789333|FG002|NOT COMPLETED|Period 3 Open-label Risankizumab SC||2
10630700|NCT02031302|11789347|FG000|STARTED|Overall Study||1014
10630701|NCT02031302|11789348|FG001|STARTED|Overall Study||50
10630702|NCT02031302|11789347|FG000|COMPLETED|Overall Study||850
10630703|NCT02031302|11789348|FG001|COMPLETED|Overall Study||50
10630704|NCT02031302|11789347|FG000|NOT COMPLETED|Overall Study||164
10630705|NCT02031302|11789348|FG001|NOT COMPLETED|Overall Study||0
10630706|NCT02031432|11789355|FG000|STARTED|Overall Study||76
10630707|NCT02031432|11789355|FG000|Completing the Titration Phase|Overall Study||67
10630708|NCT02031432|11789355|FG000|Completing the Treatment|Overall Study||39
10630709|NCT02031432|11789355|FG000|COMPLETED|Overall Study||38
10630710|NCT02031432|11789355|FG000|NOT COMPLETED|Overall Study||38
10630711|NCT02031458|11789362|FG000|STARTED|May 8, 2015 to January 11, 2019||138
10630712|NCT02031458|11789363|FG001|STARTED|May 8, 2015 to January 11, 2019||269
10630713|NCT02031458|11789364|FG002|STARTED|May 8, 2015 to January 11, 2019||252
10630714|NCT02031458|11789362|FG000|COMPLETED|May 8, 2015 to January 11, 2019||0
10630715|NCT02031458|11789363|FG001|COMPLETED|May 8, 2015 to January 11, 2019||0
10630716|NCT02031458|11789364|FG002|COMPLETED|May 8, 2015 to January 11, 2019||0
10630717|NCT02031458|11789362|FG000|NOT COMPLETED|May 8, 2015 to January 11, 2019||138
10630718|NCT02031458|11789363|FG001|NOT COMPLETED|May 8, 2015 to January 11, 2019||269
10630719|NCT02031458|11789364|FG002|NOT COMPLETED|May 8, 2015 to January 11, 2019||252
10630720|NCT02031458|11789362|FG000|STARTED|Baseline to May 8, 2015||139
10630721|NCT02031458|11789363|FG001|STARTED|Baseline to May 8, 2015||267
10705524|NCT02600611|11869987|FG000|STARTED|Overall Study||300
10705525|NCT02600611|11869988|FG001|STARTED|Overall Study||300
10705526|NCT02600611|11869987|FG000|COMPLETED|Overall Study||298
10630722|NCT02031458|11789364|FG002|STARTED|Baseline to May 8, 2015||253
10630723|NCT02031458|11789362|FG000|COMPLETED|Baseline to May 8, 2015||0
10630724|NCT02031458|11789363|FG001|COMPLETED|Baseline to May 8, 2015||0
10630725|NCT02031458|11789364|FG002|COMPLETED|Baseline to May 8, 2015||0
10630726|NCT02031458|11789362|FG000|NOT COMPLETED|Baseline to May 8, 2015||139
10630727|NCT02031458|11789363|FG001|NOT COMPLETED|Baseline to May 8, 2015||267
10630728|NCT02031458|11789364|FG002|NOT COMPLETED|Baseline to May 8, 2015||253
10630729|NCT02031471|11789374|FG000|STARTED|24 Week Treatment Period||57
10630730|NCT02031471|11789374|FG000|COMPLETED|24 Week Treatment Period||46
10630731|NCT02031471|11789374|FG000|NOT COMPLETED|24 Week Treatment Period||11
10630732|NCT02031471|11789374|FG000|STARTED|Long Term Extension (LTE) Period|Only participants who achieved at least a moderate EULAR response at Week 24 entered the LTE Period.|39
10630733|NCT02031471|11789374|FG000|COMPLETED|Long Term Extension (LTE) Period||37
10630734|NCT02031471|11789374|FG000|NOT COMPLETED|Long Term Extension (LTE) Period||2
10630735|NCT02031536|11789380|FG000|STARTED|Overall Study||2
10630736|NCT02031536|11789381|FG001|STARTED|Overall Study||0
10630737|NCT02031536|11789380|FG000|COMPLETED|Overall Study||1
10630738|NCT02031536|11789381|FG001|COMPLETED|Overall Study||0
10630739|NCT02031536|11789380|FG000|NOT COMPLETED|Overall Study||1
10630740|NCT02031536|11789381|FG001|NOT COMPLETED|Overall Study||0
10630741|NCT02031627|11789390|FG000|STARTED|Overall Study||7
10630742|NCT02031627|11789391|FG001|STARTED|Overall Study||7
10630743|NCT02031627|11789392|FG002|STARTED|Overall Study||7
10630744|NCT02031627|11789390|FG000|COMPLETED|Overall Study||7
10630745|NCT02031627|11789391|FG001|COMPLETED|Overall Study||7
10630746|NCT02031627|11789392|FG002|COMPLETED|Overall Study||7
10630747|NCT02031627|11789390|FG000|NOT COMPLETED|Overall Study||0
10630748|NCT02031627|11789391|FG001|NOT COMPLETED|Overall Study||0
10630749|NCT02031627|11789392|FG002|NOT COMPLETED|Overall Study||0
10630750|NCT02031640|11789405|FG000|STARTED|Screening Period|Consented|1113
10630751|NCT02031640|11789406|FG001|STARTED|Screening Period||0
10630752|NCT02031640|11789407|FG002|STARTED|Screening Period||0
10630753|NCT02031640|11789408|FG003|STARTED|Screening Period||0
10630754|NCT02031640|11789409|FG004|STARTED|Screening Period||0
10630755|NCT02031640|11789410|FG005|STARTED|Screening Period||0
10630756|NCT02031640|11789405|FG000|COMPLETED|Screening Period||701
10630757|NCT02031640|11789406|FG001|COMPLETED|Screening Period||0
10630758|NCT02031640|11789407|FG002|COMPLETED|Screening Period||0
10630759|NCT02031640|11789408|FG003|COMPLETED|Screening Period||0
10630760|NCT02031640|11789409|FG004|COMPLETED|Screening Period||0
10630761|NCT02031640|11789410|FG005|COMPLETED|Screening Period||0
10630762|NCT02031640|11789405|FG000|NOT COMPLETED|Screening Period||412
10630763|NCT02031640|11789406|FG001|NOT COMPLETED|Screening Period||0
10630764|NCT02031640|11789407|FG002|NOT COMPLETED|Screening Period||0
10630765|NCT02031640|11789408|FG003|NOT COMPLETED|Screening Period||0
10630766|NCT02031640|11789409|FG004|NOT COMPLETED|Screening Period||0
10630767|NCT02031640|11789410|FG005|NOT COMPLETED|Screening Period||0
10630768|NCT02031640|11789405|FG000|STARTED|Run-In Period||701
10630769|NCT02031640|11789406|FG001|STARTED|Run-In Period||0
10630770|NCT02031640|11789407|FG002|STARTED|Run-In Period||0
10630771|NCT02031640|11789408|FG003|STARTED|Run-In Period||0
10630772|NCT02031640|11789409|FG004|STARTED|Run-In Period||0
10630773|NCT02031640|11789410|FG005|STARTED|Run-In Period||0
10630774|NCT02031640|11789405|FG000|COMPLETED|Run-In Period||532
10630775|NCT02031640|11789406|FG001|COMPLETED|Run-In Period||0
10630776|NCT02031640|11789407|FG002|COMPLETED|Run-In Period||0
10630777|NCT02031640|11789408|FG003|COMPLETED|Run-In Period||0
10630778|NCT02031640|11789409|FG004|COMPLETED|Run-In Period||0
10630779|NCT02031640|11789410|FG005|COMPLETED|Run-In Period||0
10630780|NCT02031640|11789405|FG000|NOT COMPLETED|Run-In Period||169
10630781|NCT02031640|11789406|FG001|NOT COMPLETED|Run-In Period||0
10630782|NCT02031640|11789407|FG002|NOT COMPLETED|Run-In Period||0
10630783|NCT02031640|11789408|FG003|NOT COMPLETED|Run-In Period||0
10630784|NCT02031640|11789409|FG004|NOT COMPLETED|Run-In Period||0
10630785|NCT02031640|11789410|FG005|NOT COMPLETED|Run-In Period||0
10630786|NCT02031640|11789405|FG000|STARTED|Double-blind Treatment Period||0
10630787|NCT02031640|11789406|FG001|STARTED|Double-blind Treatment Period||106
10630788|NCT02031640|11789407|FG002|STARTED|Double-blind Treatment Period||106
10630789|NCT02031640|11789408|FG003|STARTED|Double-blind Treatment Period||106
10630790|NCT02031640|11789409|FG004|STARTED|Double-blind Treatment Period||107
10630791|NCT02031640|11789410|FG005|STARTED|Double-blind Treatment Period||107
10630792|NCT02031640|11789405|FG000|Full Analysis Set|Double-blind Treatment Period||0
10705527|NCT02600611|11869988|FG001|COMPLETED|Overall Study||300
10630793|NCT02031640|11789406|FG001|Full Analysis Set|Double-blind Treatment Period||106
10630794|NCT02031640|11789407|FG002|Full Analysis Set|Double-blind Treatment Period||104
10630795|NCT02031640|11789408|FG003|Full Analysis Set|Double-blind Treatment Period||106
10630796|NCT02031640|11789409|FG004|Full Analysis Set|Double-blind Treatment Period||106
10630797|NCT02031640|11789410|FG005|Full Analysis Set|Double-blind Treatment Period||107
10630798|NCT02031640|11789405|FG000|COMPLETED|Double-blind Treatment Period||0
10630799|NCT02031640|11789406|FG001|COMPLETED|Double-blind Treatment Period||84
10630800|NCT02031640|11789407|FG002|COMPLETED|Double-blind Treatment Period||100
10630801|NCT02031640|11789408|FG003|COMPLETED|Double-blind Treatment Period||99
10630802|NCT02031640|11789409|FG004|COMPLETED|Double-blind Treatment Period||96
10630803|NCT02031640|11789410|FG005|COMPLETED|Double-blind Treatment Period||104
10630804|NCT02031640|11789405|FG000|NOT COMPLETED|Double-blind Treatment Period||0
10630805|NCT02031640|11789406|FG001|NOT COMPLETED|Double-blind Treatment Period||22
10630806|NCT02031640|11789407|FG002|NOT COMPLETED|Double-blind Treatment Period||6
10630807|NCT02031640|11789408|FG003|NOT COMPLETED|Double-blind Treatment Period||7
10630808|NCT02031640|11789409|FG004|NOT COMPLETED|Double-blind Treatment Period||11
10630809|NCT02031640|11789410|FG005|NOT COMPLETED|Double-blind Treatment Period||3
10630810|NCT02031679|11789431|FG000|STARTED|Overall Study||14
10630811|NCT02031679|11789432|FG001|STARTED|Overall Study||14
10630812|NCT02031679|11789431|FG000|COMPLETED|Overall Study||14
10630813|NCT02031679|11789432|FG001|COMPLETED|Overall Study||12
10630814|NCT02031679|11789431|FG000|NOT COMPLETED|Overall Study||0
10630815|NCT02031679|11789432|FG001|NOT COMPLETED|Overall Study||2
10630816|NCT02031770|11789438|FG000|STARTED|Overall Study||10
10630817|NCT02031770|11789439|FG001|STARTED|Overall Study||10
10630818|NCT02031770|11789438|FG000|COMPLETED|Overall Study||9
10630819|NCT02031770|11789439|FG001|COMPLETED|Overall Study||9
10630820|NCT02031770|11789438|FG000|NOT COMPLETED|Overall Study||1
10630821|NCT02031770|11789439|FG001|NOT COMPLETED|Overall Study||1
10630822|NCT02032173|11789445|FG000|STARTED|Overall Study||31
10630823|NCT02032173|11789445|FG000|Included Population - Main Group|Overall Study||31
10630824|NCT02032173|11789445|FG000|Rescue Group|Overall Study|1 participant moved to Rescue Group at M6 and trial discontinued before any data was collected.|1
10630825|NCT02032173|11789445|FG000|COMPLETED|Overall Study||0
10630826|NCT02032173|11789445|FG000|NOT COMPLETED|Overall Study||31
10630827|NCT02032212|11789453|FG000|STARTED|Overall Study||3
10630828|NCT02032212|11789454|FG001|STARTED|Overall Study||3
10630829|NCT02032212|11789455|FG002|STARTED|Overall Study||3
10630830|NCT02032212|11789456|FG003|STARTED|Overall Study||3
10630831|NCT02032212|11789453|FG000|COMPLETED|Overall Study||3
10630832|NCT02032212|11789454|FG001|COMPLETED|Overall Study||3
10630833|NCT02032212|11789455|FG002|COMPLETED|Overall Study||3
10630834|NCT02032212|11789456|FG003|COMPLETED|Overall Study||3
10630835|NCT02032212|11789453|FG000|NOT COMPLETED|Overall Study||0
10630836|NCT02032212|11789454|FG001|NOT COMPLETED|Overall Study||0
10630837|NCT02032212|11789455|FG002|NOT COMPLETED|Overall Study||0
10630838|NCT02032212|11789456|FG003|NOT COMPLETED|Overall Study||0
10630839|NCT02032238|11789468|FG000|STARTED|Overall Study||12
10630840|NCT02032238|11789469|FG001|STARTED|Overall Study|Study Terminated due to slow enrollment, no subjects enrolled in this study arm|0
10630841|NCT02032238|11789468|FG000|COMPLETED|Overall Study||10
10630842|NCT02032238|11789469|FG001|COMPLETED|Overall Study||0
10630843|NCT02032238|11789468|FG000|NOT COMPLETED|Overall Study||2
10630844|NCT02032238|11789469|FG001|NOT COMPLETED|Overall Study||0
10630845|NCT02032407|11789475|FG000|STARTED|Overall Study||68
10630846|NCT02032407|11789475|FG000|COMPLETED|Overall Study||63
10630847|NCT02032407|11789475|FG000|NOT COMPLETED|Overall Study||5
10630848|NCT02032420|11789481|FG000|STARTED|Overall Study||18
10630849|NCT02032420|11789482|FG001|STARTED|Overall Study||17
10630850|NCT02032420|11789481|FG000|COMPLETED|Overall Study||18
10630851|NCT02032420|11789482|FG001|COMPLETED|Overall Study||17
10630852|NCT02032420|11789481|FG000|NOT COMPLETED|Overall Study||0
10630853|NCT02032420|11789482|FG001|NOT COMPLETED|Overall Study||0
10630854|NCT02032433|11789490|FG000|STARTED|Overall Study||283
10630855|NCT02032433|11789491|FG001|STARTED|Overall Study||287
10630856|NCT02032433|11789490|FG000|COMPLETED|Overall Study||205
10630857|NCT02032433|11789491|FG001|COMPLETED|Overall Study||225
10630858|NCT02032433|11789490|FG000|NOT COMPLETED|Overall Study||78
10630859|NCT02032433|11789491|FG001|NOT COMPLETED|Overall Study||62
10630860|NCT02032550|11789499|FG000|STARTED|Overall Study||371
10630861|NCT02032550|11789500|FG001|STARTED|Overall Study||372
10630862|NCT02032550|11789499|FG000|COMPLETED|Overall Study||343
10630863|NCT02032550|11789500|FG001|COMPLETED|Overall Study||350
10630864|NCT02032550|11789499|FG000|NOT COMPLETED|Overall Study||28
10630865|NCT02032550|11789500|FG001|NOT COMPLETED|Overall Study||22
10630866|NCT02032641|11789506|FG000|STARTED|Overall Study|18 Brows enrolled for evaluation|9
10630867|NCT02032641|11789506|FG000|COMPLETED|Overall Study|16 brows completed study (half underwent treatment, half were control)|8
10630868|NCT02032641|11789506|FG000|NOT COMPLETED|Overall Study||1
10630869|NCT02032680|11789514|FG000|STARTED|Overall Study||22
10630870|NCT02032680|11789515|FG001|STARTED|Overall Study||8
10630871|NCT02032680|11789514|FG000|COMPLETED|Overall Study||16
10630872|NCT02032680|11789515|FG001|COMPLETED|Overall Study||7
10630873|NCT02032680|11789514|FG000|NOT COMPLETED|Overall Study||6
10630874|NCT02032680|11789515|FG001|NOT COMPLETED|Overall Study||1
10630875|NCT02032706|11789521|FG000|STARTED|Overall Study||36
10630876|NCT02032706|11789521|FG000|COMPLETED|Overall Study||30
10630877|NCT02032706|11789521|FG000|NOT COMPLETED|Overall Study||6
10630878|NCT02032758|11789527|FG000|STARTED|Overall Study||27
10630879|NCT02032758|11789528|FG001|STARTED|Overall Study||11
10630880|NCT02032758|11789527|FG000|COMPLETED|Overall Study||27
10630881|NCT02032758|11789528|FG001|COMPLETED|Overall Study||11
10630882|NCT02032758|11789527|FG000|NOT COMPLETED|Overall Study||0
10630883|NCT02032758|11789528|FG001|NOT COMPLETED|Overall Study||0
10630884|NCT02032875|11789536|FG000|STARTED|Treatment Period||53
10630885|NCT02032875|11789537|FG001|STARTED|Treatment Period||60
10630886|NCT02032875|11789536|FG000|COMPLETED|Treatment Period||52
10630887|NCT02032875|11789537|FG001|COMPLETED|Treatment Period||56
10630888|NCT02032875|11789536|FG000|NOT COMPLETED|Treatment Period||1
10630889|NCT02032875|11789537|FG001|NOT COMPLETED|Treatment Period||4
10630890|NCT02032875|11789536|FG000|STARTED|Follow-up Period|Out of 53 participants who entered the treatment period, all 53 continued in the follow-up period.|53
10630891|NCT02032875|11789537|FG001|STARTED|Follow-up Period|Of 60 participants in treatment period, 57 continued in follow-up, 3 entered treatment extension.|57
10630892|NCT02032875|11789536|FG000|COMPLETED|Follow-up Period||50
10630893|NCT02032875|11789537|FG001|COMPLETED|Follow-up Period||46
10630894|NCT02032875|11789536|FG000|NOT COMPLETED|Follow-up Period||3
10630895|NCT02032875|11789537|FG001|NOT COMPLETED|Follow-up Period||11
10630896|NCT02032888|11789547|FG000|STARTED|Treatment Period||101
10630897|NCT02032888|11789548|FG001|STARTED|Treatment Period||50
10630898|NCT02032888|11789549|FG002|STARTED|Treatment Period||52
10630899|NCT02032888|11789547|FG000|COMPLETED|Treatment Period||99
10630900|NCT02032888|11789548|FG001|COMPLETED|Treatment Period||48
10630901|NCT02032888|11789549|FG002|COMPLETED|Treatment Period||52
10630902|NCT02032888|11789547|FG000|NOT COMPLETED|Treatment Period||2
10630903|NCT02032888|11789548|FG001|NOT COMPLETED|Treatment Period||2
10630904|NCT02032888|11789549|FG002|NOT COMPLETED|Treatment Period||0
10630905|NCT02032888|11789547|FG000|STARTED|Follow-up Period|All patients who received study drug and not a nonstudy HCV therapy before treatment Week 4|100
10630906|NCT02032888|11789548|FG001|STARTED|Follow-up Period|All patients who received study drug and not a nonstudy HCV therapy before treatment Week 4|49
10630907|NCT02032888|11789549|FG002|STARTED|Follow-up Period||52
10630908|NCT02032888|11789547|FG000|COMPLETED|Follow-up Period||97
10630909|NCT02032888|11789548|FG001|COMPLETED|Follow-up Period||47
10630910|NCT02032888|11789549|FG002|COMPLETED|Follow-up Period||52
10630911|NCT02032888|11789547|FG000|NOT COMPLETED|Follow-up Period||3
10630912|NCT02032888|11789548|FG001|NOT COMPLETED|Follow-up Period||2
10630913|NCT02032888|11789549|FG002|NOT COMPLETED|Follow-up Period||0
10630914|NCT02032901|11789568|FG000|STARTED|Treatment Period (12 Weeks)||101
10630915|NCT02032901|11789569|FG001|STARTED|Treatment Period (12 Weeks)||51
10630916|NCT02032901|11789568|FG000|COMPLETED|Treatment Period (12 Weeks)||100
10630917|NCT02032901|11789569|FG001|COMPLETED|Treatment Period (12 Weeks)||51
10630918|NCT02032901|11789568|FG000|NOT COMPLETED|Treatment Period (12 Weeks)||1
10630919|NCT02032901|11789569|FG001|NOT COMPLETED|Treatment Period (12 Weeks)||0
10630920|NCT02032901|11789568|FG000|STARTED|Follow-Up Period (24 Weeks)|Participant could enter follow up period even if the treatment period was not completed.|101
10630921|NCT02032901|11789569|FG001|STARTED|Follow-Up Period (24 Weeks)||51
10630922|NCT02032901|11789568|FG000|COMPLETED|Follow-Up Period (24 Weeks)||101
10630923|NCT02032901|11789569|FG001|COMPLETED|Follow-Up Period (24 Weeks)||50
10630924|NCT02032901|11789568|FG000|NOT COMPLETED|Follow-Up Period (24 Weeks)||0
10630925|NCT02032901|11789569|FG001|NOT COMPLETED|Follow-Up Period (24 Weeks)||1
10630926|NCT02033005|11789580|FG000|STARTED|Overall Study||80
10630927|NCT02033005|11789581|FG001|STARTED|Overall Study||9
10630928|NCT02033005|11789582|FG002|STARTED|Overall Study||35
10630929|NCT02033005|11789580|FG000|COMPLETED|Overall Study||36
10630930|NCT02033005|11789581|FG001|COMPLETED|Overall Study||9
10630931|NCT02033005|11789582|FG002|COMPLETED|Overall Study||25
10630932|NCT02033005|11789580|FG000|NOT COMPLETED|Overall Study||44
10630933|NCT02033005|11789581|FG001|NOT COMPLETED|Overall Study||0
10630934|NCT02033005|11789582|FG002|NOT COMPLETED|Overall Study||10
10630935|NCT02033083|11789593|FG000|STARTED|Overall Study||90
10630936|NCT02033083|11789594|FG001|STARTED|Overall Study||90
10630937|NCT02033083|11789593|FG000|COMPLETED|Overall Study||89
10630938|NCT02033083|11789594|FG001|COMPLETED|Overall Study||89
10630939|NCT02033083|11789593|FG000|NOT COMPLETED|Overall Study||1
10630940|NCT02033083|11789594|FG001|NOT COMPLETED|Overall Study||1
10630941|NCT02033174|11789600|FG000|STARTED|First Intervention||8
10630942|NCT02033174|11789601|FG001|STARTED|First Intervention||8
10630943|NCT02033174|11789600|FG000|COMPLETED|First Intervention||8
10630944|NCT02033174|11789601|FG001|COMPLETED|First Intervention||8
10630945|NCT02033174|11789600|FG000|NOT COMPLETED|First Intervention||0
10630946|NCT02033174|11789601|FG001|NOT COMPLETED|First Intervention||0
10630947|NCT02033174|11789600|FG000|STARTED|Washout (1 Week)||8
10630948|NCT02033174|11789601|FG001|STARTED|Washout (1 Week)||8
10630949|NCT02033174|11789600|FG000|COMPLETED|Washout (1 Week)||8
10630950|NCT02033174|11789601|FG001|COMPLETED|Washout (1 Week)||8
10630951|NCT02033174|11789600|FG000|NOT COMPLETED|Washout (1 Week)||0
10630952|NCT02033174|11789601|FG001|NOT COMPLETED|Washout (1 Week)||0
10630953|NCT02033174|11789600|FG000|STARTED|Second Intervention||8
10630954|NCT02033174|11789601|FG001|STARTED|Second Intervention||8
10630955|NCT02033174|11789600|FG000|COMPLETED|Second Intervention||8
10630956|NCT02033174|11789601|FG001|COMPLETED|Second Intervention||8
10630957|NCT02033174|11789600|FG000|NOT COMPLETED|Second Intervention||0
10630958|NCT02033174|11789601|FG001|NOT COMPLETED|Second Intervention||0
10630959|NCT02033200|11789609|FG000|STARTED|Overall Study||40
10630960|NCT02033200|11789610|FG001|STARTED|Overall Study||40
10630961|NCT02033200|11789609|FG000|COMPLETED|Overall Study||40
10630962|NCT02033200|11789610|FG001|COMPLETED|Overall Study||40
10630963|NCT02033200|11789609|FG000|NOT COMPLETED|Overall Study||0
10630964|NCT02033200|11789610|FG001|NOT COMPLETED|Overall Study||0
10630965|NCT02033213|11789618|FG000|STARTED|Overall Study||8
10630966|NCT02033213|11789619|FG001|STARTED|Overall Study||8
10630967|NCT02033213|11789618|FG000|COMPLETED|Overall Study||8
10630968|NCT02033213|11789619|FG001|COMPLETED|Overall Study||8
10630969|NCT02033213|11789618|FG000|NOT COMPLETED|Overall Study||0
10630970|NCT02033213|11789619|FG001|NOT COMPLETED|Overall Study||0
10630971|NCT02033317|11789627|FG000|STARTED|Overall Study||6
10630972|NCT02033317|11789627|FG000|COMPLETED|Overall Study||6
10630973|NCT02033317|11789627|FG000|NOT COMPLETED|Overall Study||0
10630974|NCT02033369|11789633|FG000|STARTED|Overall Study||26
10630975|NCT02033369|11789634|FG001|STARTED|Overall Study||26
10630976|NCT02033369|11789633|FG000|COMPLETED|Overall Study||21
10630977|NCT02033369|11789634|FG001|COMPLETED|Overall Study||21
10630978|NCT02033369|11789633|FG000|NOT COMPLETED|Overall Study||5
10630979|NCT02033369|11789634|FG001|NOT COMPLETED|Overall Study||5
10630980|NCT02033382|11789640|FG000|STARTED|Overall Study||83
10630981|NCT02033382|11789641|FG001|STARTED|Overall Study||82
10630982|NCT02033382|11789640|FG000|COMPLETED|Overall Study||32
10630983|NCT02033382|11789641|FG001|COMPLETED|Overall Study||36
10630984|NCT02033382|11789640|FG000|NOT COMPLETED|Overall Study||51
10630985|NCT02033382|11789641|FG001|NOT COMPLETED|Overall Study||46
10630986|NCT02033499|11789654|FG000|STARTED|Overall Study||152
10630987|NCT02033499|11789655|FG001|STARTED|Overall Study||150
10630988|NCT02033499|11789656|FG002|STARTED|Overall Study||148
10630989|NCT02033499|11789654|FG000|COMPLETED|Overall Study||147
10630990|NCT02033499|11789655|FG001|COMPLETED|Overall Study||142
10630991|NCT02033499|11789656|FG002|COMPLETED|Overall Study||139
10630992|NCT02033499|11789654|FG000|NOT COMPLETED|Overall Study||5
10630993|NCT02033499|11789655|FG001|NOT COMPLETED|Overall Study||8
10630994|NCT02033499|11789656|FG002|NOT COMPLETED|Overall Study||9
10630995|NCT02033694|11789665|FG000|STARTED|Overall Study||1271
10630996|NCT02033694|11789665|FG000|COMPLETED|Overall Study||1271
10630997|NCT02033694|11789665|FG000|NOT COMPLETED|Overall Study||0
10630998|NCT02033759|11789672|FG000|STARTED|Overall Study||22
10630999|NCT02033759|11789673|FG001|STARTED|Overall Study||21
10631000|NCT02033759|11789672|FG000|COMPLETED|Overall Study||19
10631001|NCT02033759|11789673|FG001|COMPLETED|Overall Study||19
10631002|NCT02033759|11789672|FG000|NOT COMPLETED|Overall Study||3
10631003|NCT02033759|11789673|FG001|NOT COMPLETED|Overall Study||2
10631004|NCT02033850|11789681|FG000|STARTED|Overall Study||23
10631005|NCT02033850|11789682|FG001|STARTED|Overall Study||23
10631006|NCT02033850|11789681|FG000|COMPLETED|Overall Study||21
10631007|NCT02033850|11789682|FG001|COMPLETED|Overall Study||22
10631008|NCT02033850|11789681|FG000|NOT COMPLETED|Overall Study||2
10631009|NCT02033850|11789682|FG001|NOT COMPLETED|Overall Study||1
10631010|NCT02033876|11789690|FG000|STARTED|Overall Study||12
10631011|NCT02033876|11789691|FG001|STARTED|Overall Study||12
10705528|NCT02600611|11869987|FG000|NOT COMPLETED|Overall Study||2
10705529|NCT02600611|11869988|FG001|NOT COMPLETED|Overall Study||0
10705530|NCT02600637|11869996|FG000|STARTED|Overall Study||19
10631012|NCT02033876|11789690|FG000|COMPLETED|Overall Study||12
10631013|NCT02033876|11789691|FG001|COMPLETED|Overall Study||12
10631014|NCT02033876|11789690|FG000|NOT COMPLETED|Overall Study||0
10631015|NCT02033876|11789691|FG001|NOT COMPLETED|Overall Study||0
10631016|NCT02033889|11789700|FG000|STARTED|Overall Study||209
10631017|NCT02033889|11789701|FG001|STARTED|Overall Study||207
10631018|NCT02033889|11789702|FG002|STARTED|Overall Study||205
10631019|NCT02033889|11789700|FG000|COMPLETED|Overall Study||175
10631020|NCT02033889|11789701|FG001|COMPLETED|Overall Study||187
10631021|NCT02033889|11789702|FG002|COMPLETED|Overall Study||180
10631022|NCT02033889|11789700|FG000|NOT COMPLETED|Overall Study||34
10631023|NCT02033889|11789701|FG001|NOT COMPLETED|Overall Study||20
10631024|NCT02033889|11789702|FG002|NOT COMPLETED|Overall Study||25
10631025|NCT02033993|11789712|FG000|STARTED|Overall Study||99
10631026|NCT02033993|11789713|FG001|STARTED|Overall Study||100
10631027|NCT02033993|11789712|FG000|COMPLETED|Overall Study||96
10631028|NCT02033993|11789713|FG001|COMPLETED|Overall Study||91
10631029|NCT02033993|11789712|FG000|NOT COMPLETED|Overall Study||3
10631030|NCT02033993|11789713|FG001|NOT COMPLETED|Overall Study||9
10631031|NCT02034006|11789721|FG000|STARTED|Overall Study||200
10631032|NCT02034006|11789721|FG000|Once Treated Patients|Overall Study||70
10631033|NCT02034006|11789721|FG000|Re-treated Patients|Overall Study||130
10631034|NCT02034006|11789721|FG000|COMPLETED|Overall Study||186
10631035|NCT02034006|11789721|FG000|NOT COMPLETED|Overall Study||14
10631036|NCT02034019|11789730|FG000|STARTED|Overall Study||164
10631037|NCT02034019|11789731|FG001|STARTED|Overall Study||83
10631038|NCT02034019|11789730|FG000|COMPLETED|Overall Study||163
10631039|NCT02034019|11789731|FG001|COMPLETED|Overall Study||81
10631040|NCT02034019|11789730|FG000|NOT COMPLETED|Overall Study||1
10631041|NCT02034019|11789731|FG001|NOT COMPLETED|Overall Study||2
10631042|NCT02034058|11789737|FG000|STARTED|Overall Study|Study stopped early per pre-defined criteria for interim analysis.|152
10631043|NCT02034058|11789737|FG000|COMPLETED|Overall Study||149
10631044|NCT02034058|11789737|FG000|NOT COMPLETED|Overall Study||3
10631045|NCT02034162|11789743|FG000|STARTED|Double-blind||146
10631046|NCT02034162|11789744|FG001|STARTED|Double-blind||149
10631047|NCT02034162|11789745|FG002|STARTED|Double-blind||0
10631048|NCT02034162|11789743|FG000|COMPLETED|Double-blind||137
10631049|NCT02034162|11789744|FG001|COMPLETED|Double-blind||141
10631050|NCT02034162|11789745|FG002|COMPLETED|Double-blind||0
10631051|NCT02034162|11789743|FG000|NOT COMPLETED|Double-blind||9
10631052|NCT02034162|11789744|FG001|NOT COMPLETED|Double-blind||8
10631053|NCT02034162|11789745|FG002|NOT COMPLETED|Double-blind||0
10631054|NCT02034162|11789743|FG000|STARTED|Open-label||0
10631055|NCT02034162|11789744|FG001|STARTED|Open-label||0
10631056|NCT02034162|11789745|FG002|STARTED|Open-label||278
10631057|NCT02034162|11789743|FG000|COMPLETED|Open-label||0
10631058|NCT02034162|11789744|FG001|COMPLETED|Open-label||0
10631059|NCT02034162|11789745|FG002|COMPLETED|Open-label||278
10631060|NCT02034162|11789743|FG000|NOT COMPLETED|Open-label||0
10631061|NCT02034162|11789744|FG001|NOT COMPLETED|Open-label||0
10631062|NCT02034162|11789745|FG002|NOT COMPLETED|Open-label||0
10631063|NCT02034175|11789756|FG000|STARTED|Overall Study||190
10631064|NCT02034175|11789756|FG000|COMPLETED|Overall Study||190
10631065|NCT02034175|11789756|FG000|NOT COMPLETED|Overall Study||0
10631066|NCT02034409|11789762|FG000|STARTED|Sham Run-in Period||140
10631067|NCT02034409|11789763|FG001|STARTED|Sham Run-in Period|Number started is zero because there is no PLIUS arm in Sham Run-in Period|0
10631068|NCT02034409|11789762|FG000|COMPLETED|Sham Run-in Period||136
10631069|NCT02034409|11789763|FG001|COMPLETED|Sham Run-in Period|Number started is zero because there is no PLIUS arm in Sham Run-in Period|0
10631070|NCT02034409|11789762|FG000|NOT COMPLETED|Sham Run-in Period||4
10631071|NCT02034409|11789763|FG001|NOT COMPLETED|Sham Run-in Period||0
10631159|NCT02034591|11789847|FG005|STARTED|Overall Study||3
10631160|NCT02034591|11789842|FG000|COMPLETED|Overall Study||4
10631161|NCT02034591|11789843|FG001|COMPLETED|Overall Study||3
10631072|NCT02034409|11789762|FG000|STARTED|Sham-Controlled Treatment Period|Number started in Sham Arm of Sham-Controlled Treatment Period Milestone not equal to Sham Run-in Period Milestone because participants in this Milestone are randomly assigned to either Sham or PLIUS treatment arm.|67
10631073|NCT02034409|11789763|FG001|STARTED|Sham-Controlled Treatment Period|Number started in PLIUS Arm of Sham-Controlled Treatment Period Milestone not equal to Sham Run-in Period Milestone because participants in this Milestone are randomly assigned to either Sham or PLIUS treatment arm.|69
10631074|NCT02034409|11789762|FG000|COMPLETED|Sham-Controlled Treatment Period||55
10631075|NCT02034409|11789763|FG001|COMPLETED|Sham-Controlled Treatment Period||54
10631076|NCT02034409|11789762|FG000|NOT COMPLETED|Sham-Controlled Treatment Period||12
10631077|NCT02034409|11789763|FG001|NOT COMPLETED|Sham-Controlled Treatment Period||15
10631078|NCT02034435|11789771|FG000|STARTED|Overall Study||13
10631079|NCT02034435|11789772|FG001|STARTED|Overall Study||15
10631080|NCT02034435|11789773|FG002|STARTED|Overall Study||7
10631081|NCT02034435|11789774|FG003|STARTED|Overall Study||9
10631082|NCT02034435|11789771|FG000|Aim 1|Overall Study||13
10631083|NCT02034435|11789772|FG001|Aim 1|Overall Study||15
10631084|NCT02034435|11789773|FG002|Aim 1|Overall Study||0
10631085|NCT02034435|11789774|FG003|Aim 1|Overall Study||0
10631086|NCT02034435|11789771|FG000|Aim 2|Overall Study||0
10631087|NCT02034435|11789772|FG001|Aim 2|Overall Study||0
10631088|NCT02034435|11789773|FG002|Aim 2|Overall Study||7
10631089|NCT02034435|11789774|FG003|Aim 2|Overall Study||9
10631090|NCT02034435|11789771|FG000|COMPLETED|Overall Study||11
10631091|NCT02034435|11789772|FG001|COMPLETED|Overall Study||13
10631092|NCT02034435|11789773|FG002|COMPLETED|Overall Study||7
10631093|NCT02034435|11789774|FG003|COMPLETED|Overall Study||8
10631094|NCT02034435|11789771|FG000|NOT COMPLETED|Overall Study||2
10631095|NCT02034435|11789772|FG001|NOT COMPLETED|Overall Study||2
10631096|NCT02034435|11789773|FG002|NOT COMPLETED|Overall Study||0
10631097|NCT02034435|11789774|FG003|NOT COMPLETED|Overall Study||1
10631098|NCT02034474|11789786|FG000|STARTED|Overall Study||19
10631099|NCT02034474|11789787|FG001|STARTED|Overall Study||17
10631100|NCT02034474|11789786|FG000|1 Dose|Overall Study||2
10631101|NCT02034474|11789787|FG001|1 Dose|Overall Study||4
10631102|NCT02034474|11789786|FG000|2 Doses|Overall Study||2
10631103|NCT02034474|11789787|FG001|2 Doses|Overall Study||0
10631104|NCT02034474|11789786|FG000|3 Doses|Overall Study||15
10631105|NCT02034474|11789787|FG001|3 Doses|Overall Study||13
10631106|NCT02034474|11789786|FG000|COMPLETED|Overall Study||15
10631107|NCT02034474|11789787|FG001|COMPLETED|Overall Study||13
10631108|NCT02034474|11789786|FG000|NOT COMPLETED|Overall Study||4
10631109|NCT02034474|11789787|FG001|NOT COMPLETED|Overall Study||4
10631110|NCT02034513|11789797|FG000|STARTED|Overall Study||249
10631111|NCT02034513|11789798|FG001|STARTED|Overall Study||252
10631112|NCT02034513|11789797|FG000|Exposed|Overall Study||249
10631113|NCT02034513|11789798|FG001|Exposed|Overall Study||251
10631114|NCT02034513|11789797|FG000|COMPLETED|Overall Study||200
10631115|NCT02034513|11789798|FG001|COMPLETED|Overall Study||195
10631116|NCT02034513|11789797|FG000|NOT COMPLETED|Overall Study||49
10631117|NCT02034513|11789798|FG001|NOT COMPLETED|Overall Study||57
10631118|NCT02034552|11789809|FG000|STARTED|Overall Study||22
10631119|NCT02034552|11789810|FG001|STARTED|Overall Study||24
10631120|NCT02034552|11789811|FG002|STARTED|Overall Study||22
10631121|NCT02034552|11789809|FG000|Received Treatment|Overall Study||19
10631122|NCT02034552|11789810|FG001|Received Treatment|Overall Study||22
10631123|NCT02034552|11789811|FG002|Received Treatment|Overall Study||22
10631124|NCT02034552|11789809|FG000|COMPLETED|Overall Study||8
10631125|NCT02034552|11789810|FG001|COMPLETED|Overall Study||4
10631126|NCT02034552|11789811|FG002|COMPLETED|Overall Study||5
10631127|NCT02034552|11789809|FG000|NOT COMPLETED|Overall Study||14
10631128|NCT02034552|11789810|FG001|NOT COMPLETED|Overall Study||20
10631129|NCT02034552|11789811|FG002|NOT COMPLETED|Overall Study||17
10631130|NCT02034565|11789819|FG000|STARTED|Overall Study||7
10631131|NCT02034565|11789820|FG001|STARTED|Overall Study||7
10631132|NCT02034565|11789819|FG000|COMPLETED|Overall Study||6
10631133|NCT02034565|11789820|FG001|COMPLETED|Overall Study||7
10631134|NCT02034565|11789819|FG000|NOT COMPLETED|Overall Study||1
10631135|NCT02034565|11789820|FG001|NOT COMPLETED|Overall Study||0
10631136|NCT02034578|11789828|FG000|STARTED|Overall Study||4
10631137|NCT02034578|11789829|FG001|STARTED|Overall Study||3
10631138|NCT02034578|11789830|FG002|STARTED|Overall Study||4
10631139|NCT02034578|11789831|FG003|STARTED|Overall Study||3
10631140|NCT02034578|11789832|FG004|STARTED|Overall Study||4
10631141|NCT02034578|11789833|FG005|STARTED|Overall Study||3
10631142|NCT02034578|11789828|FG000|COMPLETED|Overall Study||4
10631143|NCT02034578|11789829|FG001|COMPLETED|Overall Study||3
10705531|NCT02600637|11869997|FG001|STARTED|Overall Study||18
10631144|NCT02034578|11789830|FG002|COMPLETED|Overall Study||4
10631145|NCT02034578|11789831|FG003|COMPLETED|Overall Study||3
10631146|NCT02034578|11789832|FG004|COMPLETED|Overall Study||4
10631147|NCT02034578|11789833|FG005|COMPLETED|Overall Study||3
10631148|NCT02034578|11789828|FG000|NOT COMPLETED|Overall Study||0
10631149|NCT02034578|11789829|FG001|NOT COMPLETED|Overall Study||0
10631150|NCT02034578|11789830|FG002|NOT COMPLETED|Overall Study||0
10631151|NCT02034578|11789831|FG003|NOT COMPLETED|Overall Study||0
10631152|NCT02034578|11789832|FG004|NOT COMPLETED|Overall Study||0
10631153|NCT02034578|11789833|FG005|NOT COMPLETED|Overall Study||0
10631154|NCT02034591|11789842|FG000|STARTED|Overall Study||4
10631155|NCT02034591|11789843|FG001|STARTED|Overall Study||3
10631156|NCT02034591|11789844|FG002|STARTED|Overall Study||4
10631157|NCT02034591|11789845|FG003|STARTED|Overall Study||3
10631158|NCT02034591|11789846|FG004|STARTED|Overall Study||4
10631162|NCT02034591|11789844|FG002|COMPLETED|Overall Study||4
10631163|NCT02034591|11789845|FG003|COMPLETED|Overall Study||3
10631164|NCT02034591|11789846|FG004|COMPLETED|Overall Study||3
10631165|NCT02034591|11789847|FG005|COMPLETED|Overall Study||3
10631166|NCT02034591|11789842|FG000|NOT COMPLETED|Overall Study||0
10631167|NCT02034591|11789843|FG001|NOT COMPLETED|Overall Study||0
10631168|NCT02034591|11789844|FG002|NOT COMPLETED|Overall Study||0
10631169|NCT02034591|11789845|FG003|NOT COMPLETED|Overall Study||0
10631170|NCT02034591|11789846|FG004|NOT COMPLETED|Overall Study||1
10631171|NCT02034591|11789847|FG005|NOT COMPLETED|Overall Study||0
10631172|NCT02034708|11789858|FG000|STARTED|First Contrast Agent Injection (1 Day)||138
10631173|NCT02034708|11789859|FG001|STARTED|First Contrast Agent Injection (1 Day)||130
10631174|NCT02034708|11789858|FG000|COMPLETED|First Contrast Agent Injection (1 Day)||138
10631175|NCT02034708|11789859|FG001|COMPLETED|First Contrast Agent Injection (1 Day)||130
10631176|NCT02034708|11789858|FG000|NOT COMPLETED|First Contrast Agent Injection (1 Day)||0
10631177|NCT02034708|11789859|FG001|NOT COMPLETED|First Contrast Agent Injection (1 Day)||0
10631178|NCT02034708|11789858|FG000|STARTED|Wash-out (From 2 Days up to 14 Days)||138
10631179|NCT02034708|11789859|FG001|STARTED|Wash-out (From 2 Days up to 14 Days)||130
10631180|NCT02034708|11789858|FG000|COMPLETED|Wash-out (From 2 Days up to 14 Days)||129
10631181|NCT02034708|11789859|FG001|COMPLETED|Wash-out (From 2 Days up to 14 Days)||120
10631182|NCT02034708|11789858|FG000|NOT COMPLETED|Wash-out (From 2 Days up to 14 Days)||9
10631183|NCT02034708|11789859|FG001|NOT COMPLETED|Wash-out (From 2 Days up to 14 Days)||10
10631184|NCT02034708|11789858|FG000|STARTED|Second Contrast Agent Injection (1 Day)||129
10631185|NCT02034708|11789859|FG001|STARTED|Second Contrast Agent Injection (1 Day)||120
10631186|NCT02034708|11789858|FG000|COMPLETED|Second Contrast Agent Injection (1 Day)||129
10631187|NCT02034708|11789859|FG001|COMPLETED|Second Contrast Agent Injection (1 Day)||120
10631188|NCT02034708|11789858|FG000|NOT COMPLETED|Second Contrast Agent Injection (1 Day)||0
10631189|NCT02034708|11789859|FG001|NOT COMPLETED|Second Contrast Agent Injection (1 Day)||0
10631190|NCT02034799|11789872|FG000|STARTED|Overall Study||129
10631191|NCT02034799|11789873|FG001|STARTED|Overall Study||127
10631192|NCT02034799|11789872|FG000|COMPLETED|Overall Study||127
10631193|NCT02034799|11789873|FG001|COMPLETED|Overall Study||123
10631194|NCT02034799|11789872|FG000|NOT COMPLETED|Overall Study||2
10631195|NCT02034799|11789873|FG001|NOT COMPLETED|Overall Study||4
10631196|NCT02034877|11789881|FG000|STARTED|Overall Study||200
10631197|NCT02034877|11789882|FG001|STARTED|Overall Study||999
10631198|NCT02034877|11789881|FG000|COMPLETED|Overall Study||200
10631199|NCT02034877|11789882|FG001|COMPLETED|Overall Study||993
10631200|NCT02034877|11789881|FG000|NOT COMPLETED|Overall Study||0
10631201|NCT02034877|11789882|FG001|NOT COMPLETED|Overall Study||6
10631202|NCT02034916|11789890|FG000|STARTED|Overall Study||49
10631203|NCT02034916|11789891|FG001|STARTED|Overall Study||35
10631204|NCT02034916|11789890|FG000|Treated|Overall Study||48
10631205|NCT02034916|11789891|FG001|Treated|Overall Study||35
10705532|NCT02600637|11869996|FG000|COMPLETED|Overall Study||14
10631206|NCT02034916|11789890|FG000|COMPLETED|Overall Study||0
10631207|NCT02034916|11789891|FG001|COMPLETED|Overall Study||0
10631208|NCT02034916|11789890|FG000|NOT COMPLETED|Overall Study||49
10631209|NCT02034916|11789891|FG001|NOT COMPLETED|Overall Study||35
10631210|NCT02035202|11789901|FG000|STARTED|Overall Study||85
10631211|NCT02035202|11789902|FG001|STARTED|Overall Study||85
10631212|NCT02035202|11789903|FG002|STARTED|Overall Study||85
10631213|NCT02035202|11789901|FG000|COMPLETED|Overall Study||77
10631214|NCT02035202|11789902|FG001|COMPLETED|Overall Study||69
10631215|NCT02035202|11789903|FG002|COMPLETED|Overall Study||83
10631216|NCT02035202|11789901|FG000|NOT COMPLETED|Overall Study||8
10631217|NCT02035202|11789902|FG001|NOT COMPLETED|Overall Study||16
10631218|NCT02035202|11789903|FG002|NOT COMPLETED|Overall Study||2
10631219|NCT02035267|11789915|FG000|STARTED|Overall Study||31
10631220|NCT02035267|11789916|FG001|STARTED|Overall Study||16
10631221|NCT02035267|11789917|FG002|STARTED|Overall Study||30
10631222|NCT02035267|11789918|FG003|STARTED|Overall Study||16
10631223|NCT02035267|11789915|FG000|COMPLETED|Overall Study||31
10631224|NCT02035267|11789916|FG001|COMPLETED|Overall Study||15
10631225|NCT02035267|11789917|FG002|COMPLETED|Overall Study||28
10631226|NCT02035267|11789918|FG003|COMPLETED|Overall Study||15
10631227|NCT02035267|11789915|FG000|NOT COMPLETED|Overall Study||0
10631228|NCT02035267|11789916|FG001|NOT COMPLETED|Overall Study||1
10631229|NCT02035267|11789917|FG002|NOT COMPLETED|Overall Study||2
10631230|NCT02035267|11789918|FG003|NOT COMPLETED|Overall Study||1
10631231|NCT02035332|11789930|FG000|STARTED|Overall Study|Treatment Attempted|21
10631232|NCT02035332|11789930|FG000|Treated|Overall Study|Treatment Completed|20
10631233|NCT02035332|11789930|FG000|COMPLETED|Overall Study|Completed 12 Month Follow-up|20
10631234|NCT02035332|11789930|FG000|NOT COMPLETED|Overall Study||1
10631235|NCT02035345|11789934|FG000|STARTED|Overall Study||15
10631236|NCT02035345|11789934|FG000|COMPLETED|Overall Study||15
10631237|NCT02035345|11789934|FG000|NOT COMPLETED|Overall Study||0
10631238|NCT02035475|11789939|FG000|STARTED|Overall Study|120 subjects were consented for participation in the study.|120
10631239|NCT02035475|11789939|FG000|COMPLETED|Overall Study|Six subjects did not complete the study due to withdrawal of consent.|114
10631240|NCT02035475|11789939|FG000|NOT COMPLETED|Overall Study||6
10631241|NCT02035553|11789947|FG000|STARTED|Overall Study||91
10631242|NCT02035553|11789948|FG001|STARTED|Overall Study||90
10631243|NCT02035553|11789947|FG000|COMPLETED|Overall Study||73
10631244|NCT02035553|11789948|FG001|COMPLETED|Overall Study||67
10631245|NCT02035553|11789947|FG000|NOT COMPLETED|Overall Study||18
10631246|NCT02035553|11789948|FG001|NOT COMPLETED|Overall Study||23
10631247|NCT02035696|11789958|FG000|STARTED|Overall Study||174
10631248|NCT02035696|11789959|FG001|STARTED|Overall Study||166
10631249|NCT02035696|11789960|FG002|STARTED|Overall Study||167
10631250|NCT02035696|11789961|FG003|STARTED|Overall Study||164
10631251|NCT02035696|11789958|FG000|COMPLETED|Overall Study||171
10631252|NCT02035696|11789959|FG001|COMPLETED|Overall Study||163
10631253|NCT02035696|11789960|FG002|COMPLETED|Overall Study||164
10631254|NCT02035696|11789961|FG003|COMPLETED|Overall Study||161
10631255|NCT02035696|11789958|FG000|NOT COMPLETED|Overall Study||3
10631256|NCT02035696|11789959|FG001|NOT COMPLETED|Overall Study||3
10631257|NCT02035696|11789960|FG002|NOT COMPLETED|Overall Study||3
10631258|NCT02035696|11789961|FG003|NOT COMPLETED|Overall Study||3
10631259|NCT02035748|11789975|FG000|STARTED|Overall Study||468
10631260|NCT02035748|11789975|FG000|COMPLETED|Overall Study||448
10631261|NCT02035748|11789975|FG000|NOT COMPLETED|Overall Study||20
10631262|NCT02036294|11789982|FG000|STARTED|Overall Study||120
10631263|NCT02036294|11789983|FG001|STARTED|Overall Study||120
10631264|NCT02036294|11789982|FG000|COMPLETED|Overall Study||111
10631265|NCT02036294|11789983|FG001|COMPLETED|Overall Study||109
10631266|NCT02036294|11789982|FG000|NOT COMPLETED|Overall Study||9
10631267|NCT02036294|11789983|FG001|NOT COMPLETED|Overall Study||11
10631268|NCT02036320|11789989|FG000|STARTED|Period 1||95
10631269|NCT02036320|11789990|FG001|STARTED|Period 1||95
10631270|NCT02036320|11789989|FG000|COMPLETED|Period 1||95
10631271|NCT02036320|11789990|FG001|COMPLETED|Period 1||95
10631272|NCT02036320|11789989|FG000|NOT COMPLETED|Period 1||0
10631273|NCT02036320|11789990|FG001|NOT COMPLETED|Period 1||0
10631274|NCT02036320|11789989|FG000|STARTED|Period 2||95
10631275|NCT02036320|11789990|FG001|STARTED|Period 2||95
10631276|NCT02036320|11789989|FG000|COMPLETED|Period 2||95
10631277|NCT02036320|11789990|FG001|COMPLETED|Period 2||95
10631278|NCT02036320|11789989|FG000|NOT COMPLETED|Period 2||0
10631279|NCT02036320|11789990|FG001|NOT COMPLETED|Period 2||0
10631280|NCT02036424|11789998|FG000|STARTED|Overall Study|23 study eyes, not number of subjects|23
10631281|NCT02036424|11789999|FG001|STARTED|Overall Study|27 study eyes, not number of subjects|27
10631282|NCT02036424|11789998|FG000|COMPLETED|Overall Study|23 study eyes, not number of subjects|23
10631283|NCT02036424|11789999|FG001|COMPLETED|Overall Study|27 study eyes, not number of subjects|27
10631284|NCT02036424|11789998|FG000|NOT COMPLETED|Overall Study||0
10631285|NCT02036424|11789999|FG001|NOT COMPLETED|Overall Study||0
10631286|NCT02036502|11790013|FG000|STARTED|Part 1:Dose Determination/Escalation||6
10631287|NCT02036502|11790014|FG001|STARTED|Part 1:Dose Determination/Escalation||4
10631288|NCT02036502|11790015|FG002|STARTED|Part 1:Dose Determination/Escalation||0
10631289|NCT02036502|11790016|FG003|STARTED|Part 1:Dose Determination/Escalation||0
10631290|NCT02036502|11790017|FG004|STARTED|Part 1:Dose Determination/Escalation||0
10631291|NCT02036502|11790018|FG005|STARTED|Part 1:Dose Determination/Escalation||0
10631292|NCT02036502|11790019|FG006|STARTED|Part 1:Dose Determination/Escalation||0
10631293|NCT02036502|11790020|FG007|STARTED|Part 1:Dose Determination/Escalation||0
10631294|NCT02036502|11790013|FG000|Treated|Part 1:Dose Determination/Escalation||6
10631295|NCT02036502|11790014|FG001|Treated|Part 1:Dose Determination/Escalation||3
10631296|NCT02036502|11790015|FG002|Treated|Part 1:Dose Determination/Escalation||0
10631297|NCT02036502|11790016|FG003|Treated|Part 1:Dose Determination/Escalation||0
10631298|NCT02036502|11790017|FG004|Treated|Part 1:Dose Determination/Escalation||0
10631299|NCT02036502|11790018|FG005|Treated|Part 1:Dose Determination/Escalation||0
10631300|NCT02036502|11790019|FG006|Treated|Part 1:Dose Determination/Escalation||0
10631301|NCT02036502|11790020|FG007|Treated|Part 1:Dose Determination/Escalation||0
10631302|NCT02036502|11790013|FG000|COMPLETED|Part 1:Dose Determination/Escalation||0
10631303|NCT02036502|11790014|FG001|COMPLETED|Part 1:Dose Determination/Escalation||0
10631304|NCT02036502|11790015|FG002|COMPLETED|Part 1:Dose Determination/Escalation||0
10631305|NCT02036502|11790016|FG003|COMPLETED|Part 1:Dose Determination/Escalation||0
10631306|NCT02036502|11790017|FG004|COMPLETED|Part 1:Dose Determination/Escalation||0
10631307|NCT02036502|11790018|FG005|COMPLETED|Part 1:Dose Determination/Escalation||0
10631308|NCT02036502|11790019|FG006|COMPLETED|Part 1:Dose Determination/Escalation||0
10631309|NCT02036502|11790020|FG007|COMPLETED|Part 1:Dose Determination/Escalation||0
10631310|NCT02036502|11790013|FG000|NOT COMPLETED|Part 1:Dose Determination/Escalation||6
10631311|NCT02036502|11790014|FG001|NOT COMPLETED|Part 1:Dose Determination/Escalation||4
10631312|NCT02036502|11790015|FG002|NOT COMPLETED|Part 1:Dose Determination/Escalation||0
10631313|NCT02036502|11790016|FG003|NOT COMPLETED|Part 1:Dose Determination/Escalation||0
10631314|NCT02036502|11790017|FG004|NOT COMPLETED|Part 1:Dose Determination/Escalation||0
10631315|NCT02036502|11790018|FG005|NOT COMPLETED|Part 1:Dose Determination/Escalation||0
10631316|NCT02036502|11790019|FG006|NOT COMPLETED|Part 1:Dose Determination/Escalation||0
10631317|NCT02036502|11790020|FG007|NOT COMPLETED|Part 1:Dose Determination/Escalation||0
10631318|NCT02036502|11790013|FG000|STARTED|Part 2:Dose Confirmation||0
10631319|NCT02036502|11790014|FG001|STARTED|Part 2:Dose Confirmation||0
10631320|NCT02036502|11790015|FG002|STARTED|Part 2:Dose Confirmation|Participants added to study for dose confirmation.|6
10631321|NCT02036502|11790016|FG003|STARTED|Part 2:Dose Confirmation|Participants added to study for dose confirmation.|2
10631322|NCT02036502|11790017|FG004|STARTED|Part 2:Dose Confirmation|Participants added to study for dose confirmation.|1
10631323|NCT02036502|11790018|FG005|STARTED|Part 2:Dose Confirmation||0
10631324|NCT02036502|11790019|FG006|STARTED|Part 2:Dose Confirmation||0
10631325|NCT02036502|11790020|FG007|STARTED|Part 2:Dose Confirmation||0
10631326|NCT02036502|11790013|FG000|Treated|Part 2:Dose Confirmation||0
10631327|NCT02036502|11790014|FG001|Treated|Part 2:Dose Confirmation||0
10631328|NCT02036502|11790015|FG002|Treated|Part 2:Dose Confirmation||6
10631329|NCT02036502|11790016|FG003|Treated|Part 2:Dose Confirmation||1
10631330|NCT02036502|11790017|FG004|Treated|Part 2:Dose Confirmation||1
10631331|NCT02036502|11790018|FG005|Treated|Part 2:Dose Confirmation||0
10631332|NCT02036502|11790019|FG006|Treated|Part 2:Dose Confirmation||0
10631333|NCT02036502|11790020|FG007|Treated|Part 2:Dose Confirmation||0
10631334|NCT02036502|11790013|FG000|COMPLETED|Part 2:Dose Confirmation||0
10631335|NCT02036502|11790014|FG001|COMPLETED|Part 2:Dose Confirmation||0
10631336|NCT02036502|11790015|FG002|COMPLETED|Part 2:Dose Confirmation||0
10631337|NCT02036502|11790016|FG003|COMPLETED|Part 2:Dose Confirmation||0
10631338|NCT02036502|11790017|FG004|COMPLETED|Part 2:Dose Confirmation||0
10631339|NCT02036502|11790018|FG005|COMPLETED|Part 2:Dose Confirmation||0
10631340|NCT02036502|11790019|FG006|COMPLETED|Part 2:Dose Confirmation||0
10631341|NCT02036502|11790020|FG007|COMPLETED|Part 2:Dose Confirmation||0
10631342|NCT02036502|11790013|FG000|NOT COMPLETED|Part 2:Dose Confirmation||0
10631343|NCT02036502|11790014|FG001|NOT COMPLETED|Part 2:Dose Confirmation||0
10631344|NCT02036502|11790015|FG002|NOT COMPLETED|Part 2:Dose Confirmation||6
10631345|NCT02036502|11790016|FG003|NOT COMPLETED|Part 2:Dose Confirmation||2
10631346|NCT02036502|11790017|FG004|NOT COMPLETED|Part 2:Dose Confirmation||1
10631347|NCT02036502|11790018|FG005|NOT COMPLETED|Part 2:Dose Confirmation||0
10631348|NCT02036502|11790019|FG006|NOT COMPLETED|Part 2:Dose Confirmation||0
10631349|NCT02036502|11790020|FG007|NOT COMPLETED|Part 2:Dose Confirmation||0
10631350|NCT02036502|11790013|FG000|STARTED|Part 3:Dose Expansion||0
10631351|NCT02036502|11790014|FG001|STARTED|Part 3:Dose Expansion||0
10631352|NCT02036502|11790015|FG002|STARTED|Part 3:Dose Expansion||0
10631353|NCT02036502|11790016|FG003|STARTED|Part 3:Dose Expansion||0
10631354|NCT02036502|11790017|FG004|STARTED|Part 3:Dose Expansion||0
10631355|NCT02036502|11790018|FG005|STARTED|Part 3:Dose Expansion|Participants added to study for dose expansion|47
10631356|NCT02036502|11790019|FG006|STARTED|Part 3:Dose Expansion|Participants added to study for dose expansion|1
10631357|NCT02036502|11790020|FG007|STARTED|Part 3:Dose Expansion|Participants added to study for dose expansion|10
10631358|NCT02036502|11790013|FG000|Treated|Part 3:Dose Expansion||0
10631359|NCT02036502|11790014|FG001|Treated|Part 3:Dose Expansion||0
10631360|NCT02036502|11790015|FG002|Treated|Part 3:Dose Expansion||0
10631361|NCT02036502|11790016|FG003|Treated|Part 3:Dose Expansion||0
10631362|NCT02036502|11790017|FG004|Treated|Part 3:Dose Expansion||0
10631363|NCT02036502|11790018|FG005|Treated|Part 3:Dose Expansion||45
10631364|NCT02036502|11790019|FG006|Treated|Part 3:Dose Expansion||1
10631365|NCT02036502|11790020|FG007|Treated|Part 3:Dose Expansion||10
10631366|NCT02036502|11790013|FG000|COMPLETED|Part 3:Dose Expansion||0
10631367|NCT02036502|11790014|FG001|COMPLETED|Part 3:Dose Expansion||0
10631368|NCT02036502|11790015|FG002|COMPLETED|Part 3:Dose Expansion||0
10631369|NCT02036502|11790016|FG003|COMPLETED|Part 3:Dose Expansion||0
10631370|NCT02036502|11790017|FG004|COMPLETED|Part 3:Dose Expansion||0
10631371|NCT02036502|11790018|FG005|COMPLETED|Part 3:Dose Expansion||0
10631372|NCT02036502|11790019|FG006|COMPLETED|Part 3:Dose Expansion||0
10631373|NCT02036502|11790020|FG007|COMPLETED|Part 3:Dose Expansion||0
10631374|NCT02036502|11790013|FG000|NOT COMPLETED|Part 3:Dose Expansion||0
10631375|NCT02036502|11790014|FG001|NOT COMPLETED|Part 3:Dose Expansion||0
10631376|NCT02036502|11790015|FG002|NOT COMPLETED|Part 3:Dose Expansion||0
10631377|NCT02036502|11790016|FG003|NOT COMPLETED|Part 3:Dose Expansion||0
10631378|NCT02036502|11790017|FG004|NOT COMPLETED|Part 3:Dose Expansion||0
10631379|NCT02036502|11790018|FG005|NOT COMPLETED|Part 3:Dose Expansion||47
10631380|NCT02036502|11790019|FG006|NOT COMPLETED|Part 3:Dose Expansion||1
10631381|NCT02036502|11790020|FG007|NOT COMPLETED|Part 3:Dose Expansion||10
10631382|NCT02036515|11790043|FG000|STARTED|Overall Study||156
10631383|NCT02036515|11790044|FG001|STARTED|Overall Study||155
10631384|NCT02036515|11790045|FG002|STARTED|Overall Study||153
10631385|NCT02036515|11790043|FG000|Treated|Overall Study||156
10631386|NCT02036515|11790044|FG001|Treated|Overall Study||153
10631387|NCT02036515|11790045|FG002|Treated|Overall Study||153
10631388|NCT02036515|11790043|FG000|COMPLETED|Overall Study||151
10631389|NCT02036515|11790044|FG001|COMPLETED|Overall Study||143
10631390|NCT02036515|11790045|FG002|COMPLETED|Overall Study||139
10631391|NCT02036515|11790043|FG000|NOT COMPLETED|Overall Study||5
10631392|NCT02036515|11790044|FG001|NOT COMPLETED|Overall Study||12
10631393|NCT02036515|11790045|FG002|NOT COMPLETED|Overall Study||14
10631394|NCT02036541|11790053|FG000|STARTED|Overall Study||65
10631395|NCT02036541|11790053|FG000|Completed Endpoint Visit|Overall Study||54
10631396|NCT02036541|11790053|FG000|COMPLETED|Overall Study||49
10631397|NCT02036541|11790053|FG000|NOT COMPLETED|Overall Study||16
10631398|NCT02036580|11790060|FG000|STARTED|Overall Study||8
10631399|NCT02036580|11790061|FG001|STARTED|Overall Study||8
10631400|NCT02036580|11790062|FG002|STARTED|Overall Study||4
10631401|NCT02036580|11790060|FG000|COMPLETED|Overall Study||7
10631402|NCT02036580|11790061|FG001|COMPLETED|Overall Study||7
10705533|NCT02600637|11869997|FG001|COMPLETED|Overall Study||13
10705534|NCT02600637|11869996|FG000|NOT COMPLETED|Overall Study||5
10705535|NCT02600637|11869997|FG001|NOT COMPLETED|Overall Study||5
10705536|NCT02600715|11870005|FG000|STARTED|Overall Study||13
10705537|NCT02600715|11870006|FG001|STARTED|Overall Study||13
10705538|NCT02600715|11870005|FG000|Allocated to Randomization|Overall Study||13
10705539|NCT02600715|11870006|FG001|Allocated to Randomization|Overall Study||13
10705540|NCT02600715|11870005|FG000|Received Treatment and Suppository|Overall Study||13
10705541|NCT02600715|11870006|FG001|Received Treatment and Suppository|Overall Study||13
10705542|NCT02600715|11870005|FG000|Completed 2-week Follow-up Appointment|Overall Study||13
10705543|NCT02600715|11870006|FG001|Completed 2-week Follow-up Appointment|Overall Study||12
10705544|NCT02600715|11870005|FG000|COMPLETED|Overall Study||13
10705545|NCT02600715|11870006|FG001|COMPLETED|Overall Study||13
10705546|NCT02600715|11870005|FG000|NOT COMPLETED|Overall Study||0
10705547|NCT02600715|11870006|FG001|NOT COMPLETED|Overall Study||0
10705548|NCT02600767|11870015|FG000|STARTED|Overall Study||79
10705549|NCT02600767|11870015|FG000|COMPLETED|Overall Study||74
10705550|NCT02600767|11870015|FG000|NOT COMPLETED|Overall Study||5
10705551|NCT02600819|11870019|FG000|STARTED|GEN Phase||55
10705552|NCT02600819|11870020|FG001|STARTED|GEN Phase||0
10705553|NCT02600819|11870019|FG000|COMPLETED|GEN Phase||39
10705554|NCT02600819|11870020|FG001|COMPLETED|GEN Phase||0
10631403|NCT02036580|11790062|FG002|COMPLETED|Overall Study||4
10631404|NCT02036580|11790060|FG000|NOT COMPLETED|Overall Study||1
10631405|NCT02036580|11790061|FG001|NOT COMPLETED|Overall Study||1
10631406|NCT02036580|11790062|FG002|NOT COMPLETED|Overall Study||0
10631407|NCT02036645|11790082|FG000|STARTED|SAD Cohorts : Study Part 1|Pooled across cohorts 1-5 (2 per cohort)|12
10631408|NCT02036645|11790083|FG001|STARTED|SAD Cohorts : Study Part 1||3
10631409|NCT02036645|11790084|FG002|STARTED|SAD Cohorts : Study Part 1||6
10631410|NCT02036645|11790085|FG003|STARTED|SAD Cohorts : Study Part 1||6
10631411|NCT02036645|11790086|FG004|STARTED|SAD Cohorts : Study Part 1||6
10631412|NCT02036645|11790087|FG005|STARTED|SAD Cohorts : Study Part 1||6
10631413|NCT02036645|11790088|FG006|STARTED|SAD Cohorts : Study Part 1||6
10631414|NCT02036645|11790089|FG007|STARTED|SAD Cohorts : Study Part 1||0
10631415|NCT02036645|11790090|FG008|STARTED|SAD Cohorts : Study Part 1||0
10705555|NCT02600819|11870019|FG000|NOT COMPLETED|GEN Phase||16
10705556|NCT02600819|11870020|FG001|NOT COMPLETED|GEN Phase||0
10705557|NCT02600819|11870019|FG000|STARTED|BVY OL Extension Phase|Only US participants were eligible to roll over into the Extension Phase per the study protocol.|0
10631416|NCT02036645|11790091|FG009|STARTED|SAD Cohorts : Study Part 1||0
10631417|NCT02036645|11790092|FG010|STARTED|SAD Cohorts : Study Part 1||0
10631418|NCT02036645|11790093|FG011|STARTED|SAD Cohorts : Study Part 1||0
10705558|NCT02600819|11870020|FG001|STARTED|BVY OL Extension Phase|Only US participants were eligible to roll over into the Extension Phase per the study protocol.|10
10705559|NCT02600819|11870019|FG000|COMPLETED|BVY OL Extension Phase||0
10705560|NCT02600819|11870020|FG001|COMPLETED|BVY OL Extension Phase||10
10705561|NCT02600819|11870019|FG000|NOT COMPLETED|BVY OL Extension Phase||0
10705562|NCT02600819|11870020|FG001|NOT COMPLETED|BVY OL Extension Phase||0
10631419|NCT02036645|11790082|FG000|COMPLETED|SAD Cohorts : Study Part 1||12
10631420|NCT02036645|11790083|FG001|COMPLETED|SAD Cohorts : Study Part 1||3
10631421|NCT02036645|11790084|FG002|COMPLETED|SAD Cohorts : Study Part 1||6
10631422|NCT02036645|11790085|FG003|COMPLETED|SAD Cohorts : Study Part 1||5
10631423|NCT02036645|11790086|FG004|COMPLETED|SAD Cohorts : Study Part 1||6
10631424|NCT02036645|11790087|FG005|COMPLETED|SAD Cohorts : Study Part 1||6
10705563|NCT02600845|11870026|FG000|STARTED|Overall Study||122
10705564|NCT02600845|11870026|FG000|COMPLETED|Overall Study||104
10705565|NCT02600845|11870026|FG000|NOT COMPLETED|Overall Study||18
10631425|NCT02036645|11790088|FG006|COMPLETED|SAD Cohorts : Study Part 1||5
10631426|NCT02036645|11790089|FG007|COMPLETED|SAD Cohorts : Study Part 1||0
10631427|NCT02036645|11790090|FG008|COMPLETED|SAD Cohorts : Study Part 1||0
10631428|NCT02036645|11790091|FG009|COMPLETED|SAD Cohorts : Study Part 1||0
10631429|NCT02036645|11790092|FG010|COMPLETED|SAD Cohorts : Study Part 1||0
10631430|NCT02036645|11790093|FG011|COMPLETED|SAD Cohorts : Study Part 1||0
10631431|NCT02036645|11790082|FG000|NOT COMPLETED|SAD Cohorts : Study Part 1||0
10631432|NCT02036645|11790083|FG001|NOT COMPLETED|SAD Cohorts : Study Part 1||0
10631433|NCT02036645|11790084|FG002|NOT COMPLETED|SAD Cohorts : Study Part 1||0
10631434|NCT02036645|11790085|FG003|NOT COMPLETED|SAD Cohorts : Study Part 1||1
10631435|NCT02036645|11790086|FG004|NOT COMPLETED|SAD Cohorts : Study Part 1||0
10631436|NCT02036645|11790087|FG005|NOT COMPLETED|SAD Cohorts : Study Part 1||0
10631437|NCT02036645|11790088|FG006|NOT COMPLETED|SAD Cohorts : Study Part 1||1
10631438|NCT02036645|11790089|FG007|NOT COMPLETED|SAD Cohorts : Study Part 1||0
10631439|NCT02036645|11790090|FG008|NOT COMPLETED|SAD Cohorts : Study Part 1||0
10631440|NCT02036645|11790091|FG009|NOT COMPLETED|SAD Cohorts : Study Part 1||0
10631441|NCT02036645|11790092|FG010|NOT COMPLETED|SAD Cohorts : Study Part 1||0
10631442|NCT02036645|11790093|FG011|NOT COMPLETED|SAD Cohorts : Study Part 1||0
10631443|NCT02036645|11790082|FG000|STARTED|MAD Cohorts: Study Part 2|Pooled across Cohorts 7 to 9 (2 per cohort)|0
10631444|NCT02036645|11790083|FG001|STARTED|MAD Cohorts: Study Part 2||0
10631445|NCT02036645|11790084|FG002|STARTED|MAD Cohorts: Study Part 2||0
10631446|NCT02036645|11790085|FG003|STARTED|MAD Cohorts: Study Part 2||0
10631447|NCT02036645|11790086|FG004|STARTED|MAD Cohorts: Study Part 2||0
10631448|NCT02036645|11790087|FG005|STARTED|MAD Cohorts: Study Part 2||0
10631449|NCT02036645|11790088|FG006|STARTED|MAD Cohorts: Study Part 2||0
10631450|NCT02036645|11790089|FG007|STARTED|MAD Cohorts: Study Part 2||8
10631451|NCT02036645|11790090|FG008|STARTED|MAD Cohorts: Study Part 2||6
10631452|NCT02036645|11790091|FG009|STARTED|MAD Cohorts: Study Part 2||6
10631453|NCT02036645|11790092|FG010|STARTED|MAD Cohorts: Study Part 2||6
10631454|NCT02036645|11790093|FG011|STARTED|MAD Cohorts: Study Part 2||6
10631455|NCT02036645|11790082|FG000|COMPLETED|MAD Cohorts: Study Part 2||0
10631456|NCT02036645|11790083|FG001|COMPLETED|MAD Cohorts: Study Part 2||0
10631457|NCT02036645|11790084|FG002|COMPLETED|MAD Cohorts: Study Part 2||0
10631458|NCT02036645|11790085|FG003|COMPLETED|MAD Cohorts: Study Part 2||0
10631459|NCT02036645|11790086|FG004|COMPLETED|MAD Cohorts: Study Part 2||0
10631460|NCT02036645|11790087|FG005|COMPLETED|MAD Cohorts: Study Part 2||0
10631461|NCT02036645|11790088|FG006|COMPLETED|MAD Cohorts: Study Part 2||0
10631462|NCT02036645|11790089|FG007|COMPLETED|MAD Cohorts: Study Part 2||8
10631463|NCT02036645|11790090|FG008|COMPLETED|MAD Cohorts: Study Part 2||6
10631464|NCT02036645|11790091|FG009|COMPLETED|MAD Cohorts: Study Part 2||6
10631465|NCT02036645|11790092|FG010|COMPLETED|MAD Cohorts: Study Part 2||6
10631466|NCT02036645|11790093|FG011|COMPLETED|MAD Cohorts: Study Part 2||6
10631467|NCT02036645|11790082|FG000|NOT COMPLETED|MAD Cohorts: Study Part 2||0
10631468|NCT02036645|11790083|FG001|NOT COMPLETED|MAD Cohorts: Study Part 2||0
10631469|NCT02036645|11790084|FG002|NOT COMPLETED|MAD Cohorts: Study Part 2||0
10631470|NCT02036645|11790085|FG003|NOT COMPLETED|MAD Cohorts: Study Part 2||0
10631471|NCT02036645|11790086|FG004|NOT COMPLETED|MAD Cohorts: Study Part 2||0
10631472|NCT02036645|11790087|FG005|NOT COMPLETED|MAD Cohorts: Study Part 2||0
10631473|NCT02036645|11790088|FG006|NOT COMPLETED|MAD Cohorts: Study Part 2||0
10631474|NCT02036645|11790089|FG007|NOT COMPLETED|MAD Cohorts: Study Part 2||0
10631475|NCT02036645|11790090|FG008|NOT COMPLETED|MAD Cohorts: Study Part 2||0
10631476|NCT02036645|11790091|FG009|NOT COMPLETED|MAD Cohorts: Study Part 2||0
10631477|NCT02036645|11790092|FG010|NOT COMPLETED|MAD Cohorts: Study Part 2||0
10631478|NCT02036645|11790093|FG011|NOT COMPLETED|MAD Cohorts: Study Part 2||0
10631479|NCT02036775|11790131|FG000|STARTED|Treatment Period 1 (6 Days)||4
10631480|NCT02036775|11790132|FG001|STARTED|Treatment Period 1 (6 Days)||4
10631481|NCT02036775|11790133|FG002|STARTED|Treatment Period 1 (6 Days)||4
10631482|NCT02036775|11790134|FG003|STARTED|Treatment Period 1 (6 Days)||4
10631483|NCT02036775|11790135|FG004|STARTED|Treatment Period 1 (6 Days)||4
10631484|NCT02036775|11790136|FG005|STARTED|Treatment Period 1 (6 Days)||4
10631485|NCT02036775|11790131|FG000|COMPLETED|Treatment Period 1 (6 Days)||4
10631486|NCT02036775|11790132|FG001|COMPLETED|Treatment Period 1 (6 Days)||4
10705566|NCT02600871|11870032|FG000|STARTED|Overall Study||52
10705567|NCT02600871|11870033|FG001|STARTED|Overall Study||49
10705568|NCT02600871|11870032|FG000|COMPLETED|Overall Study|51 subjects completed the 7-10 day follow up 39 subjects completed the 30-day follow up|39
10705569|NCT02600871|11870033|FG001|COMPLETED|Overall Study|45 subjects completed the 7-10 day follow up 39 subjects completed the 30-day follow up|39
10705570|NCT02600871|11870032|FG000|NOT COMPLETED|Overall Study||13
10705571|NCT02600871|11870033|FG001|NOT COMPLETED|Overall Study||10
10809136|NCT03836989|11971001|FG000|Subjects < 60 Years Old + Complete Paralysis > 15 Days|Overall Study||1
10631487|NCT02036775|11790133|FG002|COMPLETED|Treatment Period 1 (6 Days)||4
10631488|NCT02036775|11790134|FG003|COMPLETED|Treatment Period 1 (6 Days)||4
10631489|NCT02036775|11790135|FG004|COMPLETED|Treatment Period 1 (6 Days)||4
10631490|NCT02036775|11790136|FG005|COMPLETED|Treatment Period 1 (6 Days)||4
10631491|NCT02036775|11790131|FG000|NOT COMPLETED|Treatment Period 1 (6 Days)||0
10631492|NCT02036775|11790132|FG001|NOT COMPLETED|Treatment Period 1 (6 Days)||0
10631493|NCT02036775|11790133|FG002|NOT COMPLETED|Treatment Period 1 (6 Days)||0
10631494|NCT02036775|11790134|FG003|NOT COMPLETED|Treatment Period 1 (6 Days)||0
10631495|NCT02036775|11790135|FG004|NOT COMPLETED|Treatment Period 1 (6 Days)||0
10631496|NCT02036775|11790136|FG005|NOT COMPLETED|Treatment Period 1 (6 Days)||0
10631497|NCT02036775|11790131|FG000|STARTED|Treatment Period 2 (6 Days)||4
10631498|NCT02036775|11790132|FG001|STARTED|Treatment Period 2 (6 Days)||4
10631499|NCT02036775|11790133|FG002|STARTED|Treatment Period 2 (6 Days)||4
10631500|NCT02036775|11790134|FG003|STARTED|Treatment Period 2 (6 Days)||4
10631501|NCT02036775|11790135|FG004|STARTED|Treatment Period 2 (6 Days)||4
10631502|NCT02036775|11790136|FG005|STARTED|Treatment Period 2 (6 Days)||4
10631503|NCT02036775|11790131|FG000|COMPLETED|Treatment Period 2 (6 Days)||4
10631504|NCT02036775|11790132|FG001|COMPLETED|Treatment Period 2 (6 Days)||4
10631505|NCT02036775|11790133|FG002|COMPLETED|Treatment Period 2 (6 Days)||4
10631506|NCT02036775|11790134|FG003|COMPLETED|Treatment Period 2 (6 Days)||4
10631507|NCT02036775|11790135|FG004|COMPLETED|Treatment Period 2 (6 Days)||4
10631508|NCT02036775|11790136|FG005|COMPLETED|Treatment Period 2 (6 Days)||3
10631509|NCT02036775|11790131|FG000|NOT COMPLETED|Treatment Period 2 (6 Days)||0
10631510|NCT02036775|11790132|FG001|NOT COMPLETED|Treatment Period 2 (6 Days)||0
10631511|NCT02036775|11790133|FG002|NOT COMPLETED|Treatment Period 2 (6 Days)||0
10631512|NCT02036775|11790134|FG003|NOT COMPLETED|Treatment Period 2 (6 Days)||0
10631513|NCT02036775|11790135|FG004|NOT COMPLETED|Treatment Period 2 (6 Days)||0
10631514|NCT02036775|11790136|FG005|NOT COMPLETED|Treatment Period 2 (6 Days)||1
10631515|NCT02036775|11790131|FG000|STARTED|Treatment Period 3 (6 Days)||4
10631516|NCT02036775|11790132|FG001|STARTED|Treatment Period 3 (6 Days)||4
10631517|NCT02036775|11790133|FG002|STARTED|Treatment Period 3 (6 Days)||4
10631518|NCT02036775|11790134|FG003|STARTED|Treatment Period 3 (6 Days)||4
10631519|NCT02036775|11790135|FG004|STARTED|Treatment Period 3 (6 Days)||4
10631520|NCT02036775|11790136|FG005|STARTED|Treatment Period 3 (6 Days)||3
10631521|NCT02036775|11790131|FG000|COMPLETED|Treatment Period 3 (6 Days)||4
10631522|NCT02036775|11790132|FG001|COMPLETED|Treatment Period 3 (6 Days)||4
10631523|NCT02036775|11790133|FG002|COMPLETED|Treatment Period 3 (6 Days)||4
10631524|NCT02036775|11790134|FG003|COMPLETED|Treatment Period 3 (6 Days)||4
10631525|NCT02036775|11790135|FG004|COMPLETED|Treatment Period 3 (6 Days)||4
10631526|NCT02036775|11790136|FG005|COMPLETED|Treatment Period 3 (6 Days)||3
10631527|NCT02036775|11790131|FG000|NOT COMPLETED|Treatment Period 3 (6 Days)||0
10631528|NCT02036775|11790132|FG001|NOT COMPLETED|Treatment Period 3 (6 Days)||0
10631529|NCT02036775|11790133|FG002|NOT COMPLETED|Treatment Period 3 (6 Days)||0
10631530|NCT02036775|11790134|FG003|NOT COMPLETED|Treatment Period 3 (6 Days)||0
10631531|NCT02036775|11790135|FG004|NOT COMPLETED|Treatment Period 3 (6 Days)||0
10631532|NCT02036775|11790136|FG005|NOT COMPLETED|Treatment Period 3 (6 Days)||0
10631533|NCT02036840|11790144|FG000|STARTED|Overall Study||513
10631534|NCT02036840|11790144|FG000|COMPLETED|Overall Study||513
10631535|NCT02036840|11790144|FG000|NOT COMPLETED|Overall Study||0
10631536|NCT02036853|11790150|FG000|STARTED|Overall Study||6
10631537|NCT02036853|11790151|FG001|STARTED|Overall Study||14
10631538|NCT02036853|11790150|FG000|COMPLETED|Overall Study||6
10631539|NCT02036853|11790151|FG001|COMPLETED|Overall Study||8
10631540|NCT02036853|11790150|FG000|NOT COMPLETED|Overall Study||0
10631541|NCT02036853|11790151|FG001|NOT COMPLETED|Overall Study||6
10631542|NCT02037061|11790159|FG000|STARTED|Overall Study||22
10631543|NCT02037061|11790160|FG001|STARTED|Overall Study||24
10631544|NCT02037061|11790159|FG000|COMPLETED|Overall Study||22
10631545|NCT02037061|11790160|FG001|COMPLETED|Overall Study||24
10631546|NCT02037061|11790159|FG000|NOT COMPLETED|Overall Study||0
10631547|NCT02037061|11790160|FG001|NOT COMPLETED|Overall Study||0
10631548|NCT02037165|11790173|FG000|STARTED|Period 1 (2 Days)|randomized subjects|5
10631549|NCT02037165|11790174|FG001|STARTED|Period 1 (2 Days)|randomized subjects|5
10631550|NCT02037165|11790175|FG002|STARTED|Period 1 (2 Days)|randomized subjects|5
10631551|NCT02037165|11790176|FG003|STARTED|Period 1 (2 Days)|randomized subjects|5
10631552|NCT02037165|11790177|FG004|STARTED|Period 1 (2 Days)|randomized subjects|5
10631553|NCT02037165|11790173|FG000|COMPLETED|Period 1 (2 Days)||5
10631554|NCT02037165|11790174|FG001|COMPLETED|Period 1 (2 Days)||5
10631555|NCT02037165|11790175|FG002|COMPLETED|Period 1 (2 Days)||5
10631556|NCT02037165|11790176|FG003|COMPLETED|Period 1 (2 Days)||5
10631557|NCT02037165|11790177|FG004|COMPLETED|Period 1 (2 Days)||5
10631558|NCT02037165|11790173|FG000|NOT COMPLETED|Period 1 (2 Days)||0
10631559|NCT02037165|11790174|FG001|NOT COMPLETED|Period 1 (2 Days)||0
10631560|NCT02037165|11790175|FG002|NOT COMPLETED|Period 1 (2 Days)||0
10631561|NCT02037165|11790176|FG003|NOT COMPLETED|Period 1 (2 Days)||0
10631562|NCT02037165|11790177|FG004|NOT COMPLETED|Period 1 (2 Days)||0
10631563|NCT02037165|11790173|FG000|STARTED|Washout Period 1 (6 Days)||5
10631564|NCT02037165|11790174|FG001|STARTED|Washout Period 1 (6 Days)||5
10631565|NCT02037165|11790175|FG002|STARTED|Washout Period 1 (6 Days)||5
10631566|NCT02037165|11790176|FG003|STARTED|Washout Period 1 (6 Days)||5
10631567|NCT02037165|11790177|FG004|STARTED|Washout Period 1 (6 Days)||5
10631568|NCT02037165|11790173|FG000|COMPLETED|Washout Period 1 (6 Days)||5
10631569|NCT02037165|11790174|FG001|COMPLETED|Washout Period 1 (6 Days)||5
10631570|NCT02037165|11790175|FG002|COMPLETED|Washout Period 1 (6 Days)||5
10631571|NCT02037165|11790176|FG003|COMPLETED|Washout Period 1 (6 Days)||5
10631572|NCT02037165|11790177|FG004|COMPLETED|Washout Period 1 (6 Days)||5
10631573|NCT02037165|11790173|FG000|NOT COMPLETED|Washout Period 1 (6 Days)||0
10631574|NCT02037165|11790174|FG001|NOT COMPLETED|Washout Period 1 (6 Days)||0
10631575|NCT02037165|11790175|FG002|NOT COMPLETED|Washout Period 1 (6 Days)||0
10631576|NCT02037165|11790176|FG003|NOT COMPLETED|Washout Period 1 (6 Days)||0
10631577|NCT02037165|11790177|FG004|NOT COMPLETED|Washout Period 1 (6 Days)||0
10631578|NCT02037165|11790173|FG000|STARTED|Period 2 (2 Days)||5
10631579|NCT02037165|11790174|FG001|STARTED|Period 2 (2 Days)||5
10631580|NCT02037165|11790175|FG002|STARTED|Period 2 (2 Days)||5
10631581|NCT02037165|11790176|FG003|STARTED|Period 2 (2 Days)||5
10631582|NCT02037165|11790177|FG004|STARTED|Period 2 (2 Days)||5
10631583|NCT02037165|11790173|FG000|COMPLETED|Period 2 (2 Days)||5
10631584|NCT02037165|11790174|FG001|COMPLETED|Period 2 (2 Days)||5
10631585|NCT02037165|11790175|FG002|COMPLETED|Period 2 (2 Days)||5
10631586|NCT02037165|11790176|FG003|COMPLETED|Period 2 (2 Days)||5
10631587|NCT02037165|11790177|FG004|COMPLETED|Period 2 (2 Days)||5
10631588|NCT02037165|11790173|FG000|NOT COMPLETED|Period 2 (2 Days)||0
10631589|NCT02037165|11790174|FG001|NOT COMPLETED|Period 2 (2 Days)||0
10631590|NCT02037165|11790175|FG002|NOT COMPLETED|Period 2 (2 Days)||0
10631591|NCT02037165|11790176|FG003|NOT COMPLETED|Period 2 (2 Days)||0
10631592|NCT02037165|11790177|FG004|NOT COMPLETED|Period 2 (2 Days)||0
10631593|NCT02037165|11790173|FG000|STARTED|Washout Period 2 (6 Days)||5
10631594|NCT02037165|11790174|FG001|STARTED|Washout Period 2 (6 Days)||5
10631595|NCT02037165|11790175|FG002|STARTED|Washout Period 2 (6 Days)||5
10631596|NCT02037165|11790176|FG003|STARTED|Washout Period 2 (6 Days)||5
10631597|NCT02037165|11790177|FG004|STARTED|Washout Period 2 (6 Days)||5
10631598|NCT02037165|11790173|FG000|COMPLETED|Washout Period 2 (6 Days)||5
10631599|NCT02037165|11790174|FG001|COMPLETED|Washout Period 2 (6 Days)||5
10631600|NCT02037165|11790175|FG002|COMPLETED|Washout Period 2 (6 Days)||5
10631601|NCT02037165|11790176|FG003|COMPLETED|Washout Period 2 (6 Days)||5
10631602|NCT02037165|11790177|FG004|COMPLETED|Washout Period 2 (6 Days)||5
10631603|NCT02037165|11790173|FG000|NOT COMPLETED|Washout Period 2 (6 Days)||0
10631604|NCT02037165|11790174|FG001|NOT COMPLETED|Washout Period 2 (6 Days)||0
10631605|NCT02037165|11790175|FG002|NOT COMPLETED|Washout Period 2 (6 Days)||0
10631606|NCT02037165|11790176|FG003|NOT COMPLETED|Washout Period 2 (6 Days)||0
10631607|NCT02037165|11790177|FG004|NOT COMPLETED|Washout Period 2 (6 Days)||0
10631608|NCT02037165|11790173|FG000|STARTED|Period 3 (2 Days)||5
10631609|NCT02037165|11790174|FG001|STARTED|Period 3 (2 Days)||5
10631610|NCT02037165|11790175|FG002|STARTED|Period 3 (2 Days)||5
10631611|NCT02037165|11790176|FG003|STARTED|Period 3 (2 Days)||5
10631612|NCT02037165|11790177|FG004|STARTED|Period 3 (2 Days)||5
10631613|NCT02037165|11790173|FG000|COMPLETED|Period 3 (2 Days)||5
10631614|NCT02037165|11790174|FG001|COMPLETED|Period 3 (2 Days)||5
10631615|NCT02037165|11790175|FG002|COMPLETED|Period 3 (2 Days)||5
10631616|NCT02037165|11790176|FG003|COMPLETED|Period 3 (2 Days)||5
10631617|NCT02037165|11790177|FG004|COMPLETED|Period 3 (2 Days)||5
10631618|NCT02037165|11790173|FG000|NOT COMPLETED|Period 3 (2 Days)||0
10631619|NCT02037165|11790174|FG001|NOT COMPLETED|Period 3 (2 Days)||0
10631620|NCT02037165|11790175|FG002|NOT COMPLETED|Period 3 (2 Days)||0
10631621|NCT02037165|11790176|FG003|NOT COMPLETED|Period 3 (2 Days)||0
10631622|NCT02037165|11790177|FG004|NOT COMPLETED|Period 3 (2 Days)||0
10631623|NCT02037165|11790173|FG000|STARTED|Washout Period 3 (6 Days)||5
10631624|NCT02037165|11790174|FG001|STARTED|Washout Period 3 (6 Days)||5
10631625|NCT02037165|11790175|FG002|STARTED|Washout Period 3 (6 Days)||5
10631626|NCT02037165|11790176|FG003|STARTED|Washout Period 3 (6 Days)||5
10631627|NCT02037165|11790177|FG004|STARTED|Washout Period 3 (6 Days)||5
10631628|NCT02037165|11790173|FG000|COMPLETED|Washout Period 3 (6 Days)||5
10631629|NCT02037165|11790174|FG001|COMPLETED|Washout Period 3 (6 Days)||5
10631630|NCT02037165|11790175|FG002|COMPLETED|Washout Period 3 (6 Days)||5
10631631|NCT02037165|11790176|FG003|COMPLETED|Washout Period 3 (6 Days)||5
10631632|NCT02037165|11790177|FG004|COMPLETED|Washout Period 3 (6 Days)||5
10631633|NCT02037165|11790173|FG000|NOT COMPLETED|Washout Period 3 (6 Days)||0
10631634|NCT02037165|11790174|FG001|NOT COMPLETED|Washout Period 3 (6 Days)||0
10631635|NCT02037165|11790175|FG002|NOT COMPLETED|Washout Period 3 (6 Days)||0
10631636|NCT02037165|11790176|FG003|NOT COMPLETED|Washout Period 3 (6 Days)||0
10631637|NCT02037165|11790177|FG004|NOT COMPLETED|Washout Period 3 (6 Days)||0
10631638|NCT02037165|11790173|FG000|STARTED|Period 4 (2 Days)||5
10631639|NCT02037165|11790174|FG001|STARTED|Period 4 (2 Days)||5
10631640|NCT02037165|11790175|FG002|STARTED|Period 4 (2 Days)||5
10631641|NCT02037165|11790176|FG003|STARTED|Period 4 (2 Days)||5
10631642|NCT02037165|11790177|FG004|STARTED|Period 4 (2 Days)||5
10631643|NCT02037165|11790173|FG000|COMPLETED|Period 4 (2 Days)||5
10631644|NCT02037165|11790174|FG001|COMPLETED|Period 4 (2 Days)||5
10631645|NCT02037165|11790175|FG002|COMPLETED|Period 4 (2 Days)||5
10631646|NCT02037165|11790176|FG003|COMPLETED|Period 4 (2 Days)||5
10631647|NCT02037165|11790177|FG004|COMPLETED|Period 4 (2 Days)||5
10631648|NCT02037165|11790173|FG000|NOT COMPLETED|Period 4 (2 Days)||0
10631649|NCT02037165|11790174|FG001|NOT COMPLETED|Period 4 (2 Days)||0
10631650|NCT02037165|11790175|FG002|NOT COMPLETED|Period 4 (2 Days)||0
10631651|NCT02037165|11790176|FG003|NOT COMPLETED|Period 4 (2 Days)||0
10631652|NCT02037165|11790177|FG004|NOT COMPLETED|Period 4 (2 Days)||0
10631653|NCT02037165|11790173|FG000|STARTED|Washout Period 4 (6 Days)||5
10631654|NCT02037165|11790174|FG001|STARTED|Washout Period 4 (6 Days)||5
10631655|NCT02037165|11790175|FG002|STARTED|Washout Period 4 (6 Days)||5
10631656|NCT02037165|11790176|FG003|STARTED|Washout Period 4 (6 Days)||5
10631657|NCT02037165|11790177|FG004|STARTED|Washout Period 4 (6 Days)||5
10631658|NCT02037165|11790173|FG000|COMPLETED|Washout Period 4 (6 Days)||5
10631659|NCT02037165|11790174|FG001|COMPLETED|Washout Period 4 (6 Days)||5
10705572|NCT02601001|11870043|FG000|STARTED|Dosing Period 1||10
10705573|NCT02601001|11870044|FG001|STARTED|Dosing Period 1||20
10705574|NCT02601001|11870045|FG002|STARTED|Dosing Period 1||20
10705575|NCT02601001|11870046|FG003|STARTED|Dosing Period 1||0
10705576|NCT02601001|11870047|FG004|STARTED|Dosing Period 1||0
10705577|NCT02601001|11870048|FG005|STARTED|Dosing Period 1||0
10705578|NCT02601001|11870049|FG006|STARTED|Dosing Period 1||0
10705579|NCT02601001|11870043|FG000|COMPLETED|Dosing Period 1||10
10705580|NCT02601001|11870044|FG001|COMPLETED|Dosing Period 1||20
10705581|NCT02601001|11870045|FG002|COMPLETED|Dosing Period 1||20
10705582|NCT02601001|11870046|FG003|COMPLETED|Dosing Period 1||0
10705583|NCT02601001|11870047|FG004|COMPLETED|Dosing Period 1||0
10705584|NCT02601001|11870048|FG005|COMPLETED|Dosing Period 1||0
10705585|NCT02601001|11870049|FG006|COMPLETED|Dosing Period 1||0
10705586|NCT02601001|11870043|FG000|NOT COMPLETED|Dosing Period 1||0
10631660|NCT02037165|11790175|FG002|COMPLETED|Washout Period 4 (6 Days)||5
10631661|NCT02037165|11790176|FG003|COMPLETED|Washout Period 4 (6 Days)||5
10631662|NCT02037165|11790177|FG004|COMPLETED|Washout Period 4 (6 Days)||4
10631663|NCT02037165|11790173|FG000|NOT COMPLETED|Washout Period 4 (6 Days)||0
10631664|NCT02037165|11790174|FG001|NOT COMPLETED|Washout Period 4 (6 Days)||0
10631665|NCT02037165|11790175|FG002|NOT COMPLETED|Washout Period 4 (6 Days)||0
10631666|NCT02037165|11790176|FG003|NOT COMPLETED|Washout Period 4 (6 Days)||0
10631667|NCT02037165|11790177|FG004|NOT COMPLETED|Washout Period 4 (6 Days)||1
10631668|NCT02037165|11790173|FG000|STARTED|Period 5 (2 Days)||5
10631669|NCT02037165|11790174|FG001|STARTED|Period 5 (2 Days)||5
10631670|NCT02037165|11790175|FG002|STARTED|Period 5 (2 Days)||5
10631671|NCT02037165|11790176|FG003|STARTED|Period 5 (2 Days)||5
10631672|NCT02037165|11790177|FG004|STARTED|Period 5 (2 Days)||4
10631673|NCT02037165|11790173|FG000|COMPLETED|Period 5 (2 Days)||5
10631674|NCT02037165|11790174|FG001|COMPLETED|Period 5 (2 Days)||5
10631675|NCT02037165|11790175|FG002|COMPLETED|Period 5 (2 Days)||5
10631676|NCT02037165|11790176|FG003|COMPLETED|Period 5 (2 Days)||5
10631677|NCT02037165|11790177|FG004|COMPLETED|Period 5 (2 Days)||4
10631678|NCT02037165|11790173|FG000|NOT COMPLETED|Period 5 (2 Days)||0
10631679|NCT02037165|11790174|FG001|NOT COMPLETED|Period 5 (2 Days)||0
10631680|NCT02037165|11790175|FG002|NOT COMPLETED|Period 5 (2 Days)||0
10631681|NCT02037165|11790176|FG003|NOT COMPLETED|Period 5 (2 Days)||0
10631682|NCT02037165|11790177|FG004|NOT COMPLETED|Period 5 (2 Days)||0
10631683|NCT02037204|11790193|FG000|STARTED|Overall Study||35
10631684|NCT02037204|11790193|FG000|COMPLETED|Overall Study||35
10631685|NCT02037204|11790193|FG000|NOT COMPLETED|Overall Study||0
10631686|NCT02037230|11790202|FG000|STARTED|Overall Study||1
10631687|NCT02037230|11790203|FG001|STARTED|Overall Study||13
10631688|NCT02037230|11790204|FG002|STARTED|Overall Study||9
10631689|NCT02037230|11790205|FG003|STARTED|Overall Study||11
10631690|NCT02037230|11790202|FG000|Completed 4 Cycles of Treatment|Overall Study||1
10631691|NCT02037230|11790203|FG001|Completed 4 Cycles of Treatment|Overall Study||9
10631692|NCT02037230|11790204|FG002|Completed 4 Cycles of Treatment|Overall Study||7
10631693|NCT02037230|11790205|FG003|Completed 4 Cycles of Treatment|Overall Study||9
10631694|NCT02037230|11790202|FG000|COMPLETED|Overall Study||0
10631695|NCT02037230|11790203|FG001|COMPLETED|Overall Study||7
10631696|NCT02037230|11790204|FG002|COMPLETED|Overall Study||3
10631697|NCT02037230|11790205|FG003|COMPLETED|Overall Study||5
10631698|NCT02037230|11790202|FG000|NOT COMPLETED|Overall Study||1
10631699|NCT02037230|11790203|FG001|NOT COMPLETED|Overall Study||6
10631700|NCT02037230|11790204|FG002|NOT COMPLETED|Overall Study||6
10631701|NCT02037230|11790205|FG003|NOT COMPLETED|Overall Study||6
10631702|NCT02037256|11790218|FG000|STARTED|Overall Study||3
10631703|NCT02037256|11790219|FG001|STARTED|Overall Study||20
10631704|NCT02037256|11790218|FG000|COMPLETED|Overall Study||3
10631705|NCT02037256|11790219|FG001|COMPLETED|Overall Study||17
10631706|NCT02037256|11790218|FG000|NOT COMPLETED|Overall Study||0
10631707|NCT02037256|11790219|FG001|NOT COMPLETED|Overall Study||3
10631708|NCT02037295|11790231|FG000|STARTED|Phase 1: Crossover UF and OF||9
10631709|NCT02037295|11790232|FG001|STARTED|Phase 1: Crossover UF and OF||7
10631710|NCT02037295|11790233|FG002|STARTED|Phase 1: Crossover UF and OF||4
10631711|NCT02037295|11790234|FG003|STARTED|Phase 1: Crossover UF and OF||7
10631712|NCT02037295|11790231|FG000|COMPLETED|Phase 1: Crossover UF and OF||9
10631713|NCT02037295|11790232|FG001|COMPLETED|Phase 1: Crossover UF and OF||7
10631714|NCT02037295|11790233|FG002|COMPLETED|Phase 1: Crossover UF and OF||4
10631715|NCT02037295|11790234|FG003|COMPLETED|Phase 1: Crossover UF and OF||7
10705587|NCT02601001|11870044|FG001|NOT COMPLETED|Dosing Period 1||0
10705588|NCT02601001|11870045|FG002|NOT COMPLETED|Dosing Period 1||0
10631716|NCT02037295|11790231|FG000|NOT COMPLETED|Phase 1: Crossover UF and OF||0
10705589|NCT02601001|11870046|FG003|NOT COMPLETED|Dosing Period 1||0
10631717|NCT02037295|11790232|FG001|NOT COMPLETED|Phase 1: Crossover UF and OF||0
10631718|NCT02037295|11790233|FG002|NOT COMPLETED|Phase 1: Crossover UF and OF||0
10631719|NCT02037295|11790234|FG003|NOT COMPLETED|Phase 1: Crossover UF and OF||0
10631720|NCT02037295|11790231|FG000|STARTED|Phase 2: Vancomycin and Placebo||9
10705590|NCT02601001|11870047|FG004|NOT COMPLETED|Dosing Period 1||0
10705591|NCT02601001|11870048|FG005|NOT COMPLETED|Dosing Period 1||0
10631721|NCT02037295|11790232|FG001|STARTED|Phase 2: Vancomycin and Placebo||7
10631722|NCT02037295|11790233|FG002|STARTED|Phase 2: Vancomycin and Placebo||4
10631723|NCT02037295|11790234|FG003|STARTED|Phase 2: Vancomycin and Placebo||7
10631724|NCT02037295|11790231|FG000|COMPLETED|Phase 2: Vancomycin and Placebo||8
10631725|NCT02037295|11790232|FG001|COMPLETED|Phase 2: Vancomycin and Placebo||7
10631726|NCT02037295|11790233|FG002|COMPLETED|Phase 2: Vancomycin and Placebo||4
10631727|NCT02037295|11790234|FG003|COMPLETED|Phase 2: Vancomycin and Placebo||6
10631728|NCT02037295|11790231|FG000|NOT COMPLETED|Phase 2: Vancomycin and Placebo||1
10631729|NCT02037295|11790232|FG001|NOT COMPLETED|Phase 2: Vancomycin and Placebo||0
10631730|NCT02037295|11790233|FG002|NOT COMPLETED|Phase 2: Vancomycin and Placebo||0
10631731|NCT02037295|11790234|FG003|NOT COMPLETED|Phase 2: Vancomycin and Placebo||1
10631732|NCT02037347|11790246|FG000|STARTED|Overall Study||1
10631733|NCT02037347|11790246|FG000|COMPLETED|Overall Study||1
10631734|NCT02037347|11790246|FG000|NOT COMPLETED|Overall Study||0
10631735|NCT02037425|11790250|FG000|STARTED|Overall Study||44
10631736|NCT02037425|11790250|FG000|Randomized to Treatment|Overall Study||32
10631737|NCT02037425|11790250|FG000|COMPLETED|Overall Study||18
10631738|NCT02037425|11790250|FG000|NOT COMPLETED|Overall Study||26
10631739|NCT02037438|11790258|FG000|STARTED|Overall Study||920
10631740|NCT02037438|11790259|FG001|STARTED|Overall Study||916
10631741|NCT02037438|11790258|FG000|COMPLETED|Overall Study||574
10631742|NCT02037438|11790259|FG001|COMPLETED|Overall Study||561
10631743|NCT02037438|11790258|FG000|NOT COMPLETED|Overall Study||346
10631744|NCT02037438|11790259|FG001|NOT COMPLETED|Overall Study||355
10631745|NCT02037477|11790269|FG000|STARTED|Treatment Period 1||5
10631746|NCT02037477|11790270|FG001|STARTED|Treatment Period 1||5
10631747|NCT02037477|11790271|FG002|STARTED|Treatment Period 1||5
10631748|NCT02037477|11790272|FG003|STARTED|Treatment Period 1||5
10631749|NCT02037477|11790269|FG000|COMPLETED|Treatment Period 1||5
10631750|NCT02037477|11790270|FG001|COMPLETED|Treatment Period 1||5
10631751|NCT02037477|11790271|FG002|COMPLETED|Treatment Period 1||4
10631752|NCT02037477|11790272|FG003|COMPLETED|Treatment Period 1||5
10631753|NCT02037477|11790269|FG000|NOT COMPLETED|Treatment Period 1||0
10631754|NCT02037477|11790270|FG001|NOT COMPLETED|Treatment Period 1||0
10631755|NCT02037477|11790271|FG002|NOT COMPLETED|Treatment Period 1||1
10631756|NCT02037477|11790272|FG003|NOT COMPLETED|Treatment Period 1||0
10631757|NCT02037477|11790269|FG000|STARTED|Treatment Period 2||5
10631758|NCT02037477|11790270|FG001|STARTED|Treatment Period 2||5
10631759|NCT02037477|11790271|FG002|STARTED|Treatment Period 2||4
10631760|NCT02037477|11790272|FG003|STARTED|Treatment Period 2||5
10631761|NCT02037477|11790269|FG000|COMPLETED|Treatment Period 2||5
10631762|NCT02037477|11790270|FG001|COMPLETED|Treatment Period 2||5
10631763|NCT02037477|11790271|FG002|COMPLETED|Treatment Period 2||4
10631764|NCT02037477|11790272|FG003|COMPLETED|Treatment Period 2||5
10631765|NCT02037477|11790269|FG000|NOT COMPLETED|Treatment Period 2||0
10631766|NCT02037477|11790270|FG001|NOT COMPLETED|Treatment Period 2||0
10631767|NCT02037477|11790271|FG002|NOT COMPLETED|Treatment Period 2||0
10631768|NCT02037477|11790272|FG003|NOT COMPLETED|Treatment Period 2||0
10631769|NCT02037555|11790284|FG000|STARTED|Overall Study||213
10631770|NCT02037555|11790285|FG001|STARTED|Overall Study||212
10631771|NCT02037555|11790284|FG000|Dosed|Overall Study||201
10631772|NCT02037555|11790285|FG001|Dosed|Overall Study||198
10631773|NCT02037555|11790284|FG000|Dosed and Operated On|Overall Study||200
10631774|NCT02037555|11790285|FG001|Dosed and Operated On|Overall Study||196
10631775|NCT02037555|11790284|FG000|COMPLETED|Overall Study||190
10631776|NCT02037555|11790285|FG001|COMPLETED|Overall Study||191
10631777|NCT02037555|11790284|FG000|NOT COMPLETED|Overall Study||23
10631778|NCT02037555|11790285|FG001|NOT COMPLETED|Overall Study||21
10631779|NCT02037568|11790293|FG000|STARTED|Overall Study||83
10631780|NCT02037568|11790294|FG001|STARTED|Overall Study||76
10631781|NCT02037568|11790293|FG000|Month 1.5 (Post Transplantation)|Overall Study||79
10631782|NCT02037568|11790294|FG001|Month 1.5 (Post Transplantation)|Overall Study||76
10631783|NCT02037568|11790293|FG000|Month 3 (Post Transplantation)|Overall Study||66
10631784|NCT02037568|11790294|FG001|Month 3 (Post Transplantation)|Overall Study||62
10631785|NCT02037568|11790293|FG000|Month 6 (Post Transplantation)|Overall Study||63
10631786|NCT02037568|11790294|FG001|Month 6 (Post Transplantation)|Overall Study||52
10631787|NCT02037568|11790293|FG000|COMPLETED|Overall Study||47
10631788|NCT02037568|11790294|FG001|COMPLETED|Overall Study||37
10631789|NCT02037568|11790293|FG000|NOT COMPLETED|Overall Study||36
10631790|NCT02037568|11790294|FG001|NOT COMPLETED|Overall Study||39
10631791|NCT02037607|11790300|FG000|STARTED|Overall Study||100
10631792|NCT02037607|11790300|FG000|COMPLETED|Overall Study||91
10631793|NCT02037607|11790300|FG000|NOT COMPLETED|Overall Study||9
10631794|NCT02037776|11790306|FG000|STARTED|Overall Study||61
10631795|NCT02037776|11790307|FG001|STARTED|Overall Study||64
10631796|NCT02037776|11790306|FG000|COMPLETED|Overall Study||56
10631797|NCT02037776|11790307|FG001|COMPLETED|Overall Study||60
10631798|NCT02037776|11790306|FG000|NOT COMPLETED|Overall Study||5
10631799|NCT02037776|11790307|FG001|NOT COMPLETED|Overall Study||4
10631800|NCT02037893|11790317|FG000|STARTED|Overall Study||32
10631801|NCT02037893|11790318|FG001|STARTED|Overall Study||25
10631802|NCT02037893|11790319|FG002|STARTED|Overall Study||27
10631803|NCT02037893|11790320|FG003|STARTED|Overall Study||28
10631804|NCT02037893|11790317|FG000|COMPLETED|Overall Study||32
10631805|NCT02037893|11790318|FG001|COMPLETED|Overall Study||25
10631806|NCT02037893|11790319|FG002|COMPLETED|Overall Study||26
10631807|NCT02037893|11790320|FG003|COMPLETED|Overall Study||28
10631808|NCT02037893|11790317|FG000|NOT COMPLETED|Overall Study||0
10631809|NCT02037893|11790318|FG001|NOT COMPLETED|Overall Study||0
10631810|NCT02037893|11790319|FG002|NOT COMPLETED|Overall Study||1
10631811|NCT02037893|11790320|FG003|NOT COMPLETED|Overall Study||0
10631812|NCT02037984|11790338|FG000|STARTED|Overall Study||20
10631813|NCT02037984|11790339|FG001|STARTED|Overall Study||20
10631814|NCT02037984|11790340|FG002|STARTED|Overall Study||50
10631815|NCT02037984|11790341|FG003|STARTED|Overall Study||51
10631816|NCT02037984|11790342|FG004|STARTED|Overall Study||50
10631817|NCT02037984|11790343|FG005|STARTED|Overall Study||49
10631818|NCT02037984|11790344|FG006|STARTED|Overall Study||50
10631819|NCT02037984|11790345|FG007|STARTED|Overall Study||51
10631820|NCT02037984|11790338|FG000|COMPLETED|Overall Study||19
10631821|NCT02037984|11790339|FG001|COMPLETED|Overall Study||20
10631822|NCT02037984|11790340|FG002|COMPLETED|Overall Study||38
10631823|NCT02037984|11790341|FG003|COMPLETED|Overall Study||30
10631824|NCT02037984|11790342|FG004|COMPLETED|Overall Study||38
10631825|NCT02037984|11790343|FG005|COMPLETED|Overall Study||37
10631826|NCT02037984|11790344|FG006|COMPLETED|Overall Study||33
10631827|NCT02037984|11790345|FG007|COMPLETED|Overall Study||39
10631828|NCT02037984|11790338|FG000|NOT COMPLETED|Overall Study||1
10631829|NCT02037984|11790339|FG001|NOT COMPLETED|Overall Study||0
10631830|NCT02037984|11790340|FG002|NOT COMPLETED|Overall Study||12
10631831|NCT02037984|11790341|FG003|NOT COMPLETED|Overall Study||21
10631832|NCT02037984|11790342|FG004|NOT COMPLETED|Overall Study||12
10631833|NCT02037984|11790343|FG005|NOT COMPLETED|Overall Study||12
10631834|NCT02037984|11790344|FG006|NOT COMPLETED|Overall Study||17
10631835|NCT02037984|11790345|FG007|NOT COMPLETED|Overall Study||12
10631836|NCT02038010|11790373|FG000|STARTED|Completed 1st Cycle and Started Cycle 2||11
10631837|NCT02038010|11790374|FG001|STARTED|Completed 1st Cycle and Started Cycle 2||6
10631838|NCT02038010|11790375|FG002|STARTED|Completed 1st Cycle and Started Cycle 2|Due to safety data, dose was de-escalated and no patients enrolled at this dose.|0
10631839|NCT02038010|11790376|FG003|STARTED|Completed 1st Cycle and Started Cycle 2|Due to safety data, dose was de-escalated and no patients enrolled at this dose.|0
10631840|NCT02038010|11790373|FG000|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||11
10631841|NCT02038010|11790374|FG001|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||5
10631842|NCT02038010|11790375|FG002|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||0
10631843|NCT02038010|11790376|FG003|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||0
10631844|NCT02038010|11790373|FG000|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||10
10631845|NCT02038010|11790374|FG001|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||4
10631846|NCT02038010|11790375|FG002|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||0
10631847|NCT02038010|11790376|FG003|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||0
10631848|NCT02038010|11790373|FG000|COMPLETED|Completed 1st Cycle and Started Cycle 2||10
10631849|NCT02038010|11790374|FG001|COMPLETED|Completed 1st Cycle and Started Cycle 2||4
10631850|NCT02038010|11790375|FG002|COMPLETED|Completed 1st Cycle and Started Cycle 2||0
10631851|NCT02038010|11790376|FG003|COMPLETED|Completed 1st Cycle and Started Cycle 2||0
10631852|NCT02038010|11790373|FG000|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||1
10631853|NCT02038010|11790374|FG001|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||2
10631854|NCT02038010|11790375|FG002|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||0
10631855|NCT02038010|11790376|FG003|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||0
10631856|NCT02038010|11790373|FG000|STARTED|Completed 3 Cycles/Reached 1st Response||10
10631857|NCT02038010|11790374|FG001|STARTED|Completed 3 Cycles/Reached 1st Response||4
10631858|NCT02038010|11790375|FG002|STARTED|Completed 3 Cycles/Reached 1st Response||0
10631859|NCT02038010|11790376|FG003|STARTED|Completed 3 Cycles/Reached 1st Response||0
10631860|NCT02038010|11790373|FG000|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||10
10631861|NCT02038010|11790374|FG001|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||4
10631862|NCT02038010|11790375|FG002|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||0
10631863|NCT02038010|11790376|FG003|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||0
10631864|NCT02038010|11790373|FG000|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||9
10631865|NCT02038010|11790374|FG001|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||3
10631866|NCT02038010|11790375|FG002|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||0
10631867|NCT02038010|11790376|FG003|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||0
10631868|NCT02038010|11790373|FG000|COMPLETED|Completed 3 Cycles/Reached 1st Response||9
10631869|NCT02038010|11790374|FG001|COMPLETED|Completed 3 Cycles/Reached 1st Response||3
10631870|NCT02038010|11790375|FG002|COMPLETED|Completed 3 Cycles/Reached 1st Response||0
10631871|NCT02038010|11790376|FG003|COMPLETED|Completed 3 Cycles/Reached 1st Response||0
10631872|NCT02038010|11790373|FG000|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||1
10631873|NCT02038010|11790374|FG001|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||1
10631874|NCT02038010|11790375|FG002|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||0
10631875|NCT02038010|11790376|FG003|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||0
10631876|NCT02038010|11790373|FG000|STARTED|Follow Up||11
10631877|NCT02038010|11790374|FG001|STARTED|Follow Up||6
10631878|NCT02038010|11790375|FG002|STARTED|Follow Up||0
10705592|NCT02601001|11870049|FG006|NOT COMPLETED|Dosing Period 1||0
10705593|NCT02601001|11870043|FG000|STARTED|Dosing Period 2||10
10705594|NCT02601001|11870044|FG001|STARTED|Dosing Period 2||0
10631879|NCT02038010|11790376|FG003|STARTED|Follow Up||0
10631880|NCT02038010|11790373|FG000|COMPLETED|Follow Up||4
10631881|NCT02038010|11790374|FG001|COMPLETED|Follow Up||3
10631882|NCT02038010|11790375|FG002|COMPLETED|Follow Up||0
10705595|NCT02601001|11870045|FG002|STARTED|Dosing Period 2||0
10631883|NCT02038010|11790376|FG003|COMPLETED|Follow Up||0
10631884|NCT02038010|11790373|FG000|NOT COMPLETED|Follow Up||7
10631885|NCT02038010|11790374|FG001|NOT COMPLETED|Follow Up||3
10631886|NCT02038010|11790375|FG002|NOT COMPLETED|Follow Up||0
10631887|NCT02038010|11790376|FG003|NOT COMPLETED|Follow Up||0
10631888|NCT02038023|11790384|FG000|STARTED|Overall Study||74
10631889|NCT02038023|11790384|FG000|COMPLETED|Overall Study||73
10631890|NCT02038023|11790384|FG000|NOT COMPLETED|Overall Study||1
10631891|NCT02038036|11790392|FG000|STARTED|Core Study||74
10631892|NCT02038036|11790393|FG001|STARTED|Core Study||75
10631893|NCT02038036|11790392|FG000|Full Analysis Set|Core Study||74
10631894|NCT02038036|11790393|FG001|Full Analysis Set|Core Study||75
10631895|NCT02038036|11790392|FG000|Crossover Set|Core Study||0
10631896|NCT02038036|11790393|FG001|Crossover Set|Core Study||58
10631897|NCT02038036|11790392|FG000|COMPLETED|Core Study||59
10631898|NCT02038036|11790393|FG001|COMPLETED|Core Study||61
10631899|NCT02038036|11790392|FG000|NOT COMPLETED|Core Study||15
10631900|NCT02038036|11790393|FG001|NOT COMPLETED|Core Study||14
10631901|NCT02038036|11790392|FG000|STARTED|Crossover Period||0
10631902|NCT02038036|11790393|FG001|STARTED|Crossover Period|58 participants were eligible to crossover to the ruxolitinib arm|58
10631903|NCT02038036|11790392|FG000|COMPLETED|Crossover Period||0
10631904|NCT02038036|11790393|FG001|COMPLETED|Crossover Period||38
10631905|NCT02038036|11790392|FG000|NOT COMPLETED|Crossover Period||0
10631906|NCT02038036|11790393|FG001|NOT COMPLETED|Crossover Period||20
10631907|NCT02038049|11790404|FG000|STARTED|Overall Study||4
10631908|NCT02038049|11790405|FG001|STARTED|Overall Study||4
10631909|NCT02038049|11790404|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||4
10631910|NCT02038049|11790405|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||4
10631911|NCT02038049|11790404|FG000|COMPLETED|Overall Study||3
10631912|NCT02038049|11790405|FG001|COMPLETED|Overall Study||4
10631913|NCT02038049|11790404|FG000|NOT COMPLETED|Overall Study||1
10631914|NCT02038049|11790405|FG001|NOT COMPLETED|Overall Study||0
10631915|NCT02038075|11790417|FG000|STARTED|Overall Study||76
10631916|NCT02038075|11790418|FG001|STARTED|Overall Study||76
10631917|NCT02038075|11790417|FG000|COMPLETED|Overall Study||73
10631918|NCT02038075|11790418|FG001|COMPLETED|Overall Study||76
10631919|NCT02038075|11790417|FG000|NOT COMPLETED|Overall Study||3
10631920|NCT02038075|11790418|FG001|NOT COMPLETED|Overall Study||0
10653756|NCT02196506|11814372|FG001|COMPLETED|Phase B||177
10653757|NCT02196506|11814373|FG002|COMPLETED|Phase B||196
10653758|NCT02196506|11814374|FG003|COMPLETED|Phase B||0
10653759|NCT02196506|11814371|FG000|NOT COMPLETED|Phase B||0
10653760|NCT02196506|11814372|FG001|NOT COMPLETED|Phase B||15
10653761|NCT02196506|11814373|FG002|NOT COMPLETED|Phase B||6
10653762|NCT02196506|11814374|FG003|NOT COMPLETED|Phase B||0
10653763|NCT02196506|11814371|FG000|STARTED|Phase A+||0
10653764|NCT02196506|11814372|FG001|STARTED|Phase A+||0
10653765|NCT02196506|11814373|FG002|STARTED|Phase A+||0
10653766|NCT02196506|11814374|FG003|STARTED|Phase A+||322
10653767|NCT02196506|11814371|FG000|COMPLETED|Phase A+||0
10705596|NCT02601001|11870046|FG003|STARTED|Dosing Period 2||7
10705597|NCT02601001|11870047|FG004|STARTED|Dosing Period 2||13
10705598|NCT02601001|11870048|FG005|STARTED|Dosing Period 2||7
10705599|NCT02601001|11870049|FG006|STARTED|Dosing Period 2||13
10705600|NCT02601001|11870043|FG000|COMPLETED|Dosing Period 2||10
10705601|NCT02601001|11870044|FG001|COMPLETED|Dosing Period 2||0
10705602|NCT02601001|11870045|FG002|COMPLETED|Dosing Period 2||0
10653768|NCT02196506|11814372|FG001|COMPLETED|Phase A+||0
10653769|NCT02196506|11814373|FG002|COMPLETED|Phase A+||0
10653770|NCT02196506|11814374|FG003|COMPLETED|Phase A+||308
10653771|NCT02196506|11814371|FG000|NOT COMPLETED|Phase A+||0
10653772|NCT02196506|11814372|FG001|NOT COMPLETED|Phase A+||0
10653773|NCT02196506|11814373|FG002|NOT COMPLETED|Phase A+||0
10653774|NCT02196506|11814374|FG003|NOT COMPLETED|Phase A+||14
10653775|NCT02196558|11814383|FG000|STARTED|Treatment Phase (12 Weeks)||12
10653776|NCT02196558|11814384|FG001|STARTED|Treatment Phase (12 Weeks)||15
10653777|NCT02196558|11814385|FG002|STARTED|Treatment Phase (12 Weeks)||10
10653778|NCT02196558|11814383|FG000|COMPLETED|Treatment Phase (12 Weeks)||12
10653779|NCT02196558|11814384|FG001|COMPLETED|Treatment Phase (12 Weeks)||12
10653780|NCT02196558|11814385|FG002|COMPLETED|Treatment Phase (12 Weeks)||8
10653781|NCT02196558|11814383|FG000|NOT COMPLETED|Treatment Phase (12 Weeks)||0
10653782|NCT02196558|11814384|FG001|NOT COMPLETED|Treatment Phase (12 Weeks)||3
10653783|NCT02196558|11814385|FG002|NOT COMPLETED|Treatment Phase (12 Weeks)||2
10653784|NCT02196558|11814383|FG000|STARTED|Extension Phase (40 Weeks)|Participants who wished to continue, had no safety issues, and had>=20% improvement in joint counts.|11
10653785|NCT02196558|11814384|FG001|STARTED|Extension Phase (40 Weeks)|Participants who wished to continue, had no safety issues, and had>=20% improvement in joint counts.|11
10653786|NCT02196558|11814385|FG002|STARTED|Extension Phase (40 Weeks)|Participants who wished to continue, had no safety issues, and had>=20% improvement in joint counts.|6
10653787|NCT02196558|11814383|FG000|COMPLETED|Extension Phase (40 Weeks)||9
10653788|NCT02196558|11814384|FG001|COMPLETED|Extension Phase (40 Weeks)||8
10653789|NCT02196558|11814385|FG002|COMPLETED|Extension Phase (40 Weeks)||5
10705603|NCT02601001|11870046|FG003|COMPLETED|Dosing Period 2||7
10653790|NCT02196558|11814383|FG000|NOT COMPLETED|Extension Phase (40 Weeks)||2
10653791|NCT02196558|11814384|FG001|NOT COMPLETED|Extension Phase (40 Weeks)||3
10653792|NCT02196558|11814385|FG002|NOT COMPLETED|Extension Phase (40 Weeks)||1
10653793|NCT02196675|11814396|FG000|STARTED|Overall Study||27
10653794|NCT02196675|11814397|FG001|STARTED|Overall Study||70
10653795|NCT02196675|11814398|FG002|STARTED|Overall Study||8
10705604|NCT02601001|11870047|FG004|COMPLETED|Dosing Period 2||13
10705605|NCT02601001|11870048|FG005|COMPLETED|Dosing Period 2||7
10631921|NCT02038179|11790424|FG000|STARTED|Phase 1 (4 Weeks)||52
10631922|NCT02038179|11790425|FG001|STARTED|Phase 1 (4 Weeks)||47
10631923|NCT02038179|11790424|FG000|COMPLETED|Phase 1 (4 Weeks)||48
10631924|NCT02038179|11790425|FG001|COMPLETED|Phase 1 (4 Weeks)||42
10631925|NCT02038179|11790424|FG000|NOT COMPLETED|Phase 1 (4 Weeks)||4
10631926|NCT02038179|11790425|FG001|NOT COMPLETED|Phase 1 (4 Weeks)||5
10631927|NCT02038179|11790424|FG000|STARTED|Washout (2-4 Weeks)||48
10631928|NCT02038179|11790425|FG001|STARTED|Washout (2-4 Weeks)||42
10631929|NCT02038179|11790424|FG000|COMPLETED|Washout (2-4 Weeks)||46
10631930|NCT02038179|11790425|FG001|COMPLETED|Washout (2-4 Weeks)||40
10631931|NCT02038179|11790424|FG000|NOT COMPLETED|Washout (2-4 Weeks)||2
10631932|NCT02038179|11790425|FG001|NOT COMPLETED|Washout (2-4 Weeks)||2
10631933|NCT02038179|11790424|FG000|STARTED|Phase 2 (4 Weeks)||46
10631934|NCT02038179|11790425|FG001|STARTED|Phase 2 (4 Weeks)||40
10631935|NCT02038179|11790424|FG000|COMPLETED|Phase 2 (4 Weeks)||44
10631936|NCT02038179|11790425|FG001|COMPLETED|Phase 2 (4 Weeks)||38
10631937|NCT02038179|11790424|FG000|NOT COMPLETED|Phase 2 (4 Weeks)||2
10631938|NCT02038179|11790425|FG001|NOT COMPLETED|Phase 2 (4 Weeks)||2
10631939|NCT02038218|11790433|FG000|STARTED|Overall Study|Drug tolerated - Arm 1: No liver disease - 98.7 mg/m2. No alterations of liver functions.|22
10631940|NCT02038218|11790434|FG001|STARTED|Overall Study|Drug tolerated - Arm 2: liver involvement - 85.5 mg/m2. No alterations of liver functions.|7
10631941|NCT02038218|11790433|FG000|COMPLETED|Overall Study|22 patients are included in a publication in progress|22
10631942|NCT02038218|11790434|FG001|COMPLETED|Overall Study|5 patients are included in a publication in progress|7
10631943|NCT02038218|11790433|FG000|NOT COMPLETED|Overall Study||0
10631944|NCT02038218|11790434|FG001|NOT COMPLETED|Overall Study||0
10631945|NCT02038543|11790444|FG000|STARTED|Overall Study||7
10631946|NCT02038543|11790445|FG001|STARTED|Overall Study||4
10631947|NCT02038543|11790446|FG002|STARTED|Overall Study||8
10631948|NCT02038543|11790447|FG003|STARTED|Overall Study||3
10631949|NCT02038543|11790444|FG000|COMPLETED|Overall Study||7
10631950|NCT02038543|11790445|FG001|COMPLETED|Overall Study||4
10631951|NCT02038543|11790446|FG002|COMPLETED|Overall Study||8
10631952|NCT02038543|11790447|FG003|COMPLETED|Overall Study||1
10631953|NCT02038543|11790444|FG000|NOT COMPLETED|Overall Study||0
10631954|NCT02038543|11790445|FG001|NOT COMPLETED|Overall Study||0
10631955|NCT02038543|11790446|FG002|NOT COMPLETED|Overall Study||0
10631956|NCT02038543|11790447|FG003|NOT COMPLETED|Overall Study||2
10631957|NCT02038569|11790457|FG000|STARTED|Overall Study||107
10631958|NCT02038569|11790457|FG000|COMPLETED|Overall Study||102
10631959|NCT02038569|11790457|FG000|NOT COMPLETED|Overall Study||5
10631960|NCT02038647|11790464|FG000|STARTED|Overall Study||89
10631961|NCT02038647|11790465|FG001|STARTED|Overall Study||89
10631962|NCT02038647|11790464|FG000|COMPLETED|Overall Study||0
10631963|NCT02038647|11790465|FG001|COMPLETED|Overall Study||0
10631964|NCT02038647|11790464|FG000|NOT COMPLETED|Overall Study||89
10631965|NCT02038647|11790465|FG001|NOT COMPLETED|Overall Study||89
10631966|NCT02038764|11790476|FG000|STARTED|Overall Study||7
10631967|NCT02038764|11790477|FG001|STARTED|Overall Study||8
10631968|NCT02038764|11790478|FG002|STARTED|Overall Study||9
10631969|NCT02038764|11790479|FG003|STARTED|Overall Study||5
10631970|NCT02038764|11790480|FG004|STARTED|Overall Study||8
10631971|NCT02038764|11790476|FG000|COMPLETED|Overall Study||6
10631972|NCT02038764|11790477|FG001|COMPLETED|Overall Study||7
10631973|NCT02038764|11790478|FG002|COMPLETED|Overall Study||7
10631974|NCT02038764|11790479|FG003|COMPLETED|Overall Study||5
10631975|NCT02038764|11790480|FG004|COMPLETED|Overall Study||7
10631976|NCT02038764|11790476|FG000|NOT COMPLETED|Overall Study||1
10631977|NCT02038764|11790477|FG001|NOT COMPLETED|Overall Study||1
10631978|NCT02038764|11790478|FG002|NOT COMPLETED|Overall Study||2
10631979|NCT02038764|11790479|FG003|NOT COMPLETED|Overall Study||0
10631980|NCT02038764|11790480|FG004|NOT COMPLETED|Overall Study||1
10631981|NCT02038790|11790496|FG000|STARTED|Day 0 - First Treatment||16
10631982|NCT02038790|11790497|FG001|STARTED|Day 0 - First Treatment||17
10631983|NCT02038790|11790496|FG000|COMPLETED|Day 0 - First Treatment||15
10631984|NCT02038790|11790497|FG001|COMPLETED|Day 0 - First Treatment||16
10631985|NCT02038790|11790496|FG000|NOT COMPLETED|Day 0 - First Treatment||1
10631986|NCT02038790|11790497|FG001|NOT COMPLETED|Day 0 - First Treatment||1
10631987|NCT02038790|11790496|FG000|STARTED|Day 1 - Second Treatment||15
10631988|NCT02038790|11790497|FG001|STARTED|Day 1 - Second Treatment||16
10631989|NCT02038790|11790496|FG000|COMPLETED|Day 1 - Second Treatment||15
10631990|NCT02038790|11790497|FG001|COMPLETED|Day 1 - Second Treatment||16
10631991|NCT02038790|11790496|FG000|NOT COMPLETED|Day 1 - Second Treatment||0
10631992|NCT02038790|11790497|FG001|NOT COMPLETED|Day 1 - Second Treatment||0
10631993|NCT02038829|11790504|FG000|STARTED|Treatment Period 1||8
10631994|NCT02038829|11790505|FG001|STARTED|Treatment Period 1||8
10631995|NCT02038829|11790506|FG002|STARTED|Treatment Period 1||8
10631996|NCT02038829|11790507|FG003|STARTED|Treatment Period 1||8
10631997|NCT02038829|11790508|FG004|STARTED|Treatment Period 1||8
10631998|NCT02038829|11790509|FG005|STARTED|Treatment Period 1||8
10631999|NCT02038829|11790510|FG006|STARTED|Treatment Period 1||8
10632000|NCT02038829|11790511|FG007|STARTED|Treatment Period 1||8
10632001|NCT02038829|11790512|FG008|STARTED|Treatment Period 1||8
10632002|NCT02038829|11790513|FG009|STARTED|Treatment Period 1||8
10632003|NCT02038829|11790514|FG010|STARTED|Treatment Period 1||8
10632004|NCT02038829|11790515|FG011|STARTED|Treatment Period 1||8
10632005|NCT02038829|11790504|FG000|COMPLETED|Treatment Period 1||8
10632006|NCT02038829|11790505|FG001|COMPLETED|Treatment Period 1||8
10632007|NCT02038829|11790506|FG002|COMPLETED|Treatment Period 1||8
10632008|NCT02038829|11790507|FG003|COMPLETED|Treatment Period 1||8
10632009|NCT02038829|11790508|FG004|COMPLETED|Treatment Period 1||8
10632010|NCT02038829|11790509|FG005|COMPLETED|Treatment Period 1||8
10632011|NCT02038829|11790510|FG006|COMPLETED|Treatment Period 1||8
10632012|NCT02038829|11790511|FG007|COMPLETED|Treatment Period 1||8
10632013|NCT02038829|11790512|FG008|COMPLETED|Treatment Period 1||8
10632014|NCT02038829|11790513|FG009|COMPLETED|Treatment Period 1||8
10632015|NCT02038829|11790514|FG010|COMPLETED|Treatment Period 1||8
10632016|NCT02038829|11790515|FG011|COMPLETED|Treatment Period 1||8
10632017|NCT02038829|11790504|FG000|NOT COMPLETED|Treatment Period 1||0
10632018|NCT02038829|11790505|FG001|NOT COMPLETED|Treatment Period 1||0
10632019|NCT02038829|11790506|FG002|NOT COMPLETED|Treatment Period 1||0
10632020|NCT02038829|11790507|FG003|NOT COMPLETED|Treatment Period 1||0
10632021|NCT02038829|11790508|FG004|NOT COMPLETED|Treatment Period 1||0
10632022|NCT02038829|11790509|FG005|NOT COMPLETED|Treatment Period 1||0
10632023|NCT02038829|11790510|FG006|NOT COMPLETED|Treatment Period 1||0
10632024|NCT02038829|11790511|FG007|NOT COMPLETED|Treatment Period 1||0
10632025|NCT02038829|11790512|FG008|NOT COMPLETED|Treatment Period 1||0
10632026|NCT02038829|11790513|FG009|NOT COMPLETED|Treatment Period 1||0
10632027|NCT02038829|11790514|FG010|NOT COMPLETED|Treatment Period 1||0
10632028|NCT02038829|11790515|FG011|NOT COMPLETED|Treatment Period 1||0
10632029|NCT02038829|11790504|FG000|STARTED|Washout Period 1||8
10632030|NCT02038829|11790505|FG001|STARTED|Washout Period 1||8
10632031|NCT02038829|11790506|FG002|STARTED|Washout Period 1||8
10632032|NCT02038829|11790507|FG003|STARTED|Washout Period 1||8
10632033|NCT02038829|11790508|FG004|STARTED|Washout Period 1||8
10632034|NCT02038829|11790509|FG005|STARTED|Washout Period 1||8
10632035|NCT02038829|11790510|FG006|STARTED|Washout Period 1||8
10632036|NCT02038829|11790511|FG007|STARTED|Washout Period 1||8
10632037|NCT02038829|11790512|FG008|STARTED|Washout Period 1||8
10632038|NCT02038829|11790513|FG009|STARTED|Washout Period 1||8
10632039|NCT02038829|11790514|FG010|STARTED|Washout Period 1||8
10632040|NCT02038829|11790515|FG011|STARTED|Washout Period 1||8
10632041|NCT02038829|11790504|FG000|COMPLETED|Washout Period 1||8
10632042|NCT02038829|11790505|FG001|COMPLETED|Washout Period 1||8
10632043|NCT02038829|11790506|FG002|COMPLETED|Washout Period 1||8
10632044|NCT02038829|11790507|FG003|COMPLETED|Washout Period 1||8
10632045|NCT02038829|11790508|FG004|COMPLETED|Washout Period 1||7
10632046|NCT02038829|11790509|FG005|COMPLETED|Washout Period 1||8
10632047|NCT02038829|11790510|FG006|COMPLETED|Washout Period 1||8
10632048|NCT02038829|11790511|FG007|COMPLETED|Washout Period 1||8
10632049|NCT02038829|11790512|FG008|COMPLETED|Washout Period 1||8
10632050|NCT02038829|11790513|FG009|COMPLETED|Washout Period 1||8
10632051|NCT02038829|11790514|FG010|COMPLETED|Washout Period 1||8
10632052|NCT02038829|11790515|FG011|COMPLETED|Washout Period 1||8
10632053|NCT02038829|11790504|FG000|NOT COMPLETED|Washout Period 1||0
10632054|NCT02038829|11790505|FG001|NOT COMPLETED|Washout Period 1||0
10632055|NCT02038829|11790506|FG002|NOT COMPLETED|Washout Period 1||0
10632056|NCT02038829|11790507|FG003|NOT COMPLETED|Washout Period 1||0
10632057|NCT02038829|11790508|FG004|NOT COMPLETED|Washout Period 1||1
10632058|NCT02038829|11790509|FG005|NOT COMPLETED|Washout Period 1||0
10632059|NCT02038829|11790510|FG006|NOT COMPLETED|Washout Period 1||0
10632060|NCT02038829|11790511|FG007|NOT COMPLETED|Washout Period 1||0
10632061|NCT02038829|11790512|FG008|NOT COMPLETED|Washout Period 1||0
10632062|NCT02038829|11790513|FG009|NOT COMPLETED|Washout Period 1||0
10632063|NCT02038829|11790514|FG010|NOT COMPLETED|Washout Period 1||0
10632064|NCT02038829|11790515|FG011|NOT COMPLETED|Washout Period 1||0
10632065|NCT02038829|11790504|FG000|STARTED|Treatment Period 2||8
10632066|NCT02038829|11790505|FG001|STARTED|Treatment Period 2||8
10632067|NCT02038829|11790506|FG002|STARTED|Treatment Period 2||8
10632068|NCT02038829|11790507|FG003|STARTED|Treatment Period 2||8
10632069|NCT02038829|11790508|FG004|STARTED|Treatment Period 2||7
10632070|NCT02038829|11790509|FG005|STARTED|Treatment Period 2||8
10632071|NCT02038829|11790510|FG006|STARTED|Treatment Period 2||8
10632072|NCT02038829|11790511|FG007|STARTED|Treatment Period 2||8
10632073|NCT02038829|11790512|FG008|STARTED|Treatment Period 2||8
10632074|NCT02038829|11790513|FG009|STARTED|Treatment Period 2||8
10632075|NCT02038829|11790514|FG010|STARTED|Treatment Period 2||8
10632076|NCT02038829|11790515|FG011|STARTED|Treatment Period 2||8
10632077|NCT02038829|11790504|FG000|COMPLETED|Treatment Period 2||7
10632078|NCT02038829|11790505|FG001|COMPLETED|Treatment Period 2||8
10632079|NCT02038829|11790506|FG002|COMPLETED|Treatment Period 2||8
10632080|NCT02038829|11790507|FG003|COMPLETED|Treatment Period 2||8
10632081|NCT02038829|11790508|FG004|COMPLETED|Treatment Period 2||7
10632082|NCT02038829|11790509|FG005|COMPLETED|Treatment Period 2||8
10632083|NCT02038829|11790510|FG006|COMPLETED|Treatment Period 2||8
10632084|NCT02038829|11790511|FG007|COMPLETED|Treatment Period 2||8
10632085|NCT02038829|11790512|FG008|COMPLETED|Treatment Period 2||8
10632086|NCT02038829|11790513|FG009|COMPLETED|Treatment Period 2||8
10632087|NCT02038829|11790514|FG010|COMPLETED|Treatment Period 2||7
10632088|NCT02038829|11790515|FG011|COMPLETED|Treatment Period 2||8
10632089|NCT02038829|11790504|FG000|NOT COMPLETED|Treatment Period 2||1
10632090|NCT02038829|11790505|FG001|NOT COMPLETED|Treatment Period 2||0
10632091|NCT02038829|11790506|FG002|NOT COMPLETED|Treatment Period 2||0
10632092|NCT02038829|11790507|FG003|NOT COMPLETED|Treatment Period 2||0
10632093|NCT02038829|11790508|FG004|NOT COMPLETED|Treatment Period 2||0
10632094|NCT02038829|11790509|FG005|NOT COMPLETED|Treatment Period 2||0
10632095|NCT02038829|11790510|FG006|NOT COMPLETED|Treatment Period 2||0
10632096|NCT02038829|11790511|FG007|NOT COMPLETED|Treatment Period 2||0
10632097|NCT02038829|11790512|FG008|NOT COMPLETED|Treatment Period 2||0
10632098|NCT02038829|11790513|FG009|NOT COMPLETED|Treatment Period 2||0
10632099|NCT02038829|11790514|FG010|NOT COMPLETED|Treatment Period 2||1
10632100|NCT02038829|11790515|FG011|NOT COMPLETED|Treatment Period 2||0
10632101|NCT02038829|11790504|FG000|STARTED|Washout Period 2||7
10632102|NCT02038829|11790505|FG001|STARTED|Washout Period 2||8
10632103|NCT02038829|11790506|FG002|STARTED|Washout Period 2||8
10632104|NCT02038829|11790507|FG003|STARTED|Washout Period 2||8
10632105|NCT02038829|11790508|FG004|STARTED|Washout Period 2||7
10632106|NCT02038829|11790509|FG005|STARTED|Washout Period 2||8
10632107|NCT02038829|11790510|FG006|STARTED|Washout Period 2||8
10632108|NCT02038829|11790511|FG007|STARTED|Washout Period 2||8
10632109|NCT02038829|11790512|FG008|STARTED|Washout Period 2||8
10632110|NCT02038829|11790513|FG009|STARTED|Washout Period 2||8
10632111|NCT02038829|11790514|FG010|STARTED|Washout Period 2||7
10632112|NCT02038829|11790515|FG011|STARTED|Washout Period 2||8
10632113|NCT02038829|11790504|FG000|COMPLETED|Washout Period 2||7
10632114|NCT02038829|11790505|FG001|COMPLETED|Washout Period 2||8
10632115|NCT02038829|11790506|FG002|COMPLETED|Washout Period 2||8
10632116|NCT02038829|11790507|FG003|COMPLETED|Washout Period 2||8
10632117|NCT02038829|11790508|FG004|COMPLETED|Washout Period 2||7
10632118|NCT02038829|11790509|FG005|COMPLETED|Washout Period 2||7
10632119|NCT02038829|11790510|FG006|COMPLETED|Washout Period 2||8
10632120|NCT02038829|11790511|FG007|COMPLETED|Washout Period 2||8
10632121|NCT02038829|11790512|FG008|COMPLETED|Washout Period 2||7
10632122|NCT02038829|11790513|FG009|COMPLETED|Washout Period 2||8
10632123|NCT02038829|11790514|FG010|COMPLETED|Washout Period 2||7
10632124|NCT02038829|11790515|FG011|COMPLETED|Washout Period 2||8
10632125|NCT02038829|11790504|FG000|NOT COMPLETED|Washout Period 2||0
10632126|NCT02038829|11790505|FG001|NOT COMPLETED|Washout Period 2||0
10632127|NCT02038829|11790506|FG002|NOT COMPLETED|Washout Period 2||0
10632128|NCT02038829|11790507|FG003|NOT COMPLETED|Washout Period 2||0
10632129|NCT02038829|11790508|FG004|NOT COMPLETED|Washout Period 2||0
10632130|NCT02038829|11790509|FG005|NOT COMPLETED|Washout Period 2||1
10632131|NCT02038829|11790510|FG006|NOT COMPLETED|Washout Period 2||0
10632132|NCT02038829|11790511|FG007|NOT COMPLETED|Washout Period 2||0
10632133|NCT02038829|11790512|FG008|NOT COMPLETED|Washout Period 2||1
10632134|NCT02038829|11790513|FG009|NOT COMPLETED|Washout Period 2||0
10632135|NCT02038829|11790514|FG010|NOT COMPLETED|Washout Period 2||0
10632136|NCT02038829|11790515|FG011|NOT COMPLETED|Washout Period 2||0
10632137|NCT02038829|11790504|FG000|STARTED|Treatment Period 3||7
10632138|NCT02038829|11790505|FG001|STARTED|Treatment Period 3||8
10632139|NCT02038829|11790506|FG002|STARTED|Treatment Period 3||8
10632140|NCT02038829|11790507|FG003|STARTED|Treatment Period 3||8
10632141|NCT02038829|11790508|FG004|STARTED|Treatment Period 3||7
10632142|NCT02038829|11790509|FG005|STARTED|Treatment Period 3||7
10632143|NCT02038829|11790510|FG006|STARTED|Treatment Period 3||8
10632144|NCT02038829|11790511|FG007|STARTED|Treatment Period 3||8
10632145|NCT02038829|11790512|FG008|STARTED|Treatment Period 3||7
10632146|NCT02038829|11790513|FG009|STARTED|Treatment Period 3||8
10632147|NCT02038829|11790514|FG010|STARTED|Treatment Period 3||7
10632148|NCT02038829|11790515|FG011|STARTED|Treatment Period 3||8
10632149|NCT02038829|11790504|FG000|COMPLETED|Treatment Period 3||7
10632150|NCT02038829|11790505|FG001|COMPLETED|Treatment Period 3||8
10632151|NCT02038829|11790506|FG002|COMPLETED|Treatment Period 3||8
10632152|NCT02038829|11790507|FG003|COMPLETED|Treatment Period 3||8
10632153|NCT02038829|11790508|FG004|COMPLETED|Treatment Period 3||7
10632154|NCT02038829|11790509|FG005|COMPLETED|Treatment Period 3||7
10632155|NCT02038829|11790510|FG006|COMPLETED|Treatment Period 3||8
10632156|NCT02038829|11790511|FG007|COMPLETED|Treatment Period 3||8
10632157|NCT02038829|11790512|FG008|COMPLETED|Treatment Period 3||7
10632158|NCT02038829|11790513|FG009|COMPLETED|Treatment Period 3||8
10632159|NCT02038829|11790514|FG010|COMPLETED|Treatment Period 3||7
10632160|NCT02038829|11790515|FG011|COMPLETED|Treatment Period 3||8
10632161|NCT02038829|11790504|FG000|NOT COMPLETED|Treatment Period 3||0
10632162|NCT02038829|11790505|FG001|NOT COMPLETED|Treatment Period 3||0
10632163|NCT02038829|11790506|FG002|NOT COMPLETED|Treatment Period 3||0
10632164|NCT02038829|11790507|FG003|NOT COMPLETED|Treatment Period 3||0
10632165|NCT02038829|11790508|FG004|NOT COMPLETED|Treatment Period 3||0
10632166|NCT02038829|11790509|FG005|NOT COMPLETED|Treatment Period 3||0
10632167|NCT02038829|11790510|FG006|NOT COMPLETED|Treatment Period 3||0
10632168|NCT02038829|11790511|FG007|NOT COMPLETED|Treatment Period 3||0
10632169|NCT02038829|11790512|FG008|NOT COMPLETED|Treatment Period 3||0
10632170|NCT02038829|11790513|FG009|NOT COMPLETED|Treatment Period 3||0
10632171|NCT02038829|11790514|FG010|NOT COMPLETED|Treatment Period 3||0
10632172|NCT02038829|11790515|FG011|NOT COMPLETED|Treatment Period 3||0
10632173|NCT02038829|11790504|FG000|STARTED|Washout Period 3||7
10632174|NCT02038829|11790505|FG001|STARTED|Washout Period 3||8
10632175|NCT02038829|11790506|FG002|STARTED|Washout Period 3||8
10632176|NCT02038829|11790507|FG003|STARTED|Washout Period 3||8
10632177|NCT02038829|11790508|FG004|STARTED|Washout Period 3||7
10632178|NCT02038829|11790509|FG005|STARTED|Washout Period 3||7
10632179|NCT02038829|11790510|FG006|STARTED|Washout Period 3||8
10632180|NCT02038829|11790511|FG007|STARTED|Washout Period 3||8
10632181|NCT02038829|11790512|FG008|STARTED|Washout Period 3||7
10632182|NCT02038829|11790513|FG009|STARTED|Washout Period 3||8
10632183|NCT02038829|11790514|FG010|STARTED|Washout Period 3||7
10632184|NCT02038829|11790515|FG011|STARTED|Washout Period 3||8
10632185|NCT02038829|11790504|FG000|COMPLETED|Washout Period 3||7
10632186|NCT02038829|11790505|FG001|COMPLETED|Washout Period 3||8
10632187|NCT02038829|11790506|FG002|COMPLETED|Washout Period 3||8
10632188|NCT02038829|11790507|FG003|COMPLETED|Washout Period 3||8
10632189|NCT02038829|11790508|FG004|COMPLETED|Washout Period 3||7
10632190|NCT02038829|11790509|FG005|COMPLETED|Washout Period 3||7
10632191|NCT02038829|11790510|FG006|COMPLETED|Washout Period 3||8
10632192|NCT02038829|11790511|FG007|COMPLETED|Washout Period 3||8
10632193|NCT02038829|11790512|FG008|COMPLETED|Washout Period 3||7
10632194|NCT02038829|11790513|FG009|COMPLETED|Washout Period 3||8
10632195|NCT02038829|11790514|FG010|COMPLETED|Washout Period 3||7
10632196|NCT02038829|11790515|FG011|COMPLETED|Washout Period 3||8
10632197|NCT02038829|11790504|FG000|NOT COMPLETED|Washout Period 3||0
10632198|NCT02038829|11790505|FG001|NOT COMPLETED|Washout Period 3||0
10632199|NCT02038829|11790506|FG002|NOT COMPLETED|Washout Period 3||0
10632200|NCT02038829|11790507|FG003|NOT COMPLETED|Washout Period 3||0
10632201|NCT02038829|11790508|FG004|NOT COMPLETED|Washout Period 3||0
10632202|NCT02038829|11790509|FG005|NOT COMPLETED|Washout Period 3||0
10632203|NCT02038829|11790510|FG006|NOT COMPLETED|Washout Period 3||0
10632204|NCT02038829|11790511|FG007|NOT COMPLETED|Washout Period 3||0
10632205|NCT02038829|11790512|FG008|NOT COMPLETED|Washout Period 3||0
10632206|NCT02038829|11790513|FG009|NOT COMPLETED|Washout Period 3||0
10632207|NCT02038829|11790514|FG010|NOT COMPLETED|Washout Period 3||0
10632208|NCT02038829|11790515|FG011|NOT COMPLETED|Washout Period 3||0
10632209|NCT02038829|11790504|FG000|STARTED|Treatment Period 4||7
10632210|NCT02038829|11790505|FG001|STARTED|Treatment Period 4||8
10632211|NCT02038829|11790506|FG002|STARTED|Treatment Period 4||8
10632212|NCT02038829|11790507|FG003|STARTED|Treatment Period 4||8
10632213|NCT02038829|11790508|FG004|STARTED|Treatment Period 4||7
10632214|NCT02038829|11790509|FG005|STARTED|Treatment Period 4||7
10632215|NCT02038829|11790510|FG006|STARTED|Treatment Period 4||8
10632216|NCT02038829|11790511|FG007|STARTED|Treatment Period 4||8
10632217|NCT02038829|11790512|FG008|STARTED|Treatment Period 4||7
10632218|NCT02038829|11790513|FG009|STARTED|Treatment Period 4||8
10632219|NCT02038829|11790514|FG010|STARTED|Treatment Period 4||7
10632220|NCT02038829|11790515|FG011|STARTED|Treatment Period 4||8
10632221|NCT02038829|11790504|FG000|COMPLETED|Treatment Period 4||7
10632222|NCT02038829|11790505|FG001|COMPLETED|Treatment Period 4||7
10632223|NCT02038829|11790506|FG002|COMPLETED|Treatment Period 4||8
10632224|NCT02038829|11790507|FG003|COMPLETED|Treatment Period 4||8
10632225|NCT02038829|11790508|FG004|COMPLETED|Treatment Period 4||7
10632226|NCT02038829|11790509|FG005|COMPLETED|Treatment Period 4||7
10632227|NCT02038829|11790510|FG006|COMPLETED|Treatment Period 4||8
10632228|NCT02038829|11790511|FG007|COMPLETED|Treatment Period 4||8
10632229|NCT02038829|11790512|FG008|COMPLETED|Treatment Period 4||7
10632230|NCT02038829|11790513|FG009|COMPLETED|Treatment Period 4||8
10632231|NCT02038829|11790514|FG010|COMPLETED|Treatment Period 4||7
10632232|NCT02038829|11790515|FG011|COMPLETED|Treatment Period 4||8
10632233|NCT02038829|11790504|FG000|NOT COMPLETED|Treatment Period 4||0
10632234|NCT02038829|11790505|FG001|NOT COMPLETED|Treatment Period 4||1
10632235|NCT02038829|11790506|FG002|NOT COMPLETED|Treatment Period 4||0
10632236|NCT02038829|11790507|FG003|NOT COMPLETED|Treatment Period 4||0
10632237|NCT02038829|11790508|FG004|NOT COMPLETED|Treatment Period 4||0
10632238|NCT02038829|11790509|FG005|NOT COMPLETED|Treatment Period 4||0
10632239|NCT02038829|11790510|FG006|NOT COMPLETED|Treatment Period 4||0
10632240|NCT02038829|11790511|FG007|NOT COMPLETED|Treatment Period 4||0
10632241|NCT02038829|11790512|FG008|NOT COMPLETED|Treatment Period 4||0
10632242|NCT02038829|11790513|FG009|NOT COMPLETED|Treatment Period 4||0
10632243|NCT02038829|11790514|FG010|NOT COMPLETED|Treatment Period 4||0
10632244|NCT02038829|11790515|FG011|NOT COMPLETED|Treatment Period 4||0
10632245|NCT02038829|11790504|FG000|STARTED|Washout Period 4||7
10632246|NCT02038829|11790505|FG001|STARTED|Washout Period 4||7
10632247|NCT02038829|11790506|FG002|STARTED|Washout Period 4||8
10632248|NCT02038829|11790507|FG003|STARTED|Washout Period 4||8
10632249|NCT02038829|11790508|FG004|STARTED|Washout Period 4||7
10632250|NCT02038829|11790509|FG005|STARTED|Washout Period 4||7
10632251|NCT02038829|11790510|FG006|STARTED|Washout Period 4||8
10632252|NCT02038829|11790511|FG007|STARTED|Washout Period 4||8
10632253|NCT02038829|11790512|FG008|STARTED|Washout Period 4||7
10632254|NCT02038829|11790513|FG009|STARTED|Washout Period 4||8
10632255|NCT02038829|11790514|FG010|STARTED|Washout Period 4||7
10632256|NCT02038829|11790515|FG011|STARTED|Washout Period 4||8
10632257|NCT02038829|11790504|FG000|COMPLETED|Washout Period 4||7
10632258|NCT02038829|11790505|FG001|COMPLETED|Washout Period 4||7
10632259|NCT02038829|11790506|FG002|COMPLETED|Washout Period 4||8
10632260|NCT02038829|11790507|FG003|COMPLETED|Washout Period 4||8
10632261|NCT02038829|11790508|FG004|COMPLETED|Washout Period 4||7
10632262|NCT02038829|11790509|FG005|COMPLETED|Washout Period 4||7
10632263|NCT02038829|11790510|FG006|COMPLETED|Washout Period 4||7
10632264|NCT02038829|11790511|FG007|COMPLETED|Washout Period 4||8
10632265|NCT02038829|11790512|FG008|COMPLETED|Washout Period 4||7
10632266|NCT02038829|11790513|FG009|COMPLETED|Washout Period 4||8
10632267|NCT02038829|11790514|FG010|COMPLETED|Washout Period 4||7
10632268|NCT02038829|11790515|FG011|COMPLETED|Washout Period 4||8
10632269|NCT02038829|11790504|FG000|NOT COMPLETED|Washout Period 4||0
10632270|NCT02038829|11790505|FG001|NOT COMPLETED|Washout Period 4||0
10632271|NCT02038829|11790506|FG002|NOT COMPLETED|Washout Period 4||0
10632272|NCT02038829|11790507|FG003|NOT COMPLETED|Washout Period 4||0
10632273|NCT02038829|11790508|FG004|NOT COMPLETED|Washout Period 4||0
10632274|NCT02038829|11790509|FG005|NOT COMPLETED|Washout Period 4||0
10632275|NCT02038829|11790510|FG006|NOT COMPLETED|Washout Period 4||1
10632276|NCT02038829|11790511|FG007|NOT COMPLETED|Washout Period 4||0
10632277|NCT02038829|11790512|FG008|NOT COMPLETED|Washout Period 4||0
10632278|NCT02038829|11790513|FG009|NOT COMPLETED|Washout Period 4||0
10632279|NCT02038829|11790514|FG010|NOT COMPLETED|Washout Period 4||0
10632280|NCT02038829|11790515|FG011|NOT COMPLETED|Washout Period 4||0
10632281|NCT02038829|11790504|FG000|STARTED|Treatment Period 5||7
10632282|NCT02038829|11790505|FG001|STARTED|Treatment Period 5||7
10632283|NCT02038829|11790506|FG002|STARTED|Treatment Period 5||8
10632284|NCT02038829|11790507|FG003|STARTED|Treatment Period 5||8
10632285|NCT02038829|11790508|FG004|STARTED|Treatment Period 5||7
10632286|NCT02038829|11790509|FG005|STARTED|Treatment Period 5||7
10632287|NCT02038829|11790510|FG006|STARTED|Treatment Period 5||7
10632288|NCT02038829|11790511|FG007|STARTED|Treatment Period 5||8
10632289|NCT02038829|11790512|FG008|STARTED|Treatment Period 5||7
10632290|NCT02038829|11790513|FG009|STARTED|Treatment Period 5||8
10632291|NCT02038829|11790514|FG010|STARTED|Treatment Period 5||7
10632292|NCT02038829|11790515|FG011|STARTED|Treatment Period 5||8
10632293|NCT02038829|11790504|FG000|COMPLETED|Treatment Period 5||7
10632294|NCT02038829|11790505|FG001|COMPLETED|Treatment Period 5||7
10632295|NCT02038829|11790506|FG002|COMPLETED|Treatment Period 5||8
10632296|NCT02038829|11790507|FG003|COMPLETED|Treatment Period 5||8
10632297|NCT02038829|11790508|FG004|COMPLETED|Treatment Period 5||7
10632298|NCT02038829|11790509|FG005|COMPLETED|Treatment Period 5||7
10632299|NCT02038829|11790510|FG006|COMPLETED|Treatment Period 5||7
10632300|NCT02038829|11790511|FG007|COMPLETED|Treatment Period 5||8
10632301|NCT02038829|11790512|FG008|COMPLETED|Treatment Period 5||7
10632302|NCT02038829|11790513|FG009|COMPLETED|Treatment Period 5||8
10632303|NCT02038829|11790514|FG010|COMPLETED|Treatment Period 5||7
10632304|NCT02038829|11790515|FG011|COMPLETED|Treatment Period 5||8
10632305|NCT02038829|11790504|FG000|NOT COMPLETED|Treatment Period 5||0
10632306|NCT02038829|11790505|FG001|NOT COMPLETED|Treatment Period 5||0
10632307|NCT02038829|11790506|FG002|NOT COMPLETED|Treatment Period 5||0
10632308|NCT02038829|11790507|FG003|NOT COMPLETED|Treatment Period 5||0
10632309|NCT02038829|11790508|FG004|NOT COMPLETED|Treatment Period 5||0
10632310|NCT02038829|11790509|FG005|NOT COMPLETED|Treatment Period 5||0
10632311|NCT02038829|11790510|FG006|NOT COMPLETED|Treatment Period 5||0
10632312|NCT02038829|11790511|FG007|NOT COMPLETED|Treatment Period 5||0
10632313|NCT02038829|11790512|FG008|NOT COMPLETED|Treatment Period 5||0
10632314|NCT02038829|11790513|FG009|NOT COMPLETED|Treatment Period 5||0
10632315|NCT02038829|11790514|FG010|NOT COMPLETED|Treatment Period 5||0
10632316|NCT02038829|11790515|FG011|NOT COMPLETED|Treatment Period 5||0
10632317|NCT02038829|11790504|FG000|STARTED|Washout Period 5||7
10632318|NCT02038829|11790505|FG001|STARTED|Washout Period 5||7
10632319|NCT02038829|11790506|FG002|STARTED|Washout Period 5||8
10632320|NCT02038829|11790507|FG003|STARTED|Washout Period 5||8
10632321|NCT02038829|11790508|FG004|STARTED|Washout Period 5||7
10632322|NCT02038829|11790509|FG005|STARTED|Washout Period 5||7
10632323|NCT02038829|11790510|FG006|STARTED|Washout Period 5||7
10632324|NCT02038829|11790511|FG007|STARTED|Washout Period 5||8
10632325|NCT02038829|11790512|FG008|STARTED|Washout Period 5||7
10632326|NCT02038829|11790513|FG009|STARTED|Washout Period 5||8
10632327|NCT02038829|11790514|FG010|STARTED|Washout Period 5||7
10632328|NCT02038829|11790515|FG011|STARTED|Washout Period 5||8
10632329|NCT02038829|11790504|FG000|COMPLETED|Washout Period 5||7
10632330|NCT02038829|11790505|FG001|COMPLETED|Washout Period 5||7
10632331|NCT02038829|11790506|FG002|COMPLETED|Washout Period 5||8
10632332|NCT02038829|11790507|FG003|COMPLETED|Washout Period 5||8
10705606|NCT02601001|11870049|FG006|COMPLETED|Dosing Period 2||12
10705607|NCT02601001|11870043|FG000|NOT COMPLETED|Dosing Period 2||0
10632333|NCT02038829|11790508|FG004|COMPLETED|Washout Period 5||7
10632334|NCT02038829|11790509|FG005|COMPLETED|Washout Period 5||7
10632335|NCT02038829|11790510|FG006|COMPLETED|Washout Period 5||7
10632336|NCT02038829|11790511|FG007|COMPLETED|Washout Period 5||8
10632337|NCT02038829|11790512|FG008|COMPLETED|Washout Period 5||7
10632338|NCT02038829|11790513|FG009|COMPLETED|Washout Period 5||8
10632339|NCT02038829|11790514|FG010|COMPLETED|Washout Period 5||7
10632340|NCT02038829|11790515|FG011|COMPLETED|Washout Period 5||8
10632341|NCT02038829|11790504|FG000|NOT COMPLETED|Washout Period 5||0
10632342|NCT02038829|11790505|FG001|NOT COMPLETED|Washout Period 5||0
10632343|NCT02038829|11790506|FG002|NOT COMPLETED|Washout Period 5||0
10632344|NCT02038829|11790507|FG003|NOT COMPLETED|Washout Period 5||0
10632345|NCT02038829|11790508|FG004|NOT COMPLETED|Washout Period 5||0
10632346|NCT02038829|11790509|FG005|NOT COMPLETED|Washout Period 5||0
10632347|NCT02038829|11790510|FG006|NOT COMPLETED|Washout Period 5||0
10632348|NCT02038829|11790511|FG007|NOT COMPLETED|Washout Period 5||0
10632349|NCT02038829|11790512|FG008|NOT COMPLETED|Washout Period 5||0
10632350|NCT02038829|11790513|FG009|NOT COMPLETED|Washout Period 5||0
10632351|NCT02038829|11790514|FG010|NOT COMPLETED|Washout Period 5||0
10632352|NCT02038829|11790515|FG011|NOT COMPLETED|Washout Period 5||0
10632353|NCT02038829|11790504|FG000|STARTED|Treatment Period 6||7
10632354|NCT02038829|11790505|FG001|STARTED|Treatment Period 6||7
10632355|NCT02038829|11790506|FG002|STARTED|Treatment Period 6||8
10632356|NCT02038829|11790507|FG003|STARTED|Treatment Period 6||8
10632357|NCT02038829|11790508|FG004|STARTED|Treatment Period 6||7
10632358|NCT02038829|11790509|FG005|STARTED|Treatment Period 6||7
10632359|NCT02038829|11790510|FG006|STARTED|Treatment Period 6||7
10632360|NCT02038829|11790511|FG007|STARTED|Treatment Period 6||8
10632361|NCT02038829|11790512|FG008|STARTED|Treatment Period 6||7
10632362|NCT02038829|11790513|FG009|STARTED|Treatment Period 6||8
10632363|NCT02038829|11790514|FG010|STARTED|Treatment Period 6||7
10632364|NCT02038829|11790515|FG011|STARTED|Treatment Period 6||8
10632365|NCT02038829|11790504|FG000|COMPLETED|Treatment Period 6||7
10632366|NCT02038829|11790505|FG001|COMPLETED|Treatment Period 6||7
10632367|NCT02038829|11790506|FG002|COMPLETED|Treatment Period 6||7
10632368|NCT02038829|11790507|FG003|COMPLETED|Treatment Period 6||8
10632369|NCT02038829|11790508|FG004|COMPLETED|Treatment Period 6||7
10632370|NCT02038829|11790509|FG005|COMPLETED|Treatment Period 6||7
10632371|NCT02038829|11790510|FG006|COMPLETED|Treatment Period 6||7
10632372|NCT02038829|11790511|FG007|COMPLETED|Treatment Period 6||8
10632373|NCT02038829|11790512|FG008|COMPLETED|Treatment Period 6||7
10632374|NCT02038829|11790513|FG009|COMPLETED|Treatment Period 6||8
10632375|NCT02038829|11790514|FG010|COMPLETED|Treatment Period 6||7
10632376|NCT02038829|11790515|FG011|COMPLETED|Treatment Period 6||8
10632377|NCT02038829|11790504|FG000|NOT COMPLETED|Treatment Period 6||0
10632378|NCT02038829|11790505|FG001|NOT COMPLETED|Treatment Period 6||0
10632379|NCT02038829|11790506|FG002|NOT COMPLETED|Treatment Period 6||1
10632380|NCT02038829|11790507|FG003|NOT COMPLETED|Treatment Period 6||0
10632381|NCT02038829|11790508|FG004|NOT COMPLETED|Treatment Period 6||0
10632382|NCT02038829|11790509|FG005|NOT COMPLETED|Treatment Period 6||0
10632383|NCT02038829|11790510|FG006|NOT COMPLETED|Treatment Period 6||0
10705608|NCT02601001|11870044|FG001|NOT COMPLETED|Dosing Period 2||0
10632384|NCT02038829|11790511|FG007|NOT COMPLETED|Treatment Period 6||0
10632385|NCT02038829|11790512|FG008|NOT COMPLETED|Treatment Period 6||0
10632386|NCT02038829|11790513|FG009|NOT COMPLETED|Treatment Period 6||0
10632387|NCT02038829|11790514|FG010|NOT COMPLETED|Treatment Period 6||0
10632388|NCT02038829|11790515|FG011|NOT COMPLETED|Treatment Period 6||0
10632389|NCT02038881|11790533|FG000|STARTED|Overall Study||27
10632390|NCT02038881|11790534|FG001|STARTED|Overall Study||29
10632391|NCT02038881|11790535|FG002|STARTED|Overall Study||31
10632392|NCT02038881|11790533|FG000|COMPLETED|Overall Study||24
10632393|NCT02038881|11790534|FG001|COMPLETED|Overall Study||29
10632394|NCT02038881|11790535|FG002|COMPLETED|Overall Study||30
10632395|NCT02038881|11790533|FG000|NOT COMPLETED|Overall Study||3
10632396|NCT02038881|11790534|FG001|NOT COMPLETED|Overall Study||0
10632397|NCT02038881|11790535|FG002|NOT COMPLETED|Overall Study||1
10632398|NCT02038894|11790548|FG000|STARTED|Overall Study||60
10632399|NCT02038894|11790549|FG001|STARTED|Overall Study||58
10632400|NCT02038894|11790550|FG002|STARTED|Overall Study||61
10632401|NCT02038894|11790548|FG000|COMPLETED|Overall Study||60
10632402|NCT02038894|11790549|FG001|COMPLETED|Overall Study||58
10632403|NCT02038894|11790550|FG002|COMPLETED|Overall Study||61
10632404|NCT02038894|11790548|FG000|NOT COMPLETED|Overall Study||0
10632405|NCT02038894|11790549|FG001|NOT COMPLETED|Overall Study||0
10632406|NCT02038894|11790550|FG002|NOT COMPLETED|Overall Study||0
10632407|NCT02038907|11790576|FG000|STARTED|Overall Study||30
10632408|NCT02038907|11790577|FG001|STARTED|Overall Study||30
10632409|NCT02038907|11790578|FG002|STARTED|Overall Study||30
10632410|NCT02038907|11790579|FG003|STARTED|Overall Study||31
10632411|NCT02038907|11790580|FG004|STARTED|Overall Study||30
10632412|NCT02038907|11790581|FG005|STARTED|Overall Study||31
10632413|NCT02038907|11790582|FG006|STARTED|Overall Study||30
10632414|NCT02038907|11790583|FG007|STARTED|Overall Study||32
10632415|NCT02038907|11790584|FG008|STARTED|Overall Study||29
10632416|NCT02038907|11790585|FG009|STARTED|Overall Study||30
10632417|NCT02038907|11790586|FG010|STARTED|Overall Study||29
10632418|NCT02038907|11790587|FG011|STARTED|Overall Study||28
10632419|NCT02038907|11790588|FG012|STARTED|Overall Study||29
10632420|NCT02038907|11790589|FG013|STARTED|Overall Study||31
10632421|NCT02038907|11790576|FG000|COMPLETED|Overall Study||30
10632422|NCT02038907|11790577|FG001|COMPLETED|Overall Study||30
10632423|NCT02038907|11790578|FG002|COMPLETED|Overall Study||30
10632424|NCT02038907|11790579|FG003|COMPLETED|Overall Study||31
10632425|NCT02038907|11790580|FG004|COMPLETED|Overall Study||30
10632426|NCT02038907|11790581|FG005|COMPLETED|Overall Study||31
10632427|NCT02038907|11790582|FG006|COMPLETED|Overall Study||30
10632428|NCT02038907|11790583|FG007|COMPLETED|Overall Study||32
10632429|NCT02038907|11790584|FG008|COMPLETED|Overall Study||29
10632430|NCT02038907|11790585|FG009|COMPLETED|Overall Study||30
10632431|NCT02038907|11790586|FG010|COMPLETED|Overall Study||27
10632432|NCT02038907|11790587|FG011|COMPLETED|Overall Study||28
10632433|NCT02038907|11790588|FG012|COMPLETED|Overall Study||29
10632434|NCT02038907|11790589|FG013|COMPLETED|Overall Study||31
10632435|NCT02038907|11790576|FG000|NOT COMPLETED|Overall Study||0
10632436|NCT02038907|11790577|FG001|NOT COMPLETED|Overall Study||0
10632437|NCT02038907|11790578|FG002|NOT COMPLETED|Overall Study||0
10632438|NCT02038907|11790579|FG003|NOT COMPLETED|Overall Study||0
10632439|NCT02038907|11790580|FG004|NOT COMPLETED|Overall Study||0
10632440|NCT02038907|11790581|FG005|NOT COMPLETED|Overall Study||0
10632441|NCT02038907|11790582|FG006|NOT COMPLETED|Overall Study||0
10632442|NCT02038907|11790583|FG007|NOT COMPLETED|Overall Study||0
10632443|NCT02038907|11790584|FG008|NOT COMPLETED|Overall Study||0
10632444|NCT02038907|11790585|FG009|NOT COMPLETED|Overall Study||0
10632445|NCT02038907|11790586|FG010|NOT COMPLETED|Overall Study||2
10632446|NCT02038907|11790587|FG011|NOT COMPLETED|Overall Study||0
10632447|NCT02038907|11790588|FG012|NOT COMPLETED|Overall Study||0
10632448|NCT02038907|11790589|FG013|NOT COMPLETED|Overall Study||0
10632449|NCT02038920|11790623|FG000|STARTED|Induction Phase (Week 0 to 14)||79
10632450|NCT02038920|11790624|FG001|STARTED|Induction Phase (Week 0 to 14)||78
10632451|NCT02038920|11790625|FG002|STARTED|Induction Phase (Week 0 to 14)||0
10632452|NCT02038920|11790626|FG003|STARTED|Induction Phase (Week 0 to 14)||0
10632453|NCT02038920|11790627|FG004|STARTED|Induction Phase (Week 0 to 14)||0
10632454|NCT02038920|11790628|FG005|STARTED|Induction Phase (Week 0 to 14)||0
10632455|NCT02038920|11790623|FG000|COMPLETED|Induction Phase (Week 0 to 14)||73
10632456|NCT02038920|11790624|FG001|COMPLETED|Induction Phase (Week 0 to 14)||66
10632457|NCT02038920|11790625|FG002|COMPLETED|Induction Phase (Week 0 to 14)||0
10705609|NCT02601001|11870045|FG002|NOT COMPLETED|Dosing Period 2||0
10705610|NCT02601001|11870046|FG003|NOT COMPLETED|Dosing Period 2||0
10705611|NCT02601001|11870047|FG004|NOT COMPLETED|Dosing Period 2||0
10705612|NCT02601001|11870048|FG005|NOT COMPLETED|Dosing Period 2||0
10705613|NCT02601001|11870049|FG006|NOT COMPLETED|Dosing Period 2||1
10705614|NCT02601027|11870072|FG000|STARTED|Registration to Surgery||64
10705615|NCT02601027|11870073|FG001|STARTED|Registration to Surgery||56
10705616|NCT02601027|11870072|FG000|COMPLETED|Registration to Surgery||44
10705617|NCT02601027|11870073|FG001|COMPLETED|Registration to Surgery||46
10705618|NCT02601027|11870072|FG000|NOT COMPLETED|Registration to Surgery||20
10705619|NCT02601027|11870073|FG001|NOT COMPLETED|Registration to Surgery||10
10705620|NCT02601027|11870072|FG000|STARTED|Surgery to Assessments||44
10705621|NCT02601027|11870073|FG001|STARTED|Surgery to Assessments||46
10705622|NCT02601027|11870072|FG000|COMPLETED|Surgery to Assessments||44
10705623|NCT02601027|11870073|FG001|COMPLETED|Surgery to Assessments||46
10705624|NCT02601027|11870072|FG000|NOT COMPLETED|Surgery to Assessments||0
10705625|NCT02601027|11870073|FG001|NOT COMPLETED|Surgery to Assessments||0
10632458|NCT02038920|11790626|FG003|COMPLETED|Induction Phase (Week 0 to 14)||0
10632459|NCT02038920|11790627|FG004|COMPLETED|Induction Phase (Week 0 to 14)||0
10632460|NCT02038920|11790628|FG005|COMPLETED|Induction Phase (Week 0 to 14)||0
10632461|NCT02038920|11790623|FG000|NOT COMPLETED|Induction Phase (Week 0 to 14)||6
10632462|NCT02038920|11790624|FG001|NOT COMPLETED|Induction Phase (Week 0 to 14)||12
10632463|NCT02038920|11790625|FG002|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
10632464|NCT02038920|11790626|FG003|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
10632465|NCT02038920|11790627|FG004|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
10632466|NCT02038920|11790628|FG005|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
10632467|NCT02038920|11790623|FG000|STARTED|Maintenance Phase (Week 14 to 60)||0
10632468|NCT02038920|11790624|FG001|STARTED|Maintenance Phase (Week 14 to 60)||0
10632469|NCT02038920|11790625|FG002|STARTED|Maintenance Phase (Week 14 to 60)||12
10632470|NCT02038920|11790626|FG003|STARTED|Maintenance Phase (Week 14 to 60)||12
10632471|NCT02038920|11790627|FG004|STARTED|Maintenance Phase (Week 14 to 60)||17
10632472|NCT02038920|11790628|FG005|STARTED|Maintenance Phase (Week 14 to 60)||0
10705626|NCT02601105|11870079|FG000|STARTED|Placebo Cream; Centella Asiatica Bsln.||15
10632473|NCT02038920|11790623|FG000|COMPLETED|Maintenance Phase (Week 14 to 60)||0
10632474|NCT02038920|11790624|FG001|COMPLETED|Maintenance Phase (Week 14 to 60)||0
10632475|NCT02038920|11790625|FG002|COMPLETED|Maintenance Phase (Week 14 to 60)||7
10632476|NCT02038920|11790626|FG003|COMPLETED|Maintenance Phase (Week 14 to 60)||4
10632477|NCT02038920|11790627|FG004|COMPLETED|Maintenance Phase (Week 14 to 60)||5
10632478|NCT02038920|11790628|FG005|COMPLETED|Maintenance Phase (Week 14 to 60)||0
10632479|NCT02038920|11790623|FG000|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||0
10632480|NCT02038920|11790624|FG001|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||0
10632481|NCT02038920|11790625|FG002|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||5
10632482|NCT02038920|11790626|FG003|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||8
10632483|NCT02038920|11790627|FG004|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||12
10632484|NCT02038920|11790628|FG005|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||0
10632485|NCT02038920|11790623|FG000|STARTED|Open Label Cohort (Week 10 to 154)||0
10632486|NCT02038920|11790624|FG001|STARTED|Open Label Cohort (Week 10 to 154)||0
10632487|NCT02038920|11790625|FG002|STARTED|Open Label Cohort (Week 10 to 154)||0
10632488|NCT02038920|11790626|FG003|STARTED|Open Label Cohort (Week 10 to 154)||0
10632489|NCT02038920|11790627|FG004|STARTED|Open Label Cohort (Week 10 to 154)||0
10632490|NCT02038920|11790628|FG005|STARTED|Open Label Cohort (Week 10 to 154)||134
10632491|NCT02038920|11790623|FG000|COMPLETED|Open Label Cohort (Week 10 to 154)||0
10632492|NCT02038920|11790624|FG001|COMPLETED|Open Label Cohort (Week 10 to 154)||0
10632493|NCT02038920|11790625|FG002|COMPLETED|Open Label Cohort (Week 10 to 154)||0
10632494|NCT02038920|11790626|FG003|COMPLETED|Open Label Cohort (Week 10 to 154)||0
10632495|NCT02038920|11790627|FG004|COMPLETED|Open Label Cohort (Week 10 to 154)||0
10632496|NCT02038920|11790628|FG005|COMPLETED|Open Label Cohort (Week 10 to 154)||57
10632497|NCT02038920|11790623|FG000|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
10632498|NCT02038920|11790624|FG001|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
10632499|NCT02038920|11790625|FG002|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
10632500|NCT02038920|11790626|FG003|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
10632501|NCT02038920|11790627|FG004|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
10632502|NCT02038920|11790628|FG005|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||77
10632503|NCT02038933|11790647|FG000|STARTED|Overall Study||121
10632504|NCT02038933|11790647|FG000|COMPLETED|Overall Study||0
10632505|NCT02038933|11790647|FG000|NOT COMPLETED|Overall Study||121
10632506|NCT02038959|11790654|FG000|STARTED|Overall Study||98
10632507|NCT02038959|11790655|FG001|STARTED|Overall Study||97
10632508|NCT02038959|11790654|FG000|COMPLETED|Overall Study||92
10632509|NCT02038959|11790655|FG001|COMPLETED|Overall Study||89
10632510|NCT02038959|11790654|FG000|NOT COMPLETED|Overall Study||6
10632511|NCT02038959|11790655|FG001|NOT COMPLETED|Overall Study||8
10632512|NCT02039115|11790663|FG000|STARTED|Overall Study||1
10632513|NCT02039115|11790664|FG001|STARTED|Overall Study||0
10632514|NCT02039115|11790663|FG000|COMPLETED|Overall Study||1
10632515|NCT02039115|11790664|FG001|COMPLETED|Overall Study||0
10632516|NCT02039115|11790663|FG000|NOT COMPLETED|Overall Study||0
10632517|NCT02039115|11790664|FG001|NOT COMPLETED|Overall Study||0
10632518|NCT02039219|11790672|FG000|STARTED|Treatment||11
10632519|NCT02039219|11790673|FG001|STARTED|Treatment||8
10632520|NCT02039219|11790672|FG000|COMPLETED|Treatment||7
10632521|NCT02039219|11790673|FG001|COMPLETED|Treatment||6
10632522|NCT02039219|11790672|FG000|NOT COMPLETED|Treatment||4
10632523|NCT02039219|11790673|FG001|NOT COMPLETED|Treatment||2
10632524|NCT02039219|11790672|FG000|STARTED|Follow up||7
10632525|NCT02039219|11790673|FG001|STARTED|Follow up||6
10632526|NCT02039219|11790672|FG000|COMPLETED|Follow up||7
10632527|NCT02039219|11790673|FG001|COMPLETED|Follow up||5
10632528|NCT02039219|11790672|FG000|NOT COMPLETED|Follow up||0
10632529|NCT02039219|11790673|FG001|NOT COMPLETED|Follow up||1
10632530|NCT02039375|11790679|FG000|STARTED|Overall Study||35
10632531|NCT02039375|11790679|FG000|COMPLETED|Overall Study||33
10632532|NCT02039375|11790679|FG000|NOT COMPLETED|Overall Study||2
10632533|NCT02039414|11790685|FG000|STARTED|Overall Study||22
10632534|NCT02039414|11790686|FG001|STARTED|Overall Study||18
10632535|NCT02039414|11790685|FG000|COMPLETED|Overall Study||16
10632536|NCT02039414|11790686|FG001|COMPLETED|Overall Study||16
10632537|NCT02039414|11790685|FG000|NOT COMPLETED|Overall Study||6
10632538|NCT02039414|11790686|FG001|NOT COMPLETED|Overall Study||2
10632539|NCT02039427|11790696|FG000|STARTED|Overall Study||48
10632540|NCT02039427|11790697|FG001|STARTED|Overall Study||48
10632541|NCT02039427|11790698|FG002|STARTED|Overall Study||48
10632542|NCT02039427|11790699|FG003|STARTED|Overall Study||48
10632543|NCT02039427|11790696|FG000|COMPLETED|Overall Study||45
10632544|NCT02039427|11790697|FG001|COMPLETED|Overall Study||47
10632545|NCT02039427|11790698|FG002|COMPLETED|Overall Study||45
10632546|NCT02039427|11790699|FG003|COMPLETED|Overall Study||43
10632547|NCT02039427|11790696|FG000|NOT COMPLETED|Overall Study||3
10632548|NCT02039427|11790697|FG001|NOT COMPLETED|Overall Study||1
10632549|NCT02039427|11790698|FG002|NOT COMPLETED|Overall Study||3
10632550|NCT02039427|11790699|FG003|NOT COMPLETED|Overall Study||5
10632551|NCT02039505|11790716|FG000|STARTED|Induction Phase (Week 0 to Week 14)||82
10632552|NCT02039505|11790717|FG001|STARTED|Induction Phase (Week 0 to Week 14)||164
10632553|NCT02039505|11790718|FG002|STARTED|Induction Phase (Week 0 to Week 14)||46
10632554|NCT02039505|11790719|FG003|STARTED|Induction Phase (Week 0 to Week 14)||0
10632555|NCT02039505|11790720|FG004|STARTED|Induction Phase (Week 0 to Week 14)||0
10632556|NCT02039505|11790721|FG005|STARTED|Induction Phase (Week 0 to Week 14)||0
10632557|NCT02039505|11790722|FG006|STARTED|Induction Phase (Week 0 to Week 14)||0
10632558|NCT02039505|11790716|FG000|COMPLETED|Induction Phase (Week 0 to Week 14)||78
10632559|NCT02039505|11790717|FG001|COMPLETED|Induction Phase (Week 0 to Week 14)||155
10632560|NCT02039505|11790718|FG002|COMPLETED|Induction Phase (Week 0 to Week 14)||36
10632561|NCT02039505|11790719|FG003|COMPLETED|Induction Phase (Week 0 to Week 14)||0
10632562|NCT02039505|11790720|FG004|COMPLETED|Induction Phase (Week 0 to Week 14)||0
10632563|NCT02039505|11790721|FG005|COMPLETED|Induction Phase (Week 0 to Week 14)||0
10632564|NCT02039505|11790722|FG006|COMPLETED|Induction Phase (Week 0 to Week 14)||0
10632565|NCT02039505|11790716|FG000|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||4
10632566|NCT02039505|11790717|FG001|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||9
10632567|NCT02039505|11790718|FG002|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||10
10632568|NCT02039505|11790719|FG003|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
10632569|NCT02039505|11790720|FG004|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
10632570|NCT02039505|11790721|FG005|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
10632571|NCT02039505|11790722|FG006|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
10632572|NCT02039505|11790716|FG000|STARTED|Maintenance Phase (Week 14 to Week 60)||0
10632573|NCT02039505|11790717|FG001|STARTED|Maintenance Phase (Week 14 to Week 60)||0
10632574|NCT02039505|11790718|FG002|STARTED|Maintenance Phase (Week 14 to Week 60)||0
10632575|NCT02039505|11790719|FG003|STARTED|Maintenance Phase (Week 14 to Week 60)||42
10632576|NCT02039505|11790720|FG004|STARTED|Maintenance Phase (Week 14 to Week 60)||41
10632577|NCT02039505|11790721|FG005|STARTED|Maintenance Phase (Week 14 to Week 60)||26
10632578|NCT02039505|11790722|FG006|STARTED|Maintenance Phase (Week 14 to Week 60)||0
10632579|NCT02039505|11790716|FG000|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
10632580|NCT02039505|11790717|FG001|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
10632581|NCT02039505|11790718|FG002|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
10632582|NCT02039505|11790719|FG003|COMPLETED|Maintenance Phase (Week 14 to Week 60)||18
10632583|NCT02039505|11790720|FG004|COMPLETED|Maintenance Phase (Week 14 to Week 60)||30
10632584|NCT02039505|11790721|FG005|COMPLETED|Maintenance Phase (Week 14 to Week 60)||12
10632585|NCT02039505|11790722|FG006|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
10632586|NCT02039505|11790716|FG000|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
10632587|NCT02039505|11790717|FG001|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
10632588|NCT02039505|11790718|FG002|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
10632589|NCT02039505|11790719|FG003|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||24
10632590|NCT02039505|11790720|FG004|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||11
10632591|NCT02039505|11790721|FG005|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||14
10632592|NCT02039505|11790722|FG006|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
10632593|NCT02039505|11790716|FG000|STARTED|Open-Label (Week 10 up to Week 154)||0
10632594|NCT02039505|11790717|FG001|STARTED|Open-Label (Week 10 up to Week 154)||0
10632595|NCT02039505|11790718|FG002|STARTED|Open-Label (Week 10 up to Week 154)||0
10632596|NCT02039505|11790719|FG003|STARTED|Open-Label (Week 10 up to Week 154)||0
10632597|NCT02039505|11790720|FG004|STARTED|Open-Label (Week 10 up to Week 154)||0
10632598|NCT02039505|11790721|FG005|STARTED|Open-Label (Week 10 up to Week 154)||0
10632599|NCT02039505|11790722|FG006|STARTED|Open-Label (Week 10 up to Week 154)||259
10632600|NCT02039505|11790716|FG000|COMPLETED|Open-Label (Week 10 up to Week 154)||0
10632601|NCT02039505|11790717|FG001|COMPLETED|Open-Label (Week 10 up to Week 154)||0
10632602|NCT02039505|11790718|FG002|COMPLETED|Open-Label (Week 10 up to Week 154)||0
10632603|NCT02039505|11790719|FG003|COMPLETED|Open-Label (Week 10 up to Week 154)||0
10632604|NCT02039505|11790720|FG004|COMPLETED|Open-Label (Week 10 up to Week 154)||0
10632605|NCT02039505|11790721|FG005|COMPLETED|Open-Label (Week 10 up to Week 154)||0
10632606|NCT02039505|11790722|FG006|COMPLETED|Open-Label (Week 10 up to Week 154)||188
10632607|NCT02039505|11790716|FG000|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
10632608|NCT02039505|11790717|FG001|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
10632609|NCT02039505|11790718|FG002|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
10632610|NCT02039505|11790719|FG003|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
10632611|NCT02039505|11790720|FG004|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
10632612|NCT02039505|11790721|FG005|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
10632613|NCT02039505|11790722|FG006|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||71
10632614|NCT02039674|11790756|FG000|STARTED|Overall Study||13
10632615|NCT02039674|11790757|FG001|STARTED|Overall Study||12
10632616|NCT02039674|11790758|FG002|STARTED|Overall Study||12
10632617|NCT02039674|11790759|FG003|STARTED|Overall Study||13
10632618|NCT02039674|11790760|FG004|STARTED|Overall Study||12
10632619|NCT02039674|11790761|FG005|STARTED|Overall Study||12
10632620|NCT02039674|11790762|FG006|STARTED|Overall Study||3
10632621|NCT02039674|11790763|FG007|STARTED|Overall Study||3
10632622|NCT02039674|11790764|FG008|STARTED|Overall Study||12
10632623|NCT02039674|11790765|FG009|STARTED|Overall Study||12
10632624|NCT02039674|11790766|FG010|STARTED|Overall Study||7
10632625|NCT02039674|11790767|FG011|STARTED|Overall Study||60
10632626|NCT02039674|11790768|FG012|STARTED|Overall Study||63
10632627|NCT02039674|11790769|FG013|STARTED|Overall Study||33
10632628|NCT02039674|11790756|FG000|Treated|Overall Study||13
10632629|NCT02039674|11790757|FG001|Treated|Overall Study||12
10632630|NCT02039674|11790758|FG002|Treated|Overall Study||11
10632631|NCT02039674|11790759|FG003|Treated|Overall Study||13
10632632|NCT02039674|11790760|FG004|Treated|Overall Study||12
10632633|NCT02039674|11790761|FG005|Treated|Overall Study||12
10632634|NCT02039674|11790762|FG006|Treated|Overall Study||3
10632635|NCT02039674|11790763|FG007|Treated|Overall Study||3
10632636|NCT02039674|11790764|FG008|Treated|Overall Study||12
10632637|NCT02039674|11790765|FG009|Treated|Overall Study||12
10632638|NCT02039674|11790766|FG010|Treated|Overall Study||7
10632639|NCT02039674|11790767|FG011|Treated|Overall Study||59
10632640|NCT02039674|11790768|FG012|Treated|Overall Study||62
10632641|NCT02039674|11790769|FG013|Treated|Overall Study||33
10632642|NCT02039674|11790756|FG000|COMPLETED|Overall Study||1
10632643|NCT02039674|11790757|FG001|COMPLETED|Overall Study||0
10632644|NCT02039674|11790758|FG002|COMPLETED|Overall Study||0
10632645|NCT02039674|11790759|FG003|COMPLETED|Overall Study||0
10632646|NCT02039674|11790760|FG004|COMPLETED|Overall Study||0
10632647|NCT02039674|11790761|FG005|COMPLETED|Overall Study||0
10632648|NCT02039674|11790762|FG006|COMPLETED|Overall Study||0
10632649|NCT02039674|11790763|FG007|COMPLETED|Overall Study||0
10632650|NCT02039674|11790764|FG008|COMPLETED|Overall Study||0
10632651|NCT02039674|11790765|FG009|COMPLETED|Overall Study||0
10632652|NCT02039674|11790766|FG010|COMPLETED|Overall Study||0
10632653|NCT02039674|11790767|FG011|COMPLETED|Overall Study||0
10632654|NCT02039674|11790768|FG012|COMPLETED|Overall Study||0
10632655|NCT02039674|11790769|FG013|COMPLETED|Overall Study||0
10632656|NCT02039674|11790756|FG000|NOT COMPLETED|Overall Study||12
10632657|NCT02039674|11790757|FG001|NOT COMPLETED|Overall Study||12
10632658|NCT02039674|11790758|FG002|NOT COMPLETED|Overall Study||12
10632659|NCT02039674|11790759|FG003|NOT COMPLETED|Overall Study||13
10632660|NCT02039674|11790760|FG004|NOT COMPLETED|Overall Study||12
10632661|NCT02039674|11790761|FG005|NOT COMPLETED|Overall Study||12
10632662|NCT02039674|11790762|FG006|NOT COMPLETED|Overall Study||3
10632663|NCT02039674|11790763|FG007|NOT COMPLETED|Overall Study||3
10632664|NCT02039674|11790764|FG008|NOT COMPLETED|Overall Study||12
10632665|NCT02039674|11790765|FG009|NOT COMPLETED|Overall Study||12
10632666|NCT02039674|11790766|FG010|NOT COMPLETED|Overall Study||7
10632667|NCT02039674|11790767|FG011|NOT COMPLETED|Overall Study||60
10632668|NCT02039674|11790768|FG012|NOT COMPLETED|Overall Study||63
10632669|NCT02039674|11790769|FG013|NOT COMPLETED|Overall Study||33
10632670|NCT02039687|11790806|FG000|STARTED|Overall Study||16
10632671|NCT02039687|11790807|FG001|STARTED|Overall Study||16
10632672|NCT02039687|11790808|FG002|STARTED|Overall Study||16
10632673|NCT02039687|11790809|FG003|STARTED|Overall Study||16
10632674|NCT02039687|11790806|FG000|COMPLETED|Overall Study||16
10632675|NCT02039687|11790807|FG001|COMPLETED|Overall Study||15
10632676|NCT02039687|11790808|FG002|COMPLETED|Overall Study||13
10632677|NCT02039687|11790809|FG003|COMPLETED|Overall Study||16
10632678|NCT02039687|11790806|FG000|NOT COMPLETED|Overall Study||0
10632679|NCT02039687|11790807|FG001|NOT COMPLETED|Overall Study||1
10632680|NCT02039687|11790808|FG002|NOT COMPLETED|Overall Study||3
10632681|NCT02039687|11790809|FG003|NOT COMPLETED|Overall Study||0
10632682|NCT02039726|11790821|FG000|STARTED|Overall Study||245
10632683|NCT02039726|11790822|FG001|STARTED|Overall Study||122
10632684|NCT02039726|11790821|FG000|Ongoing (as of Data Cutoff)|Overall Study||45
10632685|NCT02039726|11790822|FG001|Ongoing (as of Data Cutoff)|Overall Study||16
10632686|NCT02039726|11790821|FG000|Did Not Receive Treatment|Overall Study||4
10632687|NCT02039726|11790822|FG001|Did Not Receive Treatment|Overall Study||28
10632688|NCT02039726|11790821|FG000|COMPLETED|Overall Study||200
10632689|NCT02039726|11790822|FG001|COMPLETED|Overall Study||106
10632690|NCT02039726|11790821|FG000|NOT COMPLETED|Overall Study||45
10632691|NCT02039726|11790822|FG001|NOT COMPLETED|Overall Study||16
10632692|NCT02039778|11790828|FG000|STARTED|Overall Study||4
10632693|NCT02039778|11790828|FG000|COMPLETED|Overall Study||0
10632694|NCT02039778|11790828|FG000|NOT COMPLETED|Overall Study||4
10632695|NCT02039817|11790834|FG000|STARTED|Overall Study||8
10632696|NCT02039817|11790835|FG001|STARTED|Overall Study||8
10632697|NCT02039817|11790834|FG000|COMPLETED|Overall Study||8
10632698|NCT02039817|11790835|FG001|COMPLETED|Overall Study||8
10632699|NCT02039817|11790834|FG000|NOT COMPLETED|Overall Study||0
10632700|NCT02039817|11790835|FG001|NOT COMPLETED|Overall Study||0
10632701|NCT02039856|11790842|FG000|STARTED|Overall Study||2720
10632702|NCT02039856|11790843|FG001|STARTED|Overall Study||1180
10632703|NCT02039856|11790842|FG000|Baseline Started - Patients|Overall Study||2183
10632704|NCT02039856|11790843|FG001|Baseline Started - Patients|Overall Study||919
10632705|NCT02039856|11790842|FG000|Baseline Completed - Patients|Overall Study||953
10632706|NCT02039856|11790843|FG001|Baseline Completed - Patients|Overall Study||442
10632707|NCT02039856|11790842|FG000|Baseline Started - Providers/Staff|Overall Study||537
10632708|NCT02039856|11790843|FG001|Baseline Started - Providers/Staff|Overall Study||261
10632709|NCT02039856|11790842|FG000|Baseline Completed -Providers/Staff|Overall Study||194
10632710|NCT02039856|11790843|FG001|Baseline Completed -Providers/Staff|Overall Study||94
10632711|NCT02039856|11790842|FG000|Total Baseline Completed|Overall Study||1147
10632712|NCT02039856|11790843|FG001|Total Baseline Completed|Overall Study||536
10632713|NCT02039856|11790842|FG000|12-month Started-patients|Overall Study||953
10632714|NCT02039856|11790843|FG001|12-month Started-patients|Overall Study||442
10632715|NCT02039856|11790842|FG000|12-month Completed- Patients|Overall Study||580
10632716|NCT02039856|11790843|FG001|12-month Completed- Patients|Overall Study||241
10632717|NCT02039856|11790842|FG000|12-month Providers/Staff|Overall Study||0
10632718|NCT02039856|11790843|FG001|12-month Providers/Staff|Overall Study||0
10632719|NCT02039856|11790842|FG000|24-month Started|Overall Study||1518
10632720|NCT02039856|11790843|FG001|24-month Started|Overall Study||746
10632721|NCT02039856|11790842|FG000|24-month Started - Patients|Overall Study||953
10632722|NCT02039856|11790843|FG001|24-month Started - Patients|Overall Study||442
10632723|NCT02039856|11790842|FG000|24-month Completed - Patients|Overall Study||519
10632724|NCT02039856|11790843|FG001|24-month Completed - Patients|Overall Study||222
10632725|NCT02039856|11790842|FG000|24-month Started Providers/Staff|Overall Study||565
10632726|NCT02039856|11790843|FG001|24-month Started Providers/Staff|Overall Study||304
10632727|NCT02039856|11790842|FG000|24-month Completed Providers/Staff|Overall Study||174
10632728|NCT02039856|11790843|FG001|24-month Completed Providers/Staff|Overall Study||105
10632729|NCT02039856|11790842|FG000|Total 24-month Completed|Overall Study||693
10632730|NCT02039856|11790843|FG001|Total 24-month Completed|Overall Study||327
10632731|NCT02039856|11790842|FG000|COMPLETED|Overall Study||693
10632732|NCT02039856|11790843|FG001|COMPLETED|Overall Study||327
10632733|NCT02039856|11790842|FG000|NOT COMPLETED|Overall Study||2027
10632734|NCT02039856|11790843|FG001|NOT COMPLETED|Overall Study||853
10632735|NCT02039908|11790851|FG000|STARTED|Phase 1-Summer||129
10632736|NCT02039908|11790852|FG001|STARTED|Phase 1-Summer||138
10632737|NCT02039908|11790853|FG002|STARTED|Phase 1-Summer||0
10632738|NCT02039908|11790854|FG003|STARTED|Phase 1-Summer||0
10632739|NCT02039908|11790851|FG000|COMPLETED|Phase 1-Summer||116
10632740|NCT02039908|11790852|FG001|COMPLETED|Phase 1-Summer||132
10632741|NCT02039908|11790853|FG002|COMPLETED|Phase 1-Summer||0
10632742|NCT02039908|11790854|FG003|COMPLETED|Phase 1-Summer||0
10632743|NCT02039908|11790851|FG000|NOT COMPLETED|Phase 1-Summer||13
10632744|NCT02039908|11790852|FG001|NOT COMPLETED|Phase 1-Summer||6
10632745|NCT02039908|11790853|FG002|NOT COMPLETED|Phase 1-Summer||0
10632746|NCT02039908|11790854|FG003|NOT COMPLETED|Phase 1-Summer||0
10632747|NCT02039908|11790851|FG000|STARTED|Phase 2-School Year||0
10632748|NCT02039908|11790852|FG001|STARTED|Phase 2-School Year||0
10632749|NCT02039908|11790853|FG002|STARTED|Phase 2-School Year||121
10632750|NCT02039908|11790854|FG003|STARTED|Phase 2-School Year||124
10632751|NCT02039908|11790851|FG000|COMPLETED|Phase 2-School Year||0
10632752|NCT02039908|11790852|FG001|COMPLETED|Phase 2-School Year||0
10632753|NCT02039908|11790853|FG002|COMPLETED|Phase 2-School Year||109
10632754|NCT02039908|11790854|FG003|COMPLETED|Phase 2-School Year||116
10632755|NCT02039908|11790851|FG000|NOT COMPLETED|Phase 2-School Year||0
10632756|NCT02039908|11790852|FG001|NOT COMPLETED|Phase 2-School Year||0
10632757|NCT02039908|11790853|FG002|NOT COMPLETED|Phase 2-School Year||12
10632758|NCT02039908|11790854|FG003|NOT COMPLETED|Phase 2-School Year||8
10632759|NCT02039947|11790866|FG000|STARTED|Overall Study||76
10632760|NCT02039947|11790867|FG001|STARTED|Overall Study||16
10632761|NCT02039947|11790868|FG002|STARTED|Overall Study||16
10632762|NCT02039947|11790869|FG003|STARTED|Overall Study||17
10632763|NCT02039947|11790866|FG000|COMPLETED|Overall Study||76
10632764|NCT02039947|11790867|FG001|COMPLETED|Overall Study||16
10632765|NCT02039947|11790868|FG002|COMPLETED|Overall Study||16
10632766|NCT02039947|11790869|FG003|COMPLETED|Overall Study||17
10632767|NCT02039947|11790866|FG000|NOT COMPLETED|Overall Study||0
10632768|NCT02039947|11790867|FG001|NOT COMPLETED|Overall Study||0
10632769|NCT02039947|11790868|FG002|NOT COMPLETED|Overall Study||0
10632770|NCT02039947|11790869|FG003|NOT COMPLETED|Overall Study||0
10632771|NCT02040077|11790886|FG000|STARTED|Overall Study||27
10632772|NCT02040077|11790887|FG001|STARTED|Overall Study||24
10632773|NCT02040077|11790888|FG002|STARTED|Overall Study||25
10632774|NCT02040077|11790886|FG000|COMPLETED|Overall Study||27
10632775|NCT02040077|11790887|FG001|COMPLETED|Overall Study||24
10632776|NCT02040077|11790888|FG002|COMPLETED|Overall Study||25
10632777|NCT02040077|11790886|FG000|NOT COMPLETED|Overall Study||0
10632778|NCT02040077|11790887|FG001|NOT COMPLETED|Overall Study||0
10632779|NCT02040077|11790888|FG002|NOT COMPLETED|Overall Study||0
10632780|NCT02040090|11790899|FG000|STARTED|Overall Study||59
10632781|NCT02040090|11790900|FG001|STARTED|Overall Study||59
10632782|NCT02040090|11790899|FG000|COMPLETED|Overall Study||56
10632783|NCT02040090|11790900|FG001|COMPLETED|Overall Study||57
10632784|NCT02040090|11790899|FG000|NOT COMPLETED|Overall Study||3
10632785|NCT02040090|11790900|FG001|NOT COMPLETED|Overall Study||2
10632786|NCT02040116|11790906|FG000|STARTED|Overall Study||19
10632787|NCT02040116|11790906|FG000|COMPLETED|Overall Study||19
10632788|NCT02040116|11790906|FG000|NOT COMPLETED|Overall Study||0
10632789|NCT02040259|11790914|FG000|STARTED|Overall Study||2008
10632790|NCT02040259|11790914|FG000|COMPLETED|Overall Study||1645
10632791|NCT02040259|11790914|FG000|NOT COMPLETED|Overall Study||363
10632792|NCT02040298|11790922|FG000|STARTED|First Intervention (3 Months)||25
10632793|NCT02040298|11790923|FG001|STARTED|First Intervention (3 Months)||25
10632794|NCT02040298|11790922|FG000|COMPLETED|First Intervention (3 Months)||25
10632795|NCT02040298|11790923|FG001|COMPLETED|First Intervention (3 Months)||25
10632796|NCT02040298|11790922|FG000|NOT COMPLETED|First Intervention (3 Months)||0
10632797|NCT02040298|11790923|FG001|NOT COMPLETED|First Intervention (3 Months)||0
10632798|NCT02040298|11790922|FG000|STARTED|Second Intervention (2 Months)||25
10632799|NCT02040298|11790923|FG001|STARTED|Second Intervention (2 Months)||25
10632800|NCT02040298|11790922|FG000|COMPLETED|Second Intervention (2 Months)||25
10632801|NCT02040298|11790923|FG001|COMPLETED|Second Intervention (2 Months)||25
10632802|NCT02040298|11790922|FG000|NOT COMPLETED|Second Intervention (2 Months)||0
10632803|NCT02040298|11790923|FG001|NOT COMPLETED|Second Intervention (2 Months)||0
10632804|NCT02040428|11790937|FG000|STARTED|Overall Study||75
10632805|NCT02040428|11790938|FG001|STARTED|Overall Study||81
10632806|NCT02040428|11790937|FG000|Intent to Treat (Randomized Subjects)|Overall Study||76
10632807|NCT02040428|11790938|FG001|Intent to Treat (Randomized Subjects)|Overall Study||80
10632808|NCT02040428|11790937|FG000|COMPLETED|Overall Study||70
10632809|NCT02040428|11790938|FG001|COMPLETED|Overall Study||77
10632810|NCT02040428|11790937|FG000|NOT COMPLETED|Overall Study||5
10632811|NCT02040428|11790938|FG001|NOT COMPLETED|Overall Study||4
10632812|NCT02040532|11790944|FG000|STARTED|Overall Study||32
10632813|NCT02040532|11790944|FG000|Received at Least One Dose of Medication|Overall Study||26
10632814|NCT02040532|11790944|FG000|COMPLETED|Overall Study||20
10632815|NCT02040532|11790944|FG000|NOT COMPLETED|Overall Study||12
10632816|NCT02040623|11790951|FG000|STARTED|Overall Study||11
10632817|NCT02040623|11790952|FG001|STARTED|Overall Study||12
10632818|NCT02040623|11790953|FG002|STARTED|Overall Study||12
10632819|NCT02040623|11790951|FG000|COMPLETED|Overall Study||7
10632820|NCT02040623|11790952|FG001|COMPLETED|Overall Study||6
10632821|NCT02040623|11790953|FG002|COMPLETED|Overall Study||10
10632822|NCT02040623|11790951|FG000|NOT COMPLETED|Overall Study||4
10632823|NCT02040623|11790952|FG001|NOT COMPLETED|Overall Study||6
10632824|NCT02040623|11790953|FG002|NOT COMPLETED|Overall Study||2
10632825|NCT02040766|11790966|FG000|STARTED|Overall Study||127
10632826|NCT02040766|11790967|FG001|STARTED|Overall Study||126
10632827|NCT02040766|11790968|FG002|STARTED|Overall Study||125
10632828|NCT02040766|11790969|FG003|STARTED|Overall Study||125
10632829|NCT02040766|11790970|FG004|STARTED|Overall Study||125
10632830|NCT02040766|11790966|FG000|COMPLETED|Overall Study||109
10632831|NCT02040766|11790967|FG001|COMPLETED|Overall Study||116
10632832|NCT02040766|11790968|FG002|COMPLETED|Overall Study||113
10632833|NCT02040766|11790969|FG003|COMPLETED|Overall Study||112
10632834|NCT02040766|11790970|FG004|COMPLETED|Overall Study||112
10632835|NCT02040766|11790966|FG000|NOT COMPLETED|Overall Study||18
10632836|NCT02040766|11790967|FG001|NOT COMPLETED|Overall Study||10
10632837|NCT02040766|11790968|FG002|NOT COMPLETED|Overall Study||12
10632838|NCT02040766|11790969|FG003|NOT COMPLETED|Overall Study||13
10632839|NCT02040766|11790970|FG004|NOT COMPLETED|Overall Study||13
10632840|NCT02040779|11790986|FG000|STARTED|Overall Study||91
10632841|NCT02040779|11790987|FG001|STARTED|Overall Study||90
10632842|NCT02040779|11790988|FG002|STARTED|Overall Study||92
10632843|NCT02040779|11790986|FG000|Full Analysis Set (FAS)|Overall Study||90
10632844|NCT02040779|11790987|FG001|Full Analysis Set (FAS)|Overall Study||88
10632845|NCT02040779|11790988|FG002|Full Analysis Set (FAS)|Overall Study||92
10632846|NCT02040779|11790986|FG000|COMPLETED|Overall Study||79
10632847|NCT02040779|11790987|FG001|COMPLETED|Overall Study||83
10632848|NCT02040779|11790988|FG002|COMPLETED|Overall Study||88
10632849|NCT02040779|11790986|FG000|NOT COMPLETED|Overall Study||12
10632850|NCT02040779|11790987|FG001|NOT COMPLETED|Overall Study||7
10632851|NCT02040779|11790988|FG002|NOT COMPLETED|Overall Study||4
10632852|NCT02040805|11790998|FG000|STARTED|Overall Study||160
10632853|NCT02040805|11790999|FG001|STARTED|Overall Study||163
10632854|NCT02040805|11790998|FG000|COMPLETED|Overall Study||118
10632855|NCT02040805|11790999|FG001|COMPLETED|Overall Study||113
10632856|NCT02040805|11790998|FG000|NOT COMPLETED|Overall Study||42
10632857|NCT02040805|11790999|FG001|NOT COMPLETED|Overall Study||50
10632858|NCT02040844|11791008|FG000|STARTED|Overall Study||138
10632859|NCT02040844|11791009|FG001|STARTED|Overall Study||148
10632860|NCT02040844|11791010|FG002|STARTED|Overall Study||144
10632861|NCT02040844|11791008|FG000|COMPLETED|Overall Study||88
10632862|NCT02040844|11791009|FG001|COMPLETED|Overall Study||109
10632863|NCT02040844|11791010|FG002|COMPLETED|Overall Study||97
10632864|NCT02040844|11791008|FG000|NOT COMPLETED|Overall Study||50
10632865|NCT02040844|11791009|FG001|NOT COMPLETED|Overall Study||39
10632866|NCT02040844|11791010|FG002|NOT COMPLETED|Overall Study||47
10632867|NCT02040870|11791018|FG000|STARTED|Overall Study||103
10632868|NCT02040870|11791018|FG000|Entered Post-treatment Follow-up|Overall Study||2
10632869|NCT02040870|11791018|FG000|Entered Survival Follow-up|Overall Study||75
10632870|NCT02040870|11791018|FG000|Discontinue From Study|Overall Study||26
10632871|NCT02040870|11791018|FG000|COMPLETED|Overall Study||0
10632872|NCT02040870|11791018|FG000|NOT COMPLETED|Overall Study||103
10632873|NCT02041091|11791024|FG000|STARTED|Treatment||112
10632874|NCT02041091|11791025|FG001|STARTED|Treatment||114
10632875|NCT02041091|11791024|FG000|Received At Least One Dose of Study Drug|Treatment||112
10632876|NCT02041091|11791025|FG001|Received At Least One Dose of Study Drug|Treatment||114
10632877|NCT02041091|11791024|FG000|Participated in Follow Up|Treatment||106
10632878|NCT02041091|11791025|FG001|Participated in Follow Up|Treatment||96
10632879|NCT02041091|11791024|FG000|COMPLETED|Treatment||90
10632880|NCT02041091|11791025|FG001|COMPLETED|Treatment||91
10632881|NCT02041091|11791024|FG000|NOT COMPLETED|Treatment||22
10632882|NCT02041091|11791025|FG001|NOT COMPLETED|Treatment||23
10632883|NCT02041091|11791024|FG000|STARTED|Optional Safety Extension Period|Participation was optional for the Safety Extension Period.|85
10632884|NCT02041091|11791025|FG001|STARTED|Optional Safety Extension Period|Participation was optional for the Safety Extension Period.|82
10632885|NCT02041091|11791024|FG000|COMPLETED|Optional Safety Extension Period||0
10632886|NCT02041091|11791025|FG001|COMPLETED|Optional Safety Extension Period||0
10632887|NCT02041091|11791024|FG000|NOT COMPLETED|Optional Safety Extension Period||85
10632888|NCT02041091|11791025|FG001|NOT COMPLETED|Optional Safety Extension Period||82
10632889|NCT02041104|11791039|FG000|STARTED|Overall Study||28
10632890|NCT02041104|11791040|FG001|STARTED|Overall Study||23
10632891|NCT02041104|11791039|FG000|COMPLETED|Overall Study||27
10632892|NCT02041104|11791040|FG001|COMPLETED|Overall Study||16
10632893|NCT02041104|11791039|FG000|NOT COMPLETED|Overall Study||1
10632894|NCT02041104|11791040|FG001|NOT COMPLETED|Overall Study||7
10632895|NCT02041221|11791054|FG000|STARTED|Part 1||6
10632896|NCT02041221|11791055|FG001|STARTED|Part 1||6
10632897|NCT02041221|11791056|FG002|STARTED|Part 1||6
10632898|NCT02041221|11791057|FG003|STARTED|Part 1||6
10632899|NCT02041221|11791058|FG004|STARTED|Part 1||6
10632900|NCT02041221|11791059|FG005|STARTED|Part 1||10
10632901|NCT02041221|11791054|FG000|COMPLETED|Part 1||6
10632902|NCT02041221|11791055|FG001|COMPLETED|Part 1||6
10632903|NCT02041221|11791056|FG002|COMPLETED|Part 1||6
10632904|NCT02041221|11791057|FG003|COMPLETED|Part 1||6
10632905|NCT02041221|11791058|FG004|COMPLETED|Part 1||6
10632906|NCT02041221|11791059|FG005|COMPLETED|Part 1||10
10632907|NCT02041221|11791054|FG000|NOT COMPLETED|Part 1||0
10632908|NCT02041221|11791055|FG001|NOT COMPLETED|Part 1||0
10632909|NCT02041221|11791056|FG002|NOT COMPLETED|Part 1||0
10632910|NCT02041221|11791057|FG003|NOT COMPLETED|Part 1||0
10632911|NCT02041221|11791058|FG004|NOT COMPLETED|Part 1||0
10632912|NCT02041221|11791059|FG005|NOT COMPLETED|Part 1||0
10632913|NCT02041221|11791054|FG000|STARTED|Part 2||6
10632914|NCT02041221|11791055|FG001|STARTED|Part 2||6
10632915|NCT02041221|11791056|FG002|STARTED|Part 2||6
10632916|NCT02041221|11791057|FG003|STARTED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually.|0
10632917|NCT02041221|11791058|FG004|STARTED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
10632918|NCT02041221|11791059|FG005|STARTED|Part 2||6
10632919|NCT02041221|11791054|FG000|COMPLETED|Part 2||6
10632920|NCT02041221|11791055|FG001|COMPLETED|Part 2||6
10632921|NCT02041221|11791056|FG002|COMPLETED|Part 2||5
10632922|NCT02041221|11791057|FG003|COMPLETED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
10632923|NCT02041221|11791058|FG004|COMPLETED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
10632924|NCT02041221|11791059|FG005|COMPLETED|Part 2||6
10632925|NCT02041221|11791054|FG000|NOT COMPLETED|Part 2||0
10632926|NCT02041221|11791055|FG001|NOT COMPLETED|Part 2||0
10632927|NCT02041221|11791056|FG002|NOT COMPLETED|Part 2||1
10632928|NCT02041221|11791057|FG003|NOT COMPLETED|Part 2||0
10705627|NCT02601105|11870079|FG000|COMPLETED|Placebo Cream; Centella Asiatica Bsln.||15
10705628|NCT02601105|11870079|FG000|NOT COMPLETED|Placebo Cream; Centella Asiatica Bsln.||0
10705629|NCT02601105|11870079|FG000|STARTED|Placebo Cream; Centella Asiatica Week 6||15
10632929|NCT02041221|11791058|FG004|NOT COMPLETED|Part 2||0
10632930|NCT02041221|11791059|FG005|NOT COMPLETED|Part 2||0
10632931|NCT02041286|11791073|FG000|STARTED|Overall Study||136
10632932|NCT02041286|11791073|FG000|COMPLETED|Overall Study|One subject discontinued from testing after low BG fingerstick result (hypoglycemia AE).|135
10632933|NCT02041286|11791073|FG000|NOT COMPLETED|Overall Study||1
10632934|NCT02041299|11791081|FG000|STARTED|Overall Study||152
10632935|NCT02041299|11791082|FG001|STARTED|Overall Study|Two participants double-enrolled under different subject numbers so were each counted twice.|78
10632936|NCT02041299|11791081|FG000|COMPLETED|Overall Study||106
10632937|NCT02041299|11791082|FG001|COMPLETED|Overall Study||58
10632938|NCT02041299|11791081|FG000|NOT COMPLETED|Overall Study||46
10632939|NCT02041299|11791082|FG001|NOT COMPLETED|Overall Study||20
10632940|NCT02041325|11791094|FG000|STARTED|Overall Study||22
10632941|NCT02041325|11791095|FG001|STARTED|Overall Study||16
10632942|NCT02041325|11791094|FG000|COMPLETED|Overall Study||19
10632943|NCT02041325|11791095|FG001|COMPLETED|Overall Study||13
10632944|NCT02041325|11791094|FG000|NOT COMPLETED|Overall Study||3
10632945|NCT02041325|11791095|FG001|NOT COMPLETED|Overall Study||3
10632946|NCT02041377|11791105|FG000|STARTED|Overall Study||134
10632947|NCT02041377|11791105|FG000|COMPLETED|Overall Study||134
10632948|NCT02041377|11791105|FG000|NOT COMPLETED|Overall Study||0
10632949|NCT02041429|11791113|FG000|STARTED|Overall Study||3
10632950|NCT02041429|11791114|FG001|STARTED|Overall Study||4
10705630|NCT02601105|11870079|FG000|COMPLETED|Placebo Cream; Centella Asiatica Week 6||15
10705631|NCT02601105|11870079|FG000|NOT COMPLETED|Placebo Cream; Centella Asiatica Week 6||0
10705632|NCT02601105|11870079|FG000|STARTED|Placebo Cream; Centella Asiatica Week 12||15
10705633|NCT02601105|11870079|FG000|COMPLETED|Placebo Cream; Centella Asiatica Week 12||13
10705634|NCT02601105|11870079|FG000|NOT COMPLETED|Placebo Cream; Centella Asiatica Week 12||2
10632951|NCT02041429|11791115|FG002|STARTED|Overall Study||7
10632952|NCT02041429|11791116|FG003|STARTED|Overall Study||6
10632953|NCT02041429|11791113|FG000|Treated|Overall Study||3
10632954|NCT02041429|11791114|FG001|Treated|Overall Study||3
10632955|NCT02041429|11791115|FG002|Treated|Overall Study||7
10632956|NCT02041429|11791116|FG003|Treated|Overall Study||6
10632957|NCT02041429|11791113|FG000|Evaluable for Dose Limiting Toxicity|Overall Study||3
10632958|NCT02041429|11791114|FG001|Evaluable for Dose Limiting Toxicity|Overall Study||3
10632959|NCT02041429|11791115|FG002|Evaluable for Dose Limiting Toxicity|Overall Study||6
10632960|NCT02041429|11791116|FG003|Evaluable for Dose Limiting Toxicity|Overall Study||6
10632961|NCT02041429|11791113|FG000|COMPLETED|Overall Study||0
10632962|NCT02041429|11791114|FG001|COMPLETED|Overall Study||0
10632963|NCT02041429|11791115|FG002|COMPLETED|Overall Study||0
10632964|NCT02041429|11791116|FG003|COMPLETED|Overall Study||0
10632965|NCT02041429|11791113|FG000|NOT COMPLETED|Overall Study||3
10632966|NCT02041429|11791114|FG001|NOT COMPLETED|Overall Study||4
10632967|NCT02041429|11791115|FG002|NOT COMPLETED|Overall Study||7
10632968|NCT02041429|11791116|FG003|NOT COMPLETED|Overall Study||6
10632969|NCT02041494|11791133|FG000|STARTED|Overall Study||82
10632970|NCT02041494|11791134|FG001|STARTED|Overall Study||83
10632971|NCT02041494|11791133|FG000|COMPLETED|Overall Study||63
10632972|NCT02041494|11791134|FG001|COMPLETED|Overall Study||63
10632973|NCT02041494|11791133|FG000|NOT COMPLETED|Overall Study||19
10632974|NCT02041494|11791134|FG001|NOT COMPLETED|Overall Study||20
10632975|NCT02041520|11791143|FG000|STARTED|Overall Study|35 patients randomly assigned to omega 3 fatty acids|35
10632976|NCT02041520|11791144|FG001|STARTED|Overall Study|35 patients randomly assigned to placebo|35
10632977|NCT02041520|11791143|FG000|COMPLETED|Overall Study||29
10632978|NCT02041520|11791144|FG001|COMPLETED|Overall Study||28
10632979|NCT02041520|11791143|FG000|NOT COMPLETED|Overall Study||6
10632980|NCT02041520|11791144|FG001|NOT COMPLETED|Overall Study||7
10632981|NCT02041702|11791154|FG000|STARTED|Overall Study||140
10632982|NCT02041702|11791155|FG001|STARTED|Overall Study||143
10632983|NCT02041702|11791154|FG000|Pre MRI Scan/ Pre Waitng|Overall Study||129
10632984|NCT02041702|11791155|FG001|Pre MRI Scan/ Pre Waitng|Overall Study||140
10632985|NCT02041702|11791154|FG000|Post MRI Scan/ Post Waiting|Overall Study||129
10632986|NCT02041702|11791155|FG001|Post MRI Scan/ Post Waiting|Overall Study||140
10632987|NCT02041702|11791154|FG000|COMPLETED|Overall Study||129
10632988|NCT02041702|11791155|FG001|COMPLETED|Overall Study||134
10632989|NCT02041702|11791154|FG000|NOT COMPLETED|Overall Study||11
10632990|NCT02041702|11791155|FG001|NOT COMPLETED|Overall Study||9
10632991|NCT02041923|11791163|FG000|STARTED|Overall Study||102
10632992|NCT02041923|11791164|FG001|STARTED|Overall Study||96
10632993|NCT02041923|11791163|FG000|COMPLETED|Overall Study||76
10632994|NCT02041923|11791164|FG001|COMPLETED|Overall Study||66
10632995|NCT02041923|11791163|FG000|NOT COMPLETED|Overall Study||26
10632996|NCT02041923|11791164|FG001|NOT COMPLETED|Overall Study||30
10632997|NCT02041962|11791174|FG000|STARTED|Overall Study||123
10632998|NCT02041962|11791175|FG001|STARTED|Overall Study||115
10632999|NCT02041962|11791174|FG000|Participants Completing 6 mo. f/up|Overall Study||69
10633000|NCT02041962|11791175|FG001|Participants Completing 6 mo. f/up|Overall Study||44
10633001|NCT02041962|11791174|FG000|Participants Completing 12 mo. f/up|Overall Study||42
10633002|NCT02041962|11791175|FG001|Participants Completing 12 mo. f/up|Overall Study||31
10633003|NCT02041962|11791174|FG000|COMPLETED|Overall Study||42
10633004|NCT02041962|11791175|FG001|COMPLETED|Overall Study||31
10633005|NCT02041962|11791174|FG000|NOT COMPLETED|Overall Study||81
10633006|NCT02041962|11791175|FG001|NOT COMPLETED|Overall Study||84
10633007|NCT02042014|11791181|FG000|STARTED|Overall Study||8
10633008|NCT02042014|11791181|FG000|COMPLETED|Overall Study||0
10633009|NCT02042014|11791181|FG000|NOT COMPLETED|Overall Study||8
10633010|NCT02042131|11791188|FG000|STARTED|Overall Study||32
10633011|NCT02042131|11791189|FG001|STARTED|Overall Study||32
10633012|NCT02042131|11791190|FG002|STARTED|Overall Study||33
10633013|NCT02042131|11791188|FG000|COMPLETED|Overall Study||32
10633014|NCT02042131|11791189|FG001|COMPLETED|Overall Study||32
10633015|NCT02042131|11791190|FG002|COMPLETED|Overall Study||33
10633016|NCT02042131|11791188|FG000|NOT COMPLETED|Overall Study||0
10633017|NCT02042131|11791189|FG001|NOT COMPLETED|Overall Study||0
10633018|NCT02042131|11791190|FG002|NOT COMPLETED|Overall Study||0
10633019|NCT02042183|11791202|FG000|STARTED|Overall Study||404
10633020|NCT02042183|11791203|FG001|STARTED|Overall Study||202
10633021|NCT02042183|11791202|FG000|Safety Population|Overall Study||400
10633022|NCT02042183|11791203|FG001|Safety Population|Overall Study||195
10633023|NCT02042183|11791202|FG000|Modified Intent-to-treat (mITT)|Overall Study||399
10633024|NCT02042183|11791203|FG001|Modified Intent-to-treat (mITT)|Overall Study||195
10633025|NCT02042183|11791202|FG000|COMPLETED|Overall Study||339
10633026|NCT02042183|11791203|FG001|COMPLETED|Overall Study||166
10633027|NCT02042183|11791202|FG000|NOT COMPLETED|Overall Study||65
10633028|NCT02042183|11791203|FG001|NOT COMPLETED|Overall Study||36
10633029|NCT02042274|11791211|FG000|STARTED|Overall Study||12
10633030|NCT02042274|11791211|FG000|COMPLETED|Overall Study||12
10633031|NCT02042274|11791211|FG000|NOT COMPLETED|Overall Study||0
10633032|NCT02042404|11791215|FG000|STARTED|Overall Study|Enrollment was stopped after 43 were enrolled, had approval to enroll 45 primary cohort subjects|43
10633033|NCT02042404|11791216|FG001|STARTED|Overall Study||5
10633034|NCT02042404|11791215|FG000|COMPLETED|Overall Study|39 subjects completed 30 days evaluation. 38 subjects completed 120 days evaluation.|38
10633035|NCT02042404|11791216|FG001|COMPLETED|Overall Study||5
10633036|NCT02042404|11791215|FG000|NOT COMPLETED|Overall Study||5
10633037|NCT02042404|11791216|FG001|NOT COMPLETED|Overall Study||0
10633038|NCT02042443|11791225|FG000|STARTED|Overall Study||27
10633039|NCT02042443|11791226|FG001|STARTED|Overall Study||26
10633040|NCT02042443|11791225|FG000|Eligible and Analyzable|Overall Study||24
10633041|NCT02042443|11791226|FG001|Eligible and Analyzable|Overall Study||20
10633042|NCT02042443|11791225|FG000|COMPLETED|Overall Study||0
10633043|NCT02042443|11791226|FG001|COMPLETED|Overall Study||0
10633044|NCT02042443|11791225|FG000|NOT COMPLETED|Overall Study||27
10633045|NCT02042443|11791226|FG001|NOT COMPLETED|Overall Study||26
10633046|NCT02042534|11791235|FG000|STARTED|Overall Study||101
10633047|NCT02042534|11791236|FG001|STARTED|Overall Study||94
10633048|NCT02042534|11791235|FG000|COMPLETED|Overall Study||101
10633049|NCT02042534|11791236|FG001|COMPLETED|Overall Study||94
10633050|NCT02042534|11791235|FG000|NOT COMPLETED|Overall Study||0
10633051|NCT02042534|11791236|FG001|NOT COMPLETED|Overall Study||0
10633052|NCT02042872|11791244|FG000|STARTED|Overall Study||8
10633053|NCT02042872|11791245|FG001|STARTED|Overall Study||13
10633054|NCT02042872|11791244|FG000|COMPLETED|Overall Study||8
10633055|NCT02042872|11791245|FG001|COMPLETED|Overall Study||8
10633056|NCT02042872|11791244|FG000|NOT COMPLETED|Overall Study||0
10633057|NCT02042872|11791245|FG001|NOT COMPLETED|Overall Study||5
10633058|NCT02042911|11791251|FG000|STARTED|Overall Study||10
10633059|NCT02042911|11791251|FG000|COMPLETED|Overall Study||9
10633060|NCT02042911|11791251|FG000|NOT COMPLETED|Overall Study||1
10633061|NCT02043015|11791255|FG000|STARTED|Overall Study||115
10633062|NCT02043015|11791255|FG000|COMPLETED|Overall Study||87
10633063|NCT02043015|11791255|FG000|NOT COMPLETED|Overall Study||28
10653796|NCT02196675|11814396|FG000|COMPLETED|Overall Study||25
10653797|NCT02196675|11814397|FG001|COMPLETED|Overall Study||68
10653798|NCT02196675|11814398|FG002|COMPLETED|Overall Study||7
10653799|NCT02196675|11814396|FG000|NOT COMPLETED|Overall Study||2
10653800|NCT02196675|11814397|FG001|NOT COMPLETED|Overall Study||2
10633064|NCT02043132|11791263|FG000|STARTED|Overall Study||58
10633065|NCT02043132|11791264|FG001|STARTED|Overall Study||58
10633066|NCT02043132|11791263|FG000|COMPLETED|Overall Study||53
10633067|NCT02043132|11791264|FG001|COMPLETED|Overall Study||49
10633068|NCT02043132|11791263|FG000|NOT COMPLETED|Overall Study||5
10633069|NCT02043132|11791264|FG001|NOT COMPLETED|Overall Study||9
10633070|NCT02043145|11791273|FG000|STARTED|Overall Study||55
10633071|NCT02043145|11791274|FG001|STARTED|Overall Study||247
10633072|NCT02043145|11791275|FG002|STARTED|Overall Study||425
10633073|NCT02043145|11791273|FG000|COMPLETED|Overall Study||55
10633074|NCT02043145|11791274|FG001|COMPLETED|Overall Study||247
10633075|NCT02043145|11791275|FG002|COMPLETED|Overall Study||425
10633076|NCT02043145|11791273|FG000|NOT COMPLETED|Overall Study||0
10633077|NCT02043145|11791274|FG001|NOT COMPLETED|Overall Study||0
10633078|NCT02043145|11791275|FG002|NOT COMPLETED|Overall Study||0
10633079|NCT02043197|11791285|FG000|STARTED|Overall Study||300
10633080|NCT02043197|11791285|FG000|COMPLETED|Overall Study||292
10633081|NCT02043197|11791285|FG000|NOT COMPLETED|Overall Study||8
10633082|NCT02043301|11791292|FG000|STARTED|Overall Study||25
10633083|NCT02043301|11791293|FG001|STARTED|Overall Study||25
10633084|NCT02043301|11791294|FG002|STARTED|Overall Study||25
10633085|NCT02043301|11791292|FG000|COMPLETED|Overall Study||25
10633086|NCT02043301|11791293|FG001|COMPLETED|Overall Study||24
10633087|NCT02043301|11791294|FG002|COMPLETED|Overall Study||25
10633088|NCT02043301|11791292|FG000|NOT COMPLETED|Overall Study||0
10633089|NCT02043301|11791293|FG001|NOT COMPLETED|Overall Study||1
10633090|NCT02043301|11791294|FG002|NOT COMPLETED|Overall Study||0
10633091|NCT02043366|11791308|FG000|STARTED|Overall Study||30
10633092|NCT02043366|11791309|FG001|STARTED|Overall Study||30
10633093|NCT02043366|11791310|FG002|STARTED|Overall Study||30
10633094|NCT02043366|11791311|FG003|STARTED|Overall Study||30
10633095|NCT02043366|11791312|FG004|STARTED|Overall Study||30
10633096|NCT02043366|11791313|FG005|STARTED|Overall Study||30
10633097|NCT02043366|11791308|FG000|COMPLETED|Overall Study||28
10633098|NCT02043366|11791309|FG001|COMPLETED|Overall Study||28
10633099|NCT02043366|11791310|FG002|COMPLETED|Overall Study||28
10633100|NCT02043366|11791311|FG003|COMPLETED|Overall Study||28
10633101|NCT02043366|11791312|FG004|COMPLETED|Overall Study||28
10633102|NCT02043366|11791313|FG005|COMPLETED|Overall Study||28
10633103|NCT02043366|11791308|FG000|NOT COMPLETED|Overall Study||2
10633104|NCT02043366|11791309|FG001|NOT COMPLETED|Overall Study||2
10633105|NCT02043366|11791310|FG002|NOT COMPLETED|Overall Study||2
10633106|NCT02043366|11791311|FG003|NOT COMPLETED|Overall Study||2
10633107|NCT02043366|11791312|FG004|NOT COMPLETED|Overall Study||2
10633108|NCT02043366|11791313|FG005|NOT COMPLETED|Overall Study||2
10633109|NCT02043379|11791331|FG000|STARTED|Overall Study||30
10633110|NCT02043379|11791332|FG001|STARTED|Overall Study||20
10633111|NCT02043379|11791331|FG000|COMPLETED|Overall Study||30
10633112|NCT02043379|11791332|FG001|COMPLETED|Overall Study||20
10633113|NCT02043379|11791331|FG000|NOT COMPLETED|Overall Study||0
10633114|NCT02043379|11791332|FG001|NOT COMPLETED|Overall Study||0
10633115|NCT02043509|11791340|FG000|STARTED|Baseline to 1st Follow-up||203
10705635|NCT02601170|11870087|FG000|STARTED|Overall Study||11
10705636|NCT02601170|11870088|FG001|STARTED|Overall Study||11
10705637|NCT02601170|11870087|FG000|COMPLETED|Overall Study||11
10705638|NCT02601170|11870088|FG001|COMPLETED|Overall Study||11
10633116|NCT02043509|11791341|FG001|STARTED|Baseline to 1st Follow-up||204
10633117|NCT02043509|11791340|FG000|COMPLETED|Baseline to 1st Follow-up||138
10633118|NCT02043509|11791341|FG001|COMPLETED|Baseline to 1st Follow-up||157
10633119|NCT02043509|11791340|FG000|NOT COMPLETED|Baseline to 1st Follow-up||65
10633120|NCT02043509|11791341|FG001|NOT COMPLETED|Baseline to 1st Follow-up||47
10633121|NCT02043509|11791340|FG000|STARTED|Baseline to 2nd Follow-up||203
10633122|NCT02043509|11791341|FG001|STARTED|Baseline to 2nd Follow-up||204
10633123|NCT02043509|11791340|FG000|COMPLETED|Baseline to 2nd Follow-up||129
10633124|NCT02043509|11791341|FG001|COMPLETED|Baseline to 2nd Follow-up||132
10633125|NCT02043509|11791340|FG000|NOT COMPLETED|Baseline to 2nd Follow-up||74
10633126|NCT02043509|11791341|FG001|NOT COMPLETED|Baseline to 2nd Follow-up||72
10633127|NCT02043548|11791349|FG000|STARTED|Overall Study||18
10633128|NCT02043548|11791350|FG001|STARTED|Overall Study||18
10633129|NCT02043548|11791349|FG000|COMPLETED|Overall Study||17
10633130|NCT02043548|11791350|FG001|COMPLETED|Overall Study||17
10633131|NCT02043548|11791349|FG000|NOT COMPLETED|Overall Study||1
10705639|NCT02601170|11870087|FG000|NOT COMPLETED|Overall Study||0
10633132|NCT02043548|11791350|FG001|NOT COMPLETED|Overall Study||1
10633133|NCT02043574|11791358|FG000|STARTED|Overall Study||25
10633134|NCT02043574|11791359|FG001|STARTED|Overall Study||26
10633135|NCT02043574|11791358|FG000|COMPLETED|Overall Study||19
10633136|NCT02043574|11791359|FG001|COMPLETED|Overall Study||20
10633137|NCT02043574|11791358|FG000|NOT COMPLETED|Overall Study||6
10633138|NCT02043574|11791359|FG001|NOT COMPLETED|Overall Study||6
10633139|NCT02043652|11791366|FG000|STARTED|Overall Study||119
10633140|NCT02043652|11791366|FG000|COMPLETED|Overall Study||93
10633141|NCT02043652|11791366|FG000|NOT COMPLETED|Overall Study||26
10633142|NCT02043704|11791372|FG000|STARTED|Overall Study||50
10633143|NCT02043704|11791373|FG001|STARTED|Overall Study||50
10633144|NCT02043704|11791372|FG000|COMPLETED|Overall Study||47
10633145|NCT02043704|11791373|FG001|COMPLETED|Overall Study||43
10633146|NCT02043704|11791372|FG000|NOT COMPLETED|Overall Study||3
10633147|NCT02043704|11791373|FG001|NOT COMPLETED|Overall Study||7
10633148|NCT02043782|11791379|FG000|STARTED|Period 1||7
10633149|NCT02043782|11791380|FG001|STARTED|Period 1||6
10705640|NCT02601170|11870088|FG001|NOT COMPLETED|Overall Study||0
10633150|NCT02043782|11791381|FG002|STARTED|Period 1||7
10633151|NCT02043782|11791382|FG003|STARTED|Period 1||6
10633152|NCT02043782|11791383|FG004|STARTED|Period 1||6
10633153|NCT02043782|11791384|FG005|STARTED|Period 1||6
10633154|NCT02043782|11791379|FG000|COMPLETED|Period 1||7
10633155|NCT02043782|11791380|FG001|COMPLETED|Period 1||6
10633156|NCT02043782|11791381|FG002|COMPLETED|Period 1|One subject discontinued due to an adverse event while testing own product|6
10633157|NCT02043782|11791382|FG003|COMPLETED|Period 1||6
10633158|NCT02043782|11791383|FG004|COMPLETED|Period 1||6
10633159|NCT02043782|11791384|FG005|COMPLETED|Period 1||6
10633160|NCT02043782|11791379|FG000|NOT COMPLETED|Period 1||0
10633161|NCT02043782|11791380|FG001|NOT COMPLETED|Period 1||0
10633162|NCT02043782|11791381|FG002|NOT COMPLETED|Period 1||1
10633163|NCT02043782|11791382|FG003|NOT COMPLETED|Period 1||0
10633164|NCT02043782|11791383|FG004|NOT COMPLETED|Period 1||0
10633165|NCT02043782|11791384|FG005|NOT COMPLETED|Period 1||0
10633166|NCT02043782|11791379|FG000|STARTED|Period 2||7
10633167|NCT02043782|11791380|FG001|STARTED|Period 2||6
10633168|NCT02043782|11791381|FG002|STARTED|Period 2||6
10633169|NCT02043782|11791382|FG003|STARTED|Period 2||6
10633170|NCT02043782|11791383|FG004|STARTED|Period 2||6
10633171|NCT02043782|11791384|FG005|STARTED|Period 2||6
10633172|NCT02043782|11791379|FG000|COMPLETED|Period 2||7
10633173|NCT02043782|11791380|FG001|COMPLETED|Period 2||6
10633174|NCT02043782|11791381|FG002|COMPLETED|Period 2||6
10633175|NCT02043782|11791382|FG003|COMPLETED|Period 2||6
10633176|NCT02043782|11791383|FG004|COMPLETED|Period 2||6
10633177|NCT02043782|11791384|FG005|COMPLETED|Period 2||6
10633178|NCT02043782|11791379|FG000|NOT COMPLETED|Period 2||0
10633179|NCT02043782|11791380|FG001|NOT COMPLETED|Period 2||0
10633180|NCT02043782|11791381|FG002|NOT COMPLETED|Period 2||0
10633181|NCT02043782|11791382|FG003|NOT COMPLETED|Period 2||0
10633182|NCT02043782|11791383|FG004|NOT COMPLETED|Period 2||0
10633183|NCT02043782|11791384|FG005|NOT COMPLETED|Period 2||0
10633184|NCT02043782|11791379|FG000|STARTED|Period 3||7
10633185|NCT02043782|11791380|FG001|STARTED|Period 3||6
10633186|NCT02043782|11791381|FG002|STARTED|Period 3||6
10633187|NCT02043782|11791382|FG003|STARTED|Period 3||6
10633188|NCT02043782|11791383|FG004|STARTED|Period 3||6
10633189|NCT02043782|11791384|FG005|STARTED|Period 3||6
10633190|NCT02043782|11791379|FG000|COMPLETED|Period 3||7
10633191|NCT02043782|11791380|FG001|COMPLETED|Period 3||6
10633192|NCT02043782|11791381|FG002|COMPLETED|Period 3||6
10633193|NCT02043782|11791382|FG003|COMPLETED|Period 3||6
10633194|NCT02043782|11791383|FG004|COMPLETED|Period 3||6
10633195|NCT02043782|11791384|FG005|COMPLETED|Period 3||6
10633196|NCT02043782|11791379|FG000|NOT COMPLETED|Period 3||0
10633197|NCT02043782|11791380|FG001|NOT COMPLETED|Period 3||0
10633198|NCT02043782|11791381|FG002|NOT COMPLETED|Period 3||0
10633199|NCT02043782|11791382|FG003|NOT COMPLETED|Period 3||0
10633200|NCT02043782|11791383|FG004|NOT COMPLETED|Period 3||0
10633201|NCT02043782|11791384|FG005|NOT COMPLETED|Period 3||0
10633202|NCT02043808|11791394|FG000|STARTED|Overall Study||12793
10633203|NCT02043808|11791395|FG001|STARTED|Overall Study||12793
10633204|NCT02043808|11791394|FG000|COMPLETED|Overall Study||12793
10633205|NCT02043808|11791395|FG001|COMPLETED|Overall Study||12793
10633206|NCT02043808|11791394|FG000|NOT COMPLETED|Overall Study||0
10633207|NCT02043808|11791395|FG001|NOT COMPLETED|Overall Study||0
10633208|NCT02043899|11791401|FG000|STARTED|Overall Study||36
10633209|NCT02043899|11791401|FG000|Underwent Routine [123I]mIBG Planar and SPECT/CT Imaging|Overall Study||32
10633210|NCT02043899|11791401|FG000|Underwent [124I]mIBG PET/CT Imaging|Overall Study||9
10633211|NCT02043899|11791401|FG000|COMPLETED|Overall Study||9
10633212|NCT02043899|11791401|FG000|NOT COMPLETED|Overall Study||27
10633213|NCT02043938|11791405|FG000|STARTED|Overall Study||46
10633214|NCT02043938|11791405|FG000|COMPLETED|Overall Study||36
10633215|NCT02043938|11791405|FG000|NOT COMPLETED|Overall Study||10
10633216|NCT02044094|11791412|FG000|STARTED|RBP-6000 Injection 1 (Day 1 to Day 28)||39
10633217|NCT02044094|11791412|FG000|Intent to Treat Population|RBP-6000 Injection 1 (Day 1 to Day 28)|Subjects who receive >=1 dose of RBP-6000 and have >=1 complete sequence of hydromorphone challenges|38
10633218|NCT02044094|11791412|FG000|Completers Population|RBP-6000 Injection 1 (Day 1 to Day 28)|Subjects that reached Day 28 + completed all challenges at Week 4 were considered study completers.|30
10633219|NCT02044094|11791412|FG000|COMPLETED|RBP-6000 Injection 1 (Day 1 to Day 28)||30
10633220|NCT02044094|11791412|FG000|NOT COMPLETED|RBP-6000 Injection 1 (Day 1 to Day 28)||9
10633221|NCT02044094|11791412|FG000|STARTED|RBP-6000 Injection 2 (Day 29 to Week 12)||30
10633222|NCT02044094|11791412|FG000|COMPLETED|RBP-6000 Injection 2 (Day 29 to Week 12)||17
10633223|NCT02044094|11791412|FG000|NOT COMPLETED|RBP-6000 Injection 2 (Day 29 to Week 12)||13
10633224|NCT02044159|11791429|FG000|STARTED|Overall Study||27
10633225|NCT02044159|11791430|FG001|STARTED|Overall Study||30
10633226|NCT02044159|11791429|FG000|COMPLETED|Overall Study||23
10633227|NCT02044159|11791430|FG001|COMPLETED|Overall Study||26
10633228|NCT02044159|11791429|FG000|NOT COMPLETED|Overall Study||4
10633229|NCT02044159|11791430|FG001|NOT COMPLETED|Overall Study||4
10633230|NCT02044367|11791439|FG000|STARTED|Overall Study||9
10633231|NCT02044367|11791440|FG001|STARTED|Overall Study||9
10633232|NCT02044367|11791441|FG002|STARTED|Overall Study||9
10633233|NCT02044367|11791442|FG003|STARTED|Overall Study||9
10633234|NCT02044367|11791443|FG004|STARTED|Overall Study||9
10633235|NCT02044367|11791444|FG005|STARTED|Overall Study||9
10633236|NCT02044367|11791439|FG000|COMPLETED|Overall Study||9
10633237|NCT02044367|11791440|FG001|COMPLETED|Overall Study||9
10633238|NCT02044367|11791441|FG002|COMPLETED|Overall Study||9
10633239|NCT02044367|11791442|FG003|COMPLETED|Overall Study||9
10633240|NCT02044367|11791443|FG004|COMPLETED|Overall Study||9
10633241|NCT02044367|11791444|FG005|COMPLETED|Overall Study||9
10633242|NCT02044367|11791439|FG000|NOT COMPLETED|Overall Study||0
10633243|NCT02044367|11791440|FG001|NOT COMPLETED|Overall Study||0
10633244|NCT02044367|11791441|FG002|NOT COMPLETED|Overall Study||0
10633245|NCT02044367|11791442|FG003|NOT COMPLETED|Overall Study||0
10633246|NCT02044367|11791443|FG004|NOT COMPLETED|Overall Study||0
10633247|NCT02044367|11791444|FG005|NOT COMPLETED|Overall Study||0
10633248|NCT02044380|11791456|FG000|STARTED|Overall Study|Started are the treated patients|14
10633249|NCT02044380|11791456|FG000|COMPLETED|Overall Study||14
10633250|NCT02044380|11791456|FG000|NOT COMPLETED|Overall Study||0
10633251|NCT02044393|11791462|FG000|STARTED|Period 1||10
10633252|NCT02044393|11791463|FG001|STARTED|Period 1||10
10633253|NCT02044393|11791462|FG000|COMPLETED|Period 1||10
10633254|NCT02044393|11791463|FG001|COMPLETED|Period 1||10
10633255|NCT02044393|11791462|FG000|NOT COMPLETED|Period 1||0
10633256|NCT02044393|11791463|FG001|NOT COMPLETED|Period 1||0
10633257|NCT02044393|11791462|FG000|STARTED|Period 2||10
10633258|NCT02044393|11791463|FG001|STARTED|Period 2||10
10633259|NCT02044393|11791462|FG000|COMPLETED|Period 2||10
10633260|NCT02044393|11791463|FG001|COMPLETED|Period 2||10
10633261|NCT02044393|11791462|FG000|NOT COMPLETED|Period 2||0
10633262|NCT02044393|11791463|FG001|NOT COMPLETED|Period 2||0
10633263|NCT02044419|11791476|FG000|STARTED|First Intervention||11
10633264|NCT02044419|11791477|FG001|STARTED|First Intervention||10
10633265|NCT02044419|11791478|FG002|STARTED|First Intervention||11
10633266|NCT02044419|11791476|FG000|COMPLETED|First Intervention||11
10633267|NCT02044419|11791477|FG001|COMPLETED|First Intervention||9
10633268|NCT02044419|11791478|FG002|COMPLETED|First Intervention||10
10633269|NCT02044419|11791476|FG000|NOT COMPLETED|First Intervention||0
10633270|NCT02044419|11791477|FG001|NOT COMPLETED|First Intervention||1
10633271|NCT02044419|11791478|FG002|NOT COMPLETED|First Intervention||1
10633272|NCT02044419|11791476|FG000|STARTED|Second Intervention||11
10633273|NCT02044419|11791477|FG001|STARTED|Second Intervention||9
10633274|NCT02044419|11791478|FG002|STARTED|Second Intervention||10
10633275|NCT02044419|11791476|FG000|COMPLETED|Second Intervention||11
10633276|NCT02044419|11791477|FG001|COMPLETED|Second Intervention||9
10633277|NCT02044419|11791478|FG002|COMPLETED|Second Intervention||10
10633278|NCT02044419|11791476|FG000|NOT COMPLETED|Second Intervention||0
10633279|NCT02044419|11791477|FG001|NOT COMPLETED|Second Intervention||0
10633280|NCT02044419|11791478|FG002|NOT COMPLETED|Second Intervention||0
10633281|NCT02044419|11791476|FG000|STARTED|Third Intervention||11
10633282|NCT02044419|11791477|FG001|STARTED|Third Intervention||9
10633283|NCT02044419|11791478|FG002|STARTED|Third Intervention||10
10633284|NCT02044419|11791476|FG000|COMPLETED|Third Intervention||11
10633285|NCT02044419|11791477|FG001|COMPLETED|Third Intervention||9
10633286|NCT02044419|11791478|FG002|COMPLETED|Third Intervention||10
10633287|NCT02044419|11791476|FG000|NOT COMPLETED|Third Intervention||0
10633288|NCT02044419|11791477|FG001|NOT COMPLETED|Third Intervention||0
10633289|NCT02044419|11791478|FG002|NOT COMPLETED|Third Intervention||0
10633290|NCT02044458|11791488|FG000|STARTED|Overall Study||65
10633291|NCT02044458|11791489|FG001|STARTED|Overall Study||69
10633292|NCT02044458|11791488|FG000|COMPLETED|Overall Study||62
10633293|NCT02044458|11791489|FG001|COMPLETED|Overall Study||61
10633294|NCT02044458|11791488|FG000|NOT COMPLETED|Overall Study||3
10633295|NCT02044458|11791489|FG001|NOT COMPLETED|Overall Study||8
10633296|NCT02044510|11791497|FG000|STARTED|Overall Study||16
10633297|NCT02044510|11791498|FG001|STARTED|Overall Study||16
10633298|NCT02044510|11791497|FG000|COMPLETED|Overall Study||15
10633299|NCT02044510|11791498|FG001|COMPLETED|Overall Study||14
10633300|NCT02044510|11791497|FG000|NOT COMPLETED|Overall Study||1
10633301|NCT02044510|11791498|FG001|NOT COMPLETED|Overall Study||2
10633302|NCT02044796|11791506|FG000|STARTED|Overall Study||9
10633303|NCT02044796|11791507|FG001|STARTED|Overall Study||9
10633304|NCT02044796|11791508|FG002|STARTED|Overall Study||9
10633305|NCT02044796|11791509|FG003|STARTED|Overall Study||6
10633306|NCT02044796|11791510|FG004|STARTED|Overall Study||10
10633307|NCT02044796|11791511|FG005|STARTED|Overall Study||6
10633308|NCT02044796|11791512|FG006|STARTED|Overall Study||6
10633309|NCT02044796|11791513|FG007|STARTED|Overall Study||4
10633310|NCT02044796|11791514|FG008|STARTED|Overall Study||106
10633311|NCT02044796|11791515|FG009|STARTED|Overall Study||34
10633312|NCT02044796|11791506|FG000|COMPLETED|Overall Study||9
10633313|NCT02044796|11791507|FG001|COMPLETED|Overall Study||9
10633314|NCT02044796|11791508|FG002|COMPLETED|Overall Study||9
10633315|NCT02044796|11791509|FG003|COMPLETED|Overall Study||6
10633316|NCT02044796|11791510|FG004|COMPLETED|Overall Study||10
10633317|NCT02044796|11791511|FG005|COMPLETED|Overall Study||6
10633318|NCT02044796|11791512|FG006|COMPLETED|Overall Study||6
10633319|NCT02044796|11791513|FG007|COMPLETED|Overall Study||4
10633320|NCT02044796|11791514|FG008|COMPLETED|Overall Study||106
10633321|NCT02044796|11791515|FG009|COMPLETED|Overall Study||34
10633322|NCT02044796|11791506|FG000|NOT COMPLETED|Overall Study||0
10633323|NCT02044796|11791507|FG001|NOT COMPLETED|Overall Study||0
10633324|NCT02044796|11791508|FG002|NOT COMPLETED|Overall Study||0
10633325|NCT02044796|11791509|FG003|NOT COMPLETED|Overall Study||0
10633326|NCT02044796|11791510|FG004|NOT COMPLETED|Overall Study||0
10633327|NCT02044796|11791511|FG005|NOT COMPLETED|Overall Study||0
10633328|NCT02044796|11791512|FG006|NOT COMPLETED|Overall Study||0
10633329|NCT02044796|11791513|FG007|NOT COMPLETED|Overall Study||0
10633330|NCT02044796|11791514|FG008|NOT COMPLETED|Overall Study||0
10633331|NCT02044796|11791515|FG009|NOT COMPLETED|Overall Study||0
10633332|NCT02044874|11791536|FG000|STARTED|Overall Study||201
10633333|NCT02044874|11791537|FG001|STARTED|Overall Study||202
10633334|NCT02044874|11791538|FG002|STARTED|Overall Study||200
10633335|NCT02044874|11791536|FG000|COMPLETED|Overall Study||171
10633336|NCT02044874|11791537|FG001|COMPLETED|Overall Study||147
10633337|NCT02044874|11791538|FG002|COMPLETED|Overall Study||140
10633338|NCT02044874|11791536|FG000|NOT COMPLETED|Overall Study||30
10633339|NCT02044874|11791537|FG001|NOT COMPLETED|Overall Study||55
10633340|NCT02044874|11791538|FG002|NOT COMPLETED|Overall Study||60
10633341|NCT02044991|11791550|FG000|STARTED|Overall Study||2
10633342|NCT02044991|11791551|FG001|STARTED|Overall Study||0
10633343|NCT02044991|11791550|FG000|COMPLETED|Overall Study||2
10633344|NCT02044991|11791551|FG001|COMPLETED|Overall Study||0
10633345|NCT02044991|11791550|FG000|NOT COMPLETED|Overall Study||0
10633346|NCT02044991|11791551|FG001|NOT COMPLETED|Overall Study||0
10633347|NCT02045095|11791557|FG000|STARTED|Overall Study||3
10633348|NCT02045095|11791558|FG001|STARTED|Overall Study||4
10633349|NCT02045095|11791559|FG002|STARTED|Overall Study||4
10633350|NCT02045095|11791560|FG003|STARTED|Overall Study||4
10633351|NCT02045095|11791561|FG004|STARTED|Overall Study||5
10633352|NCT02045095|11791562|FG005|STARTED|Overall Study||8
10633353|NCT02045095|11791563|FG006|STARTED|Overall Study||1
10633354|NCT02045095|11791557|FG000|COMPLETED|Overall Study||0
10633355|NCT02045095|11791558|FG001|COMPLETED|Overall Study||0
10633356|NCT02045095|11791559|FG002|COMPLETED|Overall Study||0
10633357|NCT02045095|11791560|FG003|COMPLETED|Overall Study||0
10633358|NCT02045095|11791561|FG004|COMPLETED|Overall Study||0
10633359|NCT02045095|11791562|FG005|COMPLETED|Overall Study||0
10633360|NCT02045095|11791563|FG006|COMPLETED|Overall Study||0
10633361|NCT02045095|11791557|FG000|NOT COMPLETED|Overall Study||3
10633362|NCT02045095|11791558|FG001|NOT COMPLETED|Overall Study||4
10633363|NCT02045095|11791559|FG002|NOT COMPLETED|Overall Study||4
10633364|NCT02045095|11791560|FG003|NOT COMPLETED|Overall Study||4
10633365|NCT02045095|11791561|FG004|NOT COMPLETED|Overall Study||5
10633366|NCT02045095|11791562|FG005|NOT COMPLETED|Overall Study||8
10633367|NCT02045095|11791563|FG006|NOT COMPLETED|Overall Study||1
10633368|NCT02045108|11791583|FG000|STARTED|Overall Study||22
10633369|NCT02045108|11791584|FG001|STARTED|Overall Study||15
10633370|NCT02045108|11791585|FG002|STARTED|Overall Study||20
10633371|NCT02045108|11791586|FG003|STARTED|Overall Study||20
10633372|NCT02045108|11791583|FG000|COMPLETED|Overall Study||21
10633373|NCT02045108|11791584|FG001|COMPLETED|Overall Study||12
10633374|NCT02045108|11791585|FG002|COMPLETED|Overall Study||18
10633375|NCT02045108|11791586|FG003|COMPLETED|Overall Study||19
10633376|NCT02045108|11791583|FG000|NOT COMPLETED|Overall Study||1
10633377|NCT02045108|11791584|FG001|NOT COMPLETED|Overall Study||3
10633378|NCT02045108|11791585|FG002|NOT COMPLETED|Overall Study||2
10633379|NCT02045108|11791586|FG003|NOT COMPLETED|Overall Study||1
10633380|NCT02045212|11791598|FG000|STARTED|Overall Study||13
10633381|NCT02045212|11791599|FG001|STARTED|Overall Study||9
10633382|NCT02045212|11791598|FG000|COMPLETED|Overall Study||11
10633383|NCT02045212|11791599|FG001|COMPLETED|Overall Study||8
10633384|NCT02045212|11791598|FG000|NOT COMPLETED|Overall Study||2
10633385|NCT02045212|11791599|FG001|NOT COMPLETED|Overall Study||1
10633386|NCT02045238|11791611|FG000|STARTED|Overall Study||16
10633387|NCT02045238|11791612|FG001|STARTED|Overall Study||15
10633388|NCT02045238|11791611|FG000|COMPLETED|Overall Study||9
10633389|NCT02045238|11791612|FG001|COMPLETED|Overall Study||14
10633390|NCT02045238|11791611|FG000|NOT COMPLETED|Overall Study||7
10633391|NCT02045238|11791612|FG001|NOT COMPLETED|Overall Study||1
10633392|NCT02045264|11791618|FG000|STARTED|Overall Study||12
10633393|NCT02045264|11791618|FG000|COMPLETED|Overall Study||12
10633394|NCT02045264|11791618|FG000|NOT COMPLETED|Overall Study||0
10633395|NCT02045277|11791626|FG000|STARTED|Overall Study||59
10633396|NCT02045277|11791627|FG001|STARTED|Overall Study||63
10633397|NCT02045277|11791628|FG002|STARTED|Overall Study||59
10633398|NCT02045277|11791629|FG003|STARTED|Overall Study||31
10633399|NCT02045277|11791626|FG000|COMPLETED|Overall Study||55
10633400|NCT02045277|11791627|FG001|COMPLETED|Overall Study||62
10633401|NCT02045277|11791628|FG002|COMPLETED|Overall Study||47
10633402|NCT02045277|11791629|FG003|COMPLETED|Overall Study||29
10633403|NCT02045277|11791626|FG000|NOT COMPLETED|Overall Study||4
10633404|NCT02045277|11791627|FG001|NOT COMPLETED|Overall Study||1
10633405|NCT02045277|11791628|FG002|NOT COMPLETED|Overall Study||12
10633406|NCT02045277|11791629|FG003|NOT COMPLETED|Overall Study||2
10633407|NCT02045433|11791639|FG000|STARTED|Overall Study||16
10633408|NCT02045433|11791639|FG000|COMPLETED|Overall Study|Study was Prematurely ended due to toxicity|15
10633409|NCT02045433|11791639|FG000|NOT COMPLETED|Overall Study||1
10633410|NCT02045511|11791645|FG000|STARTED|Overall Study||8
10633411|NCT02045511|11791646|FG001|STARTED|Overall Study||7
10633412|NCT02045511|11791645|FG000|COMPLETED|Overall Study||8
10633413|NCT02045511|11791646|FG001|COMPLETED|Overall Study||7
10633414|NCT02045511|11791645|FG000|NOT COMPLETED|Overall Study||0
10633415|NCT02045511|11791646|FG001|NOT COMPLETED|Overall Study||0
10633416|NCT02045732|11791654|FG000|STARTED|Overall Study||1
10633417|NCT02045732|11791655|FG001|STARTED|Overall Study||3
10633418|NCT02045732|11791654|FG000|COMPLETED|Overall Study||0
10633419|NCT02045732|11791655|FG001|COMPLETED|Overall Study||2
10633420|NCT02045732|11791654|FG000|NOT COMPLETED|Overall Study||1
10633421|NCT02045732|11791655|FG001|NOT COMPLETED|Overall Study||1
10633422|NCT02045836|11791663|FG000|STARTED|Overall Study||432
10633423|NCT02045836|11791664|FG001|STARTED|Overall Study||433
10633424|NCT02045836|11791663|FG000|COMPLETED|Overall Study||423
10633425|NCT02045836|11791664|FG001|COMPLETED|Overall Study||419
10633426|NCT02045836|11791663|FG000|NOT COMPLETED|Overall Study||9
10633427|NCT02045836|11791664|FG001|NOT COMPLETED|Overall Study||14
10653801|NCT02196675|11814398|FG002|NOT COMPLETED|Overall Study||1
10653802|NCT02196688|11814408|FG000|STARTED|Overall Study||47
10653803|NCT02196688|11814409|FG001|STARTED|Overall Study||24
10653804|NCT02196688|11814408|FG000|COMPLETED|Overall Study||40
10653805|NCT02196688|11814409|FG001|COMPLETED|Overall Study||23
10653806|NCT02196688|11814408|FG000|NOT COMPLETED|Overall Study||7
10653807|NCT02196688|11814409|FG001|NOT COMPLETED|Overall Study||1
10653808|NCT02196701|11814417|FG000|STARTED|Overall Study||46
10653809|NCT02196701|11814417|FG000|COMPLETED|Overall Study||43
10653810|NCT02196701|11814417|FG000|NOT COMPLETED|Overall Study||3
10653811|NCT02196714|11814424|FG000|STARTED|Overall Study||24
10653812|NCT02196714|11814425|FG001|STARTED|Overall Study||23
10653813|NCT02196714|11814426|FG002|STARTED|Overall Study||24
10705641|NCT02601300|11870094|FG000|STARTED|Induction Phase||41
10705642|NCT02601300|11870094|FG000|COMPLETED|Induction Phase||38
10705643|NCT02601300|11870094|FG000|NOT COMPLETED|Induction Phase||3
10705644|NCT02601300|11870094|FG000|STARTED|Extension Phase|3 completed induction phase; did not enter extension due to withdrawal and lack of efficacy|35
10653814|NCT02196714|11814427|FG003|STARTED|Overall Study||24
10653815|NCT02196714|11814424|FG000|COMPLETED|Overall Study||24
10653816|NCT02196714|11814425|FG001|COMPLETED|Overall Study||23
10653817|NCT02196714|11814426|FG002|COMPLETED|Overall Study||23
10653818|NCT02196714|11814427|FG003|COMPLETED|Overall Study||24
10653819|NCT02196714|11814424|FG000|NOT COMPLETED|Overall Study||0
10653820|NCT02196714|11814425|FG001|NOT COMPLETED|Overall Study||0
10653821|NCT02196714|11814426|FG002|NOT COMPLETED|Overall Study||1
10653822|NCT02196714|11814427|FG003|NOT COMPLETED|Overall Study||0
10653823|NCT02196766|11814439|FG000|STARTED|First Intervention (7 Days)||15
10653824|NCT02196766|11814440|FG001|STARTED|First Intervention (7 Days)||15
10653825|NCT02196766|11814439|FG000|COMPLETED|First Intervention (7 Days)||15
10653826|NCT02196766|11814440|FG001|COMPLETED|First Intervention (7 Days)||15
10653827|NCT02196766|11814439|FG000|NOT COMPLETED|First Intervention (7 Days)||0
10653828|NCT02196766|11814440|FG001|NOT COMPLETED|First Intervention (7 Days)||0
10653829|NCT02196766|11814439|FG000|STARTED|Second Intervention (7 Days)||15
10653830|NCT02196766|11814440|FG001|STARTED|Second Intervention (7 Days)||15
10653831|NCT02196766|11814439|FG000|COMPLETED|Second Intervention (7 Days)||15
10653832|NCT02196766|11814440|FG001|COMPLETED|Second Intervention (7 Days)||15
10653833|NCT02196766|11814439|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
10653834|NCT02196766|11814440|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
10653835|NCT02196831|11814448|FG000|STARTED|Overall Study||30
10653836|NCT02196831|11814449|FG001|STARTED|Overall Study||30
10653837|NCT02196831|11814448|FG000|Received Follow-up Imaging|Overall Study||26
10653838|NCT02196831|11814449|FG001|Received Follow-up Imaging|Overall Study||28
10653839|NCT02196831|11814448|FG000|COMPLETED|Overall Study||21
10653840|NCT02196831|11814449|FG001|COMPLETED|Overall Study||26
10653841|NCT02196831|11814448|FG000|NOT COMPLETED|Overall Study||9
10653842|NCT02196831|11814449|FG001|NOT COMPLETED|Overall Study||4
10653843|NCT02196857|11814456|FG000|STARTED|Overall Study||16
10653844|NCT02196857|11814456|FG000|COMPLETED|Overall Study||16
10653845|NCT02196857|11814456|FG000|NOT COMPLETED|Overall Study||0
10653846|NCT02196922|11814462|FG000|STARTED|Overall Study||58
10653847|NCT02196922|11814463|FG001|STARTED|Overall Study||46
10653848|NCT02196922|11814462|FG000|COMPLETED|Overall Study||58
10653849|NCT02196922|11814463|FG001|COMPLETED|Overall Study||46
10653850|NCT02196922|11814462|FG000|NOT COMPLETED|Overall Study||0
10653851|NCT02196922|11814463|FG001|NOT COMPLETED|Overall Study||0
10653852|NCT02197065|11814473|FG000|STARTED|Overall Study||10
10653853|NCT02197065|11814474|FG001|STARTED|Overall Study||10
10653854|NCT02197065|11814473|FG000|COMPLETED|Overall Study||10
10653855|NCT02197065|11814474|FG001|COMPLETED|Overall Study||10
10653856|NCT02197065|11814473|FG000|NOT COMPLETED|Overall Study||0
10653857|NCT02197065|11814474|FG001|NOT COMPLETED|Overall Study||0
10653858|NCT02197078|11814495|FG000|STARTED|Overall Study||14688
10653859|NCT02197078|11814496|FG001|STARTED|Overall Study||14688
10653860|NCT02197078|11814497|FG002|STARTED|Overall Study||10614
10653861|NCT02197078|11814498|FG003|STARTED|Overall Study||10614
10653862|NCT02197078|11814499|FG004|STARTED|Overall Study||9538
10653863|NCT02197078|11814500|FG005|STARTED|Overall Study||9538
10653864|NCT02197078|11814501|FG006|STARTED|Overall Study||25135
10653865|NCT02197078|11814502|FG007|STARTED|Overall Study||25135
10653866|NCT02197078|11814503|FG008|STARTED|Overall Study||18996
10653867|NCT02197078|11814504|FG009|STARTED|Overall Study||18996
10653868|NCT02197078|11814505|FG010|STARTED|Overall Study||15742
10705645|NCT02601300|11870094|FG000|Treated With IP|Extension Phase||34
10653869|NCT02197078|11814506|FG011|STARTED|Overall Study||15742
10653870|NCT02197078|11814495|FG000|COMPLETED|Overall Study||14688
10653871|NCT02197078|11814496|FG001|COMPLETED|Overall Study||14688
10653872|NCT02197078|11814497|FG002|COMPLETED|Overall Study||10614
10653873|NCT02197078|11814498|FG003|COMPLETED|Overall Study||10614
10653874|NCT02197078|11814499|FG004|COMPLETED|Overall Study||9538
10653875|NCT02197078|11814500|FG005|COMPLETED|Overall Study||9538
10653876|NCT02197078|11814501|FG006|COMPLETED|Overall Study||25135
10653877|NCT02197078|11814502|FG007|COMPLETED|Overall Study||25135
10653878|NCT02197078|11814503|FG008|COMPLETED|Overall Study||18996
10653879|NCT02197078|11814504|FG009|COMPLETED|Overall Study||18996
10653880|NCT02197078|11814505|FG010|COMPLETED|Overall Study||15742
10633428|NCT02045862|11791674|FG000|STARTED|Overall Study||306
10705646|NCT02601300|11870094|FG000|COMPLETED|Extension Phase||18
10705647|NCT02601300|11870094|FG000|NOT COMPLETED|Extension Phase||17
10705648|NCT02601469|11870102|FG000|STARTED|Overall Study||25
10705649|NCT02601469|11870103|FG001|STARTED|Overall Study||1
10705650|NCT02601469|11870102|FG000|COMPLETED|Overall Study||24
10705651|NCT02601469|11870103|FG001|COMPLETED|Overall Study||1
10705652|NCT02601469|11870102|FG000|NOT COMPLETED|Overall Study||1
10705653|NCT02601469|11870103|FG001|NOT COMPLETED|Overall Study||0
10705654|NCT02601560|11870117|FG000|STARTED|Overall Study||8
10633429|NCT02045862|11791675|FG001|STARTED|Overall Study||305
10633430|NCT02045862|11791676|FG002|STARTED|Overall Study||1218
10633431|NCT02045862|11791674|FG000|Treated|Overall Study||306
10633432|NCT02045862|11791675|FG001|Treated|Overall Study||303
10633433|NCT02045862|11791676|FG002|Treated|Overall Study||1210
10633434|NCT02045862|11791674|FG000|COMPLETED|Overall Study||267
10633435|NCT02045862|11791675|FG001|COMPLETED|Overall Study||265
10633436|NCT02045862|11791676|FG002|COMPLETED|Overall Study||1092
10633437|NCT02045862|11791674|FG000|NOT COMPLETED|Overall Study||39
10633438|NCT02045862|11791675|FG001|NOT COMPLETED|Overall Study||40
10633439|NCT02045862|11791676|FG002|NOT COMPLETED|Overall Study||126
10633440|NCT02045875|11791686|FG000|STARTED|Overall Study||27
10633441|NCT02045875|11791687|FG001|STARTED|Overall Study||23
10633442|NCT02045875|11791686|FG000|COMPLETED|Overall Study||20
10633443|NCT02045875|11791687|FG001|COMPLETED|Overall Study||20
10633444|NCT02045875|11791686|FG000|NOT COMPLETED|Overall Study||7
10633445|NCT02045875|11791687|FG001|NOT COMPLETED|Overall Study||3
10633446|NCT02045979|11791696|FG000|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication.|108
10633603|NCT02047032|11791988|FG001|STARTED|Overall Study||250
10633447|NCT02045979|11791697|FG001|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication..|108
10633448|NCT02045979|11791698|FG002|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication.|108
10633449|NCT02045979|11791696|FG000|COMPLETED|Overall Study||106
10633450|NCT02045979|11791697|FG001|COMPLETED|Overall Study||107
10633451|NCT02045979|11791698|FG002|COMPLETED|Overall Study||107
10705655|NCT02601560|11870118|FG001|STARTED|Overall Study||6
10705656|NCT02601560|11870119|FG002|STARTED|Overall Study||6
10705657|NCT02601560|11870120|FG003|STARTED|Overall Study||6
10705658|NCT02601560|11870121|FG004|STARTED|Overall Study||6
10705659|NCT02601560|11870122|FG005|STARTED|Overall Study||4
10705660|NCT02601560|11870123|FG006|STARTED|Overall Study||6
10705661|NCT02601560|11870124|FG007|STARTED|Overall Study||6
10705662|NCT02601560|11870117|FG000|COMPLETED|Overall Study||8
10705663|NCT02601560|11870118|FG001|COMPLETED|Overall Study||6
10705664|NCT02601560|11870119|FG002|COMPLETED|Overall Study||6
10705665|NCT02601560|11870120|FG003|COMPLETED|Overall Study||6
10705666|NCT02601560|11870121|FG004|COMPLETED|Overall Study||6
10705667|NCT02601560|11870122|FG005|COMPLETED|Overall Study||4
10705668|NCT02601560|11870123|FG006|COMPLETED|Overall Study||5
10633452|NCT02045979|11791696|FG000|NOT COMPLETED|Overall Study||2
10633453|NCT02045979|11791697|FG001|NOT COMPLETED|Overall Study||1
10633454|NCT02045979|11791698|FG002|NOT COMPLETED|Overall Study||1
10633455|NCT02046005|11791709|FG000|STARTED|Overall Study||80
10633456|NCT02046005|11791710|FG001|STARTED|Overall Study||78
10633457|NCT02046005|11791711|FG002|STARTED|Overall Study||80
10633458|NCT02046005|11791709|FG000|COMPLETED|Overall Study||72
10633459|NCT02046005|11791710|FG001|COMPLETED|Overall Study||71
10633460|NCT02046005|11791711|FG002|COMPLETED|Overall Study||70
10633461|NCT02046005|11791709|FG000|NOT COMPLETED|Overall Study||8
10633462|NCT02046005|11791710|FG001|NOT COMPLETED|Overall Study||7
10633463|NCT02046005|11791711|FG002|NOT COMPLETED|Overall Study||10
10633464|NCT02046070|11791722|FG000|STARTED|Overall Study||36
10633465|NCT02046070|11791723|FG001|STARTED|Overall Study||34
10633466|NCT02046070|11791724|FG002|STARTED|Overall Study||78
10633467|NCT02046070|11791722|FG000|COMPLETED|Overall Study||4
10633468|NCT02046070|11791723|FG001|COMPLETED|Overall Study||6
10633469|NCT02046070|11791724|FG002|COMPLETED|Overall Study||8
10633470|NCT02046070|11791722|FG000|NOT COMPLETED|Overall Study||32
10633471|NCT02046070|11791723|FG001|NOT COMPLETED|Overall Study||28
10633472|NCT02046070|11791724|FG002|NOT COMPLETED|Overall Study||70
10705669|NCT02601560|11870124|FG007|COMPLETED|Overall Study||6
10633473|NCT02046122|11791732|FG000|STARTED|Overall Study||17
10633474|NCT02046122|11791732|FG000|COMPLETED|Overall Study||8
10633475|NCT02046122|11791732|FG000|NOT COMPLETED|Overall Study||9
10633476|NCT02046135|11791738|FG000|STARTED|Overall Study||26
10633477|NCT02046135|11791739|FG001|STARTED|Overall Study||25
10633478|NCT02046135|11791738|FG000|COMPLETED|Overall Study||26
10633479|NCT02046135|11791739|FG001|COMPLETED|Overall Study||25
10633480|NCT02046135|11791738|FG000|NOT COMPLETED|Overall Study||0
10633481|NCT02046135|11791739|FG001|NOT COMPLETED|Overall Study||0
10633482|NCT02046148|11791747|FG000|STARTED|Overall Study||49
10633483|NCT02046148|11791748|FG001|STARTED|Overall Study||26
10633484|NCT02046148|11791747|FG000|COMPLETED|Overall Study||48
10633485|NCT02046148|11791748|FG001|COMPLETED|Overall Study||23
10633486|NCT02046148|11791747|FG000|NOT COMPLETED|Overall Study||1
10633487|NCT02046148|11791748|FG001|NOT COMPLETED|Overall Study||3
10705670|NCT02601560|11870117|FG000|NOT COMPLETED|Overall Study||0
10705671|NCT02601560|11870118|FG001|NOT COMPLETED|Overall Study||0
10705672|NCT02601560|11870119|FG002|NOT COMPLETED|Overall Study||0
10705673|NCT02601560|11870120|FG003|NOT COMPLETED|Overall Study||0
10705674|NCT02601560|11870121|FG004|NOT COMPLETED|Overall Study||0
10705675|NCT02601560|11870122|FG005|NOT COMPLETED|Overall Study||0
10633488|NCT02046174|11791754|FG000|STARTED|Overall Study||42
10633489|NCT02046174|11791755|FG001|STARTED|Overall Study||3
10633490|NCT02046174|11791754|FG000|COMPLETED|Overall Study||41
10633491|NCT02046174|11791755|FG001|COMPLETED|Overall Study||3
10633492|NCT02046174|11791754|FG000|NOT COMPLETED|Overall Study||1
10633493|NCT02046174|11791755|FG001|NOT COMPLETED|Overall Study||0
10633494|NCT02046200|11791840|FG000|STARTED|First Intervention (1 Day)||5
10633495|NCT02046200|11791841|FG001|STARTED|First Intervention (1 Day)||6
10633496|NCT02046200|11791840|FG000|COMPLETED|First Intervention (1 Day)||5
10633497|NCT02046200|11791841|FG001|COMPLETED|First Intervention (1 Day)||6
10633498|NCT02046200|11791840|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10633499|NCT02046200|11791841|FG001|NOT COMPLETED|First Intervention (1 Day)||0
10633500|NCT02046200|11791840|FG000|STARTED|Second Intervention (1 Day)||5
10633501|NCT02046200|11791841|FG001|STARTED|Second Intervention (1 Day)||6
10633502|NCT02046200|11791840|FG000|COMPLETED|Second Intervention (1 Day)||5
10633503|NCT02046200|11791841|FG001|COMPLETED|Second Intervention (1 Day)||6
10633504|NCT02046200|11791840|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10633505|NCT02046200|11791841|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10633506|NCT02046265|11791859|FG000|STARTED|Overall Study||17
10633507|NCT02046265|11791860|FG001|STARTED|Overall Study||17
10633508|NCT02046265|11791861|FG002|STARTED|Overall Study||12
10633509|NCT02046265|11791862|FG003|STARTED|Overall Study||14
10633510|NCT02046265|11791859|FG000|COMPLETED|Overall Study||16
10633511|NCT02046265|11791860|FG001|COMPLETED|Overall Study||15
10633512|NCT02046265|11791861|FG002|COMPLETED|Overall Study||10
10705676|NCT02601560|11870123|FG006|NOT COMPLETED|Overall Study||1
10705677|NCT02601560|11870124|FG007|NOT COMPLETED|Overall Study||0
10705678|NCT02601573|11870154|FG000|STARTED|Overall Study|Number randomized and treated.|23
10705679|NCT02601573|11870155|FG001|STARTED|Overall Study|Number randomized and treated.|24
10633513|NCT02046265|11791862|FG003|COMPLETED|Overall Study||12
10633514|NCT02046265|11791859|FG000|NOT COMPLETED|Overall Study||1
10633515|NCT02046265|11791860|FG001|NOT COMPLETED|Overall Study||2
10633516|NCT02046265|11791861|FG002|NOT COMPLETED|Overall Study||2
10633517|NCT02046265|11791862|FG003|NOT COMPLETED|Overall Study||2
10633518|NCT02046317|11791874|FG000|STARTED|Overall Study||4
10633519|NCT02046317|11791875|FG001|STARTED|Overall Study||8
10633520|NCT02046317|11791874|FG000|COMPLETED|Overall Study||4
10633521|NCT02046317|11791875|FG001|COMPLETED|Overall Study||8
10633522|NCT02046317|11791874|FG000|NOT COMPLETED|Overall Study||0
10633523|NCT02046317|11791875|FG001|NOT COMPLETED|Overall Study||0
10633524|NCT02046369|11791883|FG000|STARTED|Overall Study||176
10633525|NCT02046369|11791884|FG001|STARTED|Overall Study||174
10633526|NCT02046369|11791883|FG000|COMPLETED|Overall Study||162
10633527|NCT02046369|11791884|FG001|COMPLETED|Overall Study||156
10633528|NCT02046369|11791883|FG000|NOT COMPLETED|Overall Study||14
10633529|NCT02046369|11791884|FG001|NOT COMPLETED|Overall Study||18
10633530|NCT02046382|11791892|FG000|STARTED|Overall Study||65
10633531|NCT02046382|11791893|FG001|STARTED|Overall Study||67
10633532|NCT02046382|11791892|FG000|COMPLETED|Overall Study||57
10633533|NCT02046382|11791893|FG001|COMPLETED|Overall Study||47
10633534|NCT02046382|11791892|FG000|NOT COMPLETED|Overall Study||8
10633535|NCT02046382|11791893|FG001|NOT COMPLETED|Overall Study||20
10633536|NCT02046525|11791901|FG000|STARTED|Overall Study||5
10633537|NCT02046525|11791902|FG001|STARTED|Overall Study||5
10633538|NCT02046525|11791901|FG000|COMPLETED|Overall Study||5
10633539|NCT02046525|11791902|FG001|COMPLETED|Overall Study||5
10633540|NCT02046525|11791901|FG000|NOT COMPLETED|Overall Study||0
10633541|NCT02046525|11791902|FG001|NOT COMPLETED|Overall Study||0
10633542|NCT02046564|11791910|FG000|STARTED|Overall Study||209
10633543|NCT02046564|11791911|FG001|STARTED|Overall Study||203
10633544|NCT02046564|11791910|FG000|COMPLETED|Overall Study||194
10633545|NCT02046564|11791911|FG001|COMPLETED|Overall Study||183
10633546|NCT02046564|11791910|FG000|NOT COMPLETED|Overall Study||15
10633547|NCT02046564|11791911|FG001|NOT COMPLETED|Overall Study||20
10633548|NCT02046603|11791919|FG000|STARTED|Overall Study||22
10633549|NCT02046603|11791920|FG001|STARTED|Overall Study||140
10633550|NCT02046603|11791919|FG000|Received at Least 1 Dose of Tocilizumab|Overall Study||21
10633551|NCT02046603|11791920|FG001|Received at Least 1 Dose of Tocilizumab|Overall Study||140
10633552|NCT02046603|11791919|FG000|COMPLETED|Overall Study||7
10633553|NCT02046603|11791920|FG001|COMPLETED|Overall Study||65
10633554|NCT02046603|11791919|FG000|NOT COMPLETED|Overall Study||15
10633555|NCT02046603|11791920|FG001|NOT COMPLETED|Overall Study||75
10633556|NCT02046616|11791927|FG000|STARTED|24-Week Treatment Period||133
10633557|NCT02046616|11791927|FG000|COMPLETED|24-Week Treatment Period||114
10633558|NCT02046616|11791927|FG000|NOT COMPLETED|24-Week Treatment Period||19
10705680|NCT02601573|11870156|FG002|STARTED|Overall Study|Number randomized and treated.|17
10633559|NCT02046616|11791927|FG000|STARTED|8-Week FU Period||114
10633560|NCT02046616|11791927|FG000|COMPLETED|8-Week FU Period||113
10633561|NCT02046616|11791927|FG000|NOT COMPLETED|8-Week FU Period||1
10633562|NCT02046772|11791933|FG000|STARTED|Overall Study||30
10633563|NCT02046772|11791934|FG001|STARTED|Overall Study||33
10633564|NCT02046772|11791933|FG000|COMPLETED|Overall Study||30
10633565|NCT02046772|11791934|FG001|COMPLETED|Overall Study||33
10633566|NCT02046772|11791933|FG000|NOT COMPLETED|Overall Study||0
10633567|NCT02046772|11791934|FG001|NOT COMPLETED|Overall Study||0
10633568|NCT02046863|11791940|FG000|STARTED|Overall Study||7
10633569|NCT02046863|11791940|FG000|COMPLETED|Overall Study||7
10633570|NCT02046863|11791940|FG000|NOT COMPLETED|Overall Study||0
10633571|NCT02046902|11791947|FG000|STARTED|Overall Study||336
10633572|NCT02046902|11791948|FG001|STARTED|Overall Study||113
10633573|NCT02046902|11791949|FG002|STARTED|Overall Study||137
10633574|NCT02046902|11791947|FG000|COMPLETED|Overall Study||336
10633575|NCT02046902|11791948|FG001|COMPLETED|Overall Study||113
10633576|NCT02046902|11791949|FG002|COMPLETED|Overall Study||137
10633577|NCT02046902|11791947|FG000|NOT COMPLETED|Overall Study||0
10633578|NCT02046902|11791948|FG001|NOT COMPLETED|Overall Study||0
10633579|NCT02046902|11791949|FG002|NOT COMPLETED|Overall Study||0
10633580|NCT02046941|11791957|FG000|STARTED|Overall Study||17
10633581|NCT02046941|11791957|FG000|COMPLETED|Overall Study||10
10633582|NCT02046941|11791957|FG000|NOT COMPLETED|Overall Study||7
10633583|NCT02046980|11791964|FG000|STARTED|Overall Study||72
10633584|NCT02046980|11791965|FG001|STARTED|Overall Study||72
10633585|NCT02046980|11791966|FG002|STARTED|Overall Study||73
10633586|NCT02046980|11791964|FG000|COMPLETED|Overall Study||70
10633587|NCT02046980|11791965|FG001|COMPLETED|Overall Study||67
10633588|NCT02046980|11791966|FG002|COMPLETED|Overall Study||72
10633589|NCT02046980|11791964|FG000|NOT COMPLETED|Overall Study||2
10633590|NCT02046980|11791965|FG001|NOT COMPLETED|Overall Study||5
10633591|NCT02046980|11791966|FG002|NOT COMPLETED|Overall Study||1
10633592|NCT02046993|11791976|FG000|STARTED|Overall Study||105
10633593|NCT02046993|11791977|FG001|STARTED|Overall Study||105
10633594|NCT02046993|11791976|FG000|3rd Month|Overall Study||104
10633595|NCT02046993|11791977|FG001|3rd Month|Overall Study||97
10633596|NCT02046993|11791976|FG000|6th Month|Overall Study||102
10633597|NCT02046993|11791977|FG001|6th Month|Overall Study||94
10633598|NCT02046993|11791976|FG000|COMPLETED|Overall Study||102
10633599|NCT02046993|11791977|FG001|COMPLETED|Overall Study||94
10633600|NCT02046993|11791976|FG000|NOT COMPLETED|Overall Study||3
10633601|NCT02046993|11791977|FG001|NOT COMPLETED|Overall Study||11
10633602|NCT02047032|11791987|FG000|STARTED|Overall Study||250
10633604|NCT02047032|11791987|FG000|COMPLETED|Overall Study||245
10633605|NCT02047032|11791988|FG001|COMPLETED|Overall Study||235
10633606|NCT02047032|11791987|FG000|NOT COMPLETED|Overall Study||5
10633607|NCT02047032|11791988|FG001|NOT COMPLETED|Overall Study||15
10633608|NCT02047045|11791998|FG000|STARTED|Baseline||280
10633609|NCT02047045|11791999|FG001|STARTED|Baseline||280
10633610|NCT02047045|11791998|FG000|COMPLETED|Baseline||277
10633611|NCT02047045|11791999|FG001|COMPLETED|Baseline||278
10633612|NCT02047045|11791998|FG000|NOT COMPLETED|Baseline||3
10633613|NCT02047045|11791999|FG001|NOT COMPLETED|Baseline||2
10633614|NCT02047045|11791998|FG000|STARTED|Treatment Period (8 Weeks )||277
10633615|NCT02047045|11791999|FG001|STARTED|Treatment Period (8 Weeks )||278
10633616|NCT02047045|11791998|FG000|COMPLETED|Treatment Period (8 Weeks )||266
10633617|NCT02047045|11791999|FG001|COMPLETED|Treatment Period (8 Weeks )||263
10633618|NCT02047045|11791998|FG000|NOT COMPLETED|Treatment Period (8 Weeks )||11
10633619|NCT02047045|11791999|FG001|NOT COMPLETED|Treatment Period (8 Weeks )||15
10633620|NCT02047045|11791998|FG000|STARTED|Follow-up Period (24 Weeks)||266
10633621|NCT02047045|11791999|FG001|STARTED|Follow-up Period (24 Weeks)||263
10633622|NCT02047045|11791998|FG000|COMPLETED|Follow-up Period (24 Weeks)||265
10633623|NCT02047045|11791999|FG001|COMPLETED|Follow-up Period (24 Weeks)||262
10633624|NCT02047045|11791998|FG000|NOT COMPLETED|Follow-up Period (24 Weeks)||1
10633625|NCT02047045|11791999|FG001|NOT COMPLETED|Follow-up Period (24 Weeks)||1
10633626|NCT02047110|11792009|FG000|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|40
10633627|NCT02047110|11792010|FG001|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|40
10633628|NCT02047110|11792011|FG002|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|39
10633629|NCT02047110|11792012|FG003|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|40
10633630|NCT02047110|11792009|FG000|COMPLETED|DB Treatment Period up to Week 24||35
10633631|NCT02047110|11792010|FG001|COMPLETED|DB Treatment Period up to Week 24||38
10633632|NCT02047110|11792011|FG002|COMPLETED|DB Treatment Period up to Week 24||36
10633633|NCT02047110|11792012|FG003|COMPLETED|DB Treatment Period up to Week 24||38
10633634|NCT02047110|11792009|FG000|NOT COMPLETED|DB Treatment Period up to Week 24||5
10633635|NCT02047110|11792010|FG001|NOT COMPLETED|DB Treatment Period up to Week 24||2
10633636|NCT02047110|11792011|FG002|NOT COMPLETED|DB Treatment Period up to Week 24||3
10633637|NCT02047110|11792012|FG003|NOT COMPLETED|DB Treatment Period up to Week 24||2
10633638|NCT02047110|11792009|FG000|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|9
10633639|NCT02047110|11792010|FG001|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|17
10633640|NCT02047110|11792011|FG002|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|13
10633641|NCT02047110|11792012|FG003|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|12
10633642|NCT02047110|11792009|FG000|COMPLETED|DB (Week 12 up to Week 24)||9
10633643|NCT02047110|11792010|FG001|COMPLETED|DB (Week 12 up to Week 24)||15
10633644|NCT02047110|11792011|FG002|COMPLETED|DB (Week 12 up to Week 24)||12
10633645|NCT02047110|11792012|FG003|COMPLETED|DB (Week 12 up to Week 24)||12
10633646|NCT02047110|11792009|FG000|NOT COMPLETED|DB (Week 12 up to Week 24)||0
10633647|NCT02047110|11792010|FG001|NOT COMPLETED|DB (Week 12 up to Week 24)||2
10633648|NCT02047110|11792011|FG002|NOT COMPLETED|DB (Week 12 up to Week 24)||1
10633649|NCT02047110|11792012|FG003|NOT COMPLETED|DB (Week 12 up to Week 24)||0
10633650|NCT02047110|11792009|FG000|STARTED|Escape Treatment Period|Assessment in SpondyloArthritis international Society (ASAS) 20 nonresponders|26
10633651|NCT02047110|11792010|FG001|STARTED|Escape Treatment Period|ASAS 20 nonresponders|21
10633652|NCT02047110|11792011|FG002|STARTED|Escape Treatment Period|ASAS 20 nonresponders|23
10633653|NCT02047110|11792012|FG003|STARTED|Escape Treatment Period|ASAS 20 nonresponders|26
10633654|NCT02047110|11792009|FG000|COMPLETED|Escape Treatment Period||23
10633655|NCT02047110|11792010|FG001|COMPLETED|Escape Treatment Period||15
10633656|NCT02047110|11792011|FG002|COMPLETED|Escape Treatment Period||20
10633657|NCT02047110|11792012|FG003|COMPLETED|Escape Treatment Period||24
10633658|NCT02047110|11792009|FG000|NOT COMPLETED|Escape Treatment Period||3
10633659|NCT02047110|11792010|FG001|NOT COMPLETED|Escape Treatment Period||6
10633660|NCT02047110|11792011|FG002|NOT COMPLETED|Escape Treatment Period||3
10633661|NCT02047110|11792012|FG003|NOT COMPLETED|Escape Treatment Period||2
10633662|NCT02047110|11792009|FG000|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|4
10633663|NCT02047110|11792010|FG001|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|8
10633664|NCT02047110|11792011|FG002|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|5
10705681|NCT02601573|11870157|FG003|STARTED|Overall Study|Number randomized and treated.|18
10705682|NCT02601573|11870158|FG004|STARTED|Overall Study|Number randomized and treated.|18
10633665|NCT02047110|11792012|FG003|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|9
10633666|NCT02047110|11792009|FG000|COMPLETED|OLE Treatment Period||4
10633667|NCT02047110|11792010|FG001|COMPLETED|OLE Treatment Period||8
10633668|NCT02047110|11792011|FG002|COMPLETED|OLE Treatment Period||4
10633669|NCT02047110|11792012|FG003|COMPLETED|OLE Treatment Period||9
10633670|NCT02047110|11792009|FG000|NOT COMPLETED|OLE Treatment Period||0
10633671|NCT02047110|11792010|FG001|NOT COMPLETED|OLE Treatment Period||0
10633672|NCT02047110|11792011|FG002|NOT COMPLETED|OLE Treatment Period||1
10633673|NCT02047110|11792012|FG003|NOT COMPLETED|OLE Treatment Period||0
10633674|NCT02047227|11792031|FG000|STARTED|Overall Study||462
10633675|NCT02047227|11792032|FG001|STARTED|Overall Study||477
10633676|NCT02047227|11792031|FG000|Completed Ovarian Stimulation Phase|Overall Study||424
10633677|NCT02047227|11792032|FG001|Completed Ovarian Stimulation Phase|Overall Study||440
10633678|NCT02047227|11792031|FG000|COMPLETED|Overall Study||318
10633679|NCT02047227|11792032|FG001|COMPLETED|Overall Study||347
10633680|NCT02047227|11792031|FG000|NOT COMPLETED|Overall Study||144
10633681|NCT02047227|11792032|FG001|NOT COMPLETED|Overall Study||130
10633682|NCT02047253|11792038|FG000|STARTED|Overall Study||28
10633683|NCT02047253|11792038|FG000|COMPLETED|Overall Study||20
10633684|NCT02047253|11792038|FG000|NOT COMPLETED|Overall Study||8
10633685|NCT02047305|11792042|FG000|STARTED|Overall Study||96
10633686|NCT02047305|11792042|FG000|COMPLETED|Overall Study||96
10633687|NCT02047305|11792042|FG000|NOT COMPLETED|Overall Study||0
10633688|NCT02047318|11792046|FG000|STARTED|Core Study Period||19
10633689|NCT02047318|11792046|FG000|Received MRX 14 ug/kg/Day|Core Study Period||6
10633690|NCT02047318|11792046|FG000|Received MRX 35 ug/kg/Day|Core Study Period||6
10633691|NCT02047318|11792046|FG000|Received MRX 70 ug/kg/Day|Core Study Period||6
10633692|NCT02047318|11792046|FG000|Received MRX 140 ug/kg/Day|Core Study Period||11
10633693|NCT02047318|11792046|FG000|Received MRX 280 ug/kg/Day|Core Study Period||19
10633694|NCT02047318|11792046|FG000|COMPLETED|Core Study Period||7
10633695|NCT02047318|11792046|FG000|NOT COMPLETED|Core Study Period||12
10633696|NCT02047318|11792046|FG000|STARTED|52-week Follow-up Treatment Period||6
10633697|NCT02047318|11792046|FG000|COMPLETED|52-week Follow-up Treatment Period||6
10633698|NCT02047318|11792046|FG000|NOT COMPLETED|52-week Follow-up Treatment Period||0
10633699|NCT02047318|11792046|FG000|STARTED|Long-term Follow-up Treatment Period||7
10633700|NCT02047318|11792046|FG000|Received MRX 280 ug/kg/Day|Long-term Follow-up Treatment Period||7
10633701|NCT02047318|11792046|FG000|Received 420 ug/kg/Day|Long-term Follow-up Treatment Period||5
10633702|NCT02047318|11792046|FG000|Received 560 ug/kg/Day|Long-term Follow-up Treatment Period||5
10633703|NCT02047318|11792046|FG000|COMPLETED|Long-term Follow-up Treatment Period||6
10633704|NCT02047318|11792046|FG000|NOT COMPLETED|Long-term Follow-up Treatment Period||1
10633705|NCT02047344|11792063|FG000|STARTED|Overall Study|one patient is not evaluable in process. however, evaluable to safety report.|16
10633706|NCT02047344|11792064|FG001|STARTED|Overall Study||15
10633707|NCT02047344|11792063|FG000|COMPLETED|Overall Study||16
10633708|NCT02047344|11792064|FG001|COMPLETED|Overall Study||15
10633709|NCT02047344|11792063|FG000|NOT COMPLETED|Overall Study||0
10633710|NCT02047344|11792064|FG001|NOT COMPLETED|Overall Study||0
10633711|NCT02047500|11792076|FG000|STARTED|Overall Study||19
10633712|NCT02047500|11792076|FG000|COMPLETED|Overall Study||0
10633713|NCT02047500|11792076|FG000|NOT COMPLETED|Overall Study||19
10633714|NCT02047604|11792086|FG000|STARTED|Overall Study||6
10633715|NCT02047604|11792087|FG001|STARTED|Overall Study||7
10633716|NCT02047604|11792088|FG002|STARTED|Overall Study||6
10633717|NCT02047604|11792089|FG003|STARTED|Overall Study||6
10633718|NCT02047604|11792090|FG004|STARTED|Overall Study||6
10633719|NCT02047604|11792091|FG005|STARTED|Overall Study||10
10633720|NCT02047604|11792086|FG000|COMPLETED|Overall Study||6
10633721|NCT02047604|11792087|FG001|COMPLETED|Overall Study||7
10633722|NCT02047604|11792088|FG002|COMPLETED|Overall Study||6
10633723|NCT02047604|11792089|FG003|COMPLETED|Overall Study||6
10633724|NCT02047604|11792090|FG004|COMPLETED|Overall Study||5
10633725|NCT02047604|11792091|FG005|COMPLETED|Overall Study||9
10633726|NCT02047604|11792086|FG000|NOT COMPLETED|Overall Study||0
10633727|NCT02047604|11792087|FG001|NOT COMPLETED|Overall Study||0
10633728|NCT02047604|11792088|FG002|NOT COMPLETED|Overall Study||0
10633729|NCT02047604|11792089|FG003|NOT COMPLETED|Overall Study||0
10633730|NCT02047604|11792090|FG004|NOT COMPLETED|Overall Study||1
10633731|NCT02047604|11792091|FG005|NOT COMPLETED|Overall Study||1
10633732|NCT02047643|11792105|FG000|STARTED|Overall Study||9
10633733|NCT02047643|11792106|FG001|STARTED|Overall Study||9
10633734|NCT02047643|11792105|FG000|COMPLETED|Overall Study||9
10633735|NCT02047643|11792106|FG001|COMPLETED|Overall Study||9
10633736|NCT02047643|11792105|FG000|NOT COMPLETED|Overall Study||0
10633737|NCT02047643|11792106|FG001|NOT COMPLETED|Overall Study||0
10633738|NCT02047734|11792115|FG000|STARTED|Overall Study||443
10633739|NCT02047734|11792116|FG001|STARTED|Overall Study||443
10633740|NCT02047734|11792117|FG002|STARTED|Overall Study||434
10633741|NCT02047734|11792115|FG000|Received Treatment|Overall Study|One participant received ozanimod 0.5 mg in error|441
10633742|NCT02047734|11792116|FG001|Received Treatment|Overall Study|One participant received ozanimod 1.0 mg in error|439
10633743|NCT02047734|11792117|FG002|Received Treatment|Overall Study||433
10633744|NCT02047734|11792115|FG000|COMPLETED|Overall Study||376
10633745|NCT02047734|11792116|FG001|COMPLETED|Overall Study||374
10633746|NCT02047734|11792117|FG002|COMPLETED|Overall Study||388
10633747|NCT02047734|11792115|FG000|NOT COMPLETED|Overall Study||67
10633748|NCT02047734|11792116|FG001|NOT COMPLETED|Overall Study||69
10633749|NCT02047734|11792117|FG002|NOT COMPLETED|Overall Study||46
10633750|NCT02047903|11792125|FG000|STARTED|Overall Study||161
10633751|NCT02047903|11792125|FG000|Treated|Overall Study||152
10633752|NCT02047903|11792125|FG000|COMPLETED|Overall Study||102
10633753|NCT02047903|11792125|FG000|NOT COMPLETED|Overall Study||59
10633754|NCT02047981|11792131|FG000|STARTED|MORDOR Stage I Year 1-2||97047
10633755|NCT02047981|11792132|FG001|STARTED|MORDOR Stage I Year 1-2||93191
10633756|NCT02047981|11792131|FG000|COMPLETED|MORDOR Stage I Year 1-2||87650
10633757|NCT02047981|11792132|FG001|COMPLETED|MORDOR Stage I Year 1-2||84474
10633758|NCT02047981|11792131|FG000|NOT COMPLETED|MORDOR Stage I Year 1-2||9397
10633759|NCT02047981|11792132|FG001|NOT COMPLETED|MORDOR Stage I Year 1-2||8717
10633760|NCT02047981|11792131|FG000|STARTED|MORDOR Stage II Year 3||37497
10633761|NCT02047981|11792132|FG001|STARTED|MORDOR Stage II Year 3||33294
10633762|NCT02047981|11792131|FG000|COMPLETED|MORDOR Stage II Year 3||34611
10633763|NCT02047981|11792132|FG001|COMPLETED|MORDOR Stage II Year 3||30931
10633764|NCT02047981|11792131|FG000|NOT COMPLETED|MORDOR Stage II Year 3||2886
10633765|NCT02047981|11792132|FG001|NOT COMPLETED|MORDOR Stage II Year 3||2363
10633766|NCT02048072|11792138|FG000|STARTED|Overall Study||33
10633767|NCT02048072|11792138|FG000|COMPLETED|Overall Study||29
10633768|NCT02048072|11792138|FG000|NOT COMPLETED|Overall Study||4
10633769|NCT02048241|11792144|FG000|STARTED|Overall Study||5
10633770|NCT02048241|11792145|FG001|STARTED|Overall Study||6
10633771|NCT02048241|11792144|FG000|COMPLETED|Overall Study||5
10633772|NCT02048241|11792145|FG001|COMPLETED|Overall Study||5
10633773|NCT02048241|11792144|FG000|NOT COMPLETED|Overall Study||0
10633774|NCT02048241|11792145|FG001|NOT COMPLETED|Overall Study||1
10633775|NCT02048670|11792153|FG000|STARTED|Overall Study||6
10633776|NCT02048670|11792154|FG001|STARTED|Overall Study||6
10633777|NCT02048670|11792153|FG000|COMPLETED|Overall Study||6
10633778|NCT02048670|11792154|FG001|COMPLETED|Overall Study||6
10633779|NCT02048670|11792153|FG000|NOT COMPLETED|Overall Study||0
10633780|NCT02048670|11792154|FG001|NOT COMPLETED|Overall Study||0
10633781|NCT02048826|11792162|FG000|STARTED|Overall Study||16
10633782|NCT02048826|11792163|FG001|STARTED|Overall Study||15
10633783|NCT02048826|11792162|FG000|COMPLETED|Overall Study||15
10633784|NCT02048826|11792163|FG001|COMPLETED|Overall Study||15
10633785|NCT02048826|11792162|FG000|NOT COMPLETED|Overall Study||1
10633786|NCT02048826|11792163|FG001|NOT COMPLETED|Overall Study||0
10633787|NCT02048878|11792171|FG000|STARTED|Overall Study||13
10633788|NCT02048878|11792172|FG001|STARTED|Overall Study||15
10633789|NCT02048878|11792171|FG000|COMPLETED|Overall Study||12
10633790|NCT02048878|11792172|FG001|COMPLETED|Overall Study||12
10633791|NCT02048878|11792171|FG000|NOT COMPLETED|Overall Study||1
10633792|NCT02048878|11792172|FG001|NOT COMPLETED|Overall Study||3
10633793|NCT02048891|11792180|FG000|STARTED|Overall Study||2
10633794|NCT02048891|11792181|FG001|STARTED|Overall Study||1
10633795|NCT02048891|11792180|FG000|COMPLETED|Overall Study||2
10633796|NCT02048891|11792181|FG001|COMPLETED|Overall Study||1
10633797|NCT02048891|11792180|FG000|NOT COMPLETED|Overall Study||0
10633798|NCT02048891|11792181|FG001|NOT COMPLETED|Overall Study||0
10633799|NCT02049151|11792189|FG000|STARTED|Overall Study|2 subjects did not receive treatment|15
10705683|NCT02601573|11870154|FG000|COMPLETED|Overall Study||23
10705684|NCT02601573|11870155|FG001|COMPLETED|Overall Study||20
10633800|NCT02049151|11792190|FG001|STARTED|Overall Study|1 subject did not receive treatment|17
10633801|NCT02049151|11792189|FG000|COMPLETED|Overall Study||15
10705685|NCT02601573|11870156|FG002|COMPLETED|Overall Study||16
10633802|NCT02049151|11792190|FG001|COMPLETED|Overall Study||17
10633803|NCT02049151|11792189|FG000|NOT COMPLETED|Overall Study||0
10633804|NCT02049151|11792190|FG001|NOT COMPLETED|Overall Study||0
10633805|NCT02049307|11792198|FG000|STARTED|Overall Study||52
10633806|NCT02049307|11792199|FG001|STARTED|Overall Study||56
10633807|NCT02049307|11792198|FG000|COMPLETED|Overall Study||50
10633808|NCT02049307|11792199|FG001|COMPLETED|Overall Study||55
10633809|NCT02049307|11792198|FG000|NOT COMPLETED|Overall Study||2
10633810|NCT02049307|11792199|FG001|NOT COMPLETED|Overall Study||1
10633811|NCT02049385|11792207|FG000|STARTED|First Intervention||4
10633812|NCT02049385|11792208|FG001|STARTED|First Intervention||2
10633813|NCT02049385|11792207|FG000|COMPLETED|First Intervention||1
10633814|NCT02049385|11792208|FG001|COMPLETED|First Intervention||2
10633815|NCT02049385|11792207|FG000|NOT COMPLETED|First Intervention||3
10705686|NCT02601573|11870157|FG003|COMPLETED|Overall Study||17
10633816|NCT02049385|11792208|FG001|NOT COMPLETED|First Intervention||0
10633817|NCT02049385|11792207|FG000|STARTED|Second Intervention||1
10633818|NCT02049385|11792208|FG001|STARTED|Second Intervention||2
10633819|NCT02049385|11792207|FG000|COMPLETED|Second Intervention||1
10633820|NCT02049385|11792208|FG001|COMPLETED|Second Intervention||0
10705687|NCT02601573|11870158|FG004|COMPLETED|Overall Study||16
10705688|NCT02601573|11870154|FG000|NOT COMPLETED|Overall Study||0
10705689|NCT02601573|11870155|FG001|NOT COMPLETED|Overall Study||4
10633821|NCT02049385|11792207|FG000|NOT COMPLETED|Second Intervention||0
10633822|NCT02049385|11792208|FG001|NOT COMPLETED|Second Intervention||2
10633823|NCT02049437|11792216|FG000|STARTED|Period 1||17
10633824|NCT02049437|11792217|FG001|STARTED|Period 1||17
10633825|NCT02049437|11792216|FG000|COMPLETED|Period 1||15
10633826|NCT02049437|11792217|FG001|COMPLETED|Period 1|Dropout due to low trough levels|16
10633827|NCT02049437|11792216|FG000|NOT COMPLETED|Period 1||2
10633828|NCT02049437|11792217|FG001|NOT COMPLETED|Period 1||1
10633829|NCT02049437|11792216|FG000|STARTED|Washout 1||15
10633830|NCT02049437|11792217|FG001|STARTED|Washout 1||16
10633831|NCT02049437|11792216|FG000|COMPLETED|Washout 1||15
10633832|NCT02049437|11792217|FG001|COMPLETED|Washout 1||16
10633833|NCT02049437|11792216|FG000|NOT COMPLETED|Washout 1||0
10633834|NCT02049437|11792217|FG001|NOT COMPLETED|Washout 1||0
10633835|NCT02049437|11792216|FG000|STARTED|Period 2||15
10633836|NCT02049437|11792217|FG001|STARTED|Period 2||16
10633837|NCT02049437|11792216|FG000|COMPLETED|Period 2||15
10633838|NCT02049437|11792217|FG001|COMPLETED|Period 2||16
10633839|NCT02049437|11792216|FG000|NOT COMPLETED|Period 2||0
10633840|NCT02049437|11792217|FG001|NOT COMPLETED|Period 2||0
10633841|NCT02049437|11792216|FG000|STARTED|Washout 2||15
10633842|NCT02049437|11792217|FG001|STARTED|Washout 2||16
10633843|NCT02049437|11792216|FG000|COMPLETED|Washout 2||15
10633844|NCT02049437|11792217|FG001|COMPLETED|Washout 2||16
10633845|NCT02049437|11792216|FG000|NOT COMPLETED|Washout 2||0
10633846|NCT02049437|11792217|FG001|NOT COMPLETED|Washout 2||0
10633847|NCT02049450|11792223|FG000|STARTED|Overall Study||30
10633848|NCT02049450|11792223|FG000|Discontinued Treatment Prior to Week 30|Overall Study||4
10633849|NCT02049450|11792223|FG000|Entered Extension Phase|Overall Study|Of 26 who completed Core phase 18 moved into Ext. phase; All 18 eventually discontinued Ext. phase|18
10633850|NCT02049450|11792223|FG000|COMPLETED|Overall Study|Completed = Completed Core phase of study|26
10633851|NCT02049450|11792223|FG000|NOT COMPLETED|Overall Study||4
10633852|NCT02049476|11792234|FG000|STARTED|Overall Study|First patient enrolled on 1/31/2014|20
10633853|NCT02049476|11792234|FG000|COMPLETED|Overall Study|20th patient completed the study|20
10633854|NCT02049476|11792234|FG000|NOT COMPLETED|Overall Study||0
10633855|NCT02049502|11792238|FG000|STARTED|Overall Study||8
10633856|NCT02049502|11792238|FG000|COMPLETED|Overall Study||8
10633857|NCT02049502|11792238|FG000|NOT COMPLETED|Overall Study||0
10633858|NCT02049749|11792244|FG000|STARTED|Overall Study|40 children plus 40 caregivers|80
10633859|NCT02049749|11792245|FG001|STARTED|Overall Study|80 children plus 80 caregivers|160
10633860|NCT02049749|11792244|FG000|COMPLETED|Overall Study||80
10633861|NCT02049749|11792245|FG001|COMPLETED|Overall Study|80 children plus 80 caregivers|160
10633862|NCT02049749|11792244|FG000|NOT COMPLETED|Overall Study||0
10633863|NCT02049749|11792245|FG001|NOT COMPLETED|Overall Study||0
10633864|NCT02049814|11792254|FG000|STARTED|Overall Study||248
10633865|NCT02049814|11792255|FG001|STARTED|Overall Study||246
10633866|NCT02049814|11792254|FG000|Safety Set|Overall Study||248
10633867|NCT02049814|11792255|FG001|Safety Set|Overall Study||245
10633868|NCT02049814|11792254|FG000|COMPLETED|Overall Study||219
10633869|NCT02049814|11792255|FG001|COMPLETED|Overall Study||219
10633870|NCT02049814|11792254|FG000|NOT COMPLETED|Overall Study||29
10633871|NCT02049814|11792255|FG001|NOT COMPLETED|Overall Study||27
10633872|NCT02049866|11792261|FG000|STARTED|Overall Study||33
10633873|NCT02049866|11792261|FG000|COMPLETED|Overall Study||32
10705690|NCT02601573|11870156|FG002|NOT COMPLETED|Overall Study||1
10705691|NCT02601573|11870157|FG003|NOT COMPLETED|Overall Study||1
10705692|NCT02601573|11870158|FG004|NOT COMPLETED|Overall Study||2
10705693|NCT02601625|11870174|FG000|STARTED|Overall Study||6
10633874|NCT02049866|11792261|FG000|NOT COMPLETED|Overall Study||1
10633875|NCT02049931|11792268|FG000|STARTED|Overall Study||20
10633876|NCT02049931|11792269|FG001|STARTED|Overall Study||20
10633877|NCT02049931|11792270|FG002|STARTED|Overall Study||20
10633878|NCT02049931|11792268|FG000|COMPLETED|Overall Study||17
10633879|NCT02049931|11792269|FG001|COMPLETED|Overall Study||15
10633880|NCT02049931|11792270|FG002|COMPLETED|Overall Study||17
10633881|NCT02049931|11792268|FG000|NOT COMPLETED|Overall Study||3
10633882|NCT02049931|11792269|FG001|NOT COMPLETED|Overall Study||5
10633883|NCT02049931|11792270|FG002|NOT COMPLETED|Overall Study||3
10633884|NCT02049944|11792278|FG000|STARTED|Overall Study||30
10633885|NCT02049944|11792278|FG000|Obese (BMI 30-40kg/m^2)|Overall Study||14
10633886|NCT02049944|11792278|FG000|Extremely Obese (BMI >40kg/m^2)|Overall Study||14
10633887|NCT02049944|11792278|FG000|COMPLETED|Overall Study||28
10633888|NCT02049944|11792278|FG000|NOT COMPLETED|Overall Study||2
10633889|NCT02049957|11792291|FG000|STARTED|Overall Study||6
10633890|NCT02049957|11792292|FG001|STARTED|Overall Study||6
10633891|NCT02049957|11792293|FG002|STARTED|Overall Study||3
10633892|NCT02049957|11792294|FG003|STARTED|Overall Study||3
10633893|NCT02049957|11792295|FG004|STARTED|Overall Study||6
10633894|NCT02049957|11792296|FG005|STARTED|Overall Study||43
10633895|NCT02049957|11792297|FG006|STARTED|Overall Study||8
10633896|NCT02049957|11792298|FG007|STARTED|Overall Study||35
10633897|NCT02049957|11792299|FG008|STARTED|Overall Study||8
10633898|NCT02049957|11792291|FG000|COMPLETED|Overall Study||0
10633899|NCT02049957|11792292|FG001|COMPLETED|Overall Study||0
10633900|NCT02049957|11792293|FG002|COMPLETED|Overall Study||0
10633901|NCT02049957|11792294|FG003|COMPLETED|Overall Study||0
10633902|NCT02049957|11792295|FG004|COMPLETED|Overall Study||0
10633903|NCT02049957|11792296|FG005|COMPLETED|Overall Study||0
10633904|NCT02049957|11792297|FG006|COMPLETED|Overall Study||0
10633905|NCT02049957|11792298|FG007|COMPLETED|Overall Study||0
10633906|NCT02049957|11792299|FG008|COMPLETED|Overall Study||0
10633907|NCT02049957|11792291|FG000|NOT COMPLETED|Overall Study||6
10633908|NCT02049957|11792292|FG001|NOT COMPLETED|Overall Study||6
10633909|NCT02049957|11792293|FG002|NOT COMPLETED|Overall Study||3
10633910|NCT02049957|11792294|FG003|NOT COMPLETED|Overall Study||3
10633911|NCT02049957|11792295|FG004|NOT COMPLETED|Overall Study||6
10633912|NCT02049957|11792296|FG005|NOT COMPLETED|Overall Study||43
10633913|NCT02049957|11792297|FG006|NOT COMPLETED|Overall Study||8
10633914|NCT02049957|11792298|FG007|NOT COMPLETED|Overall Study||35
10633915|NCT02049957|11792299|FG008|NOT COMPLETED|Overall Study||8
10633916|NCT02050048|11792321|FG000|STARTED|Overall Study||14
10633917|NCT02050048|11792322|FG001|STARTED|Overall Study||12
10633918|NCT02050048|11792321|FG000|COMPLETED|Overall Study||9
10633919|NCT02050048|11792322|FG001|COMPLETED|Overall Study||10
10633920|NCT02050048|11792321|FG000|NOT COMPLETED|Overall Study||5
10633921|NCT02050048|11792322|FG001|NOT COMPLETED|Overall Study||2
10633922|NCT02050321|11792328|FG000|STARTED|Overall Study||2
10633923|NCT02050321|11792328|FG000|COMPLETED|Overall Study||0
10633924|NCT02050321|11792328|FG000|NOT COMPLETED|Overall Study||2
10633925|NCT02050334|11792334|FG000|STARTED|Overall Study||9
10633926|NCT02050334|11792335|FG001|STARTED|Overall Study||9
10633927|NCT02050334|11792334|FG000|COMPLETED|Overall Study||9
10705694|NCT02601625|11870175|FG001|STARTED|Overall Study||6
10705695|NCT02601625|11870176|FG002|STARTED|Overall Study||6
10705696|NCT02601625|11870177|FG003|STARTED|Overall Study||12
10705697|NCT02601625|11870174|FG000|COMPLETED|Overall Study||6
10705698|NCT02601625|11870175|FG001|COMPLETED|Overall Study||6
10705699|NCT02601625|11870176|FG002|COMPLETED|Overall Study||5
10705700|NCT02601625|11870177|FG003|COMPLETED|Overall Study||11
10705701|NCT02601625|11870174|FG000|NOT COMPLETED|Overall Study||0
10705702|NCT02601625|11870175|FG001|NOT COMPLETED|Overall Study||0
10705703|NCT02601625|11870176|FG002|NOT COMPLETED|Overall Study||1
10705704|NCT02601625|11870177|FG003|NOT COMPLETED|Overall Study||1
10705705|NCT02601820|11870201|FG000|STARTED|Pre-Treatment (T1)|1601 patients were enrolled and completed Baseline PROs (T1).|1601
10705706|NCT02601820|11870201|FG000|COMPLETED|Pre-Treatment (T1)||1601
10705707|NCT02601820|11870201|FG000|NOT COMPLETED|Pre-Treatment (T1)||0
10705708|NCT02601820|11870201|FG000|STARTED|Early On-Treatment (T2)|Of 1601, 17 were excluded at T2 due to death, withdrawal, other reason. 1584 remained in the study.|1584
10705709|NCT02601820|11870201|FG000|COMPLETED|Early On-Treatment (T2)|Of 1584, 51 were excluded for a missing T2 record. 1533 provided data at T2. Some outcomes missing.|1533
10705710|NCT02601820|11870201|FG000|NOT COMPLETED|Early On-Treatment (T2)||51
10705711|NCT02601820|11870201|FG000|STARTED|Late On-Treatment (T3)|Of 1601, 28 were excluded at T3 due to death, withdrawal, other reason. 1573 remained in the study.|1573
10705712|NCT02601820|11870201|FG000|COMPLETED|Late On-Treatment (T3)|Of 1573, 49 were excluded for a missing T3 record. 1524 provided data at T3. Some outcomes missing.|1524
10705713|NCT02601820|11870201|FG000|NOT COMPLETED|Late On-Treatment (T3)||49
10705714|NCT02601820|11870201|FG000|STARTED|12 Weeks Post-Treatment (T4)|Of 1601, 37 were excluded at T4 due to death, withdrawal, other reason. 1564 remained in the study.|1564
10705715|NCT02601820|11870201|FG000|COMPLETED|12 Weeks Post-Treatment (T4)|Of 1564, 3 were excluded for a missing T4 record. 1561 provided data at T4. Some outcomes missing.|1561
10705716|NCT02601820|11870201|FG000|NOT COMPLETED|12 Weeks Post-Treatment (T4)||3
10705717|NCT02601820|11870201|FG000|STARTED|1-Yr Post-Treatment (T5)|Of 1601, 73 were excluded at T5 due to death, withdrawal, other reason. 1528 remained in the study.|1528
10705718|NCT02601820|11870201|FG000|COMPLETED|1-Yr Post-Treatment (T5)|Of 1528, 88 were excluded for a missing T5 record. 1440 provided data at T5. Some outcomes missing.|1440
10705719|NCT02601820|11870201|FG000|NOT COMPLETED|1-Yr Post-Treatment (T5)||88
10713772|NCT02681757|11879266|FG000|NOT COMPLETED|Overall Study||0
10713773|NCT02681757|11879267|FG001|NOT COMPLETED|Overall Study||0
10713774|NCT02681809|11879276|FG000|STARTED|Overall Study||20
10713775|NCT02681809|11879277|FG001|STARTED|Overall Study||19
10633928|NCT02050334|11792335|FG001|COMPLETED|Overall Study||9
10633929|NCT02050334|11792334|FG000|NOT COMPLETED|Overall Study||0
10633930|NCT02050334|11792335|FG001|NOT COMPLETED|Overall Study||0
10633931|NCT02050373|11792344|FG000|STARTED|Overall Study||34
10633932|NCT02050373|11792345|FG001|STARTED|Overall Study||34
10633933|NCT02050373|11792344|FG000|COMPLETED|Overall Study||27
10633934|NCT02050373|11792345|FG001|COMPLETED|Overall Study||24
10633935|NCT02050373|11792344|FG000|NOT COMPLETED|Overall Study||7
10633936|NCT02050373|11792345|FG001|NOT COMPLETED|Overall Study||10
10633937|NCT02050841|11792352|FG000|STARTED|Overall Study||50
10457176|NCT01009333|11604885|FG002|NOT COMPLETED|Week 3||0
10633938|NCT02050841|11792352|FG000|COMPLETED|Overall Study||49
10633939|NCT02050841|11792352|FG000|NOT COMPLETED|Overall Study||1
10633940|NCT02051296|11792364|FG000|STARTED|Overall Study||66
10633941|NCT02051296|11792365|FG001|STARTED|Overall Study||65
10633942|NCT02051296|11792364|FG000|Received Allocated Intervention|Overall Study||59
10633943|NCT02051296|11792365|FG001|Received Allocated Intervention|Overall Study||58
10633944|NCT02051296|11792364|FG000|COMPLETED|Overall Study||58
10633945|NCT02051296|11792365|FG001|COMPLETED|Overall Study||56
10633946|NCT02051296|11792364|FG000|NOT COMPLETED|Overall Study||8
10633947|NCT02051296|11792365|FG001|NOT COMPLETED|Overall Study||9
10633948|NCT02051335|11792375|FG000|STARTED|Period 1||7
10633949|NCT02051335|11792376|FG001|STARTED|Period 1||7
10633950|NCT02051335|11792377|FG002|STARTED|Period 1||7
10633951|NCT02051335|11792378|FG003|STARTED|Period 1||6
10633952|NCT02051335|11792375|FG000|COMPLETED|Period 1||7
10633953|NCT02051335|11792376|FG001|COMPLETED|Period 1||7
10633954|NCT02051335|11792377|FG002|COMPLETED|Period 1||7
10633955|NCT02051335|11792378|FG003|COMPLETED|Period 1||6
10633956|NCT02051335|11792375|FG000|NOT COMPLETED|Period 1||0
10633957|NCT02051335|11792376|FG001|NOT COMPLETED|Period 1||0
10633958|NCT02051335|11792377|FG002|NOT COMPLETED|Period 1||0
10633959|NCT02051335|11792378|FG003|NOT COMPLETED|Period 1||0
10633960|NCT02051335|11792375|FG000|STARTED|Period 2||7
10633961|NCT02051335|11792376|FG001|STARTED|Period 2||7
10633962|NCT02051335|11792377|FG002|STARTED|Period 2||7
10457177|NCT01009333|11604886|FG003|NOT COMPLETED|Week 3||0
10457178|NCT01009333|11604887|FG004|NOT COMPLETED|Week 3||0
10457179|NCT01009333|11604888|FG005|NOT COMPLETED|Week 3||0
10457180|NCT01009346|11604896|FG000|STARTED|Overall Study||9
10457181|NCT01009346|11604896|FG000|COMPLETED|Overall Study||5
10457182|NCT01009346|11604896|FG000|NOT COMPLETED|Overall Study||4
10457183|NCT01009463|11604905|FG000|STARTED|4-week, Open-label Run-In Period||2071
10457184|NCT01009463|11604906|FG001|STARTED|4-week, Open-label Run-In Period||0
10457185|NCT01009463|11604907|FG002|STARTED|4-week, Open-label Run-In Period||0
10457186|NCT01009463|11604908|FG003|STARTED|4-week, Open-label Run-In Period||0
10457187|NCT01009463|11604909|FG004|STARTED|4-week, Open-label Run-In Period||0
10457188|NCT01009463|11604905|FG000|COMPLETED|4-week, Open-label Run-In Period||1622
10457189|NCT01009463|11604906|FG001|COMPLETED|4-week, Open-label Run-In Period||0
10457190|NCT01009463|11604907|FG002|COMPLETED|4-week, Open-label Run-In Period||0
10457191|NCT01009463|11604908|FG003|COMPLETED|4-week, Open-label Run-In Period||0
10457192|NCT01009463|11604909|FG004|COMPLETED|4-week, Open-label Run-In Period||0
10457193|NCT01009463|11604905|FG000|NOT COMPLETED|4-week, Open-label Run-In Period||449
10457194|NCT01009463|11604906|FG001|NOT COMPLETED|4-week, Open-label Run-In Period||0
10457195|NCT01009463|11604907|FG002|NOT COMPLETED|4-week, Open-label Run-In Period||0
10457196|NCT01009463|11604908|FG003|NOT COMPLETED|4-week, Open-label Run-In Period||0
10457197|NCT01009463|11604909|FG004|NOT COMPLETED|4-week, Open-label Run-In Period||0
10457198|NCT01009463|11604905|FG000|STARTED|52-week, Double-blind Treatment Period||0
10457199|NCT01009463|11604906|FG001|STARTED|52-week, Double-blind Treatment Period||409
10457200|NCT01009463|11604907|FG002|STARTED|52-week, Double-blind Treatment Period||408
10633963|NCT02051335|11792378|FG003|STARTED|Period 2|2 Participants received treatment in Period 1 but discontinued prior to Period 2.|4
10633964|NCT02051335|11792375|FG000|COMPLETED|Period 2||7
10633965|NCT02051335|11792376|FG001|COMPLETED|Period 2||7
10633966|NCT02051335|11792377|FG002|COMPLETED|Period 2||7
10633967|NCT02051335|11792378|FG003|COMPLETED|Period 2||4
10633968|NCT02051335|11792375|FG000|NOT COMPLETED|Period 2||0
10633969|NCT02051335|11792376|FG001|NOT COMPLETED|Period 2||0
10633970|NCT02051335|11792377|FG002|NOT COMPLETED|Period 2||0
10633971|NCT02051335|11792378|FG003|NOT COMPLETED|Period 2||0
10457201|NCT01009463|11604908|FG003|STARTED|52-week, Double-blind Treatment Period||403
10457202|NCT01009463|11604909|FG004|STARTED|52-week, Double-blind Treatment Period||402
10457203|NCT01009463|11604905|FG000|Completed the Treatment Period|52-week, Double-blind Treatment Period||0
10457204|NCT01009463|11604906|FG001|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|295
10457205|NCT01009463|11604907|FG002|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|318
10457206|NCT01009463|11604908|FG003|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|314
10457207|NCT01009463|11604909|FG004|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|303
10457208|NCT01009463|11604905|FG000|COMPLETED|52-week, Double-blind Treatment Period||0
10457209|NCT01009463|11604906|FG001|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|294
10457210|NCT01009463|11604907|FG002|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|315
10457211|NCT01009463|11604908|FG003|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|312
10457212|NCT01009463|11604909|FG004|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|301
10457213|NCT01009463|11604905|FG000|NOT COMPLETED|52-week, Double-blind Treatment Period||0
10457214|NCT01009463|11604906|FG001|NOT COMPLETED|52-week, Double-blind Treatment Period||115
10457215|NCT01009463|11604907|FG002|NOT COMPLETED|52-week, Double-blind Treatment Period||93
10633972|NCT02051335|11792375|FG000|STARTED|Period 3||7
10633973|NCT02051335|11792376|FG001|STARTED|Period 3||7
10633974|NCT02051335|11792377|FG002|STARTED|Period 3|2 Participants received treatment in Period 2 but discontinued prior to Period 3.|5
10633975|NCT02051335|11792378|FG003|STARTED|Period 3||4
10633976|NCT02051335|11792375|FG000|COMPLETED|Period 3||7
10633977|NCT02051335|11792376|FG001|COMPLETED|Period 3||7
10633978|NCT02051335|11792377|FG002|COMPLETED|Period 3||5
10633979|NCT02051335|11792378|FG003|COMPLETED|Period 3||4
10633980|NCT02051335|11792375|FG000|NOT COMPLETED|Period 3||0
10633981|NCT02051335|11792376|FG001|NOT COMPLETED|Period 3||0
10633982|NCT02051335|11792377|FG002|NOT COMPLETED|Period 3||0
10633983|NCT02051335|11792378|FG003|NOT COMPLETED|Period 3||0
10633984|NCT02051335|11792375|FG000|STARTED|Period 4||7
10633985|NCT02051335|11792376|FG001|STARTED|Period 4||7
10633986|NCT02051335|11792377|FG002|STARTED|Period 4||5
10633987|NCT02051335|11792378|FG003|STARTED|Period 4||4
10633988|NCT02051335|11792375|FG000|COMPLETED|Period 4||7
10633989|NCT02051335|11792376|FG001|COMPLETED|Period 4||7
10633990|NCT02051335|11792377|FG002|COMPLETED|Period 4||5
10633991|NCT02051335|11792378|FG003|COMPLETED|Period 4||4
10633992|NCT02051335|11792375|FG000|NOT COMPLETED|Period 4||0
10633993|NCT02051335|11792376|FG001|NOT COMPLETED|Period 4||0
10633994|NCT02051335|11792377|FG002|NOT COMPLETED|Period 4||0
10633995|NCT02051335|11792378|FG003|NOT COMPLETED|Period 4||0
10633996|NCT02051426|11792390|FG000|STARTED|First Intervention||16
10633997|NCT02051426|11792391|FG001|STARTED|First Intervention||19
10633998|NCT02051426|11792390|FG000|COMPLETED|First Intervention||16
10633999|NCT02051426|11792391|FG001|COMPLETED|First Intervention||19
10634000|NCT02051426|11792390|FG000|NOT COMPLETED|First Intervention||0
10634001|NCT02051426|11792391|FG001|NOT COMPLETED|First Intervention||0
10634002|NCT02051426|11792390|FG000|STARTED|Washout Period of 1 Month||16
10634003|NCT02051426|11792391|FG001|STARTED|Washout Period of 1 Month||19
10634004|NCT02051426|11792390|FG000|COMPLETED|Washout Period of 1 Month||16
10634005|NCT02051426|11792391|FG001|COMPLETED|Washout Period of 1 Month||19
10634006|NCT02051426|11792390|FG000|NOT COMPLETED|Washout Period of 1 Month||0
10634007|NCT02051426|11792391|FG001|NOT COMPLETED|Washout Period of 1 Month||0
10634008|NCT02051426|11792390|FG000|STARTED|Second Intervention||16
10634009|NCT02051426|11792391|FG001|STARTED|Second Intervention||19
10634010|NCT02051426|11792390|FG000|COMPLETED|Second Intervention||16
10634011|NCT02051426|11792391|FG001|COMPLETED|Second Intervention||19
10634012|NCT02051426|11792390|FG000|NOT COMPLETED|Second Intervention||0
10634013|NCT02051426|11792391|FG001|NOT COMPLETED|Second Intervention||0
10634014|NCT02051452|11792399|FG000|STARTED|Overall Study||16
10634015|NCT02051452|11792400|FG001|STARTED|Overall Study||16
10634016|NCT02051452|11792399|FG000|COMPLETED|Overall Study||16
10634017|NCT02051452|11792400|FG001|COMPLETED|Overall Study||16
10634018|NCT02051452|11792399|FG000|NOT COMPLETED|Overall Study||0
10634019|NCT02051452|11792400|FG001|NOT COMPLETED|Overall Study||0
10634020|NCT02051595|11792406|FG000|STARTED|Overall Study||25
10634021|NCT02051595|11792406|FG000|COMPLETED|Overall Study||25
10634022|NCT02051595|11792406|FG000|NOT COMPLETED|Overall Study||0
10634023|NCT02051686|11792412|FG000|STARTED|Overall Study||42
10634024|NCT02051686|11792413|FG001|STARTED|Overall Study||46
10634025|NCT02051686|11792412|FG000|COMPLETED|Overall Study||42
10634026|NCT02051686|11792413|FG001|COMPLETED|Overall Study||46
10634027|NCT02051686|11792412|FG000|NOT COMPLETED|Overall Study||0
10634028|NCT02051686|11792413|FG001|NOT COMPLETED|Overall Study||0
10634029|NCT02051764|11792421|FG000|STARTED|Overall Study||16
10634030|NCT02051764|11792422|FG001|STARTED|Overall Study||28
10634031|NCT02051764|11792421|FG000|COMPLETED|Overall Study||16
10634032|NCT02051764|11792422|FG001|COMPLETED|Overall Study||21
10634033|NCT02051764|11792421|FG000|NOT COMPLETED|Overall Study||0
10634034|NCT02051764|11792422|FG001|NOT COMPLETED|Overall Study||7
10634035|NCT02051790|11792428|FG000|STARTED|Overall Study||241
10634036|NCT02051790|11792428|FG000|COMPLETED|Overall Study||241
10634037|NCT02051790|11792428|FG000|NOT COMPLETED|Overall Study||0
10634038|NCT02051816|11792436|FG000|STARTED|Overall Study||37
10634039|NCT02051816|11792437|FG001|STARTED|Overall Study||40
10634040|NCT02051816|11792438|FG002|STARTED|Overall Study||37
10634041|NCT02051816|11792439|FG003|STARTED|Overall Study||36
10634042|NCT02051816|11792436|FG000|COMPLETED|Overall Study||37
10634043|NCT02051816|11792437|FG001|COMPLETED|Overall Study||40
10634044|NCT02051816|11792438|FG002|COMPLETED|Overall Study||37
10634045|NCT02051816|11792439|FG003|COMPLETED|Overall Study||36
10634046|NCT02051816|11792436|FG000|NOT COMPLETED|Overall Study||0
10634047|NCT02051816|11792437|FG001|NOT COMPLETED|Overall Study||0
10634048|NCT02051816|11792438|FG002|NOT COMPLETED|Overall Study||0
10634049|NCT02051816|11792439|FG003|NOT COMPLETED|Overall Study||0
10634050|NCT02052011|11792455|FG000|STARTED|Overall Study||21
10634051|NCT02052011|11792456|FG001|STARTED|Overall Study||10
10634052|NCT02052011|11792455|FG000|COMPLETED|Overall Study||17
10634053|NCT02052011|11792456|FG001|COMPLETED|Overall Study||8
10634054|NCT02052011|11792455|FG000|NOT COMPLETED|Overall Study||4
10634055|NCT02052011|11792456|FG001|NOT COMPLETED|Overall Study||2
10634056|NCT02052141|11792464|FG000|STARTED|Intervention Period 1||5
10634057|NCT02052141|11792465|FG001|STARTED|Intervention Period 1||7
10634058|NCT02052141|11792464|FG000|COMPLETED|Intervention Period 1||5
10634059|NCT02052141|11792465|FG001|COMPLETED|Intervention Period 1||7
10634060|NCT02052141|11792464|FG000|NOT COMPLETED|Intervention Period 1||0
10634061|NCT02052141|11792465|FG001|NOT COMPLETED|Intervention Period 1||0
10634062|NCT02052141|11792464|FG000|STARTED|Intervention Period 2||5
10634063|NCT02052141|11792465|FG001|STARTED|Intervention Period 2||7
10634064|NCT02052141|11792464|FG000|COMPLETED|Intervention Period 2||5
10634065|NCT02052141|11792465|FG001|COMPLETED|Intervention Period 2||7
10634066|NCT02052141|11792464|FG000|NOT COMPLETED|Intervention Period 2||0
10634067|NCT02052141|11792465|FG001|NOT COMPLETED|Intervention Period 2||0
10634068|NCT02052310|11792473|FG000|STARTED|Overall Study||522
10634069|NCT02052310|11792474|FG001|STARTED|Overall Study||521
10634070|NCT02052310|11792473|FG000|Received at Least 1 Dose of Study Drug|Overall Study||522
10634071|NCT02052310|11792474|FG001|Received at Least 1 Dose of Study Drug|Overall Study||517
10634072|NCT02052310|11792473|FG000|COMPLETED|Overall Study||307
10634073|NCT02052310|11792474|FG001|COMPLETED|Overall Study||309
10634074|NCT02052310|11792473|FG000|NOT COMPLETED|Overall Study||215
10634075|NCT02052310|11792474|FG001|NOT COMPLETED|Overall Study||212
10634076|NCT02052414|11792480|FG000|STARTED|Overall Study||34
10634077|NCT02052414|11792480|FG000|COMPLETED|Overall Study||17
10634078|NCT02052414|11792480|FG000|NOT COMPLETED|Overall Study||17
10705720|NCT02601833|11870220|FG000|STARTED|Overall Study||56
10705721|NCT02601833|11870221|FG001|STARTED|Overall Study||42
10705722|NCT02601833|11870220|FG000|COMPLETED|Overall Study||40
10333956|NCT00337077|11470217|FG001|STARTED|Overall Study||53
10333957|NCT00337077|11470218|FG002|STARTED|Overall Study||25
10333958|NCT00337077|11470216|FG000|Treated|Overall Study||42
10333959|NCT00337077|11470217|FG001|Treated|Overall Study||52
10333960|NCT00337077|11470218|FG002|Treated|Overall Study||25
10634079|NCT02052440|11792487|FG000|STARTED|Overall Study||50
10634080|NCT02052440|11792488|FG001|STARTED|Overall Study||52
10634081|NCT02052440|11792487|FG000|COMPLETED|Overall Study||50
10634082|NCT02052440|11792488|FG001|COMPLETED|Overall Study||51
10634083|NCT02052440|11792487|FG000|NOT COMPLETED|Overall Study||0
10634084|NCT02052440|11792488|FG001|NOT COMPLETED|Overall Study||1
10634085|NCT02052466|11792494|FG000|STARTED|Overall Study||32
10634086|NCT02052466|11792494|FG000|COMPLETED|Overall Study||30
10634087|NCT02052466|11792494|FG000|NOT COMPLETED|Overall Study||2
10634088|NCT02052544|11792498|FG000|STARTED|Overall Study|First Subject In|123
10634089|NCT02052544|11792498|FG000|COMPLETED|Overall Study|Last Subject Out|123
10634090|NCT02052544|11792498|FG000|NOT COMPLETED|Overall Study||0
10634091|NCT02052557|11792505|FG000|STARTED|Overall Study||26
10634092|NCT02052557|11792506|FG001|STARTED|Overall Study||25
10634093|NCT02052557|11792505|FG000|COMPLETED|Overall Study||26
10634094|NCT02052557|11792506|FG001|COMPLETED|Overall Study||25
10634095|NCT02052557|11792505|FG000|NOT COMPLETED|Overall Study||0
10634096|NCT02052557|11792506|FG001|NOT COMPLETED|Overall Study||0
10634097|NCT02052596|11792516|FG000|STARTED|Active Phase||412
10634098|NCT02052596|11792517|FG001|STARTED|Active Phase||418
10634099|NCT02052596|11792516|FG000|COMPLETED|Active Phase||396
10634100|NCT02052596|11792517|FG001|COMPLETED|Active Phase||398
10634101|NCT02052596|11792516|FG000|NOT COMPLETED|Active Phase||16
10634102|NCT02052596|11792517|FG001|NOT COMPLETED|Active Phase||20
10634103|NCT02052596|11792516|FG000|STARTED|Safety Phase||412
10634104|NCT02052596|11792517|FG001|STARTED|Safety Phase||418
10634105|NCT02052596|11792516|FG000|COMPLETED|Safety Phase||385
10634106|NCT02052596|11792517|FG001|COMPLETED|Safety Phase||383
10634107|NCT02052596|11792516|FG000|NOT COMPLETED|Safety Phase||27
10634108|NCT02052596|11792517|FG001|NOT COMPLETED|Safety Phase||35
10634109|NCT02052635|11792525|FG000|STARTED|Overall Study||7
10634110|NCT02052635|11792526|FG001|STARTED|Overall Study||6
10634111|NCT02052635|11792525|FG000|COMPLETED|Overall Study||7
10634112|NCT02052635|11792526|FG001|COMPLETED|Overall Study||6
10634113|NCT02052635|11792525|FG000|NOT COMPLETED|Overall Study||0
10634114|NCT02052635|11792526|FG001|NOT COMPLETED|Overall Study||0
10634115|NCT02052661|11792532|FG000|STARTED|Overall Study||300
10634116|NCT02052661|11792532|FG000|COMPLETED|Overall Study||300
10634117|NCT02052661|11792532|FG000|NOT COMPLETED|Overall Study||0
10634118|NCT02052752|11792539|FG000|STARTED|Overall Study||30
10634119|NCT02052752|11792540|FG001|STARTED|Overall Study||30
10634120|NCT02052752|11792541|FG002|STARTED|Overall Study||30
10634121|NCT02052752|11792539|FG000|COMPLETED|Overall Study||30
10634122|NCT02052752|11792540|FG001|COMPLETED|Overall Study||30
10634123|NCT02052752|11792541|FG002|COMPLETED|Overall Study||30
10634124|NCT02052752|11792539|FG000|NOT COMPLETED|Overall Study||0
10634125|NCT02052752|11792540|FG001|NOT COMPLETED|Overall Study||0
10634126|NCT02052752|11792541|FG002|NOT COMPLETED|Overall Study||0
10634127|NCT02052895|11792553|FG000|STARTED|Overall Study||196
10634128|NCT02052895|11792554|FG001|STARTED|Overall Study||15
10634129|NCT02052895|11792555|FG002|STARTED|Overall Study||15
10634130|NCT02052895|11792553|FG000|COMPLETED|Overall Study||196
10634131|NCT02052895|11792554|FG001|COMPLETED|Overall Study||15
10634132|NCT02052895|11792555|FG002|COMPLETED|Overall Study||15
10634133|NCT02052895|11792553|FG000|NOT COMPLETED|Overall Study||0
10634134|NCT02052895|11792554|FG001|NOT COMPLETED|Overall Study||0
10634135|NCT02052895|11792555|FG002|NOT COMPLETED|Overall Study||0
10634136|NCT02052960|11792564|FG000|STARTED|Overall Study||117
10333961|NCT00337077|11470216|FG000|Toxicity Assessed|Overall Study||42
10333962|NCT00337077|11470217|FG001|Toxicity Assessed|Overall Study||51
10333963|NCT00337077|11470218|FG002|Toxicity Assessed|Overall Study||25
10634137|NCT02052960|11792565|FG001|STARTED|Overall Study||123
10634138|NCT02052960|11792564|FG000|Treated Patients|Overall Study||115
10634139|NCT02052960|11792565|FG001|Treated Patients|Overall Study||122
10634140|NCT02052960|11792564|FG000|COMPLETED|Overall Study||63
10634141|NCT02052960|11792565|FG001|COMPLETED|Overall Study||77
10634142|NCT02052960|11792564|FG000|NOT COMPLETED|Overall Study||54
10634143|NCT02052960|11792565|FG001|NOT COMPLETED|Overall Study||46
10705723|NCT02601833|11870221|FG001|COMPLETED|Overall Study||29
10705724|NCT02601833|11870220|FG000|NOT COMPLETED|Overall Study||16
10705725|NCT02601833|11870221|FG001|NOT COMPLETED|Overall Study||13
10705726|NCT02601976|11870230|FG000|STARTED|Overall Study||64
10705727|NCT02601976|11870230|FG000|COMPLETED|Overall Study||64
10705728|NCT02601976|11870230|FG000|NOT COMPLETED|Overall Study||0
10705729|NCT02602080|11870237|FG000|STARTED|Overall Study||21
10705730|NCT02602080|11870238|FG001|STARTED|Overall Study||16
10705731|NCT02602080|11870239|FG002|STARTED|Overall Study||18
10705732|NCT02602080|11870237|FG000|COMPLETED|Overall Study||15
10705733|NCT02602080|11870238|FG001|COMPLETED|Overall Study||15
10705734|NCT02602080|11870239|FG002|COMPLETED|Overall Study||15
10705735|NCT02602080|11870237|FG000|NOT COMPLETED|Overall Study||6
10705736|NCT02602080|11870238|FG001|NOT COMPLETED|Overall Study||1
10705737|NCT02602080|11870239|FG002|NOT COMPLETED|Overall Study||3
10705738|NCT02602223|11870247|FG000|STARTED|Overall Study||9
10705739|NCT02602223|11870247|FG000|COMPLETED|Overall Study||9
10705740|NCT02602223|11870247|FG000|NOT COMPLETED|Overall Study||0
10705741|NCT02602496|11870256|FG000|STARTED|Overall Study||15
10705742|NCT02602496|11870257|FG001|STARTED|Overall Study||20
10705743|NCT02602496|11870258|FG002|STARTED|Overall Study||17
10705744|NCT02602496|11870256|FG000|COMPLETED|Overall Study||14
10634144|NCT02053077|11792574|FG000|STARTED|Overall Study||150
10634145|NCT02053077|11792574|FG000|COMPLETED|Overall Study||150
10634146|NCT02053077|11792574|FG000|NOT COMPLETED|Overall Study||0
10634147|NCT02053168|11792578|FG000|STARTED|Overall Study||25
10634148|NCT02053168|11792578|FG000|COMPLETED|Overall Study||22
10634149|NCT02053168|11792578|FG000|NOT COMPLETED|Overall Study||3
10634150|NCT02053259|11792586|FG000|STARTED|Overall Study||25
10634151|NCT02053259|11792587|FG001|STARTED|Overall Study||24
10634152|NCT02053259|11792588|FG002|STARTED|Overall Study||24
10634153|NCT02053259|11792589|FG003|STARTED|Overall Study||23
10634154|NCT02053259|11792586|FG000|COMPLETED|Overall Study||25
10634155|NCT02053259|11792587|FG001|COMPLETED|Overall Study||24
10634156|NCT02053259|11792588|FG002|COMPLETED|Overall Study||24
10634157|NCT02053259|11792589|FG003|COMPLETED|Overall Study||23
10634158|NCT02053259|11792586|FG000|NOT COMPLETED|Overall Study||0
10634159|NCT02053259|11792587|FG001|NOT COMPLETED|Overall Study||0
10634160|NCT02053259|11792588|FG002|NOT COMPLETED|Overall Study||0
10634161|NCT02053259|11792589|FG003|NOT COMPLETED|Overall Study||0
10634162|NCT02053376|11792599|FG000|STARTED|Overall Study||43
10634163|NCT02053376|11792599|FG000|COMPLETED|Overall Study||43
10634164|NCT02053376|11792599|FG000|NOT COMPLETED|Overall Study||0
10634165|NCT02053493|11792605|FG000|STARTED|Overall Study||51
10634166|NCT02053493|11792606|FG001|STARTED|Overall Study||59
10634167|NCT02053493|11792605|FG000|COMPLETED|Overall Study||50
10634168|NCT02053493|11792606|FG001|COMPLETED|Overall Study||58
10634169|NCT02053493|11792605|FG000|NOT COMPLETED|Overall Study||1
10634170|NCT02053493|11792606|FG001|NOT COMPLETED|Overall Study||1
10634171|NCT02053610|11792614|FG000|STARTED|Overall Study||330
10634172|NCT02053610|11792615|FG001|STARTED|Overall Study||333
10634173|NCT02053610|11792614|FG000|Received Study Drug|Overall Study||326
10634174|NCT02053610|11792615|FG001|Received Study Drug|Overall Study||331
10634175|NCT02053610|11792614|FG000|COMPLETED|Overall Study|Completed=Completed Treatment|288
10634176|NCT02053610|11792615|FG001|COMPLETED|Overall Study|Completed=Completed Treatment|266
10634177|NCT02053610|11792614|FG000|NOT COMPLETED|Overall Study||42
10634178|NCT02053610|11792615|FG001|NOT COMPLETED|Overall Study||67
10634179|NCT02053753|11792623|FG000|STARTED|Overall Study||72
10634180|NCT02053753|11792624|FG001|STARTED|Overall Study||74
10634181|NCT02053753|11792623|FG000|Received Treatment|Overall Study||71
10634182|NCT02053753|11792624|FG001|Received Treatment|Overall Study||71
10634183|NCT02053753|11792623|FG000|COMPLETED|Overall Study||65
10634184|NCT02053753|11792624|FG001|COMPLETED|Overall Study||66
10634185|NCT02053753|11792623|FG000|NOT COMPLETED|Overall Study||7
10634186|NCT02053753|11792624|FG001|NOT COMPLETED|Overall Study||8
10634187|NCT02054130|11792634|FG000|STARTED|Overall Study||138
10634188|NCT02054130|11792635|FG001|STARTED|Overall Study||138
10634189|NCT02054130|11792636|FG002|STARTED|Overall Study||137
10634190|NCT02054130|11792637|FG003|STARTED|Overall Study||137
10634191|NCT02054130|11792634|FG000|COMPLETED|Overall Study||130
10634192|NCT02054130|11792635|FG001|COMPLETED|Overall Study||127
10634193|NCT02054130|11792636|FG002|COMPLETED|Overall Study||122
10634194|NCT02054130|11792637|FG003|COMPLETED|Overall Study||115
10634195|NCT02054130|11792634|FG000|NOT COMPLETED|Overall Study||8
10634196|NCT02054130|11792635|FG001|NOT COMPLETED|Overall Study||11
10634197|NCT02054130|11792636|FG002|NOT COMPLETED|Overall Study||15
10634198|NCT02054130|11792637|FG003|NOT COMPLETED|Overall Study||22
10634199|NCT02054156|11792652|FG000|STARTED|Overall Study||110
10634200|NCT02054156|11792653|FG001|STARTED|Overall Study||111
10634201|NCT02054156|11792652|FG000|COMPLETED|Overall Study||35
10634202|NCT02054156|11792653|FG001|COMPLETED|Overall Study||30
10634203|NCT02054156|11792652|FG000|NOT COMPLETED|Overall Study||75
10634204|NCT02054156|11792653|FG001|NOT COMPLETED|Overall Study||81
10634205|NCT02054325|11792661|FG000|STARTED|Overall Study||51
10634206|NCT02054325|11792662|FG001|STARTED|Overall Study||55
10634207|NCT02054325|11792661|FG000|COMPLETED|Overall Study||43
10634208|NCT02054325|11792662|FG001|COMPLETED|Overall Study||50
10634209|NCT02054325|11792661|FG000|NOT COMPLETED|Overall Study||8
10634210|NCT02054325|11792662|FG001|NOT COMPLETED|Overall Study||5
10705745|NCT02602496|11870257|FG001|COMPLETED|Overall Study||18
10705746|NCT02602496|11870258|FG002|COMPLETED|Overall Study||17
10705747|NCT02602496|11870256|FG000|NOT COMPLETED|Overall Study||1
10705748|NCT02602496|11870257|FG001|NOT COMPLETED|Overall Study||2
10705749|NCT02602496|11870258|FG002|NOT COMPLETED|Overall Study||0
10634211|NCT02054338|11792670|FG000|STARTED|Overall Study||503
10634212|NCT02054338|11792671|FG001|STARTED|Overall Study||501
10634213|NCT02054338|11792670|FG000|COMPLETED|Overall Study||0
10634214|NCT02054338|11792671|FG001|COMPLETED|Overall Study||0
10634215|NCT02054338|11792670|FG000|NOT COMPLETED|Overall Study||503
10634216|NCT02054338|11792671|FG001|NOT COMPLETED|Overall Study||501
10634217|NCT02054481|11792681|FG000|STARTED|Overall Study||43
10634218|NCT02054481|11792682|FG001|STARTED|Overall Study||41
10634219|NCT02054481|11792683|FG002|STARTED|Overall Study||42
10634220|NCT02054481|11792684|FG003|STARTED|Overall Study||40
10634221|NCT02054481|11792681|FG000|COMPLETED|Overall Study||39
10634222|NCT02054481|11792682|FG001|COMPLETED|Overall Study||39
10634223|NCT02054481|11792683|FG002|COMPLETED|Overall Study||40
10634224|NCT02054481|11792684|FG003|COMPLETED|Overall Study||39
10634225|NCT02054481|11792681|FG000|NOT COMPLETED|Overall Study||4
10634226|NCT02054481|11792682|FG001|NOT COMPLETED|Overall Study||2
10634227|NCT02054481|11792683|FG002|NOT COMPLETED|Overall Study||2
10634228|NCT02054481|11792684|FG003|NOT COMPLETED|Overall Study||1
10634229|NCT02054520|11792701|FG000|STARTED|Overall Study||11
10634230|NCT02054520|11792702|FG001|STARTED|Overall Study||16
10634231|NCT02054520|11792703|FG002|STARTED|Overall Study||6
10634232|NCT02054520|11792704|FG003|STARTED|Overall Study||6
10634233|NCT02054520|11792705|FG004|STARTED|Overall Study||5
10634234|NCT02054520|11792706|FG005|STARTED|Overall Study||3
10634235|NCT02054520|11792701|FG000|COMPLETED|Overall Study||2
10634236|NCT02054520|11792702|FG001|COMPLETED|Overall Study||11
10634237|NCT02054520|11792703|FG002|COMPLETED|Overall Study||0
10634238|NCT02054520|11792704|FG003|COMPLETED|Overall Study||0
10634239|NCT02054520|11792705|FG004|COMPLETED|Overall Study||0
10634240|NCT02054520|11792706|FG005|COMPLETED|Overall Study||0
10634241|NCT02054520|11792701|FG000|NOT COMPLETED|Overall Study||9
10634242|NCT02054520|11792702|FG001|NOT COMPLETED|Overall Study||5
10634243|NCT02054520|11792703|FG002|NOT COMPLETED|Overall Study||6
10634244|NCT02054520|11792704|FG003|NOT COMPLETED|Overall Study||6
10634245|NCT02054520|11792705|FG004|NOT COMPLETED|Overall Study||5
10634246|NCT02054520|11792706|FG005|NOT COMPLETED|Overall Study||3
10634247|NCT02054572|11792720|FG000|STARTED|Overall Study||6
10634248|NCT02054572|11792720|FG000|COMPLETED|Overall Study||6
10634249|NCT02054572|11792720|FG000|NOT COMPLETED|Overall Study||0
10634250|NCT02054702|11792726|FG000|STARTED|Overall Study||64
10634251|NCT02054702|11792727|FG001|STARTED|Overall Study||33
10634252|NCT02054702|11792726|FG000|COMPLETED|Overall Study||40
10634253|NCT02054702|11792727|FG001|COMPLETED|Overall Study||21
10634254|NCT02054702|11792726|FG000|NOT COMPLETED|Overall Study||24
10634255|NCT02054702|11792727|FG001|NOT COMPLETED|Overall Study||12
10653881|NCT02197078|11814506|FG011|COMPLETED|Overall Study||15742
10653882|NCT02197078|11814495|FG000|NOT COMPLETED|Overall Study||0
10653883|NCT02197078|11814496|FG001|NOT COMPLETED|Overall Study||0
10653884|NCT02197078|11814497|FG002|NOT COMPLETED|Overall Study||0
10653885|NCT02197078|11814498|FG003|NOT COMPLETED|Overall Study||0
10653886|NCT02197078|11814499|FG004|NOT COMPLETED|Overall Study||0
10653887|NCT02197078|11814500|FG005|NOT COMPLETED|Overall Study||0
10653888|NCT02197078|11814501|FG006|NOT COMPLETED|Overall Study||0
10653889|NCT02197078|11814502|FG007|NOT COMPLETED|Overall Study||0
10653890|NCT02197078|11814503|FG008|NOT COMPLETED|Overall Study||0
10653891|NCT02197078|11814504|FG009|NOT COMPLETED|Overall Study||0
10653892|NCT02197078|11814505|FG010|NOT COMPLETED|Overall Study||0
10653893|NCT02197078|11814506|FG011|NOT COMPLETED|Overall Study||0
10653894|NCT02197130|11814535|FG000|STARTED|Overall Study||95
10653895|NCT02197130|11814536|FG001|STARTED|Overall Study||89
10653896|NCT02197130|11814537|FG002|STARTED|Overall Study||88
10653897|NCT02197130|11814535|FG000|Received Treatment|Overall Study||95
10653898|NCT02197130|11814536|FG001|Received Treatment|Overall Study||88
10653899|NCT02197130|11814537|FG002|Received Treatment|Overall Study||87
10653900|NCT02197130|11814535|FG000|COMPLETED|Overall Study||79
10653901|NCT02197130|11814536|FG001|COMPLETED|Overall Study||81
10653902|NCT02197130|11814537|FG002|COMPLETED|Overall Study||56
10653903|NCT02197130|11814535|FG000|NOT COMPLETED|Overall Study||16
10653904|NCT02197130|11814536|FG001|NOT COMPLETED|Overall Study||8
10653905|NCT02197130|11814537|FG002|NOT COMPLETED|Overall Study||32
10653906|NCT02197247|11814545|FG000|STARTED|Part A: Day 1-28 (AZD9291 Alone)||41
10653907|NCT02197247|11814545|FG000|COMPLETED|Part A: Day 1-28 (AZD9291 Alone)||41
10653908|NCT02197247|11814545|FG000|NOT COMPLETED|Part A: Day 1-28 (AZD9291 Alone)||0
10653909|NCT02197247|11814545|FG000|STARTED|Part A: Day 29-49 (AZD9291+Rifampicin)||41
10653910|NCT02197247|11814545|FG000|COMPLETED|Part A: Day 29-49 (AZD9291+Rifampicin)||37
10653911|NCT02197247|11814545|FG000|NOT COMPLETED|Part A: Day 29-49 (AZD9291+Rifampicin)||4
10653912|NCT02197247|11814545|FG000|STARTED|Part A: Day 50-77 (AZD9291 Alone)||37
10653913|NCT02197247|11814545|FG000|COMPLETED|Part A: Day 50-77 (AZD9291 Alone)||32
10653914|NCT02197247|11814545|FG000|NOT COMPLETED|Part A: Day 50-77 (AZD9291 Alone)||5
10653915|NCT02197247|11814545|FG000|STARTED|Part B: Day 78 to End Part B (AZD9291)|32 completed Part A + 2 entered Part B without completing Part A (both due to AE) =34 started Part B|34
10653916|NCT02197247|11814545|FG000|COMPLETED|Part B: Day 78 to End Part B (AZD9291)||19
10653917|NCT02197247|11814545|FG000|NOT COMPLETED|Part B: Day 78 to End Part B (AZD9291)||15
10653918|NCT02197273|11814557|FG000|STARTED|Overall Study||107
10653919|NCT02197273|11814558|FG001|STARTED|Overall Study||104
10653920|NCT02197273|11814557|FG000|COMPLETED|Overall Study||107
10653921|NCT02197273|11814558|FG001|COMPLETED|Overall Study||104
10653922|NCT02197273|11814557|FG000|NOT COMPLETED|Overall Study||0
10653923|NCT02197273|11814558|FG001|NOT COMPLETED|Overall Study||0
10634256|NCT02054715|11792735|FG000|STARTED|Baseline/Follow-up 1||219
10634257|NCT02054715|11792736|FG001|STARTED|Baseline/Follow-up 1||199
10634258|NCT02054715|11792735|FG000|COMPLETED|Baseline/Follow-up 1||211
10634259|NCT02054715|11792736|FG001|COMPLETED|Baseline/Follow-up 1||192
10634260|NCT02054715|11792735|FG000|NOT COMPLETED|Baseline/Follow-up 1||8
10634261|NCT02054715|11792736|FG001|NOT COMPLETED|Baseline/Follow-up 1||7
10634262|NCT02054715|11792735|FG000|STARTED|Follow-up 2||211
10634263|NCT02054715|11792736|FG001|STARTED|Follow-up 2||192
10634264|NCT02054715|11792735|FG000|COMPLETED|Follow-up 2||192
10634265|NCT02054715|11792736|FG001|COMPLETED|Follow-up 2||173
10634266|NCT02054715|11792735|FG000|NOT COMPLETED|Follow-up 2||19
10634267|NCT02054715|11792736|FG001|NOT COMPLETED|Follow-up 2||19
10634268|NCT02054754|11792744|FG000|STARTED|Overall Study||6
10634269|NCT02054754|11792745|FG001|STARTED|Overall Study||6
10634270|NCT02054754|11792746|FG002|STARTED|Overall Study||6
10634271|NCT02054754|11792747|FG003|STARTED|Overall Study||6
10634272|NCT02054754|11792748|FG004|STARTED|Overall Study||6
10634273|NCT02054754|11792749|FG005|STARTED|Overall Study||10
10634274|NCT02054754|11792744|FG000|COMPLETED|Overall Study||6
10634275|NCT02054754|11792745|FG001|COMPLETED|Overall Study||6
10634276|NCT02054754|11792746|FG002|COMPLETED|Overall Study||6
10634277|NCT02054754|11792747|FG003|COMPLETED|Overall Study||6
10634278|NCT02054754|11792748|FG004|COMPLETED|Overall Study||6
10634279|NCT02054754|11792749|FG005|COMPLETED|Overall Study||10
10634280|NCT02054754|11792744|FG000|NOT COMPLETED|Overall Study||0
10634281|NCT02054754|11792745|FG001|NOT COMPLETED|Overall Study||0
10634282|NCT02054754|11792746|FG002|NOT COMPLETED|Overall Study||0
10634283|NCT02054754|11792747|FG003|NOT COMPLETED|Overall Study||0
10634284|NCT02054754|11792748|FG004|NOT COMPLETED|Overall Study||0
10634285|NCT02054754|11792749|FG005|NOT COMPLETED|Overall Study||0
10634286|NCT02054897|11792767|FG000|STARTED|Overall Study||129
10634287|NCT02054897|11792768|FG001|STARTED|Overall Study||130
10634288|NCT02054897|11792769|FG002|STARTED|Overall Study||129
10634289|NCT02054897|11792767|FG000|Exposed|Overall Study||128
10634290|NCT02054897|11792768|FG001|Exposed|Overall Study||130
10634291|NCT02054897|11792769|FG002|Exposed|Overall Study||129
10634292|NCT02054897|11792767|FG000|COMPLETED|Overall Study||119
10634293|NCT02054897|11792768|FG001|COMPLETED|Overall Study||123
10634294|NCT02054897|11792769|FG002|COMPLETED|Overall Study||117
10634295|NCT02054897|11792767|FG000|NOT COMPLETED|Overall Study||10
10634296|NCT02054897|11792768|FG001|NOT COMPLETED|Overall Study||7
10634297|NCT02054897|11792769|FG002|NOT COMPLETED|Overall Study||12
10634298|NCT02055118|11792780|FG000|STARTED|Overall Study||15
10634299|NCT02055118|11792781|FG001|STARTED|Overall Study||34
10634300|NCT02055118|11792782|FG002|STARTED|Overall Study||9
10634301|NCT02055118|11792780|FG000|COMPLETED|Overall Study||15
10634302|NCT02055118|11792781|FG001|COMPLETED|Overall Study||32
10634303|NCT02055118|11792782|FG002|COMPLETED|Overall Study||9
10634304|NCT02055118|11792780|FG000|NOT COMPLETED|Overall Study||0
10634305|NCT02055118|11792781|FG001|NOT COMPLETED|Overall Study||2
10634306|NCT02055118|11792782|FG002|NOT COMPLETED|Overall Study||0
10634307|NCT02055157|11792795|FG000|STARTED|Initial 6 Months||8
10634308|NCT02055157|11792796|FG001|STARTED|Initial 6 Months||8
10634309|NCT02055157|11792797|FG002|STARTED|Initial 6 Months||10
10634310|NCT02055157|11792798|FG003|STARTED|Initial 6 Months||9
10634311|NCT02055157|11792795|FG000|COMPLETED|Initial 6 Months||7
10634312|NCT02055157|11792796|FG001|COMPLETED|Initial 6 Months||7
10634313|NCT02055157|11792797|FG002|COMPLETED|Initial 6 Months||10
10634314|NCT02055157|11792798|FG003|COMPLETED|Initial 6 Months||8
10634315|NCT02055157|11792795|FG000|NOT COMPLETED|Initial 6 Months||1
10634316|NCT02055157|11792796|FG001|NOT COMPLETED|Initial 6 Months||1
10634317|NCT02055157|11792797|FG002|NOT COMPLETED|Initial 6 Months||0
10634318|NCT02055157|11792798|FG003|NOT COMPLETED|Initial 6 Months||1
10634319|NCT02055157|11792795|FG000|STARTED|18-month Extension||7
10634320|NCT02055157|11792796|FG001|STARTED|18-month Extension||7
10634321|NCT02055157|11792797|FG002|STARTED|18-month Extension||10
10634322|NCT02055157|11792798|FG003|STARTED|18-month Extension||8
10634323|NCT02055157|11792795|FG000|COMPLETED|18-month Extension||6
10634324|NCT02055157|11792796|FG001|COMPLETED|18-month Extension||6
10634325|NCT02055157|11792797|FG002|COMPLETED|18-month Extension||10
10634326|NCT02055157|11792798|FG003|COMPLETED|18-month Extension||8
10634327|NCT02055157|11792795|FG000|NOT COMPLETED|18-month Extension||1
10634328|NCT02055157|11792796|FG001|NOT COMPLETED|18-month Extension||1
10634329|NCT02055157|11792797|FG002|NOT COMPLETED|18-month Extension||0
10634330|NCT02055157|11792798|FG003|NOT COMPLETED|18-month Extension||0
10634331|NCT02055352|11792821|FG000|STARTED|Overall Study||109
10634332|NCT02055352|11792822|FG001|STARTED|Overall Study||113
10634333|NCT02055352|11792821|FG000|Per-Protocol Set (PPS)|Overall Study||108
10634334|NCT02055352|11792822|FG001|Per-Protocol Set (PPS)|Overall Study||111
10634335|NCT02055352|11792821|FG000|COMPLETED|Overall Study||103
10634336|NCT02055352|11792822|FG001|COMPLETED|Overall Study||96
10634337|NCT02055352|11792821|FG000|NOT COMPLETED|Overall Study||6
10634338|NCT02055352|11792822|FG001|NOT COMPLETED|Overall Study||17
10634339|NCT02055365|11792828|FG000|STARTED|Overall Study||10
10634340|NCT02055365|11792828|FG000|COMPLETED|Overall Study||9
10634341|NCT02055365|11792828|FG000|NOT COMPLETED|Overall Study||1
10634342|NCT02055404|11792839|FG000|STARTED|Overall Study||3
10634343|NCT02055404|11792839|FG000|COMPLETED|Overall Study||3
10634344|NCT02055404|11792839|FG000|NOT COMPLETED|Overall Study||0
10634345|NCT02055430|11792854|FG000|STARTED|Overall Study||45
10634346|NCT02055430|11792855|FG001|STARTED|Overall Study||45
10634347|NCT02055430|11792854|FG000|COMPLETED|Overall Study||45
10634348|NCT02055430|11792855|FG001|COMPLETED|Overall Study||45
10634349|NCT02055430|11792854|FG000|NOT COMPLETED|Overall Study||0
10634350|NCT02055430|11792855|FG001|NOT COMPLETED|Overall Study||0
10634351|NCT02055638|11792863|FG000|STARTED|Overall Study||49
10634352|NCT02055638|11792864|FG001|STARTED|Overall Study||48
10634353|NCT02055638|11792863|FG000|COMPLETED|Overall Study||39
10634354|NCT02055638|11792864|FG001|COMPLETED|Overall Study||40
10634355|NCT02055638|11792863|FG000|NOT COMPLETED|Overall Study||10
10634356|NCT02055638|11792864|FG001|NOT COMPLETED|Overall Study||8
10634357|NCT02055781|11792873|FG000|STARTED|Overall Study||104
10634358|NCT02055781|11792874|FG001|STARTED|Overall Study||107
10634359|NCT02055781|11792875|FG002|STARTED|Overall Study||100
10634360|NCT02055781|11792873|FG000|COMPLETED|Overall Study||62
10634361|NCT02055781|11792874|FG001|COMPLETED|Overall Study||79
10634362|NCT02055781|11792875|FG002|COMPLETED|Overall Study||63
10634363|NCT02055781|11792873|FG000|NOT COMPLETED|Overall Study||42
10634364|NCT02055781|11792874|FG001|NOT COMPLETED|Overall Study||28
10634365|NCT02055781|11792875|FG002|NOT COMPLETED|Overall Study||37
10634366|NCT02055820|11792893|FG000|STARTED|Phase I: Dose-Finding||7
10634367|NCT02055820|11792894|FG001|STARTED|Phase I: Dose-Finding||3
10634368|NCT02055820|11792895|FG002|STARTED|Phase I: Dose-Finding||8
10634369|NCT02055820|11792896|FG003|STARTED|Phase I: Dose-Finding||6
10634370|NCT02055820|11792897|FG004|STARTED|Phase I: Dose-Finding||0
10634371|NCT02055820|11792898|FG005|STARTED|Phase I: Dose-Finding||7
10634372|NCT02055820|11792899|FG006|STARTED|Phase I: Dose-Finding||7
10634373|NCT02055820|11792900|FG007|STARTED|Phase I: Dose-Finding||6
10634374|NCT02055820|11792901|FG008|STARTED|Phase I: Dose-Finding||6
10634375|NCT02055820|11792902|FG009|STARTED|Phase I: Dose-Finding||6
10634376|NCT02055820|11792893|FG000|COMPLETED|Phase I: Dose-Finding||6
10634377|NCT02055820|11792894|FG001|COMPLETED|Phase I: Dose-Finding||3
10705750|NCT02603107|11870268|FG000|STARTED|Randomized Phase||290
10705751|NCT02603107|11870269|FG001|STARTED|Randomized Phase||287
10634378|NCT02055820|11792895|FG002|COMPLETED|Phase I: Dose-Finding||7
10634379|NCT02055820|11792896|FG003|COMPLETED|Phase I: Dose-Finding||3
10634380|NCT02055820|11792897|FG004|COMPLETED|Phase I: Dose-Finding||0
10634381|NCT02055820|11792898|FG005|COMPLETED|Phase I: Dose-Finding||5
10634382|NCT02055820|11792899|FG006|COMPLETED|Phase I: Dose-Finding||5
10634383|NCT02055820|11792900|FG007|COMPLETED|Phase I: Dose-Finding||6
10634384|NCT02055820|11792901|FG008|COMPLETED|Phase I: Dose-Finding||6
10634385|NCT02055820|11792902|FG009|COMPLETED|Phase I: Dose-Finding||6
10634386|NCT02055820|11792893|FG000|NOT COMPLETED|Phase I: Dose-Finding||1
10634387|NCT02055820|11792894|FG001|NOT COMPLETED|Phase I: Dose-Finding||0
10634388|NCT02055820|11792895|FG002|NOT COMPLETED|Phase I: Dose-Finding||1
10634389|NCT02055820|11792896|FG003|NOT COMPLETED|Phase I: Dose-Finding||3
10634390|NCT02055820|11792897|FG004|NOT COMPLETED|Phase I: Dose-Finding||0
10634391|NCT02055820|11792898|FG005|NOT COMPLETED|Phase I: Dose-Finding||2
10634392|NCT02055820|11792899|FG006|NOT COMPLETED|Phase I: Dose-Finding||2
10634393|NCT02055820|11792900|FG007|NOT COMPLETED|Phase I: Dose-Finding||0
10634394|NCT02055820|11792901|FG008|NOT COMPLETED|Phase I: Dose-Finding||0
10634395|NCT02055820|11792902|FG009|NOT COMPLETED|Phase I: Dose-Finding||0
10634396|NCT02055820|11792893|FG000|STARTED|Phase II: Expansion||0
10634397|NCT02055820|11792894|FG001|STARTED|Phase II: Expansion||0
10634398|NCT02055820|11792895|FG002|STARTED|Phase II: Expansion||0
10634399|NCT02055820|11792896|FG003|STARTED|Phase II: Expansion||0
10634400|NCT02055820|11792897|FG004|STARTED|Phase II: Expansion||208
10634401|NCT02055820|11792898|FG005|STARTED|Phase II: Expansion||0
10634402|NCT02055820|11792899|FG006|STARTED|Phase II: Expansion||0
10634403|NCT02055820|11792900|FG007|STARTED|Phase II: Expansion||0
10526130|NCT01380093|11678039|FG007|STARTED|Treatment Phase: Washout Period||6
10526131|NCT01380093|11678040|FG008|STARTED|Treatment Phase: Washout Period||6
10526132|NCT01380093|11678032|FG000|COMPLETED|Treatment Phase: Washout Period||0
10526133|NCT01380093|11678033|FG001|COMPLETED|Treatment Phase: Washout Period||0
10526134|NCT01380093|11678034|FG002|COMPLETED|Treatment Phase: Washout Period||0
10526135|NCT01380093|11678035|FG003|COMPLETED|Treatment Phase: Washout Period||6
10526136|NCT01380093|11678036|FG004|COMPLETED|Treatment Phase: Washout Period||6
10526137|NCT01380093|11678037|FG005|COMPLETED|Treatment Phase: Washout Period||6
10526138|NCT01380093|11678038|FG006|COMPLETED|Treatment Phase: Washout Period||6
10526139|NCT01380093|11678039|FG007|COMPLETED|Treatment Phase: Washout Period||6
10526140|NCT01380093|11678040|FG008|COMPLETED|Treatment Phase: Washout Period||6
10526141|NCT01380093|11678032|FG000|NOT COMPLETED|Treatment Phase: Washout Period||0
10526142|NCT01380093|11678033|FG001|NOT COMPLETED|Treatment Phase: Washout Period||0
10526143|NCT01380093|11678034|FG002|NOT COMPLETED|Treatment Phase: Washout Period||0
10526144|NCT01380093|11678035|FG003|NOT COMPLETED|Treatment Phase: Washout Period||0
10526145|NCT01380093|11678036|FG004|NOT COMPLETED|Treatment Phase: Washout Period||0
10526146|NCT01380093|11678037|FG005|NOT COMPLETED|Treatment Phase: Washout Period||0
10526147|NCT01380093|11678038|FG006|NOT COMPLETED|Treatment Phase: Washout Period||0
10526148|NCT01380093|11678039|FG007|NOT COMPLETED|Treatment Phase: Washout Period||0
10526149|NCT01380093|11678040|FG008|NOT COMPLETED|Treatment Phase: Washout Period||0
10526150|NCT01380093|11678032|FG000|STARTED|Treatment Phase: Second Intervention||0
10634404|NCT02055820|11792901|FG008|STARTED|Phase II: Expansion||0
10634405|NCT02055820|11792902|FG009|STARTED|Phase II: Expansion||0
10634406|NCT02055820|11792893|FG000|COMPLETED|Phase II: Expansion||0
10634407|NCT02055820|11792894|FG001|COMPLETED|Phase II: Expansion||0
10634408|NCT02055820|11792895|FG002|COMPLETED|Phase II: Expansion||0
10634409|NCT02055820|11792896|FG003|COMPLETED|Phase II: Expansion||0
10634410|NCT02055820|11792897|FG004|COMPLETED|Phase II: Expansion||159
10634411|NCT02055820|11792898|FG005|COMPLETED|Phase II: Expansion||0
10634412|NCT02055820|11792899|FG006|COMPLETED|Phase II: Expansion||0
10634413|NCT02055820|11792900|FG007|COMPLETED|Phase II: Expansion||0
10634414|NCT02055820|11792901|FG008|COMPLETED|Phase II: Expansion||0
10634415|NCT02055820|11792902|FG009|COMPLETED|Phase II: Expansion||0
10634416|NCT02055820|11792893|FG000|NOT COMPLETED|Phase II: Expansion||0
10634417|NCT02055820|11792894|FG001|NOT COMPLETED|Phase II: Expansion||0
10634418|NCT02055820|11792895|FG002|NOT COMPLETED|Phase II: Expansion||0
10634419|NCT02055820|11792896|FG003|NOT COMPLETED|Phase II: Expansion||0
10634420|NCT02055820|11792897|FG004|NOT COMPLETED|Phase II: Expansion||49
10634421|NCT02055820|11792898|FG005|NOT COMPLETED|Phase II: Expansion||0
10634422|NCT02055820|11792899|FG006|NOT COMPLETED|Phase II: Expansion||0
10634423|NCT02055820|11792900|FG007|NOT COMPLETED|Phase II: Expansion||0
10634424|NCT02055820|11792901|FG008|NOT COMPLETED|Phase II: Expansion||0
10634425|NCT02055820|11792902|FG009|NOT COMPLETED|Phase II: Expansion||0
10634426|NCT02055898|11792946|FG000|STARTED|First Intervention (5 Days)||7
10634427|NCT02055898|11792947|FG001|STARTED|First Intervention (5 Days)||6
10634428|NCT02055898|11792946|FG000|COMPLETED|First Intervention (5 Days)||5
10634429|NCT02055898|11792947|FG001|COMPLETED|First Intervention (5 Days)||5
10634430|NCT02055898|11792946|FG000|NOT COMPLETED|First Intervention (5 Days)||2
10634431|NCT02055898|11792947|FG001|NOT COMPLETED|First Intervention (5 Days)||1
10634432|NCT02055898|11792946|FG000|STARTED|Washout (at Least 14 Days)||5
10634433|NCT02055898|11792947|FG001|STARTED|Washout (at Least 14 Days)||5
10634434|NCT02055898|11792946|FG000|COMPLETED|Washout (at Least 14 Days)||5
10634435|NCT02055898|11792947|FG001|COMPLETED|Washout (at Least 14 Days)||5
10634436|NCT02055898|11792946|FG000|NOT COMPLETED|Washout (at Least 14 Days)||0
10634437|NCT02055898|11792947|FG001|NOT COMPLETED|Washout (at Least 14 Days)||0
10634438|NCT02055898|11792946|FG000|STARTED|Second Intervention (5 Days)||5
10634439|NCT02055898|11792947|FG001|STARTED|Second Intervention (5 Days)||5
10634440|NCT02055898|11792946|FG000|COMPLETED|Second Intervention (5 Days)||5
10634441|NCT02055898|11792947|FG001|COMPLETED|Second Intervention (5 Days)||5
10634442|NCT02055898|11792946|FG000|NOT COMPLETED|Second Intervention (5 Days)||0
10634443|NCT02055898|11792947|FG001|NOT COMPLETED|Second Intervention (5 Days)||0
10634444|NCT02055976|11792962|FG000|STARTED|Overall Study||25
10634445|NCT02055976|11792963|FG001|STARTED|Overall Study||24
10634446|NCT02055976|11792964|FG002|STARTED|Overall Study||24
10634447|NCT02055976|11792965|FG003|STARTED|Overall Study||26
10634448|NCT02055976|11792966|FG004|STARTED|Overall Study||22
10634449|NCT02055976|11792967|FG005|STARTED|Overall Study||25
10634450|NCT02055976|11792968|FG006|STARTED|Overall Study||25
10634451|NCT02055976|11792969|FG007|STARTED|Overall Study||24
10634452|NCT02055976|11792970|FG008|STARTED|Overall Study||23
10634453|NCT02055976|11792962|FG000|COMPLETED|Overall Study||25
10634454|NCT02055976|11792963|FG001|COMPLETED|Overall Study||24
10634455|NCT02055976|11792964|FG002|COMPLETED|Overall Study||23
10634456|NCT02055976|11792965|FG003|COMPLETED|Overall Study||25
10634457|NCT02055976|11792966|FG004|COMPLETED|Overall Study||22
10634458|NCT02055976|11792967|FG005|COMPLETED|Overall Study||24
10634459|NCT02055976|11792968|FG006|COMPLETED|Overall Study||23
10634460|NCT02055976|11792969|FG007|COMPLETED|Overall Study||24
10634461|NCT02055976|11792970|FG008|COMPLETED|Overall Study||23
10634462|NCT02055976|11792962|FG000|NOT COMPLETED|Overall Study||0
10634463|NCT02055976|11792963|FG001|NOT COMPLETED|Overall Study||0
10634464|NCT02055976|11792964|FG002|NOT COMPLETED|Overall Study||1
10634465|NCT02055976|11792965|FG003|NOT COMPLETED|Overall Study||1
10634466|NCT02055976|11792966|FG004|NOT COMPLETED|Overall Study||0
10634467|NCT02055976|11792967|FG005|NOT COMPLETED|Overall Study||1
10634468|NCT02055976|11792968|FG006|NOT COMPLETED|Overall Study||2
10634469|NCT02055976|11792969|FG007|NOT COMPLETED|Overall Study||0
10634470|NCT02055976|11792970|FG008|NOT COMPLETED|Overall Study||0
10634471|NCT02056171|11792999|FG000|STARTED|Overall Study||3
10634472|NCT02056171|11793000|FG001|STARTED|Overall Study||3
10634473|NCT02056171|11792999|FG000|COMPLETED|Overall Study||3
10634474|NCT02056171|11793000|FG001|COMPLETED|Overall Study||3
10634475|NCT02056171|11792999|FG000|NOT COMPLETED|Overall Study||0
10634476|NCT02056171|11793000|FG001|NOT COMPLETED|Overall Study||0
10634477|NCT02056288|11793008|FG000|STARTED|In-Hospital Data||40
10634478|NCT02056288|11793009|FG001|STARTED|In-Hospital Data||38
10634479|NCT02056288|11793008|FG000|COMPLETED|In-Hospital Data||35
10634480|NCT02056288|11793009|FG001|COMPLETED|In-Hospital Data||38
10634481|NCT02056288|11793008|FG000|NOT COMPLETED|In-Hospital Data||5
10634482|NCT02056288|11793009|FG001|NOT COMPLETED|In-Hospital Data||0
10634483|NCT02056288|11793008|FG000|STARTED|48-Hour Post-Discharge Data||35
10634484|NCT02056288|11793009|FG001|STARTED|48-Hour Post-Discharge Data||38
10634485|NCT02056288|11793008|FG000|COMPLETED|48-Hour Post-Discharge Data||21
10634486|NCT02056288|11793009|FG001|COMPLETED|48-Hour Post-Discharge Data||18
10634487|NCT02056288|11793008|FG000|NOT COMPLETED|48-Hour Post-Discharge Data||14
10634488|NCT02056288|11793009|FG001|NOT COMPLETED|48-Hour Post-Discharge Data||20
10634489|NCT02056301|11793017|FG000|STARTED|Overall Study||33
10634490|NCT02056301|11793018|FG001|STARTED|Overall Study||29
10634491|NCT02056301|11793017|FG000|COMPLETED|Overall Study||31
10634492|NCT02056301|11793018|FG001|COMPLETED|Overall Study||23
10634493|NCT02056301|11793017|FG000|NOT COMPLETED|Overall Study||2
10634494|NCT02056301|11793018|FG001|NOT COMPLETED|Overall Study||6
10634495|NCT02056340|11793026|FG000|STARTED|Overall Study||59
10634496|NCT02056340|11793027|FG001|STARTED|Overall Study||57
10634497|NCT02056340|11793026|FG000|COMPLETED|Overall Study||52
10634498|NCT02056340|11793027|FG001|COMPLETED|Overall Study||46
10634499|NCT02056340|11793026|FG000|NOT COMPLETED|Overall Study||7
10634500|NCT02056340|11793027|FG001|NOT COMPLETED|Overall Study||11
10634501|NCT02056392|11793039|FG000|STARTED|Overall Study||10
10634502|NCT02056392|11793040|FG001|STARTED|Overall Study||9
10634503|NCT02056392|11793041|FG002|STARTED|Overall Study||9
10634504|NCT02056392|11793042|FG003|STARTED|Overall Study||9
10634505|NCT02056392|11793043|FG004|STARTED|Overall Study||8
10634506|NCT02056392|11793044|FG005|STARTED|Overall Study||9
10634507|NCT02056392|11793039|FG000|COMPLETED|Overall Study||8
10634508|NCT02056392|11793040|FG001|COMPLETED|Overall Study||8
10634509|NCT02056392|11793041|FG002|COMPLETED|Overall Study||6
10634510|NCT02056392|11793042|FG003|COMPLETED|Overall Study||9
10634511|NCT02056392|11793043|FG004|COMPLETED|Overall Study||7
10634512|NCT02056392|11793044|FG005|COMPLETED|Overall Study||9
10634513|NCT02056392|11793039|FG000|NOT COMPLETED|Overall Study||2
10634514|NCT02056392|11793040|FG001|NOT COMPLETED|Overall Study||1
10634515|NCT02056392|11793041|FG002|NOT COMPLETED|Overall Study||3
10634516|NCT02056392|11793042|FG003|NOT COMPLETED|Overall Study||0
10634517|NCT02056392|11793043|FG004|NOT COMPLETED|Overall Study||1
10634518|NCT02056392|11793044|FG005|NOT COMPLETED|Overall Study||0
10634519|NCT02056431|11793054|FG000|STARTED|Overall Study||604
10634520|NCT02056431|11793055|FG001|STARTED|Overall Study||666
10634521|NCT02056431|11793054|FG000|COMPLETED|Overall Study||560
10634522|NCT02056431|11793055|FG001|COMPLETED|Overall Study||619
10634523|NCT02056431|11793054|FG000|NOT COMPLETED|Overall Study||44
10634524|NCT02056431|11793055|FG001|NOT COMPLETED|Overall Study||47
10634525|NCT02056626|11793067|FG000|STARTED|Overall Study||13
10634526|NCT02056626|11793068|FG001|STARTED|Overall Study||13
10634527|NCT02056626|11793069|FG002|STARTED|Overall Study||4
10634528|NCT02056626|11793070|FG003|STARTED|Overall Study||14
10634529|NCT02056626|11793067|FG000|COMPLETED|Overall Study||10
10634530|NCT02056626|11793068|FG001|COMPLETED|Overall Study||12
10634531|NCT02056626|11793069|FG002|COMPLETED|Overall Study||4
10634532|NCT02056626|11793070|FG003|COMPLETED|Overall Study||14
10634533|NCT02056626|11793067|FG000|NOT COMPLETED|Overall Study||3
10634534|NCT02056626|11793068|FG001|NOT COMPLETED|Overall Study||1
10634535|NCT02056626|11793069|FG002|NOT COMPLETED|Overall Study||0
10634536|NCT02056626|11793070|FG003|NOT COMPLETED|Overall Study||0
10634537|NCT02056639|11793082|FG000|STARTED|Overall Study||23
10634538|NCT02056639|11793083|FG001|STARTED|Overall Study||23
10634539|NCT02056639|11793082|FG000|COMPLETED|Overall Study||23
10634540|NCT02056639|11793083|FG001|COMPLETED|Overall Study||23
10634541|NCT02056639|11793082|FG000|NOT COMPLETED|Overall Study||0
10634542|NCT02056639|11793083|FG001|NOT COMPLETED|Overall Study||0
10634543|NCT02056652|11793093|FG000|STARTED|Overall Study||61
10634544|NCT02056652|11793094|FG001|STARTED|Overall Study||61
10634545|NCT02056652|11793093|FG000|COMPLETED|Overall Study||60
10634546|NCT02056652|11793094|FG001|COMPLETED|Overall Study||58
10634547|NCT02056652|11793093|FG000|NOT COMPLETED|Overall Study||1
10634548|NCT02056652|11793094|FG001|NOT COMPLETED|Overall Study||3
10634549|NCT02056834|11793100|FG000|STARTED|Overall Study||36
10634550|NCT02056834|11793100|FG000|6 Weeks|Overall Study||34
10634551|NCT02056834|11793100|FG000|6 Months|Overall Study||31
10634552|NCT02056834|11793100|FG000|COMPLETED|Overall Study||29
10634553|NCT02056834|11793100|FG000|NOT COMPLETED|Overall Study||7
10634554|NCT02057042|11793107|FG000|STARTED|Overall Study||163
10634555|NCT02057042|11793108|FG001|STARTED|Overall Study||167
10634556|NCT02057042|11793107|FG000|COMPLETED|Overall Study||118
10634557|NCT02057042|11793108|FG001|COMPLETED|Overall Study||101
10634558|NCT02057042|11793107|FG000|NOT COMPLETED|Overall Study||45
10634559|NCT02057042|11793108|FG001|NOT COMPLETED|Overall Study||66
10634560|NCT02057068|11793116|FG000|STARTED|Overall Study||60
10634561|NCT02057068|11793117|FG001|STARTED|Overall Study||36
10634562|NCT02057068|11793116|FG000|COMPLETED|Overall Study||52
10634563|NCT02057068|11793117|FG001|COMPLETED|Overall Study||28
10634564|NCT02057068|11793116|FG000|NOT COMPLETED|Overall Study||8
10634565|NCT02057068|11793117|FG001|NOT COMPLETED|Overall Study||8
10634566|NCT02057081|11793127|FG000|STARTED|Overall Study||136
10634567|NCT02057081|11793128|FG001|STARTED|Overall Study||112
10634568|NCT02057081|11793127|FG000|Completed Baseline|Overall Study||88
10634569|NCT02057081|11793128|FG001|Completed Baseline|Overall Study||80
10634570|NCT02057081|11793127|FG000|Post-Treatment Assessment|Overall Study||58
10634571|NCT02057081|11793128|FG001|Post-Treatment Assessment|Overall Study||52
10634572|NCT02057081|11793127|FG000|COMPLETED|Overall Study||46
10634573|NCT02057081|11793128|FG001|COMPLETED|Overall Study||44
10634574|NCT02057081|11793127|FG000|NOT COMPLETED|Overall Study||90
10634575|NCT02057081|11793128|FG001|NOT COMPLETED|Overall Study||68
10634576|NCT02057198|11793137|FG000|STARTED|Overall Study||11
10634577|NCT02057198|11793138|FG001|STARTED|Overall Study||11
10634578|NCT02057198|11793139|FG002|STARTED|Overall Study||11
10634579|NCT02057198|11793137|FG000|COMPLETED|Overall Study||11
10634580|NCT02057198|11793138|FG001|COMPLETED|Overall Study||10
10634581|NCT02057198|11793139|FG002|COMPLETED|Overall Study||10
10634582|NCT02057198|11793137|FG000|NOT COMPLETED|Overall Study||0
10634583|NCT02057198|11793138|FG001|NOT COMPLETED|Overall Study||1
10634584|NCT02057198|11793139|FG002|NOT COMPLETED|Overall Study||1
10634585|NCT02057250|11793151|FG000|STARTED|AID Assessment Phase||56
10634586|NCT02057250|11793152|FG001|STARTED|AID Assessment Phase||53
10634587|NCT02057250|11793153|FG002|STARTED|AID Assessment Phase||52
10634588|NCT02057250|11793154|FG003|STARTED|AID Assessment Phase||56
10634589|NCT02057250|11793155|FG004|STARTED|AID Assessment Phase||0
10634590|NCT02057250|11793151|FG000|COMPLETED|AID Assessment Phase||52
10634591|NCT02057250|11793152|FG001|COMPLETED|AID Assessment Phase||50
10634592|NCT02057250|11793153|FG002|COMPLETED|AID Assessment Phase||45
10634593|NCT02057250|11793154|FG003|COMPLETED|AID Assessment Phase||54
10634594|NCT02057250|11793155|FG004|COMPLETED|AID Assessment Phase||0
10634595|NCT02057250|11793151|FG000|NOT COMPLETED|AID Assessment Phase||4
10634596|NCT02057250|11793152|FG001|NOT COMPLETED|AID Assessment Phase||3
10634597|NCT02057250|11793153|FG002|NOT COMPLETED|AID Assessment Phase||7
10634598|NCT02057250|11793154|FG003|NOT COMPLETED|AID Assessment Phase||2
10634599|NCT02057250|11793155|FG004|NOT COMPLETED|AID Assessment Phase||0
10634600|NCT02057250|11793151|FG000|STARTED|Extension Phase||0
10634601|NCT02057250|11793152|FG001|STARTED|Extension Phase||0
10634602|NCT02057250|11793153|FG002|STARTED|Extension Phase||0
10634603|NCT02057250|11793154|FG003|STARTED|Extension Phase||0
10634604|NCT02057250|11793155|FG004|STARTED|Extension Phase|9 participants who completed AID Assessment phase did not enter extension phase.|192
10634605|NCT02057250|11793151|FG000|Treated|Extension Phase||0
10634606|NCT02057250|11793152|FG001|Treated|Extension Phase||0
10634607|NCT02057250|11793153|FG002|Treated|Extension Phase||0
10634608|NCT02057250|11793154|FG003|Treated|Extension Phase||0
10634609|NCT02057250|11793155|FG004|Treated|Extension Phase||188
10634610|NCT02057250|11793151|FG000|COMPLETED|Extension Phase||0
10634611|NCT02057250|11793152|FG001|COMPLETED|Extension Phase||0
10634612|NCT02057250|11793153|FG002|COMPLETED|Extension Phase||0
10705752|NCT02603107|11870268|FG000|COMPLETED|Randomized Phase||275
10705753|NCT02603107|11870269|FG001|COMPLETED|Randomized Phase||266
10705754|NCT02603107|11870268|FG000|NOT COMPLETED|Randomized Phase||15
10705755|NCT02603107|11870269|FG001|NOT COMPLETED|Randomized Phase||21
10705756|NCT02603107|11870268|FG000|STARTED|Optional Extension Phase|3 participants who completed the Randomized Phase did not continue in the Optional Extension Phase.|272
10634613|NCT02057250|11793154|FG003|COMPLETED|Extension Phase||0
10634614|NCT02057250|11793155|FG004|COMPLETED|Extension Phase||156
10634615|NCT02057250|11793151|FG000|NOT COMPLETED|Extension Phase||0
10634616|NCT02057250|11793152|FG001|NOT COMPLETED|Extension Phase||0
10634617|NCT02057250|11793153|FG002|NOT COMPLETED|Extension Phase||0
10634618|NCT02057250|11793154|FG003|NOT COMPLETED|Extension Phase||0
10634619|NCT02057250|11793155|FG004|NOT COMPLETED|Extension Phase||36
10634620|NCT02057393|11793167|FG000|STARTED|Overall Study||89
10634621|NCT02057393|11793167|FG000|COMPLETED|Overall Study||87
10634622|NCT02057393|11793167|FG000|NOT COMPLETED|Overall Study||2
10634623|NCT02057406|11793174|FG000|STARTED|Overall Study||36
10634624|NCT02057406|11793175|FG001|STARTED|Overall Study||36
10634625|NCT02057406|11793176|FG002|STARTED|Overall Study||36
10634626|NCT02057406|11793174|FG000|COMPLETED|Overall Study||35
10634627|NCT02057406|11793175|FG001|COMPLETED|Overall Study||33
10634628|NCT02057406|11793176|FG002|COMPLETED|Overall Study||32
10634629|NCT02057406|11793174|FG000|NOT COMPLETED|Overall Study||1
10634630|NCT02057406|11793175|FG001|NOT COMPLETED|Overall Study||3
10634631|NCT02057406|11793176|FG002|NOT COMPLETED|Overall Study||4
10634632|NCT02057458|11793184|FG000|STARTED|Recruited for Participation||8
10634633|NCT02057458|11793185|FG001|STARTED|Recruited for Participation||8
10634634|NCT02057458|11793186|FG002|STARTED|Recruited for Participation||3
10634635|NCT02057458|11793184|FG000|COMPLETED|Recruited for Participation||8
10634636|NCT02057458|11793185|FG001|COMPLETED|Recruited for Participation||8
10634637|NCT02057458|11793186|FG002|COMPLETED|Recruited for Participation||3
10634638|NCT02057458|11793184|FG000|NOT COMPLETED|Recruited for Participation||0
10634639|NCT02057458|11793185|FG001|NOT COMPLETED|Recruited for Participation||0
10634640|NCT02057458|11793186|FG002|NOT COMPLETED|Recruited for Participation||0
10634641|NCT02057458|11793184|FG000|STARTED|Met Inclusion Criteria||8
10634642|NCT02057458|11793185|FG001|STARTED|Met Inclusion Criteria||8
10634643|NCT02057458|11793186|FG002|STARTED|Met Inclusion Criteria||3
10634644|NCT02057458|11793184|FG000|COMPLETED|Met Inclusion Criteria||8
10634645|NCT02057458|11793185|FG001|COMPLETED|Met Inclusion Criteria||7
10634646|NCT02057458|11793186|FG002|COMPLETED|Met Inclusion Criteria||3
10634647|NCT02057458|11793184|FG000|NOT COMPLETED|Met Inclusion Criteria||0
10634648|NCT02057458|11793185|FG001|NOT COMPLETED|Met Inclusion Criteria||1
10634649|NCT02057458|11793186|FG002|NOT COMPLETED|Met Inclusion Criteria||0
10634650|NCT02057458|11793184|FG000|STARTED|Acute Study (1 Hour): First Intervention||8
10634651|NCT02057458|11793185|FG001|STARTED|Acute Study (1 Hour): First Intervention||7
10634652|NCT02057458|11793186|FG002|STARTED|Acute Study (1 Hour): First Intervention||0
10634653|NCT02057458|11793184|FG000|COMPLETED|Acute Study (1 Hour): First Intervention||6
10634654|NCT02057458|11793185|FG001|COMPLETED|Acute Study (1 Hour): First Intervention||7
10634655|NCT02057458|11793186|FG002|COMPLETED|Acute Study (1 Hour): First Intervention||0
10634656|NCT02057458|11793184|FG000|NOT COMPLETED|Acute Study (1 Hour): First Intervention||2
10634657|NCT02057458|11793185|FG001|NOT COMPLETED|Acute Study (1 Hour): First Intervention||0
10634658|NCT02057458|11793186|FG002|NOT COMPLETED|Acute Study (1 Hour): First Intervention||0
10634659|NCT02057458|11793184|FG000|STARTED|Acute Study (1 Hour): Second Int.||6
10634660|NCT02057458|11793185|FG001|STARTED|Acute Study (1 Hour): Second Int.||7
10634661|NCT02057458|11793186|FG002|STARTED|Acute Study (1 Hour): Second Int.||0
10634662|NCT02057458|11793184|FG000|COMPLETED|Acute Study (1 Hour): Second Int.||6
10634663|NCT02057458|11793185|FG001|COMPLETED|Acute Study (1 Hour): Second Int.||7
10634664|NCT02057458|11793186|FG002|COMPLETED|Acute Study (1 Hour): Second Int.||0
10634665|NCT02057458|11793184|FG000|NOT COMPLETED|Acute Study (1 Hour): Second Int.||0
10634666|NCT02057458|11793185|FG001|NOT COMPLETED|Acute Study (1 Hour): Second Int.||0
10634667|NCT02057458|11793186|FG002|NOT COMPLETED|Acute Study (1 Hour): Second Int.||0
10634668|NCT02057458|11793184|FG000|STARTED|Sub-Chronic Study (4 Weeks)||6
10634669|NCT02057458|11793185|FG001|STARTED|Sub-Chronic Study (4 Weeks)||7
10634670|NCT02057458|11793186|FG002|STARTED|Sub-Chronic Study (4 Weeks)||3
10634671|NCT02057458|11793184|FG000|COMPLETED|Sub-Chronic Study (4 Weeks)||5
10634672|NCT02057458|11793185|FG001|COMPLETED|Sub-Chronic Study (4 Weeks)||7
10634673|NCT02057458|11793186|FG002|COMPLETED|Sub-Chronic Study (4 Weeks)||3
10634674|NCT02057458|11793184|FG000|NOT COMPLETED|Sub-Chronic Study (4 Weeks)||1
10634675|NCT02057458|11793185|FG001|NOT COMPLETED|Sub-Chronic Study (4 Weeks)||0
10634676|NCT02057458|11793186|FG002|NOT COMPLETED|Sub-Chronic Study (4 Weeks)||0
10634677|NCT02057523|11793216|FG000|STARTED|Overall Study||2
10634678|NCT02057523|11793216|FG000|COMPLETED|Overall Study||0
10634679|NCT02057523|11793216|FG000|NOT COMPLETED|Overall Study||2
10634680|NCT02057549|11793222|FG000|STARTED|Overall Study||18
10634681|NCT02057549|11793223|FG001|STARTED|Overall Study||18
10634682|NCT02057549|11793222|FG000|COMPLETED|Overall Study||15
10634683|NCT02057549|11793223|FG001|COMPLETED|Overall Study||18
10634684|NCT02057549|11793222|FG000|NOT COMPLETED|Overall Study||3
10634685|NCT02057549|11793223|FG001|NOT COMPLETED|Overall Study||0
10634686|NCT02057575|11793233|FG000|STARTED|Overall Study||74
10634687|NCT02057575|11793234|FG001|STARTED|Overall Study||73
10634688|NCT02057575|11793235|FG002|STARTED|Overall Study||78
10634689|NCT02057575|11793236|FG003|STARTED|Overall Study||73
10634690|NCT02057575|11793233|FG000|COMPLETED|Overall Study||73
10634691|NCT02057575|11793234|FG001|COMPLETED|Overall Study||69
10634692|NCT02057575|11793235|FG002|COMPLETED|Overall Study||78
10634693|NCT02057575|11793236|FG003|COMPLETED|Overall Study||72
10634694|NCT02057575|11793233|FG000|NOT COMPLETED|Overall Study||1
10634695|NCT02057575|11793234|FG001|NOT COMPLETED|Overall Study||4
10634696|NCT02057575|11793235|FG002|NOT COMPLETED|Overall Study||0
10634697|NCT02057575|11793236|FG003|NOT COMPLETED|Overall Study||1
10634698|NCT02057640|11793248|FG000|STARTED|Weeks 1-4|1 extra participant accidentally treated at DL1 (in addition to initial 3).|4
10634699|NCT02057640|11793249|FG001|STARTED|Weeks 1-4||3
10634700|NCT02057640|11793248|FG000|COMPLETED|Weeks 1-4||4
10634701|NCT02057640|11793249|FG001|COMPLETED|Weeks 1-4||3
10634702|NCT02057640|11793248|FG000|NOT COMPLETED|Weeks 1-4||0
10634703|NCT02057640|11793249|FG001|NOT COMPLETED|Weeks 1-4||0
10634704|NCT02057640|11793248|FG000|STARTED|Phase II Portion of Study at DL2||0
10634705|NCT02057640|11793249|FG001|STARTED|Phase II Portion of Study at DL2||9
10634706|NCT02057640|11793248|FG000|COMPLETED|Phase II Portion of Study at DL2||0
10634707|NCT02057640|11793249|FG001|COMPLETED|Phase II Portion of Study at DL2||9
10634708|NCT02057640|11793248|FG000|NOT COMPLETED|Phase II Portion of Study at DL2||0
10634709|NCT02057640|11793249|FG001|NOT COMPLETED|Phase II Portion of Study at DL2||0
10634710|NCT02057666|11793258|FG000|STARTED|Double Blind Treatment Period||96
10634711|NCT02057666|11793259|FG001|STARTED|Double Blind Treatment Period||50
10634712|NCT02057666|11793258|FG000|COMPLETED|Double Blind Treatment Period|Number of patients who continued into the open-label treatment period.|0
10634713|NCT02057666|11793259|FG001|COMPLETED|Double Blind Treatment Period|Number of patients who continued into the open-label treatment period.|6
10634714|NCT02057666|11793258|FG000|NOT COMPLETED|Double Blind Treatment Period||96
10634715|NCT02057666|11793259|FG001|NOT COMPLETED|Double Blind Treatment Period||44
10634716|NCT02057666|11793258|FG000|STARTED|Open-Label Treatment Period||0
10634717|NCT02057666|11793259|FG001|STARTED|Open-Label Treatment Period||6
10634718|NCT02057666|11793258|FG000|COMPLETED|Open-Label Treatment Period||0
10634719|NCT02057666|11793259|FG001|COMPLETED|Open-Label Treatment Period||0
10634720|NCT02057666|11793258|FG000|NOT COMPLETED|Open-Label Treatment Period||0
10634721|NCT02057666|11793259|FG001|NOT COMPLETED|Open-Label Treatment Period||6
10634722|NCT02057692|11793269|FG000|STARTED|Overall Study||8
10634723|NCT02057692|11793270|FG001|STARTED|Overall Study||11
10634724|NCT02057692|11793271|FG002|STARTED|Overall Study||6
10634725|NCT02057692|11793272|FG003|STARTED|Overall Study||12
10634726|NCT02057692|11793269|FG000|COMPLETED|Overall Study||7
10634727|NCT02057692|11793270|FG001|COMPLETED|Overall Study||11
10634728|NCT02057692|11793271|FG002|COMPLETED|Overall Study||6
10634729|NCT02057692|11793272|FG003|COMPLETED|Overall Study||11
10634730|NCT02057692|11793269|FG000|NOT COMPLETED|Overall Study||1
10634731|NCT02057692|11793270|FG001|NOT COMPLETED|Overall Study||0
10634732|NCT02057692|11793271|FG002|NOT COMPLETED|Overall Study||0
10634733|NCT02057692|11793272|FG003|NOT COMPLETED|Overall Study||1
10634734|NCT02057718|11793290|FG000|STARTED|Completed Study Treatment Through Wk. 72||8
10634735|NCT02057718|11793291|FG001|STARTED|Completed Study Treatment Through Wk. 72||25
10634736|NCT02057718|11793290|FG000|Completed Study Treatment Through Week 72|Completed Study Treatment Through Wk. 72||6
10634737|NCT02057718|11793291|FG001|Completed Study Treatment Through Week 72|Completed Study Treatment Through Wk. 72||16
10634738|NCT02057718|11793290|FG000|COMPLETED|Completed Study Treatment Through Wk. 72||6
10634739|NCT02057718|11793291|FG001|COMPLETED|Completed Study Treatment Through Wk. 72||16
10634740|NCT02057718|11793290|FG000|NOT COMPLETED|Completed Study Treatment Through Wk. 72||2
10634741|NCT02057718|11793291|FG001|NOT COMPLETED|Completed Study Treatment Through Wk. 72||9
10634742|NCT02057718|11793290|FG000|STARTED|Optional Follow-up Treatment Period||6
10634743|NCT02057718|11793291|FG001|STARTED|Optional Follow-up Treatment Period||16
10634744|NCT02057718|11793290|FG000|COMPLETED|Optional Follow-up Treatment Period||4
10634745|NCT02057718|11793291|FG001|COMPLETED|Optional Follow-up Treatment Period||8
10634746|NCT02057718|11793290|FG000|NOT COMPLETED|Optional Follow-up Treatment Period||2
10634747|NCT02057718|11793291|FG001|NOT COMPLETED|Optional Follow-up Treatment Period||8
10634748|NCT02057757|11793299|FG000|STARTED|Overall Study||131
10634749|NCT02057757|11793300|FG001|STARTED|Overall Study||129
10634750|NCT02057757|11793299|FG000|Intent to Treat|Overall Study||130
10705757|NCT02603107|11870269|FG001|STARTED|Optional Extension Phase|21 participants who completed the Randomized Phase did not continue in the Optional Extension Phase.|245
10705758|NCT02603107|11870268|FG000|COMPLETED|Optional Extension Phase||263
10634751|NCT02057757|11793300|FG001|Intent to Treat|Overall Study||127
10634752|NCT02057757|11793299|FG000|COMPLETED|Overall Study||117
10634753|NCT02057757|11793300|FG001|COMPLETED|Overall Study||121
10634754|NCT02057757|11793299|FG000|NOT COMPLETED|Overall Study||14
10634755|NCT02057757|11793300|FG001|NOT COMPLETED|Overall Study||8
10634756|NCT02057835|11793320|FG000|STARTED|Overall Study||8
10634757|NCT02057835|11793321|FG001|STARTED|Overall Study||6
10634758|NCT02057835|11793322|FG002|STARTED|Overall Study||6
10634759|NCT02057835|11793323|FG003|STARTED|Overall Study||6
10634760|NCT02057835|11793324|FG004|STARTED|Overall Study||6
10634761|NCT02057835|11793325|FG005|STARTED|Overall Study||8
10634762|NCT02057835|11793326|FG006|STARTED|Overall Study||6
10634763|NCT02057835|11793327|FG007|STARTED|Overall Study||6
10634764|NCT02057835|11793328|FG008|STARTED|Overall Study||6
10634765|NCT02057835|11793329|FG009|STARTED|Overall Study||6
10634766|NCT02057835|11793320|FG000|COMPLETED|Overall Study||8
10634767|NCT02057835|11793321|FG001|COMPLETED|Overall Study||4
10634768|NCT02057835|11793322|FG002|COMPLETED|Overall Study||6
10634769|NCT02057835|11793323|FG003|COMPLETED|Overall Study||6
10634770|NCT02057835|11793324|FG004|COMPLETED|Overall Study||6
10634771|NCT02057835|11793325|FG005|COMPLETED|Overall Study||8
10634772|NCT02057835|11793326|FG006|COMPLETED|Overall Study||6
10634773|NCT02057835|11793327|FG007|COMPLETED|Overall Study||6
10634774|NCT02057835|11793328|FG008|COMPLETED|Overall Study||6
10634775|NCT02057835|11793329|FG009|COMPLETED|Overall Study||6
10634776|NCT02057835|11793320|FG000|NOT COMPLETED|Overall Study||0
10634777|NCT02057835|11793321|FG001|NOT COMPLETED|Overall Study||2
10634778|NCT02057835|11793322|FG002|NOT COMPLETED|Overall Study||0
10634779|NCT02057835|11793323|FG003|NOT COMPLETED|Overall Study||0
10634780|NCT02057835|11793324|FG004|NOT COMPLETED|Overall Study||0
10634781|NCT02057835|11793325|FG005|NOT COMPLETED|Overall Study||0
10634782|NCT02057835|11793326|FG006|NOT COMPLETED|Overall Study||0
10634783|NCT02057835|11793327|FG007|NOT COMPLETED|Overall Study||0
10634784|NCT02057835|11793328|FG008|NOT COMPLETED|Overall Study||0
10634785|NCT02057835|11793329|FG009|NOT COMPLETED|Overall Study||0
10634786|NCT02057939|11793358|FG000|STARTED|Overall Study||38
10705759|NCT02603107|11870269|FG001|COMPLETED|Optional Extension Phase||232
10705760|NCT02603107|11870268|FG000|NOT COMPLETED|Optional Extension Phase||9
10457216|NCT01009463|11604908|FG003|NOT COMPLETED|52-week, Double-blind Treatment Period||91
10457217|NCT01009463|11604909|FG004|NOT COMPLETED|52-week, Double-blind Treatment Period||101
10457218|NCT01009515|11604920|FG000|STARTED|Overall Study||19
10457219|NCT01009515|11604920|FG000|COMPLETED|Overall Study||16
10457220|NCT01009515|11604920|FG000|NOT COMPLETED|Overall Study||3
10457221|NCT01009554|11604926|FG000|STARTED|Overall Study||48
10457222|NCT01009554|11604927|FG001|STARTED|Overall Study||48
10457223|NCT01009554|11604926|FG000|COMPLETED|Overall Study||46
10457224|NCT01009554|11604927|FG001|COMPLETED|Overall Study||41
10457225|NCT01009554|11604926|FG000|NOT COMPLETED|Overall Study||2
10457226|NCT01009554|11604927|FG001|NOT COMPLETED|Overall Study||7
10457227|NCT01009580|11604935|FG000|STARTED|Overall Study||224
10457228|NCT01009580|11604936|FG001|STARTED|Overall Study||223
10457229|NCT01009580|11604935|FG000|Exposed|Overall Study||224
10457230|NCT01009580|11604936|FG001|Exposed|Overall Study|One subject was randomised in error and withdrew prior to exposure to drug|222
10457231|NCT01009580|11604935|FG000|COMPLETED|Overall Study||197
10457232|NCT01009580|11604936|FG001|COMPLETED|Overall Study||188
10457233|NCT01009580|11604935|FG000|NOT COMPLETED|Overall Study||27
10457234|NCT01009580|11604936|FG001|NOT COMPLETED|Overall Study||35
10457235|NCT01009619|11604944|FG000|STARTED|Overall Study||40
10457236|NCT01009619|11604945|FG001|STARTED|Overall Study||43
10457237|NCT01009619|11604944|FG000|COMPLETED|Overall Study||40
10457238|NCT01009619|11604945|FG001|COMPLETED|Overall Study||43
10457239|NCT01009619|11604944|FG000|NOT COMPLETED|Overall Study||0
10457240|NCT01009619|11604945|FG001|NOT COMPLETED|Overall Study||0
10457241|NCT01009645|11604955|FG000|STARTED|Overall Study||31
10457242|NCT01009645|11604956|FG001|STARTED|Overall Study||31
10457243|NCT01009645|11604957|FG002|STARTED|Overall Study||32
10457244|NCT01009645|11604958|FG003|STARTED|Overall Study||31
10457245|NCT01009645|11604955|FG000|COMPLETED|Overall Study||29
10457246|NCT01009645|11604956|FG001|COMPLETED|Overall Study||23
10457247|NCT01009645|11604957|FG002|COMPLETED|Overall Study||28
10457248|NCT01009645|11604958|FG003|COMPLETED|Overall Study||26
10457249|NCT01009645|11604955|FG000|NOT COMPLETED|Overall Study||2
10634787|NCT02057939|11793358|FG000|COMPLETED|Overall Study||37
10634788|NCT02057939|11793358|FG000|NOT COMPLETED|Overall Study||1
10634789|NCT02057952|11793365|FG000|STARTED|Overall Study||51
10705761|NCT02603107|11870269|FG001|NOT COMPLETED|Optional Extension Phase||13
10705762|NCT02603120|11870279|FG000|STARTED|Double-Blind Treatment Phase||284
10705763|NCT02603120|11870280|FG001|STARTED|Double-Blind Treatment Phase||283
10634790|NCT02057952|11793366|FG001|STARTED|Overall Study||49
10457250|NCT01009645|11604956|FG001|NOT COMPLETED|Overall Study||8
10634791|NCT02057952|11793367|FG002|STARTED|Overall Study||50
10705764|NCT02603120|11870279|FG000|COMPLETED|Double-Blind Treatment Phase||265
10705765|NCT02603120|11870280|FG001|COMPLETED|Double-Blind Treatment Phase||267
10705766|NCT02603120|11870279|FG000|NOT COMPLETED|Double-Blind Treatment Phase||19
10705767|NCT02603120|11870280|FG001|NOT COMPLETED|Double-Blind Treatment Phase||16
10705768|NCT02603120|11870279|FG000|STARTED|OL Extension B/F/TAF Treatment Phase||259
10705769|NCT02603120|11870280|FG001|STARTED|OL Extension B/F/TAF Treatment Phase||265
10705770|NCT02603120|11870279|FG000|COMPLETED|OL Extension B/F/TAF Treatment Phase||254
10705771|NCT02603120|11870280|FG001|COMPLETED|OL Extension B/F/TAF Treatment Phase||254
10705772|NCT02603120|11870279|FG000|NOT COMPLETED|OL Extension B/F/TAF Treatment Phase||5
10705773|NCT02603120|11870280|FG001|NOT COMPLETED|OL Extension B/F/TAF Treatment Phase||11
10705774|NCT02603172|11870296|FG000|STARTED|Part A (Approximately 16 Weeks)||7
10705775|NCT02603172|11870297|FG001|STARTED|Part A (Approximately 16 Weeks)||1
10705776|NCT02603172|11870298|FG002|STARTED|Part A (Approximately 16 Weeks)||8
10705777|NCT02603172|11870299|FG003|STARTED|Part A (Approximately 16 Weeks)||1
10705778|NCT02603172|11870300|FG004|STARTED|Part A (Approximately 16 Weeks)||0
10705779|NCT02603172|11870301|FG005|STARTED|Part A (Approximately 16 Weeks)||0
10457251|NCT01009645|11604957|FG002|NOT COMPLETED|Overall Study||4
10457252|NCT01009645|11604958|FG003|NOT COMPLETED|Overall Study||5
10457253|NCT01009762|11604970|FG000|STARTED|Overall Study||1
10457254|NCT01009762|11604971|FG001|STARTED|Overall Study||10
10457255|NCT01009762|11604970|FG000|Primary Outcome|Overall Study|no Serious Adverse Events (SAE), no treatment related side effects DLT grade 3 or more|0
10457256|NCT01009762|11604971|FG001|Primary Outcome|Overall Study|no SAE, no treatment related side effects DLT grade 3 or more|0
10634792|NCT02057952|11793365|FG000|COMPLETED|Overall Study||43
10634793|NCT02057952|11793366|FG001|COMPLETED|Overall Study||39
10634794|NCT02057952|11793367|FG002|COMPLETED|Overall Study||28
10634795|NCT02057952|11793365|FG000|NOT COMPLETED|Overall Study||8
10634796|NCT02057952|11793366|FG001|NOT COMPLETED|Overall Study||10
10634797|NCT02057952|11793367|FG002|NOT COMPLETED|Overall Study||22
10634798|NCT02058069|11793375|FG000|STARTED|Overall Study||100
10634799|NCT02058069|11793375|FG000|COMPLETED|Overall Study||89
10634800|NCT02058069|11793375|FG000|NOT COMPLETED|Overall Study||11
10634801|NCT02058095|11793381|FG000|STARTED|Overall Study||15
10634802|NCT02058095|11793382|FG001|STARTED|Overall Study||7
10634803|NCT02058095|11793381|FG000|COMPLETED|Overall Study||14
10634804|NCT02058095|11793382|FG001|COMPLETED|Overall Study||7
10634805|NCT02058095|11793381|FG000|NOT COMPLETED|Overall Study||1
10634806|NCT02058095|11793382|FG001|NOT COMPLETED|Overall Study||0
10634807|NCT02058108|11793390|FG000|STARTED|Overall Study||43
10634808|NCT02058108|11793391|FG001|STARTED|Overall Study||10
10634809|NCT02058108|11793390|FG000|Switched to Telbivudine After Week 24|Overall Study||0
10634810|NCT02058108|11793391|FG001|Switched to Telbivudine After Week 24|Overall Study||5
10634811|NCT02058108|11793390|FG000|COMPLETED|Overall Study||2
10634812|NCT02058108|11793391|FG001|COMPLETED|Overall Study||0
10457257|NCT01009762|11604970|FG000|COMPLETED|Overall Study|according to randomization this one participant received placebo|1
10457258|NCT01009762|11604971|FG001|COMPLETED|Overall Study|10 participants received vaccine|10
10457259|NCT01009762|11604970|FG000|NOT COMPLETED|Overall Study||0
10457260|NCT01009762|11604971|FG001|NOT COMPLETED|Overall Study||0
10457261|NCT01009814|11604984|FG000|STARTED|Overall Study||10
10457262|NCT01009814|11604985|FG001|STARTED|Overall Study||10
10457263|NCT01009814|11604986|FG002|STARTED|Overall Study||10
10457264|NCT01009814|11604987|FG003|STARTED|Overall Study||10
10634813|NCT02058108|11793390|FG000|NOT COMPLETED|Overall Study||41
10634814|NCT02058108|11793391|FG001|NOT COMPLETED|Overall Study||10
10634815|NCT02058147|11793402|FG000|STARTED|Overall Study||469
10634816|NCT02058147|11793403|FG001|STARTED|Overall Study||467
10634817|NCT02058147|11793404|FG002|STARTED|Overall Study||234
10634818|NCT02058147|11793402|FG000|Treated|Overall Study||469
10634819|NCT02058147|11793403|FG001|Treated|Overall Study||467
10634820|NCT02058147|11793404|FG002|Treated|Overall Study||233
10634821|NCT02058147|11793402|FG000|COMPLETED|Overall Study||440
10634822|NCT02058147|11793403|FG001|COMPLETED|Overall Study||440
10634823|NCT02058147|11793404|FG002|COMPLETED|Overall Study||205
10705780|NCT02603172|11870302|FG006|STARTED|Part A (Approximately 16 Weeks)||0
10457265|NCT01009814|11604988|FG004|STARTED|Overall Study||10
10457266|NCT01009814|11604984|FG000|COMPLETED|Overall Study||9
10457267|NCT01009814|11604985|FG001|COMPLETED|Overall Study||9
10457268|NCT01009814|11604986|FG002|COMPLETED|Overall Study||10
10457269|NCT01009814|11604987|FG003|COMPLETED|Overall Study||10
10457270|NCT01009814|11604988|FG004|COMPLETED|Overall Study||10
10457271|NCT01009814|11604984|FG000|NOT COMPLETED|Overall Study||1
10457272|NCT01009814|11604985|FG001|NOT COMPLETED|Overall Study||1
10457273|NCT01009814|11604986|FG002|NOT COMPLETED|Overall Study||0
10457274|NCT01009814|11604987|FG003|NOT COMPLETED|Overall Study||0
10457275|NCT01009814|11604988|FG004|NOT COMPLETED|Overall Study||0
10457276|NCT01009840|11605004|FG000|STARTED|Overall Study||30
10457277|NCT01009840|11605004|FG000|COMPLETED|Overall Study||16
10457278|NCT01009840|11605004|FG000|NOT COMPLETED|Overall Study||14
10457279|NCT01009918|11605011|FG000|STARTED|Overall Study||158
10457280|NCT01009918|11605012|FG001|STARTED|Overall Study||156
10457281|NCT01009918|11605013|FG002|STARTED|Overall Study||154
10634824|NCT02058147|11793402|FG000|NOT COMPLETED|Overall Study||29
10634825|NCT02058147|11793403|FG001|NOT COMPLETED|Overall Study||27
10634826|NCT02058147|11793404|FG002|NOT COMPLETED|Overall Study||29
10634827|NCT02058160|11793414|FG000|STARTED|Overall Study||367
10634828|NCT02058160|11793415|FG001|STARTED|Overall Study||369
10634829|NCT02058160|11793414|FG000|Treated|Overall Study||365
10634830|NCT02058160|11793415|FG001|Treated|Overall Study||365
10634831|NCT02058160|11793414|FG000|COMPLETED|Overall Study||336
10634832|NCT02058160|11793415|FG001|COMPLETED|Overall Study||355
10634833|NCT02058160|11793414|FG000|NOT COMPLETED|Overall Study||31
10634834|NCT02058160|11793415|FG001|NOT COMPLETED|Overall Study||14
10634835|NCT02058251|11793423|FG000|STARTED|Overall Study||35
10634836|NCT02058251|11793424|FG001|STARTED|Overall Study||38
10634837|NCT02058251|11793423|FG000|COMPLETED|Overall Study||35
10634838|NCT02058251|11793424|FG001|COMPLETED|Overall Study||38
10634839|NCT02058251|11793423|FG000|NOT COMPLETED|Overall Study||0
10634840|NCT02058251|11793424|FG001|NOT COMPLETED|Overall Study||0
10634841|NCT02058290|11793432|FG000|STARTED|Overall Study||77
10634842|NCT02058290|11793433|FG001|STARTED|Overall Study||45
10634843|NCT02058290|11793432|FG000|COMPLETED|Overall Study||66
10634844|NCT02058290|11793433|FG001|COMPLETED|Overall Study||36
10634845|NCT02058290|11793432|FG000|NOT COMPLETED|Overall Study||11
10634846|NCT02058290|11793433|FG001|NOT COMPLETED|Overall Study||9
10634847|NCT02058368|11793441|FG000|STARTED|Overall Study||302
10634848|NCT02058368|11793442|FG001|STARTED|Overall Study||305
10634849|NCT02058368|11793441|FG000|COMPLETED|Overall Study||261
10634850|NCT02058368|11793442|FG001|COMPLETED|Overall Study||251
10634851|NCT02058368|11793441|FG000|NOT COMPLETED|Overall Study||41
10634852|NCT02058368|11793442|FG001|NOT COMPLETED|Overall Study||54
10634853|NCT02058498|11793448|FG000|STARTED|Overall Study||12
10634854|NCT02058498|11793448|FG000|6 Weeks|Overall Study||8
10634855|NCT02058498|11793448|FG000|COMPLETED|Overall Study||8
10634856|NCT02058498|11793448|FG000|NOT COMPLETED|Overall Study||4
10634857|NCT02058511|11793452|FG000|STARTED|Overall Study||24
10634858|NCT02058511|11793452|FG000|COMPLETED|Overall Study||24
10634859|NCT02058511|11793452|FG000|NOT COMPLETED|Overall Study||0
10634860|NCT02058563|11793458|FG000|STARTED|Overall Study||454
10634861|NCT02058563|11793459|FG001|STARTED|Overall Study||457
10634862|NCT02058563|11793458|FG000|COMPLETED|Overall Study||426
10634863|NCT02058563|11793459|FG001|COMPLETED|Overall Study||433
10634864|NCT02058563|11793458|FG000|NOT COMPLETED|Overall Study||28
10634865|NCT02058563|11793459|FG001|NOT COMPLETED|Overall Study||24
10634866|NCT02058589|11793467|FG000|STARTED|Overall Study||132
10634867|NCT02058589|11793468|FG001|STARTED|Overall Study||132
10634868|NCT02058589|11793467|FG000|COMPLETED|Overall Study||130
10634869|NCT02058589|11793468|FG001|COMPLETED|Overall Study||130
10634870|NCT02058589|11793467|FG000|NOT COMPLETED|Overall Study||2
10634871|NCT02058589|11793468|FG001|NOT COMPLETED|Overall Study||2
10634872|NCT02058628|11793478|FG000|STARTED|Overall Study||111
10634873|NCT02058628|11793479|FG001|STARTED|Overall Study||110
10634874|NCT02058628|11793478|FG000|COMPLETED|Overall Study||104
10634875|NCT02058628|11793479|FG001|COMPLETED|Overall Study||102
10634876|NCT02058628|11793478|FG000|NOT COMPLETED|Overall Study||7
10634877|NCT02058628|11793479|FG001|NOT COMPLETED|Overall Study||8
10634878|NCT02058836|11793490|FG000|STARTED|Overall Study||4
10634879|NCT02058836|11793491|FG001|STARTED|Overall Study||4
10634880|NCT02058836|11793490|FG000|COMPLETED|Overall Study||3
10634881|NCT02058836|11793491|FG001|COMPLETED|Overall Study||3
10634882|NCT02058836|11793490|FG000|NOT COMPLETED|Overall Study||1
10634883|NCT02058836|11793491|FG001|NOT COMPLETED|Overall Study||1
10634884|NCT02058849|11793499|FG000|STARTED|Overall Study||11
10634885|NCT02058849|11793500|FG001|STARTED|Overall Study||2
10634886|NCT02058849|11793499|FG000|COMPLETED|Overall Study||4
10705781|NCT02603172|11870303|FG007|STARTED|Part A (Approximately 16 Weeks)||0
10705782|NCT02603172|11870296|FG000|COMPLETED|Part A (Approximately 16 Weeks)||7
10705783|NCT02603172|11870297|FG001|COMPLETED|Part A (Approximately 16 Weeks)||1
10634887|NCT02058849|11793500|FG001|COMPLETED|Overall Study||1
10634888|NCT02058849|11793499|FG000|NOT COMPLETED|Overall Study||7
10634889|NCT02058849|11793500|FG001|NOT COMPLETED|Overall Study||1
10634890|NCT02058940|11793506|FG000|STARTED|Overall Study||8
10634891|NCT02058940|11793506|FG000|COMPLETED|Overall Study||7
10634892|NCT02058940|11793506|FG000|NOT COMPLETED|Overall Study||1
10634893|NCT02058966|11793510|FG000|STARTED|Open-Label Methamphetamine||19
10634894|NCT02058966|11793510|FG000|Received Methamphetamine|Open-Label Methamphetamine||18
10634895|NCT02058966|11793510|FG000|COMPLETED|Open-Label Methamphetamine||18
10634896|NCT02058966|11793510|FG000|NOT COMPLETED|Open-Label Methamphetamine||1
10634897|NCT02058966|11793510|FG000|STARTED|First Intervention||15
10634898|NCT02058966|11793510|FG000|Received Placebo-Placebo|First Intervention||3
10634899|NCT02058966|11793510|FG000|Received Placebo-Meth|First Intervention||4
10634900|NCT02058966|11793510|FG000|Received Entacapone-Placebo|First Intervention||2
10634901|NCT02058966|11793510|FG000|Received Entacapone-Meth|First Intervention||5
10634902|NCT02058966|11793510|FG000|COMPLETED|First Intervention||14
10634903|NCT02058966|11793510|FG000|NOT COMPLETED|First Intervention||1
10634904|NCT02058966|11793510|FG000|STARTED|Second Intervention||13
10634905|NCT02058966|11793510|FG000|Received Placebo-Placebo|Second Intervention||2
10634906|NCT02058966|11793510|FG000|Received Placebo-Meth|Second Intervention||2
10634907|NCT02058966|11793510|FG000|Received Entacapone-Placebo|Second Intervention||6
10634908|NCT02058966|11793510|FG000|Received Entacapone-Meth|Second Intervention||3
10634909|NCT02058966|11793510|FG000|COMPLETED|Second Intervention||13
10634910|NCT02058966|11793510|FG000|NOT COMPLETED|Second Intervention||0
10634911|NCT02058966|11793510|FG000|STARTED|Third Intervention||12
10634912|NCT02058966|11793510|FG000|Received Placebo-Placebo|Third Intervention||4
10634913|NCT02058966|11793510|FG000|Received Placebo-Meth|Third Intervention||4
10634914|NCT02058966|11793510|FG000|Received Entacapone-Placebo|Third Intervention||1
10634915|NCT02058966|11793510|FG000|Received Entacapone-Meth|Third Intervention||3
10634916|NCT02058966|11793510|FG000|COMPLETED|Third Intervention||12
10634917|NCT02058966|11793510|FG000|NOT COMPLETED|Third Intervention||0
10634918|NCT02058966|11793510|FG000|STARTED|Fourth Intervention||12
10634919|NCT02058966|11793510|FG000|Received Placebo-Placebo|Fourth Intervention||4
10634920|NCT02058966|11793510|FG000|Received Placebo-Meth|Fourth Intervention||3
10634921|NCT02058966|11793510|FG000|Received Entacapone-Placebo|Fourth Intervention||3
10634922|NCT02058966|11793510|FG000|Received Entacapone-Meth|Fourth Intervention||2
10634923|NCT02058966|11793510|FG000|COMPLETED|Fourth Intervention||12
10634924|NCT02058966|11793510|FG000|NOT COMPLETED|Fourth Intervention||0
10634925|NCT02058992|11793522|FG000|STARTED|Overall Study||3339
10634926|NCT02058992|11793522|FG000|COMPLETED|Overall Study||3223
10705784|NCT02603172|11870298|FG002|COMPLETED|Part A (Approximately 16 Weeks)||7
10634927|NCT02058992|11793522|FG000|NOT COMPLETED|Overall Study||116
10634928|NCT02059005|11793528|FG000|STARTED|Overall Study||49
10634929|NCT02059005|11793529|FG001|STARTED|Overall Study||48
10634930|NCT02059005|11793528|FG000|3 Month Assessment|Overall Study||37
10634931|NCT02059005|11793529|FG001|3 Month Assessment|Overall Study||33
10634932|NCT02059005|11793528|FG000|6 Month Assessment|Overall Study||29
10634933|NCT02059005|11793529|FG001|6 Month Assessment|Overall Study||24
10634934|NCT02059005|11793528|FG000|COMPLETED|Overall Study||29
10634935|NCT02059005|11793529|FG001|COMPLETED|Overall Study||24
10634936|NCT02059005|11793528|FG000|NOT COMPLETED|Overall Study||20
10634937|NCT02059005|11793529|FG001|NOT COMPLETED|Overall Study||24
10634938|NCT02059057|11793537|FG000|STARTED|Overall Study||102
10634939|NCT02059057|11793537|FG000|COMPLETED|Overall Study||87
10634940|NCT02059057|11793537|FG000|NOT COMPLETED|Overall Study||15
10634941|NCT02059070|11793544|FG000|STARTED|Overall Study||19
10634942|NCT02059070|11793545|FG001|STARTED|Overall Study||20
10634943|NCT02059070|11793544|FG000|COMPLETED|Overall Study||14
10634944|NCT02059070|11793545|FG001|COMPLETED|Overall Study||16
10634945|NCT02059070|11793544|FG000|NOT COMPLETED|Overall Study||5
10634946|NCT02059070|11793545|FG001|NOT COMPLETED|Overall Study||4
10634947|NCT02059135|11793553|FG000|STARTED|Maternal Follow-up (ITT Population)||62
10634948|NCT02059135|11793554|FG001|STARTED|Maternal Follow-up (ITT Population)||58
10634949|NCT02059135|11793553|FG000|COMPLETED|Maternal Follow-up (ITT Population)||59
10634950|NCT02059135|11793554|FG001|COMPLETED|Maternal Follow-up (ITT Population)||51
10634951|NCT02059135|11793553|FG000|NOT COMPLETED|Maternal Follow-up (ITT Population)||3
10634952|NCT02059135|11793554|FG001|NOT COMPLETED|Maternal Follow-up (ITT Population)||7
10634953|NCT02059135|11793553|FG000|STARTED|Neonatal Follow-up (Safety Population)||60
10634954|NCT02059135|11793554|FG001|STARTED|Neonatal Follow-up (Safety Population)||54
10634955|NCT02059135|11793553|FG000|COMPLETED|Neonatal Follow-up (Safety Population)||56
10634956|NCT02059135|11793554|FG001|COMPLETED|Neonatal Follow-up (Safety Population)||50
10634957|NCT02059135|11793553|FG000|NOT COMPLETED|Neonatal Follow-up (Safety Population)||4
10634958|NCT02059135|11793554|FG001|NOT COMPLETED|Neonatal Follow-up (Safety Population)||4
10634959|NCT02059148|11793562|FG000|STARTED|Treatment 1||4
10634960|NCT02059148|11793563|FG001|STARTED|Treatment 1||4
10634961|NCT02059148|11793564|FG002|STARTED|Treatment 1||4
10634962|NCT02059148|11793565|FG003|STARTED|Treatment 1||4
10634963|NCT02059148|11793566|FG004|STARTED|Treatment 1||4
10634964|NCT02059148|11793567|FG005|STARTED|Treatment 1||4
10634965|NCT02059148|11793562|FG000|COMPLETED|Treatment 1||4
10634966|NCT02059148|11793563|FG001|COMPLETED|Treatment 1||4
10634967|NCT02059148|11793564|FG002|COMPLETED|Treatment 1||4
10634968|NCT02059148|11793565|FG003|COMPLETED|Treatment 1||4
10634969|NCT02059148|11793566|FG004|COMPLETED|Treatment 1||4
10634970|NCT02059148|11793567|FG005|COMPLETED|Treatment 1||3
10634971|NCT02059148|11793562|FG000|NOT COMPLETED|Treatment 1||0
10634972|NCT02059148|11793563|FG001|NOT COMPLETED|Treatment 1||0
10634973|NCT02059148|11793564|FG002|NOT COMPLETED|Treatment 1||0
10634974|NCT02059148|11793565|FG003|NOT COMPLETED|Treatment 1||0
10634975|NCT02059148|11793566|FG004|NOT COMPLETED|Treatment 1||0
10634976|NCT02059148|11793567|FG005|NOT COMPLETED|Treatment 1||1
10634977|NCT02059148|11793562|FG000|STARTED|Treatment 2||4
10634978|NCT02059148|11793563|FG001|STARTED|Treatment 2||4
10634979|NCT02059148|11793564|FG002|STARTED|Treatment 2||4
10634980|NCT02059148|11793565|FG003|STARTED|Treatment 2||4
10634981|NCT02059148|11793566|FG004|STARTED|Treatment 2||4
10634982|NCT02059148|11793567|FG005|STARTED|Treatment 2||3
10634983|NCT02059148|11793562|FG000|COMPLETED|Treatment 2||4
10634984|NCT02059148|11793563|FG001|COMPLETED|Treatment 2||4
10634985|NCT02059148|11793564|FG002|COMPLETED|Treatment 2||4
10634986|NCT02059148|11793565|FG003|COMPLETED|Treatment 2||4
10634987|NCT02059148|11793566|FG004|COMPLETED|Treatment 2||4
10634988|NCT02059148|11793567|FG005|COMPLETED|Treatment 2||3
10634989|NCT02059148|11793562|FG000|NOT COMPLETED|Treatment 2||0
10634990|NCT02059148|11793563|FG001|NOT COMPLETED|Treatment 2||0
10634991|NCT02059148|11793564|FG002|NOT COMPLETED|Treatment 2||0
10634992|NCT02059148|11793565|FG003|NOT COMPLETED|Treatment 2||0
10634993|NCT02059148|11793566|FG004|NOT COMPLETED|Treatment 2||0
10634994|NCT02059148|11793567|FG005|NOT COMPLETED|Treatment 2||0
10634995|NCT02059148|11793562|FG000|STARTED|Treatment 3||4
10634996|NCT02059148|11793563|FG001|STARTED|Treatment 3||4
10634997|NCT02059148|11793564|FG002|STARTED|Treatment 3||4
10634998|NCT02059148|11793565|FG003|STARTED|Treatment 3||4
10634999|NCT02059148|11793566|FG004|STARTED|Treatment 3||4
10635000|NCT02059148|11793567|FG005|STARTED|Treatment 3||3
10635001|NCT02059148|11793562|FG000|COMPLETED|Treatment 3||4
10635002|NCT02059148|11793563|FG001|COMPLETED|Treatment 3||4
10635003|NCT02059148|11793564|FG002|COMPLETED|Treatment 3||4
10635004|NCT02059148|11793565|FG003|COMPLETED|Treatment 3||4
10635005|NCT02059148|11793566|FG004|COMPLETED|Treatment 3||4
10635006|NCT02059148|11793567|FG005|COMPLETED|Treatment 3||3
10635007|NCT02059148|11793562|FG000|NOT COMPLETED|Treatment 3||0
10635008|NCT02059148|11793563|FG001|NOT COMPLETED|Treatment 3||0
10635009|NCT02059148|11793564|FG002|NOT COMPLETED|Treatment 3||0
10635010|NCT02059148|11793565|FG003|NOT COMPLETED|Treatment 3||0
10635011|NCT02059148|11793566|FG004|NOT COMPLETED|Treatment 3||0
10635012|NCT02059148|11793567|FG005|NOT COMPLETED|Treatment 3||0
10635013|NCT02059161|11793580|FG000|STARTED|Overall Study||245
10635014|NCT02059161|11793581|FG001|STARTED|Overall Study||263
10635015|NCT02059161|11793580|FG000|Treated|Overall Study||241
10635016|NCT02059161|11793581|FG001|Treated|Overall Study||258
10635017|NCT02059161|11793580|FG000|COMPLETED|Overall Study||196
10635018|NCT02059161|11793581|FG001|COMPLETED|Overall Study||222
10809137|NCT03836989|11971002|FG001|Subjects < 60 Years Old + Complete Paralysis > 15 Days|Overall Study||0
10809138|NCT03836989|11971001|FG000|COMPLETED|Overall Study||4
10809139|NCT03836989|11971002|FG001|COMPLETED|Overall Study||0
10809140|NCT03836989|11971001|FG000|NOT COMPLETED|Overall Study||0
10809141|NCT03836989|11971002|FG001|NOT COMPLETED|Overall Study||0
10635019|NCT02059161|11793580|FG000|NOT COMPLETED|Overall Study||49
10635020|NCT02059161|11793581|FG001|NOT COMPLETED|Overall Study||41
10635021|NCT02059174|11793587|FG000|STARTED|Period 1||37
10635022|NCT02059174|11793588|FG001|STARTED|Period 1||39
10635023|NCT02059174|11793587|FG000|COMPLETED|Period 1||37
10635024|NCT02059174|11793588|FG001|COMPLETED|Period 1||37
10635025|NCT02059174|11793587|FG000|NOT COMPLETED|Period 1||0
10635026|NCT02059174|11793588|FG001|NOT COMPLETED|Period 1||2
10635027|NCT02059174|11793587|FG000|STARTED|Period 2||37
10635028|NCT02059174|11793588|FG001|STARTED|Period 2||37
10635029|NCT02059174|11793587|FG000|COMPLETED|Period 2||36
10635030|NCT02059174|11793588|FG001|COMPLETED|Period 2||35
10635031|NCT02059174|11793587|FG000|NOT COMPLETED|Period 2||1
10635032|NCT02059174|11793588|FG001|NOT COMPLETED|Period 2||2
10635033|NCT02059174|11793587|FG000|STARTED|Period 3||36
10635034|NCT02059174|11793588|FG001|STARTED|Period 3||35
10635035|NCT02059174|11793587|FG000|COMPLETED|Period 3||35
10635036|NCT02059174|11793588|FG001|COMPLETED|Period 3||35
10635037|NCT02059174|11793587|FG000|NOT COMPLETED|Period 3||1
10635038|NCT02059174|11793588|FG001|NOT COMPLETED|Period 3||0
10635039|NCT02059174|11793587|FG000|STARTED|Period 4||35
10635040|NCT02059174|11793588|FG001|STARTED|Period 4||35
10635041|NCT02059174|11793587|FG000|COMPLETED|Period 4||35
10635042|NCT02059174|11793588|FG001|COMPLETED|Period 4||35
10635043|NCT02059174|11793587|FG000|NOT COMPLETED|Period 4||0
10635044|NCT02059174|11793588|FG001|NOT COMPLETED|Period 4||0
10635045|NCT02059187|11793596|FG000|STARTED|Overall Study||265
10635046|NCT02059187|11793597|FG001|STARTED|Overall Study||266
10635047|NCT02059187|11793596|FG000|COMPLETED|Overall Study||240
10635048|NCT02059187|11793597|FG001|COMPLETED|Overall Study||244
10635049|NCT02059187|11793596|FG000|NOT COMPLETED|Overall Study||25
10635050|NCT02059187|11793597|FG001|NOT COMPLETED|Overall Study||22
10635051|NCT02059213|11793605|FG000|STARTED|Overall Study||20
10635052|NCT02059213|11793606|FG001|STARTED|Overall Study||42
10635053|NCT02059213|11793605|FG000|Initiated Treatment|Overall Study||20
10635054|NCT02059213|11793606|FG001|Initiated Treatment|Overall Study||40
10635055|NCT02059213|11793605|FG000|COMPLETED|Overall Study||20
10635056|NCT02059213|11793606|FG001|COMPLETED|Overall Study||40
10635057|NCT02059213|11793605|FG000|NOT COMPLETED|Overall Study||0
10635058|NCT02059213|11793606|FG001|NOT COMPLETED|Overall Study||2
10635059|NCT02059239|11793617|FG000|STARTED|Overall Study||18
10635060|NCT02059239|11793618|FG001|STARTED|Overall Study||16
10635061|NCT02059239|11793617|FG000|COMPLETED|Overall Study||16
10635062|NCT02059239|11793618|FG001|COMPLETED|Overall Study||13
10635063|NCT02059239|11793617|FG000|NOT COMPLETED|Overall Study||2
10635064|NCT02059239|11793618|FG001|NOT COMPLETED|Overall Study||3
10635065|NCT02059278|11793627|FG000|STARTED|Overall Study||165
10635066|NCT02059278|11793628|FG001|STARTED|Overall Study||170
10635067|NCT02059278|11793627|FG000|COMPLETED|Overall Study||162
10635068|NCT02059278|11793628|FG001|COMPLETED|Overall Study||166
10635069|NCT02059278|11793627|FG000|NOT COMPLETED|Overall Study||3
10635070|NCT02059278|11793628|FG001|NOT COMPLETED|Overall Study||4
10635071|NCT02059291|11793643|FG000|STARTED|Epoch 2||31
10635072|NCT02059291|11793644|FG001|STARTED|Epoch 2||32
10635073|NCT02059291|11793645|FG002|STARTED|Epoch 2||37
10635074|NCT02059291|11793646|FG003|STARTED|Epoch 2||35
10635075|NCT02059291|11793647|FG004|STARTED|Epoch 2||22
10635076|NCT02059291|11793648|FG005|STARTED|Epoch 2||24
10635077|NCT02059291|11793649|FG006|STARTED|Epoch 2||2
10635078|NCT02059291|11793650|FG007|STARTED|Epoch 2||2
10635079|NCT02059291|11793651|FG008|STARTED|Epoch 2|This Epoch 3 group is shown in Epoch 2 to account for the 203 patients enrolled in the study.|18
10635080|NCT02059291|11793652|FG009|STARTED|Epoch 2||0
10635081|NCT02059291|11793653|FG010|STARTED|Epoch 2||0
10635082|NCT02059291|11793654|FG011|STARTED|Epoch 2||0
10635083|NCT02059291|11793655|FG012|STARTED|Epoch 2||0
10635084|NCT02059291|11793656|FG013|STARTED|Epoch 2||0
10635085|NCT02059291|11793657|FG014|STARTED|Epoch 2||0
10635086|NCT02059291|11793658|FG015|STARTED|Epoch 2||0
10809142|NCT03827564|11971013|FG000|STARTED|Overall Study||9
10809143|NCT03827564|11971014|FG001|STARTED|Overall Study||5
10809144|NCT03827564|11971013|FG000|COMPLETED|Overall Study||8
10635087|NCT02059291|11793659|FG016|STARTED|Epoch 2||0
10635088|NCT02059291|11793660|FG017|STARTED|Epoch 2||0
10635089|NCT02059291|11793661|FG018|STARTED|Epoch 2||0
10635090|NCT02059291|11793662|FG019|STARTED|Epoch 2||0
10635091|NCT02059291|11793663|FG020|STARTED|Epoch 2||0
10635092|NCT02059291|11793664|FG021|STARTED|Epoch 2||0
10635093|NCT02059291|11793665|FG022|STARTED|Epoch 2||0
10635094|NCT02059291|11793666|FG023|STARTED|Epoch 2||0
10635095|NCT02059291|11793667|FG024|STARTED|Epoch 2||0
10809145|NCT03827564|11971014|FG001|COMPLETED|Overall Study||5
10635096|NCT02059291|11793643|FG000|COMPLETED|Epoch 2||31
10635097|NCT02059291|11793644|FG001|COMPLETED|Epoch 2||31
10635098|NCT02059291|11793645|FG002|COMPLETED|Epoch 2||36
10635099|NCT02059291|11793646|FG003|COMPLETED|Epoch 2||33
10635100|NCT02059291|11793647|FG004|COMPLETED|Epoch 2||22
10635101|NCT02059291|11793648|FG005|COMPLETED|Epoch 2||22
10635102|NCT02059291|11793649|FG006|COMPLETED|Epoch 2||2
10635103|NCT02059291|11793650|FG007|COMPLETED|Epoch 2||1
10635104|NCT02059291|11793651|FG008|COMPLETED|Epoch 2||16
10635105|NCT02059291|11793652|FG009|COMPLETED|Epoch 2||0
10635106|NCT02059291|11793653|FG010|COMPLETED|Epoch 2||0
10635107|NCT02059291|11793654|FG011|COMPLETED|Epoch 2||0
10635108|NCT02059291|11793655|FG012|COMPLETED|Epoch 2||0
10635109|NCT02059291|11793656|FG013|COMPLETED|Epoch 2||0
10635110|NCT02059291|11793657|FG014|COMPLETED|Epoch 2||0
10635111|NCT02059291|11793658|FG015|COMPLETED|Epoch 2||0
10635112|NCT02059291|11793659|FG016|COMPLETED|Epoch 2||0
10635113|NCT02059291|11793660|FG017|COMPLETED|Epoch 2||0
10635114|NCT02059291|11793661|FG018|COMPLETED|Epoch 2||0
10635115|NCT02059291|11793662|FG019|COMPLETED|Epoch 2||0
10635116|NCT02059291|11793663|FG020|COMPLETED|Epoch 2||0
10635117|NCT02059291|11793664|FG021|COMPLETED|Epoch 2||0
10635118|NCT02059291|11793665|FG022|COMPLETED|Epoch 2||0
10635119|NCT02059291|11793666|FG023|COMPLETED|Epoch 2||0
10635120|NCT02059291|11793667|FG024|COMPLETED|Epoch 2||0
10635121|NCT02059291|11793643|FG000|NOT COMPLETED|Epoch 2||0
10635122|NCT02059291|11793644|FG001|NOT COMPLETED|Epoch 2||1
10635123|NCT02059291|11793645|FG002|NOT COMPLETED|Epoch 2||1
10635124|NCT02059291|11793646|FG003|NOT COMPLETED|Epoch 2||2
10635125|NCT02059291|11793647|FG004|NOT COMPLETED|Epoch 2||0
10635126|NCT02059291|11793648|FG005|NOT COMPLETED|Epoch 2||2
10635127|NCT02059291|11793649|FG006|NOT COMPLETED|Epoch 2||0
10635128|NCT02059291|11793650|FG007|NOT COMPLETED|Epoch 2||1
10635129|NCT02059291|11793651|FG008|NOT COMPLETED|Epoch 2||2
10635130|NCT02059291|11793652|FG009|NOT COMPLETED|Epoch 2||0
10635131|NCT02059291|11793653|FG010|NOT COMPLETED|Epoch 2||0
10635132|NCT02059291|11793654|FG011|NOT COMPLETED|Epoch 2||0
10635133|NCT02059291|11793655|FG012|NOT COMPLETED|Epoch 2||0
10635134|NCT02059291|11793656|FG013|NOT COMPLETED|Epoch 2||0
10635135|NCT02059291|11793657|FG014|NOT COMPLETED|Epoch 2||0
10635136|NCT02059291|11793658|FG015|NOT COMPLETED|Epoch 2||0
10635137|NCT02059291|11793659|FG016|NOT COMPLETED|Epoch 2||0
10635138|NCT02059291|11793660|FG017|NOT COMPLETED|Epoch 2||0
10635139|NCT02059291|11793661|FG018|NOT COMPLETED|Epoch 2||0
10635140|NCT02059291|11793662|FG019|NOT COMPLETED|Epoch 2||0
10635141|NCT02059291|11793663|FG020|NOT COMPLETED|Epoch 2||0
10635142|NCT02059291|11793664|FG021|NOT COMPLETED|Epoch 2||0
10635143|NCT02059291|11793665|FG022|NOT COMPLETED|Epoch 2||0
10635144|NCT02059291|11793666|FG023|NOT COMPLETED|Epoch 2||0
10635145|NCT02059291|11793667|FG024|NOT COMPLETED|Epoch 2||0
10635146|NCT02059291|11793643|FG000|STARTED|Epoch 3||0
10635147|NCT02059291|11793644|FG001|STARTED|Epoch 3||0
10635148|NCT02059291|11793645|FG002|STARTED|Epoch 3||0
10635149|NCT02059291|11793646|FG003|STARTED|Epoch 3||0
10635150|NCT02059291|11793647|FG004|STARTED|Epoch 3||0
10635151|NCT02059291|11793648|FG005|STARTED|Epoch 3||0
10635152|NCT02059291|11793649|FG006|STARTED|Epoch 3||2
10635153|NCT02059291|11793650|FG007|STARTED|Epoch 3||1
10635154|NCT02059291|11793651|FG008|STARTED|Epoch 3|Presented in Epoch 2.|0
10635155|NCT02059291|11793652|FG009|STARTED|Epoch 3||9
10635156|NCT02059291|11793653|FG010|STARTED|Epoch 3||10
10635157|NCT02059291|11793654|FG011|STARTED|Epoch 3||6
10635158|NCT02059291|11793655|FG012|STARTED|Epoch 3||7
10635159|NCT02059291|11793656|FG013|STARTED|Epoch 3||4
10635160|NCT02059291|11793657|FG014|STARTED|Epoch 3||5
10635161|NCT02059291|11793658|FG015|STARTED|Epoch 3||126
10635162|NCT02059291|11793659|FG016|STARTED|Epoch 3||0
10635163|NCT02059291|11793660|FG017|STARTED|Epoch 3||0
10635164|NCT02059291|11793661|FG018|STARTED|Epoch 3||0
10635165|NCT02059291|11793662|FG019|STARTED|Epoch 3||0
10635166|NCT02059291|11793663|FG020|STARTED|Epoch 3||0
10635167|NCT02059291|11793664|FG021|STARTED|Epoch 3||0
10635168|NCT02059291|11793665|FG022|STARTED|Epoch 3||0
10635169|NCT02059291|11793666|FG023|STARTED|Epoch 3||0
10635170|NCT02059291|11793667|FG024|STARTED|Epoch 3||0
10635171|NCT02059291|11793643|FG000|COMPLETED|Epoch 3||0
10635172|NCT02059291|11793644|FG001|COMPLETED|Epoch 3||0
10635173|NCT02059291|11793645|FG002|COMPLETED|Epoch 3||0
10635174|NCT02059291|11793646|FG003|COMPLETED|Epoch 3||0
10635175|NCT02059291|11793647|FG004|COMPLETED|Epoch 3||0
10635176|NCT02059291|11793648|FG005|COMPLETED|Epoch 3||0
10635177|NCT02059291|11793649|FG006|COMPLETED|Epoch 3||2
10635178|NCT02059291|11793650|FG007|COMPLETED|Epoch 3||1
10635179|NCT02059291|11793651|FG008|COMPLETED|Epoch 3||0
10635180|NCT02059291|11793652|FG009|COMPLETED|Epoch 3||9
10635181|NCT02059291|11793653|FG010|COMPLETED|Epoch 3||10
10635182|NCT02059291|11793654|FG011|COMPLETED|Epoch 3||6
10635183|NCT02059291|11793655|FG012|COMPLETED|Epoch 3||7
10635184|NCT02059291|11793656|FG013|COMPLETED|Epoch 3||3
10635185|NCT02059291|11793657|FG014|COMPLETED|Epoch 3||5
10635186|NCT02059291|11793658|FG015|COMPLETED|Epoch 3||120
10635187|NCT02059291|11793659|FG016|COMPLETED|Epoch 3||0
10635188|NCT02059291|11793660|FG017|COMPLETED|Epoch 3||0
10635189|NCT02059291|11793661|FG018|COMPLETED|Epoch 3||0
10635190|NCT02059291|11793662|FG019|COMPLETED|Epoch 3||0
10635191|NCT02059291|11793663|FG020|COMPLETED|Epoch 3||0
10635192|NCT02059291|11793664|FG021|COMPLETED|Epoch 3||0
10635193|NCT02059291|11793665|FG022|COMPLETED|Epoch 3||0
10635194|NCT02059291|11793666|FG023|COMPLETED|Epoch 3||0
10635195|NCT02059291|11793667|FG024|COMPLETED|Epoch 3||0
10635196|NCT02059291|11793643|FG000|NOT COMPLETED|Epoch 3||0
10635197|NCT02059291|11793644|FG001|NOT COMPLETED|Epoch 3||0
10635198|NCT02059291|11793645|FG002|NOT COMPLETED|Epoch 3||0
10635199|NCT02059291|11793646|FG003|NOT COMPLETED|Epoch 3||0
10635200|NCT02059291|11793647|FG004|NOT COMPLETED|Epoch 3||0
10635201|NCT02059291|11793648|FG005|NOT COMPLETED|Epoch 3||0
10635202|NCT02059291|11793649|FG006|NOT COMPLETED|Epoch 3||0
10635203|NCT02059291|11793650|FG007|NOT COMPLETED|Epoch 3||0
10635204|NCT02059291|11793651|FG008|NOT COMPLETED|Epoch 3||0
10635205|NCT02059291|11793652|FG009|NOT COMPLETED|Epoch 3||0
10635206|NCT02059291|11793653|FG010|NOT COMPLETED|Epoch 3||0
10635207|NCT02059291|11793654|FG011|NOT COMPLETED|Epoch 3||0
10635208|NCT02059291|11793655|FG012|NOT COMPLETED|Epoch 3||0
10635209|NCT02059291|11793656|FG013|NOT COMPLETED|Epoch 3||1
10635210|NCT02059291|11793657|FG014|NOT COMPLETED|Epoch 3||0
10635211|NCT02059291|11793658|FG015|NOT COMPLETED|Epoch 3||6
10635212|NCT02059291|11793659|FG016|NOT COMPLETED|Epoch 3||0
10635213|NCT02059291|11793660|FG017|NOT COMPLETED|Epoch 3||0
10635214|NCT02059291|11793661|FG018|NOT COMPLETED|Epoch 3||0
10635215|NCT02059291|11793662|FG019|NOT COMPLETED|Epoch 3||0
10635216|NCT02059291|11793663|FG020|NOT COMPLETED|Epoch 3||0
10635217|NCT02059291|11793664|FG021|NOT COMPLETED|Epoch 3||0
10635218|NCT02059291|11793665|FG022|NOT COMPLETED|Epoch 3||0
10635219|NCT02059291|11793666|FG023|NOT COMPLETED|Epoch 3||0
10635220|NCT02059291|11793667|FG024|NOT COMPLETED|Epoch 3||0
10635221|NCT02059291|11793643|FG000|STARTED|Epoch 4||0
10635222|NCT02059291|11793644|FG001|STARTED|Epoch 4||0
10635223|NCT02059291|11793645|FG002|STARTED|Epoch 4||0
10635224|NCT02059291|11793646|FG003|STARTED|Epoch 4||0
10635225|NCT02059291|11793647|FG004|STARTED|Epoch 4||0
10635226|NCT02059291|11793648|FG005|STARTED|Epoch 4||0
10635227|NCT02059291|11793649|FG006|STARTED|Epoch 4||0
10635228|NCT02059291|11793650|FG007|STARTED|Epoch 4||0
10635229|NCT02059291|11793651|FG008|STARTED|Epoch 4||0
10635230|NCT02059291|11793652|FG009|STARTED|Epoch 4||0
10635231|NCT02059291|11793653|FG010|STARTED|Epoch 4||0
10635232|NCT02059291|11793654|FG011|STARTED|Epoch 4||0
10635233|NCT02059291|11793655|FG012|STARTED|Epoch 4||0
10635234|NCT02059291|11793656|FG013|STARTED|Epoch 4||0
10635235|NCT02059291|11793657|FG014|STARTED|Epoch 4||0
10635236|NCT02059291|11793658|FG015|STARTED|Epoch 4||0
10635237|NCT02059291|11793659|FG016|STARTED|Epoch 4||43
10635238|NCT02059291|11793660|FG017|STARTED|Epoch 4||14
10635239|NCT02059291|11793661|FG018|STARTED|Epoch 4||2
10635240|NCT02059291|11793662|FG019|STARTED|Epoch 4||18
10635241|NCT02059291|11793663|FG020|STARTED|Epoch 4||34
10635242|NCT02059291|11793664|FG021|STARTED|Epoch 4||14
10635243|NCT02059291|11793665|FG022|STARTED|Epoch 4||31
10635244|NCT02059291|11793666|FG023|STARTED|Epoch 4||22
10635245|NCT02059291|11793667|FG024|STARTED|Epoch 4||0
10635246|NCT02059291|11793643|FG000|COMPLETED|Epoch 4||0
10635247|NCT02059291|11793644|FG001|COMPLETED|Epoch 4||0
10635248|NCT02059291|11793645|FG002|COMPLETED|Epoch 4||0
10635249|NCT02059291|11793646|FG003|COMPLETED|Epoch 4||0
10635250|NCT02059291|11793647|FG004|COMPLETED|Epoch 4||0
10635251|NCT02059291|11793648|FG005|COMPLETED|Epoch 4||0
10635252|NCT02059291|11793649|FG006|COMPLETED|Epoch 4||0
10635253|NCT02059291|11793650|FG007|COMPLETED|Epoch 4||0
10635254|NCT02059291|11793651|FG008|COMPLETED|Epoch 4||0
10635255|NCT02059291|11793652|FG009|COMPLETED|Epoch 4||0
10635256|NCT02059291|11793653|FG010|COMPLETED|Epoch 4||0
10635257|NCT02059291|11793654|FG011|COMPLETED|Epoch 4||0
10635258|NCT02059291|11793655|FG012|COMPLETED|Epoch 4||0
10635259|NCT02059291|11793656|FG013|COMPLETED|Epoch 4||0
10635260|NCT02059291|11793657|FG014|COMPLETED|Epoch 4||0
10635261|NCT02059291|11793658|FG015|COMPLETED|Epoch 4||0
10635262|NCT02059291|11793659|FG016|COMPLETED|Epoch 4||41
10635263|NCT02059291|11793660|FG017|COMPLETED|Epoch 4||14
10635264|NCT02059291|11793661|FG018|COMPLETED|Epoch 4||2
10635265|NCT02059291|11793662|FG019|COMPLETED|Epoch 4||18
10635266|NCT02059291|11793663|FG020|COMPLETED|Epoch 4||33
10635267|NCT02059291|11793664|FG021|COMPLETED|Epoch 4||14
10635268|NCT02059291|11793665|FG022|COMPLETED|Epoch 4||30
10635269|NCT02059291|11793666|FG023|COMPLETED|Epoch 4||21
10635270|NCT02059291|11793667|FG024|COMPLETED|Epoch 4||0
10635271|NCT02059291|11793643|FG000|NOT COMPLETED|Epoch 4||0
10635272|NCT02059291|11793644|FG001|NOT COMPLETED|Epoch 4||0
10635273|NCT02059291|11793645|FG002|NOT COMPLETED|Epoch 4||0
10635274|NCT02059291|11793646|FG003|NOT COMPLETED|Epoch 4||0
10635275|NCT02059291|11793647|FG004|NOT COMPLETED|Epoch 4||0
10635276|NCT02059291|11793648|FG005|NOT COMPLETED|Epoch 4||0
10635277|NCT02059291|11793649|FG006|NOT COMPLETED|Epoch 4||0
10635278|NCT02059291|11793650|FG007|NOT COMPLETED|Epoch 4||0
10635279|NCT02059291|11793651|FG008|NOT COMPLETED|Epoch 4||0
10635280|NCT02059291|11793652|FG009|NOT COMPLETED|Epoch 4||0
10635281|NCT02059291|11793653|FG010|NOT COMPLETED|Epoch 4||0
10635282|NCT02059291|11793654|FG011|NOT COMPLETED|Epoch 4||0
10635283|NCT02059291|11793655|FG012|NOT COMPLETED|Epoch 4||0
10635284|NCT02059291|11793656|FG013|NOT COMPLETED|Epoch 4||0
10635285|NCT02059291|11793657|FG014|NOT COMPLETED|Epoch 4||0
10635286|NCT02059291|11793658|FG015|NOT COMPLETED|Epoch 4||0
10635287|NCT02059291|11793659|FG016|NOT COMPLETED|Epoch 4||2
10635288|NCT02059291|11793660|FG017|NOT COMPLETED|Epoch 4||0
10635289|NCT02059291|11793661|FG018|NOT COMPLETED|Epoch 4||0
10635290|NCT02059291|11793662|FG019|NOT COMPLETED|Epoch 4||0
10635291|NCT02059291|11793663|FG020|NOT COMPLETED|Epoch 4||1
10635292|NCT02059291|11793664|FG021|NOT COMPLETED|Epoch 4||0
10635293|NCT02059291|11793665|FG022|NOT COMPLETED|Epoch 4||1
10635294|NCT02059291|11793666|FG023|NOT COMPLETED|Epoch 4||1
10635295|NCT02059291|11793667|FG024|NOT COMPLETED|Epoch 4||0
10635296|NCT02059395|11793697|FG000|STARTED|Overall Study||22
10635297|NCT02059395|11793698|FG001|STARTED|Overall Study||27
10635298|NCT02059395|11793697|FG000|COMPLETED|Overall Study||20
10635299|NCT02059395|11793698|FG001|COMPLETED|Overall Study||23
10635300|NCT02059395|11793697|FG000|NOT COMPLETED|Overall Study||2
10635301|NCT02059395|11793698|FG001|NOT COMPLETED|Overall Study||4
10635302|NCT02059408|11793707|FG000|STARTED|Overall Study||604
10635303|NCT02059408|11793708|FG001|STARTED|Overall Study||599
10635304|NCT02059408|11793709|FG002|STARTED|Overall Study||616
10635305|NCT02059408|11793707|FG000|COMPLETED|Overall Study||604
10635306|NCT02059408|11793708|FG001|COMPLETED|Overall Study||269
10635307|NCT02059408|11793709|FG002|COMPLETED|Overall Study||258
10635308|NCT02059408|11793707|FG000|NOT COMPLETED|Overall Study||0
10635309|NCT02059408|11793708|FG001|NOT COMPLETED|Overall Study||330
10635310|NCT02059408|11793709|FG002|NOT COMPLETED|Overall Study||358
10635311|NCT02059434|11793728|FG000|STARTED|Period 1 (After Screening/run-in Period)||2
10635312|NCT02059434|11793729|FG001|STARTED|Period 1 (After Screening/run-in Period)||2
10635313|NCT02059434|11793730|FG002|STARTED|Period 1 (After Screening/run-in Period)||2
10635314|NCT02059434|11793731|FG003|STARTED|Period 1 (After Screening/run-in Period)||2
10635315|NCT02059434|11793732|FG004|STARTED|Period 1 (After Screening/run-in Period)||2
10635316|NCT02059434|11793733|FG005|STARTED|Period 1 (After Screening/run-in Period)||2
10635317|NCT02059434|11793734|FG006|STARTED|Period 1 (After Screening/run-in Period)||2
10635318|NCT02059434|11793735|FG007|STARTED|Period 1 (After Screening/run-in Period)||3
10635319|NCT02059434|11793736|FG008|STARTED|Period 1 (After Screening/run-in Period)|Part 2 followed Part 1, and comprised 5 treatment periods|0
10635320|NCT02059434|11793728|FG000|COMPLETED|Period 1 (After Screening/run-in Period)||2
10635321|NCT02059434|11793729|FG001|COMPLETED|Period 1 (After Screening/run-in Period)||2
10635322|NCT02059434|11793730|FG002|COMPLETED|Period 1 (After Screening/run-in Period)||2
10635323|NCT02059434|11793731|FG003|COMPLETED|Period 1 (After Screening/run-in Period)||2
10635324|NCT02059434|11793732|FG004|COMPLETED|Period 1 (After Screening/run-in Period)||2
10635325|NCT02059434|11793733|FG005|COMPLETED|Period 1 (After Screening/run-in Period)||2
10635326|NCT02059434|11793734|FG006|COMPLETED|Period 1 (After Screening/run-in Period)||2
10635327|NCT02059434|11793735|FG007|COMPLETED|Period 1 (After Screening/run-in Period)||3
10635328|NCT02059434|11793736|FG008|COMPLETED|Period 1 (After Screening/run-in Period)|Part 2 followed Part 1, and comprised 5 treatment periods|0
10635329|NCT02059434|11793728|FG000|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
10635330|NCT02059434|11793729|FG001|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
10635331|NCT02059434|11793730|FG002|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
10635332|NCT02059434|11793731|FG003|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
10635333|NCT02059434|11793732|FG004|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
10635334|NCT02059434|11793733|FG005|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
10635335|NCT02059434|11793734|FG006|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
10635336|NCT02059434|11793735|FG007|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
10635337|NCT02059434|11793736|FG008|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
10635338|NCT02059434|11793728|FG000|STARTED|Washout Between Periods 1 and 2||2
10635339|NCT02059434|11793729|FG001|STARTED|Washout Between Periods 1 and 2||2
10635340|NCT02059434|11793730|FG002|STARTED|Washout Between Periods 1 and 2||2
10635341|NCT02059434|11793731|FG003|STARTED|Washout Between Periods 1 and 2||2
10635342|NCT02059434|11793732|FG004|STARTED|Washout Between Periods 1 and 2||2
10635343|NCT02059434|11793733|FG005|STARTED|Washout Between Periods 1 and 2||2
10635344|NCT02059434|11793734|FG006|STARTED|Washout Between Periods 1 and 2||2
10635345|NCT02059434|11793735|FG007|STARTED|Washout Between Periods 1 and 2||3
10635686|NCT02059434|11793734|FG006|NOT COMPLETED|Period 8||0
10635346|NCT02059434|11793736|FG008|STARTED|Washout Between Periods 1 and 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
10635347|NCT02059434|11793728|FG000|COMPLETED|Washout Between Periods 1 and 2||2
10635348|NCT02059434|11793729|FG001|COMPLETED|Washout Between Periods 1 and 2||2
10635349|NCT02059434|11793730|FG002|COMPLETED|Washout Between Periods 1 and 2||2
10635350|NCT02059434|11793731|FG003|COMPLETED|Washout Between Periods 1 and 2||2
10635351|NCT02059434|11793732|FG004|COMPLETED|Washout Between Periods 1 and 2||2
10635352|NCT02059434|11793733|FG005|COMPLETED|Washout Between Periods 1 and 2||2
10635353|NCT02059434|11793734|FG006|COMPLETED|Washout Between Periods 1 and 2||2
10635354|NCT02059434|11793735|FG007|COMPLETED|Washout Between Periods 1 and 2||2
10635355|NCT02059434|11793736|FG008|COMPLETED|Washout Between Periods 1 and 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
10635356|NCT02059434|11793728|FG000|NOT COMPLETED|Washout Between Periods 1 and 2||0
10635357|NCT02059434|11793729|FG001|NOT COMPLETED|Washout Between Periods 1 and 2||0
10635358|NCT02059434|11793730|FG002|NOT COMPLETED|Washout Between Periods 1 and 2||0
10635359|NCT02059434|11793731|FG003|NOT COMPLETED|Washout Between Periods 1 and 2||0
10635360|NCT02059434|11793732|FG004|NOT COMPLETED|Washout Between Periods 1 and 2||0
10635361|NCT02059434|11793733|FG005|NOT COMPLETED|Washout Between Periods 1 and 2||0
10635362|NCT02059434|11793734|FG006|NOT COMPLETED|Washout Between Periods 1 and 2||0
10635363|NCT02059434|11793735|FG007|NOT COMPLETED|Washout Between Periods 1 and 2||1
10635364|NCT02059434|11793736|FG008|NOT COMPLETED|Washout Between Periods 1 and 2||0
10635365|NCT02059434|11793728|FG000|STARTED|Period 2||2
10635366|NCT02059434|11793729|FG001|STARTED|Period 2||2
10635367|NCT02059434|11793730|FG002|STARTED|Period 2||2
10635368|NCT02059434|11793731|FG003|STARTED|Period 2||2
10635369|NCT02059434|11793732|FG004|STARTED|Period 2||2
10635370|NCT02059434|11793733|FG005|STARTED|Period 2||2
10635371|NCT02059434|11793734|FG006|STARTED|Period 2||2
10635372|NCT02059434|11793735|FG007|STARTED|Period 2||2
10635373|NCT02059434|11793736|FG008|STARTED|Period 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
10635374|NCT02059434|11793728|FG000|COMPLETED|Period 2||2
10635375|NCT02059434|11793729|FG001|COMPLETED|Period 2||2
10635376|NCT02059434|11793730|FG002|COMPLETED|Period 2||2
10705785|NCT02603172|11870299|FG003|COMPLETED|Part A (Approximately 16 Weeks)||1
10705786|NCT02603172|11870300|FG004|COMPLETED|Part A (Approximately 16 Weeks)||0
10705787|NCT02603172|11870301|FG005|COMPLETED|Part A (Approximately 16 Weeks)||0
10705788|NCT02603172|11870302|FG006|COMPLETED|Part A (Approximately 16 Weeks)||0
10705789|NCT02603172|11870303|FG007|COMPLETED|Part A (Approximately 16 Weeks)||0
10705790|NCT02603172|11870296|FG000|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
10705791|NCT02603172|11870297|FG001|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
10705792|NCT02603172|11870298|FG002|NOT COMPLETED|Part A (Approximately 16 Weeks)||1
10705793|NCT02603172|11870299|FG003|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
10705794|NCT02603172|11870300|FG004|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
10705795|NCT02603172|11870301|FG005|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
10705796|NCT02603172|11870302|FG006|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
10635377|NCT02059434|11793731|FG003|COMPLETED|Period 2||2
10635378|NCT02059434|11793732|FG004|COMPLETED|Period 2||2
10635379|NCT02059434|11793733|FG005|COMPLETED|Period 2||2
10635380|NCT02059434|11793734|FG006|COMPLETED|Period 2||2
10635381|NCT02059434|11793735|FG007|COMPLETED|Period 2||2
10635382|NCT02059434|11793736|FG008|COMPLETED|Period 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
10635383|NCT02059434|11793728|FG000|NOT COMPLETED|Period 2||0
10635384|NCT02059434|11793729|FG001|NOT COMPLETED|Period 2||0
10635385|NCT02059434|11793730|FG002|NOT COMPLETED|Period 2||0
10635386|NCT02059434|11793731|FG003|NOT COMPLETED|Period 2||0
10635387|NCT02059434|11793732|FG004|NOT COMPLETED|Period 2||0
10635388|NCT02059434|11793733|FG005|NOT COMPLETED|Period 2||0
10635389|NCT02059434|11793734|FG006|NOT COMPLETED|Period 2||0
10635390|NCT02059434|11793735|FG007|NOT COMPLETED|Period 2||0
10635391|NCT02059434|11793736|FG008|NOT COMPLETED|Period 2||0
10635392|NCT02059434|11793728|FG000|STARTED|Washout Between Periods 2 and 3||2
10635393|NCT02059434|11793729|FG001|STARTED|Washout Between Periods 2 and 3||2
10635394|NCT02059434|11793730|FG002|STARTED|Washout Between Periods 2 and 3||2
10635395|NCT02059434|11793731|FG003|STARTED|Washout Between Periods 2 and 3||2
10635396|NCT02059434|11793732|FG004|STARTED|Washout Between Periods 2 and 3||2
10635397|NCT02059434|11793733|FG005|STARTED|Washout Between Periods 2 and 3||2
10635398|NCT02059434|11793734|FG006|STARTED|Washout Between Periods 2 and 3||2
10635399|NCT02059434|11793735|FG007|STARTED|Washout Between Periods 2 and 3||2
10635400|NCT02059434|11793736|FG008|STARTED|Washout Between Periods 2 and 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
10635401|NCT02059434|11793728|FG000|COMPLETED|Washout Between Periods 2 and 3||2
10635402|NCT02059434|11793729|FG001|COMPLETED|Washout Between Periods 2 and 3||2
10635403|NCT02059434|11793730|FG002|COMPLETED|Washout Between Periods 2 and 3||2
10635404|NCT02059434|11793731|FG003|COMPLETED|Washout Between Periods 2 and 3||2
10635405|NCT02059434|11793732|FG004|COMPLETED|Washout Between Periods 2 and 3||2
10635406|NCT02059434|11793733|FG005|COMPLETED|Washout Between Periods 2 and 3||2
10635407|NCT02059434|11793734|FG006|COMPLETED|Washout Between Periods 2 and 3||2
10635408|NCT02059434|11793735|FG007|COMPLETED|Washout Between Periods 2 and 3||2
10635409|NCT02059434|11793736|FG008|COMPLETED|Washout Between Periods 2 and 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
10635410|NCT02059434|11793728|FG000|NOT COMPLETED|Washout Between Periods 2 and 3||0
10635411|NCT02059434|11793729|FG001|NOT COMPLETED|Washout Between Periods 2 and 3||0
10635412|NCT02059434|11793730|FG002|NOT COMPLETED|Washout Between Periods 2 and 3||0
10635413|NCT02059434|11793731|FG003|NOT COMPLETED|Washout Between Periods 2 and 3||0
10635414|NCT02059434|11793732|FG004|NOT COMPLETED|Washout Between Periods 2 and 3||0
10635415|NCT02059434|11793733|FG005|NOT COMPLETED|Washout Between Periods 2 and 3||0
10635416|NCT02059434|11793734|FG006|NOT COMPLETED|Washout Between Periods 2 and 3||0
10635417|NCT02059434|11793735|FG007|NOT COMPLETED|Washout Between Periods 2 and 3||0
10635418|NCT02059434|11793736|FG008|NOT COMPLETED|Washout Between Periods 2 and 3||0
10635419|NCT02059434|11793728|FG000|STARTED|Period 3||2
10635420|NCT02059434|11793729|FG001|STARTED|Period 3||2
10635421|NCT02059434|11793730|FG002|STARTED|Period 3||2
10635422|NCT02059434|11793731|FG003|STARTED|Period 3||2
10635423|NCT02059434|11793732|FG004|STARTED|Period 3||2
10635424|NCT02059434|11793733|FG005|STARTED|Period 3||2
10635425|NCT02059434|11793734|FG006|STARTED|Period 3||2
10635426|NCT02059434|11793735|FG007|STARTED|Period 3||2
10635427|NCT02059434|11793736|FG008|STARTED|Period 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
10635428|NCT02059434|11793728|FG000|COMPLETED|Period 3||2
10635429|NCT02059434|11793729|FG001|COMPLETED|Period 3||2
10635430|NCT02059434|11793730|FG002|COMPLETED|Period 3||2
10635431|NCT02059434|11793731|FG003|COMPLETED|Period 3||2
10635432|NCT02059434|11793732|FG004|COMPLETED|Period 3||2
10635433|NCT02059434|11793733|FG005|COMPLETED|Period 3||2
10635434|NCT02059434|11793734|FG006|COMPLETED|Period 3||2
10635435|NCT02059434|11793735|FG007|COMPLETED|Period 3||2
10635436|NCT02059434|11793736|FG008|COMPLETED|Period 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
10635437|NCT02059434|11793728|FG000|NOT COMPLETED|Period 3||0
10635438|NCT02059434|11793729|FG001|NOT COMPLETED|Period 3||0
10635439|NCT02059434|11793730|FG002|NOT COMPLETED|Period 3||0
10635440|NCT02059434|11793731|FG003|NOT COMPLETED|Period 3||0
10635441|NCT02059434|11793732|FG004|NOT COMPLETED|Period 3||0
10635442|NCT02059434|11793733|FG005|NOT COMPLETED|Period 3||0
10635443|NCT02059434|11793734|FG006|NOT COMPLETED|Period 3||0
10635444|NCT02059434|11793735|FG007|NOT COMPLETED|Period 3||0
10635445|NCT02059434|11793736|FG008|NOT COMPLETED|Period 3||0
10635446|NCT02059434|11793728|FG000|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
10635447|NCT02059434|11793729|FG001|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
10635448|NCT02059434|11793730|FG002|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
10635449|NCT02059434|11793731|FG003|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
10635450|NCT02059434|11793732|FG004|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
10635451|NCT02059434|11793733|FG005|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
10635452|NCT02059434|11793734|FG006|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
10635453|NCT02059434|11793735|FG007|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
10635454|NCT02059434|11793736|FG008|STARTED|Period 4 (After Screening/run-in Period)||38
10635455|NCT02059434|11793728|FG000|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
10635456|NCT02059434|11793729|FG001|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
10635457|NCT02059434|11793730|FG002|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
10635458|NCT02059434|11793731|FG003|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
10635459|NCT02059434|11793732|FG004|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
10635460|NCT02059434|11793733|FG005|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
10635461|NCT02059434|11793734|FG006|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
10635462|NCT02059434|11793735|FG007|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
10635463|NCT02059434|11793736|FG008|COMPLETED|Period 4 (After Screening/run-in Period)||38
10635464|NCT02059434|11793728|FG000|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
10635465|NCT02059434|11793729|FG001|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
10635466|NCT02059434|11793730|FG002|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
10635467|NCT02059434|11793731|FG003|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
10635468|NCT02059434|11793732|FG004|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
10635469|NCT02059434|11793733|FG005|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
10635470|NCT02059434|11793734|FG006|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
10635471|NCT02059434|11793735|FG007|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
10635472|NCT02059434|11793736|FG008|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
10635473|NCT02059434|11793728|FG000|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
10635474|NCT02059434|11793729|FG001|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
10635475|NCT02059434|11793730|FG002|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
10635476|NCT02059434|11793731|FG003|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
10635477|NCT02059434|11793732|FG004|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
10635478|NCT02059434|11793733|FG005|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
10635479|NCT02059434|11793734|FG006|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
10635480|NCT02059434|11793735|FG007|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
10635481|NCT02059434|11793736|FG008|STARTED|Washout Between Periods 4 and 5||38
10635482|NCT02059434|11793728|FG000|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
10635483|NCT02059434|11793729|FG001|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
10635547|NCT02059434|11793730|FG002|NOT COMPLETED|Washout Between Periods 5 and 6||0
10635484|NCT02059434|11793730|FG002|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
10635485|NCT02059434|11793731|FG003|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
10635486|NCT02059434|11793732|FG004|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
10635487|NCT02059434|11793733|FG005|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
10635488|NCT02059434|11793734|FG006|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
10635489|NCT02059434|11793735|FG007|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
10635490|NCT02059434|11793736|FG008|COMPLETED|Washout Between Periods 4 and 5||37
10635491|NCT02059434|11793728|FG000|NOT COMPLETED|Washout Between Periods 4 and 5||0
10635492|NCT02059434|11793729|FG001|NOT COMPLETED|Washout Between Periods 4 and 5||0
10635493|NCT02059434|11793730|FG002|NOT COMPLETED|Washout Between Periods 4 and 5||0
10635494|NCT02059434|11793731|FG003|NOT COMPLETED|Washout Between Periods 4 and 5||0
10635495|NCT02059434|11793732|FG004|NOT COMPLETED|Washout Between Periods 4 and 5||0
10635496|NCT02059434|11793733|FG005|NOT COMPLETED|Washout Between Periods 4 and 5||0
10635497|NCT02059434|11793734|FG006|NOT COMPLETED|Washout Between Periods 4 and 5||0
10635498|NCT02059434|11793735|FG007|NOT COMPLETED|Washout Between Periods 4 and 5||0
10635499|NCT02059434|11793736|FG008|NOT COMPLETED|Washout Between Periods 4 and 5||1
10635500|NCT02059434|11793728|FG000|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
10635501|NCT02059434|11793729|FG001|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
10635502|NCT02059434|11793730|FG002|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
10635503|NCT02059434|11793731|FG003|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
10635504|NCT02059434|11793732|FG004|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
10635505|NCT02059434|11793733|FG005|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
10635506|NCT02059434|11793734|FG006|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
10635507|NCT02059434|11793735|FG007|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
10635508|NCT02059434|11793736|FG008|STARTED|Period 5||37
10635509|NCT02059434|11793728|FG000|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
10635510|NCT02059434|11793729|FG001|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
10635511|NCT02059434|11793730|FG002|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
10635512|NCT02059434|11793731|FG003|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
10635513|NCT02059434|11793732|FG004|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
10635514|NCT02059434|11793733|FG005|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
10635515|NCT02059434|11793734|FG006|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
10635516|NCT02059434|11793735|FG007|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
10635517|NCT02059434|11793736|FG008|COMPLETED|Period 5||37
10635518|NCT02059434|11793728|FG000|NOT COMPLETED|Period 5||0
10635519|NCT02059434|11793729|FG001|NOT COMPLETED|Period 5||0
10635520|NCT02059434|11793730|FG002|NOT COMPLETED|Period 5||0
10635521|NCT02059434|11793731|FG003|NOT COMPLETED|Period 5||0
10635522|NCT02059434|11793732|FG004|NOT COMPLETED|Period 5||0
10635523|NCT02059434|11793733|FG005|NOT COMPLETED|Period 5||0
10635524|NCT02059434|11793734|FG006|NOT COMPLETED|Period 5||0
10635525|NCT02059434|11793735|FG007|NOT COMPLETED|Period 5||0
10635526|NCT02059434|11793736|FG008|NOT COMPLETED|Period 5||0
10635527|NCT02059434|11793728|FG000|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
10635528|NCT02059434|11793729|FG001|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
10635529|NCT02059434|11793730|FG002|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
10635530|NCT02059434|11793731|FG003|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
10635531|NCT02059434|11793732|FG004|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
10635532|NCT02059434|11793733|FG005|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
10635533|NCT02059434|11793734|FG006|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
10635534|NCT02059434|11793735|FG007|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
10635535|NCT02059434|11793736|FG008|STARTED|Washout Between Periods 5 and 6||37
10635536|NCT02059434|11793728|FG000|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
10635537|NCT02059434|11793729|FG001|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
10635538|NCT02059434|11793730|FG002|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
10635539|NCT02059434|11793731|FG003|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
10635540|NCT02059434|11793732|FG004|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
10635541|NCT02059434|11793733|FG005|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
10635542|NCT02059434|11793734|FG006|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
10635543|NCT02059434|11793735|FG007|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
10635544|NCT02059434|11793736|FG008|COMPLETED|Washout Between Periods 5 and 6||37
10809146|NCT03827564|11971013|FG000|NOT COMPLETED|Overall Study||1
10809147|NCT03827564|11971014|FG001|NOT COMPLETED|Overall Study||0
10809148|NCT03824236|11971023|FG000|STARTED|Overall Study||25
10809149|NCT03824236|11971024|FG001|STARTED|Overall Study||24
10809150|NCT03824236|11971025|FG002|STARTED|Overall Study||12
10809151|NCT03824236|11971023|FG000|COMPLETED|Overall Study||25
10635545|NCT02059434|11793728|FG000|NOT COMPLETED|Washout Between Periods 5 and 6||0
10635546|NCT02059434|11793729|FG001|NOT COMPLETED|Washout Between Periods 5 and 6||0
10635548|NCT02059434|11793731|FG003|NOT COMPLETED|Washout Between Periods 5 and 6||0
10635549|NCT02059434|11793732|FG004|NOT COMPLETED|Washout Between Periods 5 and 6||0
10635550|NCT02059434|11793733|FG005|NOT COMPLETED|Washout Between Periods 5 and 6||0
10635551|NCT02059434|11793734|FG006|NOT COMPLETED|Washout Between Periods 5 and 6||0
10635552|NCT02059434|11793735|FG007|NOT COMPLETED|Washout Between Periods 5 and 6||0
10635553|NCT02059434|11793736|FG008|NOT COMPLETED|Washout Between Periods 5 and 6||0
10635554|NCT02059434|11793728|FG000|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
10635555|NCT02059434|11793729|FG001|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
10635556|NCT02059434|11793730|FG002|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
10635557|NCT02059434|11793731|FG003|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
10635558|NCT02059434|11793732|FG004|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
10635559|NCT02059434|11793733|FG005|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
10635560|NCT02059434|11793734|FG006|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
10635561|NCT02059434|11793735|FG007|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
10635562|NCT02059434|11793736|FG008|STARTED|Period 6||37
10635563|NCT02059434|11793728|FG000|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
10635564|NCT02059434|11793729|FG001|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
10635565|NCT02059434|11793730|FG002|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
10635566|NCT02059434|11793731|FG003|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
10635567|NCT02059434|11793732|FG004|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
10635568|NCT02059434|11793733|FG005|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
10635569|NCT02059434|11793734|FG006|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
10635570|NCT02059434|11793735|FG007|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
10635571|NCT02059434|11793736|FG008|COMPLETED|Period 6||37
10635572|NCT02059434|11793728|FG000|NOT COMPLETED|Period 6||0
10635573|NCT02059434|11793729|FG001|NOT COMPLETED|Period 6||0
10809152|NCT03824236|11971024|FG001|COMPLETED|Overall Study||24
10809153|NCT03824236|11971025|FG002|COMPLETED|Overall Study||11
10635574|NCT02059434|11793730|FG002|NOT COMPLETED|Period 6||0
10635575|NCT02059434|11793731|FG003|NOT COMPLETED|Period 6||0
10635576|NCT02059434|11793732|FG004|NOT COMPLETED|Period 6||0
10635577|NCT02059434|11793733|FG005|NOT COMPLETED|Period 6||0
10635578|NCT02059434|11793734|FG006|NOT COMPLETED|Period 6||0
10635579|NCT02059434|11793735|FG007|NOT COMPLETED|Period 6||0
10635580|NCT02059434|11793736|FG008|NOT COMPLETED|Period 6||0
10635581|NCT02059434|11793728|FG000|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
10635582|NCT02059434|11793729|FG001|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
10635583|NCT02059434|11793730|FG002|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
10635584|NCT02059434|11793731|FG003|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
10635585|NCT02059434|11793732|FG004|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
10635586|NCT02059434|11793733|FG005|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
10635587|NCT02059434|11793734|FG006|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
10635588|NCT02059434|11793735|FG007|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
10635589|NCT02059434|11793736|FG008|STARTED|Washout Between Periods 6 and 7||37
10635590|NCT02059434|11793728|FG000|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
10635591|NCT02059434|11793729|FG001|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
10635592|NCT02059434|11793730|FG002|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
10635593|NCT02059434|11793731|FG003|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
10635594|NCT02059434|11793732|FG004|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
10635595|NCT02059434|11793733|FG005|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
10635596|NCT02059434|11793734|FG006|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
10635597|NCT02059434|11793735|FG007|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
10635598|NCT02059434|11793736|FG008|COMPLETED|Washout Between Periods 6 and 7||36
10635599|NCT02059434|11793728|FG000|NOT COMPLETED|Washout Between Periods 6 and 7||0
10635600|NCT02059434|11793729|FG001|NOT COMPLETED|Washout Between Periods 6 and 7||0
10635601|NCT02059434|11793730|FG002|NOT COMPLETED|Washout Between Periods 6 and 7||0
10635602|NCT02059434|11793731|FG003|NOT COMPLETED|Washout Between Periods 6 and 7||0
10635603|NCT02059434|11793732|FG004|NOT COMPLETED|Washout Between Periods 6 and 7||0
10635604|NCT02059434|11793733|FG005|NOT COMPLETED|Washout Between Periods 6 and 7||0
10635605|NCT02059434|11793734|FG006|NOT COMPLETED|Washout Between Periods 6 and 7||0
10635606|NCT02059434|11793735|FG007|NOT COMPLETED|Washout Between Periods 6 and 7||0
10635607|NCT02059434|11793736|FG008|NOT COMPLETED|Washout Between Periods 6 and 7||1
10635608|NCT02059434|11793728|FG000|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
10635609|NCT02059434|11793729|FG001|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
10635610|NCT02059434|11793730|FG002|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
10635611|NCT02059434|11793731|FG003|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
10635612|NCT02059434|11793732|FG004|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
10635613|NCT02059434|11793733|FG005|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
10635614|NCT02059434|11793734|FG006|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
10635685|NCT02059434|11793733|FG005|NOT COMPLETED|Period 8||0
10635615|NCT02059434|11793735|FG007|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
10635616|NCT02059434|11793736|FG008|STARTED|Period 7||36
10635617|NCT02059434|11793728|FG000|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
10635618|NCT02059434|11793729|FG001|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
10635619|NCT02059434|11793730|FG002|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
10635620|NCT02059434|11793731|FG003|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
10635621|NCT02059434|11793732|FG004|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
10635622|NCT02059434|11793733|FG005|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
10635623|NCT02059434|11793734|FG006|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
10635624|NCT02059434|11793735|FG007|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
10635625|NCT02059434|11793736|FG008|COMPLETED|Period 7||36
10635626|NCT02059434|11793728|FG000|NOT COMPLETED|Period 7||0
10635627|NCT02059434|11793729|FG001|NOT COMPLETED|Period 7||0
10635628|NCT02059434|11793730|FG002|NOT COMPLETED|Period 7||0
10635629|NCT02059434|11793731|FG003|NOT COMPLETED|Period 7||0
10635630|NCT02059434|11793732|FG004|NOT COMPLETED|Period 7||0
10635631|NCT02059434|11793733|FG005|NOT COMPLETED|Period 7||0
10635632|NCT02059434|11793734|FG006|NOT COMPLETED|Period 7||0
10635633|NCT02059434|11793735|FG007|NOT COMPLETED|Period 7||0
10635634|NCT02059434|11793736|FG008|NOT COMPLETED|Period 7||0
10635635|NCT02059434|11793728|FG000|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
10635636|NCT02059434|11793729|FG001|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
10635637|NCT02059434|11793730|FG002|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
10635638|NCT02059434|11793731|FG003|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
10635639|NCT02059434|11793732|FG004|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
10635640|NCT02059434|11793733|FG005|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
10635641|NCT02059434|11793734|FG006|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
10653924|NCT02197377|11814566|FG000|STARTED|Overall Study||30
10635642|NCT02059434|11793735|FG007|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
10635643|NCT02059434|11793736|FG008|STARTED|Washout Between Periods 7 and 8||36
10635644|NCT02059434|11793728|FG000|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
10635645|NCT02059434|11793729|FG001|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
10635646|NCT02059434|11793730|FG002|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
10635647|NCT02059434|11793731|FG003|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
10635648|NCT02059434|11793732|FG004|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
10635649|NCT02059434|11793733|FG005|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
10635650|NCT02059434|11793734|FG006|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
10635651|NCT02059434|11793735|FG007|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
10635652|NCT02059434|11793736|FG008|COMPLETED|Washout Between Periods 7 and 8||34
10635653|NCT02059434|11793728|FG000|NOT COMPLETED|Washout Between Periods 7 and 8||0
10635654|NCT02059434|11793729|FG001|NOT COMPLETED|Washout Between Periods 7 and 8||0
10635655|NCT02059434|11793730|FG002|NOT COMPLETED|Washout Between Periods 7 and 8||0
10635656|NCT02059434|11793731|FG003|NOT COMPLETED|Washout Between Periods 7 and 8||0
10635657|NCT02059434|11793732|FG004|NOT COMPLETED|Washout Between Periods 7 and 8||0
10635658|NCT02059434|11793733|FG005|NOT COMPLETED|Washout Between Periods 7 and 8||0
10635659|NCT02059434|11793734|FG006|NOT COMPLETED|Washout Between Periods 7 and 8||0
10635660|NCT02059434|11793735|FG007|NOT COMPLETED|Washout Between Periods 7 and 8||0
10635661|NCT02059434|11793736|FG008|NOT COMPLETED|Washout Between Periods 7 and 8||2
10635662|NCT02059434|11793728|FG000|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
10635663|NCT02059434|11793729|FG001|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
10635664|NCT02059434|11793730|FG002|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
10635665|NCT02059434|11793731|FG003|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
10635666|NCT02059434|11793732|FG004|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
10635667|NCT02059434|11793733|FG005|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
10635668|NCT02059434|11793734|FG006|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
10635669|NCT02059434|11793735|FG007|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
10635670|NCT02059434|11793736|FG008|STARTED|Period 8||34
10635671|NCT02059434|11793728|FG000|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
10635672|NCT02059434|11793729|FG001|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
10635673|NCT02059434|11793730|FG002|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
10635674|NCT02059434|11793731|FG003|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
10635675|NCT02059434|11793732|FG004|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
10635676|NCT02059434|11793733|FG005|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
10635677|NCT02059434|11793734|FG006|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
10635678|NCT02059434|11793735|FG007|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
10635679|NCT02059434|11793736|FG008|COMPLETED|Period 8||34
10635680|NCT02059434|11793728|FG000|NOT COMPLETED|Period 8||0
10635681|NCT02059434|11793729|FG001|NOT COMPLETED|Period 8||0
10635682|NCT02059434|11793730|FG002|NOT COMPLETED|Period 8||0
10635683|NCT02059434|11793731|FG003|NOT COMPLETED|Period 8||0
10635684|NCT02059434|11793732|FG004|NOT COMPLETED|Period 8||0
10635687|NCT02059434|11793735|FG007|NOT COMPLETED|Period 8||0
10635688|NCT02059434|11793736|FG008|NOT COMPLETED|Period 8||0
10635689|NCT02059512|11793767|FG000|STARTED|Overall Study||46
10635690|NCT02059512|11793768|FG001|STARTED|Overall Study||34
10635691|NCT02059512|11793769|FG002|STARTED|Overall Study||37
10635692|NCT02059512|11793767|FG000|COMPLETED|Overall Study||37
10635693|NCT02059512|11793768|FG001|COMPLETED|Overall Study||25
10635694|NCT02059512|11793769|FG002|COMPLETED|Overall Study||23
10635695|NCT02059512|11793767|FG000|NOT COMPLETED|Overall Study||9
10635696|NCT02059512|11793768|FG001|NOT COMPLETED|Overall Study||9
10635697|NCT02059512|11793769|FG002|NOT COMPLETED|Overall Study||14
10635698|NCT02059642|11793795|FG000|STARTED|Overall Study||148
10635699|NCT02059642|11793796|FG001|STARTED|Overall Study||152
10635700|NCT02059642|11793795|FG000|COMPLETED|Overall Study||121
10635701|NCT02059642|11793796|FG001|COMPLETED|Overall Study||128
10635702|NCT02059642|11793795|FG000|NOT COMPLETED|Overall Study||27
10635703|NCT02059642|11793796|FG001|NOT COMPLETED|Overall Study||24
10635704|NCT02059902|11793804|FG000|STARTED|Overall Study||18
10635705|NCT02059902|11793805|FG001|STARTED|Overall Study||18
10635706|NCT02059902|11793804|FG000|COMPLETED|Overall Study||14
10635707|NCT02059902|11793805|FG001|COMPLETED|Overall Study||14
10635708|NCT02059902|11793804|FG000|NOT COMPLETED|Overall Study||4
10635709|NCT02059902|11793805|FG001|NOT COMPLETED|Overall Study||4
10635710|NCT02059928|11793811|FG000|STARTED|Overall Study||20
10635711|NCT02059928|11793811|FG000|COMPLETED|Overall Study||20
10635712|NCT02059928|11793811|FG000|NOT COMPLETED|Overall Study||0
10635713|NCT02059980|11793817|FG000|STARTED|Overall Study||18
10635714|NCT02059980|11793818|FG001|STARTED|Overall Study||15
10635715|NCT02059980|11793817|FG000|COMPLETED|Overall Study||16
10635716|NCT02059980|11793818|FG001|COMPLETED|Overall Study||14
10635717|NCT02059980|11793817|FG000|NOT COMPLETED|Overall Study||2
10635718|NCT02059980|11793818|FG001|NOT COMPLETED|Overall Study||1
10635719|NCT02059993|11793826|FG000|STARTED|Overall Study||42
10635720|NCT02059993|11793827|FG001|STARTED|Overall Study||41
10635721|NCT02059993|11793826|FG000|COMPLETED|Overall Study||40
10635722|NCT02059993|11793827|FG001|COMPLETED|Overall Study||37
10635723|NCT02059993|11793826|FG000|NOT COMPLETED|Overall Study||2
10635724|NCT02059993|11793827|FG001|NOT COMPLETED|Overall Study||4
10635725|NCT02060058|11793836|FG000|STARTED|Overall Study||4
10635726|NCT02060058|11793837|FG001|STARTED|Overall Study||0
10635727|NCT02060058|11793838|FG002|STARTED|Overall Study||8
10635728|NCT02060058|11793836|FG000|COMPLETED|Overall Study||4
10635729|NCT02060058|11793837|FG001|COMPLETED|Overall Study||0
10635730|NCT02060058|11793838|FG002|COMPLETED|Overall Study||8
10635731|NCT02060058|11793836|FG000|NOT COMPLETED|Overall Study||0
10635732|NCT02060058|11793837|FG001|NOT COMPLETED|Overall Study||0
10635733|NCT02060058|11793838|FG002|NOT COMPLETED|Overall Study||0
10635734|NCT02060370|11793847|FG000|STARTED|Overall Study||60
10635735|NCT02060370|11793847|FG000|COMPLETED|Overall Study||59
10635736|NCT02060370|11793847|FG000|NOT COMPLETED|Overall Study||1
10635737|NCT02060383|11793856|FG000|STARTED|Core Phase||38
10635738|NCT02060383|11793857|FG001|STARTED|Core Phase||43
10635739|NCT02060383|11793858|FG002|STARTED|Core Phase||19
10635740|NCT02060383|11793859|FG003|STARTED|Core Phase||46
10635741|NCT02060383|11793860|FG004|STARTED|Core Phase||103
10635742|NCT02060383|11793856|FG000|Completed Core/Entered Extension|Core Phase||17
10635743|NCT02060383|11793857|FG001|Completed Core/Entered Extension|Core Phase||17
10635744|NCT02060383|11793858|FG002|Completed Core/Entered Extension|Core Phase||10
10635745|NCT02060383|11793859|FG003|Completed Core/Entered Extension|Core Phase||21
10635746|NCT02060383|11793860|FG004|Completed Core/Entered Extension|Core Phase||53
10635747|NCT02060383|11793856|FG000|Completed Core/Did Not Enter Extension|Core Phase||18
10635748|NCT02060383|11793857|FG001|Completed Core/Did Not Enter Extension|Core Phase||20
10635749|NCT02060383|11793858|FG002|Completed Core/Did Not Enter Extension|Core Phase||9
10635750|NCT02060383|11793859|FG003|Completed Core/Did Not Enter Extension|Core Phase||18
10635751|NCT02060383|11793860|FG004|Completed Core/Did Not Enter Extension|Core Phase||42
10635752|NCT02060383|11793856|FG000|COMPLETED|Core Phase||35
10635753|NCT02060383|11793857|FG001|COMPLETED|Core Phase||37
10635754|NCT02060383|11793858|FG002|COMPLETED|Core Phase||19
10635755|NCT02060383|11793859|FG003|COMPLETED|Core Phase||39
10635756|NCT02060383|11793860|FG004|COMPLETED|Core Phase||95
10635757|NCT02060383|11793856|FG000|NOT COMPLETED|Core Phase||3
10635758|NCT02060383|11793857|FG001|NOT COMPLETED|Core Phase||6
10635759|NCT02060383|11793858|FG002|NOT COMPLETED|Core Phase||0
10635760|NCT02060383|11793859|FG003|NOT COMPLETED|Core Phase||7
10635761|NCT02060383|11793860|FG004|NOT COMPLETED|Core Phase||8
10635762|NCT02060383|11793856|FG000|STARTED|Extension Phase||17
10635763|NCT02060383|11793857|FG001|STARTED|Extension Phase||17
10635764|NCT02060383|11793858|FG002|STARTED|Extension Phase||10
10635765|NCT02060383|11793859|FG003|STARTED|Extension Phase||21
10635766|NCT02060383|11793860|FG004|STARTED|Extension Phase||53
10635767|NCT02060383|11793856|FG000|COMPLETED|Extension Phase||14
10635768|NCT02060383|11793857|FG001|COMPLETED|Extension Phase||14
10635769|NCT02060383|11793858|FG002|COMPLETED|Extension Phase||7
10635770|NCT02060383|11793859|FG003|COMPLETED|Extension Phase||19
10635771|NCT02060383|11793860|FG004|COMPLETED|Extension Phase||46
10635772|NCT02060383|11793856|FG000|NOT COMPLETED|Extension Phase||3
10635773|NCT02060383|11793857|FG001|NOT COMPLETED|Extension Phase||3
10635774|NCT02060383|11793858|FG002|NOT COMPLETED|Extension Phase||3
10635775|NCT02060383|11793859|FG003|NOT COMPLETED|Extension Phase||2
10635776|NCT02060383|11793860|FG004|NOT COMPLETED|Extension Phase||7
10635777|NCT02060461|11793872|FG000|STARTED|Overall Study||33
10635778|NCT02060461|11793872|FG000|COMPLETED|Overall Study||33
10635779|NCT02060461|11793872|FG000|NOT COMPLETED|Overall Study||0
10635780|NCT02060526|11793881|FG000|STARTED|Overall Study||7
10635781|NCT02060526|11793882|FG001|STARTED|Overall Study||7
10635782|NCT02060526|11793883|FG002|STARTED|Overall Study||7
10635783|NCT02060526|11793881|FG000|COMPLETED|Overall Study||7
10635784|NCT02060526|11793882|FG001|COMPLETED|Overall Study||7
10635785|NCT02060526|11793883|FG002|COMPLETED|Overall Study||7
10635786|NCT02060526|11793881|FG000|NOT COMPLETED|Overall Study||0
10635787|NCT02060526|11793882|FG001|NOT COMPLETED|Overall Study||0
10635788|NCT02060526|11793883|FG002|NOT COMPLETED|Overall Study||0
10635789|NCT02060539|11793893|FG000|STARTED|Overall Study||19
10635790|NCT02060539|11793893|FG000|COMPLETED|Overall Study||19
10635791|NCT02060539|11793893|FG000|NOT COMPLETED|Overall Study||0
10635792|NCT02060838|11793899|FG000|STARTED|Overall Study||28
10635793|NCT02060838|11793900|FG001|STARTED|Overall Study||22
10635794|NCT02060838|11793899|FG000|COMPLETED|Overall Study||28
10635795|NCT02060838|11793900|FG001|COMPLETED|Overall Study||22
10635796|NCT02060838|11793899|FG000|NOT COMPLETED|Overall Study||0
10635797|NCT02060838|11793900|FG001|NOT COMPLETED|Overall Study||0
10635798|NCT02060890|11793906|FG000|STARTED|Overall Study||20
10635799|NCT02060890|11793906|FG000|COMPLETED|Overall Study||16
10635800|NCT02060890|11793906|FG000|NOT COMPLETED|Overall Study||4
10635801|NCT02060903|11793913|FG000|STARTED|Overall Study||187
10635802|NCT02060903|11793914|FG001|STARTED|Overall Study||192
10635803|NCT02060903|11793913|FG000|COMPLETED|Overall Study||183
10635804|NCT02060903|11793914|FG001|COMPLETED|Overall Study||185
10635805|NCT02060903|11793913|FG000|NOT COMPLETED|Overall Study||4
10635806|NCT02060903|11793914|FG001|NOT COMPLETED|Overall Study||7
10635807|NCT02061202|11793922|FG000|STARTED|Overall Study||36
10635808|NCT02061202|11793923|FG001|STARTED|Overall Study||18
10635809|NCT02061202|11793922|FG000|COMPLETED|Overall Study||35
10635810|NCT02061202|11793923|FG001|COMPLETED|Overall Study||17
10635811|NCT02061202|11793922|FG000|NOT COMPLETED|Overall Study||1
10635812|NCT02061202|11793923|FG001|NOT COMPLETED|Overall Study||1
10635813|NCT02061280|11793931|FG000|STARTED|Overall Study||71
10635814|NCT02061280|11793932|FG001|STARTED|Overall Study||37
10635815|NCT02061280|11793931|FG000|Randomized to Treatment|Overall Study||54
10635816|NCT02061280|11793932|FG001|Randomized to Treatment|Overall Study||25
10635817|NCT02061280|11793931|FG000|COMPLETED|Overall Study||53
10635818|NCT02061280|11793932|FG001|COMPLETED|Overall Study||25
10635819|NCT02061280|11793931|FG000|NOT COMPLETED|Overall Study||18
10635820|NCT02061280|11793932|FG001|NOT COMPLETED|Overall Study||12
10635848|NCT02061384|11793980|FG000|STARTED|Overall Study||10
10635849|NCT02061384|11793981|FG001|STARTED|Overall Study||10
10635850|NCT02061384|11793980|FG000|COMPLETED|Overall Study||10
10635851|NCT02061384|11793981|FG001|COMPLETED|Overall Study||10
10635852|NCT02061384|11793980|FG000|NOT COMPLETED|Overall Study||0
10635853|NCT02061384|11793981|FG001|NOT COMPLETED|Overall Study||0
10635854|NCT02061397|11793987|FG000|STARTED|Simvastatin 20 mg Oral Daily for 2 Month||10
10635855|NCT02061397|11793987|FG000|COMPLETED|Simvastatin 20 mg Oral Daily for 2 Month||10
10635856|NCT02061397|11793987|FG000|NOT COMPLETED|Simvastatin 20 mg Oral Daily for 2 Month||0
10635857|NCT02061397|11793987|FG000|STARTED|Simvastatin 40 mg Oral Daily for 2 Month||10
10635858|NCT02061397|11793987|FG000|COMPLETED|Simvastatin 40 mg Oral Daily for 2 Month||10
10635859|NCT02061397|11793987|FG000|NOT COMPLETED|Simvastatin 40 mg Oral Daily for 2 Month||0
10635860|NCT02061540|11793991|FG000|STARTED|Overall Study||27
10635861|NCT02061540|11793991|FG000|Down-Titrated on LUM001 During the Study|Overall Study||5
10635862|NCT02061540|11793991|FG000|COMPLETED|Overall Study||23
10635863|NCT02061540|11793991|FG000|NOT COMPLETED|Overall Study||4
10635864|NCT02061592|11794002|FG000|STARTED|Period 1||66
10635865|NCT02061592|11794003|FG001|STARTED|Period 1||62
10635866|NCT02061592|11794002|FG000|COMPLETED|Period 1||64
10635867|NCT02061592|11794003|FG001|COMPLETED|Period 1||62
10635868|NCT02061592|11794002|FG000|NOT COMPLETED|Period 1||2
10635869|NCT02061592|11794003|FG001|NOT COMPLETED|Period 1||0
10635870|NCT02061592|11794002|FG000|STARTED|Period 2||64
10635871|NCT02061592|11794003|FG001|STARTED|Period 2||62
10635872|NCT02061592|11794002|FG000|COMPLETED|Period 2||64
10635873|NCT02061592|11794003|FG001|COMPLETED|Period 2||61
10635874|NCT02061592|11794002|FG000|NOT COMPLETED|Period 2||0
10635875|NCT02061592|11794003|FG001|NOT COMPLETED|Period 2||1
10635876|NCT02061683|11794011|FG000|STARTED|Overall Study||263
10635877|NCT02061683|11794011|FG000|COMPLETED|Overall Study||203
10635878|NCT02061683|11794011|FG000|NOT COMPLETED|Overall Study||60
10635879|NCT02061696|11794017|FG000|STARTED|Overall Study||17
10635880|NCT02061696|11794018|FG001|STARTED|Overall Study||22
10635881|NCT02061696|11794017|FG000|COMPLETED|Overall Study||17
10635882|NCT02061696|11794018|FG001|COMPLETED|Overall Study||22
10635883|NCT02061696|11794017|FG000|NOT COMPLETED|Overall Study||0
10635884|NCT02061696|11794018|FG001|NOT COMPLETED|Overall Study||0
10653925|NCT02197377|11814567|FG001|STARTED|Overall Study||30
10653926|NCT02197377|11814566|FG000|COMPLETED|Overall Study||30
10653927|NCT02197377|11814567|FG001|COMPLETED|Overall Study||27
10653928|NCT02197377|11814566|FG000|NOT COMPLETED|Overall Study||0
10653929|NCT02197377|11814567|FG001|NOT COMPLETED|Overall Study||3
10653930|NCT02197416|11814576|FG000|STARTED|Overall Study||9
10653931|NCT02197416|11814577|FG001|STARTED|Overall Study||43
10653932|NCT02197416|11814578|FG002|STARTED|Overall Study||161
10653933|NCT02197416|11814576|FG000|COMPLETED|Overall Study||8
10653934|NCT02197416|11814577|FG001|COMPLETED|Overall Study||39
10653935|NCT02197416|11814578|FG002|COMPLETED|Overall Study||153
10653936|NCT02197416|11814576|FG000|NOT COMPLETED|Overall Study||1
10653937|NCT02197416|11814577|FG001|NOT COMPLETED|Overall Study||4
10653938|NCT02197416|11814578|FG002|NOT COMPLETED|Overall Study||8
10653939|NCT02197455|11814584|FG000|STARTED|Overall Study||30
10653940|NCT02197455|11814584|FG000|COMPLETED|Overall Study||30
10653941|NCT02197455|11814584|FG000|NOT COMPLETED|Overall Study||0
10653942|NCT02197481|11814590|FG000|STARTED|Overall Study|October 2014|43
10635885|NCT02061748|11794026|FG000|STARTED|Overall Study||7646
10635886|NCT02061748|11794027|FG001|STARTED|Overall Study||30853
10635887|NCT02061748|11794026|FG000|COMPLETED|Overall Study||7646
10635888|NCT02061748|11794027|FG001|COMPLETED|Overall Study||30853
10635889|NCT02061748|11794026|FG000|NOT COMPLETED|Overall Study||0
10635890|NCT02061748|11794027|FG001|NOT COMPLETED|Overall Study||0
10635891|NCT02061774|11794035|FG000|STARTED|Overall Study||10
10635892|NCT02061774|11794036|FG001|STARTED|Overall Study||11
10635893|NCT02061774|11794035|FG000|COMPLETED|Overall Study||10
10635894|NCT02061774|11794036|FG001|COMPLETED|Overall Study||11
10635895|NCT02061774|11794035|FG000|NOT COMPLETED|Overall Study||0
10635896|NCT02061774|11794036|FG001|NOT COMPLETED|Overall Study||0
10635897|NCT02061813|11794042|FG000|STARTED|Overall Study||40
10635898|NCT02061813|11794042|FG000|Abametapir Lotion|Overall Study||40
10635899|NCT02061813|11794042|FG000|Vehicle Lotion|Overall Study||40
10635900|NCT02061813|11794042|FG000|Saline 0.9%|Overall Study||40
10635901|NCT02061813|11794042|FG000|SLS 0.2%|Overall Study||40
10635902|NCT02061813|11794042|FG000|COMPLETED|Overall Study||37
10635903|NCT02061813|11794042|FG000|NOT COMPLETED|Overall Study||3
10635904|NCT02061969|11794051|FG000|STARTED|Overall Study||73
10635905|NCT02061969|11794052|FG001|STARTED|Overall Study||67
10635906|NCT02061969|11794051|FG000|COMPLETED|Overall Study||73
10635907|NCT02061969|11794052|FG001|COMPLETED|Overall Study||67
10635908|NCT02061969|11794051|FG000|NOT COMPLETED|Overall Study||0
10635909|NCT02061969|11794052|FG001|NOT COMPLETED|Overall Study||0
10635910|NCT02062008|11794058|FG000|STARTED|Overall Study||2
10635911|NCT02062008|11794058|FG000|COMPLETED|Overall Study||2
10635912|NCT02062008|11794058|FG000|NOT COMPLETED|Overall Study||0
10635913|NCT02062151|11794062|FG000|STARTED|Overall Study||21
10635914|NCT02062151|11794062|FG000|COMPLETED|Overall Study||20
10635915|NCT02062151|11794062|FG000|NOT COMPLETED|Overall Study||1
10635916|NCT02062177|11794068|FG000|STARTED|Overall Study||70
10635917|NCT02062177|11794069|FG001|STARTED|Overall Study||70
10635918|NCT02062177|11794068|FG000|COMPLETED|Overall Study||70
10635919|NCT02062177|11794069|FG001|COMPLETED|Overall Study||70
10635920|NCT02062177|11794068|FG000|NOT COMPLETED|Overall Study||0
10635921|NCT02062177|11794069|FG001|NOT COMPLETED|Overall Study||0
10635922|NCT02062294|11794075|FG000|STARTED|Overall Study||14
10635923|NCT02062294|11794075|FG000|COMPLETED|Overall Study||14
10635924|NCT02062294|11794075|FG000|NOT COMPLETED|Overall Study||0
10635925|NCT02062359|11794079|FG000|STARTED|Overall Study||2
10635926|NCT02062359|11794079|FG000|COMPLETED|Overall Study||2
10635927|NCT02062359|11794079|FG000|NOT COMPLETED|Overall Study||0
10635928|NCT02062385|11794087|FG000|STARTED|Overall Study||1620
10635929|NCT02062385|11794088|FG001|STARTED|Overall Study||1620
10635930|NCT02062385|11794089|FG002|STARTED|Overall Study||400
10635931|NCT02062385|11794090|FG003|STARTED|Overall Study||400
10635932|NCT02062385|11794087|FG000|Received Vaccination 1|Overall Study||1618
10635933|NCT02062385|11794088|FG001|Received Vaccination 1|Overall Study||1619
10635934|NCT02062385|11794089|FG002|Received Vaccination 1|Overall Study||400
10635935|NCT02062385|11794090|FG003|Received Vaccination 1|Overall Study||400
10635936|NCT02062385|11794087|FG000|Received Vaccination 2|Overall Study||1554
10635937|NCT02062385|11794088|FG001|Received Vaccination 2|Overall Study||1566
10635938|NCT02062385|11794089|FG002|Received Vaccination 2|Overall Study||392
10635939|NCT02062385|11794090|FG003|Received Vaccination 2|Overall Study||393
10635940|NCT02062385|11794087|FG000|Received Vaccination 3|Overall Study||1543
10635941|NCT02062385|11794088|FG001|Received Vaccination 3|Overall Study||1554
10705797|NCT02603172|11870303|FG007|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
10705798|NCT02603172|11870296|FG000|STARTED|Part B (Approximately 7 Weeks)||0
10705799|NCT02603172|11870297|FG001|STARTED|Part B (Approximately 7 Weeks)||1
10635942|NCT02062385|11794089|FG002|Received Vaccination 3|Overall Study||389
10635943|NCT02062385|11794090|FG003|Received Vaccination 3|Overall Study||392
10635944|NCT02062385|11794087|FG000|COMPLETED|Overall Study||1542
10635945|NCT02062385|11794088|FG001|COMPLETED|Overall Study||1555
10635946|NCT02062385|11794089|FG002|COMPLETED|Overall Study||388
10635947|NCT02062385|11794090|FG003|COMPLETED|Overall Study||391
10635948|NCT02062385|11794087|FG000|NOT COMPLETED|Overall Study||78
10635949|NCT02062385|11794088|FG001|NOT COMPLETED|Overall Study||65
10635950|NCT02062385|11794089|FG002|NOT COMPLETED|Overall Study||12
10635951|NCT02062385|11794090|FG003|NOT COMPLETED|Overall Study||9
10635952|NCT02062398|11794098|FG000|STARTED|Overall Study||13
10635953|NCT02062398|11794098|FG000|COMPLETED|Overall Study||12
10705800|NCT02603172|11870298|FG002|STARTED|Part B (Approximately 7 Weeks)||0
10635954|NCT02062398|11794098|FG000|NOT COMPLETED|Overall Study||1
10635955|NCT02062437|11794102|FG000|STARTED|Overall Study|132 patients who undergone THR (July-Oct 2010), complying with in/exclusion criteria were identified|132
10635956|NCT02062437|11794102|FG000|COMPLETED|Overall Study|80 patients were effectively enrolled, when coming back for their 2-year follow-up visit.|80
10635957|NCT02062437|11794102|FG000|NOT COMPLETED|Overall Study||52
10635958|NCT02062450|11794108|FG000|STARTED|Overall Study|379 patients were successfully reached by phone and convoked for the 2-year follow-up visit.|379
10635959|NCT02062450|11794108|FG000|Per Protocol Cohort|Overall Study|255 patients attended their 2-year follow-up visit.|255
10635960|NCT02062450|11794108|FG000|COMPLETED|Overall Study||255
10635961|NCT02062450|11794108|FG000|NOT COMPLETED|Overall Study||124
10635962|NCT02062502|11794118|FG000|STARTED|Overall Study||306
10635963|NCT02062502|11794119|FG001|STARTED|Overall Study||305
10635964|NCT02062502|11794118|FG000|Vaccinated Dose 1|Overall Study||306
10635965|NCT02062502|11794119|FG001|Vaccinated Dose 1|Overall Study||305
10635966|NCT02062502|11794118|FG000|COMPLETED|Overall Study||263
10635967|NCT02062502|11794119|FG001|COMPLETED|Overall Study||270
10635968|NCT02062502|11794118|FG000|NOT COMPLETED|Overall Study||43
10635969|NCT02062502|11794119|FG001|NOT COMPLETED|Overall Study||35
10635970|NCT02062580|11794127|FG000|STARTED|Overall Study||71
10635971|NCT02062580|11794128|FG001|STARTED|Overall Study||78
10635972|NCT02062580|11794127|FG000|COMPLETED|Overall Study||59
10635973|NCT02062580|11794128|FG001|COMPLETED|Overall Study||65
10635974|NCT02062580|11794127|FG000|NOT COMPLETED|Overall Study||12
10635975|NCT02062580|11794128|FG001|NOT COMPLETED|Overall Study||13
10635976|NCT02062593|11794136|FG000|STARTED|Overall Study||105
10635977|NCT02062593|11794137|FG001|STARTED|Overall Study||95
10635978|NCT02062593|11794136|FG000|COMPLETED|Overall Study||105
10635979|NCT02062593|11794137|FG001|COMPLETED|Overall Study||91
10635980|NCT02062593|11794136|FG000|NOT COMPLETED|Overall Study||0
10635981|NCT02062593|11794137|FG001|NOT COMPLETED|Overall Study||4
10635982|NCT02062606|11794143|FG000|STARTED|Overall Study||188
10635983|NCT02062606|11794143|FG000|COMPLETED|Overall Study||99
10635984|NCT02062606|11794143|FG000|NOT COMPLETED|Overall Study||89
10635985|NCT02062632|11794176|FG000|STARTED|Overall Study||3
10635986|NCT02062632|11794176|FG000|COMPLETED|Overall Study||2
10635987|NCT02062632|11794176|FG000|NOT COMPLETED|Overall Study||1
10635988|NCT02062645|11794180|FG000|STARTED|Overall Study||115
10635989|NCT02062645|11794180|FG000|COMPLETED|Overall Study||100
10635990|NCT02062645|11794180|FG000|NOT COMPLETED|Overall Study||15
10635991|NCT02062658|11794184|FG000|STARTED|Overall Study||10
10635992|NCT02062658|11794184|FG000|COMPLETED|Overall Study||8
10635993|NCT02062658|11794184|FG000|NOT COMPLETED|Overall Study||2
10635994|NCT02062710|11794188|FG000|STARTED|Overall Study|3 of total 22 subjects randomized to receive the 3 study drugs in this particular sequence|3
10635995|NCT02062710|11794189|FG001|STARTED|Overall Study|4 of the total 22 subjects randomized to receive the 3 study drugs in this particular sequence|4
10635996|NCT02062710|11794190|FG002|STARTED|Overall Study|5 of total of 22 subjects randomized to receive the 3 study drugs in this particular sequence|5
10635997|NCT02062710|11794191|FG003|STARTED|Overall Study|3 of 22 subjects randomized to receive the 3 study drugs in this particular sequence|3
10635998|NCT02062710|11794192|FG004|STARTED|Overall Study|3 of 22 subjects randomized to receive the 3 study drugs in this aprticular sequence|3
10635999|NCT02062710|11794193|FG005|STARTED|Overall Study|4 of 22 subjects randomized to receive the 3 study drugs in this particular sequence|4
10636000|NCT02062710|11794188|FG000|COMPLETED|Overall Study||3
10636001|NCT02062710|11794189|FG001|COMPLETED|Overall Study||4
10636002|NCT02062710|11794190|FG002|COMPLETED|Overall Study||5
10636003|NCT02062710|11794191|FG003|COMPLETED|Overall Study||3
10636004|NCT02062710|11794192|FG004|COMPLETED|Overall Study||3
10636005|NCT02062710|11794193|FG005|COMPLETED|Overall Study||4
10636006|NCT02062710|11794188|FG000|NOT COMPLETED|Overall Study||0
10636007|NCT02062710|11794189|FG001|NOT COMPLETED|Overall Study||0
10636008|NCT02062710|11794190|FG002|NOT COMPLETED|Overall Study||0
10636009|NCT02062710|11794191|FG003|NOT COMPLETED|Overall Study||0
10636010|NCT02062710|11794192|FG004|NOT COMPLETED|Overall Study||0
10636011|NCT02062710|11794193|FG005|NOT COMPLETED|Overall Study||0
10636012|NCT02062801|11794203|FG000|STARTED|Overall Study||301
10636013|NCT02062801|11794204|FG001|STARTED|Overall Study||301
10636014|NCT02062801|11794203|FG000|COMPLETED|Overall Study||299
10636015|NCT02062801|11794204|FG001|COMPLETED|Overall Study||297
10636016|NCT02062801|11794203|FG000|NOT COMPLETED|Overall Study||2
10636017|NCT02062801|11794204|FG001|NOT COMPLETED|Overall Study||4
10636018|NCT02062879|11794212|FG000|STARTED|Overall Study||10
10636019|NCT02062879|11794213|FG001|STARTED|Overall Study||10
10636020|NCT02062879|11794212|FG000|COMPLETED|Overall Study||6
10636021|NCT02062879|11794213|FG001|COMPLETED|Overall Study||9
10636022|NCT02062879|11794212|FG000|NOT COMPLETED|Overall Study||4
10636023|NCT02062879|11794213|FG001|NOT COMPLETED|Overall Study||1
10636024|NCT02062905|11794221|FG000|STARTED|Overall Study||35
10636025|NCT02062905|11794222|FG001|STARTED|Overall Study||33
10636026|NCT02062905|11794221|FG000|COMPLETED|Overall Study||28
10636027|NCT02062905|11794222|FG001|COMPLETED|Overall Study||31
10636028|NCT02062905|11794221|FG000|NOT COMPLETED|Overall Study||7
10636029|NCT02062905|11794222|FG001|NOT COMPLETED|Overall Study||2
10636030|NCT02063035|11794230|FG000|STARTED|Overall Study||12
10636031|NCT02063035|11794231|FG001|STARTED|Overall Study||17
10636032|NCT02063035|11794230|FG000|COMPLETED|Overall Study||12
10636033|NCT02063035|11794231|FG001|COMPLETED|Overall Study||17
10636034|NCT02063035|11794230|FG000|NOT COMPLETED|Overall Study||0
10636035|NCT02063035|11794231|FG001|NOT COMPLETED|Overall Study||0
10636036|NCT02063087|11794239|FG000|STARTED|Emergency Department Intervention||493
10636037|NCT02063087|11794240|FG001|STARTED|Emergency Department Intervention||478
10636038|NCT02063087|11794239|FG000|COMPLETED|Emergency Department Intervention||493
10636039|NCT02063087|11794240|FG001|COMPLETED|Emergency Department Intervention||478
10636040|NCT02063087|11794239|FG000|NOT COMPLETED|Emergency Department Intervention||0
10636041|NCT02063087|11794240|FG001|NOT COMPLETED|Emergency Department Intervention||0
10636042|NCT02063087|11794239|FG000|STARTED|7 Day Follow-up||493
10636043|NCT02063087|11794240|FG001|STARTED|7 Day Follow-up||478
10636044|NCT02063087|11794239|FG000|COMPLETED|7 Day Follow-up||493
10636045|NCT02063087|11794240|FG001|COMPLETED|7 Day Follow-up||478
10636046|NCT02063087|11794239|FG000|NOT COMPLETED|7 Day Follow-up||0
10636047|NCT02063087|11794240|FG001|NOT COMPLETED|7 Day Follow-up||0
10636048|NCT02063178|11794248|FG000|STARTED|Overall Study||124
10636049|NCT02063178|11794249|FG001|STARTED|Overall Study||124
10636050|NCT02063178|11794248|FG000|COMPLETED|Overall Study||95
10636051|NCT02063178|11794249|FG001|COMPLETED|Overall Study||77
10636052|NCT02063178|11794248|FG000|NOT COMPLETED|Overall Study||29
10636053|NCT02063178|11794249|FG001|NOT COMPLETED|Overall Study||47
10636054|NCT02063217|11794262|FG000|STARTED|Overall Study||12
10636055|NCT02063217|11794263|FG001|STARTED|Overall Study||12
10636056|NCT02063217|11794264|FG002|STARTED|Overall Study||12
10636057|NCT02063217|11794262|FG000|COMPLETED|Overall Study||11
10636058|NCT02063217|11794263|FG001|COMPLETED|Overall Study||12
10636059|NCT02063217|11794264|FG002|COMPLETED|Overall Study||12
10636060|NCT02063217|11794262|FG000|NOT COMPLETED|Overall Study||1
10636061|NCT02063217|11794263|FG001|NOT COMPLETED|Overall Study||0
10636062|NCT02063217|11794264|FG002|NOT COMPLETED|Overall Study||0
10636063|NCT02063230|11794276|FG000|STARTED|Overall Study||8
10636064|NCT02063230|11794277|FG001|STARTED|Overall Study||8
10636065|NCT02063230|11794278|FG002|STARTED|Overall Study||8
10636066|NCT02063230|11794279|FG003|STARTED|Overall Study||8
10636067|NCT02063230|11794276|FG000|Received Treatment|Overall Study||8
10636068|NCT02063230|11794277|FG001|Received Treatment|Overall Study||8
10636069|NCT02063230|11794278|FG002|Received Treatment|Overall Study||8
10636070|NCT02063230|11794279|FG003|Received Treatment|Overall Study||8
10636071|NCT02063230|11794276|FG000|COMPLETED|Overall Study||8
10636072|NCT02063230|11794277|FG001|COMPLETED|Overall Study||8
10636073|NCT02063230|11794278|FG002|COMPLETED|Overall Study||8
10636074|NCT02063230|11794279|FG003|COMPLETED|Overall Study||8
10636075|NCT02063230|11794276|FG000|NOT COMPLETED|Overall Study||0
10636076|NCT02063230|11794277|FG001|NOT COMPLETED|Overall Study||0
10636077|NCT02063230|11794278|FG002|NOT COMPLETED|Overall Study||0
10636078|NCT02063230|11794279|FG003|NOT COMPLETED|Overall Study||0
10636079|NCT02063516|11794291|FG000|STARTED|Overall Study||40
10636080|NCT02063516|11794292|FG001|STARTED|Overall Study||40
10636081|NCT02063516|11794291|FG000|COMPLETED|Overall Study||40
10636082|NCT02063516|11794292|FG001|COMPLETED|Overall Study||40
10636083|NCT02063516|11794291|FG000|NOT COMPLETED|Overall Study||0
10636084|NCT02063516|11794292|FG001|NOT COMPLETED|Overall Study||0
10636085|NCT02063659|11794301|FG000|STARTED|Double-Blind Treatment Period||26
10636086|NCT02063659|11794302|FG001|STARTED|Double-Blind Treatment Period||25
10636087|NCT02063659|11794303|FG002|STARTED|Double-Blind Treatment Period||25
10636088|NCT02063659|11794304|FG003|STARTED|Double-Blind Treatment Period||0
10636089|NCT02063659|11794301|FG000|COMPLETED|Double-Blind Treatment Period||24
10636090|NCT02063659|11794302|FG001|COMPLETED|Double-Blind Treatment Period||22
10636091|NCT02063659|11794303|FG002|COMPLETED|Double-Blind Treatment Period||22
10636092|NCT02063659|11794304|FG003|COMPLETED|Double-Blind Treatment Period||0
10636093|NCT02063659|11794301|FG000|NOT COMPLETED|Double-Blind Treatment Period||2
10636094|NCT02063659|11794302|FG001|NOT COMPLETED|Double-Blind Treatment Period||3
10636095|NCT02063659|11794303|FG002|NOT COMPLETED|Double-Blind Treatment Period||3
10636096|NCT02063659|11794304|FG003|NOT COMPLETED|Double-Blind Treatment Period||0
10636097|NCT02063659|11794301|FG000|STARTED|Open-Label Extension Period (OLE)||0
10636098|NCT02063659|11794302|FG001|STARTED|Open-Label Extension Period (OLE)||0
10636099|NCT02063659|11794303|FG002|STARTED|Open-Label Extension Period (OLE)||0
10636100|NCT02063659|11794304|FG003|STARTED|Open-Label Extension Period (OLE)||67
10636101|NCT02063659|11794301|FG000|COMPLETED|Open-Label Extension Period (OLE)||0
10636102|NCT02063659|11794302|FG001|COMPLETED|Open-Label Extension Period (OLE)||0
10636103|NCT02063659|11794303|FG002|COMPLETED|Open-Label Extension Period (OLE)||0
10636104|NCT02063659|11794304|FG003|COMPLETED|Open-Label Extension Period (OLE)||47
10636105|NCT02063659|11794301|FG000|NOT COMPLETED|Open-Label Extension Period (OLE)||0
10636106|NCT02063659|11794302|FG001|NOT COMPLETED|Open-Label Extension Period (OLE)||0
10636107|NCT02063659|11794303|FG002|NOT COMPLETED|Open-Label Extension Period (OLE)||0
10636108|NCT02063659|11794304|FG003|NOT COMPLETED|Open-Label Extension Period (OLE)||20
10636109|NCT02063672|11794320|FG000|STARTED|Overall Study||53
10636110|NCT02063672|11794321|FG001|STARTED|Overall Study||29
10636111|NCT02063672|11794320|FG000|COMPLETED|Overall Study||18
10636112|NCT02063672|11794321|FG001|COMPLETED|Overall Study||7
10636113|NCT02063672|11794320|FG000|NOT COMPLETED|Overall Study||35
10636114|NCT02063672|11794321|FG001|NOT COMPLETED|Overall Study||22
10636115|NCT02063698|11794329|FG000|STARTED|Overall Study||15
10636116|NCT02063698|11794330|FG001|STARTED|Overall Study||15
10636117|NCT02063698|11794329|FG000|COMPLETED|Overall Study||14
10636118|NCT02063698|11794330|FG001|COMPLETED|Overall Study||13
10636119|NCT02063698|11794329|FG000|NOT COMPLETED|Overall Study||1
10636120|NCT02063698|11794330|FG001|NOT COMPLETED|Overall Study||2
10636121|NCT02063737|11794338|FG000|STARTED|Overall Study||52
10636122|NCT02063737|11794339|FG001|STARTED|Overall Study||48
10636123|NCT02063737|11794338|FG000|COMPLETED|Overall Study||41
10636124|NCT02063737|11794339|FG001|COMPLETED|Overall Study||44
10636125|NCT02063737|11794338|FG000|NOT COMPLETED|Overall Study||11
10636126|NCT02063737|11794339|FG001|NOT COMPLETED|Overall Study||4
10636127|NCT02063828|11794348|FG000|STARTED|Overall Study||14
10636128|NCT02063828|11794349|FG001|STARTED|Overall Study||14
10636129|NCT02063828|11794350|FG002|STARTED|Overall Study||18
10636130|NCT02063828|11794348|FG000|Week 6|Overall Study||11
10636131|NCT02063828|11794349|FG001|Week 6|Overall Study||9
10636132|NCT02063828|11794350|FG002|Week 6|Overall Study||14
10636133|NCT02063828|11794348|FG000|COMPLETED|Overall Study||10
10636134|NCT02063828|11794349|FG001|COMPLETED|Overall Study||8
10636135|NCT02063828|11794350|FG002|COMPLETED|Overall Study||14
10636136|NCT02063828|11794348|FG000|NOT COMPLETED|Overall Study||4
10636137|NCT02063828|11794349|FG001|NOT COMPLETED|Overall Study||6
10636138|NCT02063828|11794350|FG002|NOT COMPLETED|Overall Study||4
10636139|NCT02063854|11794365|FG000|STARTED|Overall Study||199
10636140|NCT02063854|11794366|FG001|STARTED|Overall Study||66
10636141|NCT02063854|11794367|FG002|STARTED|Overall Study||206
10636142|NCT02063854|11794368|FG003|STARTED|Overall Study||68
10636143|NCT02063854|11794369|FG004|STARTED|Overall Study||65
10636144|NCT02063854|11794370|FG005|STARTED|Overall Study||201
10636145|NCT02063854|11794371|FG006|STARTED|Overall Study||66
10636146|NCT02063854|11794365|FG000|Full Analysis Set: Received Study Drug|Overall Study||199
10636147|NCT02063854|11794366|FG001|Full Analysis Set: Received Study Drug|Overall Study||66
10636148|NCT02063854|11794367|FG002|Full Analysis Set: Received Study Drug|Overall Study||206
10636149|NCT02063854|11794368|FG003|Full Analysis Set: Received Study Drug|Overall Study||68
10636150|NCT02063854|11794369|FG004|Full Analysis Set: Received Study Drug|Overall Study||65
10636151|NCT02063854|11794370|FG005|Full Analysis Set: Received Study Drug|Overall Study||200
10636152|NCT02063854|11794371|FG006|Full Analysis Set: Received Study Drug|Overall Study||66
10636153|NCT02063854|11794365|FG000|COMPLETED|Overall Study||178
10636154|NCT02063854|11794366|FG001|COMPLETED|Overall Study||54
10636155|NCT02063854|11794367|FG002|COMPLETED|Overall Study||176
10636156|NCT02063854|11794368|FG003|COMPLETED|Overall Study||58
10636157|NCT02063854|11794369|FG004|COMPLETED|Overall Study||54
10636158|NCT02063854|11794370|FG005|COMPLETED|Overall Study||170
10636159|NCT02063854|11794371|FG006|COMPLETED|Overall Study||60
10636160|NCT02063854|11794365|FG000|NOT COMPLETED|Overall Study||21
10636161|NCT02063854|11794366|FG001|NOT COMPLETED|Overall Study||12
10636162|NCT02063854|11794367|FG002|NOT COMPLETED|Overall Study||30
10636163|NCT02063854|11794368|FG003|NOT COMPLETED|Overall Study||10
10636164|NCT02063854|11794369|FG004|NOT COMPLETED|Overall Study||11
10636165|NCT02063854|11794370|FG005|NOT COMPLETED|Overall Study||31
10636166|NCT02063854|11794371|FG006|NOT COMPLETED|Overall Study||6
10636167|NCT02063867|11794391|FG000|STARTED|Overall Study||156889
10636168|NCT02063867|11794392|FG001|STARTED|Overall Study||183013
10636169|NCT02063867|11794391|FG000|COMPLETED|Overall Study||152598
10636170|NCT02063867|11794392|FG001|COMPLETED|Overall Study||180048
10636171|NCT02063867|11794391|FG000|NOT COMPLETED|Overall Study||4291
10636172|NCT02063867|11794392|FG001|NOT COMPLETED|Overall Study||2965
10636173|NCT02063880|11794400|FG000|STARTED|Overall Study||90
10636174|NCT02063880|11794401|FG001|STARTED|Overall Study||93
10636175|NCT02063880|11794400|FG000|COMPLETED|Overall Study||62
10636176|NCT02063880|11794401|FG001|COMPLETED|Overall Study||66
10636177|NCT02063880|11794400|FG000|NOT COMPLETED|Overall Study||28
10636178|NCT02063880|11794401|FG001|NOT COMPLETED|Overall Study||27
10636179|NCT02063984|11794409|FG000|STARTED|Overall Study||29
10636180|NCT02063984|11794410|FG001|STARTED|Overall Study||30
10636181|NCT02063984|11794409|FG000|COMPLETED|Overall Study||23
10636182|NCT02063984|11794410|FG001|COMPLETED|Overall Study||25
10636183|NCT02063984|11794409|FG000|NOT COMPLETED|Overall Study||6
10636184|NCT02063984|11794410|FG001|NOT COMPLETED|Overall Study||5
10636185|NCT02064166|11794422|FG000|STARTED|Overall Study||9
10636186|NCT02064166|11794423|FG001|STARTED|Overall Study||6
10636187|NCT02064166|11794422|FG000|COMPLETED|Overall Study||8
10636188|NCT02064166|11794423|FG001|COMPLETED|Overall Study||6
10636189|NCT02064166|11794422|FG000|NOT COMPLETED|Overall Study||1
10705801|NCT02603172|11870299|FG003|STARTED|Part B (Approximately 7 Weeks)||1
10705802|NCT02603172|11870300|FG004|STARTED|Part B (Approximately 7 Weeks)||6
10705803|NCT02603172|11870301|FG005|STARTED|Part B (Approximately 7 Weeks)||0
10705804|NCT02603172|11870302|FG006|STARTED|Part B (Approximately 7 Weeks)||0
10705805|NCT02603172|11870303|FG007|STARTED|Part B (Approximately 7 Weeks)||0
10636190|NCT02064166|11794423|FG001|NOT COMPLETED|Overall Study||0
10636191|NCT02064205|11794451|FG000|STARTED|Overall Study||32
10636192|NCT02064205|11794451|FG000|Condition A|Overall Study||32
10636193|NCT02064205|11794451|FG000|Condition B|Overall Study||32
10636194|NCT02064205|11794451|FG000|Condition C|Overall Study||31
10636195|NCT02064205|11794451|FG000|Condition D|Overall Study||32
10636196|NCT02064205|11794451|FG000|COMPLETED|Overall Study||31
10636197|NCT02064205|11794451|FG000|NOT COMPLETED|Overall Study||1
10636198|NCT02064231|11794467|FG000|STARTED|First Test Period (Test A or Test C)||14
10636199|NCT02064231|11794468|FG001|STARTED|First Test Period (Test A or Test C)||12
10636200|NCT02064231|11794469|FG002|STARTED|First Test Period (Test A or Test C)||1
10636201|NCT02064231|11794470|FG003|STARTED|First Test Period (Test A or Test C)||1
10636202|NCT02064231|11794467|FG000|COMPLETED|First Test Period (Test A or Test C)||7
10636203|NCT02064231|11794468|FG001|COMPLETED|First Test Period (Test A or Test C)||8
10636204|NCT02064231|11794469|FG002|COMPLETED|First Test Period (Test A or Test C)||0
10636205|NCT02064231|11794470|FG003|COMPLETED|First Test Period (Test A or Test C)||1
10636206|NCT02064231|11794467|FG000|NOT COMPLETED|First Test Period (Test A or Test C)||7
10636207|NCT02064231|11794468|FG001|NOT COMPLETED|First Test Period (Test A or Test C)||4
10636208|NCT02064231|11794469|FG002|NOT COMPLETED|First Test Period (Test A or Test C)||1
10636209|NCT02064231|11794470|FG003|NOT COMPLETED|First Test Period (Test A or Test C)||0
10636210|NCT02064231|11794467|FG000|STARTED|Second Test Period (Test B or Test D)||7
10636211|NCT02064231|11794468|FG001|STARTED|Second Test Period (Test B or Test D)||8
10636212|NCT02064231|11794469|FG002|STARTED|Second Test Period (Test B or Test D)||0
10636213|NCT02064231|11794470|FG003|STARTED|Second Test Period (Test B or Test D)||1
10636214|NCT02064231|11794467|FG000|COMPLETED|Second Test Period (Test B or Test D)||6
10705806|NCT02603172|11870296|FG000|COMPLETED|Part B (Approximately 7 Weeks)||0
10705807|NCT02603172|11870297|FG001|COMPLETED|Part B (Approximately 7 Weeks)||1
10636215|NCT02064231|11794468|FG001|COMPLETED|Second Test Period (Test B or Test D)||7
10636216|NCT02064231|11794469|FG002|COMPLETED|Second Test Period (Test B or Test D)||0
10636217|NCT02064231|11794470|FG003|COMPLETED|Second Test Period (Test B or Test D)||1
10636218|NCT02064231|11794467|FG000|NOT COMPLETED|Second Test Period (Test B or Test D)||1
10636219|NCT02064231|11794468|FG001|NOT COMPLETED|Second Test Period (Test B or Test D)||1
10636220|NCT02064231|11794469|FG002|NOT COMPLETED|Second Test Period (Test B or Test D)||0
10636221|NCT02064231|11794470|FG003|NOT COMPLETED|Second Test Period (Test B or Test D)||0
10636222|NCT02064231|11794467|FG000|STARTED|Third Test Period (Own Product)|One subject who discontinued testing Test A proceeded to test Own product afterwards.|8
10636223|NCT02064231|11794468|FG001|STARTED|Third Test Period (Own Product)|One subject who discontinued testing Test C proceeded to test Own product afterwards|8
10636224|NCT02064231|11794469|FG002|STARTED|Third Test Period (Own Product)||0
10636225|NCT02064231|11794470|FG003|STARTED|Third Test Period (Own Product)||1
10636226|NCT02064231|11794467|FG000|COMPLETED|Third Test Period (Own Product)||8
10636227|NCT02064231|11794468|FG001|COMPLETED|Third Test Period (Own Product)||8
10636228|NCT02064231|11794469|FG002|COMPLETED|Third Test Period (Own Product)||0
10636229|NCT02064231|11794470|FG003|COMPLETED|Third Test Period (Own Product)||1
10636230|NCT02064231|11794467|FG000|NOT COMPLETED|Third Test Period (Own Product)||0
10636231|NCT02064231|11794468|FG001|NOT COMPLETED|Third Test Period (Own Product)||0
10636232|NCT02064231|11794469|FG002|NOT COMPLETED|Third Test Period (Own Product)||0
10636233|NCT02064231|11794470|FG003|NOT COMPLETED|Third Test Period (Own Product)||0
10636234|NCT02064270|11794484|FG000|STARTED|Overall Study||263
10636235|NCT02064270|11794485|FG001|STARTED|Overall Study||263
10636236|NCT02064270|11794484|FG000|COMPLETED|Overall Study||201
10636237|NCT02064270|11794485|FG001|COMPLETED|Overall Study||231
10636238|NCT02064270|11794484|FG000|NOT COMPLETED|Overall Study||62
10636239|NCT02064270|11794485|FG001|NOT COMPLETED|Overall Study||32
10636240|NCT02064439|11794494|FG000|STARTED|Overall Study|Full Analysis Set (FAS), randomized and received study medication|1127
10636241|NCT02064439|11794495|FG001|STARTED|Overall Study|FAS, randomized and received study medication|1107
10636242|NCT02064439|11794496|FG002|STARTED|Overall Study|FAS, randomized and received study medication|1131
10636243|NCT02064439|11794494|FG000|COMPLETED|Overall Study||984
10636244|NCT02064439|11794495|FG001|COMPLETED|Overall Study||969
10636245|NCT02064439|11794496|FG002|COMPLETED|Overall Study||949
10636246|NCT02064439|11794494|FG000|NOT COMPLETED|Overall Study||143
10636247|NCT02064439|11794495|FG001|NOT COMPLETED|Overall Study||138
10636248|NCT02064439|11794496|FG002|NOT COMPLETED|Overall Study||182
10636249|NCT02064582|11794504|FG000|STARTED|Overall Study||7
10636250|NCT02064582|11794504|FG000|COMPLETED|Overall Study||7
10636251|NCT02064582|11794504|FG000|NOT COMPLETED|Overall Study||0
10636252|NCT02064816|11794510|FG000|STARTED|Overall Study||104
10636253|NCT02064816|11794511|FG001|STARTED|Overall Study||96
10636254|NCT02064816|11794510|FG000|COMPLETED|Overall Study||96
10636255|NCT02064816|11794511|FG001|COMPLETED|Overall Study||88
10636256|NCT02064816|11794510|FG000|NOT COMPLETED|Overall Study||8
10636257|NCT02064816|11794511|FG001|NOT COMPLETED|Overall Study||8
10636258|NCT02064855|11794517|FG000|STARTED|Overall Study||108
10636259|NCT02064855|11794517|FG000|COMPLETED|Overall Study||53
10636260|NCT02064855|11794517|FG000|NOT COMPLETED|Overall Study||55
10636261|NCT02064868|11794566|FG000|STARTED|Overall Study||1756
10636262|NCT02064868|11794567|FG001|STARTED|Overall Study||894
10636263|NCT02064868|11794566|FG000|Full Analysis Set|Overall Study||1756
10636264|NCT02064868|11794567|FG001|Full Analysis Set|Overall Study||894
10636265|NCT02064868|11794566|FG000|Safety Set|Overall Study|The Safety Set includes one patient not randomized but treated with serelaxin|1729
10636266|NCT02064868|11794567|FG001|Safety Set|Overall Study||894
10636267|NCT02064868|11794566|FG000|Per Protocol Set|Overall Study||1155
10636268|NCT02064868|11794567|FG001|Per Protocol Set|Overall Study||627
10636269|NCT02064868|11794566|FG000|COMPLETED|Overall Study||1722
10636270|NCT02064868|11794567|FG001|COMPLETED|Overall Study||881
10636271|NCT02064868|11794566|FG000|NOT COMPLETED|Overall Study||34
10636272|NCT02064868|11794567|FG001|NOT COMPLETED|Overall Study||13
10636273|NCT02064894|11794576|FG000|STARTED|Overall Study|"Received allocated intervention (n=98)~Did not receive intervention (n=1)"|99
10636356|NCT02065245|11794638|FG005|COMPLETED|Infusion 2||6
10636274|NCT02064894|11794577|FG001|STARTED|Overall Study|"Received allocated intervention (n=198)~Did not receive allocated intervention (n=3)"|201
10636275|NCT02064894|11794578|FG002|STARTED|Overall Study|"Received allocated intervention (n=199)~Did not receive allocated intervention (n=2)"|201
10636276|NCT02064894|11794576|FG000|Available at T-60|Overall Study||91
10636277|NCT02064894|11794577|FG001|Available at T-60|Overall Study||188
10636278|NCT02064894|11794578|FG002|Available at T-60|Overall Study||177
10636279|NCT02064894|11794576|FG000|Avalaible at T-90|Overall Study||74
10636280|NCT02064894|11794577|FG001|Avalaible at T-90|Overall Study||134
10636281|NCT02064894|11794578|FG002|Avalaible at T-90|Overall Study||129
10636282|NCT02064894|11794576|FG000|COMPLETED|Overall Study||56
10636283|NCT02064894|11794577|FG001|COMPLETED|Overall Study||99
10636284|NCT02064894|11794578|FG002|COMPLETED|Overall Study||86
10636285|NCT02064894|11794576|FG000|NOT COMPLETED|Overall Study||43
10636286|NCT02064894|11794577|FG001|NOT COMPLETED|Overall Study||102
10636287|NCT02064894|11794578|FG002|NOT COMPLETED|Overall Study||115
10636288|NCT02064907|11794588|FG000|STARTED|Period 1||26
10636289|NCT02064907|11794589|FG001|STARTED|Period 1||26
10636290|NCT02064907|11794588|FG000|COMPLETED|Period 1||26
10636291|NCT02064907|11794589|FG001|COMPLETED|Period 1||26
10636292|NCT02064907|11794588|FG000|NOT COMPLETED|Period 1||0
10636293|NCT02064907|11794589|FG001|NOT COMPLETED|Period 1||0
10636294|NCT02064907|11794588|FG000|STARTED|Period 2||26
10636295|NCT02064907|11794589|FG001|STARTED|Period 2||26
10636296|NCT02064907|11794588|FG000|COMPLETED|Period 2||26
10636297|NCT02064907|11794589|FG001|COMPLETED|Period 2||26
10636298|NCT02064907|11794588|FG000|NOT COMPLETED|Period 2||0
10636299|NCT02064907|11794589|FG001|NOT COMPLETED|Period 2||0
10636300|NCT02064920|11794597|FG000|STARTED|Overall Study||6
10705808|NCT02603172|11870298|FG002|COMPLETED|Part B (Approximately 7 Weeks)||0
10705809|NCT02603172|11870299|FG003|COMPLETED|Part B (Approximately 7 Weeks)||1
10705810|NCT02603172|11870300|FG004|COMPLETED|Part B (Approximately 7 Weeks)||6
10705811|NCT02603172|11870301|FG005|COMPLETED|Part B (Approximately 7 Weeks)||0
10705812|NCT02603172|11870302|FG006|COMPLETED|Part B (Approximately 7 Weeks)||0
10705813|NCT02603172|11870303|FG007|COMPLETED|Part B (Approximately 7 Weeks)||0
10705814|NCT02603172|11870296|FG000|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
10705815|NCT02603172|11870297|FG001|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
10705816|NCT02603172|11870298|FG002|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
10636301|NCT02064920|11794598|FG001|STARTED|Overall Study||30
10636302|NCT02064920|11794597|FG000|Treated|Overall Study||6
10636303|NCT02064920|11794598|FG001|Treated|Overall Study|Two participants discontinued from study prior to treatment|28
10636304|NCT02064920|11794597|FG000|COMPLETED|Overall Study||5
10636305|NCT02064920|11794598|FG001|COMPLETED|Overall Study||21
10636306|NCT02064920|11794597|FG000|NOT COMPLETED|Overall Study||1
10636307|NCT02064920|11794598|FG001|NOT COMPLETED|Overall Study||9
10636308|NCT02064959|11794606|FG000|STARTED|Overall Study||16
10636309|NCT02064959|11794607|FG001|STARTED|Overall Study||16
10636310|NCT02064959|11794606|FG000|COMPLETED|Overall Study||16
10636311|NCT02064959|11794607|FG001|COMPLETED|Overall Study||16
10636312|NCT02064959|11794606|FG000|NOT COMPLETED|Overall Study||0
10636313|NCT02064959|11794607|FG001|NOT COMPLETED|Overall Study||0
10636314|NCT02064985|11794616|FG000|STARTED|Overall Study||12
10636315|NCT02064985|11794617|FG001|STARTED|Overall Study||12
10636316|NCT02064985|11794618|FG002|STARTED|Overall Study||12
10636317|NCT02064985|11794616|FG000|COMPLETED|Overall Study||12
10636318|NCT02064985|11794617|FG001|COMPLETED|Overall Study||12
10636319|NCT02064985|11794618|FG002|COMPLETED|Overall Study||12
10636320|NCT02064985|11794616|FG000|NOT COMPLETED|Overall Study||0
10636321|NCT02064985|11794617|FG001|NOT COMPLETED|Overall Study||0
10636322|NCT02064985|11794618|FG002|NOT COMPLETED|Overall Study||0
10636323|NCT02065245|11794633|FG000|STARTED|Infusion 1||5
10636324|NCT02065245|11794634|FG001|STARTED|Infusion 1||5
10636325|NCT02065245|11794635|FG002|STARTED|Infusion 1||5
10636326|NCT02065245|11794636|FG003|STARTED|Infusion 1||10
10636327|NCT02065245|11794637|FG004|STARTED|Infusion 1||10
10636328|NCT02065245|11794638|FG005|STARTED|Infusion 1||10
10636329|NCT02065245|11794639|FG006|STARTED|Infusion 1||20
10636330|NCT02065245|11794633|FG000|COMPLETED|Infusion 1||5
10636331|NCT02065245|11794634|FG001|COMPLETED|Infusion 1||5
10636332|NCT02065245|11794635|FG002|COMPLETED|Infusion 1||4
10636333|NCT02065245|11794636|FG003|COMPLETED|Infusion 1||10
10636334|NCT02065245|11794637|FG004|COMPLETED|Infusion 1||9
10636335|NCT02065245|11794638|FG005|COMPLETED|Infusion 1||10
10636336|NCT02065245|11794639|FG006|COMPLETED|Infusion 1||19
10636337|NCT02065245|11794633|FG000|NOT COMPLETED|Infusion 1||0
10636338|NCT02065245|11794634|FG001|NOT COMPLETED|Infusion 1||0
10636339|NCT02065245|11794635|FG002|NOT COMPLETED|Infusion 1||1
10636340|NCT02065245|11794636|FG003|NOT COMPLETED|Infusion 1||0
10636341|NCT02065245|11794637|FG004|NOT COMPLETED|Infusion 1||1
10636342|NCT02065245|11794638|FG005|NOT COMPLETED|Infusion 1||0
10636343|NCT02065245|11794639|FG006|NOT COMPLETED|Infusion 1||1
10636344|NCT02065245|11794633|FG000|STARTED|Infusion 2||5
10636345|NCT02065245|11794634|FG001|STARTED|Infusion 2||5
10636346|NCT02065245|11794635|FG002|STARTED|Infusion 2||2
10636347|NCT02065245|11794636|FG003|STARTED|Infusion 2||0
10636348|NCT02065245|11794637|FG004|STARTED|Infusion 2||0
10636349|NCT02065245|11794638|FG005|STARTED|Infusion 2||6
10636350|NCT02065245|11794639|FG006|STARTED|Infusion 2||12
10636351|NCT02065245|11794633|FG000|COMPLETED|Infusion 2||5
10636352|NCT02065245|11794634|FG001|COMPLETED|Infusion 2||5
10636353|NCT02065245|11794635|FG002|COMPLETED|Infusion 2||2
10636354|NCT02065245|11794636|FG003|COMPLETED|Infusion 2||0
10636355|NCT02065245|11794637|FG004|COMPLETED|Infusion 2||0
10636357|NCT02065245|11794639|FG006|COMPLETED|Infusion 2||11
10636358|NCT02065245|11794633|FG000|NOT COMPLETED|Infusion 2||0
10636359|NCT02065245|11794634|FG001|NOT COMPLETED|Infusion 2||0
10636360|NCT02065245|11794635|FG002|NOT COMPLETED|Infusion 2||0
10636361|NCT02065245|11794636|FG003|NOT COMPLETED|Infusion 2||0
10636362|NCT02065245|11794637|FG004|NOT COMPLETED|Infusion 2||0
10636363|NCT02065245|11794638|FG005|NOT COMPLETED|Infusion 2||0
10636364|NCT02065245|11794639|FG006|NOT COMPLETED|Infusion 2||1
10636365|NCT02065245|11794633|FG000|STARTED|Infusion 3||3
10636366|NCT02065245|11794634|FG001|STARTED|Infusion 3||5
10636367|NCT02065245|11794635|FG002|STARTED|Infusion 3||1
10636368|NCT02065245|11794636|FG003|STARTED|Infusion 3||0
10636369|NCT02065245|11794637|FG004|STARTED|Infusion 3||0
10636370|NCT02065245|11794638|FG005|STARTED|Infusion 3||0
10636371|NCT02065245|11794639|FG006|STARTED|Infusion 3||0
10636372|NCT02065245|11794633|FG000|COMPLETED|Infusion 3||2
10636373|NCT02065245|11794634|FG001|COMPLETED|Infusion 3||4
10636374|NCT02065245|11794635|FG002|COMPLETED|Infusion 3||1
10636375|NCT02065245|11794636|FG003|COMPLETED|Infusion 3||0
10636376|NCT02065245|11794637|FG004|COMPLETED|Infusion 3||0
10636377|NCT02065245|11794638|FG005|COMPLETED|Infusion 3||0
10636378|NCT02065245|11794639|FG006|COMPLETED|Infusion 3||0
10636379|NCT02065245|11794633|FG000|NOT COMPLETED|Infusion 3||1
10636380|NCT02065245|11794634|FG001|NOT COMPLETED|Infusion 3||1
10636381|NCT02065245|11794635|FG002|NOT COMPLETED|Infusion 3||0
10636382|NCT02065245|11794636|FG003|NOT COMPLETED|Infusion 3||0
10705817|NCT02603172|11870299|FG003|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
10636383|NCT02065245|11794637|FG004|NOT COMPLETED|Infusion 3||0
10636384|NCT02065245|11794638|FG005|NOT COMPLETED|Infusion 3||0
10636385|NCT02065245|11794639|FG006|NOT COMPLETED|Infusion 3||0
10636386|NCT02065245|11794633|FG000|STARTED|Infusion 4||1
10636387|NCT02065245|11794634|FG001|STARTED|Infusion 4||2
10636388|NCT02065245|11794635|FG002|STARTED|Infusion 4||1
10636389|NCT02065245|11794636|FG003|STARTED|Infusion 4||0
10636390|NCT02065245|11794637|FG004|STARTED|Infusion 4||0
10636391|NCT02065245|11794638|FG005|STARTED|Infusion 4||0
10636392|NCT02065245|11794639|FG006|STARTED|Infusion 4||0
10636393|NCT02065245|11794633|FG000|COMPLETED|Infusion 4||1
10636394|NCT02065245|11794634|FG001|COMPLETED|Infusion 4||2
10636395|NCT02065245|11794635|FG002|COMPLETED|Infusion 4||1
10636396|NCT02065245|11794636|FG003|COMPLETED|Infusion 4||0
10636397|NCT02065245|11794637|FG004|COMPLETED|Infusion 4||0
10636398|NCT02065245|11794638|FG005|COMPLETED|Infusion 4||0
10636399|NCT02065245|11794639|FG006|COMPLETED|Infusion 4||0
10636400|NCT02065245|11794633|FG000|NOT COMPLETED|Infusion 4||0
10636401|NCT02065245|11794634|FG001|NOT COMPLETED|Infusion 4||0
10636402|NCT02065245|11794635|FG002|NOT COMPLETED|Infusion 4||0
10636403|NCT02065245|11794636|FG003|NOT COMPLETED|Infusion 4||0
10636404|NCT02065245|11794637|FG004|NOT COMPLETED|Infusion 4||0
10636405|NCT02065245|11794638|FG005|NOT COMPLETED|Infusion 4||0
10636406|NCT02065245|11794639|FG006|NOT COMPLETED|Infusion 4||0
10636407|NCT02065336|11794663|FG000|STARTED|Main Study||6
10636408|NCT02065336|11794664|FG001|STARTED|Main Study||6
10636409|NCT02065336|11794665|FG002|STARTED|Main Study||6
10636410|NCT02065336|11794666|FG003|STARTED|Main Study||6
10636411|NCT02065336|11794667|FG004|STARTED|Main Study||6
10636412|NCT02065336|11794668|FG005|STARTED|Main Study||6
10636413|NCT02065336|11794669|FG006|STARTED|Main Study||12
10636414|NCT02065336|11794670|FG007|STARTED|Main Study||10
10636415|NCT02065336|11794671|FG008|STARTED|Main Study||0
10636416|NCT02065336|11794672|FG009|STARTED|Main Study||0
10636417|NCT02065336|11794663|FG000|COMPLETED|Main Study||6
10636418|NCT02065336|11794664|FG001|COMPLETED|Main Study||6
10636419|NCT02065336|11794665|FG002|COMPLETED|Main Study||6
10636420|NCT02065336|11794666|FG003|COMPLETED|Main Study||6
10636421|NCT02065336|11794667|FG004|COMPLETED|Main Study||6
10636422|NCT02065336|11794668|FG005|COMPLETED|Main Study||6
10636423|NCT02065336|11794669|FG006|COMPLETED|Main Study||12
10636424|NCT02065336|11794670|FG007|COMPLETED|Main Study||10
10636425|NCT02065336|11794671|FG008|COMPLETED|Main Study||0
10636426|NCT02065336|11794672|FG009|COMPLETED|Main Study||0
10636427|NCT02065336|11794663|FG000|NOT COMPLETED|Main Study||0
10636428|NCT02065336|11794664|FG001|NOT COMPLETED|Main Study||0
10636429|NCT02065336|11794665|FG002|NOT COMPLETED|Main Study||0
10636430|NCT02065336|11794666|FG003|NOT COMPLETED|Main Study||0
10636431|NCT02065336|11794667|FG004|NOT COMPLETED|Main Study||0
10636432|NCT02065336|11794668|FG005|NOT COMPLETED|Main Study||0
10636433|NCT02065336|11794669|FG006|NOT COMPLETED|Main Study||0
10636434|NCT02065336|11794670|FG007|NOT COMPLETED|Main Study||0
10636435|NCT02065336|11794671|FG008|NOT COMPLETED|Main Study||0
10636436|NCT02065336|11794672|FG009|NOT COMPLETED|Main Study||0
10636437|NCT02065336|11794663|FG000|STARTED|Extension Phase||0
10636438|NCT02065336|11794664|FG001|STARTED|Extension Phase||0
10636439|NCT02065336|11794665|FG002|STARTED|Extension Phase||0
10636440|NCT02065336|11794666|FG003|STARTED|Extension Phase||0
10636441|NCT02065336|11794667|FG004|STARTED|Extension Phase||0
10636442|NCT02065336|11794668|FG005|STARTED|Extension Phase||0
10636443|NCT02065336|11794669|FG006|STARTED|Extension Phase||0
10636444|NCT02065336|11794670|FG007|STARTED|Extension Phase||0
10636445|NCT02065336|11794671|FG008|STARTED|Extension Phase||2
10636446|NCT02065336|11794672|FG009|STARTED|Extension Phase||8
10636447|NCT02065336|11794663|FG000|COMPLETED|Extension Phase||0
10636448|NCT02065336|11794664|FG001|COMPLETED|Extension Phase||0
10636449|NCT02065336|11794665|FG002|COMPLETED|Extension Phase||0
10636450|NCT02065336|11794666|FG003|COMPLETED|Extension Phase||0
10636451|NCT02065336|11794667|FG004|COMPLETED|Extension Phase||0
10636452|NCT02065336|11794668|FG005|COMPLETED|Extension Phase||0
10636453|NCT02065336|11794669|FG006|COMPLETED|Extension Phase||0
10636454|NCT02065336|11794670|FG007|COMPLETED|Extension Phase||0
10636455|NCT02065336|11794671|FG008|COMPLETED|Extension Phase||0
10636456|NCT02065336|11794672|FG009|COMPLETED|Extension Phase||0
10636457|NCT02065336|11794663|FG000|NOT COMPLETED|Extension Phase||0
10636458|NCT02065336|11794664|FG001|NOT COMPLETED|Extension Phase||0
10636459|NCT02065336|11794665|FG002|NOT COMPLETED|Extension Phase||0
10636460|NCT02065336|11794666|FG003|NOT COMPLETED|Extension Phase||0
10636461|NCT02065336|11794667|FG004|NOT COMPLETED|Extension Phase||0
10636462|NCT02065336|11794668|FG005|NOT COMPLETED|Extension Phase||0
10636463|NCT02065336|11794669|FG006|NOT COMPLETED|Extension Phase||0
10713776|NCT02681809|11879278|FG002|STARTED|Overall Study||9
10636464|NCT02065336|11794670|FG007|NOT COMPLETED|Extension Phase||0
10636465|NCT02065336|11794671|FG008|NOT COMPLETED|Extension Phase||2
10636466|NCT02065336|11794672|FG009|NOT COMPLETED|Extension Phase||8
10636467|NCT02065453|11794705|FG000|STARTED|Overall Study||27
10636468|NCT02065453|11794706|FG001|STARTED|Overall Study||25
10636469|NCT02065453|11794705|FG000|COMPLETED|Overall Study||24
10636470|NCT02065453|11794706|FG001|COMPLETED|Overall Study||21
10636471|NCT02065453|11794705|FG000|NOT COMPLETED|Overall Study||3
10636472|NCT02065453|11794706|FG001|NOT COMPLETED|Overall Study||4
10636473|NCT02065479|11794713|FG000|STARTED|Overall Study||33
10636474|NCT02065479|11794714|FG001|STARTED|Overall Study||32
10636475|NCT02065479|11794713|FG000|COMPLETED|Overall Study||33
10636476|NCT02065479|11794714|FG001|COMPLETED|Overall Study||32
10636477|NCT02065479|11794713|FG000|NOT COMPLETED|Overall Study||0
10636478|NCT02065479|11794714|FG001|NOT COMPLETED|Overall Study||0
10636479|NCT02065518|11794724|FG000|STARTED|Overall Study||19
10636480|NCT02065518|11794725|FG001|STARTED|Overall Study||19
10636481|NCT02065518|11794726|FG002|STARTED|Overall Study||20
10636482|NCT02065518|11794727|FG003|STARTED|Overall Study||20
10636483|NCT02065518|11794724|FG000|COMPLETED|Overall Study||13
10636484|NCT02065518|11794725|FG001|COMPLETED|Overall Study||11
10636485|NCT02065518|11794726|FG002|COMPLETED|Overall Study||11
10636486|NCT02065518|11794727|FG003|COMPLETED|Overall Study||15
10636487|NCT02065518|11794724|FG000|NOT COMPLETED|Overall Study||6
10636488|NCT02065518|11794725|FG001|NOT COMPLETED|Overall Study||8
10636489|NCT02065518|11794726|FG002|NOT COMPLETED|Overall Study||9
10636490|NCT02065518|11794727|FG003|NOT COMPLETED|Overall Study||5
10636491|NCT02065557|11794740|FG000|STARTED|Induction Period||32
10636492|NCT02065557|11794741|FG001|STARTED|Induction Period||51
10636493|NCT02065557|11794742|FG002|STARTED|Induction Period||18
10636494|NCT02065557|11794743|FG003|STARTED|Induction Period||0
10636495|NCT02065557|11794744|FG004|STARTED|Induction Period||0
10636496|NCT02065557|11794745|FG005|STARTED|Induction Period||0
10636497|NCT02065557|11794740|FG000|Enrolled in Main Study|Induction Period||30
10636498|NCT02065557|11794741|FG001|Enrolled in Main Study|Induction Period||47
10636499|NCT02065557|11794742|FG002|Enrolled in Main Study|Induction Period||16
10636500|NCT02065557|11794743|FG003|Enrolled in Main Study|Induction Period||0
10636501|NCT02065557|11794744|FG004|Enrolled in Main Study|Induction Period||0
10636502|NCT02065557|11794745|FG005|Enrolled in Main Study|Induction Period||0
10636503|NCT02065557|11794740|FG000|Enrolled in Japan Sub-study|Induction Period||2
10636504|NCT02065557|11794741|FG001|Enrolled in Japan Sub-study|Induction Period||4
10636505|NCT02065557|11794742|FG002|Enrolled in Japan Sub-study|Induction Period||2
10636506|NCT02065557|11794743|FG003|Enrolled in Japan Sub-study|Induction Period||0
10636507|NCT02065557|11794744|FG004|Enrolled in Japan Sub-study|Induction Period||0
10636508|NCT02065557|11794745|FG005|Enrolled in Japan Sub-study|Induction Period||0
10636509|NCT02065557|11794740|FG000|COMPLETED|Induction Period||22
10636510|NCT02065557|11794741|FG001|COMPLETED|Induction Period||43
10636511|NCT02065557|11794742|FG002|COMPLETED|Induction Period||16
10636512|NCT02065557|11794743|FG003|COMPLETED|Induction Period||0
10636513|NCT02065557|11794744|FG004|COMPLETED|Induction Period||0
10636514|NCT02065557|11794745|FG005|COMPLETED|Induction Period||0
10636515|NCT02065557|11794740|FG000|NOT COMPLETED|Induction Period||10
10636516|NCT02065557|11794741|FG001|NOT COMPLETED|Induction Period||8
10636517|NCT02065557|11794742|FG002|NOT COMPLETED|Induction Period||2
10636518|NCT02065557|11794743|FG003|NOT COMPLETED|Induction Period||0
10636519|NCT02065557|11794744|FG004|NOT COMPLETED|Induction Period||0
10636520|NCT02065557|11794745|FG005|NOT COMPLETED|Induction Period||0
10636521|NCT02065557|11794740|FG000|STARTED|Maintenance Period||0
10636522|NCT02065557|11794741|FG001|STARTED|Maintenance Period||0
10636523|NCT02065557|11794742|FG002|STARTED|Maintenance Period||0
10636524|NCT02065557|11794743|FG003|STARTED|Maintenance Period||12
10636525|NCT02065557|11794744|FG004|STARTED|Maintenance Period||33
10636526|NCT02065557|11794745|FG005|STARTED|Maintenance Period||36
10636527|NCT02065557|11794740|FG000|COMPLETED|Maintenance Period||0
10636528|NCT02065557|11794741|FG001|COMPLETED|Maintenance Period||0
10636529|NCT02065557|11794742|FG002|COMPLETED|Maintenance Period||0
10636530|NCT02065557|11794743|FG003|COMPLETED|Maintenance Period||11
10636531|NCT02065557|11794744|FG004|COMPLETED|Maintenance Period||25
10636532|NCT02065557|11794745|FG005|COMPLETED|Maintenance Period||32
10636533|NCT02065557|11794740|FG000|NOT COMPLETED|Maintenance Period||0
10636534|NCT02065557|11794741|FG001|NOT COMPLETED|Maintenance Period||0
10636535|NCT02065557|11794742|FG002|NOT COMPLETED|Maintenance Period||0
10636536|NCT02065557|11794743|FG003|NOT COMPLETED|Maintenance Period||1
10636537|NCT02065557|11794744|FG004|NOT COMPLETED|Maintenance Period||8
10636538|NCT02065557|11794745|FG005|NOT COMPLETED|Maintenance Period||4
10636539|NCT02065570|11794772|FG000|STARTED|Induction Study||206
10636540|NCT02065570|11794773|FG001|STARTED|Induction Study||308
10636541|NCT02065570|11794774|FG002|STARTED|Induction Study||0
10636542|NCT02065570|11794775|FG003|STARTED|Induction Study||0
10636543|NCT02065570|11794772|FG000|COMPLETED|Induction Study||192
10636544|NCT02065570|11794773|FG001|COMPLETED|Induction Study||287
10636545|NCT02065570|11794774|FG002|COMPLETED|Induction Study||0
10636546|NCT02065570|11794775|FG003|COMPLETED|Induction Study||0
10636547|NCT02065570|11794772|FG000|NOT COMPLETED|Induction Study||14
10636548|NCT02065570|11794773|FG001|NOT COMPLETED|Induction Study||21
10636549|NCT02065570|11794774|FG002|NOT COMPLETED|Induction Study||0
10636550|NCT02065570|11794775|FG003|NOT COMPLETED|Induction Study||0
10636551|NCT02065570|11794772|FG000|STARTED|Maintenance Study||0
10636552|NCT02065570|11794773|FG001|STARTED|Maintenance Study||0
10636553|NCT02065570|11794774|FG002|STARTED|Maintenance Study||109
10636554|NCT02065570|11794775|FG003|STARTED|Maintenance Study||109
10636555|NCT02065570|11794772|FG000|COMPLETED|Maintenance Study||0
10636556|NCT02065570|11794773|FG001|COMPLETED|Maintenance Study||0
10636557|NCT02065570|11794774|FG002|COMPLETED|Maintenance Study||87
10636558|NCT02065570|11794775|FG003|COMPLETED|Maintenance Study||90
10636559|NCT02065570|11794772|FG000|NOT COMPLETED|Maintenance Study||0
10636560|NCT02065570|11794773|FG001|NOT COMPLETED|Maintenance Study||0
10636561|NCT02065570|11794774|FG002|NOT COMPLETED|Maintenance Study||22
10636562|NCT02065570|11794775|FG003|NOT COMPLETED|Maintenance Study||19
10636563|NCT02065622|11794788|FG000|STARTED|Induction Study||379
10636564|NCT02065622|11794789|FG001|STARTED|Induction Study||573
10636565|NCT02065622|11794790|FG002|STARTED|Induction Study||0
10636566|NCT02065622|11794791|FG003|STARTED|Induction Study||0
10636567|NCT02065622|11794792|FG004|STARTED|Induction Study||0
10636568|NCT02065622|11794788|FG000|Enrolled in Main Study|Induction Study||340
10636569|NCT02065622|11794789|FG001|Enrolled in Main Study|Induction Study||512
10636570|NCT02065622|11794790|FG002|Enrolled in Main Study|Induction Study||0
10636571|NCT02065622|11794791|FG003|Enrolled in Main Study|Induction Study||0
10636572|NCT02065622|11794792|FG004|Enrolled in Main Study|Induction Study||0
10636573|NCT02065622|11794788|FG000|Enrolled in Japan Sub-Study|Induction Study||39
10636574|NCT02065622|11794789|FG001|Enrolled in Japan Sub-Study|Induction Study||61
10636575|NCT02065622|11794790|FG002|Enrolled in Japan Sub-Study|Induction Study||0
10636576|NCT02065622|11794791|FG003|Enrolled in Japan Sub-Study|Induction Study||0
10636577|NCT02065622|11794792|FG004|Enrolled in Japan Sub-Study|Induction Study||0
10636578|NCT02065622|11794788|FG000|COMPLETED|Induction Study||332
10636579|NCT02065622|11794789|FG001|COMPLETED|Induction Study||514
10636580|NCT02065622|11794790|FG002|COMPLETED|Induction Study||0
10636581|NCT02065622|11794791|FG003|COMPLETED|Induction Study||0
10636582|NCT02065622|11794792|FG004|COMPLETED|Induction Study||0
10636583|NCT02065622|11794788|FG000|NOT COMPLETED|Induction Study||47
10636584|NCT02065622|11794789|FG001|NOT COMPLETED|Induction Study||59
10636585|NCT02065622|11794790|FG002|NOT COMPLETED|Induction Study||0
10636586|NCT02065622|11794791|FG003|NOT COMPLETED|Induction Study||0
10636587|NCT02065622|11794792|FG004|NOT COMPLETED|Induction Study||0
10636588|NCT02065622|11794788|FG000|STARTED|Maintenance Study||0
10636589|NCT02065622|11794789|FG001|STARTED|Maintenance Study||0
10636590|NCT02065622|11794790|FG002|STARTED|Maintenance Study||345
10636591|NCT02065622|11794791|FG003|STARTED|Maintenance Study||350
10636592|NCT02065622|11794792|FG004|STARTED|Maintenance Study||151
10636593|NCT02065622|11794788|FG000|COMPLETED|Maintenance Study||0
10636594|NCT02065622|11794789|FG001|COMPLETED|Maintenance Study||0
10636595|NCT02065622|11794790|FG002|COMPLETED|Maintenance Study||221
10636596|NCT02065622|11794791|FG003|COMPLETED|Maintenance Study||246
10636597|NCT02065622|11794792|FG004|COMPLETED|Maintenance Study||105
10636598|NCT02065622|11794788|FG000|NOT COMPLETED|Maintenance Study||0
10636599|NCT02065622|11794789|FG001|NOT COMPLETED|Maintenance Study||0
10636600|NCT02065622|11794790|FG002|NOT COMPLETED|Maintenance Study||124
10636601|NCT02065622|11794791|FG003|NOT COMPLETED|Maintenance Study||104
10636602|NCT02065622|11794792|FG004|NOT COMPLETED|Maintenance Study||46
10636603|NCT02065687|11794809|FG000|STARTED|Overall Study||234
10636604|NCT02065687|11794810|FG001|STARTED|Overall Study||235
10636605|NCT02065687|11794809|FG000|COMPLETED|Overall Study||234
10636606|NCT02065687|11794810|FG001|COMPLETED|Overall Study||235
10636607|NCT02065687|11794809|FG000|NOT COMPLETED|Overall Study||0
10636608|NCT02065687|11794810|FG001|NOT COMPLETED|Overall Study||0
10636609|NCT02065713|11794818|FG000|STARTED|Overall Study||23
10636610|NCT02065713|11794819|FG001|STARTED|Overall Study||21
10636611|NCT02065713|11794818|FG000|COMPLETED|Overall Study||22
10636612|NCT02065713|11794819|FG001|COMPLETED|Overall Study||20
10636613|NCT02065713|11794818|FG000|NOT COMPLETED|Overall Study||1
10636614|NCT02065713|11794819|FG001|NOT COMPLETED|Overall Study||1
10636615|NCT02065791|11794827|FG000|STARTED|Overall Study||2199
10636616|NCT02065791|11794828|FG001|STARTED|Overall Study||2202
10636617|NCT02065791|11794827|FG000|Treated|Overall Study||2197
10636618|NCT02065791|11794828|FG001|Treated|Overall Study||2200
10636619|NCT02065791|11794827|FG000|COMPLETED|Overall Study||2174
10636620|NCT02065791|11794828|FG001|COMPLETED|Overall Study||2187
10636621|NCT02065791|11794827|FG000|NOT COMPLETED|Overall Study||25
10636622|NCT02065791|11794828|FG001|NOT COMPLETED|Overall Study||15
10636623|NCT02065895|11794834|FG000|STARTED|Overall Study||1
10636624|NCT02065895|11794835|FG001|STARTED|Overall Study||3
10636625|NCT02065895|11794836|FG002|STARTED|Overall Study||1
10636626|NCT02065895|11794837|FG003|STARTED|Overall Study||1
10636627|NCT02065895|11794838|FG004|STARTED|Overall Study||1
10636628|NCT02065895|11794839|FG005|STARTED|Overall Study||1
10636629|NCT02065895|11794834|FG000|COMPLETED|Overall Study||0
10636630|NCT02065895|11794835|FG001|COMPLETED|Overall Study||2
10636631|NCT02065895|11794836|FG002|COMPLETED|Overall Study||1
10636632|NCT02065895|11794837|FG003|COMPLETED|Overall Study||0
10636633|NCT02065895|11794838|FG004|COMPLETED|Overall Study||1
10636634|NCT02065895|11794839|FG005|COMPLETED|Overall Study||1
10636635|NCT02065895|11794834|FG000|NOT COMPLETED|Overall Study||1
10636636|NCT02065895|11794835|FG001|NOT COMPLETED|Overall Study||1
10636637|NCT02065895|11794836|FG002|NOT COMPLETED|Overall Study||0
10636638|NCT02065895|11794837|FG003|NOT COMPLETED|Overall Study||1
10636639|NCT02065895|11794838|FG004|NOT COMPLETED|Overall Study||0
10636640|NCT02065895|11794839|FG005|NOT COMPLETED|Overall Study||0
10636641|NCT02066051|11794856|FG000|STARTED|Overall Study||8
10636642|NCT02066051|11794856|FG000|COMPLETED|Overall Study||7
10636643|NCT02066051|11794856|FG000|NOT COMPLETED|Overall Study||1
10636644|NCT02066129|11794862|FG000|STARTED|Overall Study||127
10636645|NCT02066129|11794863|FG001|STARTED|Overall Study||127
10636646|NCT02066129|11794862|FG000|COMPLETED|Overall Study||98
10636647|NCT02066129|11794863|FG001|COMPLETED|Overall Study||94
10636648|NCT02066129|11794862|FG000|NOT COMPLETED|Overall Study||29
10636649|NCT02066129|11794863|FG001|NOT COMPLETED|Overall Study||33
10636650|NCT02066233|11794871|FG000|STARTED|EG Scan II (Day 1)||50
10636651|NCT02066233|11794872|FG001|STARTED|EG Scan II (Day 1)||50
10636652|NCT02066233|11794871|FG000|COMPLETED|EG Scan II (Day 1)||44
10636653|NCT02066233|11794872|FG001|COMPLETED|EG Scan II (Day 1)||44
10636654|NCT02066233|11794871|FG000|NOT COMPLETED|EG Scan II (Day 1)||6
10636655|NCT02066233|11794872|FG001|NOT COMPLETED|EG Scan II (Day 1)||6
10636656|NCT02066233|11794871|FG000|STARTED|Standard Endoscopy (Day 2)||44
10636657|NCT02066233|11794872|FG001|STARTED|Standard Endoscopy (Day 2)||44
10636658|NCT02066233|11794871|FG000|COMPLETED|Standard Endoscopy (Day 2)||44
10636659|NCT02066233|11794872|FG001|COMPLETED|Standard Endoscopy (Day 2)||44
10636660|NCT02066233|11794871|FG000|NOT COMPLETED|Standard Endoscopy (Day 2)||0
10636661|NCT02066233|11794872|FG001|NOT COMPLETED|Standard Endoscopy (Day 2)||0
10636662|NCT02066298|11794884|FG000|STARTED|Overall Study||49
10636663|NCT02066298|11794885|FG001|STARTED|Overall Study||48
10636664|NCT02066298|11794886|FG002|STARTED|Overall Study||50
10636665|NCT02066298|11794887|FG003|STARTED|Overall Study||51
10636666|NCT02066298|11794888|FG004|STARTED|Overall Study||47
10636667|NCT02066298|11794889|FG005|STARTED|Overall Study||50
10636668|NCT02066298|11794884|FG000|Completed 1st Period|Overall Study||44
10636669|NCT02066298|11794885|FG001|Completed 1st Period|Overall Study||47
10636670|NCT02066298|11794886|FG002|Completed 1st Period|Overall Study||45
10636671|NCT02066298|11794887|FG003|Completed 1st Period|Overall Study||48
10636672|NCT02066298|11794888|FG004|Completed 1st Period|Overall Study||46
10636673|NCT02066298|11794889|FG005|Completed 1st Period|Overall Study||45
10636674|NCT02066298|11794884|FG000|Completed 2nd Period|Overall Study||41
10636675|NCT02066298|11794885|FG001|Completed 2nd Period|Overall Study||41
10636676|NCT02066298|11794886|FG002|Completed 2nd Period|Overall Study||41
10636677|NCT02066298|11794887|FG003|Completed 2nd Period|Overall Study||46
10636678|NCT02066298|11794888|FG004|Completed 2nd Period|Overall Study||42
10636679|NCT02066298|11794889|FG005|Completed 2nd Period|Overall Study||41
10636680|NCT02066298|11794884|FG000|Completed 3rd Period|Overall Study||40
10636681|NCT02066298|11794885|FG001|Completed 3rd Period|Overall Study||40
10636682|NCT02066298|11794886|FG002|Completed 3rd Period|Overall Study||40
10636683|NCT02066298|11794887|FG003|Completed 3rd Period|Overall Study||45
10636684|NCT02066298|11794888|FG004|Completed 3rd Period|Overall Study||38
10636685|NCT02066298|11794889|FG005|Completed 3rd Period|Overall Study||38
10636686|NCT02066298|11794884|FG000|COMPLETED|Overall Study||40
10636687|NCT02066298|11794885|FG001|COMPLETED|Overall Study||40
10636688|NCT02066298|11794886|FG002|COMPLETED|Overall Study||40
10636689|NCT02066298|11794887|FG003|COMPLETED|Overall Study||45
10636690|NCT02066298|11794888|FG004|COMPLETED|Overall Study||38
10636691|NCT02066298|11794889|FG005|COMPLETED|Overall Study||38
10636692|NCT02066298|11794884|FG000|NOT COMPLETED|Overall Study||9
10636693|NCT02066298|11794885|FG001|NOT COMPLETED|Overall Study||8
10636694|NCT02066298|11794886|FG002|NOT COMPLETED|Overall Study||10
10636695|NCT02066298|11794887|FG003|NOT COMPLETED|Overall Study||6
10636696|NCT02066298|11794888|FG004|NOT COMPLETED|Overall Study||9
10636697|NCT02066298|11794889|FG005|NOT COMPLETED|Overall Study||12
10636698|NCT02066311|11794901|FG000|STARTED|Overall Study||15
10636699|NCT02066311|11794901|FG000|COMPLETED|Overall Study|Stage 1 terminated 6/1/18 prior to completion of Stage 1 due to low enrollment and efficacy.|10
10636700|NCT02066311|11794901|FG000|NOT COMPLETED|Overall Study||5
10636701|NCT02066389|11794911|FG000|STARTED|Overall Study||50
10636702|NCT02066389|11794912|FG001|STARTED|Overall Study||50
10636703|NCT02066389|11794913|FG002|STARTED|Overall Study||50
10636704|NCT02066389|11794914|FG003|STARTED|Overall Study||50
10636705|NCT02066389|11794915|FG004|STARTED|Overall Study||50
10636706|NCT02066389|11794916|FG005|STARTED|Overall Study||50
10636707|NCT02066389|11794911|FG000|Received Study Drug|Overall Study||50
10636708|NCT02066389|11794912|FG001|Received Study Drug|Overall Study||50
10636709|NCT02066389|11794913|FG002|Received Study Drug|Overall Study||50
10636710|NCT02066389|11794914|FG003|Received Study Drug|Overall Study||50
10636711|NCT02066389|11794915|FG004|Received Study Drug|Overall Study||50
10636712|NCT02066389|11794916|FG005|Received Study Drug|Overall Study||49
10636713|NCT02066389|11794911|FG000|COMPLETED|Overall Study||45
10636714|NCT02066389|11794912|FG001|COMPLETED|Overall Study||49
10636715|NCT02066389|11794913|FG002|COMPLETED|Overall Study||44
10636716|NCT02066389|11794914|FG003|COMPLETED|Overall Study||47
10636717|NCT02066389|11794915|FG004|COMPLETED|Overall Study||43
10636718|NCT02066389|11794916|FG005|COMPLETED|Overall Study||45
10636719|NCT02066389|11794911|FG000|NOT COMPLETED|Overall Study||5
10636720|NCT02066389|11794912|FG001|NOT COMPLETED|Overall Study||1
10636721|NCT02066389|11794913|FG002|NOT COMPLETED|Overall Study||6
10636722|NCT02066389|11794914|FG003|NOT COMPLETED|Overall Study||3
10636723|NCT02066389|11794915|FG004|NOT COMPLETED|Overall Study||7
10636724|NCT02066389|11794916|FG005|NOT COMPLETED|Overall Study||5
10636725|NCT02066402|11794932|FG000|STARTED|Overall Study||300
10636726|NCT02066402|11794933|FG001|STARTED|Overall Study||298
10636727|NCT02066402|11794932|FG000|Participants Received Treatment|Overall Study||292
10636728|NCT02066402|11794933|FG001|Participants Received Treatment|Overall Study||297
10636729|NCT02066402|11794932|FG000|Completed Study Treatment Period|Overall Study||261
10636730|NCT02066402|11794933|FG001|Completed Study Treatment Period|Overall Study||256
10636731|NCT02066402|11794932|FG000|COMPLETED|Overall Study||274
10636732|NCT02066402|11794933|FG001|COMPLETED|Overall Study||275
10636733|NCT02066402|11794932|FG000|NOT COMPLETED|Overall Study||26
10636734|NCT02066402|11794933|FG001|NOT COMPLETED|Overall Study||23
10636735|NCT02066467|11794939|FG000|STARTED|Overall Study||863
10636736|NCT02066467|11794939|FG000|COMPLETED|Overall Study||648
10636737|NCT02066467|11794939|FG000|NOT COMPLETED|Overall Study||215
10636738|NCT02066727|11794945|FG000|STARTED|Overall Study||30
10636739|NCT02066727|11794946|FG001|STARTED|Overall Study||30
10636740|NCT02066727|11794945|FG000|COMPLETED|Overall Study||30
10636741|NCT02066727|11794946|FG001|COMPLETED|Overall Study||30
10636742|NCT02066727|11794945|FG000|NOT COMPLETED|Overall Study||0
10636743|NCT02066727|11794946|FG001|NOT COMPLETED|Overall Study||0
10636744|NCT02066740|11794952|FG000|STARTED|Overall Study||34
10636745|NCT02066740|11794952|FG000|COMPLETED|Overall Study||32
10636746|NCT02066740|11794952|FG000|NOT COMPLETED|Overall Study||2
10636747|NCT02066792|11794960|FG000|STARTED|Overall Study||40
10636748|NCT02066792|11794961|FG001|STARTED|Overall Study||38
10636749|NCT02066792|11794962|FG002|STARTED|Overall Study||38
10636750|NCT02066792|11794963|FG003|STARTED|Overall Study||36
10636751|NCT02066792|11794960|FG000|COMPLETED|Overall Study||33
10636752|NCT02066792|11794961|FG001|COMPLETED|Overall Study||33
10636753|NCT02066792|11794962|FG002|COMPLETED|Overall Study||30
10636754|NCT02066792|11794963|FG003|COMPLETED|Overall Study||27
10636755|NCT02066792|11794960|FG000|NOT COMPLETED|Overall Study||7
10636756|NCT02066792|11794961|FG001|NOT COMPLETED|Overall Study||5
10636757|NCT02066792|11794962|FG002|NOT COMPLETED|Overall Study||8
10705818|NCT02603172|11870300|FG004|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
10705819|NCT02603172|11870301|FG005|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
10636758|NCT02066792|11794963|FG003|NOT COMPLETED|Overall Study||9
10636759|NCT02066857|11794975|FG000|STARTED|Overall Study||1
10636760|NCT02066857|11794976|FG001|STARTED|Overall Study||4
10636761|NCT02066857|11794975|FG000|COMPLETED|Overall Study||0
10636762|NCT02066857|11794976|FG001|COMPLETED|Overall Study||3
10636763|NCT02066857|11794975|FG000|NOT COMPLETED|Overall Study||1
10636764|NCT02066857|11794976|FG001|NOT COMPLETED|Overall Study||1
10636765|NCT02066896|11794985|FG000|STARTED|Overall Study||33
10636766|NCT02066896|11794986|FG001|STARTED|Overall Study||33
10636767|NCT02066896|11794985|FG000|COMPLETED|Overall Study||33
10636768|NCT02066896|11794986|FG001|COMPLETED|Overall Study||33
10636769|NCT02066896|11794985|FG000|NOT COMPLETED|Overall Study||0
10636770|NCT02066896|11794986|FG001|NOT COMPLETED|Overall Study||0
10636771|NCT02066922|11794992|FG000|STARTED|Overall Study||15
10636772|NCT02066922|11794992|FG000|COMPLETED|Overall Study||14
10636773|NCT02066922|11794992|FG000|NOT COMPLETED|Overall Study||1
10636774|NCT02067000|11794999|FG000|STARTED|Overall Study||217
10636775|NCT02067000|11794999|FG000|COMPLETED|Overall Study||167
10636776|NCT02067000|11794999|FG000|NOT COMPLETED|Overall Study||50
10636777|NCT02067039|11795005|FG000|STARTED|Overall Study||1325
10636778|NCT02067039|11795006|FG001|STARTED|Overall Study||1340
10636779|NCT02067039|11795005|FG000|3 Month Survey|Overall Study||824
10636780|NCT02067039|11795006|FG001|3 Month Survey|Overall Study||766
10636781|NCT02067039|11795005|FG000|6 Month Survey|Overall Study||735
10636782|NCT02067039|11795006|FG001|6 Month Survey|Overall Study||756
10636783|NCT02067039|11795005|FG000|9 Month Survey|Overall Study||748
10636784|NCT02067039|11795006|FG001|9 Month Survey|Overall Study||838
10636785|NCT02067039|11795005|FG000|COMPLETED|Overall Study||752
10636786|NCT02067039|11795006|FG001|COMPLETED|Overall Study||832
10636787|NCT02067039|11795005|FG000|NOT COMPLETED|Overall Study||573
10636788|NCT02067039|11795006|FG001|NOT COMPLETED|Overall Study||508
10636789|NCT02067273|11795016|FG000|STARTED|Overall Study||5
10636790|NCT02067273|11795017|FG001|STARTED|Overall Study||15
10636791|NCT02067273|11795016|FG000|COMPLETED|Overall Study||5
10636792|NCT02067273|11795017|FG001|COMPLETED|Overall Study||12
10636793|NCT02067273|11795016|FG000|NOT COMPLETED|Overall Study||0
10636794|NCT02067273|11795017|FG001|NOT COMPLETED|Overall Study||3
10636795|NCT02067468|11795026|FG000|STARTED|Overall Study||882
10636796|NCT02067468|11795027|FG001|STARTED|Overall Study||890
10636797|NCT02067468|11795028|FG002|STARTED|Overall Study||889
10636798|NCT02067468|11795026|FG000|Followed-up Through Medical Records|Overall Study||882
10636799|NCT02067468|11795027|FG001|Followed-up Through Medical Records|Overall Study||890
10636800|NCT02067468|11795028|FG002|Followed-up Through Medical Records|Overall Study||889
10636801|NCT02067468|11795026|FG000|Had at Least One Routine Colposcopy|Overall Study||772
10636802|NCT02067468|11795027|FG001|Had at Least One Routine Colposcopy|Overall Study||372
10636803|NCT02067468|11795028|FG002|Had at Least One Routine Colposcopy|Overall Study||462
10636804|NCT02067468|11795026|FG000|COMPLETED|Overall Study||882
10636805|NCT02067468|11795027|FG001|COMPLETED|Overall Study||890
10636806|NCT02067468|11795028|FG002|COMPLETED|Overall Study||889
10636807|NCT02067468|11795026|FG000|NOT COMPLETED|Overall Study||0
10636808|NCT02067468|11795027|FG001|NOT COMPLETED|Overall Study||0
10636809|NCT02067468|11795028|FG002|NOT COMPLETED|Overall Study||0
10636810|NCT02067533|11795038|FG000|STARTED|Overall Study||45
10636811|NCT02067533|11795039|FG001|STARTED|Overall Study||46
10636812|NCT02067533|11795038|FG000|COMPLETED|Overall Study||41
10636813|NCT02067533|11795039|FG001|COMPLETED|Overall Study||44
10636814|NCT02067533|11795038|FG000|NOT COMPLETED|Overall Study||4
10636815|NCT02067533|11795039|FG001|NOT COMPLETED|Overall Study||2
10636816|NCT02067585|11795048|FG000|STARTED|Overall Study||16
10636817|NCT02067585|11795049|FG001|STARTED|Overall Study||16
10636818|NCT02067585|11795050|FG002|STARTED|Overall Study||16
10636819|NCT02067585|11795048|FG000|COMPLETED|Overall Study||16
10636820|NCT02067585|11795049|FG001|COMPLETED|Overall Study||16
10636821|NCT02067585|11795050|FG002|COMPLETED|Overall Study||16
10636822|NCT02067585|11795048|FG000|NOT COMPLETED|Overall Study||0
10636823|NCT02067585|11795049|FG001|NOT COMPLETED|Overall Study||0
10636824|NCT02067585|11795050|FG002|NOT COMPLETED|Overall Study||0
10636825|NCT02067663|11795060|FG000|STARTED|Overall Study||68
10636826|NCT02067663|11795061|FG001|STARTED|Overall Study||55
10636827|NCT02067663|11795060|FG000|COMPLETED|Overall Study||55
10636828|NCT02067663|11795061|FG001|COMPLETED|Overall Study||41
10636829|NCT02067663|11795060|FG000|NOT COMPLETED|Overall Study||13
10636830|NCT02067663|11795061|FG001|NOT COMPLETED|Overall Study||14
10636831|NCT02067676|11795073|FG000|STARTED|Overall Study||8
10636832|NCT02067676|11795074|FG001|STARTED|Overall Study||8
10636833|NCT02067676|11795075|FG002|STARTED|Overall Study||8
10636834|NCT02067676|11795076|FG003|STARTED|Overall Study||8
10636835|NCT02067676|11795077|FG004|STARTED|Overall Study||8
10636836|NCT02067676|11795078|FG005|STARTED|Overall Study||8
10636837|NCT02067676|11795073|FG000|COMPLETED|Overall Study||7
10636838|NCT02067676|11795074|FG001|COMPLETED|Overall Study||8
10636839|NCT02067676|11795075|FG002|COMPLETED|Overall Study||8
10636840|NCT02067676|11795076|FG003|COMPLETED|Overall Study||8
10636841|NCT02067676|11795077|FG004|COMPLETED|Overall Study||8
10636842|NCT02067676|11795078|FG005|COMPLETED|Overall Study||8
10636843|NCT02067676|11795073|FG000|NOT COMPLETED|Overall Study||1
10636844|NCT02067676|11795074|FG001|NOT COMPLETED|Overall Study||0
10636845|NCT02067676|11795075|FG002|NOT COMPLETED|Overall Study||0
10636846|NCT02067676|11795076|FG003|NOT COMPLETED|Overall Study||0
10636847|NCT02067676|11795077|FG004|NOT COMPLETED|Overall Study||0
10636848|NCT02067676|11795078|FG005|NOT COMPLETED|Overall Study||0
10636849|NCT02067728|11795099|FG000|STARTED|Baseline - 1 Month Follow up Survey||220
10636850|NCT02067728|11795100|FG001|STARTED|Baseline - 1 Month Follow up Survey||210
10636851|NCT02067728|11795099|FG000|COMPLETED|Baseline - 1 Month Follow up Survey|213 parents/guardians completed the surveys, along with 82 teens.|213
10636852|NCT02067728|11795100|FG001|COMPLETED|Baseline - 1 Month Follow up Survey|182 parent/guardians completed the surveys, along with 75 teens.|182
10636853|NCT02067728|11795099|FG000|NOT COMPLETED|Baseline - 1 Month Follow up Survey||7
10636854|NCT02067728|11795100|FG001|NOT COMPLETED|Baseline - 1 Month Follow up Survey||28
10636855|NCT02067728|11795099|FG000|STARTED|6 Month Follow up Survey|Participants completed the 6 month follow up even if 1 month data wasn't able to be collected.|220
10636856|NCT02067728|11795100|FG001|STARTED|6 Month Follow up Survey|Participants completed the 6 month follow up even if 1 month data wasn't able to be collected.|210
10636857|NCT02067728|11795099|FG000|COMPLETED|6 Month Follow up Survey|172 parent/guardians completed surveys at this time point, along with 71 teens.|172
10636858|NCT02067728|11795100|FG001|COMPLETED|6 Month Follow up Survey|150 parent/guardians completed surveys at this time point, along with 69 teens.|150
10636859|NCT02067728|11795099|FG000|NOT COMPLETED|6 Month Follow up Survey||48
10636860|NCT02067728|11795100|FG001|NOT COMPLETED|6 Month Follow up Survey||60
10636861|NCT02067728|11795099|FG000|STARTED|6 Month Measurements||220
10636862|NCT02067728|11795100|FG001|STARTED|6 Month Measurements||210
10636863|NCT02067728|11795099|FG000|COMPLETED|6 Month Measurements|Number includes 6 month measurements & chart review for visits at 6 months +/- 2 months from initial|106
10636864|NCT02067728|11795100|FG001|COMPLETED|6 Month Measurements|Number includes 6 month measurements & chart review for visits at 6 months +/- 2 months from initial|113
10636865|NCT02067728|11795099|FG000|NOT COMPLETED|6 Month Measurements||114
10636866|NCT02067728|11795100|FG001|NOT COMPLETED|6 Month Measurements||97
10636867|NCT02067806|11795106|FG000|STARTED|Overall Study||394
10636868|NCT02067806|11795106|FG000|COMPLETED|Overall Study||387
10636869|NCT02067806|11795106|FG000|NOT COMPLETED|Overall Study||7
10636870|NCT02067858|11795111|FG000|STARTED|Overall Study||6
10636871|NCT02067858|11795111|FG000|COMPLETED|Overall Study||6
10636872|NCT02067858|11795111|FG000|NOT COMPLETED|Overall Study||0
10636873|NCT02068027|11795117|FG000|STARTED|Overall Study||130
10636874|NCT02068027|11795118|FG001|STARTED|Overall Study||130
10636875|NCT02068027|11795117|FG000|COMPLETED|Overall Study||117
10636876|NCT02068027|11795118|FG001|COMPLETED|Overall Study||114
10636877|NCT02068027|11795117|FG000|NOT COMPLETED|Overall Study||13
10636878|NCT02068027|11795118|FG001|NOT COMPLETED|Overall Study||16
10636879|NCT02068118|11795126|FG000|STARTED|18-month Comparative Study Period||455
10636880|NCT02068118|11795127|FG001|STARTED|18-month Comparative Study Period||482
10636881|NCT02068118|11795126|FG000|COMPLETED|18-month Comparative Study Period||327
10636882|NCT02068118|11795127|FG001|COMPLETED|18-month Comparative Study Period||305
10636883|NCT02068118|11795126|FG000|NOT COMPLETED|18-month Comparative Study Period||128
10636884|NCT02068118|11795127|FG001|NOT COMPLETED|18-month Comparative Study Period||177
10636885|NCT02068118|11795126|FG000|STARTED|Extension Period|Standard Care/Tele-cardiology : Patients entered Period 2 if they wished and consented|7
10636886|NCT02068118|11795127|FG001|STARTED|Extension Period|Tele-cardiology/Tele-cardiology : Patients entered Period 2 if they wished and consented|13
10636887|NCT02068118|11795126|FG000|COMPLETED|Extension Period||5
10636888|NCT02068118|11795127|FG001|COMPLETED|Extension Period||10
10636889|NCT02068118|11795126|FG000|NOT COMPLETED|Extension Period||2
10636890|NCT02068118|11795127|FG001|NOT COMPLETED|Extension Period||3
10636891|NCT02068157|11795135|FG000|STARTED|Overall Study||3
10636892|NCT02068157|11795135|FG000|COMPLETED|Overall Study||3
10636893|NCT02068157|11795135|FG000|NOT COMPLETED|Overall Study||0
10636894|NCT02068222|11795139|FG000|STARTED|Overall Study||10
10636895|NCT02068222|11795139|FG000|COMPLETED|Overall Study||9
10636896|NCT02068222|11795139|FG000|NOT COMPLETED|Overall Study||1
10636897|NCT02068352|11795146|FG000|STARTED|Overall Study||41
10636898|NCT02068352|11795147|FG001|STARTED|Overall Study||43
10636899|NCT02068352|11795148|FG002|STARTED|Overall Study||37
10636900|NCT02068352|11795146|FG000|COMPLETED|Overall Study||31
10636901|NCT02068352|11795147|FG001|COMPLETED|Overall Study||35
10636902|NCT02068352|11795148|FG002|COMPLETED|Overall Study||28
10636903|NCT02068352|11795146|FG000|NOT COMPLETED|Overall Study||10
10636904|NCT02068352|11795147|FG001|NOT COMPLETED|Overall Study||8
10636905|NCT02068352|11795148|FG002|NOT COMPLETED|Overall Study||9
10636906|NCT02068443|11795159|FG000|STARTED|Overall Study||71
10636907|NCT02068443|11795160|FG001|STARTED|Overall Study||152
10636908|NCT02068443|11795161|FG002|STARTED|Overall Study||151
10636909|NCT02068443|11795159|FG000|COMPLETED|Overall Study||64
10636910|NCT02068443|11795160|FG001|COMPLETED|Overall Study||146
10636911|NCT02068443|11795161|FG002|COMPLETED|Overall Study||148
10636912|NCT02068443|11795159|FG000|NOT COMPLETED|Overall Study||7
10636913|NCT02068443|11795160|FG001|NOT COMPLETED|Overall Study||6
10636914|NCT02068443|11795161|FG002|NOT COMPLETED|Overall Study||3
10636915|NCT02068495|11795169|FG000|STARTED|Overall Study||3409
10636916|NCT02068495|11795169|FG000|COMPLETED|Overall Study||3300
10636917|NCT02068495|11795169|FG000|NOT COMPLETED|Overall Study||109
10636918|NCT02068508|11795173|FG000|STARTED|Overall Study||1067
10636919|NCT02068508|11795173|FG000|COMPLETED|Overall Study||1035
10636920|NCT02068508|11795173|FG000|NOT COMPLETED|Overall Study||32
10636921|NCT02068599|11795180|FG000|STARTED|Overall Study||130
10636922|NCT02068599|11795181|FG001|STARTED|Overall Study||129
10636923|NCT02068599|11795182|FG002|STARTED|Overall Study||130
10636924|NCT02068599|11795180|FG000|Safety Analysis Set|Overall Study|One participant withdrew before taking any study drug.|129
10636925|NCT02068599|11795181|FG001|Safety Analysis Set|Overall Study|One participant withdrew before taking any study drug.|128
10636926|NCT02068599|11795182|FG002|Safety Analysis Set|Overall Study||130
10636927|NCT02068599|11795180|FG000|Full Analysis Set|Overall Study||129
10636928|NCT02068599|11795181|FG001|Full Analysis Set|Overall Study||128
10636929|NCT02068599|11795182|FG002|Full Analysis Set|Overall Study||130
10636930|NCT02068599|11795180|FG000|COMPLETED|Overall Study||119
10636931|NCT02068599|11795181|FG001|COMPLETED|Overall Study||119
10636932|NCT02068599|11795182|FG002|COMPLETED|Overall Study||117
10636933|NCT02068599|11795180|FG000|NOT COMPLETED|Overall Study||11
10636934|NCT02068599|11795181|FG001|NOT COMPLETED|Overall Study||10
10636935|NCT02068599|11795182|FG002|NOT COMPLETED|Overall Study||13
10636936|NCT02068729|11795190|FG000|STARTED|Overall Study||131
10636937|NCT02068729|11795190|FG000|COMPLETED|Overall Study||56
10636938|NCT02068729|11795190|FG000|NOT COMPLETED|Overall Study||75
10653943|NCT02197481|11814591|FG001|STARTED|Overall Study||43
10653944|NCT02197481|11814590|FG000|COMPLETED|Overall Study|February 2016|43
10653945|NCT02197481|11814591|FG001|COMPLETED|Overall Study||43
10653946|NCT02197481|11814590|FG000|NOT COMPLETED|Overall Study||0
10653947|NCT02197481|11814591|FG001|NOT COMPLETED|Overall Study||0
10653948|NCT02197520|11814597|FG000|STARTED|Period 1||12
10653949|NCT02197520|11814598|FG001|STARTED|Period 1||12
10653950|NCT02197520|11814597|FG000|COMPLETED|Period 1||11
10653951|NCT02197520|11814598|FG001|COMPLETED|Period 1||12
10653952|NCT02197520|11814597|FG000|NOT COMPLETED|Period 1||1
10653953|NCT02197520|11814598|FG001|NOT COMPLETED|Period 1||0
10653954|NCT02197520|11814597|FG000|STARTED|Period 2||11
10653955|NCT02197520|11814598|FG001|STARTED|Period 2||12
10653956|NCT02197520|11814597|FG000|COMPLETED|Period 2||10
10653957|NCT02197520|11814598|FG001|COMPLETED|Period 2||10
10653958|NCT02197520|11814597|FG000|NOT COMPLETED|Period 2||1
10653959|NCT02197520|11814598|FG001|NOT COMPLETED|Period 2||2
10653960|NCT02197572|11814606|FG000|STARTED|Overall Study||44
10653961|NCT02197572|11814606|FG000|COMPLETED|Overall Study||0
10653962|NCT02197572|11814606|FG000|NOT COMPLETED|Overall Study||44
10653963|NCT02197767|11814610|FG000|STARTED|Overall Study||11
10653964|NCT02197767|11814610|FG000|COMPLETED|Overall Study||11
10653965|NCT02197767|11814610|FG000|NOT COMPLETED|Overall Study||0
10653966|NCT02197806|11814618|FG000|STARTED|Overall Study||15
10653967|NCT02197806|11814619|FG001|STARTED|Overall Study||17
10653968|NCT02197806|11814620|FG002|STARTED|Overall Study||16
10653969|NCT02197806|11814621|FG003|STARTED|Overall Study||17
10653970|NCT02197806|11814618|FG000|COMPLETED|Overall Study||15
10653971|NCT02197806|11814619|FG001|COMPLETED|Overall Study||16
10653972|NCT02197806|11814620|FG002|COMPLETED|Overall Study||16
10653973|NCT02197806|11814621|FG003|COMPLETED|Overall Study||16
10653974|NCT02197806|11814618|FG000|NOT COMPLETED|Overall Study||0
10653975|NCT02197806|11814619|FG001|NOT COMPLETED|Overall Study||1
10653976|NCT02197806|11814620|FG002|NOT COMPLETED|Overall Study||0
10653977|NCT02197806|11814621|FG003|NOT COMPLETED|Overall Study||1
10653978|NCT02197897|11814631|FG000|STARTED|Overall Study||15
10653979|NCT02197897|11814631|FG000|COMPLETED|Overall Study||14
10653980|NCT02197897|11814631|FG000|NOT COMPLETED|Overall Study||1
10653981|NCT02198040|11814638|FG000|STARTED|Overall Study||9
10653982|NCT02198040|11814639|FG001|STARTED|Overall Study||9
10653983|NCT02198040|11814640|FG002|STARTED|Overall Study||9
10653984|NCT02198040|11814638|FG000|COMPLETED|Overall Study||9
10653985|NCT02198040|11814639|FG001|COMPLETED|Overall Study||8
10653986|NCT02198040|11814640|FG002|COMPLETED|Overall Study||8
10653987|NCT02198040|11814638|FG000|NOT COMPLETED|Overall Study||0
10653988|NCT02198040|11814639|FG001|NOT COMPLETED|Overall Study||1
10653989|NCT02198040|11814640|FG002|NOT COMPLETED|Overall Study||1
10653990|NCT02198235|11814653|FG000|STARTED|Overall Study||30
10653991|NCT02198235|11814654|FG001|STARTED|Overall Study||30
10653992|NCT02198235|11814655|FG002|STARTED|Overall Study||30
10653993|NCT02198235|11814653|FG000|COMPLETED|Overall Study||27
10653994|NCT02198235|11814654|FG001|COMPLETED|Overall Study||28
10653995|NCT02198235|11814655|FG002|COMPLETED|Overall Study||28
10653996|NCT02198235|11814653|FG000|NOT COMPLETED|Overall Study||3
10653997|NCT02198235|11814654|FG001|NOT COMPLETED|Overall Study||2
10653998|NCT02198235|11814655|FG002|NOT COMPLETED|Overall Study||2
10653999|NCT02198430|11814665|FG000|STARTED|Overall Study||53
10654000|NCT02198430|11814666|FG001|STARTED|Overall Study||51
10654001|NCT02198430|11814665|FG000|COMPLETED|Overall Study||53
10654002|NCT02198430|11814666|FG001|COMPLETED|Overall Study||51
10654003|NCT02198430|11814665|FG000|NOT COMPLETED|Overall Study||0
10654004|NCT02198430|11814666|FG001|NOT COMPLETED|Overall Study||0
10654005|NCT02198651|11814672|FG000|STARTED|Lead-in Period||149
10654006|NCT02198651|11814673|FG001|STARTED|Lead-in Period||0
10654007|NCT02198651|11814674|FG002|STARTED|Lead-in Period||0
10654008|NCT02198651|11814675|FG003|STARTED|Lead-in Period||0
10654009|NCT02198651|11814676|FG004|STARTED|Lead-in Period||0
10654010|NCT02198651|11814672|FG000|Participants Treated in Lead-In Period|Lead-in Period||146
10654011|NCT02198651|11814673|FG001|Participants Treated in Lead-In Period|Lead-in Period||0
10654012|NCT02198651|11814674|FG002|Participants Treated in Lead-In Period|Lead-in Period||0
10654013|NCT02198651|11814675|FG003|Participants Treated in Lead-In Period|Lead-in Period||0
10654014|NCT02198651|11814676|FG004|Participants Treated in Lead-In Period|Lead-in Period||0
10654015|NCT02198651|11814672|FG000|COMPLETED|Lead-in Period||112
10654016|NCT02198651|11814673|FG001|COMPLETED|Lead-in Period||0
10654017|NCT02198651|11814674|FG002|COMPLETED|Lead-in Period||0
10654018|NCT02198651|11814675|FG003|COMPLETED|Lead-in Period||0
10654019|NCT02198651|11814676|FG004|COMPLETED|Lead-in Period||0
10654020|NCT02198651|11814672|FG000|NOT COMPLETED|Lead-in Period||37
10654021|NCT02198651|11814673|FG001|NOT COMPLETED|Lead-in Period||0
10654022|NCT02198651|11814674|FG002|NOT COMPLETED|Lead-in Period||0
10654023|NCT02198651|11814675|FG003|NOT COMPLETED|Lead-in Period||0
10654024|NCT02198651|11814676|FG004|NOT COMPLETED|Lead-in Period||0
10654025|NCT02198651|11814672|FG000|STARTED|Double-blind Period||0
10654026|NCT02198651|11814673|FG001|STARTED|Double-blind Period||102
10654027|NCT02198651|11814674|FG002|STARTED|Double-blind Period||20
10654028|NCT02198651|11814675|FG003|STARTED|Double-blind Period||0
10654029|NCT02198651|11814676|FG004|STARTED|Double-blind Period||0
10654030|NCT02198651|11814672|FG000|COMPLETED|Double-blind Period||0
10636939|NCT02068768|11795249|FG000|STARTED|Overall Study||13
10636940|NCT02068768|11795249|FG000|COMPLETED|Overall Study||6
10636941|NCT02068768|11795249|FG000|NOT COMPLETED|Overall Study||7
10636942|NCT02068820|11795255|FG000|STARTED|Overall Study||20
10636943|NCT02068820|11795256|FG001|STARTED|Overall Study||180
10636944|NCT02068820|11795255|FG000|COMPLETED|Overall Study||20
10636945|NCT02068820|11795256|FG001|COMPLETED|Overall Study||180
10636946|NCT02068820|11795255|FG000|NOT COMPLETED|Overall Study||0
10636947|NCT02068820|11795256|FG001|NOT COMPLETED|Overall Study||0
10636948|NCT02068846|11795269|FG000|STARTED|Overall Study||9
10636949|NCT02068846|11795270|FG001|STARTED|Overall Study||8
10636950|NCT02068846|11795269|FG000|COMPLETED|Overall Study||8
10636951|NCT02068846|11795270|FG001|COMPLETED|Overall Study||7
10636952|NCT02068846|11795269|FG000|NOT COMPLETED|Overall Study||1
10636953|NCT02068846|11795270|FG001|NOT COMPLETED|Overall Study||1
10636972|NCT02069015|11795292|FG000|STARTED|Overall Study|Baseline and enrollment at Emergency Department (ED)|71
10636973|NCT02069015|11795293|FG001|STARTED|Overall Study||68
10636974|NCT02069015|11795292|FG000|7 Day|Overall Study|7 day post ED discharge at Clinical Research Center (CRC)|44
10636975|NCT02069015|11795293|FG001|7 Day|Overall Study|7 day post ED discharge at CRC|45
10636976|NCT02069015|11795292|FG000|30 Day|Overall Study|30 day post-discharge at CRC|38
10636977|NCT02069015|11795293|FG001|30 Day|Overall Study|30 day post-discharge at CRC|43
10636978|NCT02069015|11795292|FG000|90 Day|Overall Study|90 day post ED discharge at CRC|32
10636979|NCT02069015|11795293|FG001|90 Day|Overall Study|90 day post ED discharge|35
10636980|NCT02069015|11795292|FG000|COMPLETED|Overall Study|180 post ED discharge at CRC|31
10636981|NCT02069015|11795293|FG001|COMPLETED|Overall Study|180 day post ED discharge at CRC|35
10636982|NCT02069015|11795292|FG000|NOT COMPLETED|Overall Study||40
10636983|NCT02069015|11795293|FG001|NOT COMPLETED|Overall Study||33
10636984|NCT02069041|11795300|FG000|STARTED|Overall Study||8
10636985|NCT02069041|11795300|FG000|Received at Least One Dose of Study Drug|Overall Study||8
10636986|NCT02069041|11795300|FG000|COMPLETED|Overall Study||8
10636987|NCT02069041|11795300|FG000|NOT COMPLETED|Overall Study||0
10636988|NCT02069093|11795304|FG000|STARTED|Overall Study||86
10636989|NCT02069093|11795304|FG000|Pharmacokinetic Analysis Set|Overall Study||50
10636990|NCT02069093|11795304|FG000|COMPLETED|Overall Study||56
10636991|NCT02069093|11795304|FG000|NOT COMPLETED|Overall Study||30
10636992|NCT02069119|11795312|FG000|STARTED|Overall Study||20
10636993|NCT02069119|11795313|FG001|STARTED|Overall Study||4
10636994|NCT02069119|11795314|FG002|STARTED|Overall Study||20
10636995|NCT02069119|11795315|FG003|STARTED|Overall Study||4
10636996|NCT02069119|11795312|FG000|COMPLETED|Overall Study||20
10636997|NCT02069119|11795313|FG001|COMPLETED|Overall Study||4
10636998|NCT02069119|11795314|FG002|COMPLETED|Overall Study||20
10636999|NCT02069119|11795315|FG003|COMPLETED|Overall Study||4
10637000|NCT02069119|11795312|FG000|NOT COMPLETED|Overall Study||0
10637001|NCT02069119|11795313|FG001|NOT COMPLETED|Overall Study||0
10637002|NCT02069119|11795314|FG002|NOT COMPLETED|Overall Study||0
10637003|NCT02069119|11795315|FG003|NOT COMPLETED|Overall Study||0
10705820|NCT02603172|11870302|FG006|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
10705821|NCT02603172|11870303|FG007|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
10705822|NCT02603172|11870296|FG000|STARTED|Part C (Approximately 13 Weeks)||0
10705823|NCT02603172|11870297|FG001|STARTED|Part C (Approximately 13 Weeks)||0
10637004|NCT02069184|11795329|FG000|STARTED|Overall Study||33
10637005|NCT02069184|11795330|FG001|STARTED|Overall Study||33
10705824|NCT02603172|11870298|FG002|STARTED|Part C (Approximately 13 Weeks)||0
10637006|NCT02069184|11795329|FG000|COMPLETED|Overall Study||27
10637007|NCT02069184|11795330|FG001|COMPLETED|Overall Study||31
10637008|NCT02069184|11795329|FG000|NOT COMPLETED|Overall Study||6
10637009|NCT02069184|11795330|FG001|NOT COMPLETED|Overall Study||2
10637010|NCT02069353|11795336|FG000|STARTED|Overall Study||4
10637011|NCT02069353|11795336|FG000|COMPLETED|Overall Study||4
10637012|NCT02069353|11795336|FG000|NOT COMPLETED|Overall Study||0
10637013|NCT02069379|11795342|FG000|STARTED|Baseline Measurements||30
10637014|NCT02069379|11795343|FG001|STARTED|Baseline Measurements||4
10637015|NCT02069379|11795344|FG002|STARTED|Baseline Measurements||2
10637016|NCT02069379|11795345|FG003|STARTED|Baseline Measurements||6
10637017|NCT02069379|11795342|FG000|Baseline Measurements Taken|Baseline Measurements||30
10637018|NCT02069379|11795343|FG001|Baseline Measurements Taken|Baseline Measurements||4
10637019|NCT02069379|11795344|FG002|Baseline Measurements Taken|Baseline Measurements||2
10637020|NCT02069379|11795345|FG003|Baseline Measurements Taken|Baseline Measurements||6
10637021|NCT02069379|11795342|FG000|COMPLETED|Baseline Measurements||27
10637022|NCT02069379|11795343|FG001|COMPLETED|Baseline Measurements||4
10637023|NCT02069379|11795344|FG002|COMPLETED|Baseline Measurements||2
10637024|NCT02069379|11795345|FG003|COMPLETED|Baseline Measurements||4
10637025|NCT02069379|11795342|FG000|NOT COMPLETED|Baseline Measurements||3
10637026|NCT02069379|11795343|FG001|NOT COMPLETED|Baseline Measurements||0
10637027|NCT02069379|11795344|FG002|NOT COMPLETED|Baseline Measurements||0
10637028|NCT02069379|11795345|FG003|NOT COMPLETED|Baseline Measurements||2
10637029|NCT02069379|11795342|FG000|STARTED|First Treatment Arm|Controls are not involved after initial baseline collection|0
10637030|NCT02069379|11795343|FG001|STARTED|First Treatment Arm||4
10637031|NCT02069379|11795344|FG002|STARTED|First Treatment Arm||2
10637032|NCT02069379|11795345|FG003|STARTED|First Treatment Arm|Insulin resistant woman not randomized are not involved after initial baseline collection|0
10637033|NCT02069379|11795342|FG000|COMPLETED|First Treatment Arm||0
10637034|NCT02069379|11795343|FG001|COMPLETED|First Treatment Arm||3
10637035|NCT02069379|11795344|FG002|COMPLETED|First Treatment Arm||1
10637036|NCT02069379|11795345|FG003|COMPLETED|First Treatment Arm||0
10637037|NCT02069379|11795342|FG000|NOT COMPLETED|First Treatment Arm||0
10637038|NCT02069379|11795343|FG001|NOT COMPLETED|First Treatment Arm||1
10637039|NCT02069379|11795344|FG002|NOT COMPLETED|First Treatment Arm||1
10637040|NCT02069379|11795345|FG003|NOT COMPLETED|First Treatment Arm||0
10637041|NCT02069379|11795342|FG000|STARTED|Washout Period (4 Weeks)|Controls are not involved after initial baseline collection|0
10637042|NCT02069379|11795343|FG001|STARTED|Washout Period (4 Weeks)||3
10637043|NCT02069379|11795344|FG002|STARTED|Washout Period (4 Weeks)||1
10637044|NCT02069379|11795345|FG003|STARTED|Washout Period (4 Weeks)|Insulin resistant woman who were not randomized are not involved after initial baseline collection|0
10637045|NCT02069379|11795342|FG000|COMPLETED|Washout Period (4 Weeks)||0
10637046|NCT02069379|11795343|FG001|COMPLETED|Washout Period (4 Weeks)||1
10637047|NCT02069379|11795344|FG002|COMPLETED|Washout Period (4 Weeks)||1
10637048|NCT02069379|11795345|FG003|COMPLETED|Washout Period (4 Weeks)||0
10637049|NCT02069379|11795342|FG000|NOT COMPLETED|Washout Period (4 Weeks)||0
10637050|NCT02069379|11795343|FG001|NOT COMPLETED|Washout Period (4 Weeks)||2
10637051|NCT02069379|11795344|FG002|NOT COMPLETED|Washout Period (4 Weeks)||0
10637052|NCT02069379|11795345|FG003|NOT COMPLETED|Washout Period (4 Weeks)||0
10637053|NCT02069379|11795342|FG000|STARTED|Second Treatment Arm|Controls are not involved after initial baseline collection|0
10637054|NCT02069379|11795343|FG001|STARTED|Second Treatment Arm||1
10637055|NCT02069379|11795344|FG002|STARTED|Second Treatment Arm||1
10637056|NCT02069379|11795345|FG003|STARTED|Second Treatment Arm|Insulin resistant women who are not randomized are not involved after initial baseline collection|0
10637057|NCT02069379|11795342|FG000|COMPLETED|Second Treatment Arm||0
10637058|NCT02069379|11795343|FG001|COMPLETED|Second Treatment Arm||1
10637059|NCT02069379|11795344|FG002|COMPLETED|Second Treatment Arm||0
10637060|NCT02069379|11795345|FG003|COMPLETED|Second Treatment Arm||0
10637061|NCT02069379|11795342|FG000|NOT COMPLETED|Second Treatment Arm||0
10637062|NCT02069379|11795343|FG001|NOT COMPLETED|Second Treatment Arm||0
10637063|NCT02069379|11795344|FG002|NOT COMPLETED|Second Treatment Arm||1
10637064|NCT02069379|11795345|FG003|NOT COMPLETED|Second Treatment Arm||0
10637065|NCT02069392|11795357|FG000|STARTED|Overall Study||14
10637066|NCT02069392|11795358|FG001|STARTED|Overall Study||17
10637067|NCT02069392|11795357|FG000|COMPLETED|Overall Study||10
10637068|NCT02069392|11795358|FG001|COMPLETED|Overall Study||15
10637069|NCT02069392|11795357|FG000|NOT COMPLETED|Overall Study||4
10637070|NCT02069392|11795358|FG001|NOT COMPLETED|Overall Study||2
10637071|NCT02069704|11795368|FG000|STARTED|Overall Study|Two patients were randomized but they did not received study treatment|69
10637072|NCT02069704|11795369|FG001|STARTED|Overall Study||71
10637073|NCT02069704|11795368|FG000|COMPLETED|Overall Study||69
10637074|NCT02069704|11795369|FG001|COMPLETED|Overall Study||71
10637075|NCT02069704|11795368|FG000|NOT COMPLETED|Overall Study||0
10637076|NCT02069704|11795369|FG001|NOT COMPLETED|Overall Study||0
10637077|NCT02069847|11795384|FG000|STARTED|Overall Study||22
10637078|NCT02069847|11795385|FG001|STARTED|Overall Study||68
10637079|NCT02069847|11795384|FG000|COMPLETED|Overall Study||22
10637080|NCT02069847|11795385|FG001|COMPLETED|Overall Study||68
10637081|NCT02069847|11795384|FG000|NOT COMPLETED|Overall Study||0
10637082|NCT02069847|11795385|FG001|NOT COMPLETED|Overall Study||0
10637083|NCT02070237|11795392|FG000|STARTED|Overall Study||45
10637084|NCT02070237|11795393|FG001|STARTED|Overall Study||45
10637085|NCT02070237|11795392|FG000|COMPLETED|Overall Study||42
10637086|NCT02070237|11795393|FG001|COMPLETED|Overall Study||42
10637087|NCT02070237|11795392|FG000|NOT COMPLETED|Overall Study||3
10637088|NCT02070237|11795393|FG001|NOT COMPLETED|Overall Study||3
10637089|NCT02070276|11795402|FG000|STARTED|Overall Study||149
10637090|NCT02070276|11795403|FG001|STARTED|Overall Study||132
10637091|NCT02070276|11795404|FG002|STARTED|Overall Study||148
10637092|NCT02070276|11795402|FG000|COMPLETED|Overall Study||149
10637093|NCT02070276|11795403|FG001|COMPLETED|Overall Study||132
10637094|NCT02070276|11795404|FG002|COMPLETED|Overall Study||148
10637095|NCT02070276|11795402|FG000|NOT COMPLETED|Overall Study||0
10637096|NCT02070276|11795403|FG001|NOT COMPLETED|Overall Study||0
10637097|NCT02070276|11795404|FG002|NOT COMPLETED|Overall Study||0
10637098|NCT02070302|11795414|FG000|STARTED|Overall Study||5
10637099|NCT02070302|11795415|FG001|STARTED|Overall Study||5
10637100|NCT02070302|11795414|FG000|COMPLETED|Overall Study||5
10637101|NCT02070302|11795415|FG001|COMPLETED|Overall Study||5
10637102|NCT02070302|11795414|FG000|NOT COMPLETED|Overall Study||0
10637103|NCT02070302|11795415|FG001|NOT COMPLETED|Overall Study||0
10637104|NCT02070380|11795425|FG000|STARTED|First Injection||31
10637105|NCT02070380|11795426|FG001|STARTED|First Injection||39
10637106|NCT02070380|11795427|FG002|STARTED|First Injection||53
10637107|NCT02070380|11795428|FG003|STARTED|First Injection||54
10637108|NCT02070380|11795425|FG000|COMPLETED|First Injection||31
10637109|NCT02070380|11795426|FG001|COMPLETED|First Injection||39
10637110|NCT02070380|11795427|FG002|COMPLETED|First Injection||53
10637111|NCT02070380|11795428|FG003|COMPLETED|First Injection||54
10637112|NCT02070380|11795425|FG000|NOT COMPLETED|First Injection||0
10637113|NCT02070380|11795426|FG001|NOT COMPLETED|First Injection||0
10637114|NCT02070380|11795427|FG002|NOT COMPLETED|First Injection||0
10637115|NCT02070380|11795428|FG003|NOT COMPLETED|First Injection||0
10637116|NCT02070380|11795425|FG000|STARTED|Washout (no Second Injection/MRI)||31
10637117|NCT02070380|11795426|FG001|STARTED|Washout (no Second Injection/MRI)||39
10637118|NCT02070380|11795427|FG002|STARTED|Washout (no Second Injection/MRI)||53
10637119|NCT02070380|11795428|FG003|STARTED|Washout (no Second Injection/MRI)||54
10637120|NCT02070380|11795425|FG000|COMPLETED|Washout (no Second Injection/MRI)||31
10637121|NCT02070380|11795426|FG001|COMPLETED|Washout (no Second Injection/MRI)||34
10637122|NCT02070380|11795427|FG002|COMPLETED|Washout (no Second Injection/MRI)||51
10637123|NCT02070380|11795428|FG003|COMPLETED|Washout (no Second Injection/MRI)||51
10637124|NCT02070380|11795425|FG000|NOT COMPLETED|Washout (no Second Injection/MRI)||0
10637125|NCT02070380|11795426|FG001|NOT COMPLETED|Washout (no Second Injection/MRI)||5
10637126|NCT02070380|11795427|FG002|NOT COMPLETED|Washout (no Second Injection/MRI)||2
10637127|NCT02070380|11795428|FG003|NOT COMPLETED|Washout (no Second Injection/MRI)||3
10637128|NCT02070380|11795425|FG000|STARTED|Second Injection||31
10637129|NCT02070380|11795426|FG001|STARTED|Second Injection||34
10637130|NCT02070380|11795427|FG002|STARTED|Second Injection||51
10637131|NCT02070380|11795428|FG003|STARTED|Second Injection||51
10637132|NCT02070380|11795425|FG000|COMPLETED|Second Injection||31
10637133|NCT02070380|11795426|FG001|COMPLETED|Second Injection||32
10637134|NCT02070380|11795427|FG002|COMPLETED|Second Injection||50
10637135|NCT02070380|11795428|FG003|COMPLETED|Second Injection||46
10637136|NCT02070380|11795425|FG000|NOT COMPLETED|Second Injection||0
10637137|NCT02070380|11795426|FG001|NOT COMPLETED|Second Injection||2
10637138|NCT02070380|11795427|FG002|NOT COMPLETED|Second Injection||1
10637139|NCT02070380|11795428|FG003|NOT COMPLETED|Second Injection||5
10637140|NCT02070484|11795442|FG000|STARTED|Overall Study||3
10637141|NCT02070484|11795443|FG001|STARTED|Overall Study||3
10637142|NCT02070484|11795442|FG000|COMPLETED|Overall Study||2
10637143|NCT02070484|11795443|FG001|COMPLETED|Overall Study||3
10637144|NCT02070484|11795442|FG000|NOT COMPLETED|Overall Study||1
10637145|NCT02070484|11795443|FG001|NOT COMPLETED|Overall Study||0
10637146|NCT02070588|11795452|FG000|STARTED|Overall Study||86
10637147|NCT02070588|11795453|FG001|STARTED|Overall Study||26
10637148|NCT02070588|11795454|FG002|STARTED|Overall Study||0
10637149|NCT02070588|11795452|FG000|COMPLETED|Overall Study||47
10637150|NCT02070588|11795453|FG001|COMPLETED|Overall Study||25
10637151|NCT02070588|11795454|FG002|COMPLETED|Overall Study||0
10637152|NCT02070588|11795452|FG000|NOT COMPLETED|Overall Study||39
10637153|NCT02070588|11795453|FG001|NOT COMPLETED|Overall Study||1
10637154|NCT02070588|11795454|FG002|NOT COMPLETED|Overall Study||0
10637155|NCT02070640|11795464|FG000|STARTED|Overall Study||93
10637156|NCT02070640|11795465|FG001|STARTED|Overall Study||6
10637157|NCT02070640|11795464|FG000|COMPLETED|Overall Study||82
10637158|NCT02070640|11795465|FG001|COMPLETED|Overall Study||6
10637159|NCT02070640|11795464|FG000|NOT COMPLETED|Overall Study||11
10637160|NCT02070640|11795465|FG001|NOT COMPLETED|Overall Study||0
10637161|NCT02070692|11795474|FG000|STARTED|Overall Study||28
10637162|NCT02070692|11795475|FG001|STARTED|Overall Study||28
10637163|NCT02070692|11795474|FG000|COMPLETED|Overall Study||18
10637164|NCT02070692|11795475|FG001|COMPLETED|Overall Study||16
10637165|NCT02070692|11795474|FG000|NOT COMPLETED|Overall Study||10
10637166|NCT02070692|11795475|FG001|NOT COMPLETED|Overall Study||12
10637167|NCT02070744|11795485|FG000|STARTED|PC Phase (12 Weeks)||6
10637168|NCT02070744|11795486|FG001|STARTED|PC Phase (12 Weeks)||5
10637169|NCT02070744|11795487|FG002|STARTED|PC Phase (12 Weeks)||15
10637170|NCT02070744|11795488|FG003|STARTED|PC Phase (12 Weeks)||14
10637171|NCT02070744|11795489|FG004|STARTED|PC Phase (12 Weeks)||0
10637172|NCT02070744|11795485|FG000|Treated|PC Phase (12 Weeks)||6
10637173|NCT02070744|11795486|FG001|Treated|PC Phase (12 Weeks)||5
10637174|NCT02070744|11795487|FG002|Treated|PC Phase (12 Weeks)||15
10637175|NCT02070744|11795488|FG003|Treated|PC Phase (12 Weeks)||13
10637176|NCT02070744|11795489|FG004|Treated|PC Phase (12 Weeks)||0
10637177|NCT02070744|11795485|FG000|COMPLETED|PC Phase (12 Weeks)||6
10637178|NCT02070744|11795486|FG001|COMPLETED|PC Phase (12 Weeks)||5
10637179|NCT02070744|11795487|FG002|COMPLETED|PC Phase (12 Weeks)||15
10637180|NCT02070744|11795488|FG003|COMPLETED|PC Phase (12 Weeks)||13
10637181|NCT02070744|11795489|FG004|COMPLETED|PC Phase (12 Weeks)||0
10637182|NCT02070744|11795485|FG000|NOT COMPLETED|PC Phase (12 Weeks)||0
10637183|NCT02070744|11795486|FG001|NOT COMPLETED|PC Phase (12 Weeks)||0
10637184|NCT02070744|11795487|FG002|NOT COMPLETED|PC Phase (12 Weeks)||0
10637185|NCT02070744|11795488|FG003|NOT COMPLETED|PC Phase (12 Weeks)||1
10637186|NCT02070744|11795489|FG004|NOT COMPLETED|PC Phase (12 Weeks)||0
10637187|NCT02070744|11795485|FG000|STARTED|OLE Phase (48 Weeks)||0
10637188|NCT02070744|11795486|FG001|STARTED|OLE Phase (48 Weeks)||0
10637189|NCT02070744|11795487|FG002|STARTED|OLE Phase (48 Weeks)||0
10637190|NCT02070744|11795488|FG003|STARTED|OLE Phase (48 Weeks)||0
10637191|NCT02070744|11795489|FG004|STARTED|OLE Phase (48 Weeks)|12 participants completed PC phase, but did not enter OLE phase.|27
10637192|NCT02070744|11795485|FG000|COMPLETED|OLE Phase (48 Weeks)||0
10637193|NCT02070744|11795486|FG001|COMPLETED|OLE Phase (48 Weeks)||0
10637194|NCT02070744|11795487|FG002|COMPLETED|OLE Phase (48 Weeks)||0
10637195|NCT02070744|11795488|FG003|COMPLETED|OLE Phase (48 Weeks)||0
10637196|NCT02070744|11795489|FG004|COMPLETED|OLE Phase (48 Weeks)||24
10637197|NCT02070744|11795485|FG000|NOT COMPLETED|OLE Phase (48 Weeks)||0
10637198|NCT02070744|11795486|FG001|NOT COMPLETED|OLE Phase (48 Weeks)||0
10637199|NCT02070744|11795487|FG002|NOT COMPLETED|OLE Phase (48 Weeks)||0
10637200|NCT02070744|11795488|FG003|NOT COMPLETED|OLE Phase (48 Weeks)||0
10637201|NCT02070744|11795489|FG004|NOT COMPLETED|OLE Phase (48 Weeks)||3
10637202|NCT02070757|11795506|FG000|STARTED|Overall Study||362
10637203|NCT02070757|11795507|FG001|STARTED|Overall Study||364
10637204|NCT02070757|11795506|FG000|Treated Participants|Overall Study||361
10637205|NCT02070757|11795507|FG001|Treated Participants|Overall Study||359
10637206|NCT02070757|11795506|FG000|COMPLETED|Overall Study||245
10637207|NCT02070757|11795507|FG001|COMPLETED|Overall Study||250
10637208|NCT02070757|11795506|FG000|NOT COMPLETED|Overall Study||117
10637209|NCT02070757|11795507|FG001|NOT COMPLETED|Overall Study||114
10637210|NCT02070965|11795516|FG000|STARTED|Overall Study||27
10637211|NCT02070965|11795517|FG001|STARTED|Overall Study||23
10637212|NCT02070965|11795518|FG002|STARTED|Overall Study||25
10637213|NCT02070965|11795516|FG000|COMPLETED|Overall Study||25
10637214|NCT02070965|11795517|FG001|COMPLETED|Overall Study||21
10637215|NCT02070965|11795518|FG002|COMPLETED|Overall Study||24
10637216|NCT02070965|11795516|FG000|NOT COMPLETED|Overall Study||2
10637217|NCT02070965|11795517|FG001|NOT COMPLETED|Overall Study||2
10637218|NCT02070965|11795518|FG002|NOT COMPLETED|Overall Study||1
10637219|NCT02070978|11795529|FG000|STARTED|Overall Study||83
10637220|NCT02070978|11795530|FG001|STARTED|Overall Study||82
10637221|NCT02070978|11795531|FG002|STARTED|Overall Study||88
10637222|NCT02070978|11795529|FG000|COMPLETED|Overall Study||36
10637223|NCT02070978|11795530|FG001|COMPLETED|Overall Study||29
10637224|NCT02070978|11795531|FG002|COMPLETED|Overall Study||35
10637225|NCT02070978|11795529|FG000|NOT COMPLETED|Overall Study||47
10637226|NCT02070978|11795530|FG001|NOT COMPLETED|Overall Study||53
10637227|NCT02070978|11795531|FG002|NOT COMPLETED|Overall Study||53
10637228|NCT02070991|11795541|FG000|STARTED|Overall Study||31
10637229|NCT02070991|11795542|FG001|STARTED|Overall Study||32
10637230|NCT02070991|11795541|FG000|COMPLETED|Overall Study||28
10637231|NCT02070991|11795542|FG001|COMPLETED|Overall Study||32
10637232|NCT02070991|11795541|FG000|NOT COMPLETED|Overall Study||3
10637233|NCT02070991|11795542|FG001|NOT COMPLETED|Overall Study||0
10637234|NCT02071082|11795550|FG000|STARTED|Overall Study||4
10637235|NCT02071082|11795551|FG001|STARTED|Overall Study||75
10637236|NCT02071082|11795550|FG000|COMPLETED|Overall Study||2
10637237|NCT02071082|11795551|FG001|COMPLETED|Overall Study||68
10637238|NCT02071082|11795550|FG000|NOT COMPLETED|Overall Study||2
10637239|NCT02071082|11795551|FG001|NOT COMPLETED|Overall Study||7
10637240|NCT02071095|11795559|FG000|STARTED|Overall Study||12
10637241|NCT02071095|11795560|FG001|STARTED|Overall Study||3
10637242|NCT02071095|11795559|FG000|COMPLETED|Overall Study||12
10637243|NCT02071095|11795560|FG001|COMPLETED|Overall Study||3
10637244|NCT02071095|11795559|FG000|NOT COMPLETED|Overall Study||0
10637245|NCT02071095|11795560|FG001|NOT COMPLETED|Overall Study||0
10637246|NCT02071108|11795566|FG000|STARTED|Overall Study||35
10637247|NCT02071108|11795566|FG000|COMPLETED|Overall Study||35
10637248|NCT02071108|11795566|FG000|NOT COMPLETED|Overall Study||0
10637249|NCT02071173|11795570|FG000|STARTED|Overall Study||2244
10637250|NCT02071173|11795570|FG000|Implanted/Attempted With a Study Device|Overall Study||2200
10637251|NCT02071173|11795570|FG000|RELIANCE 4-FRONT Endpoint Population|Overall Study|1507 with active fixation 4-FRONT lead, 37 with passive fixation 4-FRONT lead|1544
10637252|NCT02071173|11795570|FG000|ACUITY X4 Endpoint Population|Overall Study|536 with ACUITY X4 Spiral lead, 228 with ACUITY X4 Straight lead|764
10637253|NCT02071173|11795570|FG000|COMPLETED|Overall Study|Follow-up is ongoing. Data as of 5-Feb-2020.|409
10637254|NCT02071173|11795570|FG000|NOT COMPLETED|Overall Study||1835
10637255|NCT02071225|11795575|FG000|STARTED|Overall Study||72
10637256|NCT02071225|11795575|FG000|COMPLETED|Overall Study||42
10637257|NCT02071225|11795575|FG000|NOT COMPLETED|Overall Study||30
10637258|NCT02071290|11795581|FG000|STARTED|Overall Study||25
10637259|NCT02071290|11795582|FG001|STARTED|Overall Study||25
10637260|NCT02071290|11795581|FG000|COMPLETED|Overall Study||21
10637261|NCT02071290|11795582|FG001|COMPLETED|Overall Study||18
10637262|NCT02071290|11795581|FG000|NOT COMPLETED|Overall Study||4
10637263|NCT02071290|11795582|FG001|NOT COMPLETED|Overall Study||7
10637264|NCT02071420|11795590|FG000|STARTED|Overall Study||30
10637265|NCT02071420|11795591|FG001|STARTED|Overall Study||30
10637266|NCT02071420|11795590|FG000|COMPLETED|Overall Study||27
10637267|NCT02071420|11795591|FG001|COMPLETED|Overall Study||27
10637268|NCT02071420|11795590|FG000|NOT COMPLETED|Overall Study||3
10637269|NCT02071420|11795591|FG001|NOT COMPLETED|Overall Study||3
10637270|NCT02071706|11795597|FG000|STARTED|Overall Study||62
10637271|NCT02071706|11795597|FG000|COMPLETED|Overall Study||59
10637272|NCT02071706|11795597|FG000|NOT COMPLETED|Overall Study||3
10637273|NCT02071771|11795601|FG000|STARTED|Period 1: First 10 Days||41
10637274|NCT02071771|11795602|FG001|STARTED|Period 1: First 10 Days||39
10637275|NCT02071771|11795601|FG000|Dispensed|Period 1: First 10 Days||39
10637276|NCT02071771|11795602|FG001|Dispensed|Period 1: First 10 Days||39
10637277|NCT02071771|11795601|FG000|COMPLETED|Period 1: First 10 Days||39
10637278|NCT02071771|11795602|FG001|COMPLETED|Period 1: First 10 Days||39
10637279|NCT02071771|11795601|FG000|NOT COMPLETED|Period 1: First 10 Days||2
10637280|NCT02071771|11795602|FG001|NOT COMPLETED|Period 1: First 10 Days||0
10637281|NCT02071771|11795601|FG000|STARTED|Period 2: Second 10 Days||39
10637282|NCT02071771|11795602|FG001|STARTED|Period 2: Second 10 Days|One participant completed Period 1 but did not start Period 2 due to unacceptable fit with DACP T.|38
10637283|NCT02071771|11795601|FG000|COMPLETED|Period 2: Second 10 Days||39
10637284|NCT02071771|11795602|FG001|COMPLETED|Period 2: Second 10 Days||38
10637285|NCT02071771|11795601|FG000|NOT COMPLETED|Period 2: Second 10 Days||0
10637286|NCT02071771|11795602|FG001|NOT COMPLETED|Period 2: Second 10 Days||0
10637287|NCT02071810|11795613|FG000|STARTED|Overall Study||6
10637288|NCT02071810|11795614|FG001|STARTED|Overall Study||6
10637289|NCT02071810|11795615|FG002|STARTED|Overall Study||6
10637290|NCT02071810|11795616|FG003|STARTED|Overall Study||7
10637291|NCT02071810|11795617|FG004|STARTED|Overall Study||9
10637292|NCT02071810|11795613|FG000|COMPLETED|Overall Study||6
10637293|NCT02071810|11795614|FG001|COMPLETED|Overall Study||6
10637294|NCT02071810|11795615|FG002|COMPLETED|Overall Study||6
10637295|NCT02071810|11795616|FG003|COMPLETED|Overall Study||6
10637296|NCT02071810|11795617|FG004|COMPLETED|Overall Study||8
10637297|NCT02071810|11795613|FG000|NOT COMPLETED|Overall Study||0
10637298|NCT02071810|11795614|FG001|NOT COMPLETED|Overall Study||0
10637299|NCT02071810|11795615|FG002|NOT COMPLETED|Overall Study||0
10637300|NCT02071810|11795616|FG003|NOT COMPLETED|Overall Study||1
10637301|NCT02071810|11795617|FG004|NOT COMPLETED|Overall Study||1
10637302|NCT02071823|11795631|FG000|STARTED|Overall Study||6
10637303|NCT02071823|11795632|FG001|STARTED|Overall Study||6
10637304|NCT02071823|11795631|FG000|COMPLETED|Overall Study||5
10637305|NCT02071823|11795632|FG001|COMPLETED|Overall Study||6
10637306|NCT02071823|11795631|FG000|NOT COMPLETED|Overall Study||1
10637307|NCT02071823|11795632|FG001|NOT COMPLETED|Overall Study||0
10637308|NCT02071849|11795640|FG000|STARTED|6-month Primary Endpoint||20
10637309|NCT02071849|11795640|FG000|COMPLETED|6-month Primary Endpoint||15
10637310|NCT02071849|11795640|FG000|NOT COMPLETED|6-month Primary Endpoint||5
10637311|NCT02071849|11795640|FG000|STARTED|2-year Extended Follow-up||15
10637312|NCT02071849|11795640|FG000|COMPLETED|2-year Extended Follow-up||14
10637313|NCT02071849|11795640|FG000|NOT COMPLETED|2-year Extended Follow-up||1
10637314|NCT02071914|11795647|FG000|STARTED|Overall Study||27
10637315|NCT02071914|11795648|FG001|STARTED|Overall Study||27
10637316|NCT02071914|11795649|FG002|STARTED|Overall Study||27
10637317|NCT02071914|11795647|FG000|COMPLETED|Overall Study||27
10637318|NCT02071914|11795648|FG001|COMPLETED|Overall Study||27
10637319|NCT02071914|11795649|FG002|COMPLETED|Overall Study||27
10637320|NCT02071914|11795647|FG000|NOT COMPLETED|Overall Study||0
10637321|NCT02071914|11795648|FG001|NOT COMPLETED|Overall Study||0
10637322|NCT02071914|11795649|FG002|NOT COMPLETED|Overall Study||0
10637323|NCT02072096|11795659|FG000|STARTED|Overall Study||99
10637324|NCT02072096|11795660|FG001|STARTED|Overall Study||93
10637325|NCT02072096|11795659|FG000|Received at Least One Dose of Study Drug|Overall Study||98
10637326|NCT02072096|11795660|FG001|Received at Least One Dose of Study Drug|Overall Study||93
10637327|NCT02072096|11795659|FG000|COMPLETED|Overall Study||14
10637328|NCT02072096|11795660|FG001|COMPLETED|Overall Study||15
10637329|NCT02072096|11795659|FG000|NOT COMPLETED|Overall Study||85
10637330|NCT02072096|11795660|FG001|NOT COMPLETED|Overall Study||78
10637331|NCT02072174|11795669|FG000|STARTED|Overall Study||290
10637332|NCT02072174|11795670|FG001|STARTED|Overall Study||279
10637333|NCT02072174|11795669|FG000|COMPLETED|Overall Study||258
10637334|NCT02072174|11795670|FG001|COMPLETED|Overall Study||240
10637335|NCT02072174|11795669|FG000|NOT COMPLETED|Overall Study||32
10637336|NCT02072174|11795670|FG001|NOT COMPLETED|Overall Study||39
10637337|NCT02072200|11795678|FG000|STARTED|Overall Study||147
10637338|NCT02072200|11795678|FG000|COMPLETED|Overall Study||145
10637339|NCT02072200|11795678|FG000|NOT COMPLETED|Overall Study||2
10637340|NCT02072226|11795684|FG000|STARTED|Overall Study||156
10637341|NCT02072226|11795685|FG001|STARTED|Overall Study||157
10637342|NCT02072226|11795684|FG000|COMPLETED|Overall Study||141
10637343|NCT02072226|11795685|FG001|COMPLETED|Overall Study||147
10637344|NCT02072226|11795684|FG000|NOT COMPLETED|Overall Study||15
10637345|NCT02072226|11795685|FG001|NOT COMPLETED|Overall Study||10
10637346|NCT02072421|11795691|FG000|STARTED|Overall Study||2879
10637347|NCT02072421|11795691|FG000|COMPLETED|Overall Study||2489
10637348|NCT02072421|11795691|FG000|NOT COMPLETED|Overall Study||390
10637349|NCT02072434|11795698|FG000|STARTED|Overall Study||1095
10637350|NCT02072434|11795699|FG001|STARTED|Overall Study||1104
10637351|NCT02072434|11795698|FG000|Intent to Treat Analysis Set|Overall Study||1095
10637352|NCT02072434|11795699|FG001|Intent to Treat Analysis Set|Overall Study||1104
10637353|NCT02072434|11795698|FG000|Received Study Drug|Overall Study||1067
10637354|NCT02072434|11795699|FG001|Received Study Drug|Overall Study||1082
10637355|NCT02072434|11795698|FG000|Safety Analysis Set|Overall Study||1067
10637356|NCT02072434|11795699|FG001|Safety Analysis Set|Overall Study||1082
10637357|NCT02072434|11795698|FG000|COMPLETED|Overall Study||1041
10637358|NCT02072434|11795699|FG001|COMPLETED|Overall Study||1014
10637359|NCT02072434|11795698|FG000|NOT COMPLETED|Overall Study||54
10637360|NCT02072434|11795699|FG001|NOT COMPLETED|Overall Study||90
10637361|NCT02072668|11795705|FG000|STARTED|First Intervention||7
10637362|NCT02072668|11795706|FG001|STARTED|First Intervention||7
10637363|NCT02072668|11795705|FG000|COMPLETED|First Intervention||7
10637364|NCT02072668|11795706|FG001|COMPLETED|First Intervention||7
10637365|NCT02072668|11795705|FG000|NOT COMPLETED|First Intervention||0
10637366|NCT02072668|11795706|FG001|NOT COMPLETED|First Intervention||0
10637367|NCT02072668|11795705|FG000|STARTED|Washout (2 Weeks)||7
10637368|NCT02072668|11795706|FG001|STARTED|Washout (2 Weeks)||7
10637369|NCT02072668|11795705|FG000|COMPLETED|Washout (2 Weeks)||7
10637370|NCT02072668|11795706|FG001|COMPLETED|Washout (2 Weeks)||7
10637371|NCT02072668|11795705|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10637372|NCT02072668|11795706|FG001|NOT COMPLETED|Washout (2 Weeks)||0
10637373|NCT02072668|11795705|FG000|STARTED|Second Intervention||7
10637374|NCT02072668|11795706|FG001|STARTED|Second Intervention||7
10637375|NCT02072668|11795705|FG000|COMPLETED|Second Intervention||6
10637376|NCT02072668|11795706|FG001|COMPLETED|Second Intervention||7
10637377|NCT02072668|11795705|FG000|NOT COMPLETED|Second Intervention||1
10637378|NCT02072668|11795706|FG001|NOT COMPLETED|Second Intervention||0
10637379|NCT02072824|11795717|FG000|STARTED|Overall Study||71
10637380|NCT02072824|11795718|FG001|STARTED|Overall Study||34
10637381|NCT02072824|11795719|FG002|STARTED|Overall Study||70
10637382|NCT02072824|11795717|FG000|COMPLETED|Overall Study||69
10637383|NCT02072824|11795718|FG001|COMPLETED|Overall Study||33
10637384|NCT02072824|11795719|FG002|COMPLETED|Overall Study||67
10637385|NCT02072824|11795717|FG000|NOT COMPLETED|Overall Study||2
10637386|NCT02072824|11795718|FG001|NOT COMPLETED|Overall Study||1
10637387|NCT02072824|11795719|FG002|NOT COMPLETED|Overall Study||3
10637388|NCT02072928|11795727|FG000|STARTED|Overall Study||55
10637389|NCT02072928|11795727|FG000|COMPLETED|Overall Study||55
10637390|NCT02072928|11795727|FG000|NOT COMPLETED|Overall Study||0
10637391|NCT02072941|11795733|FG000|STARTED|Overall Study||219
10637392|NCT02072941|11795734|FG001|STARTED|Overall Study||226
10637393|NCT02072941|11795733|FG000|COMPLETED|Overall Study||181
10637394|NCT02072941|11795734|FG001|COMPLETED|Overall Study||197
10637395|NCT02072941|11795733|FG000|NOT COMPLETED|Overall Study||38
10637396|NCT02072941|11795734|FG001|NOT COMPLETED|Overall Study||29
10637397|NCT02072980|11795740|FG000|STARTED|Period 1, First Wear||7
10637398|NCT02072980|11795741|FG001|STARTED|Period 1, First Wear||8
10637399|NCT02072980|11795740|FG000|COMPLETED|Period 1, First Wear||7
10637400|NCT02072980|11795741|FG001|COMPLETED|Period 1, First Wear||8
10637401|NCT02072980|11795740|FG000|NOT COMPLETED|Period 1, First Wear||0
10637402|NCT02072980|11795741|FG001|NOT COMPLETED|Period 1, First Wear||0
10637403|NCT02072980|11795740|FG000|STARTED|Period 2, Second Wear||7
10637404|NCT02072980|11795741|FG001|STARTED|Period 2, Second Wear||8
10637405|NCT02072980|11795740|FG000|COMPLETED|Period 2, Second Wear||7
10637406|NCT02072980|11795741|FG001|COMPLETED|Period 2, Second Wear||7
10637407|NCT02072980|11795740|FG000|NOT COMPLETED|Period 2, Second Wear||0
10637408|NCT02072980|11795741|FG001|NOT COMPLETED|Period 2, Second Wear||1
10637409|NCT02073162|11795749|FG000|STARTED|Overall Study||1499
10637410|NCT02073162|11795750|FG001|STARTED|Overall Study||1501
10637411|NCT02073162|11795749|FG000|COMPLETED|Overall Study||1493
10637412|NCT02073162|11795750|FG001|COMPLETED|Overall Study||1490
10637413|NCT02073162|11795749|FG000|NOT COMPLETED|Overall Study||6
10637414|NCT02073162|11795750|FG001|NOT COMPLETED|Overall Study||11
10637415|NCT02073331|11795756|FG000|STARTED|Overall Study||1420
10637416|NCT02073331|11795756|FG000|COMPLETED|Overall Study||1420
10637417|NCT02073331|11795756|FG000|NOT COMPLETED|Overall Study||0
10637418|NCT02073435|11795762|FG000|STARTED|Overall Study||81
10637419|NCT02073435|11795763|FG001|STARTED|Overall Study||96
10637420|NCT02073435|11795762|FG000|COMPLETED|Overall Study||81
10637421|NCT02073435|11795763|FG001|COMPLETED|Overall Study||96
10637422|NCT02073435|11795762|FG000|NOT COMPLETED|Overall Study||0
10637423|NCT02073435|11795763|FG001|NOT COMPLETED|Overall Study||0
10637424|NCT02073448|11795772|FG000|STARTED|Overall Study||101
10637425|NCT02073448|11795773|FG001|STARTED|Overall Study||212
10637426|NCT02073448|11795774|FG002|STARTED|Overall Study||104
10637427|NCT02073448|11795772|FG000|COMPLETED|Overall Study||99
10637428|NCT02073448|11795773|FG001|COMPLETED|Overall Study||200
10637429|NCT02073448|11795774|FG002|COMPLETED|Overall Study||99
10637430|NCT02073448|11795772|FG000|NOT COMPLETED|Overall Study||2
10637431|NCT02073448|11795773|FG001|NOT COMPLETED|Overall Study||12
10637432|NCT02073448|11795774|FG002|NOT COMPLETED|Overall Study||5
10637433|NCT02073461|11795787|FG000|STARTED|Overall Study||79
10637434|NCT02073461|11795788|FG001|STARTED|Overall Study||78
10637435|NCT02073461|11795789|FG002|STARTED|Overall Study||79
10637436|NCT02073461|11795787|FG000|COMPLETED|Overall Study||75
10637437|NCT02073461|11795788|FG001|COMPLETED|Overall Study||77
10637438|NCT02073461|11795789|FG002|COMPLETED|Overall Study||78
10637439|NCT02073461|11795787|FG000|NOT COMPLETED|Overall Study||4
10637440|NCT02073461|11795788|FG001|NOT COMPLETED|Overall Study||1
10637441|NCT02073461|11795789|FG002|NOT COMPLETED|Overall Study||1
10637442|NCT02073487|11795799|FG000|STARTED|Overall Study||16
10637443|NCT02073487|11795800|FG001|STARTED|Overall Study||16
10637444|NCT02073487|11795799|FG000|COMPLETED|Overall Study||14
10637445|NCT02073487|11795800|FG001|COMPLETED|Overall Study||16
10637446|NCT02073487|11795799|FG000|NOT COMPLETED|Overall Study||2
10637447|NCT02073487|11795800|FG001|NOT COMPLETED|Overall Study||0
10637448|NCT02073643|11795807|FG000|STARTED|Overall Study||204
10637449|NCT02073643|11795807|FG000|COMPLETED|Overall Study||180
10637450|NCT02073643|11795807|FG000|NOT COMPLETED|Overall Study||24
10637451|NCT02073656|11795811|FG000|STARTED|Primary Study||335
10637452|NCT02073656|11795811|FG000|COMPLETED|Primary Study||327
10637453|NCT02073656|11795811|FG000|NOT COMPLETED|Primary Study||8
10637454|NCT02073656|11795811|FG000|STARTED|Retreatment Substudy|Only participants experiencing virologic relapse in the Primary Study were eligible for retreatment.|9
10637455|NCT02073656|11795811|FG000|COMPLETED|Retreatment Substudy||9
10637456|NCT02073656|11795811|FG000|NOT COMPLETED|Retreatment Substudy||0
10637457|NCT02073682|11795819|FG000|STARTED|Overall Study||522
10637458|NCT02073682|11795820|FG001|STARTED|Overall Study||524
10637459|NCT02073682|11795819|FG000|COMPLETED|Overall Study||200
10637460|NCT02073682|11795820|FG001|COMPLETED|Overall Study||154
10637461|NCT02073682|11795819|FG000|NOT COMPLETED|Overall Study||322
10637462|NCT02073682|11795820|FG001|NOT COMPLETED|Overall Study||370
10637463|NCT02073747|11795828|FG000|STARTED|Overall Study||15
10637464|NCT02073747|11795829|FG001|STARTED|Overall Study||15
10637465|NCT02073747|11795828|FG000|COMPLETED|Overall Study||14
10637466|NCT02073747|11795829|FG001|COMPLETED|Overall Study||14
10637467|NCT02073747|11795828|FG000|NOT COMPLETED|Overall Study||1
10637468|NCT02073747|11795829|FG001|NOT COMPLETED|Overall Study||1
10637469|NCT02073929|11795837|FG000|STARTED|Overall Study||48
10637470|NCT02073929|11795838|FG001|STARTED|Overall Study||24
10637471|NCT02073929|11795837|FG000|COMPLETED|Overall Study||44
10637472|NCT02073929|11795838|FG001|COMPLETED|Overall Study||21
10637473|NCT02073929|11795837|FG000|NOT COMPLETED|Overall Study||4
10637474|NCT02073929|11795838|FG001|NOT COMPLETED|Overall Study||3
10637475|NCT02074059|11795850|FG000|STARTED|Overall Study||8
10637476|NCT02074059|11795851|FG001|STARTED|Overall Study||8
10637477|NCT02074059|11795852|FG002|STARTED|Overall Study||8
10637478|NCT02074059|11795853|FG003|STARTED|Overall Study||8
10637479|NCT02074059|11795854|FG004|STARTED|Overall Study||8
10637480|NCT02074059|11795855|FG005|STARTED|Overall Study||40
10637481|NCT02074059|11795850|FG000|COMPLETED|Overall Study||8
10637482|NCT02074059|11795851|FG001|COMPLETED|Overall Study||8
10637483|NCT02074059|11795852|FG002|COMPLETED|Overall Study||8
10637484|NCT02074059|11795853|FG003|COMPLETED|Overall Study||8
10637485|NCT02074059|11795854|FG004|COMPLETED|Overall Study||7
10637486|NCT02074059|11795855|FG005|COMPLETED|Overall Study||39
10637487|NCT02074059|11795850|FG000|NOT COMPLETED|Overall Study||0
10637488|NCT02074059|11795851|FG001|NOT COMPLETED|Overall Study||0
10637489|NCT02074059|11795852|FG002|NOT COMPLETED|Overall Study||0
10637490|NCT02074059|11795853|FG003|NOT COMPLETED|Overall Study||0
10637491|NCT02074059|11795854|FG004|NOT COMPLETED|Overall Study||1
10637492|NCT02074059|11795855|FG005|NOT COMPLETED|Overall Study||1
10637493|NCT02074345|11795870|FG000|STARTED|Overall Study||31
10637494|NCT02074345|11795870|FG000|COMPLETED|Overall Study||31
10637495|NCT02074345|11795870|FG000|NOT COMPLETED|Overall Study||0
10637496|NCT02074358|11795874|FG000|STARTED|Overall Study||3
10637497|NCT02074358|11795875|FG001|STARTED|Overall Study||3
10637498|NCT02074358|11795876|FG002|STARTED|Overall Study||2
10637499|NCT02074358|11795877|FG003|STARTED|Overall Study||2
10637500|NCT02074358|11795878|FG004|STARTED|Overall Study||3
10637501|NCT02074358|11795879|FG005|STARTED|Overall Study||2
10637502|NCT02074358|11795874|FG000|COMPLETED|Overall Study||3
10637503|NCT02074358|11795875|FG001|COMPLETED|Overall Study||3
10637504|NCT02074358|11795876|FG002|COMPLETED|Overall Study||2
10637505|NCT02074358|11795877|FG003|COMPLETED|Overall Study||2
10637506|NCT02074358|11795878|FG004|COMPLETED|Overall Study||3
10637507|NCT02074358|11795879|FG005|COMPLETED|Overall Study||2
10637508|NCT02074358|11795874|FG000|NOT COMPLETED|Overall Study||0
10637509|NCT02074358|11795875|FG001|NOT COMPLETED|Overall Study||0
10637510|NCT02074358|11795876|FG002|NOT COMPLETED|Overall Study||0
10637511|NCT02074358|11795877|FG003|NOT COMPLETED|Overall Study||0
10637512|NCT02074358|11795878|FG004|NOT COMPLETED|Overall Study||0
10637513|NCT02074358|11795879|FG005|NOT COMPLETED|Overall Study||0
10637514|NCT02074384|11795890|FG000|STARTED|Overall Study||74
10637515|NCT02074384|11795891|FG001|STARTED|Overall Study||70
10637516|NCT02074384|11795892|FG002|STARTED|Overall Study||17
10637517|NCT02074384|11795890|FG000|COMPLETED|Overall Study||74
10637518|NCT02074384|11795891|FG001|COMPLETED|Overall Study||70
10637519|NCT02074384|11795892|FG002|COMPLETED|Overall Study||17
10637520|NCT02074384|11795890|FG000|NOT COMPLETED|Overall Study||0
10637521|NCT02074384|11795891|FG001|NOT COMPLETED|Overall Study||0
10637522|NCT02074384|11795892|FG002|NOT COMPLETED|Overall Study||0
10637523|NCT02074514|11795904|FG000|STARTED|Overall Study||59
10637524|NCT02074514|11795905|FG001|STARTED|Overall Study||58
10637525|NCT02074514|11795904|FG000|COMPLETED|Overall Study||56
10637526|NCT02074514|11795905|FG001|COMPLETED|Overall Study||54
10637527|NCT02074514|11795904|FG000|NOT COMPLETED|Overall Study||3
10637528|NCT02074514|11795905|FG001|NOT COMPLETED|Overall Study||4
10637529|NCT02074553|11795917|FG000|STARTED|Intervention Period 1||12
10637530|NCT02074553|11795918|FG001|STARTED|Intervention Period 1||12
10637531|NCT02074553|11795919|FG002|STARTED|Intervention Period 1||12
10637532|NCT02074553|11795920|FG003|STARTED|Intervention Period 1||13
10637533|NCT02074553|11795921|FG004|STARTED|Intervention Period 1||12
10637534|NCT02074553|11795922|FG005|STARTED|Intervention Period 1||12
10637535|NCT02074553|11795923|FG006|STARTED|Intervention Period 1||12
10637536|NCT02074553|11795924|FG007|STARTED|Intervention Period 1||12
10637537|NCT02074553|11795917|FG000|COMPLETED|Intervention Period 1||12
10637538|NCT02074553|11795918|FG001|COMPLETED|Intervention Period 1||12
10637539|NCT02074553|11795919|FG002|COMPLETED|Intervention Period 1||12
10637540|NCT02074553|11795920|FG003|COMPLETED|Intervention Period 1||12
10637541|NCT02074553|11795921|FG004|COMPLETED|Intervention Period 1||12
10637542|NCT02074553|11795922|FG005|COMPLETED|Intervention Period 1||12
10637543|NCT02074553|11795923|FG006|COMPLETED|Intervention Period 1||12
10637544|NCT02074553|11795924|FG007|COMPLETED|Intervention Period 1||12
10637545|NCT02074553|11795917|FG000|NOT COMPLETED|Intervention Period 1||0
10637546|NCT02074553|11795918|FG001|NOT COMPLETED|Intervention Period 1||0
10637547|NCT02074553|11795919|FG002|NOT COMPLETED|Intervention Period 1||0
10637548|NCT02074553|11795920|FG003|NOT COMPLETED|Intervention Period 1||1
10637549|NCT02074553|11795921|FG004|NOT COMPLETED|Intervention Period 1||0
10637550|NCT02074553|11795922|FG005|NOT COMPLETED|Intervention Period 1||0
10637551|NCT02074553|11795923|FG006|NOT COMPLETED|Intervention Period 1||0
10637552|NCT02074553|11795924|FG007|NOT COMPLETED|Intervention Period 1||0
10637553|NCT02074553|11795917|FG000|STARTED|Washout Period 1||12
10637554|NCT02074553|11795918|FG001|STARTED|Washout Period 1||12
10637555|NCT02074553|11795919|FG002|STARTED|Washout Period 1||12
10637556|NCT02074553|11795920|FG003|STARTED|Washout Period 1||12
10637557|NCT02074553|11795921|FG004|STARTED|Washout Period 1||12
10637558|NCT02074553|11795922|FG005|STARTED|Washout Period 1||12
10637559|NCT02074553|11795923|FG006|STARTED|Washout Period 1||12
10637560|NCT02074553|11795924|FG007|STARTED|Washout Period 1||12
10637561|NCT02074553|11795917|FG000|COMPLETED|Washout Period 1||11
10637562|NCT02074553|11795918|FG001|COMPLETED|Washout Period 1||12
10637563|NCT02074553|11795919|FG002|COMPLETED|Washout Period 1||12
10637564|NCT02074553|11795920|FG003|COMPLETED|Washout Period 1||11
10637565|NCT02074553|11795921|FG004|COMPLETED|Washout Period 1||12
10637566|NCT02074553|11795922|FG005|COMPLETED|Washout Period 1||11
10637567|NCT02074553|11795923|FG006|COMPLETED|Washout Period 1||12
10637568|NCT02074553|11795924|FG007|COMPLETED|Washout Period 1||12
10637569|NCT02074553|11795917|FG000|NOT COMPLETED|Washout Period 1||1
10637570|NCT02074553|11795918|FG001|NOT COMPLETED|Washout Period 1||0
10637571|NCT02074553|11795919|FG002|NOT COMPLETED|Washout Period 1||0
10637572|NCT02074553|11795920|FG003|NOT COMPLETED|Washout Period 1||1
10637573|NCT02074553|11795921|FG004|NOT COMPLETED|Washout Period 1||0
10637574|NCT02074553|11795922|FG005|NOT COMPLETED|Washout Period 1||1
10637575|NCT02074553|11795923|FG006|NOT COMPLETED|Washout Period 1||0
10637576|NCT02074553|11795924|FG007|NOT COMPLETED|Washout Period 1||0
10637577|NCT02074553|11795917|FG000|STARTED|Intervention Period 2||11
10637578|NCT02074553|11795918|FG001|STARTED|Intervention Period 2||12
10637579|NCT02074553|11795919|FG002|STARTED|Intervention Period 2||12
10637580|NCT02074553|11795920|FG003|STARTED|Intervention Period 2||11
10637581|NCT02074553|11795921|FG004|STARTED|Intervention Period 2||12
10637582|NCT02074553|11795922|FG005|STARTED|Intervention Period 2||11
10637583|NCT02074553|11795923|FG006|STARTED|Intervention Period 2||12
10637584|NCT02074553|11795924|FG007|STARTED|Intervention Period 2||12
10637585|NCT02074553|11795917|FG000|COMPLETED|Intervention Period 2||11
10637586|NCT02074553|11795918|FG001|COMPLETED|Intervention Period 2||12
10637587|NCT02074553|11795919|FG002|COMPLETED|Intervention Period 2||12
10637588|NCT02074553|11795920|FG003|COMPLETED|Intervention Period 2||11
10637589|NCT02074553|11795921|FG004|COMPLETED|Intervention Period 2||12
10637590|NCT02074553|11795922|FG005|COMPLETED|Intervention Period 2||11
10637591|NCT02074553|11795923|FG006|COMPLETED|Intervention Period 2||12
10637592|NCT02074553|11795924|FG007|COMPLETED|Intervention Period 2||12
10637593|NCT02074553|11795917|FG000|NOT COMPLETED|Intervention Period 2||0
10637594|NCT02074553|11795918|FG001|NOT COMPLETED|Intervention Period 2||0
10637595|NCT02074553|11795919|FG002|NOT COMPLETED|Intervention Period 2||0
10637596|NCT02074553|11795920|FG003|NOT COMPLETED|Intervention Period 2||0
10637597|NCT02074553|11795921|FG004|NOT COMPLETED|Intervention Period 2||0
10637598|NCT02074553|11795922|FG005|NOT COMPLETED|Intervention Period 2||0
10637599|NCT02074553|11795923|FG006|NOT COMPLETED|Intervention Period 2||0
10637600|NCT02074553|11795924|FG007|NOT COMPLETED|Intervention Period 2||0
10637601|NCT02074553|11795917|FG000|STARTED|Washout Period 2||11
10637602|NCT02074553|11795918|FG001|STARTED|Washout Period 2||12
10637603|NCT02074553|11795919|FG002|STARTED|Washout Period 2||12
10637604|NCT02074553|11795920|FG003|STARTED|Washout Period 2||11
10637605|NCT02074553|11795921|FG004|STARTED|Washout Period 2||12
10637606|NCT02074553|11795922|FG005|STARTED|Washout Period 2||11
10637607|NCT02074553|11795923|FG006|STARTED|Washout Period 2||12
10637608|NCT02074553|11795924|FG007|STARTED|Washout Period 2||12
10637609|NCT02074553|11795917|FG000|COMPLETED|Washout Period 2||11
10637610|NCT02074553|11795918|FG001|COMPLETED|Washout Period 2||12
10637611|NCT02074553|11795919|FG002|COMPLETED|Washout Period 2||11
10637612|NCT02074553|11795920|FG003|COMPLETED|Washout Period 2||11
10637613|NCT02074553|11795921|FG004|COMPLETED|Washout Period 2||12
10637614|NCT02074553|11795922|FG005|COMPLETED|Washout Period 2||10
10637615|NCT02074553|11795923|FG006|COMPLETED|Washout Period 2||11
10637616|NCT02074553|11795924|FG007|COMPLETED|Washout Period 2||12
10637617|NCT02074553|11795917|FG000|NOT COMPLETED|Washout Period 2||0
10637618|NCT02074553|11795918|FG001|NOT COMPLETED|Washout Period 2||0
10637619|NCT02074553|11795919|FG002|NOT COMPLETED|Washout Period 2||1
10637620|NCT02074553|11795920|FG003|NOT COMPLETED|Washout Period 2||0
10637621|NCT02074553|11795921|FG004|NOT COMPLETED|Washout Period 2||0
10637622|NCT02074553|11795922|FG005|NOT COMPLETED|Washout Period 2||1
10637623|NCT02074553|11795923|FG006|NOT COMPLETED|Washout Period 2||1
10637624|NCT02074553|11795924|FG007|NOT COMPLETED|Washout Period 2||0
10637625|NCT02074553|11795917|FG000|STARTED|Intervention Period 3||11
10637626|NCT02074553|11795918|FG001|STARTED|Intervention Period 3||12
10637627|NCT02074553|11795919|FG002|STARTED|Intervention Period 3||11
10637628|NCT02074553|11795920|FG003|STARTED|Intervention Period 3||11
10637629|NCT02074553|11795921|FG004|STARTED|Intervention Period 3||12
10637630|NCT02074553|11795922|FG005|STARTED|Intervention Period 3||10
10637631|NCT02074553|11795923|FG006|STARTED|Intervention Period 3||11
10637632|NCT02074553|11795924|FG007|STARTED|Intervention Period 3||12
10637633|NCT02074553|11795917|FG000|COMPLETED|Intervention Period 3||11
10637634|NCT02074553|11795918|FG001|COMPLETED|Intervention Period 3||12
10637635|NCT02074553|11795919|FG002|COMPLETED|Intervention Period 3||11
10637636|NCT02074553|11795920|FG003|COMPLETED|Intervention Period 3||11
10637637|NCT02074553|11795921|FG004|COMPLETED|Intervention Period 3||12
10637638|NCT02074553|11795922|FG005|COMPLETED|Intervention Period 3||10
10637639|NCT02074553|11795923|FG006|COMPLETED|Intervention Period 3||11
10637640|NCT02074553|11795924|FG007|COMPLETED|Intervention Period 3||12
10637641|NCT02074553|11795917|FG000|NOT COMPLETED|Intervention Period 3||0
10637642|NCT02074553|11795918|FG001|NOT COMPLETED|Intervention Period 3||0
10637643|NCT02074553|11795919|FG002|NOT COMPLETED|Intervention Period 3||0
10637644|NCT02074553|11795920|FG003|NOT COMPLETED|Intervention Period 3||0
10637645|NCT02074553|11795921|FG004|NOT COMPLETED|Intervention Period 3||0
10637646|NCT02074553|11795922|FG005|NOT COMPLETED|Intervention Period 3||0
10637647|NCT02074553|11795923|FG006|NOT COMPLETED|Intervention Period 3||0
10637648|NCT02074553|11795924|FG007|NOT COMPLETED|Intervention Period 3||0
10637649|NCT02074553|11795917|FG000|STARTED|Washout Period 3||11
10637650|NCT02074553|11795918|FG001|STARTED|Washout Period 3||12
10637651|NCT02074553|11795919|FG002|STARTED|Washout Period 3||11
10637652|NCT02074553|11795920|FG003|STARTED|Washout Period 3||11
10637653|NCT02074553|11795921|FG004|STARTED|Washout Period 3||12
10637654|NCT02074553|11795922|FG005|STARTED|Washout Period 3||10
10637655|NCT02074553|11795923|FG006|STARTED|Washout Period 3||11
10637656|NCT02074553|11795924|FG007|STARTED|Washout Period 3||12
10637657|NCT02074553|11795917|FG000|COMPLETED|Washout Period 3||11
10637658|NCT02074553|11795918|FG001|COMPLETED|Washout Period 3||12
10637659|NCT02074553|11795919|FG002|COMPLETED|Washout Period 3||11
10637660|NCT02074553|11795920|FG003|COMPLETED|Washout Period 3||11
10637661|NCT02074553|11795921|FG004|COMPLETED|Washout Period 3||12
10637662|NCT02074553|11795922|FG005|COMPLETED|Washout Period 3||10
10637663|NCT02074553|11795923|FG006|COMPLETED|Washout Period 3||11
10637664|NCT02074553|11795924|FG007|COMPLETED|Washout Period 3||11
10637665|NCT02074553|11795917|FG000|NOT COMPLETED|Washout Period 3||0
10637666|NCT02074553|11795918|FG001|NOT COMPLETED|Washout Period 3||0
10637667|NCT02074553|11795919|FG002|NOT COMPLETED|Washout Period 3||0
10637668|NCT02074553|11795920|FG003|NOT COMPLETED|Washout Period 3||0
10637669|NCT02074553|11795921|FG004|NOT COMPLETED|Washout Period 3||0
10637670|NCT02074553|11795922|FG005|NOT COMPLETED|Washout Period 3||0
10637671|NCT02074553|11795923|FG006|NOT COMPLETED|Washout Period 3||0
10637672|NCT02074553|11795924|FG007|NOT COMPLETED|Washout Period 3||1
10637673|NCT02074553|11795917|FG000|STARTED|Intervention Period 4||11
10637674|NCT02074553|11795918|FG001|STARTED|Intervention Period 4||12
10637675|NCT02074553|11795919|FG002|STARTED|Intervention Period 4||11
10637676|NCT02074553|11795920|FG003|STARTED|Intervention Period 4||11
10637677|NCT02074553|11795921|FG004|STARTED|Intervention Period 4||12
10637678|NCT02074553|11795922|FG005|STARTED|Intervention Period 4||10
10637679|NCT02074553|11795923|FG006|STARTED|Intervention Period 4||11
10705825|NCT02603172|11870299|FG003|STARTED|Part C (Approximately 13 Weeks)||0
10705826|NCT02603172|11870300|FG004|STARTED|Part C (Approximately 13 Weeks)||0
10637680|NCT02074553|11795924|FG007|STARTED|Intervention Period 4||11
10637681|NCT02074553|11795917|FG000|COMPLETED|Intervention Period 4||11
10637682|NCT02074553|11795918|FG001|COMPLETED|Intervention Period 4||12
10637683|NCT02074553|11795919|FG002|COMPLETED|Intervention Period 4||11
10637684|NCT02074553|11795920|FG003|COMPLETED|Intervention Period 4||11
10637685|NCT02074553|11795921|FG004|COMPLETED|Intervention Period 4||12
10637686|NCT02074553|11795922|FG005|COMPLETED|Intervention Period 4||10
10637687|NCT02074553|11795923|FG006|COMPLETED|Intervention Period 4||11
10637688|NCT02074553|11795924|FG007|COMPLETED|Intervention Period 4||11
10637689|NCT02074553|11795917|FG000|NOT COMPLETED|Intervention Period 4||0
10637690|NCT02074553|11795918|FG001|NOT COMPLETED|Intervention Period 4||0
10637691|NCT02074553|11795919|FG002|NOT COMPLETED|Intervention Period 4||0
10637692|NCT02074553|11795920|FG003|NOT COMPLETED|Intervention Period 4||0
10637693|NCT02074553|11795921|FG004|NOT COMPLETED|Intervention Period 4||0
10637694|NCT02074553|11795922|FG005|NOT COMPLETED|Intervention Period 4||0
10637695|NCT02074553|11795923|FG006|NOT COMPLETED|Intervention Period 4||0
10705827|NCT02603172|11870301|FG005|STARTED|Part C (Approximately 13 Weeks)||0
10705828|NCT02603172|11870302|FG006|STARTED|Part C (Approximately 13 Weeks)||0
10637696|NCT02074553|11795924|FG007|NOT COMPLETED|Intervention Period 4||0
10637697|NCT02074709|11795944|FG000|STARTED|Overall Study||30
10637698|NCT02074709|11795945|FG001|STARTED|Overall Study||30
10637699|NCT02074709|11795944|FG000|COMPLETED|Overall Study||29
10637700|NCT02074709|11795945|FG001|COMPLETED|Overall Study||29
10637701|NCT02074709|11795944|FG000|NOT COMPLETED|Overall Study||1
10637702|NCT02074709|11795945|FG001|NOT COMPLETED|Overall Study||1
10637703|NCT02074735|11795953|FG000|STARTED|Overall Study||29
10637704|NCT02074735|11795954|FG001|STARTED|Overall Study||33
10637705|NCT02074735|11795953|FG000|COMPLETED|Overall Study||26
10637706|NCT02074735|11795954|FG001|COMPLETED|Overall Study||29
10637707|NCT02074735|11795953|FG000|NOT COMPLETED|Overall Study||3
10637708|NCT02074735|11795954|FG001|NOT COMPLETED|Overall Study||4
10637709|NCT02074982|11795962|FG000|STARTED|Overall Study||337
10637710|NCT02074982|11795963|FG001|STARTED|Overall Study||339
10637711|NCT02074982|11795962|FG000|Full Analysis Set (FAS)|Overall Study||336
10637712|NCT02074982|11795963|FG001|Full Analysis Set (FAS)|Overall Study||339
10637713|NCT02074982|11795962|FG000|Safety Set (SF)|Overall Study||335
10637714|NCT02074982|11795963|FG001|Safety Set (SF)|Overall Study||336
10637715|NCT02074982|11795962|FG000|COMPLETED|Overall Study||286
10637716|NCT02074982|11795963|FG001|COMPLETED|Overall Study||285
10637717|NCT02074982|11795962|FG000|NOT COMPLETED|Overall Study||51
10637718|NCT02074982|11795963|FG001|NOT COMPLETED|Overall Study||54
10637719|NCT02074995|11795969|FG000|STARTED|Overall Study||1
10637720|NCT02074995|11795970|FG001|STARTED|Overall Study||0
10637721|NCT02074995|11795971|FG002|STARTED|Overall Study||0
10637722|NCT02074995|11795969|FG000|COMPLETED|Overall Study||1
10637723|NCT02074995|11795970|FG001|COMPLETED|Overall Study||0
10637724|NCT02074995|11795971|FG002|COMPLETED|Overall Study||0
10637725|NCT02074995|11795969|FG000|NOT COMPLETED|Overall Study||0
10637726|NCT02074995|11795970|FG001|NOT COMPLETED|Overall Study||0
10637727|NCT02074995|11795971|FG002|NOT COMPLETED|Overall Study||0
10637728|NCT02075008|11795975|FG000|STARTED|Overall Study||270
10637729|NCT02075008|11795975|FG000|COMPLETED|Overall Study||94
10637730|NCT02075008|11795975|FG000|NOT COMPLETED|Overall Study||176
10637731|NCT02075047|11795981|FG000|STARTED|Treatment Phase (4 Weeks)||86
10637732|NCT02075047|11795982|FG001|STARTED|Treatment Phase (4 Weeks)||85
10637733|NCT02075047|11795981|FG000|COMPLETED|Treatment Phase (4 Weeks)||63
10637734|NCT02075047|11795982|FG001|COMPLETED|Treatment Phase (4 Weeks)||75
10637735|NCT02075047|11795981|FG000|NOT COMPLETED|Treatment Phase (4 Weeks)||23
10637736|NCT02075047|11795982|FG001|NOT COMPLETED|Treatment Phase (4 Weeks)||10
10637737|NCT02075047|11795981|FG000|STARTED|Follow up Phase (5 Weeks)|Participants were followed up after completion or discontinuation of treatment.|86
10637738|NCT02075047|11795982|FG001|STARTED|Follow up Phase (5 Weeks)|Participants were followed up after completion or discontinuation of treatment.|85
10637739|NCT02075047|11795981|FG000|COMPLETED|Follow up Phase (5 Weeks)||60
10637740|NCT02075047|11795982|FG001|COMPLETED|Follow up Phase (5 Weeks)||72
10637741|NCT02075047|11795981|FG000|NOT COMPLETED|Follow up Phase (5 Weeks)||26
10637742|NCT02075047|11795982|FG001|NOT COMPLETED|Follow up Phase (5 Weeks)||13
10637743|NCT02075073|11795991|FG000|STARTED|Overall Study||36
10637744|NCT02075073|11795992|FG001|STARTED|Overall Study||37
10637745|NCT02075073|11795993|FG002|STARTED|Overall Study||36
10637746|NCT02075073|11795991|FG000|COMPLETED|Overall Study||36
10637747|NCT02075073|11795992|FG001|COMPLETED|Overall Study||36
10637748|NCT02075073|11795993|FG002|COMPLETED|Overall Study||36
10637749|NCT02075073|11795991|FG000|NOT COMPLETED|Overall Study||0
10637750|NCT02075073|11795992|FG001|NOT COMPLETED|Overall Study||1
10637751|NCT02075073|11795993|FG002|NOT COMPLETED|Overall Study||0
10637752|NCT02075125|11796003|FG000|STARTED|Overall Study||19
10637753|NCT02075125|11796004|FG001|STARTED|Overall Study||20
10637754|NCT02075125|11796003|FG000|COMPLETED|Overall Study||19
10637755|NCT02075125|11796004|FG001|COMPLETED|Overall Study|One patient switched to clopidogrel treatment after 18 days of ticagrelor treatment.|19
10637756|NCT02075125|11796003|FG000|NOT COMPLETED|Overall Study||0
10637757|NCT02075125|11796004|FG001|NOT COMPLETED|Overall Study||1
10637758|NCT02075203|11796013|FG000|STARTED|Overall Study||330
10637759|NCT02075203|11796014|FG001|STARTED|Overall Study||330
10637760|NCT02075203|11796015|FG002|STARTED|Overall Study||329
10637761|NCT02075203|11796013|FG000|COMPLETED|Overall Study||327
10637762|NCT02075203|11796014|FG001|COMPLETED|Overall Study||330
10637763|NCT02075203|11796015|FG002|COMPLETED|Overall Study||328
10637764|NCT02075203|11796013|FG000|NOT COMPLETED|Overall Study||3
10637765|NCT02075203|11796014|FG001|NOT COMPLETED|Overall Study||0
10637766|NCT02075203|11796015|FG002|NOT COMPLETED|Overall Study||1
10637767|NCT02075255|11796026|FG000|STARTED|Overall Study||72
10637768|NCT02075255|11796027|FG001|STARTED|Overall Study||73
10637769|NCT02075255|11796028|FG002|STARTED|Overall Study||75
10637770|NCT02075255|11796026|FG000|COMPLETED|Overall Study||68
10637771|NCT02075255|11796027|FG001|COMPLETED|Overall Study||69
10637772|NCT02075255|11796028|FG002|COMPLETED|Overall Study||72
10637773|NCT02075255|11796026|FG000|NOT COMPLETED|Overall Study||4
10637774|NCT02075255|11796027|FG001|NOT COMPLETED|Overall Study||4
10637775|NCT02075255|11796028|FG002|NOT COMPLETED|Overall Study||3
10637776|NCT02075463|11796036|FG000|STARTED|Overall Study||15
10637777|NCT02075463|11796036|FG000|COMPLETED|Overall Study||7
10637778|NCT02075463|11796036|FG000|NOT COMPLETED|Overall Study||8
10637779|NCT02075476|11796043|FG000|STARTED|Overall Study||20
10637780|NCT02075476|11796044|FG001|STARTED|Overall Study||20
10637781|NCT02075476|11796043|FG000|COMPLETED|Overall Study||17
10637782|NCT02075476|11796044|FG001|COMPLETED|Overall Study||15
10637783|NCT02075476|11796043|FG000|NOT COMPLETED|Overall Study||3
10637784|NCT02075476|11796044|FG001|NOT COMPLETED|Overall Study||5
10637785|NCT02075515|11796053|FG000|STARTED|Overall Study||218
10637786|NCT02075515|11796054|FG001|STARTED|Overall Study||217
10637787|NCT02075515|11796055|FG002|STARTED|Overall Study||216
10637788|NCT02075515|11796053|FG000|COMPLETED|Overall Study||214
10637789|NCT02075515|11796054|FG001|COMPLETED|Overall Study||212
10637790|NCT02075515|11796055|FG002|COMPLETED|Overall Study||208
10637791|NCT02075515|11796053|FG000|NOT COMPLETED|Overall Study||4
10637792|NCT02075515|11796054|FG001|NOT COMPLETED|Overall Study||5
10637793|NCT02075515|11796055|FG002|NOT COMPLETED|Overall Study||8
10637794|NCT02075541|11796066|FG000|STARTED|Overall Study||73
10637795|NCT02075541|11796067|FG001|STARTED|Overall Study||72
10637796|NCT02075541|11796066|FG000|COMPLETED|Overall Study||69
10637797|NCT02075541|11796067|FG001|COMPLETED|Overall Study||64
10637798|NCT02075541|11796066|FG000|NOT COMPLETED|Overall Study||4
10637799|NCT02075541|11796067|FG001|NOT COMPLETED|Overall Study||8
10637800|NCT02075554|11796073|FG000|STARTED|Overall Study||58
10637801|NCT02075554|11796073|FG000|COMPLETED|Overall Study||43
10637802|NCT02075554|11796073|FG000|NOT COMPLETED|Overall Study||15
10637803|NCT02075606|11796077|FG000|STARTED|Overall Study||50
10637804|NCT02075606|11796077|FG000|COMPLETED|Overall Study||40
10637805|NCT02075606|11796077|FG000|NOT COMPLETED|Overall Study||10
10637806|NCT02075632|11796088|FG000|STARTED|Overall Study||162
10637807|NCT02075632|11796089|FG001|STARTED|Overall Study||148
10637808|NCT02075632|11796088|FG000|COMPLETED|Overall Study||161
10637809|NCT02075632|11796089|FG001|COMPLETED|Overall Study||143
10637810|NCT02075632|11796088|FG000|NOT COMPLETED|Overall Study||1
10637811|NCT02075632|11796089|FG001|NOT COMPLETED|Overall Study||5
10637812|NCT02075658|11796097|FG000|STARTED|Overall Study||30
10637813|NCT02075658|11796098|FG001|STARTED|Overall Study||30
10637814|NCT02075658|11796097|FG000|COMPLETED|Overall Study||28
10637815|NCT02075658|11796098|FG001|COMPLETED|Overall Study||28
10637816|NCT02075658|11796097|FG000|NOT COMPLETED|Overall Study||2
10637817|NCT02075658|11796098|FG001|NOT COMPLETED|Overall Study||2
10637818|NCT02076022|11796106|FG000|STARTED|Overall Study||7
10637819|NCT02076022|11796107|FG001|STARTED|Overall Study||3
10637820|NCT02076022|11796106|FG000|COMPLETED|Overall Study||5
10637821|NCT02076022|11796107|FG001|COMPLETED|Overall Study||3
10637822|NCT02076022|11796106|FG000|NOT COMPLETED|Overall Study||2
10637823|NCT02076022|11796107|FG001|NOT COMPLETED|Overall Study||0
10637824|NCT02076100|11796120|FG000|STARTED|Overall Study||3
10637825|NCT02076100|11796121|FG001|STARTED|Overall Study||3
10637826|NCT02076100|11796122|FG002|STARTED|Overall Study||3
10637827|NCT02076100|11796123|FG003|STARTED|Overall Study||3
10705829|NCT02603172|11870303|FG007|STARTED|Part C (Approximately 13 Weeks)||0
10705830|NCT02603172|11870296|FG000|COMPLETED|Part C (Approximately 13 Weeks)||0
10705831|NCT02603172|11870297|FG001|COMPLETED|Part C (Approximately 13 Weeks)||0
10637828|NCT02076100|11796124|FG004|STARTED|Overall Study||3
10637829|NCT02076100|11796125|FG005|STARTED|Overall Study||3
10637830|NCT02076100|11796126|FG006|STARTED|Overall Study||4
10637831|NCT02076100|11796120|FG000|COMPLETED|Overall Study||3
10637832|NCT02076100|11796121|FG001|COMPLETED|Overall Study||3
10637833|NCT02076100|11796122|FG002|COMPLETED|Overall Study||3
10637834|NCT02076100|11796123|FG003|COMPLETED|Overall Study||3
10637835|NCT02076100|11796124|FG004|COMPLETED|Overall Study||3
10637836|NCT02076100|11796125|FG005|COMPLETED|Overall Study||3
10637837|NCT02076100|11796126|FG006|COMPLETED|Overall Study||4
10637838|NCT02076100|11796120|FG000|NOT COMPLETED|Overall Study||0
10637839|NCT02076100|11796121|FG001|NOT COMPLETED|Overall Study||0
10637840|NCT02076100|11796122|FG002|NOT COMPLETED|Overall Study||0
10637841|NCT02076100|11796123|FG003|NOT COMPLETED|Overall Study||0
10637842|NCT02076100|11796124|FG004|NOT COMPLETED|Overall Study||0
10637843|NCT02076100|11796125|FG005|NOT COMPLETED|Overall Study||0
10637844|NCT02076100|11796126|FG006|NOT COMPLETED|Overall Study||0
10637861|NCT02076152|11796160|FG000|STARTED|Overall Study||2
10637862|NCT02076152|11796161|FG001|STARTED|Overall Study||9
10637863|NCT02076152|11796160|FG000|COMPLETED|Overall Study||2
10637864|NCT02076152|11796161|FG001|COMPLETED|Overall Study||9
10637865|NCT02076152|11796160|FG000|NOT COMPLETED|Overall Study||0
10637866|NCT02076152|11796161|FG001|NOT COMPLETED|Overall Study||0
10637867|NCT02076165|11796168|FG000|STARTED|Overall Study||74
10637868|NCT02076165|11796169|FG001|STARTED|Overall Study||75
10637869|NCT02076165|11796168|FG000|COMPLETED|Overall Study||66
10637870|NCT02076165|11796169|FG001|COMPLETED|Overall Study||69
10637871|NCT02076165|11796168|FG000|NOT COMPLETED|Overall Study||8
10705832|NCT02603172|11870298|FG002|COMPLETED|Part C (Approximately 13 Weeks)||0
10637872|NCT02076165|11796169|FG001|NOT COMPLETED|Overall Study||6
10637873|NCT02076243|11796175|FG000|STARTED|Overall Study||2
10637874|NCT02076243|11796175|FG000|COMPLETED|Overall Study||0
10637875|NCT02076243|11796175|FG000|NOT COMPLETED|Overall Study||2
10637876|NCT02076321|11796181|FG000|STARTED|Overall Study||51
10637877|NCT02076321|11796182|FG001|STARTED|Overall Study||51
10637878|NCT02076321|11796181|FG000|COMPLETED|Overall Study||46
10637879|NCT02076321|11796182|FG001|COMPLETED|Overall Study||49
10637880|NCT02076321|11796181|FG000|NOT COMPLETED|Overall Study||5
10637881|NCT02076321|11796182|FG001|NOT COMPLETED|Overall Study||2
10637882|NCT02076334|11796192|FG000|STARTED|Overall Study||21
10637883|NCT02076334|11796193|FG001|STARTED|Overall Study||21
10637884|NCT02076334|11796194|FG002|STARTED|Overall Study||21
10637885|NCT02076334|11796195|FG003|STARTED|Overall Study||21
10637886|NCT02076334|11796192|FG000|COMPLETED|Overall Study||20
10637887|NCT02076334|11796193|FG001|COMPLETED|Overall Study||20
10637888|NCT02076334|11796194|FG002|COMPLETED|Overall Study||20
10637889|NCT02076334|11796195|FG003|COMPLETED|Overall Study||20
10637890|NCT02076334|11796192|FG000|NOT COMPLETED|Overall Study||1
10637891|NCT02076334|11796193|FG001|NOT COMPLETED|Overall Study||1
10637892|NCT02076334|11796194|FG002|NOT COMPLETED|Overall Study||1
10637893|NCT02076334|11796195|FG003|NOT COMPLETED|Overall Study||1
10637894|NCT02076399|11796207|FG000|STARTED|Overall Study||51
10637895|NCT02076399|11796208|FG001|STARTED|Overall Study||25
10637896|NCT02076399|11796207|FG000|COMPLETED|Overall Study||12
10637897|NCT02076399|11796208|FG001|COMPLETED|Overall Study||1
10637898|NCT02076399|11796207|FG000|NOT COMPLETED|Overall Study||39
10637899|NCT02076399|11796208|FG001|NOT COMPLETED|Overall Study||24
10637900|NCT02076412|11796216|FG000|STARTED|Overall Study||50
10637901|NCT02076412|11796217|FG001|STARTED|Overall Study||24
10637902|NCT02076412|11796216|FG000|COMPLETED|Overall Study||13
10637903|NCT02076412|11796217|FG001|COMPLETED|Overall Study||2
10637904|NCT02076412|11796216|FG000|NOT COMPLETED|Overall Study||37
10637905|NCT02076412|11796217|FG001|NOT COMPLETED|Overall Study||22
10637906|NCT02076425|11796225|FG000|STARTED|Overall Study||114
10637907|NCT02076425|11796226|FG001|STARTED|Overall Study||115
10637908|NCT02076425|11796225|FG000|COMPLETED|Overall Study||100
10637909|NCT02076425|11796226|FG001|COMPLETED|Overall Study||91
10637910|NCT02076425|11796225|FG000|NOT COMPLETED|Overall Study||14
10637911|NCT02076425|11796226|FG001|NOT COMPLETED|Overall Study||24
10637912|NCT02076776|11796235|FG000|STARTED|Overall Study||6
10637913|NCT02076776|11796236|FG001|STARTED|Overall Study||8
10637914|NCT02076776|11796237|FG002|STARTED|Overall Study||6
10637915|NCT02076776|11796235|FG000|COMPLETED|Overall Study||5
10637916|NCT02076776|11796236|FG001|COMPLETED|Overall Study||6
10637917|NCT02076776|11796237|FG002|COMPLETED|Overall Study||6
10637918|NCT02076776|11796235|FG000|NOT COMPLETED|Overall Study||1
10637919|NCT02076776|11796236|FG001|NOT COMPLETED|Overall Study||2
10637920|NCT02076776|11796237|FG002|NOT COMPLETED|Overall Study||0
10637921|NCT02076919|11796257|FG000|STARTED|Overall Study||24
10637922|NCT02076919|11796258|FG001|STARTED|Overall Study||8
10637923|NCT02076919|11796259|FG002|STARTED|Overall Study||36
10637924|NCT02076919|11796260|FG003|STARTED|Overall Study||12
10637925|NCT02076919|11796257|FG000|COMPLETED|Overall Study||24
10637926|NCT02076919|11796258|FG001|COMPLETED|Overall Study||8
10637927|NCT02076919|11796259|FG002|COMPLETED|Overall Study||36
10637928|NCT02076919|11796260|FG003|COMPLETED|Overall Study||12
10637929|NCT02076919|11796257|FG000|NOT COMPLETED|Overall Study||0
10637930|NCT02076919|11796258|FG001|NOT COMPLETED|Overall Study||0
10637931|NCT02076919|11796259|FG002|NOT COMPLETED|Overall Study||0
10637932|NCT02076919|11796260|FG003|NOT COMPLETED|Overall Study||0
10637933|NCT02076997|11796287|FG000|STARTED|Overall Study||23
10637934|NCT02076997|11796287|FG000|COMPLETED|Overall Study||22
10637935|NCT02076997|11796287|FG000|NOT COMPLETED|Overall Study||1
10654031|NCT02198651|11814673|FG001|COMPLETED|Double-blind Period||93
10654032|NCT02198651|11814674|FG002|COMPLETED|Double-blind Period||19
10654033|NCT02198651|11814675|FG003|COMPLETED|Double-blind Period||0
10654034|NCT02198651|11814676|FG004|COMPLETED|Double-blind Period||0
10654035|NCT02198651|11814672|FG000|NOT COMPLETED|Double-blind Period||0
10654036|NCT02198651|11814673|FG001|NOT COMPLETED|Double-blind Period||9
10654037|NCT02198651|11814674|FG002|NOT COMPLETED|Double-blind Period||1
10654038|NCT02198651|11814675|FG003|NOT COMPLETED|Double-blind Period||0
10654039|NCT02198651|11814676|FG004|NOT COMPLETED|Double-blind Period||0
10654040|NCT02198651|11814672|FG000|STARTED|Open-label Rescue Period||0
10654041|NCT02198651|11814673|FG001|STARTED|Open-label Rescue Period||0
10654042|NCT02198651|11814674|FG002|STARTED|Open-label Rescue Period||0
10654043|NCT02198651|11814675|FG003|STARTED|Open-label Rescue Period||31
10654044|NCT02198651|11814676|FG004|STARTED|Open-label Rescue Period||8
10654045|NCT02198651|11814672|FG000|Correctly Entered Open-label Rescue|Open-label Rescue Period||0
10654046|NCT02198651|11814673|FG001|Correctly Entered Open-label Rescue|Open-label Rescue Period||0
10654047|NCT02198651|11814674|FG002|Correctly Entered Open-label Rescue|Open-label Rescue Period||0
10654048|NCT02198651|11814675|FG003|Correctly Entered Open-label Rescue|Open-label Rescue Period||30
10654049|NCT02198651|11814676|FG004|Correctly Entered Open-label Rescue|Open-label Rescue Period||8
10654050|NCT02198651|11814672|FG000|COMPLETED|Open-label Rescue Period||0
10654051|NCT02198651|11814673|FG001|COMPLETED|Open-label Rescue Period||0
10654052|NCT02198651|11814674|FG002|COMPLETED|Open-label Rescue Period||0
10654053|NCT02198651|11814675|FG003|COMPLETED|Open-label Rescue Period||28
10654054|NCT02198651|11814676|FG004|COMPLETED|Open-label Rescue Period||8
10654055|NCT02198651|11814672|FG000|NOT COMPLETED|Open-label Rescue Period||0
10654056|NCT02198651|11814673|FG001|NOT COMPLETED|Open-label Rescue Period||0
10654057|NCT02198651|11814674|FG002|NOT COMPLETED|Open-label Rescue Period||0
10654058|NCT02198651|11814675|FG003|NOT COMPLETED|Open-label Rescue Period||3
10654059|NCT02198651|11814676|FG004|NOT COMPLETED|Open-label Rescue Period||0
10654060|NCT02198664|11814691|FG000|STARTED|Overall Study||26
10654061|NCT02198664|11814692|FG001|STARTED|Overall Study||21
10654062|NCT02198664|11814691|FG000|COMPLETED|Overall Study||10
10654063|NCT02198664|11814692|FG001|COMPLETED|Overall Study||13
10637936|NCT02077140|11796296|FG000|STARTED|Overall Study||36
10637937|NCT02077140|11796297|FG001|STARTED|Overall Study||36
10637938|NCT02077140|11796298|FG002|STARTED|Overall Study||36
10637939|NCT02077140|11796299|FG003|STARTED|Overall Study||36
10637940|NCT02077140|11796300|FG004|STARTED|Overall Study||48
10637941|NCT02077140|11796296|FG000|COMPLETED|Overall Study||32
10637942|NCT02077140|11796297|FG001|COMPLETED|Overall Study||34
10637943|NCT02077140|11796298|FG002|COMPLETED|Overall Study||34
10637944|NCT02077140|11796299|FG003|COMPLETED|Overall Study||32
10637945|NCT02077140|11796300|FG004|COMPLETED|Overall Study||43
10637946|NCT02077140|11796296|FG000|NOT COMPLETED|Overall Study||4
10637947|NCT02077140|11796297|FG001|NOT COMPLETED|Overall Study||2
10637948|NCT02077140|11796298|FG002|NOT COMPLETED|Overall Study||2
10637949|NCT02077140|11796299|FG003|NOT COMPLETED|Overall Study||4
10637950|NCT02077140|11796300|FG004|NOT COMPLETED|Overall Study||5
10637951|NCT02077374|11796317|FG000|STARTED|Overall Study||19
10637952|NCT02077374|11796318|FG001|STARTED|Overall Study||19
10637953|NCT02077374|11796317|FG000|COMPLETED|Overall Study||19
10637954|NCT02077374|11796318|FG001|COMPLETED|Overall Study||17
10637955|NCT02077374|11796317|FG000|NOT COMPLETED|Overall Study||0
10637956|NCT02077374|11796318|FG001|NOT COMPLETED|Overall Study||2
10637957|NCT02077465|11796329|FG000|STARTED|Overall Study||8
10637958|NCT02077465|11796330|FG001|STARTED|Overall Study||3
10637959|NCT02077465|11796329|FG000|COMPLETED|Overall Study||7
10637960|NCT02077465|11796330|FG001|COMPLETED|Overall Study||2
10637961|NCT02077465|11796329|FG000|NOT COMPLETED|Overall Study||1
10637962|NCT02077465|11796330|FG001|NOT COMPLETED|Overall Study||1
10637963|NCT02078102|11796338|FG000|STARTED|Overall Study||25
10637964|NCT02078102|11796339|FG001|STARTED|Overall Study||13
10637965|NCT02078102|11796338|FG000|COMPLETED|Overall Study||23
10637966|NCT02078102|11796339|FG001|COMPLETED|Overall Study||12
10637967|NCT02078102|11796338|FG000|NOT COMPLETED|Overall Study||2
10637968|NCT02078102|11796339|FG001|NOT COMPLETED|Overall Study||1
10637969|NCT02078180|11796346|FG000|STARTED|Overall Study||34
10637970|NCT02078180|11796346|FG000|IR75|Overall Study||30
10637971|NCT02078180|11796346|FG000|IR100|Overall Study||31
10637972|NCT02078180|11796346|FG000|SR100|Overall Study||31
10637973|NCT02078180|11796346|FG000|SR150|Overall Study||32
10637974|NCT02078180|11796346|FG000|XL 150|Overall Study||31
10637975|NCT02078180|11796346|FG000|XL 300|Overall Study||32
10637976|NCT02078180|11796346|FG000|COMPLETED|Overall Study||29
10637977|NCT02078180|11796346|FG000|NOT COMPLETED|Overall Study||5
10637978|NCT02078193|11796355|FG000|STARTED|Overall Study||3
10637979|NCT02078193|11796355|FG000|COMPLETED|Overall Study||3
10637980|NCT02078193|11796355|FG000|NOT COMPLETED|Overall Study||0
10637981|NCT02078219|11796365|FG000|STARTED|Overall Study||41
10637982|NCT02078219|11796366|FG001|STARTED|Overall Study||40
10637983|NCT02078219|11796367|FG002|STARTED|Overall Study||41
10637984|NCT02078219|11796368|FG003|STARTED|Overall Study||41
10637985|NCT02078219|11796369|FG004|STARTED|Overall Study||41
10637986|NCT02078219|11796365|FG000|COMPLETED|Overall Study||38
10637987|NCT02078219|11796366|FG001|COMPLETED|Overall Study||36
10637988|NCT02078219|11796367|FG002|COMPLETED|Overall Study||35
10637989|NCT02078219|11796368|FG003|COMPLETED|Overall Study||37
10637990|NCT02078219|11796369|FG004|COMPLETED|Overall Study||39
10637991|NCT02078219|11796365|FG000|NOT COMPLETED|Overall Study||3
10637992|NCT02078219|11796366|FG001|NOT COMPLETED|Overall Study||4
10637993|NCT02078219|11796367|FG002|NOT COMPLETED|Overall Study||6
10637994|NCT02078219|11796368|FG003|NOT COMPLETED|Overall Study||4
10637995|NCT02078219|11796369|FG004|NOT COMPLETED|Overall Study||2
10637996|NCT02078284|11796386|FG000|STARTED|Overall Study||5
10637997|NCT02078284|11796387|FG001|STARTED|Overall Study||7
10637998|NCT02078284|11796388|FG002|STARTED|Overall Study||6
10637999|NCT02078284|11796389|FG003|STARTED|Overall Study||6
10638000|NCT02078284|11796390|FG004|STARTED|Overall Study||4
10638001|NCT02078284|11796386|FG000|COMPLETED|Overall Study||5
10638002|NCT02078284|11796387|FG001|COMPLETED|Overall Study||7
10638003|NCT02078284|11796388|FG002|COMPLETED|Overall Study||6
10638004|NCT02078284|11796389|FG003|COMPLETED|Overall Study||6
10638005|NCT02078284|11796390|FG004|COMPLETED|Overall Study||4
10638006|NCT02078284|11796386|FG000|NOT COMPLETED|Overall Study||0
10638007|NCT02078284|11796387|FG001|NOT COMPLETED|Overall Study||0
10638008|NCT02078284|11796388|FG002|NOT COMPLETED|Overall Study||0
10638009|NCT02078284|11796389|FG003|NOT COMPLETED|Overall Study||0
10638010|NCT02078284|11796390|FG004|NOT COMPLETED|Overall Study||0
10638011|NCT02078492|11796405|FG000|STARTED|Overall Study||80
10638012|NCT02078492|11796406|FG001|STARTED|Overall Study||80
10638013|NCT02078492|11796407|FG002|STARTED|Overall Study||80
10638014|NCT02078492|11796405|FG000|COMPLETED|Overall Study||80
10638015|NCT02078492|11796406|FG001|COMPLETED|Overall Study||80
10638016|NCT02078492|11796407|FG002|COMPLETED|Overall Study||80
10638017|NCT02078492|11796405|FG000|NOT COMPLETED|Overall Study||0
10638018|NCT02078492|11796406|FG001|NOT COMPLETED|Overall Study||0
10638019|NCT02078492|11796407|FG002|NOT COMPLETED|Overall Study||0
10638020|NCT02078557|11796415|FG000|STARTED|Overall Study||4
10638021|NCT02078557|11796415|FG000|COMPLETED|Overall Study||4
10638022|NCT02078557|11796415|FG000|NOT COMPLETED|Overall Study||0
10638023|NCT02078713|11796423|FG000|STARTED|Overall Study||407
10638024|NCT02078713|11796424|FG001|STARTED|Overall Study||351
10638025|NCT02078713|11796425|FG002|STARTED|Overall Study||15
10638026|NCT02078713|11796426|FG003|STARTED|Overall Study||13
10638027|NCT02078713|11796423|FG000|COMPLETED|Overall Study||355
10638028|NCT02078713|11796424|FG001|COMPLETED|Overall Study||290
10638029|NCT02078713|11796425|FG002|COMPLETED|Overall Study||15
10638030|NCT02078713|11796426|FG003|COMPLETED|Overall Study||13
10638031|NCT02078713|11796423|FG000|NOT COMPLETED|Overall Study||52
10638032|NCT02078713|11796424|FG001|NOT COMPLETED|Overall Study||61
10638033|NCT02078713|11796425|FG002|NOT COMPLETED|Overall Study||0
10638034|NCT02078713|11796426|FG003|NOT COMPLETED|Overall Study||0
10638035|NCT02078726|11796440|FG000|STARTED|Overall Study||64
10638036|NCT02078726|11796441|FG001|STARTED|Overall Study||36
10638037|NCT02078726|11796440|FG000|COMPLETED|Overall Study||64
10638038|NCT02078726|11796441|FG001|COMPLETED|Overall Study||36
10638039|NCT02078726|11796440|FG000|NOT COMPLETED|Overall Study||0
10638040|NCT02078726|11796441|FG001|NOT COMPLETED|Overall Study||0
10638041|NCT02078752|11796457|FG000|STARTED|Overall Study||3
10638042|NCT02078752|11796458|FG001|STARTED|Overall Study||13
10638043|NCT02078752|11796459|FG002|STARTED|Overall Study||2
10638044|NCT02078752|11796460|FG003|STARTED|Overall Study||7
10638045|NCT02078752|11796461|FG004|STARTED|Overall Study||3
10638046|NCT02078752|11796462|FG005|STARTED|Overall Study||9
10638047|NCT02078752|11796463|FG006|STARTED|Overall Study||3
10638048|NCT02078752|11796464|FG007|STARTED|Overall Study||6
10638049|NCT02078752|11796465|FG008|STARTED|Overall Study||2
10638050|NCT02078752|11796466|FG009|STARTED|Overall Study||12
10638051|NCT02078752|11796457|FG000|COMPLETED|Overall Study||1
10638052|NCT02078752|11796458|FG001|COMPLETED|Overall Study||6
10638053|NCT02078752|11796459|FG002|COMPLETED|Overall Study||1
10638054|NCT02078752|11796460|FG003|COMPLETED|Overall Study||5
10638055|NCT02078752|11796461|FG004|COMPLETED|Overall Study||2
10638056|NCT02078752|11796462|FG005|COMPLETED|Overall Study||5
10638057|NCT02078752|11796463|FG006|COMPLETED|Overall Study||1
10638058|NCT02078752|11796464|FG007|COMPLETED|Overall Study||3
10638059|NCT02078752|11796465|FG008|COMPLETED|Overall Study||2
10638060|NCT02078752|11796466|FG009|COMPLETED|Overall Study||2
10638061|NCT02078752|11796457|FG000|NOT COMPLETED|Overall Study||2
10638062|NCT02078752|11796458|FG001|NOT COMPLETED|Overall Study||7
10638063|NCT02078752|11796459|FG002|NOT COMPLETED|Overall Study||1
10638064|NCT02078752|11796460|FG003|NOT COMPLETED|Overall Study||2
10638065|NCT02078752|11796461|FG004|NOT COMPLETED|Overall Study||1
10638066|NCT02078752|11796462|FG005|NOT COMPLETED|Overall Study||4
10638067|NCT02078752|11796463|FG006|NOT COMPLETED|Overall Study||2
10638068|NCT02078752|11796464|FG007|NOT COMPLETED|Overall Study||3
10638069|NCT02078752|11796465|FG008|NOT COMPLETED|Overall Study||0
10638070|NCT02078752|11796466|FG009|NOT COMPLETED|Overall Study||10
10638071|NCT02078817|11796497|FG000|STARTED|Overall Study||14
10638072|NCT02078817|11796497|FG000|COMPLETED|Overall Study||13
10638073|NCT02078817|11796497|FG000|NOT COMPLETED|Overall Study||1
10638074|NCT02078882|11796501|FG000|STARTED|Overall Study||16
10638075|NCT02078882|11796501|FG000|COMPLETED|Overall Study||16
10638076|NCT02078882|11796501|FG000|NOT COMPLETED|Overall Study||0
10638077|NCT02078960|11796508|FG000|STARTED|Treatment Period||2
10638078|NCT02078960|11796509|FG001|STARTED|Treatment Period||4
10638079|NCT02078960|11796510|FG002|STARTED|Treatment Period||4
10638080|NCT02078960|11796508|FG000|COMPLETED|Treatment Period||0
10638081|NCT02078960|11796509|FG001|COMPLETED|Treatment Period||1
10638082|NCT02078960|11796510|FG002|COMPLETED|Treatment Period||1
10638083|NCT02078960|11796508|FG000|NOT COMPLETED|Treatment Period||2
10638084|NCT02078960|11796509|FG001|NOT COMPLETED|Treatment Period||3
10638085|NCT02078960|11796510|FG002|NOT COMPLETED|Treatment Period||3
10638086|NCT02078960|11796508|FG000|STARTED|Follow-up Period||2
10638087|NCT02078960|11796509|FG001|STARTED|Follow-up Period||2
10638088|NCT02078960|11796510|FG002|STARTED|Follow-up Period||1
10638089|NCT02078960|11796508|FG000|COMPLETED|Follow-up Period||0
10638090|NCT02078960|11796509|FG001|COMPLETED|Follow-up Period||1
10638091|NCT02078960|11796510|FG002|COMPLETED|Follow-up Period||1
10638092|NCT02078960|11796508|FG000|NOT COMPLETED|Follow-up Period||2
10638093|NCT02078960|11796509|FG001|NOT COMPLETED|Follow-up Period||1
10638094|NCT02078960|11796510|FG002|NOT COMPLETED|Follow-up Period||0
10638095|NCT02079025|11796522|FG000|STARTED|Overall Study||839
10638096|NCT02079025|11796523|FG001|STARTED|Overall Study||837
10638097|NCT02079025|11796522|FG000|COMPLETED|Overall Study||839
10638098|NCT02079025|11796523|FG001|COMPLETED|Overall Study||837
10638099|NCT02079025|11796522|FG000|NOT COMPLETED|Overall Study||0
10638100|NCT02079025|11796523|FG001|NOT COMPLETED|Overall Study||0
10638101|NCT02079038|11796532|FG000|STARTED|Modified Intent to Treat Population||112
10638102|NCT02079038|11796533|FG001|STARTED|Modified Intent to Treat Population||56
10638103|NCT02079038|11796532|FG000|COMPLETED|Modified Intent to Treat Population||105
10638104|NCT02079038|11796533|FG001|COMPLETED|Modified Intent to Treat Population||51
10638105|NCT02079038|11796532|FG000|NOT COMPLETED|Modified Intent to Treat Population||7
10638106|NCT02079038|11796533|FG001|NOT COMPLETED|Modified Intent to Treat Population||5
10638107|NCT02079038|11796532|FG000|STARTED|Completed 6 Months||105
10638108|NCT02079038|11796533|FG001|STARTED|Completed 6 Months||51
10638109|NCT02079038|11796532|FG000|COMPLETED|Completed 6 Months||103
10638110|NCT02079038|11796533|FG001|COMPLETED|Completed 6 Months||50
10638111|NCT02079038|11796532|FG000|NOT COMPLETED|Completed 6 Months||2
10638112|NCT02079038|11796533|FG001|NOT COMPLETED|Completed 6 Months||1
10638113|NCT02079077|11796541|FG000|STARTED|Overall Study||43
10638114|NCT02079077|11796542|FG001|STARTED|Overall Study||48
10638115|NCT02079077|11796541|FG000|COMPLETED|Overall Study||37
10638116|NCT02079077|11796542|FG001|COMPLETED|Overall Study||39
10638117|NCT02079077|11796541|FG000|NOT COMPLETED|Overall Study||6
10638118|NCT02079077|11796542|FG001|NOT COMPLETED|Overall Study||9
10638119|NCT02079246|11796548|FG000|STARTED|OLEX||1463
10638120|NCT02079246|11796549|FG001|STARTED|OLEX||0
10638121|NCT02079246|11796548|FG000|COMPLETED|OLEX||1235
10638122|NCT02079246|11796549|FG001|COMPLETED|OLEX||0
10638123|NCT02079246|11796548|FG000|NOT COMPLETED|OLEX||228
10638124|NCT02079246|11796549|FG001|NOT COMPLETED|OLEX||0
10638125|NCT02079246|11796548|FG000|STARTED|OLEX-MEM||0
10638126|NCT02079246|11796549|FG001|STARTED|OLEX-MEM||101
10638127|NCT02079246|11796548|FG000|COMPLETED|OLEX-MEM||0
10638128|NCT02079246|11796549|FG001|COMPLETED|OLEX-MEM||82
10638129|NCT02079246|11796548|FG000|NOT COMPLETED|OLEX-MEM||0
10638130|NCT02079246|11796549|FG001|NOT COMPLETED|OLEX-MEM||19
10638131|NCT02079311|11796560|FG000|STARTED|Overall Study||28
10638132|NCT02079311|11796561|FG001|STARTED|Overall Study||27
10638133|NCT02079311|11796560|FG000|COMPLETED|Overall Study||28
10638134|NCT02079311|11796561|FG001|COMPLETED|Overall Study||26
10638135|NCT02079311|11796560|FG000|NOT COMPLETED|Overall Study||0
10638136|NCT02079311|11796561|FG001|NOT COMPLETED|Overall Study||1
10638137|NCT02079519|11796567|FG000|STARTED|Overall Study||10
10638138|NCT02079519|11796567|FG000|COMPLETED|Overall Study||0
10638139|NCT02079519|11796567|FG000|NOT COMPLETED|Overall Study||10
10638140|NCT02079532|11796571|FG000|STARTED|Overall Study||302
10638141|NCT02079532|11796571|FG000|COMPLETED|Overall Study||273
10638142|NCT02079532|11796571|FG000|NOT COMPLETED|Overall Study||29
10638143|NCT02079610|11796577|FG000|STARTED|Overall Study||19
10638144|NCT02079610|11796578|FG001|STARTED|Overall Study||17
10638145|NCT02079610|11796577|FG000|COMPLETED|Overall Study||18
10638146|NCT02079610|11796578|FG001|COMPLETED|Overall Study||16
10638147|NCT02079610|11796577|FG000|NOT COMPLETED|Overall Study||1
10638148|NCT02079610|11796578|FG001|NOT COMPLETED|Overall Study||1
10638149|NCT02079636|11796599|FG000|STARTED|Overall Study||8
10638150|NCT02079636|11796600|FG001|STARTED|Overall Study||15
10638151|NCT02079636|11796601|FG002|STARTED|Overall Study||3
10638152|NCT02079636|11796602|FG003|STARTED|Overall Study||21
10638153|NCT02079636|11796603|FG004|STARTED|Overall Study||4
10638154|NCT02079636|11796604|FG005|STARTED|Overall Study||19
10638155|NCT02079636|11796605|FG006|STARTED|Overall Study||12
10638156|NCT02079636|11796606|FG007|STARTED|Overall Study||4
10638157|NCT02079636|11796607|FG008|STARTED|Overall Study||3
10638158|NCT02079636|11796608|FG009|STARTED|Overall Study||9
10638159|NCT02079636|11796609|FG010|STARTED|Overall Study||10
10638160|NCT02079636|11796610|FG011|STARTED|Overall Study||6
10638161|NCT02079636|11796611|FG012|STARTED|Overall Study||8
10638162|NCT02079636|11796612|FG013|STARTED|Overall Study||3
10638163|NCT02079636|11796613|FG014|STARTED|Overall Study||17
10638164|NCT02079636|11796599|FG000|Received at Least One Dose of Study Drug|Overall Study||8
10638165|NCT02079636|11796600|FG001|Received at Least One Dose of Study Drug|Overall Study||15
10638166|NCT02079636|11796601|FG002|Received at Least One Dose of Study Drug|Overall Study||3
10638167|NCT02079636|11796602|FG003|Received at Least One Dose of Study Drug|Overall Study||21
10638168|NCT02079636|11796603|FG004|Received at Least One Dose of Study Drug|Overall Study||4
10638169|NCT02079636|11796604|FG005|Received at Least One Dose of Study Drug|Overall Study||19
10638170|NCT02079636|11796605|FG006|Received at Least One Dose of Study Drug|Overall Study||12
10638171|NCT02079636|11796606|FG007|Received at Least One Dose of Study Drug|Overall Study||4
10638172|NCT02079636|11796607|FG008|Received at Least One Dose of Study Drug|Overall Study||3
10638173|NCT02079636|11796608|FG009|Received at Least One Dose of Study Drug|Overall Study||9
10638174|NCT02079636|11796609|FG010|Received at Least One Dose of Study Drug|Overall Study||10
10638175|NCT02079636|11796610|FG011|Received at Least One Dose of Study Drug|Overall Study||6
10638176|NCT02079636|11796611|FG012|Received at Least One Dose of Study Drug|Overall Study||8
10638177|NCT02079636|11796612|FG013|Received at Least One Dose of Study Drug|Overall Study||3
10638178|NCT02079636|11796613|FG014|Received at Least One Dose of Study Drug|Overall Study||17
10638179|NCT02079636|11796599|FG000|COMPLETED|Overall Study||5
10638180|NCT02079636|11796600|FG001|COMPLETED|Overall Study||13
10638181|NCT02079636|11796601|FG002|COMPLETED|Overall Study||3
10638182|NCT02079636|11796602|FG003|COMPLETED|Overall Study||9
10638183|NCT02079636|11796603|FG004|COMPLETED|Overall Study||2
10638184|NCT02079636|11796604|FG005|COMPLETED|Overall Study||13
10638185|NCT02079636|11796605|FG006|COMPLETED|Overall Study||11
10638186|NCT02079636|11796606|FG007|COMPLETED|Overall Study||3
10638187|NCT02079636|11796607|FG008|COMPLETED|Overall Study||3
10638188|NCT02079636|11796608|FG009|COMPLETED|Overall Study||6
10638189|NCT02079636|11796609|FG010|COMPLETED|Overall Study||8
10638190|NCT02079636|11796610|FG011|COMPLETED|Overall Study||4
10638191|NCT02079636|11796611|FG012|COMPLETED|Overall Study||5
10638192|NCT02079636|11796612|FG013|COMPLETED|Overall Study||3
10638193|NCT02079636|11796613|FG014|COMPLETED|Overall Study||12
10638194|NCT02079636|11796599|FG000|NOT COMPLETED|Overall Study||3
10638195|NCT02079636|11796600|FG001|NOT COMPLETED|Overall Study||2
10638196|NCT02079636|11796601|FG002|NOT COMPLETED|Overall Study||0
10638197|NCT02079636|11796602|FG003|NOT COMPLETED|Overall Study||12
10638198|NCT02079636|11796603|FG004|NOT COMPLETED|Overall Study||2
10638199|NCT02079636|11796604|FG005|NOT COMPLETED|Overall Study||6
10638200|NCT02079636|11796605|FG006|NOT COMPLETED|Overall Study||1
10638201|NCT02079636|11796606|FG007|NOT COMPLETED|Overall Study||1
10638202|NCT02079636|11796607|FG008|NOT COMPLETED|Overall Study||0
10638203|NCT02079636|11796608|FG009|NOT COMPLETED|Overall Study||3
10638204|NCT02079636|11796609|FG010|NOT COMPLETED|Overall Study||2
10638205|NCT02079636|11796610|FG011|NOT COMPLETED|Overall Study||2
10638206|NCT02079636|11796611|FG012|NOT COMPLETED|Overall Study||3
10638207|NCT02079636|11796612|FG013|NOT COMPLETED|Overall Study||0
10638208|NCT02079636|11796613|FG014|NOT COMPLETED|Overall Study||5
10638209|NCT02079649|11796681|FG000|STARTED|Overall Study||42
10638210|NCT02079649|11796682|FG001|STARTED|Overall Study||41
10638211|NCT02079649|11796683|FG002|STARTED|Overall Study||41
10638212|NCT02079649|11796684|FG003|STARTED|Overall Study||40
10638213|NCT02079649|11796681|FG000|Treated|Overall Study||41
10638214|NCT02079649|11796682|FG001|Treated|Overall Study||41
10638215|NCT02079649|11796683|FG002|Treated|Overall Study||40
10638216|NCT02079649|11796684|FG003|Treated|Overall Study||40
10638217|NCT02079649|11796681|FG000|COMPLETED|Overall Study||41
10638218|NCT02079649|11796682|FG001|COMPLETED|Overall Study||41
10638219|NCT02079649|11796683|FG002|COMPLETED|Overall Study||40
10638220|NCT02079649|11796684|FG003|COMPLETED|Overall Study||38
10638221|NCT02079649|11796681|FG000|NOT COMPLETED|Overall Study||1
10638222|NCT02079649|11796682|FG001|NOT COMPLETED|Overall Study||0
10638223|NCT02079649|11796683|FG002|NOT COMPLETED|Overall Study||1
10638224|NCT02079649|11796684|FG003|NOT COMPLETED|Overall Study||2
10638225|NCT02079805|11796697|FG000|STARTED|Overall Study||16
10638226|NCT02079805|11796698|FG001|STARTED|Overall Study||17
10638227|NCT02079805|11796697|FG000|COMPLETED|Overall Study||16
10638228|NCT02079805|11796698|FG001|COMPLETED|Overall Study||15
10638229|NCT02079805|11796697|FG000|NOT COMPLETED|Overall Study||0
10638230|NCT02079805|11796698|FG001|NOT COMPLETED|Overall Study||2
10638231|NCT02079844|11796707|FG000|STARTED|Treatment Period 1||6
10638232|NCT02079844|11796708|FG001|STARTED|Treatment Period 1||7
10638233|NCT02079844|11796709|FG002|STARTED|Treatment Period 1||7
10638234|NCT02079844|11796707|FG000|COMPLETED|Treatment Period 1||6
10638235|NCT02079844|11796708|FG001|COMPLETED|Treatment Period 1||7
10638236|NCT02079844|11796709|FG002|COMPLETED|Treatment Period 1||5
10638237|NCT02079844|11796707|FG000|NOT COMPLETED|Treatment Period 1||0
10638238|NCT02079844|11796708|FG001|NOT COMPLETED|Treatment Period 1||0
10638239|NCT02079844|11796709|FG002|NOT COMPLETED|Treatment Period 1||2
10638240|NCT02079844|11796707|FG000|STARTED|Treatment Period 2|1 Participant was withdrawn due to an Adverse Event after completing Period 1.|5
10638241|NCT02079844|11796708|FG001|STARTED|Treatment Period 2||7
10638242|NCT02079844|11796709|FG002|STARTED|Treatment Period 2||5
10638243|NCT02079844|11796707|FG000|COMPLETED|Treatment Period 2||5
10638244|NCT02079844|11796708|FG001|COMPLETED|Treatment Period 2||6
10638245|NCT02079844|11796709|FG002|COMPLETED|Treatment Period 2||5
10638246|NCT02079844|11796707|FG000|NOT COMPLETED|Treatment Period 2||0
10638247|NCT02079844|11796708|FG001|NOT COMPLETED|Treatment Period 2||1
10638248|NCT02079844|11796709|FG002|NOT COMPLETED|Treatment Period 2||0
10638249|NCT02079844|11796707|FG000|STARTED|Treatment Period 3||5
10638250|NCT02079844|11796708|FG001|STARTED|Treatment Period 3|1 Participant Voluntarily Withdrew after completing Period 2.|5
10638251|NCT02079844|11796709|FG002|STARTED|Treatment Period 3||5
10638252|NCT02079844|11796707|FG000|COMPLETED|Treatment Period 3||5
10638253|NCT02079844|11796708|FG001|COMPLETED|Treatment Period 3||5
10638254|NCT02079844|11796709|FG002|COMPLETED|Treatment Period 3||5
10638255|NCT02079844|11796707|FG000|NOT COMPLETED|Treatment Period 3||0
10638256|NCT02079844|11796708|FG001|NOT COMPLETED|Treatment Period 3||0
10638257|NCT02079844|11796709|FG002|NOT COMPLETED|Treatment Period 3||0
10638258|NCT02079909|11796723|FG000|STARTED|Overall Study||158
10638259|NCT02079909|11796724|FG001|STARTED|Overall Study||166
10638260|NCT02079909|11796725|FG002|STARTED|Overall Study||158
10638261|NCT02079909|11796723|FG000|COMPLETED|Overall Study||120
10638262|NCT02079909|11796724|FG001|COMPLETED|Overall Study||117
10638263|NCT02079909|11796725|FG002|COMPLETED|Overall Study||140
10638264|NCT02079909|11796723|FG000|NOT COMPLETED|Overall Study||38
10638265|NCT02079909|11796724|FG001|NOT COMPLETED|Overall Study||49
10638266|NCT02079909|11796725|FG002|NOT COMPLETED|Overall Study||18
10638267|NCT02079987|11796735|FG000|STARTED|Overall Study||557
10638268|NCT02079987|11796736|FG001|STARTED|Overall Study||544
10638269|NCT02079987|11796735|FG000|COMPLETED|Overall Study||557
10638270|NCT02079987|11796736|FG001|COMPLETED|Overall Study||544
10638271|NCT02079987|11796735|FG000|NOT COMPLETED|Overall Study||0
10638272|NCT02079987|11796736|FG001|NOT COMPLETED|Overall Study||0
10638273|NCT02080091|11796743|FG000|STARTED|Overall Study||25
10638274|NCT02080091|11796743|FG000|COMPLETED|Overall Study||0
10638275|NCT02080091|11796743|FG000|NOT COMPLETED|Overall Study||25
10638276|NCT02080195|11796747|FG000|STARTED|Overall Study||1
10638277|NCT02080195|11796747|FG000|COMPLETED|Overall Study||1
10638278|NCT02080195|11796747|FG000|NOT COMPLETED|Overall Study||0
10638282|NCT02080273|11796758|FG000|STARTED|Overall Study||45
10638283|NCT02080273|11796759|FG001|STARTED|Overall Study||45
10638284|NCT02080273|11796760|FG002|STARTED|Overall Study||45
10638285|NCT02080273|11796758|FG000|COMPLETED|Overall Study||45
10638286|NCT02080273|11796759|FG001|COMPLETED|Overall Study||45
10638287|NCT02080273|11796760|FG002|COMPLETED|Overall Study||45
10638288|NCT02080273|11796758|FG000|NOT COMPLETED|Overall Study||0
10638289|NCT02080273|11796759|FG001|NOT COMPLETED|Overall Study||0
10638290|NCT02080273|11796760|FG002|NOT COMPLETED|Overall Study||0
10638291|NCT02080312|11796768|FG000|STARTED|Overall Study||6
10638292|NCT02080312|11796768|FG000|COMPLETED|Overall Study||6
10638293|NCT02080312|11796768|FG000|NOT COMPLETED|Overall Study||0
10638294|NCT02080364|11796777|FG000|STARTED|Baseline Period||197
10638295|NCT02080364|11796778|FG001|STARTED|Baseline Period||208
10638296|NCT02080364|11796779|FG002|STARTED|Baseline Period||247
10638297|NCT02080364|11796780|FG003|STARTED|Baseline Period||228
10638298|NCT02080364|11796777|FG000|COMPLETED|Baseline Period||195
10638299|NCT02080364|11796778|FG001|COMPLETED|Baseline Period||206
10638300|NCT02080364|11796779|FG002|COMPLETED|Baseline Period||246
10638301|NCT02080364|11796780|FG003|COMPLETED|Baseline Period||228
10638302|NCT02080364|11796777|FG000|NOT COMPLETED|Baseline Period||2
10638303|NCT02080364|11796778|FG001|NOT COMPLETED|Baseline Period||2
10638304|NCT02080364|11796779|FG002|NOT COMPLETED|Baseline Period||1
10638305|NCT02080364|11796780|FG003|NOT COMPLETED|Baseline Period||0
10638306|NCT02080364|11796777|FG000|STARTED|Treatment Period||195
10638307|NCT02080364|11796778|FG001|STARTED|Treatment Period||206
10638308|NCT02080364|11796779|FG002|STARTED|Treatment Period||246
10638309|NCT02080364|11796780|FG003|STARTED|Treatment Period||228
10638310|NCT02080364|11796777|FG000|COMPLETED|Treatment Period||148
10638311|NCT02080364|11796778|FG001|COMPLETED|Treatment Period||157
10638312|NCT02080364|11796779|FG002|COMPLETED|Treatment Period||9
10638313|NCT02080364|11796780|FG003|COMPLETED|Treatment Period||4
10638314|NCT02080364|11796777|FG000|NOT COMPLETED|Treatment Period||47
10638315|NCT02080364|11796778|FG001|NOT COMPLETED|Treatment Period||49
10638316|NCT02080364|11796779|FG002|NOT COMPLETED|Treatment Period||237
10638317|NCT02080364|11796780|FG003|NOT COMPLETED|Treatment Period||224
10638324|NCT02080455|11796801|FG000|STARTED|Overall Study||16
10638325|NCT02080455|11796802|FG001|STARTED|Overall Study||16
10638326|NCT02080455|11796801|FG000|COMPLETED|Overall Study||16
10638327|NCT02080455|11796802|FG001|COMPLETED|Overall Study||16
10638328|NCT02080455|11796801|FG000|NOT COMPLETED|Overall Study||0
10638329|NCT02080455|11796802|FG001|NOT COMPLETED|Overall Study||0
10638330|NCT02080468|11796818|FG000|STARTED|Overall Study||16
10638331|NCT02080468|11796819|FG001|STARTED|Overall Study||16
10638332|NCT02080468|11796818|FG000|COMPLETED|Overall Study||14
10638333|NCT02080468|11796819|FG001|COMPLETED|Overall Study||14
10638334|NCT02080468|11796818|FG000|NOT COMPLETED|Overall Study||2
10638335|NCT02080468|11796819|FG001|NOT COMPLETED|Overall Study||2
10638336|NCT02080481|11796834|FG000|STARTED|Overall Study||68
10638337|NCT02080481|11796835|FG001|STARTED|Overall Study||67
10638338|NCT02080481|11796834|FG000|COMPLETED|Overall Study||67
10638339|NCT02080481|11796835|FG001|COMPLETED|Overall Study||67
10638340|NCT02080481|11796834|FG000|NOT COMPLETED|Overall Study||1
10638341|NCT02080481|11796835|FG001|NOT COMPLETED|Overall Study||0
10638342|NCT02080507|11796843|FG000|STARTED|Overall Study||5
10638343|NCT02080507|11796844|FG001|STARTED|Overall Study||7
10638344|NCT02080507|11796843|FG000|COMPLETED|Overall Study||5
10638345|NCT02080507|11796844|FG001|COMPLETED|Overall Study||7
10638346|NCT02080507|11796843|FG000|NOT COMPLETED|Overall Study||0
10638347|NCT02080507|11796844|FG001|NOT COMPLETED|Overall Study||0
10638348|NCT02080546|11796852|FG000|STARTED|Overall Study||57
10638349|NCT02080546|11796853|FG001|STARTED|Overall Study||63
10638350|NCT02080546|11796852|FG000|COMPLETED|Overall Study||49
10638351|NCT02080546|11796853|FG001|COMPLETED|Overall Study||52
10638352|NCT02080546|11796852|FG000|NOT COMPLETED|Overall Study||8
10638353|NCT02080546|11796853|FG001|NOT COMPLETED|Overall Study||11
10638354|NCT02080637|11796861|FG000|STARTED|Overall Study||13
10638355|NCT02080637|11796862|FG001|STARTED|Overall Study||3
10638356|NCT02080637|11796861|FG000|COMPLETED|Overall Study||13
10638357|NCT02080637|11796862|FG001|COMPLETED|Overall Study||3
10638358|NCT02080637|11796861|FG000|NOT COMPLETED|Overall Study||0
10638359|NCT02080637|11796862|FG001|NOT COMPLETED|Overall Study||0
10638360|NCT02080780|11796868|FG000|STARTED|Overall Study||24
10638361|NCT02080780|11796868|FG000|COMPLETED|Overall Study||24
10638362|NCT02080780|11796868|FG000|NOT COMPLETED|Overall Study||0
10638363|NCT02080819|11796878|FG000|STARTED|Overall Study||63
10638364|NCT02080819|11796879|FG001|STARTED|Overall Study||35
10638365|NCT02080819|11796880|FG002|STARTED|Overall Study||33
10638366|NCT02080819|11796878|FG000|COMPLETED|Overall Study||38
10638367|NCT02080819|11796879|FG001|COMPLETED|Overall Study||9
10638368|NCT02080819|11796880|FG002|COMPLETED|Overall Study||11
10638369|NCT02080819|11796878|FG000|NOT COMPLETED|Overall Study||25
10638370|NCT02080819|11796879|FG001|NOT COMPLETED|Overall Study||26
10638371|NCT02080819|11796880|FG002|NOT COMPLETED|Overall Study||22
10638372|NCT02080832|11796891|FG000|STARTED|Overall Study||15
10638373|NCT02080832|11796892|FG001|STARTED|Overall Study||17
10638374|NCT02080832|11796893|FG002|STARTED|Overall Study||22
10638375|NCT02080832|11796891|FG000|COMPLETED|Overall Study||6
10638376|NCT02080832|11796892|FG001|COMPLETED|Overall Study||5
10638377|NCT02080832|11796893|FG002|COMPLETED|Overall Study||6
10638378|NCT02080832|11796891|FG000|NOT COMPLETED|Overall Study||9
10638379|NCT02080832|11796892|FG001|NOT COMPLETED|Overall Study||12
10638380|NCT02080832|11796893|FG002|NOT COMPLETED|Overall Study||16
10638381|NCT02080871|11796903|FG000|STARTED|Overall Study||134
10638382|NCT02080871|11796903|FG000|COMPLETED|Overall Study||132
10638383|NCT02080871|11796903|FG000|NOT COMPLETED|Overall Study||2
10638384|NCT02081001|11796909|FG000|STARTED|Overall Study||2
10638385|NCT02081001|11796910|FG001|STARTED|Overall Study||1
10638386|NCT02081001|11796911|FG002|STARTED|Overall Study||2
10638387|NCT02081001|11796912|FG003|STARTED|Overall Study||1
10638388|NCT02081001|11796913|FG004|STARTED|Overall Study||3
10638389|NCT02081001|11796914|FG005|STARTED|Overall Study||1
10638390|NCT02081001|11796915|FG006|STARTED|Overall Study||2
10638391|NCT02081001|11796916|FG007|STARTED|Overall Study||1
10638392|NCT02081001|11796917|FG008|STARTED|Overall Study||2
10638393|NCT02081001|11796918|FG009|STARTED|Overall Study||1
10638394|NCT02081001|11796919|FG010|STARTED|Overall Study||2
10638395|NCT02081001|11796920|FG011|STARTED|Overall Study||1
10638396|NCT02081001|11796909|FG000|COMPLETED|Overall Study||2
10638397|NCT02081001|11796910|FG001|COMPLETED|Overall Study||1
10638398|NCT02081001|11796911|FG002|COMPLETED|Overall Study||2
10638399|NCT02081001|11796912|FG003|COMPLETED|Overall Study||1
10638400|NCT02081001|11796913|FG004|COMPLETED|Overall Study||2
10638401|NCT02081001|11796914|FG005|COMPLETED|Overall Study||1
10638402|NCT02081001|11796915|FG006|COMPLETED|Overall Study||2
10638403|NCT02081001|11796916|FG007|COMPLETED|Overall Study||1
10638404|NCT02081001|11796917|FG008|COMPLETED|Overall Study||2
10705833|NCT02603172|11870299|FG003|COMPLETED|Part C (Approximately 13 Weeks)||0
10705834|NCT02603172|11870300|FG004|COMPLETED|Part C (Approximately 13 Weeks)||0
10705835|NCT02603172|11870301|FG005|COMPLETED|Part C (Approximately 13 Weeks)||0
10705836|NCT02603172|11870302|FG006|COMPLETED|Part C (Approximately 13 Weeks)||0
10705837|NCT02603172|11870303|FG007|COMPLETED|Part C (Approximately 13 Weeks)||0
10705838|NCT02603172|11870296|FG000|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
10705839|NCT02603172|11870297|FG001|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
10638405|NCT02081001|11796918|FG009|COMPLETED|Overall Study||1
10638406|NCT02081001|11796919|FG010|COMPLETED|Overall Study||2
10638407|NCT02081001|11796920|FG011|COMPLETED|Overall Study||1
10638408|NCT02081001|11796909|FG000|NOT COMPLETED|Overall Study||0
10638409|NCT02081001|11796910|FG001|NOT COMPLETED|Overall Study||0
10638410|NCT02081001|11796911|FG002|NOT COMPLETED|Overall Study||0
10638411|NCT02081001|11796912|FG003|NOT COMPLETED|Overall Study||0
10638412|NCT02081001|11796913|FG004|NOT COMPLETED|Overall Study||1
10638413|NCT02081001|11796914|FG005|NOT COMPLETED|Overall Study||0
10638414|NCT02081001|11796915|FG006|NOT COMPLETED|Overall Study||0
10638415|NCT02081001|11796916|FG007|NOT COMPLETED|Overall Study||0
10638416|NCT02081001|11796917|FG008|NOT COMPLETED|Overall Study||0
10638417|NCT02081001|11796918|FG009|NOT COMPLETED|Overall Study||0
10638418|NCT02081001|11796919|FG010|NOT COMPLETED|Overall Study||0
10638419|NCT02081001|11796920|FG011|NOT COMPLETED|Overall Study||0
10638420|NCT02081014|11796931|FG000|STARTED|Overall Study||2
10638421|NCT02081014|11796932|FG001|STARTED|Overall Study||2
10638422|NCT02081014|11796933|FG002|STARTED|Overall Study||2
10638423|NCT02081014|11796934|FG003|STARTED|Overall Study||2
10638424|NCT02081014|11796935|FG004|STARTED|Overall Study||2
10638425|NCT02081014|11796936|FG005|STARTED|Overall Study||2
10638426|NCT02081014|11796931|FG000|COMPLETED|Overall Study||2
10638427|NCT02081014|11796932|FG001|COMPLETED|Overall Study||2
10638428|NCT02081014|11796933|FG002|COMPLETED|Overall Study||2
10638429|NCT02081014|11796934|FG003|COMPLETED|Overall Study||2
10638430|NCT02081014|11796935|FG004|COMPLETED|Overall Study||2
10638431|NCT02081014|11796936|FG005|COMPLETED|Overall Study||2
10638432|NCT02081014|11796931|FG000|NOT COMPLETED|Overall Study||0
10638433|NCT02081014|11796932|FG001|NOT COMPLETED|Overall Study||0
10638434|NCT02081014|11796933|FG002|NOT COMPLETED|Overall Study||0
10638435|NCT02081014|11796934|FG003|NOT COMPLETED|Overall Study||0
10638436|NCT02081014|11796935|FG004|NOT COMPLETED|Overall Study||0
10638437|NCT02081014|11796936|FG005|NOT COMPLETED|Overall Study||0
10638438|NCT02081079|11796957|FG000|STARTED|Overall Study||44
10638439|NCT02081079|11796958|FG001|STARTED|Overall Study||41
10638440|NCT02081079|11796957|FG000|COMPLETED|Overall Study||40
10638441|NCT02081079|11796958|FG001|COMPLETED|Overall Study||39
10638442|NCT02081079|11796957|FG000|NOT COMPLETED|Overall Study||4
10638443|NCT02081079|11796958|FG001|NOT COMPLETED|Overall Study||2
10638444|NCT02081196|11796968|FG000|STARTED|Overall Study|Treatment on one flank. Contralateral flank was untreated control.|45
10638445|NCT02081196|11796968|FG000|Untreated Control Flank|Overall Study||45
10638446|NCT02081196|11796968|FG000|COMPLETED|Overall Study|One (1) subject was lost to FU.|44
10638447|NCT02081196|11796968|FG000|NOT COMPLETED|Overall Study||1
10638448|NCT02081248|11796976|FG000|STARTED|Overall Study||98
10638449|NCT02081248|11796977|FG001|STARTED|Overall Study||100
10638450|NCT02081248|11796976|FG000|COMPLETED|Overall Study||76
10638451|NCT02081248|11796977|FG001|COMPLETED|Overall Study||87
10638452|NCT02081248|11796976|FG000|NOT COMPLETED|Overall Study||22
10638453|NCT02081248|11796977|FG001|NOT COMPLETED|Overall Study||13
10638454|NCT02081365|11796985|FG000|STARTED|Overall Study||74
10638455|NCT02081365|11796986|FG001|STARTED|Overall Study||77
10638456|NCT02081365|11796985|FG000|Received Allocated Intervention|Overall Study||46
10638457|NCT02081365|11796986|FG001|Received Allocated Intervention|Overall Study||59
10638458|NCT02081365|11796985|FG000|COMPLETED|Overall Study||44
10638459|NCT02081365|11796986|FG001|COMPLETED|Overall Study||54
10638460|NCT02081365|11796985|FG000|NOT COMPLETED|Overall Study||30
10705840|NCT02603172|11870298|FG002|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
10705841|NCT02603172|11870299|FG003|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
10638461|NCT02081365|11796986|FG001|NOT COMPLETED|Overall Study||23
10638462|NCT02081417|11796994|FG000|STARTED|Overall Study|Randomized to intervention|163
10638463|NCT02081417|11796995|FG001|STARTED|Overall Study||166
10638464|NCT02081417|11796994|FG000|1st Interview Completed|Overall Study||146
10638465|NCT02081417|11796995|FG001|1st Interview Completed|Overall Study||145
10638466|NCT02081417|11796994|FG000|3-Month Follow-Up|Overall Study||94
10638467|NCT02081417|11796995|FG001|3-Month Follow-Up|Overall Study||95
10638468|NCT02081417|11796994|FG000|6-Month Follow-Up|Overall Study||82
10638469|NCT02081417|11796995|FG001|6-Month Follow-Up|Overall Study||92
10638470|NCT02081417|11796994|FG000|COMPLETED|Overall Study||107
10638471|NCT02081417|11796995|FG001|COMPLETED|Overall Study||115
10638472|NCT02081417|11796994|FG000|NOT COMPLETED|Overall Study||56
10638473|NCT02081417|11796995|FG001|NOT COMPLETED|Overall Study||51
10638474|NCT02081443|11797003|FG000|STARTED|Overall Study||30
10638475|NCT02081443|11797004|FG001|STARTED|Overall Study||30
10638476|NCT02081443|11797003|FG000|COMPLETED|Overall Study||30
10638477|NCT02081443|11797004|FG001|COMPLETED|Overall Study||30
10638478|NCT02081443|11797003|FG000|NOT COMPLETED|Overall Study||0
10638479|NCT02081443|11797004|FG001|NOT COMPLETED|Overall Study||0
10638480|NCT02081456|11797012|FG000|STARTED|Overall Study||11
10638481|NCT02081456|11797013|FG001|STARTED|Overall Study||12
10638482|NCT02081456|11797012|FG000|COMPLETED|Overall Study||11
10638483|NCT02081456|11797013|FG001|COMPLETED|Overall Study||12
10638484|NCT02081456|11797012|FG000|NOT COMPLETED|Overall Study||0
10638485|NCT02081456|11797013|FG001|NOT COMPLETED|Overall Study||0
10638486|NCT02081534|11797026|FG000|STARTED|Overall Study||23
10638487|NCT02081534|11797027|FG001|STARTED|Overall Study||21
10638488|NCT02081534|11797028|FG002|STARTED|Overall Study||23
10638489|NCT02081534|11797029|FG003|STARTED|Overall Study||26
10638490|NCT02081534|11797030|FG004|STARTED|Overall Study||22
10638491|NCT02081534|11797031|FG005|STARTED|Overall Study||21
10638492|NCT02081534|11797032|FG006|STARTED|Overall Study||26
10638493|NCT02081534|11797026|FG000|COMPLETED|Overall Study||18
10638494|NCT02081534|11797027|FG001|COMPLETED|Overall Study||13
10638495|NCT02081534|11797028|FG002|COMPLETED|Overall Study||19
10638496|NCT02081534|11797029|FG003|COMPLETED|Overall Study||13
10638497|NCT02081534|11797030|FG004|COMPLETED|Overall Study||18
10638498|NCT02081534|11797031|FG005|COMPLETED|Overall Study||12
10638499|NCT02081534|11797032|FG006|COMPLETED|Overall Study||22
10638500|NCT02081534|11797026|FG000|NOT COMPLETED|Overall Study||5
10638501|NCT02081534|11797027|FG001|NOT COMPLETED|Overall Study||8
10638502|NCT02081534|11797028|FG002|NOT COMPLETED|Overall Study||4
10638503|NCT02081534|11797029|FG003|NOT COMPLETED|Overall Study||13
10638504|NCT02081534|11797030|FG004|NOT COMPLETED|Overall Study||4
10638505|NCT02081534|11797031|FG005|NOT COMPLETED|Overall Study||9
10638506|NCT02081534|11797032|FG006|NOT COMPLETED|Overall Study||4
10638507|NCT02081573|11797048|FG000|STARTED|Overall Study||10
10638508|NCT02081573|11797048|FG000|COMPLETED|Overall Study||10
10638509|NCT02081573|11797048|FG000|NOT COMPLETED|Overall Study||0
10638510|NCT02081586|11797056|FG000|STARTED|Overall Study||3
10638511|NCT02081586|11797057|FG001|STARTED|Overall Study||3
10638512|NCT02081586|11797058|FG002|STARTED|Overall Study||4
10638513|NCT02081586|11797059|FG003|STARTED|Overall Study||3
10638514|NCT02081586|11797056|FG000|COMPLETED|Overall Study||3
10638515|NCT02081586|11797057|FG001|COMPLETED|Overall Study||2
10638516|NCT02081586|11797058|FG002|COMPLETED|Overall Study||3
10638517|NCT02081586|11797059|FG003|COMPLETED|Overall Study||2
10638518|NCT02081586|11797056|FG000|NOT COMPLETED|Overall Study||0
10638519|NCT02081586|11797057|FG001|NOT COMPLETED|Overall Study||1
10638520|NCT02081586|11797058|FG002|NOT COMPLETED|Overall Study||1
10638521|NCT02081586|11797059|FG003|NOT COMPLETED|Overall Study||1
10638522|NCT02081599|11797073|FG000|STARTED|Period 1：Double-blind Period||71
10638523|NCT02081599|11797074|FG001|STARTED|Period 1：Double-blind Period||77
10638524|NCT02081599|11797073|FG000|COMPLETED|Period 1：Double-blind Period||63
10638525|NCT02081599|11797074|FG001|COMPLETED|Period 1：Double-blind Period||75
10638526|NCT02081599|11797073|FG000|NOT COMPLETED|Period 1：Double-blind Period||8
10638527|NCT02081599|11797074|FG001|NOT COMPLETED|Period 1：Double-blind Period||2
10638528|NCT02081599|11797073|FG000|STARTED|Period 2：Open-label Period||63
10638529|NCT02081599|11797074|FG001|STARTED|Period 2：Open-label Period||75
10638530|NCT02081599|11797073|FG000|COMPLETED|Period 2：Open-label Period||57
10638531|NCT02081599|11797074|FG001|COMPLETED|Period 2：Open-label Period||71
10638532|NCT02081599|11797073|FG000|NOT COMPLETED|Period 2：Open-label Period||6
10638533|NCT02081599|11797074|FG001|NOT COMPLETED|Period 2：Open-label Period||4
10638534|NCT02081638|11797084|FG000|STARTED|Overall Study||26
10638535|NCT02081638|11797085|FG001|STARTED|Overall Study||27
10638536|NCT02081638|11797084|FG000|COMPLETED|Overall Study||24
10638537|NCT02081638|11797085|FG001|COMPLETED|Overall Study||20
10638538|NCT02081638|11797084|FG000|NOT COMPLETED|Overall Study||2
10638539|NCT02081638|11797085|FG001|NOT COMPLETED|Overall Study||7
10638540|NCT02081677|11797099|FG000|STARTED|Overall Study||19
10638541|NCT02081677|11797100|FG001|STARTED|Overall Study||19
10638542|NCT02081677|11797101|FG002|STARTED|Overall Study||19
10638543|NCT02081677|11797102|FG003|STARTED|Overall Study||19
10638544|NCT02081677|11797099|FG000|COMPLETED|Overall Study||18
10638545|NCT02081677|11797100|FG001|COMPLETED|Overall Study||18
10638546|NCT02081677|11797101|FG002|COMPLETED|Overall Study||17
10638547|NCT02081677|11797102|FG003|COMPLETED|Overall Study||19
10638548|NCT02081677|11797099|FG000|NOT COMPLETED|Overall Study||1
10638549|NCT02081677|11797100|FG001|NOT COMPLETED|Overall Study||1
10638550|NCT02081677|11797101|FG002|NOT COMPLETED|Overall Study||2
10638551|NCT02081677|11797102|FG003|NOT COMPLETED|Overall Study||0
10638552|NCT02081690|11797112|FG000|STARTED|Overall Study||88
10638553|NCT02081690|11797112|FG000|COMPLETED|Overall Study||81
10638554|NCT02081690|11797112|FG000|NOT COMPLETED|Overall Study||7
10638555|NCT02081807|11797124|FG000|STARTED|Overall Study||7668
10638556|NCT02081807|11797125|FG001|STARTED|Overall Study||26149
10638557|NCT02081807|11797126|FG002|STARTED|Overall Study||14852
10638558|NCT02081807|11797127|FG003|STARTED|Overall Study||9112
10638559|NCT02081807|11797128|FG004|STARTED|Overall Study||27456
10638560|NCT02081807|11797129|FG005|STARTED|Overall Study||76055
10638561|NCT02081807|11797130|FG006|STARTED|Overall Study||40207
10638562|NCT02081807|11797131|FG007|STARTED|Overall Study||19729
10638563|NCT02081807|11797124|FG000|COMPLETED|Overall Study||7668
10638564|NCT02081807|11797125|FG001|COMPLETED|Overall Study||26149
10705842|NCT02603172|11870300|FG004|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
10705843|NCT02603172|11870301|FG005|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
10638565|NCT02081807|11797126|FG002|COMPLETED|Overall Study||14852
10705844|NCT02603172|11870302|FG006|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
10705845|NCT02603172|11870303|FG007|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
10705846|NCT02603211|11870319|FG000|STARTED|Overall Study||20
10705847|NCT02603211|11870319|FG000|COMPLETED|Overall Study||20
10705848|NCT02603211|11870319|FG000|NOT COMPLETED|Overall Study||0
10705849|NCT02603393|11870326|FG000|STARTED|Overall Study||527
10638566|NCT02081807|11797127|FG003|COMPLETED|Overall Study||9112
10638567|NCT02081807|11797128|FG004|COMPLETED|Overall Study||27456
10638568|NCT02081807|11797129|FG005|COMPLETED|Overall Study||76055
10638569|NCT02081807|11797130|FG006|COMPLETED|Overall Study||40207
10638570|NCT02081807|11797131|FG007|COMPLETED|Overall Study||19729
10638571|NCT02081807|11797124|FG000|NOT COMPLETED|Overall Study||0
10638572|NCT02081807|11797125|FG001|NOT COMPLETED|Overall Study||0
10638573|NCT02081807|11797126|FG002|NOT COMPLETED|Overall Study||0
10638574|NCT02081807|11797127|FG003|NOT COMPLETED|Overall Study||0
10638575|NCT02081807|11797128|FG004|NOT COMPLETED|Overall Study||0
10638576|NCT02081807|11797129|FG005|NOT COMPLETED|Overall Study||0
10638577|NCT02081807|11797130|FG006|NOT COMPLETED|Overall Study||0
10638578|NCT02081807|11797131|FG007|NOT COMPLETED|Overall Study||0
10638579|NCT02081846|11797161|FG000|STARTED|Overall Study||751
10638580|NCT02081846|11797162|FG001|STARTED|Overall Study||749
10638581|NCT02081846|11797161|FG000|COMPLETED|Overall Study||749
10638582|NCT02081846|11797162|FG001|COMPLETED|Overall Study||749
10638583|NCT02081846|11797161|FG000|NOT COMPLETED|Overall Study||2
10638584|NCT02081846|11797162|FG001|NOT COMPLETED|Overall Study||0
10638585|NCT02081859|11797170|FG000|STARTED|Overall Study||150
10638586|NCT02081859|11797171|FG001|STARTED|Overall Study||150
10638587|NCT02081859|11797170|FG000|COMPLETED|Overall Study||116
10638588|NCT02081859|11797171|FG001|COMPLETED|Overall Study||119
10638589|NCT02081859|11797170|FG000|NOT COMPLETED|Overall Study||34
10638590|NCT02081859|11797171|FG001|NOT COMPLETED|Overall Study||31
10638591|NCT02081950|11797177|FG000|STARTED|Treatment Period 1||14
10638592|NCT02081950|11797177|FG000|COMPLETED|Treatment Period 1||14
10638593|NCT02081950|11797177|FG000|NOT COMPLETED|Treatment Period 1||0
10638594|NCT02081950|11797177|FG000|STARTED|Treatment Period 2||14
10638595|NCT02081950|11797177|FG000|COMPLETED|Treatment Period 2||14
10638596|NCT02081950|11797177|FG000|NOT COMPLETED|Treatment Period 2||0
10638597|NCT02081963|11797185|FG000|STARTED|Overall Study||79
10638598|NCT02081963|11797186|FG001|STARTED|Overall Study||73
10638599|NCT02081963|11797185|FG000|COMPLETED|Overall Study||74
10638600|NCT02081963|11797186|FG001|COMPLETED|Overall Study||69
10638601|NCT02081963|11797185|FG000|NOT COMPLETED|Overall Study||5
10638602|NCT02081963|11797186|FG001|NOT COMPLETED|Overall Study||4
10638603|NCT02082119|11797192|FG000|STARTED|Overall Study||82
10638604|NCT02082119|11797192|FG000|COMPLETED|Overall Study||82
10638605|NCT02082119|11797192|FG000|NOT COMPLETED|Overall Study||0
10638606|NCT02082145|11797198|FG000|STARTED|Overall Study||5
10638607|NCT02082145|11797199|FG001|STARTED|Overall Study||9
10638608|NCT02082145|11797198|FG000|COMPLETED|Overall Study||5
10638609|NCT02082145|11797199|FG001|COMPLETED|Overall Study||9
10638610|NCT02082145|11797198|FG000|NOT COMPLETED|Overall Study||0
10705850|NCT02603393|11870327|FG001|STARTED|Overall Study||526
10705851|NCT02603393|11870326|FG000|COMPLETED|Overall Study||456
10705852|NCT02603393|11870327|FG001|COMPLETED|Overall Study||472
10638611|NCT02082145|11797199|FG001|NOT COMPLETED|Overall Study||0
10638612|NCT02082158|11797213|FG000|STARTED|Overall Study||66
10638613|NCT02082158|11797214|FG001|STARTED|Overall Study||61
10638614|NCT02082158|11797215|FG002|STARTED|Overall Study||52
10638615|NCT02082158|11797216|FG003|STARTED|Overall Study||72
10638616|NCT02082158|11797217|FG004|STARTED|Overall Study||68
10638617|NCT02082158|11797218|FG005|STARTED|Overall Study||63
10638618|NCT02082158|11797213|FG000|COMPLETED|Overall Study||58
10638619|NCT02082158|11797214|FG001|COMPLETED|Overall Study||53
10638620|NCT02082158|11797215|FG002|COMPLETED|Overall Study||38
10638621|NCT02082158|11797216|FG003|COMPLETED|Overall Study|Includes completion with respirator from secondary randomization after fit-test failure of 1st model|68
10638622|NCT02082158|11797217|FG004|COMPLETED|Overall Study||64
10638623|NCT02082158|11797218|FG005|COMPLETED|Overall Study||56
10705853|NCT02603393|11870326|FG000|NOT COMPLETED|Overall Study||71
10638624|NCT02082158|11797213|FG000|NOT COMPLETED|Overall Study||8
10638625|NCT02082158|11797214|FG001|NOT COMPLETED|Overall Study||8
10705854|NCT02603393|11870327|FG001|NOT COMPLETED|Overall Study||54
10638626|NCT02082158|11797215|FG002|NOT COMPLETED|Overall Study||14
10638627|NCT02082158|11797216|FG003|NOT COMPLETED|Overall Study||4
10705855|NCT02603419|11870339|FG000|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6
10705856|NCT02603419|11870340|FG001|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||7
10638628|NCT02082158|11797217|FG004|NOT COMPLETED|Overall Study||4
10638629|NCT02082158|11797218|FG005|NOT COMPLETED|Overall Study||7
10638630|NCT02082184|11797240|FG000|STARTED|Overall Study||149
10638631|NCT02082184|11797241|FG001|STARTED|Overall Study||75
10638632|NCT02082184|11797240|FG000|COMPLETED|Overall Study||139
10638633|NCT02082184|11797241|FG001|COMPLETED|Overall Study||62
10638634|NCT02082184|11797240|FG000|NOT COMPLETED|Overall Study||10
10638635|NCT02082184|11797241|FG001|NOT COMPLETED|Overall Study||13
10638636|NCT02082210|11797253|FG000|STARTED|Overall Study||3
10638637|NCT02082210|11797254|FG001|STARTED|Overall Study||3
10638638|NCT02082210|11797255|FG002|STARTED|Overall Study||16
10638639|NCT02082210|11797256|FG003|STARTED|Overall Study||45
10638640|NCT02082210|11797257|FG004|STARTED|Overall Study||15
10638641|NCT02082210|11797258|FG005|STARTED|Overall Study||15
10638642|NCT02082210|11797253|FG000|Received at Least One Dose of Study Drug|Overall Study||3
10638643|NCT02082210|11797254|FG001|Received at Least One Dose of Study Drug|Overall Study||3
10638644|NCT02082210|11797255|FG002|Received at Least One Dose of Study Drug|Overall Study||16
10638645|NCT02082210|11797256|FG003|Received at Least One Dose of Study Drug|Overall Study||45
10638646|NCT02082210|11797257|FG004|Received at Least One Dose of Study Drug|Overall Study||15
10638647|NCT02082210|11797258|FG005|Received at Least One Dose of Study Drug|Overall Study||15
10638648|NCT02082210|11797253|FG000|COMPLETED|Overall Study||3
10638649|NCT02082210|11797254|FG001|COMPLETED|Overall Study||3
10638650|NCT02082210|11797255|FG002|COMPLETED|Overall Study||13
10638651|NCT02082210|11797256|FG003|COMPLETED|Overall Study||39
10638652|NCT02082210|11797257|FG004|COMPLETED|Overall Study||12
10638653|NCT02082210|11797258|FG005|COMPLETED|Overall Study||13
10638654|NCT02082210|11797253|FG000|NOT COMPLETED|Overall Study||0
10638655|NCT02082210|11797254|FG001|NOT COMPLETED|Overall Study||0
10638656|NCT02082210|11797255|FG002|NOT COMPLETED|Overall Study||3
10638657|NCT02082210|11797256|FG003|NOT COMPLETED|Overall Study||6
10638658|NCT02082210|11797257|FG004|NOT COMPLETED|Overall Study||3
10638659|NCT02082210|11797258|FG005|NOT COMPLETED|Overall Study||2
10638660|NCT02082262|11797284|FG000|STARTED|Overall Study||140
10638661|NCT02082262|11797284|FG000|COMPLETED|Overall Study||89
10638662|NCT02082262|11797284|FG000|NOT COMPLETED|Overall Study||51
10638663|NCT02082288|11797288|FG000|STARTED|Overall Study||243
10638664|NCT02082288|11797288|FG000|COMPLETED|Overall Study||243
10638665|NCT02082288|11797288|FG000|NOT COMPLETED|Overall Study||0
10638666|NCT02082340|11797294|FG000|STARTED|Overall Study||194
10638667|NCT02082340|11797295|FG001|STARTED|Overall Study||198
10638668|NCT02082340|11797294|FG000|COMPLETED|Overall Study||193
10638669|NCT02082340|11797295|FG001|COMPLETED|Overall Study||197
10638670|NCT02082340|11797294|FG000|NOT COMPLETED|Overall Study||1
10638671|NCT02082340|11797295|FG001|NOT COMPLETED|Overall Study||1
10638672|NCT02082392|11797303|FG000|STARTED|Overall Study||2
10638673|NCT02082392|11797304|FG001|STARTED|Overall Study||1
10638674|NCT02082392|11797303|FG000|COMPLETED|Overall Study||2
10638675|NCT02082392|11797304|FG001|COMPLETED|Overall Study||1
10638676|NCT02082392|11797303|FG000|NOT COMPLETED|Overall Study||0
10638677|NCT02082392|11797304|FG001|NOT COMPLETED|Overall Study||0
10638678|NCT02082483|11797312|FG000|STARTED|Overall Study||71
10638679|NCT02082483|11797313|FG001|STARTED|Overall Study||73
10638680|NCT02082483|11797312|FG000|COMPLETED|Overall Study||65
10638681|NCT02082483|11797313|FG001|COMPLETED|Overall Study||67
10638682|NCT02082483|11797312|FG000|NOT COMPLETED|Overall Study||6
10638683|NCT02082483|11797313|FG001|NOT COMPLETED|Overall Study||6
10638684|NCT02082522|11797322|FG000|STARTED|Overall Study||15
10638685|NCT02082522|11797323|FG001|STARTED|Overall Study||13
10705857|NCT02603419|11870341|FG002|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6
10705858|NCT02603419|11870342|FG003|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6
10705859|NCT02603419|11870343|FG004|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6
10638686|NCT02082522|11797322|FG000|COMPLETED|Overall Study||0
10638687|NCT02082522|11797323|FG001|COMPLETED|Overall Study||0
10638688|NCT02082522|11797322|FG000|NOT COMPLETED|Overall Study||15
10638689|NCT02082522|11797323|FG001|NOT COMPLETED|Overall Study||13
10638690|NCT02082678|11797331|FG000|STARTED|Overall Study||35
10638691|NCT02082678|11797332|FG001|STARTED|Overall Study||35
10638692|NCT02082678|11797331|FG000|COMPLETED|Overall Study||23
10638693|NCT02082678|11797332|FG001|COMPLETED|Overall Study||21
10638694|NCT02082678|11797331|FG000|NOT COMPLETED|Overall Study||12
10638695|NCT02082678|11797332|FG001|NOT COMPLETED|Overall Study||14
10638696|NCT02082717|11797340|FG000|STARTED|Overall Study||8
10638697|NCT02082717|11797341|FG001|STARTED|Overall Study||9
10638698|NCT02082717|11797340|FG000|COMPLETED|Overall Study||8
10638699|NCT02082717|11797341|FG001|COMPLETED|Overall Study||9
10638700|NCT02082717|11797340|FG000|NOT COMPLETED|Overall Study||0
10638701|NCT02082717|11797341|FG001|NOT COMPLETED|Overall Study||0
10638702|NCT02082769|11797354|FG000|STARTED|Overall Study||168
10638703|NCT02082769|11797355|FG001|STARTED|Overall Study||168
10809154|NCT03824236|11971023|FG000|NOT COMPLETED|Overall Study||0
10638704|NCT02082769|11797356|FG002|STARTED|Overall Study||168
10705860|NCT02603419|11870344|FG005|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||0
10809155|NCT03824236|11971024|FG001|NOT COMPLETED|Overall Study||0
10638705|NCT02082769|11797354|FG000|COMPLETED|Overall Study||144
10638706|NCT02082769|11797355|FG001|COMPLETED|Overall Study||141
10638707|NCT02082769|11797356|FG002|COMPLETED|Overall Study||132
10638708|NCT02082769|11797354|FG000|NOT COMPLETED|Overall Study||24
10638709|NCT02082769|11797355|FG001|NOT COMPLETED|Overall Study||27
10638710|NCT02082769|11797356|FG002|NOT COMPLETED|Overall Study||36
10638711|NCT02082912|11797366|FG000|STARTED|Overall Study||7
10638712|NCT02082912|11797367|FG001|STARTED|Overall Study||7
10705861|NCT02603419|11870339|FG000|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
10809156|NCT03824236|11971025|FG002|NOT COMPLETED|Overall Study||1
10809157|NCT03811951|11971035|FG000|STARTED|First Intervention (1 Day)||2
10809158|NCT03811951|11971036|FG001|STARTED|First Intervention (1 Day)||2
10809159|NCT03811951|11971035|FG000|COMPLETED|First Intervention (1 Day)||2
10809160|NCT03811951|11971036|FG001|COMPLETED|First Intervention (1 Day)||2
10809161|NCT03811951|11971035|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10809162|NCT03811951|11971036|FG001|NOT COMPLETED|First Intervention (1 Day)||0
10809163|NCT03811951|11971035|FG000|STARTED|Washout (1 Week)||2
10809164|NCT03811951|11971036|FG001|STARTED|Washout (1 Week)||2
10638713|NCT02082912|11797366|FG000|COMPLETED|Overall Study||7
10638714|NCT02082912|11797367|FG001|COMPLETED|Overall Study||6
10638715|NCT02082912|11797366|FG000|NOT COMPLETED|Overall Study||0
10638716|NCT02082912|11797367|FG001|NOT COMPLETED|Overall Study||1
10638717|NCT02082977|11797383|FG000|STARTED|Part 1 (Up to 3.2 Years)||2
10638718|NCT02082977|11797384|FG001|STARTED|Part 1 (Up to 3.2 Years)||1
10638719|NCT02082977|11797385|FG002|STARTED|Part 1 (Up to 3.2 Years)||1
10638720|NCT02082977|11797386|FG003|STARTED|Part 1 (Up to 3.2 Years)||1
10638721|NCT02082977|11797387|FG004|STARTED|Part 1 (Up to 3.2 Years)||3
10638722|NCT02082977|11797388|FG005|STARTED|Part 1 (Up to 3.2 Years)||4
10638723|NCT02082977|11797389|FG006|STARTED|Part 1 (Up to 3.2 Years)||10
10638724|NCT02082977|11797390|FG007|STARTED|Part 1 (Up to 3.2 Years)||12
10638725|NCT02082977|11797391|FG008|STARTED|Part 1 (Up to 3.2 Years)||7
10638726|NCT02082977|11797392|FG009|STARTED|Part 1 (Up to 3.2 Years)||0
10638727|NCT02082977|11797383|FG000|COMPLETED|Part 1 (Up to 3.2 Years)||1
10638728|NCT02082977|11797384|FG001|COMPLETED|Part 1 (Up to 3.2 Years)||1
10638729|NCT02082977|11797385|FG002|COMPLETED|Part 1 (Up to 3.2 Years)||1
10638730|NCT02082977|11797386|FG003|COMPLETED|Part 1 (Up to 3.2 Years)||1
10638731|NCT02082977|11797387|FG004|COMPLETED|Part 1 (Up to 3.2 Years)||2
10638732|NCT02082977|11797388|FG005|COMPLETED|Part 1 (Up to 3.2 Years)||1
10638733|NCT02082977|11797389|FG006|COMPLETED|Part 1 (Up to 3.2 Years)||4
10638734|NCT02082977|11797390|FG007|COMPLETED|Part 1 (Up to 3.2 Years)||7
10638735|NCT02082977|11797391|FG008|COMPLETED|Part 1 (Up to 3.2 Years)||4
10638736|NCT02082977|11797392|FG009|COMPLETED|Part 1 (Up to 3.2 Years)||0
10638737|NCT02082977|11797383|FG000|NOT COMPLETED|Part 1 (Up to 3.2 Years)||1
10638738|NCT02082977|11797384|FG001|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
10638739|NCT02082977|11797385|FG002|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
10638740|NCT02082977|11797386|FG003|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
10638741|NCT02082977|11797387|FG004|NOT COMPLETED|Part 1 (Up to 3.2 Years)||1
10638742|NCT02082977|11797388|FG005|NOT COMPLETED|Part 1 (Up to 3.2 Years)||3
10638743|NCT02082977|11797389|FG006|NOT COMPLETED|Part 1 (Up to 3.2 Years)||6
10638744|NCT02082977|11797390|FG007|NOT COMPLETED|Part 1 (Up to 3.2 Years)||5
10638745|NCT02082977|11797391|FG008|NOT COMPLETED|Part 1 (Up to 3.2 Years)||3
10638746|NCT02082977|11797392|FG009|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
10638747|NCT02082977|11797383|FG000|STARTED|Part 2 (Up to 3.2 Years)||0
10638748|NCT02082977|11797384|FG001|STARTED|Part 2 (Up to 3.2 Years)||0
10638749|NCT02082977|11797385|FG002|STARTED|Part 2 (Up to 3.2 Years)||0
10638750|NCT02082977|11797386|FG003|STARTED|Part 2 (Up to 3.2 Years)||0
10638751|NCT02082977|11797387|FG004|STARTED|Part 2 (Up to 3.2 Years)||0
10638752|NCT02082977|11797388|FG005|STARTED|Part 2 (Up to 3.2 Years)||0
10638753|NCT02082977|11797389|FG006|STARTED|Part 2 (Up to 3.2 Years)||0
10638754|NCT02082977|11797390|FG007|STARTED|Part 2 (Up to 3.2 Years)||0
10638755|NCT02082977|11797391|FG008|STARTED|Part 2 (Up to 3.2 Years)||0
10638756|NCT02082977|11797392|FG009|STARTED|Part 2 (Up to 3.2 Years)||0
10638757|NCT02082977|11797383|FG000|COMPLETED|Part 2 (Up to 3.2 Years)||0
10638758|NCT02082977|11797384|FG001|COMPLETED|Part 2 (Up to 3.2 Years)||0
10638759|NCT02082977|11797385|FG002|COMPLETED|Part 2 (Up to 3.2 Years)||0
10638760|NCT02082977|11797386|FG003|COMPLETED|Part 2 (Up to 3.2 Years)||0
10638761|NCT02082977|11797387|FG004|COMPLETED|Part 2 (Up to 3.2 Years)||0
10638762|NCT02082977|11797388|FG005|COMPLETED|Part 2 (Up to 3.2 Years)||0
10638763|NCT02082977|11797389|FG006|COMPLETED|Part 2 (Up to 3.2 Years)||0
10638764|NCT02082977|11797390|FG007|COMPLETED|Part 2 (Up to 3.2 Years)||0
10638765|NCT02082977|11797391|FG008|COMPLETED|Part 2 (Up to 3.2 Years)||0
10638766|NCT02082977|11797392|FG009|COMPLETED|Part 2 (Up to 3.2 Years)||0
10638767|NCT02082977|11797383|FG000|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
10638768|NCT02082977|11797384|FG001|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
10638769|NCT02082977|11797385|FG002|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
10638770|NCT02082977|11797386|FG003|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
10638771|NCT02082977|11797387|FG004|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
10638772|NCT02082977|11797388|FG005|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
10638773|NCT02082977|11797389|FG006|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
10638774|NCT02082977|11797390|FG007|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
10638775|NCT02082977|11797391|FG008|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
10638776|NCT02082977|11797392|FG009|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
10638777|NCT02083107|11797427|FG000|STARTED|Overall Study|212 women received 2 tablets of Misotac® sublingually and 2 placebo tablets rectally.|212
10638778|NCT02083107|11797428|FG001|STARTED|Overall Study|212 women received 2 tablets of placebo sublingually and 2 placebo tablets rectally.|212
10638779|NCT02083107|11797429|FG002|STARTED|Overall Study|212 women received 2 tablets of Misotac® rectally and 2 placebo tablets sublingually.|212
10638780|NCT02083107|11797427|FG000|COMPLETED|Overall Study|212 women received 2 tablets of Misotac® sublingually and 2 placebo tablets rectally.|212
10638781|NCT02083107|11797428|FG001|COMPLETED|Overall Study|212 women received 2 tablets of placebo sublingually and 2 placebo tablets rectally.|212
10638782|NCT02083107|11797429|FG002|COMPLETED|Overall Study|212 women received 2 tablets of Misotac® rectally and 2 placebo tablets sublingually.|212
10638783|NCT02083107|11797427|FG000|NOT COMPLETED|Overall Study||0
10638784|NCT02083107|11797428|FG001|NOT COMPLETED|Overall Study||0
10638785|NCT02083107|11797429|FG002|NOT COMPLETED|Overall Study||0
10638786|NCT02083185|11797440|FG000|STARTED|Overall Study||56
10638787|NCT02083185|11797441|FG001|STARTED|Overall Study||56
10638788|NCT02083185|11797442|FG002|STARTED|Overall Study||24
10638789|NCT02083185|11797440|FG000|Safety Population|Overall Study||56
10638790|NCT02083185|11797441|FG001|Safety Population|Overall Study||54
10638791|NCT02083185|11797442|FG002|Safety Population|Overall Study||24
10638792|NCT02083185|11797440|FG000|COMPLETED|Overall Study||36
10638793|NCT02083185|11797441|FG001|COMPLETED|Overall Study||27
10638794|NCT02083185|11797442|FG002|COMPLETED|Overall Study||17
10638795|NCT02083185|11797440|FG000|NOT COMPLETED|Overall Study||20
10638796|NCT02083185|11797441|FG001|NOT COMPLETED|Overall Study||29
10638797|NCT02083185|11797442|FG002|NOT COMPLETED|Overall Study||7
10638798|NCT02083263|11797452|FG000|STARTED|Overall Study||16
10638799|NCT02083263|11797453|FG001|STARTED|Overall Study||16
10638800|NCT02083263|11797452|FG000|COMPLETED|Overall Study||16
10638801|NCT02083263|11797453|FG001|COMPLETED|Overall Study||16
10638802|NCT02083263|11797452|FG000|NOT COMPLETED|Overall Study||0
10638803|NCT02083263|11797453|FG001|NOT COMPLETED|Overall Study||0
10638804|NCT02083380|11797462|FG000|STARTED|Overall Study|5 subjects excluded from safety / ITT population - no drug administered|148
10638805|NCT02083380|11797463|FG001|STARTED|Overall Study|3 subjects excluded from safety / ITT population - no drug administered|151
10638806|NCT02083380|11797464|FG002|STARTED|Overall Study|3 subjects excluded from safety / ITT population - no drug administered|149
10638807|NCT02083380|11797462|FG000|COMPLETED|Overall Study||57
10638808|NCT02083380|11797463|FG001|COMPLETED|Overall Study||56
10638809|NCT02083380|11797464|FG002|COMPLETED|Overall Study||65
10638810|NCT02083380|11797462|FG000|NOT COMPLETED|Overall Study||91
10638811|NCT02083380|11797463|FG001|NOT COMPLETED|Overall Study||95
10638812|NCT02083380|11797464|FG002|NOT COMPLETED|Overall Study||84
10638813|NCT02083406|11797480|FG000|STARTED|Overall Study||7
10638814|NCT02083406|11797481|FG001|STARTED|Overall Study||8
10638815|NCT02083406|11797482|FG002|STARTED|Overall Study||7
10638816|NCT02083406|11797480|FG000|COMPLETED|Overall Study||7
10638817|NCT02083406|11797481|FG001|COMPLETED|Overall Study||8
10638818|NCT02083406|11797482|FG002|COMPLETED|Overall Study||7
10638819|NCT02083406|11797480|FG000|NOT COMPLETED|Overall Study||0
10638820|NCT02083406|11797481|FG001|NOT COMPLETED|Overall Study||0
10638821|NCT02083406|11797482|FG002|NOT COMPLETED|Overall Study||0
10638822|NCT02083653|11797493|FG000|STARTED|Overall Study||83
10638823|NCT02083653|11797494|FG001|STARTED|Overall Study||86
10638824|NCT02083653|11797495|FG002|STARTED|Overall Study||85
10638825|NCT02083653|11797493|FG000|COMPLETED|Overall Study||1
10638826|NCT02083653|11797494|FG001|COMPLETED|Overall Study||1
10638827|NCT02083653|11797495|FG002|COMPLETED|Overall Study||1
10638828|NCT02083653|11797493|FG000|NOT COMPLETED|Overall Study||82
10638829|NCT02083653|11797494|FG001|NOT COMPLETED|Overall Study||85
10638830|NCT02083653|11797495|FG002|NOT COMPLETED|Overall Study||84
10638831|NCT02083679|11797507|FG000|STARTED|Overall Study||3
10638832|NCT02083679|11797508|FG001|STARTED|Overall Study||6
10638833|NCT02083679|11797509|FG002|STARTED|Overall Study||3
10638834|NCT02083679|11797510|FG003|STARTED|Overall Study||3
10638835|NCT02083679|11797507|FG000|COMPLETED|Overall Study||3
10638836|NCT02083679|11797508|FG001|COMPLETED|Overall Study||6
10638837|NCT02083679|11797509|FG002|COMPLETED|Overall Study||3
10638838|NCT02083679|11797510|FG003|COMPLETED|Overall Study||3
10638839|NCT02083679|11797507|FG000|NOT COMPLETED|Overall Study||0
10638840|NCT02083679|11797508|FG001|NOT COMPLETED|Overall Study||0
10638841|NCT02083679|11797509|FG002|NOT COMPLETED|Overall Study||0
10638842|NCT02083679|11797510|FG003|NOT COMPLETED|Overall Study||0
10638843|NCT02083783|11797522|FG000|STARTED|Overall Study||52
10638844|NCT02083783|11797523|FG001|STARTED|Overall Study||48
10638845|NCT02083783|11797522|FG000|COMPLETED|Overall Study||51
10638846|NCT02083783|11797523|FG001|COMPLETED|Overall Study||48
10638847|NCT02083783|11797522|FG000|NOT COMPLETED|Overall Study||1
10638848|NCT02083783|11797523|FG001|NOT COMPLETED|Overall Study||0
10638849|NCT02083809|11797533|FG000|STARTED|Overall Study||82
10638850|NCT02083809|11797534|FG001|STARTED|Overall Study||84
10638851|NCT02083809|11797533|FG000|COMPLETED|Overall Study||78
10638852|NCT02083809|11797534|FG001|COMPLETED|Overall Study||82
10638853|NCT02083809|11797533|FG000|NOT COMPLETED|Overall Study||4
10638854|NCT02083809|11797534|FG001|NOT COMPLETED|Overall Study||2
10638855|NCT02083861|11797542|FG000|STARTED|Overall Study||57
10638856|NCT02083861|11797543|FG001|STARTED|Overall Study||36
10638857|NCT02083861|11797542|FG000|Treated|Overall Study||55
10638858|NCT02083861|11797543|FG001|Treated|Overall Study||35
10638859|NCT02083861|11797542|FG000|COMPLETED|Overall Study||51
10638860|NCT02083861|11797543|FG001|COMPLETED|Overall Study||33
10638861|NCT02083861|11797542|FG000|NOT COMPLETED|Overall Study||6
10638862|NCT02083861|11797543|FG001|NOT COMPLETED|Overall Study||3
10638863|NCT02083926|11797553|FG000|STARTED|Overall Study||9
10638864|NCT02083926|11797554|FG001|STARTED|Overall Study||9
10638865|NCT02083926|11797553|FG000|COMPLETED|Overall Study||8
10638866|NCT02083926|11797554|FG001|COMPLETED|Overall Study||9
10638867|NCT02083926|11797553|FG000|NOT COMPLETED|Overall Study||1
10638868|NCT02083926|11797554|FG001|NOT COMPLETED|Overall Study||0
10638869|NCT02083965|11797563|FG000|STARTED|PK Period 1||10
10638870|NCT02083965|11797564|FG001|STARTED|PK Period 1||9
10638871|NCT02083965|11797563|FG000|COMPLETED|PK Period 1||10
10638872|NCT02083965|11797564|FG001|COMPLETED|PK Period 1||9
10638873|NCT02083965|11797563|FG000|NOT COMPLETED|PK Period 1||0
10638874|NCT02083965|11797564|FG001|NOT COMPLETED|PK Period 1||0
10638875|NCT02083965|11797563|FG000|STARTED|Washout Period||10
10638876|NCT02083965|11797564|FG001|STARTED|Washout Period||9
10638877|NCT02083965|11797563|FG000|COMPLETED|Washout Period||10
10638878|NCT02083965|11797564|FG001|COMPLETED|Washout Period||9
10638879|NCT02083965|11797563|FG000|NOT COMPLETED|Washout Period||0
10638880|NCT02083965|11797564|FG001|NOT COMPLETED|Washout Period||0
10638881|NCT02083965|11797563|FG000|STARTED|PK Period 2||10
10638882|NCT02083965|11797564|FG001|STARTED|PK Period 2||9
10638883|NCT02083965|11797563|FG000|COMPLETED|PK Period 2||10
10638884|NCT02083965|11797564|FG001|COMPLETED|PK Period 2||9
10638885|NCT02083965|11797563|FG000|NOT COMPLETED|PK Period 2||0
10638886|NCT02083965|11797564|FG001|NOT COMPLETED|PK Period 2||0
10638887|NCT02083965|11797563|FG000|STARTED|Treatment Period||10
10638888|NCT02083965|11797564|FG001|STARTED|Treatment Period|1 participant completed PK period 1 and 2, then chose to withdraw and did not enter treatment period|8
10638889|NCT02083965|11797563|FG000|COMPLETED|Treatment Period||9
10638890|NCT02083965|11797564|FG001|COMPLETED|Treatment Period||8
10638891|NCT02083965|11797563|FG000|NOT COMPLETED|Treatment Period||1
10638892|NCT02083965|11797564|FG001|NOT COMPLETED|Treatment Period||0
10638893|NCT02084056|11797574|FG000|STARTED|Treatment Period 1 (4 Days)||28
10638894|NCT02084056|11797575|FG001|STARTED|Treatment Period 1 (4 Days)||30
10638895|NCT02084056|11797576|FG002|STARTED|Treatment Period 1 (4 Days)||8
10638896|NCT02084056|11797577|FG003|STARTED|Treatment Period 1 (4 Days)||8
10638897|NCT02084056|11797574|FG000|COMPLETED|Treatment Period 1 (4 Days)||27
10638898|NCT02084056|11797575|FG001|COMPLETED|Treatment Period 1 (4 Days)||30
10638899|NCT02084056|11797576|FG002|COMPLETED|Treatment Period 1 (4 Days)||8
10638900|NCT02084056|11797577|FG003|COMPLETED|Treatment Period 1 (4 Days)||8
10638901|NCT02084056|11797574|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||1
10638902|NCT02084056|11797575|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||0
10638903|NCT02084056|11797576|FG002|NOT COMPLETED|Treatment Period 1 (4 Days)||0
10638904|NCT02084056|11797577|FG003|NOT COMPLETED|Treatment Period 1 (4 Days)||0
10638905|NCT02084056|11797574|FG000|STARTED|Washout Period 1 (35 Days)||27
10638906|NCT02084056|11797575|FG001|STARTED|Washout Period 1 (35 Days)||30
10638907|NCT02084056|11797576|FG002|STARTED|Washout Period 1 (35 Days)||8
10638908|NCT02084056|11797577|FG003|STARTED|Washout Period 1 (35 Days)||8
10638909|NCT02084056|11797574|FG000|COMPLETED|Washout Period 1 (35 Days)||26
10638910|NCT02084056|11797575|FG001|COMPLETED|Washout Period 1 (35 Days)||30
10638911|NCT02084056|11797576|FG002|COMPLETED|Washout Period 1 (35 Days)||8
10638912|NCT02084056|11797577|FG003|COMPLETED|Washout Period 1 (35 Days)||8
10638913|NCT02084056|11797574|FG000|NOT COMPLETED|Washout Period 1 (35 Days)||1
10638914|NCT02084056|11797575|FG001|NOT COMPLETED|Washout Period 1 (35 Days)||0
10638915|NCT02084056|11797576|FG002|NOT COMPLETED|Washout Period 1 (35 Days)||0
10638916|NCT02084056|11797577|FG003|NOT COMPLETED|Washout Period 1 (35 Days)||0
10638917|NCT02084056|11797574|FG000|STARTED|Treatment Period 2 (4 Days)||26
10638918|NCT02084056|11797575|FG001|STARTED|Treatment Period 2 (4 Days)||30
10638919|NCT02084056|11797576|FG002|STARTED|Treatment Period 2 (4 Days)||8
10638920|NCT02084056|11797577|FG003|STARTED|Treatment Period 2 (4 Days)||8
10638921|NCT02084056|11797574|FG000|COMPLETED|Treatment Period 2 (4 Days)||26
10638922|NCT02084056|11797575|FG001|COMPLETED|Treatment Period 2 (4 Days)||30
10638923|NCT02084056|11797576|FG002|COMPLETED|Treatment Period 2 (4 Days)||8
10638924|NCT02084056|11797577|FG003|COMPLETED|Treatment Period 2 (4 Days)||8
10638925|NCT02084056|11797574|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0
10638926|NCT02084056|11797575|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0
10638927|NCT02084056|11797576|FG002|NOT COMPLETED|Treatment Period 2 (4 Days)||0
10638928|NCT02084056|11797577|FG003|NOT COMPLETED|Treatment Period 2 (4 Days)||0
10638929|NCT02084069|11797589|FG000|STARTED|Overall Study||29
10638930|NCT02084069|11797590|FG001|STARTED|Overall Study||29
10638931|NCT02084069|11797589|FG000|COMPLETED|Overall Study||29
10638932|NCT02084069|11797590|FG001|COMPLETED|Overall Study||29
10638933|NCT02084069|11797589|FG000|NOT COMPLETED|Overall Study||0
10638934|NCT02084069|11797590|FG001|NOT COMPLETED|Overall Study||0
10638935|NCT02084082|11797598|FG000|STARTED|Treatment Period 1 (4 Days)||26
10638936|NCT02084082|11797599|FG001|STARTED|Treatment Period 1 (4 Days)||26
10638937|NCT02084082|11797600|FG002|STARTED|Treatment Period 1 (4 Days)||8
10638938|NCT02084082|11797601|FG003|STARTED|Treatment Period 1 (4 Days)||8
10638939|NCT02084082|11797598|FG000|COMPLETED|Treatment Period 1 (4 Days)||26
10638940|NCT02084082|11797599|FG001|COMPLETED|Treatment Period 1 (4 Days)||26
10638941|NCT02084082|11797600|FG002|COMPLETED|Treatment Period 1 (4 Days)||8
10638942|NCT02084082|11797601|FG003|COMPLETED|Treatment Period 1 (4 Days)||8
10638943|NCT02084082|11797598|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||0
10638944|NCT02084082|11797599|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||0
10638945|NCT02084082|11797600|FG002|NOT COMPLETED|Treatment Period 1 (4 Days)||0
10638946|NCT02084082|11797601|FG003|NOT COMPLETED|Treatment Period 1 (4 Days)||0
10638947|NCT02084082|11797598|FG000|STARTED|Washout Period 1 (35 Days)||26
10638948|NCT02084082|11797599|FG001|STARTED|Washout Period 1 (35 Days)||26
10638949|NCT02084082|11797600|FG002|STARTED|Washout Period 1 (35 Days)||8
10638950|NCT02084082|11797601|FG003|STARTED|Washout Period 1 (35 Days)||8
10638951|NCT02084082|11797598|FG000|COMPLETED|Washout Period 1 (35 Days)||26
10638952|NCT02084082|11797599|FG001|COMPLETED|Washout Period 1 (35 Days)||26
10638953|NCT02084082|11797600|FG002|COMPLETED|Washout Period 1 (35 Days)||7
10638954|NCT02084082|11797601|FG003|COMPLETED|Washout Period 1 (35 Days)||6
10638955|NCT02084082|11797598|FG000|NOT COMPLETED|Washout Period 1 (35 Days)||0
10638956|NCT02084082|11797599|FG001|NOT COMPLETED|Washout Period 1 (35 Days)||0
10638957|NCT02084082|11797600|FG002|NOT COMPLETED|Washout Period 1 (35 Days)||1
10638958|NCT02084082|11797601|FG003|NOT COMPLETED|Washout Period 1 (35 Days)||2
10638959|NCT02084082|11797598|FG000|STARTED|Treatment Period 2 (4 Days)||26
10638960|NCT02084082|11797599|FG001|STARTED|Treatment Period 2 (4 Days)||26
10638961|NCT02084082|11797600|FG002|STARTED|Treatment Period 2 (4 Days)||7
10638962|NCT02084082|11797601|FG003|STARTED|Treatment Period 2 (4 Days)||6
10638963|NCT02084082|11797598|FG000|COMPLETED|Treatment Period 2 (4 Days)||26
10638964|NCT02084082|11797599|FG001|COMPLETED|Treatment Period 2 (4 Days)||26
10638965|NCT02084082|11797600|FG002|COMPLETED|Treatment Period 2 (4 Days)||7
10638966|NCT02084082|11797601|FG003|COMPLETED|Treatment Period 2 (4 Days)||6
10638967|NCT02084082|11797598|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0
10638968|NCT02084082|11797599|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0
10638969|NCT02084082|11797600|FG002|NOT COMPLETED|Treatment Period 2 (4 Days)||0
10638970|NCT02084082|11797601|FG003|NOT COMPLETED|Treatment Period 2 (4 Days)||0
10638971|NCT02084134|11797613|FG000|STARTED|Overall Study||23
10638972|NCT02084134|11797614|FG001|STARTED|Overall Study||20
10638973|NCT02084134|11797613|FG000|COMPLETED|Overall Study||19
10638974|NCT02084134|11797614|FG001|COMPLETED|Overall Study||17
10638975|NCT02084134|11797613|FG000|NOT COMPLETED|Overall Study||4
10638976|NCT02084134|11797614|FG001|NOT COMPLETED|Overall Study||3
10654064|NCT02198664|11814691|FG000|NOT COMPLETED|Overall Study||16
10654065|NCT02198664|11814692|FG001|NOT COMPLETED|Overall Study||8
10654066|NCT02198963|11814700|FG000|STARTED|Overall Study||43
10654067|NCT02198963|11814700|FG000|COMPLETED|Overall Study||36
10654068|NCT02198963|11814700|FG000|NOT COMPLETED|Overall Study||7
10654069|NCT02199028|11814711|FG000|STARTED|Week 1||15
10654070|NCT02199028|11814712|FG001|STARTED|Week 1||15
10654071|NCT02199028|11814711|FG000|COMPLETED|Week 1||14
10654072|NCT02199028|11814712|FG001|COMPLETED|Week 1||15
10654073|NCT02199028|11814711|FG000|NOT COMPLETED|Week 1||1
10654074|NCT02199028|11814712|FG001|NOT COMPLETED|Week 1||0
10654075|NCT02199028|11814711|FG000|STARTED|Week 2||14
10654076|NCT02199028|11814712|FG001|STARTED|Week 2||15
10654077|NCT02199028|11814711|FG000|COMPLETED|Week 2||14
10654078|NCT02199028|11814712|FG001|COMPLETED|Week 2||15
10654079|NCT02199028|11814711|FG000|NOT COMPLETED|Week 2||0
10654080|NCT02199028|11814712|FG001|NOT COMPLETED|Week 2||0
10654081|NCT02199028|11814711|FG000|STARTED|Week 3||14
10654082|NCT02199028|11814712|FG001|STARTED|Week 3||15
10654083|NCT02199028|11814711|FG000|COMPLETED|Week 3||13
10654084|NCT02199028|11814712|FG001|COMPLETED|Week 3||15
10654085|NCT02199028|11814711|FG000|NOT COMPLETED|Week 3||1
10654086|NCT02199028|11814712|FG001|NOT COMPLETED|Week 3||0
10654087|NCT02199028|11814711|FG000|STARTED|Week 4||13
10654088|NCT02199028|11814712|FG001|STARTED|Week 4||15
10654089|NCT02199028|11814711|FG000|COMPLETED|Week 4||13
10654090|NCT02199028|11814712|FG001|COMPLETED|Week 4||15
10654091|NCT02199028|11814711|FG000|NOT COMPLETED|Week 4||0
10654092|NCT02199028|11814712|FG001|NOT COMPLETED|Week 4||0
10654093|NCT02199041|11814719|FG000|STARTED|Overall Study||12
10654094|NCT02199041|11814719|FG000|COMPLETED|Overall Study||12
10654095|NCT02199041|11814719|FG000|NOT COMPLETED|Overall Study||0
10654096|NCT02199080|11814724|FG000|STARTED|Overall Study||2506
10654097|NCT02199080|11814724|FG000|COMPLETED|Overall Study||2494
10654098|NCT02199080|11814724|FG000|NOT COMPLETED|Overall Study||12
10654099|NCT02199197|11814732|FG000|STARTED|Overall Study||35
10654100|NCT02199197|11814733|FG001|STARTED|Overall Study||14
10654101|NCT02199197|11814732|FG000|COMPLETED|Overall Study||35
10654102|NCT02199197|11814733|FG001|COMPLETED|Overall Study||12
10654103|NCT02199197|11814732|FG000|NOT COMPLETED|Overall Study||0
10654104|NCT02199197|11814733|FG001|NOT COMPLETED|Overall Study||2
10654105|NCT02199314|11814740|FG000|STARTED|Overall Study||30
10654106|NCT02199314|11814740|FG000|COMPLETED|Overall Study||14
10654107|NCT02199314|11814740|FG000|NOT COMPLETED|Overall Study||16
10654108|NCT02199496|11814746|FG000|STARTED|Ustekinumab-Single Dose||3
10654109|NCT02199496|11814747|FG001|STARTED|Ustekinumab-Single Dose||0
10654110|NCT02199496|11814746|FG000|COMPLETED|Ustekinumab-Single Dose||3
10654111|NCT02199496|11814747|FG001|COMPLETED|Ustekinumab-Single Dose||0
10654112|NCT02199496|11814746|FG000|NOT COMPLETED|Ustekinumab-Single Dose||0
10654113|NCT02199496|11814747|FG001|NOT COMPLETED|Ustekinumab-Single Dose||0
10654114|NCT02199496|11814746|FG000|STARTED|Ustekinumab-Multi-dose||3
10654115|NCT02199496|11814747|FG001|STARTED|Ustekinumab-Multi-dose|Cohort 2 only participated in multi-dose phase 2|2
10654116|NCT02199496|11814746|FG000|COMPLETED|Ustekinumab-Multi-dose||3
10654117|NCT02199496|11814747|FG001|COMPLETED|Ustekinumab-Multi-dose||2
10654118|NCT02199496|11814746|FG000|NOT COMPLETED|Ustekinumab-Multi-dose||0
10638977|NCT02084160|11797620|FG000|STARTED|Overall Study||579
10638978|NCT02084160|11797620|FG000|COMPLETED|Overall Study||579
10638979|NCT02084160|11797620|FG000|NOT COMPLETED|Overall Study||0
10638980|NCT02084238|11797624|FG000|STARTED|Overall Study||40
10638981|NCT02084238|11797624|FG000|COMPLETED|Overall Study||38
10638982|NCT02084238|11797624|FG000|NOT COMPLETED|Overall Study||2
10638983|NCT02084511|11797639|FG000|STARTED|Overall Study||20
10638984|NCT02084511|11797640|FG001|STARTED|Overall Study||20
10705862|NCT02603419|11870340|FG001|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
10638985|NCT02084511|11797641|FG002|STARTED|Overall Study||20
10638986|NCT02084511|11797642|FG003|STARTED|Overall Study||20
10638987|NCT02084511|11797639|FG000|COMPLETED|Overall Study||20
10638988|NCT02084511|11797640|FG001|COMPLETED|Overall Study||20
10638989|NCT02084511|11797641|FG002|COMPLETED|Overall Study||20
10638990|NCT02084511|11797642|FG003|COMPLETED|Overall Study||20
10638991|NCT02084511|11797639|FG000|NOT COMPLETED|Overall Study||0
10638992|NCT02084511|11797640|FG001|NOT COMPLETED|Overall Study||0
10638993|NCT02084511|11797641|FG002|NOT COMPLETED|Overall Study||0
10638994|NCT02084511|11797642|FG003|NOT COMPLETED|Overall Study||0
10638995|NCT02084628|11797652|FG000|STARTED|Overall Study||1
10638996|NCT02084628|11797652|FG000|COMPLETED|Overall Study||1
10638997|NCT02084628|11797652|FG000|NOT COMPLETED|Overall Study||0
10638998|NCT02084706|11797658|FG000|STARTED|Overall Study||29
10638999|NCT02084706|11797659|FG001|STARTED|Overall Study||31
10639000|NCT02084706|11797658|FG000|COMPLETED|Overall Study||29
10639001|NCT02084706|11797659|FG001|COMPLETED|Overall Study||31
10639002|NCT02084706|11797658|FG000|NOT COMPLETED|Overall Study||0
10639003|NCT02084706|11797659|FG001|NOT COMPLETED|Overall Study||0
10639004|NCT02084797|11797665|FG000|STARTED|Overall Study||10
10639005|NCT02084797|11797665|FG000|COMPLETED|Overall Study||10
10639006|NCT02084797|11797665|FG000|NOT COMPLETED|Overall Study||0
10639007|NCT02085070|11797671|FG000|STARTED|Overall Study||23
10639008|NCT02085070|11797672|FG001|STARTED|Overall Study||42
10639009|NCT02085070|11797671|FG000|COMPLETED|Overall Study||23
10639010|NCT02085070|11797672|FG001|COMPLETED|Overall Study||42
10639011|NCT02085070|11797671|FG000|NOT COMPLETED|Overall Study||0
10639012|NCT02085070|11797672|FG001|NOT COMPLETED|Overall Study||0
10639013|NCT02085135|11797680|FG000|STARTED|Overall Study||34
10639014|NCT02085135|11797681|FG001|STARTED|Overall Study||32
10639015|NCT02085135|11797680|FG000|COMPLETED|Overall Study||23
10639016|NCT02085135|11797681|FG001|COMPLETED|Overall Study||23
10639017|NCT02085135|11797680|FG000|NOT COMPLETED|Overall Study||11
10639018|NCT02085135|11797681|FG001|NOT COMPLETED|Overall Study||9
10639019|NCT02085161|11797691|FG000|STARTED|Overall Study||76
10639020|NCT02085161|11797692|FG001|STARTED|Overall Study||76
10639021|NCT02085161|11797693|FG002|STARTED|Overall Study||76
10639022|NCT02085161|11797694|FG003|STARTED|Overall Study||76
10639023|NCT02085161|11797691|FG000|COMPLETED|Overall Study||64
10639024|NCT02085161|11797692|FG001|COMPLETED|Overall Study||66
10639025|NCT02085161|11797693|FG002|COMPLETED|Overall Study||71
10639026|NCT02085161|11797694|FG003|COMPLETED|Overall Study||66
10639027|NCT02085161|11797691|FG000|NOT COMPLETED|Overall Study||12
10639028|NCT02085161|11797692|FG001|NOT COMPLETED|Overall Study||10
10639029|NCT02085161|11797693|FG002|NOT COMPLETED|Overall Study||5
10639030|NCT02085161|11797694|FG003|NOT COMPLETED|Overall Study||10
10639031|NCT02085252|11797707|FG000|STARTED|Overall Study||58
10639032|NCT02085252|11797708|FG001|STARTED|Overall Study||57
10639033|NCT02085252|11797707|FG000|COMPLETED|Overall Study||57
10639034|NCT02085252|11797708|FG001|COMPLETED|Overall Study||53
10639035|NCT02085252|11797707|FG000|NOT COMPLETED|Overall Study||1
10639036|NCT02085252|11797708|FG001|NOT COMPLETED|Overall Study||4
10639037|NCT02085356|11797718|FG000|STARTED|Overall Study||577
10639038|NCT02085356|11797719|FG001|STARTED|Overall Study||348
10639039|NCT02085356|11797720|FG002|STARTED|Overall Study||681
10639040|NCT02085356|11797721|FG003|STARTED|Overall Study||361
10639041|NCT02085356|11797718|FG000|COMPLETED|Overall Study||577
10639042|NCT02085356|11797719|FG001|COMPLETED|Overall Study||348
10639043|NCT02085356|11797720|FG002|COMPLETED|Overall Study||681
10639044|NCT02085356|11797721|FG003|COMPLETED|Overall Study||361
10639045|NCT02085356|11797718|FG000|NOT COMPLETED|Overall Study||0
10639046|NCT02085356|11797719|FG001|NOT COMPLETED|Overall Study||0
10639047|NCT02085356|11797720|FG002|NOT COMPLETED|Overall Study||0
10639048|NCT02085356|11797721|FG003|NOT COMPLETED|Overall Study||0
10639049|NCT02085447|11797731|FG000|STARTED|Overall Study||30
10639050|NCT02085447|11797731|FG000|COMPLETED|Overall Study||26
10639051|NCT02085447|11797731|FG000|NOT COMPLETED|Overall Study||4
10639052|NCT02085460|11797739|FG000|STARTED|Overall Study||31
10639053|NCT02085460|11797740|FG001|STARTED|Overall Study||32
10639054|NCT02085460|11797741|FG002|STARTED|Overall Study||31
10639055|NCT02085460|11797739|FG000|COMPLETED|Overall Study||17
10639056|NCT02085460|11797740|FG001|COMPLETED|Overall Study||24
10639057|NCT02085460|11797741|FG002|COMPLETED|Overall Study||21
10639058|NCT02085460|11797739|FG000|NOT COMPLETED|Overall Study||14
10705863|NCT02603419|11870341|FG002|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
10639059|NCT02085460|11797740|FG001|NOT COMPLETED|Overall Study||8
10639060|NCT02085460|11797741|FG002|NOT COMPLETED|Overall Study||10
10639061|NCT02085473|11797753|FG000|STARTED|Overall Study||15
10639062|NCT02085473|11797754|FG001|STARTED|Overall Study||15
10639063|NCT02085473|11797755|FG002|STARTED|Overall Study||15
10639064|NCT02085473|11797756|FG003|STARTED|Overall Study||15
10639065|NCT02085473|11797753|FG000|COMPLETED|Overall Study||15
10639066|NCT02085473|11797754|FG001|COMPLETED|Overall Study||15
10639067|NCT02085473|11797755|FG002|COMPLETED|Overall Study||15
10639068|NCT02085473|11797756|FG003|COMPLETED|Overall Study||15
10639069|NCT02085473|11797753|FG000|NOT COMPLETED|Overall Study||0
10639070|NCT02085473|11797754|FG001|NOT COMPLETED|Overall Study||0
10639071|NCT02085473|11797755|FG002|NOT COMPLETED|Overall Study||0
10639072|NCT02085473|11797756|FG003|NOT COMPLETED|Overall Study||0
10639073|NCT02085551|11797766|FG000|STARTED|Overall Study||85
10639074|NCT02085551|11797766|FG000|COMPLETED|Overall Study||85
10639075|NCT02085551|11797766|FG000|NOT COMPLETED|Overall Study||0
10639076|NCT02085720|11797770|FG000|STARTED|Overall Study||819
10639077|NCT02085720|11797770|FG000|COMPLETED|Overall Study||819
10639078|NCT02085720|11797770|FG000|NOT COMPLETED|Overall Study||0
10639079|NCT02085785|11797780|FG000|STARTED|Overall Study||7
10639080|NCT02085785|11797781|FG001|STARTED|Overall Study||8
10639081|NCT02085785|11797780|FG000|COMPLETED|Overall Study||5
10639082|NCT02085785|11797781|FG001|COMPLETED|Overall Study||6
10639083|NCT02085785|11797780|FG000|NOT COMPLETED|Overall Study||2
10639084|NCT02085785|11797781|FG001|NOT COMPLETED|Overall Study||2
10639085|NCT02085980|11797789|FG000|STARTED|Overall Study||30
10639086|NCT02085980|11797789|FG000|COMPLETED|Overall Study||27
10639087|NCT02085980|11797789|FG000|NOT COMPLETED|Overall Study||3
10639088|NCT02086110|11797795|FG000|STARTED|Overall Study||5
10639089|NCT02086110|11797796|FG001|STARTED|Overall Study||6
10639090|NCT02086110|11797795|FG000|COMPLETED|Overall Study||4
10639091|NCT02086110|11797796|FG001|COMPLETED|Overall Study||5
10639092|NCT02086110|11797795|FG000|NOT COMPLETED|Overall Study||1
10639093|NCT02086110|11797796|FG001|NOT COMPLETED|Overall Study||1
10639094|NCT02086162|11797805|FG000|STARTED|Overall Study||78
10639095|NCT02086162|11797806|FG001|STARTED|Overall Study||84
10639096|NCT02086162|11797805|FG000|COMPLETED|Overall Study||68
10639097|NCT02086162|11797806|FG001|COMPLETED|Overall Study||77
10639098|NCT02086162|11797805|FG000|NOT COMPLETED|Overall Study||10
10639099|NCT02086162|11797806|FG001|NOT COMPLETED|Overall Study||7
10639100|NCT02086331|11797816|FG000|STARTED|Overall Study||5
10639101|NCT02086331|11797816|FG000|COMPLETED|Overall Study||5
10639102|NCT02086331|11797816|FG000|NOT COMPLETED|Overall Study||0
10639103|NCT02086500|11797831|FG000|STARTED|Overall Study||447
10639104|NCT02086500|11797832|FG001|STARTED|Overall Study||456
10639105|NCT02086500|11797831|FG000|COMPLETED|Overall Study||447
10639106|NCT02086500|11797832|FG001|COMPLETED|Overall Study||456
10639107|NCT02086500|11797831|FG000|NOT COMPLETED|Overall Study||0
10639108|NCT02086500|11797832|FG001|NOT COMPLETED|Overall Study||0
10639109|NCT02086565|11797840|FG000|STARTED|Overall Study||151
10705864|NCT02603419|11870342|FG003|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
10705865|NCT02603419|11870343|FG004|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
10705866|NCT02603419|11870344|FG005|Treated|Lead-in Phase:Maximum Exposure:123Weeks||0
10705867|NCT02603419|11870339|FG000|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
10705868|NCT02603419|11870340|FG001|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
10705869|NCT02603419|11870341|FG002|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
10705870|NCT02603419|11870342|FG003|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
10705871|NCT02603419|11870343|FG004|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
10705872|NCT02603419|11870344|FG005|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
10639110|NCT02086565|11797841|FG001|STARTED|Overall Study||150
10639111|NCT02086565|11797840|FG000|COMPLETED|Overall Study||135
10639112|NCT02086565|11797841|FG001|COMPLETED|Overall Study||138
10639113|NCT02086565|11797840|FG000|NOT COMPLETED|Overall Study||16
10639114|NCT02086565|11797841|FG001|NOT COMPLETED|Overall Study||12
10639115|NCT02086591|11797847|FG000|STARTED|Overall Study||7
10705873|NCT02603419|11870339|FG000|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6
10705874|NCT02603419|11870340|FG001|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||7
10705875|NCT02603419|11870341|FG002|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6
10705876|NCT02603419|11870342|FG003|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6
10705877|NCT02603419|11870343|FG004|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6
10705878|NCT02603419|11870344|FG005|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
10639116|NCT02086591|11797847|FG000|COMPLETED|Overall Study||2
10639117|NCT02086591|11797847|FG000|NOT COMPLETED|Overall Study||5
10639118|NCT02086682|11797853|FG000|STARTED|Overall Study||156
10639119|NCT02086682|11797854|FG001|STARTED|Overall Study||182
10639120|NCT02086682|11797853|FG000|COMPLETED|Overall Study||156
10639121|NCT02086682|11797854|FG001|COMPLETED|Overall Study||182
10639122|NCT02086682|11797853|FG000|NOT COMPLETED|Overall Study||0
10639123|NCT02086682|11797854|FG001|NOT COMPLETED|Overall Study||0
10639124|NCT02086708|11797860|FG000|STARTED|Overall Study||24
10639125|NCT02086708|11797860|FG000|COMPLETED|Overall Study||24
10639126|NCT02086708|11797860|FG000|NOT COMPLETED|Overall Study||0
10639127|NCT02086786|11797874|FG000|STARTED|Overall Study||35
10639128|NCT02086786|11797875|FG001|STARTED|Overall Study||35
10639129|NCT02086786|11797874|FG000|COMPLETED|Overall Study||17
10639130|NCT02086786|11797875|FG001|COMPLETED|Overall Study||19
10639131|NCT02086786|11797874|FG000|NOT COMPLETED|Overall Study||18
10639132|NCT02086786|11797875|FG001|NOT COMPLETED|Overall Study||16
10639133|NCT02086968|11797885|FG000|STARTED|Overall Study||100
10639134|NCT02086968|11797886|FG001|STARTED|Overall Study||98
10639135|NCT02086968|11797885|FG000|COMPLETED|Overall Study||92
10639136|NCT02086968|11797886|FG001|COMPLETED|Overall Study||85
10639137|NCT02086968|11797885|FG000|NOT COMPLETED|Overall Study||8
10639138|NCT02086968|11797886|FG001|NOT COMPLETED|Overall Study||13
10639139|NCT02087046|11797892|FG000|STARTED|Overall Study||127
10639140|NCT02087046|11797892|FG000|Primary Endpoint|Overall Study||121
10639141|NCT02087046|11797892|FG000|COMPLETED|Overall Study||116
10639142|NCT02087046|11797892|FG000|NOT COMPLETED|Overall Study||11
10639143|NCT02087059|11797897|FG000|STARTED|Overall Study||51
10639144|NCT02087059|11797897|FG000|COMPLETED|Overall Study||44
10639145|NCT02087059|11797897|FG000|NOT COMPLETED|Overall Study||7
10639146|NCT02087085|11797903|FG000|STARTED|Overall Study||154
10639147|NCT02087085|11797904|FG001|STARTED|Overall Study||156
10639148|NCT02087085|11797903|FG000|COMPLETED|Overall Study||34
10639149|NCT02087085|11797904|FG001|COMPLETED|Overall Study||40
10639150|NCT02087085|11797903|FG000|NOT COMPLETED|Overall Study||120
10639151|NCT02087085|11797904|FG001|NOT COMPLETED|Overall Study||116
10639152|NCT02087150|11797913|FG000|STARTED|Overall Study||81
10639153|NCT02087150|11797914|FG001|STARTED|Overall Study||162
10639154|NCT02087150|11797915|FG002|STARTED|Overall Study||80
10639155|NCT02087150|11797913|FG000|Had a Lead-in or Randomized ETBC Proc|Overall Study||80
10639156|NCT02087150|11797914|FG001|Had a Lead-in or Randomized ETBC Proc|Overall Study||149
10639157|NCT02087150|11797915|FG002|Had a Lead-in or Randomized ETBC Proc|Overall Study||0
10639158|NCT02087150|11797913|FG000|Received a Crossover MM ETBC Procedure|Overall Study||0
10639159|NCT02087150|11797914|FG001|Received a Crossover MM ETBC Procedure|Overall Study||0
10639160|NCT02087150|11797915|FG002|Received a Crossover MM ETBC Procedure|Overall Study||70
10639161|NCT02087150|11797913|FG000|COMPLETED|Overall Study||71
10639162|NCT02087150|11797914|FG001|COMPLETED|Overall Study||128
10639163|NCT02087150|11797915|FG002|COMPLETED|Overall Study||69
10639164|NCT02087150|11797913|FG000|NOT COMPLETED|Overall Study||10
10705879|NCT02603419|11870339|FG000|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
10705880|NCT02603419|11870340|FG001|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
10639165|NCT02087150|11797914|FG001|NOT COMPLETED|Overall Study||34
10705881|NCT02603419|11870341|FG002|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
10705882|NCT02603419|11870342|FG003|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
10705883|NCT02603419|11870343|FG004|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
10705884|NCT02603419|11870344|FG005|STARTED|Expansion Phase:Maximum Exposure:48Weeks|Participants started expansion phase while other few participants were completing lead-in phase.|3
10705885|NCT02603419|11870339|FG000|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
10705886|NCT02603419|11870340|FG001|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
10705887|NCT02603419|11870341|FG002|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
10705888|NCT02603419|11870342|FG003|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
10705889|NCT02603419|11870343|FG004|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
10705890|NCT02603419|11870344|FG005|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
10705891|NCT02603419|11870339|FG000|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
10705892|NCT02603419|11870340|FG001|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
10639166|NCT02087150|11797915|FG002|NOT COMPLETED|Overall Study||11
10639167|NCT02087163|11797924|FG000|STARTED|Overall Study||90
10639168|NCT02087163|11797924|FG000|COMPLETED|Overall Study||73
10639169|NCT02087163|11797924|FG000|NOT COMPLETED|Overall Study||17
10639170|NCT02087176|11797928|FG000|STARTED|Overall Study||32
10639171|NCT02087176|11797928|FG000|COMPLETED|Overall Study|The sponsor terminated the study early.|0
10639172|NCT02087176|11797928|FG000|NOT COMPLETED|Overall Study||32
10639173|NCT02087241|11797936|FG000|STARTED|Overall Study||3
10639174|NCT02087241|11797937|FG001|STARTED|Overall Study||3
10639175|NCT02087241|11797938|FG002|STARTED|Overall Study||1
10639176|NCT02087241|11797939|FG003|STARTED|Overall Study||7
10639177|NCT02087241|11797936|FG000|COMPLETED|Overall Study||0
10639178|NCT02087241|11797937|FG001|COMPLETED|Overall Study||0
10639179|NCT02087241|11797938|FG002|COMPLETED|Overall Study||0
10639180|NCT02087241|11797939|FG003|COMPLETED|Overall Study||0
10639181|NCT02087241|11797936|FG000|NOT COMPLETED|Overall Study||3
10639182|NCT02087241|11797937|FG001|NOT COMPLETED|Overall Study||3
10639183|NCT02087241|11797938|FG002|NOT COMPLETED|Overall Study||1
10639184|NCT02087241|11797939|FG003|NOT COMPLETED|Overall Study||7
10639185|NCT02087306|11797956|FG000|STARTED|Overall Study||65
10639186|NCT02087306|11797957|FG001|STARTED|Overall Study||93
10639187|NCT02087306|11797958|FG002|STARTED|Overall Study||43
10639188|NCT02087306|11797956|FG000|COMPLETED|Overall Study||29
10639189|NCT02087306|11797957|FG001|COMPLETED|Overall Study||29
10639190|NCT02087306|11797958|FG002|COMPLETED|Overall Study||16
10639191|NCT02087306|11797956|FG000|NOT COMPLETED|Overall Study||36
10639192|NCT02087306|11797957|FG001|NOT COMPLETED|Overall Study||64
10639193|NCT02087306|11797958|FG002|NOT COMPLETED|Overall Study||27
10639194|NCT02087514|11797971|FG000|STARTED|Overall Study||10
10639195|NCT02087514|11797972|FG001|STARTED|Overall Study||10
10639196|NCT02087514|11797973|FG002|STARTED|Overall Study||10
10639197|NCT02087514|11797974|FG003|STARTED|Overall Study||10
10639198|NCT02087514|11797975|FG004|STARTED|Overall Study||10
10639199|NCT02087514|11797976|FG005|STARTED|Overall Study||10
10639200|NCT02087514|11797971|FG000|COMPLETED|Overall Study||8
10639201|NCT02087514|11797972|FG001|COMPLETED|Overall Study||10
10639202|NCT02087514|11797973|FG002|COMPLETED|Overall Study||7
10639203|NCT02087514|11797974|FG003|COMPLETED|Overall Study||8
10639204|NCT02087514|11797975|FG004|COMPLETED|Overall Study||10
10639205|NCT02087514|11797976|FG005|COMPLETED|Overall Study||9
10639206|NCT02087514|11797971|FG000|NOT COMPLETED|Overall Study||2
10639207|NCT02087514|11797972|FG001|NOT COMPLETED|Overall Study||0
10639208|NCT02087514|11797973|FG002|NOT COMPLETED|Overall Study||3
10639209|NCT02087514|11797974|FG003|NOT COMPLETED|Overall Study||2
10639210|NCT02087514|11797975|FG004|NOT COMPLETED|Overall Study||0
10639211|NCT02087514|11797976|FG005|NOT COMPLETED|Overall Study||1
10705893|NCT02603419|11870341|FG002|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
10705894|NCT02603419|11870342|FG003|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
10705895|NCT02603419|11870343|FG004|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
10705896|NCT02603419|11870344|FG005|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||3
10705897|NCT02603666|11870359|FG000|STARTED|Overall Study||130
10705898|NCT02603666|11870359|FG000|COMPLETED|Overall Study||130
10705899|NCT02603666|11870359|FG000|NOT COMPLETED|Overall Study||0
10705900|NCT02603809|11870369|FG000|STARTED|Overall Study||82
10639212|NCT02087670|11797992|FG000|STARTED|Overall Study||20
10639213|NCT02087670|11797993|FG001|STARTED|Overall Study||22
10639214|NCT02087670|11797992|FG000|COMPLETED|Overall Study||17
10639215|NCT02087670|11797993|FG001|COMPLETED|Overall Study||20
10639216|NCT02087670|11797992|FG000|NOT COMPLETED|Overall Study||3
10639217|NCT02087670|11797993|FG001|NOT COMPLETED|Overall Study||2
10639218|NCT02087748|11797999|FG000|STARTED|Overall Study||24
10639219|NCT02087748|11797999|FG000|COMPLETED|Overall Study||24
10639220|NCT02087748|11797999|FG000|NOT COMPLETED|Overall Study||0
10639221|NCT02087774|11798009|FG000|STARTED|Overall Study||150
10639222|NCT02087774|11798010|FG001|STARTED|Overall Study||150
10639223|NCT02087774|11798009|FG000|COMPLETED|Overall Study||142
10639224|NCT02087774|11798010|FG001|COMPLETED|Overall Study||130
10639225|NCT02087774|11798009|FG000|NOT COMPLETED|Overall Study||8
10639226|NCT02087774|11798010|FG001|NOT COMPLETED|Overall Study||20
10639227|NCT02087904|11798020|FG000|STARTED|Overall Study||85
10639228|NCT02087904|11798021|FG001|STARTED|Overall Study||89
10639229|NCT02087904|11798022|FG002|STARTED|Overall Study||87
10639230|NCT02087904|11798023|FG003|STARTED|Overall Study||89
10639231|NCT02087904|11798020|FG000|COMPLETED|Overall Study||60
10639232|NCT02087904|11798021|FG001|COMPLETED|Overall Study||70
10639233|NCT02087904|11798022|FG002|COMPLETED|Overall Study||65
10639234|NCT02087904|11798023|FG003|COMPLETED|Overall Study||64
10639235|NCT02087904|11798020|FG000|NOT COMPLETED|Overall Study||25
10639236|NCT02087904|11798021|FG001|NOT COMPLETED|Overall Study||19
10639237|NCT02087904|11798022|FG002|NOT COMPLETED|Overall Study||22
10639238|NCT02087904|11798023|FG003|NOT COMPLETED|Overall Study||25
10639239|NCT02087943|11798036|FG000|STARTED|Placebo-Controlled Phase Week 0-12||64
10639240|NCT02087943|11798037|FG001|STARTED|Placebo-Controlled Phase Week 0-12||58
10639241|NCT02087943|11798038|FG002|STARTED|Placebo-Controlled Phase Week 0-12||63
10639242|NCT02087943|11798039|FG003|STARTED|Placebo-Controlled Phase Week 0-12||0
10639243|NCT02087943|11798040|FG004|STARTED|Placebo-Controlled Phase Week 0-12||0
10639244|NCT02087943|11798036|FG000|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|64
10639245|NCT02087943|11798037|FG001|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|58
10639246|NCT02087943|11798038|FG002|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|63
10639247|NCT02087943|11798039|FG003|Safety Population|Placebo-Controlled Phase Week 0-12||0
10639248|NCT02087943|11798040|FG004|Safety Population|Placebo-Controlled Phase Week 0-12||0
10639249|NCT02087943|11798036|FG000|COMPLETED|Placebo-Controlled Phase Week 0-12|3 participants who completed week 12 did not enter the active treatment phase.|50
10639250|NCT02087943|11798037|FG001|COMPLETED|Placebo-Controlled Phase Week 0-12||46
10639251|NCT02087943|11798038|FG002|COMPLETED|Placebo-Controlled Phase Week 0-12|1 participant who completed week 12 did not enter the active treatment phase.|50
10639252|NCT02087943|11798039|FG003|COMPLETED|Placebo-Controlled Phase Week 0-12||0
10639253|NCT02087943|11798040|FG004|COMPLETED|Placebo-Controlled Phase Week 0-12||0
10639254|NCT02087943|11798036|FG000|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||14
10639255|NCT02087943|11798037|FG001|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||12
10639256|NCT02087943|11798038|FG002|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||13
10639257|NCT02087943|11798039|FG003|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||0
10639258|NCT02087943|11798040|FG004|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||0
10639259|NCT02087943|11798036|FG000|STARTED|Active Treatment Phase Week 12-24||0
10639260|NCT02087943|11798037|FG001|STARTED|Active Treatment Phase Week 12-24||46
10639261|NCT02087943|11798038|FG002|STARTED|Active Treatment Phase Week 12-24||49
10639262|NCT02087943|11798039|FG003|STARTED|Active Treatment Phase Week 12-24||24
10639263|NCT02087943|11798040|FG004|STARTED|Active Treatment Phase Week 12-24||23
10639264|NCT02087943|11798036|FG000|COMPLETED|Active Treatment Phase Week 12-24||0
10639265|NCT02087943|11798037|FG001|COMPLETED|Active Treatment Phase Week 12-24||42
10639266|NCT02087943|11798038|FG002|COMPLETED|Active Treatment Phase Week 12-24||44
10639267|NCT02087943|11798039|FG003|COMPLETED|Active Treatment Phase Week 12-24||22
10639268|NCT02087943|11798040|FG004|COMPLETED|Active Treatment Phase Week 12-24||21
10639269|NCT02087943|11798036|FG000|NOT COMPLETED|Active Treatment Phase Week 12-24||0
10639270|NCT02087943|11798037|FG001|NOT COMPLETED|Active Treatment Phase Week 12-24||4
10639271|NCT02087943|11798038|FG002|NOT COMPLETED|Active Treatment Phase Week 12-24||5
10639272|NCT02087943|11798039|FG003|NOT COMPLETED|Active Treatment Phase Week 12-24||2
10639273|NCT02087943|11798040|FG004|NOT COMPLETED|Active Treatment Phase Week 12-24||2
10639274|NCT02087943|11798036|FG000|STARTED|Observational Follow-up Phase Week 24-30||0
10639275|NCT02087943|11798037|FG001|STARTED|Observational Follow-up Phase Week 24-30||46
10639276|NCT02087943|11798038|FG002|STARTED|Observational Follow-up Phase Week 24-30||48
10639277|NCT02087943|11798039|FG003|STARTED|Observational Follow-up Phase Week 24-30||24
10639278|NCT02087943|11798040|FG004|STARTED|Observational Follow-up Phase Week 24-30||23
10639279|NCT02087943|11798036|FG000|COMPLETED|Observational Follow-up Phase Week 24-30||0
10639280|NCT02087943|11798037|FG001|COMPLETED|Observational Follow-up Phase Week 24-30||46
10639281|NCT02087943|11798038|FG002|COMPLETED|Observational Follow-up Phase Week 24-30||45
10639282|NCT02087943|11798039|FG003|COMPLETED|Observational Follow-up Phase Week 24-30||23
10639283|NCT02087943|11798040|FG004|COMPLETED|Observational Follow-up Phase Week 24-30||22
10639284|NCT02087943|11798036|FG000|NOT COMPLETED|Observational Follow-up Phase Week 24-30||0
10639285|NCT02087943|11798037|FG001|NOT COMPLETED|Observational Follow-up Phase Week 24-30||0
10639286|NCT02087943|11798038|FG002|NOT COMPLETED|Observational Follow-up Phase Week 24-30||3
10639287|NCT02087943|11798039|FG003|NOT COMPLETED|Observational Follow-up Phase Week 24-30||1
10809165|NCT03811951|11971035|FG000|COMPLETED|Washout (1 Week)||2
10809166|NCT03811951|11971036|FG001|COMPLETED|Washout (1 Week)||2
10809167|NCT03811951|11971035|FG000|NOT COMPLETED|Washout (1 Week)||0
10809168|NCT03811951|11971036|FG001|NOT COMPLETED|Washout (1 Week)||0
10809169|NCT03811951|11971035|FG000|STARTED|Second Intervention (1 Day)||2
10639288|NCT02087943|11798040|FG004|NOT COMPLETED|Observational Follow-up Phase Week 24-30||1
10639289|NCT02087956|11798054|FG000|STARTED|Overall Study||111
10639290|NCT02087956|11798055|FG001|STARTED|Overall Study||112
10639291|NCT02087956|11798054|FG000|COMPLETED|Overall Study||105
10639292|NCT02087956|11798055|FG001|COMPLETED|Overall Study||107
10639293|NCT02087956|11798054|FG000|NOT COMPLETED|Overall Study||6
10639294|NCT02087956|11798055|FG001|NOT COMPLETED|Overall Study||5
10639295|NCT02087995|11798063|FG000|STARTED|Overall Study||51
10639296|NCT02087995|11798063|FG000|COMPLETED|Overall Study||51
10639297|NCT02087995|11798063|FG000|NOT COMPLETED|Overall Study||0
10639298|NCT02088034|11798070|FG000|STARTED|Overall Study||33
10639299|NCT02088034|11798071|FG001|STARTED|Overall Study||30
10639300|NCT02088034|11798072|FG002|STARTED|Overall Study||29
10639301|NCT02088034|11798070|FG000|COMPLETED|Overall Study||30
10639302|NCT02088034|11798071|FG001|COMPLETED|Overall Study||28
10639303|NCT02088034|11798072|FG002|COMPLETED|Overall Study||27
10639304|NCT02088034|11798070|FG000|NOT COMPLETED|Overall Study||3
10639305|NCT02088034|11798071|FG001|NOT COMPLETED|Overall Study||2
10639306|NCT02088034|11798072|FG002|NOT COMPLETED|Overall Study||2
10639307|NCT02088047|11798082|FG000|STARTED|Overall Study||3
10639308|NCT02088047|11798083|FG001|STARTED|Overall Study||1
10639309|NCT02088047|11798082|FG000|COMPLETED|Overall Study||2
10639310|NCT02088047|11798083|FG001|COMPLETED|Overall Study||1
10639311|NCT02088047|11798082|FG000|NOT COMPLETED|Overall Study||1
10639312|NCT02088047|11798083|FG001|NOT COMPLETED|Overall Study||0
10639313|NCT02088073|11798094|FG000|STARTED|Acute Phase||258
10639314|NCT02088073|11798095|FG001|STARTED|Acute Phase||0
10639315|NCT02088073|11798096|FG002|STARTED|Acute Phase||0
10639316|NCT02088073|11798097|FG003|STARTED|Acute Phase||0
10639317|NCT02088073|11798098|FG004|STARTED|Acute Phase||0
10639318|NCT02088073|11798094|FG000|COMPLETED|Acute Phase||251
10639319|NCT02088073|11798095|FG001|COMPLETED|Acute Phase||0
10639320|NCT02088073|11798096|FG002|COMPLETED|Acute Phase||0
10639321|NCT02088073|11798097|FG003|COMPLETED|Acute Phase||0
10639322|NCT02088073|11798098|FG004|COMPLETED|Acute Phase||0
10639323|NCT02088073|11798094|FG000|NOT COMPLETED|Acute Phase||7
10639324|NCT02088073|11798095|FG001|NOT COMPLETED|Acute Phase||0
10639325|NCT02088073|11798096|FG002|NOT COMPLETED|Acute Phase||0
10639326|NCT02088073|11798097|FG003|NOT COMPLETED|Acute Phase||0
10639327|NCT02088073|11798098|FG004|NOT COMPLETED|Acute Phase||0
10639328|NCT02088073|11798094|FG000|STARTED|Maintanance Phase||0
10639329|NCT02088073|11798095|FG001|STARTED|Maintanance Phase||85
10639330|NCT02088073|11798096|FG002|STARTED|Maintanance Phase||45
10639331|NCT02088073|11798097|FG003|STARTED|Maintanance Phase||51
10639332|NCT02088073|11798098|FG004|STARTED|Maintanance Phase||56
10639333|NCT02088073|11798094|FG000|COMPLETED|Maintanance Phase|251 subjects completed the AP; 240 were eligible to enter the MP. 237 entered the MP.|0
10639334|NCT02088073|11798095|FG001|COMPLETED|Maintanance Phase||75
10639335|NCT02088073|11798096|FG002|COMPLETED|Maintanance Phase||40
10639336|NCT02088073|11798097|FG003|COMPLETED|Maintanance Phase||44
10639337|NCT02088073|11798098|FG004|COMPLETED|Maintanance Phase||49
10639338|NCT02088073|11798094|FG000|NOT COMPLETED|Maintanance Phase||0
10639339|NCT02088073|11798095|FG001|NOT COMPLETED|Maintanance Phase||10
10639340|NCT02088073|11798096|FG002|NOT COMPLETED|Maintanance Phase||5
10639341|NCT02088073|11798097|FG003|NOT COMPLETED|Maintanance Phase||7
10639342|NCT02088073|11798098|FG004|NOT COMPLETED|Maintanance Phase||7
10639343|NCT02088177|11798111|FG000|STARTED|Overall Study||12
10639344|NCT02088177|11798111|FG000|COMPLETED|Overall Study||9
10639345|NCT02088177|11798111|FG000|NOT COMPLETED|Overall Study||3
10639346|NCT02088216|11798117|FG000|STARTED|Overall Study||81
10639347|NCT02088216|11798118|FG001|STARTED|Overall Study||80
10639348|NCT02088216|11798117|FG000|COMPLETED|Overall Study||69
10639349|NCT02088216|11798118|FG001|COMPLETED|Overall Study||70
10639350|NCT02088216|11798117|FG000|NOT COMPLETED|Overall Study||12
10639351|NCT02088216|11798118|FG001|NOT COMPLETED|Overall Study||10
10639352|NCT02088385|11798126|FG000|STARTED|Overall Study||10
10639353|NCT02088385|11798127|FG001|STARTED|Overall Study||10
10639354|NCT02088385|11798126|FG000|COMPLETED|Overall Study||10
10639355|NCT02088385|11798127|FG001|COMPLETED|Overall Study||10
10639356|NCT02088385|11798126|FG000|NOT COMPLETED|Overall Study||0
10639357|NCT02088385|11798127|FG001|NOT COMPLETED|Overall Study||0
10639358|NCT02088541|11798138|FG000|STARTED|Overall Study||71
10639359|NCT02088541|11798139|FG001|STARTED|Overall Study||27
10639360|NCT02088541|11798140|FG002|STARTED|Overall Study||117
10639361|NCT02088541|11798141|FG003|STARTED|Overall Study||44
10639362|NCT02088541|11798142|FG004|STARTED|Overall Study||58
10639363|NCT02088541|11798138|FG000|Safety Population|Overall Study||71
10639364|NCT02088541|11798139|FG001|Safety Population|Overall Study||27
10639365|NCT02088541|11798140|FG002|Safety Population|Overall Study||115
10639366|NCT02088541|11798141|FG003|Safety Population|Overall Study||39
10639367|NCT02088541|11798142|FG004|Safety Population|Overall Study||45
10639368|NCT02088541|11798138|FG000|Intent-to-treat (ITT) Population|Overall Study||0
10639369|NCT02088541|11798139|FG001|Intent-to-treat (ITT) Population|Overall Study||0
10639370|NCT02088541|11798140|FG002|Intent-to-treat (ITT) Population|Overall Study|1 randomized to Selinexor 60mg (PV>=5) but treated with physician choice 2, counted under this arm.|118
10639371|NCT02088541|11798141|FG003|Intent-to-treat (ITT) Population|Overall Study||0
10639372|NCT02088541|11798142|FG004|Intent-to-treat (ITT) Population|Overall Study||57
10639373|NCT02088541|11798138|FG000|COMPLETED|Overall Study||0
10639374|NCT02088541|11798139|FG001|COMPLETED|Overall Study||0
10639375|NCT02088541|11798140|FG002|COMPLETED|Overall Study||0
10639376|NCT02088541|11798141|FG003|COMPLETED|Overall Study||0
10639377|NCT02088541|11798142|FG004|COMPLETED|Overall Study||0
10639378|NCT02088541|11798138|FG000|NOT COMPLETED|Overall Study||71
10639379|NCT02088541|11798139|FG001|NOT COMPLETED|Overall Study||27
10639380|NCT02088541|11798140|FG002|NOT COMPLETED|Overall Study||117
10639381|NCT02088541|11798141|FG003|NOT COMPLETED|Overall Study||44
10639382|NCT02088541|11798142|FG004|NOT COMPLETED|Overall Study||58
10639383|NCT02088697|11798154|FG000|STARTED|Period I||25
10639384|NCT02088697|11798155|FG001|STARTED|Period I||25
10639385|NCT02088697|11798154|FG000|COMPLETED|Period I||24
10639386|NCT02088697|11798155|FG001|COMPLETED|Period I||21
10639387|NCT02088697|11798154|FG000|NOT COMPLETED|Period I||1
10639388|NCT02088697|11798155|FG001|NOT COMPLETED|Period I||4
10639389|NCT02088697|11798154|FG000|STARTED|Wash-out Period (at Least 10 Days)||24
10639390|NCT02088697|11798155|FG001|STARTED|Wash-out Period (at Least 10 Days)||21
10639391|NCT02088697|11798154|FG000|COMPLETED|Wash-out Period (at Least 10 Days)||23
10639392|NCT02088697|11798155|FG001|COMPLETED|Wash-out Period (at Least 10 Days)||21
10639393|NCT02088697|11798154|FG000|NOT COMPLETED|Wash-out Period (at Least 10 Days)||1
10639394|NCT02088697|11798155|FG001|NOT COMPLETED|Wash-out Period (at Least 10 Days)||0
10639395|NCT02088697|11798154|FG000|STARTED|Period II||23
10639396|NCT02088697|11798155|FG001|STARTED|Period II||21
10639397|NCT02088697|11798154|FG000|COMPLETED|Period II||23
10639398|NCT02088697|11798155|FG001|COMPLETED|Period II||21
10639399|NCT02088697|11798154|FG000|NOT COMPLETED|Period II||0
10639400|NCT02088697|11798155|FG001|NOT COMPLETED|Period II||0
10639401|NCT02088788|11798163|FG000|STARTED|Overall Study||135
10639402|NCT02088788|11798164|FG001|STARTED|Overall Study||130
10639403|NCT02088788|11798163|FG000|COMPLETED|Overall Study||105
10639404|NCT02088788|11798164|FG001|COMPLETED|Overall Study||89
10639405|NCT02088788|11798163|FG000|NOT COMPLETED|Overall Study||30
10639406|NCT02088788|11798164|FG001|NOT COMPLETED|Overall Study||41
10639407|NCT02088905|11798172|FG000|STARTED|Overall Study||13
10639408|NCT02088905|11798173|FG001|STARTED|Overall Study||10
10639409|NCT02088905|11798172|FG000|Week 9|Overall Study||10
10639410|NCT02088905|11798173|FG001|Week 9|Overall Study||9
10639411|NCT02088905|11798172|FG000|COMPLETED|Overall Study||8
10639412|NCT02088905|11798173|FG001|COMPLETED|Overall Study||9
10639413|NCT02088905|11798172|FG000|NOT COMPLETED|Overall Study||5
10639414|NCT02088905|11798173|FG001|NOT COMPLETED|Overall Study||1
10639415|NCT02089113|11798181|FG000|STARTED|Overall Study||161
10639416|NCT02089113|11798182|FG001|STARTED|Overall Study||80
10639417|NCT02089113|11798181|FG000|COMPLETED|Overall Study||160
10639418|NCT02089113|11798182|FG001|COMPLETED|Overall Study||80
10639419|NCT02089113|11798181|FG000|NOT COMPLETED|Overall Study||1
10639420|NCT02089113|11798182|FG001|NOT COMPLETED|Overall Study||0
10639421|NCT02089191|11798188|FG000|STARTED|Period 1, First 12 Hours||16
10639422|NCT02089191|11798189|FG001|STARTED|Period 1, First 12 Hours||15
10639423|NCT02089191|11798188|FG000|COMPLETED|Period 1, First 12 Hours||16
10639424|NCT02089191|11798189|FG001|COMPLETED|Period 1, First 12 Hours||15
10639425|NCT02089191|11798188|FG000|NOT COMPLETED|Period 1, First 12 Hours||0
10639426|NCT02089191|11798189|FG001|NOT COMPLETED|Period 1, First 12 Hours||0
10639427|NCT02089191|11798188|FG000|STARTED|Period 2, Second 12 Hours|One participant discontinued between Period 1 and Period 2 due to availability|15
10639428|NCT02089191|11798189|FG001|STARTED|Period 2, Second 12 Hours||15
10639429|NCT02089191|11798188|FG000|COMPLETED|Period 2, Second 12 Hours||15
10639430|NCT02089191|11798189|FG001|COMPLETED|Period 2, Second 12 Hours||15
10639431|NCT02089191|11798188|FG000|NOT COMPLETED|Period 2, Second 12 Hours||0
10639432|NCT02089191|11798189|FG001|NOT COMPLETED|Period 2, Second 12 Hours||0
10639433|NCT02089230|11798198|FG000|STARTED|Overall Study||3
10639434|NCT02089230|11798199|FG001|STARTED|Overall Study||4
10639435|NCT02089230|11798200|FG002|STARTED|Overall Study||12
10639436|NCT02089230|11798198|FG000|COMPLETED|Overall Study||3
10639437|NCT02089230|11798199|FG001|COMPLETED|Overall Study||4
10639438|NCT02089230|11798200|FG002|COMPLETED|Overall Study||6
10639439|NCT02089230|11798198|FG000|NOT COMPLETED|Overall Study||0
10639440|NCT02089230|11798199|FG001|NOT COMPLETED|Overall Study||0
10639441|NCT02089230|11798200|FG002|NOT COMPLETED|Overall Study||6
10639442|NCT02089334|11798212|FG000|STARTED|Overall Study||3
10639443|NCT02089334|11798213|FG001|STARTED|Overall Study||4
10639444|NCT02089334|11798214|FG002|STARTED|Overall Study||4
10639445|NCT02089334|11798215|FG003|STARTED|Overall Study||13
10639446|NCT02089334|11798212|FG000|Received Study Drug|Overall Study||3
10639447|NCT02089334|11798213|FG001|Received Study Drug|Overall Study||4
10639448|NCT02089334|11798214|FG002|Received Study Drug|Overall Study||3
10639449|NCT02089334|11798215|FG003|Received Study Drug|Overall Study||11
10639450|NCT02089334|11798212|FG000|COMPLETED|Overall Study||3
10639451|NCT02089334|11798213|FG001|COMPLETED|Overall Study||4
10639452|NCT02089334|11798214|FG002|COMPLETED|Overall Study||3
10639453|NCT02089334|11798215|FG003|COMPLETED|Overall Study||6
10639454|NCT02089334|11798212|FG000|NOT COMPLETED|Overall Study||0
10639455|NCT02089334|11798213|FG001|NOT COMPLETED|Overall Study||0
10639456|NCT02089334|11798214|FG002|NOT COMPLETED|Overall Study||1
10639457|NCT02089334|11798215|FG003|NOT COMPLETED|Overall Study||7
10639458|NCT02089347|11798230|FG000|STARTED|Overall Study||356
10639459|NCT02089347|11798231|FG001|STARTED|Overall Study||178
10639460|NCT02089347|11798230|FG000|COMPLETED|Overall Study||355
10639461|NCT02089347|11798231|FG001|COMPLETED|Overall Study||178
10639462|NCT02089347|11798230|FG000|NOT COMPLETED|Overall Study||1
10639463|NCT02089347|11798231|FG001|NOT COMPLETED|Overall Study||0
10639464|NCT02089464|11798239|FG000|STARTED|Overall Study||132
10639465|NCT02089464|11798240|FG001|STARTED|Overall Study||67
10639466|NCT02089464|11798239|FG000|COMPLETED|Overall Study||104
10639467|NCT02089464|11798240|FG001|COMPLETED|Overall Study||51
10639468|NCT02089464|11798239|FG000|NOT COMPLETED|Overall Study||28
10639469|NCT02089464|11798240|FG001|NOT COMPLETED|Overall Study||16
10639470|NCT02089659|11798248|FG000|STARTED|Overall Study||8
10639471|NCT02089659|11798249|FG001|STARTED|Overall Study||8
10639472|NCT02089659|11798250|FG002|STARTED|Overall Study||0
10639473|NCT02089659|11798248|FG000|COMPLETED|Overall Study||8
10639474|NCT02089659|11798249|FG001|COMPLETED|Overall Study||8
10639475|NCT02089659|11798250|FG002|COMPLETED|Overall Study||0
10639476|NCT02089659|11798248|FG000|NOT COMPLETED|Overall Study||0
10639477|NCT02089659|11798249|FG001|NOT COMPLETED|Overall Study||0
10639478|NCT02089659|11798250|FG002|NOT COMPLETED|Overall Study||0
10639479|NCT02089737|11798256|FG000|STARTED|Overall Study||3091
10639480|NCT02089737|11798256|FG000|COMPLETED|Overall Study||3085
10639481|NCT02089737|11798256|FG000|NOT COMPLETED|Overall Study||6
10639482|NCT02089997|11798261|FG000|STARTED|Overall Study||3304
10639483|NCT02089997|11798261|FG000|COMPLETED|Overall Study||3058
10639484|NCT02089997|11798261|FG000|NOT COMPLETED|Overall Study||246
10639485|NCT02090075|11798267|FG000|STARTED|Overall Study||33
10639486|NCT02090075|11798268|FG001|STARTED|Overall Study||33
10639487|NCT02090075|11798267|FG000|COMPLETED|Overall Study||26
10639488|NCT02090075|11798268|FG001|COMPLETED|Overall Study||30
10639489|NCT02090075|11798267|FG000|NOT COMPLETED|Overall Study||7
10639490|NCT02090075|11798268|FG001|NOT COMPLETED|Overall Study||3
10639491|NCT02090088|11798274|FG000|STARTED|Overall Study||4
10639492|NCT02090088|11798274|FG000|Gave Birth|Overall Study||4
10639493|NCT02090088|11798274|FG000|COMPLETED|Overall Study||4
10639494|NCT02090088|11798274|FG000|NOT COMPLETED|Overall Study||0
10639495|NCT02090283|11798282|FG000|STARTED|Overall Study||17
10639496|NCT02090283|11798283|FG001|STARTED|Overall Study||15
10639497|NCT02090283|11798284|FG002|STARTED|Overall Study||10
10639498|NCT02090283|11798282|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||17
10639499|NCT02090283|11798283|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||15
10639500|NCT02090283|11798284|FG002|Received At Least 1 Dose Of Study Drug|Overall Study||10
10639501|NCT02090283|11798282|FG000|COMPLETED|Overall Study||0
10639502|NCT02090283|11798283|FG001|COMPLETED|Overall Study||0
10639503|NCT02090283|11798284|FG002|COMPLETED|Overall Study||0
10639504|NCT02090283|11798282|FG000|NOT COMPLETED|Overall Study||17
10639505|NCT02090283|11798283|FG001|NOT COMPLETED|Overall Study||15
10639506|NCT02090283|11798284|FG002|NOT COMPLETED|Overall Study||10
10639507|NCT02090374|11798300|FG000|STARTED|Overall Study||8
10639508|NCT02090374|11798301|FG001|STARTED|Overall Study||4
10639509|NCT02090374|11798302|FG002|STARTED|Overall Study||4
10639510|NCT02090374|11798303|FG003|STARTED|Overall Study||9
10639511|NCT02090374|11798304|FG004|STARTED|Overall Study||35
10639512|NCT02090374|11798305|FG005|STARTED|Overall Study||15
10639513|NCT02090374|11798306|FG006|STARTED|Overall Study||16
10639514|NCT02090374|11798307|FG007|STARTED|Overall Study||2
10639515|NCT02090374|11798300|FG000|COMPLETED|Overall Study||8
10639516|NCT02090374|11798301|FG001|COMPLETED|Overall Study||4
10639517|NCT02090374|11798302|FG002|COMPLETED|Overall Study||4
10639518|NCT02090374|11798303|FG003|COMPLETED|Overall Study||9
10639519|NCT02090374|11798304|FG004|COMPLETED|Overall Study||35
10639520|NCT02090374|11798305|FG005|COMPLETED|Overall Study||15
10639521|NCT02090374|11798306|FG006|COMPLETED|Overall Study||16
10639522|NCT02090374|11798307|FG007|COMPLETED|Overall Study||2
10639523|NCT02090374|11798300|FG000|NOT COMPLETED|Overall Study||0
10639524|NCT02090374|11798301|FG001|NOT COMPLETED|Overall Study||0
10639525|NCT02090374|11798302|FG002|NOT COMPLETED|Overall Study||0
10639526|NCT02090374|11798303|FG003|NOT COMPLETED|Overall Study||0
10639527|NCT02090374|11798304|FG004|NOT COMPLETED|Overall Study||0
10639528|NCT02090374|11798305|FG005|NOT COMPLETED|Overall Study||0
10639529|NCT02090374|11798306|FG006|NOT COMPLETED|Overall Study||0
10639530|NCT02090374|11798307|FG007|NOT COMPLETED|Overall Study||0
10639531|NCT02090413|11798328|FG000|STARTED|Overall Study||81
10639532|NCT02090413|11798329|FG001|STARTED|Overall Study||80
10639533|NCT02090413|11798330|FG002|STARTED|Overall Study||80
10639534|NCT02090413|11798328|FG000|COMPLETED|Overall Study||62
10639535|NCT02090413|11798329|FG001|COMPLETED|Overall Study||60
10639536|NCT02090413|11798330|FG002|COMPLETED|Overall Study||57
10639537|NCT02090413|11798328|FG000|NOT COMPLETED|Overall Study||19
10639538|NCT02090413|11798329|FG001|NOT COMPLETED|Overall Study||20
10639539|NCT02090413|11798330|FG002|NOT COMPLETED|Overall Study||23
10639540|NCT02090426|11798341|FG000|STARTED|Overall Study||401
10639541|NCT02090426|11798342|FG001|STARTED|Overall Study||399
10639542|NCT02090426|11798341|FG000|Analysis Population|Overall Study||389
10639543|NCT02090426|11798342|FG001|Analysis Population|Overall Study||393
10639544|NCT02090426|11798341|FG000|COMPLETED|Overall Study||389
10639545|NCT02090426|11798342|FG001|COMPLETED|Overall Study||393
10639546|NCT02090426|11798341|FG000|NOT COMPLETED|Overall Study||12
10639547|NCT02090426|11798342|FG001|NOT COMPLETED|Overall Study||6
10639548|NCT02090634|11798350|FG000|STARTED|Overall Study||30
10639549|NCT02090634|11798351|FG001|STARTED|Overall Study||28
10639550|NCT02090634|11798350|FG000|COMPLETED|Overall Study||25
10639551|NCT02090634|11798351|FG001|COMPLETED|Overall Study||25
10639552|NCT02090634|11798350|FG000|NOT COMPLETED|Overall Study||5
10639553|NCT02090634|11798351|FG001|NOT COMPLETED|Overall Study||3
10639554|NCT02090725|11798357|FG000|STARTED|Overall Study||4
10639555|NCT02090725|11798357|FG000|COMPLETED|Overall Study||0
10639556|NCT02090725|11798357|FG000|NOT COMPLETED|Overall Study||4
10639557|NCT02090764|11798363|FG000|STARTED|Overall Study||206
10639558|NCT02090764|11798364|FG001|STARTED|Overall Study||206
10639559|NCT02090764|11798363|FG000|COMPLETED|Overall Study||200
10639560|NCT02090764|11798364|FG001|COMPLETED|Overall Study||186
10639561|NCT02090764|11798363|FG000|NOT COMPLETED|Overall Study||6
10639562|NCT02090764|11798364|FG001|NOT COMPLETED|Overall Study||20
10639563|NCT02090777|11798370|FG000|STARTED|Overall Study||4
10639564|NCT02090777|11798370|FG000|COMPLETED|Overall Study||4
10639565|NCT02090777|11798370|FG000|NOT COMPLETED|Overall Study||0
10639566|NCT02090855|11798374|FG000|STARTED|Overall Study||108
10639567|NCT02090855|11798374|FG000|COMPLETED|Overall Study||106
10639568|NCT02090855|11798374|FG000|NOT COMPLETED|Overall Study||2
10639569|NCT02090894|11798381|FG000|STARTED|Overall Study||11
10639570|NCT02090894|11798381|FG000|COMPLETED|Overall Study||11
10639571|NCT02090894|11798381|FG000|NOT COMPLETED|Overall Study||0
10639572|NCT02090959|11798385|FG000|STARTED|Overall Study||219
10639573|NCT02090959|11798385|FG000|As-treated Population|Overall Study||218
10639574|NCT02090959|11798385|FG000|COMPLETED|Overall Study||68
10639575|NCT02090959|11798385|FG000|NOT COMPLETED|Overall Study||151
10639576|NCT02091089|11798389|FG000|STARTED|Overall Study||20
10639577|NCT02091089|11798389|FG000|COMPLETED|Overall Study||18
10639578|NCT02091089|11798389|FG000|NOT COMPLETED|Overall Study||2
10639579|NCT02091102|11798393|FG000|STARTED|Overall Study||20
10639580|NCT02091102|11798393|FG000|COMPLETED|Overall Study||20
10639581|NCT02091102|11798393|FG000|NOT COMPLETED|Overall Study||0
10639582|NCT02091167|11798399|FG000|STARTED|Overall Study||19
10639583|NCT02091167|11798400|FG001|STARTED|Overall Study||16
10639584|NCT02091167|11798399|FG000|COMPLETED|Overall Study||19
10639585|NCT02091167|11798400|FG001|COMPLETED|Overall Study||14
10639586|NCT02091167|11798399|FG000|NOT COMPLETED|Overall Study||0
10639587|NCT02091167|11798400|FG001|NOT COMPLETED|Overall Study||2
10639616|NCT02091284|11798425|FG000|STARTED|Overall Study|Two subjects from this group discontinued the protocol, data from one subject could not be included.|26
10639617|NCT02091284|11798426|FG001|STARTED|Overall Study|One subject from this group discontinued the protocol|23
10639618|NCT02091284|11798425|FG000|COMPLETED|Overall Study||23
10639619|NCT02091284|11798426|FG001|COMPLETED|Overall Study||22
10639620|NCT02091284|11798425|FG000|NOT COMPLETED|Overall Study||3
10639621|NCT02091284|11798426|FG001|NOT COMPLETED|Overall Study||1
10639622|NCT02091362|11798436|FG000|STARTED|Period 1||133
10639623|NCT02091362|11798437|FG001|STARTED|Period 1||137
10639624|NCT02091362|11798436|FG000|COMPLETED|Period 1||128
10639625|NCT02091362|11798437|FG001|COMPLETED|Period 1||133
10639626|NCT02091362|11798436|FG000|NOT COMPLETED|Period 1||5
10639627|NCT02091362|11798437|FG001|NOT COMPLETED|Period 1||4
10639628|NCT02091362|11798436|FG000|STARTED|Wash-out||128
10639629|NCT02091362|11798437|FG001|STARTED|Wash-out||133
10639630|NCT02091362|11798436|FG000|COMPLETED|Wash-out||127
10639631|NCT02091362|11798437|FG001|COMPLETED|Wash-out||130
10639632|NCT02091362|11798436|FG000|NOT COMPLETED|Wash-out||1
10639633|NCT02091362|11798437|FG001|NOT COMPLETED|Wash-out||3
10639634|NCT02091362|11798436|FG000|STARTED|Period 2||127
10639635|NCT02091362|11798437|FG001|STARTED|Period 2||130
10639636|NCT02091362|11798436|FG000|COMPLETED|Period 2||125
10639637|NCT02091362|11798437|FG001|COMPLETED|Period 2||128
10639638|NCT02091362|11798436|FG000|NOT COMPLETED|Period 2||2
10639639|NCT02091362|11798437|FG001|NOT COMPLETED|Period 2||2
10639650|NCT02091414|11798456|FG000|STARTED|Overall Study||36
10639651|NCT02091414|11798456|FG000|COMPLETED|Overall Study||32
10705901|NCT02603809|11870370|FG001|STARTED|Overall Study||82
10705902|NCT02603809|11870371|FG002|STARTED|Overall Study||82
10705903|NCT02603809|11870372|FG003|STARTED|Overall Study||82
10705904|NCT02603809|11870373|FG004|STARTED|Overall Study||81
10705905|NCT02603809|11870374|FG005|STARTED|Overall Study||81
10639652|NCT02091414|11798456|FG000|NOT COMPLETED|Overall Study||4
10639653|NCT02091440|11798460|FG000|STARTED|Overall Study||6
10639654|NCT02091440|11798460|FG000|Primary Endpoint (Success at 180 Days)|Overall Study||6
10639655|NCT02091440|11798460|FG000|Overall Survival at 180 Days|Overall Study||6
10639656|NCT02091440|11798460|FG000|COMPLETED|Overall Study||4
10639657|NCT02091440|11798460|FG000|NOT COMPLETED|Overall Study||2
10639658|NCT02091466|11798466|FG000|STARTED|Overall Study||20
10639659|NCT02091466|11798467|FG001|STARTED|Overall Study||20
10639660|NCT02091466|11798466|FG000|COMPLETED|Overall Study||20
10639661|NCT02091466|11798467|FG001|COMPLETED|Overall Study||20
10639662|NCT02091466|11798466|FG000|NOT COMPLETED|Overall Study||0
10639663|NCT02091466|11798467|FG001|NOT COMPLETED|Overall Study||0
10639664|NCT02091531|11798473|FG000|STARTED|Overall Study||9
10639665|NCT02091531|11798473|FG000|COMPLETED|Overall Study||9
10639666|NCT02091531|11798473|FG000|NOT COMPLETED|Overall Study||0
10639667|NCT02091726|11798477|FG000|STARTED|Overall Study||110
10639668|NCT02091726|11798477|FG000|1 Week Followup|Overall Study||110
10639669|NCT02091726|11798477|FG000|4 Week Followup|Overall Study||104
10639670|NCT02091726|11798477|FG000|COMPLETED|Overall Study||104
10639671|NCT02091726|11798477|FG000|NOT COMPLETED|Overall Study||6
10639672|NCT02091739|11798484|FG000|STARTED|MP: 16 Weeks||36
10639673|NCT02091739|11798485|FG001|STARTED|MP: 16 Weeks||74
10639674|NCT02091739|11798486|FG002|STARTED|MP: 16 Weeks||74
10639675|NCT02091739|11798487|FG003|STARTED|MP: 16 Weeks||0
10639676|NCT02091739|11798488|FG004|STARTED|MP: 16 Weeks||0
10639677|NCT02091739|11798484|FG000|COMPLETED|MP: 16 Weeks||32
10639678|NCT02091739|11798485|FG001|COMPLETED|MP: 16 Weeks||69
10639679|NCT02091739|11798486|FG002|COMPLETED|MP: 16 Weeks||72
10639680|NCT02091739|11798487|FG003|COMPLETED|MP: 16 Weeks||0
10639681|NCT02091739|11798488|FG004|COMPLETED|MP: 16 Weeks||0
10639682|NCT02091739|11798484|FG000|NOT COMPLETED|MP: 16 Weeks||4
10639683|NCT02091739|11798485|FG001|NOT COMPLETED|MP: 16 Weeks||5
10639684|NCT02091739|11798486|FG002|NOT COMPLETED|MP: 16 Weeks||2
10639685|NCT02091739|11798487|FG003|NOT COMPLETED|MP: 16 Weeks||0
10639686|NCT02091739|11798488|FG004|NOT COMPLETED|MP: 16 Weeks||0
10639687|NCT02091739|11798484|FG000|STARTED|EP: 48 Weeks||0
10639688|NCT02091739|11798485|FG001|STARTED|EP: 48 Weeks||0
10639689|NCT02091739|11798486|FG002|STARTED|EP: 48 Weeks||0
10639690|NCT02091739|11798487|FG003|STARTED|EP: 48 Weeks||84
10639691|NCT02091739|11798488|FG004|STARTED|EP: 48 Weeks||89
10639692|NCT02091739|11798484|FG000|COMPLETED|EP: 48 Weeks||0
10639693|NCT02091739|11798485|FG001|COMPLETED|EP: 48 Weeks||0
10639694|NCT02091739|11798486|FG002|COMPLETED|EP: 48 Weeks||0
10639695|NCT02091739|11798487|FG003|COMPLETED|EP: 48 Weeks||76
10639696|NCT02091739|11798488|FG004|COMPLETED|EP: 48 Weeks||75
10639697|NCT02091739|11798484|FG000|NOT COMPLETED|EP: 48 Weeks||0
10639698|NCT02091739|11798485|FG001|NOT COMPLETED|EP: 48 Weeks||0
10639699|NCT02091739|11798486|FG002|NOT COMPLETED|EP: 48 Weeks||0
10639700|NCT02091739|11798487|FG003|NOT COMPLETED|EP: 48 Weeks||8
10639701|NCT02091739|11798488|FG004|NOT COMPLETED|EP: 48 Weeks||14
10639702|NCT02091778|11798498|FG000|STARTED|Overall Study||21
10639703|NCT02091778|11798498|FG000|COMPLETED|Overall Study||20
10639704|NCT02091778|11798498|FG000|NOT COMPLETED|Overall Study||1
10705906|NCT02603809|11870369|FG000|Per-protocol Set|Overall Study||67
10639705|NCT02091856|11798505|FG000|STARTED|Active Intervention Interval||34
10639706|NCT02091856|11798506|FG001|STARTED|Active Intervention Interval||19
10639707|NCT02091856|11798507|FG002|STARTED|Active Intervention Interval||26
10639708|NCT02091856|11798505|FG000|COMPLETED|Active Intervention Interval||15
10639709|NCT02091856|11798506|FG001|COMPLETED|Active Intervention Interval||12
10639710|NCT02091856|11798507|FG002|COMPLETED|Active Intervention Interval||19
10639711|NCT02091856|11798505|FG000|NOT COMPLETED|Active Intervention Interval||19
10639712|NCT02091856|11798506|FG001|NOT COMPLETED|Active Intervention Interval||7
10639713|NCT02091856|11798507|FG002|NOT COMPLETED|Active Intervention Interval||7
10639714|NCT02091856|11798505|FG000|STARTED|Follow-up Assessment|Only a subset of C-CBT participants responded to our request to complete the follow-up assessment.|15
10639715|NCT02091856|11798506|FG001|STARTED|Follow-up Assessment|Only a subset of R-CBT participants responded to our request to complete the follow-up assessment.|12
10639716|NCT02091856|11798507|FG002|STARTED|Follow-up Assessment|WLCG participants were lost at follow-up.|0
10639717|NCT02091856|11798505|FG000|COMPLETED|Follow-up Assessment||10
10639718|NCT02091856|11798506|FG001|COMPLETED|Follow-up Assessment||9
10639719|NCT02091856|11798507|FG002|COMPLETED|Follow-up Assessment||0
10639720|NCT02091856|11798505|FG000|NOT COMPLETED|Follow-up Assessment||5
10639721|NCT02091856|11798506|FG001|NOT COMPLETED|Follow-up Assessment||3
10639722|NCT02091856|11798507|FG002|NOT COMPLETED|Follow-up Assessment||0
10639723|NCT02091869|11798517|FG000|STARTED|Overall Study||17
10639724|NCT02091869|11798518|FG001|STARTED|Overall Study||17
10639725|NCT02091869|11798517|FG000|COMPLETED|Overall Study||17
10639726|NCT02091869|11798518|FG001|COMPLETED|Overall Study||14
10639727|NCT02091869|11798517|FG000|NOT COMPLETED|Overall Study||0
10639728|NCT02091869|11798518|FG001|NOT COMPLETED|Overall Study||3
10639729|NCT02091882|11798524|FG000|STARTED|Overall Study||30
10639730|NCT02091882|11798524|FG000|COMPLETED|Overall Study||30
10639731|NCT02091882|11798524|FG000|NOT COMPLETED|Overall Study||0
10639732|NCT02091921|11798528|FG000|STARTED|Overall Study||53
10639733|NCT02091921|11798528|FG000|COMPLETED|Overall Study||50
10639734|NCT02091921|11798528|FG000|NOT COMPLETED|Overall Study||3
10639735|NCT02091986|11798538|FG000|STARTED|Overall Study||92
10639736|NCT02091986|11798539|FG001|STARTED|Overall Study||95
10639737|NCT02091986|11798540|FG002|STARTED|Overall Study||92
10639738|NCT02091986|11798538|FG000|COMPLETED|Overall Study||85
10639739|NCT02091986|11798539|FG001|COMPLETED|Overall Study||84
10639740|NCT02091986|11798540|FG002|COMPLETED|Overall Study||84
10639741|NCT02091986|11798538|FG000|NOT COMPLETED|Overall Study||7
10639742|NCT02091986|11798539|FG001|NOT COMPLETED|Overall Study||11
10639743|NCT02091986|11798540|FG002|NOT COMPLETED|Overall Study||8
10639744|NCT02092025|11798548|FG000|STARTED|Overall Study||3437
10639745|NCT02092025|11798548|FG000|COMPLETED|Overall Study||3369
10639746|NCT02092025|11798548|FG000|NOT COMPLETED|Overall Study||68
10639747|NCT02092116|11798554|FG000|STARTED|Overall Study||6
10639748|NCT02092116|11798555|FG001|STARTED|Overall Study||20
10639749|NCT02092116|11798554|FG000|COMPLETED|Overall Study||6
10639750|NCT02092116|11798555|FG001|COMPLETED|Overall Study||16
10639751|NCT02092116|11798554|FG000|NOT COMPLETED|Overall Study||0
10639752|NCT02092116|11798555|FG001|NOT COMPLETED|Overall Study||4
10639753|NCT02092168|11798563|FG000|STARTED|Overall Study||12
10639754|NCT02092168|11798564|FG001|STARTED|Overall Study||12
10639755|NCT02092168|11798563|FG000|COMPLETED|Overall Study||12
10639756|NCT02092168|11798564|FG001|COMPLETED|Overall Study||12
10639757|NCT02092168|11798563|FG000|NOT COMPLETED|Overall Study||0
10639758|NCT02092168|11798564|FG001|NOT COMPLETED|Overall Study||0
10639759|NCT02092181|11798572|FG000|STARTED|Overall Study||15
10639760|NCT02092181|11798573|FG001|STARTED|Overall Study||15
10639761|NCT02092181|11798572|FG000|COMPLETED|Overall Study||12
10639762|NCT02092181|11798573|FG001|COMPLETED|Overall Study||14
10639763|NCT02092181|11798572|FG000|NOT COMPLETED|Overall Study||3
10639764|NCT02092181|11798573|FG001|NOT COMPLETED|Overall Study||1
10639765|NCT02092220|11798579|FG000|STARTED|Period 1||21
10639766|NCT02092220|11798580|FG001|STARTED|Period 1||22
10639767|NCT02092220|11798579|FG000|COMPLETED|Period 1||21
10639768|NCT02092220|11798580|FG001|COMPLETED|Period 1||20
10639769|NCT02092220|11798579|FG000|NOT COMPLETED|Period 1||0
10639770|NCT02092220|11798580|FG001|NOT COMPLETED|Period 1||2
10639771|NCT02092220|11798579|FG000|STARTED|Period 2||21
10639772|NCT02092220|11798580|FG001|STARTED|Period 2||20
10639773|NCT02092220|11798579|FG000|COMPLETED|Period 2||20
10639774|NCT02092220|11798580|FG001|COMPLETED|Period 2||19
10639775|NCT02092220|11798579|FG000|NOT COMPLETED|Period 2||1
10639776|NCT02092220|11798580|FG001|NOT COMPLETED|Period 2||1
10654119|NCT02199496|11814747|FG001|NOT COMPLETED|Ustekinumab-Multi-dose||0
10654120|NCT02199509|11814755|FG000|STARTED|Overall Study||3
10654121|NCT02199509|11814756|FG001|STARTED|Overall Study||4
10654122|NCT02199509|11814755|FG000|COMPLETED|Overall Study||2
10654123|NCT02199509|11814756|FG001|COMPLETED|Overall Study||3
10654124|NCT02199509|11814755|FG000|NOT COMPLETED|Overall Study||1
10654125|NCT02199509|11814756|FG001|NOT COMPLETED|Overall Study||1
10654126|NCT02199574|11814766|FG000|STARTED|Overall Study||12
10654127|NCT02199574|11814766|FG000|COMPLETED|Overall Study||12
10654128|NCT02199574|11814766|FG000|NOT COMPLETED|Overall Study||0
10654129|NCT02199652|11814774|FG000|STARTED|Overall Study||10
10654130|NCT02199652|11814775|FG001|STARTED|Overall Study||10
10654131|NCT02199652|11814774|FG000|COMPLETED|Overall Study||3
10654132|NCT02199652|11814775|FG001|COMPLETED|Overall Study||3
10654133|NCT02199652|11814774|FG000|NOT COMPLETED|Overall Study||7
10654134|NCT02199652|11814775|FG001|NOT COMPLETED|Overall Study||7
10654135|NCT02199717|11814781|FG000|STARTED|Overall Study||66
10654136|NCT02199717|11814781|FG000|COMPLETED|Overall Study||66
10654137|NCT02199717|11814781|FG000|NOT COMPLETED|Overall Study||0
10654611|NCT02203591|11815406|FG001|STARTED|Overall Study||344
10654612|NCT02203591|11815407|FG002|STARTED|Overall Study||347
10654613|NCT02203591|11815408|FG003|STARTED|Overall Study||104
10654614|NCT02203591|11815409|FG004|STARTED|Overall Study||242
10654615|NCT02203591|11815410|FG005|STARTED|Overall Study||244
10654616|NCT02203591|11815411|FG006|STARTED|Overall Study||248
10654617|NCT02203591|11815412|FG007|STARTED|Overall Study||74
10654618|NCT02203591|11815405|FG000|COMPLETED|Overall Study||196
10654619|NCT02203591|11815406|FG001|COMPLETED|Overall Study||202
10654620|NCT02203591|11815407|FG002|COMPLETED|Overall Study||196
10654621|NCT02203591|11815408|FG003|COMPLETED|Overall Study||59
10654622|NCT02203591|11815409|FG004|COMPLETED|Overall Study||208
10654623|NCT02203591|11815410|FG005|COMPLETED|Overall Study||209
10654624|NCT02203591|11815411|FG006|COMPLETED|Overall Study||219
10639777|NCT02092285|11798588|FG000|STARTED|Induction Phase||205
10639778|NCT02092285|11798588|FG000|COMPLETED|Induction Phase||170
10639779|NCT02092285|11798588|FG000|NOT COMPLETED|Induction Phase||35
10639780|NCT02092285|11798588|FG000|STARTED|Maintenance Phase & Follow-up||170
10639781|NCT02092285|11798588|FG000|COMPLETED|Maintenance Phase & Follow-up||60
10639782|NCT02092285|11798588|FG000|NOT COMPLETED|Maintenance Phase & Follow-up||110
10639783|NCT02092298|11798592|FG000|STARTED|Overall Study||19
10639784|NCT02092298|11798592|FG000|COMPLETED|Overall Study||19
10639785|NCT02092298|11798592|FG000|NOT COMPLETED|Overall Study||0
10639786|NCT02092311|11798598|FG000|STARTED|Overall Study||285
10639787|NCT02092311|11798599|FG001|STARTED|Overall Study||285
10639788|NCT02092311|11798598|FG000|COMPLETED|Overall Study||285
10639789|NCT02092311|11798599|FG001|COMPLETED|Overall Study||285
10639790|NCT02092311|11798598|FG000|NOT COMPLETED|Overall Study||0
10639791|NCT02092311|11798599|FG001|NOT COMPLETED|Overall Study||0
10639792|NCT02092324|11798607|FG000|STARTED|Overall Study||51
10639793|NCT02092324|11798607|FG000|End of Cycle 6|Overall Study|This study has an accrual goal of 25 evaluable subjects who reach cycle 7, week 1.|25
10639794|NCT02092324|11798607|FG000|Wildtype CSF3R|Overall Study||23
10639795|NCT02092324|11798607|FG000|Mutant CSF3R|Overall Study||26
10639796|NCT02092324|11798607|FG000|COMPLETED|Overall Study||32
10639797|NCT02092324|11798607|FG000|NOT COMPLETED|Overall Study||19
10639798|NCT02092350|11798616|FG000|STARTED|Overall Study||123
10639799|NCT02092350|11798617|FG001|STARTED|Overall Study||114
10639800|NCT02092350|11798616|FG000|COMPLETED|Overall Study||113
10639801|NCT02092350|11798617|FG001|COMPLETED|Overall Study||102
10639802|NCT02092350|11798616|FG000|NOT COMPLETED|Overall Study||10
10639803|NCT02092350|11798617|FG001|NOT COMPLETED|Overall Study||12
10639804|NCT02092389|11798625|FG000|STARTED|Overall Study||10
10639805|NCT02092389|11798625|FG000|COMPLETED|Overall Study||4
10639806|NCT02092389|11798625|FG000|NOT COMPLETED|Overall Study||6
10639807|NCT02092415|11798629|FG000|STARTED|Overall Study||10
10639808|NCT02092415|11798629|FG000|COMPLETED|Overall Study||10
10639809|NCT02092415|11798629|FG000|NOT COMPLETED|Overall Study||0
10639810|NCT02092441|11798636|FG000|STARTED|Overall Study||37
10639811|NCT02092441|11798637|FG001|STARTED|Overall Study||43
10639812|NCT02092441|11798636|FG000|COMPLETED|Overall Study||37
10639813|NCT02092441|11798637|FG001|COMPLETED|Overall Study||43
10639814|NCT02092441|11798636|FG000|NOT COMPLETED|Overall Study||0
10639815|NCT02092441|11798637|FG001|NOT COMPLETED|Overall Study||0
10639816|NCT02092467|11798646|FG000|STARTED|Overall Study||1457
10639817|NCT02092467|11798647|FG001|STARTED|Overall Study||1457
10639818|NCT02092467|11798648|FG002|STARTED|Overall Study||1458
10639819|NCT02092467|11798646|FG000|Treated|Overall Study||1455
10639820|NCT02092467|11798647|FG001|Treated|Overall Study||1456
10639821|NCT02092467|11798648|FG002|Treated|Overall Study||1451
10639822|NCT02092467|11798646|FG000|COMPLETED|Overall Study||1053
10639823|NCT02092467|11798647|FG001|COMPLETED|Overall Study||998
10639824|NCT02092467|11798648|FG002|COMPLETED|Overall Study||1060
10639825|NCT02092467|11798646|FG000|NOT COMPLETED|Overall Study||404
10639826|NCT02092467|11798647|FG001|NOT COMPLETED|Overall Study||459
10639827|NCT02092467|11798648|FG002|NOT COMPLETED|Overall Study||398
10639828|NCT02092610|11798660|FG000|STARTED|Overall Study||25
10639829|NCT02092610|11798661|FG001|STARTED|Overall Study||52
10639830|NCT02092610|11798660|FG000|COMPLETED|Overall Study||17
10639831|NCT02092610|11798661|FG001|COMPLETED|Overall Study||40
10639832|NCT02092610|11798660|FG000|NOT COMPLETED|Overall Study||8
10639833|NCT02092610|11798661|FG001|NOT COMPLETED|Overall Study||12
10639834|NCT02092649|11798669|FG000|STARTED|Overall Study|13 participants recruited|13
10639835|NCT02092649|11798670|FG001|STARTED|Overall Study|13 participants recruited|13
10639836|NCT02092649|11798669|FG000|COMPLETED|Overall Study|13 participants finished study|13
10705907|NCT02603809|11870370|FG001|Per-protocol Set|Overall Study||68
10705908|NCT02603809|11870371|FG002|Per-protocol Set|Overall Study||71
10705909|NCT02603809|11870372|FG003|Per-protocol Set|Overall Study||67
10705910|NCT02603809|11870373|FG004|Per-protocol Set|Overall Study||68
10705911|NCT02603809|11870374|FG005|Per-protocol Set|Overall Study||69
10639837|NCT02092649|11798670|FG001|COMPLETED|Overall Study|13 participants finished study|13
10639838|NCT02092649|11798669|FG000|NOT COMPLETED|Overall Study||0
10639839|NCT02092649|11798670|FG001|NOT COMPLETED|Overall Study||0
10639840|NCT02092662|11798678|FG000|STARTED|Overall Study||38
10639841|NCT02092662|11798679|FG001|STARTED|Overall Study||19
10639842|NCT02092662|11798678|FG000|Recruited|Overall Study||38
10639843|NCT02092662|11798679|FG001|Recruited|Overall Study||19
10639844|NCT02092662|11798678|FG000|COMPLETED|Overall Study||25
10639845|NCT02092662|11798679|FG001|COMPLETED|Overall Study||19
10639846|NCT02092662|11798678|FG000|NOT COMPLETED|Overall Study||13
10639847|NCT02092662|11798679|FG001|NOT COMPLETED|Overall Study||0
10639848|NCT02092857|11798689|FG000|STARTED|Overall Study||30
10713777|NCT02681809|11879276|FG000|COMPLETED|Overall Study||15
10639849|NCT02092857|11798690|FG001|STARTED|Overall Study||30
10639850|NCT02092857|11798691|FG002|STARTED|Overall Study||29
10639851|NCT02092857|11798689|FG000|COMPLETED|Overall Study||20
10713778|NCT02681809|11879277|FG001|COMPLETED|Overall Study||15
10639852|NCT02092857|11798690|FG001|COMPLETED|Overall Study||18
10639853|NCT02092857|11798691|FG002|COMPLETED|Overall Study||16
10639854|NCT02092857|11798689|FG000|NOT COMPLETED|Overall Study||10
10639855|NCT02092857|11798690|FG001|NOT COMPLETED|Overall Study||12
10639856|NCT02092857|11798691|FG002|NOT COMPLETED|Overall Study||13
10639857|NCT02092909|11798703|FG000|STARTED|Overall Study||6
10639858|NCT02092909|11798704|FG001|STARTED|Overall Study||5
10639859|NCT02092909|11798705|FG002|STARTED|Overall Study||14
10639860|NCT02092909|11798706|FG003|STARTED|Overall Study||6
10639861|NCT02092909|11798703|FG000|COMPLETED|Overall Study||5
10639862|NCT02092909|11798704|FG001|COMPLETED|Overall Study||2
10639863|NCT02092909|11798705|FG002|COMPLETED|Overall Study||5
10639864|NCT02092909|11798706|FG003|COMPLETED|Overall Study||0
10639865|NCT02092909|11798703|FG000|NOT COMPLETED|Overall Study||1
10639866|NCT02092909|11798704|FG001|NOT COMPLETED|Overall Study||3
10639867|NCT02092909|11798705|FG002|NOT COMPLETED|Overall Study||9
10639868|NCT02092909|11798706|FG003|NOT COMPLETED|Overall Study||6
10639869|NCT02092961|11798719|FG000|STARTED|Overall Study|Patients who received treatment|33
10639870|NCT02092961|11798720|FG001|STARTED|Overall Study|Patients who received treatment|28
10639871|NCT02092961|11798721|FG002|STARTED|Overall Study|Patients who received treatment|29
10639872|NCT02092961|11798719|FG000|Randomised But Did Not Receive Treatment|Overall Study|Study stopped|1
10639873|NCT02092961|11798720|FG001|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/study stopped|5
10639874|NCT02092961|11798721|FG002|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled|1
10639875|NCT02092961|11798719|FG000|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|12
10639876|NCT02092961|11798720|FG001|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|14
10639877|NCT02092961|11798721|FG002|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|13
10639878|NCT02092961|11798719|FG000|NOT COMPLETED|Overall Study||21
10639879|NCT02092961|11798720|FG001|NOT COMPLETED|Overall Study||14
10639880|NCT02092961|11798721|FG002|NOT COMPLETED|Overall Study||16
10639881|NCT02092987|11798732|FG000|STARTED|Overall Study||110
10639882|NCT02092987|11798733|FG001|STARTED|Overall Study||111
10639883|NCT02092987|11798732|FG000|COMPLETED|Overall Study||106
10639884|NCT02092987|11798733|FG001|COMPLETED|Overall Study||103
10639885|NCT02092987|11798732|FG000|NOT COMPLETED|Overall Study||4
10639886|NCT02092987|11798733|FG001|NOT COMPLETED|Overall Study||8
10639887|NCT02093026|11798742|FG000|STARTED|Overall Study||465
10639888|NCT02093026|11798742|FG000|COMPLETED|Overall Study|At predefined end-of-treatment date, 272 ongoing participants were designated as completed study.|272
10639889|NCT02093026|11798742|FG000|NOT COMPLETED|Overall Study||193
10639890|NCT02093221|11798752|FG000|STARTED|Overall Study||15
10639891|NCT02093221|11798753|FG001|STARTED|Overall Study||16
10639892|NCT02093221|11798754|FG002|STARTED|Overall Study||15
10639893|NCT02093221|11798755|FG003|STARTED|Overall Study||15
10639894|NCT02093221|11798756|FG004|STARTED|Overall Study||15
10639895|NCT02093221|11798752|FG000|COMPLETED|Overall Study||5
10639896|NCT02093221|11798753|FG001|COMPLETED|Overall Study||8
10639897|NCT02093221|11798754|FG002|COMPLETED|Overall Study||6
10639898|NCT02093221|11798755|FG003|COMPLETED|Overall Study||7
10639899|NCT02093221|11798756|FG004|COMPLETED|Overall Study||7
10639900|NCT02093221|11798752|FG000|NOT COMPLETED|Overall Study||10
10639901|NCT02093221|11798753|FG001|NOT COMPLETED|Overall Study||8
10639902|NCT02093221|11798754|FG002|NOT COMPLETED|Overall Study||9
10639903|NCT02093221|11798755|FG003|NOT COMPLETED|Overall Study||8
10639904|NCT02093221|11798756|FG004|NOT COMPLETED|Overall Study||8
10639905|NCT02093234|11798771|FG000|STARTED|Overall Study||56
10639906|NCT02093234|11798772|FG001|STARTED|Overall Study||56
10639907|NCT02093234|11798773|FG002|STARTED|Overall Study||54
10639908|NCT02093234|11798771|FG000|COMPLETED|Overall Study||53
10639909|NCT02093234|11798772|FG001|COMPLETED|Overall Study||52
10639910|NCT02093234|11798773|FG002|COMPLETED|Overall Study||50
10639911|NCT02093234|11798771|FG000|NOT COMPLETED|Overall Study||3
10639912|NCT02093234|11798772|FG001|NOT COMPLETED|Overall Study||4
10639913|NCT02093234|11798773|FG002|NOT COMPLETED|Overall Study||4
10639914|NCT02093351|11798784|FG000|STARTED|Part A||30
10639915|NCT02093351|11798785|FG001|STARTED|Part A||23
10639916|NCT02093351|11798786|FG002|STARTED|Part A||26
10639917|NCT02093351|11798787|FG003|STARTED|Part A||0
10639918|NCT02093351|11798784|FG000|Completing Treatment Period 1|Part A||29
10639919|NCT02093351|11798785|FG001|Completing Treatment Period 1|Part A||22
10639920|NCT02093351|11798786|FG002|Completing Treatment Period 1|Part A||23
10639921|NCT02093351|11798787|FG003|Completing Treatment Period 1|Part A||0
10639922|NCT02093351|11798784|FG000|Completing Treatment Period 2|Part A||29
10639923|NCT02093351|11798785|FG001|Completing Treatment Period 2|Part A||21
10639924|NCT02093351|11798786|FG002|Completing Treatment Period 2|Part A||23
10639925|NCT02093351|11798787|FG003|Completing Treatment Period 2|Part A||0
10639926|NCT02093351|11798784|FG000|Completing Treatment Period 3|Part A||28
10639927|NCT02093351|11798785|FG001|Completing Treatment Period 3|Part A||21
10639928|NCT02093351|11798786|FG002|Completing Treatment Period 3|Part A||23
10639929|NCT02093351|11798787|FG003|Completing Treatment Period 3|Part A||0
10639930|NCT02093351|11798784|FG000|COMPLETED|Part A||28
10639931|NCT02093351|11798785|FG001|COMPLETED|Part A||21
10639932|NCT02093351|11798786|FG002|COMPLETED|Part A||23
10639933|NCT02093351|11798787|FG003|COMPLETED|Part A||0
10639934|NCT02093351|11798784|FG000|NOT COMPLETED|Part A||2
10639935|NCT02093351|11798785|FG001|NOT COMPLETED|Part A||2
10639936|NCT02093351|11798786|FG002|NOT COMPLETED|Part A||3
10639937|NCT02093351|11798787|FG003|NOT COMPLETED|Part A||0
10639938|NCT02093351|11798784|FG000|STARTED|Part B|Only the Olaparib (Part B) arm is applicable for this period.|0
10639939|NCT02093351|11798785|FG001|STARTED|Part B|Only the Olaparib (Part B) arm is applicable for this period.|0
10639940|NCT02093351|11798786|FG002|STARTED|Part B|Only the Olaparib (Part B) arm is applicable for this period.|0
10639941|NCT02093351|11798787|FG003|STARTED|Part B|Eligible patients completing Part A entered Part B for continued access to olaparib.|69
10639942|NCT02093351|11798784|FG000|COMPLETED|Part B||0
10639943|NCT02093351|11798785|FG001|COMPLETED|Part B||0
10639944|NCT02093351|11798786|FG002|COMPLETED|Part B||0
10639945|NCT02093351|11798787|FG003|COMPLETED|Part B||6
10639946|NCT02093351|11798784|FG000|NOT COMPLETED|Part B||0
10639947|NCT02093351|11798785|FG001|NOT COMPLETED|Part B||0
10639948|NCT02093351|11798786|FG002|NOT COMPLETED|Part B||0
10639949|NCT02093351|11798787|FG003|NOT COMPLETED|Part B||63
10639950|NCT02093390|11798804|FG000|STARTED|Overall Study||20
10639951|NCT02093390|11798805|FG001|STARTED|Overall Study||20
10639952|NCT02093390|11798804|FG000|COMPLETED|Overall Study||20
10457282|NCT01009918|11605011|FG000|COMPLETED|Overall Study||134
10457283|NCT01009918|11605012|FG001|COMPLETED|Overall Study||132
10457284|NCT01009918|11605013|FG002|COMPLETED|Overall Study||124
10457285|NCT01009918|11605011|FG000|NOT COMPLETED|Overall Study||24
10457286|NCT01009918|11605012|FG001|NOT COMPLETED|Overall Study||24
10457287|NCT01009918|11605013|FG002|NOT COMPLETED|Overall Study||30
10457288|NCT01009983|11605021|FG000|STARTED|Overall Study||14
10457289|NCT01009983|11605021|FG000|COMPLETED|Overall Study||13
10457290|NCT01009983|11605021|FG000|NOT COMPLETED|Overall Study||1
10457291|NCT01010009|11605028|FG000|STARTED|Overall Study||8
10457292|NCT01010009|11605029|FG001|STARTED|Overall Study||8
10457293|NCT01010009|11605030|FG002|STARTED|Overall Study||8
10457294|NCT01010009|11605028|FG000|COMPLETED|Overall Study||8
10457295|NCT01010009|11605029|FG001|COMPLETED|Overall Study||8
10457296|NCT01010009|11605030|FG002|COMPLETED|Overall Study||8
10639953|NCT02093390|11798805|FG001|COMPLETED|Overall Study||19
10639954|NCT02093390|11798804|FG000|NOT COMPLETED|Overall Study||0
10639955|NCT02093390|11798805|FG001|NOT COMPLETED|Overall Study||1
10639956|NCT02093520|11798814|FG000|STARTED|Overall Study||149
10639957|NCT02093520|11798815|FG001|STARTED|Overall Study||153
10639958|NCT02093520|11798814|FG000|COMPLETED|Overall Study||143
10639959|NCT02093520|11798815|FG001|COMPLETED|Overall Study||131
10639960|NCT02093520|11798814|FG000|NOT COMPLETED|Overall Study||6
10639961|NCT02093520|11798815|FG001|NOT COMPLETED|Overall Study||22
10639962|NCT02093663|11798821|FG000|STARTED|Double Blind Acute Phase (8 Weeks)||27
10639963|NCT02093663|11798822|FG001|STARTED|Double Blind Acute Phase (8 Weeks)||26
10639964|NCT02093663|11798823|FG002|STARTED|Double Blind Acute Phase (8 Weeks)||0
10639965|NCT02093663|11798824|FG003|STARTED|Double Blind Acute Phase (8 Weeks)||0
10639966|NCT02093663|11798825|FG004|STARTED|Double Blind Acute Phase (8 Weeks)||0
10639967|NCT02093663|11798821|FG000|COMPLETED|Double Blind Acute Phase (8 Weeks)||19
10639968|NCT02093663|11798822|FG001|COMPLETED|Double Blind Acute Phase (8 Weeks)||22
10639969|NCT02093663|11798823|FG002|COMPLETED|Double Blind Acute Phase (8 Weeks)||0
10639970|NCT02093663|11798824|FG003|COMPLETED|Double Blind Acute Phase (8 Weeks)||0
10639971|NCT02093663|11798825|FG004|COMPLETED|Double Blind Acute Phase (8 Weeks)||0
10639972|NCT02093663|11798821|FG000|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||8
10639973|NCT02093663|11798822|FG001|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||4
10639974|NCT02093663|11798823|FG002|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||0
10639975|NCT02093663|11798824|FG003|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||0
10639976|NCT02093663|11798825|FG004|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||0
10639977|NCT02093663|11798821|FG000|STARTED|Open Label Acute Phase (8 Weeks)||0
10639978|NCT02093663|11798822|FG001|STARTED|Open Label Acute Phase (8 Weeks)||0
10639979|NCT02093663|11798823|FG002|STARTED|Open Label Acute Phase (8 Weeks)||18
10639980|NCT02093663|11798824|FG003|STARTED|Open Label Acute Phase (8 Weeks)||0
10639981|NCT02093663|11798825|FG004|STARTED|Open Label Acute Phase (8 Weeks)||0
10639982|NCT02093663|11798821|FG000|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
10639983|NCT02093663|11798822|FG001|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
10639984|NCT02093663|11798823|FG002|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||18
10639985|NCT02093663|11798824|FG003|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
10639986|NCT02093663|11798825|FG004|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
10639987|NCT02093663|11798821|FG000|COMPLETED|Open Label Acute Phase (8 Weeks)||0
10639988|NCT02093663|11798822|FG001|COMPLETED|Open Label Acute Phase (8 Weeks)||0
10639989|NCT02093663|11798823|FG002|COMPLETED|Open Label Acute Phase (8 Weeks)||12
10639990|NCT02093663|11798824|FG003|COMPLETED|Open Label Acute Phase (8 Weeks)||0
10639991|NCT02093663|11798825|FG004|COMPLETED|Open Label Acute Phase (8 Weeks)||0
10639992|NCT02093663|11798821|FG000|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
10639993|NCT02093663|11798822|FG001|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
10639994|NCT02093663|11798823|FG002|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||6
10639995|NCT02093663|11798824|FG003|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
10639996|NCT02093663|11798825|FG004|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
10639997|NCT02093663|11798821|FG000|STARTED|Double Blind Maintenance Phase(26 Weeks)||0
10639998|NCT02093663|11798822|FG001|STARTED|Double Blind Maintenance Phase(26 Weeks)||0
10639999|NCT02093663|11798823|FG002|STARTED|Double Blind Maintenance Phase(26 Weeks)||0
10640000|NCT02093663|11798824|FG003|STARTED|Double Blind Maintenance Phase(26 Weeks)||42
10640001|NCT02093663|11798825|FG004|STARTED|Double Blind Maintenance Phase(26 Weeks)||45
10640002|NCT02093663|11798821|FG000|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||0
10640003|NCT02093663|11798822|FG001|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||0
10640004|NCT02093663|11798823|FG002|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||0
10640005|NCT02093663|11798824|FG003|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||26
10640006|NCT02093663|11798825|FG004|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||26
10457297|NCT01010009|11605028|FG000|NOT COMPLETED|Overall Study||0
10640007|NCT02093663|11798821|FG000|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||0
10640008|NCT02093663|11798822|FG001|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||0
10640009|NCT02093663|11798823|FG002|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||0
10640079|NCT02093923|11798923|FG000|Treated - 1 Dose Only:|Overall Study||0
10640010|NCT02093663|11798824|FG003|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||12
10640011|NCT02093663|11798825|FG004|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||15
10640012|NCT02093663|11798821|FG000|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||0
10640013|NCT02093663|11798822|FG001|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||0
10640014|NCT02093663|11798823|FG002|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||0
10640015|NCT02093663|11798824|FG003|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||4
10640016|NCT02093663|11798825|FG004|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||4
10640017|NCT02093663|11798821|FG000|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
10640018|NCT02093663|11798822|FG001|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
10640019|NCT02093663|11798823|FG002|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
10640020|NCT02093663|11798824|FG003|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||32
10640021|NCT02093663|11798825|FG004|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||34
10640022|NCT02093663|11798821|FG000|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
10640023|NCT02093663|11798822|FG001|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
10640024|NCT02093663|11798823|FG002|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
10640025|NCT02093663|11798824|FG003|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||10
10640026|NCT02093663|11798825|FG004|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||11
10640027|NCT02093702|11798844|FG000|STARTED|Overall Study||2
10640028|NCT02093702|11798845|FG001|STARTED|Overall Study||3
10640029|NCT02093702|11798844|FG000|COMPLETED|Overall Study||2
10640030|NCT02093702|11798845|FG001|COMPLETED|Overall Study||3
10640031|NCT02093702|11798844|FG000|NOT COMPLETED|Overall Study||0
10640032|NCT02093702|11798845|FG001|NOT COMPLETED|Overall Study||0
10640033|NCT02093793|11798855|FG000|STARTED|Overall Study||98
10640034|NCT02093793|11798856|FG001|STARTED|Overall Study||90
10640035|NCT02093793|11798857|FG002|STARTED|Overall Study||68
10640036|NCT02093793|11798855|FG000|COMPLETED|Overall Study||91
10640037|NCT02093793|11798856|FG001|COMPLETED|Overall Study||80
10640038|NCT02093793|11798857|FG002|COMPLETED|Overall Study||65
10640039|NCT02093793|11798855|FG000|NOT COMPLETED|Overall Study||7
10640040|NCT02093793|11798856|FG001|NOT COMPLETED|Overall Study||10
10705912|NCT02603809|11870369|FG000|Modified Per-Protocol Set|Overall Study|One participant had out of analysis window blood pressure measurements.|66
10705913|NCT02603809|11870370|FG001|Modified Per-Protocol Set|Overall Study||68
10705914|NCT02603809|11870371|FG002|Modified Per-Protocol Set|Overall Study||71
10705915|NCT02603809|11870372|FG003|Modified Per-Protocol Set|Overall Study||67
10705916|NCT02603809|11870373|FG004|Modified Per-Protocol Set|Overall Study||68
10705917|NCT02603809|11870374|FG005|Modified Per-Protocol Set|Overall Study||69
10705918|NCT02603809|11870369|FG000|Completed Study|Overall Study||75
10705919|NCT02603809|11870370|FG001|Completed Study|Overall Study||79
10705920|NCT02603809|11870371|FG002|Completed Study|Overall Study||79
10705921|NCT02603809|11870372|FG003|Completed Study|Overall Study||76
10705922|NCT02603809|11870373|FG004|Completed Study|Overall Study||78
10705923|NCT02603809|11870374|FG005|Completed Study|Overall Study||75
10640041|NCT02093793|11798857|FG002|NOT COMPLETED|Overall Study||3
10640042|NCT02093819|11798873|FG000|STARTED|Overall Study||15
10640043|NCT02093819|11798874|FG001|STARTED|Overall Study||6
10640044|NCT02093819|11798875|FG002|STARTED|Overall Study||10
10640045|NCT02093819|11798876|FG003|STARTED|Overall Study||6
10640046|NCT02093819|11798877|FG004|STARTED|Overall Study||6
10640047|NCT02093819|11798878|FG005|STARTED|Overall Study||6
10640048|NCT02093819|11798879|FG006|STARTED|Overall Study||5
10640049|NCT02093819|11798880|FG007|STARTED|Overall Study||6
10640050|NCT02093819|11798873|FG000|COMPLETED|Overall Study||15
10640051|NCT02093819|11798874|FG001|COMPLETED|Overall Study||6
10640052|NCT02093819|11798875|FG002|COMPLETED|Overall Study||10
10640053|NCT02093819|11798876|FG003|COMPLETED|Overall Study||6
10640054|NCT02093819|11798877|FG004|COMPLETED|Overall Study||6
10640055|NCT02093819|11798878|FG005|COMPLETED|Overall Study||6
10640056|NCT02093819|11798879|FG006|COMPLETED|Overall Study||5
10640057|NCT02093819|11798880|FG007|COMPLETED|Overall Study||6
10640058|NCT02093819|11798873|FG000|NOT COMPLETED|Overall Study||0
10640059|NCT02093819|11798874|FG001|NOT COMPLETED|Overall Study||0
10640060|NCT02093819|11798875|FG002|NOT COMPLETED|Overall Study||0
10640061|NCT02093819|11798876|FG003|NOT COMPLETED|Overall Study||0
10640062|NCT02093819|11798877|FG004|NOT COMPLETED|Overall Study||0
10640063|NCT02093819|11798878|FG005|NOT COMPLETED|Overall Study||0
10640064|NCT02093819|11798879|FG006|NOT COMPLETED|Overall Study||0
10705924|NCT02603809|11870369|FG000|COMPLETED|Overall Study||70
10640065|NCT02093819|11798880|FG007|NOT COMPLETED|Overall Study||0
10640066|NCT02093897|11798907|FG000|STARTED|Overall Study||84
10640067|NCT02093897|11798907|FG000|COMPLETED|Overall Study||65
10705925|NCT02603809|11870370|FG001|COMPLETED|Overall Study||74
10705926|NCT02603809|11870371|FG002|COMPLETED|Overall Study||75
10640068|NCT02093897|11798907|FG000|NOT COMPLETED|Overall Study||19
10640069|NCT02093923|11798923|FG000|STARTED|Overall Study||4
10640070|NCT02093923|11798924|FG001|STARTED|Overall Study||4
10640071|NCT02093923|11798925|FG002|STARTED|Overall Study||5
10640072|NCT02093923|11798926|FG003|STARTED|Overall Study||12
10640073|NCT02093923|11798927|FG004|STARTED|Overall Study||13
10640074|NCT02093923|11798923|FG000|Total Treated|Overall Study||4
10640075|NCT02093923|11798924|FG001|Total Treated|Overall Study||4
10640076|NCT02093923|11798925|FG002|Total Treated|Overall Study||5
10640077|NCT02093923|11798926|FG003|Total Treated|Overall Study||11
10640078|NCT02093923|11798927|FG004|Total Treated|Overall Study||13
10640080|NCT02093923|11798924|FG001|Treated - 1 Dose Only:|Overall Study||0
10640081|NCT02093923|11798925|FG002|Treated - 1 Dose Only:|Overall Study||0
10640082|NCT02093923|11798926|FG003|Treated - 1 Dose Only:|Overall Study||1
10640083|NCT02093923|11798927|FG004|Treated - 1 Dose Only:|Overall Study||0
10640084|NCT02093923|11798923|FG000|Treated - 2 Doses:|Overall Study||4
10640085|NCT02093923|11798924|FG001|Treated - 2 Doses:|Overall Study||4
10640086|NCT02093923|11798925|FG002|Treated - 2 Doses:|Overall Study||5
10640087|NCT02093923|11798926|FG003|Treated - 2 Doses:|Overall Study||10
10640088|NCT02093923|11798927|FG004|Treated - 2 Doses:|Overall Study||13
10640089|NCT02093923|11798923|FG000|COMPLETED|Overall Study||4
10640090|NCT02093923|11798924|FG001|COMPLETED|Overall Study||4
10640091|NCT02093923|11798925|FG002|COMPLETED|Overall Study||5
10640092|NCT02093923|11798926|FG003|COMPLETED|Overall Study||10
10640093|NCT02093923|11798927|FG004|COMPLETED|Overall Study||13
10640094|NCT02093923|11798923|FG000|NOT COMPLETED|Overall Study||0
10640095|NCT02093923|11798924|FG001|NOT COMPLETED|Overall Study||0
10640096|NCT02093923|11798925|FG002|NOT COMPLETED|Overall Study||0
10640097|NCT02093923|11798926|FG003|NOT COMPLETED|Overall Study||2
10640098|NCT02093923|11798927|FG004|NOT COMPLETED|Overall Study||0
10640099|NCT02093949|11798945|FG000|STARTED|Overall Study||105
10640100|NCT02093949|11798946|FG001|STARTED|Overall Study||47
10640101|NCT02093949|11798945|FG000|COMPLETED|Overall Study||105
10640102|NCT02093949|11798946|FG001|COMPLETED|Overall Study||47
10640103|NCT02093949|11798945|FG000|NOT COMPLETED|Overall Study||0
10640104|NCT02093949|11798946|FG001|NOT COMPLETED|Overall Study||0
10640105|NCT02093962|11798962|FG000|STARTED|Overall Study||134
10640106|NCT02093962|11798963|FG001|STARTED|Overall Study||131
10640107|NCT02093962|11798962|FG000|Received Treatment|Overall Study||130
10640108|NCT02093962|11798963|FG001|Received Treatment|Overall Study||130
10640109|NCT02093962|11798962|FG000|COMPLETED|Overall Study||0
10640110|NCT02093962|11798963|FG001|COMPLETED|Overall Study||0
10640111|NCT02093962|11798962|FG000|NOT COMPLETED|Overall Study||134
10640112|NCT02093962|11798963|FG001|NOT COMPLETED|Overall Study||131
10640113|NCT02094118|11798971|FG000|STARTED|Overall Study||85
10640114|NCT02094118|11798972|FG001|STARTED|Overall Study||86
10640115|NCT02094118|11798971|FG000|COMPLETED|Overall Study||73
10640116|NCT02094118|11798972|FG001|COMPLETED|Overall Study||81
10640117|NCT02094118|11798971|FG000|NOT COMPLETED|Overall Study||12
10640118|NCT02094118|11798972|FG001|NOT COMPLETED|Overall Study||5
10640119|NCT02094300|11798982|FG000|STARTED|Overall Study||26
10640120|NCT02094300|11798982|FG000|30 Days|Overall Study||24
10640121|NCT02094300|11798982|FG000|COMPLETED|Overall Study||6
10640122|NCT02094300|11798982|FG000|NOT COMPLETED|Overall Study||20
10640123|NCT02094326|11798986|FG000|STARTED|Overall Study||301
10640124|NCT02094326|11798986|FG000|COMPLETED|Overall Study||301
10640125|NCT02094326|11798986|FG000|NOT COMPLETED|Overall Study||0
10640126|NCT02094417|11798995|FG000|STARTED|Overall Study||7
10640127|NCT02094417|11798996|FG001|STARTED|Overall Study||9
10640128|NCT02094417|11798997|FG002|STARTED|Overall Study||9
10640129|NCT02094417|11798998|FG003|STARTED|Overall Study||10
10640130|NCT02094417|11798995|FG000|COMPLETED|Overall Study||2
10640131|NCT02094417|11798996|FG001|COMPLETED|Overall Study||1
10640132|NCT02094417|11798997|FG002|COMPLETED|Overall Study||4
10640133|NCT02094417|11798998|FG003|COMPLETED|Overall Study||3
10640134|NCT02094417|11798995|FG000|NOT COMPLETED|Overall Study||5
10640135|NCT02094417|11798996|FG001|NOT COMPLETED|Overall Study||8
10640136|NCT02094417|11798997|FG002|NOT COMPLETED|Overall Study||5
10640137|NCT02094417|11798998|FG003|NOT COMPLETED|Overall Study||7
10640138|NCT02094443|11799010|FG000|STARTED|Overall Study||26
10640139|NCT02094443|11799011|FG001|STARTED|Overall Study||26
10640140|NCT02094443|11799010|FG000|Completed at Week 12|Overall Study||0
10640141|NCT02094443|11799011|FG001|Completed at Week 12|Overall Study||1
10640142|NCT02094443|11799010|FG000|Completed at Week 24|Overall Study||11
10640143|NCT02094443|11799011|FG001|Completed at Week 24|Overall Study||8
10640144|NCT02094443|11799010|FG000|COMPLETED|Overall Study||11
10640145|NCT02094443|11799011|FG001|COMPLETED|Overall Study||9
10640146|NCT02094443|11799010|FG000|NOT COMPLETED|Overall Study||15
10640147|NCT02094443|11799011|FG001|NOT COMPLETED|Overall Study||17
10640148|NCT02094534|11799019|FG000|STARTED|Overall Study||15
10640149|NCT02094534|11799020|FG001|STARTED|Overall Study||10
10640150|NCT02094534|11799019|FG000|COMPLETED|Overall Study||15
10640151|NCT02094534|11799020|FG001|COMPLETED|Overall Study||10
10640152|NCT02094534|11799019|FG000|NOT COMPLETED|Overall Study||0
10640153|NCT02094534|11799020|FG001|NOT COMPLETED|Overall Study||0
10640154|NCT02094573|11799028|FG000|STARTED|Overall Study||112
10640155|NCT02094573|11799029|FG001|STARTED|Overall Study||110
10640156|NCT02094573|11799028|FG000|Treated|Overall Study||109
10640157|NCT02094573|11799029|FG001|Treated|Overall Study||110
10640158|NCT02094573|11799028|FG000|COMPLETED|Overall Study||0
10640159|NCT02094573|11799029|FG001|COMPLETED|Overall Study||0
10640160|NCT02094573|11799028|FG000|NOT COMPLETED|Overall Study||112
10640161|NCT02094573|11799029|FG001|NOT COMPLETED|Overall Study||110
10640162|NCT02094586|11799039|FG000|STARTED|Overall Study||927
10640163|NCT02094586|11799040|FG001|STARTED|Overall Study||933
10640164|NCT02094586|11799041|FG002|STARTED|Overall Study||935
10640165|NCT02094586|11799042|FG003|STARTED|Overall Study||351
10640166|NCT02094586|11799039|FG000|COMPLETED|Overall Study||848
10640167|NCT02094586|11799040|FG001|COMPLETED|Overall Study||866
10640168|NCT02094586|11799041|FG002|COMPLETED|Overall Study||876
10640169|NCT02094586|11799042|FG003|COMPLETED|Overall Study||331
10640170|NCT02094586|11799039|FG000|NOT COMPLETED|Overall Study||79
10640171|NCT02094586|11799040|FG001|NOT COMPLETED|Overall Study||67
10640172|NCT02094586|11799041|FG002|NOT COMPLETED|Overall Study||59
10640173|NCT02094586|11799042|FG003|NOT COMPLETED|Overall Study||20
10640174|NCT02094612|11799066|FG000|STARTED|Overall Study||112
10640175|NCT02094612|11799067|FG001|STARTED|Overall Study||95
10640176|NCT02094612|11799066|FG000|1 Month Follow up|Overall Study||67
10640177|NCT02094612|11799067|FG001|1 Month Follow up|Overall Study||50
10640178|NCT02094612|11799066|FG000|3 Month Follow up|Overall Study||50
10640179|NCT02094612|11799067|FG001|3 Month Follow up|Overall Study||43
10640180|NCT02094612|11799066|FG000|6 Month Follow up|Overall Study||33
10640181|NCT02094612|11799067|FG001|6 Month Follow up|Overall Study||25
10640182|NCT02094612|11799066|FG000|COMPLETED|Overall Study||33
10640183|NCT02094612|11799067|FG001|COMPLETED|Overall Study||25
10640184|NCT02094612|11799066|FG000|NOT COMPLETED|Overall Study||79
10640185|NCT02094612|11799067|FG001|NOT COMPLETED|Overall Study||70
10640186|NCT02094664|11799075|FG000|STARTED|Overall Study||16
10640187|NCT02094664|11799076|FG001|STARTED|Overall Study||16
10640188|NCT02094664|11799075|FG000|COMPLETED|Overall Study||16
10640189|NCT02094664|11799076|FG001|COMPLETED|Overall Study||16
10640190|NCT02094664|11799075|FG000|NOT COMPLETED|Overall Study||0
10640191|NCT02094664|11799076|FG001|NOT COMPLETED|Overall Study||0
10640192|NCT02094677|11799084|FG000|STARTED|Overall Study||43
10640193|NCT02094677|11799085|FG001|STARTED|Overall Study||31
10640194|NCT02094677|11799084|FG000|COMPLETED|Overall Study||40
10640195|NCT02094677|11799085|FG001|COMPLETED|Overall Study||30
10640196|NCT02094677|11799084|FG000|NOT COMPLETED|Overall Study||3
10640197|NCT02094677|11799085|FG001|NOT COMPLETED|Overall Study||1
10640198|NCT02094755|11799098|FG000|STARTED|Overall Study||100
10640199|NCT02094755|11799098|FG000|COMPLETED|Overall Study||100
10640200|NCT02094755|11799098|FG000|NOT COMPLETED|Overall Study||0
10640201|NCT02094872|11799102|FG000|STARTED|Overall Study||49
10640202|NCT02094872|11799102|FG000|Received Biopsy|Overall Study||37
10640203|NCT02094872|11799102|FG000|Received Tumor-board Recommendation|Overall Study|1 individual withdrew consent after biopsy.|36
10640204|NCT02094872|11799102|FG000|Received Targeted Therapy|Overall Study||20
10640205|NCT02094872|11799102|FG000|Received Standard of Care|Overall Study|7 standard-of-care patients crossed-over and received targeted therapy.|9
10640206|NCT02094872|11799102|FG000|Patients Treated With MEK162|Overall Study||20
10640207|NCT02094872|11799102|FG000|COMPLETED|Overall Study||20
10640208|NCT02094872|11799102|FG000|NOT COMPLETED|Overall Study||29
10640209|NCT02094885|11799108|FG000|STARTED|Overall Study||125
10640210|NCT02094885|11799109|FG001|STARTED|Overall Study||127
10640211|NCT02094885|11799108|FG000|COMPLETED|Overall Study||123
10640212|NCT02094885|11799109|FG001|COMPLETED|Overall Study||122
10640213|NCT02094885|11799108|FG000|NOT COMPLETED|Overall Study||2
10640214|NCT02094885|11799109|FG001|NOT COMPLETED|Overall Study||5
10640215|NCT02094898|11799115|FG000|STARTED|Overall Study||12
10640216|NCT02094898|11799115|FG000|COMPLETED|Overall Study||7
10640217|NCT02094898|11799115|FG000|NOT COMPLETED|Overall Study||5
10640218|NCT02094937|11799121|FG000|STARTED|8 Weeks in Period 1||430
10640219|NCT02094937|11799122|FG001|STARTED|8 Weeks in Period 1||0
10640220|NCT02094937|11799123|FG002|STARTED|8 Weeks in Period 1||0
10640221|NCT02094937|11799124|FG003|STARTED|8 Weeks in Period 1||0
10640222|NCT02094937|11799121|FG000|COMPLETED|8 Weeks in Period 1||370
10640223|NCT02094937|11799122|FG001|COMPLETED|8 Weeks in Period 1||0
10640224|NCT02094937|11799123|FG002|COMPLETED|8 Weeks in Period 1||0
10640225|NCT02094937|11799124|FG003|COMPLETED|8 Weeks in Period 1||0
10640226|NCT02094937|11799121|FG000|NOT COMPLETED|8 Weeks in Period 1||60
10640227|NCT02094937|11799122|FG001|NOT COMPLETED|8 Weeks in Period 1||0
10640228|NCT02094937|11799123|FG002|NOT COMPLETED|8 Weeks in Period 1||0
10640229|NCT02094937|11799124|FG003|NOT COMPLETED|8 Weeks in Period 1||0
10640230|NCT02094937|11799121|FG000|STARTED|12 Weeks in Period 2||0
10640231|NCT02094937|11799122|FG001|STARTED|12 Weeks in Period 2||123
10640232|NCT02094937|11799123|FG002|STARTED|12 Weeks in Period 2||124
10640233|NCT02094937|11799124|FG003|STARTED|12 Weeks in Period 2||124
10640234|NCT02094937|11799121|FG000|COMPLETED|12 Weeks in Period 2||0
10640235|NCT02094937|11799122|FG001|COMPLETED|12 Weeks in Period 2||112
10640236|NCT02094937|11799123|FG002|COMPLETED|12 Weeks in Period 2||112
10640237|NCT02094937|11799124|FG003|COMPLETED|12 Weeks in Period 2||112
10640238|NCT02094937|11799121|FG000|NOT COMPLETED|12 Weeks in Period 2||0
10640239|NCT02094937|11799122|FG001|NOT COMPLETED|12 Weeks in Period 2||11
10640240|NCT02094937|11799123|FG002|NOT COMPLETED|12 Weeks in Period 2||12
10640241|NCT02094937|11799124|FG003|NOT COMPLETED|12 Weeks in Period 2||12
10640242|NCT02095106|11799135|FG000|STARTED|First Intervention (14 Days)||14
10640243|NCT02095106|11799136|FG001|STARTED|First Intervention (14 Days)||13
10640244|NCT02095106|11799135|FG000|COMPLETED|First Intervention (14 Days)||14
10640245|NCT02095106|11799136|FG001|COMPLETED|First Intervention (14 Days)||13
10640246|NCT02095106|11799135|FG000|NOT COMPLETED|First Intervention (14 Days)||0
10640247|NCT02095106|11799136|FG001|NOT COMPLETED|First Intervention (14 Days)||0
10640248|NCT02095106|11799135|FG000|STARTED|Second Intervention (14 Days)||14
10640249|NCT02095106|11799136|FG001|STARTED|Second Intervention (14 Days)||13
10640250|NCT02095106|11799135|FG000|COMPLETED|Second Intervention (14 Days)||14
10640251|NCT02095106|11799136|FG001|COMPLETED|Second Intervention (14 Days)||12
10640252|NCT02095106|11799135|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
10705927|NCT02603809|11870372|FG003|COMPLETED|Overall Study||70
10705928|NCT02603809|11870373|FG004|COMPLETED|Overall Study||70
10705929|NCT02603809|11870374|FG005|COMPLETED|Overall Study||71
10705930|NCT02603809|11870369|FG000|NOT COMPLETED|Overall Study||12
10705931|NCT02603809|11870370|FG001|NOT COMPLETED|Overall Study||8
10705932|NCT02603809|11870371|FG002|NOT COMPLETED|Overall Study||7
10705933|NCT02603809|11870372|FG003|NOT COMPLETED|Overall Study||12
10705934|NCT02603809|11870373|FG004|NOT COMPLETED|Overall Study||11
10705935|NCT02603809|11870374|FG005|NOT COMPLETED|Overall Study||10
10705936|NCT02603926|11870390|FG000|STARTED|Overall Study||6
10705937|NCT02603926|11870390|FG000|COMPLETED|Overall Study||6
10705938|NCT02603926|11870390|FG000|NOT COMPLETED|Overall Study||0
10705939|NCT02603952|11870399|FG000|STARTED|Overall Study||32
10705940|NCT02603952|11870400|FG001|STARTED|Overall Study||31
10705941|NCT02603952|11870401|FG002|STARTED|Overall Study||31
10640253|NCT02095106|11799136|FG001|NOT COMPLETED|Second Intervention (14 Days)||1
10640254|NCT02095145|11799148|FG000|STARTED|Overall Study||15
10640255|NCT02095145|11799149|FG001|STARTED|Overall Study||15
10640256|NCT02095145|11799148|FG000|COMPLETED|Overall Study||14
10640257|NCT02095145|11799149|FG001|COMPLETED|Overall Study||15
10640258|NCT02095145|11799148|FG000|NOT COMPLETED|Overall Study||1
10640259|NCT02095145|11799149|FG001|NOT COMPLETED|Overall Study||0
10640260|NCT02095158|11799157|FG000|STARTED|Overall Study||440
10640261|NCT02095158|11799157|FG000|COMPLETED|Overall Study||365
10640262|NCT02095158|11799157|FG000|NOT COMPLETED|Overall Study||75
10640263|NCT02095197|11799163|FG000|STARTED|Overall Study||40
10640264|NCT02095197|11799164|FG001|STARTED|Overall Study||39
10640265|NCT02095197|11799163|FG000|COMPLETED|Overall Study||40
10640266|NCT02095197|11799164|FG001|COMPLETED|Overall Study||36
10640267|NCT02095197|11799163|FG000|NOT COMPLETED|Overall Study||0
10640268|NCT02095197|11799164|FG001|NOT COMPLETED|Overall Study||3
10640269|NCT02095223|11799172|FG000|STARTED|Overall Study||2
10640270|NCT02095223|11799173|FG001|STARTED|Overall Study||2
10640271|NCT02095223|11799172|FG000|COMPLETED|Overall Study|1 participant dropped out of this study due to the time commitment associated with participation.|1
10640272|NCT02095223|11799173|FG001|COMPLETED|Overall Study||2
10640273|NCT02095223|11799172|FG000|NOT COMPLETED|Overall Study||1
10640274|NCT02095223|11799173|FG001|NOT COMPLETED|Overall Study||0
10640275|NCT02095340|11799182|FG000|STARTED|Overall Study|Mother (not the child) received the training.|51
10640276|NCT02095340|11799183|FG001|STARTED|Overall Study|Mother (not the child) received the training.|54
10640277|NCT02095340|11799184|FG002|STARTED|Overall Study||105
10640278|NCT02095340|11799182|FG000|COMPLETED|Overall Study||51
10640279|NCT02095340|11799183|FG001|COMPLETED|Overall Study||54
10640280|NCT02095340|11799184|FG002|COMPLETED|Overall Study||105
10640281|NCT02095340|11799182|FG000|NOT COMPLETED|Overall Study||0
10640282|NCT02095340|11799183|FG001|NOT COMPLETED|Overall Study||0
10640283|NCT02095340|11799184|FG002|NOT COMPLETED|Overall Study||0
10640284|NCT02095535|11799193|FG000|STARTED|Recruitment||20
10640285|NCT02095535|11799193|FG000|COMPLETED|Recruitment||18
10640286|NCT02095535|11799193|FG000|NOT COMPLETED|Recruitment||2
10640287|NCT02095535|11799193|FG000|STARTED|Analysis||18
10640288|NCT02095535|11799193|FG000|COMPLETED|Analysis||18
10640289|NCT02095535|11799193|FG000|NOT COMPLETED|Analysis||0
10640290|NCT02095561|11799199|FG000|STARTED|Overall Study||3049
10640291|NCT02095561|11799200|FG001|STARTED|Overall Study||2964
10640292|NCT02095561|11799199|FG000|Self-testing Acceptability|Overall Study||2616
10640293|NCT02095561|11799200|FG001|Self-testing Acceptability|Overall Study|Acceptablity only applies to the group of women being offered self-testing.|0
10640294|NCT02095561|11799199|FG000|HPV Self-tested Women|Overall Study||2519
10640295|NCT02095561|11799200|FG001|HPV Self-tested Women|Overall Study|HPV self-testing only applies to the HPV self-testing arm|0
10640296|NCT02095561|11799199|FG000|HPV Tested at Health Centers|Overall Study||99
10640297|NCT02095561|11799200|FG001|HPV Tested at Health Centers|Overall Study||599
10640298|NCT02095561|11799199|FG000|COMPLETED|Overall Study|All women are part of the study, independently of whether they were tested or not.|3049
10640299|NCT02095561|11799200|FG001|COMPLETED|Overall Study|All women are part of the study, independently of whether they were tested or not.|2964
10640300|NCT02095561|11799199|FG000|NOT COMPLETED|Overall Study||0
10640301|NCT02095561|11799200|FG001|NOT COMPLETED|Overall Study||0
10640302|NCT02095691|11799206|FG000|STARTED|Overall Study|Subjects who were consented and treated with study ablation catheter.|19
10640303|NCT02095691|11799206|FG000|COMPLETED|Overall Study|Subjects with follow up available at 12 months.|18
10640304|NCT02095691|11799206|FG000|NOT COMPLETED|Overall Study||1
10640305|NCT02095873|11799224|FG000|STARTED|First Intervention (8 Weeks)||16
10640306|NCT02095873|11799225|FG001|STARTED|First Intervention (8 Weeks)||16
10640307|NCT02095873|11799224|FG000|COMPLETED|First Intervention (8 Weeks)||15
10640308|NCT02095873|11799225|FG001|COMPLETED|First Intervention (8 Weeks)||16
10705942|NCT02603952|11870402|FG003|STARTED|Overall Study||32
10705943|NCT02603952|11870399|FG000|Treated|Overall Study||32
10640309|NCT02095873|11799224|FG000|NOT COMPLETED|First Intervention (8 Weeks)||1
10705944|NCT02603952|11870400|FG001|Treated|Overall Study||31
10705945|NCT02603952|11870401|FG002|Treated|Overall Study||31
10705946|NCT02603952|11870402|FG003|Treated|Overall Study||31
10705947|NCT02603952|11870399|FG000|COMPLETED|Overall Study||31
10705948|NCT02603952|11870400|FG001|COMPLETED|Overall Study||31
10640310|NCT02095873|11799225|FG001|NOT COMPLETED|First Intervention (8 Weeks)||0
10640311|NCT02095873|11799224|FG000|STARTED|Second Intervention (8 Weeks)||15
10640312|NCT02095873|11799225|FG001|STARTED|Second Intervention (8 Weeks)||16
10640313|NCT02095873|11799224|FG000|COMPLETED|Second Intervention (8 Weeks)||13
10640314|NCT02095873|11799225|FG001|COMPLETED|Second Intervention (8 Weeks)||16
10640315|NCT02095873|11799224|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||2
10640316|NCT02095873|11799225|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0
10640317|NCT02095951|11799235|FG000|STARTED|Overall Study|2 participants with 4 episodes of catheter infection was enrolled twice in this group.|13
10640408|NCT02096731|11799356|FG000|NOT COMPLETED|Overall Study||0
10640318|NCT02095951|11799236|FG001|STARTED|Overall Study|1 participant with 2 episodes of catheter infection was enrolled twice in this group.|14
10640319|NCT02095951|11799235|FG000|COMPLETED|Overall Study||4
10640320|NCT02095951|11799236|FG001|COMPLETED|Overall Study||8
10640321|NCT02095951|11799235|FG000|NOT COMPLETED|Overall Study||9
10640322|NCT02095951|11799236|FG001|NOT COMPLETED|Overall Study||6
10640323|NCT02096003|11799248|FG000|STARTED|Overall Study||40
10640324|NCT02096003|11799249|FG001|STARTED|Overall Study||40
10640325|NCT02096003|11799248|FG000|COMPLETED|Overall Study||38
10640326|NCT02096003|11799249|FG001|COMPLETED|Overall Study||37
10640327|NCT02096003|11799248|FG000|NOT COMPLETED|Overall Study||2
10640328|NCT02096003|11799249|FG001|NOT COMPLETED|Overall Study||3
10640329|NCT02096029|11799257|FG000|STARTED|Overall Study||652
10640330|NCT02096029|11799258|FG001|STARTED|Overall Study||593
10640331|NCT02096029|11799257|FG000|COMPLETED|Overall Study||652
10640332|NCT02096029|11799258|FG001|COMPLETED|Overall Study||593
10640333|NCT02096029|11799257|FG000|NOT COMPLETED|Overall Study||0
10640334|NCT02096029|11799258|FG001|NOT COMPLETED|Overall Study||0
10640335|NCT02096081|11799266|FG000|STARTED|Overall Study||122
10640336|NCT02096081|11799267|FG001|STARTED|Overall Study||128
10640337|NCT02096081|11799266|FG000|COMPLETED|Overall Study||119
10640338|NCT02096081|11799267|FG001|COMPLETED|Overall Study||124
10640339|NCT02096081|11799266|FG000|NOT COMPLETED|Overall Study||3
10640340|NCT02096081|11799267|FG001|NOT COMPLETED|Overall Study||4
10640341|NCT02096107|11799275|FG000|STARTED|Overall Study||30
10640342|NCT02096107|11799276|FG001|STARTED|Overall Study||30
10640343|NCT02096107|11799275|FG000|COMPLETED|Overall Study||30
10640344|NCT02096107|11799276|FG001|COMPLETED|Overall Study||30
10640345|NCT02096107|11799275|FG000|NOT COMPLETED|Overall Study||0
10640346|NCT02096107|11799276|FG001|NOT COMPLETED|Overall Study||0
10640347|NCT02096263|11799285|FG000|STARTED|Overall Study||195
10640348|NCT02096263|11799286|FG001|STARTED|Overall Study||194
10640349|NCT02096263|11799287|FG002|STARTED|Overall Study||196
10640350|NCT02096263|11799285|FG000|COMPLETED|Overall Study||161
10640351|NCT02096263|11799286|FG001|COMPLETED|Overall Study||158
10640352|NCT02096263|11799287|FG002|COMPLETED|Overall Study||157
10640353|NCT02096263|11799285|FG000|NOT COMPLETED|Overall Study||34
10640354|NCT02096263|11799286|FG001|NOT COMPLETED|Overall Study||36
10640355|NCT02096263|11799287|FG002|NOT COMPLETED|Overall Study||39
10640356|NCT02096276|11799297|FG000|STARTED|Overall Study||250
10640357|NCT02096276|11799298|FG001|STARTED|Overall Study||55
10640358|NCT02096276|11799297|FG000|COMPLETED|Overall Study||250
10640359|NCT02096276|11799298|FG001|COMPLETED|Overall Study||55
10640360|NCT02096276|11799297|FG000|NOT COMPLETED|Overall Study||0
10640361|NCT02096276|11799298|FG001|NOT COMPLETED|Overall Study||0
10640362|NCT02096458|11799304|FG000|STARTED|Overall Study||8
10640363|NCT02096458|11799304|FG000|COMPLETED|Overall Study||8
10640364|NCT02096458|11799304|FG000|NOT COMPLETED|Overall Study||0
10640365|NCT02096471|11799308|FG000|STARTED|Overall Study||19
10640366|NCT02096471|11799308|FG000|COMPLETED|Overall Study|Participants terminated the study if a partial response was not achieved and/or maintained.|6
10640367|NCT02096471|11799308|FG000|NOT COMPLETED|Overall Study||13
10640368|NCT02096575|11799314|FG000|STARTED|Overall Study||68
10640369|NCT02096575|11799315|FG001|STARTED|Overall Study||67
10640370|NCT02096575|11799316|FG002|STARTED|Overall Study||5
10640371|NCT02096575|11799314|FG000|COMPLETED|Overall Study||68
10640372|NCT02096575|11799315|FG001|COMPLETED|Overall Study||67
10640373|NCT02096575|11799316|FG002|COMPLETED|Overall Study||0
10640374|NCT02096575|11799314|FG000|NOT COMPLETED|Overall Study||0
10640375|NCT02096575|11799315|FG001|NOT COMPLETED|Overall Study||0
10640376|NCT02096575|11799316|FG002|NOT COMPLETED|Overall Study||5
10640377|NCT02096679|11799323|FG000|STARTED|Overall Study||8
10640378|NCT02096679|11799323|FG000|COMPLETED|Overall Study||8
10640379|NCT02096679|11799323|FG000|NOT COMPLETED|Overall Study||0
10640380|NCT02096692|11799327|FG000|STARTED|Overall Study||154
10640381|NCT02096692|11799327|FG000|COMPLETED|Overall Study||150
10640382|NCT02096692|11799327|FG000|NOT COMPLETED|Overall Study||4
10640383|NCT02096705|11799333|FG000|STARTED|Treatment||133
10640384|NCT02096705|11799334|FG001|STARTED|Treatment||139
10640385|NCT02096705|11799333|FG000|COMPLETED|Treatment||124
10640386|NCT02096705|11799334|FG001|COMPLETED|Treatment||134
10640387|NCT02096705|11799333|FG000|NOT COMPLETED|Treatment||9
10640388|NCT02096705|11799334|FG001|NOT COMPLETED|Treatment||5
10640389|NCT02096705|11799333|FG000|STARTED|Follow-up|5 participants in this arm did not complete the treatment period and rejoined for follow-up|129
10640390|NCT02096705|11799334|FG001|STARTED|Follow-up|5 participants in this arm did not complete the treatment period and rejoined for follow-up|139
10640391|NCT02096705|11799333|FG000|COMPLETED|Follow-up||125
10640392|NCT02096705|11799334|FG001|COMPLETED|Follow-up||135
10640393|NCT02096705|11799333|FG000|NOT COMPLETED|Follow-up||4
10640394|NCT02096705|11799334|FG001|NOT COMPLETED|Follow-up||4
10640395|NCT02096718|11799343|FG000|STARTED|Overall Study||8
10640396|NCT02096718|11799344|FG001|STARTED|Overall Study||8
10640397|NCT02096718|11799345|FG002|STARTED|Overall Study||14
10640398|NCT02096718|11799343|FG000|COMPLETED|Overall Study||8
10640399|NCT02096718|11799344|FG001|COMPLETED|Overall Study||8
10640400|NCT02096718|11799345|FG002|COMPLETED|Overall Study||14
10640401|NCT02096718|11799343|FG000|NOT COMPLETED|Overall Study||0
10640402|NCT02096718|11799344|FG001|NOT COMPLETED|Overall Study||0
10640403|NCT02096718|11799345|FG002|NOT COMPLETED|Overall Study||0
10640404|NCT02096731|11799356|FG000|STARTED|Overall Study||26442
10640405|NCT02096731|11799357|FG001|STARTED|Overall Study||88955
10640406|NCT02096731|11799356|FG000|COMPLETED|Overall Study||26442
10640407|NCT02096731|11799357|FG001|COMPLETED|Overall Study||88955
10640409|NCT02096731|11799357|FG001|NOT COMPLETED|Overall Study||0
10640410|NCT02096744|11799366|FG000|STARTED|Treatment Period 1(7 Days)||29
10640411|NCT02096744|11799367|FG001|STARTED|Treatment Period 1(7 Days)||29
10640412|NCT02096744|11799366|FG000|COMPLETED|Treatment Period 1(7 Days)||28
10640413|NCT02096744|11799367|FG001|COMPLETED|Treatment Period 1(7 Days)||28
10640414|NCT02096744|11799366|FG000|NOT COMPLETED|Treatment Period 1(7 Days)||1
10640415|NCT02096744|11799367|FG001|NOT COMPLETED|Treatment Period 1(7 Days)||1
10640416|NCT02096744|11799366|FG000|STARTED|Washout Period 1(7 Days)||28
10640417|NCT02096744|11799367|FG001|STARTED|Washout Period 1(7 Days)||28
10640418|NCT02096744|11799366|FG000|COMPLETED|Washout Period 1(7 Days)||28
10640419|NCT02096744|11799367|FG001|COMPLETED|Washout Period 1(7 Days)||28
10640420|NCT02096744|11799366|FG000|NOT COMPLETED|Washout Period 1(7 Days)||0
10640421|NCT02096744|11799367|FG001|NOT COMPLETED|Washout Period 1(7 Days)||0
10640422|NCT02096744|11799366|FG000|STARTED|Treatment Period 2 (7 Days)||28
10640423|NCT02096744|11799367|FG001|STARTED|Treatment Period 2 (7 Days)||28
10640424|NCT02096744|11799366|FG000|COMPLETED|Treatment Period 2 (7 Days)||28
10640425|NCT02096744|11799367|FG001|COMPLETED|Treatment Period 2 (7 Days)||28
10640426|NCT02096744|11799366|FG000|NOT COMPLETED|Treatment Period 2 (7 Days)||0
10640427|NCT02096744|11799367|FG001|NOT COMPLETED|Treatment Period 2 (7 Days)||0
10640428|NCT02096744|11799366|FG000|STARTED|Washout Period 2 (3 Days)||28
10640429|NCT02096744|11799367|FG001|STARTED|Washout Period 2 (3 Days)||28
10640430|NCT02096744|11799366|FG000|COMPLETED|Washout Period 2 (3 Days)||28
10640431|NCT02096744|11799367|FG001|COMPLETED|Washout Period 2 (3 Days)||28
10640432|NCT02096744|11799366|FG000|NOT COMPLETED|Washout Period 2 (3 Days)||0
10640433|NCT02096744|11799367|FG001|NOT COMPLETED|Washout Period 2 (3 Days)||0
10640434|NCT02096744|11799366|FG000|STARTED|Treatment Period 3 (7 Days)||28
10640435|NCT02096744|11799367|FG001|STARTED|Treatment Period 3 (7 Days)||28
10640436|NCT02096744|11799366|FG000|COMPLETED|Treatment Period 3 (7 Days)||28
10640437|NCT02096744|11799367|FG001|COMPLETED|Treatment Period 3 (7 Days)||27
10640438|NCT02096744|11799366|FG000|NOT COMPLETED|Treatment Period 3 (7 Days)||0
10640439|NCT02096744|11799367|FG001|NOT COMPLETED|Treatment Period 3 (7 Days)||1
10640440|NCT02096835|11799378|FG000|STARTED|Overall Study||53
10640441|NCT02096835|11799379|FG001|STARTED|Overall Study||53
10640442|NCT02096835|11799380|FG002|STARTED|Overall Study||51
10640443|NCT02096835|11799378|FG000|COMPLETED|Overall Study||50
10640444|NCT02096835|11799379|FG001|COMPLETED|Overall Study||53
10640445|NCT02096835|11799380|FG002|COMPLETED|Overall Study||50
10640446|NCT02096835|11799378|FG000|NOT COMPLETED|Overall Study||3
10640447|NCT02096835|11799379|FG001|NOT COMPLETED|Overall Study||0
10640448|NCT02096835|11799380|FG002|NOT COMPLETED|Overall Study||1
10640449|NCT02096861|11799392|FG000|STARTED|Overall Study|CT-P13 followed by CT-P13 from Week 30|56
10640450|NCT02096861|11799393|FG001|STARTED|Overall Study|CT-P13 followed by Remicade from Week 30|55
10640451|NCT02096861|11799394|FG002|STARTED|Overall Study|Remicade followed by Remicade from Week 30|54
10640452|NCT02096861|11799395|FG003|STARTED|Overall Study|Remicade followed by CT-P13 from Week 30|55
10640453|NCT02096861|11799392|FG000|Drug Switching at Week 30|Overall Study||48
10640454|NCT02096861|11799393|FG001|Drug Switching at Week 30|Overall Study||44
10640455|NCT02096861|11799394|FG002|Drug Switching at Week 30|Overall Study||41
10640456|NCT02096861|11799395|FG003|Drug Switching at Week 30|Overall Study||47
10640457|NCT02096861|11799392|FG000|COMPLETED|Overall Study||44
10640458|NCT02096861|11799393|FG001|COMPLETED|Overall Study||40
10640459|NCT02096861|11799394|FG002|COMPLETED|Overall Study||37
10640460|NCT02096861|11799395|FG003|COMPLETED|Overall Study||45
10640461|NCT02096861|11799392|FG000|NOT COMPLETED|Overall Study||12
10640462|NCT02096861|11799393|FG001|NOT COMPLETED|Overall Study||15
10640463|NCT02096861|11799394|FG002|NOT COMPLETED|Overall Study||17
10640464|NCT02096861|11799395|FG003|NOT COMPLETED|Overall Study||10
10640465|NCT02096900|11799409|FG000|STARTED|Overall Study|Allocated to Midazolam|42
10640466|NCT02096900|11799410|FG001|STARTED|Overall Study|Allocated to Zolpidem|44
10640467|NCT02096900|11799409|FG000|COMPLETED|Overall Study||38
10640468|NCT02096900|11799410|FG001|COMPLETED|Overall Study||42
10640469|NCT02096900|11799409|FG000|NOT COMPLETED|Overall Study||4
10640470|NCT02096900|11799410|FG001|NOT COMPLETED|Overall Study||2
10640471|NCT02096952|11799416|FG000|STARTED|Overall Study||15
10640472|NCT02096952|11799416|FG000|COMPLETED|Overall Study||14
10640473|NCT02096952|11799416|FG000|NOT COMPLETED|Overall Study||1
10640474|NCT02097030|11799422|FG000|STARTED|First Intervention (3 Days)||15
10640475|NCT02097030|11799423|FG001|STARTED|First Intervention (3 Days)||17
10640476|NCT02097030|11799422|FG000|COMPLETED|First Intervention (3 Days)||14
10640477|NCT02097030|11799423|FG001|COMPLETED|First Intervention (3 Days)||16
10640478|NCT02097030|11799422|FG000|NOT COMPLETED|First Intervention (3 Days)||1
10640479|NCT02097030|11799423|FG001|NOT COMPLETED|First Intervention (3 Days)||1
10640480|NCT02097030|11799422|FG000|STARTED|Second Intervention (3 Days)||14
10640481|NCT02097030|11799423|FG001|STARTED|Second Intervention (3 Days)||16
10640482|NCT02097030|11799422|FG000|COMPLETED|Second Intervention (3 Days)||14
10640483|NCT02097030|11799423|FG001|COMPLETED|Second Intervention (3 Days)||16
10640484|NCT02097030|11799422|FG000|NOT COMPLETED|Second Intervention (3 Days)||0
10640485|NCT02097030|11799423|FG001|NOT COMPLETED|Second Intervention (3 Days)||0
10640486|NCT02097056|11799433|FG000|STARTED|Overall Study||171
10640487|NCT02097056|11799433|FG000|ParticipantsTreated|Overall Study||170
10640488|NCT02097056|11799433|FG000|COMPLETED|Overall Study||113
10640489|NCT02097056|11799433|FG000|NOT COMPLETED|Overall Study||58
10640490|NCT02097108|11799437|FG000|STARTED|Overall Study||11
10640491|NCT02097108|11799437|FG000|COMPLETED|Overall Study||9
10640492|NCT02097108|11799437|FG000|NOT COMPLETED|Overall Study||2
10640493|NCT02097238|11799441|FG000|STARTED|Overall Study||19
10640494|NCT02097238|11799441|FG000|COMPLETED|Overall Study||0
10640495|NCT02097238|11799441|FG000|NOT COMPLETED|Overall Study||19
10640496|NCT02097277|11799451|FG000|STARTED|Overall Study||24
10640497|NCT02097277|11799452|FG001|STARTED|Overall Study||24
10640498|NCT02097277|11799453|FG002|STARTED|Overall Study||24
10640499|NCT02097277|11799454|FG003|STARTED|Overall Study||24
10640500|NCT02097277|11799455|FG004|STARTED|Overall Study||24
10640501|NCT02097277|11799451|FG000|COMPLETED|Overall Study||22
10640502|NCT02097277|11799452|FG001|COMPLETED|Overall Study||21
10640503|NCT02097277|11799453|FG002|COMPLETED|Overall Study||22
10640504|NCT02097277|11799454|FG003|COMPLETED|Overall Study||20
10640505|NCT02097277|11799455|FG004|COMPLETED|Overall Study||23
10640506|NCT02097277|11799451|FG000|NOT COMPLETED|Overall Study||2
10640507|NCT02097277|11799452|FG001|NOT COMPLETED|Overall Study||3
10640508|NCT02097277|11799453|FG002|NOT COMPLETED|Overall Study||2
10640509|NCT02097277|11799454|FG003|NOT COMPLETED|Overall Study||4
10640510|NCT02097277|11799455|FG004|NOT COMPLETED|Overall Study||1
10640511|NCT02097290|11799471|FG000|STARTED|Overall Study||210
10640512|NCT02097290|11799471|FG000|COMPLETED|Overall Study|Active subjects at the end of 3 month follow up visit for primary end point data collection|193
10640513|NCT02097290|11799471|FG000|NOT COMPLETED|Overall Study||17
10640514|NCT02097303|11799475|FG000|STARTED|Overall Study||36
10640515|NCT02097303|11799475|FG000|COMPLETED|Overall Study||31
10640516|NCT02097303|11799475|FG000|NOT COMPLETED|Overall Study||5
10640517|NCT02097472|11799487|FG000|STARTED|Received Vaccination 1||18
10640518|NCT02097472|11799488|FG001|STARTED|Received Vaccination 1||18
10640519|NCT02097472|11799489|FG002|STARTED|Received Vaccination 1||18
10640520|NCT02097472|11799490|FG003|STARTED|Received Vaccination 1||50
10640521|NCT02097472|11799491|FG004|STARTED|Received Vaccination 1||50
10640522|NCT02097472|11799492|FG005|STARTED|Received Vaccination 1||50
10640523|NCT02097472|11799493|FG006|STARTED|Received Vaccination 1||50
10640524|NCT02097472|11799494|FG007|STARTED|Received Vaccination 1||50
10640525|NCT02097472|11799487|FG000|COMPLETED|Received Vaccination 1||18
10640526|NCT02097472|11799488|FG001|COMPLETED|Received Vaccination 1||18
10640527|NCT02097472|11799489|FG002|COMPLETED|Received Vaccination 1||18
10640528|NCT02097472|11799490|FG003|COMPLETED|Received Vaccination 1||50
10640529|NCT02097472|11799491|FG004|COMPLETED|Received Vaccination 1||50
10640530|NCT02097472|11799492|FG005|COMPLETED|Received Vaccination 1||50
10640531|NCT02097472|11799493|FG006|COMPLETED|Received Vaccination 1||50
10640532|NCT02097472|11799494|FG007|COMPLETED|Received Vaccination 1||50
10640533|NCT02097472|11799487|FG000|NOT COMPLETED|Received Vaccination 1||0
10640534|NCT02097472|11799488|FG001|NOT COMPLETED|Received Vaccination 1||0
10640535|NCT02097472|11799489|FG002|NOT COMPLETED|Received Vaccination 1||0
10640536|NCT02097472|11799490|FG003|NOT COMPLETED|Received Vaccination 1||0
10640537|NCT02097472|11799491|FG004|NOT COMPLETED|Received Vaccination 1||0
10640538|NCT02097472|11799492|FG005|NOT COMPLETED|Received Vaccination 1||0
10640539|NCT02097472|11799493|FG006|NOT COMPLETED|Received Vaccination 1||0
10640540|NCT02097472|11799494|FG007|NOT COMPLETED|Received Vaccination 1||0
10640541|NCT02097472|11799487|FG000|STARTED|Received Vaccination 2||18
10640542|NCT02097472|11799488|FG001|STARTED|Received Vaccination 2||18
10640543|NCT02097472|11799489|FG002|STARTED|Received Vaccination 2||18
10640544|NCT02097472|11799490|FG003|STARTED|Received Vaccination 2||50
10640545|NCT02097472|11799491|FG004|STARTED|Received Vaccination 2||50
10640546|NCT02097472|11799492|FG005|STARTED|Received Vaccination 2||50
10640547|NCT02097472|11799493|FG006|STARTED|Received Vaccination 2||50
10640548|NCT02097472|11799494|FG007|STARTED|Received Vaccination 2||50
10640549|NCT02097472|11799487|FG000|COMPLETED|Received Vaccination 2||18
10640550|NCT02097472|11799488|FG001|COMPLETED|Received Vaccination 2||18
10640551|NCT02097472|11799489|FG002|COMPLETED|Received Vaccination 2||18
10640552|NCT02097472|11799490|FG003|COMPLETED|Received Vaccination 2||50
10640553|NCT02097472|11799491|FG004|COMPLETED|Received Vaccination 2||50
10640554|NCT02097472|11799492|FG005|COMPLETED|Received Vaccination 2||50
10640555|NCT02097472|11799493|FG006|COMPLETED|Received Vaccination 2||49
10640556|NCT02097472|11799494|FG007|COMPLETED|Received Vaccination 2||50
10640557|NCT02097472|11799487|FG000|NOT COMPLETED|Received Vaccination 2||0
10640558|NCT02097472|11799488|FG001|NOT COMPLETED|Received Vaccination 2||0
10640559|NCT02097472|11799489|FG002|NOT COMPLETED|Received Vaccination 2||0
10640560|NCT02097472|11799490|FG003|NOT COMPLETED|Received Vaccination 2||0
10640561|NCT02097472|11799491|FG004|NOT COMPLETED|Received Vaccination 2||0
10640562|NCT02097472|11799492|FG005|NOT COMPLETED|Received Vaccination 2||0
10640563|NCT02097472|11799493|FG006|NOT COMPLETED|Received Vaccination 2||1
10640564|NCT02097472|11799494|FG007|NOT COMPLETED|Received Vaccination 2||0
10640565|NCT02097472|11799487|FG000|STARTED|Assessed for Immunogenicity||18
10640566|NCT02097472|11799488|FG001|STARTED|Assessed for Immunogenicity||18
10640567|NCT02097472|11799489|FG002|STARTED|Assessed for Immunogenicity||18
10640568|NCT02097472|11799490|FG003|STARTED|Assessed for Immunogenicity||50
10640569|NCT02097472|11799491|FG004|STARTED|Assessed for Immunogenicity||50
10640570|NCT02097472|11799492|FG005|STARTED|Assessed for Immunogenicity||50
10640571|NCT02097472|11799493|FG006|STARTED|Assessed for Immunogenicity||49
10640572|NCT02097472|11799494|FG007|STARTED|Assessed for Immunogenicity||50
10640573|NCT02097472|11799487|FG000|COMPLETED|Assessed for Immunogenicity||18
10640574|NCT02097472|11799488|FG001|COMPLETED|Assessed for Immunogenicity||18
10640575|NCT02097472|11799489|FG002|COMPLETED|Assessed for Immunogenicity||17
10640576|NCT02097472|11799490|FG003|COMPLETED|Assessed for Immunogenicity||48
10640577|NCT02097472|11799491|FG004|COMPLETED|Assessed for Immunogenicity||50
10640578|NCT02097472|11799492|FG005|COMPLETED|Assessed for Immunogenicity||48
10640579|NCT02097472|11799493|FG006|COMPLETED|Assessed for Immunogenicity||47
10640580|NCT02097472|11799494|FG007|COMPLETED|Assessed for Immunogenicity||49
10640581|NCT02097472|11799487|FG000|NOT COMPLETED|Assessed for Immunogenicity||0
10640582|NCT02097472|11799488|FG001|NOT COMPLETED|Assessed for Immunogenicity||0
10640583|NCT02097472|11799489|FG002|NOT COMPLETED|Assessed for Immunogenicity||1
10640584|NCT02097472|11799490|FG003|NOT COMPLETED|Assessed for Immunogenicity||2
10640585|NCT02097472|11799491|FG004|NOT COMPLETED|Assessed for Immunogenicity||0
10640586|NCT02097472|11799492|FG005|NOT COMPLETED|Assessed for Immunogenicity||2
10640587|NCT02097472|11799493|FG006|NOT COMPLETED|Assessed for Immunogenicity||2
10640588|NCT02097472|11799494|FG007|NOT COMPLETED|Assessed for Immunogenicity||1
10640589|NCT02097485|11799580|FG000|STARTED|Overall Study||25
10640590|NCT02097485|11799581|FG001|STARTED|Overall Study||25
10640591|NCT02097485|11799580|FG000|COMPLETED|Overall Study||25
10640592|NCT02097485|11799581|FG001|COMPLETED|Overall Study||25
10640593|NCT02097485|11799580|FG000|NOT COMPLETED|Overall Study||0
10640594|NCT02097485|11799581|FG001|NOT COMPLETED|Overall Study||0
10640595|NCT02097537|11799587|FG000|STARTED|Overall Study||10
10640596|NCT02097537|11799587|FG000|Enrollment|Overall Study|Inhalation of Methacholine Chloride|10
10640597|NCT02097537|11799587|FG000|Follow-Up|Overall Study||10
10640598|NCT02097537|11799587|FG000|COMPLETED|Overall Study||10
10640599|NCT02097537|11799587|FG000|NOT COMPLETED|Overall Study||0
10640600|NCT02097641|11799593|FG000|STARTED|Overall Study||40
10640601|NCT02097641|11799594|FG001|STARTED|Overall Study||20
10640602|NCT02097641|11799593|FG000|COMPLETED|Overall Study||40
10640603|NCT02097641|11799594|FG001|COMPLETED|Overall Study||20
10640604|NCT02097641|11799593|FG000|NOT COMPLETED|Overall Study||0
10640605|NCT02097641|11799594|FG001|NOT COMPLETED|Overall Study||0
10640606|NCT02097719|11799604|FG000|STARTED|Overall Study||49
10640607|NCT02097719|11799605|FG001|STARTED|Overall Study||51
10640608|NCT02097719|11799604|FG000|COMPLETED|Overall Study||46
10640609|NCT02097719|11799605|FG001|COMPLETED|Overall Study||50
10640610|NCT02097719|11799604|FG000|NOT COMPLETED|Overall Study||3
10640611|NCT02097719|11799605|FG001|NOT COMPLETED|Overall Study||1
10640612|NCT02097732|11799613|FG000|STARTED|Overall Study||1
10640613|NCT02097732|11799614|FG001|STARTED|Overall Study||3
10640614|NCT02097732|11799613|FG000|COMPLETED|Overall Study||1
10640615|NCT02097732|11799614|FG001|COMPLETED|Overall Study||3
10640616|NCT02097732|11799613|FG000|NOT COMPLETED|Overall Study||0
10640617|NCT02097732|11799614|FG001|NOT COMPLETED|Overall Study||0
10640618|NCT02097745|11799621|FG000|STARTED|Overall Study|Six participants did not receive any treatment and were not included in any analyses.|335
10640619|NCT02097745|11799621|FG000|COMPLETED|Overall Study||157
10640620|NCT02097745|11799621|FG000|NOT COMPLETED|Overall Study||178
10640621|NCT02097823|11799630|FG000|STARTED|Overall Study||11
10640622|NCT02097823|11799631|FG001|STARTED|Overall Study||4
10640623|NCT02097823|11799630|FG000|COMPLETED|Overall Study||10
10640624|NCT02097823|11799631|FG001|COMPLETED|Overall Study||3
10640625|NCT02097823|11799630|FG000|NOT COMPLETED|Overall Study||1
10640626|NCT02097823|11799631|FG001|NOT COMPLETED|Overall Study||1
10640627|NCT02097849|11799640|FG000|STARTED|Overall Study||33
10640628|NCT02097849|11799641|FG001|STARTED|Overall Study||38
10640629|NCT02097849|11799640|FG000|COMPLETED|Overall Study||33
10640630|NCT02097849|11799641|FG001|COMPLETED|Overall Study||38
10640631|NCT02097849|11799640|FG000|NOT COMPLETED|Overall Study||0
10640632|NCT02097849|11799641|FG001|NOT COMPLETED|Overall Study||0
10640633|NCT02097992|11799651|FG000|STARTED|Treatment 1 (1 Day)||2
10640634|NCT02097992|11799652|FG001|STARTED|Treatment 1 (1 Day)||3
10640635|NCT02097992|11799653|FG002|STARTED|Treatment 1 (1 Day)||4
10640636|NCT02097992|11799654|FG003|STARTED|Treatment 1 (1 Day)||2
10640637|NCT02097992|11799651|FG000|COMPLETED|Treatment 1 (1 Day)||2
10640638|NCT02097992|11799652|FG001|COMPLETED|Treatment 1 (1 Day)||3
10640639|NCT02097992|11799653|FG002|COMPLETED|Treatment 1 (1 Day)||4
10640640|NCT02097992|11799654|FG003|COMPLETED|Treatment 1 (1 Day)||2
10640641|NCT02097992|11799651|FG000|NOT COMPLETED|Treatment 1 (1 Day)||0
10640642|NCT02097992|11799652|FG001|NOT COMPLETED|Treatment 1 (1 Day)||0
10640643|NCT02097992|11799653|FG002|NOT COMPLETED|Treatment 1 (1 Day)||0
10640644|NCT02097992|11799654|FG003|NOT COMPLETED|Treatment 1 (1 Day)||0
10640645|NCT02097992|11799651|FG000|STARTED|Treatment 2 (4 Weeks)||2
10640646|NCT02097992|11799652|FG001|STARTED|Treatment 2 (4 Weeks)||3
10640647|NCT02097992|11799653|FG002|STARTED|Treatment 2 (4 Weeks)||4
10640648|NCT02097992|11799654|FG003|STARTED|Treatment 2 (4 Weeks)||2
10640649|NCT02097992|11799651|FG000|COMPLETED|Treatment 2 (4 Weeks)||2
10640650|NCT02097992|11799652|FG001|COMPLETED|Treatment 2 (4 Weeks)||3
10640651|NCT02097992|11799653|FG002|COMPLETED|Treatment 2 (4 Weeks)||4
10640652|NCT02097992|11799654|FG003|COMPLETED|Treatment 2 (4 Weeks)||2
10640653|NCT02097992|11799651|FG000|NOT COMPLETED|Treatment 2 (4 Weeks)||0
10640654|NCT02097992|11799652|FG001|NOT COMPLETED|Treatment 2 (4 Weeks)||0
10640655|NCT02097992|11799653|FG002|NOT COMPLETED|Treatment 2 (4 Weeks)||0
10640656|NCT02097992|11799654|FG003|NOT COMPLETED|Treatment 2 (4 Weeks)||0
10640657|NCT02097992|11799651|FG000|STARTED|Washout (4 Weeks)||2
10640658|NCT02097992|11799652|FG001|STARTED|Washout (4 Weeks)||3
10640659|NCT02097992|11799653|FG002|STARTED|Washout (4 Weeks)||4
10640660|NCT02097992|11799654|FG003|STARTED|Washout (4 Weeks)||2
10640661|NCT02097992|11799651|FG000|COMPLETED|Washout (4 Weeks)||2
10640662|NCT02097992|11799652|FG001|COMPLETED|Washout (4 Weeks)||3
10640663|NCT02097992|11799653|FG002|COMPLETED|Washout (4 Weeks)||4
10640664|NCT02097992|11799654|FG003|COMPLETED|Washout (4 Weeks)||2
10640665|NCT02097992|11799651|FG000|NOT COMPLETED|Washout (4 Weeks)||0
10640666|NCT02097992|11799652|FG001|NOT COMPLETED|Washout (4 Weeks)||0
10640667|NCT02097992|11799653|FG002|NOT COMPLETED|Washout (4 Weeks)||0
10640668|NCT02097992|11799654|FG003|NOT COMPLETED|Washout (4 Weeks)||0
10640669|NCT02097992|11799651|FG000|STARTED|Treatment 3 (4 Weeks)||2
10640670|NCT02097992|11799652|FG001|STARTED|Treatment 3 (4 Weeks)||3
10640671|NCT02097992|11799653|FG002|STARTED|Treatment 3 (4 Weeks)||4
10640672|NCT02097992|11799654|FG003|STARTED|Treatment 3 (4 Weeks)||2
10640673|NCT02097992|11799651|FG000|COMPLETED|Treatment 3 (4 Weeks)||2
10640674|NCT02097992|11799652|FG001|COMPLETED|Treatment 3 (4 Weeks)||3
10640675|NCT02097992|11799653|FG002|COMPLETED|Treatment 3 (4 Weeks)||4
10640676|NCT02097992|11799654|FG003|COMPLETED|Treatment 3 (4 Weeks)||2
10640677|NCT02097992|11799651|FG000|NOT COMPLETED|Treatment 3 (4 Weeks)||0
10640678|NCT02097992|11799652|FG001|NOT COMPLETED|Treatment 3 (4 Weeks)||0
10640679|NCT02097992|11799653|FG002|NOT COMPLETED|Treatment 3 (4 Weeks)||0
10640680|NCT02097992|11799654|FG003|NOT COMPLETED|Treatment 3 (4 Weeks)||0
10640681|NCT02098109|11799664|FG000|STARTED|Overall Study||49
10640682|NCT02098109|11799665|FG001|STARTED|Overall Study||51
10640683|NCT02098109|11799664|FG000|COMPLETED|Overall Study||46
10640684|NCT02098109|11799665|FG001|COMPLETED|Overall Study||51
10640685|NCT02098109|11799664|FG000|NOT COMPLETED|Overall Study||3
10640686|NCT02098109|11799665|FG001|NOT COMPLETED|Overall Study||0
10640687|NCT02098304|11799671|FG000|STARTED|Overall Study||42
10640688|NCT02098304|11799671|FG000|COMPLETED|Overall Study||42
10640689|NCT02098304|11799671|FG000|NOT COMPLETED|Overall Study||0
10640690|NCT02098369|11799680|FG000|STARTED|Overall Study||142
10640691|NCT02098369|11799681|FG001|STARTED|Overall Study||154
10640692|NCT02098369|11799682|FG002|STARTED|Overall Study||148
10640693|NCT02098369|11799680|FG000|COMPLETED|Overall Study||135
10640694|NCT02098369|11799681|FG001|COMPLETED|Overall Study||145
10640695|NCT02098369|11799682|FG002|COMPLETED|Overall Study||143
10640696|NCT02098369|11799680|FG000|NOT COMPLETED|Overall Study||7
10640697|NCT02098369|11799681|FG001|NOT COMPLETED|Overall Study||9
10640698|NCT02098369|11799682|FG002|NOT COMPLETED|Overall Study||5
10640699|NCT02098395|11799694|FG000|STARTED|Overall Study||212
10640700|NCT02098395|11799695|FG001|STARTED|Overall Study||209
10640701|NCT02098395|11799696|FG002|STARTED|Overall Study||207
10640702|NCT02098395|11799697|FG003|STARTED|Overall Study||207
10640703|NCT02098395|11799694|FG000|Exposed|Overall Study||211
10640704|NCT02098395|11799695|FG001|Exposed|Overall Study||209
10640705|NCT02098395|11799696|FG002|Exposed|Overall Study||206
10640706|NCT02098395|11799697|FG003|Exposed|Overall Study||206
10640707|NCT02098395|11799694|FG000|COMPLETED|Overall Study||186
10640708|NCT02098395|11799695|FG001|COMPLETED|Overall Study||177
10640709|NCT02098395|11799696|FG002|COMPLETED|Overall Study||165
10640710|NCT02098395|11799697|FG003|COMPLETED|Overall Study||180
10640711|NCT02098395|11799694|FG000|NOT COMPLETED|Overall Study||26
10640712|NCT02098395|11799695|FG001|NOT COMPLETED|Overall Study||32
10640713|NCT02098395|11799696|FG002|NOT COMPLETED|Overall Study||42
10640714|NCT02098395|11799697|FG003|NOT COMPLETED|Overall Study||27
10640715|NCT02098733|11799707|FG000|STARTED|Overall Study||1168
10640716|NCT02098733|11799707|FG000|COMPLETED|Overall Study||1158
10640717|NCT02098733|11799707|FG000|NOT COMPLETED|Overall Study||10
10640718|NCT02098746|11799711|FG000|STARTED|Overall Study||294
10640719|NCT02098746|11799711|FG000|COMPLETED|Overall Study||289
10640720|NCT02098746|11799711|FG000|NOT COMPLETED|Overall Study||5
10640721|NCT02098993|11799717|FG000|STARTED|Overall Study||4
10640722|NCT02098993|11799718|FG001|STARTED|Overall Study||3
10640723|NCT02098993|11799717|FG000|COMPLETED|Overall Study||4
10640724|NCT02098993|11799718|FG001|COMPLETED|Overall Study||3
10640725|NCT02098993|11799717|FG000|NOT COMPLETED|Overall Study||0
10640726|NCT02098993|11799718|FG001|NOT COMPLETED|Overall Study||0
10654138|NCT02199743|11814788|FG000|STARTED|Overall Study||14
10654139|NCT02199743|11814789|FG001|STARTED|Overall Study||10
10654140|NCT02199743|11814788|FG000|COMPLETED|Overall Study||14
10654141|NCT02199743|11814789|FG001|COMPLETED|Overall Study||8
10654142|NCT02199743|11814788|FG000|NOT COMPLETED|Overall Study||0
10654143|NCT02199743|11814789|FG001|NOT COMPLETED|Overall Study||2
10654144|NCT02199795|11814799|FG000|STARTED|Overall Study||4
10654145|NCT02199795|11814800|FG001|STARTED|Overall Study||3
10654146|NCT02199795|11814799|FG000|COMPLETED|Overall Study||2
10654147|NCT02199795|11814800|FG001|COMPLETED|Overall Study||3
10654148|NCT02199795|11814799|FG000|NOT COMPLETED|Overall Study||2
10654149|NCT02199795|11814800|FG001|NOT COMPLETED|Overall Study||0
10654150|NCT02199964|11814808|FG000|STARTED|Overall Study||2
10654151|NCT02199964|11814809|FG001|STARTED|Overall Study||2
10654152|NCT02199964|11814808|FG000|COMPLETED|Overall Study||2
10654153|NCT02199964|11814809|FG001|COMPLETED|Overall Study||2
10654154|NCT02199964|11814808|FG000|NOT COMPLETED|Overall Study||0
10654155|NCT02199964|11814809|FG001|NOT COMPLETED|Overall Study||0
10654156|NCT02200055|11814815|FG000|STARTED|Overall Study||86
10640727|NCT02099006|11799724|FG000|STARTED|Overall Study||9
10640728|NCT02099006|11799724|FG000|Received Placebo|Overall Study||9
10640729|NCT02099006|11799724|FG000|Received Amitriptyline/ Baclofen|Overall Study||7
10640730|NCT02099006|11799724|FG000|Received Ketoprofen|Overall Study||3
10640731|NCT02099006|11799724|FG000|Received Loperamide|Overall Study||7
10640732|NCT02099006|11799724|FG000|Received Ketamine|Overall Study||6
10640733|NCT02099006|11799724|FG000|Received Gabapentin|Overall Study||8
10640734|NCT02099006|11799724|FG000|COMPLETED|Overall Study||8
10640735|NCT02099006|11799724|FG000|NOT COMPLETED|Overall Study||1
10640736|NCT02099084|11799730|FG000|STARTED|First Intervention||4
10640737|NCT02099084|11799731|FG001|STARTED|First Intervention||4
10640738|NCT02099084|11799730|FG000|COMPLETED|First Intervention||4
10640739|NCT02099084|11799731|FG001|COMPLETED|First Intervention||4
10705949|NCT02603952|11870401|FG002|COMPLETED|Overall Study||31
10705950|NCT02603952|11870402|FG003|COMPLETED|Overall Study||31
10705951|NCT02603952|11870399|FG000|NOT COMPLETED|Overall Study||1
10640740|NCT02099084|11799730|FG000|NOT COMPLETED|First Intervention||0
10640741|NCT02099084|11799731|FG001|NOT COMPLETED|First Intervention||0
10640742|NCT02099084|11799730|FG000|STARTED|Washout Period of 14 Days||4
10640743|NCT02099084|11799731|FG001|STARTED|Washout Period of 14 Days||4
10640744|NCT02099084|11799730|FG000|COMPLETED|Washout Period of 14 Days||4
10640745|NCT02099084|11799731|FG001|COMPLETED|Washout Period of 14 Days||4
10640746|NCT02099084|11799730|FG000|NOT COMPLETED|Washout Period of 14 Days||0
10640747|NCT02099084|11799731|FG001|NOT COMPLETED|Washout Period of 14 Days||0
10640748|NCT02099084|11799730|FG000|STARTED|Second Intervention||4
10640749|NCT02099084|11799731|FG001|STARTED|Second Intervention||4
10640750|NCT02099084|11799730|FG000|COMPLETED|Second Intervention||4
10640751|NCT02099084|11799731|FG001|COMPLETED|Second Intervention||4
10640752|NCT02099084|11799730|FG000|NOT COMPLETED|Second Intervention||0
10640753|NCT02099084|11799731|FG001|NOT COMPLETED|Second Intervention||0
10640754|NCT02099110|11799742|FG000|STARTED|Overall Study||250
10640755|NCT02099110|11799743|FG001|STARTED|Overall Study||248
10640756|NCT02099110|11799744|FG002|STARTED|Overall Study||247
10640757|NCT02099110|11799745|FG003|STARTED|Overall Study||243
10640758|NCT02099110|11799746|FG004|STARTED|Overall Study||245
10640759|NCT02099110|11799742|FG000|Treated|Overall Study||250
10640760|NCT02099110|11799743|FG001|Treated|Overall Study||248
10640761|NCT02099110|11799744|FG002|Treated|Overall Study||247
10640762|NCT02099110|11799745|FG003|Treated|Overall Study||243
10640763|NCT02099110|11799746|FG004|Treated|Overall Study||244
10640764|NCT02099110|11799742|FG000|COMPLETED|Overall Study||226
10640765|NCT02099110|11799743|FG001|COMPLETED|Overall Study||217
10640766|NCT02099110|11799744|FG002|COMPLETED|Overall Study||219
10640767|NCT02099110|11799745|FG003|COMPLETED|Overall Study||221
10640768|NCT02099110|11799746|FG004|COMPLETED|Overall Study||218
10640769|NCT02099110|11799742|FG000|NOT COMPLETED|Overall Study||24
10640770|NCT02099110|11799743|FG001|NOT COMPLETED|Overall Study||31
10640771|NCT02099110|11799744|FG002|NOT COMPLETED|Overall Study||28
10640772|NCT02099110|11799745|FG003|NOT COMPLETED|Overall Study||22
10640773|NCT02099110|11799746|FG004|NOT COMPLETED|Overall Study||27
10640774|NCT02099266|11799758|FG000|STARTED|Overall Study||15
10640775|NCT02099266|11799758|FG000|COMPLETED|Overall Study||15
10640776|NCT02099266|11799758|FG000|NOT COMPLETED|Overall Study||0
10640777|NCT02099461|11799768|FG000|STARTED|Overall Study||27
10640778|NCT02099461|11799769|FG001|STARTED|Overall Study||27
10640779|NCT02099461|11799770|FG002|STARTED|Overall Study||28
10640780|NCT02099461|11799768|FG000|COMPLETED|Overall Study||27
10640781|NCT02099461|11799769|FG001|COMPLETED|Overall Study||27
10640782|NCT02099461|11799770|FG002|COMPLETED|Overall Study||28
10640783|NCT02099461|11799768|FG000|NOT COMPLETED|Overall Study||0
10640784|NCT02099461|11799769|FG001|NOT COMPLETED|Overall Study||0
10640785|NCT02099461|11799770|FG002|NOT COMPLETED|Overall Study||0
10640786|NCT02099682|11799778|FG000|STARTED|Overall Study|Number of cases.|3366
10640787|NCT02099682|11799778|FG000|Safety Analysis Set (SAS)|Overall Study|All participants who took the study drug at least once.|3255
10640788|NCT02099682|11799778|FG000|COMPLETED|Overall Study||3255
10640789|NCT02099682|11799778|FG000|NOT COMPLETED|Overall Study||111
10640790|NCT02099708|11799782|FG000|STARTED|Overall Study|Number of cases.|3502
10705952|NCT02603952|11870400|FG001|NOT COMPLETED|Overall Study||0
10705953|NCT02603952|11870401|FG002|NOT COMPLETED|Overall Study||0
10705954|NCT02603952|11870402|FG003|NOT COMPLETED|Overall Study||1
10705955|NCT02604017|11870417|FG000|STARTED|Overall Study||352
10640791|NCT02099708|11799782|FG000|Safety Analysis Set (SAS)|Overall Study|All participants who took the study drug at least once.|3302
10640792|NCT02099708|11799782|FG000|COMPLETED|Overall Study||3302
10640793|NCT02099708|11799782|FG000|NOT COMPLETED|Overall Study||200
10640794|NCT02099721|11799792|FG000|STARTED|Overall Study||1066
10640795|NCT02099721|11799793|FG001|STARTED|Overall Study||127
10640796|NCT02099721|11799794|FG002|STARTED|Overall Study||1068
10640797|NCT02099721|11799795|FG003|STARTED|Overall Study||845
10640798|NCT02099721|11799796|FG004|STARTED|Overall Study||331
10640799|NCT02099721|11799797|FG005|STARTED|Overall Study||452
10640800|NCT02099721|11799792|FG000|COMPLETED|Overall Study||990
10640801|NCT02099721|11799793|FG001|COMPLETED|Overall Study|Not implanted secondary patients were automatically exited.|0
10640802|NCT02099721|11799794|FG002|COMPLETED|Overall Study||983
10640803|NCT02099721|11799795|FG003|COMPLETED|Overall Study||774
10705956|NCT02604017|11870418|FG001|STARTED|Overall Study||351
10640804|NCT02099721|11799796|FG004|COMPLETED|Overall Study||304
10640805|NCT02099721|11799797|FG005|COMPLETED|Overall Study||432
10640806|NCT02099721|11799792|FG000|NOT COMPLETED|Overall Study||76
10640807|NCT02099721|11799793|FG001|NOT COMPLETED|Overall Study||127
10640808|NCT02099721|11799794|FG002|NOT COMPLETED|Overall Study||85
10640809|NCT02099721|11799795|FG003|NOT COMPLETED|Overall Study||71
10640810|NCT02099721|11799796|FG004|NOT COMPLETED|Overall Study||27
10640811|NCT02099721|11799797|FG005|NOT COMPLETED|Overall Study||20
10640812|NCT02099786|11799811|FG000|STARTED|Overall Study||24
10640813|NCT02099786|11799812|FG001|STARTED|Overall Study||23
10640814|NCT02099786|11799811|FG000|Program Eval 1|Overall Study|Baseline (prior to randomization and first cisplatin dose)|24
10640815|NCT02099786|11799812|FG001|Program Eval 1|Overall Study|Baseline (prior to randomization and first cisplatin dose)|23
10640816|NCT02099786|11799811|FG000|Program Eval 2|Overall Study|One month post randomization|23
10640817|NCT02099786|11799812|FG001|Program Eval 2|Overall Study|One month post randomization|19
10640818|NCT02099786|11799811|FG000|Program Eval 3|Overall Study|One year post randomization|21
10640819|NCT02099786|11799812|FG001|Program Eval 3|Overall Study|One year post randomization|15
10640820|NCT02099786|11799811|FG000|COMPLETED|Overall Study||21
10640821|NCT02099786|11799812|FG001|COMPLETED|Overall Study||15
10640822|NCT02099786|11799811|FG000|NOT COMPLETED|Overall Study||3
10640823|NCT02099786|11799812|FG001|NOT COMPLETED|Overall Study||8
10640824|NCT02099799|11799821|FG000|STARTED|Overall Study||75
10640825|NCT02099799|11799822|FG001|STARTED|Overall Study||78
10640826|NCT02099799|11799821|FG000|COMPLETED|Overall Study||60
10640827|NCT02099799|11799822|FG001|COMPLETED|Overall Study||54
10640828|NCT02099799|11799821|FG000|NOT COMPLETED|Overall Study||15
10705957|NCT02604017|11870417|FG000|COMPLETED|Overall Study||346
10705958|NCT02604017|11870418|FG001|COMPLETED|Overall Study||343
10705959|NCT02604017|11870417|FG000|NOT COMPLETED|Overall Study||6
10705960|NCT02604017|11870418|FG001|NOT COMPLETED|Overall Study||8
10705961|NCT02604160|11870426|FG000|STARTED|Overall Study||2
10705962|NCT02604160|11870427|FG001|STARTED|Overall Study||5
10640829|NCT02099799|11799822|FG001|NOT COMPLETED|Overall Study||24
10640830|NCT02099838|11799832|FG000|STARTED|Overall Study||47
10640831|NCT02099838|11799833|FG001|STARTED|Overall Study||51
10640832|NCT02099838|11799832|FG000|COMPLETED|Overall Study||43
10640833|NCT02099838|11799833|FG001|COMPLETED|Overall Study||49
10640834|NCT02099838|11799832|FG000|NOT COMPLETED|Overall Study||4
10705963|NCT02604160|11870426|FG000|Received at Least One Dose of Study Drug|Overall Study||2
10705964|NCT02604160|11870427|FG001|Received at Least One Dose of Study Drug|Overall Study||5
10705965|NCT02604160|11870426|FG000|COMPLETED|Overall Study||2
10705966|NCT02604160|11870427|FG001|COMPLETED|Overall Study||3
10705967|NCT02604160|11870426|FG000|NOT COMPLETED|Overall Study||0
10705968|NCT02604160|11870427|FG001|NOT COMPLETED|Overall Study||2
10640835|NCT02099838|11799833|FG001|NOT COMPLETED|Overall Study||2
10809170|NCT03811951|11971036|FG001|STARTED|Second Intervention (1 Day)||2
10809171|NCT03811951|11971035|FG000|COMPLETED|Second Intervention (1 Day)||2
10640839|NCT02100007|11799847|FG000|STARTED|Overall Study||46
10640840|NCT02100007|11799847|FG000|COMPLETED|Overall Study||46
10640841|NCT02100007|11799847|FG000|NOT COMPLETED|Overall Study||0
10640842|NCT02100072|11799852|FG000|STARTED|Overall Study||5
10640843|NCT02100072|11799852|FG000|COMPLETED|Overall Study||5
10640844|NCT02100072|11799852|FG000|NOT COMPLETED|Overall Study||0
10640845|NCT02100124|11799859|FG000|STARTED|Overall Study||329
10640846|NCT02100124|11799860|FG001|STARTED|Overall Study||329
10640847|NCT02100124|11799861|FG002|STARTED|Overall Study||326
10640848|NCT02100124|11799859|FG000|COMPLETED|Overall Study||323
10640849|NCT02100124|11799860|FG001|COMPLETED|Overall Study||318
10640850|NCT02100124|11799861|FG002|COMPLETED|Overall Study||323
10640851|NCT02100124|11799859|FG000|NOT COMPLETED|Overall Study||6
10640852|NCT02100124|11799860|FG001|NOT COMPLETED|Overall Study||11
10640853|NCT02100124|11799861|FG002|NOT COMPLETED|Overall Study||3
10640854|NCT02100189|11799869|FG000|STARTED|Overall Study||50
10640855|NCT02100189|11799869|FG000|COMPLETED|Overall Study||50
10640856|NCT02100189|11799869|FG000|NOT COMPLETED|Overall Study||0
10640857|NCT02100228|11799875|FG000|STARTED|Overall Study|735 treated with Apixaban|753
10640858|NCT02100228|11799876|FG001|STARTED|Overall Study|721 treated with Usual Care|747
10640859|NCT02100228|11799875|FG000|COMPLETED|Overall Study||678
10640860|NCT02100228|11799876|FG001|COMPLETED|Overall Study||657
10640861|NCT02100228|11799875|FG000|NOT COMPLETED|Overall Study||75
10640862|NCT02100228|11799876|FG001|NOT COMPLETED|Overall Study||90
10640863|NCT02100280|11799884|FG000|STARTED|Overall Study||48
10640864|NCT02100280|11799885|FG001|STARTED|Overall Study||48
10640865|NCT02100280|11799884|FG000|COMPLETED|Overall Study||44
10640866|NCT02100280|11799885|FG001|COMPLETED|Overall Study||44
10640867|NCT02100280|11799884|FG000|NOT COMPLETED|Overall Study||4
10640868|NCT02100280|11799885|FG001|NOT COMPLETED|Overall Study||4
10640869|NCT02100319|11799893|FG000|STARTED|Overall Study||387
10640870|NCT02100319|11799893|FG000|COMPLETED|Overall Study||371
10705969|NCT02604173|11870438|FG000|STARTED|Overall Study||33
10705970|NCT02604173|11870439|FG001|STARTED|Overall Study||35
10705971|NCT02604173|11870440|FG002|STARTED|Overall Study||35
10705972|NCT02604173|11870438|FG000|COMPLETED|Overall Study||33
10640871|NCT02100319|11799893|FG000|NOT COMPLETED|Overall Study||16
10640872|NCT02100410|11799897|FG000|STARTED|Exposure Pair 1, 30 Minutes||8
10640873|NCT02100410|11799898|FG001|STARTED|Exposure Pair 1, 30 Minutes||8
10640874|NCT02100410|11799899|FG002|STARTED|Exposure Pair 1, 30 Minutes||8
10640875|NCT02100410|11799900|FG003|STARTED|Exposure Pair 1, 30 Minutes||8
10640876|NCT02100410|11799901|FG004|STARTED|Exposure Pair 1, 30 Minutes||8
10640877|NCT02100410|11799902|FG005|STARTED|Exposure Pair 1, 30 Minutes||9
10640878|NCT02100410|11799897|FG000|COMPLETED|Exposure Pair 1, 30 Minutes||8
10640879|NCT02100410|11799898|FG001|COMPLETED|Exposure Pair 1, 30 Minutes||8
10640880|NCT02100410|11799899|FG002|COMPLETED|Exposure Pair 1, 30 Minutes||8
10640881|NCT02100410|11799900|FG003|COMPLETED|Exposure Pair 1, 30 Minutes||8
10640882|NCT02100410|11799901|FG004|COMPLETED|Exposure Pair 1, 30 Minutes||8
10705973|NCT02604173|11870439|FG001|COMPLETED|Overall Study||35
10640883|NCT02100410|11799902|FG005|COMPLETED|Exposure Pair 1, 30 Minutes||9
10640884|NCT02100410|11799897|FG000|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
10640885|NCT02100410|11799898|FG001|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
10640886|NCT02100410|11799899|FG002|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
10640887|NCT02100410|11799900|FG003|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
10640888|NCT02100410|11799901|FG004|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
10640889|NCT02100410|11799902|FG005|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
10640890|NCT02100410|11799897|FG000|STARTED|Exposure Pair 2, 30 Minutes||8
10640891|NCT02100410|11799898|FG001|STARTED|Exposure Pair 2, 30 Minutes||8
10640892|NCT02100410|11799899|FG002|STARTED|Exposure Pair 2, 30 Minutes||8
10640893|NCT02100410|11799900|FG003|STARTED|Exposure Pair 2, 30 Minutes||8
10640894|NCT02100410|11799901|FG004|STARTED|Exposure Pair 2, 30 Minutes||8
10705974|NCT02604173|11870440|FG002|COMPLETED|Overall Study||35
10705975|NCT02604173|11870438|FG000|NOT COMPLETED|Overall Study||0
10640895|NCT02100410|11799902|FG005|STARTED|Exposure Pair 2, 30 Minutes||9
10640896|NCT02100410|11799897|FG000|COMPLETED|Exposure Pair 2, 30 Minutes||8
10640897|NCT02100410|11799898|FG001|COMPLETED|Exposure Pair 2, 30 Minutes||8
10640898|NCT02100410|11799899|FG002|COMPLETED|Exposure Pair 2, 30 Minutes||8
10640899|NCT02100410|11799900|FG003|COMPLETED|Exposure Pair 2, 30 Minutes||8
10640900|NCT02100410|11799901|FG004|COMPLETED|Exposure Pair 2, 30 Minutes||8
10640901|NCT02100410|11799902|FG005|COMPLETED|Exposure Pair 2, 30 Minutes||9
10640902|NCT02100410|11799897|FG000|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
10640903|NCT02100410|11799898|FG001|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
10640904|NCT02100410|11799899|FG002|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
10640905|NCT02100410|11799900|FG003|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
10640906|NCT02100410|11799901|FG004|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
10640907|NCT02100410|11799902|FG005|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
10640908|NCT02100410|11799897|FG000|STARTED|Exposure Pair 3, 30 Minutes||8
10640909|NCT02100410|11799898|FG001|STARTED|Exposure Pair 3, 30 Minutes||8
10640910|NCT02100410|11799899|FG002|STARTED|Exposure Pair 3, 30 Minutes||8
10640911|NCT02100410|11799900|FG003|STARTED|Exposure Pair 3, 30 Minutes||8
10640912|NCT02100410|11799901|FG004|STARTED|Exposure Pair 3, 30 Minutes||8
10640913|NCT02100410|11799902|FG005|STARTED|Exposure Pair 3, 30 Minutes||9
10640914|NCT02100410|11799897|FG000|COMPLETED|Exposure Pair 3, 30 Minutes||8
10640915|NCT02100410|11799898|FG001|COMPLETED|Exposure Pair 3, 30 Minutes||8
10640916|NCT02100410|11799899|FG002|COMPLETED|Exposure Pair 3, 30 Minutes||8
10640917|NCT02100410|11799900|FG003|COMPLETED|Exposure Pair 3, 30 Minutes||8
10640918|NCT02100410|11799901|FG004|COMPLETED|Exposure Pair 3, 30 Minutes||8
10640919|NCT02100410|11799902|FG005|COMPLETED|Exposure Pair 3, 30 Minutes||9
10640920|NCT02100410|11799897|FG000|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
10640921|NCT02100410|11799898|FG001|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
10640922|NCT02100410|11799899|FG002|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
10640923|NCT02100410|11799900|FG003|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
10640924|NCT02100410|11799901|FG004|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
10640925|NCT02100410|11799902|FG005|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
10640926|NCT02100475|11799916|FG000|STARTED|Overall Study||16
10640927|NCT02100475|11799917|FG001|STARTED|Overall Study||15
10640928|NCT02100475|11799916|FG000|COMPLETED|Overall Study||14
10640929|NCT02100475|11799917|FG001|COMPLETED|Overall Study||13
10640930|NCT02100475|11799916|FG000|NOT COMPLETED|Overall Study||2
10640931|NCT02100475|11799917|FG001|NOT COMPLETED|Overall Study||2
10640932|NCT02100514|11799925|FG000|STARTED|Treatment Period||247
10640933|NCT02100514|11799926|FG001|STARTED|Treatment Period||499
10640934|NCT02100514|11799927|FG002|STARTED|Treatment Period||0
10640935|NCT02100514|11799928|FG003|STARTED|Treatment Period||0
10640936|NCT02100514|11799929|FG004|STARTED|Treatment Period||0
10640937|NCT02100514|11799925|FG000|COMPLETED|Treatment Period||218
10640938|NCT02100514|11799926|FG001|COMPLETED|Treatment Period||425
10640939|NCT02100514|11799927|FG002|COMPLETED|Treatment Period||0
10640940|NCT02100514|11799928|FG003|COMPLETED|Treatment Period||0
10640941|NCT02100514|11799929|FG004|COMPLETED|Treatment Period||0
10640942|NCT02100514|11799925|FG000|NOT COMPLETED|Treatment Period||29
10640943|NCT02100514|11799926|FG001|NOT COMPLETED|Treatment Period||74
10640944|NCT02100514|11799927|FG002|NOT COMPLETED|Treatment Period||0
10640945|NCT02100514|11799928|FG003|NOT COMPLETED|Treatment Period||0
10640946|NCT02100514|11799929|FG004|NOT COMPLETED|Treatment Period||0
10640947|NCT02100514|11799925|FG000|STARTED|Extension Period||0
10640948|NCT02100514|11799926|FG001|STARTED|Extension Period||0
10640949|NCT02100514|11799927|FG002|STARTED|Extension Period||44
10640950|NCT02100514|11799928|FG003|STARTED|Extension Period||33
10640951|NCT02100514|11799929|FG004|STARTED|Extension Period||56
10640952|NCT02100514|11799925|FG000|COMPLETED|Extension Period||0
10640953|NCT02100514|11799926|FG001|COMPLETED|Extension Period||0
10640954|NCT02100514|11799927|FG002|COMPLETED|Extension Period||42
10640955|NCT02100514|11799928|FG003|COMPLETED|Extension Period||33
10640956|NCT02100514|11799929|FG004|COMPLETED|Extension Period||56
10640957|NCT02100514|11799925|FG000|NOT COMPLETED|Extension Period||0
10640958|NCT02100514|11799926|FG001|NOT COMPLETED|Extension Period||0
10640959|NCT02100514|11799927|FG002|NOT COMPLETED|Extension Period||2
10640960|NCT02100514|11799928|FG003|NOT COMPLETED|Extension Period||0
10640961|NCT02100514|11799929|FG004|NOT COMPLETED|Extension Period||0
10640962|NCT02100579|11799945|FG000|STARTED|Overall Study||20
10640963|NCT02100579|11799946|FG001|STARTED|Overall Study||20
10640964|NCT02100579|11799945|FG000|COMPLETED|Overall Study||20
10640965|NCT02100579|11799946|FG001|COMPLETED|Overall Study||20
10640966|NCT02100579|11799945|FG000|NOT COMPLETED|Overall Study||0
10640967|NCT02100579|11799946|FG001|NOT COMPLETED|Overall Study||0
10640968|NCT02100631|11799955|FG000|STARTED|Overall Study||299
10640969|NCT02100631|11799956|FG001|STARTED|Overall Study||99
10640970|NCT02100631|11799957|FG002|STARTED|Overall Study||2688
10640971|NCT02100631|11799955|FG000|COMPLETED|Overall Study||292
10640972|NCT02100631|11799956|FG001|COMPLETED|Overall Study||95
10640973|NCT02100631|11799957|FG002|COMPLETED|Overall Study||2688
10640974|NCT02100631|11799955|FG000|NOT COMPLETED|Overall Study||7
10640975|NCT02100631|11799956|FG001|NOT COMPLETED|Overall Study||4
10640976|NCT02100631|11799957|FG002|NOT COMPLETED|Overall Study||0
10640977|NCT02100644|11799965|FG000|STARTED|LTG Escalation Phase||33
10640978|NCT02100644|11799966|FG001|STARTED|LTG Escalation Phase||0
10640979|NCT02100644|11799967|FG002|STARTED|LTG Escalation Phase||0
10640980|NCT02100644|11799965|FG000|COMPLETED|LTG Escalation Phase||20
10640981|NCT02100644|11799966|FG001|COMPLETED|LTG Escalation Phase||0
10640982|NCT02100644|11799967|FG002|COMPLETED|LTG Escalation Phase||0
10640983|NCT02100644|11799965|FG000|NOT COMPLETED|LTG Escalation Phase||13
10640984|NCT02100644|11799966|FG001|NOT COMPLETED|LTG Escalation Phase||0
10640985|NCT02100644|11799967|FG002|NOT COMPLETED|LTG Escalation Phase||0
10809172|NCT03811951|11971036|FG001|COMPLETED|Second Intervention (1 Day)||2
10809173|NCT03811951|11971035|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10809174|NCT03811951|11971036|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10809175|NCT03810235|11971046|FG000|STARTED|Overall Study||32
10809176|NCT03810235|11971047|FG001|STARTED|Overall Study||31
10809177|NCT03810235|11971046|FG000|Participant Data Analyzed|Overall Study||30
10809178|NCT03810235|11971047|FG001|Participant Data Analyzed|Overall Study||31
10640986|NCT02100644|11799965|FG000|STARTED|VPA Reduction Phase||0
10640987|NCT02100644|11799966|FG001|STARTED|VPA Reduction Phase||20
10640988|NCT02100644|11799967|FG002|STARTED|VPA Reduction Phase||0
10640989|NCT02100644|11799965|FG000|COMPLETED|VPA Reduction Phase||0
10640990|NCT02100644|11799966|FG001|COMPLETED|VPA Reduction Phase||20
10640991|NCT02100644|11799967|FG002|COMPLETED|VPA Reduction Phase||0
10640992|NCT02100644|11799965|FG000|NOT COMPLETED|VPA Reduction Phase||0
10640993|NCT02100644|11799966|FG001|NOT COMPLETED|VPA Reduction Phase||0
10640994|NCT02100644|11799967|FG002|NOT COMPLETED|VPA Reduction Phase||0
10640995|NCT02100644|11799965|FG000|STARTED|LTG and VPA Maintenance Phase||0
10640996|NCT02100644|11799966|FG001|STARTED|LTG and VPA Maintenance Phase||0
10640997|NCT02100644|11799967|FG002|STARTED|LTG and VPA Maintenance Phase||20
10640998|NCT02100644|11799965|FG000|COMPLETED|LTG and VPA Maintenance Phase||0
10640999|NCT02100644|11799966|FG001|COMPLETED|LTG and VPA Maintenance Phase||0
10641000|NCT02100644|11799967|FG002|COMPLETED|LTG and VPA Maintenance Phase||20
10641001|NCT02100644|11799965|FG000|NOT COMPLETED|LTG and VPA Maintenance Phase||0
10641002|NCT02100644|11799966|FG001|NOT COMPLETED|LTG and VPA Maintenance Phase||0
10641003|NCT02100644|11799967|FG002|NOT COMPLETED|LTG and VPA Maintenance Phase||0
10641004|NCT02100657|11799974|FG000|STARTED|Cohort 1: Dose Level 1||8
10641005|NCT02100657|11799975|FG001|STARTED|Cohort 1: Dose Level 1||0
10641006|NCT02100657|11799976|FG002|STARTED|Cohort 1: Dose Level 1||0
10641007|NCT02100657|11799974|FG000|COMPLETED|Cohort 1: Dose Level 1||0
10641008|NCT02100657|11799975|FG001|COMPLETED|Cohort 1: Dose Level 1||0
10641009|NCT02100657|11799976|FG002|COMPLETED|Cohort 1: Dose Level 1||0
10641010|NCT02100657|11799974|FG000|NOT COMPLETED|Cohort 1: Dose Level 1||8
10641011|NCT02100657|11799975|FG001|NOT COMPLETED|Cohort 1: Dose Level 1||0
10641012|NCT02100657|11799976|FG002|NOT COMPLETED|Cohort 1: Dose Level 1||0
10641013|NCT02100657|11799974|FG000|STARTED|Cohort 2: Dose Level 2||0
10641014|NCT02100657|11799975|FG001|STARTED|Cohort 2: Dose Level 2||4
10641015|NCT02100657|11799976|FG002|STARTED|Cohort 2: Dose Level 2||0
10641016|NCT02100657|11799974|FG000|COMPLETED|Cohort 2: Dose Level 2||0
10641017|NCT02100657|11799975|FG001|COMPLETED|Cohort 2: Dose Level 2||0
10641018|NCT02100657|11799976|FG002|COMPLETED|Cohort 2: Dose Level 2||0
10641019|NCT02100657|11799974|FG000|NOT COMPLETED|Cohort 2: Dose Level 2||0
10641020|NCT02100657|11799975|FG001|NOT COMPLETED|Cohort 2: Dose Level 2||4
10641021|NCT02100657|11799976|FG002|NOT COMPLETED|Cohort 2: Dose Level 2||0
10641022|NCT02100657|11799974|FG000|STARTED|Cohort 3: Dose Level 3||0
10641023|NCT02100657|11799975|FG001|STARTED|Cohort 3: Dose Level 3||0
10641024|NCT02100657|11799976|FG002|STARTED|Cohort 3: Dose Level 3||27
10641025|NCT02100657|11799974|FG000|COMPLETED|Cohort 3: Dose Level 3||0
10641026|NCT02100657|11799975|FG001|COMPLETED|Cohort 3: Dose Level 3||0
10641027|NCT02100657|11799976|FG002|COMPLETED|Cohort 3: Dose Level 3||0
10641028|NCT02100657|11799974|FG000|NOT COMPLETED|Cohort 3: Dose Level 3||0
10641029|NCT02100657|11799975|FG001|NOT COMPLETED|Cohort 3: Dose Level 3||0
10641030|NCT02100657|11799976|FG002|NOT COMPLETED|Cohort 3: Dose Level 3||27
10641031|NCT02100670|11799989|FG000|STARTED|Overall Study||118
10641032|NCT02100670|11799990|FG001|STARTED|Overall Study||113
10641033|NCT02100670|11799991|FG002|STARTED|Overall Study||78
10641034|NCT02100670|11799992|FG003|STARTED|Overall Study||76
10641035|NCT02100670|11799989|FG000|COMPLETED|Overall Study||105
10641036|NCT02100670|11799990|FG001|COMPLETED|Overall Study||106
10641037|NCT02100670|11799991|FG002|COMPLETED|Overall Study||74
10641038|NCT02100670|11799992|FG003|COMPLETED|Overall Study||75
10641039|NCT02100670|11799989|FG000|NOT COMPLETED|Overall Study||13
10641040|NCT02100670|11799990|FG001|NOT COMPLETED|Overall Study||7
10641041|NCT02100670|11799991|FG002|NOT COMPLETED|Overall Study||4
10641042|NCT02100670|11799992|FG003|NOT COMPLETED|Overall Study||1
10641043|NCT02100696|11800015|FG000|STARTED|Induction Phase||130
10641044|NCT02100696|11800016|FG001|STARTED|Induction Phase||95
10641045|NCT02100696|11800017|FG002|STARTED|Induction Phase||384
10641046|NCT02100696|11800018|FG003|STARTED|Induction Phase||0
10641047|NCT02100696|11800019|FG004|STARTED|Induction Phase||0
10641048|NCT02100696|11800020|FG005|STARTED|Induction Phase||0
10641049|NCT02100696|11800015|FG000|COMPLETED|Induction Phase||115
10641050|NCT02100696|11800016|FG001|COMPLETED|Induction Phase||90
10641051|NCT02100696|11800017|FG002|COMPLETED|Induction Phase||358
10641052|NCT02100696|11800018|FG003|COMPLETED|Induction Phase||0
10641053|NCT02100696|11800019|FG004|COMPLETED|Induction Phase||0
10641054|NCT02100696|11800020|FG005|COMPLETED|Induction Phase||0
10641055|NCT02100696|11800015|FG000|NOT COMPLETED|Induction Phase||15
10641056|NCT02100696|11800016|FG001|NOT COMPLETED|Induction Phase||5
10641057|NCT02100696|11800017|FG002|NOT COMPLETED|Induction Phase||26
10641058|NCT02100696|11800018|FG003|NOT COMPLETED|Induction Phase||0
10641059|NCT02100696|11800019|FG004|NOT COMPLETED|Induction Phase||0
10641060|NCT02100696|11800020|FG005|NOT COMPLETED|Induction Phase||0
10641061|NCT02100696|11800015|FG000|STARTED|Maintenance Phase||0
10641062|NCT02100696|11800016|FG001|STARTED|Maintenance Phase||0
10641063|NCT02100696|11800017|FG002|STARTED|Maintenance Phase||0
10641064|NCT02100696|11800018|FG003|STARTED|Maintenance Phase||27
10641065|NCT02100696|11800019|FG004|STARTED|Maintenance Phase||115
10641066|NCT02100696|11800020|FG005|STARTED|Maintenance Phase||117
10641067|NCT02100696|11800015|FG000|COMPLETED|Maintenance Phase||0
10641068|NCT02100696|11800016|FG001|COMPLETED|Maintenance Phase||0
10641069|NCT02100696|11800017|FG002|COMPLETED|Maintenance Phase||0
10641070|NCT02100696|11800018|FG003|COMPLETED|Maintenance Phase||26
10641071|NCT02100696|11800019|FG004|COMPLETED|Maintenance Phase||106
10641072|NCT02100696|11800020|FG005|COMPLETED|Maintenance Phase||112
10641073|NCT02100696|11800015|FG000|NOT COMPLETED|Maintenance Phase||0
10641074|NCT02100696|11800016|FG001|NOT COMPLETED|Maintenance Phase||0
10641075|NCT02100696|11800017|FG002|NOT COMPLETED|Maintenance Phase||0
10641076|NCT02100696|11800018|FG003|NOT COMPLETED|Maintenance Phase||1
10641077|NCT02100696|11800019|FG004|NOT COMPLETED|Maintenance Phase||9
10641078|NCT02100696|11800020|FG005|NOT COMPLETED|Maintenance Phase||5
10641079|NCT02100748|11800053|FG000|STARTED|Overall Study||25
10641080|NCT02100748|11800054|FG001|STARTED|Overall Study||24
10641081|NCT02100748|11800055|FG002|STARTED|Overall Study||22
10641082|NCT02100748|11800056|FG003|STARTED|Overall Study||22
10641083|NCT02100748|11800057|FG004|STARTED|Overall Study||25
10641084|NCT02100748|11800058|FG005|STARTED|Overall Study||23
10641085|NCT02100748|11800059|FG006|STARTED|Overall Study||20
10641086|NCT02100748|11800060|FG007|STARTED|Overall Study||38
10641087|NCT02100748|11800061|FG008|STARTED|Overall Study||36
10641088|NCT02100748|11800062|FG009|STARTED|Overall Study||31
10641089|NCT02100748|11800063|FG010|STARTED|Overall Study||28
10641090|NCT02100748|11800064|FG011|STARTED|Overall Study||39
10641091|NCT02100748|11800053|FG000|COMPLETED|Overall Study||23
10641092|NCT02100748|11800054|FG001|COMPLETED|Overall Study||23
10641093|NCT02100748|11800055|FG002|COMPLETED|Overall Study||21
10641094|NCT02100748|11800056|FG003|COMPLETED|Overall Study||21
10641095|NCT02100748|11800057|FG004|COMPLETED|Overall Study||23
10641096|NCT02100748|11800058|FG005|COMPLETED|Overall Study||23
10641097|NCT02100748|11800059|FG006|COMPLETED|Overall Study||18
10641098|NCT02100748|11800060|FG007|COMPLETED|Overall Study||34
10641099|NCT02100748|11800061|FG008|COMPLETED|Overall Study||33
10641100|NCT02100748|11800062|FG009|COMPLETED|Overall Study||29
10641101|NCT02100748|11800063|FG010|COMPLETED|Overall Study||26
10641102|NCT02100748|11800064|FG011|COMPLETED|Overall Study||39
10641103|NCT02100748|11800053|FG000|NOT COMPLETED|Overall Study||2
10641104|NCT02100748|11800054|FG001|NOT COMPLETED|Overall Study||1
10641105|NCT02100748|11800055|FG002|NOT COMPLETED|Overall Study||1
10641106|NCT02100748|11800056|FG003|NOT COMPLETED|Overall Study||1
10641107|NCT02100748|11800057|FG004|NOT COMPLETED|Overall Study||2
10641108|NCT02100748|11800058|FG005|NOT COMPLETED|Overall Study||0
10641109|NCT02100748|11800059|FG006|NOT COMPLETED|Overall Study||2
10641110|NCT02100748|11800060|FG007|NOT COMPLETED|Overall Study||4
10641111|NCT02100748|11800061|FG008|NOT COMPLETED|Overall Study||3
10641112|NCT02100748|11800062|FG009|NOT COMPLETED|Overall Study||2
10641113|NCT02100748|11800063|FG010|NOT COMPLETED|Overall Study||2
10641114|NCT02100748|11800064|FG011|NOT COMPLETED|Overall Study||0
10641115|NCT02100813|11800098|FG000|STARTED|Overall Study||10
10641116|NCT02100813|11800099|FG001|STARTED|Overall Study||11
10641117|NCT02100813|11800100|FG002|STARTED|Overall Study||12
10641118|NCT02100813|11800101|FG003|STARTED|Overall Study||12
10641119|NCT02100813|11800102|FG004|STARTED|Overall Study||12
10641120|NCT02100813|11800103|FG005|STARTED|Overall Study||32
10641121|NCT02100813|11800104|FG006|STARTED|Overall Study||64
10641122|NCT02100813|11800105|FG007|STARTED|Overall Study||67
10641123|NCT02100813|11800098|FG000|COMPLETED|Overall Study||10
10641124|NCT02100813|11800099|FG001|COMPLETED|Overall Study||11
10641125|NCT02100813|11800100|FG002|COMPLETED|Overall Study||12
10641126|NCT02100813|11800101|FG003|COMPLETED|Overall Study||12
10641127|NCT02100813|11800102|FG004|COMPLETED|Overall Study||12
10641128|NCT02100813|11800103|FG005|COMPLETED|Overall Study||32
10641129|NCT02100813|11800104|FG006|COMPLETED|Overall Study||64
10641130|NCT02100813|11800105|FG007|COMPLETED|Overall Study||66
10641131|NCT02100813|11800098|FG000|NOT COMPLETED|Overall Study||0
10641132|NCT02100813|11800099|FG001|NOT COMPLETED|Overall Study||0
10641133|NCT02100813|11800100|FG002|NOT COMPLETED|Overall Study||0
10641134|NCT02100813|11800101|FG003|NOT COMPLETED|Overall Study||0
10641135|NCT02100813|11800102|FG004|NOT COMPLETED|Overall Study||0
10641136|NCT02100813|11800103|FG005|NOT COMPLETED|Overall Study||0
10641137|NCT02100813|11800104|FG006|NOT COMPLETED|Overall Study||0
10641138|NCT02100813|11800105|FG007|NOT COMPLETED|Overall Study||1
10641139|NCT02100826|11800123|FG000|STARTED|Period 1 (7 Days)||14
10641140|NCT02100826|11800124|FG001|STARTED|Period 1 (7 Days)||14
10641141|NCT02100826|11800123|FG000|COMPLETED|Period 1 (7 Days)||14
10641142|NCT02100826|11800124|FG001|COMPLETED|Period 1 (7 Days)||14
10641143|NCT02100826|11800123|FG000|NOT COMPLETED|Period 1 (7 Days)||0
10641144|NCT02100826|11800124|FG001|NOT COMPLETED|Period 1 (7 Days)||0
10641145|NCT02100826|11800123|FG000|STARTED|Washout Period (1 Day)||14
10641146|NCT02100826|11800124|FG001|STARTED|Washout Period (1 Day)||14
10641147|NCT02100826|11800123|FG000|COMPLETED|Washout Period (1 Day)||14
10641148|NCT02100826|11800124|FG001|COMPLETED|Washout Period (1 Day)||14
10641149|NCT02100826|11800123|FG000|NOT COMPLETED|Washout Period (1 Day)||0
10641150|NCT02100826|11800124|FG001|NOT COMPLETED|Washout Period (1 Day)||0
10641151|NCT02100826|11800123|FG000|STARTED|Period 2 (7 Days)||14
10641152|NCT02100826|11800124|FG001|STARTED|Period 2 (7 Days)||14
10641153|NCT02100826|11800123|FG000|COMPLETED|Period 2 (7 Days)||14
10641154|NCT02100826|11800124|FG001|COMPLETED|Period 2 (7 Days)||14
10641155|NCT02100826|11800123|FG000|NOT COMPLETED|Period 2 (7 Days)||0
10641156|NCT02100826|11800124|FG001|NOT COMPLETED|Period 2 (7 Days)||0
10641157|NCT02100839|11800132|FG000|STARTED|Single Ascending Dose||24
10641158|NCT02100839|11800133|FG001|STARTED|Single Ascending Dose||12
10641159|NCT02100839|11800132|FG000|COMPLETED|Single Ascending Dose||24
10641160|NCT02100839|11800133|FG001|COMPLETED|Single Ascending Dose||12
10641161|NCT02100839|11800132|FG000|NOT COMPLETED|Single Ascending Dose||0
10641162|NCT02100839|11800133|FG001|NOT COMPLETED|Single Ascending Dose||0
10641163|NCT02100839|11800132|FG000|STARTED|Multiple Ascending Dose||13
10641164|NCT02100839|11800133|FG001|STARTED|Multiple Ascending Dose||3
10641165|NCT02100839|11800132|FG000|COMPLETED|Multiple Ascending Dose||9
10641166|NCT02100839|11800133|FG001|COMPLETED|Multiple Ascending Dose||3
10641167|NCT02100839|11800132|FG000|NOT COMPLETED|Multiple Ascending Dose||4
10641168|NCT02100839|11800133|FG001|NOT COMPLETED|Multiple Ascending Dose||0
10641169|NCT02100930|11800139|FG000|STARTED|Overall Study||69
10641170|NCT02100930|11800139|FG000|COMPLETED|Overall Study||69
10641171|NCT02100930|11800139|FG000|NOT COMPLETED|Overall Study||0
10641172|NCT02100969|11800143|FG000|STARTED|Overall Study||23
10641173|NCT02100969|11800143|FG000|COMPLETED|Overall Study||22
10641174|NCT02100969|11800143|FG000|NOT COMPLETED|Overall Study||1
10641175|NCT02101008|11800148|FG000|STARTED|Overall Study||12
10641176|NCT02101008|11800148|FG000|COMPLETED|Overall Study||12
10641177|NCT02101008|11800148|FG000|NOT COMPLETED|Overall Study||0
10641178|NCT02101021|11800157|FG000|STARTED|Overall Study||7
10641179|NCT02101021|11800158|FG001|STARTED|Overall Study||4
10641180|NCT02101021|11800159|FG002|STARTED|Overall Study||7
10641181|NCT02101021|11800160|FG003|STARTED|Overall Study||3
10641182|NCT02101021|11800161|FG004|STARTED|Overall Study||4
10641183|NCT02101021|11800157|FG000|COMPLETED|Overall Study||0
10641184|NCT02101021|11800158|FG001|COMPLETED|Overall Study||0
10641185|NCT02101021|11800159|FG002|COMPLETED|Overall Study||0
10641186|NCT02101021|11800160|FG003|COMPLETED|Overall Study||0
10641187|NCT02101021|11800161|FG004|COMPLETED|Overall Study||0
10641188|NCT02101021|11800157|FG000|NOT COMPLETED|Overall Study||7
10641189|NCT02101021|11800158|FG001|NOT COMPLETED|Overall Study||4
10641190|NCT02101021|11800159|FG002|NOT COMPLETED|Overall Study||7
10641191|NCT02101021|11800160|FG003|NOT COMPLETED|Overall Study||3
10641192|NCT02101021|11800161|FG004|NOT COMPLETED|Overall Study||4
10641193|NCT02101060|11800175|FG000|STARTED|Overall Study||17
10641194|NCT02101060|11800176|FG001|STARTED|Overall Study||16
10641195|NCT02101060|11800175|FG000|COMPLETED|Overall Study||12
10641196|NCT02101060|11800176|FG001|COMPLETED|Overall Study||12
10641197|NCT02101060|11800175|FG000|NOT COMPLETED|Overall Study||5
10641198|NCT02101060|11800176|FG001|NOT COMPLETED|Overall Study||4
10641199|NCT02101112|11800182|FG000|STARTED|Overall Study||6
10641200|NCT02101112|11800183|FG001|STARTED|Overall Study||5
10641201|NCT02101112|11800184|FG002|STARTED|Overall Study||6
10641202|NCT02101112|11800185|FG003|STARTED|Overall Study||5
10641203|NCT02101112|11800186|FG004|STARTED|Overall Study||6
10641204|NCT02101112|11800187|FG005|STARTED|Overall Study||5
10641205|NCT02101112|11800182|FG000|COMPLETED|Overall Study||6
10641206|NCT02101112|11800183|FG001|COMPLETED|Overall Study||5
10641207|NCT02101112|11800184|FG002|COMPLETED|Overall Study||5
10641208|NCT02101112|11800185|FG003|COMPLETED|Overall Study||5
10641209|NCT02101112|11800186|FG004|COMPLETED|Overall Study||5
10641210|NCT02101112|11800187|FG005|COMPLETED|Overall Study||5
10641211|NCT02101112|11800182|FG000|NOT COMPLETED|Overall Study||0
10641212|NCT02101112|11800183|FG001|NOT COMPLETED|Overall Study||0
10641213|NCT02101112|11800184|FG002|NOT COMPLETED|Overall Study||1
10641214|NCT02101112|11800185|FG003|NOT COMPLETED|Overall Study||0
10641215|NCT02101112|11800186|FG004|NOT COMPLETED|Overall Study||1
10641216|NCT02101112|11800187|FG005|NOT COMPLETED|Overall Study||0
10641217|NCT02101190|11800199|FG000|STARTED|Overall Study||8
10641218|NCT02101190|11800200|FG001|STARTED|Overall Study||8
10641219|NCT02101190|11800199|FG000|COMPLETED|Overall Study||8
10641220|NCT02101190|11800200|FG001|COMPLETED|Overall Study||8
10641221|NCT02101190|11800199|FG000|NOT COMPLETED|Overall Study||0
10641222|NCT02101190|11800200|FG001|NOT COMPLETED|Overall Study||0
10641223|NCT02101281|11800208|FG000|STARTED|Overall Study||20
10641224|NCT02101281|11800209|FG001|STARTED|Overall Study||20
10641225|NCT02101281|11800208|FG000|COMPLETED|Overall Study||20
10641226|NCT02101281|11800209|FG001|COMPLETED|Overall Study||19
10641227|NCT02101281|11800208|FG000|NOT COMPLETED|Overall Study||0
10641228|NCT02101281|11800209|FG001|NOT COMPLETED|Overall Study||1
10641229|NCT02101294|11800221|FG000|STARTED|Overall Study||31
10641230|NCT02101294|11800221|FG000|COMPLETED|Overall Study||20
10641231|NCT02101294|11800221|FG000|NOT COMPLETED|Overall Study||11
10641232|NCT02101359|11800230|FG000|STARTED|Overall Study||295
10641233|NCT02101359|11800231|FG001|STARTED|Overall Study||296
10641234|NCT02101359|11800230|FG000|COMPLETED|Overall Study||266
10641235|NCT02101359|11800231|FG001|COMPLETED|Overall Study||277
10641236|NCT02101359|11800230|FG000|NOT COMPLETED|Overall Study||29
10641237|NCT02101359|11800231|FG001|NOT COMPLETED|Overall Study||19
10641238|NCT02101411|11800240|FG000|STARTED|Overall Study||111
10641239|NCT02101411|11800241|FG001|STARTED|Overall Study||109
10641240|NCT02101411|11800242|FG002|STARTED|Overall Study||114
10641241|NCT02101411|11800240|FG000|COMPLETED|Overall Study||107
10641242|NCT02101411|11800241|FG001|COMPLETED|Overall Study||102
10641243|NCT02101411|11800242|FG002|COMPLETED|Overall Study||104
10641244|NCT02101411|11800240|FG000|NOT COMPLETED|Overall Study||4
10641245|NCT02101411|11800241|FG001|NOT COMPLETED|Overall Study||7
10641246|NCT02101411|11800242|FG002|NOT COMPLETED|Overall Study||10
10641247|NCT02101437|11800254|FG000|STARTED|Overall Study||20
10641248|NCT02101437|11800255|FG001|STARTED|Overall Study||54
10641249|NCT02101437|11800256|FG002|STARTED|Overall Study||52
10641250|NCT02101437|11800257|FG003|STARTED|Overall Study||49
10641251|NCT02101437|11800254|FG000|COMPLETED|Overall Study||20
10641252|NCT02101437|11800255|FG001|COMPLETED|Overall Study||54
10641253|NCT02101437|11800256|FG002|COMPLETED|Overall Study||52
10641254|NCT02101437|11800257|FG003|COMPLETED|Overall Study||49
10641255|NCT02101437|11800254|FG000|NOT COMPLETED|Overall Study||0
10641256|NCT02101437|11800255|FG001|NOT COMPLETED|Overall Study||0
10641257|NCT02101437|11800256|FG002|NOT COMPLETED|Overall Study||0
10641258|NCT02101437|11800257|FG003|NOT COMPLETED|Overall Study||0
10641259|NCT02101515|11800269|FG000|STARTED|Overall Study||37
10641260|NCT02101515|11800270|FG001|STARTED|Overall Study||41
10641261|NCT02101515|11800269|FG000|COMPLETED|Overall Study||37
10641262|NCT02101515|11800270|FG001|COMPLETED|Overall Study||41
10641263|NCT02101515|11800269|FG000|NOT COMPLETED|Overall Study||0
10641264|NCT02101515|11800270|FG001|NOT COMPLETED|Overall Study||0
10641265|NCT02101554|11800279|FG000|STARTED|Overall Study||6
10641266|NCT02101554|11800280|FG001|STARTED|Overall Study||10
10641267|NCT02101554|11800281|FG002|STARTED|Overall Study||3
10641268|NCT02101554|11800279|FG000|COMPLETED|Overall Study||3
10641269|NCT02101554|11800280|FG001|COMPLETED|Overall Study||5
10641270|NCT02101554|11800281|FG002|COMPLETED|Overall Study||2
10641271|NCT02101554|11800279|FG000|NOT COMPLETED|Overall Study||3
10641272|NCT02101554|11800280|FG001|NOT COMPLETED|Overall Study||5
10641273|NCT02101554|11800281|FG002|NOT COMPLETED|Overall Study||1
10641274|NCT02101918|11800289|FG000|STARTED|Overall Study||22
10641275|NCT02101918|11800289|FG000|COMPLETED|Overall Study||22
10641276|NCT02101918|11800289|FG000|NOT COMPLETED|Overall Study||0
10641277|NCT02101983|11800295|FG000|STARTED|Overall Study||5
10641278|NCT02101983|11800296|FG001|STARTED|Overall Study||6
10641279|NCT02101983|11800295|FG000|COMPLETED|Overall Study||4
10641280|NCT02101983|11800296|FG001|COMPLETED|Overall Study||6
10641281|NCT02101983|11800295|FG000|NOT COMPLETED|Overall Study||1
10641282|NCT02101983|11800296|FG001|NOT COMPLETED|Overall Study||0
10641283|NCT02102100|11800304|FG000|STARTED|Overall Study||32
10641284|NCT02102100|11800305|FG001|STARTED|Overall Study||25
10641285|NCT02102100|11800304|FG000|COMPLETED|Overall Study||23
10641286|NCT02102100|11800305|FG001|COMPLETED|Overall Study||18
10641287|NCT02102100|11800304|FG000|NOT COMPLETED|Overall Study||9
10641288|NCT02102100|11800305|FG001|NOT COMPLETED|Overall Study||7
10641289|NCT02102204|11800311|FG000|STARTED|Overall Study||902
10641290|NCT02102204|11800311|FG000|Received Etelcalcetide|Overall Study||884
10641291|NCT02102204|11800311|FG000|COMPLETED|Overall Study||598
10641292|NCT02102204|11800311|FG000|NOT COMPLETED|Overall Study||304
10641293|NCT02102230|11800318|FG000|STARTED|Overall Study||42
10641294|NCT02102230|11800319|FG001|STARTED|Overall Study||28
10641295|NCT02102230|11800320|FG002|STARTED|Overall Study||41
10641296|NCT02102230|11800318|FG000|COMPLETED|Overall Study||25
10641297|NCT02102230|11800319|FG001|COMPLETED|Overall Study||11
10641298|NCT02102230|11800320|FG002|COMPLETED|Overall Study||24
10641299|NCT02102230|11800318|FG000|NOT COMPLETED|Overall Study||17
10641300|NCT02102230|11800319|FG001|NOT COMPLETED|Overall Study||17
10641301|NCT02102230|11800320|FG002|NOT COMPLETED|Overall Study||17
10641302|NCT02102399|11800331|FG000|STARTED|Overall Study||20
10641303|NCT02102399|11800332|FG001|STARTED|Overall Study||21
10641304|NCT02102399|11800331|FG000|COMPLETED|Overall Study||14
10641305|NCT02102399|11800332|FG001|COMPLETED|Overall Study||17
10641306|NCT02102399|11800331|FG000|NOT COMPLETED|Overall Study||6
10641307|NCT02102399|11800332|FG001|NOT COMPLETED|Overall Study||4
10641308|NCT02102464|11800345|FG000|STARTED|Randomized Study||29
10705976|NCT02604173|11870439|FG001|NOT COMPLETED|Overall Study||0
10705977|NCT02604173|11870440|FG002|NOT COMPLETED|Overall Study||0
10705978|NCT02604199|11870452|FG000|STARTED|Overall Study||9
10705979|NCT02604199|11870453|FG001|STARTED|Overall Study||11
10641309|NCT02102464|11800346|FG001|STARTED|Randomized Study||26
10641310|NCT02102464|11800347|FG002|STARTED|Randomized Study||0
10641311|NCT02102464|11800345|FG000|COMPLETED|Randomized Study||29
10641312|NCT02102464|11800346|FG001|COMPLETED|Randomized Study||25
10641313|NCT02102464|11800347|FG002|COMPLETED|Randomized Study||0
10641314|NCT02102464|11800345|FG000|NOT COMPLETED|Randomized Study||0
10705980|NCT02604199|11870454|FG002|STARTED|Overall Study||17
10705981|NCT02604199|11870455|FG003|STARTED|Overall Study||21
10641315|NCT02102464|11800346|FG001|NOT COMPLETED|Randomized Study||1
10641316|NCT02102464|11800347|FG002|NOT COMPLETED|Randomized Study||0
10641317|NCT02102464|11800345|FG000|STARTED|Crossover LipiFlow Treatment of Control||0
10641318|NCT02102464|11800346|FG001|STARTED|Crossover LipiFlow Treatment of Control||0
10705982|NCT02604199|11870452|FG000|COMPLETED|Overall Study||9
10641319|NCT02102464|11800347|FG002|STARTED|Crossover LipiFlow Treatment of Control||25
10705983|NCT02604199|11870453|FG001|COMPLETED|Overall Study||8
10641320|NCT02102464|11800345|FG000|COMPLETED|Crossover LipiFlow Treatment of Control||0
10641321|NCT02102464|11800346|FG001|COMPLETED|Crossover LipiFlow Treatment of Control||0
10641322|NCT02102464|11800347|FG002|COMPLETED|Crossover LipiFlow Treatment of Control||25
10641323|NCT02102464|11800345|FG000|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
10641324|NCT02102464|11800346|FG001|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
10641325|NCT02102464|11800347|FG002|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
10641326|NCT02102490|11800356|FG000|STARTED|Overall Study||132
10641354|NCT02102932|11800379|FG002|NOT COMPLETED|Overall Study||0
10641327|NCT02102490|11800356|FG000|Received at Least 1 Dose of Study Drug|Overall Study||132
10641328|NCT02102490|11800356|FG000|COMPLETED|Overall Study||125
10641329|NCT02102490|11800356|FG000|NOT COMPLETED|Overall Study||7
10641330|NCT02102724|11800362|FG000|STARTED|Overall Study||18
10641331|NCT02102724|11800363|FG001|STARTED|Overall Study||19
10705984|NCT02604199|11870454|FG002|COMPLETED|Overall Study||17
10705985|NCT02604199|11870455|FG003|COMPLETED|Overall Study||18
10705986|NCT02604199|11870452|FG000|NOT COMPLETED|Overall Study||0
10705987|NCT02604199|11870453|FG001|NOT COMPLETED|Overall Study||3
10705988|NCT02604199|11870454|FG002|NOT COMPLETED|Overall Study||0
10457298|NCT01010009|11605029|FG001|NOT COMPLETED|Overall Study||0
10457299|NCT01010009|11605030|FG002|NOT COMPLETED|Overall Study||0
10526151|NCT01380093|11678033|FG001|STARTED|Treatment Phase: Second Intervention||0
10526152|NCT01380093|11678034|FG002|STARTED|Treatment Phase: Second Intervention||0
10526153|NCT01380093|11678035|FG003|STARTED|Treatment Phase: Second Intervention||6
10526154|NCT01380093|11678036|FG004|STARTED|Treatment Phase: Second Intervention||6
10526155|NCT01380093|11678037|FG005|STARTED|Treatment Phase: Second Intervention||6
10526156|NCT01380093|11678038|FG006|STARTED|Treatment Phase: Second Intervention||6
10526157|NCT01380093|11678039|FG007|STARTED|Treatment Phase: Second Intervention||6
10526158|NCT01380093|11678040|FG008|STARTED|Treatment Phase: Second Intervention||6
10526159|NCT01380093|11678032|FG000|COMPLETED|Treatment Phase: Second Intervention||0
10526160|NCT01380093|11678033|FG001|COMPLETED|Treatment Phase: Second Intervention||0
10526161|NCT01380093|11678034|FG002|COMPLETED|Treatment Phase: Second Intervention||0
10526162|NCT01380093|11678035|FG003|COMPLETED|Treatment Phase: Second Intervention||5
10526163|NCT01380093|11678036|FG004|COMPLETED|Treatment Phase: Second Intervention||6
10526164|NCT01380093|11678037|FG005|COMPLETED|Treatment Phase: Second Intervention||6
10526165|NCT01380093|11678038|FG006|COMPLETED|Treatment Phase: Second Intervention||6
10526166|NCT01380093|11678039|FG007|COMPLETED|Treatment Phase: Second Intervention||6
10526167|NCT01380093|11678040|FG008|COMPLETED|Treatment Phase: Second Intervention||6
10526168|NCT01380093|11678032|FG000|NOT COMPLETED|Treatment Phase: Second Intervention||0
10526169|NCT01380093|11678033|FG001|NOT COMPLETED|Treatment Phase: Second Intervention||0
10526170|NCT01380093|11678034|FG002|NOT COMPLETED|Treatment Phase: Second Intervention||0
10526171|NCT01380093|11678035|FG003|NOT COMPLETED|Treatment Phase: Second Intervention||1
10526172|NCT01380093|11678036|FG004|NOT COMPLETED|Treatment Phase: Second Intervention||0
10526173|NCT01380093|11678037|FG005|NOT COMPLETED|Treatment Phase: Second Intervention||0
10526174|NCT01380093|11678038|FG006|NOT COMPLETED|Treatment Phase: Second Intervention||0
10526175|NCT01380093|11678039|FG007|NOT COMPLETED|Treatment Phase: Second Intervention||0
10526176|NCT01380093|11678040|FG008|NOT COMPLETED|Treatment Phase: Second Intervention||0
10526177|NCT01380093|11678032|FG000|STARTED|Treatment Phase: Washout Period||0
10526178|NCT01380093|11678033|FG001|STARTED|Treatment Phase: Washout Period||0
10526179|NCT01380093|11678034|FG002|STARTED|Treatment Phase: Washout Period||0
10526180|NCT01380093|11678035|FG003|STARTED|Treatment Phase: Washout Period||5
10526181|NCT01380093|11678036|FG004|STARTED|Treatment Phase: Washout Period||6
10526182|NCT01380093|11678037|FG005|STARTED|Treatment Phase: Washout Period||6
10526183|NCT01380093|11678038|FG006|STARTED|Treatment Phase: Washout Period||6
10526184|NCT01380093|11678039|FG007|STARTED|Treatment Phase: Washout Period||6
10526185|NCT01380093|11678040|FG008|STARTED|Treatment Phase: Washout Period||6
10526186|NCT01380093|11678032|FG000|COMPLETED|Treatment Phase: Washout Period||0
10526187|NCT01380093|11678033|FG001|COMPLETED|Treatment Phase: Washout Period||0
10526188|NCT01380093|11678034|FG002|COMPLETED|Treatment Phase: Washout Period||0
10526189|NCT01380093|11678035|FG003|COMPLETED|Treatment Phase: Washout Period||5
10526190|NCT01380093|11678036|FG004|COMPLETED|Treatment Phase: Washout Period||6
10526191|NCT01380093|11678037|FG005|COMPLETED|Treatment Phase: Washout Period||6
10526192|NCT01380093|11678038|FG006|COMPLETED|Treatment Phase: Washout Period||6
10526193|NCT01380093|11678039|FG007|COMPLETED|Treatment Phase: Washout Period||6
10526194|NCT01380093|11678040|FG008|COMPLETED|Treatment Phase: Washout Period||6
10526195|NCT01380093|11678032|FG000|NOT COMPLETED|Treatment Phase: Washout Period||0
10526196|NCT01380093|11678033|FG001|NOT COMPLETED|Treatment Phase: Washout Period||0
10526197|NCT01380093|11678034|FG002|NOT COMPLETED|Treatment Phase: Washout Period||0
10526198|NCT01380093|11678035|FG003|NOT COMPLETED|Treatment Phase: Washout Period||0
10641332|NCT02102724|11800362|FG000|COMPLETED|Overall Study||16
10641333|NCT02102724|11800363|FG001|COMPLETED|Overall Study||18
10641334|NCT02102724|11800362|FG000|NOT COMPLETED|Overall Study||2
10641335|NCT02102724|11800363|FG001|NOT COMPLETED|Overall Study||1
10641336|NCT02102932|11800377|FG000|STARTED|Overall Study||12
10641337|NCT02102932|11800378|FG001|STARTED|Overall Study||12
10641338|NCT02102932|11800379|FG002|STARTED|Overall Study||12
10641339|NCT02102932|11800380|FG003|STARTED|Overall Study||12
10641340|NCT02102932|11800381|FG004|STARTED|Overall Study||12
10641341|NCT02102932|11800382|FG005|STARTED|Overall Study||12
10641342|NCT02102932|11800383|FG006|STARTED|Overall Study||12
10641343|NCT02102932|11800384|FG007|STARTED|Overall Study||12
10641344|NCT02102932|11800377|FG000|COMPLETED|Overall Study||12
10641345|NCT02102932|11800378|FG001|COMPLETED|Overall Study||12
10641346|NCT02102932|11800379|FG002|COMPLETED|Overall Study||12
10641347|NCT02102932|11800380|FG003|COMPLETED|Overall Study||12
10641348|NCT02102932|11800381|FG004|COMPLETED|Overall Study||12
10641349|NCT02102932|11800382|FG005|COMPLETED|Overall Study||12
10641350|NCT02102932|11800383|FG006|COMPLETED|Overall Study||12
10641351|NCT02102932|11800384|FG007|COMPLETED|Overall Study||12
10641352|NCT02102932|11800377|FG000|NOT COMPLETED|Overall Study||0
10641353|NCT02102932|11800378|FG001|NOT COMPLETED|Overall Study||0
10641355|NCT02102932|11800380|FG003|NOT COMPLETED|Overall Study||0
10641356|NCT02102932|11800381|FG004|NOT COMPLETED|Overall Study||0
10641357|NCT02102932|11800382|FG005|NOT COMPLETED|Overall Study||0
10641358|NCT02102932|11800383|FG006|NOT COMPLETED|Overall Study||0
10641359|NCT02102932|11800384|FG007|NOT COMPLETED|Overall Study||0
10641360|NCT02103062|11800404|FG000|STARTED|Overall Study||18
10641361|NCT02103062|11800405|FG001|STARTED|Overall Study||23
10641362|NCT02103062|11800404|FG000|Safety Population|Overall Study|Includes participants who received at least one dose of study drug.|18
10641363|NCT02103062|11800405|FG001|Safety Population|Overall Study|Includes participants who received at least one dose of study drug.|23
10641364|NCT02103062|11800404|FG000|Intent to Treat Population|Overall Study|Includes participants who met all eligibility criteria and received at least one dose of study drug.|17
10641365|NCT02103062|11800405|FG001|Intent to Treat Population|Overall Study|Includes participants who met all eligibility criteria and received at least one dose of study drug.|20
10641366|NCT02103062|11800404|FG000|COMPLETED|Overall Study||0
10641367|NCT02103062|11800405|FG001|COMPLETED|Overall Study||0
10641368|NCT02103062|11800404|FG000|NOT COMPLETED|Overall Study||18
10641369|NCT02103062|11800405|FG001|NOT COMPLETED|Overall Study||23
10641370|NCT02103114|11800415|FG000|STARTED|Overall Study||20
10641371|NCT02103114|11800416|FG001|STARTED|Overall Study||20
10641372|NCT02103114|11800415|FG000|COMPLETED|Overall Study||20
10641373|NCT02103114|11800416|FG001|COMPLETED|Overall Study||19
10641374|NCT02103114|11800415|FG000|NOT COMPLETED|Overall Study||0
10641375|NCT02103114|11800416|FG001|NOT COMPLETED|Overall Study||1
10641376|NCT02103127|11800423|FG000|STARTED|Overall Study||20
10641377|NCT02103127|11800423|FG000|COMPLETED|Overall Study||17
10641378|NCT02103127|11800423|FG000|NOT COMPLETED|Overall Study||3
10641379|NCT02103153|11800427|FG000|STARTED|Overall Study||44
10641380|NCT02103153|11800427|FG000|COMPLETED|Overall Study||27
10641381|NCT02103153|11800427|FG000|NOT COMPLETED|Overall Study||17
10641382|NCT02103218|11800438|FG000|STARTED|Overall Study||51
10641383|NCT02103218|11800439|FG001|STARTED|Overall Study||59
10641384|NCT02103218|11800440|FG002|STARTED|Overall Study||48
10641385|NCT02103218|11800441|FG003|STARTED|Overall Study||54
10641386|NCT02103218|11800438|FG000|COMPLETED|Overall Study||46
10641387|NCT02103218|11800439|FG001|COMPLETED|Overall Study||51
10641388|NCT02103218|11800440|FG002|COMPLETED|Overall Study||44
10641389|NCT02103218|11800441|FG003|COMPLETED|Overall Study||47
10641390|NCT02103218|11800438|FG000|NOT COMPLETED|Overall Study||5
10641391|NCT02103218|11800439|FG001|NOT COMPLETED|Overall Study||8
10641392|NCT02103218|11800440|FG002|NOT COMPLETED|Overall Study||4
10641393|NCT02103218|11800441|FG003|NOT COMPLETED|Overall Study||7
10641394|NCT02103270|11800452|FG000|STARTED|Overall Study||60
10641395|NCT02103270|11800453|FG001|STARTED|Overall Study||35
10641396|NCT02103270|11800454|FG002|STARTED|Overall Study||25
10641397|NCT02103270|11800452|FG000|COMPLETED|Overall Study||51
10641398|NCT02103270|11800453|FG001|COMPLETED|Overall Study||29
10641399|NCT02103270|11800454|FG002|COMPLETED|Overall Study||1
10641400|NCT02103270|11800452|FG000|NOT COMPLETED|Overall Study||9
10641401|NCT02103270|11800453|FG001|NOT COMPLETED|Overall Study||6
10641402|NCT02103270|11800454|FG002|NOT COMPLETED|Overall Study||24
10641403|NCT02103309|11800465|FG000|STARTED|Overall Study||20
10641404|NCT02103309|11800466|FG001|STARTED|Overall Study||22
10641405|NCT02103309|11800465|FG000|COMPLETED|Overall Study||20
10641406|NCT02103309|11800466|FG001|COMPLETED|Overall Study||22
10641407|NCT02103309|11800465|FG000|NOT COMPLETED|Overall Study||0
10641408|NCT02103309|11800466|FG001|NOT COMPLETED|Overall Study||0
10641409|NCT02103439|11800474|FG000|STARTED|Overall Study||70
10641410|NCT02103439|11800475|FG001|STARTED|Overall Study||70
10641411|NCT02103439|11800474|FG000|COMPLETED|Overall Study||67
10641412|NCT02103439|11800475|FG001|COMPLETED|Overall Study||67
10641413|NCT02103439|11800474|FG000|NOT COMPLETED|Overall Study||3
10641414|NCT02103439|11800475|FG001|NOT COMPLETED|Overall Study||3
10641415|NCT02103478|11800492|FG000|STARTED|Overall Study||7
10641416|NCT02103478|11800493|FG001|STARTED|Overall Study||6
10641417|NCT02103478|11800494|FG002|STARTED|Overall Study||6
10641418|NCT02103478|11800495|FG003|STARTED|Overall Study||6
10641419|NCT02103478|11800496|FG004|STARTED|Overall Study||19
10641420|NCT02103478|11800497|FG005|STARTED|Overall Study||25
10641421|NCT02103478|11800498|FG006|STARTED|Overall Study||25
10641422|NCT02103478|11800499|FG007|STARTED|Overall Study||16
10641423|NCT02103478|11800500|FG008|STARTED|Overall Study||14
10641424|NCT02103478|11800492|FG000|COMPLETED|Overall Study||0
10641425|NCT02103478|11800493|FG001|COMPLETED|Overall Study||0
10641426|NCT02103478|11800494|FG002|COMPLETED|Overall Study||0
10641427|NCT02103478|11800495|FG003|COMPLETED|Overall Study||0
10641428|NCT02103478|11800496|FG004|COMPLETED|Overall Study||0
10641429|NCT02103478|11800497|FG005|COMPLETED|Overall Study||0
10641430|NCT02103478|11800498|FG006|COMPLETED|Overall Study||0
10641431|NCT02103478|11800499|FG007|COMPLETED|Overall Study||0
10641432|NCT02103478|11800500|FG008|COMPLETED|Overall Study||0
10641433|NCT02103478|11800492|FG000|NOT COMPLETED|Overall Study||7
10641434|NCT02103478|11800493|FG001|NOT COMPLETED|Overall Study||6
10641435|NCT02103478|11800494|FG002|NOT COMPLETED|Overall Study||6
10641436|NCT02103478|11800495|FG003|NOT COMPLETED|Overall Study||6
10641437|NCT02103478|11800496|FG004|NOT COMPLETED|Overall Study||19
10641438|NCT02103478|11800497|FG005|NOT COMPLETED|Overall Study||25
10641439|NCT02103478|11800498|FG006|NOT COMPLETED|Overall Study||25
10641440|NCT02103478|11800499|FG007|NOT COMPLETED|Overall Study||16
10641441|NCT02103478|11800500|FG008|NOT COMPLETED|Overall Study||14
10641442|NCT02103608|11800530|FG000|STARTED|Overall Study||17
10641443|NCT02103608|11800530|FG000|COMPLETED|Overall Study||15
10641444|NCT02103608|11800530|FG000|NOT COMPLETED|Overall Study||2
10641445|NCT02103816|11800534|FG000|STARTED|Overall Study||21
10641446|NCT02103816|11800534|FG000|COMPLETED|Overall Study||13
10641447|NCT02103816|11800534|FG000|NOT COMPLETED|Overall Study||8
10641448|NCT02103855|11800538|FG000|STARTED|Overall Study||6
10641449|NCT02103855|11800538|FG000|COMPLETED|Overall Study||4
10641450|NCT02103855|11800538|FG000|NOT COMPLETED|Overall Study||2
10641451|NCT02104141|11800542|FG000|STARTED|Overall Study||51
10641452|NCT02104141|11800542|FG000|COMPLETED|Overall Study||51
10641453|NCT02104141|11800542|FG000|NOT COMPLETED|Overall Study||0
10641454|NCT02104167|11800546|FG000|STARTED|Overall Study||110
10641455|NCT02104167|11800546|FG000|COMPLETED|Overall Study||110
10641456|NCT02104167|11800546|FG000|NOT COMPLETED|Overall Study||0
10641457|NCT02104219|11800550|FG000|STARTED|Overall Study||32
10641458|NCT02104219|11800550|FG000|COMPLETED|Overall Study||32
10641459|NCT02104219|11800550|FG000|NOT COMPLETED|Overall Study||0
10641460|NCT02104414|11800557|FG000|STARTED|Overall Study||5
10641461|NCT02104414|11800558|FG001|STARTED|Overall Study||4
10641462|NCT02104414|11800559|FG002|STARTED|Overall Study||2
10641463|NCT02104414|11800557|FG000|COMPLETED|Overall Study||5
10641464|NCT02104414|11800558|FG001|COMPLETED|Overall Study||4
10641465|NCT02104414|11800559|FG002|COMPLETED|Overall Study||2
10641466|NCT02104414|11800557|FG000|NOT COMPLETED|Overall Study||0
10641467|NCT02104414|11800558|FG001|NOT COMPLETED|Overall Study||0
10641468|NCT02104414|11800559|FG002|NOT COMPLETED|Overall Study||0
10641469|NCT02104427|11800567|FG000|STARTED|Overall Study||12
10641470|NCT02104427|11800567|FG000|COMPLETED|Overall Study||12
10641471|NCT02104427|11800567|FG000|NOT COMPLETED|Overall Study||0
10641472|NCT02104505|11800591|FG000|STARTED|First Intervention (14 Days)||12
10641473|NCT02104505|11800592|FG001|STARTED|First Intervention (14 Days)|one participant withdrew prior to receiving study drug|11
10641474|NCT02104505|11800591|FG000|COMPLETED|First Intervention (14 Days)||10
10641475|NCT02104505|11800592|FG001|COMPLETED|First Intervention (14 Days)||8
10641476|NCT02104505|11800591|FG000|NOT COMPLETED|First Intervention (14 Days)||2
10641477|NCT02104505|11800592|FG001|NOT COMPLETED|First Intervention (14 Days)||3
10641478|NCT02104505|11800591|FG000|STARTED|Washout (Minimum 3 Weeks)||10
10641479|NCT02104505|11800592|FG001|STARTED|Washout (Minimum 3 Weeks)||8
10641480|NCT02104505|11800591|FG000|COMPLETED|Washout (Minimum 3 Weeks)||10
10641481|NCT02104505|11800592|FG001|COMPLETED|Washout (Minimum 3 Weeks)||8
10641482|NCT02104505|11800591|FG000|NOT COMPLETED|Washout (Minimum 3 Weeks)||0
10641483|NCT02104505|11800592|FG001|NOT COMPLETED|Washout (Minimum 3 Weeks)||0
10641484|NCT02104505|11800591|FG000|STARTED|Second Intervention (14 Days)||10
10641485|NCT02104505|11800592|FG001|STARTED|Second Intervention (14 Days)||8
10641486|NCT02104505|11800591|FG000|COMPLETED|Second Intervention (14 Days)||8
10641487|NCT02104505|11800592|FG001|COMPLETED|Second Intervention (14 Days)||7
10641488|NCT02104505|11800591|FG000|NOT COMPLETED|Second Intervention (14 Days)||2
10641489|NCT02104505|11800592|FG001|NOT COMPLETED|Second Intervention (14 Days)||1
10641490|NCT02104557|11800599|FG000|STARTED|Overall Study||362
10641491|NCT02104557|11800599|FG000|Safety Population|Overall Study||337
10641492|NCT02104557|11800599|FG000|COMPLETED|Overall Study||185
10641493|NCT02104557|11800599|FG000|NOT COMPLETED|Overall Study||177
10641494|NCT02104583|11800608|FG000|STARTED|Overall Study||48
10641495|NCT02104583|11800609|FG001|STARTED|Overall Study||46
10641496|NCT02104583|11800610|FG002|STARTED|Overall Study||70
10641497|NCT02104583|11800611|FG003|STARTED|Overall Study||74
10641498|NCT02104583|11800612|FG004|STARTED|Overall Study||75
10641499|NCT02104583|11800608|FG000|COMPLETED|Overall Study||30
10641500|NCT02104583|11800609|FG001|COMPLETED|Overall Study||35
10641501|NCT02104583|11800610|FG002|COMPLETED|Overall Study||54
10641502|NCT02104583|11800611|FG003|COMPLETED|Overall Study||57
10641503|NCT02104583|11800612|FG004|COMPLETED|Overall Study||63
10641504|NCT02104583|11800608|FG000|NOT COMPLETED|Overall Study||18
10641505|NCT02104583|11800609|FG001|NOT COMPLETED|Overall Study||11
10641506|NCT02104583|11800610|FG002|NOT COMPLETED|Overall Study||16
10641507|NCT02104583|11800611|FG003|NOT COMPLETED|Overall Study||17
10641508|NCT02104583|11800612|FG004|NOT COMPLETED|Overall Study||12
10641509|NCT02104739|11800633|FG000|STARTED|First Intervention (1 Day)||2
10641510|NCT02104739|11800634|FG001|STARTED|First Intervention (1 Day)||5
10641511|NCT02104739|11800635|FG002|STARTED|First Intervention (1 Day)||2
10641512|NCT02104739|11800636|FG003|STARTED|First Intervention (1 Day)||8
10641513|NCT02104739|11800637|FG004|STARTED|First Intervention (1 Day)||0
10641514|NCT02104739|11800638|FG005|STARTED|First Intervention (1 Day)||3
10641515|NCT02104739|11800639|FG006|STARTED|First Intervention (1 Day)||0
10641516|NCT02104739|11800633|FG000|COMPLETED|First Intervention (1 Day)||2
10641517|NCT02104739|11800634|FG001|COMPLETED|First Intervention (1 Day)||4
10641518|NCT02104739|11800635|FG002|COMPLETED|First Intervention (1 Day)||2
10641519|NCT02104739|11800636|FG003|COMPLETED|First Intervention (1 Day)||7
10641520|NCT02104739|11800637|FG004|COMPLETED|First Intervention (1 Day)||0
10641521|NCT02104739|11800638|FG005|COMPLETED|First Intervention (1 Day)||3
10641522|NCT02104739|11800639|FG006|COMPLETED|First Intervention (1 Day)||0
10641523|NCT02104739|11800633|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10641524|NCT02104739|11800634|FG001|NOT COMPLETED|First Intervention (1 Day)||1
10641525|NCT02104739|11800635|FG002|NOT COMPLETED|First Intervention (1 Day)||0
10641526|NCT02104739|11800636|FG003|NOT COMPLETED|First Intervention (1 Day)||1
10641527|NCT02104739|11800637|FG004|NOT COMPLETED|First Intervention (1 Day)||0
10641528|NCT02104739|11800638|FG005|NOT COMPLETED|First Intervention (1 Day)||0
10641529|NCT02104739|11800639|FG006|NOT COMPLETED|First Intervention (1 Day)||0
10641530|NCT02104739|11800633|FG000|STARTED|Washout (Min of 10 and Max of 107 Days)||1
10641531|NCT02104739|11800634|FG001|STARTED|Washout (Min of 10 and Max of 107 Days)||4
10641532|NCT02104739|11800635|FG002|STARTED|Washout (Min of 10 and Max of 107 Days)||2
10641533|NCT02104739|11800636|FG003|STARTED|Washout (Min of 10 and Max of 107 Days)||7
10641534|NCT02104739|11800637|FG004|STARTED|Washout (Min of 10 and Max of 107 Days)||0
10641535|NCT02104739|11800638|FG005|STARTED|Washout (Min of 10 and Max of 107 Days)||2
10641536|NCT02104739|11800639|FG006|STARTED|Washout (Min of 10 and Max of 107 Days)||0
10641537|NCT02104739|11800633|FG000|COMPLETED|Washout (Min of 10 and Max of 107 Days)||1
10641538|NCT02104739|11800634|FG001|COMPLETED|Washout (Min of 10 and Max of 107 Days)||4
10641539|NCT02104739|11800635|FG002|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
10641540|NCT02104739|11800636|FG003|COMPLETED|Washout (Min of 10 and Max of 107 Days)||7
10641541|NCT02104739|11800637|FG004|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
10641542|NCT02104739|11800638|FG005|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
10641543|NCT02104739|11800639|FG006|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
10641544|NCT02104739|11800633|FG000|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
10641545|NCT02104739|11800634|FG001|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
10641546|NCT02104739|11800635|FG002|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
10641547|NCT02104739|11800636|FG003|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
10641548|NCT02104739|11800637|FG004|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
10641549|NCT02104739|11800638|FG005|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
10641550|NCT02104739|11800639|FG006|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
10641551|NCT02104739|11800633|FG000|STARTED|Second Intervention (1 Day)||1
10641552|NCT02104739|11800634|FG001|STARTED|Second Intervention (1 Day)||4
10641553|NCT02104739|11800635|FG002|STARTED|Second Intervention (1 Day)||2
10641554|NCT02104739|11800636|FG003|STARTED|Second Intervention (1 Day)||7
10641555|NCT02104739|11800637|FG004|STARTED|Second Intervention (1 Day)||0
10641556|NCT02104739|11800638|FG005|STARTED|Second Intervention (1 Day)||2
10641557|NCT02104739|11800639|FG006|STARTED|Second Intervention (1 Day)||0
10641558|NCT02104739|11800633|FG000|COMPLETED|Second Intervention (1 Day)||1
10641559|NCT02104739|11800634|FG001|COMPLETED|Second Intervention (1 Day)||4
10641560|NCT02104739|11800635|FG002|COMPLETED|Second Intervention (1 Day)||2
10641561|NCT02104739|11800636|FG003|COMPLETED|Second Intervention (1 Day)||7
10641562|NCT02104739|11800637|FG004|COMPLETED|Second Intervention (1 Day)||0
10641563|NCT02104739|11800638|FG005|COMPLETED|Second Intervention (1 Day)||2
10641564|NCT02104739|11800639|FG006|COMPLETED|Second Intervention (1 Day)||0
10641565|NCT02104739|11800633|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10641566|NCT02104739|11800634|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10641567|NCT02104739|11800635|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
10641568|NCT02104739|11800636|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
10641569|NCT02104739|11800637|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
10641570|NCT02104739|11800638|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
10641571|NCT02104739|11800639|FG006|NOT COMPLETED|Second Intervention (1 Day)||0
10641572|NCT02104739|11800633|FG000|STARTED|Washout (Min of 10 and Max of 107 Days)||1
10654157|NCT02200055|11814815|FG000|COMPLETED|Overall Study||86
10641573|NCT02104739|11800634|FG001|STARTED|Washout (Min of 10 and Max of 107 Days)||4
10641574|NCT02104739|11800635|FG002|STARTED|Washout (Min of 10 and Max of 107 Days)||2
10641575|NCT02104739|11800636|FG003|STARTED|Washout (Min of 10 and Max of 107 Days)||7
10641576|NCT02104739|11800637|FG004|STARTED|Washout (Min of 10 and Max of 107 Days)||0
10641577|NCT02104739|11800638|FG005|STARTED|Washout (Min of 10 and Max of 107 Days)||2
10641578|NCT02104739|11800639|FG006|STARTED|Washout (Min of 10 and Max of 107 Days)||0
10641579|NCT02104739|11800633|FG000|COMPLETED|Washout (Min of 10 and Max of 107 Days)||1
10641580|NCT02104739|11800634|FG001|COMPLETED|Washout (Min of 10 and Max of 107 Days)||4
10641581|NCT02104739|11800635|FG002|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
10641582|NCT02104739|11800636|FG003|COMPLETED|Washout (Min of 10 and Max of 107 Days)||7
10641583|NCT02104739|11800637|FG004|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
10641584|NCT02104739|11800638|FG005|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
10641585|NCT02104739|11800639|FG006|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
10641586|NCT02104739|11800633|FG000|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
10641587|NCT02104739|11800634|FG001|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
10641588|NCT02104739|11800635|FG002|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
10641589|NCT02104739|11800636|FG003|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
10641590|NCT02104739|11800637|FG004|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
10641591|NCT02104739|11800638|FG005|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
10641592|NCT02104739|11800639|FG006|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
10641593|NCT02104739|11800633|FG000|STARTED|Third Intervention (1 Day)||1
10641594|NCT02104739|11800634|FG001|STARTED|Third Intervention (1 Day)||4
10641595|NCT02104739|11800635|FG002|STARTED|Third Intervention (1 Day)||2
10641596|NCT02104739|11800636|FG003|STARTED|Third Intervention (1 Day)||7
10641597|NCT02104739|11800637|FG004|STARTED|Third Intervention (1 Day)||0
10641598|NCT02104739|11800638|FG005|STARTED|Third Intervention (1 Day)||2
10641599|NCT02104739|11800639|FG006|STARTED|Third Intervention (1 Day)||0
10641600|NCT02104739|11800633|FG000|COMPLETED|Third Intervention (1 Day)||1
10641601|NCT02104739|11800634|FG001|COMPLETED|Third Intervention (1 Day)||4
10641602|NCT02104739|11800635|FG002|COMPLETED|Third Intervention (1 Day)||2
10641603|NCT02104739|11800636|FG003|COMPLETED|Third Intervention (1 Day)||7
10641604|NCT02104739|11800637|FG004|COMPLETED|Third Intervention (1 Day)||0
10641605|NCT02104739|11800638|FG005|COMPLETED|Third Intervention (1 Day)||2
10641606|NCT02104739|11800639|FG006|COMPLETED|Third Intervention (1 Day)||0
10641607|NCT02104739|11800633|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
10641608|NCT02104739|11800634|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
10641609|NCT02104739|11800635|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
10641610|NCT02104739|11800636|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
10641611|NCT02104739|11800637|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
10641612|NCT02104739|11800638|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
10641613|NCT02104739|11800639|FG006|NOT COMPLETED|Third Intervention (1 Day)||0
10641614|NCT02104739|11800633|FG000|STARTED|Washout (Min of 10 and Max of 323 Days)||0
10641615|NCT02104739|11800634|FG001|STARTED|Washout (Min of 10 and Max of 323 Days)||0
10641616|NCT02104739|11800635|FG002|STARTED|Washout (Min of 10 and Max of 323 Days)||0
10641617|NCT02104739|11800636|FG003|STARTED|Washout (Min of 10 and Max of 323 Days)||0
10641618|NCT02104739|11800637|FG004|STARTED|Washout (Min of 10 and Max of 323 Days)||0
10641619|NCT02104739|11800638|FG005|STARTED|Washout (Min of 10 and Max of 323 Days)||0
10641620|NCT02104739|11800639|FG006|STARTED|Washout (Min of 10 and Max of 323 Days)||8
10641621|NCT02104739|11800633|FG000|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
10641622|NCT02104739|11800634|FG001|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
10641623|NCT02104739|11800635|FG002|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
10641624|NCT02104739|11800636|FG003|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
10641625|NCT02104739|11800637|FG004|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
10641626|NCT02104739|11800638|FG005|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
10641627|NCT02104739|11800639|FG006|COMPLETED|Washout (Min of 10 and Max of 323 Days)||7
10641628|NCT02104739|11800633|FG000|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
10641629|NCT02104739|11800634|FG001|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
10641630|NCT02104739|11800635|FG002|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
10641631|NCT02104739|11800636|FG003|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
10641632|NCT02104739|11800637|FG004|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
10641633|NCT02104739|11800638|FG005|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
10641634|NCT02104739|11800639|FG006|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||1
10641635|NCT02104739|11800633|FG000|STARTED|Extension Phase (6 Weeks)||0
10641636|NCT02104739|11800634|FG001|STARTED|Extension Phase (6 Weeks)||0
10641637|NCT02104739|11800635|FG002|STARTED|Extension Phase (6 Weeks)||0
10641638|NCT02104739|11800636|FG003|STARTED|Extension Phase (6 Weeks)||0
10641639|NCT02104739|11800637|FG004|STARTED|Extension Phase (6 Weeks)||0
10641640|NCT02104739|11800638|FG005|STARTED|Extension Phase (6 Weeks)||0
10641641|NCT02104739|11800639|FG006|STARTED|Extension Phase (6 Weeks)||8
10641642|NCT02104739|11800633|FG000|COMPLETED|Extension Phase (6 Weeks)||0
10641643|NCT02104739|11800634|FG001|COMPLETED|Extension Phase (6 Weeks)||0
10641644|NCT02104739|11800635|FG002|COMPLETED|Extension Phase (6 Weeks)||0
10641645|NCT02104739|11800636|FG003|COMPLETED|Extension Phase (6 Weeks)||0
10641646|NCT02104739|11800637|FG004|COMPLETED|Extension Phase (6 Weeks)||0
10641647|NCT02104739|11800638|FG005|COMPLETED|Extension Phase (6 Weeks)||0
10641648|NCT02104739|11800639|FG006|COMPLETED|Extension Phase (6 Weeks)||7
10641649|NCT02104739|11800633|FG000|NOT COMPLETED|Extension Phase (6 Weeks)||0
10641650|NCT02104739|11800634|FG001|NOT COMPLETED|Extension Phase (6 Weeks)||0
10641651|NCT02104739|11800635|FG002|NOT COMPLETED|Extension Phase (6 Weeks)||0
10641652|NCT02104739|11800636|FG003|NOT COMPLETED|Extension Phase (6 Weeks)||0
10641653|NCT02104739|11800637|FG004|NOT COMPLETED|Extension Phase (6 Weeks)||0
10641654|NCT02104739|11800638|FG005|NOT COMPLETED|Extension Phase (6 Weeks)||0
10641655|NCT02104739|11800639|FG006|NOT COMPLETED|Extension Phase (6 Weeks)||1
10641656|NCT02104752|11800651|FG000|STARTED|Overall Study||18
10641657|NCT02104752|11800652|FG001|STARTED|Overall Study||21
10641658|NCT02104752|11800651|FG000|COMPLETED|Overall Study||17
10641659|NCT02104752|11800652|FG001|COMPLETED|Overall Study||19
10641660|NCT02104752|11800651|FG000|NOT COMPLETED|Overall Study||1
10641661|NCT02104752|11800652|FG001|NOT COMPLETED|Overall Study||2
10641662|NCT02104765|11800665|FG000|STARTED|Overall Study||8
10641663|NCT02104765|11800666|FG001|STARTED|Overall Study||6
10641664|NCT02104765|11800667|FG002|STARTED|Overall Study||6
10641665|NCT02104765|11800668|FG003|STARTED|Overall Study||7
10641666|NCT02104765|11800669|FG004|STARTED|Overall Study||8
10641667|NCT02104765|11800670|FG005|STARTED|Overall Study||2
10641668|NCT02104765|11800671|FG006|STARTED|Overall Study||8
10641669|NCT02104765|11800665|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
10641670|NCT02104765|11800666|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
10641671|NCT02104765|11800667|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
10641672|NCT02104765|11800668|FG003|Received at Least 1 Dose of Study Drug|Overall Study||7
10641673|NCT02104765|11800669|FG004|Received at Least 1 Dose of Study Drug|Overall Study||8
10641674|NCT02104765|11800670|FG005|Received at Least 1 Dose of Study Drug|Overall Study||2
10641675|NCT02104765|11800671|FG006|Received at Least 1 Dose of Study Drug|Overall Study||8
10641676|NCT02104765|11800665|FG000|COMPLETED|Overall Study||8
10641677|NCT02104765|11800666|FG001|COMPLETED|Overall Study||6
10641678|NCT02104765|11800667|FG002|COMPLETED|Overall Study||5
10641679|NCT02104765|11800668|FG003|COMPLETED|Overall Study||6
10641680|NCT02104765|11800669|FG004|COMPLETED|Overall Study||7
10641681|NCT02104765|11800670|FG005|COMPLETED|Overall Study||2
10641682|NCT02104765|11800671|FG006|COMPLETED|Overall Study||7
10641683|NCT02104765|11800665|FG000|NOT COMPLETED|Overall Study||0
10641684|NCT02104765|11800666|FG001|NOT COMPLETED|Overall Study||0
10641685|NCT02104765|11800667|FG002|NOT COMPLETED|Overall Study||1
10641686|NCT02104765|11800668|FG003|NOT COMPLETED|Overall Study||1
10641687|NCT02104765|11800669|FG004|NOT COMPLETED|Overall Study||1
10641688|NCT02104765|11800670|FG005|NOT COMPLETED|Overall Study||0
10641689|NCT02104765|11800671|FG006|NOT COMPLETED|Overall Study||1
10641690|NCT02104804|11800695|FG000|STARTED|Overall Study|Number of patients who were randomized|234
10641691|NCT02104804|11800696|FG001|STARTED|Overall Study|Number of patients who were randomized|232
10641692|NCT02104804|11800695|FG000|COMPLETED|Overall Study|Number of patients who completed 24 weeks of treatment|218
10641693|NCT02104804|11800696|FG001|COMPLETED|Overall Study|Of the 19 who did not complete, 1 did not take study medication after randomization.|213
10641694|NCT02104804|11800695|FG000|NOT COMPLETED|Overall Study||16
10641695|NCT02104804|11800696|FG001|NOT COMPLETED|Overall Study||19
10641696|NCT02104817|11800704|FG000|STARTED|Overall Study||6539
10641697|NCT02104817|11800705|FG001|STARTED|Overall Study||6539
10641698|NCT02104817|11800704|FG000|COMPLETED|Overall Study||80
10641699|NCT02104817|11800705|FG001|COMPLETED|Overall Study||92
10641700|NCT02104817|11800704|FG000|NOT COMPLETED|Overall Study||6459
10641701|NCT02104817|11800705|FG001|NOT COMPLETED|Overall Study||6447
10641702|NCT02104830|11800714|FG000|STARTED|Overall Study||42
10641703|NCT02104830|11800715|FG001|STARTED|Overall Study||43
10641704|NCT02104830|11800716|FG002|STARTED|Overall Study||43
10641705|NCT02104830|11800714|FG000|COMPLETED|Overall Study||38
10641706|NCT02104830|11800715|FG001|COMPLETED|Overall Study||36
10641707|NCT02104830|11800716|FG002|COMPLETED|Overall Study||36
10641708|NCT02104830|11800714|FG000|NOT COMPLETED|Overall Study||4
10641709|NCT02104830|11800715|FG001|NOT COMPLETED|Overall Study||7
10641710|NCT02104830|11800716|FG002|NOT COMPLETED|Overall Study||7
10641711|NCT02104895|11800726|FG000|STARTED|Overall Study||260
10641712|NCT02104895|11800727|FG001|STARTED|Overall Study||260
10641713|NCT02104895|11800726|FG000|COMPLETED|Overall Study||260
10641714|NCT02104895|11800727|FG001|COMPLETED|Overall Study||246
10641715|NCT02104895|11800726|FG000|NOT COMPLETED|Overall Study||0
10641716|NCT02104895|11800727|FG001|NOT COMPLETED|Overall Study||14
10641717|NCT02104947|11800735|FG000|STARTED|Overall Study||301
10641718|NCT02104947|11800736|FG001|STARTED|Overall Study||202
10641719|NCT02104947|11800735|FG000|COMPLETED|Overall Study||222
10641720|NCT02104947|11800736|FG001|COMPLETED|Overall Study||146
10641721|NCT02104947|11800735|FG000|NOT COMPLETED|Overall Study||79
10641722|NCT02104947|11800736|FG001|NOT COMPLETED|Overall Study||56
10641723|NCT02105012|11800746|FG000|STARTED|Overall Study||147
10641724|NCT02105012|11800746|FG000|BD MDI 320 µg|Overall Study||124
10641725|NCT02105012|11800746|FG000|BD MDI 160 µg|Overall Study||132
10641726|NCT02105012|11800746|FG000|BD MDI 80 µg|Overall Study||64
10641727|NCT02105012|11800746|FG000|BD MDI 40 µg|Overall Study||63
10641728|NCT02105012|11800746|FG000|Placebo MDI|Overall Study||127
10641729|NCT02105012|11800746|FG000|COMPLETED|Overall Study||114
10641730|NCT02105012|11800746|FG000|NOT COMPLETED|Overall Study||33
10641731|NCT02105246|11800760|FG000|STARTED|Overall Study||557
10641732|NCT02105246|11800761|FG001|STARTED|Overall Study||597
10641733|NCT02105246|11800760|FG000|COMPLETED|Overall Study||557
10641734|NCT02105246|11800761|FG001|COMPLETED|Overall Study||597
10641735|NCT02105246|11800760|FG000|NOT COMPLETED|Overall Study||0
10641736|NCT02105246|11800761|FG001|NOT COMPLETED|Overall Study||0
10641737|NCT02105272|11800773|FG000|STARTED|Overall Study||118
10641738|NCT02105272|11800774|FG001|STARTED|Overall Study||119
10641739|NCT02105272|11800773|FG000|COMPLETED|Overall Study||113
10641740|NCT02105272|11800774|FG001|COMPLETED|Overall Study||116
10641741|NCT02105272|11800773|FG000|NOT COMPLETED|Overall Study||5
10641742|NCT02105272|11800774|FG001|NOT COMPLETED|Overall Study||3
10641743|NCT02105285|11800783|FG000|STARTED|Overall Study||78
10641744|NCT02105285|11800784|FG001|STARTED|Overall Study||78
10641745|NCT02105285|11800785|FG002|STARTED|Overall Study||37
10641746|NCT02105285|11800783|FG000|COMPLETED|Overall Study||76
10641747|NCT02105285|11800784|FG001|COMPLETED|Overall Study||76
10641748|NCT02105285|11800785|FG002|COMPLETED|Overall Study||37
10641749|NCT02105285|11800783|FG000|NOT COMPLETED|Overall Study||2
10641750|NCT02105285|11800784|FG001|NOT COMPLETED|Overall Study||2
10641751|NCT02105285|11800785|FG002|NOT COMPLETED|Overall Study||0
10641752|NCT02105324|11800792|FG000|STARTED|Period 1||9
10641753|NCT02105324|11800793|FG001|STARTED|Period 1||10
10641754|NCT02105324|11800792|FG000|COMPLETED|Period 1||9
10641755|NCT02105324|11800793|FG001|COMPLETED|Period 1||10
10641756|NCT02105324|11800792|FG000|NOT COMPLETED|Period 1||0
10641757|NCT02105324|11800793|FG001|NOT COMPLETED|Period 1||0
10641758|NCT02105324|11800792|FG000|STARTED|Period 2||9
10641759|NCT02105324|11800793|FG001|STARTED|Period 2||10
10641760|NCT02105324|11800792|FG000|COMPLETED|Period 2||9
10641761|NCT02105324|11800793|FG001|COMPLETED|Period 2||10
10641762|NCT02105324|11800792|FG000|NOT COMPLETED|Period 2||0
10641763|NCT02105324|11800793|FG001|NOT COMPLETED|Period 2||0
10641764|NCT02105415|11800804|FG000|STARTED|Overall Study||76
10641765|NCT02105415|11800805|FG001|STARTED|Overall Study||84
10641766|NCT02105415|11800804|FG000|COMPLETED|Overall Study||73
10641767|NCT02105415|11800805|FG001|COMPLETED|Overall Study||79
10641768|NCT02105415|11800804|FG000|NOT COMPLETED|Overall Study||3
10641769|NCT02105415|11800805|FG001|NOT COMPLETED|Overall Study||5
10641770|NCT02105454|11800816|FG000|STARTED|Overall Study||79
10641771|NCT02105454|11800816|FG000|COMPLETED|Overall Study||78
10641772|NCT02105454|11800816|FG000|NOT COMPLETED|Overall Study||1
10641773|NCT02105467|11800822|FG000|STARTED|Period 1||316
10641774|NCT02105467|11800823|FG001|STARTED|Period 1||105
10641775|NCT02105467|11800822|FG000|COMPLETED|Period 1||314
10641776|NCT02105467|11800823|FG001|COMPLETED|Period 1||105
10641777|NCT02105467|11800822|FG000|NOT COMPLETED|Period 1||2
10641778|NCT02105467|11800823|FG001|NOT COMPLETED|Period 1||0
10641779|NCT02105467|11800822|FG000|STARTED|Period 2||314
10641847|NCT02105948|11800888|FG003|Withdrew IP Due to: Adverse Event|Overall Study||13
10641780|NCT02105467|11800823|FG001|STARTED|Period 2|One participant did not receive deferred treatment (Period 2) but proceeded directly to Period 3|104
10641781|NCT02105467|11800822|FG000|COMPLETED|Period 2||312
10641782|NCT02105467|11800823|FG001|COMPLETED|Period 2||102
10641783|NCT02105467|11800822|FG000|NOT COMPLETED|Period 2||2
10641784|NCT02105467|11800823|FG001|NOT COMPLETED|Period 2||2
10641785|NCT02105467|11800822|FG000|STARTED|Period 3|The Immediate Treatment Group completed the study with Period 2|0
10641786|NCT02105467|11800823|FG001|STARTED|Period 3|One participant did not receive deferred treatment (Period 2) but proceeded directly to Period 3|103
10641787|NCT02105467|11800822|FG000|COMPLETED|Period 3||0
10641788|NCT02105467|11800823|FG001|COMPLETED|Period 3||102
10641789|NCT02105467|11800822|FG000|NOT COMPLETED|Period 3||0
10641790|NCT02105467|11800823|FG001|NOT COMPLETED|Period 3||1
10641791|NCT02105558|11800832|FG000|STARTED|Overall Study||15
10641792|NCT02105558|11800833|FG001|STARTED|Overall Study||28
10641793|NCT02105558|11800832|FG000|COMPLETED|Overall Study||15
10641794|NCT02105558|11800833|FG001|COMPLETED|Overall Study||28
10641795|NCT02105558|11800832|FG000|NOT COMPLETED|Overall Study||0
10641796|NCT02105558|11800833|FG001|NOT COMPLETED|Overall Study||0
10641797|NCT02105662|11800839|FG000|STARTED|Overall Study||218
10641798|NCT02105662|11800839|FG000|COMPLETED|Overall Study||212
10641799|NCT02105662|11800839|FG000|NOT COMPLETED|Overall Study||6
10641800|NCT02105688|11800845|FG000|STARTED|Part A: Double-Blind||201
10641801|NCT02105688|11800846|FG001|STARTED|Part A: Double-Blind||100
10641802|NCT02105688|11800845|FG000|COMPLETED|Part A: Double-Blind|Completed Part A|181
10641803|NCT02105688|11800846|FG001|COMPLETED|Part A: Double-Blind|Completed Part A|83
10641804|NCT02105688|11800845|FG000|NOT COMPLETED|Part A: Double-Blind||20
10641805|NCT02105688|11800846|FG001|NOT COMPLETED|Part A: Double-Blind||17
10641806|NCT02105688|11800845|FG000|STARTED|Part B: Observational Follow-up|Completed Part A and met Part B Extension criteria|131
10641807|NCT02105688|11800846|FG001|STARTED|Part B: Observational Follow-up|Completed Part A and met Part B Extension criteria|68
10641808|NCT02105688|11800845|FG000|COMPLETED|Part B: Observational Follow-up|Completed Part B extension|94
10641809|NCT02105688|11800846|FG001|COMPLETED|Part B: Observational Follow-up|Completed Part B extension|48
10641810|NCT02105688|11800845|FG000|NOT COMPLETED|Part B: Observational Follow-up||37
10641811|NCT02105688|11800846|FG001|NOT COMPLETED|Part B: Observational Follow-up||20
10641812|NCT02105701|11800857|FG000|STARTED|Overall Study||105
10641813|NCT02105701|11800858|FG001|STARTED|Overall Study||104
10641814|NCT02105701|11800859|FG002|STARTED|Overall Study||105
10641815|NCT02105701|11800860|FG003|STARTED|Overall Study||106
10641816|NCT02105701|11800857|FG000|COMPLETED|Overall Study||101
10641817|NCT02105701|11800858|FG001|COMPLETED|Overall Study||103
10641818|NCT02105701|11800859|FG002|COMPLETED|Overall Study||102
10641819|NCT02105701|11800860|FG003|COMPLETED|Overall Study||104
10641820|NCT02105701|11800857|FG000|NOT COMPLETED|Overall Study||4
10641821|NCT02105701|11800858|FG001|NOT COMPLETED|Overall Study||1
10641822|NCT02105701|11800859|FG002|NOT COMPLETED|Overall Study||3
10641823|NCT02105701|11800860|FG003|NOT COMPLETED|Overall Study||2
10641824|NCT02105740|11800872|FG000|STARTED|Overall Study|Application of EVA and HADS scales and after that application of hypnosis intervention|12
10641825|NCT02105740|11800873|FG001|STARTED|Overall Study|Application of EVA and HADS scales|12
10641826|NCT02105740|11800872|FG000|Second|Overall Study|Intervention with hypnosis and application of EVA scales and HADS (n = 12)|12
10641827|NCT02105740|11800873|FG001|Second|Overall Study|Application of EVA and HADS scales. One accompanying lost|11
10705989|NCT02604199|11870455|FG003|NOT COMPLETED|Overall Study||3
10705990|NCT02604212|11870472|FG000|STARTED|Overall Study||6
10705991|NCT02604212|11870473|FG001|STARTED|Overall Study||5
10705992|NCT02604212|11870474|FG002|STARTED|Overall Study||10
10705993|NCT02604212|11870475|FG003|STARTED|Overall Study||11
10705994|NCT02604212|11870472|FG000|COMPLETED|Overall Study||4
10705995|NCT02604212|11870473|FG001|COMPLETED|Overall Study||4
10705996|NCT02604212|11870474|FG002|COMPLETED|Overall Study||6
10705997|NCT02604212|11870475|FG003|COMPLETED|Overall Study||8
10705998|NCT02604212|11870472|FG000|NOT COMPLETED|Overall Study||2
10705999|NCT02604212|11870473|FG001|NOT COMPLETED|Overall Study||1
10706000|NCT02604212|11870474|FG002|NOT COMPLETED|Overall Study||4
10706001|NCT02604212|11870475|FG003|NOT COMPLETED|Overall Study||3
10706002|NCT02604264|11870492|FG000|STARTED|Run-In||618
10641828|NCT02105740|11800872|FG000|COMPLETED|Overall Study|Application of EVA and HADS scales and data analysis|12
10641829|NCT02105740|11800873|FG001|COMPLETED|Overall Study|Application of EVA and HADS scales and data analysis|11
10641830|NCT02105740|11800872|FG000|NOT COMPLETED|Overall Study||0
10641831|NCT02105740|11800873|FG001|NOT COMPLETED|Overall Study||1
10641832|NCT02105948|11800885|FG000|STARTED|Overall Study||229
10641833|NCT02105948|11800886|FG001|STARTED|Overall Study||233
10641834|NCT02105948|11800887|FG002|STARTED|Overall Study||190
10641835|NCT02105948|11800888|FG003|STARTED|Overall Study||184
10641836|NCT02105948|11800885|FG000|Completed Investigational Product (IP)|Overall Study||185
10641837|NCT02105948|11800886|FG001|Completed Investigational Product (IP)|Overall Study||203
10641838|NCT02105948|11800887|FG002|Completed Investigational Product (IP)|Overall Study||148
10641839|NCT02105948|11800888|FG003|Completed Investigational Product (IP)|Overall Study||149
10641840|NCT02105948|11800885|FG000|Not Completed IP|Overall Study||44
10641841|NCT02105948|11800886|FG001|Not Completed IP|Overall Study||30
10641842|NCT02105948|11800887|FG002|Not Completed IP|Overall Study||42
10641843|NCT02105948|11800888|FG003|Not Completed IP|Overall Study||35
10641844|NCT02105948|11800885|FG000|Withdrew IP Due to: Adverse Event|Overall Study||20
10641845|NCT02105948|11800886|FG001|Withdrew IP Due to: Adverse Event|Overall Study||16
10641846|NCT02105948|11800887|FG002|Withdrew IP Due to: Adverse Event|Overall Study||15
10641848|NCT02105948|11800885|FG000|Withdrew IP Due to: Lack of Efficacy|Overall Study||5
10641849|NCT02105948|11800886|FG001|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
10641850|NCT02105948|11800887|FG002|Withdrew IP Due to: Lack of Efficacy|Overall Study||8
10641851|NCT02105948|11800888|FG003|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
10641852|NCT02105948|11800885|FG000|Withdrew IP Due to: Protocol Deviation|Overall Study||1
10641853|NCT02105948|11800886|FG001|Withdrew IP Due to: Protocol Deviation|Overall Study||3
10641854|NCT02105948|11800887|FG002|Withdrew IP Due to: Protocol Deviation|Overall Study||3
10641855|NCT02105948|11800888|FG003|Withdrew IP Due to: Protocol Deviation|Overall Study||0
10641856|NCT02105948|11800885|FG000|Withdrew IP Due to: Lost to Follow-up|Overall Study||0
10641857|NCT02105948|11800886|FG001|Withdrew IP Due to: Lost to Follow-up|Overall Study||0
10641858|NCT02105948|11800887|FG002|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
10641859|NCT02105948|11800888|FG003|Withdrew IP Due to: Lost to Follow-up|Overall Study||2
10641860|NCT02105948|11800885|FG000|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||16
10641861|NCT02105948|11800886|FG001|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||8
10641862|NCT02105948|11800887|FG002|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
10706003|NCT02604264|11870493|FG001|STARTED|Run-In|The 1-mo run-in period data was used to determine pre-study demographics and PBC rate.|611
10706004|NCT02604264|11870492|FG000|COMPLETED|Run-In||618
10706005|NCT02604264|11870493|FG001|COMPLETED|Run-In||611
10706006|NCT02604264|11870492|FG000|NOT COMPLETED|Run-In||0
10706007|NCT02604264|11870493|FG001|NOT COMPLETED|Run-In||0
10706008|NCT02604264|11870492|FG000|STARTED|Intervention||1445
10706009|NCT02604264|11870493|FG001|STARTED|Intervention||1467
10641863|NCT02105948|11800888|FG003|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||15
10641864|NCT02105948|11800885|FG000|Withdrew IP Due to: Physician Decision|Overall Study||2
10641865|NCT02105948|11800886|FG001|Withdrew IP Due to: Physician Decision|Overall Study||1
10641866|NCT02105948|11800887|FG002|Withdrew IP Due to: Physician Decision|Overall Study||4
10641867|NCT02105948|11800888|FG003|Withdrew IP Due to: Physician Decision|Overall Study||2
10641868|NCT02105948|11800885|FG000|Withdrew IP Due to: Stopping Criteria|Overall Study||0
10641869|NCT02105948|11800886|FG001|Withdrew IP Due to: Stopping Criteria|Overall Study||0
10641870|NCT02105948|11800887|FG002|Withdrew IP Due to: Stopping Criteria|Overall Study||0
10641871|NCT02105948|11800888|FG003|Withdrew IP Due to: Stopping Criteria|Overall Study||1
10641872|NCT02105948|11800885|FG000|COMPLETED|Overall Study||202
10641873|NCT02105948|11800886|FG001|COMPLETED|Overall Study||213
10641874|NCT02105948|11800887|FG002|COMPLETED|Overall Study||162
10641875|NCT02105948|11800888|FG003|COMPLETED|Overall Study||157
10641876|NCT02105948|11800885|FG000|NOT COMPLETED|Overall Study||27
10641877|NCT02105948|11800886|FG001|NOT COMPLETED|Overall Study||20
10641878|NCT02105948|11800887|FG002|NOT COMPLETED|Overall Study||28
10641879|NCT02105948|11800888|FG003|NOT COMPLETED|Overall Study||27
10641880|NCT02105961|11800902|FG000|STARTED|Overall Study||226
10641881|NCT02105961|11800903|FG001|STARTED|Overall Study||223
10641882|NCT02105961|11800904|FG002|STARTED|Overall Study||225
10641883|NCT02105961|11800902|FG000|Completed Investigational Product (IP)|Overall Study||170
10641884|NCT02105961|11800903|FG001|Completed Investigational Product (IP)|Overall Study||196
10641885|NCT02105961|11800904|FG002|Completed Investigational Product (IP)|Overall Study||183
10641886|NCT02105961|11800902|FG000|Not Completed IP|Overall Study||56
10641887|NCT02105961|11800903|FG001|Not Completed IP|Overall Study||27
10641888|NCT02105961|11800904|FG002|Not Completed IP|Overall Study||42
10641889|NCT02105961|11800902|FG000|Withdrew IP Due to: Adverse Event|Overall Study||27
10641890|NCT02105961|11800903|FG001|Withdrew IP Due to: Adverse Event|Overall Study||9
10641891|NCT02105961|11800904|FG002|Withdrew IP Due to: Adverse Event|Overall Study||25
10641892|NCT02105961|11800902|FG000|Withdrew IP Due to: Stopping Criteria|Overall Study||1
10641893|NCT02105961|11800903|FG001|Withdrew IP Due to: Stopping Criteria|Overall Study||1
10641894|NCT02105961|11800904|FG002|Withdrew IP Due to: Stopping Criteria|Overall Study||0
10641895|NCT02105961|11800902|FG000|Withdrew IP Due to: Lack of Efficacy|Overall Study||6
10641896|NCT02105961|11800903|FG001|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
10641897|NCT02105961|11800904|FG002|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
10641898|NCT02105961|11800902|FG000|Withdrew IP Due to: Protocol Deviation|Overall Study||2
10641899|NCT02105961|11800903|FG001|Withdrew IP Due to: Protocol Deviation|Overall Study||0
10641900|NCT02105961|11800904|FG002|Withdrew IP Due to: Protocol Deviation|Overall Study||1
10641901|NCT02105961|11800902|FG000|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
10641902|NCT02105961|11800903|FG001|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
10641903|NCT02105961|11800904|FG002|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
10641904|NCT02105961|11800902|FG000|Withdrew IP Due to: Physician Decision|Overall Study||2
10641905|NCT02105961|11800903|FG001|Withdrew IP Due to: Physician Decision|Overall Study||3
10641906|NCT02105961|11800904|FG002|Withdrew IP Due to: Physician Decision|Overall Study||1
10641907|NCT02105961|11800902|FG000|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||16
10641908|NCT02105961|11800903|FG001|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
10641909|NCT02105961|11800904|FG002|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
10641910|NCT02105961|11800902|FG000|Withdrew IP Due to: Site Closed|Overall Study||1
10641911|NCT02105961|11800903|FG001|Withdrew IP Due to: Site Closed|Overall Study||0
10641912|NCT02105961|11800904|FG002|Withdrew IP Due to: Site Closed|Overall Study||1
10641913|NCT02105961|11800902|FG000|COMPLETED|Overall Study||185
10641914|NCT02105961|11800903|FG001|COMPLETED|Overall Study||206
10641915|NCT02105961|11800904|FG002|COMPLETED|Overall Study||195
10641916|NCT02105961|11800902|FG000|NOT COMPLETED|Overall Study||41
10641917|NCT02105961|11800903|FG001|NOT COMPLETED|Overall Study||17
10641918|NCT02105961|11800904|FG002|NOT COMPLETED|Overall Study||30
10641919|NCT02105974|11800915|FG000|STARTED|2 Week Run-in Period||2423
10641920|NCT02105974|11800916|FG001|STARTED|2 Week Run-in Period||0
10641921|NCT02105974|11800917|FG002|STARTED|2 Week Run-in Period||0
10641922|NCT02105974|11800915|FG000|COMPLETED|2 Week Run-in Period||1622
10641923|NCT02105974|11800916|FG001|COMPLETED|2 Week Run-in Period||0
10641924|NCT02105974|11800917|FG002|COMPLETED|2 Week Run-in Period||0
10641925|NCT02105974|11800915|FG000|NOT COMPLETED|2 Week Run-in Period||801
10641926|NCT02105974|11800916|FG001|NOT COMPLETED|2 Week Run-in Period||0
10641927|NCT02105974|11800917|FG002|NOT COMPLETED|2 Week Run-in Period||0
10641928|NCT02105974|11800915|FG000|STARTED|12 Week (Wk) Treatment Period (TP)||0
10641929|NCT02105974|11800916|FG001|STARTED|12 Week (Wk) Treatment Period (TP)||806
10641930|NCT02105974|11800917|FG002|STARTED|12 Week (Wk) Treatment Period (TP)||814
10641931|NCT02105974|11800915|FG000|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)||0
10641932|NCT02105974|11800916|FG001|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)|Par completed TP if attended Visit (V7, Wk12), did not withdraw at V7 and did not stop trt before V7|764
10641933|NCT02105974|11800917|FG002|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)|Par completed TP if attended Visit (V7, Wk12), did not withdraw at V7 and did not stop trt before V7|754
10641934|NCT02105974|11800915|FG000|COMPLETED|12 Week (Wk) Treatment Period (TP)||0
10641935|NCT02105974|11800916|FG001|COMPLETED|12 Week (Wk) Treatment Period (TP)|Par. completed study if attended visit 7, had follow-up contact and no early withdrawal|764
10654158|NCT02200055|11814815|FG000|NOT COMPLETED|Overall Study||0
10641936|NCT02105974|11800917|FG002|COMPLETED|12 Week (Wk) Treatment Period (TP)|Par. completed study if attended visit 7, had follow-up contact and no early withdrawal|756
10641937|NCT02105974|11800915|FG000|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||0
10641938|NCT02105974|11800916|FG001|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||42
10641939|NCT02105974|11800917|FG002|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||58
10654159|NCT02200211|11814825|FG000|STARTED|Overall Study||190
10654160|NCT02200211|11814826|FG001|STARTED|Overall Study||195
10654161|NCT02200211|11814827|FG002|STARTED|Overall Study||40
10654162|NCT02200211|11814828|FG003|STARTED|Overall Study||60
10654163|NCT02200211|11814825|FG000|Included in 16-week Primary Analysis|Overall Study||177
10654164|NCT02200211|11814826|FG001|Included in 16-week Primary Analysis|Overall Study||186
10654165|NCT02200211|11814827|FG002|Included in 16-week Primary Analysis|Overall Study||39
10654166|NCT02200211|11814828|FG003|Included in 16-week Primary Analysis|Overall Study||56
10654167|NCT02200211|11814825|FG000|COMPLETED|Overall Study||182
10654168|NCT02200211|11814826|FG001|COMPLETED|Overall Study||188
10654169|NCT02200211|11814827|FG002|COMPLETED|Overall Study||39
10654170|NCT02200211|11814828|FG003|COMPLETED|Overall Study||58
10654171|NCT02200211|11814825|FG000|NOT COMPLETED|Overall Study||8
10654172|NCT02200211|11814826|FG001|NOT COMPLETED|Overall Study||7
10654173|NCT02200211|11814827|FG002|NOT COMPLETED|Overall Study||1
10654174|NCT02200211|11814828|FG003|NOT COMPLETED|Overall Study||2
10654184|NCT02200458|11814859|FG000|STARTED|Overall Study||62
10654185|NCT02200458|11814859|FG000|COMPLETED|Overall Study||62
10654186|NCT02200458|11814859|FG000|NOT COMPLETED|Overall Study||0
10654187|NCT02200510|11814865|FG000|STARTED|Overall Study|Number who only completed self-management or completed it before portal (could do 6 months later).|31
10654188|NCT02200510|11814866|FG001|STARTED|Overall Study|Number who only completed portal or completed it before self-management (could do 6 months later).|47
10654189|NCT02200510|11814865|FG000|COMPLETED|Overall Study|This is the number of participants with baseline and post data.|22
10654190|NCT02200510|11814866|FG001|COMPLETED|Overall Study|This number is the number of participants with both baseline and post data.|44
10654191|NCT02200510|11814865|FG000|NOT COMPLETED|Overall Study||9
10457300|NCT01010061|11605040|FG000|STARTED|Overall Study||238
10457301|NCT01010061|11605041|FG001|STARTED|Overall Study||118
10457302|NCT01010061|11605040|FG000|Received Study Drug|Overall Study||236
10654192|NCT02200510|11814866|FG001|NOT COMPLETED|Overall Study||3
10654193|NCT02200523|11814874|FG000|STARTED|Overall Study||20
10654194|NCT02200523|11814875|FG001|STARTED|Overall Study||20
10654195|NCT02200523|11814874|FG000|COMPLETED|Overall Study||20
10654196|NCT02200523|11814875|FG001|COMPLETED|Overall Study||20
10654197|NCT02200523|11814874|FG000|NOT COMPLETED|Overall Study||0
10654198|NCT02200523|11814875|FG001|NOT COMPLETED|Overall Study||0
10654199|NCT02200536|11814884|FG000|STARTED|Overall Study||32
10654200|NCT02200536|11814885|FG001|STARTED|Overall Study||30
10654201|NCT02200536|11814886|FG002|STARTED|Overall Study||30
10654202|NCT02200536|11814884|FG000|COMPLETED|Overall Study||32
10654203|NCT02200536|11814885|FG001|COMPLETED|Overall Study||30
10654204|NCT02200536|11814886|FG002|COMPLETED|Overall Study||30
10654205|NCT02200536|11814884|FG000|NOT COMPLETED|Overall Study||0
10654206|NCT02200536|11814885|FG001|NOT COMPLETED|Overall Study||0
10654207|NCT02200536|11814886|FG002|NOT COMPLETED|Overall Study||0
10654208|NCT02201056|11814901|FG000|STARTED|Overall Study||12
10654209|NCT02201056|11814902|FG001|STARTED|Overall Study||6
10654210|NCT02201056|11814903|FG002|STARTED|Overall Study||6
10654211|NCT02201056|11814904|FG003|STARTED|Overall Study||6
10654212|NCT02201056|11814905|FG004|STARTED|Overall Study||6
10654213|NCT02201056|11814906|FG005|STARTED|Overall Study||6
10654214|NCT02201056|11814907|FG006|STARTED|Overall Study||6
10654215|NCT02201056|11814901|FG000|COMPLETED|Overall Study||12
10654216|NCT02201056|11814902|FG001|COMPLETED|Overall Study||6
10654217|NCT02201056|11814903|FG002|COMPLETED|Overall Study||6
10654218|NCT02201056|11814904|FG003|COMPLETED|Overall Study||6
10654219|NCT02201056|11814905|FG004|COMPLETED|Overall Study||6
10654220|NCT02201056|11814906|FG005|COMPLETED|Overall Study||6
10654221|NCT02201056|11814907|FG006|COMPLETED|Overall Study||6
10457303|NCT01010061|11605041|FG001|Received Study Drug|Overall Study||116
10654222|NCT02201056|11814901|FG000|NOT COMPLETED|Overall Study||0
10641940|NCT02105987|11800925|FG000|STARTED|Early Switch Phase (24 Weeks)|Number Started represents the number of par. in the Intent-To-Treat Exposed (ITT-E) Population.|275
10641941|NCT02105987|11800926|FG001|STARTED|Early Switch Phase (24 Weeks)|Number Started represents the number of par. in the Intent-To-Treat Exposed (ITT-E) Population.|278
10641942|NCT02105987|11800927|FG002|STARTED|Early Switch Phase (24 Weeks)||0
10641943|NCT02105987|11800928|FG003|STARTED|Early Switch Phase (24 Weeks)||0
10641944|NCT02105987|11800929|FG004|STARTED|Early Switch Phase (24 Weeks)||0
10641945|NCT02105987|11800930|FG005|STARTED|Early Switch Phase (24 Weeks)||0
10641946|NCT02105987|11800925|FG000|COMPLETED|Early Switch Phase (24 Weeks)||239
10641947|NCT02105987|11800926|FG001|COMPLETED|Early Switch Phase (24 Weeks)||244
10641948|NCT02105987|11800927|FG002|COMPLETED|Early Switch Phase (24 Weeks)||0
10641949|NCT02105987|11800928|FG003|COMPLETED|Early Switch Phase (24 Weeks)||0
10641950|NCT02105987|11800929|FG004|COMPLETED|Early Switch Phase (24 Weeks)||0
10641951|NCT02105987|11800930|FG005|COMPLETED|Early Switch Phase (24 Weeks)||0
10641952|NCT02105987|11800925|FG000|NOT COMPLETED|Early Switch Phase (24 Weeks)||36
10641953|NCT02105987|11800926|FG001|NOT COMPLETED|Early Switch Phase (24 Weeks)||34
10641954|NCT02105987|11800927|FG002|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
10641955|NCT02105987|11800928|FG003|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
10641956|NCT02105987|11800929|FG004|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
10641957|NCT02105987|11800930|FG005|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
10641958|NCT02105987|11800925|FG000|STARTED|Late Switch Phase (24 Weeks)||0
10641959|NCT02105987|11800926|FG001|STARTED|Late Switch Phase (24 Weeks)||0
10641960|NCT02105987|11800927|FG002|STARTED|Late Switch Phase (24 Weeks)||275
10641961|NCT02105987|11800928|FG003|STARTED|Late Switch Phase (24 Weeks)||244
10641962|NCT02105987|11800929|FG004|STARTED|Late Switch Phase (24 Weeks)||0
10641963|NCT02105987|11800930|FG005|STARTED|Late Switch Phase (24 Weeks)||0
10641964|NCT02105987|11800925|FG000|COMPLETED|Late Switch Phase (24 Weeks)||0
10641965|NCT02105987|11800926|FG001|COMPLETED|Late Switch Phase (24 Weeks)||0
10641966|NCT02105987|11800927|FG002|COMPLETED|Late Switch Phase (24 Weeks)||230
10641967|NCT02105987|11800928|FG003|COMPLETED|Late Switch Phase (24 Weeks)||230
10641968|NCT02105987|11800929|FG004|COMPLETED|Late Switch Phase (24 Weeks)||0
10641969|NCT02105987|11800930|FG005|COMPLETED|Late Switch Phase (24 Weeks)||0
10641970|NCT02105987|11800925|FG000|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
10641971|NCT02105987|11800926|FG001|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
10641972|NCT02105987|11800927|FG002|NOT COMPLETED|Late Switch Phase (24 Weeks)||45
10641973|NCT02105987|11800928|FG003|NOT COMPLETED|Late Switch Phase (24 Weeks)||14
10641974|NCT02105987|11800929|FG004|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
10641975|NCT02105987|11800930|FG005|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
10641976|NCT02105987|11800925|FG000|STARTED|Continuation Phase||0
10641977|NCT02105987|11800926|FG001|STARTED|Continuation Phase||0
10641978|NCT02105987|11800927|FG002|STARTED|Continuation Phase||0
10641979|NCT02105987|11800928|FG003|STARTED|Continuation Phase||0
10641980|NCT02105987|11800929|FG004|STARTED|Continuation Phase||14
10641981|NCT02105987|11800930|FG005|STARTED|Continuation Phase||23
10641982|NCT02105987|11800925|FG000|COMPLETED|Continuation Phase||0
10641983|NCT02105987|11800926|FG001|COMPLETED|Continuation Phase||0
10641984|NCT02105987|11800927|FG002|COMPLETED|Continuation Phase||0
10641985|NCT02105987|11800928|FG003|COMPLETED|Continuation Phase||0
10641986|NCT02105987|11800929|FG004|COMPLETED|Continuation Phase||13
10641987|NCT02105987|11800930|FG005|COMPLETED|Continuation Phase||23
10641988|NCT02105987|11800925|FG000|NOT COMPLETED|Continuation Phase||0
10641989|NCT02105987|11800926|FG001|NOT COMPLETED|Continuation Phase||0
10641990|NCT02105987|11800927|FG002|NOT COMPLETED|Continuation Phase||0
10641991|NCT02105987|11800928|FG003|NOT COMPLETED|Continuation Phase||0
10641992|NCT02105987|11800929|FG004|NOT COMPLETED|Continuation Phase||1
10641993|NCT02105987|11800930|FG005|NOT COMPLETED|Continuation Phase||0
10641994|NCT02106065|11800939|FG000|STARTED|Overall Study||6
10641995|NCT02106065|11800940|FG001|STARTED|Overall Study||11
10641996|NCT02106065|11800941|FG002|STARTED|Overall Study||15
10641997|NCT02106065|11800939|FG000|6 Month Completion|Overall Study||3
10641998|NCT02106065|11800940|FG001|6 Month Completion|Overall Study||8
10641999|NCT02106065|11800941|FG002|6 Month Completion|Overall Study||5
10642000|NCT02106065|11800939|FG000|COMPLETED|Overall Study||3
10642001|NCT02106065|11800940|FG001|COMPLETED|Overall Study||8
10642002|NCT02106065|11800941|FG002|COMPLETED|Overall Study||5
10642003|NCT02106065|11800939|FG000|NOT COMPLETED|Overall Study||3
10642004|NCT02106065|11800940|FG001|NOT COMPLETED|Overall Study||3
10642005|NCT02106065|11800941|FG002|NOT COMPLETED|Overall Study||10
10642006|NCT02106156|11800952|FG000|STARTED|Overall Study||9620
10642007|NCT02106156|11800953|FG001|STARTED|Overall Study||90
10642008|NCT02106156|11800954|FG002|STARTED|Overall Study||518
10642009|NCT02106156|11800952|FG000|COMPLETED|Overall Study||7071
10642010|NCT02106156|11800953|FG001|COMPLETED|Overall Study||50
10642011|NCT02106156|11800954|FG002|COMPLETED|Overall Study||518
10642012|NCT02106156|11800952|FG000|NOT COMPLETED|Overall Study||2549
10642013|NCT02106156|11800953|FG001|NOT COMPLETED|Overall Study||40
10642014|NCT02106156|11800954|FG002|NOT COMPLETED|Overall Study||0
10642015|NCT02106325|11800963|FG000|STARTED|Phase 1||5
10642016|NCT02106325|11800964|FG001|STARTED|Phase 1||3
10642017|NCT02106325|11800963|FG000|COMPLETED|Phase 1||3
10642018|NCT02106325|11800964|FG001|COMPLETED|Phase 1||1
10642019|NCT02106325|11800963|FG000|NOT COMPLETED|Phase 1||2
10642020|NCT02106325|11800964|FG001|NOT COMPLETED|Phase 1||2
10642021|NCT02106325|11800963|FG000|STARTED|Phase 2||4
10642022|NCT02106325|11800964|FG001|STARTED|Phase 2||4
10642023|NCT02106325|11800963|FG000|COMPLETED|Phase 2||2
10642024|NCT02106325|11800964|FG001|COMPLETED|Phase 2||1
10642025|NCT02106325|11800963|FG000|NOT COMPLETED|Phase 2||2
10642026|NCT02106325|11800964|FG001|NOT COMPLETED|Phase 2||3
10642027|NCT02106325|11800963|FG000|STARTED|Phase 3||2
10642028|NCT02106325|11800964|FG001|STARTED|Phase 3||3
10642029|NCT02106325|11800963|FG000|COMPLETED|Phase 3||0
10642030|NCT02106325|11800964|FG001|COMPLETED|Phase 3||2
10642031|NCT02106325|11800963|FG000|NOT COMPLETED|Phase 3||2
10642032|NCT02106325|11800964|FG001|NOT COMPLETED|Phase 3||1
10706010|NCT02604264|11870492|FG000|COMPLETED|Intervention||1245
10706011|NCT02604264|11870493|FG001|COMPLETED|Intervention||1225
10706012|NCT02604264|11870492|FG000|NOT COMPLETED|Intervention||200
10706013|NCT02604264|11870493|FG001|NOT COMPLETED|Intervention||242
10706014|NCT02604342|11870501|FG000|STARTED|Overall Study||79
10706015|NCT02604342|11870502|FG001|STARTED|Overall Study||40
10706016|NCT02604342|11870501|FG000|COMPLETED|Overall Study||36
10706017|NCT02604342|11870502|FG001|COMPLETED|Overall Study||17
10706018|NCT02604342|11870501|FG000|NOT COMPLETED|Overall Study||43
10706019|NCT02604342|11870502|FG001|NOT COMPLETED|Overall Study||23
10706020|NCT02604407|11870511|FG000|STARTED|Overall Study||91
10706021|NCT02604407|11870512|FG001|STARTED|Overall Study||92
10706022|NCT02604407|11870513|FG002|STARTED|Overall Study||92
10706023|NCT02604407|11870511|FG000|TREATED|Overall Study||89
10706024|NCT02604407|11870512|FG001|TREATED|Overall Study||92
10642072|NCT02106390|11800992|FG000|STARTED|Overall Study||252
10642073|NCT02106390|11800993|FG001|STARTED|Overall Study||250
10642074|NCT02106390|11800994|FG002|STARTED|Overall Study||248
10642075|NCT02106390|11800992|FG000|COMPLETED|Overall Study||203
10642076|NCT02106390|11800993|FG001|COMPLETED|Overall Study||202
10642077|NCT02106390|11800994|FG002|COMPLETED|Overall Study||205
10642078|NCT02106390|11800992|FG000|NOT COMPLETED|Overall Study||49
10642079|NCT02106390|11800993|FG001|NOT COMPLETED|Overall Study||48
10642080|NCT02106390|11800994|FG002|NOT COMPLETED|Overall Study||43
10706025|NCT02604407|11870513|FG002|TREATED|Overall Study||90
10642081|NCT02106403|11801005|FG000|STARTED|Visit 1, Treatment Period 1||8
10642082|NCT02106403|11801006|FG001|STARTED|Visit 1, Treatment Period 1||8
10642083|NCT02106403|11801007|FG002|STARTED|Visit 1, Treatment Period 1||9
10642084|NCT02106403|11801008|FG003|STARTED|Visit 1, Treatment Period 1||8
10642085|NCT02106403|11801009|FG004|STARTED|Visit 1, Treatment Period 1||8
10642086|NCT02106403|11801010|FG005|STARTED|Visit 1, Treatment Period 1||9
10642087|NCT02106403|11801005|FG000|COMPLETED|Visit 1, Treatment Period 1||8
10642088|NCT02106403|11801006|FG001|COMPLETED|Visit 1, Treatment Period 1||8
10642089|NCT02106403|11801007|FG002|COMPLETED|Visit 1, Treatment Period 1||9
10642090|NCT02106403|11801008|FG003|COMPLETED|Visit 1, Treatment Period 1||8
10642091|NCT02106403|11801009|FG004|COMPLETED|Visit 1, Treatment Period 1||8
10642092|NCT02106403|11801010|FG005|COMPLETED|Visit 1, Treatment Period 1||9
10642093|NCT02106403|11801005|FG000|NOT COMPLETED|Visit 1, Treatment Period 1||0
10642094|NCT02106403|11801006|FG001|NOT COMPLETED|Visit 1, Treatment Period 1||0
10642095|NCT02106403|11801007|FG002|NOT COMPLETED|Visit 1, Treatment Period 1||0
10642096|NCT02106403|11801008|FG003|NOT COMPLETED|Visit 1, Treatment Period 1||0
10642097|NCT02106403|11801009|FG004|NOT COMPLETED|Visit 1, Treatment Period 1||0
10642098|NCT02106403|11801010|FG005|NOT COMPLETED|Visit 1, Treatment Period 1||0
10642099|NCT02106403|11801005|FG000|STARTED|Visit 1, Treatment Period 2||8
10642100|NCT02106403|11801006|FG001|STARTED|Visit 1, Treatment Period 2||8
10642101|NCT02106403|11801007|FG002|STARTED|Visit 1, Treatment Period 2||9
10642102|NCT02106403|11801008|FG003|STARTED|Visit 1, Treatment Period 2||8
10642103|NCT02106403|11801009|FG004|STARTED|Visit 1, Treatment Period 2||8
10642104|NCT02106403|11801010|FG005|STARTED|Visit 1, Treatment Period 2||9
10642105|NCT02106403|11801005|FG000|COMPLETED|Visit 1, Treatment Period 2||8
10642106|NCT02106403|11801006|FG001|COMPLETED|Visit 1, Treatment Period 2||8
10642107|NCT02106403|11801007|FG002|COMPLETED|Visit 1, Treatment Period 2||9
10642108|NCT02106403|11801008|FG003|COMPLETED|Visit 1, Treatment Period 2||8
10642109|NCT02106403|11801009|FG004|COMPLETED|Visit 1, Treatment Period 2||8
10642110|NCT02106403|11801010|FG005|COMPLETED|Visit 1, Treatment Period 2||9
10642111|NCT02106403|11801005|FG000|NOT COMPLETED|Visit 1, Treatment Period 2||0
10642112|NCT02106403|11801006|FG001|NOT COMPLETED|Visit 1, Treatment Period 2||0
10642113|NCT02106403|11801007|FG002|NOT COMPLETED|Visit 1, Treatment Period 2||0
10642114|NCT02106403|11801008|FG003|NOT COMPLETED|Visit 1, Treatment Period 2||0
10642115|NCT02106403|11801009|FG004|NOT COMPLETED|Visit 1, Treatment Period 2||0
10642116|NCT02106403|11801010|FG005|NOT COMPLETED|Visit 1, Treatment Period 2||0
10642117|NCT02106403|11801005|FG000|STARTED|Visit 1, Treatment Period 3||8
10642118|NCT02106403|11801006|FG001|STARTED|Visit 1, Treatment Period 3||8
10642119|NCT02106403|11801007|FG002|STARTED|Visit 1, Treatment Period 3||9
10642120|NCT02106403|11801008|FG003|STARTED|Visit 1, Treatment Period 3||8
10642121|NCT02106403|11801009|FG004|STARTED|Visit 1, Treatment Period 3||8
10642122|NCT02106403|11801010|FG005|STARTED|Visit 1, Treatment Period 3||9
10642123|NCT02106403|11801005|FG000|COMPLETED|Visit 1, Treatment Period 3||8
10642124|NCT02106403|11801006|FG001|COMPLETED|Visit 1, Treatment Period 3||8
10642125|NCT02106403|11801007|FG002|COMPLETED|Visit 1, Treatment Period 3||9
10642126|NCT02106403|11801008|FG003|COMPLETED|Visit 1, Treatment Period 3||8
10642127|NCT02106403|11801009|FG004|COMPLETED|Visit 1, Treatment Period 3||8
10642128|NCT02106403|11801010|FG005|COMPLETED|Visit 1, Treatment Period 3||9
10642129|NCT02106403|11801005|FG000|NOT COMPLETED|Visit 1, Treatment Period 3||0
10642130|NCT02106403|11801006|FG001|NOT COMPLETED|Visit 1, Treatment Period 3||0
10642131|NCT02106403|11801007|FG002|NOT COMPLETED|Visit 1, Treatment Period 3||0
10642132|NCT02106403|11801008|FG003|NOT COMPLETED|Visit 1, Treatment Period 3||0
10642133|NCT02106403|11801009|FG004|NOT COMPLETED|Visit 1, Treatment Period 3||0
10642134|NCT02106403|11801010|FG005|NOT COMPLETED|Visit 1, Treatment Period 3||0
10642135|NCT02106403|11801005|FG000|STARTED|Follow-Up Visit 2||8
10642136|NCT02106403|11801006|FG001|STARTED|Follow-Up Visit 2||8
10642137|NCT02106403|11801007|FG002|STARTED|Follow-Up Visit 2||9
10642138|NCT02106403|11801008|FG003|STARTED|Follow-Up Visit 2||8
10642139|NCT02106403|11801009|FG004|STARTED|Follow-Up Visit 2||8
10642140|NCT02106403|11801010|FG005|STARTED|Follow-Up Visit 2||9
10642141|NCT02106403|11801005|FG000|COMPLETED|Follow-Up Visit 2||8
10642142|NCT02106403|11801006|FG001|COMPLETED|Follow-Up Visit 2||8
10642143|NCT02106403|11801007|FG002|COMPLETED|Follow-Up Visit 2||9
10642144|NCT02106403|11801008|FG003|COMPLETED|Follow-Up Visit 2||8
10642145|NCT02106403|11801009|FG004|COMPLETED|Follow-Up Visit 2||8
10642146|NCT02106403|11801010|FG005|COMPLETED|Follow-Up Visit 2||9
10642147|NCT02106403|11801005|FG000|NOT COMPLETED|Follow-Up Visit 2||0
10642148|NCT02106403|11801006|FG001|NOT COMPLETED|Follow-Up Visit 2||0
10642149|NCT02106403|11801007|FG002|NOT COMPLETED|Follow-Up Visit 2||0
10642150|NCT02106403|11801008|FG003|NOT COMPLETED|Follow-Up Visit 2||0
10642151|NCT02106403|11801009|FG004|NOT COMPLETED|Follow-Up Visit 2||0
10642152|NCT02106403|11801010|FG005|NOT COMPLETED|Follow-Up Visit 2||0
10642153|NCT02106403|11801005|FG000|STARTED|Follow-Up Visit 3||8
10642154|NCT02106403|11801006|FG001|STARTED|Follow-Up Visit 3||8
10642155|NCT02106403|11801007|FG002|STARTED|Follow-Up Visit 3||9
10642156|NCT02106403|11801008|FG003|STARTED|Follow-Up Visit 3||8
10642157|NCT02106403|11801009|FG004|STARTED|Follow-Up Visit 3||8
10642158|NCT02106403|11801010|FG005|STARTED|Follow-Up Visit 3||9
10642159|NCT02106403|11801005|FG000|COMPLETED|Follow-Up Visit 3||8
10642160|NCT02106403|11801006|FG001|COMPLETED|Follow-Up Visit 3||8
10642161|NCT02106403|11801007|FG002|COMPLETED|Follow-Up Visit 3||9
10642162|NCT02106403|11801008|FG003|COMPLETED|Follow-Up Visit 3||8
10642163|NCT02106403|11801009|FG004|COMPLETED|Follow-Up Visit 3||8
10642164|NCT02106403|11801010|FG005|COMPLETED|Follow-Up Visit 3||8
10642165|NCT02106403|11801005|FG000|NOT COMPLETED|Follow-Up Visit 3||0
10642166|NCT02106403|11801006|FG001|NOT COMPLETED|Follow-Up Visit 3||0
10642167|NCT02106403|11801007|FG002|NOT COMPLETED|Follow-Up Visit 3||0
10642168|NCT02106403|11801008|FG003|NOT COMPLETED|Follow-Up Visit 3||0
10642169|NCT02106403|11801009|FG004|NOT COMPLETED|Follow-Up Visit 3||0
10642170|NCT02106403|11801010|FG005|NOT COMPLETED|Follow-Up Visit 3||1
10642171|NCT02106442|11801020|FG000|STARTED|Overall Study||579
10642172|NCT02106442|11801020|FG000|COMPLETED|Overall Study||542
10642173|NCT02106442|11801020|FG000|NOT COMPLETED|Overall Study||37
10642174|NCT02106455|11801024|FG000|STARTED|Overall Study||315
10642175|NCT02106455|11801024|FG000|COMPLETED|Overall Study||307
10642176|NCT02106455|11801024|FG000|NOT COMPLETED|Overall Study||8
10642177|NCT02106494|11801030|FG000|STARTED|Overall Study||471
10642178|NCT02106494|11801031|FG001|STARTED|Overall Study||471
10642179|NCT02106494|11801030|FG000|Safety Population|Overall Study||456
10642180|NCT02106494|11801031|FG001|Safety Population|Overall Study||459
10642181|NCT02106494|11801030|FG000|Efficacy Population|Overall Study||450
10642182|NCT02106494|11801031|FG001|Efficacy Population|Overall Study||452
10706026|NCT02604407|11870511|FG000|COMPLETED|Overall Study||80
10706027|NCT02604407|11870512|FG001|COMPLETED|Overall Study||80
10706028|NCT02604407|11870513|FG002|COMPLETED|Overall Study||76
10706029|NCT02604407|11870511|FG000|NOT COMPLETED|Overall Study||11
10706030|NCT02604407|11870512|FG001|NOT COMPLETED|Overall Study||12
10706031|NCT02604407|11870513|FG002|NOT COMPLETED|Overall Study||16
10706032|NCT02604550|11870523|FG000|STARTED|Overall Study||56
10642183|NCT02106494|11801030|FG000|COMPLETED|Overall Study||445
10642184|NCT02106494|11801031|FG001|COMPLETED|Overall Study||446
10642185|NCT02106494|11801030|FG000|NOT COMPLETED|Overall Study||26
10642186|NCT02106494|11801031|FG001|NOT COMPLETED|Overall Study||25
10642187|NCT02106728|11801041|FG000|STARTED|Overall Study||70
10642188|NCT02106728|11801042|FG001|STARTED|Overall Study||47
10642189|NCT02106728|11801041|FG000|COMPLETED|Overall Study||70
10642190|NCT02106728|11801042|FG001|COMPLETED|Overall Study||47
10642191|NCT02106728|11801041|FG000|NOT COMPLETED|Overall Study||0
10642192|NCT02106728|11801042|FG001|NOT COMPLETED|Overall Study||0
10642193|NCT02106832|11801058|FG000|STARTED|Overall Study||171
10642194|NCT02106832|11801059|FG001|STARTED|Overall Study||176
10642195|NCT02106832|11801060|FG002|STARTED|Overall Study||86
10642196|NCT02106832|11801061|FG003|STARTED|Overall Study||88
10642197|NCT02106832|11801058|FG000|Participants Received Treatment|Overall Study||171
10642198|NCT02106832|11801059|FG001|Participants Received Treatment|Overall Study||174
10642199|NCT02106832|11801060|FG002|Participants Received Treatment|Overall Study||86
10642200|NCT02106832|11801061|FG003|Participants Received Treatment|Overall Study||88
10642201|NCT02106832|11801058|FG000|COMPLETED|Overall Study||148
10642202|NCT02106832|11801059|FG001|COMPLETED|Overall Study||151
10642203|NCT02106832|11801060|FG002|COMPLETED|Overall Study||70
10642204|NCT02106832|11801061|FG003|COMPLETED|Overall Study||73
10642205|NCT02106832|11801058|FG000|NOT COMPLETED|Overall Study||23
10642206|NCT02106832|11801059|FG001|NOT COMPLETED|Overall Study||25
10642207|NCT02106832|11801060|FG002|NOT COMPLETED|Overall Study||16
10642208|NCT02106832|11801061|FG003|NOT COMPLETED|Overall Study||15
10642209|NCT02106884|11801075|FG000|STARTED|Overall Study||72
10642210|NCT02106884|11801076|FG001|STARTED|Overall Study||74
10642211|NCT02106884|11801075|FG000|COMPLETED|Overall Study||72
10642212|NCT02106884|11801076|FG001|COMPLETED|Overall Study|ITT analysis based on treatment assigned at baseline.|73
10642213|NCT02106884|11801075|FG000|NOT COMPLETED|Overall Study||0
10642214|NCT02106884|11801076|FG001|NOT COMPLETED|Overall Study||1
10642215|NCT02106910|11801087|FG000|STARTED|Overall Study||49
10642216|NCT02106910|11801088|FG001|STARTED|Overall Study||89
10642217|NCT02106910|11801087|FG000|COMPLETED|Overall Study||48
10642218|NCT02106910|11801088|FG001|COMPLETED|Overall Study||88
10642219|NCT02106910|11801087|FG000|NOT COMPLETED|Overall Study||1
10642220|NCT02106910|11801088|FG001|NOT COMPLETED|Overall Study||1
10642221|NCT02106923|11801098|FG000|STARTED|Overall Study||12
10642222|NCT02106923|11801099|FG001|STARTED|Overall Study||12
10642223|NCT02106923|11801100|FG002|STARTED|Overall Study||12
10642224|NCT02106923|11801101|FG003|STARTED|Overall Study||12
10642225|NCT02106923|11801102|FG004|STARTED|Overall Study||12
10642226|NCT02106923|11801103|FG005|STARTED|Overall Study||12
10642227|NCT02106923|11801098|FG000|COMPLETED|Overall Study||12
10642228|NCT02106923|11801099|FG001|COMPLETED|Overall Study||12
10642229|NCT02106923|11801100|FG002|COMPLETED|Overall Study||12
10642230|NCT02106923|11801101|FG003|COMPLETED|Overall Study||12
10642231|NCT02106923|11801102|FG004|COMPLETED|Overall Study||12
10642232|NCT02106923|11801103|FG005|COMPLETED|Overall Study||11
10642233|NCT02106923|11801098|FG000|NOT COMPLETED|Overall Study||0
10642234|NCT02106923|11801099|FG001|NOT COMPLETED|Overall Study||0
10642235|NCT02106923|11801100|FG002|NOT COMPLETED|Overall Study||0
10642236|NCT02106923|11801101|FG003|NOT COMPLETED|Overall Study||0
10642237|NCT02106923|11801102|FG004|NOT COMPLETED|Overall Study||0
10642238|NCT02106923|11801103|FG005|NOT COMPLETED|Overall Study||1
10642239|NCT02106962|11801119|FG000|STARTED|Overall Study||8
10642240|NCT02106962|11801120|FG001|STARTED|Overall Study||9
10642241|NCT02106962|11801119|FG000|COMPLETED|Overall Study||8
10706033|NCT02604550|11870524|FG001|STARTED|Overall Study||59
10706034|NCT02604550|11870523|FG000|COMPLETED|Overall Study||31
10706035|NCT02604550|11870524|FG001|COMPLETED|Overall Study||33
10706036|NCT02604550|11870523|FG000|NOT COMPLETED|Overall Study||25
10642242|NCT02106962|11801120|FG001|COMPLETED|Overall Study||9
10642243|NCT02106962|11801119|FG000|NOT COMPLETED|Overall Study||0
10642244|NCT02106962|11801120|FG001|NOT COMPLETED|Overall Study||0
10642245|NCT02106975|11801130|FG000|STARTED|Overall Study||84
10642246|NCT02106975|11801131|FG001|STARTED|Overall Study||83
10642247|NCT02106975|11801130|FG000|COMPLETED|Overall Study||59
10642248|NCT02106975|11801131|FG001|COMPLETED|Overall Study||44
10642249|NCT02106975|11801130|FG000|NOT COMPLETED|Overall Study||25
10706037|NCT02604550|11870524|FG001|NOT COMPLETED|Overall Study||26
10706038|NCT02604589|11870533|FG000|STARTED|Overall Study||3
10706039|NCT02604589|11870534|FG001|STARTED|Overall Study||5
10706040|NCT02604589|11870535|FG002|STARTED|Overall Study||2
10706041|NCT02604589|11870533|FG000|COMPLETED|Overall Study||3
10706042|NCT02604589|11870534|FG001|COMPLETED|Overall Study||5
10706043|NCT02604589|11870535|FG002|COMPLETED|Overall Study||1
10706044|NCT02604589|11870533|FG000|NOT COMPLETED|Overall Study||0
10706045|NCT02604589|11870534|FG001|NOT COMPLETED|Overall Study||0
10706046|NCT02604589|11870535|FG002|NOT COMPLETED|Overall Study||1
10706047|NCT02604810|11870543|FG000|STARTED|IGIV-C 10%, 4-5 Weeks||52
10706048|NCT02604810|11870543|FG000|COMPLETED|IGIV-C 10%, 4-5 Weeks||49
10706049|NCT02604810|11870543|FG000|NOT COMPLETED|IGIV-C 10%, 4-5 Weeks||3
10706050|NCT02604810|11870543|FG000|STARTED|IGSC 20%, 24 Weeks||49
10706051|NCT02604810|11870543|FG000|COMPLETED|IGSC 20%, 24 Weeks||42
10706052|NCT02604810|11870543|FG000|NOT COMPLETED|IGSC 20%, 24 Weeks||7
10706053|NCT02605122|11870551|FG000|STARTED|Overall Study||73
10642250|NCT02106975|11801131|FG001|NOT COMPLETED|Overall Study||39
10642251|NCT02107014|11801137|FG000|STARTED|Overall Study||9
10642252|NCT02107014|11801137|FG000|COMPLETED|Overall Study||8
10642253|NCT02107014|11801137|FG000|NOT COMPLETED|Overall Study||1
10642254|NCT02107092|11801141|FG000|STARTED|Overall Study||123
10642255|NCT02107092|11801141|FG000|COMPLETED|Overall Study||79
10642256|NCT02107092|11801141|FG000|NOT COMPLETED|Overall Study||44
10642257|NCT02107131|11801147|FG000|STARTED|Overall Study||20
10642258|NCT02107131|11801148|FG001|STARTED|Overall Study||20
10642259|NCT02107131|11801147|FG000|COMPLETED|Overall Study||12
10642260|NCT02107131|11801148|FG001|COMPLETED|Overall Study||11
10642261|NCT02107131|11801147|FG000|NOT COMPLETED|Overall Study||8
10642262|NCT02107131|11801148|FG001|NOT COMPLETED|Overall Study||9
10642263|NCT02107157|11801159|FG000|STARTED|Overall Study||11
10642264|NCT02107157|11801160|FG001|STARTED|Overall Study||12
10642265|NCT02107157|11801161|FG002|STARTED|Overall Study||4
10642266|NCT02107157|11801159|FG000|COMPLETED|Overall Study||6
10642267|NCT02107157|11801160|FG001|COMPLETED|Overall Study||11
10642268|NCT02107157|11801161|FG002|COMPLETED|Overall Study||4
10642269|NCT02107157|11801159|FG000|NOT COMPLETED|Overall Study||5
10642270|NCT02107157|11801160|FG001|NOT COMPLETED|Overall Study||1
10642271|NCT02107157|11801161|FG002|NOT COMPLETED|Overall Study||0
10642272|NCT02107196|11801171|FG000|STARTED|12-week Treatment Period|Safety population, all enrolled patients who received at least one dose of study drug|271
10642273|NCT02107196|11801172|FG001|STARTED|12-week Treatment Period|Safety population, all enrolled patients who received at least one dose of study drug|264
10642274|NCT02107196|11801171|FG000|Intention To Treat (ITT)|12-week Treatment Period|All randomised patients who took at least one dose of study drug during 12-week treatment period|271
10642275|NCT02107196|11801172|FG001|Intention To Treat (ITT)|12-week Treatment Period|All randomised patients who took at least one dose of study drug during 12-week treatment period|264
10642276|NCT02107196|11801171|FG000|Modified ITT|12-week Treatment Period|All ITT patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|221
10642277|NCT02107196|11801172|FG001|Modified ITT|12-week Treatment Period|All ITT patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|216
10642278|NCT02107196|11801171|FG000|COMPLETED|12-week Treatment Period||227
10642279|NCT02107196|11801172|FG001|COMPLETED|12-week Treatment Period||225
10642280|NCT02107196|11801171|FG000|NOT COMPLETED|12-week Treatment Period||44
10642281|NCT02107196|11801172|FG001|NOT COMPLETED|12-week Treatment Period||39
10642282|NCT02107196|11801171|FG000|STARTED|4-week Randomized Withdrawal (RW) Period|all re-randomized patients at Visit 6 [Day85]|338
10642283|NCT02107196|11801172|FG001|STARTED|4-week Randomized Withdrawal (RW) Period|all re-randomized patients at Visit 6 [Day85]|114
10642284|NCT02107196|11801171|FG000|RW Population|4-week Randomized Withdrawal (RW) Period|All re-randomized ITT patients,who received at least 1 dose of ibodutant during RW period|338
10642285|NCT02107196|11801172|FG001|RW Population|4-week Randomized Withdrawal (RW) Period|All re-randomized ITT patients,who received at least 1 dose of placebo during RW period|114
10642286|NCT02107196|11801171|FG000|Modified RW Population|4-week Randomized Withdrawal (RW) Period|all RW patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|272
10642287|NCT02107196|11801172|FG001|Modified RW Population|4-week Randomized Withdrawal (RW) Period|all RW patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|90
10642288|NCT02107196|11801171|FG000|COMPLETED|4-week Randomized Withdrawal (RW) Period||315
10642289|NCT02107196|11801172|FG001|COMPLETED|4-week Randomized Withdrawal (RW) Period||109
10642290|NCT02107196|11801171|FG000|NOT COMPLETED|4-week Randomized Withdrawal (RW) Period||23
10642291|NCT02107196|11801172|FG001|NOT COMPLETED|4-week Randomized Withdrawal (RW) Period||5
10642292|NCT02107274|11801180|FG000|STARTED|Treatment vs. Placebo||39
10642293|NCT02107274|11801181|FG001|STARTED|Treatment vs. Placebo||39
10642294|NCT02107274|11801180|FG000|COMPLETED|Treatment vs. Placebo||36
10642295|NCT02107274|11801181|FG001|COMPLETED|Treatment vs. Placebo||37
10642296|NCT02107274|11801180|FG000|NOT COMPLETED|Treatment vs. Placebo||3
10706054|NCT02605122|11870552|FG001|STARTED|Overall Study||24
10706055|NCT02605122|11870551|FG000|Received Study Drug|Overall Study||70
10706056|NCT02605122|11870552|FG001|Received Study Drug|Overall Study||24
10706057|NCT02605122|11870551|FG000|COMPLETED|Overall Study||68
10706058|NCT02605122|11870552|FG001|COMPLETED|Overall Study||22
10706059|NCT02605122|11870551|FG000|NOT COMPLETED|Overall Study||5
10706060|NCT02605122|11870552|FG001|NOT COMPLETED|Overall Study||2
10706061|NCT02605174|11870562|FG000|STARTED|Overall Study||501
10642297|NCT02107274|11801181|FG001|NOT COMPLETED|Treatment vs. Placebo||2
10642298|NCT02107274|11801180|FG000|STARTED|Control Phase||36
10642299|NCT02107274|11801181|FG001|STARTED|Control Phase||37
10642300|NCT02107274|11801180|FG000|COMPLETED|Control Phase||33
10642301|NCT02107274|11801181|FG001|COMPLETED|Control Phase||35
10642302|NCT02107274|11801180|FG000|NOT COMPLETED|Control Phase||3
10642303|NCT02107274|11801181|FG001|NOT COMPLETED|Control Phase||2
10642304|NCT02107300|11801189|FG000|STARTED|Overall Study||16
10642305|NCT02107300|11801190|FG001|STARTED|Overall Study||15
10642306|NCT02107300|11801189|FG000|COMPLETED|Overall Study||16
10642307|NCT02107300|11801190|FG001|COMPLETED|Overall Study||15
10642308|NCT02107300|11801189|FG000|NOT COMPLETED|Overall Study||0
10706062|NCT02605174|11870563|FG001|STARTED|Overall Study||249
10706063|NCT02605174|11870564|FG002|STARTED|Overall Study||502
10706064|NCT02605174|11870565|FG003|STARTED|Overall Study||252
10706065|NCT02605174|11870566|FG004|STARTED|Overall Study||501
10642309|NCT02107300|11801190|FG001|NOT COMPLETED|Overall Study||0
10642310|NCT02107313|11801196|FG000|STARTED|Overall Study||9
10642311|NCT02107313|11801197|FG001|STARTED|Overall Study|One participant from the study did not cross over and participate in the FED cohort|9
10642312|NCT02107313|11801196|FG000|COMPLETED|Overall Study||9
10642313|NCT02107313|11801197|FG001|COMPLETED|Overall Study||8
10642314|NCT02107313|11801196|FG000|NOT COMPLETED|Overall Study||0
10642315|NCT02107313|11801197|FG001|NOT COMPLETED|Overall Study||1
10642316|NCT02107339|11801205|FG000|STARTED|Overall Study||63
10642317|NCT02107339|11801206|FG001|STARTED|Overall Study||57
10642318|NCT02107339|11801205|FG000|COMPLETED|Overall Study||62
10642319|NCT02107339|11801206|FG001|COMPLETED|Overall Study||53
10642320|NCT02107339|11801205|FG000|NOT COMPLETED|Overall Study||1
10642321|NCT02107339|11801206|FG001|NOT COMPLETED|Overall Study||4
10642322|NCT02107443|11801214|FG000|STARTED|Overall Study||296
10642323|NCT02107443|11801215|FG001|STARTED|Overall Study||250
10642324|NCT02107443|11801214|FG000|COMPLETED|Overall Study||198
10642325|NCT02107443|11801215|FG001|COMPLETED|Overall Study||167
10642326|NCT02107443|11801214|FG000|NOT COMPLETED|Overall Study||98
10642327|NCT02107443|11801215|FG001|NOT COMPLETED|Overall Study||83
10642328|NCT02107482|11801222|FG000|STARTED|Overall Study|21 participants enrolled. Total of 21 participants recvd both active and sham|21
10642329|NCT02107482|11801222|FG000|COMPLETED|Overall Study||17
10642330|NCT02107482|11801222|FG000|NOT COMPLETED|Overall Study||4
10642331|NCT02107599|11801226|FG000|STARTED|Overall Study||96
10642332|NCT02107599|11801226|FG000|COMPLETED|Overall Study||96
10642333|NCT02107599|11801226|FG000|NOT COMPLETED|Overall Study||0
10642334|NCT02107703|11801235|FG000|STARTED|Overall Study||446
10642335|NCT02107703|11801236|FG001|STARTED|Overall Study||223
10642336|NCT02107703|11801235|FG000|Received at Least 1 Dose of Study Drug|Overall Study||441
10642337|NCT02107703|11801236|FG001|Received at Least 1 Dose of Study Drug|Overall Study||223
10642338|NCT02107703|11801235|FG000|COMPLETED|Overall Study||85
10642339|NCT02107703|11801236|FG001|COMPLETED|Overall Study||48
10642340|NCT02107703|11801235|FG000|NOT COMPLETED|Overall Study||361
10642341|NCT02107703|11801236|FG001|NOT COMPLETED|Overall Study||175
10642342|NCT02107859|11801245|FG000|STARTED|Overall Study||61
10642343|NCT02107859|11801245|FG000|As-treated Population|Overall Study||61
10642344|NCT02107859|11801245|FG000|Intent-to-treat (ITT) Population|Overall Study||60
10642345|NCT02107859|11801245|FG000|COMPLETED|Overall Study||0
10642346|NCT02107859|11801245|FG000|NOT COMPLETED|Overall Study||61
10642347|NCT02107898|11801251|FG000|STARTED|Overall Study|Randomized|72
10642348|NCT02107898|11801252|FG001|STARTED|Overall Study|Randomized|144
10642349|NCT02107898|11801251|FG000|Treated|Overall Study||72
10642350|NCT02107898|11801252|FG001|Treated|Overall Study||143
10642351|NCT02107898|11801251|FG000|COMPLETED|Overall Study||66
10642352|NCT02107898|11801252|FG001|COMPLETED|Overall Study||132
10642353|NCT02107898|11801251|FG000|NOT COMPLETED|Overall Study||6
10642354|NCT02107898|11801252|FG001|NOT COMPLETED|Overall Study||12
10642355|NCT02108171|11801260|FG000|STARTED|Overall Study||40
10642356|NCT02108171|11801261|FG001|STARTED|Overall Study||41
10642357|NCT02108171|11801260|FG000|COMPLETED|Overall Study||40
10642358|NCT02108171|11801261|FG001|COMPLETED|Overall Study||41
10642359|NCT02108171|11801260|FG000|NOT COMPLETED|Overall Study||0
10642360|NCT02108171|11801261|FG001|NOT COMPLETED|Overall Study||0
10642361|NCT02108223|11801271|FG000|STARTED|Overall Study||52
10642362|NCT02108223|11801272|FG001|STARTED|Overall Study||50
10706066|NCT02605174|11870567|FG005|STARTED|Overall Study||249
10642363|NCT02108223|11801273|FG002|STARTED|Overall Study||35
10642364|NCT02108223|11801271|FG000|COMPLETED|Overall Study||52
10642365|NCT02108223|11801272|FG001|COMPLETED|Overall Study||50
10642366|NCT02108223|11801273|FG002|COMPLETED|Overall Study||35
10642367|NCT02108223|11801271|FG000|NOT COMPLETED|Overall Study||0
10642368|NCT02108223|11801272|FG001|NOT COMPLETED|Overall Study||0
10642369|NCT02108223|11801273|FG002|NOT COMPLETED|Overall Study||0
10642370|NCT02108262|11801288|FG000|STARTED|Overall Study||9
10642371|NCT02108262|11801289|FG001|STARTED|Overall Study||419
10642372|NCT02108262|11801290|FG002|STARTED|Overall Study||421
10642373|NCT02108262|11801291|FG003|STARTED|Overall Study||418
10642374|NCT02108262|11801288|FG000|COMPLETED|Overall Study||9
10642375|NCT02108262|11801289|FG001|COMPLETED|Overall Study||375
10642376|NCT02108262|11801290|FG002|COMPLETED|Overall Study||379
10642377|NCT02108262|11801291|FG003|COMPLETED|Overall Study||376
10642378|NCT02108262|11801288|FG000|NOT COMPLETED|Overall Study||0
10642379|NCT02108262|11801289|FG001|NOT COMPLETED|Overall Study||44
10642380|NCT02108262|11801290|FG002|NOT COMPLETED|Overall Study||42
10642381|NCT02108262|11801291|FG003|NOT COMPLETED|Overall Study||42
10642382|NCT02108288|11801303|FG000|STARTED|Overall Study||10
10642383|NCT02108288|11801304|FG001|STARTED|Overall Study||10
10706067|NCT02605174|11870568|FG006|STARTED|Overall Study||751
10706068|NCT02605174|11870562|FG000|Received at Least 1 Dose of Study Drug|Overall Study||429
10706069|NCT02605174|11870563|FG001|Received at Least 1 Dose of Study Drug|Overall Study||225
10706070|NCT02605174|11870564|FG002|Received at Least 1 Dose of Study Drug|Overall Study||423
10706071|NCT02605174|11870565|FG003|Received at Least 1 Dose of Study Drug|Overall Study||212
10706072|NCT02605174|11870566|FG004|Received at Least 1 Dose of Study Drug|Overall Study||434
10642384|NCT02108288|11801305|FG002|STARTED|Overall Study||10
10642385|NCT02108288|11801303|FG000|COMPLETED|Overall Study||10
10642386|NCT02108288|11801304|FG001|COMPLETED|Overall Study||10
10642387|NCT02108288|11801305|FG002|COMPLETED|Overall Study||10
10642388|NCT02108288|11801303|FG000|NOT COMPLETED|Overall Study||0
10642389|NCT02108288|11801304|FG001|NOT COMPLETED|Overall Study||0
10642390|NCT02108288|11801305|FG002|NOT COMPLETED|Overall Study||0
10642391|NCT02108457|11801315|FG000|STARTED|Overall Study||3
10642392|NCT02108457|11801316|FG001|STARTED|Overall Study||12
10642393|NCT02108457|11801315|FG000|COMPLETED|Overall Study||3
10642394|NCT02108457|11801316|FG001|COMPLETED|Overall Study||10
10642395|NCT02108457|11801315|FG000|NOT COMPLETED|Overall Study||0
10642396|NCT02108457|11801316|FG001|NOT COMPLETED|Overall Study||2
10642397|NCT02108522|11801322|FG000|STARTED|Screening Period||82
10642398|NCT02108522|11801322|FG000|COMPLETED|Screening Period||58
10642399|NCT02108522|11801322|FG000|NOT COMPLETED|Screening Period||24
10642400|NCT02108522|11801322|FG000|STARTED|Period 1: Initial Cohort||50
10642401|NCT02108522|11801322|FG000|COMPLETED|Period 1: Initial Cohort||28
10642402|NCT02108522|11801322|FG000|NOT COMPLETED|Period 1: Initial Cohort||22
10642403|NCT02108522|11801322|FG000|STARTED|Period 2: Expansion Cohort||8
10642404|NCT02108522|11801322|FG000|COMPLETED|Period 2: Expansion Cohort||2
10642405|NCT02108522|11801322|FG000|NOT COMPLETED|Period 2: Expansion Cohort||6
10642406|NCT02108600|11801328|FG000|STARTED|Overall Study||17
10642407|NCT02108600|11801329|FG001|STARTED|Overall Study||16
10642408|NCT02108600|11801328|FG000|COMPLETED|Overall Study||14
10642409|NCT02108600|11801329|FG001|COMPLETED|Overall Study|1 patient lost to follow up after the primary endpoint biopsy|15
10642410|NCT02108600|11801328|FG000|NOT COMPLETED|Overall Study||3
10642411|NCT02108600|11801329|FG001|NOT COMPLETED|Overall Study||1
10642412|NCT02108691|11801337|FG000|STARTED|Overall Study||40
10642413|NCT02108691|11801338|FG001|STARTED|Overall Study||40
10642414|NCT02108691|11801337|FG000|COMPLETED|Overall Study||32
10642415|NCT02108691|11801338|FG001|COMPLETED|Overall Study||31
10642416|NCT02108691|11801337|FG000|NOT COMPLETED|Overall Study||8
10642417|NCT02108691|11801338|FG001|NOT COMPLETED|Overall Study||9
10642418|NCT02108821|11801344|FG000|STARTED|Overall Study||23
10642419|NCT02108821|11801344|FG000|COMPLETED|Overall Study||23
10642420|NCT02108821|11801344|FG000|NOT COMPLETED|Overall Study||0
10642421|NCT02108912|11801352|FG000|STARTED|Overall Study||9
10642422|NCT02108912|11801353|FG001|STARTED|Overall Study||7
10642423|NCT02108912|11801352|FG000|COMPLETED|Overall Study||6
10642424|NCT02108912|11801353|FG001|COMPLETED|Overall Study||6
10642425|NCT02108912|11801352|FG000|NOT COMPLETED|Overall Study||3
10642426|NCT02108912|11801353|FG001|NOT COMPLETED|Overall Study||1
10642427|NCT02108951|11801359|FG000|STARTED|Overall Study|Indicates patients in enrolled, full analysis and safety set|20
10642428|NCT02108951|11801359|FG000|COMPLETED|Overall Study||4
10642429|NCT02108951|11801359|FG000|NOT COMPLETED|Overall Study||16
10642430|NCT02108977|11801365|FG000|STARTED|Overall Study||18
10642431|NCT02108977|11801366|FG001|STARTED|Overall Study||20
10642432|NCT02108977|11801365|FG000|COMPLETED|Overall Study||8
10642433|NCT02108977|11801366|FG001|COMPLETED|Overall Study||19
10642434|NCT02108977|11801365|FG000|NOT COMPLETED|Overall Study||10
10642435|NCT02108977|11801366|FG001|NOT COMPLETED|Overall Study||1
10642436|NCT02109029|11801377|FG000|STARTED|Part A||2
10642437|NCT02109029|11801378|FG001|STARTED|Part A||2
10642438|NCT02109029|11801379|FG002|STARTED|Part A||4
10642439|NCT02109029|11801380|FG003|STARTED|Part A||4
10642440|NCT02109029|11801381|FG004|STARTED|Part A||0
10642441|NCT02109029|11801382|FG005|STARTED|Part A||0
10642442|NCT02109029|11801377|FG000|Received One Dose of Study Drug|Part A||2
10642443|NCT02109029|11801378|FG001|Received One Dose of Study Drug|Part A||2
10642444|NCT02109029|11801379|FG002|Received One Dose of Study Drug|Part A||4
10642445|NCT02109029|11801380|FG003|Received One Dose of Study Drug|Part A||4
10706073|NCT02605174|11870567|FG005|Received at Least 1 Dose of Study Drug|Overall Study||215
10706074|NCT02605174|11870568|FG006|Received at Least 1 Dose of Study Drug|Overall Study||645
10642446|NCT02109029|11801381|FG004|Received One Dose of Study Drug|Part A||0
10642447|NCT02109029|11801382|FG005|Received One Dose of Study Drug|Part A||0
10642448|NCT02109029|11801377|FG000|COMPLETED|Part A|Participants from Part A did not move on to Part B.|2
10642449|NCT02109029|11801378|FG001|COMPLETED|Part A|Participants from Part A did not move on to Part B.|2
10642450|NCT02109029|11801379|FG002|COMPLETED|Part A|Participants from Part A did not move on to Part B.|4
10642451|NCT02109029|11801380|FG003|COMPLETED|Part A|Participants from Part A did not move on to Part B.|4
10642452|NCT02109029|11801381|FG004|COMPLETED|Part A||0
10706075|NCT02605174|11870562|FG000|Received Optional 2nd Dose|Overall Study||206
10642453|NCT02109029|11801382|FG005|COMPLETED|Part A||0
10642454|NCT02109029|11801377|FG000|NOT COMPLETED|Part A||0
10642455|NCT02109029|11801378|FG001|NOT COMPLETED|Part A||0
10642456|NCT02109029|11801379|FG002|NOT COMPLETED|Part A||0
10642457|NCT02109029|11801380|FG003|NOT COMPLETED|Part A||0
10642458|NCT02109029|11801381|FG004|NOT COMPLETED|Part A||0
10642459|NCT02109029|11801382|FG005|NOT COMPLETED|Part A||0
10642460|NCT02109029|11801377|FG000|STARTED|Part B||0
10642461|NCT02109029|11801378|FG001|STARTED|Part B||0
10642462|NCT02109029|11801379|FG002|STARTED|Part B||0
10642463|NCT02109029|11801380|FG003|STARTED|Part B||0
10642464|NCT02109029|11801381|FG004|STARTED|Part B|New participants entered Part B.|6
10642465|NCT02109029|11801382|FG005|STARTED|Part B|New participants entered Part B.|6
10642466|NCT02109029|11801377|FG000|Received at Least One Dose of Study Drug|Part B||0
10642467|NCT02109029|11801378|FG001|Received at Least One Dose of Study Drug|Part B||0
10642468|NCT02109029|11801379|FG002|Received at Least One Dose of Study Drug|Part B||0
10642469|NCT02109029|11801380|FG003|Received at Least One Dose of Study Drug|Part B||0
10642470|NCT02109029|11801381|FG004|Received at Least One Dose of Study Drug|Part B||6
10642471|NCT02109029|11801382|FG005|Received at Least One Dose of Study Drug|Part B||6
10642472|NCT02109029|11801377|FG000|COMPLETED|Part B||0
10642473|NCT02109029|11801378|FG001|COMPLETED|Part B||0
10642474|NCT02109029|11801379|FG002|COMPLETED|Part B||0
10642475|NCT02109029|11801380|FG003|COMPLETED|Part B||0
10642476|NCT02109029|11801381|FG004|COMPLETED|Part B||5
10642477|NCT02109029|11801382|FG005|COMPLETED|Part B||5
10642478|NCT02109029|11801377|FG000|NOT COMPLETED|Part B||0
10642479|NCT02109029|11801378|FG001|NOT COMPLETED|Part B||0
10642480|NCT02109029|11801379|FG002|NOT COMPLETED|Part B||0
10642481|NCT02109029|11801380|FG003|NOT COMPLETED|Part B||0
10642482|NCT02109029|11801381|FG004|NOT COMPLETED|Part B||1
10642483|NCT02109029|11801382|FG005|NOT COMPLETED|Part B||1
10642484|NCT02109042|11801393|FG000|STARTED|Overall Study||15
10642485|NCT02109042|11801393|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
10642486|NCT02109042|11801393|FG000|Received 180 mg Loading Dose|Overall Study||15
10642487|NCT02109042|11801393|FG000|Receive at Least 1 Subsequent 90 mg Dose|Overall Study||15
10642488|NCT02109042|11801393|FG000|COMPLETED|Overall Study||0
10642489|NCT02109042|11801393|FG000|NOT COMPLETED|Overall Study||15
10642490|NCT02109107|11801398|FG000|STARTED|Overall Study||54
10642491|NCT02109107|11801398|FG000|COMPLETED|Overall Study||52
10642492|NCT02109107|11801398|FG000|NOT COMPLETED|Overall Study||2
10642493|NCT02109133|11801404|FG000|STARTED|Overall Study||33
10642494|NCT02109133|11801405|FG001|STARTED|Overall Study||34
10642495|NCT02109133|11801404|FG000|COMPLETED|Overall Study||32
10642496|NCT02109133|11801405|FG001|COMPLETED|Overall Study||34
10642497|NCT02109133|11801404|FG000|NOT COMPLETED|Overall Study||1
10642498|NCT02109133|11801405|FG001|NOT COMPLETED|Overall Study||0
10642499|NCT02109159|11801415|FG000|STARTED|Overall Study||4178
10642500|NCT02109159|11801416|FG001|STARTED|Overall Study||4175
10642501|NCT02109159|11801415|FG000|COMPLETED|Overall Study||4178
10642502|NCT02109159|11801416|FG001|COMPLETED|Overall Study||4175
10642503|NCT02109159|11801415|FG000|NOT COMPLETED|Overall Study||0
10642504|NCT02109159|11801416|FG001|NOT COMPLETED|Overall Study||0
10642505|NCT02109419|11801422|FG000|STARTED|Overall Study||57
10642506|NCT02109419|11801422|FG000|COMPLETED|Overall Study||57
10642507|NCT02109419|11801422|FG000|NOT COMPLETED|Overall Study||0
10642508|NCT02109432|11801428|FG000|STARTED|Overall Study||7
10642509|NCT02109432|11801428|FG000|COMPLETED|Overall Study||6
10642510|NCT02109432|11801428|FG000|NOT COMPLETED|Overall Study||1
10642511|NCT02109445|11801432|FG000|STARTED|Overall Study||3
10642512|NCT02109445|11801432|FG000|COMPLETED|Overall Study||0
10642513|NCT02109445|11801432|FG000|NOT COMPLETED|Overall Study||3
10642514|NCT02109458|11801436|FG000|STARTED|Overall Study||24
10642515|NCT02109458|11801436|FG000|COMPLETED|Overall Study||24
10642516|NCT02109458|11801436|FG000|NOT COMPLETED|Overall Study||0
10642517|NCT02109484|11801448|FG000|STARTED|Overall Study||5
10642518|NCT02109484|11801449|FG001|STARTED|Overall Study||13
10642519|NCT02109484|11801450|FG002|STARTED|Overall Study||12
10642520|NCT02109484|11801451|FG003|STARTED|Overall Study||12
10642521|NCT02109484|11801452|FG004|STARTED|Overall Study||50
10642522|NCT02109484|11801453|FG005|STARTED|Overall Study||12
10642523|NCT02109484|11801454|FG006|STARTED|Overall Study||50
10642524|NCT02109484|11801455|FG007|STARTED|Overall Study||50
10642525|NCT02109484|11801448|FG000|COMPLETED|Overall Study||5
10642526|NCT02109484|11801449|FG001|COMPLETED|Overall Study||13
10642527|NCT02109484|11801450|FG002|COMPLETED|Overall Study||12
10642528|NCT02109484|11801451|FG003|COMPLETED|Overall Study||11
10642529|NCT02109484|11801452|FG004|COMPLETED|Overall Study||46
10642530|NCT02109484|11801453|FG005|COMPLETED|Overall Study||11
10642531|NCT02109484|11801454|FG006|COMPLETED|Overall Study||47
10642532|NCT02109484|11801455|FG007|COMPLETED|Overall Study||47
10642533|NCT02109484|11801448|FG000|NOT COMPLETED|Overall Study||0
10642534|NCT02109484|11801449|FG001|NOT COMPLETED|Overall Study||0
10642535|NCT02109484|11801450|FG002|NOT COMPLETED|Overall Study||0
10642536|NCT02109484|11801451|FG003|NOT COMPLETED|Overall Study||1
10642537|NCT02109484|11801452|FG004|NOT COMPLETED|Overall Study||4
10642538|NCT02109484|11801453|FG005|NOT COMPLETED|Overall Study||1
10642539|NCT02109484|11801454|FG006|NOT COMPLETED|Overall Study||3
10642540|NCT02109484|11801455|FG007|NOT COMPLETED|Overall Study||3
10642541|NCT02109497|11801490|FG000|STARTED|Overall Study||18
10642542|NCT02109497|11801490|FG000|COMPLETED|Overall Study|One participant completed the safety assessments but did not complete all doses of the study drugs.|17
10642543|NCT02109497|11801490|FG000|NOT COMPLETED|Overall Study||1
10642544|NCT02109562|11801497|FG000|STARTED|Overall Study||116
10642545|NCT02109562|11801498|FG001|STARTED|Overall Study||119
10706076|NCT02605174|11870563|FG001|Received Optional 2nd Dose|Overall Study||96
10706077|NCT02605174|11870564|FG002|Received Optional 2nd Dose|Overall Study||177
10706078|NCT02605174|11870565|FG003|Received Optional 2nd Dose|Overall Study||83
10706079|NCT02605174|11870566|FG004|Received Optional 2nd Dose|Overall Study||144
10642546|NCT02109562|11801499|FG002|STARTED|Overall Study||119
10642547|NCT02109562|11801497|FG000|Safety|Overall Study||115
10642548|NCT02109562|11801498|FG001|Safety|Overall Study||117
10642549|NCT02109562|11801499|FG002|Safety|Overall Study||118
10642550|NCT02109562|11801497|FG000|Intent to Treat (ITT)|Overall Study||111
10642551|NCT02109562|11801498|FG001|Intent to Treat (ITT)|Overall Study||114
10642552|NCT02109562|11801499|FG002|Intent to Treat (ITT)|Overall Study||112
10642553|NCT02109562|11801497|FG000|COMPLETED|Overall Study||90
10642554|NCT02109562|11801498|FG001|COMPLETED|Overall Study||85
10642555|NCT02109562|11801499|FG002|COMPLETED|Overall Study||84
10642556|NCT02109562|11801497|FG000|NOT COMPLETED|Overall Study||26
10642557|NCT02109562|11801498|FG001|NOT COMPLETED|Overall Study||34
10642558|NCT02109562|11801499|FG002|NOT COMPLETED|Overall Study||35
10642559|NCT02109640|11801509|FG000|STARTED|Overall Study||27
10642560|NCT02109640|11801510|FG001|STARTED|Overall Study||23
10642561|NCT02109640|11801509|FG000|COMPLETED|Overall Study||27
10642562|NCT02109640|11801510|FG001|COMPLETED|Overall Study||23
10642563|NCT02109640|11801509|FG000|NOT COMPLETED|Overall Study||0
10642564|NCT02109640|11801510|FG001|NOT COMPLETED|Overall Study||0
10642565|NCT02109731|11801516|FG000|STARTED|Overall Study||15
10642566|NCT02109731|11801516|FG000|COMPLETED|Overall Study||15
10642567|NCT02109731|11801516|FG000|NOT COMPLETED|Overall Study||0
10642568|NCT02109939|11801522|FG000|STARTED|Overall Study||681
10642569|NCT02109939|11801523|FG001|STARTED|Overall Study||717
10642570|NCT02109939|11801522|FG000|COMPLETED|Overall Study||560
10642571|NCT02109939|11801523|FG001|COMPLETED|Overall Study||607
10642572|NCT02109939|11801522|FG000|NOT COMPLETED|Overall Study||121
10642573|NCT02109939|11801523|FG001|NOT COMPLETED|Overall Study||110
10642574|NCT02110095|11801533|FG000|STARTED|Overall Study||15
10642575|NCT02110095|11801533|FG000|COMPLETED|Overall Study||8
10642576|NCT02110095|11801533|FG000|NOT COMPLETED|Overall Study||7
10642577|NCT02110108|11801537|FG000|STARTED|Overall Study||10
10642578|NCT02110108|11801537|FG000|RevLite Single Wavelength|Overall Study||10
10642579|NCT02110108|11801537|FG000|RevLite Combo Wavelength|Overall Study||10
10642580|NCT02110108|11801537|FG000|COMPLETED|Overall Study||7
10642581|NCT02110108|11801537|FG000|NOT COMPLETED|Overall Study||3
10642582|NCT02110121|11801547|FG000|STARTED|Overall Study||58
10642583|NCT02110121|11801548|FG001|STARTED|Overall Study||5
10642584|NCT02110121|11801547|FG000|COMPLETED|Overall Study||42
10642585|NCT02110121|11801548|FG001|COMPLETED|Overall Study||5
10642586|NCT02110121|11801547|FG000|NOT COMPLETED|Overall Study||16
10642587|NCT02110121|11801548|FG001|NOT COMPLETED|Overall Study||0
10642588|NCT02110147|11801554|FG000|STARTED|Overall Study||4
10642589|NCT02110147|11801554|FG000|COMPLETED|Overall Study||4
10642590|NCT02110147|11801554|FG000|NOT COMPLETED|Overall Study||0
10642591|NCT02110225|11801561|FG000|STARTED|Overall Study||20
10642592|NCT02110225|11801562|FG001|STARTED|Overall Study||20
10642593|NCT02110225|11801563|FG002|STARTED|Overall Study||10
10642594|NCT02110225|11801561|FG000|COMPLETED|Overall Study||20
10642595|NCT02110225|11801562|FG001|COMPLETED|Overall Study||19
10642596|NCT02110225|11801563|FG002|COMPLETED|Overall Study||10
10642597|NCT02110225|11801561|FG000|NOT COMPLETED|Overall Study||0
10642598|NCT02110225|11801562|FG001|NOT COMPLETED|Overall Study||1
10642599|NCT02110225|11801563|FG002|NOT COMPLETED|Overall Study||0
10642600|NCT02110238|11801574|FG000|STARTED|12 Week Pivotal Phase|One subject was randomized but not treated. As a result there were 211 safety subjects|212
10642601|NCT02110238|11801575|FG001|STARTED|12 Week Pivotal Phase||209
10642602|NCT02110238|11801574|FG000|COMPLETED|12 Week Pivotal Phase||202
10642603|NCT02110238|11801575|FG001|COMPLETED|12 Week Pivotal Phase||200
10642604|NCT02110238|11801574|FG000|NOT COMPLETED|12 Week Pivotal Phase||10
10642605|NCT02110238|11801575|FG001|NOT COMPLETED|12 Week Pivotal Phase||9
10642606|NCT02110238|11801574|FG000|STARTED|14 Week Blinded Extension Phase||202
10642607|NCT02110238|11801575|FG001|STARTED|14 Week Blinded Extension Phase||200
10642608|NCT02110238|11801574|FG000|COMPLETED|14 Week Blinded Extension Phase||190
10642609|NCT02110238|11801575|FG001|COMPLETED|14 Week Blinded Extension Phase||188
10642610|NCT02110238|11801574|FG000|NOT COMPLETED|14 Week Blinded Extension Phase||12
10642611|NCT02110238|11801575|FG001|NOT COMPLETED|14 Week Blinded Extension Phase||12
10642612|NCT02110264|11801584|FG000|STARTED|Overall Study||53
10642613|NCT02110264|11801585|FG001|STARTED|Overall Study||50
10642614|NCT02110264|11801586|FG002|STARTED|Overall Study||48
10642615|NCT02110264|11801584|FG000|COMPLETED|Overall Study||35
10642616|NCT02110264|11801585|FG001|COMPLETED|Overall Study||38
10642617|NCT02110264|11801586|FG002|COMPLETED|Overall Study||39
10706080|NCT02605174|11870567|FG005|Received Optional 2nd Dose|Overall Study||74
10642618|NCT02110264|11801584|FG000|NOT COMPLETED|Overall Study||18
10642619|NCT02110264|11801585|FG001|NOT COMPLETED|Overall Study||12
10642620|NCT02110264|11801586|FG002|NOT COMPLETED|Overall Study||9
10642621|NCT02110381|11801596|FG000|STARTED|Single Modality||9
10642622|NCT02110381|11801597|FG001|STARTED|Single Modality||9
10642623|NCT02110381|11801596|FG000|COMPLETED|Single Modality||7
10642624|NCT02110381|11801597|FG001|COMPLETED|Single Modality||8
10642625|NCT02110381|11801596|FG000|NOT COMPLETED|Single Modality||2
10642626|NCT02110381|11801597|FG001|NOT COMPLETED|Single Modality||1
10642627|NCT02110381|11801596|FG000|STARTED|Dual Modality||7
10642628|NCT02110381|11801597|FG001|STARTED|Dual Modality||8
10642629|NCT02110381|11801596|FG000|Began Active Treatment|Dual Modality||7
10642630|NCT02110381|11801597|FG001|Began Active Treatment|Dual Modality||7
10642631|NCT02110381|11801596|FG000|COMPLETED|Dual Modality||5
10642632|NCT02110381|11801597|FG001|COMPLETED|Dual Modality||7
10642633|NCT02110381|11801596|FG000|NOT COMPLETED|Dual Modality||2
10642634|NCT02110381|11801597|FG001|NOT COMPLETED|Dual Modality||1
10642635|NCT02110485|11801606|FG000|STARTED|Overall Study||98
10642636|NCT02110485|11801607|FG001|STARTED|Overall Study||102
10642637|NCT02110485|11801606|FG000|COMPLETED|Overall Study||91
10642638|NCT02110485|11801607|FG001|COMPLETED|Overall Study||83
10642639|NCT02110485|11801606|FG000|NOT COMPLETED|Overall Study||7
10642640|NCT02110485|11801607|FG001|NOT COMPLETED|Overall Study||19
10642641|NCT02110693|11801613|FG000|STARTED|Overall Study||1026
10642642|NCT02110693|11801614|FG001|STARTED|Overall Study||1031
10642643|NCT02110693|11801613|FG000|COMPLETED|Overall Study||998
10642644|NCT02110693|11801614|FG001|COMPLETED|Overall Study||1002
10642645|NCT02110693|11801613|FG000|NOT COMPLETED|Overall Study||28
10642646|NCT02110693|11801614|FG001|NOT COMPLETED|Overall Study||29
10642647|NCT02110706|11801636|FG000|STARTED|Overall Study||25
10642648|NCT02110706|11801637|FG001|STARTED|Overall Study||27
10642649|NCT02110706|11801636|FG000|No. Completing Study Through Week 52|Overall Study||23
10642650|NCT02110706|11801637|FG001|No. Completing Study Through Week 52|Overall Study||24
10642651|NCT02110706|11801636|FG000|COMPLETED|Overall Study||20
10642652|NCT02110706|11801637|FG001|COMPLETED|Overall Study||23
10642653|NCT02110706|11801636|FG000|NOT COMPLETED|Overall Study||5
10642654|NCT02110706|11801637|FG001|NOT COMPLETED|Overall Study||4
10642655|NCT02110732|11801647|FG000|STARTED|Overall Study||20
10642656|NCT02110732|11801648|FG001|STARTED|Overall Study||20
10642657|NCT02110732|11801647|FG000|COMPLETED|Overall Study||14
10642658|NCT02110732|11801648|FG001|COMPLETED|Overall Study||17
10642659|NCT02110732|11801647|FG000|NOT COMPLETED|Overall Study||6
10642660|NCT02110732|11801648|FG001|NOT COMPLETED|Overall Study||3
10642661|NCT02110758|11801659|FG000|STARTED|Baseline: August 2011-July 2013||0
10642662|NCT02110758|11801660|FG001|STARTED|Baseline: August 2011-July 2013||0
10642663|NCT02110758|11801661|FG002|STARTED|Baseline: August 2011-July 2013||9832
10642664|NCT02110758|11801662|FG003|STARTED|Baseline: August 2011-July 2013||18994
10642665|NCT02110758|11801663|FG004|STARTED|Baseline: August 2011-July 2013||308
10642666|NCT02110758|11801659|FG000|COMPLETED|Baseline: August 2011-July 2013||0
10642667|NCT02110758|11801660|FG001|COMPLETED|Baseline: August 2011-July 2013||0
10642668|NCT02110758|11801661|FG002|COMPLETED|Baseline: August 2011-July 2013||9832
10642669|NCT02110758|11801662|FG003|COMPLETED|Baseline: August 2011-July 2013||18994
10642670|NCT02110758|11801663|FG004|COMPLETED|Baseline: August 2011-July 2013||308
10642671|NCT02110758|11801659|FG000|NOT COMPLETED|Baseline: August 2011-July 2013||0
10642672|NCT02110758|11801660|FG001|NOT COMPLETED|Baseline: August 2011-July 2013||0
10642673|NCT02110758|11801661|FG002|NOT COMPLETED|Baseline: August 2011-July 2013||0
10642674|NCT02110758|11801662|FG003|NOT COMPLETED|Baseline: August 2011-July 2013||0
10642675|NCT02110758|11801663|FG004|NOT COMPLETED|Baseline: August 2011-July 2013||0
10706081|NCT02605174|11870568|FG006|Received Optional 2nd Dose|Overall Study||361
10706082|NCT02605174|11870562|FG000|COMPLETED|Overall Study||437
10706083|NCT02605174|11870563|FG001|COMPLETED|Overall Study||226
10706084|NCT02605174|11870564|FG002|COMPLETED|Overall Study||426
10706085|NCT02605174|11870565|FG003|COMPLETED|Overall Study||216
10706086|NCT02605174|11870566|FG004|COMPLETED|Overall Study||448
10706087|NCT02605174|11870567|FG005|COMPLETED|Overall Study||217
10706088|NCT02605174|11870568|FG006|COMPLETED|Overall Study||662
10706089|NCT02605174|11870562|FG000|NOT COMPLETED|Overall Study||64
10706090|NCT02605174|11870563|FG001|NOT COMPLETED|Overall Study||23
10706091|NCT02605174|11870564|FG002|NOT COMPLETED|Overall Study||76
10642676|NCT02110758|11801659|FG000|STARTED|Start-Up: August 2013-June 2014||175
10642677|NCT02110758|11801660|FG001|STARTED|Start-Up: August 2013-June 2014||431
10642678|NCT02110758|11801661|FG002|STARTED|Start-Up: August 2013-June 2014||8057
10642679|NCT02110758|11801662|FG003|STARTED|Start-Up: August 2013-June 2014||12883
10642680|NCT02110758|11801663|FG004|STARTED|Start-Up: August 2013-June 2014||0
10642681|NCT02110758|11801659|FG000|COMPLETED|Start-Up: August 2013-June 2014||175
10706092|NCT02605174|11870565|FG003|NOT COMPLETED|Overall Study||36
10642682|NCT02110758|11801660|FG001|COMPLETED|Start-Up: August 2013-June 2014||431
10642683|NCT02110758|11801661|FG002|COMPLETED|Start-Up: August 2013-June 2014||8057
10642684|NCT02110758|11801662|FG003|COMPLETED|Start-Up: August 2013-June 2014||12883
10642685|NCT02110758|11801663|FG004|COMPLETED|Start-Up: August 2013-June 2014||0
10642686|NCT02110758|11801659|FG000|NOT COMPLETED|Start-Up: August 2013-June 2014||0
10642687|NCT02110758|11801660|FG001|NOT COMPLETED|Start-Up: August 2013-June 2014||0
10642688|NCT02110758|11801661|FG002|NOT COMPLETED|Start-Up: August 2013-June 2014||0
10642689|NCT02110758|11801662|FG003|NOT COMPLETED|Start-Up: August 2013-June 2014||0
10642690|NCT02110758|11801663|FG004|NOT COMPLETED|Start-Up: August 2013-June 2014||0
10706093|NCT02605174|11870566|FG004|NOT COMPLETED|Overall Study||53
10706094|NCT02605174|11870567|FG005|NOT COMPLETED|Overall Study||32
10642691|NCT02110758|11801659|FG000|STARTED|Intervention: July 2014-December 2015||0
10642692|NCT02110758|11801660|FG001|STARTED|Intervention: July 2014-December 2015||0
10642693|NCT02110758|11801661|FG002|STARTED|Intervention: July 2014-December 2015||10106
10642694|NCT02110758|11801662|FG003|STARTED|Intervention: July 2014-December 2015||33012
10642695|NCT02110758|11801663|FG004|STARTED|Intervention: July 2014-December 2015||0
10642696|NCT02110758|11801659|FG000|COMPLETED|Intervention: July 2014-December 2015||0
10642697|NCT02110758|11801660|FG001|COMPLETED|Intervention: July 2014-December 2015||0
10642698|NCT02110758|11801661|FG002|COMPLETED|Intervention: July 2014-December 2015||10106
10642699|NCT02110758|11801662|FG003|COMPLETED|Intervention: July 2014-December 2015||33012
10642700|NCT02110758|11801663|FG004|COMPLETED|Intervention: July 2014-December 2015||0
10642701|NCT02110758|11801659|FG000|NOT COMPLETED|Intervention: July 2014-December 2015||0
10642702|NCT02110758|11801660|FG001|NOT COMPLETED|Intervention: July 2014-December 2015||0
10642703|NCT02110758|11801661|FG002|NOT COMPLETED|Intervention: July 2014-December 2015||0
10642704|NCT02110758|11801662|FG003|NOT COMPLETED|Intervention: July 2014-December 2015||0
10642705|NCT02110758|11801663|FG004|NOT COMPLETED|Intervention: July 2014-December 2015||0
10642706|NCT02110758|11801659|FG000|STARTED|Follow-Up: January-July 2016||81
10642707|NCT02110758|11801660|FG001|STARTED|Follow-Up: January-July 2016||179
10642708|NCT02110758|11801661|FG002|STARTED|Follow-Up: January-July 2016||6451
10642709|NCT02110758|11801662|FG003|STARTED|Follow-Up: January-July 2016||24392
10642710|NCT02110758|11801663|FG004|STARTED|Follow-Up: January-July 2016||349
10642711|NCT02110758|11801659|FG000|COMPLETED|Follow-Up: January-July 2016||81
10642712|NCT02110758|11801660|FG001|COMPLETED|Follow-Up: January-July 2016||179
10642713|NCT02110758|11801661|FG002|COMPLETED|Follow-Up: January-July 2016||6451
10642714|NCT02110758|11801662|FG003|COMPLETED|Follow-Up: January-July 2016||24392
10642715|NCT02110758|11801663|FG004|COMPLETED|Follow-Up: January-July 2016||349
10642716|NCT02110758|11801659|FG000|NOT COMPLETED|Follow-Up: January-July 2016||0
10642717|NCT02110758|11801660|FG001|NOT COMPLETED|Follow-Up: January-July 2016||0
10642718|NCT02110758|11801661|FG002|NOT COMPLETED|Follow-Up: January-July 2016||0
10642719|NCT02110758|11801662|FG003|NOT COMPLETED|Follow-Up: January-July 2016||0
10642720|NCT02110758|11801663|FG004|NOT COMPLETED|Follow-Up: January-July 2016||0
10642721|NCT02110901|11801677|FG000|STARTED|Overall Study||209
10642722|NCT02110901|11801678|FG001|STARTED|Overall Study||102
10642723|NCT02110901|11801677|FG000|COMPLETED|Overall Study||179
10642724|NCT02110901|11801678|FG001|COMPLETED|Overall Study||88
10642725|NCT02110901|11801677|FG000|NOT COMPLETED|Overall Study||30
10642726|NCT02110901|11801678|FG001|NOT COMPLETED|Overall Study||14
10642727|NCT02111083|11801687|FG000|STARTED|First Intervention (1 Day)||19
10642728|NCT02111083|11801688|FG001|STARTED|First Intervention (1 Day)||19
10642729|NCT02111083|11801687|FG000|COMPLETED|First Intervention (1 Day)||19
10642730|NCT02111083|11801688|FG001|COMPLETED|First Intervention (1 Day)||19
10642731|NCT02111083|11801687|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10642732|NCT02111083|11801688|FG001|NOT COMPLETED|First Intervention (1 Day)||0
10642733|NCT02111083|11801687|FG000|STARTED|Interval Between Dosing (7-8 Days)||19
10642734|NCT02111083|11801688|FG001|STARTED|Interval Between Dosing (7-8 Days)||19
10642735|NCT02111083|11801687|FG000|COMPLETED|Interval Between Dosing (7-8 Days)||19
10642736|NCT02111083|11801688|FG001|COMPLETED|Interval Between Dosing (7-8 Days)||19
10642737|NCT02111083|11801687|FG000|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
10642738|NCT02111083|11801688|FG001|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
10642739|NCT02111083|11801687|FG000|STARTED|Second Intervention (1 Day)||19
10642740|NCT02111083|11801688|FG001|STARTED|Second Intervention (1 Day)||19
10642741|NCT02111083|11801687|FG000|COMPLETED|Second Intervention (1 Day)||19
10642742|NCT02111083|11801688|FG001|COMPLETED|Second Intervention (1 Day)||19
10642743|NCT02111083|11801687|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10642744|NCT02111083|11801688|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10642745|NCT02111083|11801687|FG000|STARTED|Interval Between Dosing (7-8 Days)||19
10642746|NCT02111083|11801688|FG001|STARTED|Interval Between Dosing (7-8 Days)||19
10642747|NCT02111083|11801687|FG000|COMPLETED|Interval Between Dosing (7-8 Days)||19
10642748|NCT02111083|11801688|FG001|COMPLETED|Interval Between Dosing (7-8 Days)||19
10642749|NCT02111083|11801687|FG000|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
10642750|NCT02111083|11801688|FG001|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
10642751|NCT02111083|11801687|FG000|STARTED|Third Intervention (1 Day)||19
10642752|NCT02111083|11801688|FG001|STARTED|Third Intervention (1 Day)||19
10642753|NCT02111083|11801687|FG000|COMPLETED|Third Intervention (1 Day)||19
10642754|NCT02111083|11801688|FG001|COMPLETED|Third Intervention (1 Day)||19
10642755|NCT02111083|11801687|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
10642756|NCT02111083|11801688|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
10642757|NCT02111083|11801687|FG000|STARTED|Interval Between Dosing (7-8 Days)||19
10642758|NCT02111083|11801688|FG001|STARTED|Interval Between Dosing (7-8 Days)||19
10642759|NCT02111083|11801687|FG000|COMPLETED|Interval Between Dosing (7-8 Days)||18
10642760|NCT02111083|11801688|FG001|COMPLETED|Interval Between Dosing (7-8 Days)||18
10642761|NCT02111083|11801687|FG000|NOT COMPLETED|Interval Between Dosing (7-8 Days)||1
10642762|NCT02111083|11801688|FG001|NOT COMPLETED|Interval Between Dosing (7-8 Days)||1
10642763|NCT02111083|11801687|FG000|STARTED|Fourth Intervention (1 Day)||18
10642764|NCT02111083|11801688|FG001|STARTED|Fourth Intervention (1 Day)||18
10642765|NCT02111083|11801687|FG000|COMPLETED|Fourth Intervention (1 Day)||18
10642766|NCT02111083|11801688|FG001|COMPLETED|Fourth Intervention (1 Day)||18
10642767|NCT02111083|11801687|FG000|NOT COMPLETED|Fourth Intervention (1 Day)||0
10642768|NCT02111083|11801688|FG001|NOT COMPLETED|Fourth Intervention (1 Day)||0
10642769|NCT02111096|11801697|FG000|STARTED|Overall Study||65
10642770|NCT02111096|11801698|FG001|STARTED|Overall Study||41
10642771|NCT02111096|11801699|FG002|STARTED|Overall Study||68
10642772|NCT02111096|11801697|FG000|Received at Least 1 Dose of Study Drug|Overall Study||65
10642773|NCT02111096|11801698|FG001|Received at Least 1 Dose of Study Drug|Overall Study||41
10642774|NCT02111096|11801699|FG002|Received at Least 1 Dose of Study Drug|Overall Study||68
10642775|NCT02111096|11801697|FG000|COMPLETED|Overall Study||1
10642776|NCT02111096|11801698|FG001|COMPLETED|Overall Study||0
10642777|NCT02111096|11801699|FG002|COMPLETED|Overall Study||2
10642778|NCT02111096|11801697|FG000|NOT COMPLETED|Overall Study||64
10642779|NCT02111096|11801698|FG001|NOT COMPLETED|Overall Study||41
10642780|NCT02111096|11801699|FG002|NOT COMPLETED|Overall Study||66
10642781|NCT02111174|11801712|FG000|STARTED|Treatment and Primary Outcome||18
10642782|NCT02111174|11801713|FG001|STARTED|Treatment and Primary Outcome||18
10706095|NCT02605174|11870568|FG006|NOT COMPLETED|Overall Study||89
10706096|NCT02605187|11870598|FG000|STARTED|Overall Study||40
10642783|NCT02111174|11801712|FG000|COMPLETED|Treatment and Primary Outcome||15
10642784|NCT02111174|11801713|FG001|COMPLETED|Treatment and Primary Outcome||16
10642785|NCT02111174|11801712|FG000|NOT COMPLETED|Treatment and Primary Outcome||3
10642786|NCT02111174|11801713|FG001|NOT COMPLETED|Treatment and Primary Outcome||2
10642787|NCT02111174|11801712|FG000|STARTED|Secondary Outcomes (2 and 3 Month f/u)||15
10642788|NCT02111174|11801713|FG001|STARTED|Secondary Outcomes (2 and 3 Month f/u)||16
10642789|NCT02111174|11801712|FG000|2 Month Follow up Complete|Secondary Outcomes (2 and 3 Month f/u)||8
10642790|NCT02111174|11801713|FG001|2 Month Follow up Complete|Secondary Outcomes (2 and 3 Month f/u)||11
10642791|NCT02111174|11801712|FG000|COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||7
10642792|NCT02111174|11801713|FG001|COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||9
10642793|NCT02111174|11801712|FG000|NOT COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||8
10642794|NCT02111174|11801713|FG001|NOT COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||7
10642795|NCT02111187|11801721|FG000|STARTED|Overall Study||7
10642796|NCT02111187|11801722|FG001|STARTED|Overall Study||7
10642797|NCT02111187|11801721|FG000|COMPLETED|Overall Study||7
10642798|NCT02111187|11801722|FG001|COMPLETED|Overall Study||7
10642799|NCT02111187|11801721|FG000|NOT COMPLETED|Overall Study||0
10642800|NCT02111187|11801722|FG001|NOT COMPLETED|Overall Study||0
10642801|NCT02111200|11801732|FG000|STARTED|Overall Study||3
10642802|NCT02111200|11801733|FG001|STARTED|Overall Study||2
10642803|NCT02111200|11801734|FG002|STARTED|Overall Study||1
10642804|NCT02111200|11801735|FG003|STARTED|Overall Study||1
10642805|NCT02111200|11801732|FG000|COMPLETED|Overall Study||3
10642806|NCT02111200|11801733|FG001|COMPLETED|Overall Study||2
10642807|NCT02111200|11801734|FG002|COMPLETED|Overall Study||1
10642808|NCT02111200|11801735|FG003|COMPLETED|Overall Study||1
10642809|NCT02111200|11801732|FG000|NOT COMPLETED|Overall Study||0
10642810|NCT02111200|11801733|FG001|NOT COMPLETED|Overall Study||0
10642811|NCT02111200|11801734|FG002|NOT COMPLETED|Overall Study||0
10642812|NCT02111200|11801735|FG003|NOT COMPLETED|Overall Study||0
10642813|NCT02111213|11801745|FG000|STARTED|Overall Study||122
10642814|NCT02111213|11801746|FG001|STARTED|Overall Study||123
10642815|NCT02111213|11801745|FG000|COMPLETED|Overall Study||116
10642816|NCT02111213|11801746|FG001|COMPLETED|Overall Study||117
10642817|NCT02111213|11801745|FG000|NOT COMPLETED|Overall Study||6
10642818|NCT02111213|11801746|FG001|NOT COMPLETED|Overall Study||6
10642819|NCT02111252|11801752|FG000|STARTED|Overall Study||55
10642820|NCT02111252|11801752|FG000|COMPLETED|Overall Study||55
10642821|NCT02111252|11801752|FG000|NOT COMPLETED|Overall Study||0
10642822|NCT02111369|11801756|FG000|STARTED|Overall Study||18
10642823|NCT02111369|11801756|FG000|COMPLETED|Overall Study||15
10642824|NCT02111369|11801756|FG000|NOT COMPLETED|Overall Study||3
10642825|NCT02111447|11801764|FG000|STARTED|Overall Study||0
10642826|NCT02111447|11801765|FG001|STARTED|Overall Study||5
10642827|NCT02111447|11801766|FG002|STARTED|Overall Study||1
10642828|NCT02111447|11801767|FG003|STARTED|Overall Study||0
10642829|NCT02111447|11801764|FG000|COMPLETED|Overall Study||0
10642830|NCT02111447|11801765|FG001|COMPLETED|Overall Study||5
10642831|NCT02111447|11801766|FG002|COMPLETED|Overall Study||1
10642832|NCT02111447|11801767|FG003|COMPLETED|Overall Study||0
10642833|NCT02111447|11801764|FG000|NOT COMPLETED|Overall Study||0
10642834|NCT02111447|11801765|FG001|NOT COMPLETED|Overall Study||0
10642835|NCT02111447|11801766|FG002|NOT COMPLETED|Overall Study||0
10642836|NCT02111447|11801767|FG003|NOT COMPLETED|Overall Study||0
10642837|NCT02111564|11801779|FG000|STARTED|Overall Study||6007
10642838|NCT02111564|11801780|FG001|STARTED|Overall Study||6012
10642839|NCT02111564|11801779|FG000|Treated|Overall Study||5982
10642840|NCT02111564|11801780|FG001|Treated|Overall Study||5980
10642841|NCT02111564|11801779|FG000|COMPLETED|Overall Study||5876
10642842|NCT02111564|11801780|FG001|COMPLETED|Overall Study||5869
10642843|NCT02111564|11801779|FG000|NOT COMPLETED|Overall Study||131
10642844|NCT02111564|11801780|FG001|NOT COMPLETED|Overall Study||143
10642845|NCT02111577|11801788|FG000|STARTED|Overall Study||787
10642846|NCT02111577|11801789|FG001|STARTED|Overall Study||395
10642847|NCT02111577|11801788|FG000|COMPLETED|Overall Study||188
10642848|NCT02111577|11801789|FG001|COMPLETED|Overall Study||106
10642849|NCT02111577|11801788|FG000|NOT COMPLETED|Overall Study||599
10642850|NCT02111577|11801789|FG001|NOT COMPLETED|Overall Study||289
10642851|NCT02111603|11801797|FG000|STARTED|Overall Study||13
10642852|NCT02111603|11801797|FG000|COMPLETED|Overall Study||12
10642853|NCT02111603|11801797|FG000|NOT COMPLETED|Overall Study||1
10642854|NCT02111746|11801803|FG000|STARTED|Overall Study||172
10642855|NCT02111746|11801804|FG001|STARTED|Overall Study||171
10642856|NCT02111746|11801803|FG000|COMPLETED|Overall Study||169
10642857|NCT02111746|11801804|FG001|COMPLETED|Overall Study||169
10642858|NCT02111746|11801803|FG000|NOT COMPLETED|Overall Study||3
10642859|NCT02111746|11801804|FG001|NOT COMPLETED|Overall Study||2
10642860|NCT02111772|11801812|FG000|STARTED|Overall Study||12
10642861|NCT02111772|11801813|FG001|STARTED|Overall Study||14
10642862|NCT02111772|11801812|FG000|COMPLETED|Overall Study||12
10642863|NCT02111772|11801813|FG001|COMPLETED|Overall Study||14
10642864|NCT02111772|11801812|FG000|NOT COMPLETED|Overall Study||0
10642865|NCT02111772|11801813|FG001|NOT COMPLETED|Overall Study||0
10642866|NCT02111785|11801823|FG000|STARTED|Overall Study||3
10642867|NCT02111785|11801824|FG001|STARTED|Overall Study||5
10642868|NCT02111785|11801825|FG002|STARTED|Overall Study||1
10642869|NCT02111785|11801826|FG003|STARTED|Overall Study||1
10642870|NCT02111785|11801823|FG000|COMPLETED|Overall Study||3
10642871|NCT02111785|11801824|FG001|COMPLETED|Overall Study||4
10642872|NCT02111785|11801825|FG002|COMPLETED|Overall Study||1
10642873|NCT02111785|11801826|FG003|COMPLETED|Overall Study||1
10642874|NCT02111785|11801823|FG000|NOT COMPLETED|Overall Study||0
10642875|NCT02111785|11801824|FG001|NOT COMPLETED|Overall Study||1
10642876|NCT02111785|11801825|FG002|NOT COMPLETED|Overall Study||0
10642877|NCT02111785|11801826|FG003|NOT COMPLETED|Overall Study||0
10642878|NCT02111798|11801844|FG000|STARTED|Overall Study||31
10642879|NCT02111798|11801845|FG001|STARTED|Overall Study||32
10642880|NCT02111798|11801846|FG002|STARTED|Overall Study||10
10642881|NCT02111798|11801847|FG003|STARTED|Overall Study||10
10642882|NCT02111798|11801844|FG000|COMPLETED|Overall Study||20
10642883|NCT02111798|11801845|FG001|COMPLETED|Overall Study||16
10642884|NCT02111798|11801846|FG002|COMPLETED|Overall Study||10
10642885|NCT02111798|11801847|FG003|COMPLETED|Overall Study||7
10642886|NCT02111798|11801844|FG000|NOT COMPLETED|Overall Study||11
10642887|NCT02111798|11801845|FG001|NOT COMPLETED|Overall Study||16
10642888|NCT02111798|11801846|FG002|NOT COMPLETED|Overall Study||0
10642889|NCT02111798|11801847|FG003|NOT COMPLETED|Overall Study||3
10642890|NCT02111811|11801860|FG000|STARTED|Treatment Phase||139
10642891|NCT02111811|11801861|FG001|STARTED|Treatment Phase||114
10642892|NCT02111811|11801860|FG000|COMPLETED|Treatment Phase||115
10642893|NCT02111811|11801861|FG001|COMPLETED|Treatment Phase||96
10642894|NCT02111811|11801860|FG000|NOT COMPLETED|Treatment Phase||24
10642895|NCT02111811|11801861|FG001|NOT COMPLETED|Treatment Phase||18
10642896|NCT02111811|11801860|FG000|STARTED|Follow up Period (Aim 2)||139
10642897|NCT02111811|11801861|FG001|STARTED|Follow up Period (Aim 2)|All subjects were approached for followup, 1 patient completed the 2nd followup and not the first.|114
10642898|NCT02111811|11801860|FG000|COMPLETED|Follow up Period (Aim 2)||111
10642899|NCT02111811|11801861|FG001|COMPLETED|Follow up Period (Aim 2)||97
10642900|NCT02111811|11801860|FG000|NOT COMPLETED|Follow up Period (Aim 2)||28
10642901|NCT02111811|11801861|FG001|NOT COMPLETED|Follow up Period (Aim 2)||17
10642902|NCT02111863|11801867|FG000|STARTED|Overall Study||6
10642903|NCT02111863|11801867|FG000|COMPLETED|Overall Study||6
10642904|NCT02111863|11801867|FG000|NOT COMPLETED|Overall Study||0
10642905|NCT02111980|11801871|FG000|STARTED|Overall Study||50
10642906|NCT02111980|11801871|FG000|COMPLETED|Overall Study||50
10642907|NCT02111980|11801871|FG000|NOT COMPLETED|Overall Study||0
10642908|NCT02111993|11801880|FG000|STARTED|Overall Study||30
10642909|NCT02111993|11801881|FG001|STARTED|Overall Study||30
10642910|NCT02111993|11801880|FG000|COMPLETED|Overall Study||25
10642911|NCT02111993|11801881|FG001|COMPLETED|Overall Study||26
10642912|NCT02111993|11801880|FG000|NOT COMPLETED|Overall Study||5
10642913|NCT02111993|11801881|FG001|NOT COMPLETED|Overall Study||4
10642914|NCT02112045|11801891|FG000|STARTED|Overall Study||45
10642915|NCT02112045|11801892|FG001|STARTED|Overall Study||45
10642916|NCT02112045|11801891|FG000|COMPLETED|Overall Study||44
10642917|NCT02112045|11801892|FG001|COMPLETED|Overall Study||45
10642918|NCT02112045|11801891|FG000|NOT COMPLETED|Overall Study||1
10642919|NCT02112045|11801892|FG001|NOT COMPLETED|Overall Study||0
10642920|NCT02112370|11801900|FG000|STARTED|Overall Study||74
10642921|NCT02112370|11801901|FG001|STARTED|Overall Study||74
10642922|NCT02112370|11801900|FG000|COMPLETED|Overall Study||74
10642923|NCT02112370|11801901|FG001|COMPLETED|Overall Study||74
10642924|NCT02112370|11801900|FG000|NOT COMPLETED|Overall Study||0
10642925|NCT02112370|11801901|FG001|NOT COMPLETED|Overall Study||0
10642926|NCT02112448|11801909|FG000|STARTED|Overall Study||38
10642927|NCT02112448|11801910|FG001|STARTED|Overall Study||40
10642928|NCT02112448|11801909|FG000|COMPLETED|Overall Study||30
10642929|NCT02112448|11801910|FG001|COMPLETED|Overall Study||30
10642930|NCT02112448|11801909|FG000|NOT COMPLETED|Overall Study||8
10642931|NCT02112448|11801910|FG001|NOT COMPLETED|Overall Study||10
10642932|NCT02112838|11801921|FG000|STARTED|Overall Study||25
10642933|NCT02112838|11801922|FG001|STARTED|Overall Study||26
10642934|NCT02112838|11801923|FG002|STARTED|Overall Study||25
10642935|NCT02112838|11801921|FG000|COMPLETED|Overall Study||20
10642936|NCT02112838|11801922|FG001|COMPLETED|Overall Study||24
10642937|NCT02112838|11801923|FG002|COMPLETED|Overall Study||24
10642938|NCT02112838|11801921|FG000|NOT COMPLETED|Overall Study||5
10642939|NCT02112838|11801922|FG001|NOT COMPLETED|Overall Study||2
10642940|NCT02112838|11801923|FG002|NOT COMPLETED|Overall Study||1
10642941|NCT02112877|11801933|FG000|STARTED|Overall Study||30
10642942|NCT02112877|11801934|FG001|STARTED|Overall Study||170
10642943|NCT02112877|11801933|FG000|COMPLETED|Overall Study||28
10642944|NCT02112877|11801934|FG001|COMPLETED|Overall Study||157
10642945|NCT02112877|11801933|FG000|NOT COMPLETED|Overall Study||2
10642946|NCT02112877|11801934|FG001|NOT COMPLETED|Overall Study||13
10642947|NCT02112994|11801942|FG000|STARTED|Overall Study||6
10642948|NCT02112994|11801943|FG001|STARTED|Overall Study||16
10642949|NCT02112994|11801944|FG002|STARTED|Overall Study||9
10642950|NCT02112994|11801942|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
10642951|NCT02112994|11801943|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16
10642952|NCT02112994|11801944|FG002|Received at Least 1 Dose of Study Drug|Overall Study||9
10642953|NCT02112994|11801942|FG000|Received 0.35 mg/kg QOW|Overall Study||0
10642954|NCT02112994|11801943|FG001|Received 0.35 mg/kg QOW|Overall Study||0
10642955|NCT02112994|11801944|FG002|Received 0.35 mg/kg QOW|Overall Study||1
10642956|NCT02112994|11801942|FG000|Received 1 mg/kg QOW|Overall Study||6
10642957|NCT02112994|11801943|FG001|Received 1 mg/kg QOW|Overall Study||16
10642958|NCT02112994|11801944|FG002|Received 1 mg/kg QOW|Overall Study||9
10642959|NCT02112994|11801942|FG000|Received 1 mg/kg QW|Overall Study||1
10642960|NCT02112994|11801943|FG001|Received 1 mg/kg QW|Overall Study||1
10642961|NCT02112994|11801944|FG002|Received 1 mg/kg QW|Overall Study||0
10642962|NCT02112994|11801942|FG000|Received 3 mg/kg QOW|Overall Study||3
10642963|NCT02112994|11801943|FG001|Received 3 mg/kg QOW|Overall Study||5
10642964|NCT02112994|11801944|FG002|Received 3 mg/kg QOW|Overall Study||3
10642965|NCT02112994|11801942|FG000|Received 3 mg/kg QW|Overall Study||2
10642966|NCT02112994|11801943|FG001|Received 3 mg/kg QW|Overall Study||1
10642967|NCT02112994|11801944|FG002|Received 3 mg/kg QW|Overall Study||1
10642968|NCT02112994|11801942|FG000|Completed 96-week Treatment Period|Overall Study||6
10642969|NCT02112994|11801943|FG001|Completed 96-week Treatment Period|Overall Study||14
10642970|NCT02112994|11801944|FG002|Completed 96-week Treatment Period|Overall Study||8
10642971|NCT02112994|11801942|FG000|COMPLETED|Overall Study||6
10642972|NCT02112994|11801943|FG001|COMPLETED|Overall Study||14
10642973|NCT02112994|11801944|FG002|COMPLETED|Overall Study||6
10642974|NCT02112994|11801942|FG000|NOT COMPLETED|Overall Study||0
10642975|NCT02112994|11801943|FG001|NOT COMPLETED|Overall Study||2
10642976|NCT02112994|11801944|FG002|NOT COMPLETED|Overall Study||3
10642977|NCT02113007|11801956|FG000|STARTED|Overall Study||2
10642978|NCT02113007|11801956|FG000|COMPLETED|Overall Study||0
10642979|NCT02113007|11801956|FG000|NOT COMPLETED|Overall Study||2
10654223|NCT02201056|11814902|FG001|NOT COMPLETED|Overall Study||0
10654224|NCT02201056|11814903|FG002|NOT COMPLETED|Overall Study||0
10654225|NCT02201056|11814904|FG003|NOT COMPLETED|Overall Study||0
10654226|NCT02201056|11814905|FG004|NOT COMPLETED|Overall Study||0
10654227|NCT02201056|11814906|FG005|NOT COMPLETED|Overall Study||0
10642980|NCT02113124|11801962|FG000|STARTED|Overall Study||18
10642981|NCT02113124|11801963|FG001|STARTED|Overall Study||25
10642982|NCT02113124|11801962|FG000|COMPLETED|Overall Study||17
10642983|NCT02113124|11801963|FG001|COMPLETED|Overall Study||24
10642984|NCT02113124|11801962|FG000|NOT COMPLETED|Overall Study||1
10642985|NCT02113124|11801963|FG001|NOT COMPLETED|Overall Study||1
10642986|NCT02113189|11801972|FG000|STARTED|Overall Study||4
10642987|NCT02113189|11801973|FG001|STARTED|Overall Study||4
10642988|NCT02113189|11801974|FG002|STARTED|Overall Study||5
10642989|NCT02113189|11801972|FG000|COMPLETED|Overall Study||2
10642990|NCT02113189|11801973|FG001|COMPLETED|Overall Study||3
10642991|NCT02113189|11801974|FG002|COMPLETED|Overall Study||2
10642992|NCT02113189|11801972|FG000|NOT COMPLETED|Overall Study||2
10642993|NCT02113189|11801973|FG001|NOT COMPLETED|Overall Study||1
10642994|NCT02113189|11801974|FG002|NOT COMPLETED|Overall Study||3
10642995|NCT02113241|11801987|FG000|STARTED|Overall Study||12
10642996|NCT02113241|11801988|FG001|STARTED|Overall Study||12
10642997|NCT02113241|11801987|FG000|COMPLETED|Overall Study||12
10642998|NCT02113241|11801988|FG001|COMPLETED|Overall Study||11
10642999|NCT02113241|11801987|FG000|NOT COMPLETED|Overall Study||0
10643000|NCT02113241|11801988|FG001|NOT COMPLETED|Overall Study||1
10643001|NCT02113410|11801996|FG000|STARTED|Overall Study||65
10643002|NCT02113410|11801997|FG001|STARTED|Overall Study||66
10643003|NCT02113410|11801996|FG000|COMPLETED|Overall Study||49
10643004|NCT02113410|11801997|FG001|COMPLETED|Overall Study||63
10643005|NCT02113410|11801996|FG000|NOT COMPLETED|Overall Study||16
10643006|NCT02113410|11801997|FG001|NOT COMPLETED|Overall Study||3
10643007|NCT02113436|11802007|FG000|STARTED|Period 1: 8 Weeks||150
10643008|NCT02113436|11802008|FG001|STARTED|Period 1: 8 Weeks||150
10643009|NCT02113436|11802009|FG002|STARTED|Period 1: 8 Weeks||0
10643010|NCT02113436|11802010|FG003|STARTED|Period 1: 8 Weeks||0
10643011|NCT02113436|11802007|FG000|COMPLETED|Period 1: 8 Weeks||142
10643012|NCT02113436|11802008|FG001|COMPLETED|Period 1: 8 Weeks||148
10643013|NCT02113436|11802009|FG002|COMPLETED|Period 1: 8 Weeks||0
10643014|NCT02113436|11802010|FG003|COMPLETED|Period 1: 8 Weeks||0
10643015|NCT02113436|11802007|FG000|NOT COMPLETED|Period 1: 8 Weeks||8
10643016|NCT02113436|11802008|FG001|NOT COMPLETED|Period 1: 8 Weeks||2
10643017|NCT02113436|11802009|FG002|NOT COMPLETED|Period 1: 8 Weeks||0
10643018|NCT02113436|11802010|FG003|NOT COMPLETED|Period 1: 8 Weeks||0
10706097|NCT02605187|11870599|FG001|STARTED|Overall Study||21
10706098|NCT02605187|11870600|FG002|STARTED|Overall Study||83
10706099|NCT02605187|11870601|FG003|STARTED|Overall Study||16
10706100|NCT02605187|11870598|FG000|COMPLETED|Overall Study||32
10643019|NCT02113436|11802007|FG000|STARTED|Period 2: 16 Weeks||0
10643020|NCT02113436|11802008|FG001|STARTED|Period 2: 16 Weeks||0
10643021|NCT02113436|11802009|FG002|STARTED|Period 2: 16 Weeks|Par. started TP2 are not equal to that completed TP1 as 1 par. in each arm didn't transfer to TP2.|141
10643022|NCT02113436|11802010|FG003|STARTED|Period 2: 16 Weeks|Par. started TP2 are not equal to that completed TP1 as 1 par. in each arm didn't transfer to TP2.|147
10643023|NCT02113436|11802007|FG000|COMPLETED|Period 2: 16 Weeks||0
10643024|NCT02113436|11802008|FG001|COMPLETED|Period 2: 16 Weeks||0
10643025|NCT02113436|11802009|FG002|COMPLETED|Period 2: 16 Weeks||132
10643026|NCT02113436|11802010|FG003|COMPLETED|Period 2: 16 Weeks||136
10643027|NCT02113436|11802007|FG000|NOT COMPLETED|Period 2: 16 Weeks||0
10643028|NCT02113436|11802008|FG001|NOT COMPLETED|Period 2: 16 Weeks||0
10643029|NCT02113436|11802009|FG002|NOT COMPLETED|Period 2: 16 Weeks||9
10643030|NCT02113436|11802010|FG003|NOT COMPLETED|Period 2: 16 Weeks||11
10643031|NCT02113449|11802019|FG000|STARTED|Overall Study||147
10643032|NCT02113449|11802019|FG000|COMPLETED|Overall Study||143
10643033|NCT02113449|11802019|FG000|NOT COMPLETED|Overall Study||4
10643034|NCT02113579|11802029|FG000|STARTED|Overall Study||186
10643035|NCT02113579|11802030|FG001|STARTED|Overall Study||189
10643036|NCT02113579|11802029|FG000|COMPLETED|Overall Study||176
10643037|NCT02113579|11802030|FG001|COMPLETED|Overall Study||185
10643038|NCT02113579|11802029|FG000|NOT COMPLETED|Overall Study||10
10643039|NCT02113579|11802030|FG001|NOT COMPLETED|Overall Study||4
10643040|NCT02113956|11802038|FG000|STARTED|Intervention End (5 Weeks Post Baseline)||150
10643041|NCT02113956|11802039|FG001|STARTED|Intervention End (5 Weeks Post Baseline)||152
10643042|NCT02113956|11802038|FG000|COMPLETED|Intervention End (5 Weeks Post Baseline)||141
10643043|NCT02113956|11802039|FG001|COMPLETED|Intervention End (5 Weeks Post Baseline)||148
10643044|NCT02113956|11802038|FG000|NOT COMPLETED|Intervention End (5 Weeks Post Baseline)||9
10643045|NCT02113956|11802039|FG001|NOT COMPLETED|Intervention End (5 Weeks Post Baseline)||4
10643046|NCT02113956|11802038|FG000|STARTED|3 Month Post-intervention||141
10643047|NCT02113956|11802039|FG001|STARTED|3 Month Post-intervention||148
10643048|NCT02113956|11802038|FG000|COMPLETED|3 Month Post-intervention||137
10643049|NCT02113956|11802039|FG001|COMPLETED|3 Month Post-intervention||146
10643050|NCT02113956|11802038|FG000|NOT COMPLETED|3 Month Post-intervention||4
10643051|NCT02113956|11802039|FG001|NOT COMPLETED|3 Month Post-intervention||2
10643052|NCT02114151|11802045|FG000|STARTED|Overall Study||103
10643053|NCT02114151|11802045|FG000|COMPLETED|Overall Study||96
10643054|NCT02114151|11802045|FG000|NOT COMPLETED|Overall Study||7
10643055|NCT02114164|11802051|FG000|STARTED|Overall Study||50
10643056|NCT02114164|11802052|FG001|STARTED|Overall Study||50
10643057|NCT02114164|11802051|FG000|COMPLETED|Overall Study||50
10643058|NCT02114164|11802052|FG001|COMPLETED|Overall Study||50
10643059|NCT02114164|11802051|FG000|NOT COMPLETED|Overall Study||0
10643060|NCT02114164|11802052|FG001|NOT COMPLETED|Overall Study||0
10643061|NCT02114177|11802060|FG000|STARTED|Overall Study||155
10643062|NCT02114177|11802061|FG001|STARTED|Overall Study||155
10643063|NCT02114177|11802060|FG000|COMPLETED|Overall Study||146
10643064|NCT02114177|11802061|FG001|COMPLETED|Overall Study||151
10643065|NCT02114177|11802060|FG000|NOT COMPLETED|Overall Study||9
10643066|NCT02114177|11802061|FG001|NOT COMPLETED|Overall Study||4
10643067|NCT02114203|11802070|FG000|STARTED|Overall Study||7
10643068|NCT02114203|11802071|FG001|STARTED|Overall Study||16
10643069|NCT02114203|11802072|FG002|STARTED|Overall Study||7
10643070|NCT02114203|11802070|FG000|COMPLETED|Overall Study||7
10643071|NCT02114203|11802071|FG001|COMPLETED|Overall Study||14
10643072|NCT02114203|11802072|FG002|COMPLETED|Overall Study||7
10643073|NCT02114203|11802070|FG000|NOT COMPLETED|Overall Study||0
10643074|NCT02114203|11802071|FG001|NOT COMPLETED|Overall Study||2
10643075|NCT02114203|11802072|FG002|NOT COMPLETED|Overall Study||0
10643076|NCT02114216|11802083|FG000|STARTED|Overall Study||16
10643077|NCT02114216|11802084|FG001|STARTED|Overall Study||45
10643078|NCT02114216|11802085|FG002|STARTED|Overall Study||14
10643079|NCT02114216|11802083|FG000|COMPLETED|Overall Study||16
10643080|NCT02114216|11802084|FG001|COMPLETED|Overall Study||45
10643081|NCT02114216|11802085|FG002|COMPLETED|Overall Study||14
10643082|NCT02114216|11802083|FG000|NOT COMPLETED|Overall Study||0
10643083|NCT02114216|11802084|FG001|NOT COMPLETED|Overall Study||0
10643084|NCT02114216|11802085|FG002|NOT COMPLETED|Overall Study||0
10643085|NCT02114268|11802102|FG000|STARTED|Overall Study||34
10643086|NCT02114268|11802103|FG001|STARTED|Overall Study||6
10643087|NCT02114268|11802104|FG002|STARTED|Overall Study||6
10643088|NCT02114268|11802105|FG003|STARTED|Overall Study||6
10643089|NCT02114268|11802106|FG004|STARTED|Overall Study||6
10643090|NCT02114268|11802107|FG005|STARTED|Overall Study||78
10643091|NCT02114268|11802102|FG000|COMPLETED|Overall Study||28
10643092|NCT02114268|11802103|FG001|COMPLETED|Overall Study||5
10643093|NCT02114268|11802104|FG002|COMPLETED|Overall Study||5
10643094|NCT02114268|11802105|FG003|COMPLETED|Overall Study||6
10643095|NCT02114268|11802106|FG004|COMPLETED|Overall Study||6
10643096|NCT02114268|11802107|FG005|COMPLETED|Overall Study||75
10643097|NCT02114268|11802102|FG000|NOT COMPLETED|Overall Study||6
10643098|NCT02114268|11802103|FG001|NOT COMPLETED|Overall Study||1
10643099|NCT02114268|11802104|FG002|NOT COMPLETED|Overall Study||1
10643100|NCT02114268|11802105|FG003|NOT COMPLETED|Overall Study||0
10643101|NCT02114268|11802106|FG004|NOT COMPLETED|Overall Study||0
10643102|NCT02114268|11802107|FG005|NOT COMPLETED|Overall Study||3
10643103|NCT02114307|11802128|FG000|STARTED|Overall Study||11
10643104|NCT02114307|11802129|FG001|STARTED|Overall Study||11
10643105|NCT02114307|11802128|FG000|COMPLETED|Overall Study||10
10643106|NCT02114307|11802129|FG001|COMPLETED|Overall Study||11
10643107|NCT02114307|11802128|FG000|NOT COMPLETED|Overall Study||1
10643108|NCT02114307|11802129|FG001|NOT COMPLETED|Overall Study||0
10643109|NCT02114385|11802139|FG000|STARTED|Overall Study||249
10643110|NCT02114385|11802140|FG001|STARTED|Overall Study||251
10643111|NCT02114385|11802139|FG000|Vaccinated|Overall Study||249
10643112|NCT02114385|11802140|FG001|Vaccinated|Overall Study||251
10643113|NCT02114385|11802139|FG000|COMPLETED|Overall Study||246
10643114|NCT02114385|11802140|FG001|COMPLETED|Overall Study||243
10643115|NCT02114385|11802139|FG000|NOT COMPLETED|Overall Study||3
10643116|NCT02114385|11802140|FG001|NOT COMPLETED|Overall Study||8
10643117|NCT02114515|11802148|FG000|STARTED|Overall Study||511
10643118|NCT02114515|11802149|FG001|STARTED|Overall Study||518
10643119|NCT02114515|11802148|FG000|COMPLETED|Overall Study||378
10643120|NCT02114515|11802149|FG001|COMPLETED|Overall Study||368
10643121|NCT02114515|11802148|FG000|NOT COMPLETED|Overall Study||133
10643122|NCT02114515|11802149|FG001|NOT COMPLETED|Overall Study||150
10643123|NCT02114606|11802155|FG000|STARTED|Overall Study||86
10643124|NCT02114606|11802155|FG000|COMPLETED|Overall Study||80
10643125|NCT02114606|11802155|FG000|NOT COMPLETED|Overall Study||6
10643126|NCT02114684|11802161|FG000|STARTED|Overall Study||98
10643127|NCT02114684|11802162|FG001|STARTED|Overall Study||98
10643128|NCT02114684|11802161|FG000|COMPLETED|Overall Study||86
10643129|NCT02114684|11802162|FG001|COMPLETED|Overall Study||88
10643130|NCT02114684|11802161|FG000|NOT COMPLETED|Overall Study||12
10643131|NCT02114684|11802162|FG001|NOT COMPLETED|Overall Study||10
10643132|NCT02114879|11802174|FG000|STARTED|Overall Study||115
10643133|NCT02114879|11802175|FG001|STARTED|Overall Study||114
10643134|NCT02114879|11802174|FG000|COMPLETED|Overall Study||96
10643135|NCT02114879|11802175|FG001|COMPLETED|Overall Study||90
10643136|NCT02114879|11802174|FG000|NOT COMPLETED|Overall Study||19
10643137|NCT02114879|11802175|FG001|NOT COMPLETED|Overall Study||24
10643138|NCT02114892|11802183|FG000|STARTED|Overall Study||12
10643139|NCT02114892|11802184|FG001|STARTED|Overall Study||12
10643140|NCT02114892|11802183|FG000|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
10643141|NCT02114892|11802184|FG001|COMPLETED|Overall Study|Two patients did not complete the study due to early withdrawl|10
10643142|NCT02114892|11802183|FG000|NOT COMPLETED|Overall Study||1
10643143|NCT02114892|11802184|FG001|NOT COMPLETED|Overall Study||2
10643144|NCT02114931|11802192|FG000|STARTED|Overall Study||230
10643145|NCT02114931|11802193|FG001|STARTED|Overall Study||237
10643146|NCT02114931|11802192|FG000|Received Treatment|Overall Study|One participant was enrolled in error and did not receive treatment in the extension study|229
10643147|NCT02114931|11802193|FG001|Received Treatment|Overall Study||237
10643148|NCT02114931|11802192|FG000|COMPLETED|Overall Study||205
10643149|NCT02114931|11802193|FG001|COMPLETED|Overall Study||207
10643150|NCT02114931|11802192|FG000|NOT COMPLETED|Overall Study||25
10643151|NCT02114931|11802193|FG001|NOT COMPLETED|Overall Study||30
10643152|NCT02115048|11802201|FG000|STARTED|Overall Study||23
10643153|NCT02115048|11802202|FG001|STARTED|Overall Study||21
10643154|NCT02115048|11802201|FG000|COMPLETED|Overall Study||23
10643155|NCT02115048|11802202|FG001|COMPLETED|Overall Study||21
10643156|NCT02115048|11802201|FG000|NOT COMPLETED|Overall Study||0
10643157|NCT02115048|11802202|FG001|NOT COMPLETED|Overall Study||0
10643158|NCT02115113|11802208|FG000|STARTED|Participants in Run-in Period||0
10643159|NCT02115113|11802209|FG001|STARTED|Participants in Run-in Period||0
10643160|NCT02115113|11802210|FG002|STARTED|Participants in Run-in Period||78
10643161|NCT02115113|11802208|FG000|COMPLETED|Participants in Run-in Period||0
10643162|NCT02115113|11802209|FG001|COMPLETED|Participants in Run-in Period||0
10643163|NCT02115113|11802210|FG002|COMPLETED|Participants in Run-in Period||68
10643164|NCT02115113|11802208|FG000|NOT COMPLETED|Participants in Run-in Period||0
10643165|NCT02115113|11802209|FG001|NOT COMPLETED|Participants in Run-in Period||0
10643166|NCT02115113|11802210|FG002|NOT COMPLETED|Participants in Run-in Period||10
10643167|NCT02115113|11802208|FG000|STARTED|Participants Randomized||24
10643168|NCT02115113|11802209|FG001|STARTED|Participants Randomized||26
10643169|NCT02115113|11802210|FG002|STARTED|Participants Randomized||0
10643170|NCT02115113|11802208|FG000|COMPLETED|Participants Randomized||22
10706101|NCT02605187|11870599|FG001|COMPLETED|Overall Study||19
10706102|NCT02605187|11870600|FG002|COMPLETED|Overall Study||72
10706103|NCT02605187|11870601|FG003|COMPLETED|Overall Study||15
10643171|NCT02115113|11802209|FG001|COMPLETED|Participants Randomized||26
10643172|NCT02115113|11802210|FG002|COMPLETED|Participants Randomized||0
10643173|NCT02115113|11802208|FG000|NOT COMPLETED|Participants Randomized||2
10643174|NCT02115113|11802209|FG001|NOT COMPLETED|Participants Randomized||0
10643175|NCT02115113|11802210|FG002|NOT COMPLETED|Participants Randomized||0
10643176|NCT02115139|11802219|FG000|STARTED|Overall Study||58
10643177|NCT02115139|11802219|FG000|COMPLETED|Overall Study||51
10643178|NCT02115139|11802219|FG000|NOT COMPLETED|Overall Study||7
10643179|NCT02115256|11802225|FG000|STARTED|Overall Study||3
10643180|NCT02115256|11802226|FG001|STARTED|Overall Study||3
10643181|NCT02115256|11802225|FG000|COMPLETED|Overall Study||3
10643182|NCT02115256|11802226|FG001|COMPLETED|Overall Study||2
10643183|NCT02115256|11802225|FG000|NOT COMPLETED|Overall Study||0
10643184|NCT02115256|11802226|FG001|NOT COMPLETED|Overall Study||1
10643185|NCT02115269|11802232|FG000|STARTED|Overall Study||759
10643186|NCT02115269|11802232|FG000|COMPLETED|Overall Study||702
10643187|NCT02115269|11802232|FG000|NOT COMPLETED|Overall Study||57
10643188|NCT02115282|11802249|FG000|STARTED|Overall Study||305
10643189|NCT02115282|11802250|FG001|STARTED|Overall Study||303
10643190|NCT02115282|11802249|FG000|Eligible|Overall Study||265
10643191|NCT02115282|11802250|FG001|Eligible|Overall Study||257
10643192|NCT02115282|11802249|FG000|Treated|Overall Study||296
10643193|NCT02115282|11802250|FG001|Treated|Overall Study||293
10643194|NCT02115282|11802249|FG000|COMPLETED|Overall Study||0
10643195|NCT02115282|11802250|FG001|COMPLETED|Overall Study||0
10643196|NCT02115282|11802249|FG000|NOT COMPLETED|Overall Study||305
10643197|NCT02115282|11802250|FG001|NOT COMPLETED|Overall Study||303
10643198|NCT02115308|11802260|FG000|STARTED|Overall Study|Number of subjects recruited for the CONTROL group.|15
10643199|NCT02115308|11802261|FG001|STARTED|Overall Study|Number of subjects recruited for the CAD group.|25
10643200|NCT02115308|11802260|FG000|COMPLETED|Overall Study|Number of subjects recruited to the Control group meeting all inclusion criteria.|13
10643201|NCT02115308|11802261|FG001|COMPLETED|Overall Study|Number of subjects recruited to the CAD group meeting all inclusion criteria.|23
10643202|NCT02115308|11802260|FG000|NOT COMPLETED|Overall Study||2
10643203|NCT02115308|11802261|FG001|NOT COMPLETED|Overall Study||2
10643204|NCT02115321|11802273|FG000|STARTED|Overall Study||30
10643205|NCT02115321|11802274|FG001|STARTED|Overall Study||10
10643206|NCT02115321|11802273|FG000|COMPLETED|Overall Study||29
10643207|NCT02115321|11802274|FG001|COMPLETED|Overall Study||10
10643208|NCT02115321|11802273|FG000|NOT COMPLETED|Overall Study||1
10643209|NCT02115321|11802274|FG001|NOT COMPLETED|Overall Study||0
10643210|NCT02115347|11802282|FG000|STARTED|Overall Study||8
10643211|NCT02115347|11802283|FG001|STARTED|Overall Study||8
10643212|NCT02115347|11802284|FG002|STARTED|Overall Study||0
10643213|NCT02115347|11802282|FG000|COMPLETED|Overall Study||8
10643214|NCT02115347|11802283|FG001|COMPLETED|Overall Study||8
10643215|NCT02115347|11802284|FG002|COMPLETED|Overall Study||0
10643216|NCT02115347|11802282|FG000|NOT COMPLETED|Overall Study||0
10643217|NCT02115347|11802283|FG001|NOT COMPLETED|Overall Study||0
10643218|NCT02115347|11802284|FG002|NOT COMPLETED|Overall Study||0
10643228|NCT02115386|11802310|FG000|STARTED|Overall Study||7
10643229|NCT02115386|11802310|FG000|COMPLETED|Overall Study||0
10643230|NCT02115386|11802310|FG000|NOT COMPLETED|Overall Study||7
10643231|NCT02115542|11802314|FG000|STARTED|Overall Study||39
10643232|NCT02115542|11802314|FG000|COMPLETED|Overall Study||39
10643233|NCT02115542|11802314|FG000|NOT COMPLETED|Overall Study||0
10643234|NCT02115581|11802320|FG000|STARTED|Overall Study||17
10643235|NCT02115581|11802321|FG001|STARTED|Overall Study||21
10643236|NCT02115581|11802320|FG000|COMPLETED|Overall Study||17
10643237|NCT02115581|11802321|FG001|COMPLETED|Overall Study||21
10643238|NCT02115581|11802320|FG000|NOT COMPLETED|Overall Study||0
10643239|NCT02115581|11802321|FG001|NOT COMPLETED|Overall Study||0
10643240|NCT02115607|11802327|FG000|STARTED|Overall Study||17
10643241|NCT02115607|11802327|FG000|COMPLETED|Overall Study||16
10643242|NCT02115607|11802327|FG000|NOT COMPLETED|Overall Study||1
10643243|NCT02115633|11802333|FG000|STARTED|Overall Study||15
10643244|NCT02115633|11802334|FG001|STARTED|Overall Study||16
10643245|NCT02115633|11802333|FG000|COMPLETED|Overall Study||15
10643246|NCT02115633|11802334|FG001|COMPLETED|Overall Study||16
10643247|NCT02115633|11802333|FG000|NOT COMPLETED|Overall Study||0
10643248|NCT02115633|11802334|FG001|NOT COMPLETED|Overall Study||0
10643249|NCT02115646|11802343|FG000|STARTED|Overall Study||29
10643250|NCT02115646|11802343|FG000|COMPLETED|Overall Study||22
10643251|NCT02115646|11802343|FG000|NOT COMPLETED|Overall Study||7
10643252|NCT02115750|11802354|FG000|STARTED|Part 1||323
10643253|NCT02115750|11802355|FG001|STARTED|Part 1||324
10643254|NCT02115750|11802354|FG000|COMPLETED|Part 1||301
10643255|NCT02115750|11802355|FG001|COMPLETED|Part 1||312
10643256|NCT02115750|11802354|FG000|NOT COMPLETED|Part 1||22
10643257|NCT02115750|11802355|FG001|NOT COMPLETED|Part 1||12
10643258|NCT02115750|11802354|FG000|STARTED|Part 2: All Subjects Receive CHS-0214||280
10643259|NCT02115750|11802355|FG001|STARTED|Part 2: All Subjects Receive CHS-0214||284
10643260|NCT02115750|11802354|FG000|COMPLETED|Part 2: All Subjects Receive CHS-0214||269
10643261|NCT02115750|11802355|FG001|COMPLETED|Part 2: All Subjects Receive CHS-0214||272
10643262|NCT02115750|11802354|FG000|NOT COMPLETED|Part 2: All Subjects Receive CHS-0214||11
10643263|NCT02115750|11802355|FG001|NOT COMPLETED|Part 2: All Subjects Receive CHS-0214||12
10643264|NCT02115815|11802370|FG000|STARTED|Overall Study||24
10643265|NCT02115815|11802371|FG001|STARTED|Overall Study||20
10643266|NCT02115815|11802372|FG002|STARTED|Overall Study||20
10643267|NCT02115815|11802373|FG003|STARTED|Overall Study||20
10643268|NCT02115815|11802374|FG004|STARTED|Overall Study||20
10643269|NCT02115815|11802375|FG005|STARTED|Overall Study||22
10643270|NCT02115815|11802376|FG006|STARTED|Overall Study||20
10643271|NCT02115815|11802370|FG000|COMPLETED|Overall Study||22
10643272|NCT02115815|11802371|FG001|COMPLETED|Overall Study||20
10643273|NCT02115815|11802372|FG002|COMPLETED|Overall Study||20
10643274|NCT02115815|11802373|FG003|COMPLETED|Overall Study||20
10643275|NCT02115815|11802374|FG004|COMPLETED|Overall Study||20
10643276|NCT02115815|11802375|FG005|COMPLETED|Overall Study||20
10643277|NCT02115815|11802376|FG006|COMPLETED|Overall Study||20
10643278|NCT02115815|11802370|FG000|NOT COMPLETED|Overall Study||2
10643279|NCT02115815|11802371|FG001|NOT COMPLETED|Overall Study||0
10643280|NCT02115815|11802372|FG002|NOT COMPLETED|Overall Study||0
10643281|NCT02115815|11802373|FG003|NOT COMPLETED|Overall Study||0
10643282|NCT02115815|11802374|FG004|NOT COMPLETED|Overall Study||0
10643283|NCT02115815|11802375|FG005|NOT COMPLETED|Overall Study||2
10643284|NCT02115815|11802376|FG006|NOT COMPLETED|Overall Study||0
10643285|NCT02115828|11802392|FG000|STARTED|Overall Study||9
10643286|NCT02115828|11802392|FG000|COMPLETED|Overall Study||9
10643287|NCT02115828|11802392|FG000|NOT COMPLETED|Overall Study||0
10643288|NCT02115984|11802398|FG000|STARTED|Overall Study||57
10643289|NCT02115984|11802399|FG001|STARTED|Overall Study||23
10643290|NCT02115984|11802398|FG000|COMPLETED|Overall Study||51
10643291|NCT02115984|11802399|FG001|COMPLETED|Overall Study||16
10643292|NCT02115984|11802398|FG000|NOT COMPLETED|Overall Study||6
10643293|NCT02115984|11802399|FG001|NOT COMPLETED|Overall Study||7
10643294|NCT02116205|11802409|FG000|STARTED|Overall Study||31
10643295|NCT02116205|11802410|FG001|STARTED|Overall Study||33
10643296|NCT02116205|11802411|FG002|STARTED|Overall Study||33
10643297|NCT02116205|11802412|FG003|STARTED|Overall Study||33
10643298|NCT02116205|11802409|FG000|COMPLETED|Overall Study||29
10643299|NCT02116205|11802410|FG001|COMPLETED|Overall Study||26
10643300|NCT02116205|11802411|FG002|COMPLETED|Overall Study||29
10643301|NCT02116205|11802412|FG003|COMPLETED|Overall Study||27
10643302|NCT02116205|11802409|FG000|NOT COMPLETED|Overall Study||2
10643303|NCT02116205|11802410|FG001|NOT COMPLETED|Overall Study||7
10643304|NCT02116205|11802411|FG002|NOT COMPLETED|Overall Study||4
10643305|NCT02116205|11802412|FG003|NOT COMPLETED|Overall Study||6
10643306|NCT02116309|11802424|FG000|STARTED|Overall Study||482
10643307|NCT02116309|11802425|FG001|STARTED|Overall Study||478
10643308|NCT02116309|11802424|FG000|COMPLETED|Overall Study||482
10643309|NCT02116309|11802425|FG001|COMPLETED|Overall Study||477
10643310|NCT02116309|11802424|FG000|NOT COMPLETED|Overall Study||0
10643311|NCT02116309|11802425|FG001|NOT COMPLETED|Overall Study||1
10643312|NCT02116322|11802431|FG000|STARTED|Overall Study||1
10643313|NCT02116322|11802431|FG000|COMPLETED|Overall Study||1
10643314|NCT02116322|11802431|FG000|NOT COMPLETED|Overall Study||0
10643315|NCT02116361|11802439|FG000|STARTED|Overall Study||69
10643316|NCT02116361|11802440|FG001|STARTED|Overall Study||65
10643317|NCT02116361|11802441|FG002|STARTED|Overall Study||59
10643318|NCT02116361|11802442|FG003|STARTED|Overall Study||65
10643319|NCT02116361|11802439|FG000|COMPLETED|Overall Study||38
10643320|NCT02116361|11802440|FG001|COMPLETED|Overall Study||34
10643321|NCT02116361|11802441|FG002|COMPLETED|Overall Study||33
10643322|NCT02116361|11802442|FG003|COMPLETED|Overall Study||34
10643323|NCT02116361|11802439|FG000|NOT COMPLETED|Overall Study||31
10643324|NCT02116361|11802440|FG001|NOT COMPLETED|Overall Study||31
10643325|NCT02116361|11802441|FG002|NOT COMPLETED|Overall Study||26
10643326|NCT02116361|11802442|FG003|NOT COMPLETED|Overall Study||31
10643327|NCT02116530|11802454|FG000|STARTED|Overall Study||192
10643328|NCT02116530|11802455|FG001|STARTED|Overall Study||188
10706104|NCT02605187|11870598|FG000|NOT COMPLETED|Overall Study||8
10706105|NCT02605187|11870599|FG001|NOT COMPLETED|Overall Study||2
10706106|NCT02605187|11870600|FG002|NOT COMPLETED|Overall Study||11
10643329|NCT02116530|11802454|FG000|COMPLETED|Overall Study||183
10643330|NCT02116530|11802455|FG001|COMPLETED|Overall Study||184
10643331|NCT02116530|11802454|FG000|NOT COMPLETED|Overall Study||9
10643332|NCT02116530|11802455|FG001|NOT COMPLETED|Overall Study||4
10643333|NCT02116582|11802461|FG000|STARTED|Overall Study||215
10643334|NCT02116582|11802461|FG000|Treated|Overall Study||214
10643335|NCT02116582|11802461|FG000|COMPLETED|Overall Study||0
10643336|NCT02116582|11802461|FG000|NOT COMPLETED|Overall Study||215
10643337|NCT02116608|11802468|FG000|STARTED|Overall Study||9
10643338|NCT02116608|11802469|FG001|STARTED|Overall Study||9
10643339|NCT02116608|11802470|FG002|STARTED|Overall Study||8
10643340|NCT02116608|11802468|FG000|COMPLETED|Overall Study||9
10643341|NCT02116608|11802469|FG001|COMPLETED|Overall Study||7
10643342|NCT02116608|11802470|FG002|COMPLETED|Overall Study||7
10643343|NCT02116608|11802468|FG000|NOT COMPLETED|Overall Study||0
10643344|NCT02116608|11802469|FG001|NOT COMPLETED|Overall Study||2
10643345|NCT02116608|11802470|FG002|NOT COMPLETED|Overall Study||1
10643346|NCT02116621|11802480|FG000|STARTED|Baseline||108
10643347|NCT02116621|11802481|FG001|STARTED|Baseline||107
10706107|NCT02605187|11870601|FG003|NOT COMPLETED|Overall Study||1
10706108|NCT02605304|11870613|FG000|STARTED|Overall Study||4
10643348|NCT02116621|11802480|FG000|Completed Baseline Visit|Baseline||108
10643349|NCT02116621|11802481|FG001|Completed Baseline Visit|Baseline||103
10643350|NCT02116621|11802480|FG000|Completed Intervention Period|Baseline||95
10643351|NCT02116621|11802481|FG001|Completed Intervention Period|Baseline||103
10643352|NCT02116621|11802480|FG000|COMPLETED|Baseline||108
10643353|NCT02116621|11802481|FG001|COMPLETED|Baseline||103
10643354|NCT02116621|11802480|FG000|NOT COMPLETED|Baseline||0
10643355|NCT02116621|11802481|FG001|NOT COMPLETED|Baseline||4
10643356|NCT02116621|11802480|FG000|STARTED|Three Month Follow-up||108
10643357|NCT02116621|11802481|FG001|STARTED|Three Month Follow-up||103
10643358|NCT02116621|11802480|FG000|COMPLETED|Three Month Follow-up||89
10643359|NCT02116621|11802481|FG001|COMPLETED|Three Month Follow-up||96
10706109|NCT02605304|11870614|FG001|STARTED|Overall Study||3
10643360|NCT02116621|11802480|FG000|NOT COMPLETED|Three Month Follow-up||19
10643361|NCT02116621|11802481|FG001|NOT COMPLETED|Three Month Follow-up||7
10643362|NCT02116621|11802480|FG000|STARTED|Six Month Follow-up|Patients who didn't complete 3mo survey but didn't drop from study were contacted for 6mo follow-up.|103
10643363|NCT02116621|11802481|FG001|STARTED|Six Month Follow-up|Patients who didn't complete 3mo survey but didn't drop from study were contacted for 6mo follow-up|100
10643364|NCT02116621|11802480|FG000|COMPLETED|Six Month Follow-up||99
10643365|NCT02116621|11802481|FG001|COMPLETED|Six Month Follow-up||97
10643366|NCT02116621|11802480|FG000|NOT COMPLETED|Six Month Follow-up||4
10643367|NCT02116621|11802481|FG001|NOT COMPLETED|Six Month Follow-up||3
10643368|NCT02116621|11802480|FG000|STARTED|Twelve Month Follow-up|Patients who didn't complete 6mo survey but didn't drop from study were contacted for 12mo follow-up|100
10643369|NCT02116621|11802481|FG001|STARTED|Twelve Month Follow-up|Patients who didn't complete 6mo survey but didn't drop from study were contacted for 12mo follow-up|98
10643370|NCT02116621|11802480|FG000|COMPLETED|Twelve Month Follow-up||84
10643371|NCT02116621|11802481|FG001|COMPLETED|Twelve Month Follow-up||86
10643372|NCT02116621|11802480|FG000|NOT COMPLETED|Twelve Month Follow-up||16
10643373|NCT02116621|11802481|FG001|NOT COMPLETED|Twelve Month Follow-up||12
10643374|NCT02116660|11802489|FG000|STARTED|Overall Study||6
10643375|NCT02116660|11802490|FG001|STARTED|Overall Study||5
10643376|NCT02116660|11802489|FG000|COMPLETED|Overall Study||4
10643377|NCT02116660|11802490|FG001|COMPLETED|Overall Study||1
10643378|NCT02116660|11802489|FG000|NOT COMPLETED|Overall Study||2
10643379|NCT02116660|11802490|FG001|NOT COMPLETED|Overall Study||4
10643380|NCT02116777|11802505|FG000|STARTED|Overall Study||3
10643381|NCT02116777|11802506|FG001|STARTED|Overall Study||3
10643382|NCT02116777|11802507|FG002|STARTED|Overall Study||3
10643383|NCT02116777|11802508|FG003|STARTED|Overall Study||13
10643384|NCT02116777|11802509|FG004|STARTED|Overall Study||6
10643385|NCT02116777|11802510|FG005|STARTED|Overall Study||3
10643386|NCT02116777|11802511|FG006|STARTED|Overall Study||9
10643387|NCT02116777|11802505|FG000|COMPLETED|Overall Study||0
10643388|NCT02116777|11802506|FG001|COMPLETED|Overall Study||0
10643389|NCT02116777|11802507|FG002|COMPLETED|Overall Study||0
10643390|NCT02116777|11802508|FG003|COMPLETED|Overall Study||0
10643391|NCT02116777|11802509|FG004|COMPLETED|Overall Study||0
10643392|NCT02116777|11802510|FG005|COMPLETED|Overall Study||0
10643393|NCT02116777|11802511|FG006|COMPLETED|Overall Study||0
10643394|NCT02116777|11802505|FG000|NOT COMPLETED|Overall Study||3
10643395|NCT02116777|11802506|FG001|NOT COMPLETED|Overall Study||3
10643396|NCT02116777|11802507|FG002|NOT COMPLETED|Overall Study||3
10643397|NCT02116777|11802508|FG003|NOT COMPLETED|Overall Study||13
10643398|NCT02116777|11802509|FG004|NOT COMPLETED|Overall Study||6
10643399|NCT02116777|11802510|FG005|NOT COMPLETED|Overall Study||3
10643400|NCT02116777|11802511|FG006|NOT COMPLETED|Overall Study||9
10643401|NCT02116803|11802532|FG000|STARTED|Overall Study||10
10643402|NCT02116803|11802533|FG001|STARTED|Overall Study||2
10643403|NCT02116803|11802532|FG000|COMPLETED|Overall Study||0
10643404|NCT02116803|11802533|FG001|COMPLETED|Overall Study||0
10643405|NCT02116803|11802532|FG000|NOT COMPLETED|Overall Study||10
10643406|NCT02116803|11802533|FG001|NOT COMPLETED|Overall Study||2
10643407|NCT02116972|11802542|FG000|STARTED|Overall Study||102
10643408|NCT02116972|11802543|FG001|STARTED|Overall Study||104
10643409|NCT02116972|11802544|FG002|STARTED|Overall Study||104
10643410|NCT02116972|11802542|FG000|COMPLETED|Overall Study||83
10643411|NCT02116972|11802543|FG001|COMPLETED|Overall Study||87
10643412|NCT02116972|11802544|FG002|COMPLETED|Overall Study||85
10643413|NCT02116972|11802542|FG000|NOT COMPLETED|Overall Study||19
10643414|NCT02116972|11802543|FG001|NOT COMPLETED|Overall Study||17
10643415|NCT02116972|11802544|FG002|NOT COMPLETED|Overall Study||19
10643416|NCT02117024|11802556|FG000|STARTED|Overall Study||45
10643417|NCT02117024|11802557|FG001|STARTED|Overall Study||21
10643418|NCT02117024|11802556|FG000|COMPLETED|Overall Study||1
10643419|NCT02117024|11802557|FG001|COMPLETED|Overall Study||1
10643420|NCT02117024|11802556|FG000|NOT COMPLETED|Overall Study||44
10643421|NCT02117024|11802557|FG001|NOT COMPLETED|Overall Study||20
10643422|NCT02117193|11802563|FG000|STARTED|Overall Study||10
10643423|NCT02117193|11802563|FG000|Alcohol Intake + Normal Sleep|Overall Study||10
10643424|NCT02117193|11802563|FG000|Placebo Intake + Normal Sleep|Overall Study||10
10643425|NCT02117193|11802563|FG000|Alcohol Intake + Sleep Deprivation|Overall Study||10
10643426|NCT02117193|11802563|FG000|Placebo Intake + Sleep Deprivation|Overall Study||10
10643427|NCT02117193|11802563|FG000|COMPLETED|Overall Study||10
10643428|NCT02117193|11802563|FG000|NOT COMPLETED|Overall Study||0
10643429|NCT02117310|11802582|FG000|STARTED|Overall Study||5
10643430|NCT02117310|11802582|FG000|COMPLETED|Overall Study||5
10643431|NCT02117310|11802582|FG000|NOT COMPLETED|Overall Study||0
10643432|NCT02117349|11802588|FG000|STARTED|Overall Study||37
10643433|NCT02117349|11802589|FG001|STARTED|Overall Study||18
10643434|NCT02117349|11802588|FG000|Intent-to-treat Population|Overall Study||37
10643435|NCT02117349|11802589|FG001|Intent-to-treat Population|Overall Study||18
10643436|NCT02117349|11802588|FG000|Safety Population|Overall Study||36
10643437|NCT02117349|11802589|FG001|Safety Population|Overall Study||18
10643438|NCT02117349|11802588|FG000|Modified Intent-to-treat (mITT)|Overall Study||36
10643439|NCT02117349|11802589|FG001|Modified Intent-to-treat (mITT)|Overall Study||18
10643440|NCT02117349|11802588|FG000|COMPLETED|Overall Study||34
10643441|NCT02117349|11802589|FG001|COMPLETED|Overall Study||17
10643442|NCT02117349|11802588|FG000|NOT COMPLETED|Overall Study||3
10643443|NCT02117349|11802589|FG001|NOT COMPLETED|Overall Study||1
10643444|NCT02117414|11802597|FG000|STARTED|Overall Study|Subjects randomized to the MRI group.|175
10643445|NCT02117414|11802598|FG001|STARTED|Overall Study|Subjects randomized to the Control group.|88
10643446|NCT02117414|11802597|FG000|COMPLETED|Overall Study|Subject followed up at least to the one-month post MRI/Waiting period visit in the MRI group.|160
10643447|NCT02117414|11802598|FG001|COMPLETED|Overall Study|Subject followed up at least to the one-month post MRI/Waiting period visit in the Control group.|82
10643448|NCT02117414|11802597|FG000|NOT COMPLETED|Overall Study||15
10643449|NCT02117414|11802598|FG001|NOT COMPLETED|Overall Study||6
10643450|NCT02117427|11802609|FG000|STARTED|Overall Study||6
10706110|NCT02605304|11870613|FG000|COMPLETED|Overall Study||4
10706111|NCT02605304|11870614|FG001|COMPLETED|Overall Study||3
10706112|NCT02605304|11870613|FG000|NOT COMPLETED|Overall Study||0
10706113|NCT02605304|11870614|FG001|NOT COMPLETED|Overall Study||0
10706114|NCT02605395|11870620|FG000|STARTED|Period 1, Day 1||35
10706115|NCT02605395|11870621|FG001|STARTED|Period 1, Day 1||35
10706116|NCT02605395|11870620|FG000|COMPLETED|Period 1, Day 1||35
10706117|NCT02605395|11870621|FG001|COMPLETED|Period 1, Day 1||35
10706118|NCT02605395|11870620|FG000|NOT COMPLETED|Period 1, Day 1||0
10643451|NCT02117427|11802610|FG001|STARTED|Overall Study||5
10643452|NCT02117427|11802611|FG002|STARTED|Overall Study||0
10643453|NCT02117427|11802609|FG000|Run in Phase & Harvest|Overall Study||6
10643454|NCT02117427|11802610|FG001|Run in Phase & Harvest|Overall Study||4
10643455|NCT02117427|11802611|FG002|Run in Phase & Harvest|Overall Study||0
10643456|NCT02117427|11802609|FG000|Implantation & Efficacy|Overall Study||6
10643457|NCT02117427|11802610|FG001|Implantation & Efficacy|Overall Study||4
10643458|NCT02117427|11802611|FG002|Implantation & Efficacy|Overall Study||0
10643459|NCT02117427|11802609|FG000|Safety Follow-up|Overall Study||1
10643460|NCT02117427|11802610|FG001|Safety Follow-up|Overall Study||0
10643461|NCT02117427|11802611|FG002|Safety Follow-up|Overall Study||0
10643462|NCT02117427|11802609|FG000|Long Term Safety Follow-up|Overall Study||1
10643463|NCT02117427|11802610|FG001|Long Term Safety Follow-up|Overall Study||0
10643464|NCT02117427|11802611|FG002|Long Term Safety Follow-up|Overall Study||0
10643465|NCT02117427|11802609|FG000|COMPLETED|Overall Study||1
10643466|NCT02117427|11802610|FG001|COMPLETED|Overall Study||0
10643467|NCT02117427|11802611|FG002|COMPLETED|Overall Study||0
10643468|NCT02117427|11802609|FG000|NOT COMPLETED|Overall Study||5
10643469|NCT02117427|11802610|FG001|NOT COMPLETED|Overall Study||5
10643470|NCT02117427|11802611|FG002|NOT COMPLETED|Overall Study||0
10643471|NCT02117479|11802619|FG000|STARTED|Overall Study||161
10643472|NCT02117479|11802620|FG001|STARTED|Overall Study||160
10643473|NCT02117479|11802619|FG000|COMPLETED|Overall Study|Treatment ongoing as of 20APR2016 for remaining participants in the study.|5
10643474|NCT02117479|11802620|FG001|COMPLETED|Overall Study|Treatment ongoing as of 20APR2016 for remaining participants in the study.|4
10643475|NCT02117479|11802619|FG000|NOT COMPLETED|Overall Study||156
10643476|NCT02117479|11802620|FG001|NOT COMPLETED|Overall Study||156
10643477|NCT02117544|11802626|FG000|STARTED|Period 1||54
10643478|NCT02117544|11802627|FG001|STARTED|Period 1||55
10643479|NCT02117544|11802626|FG000|Treated|Period 1||52
10643480|NCT02117544|11802627|FG001|Treated|Period 1||55
10643481|NCT02117544|11802626|FG000|COMPLETED|Period 1||52
10643482|NCT02117544|11802627|FG001|COMPLETED|Period 1||55
10643483|NCT02117544|11802626|FG000|NOT COMPLETED|Period 1||2
10643484|NCT02117544|11802627|FG001|NOT COMPLETED|Period 1||0
10643485|NCT02117544|11802626|FG000|STARTED|Period 2||52
10643486|NCT02117544|11802627|FG001|STARTED|Period 2||55
10643487|NCT02117544|11802626|FG000|COMPLETED|Period 2||52
10643488|NCT02117544|11802627|FG001|COMPLETED|Period 2||55
10643489|NCT02117544|11802626|FG000|NOT COMPLETED|Period 2||0
10643490|NCT02117544|11802627|FG001|NOT COMPLETED|Period 2||0
10643491|NCT02117570|11802637|FG000|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|6
10643492|NCT02117570|11802638|FG001|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|18
10706119|NCT02605395|11870621|FG001|NOT COMPLETED|Period 1, Day 1||0
10706120|NCT02605395|11870620|FG000|STARTED|Washout Period, Day 2 to Day 7||35
10706121|NCT02605395|11870621|FG001|STARTED|Washout Period, Day 2 to Day 7||35
10706122|NCT02605395|11870620|FG000|COMPLETED|Washout Period, Day 2 to Day 7||35
10643493|NCT02117570|11802639|FG002|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|18
10643494|NCT02117570|11802637|FG000|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||6
10643495|NCT02117570|11802638|FG001|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||18
10643496|NCT02117570|11802639|FG002|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||18
10643497|NCT02117570|11802637|FG000|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||6
10706123|NCT02605395|11870621|FG001|COMPLETED|Washout Period, Day 2 to Day 7||35
10643498|NCT02117570|11802638|FG001|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||18
10643499|NCT02117570|11802639|FG002|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||18
10643500|NCT02117570|11802637|FG000|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||6
10643501|NCT02117570|11802638|FG001|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||17
10643502|NCT02117570|11802639|FG002|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||18
10643503|NCT02117570|11802637|FG000|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||5
10643504|NCT02117570|11802638|FG001|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||15
10643505|NCT02117570|11802639|FG002|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||17
10643506|NCT02117570|11802637|FG000|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||1
10643507|NCT02117570|11802638|FG001|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||3
10643508|NCT02117570|11802639|FG002|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||1
10643509|NCT02117570|11802637|FG000|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|21
10643510|NCT02117570|11802638|FG001|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|62
10643511|NCT02117570|11802639|FG002|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|60
10643512|NCT02117570|11802637|FG000|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||21
10706124|NCT02605395|11870620|FG000|NOT COMPLETED|Washout Period, Day 2 to Day 7||0
10706125|NCT02605395|11870621|FG001|NOT COMPLETED|Washout Period, Day 2 to Day 7||0
10706126|NCT02605395|11870620|FG000|STARTED|Period 2, Day 8||35
10643513|NCT02117570|11802638|FG001|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||61
10643514|NCT02117570|11802639|FG002|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||60
10643515|NCT02117570|11802637|FG000|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||17
10643516|NCT02117570|11802638|FG001|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||53
10643517|NCT02117570|11802639|FG002|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||50
10643518|NCT02117570|11802637|FG000|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||4
10643519|NCT02117570|11802638|FG001|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||12
10643520|NCT02117570|11802639|FG002|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||12
10643521|NCT02117570|11802637|FG000|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||20
10643522|NCT02117570|11802638|FG001|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||59
10643523|NCT02117570|11802639|FG002|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||54
10643524|NCT02117570|11802637|FG000|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||1
10643525|NCT02117570|11802638|FG001|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||3
10643526|NCT02117570|11802639|FG002|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||6
10643527|NCT02117648|11802650|FG000|STARTED|Abemaciclib Alone Period 1||26
10643528|NCT02117648|11802650|FG000|Received at Least 1 Dose of Study Drug|Abemaciclib Alone Period 1||26
10643529|NCT02117648|11802650|FG000|COMPLETED|Abemaciclib Alone Period 1||24
10643530|NCT02117648|11802650|FG000|NOT COMPLETED|Abemaciclib Alone Period 1||2
10643531|NCT02117648|11802650|FG000|STARTED|Abemaciclib + Clarithromycin Period 2||24
10643532|NCT02117648|11802650|FG000|Received at Least 1 Dose of Study Drug|Abemaciclib + Clarithromycin Period 2||21
10643533|NCT02117648|11802650|FG000|COMPLETED|Abemaciclib + Clarithromycin Period 2||20
10643534|NCT02117648|11802650|FG000|NOT COMPLETED|Abemaciclib + Clarithromycin Period 2||4
10643535|NCT02117648|11802650|FG000|STARTED|Abemaciclib Safety-Extension Phase||20
10706127|NCT02605395|11870621|FG001|STARTED|Period 2, Day 8||35
10643536|NCT02117648|11802650|FG000|COMPLETED|Abemaciclib Safety-Extension Phase||0
10643537|NCT02117648|11802650|FG000|NOT COMPLETED|Abemaciclib Safety-Extension Phase||20
10643538|NCT02117687|11802660|FG000|STARTED|Overall Study||40
10643539|NCT02117687|11802661|FG001|STARTED|Overall Study||40
10706128|NCT02605395|11870620|FG000|COMPLETED|Period 2, Day 8||35
10706129|NCT02605395|11870621|FG001|COMPLETED|Period 2, Day 8||35
10643540|NCT02117687|11802660|FG000|COMPLETED|Overall Study||39
10643541|NCT02117687|11802661|FG001|COMPLETED|Overall Study||36
10643542|NCT02117687|11802660|FG000|NOT COMPLETED|Overall Study||1
10643543|NCT02117687|11802661|FG001|NOT COMPLETED|Overall Study||4
10643544|NCT02117713|11802667|FG000|STARTED|Week 48||34
10643545|NCT02117713|11802667|FG000|COMPLETED|Week 48||26
10643546|NCT02117713|11802667|FG000|NOT COMPLETED|Week 48||8
10643547|NCT02117713|11802667|FG000|STARTED|Long Term Follow-up Treatment||26
10643548|NCT02117713|11802667|FG000|COMPLETED|Long Term Follow-up Treatment||20
10643549|NCT02117713|11802667|FG000|NOT COMPLETED|Long Term Follow-up Treatment||6
10643550|NCT02117934|11802681|FG000|STARTED|Overall Study||5592
10643551|NCT02117934|11802682|FG001|STARTED|Overall Study||2782
10643552|NCT02117934|11802681|FG000|COMPLETED|Overall Study||5092
10643553|NCT02117934|11802682|FG001|COMPLETED|Overall Study||2567
10643554|NCT02117934|11802681|FG000|NOT COMPLETED|Overall Study||500
10643555|NCT02117934|11802682|FG001|NOT COMPLETED|Overall Study||215
10643556|NCT02117999|11802690|FG000|STARTED|Overall Study||20
10643557|NCT02117999|11802691|FG001|STARTED|Overall Study||10
10643558|NCT02117999|11802690|FG000|Mean Kmax Change in Corneal Topography|Overall Study||20
10643559|NCT02117999|11802691|FG001|Mean Kmax Change in Corneal Topography|Overall Study||10
10643560|NCT02117999|11802690|FG000|COMPLETED|Overall Study||20
10643561|NCT02117999|11802691|FG001|COMPLETED|Overall Study||10
10643562|NCT02117999|11802690|FG000|NOT COMPLETED|Overall Study||0
10643563|NCT02117999|11802691|FG001|NOT COMPLETED|Overall Study||0
10643564|NCT02118012|11802701|FG000|STARTED|Overall Study||12
10643565|NCT02118012|11802702|FG001|STARTED|Overall Study||12
10643566|NCT02118012|11802701|FG000|Day 5|Overall Study||12
10643567|NCT02118012|11802702|FG001|Day 5|Overall Study||11
10643568|NCT02118012|11802701|FG000|Day 14|Overall Study||12
10643569|NCT02118012|11802702|FG001|Day 14|Overall Study||10
10643570|NCT02118012|11802701|FG000|COMPLETED|Overall Study||12
10643571|NCT02118012|11802702|FG001|COMPLETED|Overall Study||10
10643572|NCT02118012|11802701|FG000|NOT COMPLETED|Overall Study||0
10643573|NCT02118012|11802702|FG001|NOT COMPLETED|Overall Study||2
10643574|NCT02118337|11802717|FG000|STARTED|Overall Study||4
10643575|NCT02118337|11802718|FG001|STARTED|Overall Study||5
10643576|NCT02118337|11802719|FG002|STARTED|Overall Study||3
10643577|NCT02118337|11802720|FG003|STARTED|Overall Study||3
10643578|NCT02118337|11802721|FG004|STARTED|Overall Study||9
10643579|NCT02118337|11802722|FG005|STARTED|Overall Study||6
10643580|NCT02118337|11802723|FG006|STARTED|Overall Study||4
10643581|NCT02118337|11802724|FG007|STARTED|Overall Study||42
10643582|NCT02118337|11802725|FG008|STARTED|Overall Study||21
10643583|NCT02118337|11802717|FG000|COMPLETED|Overall Study||0
10643584|NCT02118337|11802718|FG001|COMPLETED|Overall Study||0
10643585|NCT02118337|11802719|FG002|COMPLETED|Overall Study||0
10643586|NCT02118337|11802720|FG003|COMPLETED|Overall Study||0
10643587|NCT02118337|11802721|FG004|COMPLETED|Overall Study||0
10643588|NCT02118337|11802722|FG005|COMPLETED|Overall Study||0
10643589|NCT02118337|11802723|FG006|COMPLETED|Overall Study||0
10643590|NCT02118337|11802724|FG007|COMPLETED|Overall Study||0
10643591|NCT02118337|11802725|FG008|COMPLETED|Overall Study||0
10643592|NCT02118337|11802717|FG000|NOT COMPLETED|Overall Study||4
10643593|NCT02118337|11802718|FG001|NOT COMPLETED|Overall Study||5
10643594|NCT02118337|11802719|FG002|NOT COMPLETED|Overall Study||3
10643595|NCT02118337|11802720|FG003|NOT COMPLETED|Overall Study||3
10643596|NCT02118337|11802721|FG004|NOT COMPLETED|Overall Study||9
10706130|NCT02605395|11870620|FG000|NOT COMPLETED|Period 2, Day 8||0
10706131|NCT02605395|11870621|FG001|NOT COMPLETED|Period 2, Day 8||0
10706132|NCT02605447|11870627|FG000|STARTED|Overall Study||1487
10643597|NCT02118337|11802722|FG005|NOT COMPLETED|Overall Study||6
10643598|NCT02118337|11802723|FG006|NOT COMPLETED|Overall Study||4
10643599|NCT02118337|11802724|FG007|NOT COMPLETED|Overall Study||42
10706133|NCT02605447|11870627|FG000|COMPLETED|Overall Study||1385
10643600|NCT02118337|11802725|FG008|NOT COMPLETED|Overall Study||21
10643601|NCT02118428|11802751|FG000|STARTED|Overall Study||113
10643602|NCT02118428|11802752|FG001|STARTED|Overall Study||113
10643603|NCT02118428|11802753|FG002|STARTED|Overall Study||1
10643604|NCT02118428|11802751|FG000|Received Study Transfusion|Overall Study||111
10643605|NCT02118428|11802752|FG001|Received Study Transfusion|Overall Study||112
10643606|NCT02118428|11802753|FG002|Received Study Transfusion|Overall Study||0
10643607|NCT02118428|11802751|FG000|COMPLETED|Overall Study||100
10706134|NCT02605447|11870627|FG000|NOT COMPLETED|Overall Study||102
10706135|NCT02605642|11870634|FG000|STARTED|Overall Study||227
10643608|NCT02118428|11802752|FG001|COMPLETED|Overall Study||104
10643609|NCT02118428|11802753|FG002|COMPLETED|Overall Study||0
10643610|NCT02118428|11802751|FG000|NOT COMPLETED|Overall Study||13
10643611|NCT02118428|11802752|FG001|NOT COMPLETED|Overall Study||9
10643612|NCT02118428|11802753|FG002|NOT COMPLETED|Overall Study||1
10643613|NCT02118441|11802761|FG000|STARTED|Overall Study||65
10643614|NCT02118441|11802762|FG001|STARTED|Overall Study||64
10643615|NCT02118441|11802761|FG000|COMPLETED|Overall Study||62
10643616|NCT02118441|11802762|FG001|COMPLETED|Overall Study||63
10643617|NCT02118441|11802761|FG000|NOT COMPLETED|Overall Study||3
10643618|NCT02118441|11802762|FG001|NOT COMPLETED|Overall Study||1
10643619|NCT02118597|11802769|FG000|STARTED|Overall Study||19
10643620|NCT02118597|11802769|FG000|COMPLETED|Overall Study||3
10643621|NCT02118597|11802769|FG000|NOT COMPLETED|Overall Study||16
10643622|NCT02118714|11802773|FG000|STARTED|Overall Study||20
10643623|NCT02118714|11802773|FG000|COMPLETED|Overall Study||17
10643624|NCT02118714|11802773|FG000|NOT COMPLETED|Overall Study||3
10643625|NCT02118766|11802779|FG000|STARTED|Overall Study||507
10643626|NCT02118766|11802780|FG001|STARTED|Overall Study||256
10643627|NCT02118766|11802779|FG000|Treated|Overall Study||503
10643628|NCT02118766|11802780|FG001|Treated|Overall Study||256
10643629|NCT02118766|11802779|FG000|COMPLETED|Overall Study||477
10643630|NCT02118766|11802780|FG001|COMPLETED|Overall Study||225
10643631|NCT02118766|11802779|FG000|NOT COMPLETED|Overall Study||30
10643632|NCT02118766|11802780|FG001|NOT COMPLETED|Overall Study||31
10643633|NCT02118792|11802788|FG000|STARTED|Overall Study||514
10643634|NCT02118792|11802789|FG001|STARTED|Overall Study||250
10643635|NCT02118792|11802788|FG000|Treated|Overall Study||513
10643636|NCT02118792|11802789|FG001|Treated|Overall Study||250
10643637|NCT02118792|11802788|FG000|COMPLETED|Overall Study||483
10643638|NCT02118792|11802789|FG001|COMPLETED|Overall Study||213
10643639|NCT02118792|11802788|FG000|NOT COMPLETED|Overall Study||31
10643640|NCT02118792|11802789|FG001|NOT COMPLETED|Overall Study||37
10643641|NCT02118831|11802800|FG000|STARTED|Overall Study||21
10643642|NCT02118831|11802801|FG001|STARTED|Overall Study||15
10643643|NCT02118831|11802802|FG002|STARTED|Overall Study||20
10643644|NCT02118831|11802800|FG000|COMPLETED|Overall Study||21
10643645|NCT02118831|11802801|FG001|COMPLETED|Overall Study||15
10643646|NCT02118831|11802802|FG002|COMPLETED|Overall Study||20
10643647|NCT02118831|11802800|FG000|NOT COMPLETED|Overall Study||0
10643648|NCT02118831|11802801|FG001|NOT COMPLETED|Overall Study||0
10643649|NCT02118831|11802802|FG002|NOT COMPLETED|Overall Study||0
10643650|NCT02118896|11802820|FG000|STARTED|Overall Study||47
10643651|NCT02118896|11802821|FG001|STARTED|Overall Study||47
10643652|NCT02118896|11802822|FG002|STARTED|Overall Study||67
10643653|NCT02118896|11802823|FG003|STARTED|Overall Study||79
10643654|NCT02118896|11802824|FG004|STARTED|Overall Study||130
10643655|NCT02118896|11802825|FG005|STARTED|Overall Study||191
10643656|NCT02118896|11802826|FG006|STARTED|Overall Study||85
10643657|NCT02118896|11802827|FG007|STARTED|Overall Study||107
10643658|NCT02118896|11802828|FG008|STARTED|Overall Study||88
10643659|NCT02118896|11802829|FG009|STARTED|Overall Study||9
10643660|NCT02118896|11802820|FG000|COMPLETED|Overall Study||30
10643661|NCT02118896|11802821|FG001|COMPLETED|Overall Study||32
10643662|NCT02118896|11802822|FG002|COMPLETED|Overall Study||53
10643663|NCT02118896|11802823|FG003|COMPLETED|Overall Study||55
10643664|NCT02118896|11802824|FG004|COMPLETED|Overall Study||113
10643665|NCT02118896|11802825|FG005|COMPLETED|Overall Study||163
10643666|NCT02118896|11802826|FG006|COMPLETED|Overall Study||83
10643667|NCT02118896|11802827|FG007|COMPLETED|Overall Study||105
10643668|NCT02118896|11802828|FG008|COMPLETED|Overall Study||84
10643669|NCT02118896|11802829|FG009|COMPLETED|Overall Study||7
10643670|NCT02118896|11802820|FG000|NOT COMPLETED|Overall Study||17
10643671|NCT02118896|11802821|FG001|NOT COMPLETED|Overall Study||15
10643672|NCT02118896|11802822|FG002|NOT COMPLETED|Overall Study||14
10643673|NCT02118896|11802823|FG003|NOT COMPLETED|Overall Study||24
10643674|NCT02118896|11802824|FG004|NOT COMPLETED|Overall Study||17
10643675|NCT02118896|11802825|FG005|NOT COMPLETED|Overall Study||28
10643676|NCT02118896|11802826|FG006|NOT COMPLETED|Overall Study||2
10643677|NCT02118896|11802827|FG007|NOT COMPLETED|Overall Study||2
10643678|NCT02118896|11802828|FG008|NOT COMPLETED|Overall Study||4
10643679|NCT02118896|11802829|FG009|NOT COMPLETED|Overall Study||2
10643680|NCT02118961|11802854|FG000|STARTED|Overall Study||224
10643681|NCT02118961|11802855|FG001|STARTED|Overall Study||222
10643682|NCT02118961|11802854|FG000|COMPLETED|Overall Study||223
10643683|NCT02118961|11802855|FG001|COMPLETED|Overall Study||222
10643684|NCT02118961|11802854|FG000|NOT COMPLETED|Overall Study||1
10643685|NCT02118961|11802855|FG001|NOT COMPLETED|Overall Study||0
10643686|NCT02119026|11802863|FG000|STARTED|1st-line Treatment||58
10643687|NCT02119026|11802864|FG001|STARTED|1st-line Treatment||62
10643688|NCT02119026|11802863|FG000|COMPLETED|1st-line Treatment||32
10643689|NCT02119026|11802864|FG001|COMPLETED|1st-line Treatment||24
10643690|NCT02119026|11802863|FG000|NOT COMPLETED|1st-line Treatment||26
10643691|NCT02119026|11802864|FG001|NOT COMPLETED|1st-line Treatment||38
10643692|NCT02119026|11802863|FG000|STARTED|2nd-line Treatment||32
10643693|NCT02119026|11802864|FG001|STARTED|2nd-line Treatment||24
10643694|NCT02119026|11802863|FG000|COMPLETED|2nd-line Treatment||23
10643695|NCT02119026|11802864|FG001|COMPLETED|2nd-line Treatment||22
10643696|NCT02119026|11802863|FG000|NOT COMPLETED|2nd-line Treatment||9
10643697|NCT02119026|11802864|FG001|NOT COMPLETED|2nd-line Treatment||2
10643698|NCT02119104|11802870|FG000|STARTED|Overall Study||1087
10643699|NCT02119104|11802870|FG000|COMPLETED|Overall Study||1071
10643700|NCT02119104|11802870|FG000|NOT COMPLETED|Overall Study||16
10643701|NCT02119156|11802877|FG000|STARTED|Treatment Phase (Up to 52 Weeks)||39
10643702|NCT02119156|11802878|FG001|STARTED|Treatment Phase (Up to 52 Weeks)||29
10643703|NCT02119156|11802879|FG002|STARTED|Treatment Phase (Up to 52 Weeks)||12
10643704|NCT02119156|11802877|FG000|COMPLETED|Treatment Phase (Up to 52 Weeks)||33
10643705|NCT02119156|11802878|FG001|COMPLETED|Treatment Phase (Up to 52 Weeks)||27
10643706|NCT02119156|11802879|FG002|COMPLETED|Treatment Phase (Up to 52 Weeks)||11
10643707|NCT02119156|11802877|FG000|NOT COMPLETED|Treatment Phase (Up to 52 Weeks)||6
10643708|NCT02119156|11802878|FG001|NOT COMPLETED|Treatment Phase (Up to 52 Weeks)||2
10643709|NCT02119156|11802879|FG002|NOT COMPLETED|Treatment Phase (Up to 52 Weeks)||1
10643710|NCT02119156|11802877|FG000|STARTED|Maintenance (Up to 48 Weeks of Year 2-4)|Long-term discontinuation participants were not allowed in Maintenance period|0
10643711|NCT02119156|11802878|FG001|STARTED|Maintenance (Up to 48 Weeks of Year 2-4)|Eligible participants of Treatment control and holiday group on completion of 52-weeks were included|16
10643712|NCT02119156|11802879|FG002|STARTED|Maintenance (Up to 48 Weeks of Year 2-4)|Eligible participants of Treatment control and holiday group on completion of 52-weeks were included|10
10643713|NCT02119156|11802877|FG000|COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||0
10643714|NCT02119156|11802878|FG001|COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||6
10643715|NCT02119156|11802879|FG002|COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||3
10643716|NCT02119156|11802877|FG000|NOT COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||0
10643717|NCT02119156|11802878|FG001|NOT COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||10
10643718|NCT02119156|11802879|FG002|NOT COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||7
10643719|NCT02119260|11802901|FG000|STARTED|Overall Study||9
10643720|NCT02119260|11802902|FG001|STARTED|Overall Study||12
10643721|NCT02119260|11802903|FG002|STARTED|Overall Study||8
10643722|NCT02119260|11802904|FG003|STARTED|Overall Study||10
10643723|NCT02119260|11802905|FG004|STARTED|Overall Study||13
10643724|NCT02119260|11802906|FG005|STARTED|Overall Study||6
10643725|NCT02119260|11802907|FG006|STARTED|Overall Study||2
10643726|NCT02119260|11802901|FG000|COMPLETED|Overall Study||8
10643727|NCT02119260|11802902|FG001|COMPLETED|Overall Study||11
10643728|NCT02119260|11802903|FG002|COMPLETED|Overall Study||7
10643729|NCT02119260|11802904|FG003|COMPLETED|Overall Study||10
10643730|NCT02119260|11802905|FG004|COMPLETED|Overall Study||13
10643731|NCT02119260|11802906|FG005|COMPLETED|Overall Study||6
10643732|NCT02119260|11802907|FG006|COMPLETED|Overall Study||2
10643733|NCT02119260|11802901|FG000|NOT COMPLETED|Overall Study||1
10643734|NCT02119260|11802902|FG001|NOT COMPLETED|Overall Study||1
10643735|NCT02119260|11802903|FG002|NOT COMPLETED|Overall Study||1
10643736|NCT02119260|11802904|FG003|NOT COMPLETED|Overall Study||0
10643737|NCT02119260|11802905|FG004|NOT COMPLETED|Overall Study||0
10643738|NCT02119260|11802906|FG005|NOT COMPLETED|Overall Study||0
10643739|NCT02119260|11802907|FG006|NOT COMPLETED|Overall Study||0
10643740|NCT02119286|11802935|FG000|STARTED|Overall Study||206
10643741|NCT02119286|11802936|FG001|STARTED|Overall Study||206
10643742|NCT02119286|11802937|FG002|STARTED|Overall Study||207
10643743|NCT02119286|11802935|FG000|COMPLETED|Overall Study||180
10643744|NCT02119286|11802936|FG001|COMPLETED|Overall Study||195
10643745|NCT02119286|11802937|FG002|COMPLETED|Overall Study||200
10643746|NCT02119286|11802935|FG000|NOT COMPLETED|Overall Study||26
10643747|NCT02119286|11802936|FG001|NOT COMPLETED|Overall Study||11
10643748|NCT02119286|11802937|FG002|NOT COMPLETED|Overall Study||7
10643749|NCT02119299|11802945|FG000|STARTED|Overall Study||76
10643750|NCT02119299|11802945|FG000|COMPLETED|Overall Study||67
10643751|NCT02119299|11802945|FG000|NOT COMPLETED|Overall Study||9
10643752|NCT02119325|11802949|FG000|STARTED|Period 1||48
10643753|NCT02119325|11802950|FG001|STARTED|Period 1||48
10643754|NCT02119325|11802949|FG000|COMPLETED|Period 1||48
10643755|NCT02119325|11802950|FG001|COMPLETED|Period 1||48
10643756|NCT02119325|11802949|FG000|NOT COMPLETED|Period 1||0
10643757|NCT02119325|11802950|FG001|NOT COMPLETED|Period 1||0
10643758|NCT02119325|11802949|FG000|STARTED|Washout Period 1||48
10643759|NCT02119325|11802950|FG001|STARTED|Washout Period 1||48
10643760|NCT02119325|11802949|FG000|COMPLETED|Washout Period 1||48
10643761|NCT02119325|11802950|FG001|COMPLETED|Washout Period 1||47
10643762|NCT02119325|11802949|FG000|NOT COMPLETED|Washout Period 1||0
10643763|NCT02119325|11802950|FG001|NOT COMPLETED|Washout Period 1||1
10643764|NCT02119325|11802949|FG000|STARTED|Period 2||48
10643765|NCT02119325|11802950|FG001|STARTED|Period 2||47
10643766|NCT02119325|11802949|FG000|COMPLETED|Period 2||48
10643767|NCT02119325|11802950|FG001|COMPLETED|Period 2||47
10643768|NCT02119325|11802949|FG000|NOT COMPLETED|Period 2||0
10643769|NCT02119325|11802950|FG001|NOT COMPLETED|Period 2||0
10643770|NCT02119442|11802958|FG000|STARTED|Overall Study||90
10643771|NCT02119442|11802958|FG000|COMPLETED|Overall Study||90
10643772|NCT02119442|11802958|FG000|NOT COMPLETED|Overall Study||0
10643773|NCT02119455|11802964|FG000|STARTED|Overall Study||20
10643774|NCT02119455|11802965|FG001|STARTED|Overall Study||20
10643775|NCT02119455|11802964|FG000|COMPLETED|Overall Study||20
10643776|NCT02119455|11802965|FG001|COMPLETED|Overall Study||17
10643777|NCT02119455|11802964|FG000|NOT COMPLETED|Overall Study||0
10643778|NCT02119455|11802965|FG001|NOT COMPLETED|Overall Study||3
10643779|NCT02119650|11802973|FG000|STARTED|Overall Study||39
10643780|NCT02119650|11802974|FG001|STARTED|Overall Study||37
10643781|NCT02119650|11802973|FG000|COMPLETED|Overall Study|Participants with treatment ongoing when the study was terminated.|14
10643782|NCT02119650|11802974|FG001|COMPLETED|Overall Study|Participants with treatment ongoing when the study was terminated.|11
10643783|NCT02119650|11802973|FG000|NOT COMPLETED|Overall Study||25
10643784|NCT02119650|11802974|FG001|NOT COMPLETED|Overall Study||26
10643785|NCT02119663|11802982|FG000|STARTED|Overall Study||43
10643786|NCT02119663|11802983|FG001|STARTED|Overall Study||43
10643787|NCT02119663|11802982|FG000|COMPLETED|Overall Study|Treatment ongoing as of 13APR2016 for remaining participants in the study.|3
10643788|NCT02119663|11802983|FG001|COMPLETED|Overall Study|Treatment ongoing as of 13APR2016 for remaining participants in the study.|2
10643789|NCT02119663|11802982|FG000|NOT COMPLETED|Overall Study||40
10643790|NCT02119663|11802983|FG001|NOT COMPLETED|Overall Study||41
10643791|NCT02119676|11802993|FG000|STARTED|Overall Study||87
10643792|NCT02119676|11802994|FG001|STARTED|Overall Study||88
10643793|NCT02119676|11802995|FG002|STARTED|Overall Study||110
10643794|NCT02119676|11802996|FG003|STARTED|Overall Study||111
10643795|NCT02119676|11802993|FG000|Treated Patients|Overall Study||85
10643796|NCT02119676|11802994|FG001|Treated Patients|Overall Study||86
10643797|NCT02119676|11802995|FG002|Treated Patients|Overall Study||106
10643798|NCT02119676|11802996|FG003|Treated Patients|Overall Study||106
10643799|NCT02119676|11802993|FG000|COMPLETED|Overall Study||4
10643800|NCT02119676|11802994|FG001|COMPLETED|Overall Study||2
10643801|NCT02119676|11802995|FG002|COMPLETED|Overall Study||13
10643802|NCT02119676|11802996|FG003|COMPLETED|Overall Study||10
10643803|NCT02119676|11802993|FG000|NOT COMPLETED|Overall Study||83
10643804|NCT02119676|11802994|FG001|NOT COMPLETED|Overall Study||86
10643805|NCT02119676|11802995|FG002|NOT COMPLETED|Overall Study||97
10643806|NCT02119676|11802996|FG003|NOT COMPLETED|Overall Study||101
10643807|NCT02119819|11803012|FG000|STARTED|Overall Study||66
10643808|NCT02119819|11803013|FG001|STARTED|Overall Study||71
10643809|NCT02119819|11803014|FG002|STARTED|Overall Study||73
10643810|NCT02119819|11803015|FG003|STARTED|Overall Study||70
10643811|NCT02119819|11803016|FG004|STARTED|Overall Study||69
10643812|NCT02119819|11803017|FG005|STARTED|Overall Study||71
10643813|NCT02119819|11803012|FG000|COMPLETED|Overall Study||57
10643814|NCT02119819|11803013|FG001|COMPLETED|Overall Study||66
10643815|NCT02119819|11803014|FG002|COMPLETED|Overall Study||69
10643816|NCT02119819|11803015|FG003|COMPLETED|Overall Study||63
10643817|NCT02119819|11803016|FG004|COMPLETED|Overall Study||62
10643818|NCT02119819|11803017|FG005|COMPLETED|Overall Study||56
10643819|NCT02119819|11803012|FG000|NOT COMPLETED|Overall Study||9
10643820|NCT02119819|11803013|FG001|NOT COMPLETED|Overall Study||5
10643821|NCT02119819|11803014|FG002|NOT COMPLETED|Overall Study||4
10643822|NCT02119819|11803015|FG003|NOT COMPLETED|Overall Study||7
10643823|NCT02119819|11803016|FG004|NOT COMPLETED|Overall Study||7
10643824|NCT02119819|11803017|FG005|NOT COMPLETED|Overall Study||15
10643825|NCT02119871|11803033|FG000|STARTED|Overall Study||10
10643826|NCT02119871|11803034|FG001|STARTED|Overall Study||10
10643827|NCT02119871|11803033|FG000|COMPLETED|Overall Study||10
10643828|NCT02119871|11803034|FG001|COMPLETED|Overall Study||10
10643829|NCT02119871|11803033|FG000|NOT COMPLETED|Overall Study||0
10643830|NCT02119871|11803034|FG001|NOT COMPLETED|Overall Study||0
10643831|NCT02119936|11803040|FG000|STARTED|Overall Study||10
10643832|NCT02119936|11803040|FG000|COMPLETED|Overall Study||0
10643833|NCT02119936|11803040|FG000|NOT COMPLETED|Overall Study||10
10643834|NCT02120001|11803046|FG000|STARTED|Overall Study||17
10643835|NCT02120001|11803047|FG001|STARTED|Overall Study||19
10643836|NCT02120001|11803046|FG000|COMPLETED|Overall Study||17
10643837|NCT02120001|11803047|FG001|COMPLETED|Overall Study||19
10643838|NCT02120001|11803046|FG000|NOT COMPLETED|Overall Study||0
10643839|NCT02120001|11803047|FG001|NOT COMPLETED|Overall Study||0
10643840|NCT02120027|11803055|FG000|STARTED|Overall Study||277
10643841|NCT02120027|11803056|FG001|STARTED|Overall Study||279
10643842|NCT02120027|11803055|FG000|COMPLETED|Overall Study||161
10643843|NCT02120027|11803056|FG001|COMPLETED|Overall Study||160
10643844|NCT02120027|11803055|FG000|NOT COMPLETED|Overall Study||116
10643845|NCT02120027|11803056|FG001|NOT COMPLETED|Overall Study||119
10706136|NCT02605642|11870635|FG001|STARTED|Overall Study||107
10706137|NCT02605642|11870634|FG000|Safety Set|Overall Study||221
10706138|NCT02605642|11870635|FG001|Safety Set|Overall Study||107
10706139|NCT02605642|11870634|FG000|COMPLETED|Overall Study||131
10706140|NCT02605642|11870635|FG001|COMPLETED|Overall Study||86
10706141|NCT02605642|11870634|FG000|NOT COMPLETED|Overall Study||96
10809179|NCT03810235|11971046|FG000|COMPLETED|Overall Study||30
10706142|NCT02605642|11870635|FG001|NOT COMPLETED|Overall Study||21
10706143|NCT02605837|11870643|FG000|STARTED|Overall Study||105
10706144|NCT02605837|11870644|FG001|STARTED|Overall Study||213
10809180|NCT03810235|11971047|FG001|COMPLETED|Overall Study||31
10809181|NCT03810235|11971046|FG000|NOT COMPLETED|Overall Study||2
10809182|NCT03810235|11971047|FG001|NOT COMPLETED|Overall Study||0
10809183|NCT03806556|11971056|FG000|STARTED|Overall Study||6
10809184|NCT03806556|11971057|FG001|STARTED|Overall Study||5
10809185|NCT03806556|11971056|FG000|COMPLETED|Overall Study||6
10809186|NCT03806556|11971057|FG001|COMPLETED|Overall Study||5
10809187|NCT03806556|11971056|FG000|NOT COMPLETED|Overall Study||0
10809188|NCT03806556|11971057|FG001|NOT COMPLETED|Overall Study||0
10643846|NCT02120157|11803062|FG000|STARTED|Overall Study||32
10643847|NCT02120157|11803062|FG000|Completed 180 Days|Overall Study||30
10643848|NCT02120157|11803062|FG000|COMPLETED|Overall Study||24
10643849|NCT02120157|11803062|FG000|NOT COMPLETED|Overall Study||8
10643850|NCT02120261|11803070|FG000|STARTED|Overall Study||23
10643851|NCT02120261|11803071|FG001|STARTED|Overall Study||25
10643852|NCT02120261|11803070|FG000|COMPLETED|Overall Study||23
10643853|NCT02120261|11803071|FG001|COMPLETED|Overall Study||25
10643854|NCT02120261|11803070|FG000|NOT COMPLETED|Overall Study||0
10643855|NCT02120261|11803071|FG001|NOT COMPLETED|Overall Study||0
10643856|NCT02120287|11803077|FG000|STARTED|Overall Study||16
10643857|NCT02120287|11803077|FG000|COMPLETED|Overall Study||16
10643858|NCT02120287|11803077|FG000|NOT COMPLETED|Overall Study||0
10643859|NCT02120300|11803085|FG000|STARTED|Overall Study||101
10643860|NCT02120300|11803086|FG001|STARTED|Overall Study||5
10643861|NCT02120300|11803087|FG002|STARTED|Overall Study||10
10706145|NCT02605837|11870643|FG000|COMPLETED|Overall Study||94
10706146|NCT02605837|11870644|FG001|COMPLETED|Overall Study||202
10706147|NCT02605837|11870643|FG000|NOT COMPLETED|Overall Study||11
10809189|NCT03836664|11971066|FG000|STARTED|Overall Study||14
10809190|NCT03836664|11971067|FG001|STARTED|Overall Study||11
10643862|NCT02120300|11803088|FG003|STARTED|Overall Study||6
10643863|NCT02120300|11803085|FG000|COMPLETED|Overall Study||98
10643864|NCT02120300|11803086|FG001|COMPLETED|Overall Study||5
10643865|NCT02120300|11803087|FG002|COMPLETED|Overall Study||10
10643866|NCT02120300|11803088|FG003|COMPLETED|Overall Study||5
10643867|NCT02120300|11803085|FG000|NOT COMPLETED|Overall Study||3
10643868|NCT02120300|11803086|FG001|NOT COMPLETED|Overall Study||0
10643869|NCT02120300|11803087|FG002|NOT COMPLETED|Overall Study||0
10643870|NCT02120300|11803088|FG003|NOT COMPLETED|Overall Study||1
10654228|NCT02201056|11814907|FG006|NOT COMPLETED|Overall Study||0
10654237|NCT02201212|11814941|FG000|STARTED|Overall Study||30
10654238|NCT02201212|11814941|FG000|COMPLETED|Overall Study||30
10654239|NCT02201212|11814941|FG000|NOT COMPLETED|Overall Study||0
10654240|NCT02201277|11814947|FG000|STARTED|Overall Study|24 patients were consented but 1 patient had denali filter placed twice.|24
10654241|NCT02201277|11814948|FG001|STARTED|Overall Study|1 patient was withdrawn after signing consent due to physician preference for the option filter.|21
10654242|NCT02201277|11814947|FG000|Filter Retrieval|Overall Study||17
10654243|NCT02201277|11814948|FG001|Filter Retrieval|Overall Study||16
10654244|NCT02201277|11814947|FG000|Signed ICF But Did Not Enroll|Overall Study|Physician had preference for a specific filter so patient not randomized.|0
10654245|NCT02201277|11814948|FG001|Signed ICF But Did Not Enroll|Overall Study||1
10654246|NCT02201277|11814947|FG000|Filter Ruled to be Permanent|Overall Study||2
10654247|NCT02201277|11814948|FG001|Filter Ruled to be Permanent|Overall Study||2
10654248|NCT02201277|11814947|FG000|Lost to Follow up|Overall Study||2
10654249|NCT02201277|11814948|FG001|Lost to Follow up|Overall Study||1
10654250|NCT02201277|11814947|FG000|Death (Before Removal)|Overall Study||3
10654251|NCT02201277|11814948|FG001|Death (Before Removal)|Overall Study||4
10654252|NCT02201277|11814947|FG000|Complicated Retrieval|Overall Study||2
10654253|NCT02201277|11814948|FG001|Complicated Retrieval|Overall Study||0
10654254|NCT02201277|11814947|FG000|Failed Retrieval (Referred Elsewhere)|Overall Study||1
10654255|NCT02201277|11814948|FG001|Failed Retrieval (Referred Elsewhere)|Overall Study||0
10654256|NCT02201277|11814947|FG000|COMPLETED|Overall Study||17
10654257|NCT02201277|11814948|FG001|COMPLETED|Overall Study||16
10654258|NCT02201277|11814947|FG000|NOT COMPLETED|Overall Study||7
10654259|NCT02201277|11814948|FG001|NOT COMPLETED|Overall Study||5
10654260|NCT02201290|11814958|FG000|STARTED|Overall Study||9
10654261|NCT02201290|11814958|FG000|COMPLETED|Overall Study||4
10654262|NCT02201290|11814958|FG000|NOT COMPLETED|Overall Study||5
10654263|NCT02201329|11814962|FG000|STARTED|Overall Study||5
10654264|NCT02201329|11814962|FG000|COMPLETED|Overall Study||0
10654265|NCT02201329|11814962|FG000|NOT COMPLETED|Overall Study||5
10654266|NCT02201394|11814966|FG000|STARTED|Loading Dose||20
10654267|NCT02201394|11814966|FG000|COMPLETED|Loading Dose||20
10654268|NCT02201394|11814966|FG000|NOT COMPLETED|Loading Dose||0
10654269|NCT02201394|11814966|FG000|STARTED|Maintenance Dose||20
10654270|NCT02201394|11814966|FG000|COMPLETED|Maintenance Dose||20
10654271|NCT02201394|11814966|FG000|NOT COMPLETED|Maintenance Dose||0
10654272|NCT02201420|11814971|FG000|STARTED|Overall Study||5
10654273|NCT02201420|11814971|FG000|COMPLETED|Overall Study||5
10654274|NCT02201420|11814971|FG000|NOT COMPLETED|Overall Study||0
10654275|NCT02201446|11814977|FG000|STARTED|Overall Study||81
10654276|NCT02201446|11814978|FG001|STARTED|Overall Study||58
10654277|NCT02201446|11814977|FG000|COMPLETED|Overall Study||81
10654278|NCT02201446|11814978|FG001|COMPLETED|Overall Study||58
10654279|NCT02201446|11814977|FG000|NOT COMPLETED|Overall Study||0
10654280|NCT02201446|11814978|FG001|NOT COMPLETED|Overall Study||0
10654281|NCT02201524|11814988|FG000|STARTED|Overall Study||14
10654282|NCT02201524|11814989|FG001|STARTED|Overall Study||15
10654283|NCT02201524|11814990|FG002|STARTED|Overall Study||16
10654284|NCT02201524|11814991|FG003|STARTED|Overall Study||14
10654285|NCT02201524|11814988|FG000|COMPLETED|Overall Study||12
10654286|NCT02201524|11814989|FG001|COMPLETED|Overall Study||12
10654287|NCT02201524|11814990|FG002|COMPLETED|Overall Study||12
10654288|NCT02201524|11814991|FG003|COMPLETED|Overall Study||10
10654289|NCT02201524|11814988|FG000|NOT COMPLETED|Overall Study||2
10654290|NCT02201524|11814989|FG001|NOT COMPLETED|Overall Study||3
10654291|NCT02201524|11814990|FG002|NOT COMPLETED|Overall Study||4
10654292|NCT02201524|11814991|FG003|NOT COMPLETED|Overall Study||4
10654293|NCT02201771|11815004|FG000|STARTED|Overall Study||166
10654294|NCT02201771|11815005|FG001|STARTED|Overall Study||168
10654295|NCT02201771|11815006|FG002|STARTED|Overall Study||166
10654296|NCT02201771|11815004|FG000|COMPLETED|Overall Study||153
10654297|NCT02201771|11815005|FG001|COMPLETED|Overall Study||158
10654298|NCT02201771|11815006|FG002|COMPLETED|Overall Study||156
10654299|NCT02201771|11815004|FG000|NOT COMPLETED|Overall Study||13
10654300|NCT02201771|11815005|FG001|NOT COMPLETED|Overall Study||10
10654301|NCT02201771|11815006|FG002|NOT COMPLETED|Overall Study||10
10654302|NCT02201784|11815016|FG000|STARTED|Overall Study||30
10654303|NCT02201784|11815017|FG001|STARTED|Overall Study||30
10654304|NCT02201784|11815016|FG000|COMPLETED|Overall Study||28
10654305|NCT02201784|11815017|FG001|COMPLETED|Overall Study||30
10654306|NCT02201784|11815016|FG000|NOT COMPLETED|Overall Study||2
10643871|NCT02120417|11803102|FG000|STARTED|Overall Study||76
10643872|NCT02120417|11803103|FG001|STARTED|Overall Study||73
10643873|NCT02120417|11803102|FG000|COMPLETED|Overall Study||16
10643874|NCT02120417|11803103|FG001|COMPLETED|Overall Study||5
10643875|NCT02120417|11803102|FG000|NOT COMPLETED|Overall Study||60
10643876|NCT02120417|11803103|FG001|NOT COMPLETED|Overall Study||68
10643877|NCT02120443|11803109|FG000|STARTED|Overall Study||43
10643878|NCT02120443|11803109|FG000|COMPLETED|Overall Study||43
10643879|NCT02120443|11803109|FG000|NOT COMPLETED|Overall Study||0
10643880|NCT02120456|11803122|FG000|STARTED|Part 1 Open-label, Dose-escalation Phase||12
10643881|NCT02120456|11803123|FG001|STARTED|Part 1 Open-label, Dose-escalation Phase||12
10643882|NCT02120456|11803124|FG002|STARTED|Part 1 Open-label, Dose-escalation Phase||12
10643883|NCT02120456|11803125|FG003|STARTED|Part 1 Open-label, Dose-escalation Phase||12
10643884|NCT02120456|11803126|FG004|STARTED|Part 1 Open-label, Dose-escalation Phase||12
10643885|NCT02120456|11803127|FG005|STARTED|Part 1 Open-label, Dose-escalation Phase||9
10643886|NCT02120456|11803128|FG006|STARTED|Part 1 Open-label, Dose-escalation Phase||0
10643887|NCT02120456|11803129|FG007|STARTED|Part 1 Open-label, Dose-escalation Phase||0
10643888|NCT02120456|11803130|FG008|STARTED|Part 1 Open-label, Dose-escalation Phase||0
10643889|NCT02120456|11803122|FG000|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
10643890|NCT02120456|11803123|FG001|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
10643891|NCT02120456|11803124|FG002|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
10643892|NCT02120456|11803125|FG003|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
10643893|NCT02120456|11803126|FG004|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
10643894|NCT02120456|11803127|FG005|COMPLETED|Part 1 Open-label, Dose-escalation Phase||9
10643895|NCT02120456|11803128|FG006|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10643896|NCT02120456|11803129|FG007|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10643897|NCT02120456|11803130|FG008|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10643898|NCT02120456|11803122|FG000|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10643899|NCT02120456|11803123|FG001|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10643900|NCT02120456|11803124|FG002|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10643901|NCT02120456|11803125|FG003|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10643902|NCT02120456|11803126|FG004|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10643903|NCT02120456|11803127|FG005|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10643904|NCT02120456|11803128|FG006|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10643905|NCT02120456|11803129|FG007|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10643906|NCT02120456|11803130|FG008|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
10643907|NCT02120456|11803122|FG000|STARTED|Part 2 Double-blind Phase||0
10643908|NCT02120456|11803123|FG001|STARTED|Part 2 Double-blind Phase||0
10643909|NCT02120456|11803124|FG002|STARTED|Part 2 Double-blind Phase||0
10643910|NCT02120456|11803125|FG003|STARTED|Part 2 Double-blind Phase||0
10643911|NCT02120456|11803126|FG004|STARTED|Part 2 Double-blind Phase||0
10643912|NCT02120456|11803127|FG005|STARTED|Part 2 Double-blind Phase||0
10643913|NCT02120456|11803128|FG006|STARTED|Part 2 Double-blind Phase||32
10643914|NCT02120456|11803129|FG007|STARTED|Part 2 Double-blind Phase||60
10643915|NCT02120456|11803130|FG008|STARTED|Part 2 Double-blind Phase||63
10643916|NCT02120456|11803122|FG000|COMPLETED|Part 2 Double-blind Phase||0
10643917|NCT02120456|11803123|FG001|COMPLETED|Part 2 Double-blind Phase||0
10643918|NCT02120456|11803124|FG002|COMPLETED|Part 2 Double-blind Phase||0
10643919|NCT02120456|11803125|FG003|COMPLETED|Part 2 Double-blind Phase||0
10643920|NCT02120456|11803126|FG004|COMPLETED|Part 2 Double-blind Phase||0
10643921|NCT02120456|11803127|FG005|COMPLETED|Part 2 Double-blind Phase||0
10643922|NCT02120456|11803128|FG006|COMPLETED|Part 2 Double-blind Phase||30
10643923|NCT02120456|11803129|FG007|COMPLETED|Part 2 Double-blind Phase||60
10643924|NCT02120456|11803130|FG008|COMPLETED|Part 2 Double-blind Phase||62
10643925|NCT02120456|11803122|FG000|NOT COMPLETED|Part 2 Double-blind Phase||0
10643926|NCT02120456|11803123|FG001|NOT COMPLETED|Part 2 Double-blind Phase||0
10643927|NCT02120456|11803124|FG002|NOT COMPLETED|Part 2 Double-blind Phase||0
10643928|NCT02120456|11803125|FG003|NOT COMPLETED|Part 2 Double-blind Phase||0
10643929|NCT02120456|11803126|FG004|NOT COMPLETED|Part 2 Double-blind Phase||0
10643930|NCT02120456|11803127|FG005|NOT COMPLETED|Part 2 Double-blind Phase||0
10643931|NCT02120456|11803128|FG006|NOT COMPLETED|Part 2 Double-blind Phase||2
10643932|NCT02120456|11803129|FG007|NOT COMPLETED|Part 2 Double-blind Phase||0
10643933|NCT02120456|11803130|FG008|NOT COMPLETED|Part 2 Double-blind Phase||1
10643934|NCT02120625|11803150|FG000|STARTED|Overall Study||8
10643935|NCT02120625|11803150|FG000|COMPLETED|Overall Study||6
10643936|NCT02120625|11803150|FG000|NOT COMPLETED|Overall Study||2
10643937|NCT02120664|11803159|FG000|STARTED|Overall Study||10
10643938|NCT02120664|11803160|FG001|STARTED|Overall Study||4
10643939|NCT02120664|11803161|FG002|STARTED|Overall Study||7
10643940|NCT02120664|11803162|FG003|STARTED|Overall Study||4
10643941|NCT02120664|11803163|FG004|STARTED|Overall Study||10
10643942|NCT02120664|11803159|FG000|COMPLETED|Overall Study||10
10643943|NCT02120664|11803160|FG001|COMPLETED|Overall Study||4
10643944|NCT02120664|11803161|FG002|COMPLETED|Overall Study||7
10643945|NCT02120664|11803162|FG003|COMPLETED|Overall Study||3
10643946|NCT02120664|11803163|FG004|COMPLETED|Overall Study||10
10643947|NCT02120664|11803159|FG000|NOT COMPLETED|Overall Study||0
10643948|NCT02120664|11803160|FG001|NOT COMPLETED|Overall Study||0
10643949|NCT02120664|11803161|FG002|NOT COMPLETED|Overall Study||0
10643950|NCT02120664|11803162|FG003|NOT COMPLETED|Overall Study||1
10643951|NCT02120664|11803163|FG004|NOT COMPLETED|Overall Study||0
10643952|NCT02120716|11803178|FG000|STARTED|Overall Study||31
10643953|NCT02120716|11803179|FG001|STARTED|Overall Study||19
10643954|NCT02120716|11803178|FG000|COMPLETED|Overall Study||30
10643955|NCT02120716|11803179|FG001|COMPLETED|Overall Study||19
10643956|NCT02120716|11803178|FG000|NOT COMPLETED|Overall Study||1
10643957|NCT02120716|11803179|FG001|NOT COMPLETED|Overall Study||0
10643958|NCT02120781|11803187|FG000|STARTED|Overall Study||15
10643959|NCT02120781|11803188|FG001|STARTED|Overall Study||6
10643960|NCT02120781|11803187|FG000|COMPLETED|Overall Study||11
10643961|NCT02120781|11803188|FG001|COMPLETED|Overall Study||5
10643962|NCT02120781|11803187|FG000|NOT COMPLETED|Overall Study||4
10643963|NCT02120781|11803188|FG001|NOT COMPLETED|Overall Study||1
10643964|NCT02120794|11803194|FG000|STARTED|Overall Study||194
10643965|NCT02120794|11803194|FG000|COMPLETED|Overall Study||136
10643966|NCT02120794|11803194|FG000|NOT COMPLETED|Overall Study||58
10643967|NCT02120833|11803200|FG000|STARTED|Overall Study||39
10643968|NCT02120833|11803201|FG001|STARTED|Overall Study||12
10643969|NCT02120833|11803200|FG000|COMPLETED|Overall Study||35
10643970|NCT02120833|11803201|FG001|COMPLETED|Overall Study||11
10643971|NCT02120833|11803200|FG000|NOT COMPLETED|Overall Study||4
10643972|NCT02120833|11803201|FG001|NOT COMPLETED|Overall Study||1
10643973|NCT02120898|11803210|FG000|STARTED|Overall Study||187
10643974|NCT02120898|11803211|FG001|STARTED|Overall Study||187
10643975|NCT02120898|11803212|FG002|STARTED|Overall Study||93
10643976|NCT02120898|11803210|FG000|Safety Population|Overall Study||187
10643977|NCT02120898|11803211|FG001|Safety Population|Overall Study||187
10643978|NCT02120898|11803212|FG002|Safety Population|Overall Study||93
10643979|NCT02120898|11803210|FG000|Intent-to-Treat (ITT) Population|Overall Study||183
10643980|NCT02120898|11803211|FG001|Intent-to-Treat (ITT) Population|Overall Study||185
10643981|NCT02120898|11803212|FG002|Intent-to-Treat (ITT) Population|Overall Study||93
10643982|NCT02120898|11803210|FG000|COMPLETED|Overall Study||178
10643983|NCT02120898|11803211|FG001|COMPLETED|Overall Study||181
10643984|NCT02120898|11803212|FG002|COMPLETED|Overall Study||89
10643985|NCT02120898|11803210|FG000|NOT COMPLETED|Overall Study||9
10643986|NCT02120898|11803211|FG001|NOT COMPLETED|Overall Study||6
10643987|NCT02120898|11803212|FG002|NOT COMPLETED|Overall Study||4
10643988|NCT02120924|11803223|FG000|STARTED|Overall Study||404
10643989|NCT02120924|11803224|FG001|STARTED|Overall Study||403
10643990|NCT02120924|11803225|FG002|STARTED|Overall Study||202
10643991|NCT02120924|11803223|FG000|COMPLETED|Overall Study||362
10643992|NCT02120924|11803224|FG001|COMPLETED|Overall Study||357
10643993|NCT02120924|11803225|FG002|COMPLETED|Overall Study||173
10643994|NCT02120924|11803223|FG000|NOT COMPLETED|Overall Study||42
10643995|NCT02120924|11803224|FG001|NOT COMPLETED|Overall Study||46
10643996|NCT02120924|11803225|FG002|NOT COMPLETED|Overall Study||29
10643997|NCT02120950|11803236|FG000|STARTED|Overall Study||157
10643998|NCT02120950|11803237|FG001|STARTED|Overall Study||161
10643999|NCT02120950|11803238|FG002|STARTED|Overall Study||15
10644000|NCT02120950|11803236|FG000|COMPLETED|Overall Study|Completed Treatment (Week 96)|137
10644001|NCT02120950|11803237|FG001|COMPLETED|Overall Study|Completed Treatment (Week 96)|147
10644002|NCT02120950|11803238|FG002|COMPLETED|Overall Study||0
10644003|NCT02120950|11803236|FG000|NOT COMPLETED|Overall Study||20
10644004|NCT02120950|11803237|FG001|NOT COMPLETED|Overall Study||14
10644005|NCT02120950|11803238|FG002|NOT COMPLETED|Overall Study||15
10644006|NCT02121002|11803248|FG000|STARTED|Overall Study||392
10644007|NCT02121002|11803249|FG001|STARTED|Overall Study||393
10644008|NCT02121002|11803250|FG002|STARTED|Overall Study||391
10644009|NCT02121002|11803248|FG000|COMPLETED|Overall Study||385
10644010|NCT02121002|11803249|FG001|COMPLETED|Overall Study||389
10644011|NCT02121002|11803250|FG002|COMPLETED|Overall Study||381
10644012|NCT02121002|11803248|FG000|NOT COMPLETED|Overall Study||7
10644013|NCT02121002|11803249|FG001|NOT COMPLETED|Overall Study||4
10644014|NCT02121002|11803250|FG002|NOT COMPLETED|Overall Study||10
10644015|NCT02121041|11803260|FG000|STARTED|Overall Study||14
10644016|NCT02121041|11803261|FG001|STARTED|Overall Study||14
10644017|NCT02121041|11803260|FG000|COMPLETED|Overall Study||13
10644018|NCT02121041|11803261|FG001|COMPLETED|Overall Study||8
10644019|NCT02121041|11803260|FG000|NOT COMPLETED|Overall Study||1
10644020|NCT02121041|11803261|FG001|NOT COMPLETED|Overall Study||6
10644021|NCT02121067|11803267|FG000|STARTED|Overall Study||50
10644022|NCT02121067|11803267|FG000|COMPLETED|Overall Study||50
10644023|NCT02121067|11803267|FG000|NOT COMPLETED|Overall Study||0
10644024|NCT02121210|11803274|FG000|STARTED|Overall Study||65
10644025|NCT02121210|11803275|FG001|STARTED|Overall Study||67
10644026|NCT02121210|11803274|FG000|COMPLETED|Overall Study||58
10644027|NCT02121210|11803275|FG001|COMPLETED|Overall Study||58
10644028|NCT02121210|11803274|FG000|NOT COMPLETED|Overall Study||7
10644029|NCT02121210|11803275|FG001|NOT COMPLETED|Overall Study||9
10644030|NCT02121262|11803283|FG000|STARTED|Overall Study||139
10644031|NCT02121262|11803284|FG001|STARTED|Overall Study||145
10644032|NCT02121262|11803283|FG000|Treated|Overall Study||129
10644033|NCT02121262|11803284|FG001|Treated|Overall Study||145
10644034|NCT02121262|11803283|FG000|Modified Intent-to-treat Population|Overall Study||127
10644035|NCT02121262|11803284|FG001|Modified Intent-to-treat Population|Overall Study||145
10644036|NCT02121262|11803283|FG000|COMPLETED|Overall Study||108
10644037|NCT02121262|11803284|FG001|COMPLETED|Overall Study||135
10644038|NCT02121262|11803283|FG000|NOT COMPLETED|Overall Study||31
10644039|NCT02121262|11803284|FG001|NOT COMPLETED|Overall Study||10
10644040|NCT02121301|11803293|FG000|STARTED|Overall Study||30
10644041|NCT02121301|11803294|FG001|STARTED|Overall Study||30
10644042|NCT02121301|11803295|FG002|STARTED|Overall Study||31
10644043|NCT02121301|11803293|FG000|COMPLETED|Overall Study||29
10644044|NCT02121301|11803294|FG001|COMPLETED|Overall Study||26
10644045|NCT02121301|11803295|FG002|COMPLETED|Overall Study||30
10644046|NCT02121301|11803293|FG000|NOT COMPLETED|Overall Study||1
10644047|NCT02121301|11803294|FG001|NOT COMPLETED|Overall Study||4
10644048|NCT02121301|11803295|FG002|NOT COMPLETED|Overall Study||1
10644049|NCT02121392|11803305|FG000|STARTED|Prior to Intervention||83
10644050|NCT02121392|11803306|FG001|STARTED|Prior to Intervention||82
10644051|NCT02121392|11803305|FG000|COMPLETED|Prior to Intervention||35
10644052|NCT02121392|11803306|FG001|COMPLETED|Prior to Intervention||41
10644053|NCT02121392|11803305|FG000|NOT COMPLETED|Prior to Intervention||48
10644054|NCT02121392|11803306|FG001|NOT COMPLETED|Prior to Intervention||41
10644055|NCT02121392|11803305|FG000|STARTED|After Placement of AC Block vs Sham||35
10644056|NCT02121392|11803306|FG001|STARTED|After Placement of AC Block vs Sham||41
10706148|NCT02605837|11870644|FG001|NOT COMPLETED|Overall Study||11
10706149|NCT02605863|11870653|FG000|STARTED|Overall Study||1
10706150|NCT02605863|11870654|FG001|STARTED|Overall Study||0
10706151|NCT02605863|11870653|FG000|COMPLETED|Overall Study||1
10706152|NCT02605863|11870654|FG001|COMPLETED|Overall Study||0
10706153|NCT02605863|11870653|FG000|NOT COMPLETED|Overall Study||0
10644057|NCT02121392|11803305|FG000|COMPLETED|After Placement of AC Block vs Sham||32
10644058|NCT02121392|11803306|FG001|COMPLETED|After Placement of AC Block vs Sham||38
10644059|NCT02121392|11803305|FG000|NOT COMPLETED|After Placement of AC Block vs Sham||3
10644060|NCT02121392|11803306|FG001|NOT COMPLETED|After Placement of AC Block vs Sham||3
10644061|NCT02121418|11803312|FG000|STARTED|Overall Study||12
10644062|NCT02121418|11803312|FG000|COMPLETED|Overall Study||12
10644063|NCT02121418|11803312|FG000|NOT COMPLETED|Overall Study||0
10644064|NCT02121483|11803319|FG000|STARTED|Overall Study||9
10644065|NCT02121483|11803320|FG001|STARTED|Overall Study||8
10644066|NCT02121483|11803321|FG002|STARTED|Overall Study||10
10644067|NCT02121483|11803319|FG000|COMPLETED|Overall Study||9
10644068|NCT02121483|11803320|FG001|COMPLETED|Overall Study||8
10644069|NCT02121483|11803321|FG002|COMPLETED|Overall Study||10
10644070|NCT02121483|11803319|FG000|NOT COMPLETED|Overall Study||0
10644071|NCT02121483|11803320|FG001|NOT COMPLETED|Overall Study||0
10644072|NCT02121483|11803321|FG002|NOT COMPLETED|Overall Study||0
10644073|NCT02121509|11803331|FG000|STARTED|Treatment Period-1 (4 Days)||30
10644074|NCT02121509|11803332|FG001|STARTED|Treatment Period-1 (4 Days)||28
10644075|NCT02121509|11803333|FG002|STARTED|Treatment Period-1 (4 Days)||8
10644076|NCT02121509|11803334|FG003|STARTED|Treatment Period-1 (4 Days)||8
10644077|NCT02121509|11803331|FG000|COMPLETED|Treatment Period-1 (4 Days)||30
10644078|NCT02121509|11803332|FG001|COMPLETED|Treatment Period-1 (4 Days)||28
10644079|NCT02121509|11803333|FG002|COMPLETED|Treatment Period-1 (4 Days)||8
10706154|NCT02605863|11870654|FG001|NOT COMPLETED|Overall Study||0
10706155|NCT02605876|11870663|FG000|STARTED|Overall Study||25
10706156|NCT02605876|11870664|FG001|STARTED|Overall Study||25
10706157|NCT02605876|11870665|FG002|STARTED|Overall Study||25
10706158|NCT02605876|11870663|FG000|COMPLETED|Overall Study||25
10706159|NCT02605876|11870664|FG001|COMPLETED|Overall Study||25
10706160|NCT02605876|11870665|FG002|COMPLETED|Overall Study||25
10706161|NCT02605876|11870663|FG000|NOT COMPLETED|Overall Study||0
10706162|NCT02605876|11870664|FG001|NOT COMPLETED|Overall Study||0
10706163|NCT02605876|11870665|FG002|NOT COMPLETED|Overall Study||0
10706164|NCT02605928|11870673|FG000|STARTED|Overall Study||79
10706165|NCT02605928|11870673|FG000|Pivotal Phase, Statistical Phase|Overall Study||51
10706166|NCT02605928|11870673|FG000|COMPLETED|Overall Study||46
10644080|NCT02121509|11803334|FG003|COMPLETED|Treatment Period-1 (4 Days)||8
10644081|NCT02121509|11803331|FG000|NOT COMPLETED|Treatment Period-1 (4 Days)||0
10644082|NCT02121509|11803332|FG001|NOT COMPLETED|Treatment Period-1 (4 Days)||0
10644083|NCT02121509|11803333|FG002|NOT COMPLETED|Treatment Period-1 (4 Days)||0
10644084|NCT02121509|11803334|FG003|NOT COMPLETED|Treatment Period-1 (4 Days)||0
10644085|NCT02121509|11803331|FG000|STARTED|Washout Period (35 Days)||30
10644086|NCT02121509|11803332|FG001|STARTED|Washout Period (35 Days)||28
10706167|NCT02605928|11870673|FG000|NOT COMPLETED|Overall Study||33
10706168|NCT02605954|11870679|FG000|STARTED|Overall Study||183
10706169|NCT02605954|11870680|FG001|STARTED|Overall Study||92
10706170|NCT02605954|11870679|FG000|COMPLETED|Overall Study||171
10706171|NCT02605954|11870680|FG001|COMPLETED|Overall Study||88
10706172|NCT02605954|11870679|FG000|NOT COMPLETED|Overall Study||12
10644087|NCT02121509|11803333|FG002|STARTED|Washout Period (35 Days)||8
10644088|NCT02121509|11803334|FG003|STARTED|Washout Period (35 Days)||8
10644089|NCT02121509|11803331|FG000|COMPLETED|Washout Period (35 Days)||28
10644090|NCT02121509|11803332|FG001|COMPLETED|Washout Period (35 Days)||24
10644091|NCT02121509|11803333|FG002|COMPLETED|Washout Period (35 Days)||8
10644092|NCT02121509|11803334|FG003|COMPLETED|Washout Period (35 Days)||8
10644093|NCT02121509|11803331|FG000|NOT COMPLETED|Washout Period (35 Days)||2
10644094|NCT02121509|11803332|FG001|NOT COMPLETED|Washout Period (35 Days)||4
10644095|NCT02121509|11803333|FG002|NOT COMPLETED|Washout Period (35 Days)||0
10644096|NCT02121509|11803334|FG003|NOT COMPLETED|Washout Period (35 Days)||0
10644097|NCT02121509|11803331|FG000|STARTED|Treatment Period-2 (4 Days)||28
10644098|NCT02121509|11803332|FG001|STARTED|Treatment Period-2 (4 Days)||24
10644099|NCT02121509|11803333|FG002|STARTED|Treatment Period-2 (4 Days)||8
10644100|NCT02121509|11803334|FG003|STARTED|Treatment Period-2 (4 Days)||8
10644101|NCT02121509|11803331|FG000|COMPLETED|Treatment Period-2 (4 Days)||28
10644102|NCT02121509|11803332|FG001|COMPLETED|Treatment Period-2 (4 Days)||24
10644103|NCT02121509|11803333|FG002|COMPLETED|Treatment Period-2 (4 Days)||8
10644104|NCT02121509|11803334|FG003|COMPLETED|Treatment Period-2 (4 Days)||8
10644105|NCT02121509|11803331|FG000|NOT COMPLETED|Treatment Period-2 (4 Days)||0
10644106|NCT02121509|11803332|FG001|NOT COMPLETED|Treatment Period-2 (4 Days)||0
10644107|NCT02121509|11803333|FG002|NOT COMPLETED|Treatment Period-2 (4 Days)||0
10644108|NCT02121509|11803334|FG003|NOT COMPLETED|Treatment Period-2 (4 Days)||0
10644109|NCT02121522|11803344|FG000|STARTED|Overall Study||14
10644110|NCT02121522|11803344|FG000|COMPLETED|Overall Study||13
10644111|NCT02121522|11803344|FG000|NOT COMPLETED|Overall Study||1
10644112|NCT02121535|11803350|FG000|STARTED|Period 1 (8 Trial Days)||36
10644113|NCT02121535|11803351|FG001|STARTED|Period 1 (8 Trial Days)||36
10644114|NCT02121535|11803350|FG000|COMPLETED|Period 1 (8 Trial Days)||36
10644115|NCT02121535|11803351|FG001|COMPLETED|Period 1 (8 Trial Days)|1 subject withdrew his consent during the washout period between Period 1 and 2.|35
10644116|NCT02121535|11803350|FG000|NOT COMPLETED|Period 1 (8 Trial Days)||0
10644117|NCT02121535|11803351|FG001|NOT COMPLETED|Period 1 (8 Trial Days)||1
10644118|NCT02121535|11803350|FG000|STARTED|Period 2 (8 Trial Days)||36
10644119|NCT02121535|11803351|FG001|STARTED|Period 2 (8 Trial Days)||35
10644120|NCT02121535|11803350|FG000|COMPLETED|Period 2 (8 Trial Days)||36
10644121|NCT02121535|11803351|FG001|COMPLETED|Period 2 (8 Trial Days)||35
10644122|NCT02121535|11803350|FG000|NOT COMPLETED|Period 2 (8 Trial Days)||0
10644123|NCT02121535|11803351|FG001|NOT COMPLETED|Period 2 (8 Trial Days)||0
10644124|NCT02121535|11803350|FG000|STARTED|Period 3 (8 Trial Days)||36
10644125|NCT02121535|11803351|FG001|STARTED|Period 3 (8 Trial Days)||35
10644126|NCT02121535|11803350|FG000|COMPLETED|Period 3 (8 Trial Days)|1 subject withdrew consent during the washout period between Period 3 and 4.|35
10644127|NCT02121535|11803351|FG001|COMPLETED|Period 3 (8 Trial Days)||35
10644128|NCT02121535|11803350|FG000|NOT COMPLETED|Period 3 (8 Trial Days)||1
10644129|NCT02121535|11803351|FG001|NOT COMPLETED|Period 3 (8 Trial Days)||0
10644130|NCT02121535|11803350|FG000|STARTED|Period 4 (8 Trial Days)||35
10644131|NCT02121535|11803351|FG001|STARTED|Period 4 (8 Trial Days)||35
10644132|NCT02121535|11803350|FG000|COMPLETED|Period 4 (8 Trial Days)||35
10644133|NCT02121535|11803351|FG001|COMPLETED|Period 4 (8 Trial Days)||35
10644134|NCT02121535|11803350|FG000|NOT COMPLETED|Period 4 (8 Trial Days)||0
10809191|NCT03836664|11971066|FG000|COMPLETED|Overall Study||11
10809192|NCT03836664|11971067|FG001|COMPLETED|Overall Study||8
10809193|NCT03836664|11971066|FG000|NOT COMPLETED|Overall Study||3
10809194|NCT03836664|11971067|FG001|NOT COMPLETED|Overall Study||3
10809195|NCT03832738|11971080|FG000|STARTED|Overall Study||51
10809196|NCT03832738|11971081|FG001|STARTED|Overall Study||50
10644135|NCT02121535|11803351|FG001|NOT COMPLETED|Period 4 (8 Trial Days)||0
10644136|NCT02121756|11803360|FG000|STARTED|Overall Study||21
10644137|NCT02121756|11803361|FG001|STARTED|Overall Study||19
10644138|NCT02121756|11803360|FG000|COMPLETED|Overall Study||15
10644139|NCT02121756|11803361|FG001|COMPLETED|Overall Study||17
10644140|NCT02121756|11803360|FG000|NOT COMPLETED|Overall Study||6
10644141|NCT02121756|11803361|FG001|NOT COMPLETED|Overall Study||2
10644142|NCT02121795|11803372|FG000|STARTED|Double-Blind Phase||334
10644143|NCT02121795|11803373|FG001|STARTED|Double-Blind Phase||334
10644144|NCT02121795|11803372|FG000|Safety Analysis Set|Double-Blind Phase||333
10644145|NCT02121795|11803373|FG001|Safety Analysis Set|Double-Blind Phase||330
10644146|NCT02121795|11803372|FG000|COMPLETED|Double-Blind Phase||296
10644147|NCT02121795|11803373|FG001|COMPLETED|Double-Blind Phase||300
10644148|NCT02121795|11803372|FG000|NOT COMPLETED|Double-Blind Phase||38
10644149|NCT02121795|11803373|FG001|NOT COMPLETED|Double-Blind Phase||34
10644150|NCT02121795|11803372|FG000|STARTED|Open-Label Phase|Not all participants entered the Open-Label Phase.|33
10644151|NCT02121795|11803373|FG001|STARTED|Open-Label Phase|Not all participants entered the Open-Label Phase.|31
10644152|NCT02121795|11803372|FG000|COMPLETED|Open-Label Phase||21
10644153|NCT02121795|11803373|FG001|COMPLETED|Open-Label Phase||21
10644154|NCT02121795|11803372|FG000|NOT COMPLETED|Open-Label Phase||12
10644155|NCT02121795|11803373|FG001|NOT COMPLETED|Open-Label Phase||10
10644156|NCT02121808|11803381|FG000|STARTED|Overall Study||20
10644157|NCT02121808|11803381|FG000|COMPLETED|Overall Study||17
10644158|NCT02121808|11803381|FG000|NOT COMPLETED|Overall Study||3
10644159|NCT02121834|11803397|FG000|STARTED|Overall Study||12
10644160|NCT02121834|11803398|FG001|STARTED|Overall Study||11
10644161|NCT02121834|11803399|FG002|STARTED|Overall Study||9
10644162|NCT02121834|11803400|FG003|STARTED|Overall Study||10
10644163|NCT02121834|11803401|FG004|STARTED|Overall Study||9
10644164|NCT02121834|11803402|FG005|STARTED|Overall Study||9
10644165|NCT02121834|11803403|FG006|STARTED|Overall Study||3
10644166|NCT02121834|11803397|FG000|Received at Least One Dose of Study Drug|Overall Study||12
10644167|NCT02121834|11803398|FG001|Received at Least One Dose of Study Drug|Overall Study||11
10644168|NCT02121834|11803399|FG002|Received at Least One Dose of Study Drug|Overall Study||9
10809197|NCT03832738|11971082|FG002|STARTED|Overall Study||51
10809198|NCT03832738|11971080|FG000|COMPLETED|Overall Study||43
10809199|NCT03832738|11971081|FG001|COMPLETED|Overall Study||38
10809200|NCT03832738|11971082|FG002|COMPLETED|Overall Study||32
10809201|NCT03832738|11971080|FG000|NOT COMPLETED|Overall Study||8
10809202|NCT03832738|11971081|FG001|NOT COMPLETED|Overall Study||12
10644169|NCT02121834|11803400|FG003|Received at Least One Dose of Study Drug|Overall Study||10
10644170|NCT02121834|11803401|FG004|Received at Least One Dose of Study Drug|Overall Study||9
10644171|NCT02121834|11803402|FG005|Received at Least One Dose of Study Drug|Overall Study||9
10644172|NCT02121834|11803403|FG006|Received at Least One Dose of Study Drug|Overall Study||3
10644173|NCT02121834|11803397|FG000|COMPLETED|Overall Study||12
10644174|NCT02121834|11803398|FG001|COMPLETED|Overall Study||9
10644175|NCT02121834|11803399|FG002|COMPLETED|Overall Study||7
10644176|NCT02121834|11803400|FG003|COMPLETED|Overall Study||10
10644177|NCT02121834|11803401|FG004|COMPLETED|Overall Study||9
10644178|NCT02121834|11803402|FG005|COMPLETED|Overall Study||9
10644179|NCT02121834|11803403|FG006|COMPLETED|Overall Study||3
10644180|NCT02121834|11803397|FG000|NOT COMPLETED|Overall Study||0
10644181|NCT02121834|11803398|FG001|NOT COMPLETED|Overall Study||2
10644182|NCT02121834|11803399|FG002|NOT COMPLETED|Overall Study||2
10644183|NCT02121834|11803400|FG003|NOT COMPLETED|Overall Study||0
10644184|NCT02121834|11803401|FG004|NOT COMPLETED|Overall Study||0
10644185|NCT02121834|11803402|FG005|NOT COMPLETED|Overall Study||0
10644186|NCT02121834|11803403|FG006|NOT COMPLETED|Overall Study||0
10644187|NCT02121847|11803429|FG000|STARTED|Overall Study||40
10644188|NCT02121847|11803429|FG000|COMPLETED|Overall Study||37
10644189|NCT02121847|11803429|FG000|NOT COMPLETED|Overall Study||3
10644190|NCT02121860|11803437|FG000|STARTED|Overall Study||8
10644191|NCT02121860|11803438|FG001|STARTED|Overall Study||12
10644192|NCT02121860|11803439|FG002|STARTED|Overall Study||8
10644193|NCT02121860|11803440|FG003|STARTED|Overall Study||8
10644194|NCT02121860|11803437|FG000|COMPLETED|Overall Study||8
10644195|NCT02121860|11803438|FG001|COMPLETED|Overall Study||12
10644196|NCT02121860|11803439|FG002|COMPLETED|Overall Study||8
10644197|NCT02121860|11803440|FG003|COMPLETED|Overall Study||8
10644198|NCT02121860|11803437|FG000|NOT COMPLETED|Overall Study||0
10644199|NCT02121860|11803438|FG001|NOT COMPLETED|Overall Study||0
10644200|NCT02121860|11803439|FG002|NOT COMPLETED|Overall Study||0
10644201|NCT02121860|11803440|FG003|NOT COMPLETED|Overall Study||0
10644202|NCT02121912|11803449|FG000|STARTED|Overall Study||25
10644203|NCT02121912|11803450|FG001|STARTED|Overall Study||25
10644204|NCT02121912|11803449|FG000|COMPLETED|Overall Study||21
10644205|NCT02121912|11803450|FG001|COMPLETED|Overall Study||25
10644206|NCT02121912|11803449|FG000|NOT COMPLETED|Overall Study||4
10644207|NCT02121912|11803450|FG001|NOT COMPLETED|Overall Study||0
10644208|NCT02122146|11803464|FG000|STARTED|Part 1: Dose Escalation||2
10644209|NCT02122146|11803465|FG001|STARTED|Part 1: Dose Escalation||2
10644210|NCT02122146|11803466|FG002|STARTED|Part 1: Dose Escalation||4
10644211|NCT02122146|11803467|FG003|STARTED|Part 1: Dose Escalation||4
10644212|NCT02122146|11803468|FG004|STARTED|Part 1: Dose Escalation||4
10644213|NCT02122146|11803469|FG005|STARTED|Part 1: Dose Escalation||6
10644214|NCT02122146|11803470|FG006|STARTED|Part 1: Dose Escalation||1
10644215|NCT02122146|11803471|FG007|STARTED|Part 1: Dose Escalation||8
10644216|NCT02122146|11803464|FG000|COMPLETED|Part 1: Dose Escalation||1
10644217|NCT02122146|11803465|FG001|COMPLETED|Part 1: Dose Escalation||1
10644218|NCT02122146|11803466|FG002|COMPLETED|Part 1: Dose Escalation||2
10644219|NCT02122146|11803467|FG003|COMPLETED|Part 1: Dose Escalation||3
10644220|NCT02122146|11803468|FG004|COMPLETED|Part 1: Dose Escalation||3
10644221|NCT02122146|11803469|FG005|COMPLETED|Part 1: Dose Escalation||5
10644222|NCT02122146|11803470|FG006|COMPLETED|Part 1: Dose Escalation||0
10644223|NCT02122146|11803471|FG007|COMPLETED|Part 1: Dose Escalation||6
10644224|NCT02122146|11803464|FG000|NOT COMPLETED|Part 1: Dose Escalation||1
10644225|NCT02122146|11803465|FG001|NOT COMPLETED|Part 1: Dose Escalation||1
10644226|NCT02122146|11803466|FG002|NOT COMPLETED|Part 1: Dose Escalation||2
10644227|NCT02122146|11803467|FG003|NOT COMPLETED|Part 1: Dose Escalation||1
10644228|NCT02122146|11803468|FG004|NOT COMPLETED|Part 1: Dose Escalation||1
10644229|NCT02122146|11803469|FG005|NOT COMPLETED|Part 1: Dose Escalation||1
10644230|NCT02122146|11803470|FG006|NOT COMPLETED|Part 1: Dose Escalation||1
10644231|NCT02122146|11803471|FG007|NOT COMPLETED|Part 1: Dose Escalation||2
10644232|NCT02122146|11803464|FG000|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
10644233|NCT02122146|11803465|FG001|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
10644234|NCT02122146|11803466|FG002|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
10644235|NCT02122146|11803467|FG003|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
10644236|NCT02122146|11803468|FG004|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
10644237|NCT02122146|11803469|FG005|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
10644238|NCT02122146|11803470|FG006|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
10644239|NCT02122146|11803471|FG007|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
10644240|NCT02122146|11803464|FG000|COMPLETED|Part 2: Maximum Tolerated Dose||0
10644241|NCT02122146|11803465|FG001|COMPLETED|Part 2: Maximum Tolerated Dose||0
10644242|NCT02122146|11803466|FG002|COMPLETED|Part 2: Maximum Tolerated Dose||0
10644243|NCT02122146|11803467|FG003|COMPLETED|Part 2: Maximum Tolerated Dose||0
10644244|NCT02122146|11803468|FG004|COMPLETED|Part 2: Maximum Tolerated Dose||0
10644245|NCT02122146|11803469|FG005|COMPLETED|Part 2: Maximum Tolerated Dose||0
10644246|NCT02122146|11803470|FG006|COMPLETED|Part 2: Maximum Tolerated Dose||0
10644247|NCT02122146|11803471|FG007|COMPLETED|Part 2: Maximum Tolerated Dose||0
10644248|NCT02122146|11803464|FG000|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
10644249|NCT02122146|11803465|FG001|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
10644250|NCT02122146|11803466|FG002|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
10644251|NCT02122146|11803467|FG003|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
10644252|NCT02122146|11803468|FG004|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
10644253|NCT02122146|11803469|FG005|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
10644254|NCT02122146|11803470|FG006|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
10644255|NCT02122146|11803471|FG007|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
10644256|NCT02122146|11803464|FG000|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
10644257|NCT02122146|11803465|FG001|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
10644258|NCT02122146|11803466|FG002|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
10644259|NCT02122146|11803467|FG003|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
10644260|NCT02122146|11803468|FG004|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
10644261|NCT02122146|11803469|FG005|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
10644262|NCT02122146|11803470|FG006|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
10644263|NCT02122146|11803471|FG007|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
10644264|NCT02122146|11803464|FG000|COMPLETED|Part 3: Expansion||0
10644265|NCT02122146|11803465|FG001|COMPLETED|Part 3: Expansion||0
10644266|NCT02122146|11803466|FG002|COMPLETED|Part 3: Expansion||0
10644267|NCT02122146|11803467|FG003|COMPLETED|Part 3: Expansion||0
10644268|NCT02122146|11803468|FG004|COMPLETED|Part 3: Expansion||0
10644269|NCT02122146|11803469|FG005|COMPLETED|Part 3: Expansion||0
10644270|NCT02122146|11803470|FG006|COMPLETED|Part 3: Expansion||0
10644271|NCT02122146|11803471|FG007|COMPLETED|Part 3: Expansion||0
10644272|NCT02122146|11803464|FG000|NOT COMPLETED|Part 3: Expansion||0
10644273|NCT02122146|11803465|FG001|NOT COMPLETED|Part 3: Expansion||0
10644274|NCT02122146|11803466|FG002|NOT COMPLETED|Part 3: Expansion||0
10644275|NCT02122146|11803467|FG003|NOT COMPLETED|Part 3: Expansion||0
10644276|NCT02122146|11803468|FG004|NOT COMPLETED|Part 3: Expansion||0
10644277|NCT02122146|11803469|FG005|NOT COMPLETED|Part 3: Expansion||0
10644278|NCT02122146|11803470|FG006|NOT COMPLETED|Part 3: Expansion||0
10644279|NCT02122146|11803471|FG007|NOT COMPLETED|Part 3: Expansion||0
10644280|NCT02122341|11803492|FG000|STARTED|Overall Study||17
10644281|NCT02122341|11803493|FG001|STARTED|Overall Study||18
10644282|NCT02122341|11803492|FG000|COMPLETED|Overall Study||17
10644283|NCT02122341|11803493|FG001|COMPLETED|Overall Study||18
10644284|NCT02122341|11803492|FG000|NOT COMPLETED|Overall Study||0
10644285|NCT02122341|11803493|FG001|NOT COMPLETED|Overall Study||0
10644286|NCT02122380|11803501|FG000|STARTED|First Intervention (30 Days)||11
10644287|NCT02122380|11803502|FG001|STARTED|First Intervention (30 Days)||12
10644288|NCT02122380|11803501|FG000|COMPLETED|First Intervention (30 Days)||10
10644289|NCT02122380|11803502|FG001|COMPLETED|First Intervention (30 Days)||11
10644290|NCT02122380|11803501|FG000|NOT COMPLETED|First Intervention (30 Days)||1
10644291|NCT02122380|11803502|FG001|NOT COMPLETED|First Intervention (30 Days)||1
10644292|NCT02122380|11803501|FG000|STARTED|Washout (8 Weeks)||10
10644293|NCT02122380|11803502|FG001|STARTED|Washout (8 Weeks)||11
10644294|NCT02122380|11803501|FG000|COMPLETED|Washout (8 Weeks)||9
10644295|NCT02122380|11803502|FG001|COMPLETED|Washout (8 Weeks)||9
10644296|NCT02122380|11803501|FG000|NOT COMPLETED|Washout (8 Weeks)||1
10644297|NCT02122380|11803502|FG001|NOT COMPLETED|Washout (8 Weeks)||2
10644298|NCT02122380|11803501|FG000|STARTED|Second Intervention (30 Days)||9
10644299|NCT02122380|11803502|FG001|STARTED|Second Intervention (30 Days)||9
10644300|NCT02122380|11803501|FG000|COMPLETED|Second Intervention (30 Days)||9
10644301|NCT02122380|11803502|FG001|COMPLETED|Second Intervention (30 Days)||7
10644302|NCT02122380|11803501|FG000|NOT COMPLETED|Second Intervention (30 Days)||0
10644303|NCT02122380|11803502|FG001|NOT COMPLETED|Second Intervention (30 Days)||2
10644304|NCT02122406|11803509|FG000|STARTED|Overall Study||200
10644305|NCT02122406|11803509|FG000|COMPLETED|Overall Study||200
10644306|NCT02122406|11803509|FG000|NOT COMPLETED|Overall Study||0
10644307|NCT02122445|11803513|FG000|STARTED|Overall Study||20
10644308|NCT02122445|11803513|FG000|COMPLETED|Overall Study||20
10644309|NCT02122445|11803513|FG000|NOT COMPLETED|Overall Study||0
10644310|NCT02122471|11803520|FG000|STARTED|Overall Study||445
10644311|NCT02122471|11803521|FG001|STARTED|Overall Study||443
10644312|NCT02122471|11803522|FG002|STARTED|Overall Study||449
10644313|NCT02122471|11803520|FG000|COMPLETED|Overall Study||406
10644314|NCT02122471|11803521|FG001|COMPLETED|Overall Study||392
10644315|NCT02122471|11803522|FG002|COMPLETED|Overall Study||405
10644316|NCT02122471|11803520|FG000|NOT COMPLETED|Overall Study||39
10644317|NCT02122471|11803521|FG001|NOT COMPLETED|Overall Study||51
10644318|NCT02122471|11803522|FG002|NOT COMPLETED|Overall Study||44
10644319|NCT02122549|11803531|FG000|STARTED|Overall Study||59
10644320|NCT02122549|11803531|FG000|COMPLETED|Overall Study||59
10644321|NCT02122549|11803531|FG000|NOT COMPLETED|Overall Study||0
10644322|NCT02122770|11803539|FG000|STARTED|Part A: Drug-drug Interaction 2||13
10644323|NCT02122770|11803540|FG001|STARTED|Part A: Drug-drug Interaction 2||13
10644324|NCT02122770|11803541|FG002|STARTED|Part A: Drug-drug Interaction 2||6
10644325|NCT02122770|11803542|FG003|STARTED|Part A: Drug-drug Interaction 2||19
10644326|NCT02122770|11803543|FG004|STARTED|Part A: Drug-drug Interaction 2||0
10644327|NCT02122770|11803544|FG005|STARTED|Part A: Drug-drug Interaction 2||0
10644328|NCT02122770|11803539|FG000|COMPLETED|Part A: Drug-drug Interaction 2||9
10644329|NCT02122770|11803540|FG001|COMPLETED|Part A: Drug-drug Interaction 2||7
10644330|NCT02122770|11803541|FG002|COMPLETED|Part A: Drug-drug Interaction 2||4
10644331|NCT02122770|11803542|FG003|COMPLETED|Part A: Drug-drug Interaction 2||16
10644332|NCT02122770|11803543|FG004|COMPLETED|Part A: Drug-drug Interaction 2||0
10644333|NCT02122770|11803544|FG005|COMPLETED|Part A: Drug-drug Interaction 2||0
10644334|NCT02122770|11803539|FG000|NOT COMPLETED|Part A: Drug-drug Interaction 2||4
10644335|NCT02122770|11803540|FG001|NOT COMPLETED|Part A: Drug-drug Interaction 2||6
10644336|NCT02122770|11803541|FG002|NOT COMPLETED|Part A: Drug-drug Interaction 2||2
10644337|NCT02122770|11803542|FG003|NOT COMPLETED|Part A: Drug-drug Interaction 2||3
10644338|NCT02122770|11803543|FG004|NOT COMPLETED|Part A: Drug-drug Interaction 2||0
10644339|NCT02122770|11803544|FG005|NOT COMPLETED|Part A: Drug-drug Interaction 2||0
10644340|NCT02122770|11803539|FG000|STARTED|Part B: Standard of Care||0
10644341|NCT02122770|11803540|FG001|STARTED|Part B: Standard of Care||0
10644342|NCT02122770|11803541|FG002|STARTED|Part B: Standard of Care||0
10644343|NCT02122770|11803542|FG003|STARTED|Part B: Standard of Care||0
10644344|NCT02122770|11803543|FG004|STARTED|Part B: Standard of Care||23
10644345|NCT02122770|11803544|FG005|STARTED|Part B: Standard of Care||13
10644346|NCT02122770|11803539|FG000|COMPLETED|Part B: Standard of Care||0
10644347|NCT02122770|11803540|FG001|COMPLETED|Part B: Standard of Care||0
10644348|NCT02122770|11803541|FG002|COMPLETED|Part B: Standard of Care||0
10644349|NCT02122770|11803542|FG003|COMPLETED|Part B: Standard of Care||0
10644350|NCT02122770|11803543|FG004|COMPLETED|Part B: Standard of Care||0
10644351|NCT02122770|11803544|FG005|COMPLETED|Part B: Standard of Care||0
10644352|NCT02122770|11803539|FG000|NOT COMPLETED|Part B: Standard of Care||0
10644353|NCT02122770|11803540|FG001|NOT COMPLETED|Part B: Standard of Care||0
10644354|NCT02122770|11803541|FG002|NOT COMPLETED|Part B: Standard of Care||0
10644355|NCT02122770|11803542|FG003|NOT COMPLETED|Part B: Standard of Care||0
10644356|NCT02122770|11803543|FG004|NOT COMPLETED|Part B: Standard of Care||23
10644357|NCT02122770|11803544|FG005|NOT COMPLETED|Part B: Standard of Care||13
10644358|NCT02122783|11803569|FG000|STARTED|Overall Study||2
10644359|NCT02122783|11803570|FG001|STARTED|Overall Study||3
10644360|NCT02122783|11803569|FG000|COMPLETED|Overall Study||2
10644361|NCT02122783|11803570|FG001|COMPLETED|Overall Study||2
10644362|NCT02122783|11803569|FG000|NOT COMPLETED|Overall Study||0
10644363|NCT02122783|11803570|FG001|NOT COMPLETED|Overall Study||1
10644364|NCT02122796|11803581|FG000|STARTED|Visit 1||15
10644365|NCT02122796|11803582|FG001|STARTED|Visit 1||15
10644366|NCT02122796|11803581|FG000|COMPLETED|Visit 1||15
10644367|NCT02122796|11803582|FG001|COMPLETED|Visit 1||15
10644368|NCT02122796|11803581|FG000|NOT COMPLETED|Visit 1||0
10644369|NCT02122796|11803582|FG001|NOT COMPLETED|Visit 1||0
10644370|NCT02122796|11803581|FG000|STARTED|Visit 2||15
10644371|NCT02122796|11803582|FG001|STARTED|Visit 2||15
10644372|NCT02122796|11803581|FG000|COMPLETED|Visit 2||12
10644373|NCT02122796|11803582|FG001|COMPLETED|Visit 2||14
10644374|NCT02122796|11803581|FG000|NOT COMPLETED|Visit 2||3
10644375|NCT02122796|11803582|FG001|NOT COMPLETED|Visit 2||1
10644376|NCT02122887|11803591|FG000|STARTED|Overall Study||60
10644377|NCT02122887|11803592|FG001|STARTED|Overall Study||41
10644378|NCT02122887|11803591|FG000|COMPLETED|Overall Study||40
10644379|NCT02122887|11803592|FG001|COMPLETED|Overall Study||39
10644380|NCT02122887|11803591|FG000|NOT COMPLETED|Overall Study||20
10644381|NCT02122887|11803592|FG001|NOT COMPLETED|Overall Study||2
10644388|NCT02123017|11803610|FG000|STARTED|Overall Study||8
10644389|NCT02123017|11803611|FG001|STARTED|Overall Study||12
10644390|NCT02123017|11803612|FG002|STARTED|Overall Study||12
10644391|NCT02123017|11803610|FG000|COMPLETED|Overall Study||8
10644392|NCT02123017|11803611|FG001|COMPLETED|Overall Study||12
10644393|NCT02123017|11803612|FG002|COMPLETED|Overall Study||12
10644394|NCT02123017|11803610|FG000|NOT COMPLETED|Overall Study||0
10644395|NCT02123017|11803611|FG001|NOT COMPLETED|Overall Study||0
10644396|NCT02123017|11803612|FG002|NOT COMPLETED|Overall Study||0
10644397|NCT02123134|11803622|FG000|STARTED|Overall Study||28
10644398|NCT02123134|11803623|FG001|STARTED|Overall Study||27
10644399|NCT02123134|11803622|FG000|COMPLETED|Overall Study||25
10644400|NCT02123134|11803623|FG001|COMPLETED|Overall Study||24
10644401|NCT02123134|11803622|FG000|NOT COMPLETED|Overall Study||3
10644402|NCT02123134|11803623|FG001|NOT COMPLETED|Overall Study||3
10644403|NCT02123251|11803631|FG000|STARTED|Overall Study||159
10644404|NCT02123251|11803632|FG001|STARTED|Overall Study||161
10644405|NCT02123251|11803631|FG000|COMPLETED|Overall Study||125
10644406|NCT02123251|11803632|FG001|COMPLETED|Overall Study||131
10644407|NCT02123251|11803631|FG000|NOT COMPLETED|Overall Study||34
10644408|NCT02123251|11803632|FG001|NOT COMPLETED|Overall Study||30
10644409|NCT02123329|11803641|FG000|STARTED|3 Month Outcome Measure||147
10644410|NCT02123329|11803642|FG001|STARTED|3 Month Outcome Measure||167
10644411|NCT02123329|11803641|FG000|COMPLETED|3 Month Outcome Measure||98
10644412|NCT02123329|11803642|FG001|COMPLETED|3 Month Outcome Measure||101
10644413|NCT02123329|11803641|FG000|NOT COMPLETED|3 Month Outcome Measure||49
10644414|NCT02123329|11803642|FG001|NOT COMPLETED|3 Month Outcome Measure||66
10644415|NCT02123329|11803641|FG000|STARTED|6 Month Outcome Measure||147
10644416|NCT02123329|11803642|FG001|STARTED|6 Month Outcome Measure||167
10644417|NCT02123329|11803641|FG000|COMPLETED|6 Month Outcome Measure||99
10644418|NCT02123329|11803642|FG001|COMPLETED|6 Month Outcome Measure||100
10644419|NCT02123329|11803641|FG000|NOT COMPLETED|6 Month Outcome Measure||48
10644420|NCT02123329|11803642|FG001|NOT COMPLETED|6 Month Outcome Measure||67
10644421|NCT02123329|11803641|FG000|STARTED|12 Month Outcome Measure||147
10644422|NCT02123329|11803642|FG001|STARTED|12 Month Outcome Measure||167
10644423|NCT02123329|11803641|FG000|COMPLETED|12 Month Outcome Measure||83
10644424|NCT02123329|11803642|FG001|COMPLETED|12 Month Outcome Measure||88
10644425|NCT02123329|11803641|FG000|NOT COMPLETED|12 Month Outcome Measure||64
10644426|NCT02123329|11803642|FG001|NOT COMPLETED|12 Month Outcome Measure||79
10644427|NCT02123446|11803648|FG000|STARTED|Period 1 (7 Days)||14
10644428|NCT02123446|11803649|FG001|STARTED|Period 1 (7 Days)||14
10644429|NCT02123446|11803648|FG000|COMPLETED|Period 1 (7 Days)||14
10644430|NCT02123446|11803649|FG001|COMPLETED|Period 1 (7 Days)||14
10644431|NCT02123446|11803648|FG000|NOT COMPLETED|Period 1 (7 Days)||0
10644432|NCT02123446|11803649|FG001|NOT COMPLETED|Period 1 (7 Days)||0
10644433|NCT02123446|11803648|FG000|STARTED|Washout Period (1 Day)||14
10644434|NCT02123446|11803649|FG001|STARTED|Washout Period (1 Day)||14
10644435|NCT02123446|11803648|FG000|COMPLETED|Washout Period (1 Day)||13
10644436|NCT02123446|11803649|FG001|COMPLETED|Washout Period (1 Day)||14
10644437|NCT02123446|11803648|FG000|NOT COMPLETED|Washout Period (1 Day)||1
10644438|NCT02123446|11803649|FG001|NOT COMPLETED|Washout Period (1 Day)||0
10644439|NCT02123446|11803648|FG000|STARTED|Period 2 (7 Days)||13
10644440|NCT02123446|11803649|FG001|STARTED|Period 2 (7 Days)||14
10644441|NCT02123446|11803648|FG000|COMPLETED|Period 2 (7 Days)||13
10644442|NCT02123446|11803649|FG001|COMPLETED|Period 2 (7 Days)||14
10644443|NCT02123446|11803648|FG000|NOT COMPLETED|Period 2 (7 Days)||0
10644444|NCT02123446|11803649|FG001|NOT COMPLETED|Period 2 (7 Days)||0
10644445|NCT02123459|11803655|FG000|STARTED|Period 1 (7 Days)||14
10644446|NCT02123459|11803656|FG001|STARTED|Period 1 (7 Days)||14
10644447|NCT02123459|11803655|FG000|COMPLETED|Period 1 (7 Days)||14
10644448|NCT02123459|11803656|FG001|COMPLETED|Period 1 (7 Days)||14
10644449|NCT02123459|11803655|FG000|NOT COMPLETED|Period 1 (7 Days)||0
10644450|NCT02123459|11803656|FG001|NOT COMPLETED|Period 1 (7 Days)||0
10644451|NCT02123459|11803655|FG000|STARTED|Washout Period (1 Day)||14
10644452|NCT02123459|11803656|FG001|STARTED|Washout Period (1 Day)||14
10644453|NCT02123459|11803655|FG000|COMPLETED|Washout Period (1 Day)||13
10644454|NCT02123459|11803656|FG001|COMPLETED|Washout Period (1 Day)||14
10644455|NCT02123459|11803655|FG000|NOT COMPLETED|Washout Period (1 Day)||1
10644456|NCT02123459|11803656|FG001|NOT COMPLETED|Washout Period (1 Day)||0
10644457|NCT02123459|11803655|FG000|STARTED|Period 2 (7 Days)||13
10644458|NCT02123459|11803656|FG001|STARTED|Period 2 (7 Days)||14
10644459|NCT02123459|11803655|FG000|COMPLETED|Period 2 (7 Days)||13
10644460|NCT02123459|11803656|FG001|COMPLETED|Period 2 (7 Days)||14
10644461|NCT02123459|11803655|FG000|NOT COMPLETED|Period 2 (7 Days)||0
10644462|NCT02123459|11803656|FG001|NOT COMPLETED|Period 2 (7 Days)||0
10644463|NCT02123472|11803662|FG000|STARTED|Period 1 (7 Days)||14
10644464|NCT02123472|11803663|FG001|STARTED|Period 1 (7 Days)||14
10644465|NCT02123472|11803662|FG000|COMPLETED|Period 1 (7 Days)||14
10644466|NCT02123472|11803663|FG001|COMPLETED|Period 1 (7 Days)||14
10644467|NCT02123472|11803662|FG000|NOT COMPLETED|Period 1 (7 Days)||0
10644468|NCT02123472|11803663|FG001|NOT COMPLETED|Period 1 (7 Days)||0
10644469|NCT02123472|11803662|FG000|STARTED|Washout Period (1 Day)||14
10644470|NCT02123472|11803663|FG001|STARTED|Washout Period (1 Day)||14
10644471|NCT02123472|11803662|FG000|COMPLETED|Washout Period (1 Day)||14
10644472|NCT02123472|11803663|FG001|COMPLETED|Washout Period (1 Day)||14
10644473|NCT02123472|11803662|FG000|NOT COMPLETED|Washout Period (1 Day)||0
10644474|NCT02123472|11803663|FG001|NOT COMPLETED|Washout Period (1 Day)||0
10644475|NCT02123472|11803662|FG000|STARTED|Period 2 (7 Days)||14
10644476|NCT02123472|11803663|FG001|STARTED|Period 2 (7 Days)||14
10644477|NCT02123472|11803662|FG000|COMPLETED|Period 2 (7 Days)||14
10644478|NCT02123472|11803663|FG001|COMPLETED|Period 2 (7 Days)||13
10644479|NCT02123472|11803662|FG000|NOT COMPLETED|Period 2 (7 Days)||0
10644480|NCT02123472|11803663|FG001|NOT COMPLETED|Period 2 (7 Days)||1
10644481|NCT02123485|11803671|FG000|STARTED|Overall Study||18
10644482|NCT02123485|11803672|FG001|STARTED|Overall Study||17
10644483|NCT02123485|11803671|FG000|COMPLETED|Overall Study||17
10644484|NCT02123485|11803672|FG001|COMPLETED|Overall Study||17
10644485|NCT02123485|11803671|FG000|NOT COMPLETED|Overall Study||1
10644486|NCT02123485|11803672|FG001|NOT COMPLETED|Overall Study||0
10644487|NCT02123511|11803680|FG000|STARTED|Overall Study||18
10644488|NCT02123511|11803681|FG001|STARTED|Overall Study||16
10644489|NCT02123511|11803680|FG000|Eligible Patients|Overall Study||17
10644490|NCT02123511|11803681|FG001|Eligible Patients|Overall Study||15
10644491|NCT02123511|11803680|FG000|COMPLETED|Overall Study||16
10644492|NCT02123511|11803681|FG001|COMPLETED|Overall Study||12
10644493|NCT02123511|11803680|FG000|NOT COMPLETED|Overall Study||2
10644494|NCT02123511|11803681|FG001|NOT COMPLETED|Overall Study||4
10644495|NCT02123576|11803689|FG000|STARTED|Overall Study||6
10644496|NCT02123576|11803690|FG001|STARTED|Overall Study||6
10644497|NCT02123576|11803689|FG000|COMPLETED|Overall Study||5
10644498|NCT02123576|11803690|FG001|COMPLETED|Overall Study||6
10644499|NCT02123576|11803689|FG000|NOT COMPLETED|Overall Study||1
10644500|NCT02123576|11803690|FG001|NOT COMPLETED|Overall Study||0
10644501|NCT02123745|11803696|FG000|STARTED|Overall Study||71
10644502|NCT02123745|11803696|FG000|COMPLETED|Overall Study||71
10644503|NCT02123745|11803696|FG000|NOT COMPLETED|Overall Study||0
10644504|NCT02123797|11803702|FG000|STARTED|Baseline Intervention||178
10644505|NCT02123797|11803703|FG001|STARTED|Baseline Intervention||348
10644506|NCT02123797|11803704|FG002|STARTED|Baseline Intervention||100
10644507|NCT02123797|11803705|FG003|STARTED|Baseline Intervention||144
10644508|NCT02123797|11803706|FG004|STARTED|Baseline Intervention||11
10644509|NCT02123797|11803702|FG000|COMPLETED|Baseline Intervention||156
10644510|NCT02123797|11803703|FG001|COMPLETED|Baseline Intervention||306
10644511|NCT02123797|11803704|FG002|COMPLETED|Baseline Intervention||100
10644512|NCT02123797|11803705|FG003|COMPLETED|Baseline Intervention||144
10644513|NCT02123797|11803706|FG004|COMPLETED|Baseline Intervention||11
10644514|NCT02123797|11803702|FG000|NOT COMPLETED|Baseline Intervention||22
10644515|NCT02123797|11803703|FG001|NOT COMPLETED|Baseline Intervention||42
10644516|NCT02123797|11803704|FG002|NOT COMPLETED|Baseline Intervention||0
10644517|NCT02123797|11803705|FG003|NOT COMPLETED|Baseline Intervention||0
10644518|NCT02123797|11803706|FG004|NOT COMPLETED|Baseline Intervention||0
10644519|NCT02123797|11803702|FG000|STARTED|3-month Follow up (Cumulative Counts)||156
10644520|NCT02123797|11803703|FG001|STARTED|3-month Follow up (Cumulative Counts)||306
10644521|NCT02123797|11803704|FG002|STARTED|3-month Follow up (Cumulative Counts)||100
10644522|NCT02123797|11803705|FG003|STARTED|3-month Follow up (Cumulative Counts)||144
10644523|NCT02123797|11803706|FG004|STARTED|3-month Follow up (Cumulative Counts)|Clinical providers received 6 month follow-up rather than 3 month follow-up at this stage.|11
10644524|NCT02123797|11803702|FG000|COMPLETED|3-month Follow up (Cumulative Counts)||99
10644525|NCT02123797|11803703|FG001|COMPLETED|3-month Follow up (Cumulative Counts)||189
10644526|NCT02123797|11803704|FG002|COMPLETED|3-month Follow up (Cumulative Counts)||50
10644527|NCT02123797|11803705|FG003|COMPLETED|3-month Follow up (Cumulative Counts)||62
10644528|NCT02123797|11803706|FG004|COMPLETED|3-month Follow up (Cumulative Counts)||8
10644529|NCT02123797|11803702|FG000|NOT COMPLETED|3-month Follow up (Cumulative Counts)||57
10644530|NCT02123797|11803703|FG001|NOT COMPLETED|3-month Follow up (Cumulative Counts)||117
10644531|NCT02123797|11803704|FG002|NOT COMPLETED|3-month Follow up (Cumulative Counts)||50
10644532|NCT02123797|11803705|FG003|NOT COMPLETED|3-month Follow up (Cumulative Counts)||82
10644533|NCT02123797|11803706|FG004|NOT COMPLETED|3-month Follow up (Cumulative Counts)||3
10644534|NCT02123797|11803702|FG000|STARTED|6-month Follow up (Cumulative Counts)||156
10644535|NCT02123797|11803703|FG001|STARTED|6-month Follow up (Cumulative Counts)||306
10644536|NCT02123797|11803704|FG002|STARTED|6-month Follow up (Cumulative Counts)||100
10644537|NCT02123797|11803705|FG003|STARTED|6-month Follow up (Cumulative Counts)||144
10644538|NCT02123797|11803706|FG004|STARTED|6-month Follow up (Cumulative Counts)|Clinical providers received 12 month follow-up rather than 6-month follow-up at this stage.|8
10644539|NCT02123797|11803702|FG000|COMPLETED|6-month Follow up (Cumulative Counts)||101
10644540|NCT02123797|11803703|FG001|COMPLETED|6-month Follow up (Cumulative Counts)||178
10644541|NCT02123797|11803704|FG002|COMPLETED|6-month Follow up (Cumulative Counts)||34
10644542|NCT02123797|11803705|FG003|COMPLETED|6-month Follow up (Cumulative Counts)||31
10644543|NCT02123797|11803706|FG004|COMPLETED|6-month Follow up (Cumulative Counts)||5
10644544|NCT02123797|11803702|FG000|NOT COMPLETED|6-month Follow up (Cumulative Counts)||55
10644545|NCT02123797|11803703|FG001|NOT COMPLETED|6-month Follow up (Cumulative Counts)||128
10644546|NCT02123797|11803704|FG002|NOT COMPLETED|6-month Follow up (Cumulative Counts)||66
10644547|NCT02123797|11803705|FG003|NOT COMPLETED|6-month Follow up (Cumulative Counts)||113
10644548|NCT02123797|11803706|FG004|NOT COMPLETED|6-month Follow up (Cumulative Counts)||3
10644549|NCT02123849|11803728|FG000|STARTED|Overall Study||27
10644550|NCT02123849|11803729|FG001|STARTED|Overall Study||27
10644551|NCT02123849|11803728|FG000|COMPLETED|Overall Study||23
10644552|NCT02123849|11803729|FG001|COMPLETED|Overall Study||18
10644553|NCT02123849|11803728|FG000|NOT COMPLETED|Overall Study||4
10644554|NCT02123849|11803729|FG001|NOT COMPLETED|Overall Study||9
10644555|NCT02123966|11803737|FG000|STARTED|Overall Study||10
10644556|NCT02123966|11803737|FG000|COMPLETED|Overall Study||9
10644557|NCT02123966|11803737|FG000|NOT COMPLETED|Overall Study||1
10644558|NCT02124018|11803744|FG000|STARTED|Overall Study||371
10644559|NCT02124018|11803745|FG001|STARTED|Overall Study||111
10644560|NCT02124018|11803746|FG002|STARTED|Overall Study||41
10644561|NCT02124018|11803744|FG000|COMPLETED|Overall Study||371
10644562|NCT02124018|11803745|FG001|COMPLETED|Overall Study||111
10644563|NCT02124018|11803746|FG002|COMPLETED|Overall Study|Numbers do not add up to 575 (enrolled) due to refusals of programmed ventricular stimulation|41
10644564|NCT02124018|11803744|FG000|NOT COMPLETED|Overall Study||0
10644565|NCT02124018|11803745|FG001|NOT COMPLETED|Overall Study||0
10644566|NCT02124018|11803746|FG002|NOT COMPLETED|Overall Study||0
10644567|NCT02124044|11803759|FG000|STARTED|Overall Study||20
10644568|NCT02124044|11803760|FG001|STARTED|Overall Study||10
10644569|NCT02124044|11803759|FG000|COMPLETED|Overall Study||20
10644570|NCT02124044|11803760|FG001|COMPLETED|Overall Study||9
10644571|NCT02124044|11803759|FG000|NOT COMPLETED|Overall Study||0
10644572|NCT02124044|11803760|FG001|NOT COMPLETED|Overall Study||1
10644573|NCT02124083|11803766|FG000|STARTED|Overall Study||12
10644574|NCT02124083|11803766|FG000|COMPLETED|Overall Study||11
10644575|NCT02124083|11803766|FG000|NOT COMPLETED|Overall Study||1
10644576|NCT02124122|11803772|FG000|STARTED|Overall Study||41
10644577|NCT02124122|11803773|FG001|STARTED|Overall Study||19
10644578|NCT02124122|11803772|FG000|COMPLETED|Overall Study||41
10644579|NCT02124122|11803773|FG001|COMPLETED|Overall Study||19
10644580|NCT02124122|11803772|FG000|NOT COMPLETED|Overall Study||0
10644581|NCT02124122|11803773|FG001|NOT COMPLETED|Overall Study||0
10644582|NCT02124161|11803781|FG000|STARTED|Overall Study||441
10644583|NCT02124161|11803782|FG001|STARTED|Overall Study||441
10644584|NCT02124161|11803781|FG000|Vaccination 1|Overall Study||439
10644585|NCT02124161|11803782|FG001|Vaccination 1|Overall Study||437
10644586|NCT02124161|11803781|FG000|Vaccination 2|Overall Study||431
10644587|NCT02124161|11803782|FG001|Vaccination 2|Overall Study||432
10644588|NCT02124161|11803781|FG000|COMPLETED|Overall Study||425
10644589|NCT02124161|11803782|FG001|COMPLETED|Overall Study||426
10644590|NCT02124161|11803781|FG000|NOT COMPLETED|Overall Study||16
10644591|NCT02124161|11803782|FG001|NOT COMPLETED|Overall Study||15
10644592|NCT02124265|11803795|FG000|STARTED|Overall Study||3
10644593|NCT02124265|11803795|FG000|COMPLETED|Overall Study||2
10644594|NCT02124265|11803795|FG000|NOT COMPLETED|Overall Study||1
10644595|NCT02124304|11803801|FG000|STARTED|Overall Study||15
10644596|NCT02124304|11803802|FG001|STARTED|Overall Study||15
10644597|NCT02124304|11803801|FG000|COMPLETED|Overall Study||15
10644598|NCT02124304|11803802|FG001|COMPLETED|Overall Study||15
10644599|NCT02124304|11803801|FG000|NOT COMPLETED|Overall Study||0
10644600|NCT02124304|11803802|FG001|NOT COMPLETED|Overall Study||0
10644601|NCT02124460|11803810|FG000|STARTED|Overall Study||361
10644602|NCT02124460|11803811|FG001|STARTED|Overall Study||360
10644603|NCT02124460|11803810|FG000|COMPLETED|Overall Study||328
10644604|NCT02124460|11803811|FG001|COMPLETED|Overall Study||336
10644605|NCT02124460|11803810|FG000|NOT COMPLETED|Overall Study||33
10644606|NCT02124460|11803811|FG001|NOT COMPLETED|Overall Study||24
10644607|NCT02124512|11803820|FG000|STARTED|Overall Study||6
10644608|NCT02124512|11803821|FG001|STARTED|Overall Study||6
10644609|NCT02124512|11803820|FG000|COMPLETED|Overall Study||6
10644610|NCT02124512|11803821|FG001|COMPLETED|Overall Study||6
10644611|NCT02124512|11803820|FG000|NOT COMPLETED|Overall Study||0
10644612|NCT02124512|11803821|FG001|NOT COMPLETED|Overall Study||0
10644613|NCT02124564|11803827|FG000|STARTED|Treatment Period||19
10644614|NCT02124564|11803827|FG000|Started Treatment Period|Treatment Period||19
10644615|NCT02124564|11803827|FG000|Started Titration Period|Treatment Period||19
10644616|NCT02124564|11803827|FG000|Started AED Withdrawal Period|Treatment Period||19
10644617|NCT02124564|11803827|FG000|Started Monotherapy Period|Treatment Period||17
10644618|NCT02124564|11803827|FG000|Started Evaluation Period|Treatment Period||17
10644619|NCT02124564|11803827|FG000|Started Follow-Up Period|Treatment Period||13
10644620|NCT02124564|11803827|FG000|COMPLETED|Treatment Period||12
10644621|NCT02124564|11803827|FG000|NOT COMPLETED|Treatment Period||7
10644622|NCT02124564|11803827|FG000|STARTED|Taper Period||2
10644623|NCT02124564|11803827|FG000|COMPLETED|Taper Period||2
10644624|NCT02124564|11803827|FG000|NOT COMPLETED|Taper Period||0
10644625|NCT02124603|11803832|FG000|STARTED|Overall Study||120
10644626|NCT02124603|11803832|FG000|COMPLETED|Overall Study||120
10644627|NCT02124603|11803832|FG000|NOT COMPLETED|Overall Study||0
10644628|NCT02124707|11803837|FG000|STARTED|Overall Study||14
10644629|NCT02124707|11803837|FG000|COMPLETED|Overall Study||7
10644630|NCT02124707|11803837|FG000|NOT COMPLETED|Overall Study||7
10644631|NCT02124746|11803845|FG000|STARTED|Overall Study||30
10644632|NCT02124746|11803846|FG001|STARTED|Overall Study||22
10644633|NCT02124746|11803847|FG002|STARTED|Overall Study||22
10644634|NCT02124746|11803845|FG000|COMPLETED|Overall Study||11
10644635|NCT02124746|11803846|FG001|COMPLETED|Overall Study||4
10706173|NCT02605954|11870680|FG001|NOT COMPLETED|Overall Study||4
10706174|NCT02606253|11870692|FG000|STARTED|Overall Study||20
10706175|NCT02606253|11870693|FG001|STARTED|Overall Study||20
10644636|NCT02124746|11803847|FG002|COMPLETED|Overall Study||0
10644637|NCT02124746|11803845|FG000|NOT COMPLETED|Overall Study||19
10644638|NCT02124746|11803846|FG001|NOT COMPLETED|Overall Study||18
10644639|NCT02124746|11803847|FG002|NOT COMPLETED|Overall Study||22
10644640|NCT02124759|11803858|FG000|STARTED|Overall Study||6
10644641|NCT02124759|11803859|FG001|STARTED|Overall Study||7
10644642|NCT02124759|11803860|FG002|STARTED|Overall Study||7
10644643|NCT02124759|11803858|FG000|Subjects Randomized to Intervention|Overall Study||4
10644644|NCT02124759|11803859|FG001|Subjects Randomized to Intervention|Overall Study||5
10644645|NCT02124759|11803860|FG002|Subjects Randomized to Intervention|Overall Study||4
10644646|NCT02124759|11803858|FG000|Low Fat Diet|Overall Study|2 subjects did not complete and were withdrawn|4
10644647|NCT02124759|11803859|FG001|Low Fat Diet|Overall Study||4
10644648|NCT02124759|11803860|FG002|Low Fat Diet|Overall Study||4
10706176|NCT02606253|11870694|FG002|STARTED|Overall Study||20
10706177|NCT02606253|11870692|FG000|COMPLETED|Overall Study||15
10706178|NCT02606253|11870693|FG001|COMPLETED|Overall Study||18
10706179|NCT02606253|11870694|FG002|COMPLETED|Overall Study||20
10706180|NCT02606253|11870692|FG000|NOT COMPLETED|Overall Study||5
10706181|NCT02606253|11870693|FG001|NOT COMPLETED|Overall Study||2
10706182|NCT02606253|11870694|FG002|NOT COMPLETED|Overall Study||0
10706183|NCT02606500|11870704|FG000|STARTED|Overall Study||35
10706184|NCT02606500|11870705|FG001|STARTED|Overall Study||35
10706185|NCT02606500|11870704|FG000|COMPLETED|Overall Study||35
10706186|NCT02606500|11870705|FG001|COMPLETED|Overall Study||35
10644649|NCT02124759|11803858|FG000|High Fat Diet|Overall Study|1 subject did not complete|2
10644650|NCT02124759|11803859|FG001|High Fat Diet|Overall Study|One subject withdrew (low fat diet had already been completed)|5
10644651|NCT02124759|11803860|FG002|High Fat Diet|Overall Study|One subject withdrew and did not complete the low fat diet|4
10644652|NCT02124759|11803858|FG000|COMPLETED|Overall Study||1
10644653|NCT02124759|11803859|FG001|COMPLETED|Overall Study||4
10644654|NCT02124759|11803860|FG002|COMPLETED|Overall Study||3
10644655|NCT02124759|11803858|FG000|NOT COMPLETED|Overall Study||5
10644656|NCT02124759|11803859|FG001|NOT COMPLETED|Overall Study||3
10644657|NCT02124759|11803860|FG002|NOT COMPLETED|Overall Study||4
10644658|NCT02124772|11803886|FG000|STARTED|Overall Study||3
10644659|NCT02124772|11803887|FG001|STARTED|Overall Study||19
10644660|NCT02124772|11803888|FG002|STARTED|Overall Study||12
10644661|NCT02124772|11803889|FG003|STARTED|Overall Study||16
10644662|NCT02124772|11803890|FG004|STARTED|Overall Study||11
10644663|NCT02124772|11803891|FG005|STARTED|Overall Study||10
10644664|NCT02124772|11803892|FG006|STARTED|Overall Study||10
10644665|NCT02124772|11803893|FG007|STARTED|Overall Study||10
10644666|NCT02124772|11803894|FG008|STARTED|Overall Study||3
10644667|NCT02124772|11803895|FG009|STARTED|Overall Study||9
10644668|NCT02124772|11803896|FG010|STARTED|Overall Study||6
10644669|NCT02124772|11803897|FG011|STARTED|Overall Study||20
10644670|NCT02124772|11803898|FG012|STARTED|Overall Study||10
10644671|NCT02124772|11803886|FG000|COMPLETED|Overall Study||0
10644672|NCT02124772|11803887|FG001|COMPLETED|Overall Study||5
10644673|NCT02124772|11803888|FG002|COMPLETED|Overall Study||6
10644674|NCT02124772|11803889|FG003|COMPLETED|Overall Study||3
10706187|NCT02606500|11870704|FG000|NOT COMPLETED|Overall Study||0
10706188|NCT02606500|11870705|FG001|NOT COMPLETED|Overall Study||0
10644675|NCT02124772|11803890|FG004|COMPLETED|Overall Study||2
10644676|NCT02124772|11803891|FG005|COMPLETED|Overall Study||2
10644677|NCT02124772|11803892|FG006|COMPLETED|Overall Study||2
10644678|NCT02124772|11803893|FG007|COMPLETED|Overall Study||1
10644679|NCT02124772|11803894|FG008|COMPLETED|Overall Study||2
10644680|NCT02124772|11803895|FG009|COMPLETED|Overall Study||2
10644681|NCT02124772|11803896|FG010|COMPLETED|Overall Study||4
10644682|NCT02124772|11803897|FG011|COMPLETED|Overall Study||14
10644683|NCT02124772|11803898|FG012|COMPLETED|Overall Study||8
10644684|NCT02124772|11803886|FG000|NOT COMPLETED|Overall Study||3
10644685|NCT02124772|11803887|FG001|NOT COMPLETED|Overall Study||14
10644686|NCT02124772|11803888|FG002|NOT COMPLETED|Overall Study||6
10644687|NCT02124772|11803889|FG003|NOT COMPLETED|Overall Study||13
10644688|NCT02124772|11803890|FG004|NOT COMPLETED|Overall Study||9
10644689|NCT02124772|11803891|FG005|NOT COMPLETED|Overall Study||8
10644690|NCT02124772|11803892|FG006|NOT COMPLETED|Overall Study||8
10644691|NCT02124772|11803893|FG007|NOT COMPLETED|Overall Study||9
10644692|NCT02124772|11803894|FG008|NOT COMPLETED|Overall Study||1
10644693|NCT02124772|11803895|FG009|NOT COMPLETED|Overall Study||7
10644694|NCT02124772|11803896|FG010|NOT COMPLETED|Overall Study||2
10644695|NCT02124772|11803897|FG011|NOT COMPLETED|Overall Study||6
10644696|NCT02124772|11803898|FG012|NOT COMPLETED|Overall Study||2
10644697|NCT02124798|11803950|FG000|STARTED|Overall Study||95
10644698|NCT02124798|11803950|FG000|COMPLETED|Overall Study||91
10644699|NCT02124798|11803950|FG000|NOT COMPLETED|Overall Study||4
10644700|NCT02124811|11803956|FG000|STARTED|Overall Study||5
10644701|NCT02124811|11803957|FG001|STARTED|Overall Study||5
10644702|NCT02124811|11803956|FG000|COMPLETED|Overall Study||2
10644703|NCT02124811|11803957|FG001|COMPLETED|Overall Study||3
10644704|NCT02124811|11803956|FG000|NOT COMPLETED|Overall Study||3
10644705|NCT02124811|11803957|FG001|NOT COMPLETED|Overall Study||2
10644706|NCT02124863|11803963|FG000|STARTED|Overall Study||67
10644707|NCT02124863|11803963|FG000|COMPLETED|Overall Study||50
10644708|NCT02124863|11803963|FG000|NOT COMPLETED|Overall Study||17
10644709|NCT02124889|11803971|FG000|STARTED|Overall Study||12
10644710|NCT02124889|11803972|FG001|STARTED|Overall Study||12
10644711|NCT02124889|11803971|FG000|COMPLETED|Overall Study||12
10644712|NCT02124889|11803972|FG001|COMPLETED|Overall Study||12
10644713|NCT02124889|11803971|FG000|NOT COMPLETED|Overall Study||0
10644714|NCT02124889|11803972|FG001|NOT COMPLETED|Overall Study||0
10644715|NCT02125279|11803978|FG000|STARTED|Overall Study||54
10644716|NCT02125279|11803978|FG000|COMPLETED|Overall Study||41
10644717|NCT02125279|11803978|FG000|NOT COMPLETED|Overall Study||13
10644718|NCT02125292|11803984|FG000|STARTED|First Intervention (1 Hour)||3
10644719|NCT02125292|11803985|FG001|STARTED|First Intervention (1 Hour)||3
10644720|NCT02125292|11803986|FG002|STARTED|First Intervention (1 Hour)||3
10644721|NCT02125292|11803987|FG003|STARTED|First Intervention (1 Hour)||3
10644722|NCT02125292|11803988|FG004|STARTED|First Intervention (1 Hour)||3
10644723|NCT02125292|11803989|FG005|STARTED|First Intervention (1 Hour)||3
10644724|NCT02125292|11803984|FG000|COMPLETED|First Intervention (1 Hour)||3
10644725|NCT02125292|11803985|FG001|COMPLETED|First Intervention (1 Hour)||3
10644726|NCT02125292|11803986|FG002|COMPLETED|First Intervention (1 Hour)||3
10644727|NCT02125292|11803987|FG003|COMPLETED|First Intervention (1 Hour)||3
10644728|NCT02125292|11803988|FG004|COMPLETED|First Intervention (1 Hour)||3
10644729|NCT02125292|11803989|FG005|COMPLETED|First Intervention (1 Hour)||3
10644730|NCT02125292|11803984|FG000|NOT COMPLETED|First Intervention (1 Hour)||0
10644731|NCT02125292|11803985|FG001|NOT COMPLETED|First Intervention (1 Hour)||0
10644732|NCT02125292|11803986|FG002|NOT COMPLETED|First Intervention (1 Hour)||0
10644733|NCT02125292|11803987|FG003|NOT COMPLETED|First Intervention (1 Hour)||0
10644734|NCT02125292|11803988|FG004|NOT COMPLETED|First Intervention (1 Hour)||0
10644735|NCT02125292|11803989|FG005|NOT COMPLETED|First Intervention (1 Hour)||0
10644736|NCT02125292|11803984|FG000|STARTED|Washout (2 Hours)||3
10644737|NCT02125292|11803985|FG001|STARTED|Washout (2 Hours)||3
10644738|NCT02125292|11803986|FG002|STARTED|Washout (2 Hours)||3
10644739|NCT02125292|11803987|FG003|STARTED|Washout (2 Hours)||3
10644740|NCT02125292|11803988|FG004|STARTED|Washout (2 Hours)||3
10644741|NCT02125292|11803989|FG005|STARTED|Washout (2 Hours)||3
10644742|NCT02125292|11803984|FG000|COMPLETED|Washout (2 Hours)||3
10644743|NCT02125292|11803985|FG001|COMPLETED|Washout (2 Hours)||3
10644744|NCT02125292|11803986|FG002|COMPLETED|Washout (2 Hours)||3
10644745|NCT02125292|11803987|FG003|COMPLETED|Washout (2 Hours)||3
10644746|NCT02125292|11803988|FG004|COMPLETED|Washout (2 Hours)||3
10644747|NCT02125292|11803989|FG005|COMPLETED|Washout (2 Hours)||3
10644748|NCT02125292|11803984|FG000|NOT COMPLETED|Washout (2 Hours)||0
10644749|NCT02125292|11803985|FG001|NOT COMPLETED|Washout (2 Hours)||0
10644750|NCT02125292|11803986|FG002|NOT COMPLETED|Washout (2 Hours)||0
10644751|NCT02125292|11803987|FG003|NOT COMPLETED|Washout (2 Hours)||0
10644752|NCT02125292|11803988|FG004|NOT COMPLETED|Washout (2 Hours)||0
10644753|NCT02125292|11803989|FG005|NOT COMPLETED|Washout (2 Hours)||0
10644754|NCT02125292|11803984|FG000|STARTED|Second Intervention (1 Hour)||3
10644755|NCT02125292|11803985|FG001|STARTED|Second Intervention (1 Hour)||3
10644756|NCT02125292|11803986|FG002|STARTED|Second Intervention (1 Hour)||3
10644757|NCT02125292|11803987|FG003|STARTED|Second Intervention (1 Hour)||3
10644758|NCT02125292|11803988|FG004|STARTED|Second Intervention (1 Hour)||3
10644759|NCT02125292|11803989|FG005|STARTED|Second Intervention (1 Hour)||3
10644760|NCT02125292|11803984|FG000|COMPLETED|Second Intervention (1 Hour)||3
10644761|NCT02125292|11803985|FG001|COMPLETED|Second Intervention (1 Hour)||3
10644762|NCT02125292|11803986|FG002|COMPLETED|Second Intervention (1 Hour)||3
10644763|NCT02125292|11803987|FG003|COMPLETED|Second Intervention (1 Hour)||3
10644764|NCT02125292|11803988|FG004|COMPLETED|Second Intervention (1 Hour)||3
10644765|NCT02125292|11803989|FG005|COMPLETED|Second Intervention (1 Hour)||3
10644766|NCT02125292|11803984|FG000|NOT COMPLETED|Second Intervention (1 Hour)||0
10644767|NCT02125292|11803985|FG001|NOT COMPLETED|Second Intervention (1 Hour)||0
10644768|NCT02125292|11803986|FG002|NOT COMPLETED|Second Intervention (1 Hour)||0
10644769|NCT02125292|11803987|FG003|NOT COMPLETED|Second Intervention (1 Hour)||0
10644770|NCT02125292|11803988|FG004|NOT COMPLETED|Second Intervention (1 Hour)||0
10654307|NCT02201784|11815017|FG001|NOT COMPLETED|Overall Study||0
10644771|NCT02125292|11803989|FG005|NOT COMPLETED|Second Intervention (1 Hour)||0
10644772|NCT02125292|11803984|FG000|STARTED|Washout (2 Hours)||3
10644773|NCT02125292|11803985|FG001|STARTED|Washout (2 Hours)||3
10706189|NCT02606604|11870713|FG000|STARTED|Overall Study||8
10706190|NCT02606604|11870714|FG001|STARTED|Overall Study||7
10644774|NCT02125292|11803986|FG002|STARTED|Washout (2 Hours)||3
10644775|NCT02125292|11803987|FG003|STARTED|Washout (2 Hours)||3
10644776|NCT02125292|11803988|FG004|STARTED|Washout (2 Hours)||3
10644777|NCT02125292|11803989|FG005|STARTED|Washout (2 Hours)||3
10644778|NCT02125292|11803984|FG000|COMPLETED|Washout (2 Hours)||3
10644779|NCT02125292|11803985|FG001|COMPLETED|Washout (2 Hours)||3
10644780|NCT02125292|11803986|FG002|COMPLETED|Washout (2 Hours)||3
10644781|NCT02125292|11803987|FG003|COMPLETED|Washout (2 Hours)||3
10644782|NCT02125292|11803988|FG004|COMPLETED|Washout (2 Hours)||3
10644783|NCT02125292|11803989|FG005|COMPLETED|Washout (2 Hours)||3
10644784|NCT02125292|11803984|FG000|NOT COMPLETED|Washout (2 Hours)||0
10644785|NCT02125292|11803985|FG001|NOT COMPLETED|Washout (2 Hours)||0
10644786|NCT02125292|11803986|FG002|NOT COMPLETED|Washout (2 Hours)||0
10644787|NCT02125292|11803987|FG003|NOT COMPLETED|Washout (2 Hours)||0
10644788|NCT02125292|11803988|FG004|NOT COMPLETED|Washout (2 Hours)||0
10644789|NCT02125292|11803989|FG005|NOT COMPLETED|Washout (2 Hours)||0
10644790|NCT02125292|11803984|FG000|STARTED|Third Intervention (1 Hour)||3
10644791|NCT02125292|11803985|FG001|STARTED|Third Intervention (1 Hour)||3
10644792|NCT02125292|11803986|FG002|STARTED|Third Intervention (1 Hour)||3
10644793|NCT02125292|11803987|FG003|STARTED|Third Intervention (1 Hour)||3
10644794|NCT02125292|11803988|FG004|STARTED|Third Intervention (1 Hour)||3
10644795|NCT02125292|11803989|FG005|STARTED|Third Intervention (1 Hour)||3
10644796|NCT02125292|11803984|FG000|COMPLETED|Third Intervention (1 Hour)||3
10706191|NCT02606604|11870713|FG000|COMPLETED|Overall Study||7
10644797|NCT02125292|11803985|FG001|COMPLETED|Third Intervention (1 Hour)||3
10644798|NCT02125292|11803986|FG002|COMPLETED|Third Intervention (1 Hour)||3
10644799|NCT02125292|11803987|FG003|COMPLETED|Third Intervention (1 Hour)||3
10644800|NCT02125292|11803988|FG004|COMPLETED|Third Intervention (1 Hour)||3
10706192|NCT02606604|11870714|FG001|COMPLETED|Overall Study||7
10706193|NCT02606604|11870713|FG000|NOT COMPLETED|Overall Study||1
10644801|NCT02125292|11803989|FG005|COMPLETED|Third Intervention (1 Hour)||3
10644802|NCT02125292|11803984|FG000|NOT COMPLETED|Third Intervention (1 Hour)||0
10644803|NCT02125292|11803985|FG001|NOT COMPLETED|Third Intervention (1 Hour)||0
10644804|NCT02125292|11803986|FG002|NOT COMPLETED|Third Intervention (1 Hour)||0
10644805|NCT02125292|11803987|FG003|NOT COMPLETED|Third Intervention (1 Hour)||0
10644806|NCT02125292|11803988|FG004|NOT COMPLETED|Third Intervention (1 Hour)||0
10644807|NCT02125292|11803989|FG005|NOT COMPLETED|Third Intervention (1 Hour)||0
10644808|NCT02125331|11804000|FG000|STARTED|Overall Study||58
10644809|NCT02125331|11804001|FG001|STARTED|Overall Study||25
10644810|NCT02125331|11804000|FG000|COMPLETED|Overall Study||53
10644811|NCT02125331|11804001|FG001|COMPLETED|Overall Study||25
10644812|NCT02125331|11804000|FG000|NOT COMPLETED|Overall Study||5
10644813|NCT02125331|11804001|FG001|NOT COMPLETED|Overall Study||0
10644814|NCT02125604|11804007|FG000|STARTED|Overall Study|enrolled and received at least 1 dose of study drug|211
10644815|NCT02125604|11804007|FG000|COMPLETED|Overall Study||180
10809203|NCT03832738|11971082|FG002|NOT COMPLETED|Overall Study||19
10809204|NCT03823391|11971092|FG000|STARTED|Period 1: Week 1 to Week 12||17
10809205|NCT03823391|11971093|FG001|STARTED|Period 1: Week 1 to Week 12||31
10644816|NCT02125604|11804007|FG000|NOT COMPLETED|Overall Study||31
10644817|NCT02125721|11804011|FG000|STARTED|Overall Study||10
10644818|NCT02125721|11804011|FG000|COMPLETED|Overall Study||10
10644819|NCT02125721|11804011|FG000|NOT COMPLETED|Overall Study||0
10644820|NCT02125734|11804017|FG000|STARTED|Period 1||40
10644821|NCT02125734|11804018|FG001|STARTED|Period 1||48
10644822|NCT02125734|11804017|FG000|COMPLETED|Period 1||40
10644823|NCT02125734|11804018|FG001|COMPLETED|Period 1||48
10644824|NCT02125734|11804017|FG000|NOT COMPLETED|Period 1||0
10644825|NCT02125734|11804018|FG001|NOT COMPLETED|Period 1||0
10644826|NCT02125734|11804017|FG000|STARTED|Period 2||40
10644827|NCT02125734|11804018|FG001|STARTED|Period 2||48
10644828|NCT02125734|11804017|FG000|COMPLETED|Period 2||40
10644829|NCT02125734|11804018|FG001|COMPLETED|Period 2||47
10644830|NCT02125734|11804017|FG000|NOT COMPLETED|Period 2||0
10644831|NCT02125734|11804018|FG001|NOT COMPLETED|Period 2||1
10644832|NCT02125838|11804026|FG000|STARTED|Overall Study|Lost to follow-up (n= 4 ) Turned to laparotomy (Adhesions)(n= 2) NBA used (n= 2)|54
10644833|NCT02125838|11804027|FG001|STARTED|Overall Study|Lost to follow-up (n= 4 ) Turned to laparotomy (Adhesions) (n= 2) NBA used (n= 2)|54
10644834|NCT02125838|11804026|FG000|COMPLETED|Overall Study|Analysed (n=50 )|50
10644835|NCT02125838|11804027|FG001|COMPLETED|Overall Study|Analysed (n=50 )|50
10644836|NCT02125838|11804026|FG000|NOT COMPLETED|Overall Study||4
10809206|NCT03823391|11971092|FG000|COMPLETED|Period 1: Week 1 to Week 12||17
10809207|NCT03823391|11971093|FG001|COMPLETED|Period 1: Week 1 to Week 12||31
10809208|NCT03823391|11971092|FG000|NOT COMPLETED|Period 1: Week 1 to Week 12||0
10809209|NCT03823391|11971093|FG001|NOT COMPLETED|Period 1: Week 1 to Week 12||0
10809210|NCT03823391|11971092|FG000|STARTED|Period 2: Weeks 12 to Week 24||17
10809211|NCT03823391|11971093|FG001|STARTED|Period 2: Weeks 12 to Week 24||31
10809212|NCT03823391|11971092|FG000|COMPLETED|Period 2: Weeks 12 to Week 24||15
10809213|NCT03823391|11971093|FG001|COMPLETED|Period 2: Weeks 12 to Week 24||30
10809214|NCT03823391|11971092|FG000|NOT COMPLETED|Period 2: Weeks 12 to Week 24||2
10809215|NCT03823391|11971093|FG001|NOT COMPLETED|Period 2: Weeks 12 to Week 24||1
10644837|NCT02125838|11804027|FG001|NOT COMPLETED|Overall Study||4
10644838|NCT02125877|11804035|FG000|STARTED|Overall Study||86
10644839|NCT02125877|11804036|FG001|STARTED|Overall Study||87
10644840|NCT02125877|11804035|FG000|Pharmacokinetic Analysis Set|Overall Study||83
10644841|NCT02125877|11804036|FG001|Pharmacokinetic Analysis Set|Overall Study||83
10644842|NCT02125877|11804035|FG000|Pharmacokinetic Subset A|Overall Study||16
10644843|NCT02125877|11804036|FG001|Pharmacokinetic Subset A|Overall Study||15
10644844|NCT02125877|11804035|FG000|Safety Set|Overall Study||86
10644845|NCT02125877|11804036|FG001|Safety Set|Overall Study||87
10644846|NCT02125877|11804035|FG000|COMPLETED|Overall Study||73
10644847|NCT02125877|11804036|FG001|COMPLETED|Overall Study||77
10644848|NCT02125877|11804035|FG000|NOT COMPLETED|Overall Study||13
10644849|NCT02125877|11804036|FG001|NOT COMPLETED|Overall Study||10
10644850|NCT02126306|11804044|FG000|STARTED|Overall Study||10
10644851|NCT02126306|11804045|FG001|STARTED|Overall Study||13
10644852|NCT02126306|11804044|FG000|COMPLETED|Overall Study||10
10644853|NCT02126306|11804045|FG001|COMPLETED|Overall Study||13
10644854|NCT02126306|11804044|FG000|NOT COMPLETED|Overall Study||0
10644855|NCT02126306|11804045|FG001|NOT COMPLETED|Overall Study||0
10644856|NCT02126319|11804053|FG000|STARTED|Overall Study||61
10644857|NCT02126319|11804054|FG001|STARTED|Overall Study||67
10644858|NCT02126319|11804053|FG000|COMPLETED|Overall Study||40
10644859|NCT02126319|11804054|FG001|COMPLETED|Overall Study||43
10644860|NCT02126319|11804053|FG000|NOT COMPLETED|Overall Study||21
10644861|NCT02126319|11804054|FG001|NOT COMPLETED|Overall Study||24
10644862|NCT02126670|11804066|FG000|STARTED|Overall Study||26
10644863|NCT02126670|11804067|FG001|STARTED|Overall Study||24
10644864|NCT02126670|11804068|FG002|STARTED|Overall Study||25
10644865|NCT02126670|11804069|FG003|STARTED|Overall Study||25
10644866|NCT02126670|11804066|FG000|COMPLETED|Overall Study||25
10644867|NCT02126670|11804067|FG001|COMPLETED|Overall Study||24
10644868|NCT02126670|11804068|FG002|COMPLETED|Overall Study||25
10644869|NCT02126670|11804069|FG003|COMPLETED|Overall Study||24
10644870|NCT02126670|11804066|FG000|NOT COMPLETED|Overall Study||1
10644871|NCT02126670|11804067|FG001|NOT COMPLETED|Overall Study||0
10644872|NCT02126670|11804068|FG002|NOT COMPLETED|Overall Study||0
10644873|NCT02126670|11804069|FG003|NOT COMPLETED|Overall Study||1
10644874|NCT02126748|11804082|FG000|STARTED|Overall Study||33
10644875|NCT02126748|11804083|FG001|STARTED|Overall Study||34
10644876|NCT02126748|11804084|FG002|STARTED|Overall Study||36
10644877|NCT02126748|11804082|FG000|COMPLETED|Overall Study||31
10644878|NCT02126748|11804083|FG001|COMPLETED|Overall Study||31
10644879|NCT02126748|11804084|FG002|COMPLETED|Overall Study||31
10644880|NCT02126748|11804082|FG000|NOT COMPLETED|Overall Study||2
10644881|NCT02126748|11804083|FG001|NOT COMPLETED|Overall Study||3
10644882|NCT02126748|11804084|FG002|NOT COMPLETED|Overall Study||5
10644883|NCT02126826|11804099|FG000|STARTED|Overall Study||9
10644884|NCT02126826|11804100|FG001|STARTED|Overall Study||9
10644885|NCT02126826|11804101|FG002|STARTED|Overall Study||9
10644886|NCT02126826|11804102|FG003|STARTED|Overall Study||9
10644887|NCT02126826|11804103|FG004|STARTED|Overall Study||5
10644888|NCT02126826|11804104|FG005|STARTED|Overall Study||9
10644889|NCT02126826|11804105|FG006|STARTED|Overall Study||8
10644890|NCT02126826|11804099|FG000|COMPLETED|Overall Study||9
10644891|NCT02126826|11804100|FG001|COMPLETED|Overall Study||9
10644892|NCT02126826|11804101|FG002|COMPLETED|Overall Study||9
10644893|NCT02126826|11804102|FG003|COMPLETED|Overall Study||8
10644894|NCT02126826|11804103|FG004|COMPLETED|Overall Study||5
10644895|NCT02126826|11804104|FG005|COMPLETED|Overall Study||9
10644896|NCT02126826|11804105|FG006|COMPLETED|Overall Study||8
10644897|NCT02126826|11804099|FG000|NOT COMPLETED|Overall Study||0
10644898|NCT02126826|11804100|FG001|NOT COMPLETED|Overall Study||0
10644899|NCT02126826|11804101|FG002|NOT COMPLETED|Overall Study||0
10644900|NCT02126826|11804102|FG003|NOT COMPLETED|Overall Study||1
10644901|NCT02126826|11804103|FG004|NOT COMPLETED|Overall Study||0
10644902|NCT02126826|11804104|FG005|NOT COMPLETED|Overall Study||0
10644903|NCT02126826|11804105|FG006|NOT COMPLETED|Overall Study||0
10644904|NCT02126839|11804128|FG000|STARTED|Overall Study||92
10644905|NCT02126839|11804129|FG001|STARTED|Overall Study||94
10644906|NCT02126839|11804128|FG000|Safety Population|Overall Study||92
10644907|NCT02126839|11804129|FG001|Safety Population|Overall Study||93
10644908|NCT02126839|11804128|FG000|Full Analysis Set|Overall Study||92
10644909|NCT02126839|11804129|FG001|Full Analysis Set|Overall Study||92
10644910|NCT02126839|11804128|FG000|COMPLETED|Overall Study||82
10644911|NCT02126839|11804129|FG001|COMPLETED|Overall Study||80
10644912|NCT02126839|11804128|FG000|NOT COMPLETED|Overall Study||10
10644913|NCT02126839|11804129|FG001|NOT COMPLETED|Overall Study||14
10644920|NCT02127125|11804153|FG000|STARTED|Overall Study||6
10644921|NCT02127125|11804154|FG001|STARTED|Overall Study||8
10644922|NCT02127125|11804155|FG002|STARTED|Overall Study||9
10644923|NCT02127125|11804156|FG003|STARTED|Overall Study||11
10644924|NCT02127125|11804157|FG004|STARTED|Overall Study||12
10644925|NCT02127125|11804158|FG005|STARTED|Overall Study||12
10644926|NCT02127125|11804159|FG006|STARTED|Overall Study||2
10644927|NCT02127125|11804160|FG007|STARTED|Overall Study||0
10644928|NCT02127125|11804161|FG008|STARTED|Overall Study||1
10644929|NCT02127125|11804153|FG000|COMPLETED|Overall Study||6
10644930|NCT02127125|11804154|FG001|COMPLETED|Overall Study||8
10644931|NCT02127125|11804155|FG002|COMPLETED|Overall Study||8
10644932|NCT02127125|11804156|FG003|COMPLETED|Overall Study||10
10644933|NCT02127125|11804157|FG004|COMPLETED|Overall Study||9
10644934|NCT02127125|11804158|FG005|COMPLETED|Overall Study||9
10644935|NCT02127125|11804159|FG006|COMPLETED|Overall Study||2
10644936|NCT02127125|11804160|FG007|COMPLETED|Overall Study||0
10644937|NCT02127125|11804161|FG008|COMPLETED|Overall Study||1
10644938|NCT02127125|11804153|FG000|NOT COMPLETED|Overall Study||0
10644939|NCT02127125|11804154|FG001|NOT COMPLETED|Overall Study||0
10644940|NCT02127125|11804155|FG002|NOT COMPLETED|Overall Study||1
10644941|NCT02127125|11804156|FG003|NOT COMPLETED|Overall Study||1
10644942|NCT02127125|11804157|FG004|NOT COMPLETED|Overall Study||3
10644943|NCT02127125|11804158|FG005|NOT COMPLETED|Overall Study||3
10644944|NCT02127125|11804159|FG006|NOT COMPLETED|Overall Study||0
10644945|NCT02127125|11804160|FG007|NOT COMPLETED|Overall Study||0
10644946|NCT02127125|11804161|FG008|NOT COMPLETED|Overall Study||0
10644947|NCT02127281|11804183|FG000|STARTED|Overall Study||80
10644948|NCT02127281|11804184|FG001|STARTED|Overall Study||80
10644949|NCT02127281|11804183|FG000|COMPLETED|Overall Study||79
10644950|NCT02127281|11804184|FG001|COMPLETED|Overall Study||80
10644951|NCT02127281|11804183|FG000|NOT COMPLETED|Overall Study||1
10644952|NCT02127281|11804184|FG001|NOT COMPLETED|Overall Study||0
10644953|NCT02127307|11804190|FG000|STARTED|Overall Study||964
10644954|NCT02127307|11804190|FG000|COMPLETED|Overall Study||656
10644955|NCT02127307|11804190|FG000|NOT COMPLETED|Overall Study||308
10644956|NCT02127372|11804196|FG000|STARTED|Overall Study|Signed Consent|15
10644957|NCT02127372|11804197|FG001|STARTED|Overall Study|Signed Consent|28
10644958|NCT02127372|11804196|FG000|Started Study Treatment|Overall Study||15
10644959|NCT02127372|11804197|FG001|Started Study Treatment|Overall Study||28
10644960|NCT02127372|11804196|FG000|COMPLETED|Overall Study|Completed at least one cycle and were available for dose limiting toxicity (DLT) evaluation.|14
10644961|NCT02127372|11804197|FG001|COMPLETED|Overall Study||28
10644962|NCT02127372|11804196|FG000|NOT COMPLETED|Overall Study||1
10644963|NCT02127372|11804197|FG001|NOT COMPLETED|Overall Study||0
10644964|NCT02127567|11804204|FG000|STARTED|Overall Study|41 participants completed 123 domains, 3 domains were completed with the tool per participant|41
10644965|NCT02127567|11804204|FG000|COMPLETED|Overall Study||41
10644966|NCT02127567|11804204|FG000|NOT COMPLETED|Overall Study||0
10644967|NCT02127632|11804214|FG000|STARTED|Overall Study||50
10644968|NCT02127632|11804215|FG001|STARTED|Overall Study||50
10644969|NCT02127632|11804214|FG000|COMPLETED|Overall Study||50
10644970|NCT02127632|11804215|FG001|COMPLETED|Overall Study||50
10644971|NCT02127632|11804214|FG000|NOT COMPLETED|Overall Study||0
10644972|NCT02127632|11804215|FG001|NOT COMPLETED|Overall Study||0
10644973|NCT02127710|11804224|FG000|STARTED|Overall Study||46
10644974|NCT02127710|11804225|FG001|STARTED|Overall Study||47
10644975|NCT02127710|11804226|FG002|STARTED|Overall Study||16
10644976|NCT02127710|11804224|FG000|COMPLETED|Overall Study||46
10644977|NCT02127710|11804225|FG001|COMPLETED|Overall Study||47
10644978|NCT02127710|11804226|FG002|COMPLETED|Overall Study||16
10644979|NCT02127710|11804224|FG000|NOT COMPLETED|Overall Study||0
10644980|NCT02127710|11804225|FG001|NOT COMPLETED|Overall Study||0
10644981|NCT02127710|11804226|FG002|NOT COMPLETED|Overall Study||0
10644985|NCT02127892|11804245|FG000|STARTED|Overall Study||7
10644986|NCT02127892|11804246|FG001|STARTED|Overall Study||2
10644987|NCT02127892|11804247|FG002|STARTED|Overall Study||0
10644988|NCT02127892|11804248|FG003|STARTED|Overall Study||0
10644989|NCT02127892|11804245|FG000|COMPLETED|Overall Study||6
10644990|NCT02127892|11804246|FG001|COMPLETED|Overall Study||1
10644991|NCT02127892|11804247|FG002|COMPLETED|Overall Study||0
10644992|NCT02127892|11804248|FG003|COMPLETED|Overall Study||0
10644993|NCT02127892|11804245|FG000|NOT COMPLETED|Overall Study||1
10644994|NCT02127892|11804246|FG001|NOT COMPLETED|Overall Study||1
10644995|NCT02127892|11804247|FG002|NOT COMPLETED|Overall Study||0
10644996|NCT02127892|11804248|FG003|NOT COMPLETED|Overall Study||0
10654308|NCT02201901|11815026|FG000|STARTED|Overall Study||90
10654309|NCT02201901|11815027|FG001|STARTED|Overall Study||88
10654310|NCT02201901|11815028|FG002|STARTED|Overall Study||90
10654311|NCT02201901|11815026|FG000|COMPLETED|Overall Study||75
10654312|NCT02201901|11815027|FG001|COMPLETED|Overall Study||79
10654313|NCT02201901|11815028|FG002|COMPLETED|Overall Study||77
10654314|NCT02201901|11815026|FG000|NOT COMPLETED|Overall Study||15
10654315|NCT02201901|11815027|FG001|NOT COMPLETED|Overall Study||9
10654316|NCT02201901|11815028|FG002|NOT COMPLETED|Overall Study||13
10654317|NCT02201940|11815039|FG000|STARTED|Overall Study||625
10654318|NCT02201940|11815040|FG001|STARTED|Overall Study||116
10706194|NCT02606604|11870714|FG001|NOT COMPLETED|Overall Study||0
10706195|NCT02606643|11870724|FG000|STARTED|Overall Study||68
10706196|NCT02606643|11870725|FG001|STARTED|Overall Study||76
10654319|NCT02201940|11815039|FG000|COMPLETED|Overall Study||613
10654320|NCT02201940|11815040|FG001|COMPLETED|Overall Study||0
10654321|NCT02201940|11815039|FG000|NOT COMPLETED|Overall Study||12
10654322|NCT02201940|11815040|FG001|NOT COMPLETED|Overall Study||116
10654323|NCT02201953|11815048|FG000|STARTED|Overall Study||278
10654324|NCT02201953|11815049|FG001|STARTED|Overall Study||280
10654325|NCT02201953|11815048|FG000|COMPLETED|Overall Study||258
10654326|NCT02201953|11815049|FG001|COMPLETED|Overall Study||224
10654327|NCT02201953|11815048|FG000|NOT COMPLETED|Overall Study||20
10654328|NCT02201953|11815049|FG001|NOT COMPLETED|Overall Study||56
10654329|NCT02202031|11815057|FG000|STARTED|Overall Study||82
10654330|NCT02202031|11815058|FG001|STARTED|Overall Study||79
10654331|NCT02202031|11815057|FG000|COMPLETED|Overall Study||77
10654332|NCT02202031|11815058|FG001|COMPLETED|Overall Study||74
10654333|NCT02202031|11815057|FG000|NOT COMPLETED|Overall Study||5
10654334|NCT02202031|11815058|FG001|NOT COMPLETED|Overall Study||5
10654335|NCT02202109|11815066|FG000|STARTED|Overall Study||302
10654336|NCT02202109|11815067|FG001|STARTED|Overall Study||300
10654337|NCT02202109|11815066|FG000|COMPLETED|Overall Study||212
10654338|NCT02202109|11815067|FG001|COMPLETED|Overall Study||213
10654339|NCT02202109|11815066|FG000|NOT COMPLETED|Overall Study||90
10654340|NCT02202109|11815067|FG001|NOT COMPLETED|Overall Study||87
10654341|NCT02202135|11815073|FG000|STARTED|Overall Study||4
10654342|NCT02202135|11815073|FG000|COMPLETED|Overall Study||4
10654343|NCT02202135|11815073|FG000|NOT COMPLETED|Overall Study||0
10654344|NCT02202161|11815085|FG000|STARTED|Overall Study||13
10654345|NCT02202161|11815086|FG001|STARTED|Overall Study||5
10654346|NCT02202161|11815087|FG002|STARTED|Overall Study||5
10654347|NCT02202161|11815088|FG003|STARTED|Overall Study||9
10654348|NCT02202161|11815089|FG004|STARTED|Overall Study||9
10654349|NCT02202161|11815090|FG005|STARTED|Overall Study||10
10654350|NCT02202161|11815091|FG006|STARTED|Overall Study||13
10654351|NCT02202161|11815092|FG007|STARTED|Overall Study||6
10654352|NCT02202161|11815085|FG000|COMPLETED|Overall Study||12
10654353|NCT02202161|11815086|FG001|COMPLETED|Overall Study||4
10654354|NCT02202161|11815087|FG002|COMPLETED|Overall Study||5
10654355|NCT02202161|11815088|FG003|COMPLETED|Overall Study||9
10654356|NCT02202161|11815089|FG004|COMPLETED|Overall Study||8
10654357|NCT02202161|11815090|FG005|COMPLETED|Overall Study||9
10654358|NCT02202161|11815091|FG006|COMPLETED|Overall Study||13
10654359|NCT02202161|11815092|FG007|COMPLETED|Overall Study||0
10706197|NCT02606643|11870724|FG000|COMPLETED|Overall Study||67
10654360|NCT02202161|11815085|FG000|NOT COMPLETED|Overall Study||1
10654361|NCT02202161|11815086|FG001|NOT COMPLETED|Overall Study||1
10654362|NCT02202161|11815087|FG002|NOT COMPLETED|Overall Study||0
10654363|NCT02202161|11815088|FG003|NOT COMPLETED|Overall Study||0
10654364|NCT02202161|11815089|FG004|NOT COMPLETED|Overall Study||1
10654365|NCT02202161|11815090|FG005|NOT COMPLETED|Overall Study||1
10654366|NCT02202161|11815091|FG006|NOT COMPLETED|Overall Study||0
10654367|NCT02202161|11815092|FG007|NOT COMPLETED|Overall Study||6
10654368|NCT02202252|11815113|FG000|STARTED|Overall Study||30
10654369|NCT02202252|11815114|FG001|STARTED|Overall Study||30
10654370|NCT02202252|11815113|FG000|COMPLETED|Overall Study||30
10706198|NCT02606643|11870725|FG001|COMPLETED|Overall Study||73
10654371|NCT02202252|11815114|FG001|COMPLETED|Overall Study||30
10654372|NCT02202252|11815113|FG000|NOT COMPLETED|Overall Study||0
10654373|NCT02202252|11815114|FG001|NOT COMPLETED|Overall Study||0
10654374|NCT02202317|11815120|FG000|STARTED|Overall Study||9
10654375|NCT02202317|11815120|FG000|COMPLETED|Overall Study||8
10654376|NCT02202317|11815120|FG000|NOT COMPLETED|Overall Study||1
10654377|NCT02202499|11815127|FG000|STARTED|Overall Study||21
10654378|NCT02202499|11815128|FG001|STARTED|Overall Study||20
10654379|NCT02202499|11815129|FG002|STARTED|Overall Study||21
10654380|NCT02202499|11815127|FG000|COMPLETED|Overall Study||19
10654381|NCT02202499|11815128|FG001|COMPLETED|Overall Study||20
10654382|NCT02202499|11815129|FG002|COMPLETED|Overall Study||19
10644997|NCT02127931|11804258|FG000|STARTED|Overall Study||18
10644998|NCT02127931|11804258|FG000|COMPLETED|Overall Study||17
10644999|NCT02127931|11804258|FG000|NOT COMPLETED|Overall Study||1
10645000|NCT02127970|11804265|FG000|STARTED|Overall Study||349
10645001|NCT02127970|11804266|FG001|STARTED|Overall Study||349
10645002|NCT02127970|11804265|FG000|COMPLETED|Overall Study||323
10645003|NCT02127970|11804266|FG001|COMPLETED|Overall Study||322
10645004|NCT02127970|11804265|FG000|NOT COMPLETED|Overall Study||26
10645005|NCT02127970|11804266|FG001|NOT COMPLETED|Overall Study||27
10645006|NCT02128074|11804272|FG000|STARTED|Overall Study||32
10645007|NCT02128074|11804272|FG000|COMPLETED|Overall Study||26
10645008|NCT02128074|11804272|FG000|NOT COMPLETED|Overall Study||6
10645009|NCT02128217|11804278|FG000|STARTED|Overall Study||17
10645010|NCT02128217|11804279|FG001|STARTED|Overall Study||27
10645011|NCT02128217|11804278|FG000|COMPLETED|Overall Study||17
10645012|NCT02128217|11804279|FG001|COMPLETED|Overall Study||26
10645013|NCT02128217|11804278|FG000|NOT COMPLETED|Overall Study||0
10645014|NCT02128217|11804279|FG001|NOT COMPLETED|Overall Study||1
10645015|NCT02128230|11804290|FG000|STARTED|Overall Study||20
10645016|NCT02128230|11804290|FG000|COMPLETED|Overall Study||1
10645017|NCT02128230|11804290|FG000|NOT COMPLETED|Overall Study||19
10645018|NCT02128269|11804294|FG000|STARTED|Treatment Period||9
10645019|NCT02128269|11804294|FG000|COMPLETED|Treatment Period||7
10645020|NCT02128269|11804294|FG000|NOT COMPLETED|Treatment Period||2
10645021|NCT02128269|11804294|FG000|STARTED|Follow-up|All enrolled patients were followed for 12 weeks after their last infusion of ALXN1007.|9
10645022|NCT02128269|11804294|FG000|COMPLETED|Follow-up||9
10645023|NCT02128269|11804294|FG000|NOT COMPLETED|Follow-up||0
10645024|NCT02128490|11804303|FG000|STARTED|Overall Study||38
10645025|NCT02128490|11804304|FG001|STARTED|Overall Study||37
10645026|NCT02128490|11804305|FG002|STARTED|Overall Study||39
10645027|NCT02128490|11804306|FG003|STARTED|Overall Study||37
10645028|NCT02128490|11804307|FG004|STARTED|Overall Study||38
10645029|NCT02128490|11804303|FG000|COMPLETED|Overall Study||33
10645030|NCT02128490|11804304|FG001|COMPLETED|Overall Study||31
10645031|NCT02128490|11804305|FG002|COMPLETED|Overall Study||34
10645032|NCT02128490|11804306|FG003|COMPLETED|Overall Study||31
10645033|NCT02128490|11804307|FG004|COMPLETED|Overall Study||31
10645034|NCT02128490|11804303|FG000|NOT COMPLETED|Overall Study||5
10645035|NCT02128490|11804304|FG001|NOT COMPLETED|Overall Study||6
10645036|NCT02128490|11804305|FG002|NOT COMPLETED|Overall Study||5
10645037|NCT02128490|11804306|FG003|NOT COMPLETED|Overall Study||6
10645038|NCT02128490|11804307|FG004|NOT COMPLETED|Overall Study||7
10645039|NCT02128542|11804321|FG000|STARTED|Overall Study||47
10645040|NCT02128542|11804322|FG001|STARTED|Overall Study||19
10645041|NCT02128542|11804321|FG000|COMPLETED|Overall Study||43
10645042|NCT02128542|11804322|FG001|COMPLETED|Overall Study||19
10645043|NCT02128542|11804321|FG000|NOT COMPLETED|Overall Study||4
10645044|NCT02128542|11804322|FG001|NOT COMPLETED|Overall Study||0
10645045|NCT02128724|11804334|FG000|STARTED|Overall Study||4
10645046|NCT02128724|11804335|FG001|STARTED|Overall Study||4
10645047|NCT02128724|11804336|FG002|STARTED|Overall Study||3
10645048|NCT02128724|11804337|FG003|STARTED|Overall Study||10
10645049|NCT02128724|11804334|FG000|COMPLETED|Overall Study||3
10645050|NCT02128724|11804335|FG001|COMPLETED|Overall Study||3
10645051|NCT02128724|11804336|FG002|COMPLETED|Overall Study||3
10645052|NCT02128724|11804337|FG003|COMPLETED|Overall Study||7
10645053|NCT02128724|11804334|FG000|NOT COMPLETED|Overall Study||1
10645054|NCT02128724|11804335|FG001|NOT COMPLETED|Overall Study||1
10645055|NCT02128724|11804336|FG002|NOT COMPLETED|Overall Study||0
10645056|NCT02128724|11804337|FG003|NOT COMPLETED|Overall Study||3
10645063|NCT02128828|11804358|FG000|STARTED|Overall Study||20
10645064|NCT02128828|11804358|FG000|COMPLETED|Overall Study||17
10645065|NCT02128828|11804358|FG000|NOT COMPLETED|Overall Study||3
10645066|NCT02128867|11804365|FG000|STARTED|Overall Study||53
10645067|NCT02128867|11804366|FG001|STARTED|Overall Study||52
10645068|NCT02128867|11804367|FG002|STARTED|Overall Study||54
10645069|NCT02128867|11804365|FG000|COMPLETED|Overall Study||50
10645070|NCT02128867|11804366|FG001|COMPLETED|Overall Study||50
10645071|NCT02128867|11804367|FG002|COMPLETED|Overall Study||50
10645072|NCT02128867|11804365|FG000|NOT COMPLETED|Overall Study||3
10645073|NCT02128867|11804366|FG001|NOT COMPLETED|Overall Study||2
10645074|NCT02128867|11804367|FG002|NOT COMPLETED|Overall Study||4
10645075|NCT02128919|11804377|FG000|STARTED|Overall Study||17
10645076|NCT02128919|11804378|FG001|STARTED|Overall Study||16
10645077|NCT02128919|11804377|FG000|COMPLETED|Overall Study||14
10645078|NCT02128919|11804378|FG001|COMPLETED|Overall Study||15
10645079|NCT02128919|11804377|FG000|NOT COMPLETED|Overall Study||3
10645080|NCT02128919|11804378|FG001|NOT COMPLETED|Overall Study||1
10645081|NCT02128932|11804388|FG000|STARTED|Overall Study||362
10645082|NCT02128932|11804389|FG001|STARTED|Overall Study||360
10645083|NCT02128932|11804390|FG002|STARTED|Overall Study||360
10645084|NCT02128932|11804388|FG000|COMPLETED|Overall Study||335
10645085|NCT02128932|11804389|FG001|COMPLETED|Overall Study||341
10645086|NCT02128932|11804390|FG002|COMPLETED|Overall Study||342
10645087|NCT02128932|11804388|FG000|NOT COMPLETED|Overall Study||27
10645088|NCT02128932|11804389|FG001|NOT COMPLETED|Overall Study||19
10645089|NCT02128932|11804390|FG002|NOT COMPLETED|Overall Study||18
10645090|NCT02128997|11804400|FG000|STARTED|Overall Study||67
10645091|NCT02128997|11804401|FG001|STARTED|Overall Study||69
10645092|NCT02128997|11804400|FG000|COMPLETED|Overall Study||61
10645093|NCT02128997|11804401|FG001|COMPLETED|Overall Study||58
10645094|NCT02128997|11804400|FG000|NOT COMPLETED|Overall Study||6
10645095|NCT02128997|11804401|FG001|NOT COMPLETED|Overall Study||11
10645096|NCT02129062|11804407|FG000|STARTED|Overall Study||3
10645097|NCT02129062|11804407|FG000|COMPLETED|Overall Study||0
10645098|NCT02129062|11804407|FG000|NOT COMPLETED|Overall Study||3
10645099|NCT02129075|11804413|FG000|STARTED|Overall Study||30
10645100|NCT02129075|11804414|FG001|STARTED|Overall Study||30
10645101|NCT02129075|11804413|FG000|COMPLETED|Overall Study||30
10645102|NCT02129075|11804414|FG001|COMPLETED|Overall Study||30
10645103|NCT02129075|11804413|FG000|NOT COMPLETED|Overall Study||0
10645104|NCT02129075|11804414|FG001|NOT COMPLETED|Overall Study||0
10645105|NCT02129192|11804424|FG000|STARTED|Period 1 Including Washout Period||36
10645106|NCT02129192|11804425|FG001|STARTED|Period 1 Including Washout Period||36
10645107|NCT02129192|11804424|FG000|COMPLETED|Period 1 Including Washout Period||36
10645108|NCT02129192|11804425|FG001|COMPLETED|Period 1 Including Washout Period|Withdrawal by one subject in washout period|35
10645109|NCT02129192|11804424|FG000|NOT COMPLETED|Period 1 Including Washout Period||0
10645110|NCT02129192|11804425|FG001|NOT COMPLETED|Period 1 Including Washout Period||1
10645111|NCT02129192|11804424|FG000|STARTED|Period 2 Including Washout Period||36
10645112|NCT02129192|11804425|FG001|STARTED|Period 2 Including Washout Period||35
10645113|NCT02129192|11804424|FG000|COMPLETED|Period 2 Including Washout Period||36
10645114|NCT02129192|11804425|FG001|COMPLETED|Period 2 Including Washout Period||35
10645115|NCT02129192|11804424|FG000|NOT COMPLETED|Period 2 Including Washout Period||0
10645116|NCT02129192|11804425|FG001|NOT COMPLETED|Period 2 Including Washout Period||0
10645117|NCT02129192|11804424|FG000|STARTED|Period 3 Including Washout Period||36
10645118|NCT02129192|11804425|FG001|STARTED|Period 3 Including Washout Period||35
10645119|NCT02129192|11804424|FG000|COMPLETED|Period 3 Including Washout Period||36
10645120|NCT02129192|11804425|FG001|COMPLETED|Period 3 Including Washout Period||35
10645121|NCT02129192|11804424|FG000|NOT COMPLETED|Period 3 Including Washout Period||0
10645122|NCT02129192|11804425|FG001|NOT COMPLETED|Period 3 Including Washout Period||0
10645123|NCT02129192|11804424|FG000|STARTED|Period 4 Including Washout Period||36
10645124|NCT02129192|11804425|FG001|STARTED|Period 4 Including Washout Period||35
10645125|NCT02129192|11804424|FG000|COMPLETED|Period 4 Including Washout Period||36
10645126|NCT02129192|11804425|FG001|COMPLETED|Period 4 Including Washout Period||35
10645127|NCT02129192|11804424|FG000|NOT COMPLETED|Period 4 Including Washout Period||0
10645128|NCT02129192|11804425|FG001|NOT COMPLETED|Period 4 Including Washout Period||0
10645129|NCT02129192|11804424|FG000|STARTED|Period 5||36
10645130|NCT02129192|11804425|FG001|STARTED|Period 5|This sequence consists of only 4 periods.|0
10645131|NCT02129192|11804424|FG000|COMPLETED|Period 5||36
10645132|NCT02129192|11804425|FG001|COMPLETED|Period 5||0
10645133|NCT02129192|11804424|FG000|NOT COMPLETED|Period 5||0
10645134|NCT02129192|11804425|FG001|NOT COMPLETED|Period 5||0
10645135|NCT02129205|11804444|FG000|STARTED|Overall Study||2
10645136|NCT02129205|11804445|FG001|STARTED|Overall Study||2
10645137|NCT02129205|11804446|FG002|STARTED|Overall Study||2
10645138|NCT02129205|11804447|FG003|STARTED|Overall Study||2
10645139|NCT02129205|11804448|FG004|STARTED|Overall Study||7
10645140|NCT02129205|11804449|FG005|STARTED|Overall Study||11
10645141|NCT02129205|11804450|FG006|STARTED|Overall Study||6
10645142|NCT02129205|11804451|FG007|STARTED|Overall Study||6
10645143|NCT02129205|11804452|FG008|STARTED|Overall Study||2
10645144|NCT02129205|11804453|FG009|STARTED|Overall Study||0
10645145|NCT02129205|11804444|FG000|COMPLETED|Overall Study||1
10645146|NCT02129205|11804445|FG001|COMPLETED|Overall Study||2
10645147|NCT02129205|11804446|FG002|COMPLETED|Overall Study||2
10645148|NCT02129205|11804447|FG003|COMPLETED|Overall Study||2
10645149|NCT02129205|11804448|FG004|COMPLETED|Overall Study||4
10645150|NCT02129205|11804449|FG005|COMPLETED|Overall Study||7
10645151|NCT02129205|11804450|FG006|COMPLETED|Overall Study||2
10645152|NCT02129205|11804451|FG007|COMPLETED|Overall Study||4
10645153|NCT02129205|11804452|FG008|COMPLETED|Overall Study||0
10645154|NCT02129205|11804453|FG009|COMPLETED|Overall Study||0
10645155|NCT02129205|11804444|FG000|NOT COMPLETED|Overall Study||1
10645156|NCT02129205|11804445|FG001|NOT COMPLETED|Overall Study||0
10645157|NCT02129205|11804446|FG002|NOT COMPLETED|Overall Study||0
10645158|NCT02129205|11804447|FG003|NOT COMPLETED|Overall Study||0
10645159|NCT02129205|11804448|FG004|NOT COMPLETED|Overall Study||3
10645160|NCT02129205|11804449|FG005|NOT COMPLETED|Overall Study||4
10645161|NCT02129205|11804450|FG006|NOT COMPLETED|Overall Study||4
10645162|NCT02129205|11804451|FG007|NOT COMPLETED|Overall Study||2
10645163|NCT02129205|11804452|FG008|NOT COMPLETED|Overall Study||2
10645164|NCT02129205|11804453|FG009|NOT COMPLETED|Overall Study||0
10645165|NCT02129426|11804479|FG000|STARTED|Overall Study||7
10645166|NCT02129426|11804480|FG001|STARTED|Overall Study||13
10645167|NCT02129426|11804479|FG000|COMPLETED|Overall Study||0
10645168|NCT02129426|11804480|FG001|COMPLETED|Overall Study||0
10645169|NCT02129426|11804479|FG000|NOT COMPLETED|Overall Study||7
10645170|NCT02129426|11804480|FG001|NOT COMPLETED|Overall Study||13
10645171|NCT02129478|11804486|FG000|STARTED|Overall Study||15
10645172|NCT02129478|11804486|FG000|COMPLETED|Overall Study||15
10645173|NCT02129478|11804486|FG000|NOT COMPLETED|Overall Study||0
10645174|NCT02129556|11804493|FG000|STARTED|Overall Study||3
10645175|NCT02129556|11804494|FG001|STARTED|Overall Study||3
10645176|NCT02129556|11804495|FG002|STARTED|Overall Study||40
10645177|NCT02129556|11804496|FG003|STARTED|Overall Study||12
10645178|NCT02129556|11804493|FG000|COMPLETED|Overall Study||3
10645179|NCT02129556|11804494|FG001|COMPLETED|Overall Study||3
10645180|NCT02129556|11804495|FG002|COMPLETED|Overall Study||37
10645181|NCT02129556|11804496|FG003|COMPLETED|Overall Study||12
10645182|NCT02129556|11804493|FG000|NOT COMPLETED|Overall Study||0
10645183|NCT02129556|11804494|FG001|NOT COMPLETED|Overall Study||0
10645184|NCT02129556|11804495|FG002|NOT COMPLETED|Overall Study||3
10645185|NCT02129556|11804496|FG003|NOT COMPLETED|Overall Study||0
10645186|NCT02129608|11804508|FG000|STARTED|Overall Study||15
10645187|NCT02129608|11804509|FG001|STARTED|Overall Study||14
10645188|NCT02129608|11804510|FG002|STARTED|Overall Study||15
10645189|NCT02129608|11804508|FG000|End of Treatment|Overall Study||15
10645190|NCT02129608|11804509|FG001|End of Treatment|Overall Study||13
10645191|NCT02129608|11804510|FG002|End of Treatment|Overall Study||12
10645192|NCT02129608|11804508|FG000|COMPLETED|Overall Study||15
10645193|NCT02129608|11804509|FG001|COMPLETED|Overall Study||13
10645194|NCT02129608|11804510|FG002|COMPLETED|Overall Study||12
10645195|NCT02129608|11804508|FG000|NOT COMPLETED|Overall Study||0
10645196|NCT02129608|11804509|FG001|NOT COMPLETED|Overall Study||1
10645197|NCT02129608|11804510|FG002|NOT COMPLETED|Overall Study||3
10645198|NCT02129660|11804523|FG000|STARTED|Overall Study||21
10645199|NCT02129660|11804524|FG001|STARTED|Overall Study||20
10645200|NCT02129660|11804525|FG002|STARTED|Overall Study||22
10645201|NCT02129660|11804526|FG003|STARTED|Overall Study||20
10645202|NCT02129660|11804527|FG004|STARTED|Overall Study||22
10645203|NCT02129660|11804523|FG000|COMPLETED|Overall Study||19
10645204|NCT02129660|11804524|FG001|COMPLETED|Overall Study||20
10645205|NCT02129660|11804525|FG002|COMPLETED|Overall Study||21
10645206|NCT02129660|11804526|FG003|COMPLETED|Overall Study||20
10645207|NCT02129660|11804527|FG004|COMPLETED|Overall Study||20
10645208|NCT02129660|11804523|FG000|NOT COMPLETED|Overall Study||2
10645209|NCT02129660|11804524|FG001|NOT COMPLETED|Overall Study||0
10645210|NCT02129660|11804525|FG002|NOT COMPLETED|Overall Study||1
10645211|NCT02129660|11804526|FG003|NOT COMPLETED|Overall Study||0
10645212|NCT02129660|11804527|FG004|NOT COMPLETED|Overall Study||2
10645213|NCT02129725|11804542|FG000|STARTED|Overall Study||8
10645214|NCT02129725|11804543|FG001|STARTED|Overall Study||7
10645215|NCT02129725|11804542|FG000|COMPLETED|Overall Study||6
10645216|NCT02129725|11804543|FG001|COMPLETED|Overall Study||4
10645217|NCT02129725|11804542|FG000|NOT COMPLETED|Overall Study||2
10645218|NCT02129725|11804543|FG001|NOT COMPLETED|Overall Study||3
10645219|NCT02129777|11804554|FG000|STARTED|Double-Blind Period||24
10645220|NCT02129777|11804555|FG001|STARTED|Double-Blind Period||24
10645221|NCT02129777|11804556|FG002|STARTED|Double-Blind Period||24
10645222|NCT02129777|11804557|FG003|STARTED|Double-Blind Period||25
10645223|NCT02129777|11804558|FG004|STARTED|Double-Blind Period||25
10645224|NCT02129777|11804559|FG005|STARTED|Double-Blind Period||0
10645225|NCT02129777|11804560|FG006|STARTED|Double-Blind Period||0
10645226|NCT02129777|11804554|FG000|COMPLETED|Double-Blind Period||17
10645227|NCT02129777|11804555|FG001|COMPLETED|Double-Blind Period||16
10645228|NCT02129777|11804556|FG002|COMPLETED|Double-Blind Period||20
10645229|NCT02129777|11804557|FG003|COMPLETED|Double-Blind Period||18
10645230|NCT02129777|11804558|FG004|COMPLETED|Double-Blind Period||18
10645231|NCT02129777|11804559|FG005|COMPLETED|Double-Blind Period||0
10645232|NCT02129777|11804560|FG006|COMPLETED|Double-Blind Period||0
10645233|NCT02129777|11804554|FG000|NOT COMPLETED|Double-Blind Period||7
10645234|NCT02129777|11804555|FG001|NOT COMPLETED|Double-Blind Period||8
10645235|NCT02129777|11804556|FG002|NOT COMPLETED|Double-Blind Period||4
10645236|NCT02129777|11804557|FG003|NOT COMPLETED|Double-Blind Period||7
10645237|NCT02129777|11804558|FG004|NOT COMPLETED|Double-Blind Period||7
10645238|NCT02129777|11804559|FG005|NOT COMPLETED|Double-Blind Period||0
10645239|NCT02129777|11804560|FG006|NOT COMPLETED|Double-Blind Period||0
10645240|NCT02129777|11804554|FG000|STARTED|Open-Label Period||0
10645241|NCT02129777|11804555|FG001|STARTED|Open-Label Period||0
10645242|NCT02129777|11804556|FG002|STARTED|Open-Label Period||0
10645243|NCT02129777|11804557|FG003|STARTED|Open-Label Period||0
10645244|NCT02129777|11804558|FG004|STARTED|Open-Label Period||0
10645245|NCT02129777|11804559|FG005|STARTED|Open-Label Period||12
10645246|NCT02129777|11804560|FG006|STARTED|Open-Label Period||48
10645247|NCT02129777|11804554|FG000|COMPLETED|Open-Label Period||0
10645248|NCT02129777|11804555|FG001|COMPLETED|Open-Label Period||0
10645249|NCT02129777|11804556|FG002|COMPLETED|Open-Label Period||0
10645250|NCT02129777|11804557|FG003|COMPLETED|Open-Label Period||0
10645251|NCT02129777|11804558|FG004|COMPLETED|Open-Label Period||0
10645252|NCT02129777|11804559|FG005|COMPLETED|Open-Label Period||0
10645253|NCT02129777|11804560|FG006|COMPLETED|Open-Label Period||0
10645254|NCT02129777|11804554|FG000|NOT COMPLETED|Open-Label Period||0
10645255|NCT02129777|11804555|FG001|NOT COMPLETED|Open-Label Period||0
10645256|NCT02129777|11804556|FG002|NOT COMPLETED|Open-Label Period||0
10645257|NCT02129777|11804557|FG003|NOT COMPLETED|Open-Label Period||0
10645258|NCT02129777|11804558|FG004|NOT COMPLETED|Open-Label Period||0
10645259|NCT02129777|11804559|FG005|NOT COMPLETED|Open-Label Period||12
10645260|NCT02129777|11804560|FG006|NOT COMPLETED|Open-Label Period||48
10645261|NCT02129803|11804581|FG000|STARTED|Overall Study||12
10645262|NCT02129803|11804582|FG001|STARTED|Overall Study||12
10645263|NCT02129803|11804581|FG000|COMPLETED|Overall Study||6
10645264|NCT02129803|11804582|FG001|COMPLETED|Overall Study||9
10645265|NCT02129803|11804581|FG000|NOT COMPLETED|Overall Study||6
10645266|NCT02129803|11804582|FG001|NOT COMPLETED|Overall Study||3
10645267|NCT02130024|11804590|FG000|STARTED|Overall Study||142
10645268|NCT02130024|11804591|FG001|STARTED|Overall Study||139
10645269|NCT02130024|11804590|FG000|Safety Set|Overall Study|One randomized patient did not receive treatment|141
10645270|NCT02130024|11804591|FG001|Safety Set|Overall Study||139
10645271|NCT02130024|11804590|FG000|Full Analysis Set (FAS)|Overall Study||141
10645272|NCT02130024|11804591|FG001|Full Analysis Set (FAS)|Overall Study|2 patients had no post Baseline geographic atrophy (GA) data|137
10645273|NCT02130024|11804590|FG000|COMPLETED|Overall Study||117
10645274|NCT02130024|11804591|FG001|COMPLETED|Overall Study||108
10645275|NCT02130024|11804590|FG000|NOT COMPLETED|Overall Study||25
10645276|NCT02130024|11804591|FG001|NOT COMPLETED|Overall Study||31
10645277|NCT02130063|11804599|FG000|STARTED|Overall Study||342
10645278|NCT02130063|11804600|FG001|STARTED|Overall Study||169
10645279|NCT02130063|11804599|FG000|COMPLETED|Overall Study||317
10645280|NCT02130063|11804600|FG001|COMPLETED|Overall Study||152
10645281|NCT02130063|11804599|FG000|NOT COMPLETED|Overall Study||25
10645282|NCT02130063|11804600|FG001|NOT COMPLETED|Overall Study||17
10645283|NCT02130193|11804608|FG000|STARTED|Part A: 4-week Open-label Period||9
10645284|NCT02130193|11804609|FG001|STARTED|Part A: 4-week Open-label Period||0
10645285|NCT02130193|11804610|FG002|STARTED|Part A: 4-week Open-label Period||0
10645286|NCT02130193|11804608|FG000|COMPLETED|Part A: 4-week Open-label Period||9
10645287|NCT02130193|11804609|FG001|COMPLETED|Part A: 4-week Open-label Period||0
10645288|NCT02130193|11804610|FG002|COMPLETED|Part A: 4-week Open-label Period||0
10645289|NCT02130193|11804608|FG000|NOT COMPLETED|Part A: 4-week Open-label Period||0
10645290|NCT02130193|11804609|FG001|NOT COMPLETED|Part A: 4-week Open-label Period||0
10645291|NCT02130193|11804610|FG002|NOT COMPLETED|Part A: 4-week Open-label Period||0
10645292|NCT02130193|11804608|FG000|STARTED|Part B: 52-week Double-blind Period||0
10645293|NCT02130193|11804609|FG001|STARTED|Part B: 52-week Double-blind Period||48
10645294|NCT02130193|11804610|FG002|STARTED|Part B: 52-week Double-blind Period||45
10645295|NCT02130193|11804608|FG000|COMPLETED|Part B: 52-week Double-blind Period||0
10645296|NCT02130193|11804609|FG001|COMPLETED|Part B: 52-week Double-blind Period||38
10645297|NCT02130193|11804610|FG002|COMPLETED|Part B: 52-week Double-blind Period||37
10645298|NCT02130193|11804608|FG000|NOT COMPLETED|Part B: 52-week Double-blind Period||0
10645299|NCT02130193|11804609|FG001|NOT COMPLETED|Part B: 52-week Double-blind Period||10
10645300|NCT02130193|11804610|FG002|NOT COMPLETED|Part B: 52-week Double-blind Period||8
10645301|NCT02130258|11804621|FG000|STARTED|Overall Study||9
10645302|NCT02130258|11804622|FG001|STARTED|Overall Study||11
10645303|NCT02130258|11804621|FG000|COMPLETED|Overall Study||9
10645304|NCT02130258|11804622|FG001|COMPLETED|Overall Study||11
10645305|NCT02130258|11804621|FG000|NOT COMPLETED|Overall Study||0
10645306|NCT02130258|11804622|FG001|NOT COMPLETED|Overall Study||0
10645307|NCT02130284|11804628|FG000|STARTED|Overall Study||80
10645308|NCT02130284|11804628|FG000|COMPLETED|Overall Study||71
10645309|NCT02130284|11804628|FG000|NOT COMPLETED|Overall Study||9
10645310|NCT02130297|11804632|FG000|STARTED|Overall Study||30
10645311|NCT02130297|11804632|FG000|COMPLETED|Overall Study||26
10645312|NCT02130297|11804632|FG000|NOT COMPLETED|Overall Study||4
10645316|NCT02130557|11804642|FG000|STARTED|Overall Study||268
10645317|NCT02130557|11804643|FG001|STARTED|Overall Study||268
10645318|NCT02130557|11804642|FG000|Treated|Overall Study||268
10645319|NCT02130557|11804643|FG001|Treated|Overall Study||265
10645320|NCT02130557|11804642|FG000|mITT Population|Overall Study||246
10645321|NCT02130557|11804643|FG001|mITT Population|Overall Study||241
10645322|NCT02130557|11804642|FG000|COMPLETED|Overall Study||232
10706199|NCT02606643|11870724|FG000|NOT COMPLETED|Overall Study||1
10706200|NCT02606643|11870725|FG001|NOT COMPLETED|Overall Study||3
10706201|NCT02606708|11870735|FG000|STARTED|Overall Study||314
10706202|NCT02606708|11870735|FG000|COMPLETED|Overall Study||314
10706203|NCT02606708|11870735|FG000|NOT COMPLETED|Overall Study||0
10706204|NCT02606734|11870739|FG000|STARTED|Overall Study||44
10706205|NCT02606734|11870739|FG000|COMPLETED|Overall Study||44
10706206|NCT02606734|11870739|FG000|NOT COMPLETED|Overall Study||0
10706207|NCT02606838|11870743|FG000|STARTED|Overall Study||119
10645323|NCT02130557|11804643|FG001|COMPLETED|Overall Study||231
10645324|NCT02130557|11804642|FG000|NOT COMPLETED|Overall Study||36
10645325|NCT02130557|11804643|FG001|NOT COMPLETED|Overall Study||37
10645326|NCT02130570|11804651|FG000|STARTED|Overall Study||987
10645327|NCT02130570|11804652|FG001|STARTED|Overall Study||692
10645328|NCT02130570|11804651|FG000|COMPLETED|Overall Study|Participants enrolled, did not die during index admission, did not withdraw consent|978
10645329|NCT02130570|11804652|FG001|COMPLETED|Overall Study|Participants enrolled, did not die during index admission, did not withdraw consent|679
10645330|NCT02130570|11804651|FG000|NOT COMPLETED|Overall Study||9
10645331|NCT02130570|11804652|FG001|NOT COMPLETED|Overall Study||13
10645332|NCT02130583|11804661|FG000|STARTED|Overall Study||26
10645333|NCT02130583|11804662|FG001|STARTED|Overall Study||26
10645334|NCT02130583|11804661|FG000|COMPLETED|Overall Study||17
10645335|NCT02130583|11804662|FG001|COMPLETED|Overall Study||19
10645336|NCT02130583|11804661|FG000|NOT COMPLETED|Overall Study||9
10645337|NCT02130583|11804662|FG001|NOT COMPLETED|Overall Study||7
10645338|NCT02130635|11804677|FG000|STARTED|Part A-Safety and Tolerability||7
10645339|NCT02130635|11804678|FG001|STARTED|Part A-Safety and Tolerability||21
10645340|NCT02130635|11804679|FG002|STARTED|Part A-Safety and Tolerability||0
10645341|NCT02130635|11804680|FG003|STARTED|Part A-Safety and Tolerability||0
10457304|NCT01010061|11605040|FG000|COMPLETED|Overall Study|Completed=Completed treatment.|190
10457305|NCT01010061|11605041|FG001|COMPLETED|Overall Study||78
10457306|NCT01010061|11605040|FG000|NOT COMPLETED|Overall Study||48
10457307|NCT01010061|11605041|FG001|NOT COMPLETED|Overall Study||40
10457308|NCT01010126|11605055|FG000|STARTED|Overall Study||27
10457309|NCT01010126|11605056|FG001|STARTED|Overall Study||58
10645342|NCT02130635|11804681|FG004|STARTED|Part A-Safety and Tolerability||0
10645343|NCT02130635|11804682|FG005|STARTED|Part A-Safety and Tolerability||0
10645344|NCT02130635|11804683|FG006|STARTED|Part A-Safety and Tolerability||0
10645345|NCT02130635|11804684|FG007|STARTED|Part A-Safety and Tolerability||0
10645346|NCT02130635|11804685|FG008|STARTED|Part A-Safety and Tolerability||0
10645347|NCT02130635|11804677|FG000|COMPLETED|Part A-Safety and Tolerability||7
10645348|NCT02130635|11804678|FG001|COMPLETED|Part A-Safety and Tolerability||21
10645349|NCT02130635|11804679|FG002|COMPLETED|Part A-Safety and Tolerability||0
10645350|NCT02130635|11804680|FG003|COMPLETED|Part A-Safety and Tolerability||0
10645351|NCT02130635|11804681|FG004|COMPLETED|Part A-Safety and Tolerability||0
10645352|NCT02130635|11804682|FG005|COMPLETED|Part A-Safety and Tolerability||0
10645353|NCT02130635|11804683|FG006|COMPLETED|Part A-Safety and Tolerability||0
10645354|NCT02130635|11804684|FG007|COMPLETED|Part A-Safety and Tolerability||0
10645355|NCT02130635|11804685|FG008|COMPLETED|Part A-Safety and Tolerability||0
10645356|NCT02130635|11804677|FG000|NOT COMPLETED|Part A-Safety and Tolerability||0
10645357|NCT02130635|11804678|FG001|NOT COMPLETED|Part A-Safety and Tolerability||0
10645358|NCT02130635|11804679|FG002|NOT COMPLETED|Part A-Safety and Tolerability||0
10645359|NCT02130635|11804680|FG003|NOT COMPLETED|Part A-Safety and Tolerability||0
10645360|NCT02130635|11804681|FG004|NOT COMPLETED|Part A-Safety and Tolerability||0
10645361|NCT02130635|11804682|FG005|NOT COMPLETED|Part A-Safety and Tolerability||0
10645362|NCT02130635|11804683|FG006|NOT COMPLETED|Part A-Safety and Tolerability||0
10645363|NCT02130635|11804684|FG007|NOT COMPLETED|Part A-Safety and Tolerability||0
10645364|NCT02130635|11804685|FG008|NOT COMPLETED|Part A-Safety and Tolerability||0
10645365|NCT02130635|11804677|FG000|STARTED|Part B-Dose-Response Relationship||0
10645366|NCT02130635|11804678|FG001|STARTED|Part B-Dose-Response Relationship||0
10645367|NCT02130635|11804679|FG002|STARTED|Part B-Dose-Response Relationship||5
10706208|NCT02606838|11870743|FG000|COMPLETED|Overall Study||119
10706209|NCT02606838|11870743|FG000|NOT COMPLETED|Overall Study||0
10706210|NCT02606877|11870753|FG000|STARTED|Overall Study||20
10645368|NCT02130635|11804680|FG003|STARTED|Part B-Dose-Response Relationship||5
10645369|NCT02130635|11804681|FG004|STARTED|Part B-Dose-Response Relationship||5
10645370|NCT02130635|11804682|FG005|STARTED|Part B-Dose-Response Relationship||5
10645371|NCT02130635|11804683|FG006|STARTED|Part B-Dose-Response Relationship||6
10645372|NCT02130635|11804684|FG007|STARTED|Part B-Dose-Response Relationship||5
10645373|NCT02130635|11804685|FG008|STARTED|Part B-Dose-Response Relationship||5
10645374|NCT02130635|11804677|FG000|COMPLETED|Part B-Dose-Response Relationship||0
10706211|NCT02606877|11870754|FG001|STARTED|Overall Study||17
10457310|NCT01010126|11605057|FG002|STARTED|Overall Study||28
10457311|NCT01010126|11605058|FG003|STARTED|Overall Study||57
10457312|NCT01010126|11605059|FG004|STARTED|Overall Study||58
10645375|NCT02130635|11804678|FG001|COMPLETED|Part B-Dose-Response Relationship||0
10645376|NCT02130635|11804679|FG002|COMPLETED|Part B-Dose-Response Relationship||5
10645377|NCT02130635|11804680|FG003|COMPLETED|Part B-Dose-Response Relationship||5
10645378|NCT02130635|11804681|FG004|COMPLETED|Part B-Dose-Response Relationship||5
10645379|NCT02130635|11804682|FG005|COMPLETED|Part B-Dose-Response Relationship||5
10645380|NCT02130635|11804683|FG006|COMPLETED|Part B-Dose-Response Relationship||6
10645381|NCT02130635|11804684|FG007|COMPLETED|Part B-Dose-Response Relationship||5
10645382|NCT02130635|11804685|FG008|COMPLETED|Part B-Dose-Response Relationship||5
10645470|NCT02131662|11804893|FG002|STARTED|Overall Study||63
10645383|NCT02130635|11804677|FG000|NOT COMPLETED|Part B-Dose-Response Relationship||0
10645384|NCT02130635|11804678|FG001|NOT COMPLETED|Part B-Dose-Response Relationship||0
10645385|NCT02130635|11804679|FG002|NOT COMPLETED|Part B-Dose-Response Relationship||0
10645386|NCT02130635|11804680|FG003|NOT COMPLETED|Part B-Dose-Response Relationship||0
10645387|NCT02130635|11804681|FG004|NOT COMPLETED|Part B-Dose-Response Relationship||0
10645388|NCT02130635|11804682|FG005|NOT COMPLETED|Part B-Dose-Response Relationship||0
10645389|NCT02130635|11804683|FG006|NOT COMPLETED|Part B-Dose-Response Relationship||0
10645390|NCT02130635|11804684|FG007|NOT COMPLETED|Part B-Dose-Response Relationship||0
10645391|NCT02130635|11804685|FG008|NOT COMPLETED|Part B-Dose-Response Relationship||0
10645392|NCT02130765|11804716|FG000|STARTED|Overall Study||11
10645393|NCT02130765|11804717|FG001|STARTED|Overall Study||8
10645394|NCT02130765|11804718|FG002|STARTED|Overall Study||26
10645395|NCT02130765|11804719|FG003|STARTED|Overall Study||19
10645396|NCT02130765|11804716|FG000|COMPLETED|Overall Study||7
10645397|NCT02130765|11804717|FG001|COMPLETED|Overall Study||8
10645398|NCT02130765|11804718|FG002|COMPLETED|Overall Study||26
10645399|NCT02130765|11804719|FG003|COMPLETED|Overall Study||19
10645400|NCT02130765|11804716|FG000|NOT COMPLETED|Overall Study||4
10645401|NCT02130765|11804717|FG001|NOT COMPLETED|Overall Study||0
10645402|NCT02130765|11804718|FG002|NOT COMPLETED|Overall Study||0
10645403|NCT02130765|11804719|FG003|NOT COMPLETED|Overall Study||0
10645404|NCT02130986|11804733|FG000|STARTED|Overall Study||830
10645405|NCT02130986|11804734|FG001|STARTED|Overall Study||834
10645406|NCT02130986|11804733|FG000|COMPLETED|Overall Study||675
10645407|NCT02130986|11804734|FG001|COMPLETED|Overall Study||670
10645408|NCT02130986|11804733|FG000|NOT COMPLETED|Overall Study||155
10645409|NCT02130986|11804734|FG001|NOT COMPLETED|Overall Study||164
10645410|NCT02130999|11804742|FG000|STARTED|Overall Study||6
10645411|NCT02130999|11804743|FG001|STARTED|Overall Study||8
10645412|NCT02130999|11804742|FG000|COMPLETED|Overall Study||6
10645413|NCT02130999|11804743|FG001|COMPLETED|Overall Study||8
10645414|NCT02130999|11804742|FG000|NOT COMPLETED|Overall Study||0
10645415|NCT02130999|11804743|FG001|NOT COMPLETED|Overall Study||0
10645416|NCT02131064|11804756|FG000|STARTED|Overall Study||221
10645417|NCT02131064|11804757|FG001|STARTED|Overall Study||223
10645418|NCT02131064|11804756|FG000|COMPLETED|Overall Study||196
10645419|NCT02131064|11804757|FG001|COMPLETED|Overall Study||189
10645420|NCT02131064|11804756|FG000|NOT COMPLETED|Overall Study||25
10645421|NCT02131064|11804757|FG001|NOT COMPLETED|Overall Study||34
10645422|NCT02131129|11804766|FG000|STARTED|Overall Study||10
10645423|NCT02131129|11804767|FG001|STARTED|Overall Study||10
10645424|NCT02131129|11804766|FG000|COMPLETED|Overall Study||9
10645425|NCT02131129|11804767|FG001|COMPLETED|Overall Study||10
10645426|NCT02131129|11804766|FG000|NOT COMPLETED|Overall Study||1
10645427|NCT02131129|11804767|FG001|NOT COMPLETED|Overall Study||0
10645428|NCT02131233|11804775|FG000|STARTED|Overall Study|Enrolled participants|533
10645429|NCT02131233|11804776|FG001|STARTED|Overall Study|Enrolled participants|269
10645430|NCT02131233|11804775|FG000|Treated|Overall Study||531
10645431|NCT02131233|11804776|FG001|Treated|Overall Study||266
10645432|NCT02131233|11804775|FG000|COMPLETED|Overall Study|Completed to Week 96|467
10645433|NCT02131233|11804776|FG001|COMPLETED|Overall Study|Completed to Week 96|227
10645434|NCT02131233|11804775|FG000|NOT COMPLETED|Overall Study||66
10645435|NCT02131233|11804776|FG001|NOT COMPLETED|Overall Study||42
10645436|NCT02131259|11804782|FG000|STARTED|Overall Study|Patients received treatment of GIOTRIF® Tablets|1602
10645437|NCT02131259|11804782|FG000|COMPLETED|Overall Study|Completed is defined as 52 weeks follow-up after starting administration of GIOTRIF® tablets.|377
10645438|NCT02131259|11804782|FG000|NOT COMPLETED|Overall Study||1225
10645439|NCT02131272|11804788|FG000|STARTED|Overall Study||20
10645440|NCT02131272|11804789|FG001|STARTED|Overall Study||22
10645441|NCT02131272|11804788|FG000|COMPLETED|Overall Study||19
10645442|NCT02131272|11804789|FG001|COMPLETED|Overall Study||20
10645443|NCT02131272|11804788|FG000|NOT COMPLETED|Overall Study||1
10645444|NCT02131272|11804789|FG001|NOT COMPLETED|Overall Study||2
10645445|NCT02131311|11804795|FG000|STARTED|Overall Study||90
10645446|NCT02131311|11804795|FG000|COMPLETED|Overall Study||86
10645447|NCT02131311|11804795|FG000|NOT COMPLETED|Overall Study||4
10645448|NCT02131324|11804802|FG000|STARTED|Overall Study|2 subjects randomized into Comp01 not included in analysis as there was no post-baseline information|24
10645449|NCT02131324|11804803|FG001|STARTED|Overall Study|2 subjects randomized into DFD-06 not included in analysis as there was no post-baseline information|26
10645450|NCT02131324|11804802|FG000|Analyzed|Overall Study||22
10645451|NCT02131324|11804803|FG001|Analyzed|Overall Study||24
10645452|NCT02131324|11804802|FG000|COMPLETED|Overall Study||22
10645453|NCT02131324|11804803|FG001|COMPLETED|Overall Study||23
10645454|NCT02131324|11804802|FG000|NOT COMPLETED|Overall Study||2
10645455|NCT02131324|11804803|FG001|NOT COMPLETED|Overall Study||3
10645456|NCT02131402|11804809|FG000|STARTED|Overall Study||60
10645457|NCT02131402|11804809|FG000|COMPLETED|Overall Study||60
10645458|NCT02131402|11804809|FG000|NOT COMPLETED|Overall Study||0
10645459|NCT02131532|11804872|FG000|STARTED|Overall Study||12
10645460|NCT02131532|11804872|FG000|COMPLETED|Overall Study||8
10645461|NCT02131532|11804872|FG000|NOT COMPLETED|Overall Study||4
10645462|NCT02131636|11804879|FG000|STARTED|Overall Study||222
10645463|NCT02131636|11804880|FG001|STARTED|Overall Study||218
10645464|NCT02131636|11804879|FG000|COMPLETED|Overall Study||210
10645465|NCT02131636|11804880|FG001|COMPLETED|Overall Study||213
10645466|NCT02131636|11804879|FG000|NOT COMPLETED|Overall Study||12
10645467|NCT02131636|11804880|FG001|NOT COMPLETED|Overall Study||5
10645468|NCT02131662|11804891|FG000|STARTED|Overall Study||62
10645469|NCT02131662|11804892|FG001|STARTED|Overall Study||61
10645471|NCT02131662|11804894|FG003|STARTED|Overall Study||62
10645472|NCT02131662|11804895|FG004|STARTED|Overall Study||61
10645473|NCT02131662|11804891|FG000|Treated|Overall Study||60
10645474|NCT02131662|11804892|FG001|Treated|Overall Study||61
10645475|NCT02131662|11804893|FG002|Treated|Overall Study||61
10645476|NCT02131662|11804894|FG003|Treated|Overall Study||60
10645477|NCT02131662|11804895|FG004|Treated|Overall Study||58
10645478|NCT02131662|11804891|FG000|Completed Treatment|Overall Study||57
10645479|NCT02131662|11804892|FG001|Completed Treatment|Overall Study||60
10645480|NCT02131662|11804893|FG002|Completed Treatment|Overall Study||61
10645481|NCT02131662|11804894|FG003|Completed Treatment|Overall Study||56
10645482|NCT02131662|11804895|FG004|Completed Treatment|Overall Study||52
10645483|NCT02131662|11804891|FG000|Completed Follow-up|Overall Study||54
10645484|NCT02131662|11804892|FG001|Completed Follow-up|Overall Study||47
10645485|NCT02131662|11804893|FG002|Completed Follow-up|Overall Study||56
10645486|NCT02131662|11804894|FG003|Completed Follow-up|Overall Study||42
10645487|NCT02131662|11804895|FG004|Completed Follow-up|Overall Study||44
10645488|NCT02131662|11804891|FG000|COMPLETED|Overall Study||54
10645489|NCT02131662|11804892|FG001|COMPLETED|Overall Study||47
10645490|NCT02131662|11804893|FG002|COMPLETED|Overall Study||56
10645491|NCT02131662|11804894|FG003|COMPLETED|Overall Study||41
10645492|NCT02131662|11804895|FG004|COMPLETED|Overall Study||43
10645493|NCT02131662|11804891|FG000|NOT COMPLETED|Overall Study||8
10645494|NCT02131662|11804892|FG001|NOT COMPLETED|Overall Study||14
10645495|NCT02131662|11804893|FG002|NOT COMPLETED|Overall Study||7
10645496|NCT02131662|11804894|FG003|NOT COMPLETED|Overall Study||21
10645497|NCT02131662|11804895|FG004|NOT COMPLETED|Overall Study||18
10645498|NCT02131766|11804911|FG000|STARTED|Overall Study||44
10645499|NCT02131766|11804911|FG000|COMPLETED|Overall Study||40
10645500|NCT02131766|11804911|FG000|NOT COMPLETED|Overall Study||4
10645501|NCT02132117|11804920|FG000|STARTED|Overall Study||224
10645502|NCT02132117|11804921|FG001|STARTED|Overall Study||221
10645503|NCT02132117|11804920|FG000|COMPLETED|Overall Study||213
10645504|NCT02132117|11804921|FG001|COMPLETED|Overall Study||216
10645505|NCT02132117|11804920|FG000|NOT COMPLETED|Overall Study||11
10645506|NCT02132117|11804921|FG001|NOT COMPLETED|Overall Study||5
10645507|NCT02132130|11804931|FG000|STARTED|Overall Study||3
10645508|NCT02132130|11804932|FG001|STARTED|Overall Study||12
10645509|NCT02132130|11804933|FG002|STARTED|Overall Study||4
10645510|NCT02132130|11804934|FG003|STARTED|Overall Study||3
10645511|NCT02132130|11804931|FG000|COMPLETED|Overall Study||3
10645512|NCT02132130|11804932|FG001|COMPLETED|Overall Study||10
10645513|NCT02132130|11804933|FG002|COMPLETED|Overall Study||4
10645514|NCT02132130|11804934|FG003|COMPLETED|Overall Study||2
10645515|NCT02132130|11804931|FG000|NOT COMPLETED|Overall Study||0
10645516|NCT02132130|11804932|FG001|NOT COMPLETED|Overall Study||2
10645517|NCT02132130|11804933|FG002|NOT COMPLETED|Overall Study||0
10645518|NCT02132130|11804934|FG003|NOT COMPLETED|Overall Study||1
10645519|NCT02132169|11804950|FG000|STARTED|Overall Study||341
10645520|NCT02132169|11804951|FG001|STARTED|Overall Study||171
10645521|NCT02132169|11804950|FG000|COMPLETED|Overall Study||326
10645522|NCT02132169|11804951|FG001|COMPLETED|Overall Study||162
10645523|NCT02132169|11804950|FG000|NOT COMPLETED|Overall Study||15
10645524|NCT02132169|11804951|FG001|NOT COMPLETED|Overall Study||9
10645525|NCT02132195|11804960|FG000|STARTED|Initial Assignment||15
10645526|NCT02132195|11804961|FG001|STARTED|Initial Assignment||16
10645527|NCT02132195|11804962|FG002|STARTED|Initial Assignment||0
10645528|NCT02132195|11804960|FG000|COMPLETED|Initial Assignment||1
10645529|NCT02132195|11804961|FG001|COMPLETED|Initial Assignment||16
10645530|NCT02132195|11804962|FG002|COMPLETED|Initial Assignment||0
10645531|NCT02132195|11804960|FG000|NOT COMPLETED|Initial Assignment||14
10645532|NCT02132195|11804961|FG001|NOT COMPLETED|Initial Assignment||0
10645533|NCT02132195|11804962|FG002|NOT COMPLETED|Initial Assignment||0
10645534|NCT02132195|11804960|FG000|STARTED|Rescue Therapy||0
10645535|NCT02132195|11804961|FG001|STARTED|Rescue Therapy||0
10645536|NCT02132195|11804962|FG002|STARTED|Rescue Therapy||13
10645537|NCT02132195|11804960|FG000|COMPLETED|Rescue Therapy||0
10645538|NCT02132195|11804961|FG001|COMPLETED|Rescue Therapy||0
10645539|NCT02132195|11804962|FG002|COMPLETED|Rescue Therapy||2
10645540|NCT02132195|11804960|FG000|NOT COMPLETED|Rescue Therapy||0
10645541|NCT02132195|11804961|FG001|NOT COMPLETED|Rescue Therapy||0
10645542|NCT02132195|11804962|FG002|NOT COMPLETED|Rescue Therapy||11
10645543|NCT02132247|11804972|FG000|STARTED|Overall Study||52
10645544|NCT02132247|11804973|FG001|STARTED|Overall Study||52
10645545|NCT02132247|11804972|FG000|COMPLETED|Overall Study||51
10645546|NCT02132247|11804973|FG001|COMPLETED|Overall Study||52
10645547|NCT02132247|11804972|FG000|NOT COMPLETED|Overall Study||1
10645548|NCT02132247|11804973|FG001|NOT COMPLETED|Overall Study||0
10645549|NCT02132312|11804981|FG000|STARTED|Overall Study||37
10645550|NCT02132312|11804982|FG001|STARTED|Overall Study||41
10645551|NCT02132312|11804981|FG000|COMPLETED|Overall Study||31
10645552|NCT02132312|11804982|FG001|COMPLETED|Overall Study||38
10645553|NCT02132312|11804981|FG000|NOT COMPLETED|Overall Study||6
10645554|NCT02132312|11804982|FG001|NOT COMPLETED|Overall Study||3
10645555|NCT02132468|11804988|FG000|STARTED|Overall Study||18
10645556|NCT02132468|11804988|FG000|COMPLETED|Overall Study||11
10645557|NCT02132468|11804988|FG000|NOT COMPLETED|Overall Study||7
10645558|NCT02132520|11804995|FG000|STARTED|Overall Study||0
10645559|NCT02132520|11804996|FG001|STARTED|Overall Study||1
10645560|NCT02132520|11804997|FG002|STARTED|Overall Study||2
10645561|NCT02132520|11804995|FG000|COMPLETED|Overall Study||0
10645562|NCT02132520|11804996|FG001|COMPLETED|Overall Study||1
10645563|NCT02132520|11804997|FG002|COMPLETED|Overall Study||2
10645564|NCT02132520|11804995|FG000|NOT COMPLETED|Overall Study||0
10645565|NCT02132520|11804996|FG001|NOT COMPLETED|Overall Study||0
10645566|NCT02132520|11804997|FG002|NOT COMPLETED|Overall Study||0
10645567|NCT02132533|11805006|FG000|STARTED|Overall Study||46
10645568|NCT02132533|11805007|FG001|STARTED|Overall Study||42
10645569|NCT02132533|11805006|FG000|COMPLETED|Overall Study||46
10645570|NCT02132533|11805007|FG001|COMPLETED|Overall Study||42
10645571|NCT02132533|11805006|FG000|NOT COMPLETED|Overall Study||0
10645572|NCT02132533|11805007|FG001|NOT COMPLETED|Overall Study||0
10645573|NCT02132572|11805013|FG000|STARTED|Overall Study||201
10645574|NCT02132572|11805013|FG000|COMPLETED|Overall Study||201
10645575|NCT02132572|11805013|FG000|NOT COMPLETED|Overall Study||0
10645576|NCT02132598|11805017|FG000|STARTED|Overall Study||5
10645577|NCT02132598|11805017|FG000|COMPLETED|Overall Study||5
10645578|NCT02132598|11805017|FG000|NOT COMPLETED|Overall Study||0
10645579|NCT02132637|11805023|FG000|STARTED|Study Period 1||34
10645580|NCT02132637|11805024|FG001|STARTED|Study Period 1||34
10645581|NCT02132637|11805023|FG000|Received at Least One Dose of Study Drug|Study Period 1||34
10645582|NCT02132637|11805024|FG001|Received at Least One Dose of Study Drug|Study Period 1||34
10645583|NCT02132637|11805023|FG000|COMPLETED|Study Period 1||33
10645584|NCT02132637|11805024|FG001|COMPLETED|Study Period 1||30
10645585|NCT02132637|11805023|FG000|NOT COMPLETED|Study Period 1||1
10645586|NCT02132637|11805024|FG001|NOT COMPLETED|Study Period 1||4
10645587|NCT02132637|11805023|FG000|STARTED|Study Period 2 (Crossover)||33
10645588|NCT02132637|11805024|FG001|STARTED|Study Period 2 (Crossover)||30
10645589|NCT02132637|11805023|FG000|COMPLETED|Study Period 2 (Crossover)||31
10645590|NCT02132637|11805024|FG001|COMPLETED|Study Period 2 (Crossover)||29
10645591|NCT02132637|11805023|FG000|NOT COMPLETED|Study Period 2 (Crossover)||2
10457313|NCT01010126|11605060|FG005|STARTED|Overall Study||24
10457314|NCT01010126|11605055|FG000|COMPLETED|Overall Study||26
10457315|NCT01010126|11605056|FG001|COMPLETED|Overall Study||58
10457316|NCT01010126|11605057|FG002|COMPLETED|Overall Study||27
10457317|NCT01010126|11605058|FG003|COMPLETED|Overall Study||57
10457318|NCT01010126|11605059|FG004|COMPLETED|Overall Study||55
10457319|NCT01010126|11605060|FG005|COMPLETED|Overall Study||24
10457320|NCT01010126|11605055|FG000|NOT COMPLETED|Overall Study||1
10457321|NCT01010126|11605056|FG001|NOT COMPLETED|Overall Study||0
10457322|NCT01010126|11605057|FG002|NOT COMPLETED|Overall Study||1
10457323|NCT01010126|11605058|FG003|NOT COMPLETED|Overall Study||0
10457324|NCT01010126|11605059|FG004|NOT COMPLETED|Overall Study||3
10457325|NCT01010126|11605060|FG005|NOT COMPLETED|Overall Study||0
10457326|NCT01010204|11605076|FG000|STARTED|Overall Study||31
10457327|NCT01010204|11605077|FG001|STARTED|Overall Study||29
10457328|NCT01010204|11605076|FG000|COMPLETED|Overall Study||24
10457329|NCT01010204|11605077|FG001|COMPLETED|Overall Study||20
10457330|NCT01010204|11605076|FG000|NOT COMPLETED|Overall Study||7
10457331|NCT01010204|11605077|FG001|NOT COMPLETED|Overall Study||9
10457332|NCT01010217|11605088|FG000|STARTED|Overall Study||89
10457333|NCT01010217|11605089|FG001|STARTED|Overall Study||56
10457334|NCT01010217|11605090|FG002|STARTED|Overall Study||22
10457335|NCT01010217|11605091|FG003|STARTED|Overall Study||6
10457336|NCT01010217|11605092|FG004|STARTED|Overall Study||3
10457337|NCT01010217|11605088|FG000|COMPLETED|Overall Study||84
10457338|NCT01010217|11605089|FG001|COMPLETED|Overall Study||51
10457339|NCT01010217|11605090|FG002|COMPLETED|Overall Study||21
10457340|NCT01010217|11605091|FG003|COMPLETED|Overall Study||0
10457341|NCT01010217|11605092|FG004|COMPLETED|Overall Study||0
10457342|NCT01010217|11605088|FG000|NOT COMPLETED|Overall Study||5
10645592|NCT02132637|11805024|FG001|NOT COMPLETED|Study Period 2 (Crossover)||1
10645593|NCT02132676|11805032|FG000|STARTED|Overall Study||727
10645594|NCT02132676|11805033|FG001|STARTED|Overall Study||809
10645595|NCT02132676|11805032|FG000|COMPLETED|Overall Study||727
10645596|NCT02132676|11805033|FG001|COMPLETED|Overall Study||809
10645597|NCT02132676|11805032|FG000|NOT COMPLETED|Overall Study||0
10645598|NCT02132676|11805033|FG001|NOT COMPLETED|Overall Study||0
10457343|NCT01010217|11605089|FG001|NOT COMPLETED|Overall Study||5
10457344|NCT01010217|11605090|FG002|NOT COMPLETED|Overall Study||1
10645599|NCT02132754|11805074|FG000|STARTED|Overall Study||1
10645600|NCT02132754|11805075|FG001|STARTED|Overall Study||1
10645601|NCT02132754|11805076|FG002|STARTED|Overall Study||1
10645602|NCT02132754|11805077|FG003|STARTED|Overall Study||1
10457345|NCT01010217|11605091|FG003|NOT COMPLETED|Overall Study||6
10645603|NCT02132754|11805078|FG004|STARTED|Overall Study||1
10645604|NCT02132754|11805079|FG005|STARTED|Overall Study||1
10645605|NCT02132754|11805080|FG006|STARTED|Overall Study||1
10645606|NCT02132754|11805081|FG007|STARTED|Overall Study||1
10645607|NCT02132754|11805082|FG008|STARTED|Overall Study||1
10645608|NCT02132754|11805083|FG009|STARTED|Overall Study||6
10645609|NCT02132754|11805084|FG010|STARTED|Overall Study||3
10645610|NCT02132754|11805085|FG011|STARTED|Overall Study||3
10645611|NCT02132754|11805086|FG012|STARTED|Overall Study||4
10645612|NCT02132754|11805087|FG013|STARTED|Overall Study||3
10645613|NCT02132754|11805088|FG014|STARTED|Overall Study||3
10645614|NCT02132754|11805089|FG015|STARTED|Overall Study||5
10645615|NCT02132754|11805090|FG016|STARTED|Overall Study||4
10645616|NCT02132754|11805091|FG017|STARTED|Overall Study||3
10645617|NCT02132754|11805092|FG018|STARTED|Overall Study||3
10645618|NCT02132754|11805093|FG019|STARTED|Overall Study||4
10645619|NCT02132754|11805094|FG020|STARTED|Overall Study||3
10645620|NCT02132754|11805095|FG021|STARTED|Overall Study||5
10645621|NCT02132754|11805096|FG022|STARTED|Overall Study||3
10645622|NCT02132754|11805097|FG023|STARTED|Overall Study||3
10645623|NCT02132754|11805098|FG024|STARTED|Overall Study||3
10645624|NCT02132754|11805099|FG025|STARTED|Overall Study||3
10645625|NCT02132754|11805100|FG026|STARTED|Overall Study||4
10645626|NCT02132754|11805101|FG027|STARTED|Overall Study||3
10645627|NCT02132754|11805102|FG028|STARTED|Overall Study||3
10645628|NCT02132754|11805103|FG029|STARTED|Overall Study||3
10645629|NCT02132754|11805104|FG030|STARTED|Overall Study||3
10645630|NCT02132754|11805105|FG031|STARTED|Overall Study||3
10645631|NCT02132754|11805106|FG032|STARTED|Overall Study||4
10645632|NCT02132754|11805107|FG033|STARTED|Overall Study||23
10645633|NCT02132754|11805074|FG000|Treated|Overall Study||1
10706212|NCT02606877|11870753|FG000|COMPLETED|Overall Study||16
10706213|NCT02606877|11870754|FG001|COMPLETED|Overall Study||16
10645634|NCT02132754|11805075|FG001|Treated|Overall Study||1
10645635|NCT02132754|11805076|FG002|Treated|Overall Study||1
10645636|NCT02132754|11805077|FG003|Treated|Overall Study||1
10645637|NCT02132754|11805078|FG004|Treated|Overall Study||1
10645638|NCT02132754|11805079|FG005|Treated|Overall Study||1
10645639|NCT02132754|11805080|FG006|Treated|Overall Study||1
10645640|NCT02132754|11805081|FG007|Treated|Overall Study||1
10645641|NCT02132754|11805082|FG008|Treated|Overall Study||1
10645642|NCT02132754|11805083|FG009|Treated|Overall Study||6
10645643|NCT02132754|11805084|FG010|Treated|Overall Study||3
10645644|NCT02132754|11805085|FG011|Treated|Overall Study||3
10645645|NCT02132754|11805086|FG012|Treated|Overall Study||3
10645646|NCT02132754|11805087|FG013|Treated|Overall Study||3
10645647|NCT02132754|11805088|FG014|Treated|Overall Study||3
10645648|NCT02132754|11805089|FG015|Treated|Overall Study||5
10645649|NCT02132754|11805090|FG016|Treated|Overall Study||4
10645650|NCT02132754|11805091|FG017|Treated|Overall Study||3
10645651|NCT02132754|11805092|FG018|Treated|Overall Study||3
10645652|NCT02132754|11805093|FG019|Treated|Overall Study||3
10645653|NCT02132754|11805094|FG020|Treated|Overall Study||3
10645654|NCT02132754|11805095|FG021|Treated|Overall Study||4
10645655|NCT02132754|11805096|FG022|Treated|Overall Study||3
10645656|NCT02132754|11805097|FG023|Treated|Overall Study||3
10645657|NCT02132754|11805098|FG024|Treated|Overall Study||3
10645658|NCT02132754|11805099|FG025|Treated|Overall Study||3
10645659|NCT02132754|11805100|FG026|Treated|Overall Study||4
10645660|NCT02132754|11805101|FG027|Treated|Overall Study||3
10645661|NCT02132754|11805102|FG028|Treated|Overall Study||3
10645662|NCT02132754|11805103|FG029|Treated|Overall Study||3
10645663|NCT02132754|11805104|FG030|Treated|Overall Study||3
10645664|NCT02132754|11805105|FG031|Treated|Overall Study||3
10645665|NCT02132754|11805106|FG032|Treated|Overall Study||4
10645666|NCT02132754|11805107|FG033|Treated|Overall Study||23
10645667|NCT02132754|11805074|FG000|COMPLETED|Overall Study||0
10645668|NCT02132754|11805075|FG001|COMPLETED|Overall Study||0
10645669|NCT02132754|11805076|FG002|COMPLETED|Overall Study||0
10645670|NCT02132754|11805077|FG003|COMPLETED|Overall Study||0
10645671|NCT02132754|11805078|FG004|COMPLETED|Overall Study||0
10645672|NCT02132754|11805079|FG005|COMPLETED|Overall Study||0
10645673|NCT02132754|11805080|FG006|COMPLETED|Overall Study||0
10645674|NCT02132754|11805081|FG007|COMPLETED|Overall Study||0
10645675|NCT02132754|11805082|FG008|COMPLETED|Overall Study||0
10645676|NCT02132754|11805083|FG009|COMPLETED|Overall Study||0
10645677|NCT02132754|11805084|FG010|COMPLETED|Overall Study||0
10645678|NCT02132754|11805085|FG011|COMPLETED|Overall Study||0
10645679|NCT02132754|11805086|FG012|COMPLETED|Overall Study||0
10645680|NCT02132754|11805087|FG013|COMPLETED|Overall Study||0
10645681|NCT02132754|11805088|FG014|COMPLETED|Overall Study||0
10645682|NCT02132754|11805089|FG015|COMPLETED|Overall Study||0
10645683|NCT02132754|11805090|FG016|COMPLETED|Overall Study||0
10645684|NCT02132754|11805091|FG017|COMPLETED|Overall Study||0
10645685|NCT02132754|11805092|FG018|COMPLETED|Overall Study||0
10706214|NCT02606877|11870753|FG000|NOT COMPLETED|Overall Study||4
10645686|NCT02132754|11805093|FG019|COMPLETED|Overall Study||0
10645687|NCT02132754|11805094|FG020|COMPLETED|Overall Study||0
10645688|NCT02132754|11805095|FG021|COMPLETED|Overall Study||0
10645689|NCT02132754|11805096|FG022|COMPLETED|Overall Study||0
10706215|NCT02606877|11870754|FG001|NOT COMPLETED|Overall Study||1
10645690|NCT02132754|11805097|FG023|COMPLETED|Overall Study||0
10645691|NCT02132754|11805098|FG024|COMPLETED|Overall Study||0
10645692|NCT02132754|11805099|FG025|COMPLETED|Overall Study||0
10645693|NCT02132754|11805100|FG026|COMPLETED|Overall Study||0
10645694|NCT02132754|11805101|FG027|COMPLETED|Overall Study||0
10645695|NCT02132754|11805102|FG028|COMPLETED|Overall Study||0
10645696|NCT02132754|11805103|FG029|COMPLETED|Overall Study||0
10645697|NCT02132754|11805104|FG030|COMPLETED|Overall Study||0
10645698|NCT02132754|11805105|FG031|COMPLETED|Overall Study||0
10645699|NCT02132754|11805106|FG032|COMPLETED|Overall Study||0
10645700|NCT02132754|11805107|FG033|COMPLETED|Overall Study||0
10645701|NCT02132754|11805074|FG000|NOT COMPLETED|Overall Study||1
10645702|NCT02132754|11805075|FG001|NOT COMPLETED|Overall Study||1
10645703|NCT02132754|11805076|FG002|NOT COMPLETED|Overall Study||1
10645704|NCT02132754|11805077|FG003|NOT COMPLETED|Overall Study||1
10645705|NCT02132754|11805078|FG004|NOT COMPLETED|Overall Study||1
10645706|NCT02132754|11805079|FG005|NOT COMPLETED|Overall Study||1
10645707|NCT02132754|11805080|FG006|NOT COMPLETED|Overall Study||1
10645708|NCT02132754|11805081|FG007|NOT COMPLETED|Overall Study||1
10645709|NCT02132754|11805082|FG008|NOT COMPLETED|Overall Study||1
10645710|NCT02132754|11805083|FG009|NOT COMPLETED|Overall Study||6
10645711|NCT02132754|11805084|FG010|NOT COMPLETED|Overall Study||3
10645712|NCT02132754|11805085|FG011|NOT COMPLETED|Overall Study||3
10645713|NCT02132754|11805086|FG012|NOT COMPLETED|Overall Study||4
10645714|NCT02132754|11805087|FG013|NOT COMPLETED|Overall Study||3
10645715|NCT02132754|11805088|FG014|NOT COMPLETED|Overall Study||3
10645716|NCT02132754|11805089|FG015|NOT COMPLETED|Overall Study||5
10645717|NCT02132754|11805090|FG016|NOT COMPLETED|Overall Study||4
10645718|NCT02132754|11805091|FG017|NOT COMPLETED|Overall Study||3
10645719|NCT02132754|11805092|FG018|NOT COMPLETED|Overall Study||3
10645720|NCT02132754|11805093|FG019|NOT COMPLETED|Overall Study||4
10645721|NCT02132754|11805094|FG020|NOT COMPLETED|Overall Study||3
10645722|NCT02132754|11805095|FG021|NOT COMPLETED|Overall Study||5
10645723|NCT02132754|11805096|FG022|NOT COMPLETED|Overall Study||3
10645724|NCT02132754|11805097|FG023|NOT COMPLETED|Overall Study||3
10645725|NCT02132754|11805098|FG024|NOT COMPLETED|Overall Study||3
10645726|NCT02132754|11805099|FG025|NOT COMPLETED|Overall Study||3
10645727|NCT02132754|11805100|FG026|NOT COMPLETED|Overall Study||4
10645728|NCT02132754|11805101|FG027|NOT COMPLETED|Overall Study||3
10645729|NCT02132754|11805102|FG028|NOT COMPLETED|Overall Study||3
10645730|NCT02132754|11805103|FG029|NOT COMPLETED|Overall Study||3
10645731|NCT02132754|11805104|FG030|NOT COMPLETED|Overall Study||3
10645732|NCT02132754|11805105|FG031|NOT COMPLETED|Overall Study||3
10645733|NCT02132754|11805106|FG032|NOT COMPLETED|Overall Study||4
10645734|NCT02132754|11805107|FG033|NOT COMPLETED|Overall Study||23
10645735|NCT02132767|11805219|FG000|STARTED|Overall Study||262
10645736|NCT02132767|11805220|FG001|STARTED|Overall Study||261
10645737|NCT02132767|11805219|FG000|COMPLETED|Overall Study||245
10645738|NCT02132767|11805220|FG001|COMPLETED|Overall Study||246
10645739|NCT02132767|11805219|FG000|NOT COMPLETED|Overall Study||17
10645740|NCT02132767|11805220|FG001|NOT COMPLETED|Overall Study||15
10645741|NCT02132832|11805228|FG000|STARTED|Overall Study||19
10645742|NCT02132832|11805229|FG001|STARTED|Overall Study||23
10645743|NCT02132832|11805228|FG000|COMPLETED|Overall Study||16
10645744|NCT02132832|11805229|FG001|COMPLETED|Overall Study||16
10645745|NCT02132832|11805228|FG000|NOT COMPLETED|Overall Study||3
10645746|NCT02132832|11805229|FG001|NOT COMPLETED|Overall Study||7
10645747|NCT02132910|11805237|FG000|STARTED|Overall Study||34
10645748|NCT02132910|11805238|FG001|STARTED|Overall Study||34
10645749|NCT02132910|11805237|FG000|COMPLETED|Overall Study||34
10645750|NCT02132910|11805238|FG001|COMPLETED|Overall Study||34
10645751|NCT02132910|11805237|FG000|NOT COMPLETED|Overall Study||0
10645752|NCT02132910|11805238|FG001|NOT COMPLETED|Overall Study||0
10645753|NCT02132936|11805248|FG000|STARTED|Overall Study||185
10645754|NCT02132936|11805249|FG001|STARTED|Overall Study||47
10645755|NCT02132936|11805250|FG002|STARTED|Overall Study||188
10645756|NCT02132936|11805251|FG003|STARTED|Overall Study||43
10645757|NCT02132936|11805248|FG000|COMPLETED|Overall Study||175
10645758|NCT02132936|11805249|FG001|COMPLETED|Overall Study||38
10645759|NCT02132936|11805250|FG002|COMPLETED|Overall Study||174
10645760|NCT02132936|11805251|FG003|COMPLETED|Overall Study||29
10645761|NCT02132936|11805248|FG000|NOT COMPLETED|Overall Study||10
10645762|NCT02132936|11805249|FG001|NOT COMPLETED|Overall Study||9
10645763|NCT02132936|11805250|FG002|NOT COMPLETED|Overall Study||14
10645764|NCT02132936|11805251|FG003|NOT COMPLETED|Overall Study||14
10645765|NCT02132949|11805264|FG000|STARTED|Overall Study||199
10645766|NCT02132949|11805265|FG001|STARTED|Overall Study|1 participant enrolled in Cohort B received Cohort A treatment (and was counted as part of Cohort B for efficacy).|201
10645767|NCT02132949|11805264|FG000|Received Any Cohort A Study Treatment|Overall Study|1 participant withdrew prior to receiving any study drug.|198
10645768|NCT02132949|11805265|FG001|Received Any Cohort A Study Treatment|Overall Study|1 participant enrolled in Cohort B received Cohort A treatment (and was counted as part of Cohort A for safety).|1
10645769|NCT02132949|11805264|FG000|Received Any Cohort B Study Treatment|Overall Study||0
10645770|NCT02132949|11805265|FG001|Received Any Cohort B Study Treatment|Overall Study|2 participants withdrew prior to receiving any study drug.|198
10645771|NCT02132949|11805264|FG000|Underwent Surgery|Overall Study||187
10645772|NCT02132949|11805265|FG001|Underwent Surgery|Overall Study||194
10645773|NCT02132949|11805264|FG000|Completed Neoadjuvant Treatment (25 Weeks)|Overall Study||182
10645774|NCT02132949|11805265|FG001|Completed Neoadjuvant Treatment (25 Weeks)|Overall Study||189
10645775|NCT02132949|11805264|FG000|Started Adjuvant Treatment|Overall Study||181
10645776|NCT02132949|11805265|FG001|Started Adjuvant Treatment|Overall Study|1 participant did not complete neoadjuvant treatment but started adjuvant treatment.|190
10645777|NCT02132949|11805264|FG000|Completed Adjuvant Treatment (Up to 39 Weeks)|Overall Study||163
10645778|NCT02132949|11805265|FG001|Completed Adjuvant Treatment (Up to 39 Weeks)|Overall Study||176
10645779|NCT02132949|11805264|FG000|Started Treatment-Free Follow-Up (Up to 5 Years)|Overall Study||195
10645780|NCT02132949|11805265|FG001|Started Treatment-Free Follow-Up (Up to 5 Years)|Overall Study||195
10645781|NCT02132949|11805264|FG000|COMPLETED|Overall Study||158
10645782|NCT02132949|11805265|FG001|COMPLETED|Overall Study||173
10645783|NCT02132949|11805264|FG000|NOT COMPLETED|Overall Study||41
10645784|NCT02132949|11805265|FG001|NOT COMPLETED|Overall Study||28
10645785|NCT02133001|11805273|FG000|STARTED|Double Blind (Day 1-25)||32
10645786|NCT02133001|11805274|FG001|STARTED|Double Blind (Day 1-25)||36
10645787|NCT02133001|11805273|FG000|Safety|Double Blind (Day 1-25)||31
10645788|NCT02133001|11805274|FG001|Safety|Double Blind (Day 1-25)||35
10645789|NCT02133001|11805273|FG000|COMPLETED|Double Blind (Day 1-25)|Participants who completed continued to follow-up phase.|22
10645790|NCT02133001|11805274|FG001|COMPLETED|Double Blind (Day 1-25)|Participants who completed continued to follow-up phase.|27
10645791|NCT02133001|11805273|FG000|NOT COMPLETED|Double Blind (Day 1-25)||10
10645792|NCT02133001|11805274|FG001|NOT COMPLETED|Double Blind (Day 1-25)||9
10645793|NCT02133001|11805273|FG000|STARTED|Follow-Up Phase (Day 26-81)||22
10645794|NCT02133001|11805274|FG001|STARTED|Follow-Up Phase (Day 26-81)||27
10645795|NCT02133001|11805273|FG000|COMPLETED|Follow-Up Phase (Day 26-81)||20
10645796|NCT02133001|11805274|FG001|COMPLETED|Follow-Up Phase (Day 26-81)||24
10645797|NCT02133001|11805273|FG000|NOT COMPLETED|Follow-Up Phase (Day 26-81)||2
10645798|NCT02133001|11805274|FG001|NOT COMPLETED|Follow-Up Phase (Day 26-81)||3
10645799|NCT02133066|11805284|FG000|STARTED|Overall Study||64
10645800|NCT02133066|11805285|FG001|STARTED|Overall Study||64
10645801|NCT02133066|11805284|FG000|COMPLETED|Overall Study||64
10645802|NCT02133066|11805285|FG001|COMPLETED|Overall Study||64
10645803|NCT02133066|11805284|FG000|NOT COMPLETED|Overall Study||0
10645804|NCT02133066|11805285|FG001|NOT COMPLETED|Overall Study||0
10645805|NCT02133131|11805298|FG000|STARTED|Overall Study||31
10645806|NCT02133131|11805299|FG001|STARTED|Overall Study||30
10645807|NCT02133131|11805300|FG002|STARTED|Overall Study||20
10645808|NCT02133131|11805301|FG003|STARTED|Overall Study||21
10645809|NCT02133131|11805302|FG004|STARTED|Overall Study||15
10645810|NCT02133131|11805303|FG005|STARTED|Overall Study||14
10645811|NCT02133131|11805304|FG006|STARTED|Overall Study||12
10645812|NCT02133131|11805298|FG000|COMPLETED|Overall Study||26
10645813|NCT02133131|11805299|FG001|COMPLETED|Overall Study||25
10645814|NCT02133131|11805300|FG002|COMPLETED|Overall Study||19
10645815|NCT02133131|11805301|FG003|COMPLETED|Overall Study||15
10645816|NCT02133131|11805302|FG004|COMPLETED|Overall Study||0
10645817|NCT02133131|11805303|FG005|COMPLETED|Overall Study||0
10645818|NCT02133131|11805304|FG006|COMPLETED|Overall Study||0
10645819|NCT02133131|11805298|FG000|NOT COMPLETED|Overall Study||5
10645820|NCT02133131|11805299|FG001|NOT COMPLETED|Overall Study||5
10645821|NCT02133131|11805300|FG002|NOT COMPLETED|Overall Study||1
10645822|NCT02133131|11805301|FG003|NOT COMPLETED|Overall Study||6
10645823|NCT02133131|11805302|FG004|NOT COMPLETED|Overall Study||15
10645824|NCT02133131|11805303|FG005|NOT COMPLETED|Overall Study||14
10645825|NCT02133131|11805304|FG006|NOT COMPLETED|Overall Study||12
10645826|NCT02133235|11805322|FG000|STARTED|Overall Study||55
10645827|NCT02133235|11805323|FG001|STARTED|Overall Study||57
10645828|NCT02133235|11805322|FG000|COMPLETED|Overall Study||55
10645829|NCT02133235|11805323|FG001|COMPLETED|Overall Study||57
10645830|NCT02133235|11805322|FG000|NOT COMPLETED|Overall Study||0
10645831|NCT02133235|11805323|FG001|NOT COMPLETED|Overall Study||0
10645832|NCT02133352|11805335|FG000|STARTED|Main Study (180 Day)||10
10645833|NCT02133352|11805335|FG000|COMPLETED|Main Study (180 Day)||10
10645834|NCT02133352|11805335|FG000|NOT COMPLETED|Main Study (180 Day)||0
10645835|NCT02133352|11805335|FG000|STARTED|Longer Term Extension||10
10645836|NCT02133352|11805335|FG000|COMPLETED|Longer Term Extension||4
10645837|NCT02133352|11805335|FG000|NOT COMPLETED|Longer Term Extension||6
10645838|NCT02133508|11805339|FG000|STARTED|Overall Study||156
10645839|NCT02133508|11805339|FG000|COMPLETED|Overall Study||141
10645840|NCT02133508|11805339|FG000|NOT COMPLETED|Overall Study||15
10645841|NCT02133664|11805345|FG000|STARTED|Overall Study||26
10645842|NCT02133664|11805346|FG001|STARTED|Overall Study||28
10645843|NCT02133664|11805345|FG000|COMPLETED|Overall Study||21
10645844|NCT02133664|11805346|FG001|COMPLETED|Overall Study||21
10645845|NCT02133664|11805345|FG000|NOT COMPLETED|Overall Study||5
10645846|NCT02133664|11805346|FG001|NOT COMPLETED|Overall Study||7
10645847|NCT02133742|11805352|FG000|STARTED|Period 1: Dose Finding Phase (6 Months)||11
10645848|NCT02133742|11805352|FG000|COMPLETED|Period 1: Dose Finding Phase (6 Months)||11
10645849|NCT02133742|11805352|FG000|NOT COMPLETED|Period 1: Dose Finding Phase (6 Months)||0
10645850|NCT02133742|11805352|FG000|STARTED|Period 2:Dose Expansion Phase (1344days)|Participants participated in dose finding phase continued treatment in dose expansion phase.|52
10645851|NCT02133742|11805352|FG000|COMPLETED|Period 2:Dose Expansion Phase (1344days)||0
10645852|NCT02133742|11805352|FG000|NOT COMPLETED|Period 2:Dose Expansion Phase (1344days)||52
10645853|NCT02133781|11805361|FG000|STARTED|Overall Study||6
10645854|NCT02133781|11805362|FG001|STARTED|Overall Study||24
10645855|NCT02133781|11805363|FG002|STARTED|Overall Study||21
10645856|NCT02133781|11805361|FG000|COMPLETED|Overall Study||6
10645857|NCT02133781|11805362|FG001|COMPLETED|Overall Study||24
10645858|NCT02133781|11805363|FG002|COMPLETED|Overall Study||21
10645859|NCT02133781|11805361|FG000|NOT COMPLETED|Overall Study||0
10645860|NCT02133781|11805362|FG001|NOT COMPLETED|Overall Study||0
10645861|NCT02133781|11805363|FG002|NOT COMPLETED|Overall Study||0
10645862|NCT02134015|11805373|FG000|STARTED|Overall Study||71
10645863|NCT02134015|11805374|FG001|STARTED|Overall Study||74
10645864|NCT02134015|11805373|FG000|COMPLETED|Overall Study||0
10645865|NCT02134015|11805374|FG001|COMPLETED|Overall Study||0
10645866|NCT02134015|11805373|FG000|NOT COMPLETED|Overall Study||71
10645867|NCT02134015|11805374|FG001|NOT COMPLETED|Overall Study||74
10645868|NCT02134119|11805382|FG000|STARTED|Overall Study||30
10645869|NCT02134119|11805383|FG001|STARTED|Overall Study||15
10645870|NCT02134119|11805382|FG000|COMPLETED|Overall Study||30
10645871|NCT02134119|11805383|FG001|COMPLETED|Overall Study||15
10645872|NCT02134119|11805382|FG000|NOT COMPLETED|Overall Study||0
10645873|NCT02134119|11805383|FG001|NOT COMPLETED|Overall Study||0
10645874|NCT02134184|11805392|FG000|STARTED|Overall Study||33
10645875|NCT02134184|11805393|FG001|STARTED|Overall Study||37
10645876|NCT02134184|11805394|FG002|STARTED|Overall Study||8
10645877|NCT02134184|11805392|FG000|COMPLETED|Overall Study||33
10645878|NCT02134184|11805393|FG001|COMPLETED|Overall Study||37
10645879|NCT02134184|11805394|FG002|COMPLETED|Overall Study||8
10645880|NCT02134184|11805392|FG000|NOT COMPLETED|Overall Study||0
10645881|NCT02134184|11805393|FG001|NOT COMPLETED|Overall Study||0
10645882|NCT02134184|11805394|FG002|NOT COMPLETED|Overall Study||0
10645883|NCT02134210|11805404|FG000|STARTED|Part One: Weeks 0-12||260
10645884|NCT02134210|11805405|FG001|STARTED|Part One: Weeks 0-12||261
10645885|NCT02134210|11805404|FG000|COMPLETED|Part One: Weeks 0-12||241
10645886|NCT02134210|11805405|FG001|COMPLETED|Part One: Weeks 0-12||255
10645887|NCT02134210|11805404|FG000|NOT COMPLETED|Part One: Weeks 0-12||19
10645888|NCT02134210|11805405|FG001|NOT COMPLETED|Part One: Weeks 0-12||6
10645889|NCT02134210|11805404|FG000|STARTED|Part Two: Weeks 13-48||241
10645890|NCT02134210|11805405|FG001|STARTED|Part Two: Weeks 13-48||255
10645891|NCT02134210|11805404|FG000|COMPLETED|Part Two: Weeks 13-48||211
10645892|NCT02134210|11805405|FG001|COMPLETED|Part Two: Weeks 13-48||227
10645893|NCT02134210|11805404|FG000|NOT COMPLETED|Part Two: Weeks 13-48||30
10645894|NCT02134210|11805405|FG001|NOT COMPLETED|Part Two: Weeks 13-48||28
10645895|NCT02134314|11805413|FG000|STARTED|Overall Study||35
10645896|NCT02134314|11805414|FG001|STARTED|Overall Study||35
10645897|NCT02134314|11805413|FG000|COMPLETED|Overall Study||34
10645898|NCT02134314|11805414|FG001|COMPLETED|Overall Study||34
10645899|NCT02134314|11805413|FG000|NOT COMPLETED|Overall Study||1
10645900|NCT02134314|11805414|FG001|NOT COMPLETED|Overall Study||1
10645901|NCT02134353|11805423|FG000|STARTED|Overall Study||209
10645902|NCT02134353|11805424|FG001|STARTED|Overall Study||214
10645903|NCT02134353|11805423|FG000|COMPLETED|Overall Study||183
10645904|NCT02134353|11805424|FG001|COMPLETED|Overall Study||190
10645905|NCT02134353|11805423|FG000|NOT COMPLETED|Overall Study||26
10645906|NCT02134353|11805424|FG001|NOT COMPLETED|Overall Study||24
10645907|NCT02134522|11805430|FG000|STARTED|Overall Study||1
10645908|NCT02134522|11805430|FG000|COMPLETED|Overall Study||1
10645909|NCT02134522|11805430|FG000|NOT COMPLETED|Overall Study||0
10645910|NCT02134587|11805434|FG000|STARTED|Overall Study||203
10645911|NCT02134587|11805434|FG000|COMPLETED|Overall Study||173
10645912|NCT02134587|11805434|FG000|NOT COMPLETED|Overall Study||30
10645913|NCT02134756|11805445|FG000|STARTED|Overall Study||15
10645914|NCT02134756|11805446|FG001|STARTED|Overall Study||15
10645915|NCT02134756|11805445|FG000|COMPLETED|Overall Study||14
10645916|NCT02134756|11805446|FG001|COMPLETED|Overall Study||13
10645917|NCT02134756|11805445|FG000|NOT COMPLETED|Overall Study||1
10645918|NCT02134756|11805446|FG001|NOT COMPLETED|Overall Study||2
10645919|NCT02134951|11805454|FG000|STARTED|Overall Study||39
10645920|NCT02134951|11805455|FG001|STARTED|Overall Study||20
10645921|NCT02134951|11805454|FG000|COMPLETED|Overall Study|number of subjects with at least one valid scan|39
10645922|NCT02134951|11805455|FG001|COMPLETED|Overall Study|number of subjects with at least one valid scan|20
10645923|NCT02134951|11805454|FG000|NOT COMPLETED|Overall Study||0
10645924|NCT02134951|11805455|FG001|NOT COMPLETED|Overall Study||0
10645925|NCT02134977|11805461|FG000|STARTED|Overall Study||2816
10645926|NCT02134977|11805461|FG000|COMPLETED|Overall Study||2714
10645927|NCT02134977|11805461|FG000|NOT COMPLETED|Overall Study||102
10645928|NCT02135016|11805468|FG000|STARTED|Overall Study||15
10645929|NCT02135016|11805469|FG001|STARTED|Overall Study||15
10645930|NCT02135016|11805470|FG002|STARTED|Overall Study||15
10645931|NCT02135016|11805468|FG000|COMPLETED|Overall Study||15
10645932|NCT02135016|11805469|FG001|COMPLETED|Overall Study||15
10645933|NCT02135016|11805470|FG002|COMPLETED|Overall Study||15
10645934|NCT02135016|11805468|FG000|NOT COMPLETED|Overall Study||0
10645935|NCT02135016|11805469|FG001|NOT COMPLETED|Overall Study||0
10645936|NCT02135016|11805470|FG002|NOT COMPLETED|Overall Study||0
10645937|NCT02135094|11805480|FG000|STARTED|Overall Study||25
10645938|NCT02135094|11805481|FG001|STARTED|Overall Study||8
10706216|NCT02606903|11870764|FG000|STARTED|Overall Study||35
10706217|NCT02606903|11870765|FG001|STARTED|Overall Study||36
10706218|NCT02606903|11870764|FG000|COMPLETED|Overall Study||35
10706219|NCT02606903|11870765|FG001|COMPLETED|Overall Study||36
10645939|NCT02135094|11805480|FG000|Week 2|Overall Study||25
10645940|NCT02135094|11805481|FG001|Week 2|Overall Study||8
10645941|NCT02135094|11805480|FG000|Week 3|Overall Study||25
10645942|NCT02135094|11805481|FG001|Week 3|Overall Study||8
10645943|NCT02135094|11805480|FG000|Week 4|Overall Study||25
10645944|NCT02135094|11805481|FG001|Week 4|Overall Study||8
10645945|NCT02135094|11805480|FG000|COMPLETED|Overall Study||25
10645946|NCT02135094|11805481|FG001|COMPLETED|Overall Study||8
10645947|NCT02135094|11805480|FG000|NOT COMPLETED|Overall Study||0
10645948|NCT02135094|11805481|FG001|NOT COMPLETED|Overall Study||0
10645949|NCT02135107|11805489|FG000|STARTED|Treatment Period||437
10645950|NCT02135107|11805490|FG001|STARTED|Treatment Period||80
10645951|NCT02135107|11805491|FG002|STARTED|Treatment Period||0
10645952|NCT02135107|11805492|FG003|STARTED|Treatment Period||0
10645953|NCT02135107|11805489|FG000|COMPLETED|Treatment Period||305
10645954|NCT02135107|11805490|FG001|COMPLETED|Treatment Period||54
10645955|NCT02135107|11805491|FG002|COMPLETED|Treatment Period||0
10645956|NCT02135107|11805492|FG003|COMPLETED|Treatment Period||0
10645957|NCT02135107|11805489|FG000|NOT COMPLETED|Treatment Period||132
10645958|NCT02135107|11805490|FG001|NOT COMPLETED|Treatment Period||26
10645959|NCT02135107|11805491|FG002|NOT COMPLETED|Treatment Period||0
10645960|NCT02135107|11805492|FG003|NOT COMPLETED|Treatment Period||0
10645961|NCT02135107|11805489|FG000|STARTED|Maintenance Therapy Period|Treatment Phase only|0
10645962|NCT02135107|11805490|FG001|STARTED|Maintenance Therapy Period|Treatment Phase only|0
10645963|NCT02135107|11805491|FG002|STARTED|Maintenance Therapy Period|Only eligible participants entered into the Maintenance Therapy Period|178
10645964|NCT02135107|11805492|FG003|STARTED|Maintenance Therapy Period|Only eligible participants entered into the Maintenance Therapy Period|181
10645965|NCT02135107|11805489|FG000|COMPLETED|Maintenance Therapy Period||0
10645966|NCT02135107|11805490|FG001|COMPLETED|Maintenance Therapy Period||0
10645967|NCT02135107|11805491|FG002|COMPLETED|Maintenance Therapy Period||163
10645968|NCT02135107|11805492|FG003|COMPLETED|Maintenance Therapy Period||161
10645969|NCT02135107|11805489|FG000|NOT COMPLETED|Maintenance Therapy Period||0
10645970|NCT02135107|11805490|FG001|NOT COMPLETED|Maintenance Therapy Period||0
10645971|NCT02135107|11805491|FG002|NOT COMPLETED|Maintenance Therapy Period||15
10645972|NCT02135107|11805492|FG003|NOT COMPLETED|Maintenance Therapy Period||20
10645973|NCT02135146|11805506|FG000|STARTED|Overall Study||20
10645974|NCT02135146|11805507|FG001|STARTED|Overall Study||20
10645975|NCT02135146|11805506|FG000|COMPLETED|Overall Study||20
10645976|NCT02135146|11805507|FG001|COMPLETED|Overall Study||20
10645977|NCT02135146|11805506|FG000|NOT COMPLETED|Overall Study||0
10645978|NCT02135146|11805507|FG001|NOT COMPLETED|Overall Study||0
10645979|NCT02135432|11805515|FG000|STARTED|Overall Study||8
10645980|NCT02135432|11805516|FG001|STARTED|Overall Study||4
10645981|NCT02135432|11805515|FG000|COMPLETED|Overall Study||8
10645982|NCT02135432|11805516|FG001|COMPLETED|Overall Study||4
10645983|NCT02135432|11805515|FG000|NOT COMPLETED|Overall Study||0
10645984|NCT02135432|11805516|FG001|NOT COMPLETED|Overall Study||0
10645985|NCT02135445|11805525|FG000|STARTED|Overall Study||65
10645986|NCT02135445|11805526|FG001|STARTED|Overall Study||38
10645987|NCT02135445|11805525|FG000|COMPLETED|Overall Study||63
10645988|NCT02135445|11805526|FG001|COMPLETED|Overall Study||38
10645989|NCT02135445|11805525|FG000|NOT COMPLETED|Overall Study||2
10645990|NCT02135445|11805526|FG001|NOT COMPLETED|Overall Study||0
10645991|NCT02135614|11805534|FG000|STARTED|Overall Study||94
10645992|NCT02135614|11805535|FG001|STARTED|Overall Study||95
10645993|NCT02135614|11805534|FG000|COMPLETED|Overall Study||86
10645994|NCT02135614|11805535|FG001|COMPLETED|Overall Study||90
10645995|NCT02135614|11805534|FG000|NOT COMPLETED|Overall Study||8
10645996|NCT02135614|11805535|FG001|NOT COMPLETED|Overall Study||5
10645997|NCT02135653|11805543|FG000|STARTED|Overall Study||35
10645998|NCT02135653|11805544|FG001|STARTED|Overall Study||33
10645999|NCT02135653|11805543|FG000|COMPLETED|Overall Study||22
10646000|NCT02135653|11805544|FG001|COMPLETED|Overall Study||28
10646001|NCT02135653|11805543|FG000|NOT COMPLETED|Overall Study||13
10646002|NCT02135653|11805544|FG001|NOT COMPLETED|Overall Study||5
10654383|NCT02202499|11815127|FG000|NOT COMPLETED|Overall Study||2
10654384|NCT02202499|11815128|FG001|NOT COMPLETED|Overall Study||0
10654385|NCT02202499|11815129|FG002|NOT COMPLETED|Overall Study||2
10654386|NCT02202538|11815142|FG000|STARTED|Overall Study||53
10654387|NCT02202538|11815142|FG000|Screen Failure|Overall Study||2
10654388|NCT02202538|11815142|FG000|COMPLETED|Overall Study||45
10654389|NCT02202538|11815142|FG000|NOT COMPLETED|Overall Study||8
10654390|NCT02202551|11815150|FG000|STARTED|Overall Study||60
10654391|NCT02202551|11815151|FG001|STARTED|Overall Study||78
10654392|NCT02202551|11815152|FG002|STARTED|Overall Study||24
10654393|NCT02202551|11815153|FG003|STARTED|Overall Study||61
10654394|NCT02202551|11815150|FG000|COMPLETED|Overall Study||35
10654395|NCT02202551|11815151|FG001|COMPLETED|Overall Study||41
10654396|NCT02202551|11815152|FG002|COMPLETED|Overall Study||14
10654397|NCT02202551|11815153|FG003|COMPLETED|Overall Study||39
10654398|NCT02202551|11815150|FG000|NOT COMPLETED|Overall Study||25
10654399|NCT02202551|11815151|FG001|NOT COMPLETED|Overall Study||37
10654400|NCT02202551|11815152|FG002|NOT COMPLETED|Overall Study||10
10654401|NCT02202551|11815153|FG003|NOT COMPLETED|Overall Study||22
10654402|NCT02202616|11815167|FG000|STARTED|Overall Study||401
10706220|NCT02606903|11870764|FG000|NOT COMPLETED|Overall Study||0
10646003|NCT02135692|11805552|FG000|STARTED|Overall Study||339
10646004|NCT02135692|11805552|FG000|COMPLETED|Overall Study||0
10646005|NCT02135692|11805552|FG000|NOT COMPLETED|Overall Study||339
10646006|NCT02135848|11805558|FG000|STARTED|Overall Study||26
10646007|NCT02135848|11805559|FG001|STARTED|Overall Study||20
10646008|NCT02135848|11805558|FG000|COMPLETED|Overall Study||23
10646009|NCT02135848|11805559|FG001|COMPLETED|Overall Study||19
10646010|NCT02135848|11805558|FG000|NOT COMPLETED|Overall Study||3
10646011|NCT02135848|11805559|FG001|NOT COMPLETED|Overall Study||1
10646012|NCT02135861|11805575|FG000|STARTED|Overall Study||21
10646013|NCT02135861|11805576|FG001|STARTED|Overall Study||12
10646014|NCT02135861|11805577|FG002|STARTED|Overall Study||3
10646015|NCT02135861|11805575|FG000|COMPLETED|Overall Study||21
10646016|NCT02135861|11805576|FG001|COMPLETED|Overall Study||12
10646017|NCT02135861|11805577|FG002|COMPLETED|Overall Study||3
10646018|NCT02135861|11805575|FG000|NOT COMPLETED|Overall Study||0
10646019|NCT02135861|11805576|FG001|NOT COMPLETED|Overall Study||0
10646020|NCT02135861|11805577|FG002|NOT COMPLETED|Overall Study||0
10646021|NCT02135900|11805587|FG000|STARTED|Overall Study|32 subjects started the study. 50 subjects were screened.|32
10646022|NCT02135900|11805587|FG000|COMPLETED|Overall Study||32
10646023|NCT02135900|11805587|FG000|NOT COMPLETED|Overall Study||0
10646024|NCT02136004|11805593|FG000|STARTED|Overall Study|Enrollment commenced on May 20, 2014 and the last subject completed follow-up on February 28, 2015|220
10646025|NCT02136004|11805593|FG000|COMPLETED|Overall Study||219
10646026|NCT02136004|11805593|FG000|NOT COMPLETED|Overall Study||1
10646027|NCT02136238|11805599|FG000|STARTED|Overall Study||4
10646028|NCT02136238|11805600|FG001|STARTED|Overall Study||4
10646029|NCT02136238|11805601|FG002|STARTED|Overall Study||10
10646030|NCT02136238|11805599|FG000|COMPLETED|Overall Study||4
10646031|NCT02136238|11805600|FG001|COMPLETED|Overall Study||4
10646032|NCT02136238|11805601|FG002|COMPLETED|Overall Study||10
10646033|NCT02136238|11805599|FG000|NOT COMPLETED|Overall Study||0
10646034|NCT02136238|11805600|FG001|NOT COMPLETED|Overall Study||0
10646035|NCT02136238|11805601|FG002|NOT COMPLETED|Overall Study||0
10646036|NCT02136420|11805616|FG000|STARTED|Overall Study||10
10646037|NCT02136420|11805617|FG001|STARTED|Overall Study||0
10646038|NCT02136420|11805618|FG002|STARTED|Overall Study||0
10646039|NCT02136420|11805619|FG003|STARTED|Overall Study||0
10646040|NCT02136420|11805620|FG004|STARTED|Overall Study||10
10646041|NCT02136420|11805621|FG005|STARTED|Overall Study||0
10646042|NCT02136420|11805622|FG006|STARTED|Overall Study||0
10646043|NCT02136420|11805623|FG007|STARTED|Overall Study||0
10646044|NCT02136420|11805624|FG008|STARTED|Overall Study||5
10646045|NCT02136420|11805625|FG009|STARTED|Overall Study||5
10646046|NCT02136420|11805616|FG000|COMPLETED|Overall Study||9
10646047|NCT02136420|11805617|FG001|COMPLETED|Overall Study||0
10646048|NCT02136420|11805618|FG002|COMPLETED|Overall Study||0
10646049|NCT02136420|11805619|FG003|COMPLETED|Overall Study||0
10646050|NCT02136420|11805620|FG004|COMPLETED|Overall Study||10
10646051|NCT02136420|11805621|FG005|COMPLETED|Overall Study||0
10646052|NCT02136420|11805622|FG006|COMPLETED|Overall Study||0
10646053|NCT02136420|11805623|FG007|COMPLETED|Overall Study||0
10646054|NCT02136420|11805624|FG008|COMPLETED|Overall Study||5
10646055|NCT02136420|11805625|FG009|COMPLETED|Overall Study||5
10706221|NCT02606903|11870765|FG001|NOT COMPLETED|Overall Study||0
10706222|NCT02607124|11870771|FG000|STARTED|Overall Study|11 participants were enrolled however 1 participant withdrew before starting study treatment.|10
10706223|NCT02607124|11870771|FG000|COMPLETED|Overall Study||10
10706224|NCT02607124|11870771|FG000|NOT COMPLETED|Overall Study||0
10706225|NCT02607228|11870783|FG000|STARTED|Overall Study||5
10706226|NCT02607228|11870784|FG001|STARTED|Overall Study||4
10646056|NCT02136420|11805616|FG000|NOT COMPLETED|Overall Study||1
10646057|NCT02136420|11805617|FG001|NOT COMPLETED|Overall Study||0
10646058|NCT02136420|11805618|FG002|NOT COMPLETED|Overall Study||0
10646059|NCT02136420|11805619|FG003|NOT COMPLETED|Overall Study||0
10646060|NCT02136420|11805620|FG004|NOT COMPLETED|Overall Study||0
10646061|NCT02136420|11805621|FG005|NOT COMPLETED|Overall Study||0
10646062|NCT02136420|11805622|FG006|NOT COMPLETED|Overall Study||0
10646063|NCT02136420|11805623|FG007|NOT COMPLETED|Overall Study||0
10646064|NCT02136420|11805624|FG008|NOT COMPLETED|Overall Study||0
10646065|NCT02136420|11805625|FG009|NOT COMPLETED|Overall Study||0
10646066|NCT02136498|11805642|FG000|STARTED|Overall Study||33
10646067|NCT02136498|11805643|FG001|STARTED|Overall Study||33
10646068|NCT02136498|11805642|FG000|COMPLETED|Overall Study||33
10646069|NCT02136498|11805643|FG001|COMPLETED|Overall Study||33
10646070|NCT02136498|11805642|FG000|NOT COMPLETED|Overall Study||0
10646071|NCT02136498|11805643|FG001|NOT COMPLETED|Overall Study||0
10646072|NCT02136576|11805652|FG000|STARTED|Overall Study||13
10646073|NCT02136576|11805653|FG001|STARTED|Overall Study||13
10646074|NCT02136576|11805654|FG002|STARTED|Overall Study||13
10646075|NCT02136576|11805652|FG000|COMPLETED|Overall Study||11
10646076|NCT02136576|11805653|FG001|COMPLETED|Overall Study||13
10646077|NCT02136576|11805654|FG002|COMPLETED|Overall Study||13
10646078|NCT02136576|11805652|FG000|NOT COMPLETED|Overall Study||2
10646079|NCT02136576|11805653|FG001|NOT COMPLETED|Overall Study||0
10646080|NCT02136576|11805654|FG002|NOT COMPLETED|Overall Study||0
10646081|NCT02136680|11805664|FG000|STARTED|Overall Study||112
10646082|NCT02136680|11805665|FG001|STARTED|Overall Study||85
10646083|NCT02136680|11805664|FG000|Interview 1|Overall Study||112
10646084|NCT02136680|11805665|FG001|Interview 1|Overall Study||85
10646085|NCT02136680|11805664|FG000|Interview 2|Overall Study||97
10646086|NCT02136680|11805665|FG001|Interview 2|Overall Study||70
10706227|NCT02607228|11870785|FG002|STARTED|Overall Study||3
10646087|NCT02136680|11805664|FG000|Interview 3|Overall Study||80
10646088|NCT02136680|11805665|FG001|Interview 3|Overall Study||56
10646089|NCT02136680|11805664|FG000|COMPLETED|Overall Study||80
10646090|NCT02136680|11805665|FG001|COMPLETED|Overall Study||56
10646091|NCT02136680|11805664|FG000|NOT COMPLETED|Overall Study||32
10646092|NCT02136680|11805665|FG001|NOT COMPLETED|Overall Study||29
10646093|NCT02136810|11805671|FG000|STARTED|Overall Study||200
10646094|NCT02136810|11805671|FG000|COMPLETED|Overall Study||200
10646095|NCT02136810|11805671|FG000|NOT COMPLETED|Overall Study||0
10706228|NCT02607228|11870786|FG003|STARTED|Overall Study||6
10646096|NCT02136914|11805677|FG000|STARTED|Overall Study||63
10646097|NCT02136914|11805678|FG001|STARTED|Overall Study||63
10646098|NCT02136914|11805677|FG000|Received Study Drug|Overall Study||60
10646099|NCT02136914|11805678|FG001|Received Study Drug|Overall Study||63
10646100|NCT02136914|11805677|FG000|COMPLETED|Overall Study||42
10646101|NCT02136914|11805678|FG001|COMPLETED|Overall Study||42
10646102|NCT02136914|11805677|FG000|NOT COMPLETED|Overall Study||21
10646103|NCT02136914|11805678|FG001|NOT COMPLETED|Overall Study||21
10646104|NCT02137226|11805686|FG000|STARTED|Period 1 (Initial Randomization)||324
10646105|NCT02137226|11805687|FG001|STARTED|Period 1 (Initial Randomization)||321
10646106|NCT02137226|11805688|FG002|STARTED|Period 1 (Initial Randomization)||0
10646107|NCT02137226|11805689|FG003|STARTED|Period 1 (Initial Randomization)||0
10646108|NCT02137226|11805690|FG004|STARTED|Period 1 (Initial Randomization)||0
10646109|NCT02137226|11805686|FG000|COMPLETED|Period 1 (Initial Randomization)|Not completed are discontinued from study|304
10646110|NCT02137226|11805687|FG001|COMPLETED|Period 1 (Initial Randomization)|Not completed are discontinued from study|305
10646111|NCT02137226|11805688|FG002|COMPLETED|Period 1 (Initial Randomization)||0
10646112|NCT02137226|11805689|FG003|COMPLETED|Period 1 (Initial Randomization)||0
10646113|NCT02137226|11805690|FG004|COMPLETED|Period 1 (Initial Randomization)||0
10646114|NCT02137226|11805686|FG000|NOT COMPLETED|Period 1 (Initial Randomization)||20
10646115|NCT02137226|11805687|FG001|NOT COMPLETED|Period 1 (Initial Randomization)||16
10646116|NCT02137226|11805688|FG002|NOT COMPLETED|Period 1 (Initial Randomization)||0
10646117|NCT02137226|11805689|FG003|NOT COMPLETED|Period 1 (Initial Randomization)||0
10646118|NCT02137226|11805690|FG004|NOT COMPLETED|Period 1 (Initial Randomization)||0
10646119|NCT02137226|11805686|FG000|STARTED|Period 2 (Re - Randomization)||0
10646120|NCT02137226|11805687|FG001|STARTED|Period 2 (Re - Randomization)||0
10646121|NCT02137226|11805688|FG002|STARTED|Period 2 (Re - Randomization)||298
10646122|NCT02137226|11805689|FG003|STARTED|Period 2 (Re - Randomization)||148
10646123|NCT02137226|11805690|FG004|STARTED|Period 2 (Re - Randomization)||147
10646124|NCT02137226|11805686|FG000|COMPLETED|Period 2 (Re - Randomization)||0
10646125|NCT02137226|11805687|FG001|COMPLETED|Period 2 (Re - Randomization)||0
10646126|NCT02137226|11805688|FG002|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|281
10646127|NCT02137226|11805689|FG003|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|140
10646128|NCT02137226|11805690|FG004|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|138
10646129|NCT02137226|11805686|FG000|NOT COMPLETED|Period 2 (Re - Randomization)||0
10646130|NCT02137226|11805687|FG001|NOT COMPLETED|Period 2 (Re - Randomization)||0
10646131|NCT02137226|11805688|FG002|NOT COMPLETED|Period 2 (Re - Randomization)||17
10646132|NCT02137226|11805689|FG003|NOT COMPLETED|Period 2 (Re - Randomization)||8
10646133|NCT02137226|11805690|FG004|NOT COMPLETED|Period 2 (Re - Randomization)||9
10646134|NCT02137369|11805700|FG000|STARTED|Overall Study||49
10646135|NCT02137369|11805701|FG001|STARTED|Overall Study||11
10646136|NCT02137369|11805700|FG000|COMPLETED|Overall Study||41
10646137|NCT02137369|11805701|FG001|COMPLETED|Overall Study||9
10646138|NCT02137369|11805700|FG000|NOT COMPLETED|Overall Study||8
10646139|NCT02137369|11805701|FG001|NOT COMPLETED|Overall Study||2
10646140|NCT02137382|11805708|FG000|STARTED|Cross-over Period 1||20
10646141|NCT02137382|11805709|FG001|STARTED|Cross-over Period 1||21
10646142|NCT02137382|11805708|FG000|COMPLETED|Cross-over Period 1||18
10646143|NCT02137382|11805709|FG001|COMPLETED|Cross-over Period 1||21
10646144|NCT02137382|11805708|FG000|NOT COMPLETED|Cross-over Period 1||2
10646145|NCT02137382|11805709|FG001|NOT COMPLETED|Cross-over Period 1||0
10646146|NCT02137382|11805708|FG000|STARTED|Wash Out||18
10646147|NCT02137382|11805709|FG001|STARTED|Wash Out||21
10646148|NCT02137382|11805708|FG000|COMPLETED|Wash Out||18
10646149|NCT02137382|11805709|FG001|COMPLETED|Wash Out||21
10646150|NCT02137382|11805708|FG000|NOT COMPLETED|Wash Out||0
10646151|NCT02137382|11805709|FG001|NOT COMPLETED|Wash Out||0
10646152|NCT02137382|11805708|FG000|STARTED|Cross-over Period 2||18
10646153|NCT02137382|11805709|FG001|STARTED|Cross-over Period 2||21
10646154|NCT02137382|11805708|FG000|COMPLETED|Cross-over Period 2||18
10646155|NCT02137382|11805709|FG001|COMPLETED|Cross-over Period 2||21
10646156|NCT02137382|11805708|FG000|NOT COMPLETED|Cross-over Period 2||0
10646157|NCT02137382|11805709|FG001|NOT COMPLETED|Cross-over Period 2||0
10646158|NCT02137447|11805716|FG000|STARTED|Overall Study||10
10646159|NCT02137447|11805716|FG000|COMPLETED|Overall Study||10
10646160|NCT02137447|11805716|FG000|NOT COMPLETED|Overall Study||0
10646161|NCT02137486|11805722|FG000|STARTED|Overall Study||112
10646162|NCT02137486|11805723|FG001|STARTED|Overall Study||102
10646163|NCT02137486|11805722|FG000|COMPLETED|Overall Study||112
10646164|NCT02137486|11805723|FG001|COMPLETED|Overall Study||102
10646165|NCT02137486|11805722|FG000|NOT COMPLETED|Overall Study||0
10646166|NCT02137486|11805723|FG001|NOT COMPLETED|Overall Study||0
10646167|NCT02137499|11805737|FG000|STARTED|Overall Study||10
10646168|NCT02137499|11805738|FG001|STARTED|Overall Study||10
10646169|NCT02137499|11805739|FG002|STARTED|Overall Study||10
10646170|NCT02137499|11805740|FG003|STARTED|Overall Study||10
10646171|NCT02137499|11805737|FG000|COMPLETED|Overall Study||10
10646172|NCT02137499|11805738|FG001|COMPLETED|Overall Study||10
10646173|NCT02137499|11805739|FG002|COMPLETED|Overall Study||10
10646174|NCT02137499|11805740|FG003|COMPLETED|Overall Study||10
10646175|NCT02137499|11805737|FG000|NOT COMPLETED|Overall Study||0
10646176|NCT02137499|11805738|FG001|NOT COMPLETED|Overall Study||0
10646177|NCT02137499|11805739|FG002|NOT COMPLETED|Overall Study||0
10646178|NCT02137499|11805740|FG003|NOT COMPLETED|Overall Study||0
10646179|NCT02137512|11805750|FG000|STARTED|2-Week Baseline Sensor-Augmented Pump||30
10646180|NCT02137512|11805750|FG000|COMPLETED|2-Week Baseline Sensor-Augmented Pump||30
10646181|NCT02137512|11805750|FG000|NOT COMPLETED|2-Week Baseline Sensor-Augmented Pump||0
10646182|NCT02137512|11805750|FG000|STARTED|2-Week Overnight-Only Closed-Loop||30
10646183|NCT02137512|11805750|FG000|COMPLETED|2-Week Overnight-Only Closed-Loop||30
10646184|NCT02137512|11805750|FG000|NOT COMPLETED|2-Week Overnight-Only Closed-Loop||0
10646185|NCT02137512|11805750|FG000|STARTED|2-Week 24/7 Closed-Loop||30
10646186|NCT02137512|11805750|FG000|COMPLETED|2-Week 24/7 Closed-Loop||30
10646187|NCT02137512|11805750|FG000|NOT COMPLETED|2-Week 24/7 Closed-Loop||0
10646188|NCT02137512|11805750|FG000|STARTED|5-Month 24/7 Closed-Loop||14
10646189|NCT02137512|11805750|FG000|COMPLETED|5-Month 24/7 Closed-Loop||14
10646190|NCT02137512|11805750|FG000|NOT COMPLETED|5-Month 24/7 Closed-Loop||0
10646191|NCT02137538|11805760|FG000|STARTED|Overall Study||39
10646192|NCT02137538|11805761|FG001|STARTED|Overall Study||40
10646193|NCT02137538|11805760|FG000|COMPLETED|Overall Study||23
10646194|NCT02137538|11805761|FG001|COMPLETED|Overall Study||26
10646195|NCT02137538|11805760|FG000|NOT COMPLETED|Overall Study||16
10646196|NCT02137538|11805761|FG001|NOT COMPLETED|Overall Study||14
10646197|NCT02137603|11805769|FG000|STARTED|Overall Study||18
10646198|NCT02137603|11805770|FG001|STARTED|Overall Study||18
10646199|NCT02137603|11805769|FG000|COMPLETED|Overall Study||16
10646200|NCT02137603|11805770|FG001|COMPLETED|Overall Study||18
10646201|NCT02137603|11805769|FG000|NOT COMPLETED|Overall Study||2
10706229|NCT02607228|11870787|FG004|STARTED|Overall Study||5
10706230|NCT02607228|11870788|FG005|STARTED|Overall Study||6
10706231|NCT02607228|11870789|FG006|STARTED|Overall Study||2
10706232|NCT02607228|11870783|FG000|COMPLETED|Overall Study||0
10706233|NCT02607228|11870784|FG001|COMPLETED|Overall Study||0
10646202|NCT02137603|11805770|FG001|NOT COMPLETED|Overall Study||0
10646203|NCT02137772|11805778|FG000|STARTED|Overall Study|Randomized participants|376
10646204|NCT02137772|11805779|FG001|STARTED|Overall Study|Randomized participants|194
10646205|NCT02137772|11805778|FG000|Treated Participants|Overall Study||373
10646206|NCT02137772|11805779|FG001|Treated Participants|Overall Study||192
10646207|NCT02137772|11805778|FG000|COMPLETED|Overall Study||244
10646208|NCT02137772|11805779|FG001|COMPLETED|Overall Study||119
10646209|NCT02137772|11805778|FG000|NOT COMPLETED|Overall Study||132
10646210|NCT02137772|11805779|FG001|NOT COMPLETED|Overall Study||75
10646211|NCT02137785|11805787|FG000|STARTED|Overall Study||135
10646212|NCT02137785|11805788|FG001|STARTED|Overall Study||134
10646213|NCT02137785|11805787|FG000|COMPLETED|Overall Study||132
10646214|NCT02137785|11805788|FG001|COMPLETED|Overall Study||130
10646215|NCT02137785|11805787|FG000|NOT COMPLETED|Overall Study||3
10646216|NCT02137785|11805788|FG001|NOT COMPLETED|Overall Study||4
10646217|NCT02137837|11805797|FG000|STARTED|Overall Study||13
10646218|NCT02137837|11805798|FG001|STARTED|Overall Study||12
10646219|NCT02137837|11805799|FG002|STARTED|Overall Study||12
10646220|NCT02137837|11805797|FG000|Received Protocol Therapy|Overall Study||13
10646221|NCT02137837|11805798|FG001|Received Protocol Therapy|Overall Study||11
10706234|NCT02607228|11870785|FG002|COMPLETED|Overall Study||0
10646222|NCT02137837|11805799|FG002|Received Protocol Therapy|Overall Study||12
10646223|NCT02137837|11805797|FG000|COMPLETED|Overall Study||0
10646224|NCT02137837|11805798|FG001|COMPLETED|Overall Study||0
10646225|NCT02137837|11805799|FG002|COMPLETED|Overall Study||0
10646226|NCT02137837|11805797|FG000|NOT COMPLETED|Overall Study||13
10646227|NCT02137837|11805798|FG001|NOT COMPLETED|Overall Study||12
10646228|NCT02137837|11805799|FG002|NOT COMPLETED|Overall Study||12
10646229|NCT02138006|11805814|FG000|STARTED|Overall Study||48
10646230|NCT02138006|11805815|FG001|STARTED|Overall Study||54
10646231|NCT02138006|11805814|FG000|COMPLETED|Overall Study||48
10646232|NCT02138006|11805815|FG001|COMPLETED|Overall Study||54
10646233|NCT02138006|11805814|FG000|NOT COMPLETED|Overall Study||0
10646234|NCT02138006|11805815|FG001|NOT COMPLETED|Overall Study||0
10646235|NCT02138097|11805839|FG000|STARTED|Overall Study||155345
10646236|NCT02138097|11805840|FG001|STARTED|Overall Study||459722
10706235|NCT02607228|11870786|FG003|COMPLETED|Overall Study||0
10646237|NCT02138097|11805839|FG000|COMPLETED|Overall Study||155345
10646238|NCT02138097|11805840|FG001|COMPLETED|Overall Study||459722
10646239|NCT02138097|11805839|FG000|NOT COMPLETED|Overall Study||0
10646240|NCT02138097|11805840|FG001|NOT COMPLETED|Overall Study||0
10646241|NCT02138110|11805864|FG000|STARTED|Enrolled in Study||20
10646242|NCT02138110|11805864|FG000|COMPLETED|Enrolled in Study||20
10646243|NCT02138110|11805864|FG000|NOT COMPLETED|Enrolled in Study||0
10646244|NCT02138110|11805864|FG000|STARTED|Enrolled for Scaffold Implantation||20
10646245|NCT02138110|11805864|FG000|COMPLETED|Enrolled for Scaffold Implantation||19
10646246|NCT02138110|11805864|FG000|NOT COMPLETED|Enrolled for Scaffold Implantation||1
10646247|NCT02138110|11805864|FG000|STARTED|Overall Scaffold Implantation||19
10646248|NCT02138110|11805864|FG000|6-month Follow-Up|Overall Scaffold Implantation||16
10646249|NCT02138110|11805864|FG000|COMPLETED|Overall Scaffold Implantation||16
10646250|NCT02138110|11805864|FG000|NOT COMPLETED|Overall Scaffold Implantation||3
10646251|NCT02138136|11805868|FG000|STARTED|Overall Study||419
10646252|NCT02138136|11805868|FG000|Safety Analysis Set|Overall Study||419
10646253|NCT02138136|11805868|FG000|Modified Intent to Treat (mITT)|Overall Study||418
10646254|NCT02138136|11805868|FG000|COMPLETED|Overall Study||280
10646255|NCT02138136|11805868|FG000|NOT COMPLETED|Overall Study||139
10646256|NCT02138214|11805876|FG000|STARTED|Overall Study||30
10646257|NCT02138214|11805877|FG001|STARTED|Overall Study||30
10646258|NCT02138214|11805878|FG002|STARTED|Overall Study||30
10646259|NCT02138214|11805876|FG000|Analyzed for Baseline Measures|Overall Study||30
10646260|NCT02138214|11805877|FG001|Analyzed for Baseline Measures|Overall Study||29
10646261|NCT02138214|11805878|FG002|Analyzed for Baseline Measures|Overall Study||30
10646262|NCT02138214|11805876|FG000|COMPLETED|Overall Study||30
10646263|NCT02138214|11805877|FG001|COMPLETED|Overall Study||26
10646264|NCT02138214|11805878|FG002|COMPLETED|Overall Study||26
10646265|NCT02138214|11805876|FG000|NOT COMPLETED|Overall Study||0
10646266|NCT02138214|11805877|FG001|NOT COMPLETED|Overall Study||4
10646267|NCT02138214|11805878|FG002|NOT COMPLETED|Overall Study||4
10646268|NCT02138227|11805887|FG000|STARTED|Overall Study||55
10646269|NCT02138227|11805888|FG001|STARTED|Overall Study||218
10646270|NCT02138227|11805887|FG000|COMPLETED|Overall Study||55
10646271|NCT02138227|11805888|FG001|COMPLETED|Overall Study||218
10646272|NCT02138227|11805887|FG000|NOT COMPLETED|Overall Study||0
10646273|NCT02138227|11805888|FG001|NOT COMPLETED|Overall Study||0
10646274|NCT02138240|11805919|FG000|STARTED|Overall Study||34
10646275|NCT02138240|11805919|FG000|COMPLETED|Overall Study||34
10646276|NCT02138240|11805919|FG000|NOT COMPLETED|Overall Study||0
10646277|NCT02138253|11805925|FG000|STARTED|Overall Study||41
10646278|NCT02138253|11805926|FG001|STARTED|Overall Study||23
10646279|NCT02138253|11805925|FG000|COMPLETED|Overall Study||32
10646280|NCT02138253|11805926|FG001|COMPLETED|Overall Study||19
10646281|NCT02138253|11805925|FG000|NOT COMPLETED|Overall Study||9
10646282|NCT02138253|11805926|FG001|NOT COMPLETED|Overall Study||4
10646283|NCT02138461|11805934|FG000|STARTED|Overall Study||101
10646284|NCT02138461|11805935|FG001|STARTED|Overall Study||110
10646285|NCT02138461|11805934|FG000|COMPLETED|Overall Study||101
10646286|NCT02138461|11805935|FG001|COMPLETED|Overall Study||110
10646287|NCT02138461|11805934|FG000|NOT COMPLETED|Overall Study||0
10646288|NCT02138461|11805935|FG001|NOT COMPLETED|Overall Study||0
10646289|NCT02138578|11805944|FG000|STARTED|Overall Study||1
10646290|NCT02138578|11805945|FG001|STARTED|Overall Study||0
10646291|NCT02138578|11805946|FG002|STARTED|Overall Study||3
10646292|NCT02138578|11805944|FG000|COMPLETED|Overall Study||1
10646293|NCT02138578|11805945|FG001|COMPLETED|Overall Study||0
10646294|NCT02138578|11805946|FG002|COMPLETED|Overall Study||3
10646295|NCT02138578|11805944|FG000|NOT COMPLETED|Overall Study||0
10646296|NCT02138578|11805945|FG001|NOT COMPLETED|Overall Study||0
10646297|NCT02138578|11805946|FG002|NOT COMPLETED|Overall Study||0
10646298|NCT02138747|11805958|FG000|STARTED|Treatment Period 1||156
10646299|NCT02138747|11805959|FG001|STARTED|Treatment Period 1||157
10646300|NCT02138747|11805960|FG002|STARTED|Treatment Period 1||31
10646301|NCT02138747|11805961|FG003|STARTED|Treatment Period 1||32
10646302|NCT02138747|11805958|FG000|COMPLETED|Treatment Period 1||136
10646303|NCT02138747|11805959|FG001|COMPLETED|Treatment Period 1||132
10646304|NCT02138747|11805960|FG002|COMPLETED|Treatment Period 1||27
10646305|NCT02138747|11805961|FG003|COMPLETED|Treatment Period 1||28
10646306|NCT02138747|11805958|FG000|NOT COMPLETED|Treatment Period 1||20
10646307|NCT02138747|11805959|FG001|NOT COMPLETED|Treatment Period 1||25
10646308|NCT02138747|11805960|FG002|NOT COMPLETED|Treatment Period 1||4
10646309|NCT02138747|11805961|FG003|NOT COMPLETED|Treatment Period 1||4
10646310|NCT02138747|11805958|FG000|STARTED|Treatment Period 2|Two participants who discontinued treatment in period 1 entered period 2.|138
10646311|NCT02138747|11805959|FG001|STARTED|Treatment Period 2||132
10646312|NCT02138747|11805960|FG002|STARTED|Treatment Period 2|One participant completed treatment in period 1.|26
10646313|NCT02138747|11805961|FG003|STARTED|Treatment Period 2|One participant completed treatment in period 1.|27
10646314|NCT02138747|11805958|FG000|COMPLETED|Treatment Period 2||121
10646315|NCT02138747|11805959|FG001|COMPLETED|Treatment Period 2||125
10646316|NCT02138747|11805960|FG002|COMPLETED|Treatment Period 2||24
10646317|NCT02138747|11805961|FG003|COMPLETED|Treatment Period 2||24
10646318|NCT02138747|11805958|FG000|NOT COMPLETED|Treatment Period 2||17
10646319|NCT02138747|11805959|FG001|NOT COMPLETED|Treatment Period 2||7
10646320|NCT02138747|11805960|FG002|NOT COMPLETED|Treatment Period 2||2
10646321|NCT02138747|11805961|FG003|NOT COMPLETED|Treatment Period 2||3
10646322|NCT02138786|11805974|FG000|STARTED|Overall Study||3
10646323|NCT02138786|11805975|FG001|STARTED|Overall Study||15
10646324|NCT02138786|11805976|FG002|STARTED|Overall Study||8
10646325|NCT02138786|11805974|FG000|COMPLETED|Overall Study||0
10646326|NCT02138786|11805975|FG001|COMPLETED|Overall Study||0
10646327|NCT02138786|11805976|FG002|COMPLETED|Overall Study||0
10646328|NCT02138786|11805974|FG000|NOT COMPLETED|Overall Study||3
10646329|NCT02138786|11805975|FG001|NOT COMPLETED|Overall Study||15
10646330|NCT02138786|11805976|FG002|NOT COMPLETED|Overall Study||8
10646331|NCT02138825|11805984|FG000|STARTED|Main Study Treatment|safety population|73
10646332|NCT02138825|11805985|FG001|STARTED|Main Study Treatment|safety population|74
10646333|NCT02138825|11805984|FG000|COMPLETED|Main Study Treatment||33
10646334|NCT02138825|11805985|FG001|COMPLETED|Main Study Treatment||39
10646335|NCT02138825|11805984|FG000|NOT COMPLETED|Main Study Treatment||40
10646336|NCT02138825|11805985|FG001|NOT COMPLETED|Main Study Treatment||35
10646337|NCT02138825|11805984|FG000|STARTED|Long-term Extension||32
10646338|NCT02138825|11805985|FG001|STARTED|Long-term Extension||38
10646339|NCT02138825|11805984|FG000|COMPLETED|Long-term Extension|no participants were considered as completed LTE phase at time of study termination|0
10646340|NCT02138825|11805985|FG001|COMPLETED|Long-term Extension|no participants were considered as completed LTE phase at time of study termination|0
10646341|NCT02138825|11805984|FG000|NOT COMPLETED|Long-term Extension||32
10646342|NCT02138825|11805985|FG001|NOT COMPLETED|Long-term Extension||38
10646343|NCT02138825|11805984|FG000|STARTED|Safety Follow-up|Participants from main study treatment and LTE phase entered safety follow-up|72
10646344|NCT02138825|11805985|FG001|STARTED|Safety Follow-up|Participants from main study treatment and LTE phase entered safety follow-up|64
10646345|NCT02138825|11805984|FG000|COMPLETED|Safety Follow-up||50
10646346|NCT02138825|11805985|FG001|COMPLETED|Safety Follow-up||47
10646347|NCT02138825|11805984|FG000|NOT COMPLETED|Safety Follow-up||22
10646348|NCT02138825|11805985|FG001|NOT COMPLETED|Safety Follow-up||17
10646349|NCT02138838|11805998|FG000|STARTED|Overall Study||28
10646350|NCT02138838|11805999|FG001|STARTED|Overall Study||27
10646351|NCT02138838|11805998|FG000|Received Study Drug|Overall Study||28
10646352|NCT02138838|11805999|FG001|Received Study Drug|Overall Study||25
10646353|NCT02138838|11805998|FG000|COMPLETED|Overall Study||20
10646354|NCT02138838|11805999|FG001|COMPLETED|Overall Study||16
10646355|NCT02138838|11805998|FG000|NOT COMPLETED|Overall Study||8
10646356|NCT02138838|11805999|FG001|NOT COMPLETED|Overall Study||11
10646357|NCT02138890|11806007|FG000|STARTED|Overall Study||31
10646358|NCT02138890|11806008|FG001|STARTED|Overall Study||15
10646359|NCT02138890|11806007|FG000|COMPLETED|Overall Study||30
10646360|NCT02138890|11806008|FG001|COMPLETED|Overall Study||15
10646361|NCT02138890|11806007|FG000|NOT COMPLETED|Overall Study||1
10646362|NCT02138890|11806008|FG001|NOT COMPLETED|Overall Study||0
10646363|NCT02138916|11806018|FG000|STARTED|Overall Study||554
10646364|NCT02138916|11806019|FG001|STARTED|Overall Study||552
10646365|NCT02138916|11806020|FG002|STARTED|Overall Study||550
10646366|NCT02138916|11806018|FG000|COMPLETED|Overall Study||497
10646367|NCT02138916|11806019|FG001|COMPLETED|Overall Study||492
10646368|NCT02138916|11806020|FG002|COMPLETED|Overall Study||491
10646369|NCT02138916|11806018|FG000|NOT COMPLETED|Overall Study||57
10706236|NCT02607228|11870787|FG004|COMPLETED|Overall Study||0
10646370|NCT02138916|11806019|FG001|NOT COMPLETED|Overall Study||60
10646371|NCT02138916|11806020|FG002|NOT COMPLETED|Overall Study||59
10646372|NCT02139007|11806030|FG000|STARTED|Study Site Recruitment||4
10646373|NCT02139007|11806031|FG001|STARTED|Study Site Recruitment||5
10646374|NCT02139007|11806030|FG000|COMPLETED|Study Site Recruitment||1
10646375|NCT02139007|11806031|FG001|COMPLETED|Study Site Recruitment||1
10646376|NCT02139007|11806030|FG000|NOT COMPLETED|Study Site Recruitment||3
10646377|NCT02139007|11806031|FG001|NOT COMPLETED|Study Site Recruitment||4
10646378|NCT02139007|11806030|FG000|STARTED|Patient Participant Recruitment||13
10646379|NCT02139007|11806031|FG001|STARTED|Patient Participant Recruitment||14
10646380|NCT02139007|11806030|FG000|COMPLETED|Patient Participant Recruitment||11
10646381|NCT02139007|11806031|FG001|COMPLETED|Patient Participant Recruitment||13
10646382|NCT02139007|11806030|FG000|NOT COMPLETED|Patient Participant Recruitment||2
10646383|NCT02139007|11806031|FG001|NOT COMPLETED|Patient Participant Recruitment||1
10646384|NCT02139046|11806045|FG000|STARTED|Overall Study||358
10646385|NCT02139046|11806046|FG001|STARTED|Overall Study||359
10646386|NCT02139046|11806047|FG002|STARTED|Overall Study||357
10646387|NCT02139046|11806048|FG003|STARTED|Overall Study||358
10646388|NCT02139046|11806049|FG004|STARTED|Overall Study||358
10646389|NCT02139046|11806045|FG000|Safety Analysis Set|Overall Study||356
10646390|NCT02139046|11806046|FG001|Safety Analysis Set|Overall Study||358
10646391|NCT02139046|11806047|FG002|Safety Analysis Set|Overall Study||355
10646392|NCT02139046|11806048|FG003|Safety Analysis Set|Overall Study||357
10646393|NCT02139046|11806049|FG004|Safety Analysis Set|Overall Study||357
10646394|NCT02139046|11806045|FG000|Full Analysis Set|Overall Study||357
10646395|NCT02139046|11806046|FG001|Full Analysis Set|Overall Study||357
10646396|NCT02139046|11806047|FG002|Full Analysis Set|Overall Study||355
10646397|NCT02139046|11806048|FG003|Full Analysis Set|Overall Study||357
10646398|NCT02139046|11806049|FG004|Full Analysis Set|Overall Study||357
10646399|NCT02139046|11806045|FG000|COMPLETED|Overall Study|Completed=Completed Study Drug|296
10646400|NCT02139046|11806046|FG001|COMPLETED|Overall Study||305
10646401|NCT02139046|11806047|FG002|COMPLETED|Overall Study||298
10646402|NCT02139046|11806048|FG003|COMPLETED|Overall Study||290
10646403|NCT02139046|11806049|FG004|COMPLETED|Overall Study||301
10706237|NCT02607228|11870788|FG005|COMPLETED|Overall Study||0
10646404|NCT02139046|11806045|FG000|NOT COMPLETED|Overall Study||62
10646405|NCT02139046|11806046|FG001|NOT COMPLETED|Overall Study||54
10646406|NCT02139046|11806047|FG002|NOT COMPLETED|Overall Study||59
10646407|NCT02139046|11806048|FG003|NOT COMPLETED|Overall Study||68
10646408|NCT02139046|11806049|FG004|NOT COMPLETED|Overall Study||57
10646409|NCT02139124|11806066|FG000|STARTED|Overall Study||78
10646410|NCT02139124|11806067|FG001|STARTED|Overall Study||77
10646411|NCT02139124|11806068|FG002|STARTED|Overall Study||73
10646412|NCT02139124|11806069|FG003|STARTED|Overall Study||73
10646413|NCT02139124|11806070|FG004|STARTED|Overall Study||74
10646414|NCT02139124|11806066|FG000|COMPLETED|Overall Study||69
10646415|NCT02139124|11806067|FG001|COMPLETED|Overall Study||73
10646416|NCT02139124|11806068|FG002|COMPLETED|Overall Study||69
10646417|NCT02139124|11806069|FG003|COMPLETED|Overall Study||61
10646418|NCT02139124|11806070|FG004|COMPLETED|Overall Study||61
10646419|NCT02139124|11806066|FG000|NOT COMPLETED|Overall Study||9
10646420|NCT02139124|11806067|FG001|NOT COMPLETED|Overall Study||4
10646421|NCT02139124|11806068|FG002|NOT COMPLETED|Overall Study||4
10646422|NCT02139124|11806069|FG003|NOT COMPLETED|Overall Study||12
10646423|NCT02139124|11806070|FG004|NOT COMPLETED|Overall Study||13
10646424|NCT02139137|11806084|FG000|STARTED|Overall Study||22
10646425|NCT02139137|11806085|FG001|STARTED|Overall Study||20
10646426|NCT02139137|11806084|FG000|COMPLETED|Overall Study||15
10809216|NCT03820258|11971101|FG000|STARTED|Overall Study||21
10809217|NCT03820258|11971101|FG000|COMPLETED|Overall Study||21
10809218|NCT03820258|11971101|FG000|NOT COMPLETED|Overall Study||0
10809219|NCT03819491|11971107|FG000|STARTED|Before Randomization||24
10809220|NCT03819491|11971108|FG001|STARTED|Before Randomization||0
10809221|NCT03819491|11971107|FG000|COMPLETED|Before Randomization||24
10809222|NCT03819491|11971108|FG001|COMPLETED|Before Randomization||0
10809223|NCT03819491|11971107|FG000|NOT COMPLETED|Before Randomization||0
10809224|NCT03819491|11971108|FG001|NOT COMPLETED|Before Randomization||0
10809225|NCT03819491|11971107|FG000|STARTED|After Randomization||12
10646427|NCT02139137|11806085|FG001|COMPLETED|Overall Study||10
10457346|NCT01010217|11605092|FG004|NOT COMPLETED|Overall Study||3
10457347|NCT01010230|11605106|FG000|STARTED|Overall Study||32
10457348|NCT01010230|11605107|FG001|STARTED|Overall Study||33
10457349|NCT01010230|11605106|FG000|COMPLETED|Overall Study||22
10457350|NCT01010230|11605107|FG001|COMPLETED|Overall Study||26
10457351|NCT01010230|11605106|FG000|NOT COMPLETED|Overall Study||10
10646428|NCT02139137|11806084|FG000|NOT COMPLETED|Overall Study||7
10646429|NCT02139137|11806085|FG001|NOT COMPLETED|Overall Study||10
10646430|NCT02139176|11806093|FG000|STARTED|Overall Study||100
10646431|NCT02139176|11806094|FG001|STARTED|Overall Study||100
10646432|NCT02139176|11806093|FG000|COMPLETED|Overall Study||100
10646433|NCT02139176|11806094|FG001|COMPLETED|Overall Study||100
10646434|NCT02139176|11806093|FG000|NOT COMPLETED|Overall Study||0
10646435|NCT02139176|11806094|FG001|NOT COMPLETED|Overall Study||0
10646436|NCT02139228|11806103|FG000|STARTED|Overall Study||215
10646437|NCT02139228|11806104|FG001|STARTED|Overall Study||211
10646438|NCT02139228|11806103|FG000|COMPLETED|Overall Study||215
10646439|NCT02139228|11806104|FG001|COMPLETED|Overall Study||211
10646440|NCT02139228|11806103|FG000|NOT COMPLETED|Overall Study||0
10646441|NCT02139228|11806104|FG001|NOT COMPLETED|Overall Study||0
10646442|NCT02139280|11806112|FG000|STARTED|Overall Study||34
10646443|NCT02139280|11806113|FG001|STARTED|Overall Study||20
10646444|NCT02139280|11806112|FG000|COMPLETED|Overall Study||32
10646445|NCT02139280|11806113|FG001|COMPLETED|Overall Study||20
10646446|NCT02139280|11806112|FG000|NOT COMPLETED|Overall Study||2
10646447|NCT02139280|11806113|FG001|NOT COMPLETED|Overall Study||0
10646448|NCT02139306|11806121|FG000|STARTED|Overall Study||140
10646449|NCT02139306|11806122|FG001|STARTED|Overall Study||139
10646450|NCT02139306|11806121|FG000|COMPLETED|Overall Study||127
10646451|NCT02139306|11806122|FG001|COMPLETED|Overall Study||125
10646452|NCT02139306|11806121|FG000|NOT COMPLETED|Overall Study||13
10646453|NCT02139306|11806122|FG001|NOT COMPLETED|Overall Study||14
10646454|NCT02139358|11806129|FG000|STARTED|Overall Study||15
10646455|NCT02139358|11806129|FG000|COMPLETED|Overall Study||15
10646456|NCT02139358|11806129|FG000|NOT COMPLETED|Overall Study||0
10646457|NCT02139592|11806133|FG000|STARTED|Overall Study||292
10646458|NCT02139592|11806133|FG000|COMPLETED|Overall Study||284
10646459|NCT02139592|11806133|FG000|NOT COMPLETED|Overall Study||8
10646460|NCT02139644|11806142|FG000|STARTED|Run-In Period (Pre-assignment)|Enrolled|787
10646461|NCT02139644|11806143|FG001|STARTED|Run-In Period (Pre-assignment)||0
10646462|NCT02139644|11806144|FG002|STARTED|Run-In Period (Pre-assignment)||0
10646463|NCT02139644|11806145|FG003|STARTED|Run-In Period (Pre-assignment)||0
10646464|NCT02139644|11806146|FG004|STARTED|Run-In Period (Pre-assignment)||0
10646465|NCT02139644|11806147|FG005|STARTED|Run-In Period (Pre-assignment)||0
10646466|NCT02139644|11806142|FG000|COMPLETED|Run-In Period (Pre-assignment)||647
10646467|NCT02139644|11806143|FG001|COMPLETED|Run-In Period (Pre-assignment)||0
10646468|NCT02139644|11806144|FG002|COMPLETED|Run-In Period (Pre-assignment)||0
10646469|NCT02139644|11806145|FG003|COMPLETED|Run-In Period (Pre-assignment)||0
10646470|NCT02139644|11806146|FG004|COMPLETED|Run-In Period (Pre-assignment)||0
10646471|NCT02139644|11806147|FG005|COMPLETED|Run-In Period (Pre-assignment)||0
10646472|NCT02139644|11806142|FG000|NOT COMPLETED|Run-In Period (Pre-assignment)||140
10646473|NCT02139644|11806143|FG001|NOT COMPLETED|Run-In Period (Pre-assignment)||0
10646474|NCT02139644|11806144|FG002|NOT COMPLETED|Run-In Period (Pre-assignment)||0
10646475|NCT02139644|11806145|FG003|NOT COMPLETED|Run-In Period (Pre-assignment)||0
10646476|NCT02139644|11806146|FG004|NOT COMPLETED|Run-In Period (Pre-assignment)||0
10646477|NCT02139644|11806147|FG005|NOT COMPLETED|Run-In Period (Pre-assignment)||0
10646478|NCT02139644|11806142|FG000|STARTED|Treatment Period||0
10646479|NCT02139644|11806143|FG001|STARTED|Treatment Period|Randomized|129
10646480|NCT02139644|11806144|FG002|STARTED|Treatment Period|Randomized|129
10646481|NCT02139644|11806145|FG003|STARTED|Treatment Period|Randomized|130
10646482|NCT02139644|11806146|FG004|STARTED|Treatment Period|Randomized|129
10646483|NCT02139644|11806147|FG005|STARTED|Treatment Period|Randomized|130
10646484|NCT02139644|11806142|FG000|COMPLETED|Treatment Period||0
10646485|NCT02139644|11806143|FG001|COMPLETED|Treatment Period||126
10646486|NCT02139644|11806144|FG002|COMPLETED|Treatment Period||121
10646487|NCT02139644|11806145|FG003|COMPLETED|Treatment Period||121
10646488|NCT02139644|11806146|FG004|COMPLETED|Treatment Period||121
10646489|NCT02139644|11806147|FG005|COMPLETED|Treatment Period||113
10646490|NCT02139644|11806142|FG000|NOT COMPLETED|Treatment Period||0
10646491|NCT02139644|11806143|FG001|NOT COMPLETED|Treatment Period||3
10646492|NCT02139644|11806144|FG002|NOT COMPLETED|Treatment Period||8
10646493|NCT02139644|11806145|FG003|NOT COMPLETED|Treatment Period||9
10646494|NCT02139644|11806146|FG004|NOT COMPLETED|Treatment Period||8
10646495|NCT02139644|11806147|FG005|NOT COMPLETED|Treatment Period||17
10646496|NCT02139800|11806161|FG000|STARTED|Overall Study||224
10646497|NCT02139800|11806162|FG001|STARTED|Overall Study||236
10646498|NCT02139800|11806161|FG000|COMPLETED|Overall Study||211
10646499|NCT02139800|11806162|FG001|COMPLETED|Overall Study||215
10646500|NCT02139800|11806161|FG000|NOT COMPLETED|Overall Study||13
10646501|NCT02139800|11806162|FG001|NOT COMPLETED|Overall Study||21
10646502|NCT02139826|11806168|FG000|STARTED|Overall Study||12
10646503|NCT02139826|11806168|FG000|COMPLETED|Overall Study||11
10646504|NCT02139826|11806168|FG000|NOT COMPLETED|Overall Study||1
10646505|NCT02139878|11806178|FG000|STARTED|First Intervention (7 Days)||10
10646506|NCT02139878|11806179|FG001|STARTED|First Intervention (7 Days)||10
10646507|NCT02139878|11806178|FG000|COMPLETED|First Intervention (7 Days)||9
10646508|NCT02139878|11806179|FG001|COMPLETED|First Intervention (7 Days)||10
10809226|NCT03819491|11971108|FG001|STARTED|After Randomization||12
10809227|NCT03819491|11971107|FG000|COMPLETED|After Randomization||12
10809228|NCT03819491|11971108|FG001|COMPLETED|After Randomization||12
10809229|NCT03819491|11971107|FG000|NOT COMPLETED|After Randomization||0
10809230|NCT03819491|11971108|FG001|NOT COMPLETED|After Randomization||0
10809231|NCT03808298|11971115|FG000|STARTED|Overall Study||57
10809232|NCT03808298|11971115|FG000|COMPLETED|Overall Study||49
10809233|NCT03808298|11971115|FG000|NOT COMPLETED|Overall Study||8
10809234|NCT03836729|11971144|FG000|STARTED|Treatment Period 1 (Up to Day 14)||16
10809235|NCT03836729|11971144|FG000|COMPLETED|Treatment Period 1 (Up to Day 14)||16
10809236|NCT03836729|11971144|FG000|NOT COMPLETED|Treatment Period 1 (Up to Day 14)||0
10809237|NCT03836729|11971144|FG000|STARTED|Treatment Period 2 (Up to Day 7)||16
10809238|NCT03836729|11971144|FG000|COMPLETED|Treatment Period 2 (Up to Day 7)||15
10809239|NCT03836729|11971144|FG000|NOT COMPLETED|Treatment Period 2 (Up to Day 7)||1
10646509|NCT02139878|11806178|FG000|NOT COMPLETED|First Intervention (7 Days)||1
10646510|NCT02139878|11806179|FG001|NOT COMPLETED|First Intervention (7 Days)||0
10646511|NCT02139878|11806178|FG000|STARTED|Washout Period (8 Days)||9
10646512|NCT02139878|11806179|FG001|STARTED|Washout Period (8 Days)||10
10646513|NCT02139878|11806178|FG000|COMPLETED|Washout Period (8 Days)||9
10646514|NCT02139878|11806179|FG001|COMPLETED|Washout Period (8 Days)||10
10646515|NCT02139878|11806178|FG000|NOT COMPLETED|Washout Period (8 Days)||0
10646516|NCT02139878|11806179|FG001|NOT COMPLETED|Washout Period (8 Days)||0
10646517|NCT02139878|11806178|FG000|STARTED|Second Intervention (7 Days)||9
10646518|NCT02139878|11806179|FG001|STARTED|Second Intervention (7 Days)||10
10646519|NCT02139878|11806178|FG000|COMPLETED|Second Intervention (7 Days)||9
10646520|NCT02139878|11806179|FG001|COMPLETED|Second Intervention (7 Days)||10
10646521|NCT02139878|11806178|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
10646522|NCT02139878|11806179|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
10646523|NCT02139943|11806188|FG000|STARTED|Overall Study||117
10646524|NCT02139943|11806189|FG001|STARTED|Overall Study||117
10646525|NCT02139943|11806190|FG002|STARTED|Overall Study||117
10646526|NCT02139943|11806188|FG000|COMPLETED|Overall Study||107
10646527|NCT02139943|11806189|FG001|COMPLETED|Overall Study||111
10646528|NCT02139943|11806190|FG002|COMPLETED|Overall Study||110
10646529|NCT02139943|11806188|FG000|NOT COMPLETED|Overall Study||10
10646530|NCT02139943|11806189|FG001|NOT COMPLETED|Overall Study||6
10646531|NCT02139943|11806190|FG002|NOT COMPLETED|Overall Study||7
10646532|NCT02139969|11806198|FG000|STARTED|Overall Study||956
10809240|NCT03835975|11971157|FG000|STARTED|Overall Study||253
10809241|NCT03835975|11971158|FG001|STARTED|Overall Study||122
10646533|NCT02139969|11806198|FG000|COMPLETED|Overall Study||956
10646534|NCT02139969|11806198|FG000|NOT COMPLETED|Overall Study||0
10646535|NCT02139982|11806212|FG000|STARTED|Overall Study||8
10646536|NCT02139982|11806213|FG001|STARTED|Overall Study||8
10646537|NCT02139982|11806214|FG002|STARTED|Overall Study||8
10646538|NCT02139982|11806215|FG003|STARTED|Overall Study||8
10646539|NCT02139982|11806216|FG004|STARTED|Overall Study||13
10646540|NCT02139982|11806217|FG005|STARTED|Overall Study||13
10646541|NCT02139982|11806218|FG006|STARTED|Overall Study||13
10646542|NCT02139982|11806219|FG007|STARTED|Overall Study||13
10646543|NCT02139982|11806220|FG008|STARTED|Overall Study||13
10809242|NCT03835975|11971159|FG002|STARTED|Overall Study||248
10646544|NCT02139982|11806221|FG009|STARTED|Overall Study||13
10646545|NCT02139982|11806212|FG000|COMPLETED|Overall Study||8
10646546|NCT02139982|11806213|FG001|COMPLETED|Overall Study||7
10646547|NCT02139982|11806214|FG002|COMPLETED|Overall Study||8
10646548|NCT02139982|11806215|FG003|COMPLETED|Overall Study||7
10646549|NCT02139982|11806216|FG004|COMPLETED|Overall Study||13
10646550|NCT02139982|11806217|FG005|COMPLETED|Overall Study||13
10646551|NCT02139982|11806218|FG006|COMPLETED|Overall Study||13
10646552|NCT02139982|11806219|FG007|COMPLETED|Overall Study||13
10646553|NCT02139982|11806220|FG008|COMPLETED|Overall Study||13
10646554|NCT02139982|11806221|FG009|COMPLETED|Overall Study||13
10646555|NCT02139982|11806212|FG000|NOT COMPLETED|Overall Study||0
10646556|NCT02139982|11806213|FG001|NOT COMPLETED|Overall Study||1
10646557|NCT02139982|11806214|FG002|NOT COMPLETED|Overall Study||0
10646558|NCT02139982|11806215|FG003|NOT COMPLETED|Overall Study||1
10646559|NCT02139982|11806216|FG004|NOT COMPLETED|Overall Study||0
10646560|NCT02139982|11806217|FG005|NOT COMPLETED|Overall Study||0
10646561|NCT02139982|11806218|FG006|NOT COMPLETED|Overall Study||0
10646562|NCT02139982|11806219|FG007|NOT COMPLETED|Overall Study||0
10646563|NCT02139982|11806220|FG008|NOT COMPLETED|Overall Study||0
10646564|NCT02139982|11806221|FG009|NOT COMPLETED|Overall Study||0
10646565|NCT02140060|11806249|FG000|STARTED|Overall Study||44
10646566|NCT02140060|11806250|FG001|STARTED|Overall Study||44
10646567|NCT02140060|11806251|FG002|STARTED|Overall Study||44
10646568|NCT02140060|11806252|FG003|STARTED|Overall Study||45
10646569|NCT02140060|11806253|FG004|STARTED|Overall Study||45
10646570|NCT02140060|11806254|FG005|STARTED|Overall Study||44
10646571|NCT02140060|11806249|FG000|COMPLETED|Overall Study||44
10646572|NCT02140060|11806250|FG001|COMPLETED|Overall Study||44
10646573|NCT02140060|11806251|FG002|COMPLETED|Overall Study||44
10646574|NCT02140060|11806252|FG003|COMPLETED|Overall Study||43
10646575|NCT02140060|11806253|FG004|COMPLETED|Overall Study||44
10646576|NCT02140060|11806254|FG005|COMPLETED|Overall Study||43
10646577|NCT02140060|11806249|FG000|NOT COMPLETED|Overall Study||0
10646578|NCT02140060|11806250|FG001|NOT COMPLETED|Overall Study||0
10646579|NCT02140060|11806251|FG002|NOT COMPLETED|Overall Study||0
10646580|NCT02140060|11806252|FG003|NOT COMPLETED|Overall Study||2
10646581|NCT02140060|11806253|FG004|NOT COMPLETED|Overall Study||1
10646582|NCT02140060|11806254|FG005|NOT COMPLETED|Overall Study||1
10646583|NCT02140164|11806269|FG000|STARTED|Overall Study||7
10646584|NCT02140164|11806269|FG000|COMPLETED|Overall Study||5
10646585|NCT02140164|11806269|FG000|NOT COMPLETED|Overall Study||2
10646586|NCT02140372|11806273|FG000|STARTED|Overall Study||10
10646587|NCT02140372|11806273|FG000|COMPLETED|Overall Study||10
10646588|NCT02140372|11806273|FG000|NOT COMPLETED|Overall Study||0
10646589|NCT02140411|11806277|FG000|STARTED|Overall Study||21
10646590|NCT02140411|11806277|FG000|COMPLETED|Overall Study||20
10646591|NCT02140411|11806277|FG000|NOT COMPLETED|Overall Study||1
10646592|NCT02140567|11806281|FG000|STARTED|Overall Study||140
10646593|NCT02140567|11806281|FG000|COMPLETED|Overall Study||134
10646594|NCT02140567|11806281|FG000|NOT COMPLETED|Overall Study||6
10646595|NCT02140593|11806288|FG000|STARTED|Overall Study||63
10646596|NCT02140593|11806289|FG001|STARTED|Overall Study||65
10646597|NCT02140593|11806288|FG000|COMPLETED|Overall Study||63
10646598|NCT02140593|11806289|FG001|COMPLETED|Overall Study||65
10646599|NCT02140593|11806288|FG000|NOT COMPLETED|Overall Study||0
10646600|NCT02140593|11806289|FG001|NOT COMPLETED|Overall Study||0
10646601|NCT02140645|11806301|FG000|STARTED|Overall Study||5732
10646602|NCT02140645|11806302|FG001|STARTED|Overall Study||64695
10646603|NCT02140645|11806303|FG002|STARTED|Overall Study||4441
10646604|NCT02140645|11806304|FG003|STARTED|Overall Study||14363
10646605|NCT02140645|11806305|FG004|STARTED|Overall Study||3436
10646606|NCT02140645|11806306|FG005|STARTED|Overall Study||73946
10646607|NCT02140645|11806301|FG000|COMPLETED|Overall Study||243
10646608|NCT02140645|11806302|FG001|COMPLETED|Overall Study||3041
10646609|NCT02140645|11806303|FG002|COMPLETED|Overall Study||205
10646610|NCT02140645|11806304|FG003|COMPLETED|Overall Study||530
10646611|NCT02140645|11806305|FG004|COMPLETED|Overall Study||150
10646612|NCT02140645|11806306|FG005|COMPLETED|Overall Study||3050
10646613|NCT02140645|11806301|FG000|NOT COMPLETED|Overall Study||5489
10646614|NCT02140645|11806302|FG001|NOT COMPLETED|Overall Study||61654
10646615|NCT02140645|11806303|FG002|NOT COMPLETED|Overall Study||4236
10646616|NCT02140645|11806304|FG003|NOT COMPLETED|Overall Study||13833
10646617|NCT02140645|11806305|FG004|NOT COMPLETED|Overall Study||3286
10646618|NCT02140645|11806306|FG005|NOT COMPLETED|Overall Study||70896
10646619|NCT02140762|11806317|FG000|STARTED|Overall Study||154
10646620|NCT02140762|11806318|FG001|STARTED|Overall Study||151
10646621|NCT02140762|11806317|FG000|COMPLETED|Overall Study||137
10646622|NCT02140762|11806318|FG001|COMPLETED|Overall Study||139
10646623|NCT02140762|11806317|FG000|NOT COMPLETED|Overall Study||17
10646624|NCT02140762|11806318|FG001|NOT COMPLETED|Overall Study||12
10646625|NCT02140775|11806331|FG000|STARTED|Overall Study||87
10646626|NCT02140775|11806332|FG001|STARTED|Overall Study||29
10646627|NCT02140775|11806331|FG000|COMPLETED|Overall Study||57
10646628|NCT02140775|11806332|FG001|COMPLETED|Overall Study||22
10646629|NCT02140775|11806331|FG000|NOT COMPLETED|Overall Study||30
10646630|NCT02140775|11806332|FG001|NOT COMPLETED|Overall Study||7
10646631|NCT02140957|11806342|FG000|STARTED|Overall Study||129
10646632|NCT02140957|11806343|FG001|STARTED|Overall Study||122
10646633|NCT02140957|11806342|FG000|COMPLETED|Overall Study||102
10646634|NCT02140957|11806343|FG001|COMPLETED|Overall Study||99
10646635|NCT02140957|11806342|FG000|NOT COMPLETED|Overall Study||27
10646636|NCT02140957|11806343|FG001|NOT COMPLETED|Overall Study||23
10646637|NCT02140970|11806351|FG000|STARTED|Overall Study||24
10646638|NCT02140970|11806352|FG001|STARTED|Overall Study||25
10646639|NCT02140970|11806351|FG000|Received Intervention|Overall Study||23
10646640|NCT02140970|11806352|FG001|Received Intervention|Overall Study||25
10646641|NCT02140970|11806351|FG000|Analyzed|Overall Study||22
10646642|NCT02140970|11806352|FG001|Analyzed|Overall Study||22
10646643|NCT02140970|11806351|FG000|COMPLETED|Overall Study||22
10646644|NCT02140970|11806352|FG001|COMPLETED|Overall Study||22
10646645|NCT02140970|11806351|FG000|NOT COMPLETED|Overall Study||2
10646646|NCT02140970|11806352|FG001|NOT COMPLETED|Overall Study||3
10646647|NCT02141204|11806360|FG000|STARTED|Overall Study||224
10646648|NCT02141204|11806361|FG001|STARTED|Overall Study||225
10646649|NCT02141204|11806360|FG000|COMPLETED|Overall Study||209
10646650|NCT02141204|11806361|FG001|COMPLETED|Overall Study||210
10646651|NCT02141204|11806360|FG000|NOT COMPLETED|Overall Study||15
10646652|NCT02141204|11806361|FG001|NOT COMPLETED|Overall Study||15
10646653|NCT02141217|11806369|FG000|STARTED|Overall Study||234
10646654|NCT02141217|11806370|FG001|STARTED|Overall Study||237
10646655|NCT02141217|11806369|FG000|ITT Population-Randomized Treatment Arm|Overall Study||234
10646656|NCT02141217|11806370|FG001|ITT Population-Randomized Treatment Arm|Overall Study||237
10646657|NCT02141217|11806369|FG000|ITT Population-Actual Treatment Received|Overall Study||236
10646658|NCT02141217|11806370|FG001|ITT Population-Actual Treatment Received|Overall Study||235
10646659|NCT02141217|11806369|FG000|COMPLETED|Overall Study||223
10646660|NCT02141217|11806370|FG001|COMPLETED|Overall Study||229
10646661|NCT02141217|11806369|FG000|NOT COMPLETED|Overall Study||11
10646662|NCT02141217|11806370|FG001|NOT COMPLETED|Overall Study||8
10646663|NCT02141295|11806382|FG000|STARTED|Overall Study||8
10646664|NCT02141295|11806383|FG001|STARTED|Overall Study||94
10646665|NCT02141295|11806384|FG002|STARTED|Overall Study||95
10646666|NCT02141295|11806382|FG000|COMPLETED|Overall Study||2
10646667|NCT02141295|11806383|FG001|COMPLETED|Overall Study||0
10646668|NCT02141295|11806384|FG002|COMPLETED|Overall Study||0
10646669|NCT02141295|11806382|FG000|NOT COMPLETED|Overall Study||6
10646670|NCT02141295|11806383|FG001|NOT COMPLETED|Overall Study||94
10646671|NCT02141295|11806384|FG002|NOT COMPLETED|Overall Study||95
10646672|NCT02141360|11806396|FG000|STARTED|Overall Study||11
10646673|NCT02141360|11806397|FG001|STARTED|Overall Study||6
10646674|NCT02141360|11806398|FG002|STARTED|Overall Study||6
10646675|NCT02141360|11806396|FG000|COMPLETED|Overall Study||4
10646676|NCT02141360|11806397|FG001|COMPLETED|Overall Study||6
10646677|NCT02141360|11806398|FG002|COMPLETED|Overall Study||6
10646678|NCT02141360|11806396|FG000|NOT COMPLETED|Overall Study||7
10646679|NCT02141360|11806397|FG001|NOT COMPLETED|Overall Study||0
10646680|NCT02141360|11806398|FG002|NOT COMPLETED|Overall Study||0
10646681|NCT02141399|11806406|FG000|STARTED|Overall Study||1485
10646682|NCT02141399|11806406|FG000|COMPLETED|Overall Study||741
10646683|NCT02141399|11806406|FG000|NOT COMPLETED|Overall Study||744
10646684|NCT02141451|11806414|FG000|STARTED|Overall Study||3
10646685|NCT02141451|11806415|FG001|STARTED|Overall Study||4
10646686|NCT02141451|11806416|FG002|STARTED|Overall Study||7
10646687|NCT02141451|11806417|FG003|STARTED|Overall Study||16
10646688|NCT02141451|11806414|FG000|COMPLETED|Overall Study||3
10646689|NCT02141451|11806415|FG001|COMPLETED|Overall Study||2
10646690|NCT02141451|11806416|FG002|COMPLETED|Overall Study||2
10646691|NCT02141451|11806417|FG003|COMPLETED|Overall Study||7
10646692|NCT02141451|11806414|FG000|NOT COMPLETED|Overall Study||0
10646693|NCT02141451|11806415|FG001|NOT COMPLETED|Overall Study||2
10646694|NCT02141451|11806416|FG002|NOT COMPLETED|Overall Study||5
10646695|NCT02141451|11806417|FG003|NOT COMPLETED|Overall Study||9
10646696|NCT02141490|11806433|FG000|STARTED|Overall Study||34
10646697|NCT02141490|11806434|FG001|STARTED|Overall Study||6
10646698|NCT02141490|11806435|FG002|STARTED|Overall Study||3
10646699|NCT02141490|11806433|FG000|COMPLETED|Overall Study||30
10646700|NCT02141490|11806434|FG001|COMPLETED|Overall Study||6
10646701|NCT02141490|11806435|FG002|COMPLETED|Overall Study||3
10646702|NCT02141490|11806433|FG000|NOT COMPLETED|Overall Study||4
10646703|NCT02141490|11806434|FG001|NOT COMPLETED|Overall Study||0
10646704|NCT02141490|11806435|FG002|NOT COMPLETED|Overall Study||0
10646705|NCT02141516|11806448|FG000|STARTED|Overall Study||40
10646706|NCT02141516|11806449|FG001|STARTED|Overall Study||112
10646707|NCT02141516|11806450|FG002|STARTED|Overall Study||87
10646708|NCT02141516|11806448|FG000|COMPLETED|Overall Study||40
10646709|NCT02141516|11806449|FG001|COMPLETED|Overall Study||107
10646710|NCT02141516|11806450|FG002|COMPLETED|Overall Study||87
10646711|NCT02141516|11806448|FG000|NOT COMPLETED|Overall Study||0
10646712|NCT02141516|11806449|FG001|NOT COMPLETED|Overall Study||5
10646713|NCT02141516|11806450|FG002|NOT COMPLETED|Overall Study||0
10646714|NCT02141555|11806464|FG000|STARTED|Overall Study||2
10646715|NCT02141555|11806465|FG001|STARTED|Overall Study||2
10646716|NCT02141555|11806464|FG000|COMPLETED|Overall Study||2
10646717|NCT02141555|11806465|FG001|COMPLETED|Overall Study||2
10646718|NCT02141555|11806464|FG000|NOT COMPLETED|Overall Study||0
10646719|NCT02141555|11806465|FG001|NOT COMPLETED|Overall Study||0
10646720|NCT02141581|11806474|FG000|STARTED|Overall Study||42
10646721|NCT02141581|11806475|FG001|STARTED|Overall Study||19
10646722|NCT02141581|11806476|FG002|STARTED|Overall Study||25
10646723|NCT02141581|11806474|FG000|COMPLETED|Overall Study||42
10646724|NCT02141581|11806475|FG001|COMPLETED|Overall Study||19
10646725|NCT02141581|11806476|FG002|COMPLETED|Overall Study||25
10646726|NCT02141581|11806474|FG000|NOT COMPLETED|Overall Study||0
10646727|NCT02141581|11806475|FG001|NOT COMPLETED|Overall Study||0
10646728|NCT02141581|11806476|FG002|NOT COMPLETED|Overall Study||0
10646729|NCT02141620|11806484|FG000|STARTED|Treatment Condition 1 (7 Days)||8
10646730|NCT02141620|11806485|FG001|STARTED|Treatment Condition 1 (7 Days)||7
10646731|NCT02141620|11806484|FG000|COMPLETED|Treatment Condition 1 (7 Days)|7 completing subjects switched to n-acetylcysteine for Condition 2.|7
10646732|NCT02141620|11806485|FG001|COMPLETED|Treatment Condition 1 (7 Days)|7 completing subjects switched to placebo for Condition 2.|7
10646733|NCT02141620|11806484|FG000|NOT COMPLETED|Treatment Condition 1 (7 Days)||1
10646734|NCT02141620|11806485|FG001|NOT COMPLETED|Treatment Condition 1 (7 Days)||0
10646735|NCT02141620|11806484|FG000|STARTED|Treatment Condition 2 (7 Days)||7
10646736|NCT02141620|11806485|FG001|STARTED|Treatment Condition 2 (7 Days)||7
10646737|NCT02141620|11806484|FG000|COMPLETED|Treatment Condition 2 (7 Days)||7
10646738|NCT02141620|11806485|FG001|COMPLETED|Treatment Condition 2 (7 Days)||7
10646739|NCT02141620|11806484|FG000|NOT COMPLETED|Treatment Condition 2 (7 Days)||0
10646740|NCT02141620|11806485|FG001|NOT COMPLETED|Treatment Condition 2 (7 Days)||0
10646741|NCT02141633|11806493|FG000|STARTED|Overall Study||16
10646742|NCT02141633|11806494|FG001|STARTED|Overall Study||15
10646743|NCT02141633|11806493|FG000|COMPLETED|Overall Study||15
10646744|NCT02141633|11806494|FG001|COMPLETED|Overall Study||15
10646745|NCT02141633|11806493|FG000|NOT COMPLETED|Overall Study||1
10646746|NCT02141633|11806494|FG001|NOT COMPLETED|Overall Study||0
10646747|NCT02141659|11806506|FG000|STARTED|Overall Study||3
10646748|NCT02141659|11806507|FG001|STARTED|Overall Study||4
10646749|NCT02141659|11806508|FG002|STARTED|Overall Study||3
10646750|NCT02141659|11806509|FG003|STARTED|Overall Study||3
10646751|NCT02141659|11806510|FG004|STARTED|Overall Study||15
10646752|NCT02141659|11806511|FG005|STARTED|Overall Study||15
10646753|NCT02141659|11806506|FG000|COMPLETED|Overall Study||3
10646754|NCT02141659|11806507|FG001|COMPLETED|Overall Study||3
10646755|NCT02141659|11806508|FG002|COMPLETED|Overall Study||3
10646756|NCT02141659|11806509|FG003|COMPLETED|Overall Study||3
10646757|NCT02141659|11806510|FG004|COMPLETED|Overall Study||13
10646758|NCT02141659|11806511|FG005|COMPLETED|Overall Study||13
10646759|NCT02141659|11806506|FG000|NOT COMPLETED|Overall Study||0
10646760|NCT02141659|11806507|FG001|NOT COMPLETED|Overall Study||1
10646761|NCT02141659|11806508|FG002|NOT COMPLETED|Overall Study||0
10646762|NCT02141659|11806509|FG003|NOT COMPLETED|Overall Study||0
10646763|NCT02141659|11806510|FG004|NOT COMPLETED|Overall Study||2
10646764|NCT02141659|11806511|FG005|NOT COMPLETED|Overall Study||2
10646765|NCT02141672|11806528|FG000|STARTED|Overall Study||89
10646766|NCT02141672|11806529|FG001|STARTED|Overall Study||88
10646767|NCT02141672|11806530|FG002|STARTED|Overall Study||88
10646768|NCT02141672|11806528|FG000|COMPLETED|Overall Study||73
10646769|NCT02141672|11806529|FG001|COMPLETED|Overall Study||80
10646770|NCT02141672|11806530|FG002|COMPLETED|Overall Study||70
10646771|NCT02141672|11806528|FG000|NOT COMPLETED|Overall Study||16
10646772|NCT02141672|11806529|FG001|NOT COMPLETED|Overall Study||8
10646773|NCT02141672|11806530|FG002|NOT COMPLETED|Overall Study||18
10646774|NCT02141854|11806543|FG000|STARTED|Run-In Period (Pre-assignment)||882
10646775|NCT02141854|11806544|FG001|STARTED|Run-In Period (Pre-assignment)||0
10646776|NCT02141854|11806545|FG002|STARTED|Run-In Period (Pre-assignment)||0
10646777|NCT02141854|11806546|FG003|STARTED|Run-In Period (Pre-assignment)||0
10646778|NCT02141854|11806547|FG004|STARTED|Run-In Period (Pre-assignment)||0
10646779|NCT02141854|11806548|FG005|STARTED|Run-In Period (Pre-assignment)||0
10646780|NCT02141854|11806543|FG000|COMPLETED|Run-In Period (Pre-assignment)||728
10646781|NCT02141854|11806544|FG001|COMPLETED|Run-In Period (Pre-assignment)||0
10646782|NCT02141854|11806545|FG002|COMPLETED|Run-In Period (Pre-assignment)||0
10646783|NCT02141854|11806546|FG003|COMPLETED|Run-In Period (Pre-assignment)||0
10646784|NCT02141854|11806547|FG004|COMPLETED|Run-In Period (Pre-assignment)||0
10646785|NCT02141854|11806548|FG005|COMPLETED|Run-In Period (Pre-assignment)||0
10646786|NCT02141854|11806543|FG000|NOT COMPLETED|Run-In Period (Pre-assignment)||154
10646787|NCT02141854|11806544|FG001|NOT COMPLETED|Run-In Period (Pre-assignment)||0
10646788|NCT02141854|11806545|FG002|NOT COMPLETED|Run-In Period (Pre-assignment)||0
10646789|NCT02141854|11806546|FG003|NOT COMPLETED|Run-In Period (Pre-assignment)||0
10646790|NCT02141854|11806547|FG004|NOT COMPLETED|Run-In Period (Pre-assignment)||0
10646791|NCT02141854|11806548|FG005|NOT COMPLETED|Run-In Period (Pre-assignment)||0
10646792|NCT02141854|11806543|FG000|STARTED|Treatment Period||0
10646793|NCT02141854|11806544|FG001|STARTED|Treatment Period||146
10646794|NCT02141854|11806545|FG002|STARTED|Treatment Period||145
10646795|NCT02141854|11806546|FG003|STARTED|Treatment Period||146
10646796|NCT02141854|11806547|FG004|STARTED|Treatment Period||146
10646797|NCT02141854|11806548|FG005|STARTED|Treatment Period||145
10646798|NCT02141854|11806543|FG000|Intent to Treat Population|Treatment Period||0
10646799|NCT02141854|11806544|FG001|Intent to Treat Population|Treatment Period||146
10646800|NCT02141854|11806545|FG002|Intent to Treat Population|Treatment Period||145
10646801|NCT02141854|11806546|FG003|Intent to Treat Population|Treatment Period||146
10646802|NCT02141854|11806547|FG004|Intent to Treat Population|Treatment Period||146
10646803|NCT02141854|11806548|FG005|Intent to Treat Population|Treatment Period||145
10646804|NCT02141854|11806543|FG000|Safety Population|Treatment Period||0
10646805|NCT02141854|11806544|FG001|Safety Population|Treatment Period||145
10646806|NCT02141854|11806545|FG002|Safety Population|Treatment Period||143
10646807|NCT02141854|11806546|FG003|Safety Population|Treatment Period||146
10646808|NCT02141854|11806547|FG004|Safety Population|Treatment Period||145
10646809|NCT02141854|11806548|FG005|Safety Population|Treatment Period||144
10646810|NCT02141854|11806543|FG000|Full Analysis Set|Treatment Period||0
10646811|NCT02141854|11806544|FG001|Full Analysis Set|Treatment Period||145
10646812|NCT02141854|11806545|FG002|Full Analysis Set|Treatment Period||141
10646813|NCT02141854|11806546|FG003|Full Analysis Set|Treatment Period||146
10646814|NCT02141854|11806547|FG004|Full Analysis Set|Treatment Period||145
10646815|NCT02141854|11806548|FG005|Full Analysis Set|Treatment Period||143
10646816|NCT02141854|11806543|FG000|COMPLETED|Treatment Period||0
10646817|NCT02141854|11806544|FG001|COMPLETED|Treatment Period||136
10646818|NCT02141854|11806545|FG002|COMPLETED|Treatment Period||136
10646819|NCT02141854|11806546|FG003|COMPLETED|Treatment Period||135
10646820|NCT02141854|11806547|FG004|COMPLETED|Treatment Period||136
10646821|NCT02141854|11806548|FG005|COMPLETED|Treatment Period||107
10646822|NCT02141854|11806543|FG000|NOT COMPLETED|Treatment Period||0
10646823|NCT02141854|11806544|FG001|NOT COMPLETED|Treatment Period||10
10646824|NCT02141854|11806545|FG002|NOT COMPLETED|Treatment Period||9
10646825|NCT02141854|11806546|FG003|NOT COMPLETED|Treatment Period||11
10646826|NCT02141854|11806547|FG004|NOT COMPLETED|Treatment Period||10
10646827|NCT02141854|11806548|FG005|NOT COMPLETED|Treatment Period||38
10646828|NCT02141867|11806560|FG000|STARTED|Overall Study||4021
10646829|NCT02141867|11806560|FG000|COMPLETED|Overall Study||3927
10646830|NCT02141867|11806560|FG000|NOT COMPLETED|Overall Study||94
10646831|NCT02141984|11806564|FG000|STARTED|Overall Study||28
10646832|NCT02141984|11806564|FG000|COMPLETED|Overall Study||26
10646833|NCT02141984|11806564|FG000|NOT COMPLETED|Overall Study||2
10646834|NCT02141997|11806572|FG000|STARTED|Overall Study||56
10646835|NCT02141997|11806573|FG001|STARTED|Overall Study||55
10646836|NCT02141997|11806574|FG002|STARTED|Overall Study||56
10646837|NCT02141997|11806575|FG003|STARTED|Overall Study||55
10646838|NCT02141997|11806572|FG000|COMPLETED|Overall Study||53
10646839|NCT02141997|11806573|FG001|COMPLETED|Overall Study||49
10646840|NCT02141997|11806574|FG002|COMPLETED|Overall Study||53
10646841|NCT02141997|11806575|FG003|COMPLETED|Overall Study||54
10646842|NCT02141997|11806572|FG000|NOT COMPLETED|Overall Study||3
10646843|NCT02141997|11806573|FG001|NOT COMPLETED|Overall Study||6
10646844|NCT02141997|11806574|FG002|NOT COMPLETED|Overall Study||3
10646845|NCT02141997|11806575|FG003|NOT COMPLETED|Overall Study||1
10646846|NCT02142049|11806590|FG000|STARTED|Overall Study||3
10646847|NCT02142049|11806591|FG001|STARTED|Overall Study||3
10646848|NCT02142049|11806592|FG002|STARTED|Overall Study||3
10646849|NCT02142049|11806593|FG003|STARTED|Overall Study||6
10646850|NCT02142049|11806594|FG004|STARTED|Overall Study||20
10646851|NCT02142049|11806590|FG000|COMPLETED|Overall Study||3
10646852|NCT02142049|11806591|FG001|COMPLETED|Overall Study||3
10646853|NCT02142049|11806592|FG002|COMPLETED|Overall Study||3
10646854|NCT02142049|11806593|FG003|COMPLETED|Overall Study||6
10646855|NCT02142049|11806594|FG004|COMPLETED|Overall Study||20
10646856|NCT02142049|11806590|FG000|NOT COMPLETED|Overall Study||0
10646857|NCT02142049|11806591|FG001|NOT COMPLETED|Overall Study||0
10646858|NCT02142049|11806592|FG002|NOT COMPLETED|Overall Study||0
10646859|NCT02142049|11806593|FG003|NOT COMPLETED|Overall Study||0
10646860|NCT02142049|11806594|FG004|NOT COMPLETED|Overall Study||0
10646861|NCT02142153|11806621|FG000|STARTED|Overall Study||6
10646862|NCT02142153|11806622|FG001|STARTED|Overall Study||2
10646863|NCT02142153|11806623|FG002|STARTED|Overall Study||6
10646864|NCT02142153|11806624|FG003|STARTED|Overall Study||2
10646865|NCT02142153|11806625|FG004|STARTED|Overall Study||6
10646866|NCT02142153|11806626|FG005|STARTED|Overall Study||2
10646867|NCT02142153|11806627|FG006|STARTED|Overall Study||6
10646868|NCT02142153|11806628|FG007|STARTED|Overall Study||2
10646869|NCT02142153|11806629|FG008|STARTED|Overall Study||6
10646870|NCT02142153|11806630|FG009|STARTED|Overall Study||2
10646871|NCT02142153|11806621|FG000|COMPLETED|Overall Study||6
10646872|NCT02142153|11806622|FG001|COMPLETED|Overall Study||2
10646873|NCT02142153|11806623|FG002|COMPLETED|Overall Study||6
10646874|NCT02142153|11806624|FG003|COMPLETED|Overall Study||2
10646875|NCT02142153|11806625|FG004|COMPLETED|Overall Study||6
10646876|NCT02142153|11806626|FG005|COMPLETED|Overall Study||2
10646877|NCT02142153|11806627|FG006|COMPLETED|Overall Study||6
10646878|NCT02142153|11806628|FG007|COMPLETED|Overall Study||2
10646879|NCT02142153|11806629|FG008|COMPLETED|Overall Study||6
10646880|NCT02142153|11806630|FG009|COMPLETED|Overall Study||2
10646881|NCT02142153|11806621|FG000|NOT COMPLETED|Overall Study||0
10646882|NCT02142153|11806622|FG001|NOT COMPLETED|Overall Study||0
10646883|NCT02142153|11806623|FG002|NOT COMPLETED|Overall Study||0
10646884|NCT02142153|11806624|FG003|NOT COMPLETED|Overall Study||0
10646885|NCT02142153|11806625|FG004|NOT COMPLETED|Overall Study||0
10646886|NCT02142153|11806626|FG005|NOT COMPLETED|Overall Study||0
10646887|NCT02142153|11806627|FG006|NOT COMPLETED|Overall Study||0
10646888|NCT02142153|11806628|FG007|NOT COMPLETED|Overall Study||0
10646889|NCT02142153|11806629|FG008|NOT COMPLETED|Overall Study||0
10646890|NCT02142153|11806630|FG009|NOT COMPLETED|Overall Study||0
10646891|NCT02142283|11806664|FG000|STARTED|Overall Study||107
10646892|NCT02142283|11806665|FG001|STARTED|Overall Study||99
10646893|NCT02142283|11806664|FG000|COMPLETED|Overall Study||86
10646894|NCT02142283|11806665|FG001|COMPLETED|Overall Study||78
10646895|NCT02142283|11806664|FG000|NOT COMPLETED|Overall Study||21
10646896|NCT02142283|11806665|FG001|NOT COMPLETED|Overall Study||21
10646897|NCT02142361|11806671|FG000|STARTED|Overall Study||20
10646898|NCT02142361|11806672|FG001|STARTED|Overall Study||20
10646899|NCT02142361|11806673|FG002|STARTED|Overall Study||20
10646900|NCT02142361|11806671|FG000|COMPLETED|Overall Study||20
10646901|NCT02142361|11806672|FG001|COMPLETED|Overall Study||20
10646902|NCT02142361|11806673|FG002|COMPLETED|Overall Study||20
10646903|NCT02142361|11806671|FG000|NOT COMPLETED|Overall Study||0
10646904|NCT02142361|11806672|FG001|NOT COMPLETED|Overall Study||0
10646905|NCT02142361|11806673|FG002|NOT COMPLETED|Overall Study||0
10646906|NCT02142387|11806686|FG000|STARTED|Overall Study|Out-of-hospital cardiac arrest (OHCA) patients with presumed cardiac etiology.|2551
10646907|NCT02142387|11806687|FG001|STARTED|Overall Study||16271
10646908|NCT02142387|11806686|FG000|COMPLETED|Overall Study|Limited to the case where OHCA occurred in the private place.|1486
10646909|NCT02142387|11806687|FG001|COMPLETED|Overall Study||8641
10646910|NCT02142387|11806686|FG000|NOT COMPLETED|Overall Study||1065
10646911|NCT02142387|11806687|FG001|NOT COMPLETED|Overall Study||7630
10646912|NCT02142504|11806696|FG000|STARTED|Overall Study||153
10646913|NCT02142504|11806697|FG001|STARTED|Overall Study||147
10646914|NCT02142504|11806698|FG002|STARTED|Overall Study||154
10646915|NCT02142504|11806696|FG000|Randomized and Received Treatment|Overall Study||153
10646916|NCT02142504|11806697|FG001|Randomized and Received Treatment|Overall Study||145
10646917|NCT02142504|11806698|FG002|Randomized and Received Treatment|Overall Study||154
10646918|NCT02142504|11806696|FG000|Received Booster (Second Vaccination)|Overall Study||126
10646919|NCT02142504|11806697|FG001|Received Booster (Second Vaccination)|Overall Study||109
10646920|NCT02142504|11806698|FG002|Received Booster (Second Vaccination)|Overall Study||116
10646921|NCT02142504|11806696|FG000|COMPLETED|Overall Study||122
10646922|NCT02142504|11806697|FG001|COMPLETED|Overall Study||105
10646923|NCT02142504|11806698|FG002|COMPLETED|Overall Study||111
10646924|NCT02142504|11806696|FG000|NOT COMPLETED|Overall Study||31
10646925|NCT02142504|11806697|FG001|NOT COMPLETED|Overall Study||42
10646926|NCT02142504|11806698|FG002|NOT COMPLETED|Overall Study||43
10646927|NCT02142608|11806706|FG000|STARTED|Overall Study||18
10646928|NCT02142608|11806706|FG000|COMPLETED|Overall Study||18
10706238|NCT02607228|11870789|FG006|COMPLETED|Overall Study||0
10706239|NCT02607228|11870783|FG000|NOT COMPLETED|Overall Study||5
10706240|NCT02607228|11870784|FG001|NOT COMPLETED|Overall Study||4
10706241|NCT02607228|11870785|FG002|NOT COMPLETED|Overall Study||3
10706242|NCT02607228|11870786|FG003|NOT COMPLETED|Overall Study||6
10706243|NCT02607228|11870787|FG004|NOT COMPLETED|Overall Study||5
10646929|NCT02142608|11806706|FG000|NOT COMPLETED|Overall Study||0
10646930|NCT02142712|11806714|FG000|STARTED|Overall Study||1
10646931|NCT02142712|11806715|FG001|STARTED|Overall Study||1
10646932|NCT02142712|11806716|FG002|STARTED|Overall Study||1
10646933|NCT02142712|11806717|FG003|STARTED|Overall Study||0
10646934|NCT02142712|11806714|FG000|COMPLETED|Overall Study||0
10646935|NCT02142712|11806715|FG001|COMPLETED|Overall Study||0
10646936|NCT02142712|11806716|FG002|COMPLETED|Overall Study||0
10646937|NCT02142712|11806717|FG003|COMPLETED|Overall Study||0
10646938|NCT02142712|11806714|FG000|NOT COMPLETED|Overall Study||1
10646939|NCT02142712|11806715|FG001|NOT COMPLETED|Overall Study||1
10646940|NCT02142712|11806716|FG002|NOT COMPLETED|Overall Study||1
10646941|NCT02142712|11806717|FG003|NOT COMPLETED|Overall Study||0
10646942|NCT02142894|11806726|FG000|STARTED|Overall Study||33
10646943|NCT02142894|11806726|FG000|COMPLETED|Overall Study||25
10646944|NCT02142894|11806726|FG000|NOT COMPLETED|Overall Study||8
10646945|NCT02143024|11806732|FG000|STARTED|Overall Study||15
10646946|NCT02143024|11806733|FG001|STARTED|Overall Study||8
10646947|NCT02143024|11806732|FG000|Received Treatment|Overall Study||13
10646948|NCT02143024|11806733|FG001|Received Treatment|Overall Study||7
10646949|NCT02143024|11806732|FG000|COMPLETED|Overall Study||13
10646950|NCT02143024|11806733|FG001|COMPLETED|Overall Study||7
10646951|NCT02143024|11806732|FG000|NOT COMPLETED|Overall Study||2
10646952|NCT02143024|11806733|FG001|NOT COMPLETED|Overall Study||1
10646953|NCT02143102|11806741|FG000|STARTED|Overall Study||97
10646954|NCT02143102|11806742|FG001|STARTED|Overall Study||28
10646955|NCT02143102|11806741|FG000|COMPLETED|Overall Study||86
10646956|NCT02143102|11806742|FG001|COMPLETED|Overall Study||28
10646957|NCT02143102|11806741|FG000|NOT COMPLETED|Overall Study||11
10646958|NCT02143102|11806742|FG001|NOT COMPLETED|Overall Study||0
10646959|NCT02143141|11806750|FG000|STARTED|Overall Study||7
10646960|NCT02143141|11806751|FG001|STARTED|Overall Study||6
10646961|NCT02143141|11806750|FG000|COMPLETED|Overall Study||6
10646962|NCT02143141|11806751|FG001|COMPLETED|Overall Study||6
10646963|NCT02143141|11806750|FG000|NOT COMPLETED|Overall Study||1
10646964|NCT02143141|11806751|FG001|NOT COMPLETED|Overall Study||0
10646965|NCT02143310|11806757|FG000|STARTED|Overall Study||209
10646966|NCT02143310|11806757|FG000|COMPLETED|Overall Study||102
10646967|NCT02143310|11806757|FG000|NOT COMPLETED|Overall Study||107
10646968|NCT02143583|11806764|FG000|STARTED|Overall Study||62
10646969|NCT02143583|11806765|FG001|STARTED|Overall Study||66
10646970|NCT02143583|11806766|FG002|STARTED|Overall Study||68
10706244|NCT02607228|11870788|FG005|NOT COMPLETED|Overall Study||6
10706245|NCT02607228|11870789|FG006|NOT COMPLETED|Overall Study||2
10706246|NCT02607254|11870809|FG000|STARTED|Overall Study||3
10706247|NCT02607254|11870810|FG001|STARTED|Overall Study||3
10706248|NCT02607254|11870811|FG002|STARTED|Overall Study||5
10706249|NCT02607254|11870809|FG000|COMPLETED|Overall Study||3
10646971|NCT02143583|11806764|FG000|COMPLETED|Overall Study||61
10646972|NCT02143583|11806765|FG001|COMPLETED|Overall Study||66
10646973|NCT02143583|11806766|FG002|COMPLETED|Overall Study||66
10646974|NCT02143583|11806764|FG000|NOT COMPLETED|Overall Study||1
10646975|NCT02143583|11806765|FG001|NOT COMPLETED|Overall Study||0
10646976|NCT02143583|11806766|FG002|NOT COMPLETED|Overall Study||2
10654403|NCT02202616|11815167|FG000|Intent to Treat Set (ITT)|Overall Study||338
10654404|NCT02202616|11815167|FG000|COMPLETED|Overall Study||301
10654405|NCT02202616|11815167|FG000|NOT COMPLETED|Overall Study||100
10654406|NCT02202746|11815174|FG000|STARTED|Overall Study||109
10706250|NCT02607254|11870810|FG001|COMPLETED|Overall Study||3
10706251|NCT02607254|11870811|FG002|COMPLETED|Overall Study||5
10646977|NCT02143648|11806777|FG000|STARTED|Overall Study||128
10646978|NCT02143648|11806778|FG001|STARTED|Overall Study||120
10646979|NCT02143648|11806779|FG002|STARTED|Overall Study||125
10646980|NCT02143648|11806777|FG000|COMPLETED|Overall Study||74
10646981|NCT02143648|11806778|FG001|COMPLETED|Overall Study||78
10646982|NCT02143648|11806779|FG002|COMPLETED|Overall Study||101
10646983|NCT02143648|11806777|FG000|NOT COMPLETED|Overall Study||54
10646984|NCT02143648|11806778|FG001|NOT COMPLETED|Overall Study||42
10646985|NCT02143648|11806779|FG002|NOT COMPLETED|Overall Study||24
10646986|NCT02143713|11806791|FG000|STARTED|Treatment Period (6 Months)||102
10646987|NCT02143713|11806792|FG001|STARTED|Treatment Period (6 Months)||111
10646988|NCT02143713|11806793|FG002|STARTED|Treatment Period (6 Months)||142
10646989|NCT02143713|11806794|FG003|STARTED|Treatment Period (6 Months)||140
10646990|NCT02143713|11806791|FG000|Received Elagolix|Treatment Period (6 Months)||102
10646991|NCT02143713|11806792|FG001|Received Elagolix|Treatment Period (6 Months)||111
10646992|NCT02143713|11806793|FG002|Received Elagolix|Treatment Period (6 Months)||142
10646993|NCT02143713|11806794|FG003|Received Elagolix|Treatment Period (6 Months)||140
10646994|NCT02143713|11806791|FG000|COMPLETED|Treatment Period (6 Months)||82
10646995|NCT02143713|11806792|FG001|COMPLETED|Treatment Period (6 Months)||99
10646996|NCT02143713|11806793|FG002|COMPLETED|Treatment Period (6 Months)||120
10646997|NCT02143713|11806794|FG003|COMPLETED|Treatment Period (6 Months)||112
10646998|NCT02143713|11806791|FG000|NOT COMPLETED|Treatment Period (6 Months)||20
10646999|NCT02143713|11806792|FG001|NOT COMPLETED|Treatment Period (6 Months)||12
10647000|NCT02143713|11806793|FG002|NOT COMPLETED|Treatment Period (6 Months)||22
10647001|NCT02143713|11806794|FG003|NOT COMPLETED|Treatment Period (6 Months)||28
10647002|NCT02143713|11806791|FG000|STARTED|Post-treatment Follow-up (12 Months)||85
10647003|NCT02143713|11806792|FG001|STARTED|Post-treatment Follow-up (12 Months)||105
10647004|NCT02143713|11806793|FG002|STARTED|Post-treatment Follow-up (12 Months)||125
10647005|NCT02143713|11806794|FG003|STARTED|Post-treatment Follow-up (12 Months)||122
10647006|NCT02143713|11806791|FG000|COMPLETED|Post-treatment Follow-up (12 Months)||73
10647007|NCT02143713|11806792|FG001|COMPLETED|Post-treatment Follow-up (12 Months)||81
10647008|NCT02143713|11806793|FG002|COMPLETED|Post-treatment Follow-up (12 Months)||96
10647009|NCT02143713|11806794|FG003|COMPLETED|Post-treatment Follow-up (12 Months)||95
10647010|NCT02143713|11806791|FG000|NOT COMPLETED|Post-treatment Follow-up (12 Months)||12
10647011|NCT02143713|11806792|FG001|NOT COMPLETED|Post-treatment Follow-up (12 Months)||24
10647012|NCT02143713|11806793|FG002|NOT COMPLETED|Post-treatment Follow-up (12 Months)||29
10647013|NCT02143713|11806794|FG003|NOT COMPLETED|Post-treatment Follow-up (12 Months)||27
10647014|NCT02143778|11806805|FG000|STARTED|Overall Study||246
10647015|NCT02143778|11806805|FG000|COMPLETED|Overall Study||243
10647016|NCT02143778|11806805|FG000|NOT COMPLETED|Overall Study||3
10647017|NCT02143843|11806810|FG000|STARTED|Overall Study||75
10647018|NCT02143843|11806810|FG000|COMPLETED|Overall Study||63
10647019|NCT02143843|11806810|FG000|NOT COMPLETED|Overall Study||12
10647020|NCT02143947|11806816|FG000|STARTED|Overall Study||36
10647021|NCT02143947|11806817|FG001|STARTED|Overall Study||44
10647022|NCT02143947|11806816|FG000|COMPLETED|Overall Study||32
10647023|NCT02143947|11806817|FG001|COMPLETED|Overall Study||42
10647024|NCT02143947|11806816|FG000|NOT COMPLETED|Overall Study||4
10647025|NCT02143947|11806817|FG001|NOT COMPLETED|Overall Study||2
10647026|NCT02143973|11806825|FG000|STARTED|Overall Study||167
10647027|NCT02143973|11806825|FG000|COMPLETED|Overall Study||101
10647028|NCT02143973|11806825|FG000|NOT COMPLETED|Overall Study||66
10647029|NCT02144012|11806831|FG000|STARTED|Overall Study||34
10647030|NCT02144012|11806832|FG001|STARTED|Overall Study||15
10647031|NCT02144012|11806831|FG000|COMPLETED|Overall Study||0
10647032|NCT02144012|11806832|FG001|COMPLETED|Overall Study||0
10647033|NCT02144012|11806831|FG000|NOT COMPLETED|Overall Study||34
10647034|NCT02144012|11806832|FG001|NOT COMPLETED|Overall Study||15
10647035|NCT02144077|11806840|FG000|STARTED|Overall Study||138
10647036|NCT02144077|11806841|FG001|STARTED|Overall Study||143
10647037|NCT02144077|11806840|FG000|COMPLETED|Overall Study||128
10647038|NCT02144077|11806841|FG001|COMPLETED|Overall Study||132
10647039|NCT02144077|11806840|FG000|NOT COMPLETED|Overall Study||10
10647040|NCT02144077|11806841|FG001|NOT COMPLETED|Overall Study||11
10647041|NCT02144220|11806847|FG000|STARTED|Overall Study||277
10647042|NCT02144220|11806847|FG000|COMPLETED|Overall Study||258
10647043|NCT02144220|11806847|FG000|NOT COMPLETED|Overall Study||19
10647044|NCT02144233|11806853|FG000|STARTED|Overall Study||39
10647045|NCT02144233|11806854|FG001|STARTED|Overall Study||38
10647046|NCT02144233|11806853|FG000|COMPLETED|Overall Study|The last participant was assessed at month 3 due to early study stop|39
10647047|NCT02144233|11806854|FG001|COMPLETED|Overall Study||38
10647048|NCT02144233|11806853|FG000|NOT COMPLETED|Overall Study||0
10706252|NCT02607254|11870809|FG000|NOT COMPLETED|Overall Study||0
10706253|NCT02607254|11870810|FG001|NOT COMPLETED|Overall Study||0
10706254|NCT02607254|11870811|FG002|NOT COMPLETED|Overall Study||0
10647049|NCT02144233|11806854|FG001|NOT COMPLETED|Overall Study||0
10647050|NCT02144259|11806863|FG000|STARTED|Overall Study||33
10647051|NCT02144259|11806864|FG001|STARTED|Overall Study||33
10647052|NCT02144259|11806865|FG002|STARTED|Overall Study||34
10647053|NCT02144259|11806863|FG000|COMPLETED|Overall Study||23
10647054|NCT02144259|11806864|FG001|COMPLETED|Overall Study||28
10647055|NCT02144259|11806865|FG002|COMPLETED|Overall Study||16
10647056|NCT02144259|11806863|FG000|NOT COMPLETED|Overall Study||10
10647057|NCT02144259|11806864|FG001|NOT COMPLETED|Overall Study||5
10647058|NCT02144259|11806865|FG002|NOT COMPLETED|Overall Study||18
10706255|NCT02607280|11870827|FG000|STARTED|Overall Study||30
10647059|NCT02144285|11806883|FG000|STARTED|Overall Study||14
10647060|NCT02144285|11806884|FG001|STARTED|Overall Study||6
10647061|NCT02144285|11806885|FG002|STARTED|Overall Study||6
10647062|NCT02144285|11806886|FG003|STARTED|Overall Study||6
10647063|NCT02144285|11806887|FG004|STARTED|Overall Study||6
10647064|NCT02144285|11806888|FG005|STARTED|Overall Study||6
10647065|NCT02144285|11806889|FG006|STARTED|Overall Study||6
10647066|NCT02144285|11806890|FG007|STARTED|Overall Study||6
10647067|NCT02144285|11806891|FG008|STARTED|Overall Study||2
10647068|NCT02144285|11806892|FG009|STARTED|Overall Study||6
10647069|NCT02144285|11806883|FG000|Received At Least One Dose of Study Drug|Overall Study||14
10647070|NCT02144285|11806884|FG001|Received At Least One Dose of Study Drug|Overall Study||6
10647071|NCT02144285|11806885|FG002|Received At Least One Dose of Study Drug|Overall Study||6
10647072|NCT02144285|11806886|FG003|Received At Least One Dose of Study Drug|Overall Study||6
10647073|NCT02144285|11806887|FG004|Received At Least One Dose of Study Drug|Overall Study||6
10647074|NCT02144285|11806888|FG005|Received At Least One Dose of Study Drug|Overall Study||6
10647075|NCT02144285|11806889|FG006|Received At Least One Dose of Study Drug|Overall Study||6
10647076|NCT02144285|11806890|FG007|Received At Least One Dose of Study Drug|Overall Study||6
10647077|NCT02144285|11806891|FG008|Received At Least One Dose of Study Drug|Overall Study||2
10647078|NCT02144285|11806892|FG009|Received At Least One Dose of Study Drug|Overall Study||6
10647079|NCT02144285|11806883|FG000|COMPLETED|Overall Study||14
10647080|NCT02144285|11806884|FG001|COMPLETED|Overall Study||6
10647081|NCT02144285|11806885|FG002|COMPLETED|Overall Study||6
10706256|NCT02607280|11870828|FG001|STARTED|Overall Study||5
10706257|NCT02607280|11870827|FG000|Received Study Drug|Overall Study||30
10706258|NCT02607280|11870828|FG001|Received Study Drug|Overall Study||5
10647082|NCT02144285|11806886|FG003|COMPLETED|Overall Study||6
10647083|NCT02144285|11806887|FG004|COMPLETED|Overall Study||5
10647084|NCT02144285|11806888|FG005|COMPLETED|Overall Study||6
10647085|NCT02144285|11806889|FG006|COMPLETED|Overall Study||6
10647086|NCT02144285|11806890|FG007|COMPLETED|Overall Study||6
10647087|NCT02144285|11806891|FG008|COMPLETED|Overall Study||2
10647088|NCT02144285|11806892|FG009|COMPLETED|Overall Study||6
10647089|NCT02144285|11806883|FG000|NOT COMPLETED|Overall Study||0
10647090|NCT02144285|11806884|FG001|NOT COMPLETED|Overall Study||0
10647091|NCT02144285|11806885|FG002|NOT COMPLETED|Overall Study||0
10647092|NCT02144285|11806886|FG003|NOT COMPLETED|Overall Study||0
10647093|NCT02144285|11806887|FG004|NOT COMPLETED|Overall Study||1
10647094|NCT02144285|11806888|FG005|NOT COMPLETED|Overall Study||0
10647095|NCT02144285|11806889|FG006|NOT COMPLETED|Overall Study||0
10647096|NCT02144285|11806890|FG007|NOT COMPLETED|Overall Study||0
10647097|NCT02144285|11806891|FG008|NOT COMPLETED|Overall Study||0
10647098|NCT02144285|11806892|FG009|NOT COMPLETED|Overall Study||0
10647099|NCT02144337|11806930|FG000|STARTED|Baseline 0 Months||8
10647100|NCT02144337|11806931|FG001|STARTED|Baseline 0 Months||5
10647101|NCT02144337|11806930|FG000|COMPLETED|Baseline 0 Months||8
10647102|NCT02144337|11806931|FG001|COMPLETED|Baseline 0 Months||5
10647103|NCT02144337|11806930|FG000|NOT COMPLETED|Baseline 0 Months||0
10647104|NCT02144337|11806931|FG001|NOT COMPLETED|Baseline 0 Months||0
10647105|NCT02144337|11806930|FG000|STARTED|T2 Follow-up (Post-intervention)||8
10647106|NCT02144337|11806931|FG001|STARTED|T2 Follow-up (Post-intervention)||5
10647107|NCT02144337|11806930|FG000|COMPLETED|T2 Follow-up (Post-intervention)||4
10647108|NCT02144337|11806931|FG001|COMPLETED|T2 Follow-up (Post-intervention)||4
10647109|NCT02144337|11806930|FG000|NOT COMPLETED|T2 Follow-up (Post-intervention)||4
10647110|NCT02144337|11806931|FG001|NOT COMPLETED|T2 Follow-up (Post-intervention)||1
10647111|NCT02144337|11806930|FG000|STARTED|T3 Follow-up (3 Month Post-intervention)|Number not the same as number who completed previous period due to absence/loss of data at T2|8
10647112|NCT02144337|11806931|FG001|STARTED|T3 Follow-up (3 Month Post-intervention)|Number not the same as number who completed previous period due to absence/loss of data at T2|5
10647113|NCT02144337|11806930|FG000|COMPLETED|T3 Follow-up (3 Month Post-intervention)||5
10647202|NCT02145182|11807037|FG001|NOT COMPLETED|Overall Study||16
10647114|NCT02144337|11806931|FG001|COMPLETED|T3 Follow-up (3 Month Post-intervention)||5
10647115|NCT02144337|11806930|FG000|NOT COMPLETED|T3 Follow-up (3 Month Post-intervention)||3
10647116|NCT02144337|11806931|FG001|NOT COMPLETED|T3 Follow-up (3 Month Post-intervention)||0
10647117|NCT02139540|11806940|FG000|STARTED|Overall Study||11
10647118|NCT02139540|11806941|FG001|STARTED|Overall Study||10
10647119|NCT02139540|11806940|FG000|COMPLETED|Overall Study||10
10647120|NCT02139540|11806941|FG001|COMPLETED|Overall Study||10
10647121|NCT02139540|11806940|FG000|NOT COMPLETED|Overall Study||1
10647122|NCT02139540|11806941|FG001|NOT COMPLETED|Overall Study||0
10647123|NCT02144519|11806949|FG000|STARTED|Year 1||895
10647124|NCT02144519|11806950|FG001|STARTED|Year 1||870
10647125|NCT02144519|11806949|FG000|COMPLETED|Year 1||895
10647126|NCT02144519|11806950|FG001|COMPLETED|Year 1||870
10647127|NCT02144519|11806949|FG000|NOT COMPLETED|Year 1||0
10647128|NCT02144519|11806950|FG001|NOT COMPLETED|Year 1||0
10647129|NCT02144519|11806949|FG000|STARTED|Year 2||763
10647130|NCT02144519|11806950|FG001|STARTED|Year 2||864
10647131|NCT02144519|11806949|FG000|COMPLETED|Year 2||763
10647132|NCT02144519|11806950|FG001|COMPLETED|Year 2||864
10647133|NCT02144519|11806949|FG000|NOT COMPLETED|Year 2||0
10647134|NCT02144519|11806950|FG001|NOT COMPLETED|Year 2||0
10647135|NCT02144519|11806949|FG000|STARTED|Year 3||894
10647136|NCT02144519|11806950|FG001|STARTED|Year 3||760
10647137|NCT02144519|11806949|FG000|COMPLETED|Year 3||894
10647138|NCT02144519|11806950|FG001|COMPLETED|Year 3||760
10647139|NCT02144519|11806949|FG000|NOT COMPLETED|Year 3||0
10706259|NCT02607280|11870827|FG000|COMPLETED|Overall Study||26
10706260|NCT02607280|11870828|FG001|COMPLETED|Overall Study||4
10647140|NCT02144519|11806950|FG001|NOT COMPLETED|Year 3||0
10647141|NCT02144597|11806959|FG000|STARTED|Overall Study||10
10647142|NCT02144597|11806960|FG001|STARTED|Overall Study||10
10647143|NCT02144597|11806961|FG002|STARTED|Overall Study||10
10647144|NCT02144597|11806959|FG000|COMPLETED|Overall Study||4
10647145|NCT02144597|11806960|FG001|COMPLETED|Overall Study||6
10647146|NCT02144597|11806961|FG002|COMPLETED|Overall Study||6
10647147|NCT02144597|11806959|FG000|NOT COMPLETED|Overall Study||6
10647148|NCT02144597|11806960|FG001|NOT COMPLETED|Overall Study||4
10647149|NCT02144597|11806961|FG002|NOT COMPLETED|Overall Study||4
10647150|NCT02144610|11806971|FG000|STARTED|Overall Study||23
10647151|NCT02144610|11806972|FG001|STARTED|Overall Study||23
10647152|NCT02144610|11806971|FG000|COMPLETED|Overall Study||0
10647153|NCT02144610|11806972|FG001|COMPLETED|Overall Study||1
10647154|NCT02144610|11806971|FG000|NOT COMPLETED|Overall Study||23
10647155|NCT02144610|11806972|FG001|NOT COMPLETED|Overall Study||22
10647156|NCT02144675|11806980|FG000|STARTED|Overall Study||13
10647157|NCT02144675|11806981|FG001|STARTED|Overall Study||14
10647158|NCT02144675|11806980|FG000|COMPLETED|Overall Study||13
10647159|NCT02144675|11806981|FG001|COMPLETED|Overall Study||14
10647160|NCT02144675|11806980|FG000|NOT COMPLETED|Overall Study||0
10647161|NCT02144675|11806981|FG001|NOT COMPLETED|Overall Study||0
10647162|NCT02144701|11806989|FG000|STARTED|Overall Study||22
10647163|NCT02144701|11806990|FG001|STARTED|Overall Study||11
10647164|NCT02144701|11806989|FG000|COMPLETED|Overall Study||13
10647165|NCT02144701|11806990|FG001|COMPLETED|Overall Study||8
10647166|NCT02144701|11806989|FG000|NOT COMPLETED|Overall Study||9
10647167|NCT02144701|11806990|FG001|NOT COMPLETED|Overall Study||3
10647168|NCT02144714|11806999|FG000|STARTED|Overall Study||63
10647169|NCT02144714|11807000|FG001|STARTED|Overall Study||63
10647170|NCT02144714|11807001|FG002|STARTED|Overall Study||63
10647171|NCT02144714|11806999|FG000|COMPLETED|Overall Study||63
10647172|NCT02144714|11807000|FG001|COMPLETED|Overall Study||63
10647173|NCT02144714|11807001|FG002|COMPLETED|Overall Study||63
10647174|NCT02144714|11806999|FG000|NOT COMPLETED|Overall Study||0
10647175|NCT02144714|11807000|FG001|NOT COMPLETED|Overall Study||0
10647176|NCT02144714|11807001|FG002|NOT COMPLETED|Overall Study||0
10647177|NCT02145026|11807009|FG000|STARTED|Overall Study||100
10647178|NCT02145026|11807009|FG000|COMPLETED|Overall Study||88
10647179|NCT02145026|11807009|FG000|NOT COMPLETED|Overall Study||12
10647180|NCT02145039|11807013|FG000|STARTED|Overall Study||2
10647181|NCT02145039|11807013|FG000|COMPLETED|Overall Study||2
10647182|NCT02145039|11807013|FG000|NOT COMPLETED|Overall Study||0
10647183|NCT02145078|11807017|FG000|STARTED|Overall Study||4
10647184|NCT02145078|11807017|FG000|COMPLETED|Overall Study||0
10647185|NCT02145078|11807017|FG000|NOT COMPLETED|Overall Study||4
10647186|NCT02145156|11807024|FG000|STARTED|Overall Study||430
10647187|NCT02145156|11807025|FG001|STARTED|Overall Study||425
10647188|NCT02145156|11807026|FG002|STARTED|Overall Study||439
10647189|NCT02145156|11807024|FG000|COMPLETED|Overall Study||370
10647190|NCT02145156|11807025|FG001|COMPLETED|Overall Study||373
10647191|NCT02145156|11807026|FG002|COMPLETED|Overall Study||398
10647192|NCT02145156|11807024|FG000|NOT COMPLETED|Overall Study||60
10647193|NCT02145156|11807025|FG001|NOT COMPLETED|Overall Study||52
10647194|NCT02145156|11807026|FG002|NOT COMPLETED|Overall Study||41
10647195|NCT02145182|11807036|FG000|STARTED|Overall Study||142
10647196|NCT02145182|11807037|FG001|STARTED|Overall Study||146
10647197|NCT02145182|11807036|FG000|Received at Least 1 Dose of Study Drug|Overall Study||142
10647198|NCT02145182|11807037|FG001|Received at Least 1 Dose of Study Drug|Overall Study||146
10647199|NCT02145182|11807036|FG000|COMPLETED|Overall Study||124
10706261|NCT02607280|11870827|FG000|NOT COMPLETED|Overall Study||4
10706262|NCT02607280|11870828|FG001|NOT COMPLETED|Overall Study||1
10706263|NCT02607306|11870837|FG000|STARTED|Overall Study||275
10706264|NCT02607306|11870838|FG001|STARTED|Overall Study||271
10647200|NCT02145182|11807037|FG001|COMPLETED|Overall Study||130
10647201|NCT02145182|11807036|FG000|NOT COMPLETED|Overall Study||18
10647203|NCT02145247|11807045|FG000|STARTED|Overall Study||20
10647204|NCT02145247|11807046|FG001|STARTED|Overall Study||19
10647205|NCT02145247|11807045|FG000|COMPLETED|Overall Study||20
10647206|NCT02145247|11807046|FG001|COMPLETED|Overall Study||19
10647207|NCT02145247|11807045|FG000|NOT COMPLETED|Overall Study||0
10647208|NCT02145247|11807046|FG001|NOT COMPLETED|Overall Study||0
10647209|NCT02145299|11807054|FG000|STARTED|Overall Study||6
10647210|NCT02145299|11807055|FG001|STARTED|Overall Study||2
10647211|NCT02145299|11807054|FG000|COMPLETED|Overall Study||6
10647212|NCT02145299|11807055|FG001|COMPLETED|Overall Study||2
10647213|NCT02145299|11807054|FG000|NOT COMPLETED|Overall Study||0
10647214|NCT02145299|11807055|FG001|NOT COMPLETED|Overall Study||0
10647215|NCT02145429|11807063|FG000|STARTED|Overall Study||91
10647216|NCT02145429|11807064|FG001|STARTED|Overall Study||90
10647217|NCT02145429|11807063|FG000|COMPLETED|Overall Study||75
10647218|NCT02145429|11807064|FG001|COMPLETED|Overall Study||79
10647219|NCT02145429|11807063|FG000|NOT COMPLETED|Overall Study||16
10647220|NCT02145429|11807064|FG001|NOT COMPLETED|Overall Study||11
10647221|NCT02145468|11807072|FG000|STARTED|Overall Study||1758
10647222|NCT02145468|11807073|FG001|STARTED|Overall Study||1731
10647223|NCT02145468|11807072|FG000|COMPLETED|Overall Study||1753
10647224|NCT02145468|11807073|FG001|COMPLETED|Overall Study||1723
10647225|NCT02145468|11807072|FG000|NOT COMPLETED|Overall Study||5
10647226|NCT02145468|11807073|FG001|NOT COMPLETED|Overall Study||8
10647227|NCT02145676|11807082|FG000|STARTED|Overall Study||17
10706265|NCT02607306|11870839|FG002|STARTED|Overall Study||273
10647228|NCT02145676|11807083|FG001|STARTED|Overall Study||18
10647229|NCT02145676|11807084|FG002|STARTED|Overall Study||18
10647230|NCT02145676|11807082|FG000|COMPLETED|Overall Study||17
10647231|NCT02145676|11807083|FG001|COMPLETED|Overall Study||18
10647232|NCT02145676|11807084|FG002|COMPLETED|Overall Study||18
10647233|NCT02145676|11807082|FG000|NOT COMPLETED|Overall Study||0
10647234|NCT02145676|11807083|FG001|NOT COMPLETED|Overall Study||0
10647235|NCT02145676|11807084|FG002|NOT COMPLETED|Overall Study||0
10647236|NCT02145754|11807092|FG000|STARTED|Overall Study||235
10647237|NCT02145754|11807092|FG000|COMPLETED|Overall Study||235
10647238|NCT02145754|11807092|FG000|NOT COMPLETED|Overall Study||0
10647239|NCT02146001|11807098|FG000|STARTED|Overall Study||19
10647240|NCT02146001|11807099|FG001|STARTED|Overall Study||19
10647241|NCT02146001|11807098|FG000|COMPLETED|Overall Study||19
10647242|NCT02146001|11807099|FG001|COMPLETED|Overall Study||19
10647243|NCT02146001|11807098|FG000|NOT COMPLETED|Overall Study||0
10647244|NCT02146001|11807099|FG001|NOT COMPLETED|Overall Study||0
10647245|NCT02146105|11807105|FG000|STARTED|Overall Study||45
10647246|NCT02146105|11807105|FG000|COMPLETED|Overall Study||39
10647247|NCT02146105|11807105|FG000|NOT COMPLETED|Overall Study||6
10647248|NCT02146131|11807111|FG000|STARTED|Overall Study||170
10647249|NCT02146131|11807112|FG001|STARTED|Overall Study||169
10647250|NCT02146131|11807111|FG000|COMPLETED|Overall Study||109
10647251|NCT02146131|11807112|FG001|COMPLETED|Overall Study||113
10647252|NCT02146131|11807111|FG000|NOT COMPLETED|Overall Study||61
10647253|NCT02146131|11807112|FG001|NOT COMPLETED|Overall Study||56
10647254|NCT02146248|11807118|FG000|STARTED|Overall Study||11
10647255|NCT02146248|11807118|FG000|Enrolled|Overall Study||11
10647256|NCT02146248|11807118|FG000|Uterine Sounding|Overall Study|one subject dropped out after uterine sound before HSG #1|11
10647257|NCT02146248|11807118|FG000|HSG 1|Overall Study||10
10647258|NCT02146248|11807118|FG000|HSG 2|Overall Study||10
10647259|NCT02146248|11807118|FG000|HSG 3|Overall Study||9
10647260|NCT02146248|11807118|FG000|HSG 4|Overall Study||7
10647261|NCT02146248|11807118|FG000|HSG 5|Overall Study||1
10647262|NCT02146248|11807118|FG000|COMPLETED|Overall Study||9
10647263|NCT02146248|11807118|FG000|NOT COMPLETED|Overall Study||2
10647264|NCT02146274|11807126|FG000|STARTED|Overall Study||1877
10647265|NCT02146274|11807126|FG000|COMPLETED|Overall Study||1804
10647266|NCT02146274|11807126|FG000|NOT COMPLETED|Overall Study||73
10647267|NCT02146326|11807137|FG000|STARTED|Overall Study||89
10647268|NCT02146326|11807138|FG001|STARTED|Overall Study||103
10647269|NCT02146326|11807139|FG002|STARTED|Overall Study||211
10647270|NCT02146326|11807140|FG003|STARTED|Overall Study||258
10647271|NCT02146326|11807137|FG000|Baseline|Overall Study||89
10647272|NCT02146326|11807138|FG001|Baseline|Overall Study||103
10647273|NCT02146326|11807139|FG002|Baseline|Overall Study||211
10647274|NCT02146326|11807140|FG003|Baseline|Overall Study||258
10647275|NCT02146326|11807137|FG000|3 Months|Overall Study||71
10647276|NCT02146326|11807138|FG001|3 Months|Overall Study||83
10647277|NCT02146326|11807139|FG002|3 Months|Overall Study||0
10647278|NCT02146326|11807140|FG003|3 Months|Overall Study||0
10647279|NCT02146326|11807137|FG000|6 Months|Overall Study||71
10647280|NCT02146326|11807138|FG001|6 Months|Overall Study||71
10647281|NCT02146326|11807139|FG002|6 Months|Overall Study||186
10647282|NCT02146326|11807140|FG003|6 Months|Overall Study||235
10647283|NCT02146326|11807137|FG000|12 Months|Overall Study||61
10647284|NCT02146326|11807138|FG001|12 Months|Overall Study||66
10647285|NCT02146326|11807139|FG002|12 Months|Overall Study||168
10647286|NCT02146326|11807140|FG003|12 Months|Overall Study||210
10647287|NCT02146326|11807137|FG000|COMPLETED|Overall Study||61
10647288|NCT02146326|11807138|FG001|COMPLETED|Overall Study||66
10647289|NCT02146326|11807139|FG002|COMPLETED|Overall Study||168
10647290|NCT02146326|11807140|FG003|COMPLETED|Overall Study||210
10647291|NCT02146326|11807137|FG000|NOT COMPLETED|Overall Study||28
10647292|NCT02146326|11807138|FG001|NOT COMPLETED|Overall Study||37
10647293|NCT02146326|11807139|FG002|NOT COMPLETED|Overall Study||43
10647294|NCT02146326|11807140|FG003|NOT COMPLETED|Overall Study||48
10647295|NCT02146352|11807156|FG000|STARTED|Overall Study||30
10647296|NCT02146352|11807156|FG000|30 or 60 Days Post-procedure|Overall Study||30
10647297|NCT02146352|11807156|FG000|7 Days Post-stent Removal|Overall Study||28
10647298|NCT02146352|11807156|FG000|COMPLETED|Overall Study||28
10647299|NCT02146352|11807156|FG000|NOT COMPLETED|Overall Study||2
10647300|NCT02146365|11807166|FG000|STARTED|Overall Study||49
10647301|NCT02146365|11807167|FG001|STARTED|Overall Study||49
10647302|NCT02146365|11807168|FG002|STARTED|Overall Study||50
10647303|NCT02146365|11807169|FG003|STARTED|Overall Study||50
10647304|NCT02146365|11807170|FG004|STARTED|Overall Study||24
10647305|NCT02146365|11807171|FG005|STARTED|Overall Study||25
10647306|NCT02146365|11807172|FG006|STARTED|Overall Study||25
10647307|NCT02146365|11807173|FG007|STARTED|Overall Study||25
10647308|NCT02146365|11807166|FG000|COMPLETED|Overall Study||45
10647309|NCT02146365|11807167|FG001|COMPLETED|Overall Study||45
10647310|NCT02146365|11807168|FG002|COMPLETED|Overall Study||43
10647311|NCT02146365|11807169|FG003|COMPLETED|Overall Study||41
10647312|NCT02146365|11807170|FG004|COMPLETED|Overall Study||22
10647313|NCT02146365|11807171|FG005|COMPLETED|Overall Study||24
10647314|NCT02146365|11807172|FG006|COMPLETED|Overall Study||25
10647315|NCT02146365|11807173|FG007|COMPLETED|Overall Study||24
10647316|NCT02146365|11807166|FG000|NOT COMPLETED|Overall Study||4
10647317|NCT02146365|11807167|FG001|NOT COMPLETED|Overall Study||4
10647318|NCT02146365|11807168|FG002|NOT COMPLETED|Overall Study||7
10647319|NCT02146365|11807169|FG003|NOT COMPLETED|Overall Study||9
10647320|NCT02146365|11807170|FG004|NOT COMPLETED|Overall Study||2
10647321|NCT02146365|11807171|FG005|NOT COMPLETED|Overall Study||1
10647322|NCT02146365|11807172|FG006|NOT COMPLETED|Overall Study||0
10647323|NCT02146365|11807173|FG007|NOT COMPLETED|Overall Study||1
10647324|NCT02146430|11807195|FG000|STARTED|Overall Study||323
10647325|NCT02146430|11807196|FG001|STARTED|Overall Study||323
10647326|NCT02146430|11807197|FG002|STARTED|Overall Study||324
10647327|NCT02146430|11807198|FG003|STARTED|Overall Study||323
10647328|NCT02146430|11807195|FG000|Safety Analysis Set|Overall Study||318
10647329|NCT02146430|11807196|FG001|Safety Analysis Set|Overall Study||318
10647330|NCT02146430|11807197|FG002|Safety Analysis Set|Overall Study||320
10647331|NCT02146430|11807198|FG003|Safety Analysis Set|Overall Study||320
10647332|NCT02146430|11807195|FG000|Modified Intent to Treat Set (mITT)|Overall Study||318
10647333|NCT02146430|11807196|FG001|Modified Intent to Treat Set (mITT)|Overall Study||317
10647334|NCT02146430|11807197|FG002|Modified Intent to Treat Set (mITT)|Overall Study||319
10647335|NCT02146430|11807198|FG003|Modified Intent to Treat Set (mITT)|Overall Study||319
10647336|NCT02146430|11807195|FG000|COMPLETED|Overall Study||256
10647337|NCT02146430|11807196|FG001|COMPLETED|Overall Study||236
10647338|NCT02146430|11807197|FG002|COMPLETED|Overall Study||242
10647339|NCT02146430|11807198|FG003|COMPLETED|Overall Study||224
10647340|NCT02146430|11807195|FG000|NOT COMPLETED|Overall Study||67
10647341|NCT02146430|11807196|FG001|NOT COMPLETED|Overall Study||87
10647342|NCT02146430|11807197|FG002|NOT COMPLETED|Overall Study||82
10647343|NCT02146430|11807198|FG003|NOT COMPLETED|Overall Study||99
10647344|NCT02146482|11807214|FG000|STARTED|Overall Study|11 participants total enrolled in study but withdrew prior to randomization|21
10647345|NCT02146482|11807215|FG001|STARTED|Overall Study|11 participants total enrolled in study but withdrew prior to randomization|25
10647346|NCT02146482|11807214|FG000|COMPLETED|Overall Study||21
10647347|NCT02146482|11807215|FG001|COMPLETED|Overall Study||25
10647348|NCT02146482|11807214|FG000|NOT COMPLETED|Overall Study||0
10647349|NCT02146482|11807215|FG001|NOT COMPLETED|Overall Study||0
10647350|NCT02146599|11807221|FG000|STARTED|Overall Study||301
10647351|NCT02146599|11807221|FG000|COMPLETED|Overall Study||296
10647352|NCT02146599|11807221|FG000|NOT COMPLETED|Overall Study||5
10647353|NCT02146833|11807225|FG000|STARTED|Overall Study||20
10647354|NCT02146833|11807225|FG000|COMPLETED|Overall Study||9
10647355|NCT02146833|11807225|FG000|NOT COMPLETED|Overall Study||11
10647356|NCT02147067|11807231|FG000|STARTED|Overall Study||13
10647357|NCT02147067|11807232|FG001|STARTED|Overall Study||13
10647358|NCT02147067|11807231|FG000|COMPLETED|Overall Study||11
10647359|NCT02147067|11807232|FG001|COMPLETED|Overall Study||11
10647360|NCT02147067|11807231|FG000|NOT COMPLETED|Overall Study||2
10647361|NCT02147067|11807232|FG001|NOT COMPLETED|Overall Study||2
10647362|NCT02147093|11807240|FG000|STARTED|Period 1||20
10647363|NCT02147093|11807241|FG001|STARTED|Period 1||20
10647364|NCT02147093|11807240|FG000|COMPLETED|Period 1||20
10647365|NCT02147093|11807241|FG001|COMPLETED|Period 1||19
10647366|NCT02147093|11807240|FG000|NOT COMPLETED|Period 1||0
10647367|NCT02147093|11807241|FG001|NOT COMPLETED|Period 1||1
10647368|NCT02147093|11807240|FG000|STARTED|Period 2||20
10647369|NCT02147093|11807241|FG001|STARTED|Period 2||19
10647370|NCT02147093|11807240|FG000|COMPLETED|Period 2||18
10647371|NCT02147093|11807241|FG001|COMPLETED|Period 2||19
10647372|NCT02147093|11807240|FG000|NOT COMPLETED|Period 2||2
10647373|NCT02147093|11807241|FG001|NOT COMPLETED|Period 2||0
10647374|NCT02147132|11807247|FG000|STARTED|Overall Study||2
10647375|NCT02147132|11807248|FG001|STARTED|Overall Study||2
10647376|NCT02147132|11807249|FG002|STARTED|Overall Study||1
10647377|NCT02147132|11807250|FG003|STARTED|Overall Study||2
10647378|NCT02147132|11807247|FG000|COMPLETED|Overall Study||1
10647379|NCT02147132|11807248|FG001|COMPLETED|Overall Study||2
10647380|NCT02147132|11807249|FG002|COMPLETED|Overall Study||1
10647381|NCT02147132|11807250|FG003|COMPLETED|Overall Study||2
10647382|NCT02147132|11807247|FG000|NOT COMPLETED|Overall Study||1
10647383|NCT02147132|11807248|FG001|NOT COMPLETED|Overall Study||0
10647384|NCT02147132|11807249|FG002|NOT COMPLETED|Overall Study||0
10647385|NCT02147132|11807250|FG003|NOT COMPLETED|Overall Study||0
10647386|NCT02147158|11807266|FG000|STARTED|Treatment Course 1||55
10647387|NCT02147158|11807267|FG001|STARTED|Treatment Course 1||47
10647388|NCT02147158|11807268|FG002|STARTED|Treatment Course 1||107
10647389|NCT02147158|11807269|FG003|STARTED|Treatment Course 1||110
10647390|NCT02147158|11807270|FG004|STARTED|Treatment Course 1||55
10647391|NCT02147158|11807271|FG005|STARTED|Treatment Course 1||58
10647392|NCT02147158|11807266|FG000|COMPLETED|Treatment Course 1||51
10647393|NCT02147158|11807267|FG001|COMPLETED|Treatment Course 1||38
10647394|NCT02147158|11807268|FG002|COMPLETED|Treatment Course 1||99
10647395|NCT02147158|11807269|FG003|COMPLETED|Treatment Course 1||97
10647396|NCT02147158|11807270|FG004|COMPLETED|Treatment Course 1||49
10647397|NCT02147158|11807271|FG005|COMPLETED|Treatment Course 1||50
10647398|NCT02147158|11807266|FG000|NOT COMPLETED|Treatment Course 1||4
10647399|NCT02147158|11807267|FG001|NOT COMPLETED|Treatment Course 1||9
10647400|NCT02147158|11807268|FG002|NOT COMPLETED|Treatment Course 1||8
10647401|NCT02147158|11807269|FG003|NOT COMPLETED|Treatment Course 1||13
10647402|NCT02147158|11807270|FG004|NOT COMPLETED|Treatment Course 1||6
10647403|NCT02147158|11807271|FG005|NOT COMPLETED|Treatment Course 1||8
10647404|NCT02147158|11807266|FG000|STARTED|Off-Treatment Interval 1||51
10647405|NCT02147158|11807267|FG001|STARTED|Off-Treatment Interval 1||38
10647406|NCT02147158|11807268|FG002|STARTED|Off-Treatment Interval 1||99
10647407|NCT02147158|11807269|FG003|STARTED|Off-Treatment Interval 1||97
10647408|NCT02147158|11807270|FG004|STARTED|Off-Treatment Interval 1||49
10647409|NCT02147158|11807271|FG005|STARTED|Off-Treatment Interval 1||50
10647410|NCT02147158|11807266|FG000|COMPLETED|Off-Treatment Interval 1||41
10647411|NCT02147158|11807267|FG001|COMPLETED|Off-Treatment Interval 1||34
10647412|NCT02147158|11807268|FG002|COMPLETED|Off-Treatment Interval 1||84
10647413|NCT02147158|11807269|FG003|COMPLETED|Off-Treatment Interval 1||82
10647414|NCT02147158|11807270|FG004|COMPLETED|Off-Treatment Interval 1||41
10647415|NCT02147158|11807271|FG005|COMPLETED|Off-Treatment Interval 1||45
10647416|NCT02147158|11807266|FG000|NOT COMPLETED|Off-Treatment Interval 1||10
10647417|NCT02147158|11807267|FG001|NOT COMPLETED|Off-Treatment Interval 1||4
10647418|NCT02147158|11807268|FG002|NOT COMPLETED|Off-Treatment Interval 1||15
10647419|NCT02147158|11807269|FG003|NOT COMPLETED|Off-Treatment Interval 1||15
10647420|NCT02147158|11807270|FG004|NOT COMPLETED|Off-Treatment Interval 1||8
10647421|NCT02147158|11807271|FG005|NOT COMPLETED|Off-Treatment Interval 1||5
10647422|NCT02147158|11807266|FG000|STARTED|Treatment Course 2||41
10647423|NCT02147158|11807267|FG001|STARTED|Treatment Course 2||34
10647424|NCT02147158|11807268|FG002|STARTED|Treatment Course 2||84
10647425|NCT02147158|11807269|FG003|STARTED|Treatment Course 2||82
10647426|NCT02147158|11807270|FG004|STARTED|Treatment Course 2||41
10647427|NCT02147158|11807271|FG005|STARTED|Treatment Course 2||45
10647428|NCT02147158|11807266|FG000|COMPLETED|Treatment Course 2||40
10647429|NCT02147158|11807267|FG001|COMPLETED|Treatment Course 2||29
10647430|NCT02147158|11807268|FG002|COMPLETED|Treatment Course 2||79
10647431|NCT02147158|11807269|FG003|COMPLETED|Treatment Course 2||77
10647432|NCT02147158|11807270|FG004|COMPLETED|Treatment Course 2||41
10647433|NCT02147158|11807271|FG005|COMPLETED|Treatment Course 2||43
10647434|NCT02147158|11807266|FG000|NOT COMPLETED|Treatment Course 2||1
10647435|NCT02147158|11807267|FG001|NOT COMPLETED|Treatment Course 2||5
10647436|NCT02147158|11807268|FG002|NOT COMPLETED|Treatment Course 2||5
10647437|NCT02147158|11807269|FG003|NOT COMPLETED|Treatment Course 2||5
10647438|NCT02147158|11807270|FG004|NOT COMPLETED|Treatment Course 2||0
10647439|NCT02147158|11807271|FG005|NOT COMPLETED|Treatment Course 2||2
10647440|NCT02147158|11807266|FG000|STARTED|Off-Treatment Interval 2||40
10647441|NCT02147158|11807267|FG001|STARTED|Off-Treatment Interval 2||29
10647442|NCT02147158|11807268|FG002|STARTED|Off-Treatment Interval 2||79
10647443|NCT02147158|11807269|FG003|STARTED|Off-Treatment Interval 2||77
10647444|NCT02147158|11807270|FG004|STARTED|Off-Treatment Interval 2||41
10647445|NCT02147158|11807271|FG005|STARTED|Off-Treatment Interval 2||43
10647446|NCT02147158|11807266|FG000|COMPLETED|Off-Treatment Interval 2||36
10647447|NCT02147158|11807267|FG001|COMPLETED|Off-Treatment Interval 2||25
10647448|NCT02147158|11807268|FG002|COMPLETED|Off-Treatment Interval 2||69
10647449|NCT02147158|11807269|FG003|COMPLETED|Off-Treatment Interval 2||66
10647450|NCT02147158|11807270|FG004|COMPLETED|Off-Treatment Interval 2||39
10647451|NCT02147158|11807271|FG005|COMPLETED|Off-Treatment Interval 2||39
10647452|NCT02147158|11807266|FG000|NOT COMPLETED|Off-Treatment Interval 2||4
10647453|NCT02147158|11807267|FG001|NOT COMPLETED|Off-Treatment Interval 2||4
10647454|NCT02147158|11807268|FG002|NOT COMPLETED|Off-Treatment Interval 2||10
10647455|NCT02147158|11807269|FG003|NOT COMPLETED|Off-Treatment Interval 2||11
10647456|NCT02147158|11807270|FG004|NOT COMPLETED|Off-Treatment Interval 2||2
10647457|NCT02147158|11807271|FG005|NOT COMPLETED|Off-Treatment Interval 2||4
10647458|NCT02147197|11807291|FG000|STARTED|Overall Study||56
10647459|NCT02147197|11807292|FG001|STARTED|Overall Study||53
10647460|NCT02147197|11807293|FG002|STARTED|Overall Study||48
10647461|NCT02147197|11807291|FG000|COMPLETED|Overall Study||47
10647462|NCT02147197|11807292|FG001|COMPLETED|Overall Study||47
10647463|NCT02147197|11807293|FG002|COMPLETED|Overall Study||39
10647464|NCT02147197|11807291|FG000|NOT COMPLETED|Overall Study||9
10647465|NCT02147197|11807292|FG001|NOT COMPLETED|Overall Study||6
10647466|NCT02147197|11807293|FG002|NOT COMPLETED|Overall Study||9
10647467|NCT02147288|11807303|FG000|STARTED|Overall Study||22
10647468|NCT02147288|11807304|FG001|STARTED|Overall Study||24
10647469|NCT02147288|11807305|FG002|STARTED|Overall Study||0
10647470|NCT02147288|11807306|FG003|STARTED|Overall Study||0
10647471|NCT02147288|11807307|FG004|STARTED|Overall Study||0
10647472|NCT02147288|11807308|FG005|STARTED|Overall Study||0
10647473|NCT02147288|11807309|FG006|STARTED|Overall Study||0
10647474|NCT02147288|11807310|FG007|STARTED|Overall Study||0
10647475|NCT02147288|11807311|FG008|STARTED|Overall Study||0
10647476|NCT02147288|11807312|FG009|STARTED|Overall Study||0
10647477|NCT02147288|11807303|FG000|COMPLETED|Overall Study||21
10647478|NCT02147288|11807304|FG001|COMPLETED|Overall Study||22
10647479|NCT02147288|11807305|FG002|COMPLETED|Overall Study||0
10647480|NCT02147288|11807306|FG003|COMPLETED|Overall Study||0
10647481|NCT02147288|11807307|FG004|COMPLETED|Overall Study||0
10647482|NCT02147288|11807308|FG005|COMPLETED|Overall Study||0
10647483|NCT02147288|11807309|FG006|COMPLETED|Overall Study||0
10647484|NCT02147288|11807310|FG007|COMPLETED|Overall Study||0
10647485|NCT02147288|11807311|FG008|COMPLETED|Overall Study||0
10647486|NCT02147288|11807312|FG009|COMPLETED|Overall Study||0
10647487|NCT02147288|11807303|FG000|NOT COMPLETED|Overall Study||1
10647488|NCT02147288|11807304|FG001|NOT COMPLETED|Overall Study||2
10647489|NCT02147288|11807305|FG002|NOT COMPLETED|Overall Study||0
10647490|NCT02147288|11807306|FG003|NOT COMPLETED|Overall Study||0
10647491|NCT02147288|11807307|FG004|NOT COMPLETED|Overall Study||0
10647492|NCT02147288|11807308|FG005|NOT COMPLETED|Overall Study||0
10647493|NCT02147288|11807309|FG006|NOT COMPLETED|Overall Study||0
10647494|NCT02147288|11807310|FG007|NOT COMPLETED|Overall Study||0
10706266|NCT02607306|11870837|FG000|COMPLETED|Overall Study||254
10706267|NCT02607306|11870838|FG001|COMPLETED|Overall Study||248
10706268|NCT02607306|11870839|FG002|COMPLETED|Overall Study||263
10706269|NCT02607306|11870837|FG000|NOT COMPLETED|Overall Study||21
10706270|NCT02607306|11870838|FG001|NOT COMPLETED|Overall Study||23
10706271|NCT02607306|11870839|FG002|NOT COMPLETED|Overall Study||10
10647495|NCT02147288|11807311|FG008|NOT COMPLETED|Overall Study||0
10647496|NCT02147288|11807312|FG009|NOT COMPLETED|Overall Study||0
10647497|NCT02147301|11807318|FG000|STARTED|Overall Study||17
10647498|NCT02147301|11807318|FG000|COMPLETED|Overall Study||17
10647499|NCT02147301|11807318|FG000|NOT COMPLETED|Overall Study||0
10647500|NCT02147353|11807324|FG000|STARTED|Overall Study||21
10647501|NCT02147353|11807325|FG001|STARTED|Overall Study||21
10647502|NCT02147353|11807324|FG000|COMPLETED|Overall Study||12
10647503|NCT02147353|11807325|FG001|COMPLETED|Overall Study||21
10647504|NCT02147353|11807324|FG000|NOT COMPLETED|Overall Study||9
10647505|NCT02147353|11807325|FG001|NOT COMPLETED|Overall Study||0
10647506|NCT02147522|11807333|FG000|STARTED|Overall Study||178
10647507|NCT02147522|11807334|FG001|STARTED|Overall Study||170
10647508|NCT02147522|11807333|FG000|COMPLETED|Overall Study||122
10647509|NCT02147522|11807334|FG001|COMPLETED|Overall Study||122
10647510|NCT02147522|11807333|FG000|NOT COMPLETED|Overall Study||56
10647511|NCT02147522|11807334|FG001|NOT COMPLETED|Overall Study||48
10647512|NCT02147561|11807340|FG000|STARTED|Overall Study||280
10647513|NCT02147561|11807340|FG000|COMPLETED|Overall Study||276
10647514|NCT02147561|11807340|FG000|NOT COMPLETED|Overall Study||4
10647515|NCT02147587|11807346|FG000|STARTED|Overall Study||57
10647516|NCT02147587|11807347|FG001|STARTED|Overall Study||55
10647517|NCT02147587|11807346|FG000|COMPLETED|Overall Study||46
10706272|NCT02607618|11870850|FG000|STARTED|Overall Study||306
10647518|NCT02147587|11807347|FG001|COMPLETED|Overall Study||50
10647519|NCT02147587|11807346|FG000|NOT COMPLETED|Overall Study||11
10647520|NCT02147587|11807347|FG001|NOT COMPLETED|Overall Study||5
10647521|NCT02147613|11807355|FG000|STARTED|Overall Study||10
10647522|NCT02147613|11807356|FG001|STARTED|Overall Study||9
10647523|NCT02147613|11807355|FG000|COMPLETED|Overall Study||9
10647524|NCT02147613|11807356|FG001|COMPLETED|Overall Study||6
10647525|NCT02147613|11807355|FG000|NOT COMPLETED|Overall Study||1
10706273|NCT02607618|11870851|FG001|STARTED|Overall Study||307
10647526|NCT02147613|11807356|FG001|NOT COMPLETED|Overall Study||3
10647527|NCT02147626|11807364|FG000|STARTED|Overall Study||75
10647528|NCT02147626|11807365|FG001|STARTED|Overall Study||76
10647529|NCT02147626|11807364|FG000|COMPLETED|Overall Study||70
10647530|NCT02147626|11807365|FG001|COMPLETED|Overall Study||69
10647531|NCT02147626|11807364|FG000|NOT COMPLETED|Overall Study||5
10647532|NCT02147626|11807365|FG001|NOT COMPLETED|Overall Study||7
10647533|NCT02147691|11807373|FG000|STARTED|Overall Study||10
10647534|NCT02147691|11807374|FG001|STARTED|Overall Study||12
10647535|NCT02147691|11807373|FG000|COMPLETED|Overall Study||6
10647536|NCT02147691|11807374|FG001|COMPLETED|Overall Study||11
10647537|NCT02147691|11807373|FG000|NOT COMPLETED|Overall Study||4
10647538|NCT02147691|11807374|FG001|NOT COMPLETED|Overall Study||1
10647539|NCT02147769|11807380|FG000|STARTED|Overall Study||111
10647540|NCT02147769|11807380|FG000|COMPLETED|Overall Study||111
10647541|NCT02147769|11807380|FG000|NOT COMPLETED|Overall Study||0
10647542|NCT02147899|11807387|FG000|STARTED|Overall Study||71
10647543|NCT02147899|11807388|FG001|STARTED|Overall Study||72
10647544|NCT02147899|11807389|FG002|STARTED|Overall Study||72
10647545|NCT02147899|11807387|FG000|COMPLETED|Overall Study||71
10647546|NCT02147899|11807388|FG001|COMPLETED|Overall Study||72
10647547|NCT02147899|11807389|FG002|COMPLETED|Overall Study||72
10647548|NCT02147899|11807387|FG000|NOT COMPLETED|Overall Study||0
10647549|NCT02147899|11807388|FG001|NOT COMPLETED|Overall Study||0
10647550|NCT02147899|11807389|FG002|NOT COMPLETED|Overall Study||0
10647551|NCT02147990|11807400|FG000|STARTED|Overall Study||154
10647552|NCT02147990|11807401|FG001|STARTED|Overall Study||100
10647553|NCT02147990|11807402|FG002|STARTED|Overall Study||63
10647554|NCT02147990|11807400|FG000|COMPLETED|Overall Study||154
10647555|NCT02147990|11807401|FG001|COMPLETED|Overall Study||100
10647556|NCT02147990|11807402|FG002|COMPLETED|Overall Study||63
10647557|NCT02147990|11807400|FG000|NOT COMPLETED|Overall Study||0
10647558|NCT02147990|11807401|FG001|NOT COMPLETED|Overall Study||0
10647559|NCT02147990|11807402|FG002|NOT COMPLETED|Overall Study||0
10647560|NCT02148107|11807414|FG000|STARTED|Overall Study||8
10647561|NCT02148107|11807415|FG001|STARTED|Overall Study||7
10647562|NCT02148107|11807416|FG002|STARTED|Overall Study||3
10647563|NCT02148107|11807414|FG000|COMPLETED|Overall Study||8
10647564|NCT02148107|11807415|FG001|COMPLETED|Overall Study||7
10647565|NCT02148107|11807416|FG002|COMPLETED|Overall Study||3
10647566|NCT02148107|11807414|FG000|NOT COMPLETED|Overall Study||0
10647567|NCT02148107|11807415|FG001|NOT COMPLETED|Overall Study||0
10647568|NCT02148107|11807416|FG002|NOT COMPLETED|Overall Study||0
10647569|NCT02148211|11807424|FG000|STARTED|Overall Study||507
10647570|NCT02148211|11807424|FG000|COMPLETED|Overall Study||155
10647571|NCT02148211|11807424|FG000|NOT COMPLETED|Overall Study||352
10647572|NCT02148250|11807428|FG000|STARTED|Screening||17
10647573|NCT02148250|11807429|FG001|STARTED|Screening||0
10647574|NCT02148250|11807428|FG000|COMPLETED|Screening||12
10647575|NCT02148250|11807429|FG001|COMPLETED|Screening||0
10647576|NCT02148250|11807428|FG000|NOT COMPLETED|Screening||5
10647577|NCT02148250|11807429|FG001|NOT COMPLETED|Screening||0
10706274|NCT02607618|11870850|FG000|COMPLETED|Overall Study||295
10706275|NCT02607618|11870851|FG001|COMPLETED|Overall Study||305
10647578|NCT02148250|11807428|FG000|STARTED|Period 1||6
10647579|NCT02148250|11807429|FG001|STARTED|Period 1||6
10647580|NCT02148250|11807428|FG000|COMPLETED|Period 1||6
10647581|NCT02148250|11807429|FG001|COMPLETED|Period 1||6
10647582|NCT02148250|11807428|FG000|NOT COMPLETED|Period 1||0
10647583|NCT02148250|11807429|FG001|NOT COMPLETED|Period 1||0
10647584|NCT02148250|11807428|FG000|STARTED|Period 2||6
10647585|NCT02148250|11807429|FG001|STARTED|Period 2||6
10647586|NCT02148250|11807428|FG000|COMPLETED|Period 2||6
10647587|NCT02148250|11807429|FG001|COMPLETED|Period 2||6
10647588|NCT02148250|11807428|FG000|NOT COMPLETED|Period 2||0
10647589|NCT02148250|11807429|FG001|NOT COMPLETED|Period 2||0
10647590|NCT02148302|11807438|FG000|STARTED|Overall Study||57
10647591|NCT02148302|11807439|FG001|STARTED|Overall Study||66
10647592|NCT02148302|11807438|FG000|COMPLETED|Overall Study||57
10706276|NCT02607618|11870850|FG000|NOT COMPLETED|Overall Study||11
10647593|NCT02148302|11807439|FG001|COMPLETED|Overall Study||66
10647594|NCT02148302|11807438|FG000|NOT COMPLETED|Overall Study||0
10647595|NCT02148302|11807439|FG001|NOT COMPLETED|Overall Study||0
10647596|NCT02148445|11807447|FG000|STARTED|Overall Study||198
10647597|NCT02148445|11807448|FG001|STARTED|Overall Study||200
10647598|NCT02148445|11807447|FG000|COMPLETED|Overall Study||197
10647599|NCT02148445|11807448|FG001|COMPLETED|Overall Study||197
10647600|NCT02148445|11807447|FG000|NOT COMPLETED|Overall Study||1
10647601|NCT02148445|11807448|FG001|NOT COMPLETED|Overall Study||3
10647602|NCT02148523|11807459|FG000|STARTED|Overall Study||67
10647603|NCT02148523|11807460|FG001|STARTED|Overall Study||67
10647604|NCT02148523|11807461|FG002|STARTED|Overall Study||67
10647605|NCT02148523|11807459|FG000|COMPLETED|Overall Study||67
10647606|NCT02148523|11807460|FG001|COMPLETED|Overall Study||67
10647607|NCT02148523|11807461|FG002|COMPLETED|Overall Study||67
10647608|NCT02148523|11807459|FG000|NOT COMPLETED|Overall Study||0
10647609|NCT02148523|11807460|FG001|NOT COMPLETED|Overall Study||0
10647610|NCT02148523|11807461|FG002|NOT COMPLETED|Overall Study||0
10647611|NCT02148588|11807469|FG000|STARTED|Overall Study||8
10647612|NCT02148588|11807469|FG000|COMPLETED|Overall Study||8
10647613|NCT02148588|11807469|FG000|NOT COMPLETED|Overall Study||0
10647614|NCT02148718|11807473|FG000|STARTED|Overall Study||86
10647615|NCT02148718|11807473|FG000|COMPLETED|Overall Study||55
10647616|NCT02148718|11807473|FG000|NOT COMPLETED|Overall Study||31
10647617|NCT02148809|11807477|FG000|STARTED|Overall Study||14
10647618|NCT02148809|11807477|FG000|COMPLETED|Overall Study||14
10647619|NCT02148809|11807477|FG000|NOT COMPLETED|Overall Study||0
10647620|NCT02148835|11807484|FG000|STARTED|Overall Study||22
10647621|NCT02148835|11807485|FG001|STARTED|Overall Study||22
10647622|NCT02148835|11807484|FG000|COMPLETED|Overall Study||22
10647623|NCT02148835|11807485|FG001|COMPLETED|Overall Study||22
10647624|NCT02148835|11807484|FG000|NOT COMPLETED|Overall Study||0
10647625|NCT02148835|11807485|FG001|NOT COMPLETED|Overall Study||0
10647626|NCT02148874|11807493|FG000|STARTED|Overall Study||201
10647627|NCT02148874|11807494|FG001|STARTED|Overall Study||86
10647628|NCT02148874|11807493|FG000|COMPLETED|Overall Study||194
10706277|NCT02607618|11870851|FG001|NOT COMPLETED|Overall Study||2
10706278|NCT02607735|11870859|FG000|STARTED|Primary Study||264
10706279|NCT02607735|11870860|FG001|STARTED|Primary Study||152
10647629|NCT02148874|11807494|FG001|COMPLETED|Overall Study||84
10647630|NCT02148874|11807493|FG000|NOT COMPLETED|Overall Study||7
10647631|NCT02148874|11807494|FG001|NOT COMPLETED|Overall Study||2
10647632|NCT02148952|11807502|FG000|STARTED|Assessing Eligibility and Consent||83166
10647633|NCT02148952|11807503|FG001|STARTED|Assessing Eligibility and Consent||80773
10647634|NCT02148952|11807502|FG000|COMPLETED|Assessing Eligibility and Consent||80063
10647635|NCT02148952|11807503|FG001|COMPLETED|Assessing Eligibility and Consent||77626
10647636|NCT02148952|11807502|FG000|NOT COMPLETED|Assessing Eligibility and Consent||3103
10647637|NCT02148952|11807503|FG001|NOT COMPLETED|Assessing Eligibility and Consent||3147
10647638|NCT02148952|11807502|FG000|STARTED|Follow-Up||80063
10647639|NCT02148952|11807503|FG001|STARTED|Follow-Up||77626
10647640|NCT02148952|11807502|FG000|COMPLETED|Follow-Up||79798
10647641|NCT02148952|11807503|FG001|COMPLETED|Follow-Up||77347
10647642|NCT02148952|11807502|FG000|NOT COMPLETED|Follow-Up||265
10647643|NCT02148952|11807503|FG001|NOT COMPLETED|Follow-Up||279
10647644|NCT02149108|11807519|FG000|STARTED|Overall Study|Randomised patients.|382
10647645|NCT02149108|11807520|FG001|STARTED|Overall Study|Randomised patients.|386
10647646|NCT02149108|11807519|FG000|COMPLETED|Overall Study|On-treatment at analysis cut-off date (14JUN2016).|2
10647647|NCT02149108|11807520|FG001|COMPLETED|Overall Study|On-treatment at analysis cut-off date (14JUN2016).|3
10647648|NCT02149108|11807519|FG000|NOT COMPLETED|Overall Study||380
10647649|NCT02149108|11807520|FG001|NOT COMPLETED|Overall Study||383
10647650|NCT02149173|11807526|FG000|STARTED|Overall Study||29
10647651|NCT02149173|11807526|FG000|COMPLETED|Overall Study||29
10647652|NCT02149173|11807526|FG000|NOT COMPLETED|Overall Study||0
10647653|NCT02149199|11807539|FG000|STARTED|Overall Study||1277
10647654|NCT02149199|11807540|FG001|STARTED|Overall Study||1277
10647655|NCT02149199|11807541|FG002|STARTED|Overall Study||1282
10647656|NCT02149199|11807539|FG000|COMPLETED|Overall Study||1144
10647657|NCT02149199|11807540|FG001|COMPLETED|Overall Study||1084
10647658|NCT02149199|11807541|FG002|COMPLETED|Overall Study||1135
10647659|NCT02149199|11807539|FG000|NOT COMPLETED|Overall Study||133
10647660|NCT02149199|11807540|FG001|NOT COMPLETED|Overall Study||193
10647661|NCT02149199|11807541|FG002|NOT COMPLETED|Overall Study||147
10647662|NCT02149264|11807549|FG000|STARTED|Overall Study|Of the 160 enrolled subjects, one discontinued before receiving treatment.|159
10647663|NCT02149264|11807549|FG000|COMPLETED|Overall Study||139
10647664|NCT02149264|11807549|FG000|NOT COMPLETED|Overall Study||20
10706280|NCT02607735|11870861|FG002|STARTED|Primary Study||0
10647665|NCT02149290|11807553|FG000|STARTED|Overall Study||198
10647666|NCT02149290|11807553|FG000|COMPLETED|Overall Study||198
10647667|NCT02149290|11807553|FG000|NOT COMPLETED|Overall Study||0
10647668|NCT02149303|11807559|FG000|STARTED|Overall Study||191
10647669|NCT02149303|11807559|FG000|COMPLETED|Overall Study||191
10647670|NCT02149303|11807559|FG000|NOT COMPLETED|Overall Study||0
10647671|NCT02149342|11807563|FG000|STARTED|Overall Study|14 patients|14
10647672|NCT02149342|11807563|FG000|COMPLETED|Overall Study|14 patients|14
10647673|NCT02149342|11807563|FG000|NOT COMPLETED|Overall Study||0
10647674|NCT02149420|11807573|FG000|STARTED|Core Study||9
10647675|NCT02149420|11807574|FG001|STARTED|Core Study||6
10647676|NCT02149420|11807575|FG002|STARTED|Core Study||12
10647677|NCT02149420|11807573|FG000|Safety Analysis Set|Core Study||9
10647678|NCT02149420|11807574|FG001|Safety Analysis Set|Core Study||6
10647679|NCT02149420|11807575|FG002|Safety Analysis Set|Core Study||12
10647680|NCT02149420|11807573|FG000|PK Analysis Set|Core Study|for patients entering open label VAY736 10 mg/kg at Week 24|5
10706281|NCT02607735|11870859|FG000|COMPLETED|Primary Study||257
10706282|NCT02607735|11870860|FG001|COMPLETED|Primary Study||152
10647681|NCT02149420|11807574|FG001|PK Analysis Set|Core Study||6
10647682|NCT02149420|11807575|FG002|PK Analysis Set|Core Study||12
10647683|NCT02149420|11807573|FG000|PD (Pharmacodynamics) Analysis Set|Core Study||9
10647684|NCT02149420|11807574|FG001|PD (Pharmacodynamics) Analysis Set|Core Study||6
10647685|NCT02149420|11807575|FG002|PD (Pharmacodynamics) Analysis Set|Core Study||12
10706283|NCT02607735|11870861|FG002|COMPLETED|Primary Study||0
10647686|NCT02149420|11807573|FG000|COMPLETED|Core Study||9
10647687|NCT02149420|11807574|FG001|COMPLETED|Core Study||5
10647688|NCT02149420|11807575|FG002|COMPLETED|Core Study||10
10647689|NCT02149420|11807573|FG000|NOT COMPLETED|Core Study||0
10647690|NCT02149420|11807574|FG001|NOT COMPLETED|Core Study||1
10647691|NCT02149420|11807575|FG002|NOT COMPLETED|Core Study||2
10647692|NCT02149420|11807573|FG000|STARTED|Open Label VAY736 10 mg/kg Extension|Patients received single dose of VAY736 10mg/kg at Week 24.|5
10647693|NCT02149420|11807574|FG001|STARTED|Open Label VAY736 10 mg/kg Extension|Only patients origianally randomized to Placebo were allowed to enter this Period.|0
10647694|NCT02149420|11807575|FG002|STARTED|Open Label VAY736 10 mg/kg Extension|Only patients origianally randomized to Placebo were allowed to enter this Period.|0
10647695|NCT02149420|11807573|FG000|COMPLETED|Open Label VAY736 10 mg/kg Extension||4
10647696|NCT02149420|11807574|FG001|COMPLETED|Open Label VAY736 10 mg/kg Extension||0
10647697|NCT02149420|11807575|FG002|COMPLETED|Open Label VAY736 10 mg/kg Extension||0
10647698|NCT02149420|11807573|FG000|NOT COMPLETED|Open Label VAY736 10 mg/kg Extension||1
10647699|NCT02149420|11807574|FG001|NOT COMPLETED|Open Label VAY736 10 mg/kg Extension||0
10647700|NCT02149420|11807575|FG002|NOT COMPLETED|Open Label VAY736 10 mg/kg Extension||0
10647701|NCT02149524|11807590|FG000|STARTED|Overall Study||438
10647702|NCT02149524|11807591|FG001|STARTED|Overall Study||437
10647703|NCT02149524|11807590|FG000|COMPLETED|Overall Study||384
10647704|NCT02149524|11807591|FG001|COMPLETED|Overall Study||380
10647705|NCT02149524|11807590|FG000|NOT COMPLETED|Overall Study||54
10647706|NCT02149524|11807591|FG001|NOT COMPLETED|Overall Study||57
10647707|NCT02149810|11807599|FG000|STARTED|Overall Study||48
10647708|NCT02149810|11807600|FG001|STARTED|Overall Study||47
10647709|NCT02149810|11807599|FG000|Baseline|Overall Study||47
10333964|NCT00337077|11470216|FG000|Eligible and Treated|Overall Study||41
10333965|NCT00337077|11470217|FG001|Eligible and Treated|Overall Study||51
10333966|NCT00337077|11470218|FG002|Eligible and Treated|Overall Study||24
10333967|NCT00337077|11470216|FG000|Patients With Measurable Disease|Overall Study||26
10333968|NCT00337077|11470217|FG001|Patients With Measurable Disease|Overall Study||38
10333969|NCT00337077|11470218|FG002|Patients With Measurable Disease|Overall Study||13
10647710|NCT02149810|11807600|FG001|Baseline|Overall Study||44
10647711|NCT02149810|11807599|FG000|Week 4|Overall Study||43
10647712|NCT02149810|11807600|FG001|Week 4|Overall Study||42
10647713|NCT02149810|11807599|FG000|Week 8|Overall Study||40
10647714|NCT02149810|11807600|FG001|Week 8|Overall Study||43
10647715|NCT02149810|11807599|FG000|Week 12|Overall Study||40
10647716|NCT02149810|11807600|FG001|Week 12|Overall Study||43
10647717|NCT02149810|11807599|FG000|Week 24|Overall Study||31
10647718|NCT02149810|11807600|FG001|Week 24|Overall Study|Not applicable study was amended such that week 24 data was not collected for TAU participants.|0
10647719|NCT02149810|11807599|FG000|COMPLETED|Overall Study||40
10647720|NCT02149810|11807600|FG001|COMPLETED|Overall Study||43
10647721|NCT02149810|11807599|FG000|NOT COMPLETED|Overall Study||8
10647722|NCT02149810|11807600|FG001|NOT COMPLETED|Overall Study||4
10647723|NCT02149836|11807606|FG000|STARTED|Overall Study||18
10647724|NCT02149836|11807606|FG000|COMPLETED|Overall Study||17
10647725|NCT02149836|11807606|FG000|NOT COMPLETED|Overall Study||1
10647726|NCT02149875|11807613|FG000|STARTED|Overall Study||27
10647727|NCT02149875|11807614|FG001|STARTED|Overall Study||28
10647728|NCT02149875|11807615|FG002|STARTED|Overall Study||29
10647729|NCT02149875|11807613|FG000|COMPLETED|Overall Study||20
10647730|NCT02149875|11807614|FG001|COMPLETED|Overall Study||20
10647731|NCT02149875|11807615|FG002|COMPLETED|Overall Study||20
10647732|NCT02149875|11807613|FG000|NOT COMPLETED|Overall Study||7
10647733|NCT02149875|11807614|FG001|NOT COMPLETED|Overall Study||8
10647734|NCT02149875|11807615|FG002|NOT COMPLETED|Overall Study||9
10647735|NCT02150044|11807623|FG000|STARTED|Overall Study||29
10647736|NCT02150044|11807623|FG000|Lead-In Subjects|Overall Study||16
10647737|NCT02150044|11807623|FG000|Study Cohort|Overall Study||13
10647738|NCT02150044|11807623|FG000|COMPLETED|Overall Study||29
10647739|NCT02150044|11807623|FG000|NOT COMPLETED|Overall Study||0
10647740|NCT02150057|11807629|FG000|STARTED|Overall Study||25
10647741|NCT02150057|11807630|FG001|STARTED|Overall Study||26
10647742|NCT02150057|11807629|FG000|COMPLETED|Overall Study||19
10647743|NCT02150057|11807630|FG001|COMPLETED|Overall Study||22
10647744|NCT02150057|11807629|FG000|NOT COMPLETED|Overall Study||6
10647745|NCT02150057|11807630|FG001|NOT COMPLETED|Overall Study||4
10647746|NCT02150109|11807636|FG000|STARTED|Overall Study||372
10647747|NCT02150109|11807636|FG000|COMPLETED|Overall Study||372
10647748|NCT02150109|11807636|FG000|NOT COMPLETED|Overall Study||0
10647749|NCT02150213|11807646|FG000|STARTED|Overall Study||59
10647750|NCT02150213|11807646|FG000|COMPLETED|Overall Study||57
10647751|NCT02150213|11807646|FG000|NOT COMPLETED|Overall Study||2
10647752|NCT02150343|11807654|FG000|STARTED|Overall Study||180
10647753|NCT02150343|11807655|FG001|STARTED|Overall Study||178
10647754|NCT02150343|11807656|FG002|STARTED|Overall Study||178
10647755|NCT02150343|11807657|FG003|STARTED|Overall Study||178
10647756|NCT02150343|11807654|FG000|COMPLETED|Overall Study||159
10647757|NCT02150343|11807655|FG001|COMPLETED|Overall Study||158
10647758|NCT02150343|11807656|FG002|COMPLETED|Overall Study||166
10647759|NCT02150343|11807657|FG003|COMPLETED|Overall Study||168
10647760|NCT02150343|11807654|FG000|NOT COMPLETED|Overall Study||21
10647761|NCT02150343|11807655|FG001|NOT COMPLETED|Overall Study||20
10647762|NCT02150343|11807656|FG002|NOT COMPLETED|Overall Study||12
10647763|NCT02150343|11807657|FG003|NOT COMPLETED|Overall Study||10
10647764|NCT02150460|11807669|FG000|STARTED|Overall Study||50
10647765|NCT02150460|11807670|FG001|STARTED|Overall Study||50
10647766|NCT02150460|11807669|FG000|COMPLETED|Overall Study||50
10647767|NCT02150460|11807670|FG001|COMPLETED|Overall Study||50
10647768|NCT02150460|11807669|FG000|NOT COMPLETED|Overall Study||0
10647769|NCT02150460|11807670|FG001|NOT COMPLETED|Overall Study||0
10647770|NCT02150499|11807678|FG000|STARTED|Overall Study||9
10647771|NCT02150499|11807679|FG001|STARTED|Overall Study||9
10647772|NCT02150499|11807678|FG000|COMPLETED|Overall Study||9
10647773|NCT02150499|11807679|FG001|COMPLETED|Overall Study||9
10647774|NCT02150499|11807678|FG000|NOT COMPLETED|Overall Study||0
10647775|NCT02150499|11807679|FG001|NOT COMPLETED|Overall Study||0
10647776|NCT02150759|11807687|FG000|STARTED|Overall Study||23
10647777|NCT02150759|11807688|FG001|STARTED|Overall Study||23
10647778|NCT02150759|11807687|FG000|COMPLETED|Overall Study||22
10647779|NCT02150759|11807688|FG001|COMPLETED|Overall Study||21
10647780|NCT02150759|11807687|FG000|NOT COMPLETED|Overall Study||1
10647781|NCT02150759|11807688|FG001|NOT COMPLETED|Overall Study||2
10647782|NCT02150837|11807696|FG000|STARTED|Overall Study|87 Charts were screened with 25 screen failures due to exclusion criteria.|62
10647783|NCT02150837|11807697|FG001|STARTED|Overall Study|478 charts were screened with 168 screen failures due to exclusion criteria.|310
10647784|NCT02150837|11807696|FG000|COMPLETED|Overall Study|There was no predefined study period to complete. 37 remained through the 12 wk primary endpoint.|37
10647785|NCT02150837|11807697|FG001|COMPLETED|Overall Study|There was no predefined study period to complete. 185 remained through the 12 wk primary endpoint.|185
10647786|NCT02150837|11807696|FG000|NOT COMPLETED|Overall Study||25
10647787|NCT02150837|11807697|FG001|NOT COMPLETED|Overall Study||125
10647788|NCT02150954|11807705|FG000|STARTED|Overall Study||58
10647789|NCT02150954|11807706|FG001|STARTED|Overall Study||59
10647790|NCT02150954|11807705|FG000|COMPLETED|Overall Study||57
10647791|NCT02150954|11807706|FG001|COMPLETED|Overall Study||59
10647792|NCT02150954|11807705|FG000|NOT COMPLETED|Overall Study||1
10647793|NCT02150954|11807706|FG001|NOT COMPLETED|Overall Study||0
10647794|NCT02151058|11807715|FG000|STARTED|Overall Study||45
10647795|NCT02151058|11807716|FG001|STARTED|Overall Study||91
10647796|NCT02151058|11807717|FG002|STARTED|Overall Study||91
10647797|NCT02151058|11807715|FG000|COMPLETED|Overall Study||43
10647798|NCT02151058|11807716|FG001|COMPLETED|Overall Study||90
10647799|NCT02151058|11807717|FG002|COMPLETED|Overall Study||86
10647800|NCT02151058|11807715|FG000|NOT COMPLETED|Overall Study||2
10647801|NCT02151058|11807716|FG001|NOT COMPLETED|Overall Study||1
10647802|NCT02151058|11807717|FG002|NOT COMPLETED|Overall Study||5
10647803|NCT02151110|11807733|FG000|STARTED|Overall Study||12
10647804|NCT02151110|11807734|FG001|STARTED|Overall Study||2
10647805|NCT02151110|11807735|FG002|STARTED|Overall Study||2
10647806|NCT02151110|11807736|FG003|STARTED|Overall Study||8
10647807|NCT02151110|11807737|FG004|STARTED|Overall Study||8
10647808|NCT02151110|11807738|FG005|STARTED|Overall Study||8
10647809|NCT02151110|11807739|FG006|STARTED|Overall Study||8
10647810|NCT02151110|11807740|FG007|STARTED|Overall Study||8
10647811|NCT02151110|11807733|FG000|COMPLETED|Overall Study||12
10647812|NCT02151110|11807734|FG001|COMPLETED|Overall Study||2
10647813|NCT02151110|11807735|FG002|COMPLETED|Overall Study||2
10647814|NCT02151110|11807736|FG003|COMPLETED|Overall Study||8
10647815|NCT02151110|11807737|FG004|COMPLETED|Overall Study||8
10647816|NCT02151110|11807738|FG005|COMPLETED|Overall Study||8
10647817|NCT02151110|11807739|FG006|COMPLETED|Overall Study||8
10706284|NCT02607735|11870859|FG000|NOT COMPLETED|Primary Study||7
10706285|NCT02607735|11870860|FG001|NOT COMPLETED|Primary Study||0
10706286|NCT02607735|11870861|FG002|NOT COMPLETED|Primary Study||0
10647818|NCT02151110|11807740|FG007|COMPLETED|Overall Study||5
10647819|NCT02151110|11807733|FG000|NOT COMPLETED|Overall Study||0
10647820|NCT02151110|11807734|FG001|NOT COMPLETED|Overall Study||0
10647821|NCT02151110|11807735|FG002|NOT COMPLETED|Overall Study||0
10647822|NCT02151110|11807736|FG003|NOT COMPLETED|Overall Study||0
10647823|NCT02151110|11807737|FG004|NOT COMPLETED|Overall Study||0
10647824|NCT02151110|11807738|FG005|NOT COMPLETED|Overall Study||0
10647825|NCT02151110|11807739|FG006|NOT COMPLETED|Overall Study||0
10647826|NCT02151110|11807740|FG007|NOT COMPLETED|Overall Study||3
10647827|NCT02151149|11807767|FG000|STARTED|Treatment Period|3 participants did not receive treatment|71
10647828|NCT02151149|11807768|FG001|STARTED|Treatment Period|2 participants did not receive treatment|72
10647829|NCT02151149|11807767|FG000|Treated Population|Treatment Period||68
10647830|NCT02151149|11807768|FG001|Treated Population|Treatment Period||70
10647831|NCT02151149|11807767|FG000|COMPLETED|Treatment Period||1
10647832|NCT02151149|11807768|FG001|COMPLETED|Treatment Period||1
10647833|NCT02151149|11807767|FG000|NOT COMPLETED|Treatment Period||70
10647834|NCT02151149|11807768|FG001|NOT COMPLETED|Treatment Period||71
10647835|NCT02151149|11807767|FG000|STARTED|Follow-Up Period||58
10647836|NCT02151149|11807768|FG001|STARTED|Follow-Up Period||55
10647837|NCT02151149|11807767|FG000|COMPLETED|Follow-Up Period|Completed = participants alive at final data cut-off date|19
10647838|NCT02151149|11807768|FG001|COMPLETED|Follow-Up Period|Completed = participants alive at final data cut-off date|18
10647839|NCT02151149|11807767|FG000|NOT COMPLETED|Follow-Up Period||39
10647840|NCT02151149|11807768|FG001|NOT COMPLETED|Follow-Up Period||37
10647841|NCT02151253|11807774|FG000|STARTED|Overall Study||13
10647842|NCT02151253|11807775|FG001|STARTED|Overall Study||15
10647843|NCT02151253|11807774|FG000|COMPLETED|Overall Study||13
10647844|NCT02151253|11807775|FG001|COMPLETED|Overall Study||15
10647845|NCT02151253|11807774|FG000|NOT COMPLETED|Overall Study||0
10647846|NCT02151253|11807775|FG001|NOT COMPLETED|Overall Study||0
10647847|NCT02151266|11807784|FG000|STARTED|Overall Study||19
10647848|NCT02151266|11807785|FG001|STARTED|Overall Study||29
10647849|NCT02151266|11807786|FG002|STARTED|Overall Study||21
10647850|NCT02151266|11807784|FG000|COMPLETED|Overall Study||11
10647851|NCT02151266|11807785|FG001|COMPLETED|Overall Study||14
10647852|NCT02151266|11807786|FG002|COMPLETED|Overall Study||14
10647853|NCT02151266|11807784|FG000|NOT COMPLETED|Overall Study||8
10647854|NCT02151266|11807785|FG001|NOT COMPLETED|Overall Study||15
10647855|NCT02151266|11807786|FG002|NOT COMPLETED|Overall Study||7
10647856|NCT02151331|11807796|FG000|STARTED|Overall Study||77
10647857|NCT02151331|11807797|FG001|STARTED|Overall Study||92
10647858|NCT02151331|11807796|FG000|COMPLETED|Overall Study||45
10647859|NCT02151331|11807797|FG001|COMPLETED|Overall Study||52
10647860|NCT02151331|11807796|FG000|NOT COMPLETED|Overall Study||32
10647861|NCT02151331|11807797|FG001|NOT COMPLETED|Overall Study||40
10654407|NCT02202746|11815175|FG001|STARTED|Overall Study||69
10654408|NCT02202746|11815174|FG000|COMPLETED|Overall Study||109
10654409|NCT02202746|11815175|FG001|COMPLETED|Overall Study||69
10654410|NCT02202746|11815174|FG000|NOT COMPLETED|Overall Study||0
10654411|NCT02202746|11815175|FG001|NOT COMPLETED|Overall Study||0
10654412|NCT02202759|11815187|FG000|STARTED|Overall Study||9
10654413|NCT02202759|11815188|FG001|STARTED|Overall Study||15
10654414|NCT02202759|11815189|FG002|STARTED|Overall Study||14
10654415|NCT02202759|11815187|FG000|COMPLETED|Overall Study||0
10654416|NCT02202759|11815188|FG001|COMPLETED|Overall Study||0
10654417|NCT02202759|11815189|FG002|COMPLETED|Overall Study||0
10654418|NCT02202759|11815187|FG000|NOT COMPLETED|Overall Study||9
10706287|NCT02607735|11870859|FG000|STARTED|Deferred Treatment Substudy||0
10706288|NCT02607735|11870860|FG001|STARTED|Deferred Treatment Substudy||0
10706289|NCT02607735|11870861|FG002|STARTED|Deferred Treatment Substudy||147
10706290|NCT02607735|11870859|FG000|COMPLETED|Deferred Treatment Substudy||0
10654419|NCT02202759|11815188|FG001|NOT COMPLETED|Overall Study||15
10654420|NCT02202759|11815189|FG002|NOT COMPLETED|Overall Study||14
10654421|NCT02202785|11815199|FG000|STARTED|Overall Study||11
10654422|NCT02202785|11815200|FG001|STARTED|Overall Study||15
10654423|NCT02202785|11815201|FG002|STARTED|Overall Study||17
10654424|NCT02202785|11815199|FG000|COMPLETED|Overall Study||0
10654425|NCT02202785|11815200|FG001|COMPLETED|Overall Study||0
10647862|NCT02151448|11807803|FG000|STARTED|Phase 1||9
10647863|NCT02151448|11807803|FG000|COMPLETED|Phase 1||9
10647864|NCT02151448|11807803|FG000|NOT COMPLETED|Phase 1||0
10647865|NCT02151448|11807803|FG000|STARTED|Phase 2||55
10647866|NCT02151448|11807803|FG000|COMPLETED|Phase 2||55
10647867|NCT02151448|11807803|FG000|NOT COMPLETED|Phase 2||0
10647868|NCT02151461|11807815|FG000|STARTED|Overall Study||24
10647869|NCT02151461|11807816|FG001|STARTED|Overall Study||25
10647870|NCT02151461|11807817|FG002|STARTED|Overall Study||24
10647871|NCT02151461|11807818|FG003|STARTED|Overall Study||23
10647872|NCT02151461|11807815|FG000|COMPLETED|Overall Study||18
10647873|NCT02151461|11807816|FG001|COMPLETED|Overall Study||24
10647874|NCT02151461|11807817|FG002|COMPLETED|Overall Study||21
10647875|NCT02151461|11807818|FG003|COMPLETED|Overall Study||19
10647876|NCT02151461|11807815|FG000|NOT COMPLETED|Overall Study||6
10647877|NCT02151461|11807816|FG001|NOT COMPLETED|Overall Study||1
10647878|NCT02151461|11807817|FG002|NOT COMPLETED|Overall Study||3
10647879|NCT02151461|11807818|FG003|NOT COMPLETED|Overall Study||4
10647880|NCT02151487|11807832|FG000|STARTED|Overall Study||27
10647881|NCT02151487|11807833|FG001|STARTED|Overall Study||27
10647882|NCT02151487|11807834|FG002|STARTED|Overall Study||20
10647883|NCT02151487|11807835|FG003|STARTED|Overall Study||23
10647884|NCT02151487|11807832|FG000|COMPLETED|Overall Study||25
10647885|NCT02151487|11807833|FG001|COMPLETED|Overall Study||22
10647886|NCT02151487|11807834|FG002|COMPLETED|Overall Study||16
10647887|NCT02151487|11807835|FG003|COMPLETED|Overall Study||20
10647888|NCT02151487|11807832|FG000|NOT COMPLETED|Overall Study||2
10647889|NCT02151487|11807833|FG001|NOT COMPLETED|Overall Study||5
10647890|NCT02151487|11807834|FG002|NOT COMPLETED|Overall Study||4
10647891|NCT02151487|11807835|FG003|NOT COMPLETED|Overall Study||3
10647892|NCT02151591|11807847|FG000|STARTED|Overall Study||13
10647893|NCT02151591|11807848|FG001|STARTED|Overall Study||13
10647894|NCT02151591|11807847|FG000|COMPLETED|Overall Study||7
10647895|NCT02151591|11807848|FG001|COMPLETED|Overall Study||10
10647896|NCT02151591|11807847|FG000|NOT COMPLETED|Overall Study||6
10647897|NCT02151591|11807848|FG001|NOT COMPLETED|Overall Study||3
10647898|NCT02151643|11807859|FG000|STARTED|Overall Study||26
10647899|NCT02151643|11807860|FG001|STARTED|Overall Study||25
10647900|NCT02151643|11807861|FG002|STARTED|Overall Study||25
10647901|NCT02151643|11807862|FG003|STARTED|Overall Study||39
10647902|NCT02151643|11807863|FG004|STARTED|Overall Study||38
10647903|NCT02151643|11807859|FG000|COMPLETED|Overall Study||20
10647904|NCT02151643|11807860|FG001|COMPLETED|Overall Study||21
10647905|NCT02151643|11807861|FG002|COMPLETED|Overall Study||21
10647906|NCT02151643|11807862|FG003|COMPLETED|Overall Study||32
10647907|NCT02151643|11807863|FG004|COMPLETED|Overall Study||35
10647908|NCT02151643|11807859|FG000|NOT COMPLETED|Overall Study||6
10647909|NCT02151643|11807860|FG001|NOT COMPLETED|Overall Study||4
10647910|NCT02151643|11807861|FG002|NOT COMPLETED|Overall Study||4
10647911|NCT02151643|11807862|FG003|NOT COMPLETED|Overall Study||7
10706291|NCT02607735|11870860|FG001|COMPLETED|Deferred Treatment Substudy||0
10706292|NCT02607735|11870861|FG002|COMPLETED|Deferred Treatment Substudy||142
10706293|NCT02607735|11870859|FG000|NOT COMPLETED|Deferred Treatment Substudy||0
10706294|NCT02607735|11870860|FG001|NOT COMPLETED|Deferred Treatment Substudy||0
10647912|NCT02151643|11807863|FG004|NOT COMPLETED|Overall Study||3
10647913|NCT02151682|11807877|FG000|STARTED|Part 1: 14 Days Morphine or Tapentadol||24
10647914|NCT02151682|11807878|FG001|STARTED|Part 1: 14 Days Morphine or Tapentadol||45
10647915|NCT02151682|11807879|FG002|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
10647916|NCT02151682|11807880|FG003|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
10647917|NCT02151682|11807881|FG004|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
10647918|NCT02151682|11807882|FG005|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
10647919|NCT02151682|11807877|FG000|COMPLETED|Part 1: 14 Days Morphine or Tapentadol|14-Day treatment and final post-treatment visit completed or tapentadol treatment in Part 2 entered.|22
10647920|NCT02151682|11807878|FG001|COMPLETED|Part 1: 14 Days Morphine or Tapentadol|14-Day treatment and final post-treatment visit completed or tapentadol treatment in Part 2 entered.|40
10647921|NCT02151682|11807879|FG002|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
10647922|NCT02151682|11807880|FG003|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
10647923|NCT02151682|11807881|FG004|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
10647924|NCT02151682|11807882|FG005|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
10647925|NCT02151682|11807877|FG000|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||2
10647926|NCT02151682|11807878|FG001|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||5
10647927|NCT02151682|11807879|FG002|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
10647928|NCT02151682|11807880|FG003|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
10647929|NCT02151682|11807881|FG004|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
10647930|NCT02151682|11807882|FG005|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
10647931|NCT02151682|11807877|FG000|STARTED|Part 2: Tapent. Extension or Observation|Group not defined for Part 2.|0
10647932|NCT02151682|11807878|FG001|STARTED|Part 2: Tapent. Extension or Observation|Group not defined for Part 2.|0
10647933|NCT02151682|11807879|FG002|STARTED|Part 2: Tapent. Extension or Observation|26 Completers on tapentadol PR and 10 completers on morphine PR from Part 1.|36
10647934|NCT02151682|11807880|FG003|STARTED|Part 2: Tapent. Extension or Observation|14 Completers and 4 of 5 non-completers on tapentadol in Part 1.|18
10647935|NCT02151682|11807881|FG004|STARTED|Part 2: Tapent. Extension or Observation|12 Completers and 2 non-completers from morphine treatment in Part 1.|14
10647936|NCT02151682|11807882|FG005|STARTED|Part 2: Tapent. Extension or Observation||0
10647937|NCT02151682|11807877|FG000|COMPLETED|Part 2: Tapent. Extension or Observation||0
10647938|NCT02151682|11807878|FG001|COMPLETED|Part 2: Tapent. Extension or Observation||0
10647939|NCT02151682|11807879|FG002|COMPLETED|Part 2: Tapent. Extension or Observation|12 Month of tapentadol treatment completed and final visit of Part 2 performed.|8
10647940|NCT02151682|11807880|FG003|COMPLETED|Part 2: Tapent. Extension or Observation||14
10647941|NCT02151682|11807881|FG004|COMPLETED|Part 2: Tapent. Extension or Observation||14
10647942|NCT02151682|11807882|FG005|COMPLETED|Part 2: Tapent. Extension or Observation||0
10647943|NCT02151682|11807877|FG000|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
10647944|NCT02151682|11807878|FG001|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
10647945|NCT02151682|11807879|FG002|NOT COMPLETED|Part 2: Tapent. Extension or Observation||28
10647946|NCT02151682|11807880|FG003|NOT COMPLETED|Part 2: Tapent. Extension or Observation||4
10647947|NCT02151682|11807881|FG004|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
10647948|NCT02151682|11807882|FG005|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
10647949|NCT02151682|11807877|FG000|STARTED|Part 2: Observ. Aft. Tapent. Extension|Group not defined for Part 2.|0
10647950|NCT02151682|11807878|FG001|STARTED|Part 2: Observ. Aft. Tapent. Extension|Group not defined for Part 2.|0
10647951|NCT02151682|11807879|FG002|STARTED|Part 2: Observ. Aft. Tapent. Extension|Not applicable for this period.|0
10706295|NCT02607735|11870861|FG002|NOT COMPLETED|Deferred Treatment Substudy||5
10706296|NCT02607800|11870871|FG000|STARTED|Overall Study||502
10457352|NCT01010230|11605107|FG001|NOT COMPLETED|Overall Study||7
10457353|NCT01010282|11605116|FG000|STARTED|Overall Study||97
10457354|NCT01010282|11605117|FG001|STARTED|Overall Study||95
10457355|NCT01010282|11605118|FG002|STARTED|Overall Study||96
10457356|NCT01010282|11605116|FG000|COMPLETED|Overall Study||91
10457357|NCT01010282|11605117|FG001|COMPLETED|Overall Study||88
10457358|NCT01010282|11605118|FG002|COMPLETED|Overall Study||77
10457359|NCT01010282|11605116|FG000|NOT COMPLETED|Overall Study||6
10457360|NCT01010282|11605117|FG001|NOT COMPLETED|Overall Study||7
10457361|NCT01010282|11605118|FG002|NOT COMPLETED|Overall Study||19
10457362|NCT01010399|11605126|FG000|STARTED|Overall Study||36
10457363|NCT01010399|11605126|FG000|COMPLETED|Overall Study||31
10647952|NCT02151682|11807880|FG003|STARTED|Part 2: Observ. Aft. Tapent. Extension|Not applicable for this period.|0
10647953|NCT02151682|11807881|FG004|STARTED|Part 2: Observ. Aft. Tapent. Extension|Not applicable for this period.|0
10647954|NCT02151682|11807882|FG005|STARTED|Part 2: Observ. Aft. Tapent. Extension|19 tapentadol and 7 morphine completers (Part 1) who discontinued from tapentadol treatm. in Part 2.|26
10647955|NCT02151682|11807877|FG000|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
10647956|NCT02151682|11807878|FG001|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
10647957|NCT02151682|11807879|FG002|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
10647958|NCT02151682|11807880|FG003|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
10647959|NCT02151682|11807881|FG004|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
10647960|NCT02151682|11807882|FG005|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||19
10647961|NCT02151682|11807877|FG000|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
10647962|NCT02151682|11807878|FG001|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
10647963|NCT02151682|11807879|FG002|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
10647964|NCT02151682|11807880|FG003|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
10647965|NCT02151682|11807881|FG004|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
10647966|NCT02151682|11807882|FG005|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||7
10647967|NCT02151773|11807900|FG000|STARTED|Overall Study||3493
10647968|NCT02151773|11807900|FG000|COMPLETED|Overall Study||3429
10647969|NCT02151773|11807900|FG000|NOT COMPLETED|Overall Study||64
10647970|NCT02151786|11807904|FG000|STARTED|Overall Study||1120
10647971|NCT02151786|11807904|FG000|COMPLETED|Overall Study||1084
10647972|NCT02151786|11807904|FG000|NOT COMPLETED|Overall Study||36
10647973|NCT02151851|11807910|FG000|STARTED|Overall Study||114
10647974|NCT02151851|11807911|FG001|STARTED|Overall Study||316
10647975|NCT02151851|11807910|FG000|Included in the Safety Set|Overall Study||113
10647976|NCT02151851|11807911|FG001|Included in the Safety Set|Overall Study||316
10647977|NCT02151851|11807910|FG000|COMPLETED|Overall Study||38
10647978|NCT02151851|11807911|FG001|COMPLETED|Overall Study||186
10647979|NCT02151851|11807910|FG000|NOT COMPLETED|Overall Study||76
10647980|NCT02151851|11807911|FG001|NOT COMPLETED|Overall Study||130
10647981|NCT02151877|11807919|FG000|STARTED|Overall Study||12
10647982|NCT02151877|11807920|FG001|STARTED|Overall Study||12
10647983|NCT02151877|11807919|FG000|COMPLETED|Overall Study||12
10647984|NCT02151877|11807920|FG001|COMPLETED|Overall Study||12
10647985|NCT02151877|11807919|FG000|NOT COMPLETED|Overall Study||0
10647986|NCT02151877|11807920|FG001|NOT COMPLETED|Overall Study||0
10647987|NCT02151903|11807930|FG000|STARTED|Overall Study||3
10647988|NCT02151903|11807931|FG001|STARTED|Overall Study||2
10647989|NCT02151903|11807930|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
10647990|NCT02151903|11807931|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2
10647991|NCT02151903|11807930|FG000|COMPLETED|Overall Study||0
10647992|NCT02151903|11807931|FG001|COMPLETED|Overall Study||1
10647993|NCT02151903|11807930|FG000|NOT COMPLETED|Overall Study||3
10647994|NCT02151903|11807931|FG001|NOT COMPLETED|Overall Study||1
10647995|NCT02151994|11807940|FG000|STARTED|Single Ascending Dose (SAD)||18
10457364|NCT01010399|11605126|FG000|NOT COMPLETED|Overall Study||5
10457365|NCT01010477|11605132|FG000|STARTED|Overall Study||27
10457366|NCT01010477|11605133|FG001|STARTED|Overall Study||25
10457367|NCT01010477|11605132|FG000|COMPLETED|Overall Study||21
10457368|NCT01010477|11605133|FG001|COMPLETED|Overall Study||22
10457369|NCT01010477|11605132|FG000|NOT COMPLETED|Overall Study||6
10647996|NCT02151994|11807941|FG001|STARTED|Single Ascending Dose (SAD)||6
10647997|NCT02151994|11807942|FG002|STARTED|Single Ascending Dose (SAD)||6
10647998|NCT02151994|11807943|FG003|STARTED|Single Ascending Dose (SAD)||6
10647999|NCT02151994|11807944|FG004|STARTED|Single Ascending Dose (SAD)||6
10648000|NCT02151994|11807945|FG005|STARTED|Single Ascending Dose (SAD)||6
10648001|NCT02151994|11807946|FG006|STARTED|Single Ascending Dose (SAD)||6
10648002|NCT02151994|11807947|FG007|STARTED|Single Ascending Dose (SAD)||6
10648003|NCT02151994|11807948|FG008|STARTED|Single Ascending Dose (SAD)||0
10648004|NCT02151994|11807949|FG009|STARTED|Single Ascending Dose (SAD)||6
10648005|NCT02151994|11807950|FG010|STARTED|Single Ascending Dose (SAD)||6
10648006|NCT02151994|11807951|FG011|STARTED|Single Ascending Dose (SAD)||0
10648007|NCT02151994|11807952|FG012|STARTED|Single Ascending Dose (SAD)||0
10648008|NCT02151994|11807940|FG000|COMPLETED|Single Ascending Dose (SAD)||18
10648009|NCT02151994|11807941|FG001|COMPLETED|Single Ascending Dose (SAD)||6
10648010|NCT02151994|11807942|FG002|COMPLETED|Single Ascending Dose (SAD)||6
10648011|NCT02151994|11807943|FG003|COMPLETED|Single Ascending Dose (SAD)||6
10648012|NCT02151994|11807944|FG004|COMPLETED|Single Ascending Dose (SAD)||6
10648013|NCT02151994|11807945|FG005|COMPLETED|Single Ascending Dose (SAD)||6
10648014|NCT02151994|11807946|FG006|COMPLETED|Single Ascending Dose (SAD)||6
10648015|NCT02151994|11807947|FG007|COMPLETED|Single Ascending Dose (SAD)||6
10648016|NCT02151994|11807948|FG008|COMPLETED|Single Ascending Dose (SAD)||0
10648017|NCT02151994|11807949|FG009|COMPLETED|Single Ascending Dose (SAD)||6
10648018|NCT02151994|11807950|FG010|COMPLETED|Single Ascending Dose (SAD)||6
10648019|NCT02151994|11807951|FG011|COMPLETED|Single Ascending Dose (SAD)||0
10648020|NCT02151994|11807952|FG012|COMPLETED|Single Ascending Dose (SAD)||0
10648021|NCT02151994|11807940|FG000|NOT COMPLETED|Single Ascending Dose (SAD)||0
10648022|NCT02151994|11807941|FG001|NOT COMPLETED|Single Ascending Dose (SAD)||0
10648023|NCT02151994|11807942|FG002|NOT COMPLETED|Single Ascending Dose (SAD)||0
10648024|NCT02151994|11807943|FG003|NOT COMPLETED|Single Ascending Dose (SAD)||0
10648025|NCT02151994|11807944|FG004|NOT COMPLETED|Single Ascending Dose (SAD)||0
10648026|NCT02151994|11807945|FG005|NOT COMPLETED|Single Ascending Dose (SAD)||0
10648027|NCT02151994|11807946|FG006|NOT COMPLETED|Single Ascending Dose (SAD)||0
10648028|NCT02151994|11807947|FG007|NOT COMPLETED|Single Ascending Dose (SAD)||0
10648029|NCT02151994|11807948|FG008|NOT COMPLETED|Single Ascending Dose (SAD)||0
10648030|NCT02151994|11807949|FG009|NOT COMPLETED|Single Ascending Dose (SAD)||0
10648031|NCT02151994|11807950|FG010|NOT COMPLETED|Single Ascending Dose (SAD)||0
10648032|NCT02151994|11807951|FG011|NOT COMPLETED|Single Ascending Dose (SAD)||0
10648033|NCT02151994|11807952|FG012|NOT COMPLETED|Single Ascending Dose (SAD)||0
10648034|NCT02151994|11807940|FG000|STARTED|Multiple Ascending Dose (MAD)||10
10648035|NCT02151994|11807941|FG001|STARTED|Multiple Ascending Dose (MAD)||0
10648036|NCT02151994|11807942|FG002|STARTED|Multiple Ascending Dose (MAD)||0
10648037|NCT02151994|11807943|FG003|STARTED|Multiple Ascending Dose (MAD)||6
10648038|NCT02151994|11807944|FG004|STARTED|Multiple Ascending Dose (MAD)||6
10648039|NCT02151994|11807945|FG005|STARTED|Multiple Ascending Dose (MAD)||6
10648040|NCT02151994|11807946|FG006|STARTED|Multiple Ascending Dose (MAD)||6
10648041|NCT02151994|11807947|FG007|STARTED|Multiple Ascending Dose (MAD)||0
10648042|NCT02151994|11807948|FG008|STARTED|Multiple Ascending Dose (MAD)||6
10648043|NCT02151994|11807949|FG009|STARTED|Multiple Ascending Dose (MAD)||0
10648044|NCT02151994|11807950|FG010|STARTED|Multiple Ascending Dose (MAD)||0
10648045|NCT02151994|11807951|FG011|STARTED|Multiple Ascending Dose (MAD)||0
10648046|NCT02151994|11807952|FG012|STARTED|Multiple Ascending Dose (MAD)||0
10648047|NCT02151994|11807940|FG000|COMPLETED|Multiple Ascending Dose (MAD)||10
10648048|NCT02151994|11807941|FG001|COMPLETED|Multiple Ascending Dose (MAD)||0
10648049|NCT02151994|11807942|FG002|COMPLETED|Multiple Ascending Dose (MAD)||0
10648050|NCT02151994|11807943|FG003|COMPLETED|Multiple Ascending Dose (MAD)||6
10648051|NCT02151994|11807944|FG004|COMPLETED|Multiple Ascending Dose (MAD)||6
10648052|NCT02151994|11807945|FG005|COMPLETED|Multiple Ascending Dose (MAD)||6
10648053|NCT02151994|11807946|FG006|COMPLETED|Multiple Ascending Dose (MAD)||6
10648054|NCT02151994|11807947|FG007|COMPLETED|Multiple Ascending Dose (MAD)||0
10648055|NCT02151994|11807948|FG008|COMPLETED|Multiple Ascending Dose (MAD)||6
10648056|NCT02151994|11807949|FG009|COMPLETED|Multiple Ascending Dose (MAD)||0
10648057|NCT02151994|11807950|FG010|COMPLETED|Multiple Ascending Dose (MAD)||0
10648058|NCT02151994|11807951|FG011|COMPLETED|Multiple Ascending Dose (MAD)||0
10648059|NCT02151994|11807952|FG012|COMPLETED|Multiple Ascending Dose (MAD)||0
10648060|NCT02151994|11807940|FG000|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
10648061|NCT02151994|11807941|FG001|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
10648062|NCT02151994|11807942|FG002|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
10648063|NCT02151994|11807943|FG003|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
10648064|NCT02151994|11807944|FG004|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
10648065|NCT02151994|11807945|FG005|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
10648066|NCT02151994|11807946|FG006|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
10648067|NCT02151994|11807947|FG007|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
10648068|NCT02151994|11807948|FG008|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
10648069|NCT02151994|11807949|FG009|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
10648070|NCT02151994|11807950|FG010|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
10648071|NCT02151994|11807951|FG011|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
10648072|NCT02151994|11807952|FG012|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
10648073|NCT02151994|11807940|FG000|STARTED|Food Effect (FE): Fasted||0
10648074|NCT02151994|11807941|FG001|STARTED|Food Effect (FE): Fasted||0
10648075|NCT02151994|11807942|FG002|STARTED|Food Effect (FE): Fasted||0
10648076|NCT02151994|11807943|FG003|STARTED|Food Effect (FE): Fasted||0
10648077|NCT02151994|11807944|FG004|STARTED|Food Effect (FE): Fasted||0
10648078|NCT02151994|11807945|FG005|STARTED|Food Effect (FE): Fasted||0
10648079|NCT02151994|11807946|FG006|STARTED|Food Effect (FE): Fasted||0
10648080|NCT02151994|11807947|FG007|STARTED|Food Effect (FE): Fasted||0
10648081|NCT02151994|11807948|FG008|STARTED|Food Effect (FE): Fasted||0
10648082|NCT02151994|11807949|FG009|STARTED|Food Effect (FE): Fasted||0
10648083|NCT02151994|11807950|FG010|STARTED|Food Effect (FE): Fasted||0
10648084|NCT02151994|11807951|FG011|STARTED|Food Effect (FE): Fasted||12
10648085|NCT02151994|11807952|FG012|STARTED|Food Effect (FE): Fasted||0
10648086|NCT02151994|11807940|FG000|COMPLETED|Food Effect (FE): Fasted||0
10648087|NCT02151994|11807941|FG001|COMPLETED|Food Effect (FE): Fasted||0
10648088|NCT02151994|11807942|FG002|COMPLETED|Food Effect (FE): Fasted||0
10648089|NCT02151994|11807943|FG003|COMPLETED|Food Effect (FE): Fasted||0
10648090|NCT02151994|11807944|FG004|COMPLETED|Food Effect (FE): Fasted||0
10648091|NCT02151994|11807945|FG005|COMPLETED|Food Effect (FE): Fasted||0
10648092|NCT02151994|11807946|FG006|COMPLETED|Food Effect (FE): Fasted||0
10648093|NCT02151994|11807947|FG007|COMPLETED|Food Effect (FE): Fasted||0
10648094|NCT02151994|11807948|FG008|COMPLETED|Food Effect (FE): Fasted||0
10648095|NCT02151994|11807949|FG009|COMPLETED|Food Effect (FE): Fasted||0
10648096|NCT02151994|11807950|FG010|COMPLETED|Food Effect (FE): Fasted||0
10648097|NCT02151994|11807951|FG011|COMPLETED|Food Effect (FE): Fasted||12
10648098|NCT02151994|11807952|FG012|COMPLETED|Food Effect (FE): Fasted||0
10648099|NCT02151994|11807940|FG000|NOT COMPLETED|Food Effect (FE): Fasted||0
10648100|NCT02151994|11807941|FG001|NOT COMPLETED|Food Effect (FE): Fasted||0
10648101|NCT02151994|11807942|FG002|NOT COMPLETED|Food Effect (FE): Fasted||0
10648102|NCT02151994|11807943|FG003|NOT COMPLETED|Food Effect (FE): Fasted||0
10648103|NCT02151994|11807944|FG004|NOT COMPLETED|Food Effect (FE): Fasted||0
10648104|NCT02151994|11807945|FG005|NOT COMPLETED|Food Effect (FE): Fasted||0
10648105|NCT02151994|11807946|FG006|NOT COMPLETED|Food Effect (FE): Fasted||0
10648106|NCT02151994|11807947|FG007|NOT COMPLETED|Food Effect (FE): Fasted||0
10648107|NCT02151994|11807948|FG008|NOT COMPLETED|Food Effect (FE): Fasted||0
10648108|NCT02151994|11807949|FG009|NOT COMPLETED|Food Effect (FE): Fasted||0
10648109|NCT02151994|11807950|FG010|NOT COMPLETED|Food Effect (FE): Fasted||0
10648110|NCT02151994|11807951|FG011|NOT COMPLETED|Food Effect (FE): Fasted||0
10648111|NCT02151994|11807952|FG012|NOT COMPLETED|Food Effect (FE): Fasted||0
10648112|NCT02151994|11807940|FG000|STARTED|Food Effect (FE): Fed||0
10648113|NCT02151994|11807941|FG001|STARTED|Food Effect (FE): Fed||0
10648114|NCT02151994|11807942|FG002|STARTED|Food Effect (FE): Fed||0
10648115|NCT02151994|11807943|FG003|STARTED|Food Effect (FE): Fed||0
10648116|NCT02151994|11807944|FG004|STARTED|Food Effect (FE): Fed||0
10648117|NCT02151994|11807945|FG005|STARTED|Food Effect (FE): Fed||0
10648118|NCT02151994|11807946|FG006|STARTED|Food Effect (FE): Fed||0
10648119|NCT02151994|11807947|FG007|STARTED|Food Effect (FE): Fed||0
10648120|NCT02151994|11807948|FG008|STARTED|Food Effect (FE): Fed||0
10648121|NCT02151994|11807949|FG009|STARTED|Food Effect (FE): Fed||0
10648122|NCT02151994|11807950|FG010|STARTED|Food Effect (FE): Fed||0
10648123|NCT02151994|11807951|FG011|STARTED|Food Effect (FE): Fed||0
10648124|NCT02151994|11807952|FG012|STARTED|Food Effect (FE): Fed||12
10648125|NCT02151994|11807940|FG000|COMPLETED|Food Effect (FE): Fed||0
10648126|NCT02151994|11807941|FG001|COMPLETED|Food Effect (FE): Fed||0
10648127|NCT02151994|11807942|FG002|COMPLETED|Food Effect (FE): Fed||0
10457370|NCT01010477|11605133|FG001|NOT COMPLETED|Overall Study||3
10457371|NCT01010503|11605139|FG000|STARTED|Overall Study||32
10457372|NCT01010503|11605139|FG000|COMPLETED|Overall Study||30
10457373|NCT01010503|11605139|FG000|NOT COMPLETED|Overall Study||2
10457374|NCT01010555|11605143|FG000|STARTED|First Four Weeks of Wear||11
10648128|NCT02151994|11807943|FG003|COMPLETED|Food Effect (FE): Fed||0
10648129|NCT02151994|11807944|FG004|COMPLETED|Food Effect (FE): Fed||0
10648130|NCT02151994|11807945|FG005|COMPLETED|Food Effect (FE): Fed||0
10648131|NCT02151994|11807946|FG006|COMPLETED|Food Effect (FE): Fed||0
10648132|NCT02151994|11807947|FG007|COMPLETED|Food Effect (FE): Fed||0
10648133|NCT02151994|11807948|FG008|COMPLETED|Food Effect (FE): Fed||0
10648134|NCT02151994|11807949|FG009|COMPLETED|Food Effect (FE): Fed||0
10648135|NCT02151994|11807950|FG010|COMPLETED|Food Effect (FE): Fed||0
10648136|NCT02151994|11807951|FG011|COMPLETED|Food Effect (FE): Fed||0
10648137|NCT02151994|11807952|FG012|COMPLETED|Food Effect (FE): Fed||12
10648138|NCT02151994|11807940|FG000|NOT COMPLETED|Food Effect (FE): Fed||0
10648139|NCT02151994|11807941|FG001|NOT COMPLETED|Food Effect (FE): Fed||0
10648140|NCT02151994|11807942|FG002|NOT COMPLETED|Food Effect (FE): Fed||0
10648141|NCT02151994|11807943|FG003|NOT COMPLETED|Food Effect (FE): Fed||0
10648142|NCT02151994|11807944|FG004|NOT COMPLETED|Food Effect (FE): Fed||0
10648143|NCT02151994|11807945|FG005|NOT COMPLETED|Food Effect (FE): Fed||0
10648144|NCT02151994|11807946|FG006|NOT COMPLETED|Food Effect (FE): Fed||0
10648145|NCT02151994|11807947|FG007|NOT COMPLETED|Food Effect (FE): Fed||0
10648146|NCT02151994|11807948|FG008|NOT COMPLETED|Food Effect (FE): Fed||0
10648147|NCT02151994|11807949|FG009|NOT COMPLETED|Food Effect (FE): Fed||0
10648148|NCT02151994|11807950|FG010|NOT COMPLETED|Food Effect (FE): Fed||0
10648149|NCT02151994|11807951|FG011|NOT COMPLETED|Food Effect (FE): Fed||0
10648150|NCT02151994|11807952|FG012|NOT COMPLETED|Food Effect (FE): Fed||0
10648151|NCT02152007|11807989|FG000|STARTED|Overall Study||15
10648152|NCT02152007|11807989|FG000|COMPLETED|Overall Study||14
10648153|NCT02152007|11807989|FG000|NOT COMPLETED|Overall Study||1
10648154|NCT02152085|11807996|FG000|STARTED|Overall Study||14
10648155|NCT02152085|11807997|FG001|STARTED|Overall Study||15
10648156|NCT02152085|11807996|FG000|COMPLETED|Overall Study||13
10648157|NCT02152085|11807997|FG001|COMPLETED|Overall Study||14
10648158|NCT02152085|11807996|FG000|NOT COMPLETED|Overall Study||1
10648159|NCT02152085|11807997|FG001|NOT COMPLETED|Overall Study||1
10648160|NCT02152137|11808003|FG000|STARTED|Overall Study||19
10648161|NCT02152137|11808003|FG000|Originally Assigned to Arm A|Overall Study||16
10648162|NCT02152137|11808003|FG000|Originally Assigned to Arm B|Overall Study|With update #2, Arm B is closed and all patients should receive paclitaxel and efatutazone.|3
10648163|NCT02152137|11808003|FG000|COMPLETED|Overall Study||15
10648164|NCT02152137|11808003|FG000|NOT COMPLETED|Overall Study||4
10648165|NCT02152163|11808009|FG000|STARTED|Overall Study||51
10648166|NCT02152163|11808010|FG001|STARTED|Overall Study||48
10648167|NCT02152163|11808009|FG000|COMPLETED|Overall Study||39
10648168|NCT02152163|11808010|FG001|COMPLETED|Overall Study||35
10648169|NCT02152163|11808009|FG000|NOT COMPLETED|Overall Study||12
10648170|NCT02152163|11808010|FG001|NOT COMPLETED|Overall Study||13
10648171|NCT02152345|11808018|FG000|STARTED|Overall Study|The first subject randomized to Belatacept was on 15-Sep-2014.|28
10648172|NCT02152345|11808019|FG001|STARTED|Overall Study|The first subject randomized to Standard Immunosuppression was on 14-Jun-2014.|29
10457375|NCT01010555|11605144|FG001|STARTED|First Four Weeks of Wear||10
10457376|NCT01010555|11605143|FG000|COMPLETED|First Four Weeks of Wear|One participant who completed Period 1 did not start Period 2. Relocation.|11
10648173|NCT02152345|11808018|FG000|COMPLETED|Overall Study|The last subject randomized to Belatacept was on 29-Dec-2016.|24
10648174|NCT02152345|11808019|FG001|COMPLETED|Overall Study|The last subject randomized to Standard Immunosuppression was on 25-Dec-2016.|24
10648175|NCT02152345|11808018|FG000|NOT COMPLETED|Overall Study||4
10648176|NCT02152345|11808019|FG001|NOT COMPLETED|Overall Study||5
10648177|NCT02152371|11808027|FG000|STARTED|Overall Study||150
10648178|NCT02152371|11808028|FG001|STARTED|Overall Study||150
10648179|NCT02152371|11808027|FG000|Received at Least 1 Dose of Study Drug.|Overall Study||150
10648180|NCT02152371|11808028|FG001|Received at Least 1 Dose of Study Drug.|Overall Study||150
10648181|NCT02152371|11808027|FG000|COMPLETED|Overall Study||138
10648182|NCT02152371|11808028|FG001|COMPLETED|Overall Study||134
10648183|NCT02152371|11808027|FG000|NOT COMPLETED|Overall Study||12
10648184|NCT02152371|11808028|FG001|NOT COMPLETED|Overall Study||16
10648185|NCT02152384|11808034|FG000|STARTED|Run In (1-5 Week Transition)||14
10648186|NCT02152384|11808035|FG001|STARTED|Run In (1-5 Week Transition)||14
10648187|NCT02152384|11808034|FG000|COMPLETED|Run In (1-5 Week Transition)||14
10648188|NCT02152384|11808035|FG001|COMPLETED|Run In (1-5 Week Transition)||14
10648189|NCT02152384|11808034|FG000|NOT COMPLETED|Run In (1-5 Week Transition)||0
10648190|NCT02152384|11808035|FG001|NOT COMPLETED|Run In (1-5 Week Transition)||0
10648191|NCT02152384|11808034|FG000|STARTED|Period 1||14
10648192|NCT02152384|11808035|FG001|STARTED|Period 1||14
10648193|NCT02152384|11808034|FG000|Received at Least 1 Dose of Study Drug|Period 1||14
10648194|NCT02152384|11808035|FG001|Received at Least 1 Dose of Study Drug|Period 1||14
10648195|NCT02152384|11808034|FG000|COMPLETED|Period 1||13
10648196|NCT02152384|11808035|FG001|COMPLETED|Period 1||12
10648197|NCT02152384|11808034|FG000|NOT COMPLETED|Period 1||1
10648198|NCT02152384|11808035|FG001|NOT COMPLETED|Period 1||2
10648199|NCT02152384|11808034|FG000|STARTED|Period 2||13
10648200|NCT02152384|11808035|FG001|STARTED|Period 2||12
10648201|NCT02152384|11808034|FG000|COMPLETED|Period 2||13
10648202|NCT02152384|11808035|FG001|COMPLETED|Period 2||12
10648203|NCT02152384|11808034|FG000|NOT COMPLETED|Period 2||0
10648204|NCT02152384|11808035|FG001|NOT COMPLETED|Period 2||0
10648205|NCT02152540|11808047|FG000|STARTED|Overall Study||17
10648206|NCT02152540|11808048|FG001|STARTED|Overall Study||16
10457377|NCT01010555|11605144|FG001|COMPLETED|First Four Weeks of Wear|One participant who completed Period 1 did not start Period 2. Non-compliance with visit schedule.|10
10457378|NCT01010555|11605143|FG000|NOT COMPLETED|First Four Weeks of Wear||0
10457379|NCT01010555|11605144|FG001|NOT COMPLETED|First Four Weeks of Wear||0
10648207|NCT02152540|11808047|FG000|COMPLETED|Overall Study||17
10648208|NCT02152540|11808048|FG001|COMPLETED|Overall Study||16
10648209|NCT02152540|11808047|FG000|NOT COMPLETED|Overall Study||0
10648210|NCT02152540|11808048|FG001|NOT COMPLETED|Overall Study||0
10648211|NCT02152605|11808063|FG000|STARTED|Overall Study||248
10648212|NCT02152605|11808064|FG001|STARTED|Overall Study||248
10648213|NCT02152605|11808063|FG000|COMPLETED|Overall Study||229
10648214|NCT02152605|11808064|FG001|COMPLETED|Overall Study||230
10648215|NCT02152605|11808063|FG000|NOT COMPLETED|Overall Study||19
10648216|NCT02152605|11808064|FG001|NOT COMPLETED|Overall Study||18
10648231|NCT02152696|11808083|FG000|STARTED|Overall Study||86
10648232|NCT02152696|11808084|FG001|STARTED|Overall Study||87
10648233|NCT02152696|11808085|FG002|STARTED|Overall Study||82
10648234|NCT02152696|11808083|FG000|COMPLETED|Overall Study||86
10648235|NCT02152696|11808084|FG001|COMPLETED|Overall Study||86
10648236|NCT02152696|11808085|FG002|COMPLETED|Overall Study||81
10648237|NCT02152696|11808083|FG000|NOT COMPLETED|Overall Study||0
10648238|NCT02152696|11808084|FG001|NOT COMPLETED|Overall Study||1
10648239|NCT02152696|11808085|FG002|NOT COMPLETED|Overall Study||1
10648240|NCT02152761|11808097|FG000|STARTED|Epoch: Treatment Epoch||75
10648241|NCT02152761|11808098|FG001|STARTED|Epoch: Treatment Epoch||70
10648242|NCT02152761|11808099|FG002|STARTED|Epoch: Treatment Epoch||34
10648243|NCT02152761|11808100|FG003|STARTED|Epoch: Treatment Epoch||72
10648244|NCT02152761|11808097|FG000|COMPLETED|Epoch: Treatment Epoch||64
10648245|NCT02152761|11808098|FG001|COMPLETED|Epoch: Treatment Epoch||50
10648246|NCT02152761|11808099|FG002|COMPLETED|Epoch: Treatment Epoch||29
10648247|NCT02152761|11808100|FG003|COMPLETED|Epoch: Treatment Epoch||64
10648248|NCT02152761|11808097|FG000|NOT COMPLETED|Epoch: Treatment Epoch||11
10648249|NCT02152761|11808098|FG001|NOT COMPLETED|Epoch: Treatment Epoch||20
10648250|NCT02152761|11808099|FG002|NOT COMPLETED|Epoch: Treatment Epoch||5
10648251|NCT02152761|11808100|FG003|NOT COMPLETED|Epoch: Treatment Epoch||8
10648252|NCT02152761|11808097|FG000|STARTED|Epoch: Post-treatment Follow-up Epoch||67
10648253|NCT02152761|11808098|FG001|STARTED|Epoch: Post-treatment Follow-up Epoch||54
10648254|NCT02152761|11808099|FG002|STARTED|Epoch: Post-treatment Follow-up Epoch||30
10648255|NCT02152761|11808100|FG003|STARTED|Epoch: Post-treatment Follow-up Epoch||68
10648256|NCT02152761|11808097|FG000|COMPLETED|Epoch: Post-treatment Follow-up Epoch||63
10648257|NCT02152761|11808098|FG001|COMPLETED|Epoch: Post-treatment Follow-up Epoch||47
10648258|NCT02152761|11808099|FG002|COMPLETED|Epoch: Post-treatment Follow-up Epoch||30
10648259|NCT02152761|11808100|FG003|COMPLETED|Epoch: Post-treatment Follow-up Epoch||66
10648260|NCT02152761|11808097|FG000|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||4
10648261|NCT02152761|11808098|FG001|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||7
10648262|NCT02152761|11808099|FG002|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||0
10648263|NCT02152761|11808100|FG003|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||2
10648264|NCT02152826|11808118|FG000|STARTED|Overall Study||45
10648265|NCT02152826|11808119|FG001|STARTED|Overall Study||35
10648266|NCT02152826|11808118|FG000|COMPLETED|Overall Study||44
10648267|NCT02152826|11808119|FG001|COMPLETED|Overall Study||34
10648268|NCT02152826|11808118|FG000|NOT COMPLETED|Overall Study||1
10648269|NCT02152826|11808119|FG001|NOT COMPLETED|Overall Study||1
10648270|NCT02153073|11808125|FG000|STARTED|Overall Study||3084
10648271|NCT02153073|11808125|FG000|COMPLETED|Overall Study||2786
10648272|NCT02153073|11808125|FG000|NOT COMPLETED|Overall Study||298
10648273|NCT02153086|11808129|FG000|STARTED|Overall Study||236
10648274|NCT02153086|11808129|FG000|COMPLETED|Overall Study||232
10648275|NCT02153086|11808129|FG000|NOT COMPLETED|Overall Study||4
10648276|NCT02153099|11808140|FG000|STARTED|Overall Study||6
10648277|NCT02153099|11808141|FG001|STARTED|Overall Study||6
10648278|NCT02153099|11808142|FG002|STARTED|Overall Study||6
10648279|NCT02153099|11808143|FG003|STARTED|Overall Study||6
10648280|NCT02153099|11808144|FG004|STARTED|Overall Study||6
10648281|NCT02153099|11808145|FG005|STARTED|Overall Study||6
10648282|NCT02153099|11808146|FG006|STARTED|Overall Study||12
10648283|NCT02153099|11808140|FG000|COMPLETED|Overall Study||6
10648284|NCT02153099|11808141|FG001|COMPLETED|Overall Study||6
10648285|NCT02153099|11808142|FG002|COMPLETED|Overall Study||6
10648286|NCT02153099|11808143|FG003|COMPLETED|Overall Study||6
10648287|NCT02153099|11808144|FG004|COMPLETED|Overall Study||6
10648288|NCT02153099|11808145|FG005|COMPLETED|Overall Study||6
10648289|NCT02153099|11808146|FG006|COMPLETED|Overall Study||12
10648290|NCT02153099|11808140|FG000|NOT COMPLETED|Overall Study||0
10648291|NCT02153099|11808141|FG001|NOT COMPLETED|Overall Study||0
10648292|NCT02153099|11808142|FG002|NOT COMPLETED|Overall Study||0
10648293|NCT02153099|11808143|FG003|NOT COMPLETED|Overall Study||0
10648294|NCT02153099|11808144|FG004|NOT COMPLETED|Overall Study||0
10648295|NCT02153099|11808145|FG005|NOT COMPLETED|Overall Study||0
10648296|NCT02153099|11808146|FG006|NOT COMPLETED|Overall Study||0
10648297|NCT02153112|11808172|FG000|STARTED|Overall Study||61
10648298|NCT02153112|11808173|FG001|STARTED|Overall Study||59
10648299|NCT02153112|11808174|FG002|STARTED|Overall Study||61
10648300|NCT02153112|11808175|FG003|STARTED|Overall Study||59
10648301|NCT02153112|11808176|FG004|STARTED|Overall Study||60
10648302|NCT02153112|11808177|FG005|STARTED|Overall Study||60
10648303|NCT02153112|11808178|FG006|STARTED|Overall Study||60
10648304|NCT02153112|11808179|FG007|STARTED|Overall Study||60
10648305|NCT02153112|11808180|FG008|STARTED|Overall Study||180
10648306|NCT02153112|11808181|FG009|STARTED|Overall Study||180
10648307|NCT02153112|11808172|FG000|COMPLETED|Overall Study||57
10648308|NCT02153112|11808173|FG001|COMPLETED|Overall Study||57
10648309|NCT02153112|11808174|FG002|COMPLETED|Overall Study||58
10648310|NCT02153112|11808175|FG003|COMPLETED|Overall Study||57
10648311|NCT02153112|11808176|FG004|COMPLETED|Overall Study||57
10648312|NCT02153112|11808177|FG005|COMPLETED|Overall Study||58
10648313|NCT02153112|11808178|FG006|COMPLETED|Overall Study||52
10648314|NCT02153112|11808179|FG007|COMPLETED|Overall Study||58
10648315|NCT02153112|11808180|FG008|COMPLETED|Overall Study||165
10648316|NCT02153112|11808181|FG009|COMPLETED|Overall Study||166
10648317|NCT02153112|11808172|FG000|NOT COMPLETED|Overall Study||4
10648318|NCT02153112|11808173|FG001|NOT COMPLETED|Overall Study||2
10648319|NCT02153112|11808174|FG002|NOT COMPLETED|Overall Study||3
10648320|NCT02153112|11808175|FG003|NOT COMPLETED|Overall Study||2
10648321|NCT02153112|11808176|FG004|NOT COMPLETED|Overall Study||3
10648322|NCT02153112|11808177|FG005|NOT COMPLETED|Overall Study||2
10648323|NCT02153112|11808178|FG006|NOT COMPLETED|Overall Study||8
10648324|NCT02153112|11808179|FG007|NOT COMPLETED|Overall Study||2
10648325|NCT02153112|11808180|FG008|NOT COMPLETED|Overall Study||15
10648326|NCT02153112|11808181|FG009|NOT COMPLETED|Overall Study||14
10648327|NCT02153346|11808205|FG000|STARTED|Overall Study||101
10648328|NCT02153346|11808205|FG000|COMPLETED|Overall Study||90
10648329|NCT02153346|11808205|FG000|NOT COMPLETED|Overall Study||11
10648330|NCT02153359|11808210|FG000|STARTED|Intervention 1 (1 Month)||11
10648331|NCT02153359|11808211|FG001|STARTED|Intervention 1 (1 Month)||12
10648332|NCT02153359|11808210|FG000|COMPLETED|Intervention 1 (1 Month)||11
10648333|NCT02153359|11808211|FG001|COMPLETED|Intervention 1 (1 Month)||12
10648334|NCT02153359|11808210|FG000|NOT COMPLETED|Intervention 1 (1 Month)||0
10648335|NCT02153359|11808211|FG001|NOT COMPLETED|Intervention 1 (1 Month)||0
10648336|NCT02153359|11808210|FG000|STARTED|Washout (at Least 1 Month)||11
10648337|NCT02153359|11808211|FG001|STARTED|Washout (at Least 1 Month)||12
10648338|NCT02153359|11808210|FG000|COMPLETED|Washout (at Least 1 Month)||11
10648339|NCT02153359|11808211|FG001|COMPLETED|Washout (at Least 1 Month)||12
10648340|NCT02153359|11808210|FG000|NOT COMPLETED|Washout (at Least 1 Month)||0
10648341|NCT02153359|11808211|FG001|NOT COMPLETED|Washout (at Least 1 Month)||0
10648342|NCT02153359|11808210|FG000|STARTED|Intervention 2 (1 Month)||11
10648343|NCT02153359|11808211|FG001|STARTED|Intervention 2 (1 Month)||12
10648344|NCT02153359|11808210|FG000|COMPLETED|Intervention 2 (1 Month)||11
10648345|NCT02153359|11808211|FG001|COMPLETED|Intervention 2 (1 Month)||10
10648346|NCT02153359|11808210|FG000|NOT COMPLETED|Intervention 2 (1 Month)||0
10648347|NCT02153359|11808211|FG001|NOT COMPLETED|Intervention 2 (1 Month)||2
10648348|NCT02153398|11808225|FG000|STARTED|Overall Study||10
10648349|NCT02153398|11808226|FG001|STARTED|Overall Study||10
10648350|NCT02153398|11808227|FG002|STARTED|Overall Study||10
10648351|NCT02153398|11808228|FG003|STARTED|Overall Study||10
10648352|NCT02153398|11808229|FG004|STARTED|Overall Study||10
10648353|NCT02153398|11808225|FG000|COMPLETED|Overall Study||9
10648354|NCT02153398|11808226|FG001|COMPLETED|Overall Study||10
10648355|NCT02153398|11808227|FG002|COMPLETED|Overall Study||9
10648356|NCT02153398|11808228|FG003|COMPLETED|Overall Study||9
10648357|NCT02153398|11808229|FG004|COMPLETED|Overall Study||10
10648358|NCT02153398|11808225|FG000|NOT COMPLETED|Overall Study||1
10648359|NCT02153398|11808226|FG001|NOT COMPLETED|Overall Study||0
10648360|NCT02153398|11808227|FG002|NOT COMPLETED|Overall Study||1
10648361|NCT02153398|11808228|FG003|NOT COMPLETED|Overall Study||1
10648362|NCT02153398|11808229|FG004|NOT COMPLETED|Overall Study||0
10648363|NCT02153476|11808243|FG000|STARTED|Overall Study||23
10648364|NCT02153476|11808244|FG001|STARTED|Overall Study||22
10648365|NCT02153476|11808243|FG000|COMPLETED|Overall Study||22
10648366|NCT02153476|11808244|FG001|COMPLETED|Overall Study||22
10648367|NCT02153476|11808243|FG000|NOT COMPLETED|Overall Study||1
10648368|NCT02153476|11808244|FG001|NOT COMPLETED|Overall Study||0
10648369|NCT02153489|11808250|FG000|STARTED|Period 1||15
10648370|NCT02153489|11808251|FG001|STARTED|Period 1||15
10648371|NCT02153489|11808250|FG000|COMPLETED|Period 1||15
10648372|NCT02153489|11808251|FG001|COMPLETED|Period 1||15
10648373|NCT02153489|11808250|FG000|NOT COMPLETED|Period 1||0
10648374|NCT02153489|11808251|FG001|NOT COMPLETED|Period 1||0
10648375|NCT02153489|11808250|FG000|STARTED|Period 2||15
10648376|NCT02153489|11808251|FG001|STARTED|Period 2||15
10648377|NCT02153489|11808250|FG000|COMPLETED|Period 2||15
10648378|NCT02153489|11808251|FG001|COMPLETED|Period 2||15
10648379|NCT02153489|11808250|FG000|NOT COMPLETED|Period 2||0
10648380|NCT02153489|11808251|FG001|NOT COMPLETED|Period 2||0
10648381|NCT02153528|11808259|FG000|STARTED|Overall Study||348
10648382|NCT02153528|11808260|FG001|STARTED|Overall Study||353
10648383|NCT02153528|11808259|FG000|COMPLETED|Overall Study||348
10648384|NCT02153528|11808260|FG001|COMPLETED|Overall Study||353
10648385|NCT02153528|11808259|FG000|NOT COMPLETED|Overall Study||0
10648386|NCT02153528|11808260|FG001|NOT COMPLETED|Overall Study||0
10648387|NCT02153671|11808270|FG000|STARTED|Overall Study||19
10648388|NCT02153671|11808271|FG001|STARTED|Overall Study||24
10648389|NCT02153671|11808270|FG000|COMPLETED|Overall Study||19
10648390|NCT02153671|11808271|FG001|COMPLETED|Overall Study||24
10648391|NCT02153671|11808270|FG000|NOT COMPLETED|Overall Study||0
10648392|NCT02153671|11808271|FG001|NOT COMPLETED|Overall Study||0
10648393|NCT02153710|11808279|FG000|STARTED|Overall Study||28
10648394|NCT02153710|11808280|FG001|STARTED|Overall Study||30
10648395|NCT02153710|11808279|FG000|COMPLETED|Overall Study||28
10648396|NCT02153710|11808280|FG001|COMPLETED|Overall Study||30
10648397|NCT02153710|11808279|FG000|NOT COMPLETED|Overall Study||0
10648398|NCT02153710|11808280|FG001|NOT COMPLETED|Overall Study||0
10648399|NCT02153723|11808286|FG000|STARTED|Overall Study||10
10648400|NCT02153723|11808286|FG000|COMPLETED|Overall Study||10
10648401|NCT02153723|11808286|FG000|NOT COMPLETED|Overall Study||0
10648402|NCT02153736|11808292|FG000|STARTED|Overall Study||7
10648403|NCT02153736|11808293|FG001|STARTED|Overall Study||7
10648404|NCT02153736|11808292|FG000|COMPLETED|Overall Study||5
10648405|NCT02153736|11808293|FG001|COMPLETED|Overall Study||5
10648406|NCT02153736|11808292|FG000|NOT COMPLETED|Overall Study||2
10648407|NCT02153736|11808293|FG001|NOT COMPLETED|Overall Study||2
10648408|NCT02153788|11808301|FG000|STARTED|Overall Study||25
10648409|NCT02153788|11808302|FG001|STARTED|Overall Study||19
10648410|NCT02153788|11808301|FG000|COMPLETED|Overall Study||23
10648411|NCT02153788|11808302|FG001|COMPLETED|Overall Study||18
10648412|NCT02153788|11808301|FG000|NOT COMPLETED|Overall Study||2
10648413|NCT02153788|11808302|FG001|NOT COMPLETED|Overall Study||1
10648414|NCT02153827|11808310|FG000|STARTED|Overall Study||25
10648415|NCT02153827|11808311|FG001|STARTED|Overall Study||23
10648416|NCT02153827|11808310|FG000|COMPLETED|Overall Study||22
10648417|NCT02153827|11808311|FG001|COMPLETED|Overall Study||14
10648418|NCT02153827|11808310|FG000|NOT COMPLETED|Overall Study||3
10648419|NCT02153827|11808311|FG001|NOT COMPLETED|Overall Study||9
10648420|NCT02153905|11808319|FG000|STARTED|Overall Study||1
10648421|NCT02153905|11808320|FG001|STARTED|Overall Study||2
10648422|NCT02153905|11808319|FG000|COMPLETED|Overall Study||0
10648423|NCT02153905|11808320|FG001|COMPLETED|Overall Study||2
10648424|NCT02153905|11808319|FG000|NOT COMPLETED|Overall Study||1
10648425|NCT02153905|11808320|FG001|NOT COMPLETED|Overall Study||0
10648426|NCT02153918|11808326|FG000|STARTED|Overall Study||27
10648427|NCT02153918|11808326|FG000|COMPLETED|Overall Study||26
10648428|NCT02153918|11808326|FG000|NOT COMPLETED|Overall Study||1
10648429|NCT02153983|11808336|FG000|STARTED|Overall Study||19
10648430|NCT02153983|11808337|FG001|STARTED|Overall Study||21
10648431|NCT02153983|11808338|FG002|STARTED|Overall Study||4
10648432|NCT02153983|11808339|FG003|STARTED|Overall Study||13
10648433|NCT02153983|11808340|FG004|STARTED|Overall Study||19
10648434|NCT02153983|11808341|FG005|STARTED|Overall Study||1
10648435|NCT02153983|11808336|FG000|COMPLETED|Overall Study||19
10648436|NCT02153983|11808337|FG001|COMPLETED|Overall Study||18
10648437|NCT02153983|11808338|FG002|COMPLETED|Overall Study||2
10648438|NCT02153983|11808339|FG003|COMPLETED|Overall Study||13
10648439|NCT02153983|11808340|FG004|COMPLETED|Overall Study||19
10648440|NCT02153983|11808341|FG005|COMPLETED|Overall Study||1
10648441|NCT02153983|11808336|FG000|NOT COMPLETED|Overall Study||0
10648442|NCT02153983|11808337|FG001|NOT COMPLETED|Overall Study||3
10648443|NCT02153983|11808338|FG002|NOT COMPLETED|Overall Study||2
10648444|NCT02153983|11808339|FG003|NOT COMPLETED|Overall Study||0
10648445|NCT02153983|11808340|FG004|NOT COMPLETED|Overall Study||0
10648446|NCT02153983|11808341|FG005|NOT COMPLETED|Overall Study||0
10648447|NCT02154048|11808358|FG000|STARTED|Overall Study||2
10648448|NCT02154048|11808359|FG001|STARTED|Overall Study||2
10648449|NCT02154048|11808360|FG002|STARTED|Overall Study||1
10648450|NCT02154048|11808358|FG000|COMPLETED|Overall Study||2
10648451|NCT02154048|11808359|FG001|COMPLETED|Overall Study||2
10648452|NCT02154048|11808360|FG002|COMPLETED|Overall Study||1
10648453|NCT02154048|11808358|FG000|NOT COMPLETED|Overall Study||0
10648454|NCT02154048|11808359|FG001|NOT COMPLETED|Overall Study||0
10648455|NCT02154048|11808360|FG002|NOT COMPLETED|Overall Study||0
10648456|NCT02154061|11808370|FG000|STARTED|Overall Study||16
10648457|NCT02154061|11808371|FG001|STARTED|Overall Study||17
10648458|NCT02154061|11808370|FG000|COMPLETED|Overall Study||14
10648459|NCT02154061|11808371|FG001|COMPLETED|Overall Study||17
10648460|NCT02154061|11808370|FG000|NOT COMPLETED|Overall Study||2
10648461|NCT02154061|11808371|FG001|NOT COMPLETED|Overall Study||0
10648462|NCT02154139|11808377|FG000|STARTED|Overall Study||651
10648463|NCT02154139|11808377|FG000|COMPLETED|Overall Study||644
10648464|NCT02154139|11808377|FG000|NOT COMPLETED|Overall Study||7
10648465|NCT02154243|11808384|FG000|STARTED|Overall Study||5
10648466|NCT02154243|11808385|FG001|STARTED|Overall Study||4
10648467|NCT02154243|11808386|FG002|STARTED|Overall Study||4
10648468|NCT02154243|11808384|FG000|COMPLETED|Overall Study||5
10648469|NCT02154243|11808385|FG001|COMPLETED|Overall Study||4
10648470|NCT02154243|11808386|FG002|COMPLETED|Overall Study||4
10648471|NCT02154243|11808384|FG000|NOT COMPLETED|Overall Study||0
10648472|NCT02154243|11808385|FG001|NOT COMPLETED|Overall Study||0
10648473|NCT02154243|11808386|FG002|NOT COMPLETED|Overall Study||0
10648474|NCT02154347|11808396|FG000|STARTED|Double-blind Period||60
10648475|NCT02154347|11808397|FG001|STARTED|Double-blind Period||118
10648476|NCT02154347|11808396|FG000|COMPLETED|Double-blind Period||57
10648477|NCT02154347|11808397|FG001|COMPLETED|Double-blind Period||114
10648478|NCT02154347|11808396|FG000|NOT COMPLETED|Double-blind Period||3
10648479|NCT02154347|11808397|FG001|NOT COMPLETED|Double-blind Period||4
10648480|NCT02154347|11808396|FG000|STARTED|Open-label Period||57
10648481|NCT02154347|11808397|FG001|STARTED|Open-label Period||113
10648482|NCT02154347|11808396|FG000|COMPLETED|Open-label Period||50
10648483|NCT02154347|11808397|FG001|COMPLETED|Open-label Period||88
10648484|NCT02154347|11808396|FG000|NOT COMPLETED|Open-label Period||7
10648485|NCT02154347|11808397|FG001|NOT COMPLETED|Open-label Period||25
10648486|NCT02154386|11808406|FG000|STARTED|Overall Study||23
10648487|NCT02154386|11808407|FG001|STARTED|Overall Study||23
10648488|NCT02154386|11808406|FG000|COMPLETED|Overall Study||22
10648489|NCT02154386|11808407|FG001|COMPLETED|Overall Study||21
10648490|NCT02154386|11808406|FG000|NOT COMPLETED|Overall Study||1
10648491|NCT02154386|11808407|FG001|NOT COMPLETED|Overall Study||2
10648492|NCT02154425|11808413|FG000|STARTED|Screening Period||18
10648493|NCT02154425|11808413|FG000|COMPLETED|Screening Period||17
10648494|NCT02154425|11808413|FG000|NOT COMPLETED|Screening Period||1
10648495|NCT02154425|11808413|FG000|STARTED|Sampling Period||17
10648496|NCT02154425|11808413|FG000|COMPLETED|Sampling Period||17
10648497|NCT02154425|11808413|FG000|NOT COMPLETED|Sampling Period||0
10648498|NCT02154477|11808423|FG000|STARTED|Overall Study||6
10648499|NCT02154477|11808424|FG001|STARTED|Overall Study||8
10648500|NCT02154477|11808423|FG000|COMPLETED|Overall Study||6
10648501|NCT02154477|11808424|FG001|COMPLETED|Overall Study||8
10648502|NCT02154477|11808423|FG000|NOT COMPLETED|Overall Study||0
10648503|NCT02154477|11808424|FG001|NOT COMPLETED|Overall Study||0
10648504|NCT02154581|11808432|FG000|STARTED|Overall Study||21
10648505|NCT02154581|11808433|FG001|STARTED|Overall Study||20
10648506|NCT02154581|11808432|FG000|COMPLETED|Overall Study||14
10648507|NCT02154581|11808433|FG001|COMPLETED|Overall Study||12
10648508|NCT02154581|11808432|FG000|NOT COMPLETED|Overall Study||7
10648509|NCT02154581|11808433|FG001|NOT COMPLETED|Overall Study||8
10648510|NCT02154672|11808441|FG000|STARTED|Overall Study||1
10648511|NCT02154672|11808441|FG000|COMPLETED|Overall Study||1
10648512|NCT02154672|11808441|FG000|NOT COMPLETED|Overall Study||0
10648513|NCT02154763|11808447|FG000|STARTED|Overall Study||60
10648514|NCT02154763|11808448|FG001|STARTED|Overall Study||60
10648515|NCT02154763|11808447|FG000|COMPLETED|Overall Study||46
10648516|NCT02154763|11808448|FG001|COMPLETED|Overall Study||46
10648517|NCT02154763|11808447|FG000|NOT COMPLETED|Overall Study||14
10648518|NCT02154763|11808448|FG001|NOT COMPLETED|Overall Study||14
10648519|NCT02154906|11808458|FG000|STARTED|Overall Study||21
10648520|NCT02154906|11808459|FG001|STARTED|Overall Study||20
10648521|NCT02154906|11808458|FG000|COMPLETED|Overall Study||19
10648522|NCT02154906|11808459|FG001|COMPLETED|Overall Study||17
10648523|NCT02154906|11808458|FG000|NOT COMPLETED|Overall Study||2
10648524|NCT02154906|11808459|FG001|NOT COMPLETED|Overall Study||3
10648525|NCT02155010|11808467|FG000|STARTED|Overall Study||37
10648526|NCT02155010|11808468|FG001|STARTED|Overall Study||37
10648527|NCT02155010|11808467|FG000|COMPLETED|Overall Study||31
10648528|NCT02155010|11808468|FG001|COMPLETED|Overall Study||31
10648529|NCT02155010|11808467|FG000|NOT COMPLETED|Overall Study||6
10648530|NCT02155010|11808468|FG001|NOT COMPLETED|Overall Study||6
10648531|NCT02155101|11808476|FG000|STARTED|Overall Study||39
10648532|NCT02155101|11808477|FG001|STARTED|Overall Study||81
10648533|NCT02155101|11808476|FG000|COMPLETED|Overall Study||39
10648534|NCT02155101|11808477|FG001|COMPLETED|Overall Study||80
10648535|NCT02155101|11808476|FG000|NOT COMPLETED|Overall Study||0
10648536|NCT02155101|11808477|FG001|NOT COMPLETED|Overall Study||1
10648537|NCT02155257|11808486|FG000|STARTED|Overall Study||10
10648538|NCT02155257|11808487|FG001|STARTED|Overall Study||10
10648539|NCT02155257|11808488|FG002|STARTED|Overall Study||10
10648540|NCT02155257|11808486|FG000|COMPLETED|Overall Study||10
10648541|NCT02155257|11808487|FG001|COMPLETED|Overall Study||10
10648542|NCT02155257|11808488|FG002|COMPLETED|Overall Study||10
10648543|NCT02155257|11808486|FG000|NOT COMPLETED|Overall Study||0
10648544|NCT02155257|11808487|FG001|NOT COMPLETED|Overall Study||0
10648545|NCT02155257|11808488|FG002|NOT COMPLETED|Overall Study||0
10648546|NCT02155283|11808496|FG000|STARTED|Overall Study||16
10648547|NCT02155283|11808496|FG000|COMPLETED|Overall Study||9
10648548|NCT02155283|11808496|FG000|NOT COMPLETED|Overall Study||7
10648549|NCT02155309|11808502|FG000|STARTED|Overall Study||13
10648550|NCT02155309|11808503|FG001|STARTED|Overall Study||10
10648551|NCT02155309|11808504|FG002|STARTED|Overall Study||13
10648552|NCT02155309|11808502|FG000|COMPLETED|Overall Study||13
10648553|NCT02155309|11808503|FG001|COMPLETED|Overall Study||10
10648554|NCT02155309|11808504|FG002|COMPLETED|Overall Study||12
10648555|NCT02155309|11808502|FG000|NOT COMPLETED|Overall Study||0
10648556|NCT02155309|11808503|FG001|NOT COMPLETED|Overall Study||0
10648557|NCT02155309|11808504|FG002|NOT COMPLETED|Overall Study||1
10648558|NCT02155322|11808511|FG000|STARTED|Overall Study||33
10648559|NCT02155322|11808511|FG000|Treated|Overall Study|32 of 33 participants treated. 1 participant not treated at the discretion of the investigator.|32
10648560|NCT02155322|11808511|FG000|COMPLETED|Overall Study||19
10648561|NCT02155322|11808511|FG000|NOT COMPLETED|Overall Study||14
10648562|NCT02155335|11808515|FG000|STARTED|Period 1||50
10648563|NCT02155335|11808516|FG001|STARTED|Period 1||50
10648564|NCT02155335|11808515|FG000|Treated|Period 1||50
10648565|NCT02155335|11808516|FG001|Treated|Period 1||49
10648566|NCT02155335|11808515|FG000|COMPLETED|Period 1||50
10648567|NCT02155335|11808516|FG001|COMPLETED|Period 1||49
10648568|NCT02155335|11808515|FG000|NOT COMPLETED|Period 1||0
10648569|NCT02155335|11808516|FG001|NOT COMPLETED|Period 1||1
10648570|NCT02155335|11808515|FG000|STARTED|Period 2||50
10648571|NCT02155335|11808516|FG001|STARTED|Period 2||49
10648572|NCT02155335|11808515|FG000|COMPLETED|Period 2||50
10648573|NCT02155335|11808516|FG001|COMPLETED|Period 2||49
10648574|NCT02155335|11808515|FG000|NOT COMPLETED|Period 2||0
10648575|NCT02155335|11808516|FG001|NOT COMPLETED|Period 2||0
10648576|NCT02155465|11808527|FG000|STARTED|Overall Study||3
10648577|NCT02155465|11808528|FG001|STARTED|Overall Study||3
10648578|NCT02155465|11808529|FG002|STARTED|Overall Study||6
10648579|NCT02155465|11808530|FG003|STARTED|Overall Study||2
10648580|NCT02155465|11808531|FG004|STARTED|Overall Study||1
10648581|NCT02155465|11808532|FG005|STARTED|Overall Study||2
10648582|NCT02155465|11808533|FG006|STARTED|Overall Study||5
10648583|NCT02155465|11808527|FG000|COMPLETED|Overall Study||3
10648584|NCT02155465|11808528|FG001|COMPLETED|Overall Study||3
10648585|NCT02155465|11808529|FG002|COMPLETED|Overall Study||6
10648586|NCT02155465|11808530|FG003|COMPLETED|Overall Study||2
10648587|NCT02155465|11808531|FG004|COMPLETED|Overall Study||1
10648588|NCT02155465|11808532|FG005|COMPLETED|Overall Study||2
10648589|NCT02155465|11808533|FG006|COMPLETED|Overall Study||5
10648590|NCT02155465|11808527|FG000|NOT COMPLETED|Overall Study||0
10648591|NCT02155465|11808528|FG001|NOT COMPLETED|Overall Study||0
10648592|NCT02155465|11808529|FG002|NOT COMPLETED|Overall Study||0
10648593|NCT02155465|11808530|FG003|NOT COMPLETED|Overall Study||0
10648594|NCT02155465|11808531|FG004|NOT COMPLETED|Overall Study||0
10648595|NCT02155465|11808532|FG005|NOT COMPLETED|Overall Study||0
10648596|NCT02155465|11808533|FG006|NOT COMPLETED|Overall Study||0
10648597|NCT02155543|11808559|FG000|STARTED|Overall Study||9
10648598|NCT02155543|11808560|FG001|STARTED|Overall Study||9
10648599|NCT02155543|11808561|FG002|STARTED|Overall Study||9
10648600|NCT02155543|11808562|FG003|STARTED|Overall Study||9
10648601|NCT02155543|11808563|FG004|STARTED|Overall Study||3
10648602|NCT02155543|11808564|FG005|STARTED|Overall Study||3
10648603|NCT02155543|11808565|FG006|STARTED|Overall Study||9
10648604|NCT02155543|11808559|FG000|COMPLETED|Overall Study||9
10648605|NCT02155543|11808560|FG001|COMPLETED|Overall Study||9
10648606|NCT02155543|11808561|FG002|COMPLETED|Overall Study||9
10648607|NCT02155543|11808562|FG003|COMPLETED|Overall Study||9
10648608|NCT02155543|11808563|FG004|COMPLETED|Overall Study||3
10648609|NCT02155543|11808564|FG005|COMPLETED|Overall Study||3
10648610|NCT02155543|11808565|FG006|COMPLETED|Overall Study||9
10648611|NCT02155543|11808559|FG000|NOT COMPLETED|Overall Study||0
10648612|NCT02155543|11808560|FG001|NOT COMPLETED|Overall Study||0
10648613|NCT02155543|11808561|FG002|NOT COMPLETED|Overall Study||0
10648614|NCT02155543|11808562|FG003|NOT COMPLETED|Overall Study||0
10648615|NCT02155543|11808563|FG004|NOT COMPLETED|Overall Study||0
10648616|NCT02155543|11808564|FG005|NOT COMPLETED|Overall Study||0
10648617|NCT02155543|11808565|FG006|NOT COMPLETED|Overall Study||0
10648618|NCT02155608|11808580|FG000|STARTED|1a: 4 Week Double Blind Sham Controlled||32
10648619|NCT02155608|11808581|FG001|STARTED|1a: 4 Week Double Blind Sham Controlled||30
10648620|NCT02155608|11808580|FG000|COMPLETED|1a: 4 Week Double Blind Sham Controlled||32
10648621|NCT02155608|11808581|FG001|COMPLETED|1a: 4 Week Double Blind Sham Controlled||29
10648622|NCT02155608|11808580|FG000|NOT COMPLETED|1a: 4 Week Double Blind Sham Controlled||0
10648623|NCT02155608|11808581|FG001|NOT COMPLETED|1a: 4 Week Double Blind Sham Controlled||1
10648624|NCT02155608|11808580|FG000|STARTED|1b: 1 Week Blinded Post Treatment||32
10648625|NCT02155608|11808581|FG001|STARTED|1b: 1 Week Blinded Post Treatment||29
10648626|NCT02155608|11808580|FG000|COMPLETED|1b: 1 Week Blinded Post Treatment||31
10648627|NCT02155608|11808581|FG001|COMPLETED|1b: 1 Week Blinded Post Treatment||28
10648628|NCT02155608|11808580|FG000|NOT COMPLETED|1b: 1 Week Blinded Post Treatment||1
10648629|NCT02155608|11808581|FG001|NOT COMPLETED|1b: 1 Week Blinded Post Treatment||1
10648630|NCT02155660|11808597|FG000|STARTED|Overall Study||562
10648631|NCT02155660|11808598|FG001|STARTED|Overall Study||562
10648632|NCT02155660|11808599|FG002|STARTED|Overall Study||562
10648633|NCT02155660|11808600|FG003|STARTED|Overall Study||568
10648634|NCT02155660|11808597|FG000|COMPLETED|Overall Study||504
10648635|NCT02155660|11808598|FG001|COMPLETED|Overall Study||489
10648636|NCT02155660|11808599|FG002|COMPLETED|Overall Study||502
10648637|NCT02155660|11808600|FG003|COMPLETED|Overall Study||507
10648638|NCT02155660|11808597|FG000|NOT COMPLETED|Overall Study||58
10648639|NCT02155660|11808598|FG001|NOT COMPLETED|Overall Study||73
10648640|NCT02155660|11808599|FG002|NOT COMPLETED|Overall Study||60
10648641|NCT02155660|11808600|FG003|NOT COMPLETED|Overall Study||61
10648654|NCT02155725|11808621|FG000|STARTED|Treatment Period||224
10648655|NCT02155725|11808622|FG001|STARTED|Treatment Period||213
10648656|NCT02155725|11808621|FG000|COMPLETED|Treatment Period||224
10648657|NCT02155725|11808622|FG001|COMPLETED|Treatment Period||213
10648658|NCT02155725|11808621|FG000|NOT COMPLETED|Treatment Period||0
10648659|NCT02155725|11808622|FG001|NOT COMPLETED|Treatment Period||0
10648660|NCT02155725|11808621|FG000|STARTED|Follow-up Period||224
10648661|NCT02155725|11808622|FG001|STARTED|Follow-up Period||213
10648662|NCT02155725|11808621|FG000|COMPLETED|Follow-up Period||207
10648663|NCT02155725|11808622|FG001|COMPLETED|Follow-up Period||202
10648664|NCT02155725|11808621|FG000|NOT COMPLETED|Follow-up Period||17
10648665|NCT02155725|11808622|FG001|NOT COMPLETED|Follow-up Period||11
10648666|NCT02155738|11808638|FG000|STARTED|Overall Study||50
10648667|NCT02155738|11808639|FG001|STARTED|Overall Study||52
10648668|NCT02155738|11808640|FG002|STARTED|Overall Study||51
10648669|NCT02155738|11808641|FG003|STARTED|Overall Study||51
10648670|NCT02155738|11808638|FG000|COMPLETED|Overall Study||49
10648671|NCT02155738|11808639|FG001|COMPLETED|Overall Study||52
10648672|NCT02155738|11808640|FG002|COMPLETED|Overall Study||51
10648673|NCT02155738|11808641|FG003|COMPLETED|Overall Study||50
10648674|NCT02155738|11808638|FG000|NOT COMPLETED|Overall Study||1
10648675|NCT02155738|11808639|FG001|NOT COMPLETED|Overall Study||0
10648676|NCT02155738|11808640|FG002|NOT COMPLETED|Overall Study||0
10648677|NCT02155738|11808641|FG003|NOT COMPLETED|Overall Study||1
10648678|NCT02155829|11808653|FG000|STARTED|Overall Study||37
10648679|NCT02155829|11808654|FG001|STARTED|Overall Study||38
10648680|NCT02155829|11808653|FG000|COMPLETED|Overall Study||31
10648681|NCT02155829|11808654|FG001|COMPLETED|Overall Study||35
10648682|NCT02155829|11808653|FG000|NOT COMPLETED|Overall Study||6
10648683|NCT02155829|11808654|FG001|NOT COMPLETED|Overall Study||3
10648684|NCT02155881|11808663|FG000|STARTED|Overall Study||40
10648685|NCT02155881|11808664|FG001|STARTED|Overall Study||40
10648686|NCT02155881|11808663|FG000|COMPLETED|Overall Study||38
10648687|NCT02155881|11808664|FG001|COMPLETED|Overall Study||36
10648688|NCT02155881|11808663|FG000|NOT COMPLETED|Overall Study||2
10648689|NCT02155881|11808664|FG001|NOT COMPLETED|Overall Study||4
10648690|NCT02155985|11808673|FG000|STARTED|Overall Study||40
10648691|NCT02155985|11808674|FG001|STARTED|Overall Study||41
10648692|NCT02155985|11808675|FG002|STARTED|Overall Study||40
10648693|NCT02155985|11808673|FG000|COMPLETED|Overall Study||39
10648694|NCT02155985|11808674|FG001|COMPLETED|Overall Study||41
10648695|NCT02155985|11808675|FG002|COMPLETED|Overall Study||39
10648696|NCT02155985|11808673|FG000|NOT COMPLETED|Overall Study||1
10648697|NCT02155985|11808674|FG001|NOT COMPLETED|Overall Study||0
10648698|NCT02155985|11808675|FG002|NOT COMPLETED|Overall Study||1
10648699|NCT02156076|11808687|FG000|STARTED|Treatment Period||7
10648700|NCT02156076|11808688|FG001|STARTED|Treatment Period||7
10648701|NCT02156076|11808689|FG002|STARTED|Treatment Period||6
10648702|NCT02156076|11808690|FG003|STARTED|Treatment Period||6
10648703|NCT02156076|11808687|FG000|COMPLETED|Treatment Period||7
10648704|NCT02156076|11808688|FG001|COMPLETED|Treatment Period||5
10648705|NCT02156076|11808689|FG002|COMPLETED|Treatment Period||4
10648706|NCT02156076|11808690|FG003|COMPLETED|Treatment Period||4
10648707|NCT02156076|11808687|FG000|NOT COMPLETED|Treatment Period||0
10648708|NCT02156076|11808688|FG001|NOT COMPLETED|Treatment Period||2
10648709|NCT02156076|11808689|FG002|NOT COMPLETED|Treatment Period||2
10648710|NCT02156076|11808690|FG003|NOT COMPLETED|Treatment Period||2
10648711|NCT02156076|11808687|FG000|STARTED|Follow-up Period||7
10648712|NCT02156076|11808688|FG001|STARTED|Follow-up Period||5
10648713|NCT02156076|11808689|FG002|STARTED|Follow-up Period||4
10648714|NCT02156076|11808690|FG003|STARTED|Follow-up Period||4
10648715|NCT02156076|11808687|FG000|COMPLETED|Follow-up Period||6
10648716|NCT02156076|11808688|FG001|COMPLETED|Follow-up Period||5
10648717|NCT02156076|11808689|FG002|COMPLETED|Follow-up Period||4
10648718|NCT02156076|11808690|FG003|COMPLETED|Follow-up Period||4
10648719|NCT02156076|11808687|FG000|NOT COMPLETED|Follow-up Period||1
10648720|NCT02156076|11808688|FG001|NOT COMPLETED|Follow-up Period||0
10648721|NCT02156076|11808689|FG002|NOT COMPLETED|Follow-up Period||0
10648722|NCT02156076|11808690|FG003|NOT COMPLETED|Follow-up Period||0
10648723|NCT02156154|11808702|FG000|STARTED|Overall Study||291
10648724|NCT02156154|11808703|FG001|STARTED|Overall Study||289
10648725|NCT02156154|11808702|FG000|COMPLETED|Overall Study||287
10648726|NCT02156154|11808703|FG001|COMPLETED|Overall Study||283
10648727|NCT02156154|11808702|FG000|NOT COMPLETED|Overall Study||4
10648728|NCT02156154|11808703|FG001|NOT COMPLETED|Overall Study||6
10648729|NCT02156167|11808709|FG000|STARTED|Overall Study||15
10648730|NCT02156167|11808709|FG000|COMPLETED|Overall Study||15
10648731|NCT02156167|11808709|FG000|NOT COMPLETED|Overall Study||0
10648732|NCT02156258|11808716|FG000|STARTED|Overall Study||674
10648733|NCT02156258|11808717|FG001|STARTED|Overall Study||203
10648734|NCT02156258|11808718|FG002|STARTED|Overall Study||355
10648735|NCT02156258|11808716|FG000|COMPLETED|Overall Study||642
10648736|NCT02156258|11808717|FG001|COMPLETED|Overall Study||124
10648737|NCT02156258|11808718|FG002|COMPLETED|Overall Study||244
10648738|NCT02156258|11808716|FG000|NOT COMPLETED|Overall Study||32
10648739|NCT02156258|11808717|FG001|NOT COMPLETED|Overall Study||79
10648740|NCT02156258|11808718|FG002|NOT COMPLETED|Overall Study||111
10648741|NCT02156271|11808728|FG000|STARTED|Overall Study||26
10648742|NCT02156271|11808729|FG001|STARTED|Overall Study||13
10648743|NCT02156271|11808728|FG000|COMPLETED|Overall Study||22
10648744|NCT02156271|11808729|FG001|COMPLETED|Overall Study||10
10648745|NCT02156271|11808728|FG000|NOT COMPLETED|Overall Study||4
10648746|NCT02156271|11808729|FG001|NOT COMPLETED|Overall Study||3
10648747|NCT02156466|11808740|FG000|STARTED|Overall Study||8
10648748|NCT02156466|11808741|FG001|STARTED|Overall Study||8
10648749|NCT02156466|11808742|FG002|STARTED|Overall Study||8
10648750|NCT02156466|11808743|FG003|STARTED|Overall Study||9
10648751|NCT02156466|11808744|FG004|STARTED|Overall Study||8
10648752|NCT02156466|11808740|FG000|COMPLETED|Overall Study||8
10648753|NCT02156466|11808741|FG001|COMPLETED|Overall Study||8
10648754|NCT02156466|11808742|FG002|COMPLETED|Overall Study||7
10648755|NCT02156466|11808743|FG003|COMPLETED|Overall Study||7
10648756|NCT02156466|11808744|FG004|COMPLETED|Overall Study||8
10648757|NCT02156466|11808740|FG000|NOT COMPLETED|Overall Study||0
10648758|NCT02156466|11808741|FG001|NOT COMPLETED|Overall Study||0
10648759|NCT02156466|11808742|FG002|NOT COMPLETED|Overall Study||1
10648760|NCT02156466|11808743|FG003|NOT COMPLETED|Overall Study||2
10648761|NCT02156466|11808744|FG004|NOT COMPLETED|Overall Study||0
10648762|NCT02156492|11808768|FG000|STARTED|Period 1||16
10648763|NCT02156492|11808769|FG001|STARTED|Period 1||24
10648764|NCT02156492|11808770|FG002|STARTED|Period 1||22
10648765|NCT02156492|11808768|FG000|Received at Least One Dose of Study Drug|Period 1||16
10648766|NCT02156492|11808769|FG001|Received at Least One Dose of Study Drug|Period 1||24
10648767|NCT02156492|11808770|FG002|Received at Least One Dose of Study Drug|Period 1||22
10648768|NCT02156492|11808768|FG000|COMPLETED|Period 1||16
10648769|NCT02156492|11808769|FG001|COMPLETED|Period 1||23
10648770|NCT02156492|11808770|FG002|COMPLETED|Period 1||22
10648771|NCT02156492|11808768|FG000|NOT COMPLETED|Period 1||0
10648772|NCT02156492|11808769|FG001|NOT COMPLETED|Period 1||1
10648773|NCT02156492|11808770|FG002|NOT COMPLETED|Period 1||0
10648774|NCT02156492|11808768|FG000|STARTED|Period 2||16
10648775|NCT02156492|11808769|FG001|STARTED|Period 2||23
10648776|NCT02156492|11808770|FG002|STARTED|Period 2||22
10648777|NCT02156492|11808768|FG000|COMPLETED|Period 2||16
10648778|NCT02156492|11808769|FG001|COMPLETED|Period 2||23
10648779|NCT02156492|11808770|FG002|COMPLETED|Period 2||22
10648780|NCT02156492|11808768|FG000|NOT COMPLETED|Period 2||0
10648781|NCT02156492|11808769|FG001|NOT COMPLETED|Period 2||0
10648782|NCT02156492|11808770|FG002|NOT COMPLETED|Period 2||0
10648783|NCT02156492|11808768|FG000|STARTED|Period 3|Cohort A participated in Period 1 and Period 2 only.|0
10648784|NCT02156492|11808769|FG001|STARTED|Period 3||23
10648785|NCT02156492|11808770|FG002|STARTED|Period 3||22
10648786|NCT02156492|11808768|FG000|COMPLETED|Period 3||0
10648787|NCT02156492|11808769|FG001|COMPLETED|Period 3||22
10648788|NCT02156492|11808770|FG002|COMPLETED|Period 3||22
10648789|NCT02156492|11808768|FG000|NOT COMPLETED|Period 3||0
10648790|NCT02156492|11808769|FG001|NOT COMPLETED|Period 3||1
10648791|NCT02156492|11808770|FG002|NOT COMPLETED|Period 3||0
10648792|NCT02156674|11808788|FG000|STARTED|Overall Study||1
10648793|NCT02156674|11808788|FG000|COMPLETED|Overall Study||1
10648794|NCT02156674|11808788|FG000|NOT COMPLETED|Overall Study||0
10648795|NCT02156687|11808794|FG000|STARTED|Overall Study||30
10648796|NCT02156687|11808795|FG001|STARTED|Overall Study||29
10648797|NCT02156687|11808794|FG000|COMPLETED|Overall Study||20
10648798|NCT02156687|11808795|FG001|COMPLETED|Overall Study||24
10648799|NCT02156687|11808794|FG000|NOT COMPLETED|Overall Study||10
10648800|NCT02156687|11808795|FG001|NOT COMPLETED|Overall Study||5
10648801|NCT02156804|11808801|FG000|STARTED|Overall Study||1009
10648802|NCT02156804|11808801|FG000|COMPLETED|Overall Study||1008
10648803|NCT02156804|11808801|FG000|NOT COMPLETED|Overall Study||1
10648804|NCT02156908|11808807|FG000|STARTED|Overall Study||5
10648805|NCT02156908|11808808|FG001|STARTED|Overall Study||3
10648806|NCT02156908|11808807|FG000|COMPLETED|Overall Study||5
10648807|NCT02156908|11808808|FG001|COMPLETED|Overall Study||3
10648808|NCT02156908|11808807|FG000|NOT COMPLETED|Overall Study||0
10648809|NCT02156908|11808808|FG001|NOT COMPLETED|Overall Study||0
10648810|NCT02157103|11808815|FG000|STARTED|Overall Study||3
10648811|NCT02157103|11808815|FG000|COMPLETED|Overall Study||3
10648812|NCT02157103|11808815|FG000|NOT COMPLETED|Overall Study||0
10648813|NCT02157168|11808822|FG000|STARTED|Overall Study||746
10648814|NCT02157168|11808823|FG001|STARTED|Overall Study||159
10648815|NCT02157168|11808824|FG002|STARTED|Overall Study||1362
10648816|NCT02157168|11808822|FG000|COMPLETED|Overall Study||746
10648817|NCT02157168|11808823|FG001|COMPLETED|Overall Study||159
10648818|NCT02157168|11808824|FG002|COMPLETED|Overall Study||1362
10648819|NCT02157168|11808822|FG000|NOT COMPLETED|Overall Study||0
10648820|NCT02157168|11808823|FG001|NOT COMPLETED|Overall Study||0
10648821|NCT02157168|11808824|FG002|NOT COMPLETED|Overall Study||0
10648822|NCT02157298|11808837|FG000|STARTED|Overall Study||123
10648823|NCT02157298|11808838|FG001|STARTED|Overall Study||60
10648824|NCT02157298|11808837|FG000|COMPLETED|Overall Study||119
10648825|NCT02157298|11808838|FG001|COMPLETED|Overall Study||58
10648826|NCT02157298|11808837|FG000|NOT COMPLETED|Overall Study||4
10648827|NCT02157298|11808838|FG001|NOT COMPLETED|Overall Study||2
10648828|NCT02157376|11808846|FG000|STARTED|Overall Study||155
10648829|NCT02157376|11808847|FG001|STARTED|Overall Study||156
10648830|NCT02157376|11808846|FG000|COMPLETED|Overall Study||133
10648831|NCT02157376|11808847|FG001|COMPLETED|Overall Study||138
10648832|NCT02157376|11808846|FG000|NOT COMPLETED|Overall Study||22
10648833|NCT02157376|11808847|FG001|NOT COMPLETED|Overall Study||18
10648834|NCT02157506|11808858|FG000|STARTED|Overall Study||12
10648835|NCT02157506|11808859|FG001|STARTED|Overall Study||6
10648836|NCT02157506|11808860|FG002|STARTED|Overall Study||9
10648837|NCT02157506|11808861|FG003|STARTED|Overall Study||12
10648838|NCT02157506|11808862|FG004|STARTED|Overall Study||7
10648839|NCT02157506|11808858|FG000|COMPLETED|Overall Study||12
10648840|NCT02157506|11808859|FG001|COMPLETED|Overall Study||5
10648841|NCT02157506|11808860|FG002|COMPLETED|Overall Study||8
10648842|NCT02157506|11808861|FG003|COMPLETED|Overall Study||12
10648843|NCT02157506|11808862|FG004|COMPLETED|Overall Study||7
10648844|NCT02157506|11808858|FG000|NOT COMPLETED|Overall Study||0
10648845|NCT02157506|11808859|FG001|NOT COMPLETED|Overall Study||1
10648846|NCT02157506|11808860|FG002|NOT COMPLETED|Overall Study||1
10648847|NCT02157506|11808861|FG003|NOT COMPLETED|Overall Study||0
10648848|NCT02157506|11808862|FG004|NOT COMPLETED|Overall Study||0
10648849|NCT02157519|11808876|FG000|STARTED|Overall Study||91
10648850|NCT02157519|11808877|FG001|STARTED|Overall Study||90
10648851|NCT02157519|11808876|FG000|MEMScap Collected|Overall Study||84
10648852|NCT02157519|11808877|FG001|MEMScap Collected|Overall Study||86
10648853|NCT02157519|11808876|FG000|COMPLETED|Overall Study||80
10648854|NCT02157519|11808877|FG001|COMPLETED|Overall Study||89
10648855|NCT02157519|11808876|FG000|NOT COMPLETED|Overall Study||11
10648856|NCT02157519|11808877|FG001|NOT COMPLETED|Overall Study||1
10648857|NCT02157623|11808883|FG000|STARTED|Overall Study|3 patients, each received red light on half of body and blue light on the contralateral side.|3
10648858|NCT02157623|11808883|FG000|COMPLETED|Overall Study||3
10648859|NCT02157623|11808883|FG000|NOT COMPLETED|Overall Study||0
10648860|NCT02157779|11808895|FG000|STARTED|Overall Study||47
10648861|NCT02157779|11808896|FG001|STARTED|Overall Study||45
10648862|NCT02157779|11808895|FG000|COMPLETED|Overall Study||23
10648863|NCT02157779|11808896|FG001|COMPLETED|Overall Study||34
10648864|NCT02157779|11808895|FG000|NOT COMPLETED|Overall Study||24
10648865|NCT02157779|11808896|FG001|NOT COMPLETED|Overall Study||11
10648866|NCT02157909|11808907|FG000|STARTED|Overall Study||66
10648867|NCT02157909|11808908|FG001|STARTED|Overall Study||66
10648868|NCT02157909|11808907|FG000|COMPLETED|Overall Study||66
10648869|NCT02157909|11808908|FG001|COMPLETED|Overall Study||66
10648870|NCT02157909|11808907|FG000|NOT COMPLETED|Overall Study||0
10648871|NCT02157909|11808908|FG001|NOT COMPLETED|Overall Study||0
10648872|NCT02157935|11808917|FG000|STARTED|Overall Study||606
10648873|NCT02157935|11808918|FG001|STARTED|Overall Study||613
10648874|NCT02157935|11808917|FG000|COMPLETED|Overall Study||567
10648875|NCT02157935|11808918|FG001|COMPLETED|Overall Study||548
10648876|NCT02157935|11808917|FG000|NOT COMPLETED|Overall Study||39
10648877|NCT02157935|11808918|FG001|NOT COMPLETED|Overall Study||65
10648878|NCT02157948|11808926|FG000|STARTED|Overall Study||197
10648879|NCT02157948|11808927|FG001|STARTED|Overall Study||197
10648880|NCT02157948|11808926|FG000|Received Treatment|Overall Study||196
10648881|NCT02157948|11808927|FG001|Received Treatment|Overall Study||196
10648882|NCT02157948|11808926|FG000|COMPLETED|Overall Study||188
10648883|NCT02157948|11808927|FG001|COMPLETED|Overall Study||188
10648884|NCT02157948|11808926|FG000|NOT COMPLETED|Overall Study||9
10648885|NCT02157948|11808927|FG001|NOT COMPLETED|Overall Study||9
10648886|NCT02158039|11808933|FG000|STARTED|Overall Study||33
10648887|NCT02158039|11808933|FG000|COMPLETED|Overall Study||23
10648888|NCT02158039|11808933|FG000|NOT COMPLETED|Overall Study||10
10648889|NCT02158247|11808939|FG000|STARTED|Overall Study||181
10648890|NCT02158247|11808939|FG000|COMPLETED|Overall Study||176
10648891|NCT02158247|11808939|FG000|NOT COMPLETED|Overall Study||5
10648892|NCT02158273|11808957|FG000|STARTED|Overall Study||25
10648893|NCT02158273|11808958|FG001|STARTED|Overall Study||25
10648894|NCT02158273|11808957|FG000|COMPLETED|Overall Study||22
10648895|NCT02158273|11808958|FG001|COMPLETED|Overall Study||22
10648896|NCT02158273|11808957|FG000|NOT COMPLETED|Overall Study||3
10648897|NCT02158273|11808958|FG001|NOT COMPLETED|Overall Study||3
10648898|NCT02158364|11808964|FG000|STARTED|Overall Study||3331
10648899|NCT02158364|11808964|FG000|COMPLETED|Overall Study||3271
10648900|NCT02158364|11808964|FG000|NOT COMPLETED|Overall Study||60
10648901|NCT02158442|11808970|FG000|STARTED|Overall Study||8
10809243|NCT03835975|11971160|FG003|STARTED|Overall Study||127
10809244|NCT03835975|11971161|FG004|STARTED|Overall Study||125
10809245|NCT03835975|11971157|FG000|Vaccinated|Overall Study||253
10809246|NCT03835975|11971158|FG001|Vaccinated|Overall Study||122
10809247|NCT03835975|11971159|FG002|Vaccinated|Overall Study||246
10809248|NCT03835975|11971160|FG003|Vaccinated|Overall Study||127
10809249|NCT03835975|11971161|FG004|Vaccinated|Overall Study||125
10809250|NCT03835975|11971157|FG000|Safety Population|Overall Study||253
10809251|NCT03835975|11971158|FG001|Safety Population|Overall Study||122
10809252|NCT03835975|11971159|FG002|Safety Population|Overall Study||246
10809253|NCT03835975|11971160|FG003|Safety Population|Overall Study||127
10809254|NCT03835975|11971161|FG004|Safety Population|Overall Study||125
10809255|NCT03835975|11971157|FG000|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||247
10648902|NCT02158442|11808971|FG001|STARTED|Overall Study||7
10648903|NCT02158442|11808970|FG000|COMPLETED|Overall Study||6
10648904|NCT02158442|11808971|FG001|COMPLETED|Overall Study||7
10648905|NCT02158442|11808970|FG000|NOT COMPLETED|Overall Study||2
10648906|NCT02158442|11808971|FG001|NOT COMPLETED|Overall Study||0
10654426|NCT02202785|11815201|FG002|COMPLETED|Overall Study||0
10654427|NCT02202785|11815199|FG000|NOT COMPLETED|Overall Study||11
10654428|NCT02202785|11815200|FG001|NOT COMPLETED|Overall Study||15
10654429|NCT02202785|11815201|FG002|NOT COMPLETED|Overall Study||17
10654430|NCT02202837|11815211|FG000|STARTED|Overall Study||140
10654431|NCT02202837|11815212|FG001|STARTED|Overall Study||17
10654432|NCT02202837|11815211|FG000|COMPLETED|Overall Study||87
10654433|NCT02202837|11815212|FG001|COMPLETED|Overall Study||12
10654434|NCT02202837|11815211|FG000|NOT COMPLETED|Overall Study||53
10654435|NCT02202837|11815212|FG001|NOT COMPLETED|Overall Study||5
10654436|NCT02202850|11815220|FG000|STARTED|Overall Study||70
10654437|NCT02202850|11815221|FG001|STARTED|Overall Study||14
10654438|NCT02202850|11815220|FG000|COMPLETED|Overall Study||46
10654439|NCT02202850|11815221|FG001|COMPLETED|Overall Study||8
10654440|NCT02202850|11815220|FG000|NOT COMPLETED|Overall Study||24
10654441|NCT02202850|11815221|FG001|NOT COMPLETED|Overall Study||6
10654442|NCT02202980|11815241|FG000|STARTED|Overall Study||14
10654443|NCT02202980|11815242|FG001|STARTED|Overall Study||26
10654444|NCT02202980|11815243|FG002|STARTED|Overall Study||27
10654445|NCT02202980|11815244|FG003|STARTED|Overall Study||32
10654446|NCT02202980|11815245|FG004|STARTED|Overall Study||13
10648907|NCT02158494|11808979|FG000|STARTED|Overall Study||22
10648908|NCT02158494|11808980|FG001|STARTED|Overall Study||22
10648909|NCT02158494|11808979|FG000|COMPLETED|Overall Study||22
10648910|NCT02158494|11808980|FG001|COMPLETED|Overall Study||21
10648911|NCT02158494|11808979|FG000|NOT COMPLETED|Overall Study||0
10648912|NCT02158494|11808980|FG001|NOT COMPLETED|Overall Study||1
10648913|NCT02158520|11808993|FG000|STARTED|Overall Study||12
10648914|NCT02158520|11808994|FG001|STARTED|Overall Study||12
10648915|NCT02158520|11808993|FG000|AE Evaluated Prior to Crossover|Overall Study||12
10648916|NCT02158520|11808994|FG001|AE Evaluated Prior to Crossover|Overall Study||12
10706297|NCT02607800|11870872|FG001|STARTED|Overall Study||441
10706298|NCT02607800|11870871|FG000|COMPLETED|Overall Study||492
10706299|NCT02607800|11870872|FG001|COMPLETED|Overall Study||430
10648917|NCT02158520|11808993|FG000|Eligible for Crossover|Overall Study||8
10648918|NCT02158520|11808994|FG001|Eligible for Crossover|Overall Study||8
10648919|NCT02158520|11808993|FG000|Eligible for Crossover With AE Evaluated|Overall Study||7
10648920|NCT02158520|11808994|FG001|Eligible for Crossover With AE Evaluated|Overall Study||7
10648921|NCT02158520|11808993|FG000|Crossover Cohort|Overall Study||4
10648922|NCT02158520|11808994|FG001|Crossover Cohort|Overall Study||6
10648923|NCT02158520|11808993|FG000|COMPLETED|Overall Study||12
10648924|NCT02158520|11808994|FG001|COMPLETED|Overall Study||12
10648925|NCT02158520|11808993|FG000|NOT COMPLETED|Overall Study||0
10648926|NCT02158520|11808994|FG001|NOT COMPLETED|Overall Study||0
10648927|NCT02158533|11809005|FG000|STARTED|Stage 1||265
10648928|NCT02158533|11809006|FG001|STARTED|Stage 1||59
10648929|NCT02158533|11809007|FG002|STARTED|Stage 1||60
10648930|NCT02158533|11809008|FG003|STARTED|Stage 1||0
10648931|NCT02158533|11809009|FG004|STARTED|Stage 1||0
10648932|NCT02158533|11809010|FG005|STARTED|Stage 1||0
10648933|NCT02158533|11809005|FG000|COMPLETED|Stage 1||251
10648934|NCT02158533|11809006|FG001|COMPLETED|Stage 1||51
10648935|NCT02158533|11809007|FG002|COMPLETED|Stage 1||52
10648936|NCT02158533|11809008|FG003|COMPLETED|Stage 1||0
10648937|NCT02158533|11809009|FG004|COMPLETED|Stage 1||0
10648938|NCT02158533|11809010|FG005|COMPLETED|Stage 1||0
10648939|NCT02158533|11809005|FG000|NOT COMPLETED|Stage 1||14
10648940|NCT02158533|11809006|FG001|NOT COMPLETED|Stage 1||8
10648941|NCT02158533|11809007|FG002|NOT COMPLETED|Stage 1||8
10648942|NCT02158533|11809008|FG003|NOT COMPLETED|Stage 1||0
10648943|NCT02158533|11809009|FG004|NOT COMPLETED|Stage 1||0
10648944|NCT02158533|11809010|FG005|NOT COMPLETED|Stage 1||0
10648945|NCT02158533|11809005|FG000|STARTED|Stage 2||0
10648946|NCT02158533|11809006|FG001|STARTED|Stage 2||0
10648947|NCT02158533|11809007|FG002|STARTED|Stage 2||0
10648948|NCT02158533|11809008|FG003|STARTED|Stage 2||56
10648949|NCT02158533|11809009|FG004|STARTED|Stage 2||56
10648950|NCT02158533|11809010|FG005|STARTED|Stage 2||56
10648951|NCT02158533|11809005|FG000|COMPLETED|Stage 2||0
10648952|NCT02158533|11809006|FG001|COMPLETED|Stage 2||0
10648953|NCT02158533|11809007|FG002|COMPLETED|Stage 2||0
10706300|NCT02607800|11870871|FG000|NOT COMPLETED|Overall Study||10
10648954|NCT02158533|11809008|FG003|COMPLETED|Stage 2||53
10648955|NCT02158533|11809009|FG004|COMPLETED|Stage 2||52
10648956|NCT02158533|11809010|FG005|COMPLETED|Stage 2||50
10648957|NCT02158533|11809005|FG000|NOT COMPLETED|Stage 2||0
10648958|NCT02158533|11809006|FG001|NOT COMPLETED|Stage 2||0
10648959|NCT02158533|11809007|FG002|NOT COMPLETED|Stage 2||0
10648960|NCT02158533|11809008|FG003|NOT COMPLETED|Stage 2||3
10648961|NCT02158533|11809009|FG004|NOT COMPLETED|Stage 2||4
10648962|NCT02158533|11809010|FG005|NOT COMPLETED|Stage 2||6
10648963|NCT02158546|11809028|FG000|STARTED|Overall Study||152
10648964|NCT02158546|11809029|FG001|STARTED|Overall Study||153
10648965|NCT02158546|11809030|FG002|STARTED|Overall Study||18
10648966|NCT02158546|11809031|FG003|STARTED|Overall Study||19
10648967|NCT02158546|11809028|FG000|COMPLETED|Overall Study||133
10648968|NCT02158546|11809029|FG001|COMPLETED|Overall Study||136
10648969|NCT02158546|11809030|FG002|COMPLETED|Overall Study||14
10648970|NCT02158546|11809031|FG003|COMPLETED|Overall Study||13
10648971|NCT02158546|11809028|FG000|NOT COMPLETED|Overall Study||19
10648972|NCT02158546|11809029|FG001|NOT COMPLETED|Overall Study||17
10648973|NCT02158546|11809030|FG002|NOT COMPLETED|Overall Study||4
10648974|NCT02158546|11809031|FG003|NOT COMPLETED|Overall Study||6
10648975|NCT02158572|11809041|FG000|STARTED|Overall Study||2032
10648976|NCT02158572|11809041|FG000|COMPLETED|Overall Study||989
10648977|NCT02158572|11809041|FG000|NOT COMPLETED|Overall Study||1043
10648978|NCT02158663|11809047|FG000|STARTED|Overall Study||22
10648979|NCT02158663|11809048|FG001|STARTED|Overall Study||22
10648980|NCT02158663|11809047|FG000|COMPLETED|Overall Study||17
10648981|NCT02158663|11809048|FG001|COMPLETED|Overall Study||18
10648982|NCT02158663|11809047|FG000|NOT COMPLETED|Overall Study||5
10648983|NCT02158663|11809048|FG001|NOT COMPLETED|Overall Study||4
10648984|NCT02158728|11809056|FG000|STARTED|Overall Study||80
10648985|NCT02158728|11809056|FG000|COMPLETED|Overall Study||53
10648986|NCT02158728|11809056|FG000|NOT COMPLETED|Overall Study||27
10648987|NCT02158806|11809062|FG000|STARTED|Overall Study||125
10648988|NCT02158806|11809063|FG001|STARTED|Overall Study||126
10648989|NCT02158806|11809062|FG000|COMPLETED|Overall Study|We had information on all participants for the primary outcome (time to complete healing).|121
10648990|NCT02158806|11809063|FG001|COMPLETED|Overall Study|We had information on all participants for the primary outcome (time to complete healing).|121
10648991|NCT02158806|11809062|FG000|NOT COMPLETED|Overall Study||4
10648992|NCT02158806|11809063|FG001|NOT COMPLETED|Overall Study||5
10648993|NCT02158884|11809069|FG000|STARTED|Baseline Assessment||91
10648994|NCT02158884|11809069|FG000|COMPLETED|Baseline Assessment||87
10648995|NCT02158884|11809069|FG000|NOT COMPLETED|Baseline Assessment||4
10648996|NCT02158884|11809069|FG000|STARTED|Intervention: IDEO and PT Program||87
10648997|NCT02158884|11809069|FG000|COMPLETED|Intervention: IDEO and PT Program||81
10648998|NCT02158884|11809069|FG000|NOT COMPLETED|Intervention: IDEO and PT Program||6
10648999|NCT02158884|11809069|FG000|STARTED|Post Intervention (~4 Weeks)||81
10649000|NCT02158884|11809069|FG000|COMPLETED|Post Intervention (~4 Weeks)||71
10649001|NCT02158884|11809069|FG000|NOT COMPLETED|Post Intervention (~4 Weeks)||10
10649002|NCT02158884|11809069|FG000|STARTED|6 Month Assessment||81
10649003|NCT02158884|11809069|FG000|COMPLETED|6 Month Assessment||61
10649004|NCT02158884|11809069|FG000|NOT COMPLETED|6 Month Assessment||20
10649005|NCT02158884|11809069|FG000|STARTED|12 Month Assessment||81
10649006|NCT02158884|11809069|FG000|COMPLETED|12 Month Assessment||64
10649007|NCT02158884|11809069|FG000|NOT COMPLETED|12 Month Assessment||17
10649008|NCT02158936|11809076|FG000|STARTED|Overall Study||179
10649009|NCT02158936|11809077|FG001|STARTED|Overall Study||177
10649010|NCT02158936|11809076|FG000|Treated|Overall Study||177
10649011|NCT02158936|11809077|FG001|Treated|Overall Study||177
10649012|NCT02158936|11809076|FG000|Untreated|Overall Study||2
10649013|NCT02158936|11809077|FG001|Untreated|Overall Study||0
10649014|NCT02158936|11809076|FG000|COMPLETED|Overall Study||0
10649015|NCT02158936|11809077|FG001|COMPLETED|Overall Study||0
10649016|NCT02158936|11809076|FG000|NOT COMPLETED|Overall Study||179
10649017|NCT02158936|11809077|FG001|NOT COMPLETED|Overall Study||177
10649018|NCT02158949|11809085|FG000|STARTED|Overall Study||24
10649019|NCT02158949|11809086|FG001|STARTED|Overall Study||24
10649020|NCT02158949|11809085|FG000|COMPLETED|Overall Study||18
10649021|NCT02158949|11809086|FG001|COMPLETED|Overall Study||13
10649022|NCT02158949|11809085|FG000|NOT COMPLETED|Overall Study||6
10649023|NCT02158949|11809086|FG001|NOT COMPLETED|Overall Study||11
10649024|NCT02158975|11809092|FG000|STARTED|Overall Study||13
10649025|NCT02158975|11809092|FG000|COMPLETED|Overall Study||12
10649026|NCT02158975|11809092|FG000|NOT COMPLETED|Overall Study||1
10649027|NCT02159053|11809100|FG000|STARTED|Overall Study||116
10649028|NCT02159053|11809101|FG001|STARTED|Overall Study||117
10649029|NCT02159053|11809102|FG002|STARTED|Overall Study||117
10649030|NCT02159053|11809100|FG000|Paticipants Week 16 Onwards|Overall Study||116
10649031|NCT02159053|11809101|FG001|Paticipants Week 16 Onwards|Overall Study||117
10649032|NCT02159053|11809102|FG002|Paticipants Week 16 Onwards|Overall Study||113
10649033|NCT02159053|11809100|FG000|COMPLETED|Overall Study||96
10649034|NCT02159053|11809101|FG001|COMPLETED|Overall Study||96
10649035|NCT02159053|11809102|FG002|COMPLETED|Overall Study||97
10649036|NCT02159053|11809100|FG000|NOT COMPLETED|Overall Study||20
10649037|NCT02159053|11809101|FG001|NOT COMPLETED|Overall Study||21
10649038|NCT02159053|11809102|FG002|NOT COMPLETED|Overall Study||20
10649039|NCT02159079|11809114|FG000|STARTED|Overall Study||15
10649040|NCT02159079|11809115|FG001|STARTED|Overall Study||15
10649041|NCT02159079|11809114|FG000|COMPLETED|Overall Study||15
10649042|NCT02159079|11809115|FG001|COMPLETED|Overall Study||15
10649043|NCT02159079|11809114|FG000|NOT COMPLETED|Overall Study||0
10649044|NCT02159079|11809115|FG001|NOT COMPLETED|Overall Study||0
10649045|NCT02159118|11809123|FG000|STARTED|Overall Study||22
10649046|NCT02159118|11809124|FG001|STARTED|Overall Study||22
10649047|NCT02159118|11809123|FG000|COMPLETED|Overall Study||22
10649048|NCT02159118|11809124|FG001|COMPLETED|Overall Study||22
10649049|NCT02159118|11809123|FG000|NOT COMPLETED|Overall Study||0
10649050|NCT02159118|11809124|FG001|NOT COMPLETED|Overall Study||0
10649051|NCT02159183|11809132|FG000|STARTED|Analysis After the 36 Months Follow-up||22
10649052|NCT02159183|11809133|FG001|STARTED|Analysis After the 36 Months Follow-up||21
10649053|NCT02159183|11809132|FG000|COMPLETED|Analysis After the 36 Months Follow-up||19
10649054|NCT02159183|11809133|FG001|COMPLETED|Analysis After the 36 Months Follow-up||19
10649055|NCT02159183|11809132|FG000|NOT COMPLETED|Analysis After the 36 Months Follow-up||3
10649056|NCT02159183|11809133|FG001|NOT COMPLETED|Analysis After the 36 Months Follow-up||2
10649057|NCT02159183|11809132|FG000|STARTED|Analysis of Primary Endpoint (12 Mts)||22
10649058|NCT02159183|11809133|FG001|STARTED|Analysis of Primary Endpoint (12 Mts)||21
10649059|NCT02159183|11809132|FG000|COMPLETED|Analysis of Primary Endpoint (12 Mts)||19
10649060|NCT02159183|11809133|FG001|COMPLETED|Analysis of Primary Endpoint (12 Mts)||20
10649061|NCT02159183|11809132|FG000|NOT COMPLETED|Analysis of Primary Endpoint (12 Mts)||3
10649062|NCT02159183|11809133|FG001|NOT COMPLETED|Analysis of Primary Endpoint (12 Mts)||1
10649063|NCT02159352|11809141|FG000|STARTED|Overall Study||14
10649064|NCT02159352|11809142|FG001|STARTED|Overall Study||14
10649065|NCT02159352|11809141|FG000|Phase 1 (Day 1- 4)|Overall Study||14
10706301|NCT02607800|11870872|FG001|NOT COMPLETED|Overall Study||11
10649066|NCT02159352|11809142|FG001|Phase 1 (Day 1- 4)|Overall Study||14
10649067|NCT02159352|11809141|FG000|Phase 2 (Day 5-14)|Overall Study||11
10649068|NCT02159352|11809142|FG001|Phase 2 (Day 5-14)|Overall Study||12
10649069|NCT02159352|11809141|FG000|COMPLETED|Overall Study||11
10649070|NCT02159352|11809142|FG001|COMPLETED|Overall Study||12
10649071|NCT02159352|11809141|FG000|NOT COMPLETED|Overall Study||3
10649072|NCT02159352|11809142|FG001|NOT COMPLETED|Overall Study||2
10649073|NCT02159365|11809167|FG000|STARTED|Overall Study||70
10649074|NCT02159365|11809167|FG000|COMPLETED|Overall Study|Completed = Still on treatment|0
10649075|NCT02159365|11809167|FG000|NOT COMPLETED|Overall Study||70
10649076|NCT02159469|11809171|FG000|STARTED|Overall Study||150
10649077|NCT02159469|11809171|FG000|Completed 12 Week|Overall Study||137
10649078|NCT02159469|11809171|FG000|COMPLETED|Overall Study||97
10649079|NCT02159469|11809171|FG000|NOT COMPLETED|Overall Study||53
10649080|NCT02159482|11809176|FG000|STARTED|Overall Study||11
10649081|NCT02159482|11809176|FG000|COMPLETED|Overall Study||6
10649082|NCT02159482|11809176|FG000|NOT COMPLETED|Overall Study||5
10649083|NCT02159521|11809180|FG000|STARTED|Overall Study|4 participants had both limbs treated.|81
10649084|NCT02159521|11809180|FG000|Received EkoSonic® Treatment|Overall Study||78
10649085|NCT02159521|11809180|FG000|COMPLETED|Overall Study||63
10649086|NCT02159521|11809180|FG000|NOT COMPLETED|Overall Study||18
10649087|NCT02159547|11809186|FG000|STARTED|Overall Study||112
10649088|NCT02159547|11809187|FG001|STARTED|Overall Study||112
10649089|NCT02159547|11809186|FG000|COMPLETED|Overall Study||112
10649090|NCT02159547|11809187|FG001|COMPLETED|Overall Study||112
10649091|NCT02159547|11809186|FG000|NOT COMPLETED|Overall Study||0
10649092|NCT02159547|11809187|FG001|NOT COMPLETED|Overall Study||0
10649093|NCT02159703|11809194|FG000|STARTED|Overall Study||60
10649094|NCT02159703|11809194|FG000|COMPLETED|Overall Study||60
10649095|NCT02159703|11809194|FG000|NOT COMPLETED|Overall Study||0
10649096|NCT02159729|11809200|FG000|STARTED|Overall Study||140
10649097|NCT02159729|11809201|FG001|STARTED|Overall Study||65
10649098|NCT02159729|11809200|FG000|COMPLETED|Overall Study||98
10649099|NCT02159729|11809201|FG001|COMPLETED|Overall Study||44
10649100|NCT02159729|11809200|FG000|NOT COMPLETED|Overall Study||42
10649101|NCT02159729|11809201|FG001|NOT COMPLETED|Overall Study||21
10649102|NCT02159768|11809207|FG000|STARTED|Overall Study|Started 16 July 2014|30
10649103|NCT02159768|11809207|FG000|COMPLETED|Overall Study|Completed 27 July 2015|30
10649104|NCT02159768|11809207|FG000|NOT COMPLETED|Overall Study||0
10649105|NCT02159807|11809214|FG000|STARTED|Overall Study||67
10649106|NCT02159807|11809215|FG001|STARTED|Overall Study||52
10649107|NCT02159807|11809216|FG002|STARTED|Overall Study||51
10649108|NCT02159807|11809214|FG000|COMPLETED|Overall Study||66
10649109|NCT02159807|11809215|FG001|COMPLETED|Overall Study||51
10649110|NCT02159807|11809216|FG002|COMPLETED|Overall Study||48
10649111|NCT02159807|11809214|FG000|NOT COMPLETED|Overall Study||1
10649112|NCT02159807|11809215|FG001|NOT COMPLETED|Overall Study||1
10649113|NCT02159807|11809216|FG002|NOT COMPLETED|Overall Study||3
10649114|NCT02159859|11809224|FG000|STARTED|Overall Study||7
10649115|NCT02159859|11809224|FG000|COMPLETED|Overall Study||7
10649116|NCT02159859|11809224|FG000|NOT COMPLETED|Overall Study||0
10649117|NCT02159872|11809228|FG000|STARTED|Overall Study||48
10649118|NCT02159872|11809228|FG000|COMPLETED|Overall Study||48
10649119|NCT02159872|11809228|FG000|NOT COMPLETED|Overall Study||0
10649120|NCT02159898|11809234|FG000|STARTED|Overall Study||30
10649121|NCT02159898|11809235|FG001|STARTED|Overall Study||30
10649122|NCT02159898|11809234|FG000|COMPLETED|Overall Study||29
10649123|NCT02159898|11809235|FG001|COMPLETED|Overall Study||30
10649124|NCT02159898|11809234|FG000|NOT COMPLETED|Overall Study||1
10649125|NCT02159898|11809235|FG001|NOT COMPLETED|Overall Study||0
10649126|NCT02159950|11809245|FG000|STARTED|Overall Study||0
10649127|NCT02159950|11809246|FG001|STARTED|Overall Study||2
10649128|NCT02159950|11809245|FG000|COMPLETED|Overall Study||0
10649129|NCT02159950|11809246|FG001|COMPLETED|Overall Study||0
10649130|NCT02159950|11809245|FG000|NOT COMPLETED|Overall Study||0
10649131|NCT02159950|11809246|FG001|NOT COMPLETED|Overall Study||2
10649132|NCT02159976|11809254|FG000|STARTED|Overall Study||195
10649133|NCT02159976|11809255|FG001|STARTED|Overall Study||195
10649134|NCT02159976|11809254|FG000|COMPLETED|Overall Study||165
10649135|NCT02159976|11809255|FG001|COMPLETED|Overall Study||170
10649136|NCT02159976|11809254|FG000|NOT COMPLETED|Overall Study||30
10649137|NCT02159976|11809255|FG001|NOT COMPLETED|Overall Study||25
10649138|NCT02160002|11809265|FG000|STARTED|Overall Study||187
10649139|NCT02160002|11809266|FG001|STARTED|Overall Study||179
10649140|NCT02160002|11809265|FG000|Primary Outcome|Overall Study||185
10649141|NCT02160002|11809266|FG001|Primary Outcome|Overall Study||178
10649142|NCT02160002|11809265|FG000|COMPLETED|Overall Study||185
10649143|NCT02160002|11809266|FG001|COMPLETED|Overall Study||178
10649144|NCT02160002|11809265|FG000|NOT COMPLETED|Overall Study||2
10649145|NCT02160002|11809266|FG001|NOT COMPLETED|Overall Study||1
10649146|NCT02160041|11809272|FG000|STARTED|Overall Study||84
10649147|NCT02160041|11809272|FG000|COMPLETED|Overall Study||0
10649148|NCT02160041|11809272|FG000|NOT COMPLETED|Overall Study||84
10649149|NCT02160145|11809278|FG000|STARTED|Prerandomization Single-blind Period||1519
10649150|NCT02160145|11809279|FG001|STARTED|Prerandomization Single-blind Period||0
10649151|NCT02160145|11809280|FG002|STARTED|Prerandomization Single-blind Period||0
10649152|NCT02160145|11809278|FG000|Treated in Placebo Run-in|Prerandomization Single-blind Period||1514
10649153|NCT02160145|11809279|FG001|Treated in Placebo Run-in|Prerandomization Single-blind Period||0
10649154|NCT02160145|11809280|FG002|Treated in Placebo Run-in|Prerandomization Single-blind Period||0
10649155|NCT02160145|11809278|FG000|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||1491
10649156|NCT02160145|11809279|FG001|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||0
10649157|NCT02160145|11809280|FG002|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||0
10649158|NCT02160145|11809278|FG000|Randomized|Prerandomization Single-blind Period||1370
10649159|NCT02160145|11809279|FG001|Randomized|Prerandomization Single-blind Period||0
10649160|NCT02160145|11809280|FG002|Randomized|Prerandomization Single-blind Period||0
10649161|NCT02160145|11809278|FG000|COMPLETED|Prerandomization Single-blind Period||1370
10649162|NCT02160145|11809279|FG001|COMPLETED|Prerandomization Single-blind Period||0
10649163|NCT02160145|11809280|FG002|COMPLETED|Prerandomization Single-blind Period||0
10649164|NCT02160145|11809278|FG000|NOT COMPLETED|Prerandomization Single-blind Period||149
10649165|NCT02160145|11809279|FG001|NOT COMPLETED|Prerandomization Single-blind Period||0
10649166|NCT02160145|11809280|FG002|NOT COMPLETED|Prerandomization Single-blind Period||0
10649167|NCT02160145|11809278|FG000|STARTED|Randomized Double-blind Period|1370 subjects were randomized to receive tolvaptan or placebo in the double-blind period.|0
10649168|NCT02160145|11809279|FG001|STARTED|Randomized Double-blind Period|Subjects completed the single-blind period and were randomized to receive tolvaptan.|683
10649169|NCT02160145|11809280|FG002|STARTED|Randomized Double-blind Period|Subjects completed the single-blind period and were randomized to receive placebo.|687
10649170|NCT02160145|11809278|FG000|On-treatment Completers|Randomized Double-blind Period||0
10649171|NCT02160145|11809279|FG001|On-treatment Completers|Randomized Double-blind Period||578
10649172|NCT02160145|11809280|FG002|On-treatment Completers|Randomized Double-blind Period||637
10649173|NCT02160145|11809278|FG000|Off-treatment Completers|Randomized Double-blind Period||0
10649174|NCT02160145|11809279|FG001|Off-treatment Completers|Randomized Double-blind Period||76
10649175|NCT02160145|11809280|FG002|Off-treatment Completers|Randomized Double-blind Period||22
10649176|NCT02160145|11809278|FG000|COMPLETED|Randomized Double-blind Period||0
10649177|NCT02160145|11809279|FG001|COMPLETED|Randomized Double-blind Period||654
10649178|NCT02160145|11809280|FG002|COMPLETED|Randomized Double-blind Period||659
10649179|NCT02160145|11809278|FG000|NOT COMPLETED|Randomized Double-blind Period||0
10649180|NCT02160145|11809279|FG001|NOT COMPLETED|Randomized Double-blind Period||29
10649181|NCT02160145|11809280|FG002|NOT COMPLETED|Randomized Double-blind Period||28
10649182|NCT02160288|11809289|FG000|STARTED|Overall Study||1
10649183|NCT02160288|11809290|FG001|STARTED|Overall Study||0
10649184|NCT02160288|11809289|FG000|COMPLETED|Overall Study||1
10649185|NCT02160288|11809290|FG001|COMPLETED|Overall Study||0
10649186|NCT02160288|11809289|FG000|NOT COMPLETED|Overall Study||0
10649187|NCT02160288|11809290|FG001|NOT COMPLETED|Overall Study||0
10649188|NCT02160314|11809298|FG000|STARTED|Overall Study||73
10649189|NCT02160314|11809299|FG001|STARTED|Overall Study||72
10649190|NCT02160314|11809298|FG000|COMPLETED|Overall Study||72
10649191|NCT02160314|11809299|FG001|COMPLETED|Overall Study||59
10649192|NCT02160314|11809298|FG000|NOT COMPLETED|Overall Study||1
10649193|NCT02160314|11809299|FG001|NOT COMPLETED|Overall Study||13
10649194|NCT02160535|11809305|FG000|STARTED|Overall Study||13
10649195|NCT02160535|11809305|FG000|COMPLETED|Overall Study||10
10649196|NCT02160535|11809305|FG000|NOT COMPLETED|Overall Study||3
10649197|NCT02160626|11809312|FG000|STARTED|Overall Study||58
10649198|NCT02160626|11809313|FG001|STARTED|Overall Study||57
10649199|NCT02160626|11809314|FG002|STARTED|Overall Study||57
10649200|NCT02160626|11809312|FG000|COMPLETED|Overall Study||57
10649201|NCT02160626|11809313|FG001|COMPLETED|Overall Study||56
10649202|NCT02160626|11809314|FG002|COMPLETED|Overall Study||56
10649203|NCT02160626|11809312|FG000|NOT COMPLETED|Overall Study||1
10649204|NCT02160626|11809313|FG001|NOT COMPLETED|Overall Study||1
10649205|NCT02160626|11809314|FG002|NOT COMPLETED|Overall Study||1
10649206|NCT02160730|11809324|FG000|STARTED|Overall Study||4
10649207|NCT02160730|11809324|FG000|COMPLETED|Overall Study||4
10649208|NCT02160730|11809324|FG000|NOT COMPLETED|Overall Study||0
10649209|NCT02160782|11809329|FG000|STARTED|Open-label Period: Maralixibat||31
10649210|NCT02160782|11809330|FG001|STARTED|Open-label Period: Maralixibat||0
10649211|NCT02160782|11809331|FG002|STARTED|Open-label Period: Maralixibat||0
10649212|NCT02160782|11809332|FG003|STARTED|Open-label Period: Maralixibat||0
10649213|NCT02160782|11809333|FG004|STARTED|Open-label Period: Maralixibat||0
10649214|NCT02160782|11809329|FG000|COMPLETED|Open-label Period: Maralixibat||29
10649215|NCT02160782|11809330|FG001|COMPLETED|Open-label Period: Maralixibat||0
10649216|NCT02160782|11809331|FG002|COMPLETED|Open-label Period: Maralixibat||0
10649217|NCT02160782|11809332|FG003|COMPLETED|Open-label Period: Maralixibat||0
10649218|NCT02160782|11809333|FG004|COMPLETED|Open-label Period: Maralixibat||0
10649219|NCT02160782|11809329|FG000|NOT COMPLETED|Open-label Period: Maralixibat||2
10649220|NCT02160782|11809330|FG001|NOT COMPLETED|Open-label Period: Maralixibat||0
10649221|NCT02160782|11809331|FG002|NOT COMPLETED|Open-label Period: Maralixibat||0
10649222|NCT02160782|11809332|FG003|NOT COMPLETED|Open-label Period: Maralixibat||0
10649223|NCT02160782|11809333|FG004|NOT COMPLETED|Open-label Period: Maralixibat||0
10649224|NCT02160782|11809329|FG000|STARTED|Randomized Withdrawal Period- Pbo vs MRX||0
10649225|NCT02160782|11809330|FG001|STARTED|Randomized Withdrawal Period- Pbo vs MRX||13
10649226|NCT02160782|11809331|FG002|STARTED|Randomized Withdrawal Period- Pbo vs MRX||16
10649227|NCT02160782|11809332|FG003|STARTED|Randomized Withdrawal Period- Pbo vs MRX||0
10649228|NCT02160782|11809333|FG004|STARTED|Randomized Withdrawal Period- Pbo vs MRX||0
10649229|NCT02160782|11809329|FG000|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
10649230|NCT02160782|11809330|FG001|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||13
10649231|NCT02160782|11809331|FG002|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||16
10649232|NCT02160782|11809332|FG003|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
10649233|NCT02160782|11809333|FG004|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
10649234|NCT02160782|11809329|FG000|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
10649235|NCT02160782|11809330|FG001|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
10649236|NCT02160782|11809331|FG002|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
10649237|NCT02160782|11809332|FG003|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
10649238|NCT02160782|11809333|FG004|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
10649239|NCT02160782|11809329|FG000|STARTED|After Randomized Withdrawal: Maralixibat||0
10649240|NCT02160782|11809330|FG001|STARTED|After Randomized Withdrawal: Maralixibat||0
10649241|NCT02160782|11809331|FG002|STARTED|After Randomized Withdrawal: Maralixibat||0
10649242|NCT02160782|11809332|FG003|STARTED|After Randomized Withdrawal: Maralixibat||29
10649243|NCT02160782|11809333|FG004|STARTED|After Randomized Withdrawal: Maralixibat||0
10649244|NCT02160782|11809329|FG000|COMPLETED|After Randomized Withdrawal: Maralixibat||0
10649245|NCT02160782|11809330|FG001|COMPLETED|After Randomized Withdrawal: Maralixibat||0
10649246|NCT02160782|11809331|FG002|COMPLETED|After Randomized Withdrawal: Maralixibat||0
10649247|NCT02160782|11809332|FG003|COMPLETED|After Randomized Withdrawal: Maralixibat||23
10649248|NCT02160782|11809333|FG004|COMPLETED|After Randomized Withdrawal: Maralixibat||0
10649249|NCT02160782|11809329|FG000|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||0
10649250|NCT02160782|11809330|FG001|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||0
10649251|NCT02160782|11809331|FG002|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||0
10649252|NCT02160782|11809332|FG003|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||6
10649253|NCT02160782|11809333|FG004|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||0
10649254|NCT02160782|11809329|FG000|STARTED|Long-term Extension Period: Maralixibat||0
10649255|NCT02160782|11809330|FG001|STARTED|Long-term Extension Period: Maralixibat||0
10649256|NCT02160782|11809331|FG002|STARTED|Long-term Extension Period: Maralixibat||0
10649257|NCT02160782|11809332|FG003|STARTED|Long-term Extension Period: Maralixibat||0
10649258|NCT02160782|11809333|FG004|STARTED|Long-term Extension Period: Maralixibat||23
10649259|NCT02160782|11809329|FG000|COMPLETED|Long-term Extension Period: Maralixibat||0
10649260|NCT02160782|11809330|FG001|COMPLETED|Long-term Extension Period: Maralixibat||0
10649261|NCT02160782|11809331|FG002|COMPLETED|Long-term Extension Period: Maralixibat||0
10649262|NCT02160782|11809332|FG003|COMPLETED|Long-term Extension Period: Maralixibat||0
10649263|NCT02160782|11809333|FG004|COMPLETED|Long-term Extension Period: Maralixibat||14
10649264|NCT02160782|11809329|FG000|NOT COMPLETED|Long-term Extension Period: Maralixibat||0
10649265|NCT02160782|11809330|FG001|NOT COMPLETED|Long-term Extension Period: Maralixibat||0
10649266|NCT02160782|11809331|FG002|NOT COMPLETED|Long-term Extension Period: Maralixibat||0
10457380|NCT01010555|11605143|FG000|STARTED|Second Four Weeks of Wear||10
10457381|NCT01010555|11605144|FG001|STARTED|Second Four Weeks of Wear||9
10457382|NCT01010555|11605143|FG000|COMPLETED|Second Four Weeks of Wear||10
10457383|NCT01010555|11605144|FG001|COMPLETED|Second Four Weeks of Wear||9
10457384|NCT01010555|11605143|FG000|NOT COMPLETED|Second Four Weeks of Wear||0
10457385|NCT01010555|11605144|FG001|NOT COMPLETED|Second Four Weeks of Wear||0
10457386|NCT01010568|11605154|FG000|STARTED|Overall Study||10
10457387|NCT01010568|11605154|FG000|COMPLETED|Overall Study||5
10457388|NCT01010568|11605154|FG000|NOT COMPLETED|Overall Study||5
10457389|NCT01010633|11605161|FG000|STARTED|Overall Study||203
10457390|NCT01010633|11605162|FG001|STARTED|Overall Study||203
10457391|NCT01010633|11605161|FG000|COMPLETED|Overall Study||199
10649267|NCT02160782|11809332|FG003|NOT COMPLETED|Long-term Extension Period: Maralixibat||0
10649268|NCT02160782|11809333|FG004|NOT COMPLETED|Long-term Extension Period: Maralixibat||9
10649269|NCT02160808|11809359|FG000|STARTED|Overall Study||87
10649270|NCT02160808|11809360|FG001|STARTED|Overall Study||83
10649271|NCT02160808|11809359|FG000|COMPLETED|Overall Study||87
10649272|NCT02160808|11809360|FG001|COMPLETED|Overall Study||83
10649273|NCT02160808|11809359|FG000|NOT COMPLETED|Overall Study||0
10649274|NCT02160808|11809360|FG001|NOT COMPLETED|Overall Study||0
10649275|NCT02160847|11809368|FG000|STARTED|Overall Study||16
10649276|NCT02160847|11809369|FG001|STARTED|Overall Study||16
10649277|NCT02160847|11809368|FG000|COMPLETED|Overall Study||16
10649278|NCT02160847|11809369|FG001|COMPLETED|Overall Study||16
10649279|NCT02160847|11809368|FG000|NOT COMPLETED|Overall Study||0
10649280|NCT02160847|11809369|FG001|NOT COMPLETED|Overall Study||0
10649281|NCT02160873|11809377|FG000|STARTED|Overall Study||6
10649282|NCT02160873|11809378|FG001|STARTED|Overall Study||6
10649283|NCT02160873|11809377|FG000|COMPLETED|Overall Study||6
10649284|NCT02160873|11809378|FG001|COMPLETED|Overall Study||6
10649285|NCT02160873|11809377|FG000|NOT COMPLETED|Overall Study||0
10649286|NCT02160873|11809378|FG001|NOT COMPLETED|Overall Study||0
10649287|NCT02160899|11809396|FG000|STARTED|Overall Study||26
10649288|NCT02160899|11809397|FG001|STARTED|Overall Study||4
10649289|NCT02160899|11809398|FG002|STARTED|Overall Study||21
10649290|NCT02160899|11809399|FG003|STARTED|Overall Study||3
10649291|NCT02160899|11809400|FG004|STARTED|Overall Study||2
10649292|NCT02160899|11809401|FG005|STARTED|Overall Study||8
10649293|NCT02160899|11809396|FG000|COMPLETED|Overall Study||26
10649294|NCT02160899|11809397|FG001|COMPLETED|Overall Study||3
10649295|NCT02160899|11809398|FG002|COMPLETED|Overall Study||21
10649296|NCT02160899|11809399|FG003|COMPLETED|Overall Study||2
10649297|NCT02160899|11809400|FG004|COMPLETED|Overall Study||0
10649298|NCT02160899|11809401|FG005|COMPLETED|Overall Study||8
10649299|NCT02160899|11809396|FG000|NOT COMPLETED|Overall Study||0
10649300|NCT02160899|11809397|FG001|NOT COMPLETED|Overall Study||1
10649301|NCT02160899|11809398|FG002|NOT COMPLETED|Overall Study||0
10649302|NCT02160899|11809399|FG003|NOT COMPLETED|Overall Study||1
10649303|NCT02160899|11809400|FG004|NOT COMPLETED|Overall Study||2
10649304|NCT02160899|11809401|FG005|NOT COMPLETED|Overall Study||0
10649305|NCT02160977|11809417|FG000|STARTED|One Week After Surgery||45
10649306|NCT02160977|11809418|FG001|STARTED|One Week After Surgery||45
10649307|NCT02160977|11809417|FG000|COMPLETED|One Week After Surgery||45
10649308|NCT02160977|11809418|FG001|COMPLETED|One Week After Surgery||45
10649309|NCT02160977|11809417|FG000|NOT COMPLETED|One Week After Surgery||0
10649310|NCT02160977|11809418|FG001|NOT COMPLETED|One Week After Surgery||0
10649311|NCT02160977|11809417|FG000|STARTED|Six Weeks After Surgery||45
10649312|NCT02160977|11809418|FG001|STARTED|Six Weeks After Surgery||45
10649313|NCT02160977|11809417|FG000|COMPLETED|Six Weeks After Surgery||44
10649314|NCT02160977|11809418|FG001|COMPLETED|Six Weeks After Surgery||45
10649315|NCT02160977|11809417|FG000|NOT COMPLETED|Six Weeks After Surgery||1
10649316|NCT02160977|11809418|FG001|NOT COMPLETED|Six Weeks After Surgery||0
10649317|NCT02160977|11809417|FG000|STARTED|Three Months After Surgery||44
10649318|NCT02160977|11809418|FG001|STARTED|Three Months After Surgery||45
10649319|NCT02160977|11809417|FG000|COMPLETED|Three Months After Surgery||44
10649320|NCT02160977|11809418|FG001|COMPLETED|Three Months After Surgery||43
10649321|NCT02160977|11809417|FG000|NOT COMPLETED|Three Months After Surgery||0
10649322|NCT02160977|11809418|FG001|NOT COMPLETED|Three Months After Surgery||2
10649323|NCT02160977|11809417|FG000|STARTED|Six Months After Surgery||44
10649324|NCT02160977|11809418|FG001|STARTED|Six Months After Surgery||43
10649325|NCT02160977|11809417|FG000|COMPLETED|Six Months After Surgery||42
10649326|NCT02160977|11809418|FG001|COMPLETED|Six Months After Surgery||42
10649327|NCT02160977|11809417|FG000|NOT COMPLETED|Six Months After Surgery||2
10649328|NCT02160977|11809418|FG001|NOT COMPLETED|Six Months After Surgery||1
10649329|NCT02160990|11809426|FG000|STARTED|Overall Study||10
10649330|NCT02160990|11809427|FG001|STARTED|Overall Study||10
10649331|NCT02160990|11809426|FG000|COMPLETED|Overall Study||10
10649332|NCT02160990|11809427|FG001|COMPLETED|Overall Study||10
10649333|NCT02160990|11809426|FG000|NOT COMPLETED|Overall Study||0
10649334|NCT02160990|11809427|FG001|NOT COMPLETED|Overall Study||0
10649335|NCT02161133|11809435|FG000|STARTED|Overall Study||135
10649336|NCT02161133|11809436|FG001|STARTED|Overall Study||133
10649337|NCT02161133|11809435|FG000|COMPLETED|Overall Study||116
10649338|NCT02161133|11809436|FG001|COMPLETED|Overall Study||122
10649339|NCT02161133|11809435|FG000|NOT COMPLETED|Overall Study||19
10649340|NCT02161133|11809436|FG001|NOT COMPLETED|Overall Study||11
10649341|NCT02161146|11809447|FG000|STARTED|Overall Study||47
10649342|NCT02161146|11809448|FG001|STARTED|Overall Study||47
10649343|NCT02161146|11809449|FG002|STARTED|Overall Study||49
10649344|NCT02161146|11809450|FG003|STARTED|Overall Study||48
10649345|NCT02161146|11809451|FG004|STARTED|Overall Study||49
10649346|NCT02161146|11809447|FG000|COMPLETED|Overall Study||46
10649347|NCT02161146|11809448|FG001|COMPLETED|Overall Study||43
10649348|NCT02161146|11809449|FG002|COMPLETED|Overall Study||49
10649349|NCT02161146|11809450|FG003|COMPLETED|Overall Study||45
10649350|NCT02161146|11809451|FG004|COMPLETED|Overall Study||48
10649351|NCT02161146|11809447|FG000|NOT COMPLETED|Overall Study||1
10649352|NCT02161146|11809448|FG001|NOT COMPLETED|Overall Study||4
10649353|NCT02161146|11809449|FG002|NOT COMPLETED|Overall Study||0
10649354|NCT02161146|11809450|FG003|NOT COMPLETED|Overall Study||3
10649355|NCT02161146|11809451|FG004|NOT COMPLETED|Overall Study||1
10649356|NCT02161185|11809461|FG000|STARTED|Test Dose Phase||7
10649357|NCT02161185|11809461|FG000|COMPLETED|Test Dose Phase||7
10649358|NCT02161185|11809461|FG000|NOT COMPLETED|Test Dose Phase||0
10649359|NCT02161185|11809461|FG000|STARTED|Treatment Phase||7
10649360|NCT02161185|11809461|FG000|COMPLETED|Treatment Phase||0
10649361|NCT02161185|11809461|FG000|NOT COMPLETED|Treatment Phase||7
10649362|NCT02161406|11809467|FG000|STARTED|Overall Study||44
10649363|NCT02161406|11809468|FG001|STARTED|Overall Study||44
10649364|NCT02161406|11809467|FG000|COMPLETED|Overall Study||34
10649365|NCT02161406|11809468|FG001|COMPLETED|Overall Study||35
10649366|NCT02161406|11809467|FG000|NOT COMPLETED|Overall Study||10
10649367|NCT02161406|11809468|FG001|NOT COMPLETED|Overall Study||9
10649368|NCT02161458|11809478|FG000|STARTED|Overall Study||22
10649369|NCT02161458|11809479|FG001|STARTED|Overall Study||35
10649370|NCT02161458|11809480|FG002|STARTED|Overall Study||33
10649371|NCT02161458|11809481|FG003|STARTED|Overall Study||8
10649372|NCT02161458|11809478|FG000|COMPLETED|Overall Study||22
10649373|NCT02161458|11809479|FG001|COMPLETED|Overall Study||29
10649374|NCT02161458|11809480|FG002|COMPLETED|Overall Study||28
10649375|NCT02161458|11809481|FG003|COMPLETED|Overall Study||8
10649376|NCT02161458|11809478|FG000|NOT COMPLETED|Overall Study||0
10649377|NCT02161458|11809479|FG001|NOT COMPLETED|Overall Study||6
10649378|NCT02161458|11809480|FG002|NOT COMPLETED|Overall Study||5
10649379|NCT02161458|11809481|FG003|NOT COMPLETED|Overall Study||0
10649380|NCT02161484|11809493|FG000|STARTED|Overall Study||5
10706322|NCT02608099|11870898|FG000|STARTED|Overall Study||148
10706323|NCT02608099|11870899|FG001|STARTED|Overall Study||152
10706324|NCT02608099|11870898|FG000|Safety|Overall Study||149
10706325|NCT02608099|11870899|FG001|Safety|Overall Study||151
10706326|NCT02608099|11870898|FG000|COMPLETED|Overall Study||145
10649381|NCT02161484|11809494|FG001|STARTED|Overall Study||5
10649382|NCT02161484|11809493|FG000|COMPLETED|Overall Study||1
10649383|NCT02161484|11809494|FG001|COMPLETED|Overall Study||2
10649384|NCT02161484|11809493|FG000|NOT COMPLETED|Overall Study||4
10649385|NCT02161484|11809494|FG001|NOT COMPLETED|Overall Study||3
10649386|NCT02161536|11809503|FG000|STARTED|Overall Study||6
10649387|NCT02161536|11809504|FG001|STARTED|Overall Study||21
10649388|NCT02161536|11809505|FG002|STARTED|Overall Study||20
10649389|NCT02161536|11809503|FG000|COMPLETED|Overall Study||6
10706327|NCT02608099|11870899|FG001|COMPLETED|Overall Study||150
10649390|NCT02161536|11809504|FG001|COMPLETED|Overall Study||21
10649391|NCT02161536|11809505|FG002|COMPLETED|Overall Study||20
10649392|NCT02161536|11809503|FG000|NOT COMPLETED|Overall Study||0
10649393|NCT02161536|11809504|FG001|NOT COMPLETED|Overall Study||0
10649394|NCT02161536|11809505|FG002|NOT COMPLETED|Overall Study||0
10649395|NCT02161549|11809515|FG000|STARTED|Overall Study||40
10649396|NCT02161549|11809516|FG001|STARTED|Overall Study||31
10649397|NCT02161549|11809515|FG000|COMPLETED|Overall Study||34
10649398|NCT02161549|11809516|FG001|COMPLETED|Overall Study||29
10649399|NCT02161549|11809515|FG000|NOT COMPLETED|Overall Study||6
10649400|NCT02161549|11809516|FG001|NOT COMPLETED|Overall Study||2
10649401|NCT02161562|11809524|FG000|STARTED|Overall Study||178
10649402|NCT02161562|11809525|FG001|STARTED|Overall Study||136
10649403|NCT02161562|11809524|FG000|COMPLETED|Overall Study||152
10649404|NCT02161562|11809525|FG001|COMPLETED|Overall Study||119
10649405|NCT02161562|11809524|FG000|NOT COMPLETED|Overall Study||26
10649406|NCT02161562|11809525|FG001|NOT COMPLETED|Overall Study||17
10649407|NCT02161575|11809544|FG000|STARTED|Overall Study||103
10649408|NCT02161575|11809544|FG000|Full Analysis Set (FAS) Population|Overall Study||100
10649409|NCT02161575|11809544|FG000|Safety (SAF) Population|Overall Study||100
10649410|NCT02161575|11809544|FG000|COMPLETED|Overall Study||92
10649411|NCT02161575|11809544|FG000|NOT COMPLETED|Overall Study||11
10649412|NCT02161705|11809550|FG000|STARTED|Overall Study||9
10649413|NCT02161705|11809551|FG001|STARTED|Overall Study||9
10649414|NCT02161705|11809550|FG000|COMPLETED|Overall Study||9
10649415|NCT02161705|11809551|FG001|COMPLETED|Overall Study||9
10649416|NCT02161705|11809550|FG000|NOT COMPLETED|Overall Study||0
10649417|NCT02161705|11809551|FG001|NOT COMPLETED|Overall Study||0
10649418|NCT02161718|11809559|FG000|STARTED|Open-Label ALKS 3831 Period||255
10649419|NCT02161718|11809560|FG001|STARTED|Open-Label ALKS 3831 Period||0
10649420|NCT02161718|11809561|FG002|STARTED|Open-Label ALKS 3831 Period||0
10649421|NCT02161718|11809559|FG000|COMPLETED|Open-Label ALKS 3831 Period||234
10649422|NCT02161718|11809560|FG001|COMPLETED|Open-Label ALKS 3831 Period||0
10649423|NCT02161718|11809561|FG002|COMPLETED|Open-Label ALKS 3831 Period||0
10649424|NCT02161718|11809559|FG000|NOT COMPLETED|Open-Label ALKS 3831 Period||21
10649425|NCT02161718|11809560|FG001|NOT COMPLETED|Open-Label ALKS 3831 Period||0
10649426|NCT02161718|11809561|FG002|NOT COMPLETED|Open-Label ALKS 3831 Period||0
10649427|NCT02161718|11809559|FG000|STARTED|Post- Randomization Period||0
10649428|NCT02161718|11809560|FG001|STARTED|Post- Randomization Period||112
10649429|NCT02161718|11809561|FG002|STARTED|Post- Randomization Period||117
10649430|NCT02161718|11809559|FG000|COMPLETED|Post- Randomization Period||0
10649431|NCT02161718|11809560|FG001|COMPLETED|Post- Randomization Period||53
10649432|NCT02161718|11809561|FG002|COMPLETED|Post- Randomization Period||58
10649433|NCT02161718|11809559|FG000|NOT COMPLETED|Post- Randomization Period||0
10649434|NCT02161718|11809560|FG001|NOT COMPLETED|Post- Randomization Period||59
10649435|NCT02161718|11809561|FG002|NOT COMPLETED|Post- Randomization Period||59
10649436|NCT02161731|11809568|FG000|STARTED|Period 1 (Day -1 to Day 7 Predose)||24
10649437|NCT02161731|11809569|FG001|STARTED|Period 1 (Day -1 to Day 7 Predose)||0
10649438|NCT02161731|11809568|FG000|Received 1 Dose of Study Drug|Period 1 (Day -1 to Day 7 Predose)||24
10649439|NCT02161731|11809569|FG001|Received 1 Dose of Study Drug|Period 1 (Day -1 to Day 7 Predose)||0
10649440|NCT02161731|11809568|FG000|COMPLETED|Period 1 (Day -1 to Day 7 Predose)||24
10649441|NCT02161731|11809569|FG001|COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0
10649442|NCT02161731|11809568|FG000|NOT COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0
10649443|NCT02161731|11809569|FG001|NOT COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0
10649444|NCT02161731|11809568|FG000|STARTED|Period 2 (Day 7 Dosing to Day 23)||0
10649445|NCT02161731|11809569|FG001|STARTED|Period 2 (Day 7 Dosing to Day 23)||24
10649446|NCT02161731|11809568|FG000|Received 1 Dose of Study Drug|Period 2 (Day 7 Dosing to Day 23)||0
10649447|NCT02161731|11809569|FG001|Received 1 Dose of Study Drug|Period 2 (Day 7 Dosing to Day 23)||24
10649448|NCT02161731|11809568|FG000|COMPLETED|Period 2 (Day 7 Dosing to Day 23)||0
10649449|NCT02161731|11809569|FG001|COMPLETED|Period 2 (Day 7 Dosing to Day 23)||22
10649450|NCT02161731|11809568|FG000|NOT COMPLETED|Period 2 (Day 7 Dosing to Day 23)||0
10649451|NCT02161731|11809569|FG001|NOT COMPLETED|Period 2 (Day 7 Dosing to Day 23)||2
10649452|NCT02161757|11809579|FG000|STARTED|Randomised Through Start Treatment||401
10649453|NCT02161757|11809580|FG001|STARTED|Randomised Through Start Treatment||406
10649454|NCT02161757|11809581|FG002|STARTED|Randomised Through Start Treatment||400
10649455|NCT02161757|11809579|FG000|COMPLETED|Randomised Through Start Treatment||398
10649456|NCT02161757|11809580|FG001|COMPLETED|Randomised Through Start Treatment||404
10649457|NCT02161757|11809581|FG002|COMPLETED|Randomised Through Start Treatment||400
10649458|NCT02161757|11809579|FG000|NOT COMPLETED|Randomised Through Start Treatment||3
10649459|NCT02161757|11809580|FG001|NOT COMPLETED|Randomised Through Start Treatment||2
10649460|NCT02161757|11809581|FG002|NOT COMPLETED|Randomised Through Start Treatment||0
10649461|NCT02161757|11809579|FG000|STARTED|Treatment Through Study Completion||398
10649462|NCT02161757|11809580|FG001|STARTED|Treatment Through Study Completion||404
10649463|NCT02161757|11809581|FG002|STARTED|Treatment Through Study Completion||400
10649464|NCT02161757|11809579|FG000|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||332
10649465|NCT02161757|11809580|FG001|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||355
10649466|NCT02161757|11809581|FG002|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||360
10649467|NCT02161757|11809579|FG000|COMPLETED|Treatment Through Study Completion||341
10649468|NCT02161757|11809580|FG001|COMPLETED|Treatment Through Study Completion||361
10649469|NCT02161757|11809581|FG002|COMPLETED|Treatment Through Study Completion||361
10649470|NCT02161757|11809579|FG000|NOT COMPLETED|Treatment Through Study Completion||57
10649471|NCT02161757|11809580|FG001|NOT COMPLETED|Treatment Through Study Completion||43
10649472|NCT02161757|11809581|FG002|NOT COMPLETED|Treatment Through Study Completion||39
10649473|NCT02162433|11809593|FG000|STARTED|Overall Study||23
10649474|NCT02162433|11809594|FG001|STARTED|Overall Study||23
10649475|NCT02162433|11809595|FG002|STARTED|Overall Study||23
10649476|NCT02162433|11809596|FG003|STARTED|Overall Study||23
10649477|NCT02162433|11809593|FG000|COMPLETED|Overall Study||22
10706328|NCT02608099|11870898|FG000|NOT COMPLETED|Overall Study||3
10706329|NCT02608099|11870899|FG001|NOT COMPLETED|Overall Study||2
10706330|NCT02608177|11870907|FG000|STARTED|Overall Study||2
10706331|NCT02608177|11870908|FG001|STARTED|Overall Study||1
10333970|NCT00337077|11470216|FG000|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
10333971|NCT00337077|11470217|FG001|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
10333972|NCT00337077|11470218|FG002|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
10333973|NCT00337077|11470216|FG000|NOT COMPLETED|Overall Study||43
10333974|NCT00337077|11470217|FG001|NOT COMPLETED|Overall Study||53
10333975|NCT00337077|11470218|FG002|NOT COMPLETED|Overall Study||25
10333976|NCT00337103|11470226|FG000|STARTED|Overall Study||554
10706332|NCT02608177|11870907|FG000|COMPLETED|Overall Study||2
10706333|NCT02608177|11870908|FG001|COMPLETED|Overall Study||1
10706334|NCT02608177|11870907|FG000|NOT COMPLETED|Overall Study||0
10649478|NCT02162433|11809594|FG001|COMPLETED|Overall Study||21
10649479|NCT02162433|11809595|FG002|COMPLETED|Overall Study||21
10649480|NCT02162433|11809596|FG003|COMPLETED|Overall Study||22
10649481|NCT02162433|11809593|FG000|NOT COMPLETED|Overall Study||1
10649482|NCT02162433|11809594|FG001|NOT COMPLETED|Overall Study||2
10649483|NCT02162433|11809595|FG002|NOT COMPLETED|Overall Study||2
10649484|NCT02162433|11809596|FG003|NOT COMPLETED|Overall Study||1
10649485|NCT02162446|11809606|FG000|STARTED|Overall Study||12
10649486|NCT02162446|11809606|FG000|COMPLETED|Overall Study||12
10649487|NCT02162446|11809606|FG000|NOT COMPLETED|Overall Study||0
10649488|NCT02162576|11809615|FG000|STARTED|Overall Study||95
10649489|NCT02162576|11809615|FG000|COMPLETED|Overall Study||95
10649490|NCT02162576|11809615|FG000|NOT COMPLETED|Overall Study||0
10706335|NCT02608177|11870908|FG001|NOT COMPLETED|Overall Study||0
10706336|NCT02608229|11870918|FG000|STARTED|Overall Study||10
10706337|NCT02608229|11870919|FG001|STARTED|Overall Study||8
10649503|NCT02162680|11809636|FG000|STARTED|Overall Study||33
10649504|NCT02162680|11809637|FG001|STARTED|Overall Study||33
10649505|NCT02162680|11809638|FG002|STARTED|Overall Study||32
10649506|NCT02162680|11809636|FG000|COMPLETED|Overall Study||33
10649507|NCT02162680|11809637|FG001|COMPLETED|Overall Study||33
10649508|NCT02162680|11809638|FG002|COMPLETED|Overall Study||32
10649509|NCT02162680|11809636|FG000|NOT COMPLETED|Overall Study||0
10649510|NCT02162680|11809637|FG001|NOT COMPLETED|Overall Study||0
10649511|NCT02162680|11809638|FG002|NOT COMPLETED|Overall Study||0
10649512|NCT02162719|11809648|FG000|STARTED|Overall Study||62
10649513|NCT02162719|11809649|FG001|STARTED|Overall Study||62
10649514|NCT02162719|11809648|FG000|COMPLETED|Overall Study||0
10649515|NCT02162719|11809649|FG001|COMPLETED|Overall Study||0
10649516|NCT02162719|11809648|FG000|NOT COMPLETED|Overall Study||62
10649517|NCT02162719|11809649|FG001|NOT COMPLETED|Overall Study||62
10649518|NCT02162758|11809657|FG000|STARTED|Overall Study||3
10649519|NCT02162758|11809658|FG001|STARTED|Overall Study||3
10649520|NCT02162758|11809657|FG000|COMPLETED|Overall Study||3
10649521|NCT02162758|11809658|FG001|COMPLETED|Overall Study||2
10649522|NCT02162758|11809657|FG000|NOT COMPLETED|Overall Study||0
10649523|NCT02162758|11809658|FG001|NOT COMPLETED|Overall Study||1
10649524|NCT02162771|11809666|FG000|STARTED|Core Study Period (Part 2)||70
10706338|NCT02608229|11870918|FG000|600 mg BVD-523|Overall Study||10
10706339|NCT02608229|11870919|FG001|600 mg BVD-523|Overall Study||2
10706340|NCT02608229|11870918|FG000|450 mg BVD-523|Overall Study||0
10706341|NCT02608229|11870919|FG001|450 mg BVD-523|Overall Study||6
10706342|NCT02608229|11870918|FG000|COMPLETED|Overall Study||10
10706343|NCT02608229|11870919|FG001|COMPLETED|Overall Study||8
10706344|NCT02608229|11870918|FG000|NOT COMPLETED|Overall Study||0
10706345|NCT02608229|11870919|FG001|NOT COMPLETED|Overall Study||0
10706346|NCT02608450|11870929|FG000|STARTED|Overall Study||353
10649525|NCT02162771|11809667|FG001|STARTED|Core Study Period (Part 2)||70
10649526|NCT02162771|11809666|FG000|COMPLETED|Core Study Period (Part 2)||62
10649527|NCT02162771|11809667|FG001|COMPLETED|Core Study Period (Part 2)||62
10649528|NCT02162771|11809666|FG000|NOT COMPLETED|Core Study Period (Part 2)||8
10649529|NCT02162771|11809667|FG001|NOT COMPLETED|Core Study Period (Part 2)||8
10706347|NCT02608450|11870930|FG001|STARTED|Overall Study||355
10706348|NCT02608450|11870929|FG000|COMPLETED|Overall Study||287
10706349|NCT02608450|11870930|FG001|COMPLETED|Overall Study||290
10706350|NCT02608450|11870929|FG000|NOT COMPLETED|Overall Study||66
10649530|NCT02162771|11809666|FG000|STARTED|Maintenance Study Period (Part 2)||62
10654447|NCT02202980|11815246|FG005|STARTED|Overall Study||15
10706351|NCT02608450|11870930|FG001|NOT COMPLETED|Overall Study||65
10706352|NCT02608463|11870939|FG000|STARTED|Overall Study||10
10706353|NCT02608463|11870940|FG001|STARTED|Overall Study||5
10706354|NCT02608463|11870941|FG002|STARTED|Overall Study||0
10706355|NCT02608463|11870942|FG003|STARTED|Overall Study|No study participants were enrolled in Part B.|0
10706356|NCT02608463|11870939|FG000|COMPLETED|Overall Study||10
10706357|NCT02608463|11870940|FG001|COMPLETED|Overall Study||5
10706358|NCT02608463|11870941|FG002|COMPLETED|Overall Study||0
10706359|NCT02608463|11870942|FG003|COMPLETED|Overall Study||0
10706360|NCT02608463|11870939|FG000|NOT COMPLETED|Overall Study||0
10706361|NCT02608463|11870940|FG001|NOT COMPLETED|Overall Study||0
10706362|NCT02608463|11870941|FG002|NOT COMPLETED|Overall Study||0
10706363|NCT02608463|11870942|FG003|NOT COMPLETED|Overall Study||0
10706364|NCT02608476|11870952|FG000|STARTED|Overall Study||369
10706365|NCT02608476|11870953|FG001|STARTED|Overall Study||363
10706366|NCT02608476|11870952|FG000|COMPLETED|Overall Study||302
10706367|NCT02608476|11870953|FG001|COMPLETED|Overall Study||282
10706368|NCT02608476|11870952|FG000|NOT COMPLETED|Overall Study||67
10706369|NCT02608476|11870953|FG001|NOT COMPLETED|Overall Study||81
10706370|NCT02608489|11870961|FG000|STARTED|Overall Study||43
10706371|NCT02608489|11870962|FG001|STARTED|Overall Study||43
10706372|NCT02608489|11870961|FG000|COMPLETED|Overall Study||30
10706373|NCT02608489|11870962|FG001|COMPLETED|Overall Study||33
10706374|NCT02608489|11870961|FG000|NOT COMPLETED|Overall Study||13
10706375|NCT02608489|11870962|FG001|NOT COMPLETED|Overall Study||10
10706376|NCT02608879|11870971|FG000|STARTED|Overall Study||10
10706377|NCT02608879|11870972|FG001|STARTED|Overall Study||6
10706378|NCT02608879|11870973|FG002|STARTED|Overall Study||3
10706379|NCT02608879|11870971|FG000|COMPLETED|Overall Study||9
10706380|NCT02608879|11870972|FG001|COMPLETED|Overall Study||6
10706381|NCT02608879|11870973|FG002|COMPLETED|Overall Study||0
10706382|NCT02608879|11870971|FG000|NOT COMPLETED|Overall Study||1
10706383|NCT02608879|11870972|FG001|NOT COMPLETED|Overall Study||0
10706384|NCT02608879|11870973|FG002|NOT COMPLETED|Overall Study||3
10649531|NCT02162771|11809667|FG001|STARTED|Maintenance Study Period (Part 2)|Two subjects did not enter this period due to Withdrawal by subject and Non-responder, 1 for each.|60
10649532|NCT02162771|11809666|FG000|COMPLETED|Maintenance Study Period (Part 2)||46
10649533|NCT02162771|11809667|FG001|COMPLETED|Maintenance Study Period (Part 2)||38
10649534|NCT02162771|11809666|FG000|NOT COMPLETED|Maintenance Study Period (Part 2)||16
10649535|NCT02162771|11809667|FG001|NOT COMPLETED|Maintenance Study Period (Part 2)||22
10649536|NCT02162862|11809676|FG000|STARTED|Overall Study||31
10649537|NCT02162862|11809677|FG001|STARTED|Overall Study||35
10649538|NCT02162862|11809678|FG002|STARTED|Overall Study||33
10649539|NCT02162862|11809676|FG000|COMPLETED|Overall Study||31
10649540|NCT02162862|11809677|FG001|COMPLETED|Overall Study||24
10649541|NCT02162862|11809678|FG002|COMPLETED|Overall Study||29
10649542|NCT02162862|11809676|FG000|NOT COMPLETED|Overall Study||0
10649543|NCT02162862|11809677|FG001|NOT COMPLETED|Overall Study||11
10649544|NCT02162862|11809678|FG002|NOT COMPLETED|Overall Study||4
10649545|NCT02162992|11809690|FG000|STARTED|Overall Study||51
10649546|NCT02162992|11809691|FG001|STARTED|Overall Study||100
10649547|NCT02162992|11809690|FG000|COMPLETED|Overall Study||46
10649548|NCT02162992|11809691|FG001|COMPLETED|Overall Study||99
10649549|NCT02162992|11809690|FG000|NOT COMPLETED|Overall Study||5
10649550|NCT02162992|11809691|FG001|NOT COMPLETED|Overall Study||1
10649551|NCT02163057|11809699|FG000|STARTED|Overall Study||6
10649552|NCT02163057|11809700|FG001|STARTED|Overall Study||16
10649553|NCT02163057|11809699|FG000|COMPLETED|Overall Study||3
10649554|NCT02163057|11809700|FG001|COMPLETED|Overall Study||11
10649555|NCT02163057|11809699|FG000|NOT COMPLETED|Overall Study||3
10649556|NCT02163057|11809700|FG001|NOT COMPLETED|Overall Study||5
10649557|NCT02163226|11809710|FG000|STARTED|Overall Study||79
10649558|NCT02163226|11809711|FG001|STARTED|Overall Study||81
10649559|NCT02163226|11809710|FG000|COMPLETED|Overall Study||63
10649560|NCT02163226|11809711|FG001|COMPLETED|Overall Study||70
10649561|NCT02163226|11809710|FG000|NOT COMPLETED|Overall Study||16
10649562|NCT02163226|11809711|FG001|NOT COMPLETED|Overall Study||11
10706385|NCT02608892|11870983|FG000|STARTED|Overall Study||51
10706386|NCT02608892|11870984|FG001|STARTED|Overall Study||49
10706387|NCT02608892|11870983|FG000|COMPLETED|Overall Study||50
10706388|NCT02608892|11870984|FG001|COMPLETED|Overall Study||49
10706389|NCT02608892|11870983|FG000|NOT COMPLETED|Overall Study||1
10706390|NCT02608892|11870984|FG001|NOT COMPLETED|Overall Study||0
10706391|NCT02609100|11870993|FG000|STARTED|Overall Study||2
10649563|NCT02163421|11809721|FG000|STARTED|Overall Study||12
10649564|NCT02163421|11809722|FG001|STARTED|Overall Study||12
10649565|NCT02163421|11809723|FG002|STARTED|Overall Study||12
10649566|NCT02163421|11809724|FG003|STARTED|Overall Study||12
10649567|NCT02163421|11809721|FG000|COMPLETED|Overall Study||12
10649568|NCT02163421|11809722|FG001|COMPLETED|Overall Study||12
10649569|NCT02163421|11809723|FG002|COMPLETED|Overall Study||12
10706392|NCT02609100|11870994|FG001|STARTED|Overall Study||2
10706393|NCT02609100|11870993|FG000|COMPLETED|Overall Study||2
10649570|NCT02163421|11809724|FG003|COMPLETED|Overall Study||12
10649571|NCT02163421|11809721|FG000|NOT COMPLETED|Overall Study||0
10649572|NCT02163421|11809722|FG001|NOT COMPLETED|Overall Study||0
10649573|NCT02163421|11809723|FG002|NOT COMPLETED|Overall Study||0
10706394|NCT02609100|11870994|FG001|COMPLETED|Overall Study||2
10649574|NCT02163421|11809724|FG003|NOT COMPLETED|Overall Study||0
10649575|NCT02163434|11809733|FG000|STARTED|Overall Study||15
10649576|NCT02163434|11809734|FG001|STARTED|Overall Study||16
10649577|NCT02163434|11809733|FG000|COMPLETED|Overall Study||12
10649578|NCT02163434|11809734|FG001|COMPLETED|Overall Study||9
10649579|NCT02163434|11809733|FG000|NOT COMPLETED|Overall Study||3
10649580|NCT02163434|11809734|FG001|NOT COMPLETED|Overall Study||7
10649581|NCT02163447|11809743|FG000|STARTED|Overall Study||106
10649582|NCT02163447|11809744|FG001|STARTED|Overall Study||94
10649583|NCT02163447|11809745|FG002|STARTED|Overall Study||100
10649584|NCT02163447|11809743|FG000|Infants Born|Overall Study||101
10649585|NCT02163447|11809744|FG001|Infants Born|Overall Study||93
10649586|NCT02163447|11809745|FG002|Infants Born|Overall Study||100
10649587|NCT02163447|11809743|FG000|COMPLETED|Overall Study||100
10333977|NCT00337103|11470227|FG001|STARTED|Overall Study||548
10333978|NCT00337103|11470226|FG000|Treated (Safety Population)|Overall Study||544
10333979|NCT00337103|11470227|FG001|Treated (Safety Population)|Overall Study||546
10333980|NCT00337103|11470226|FG000|COMPLETED|Overall Study||0
10333981|NCT00337103|11470227|FG001|COMPLETED|Overall Study||0
10333982|NCT00337103|11470226|FG000|NOT COMPLETED|Overall Study||554
10649588|NCT02163447|11809744|FG001|COMPLETED|Overall Study||88
10649589|NCT02163447|11809745|FG002|COMPLETED|Overall Study||97
10649590|NCT02163447|11809743|FG000|NOT COMPLETED|Overall Study||6
10649591|NCT02163447|11809744|FG001|NOT COMPLETED|Overall Study||6
10706395|NCT02609100|11870993|FG000|NOT COMPLETED|Overall Study||0
10706396|NCT02609100|11870994|FG001|NOT COMPLETED|Overall Study||0
10706397|NCT02609113|11871004|FG000|STARTED|Overall Study||11
10706398|NCT02609113|11871005|FG001|STARTED|Overall Study||11
10706399|NCT02609113|11871004|FG000|COMPLETED|Overall Study||9
10649592|NCT02163447|11809745|FG002|NOT COMPLETED|Overall Study||3
10649593|NCT02163486|11809765|FG000|STARTED|Overall Study||51
10649594|NCT02163486|11809766|FG001|STARTED|Overall Study||52
10649595|NCT02163486|11809765|FG000|COMPLETED|Overall Study||50
10649596|NCT02163486|11809766|FG001|COMPLETED|Overall Study||50
10649597|NCT02163486|11809765|FG000|NOT COMPLETED|Overall Study||1
10649598|NCT02163486|11809766|FG001|NOT COMPLETED|Overall Study||2
10649599|NCT02163499|11809772|FG000|STARTED|Acute Phase: ZS 10 g TID||751
10649600|NCT02163499|11809772|FG000|COMPLETED|Acute Phase: ZS 10 g TID||746
10706400|NCT02609113|11871005|FG001|COMPLETED|Overall Study||9
10706401|NCT02609113|11871004|FG000|NOT COMPLETED|Overall Study||2
10706402|NCT02609113|11871005|FG001|NOT COMPLETED|Overall Study||2
10706403|NCT02609178|11871011|FG000|STARTED|First Crown||0
10706404|NCT02609178|11871012|FG001|STARTED|First Crown||1
10706405|NCT02609178|11871013|FG002|STARTED|First Crown||6
10706406|NCT02609178|11871014|FG003|STARTED|First Crown||3
10706407|NCT02609178|11871015|FG004|STARTED|First Crown||0
10706408|NCT02609178|11871016|FG005|STARTED|First Crown||2
10706409|NCT02609178|11871011|FG000|COMPLETED|First Crown||0
10706410|NCT02609178|11871012|FG001|COMPLETED|First Crown||1
10706411|NCT02609178|11871013|FG002|COMPLETED|First Crown||5
10706412|NCT02609178|11871014|FG003|COMPLETED|First Crown||2
10706413|NCT02609178|11871015|FG004|COMPLETED|First Crown||0
10706414|NCT02609178|11871016|FG005|COMPLETED|First Crown||2
10706415|NCT02609178|11871011|FG000|NOT COMPLETED|First Crown||0
10706416|NCT02609178|11871012|FG001|NOT COMPLETED|First Crown||0
10706417|NCT02609178|11871013|FG002|NOT COMPLETED|First Crown||1
10706418|NCT02609178|11871014|FG003|NOT COMPLETED|First Crown||1
10706419|NCT02609178|11871015|FG004|NOT COMPLETED|First Crown||0
10706420|NCT02609178|11871016|FG005|NOT COMPLETED|First Crown||0
10706421|NCT02609178|11871011|FG000|STARTED|5-minute Washout Time||0
10706422|NCT02609178|11871012|FG001|STARTED|5-minute Washout Time||1
10706423|NCT02609178|11871013|FG002|STARTED|5-minute Washout Time||5
10706424|NCT02609178|11871014|FG003|STARTED|5-minute Washout Time||2
10706425|NCT02609178|11871015|FG004|STARTED|5-minute Washout Time||0
10706426|NCT02609178|11871016|FG005|STARTED|5-minute Washout Time||2
10706427|NCT02609178|11871011|FG000|COMPLETED|5-minute Washout Time||0
10333983|NCT00337103|11470227|FG001|NOT COMPLETED|Overall Study||548
10333984|NCT00337129|11470234|FG000|STARTED|Overall Study||40
10339040|NCT00371137|11475999|FG000|NOT COMPLETED|Overall Study||72
10457392|NCT01010633|11605162|FG001|COMPLETED|Overall Study||198
10457393|NCT01010633|11605161|FG000|NOT COMPLETED|Overall Study||4
10706428|NCT02609178|11871012|FG001|COMPLETED|5-minute Washout Time||1
10706429|NCT02609178|11871013|FG002|COMPLETED|5-minute Washout Time||5
10706430|NCT02609178|11871014|FG003|COMPLETED|5-minute Washout Time||2
10809256|NCT03835975|11971158|FG001|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||0
10809257|NCT03835975|11971159|FG002|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||243
10809258|NCT03835975|11971160|FG003|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||0
10809259|NCT03835975|11971161|FG004|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||121
10809260|NCT03835975|11971157|FG000|COMPLETED|Overall Study||250
10809261|NCT03835975|11971158|FG001|COMPLETED|Overall Study||119
10809262|NCT03835975|11971159|FG002|COMPLETED|Overall Study||245
10809263|NCT03835975|11971160|FG003|COMPLETED|Overall Study||126
10809264|NCT03835975|11971161|FG004|COMPLETED|Overall Study||125
10809265|NCT03835975|11971157|FG000|NOT COMPLETED|Overall Study||3
10809266|NCT03835975|11971158|FG001|NOT COMPLETED|Overall Study||3
10809267|NCT03835975|11971159|FG002|NOT COMPLETED|Overall Study||3
10809268|NCT03835975|11971160|FG003|NOT COMPLETED|Overall Study||1
10809269|NCT03835975|11971161|FG004|NOT COMPLETED|Overall Study||0
10809270|NCT03821259|11971175|FG000|STARTED|Overall Study||88
10809271|NCT03821259|11971175|FG000|COMPLETED|Overall Study||88
10809272|NCT03821259|11971175|FG000|NOT COMPLETED|Overall Study||0
10809273|NCT03803085|11971181|FG000|STARTED|Overall Study||30
10809274|NCT03803085|11971182|FG001|STARTED|Overall Study||30
10809275|NCT03803085|11971181|FG000|COMPLETED|Overall Study||28
10809276|NCT03803085|11971182|FG001|COMPLETED|Overall Study||28
10809277|NCT03803085|11971181|FG000|NOT COMPLETED|Overall Study||2
10809278|NCT03803085|11971182|FG001|NOT COMPLETED|Overall Study||2
10809279|NCT03801473|11971191|FG000|STARTED|Overall Study||21
10809280|NCT03801473|11971192|FG001|STARTED|Overall Study||21
10809281|NCT03801473|11971191|FG000|COMPLETED|Overall Study||18
10809282|NCT03801473|11971192|FG001|COMPLETED|Overall Study||19
10809283|NCT03801473|11971191|FG000|NOT COMPLETED|Overall Study||3
10809284|NCT03801473|11971192|FG001|NOT COMPLETED|Overall Study||2
10809303|NCT03828149|11971209|FG000|STARTED|First Intervention (Single Dose)||9
10809304|NCT03828149|11971210|FG001|STARTED|First Intervention (Single Dose)||8
10809305|NCT03828149|11971209|FG000|COMPLETED|First Intervention (Single Dose)||9
10809306|NCT03828149|11971210|FG001|COMPLETED|First Intervention (Single Dose)||8
10809307|NCT03828149|11971209|FG000|NOT COMPLETED|First Intervention (Single Dose)||0
10809308|NCT03828149|11971210|FG001|NOT COMPLETED|First Intervention (Single Dose)||0
10809309|NCT03828149|11971209|FG000|STARTED|Washout (6 Days)||9
10809310|NCT03828149|11971210|FG001|STARTED|Washout (6 Days)||8
10333985|NCT00337129|11470234|FG000|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until discontinuation criterion is met.|0
10333986|NCT00337129|11470234|FG000|NOT COMPLETED|Overall Study||40
10333987|NCT00337168|11470238|FG000|STARTED|Overall Study||37
10333988|NCT00337168|11470238|FG000|Eligible|Overall Study||37
10333989|NCT00337168|11470238|FG000|Eligible and Treated|Overall Study||36
10333990|NCT00337168|11470238|FG000|COMPLETED|Overall Study||29
10333991|NCT00337168|11470238|FG000|NOT COMPLETED|Overall Study||8
10333992|NCT00337181|11470245|FG000|STARTED|Overall Study||49
10333993|NCT00337181|11470246|FG001|STARTED|Overall Study||65
10333994|NCT00337181|11470245|FG000|COMPLETED|Overall Study||49
10333995|NCT00337181|11470246|FG001|COMPLETED|Overall Study||65
10333996|NCT00337181|11470245|FG000|NOT COMPLETED|Overall Study||0
10333997|NCT00337181|11470246|FG001|NOT COMPLETED|Overall Study||0
10333998|NCT00337194|11470254|FG000|STARTED|Overall Study||23
10333999|NCT00337194|11470255|FG001|STARTED|Overall Study||7
10334000|NCT00337194|11470254|FG000|COMPLETED|Overall Study||11
10334001|NCT00337194|11470255|FG001|COMPLETED|Overall Study||3
10334002|NCT00337194|11470254|FG000|NOT COMPLETED|Overall Study||12
10334003|NCT00337194|11470255|FG001|NOT COMPLETED|Overall Study||4
10334004|NCT00337207|11470263|FG000|STARTED|Overall Study||55
10334005|NCT00337207|11470263|FG000|COMPLETED|Overall Study||52
10334006|NCT00337207|11470263|FG000|NOT COMPLETED|Overall Study||3
10334007|NCT00337272|11470270|FG000|STARTED|Screening Period (Pre-randomization)|22 subjects were consented. All subjects received placebo during the 2 week screening period.|22
10334008|NCT00337272|11470271|FG001|STARTED|Screening Period (Pre-randomization)||0
10334009|NCT00337272|11470270|FG000|COMPLETED|Screening Period (Pre-randomization)|16 subjects completed the screening period and were eligible for randomization.|16
10334010|NCT00337272|11470271|FG001|COMPLETED|Screening Period (Pre-randomization)||0
10334011|NCT00337272|11470270|FG000|NOT COMPLETED|Screening Period (Pre-randomization)||6
10334012|NCT00337272|11470271|FG001|NOT COMPLETED|Screening Period (Pre-randomization)||0
10334013|NCT00337272|11470270|FG000|STARTED|Treatment Period|16 subjects were randomized to either placebo or ramelteon before starting treatment period.|7
10334014|NCT00337272|11470271|FG001|STARTED|Treatment Period|16 subjects were randomized to either placebo or ramelteon before starting treatment period.|9
10334015|NCT00337272|11470270|FG000|Randomization|Treatment Period||7
10334016|NCT00337272|11470271|FG001|Randomization|Treatment Period||9
10334017|NCT00337272|11470270|FG000|COMPLETED|Treatment Period||6
10334018|NCT00337272|11470271|FG001|COMPLETED|Treatment Period||7
10334019|NCT00337272|11470270|FG000|NOT COMPLETED|Treatment Period||1
10334020|NCT00337272|11470271|FG001|NOT COMPLETED|Treatment Period||2
10334021|NCT00337272|11470270|FG000|STARTED|Withdrawal Period|Subjects in both groups received placebo for one week.|6
10334022|NCT00337272|11470271|FG001|STARTED|Withdrawal Period|Subjects in both groups received placebo for one week.|7
10334023|NCT00337272|11470270|FG000|COMPLETED|Withdrawal Period||6
10334024|NCT00337272|11470271|FG001|COMPLETED|Withdrawal Period||6
10334025|NCT00337272|11470270|FG000|NOT COMPLETED|Withdrawal Period||0
10334026|NCT00337272|11470271|FG001|NOT COMPLETED|Withdrawal Period||1
10334027|NCT00337285|11470277|FG000|STARTED|Overall Study||349
10334028|NCT00337285|11470277|FG000|COMPLETED|Overall Study||191
10334029|NCT00337285|11470277|FG000|NOT COMPLETED|Overall Study||158
10706431|NCT02609178|11871015|FG004|COMPLETED|5-minute Washout Time||0
10706432|NCT02609178|11871016|FG005|COMPLETED|5-minute Washout Time||2
10706433|NCT02609178|11871011|FG000|NOT COMPLETED|5-minute Washout Time||0
10706434|NCT02609178|11871012|FG001|NOT COMPLETED|5-minute Washout Time||0
10706435|NCT02609178|11871013|FG002|NOT COMPLETED|5-minute Washout Time||0
10706436|NCT02609178|11871014|FG003|NOT COMPLETED|5-minute Washout Time||0
10706437|NCT02609178|11871015|FG004|NOT COMPLETED|5-minute Washout Time||0
10334030|NCT00337350|11470283|FG000|STARTED|Overall Study||9
10334031|NCT00337350|11470284|FG001|STARTED|Overall Study||11
10334032|NCT00337350|11470283|FG000|COMPLETED|Overall Study||8
10706438|NCT02609178|11871016|FG005|NOT COMPLETED|5-minute Washout Time||0
10706439|NCT02609178|11871011|FG000|STARTED|Second Crown||0
10706440|NCT02609178|11871012|FG001|STARTED|Second Crown||1
10706441|NCT02609178|11871013|FG002|STARTED|Second Crown||5
10706442|NCT02609178|11871014|FG003|STARTED|Second Crown||2
10706443|NCT02609178|11871015|FG004|STARTED|Second Crown||0
10706444|NCT02609178|11871016|FG005|STARTED|Second Crown||2
10706445|NCT02609178|11871011|FG000|COMPLETED|Second Crown||0
10706446|NCT02609178|11871012|FG001|COMPLETED|Second Crown||1
10706447|NCT02609178|11871013|FG002|COMPLETED|Second Crown||5
10706448|NCT02609178|11871014|FG003|COMPLETED|Second Crown||2
10706449|NCT02609178|11871015|FG004|COMPLETED|Second Crown||0
10706450|NCT02609178|11871016|FG005|COMPLETED|Second Crown||2
10706451|NCT02609178|11871011|FG000|NOT COMPLETED|Second Crown||0
10706452|NCT02609178|11871012|FG001|NOT COMPLETED|Second Crown||0
10706453|NCT02609178|11871013|FG002|NOT COMPLETED|Second Crown||0
10706454|NCT02609178|11871014|FG003|NOT COMPLETED|Second Crown||0
10706455|NCT02609178|11871015|FG004|NOT COMPLETED|Second Crown||0
10706456|NCT02609178|11871016|FG005|NOT COMPLETED|Second Crown||0
10706457|NCT02609178|11871011|FG000|STARTED|5-minute Washout Time||0
10706458|NCT02609178|11871012|FG001|STARTED|5-minute Washout Time||1
10706459|NCT02609178|11871013|FG002|STARTED|5-minute Washout Time||5
10706460|NCT02609178|11871014|FG003|STARTED|5-minute Washout Time||2
10706461|NCT02609178|11871015|FG004|STARTED|5-minute Washout Time||0
10706462|NCT02609178|11871016|FG005|STARTED|5-minute Washout Time||2
10706463|NCT02609178|11871011|FG000|COMPLETED|5-minute Washout Time||0
10706464|NCT02609178|11871012|FG001|COMPLETED|5-minute Washout Time||1
10706465|NCT02609178|11871013|FG002|COMPLETED|5-minute Washout Time||5
10706466|NCT02609178|11871014|FG003|COMPLETED|5-minute Washout Time||2
10706467|NCT02609178|11871015|FG004|COMPLETED|5-minute Washout Time||0
10706468|NCT02609178|11871016|FG005|COMPLETED|5-minute Washout Time||2
10706469|NCT02609178|11871011|FG000|NOT COMPLETED|5-minute Washout Time||0
10706470|NCT02609178|11871012|FG001|NOT COMPLETED|5-minute Washout Time||0
10706471|NCT02609178|11871013|FG002|NOT COMPLETED|5-minute Washout Time||0
10706472|NCT02609178|11871014|FG003|NOT COMPLETED|5-minute Washout Time||0
10706473|NCT02609178|11871015|FG004|NOT COMPLETED|5-minute Washout Time||0
10706474|NCT02609178|11871016|FG005|NOT COMPLETED|5-minute Washout Time||0
10706475|NCT02609178|11871011|FG000|STARTED|Third Crown||0
10706476|NCT02609178|11871012|FG001|STARTED|Third Crown||1
10457394|NCT01010633|11605162|FG001|NOT COMPLETED|Overall Study||5
10457395|NCT01010750|11605174|FG000|STARTED|First Intervention||3
10457396|NCT01010750|11605175|FG001|STARTED|First Intervention||4
10457397|NCT01010750|11605176|FG002|STARTED|First Intervention||3
10457398|NCT01010750|11605177|FG003|STARTED|First Intervention||3
10457399|NCT01010750|11605178|FG004|STARTED|First Intervention||2
10706477|NCT02609178|11871013|FG002|STARTED|Third Crown||5
10706478|NCT02609178|11871014|FG003|STARTED|Third Crown||2
10706479|NCT02609178|11871015|FG004|STARTED|Third Crown||0
10706480|NCT02609178|11871016|FG005|STARTED|Third Crown||2
10706481|NCT02609178|11871011|FG000|COMPLETED|Third Crown||0
10706482|NCT02609178|11871012|FG001|COMPLETED|Third Crown||1
10706483|NCT02609178|11871013|FG002|COMPLETED|Third Crown||5
10706484|NCT02609178|11871014|FG003|COMPLETED|Third Crown||2
10706485|NCT02609178|11871015|FG004|COMPLETED|Third Crown||0
10334033|NCT00337350|11470284|FG001|COMPLETED|Overall Study||10
10334034|NCT00337350|11470283|FG000|NOT COMPLETED|Overall Study||1
10334035|NCT00337350|11470284|FG001|NOT COMPLETED|Overall Study||1
10334036|NCT00337428|11470292|FG000|STARTED|Overall Study||419
10457400|NCT01010750|11605179|FG005|STARTED|First Intervention||3
10457401|NCT01010750|11605174|FG000|COMPLETED|First Intervention||3
10457402|NCT01010750|11605175|FG001|COMPLETED|First Intervention||4
10457403|NCT01010750|11605176|FG002|COMPLETED|First Intervention||3
10457404|NCT01010750|11605177|FG003|COMPLETED|First Intervention||3
10457405|NCT01010750|11605178|FG004|COMPLETED|First Intervention||2
10457406|NCT01010750|11605179|FG005|COMPLETED|First Intervention||3
10706486|NCT02609178|11871016|FG005|COMPLETED|Third Crown||2
10706487|NCT02609178|11871011|FG000|NOT COMPLETED|Third Crown||0
10706488|NCT02609178|11871012|FG001|NOT COMPLETED|Third Crown||0
10706489|NCT02609178|11871013|FG002|NOT COMPLETED|Third Crown||0
10706490|NCT02609178|11871014|FG003|NOT COMPLETED|Third Crown||0
10706491|NCT02609178|11871015|FG004|NOT COMPLETED|Third Crown||0
10706492|NCT02609178|11871016|FG005|NOT COMPLETED|Third Crown||0
10706493|NCT02609204|11871022|FG000|STARTED|Overall Study||51
10706494|NCT02609204|11871022|FG000|COMPLETED|Overall Study||51
10706495|NCT02609204|11871022|FG000|NOT COMPLETED|Overall Study||0
10706496|NCT02609308|11871029|FG000|STARTED|Overall Study||10
10706497|NCT02609308|11871030|FG001|STARTED|Overall Study||11
10706498|NCT02609308|11871029|FG000|COMPLETED|Overall Study||10
10706499|NCT02609308|11871030|FG001|COMPLETED|Overall Study||11
10706500|NCT02609308|11871029|FG000|NOT COMPLETED|Overall Study||0
10706501|NCT02609308|11871030|FG001|NOT COMPLETED|Overall Study||0
10706502|NCT02609399|11871038|FG000|STARTED|Influenza Season 2015-2016||27
10706503|NCT02609399|11871039|FG001|STARTED|Influenza Season 2015-2016||31
10706504|NCT02609399|11871038|FG000|COMPLETED|Influenza Season 2015-2016||24
10706505|NCT02609399|11871039|FG001|COMPLETED|Influenza Season 2015-2016||29
10706506|NCT02609399|11871038|FG000|NOT COMPLETED|Influenza Season 2015-2016||3
10706507|NCT02609399|11871039|FG001|NOT COMPLETED|Influenza Season 2015-2016||2
10706508|NCT02609399|11871038|FG000|STARTED|Influenza Season 2016-2017||58
10706509|NCT02609399|11871039|FG001|STARTED|Influenza Season 2016-2017||64
10706510|NCT02609399|11871038|FG000|COMPLETED|Influenza Season 2016-2017||49
10649601|NCT02163499|11809772|FG000|NOT COMPLETED|Acute Phase: ZS 10 g TID||5
10649602|NCT02163499|11809772|FG000|STARTED|Extended Dosing Phase: ZS||746
10334037|NCT00337428|11470293|FG001|STARTED|Overall Study||424
10334038|NCT00337428|11470292|FG000|COMPLETED|Overall Study||415
10334039|NCT00337428|11470293|FG001|COMPLETED|Overall Study||421
10334040|NCT00337428|11470292|FG000|NOT COMPLETED|Overall Study||4
10334041|NCT00337428|11470293|FG001|NOT COMPLETED|Overall Study||3
10334042|NCT00337467|11470299|FG000|STARTED|Overall Study||61
10334043|NCT00337467|11470299|FG000|Discontinued Prior to Week 96|Overall Study|5 of these participants discontinued prior to Week 48|10
10334044|NCT00337467|11470299|FG000|COMPLETED|Overall Study||51
10334045|NCT00337467|11470299|FG000|NOT COMPLETED|Overall Study||10
10334046|NCT00337571|11470310|FG000|STARTED|Overall Study||52
10334047|NCT00337571|11470311|FG001|STARTED|Overall Study||53
10334048|NCT00337571|11470312|FG002|STARTED|Overall Study||59
10334049|NCT00337571|11470313|FG003|STARTED|Overall Study||54
10334050|NCT00337571|11470310|FG000|COMPLETED|Overall Study||38
10334051|NCT00337571|11470311|FG001|COMPLETED|Overall Study||44
10334052|NCT00337571|11470312|FG002|COMPLETED|Overall Study||49
10334053|NCT00337571|11470313|FG003|COMPLETED|Overall Study||47
10334054|NCT00337571|11470310|FG000|NOT COMPLETED|Overall Study||14
10334055|NCT00337571|11470311|FG001|NOT COMPLETED|Overall Study||9
10334056|NCT00337571|11470312|FG002|NOT COMPLETED|Overall Study||10
10334057|NCT00337571|11470313|FG003|NOT COMPLETED|Overall Study||7
10334058|NCT00337610|11470325|FG000|STARTED|Overall Study||96
10334059|NCT00337610|11470326|FG001|STARTED|Overall Study||94
10334060|NCT00337610|11470325|FG000|Completed Week 18|Overall Study||89
10334061|NCT00337610|11470326|FG001|Completed Week 18|Overall Study||82
10334062|NCT00337610|11470325|FG000|COMPLETED|Overall Study||79
10334063|NCT00337610|11470326|FG001|COMPLETED|Overall Study||80
10334064|NCT00337610|11470325|FG000|NOT COMPLETED|Overall Study||17
10334065|NCT00337610|11470326|FG001|NOT COMPLETED|Overall Study||14
10334066|NCT00337662|11470335|FG000|STARTED|Study Period II||0
10334067|NCT00337662|11470336|FG001|STARTED|Study Period II||0
10334068|NCT00337662|11470337|FG002|STARTED|Study Period II||0
10334069|NCT00337662|11470338|FG003|STARTED|Study Period II||628
10334070|NCT00337662|11470335|FG000|COMPLETED|Study Period II||0
10334071|NCT00337662|11470336|FG001|COMPLETED|Study Period II||0
10334072|NCT00337662|11470337|FG002|COMPLETED|Study Period II||0
10334073|NCT00337662|11470338|FG003|COMPLETED|Study Period II||522
10334074|NCT00337662|11470335|FG000|NOT COMPLETED|Study Period II||0
10334075|NCT00337662|11470336|FG001|NOT COMPLETED|Study Period II||0
10334076|NCT00337662|11470337|FG002|NOT COMPLETED|Study Period II||0
10334077|NCT00337662|11470338|FG003|NOT COMPLETED|Study Period II||106
10334078|NCT00337662|11470335|FG000|STARTED|Study Period III||186
10334079|NCT00337662|11470336|FG001|STARTED|Study Period III||192
10334080|NCT00337662|11470337|FG002|STARTED|Study Period III||144
10334081|NCT00337662|11470338|FG003|STARTED|Study Period III||0
10706511|NCT02609399|11871039|FG001|COMPLETED|Influenza Season 2016-2017||59
10706512|NCT02609399|11871038|FG000|NOT COMPLETED|Influenza Season 2016-2017||9
10706513|NCT02609399|11871039|FG001|NOT COMPLETED|Influenza Season 2016-2017||5
10706514|NCT02609607|11871049|FG000|STARTED|Overall Study||6
10706515|NCT02609607|11871050|FG001|STARTED|Overall Study||5
10706516|NCT02609607|11871049|FG000|COMPLETED|Overall Study||6
10334082|NCT00337662|11470335|FG000|COMPLETED|Study Period III||126
10334083|NCT00337662|11470336|FG001|COMPLETED|Study Period III||134
10706517|NCT02609607|11871050|FG001|COMPLETED|Overall Study||4
10334084|NCT00337662|11470337|FG002|COMPLETED|Study Period III||100
10334085|NCT00337662|11470338|FG003|COMPLETED|Study Period III||0
10334086|NCT00337662|11470335|FG000|NOT COMPLETED|Study Period III||60
10706518|NCT02609607|11871049|FG000|NOT COMPLETED|Overall Study||0
10706519|NCT02609607|11871050|FG001|NOT COMPLETED|Overall Study||1
10706520|NCT02609633|11871058|FG000|STARTED|Overall Study||42
10706521|NCT02609633|11871059|FG001|STARTED|Overall Study||56
10457407|NCT01010750|11605174|FG000|NOT COMPLETED|First Intervention||0
10457408|NCT01010750|11605175|FG001|NOT COMPLETED|First Intervention||0
10457409|NCT01010750|11605176|FG002|NOT COMPLETED|First Intervention||0
10457410|NCT01010750|11605177|FG003|NOT COMPLETED|First Intervention||0
10457411|NCT01010750|11605178|FG004|NOT COMPLETED|First Intervention||0
10457412|NCT01010750|11605179|FG005|NOT COMPLETED|First Intervention||0
10457413|NCT01010750|11605174|FG000|STARTED|Second Intervention||3
10457414|NCT01010750|11605175|FG001|STARTED|Second Intervention||4
10457415|NCT01010750|11605176|FG002|STARTED|Second Intervention||3
10457416|NCT01010750|11605177|FG003|STARTED|Second Intervention||3
10457417|NCT01010750|11605178|FG004|STARTED|Second Intervention||2
10457418|NCT01010750|11605179|FG005|STARTED|Second Intervention||3
10457419|NCT01010750|11605174|FG000|COMPLETED|Second Intervention||3
10457420|NCT01010750|11605175|FG001|COMPLETED|Second Intervention||3
10706522|NCT02609633|11871058|FG000|Full Analysis Set (FAS)|Overall Study||32
10706523|NCT02609633|11871059|FG001|Full Analysis Set (FAS)|Overall Study||46
10706524|NCT02609633|11871058|FG000|COMPLETED|Overall Study||37
10706525|NCT02609633|11871059|FG001|COMPLETED|Overall Study||54
10706526|NCT02609633|11871058|FG000|NOT COMPLETED|Overall Study||5
10706527|NCT02609633|11871059|FG001|NOT COMPLETED|Overall Study||2
10706528|NCT02609659|11871066|FG000|STARTED|Overall Study||105
10706529|NCT02609659|11871066|FG000|COMPLETED|Overall Study||97
10706530|NCT02609659|11871066|FG000|NOT COMPLETED|Overall Study||8
10706531|NCT02609672|11871072|FG000|STARTED|Overall Study||12
10809311|NCT03828149|11971209|FG000|COMPLETED|Washout (6 Days)||9
10809312|NCT03828149|11971210|FG001|COMPLETED|Washout (6 Days)||8
10809313|NCT03828149|11971209|FG000|NOT COMPLETED|Washout (6 Days)||0
10809314|NCT03828149|11971210|FG001|NOT COMPLETED|Washout (6 Days)||0
10809315|NCT03828149|11971209|FG000|STARTED|Second Intervention (Single Dose)||9
10809316|NCT03828149|11971210|FG001|STARTED|Second Intervention (Single Dose)||8
10706532|NCT02609672|11871073|FG001|STARTED|Overall Study||12
10706533|NCT02609672|11871072|FG000|COMPLETED|Overall Study||9
10706534|NCT02609672|11871073|FG001|COMPLETED|Overall Study||11
10706535|NCT02609672|11871072|FG000|NOT COMPLETED|Overall Study||3
10706536|NCT02609672|11871073|FG001|NOT COMPLETED|Overall Study||1
10706537|NCT02609841|11871081|FG000|STARTED|Overall Study||240
10706538|NCT02609841|11871081|FG000|COMPLETED|Overall Study||212
10706539|NCT02609841|11871081|FG000|NOT COMPLETED|Overall Study||28
10809317|NCT03828149|11971209|FG000|COMPLETED|Second Intervention (Single Dose)||9
10809318|NCT03828149|11971210|FG001|COMPLETED|Second Intervention (Single Dose)||8
10809319|NCT03828149|11971209|FG000|NOT COMPLETED|Second Intervention (Single Dose)||0
10809320|NCT03828149|11971210|FG001|NOT COMPLETED|Second Intervention (Single Dose)||0
10809321|NCT03835221|11971216|FG000|STARTED|Methafilcon A||43
10809322|NCT03835221|11971216|FG000|COMPLETED|Methafilcon A||42
10809323|NCT03835221|11971216|FG000|NOT COMPLETED|Methafilcon A||1
10809324|NCT03835221|11971216|FG000|STARTED|Fanfilcon A||42
10809325|NCT03835221|11971216|FG000|COMPLETED|Fanfilcon A||42
10809326|NCT03835221|11971216|FG000|NOT COMPLETED|Fanfilcon A||0
10809327|NCT03819634|11971222|FG000|STARTED|Overall Study||24
10809328|NCT03819634|11971222|FG000|COMPLETED|Overall Study||22
10809329|NCT03819634|11971222|FG000|NOT COMPLETED|Overall Study||2
10809330|NCT03812679|11971226|FG000|STARTED|Overall Study||22
10809331|NCT03812679|11971226|FG000|COMPLETED|Overall Study||14
10809332|NCT03812679|11971226|FG000|NOT COMPLETED|Overall Study||8
10809333|NCT03809052|11971241|FG000|STARTED|Overall Study||6
10809334|NCT03809052|11971242|FG001|STARTED|Overall Study||6
10809335|NCT03809052|11971243|FG002|STARTED|Overall Study||6
10809336|NCT03809052|11971244|FG003|STARTED|Overall Study||6
10809337|NCT03809052|11971245|FG004|STARTED|Overall Study||6
10809338|NCT03809052|11971246|FG005|STARTED|Overall Study||6
10809339|NCT03809052|11971247|FG006|STARTED|Overall Study||6
10809340|NCT03809052|11971248|FG007|STARTED|Overall Study||14
10809341|NCT03809052|11971249|FG008|STARTED|Overall Study||8
10706540|NCT02609984|11871089|FG000|STARTED|Overall Study||45
10706541|NCT02609984|11871090|FG001|STARTED|Overall Study||44
10706542|NCT02609984|11871089|FG000|Treated|Overall Study||45
10706543|NCT02609984|11871090|FG001|Treated|Overall Study||43
10706544|NCT02609984|11871089|FG000|COMPLETED|Overall Study||1
10706545|NCT02609984|11871090|FG001|COMPLETED|Overall Study||5
10706546|NCT02609984|11871089|FG000|NOT COMPLETED|Overall Study||44
10706547|NCT02609984|11871090|FG001|NOT COMPLETED|Overall Study||39
10334087|NCT00337662|11470336|FG001|NOT COMPLETED|Study Period III||58
10334088|NCT00337662|11470337|FG002|NOT COMPLETED|Study Period III||44
10334089|NCT00337662|11470338|FG003|NOT COMPLETED|Study Period III||0
10334090|NCT00337727|11470351|FG000|STARTED|Overall Study||430
10334091|NCT00337727|11470352|FG001|STARTED|Overall Study||418
10334092|NCT00337727|11470351|FG000|COMPLETED|Overall Study||412
10334093|NCT00337727|11470352|FG001|COMPLETED|Overall Study||406
10706548|NCT02610140|11871098|FG000|STARTED|Randomization and Treatment Period||166
10334094|NCT00337727|11470351|FG000|NOT COMPLETED|Overall Study||18
10706549|NCT02610140|11871099|FG001|STARTED|Randomization and Treatment Period||82
10706550|NCT02610140|11871098|FG000|Participants Received Treatment|Randomization and Treatment Period|Safety analysis set|163
10706551|NCT02610140|11871099|FG001|Participants Received Treatment|Randomization and Treatment Period|Safety analysis set|72
10706552|NCT02610140|11871098|FG000|COMPLETED|Randomization and Treatment Period||0
10706553|NCT02610140|11871099|FG001|COMPLETED|Randomization and Treatment Period||0
10706554|NCT02610140|11871098|FG000|NOT COMPLETED|Randomization and Treatment Period||166
10706555|NCT02610140|11871099|FG001|NOT COMPLETED|Randomization and Treatment Period||82
10706556|NCT02610140|11871098|FG000|STARTED|Safety Follow-up||102
10706557|NCT02610140|11871099|FG001|STARTED|Safety Follow-up||45
10706558|NCT02610140|11871098|FG000|COMPLETED|Safety Follow-up||57
10706559|NCT02610140|11871099|FG001|COMPLETED|Safety Follow-up||21
10706560|NCT02610140|11871098|FG000|NOT COMPLETED|Safety Follow-up||45
10706561|NCT02610140|11871099|FG001|NOT COMPLETED|Safety Follow-up||24
10706562|NCT02610140|11871098|FG000|STARTED|Active Follow-up||48
10706563|NCT02610140|11871099|FG001|STARTED|Active Follow-up||26
10706564|NCT02610140|11871098|FG000|COMPLETED|Active Follow-up||0
10706565|NCT02610140|11871099|FG001|COMPLETED|Active Follow-up||0
10706566|NCT02610140|11871098|FG000|NOT COMPLETED|Active Follow-up||48
10706567|NCT02610140|11871099|FG001|NOT COMPLETED|Active Follow-up||26
10706568|NCT02610140|11871098|FG000|STARTED|Long-term Follow-up||123
10706569|NCT02610140|11871099|FG001|STARTED|Long-term Follow-up||66
10706570|NCT02610140|11871098|FG000|COMPLETED|Long-term Follow-up||0
10706571|NCT02610140|11871099|FG001|COMPLETED|Long-term Follow-up||0
10706572|NCT02610140|11871098|FG000|NOT COMPLETED|Long-term Follow-up||123
10706573|NCT02610140|11871099|FG001|NOT COMPLETED|Long-term Follow-up||66
10706574|NCT02610192|11871105|FG000|STARTED|Overall Study|52 subjects had signed consent form, but 50 subjects have been treated. 2 subjects became SF.|50
10706575|NCT02610192|11871105|FG000|COMPLETED|Overall Study||41
10706576|NCT02610192|11871105|FG000|NOT COMPLETED|Overall Study||9
10706577|NCT02610231|11871109|FG000|STARTED|Overall Study||239
10706578|NCT02610231|11871109|FG000|COMPLETED|Overall Study||179
10706579|NCT02610231|11871109|FG000|NOT COMPLETED|Overall Study||60
10706580|NCT02610634|11871118|FG000|STARTED|Overall Study||60
10706581|NCT02610634|11871119|FG001|STARTED|Overall Study||40
10706582|NCT02610634|11871118|FG000|COMPLETED|Overall Study||60
10706583|NCT02610634|11871119|FG001|COMPLETED|Overall Study||40
10706584|NCT02610634|11871118|FG000|NOT COMPLETED|Overall Study||0
10706585|NCT02610634|11871119|FG001|NOT COMPLETED|Overall Study||0
10706586|NCT02610725|11871125|FG000|STARTED|Overall Study||281
10706587|NCT02610725|11871125|FG000|COMPLETED|Overall Study||75
10706588|NCT02610725|11871125|FG000|NOT COMPLETED|Overall Study||206
10706589|NCT02610816|11871131|FG000|STARTED|Phase 1||38
10706590|NCT02610816|11871132|FG001|STARTED|Phase 1||25
10706591|NCT02610816|11871133|FG002|STARTED|Phase 1||0
10706592|NCT02610816|11871134|FG003|STARTED|Phase 1||0
10706593|NCT02610816|11871131|FG000|COMPLETED|Phase 1||34
10706594|NCT02610816|11871132|FG001|COMPLETED|Phase 1||17
10706595|NCT02610816|11871133|FG002|COMPLETED|Phase 1||0
10706596|NCT02610816|11871134|FG003|COMPLETED|Phase 1||0
10457421|NCT01010750|11605176|FG002|COMPLETED|Second Intervention||3
10457422|NCT01010750|11605177|FG003|COMPLETED|Second Intervention||3
10457423|NCT01010750|11605178|FG004|COMPLETED|Second Intervention||2
10457424|NCT01010750|11605179|FG005|COMPLETED|Second Intervention||3
10457425|NCT01010750|11605174|FG000|NOT COMPLETED|Second Intervention||0
10457426|NCT01010750|11605175|FG001|NOT COMPLETED|Second Intervention||1
10457427|NCT01010750|11605176|FG002|NOT COMPLETED|Second Intervention||0
10457428|NCT01010750|11605177|FG003|NOT COMPLETED|Second Intervention||0
10457429|NCT01010750|11605178|FG004|NOT COMPLETED|Second Intervention||0
10457430|NCT01010750|11605179|FG005|NOT COMPLETED|Second Intervention||0
10457431|NCT01010750|11605174|FG000|STARTED|Third Intervention||3
10457432|NCT01010750|11605175|FG001|STARTED|Third Intervention||3
10809342|NCT03809052|11971250|FG009|STARTED|Overall Study||8
10809343|NCT03809052|11971251|FG010|STARTED|Overall Study||6
10809344|NCT03809052|11971241|FG000|COMPLETED|Overall Study||6
10809345|NCT03809052|11971242|FG001|COMPLETED|Overall Study||6
10809346|NCT03809052|11971243|FG002|COMPLETED|Overall Study||6
10809347|NCT03809052|11971244|FG003|COMPLETED|Overall Study||6
10809348|NCT03809052|11971245|FG004|COMPLETED|Overall Study||6
10809349|NCT03809052|11971246|FG005|COMPLETED|Overall Study||6
10809350|NCT03809052|11971247|FG006|COMPLETED|Overall Study||6
10809351|NCT03809052|11971248|FG007|COMPLETED|Overall Study||14
10809352|NCT03809052|11971249|FG008|COMPLETED|Overall Study||8
10809353|NCT03809052|11971250|FG009|COMPLETED|Overall Study||8
10809354|NCT03809052|11971251|FG010|COMPLETED|Overall Study||6
10809355|NCT03809052|11971241|FG000|NOT COMPLETED|Overall Study||0
10809356|NCT03809052|11971242|FG001|NOT COMPLETED|Overall Study||0
10809357|NCT03809052|11971243|FG002|NOT COMPLETED|Overall Study||0
10809358|NCT03809052|11971244|FG003|NOT COMPLETED|Overall Study||0
10809359|NCT03809052|11971245|FG004|NOT COMPLETED|Overall Study||0
10809360|NCT03809052|11971246|FG005|NOT COMPLETED|Overall Study||0
10809361|NCT03809052|11971247|FG006|NOT COMPLETED|Overall Study||0
10809362|NCT03809052|11971248|FG007|NOT COMPLETED|Overall Study||0
10809363|NCT03809052|11971249|FG008|NOT COMPLETED|Overall Study||0
10809364|NCT03809052|11971250|FG009|NOT COMPLETED|Overall Study||0
10809365|NCT03809052|11971251|FG010|NOT COMPLETED|Overall Study||0
10809366|NCT03801148|11971281|FG000|STARTED|Period 1 (2 Days)||31
10809367|NCT03801148|11971282|FG001|STARTED|Period 1 (2 Days)||31
10809368|NCT03801148|11971283|FG002|STARTED|Period 1 (2 Days)||30
10809369|NCT03801148|11971284|FG003|STARTED|Period 1 (2 Days)||30
10809370|NCT03801148|11971281|FG000|COMPLETED|Period 1 (2 Days)||30
10334095|NCT00337727|11470352|FG001|NOT COMPLETED|Overall Study||12
10334096|NCT00337779|11470360|FG000|STARTED|Overall Study||586
10334097|NCT00337779|11470361|FG001|STARTED|Overall Study||569
10334098|NCT00337779|11470360|FG000|COMPLETED|Overall Study||534
10334099|NCT00337779|11470361|FG001|COMPLETED|Overall Study||490
10334100|NCT00337779|11470360|FG000|NOT COMPLETED|Overall Study||52
10334101|NCT00337779|11470361|FG001|NOT COMPLETED|Overall Study||79
10334102|NCT00337818|11470370|FG000|STARTED|Overall Study||458
10334103|NCT00337818|11470371|FG001|STARTED|Overall Study||154
10334104|NCT00337818|11470372|FG002|STARTED|Overall Study||158
10334105|NCT00337818|11470370|FG000|COMPLETED|Overall Study||169
10334106|NCT00337818|11470371|FG001|COMPLETED|Overall Study||63
10334107|NCT00337818|11470372|FG002|COMPLETED|Overall Study||51
10334108|NCT00337818|11470370|FG000|NOT COMPLETED|Overall Study||289
10334109|NCT00337818|11470371|FG001|NOT COMPLETED|Overall Study||91
10334110|NCT00337818|11470372|FG002|NOT COMPLETED|Overall Study||107
10334111|NCT00337935|11470382|FG000|STARTED|Overall Study||39
10334112|NCT00337935|11470383|FG001|STARTED|Overall Study||118
10334113|NCT00337935|11470382|FG000|COMPLETED|Overall Study||29
10334114|NCT00337935|11470383|FG001|COMPLETED|Overall Study||91
10334115|NCT00337935|11470382|FG000|NOT COMPLETED|Overall Study||10
10334116|NCT00337935|11470383|FG001|NOT COMPLETED|Overall Study||27
10334117|NCT00337987|11470390|FG000|STARTED|Overall Study||49
10334118|NCT00337987|11470390|FG000|COMPLETED|Overall Study||49
10334119|NCT00337987|11470390|FG000|NOT COMPLETED|Overall Study||0
10334120|NCT00338039|11470394|FG000|STARTED|Overall Study||69
10334121|NCT00338039|11470394|FG000|COMPLETED|Overall Study||69
10334122|NCT00338039|11470394|FG000|NOT COMPLETED|Overall Study||0
10334123|NCT00338286|11470400|FG000|STARTED|Overall Study||1048
10334124|NCT00338286|11470401|FG001|STARTED|Overall Study||1050
10334125|NCT00338286|11470400|FG000|COMPLETED|Overall Study||815
10334126|NCT00338286|11470401|FG001|COMPLETED|Overall Study||837
10334127|NCT00338286|11470400|FG000|NOT COMPLETED|Overall Study||233
10334128|NCT00338286|11470401|FG001|NOT COMPLETED|Overall Study||213
10334129|NCT00338598|11470409|FG000|STARTED|Overall Study||10
10334130|NCT00338598|11470410|FG001|STARTED|Overall Study||10
10334131|NCT00338598|11470409|FG000|COMPLETED|Overall Study||10
10334132|NCT00338598|11470410|FG001|COMPLETED|Overall Study||8
10334133|NCT00338598|11470409|FG000|NOT COMPLETED|Overall Study||0
10334134|NCT00338598|11470410|FG001|NOT COMPLETED|Overall Study||2
10334135|NCT00338728|11470416|FG000|STARTED|Overall Study||59
10334136|NCT00338728|11470416|FG000|COMPLETED|Overall Study||45
10334137|NCT00338728|11470416|FG000|NOT COMPLETED|Overall Study||14
10334138|NCT00338741|11470422|FG000|STARTED|Overall Study|2 subjects signed a consent form but no data were received for either subject|34
10334139|NCT00338741|11470423|FG001|STARTED|Overall Study||2
10334140|NCT00338741|11470422|FG000|COMPLETED|Overall Study||32
10334141|NCT00338741|11470423|FG001|COMPLETED|Overall Study||2
10809371|NCT03801148|11971282|FG001|COMPLETED|Period 1 (2 Days)||30
10809372|NCT03801148|11971283|FG002|COMPLETED|Period 1 (2 Days)||30
10809373|NCT03801148|11971284|FG003|COMPLETED|Period 1 (2 Days)||30
10334142|NCT00338741|11470422|FG000|NOT COMPLETED|Overall Study||2
10334143|NCT00338741|11470423|FG001|NOT COMPLETED|Overall Study||0
10334144|NCT00338806|11470431|FG000|STARTED|Acute Phase||2
10334145|NCT00338806|11470432|FG001|STARTED|Acute Phase||5
10334146|NCT00338806|11470431|FG000|COMPLETED|Acute Phase||2
10334147|NCT00338806|11470432|FG001|COMPLETED|Acute Phase||4
10334148|NCT00338806|11470431|FG000|NOT COMPLETED|Acute Phase||0
10334149|NCT00338806|11470432|FG001|NOT COMPLETED|Acute Phase||1
10334150|NCT00338806|11470431|FG000|STARTED|Follow-up||2
10334151|NCT00338806|11470432|FG001|STARTED|Follow-up||4
10334152|NCT00338806|11470431|FG000|COMPLETED|Follow-up||1
10334153|NCT00338806|11470432|FG001|COMPLETED|Follow-up||1
10334154|NCT00338806|11470431|FG000|NOT COMPLETED|Follow-up||1
10334155|NCT00338806|11470432|FG001|NOT COMPLETED|Follow-up||3
10334156|NCT00338884|11470440|FG000|STARTED|Overall Study||120
10334157|NCT00338884|11470440|FG000|Received Treatment|Overall Study||119
10334158|NCT00338884|11470440|FG000|COMPLETED|Overall Study||42
10334159|NCT00338884|11470440|FG000|NOT COMPLETED|Overall Study||78
10334160|NCT00338949|11470446|FG000|STARTED|Subject Screening||36
10706597|NCT02610816|11871131|FG000|NOT COMPLETED|Phase 1||4
10706598|NCT02610816|11871132|FG001|NOT COMPLETED|Phase 1||8
10706599|NCT02610816|11871133|FG002|NOT COMPLETED|Phase 1||0
10706600|NCT02610816|11871134|FG003|NOT COMPLETED|Phase 1||0
10706601|NCT02610816|11871131|FG000|STARTED|Phase 2||0
10706602|NCT02610816|11871132|FG001|STARTED|Phase 2||0
10706603|NCT02610816|11871133|FG002|STARTED|Phase 2||19
10706604|NCT02610816|11871134|FG003|STARTED|Phase 2||10
10706605|NCT02610816|11871131|FG000|COMPLETED|Phase 2||0
10706606|NCT02610816|11871132|FG001|COMPLETED|Phase 2||0
10706607|NCT02610816|11871133|FG002|COMPLETED|Phase 2||8
10706608|NCT02610816|11871134|FG003|COMPLETED|Phase 2||4
10334161|NCT00338949|11470447|FG001|STARTED|Subject Screening||41
10706609|NCT02610816|11871131|FG000|NOT COMPLETED|Phase 2||0
10706610|NCT02610816|11871132|FG001|NOT COMPLETED|Phase 2||0
10706611|NCT02610816|11871133|FG002|NOT COMPLETED|Phase 2||11
10706612|NCT02610816|11871134|FG003|NOT COMPLETED|Phase 2||6
10706613|NCT02610842|11871144|FG000|STARTED|Overall Study||27
10706614|NCT02610842|11871144|FG000|COMPLETED|Overall Study||22
10334162|NCT00338949|11470446|FG000|COMPLETED|Subject Screening||25
10334163|NCT00338949|11470447|FG001|COMPLETED|Subject Screening||30
10334164|NCT00338949|11470446|FG000|NOT COMPLETED|Subject Screening||11
10334165|NCT00338949|11470447|FG001|NOT COMPLETED|Subject Screening||11
10334166|NCT00338949|11470446|FG000|STARTED|Randomization||25
10334167|NCT00338949|11470447|FG001|STARTED|Randomization||30
10334168|NCT00338949|11470446|FG000|COMPLETED|Randomization|1 subject withdrew after relapse and hospitalization|24
10334169|NCT00338949|11470447|FG001|COMPLETED|Randomization|"Reasons for drop out:~2- insomnia 2- symptom exacerbation~1- akathisia"|25
10334170|NCT00338949|11470446|FG000|NOT COMPLETED|Randomization||1
10334171|NCT00338949|11470447|FG001|NOT COMPLETED|Randomization||5
10334172|NCT00338962|11470457|FG000|STARTED|Overall Study||22
10334173|NCT00338962|11470458|FG001|STARTED|Overall Study||20
10334174|NCT00338962|11470459|FG002|STARTED|Overall Study||22
10334175|NCT00338962|11470460|FG003|STARTED|Overall Study||24
10334176|NCT00338962|11470457|FG000|COMPLETED|Overall Study||14
10334177|NCT00338962|11470458|FG001|COMPLETED|Overall Study||16
10334178|NCT00338962|11470459|FG002|COMPLETED|Overall Study||16
10334179|NCT00338962|11470460|FG003|COMPLETED|Overall Study||21
10334180|NCT00338962|11470457|FG000|NOT COMPLETED|Overall Study||8
10334181|NCT00338962|11470458|FG001|NOT COMPLETED|Overall Study||4
10334182|NCT00338962|11470459|FG002|NOT COMPLETED|Overall Study||6
10334183|NCT00338962|11470460|FG003|NOT COMPLETED|Overall Study||3
10334184|NCT00338988|11470470|FG000|STARTED|Overall Study||44
10334185|NCT00338988|11470470|FG000|COMPLETED|Overall Study||43
10334186|NCT00338988|11470470|FG000|NOT COMPLETED|Overall Study||1
10334187|NCT00339040|11470477|FG000|STARTED|Stage I||96
10334188|NCT00339040|11470478|FG001|STARTED|Stage I||30
10334189|NCT00339040|11470477|FG000|Vaccination 1 at Week 0|Stage I||96
10706615|NCT02610842|11871144|FG000|NOT COMPLETED|Overall Study||5
10706616|NCT02610868|11871150|FG000|STARTED|MYOBLOC: Treatment Session 1||187
10706617|NCT02610868|11871150|FG000|COMPLETED|MYOBLOC: Treatment Session 1||180
10706618|NCT02610868|11871150|FG000|NOT COMPLETED|MYOBLOC: Treatment Session 1||7
10706619|NCT02610868|11871150|FG000|STARTED|MYOBLOC: Treatment Session 2||177
10706620|NCT02610868|11871150|FG000|COMPLETED|MYOBLOC: Treatment Session 2||165
10706621|NCT02610868|11871150|FG000|NOT COMPLETED|MYOBLOC: Treatment Session 2||12
10706622|NCT02610868|11871150|FG000|STARTED|MYOBLOC: Treatment Session 3||50
10706623|NCT02610868|11871150|FG000|COMPLETED|MYOBLOC: Treatment Session 3||43
10706624|NCT02610868|11871150|FG000|NOT COMPLETED|MYOBLOC: Treatment Session 3||7
10706625|NCT02610868|11871150|FG000|STARTED|MYOBLOC: Treatment Session 4||24
10706626|NCT02610868|11871150|FG000|COMPLETED|MYOBLOC: Treatment Session 4||22
10706627|NCT02610868|11871150|FG000|NOT COMPLETED|MYOBLOC: Treatment Session 4||2
10706628|NCT02610972|11871172|FG000|STARTED|Overall Study||100
10706629|NCT02610972|11871173|FG001|STARTED|Overall Study||50
10706630|NCT02610972|11871172|FG000|COMPLETED|Overall Study||100
10706631|NCT02610972|11871173|FG001|COMPLETED|Overall Study||50
10706632|NCT02610972|11871172|FG000|NOT COMPLETED|Overall Study||0
10706633|NCT02610972|11871173|FG001|NOT COMPLETED|Overall Study||0
10706634|NCT02611154|11871179|FG000|STARTED|Overall Study||5
10706635|NCT02611154|11871179|FG000|COMPLETED|Overall Study||5
10706636|NCT02611154|11871179|FG000|NOT COMPLETED|Overall Study||0
10706637|NCT02611362|11871200|FG000|STARTED|Overall Study||41
10706638|NCT02611362|11871201|FG001|STARTED|Overall Study||41
10706639|NCT02611362|11871200|FG000|Immediate Posttest (3 Months)|Overall Study||33
10706640|NCT02611362|11871201|FG001|Immediate Posttest (3 Months)|Overall Study||34
10706641|NCT02611362|11871200|FG000|6-month Follow-up|Overall Study||32
10706642|NCT02611362|11871201|FG001|6-month Follow-up|Overall Study||35
10706643|NCT02611362|11871200|FG000|COMPLETED|Overall Study||32
10706644|NCT02611362|11871201|FG001|COMPLETED|Overall Study||35
10706645|NCT02611362|11871200|FG000|NOT COMPLETED|Overall Study||9
10706646|NCT02611362|11871201|FG001|NOT COMPLETED|Overall Study||6
10706647|NCT02611479|11871208|FG000|STARTED|Baseline Enrollment||184
10706648|NCT02611479|11871208|FG000|COMPLETED|Baseline Enrollment||171
10706649|NCT02611479|11871208|FG000|NOT COMPLETED|Baseline Enrollment||13
10706650|NCT02611479|11871208|FG000|STARTED|Post-Surgery Follow-up at 30-90 Days||171
10706651|NCT02611479|11871208|FG000|COMPLETED|Post-Surgery Follow-up at 30-90 Days||169
10706652|NCT02611479|11871208|FG000|NOT COMPLETED|Post-Surgery Follow-up at 30-90 Days||2
10706653|NCT02611479|11871208|FG000|STARTED|Post-Surgery Follow-up at 1-Year||169
10706654|NCT02611479|11871208|FG000|COMPLETED|Post-Surgery Follow-up at 1-Year||151
10706655|NCT02611479|11871208|FG000|NOT COMPLETED|Post-Surgery Follow-up at 1-Year||18
10809374|NCT03801148|11971281|FG000|NOT COMPLETED|Period 1 (2 Days)||1
10809375|NCT03801148|11971282|FG001|NOT COMPLETED|Period 1 (2 Days)||1
10706656|NCT02611479|11871208|FG000|STARTED|Data Cleaning||151
10706657|NCT02611479|11871208|FG000|COMPLETED|Data Cleaning||149
10706658|NCT02611479|11871208|FG000|NOT COMPLETED|Data Cleaning||2
10809376|NCT03801148|11971283|FG002|NOT COMPLETED|Period 1 (2 Days)||0
10809377|NCT03801148|11971284|FG003|NOT COMPLETED|Period 1 (2 Days)||0
10809378|NCT03801148|11971281|FG000|STARTED|Washout Period (at Least 5 Days)||30
10809379|NCT03801148|11971282|FG001|STARTED|Washout Period (at Least 5 Days)||30
10809380|NCT03801148|11971283|FG002|STARTED|Washout Period (at Least 5 Days)||30
10809381|NCT03801148|11971284|FG003|STARTED|Washout Period (at Least 5 Days)||30
10809382|NCT03801148|11971281|FG000|COMPLETED|Washout Period (at Least 5 Days)||30
10809383|NCT03801148|11971282|FG001|COMPLETED|Washout Period (at Least 5 Days)||30
10809384|NCT03801148|11971283|FG002|COMPLETED|Washout Period (at Least 5 Days)||29
10809385|NCT03801148|11971284|FG003|COMPLETED|Washout Period (at Least 5 Days)||29
10809386|NCT03801148|11971281|FG000|NOT COMPLETED|Washout Period (at Least 5 Days)||0
10809387|NCT03801148|11971282|FG001|NOT COMPLETED|Washout Period (at Least 5 Days)||0
10809388|NCT03801148|11971283|FG002|NOT COMPLETED|Washout Period (at Least 5 Days)||1
10809389|NCT03801148|11971284|FG003|NOT COMPLETED|Washout Period (at Least 5 Days)||1
10809390|NCT03801148|11971281|FG000|STARTED|Period 2 (2 Days)||30
10809391|NCT03801148|11971282|FG001|STARTED|Period 2 (2 Days)||30
10809392|NCT03801148|11971283|FG002|STARTED|Period 2 (2 Days)||29
10809393|NCT03801148|11971284|FG003|STARTED|Period 2 (2 Days)||29
10809394|NCT03801148|11971281|FG000|COMPLETED|Period 2 (2 Days)||30
10809395|NCT03801148|11971282|FG001|COMPLETED|Period 2 (2 Days)||30
10809396|NCT03801148|11971283|FG002|COMPLETED|Period 2 (2 Days)||29
10809397|NCT03801148|11971284|FG003|COMPLETED|Period 2 (2 Days)||29
10809398|NCT03801148|11971281|FG000|NOT COMPLETED|Period 2 (2 Days)||0
10809399|NCT03801148|11971282|FG001|NOT COMPLETED|Period 2 (2 Days)||0
10809400|NCT03801148|11971283|FG002|NOT COMPLETED|Period 2 (2 Days)||0
10809401|NCT03801148|11971284|FG003|NOT COMPLETED|Period 2 (2 Days)||0
10809402|NCT03801148|11971281|FG000|STARTED|Follow-Up (12 Days)||30
10809403|NCT03801148|11971282|FG001|STARTED|Follow-Up (12 Days)||30
10809404|NCT03801148|11971283|FG002|STARTED|Follow-Up (12 Days)||29
10809405|NCT03801148|11971284|FG003|STARTED|Follow-Up (12 Days)||29
10809406|NCT03801148|11971281|FG000|COMPLETED|Follow-Up (12 Days)||30
10809407|NCT03801148|11971282|FG001|COMPLETED|Follow-Up (12 Days)||29
10809408|NCT03801148|11971283|FG002|COMPLETED|Follow-Up (12 Days)||28
10809409|NCT03801148|11971284|FG003|COMPLETED|Follow-Up (12 Days)||29
10809410|NCT03801148|11971281|FG000|NOT COMPLETED|Follow-Up (12 Days)||0
10809411|NCT03801148|11971282|FG001|NOT COMPLETED|Follow-Up (12 Days)||1
10809412|NCT03801148|11971283|FG002|NOT COMPLETED|Follow-Up (12 Days)||1
10706659|NCT02611752|11871214|FG000|STARTED|Overall Study||22
10706660|NCT02611752|11871215|FG001|STARTED|Overall Study||25
10706661|NCT02611752|11871214|FG000|Day 1-3 Hydromorphone Challenge Injs|Overall Study||22
10706662|NCT02611752|11871215|FG001|Day 1-3 Hydromorphone Challenge Injs|Overall Study||25
10706663|NCT02611752|11871214|FG000|Day 4-6 Hydromorphone Challenge Injs|Overall Study||22
10706664|NCT02611752|11871215|FG001|Day 4-6 Hydromorphone Challenge Injs|Overall Study||24
10706665|NCT02611752|11871214|FG000|Day 8-10 Hydromorphone Challenge Injs|Overall Study||22
10706666|NCT02611752|11871215|FG001|Day 8-10 Hydromorphone Challenge Injs|Overall Study||24
10706667|NCT02611752|11871214|FG000|Day11-13 Hydromorphone Challenge Injs|Overall Study||22
10706668|NCT02611752|11871215|FG001|Day11-13 Hydromorphone Challenge Injs|Overall Study||24
10706669|NCT02611752|11871214|FG000|COMPLETED|Overall Study||22
10706670|NCT02611752|11871215|FG001|COMPLETED|Overall Study||24
10706671|NCT02611752|11871214|FG000|NOT COMPLETED|Overall Study||0
10706672|NCT02611752|11871215|FG001|NOT COMPLETED|Overall Study||1
10706673|NCT02611765|11871236|FG000|STARTED|Overall Study||29
10706674|NCT02611765|11871237|FG001|STARTED|Overall Study||35
10706675|NCT02611765|11871236|FG000|COMPLETED|Overall Study||27
10706676|NCT02611765|11871237|FG001|COMPLETED|Overall Study||29
10706677|NCT02611765|11871236|FG000|NOT COMPLETED|Overall Study||2
10706678|NCT02611765|11871237|FG001|NOT COMPLETED|Overall Study||6
10706679|NCT02611778|11871245|FG000|STARTED|Overall Study||238
10706680|NCT02611778|11871246|FG001|STARTED|Overall Study||239
10706681|NCT02611778|11871245|FG000|COMPLETED|Overall Study||226
10706682|NCT02611778|11871246|FG001|COMPLETED|Overall Study||226
10706683|NCT02611778|11871245|FG000|NOT COMPLETED|Overall Study||12
10706684|NCT02611778|11871246|FG001|NOT COMPLETED|Overall Study||13
10706685|NCT02611882|11871256|FG000|STARTED|Overall Study||75
10706686|NCT02611882|11871257|FG001|STARTED|Overall Study||150
10706687|NCT02611882|11871258|FG002|STARTED|Overall Study||0
10706688|NCT02611882|11871256|FG000|Completed Surgery Per Protocol|Overall Study||42
10706689|NCT02611882|11871257|FG001|Completed Surgery Per Protocol|Overall Study||0
10706690|NCT02611882|11871258|FG002|Completed Surgery Per Protocol|Overall Study||0
10706691|NCT02611882|11871256|FG000|COMPLETED|Overall Study||42
10706692|NCT02611882|11871257|FG001|COMPLETED|Overall Study||150
10706693|NCT02611882|11871258|FG002|COMPLETED|Overall Study||0
10706694|NCT02611882|11871256|FG000|NOT COMPLETED|Overall Study||33
10706695|NCT02611882|11871257|FG001|NOT COMPLETED|Overall Study||0
10706696|NCT02611882|11871258|FG002|NOT COMPLETED|Overall Study||0
10706697|NCT02612064|11871267|FG000|STARTED|Overall Study||115
10706698|NCT02612064|11871268|FG001|STARTED|Overall Study||115
10706699|NCT02612064|11871267|FG000|COMPLETED|Overall Study||114
10706700|NCT02612064|11871268|FG001|COMPLETED|Overall Study||112
10706701|NCT02612064|11871267|FG000|NOT COMPLETED|Overall Study||1
10706702|NCT02612064|11871268|FG001|NOT COMPLETED|Overall Study||3
10706703|NCT02612077|11871274|FG000|STARTED|Overall Study||765
10706704|NCT02612077|11871274|FG000|Did Not Receive Study Product|Overall Study||5
10706705|NCT02612077|11871274|FG000|Safety Analysis Set|Overall Study||760
10706706|NCT02612077|11871274|FG000|Efficacy Analysis Set|Overall Study||737
10706707|NCT02612077|11871274|FG000|COMPLETED|Overall Study||299
10706708|NCT02612077|11871274|FG000|NOT COMPLETED|Overall Study||466
10706709|NCT02612155|11871283|FG000|STARTED|Overall Study||17
10706710|NCT02612155|11871284|FG001|STARTED|Overall Study||18
10706711|NCT02612155|11871283|FG000|COMPLETED|Overall Study||14
10706712|NCT02612155|11871284|FG001|COMPLETED|Overall Study||15
10706713|NCT02612155|11871283|FG000|NOT COMPLETED|Overall Study||3
10706714|NCT02612155|11871284|FG001|NOT COMPLETED|Overall Study||3
10706715|NCT02612428|11871292|FG000|STARTED|VTL-308||78
10706716|NCT02612428|11871293|FG001|STARTED|VTL-308||73
10706717|NCT02612428|11871292|FG000|COMPLETED|VTL-308||64
10706718|NCT02612428|11871293|FG001|COMPLETED|VTL-308||56
10706719|NCT02612428|11871292|FG000|NOT COMPLETED|VTL-308||14
10706720|NCT02612428|11871293|FG001|NOT COMPLETED|VTL-308||17
10706721|NCT02612428|11871292|FG000|STARTED|VTL-308E||64
10706722|NCT02612428|11871293|FG001|STARTED|VTL-308E||56
10706723|NCT02612428|11871292|FG000|COMPLETED|VTL-308E||53
10706724|NCT02612428|11871293|FG001|COMPLETED|VTL-308E||49
10706725|NCT02612428|11871292|FG000|NOT COMPLETED|VTL-308E||11
10706726|NCT02612428|11871293|FG001|NOT COMPLETED|VTL-308E||7
10706727|NCT02612610|11871303|FG000|STARTED|Overall Study||63
10706728|NCT02612610|11871304|FG001|STARTED|Overall Study||64
10706729|NCT02612610|11871305|FG002|STARTED|Overall Study||63
10706730|NCT02612610|11871306|FG003|STARTED|Overall Study||63
10706731|NCT02612610|11871303|FG000|Treated|Overall Study||63
10706732|NCT02612610|11871304|FG001|Treated|Overall Study||63
10706733|NCT02612610|11871305|FG002|Treated|Overall Study||63
10706734|NCT02612610|11871306|FG003|Treated|Overall Study||63
10706735|NCT02612610|11871303|FG000|COMPLETED|Overall Study||58
10706736|NCT02612610|11871304|FG001|COMPLETED|Overall Study||56
10706737|NCT02612610|11871305|FG002|COMPLETED|Overall Study||58
10706738|NCT02612610|11871306|FG003|COMPLETED|Overall Study||50
10706739|NCT02612610|11871303|FG000|NOT COMPLETED|Overall Study||5
10706740|NCT02612610|11871304|FG001|NOT COMPLETED|Overall Study||8
10706741|NCT02612610|11871305|FG002|NOT COMPLETED|Overall Study||5
10706742|NCT02612610|11871306|FG003|NOT COMPLETED|Overall Study||13
10706743|NCT02612623|11871320|FG000|STARTED|Overall Study||8
10706744|NCT02612623|11871321|FG001|STARTED|Overall Study||6
10706745|NCT02612623|11871322|FG002|STARTED|Overall Study||6
10706746|NCT02612623|11871323|FG003|STARTED|Overall Study||4
10706747|NCT02612623|11871320|FG000|Treated|Overall Study||8
10706748|NCT02612623|11871321|FG001|Treated|Overall Study||5
10706749|NCT02612623|11871322|FG002|Treated|Overall Study||6
10706750|NCT02612623|11871323|FG003|Treated|Overall Study||4
10706751|NCT02612623|11871320|FG000|COMPLETED|Overall Study||7
10706752|NCT02612623|11871321|FG001|COMPLETED|Overall Study||5
10706753|NCT02612623|11871322|FG002|COMPLETED|Overall Study||5
10706754|NCT02612623|11871323|FG003|COMPLETED|Overall Study||4
10706755|NCT02612623|11871320|FG000|NOT COMPLETED|Overall Study||1
10706756|NCT02612623|11871321|FG001|NOT COMPLETED|Overall Study||1
10706757|NCT02612623|11871322|FG002|NOT COMPLETED|Overall Study||1
10706758|NCT02612623|11871323|FG003|NOT COMPLETED|Overall Study||0
10706759|NCT02612688|11871335|FG000|STARTED|Overall Study||33035
10706760|NCT02612688|11871336|FG001|STARTED|Overall Study||70013
10706761|NCT02612688|11871335|FG000|COMPLETED|Overall Study||33035
10706762|NCT02612688|11871336|FG001|COMPLETED|Overall Study||70013
10706763|NCT02612688|11871335|FG000|NOT COMPLETED|Overall Study||0
10706764|NCT02612688|11871336|FG001|NOT COMPLETED|Overall Study||0
10713779|NCT02681809|11879278|FG002|COMPLETED|Overall Study||8
10713780|NCT02681809|11879276|FG000|NOT COMPLETED|Overall Study||5
10713781|NCT02681809|11879277|FG001|NOT COMPLETED|Overall Study||4
10713782|NCT02681809|11879278|FG002|NOT COMPLETED|Overall Study||1
10713783|NCT02682030|11879288|FG000|STARTED|Overall Study||1
10713784|NCT02682030|11879289|FG001|STARTED|Overall Study||4
10713785|NCT02682030|11879288|FG000|COMPLETED|Overall Study||0
10713786|NCT02682030|11879289|FG001|COMPLETED|Overall Study||2
10713787|NCT02682030|11879288|FG000|NOT COMPLETED|Overall Study||1
10713788|NCT02682030|11879289|FG001|NOT COMPLETED|Overall Study||2
10713789|NCT02682056|11879296|FG000|STARTED|Overall Study||15
10713790|NCT02682056|11879296|FG000|COMPLETED|Overall Study||15
10713791|NCT02682056|11879296|FG000|NOT COMPLETED|Overall Study||0
10713792|NCT02682069|11879304|FG000|STARTED|Overall Study||30
10713793|NCT02682069|11879304|FG000|COMPLETED|Overall Study||30
10713794|NCT02682069|11879304|FG000|NOT COMPLETED|Overall Study||0
10713795|NCT02682264|11879310|FG000|STARTED|Overall Study||317
10713796|NCT02682264|11879311|FG001|STARTED|Overall Study||290
10713797|NCT02682264|11879310|FG000|COMPLETED|Overall Study||179
10713798|NCT02682264|11879311|FG001|COMPLETED|Overall Study||168
10713799|NCT02682264|11879310|FG000|NOT COMPLETED|Overall Study||138
10713800|NCT02682264|11879311|FG001|NOT COMPLETED|Overall Study||122
10713801|NCT02682381|11879320|FG000|STARTED|Overall Study||24
10713802|NCT02682381|11879321|FG001|STARTED|Overall Study||26
10713803|NCT02682381|11879322|FG002|STARTED|Overall Study||9
10713804|NCT02682381|11879320|FG000|COMPLETED|Overall Study||24
10713805|NCT02682381|11879321|FG001|COMPLETED|Overall Study||26
10713806|NCT02682381|11879322|FG002|COMPLETED|Overall Study||9
10713807|NCT02682381|11879320|FG000|NOT COMPLETED|Overall Study||0
10706765|NCT02612727|11871346|FG000|STARTED|Overall Study||87
10706766|NCT02612727|11871347|FG001|STARTED|Overall Study||87
10706767|NCT02612727|11871346|FG000|COMPLETED|Overall Study||82
10706768|NCT02612727|11871347|FG001|COMPLETED|Overall Study||83
10706769|NCT02612727|11871346|FG000|NOT COMPLETED|Overall Study||5
10706770|NCT02612727|11871347|FG001|NOT COMPLETED|Overall Study||4
10706771|NCT02612779|11871355|FG000|STARTED|Overall Study||68
10706772|NCT02612779|11871356|FG001|STARTED|Overall Study||6
10706773|NCT02612779|11871355|FG000|COMPLETED|Overall Study||0
10706774|NCT02612779|11871356|FG001|COMPLETED|Overall Study||0
10706775|NCT02612779|11871355|FG000|NOT COMPLETED|Overall Study||68
10706776|NCT02612779|11871356|FG001|NOT COMPLETED|Overall Study||6
10706777|NCT02612857|11871366|FG000|STARTED|Overall Study||11
10706778|NCT02612857|11871367|FG001|STARTED|Overall Study||9
10706779|NCT02612857|11871368|FG002|STARTED|Overall Study||10
10706780|NCT02612857|11871366|FG000|COMPLETED|Overall Study||8
10706781|NCT02612857|11871367|FG001|COMPLETED|Overall Study||5
10706782|NCT02612857|11871368|FG002|COMPLETED|Overall Study||6
10706783|NCT02612857|11871366|FG000|NOT COMPLETED|Overall Study||3
10706784|NCT02612857|11871367|FG001|NOT COMPLETED|Overall Study||4
10706785|NCT02612857|11871368|FG002|NOT COMPLETED|Overall Study||4
10706786|NCT02612909|11871381|FG000|STARTED|Phase 2||100
10706787|NCT02612909|11871382|FG001|STARTED|Phase 2||100
10706788|NCT02612909|11871383|FG002|STARTED|Phase 2||100
10706789|NCT02612909|11871384|FG003|STARTED|Phase 2||0
10706790|NCT02612909|11871385|FG004|STARTED|Phase 2||0
10706791|NCT02612909|11871381|FG000|Received Injection 1|Phase 2||100
10706792|NCT02612909|11871382|FG001|Received Injection 1|Phase 2||100
10706793|NCT02612909|11871383|FG002|Received Injection 1|Phase 2||100
10706794|NCT02612909|11871384|FG003|Received Injection 1|Phase 2||0
10706795|NCT02612909|11871385|FG004|Received Injection 1|Phase 2||0
10706796|NCT02612909|11871381|FG000|Received Injection 2|Phase 2||98
10706797|NCT02612909|11871382|FG001|Received Injection 2|Phase 2||95
10706798|NCT02612909|11871383|FG002|Received Injection 2|Phase 2||99
10706799|NCT02612909|11871384|FG003|Received Injection 2|Phase 2||0
10706800|NCT02612909|11871385|FG004|Received Injection 2|Phase 2||0
10706801|NCT02612909|11871381|FG000|Completed Day 29 Clinic Visit|Phase 2||98
10706802|NCT02612909|11871382|FG001|Completed Day 29 Clinic Visit|Phase 2||95
10706803|NCT02612909|11871383|FG002|Completed Day 29 Clinic Visit|Phase 2||99
10706804|NCT02612909|11871384|FG003|Completed Day 29 Clinic Visit|Phase 2||0
10706805|NCT02612909|11871385|FG004|Completed Day 29 Clinic Visit|Phase 2||0
10706806|NCT02612909|11871381|FG000|Completed Day 43 Clinic Visit|Phase 2||97
10706807|NCT02612909|11871382|FG001|Completed Day 43 Clinic Visit|Phase 2||94
10706808|NCT02612909|11871383|FG002|Completed Day 43 Clinic Visit|Phase 2||99
10706809|NCT02612909|11871384|FG003|Completed Day 43 Clinic Visit|Phase 2||0
10809413|NCT03801148|11971284|FG003|NOT COMPLETED|Follow-Up (12 Days)||0
10809414|NCT03832907|11971294|FG000|STARTED|Overall Study||101
10809415|NCT03832907|11971294|FG000|COMPLETED|Overall Study||91
10809416|NCT03832907|11971294|FG000|NOT COMPLETED|Overall Study||10
10809417|NCT03832322|11971300|FG000|STARTED|Overall Study||89
10809418|NCT03832322|11971301|FG001|STARTED|Overall Study||87
10809419|NCT03832322|11971300|FG000|COMPLETED|Overall Study||86
10809420|NCT03832322|11971301|FG001|COMPLETED|Overall Study||86
10809421|NCT03832322|11971300|FG000|NOT COMPLETED|Overall Study||3
10809422|NCT03832322|11971301|FG001|NOT COMPLETED|Overall Study||1
10809423|NCT03832387|11971311|FG000|STARTED|Overall Study||38
10809424|NCT03832387|11971312|FG001|STARTED|Overall Study||39
10809425|NCT03832387|11971311|FG000|COMPLETED|Overall Study||33
10809426|NCT03832387|11971312|FG001|COMPLETED|Overall Study||32
10706810|NCT02612909|11871385|FG004|Completed Day 43 Clinic Visit|Phase 2||0
10706811|NCT02612909|11871381|FG000|COMPLETED|Phase 2||98
10706812|NCT02612909|11871382|FG001|COMPLETED|Phase 2||95
10334190|NCT00339040|11470478|FG001|Vaccination 1 at Week 0|Stage I||30
10334191|NCT00339040|11470477|FG000|Vaccination 2 at Week 8|Stage I||95
10334192|NCT00339040|11470478|FG001|Vaccination 2 at Week 8|Stage I||30
10334193|NCT00339040|11470477|FG000|Vaccination 3 at Week 24|Stage I||94
10334194|NCT00339040|11470478|FG001|Vaccination 3 at Week 24|Stage I||30
10334195|NCT00339040|11470477|FG000|COMPLETED|Stage I||94
10334196|NCT00339040|11470478|FG001|COMPLETED|Stage I||29
10334197|NCT00339040|11470477|FG000|NOT COMPLETED|Stage I||2
10334198|NCT00339040|11470478|FG001|NOT COMPLETED|Stage I||1
10334199|NCT00339040|11470477|FG000|STARTED|Stage II||94
10334200|NCT00339040|11470478|FG001|STARTED|Stage II||29
10334201|NCT00339040|11470477|FG000|Vaccination 4 at Week 96|Stage II||84
10334202|NCT00339040|11470478|FG001|Vaccination 4 at Week 96|Stage II||29
10334203|NCT00339040|11470477|FG000|Vaccination 5 at Week 104|Stage II||0
10334204|NCT00339040|11470478|FG001|Vaccination 5 at Week 104|Stage II||28
10706813|NCT02612909|11871383|FG002|COMPLETED|Phase 2||99
10334205|NCT00339040|11470477|FG000|Vaccination 6 at Week 120|Stage II||0
10334206|NCT00339040|11470478|FG001|Vaccination 6 at Week 120|Stage II||27
10334207|NCT00339040|11470477|FG000|COMPLETED|Stage II||84
10457433|NCT01010750|11605176|FG002|STARTED|Third Intervention||3
10457434|NCT01010750|11605177|FG003|STARTED|Third Intervention||3
10457435|NCT01010750|11605178|FG004|STARTED|Third Intervention||2
10706814|NCT02612909|11871384|FG003|COMPLETED|Phase 2||0
10706815|NCT02612909|11871385|FG004|COMPLETED|Phase 2||0
10706816|NCT02612909|11871381|FG000|NOT COMPLETED|Phase 2||2
10706817|NCT02612909|11871382|FG001|NOT COMPLETED|Phase 2||5
10334208|NCT00339040|11470478|FG001|COMPLETED|Stage II||27
10334209|NCT00339040|11470477|FG000|NOT COMPLETED|Stage II||10
10334210|NCT00339040|11470478|FG001|NOT COMPLETED|Stage II||2
10334211|NCT00339079|11470488|FG000|STARTED|Overall Study||53
10334212|NCT00339079|11470489|FG001|STARTED|Overall Study||44
10334213|NCT00339079|11470490|FG002|STARTED|Overall Study||45
10334214|NCT00339079|11470491|FG003|STARTED|Overall Study||53
10334215|NCT00339079|11470488|FG000|COMPLETED|Overall Study||20
10334216|NCT00339079|11470489|FG001|COMPLETED|Overall Study||21
10334217|NCT00339079|11470490|FG002|COMPLETED|Overall Study||27
10334218|NCT00339079|11470491|FG003|COMPLETED|Overall Study||29
10334219|NCT00339079|11470488|FG000|NOT COMPLETED|Overall Study||33
10334220|NCT00339079|11470489|FG001|NOT COMPLETED|Overall Study||23
10334221|NCT00339079|11470490|FG002|NOT COMPLETED|Overall Study||18
10334222|NCT00339079|11470491|FG003|NOT COMPLETED|Overall Study||24
10334223|NCT00339144|11470508|FG000|STARTED|Overall Study|Number of participants enrolled and treated|9
10334224|NCT00339144|11470509|FG001|STARTED|Overall Study|Number of participants enrolled and treated|3
10334225|NCT00339144|11470510|FG002|STARTED|Overall Study|Number of participants enrolled and treated|4
10334226|NCT00339144|11470508|FG000|COMPLETED|Overall Study||0
10334227|NCT00339144|11470509|FG001|COMPLETED|Overall Study||0
10334228|NCT00339144|11470510|FG002|COMPLETED|Overall Study||0
10334229|NCT00339144|11470508|FG000|NOT COMPLETED|Overall Study||9
10334230|NCT00339144|11470509|FG001|NOT COMPLETED|Overall Study||3
10334231|NCT00339144|11470510|FG002|NOT COMPLETED|Overall Study||4
10706818|NCT02612909|11871383|FG002|NOT COMPLETED|Phase 2||1
10706819|NCT02612909|11871384|FG003|NOT COMPLETED|Phase 2||0
10706820|NCT02612909|11871385|FG004|NOT COMPLETED|Phase 2||0
10706821|NCT02612909|11871381|FG000|STARTED|Phase 3||0
10706822|NCT02612909|11871382|FG001|STARTED|Phase 3||0
10706823|NCT02612909|11871383|FG002|STARTED|Phase 3||0
10706824|NCT02612909|11871384|FG003|STARTED|Phase 3||105
10706825|NCT02612909|11871385|FG004|STARTED|Phase 3||525
10706826|NCT02612909|11871381|FG000|Received Injection 1|Phase 3||0
10706827|NCT02612909|11871382|FG001|Received Injection 1|Phase 3||0
10706828|NCT02612909|11871383|FG002|Received Injection 1|Phase 3||0
10706829|NCT02612909|11871384|FG003|Received Injection 1|Phase 3||105
10706830|NCT02612909|11871385|FG004|Received Injection 1|Phase 3||525
10706831|NCT02612909|11871381|FG000|Received Injection 2|Phase 3||0
10706832|NCT02612909|11871382|FG001|Received Injection 2|Phase 3||0
10706833|NCT02612909|11871383|FG002|Received Injection 2|Phase 3||0
10706834|NCT02612909|11871384|FG003|Received Injection 2|Phase 3||103
10706835|NCT02612909|11871385|FG004|Received Injection 2|Phase 3||520
10706836|NCT02612909|11871381|FG000|Completed Day 29 Clinic Visit|Phase 3||0
10706837|NCT02612909|11871382|FG001|Completed Day 29 Clinic Visit|Phase 3||0
10706838|NCT02612909|11871383|FG002|Completed Day 29 Clinic Visit|Phase 3||0
10706839|NCT02612909|11871384|FG003|Completed Day 29 Clinic Visit|Phase 3||104
10706840|NCT02612909|11871385|FG004|Completed Day 29 Clinic Visit|Phase 3||525
10706841|NCT02612909|11871381|FG000|Completed Day 43 Clinic Visit|Phase 3||0
10706842|NCT02612909|11871382|FG001|Completed Day 43 Clinic Visit|Phase 3||0
10706843|NCT02612909|11871383|FG002|Completed Day 43 Clinic Visit|Phase 3||0
10706844|NCT02612909|11871384|FG003|Completed Day 43 Clinic Visit|Phase 3||104
10706845|NCT02612909|11871385|FG004|Completed Day 43 Clinic Visit|Phase 3||524
10706846|NCT02612909|11871381|FG000|COMPLETED|Phase 3||0
10706847|NCT02612909|11871382|FG001|COMPLETED|Phase 3||0
10706848|NCT02612909|11871383|FG002|COMPLETED|Phase 3||0
10706849|NCT02612909|11871384|FG003|COMPLETED|Phase 3||104
10706850|NCT02612909|11871385|FG004|COMPLETED|Phase 3||525
10706851|NCT02612909|11871381|FG000|NOT COMPLETED|Phase 3||0
10706852|NCT02612909|11871382|FG001|NOT COMPLETED|Phase 3||0
10706853|NCT02612909|11871383|FG002|NOT COMPLETED|Phase 3||0
10706854|NCT02612909|11871384|FG003|NOT COMPLETED|Phase 3||1
10706855|NCT02612909|11871385|FG004|NOT COMPLETED|Phase 3||0
10706856|NCT02613117|11871401|FG000|STARTED|Overall Study||57
10706857|NCT02613117|11871402|FG001|STARTED|Overall Study||47
10706858|NCT02613117|11871401|FG000|COMPLETED|Overall Study||57
10706859|NCT02613117|11871402|FG001|COMPLETED|Overall Study||47
10706860|NCT02613117|11871401|FG000|NOT COMPLETED|Overall Study||0
10706861|NCT02613117|11871402|FG001|NOT COMPLETED|Overall Study||0
10706862|NCT02613169|11871410|FG000|STARTED|Overall Study||150
10706863|NCT02613169|11871411|FG001|STARTED|Overall Study||150
10706864|NCT02613169|11871410|FG000|COMPLETED|Overall Study||132
10706865|NCT02613169|11871411|FG001|COMPLETED|Overall Study||133
10706866|NCT02613169|11871410|FG000|NOT COMPLETED|Overall Study||18
10706867|NCT02613169|11871411|FG001|NOT COMPLETED|Overall Study||17
10706868|NCT02613182|11871417|FG000|STARTED|Overall Study||34
10706869|NCT02613182|11871417|FG000|Number of Patients Dosed|Overall Study||34
10706870|NCT02613182|11871417|FG000|COMPLETED|Overall Study||0
10706871|NCT02613182|11871417|FG000|NOT COMPLETED|Overall Study||34
10706872|NCT02613208|11871421|FG000|STARTED|Overall Study||111
10706873|NCT02613208|11871421|FG000|COMPLETED|Overall Study||64
10706874|NCT02613208|11871421|FG000|NOT COMPLETED|Overall Study||47
10706875|NCT02613221|11871425|FG000|STARTED|Overall Study||56
10706876|NCT02613221|11871425|FG000|Safety Population: Received Study Drug|Overall Study||55
10706877|NCT02613221|11871425|FG000|COMPLETED|Overall Study||1
10706878|NCT02613221|11871425|FG000|NOT COMPLETED|Overall Study||55
10706879|NCT02613338|11871429|FG000|STARTED|Overall Study||30
10706880|NCT02613338|11871429|FG000|COMPLETED|Overall Study||30
10706881|NCT02613338|11871429|FG000|NOT COMPLETED|Overall Study||0
10706882|NCT02613364|11871436|FG000|STARTED|Overall Study||251
10706883|NCT02613364|11871437|FG001|STARTED|Overall Study||238
10706884|NCT02613364|11871438|FG002|STARTED|Overall Study||251
10706885|NCT02613364|11871436|FG000|COMPLETED|Overall Study||185
10706886|NCT02613364|11871437|FG001|COMPLETED|Overall Study||148
10706887|NCT02613364|11871438|FG002|COMPLETED|Overall Study||175
10706888|NCT02613364|11871436|FG000|NOT COMPLETED|Overall Study||66
10706889|NCT02613364|11871437|FG001|NOT COMPLETED|Overall Study||90
10706890|NCT02613364|11871438|FG002|NOT COMPLETED|Overall Study||76
10706891|NCT02613403|11871450|FG000|STARTED|Overall Study||36
10334240|NCT00339833|11470534|FG000|STARTED|Overall Study||28
10334241|NCT00339833|11470535|FG001|STARTED|Overall Study||26
10334242|NCT00339833|11470534|FG000|COMPLETED|Overall Study||22
10334243|NCT00339833|11470535|FG001|COMPLETED|Overall Study||18
10334244|NCT00339833|11470534|FG000|NOT COMPLETED|Overall Study||6
10334245|NCT00339833|11470535|FG001|NOT COMPLETED|Overall Study||8
10334246|NCT00340379|11470543|FG000|STARTED|Overall Study||35
10334247|NCT00340379|11470544|FG001|STARTED|Overall Study||37
10334248|NCT00340379|11470543|FG000|COMPLETED|Overall Study||27
10334249|NCT00340379|11470544|FG001|COMPLETED|Overall Study||28
10334250|NCT00340379|11470543|FG000|NOT COMPLETED|Overall Study||8
10334251|NCT00340379|11470544|FG001|NOT COMPLETED|Overall Study||9
10334252|NCT00340678|11470554|FG000|STARTED|Overall Study||46
10334253|NCT00340678|11470555|FG001|STARTED|Overall Study||46
10334254|NCT00340678|11470556|FG002|STARTED|Overall Study||39
10334255|NCT00340678|11470557|FG003|STARTED|Overall Study||39
10334256|NCT00340678|11470554|FG000|COMPLETED|Overall Study||45
10334257|NCT00340678|11470555|FG001|COMPLETED|Overall Study||46
10334258|NCT00340678|11470556|FG002|COMPLETED|Overall Study||39
10334259|NCT00340678|11470557|FG003|COMPLETED|Overall Study||39
10334260|NCT00340678|11470554|FG000|NOT COMPLETED|Overall Study||1
10334261|NCT00340678|11470555|FG001|NOT COMPLETED|Overall Study||0
10334262|NCT00340678|11470556|FG002|NOT COMPLETED|Overall Study||0
10334263|NCT00340678|11470557|FG003|NOT COMPLETED|Overall Study||0
10334264|NCT00340704|11470574|FG000|STARTED|PK Study||10
10334265|NCT00340704|11470575|FG001|STARTED|PK Study||10
10334266|NCT00340704|11470576|FG002|STARTED|PK Study||11
10334267|NCT00340704|11470577|FG003|STARTED|PK Study||0
10334268|NCT00340704|11470578|FG004|STARTED|PK Study||0
10334269|NCT00340704|11470579|FG005|STARTED|PK Study||0
10334270|NCT00340704|11470580|FG006|STARTED|PK Study||0
10334271|NCT00340704|11470581|FG007|STARTED|PK Study||0
10334272|NCT00340704|11470582|FG008|STARTED|PK Study||0
10334273|NCT00340704|11470574|FG000|COMPLETED|PK Study||10
10334274|NCT00340704|11470575|FG001|COMPLETED|PK Study||9
10334275|NCT00340704|11470576|FG002|COMPLETED|PK Study||10
10334276|NCT00340704|11470577|FG003|COMPLETED|PK Study||0
10334277|NCT00340704|11470578|FG004|COMPLETED|PK Study||0
10334278|NCT00340704|11470579|FG005|COMPLETED|PK Study||0
10334279|NCT00340704|11470580|FG006|COMPLETED|PK Study||0
10334280|NCT00340704|11470581|FG007|COMPLETED|PK Study||0
10706892|NCT02613403|11871451|FG001|STARTED|Overall Study||36
10706893|NCT02613403|11871452|FG002|STARTED|Overall Study||9
10706894|NCT02613403|11871453|FG003|STARTED|Overall Study||13
10706895|NCT02613403|11871454|FG004|STARTED|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
10334281|NCT00340704|11470582|FG008|COMPLETED|PK Study||0
10334282|NCT00340704|11470574|FG000|NOT COMPLETED|PK Study||0
10334283|NCT00340704|11470575|FG001|NOT COMPLETED|PK Study||1
10334284|NCT00340704|11470576|FG002|NOT COMPLETED|PK Study||1
10334285|NCT00340704|11470577|FG003|NOT COMPLETED|PK Study||0
10334286|NCT00340704|11470578|FG004|NOT COMPLETED|PK Study||0
10334287|NCT00340704|11470579|FG005|NOT COMPLETED|PK Study||0
10334288|NCT00340704|11470580|FG006|NOT COMPLETED|PK Study||0
10334289|NCT00340704|11470581|FG007|NOT COMPLETED|PK Study||0
10334290|NCT00340704|11470582|FG008|NOT COMPLETED|PK Study||0
10334291|NCT00340704|11470574|FG000|STARTED|Group D- Denovo & 527.51 Rollover Study||0
10334292|NCT00340704|11470575|FG001|STARTED|Group D- Denovo & 527.51 Rollover Study||0
10334293|NCT00340704|11470576|FG002|STARTED|Group D- Denovo & 527.51 Rollover Study||0
10649603|NCT02163499|11809772|FG000|COMPLETED|Extended Dosing Phase: ZS||466
10649604|NCT02163499|11809772|FG000|NOT COMPLETED|Extended Dosing Phase: ZS||280
10649605|NCT02163538|11809782|FG000|STARTED|Overall Study||71
10649606|NCT02163538|11809783|FG001|STARTED|Overall Study||71
10649607|NCT02163538|11809782|FG000|COMPLETED|Overall Study||70
10649608|NCT02163538|11809783|FG001|COMPLETED|Overall Study||70
10649609|NCT02163538|11809782|FG000|NOT COMPLETED|Overall Study||1
10457436|NCT01010750|11605179|FG005|STARTED|Third Intervention||3
10457437|NCT01010750|11605174|FG000|COMPLETED|Third Intervention||3
10457438|NCT01010750|11605175|FG001|COMPLETED|Third Intervention||3
10457439|NCT01010750|11605176|FG002|COMPLETED|Third Intervention||3
10457440|NCT01010750|11605177|FG003|COMPLETED|Third Intervention||3
10457441|NCT01010750|11605178|FG004|COMPLETED|Third Intervention||2
10457442|NCT01010750|11605179|FG005|COMPLETED|Third Intervention||3
10457443|NCT01010750|11605174|FG000|NOT COMPLETED|Third Intervention||0
10457444|NCT01010750|11605175|FG001|NOT COMPLETED|Third Intervention||0
10457445|NCT01010750|11605176|FG002|NOT COMPLETED|Third Intervention||0
10457446|NCT01010750|11605177|FG003|NOT COMPLETED|Third Intervention||0
10457447|NCT01010750|11605178|FG004|NOT COMPLETED|Third Intervention||0
10457448|NCT01010750|11605179|FG005|NOT COMPLETED|Third Intervention||0
10457449|NCT01010763|11605189|FG000|STARTED|Overall Study||96
10457450|NCT01010763|11605190|FG001|STARTED|Overall Study||84
10457451|NCT01010763|11605189|FG000|COMPLETED|Overall Study||61
10457452|NCT01010763|11605190|FG001|COMPLETED|Overall Study||54
10457453|NCT01010763|11605189|FG000|NOT COMPLETED|Overall Study||35
10457454|NCT01010763|11605190|FG001|NOT COMPLETED|Overall Study||30
10457455|NCT01010776|11605196|FG000|STARTED|Main Phase||223
10457456|NCT01010776|11605196|FG000|Treated|Main Phase||218
10457457|NCT01010776|11605196|FG000|COMPLETED|Main Phase||174
10457458|NCT01010776|11605196|FG000|NOT COMPLETED|Main Phase||49
10457459|NCT01010776|11605196|FG000|STARTED|In-Between Main Phase & Extension Phase||174
10457460|NCT01010776|11605196|FG000|COMPLETED|In-Between Main Phase & Extension Phase||159
10457461|NCT01010776|11605196|FG000|NOT COMPLETED|In-Between Main Phase & Extension Phase||15
10457462|NCT01010776|11605196|FG000|STARTED|Extension Phase||159
10457463|NCT01010776|11605196|FG000|COMPLETED|Extension Phase||156
10457464|NCT01010776|11605196|FG000|NOT COMPLETED|Extension Phase||3
10457465|NCT01010854|11605211|FG000|STARTED|Overall Study||6
10457466|NCT01010854|11605211|FG000|COMPLETED|Overall Study||6
10457467|NCT01010854|11605211|FG000|NOT COMPLETED|Overall Study||0
10457468|NCT01010867|11605215|FG000|STARTED|Overall Study||31
10457469|NCT01010867|11605215|FG000|COMPLETED|Overall Study||30
10457470|NCT01010867|11605215|FG000|NOT COMPLETED|Overall Study||1
10457471|NCT01010906|11605225|FG000|STARTED|Overall Study||10
10457472|NCT01010906|11605226|FG001|STARTED|Overall Study||10
10457473|NCT01010906|11605227|FG002|STARTED|Overall Study||10
10457474|NCT01010906|11605228|FG003|STARTED|Overall Study||10
10457475|NCT01010906|11605229|FG004|STARTED|Overall Study||10
10457476|NCT01010906|11605230|FG005|STARTED|Overall Study||10
10457477|NCT01010906|11605225|FG000|COMPLETED|Overall Study||10
10457478|NCT01010906|11605226|FG001|COMPLETED|Overall Study||10
10457479|NCT01010906|11605227|FG002|COMPLETED|Overall Study||10
10457480|NCT01010906|11605228|FG003|COMPLETED|Overall Study||10
10457481|NCT01010906|11605229|FG004|COMPLETED|Overall Study||10
10457482|NCT01010906|11605230|FG005|COMPLETED|Overall Study||10
10457483|NCT01010906|11605225|FG000|NOT COMPLETED|Overall Study||0
10457484|NCT01010906|11605226|FG001|NOT COMPLETED|Overall Study||0
10457485|NCT01010906|11605227|FG002|NOT COMPLETED|Overall Study||0
10457486|NCT01010906|11605228|FG003|NOT COMPLETED|Overall Study||0
10457487|NCT01010906|11605229|FG004|NOT COMPLETED|Overall Study||0
10457488|NCT01010906|11605230|FG005|NOT COMPLETED|Overall Study||0
10457489|NCT01010932|11605244|FG000|STARTED|Overall Study||222
10457490|NCT01010932|11605244|FG000|COMPLETED|Overall Study||200
10457491|NCT01010932|11605244|FG000|NOT COMPLETED|Overall Study||22
10457492|NCT01010971|11605255|FG000|STARTED|Overall Study||225
10457493|NCT01010971|11605256|FG001|STARTED|Overall Study||226
10457494|NCT01010971|11605257|FG002|STARTED|Overall Study||220
10457495|NCT01010971|11605255|FG000|COMPLETED|Overall Study||222
10457496|NCT01010971|11605256|FG001|COMPLETED|Overall Study||218
10457497|NCT01010971|11605257|FG002|COMPLETED|Overall Study||207
10457498|NCT01010971|11605255|FG000|NOT COMPLETED|Overall Study||3
10457499|NCT01010971|11605256|FG001|NOT COMPLETED|Overall Study||8
10457500|NCT01010971|11605257|FG002|NOT COMPLETED|Overall Study||13
10457501|NCT01010984|11605265|FG000|STARTED|Overall Study||20
10457502|NCT01010984|11605265|FG000|COMPLETED|Overall Study||20
10457503|NCT01010984|11605265|FG000|NOT COMPLETED|Overall Study||0
10457504|NCT01011049|11605274|FG000|STARTED|Overall Study||507
10457505|NCT01011049|11605275|FG001|STARTED|Overall Study||252
10706896|NCT02613403|11871450|FG000|Treated|Overall Study||35
10706897|NCT02613403|11871451|FG001|Treated|Overall Study||36
10706898|NCT02613403|11871452|FG002|Treated|Overall Study||9
10706899|NCT02613403|11871453|FG003|Treated|Overall Study||13
10706900|NCT02613403|11871454|FG004|Treated|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
10706901|NCT02613403|11871450|FG000|COMPLETED|Overall Study||34
10706902|NCT02613403|11871451|FG001|COMPLETED|Overall Study||35
10706903|NCT02613403|11871452|FG002|COMPLETED|Overall Study||9
10706904|NCT02613403|11871453|FG003|COMPLETED|Overall Study||13
10334294|NCT00340704|11470577|FG003|STARTED|Group D- Denovo & 527.51 Rollover Study||29
10334295|NCT00340704|11470578|FG004|STARTED|Group D- Denovo & 527.51 Rollover Study||21
10334296|NCT00340704|11470579|FG005|STARTED|Group D- Denovo & 527.51 Rollover Study||37
10334297|NCT00340704|11470580|FG006|STARTED|Group D- Denovo & 527.51 Rollover Study||54
10334298|NCT00340704|11470581|FG007|STARTED|Group D- Denovo & 527.51 Rollover Study||13
10334299|NCT00340704|11470582|FG008|STARTED|Group D- Denovo & 527.51 Rollover Study||29
10334300|NCT00340704|11470574|FG000|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
10334301|NCT00340704|11470575|FG001|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
10334302|NCT00340704|11470576|FG002|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
10334303|NCT00340704|11470577|FG003|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||7
10334304|NCT00340704|11470578|FG004|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||5
10334305|NCT00340704|11470579|FG005|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||18
10334306|NCT00340704|11470580|FG006|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
10334307|NCT00340704|11470581|FG007|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
10334308|NCT00340704|11470582|FG008|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
10334309|NCT00340704|11470574|FG000|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
10334310|NCT00340704|11470575|FG001|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
10334311|NCT00340704|11470576|FG002|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
10809427|NCT03832387|11971311|FG000|NOT COMPLETED|Overall Study||5
10809428|NCT03832387|11971312|FG001|NOT COMPLETED|Overall Study||7
10809429|NCT03831971|11971318|FG000|STARTED|Overall Study||12
10809430|NCT03831971|11971318|FG000|COMPLETED|Overall Study||12
10809431|NCT03831971|11971318|FG000|NOT COMPLETED|Overall Study||0
10809432|NCT03831854|11971324|FG000|STARTED|Overall Study||23
10809433|NCT03831854|11971325|FG001|STARTED|Overall Study||23
10809434|NCT03831854|11971324|FG000|COMPLETED|Overall Study||23
10809435|NCT03831854|11971325|FG001|COMPLETED|Overall Study||23
10809436|NCT03831854|11971324|FG000|NOT COMPLETED|Overall Study||0
10809437|NCT03831854|11971325|FG001|NOT COMPLETED|Overall Study||0
10809438|NCT03807739|11971335|FG000|STARTED|Overall Study||9
10809439|NCT03807739|11971336|FG001|STARTED|Overall Study||10
10809440|NCT03807739|11971337|FG002|STARTED|Overall Study||9
10809441|NCT03807739|11971338|FG003|STARTED|Overall Study||10
10713808|NCT02682381|11879321|FG001|NOT COMPLETED|Overall Study||0
10457506|NCT01011049|11605276|FG002|STARTED|Overall Study||243
10457507|NCT01011049|11605277|FG003|STARTED|Overall Study||246
10457508|NCT01011049|11605274|FG000|COMPLETED|Overall Study||506
10706905|NCT02613403|11871454|FG004|COMPLETED|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
10706906|NCT02613403|11871450|FG000|NOT COMPLETED|Overall Study||2
10706907|NCT02613403|11871451|FG001|NOT COMPLETED|Overall Study||1
10706908|NCT02613403|11871452|FG002|NOT COMPLETED|Overall Study||0
10706909|NCT02613403|11871453|FG003|NOT COMPLETED|Overall Study||0
10706910|NCT02613403|11871454|FG004|NOT COMPLETED|Overall Study||0
10706911|NCT02613481|11871464|FG000|STARTED|Overall Study||50
10706912|NCT02613481|11871464|FG000|COMPLETED|Overall Study||41
10649610|NCT02163538|11809783|FG001|NOT COMPLETED|Overall Study||1
10649611|NCT02163577|11809791|FG000|STARTED|Overall Study||26
10649612|NCT02163577|11809792|FG001|STARTED|Overall Study||26
10649613|NCT02163577|11809791|FG000|COMPLETED|Overall Study||26
10649614|NCT02163577|11809792|FG001|COMPLETED|Overall Study||26
10649615|NCT02163577|11809791|FG000|NOT COMPLETED|Overall Study||0
10649616|NCT02163577|11809792|FG001|NOT COMPLETED|Overall Study||0
10706913|NCT02613481|11871464|FG000|NOT COMPLETED|Overall Study||9
10706914|NCT02613572|11871471|FG000|STARTED|Phase I: Tolerability, 600, 800, 1200 mg||15
10649617|NCT02163759|11809801|FG000|STARTED|Overall Study||72
10649618|NCT02163759|11809802|FG001|STARTED|Overall Study||142
10649619|NCT02163759|11809803|FG002|STARTED|Overall Study||144
10649620|NCT02163759|11809801|FG000|Completed Week 10|Overall Study||71
10706915|NCT02613572|11871472|FG001|STARTED|Phase I: Tolerability, 600, 800, 1200 mg||0
10706916|NCT02613572|11871473|FG002|STARTED|Phase I: Tolerability, 600, 800, 1200 mg||0
10706917|NCT02613572|11871471|FG000|600 mg|Phase I: Tolerability, 600, 800, 1200 mg||15
10706918|NCT02613572|11871472|FG001|600 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
10706919|NCT02613572|11871473|FG002|600 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
10706920|NCT02613572|11871471|FG000|800 mg|Phase I: Tolerability, 600, 800, 1200 mg||15
10334312|NCT00340704|11470577|FG003|COMPLETED|Group D- Denovo & 527.51 Rollover Study||27
10334313|NCT00340704|11470578|FG004|COMPLETED|Group D- Denovo & 527.51 Rollover Study||16
10334314|NCT00340704|11470579|FG005|COMPLETED|Group D- Denovo & 527.51 Rollover Study||30
10334315|NCT00340704|11470580|FG006|COMPLETED|Group D- Denovo & 527.51 Rollover Study||1
10334316|NCT00340704|11470581|FG007|COMPLETED|Group D- Denovo & 527.51 Rollover Study||1
10334317|NCT00340704|11470582|FG008|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
10334318|NCT00340704|11470574|FG000|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
10334319|NCT00340704|11470575|FG001|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
10334320|NCT00340704|11470576|FG002|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
10334321|NCT00340704|11470577|FG003|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||2
10334322|NCT00340704|11470578|FG004|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||5
10334323|NCT00340704|11470579|FG005|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||7
10334324|NCT00340704|11470580|FG006|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||53
10334325|NCT00340704|11470581|FG007|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||12
10334326|NCT00340704|11470582|FG008|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||29
10334327|NCT00340834|11470613|FG000|STARTED|Core Phase of Study||426
10334328|NCT00340834|11470614|FG001|STARTED|Core Phase of Study||431
10334329|NCT00340834|11470615|FG002|STARTED|Core Phase of Study||435
10334330|NCT00340834|11470616|FG003|STARTED|Core Phase of Study|This group was formed at the beginning of the extension phase of the study.|0
10334331|NCT00340834|11470617|FG004|STARTED|Core Phase of Study|This group was formed at the beginning of the extension phase of the study.|0
10334332|NCT00340834|11470613|FG000|COMPLETED|Core Phase of Study|On study drug: 358, Off study drug: 11|369
10334333|NCT00340834|11470614|FG001|COMPLETED|Core Phase of Study|On study drug: 385, Off study drug: 13|398
10334334|NCT00340834|11470615|FG002|COMPLETED|Core Phase of Study|On study drug: 380, Off study drug: 6|386
10334335|NCT00340834|11470616|FG003|COMPLETED|Core Phase of Study||0
10334336|NCT00340834|11470617|FG004|COMPLETED|Core Phase of Study||0
10334337|NCT00340834|11470613|FG000|NOT COMPLETED|Core Phase of Study||57
10334338|NCT00340834|11470614|FG001|NOT COMPLETED|Core Phase of Study||33
10334339|NCT00340834|11470615|FG002|NOT COMPLETED|Core Phase of Study||49
10334340|NCT00340834|11470616|FG003|NOT COMPLETED|Core Phase of Study||0
10334341|NCT00340834|11470617|FG004|NOT COMPLETED|Core Phase of Study||0
10334342|NCT00340834|11470613|FG000|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|330
10334343|NCT00340834|11470614|FG001|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|357
10334344|NCT00340834|11470615|FG002|STARTED|Extension Phase of Study|This group did not exist in the extension phase of the study.|0
10334345|NCT00340834|11470616|FG003|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|176
10334346|NCT00340834|11470617|FG004|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|167
10334347|NCT00340834|11470613|FG000|Received Study Drug|Extension Phase of Study||330
10334348|NCT00340834|11470614|FG001|Received Study Drug|Extension Phase of Study||356
10334349|NCT00340834|11470615|FG002|Received Study Drug|Extension Phase of Study||0
10334350|NCT00340834|11470616|FG003|Received Study Drug|Extension Phase of Study||174
10334351|NCT00340834|11470617|FG004|Received Study Drug|Extension Phase of Study||167
10334352|NCT00340834|11470613|FG000|COMPLETED|Extension Phase of Study||245
10334353|NCT00340834|11470614|FG001|COMPLETED|Extension Phase of Study||281
10334354|NCT00340834|11470615|FG002|COMPLETED|Extension Phase of Study||0
10334355|NCT00340834|11470616|FG003|COMPLETED|Extension Phase of Study||123
10334356|NCT00340834|11470617|FG004|COMPLETED|Extension Phase of Study||123
10334357|NCT00340834|11470613|FG000|NOT COMPLETED|Extension Phase of Study||85
10334358|NCT00340834|11470614|FG001|NOT COMPLETED|Extension Phase of Study||76
10809442|NCT03807739|11971335|FG000|COMPLETED|Overall Study||7
10809443|NCT03807739|11971336|FG001|COMPLETED|Overall Study||10
10809444|NCT03807739|11971337|FG002|COMPLETED|Overall Study||9
10809445|NCT03807739|11971338|FG003|COMPLETED|Overall Study||10
10809446|NCT03807739|11971335|FG000|NOT COMPLETED|Overall Study||2
10809447|NCT03807739|11971336|FG001|NOT COMPLETED|Overall Study||0
10809448|NCT03807739|11971337|FG002|NOT COMPLETED|Overall Study||0
10809449|NCT03807739|11971338|FG003|NOT COMPLETED|Overall Study||0
10809450|NCT03831282|11971348|FG000|STARTED|Overall Study||12
10809451|NCT03831282|11971348|FG000|COMPLETED|Overall Study||11
10809452|NCT03831282|11971348|FG000|NOT COMPLETED|Overall Study||1
10809453|NCT03824912|11971355|FG000|STARTED|Overall Study||332
10809454|NCT03824912|11971356|FG001|STARTED|Overall Study||335
10809455|NCT03824912|11971357|FG002|STARTED|Overall Study||164
10809456|NCT03824912|11971355|FG000|COMPLETED|Overall Study||192
10809457|NCT03824912|11971356|FG001|COMPLETED|Overall Study||201
10809458|NCT03824912|11971357|FG002|COMPLETED|Overall Study||96
10809459|NCT03824912|11971355|FG000|NOT COMPLETED|Overall Study||140
10706921|NCT02613572|11871472|FG001|800 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
10706922|NCT02613572|11871473|FG002|800 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
10706923|NCT02613572|11871471|FG000|1200 mg|Phase I: Tolerability, 600, 800, 1200 mg||14
10706924|NCT02613572|11871472|FG001|1200 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
10706925|NCT02613572|11871473|FG002|1200 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
10706926|NCT02613572|11871471|FG000|COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||14
10706927|NCT02613572|11871472|FG001|COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0
10706928|NCT02613572|11871473|FG002|COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0
10706929|NCT02613572|11871471|FG000|NOT COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||1
10706930|NCT02613572|11871472|FG001|NOT COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0
10706931|NCT02613572|11871473|FG002|NOT COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0
10706932|NCT02613572|11871471|FG000|STARTED|Phase II: Double-Blind Rand Plac Control||0
10706933|NCT02613572|11871472|FG001|STARTED|Phase II: Double-Blind Rand Plac Control||27
10706934|NCT02613572|11871473|FG002|STARTED|Phase II: Double-Blind Rand Plac Control||26
10334359|NCT00340834|11470615|FG002|NOT COMPLETED|Extension Phase of Study||0
10706935|NCT02613572|11871471|FG000|COMPLETED|Phase II: Double-Blind Rand Plac Control||0
10706936|NCT02613572|11871472|FG001|COMPLETED|Phase II: Double-Blind Rand Plac Control||26
10706937|NCT02613572|11871473|FG002|COMPLETED|Phase II: Double-Blind Rand Plac Control||26
10334360|NCT00340834|11470616|FG003|NOT COMPLETED|Extension Phase of Study||53
10334361|NCT00340834|11470617|FG004|NOT COMPLETED|Extension Phase of Study||44
10334362|NCT00342355|11470631|FG000|STARTED|Overall Study||444
10334363|NCT00342355|11470632|FG001|STARTED|Overall Study||440
10334364|NCT00342355|11470633|FG002|STARTED|Overall Study||444
10334365|NCT00342355|11470634|FG003|STARTED|Overall Study||443
10334366|NCT00342355|11470631|FG000|COMPLETED|Overall Study||444
10334367|NCT00342355|11470632|FG001|COMPLETED|Overall Study||440
10334368|NCT00342355|11470633|FG002|COMPLETED|Overall Study||444
10334369|NCT00342355|11470634|FG003|COMPLETED|Overall Study||443
10334370|NCT00342355|11470631|FG000|NOT COMPLETED|Overall Study||0
10334371|NCT00342355|11470632|FG001|NOT COMPLETED|Overall Study||0
10334372|NCT00342355|11470633|FG002|NOT COMPLETED|Overall Study||0
10334373|NCT00342355|11470634|FG003|NOT COMPLETED|Overall Study||0
10334374|NCT00342563|11470648|FG000|STARTED|Overall Study||41
10334375|NCT00342563|11470649|FG001|STARTED|Overall Study||27
10334376|NCT00342563|11470650|FG002|STARTED|Overall Study||40
10334377|NCT00342563|11470651|FG003|STARTED|Overall Study||28
10334378|NCT00342563|11470648|FG000|COMPLETED|Overall Study||35
10334379|NCT00342563|11470649|FG001|COMPLETED|Overall Study||19
10334380|NCT00342563|11470650|FG002|COMPLETED|Overall Study||26
10334381|NCT00342563|11470651|FG003|COMPLETED|Overall Study||22
10334382|NCT00342563|11470648|FG000|NOT COMPLETED|Overall Study||6
10334383|NCT00342563|11470649|FG001|NOT COMPLETED|Overall Study||8
10334384|NCT00342563|11470650|FG002|NOT COMPLETED|Overall Study||14
10334385|NCT00342563|11470651|FG003|NOT COMPLETED|Overall Study||6
10334386|NCT00342628|11470666|FG000|STARTED|Overall Study||100
10334387|NCT00342628|11470667|FG001|STARTED|Overall Study||101
10334388|NCT00342628|11470668|FG002|STARTED|Overall Study||100
10334389|NCT00342628|11470666|FG000|COMPLETED|Overall Study|84 completed 4 injections, 4 were lost-to-followup after the 4th injection|80
10334390|NCT00342628|11470667|FG001|COMPLETED|Overall Study|83 completed 4 injections, 3 were lost-to-followup after 4th injection|80
10334391|NCT00342628|11470668|FG002|COMPLETED|Overall Study|97 completed 3 injections of DTP alone, 16 were lost-to-followup for blood drawing at 12 months.|81
10334392|NCT00342628|11470666|FG000|NOT COMPLETED|Overall Study||20
10334393|NCT00342628|11470667|FG001|NOT COMPLETED|Overall Study||21
10334394|NCT00342628|11470668|FG002|NOT COMPLETED|Overall Study||19
10334395|NCT00343044|11470676|FG000|STARTED|Overall Study||40
10334396|NCT00343044|11470676|FG000|COMPLETED|Overall Study||40
10334397|NCT00343044|11470676|FG000|NOT COMPLETED|Overall Study||0
10334398|NCT00343083|11470680|FG000|STARTED|Overall Study||43
10334399|NCT00343083|11470680|FG000|COMPLETED|Overall Study||22
10334400|NCT00343083|11470680|FG000|NOT COMPLETED|Overall Study||21
10334401|NCT00343252|11470687|FG000|STARTED|All Randomized Participants||361
10334402|NCT00343252|11470688|FG001|STARTED|All Randomized Participants||351
10334403|NCT00343252|11470687|FG000|COMPLETED|All Randomized Participants||259
10334404|NCT00343252|11470688|FG001|COMPLETED|All Randomized Participants||269
10706938|NCT02613572|11871471|FG000|NOT COMPLETED|Phase II: Double-Blind Rand Plac Control||0
10706939|NCT02613572|11871472|FG001|NOT COMPLETED|Phase II: Double-Blind Rand Plac Control||1
10706940|NCT02613572|11871473|FG002|NOT COMPLETED|Phase II: Double-Blind Rand Plac Control||0
10706941|NCT02613871|11871485|FG000|STARTED|Overall Study||111
10457509|NCT01011049|11605275|FG001|COMPLETED|Overall Study||250
10457510|NCT01011049|11605276|FG002|COMPLETED|Overall Study||239
10457511|NCT01011049|11605277|FG003|COMPLETED|Overall Study||246
10457512|NCT01011049|11605274|FG000|NOT COMPLETED|Overall Study||1
10457513|NCT01011049|11605275|FG001|NOT COMPLETED|Overall Study||2
10457514|NCT01011049|11605276|FG002|NOT COMPLETED|Overall Study||4
10706942|NCT02613871|11871485|FG000|COMPLETED|Overall Study||108
10706943|NCT02613871|11871485|FG000|NOT COMPLETED|Overall Study||3
10706944|NCT02613884|11871489|FG000|STARTED|Overall Study||26
10334405|NCT00343252|11470687|FG000|NOT COMPLETED|All Randomized Participants||102
10334406|NCT00343252|11470688|FG001|NOT COMPLETED|All Randomized Participants||82
10706945|NCT02613884|11871489|FG000|Safety Endpoint 1|Overall Study||26
10339041|NCT00371137|11476000|FG001|NOT COMPLETED|Overall Study||63
10706946|NCT02613884|11871489|FG000|Feasibility Questionnaire|Overall Study||26
10706947|NCT02613884|11871489|FG000|Safety Endpoint 2|Overall Study||26
10706948|NCT02613884|11871489|FG000|Efficacy Endpoint 1|Overall Study||25
10706949|NCT02613884|11871489|FG000|Efficacy Timepoint 2|Overall Study||25
10706950|NCT02613884|11871489|FG000|Efficacy Timepoint 3|Overall Study||24
10706951|NCT02613884|11871489|FG000|COMPLETED|Overall Study||24
10706952|NCT02613884|11871489|FG000|NOT COMPLETED|Overall Study||2
10706953|NCT02613897|11871497|FG000|STARTED|Overall Study||22
10706954|NCT02613897|11871498|FG001|STARTED|Overall Study||22
10706955|NCT02613897|11871499|FG002|STARTED|Overall Study||12
10706956|NCT02613897|11871497|FG000|COMPLETED|Overall Study||22
10706957|NCT02613897|11871498|FG001|COMPLETED|Overall Study||22
10706958|NCT02613897|11871499|FG002|COMPLETED|Overall Study||12
10706959|NCT02613897|11871497|FG000|NOT COMPLETED|Overall Study||0
10706960|NCT02613897|11871498|FG001|NOT COMPLETED|Overall Study||0
10706961|NCT02613897|11871499|FG002|NOT COMPLETED|Overall Study||0
10334407|NCT00343252|11470687|FG000|STARTED|6 Months (All Treated Participants)|361 participants were randomized but 1 did not receive study drug and was not analyzed.|360
10334408|NCT00343252|11470688|FG001|STARTED|6 Months (All Treated Participants)|351 participants were randomized but 1 did not receive study drug and was not analyzed.|350
10334409|NCT00343252|11470687|FG000|COMPLETED|6 Months (All Treated Participants)||304
10334410|NCT00343252|11470688|FG001|COMPLETED|6 Months (All Treated Participants)||306
10334411|NCT00343252|11470687|FG000|NOT COMPLETED|6 Months (All Treated Participants)||56
10334412|NCT00343252|11470688|FG001|NOT COMPLETED|6 Months (All Treated Participants)||44
10334413|NCT00343252|11470687|FG000|STARTED|12 Months (All Treated Participants)|361 participants were randomized but 1 did not receive study drug and was not analyzed.|360
10334414|NCT00343252|11470688|FG001|STARTED|12 Months (All Treated Participants)|351 participants were randomized but 1 did not receive study drug and was not analyzed.|350
10334415|NCT00343252|11470687|FG000|COMPLETED|12 Months (All Treated Participants)|Completed 12 Months.|274
10334416|NCT00343252|11470688|FG001|COMPLETED|12 Months (All Treated Participants)|Completed 12 Months.|281
10334417|NCT00343252|11470687|FG000|NOT COMPLETED|12 Months (All Treated Participants)||86
10334418|NCT00343252|11470688|FG001|NOT COMPLETED|12 Months (All Treated Participants)||69
10334419|NCT00343252|11470687|FG000|STARTED|18 Months (All Treated Participants)||360
10334420|NCT00343252|11470688|FG001|STARTED|18 Months (All Treated Participants)||350
10706962|NCT02613910|11871508|FG000|STARTED|Overall Study||1
10706963|NCT02613910|11871508|FG000|COMPLETED|Overall Study||0
10706964|NCT02613910|11871508|FG000|NOT COMPLETED|Overall Study||1
10706965|NCT02614079|11871512|FG000|STARTED|Overall Study||6
10706966|NCT02614079|11871512|FG000|COMPLETED|Overall Study|1 participant withdrew from the study prior to completion of DSSEP testing|5
10706967|NCT02614079|11871512|FG000|NOT COMPLETED|Overall Study||1
10334421|NCT00343252|11470687|FG000|COMPLETED|18 Months (All Treated Participants)||259
10334422|NCT00343252|11470688|FG001|COMPLETED|18 Months (All Treated Participants)||269
10334423|NCT00343252|11470687|FG000|NOT COMPLETED|18 Months (All Treated Participants)||101
10334424|NCT00343252|11470688|FG001|NOT COMPLETED|18 Months (All Treated Participants)||81
10334425|NCT00343291|11470696|FG000|STARTED|Overall Study||60
10334426|NCT00343291|11470697|FG001|STARTED|Overall Study||61
10334427|NCT00343291|11470696|FG000|RECEIVED AT LEAST ONE DOSE OF STUDY DRUG|Overall Study||58
10334428|NCT00343291|11470697|FG001|RECEIVED AT LEAST ONE DOSE OF STUDY DRUG|Overall Study||58
10334429|NCT00343291|11470696|FG000|COMPLETED|Overall Study|Participants completed 6 cycles of treatment. Did not start subsequent weekly cetuximab monotherapy.|3
10334430|NCT00343291|11470697|FG001|COMPLETED|Overall Study|Participants completed 6 cycles of treatment. Did not start subsequent weekly cetuximab monotherapy.|5
10334431|NCT00343291|11470696|FG000|NOT COMPLETED|Overall Study||57
10334432|NCT00343291|11470697|FG001|NOT COMPLETED|Overall Study||56
10334433|NCT00343382|11470706|FG000|STARTED|Overall Study||64
10334434|NCT00343382|11470707|FG001|STARTED|Overall Study||65
10334435|NCT00343382|11470708|FG002|STARTED|Overall Study||66
10334436|NCT00343382|11470706|FG000|COMPLETED|Overall Study||60
10334437|NCT00343382|11470707|FG001|COMPLETED|Overall Study||51
10334438|NCT00343382|11470708|FG002|COMPLETED|Overall Study||49
10334439|NCT00343382|11470706|FG000|NOT COMPLETED|Overall Study||4
10334440|NCT00343382|11470707|FG001|NOT COMPLETED|Overall Study||14
10334441|NCT00343382|11470708|FG002|NOT COMPLETED|Overall Study||17
10334442|NCT00343460|11470722|FG000|STARTED|Cycle 1||475
10334443|NCT00343460|11470723|FG001|STARTED|Cycle 1||481
10334444|NCT00343460|11470724|FG002|STARTED|Cycle 1||472
10334445|NCT00343460|11470722|FG000|COMPLETED|Cycle 1||453
10334446|NCT00343460|11470723|FG001|COMPLETED|Cycle 1||459
10334447|NCT00343460|11470724|FG002|COMPLETED|Cycle 1||454
10334448|NCT00343460|11470722|FG000|NOT COMPLETED|Cycle 1||22
10334449|NCT00343460|11470723|FG001|NOT COMPLETED|Cycle 1||22
10334450|NCT00343460|11470724|FG002|NOT COMPLETED|Cycle 1||18
10334451|NCT00343460|11470722|FG000|STARTED|Cycle 2 - 4||584
10334452|NCT00343460|11470723|FG001|STARTED|Cycle 2 - 4||565
10706968|NCT02614131|11871523|FG000|STARTED|Overall Study||11
10706969|NCT02614131|11871524|FG001|STARTED|Overall Study||8
10706970|NCT02614131|11871525|FG002|STARTED|Overall Study||8
10706971|NCT02614131|11871526|FG003|STARTED|Overall Study||8
10706972|NCT02614131|11871527|FG004|STARTED|Overall Study||8
10706973|NCT02614131|11871528|FG005|STARTED|Overall Study||2
10457515|NCT01011049|11605277|FG003|NOT COMPLETED|Overall Study||0
10457516|NCT01011075|11605287|FG000|STARTED|Overall Study||34
10457517|NCT01011075|11605287|FG000|COMPLETED|Overall Study||34
10457518|NCT01011075|11605287|FG000|NOT COMPLETED|Overall Study||0
10457519|NCT01011153|11605294|FG000|STARTED|Overall Study||54
10457520|NCT01011153|11605295|FG001|STARTED|Overall Study||75
10457521|NCT01011153|11605296|FG002|STARTED|Overall Study||54
10457522|NCT01011153|11605294|FG000|COMPLETED|Overall Study||46
10457523|NCT01011153|11605295|FG001|COMPLETED|Overall Study||64
10457524|NCT01011153|11605296|FG002|COMPLETED|Overall Study||45
10457525|NCT01011153|11605294|FG000|NOT COMPLETED|Overall Study||8
10457526|NCT01011153|11605295|FG001|NOT COMPLETED|Overall Study||11
10457527|NCT01011153|11605296|FG002|NOT COMPLETED|Overall Study||9
10457528|NCT01011179|11605314|FG000|STARTED|Overall Study||24
10457529|NCT01011179|11605315|FG001|STARTED|Overall Study||22
10457530|NCT01011179|11605314|FG000|COMPLETED|Overall Study||20
10457531|NCT01011179|11605315|FG001|COMPLETED|Overall Study||20
10457532|NCT01011179|11605314|FG000|NOT COMPLETED|Overall Study||4
10457533|NCT01011179|11605315|FG001|NOT COMPLETED|Overall Study||2
10457534|NCT01011218|11605327|FG000|STARTED|Overall Study||9
10457535|NCT01011218|11605328|FG001|STARTED|Overall Study||9
10457536|NCT01011218|11605329|FG002|STARTED|Overall Study||26
10706974|NCT02614131|11871529|FG006|STARTED|Overall Study||5
10706975|NCT02614131|11871523|FG000|Received at Least One Dose of Drug|Overall Study||11
10706976|NCT02614131|11871524|FG001|Received at Least One Dose of Drug|Overall Study||8
10706977|NCT02614131|11871525|FG002|Received at Least One Dose of Drug|Overall Study||8
10457537|NCT01011218|11605330|FG003|STARTED|Overall Study||26
10457538|NCT01011218|11605327|FG000|COMPLETED|Overall Study||9
10457539|NCT01011218|11605328|FG001|COMPLETED|Overall Study||9
10457540|NCT01011218|11605329|FG002|COMPLETED|Overall Study||26
10706978|NCT02614131|11871526|FG003|Received at Least One Dose of Drug|Overall Study||8
10706979|NCT02614131|11871527|FG004|Received at Least One Dose of Drug|Overall Study||8
10706980|NCT02614131|11871528|FG005|Received at Least One Dose of Drug|Overall Study||2
10706981|NCT02614131|11871529|FG006|Received at Least One Dose of Drug|Overall Study||5
10706982|NCT02614131|11871523|FG000|COMPLETED|Overall Study||10
10706983|NCT02614131|11871524|FG001|COMPLETED|Overall Study||8
10706984|NCT02614131|11871525|FG002|COMPLETED|Overall Study||8
10706985|NCT02614131|11871526|FG003|COMPLETED|Overall Study||8
10706986|NCT02614131|11871527|FG004|COMPLETED|Overall Study||8
10706987|NCT02614131|11871528|FG005|COMPLETED|Overall Study||2
10706988|NCT02614131|11871529|FG006|COMPLETED|Overall Study||4
10706989|NCT02614131|11871523|FG000|NOT COMPLETED|Overall Study||1
10706990|NCT02614131|11871524|FG001|NOT COMPLETED|Overall Study||0
10706991|NCT02614131|11871525|FG002|NOT COMPLETED|Overall Study||0
10706992|NCT02614131|11871526|FG003|NOT COMPLETED|Overall Study||0
10706993|NCT02614131|11871527|FG004|NOT COMPLETED|Overall Study||0
10706994|NCT02614131|11871528|FG005|NOT COMPLETED|Overall Study||0
10706995|NCT02614131|11871529|FG006|NOT COMPLETED|Overall Study||1
10706996|NCT02614183|11871554|FG000|STARTED|Double Blind Treatment Phase||434
10706997|NCT02614183|11871555|FG001|STARTED|Double Blind Treatment Phase||214
10706998|NCT02614183|11871556|FG002|STARTED|Double Blind Treatment Phase||214
10706999|NCT02614183|11871554|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||433
10707000|NCT02614183|11871555|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||213
10713809|NCT02682381|11879322|FG002|NOT COMPLETED|Overall Study||0
10707001|NCT02614183|11871556|FG002|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||212
10707002|NCT02614183|11871554|FG000|Safety Population|Double Blind Treatment Phase||432
10707003|NCT02614183|11871555|FG001|Safety Population|Double Blind Treatment Phase|One pt randomized to placebo received galcanezumab 120mg due to dosing error moved to this group.|206
10334453|NCT00343460|11470724|FG002|STARTED|Cycle 2 - 4||0
10334454|NCT00343460|11470722|FG000|COMPLETED|Cycle 2 - 4||528
10334455|NCT00343460|11470723|FG001|COMPLETED|Cycle 2 - 4||515
10707004|NCT02614183|11871556|FG002|Safety Population|Double Blind Treatment Phase|Eight pts discontinued after loading dose of 240mg galcanezumab in 120mg group moved to this group.|220
10707005|NCT02614183|11871554|FG000|COMPLETED|Double Blind Treatment Phase||351
10707006|NCT02614183|11871555|FG001|COMPLETED|Double Blind Treatment Phase||177
10707007|NCT02614183|11871556|FG002|COMPLETED|Double Blind Treatment Phase||175
10707008|NCT02614183|11871554|FG000|NOT COMPLETED|Double Blind Treatment Phase||83
10707009|NCT02614183|11871555|FG001|NOT COMPLETED|Double Blind Treatment Phase||37
10707010|NCT02614183|11871556|FG002|NOT COMPLETED|Double Blind Treatment Phase||39
10707011|NCT02614183|11871554|FG000|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post-treatment phase.|372
10707012|NCT02614183|11871555|FG001|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post-treatment phase.|185
10707013|NCT02614183|11871556|FG002|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post-treatment phase.|183
10707014|NCT02614183|11871554|FG000|Safety Population|Post Treatment Follow-up Phase||372
10707015|NCT02614183|11871555|FG001|Safety Population|Post Treatment Follow-up Phase||183
10707016|NCT02614183|11871556|FG002|Safety Population|Post Treatment Follow-up Phase|Two participants who received only 240mg loading dose prior to discontinuation moved to this group.|185
10707017|NCT02614183|11871554|FG000|COMPLETED|Post Treatment Follow-up Phase||354
10707018|NCT02614183|11871555|FG001|COMPLETED|Post Treatment Follow-up Phase||179
10707019|NCT02614183|11871556|FG002|COMPLETED|Post Treatment Follow-up Phase||171
10707020|NCT02614183|11871554|FG000|NOT COMPLETED|Post Treatment Follow-up Phase||18
10707021|NCT02614183|11871555|FG001|NOT COMPLETED|Post Treatment Follow-up Phase||6
10707022|NCT02614183|11871556|FG002|NOT COMPLETED|Post Treatment Follow-up Phase||12
10707023|NCT02614196|11871576|FG000|STARTED|Double Blind Treatment Phase||463
10707024|NCT02614196|11871577|FG001|STARTED|Double Blind Treatment Phase||233
10707025|NCT02614196|11871578|FG002|STARTED|Double Blind Treatment Phase||226
10707026|NCT02614196|11871579|FG003|STARTED|Double Blind Treatment Phase||30
10707027|NCT02614196|11871580|FG004|STARTED|Double Blind Treatment Phase||15
10707028|NCT02614196|11871581|FG005|STARTED|Double Blind Treatment Phase||19
10707029|NCT02614196|11871576|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||461
10707030|NCT02614196|11871577|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||231
10707031|NCT02614196|11871578|FG002|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||223
10707032|NCT02614196|11871579|FG003|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||30
10707033|NCT02614196|11871580|FG004|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||14
10707034|NCT02614196|11871581|FG005|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||19
10707035|NCT02614196|11871576|FG000|COMPLETED|Double Blind Treatment Phase||387
10707036|NCT02614196|11871577|FG001|COMPLETED|Double Blind Treatment Phase||203
10707037|NCT02614196|11871578|FG002|COMPLETED|Double Blind Treatment Phase||195
10707038|NCT02614196|11871579|FG003|COMPLETED|Double Blind Treatment Phase||26
10707039|NCT02614196|11871580|FG004|COMPLETED|Double Blind Treatment Phase||14
10707040|NCT02614196|11871581|FG005|COMPLETED|Double Blind Treatment Phase||19
10334456|NCT00343460|11470724|FG002|COMPLETED|Cycle 2 - 4||0
10334457|NCT00343460|11470722|FG000|NOT COMPLETED|Cycle 2 - 4||56
10334458|NCT00343460|11470723|FG001|NOT COMPLETED|Cycle 2 - 4||50
10334459|NCT00343460|11470724|FG002|NOT COMPLETED|Cycle 2 - 4||0
10334460|NCT00343512|11470742|FG000|STARTED|Overall Study||34
10334461|NCT00343512|11470742|FG000|COMPLETED|Overall Study||32
10334462|NCT00343512|11470742|FG000|NOT COMPLETED|Overall Study||2
10334463|NCT00343564|11470758|FG000|STARTED|Overall Study||6
10334464|NCT00343564|11470759|FG001|STARTED|Overall Study||7
10334465|NCT00343564|11470760|FG002|STARTED|Overall Study||3
10334466|NCT00343564|11470761|FG003|STARTED|Overall Study||7
10334467|NCT00343564|11470762|FG004|STARTED|Overall Study||10
10334468|NCT00343564|11470763|FG005|STARTED|Overall Study||9
10334469|NCT00343564|11470764|FG006|STARTED|Overall Study||4
10334470|NCT00343564|11470765|FG007|STARTED|Overall Study||3
10334471|NCT00343564|11470766|FG008|STARTED|Overall Study||3
10334472|NCT00343564|11470767|FG009|STARTED|Overall Study||8
10334473|NCT00343564|11470768|FG010|STARTED|Overall Study||8
10334474|NCT00343564|11470758|FG000|COMPLETED|Overall Study||6
10334475|NCT00343564|11470759|FG001|COMPLETED|Overall Study||7
10334476|NCT00343564|11470760|FG002|COMPLETED|Overall Study||3
10334477|NCT00343564|11470761|FG003|COMPLETED|Overall Study||7
10334478|NCT00343564|11470762|FG004|COMPLETED|Overall Study||10
10334479|NCT00343564|11470763|FG005|COMPLETED|Overall Study||9
10334480|NCT00343564|11470764|FG006|COMPLETED|Overall Study||4
10334481|NCT00343564|11470765|FG007|COMPLETED|Overall Study||3
10334482|NCT00343564|11470766|FG008|COMPLETED|Overall Study||3
10334483|NCT00343564|11470767|FG009|COMPLETED|Overall Study||8
10334484|NCT00343564|11470768|FG010|COMPLETED|Overall Study||8
10334485|NCT00343564|11470758|FG000|NOT COMPLETED|Overall Study||0
10334486|NCT00343564|11470759|FG001|NOT COMPLETED|Overall Study||0
10334487|NCT00343564|11470760|FG002|NOT COMPLETED|Overall Study||0
10334488|NCT00343564|11470761|FG003|NOT COMPLETED|Overall Study||0
10334489|NCT00343564|11470762|FG004|NOT COMPLETED|Overall Study||0
10334490|NCT00343564|11470763|FG005|NOT COMPLETED|Overall Study||0
10334491|NCT00343564|11470764|FG006|NOT COMPLETED|Overall Study||0
10334492|NCT00343564|11470765|FG007|NOT COMPLETED|Overall Study||0
10334493|NCT00343564|11470766|FG008|NOT COMPLETED|Overall Study||0
10334494|NCT00343564|11470767|FG009|NOT COMPLETED|Overall Study||0
10334495|NCT00343564|11470768|FG010|NOT COMPLETED|Overall Study||0
10334496|NCT00343642|11470866|FG000|STARTED|Overall Study||19
10334497|NCT00343642|11470867|FG001|STARTED|Overall Study||19
10334498|NCT00343642|11470868|FG002|STARTED|Overall Study||16
10334499|NCT00343642|11470866|FG000|Upto 3 Months Complete or Flare|Overall Study||2
10334500|NCT00343642|11470867|FG001|Upto 3 Months Complete or Flare|Overall Study||0
10334501|NCT00343642|11470868|FG002|Upto 3 Months Complete or Flare|Overall Study||1
10334502|NCT00343642|11470866|FG000|3-6 Months Complete or Flare|Overall Study||4
10334503|NCT00343642|11470867|FG001|3-6 Months Complete or Flare|Overall Study||2
10334504|NCT00343642|11470868|FG002|3-6 Months Complete or Flare|Overall Study||2
10334505|NCT00343642|11470866|FG000|COMPLETED|Overall Study||10
10334506|NCT00343642|11470867|FG001|COMPLETED|Overall Study||11
10334507|NCT00343642|11470868|FG002|COMPLETED|Overall Study||9
10334508|NCT00343642|11470866|FG000|NOT COMPLETED|Overall Study||9
10334509|NCT00343642|11470867|FG001|NOT COMPLETED|Overall Study||8
10334510|NCT00343642|11470868|FG002|NOT COMPLETED|Overall Study||7
10334511|NCT00343785|11470879|FG000|STARTED|Overall Study||21
10707041|NCT02614196|11871576|FG000|NOT COMPLETED|Double Blind Treatment Phase||76
10707042|NCT02614196|11871577|FG001|NOT COMPLETED|Double Blind Treatment Phase||30
10707043|NCT02614196|11871578|FG002|NOT COMPLETED|Double Blind Treatment Phase||31
10707044|NCT02614196|11871579|FG003|NOT COMPLETED|Double Blind Treatment Phase||4
10707045|NCT02614196|11871580|FG004|NOT COMPLETED|Double Blind Treatment Phase||1
10707046|NCT02614196|11871581|FG005|NOT COMPLETED|Double Blind Treatment Phase||0
10707047|NCT02614196|11871576|FG000|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|410
10707048|NCT02614196|11871577|FG001|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|213
10707128|NCT02615145|11871687|FG000|2 DAA + Ribavirin (RBV)|Overall Study||0
10707049|NCT02614196|11871578|FG002|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|207
10707050|NCT02614196|11871579|FG003|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|25
10707051|NCT02614196|11871580|FG004|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|15
10707052|NCT02614196|11871581|FG005|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|19
10707053|NCT02614196|11871576|FG000|COMPLETED|Post Treatment Follow-up Phase||390
10707054|NCT02614196|11871577|FG001|COMPLETED|Post Treatment Follow-up Phase||208
10707055|NCT02614196|11871578|FG002|COMPLETED|Post Treatment Follow-up Phase||199
10707056|NCT02614196|11871579|FG003|COMPLETED|Post Treatment Follow-up Phase||24
10707057|NCT02614196|11871580|FG004|COMPLETED|Post Treatment Follow-up Phase||13
10707058|NCT02614196|11871581|FG005|COMPLETED|Post Treatment Follow-up Phase||19
10707059|NCT02614196|11871576|FG000|NOT COMPLETED|Post Treatment Follow-up Phase||20
10707060|NCT02614196|11871577|FG001|NOT COMPLETED|Post Treatment Follow-up Phase||5
10707061|NCT02614196|11871578|FG002|NOT COMPLETED|Post Treatment Follow-up Phase||8
10707062|NCT02614196|11871579|FG003|NOT COMPLETED|Post Treatment Follow-up Phase||1
10707063|NCT02614196|11871580|FG004|NOT COMPLETED|Post Treatment Follow-up Phase||2
10707064|NCT02614196|11871581|FG005|NOT COMPLETED|Post Treatment Follow-up Phase||0
10707065|NCT02614222|11871611|FG000|STARTED|Overall Study||13
10707066|NCT02614222|11871612|FG001|STARTED|Overall Study||14
10707067|NCT02614222|11871611|FG000|COMPLETED|Overall Study||13
10707068|NCT02614222|11871612|FG001|COMPLETED|Overall Study||14
10707069|NCT02614222|11871611|FG000|NOT COMPLETED|Overall Study||0
10707070|NCT02614222|11871612|FG001|NOT COMPLETED|Overall Study||0
10707071|NCT02614274|11871618|FG000|STARTED|Overall Study||9
10707072|NCT02614274|11871618|FG000|COMPLETED|Overall Study||5
10707073|NCT02614274|11871618|FG000|NOT COMPLETED|Overall Study||4
10707074|NCT02614287|11871624|FG000|STARTED|Open Label (OL) Treatment Phase||135
10707075|NCT02614287|11871625|FG001|STARTED|Open Label (OL) Treatment Phase||135
10707076|NCT02614287|11871624|FG000|Received at Least One Dose of Study Drug|Open Label (OL) Treatment Phase||135
10334512|NCT00343785|11470879|FG000|COMPLETED|Overall Study||21
10334513|NCT00343785|11470879|FG000|NOT COMPLETED|Overall Study||0
10707077|NCT02614287|11871625|FG001|Received at Least One Dose of Study Drug|Open Label (OL) Treatment Phase||135
10707078|NCT02614287|11871624|FG000|COMPLETED|Open Label (OL) Treatment Phase||97
10707079|NCT02614287|11871625|FG001|COMPLETED|Open Label (OL) Treatment Phase||113
10707080|NCT02614287|11871624|FG000|NOT COMPLETED|Open Label (OL) Treatment Phase||38
10707081|NCT02614287|11871625|FG001|NOT COMPLETED|Open Label (OL) Treatment Phase||22
10713810|NCT02682420|11879330|FG000|STARTED|Overall Study||100
10707082|NCT02614287|11871624|FG000|STARTED|Post Treatment Follow-up Phase|Follow-up period was optional, few participants who completed OL period didn't enter follow-up.|112
10707083|NCT02614287|11871625|FG001|STARTED|Post Treatment Follow-up Phase|Follow-up period was optional, few participants who completed OL period didn't enter follow-up.|124
10707084|NCT02614287|11871624|FG000|COMPLETED|Post Treatment Follow-up Phase||103
10707085|NCT02614287|11871625|FG001|COMPLETED|Post Treatment Follow-up Phase||119
10707086|NCT02614287|11871624|FG000|NOT COMPLETED|Post Treatment Follow-up Phase||9
10707087|NCT02614287|11871625|FG001|NOT COMPLETED|Post Treatment Follow-up Phase||5
10707088|NCT02614469|11871638|FG000|STARTED|Period 1||9
10707089|NCT02614469|11871639|FG001|STARTED|Period 1||9
10707090|NCT02614469|11871638|FG000|COMPLETED|Period 1||9
10707091|NCT02614469|11871639|FG001|COMPLETED|Period 1||9
10707092|NCT02614469|11871638|FG000|NOT COMPLETED|Period 1||0
10707093|NCT02614469|11871639|FG001|NOT COMPLETED|Period 1||0
10707094|NCT02614469|11871638|FG000|STARTED|Period 2||9
10707095|NCT02614469|11871639|FG001|STARTED|Period 2||9
10707096|NCT02614469|11871638|FG000|COMPLETED|Period 2||9
10707097|NCT02614469|11871639|FG001|COMPLETED|Period 2||9
10707098|NCT02614469|11871638|FG000|NOT COMPLETED|Period 2||0
10707099|NCT02614469|11871639|FG001|NOT COMPLETED|Period 2||0
10707100|NCT02614560|11871647|FG000|STARTED|Overall Study||6
10707101|NCT02614560|11871648|FG001|STARTED|Overall Study||8
10707102|NCT02614560|11871647|FG000|COMPLETED|Overall Study||0
10707103|NCT02614560|11871648|FG001|COMPLETED|Overall Study||6
10707104|NCT02614560|11871647|FG000|NOT COMPLETED|Overall Study||6
10707105|NCT02614560|11871648|FG001|NOT COMPLETED|Overall Study||2
10707106|NCT02614703|11871656|FG000|STARTED|Overall Study||31
10707107|NCT02614703|11871657|FG001|STARTED|Overall Study||29
10707108|NCT02614703|11871656|FG000|COMPLETED|Overall Study||24
10707109|NCT02614703|11871657|FG001|COMPLETED|Overall Study||28
10707110|NCT02614703|11871656|FG000|NOT COMPLETED|Overall Study||7
10707111|NCT02614703|11871657|FG001|NOT COMPLETED|Overall Study||1
10707112|NCT02614729|11871665|FG000|STARTED|Overall Study||18
10707113|NCT02614729|11871666|FG001|STARTED|Overall Study||17
10707114|NCT02614729|11871665|FG000|COMPLETED|Overall Study||17
10707115|NCT02614729|11871666|FG001|COMPLETED|Overall Study||17
10707116|NCT02614729|11871665|FG000|NOT COMPLETED|Overall Study||1
10707117|NCT02614729|11871666|FG001|NOT COMPLETED|Overall Study||0
10707118|NCT02614924|11871676|FG000|STARTED|Overall Study||20
10707119|NCT02614924|11871677|FG001|STARTED|Overall Study||20
10707120|NCT02614924|11871676|FG000|COMPLETED|Overall Study||20
10707121|NCT02614924|11871677|FG001|COMPLETED|Overall Study||20
10707122|NCT02614924|11871676|FG000|NOT COMPLETED|Overall Study||0
10707123|NCT02614924|11871677|FG001|NOT COMPLETED|Overall Study||0
10707124|NCT02615145|11871687|FG000|STARTED|Overall Study||145
10707125|NCT02615145|11871688|FG001|STARTED|Overall Study||278
10707126|NCT02615145|11871689|FG002|STARTED|Overall Study||48
10707127|NCT02615145|11871690|FG003|STARTED|Overall Study||1
10707129|NCT02615145|11871688|FG001|2 DAA + Ribavirin (RBV)|Overall Study||0
10457541|NCT01011218|11605330|FG003|COMPLETED|Overall Study||26
10457542|NCT01011218|11605327|FG000|NOT COMPLETED|Overall Study||0
10457543|NCT01011218|11605328|FG001|NOT COMPLETED|Overall Study||0
10457544|NCT01011218|11605329|FG002|NOT COMPLETED|Overall Study||0
10457545|NCT01011218|11605330|FG003|NOT COMPLETED|Overall Study||0
10457546|NCT01011283|11605342|FG000|STARTED|Overall Study||13
10457547|NCT01011283|11605343|FG001|STARTED|Overall Study||13
10457548|NCT01011283|11605342|FG000|COMPLETED|Overall Study||2
10457549|NCT01011283|11605343|FG001|COMPLETED|Overall Study||2
10457550|NCT01011283|11605342|FG000|NOT COMPLETED|Overall Study||11
10457551|NCT01011283|11605343|FG001|NOT COMPLETED|Overall Study||11
10457552|NCT01011309|11605352|FG000|STARTED|Overall Study||14
10457553|NCT01011309|11605353|FG001|STARTED|Overall Study||10
10457554|NCT01011309|11605354|FG002|STARTED|Overall Study||21
10457555|NCT01011309|11605352|FG000|COMPLETED|Overall Study||12
10809460|NCT03824912|11971356|FG001|NOT COMPLETED|Overall Study||134
10809461|NCT03824912|11971357|FG002|NOT COMPLETED|Overall Study||68
10809462|NCT03822884|11971371|FG000|STARTED|Overall Study||4
10809463|NCT03822884|11971372|FG001|STARTED|Overall Study||4
10809464|NCT03822884|11971373|FG002|STARTED|Overall Study||4
10809465|NCT03822884|11971374|FG003|STARTED|Overall Study||4
10809466|NCT03822884|11971375|FG004|STARTED|Overall Study||4
10809467|NCT03822884|11971376|FG005|STARTED|Overall Study||4
10809468|NCT03822884|11971371|FG000|COMPLETED|Overall Study||4
10809469|NCT03822884|11971372|FG001|COMPLETED|Overall Study||4
10809470|NCT03822884|11971373|FG002|COMPLETED|Overall Study||4
10809471|NCT03822884|11971374|FG003|COMPLETED|Overall Study||4
10809472|NCT03822884|11971375|FG004|COMPLETED|Overall Study||3
10809473|NCT03822884|11971376|FG005|COMPLETED|Overall Study||4
10809474|NCT03822884|11971371|FG000|NOT COMPLETED|Overall Study||0
10809475|NCT03822884|11971372|FG001|NOT COMPLETED|Overall Study||0
10809476|NCT03822884|11971373|FG002|NOT COMPLETED|Overall Study||0
10707130|NCT02615145|11871689|FG002|2 DAA + Ribavirin (RBV)|Overall Study||45
10707131|NCT02615145|11871690|FG003|2 DAA + Ribavirin (RBV)|Overall Study||0
10707132|NCT02615145|11871687|FG000|3DAA|Overall Study||5
10707133|NCT02615145|11871688|FG001|3DAA|Overall Study||261
10707134|NCT02615145|11871689|FG002|3DAA|Overall Study||0
10334514|NCT00343863|11470886|FG000|STARTED|Overall Study||7
10334515|NCT00343863|11470887|FG001|STARTED|Overall Study||34
10334516|NCT00343863|11470886|FG000|COMPLETED|Overall Study||7
10334517|NCT00343863|11470887|FG001|COMPLETED|Overall Study||34
10334518|NCT00343863|11470886|FG000|NOT COMPLETED|Overall Study||0
10334519|NCT00343863|11470887|FG001|NOT COMPLETED|Overall Study||0
10334520|NCT00343889|11470897|FG000|STARTED|Overall Study||190
10334521|NCT00343889|11470898|FG001|STARTED|Overall Study||189
10334522|NCT00343889|11470897|FG000|COMPLETED|Overall Study||187
10334523|NCT00343889|11470898|FG001|COMPLETED|Overall Study||188
10334524|NCT00343889|11470897|FG000|NOT COMPLETED|Overall Study||3
10334525|NCT00343889|11470898|FG001|NOT COMPLETED|Overall Study||1
10334526|NCT00343915|11470906|FG000|STARTED|Primary Study||258
10334527|NCT00343915|11470907|FG001|STARTED|Primary Study||126
10334528|NCT00343915|11470906|FG000|COMPLETED|Primary Study||254
10707135|NCT02615145|11871690|FG003|3DAA|Overall Study||0
10707136|NCT02615145|11871687|FG000|3DAA + RBV|Overall Study||140
10707137|NCT02615145|11871688|FG001|3DAA + RBV|Overall Study||17
10707138|NCT02615145|11871689|FG002|3DAA + RBV|Overall Study||2
10707139|NCT02615145|11871690|FG003|3DAA + RBV|Overall Study||0
10707140|NCT02615145|11871687|FG000|COMPLETED|Overall Study||118
10707141|NCT02615145|11871688|FG001|COMPLETED|Overall Study||263
10707142|NCT02615145|11871689|FG002|COMPLETED|Overall Study||40
10707143|NCT02615145|11871690|FG003|COMPLETED|Overall Study||0
10707144|NCT02615145|11871687|FG000|NOT COMPLETED|Overall Study||27
10707145|NCT02615145|11871688|FG001|NOT COMPLETED|Overall Study||15
10707146|NCT02615145|11871689|FG002|NOT COMPLETED|Overall Study||8
10707147|NCT02615145|11871690|FG003|NOT COMPLETED|Overall Study||1
10707148|NCT02615158|11871719|FG000|STARTED|Overall Study||94
10707149|NCT02615158|11871720|FG001|STARTED|Overall Study||92
10707150|NCT02615158|11871721|FG002|STARTED|Overall Study||91
10707151|NCT02615158|11871719|FG000|COMPLETED|Overall Study||73
10707152|NCT02615158|11871720|FG001|COMPLETED|Overall Study||76
10707153|NCT02615158|11871721|FG002|COMPLETED|Overall Study||75
10707154|NCT02615158|11871719|FG000|NOT COMPLETED|Overall Study||21
10707155|NCT02615158|11871720|FG001|NOT COMPLETED|Overall Study||16
10707156|NCT02615158|11871721|FG002|NOT COMPLETED|Overall Study||16
10707157|NCT02615171|11871731|FG000|STARTED|Overall Study||32
10707158|NCT02615171|11871732|FG001|STARTED|Overall Study||32
10707159|NCT02615171|11871731|FG000|COMPLETED|Overall Study||30
10707160|NCT02615171|11871732|FG001|COMPLETED|Overall Study||31
10707161|NCT02615171|11871731|FG000|NOT COMPLETED|Overall Study||2
10707162|NCT02615171|11871732|FG001|NOT COMPLETED|Overall Study||1
10707163|NCT02615249|11871738|FG000|STARTED|Overall Study||122
10707164|NCT02615249|11871738|FG000|COMPLETED|Overall Study||121
10707165|NCT02615249|11871738|FG000|NOT COMPLETED|Overall Study||1
10707166|NCT02615470|11871745|FG000|STARTED|Overall Study||58
10707167|NCT02615470|11871746|FG001|STARTED|Overall Study||62
10707168|NCT02615470|11871745|FG000|Completed the Baseline Surveys|Overall Study||46
10707169|NCT02615470|11871746|FG001|Completed the Baseline Surveys|Overall Study||47
10707170|NCT02615470|11871745|FG000|COMPLETED|Overall Study||37
10707171|NCT02615470|11871746|FG001|COMPLETED|Overall Study||30
10707172|NCT02615470|11871745|FG000|NOT COMPLETED|Overall Study||21
10707173|NCT02615470|11871746|FG001|NOT COMPLETED|Overall Study||32
10707174|NCT02615509|11871752|FG000|STARTED|Overall Study||347
10707175|NCT02615509|11871752|FG000|COMPLETED|Overall Study||201
10707176|NCT02615509|11871752|FG000|NOT COMPLETED|Overall Study||146
10707177|NCT02615535|11871758|FG000|STARTED|Overall Study||14
10707178|NCT02615535|11871759|FG001|STARTED|Overall Study||11
10707179|NCT02615535|11871758|FG000|COMPLETED|Overall Study||10
10707180|NCT02615535|11871759|FG001|COMPLETED|Overall Study||10
10707181|NCT02615535|11871758|FG000|NOT COMPLETED|Overall Study||4
10707182|NCT02615535|11871759|FG001|NOT COMPLETED|Overall Study||1
10707183|NCT02615717|11871767|FG000|STARTED|Overall Study||3
10707184|NCT02615717|11871768|FG001|STARTED|Overall Study||3
10707185|NCT02615717|11871767|FG000|COMPLETED|Overall Study||3
10707186|NCT02615717|11871768|FG001|COMPLETED|Overall Study||3
10707187|NCT02615717|11871767|FG000|NOT COMPLETED|Overall Study||0
10707188|NCT02615717|11871768|FG001|NOT COMPLETED|Overall Study||0
10707189|NCT02615743|11871776|FG000|STARTED|Overall Study||21
10707190|NCT02615743|11871777|FG001|STARTED|Overall Study||20
10707191|NCT02615743|11871776|FG000|COMPLETED|Overall Study||15
10707192|NCT02615743|11871777|FG001|COMPLETED|Overall Study||17
10707193|NCT02615743|11871776|FG000|NOT COMPLETED|Overall Study||6
10707194|NCT02615743|11871777|FG001|NOT COMPLETED|Overall Study||3
10707195|NCT02616029|11871785|FG000|STARTED|Overall Study||38
10707196|NCT02616029|11871786|FG001|STARTED|Overall Study||28
10707197|NCT02616029|11871785|FG000|COMPLETED|Overall Study||34
10707198|NCT02616029|11871786|FG001|COMPLETED|Overall Study||26
10707199|NCT02616029|11871785|FG000|NOT COMPLETED|Overall Study||4
10707200|NCT02616029|11871786|FG001|NOT COMPLETED|Overall Study||2
10707201|NCT02616250|11871794|FG000|STARTED|Overall Study||95
10707202|NCT02616250|11871795|FG001|STARTED|Overall Study||95
10707203|NCT02616250|11871794|FG000|COMPLETED|Overall Study||85
10707204|NCT02616250|11871795|FG001|COMPLETED|Overall Study||86
10707205|NCT02616250|11871794|FG000|NOT COMPLETED|Overall Study||10
10707206|NCT02616250|11871795|FG001|NOT COMPLETED|Overall Study||9
10707207|NCT02616380|11871801|FG000|STARTED|Overall Study||100
10707208|NCT02616380|11871801|FG000|COMPLETED|Overall Study||97
10707209|NCT02616380|11871801|FG000|NOT COMPLETED|Overall Study||3
10707210|NCT02616523|11871808|FG000|STARTED|Overall Study|June 2014|20
10707211|NCT02616523|11871809|FG001|STARTED|Overall Study|June 2014|20
10707212|NCT02616523|11871810|FG002|STARTED|Overall Study|June 2014|20
10707213|NCT02616523|11871808|FG000|COMPLETED|Overall Study|April 2015|19
10707214|NCT02616523|11871809|FG001|COMPLETED|Overall Study|April 2015|20
10707215|NCT02616523|11871810|FG002|COMPLETED|Overall Study|April 2015|20
10707216|NCT02616523|11871808|FG000|NOT COMPLETED|Overall Study||1
10707217|NCT02616523|11871809|FG001|NOT COMPLETED|Overall Study||0
10707218|NCT02616523|11871810|FG002|NOT COMPLETED|Overall Study||0
10707219|NCT02616601|11871824|FG000|STARTED|Overall Study||140
10707220|NCT02616601|11871825|FG001|STARTED|Overall Study||140
10707221|NCT02616601|11871826|FG002|STARTED|Overall Study||142
10707222|NCT02616601|11871824|FG000|Safety Population|Overall Study||140
10707223|NCT02616601|11871825|FG001|Safety Population|Overall Study||140
10707224|NCT02616601|11871826|FG002|Safety Population|Overall Study||142
10707225|NCT02616601|11871824|FG000|mITT Population|Overall Study||137
10707226|NCT02616601|11871825|FG001|mITT Population|Overall Study||136
10707227|NCT02616601|11871826|FG002|mITT Population|Overall Study||138
10707228|NCT02616601|11871824|FG000|PP Population|Overall Study||112
10707229|NCT02616601|11871825|FG001|PP Population|Overall Study||121
10707230|NCT02616601|11871826|FG002|PP Population|Overall Study||123
10707231|NCT02616601|11871824|FG000|COMPLETED|Overall Study||131
10707232|NCT02616601|11871825|FG001|COMPLETED|Overall Study||136
10707233|NCT02616601|11871826|FG002|COMPLETED|Overall Study||135
10707234|NCT02616601|11871824|FG000|NOT COMPLETED|Overall Study||9
10707235|NCT02616601|11871825|FG001|NOT COMPLETED|Overall Study||4
10707236|NCT02616601|11871826|FG002|NOT COMPLETED|Overall Study||7
10707237|NCT02616614|11871837|FG000|STARTED|Overall Study||347
10707238|NCT02616614|11871838|FG001|STARTED|Overall Study||345
10707239|NCT02616614|11871839|FG002|STARTED|Overall Study||170
10707240|NCT02616614|11871837|FG000|Safety Population|Overall Study||329
10707241|NCT02616614|11871838|FG001|Safety Population|Overall Study||328
10707242|NCT02616614|11871839|FG002|Safety Population|Overall Study||161
10707243|NCT02616614|11871837|FG000|mITT Population|Overall Study||325
10707244|NCT02616614|11871838|FG001|mITT Population|Overall Study||325
10707245|NCT02616614|11871839|FG002|mITT Population|Overall Study||160
10707246|NCT02616614|11871837|FG000|PP Population|Overall Study||253
10707247|NCT02616614|11871838|FG001|PP Population|Overall Study||255
10707248|NCT02616614|11871839|FG002|PP Population|Overall Study||122
10707249|NCT02616614|11871837|FG000|COMPLETED|Overall Study||282
10707250|NCT02616614|11871838|FG001|COMPLETED|Overall Study||285
10707251|NCT02616614|11871839|FG002|COMPLETED|Overall Study||141
10334529|NCT00343915|11470907|FG001|COMPLETED|Primary Study||123
10334530|NCT00343915|11470906|FG000|NOT COMPLETED|Primary Study||4
10334531|NCT00343915|11470907|FG001|NOT COMPLETED|Primary Study||3
10334532|NCT00343915|11470906|FG000|STARTED|Month 30 Follow-up|Subjects, previously vaccinated, that returned for the Month 30 follow-up.|179
10334533|NCT00343915|11470907|FG001|STARTED|Month 30 Follow-up||88
10334534|NCT00343915|11470906|FG000|COMPLETED|Month 30 Follow-up||179
10334535|NCT00343915|11470907|FG001|COMPLETED|Month 30 Follow-up||88
10334536|NCT00343915|11470906|FG000|NOT COMPLETED|Month 30 Follow-up||0
10334537|NCT00343915|11470907|FG001|NOT COMPLETED|Month 30 Follow-up||0
10334538|NCT00343915|11470906|FG000|STARTED|Month 42 Follow-up|Subjects, previously vaccinated, that returned for the Month 42 follow-up.|174
10334539|NCT00343915|11470907|FG001|STARTED|Month 42 Follow-up||84
10334540|NCT00343915|11470906|FG000|COMPLETED|Month 42 Follow-up||174
10334541|NCT00343915|11470907|FG001|COMPLETED|Month 42 Follow-up||84
10334542|NCT00343915|11470906|FG000|NOT COMPLETED|Month 42 Follow-up||0
10334543|NCT00343915|11470907|FG001|NOT COMPLETED|Month 42 Follow-up||0
10334544|NCT00343915|11470906|FG000|STARTED|Month 54 Follow-up|Subjects, previously vaccinated, that returned for the Month 54 follow-up.|166
10334545|NCT00343915|11470907|FG001|STARTED|Month 54 Follow-up||79
10334546|NCT00343915|11470906|FG000|COMPLETED|Month 54 Follow-up||166
10334547|NCT00343915|11470907|FG001|COMPLETED|Month 54 Follow-up||79
10334548|NCT00343915|11470906|FG000|NOT COMPLETED|Month 54 Follow-up||0
10334549|NCT00343915|11470907|FG001|NOT COMPLETED|Month 54 Follow-up||0
10334550|NCT00343915|11470906|FG000|STARTED|Month 66 Follow-up|Subjects, previously vaccinated, that returned for the Month 66 follow-up.|158
10334551|NCT00343915|11470907|FG001|STARTED|Month 66 Follow-up||76
10334552|NCT00343915|11470906|FG000|COMPLETED|Month 66 Follow-up||158
10334553|NCT00343915|11470907|FG001|COMPLETED|Month 66 Follow-up||76
10334554|NCT00343915|11470906|FG000|NOT COMPLETED|Month 66 Follow-up||0
10334555|NCT00343915|11470907|FG001|NOT COMPLETED|Month 66 Follow-up||0
10334556|NCT00344032|11470918|FG000|STARTED|Overall Study||176
10334557|NCT00344032|11470919|FG001|STARTED|Overall Study||178
10334558|NCT00344032|11470918|FG000|COMPLETED|Overall Study||162
10334559|NCT00344032|11470919|FG001|COMPLETED|Overall Study||168
10334560|NCT00344032|11470918|FG000|NOT COMPLETED|Overall Study||14
10334561|NCT00344032|11470919|FG001|NOT COMPLETED|Overall Study||10
10334562|NCT00344175|11470927|FG000|STARTED|Overall Study||121
10334563|NCT00344175|11470928|FG001|STARTED|Overall Study||57
10707252|NCT02616614|11871837|FG000|NOT COMPLETED|Overall Study||65
10707253|NCT02616614|11871838|FG001|NOT COMPLETED|Overall Study||60
10707254|NCT02616614|11871839|FG002|NOT COMPLETED|Overall Study||29
10707255|NCT02616783|11871850|FG000|STARTED|Overall Study||111
10707256|NCT02616783|11871851|FG001|STARTED|Overall Study||56
10707257|NCT02616783|11871850|FG000|COMPLETED|Overall Study||105
10707258|NCT02616783|11871851|FG001|COMPLETED|Overall Study||54
10809477|NCT03822884|11971374|FG003|NOT COMPLETED|Overall Study||0
10809478|NCT03822884|11971375|FG004|NOT COMPLETED|Overall Study||1
10809479|NCT03822884|11971376|FG005|NOT COMPLETED|Overall Study||0
10809480|NCT03816709|11971384|FG000|STARTED|Overall Study||25
10809481|NCT03816709|11971384|FG000|COMPLETED|Overall Study||25
10809482|NCT03816709|11971384|FG000|NOT COMPLETED|Overall Study||0
10809483|NCT03810014|11971392|FG000|STARTED|Overall Study||215
10809484|NCT03810014|11971393|FG001|STARTED|Overall Study||204
10809485|NCT03810014|11971394|FG002|STARTED|Overall Study||210
10809486|NCT03810014|11971395|FG003|STARTED|Overall Study||213
10809487|NCT03810014|11971392|FG000|COMPLETED|Overall Study||213
10809488|NCT03810014|11971393|FG001|COMPLETED|Overall Study||202
10809489|NCT03810014|11971394|FG002|COMPLETED|Overall Study||210
10809490|NCT03810014|11971395|FG003|COMPLETED|Overall Study||211
10809491|NCT03810014|11971392|FG000|NOT COMPLETED|Overall Study||2
10809492|NCT03810014|11971393|FG001|NOT COMPLETED|Overall Study||2
10809493|NCT03810014|11971394|FG002|NOT COMPLETED|Overall Study||0
10809494|NCT03810014|11971395|FG003|NOT COMPLETED|Overall Study||2
10809495|NCT03806270|11971408|FG000|STARTED|Overall Study||15
10809496|NCT03806270|11971409|FG001|STARTED|Overall Study||15
10809497|NCT03806270|11971410|FG002|STARTED|Overall Study||15
10809498|NCT03806270|11971408|FG000|COMPLETED|Overall Study||15
10809499|NCT03806270|11971409|FG001|COMPLETED|Overall Study||15
10809500|NCT03806270|11971410|FG002|COMPLETED|Overall Study||15
10809501|NCT03806270|11971408|FG000|NOT COMPLETED|Overall Study||0
10809502|NCT03806270|11971409|FG001|NOT COMPLETED|Overall Study||0
10809503|NCT03806270|11971410|FG002|NOT COMPLETED|Overall Study||0
10809504|NCT03830892|11971420|FG000|STARTED|Overall Study||25
10809505|NCT03830892|11971421|FG001|STARTED|Overall Study||23
10809506|NCT03830892|11971420|FG000|15 Watts, 10 mg Nicotine|Overall Study||19
10809507|NCT03830892|11971421|FG001|15 Watts, 10 mg Nicotine|Overall Study||17
10809508|NCT03830892|11971420|FG000|15 Watts, 30 mg Nicotine|Overall Study||19
10809509|NCT03830892|11971421|FG001|15 Watts, 30 mg Nicotine|Overall Study||17
10809510|NCT03830892|11971420|FG000|30 Watts, 10 mg Nicotine|Overall Study||19
10809511|NCT03830892|11971421|FG001|30 Watts, 10 mg Nicotine|Overall Study||17
10809512|NCT03830892|11971420|FG000|30 Watts, 30 mg Nicotine|Overall Study||19
10809513|NCT03830892|11971421|FG001|30 Watts, 30 mg Nicotine|Overall Study||17
10809514|NCT03830892|11971420|FG000|Own Brand|Overall Study||19
10809515|NCT03830892|11971421|FG001|Own Brand|Overall Study||17
10809516|NCT03830892|11971420|FG000|COMPLETED|Overall Study||19
10809517|NCT03830892|11971421|FG001|COMPLETED|Overall Study||17
10809518|NCT03830892|11971420|FG000|NOT COMPLETED|Overall Study||6
10809519|NCT03830892|11971421|FG001|NOT COMPLETED|Overall Study||6
10809520|NCT03830307|11971427|FG000|STARTED|Overall Study||5
10809521|NCT03830307|11971427|FG000|COMPLETED|Overall Study||5
10809522|NCT03830307|11971427|FG000|NOT COMPLETED|Overall Study||0
10809523|NCT03825042|11971433|FG000|STARTED|Overall Study||40
10809524|NCT03825042|11971434|FG001|STARTED|Overall Study||40
10809525|NCT03825042|11971433|FG000|COMPLETED|Overall Study||38
10809526|NCT03825042|11971434|FG001|COMPLETED|Overall Study||40
10809527|NCT03825042|11971433|FG000|NOT COMPLETED|Overall Study||2
10809528|NCT03825042|11971434|FG001|NOT COMPLETED|Overall Study||0
10809529|NCT03823378|11971446|FG000|STARTED|Overall Study||28
10809530|NCT03823378|11971447|FG001|STARTED|Overall Study||16
10809531|NCT03823378|11971448|FG002|STARTED|Overall Study||12
10809532|NCT03823378|11971449|FG003|STARTED|Overall Study||12
10809533|NCT03823378|11971450|FG004|STARTED|Overall Study||20
10809534|NCT03823378|11971451|FG005|STARTED|Overall Study||9
10809535|NCT03823378|11971446|FG000|COMPLETED|Overall Study||7
10809536|NCT03823378|11971447|FG001|COMPLETED|Overall Study||0
10809537|NCT03823378|11971448|FG002|COMPLETED|Overall Study||2
10809538|NCT03823378|11971449|FG003|COMPLETED|Overall Study||2
10809539|NCT03823378|11971450|FG004|COMPLETED|Overall Study||2
10809540|NCT03823378|11971451|FG005|COMPLETED|Overall Study||1
10809541|NCT03823378|11971446|FG000|NOT COMPLETED|Overall Study||21
10809542|NCT03823378|11971447|FG001|NOT COMPLETED|Overall Study||16
10809543|NCT03823378|11971448|FG002|NOT COMPLETED|Overall Study||10
10809544|NCT03823378|11971449|FG003|NOT COMPLETED|Overall Study||10
10809545|NCT03823378|11971450|FG004|NOT COMPLETED|Overall Study||18
10809546|NCT03823378|11971451|FG005|NOT COMPLETED|Overall Study||8
10809547|NCT03831191|11971469|FG000|STARTED|Induction Period (16 Weeks)||33
10809548|NCT03831191|11971470|FG001|STARTED|Induction Period (16 Weeks)||35
10809549|NCT03831191|11971471|FG002|STARTED|Induction Period (16 Weeks)||34
10809550|NCT03831191|11971472|FG003|STARTED|Induction Period (16 Weeks)||34
10809551|NCT03831191|11971473|FG004|STARTED|Induction Period (16 Weeks)||0
10809552|NCT03831191|11971474|FG005|STARTED|Induction Period (16 Weeks)||0
10809553|NCT03831191|11971475|FG006|STARTED|Induction Period (16 Weeks)||0
10809554|NCT03831191|11971476|FG007|STARTED|Induction Period (16 Weeks)||0
10809555|NCT03831191|11971477|FG008|STARTED|Induction Period (16 Weeks)||0
10809556|NCT03831191|11971478|FG009|STARTED|Induction Period (16 Weeks)||0
10809557|NCT03831191|11971479|FG010|STARTED|Induction Period (16 Weeks)||0
10809558|NCT03831191|11971480|FG011|STARTED|Induction Period (16 Weeks)||0
10809559|NCT03831191|11971481|FG012|STARTED|Induction Period (16 Weeks)||0
10809560|NCT03831191|11971482|FG013|STARTED|Induction Period (16 Weeks)||0
10809561|NCT03831191|11971483|FG014|STARTED|Induction Period (16 Weeks)||0
10809562|NCT03831191|11971469|FG000|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||33
10707259|NCT02616783|11871850|FG000|NOT COMPLETED|Overall Study||6
10707260|NCT02616783|11871851|FG001|NOT COMPLETED|Overall Study||2
10334564|NCT00344175|11470927|FG000|COMPLETED|Overall Study||109
10334565|NCT00344175|11470928|FG001|COMPLETED|Overall Study||47
10334566|NCT00344175|11470927|FG000|NOT COMPLETED|Overall Study||12
10334567|NCT00344175|11470928|FG001|NOT COMPLETED|Overall Study||10
10334568|NCT00344305|11470936|FG000|STARTED|Overall Study||100
10334569|NCT00344305|11470937|FG001|STARTED|Overall Study||100
10334570|NCT00344305|11470936|FG000|COMPLETED|Overall Study||98
10334571|NCT00344305|11470937|FG001|COMPLETED|Overall Study||99
10334572|NCT00344305|11470936|FG000|NOT COMPLETED|Overall Study||2
10334573|NCT00344305|11470937|FG001|NOT COMPLETED|Overall Study||1
10334574|NCT00344318|11470948|FG000|STARTED|Overall Study||300
10334575|NCT00344318|11470949|FG001|STARTED|Overall Study||303
10334576|NCT00344318|11470950|FG002|STARTED|Overall Study||100
10334577|NCT00344318|11470951|FG003|STARTED|Overall Study||103
10334578|NCT00344318|11470948|FG000|COMPLETED|Overall Study||296
10707261|NCT02616900|11871857|FG000|STARTED|Overall Study||74
10707262|NCT02616900|11871857|FG000|Completed 3mo Trial|Overall Study||57
10707263|NCT02616900|11871857|FG000|COMPLETED|Overall Study|Six participants not included in study results because of incomplete data.|51
10707264|NCT02616900|11871857|FG000|NOT COMPLETED|Overall Study||23
10707265|NCT02617628|11871863|FG000|STARTED|Overall Study||74
10707266|NCT02617628|11871864|FG001|STARTED|Overall Study||72
10707267|NCT02617628|11871863|FG000|COMPLETED|Overall Study||12
10707268|NCT02617628|11871864|FG001|COMPLETED|Overall Study||11
10707269|NCT02617628|11871863|FG000|NOT COMPLETED|Overall Study||62
10707270|NCT02617628|11871864|FG001|NOT COMPLETED|Overall Study||61
10707271|NCT02617667|11871876|FG000|STARTED|Overall Study||51
10707272|NCT02617667|11871877|FG001|STARTED|Overall Study||51
10707273|NCT02617667|11871878|FG002|STARTED|Overall Study||52
10707274|NCT02617667|11871879|FG003|STARTED|Overall Study||53
10457556|NCT01011309|11605353|FG001|COMPLETED|Overall Study||7
10457557|NCT01011309|11605354|FG002|COMPLETED|Overall Study||16
10457558|NCT01011309|11605352|FG000|NOT COMPLETED|Overall Study||2
10707275|NCT02617667|11871876|FG000|COMPLETED|Overall Study||50
10707276|NCT02617667|11871877|FG001|COMPLETED|Overall Study||50
10707277|NCT02617667|11871878|FG002|COMPLETED|Overall Study||48
10707278|NCT02617667|11871879|FG003|COMPLETED|Overall Study||52
10707279|NCT02617667|11871876|FG000|NOT COMPLETED|Overall Study||1
10457559|NCT01011309|11605353|FG001|NOT COMPLETED|Overall Study||3
10457560|NCT01011309|11605354|FG002|NOT COMPLETED|Overall Study||5
10457561|NCT01011335|11605366|FG000|STARTED|Overall Study||11
10457562|NCT01011335|11605367|FG001|STARTED|Overall Study||12
10457563|NCT01011335|11605368|FG002|STARTED|Overall Study||12
10457564|NCT01011335|11605369|FG003|STARTED|Overall Study||12
10457565|NCT01011335|11605370|FG004|STARTED|Overall Study||13
10457566|NCT01011335|11605371|FG005|STARTED|Overall Study||12
10457567|NCT01011335|11605372|FG006|STARTED|Overall Study||12
10457568|NCT01011335|11605373|FG007|STARTED|Overall Study||12
10457569|NCT01011335|11605374|FG008|STARTED|Overall Study||12
10457570|NCT01011335|11605375|FG009|STARTED|Overall Study||12
10334579|NCT00344318|11470949|FG001|COMPLETED|Overall Study||298
10334580|NCT00344318|11470950|FG002|COMPLETED|Overall Study||99
10334581|NCT00344318|11470951|FG003|COMPLETED|Overall Study||100
10334582|NCT00344318|11470948|FG000|NOT COMPLETED|Overall Study||4
10334583|NCT00344318|11470949|FG001|NOT COMPLETED|Overall Study||5
10334584|NCT00344318|11470950|FG002|NOT COMPLETED|Overall Study||1
10334585|NCT00344318|11470951|FG003|NOT COMPLETED|Overall Study||3
10334586|NCT00344370|11470965|FG000|STARTED|Overall Study||143
10334587|NCT00344370|11470966|FG001|STARTED|Overall Study||71
10334588|NCT00344370|11470965|FG000|COMPLETED|Overall Study||128
10334589|NCT00344370|11470966|FG001|COMPLETED|Overall Study||68
10334590|NCT00344370|11470965|FG000|NOT COMPLETED|Overall Study||15
10334591|NCT00344370|11470966|FG001|NOT COMPLETED|Overall Study||3
10339042|NCT00371137|11476001|FG002|NOT COMPLETED|Overall Study||79
10339043|NCT00371150|11476011|FG000|STARTED|Overall Study||40
10339044|NCT00371150|11476012|FG001|STARTED|Overall Study||6
10339045|NCT00371150|11476011|FG000|Discontinued Prior to Week 48 Visit|Overall Study||1
10339046|NCT00371150|11476012|FG001|Discontinued Prior to Week 48 Visit|Overall Study||1
10339047|NCT00371150|11476011|FG000|Discontinued at or After Week 48 Visit|Overall Study||2
10339048|NCT00371150|11476012|FG001|Discontinued at or After Week 48 Visit|Overall Study||1
10339049|NCT00371150|11476011|FG000|COMPLETED|Overall Study|"Completion of treatment means received treatment through Week 52"|37
10339050|NCT00371150|11476012|FG001|COMPLETED|Overall Study|"Completion of treatment means received treatment through Week 52"|4
10339051|NCT00371150|11476011|FG000|NOT COMPLETED|Overall Study||3
10339052|NCT00371150|11476012|FG001|NOT COMPLETED|Overall Study||2
10339053|NCT00371176|11476024|FG000|STARTED|Overall Study||13
10339054|NCT00371176|11476025|FG001|STARTED|Overall Study||13
10339055|NCT00371176|11476024|FG000|Completed Treatment|Overall Study||10
10339056|NCT00371176|11476025|FG001|Completed Treatment|Overall Study||9
10339057|NCT00371176|11476024|FG000|COMPLETED|Overall Study||8
10339058|NCT00371176|11476025|FG001|COMPLETED|Overall Study||5
10339059|NCT00371176|11476024|FG000|NOT COMPLETED|Overall Study||5
10339060|NCT00371176|11476025|FG001|NOT COMPLETED|Overall Study||8
10339061|NCT00371254|11476033|FG000|STARTED|Overall Study|Number of participants treated|23
10339062|NCT00371254|11476034|FG001|STARTED|Overall Study|Number of participants treated|21
10339063|NCT00371254|11476033|FG000|COMPLETED|Overall Study|Number of participants remained on study till the study drug could be tolerated|0
10339064|NCT00371254|11476034|FG001|COMPLETED|Overall Study|Number of participants remained on study till the study drug could be tolerated|0
10339065|NCT00371254|11476033|FG000|NOT COMPLETED|Overall Study||23
10339066|NCT00371254|11476034|FG001|NOT COMPLETED|Overall Study||21
10339067|NCT00371267|11476042|FG000|STARTED|Overall Study||48
10339068|NCT00371267|11476043|FG001|STARTED|Overall Study||50
10339069|NCT00371267|11476042|FG000|COMPLETED|Overall Study||39
10339070|NCT00371267|11476043|FG001|COMPLETED|Overall Study||32
10339071|NCT00371267|11476042|FG000|NOT COMPLETED|Overall Study||9
10339072|NCT00371267|11476043|FG001|NOT COMPLETED|Overall Study||18
10339073|NCT00371293|11476052|FG000|STARTED|Overall Study||58
10339074|NCT00371293|11476053|FG001|STARTED|Overall Study||61
10339075|NCT00371293|11476054|FG002|STARTED|Overall Study||62
10339076|NCT00371293|11476052|FG000|COMPLETED|Overall Study||48
10339077|NCT00371293|11476053|FG001|COMPLETED|Overall Study||42
10339078|NCT00371293|11476054|FG002|COMPLETED|Overall Study||46
10339079|NCT00371293|11476052|FG000|NOT COMPLETED|Overall Study||10
10339080|NCT00371293|11476053|FG001|NOT COMPLETED|Overall Study||19
10339081|NCT00371293|11476054|FG002|NOT COMPLETED|Overall Study||16
10339082|NCT00371345|11476065|FG000|STARTED|Overall Study||24
10339083|NCT00371345|11476066|FG001|STARTED|Overall Study||46
10339084|NCT00371345|11476065|FG000|COMPLETED|Overall Study||0
10339085|NCT00371345|11476066|FG001|COMPLETED|Overall Study||0
10339086|NCT00371345|11476065|FG000|NOT COMPLETED|Overall Study||24
10339087|NCT00371345|11476066|FG001|NOT COMPLETED|Overall Study||46
10339088|NCT00371397|11476086|FG000|STARTED|Session 1||5
10339089|NCT00371397|11476087|FG001|STARTED|Session 1||7
10339090|NCT00371397|11476088|FG002|STARTED|Session 1||5
10339091|NCT00371397|11476089|FG003|STARTED|Session 1||2
10339092|NCT00371397|11476090|FG004|STARTED|Session 1||3
10339093|NCT00371397|11476091|FG005|STARTED|Session 1||4
10339094|NCT00371397|11476092|FG006|STARTED|Session 1||4
10339095|NCT00371397|11476093|FG007|STARTED|Session 1||5
10339096|NCT00371397|11476094|FG008|STARTED|Session 1||6
10339097|NCT00371397|11476095|FG009|STARTED|Session 1||5
10339098|NCT00371397|11476096|FG010|STARTED|Session 1||4
10339099|NCT00371397|11476097|FG011|STARTED|Session 1||2
10339100|NCT00371397|11476086|FG000|COMPLETED|Session 1||4
10339101|NCT00371397|11476087|FG001|COMPLETED|Session 1||7
10334592|NCT00344448|11470974|FG000|STARTED|Screening|No randomization during the screening phase|6
10334593|NCT00344448|11470975|FG001|STARTED|Screening||4
10334594|NCT00344448|11470974|FG000|COMPLETED|Screening||6
10334595|NCT00344448|11470975|FG001|COMPLETED|Screening||3
10334596|NCT00344448|11470974|FG000|NOT COMPLETED|Screening||0
10334597|NCT00344448|11470975|FG001|NOT COMPLETED|Screening||1
10707280|NCT02617667|11871877|FG001|NOT COMPLETED|Overall Study||1
10707281|NCT02617667|11871878|FG002|NOT COMPLETED|Overall Study||4
10707282|NCT02617667|11871879|FG003|NOT COMPLETED|Overall Study||1
10713946|NCT02683746|11879497|FG000|COMPLETED|Overall Study||138
10334598|NCT00344448|11470974|FG000|STARTED|Double Blind, Placebo Controlled||6
10334599|NCT00344448|11470975|FG001|STARTED|Double Blind, Placebo Controlled||3
10334600|NCT00344448|11470974|FG000|COMPLETED|Double Blind, Placebo Controlled||4
10334601|NCT00344448|11470975|FG001|COMPLETED|Double Blind, Placebo Controlled||3
10334602|NCT00344448|11470974|FG000|NOT COMPLETED|Double Blind, Placebo Controlled||2
10334603|NCT00344448|11470975|FG001|NOT COMPLETED|Double Blind, Placebo Controlled||0
10334604|NCT00344448|11470974|FG000|STARTED|Open Label||4
10334605|NCT00344448|11470975|FG001|STARTED|Open Label||3
10334606|NCT00344448|11470974|FG000|COMPLETED|Open Label||2
10707283|NCT02617784|11871890|FG000|STARTED|Overall Study|None were prematurely withdrawn; 1 switched to CAPD mid-study and was excluded from second analysis.|12
10707284|NCT02617784|11871891|FG001|STARTED|Overall Study||12
10707285|NCT02617784|11871890|FG000|First Dose Assessment Period|Overall Study||12
10707286|NCT02617784|11871891|FG001|First Dose Assessment Period|Overall Study||12
10707287|NCT02617784|11871890|FG000|Second Dose Assessment Period|Overall Study||11
10707288|NCT02617784|11871891|FG001|Second Dose Assessment Period|Overall Study||12
10707289|NCT02617784|11871890|FG000|COMPLETED|Overall Study||12
10707290|NCT02617784|11871891|FG001|COMPLETED|Overall Study||12
10707291|NCT02617784|11871890|FG000|NOT COMPLETED|Overall Study||0
10707292|NCT02617784|11871891|FG001|NOT COMPLETED|Overall Study||0
10707293|NCT02617888|11871900|FG000|STARTED|Overall Study||50
10707294|NCT02617888|11871901|FG001|STARTED|Overall Study||51
10707295|NCT02617888|11871902|FG002|STARTED|Overall Study||127
10707296|NCT02617888|11871900|FG000|COMPLETED|Overall Study|Incomplete due to inadequate double-strand DNA break sample.|49
10707297|NCT02617888|11871901|FG001|COMPLETED|Overall Study|Incomplete due to inadequate double-strand DNA break samples.|44
10707298|NCT02617888|11871902|FG002|COMPLETED|Overall Study||127
10707299|NCT02617888|11871900|FG000|NOT COMPLETED|Overall Study||1
10707300|NCT02617888|11871901|FG001|NOT COMPLETED|Overall Study||7
10707301|NCT02617888|11871902|FG002|NOT COMPLETED|Overall Study||0
10707302|NCT02617901|11871909|FG000|STARTED|Overall Study||20
10707303|NCT02617901|11871909|FG000|COMPLETED|Overall Study||20
10707304|NCT02617901|11871909|FG000|NOT COMPLETED|Overall Study||0
10707305|NCT02618031|11871915|FG000|STARTED|Overall Study||46
10707306|NCT02618031|11871916|FG001|STARTED|Overall Study||11
10707307|NCT02618031|11871915|FG000|COMPLETED|Overall Study||45
10707308|NCT02618031|11871916|FG001|COMPLETED|Overall Study||11
10707309|NCT02618031|11871915|FG000|NOT COMPLETED|Overall Study||1
10707310|NCT02618031|11871916|FG001|NOT COMPLETED|Overall Study||0
10707311|NCT02618187|11871930|FG000|STARTED|Overall Study||15
10707312|NCT02618187|11871931|FG001|STARTED|Overall Study||11
10707313|NCT02618187|11871932|FG002|STARTED|Overall Study||15
10707314|NCT02618187|11871933|FG003|STARTED|Overall Study||17
10707315|NCT02618187|11871930|FG000|Completed|Overall Study||13
10707316|NCT02618187|11871931|FG001|Completed|Overall Study||10
10707317|NCT02618187|11871932|FG002|Completed|Overall Study||13
10707318|NCT02618187|11871933|FG003|Completed|Overall Study||13
10707319|NCT02618187|11871930|FG000|COMPLETED|Overall Study||13
10707320|NCT02618187|11871931|FG001|COMPLETED|Overall Study||9
10707321|NCT02618187|11871932|FG002|COMPLETED|Overall Study||11
10707322|NCT02618187|11871933|FG003|COMPLETED|Overall Study||12
10707323|NCT02618187|11871930|FG000|NOT COMPLETED|Overall Study||2
10707324|NCT02618187|11871931|FG001|NOT COMPLETED|Overall Study||2
10707325|NCT02618187|11871932|FG002|NOT COMPLETED|Overall Study||4
10707326|NCT02618187|11871933|FG003|NOT COMPLETED|Overall Study||5
10707327|NCT02618343|11871945|FG000|STARTED|Overall Study||28
10707328|NCT02618343|11871946|FG001|STARTED|Overall Study||23
10707329|NCT02618343|11871945|FG000|COMPLETED|Overall Study||28
10707330|NCT02618343|11871946|FG001|COMPLETED|Overall Study||23
10707331|NCT02618343|11871945|FG000|NOT COMPLETED|Overall Study||0
10707332|NCT02618343|11871946|FG001|NOT COMPLETED|Overall Study||0
10707333|NCT02618382|11871952|FG000|STARTED|Overall Study|Enrolled and consented for study treatment|32
10707334|NCT02618382|11871952|FG000|COMPLETED|Overall Study|Completed Study treatment|29
10707335|NCT02618382|11871952|FG000|NOT COMPLETED|Overall Study||3
10707336|NCT02618512|11871956|FG000|STARTED|Overall Study||3
10707337|NCT02618512|11871956|FG000|COMPLETED|Overall Study||3
10334607|NCT00344448|11470975|FG001|COMPLETED|Open Label||2
10334608|NCT00344448|11470974|FG000|NOT COMPLETED|Open Label||2
10334609|NCT00344448|11470975|FG001|NOT COMPLETED|Open Label||1
10334610|NCT00344461|11470981|FG000|STARTED|Overall Study||54
10334611|NCT00344461|11470981|FG000|COMPLETED|Overall Study||33
10334612|NCT00344461|11470981|FG000|NOT COMPLETED|Overall Study||21
10334613|NCT00344500|11470988|FG000|STARTED|Overall Study||48
10334614|NCT00344500|11470989|FG001|STARTED|Overall Study||60
10334615|NCT00344500|11470990|FG002|STARTED|Overall Study||14
10334616|NCT00344500|11470988|FG000|COMPLETED|Overall Study||25
10707338|NCT02618512|11871956|FG000|NOT COMPLETED|Overall Study||0
10707339|NCT02618616|11871962|FG000|STARTED|Overall Study||87
10334617|NCT00344500|11470989|FG001|COMPLETED|Overall Study||25
10707340|NCT02618616|11871963|FG001|STARTED|Overall Study||42
10334618|NCT00344500|11470990|FG002|COMPLETED|Overall Study||12
10707341|NCT02618616|11871962|FG000|COMPLETED|Overall Study||66
10707342|NCT02618616|11871963|FG001|COMPLETED|Overall Study||35
10334619|NCT00344500|11470988|FG000|NOT COMPLETED|Overall Study||23
10334620|NCT00344500|11470989|FG001|NOT COMPLETED|Overall Study||35
10334621|NCT00344500|11470990|FG002|NOT COMPLETED|Overall Study||2
10334622|NCT00344682|11470999|FG000|STARTED|Overall Study||16
10334623|NCT00344682|11471000|FG001|STARTED|Overall Study||15
10334624|NCT00344682|11470999|FG000|COMPLETED|Overall Study||12
10334625|NCT00344682|11471000|FG001|COMPLETED|Overall Study||14
10334626|NCT00344682|11470999|FG000|NOT COMPLETED|Overall Study||4
10334627|NCT00344682|11471000|FG001|NOT COMPLETED|Overall Study||1
10334628|NCT00344773|11471006|FG000|STARTED|Overall Study||46
10334629|NCT00344773|11471006|FG000|COMPLETED|Overall Study||25
10334630|NCT00344773|11471006|FG000|NOT COMPLETED|Overall Study||21
10334631|NCT00344968|11471013|FG000|STARTED|Overall Study||185
10334632|NCT00344968|11471014|FG001|STARTED|Overall Study||376
10334633|NCT00344968|11471015|FG002|STARTED|Overall Study||395
10334634|NCT00344968|11471013|FG000|COMPLETED|Overall Study||126
10334635|NCT00344968|11471014|FG001|COMPLETED|Overall Study||274
10334636|NCT00344968|11471015|FG002|COMPLETED|Overall Study||279
10334637|NCT00344968|11471013|FG000|NOT COMPLETED|Overall Study||59
10334638|NCT00344968|11471014|FG001|NOT COMPLETED|Overall Study||102
10334639|NCT00344968|11471015|FG002|NOT COMPLETED|Overall Study||116
10334640|NCT00345033|11471026|FG000|STARTED|Overall Study||20
10334641|NCT00345033|11471027|FG001|STARTED|Overall Study||18
10334642|NCT00345033|11471026|FG000|COMPLETED|Overall Study||16
10334643|NCT00345033|11471027|FG001|COMPLETED|Overall Study||14
10334644|NCT00345033|11471026|FG000|NOT COMPLETED|Overall Study||4
10334645|NCT00345033|11471027|FG001|NOT COMPLETED|Overall Study||4
10334646|NCT00345046|11471036|FG000|STARTED|Overall Study||18
10334647|NCT00345046|11471037|FG001|STARTED|Overall Study||22
10334648|NCT00345046|11471038|FG002|STARTED|Overall Study||16
10334649|NCT00345046|11471036|FG000|COMPLETED|Overall Study||17
10334650|NCT00345046|11471037|FG001|COMPLETED|Overall Study||21
10334651|NCT00345046|11471038|FG002|COMPLETED|Overall Study||14
10334652|NCT00345046|11471036|FG000|NOT COMPLETED|Overall Study||1
10334653|NCT00345046|11471037|FG001|NOT COMPLETED|Overall Study||1
10334654|NCT00345046|11471038|FG002|NOT COMPLETED|Overall Study||2
10334655|NCT00345176|11471050|FG000|STARTED|Overall Study||1012
10334656|NCT00345176|11471051|FG001|STARTED|Overall Study||1044
10334657|NCT00345176|11471052|FG002|STARTED|Overall Study||1068
10334658|NCT00345176|11471053|FG003|STARTED|Overall Study||1079
10334659|NCT00345176|11471050|FG000|COMPLETED|Overall Study||1007
10334660|NCT00345176|11471051|FG001|COMPLETED|Overall Study||1038
10334661|NCT00345176|11471052|FG002|COMPLETED|Overall Study||1062
10334662|NCT00345176|11471053|FG003|COMPLETED|Overall Study||1069
10334663|NCT00345176|11471050|FG000|NOT COMPLETED|Overall Study||5
10707343|NCT02618616|11871962|FG000|NOT COMPLETED|Overall Study||21
10707344|NCT02618616|11871963|FG001|NOT COMPLETED|Overall Study||7
10707345|NCT02618642|11871974|FG000|STARTED|Before 10 PILER Irradiation Treatments||15
10707346|NCT02618642|11871975|FG001|STARTED|Before 10 PILER Irradiation Treatments||15
10707347|NCT02618642|11871976|FG002|STARTED|Before 10 PILER Irradiation Treatments||15
10707348|NCT02618642|11871977|FG003|STARTED|Before 10 PILER Irradiation Treatments||15
10334664|NCT00345176|11471051|FG001|NOT COMPLETED|Overall Study||6
10334665|NCT00345176|11471052|FG002|NOT COMPLETED|Overall Study||6
10334666|NCT00345176|11471053|FG003|NOT COMPLETED|Overall Study||10
10334667|NCT00345254|11471067|FG000|STARTED|Overall Study||30
10334668|NCT00345254|11471068|FG001|STARTED|Overall Study||30
10334669|NCT00345254|11471067|FG000|COMPLETED|Overall Study||30
10334670|NCT00345254|11471068|FG001|COMPLETED|Overall Study||30
10334671|NCT00345254|11471067|FG000|NOT COMPLETED|Overall Study||0
10334672|NCT00345254|11471068|FG001|NOT COMPLETED|Overall Study||0
10334673|NCT00345293|11471074|FG000|STARTED|Overall Study||10
10334674|NCT00345293|11471075|FG001|STARTED|Overall Study||3
10334675|NCT00345293|11471074|FG000|COMPLETED|Overall Study||8
10334676|NCT00345293|11471075|FG001|COMPLETED|Overall Study||3
10334677|NCT00345293|11471074|FG000|NOT COMPLETED|Overall Study||2
10334678|NCT00345293|11471075|FG001|NOT COMPLETED|Overall Study||0
10334679|NCT00345332|11471083|FG000|STARTED|Overall Study||11
10334680|NCT00345332|11471084|FG001|STARTED|Overall Study||20
10334681|NCT00345332|11471083|FG000|COMPLETED|Overall Study||11
10334682|NCT00345332|11471084|FG001|COMPLETED|Overall Study||20
10334683|NCT00345332|11471083|FG000|NOT COMPLETED|Overall Study||0
10334684|NCT00345332|11471084|FG001|NOT COMPLETED|Overall Study||0
10334685|NCT00345371|11471092|FG000|STARTED|Overall Study||69
10334686|NCT00345371|11471093|FG001|STARTED|Overall Study||71
10334687|NCT00345371|11471092|FG000|COMPLETED|Overall Study||39
10334688|NCT00345371|11471093|FG001|COMPLETED|Overall Study||38
10334689|NCT00345371|11471092|FG000|NOT COMPLETED|Overall Study||30
10334690|NCT00345371|11471093|FG001|NOT COMPLETED|Overall Study||33
10334691|NCT00345384|11471101|FG000|STARTED|Overall Study||19
10334692|NCT00345384|11471102|FG001|STARTED|Overall Study||19
10334693|NCT00345384|11471101|FG000|COMPLETED|Overall Study||19
10334694|NCT00345384|11471102|FG001|COMPLETED|Overall Study||19
10334695|NCT00345384|11471101|FG000|NOT COMPLETED|Overall Study||0
10334696|NCT00345384|11471102|FG001|NOT COMPLETED|Overall Study||0
10334697|NCT00345397|11471110|FG000|STARTED|Overall Study||7
10334698|NCT00345397|11471110|FG000|COMPLETED|Overall Study||6
10334699|NCT00345397|11471110|FG000|NOT COMPLETED|Overall Study||1
10334700|NCT00345540|11471115|FG000|STARTED|Overall Study|1 subject enrolled but not treated (off-trial for patient discretion)|16
10334701|NCT00345540|11471115|FG000|COMPLETED|Overall Study||15
10334702|NCT00345540|11471115|FG000|NOT COMPLETED|Overall Study||1
10334703|NCT00345579|11471121|FG000|STARTED|Overall Study||3278
10334704|NCT00345579|11471122|FG001|STARTED|Overall Study||1113
10334705|NCT00345579|11471121|FG000|COMPLETED|Overall Study||3114
10334706|NCT00345579|11471122|FG001|COMPLETED|Overall Study||1048
10334707|NCT00345579|11471121|FG000|NOT COMPLETED|Overall Study||164
10334708|NCT00345579|11471122|FG001|NOT COMPLETED|Overall Study||65
10334709|NCT00345592|11471131|FG000|STARTED|Overall Study||199
10334710|NCT00345592|11471132|FG001|STARTED|Overall Study||197
10334711|NCT00345592|11471131|FG000|COMPLETED|Overall Study||174
10334712|NCT00345592|11471132|FG001|COMPLETED|Overall Study||173
10334713|NCT00345592|11471131|FG000|NOT COMPLETED|Overall Study||25
10334714|NCT00345592|11471132|FG001|NOT COMPLETED|Overall Study||24
10334715|NCT00345605|11471138|FG000|STARTED|Initial Washout||6
10334716|NCT00345605|11471139|FG001|STARTED|Initial Washout||6
10334717|NCT00345605|11471138|FG000|COMPLETED|Initial Washout||6
10334718|NCT00345605|11471139|FG001|COMPLETED|Initial Washout||6
10334719|NCT00345605|11471138|FG000|NOT COMPLETED|Initial Washout||0
10707349|NCT02618642|11871974|FG000|COMPLETED|Before 10 PILER Irradiation Treatments||15
10707350|NCT02618642|11871975|FG001|COMPLETED|Before 10 PILER Irradiation Treatments||15
10707351|NCT02618642|11871976|FG002|COMPLETED|Before 10 PILER Irradiation Treatments||15
10707352|NCT02618642|11871977|FG003|COMPLETED|Before 10 PILER Irradiation Treatments||15
10649621|NCT02163759|11809802|FG001|Completed Week 10|Overall Study||141
10649622|NCT02163759|11809803|FG002|Completed Week 10|Overall Study||143
10649623|NCT02163759|11809801|FG000|COMPLETED|Overall Study||71
10649624|NCT02163759|11809802|FG001|COMPLETED|Overall Study||137
10649625|NCT02163759|11809803|FG002|COMPLETED|Overall Study||141
10649626|NCT02163759|11809801|FG000|NOT COMPLETED|Overall Study||1
10649627|NCT02163759|11809802|FG001|NOT COMPLETED|Overall Study||5
10649628|NCT02163759|11809803|FG002|NOT COMPLETED|Overall Study||3
10649629|NCT02163811|11809816|FG000|STARTED|Overall Study||71
10649630|NCT02163811|11809817|FG001|STARTED|Overall Study||76
10649631|NCT02163811|11809816|FG000|COMPLETED|Overall Study||35
10649632|NCT02163811|11809817|FG001|COMPLETED|Overall Study||60
10649633|NCT02163811|11809816|FG000|NOT COMPLETED|Overall Study||36
10649634|NCT02163811|11809817|FG001|NOT COMPLETED|Overall Study||16
10649635|NCT02163824|11809826|FG000|STARTED|Overall Study||129
10649636|NCT02163824|11809827|FG001|STARTED|Overall Study||125
10707353|NCT02618642|11871974|FG000|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
10707354|NCT02618642|11871975|FG001|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
10707355|NCT02618642|11871976|FG002|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
10334720|NCT00345605|11471139|FG001|NOT COMPLETED|Initial Washout||0
10334721|NCT00345605|11471138|FG000|STARTED|Arm 1||6
10334722|NCT00345605|11471139|FG001|STARTED|Arm 1||6
10649637|NCT02163824|11809828|FG002|STARTED|Overall Study||126
10649638|NCT02163824|11809826|FG000|COMPLETED|Overall Study||127
10334723|NCT00345605|11471138|FG000|COMPLETED|Arm 1||6
10649639|NCT02163824|11809827|FG001|COMPLETED|Overall Study||124
10649640|NCT02163824|11809828|FG002|COMPLETED|Overall Study||124
10707356|NCT02618642|11871977|FG003|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
10707357|NCT02618642|11871974|FG000|STARTED|After 10 PILER Irradiation Treatments||15
10707358|NCT02618642|11871975|FG001|STARTED|After 10 PILER Irradiation Treatments||15
10707359|NCT02618642|11871976|FG002|STARTED|After 10 PILER Irradiation Treatments||15
10707360|NCT02618642|11871977|FG003|STARTED|After 10 PILER Irradiation Treatments||15
10707361|NCT02618642|11871974|FG000|COMPLETED|After 10 PILER Irradiation Treatments||15
10707362|NCT02618642|11871975|FG001|COMPLETED|After 10 PILER Irradiation Treatments||15
10707363|NCT02618642|11871976|FG002|COMPLETED|After 10 PILER Irradiation Treatments||15
10707364|NCT02618642|11871977|FG003|COMPLETED|After 10 PILER Irradiation Treatments||15
10707365|NCT02618642|11871974|FG000|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
10707366|NCT02618642|11871975|FG001|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
10707367|NCT02618642|11871976|FG002|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
10707368|NCT02618642|11871977|FG003|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
10707369|NCT02618759|11871996|FG000|STARTED|Overall Study||60
10707370|NCT02618759|11871997|FG001|STARTED|Overall Study||59
10707371|NCT02618759|11871996|FG000|COMPLETED|Overall Study||58
10707372|NCT02618759|11871997|FG001|COMPLETED|Overall Study||54
10707373|NCT02618759|11871996|FG000|NOT COMPLETED|Overall Study||2
10707374|NCT02618759|11871997|FG001|NOT COMPLETED|Overall Study||5
10707375|NCT02618772|11872005|FG000|STARTED|Overall Study||39
10707376|NCT02618772|11872006|FG001|STARTED|Overall Study||40
10707377|NCT02618772|11872005|FG000|Withdrawal by Subject|Overall Study|The participant's family withdrew from the study after administration of the trial intervention.|1
10707378|NCT02618772|11872006|FG001|Withdrawal by Subject|Overall Study||0
10707379|NCT02618772|11872005|FG000|COMPLETED|Overall Study||38
10707380|NCT02618772|11872006|FG001|COMPLETED|Overall Study||40
10707381|NCT02618772|11872005|FG000|NOT COMPLETED|Overall Study||1
10707382|NCT02618772|11872006|FG001|NOT COMPLETED|Overall Study||0
10707383|NCT02618915|11872014|FG000|STARTED|Overall Study||3
10707384|NCT02618915|11872015|FG001|STARTED|Overall Study||3
10707385|NCT02618915|11872014|FG000|COMPLETED|Overall Study||3
10707386|NCT02618915|11872015|FG001|COMPLETED|Overall Study||3
10707387|NCT02618915|11872014|FG000|NOT COMPLETED|Overall Study||0
10707388|NCT02618915|11872015|FG001|NOT COMPLETED|Overall Study||0
10707389|NCT02618928|11872023|FG000|STARTED|Overall Study||735
10334724|NCT00345605|11471139|FG001|COMPLETED|Arm 1||5
10334725|NCT00345605|11471138|FG000|NOT COMPLETED|Arm 1||0
10334726|NCT00345605|11471139|FG001|NOT COMPLETED|Arm 1||1
10334727|NCT00345605|11471138|FG000|STARTED|Interval||6
10334728|NCT00345605|11471139|FG001|STARTED|Interval||6
10334729|NCT00345605|11471138|FG000|COMPLETED|Interval||6
10334730|NCT00345605|11471139|FG001|COMPLETED|Interval||6
10334731|NCT00345605|11471138|FG000|NOT COMPLETED|Interval||0
10334732|NCT00345605|11471139|FG001|NOT COMPLETED|Interval||0
10334733|NCT00345605|11471138|FG000|STARTED|Crossover Wash-out||6
10334734|NCT00345605|11471139|FG001|STARTED|Crossover Wash-out||6
10334735|NCT00345605|11471138|FG000|COMPLETED|Crossover Wash-out||6
10334736|NCT00345605|11471139|FG001|COMPLETED|Crossover Wash-out||6
10334737|NCT00345605|11471138|FG000|NOT COMPLETED|Crossover Wash-out||0
10334738|NCT00345605|11471139|FG001|NOT COMPLETED|Crossover Wash-out||0
10334739|NCT00345605|11471138|FG000|STARTED|Arm 2, Opposite Treatment||6
10334740|NCT00345605|11471139|FG001|STARTED|Arm 2, Opposite Treatment||6
10334741|NCT00345605|11471138|FG000|COMPLETED|Arm 2, Opposite Treatment||5
10334742|NCT00345605|11471139|FG001|COMPLETED|Arm 2, Opposite Treatment||6
10334743|NCT00345605|11471138|FG000|NOT COMPLETED|Arm 2, Opposite Treatment||1
10334744|NCT00345605|11471139|FG001|NOT COMPLETED|Arm 2, Opposite Treatment||0
10334745|NCT00345631|11471150|FG000|STARTED|Overall Study||87
10334746|NCT00345631|11471151|FG001|STARTED|Overall Study||267
10334747|NCT00345631|11471152|FG002|STARTED|Overall Study||134
10334748|NCT00345631|11471150|FG000|COMPLETED|Overall Study||83
10334749|NCT00345631|11471151|FG001|COMPLETED|Overall Study||259
10334750|NCT00345631|11471152|FG002|COMPLETED|Overall Study||128
10334751|NCT00345631|11471150|FG000|NOT COMPLETED|Overall Study||4
10334752|NCT00345631|11471151|FG001|NOT COMPLETED|Overall Study||8
10334753|NCT00345631|11471152|FG002|NOT COMPLETED|Overall Study||6
10334754|NCT00345683|11471164|FG000|STARTED|Overall Study||3010
10334755|NCT00345683|11471165|FG001|STARTED|Overall Study||1010
10457571|NCT01011335|11605376|FG010|STARTED|Overall Study||12
10457572|NCT01011335|11605377|FG011|STARTED|Overall Study||22
10457573|NCT01011335|11605378|FG012|STARTED|Overall Study||22
10457574|NCT01011335|11605366|FG000|COMPLETED|Overall Study||10
10457575|NCT01011335|11605367|FG001|COMPLETED|Overall Study||11
10457576|NCT01011335|11605368|FG002|COMPLETED|Overall Study||11
10457577|NCT01011335|11605369|FG003|COMPLETED|Overall Study||10
10707390|NCT02618928|11872023|FG000|Received Treatment|Overall Study||728
10707391|NCT02618928|11872023|FG000|COMPLETED|Overall Study||677
10707392|NCT02618928|11872023|FG000|NOT COMPLETED|Overall Study||58
10707393|NCT02618967|11872038|FG000|STARTED|Overall Study||6
10707394|NCT02618967|11872039|FG001|STARTED|Overall Study||6
10707395|NCT02618967|11872040|FG002|STARTED|Overall Study||6
10707396|NCT02618967|11872041|FG003|STARTED|Overall Study||6
10707397|NCT02618967|11872042|FG004|STARTED|Overall Study||6
10707398|NCT02618967|11872043|FG005|STARTED|Overall Study||6
10707399|NCT02618967|11872044|FG006|STARTED|Overall Study||6
10707400|NCT02618967|11872045|FG007|STARTED|Overall Study||14
10707401|NCT02618967|11872038|FG000|Received Treatment|Overall Study||6
10707402|NCT02618967|11872039|FG001|Received Treatment|Overall Study||6
10707403|NCT02618967|11872040|FG002|Received Treatment|Overall Study||6
10707404|NCT02618967|11872041|FG003|Received Treatment|Overall Study||6
10707405|NCT02618967|11872042|FG004|Received Treatment|Overall Study||6
10707406|NCT02618967|11872043|FG005|Received Treatment|Overall Study||6
10707407|NCT02618967|11872044|FG006|Received Treatment|Overall Study||6
10707408|NCT02618967|11872045|FG007|Received Treatment|Overall Study||14
10707409|NCT02618967|11872038|FG000|COMPLETED|Overall Study||5
10707410|NCT02618967|11872039|FG001|COMPLETED|Overall Study||6
10707411|NCT02618967|11872040|FG002|COMPLETED|Overall Study||5
10707412|NCT02618967|11872041|FG003|COMPLETED|Overall Study||6
10707413|NCT02618967|11872042|FG004|COMPLETED|Overall Study||4
10707414|NCT02618967|11872043|FG005|COMPLETED|Overall Study||6
10707415|NCT02618967|11872044|FG006|COMPLETED|Overall Study||6
10707416|NCT02618967|11872045|FG007|COMPLETED|Overall Study||14
10707417|NCT02618967|11872038|FG000|NOT COMPLETED|Overall Study||1
10707418|NCT02618967|11872039|FG001|NOT COMPLETED|Overall Study||0
10707419|NCT02618967|11872040|FG002|NOT COMPLETED|Overall Study||1
10707420|NCT02618967|11872041|FG003|NOT COMPLETED|Overall Study||0
10707421|NCT02618967|11872042|FG004|NOT COMPLETED|Overall Study||2
10707422|NCT02618967|11872043|FG005|NOT COMPLETED|Overall Study||0
10707423|NCT02618967|11872044|FG006|NOT COMPLETED|Overall Study||0
10707424|NCT02618967|11872045|FG007|NOT COMPLETED|Overall Study||0
10707425|NCT02619175|11872065|FG000|STARTED|Overall Study||18
10707426|NCT02619175|11872066|FG001|STARTED|Overall Study||16
10707427|NCT02619175|11872065|FG000|COMPLETED|Overall Study||16
10707428|NCT02619175|11872066|FG001|COMPLETED|Overall Study||16
10707429|NCT02619175|11872065|FG000|NOT COMPLETED|Overall Study||2
10707430|NCT02619175|11872066|FG001|NOT COMPLETED|Overall Study||0
10707431|NCT02619396|11872080|FG000|STARTED|Overall Study||20
10707432|NCT02619396|11872081|FG001|STARTED|Overall Study||20
10707433|NCT02619396|11872082|FG002|STARTED|Overall Study||20
10707434|NCT02619396|11872083|FG003|STARTED|Overall Study||20
10707435|NCT02619396|11872080|FG000|COMPLETED|Overall Study||20
10707436|NCT02619396|11872081|FG001|COMPLETED|Overall Study||20
10707437|NCT02619396|11872082|FG002|COMPLETED|Overall Study||20
10707438|NCT02619396|11872083|FG003|COMPLETED|Overall Study||20
10707439|NCT02619396|11872080|FG000|NOT COMPLETED|Overall Study||0
10707440|NCT02619396|11872081|FG001|NOT COMPLETED|Overall Study||0
10707441|NCT02619396|11872082|FG002|NOT COMPLETED|Overall Study||0
10707442|NCT02619396|11872083|FG003|NOT COMPLETED|Overall Study||0
10707443|NCT02619409|11872099|FG000|STARTED|Overall Study||6
10707444|NCT02619409|11872100|FG001|STARTED|Overall Study||6
10707445|NCT02619409|11872101|FG002|STARTED|Overall Study||6
10707446|NCT02619409|11872102|FG003|STARTED|Overall Study||6
10707447|NCT02619409|11872103|FG004|STARTED|Overall Study||6
10707448|NCT02619409|11872099|FG000|COMPLETED|Overall Study||6
10707449|NCT02619409|11872100|FG001|COMPLETED|Overall Study||6
10707450|NCT02619409|11872101|FG002|COMPLETED|Overall Study||6
10707451|NCT02619409|11872102|FG003|COMPLETED|Overall Study||6
10707452|NCT02619409|11872103|FG004|COMPLETED|Overall Study||6
10707453|NCT02619409|11872099|FG000|NOT COMPLETED|Overall Study||0
10707454|NCT02619409|11872100|FG001|NOT COMPLETED|Overall Study||0
10707455|NCT02619409|11872101|FG002|NOT COMPLETED|Overall Study||0
10707456|NCT02619409|11872102|FG003|NOT COMPLETED|Overall Study||0
10707457|NCT02619409|11872103|FG004|NOT COMPLETED|Overall Study||0
10707458|NCT02619591|11872117|FG000|STARTED|Overall Study||139
10707459|NCT02619591|11872118|FG001|STARTED|Overall Study||121
10707460|NCT02619591|11872117|FG000|COMPLETED|Overall Study||0
10707461|NCT02619591|11872118|FG001|COMPLETED|Overall Study||0
10707462|NCT02619591|11872117|FG000|NOT COMPLETED|Overall Study||139
10707463|NCT02619591|11872118|FG001|NOT COMPLETED|Overall Study||121
10707464|NCT02619617|11872124|FG000|STARTED|Period 1 Placebo - 1st AttacK||28
10707465|NCT02619617|11872125|FG001|STARTED|Period 1 Placebo - 1st AttacK||0
10334756|NCT00345683|11471164|FG000|COMPLETED|Overall Study||2985
10334757|NCT00345683|11471165|FG001|COMPLETED|Overall Study||1001
10334758|NCT00345683|11471164|FG000|NOT COMPLETED|Overall Study||25
10334759|NCT00345683|11471165|FG001|NOT COMPLETED|Overall Study||9
10339102|NCT00371397|11476088|FG002|COMPLETED|Session 1||5
10339103|NCT00371397|11476089|FG003|COMPLETED|Session 1||2
10339104|NCT00371397|11476090|FG004|COMPLETED|Session 1||3
10339105|NCT00371397|11476091|FG005|COMPLETED|Session 1||4
10339106|NCT00371397|11476092|FG006|COMPLETED|Session 1||4
10339107|NCT00371397|11476093|FG007|COMPLETED|Session 1||4
10339108|NCT00371397|11476094|FG008|COMPLETED|Session 1||6
10339109|NCT00371397|11476095|FG009|COMPLETED|Session 1||5
10339110|NCT00371397|11476096|FG010|COMPLETED|Session 1||4
10339111|NCT00371397|11476097|FG011|COMPLETED|Session 1||2
10339112|NCT00371397|11476086|FG000|NOT COMPLETED|Session 1||1
10339113|NCT00371397|11476087|FG001|NOT COMPLETED|Session 1||0
10339114|NCT00371397|11476088|FG002|NOT COMPLETED|Session 1||0
10339115|NCT00371397|11476089|FG003|NOT COMPLETED|Session 1||0
10339116|NCT00371397|11476090|FG004|NOT COMPLETED|Session 1||0
10707466|NCT02619617|11872124|FG000|Participants Included in PD Analysis|Period 1 Placebo - 1st AttacK||20
10707467|NCT02619617|11872125|FG001|Participants Included in PD Analysis|Period 1 Placebo - 1st AttacK||0
10707468|NCT02619617|11872124|FG000|Participants in Safety Set for Period 1|Period 1 Placebo - 1st AttacK||28
10707469|NCT02619617|11872125|FG001|Participants in Safety Set for Period 1|Period 1 Placebo - 1st AttacK||0
10707470|NCT02619617|11872124|FG000|COMPLETED|Period 1 Placebo - 1st AttacK||28
10707471|NCT02619617|11872125|FG001|COMPLETED|Period 1 Placebo - 1st AttacK||0
10707472|NCT02619617|11872124|FG000|NOT COMPLETED|Period 1 Placebo - 1st AttacK||0
10339117|NCT00371397|11476091|FG005|NOT COMPLETED|Session 1||0
10707473|NCT02619617|11872125|FG001|NOT COMPLETED|Period 1 Placebo - 1st AttacK||0
10707474|NCT02619617|11872124|FG000|STARTED|Period 2 SOM230 - 2nd Attack||0
10707475|NCT02619617|11872125|FG001|STARTED|Period 2 SOM230 - 2nd Attack||28
10707476|NCT02619617|11872124|FG000|Participants in Safety Set for Period 2|Period 2 SOM230 - 2nd Attack||0
10707477|NCT02619617|11872125|FG001|Participants in Safety Set for Period 2|Period 2 SOM230 - 2nd Attack||28
10707478|NCT02619617|11872124|FG000|COMPLETED|Period 2 SOM230 - 2nd Attack||0
10707479|NCT02619617|11872125|FG001|COMPLETED|Period 2 SOM230 - 2nd Attack||24
10707480|NCT02619617|11872124|FG000|NOT COMPLETED|Period 2 SOM230 - 2nd Attack||0
10707481|NCT02619617|11872125|FG001|NOT COMPLETED|Period 2 SOM230 - 2nd Attack||4
10707482|NCT02619799|11872135|FG000|STARTED|Overall Study||25
10707483|NCT02619799|11872136|FG001|STARTED|Overall Study||25
10707484|NCT02619799|11872135|FG000|COMPLETED|Overall Study||25
10707485|NCT02619799|11872136|FG001|COMPLETED|Overall Study||25
10707486|NCT02619799|11872135|FG000|NOT COMPLETED|Overall Study||0
10707487|NCT02619799|11872136|FG001|NOT COMPLETED|Overall Study||0
10707488|NCT02620020|11872146|FG000|STARTED|Overall Study||141
10707489|NCT02620020|11872147|FG001|STARTED|Overall Study||141
10707490|NCT02620020|11872148|FG002|STARTED|Overall Study||140
10707491|NCT02620020|11872149|FG003|STARTED|Overall Study||141
10707492|NCT02620020|11872146|FG000|Modified Intent to Treat Set (mITT)|Overall Study||140
10707493|NCT02620020|11872147|FG001|Modified Intent to Treat Set (mITT)|Overall Study||139
10707494|NCT02620020|11872148|FG002|Modified Intent to Treat Set (mITT)|Overall Study||139
10707495|NCT02620020|11872149|FG003|Modified Intent to Treat Set (mITT)|Overall Study||140
10707496|NCT02620020|11872146|FG000|COMPLETED|Overall Study||97
10707497|NCT02620020|11872147|FG001|COMPLETED|Overall Study||106
10707498|NCT02620020|11872148|FG002|COMPLETED|Overall Study||115
10707499|NCT02620020|11872149|FG003|COMPLETED|Overall Study||115
10707500|NCT02620020|11872146|FG000|NOT COMPLETED|Overall Study||44
10707501|NCT02620020|11872147|FG001|NOT COMPLETED|Overall Study||35
10707502|NCT02620020|11872148|FG002|NOT COMPLETED|Overall Study||25
10707503|NCT02620020|11872149|FG003|NOT COMPLETED|Overall Study||26
10707504|NCT02620384|11872161|FG000|STARTED|Overall Study||70
10707505|NCT02620384|11872162|FG001|STARTED|Overall Study||73
10707506|NCT02620384|11872161|FG000|COMPLETED|Overall Study|Per protocol design patients must receive both doses of investigational product to be in analysis.|66
10809563|NCT03831191|11971470|FG001|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||35
10809564|NCT03831191|11971471|FG002|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||34
10809565|NCT03831191|11971472|FG003|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||33
10809566|NCT03831191|11971473|FG004|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
10809567|NCT03831191|11971474|FG005|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
10809568|NCT03831191|11971475|FG006|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
10713947|NCT02683746|11879498|FG001|COMPLETED|Overall Study||140
10713948|NCT02683746|11879497|FG000|NOT COMPLETED|Overall Study||16
10649641|NCT02163824|11809826|FG000|NOT COMPLETED|Overall Study||2
10649642|NCT02163824|11809827|FG001|NOT COMPLETED|Overall Study||1
10649643|NCT02163824|11809828|FG002|NOT COMPLETED|Overall Study||2
10649644|NCT02163837|11809836|FG000|STARTED|Before Rifaximin||15
10649645|NCT02163837|11809836|FG000|COMPLETED|Before Rifaximin||15
10649646|NCT02163837|11809836|FG000|NOT COMPLETED|Before Rifaximin||0
10649647|NCT02163837|11809836|FG000|STARTED|Day 28 of Rifaximin Treatment||15
10649648|NCT02163837|11809836|FG000|COMPLETED|Day 28 of Rifaximin Treatment||15
10649649|NCT02163837|11809836|FG000|NOT COMPLETED|Day 28 of Rifaximin Treatment||0
10649650|NCT02163902|11809842|FG000|STARTED|Overall Study||113
10457578|NCT01011335|11605370|FG004|COMPLETED|Overall Study||12
10457579|NCT01011335|11605371|FG005|COMPLETED|Overall Study||11
10457580|NCT01011335|11605372|FG006|COMPLETED|Overall Study||9
10457581|NCT01011335|11605373|FG007|COMPLETED|Overall Study||10
10457582|NCT01011335|11605374|FG008|COMPLETED|Overall Study||10
10457583|NCT01011335|11605375|FG009|COMPLETED|Overall Study||12
10457584|NCT01011335|11605376|FG010|COMPLETED|Overall Study||6
10457585|NCT01011335|11605377|FG011|COMPLETED|Overall Study||21
10457586|NCT01011335|11605378|FG012|COMPLETED|Overall Study||19
10457587|NCT01011335|11605366|FG000|NOT COMPLETED|Overall Study||1
10457588|NCT01011335|11605367|FG001|NOT COMPLETED|Overall Study||1
10457589|NCT01011335|11605368|FG002|NOT COMPLETED|Overall Study||1
10457590|NCT01011335|11605369|FG003|NOT COMPLETED|Overall Study||2
10457591|NCT01011335|11605370|FG004|NOT COMPLETED|Overall Study||1
10457592|NCT01011335|11605371|FG005|NOT COMPLETED|Overall Study||1
10457593|NCT01011335|11605372|FG006|NOT COMPLETED|Overall Study||3
10457594|NCT01011335|11605373|FG007|NOT COMPLETED|Overall Study||2
10457595|NCT01011335|11605374|FG008|NOT COMPLETED|Overall Study||2
10457596|NCT01011335|11605375|FG009|NOT COMPLETED|Overall Study||0
10457597|NCT01011335|11605376|FG010|NOT COMPLETED|Overall Study||6
10457598|NCT01011335|11605377|FG011|NOT COMPLETED|Overall Study||1
10457599|NCT01011335|11605378|FG012|NOT COMPLETED|Overall Study||3
10457600|NCT01011387|11605415|FG000|STARTED|Overall Study||16
10457601|NCT01011387|11605415|FG000|COMPLETED|Overall Study||10
10457602|NCT01011387|11605415|FG000|NOT COMPLETED|Overall Study||6
10457603|NCT01011413|11605421|FG000|STARTED|Overall Study|312 randomised|312
10457604|NCT01011413|11605422|FG001|STARTED|Overall Study|324 randomised|324
10457605|NCT01011413|11605421|FG000|Did Not Start Study Drug|Overall Study||3
10457606|NCT01011413|11605422|FG001|Did Not Start Study Drug|Overall Study||3
10457607|NCT01011413|11605421|FG000|In Modified ITT|Overall Study||309
10457608|NCT01011413|11605422|FG001|In Modified ITT|Overall Study||321
10457609|NCT01011413|11605421|FG000|Died Before Week 48|Overall Study||3
10457610|NCT01011413|11605422|FG001|Died Before Week 48|Overall Study||2
10457611|NCT01011413|11605421|FG000|Lost to Follow up Before w48|Overall Study||3
10457612|NCT01011413|11605422|FG001|Lost to Follow up Before w48|Overall Study||4
10457613|NCT01011413|11605421|FG000|Withdrew Consent Before w48|Overall Study||3
10457614|NCT01011413|11605422|FG001|Withdrew Consent Before w48|Overall Study||3
10457615|NCT01011413|11605421|FG000|Attended w48 Visit|Overall Study||295
10457616|NCT01011413|11605422|FG001|Attended w48 Visit|Overall Study||311
10457617|NCT01011413|11605421|FG000|Died Between Week 48 and 96|Overall Study||2
10457618|NCT01011413|11605422|FG001|Died Between Week 48 and 96|Overall Study||3
10457619|NCT01011413|11605421|FG000|Withdrew Consent Between Week 48 and 96|Overall Study||2
10457620|NCT01011413|11605422|FG001|Withdrew Consent Between Week 48 and 96|Overall Study||6
10457621|NCT01011413|11605421|FG000|Lost to Follow-up Between Week 48 and 96|Overall Study||10
10457622|NCT01011413|11605422|FG001|Lost to Follow-up Between Week 48 and 96|Overall Study||4
10457623|NCT01011413|11605421|FG000|COMPLETED|Overall Study||286
10457624|NCT01011413|11605422|FG001|COMPLETED|Overall Study||299
10457625|NCT01011413|11605421|FG000|NOT COMPLETED|Overall Study||26
10457626|NCT01011413|11605422|FG001|NOT COMPLETED|Overall Study||25
10457627|NCT01011439|11605435|FG000|STARTED|Overall Study||72
10457628|NCT01011439|11605435|FG000|COMPLETED|Overall Study||15
10457629|NCT01011439|11605435|FG000|NOT COMPLETED|Overall Study||57
10457630|NCT01011465|11605448|FG000|STARTED|Overall Study||36
10457631|NCT01011465|11605449|FG001|STARTED|Overall Study||20
10457632|NCT01011465|11605450|FG002|STARTED|Overall Study||36
10334766|NCT00345865|11471185|FG000|STARTED|Overall Study||171
10334767|NCT00345865|11471186|FG001|STARTED|Overall Study||149
10334768|NCT00345865|11471187|FG002|STARTED|Overall Study||2
10334769|NCT00345865|11471188|FG003|STARTED|Overall Study||5
10334770|NCT00345865|11471189|FG004|STARTED|Overall Study||146
10334771|NCT00345865|11471185|FG000|COMPLETED|Overall Study||171
10334772|NCT00345865|11471186|FG001|COMPLETED|Overall Study||149
10334773|NCT00345865|11471187|FG002|COMPLETED|Overall Study||2
10334774|NCT00345865|11471188|FG003|COMPLETED|Overall Study||5
10334775|NCT00345865|11471189|FG004|COMPLETED|Overall Study||146
10334776|NCT00345865|11471185|FG000|NOT COMPLETED|Overall Study||0
10334777|NCT00345865|11471186|FG001|NOT COMPLETED|Overall Study||0
10334778|NCT00345865|11471187|FG002|NOT COMPLETED|Overall Study||0
10334779|NCT00345865|11471188|FG003|NOT COMPLETED|Overall Study||0
10334780|NCT00345865|11471189|FG004|NOT COMPLETED|Overall Study||0
10334781|NCT00345878|11471203|FG000|STARTED|Overall Study||135
10334782|NCT00345878|11471204|FG001|STARTED|Overall Study||136
10334783|NCT00345878|11471203|FG000|COMPLETED|Overall Study||131
10334784|NCT00345878|11471204|FG001|COMPLETED|Overall Study||135
10334785|NCT00345878|11471203|FG000|NOT COMPLETED|Overall Study||4
10334786|NCT00345878|11471204|FG001|NOT COMPLETED|Overall Study||1
10334787|NCT00345969|11471212|FG000|STARTED|Overall Study||12
10334788|NCT00345969|11471213|FG001|STARTED|Overall Study||13
10334789|NCT00345969|11471212|FG000|COMPLETED|Overall Study||11
10334790|NCT00345969|11471213|FG001|COMPLETED|Overall Study||11
10334791|NCT00345969|11471212|FG000|NOT COMPLETED|Overall Study||1
10334792|NCT00345969|11471213|FG001|NOT COMPLETED|Overall Study||2
10334793|NCT00346034|11471219|FG000|STARTED|Overall Study||357
10334794|NCT00346034|11471219|FG000|COMPLETED|Overall Study||300
10334795|NCT00346034|11471219|FG000|NOT COMPLETED|Overall Study||57
10334796|NCT00346073|11471225|FG000|STARTED|Overall Study||1522
10334797|NCT00346073|11471226|FG001|STARTED|Overall Study||762
10334798|NCT00346073|11471225|FG000|COMPLETED|Overall Study||1481
10334799|NCT00346073|11471226|FG001|COMPLETED|Overall Study||738
10334800|NCT00346073|11471225|FG000|NOT COMPLETED|Overall Study||41
10334801|NCT00346073|11471226|FG001|NOT COMPLETED|Overall Study||24
10334802|NCT00346151|11471232|FG000|STARTED|Overall Study||5
10334803|NCT00346151|11471232|FG000|COMPLETED|Overall Study||2
10334804|NCT00346151|11471232|FG000|NOT COMPLETED|Overall Study||3
10334805|NCT00346216|11471239|FG000|STARTED|Overall Study||8072
10334806|NCT00346216|11471240|FG001|STARTED|Overall Study||8040
10334807|NCT00346216|11471241|FG002|STARTED|Overall Study||7969
10334808|NCT00346216|11471239|FG000|COMPLETED|Overall Study||5664
10334809|NCT00346216|11471240|FG001|COMPLETED|Overall Study||5580
10334810|NCT00346216|11471241|FG002|COMPLETED|Overall Study||5621
10334811|NCT00346216|11471239|FG000|NOT COMPLETED|Overall Study||2408
10334812|NCT00346216|11471240|FG001|NOT COMPLETED|Overall Study||2460
10334813|NCT00346216|11471241|FG002|NOT COMPLETED|Overall Study||2348
10334814|NCT00346268|11471251|FG000|STARTED|Overall Study||52
10334815|NCT00346268|11471252|FG001|STARTED|Overall Study||53
10334816|NCT00346268|11471251|FG000|COMPLETED|Overall Study||50
10334817|NCT00346268|11471252|FG001|COMPLETED|Overall Study||50
10334818|NCT00346268|11471251|FG000|NOT COMPLETED|Overall Study||2
10334819|NCT00346268|11471252|FG001|NOT COMPLETED|Overall Study||3
10334820|NCT00346333|11471260|FG000|STARTED|Overall Study||121
10334821|NCT00346333|11471261|FG001|STARTED|Overall Study||119
10334822|NCT00346333|11471260|FG000|COMPLETED|Overall Study||116
10334823|NCT00346333|11471261|FG001|COMPLETED|Overall Study||111
10334824|NCT00346333|11471260|FG000|NOT COMPLETED|Overall Study||5
10334825|NCT00346333|11471261|FG001|NOT COMPLETED|Overall Study||8
10334826|NCT00346398|11471271|FG000|STARTED|Overall Study||25
10334827|NCT00346398|11471272|FG001|STARTED|Overall Study||26
10334828|NCT00346398|11471271|FG000|COMPLETED|Overall Study||22
10457633|NCT01011465|11605451|FG003|STARTED|Overall Study||18
10457634|NCT01011465|11605452|FG004|STARTED|Overall Study||47
10457635|NCT01011465|11605453|FG005|STARTED|Overall Study||29
10457636|NCT01011465|11605454|FG006|STARTED|Overall Study||52
10457637|NCT01011465|11605455|FG007|STARTED|Overall Study||32
10457638|NCT01011465|11605448|FG000|COMPLETED|Overall Study||34
10457639|NCT01011465|11605449|FG001|COMPLETED|Overall Study||19
10457640|NCT01011465|11605450|FG002|COMPLETED|Overall Study||36
10457641|NCT01011465|11605451|FG003|COMPLETED|Overall Study||18
10457642|NCT01011465|11605452|FG004|COMPLETED|Overall Study||46
10457643|NCT01011465|11605453|FG005|COMPLETED|Overall Study||29
10457644|NCT01011465|11605454|FG006|COMPLETED|Overall Study||51
10457645|NCT01011465|11605455|FG007|COMPLETED|Overall Study||32
10457646|NCT01011465|11605448|FG000|NOT COMPLETED|Overall Study||2
10457647|NCT01011465|11605449|FG001|NOT COMPLETED|Overall Study||1
10457648|NCT01011465|11605450|FG002|NOT COMPLETED|Overall Study||0
10457649|NCT01011465|11605451|FG003|NOT COMPLETED|Overall Study||0
10457650|NCT01011465|11605452|FG004|NOT COMPLETED|Overall Study||1
10457651|NCT01011465|11605453|FG005|NOT COMPLETED|Overall Study||0
10457652|NCT01011465|11605454|FG006|NOT COMPLETED|Overall Study||1
10457653|NCT01011465|11605455|FG007|NOT COMPLETED|Overall Study||0
10457654|NCT01011556|11605475|FG000|STARTED|Overall Study||58
10457655|NCT01011556|11605476|FG001|STARTED|Overall Study||56
10457656|NCT01011556|11605477|FG002|STARTED|Overall Study||55
10457657|NCT01011556|11605478|FG003|STARTED|Overall Study||64
10457658|NCT01011556|11605475|FG000|Received at Least 1 Dose of Study Drug|Overall Study||57
10457659|NCT01011556|11605476|FG001|Received at Least 1 Dose of Study Drug|Overall Study||56
10457660|NCT01011556|11605477|FG002|Received at Least 1 Dose of Study Drug|Overall Study||54
10457661|NCT01011556|11605478|FG003|Received at Least 1 Dose of Study Drug|Overall Study||64
10457662|NCT01011556|11605475|FG000|COMPLETED|Overall Study||52
10457663|NCT01011556|11605476|FG001|COMPLETED|Overall Study||48
10457664|NCT01011556|11605477|FG002|COMPLETED|Overall Study||45
10457665|NCT01011556|11605478|FG003|COMPLETED|Overall Study||51
10457666|NCT01011556|11605475|FG000|NOT COMPLETED|Overall Study||6
10457667|NCT01011556|11605476|FG001|NOT COMPLETED|Overall Study||8
10457668|NCT01011556|11605477|FG002|NOT COMPLETED|Overall Study||10
10457669|NCT01011556|11605478|FG003|NOT COMPLETED|Overall Study||13
10457670|NCT01011673|11605493|FG000|STARTED|Randomized||62
10457671|NCT01011673|11605494|FG001|STARTED|Randomized||61
10457672|NCT01011673|11605493|FG000|COMPLETED|Randomized|2 patients were randomized but not included in analyses bc they did not truly meet study criteria.|60
10457673|NCT01011673|11605494|FG001|COMPLETED|Randomized|1 patient was randomized but not included in analyses bc they did not truly meet study criteria.|60
10457674|NCT01011673|11605493|FG000|NOT COMPLETED|Randomized||2
10457675|NCT01011673|11605494|FG001|NOT COMPLETED|Randomized||1
10457676|NCT01011673|11605493|FG000|STARTED|Emergency Department Portion||60
10457677|NCT01011673|11605494|FG001|STARTED|Emergency Department Portion||60
10457678|NCT01011673|11605493|FG000|COMPLETED|Emergency Department Portion||60
10457679|NCT01011673|11605494|FG001|COMPLETED|Emergency Department Portion||60
10457680|NCT01011673|11605493|FG000|NOT COMPLETED|Emergency Department Portion||0
10457681|NCT01011673|11605494|FG001|NOT COMPLETED|Emergency Department Portion||0
10457682|NCT01011673|11605493|FG000|STARTED|24 Hour Follow-up||60
10457683|NCT01011673|11605494|FG001|STARTED|24 Hour Follow-up||60
10457684|NCT01011673|11605493|FG000|COMPLETED|24 Hour Follow-up||57
10457685|NCT01011673|11605494|FG001|COMPLETED|24 Hour Follow-up||57
10457686|NCT01011673|11605493|FG000|NOT COMPLETED|24 Hour Follow-up||3
10457687|NCT01011673|11605494|FG001|NOT COMPLETED|24 Hour Follow-up||3
10457688|NCT01011738|11605503|FG000|STARTED|Overall Study||877
10457689|NCT01011738|11605504|FG001|STARTED|Overall Study||912
10457690|NCT01011738|11605505|FG002|STARTED|Overall Study||53
10707507|NCT02620384|11872162|FG001|COMPLETED|Overall Study|Per protocol design patients must receive both doses of investigational product to be in analysis.|66
10707508|NCT02620384|11872161|FG000|NOT COMPLETED|Overall Study||4
10707509|NCT02620384|11872162|FG001|NOT COMPLETED|Overall Study||7
10707510|NCT02620683|11872168|FG000|STARTED|First Intervention (Visit 1)||12
10707511|NCT02620683|11872169|FG001|STARTED|First Intervention (Visit 1)||11
10707512|NCT02620683|11872168|FG000|COMPLETED|First Intervention (Visit 1)||12
10707513|NCT02620683|11872169|FG001|COMPLETED|First Intervention (Visit 1)||11
10457691|NCT01011738|11605503|FG000|COMPLETED|Overall Study||553
10457692|NCT01011738|11605504|FG001|COMPLETED|Overall Study||618
10457693|NCT01011738|11605505|FG002|COMPLETED|Overall Study||36
10457694|NCT01011738|11605503|FG000|NOT COMPLETED|Overall Study||324
10457695|NCT01011738|11605504|FG001|NOT COMPLETED|Overall Study||294
10457696|NCT01011738|11605505|FG002|NOT COMPLETED|Overall Study||17
10457697|NCT01011816|11605516|FG000|STARTED|26-Week Primary Endpoint||164
10457698|NCT01011816|11605517|FG001|STARTED|26-Week Primary Endpoint||56
10457699|NCT01011816|11605516|FG000|COMPLETED|26-Week Primary Endpoint||157
10457700|NCT01011816|11605517|FG001|COMPLETED|26-Week Primary Endpoint||54
10457701|NCT01011816|11605516|FG000|NOT COMPLETED|26-Week Primary Endpoint||7
10457702|NCT01011816|11605517|FG001|NOT COMPLETED|26-Week Primary Endpoint||2
10457703|NCT01011816|11605516|FG000|STARTED|78-Week Extended Follow-up||157
10457704|NCT01011816|11605517|FG001|STARTED|78-Week Extended Follow-up||54
10457705|NCT01011816|11605516|FG000|COMPLETED|78-Week Extended Follow-up||85
10457706|NCT01011816|11605517|FG001|COMPLETED|78-Week Extended Follow-up||26
10457707|NCT01011816|11605516|FG000|NOT COMPLETED|78-Week Extended Follow-up||72
10457708|NCT01011816|11605517|FG001|NOT COMPLETED|78-Week Extended Follow-up||28
10457709|NCT01011829|11605527|FG000|STARTED|Overall Study||10
10457710|NCT01011829|11605528|FG001|STARTED|Overall Study||10
10457711|NCT01011829|11605527|FG000|COMPLETED|Overall Study||6
10457712|NCT01011829|11605528|FG001|COMPLETED|Overall Study||1
10457713|NCT01011829|11605527|FG000|NOT COMPLETED|Overall Study||4
10457714|NCT01011829|11605528|FG001|NOT COMPLETED|Overall Study||9
10457715|NCT01011868|11605537|FG000|STARTED|After Week 18 Follow-up||170
10457716|NCT01011868|11605538|FG001|STARTED|After Week 18 Follow-up||169
10457717|NCT01011868|11605539|FG002|STARTED|After Week 18 Follow-up||155
10457718|NCT01011868|11605537|FG000|COMPLETED|After Week 18 Follow-up||147
10457719|NCT01011868|11605538|FG001|COMPLETED|After Week 18 Follow-up||153
10457720|NCT01011868|11605539|FG002|COMPLETED|After Week 18 Follow-up||129
10457721|NCT01011868|11605537|FG000|NOT COMPLETED|After Week 18 Follow-up||23
10334829|NCT00346398|11471272|FG001|COMPLETED|Overall Study||24
10334830|NCT00346398|11471271|FG000|NOT COMPLETED|Overall Study||3
10334831|NCT00346398|11471272|FG001|NOT COMPLETED|Overall Study||2
10334832|NCT00346476|11471278|FG000|STARTED|Overall Study||1250
10334833|NCT00346476|11471278|FG000|COMPLETED|Overall Study||1250
10334834|NCT00346476|11471278|FG000|NOT COMPLETED|Overall Study||0
10334835|NCT00346632|11471284|FG000|STARTED|Overall Study||3
10334836|NCT00346632|11471285|FG001|STARTED|Overall Study||3
10334837|NCT00346632|11471286|FG002|STARTED|Overall Study||6
10334838|NCT00346632|11471287|FG003|STARTED|Overall Study||3
10334839|NCT00346632|11471288|FG004|STARTED|Overall Study||4
10334840|NCT00346632|11471289|FG005|STARTED|Overall Study||2
10334841|NCT00346632|11471290|FG006|STARTED|Overall Study||5
10334842|NCT00346632|11471291|FG007|STARTED|Overall Study||4
10334843|NCT00346632|11471292|FG008|STARTED|Overall Study||4
10334844|NCT00346632|11471293|FG009|STARTED|Overall Study||3
10334845|NCT00346632|11471284|FG000|COMPLETED|Overall Study||0
10334846|NCT00346632|11471285|FG001|COMPLETED|Overall Study||0
10334847|NCT00346632|11471286|FG002|COMPLETED|Overall Study||0
10334848|NCT00346632|11471287|FG003|COMPLETED|Overall Study||0
10334849|NCT00346632|11471288|FG004|COMPLETED|Overall Study||0
10334850|NCT00346632|11471289|FG005|COMPLETED|Overall Study||0
10334851|NCT00346632|11471290|FG006|COMPLETED|Overall Study||0
10334852|NCT00346632|11471291|FG007|COMPLETED|Overall Study||0
10334853|NCT00346632|11471292|FG008|COMPLETED|Overall Study||0
10334854|NCT00346632|11471293|FG009|COMPLETED|Overall Study||0
10334855|NCT00346632|11471284|FG000|NOT COMPLETED|Overall Study||3
10334856|NCT00346632|11471285|FG001|NOT COMPLETED|Overall Study||3
10334857|NCT00346632|11471286|FG002|NOT COMPLETED|Overall Study||6
10334858|NCT00346632|11471287|FG003|NOT COMPLETED|Overall Study||3
10334859|NCT00346632|11471288|FG004|NOT COMPLETED|Overall Study||4
10334860|NCT00346632|11471289|FG005|NOT COMPLETED|Overall Study||2
10334861|NCT00346632|11471290|FG006|NOT COMPLETED|Overall Study||5
10334862|NCT00346632|11471291|FG007|NOT COMPLETED|Overall Study||4
10334863|NCT00346632|11471292|FG008|NOT COMPLETED|Overall Study||4
10334864|NCT00346632|11471293|FG009|NOT COMPLETED|Overall Study||3
10334865|NCT00346697|11471357|FG000|STARTED|Overall Study||24
10334866|NCT00346697|11471358|FG001|STARTED|Overall Study||24
10334867|NCT00346697|11471357|FG000|COMPLETED|Overall Study||24
10334868|NCT00346697|11471358|FG001|COMPLETED|Overall Study||23
10334869|NCT00346697|11471357|FG000|NOT COMPLETED|Overall Study||0
10334870|NCT00346697|11471358|FG001|NOT COMPLETED|Overall Study||1
10334871|NCT00346775|11471366|FG000|STARTED|Period 1: Intervention Period 1||49
10334872|NCT00346775|11471367|FG001|STARTED|Period 1: Intervention Period 1||48
10334873|NCT00346775|11471366|FG000|COMPLETED|Period 1: Intervention Period 1||44
10334874|NCT00346775|11471367|FG001|COMPLETED|Period 1: Intervention Period 1||45
10334875|NCT00346775|11471366|FG000|NOT COMPLETED|Period 1: Intervention Period 1||5
10334876|NCT00346775|11471367|FG001|NOT COMPLETED|Period 1: Intervention Period 1||3
10334877|NCT00346775|11471366|FG000|STARTED|Period 2: Washout Period (7 Days)||44
10334878|NCT00346775|11471367|FG001|STARTED|Period 2: Washout Period (7 Days)||45
10334879|NCT00346775|11471366|FG000|COMPLETED|Period 2: Washout Period (7 Days)||44
10707514|NCT02620683|11872168|FG000|NOT COMPLETED|First Intervention (Visit 1)||0
10707515|NCT02620683|11872169|FG001|NOT COMPLETED|First Intervention (Visit 1)||0
10707516|NCT02620683|11872168|FG000|STARTED|Washout (2 Weeks)||12
10707517|NCT02620683|11872169|FG001|STARTED|Washout (2 Weeks)||11
10707518|NCT02620683|11872168|FG000|COMPLETED|Washout (2 Weeks)||12
10707519|NCT02620683|11872169|FG001|COMPLETED|Washout (2 Weeks)||11
10707520|NCT02620683|11872168|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10707521|NCT02620683|11872169|FG001|NOT COMPLETED|Washout (2 Weeks)||0
10707522|NCT02620683|11872168|FG000|STARTED|Second Intervention (Visit 2)||12
10707523|NCT02620683|11872169|FG001|STARTED|Second Intervention (Visit 2)||11
10707524|NCT02620683|11872168|FG000|COMPLETED|Second Intervention (Visit 2)||12
10707525|NCT02620683|11872169|FG001|COMPLETED|Second Intervention (Visit 2)||11
10707526|NCT02620683|11872168|FG000|NOT COMPLETED|Second Intervention (Visit 2)||0
10707527|NCT02620683|11872169|FG001|NOT COMPLETED|Second Intervention (Visit 2)||0
10707528|NCT02620774|11872176|FG000|STARTED|Overall Study||10
10707529|NCT02620774|11872177|FG001|STARTED|Overall Study||6
10707530|NCT02620774|11872176|FG000|COMPLETED|Overall Study||10
10707531|NCT02620774|11872177|FG001|COMPLETED|Overall Study||6
10707532|NCT02620774|11872176|FG000|NOT COMPLETED|Overall Study||0
10707533|NCT02620774|11872177|FG001|NOT COMPLETED|Overall Study||0
10707534|NCT02620787|11872185|FG000|STARTED|Overall Study||12
10707535|NCT02620787|11872186|FG001|STARTED|Overall Study||6
10707536|NCT02620787|11872185|FG000|COMPLETED|Overall Study||10
10707537|NCT02620787|11872186|FG001|COMPLETED|Overall Study||6
10707538|NCT02620787|11872185|FG000|NOT COMPLETED|Overall Study||2
10707539|NCT02620787|11872186|FG001|NOT COMPLETED|Overall Study||0
10707540|NCT02620878|11872192|FG000|STARTED|Overall Study||16
10707541|NCT02620878|11872193|FG001|STARTED|Overall Study||16
10707542|NCT02620878|11872192|FG000|COMPLETED|Overall Study||16
10707543|NCT02620878|11872193|FG001|COMPLETED|Overall Study||16
10707544|NCT02620878|11872192|FG000|NOT COMPLETED|Overall Study||0
10707545|NCT02620878|11872193|FG001|NOT COMPLETED|Overall Study||0
10707546|NCT02620904|11872201|FG000|STARTED|Overall Study||4
10707547|NCT02620904|11872202|FG001|STARTED|Overall Study||5
10707548|NCT02620904|11872201|FG000|COMPLETED|Overall Study||4
10707549|NCT02620904|11872202|FG001|COMPLETED|Overall Study||5
10707550|NCT02620904|11872201|FG000|NOT COMPLETED|Overall Study||0
10334880|NCT00346775|11471367|FG001|COMPLETED|Period 2: Washout Period (7 Days)||45
10334881|NCT00346775|11471366|FG000|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
10334882|NCT00346775|11471367|FG001|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
10649651|NCT02163902|11809843|FG001|STARTED|Overall Study||111
10649652|NCT02163902|11809842|FG000|COMPLETED|Overall Study||102
10649653|NCT02163902|11809843|FG001|COMPLETED|Overall Study||98
10649654|NCT02163902|11809842|FG000|NOT COMPLETED|Overall Study||11
10649655|NCT02163902|11809843|FG001|NOT COMPLETED|Overall Study||13
10649656|NCT02163915|11809854|FG000|STARTED|Overall Study||10
10649657|NCT02163915|11809855|FG001|STARTED|Overall Study||8
10649658|NCT02163915|11809856|FG002|STARTED|Overall Study||10
10649659|NCT02163915|11809857|FG003|STARTED|Overall Study||9
10649660|NCT02163915|11809858|FG004|STARTED|Overall Study||10
10649661|NCT02163915|11809854|FG000|COMPLETED|Overall Study||7
10649662|NCT02163915|11809855|FG001|COMPLETED|Overall Study||8
10649663|NCT02163915|11809856|FG002|COMPLETED|Overall Study||8
10649664|NCT02163915|11809857|FG003|COMPLETED|Overall Study||6
10649665|NCT02163915|11809858|FG004|COMPLETED|Overall Study||6
10649666|NCT02163915|11809854|FG000|NOT COMPLETED|Overall Study||3
10649667|NCT02163915|11809855|FG001|NOT COMPLETED|Overall Study||0
10649668|NCT02163915|11809856|FG002|NOT COMPLETED|Overall Study||2
10649669|NCT02163915|11809857|FG003|NOT COMPLETED|Overall Study||3
10649670|NCT02163915|11809858|FG004|NOT COMPLETED|Overall Study||4
10649671|NCT02163967|11809874|FG000|STARTED|First Intervention/ Day 1||4
10649672|NCT02163967|11809875|FG001|STARTED|First Intervention/ Day 1||4
10649673|NCT02163967|11809876|FG002|STARTED|First Intervention/ Day 1||3
10707551|NCT02620904|11872202|FG001|NOT COMPLETED|Overall Study||0
10707552|NCT02620917|11872208|FG000|STARTED|Overall Study||6623
10707553|NCT02620917|11872208|FG000|COMPLETED|Overall Study||6623
10707554|NCT02620917|11872208|FG000|NOT COMPLETED|Overall Study||0
10707555|NCT02621034|11872217|FG000|STARTED|Overall Study||53
10707556|NCT02621034|11872218|FG001|STARTED|Overall Study||52
10707557|NCT02621034|11872219|FG002|STARTED|Overall Study||55
10707558|NCT02621034|11872217|FG000|COMPLETED|Overall Study||50
10707559|NCT02621034|11872218|FG001|COMPLETED|Overall Study||50
10707560|NCT02621034|11872219|FG002|COMPLETED|Overall Study||50
10707561|NCT02621034|11872217|FG000|NOT COMPLETED|Overall Study||3
10707562|NCT02621034|11872218|FG001|NOT COMPLETED|Overall Study||2
10707563|NCT02621034|11872219|FG002|NOT COMPLETED|Overall Study||5
10707564|NCT02621047|11872232|FG000|STARTED|Overall Study||8
10649674|NCT02163967|11809877|FG003|STARTED|First Intervention/ Day 1||4
10649675|NCT02163967|11809878|FG004|STARTED|First Intervention/ Day 1||3
10649676|NCT02163967|11809879|FG005|STARTED|First Intervention/ Day 1||3
10649677|NCT02163967|11809874|FG000|COMPLETED|First Intervention/ Day 1||4
10649678|NCT02163967|11809875|FG001|COMPLETED|First Intervention/ Day 1||4
10649679|NCT02163967|11809876|FG002|COMPLETED|First Intervention/ Day 1||3
10649680|NCT02163967|11809877|FG003|COMPLETED|First Intervention/ Day 1||4
10649681|NCT02163967|11809878|FG004|COMPLETED|First Intervention/ Day 1||3
10649682|NCT02163967|11809879|FG005|COMPLETED|First Intervention/ Day 1||3
10649683|NCT02163967|11809874|FG000|NOT COMPLETED|First Intervention/ Day 1||0
10649684|NCT02163967|11809875|FG001|NOT COMPLETED|First Intervention/ Day 1||0
10707565|NCT02621047|11872233|FG001|STARTED|Overall Study||8
10707566|NCT02621047|11872234|FG002|STARTED|Overall Study||12
10707567|NCT02621047|11872232|FG000|COMPLETED|Overall Study||8
10707568|NCT02621047|11872233|FG001|COMPLETED|Overall Study||8
10707569|NCT02621047|11872234|FG002|COMPLETED|Overall Study||11
10707570|NCT02621047|11872232|FG000|NOT COMPLETED|Overall Study||0
10707571|NCT02621047|11872233|FG001|NOT COMPLETED|Overall Study||0
10707572|NCT02621047|11872234|FG002|NOT COMPLETED|Overall Study||1
10707573|NCT02621060|11872245|FG000|STARTED|Overall Study||15
10707574|NCT02621060|11872246|FG001|STARTED|Overall Study||15
10707575|NCT02621060|11872245|FG000|COMPLETED|Overall Study||12
10707576|NCT02621060|11872246|FG001|COMPLETED|Overall Study||14
10707577|NCT02621060|11872245|FG000|NOT COMPLETED|Overall Study||3
10707578|NCT02621060|11872246|FG001|NOT COMPLETED|Overall Study||1
10707579|NCT02621073|11872254|FG000|STARTED|Overall Study||4
10707580|NCT02621073|11872255|FG001|STARTED|Overall Study||3
10707581|NCT02621073|11872254|FG000|COMPLETED|Overall Study||1
10707582|NCT02621073|11872255|FG001|COMPLETED|Overall Study||0
10707583|NCT02621073|11872254|FG000|NOT COMPLETED|Overall Study||3
10707584|NCT02621073|11872255|FG001|NOT COMPLETED|Overall Study||3
10707585|NCT02621463|11872261|FG000|STARTED|Overall Study||29
10707586|NCT02621463|11872261|FG000|COMPLETED|Overall Study||29
10707587|NCT02621463|11872261|FG000|NOT COMPLETED|Overall Study||0
10707588|NCT02621619|11872267|FG000|STARTED|Overall Study||80
10707589|NCT02621619|11872268|FG001|STARTED|Overall Study||79
10707590|NCT02621619|11872267|FG000|COMPLETED|Overall Study||80
10707591|NCT02621619|11872268|FG001|COMPLETED|Overall Study||79
10707592|NCT02621619|11872267|FG000|NOT COMPLETED|Overall Study||0
10707593|NCT02621619|11872268|FG001|NOT COMPLETED|Overall Study||0
10707594|NCT02621892|11872276|FG000|STARTED|Treatment Period||307
10707595|NCT02621892|11872277|FG001|STARTED|Treatment Period||299
10649685|NCT02163967|11809876|FG002|NOT COMPLETED|First Intervention/ Day 1||0
10649686|NCT02163967|11809877|FG003|NOT COMPLETED|First Intervention/ Day 1||0
10649687|NCT02163967|11809878|FG004|NOT COMPLETED|First Intervention/ Day 1||0
10649688|NCT02163967|11809879|FG005|NOT COMPLETED|First Intervention/ Day 1||0
10649689|NCT02163967|11809874|FG000|STARTED|Second Intevention/Day 2||3
10649690|NCT02163967|11809875|FG001|STARTED|Second Intevention/Day 2||4
10649691|NCT02163967|11809876|FG002|STARTED|Second Intevention/Day 2||2
10649692|NCT02163967|11809877|FG003|STARTED|Second Intevention/Day 2||4
10649693|NCT02163967|11809878|FG004|STARTED|Second Intevention/Day 2||3
10649694|NCT02163967|11809879|FG005|STARTED|Second Intevention/Day 2||3
10649695|NCT02163967|11809874|FG000|COMPLETED|Second Intevention/Day 2||3
10649696|NCT02163967|11809875|FG001|COMPLETED|Second Intevention/Day 2||4
10649697|NCT02163967|11809876|FG002|COMPLETED|Second Intevention/Day 2||2
10649698|NCT02163967|11809877|FG003|COMPLETED|Second Intevention/Day 2||4
10649699|NCT02163967|11809878|FG004|COMPLETED|Second Intevention/Day 2||3
10649700|NCT02163967|11809879|FG005|COMPLETED|Second Intevention/Day 2||3
10649701|NCT02163967|11809874|FG000|NOT COMPLETED|Second Intevention/Day 2||0
10649702|NCT02163967|11809875|FG001|NOT COMPLETED|Second Intevention/Day 2||0
10649703|NCT02163967|11809876|FG002|NOT COMPLETED|Second Intevention/Day 2||0
10809569|NCT03831191|11971476|FG007|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
10809570|NCT03831191|11971477|FG008|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
10809571|NCT03831191|11971478|FG009|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
10809572|NCT03831191|11971479|FG010|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
10809573|NCT03831191|11971480|FG011|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
10809574|NCT03831191|11971481|FG012|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
10809575|NCT03831191|11971482|FG013|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
10809576|NCT03831191|11971483|FG014|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
10809577|NCT03831191|11971469|FG000|COMPLETED|Induction Period (16 Weeks)||10
10809578|NCT03831191|11971470|FG001|COMPLETED|Induction Period (16 Weeks)||14
10809579|NCT03831191|11971471|FG002|COMPLETED|Induction Period (16 Weeks)||13
10809580|NCT03831191|11971472|FG003|COMPLETED|Induction Period (16 Weeks)||11
10809581|NCT03831191|11971473|FG004|COMPLETED|Induction Period (16 Weeks)||0
10809582|NCT03831191|11971474|FG005|COMPLETED|Induction Period (16 Weeks)||0
10809583|NCT03831191|11971475|FG006|COMPLETED|Induction Period (16 Weeks)||0
10809584|NCT03831191|11971476|FG007|COMPLETED|Induction Period (16 Weeks)||0
10809585|NCT03831191|11971477|FG008|COMPLETED|Induction Period (16 Weeks)||0
10809586|NCT03831191|11971478|FG009|COMPLETED|Induction Period (16 Weeks)||0
10809587|NCT03831191|11971479|FG010|COMPLETED|Induction Period (16 Weeks)||0
10809588|NCT03831191|11971480|FG011|COMPLETED|Induction Period (16 Weeks)||0
10809589|NCT03831191|11971481|FG012|COMPLETED|Induction Period (16 Weeks)||0
10809590|NCT03831191|11971482|FG013|COMPLETED|Induction Period (16 Weeks)||0
10809591|NCT03831191|11971483|FG014|COMPLETED|Induction Period (16 Weeks)||0
10649704|NCT02163967|11809877|FG003|NOT COMPLETED|Second Intevention/Day 2||0
10649705|NCT02163967|11809878|FG004|NOT COMPLETED|Second Intevention/Day 2||0
10649706|NCT02163967|11809879|FG005|NOT COMPLETED|Second Intevention/Day 2||0
10649707|NCT02163967|11809874|FG000|STARTED|Third Intervention/Day 3||3
10649708|NCT02163967|11809875|FG001|STARTED|Third Intervention/Day 3||3
10649709|NCT02163967|11809876|FG002|STARTED|Third Intervention/Day 3||2
10649710|NCT02163967|11809877|FG003|STARTED|Third Intervention/Day 3||4
10334883|NCT00346775|11471366|FG000|STARTED|Period 3: Intervention Period 2||44
10649711|NCT02163967|11809878|FG004|STARTED|Third Intervention/Day 3||3
10649712|NCT02163967|11809879|FG005|STARTED|Third Intervention/Day 3||3
10649713|NCT02163967|11809874|FG000|COMPLETED|Third Intervention/Day 3||3
10649714|NCT02163967|11809875|FG001|COMPLETED|Third Intervention/Day 3||3
10649715|NCT02163967|11809876|FG002|COMPLETED|Third Intervention/Day 3||2
10649716|NCT02163967|11809877|FG003|COMPLETED|Third Intervention/Day 3||4
10707596|NCT02621892|11872276|FG000|COMPLETED|Treatment Period||261
10707597|NCT02621892|11872277|FG001|COMPLETED|Treatment Period||272
10707598|NCT02621892|11872276|FG000|NOT COMPLETED|Treatment Period||46
10707599|NCT02621892|11872277|FG001|NOT COMPLETED|Treatment Period||27
10707600|NCT02621892|11872276|FG000|STARTED|Randomized Withdrawal Period||261
10707601|NCT02621892|11872277|FG001|STARTED|Randomized Withdrawal Period||272
10707602|NCT02621892|11872276|FG000|COMPLETED|Randomized Withdrawal Period||250
10707603|NCT02621892|11872277|FG001|COMPLETED|Randomized Withdrawal Period||260
10707604|NCT02621892|11872276|FG000|NOT COMPLETED|Randomized Withdrawal Period||11
10707605|NCT02621892|11872277|FG001|NOT COMPLETED|Randomized Withdrawal Period||12
10707606|NCT02621931|11872286|FG000|STARTED|Overall Study||375
10707607|NCT02621931|11872287|FG001|STARTED|Overall Study||376
10707608|NCT02621931|11872288|FG002|STARTED|Overall Study||379
10707609|NCT02621931|11872286|FG000|Safety and ITT Populations|Overall Study||375
10707610|NCT02621931|11872287|FG001|Safety and ITT Populations|Overall Study||376
10707611|NCT02621931|11872288|FG002|Safety and ITT Populations|Overall Study||379
10707612|NCT02621931|11872286|FG000|Full Analysis Set|Overall Study||371
10707613|NCT02621931|11872287|FG001|Full Analysis Set|Overall Study||375
10707614|NCT02621931|11872288|FG002|Full Analysis Set|Overall Study||375
10707615|NCT02621931|11872286|FG000|COMPLETED|Overall Study||342
10707616|NCT02621931|11872287|FG001|COMPLETED|Overall Study||349
10649717|NCT02163967|11809878|FG004|COMPLETED|Third Intervention/Day 3||3
10707617|NCT02621931|11872288|FG002|COMPLETED|Overall Study||343
10707618|NCT02621931|11872286|FG000|NOT COMPLETED|Overall Study||33
10649718|NCT02163967|11809879|FG005|COMPLETED|Third Intervention/Day 3||3
10649719|NCT02163967|11809874|FG000|NOT COMPLETED|Third Intervention/Day 3||0
10649720|NCT02163967|11809875|FG001|NOT COMPLETED|Third Intervention/Day 3||0
10649721|NCT02163967|11809876|FG002|NOT COMPLETED|Third Intervention/Day 3||0
10649722|NCT02163967|11809877|FG003|NOT COMPLETED|Third Intervention/Day 3||0
10649723|NCT02163967|11809878|FG004|NOT COMPLETED|Third Intervention/Day 3||0
10649724|NCT02163967|11809879|FG005|NOT COMPLETED|Third Intervention/Day 3||0
10649725|NCT02163993|11809895|FG000|STARTED|Treatment Period||138
10649726|NCT02163993|11809896|FG001|STARTED|Treatment Period||68
10649727|NCT02163993|11809897|FG002|STARTED|Treatment Period||68
10649728|NCT02163993|11809898|FG003|STARTED|Treatment Period||71
10334884|NCT00346775|11471367|FG001|STARTED|Period 3: Intervention Period 2||45
10334885|NCT00346775|11471366|FG000|COMPLETED|Period 3: Intervention Period 2||44
10334886|NCT00346775|11471367|FG001|COMPLETED|Period 3: Intervention Period 2||45
10334887|NCT00346775|11471366|FG000|NOT COMPLETED|Period 3: Intervention Period 2||0
10334888|NCT00346775|11471367|FG001|NOT COMPLETED|Period 3: Intervention Period 2||0
10334889|NCT00346905|11471377|FG000|STARTED|Overall Study||16
10334890|NCT00346905|11471377|FG000|COMPLETED|Overall Study||12
10649729|NCT02163993|11809899|FG004|STARTED|Treatment Period||69
10649730|NCT02163993|11809895|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||137
10649731|NCT02163993|11809896|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||68
10649732|NCT02163993|11809897|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||68
10649733|NCT02163993|11809898|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||70
10649734|NCT02163993|11809899|FG004|Received at Least 1 Dose of Study Drug|Treatment Period||67
10649735|NCT02163993|11809895|FG000|COMPLETED|Treatment Period||126
10649736|NCT02163993|11809896|FG001|COMPLETED|Treatment Period||59
10649737|NCT02163993|11809897|FG002|COMPLETED|Treatment Period||66
10649738|NCT02163993|11809898|FG003|COMPLETED|Treatment Period||62
10649739|NCT02163993|11809899|FG004|COMPLETED|Treatment Period||62
10649740|NCT02163993|11809895|FG000|NOT COMPLETED|Treatment Period||12
10649741|NCT02163993|11809896|FG001|NOT COMPLETED|Treatment Period||9
10649742|NCT02163993|11809897|FG002|NOT COMPLETED|Treatment Period||2
10649743|NCT02163993|11809898|FG003|NOT COMPLETED|Treatment Period||9
10649744|NCT02163993|11809899|FG004|NOT COMPLETED|Treatment Period||7
10649745|NCT02163993|11809895|FG000|STARTED|Post-treatment Period|One participant discontinued after Treatment Period. Did not enter into Post-treatment Period.|125
10649746|NCT02163993|11809896|FG001|STARTED|Post-treatment Period|Participants who discontinued or completed the Treatment Period entered the Post-treatment period.|61
10649747|NCT02163993|11809897|FG002|STARTED|Post-treatment Period||66
10649748|NCT02163993|11809898|FG003|STARTED|Post-treatment Period|Participants who discontinued or completed the Treatment Period entered the Post-treatment period.|63
10649749|NCT02163993|11809899|FG004|STARTED|Post-treatment Period|Participants who discontinued or completed the Treatment Period entered the Post-treatment period.|65
10649750|NCT02163993|11809895|FG000|COMPLETED|Post-treatment Period||121
10649751|NCT02163993|11809896|FG001|COMPLETED|Post-treatment Period||55
10649752|NCT02163993|11809897|FG002|COMPLETED|Post-treatment Period||62
10649753|NCT02163993|11809898|FG003|COMPLETED|Post-treatment Period||61
10649754|NCT02163993|11809899|FG004|COMPLETED|Post-treatment Period||62
10649755|NCT02163993|11809895|FG000|NOT COMPLETED|Post-treatment Period||4
10649756|NCT02163993|11809896|FG001|NOT COMPLETED|Post-treatment Period||6
10649757|NCT02163993|11809897|FG002|NOT COMPLETED|Post-treatment Period||4
10649758|NCT02163993|11809898|FG003|NOT COMPLETED|Post-treatment Period||2
10649759|NCT02163993|11809899|FG004|NOT COMPLETED|Post-treatment Period||3
10707619|NCT02621931|11872287|FG001|NOT COMPLETED|Overall Study||27
10707620|NCT02621931|11872288|FG002|NOT COMPLETED|Overall Study||36
10334891|NCT00346905|11471377|FG000|NOT COMPLETED|Overall Study||4
10334892|NCT00347009|11471381|FG000|STARTED|Overall Study||155
10649760|NCT02164240|11809920|FG000|STARTED|Overall Study||4
10649761|NCT02164240|11809921|FG001|STARTED|Overall Study||5
10649762|NCT02164240|11809922|FG002|STARTED|Overall Study||4
10649763|NCT02164240|11809920|FG000|COMPLETED|Overall Study||4
10649764|NCT02164240|11809921|FG001|COMPLETED|Overall Study||5
10649765|NCT02164240|11809922|FG002|COMPLETED|Overall Study||4
10649766|NCT02164240|11809920|FG000|NOT COMPLETED|Overall Study||0
10649767|NCT02164240|11809921|FG001|NOT COMPLETED|Overall Study||0
10649768|NCT02164240|11809922|FG002|NOT COMPLETED|Overall Study||0
10649769|NCT02164318|11809935|FG000|STARTED|Overall Study||4
10649770|NCT02164318|11809936|FG001|STARTED|Overall Study||3
10649771|NCT02164318|11809937|FG002|STARTED|Overall Study||1
10649772|NCT02164318|11809938|FG003|STARTED|Overall Study||3
10649773|NCT02164318|11809935|FG000|COMPLETED|Overall Study||4
10649774|NCT02164318|11809936|FG001|COMPLETED|Overall Study||2
10649775|NCT02164318|11809937|FG002|COMPLETED|Overall Study||1
10649776|NCT02164318|11809938|FG003|COMPLETED|Overall Study||2
10649777|NCT02164318|11809935|FG000|NOT COMPLETED|Overall Study||0
10649778|NCT02164318|11809936|FG001|NOT COMPLETED|Overall Study||1
10649779|NCT02164318|11809937|FG002|NOT COMPLETED|Overall Study||0
10649780|NCT02164318|11809938|FG003|NOT COMPLETED|Overall Study||1
10649781|NCT02164383|11809950|FG000|STARTED|Overall Study||16
10649782|NCT02164383|11809951|FG001|STARTED|Overall Study||14
10707621|NCT02621983|11872300|FG000|STARTED|Overall Study||21
10707622|NCT02621983|11872301|FG001|STARTED|Overall Study||17
10707623|NCT02621983|11872300|FG000|COMPLETED|Overall Study||9
10707624|NCT02621983|11872301|FG001|COMPLETED|Overall Study||6
10707625|NCT02621983|11872300|FG000|NOT COMPLETED|Overall Study||12
10707626|NCT02621983|11872301|FG001|NOT COMPLETED|Overall Study||11
10707627|NCT02622074|11872313|FG000|STARTED|Overall Study||10
10707628|NCT02622074|11872314|FG001|STARTED|Overall Study||10
10707629|NCT02622074|11872315|FG002|STARTED|Overall Study||10
10707630|NCT02622074|11872316|FG003|STARTED|Overall Study||10
10707631|NCT02622074|11872317|FG004|STARTED|Overall Study||10
10707632|NCT02622074|11872318|FG005|STARTED|Overall Study||10
10457722|NCT01011868|11605538|FG001|NOT COMPLETED|After Week 18 Follow-up||16
10457723|NCT01011868|11605539|FG002|NOT COMPLETED|After Week 18 Follow-up||26
10457724|NCT01011868|11605537|FG000|STARTED|After Week 78 Follow-up||170
10457725|NCT01011868|11605538|FG001|STARTED|After Week 78 Follow-up||169
10457726|NCT01011868|11605539|FG002|STARTED|After Week 78 Follow-up||155
10457727|NCT01011868|11605537|FG000|COMPLETED|After Week 78 Follow-up||118
10457728|NCT01011868|11605538|FG001|COMPLETED|After Week 78 Follow-up||131
10457729|NCT01011868|11605539|FG002|COMPLETED|After Week 78 Follow-up||111
10457730|NCT01011868|11605537|FG000|NOT COMPLETED|After Week 78 Follow-up||52
10457731|NCT01011868|11605538|FG001|NOT COMPLETED|After Week 78 Follow-up||38
10457732|NCT01011868|11605539|FG002|NOT COMPLETED|After Week 78 Follow-up||44
10457733|NCT01011894|11605547|FG000|STARTED|Overall Study||26
10457734|NCT01011894|11605547|FG000|COMPLETED|Overall Study||26
10457735|NCT01011894|11605547|FG000|NOT COMPLETED|Overall Study||0
10457736|NCT01011907|11605553|FG000|STARTED|Overall Study||31
10457737|NCT01011907|11605554|FG001|STARTED|Overall Study||33
10457738|NCT01011907|11605553|FG000|COMPLETED|Overall Study||17
10457739|NCT01011907|11605554|FG001|COMPLETED|Overall Study||18
10457740|NCT01011907|11605553|FG000|NOT COMPLETED|Overall Study||14
10457741|NCT01011907|11605554|FG001|NOT COMPLETED|Overall Study||15
10707633|NCT02622074|11872313|FG000|COMPLETED|Overall Study||6
10707634|NCT02622074|11872314|FG001|COMPLETED|Overall Study||9
10457742|NCT01011933|11605560|FG000|STARTED|Overall Study|total enrolled|54
10707635|NCT02622074|11872315|FG002|COMPLETED|Overall Study||10
10707636|NCT02622074|11872316|FG003|COMPLETED|Overall Study||9
10707637|NCT02622074|11872317|FG004|COMPLETED|Overall Study||9
10707638|NCT02622074|11872318|FG005|COMPLETED|Overall Study||10
10707639|NCT02622074|11872313|FG000|NOT COMPLETED|Overall Study||4
10707640|NCT02622074|11872314|FG001|NOT COMPLETED|Overall Study||1
10809592|NCT03831191|11971469|FG000|NOT COMPLETED|Induction Period (16 Weeks)||23
10809593|NCT03831191|11971470|FG001|NOT COMPLETED|Induction Period (16 Weeks)||21
10809594|NCT03831191|11971471|FG002|NOT COMPLETED|Induction Period (16 Weeks)||21
10809595|NCT03831191|11971472|FG003|NOT COMPLETED|Induction Period (16 Weeks)||23
10809596|NCT03831191|11971473|FG004|NOT COMPLETED|Induction Period (16 Weeks)||0
10707641|NCT02622074|11872315|FG002|NOT COMPLETED|Overall Study||0
10707642|NCT02622074|11872316|FG003|NOT COMPLETED|Overall Study||1
10707643|NCT02622074|11872317|FG004|NOT COMPLETED|Overall Study||1
10707644|NCT02622074|11872318|FG005|NOT COMPLETED|Overall Study||0
10707645|NCT02622113|11872334|FG000|STARTED|Overall Study||67
10707646|NCT02622113|11872335|FG001|STARTED|Overall Study||76
10707647|NCT02622113|11872334|FG000|COMPLETED|Overall Study||62
10707648|NCT02622113|11872335|FG001|COMPLETED|Overall Study||66
10707649|NCT02622113|11872334|FG000|NOT COMPLETED|Overall Study||5
10707650|NCT02622113|11872335|FG001|NOT COMPLETED|Overall Study||10
10334893|NCT00347009|11471381|FG000|COMPLETED|Overall Study||128
10334894|NCT00347009|11471381|FG000|NOT COMPLETED|Overall Study||27
10334895|NCT00347022|11471387|FG000|STARTED|Overall Study||74
10334896|NCT00347022|11471388|FG001|STARTED|Overall Study||71
10334897|NCT00347022|11471387|FG000|COMPLETED|Overall Study||62
10334898|NCT00347022|11471388|FG001|COMPLETED|Overall Study||66
10334899|NCT00347022|11471387|FG000|NOT COMPLETED|Overall Study||12
10334900|NCT00347022|11471388|FG001|NOT COMPLETED|Overall Study||5
10334901|NCT00347269|11471396|FG000|STARTED|Overall Study||503
10334902|NCT00347269|11471397|FG001|STARTED|Overall Study||501
10334903|NCT00347269|11471396|FG000|COMPLETED|Overall Study||409
10334904|NCT00347269|11471397|FG001|COMPLETED|Overall Study||395
10334905|NCT00347269|11471396|FG000|NOT COMPLETED|Overall Study||94
10334906|NCT00347269|11471397|FG001|NOT COMPLETED|Overall Study||106
10334907|NCT00347308|11471403|FG000|STARTED|Overall Study||40
10334908|NCT00347308|11471403|FG000|COMPLETED|Overall Study||40
10334909|NCT00347308|11471403|FG000|NOT COMPLETED|Overall Study||0
10334910|NCT00347360|11471422|FG000|STARTED|Overall Study||44
10334911|NCT00347360|11471423|FG001|STARTED|Overall Study||43
10707651|NCT02622178|11872344|FG000|STARTED|Overall Study||42
10707652|NCT02622178|11872345|FG001|STARTED|Overall Study||45
10334912|NCT00347360|11471424|FG002|STARTED|Overall Study||43
10334913|NCT00347360|11471425|FG003|STARTED|Overall Study||43
10707653|NCT02622178|11872346|FG002|STARTED|Overall Study||49
10707654|NCT02622178|11872344|FG000|COMPLETED|Overall Study||42
10707655|NCT02622178|11872345|FG001|COMPLETED|Overall Study||45
10707656|NCT02622178|11872346|FG002|COMPLETED|Overall Study||49
10707657|NCT02622178|11872344|FG000|NOT COMPLETED|Overall Study||0
10707658|NCT02622178|11872345|FG001|NOT COMPLETED|Overall Study||0
10707659|NCT02622178|11872346|FG002|NOT COMPLETED|Overall Study||0
10707660|NCT02622191|11872357|FG000|STARTED|Overall Study||19
10707661|NCT02622191|11872358|FG001|STARTED|Overall Study||14
10707662|NCT02622191|11872357|FG000|COMPLETED|Overall Study||19
10707663|NCT02622191|11872358|FG001|COMPLETED|Overall Study||14
10707664|NCT02622191|11872357|FG000|NOT COMPLETED|Overall Study||0
10707665|NCT02622191|11872358|FG001|NOT COMPLETED|Overall Study||0
10707666|NCT02622321|11872369|FG000|STARTED|Overall Study||35
10707667|NCT02622321|11872370|FG001|STARTED|Overall Study||18
10707668|NCT02622321|11872371|FG002|STARTED|Overall Study||49
10707669|NCT02622321|11872372|FG003|STARTED|Overall Study||11
10707670|NCT02622321|11872369|FG000|Received at Least One Dose of Treatment|Overall Study|1 participant withdrew prior to study Day 1.|34
10707671|NCT02622321|11872370|FG001|Received at Least One Dose of Treatment|Overall Study||18
10707672|NCT02622321|11872371|FG002|Received at Least One Dose of Treatment|Overall Study||49
10707673|NCT02622321|11872372|FG003|Received at Least One Dose of Treatment|Overall Study||11
10707674|NCT02622321|11872369|FG000|Completed 24 Weeks in the Study|Overall Study||31
10707675|NCT02622321|11872370|FG001|Completed 24 Weeks in the Study|Overall Study|After 24 weeks, all 18 participants in Arm B switched to receive emicizumab prophylaxis.|18
10707676|NCT02622321|11872371|FG002|Completed 24 Weeks in the Study|Overall Study||49
10707677|NCT02622321|11872372|FG003|Completed 24 Weeks in the Study|Overall Study||11
10707678|NCT02622321|11872369|FG000|Dose Up-Titrated to 3 mg/kg QW|Overall Study||2
10707679|NCT02622321|11872370|FG001|Dose Up-Titrated to 3 mg/kg QW|Overall Study||0
10707680|NCT02622321|11872371|FG002|Dose Up-Titrated to 3 mg/kg QW|Overall Study||3
10707681|NCT02622321|11872372|FG003|Dose Up-Titrated to 3 mg/kg QW|Overall Study||2
10707682|NCT02622321|11872369|FG000|COMPLETED|Overall Study||32
10707683|NCT02622321|11872370|FG001|COMPLETED|Overall Study||18
10707684|NCT02622321|11872371|FG002|COMPLETED|Overall Study||48
10707685|NCT02622321|11872372|FG003|COMPLETED|Overall Study||11
10707686|NCT02622321|11872369|FG000|NOT COMPLETED|Overall Study||3
10707687|NCT02622321|11872370|FG001|NOT COMPLETED|Overall Study||0
10707688|NCT02622321|11872371|FG002|NOT COMPLETED|Overall Study||1
10707689|NCT02622321|11872372|FG003|NOT COMPLETED|Overall Study||0
10707690|NCT02622568|11872398|FG000|STARTED|Overall Study||14
10707691|NCT02622568|11872399|FG001|STARTED|Overall Study||14
10707692|NCT02622568|11872398|FG000|COMPLETED|Overall Study||9
10707693|NCT02622568|11872399|FG001|COMPLETED|Overall Study||9
10707694|NCT02622568|11872398|FG000|NOT COMPLETED|Overall Study||5
10707695|NCT02622568|11872399|FG001|NOT COMPLETED|Overall Study||5
10707696|NCT02622724|11872407|FG000|STARTED|Overall Study||144
10707697|NCT02622724|11872408|FG001|STARTED|Overall Study||152
10707698|NCT02622724|11872407|FG000|Subjects Randomised|Overall Study||146
10707699|NCT02622724|11872408|FG001|Subjects Randomised|Overall Study||155
10707700|NCT02622724|11872407|FG000|Short-Term Follow-Up (Day 28)|Overall Study||105
10707701|NCT02622724|11872408|FG001|Short-Term Follow-Up (Day 28)|Overall Study||115
10707702|NCT02622724|11872407|FG000|Long-Term Follow-Up (Day 90)|Overall Study||96
10707703|NCT02622724|11872408|FG001|Long-Term Follow-Up (Day 90)|Overall Study||101
10334914|NCT00347360|11471426|FG004|STARTED|Overall Study||44
10334915|NCT00347360|11471427|FG005|STARTED|Overall Study||44
10334916|NCT00347360|11471428|FG006|STARTED|Overall Study||44
10334917|NCT00347360|11471429|FG007|STARTED|Overall Study||43
10334918|NCT00347360|11471430|FG008|STARTED|Overall Study||44
10334919|NCT00347360|11471431|FG009|STARTED|Overall Study||44
10334920|NCT00347360|11471432|FG010|STARTED|Overall Study||44
10334921|NCT00347360|11471433|FG011|STARTED|Overall Study||43
10334922|NCT00347360|11471434|FG012|STARTED|Overall Study||44
10334923|NCT00347360|11471435|FG013|STARTED|Overall Study||44
10334924|NCT00347360|11471436|FG014|STARTED|Overall Study||43
10334925|NCT00347360|11471422|FG000|COMPLETED|Overall Study||39
10334926|NCT00347360|11471423|FG001|COMPLETED|Overall Study||35
10334927|NCT00347360|11471424|FG002|COMPLETED|Overall Study||37
10334928|NCT00347360|11471425|FG003|COMPLETED|Overall Study||30
10334929|NCT00347360|11471426|FG004|COMPLETED|Overall Study||39
10334930|NCT00347360|11471427|FG005|COMPLETED|Overall Study||36
10334931|NCT00347360|11471428|FG006|COMPLETED|Overall Study||37
10334932|NCT00347360|11471429|FG007|COMPLETED|Overall Study||40
10334933|NCT00347360|11471430|FG008|COMPLETED|Overall Study||38
10334934|NCT00347360|11471431|FG009|COMPLETED|Overall Study||35
10334935|NCT00347360|11471432|FG010|COMPLETED|Overall Study||39
10334936|NCT00347360|11471433|FG011|COMPLETED|Overall Study||37
10334937|NCT00347360|11471434|FG012|COMPLETED|Overall Study||34
10334938|NCT00347360|11471435|FG013|COMPLETED|Overall Study||36
10334939|NCT00347360|11471436|FG014|COMPLETED|Overall Study||39
10334940|NCT00347360|11471422|FG000|NOT COMPLETED|Overall Study||5
10334941|NCT00347360|11471423|FG001|NOT COMPLETED|Overall Study||8
10334942|NCT00347360|11471424|FG002|NOT COMPLETED|Overall Study||6
10334943|NCT00347360|11471425|FG003|NOT COMPLETED|Overall Study||13
10334944|NCT00347360|11471426|FG004|NOT COMPLETED|Overall Study||5
10334945|NCT00347360|11471427|FG005|NOT COMPLETED|Overall Study||8
10707704|NCT02622724|11872407|FG000|Long-Term Follow-Up (Day 180)|Overall Study||73
10707705|NCT02622724|11872408|FG001|Long-Term Follow-Up (Day 180)|Overall Study||74
10707706|NCT02622724|11872407|FG000|COMPLETED|Overall Study||51
10707707|NCT02622724|11872408|FG001|COMPLETED|Overall Study||49
10334946|NCT00347360|11471428|FG006|NOT COMPLETED|Overall Study||7
10334947|NCT00347360|11471429|FG007|NOT COMPLETED|Overall Study||3
10334948|NCT00347360|11471430|FG008|NOT COMPLETED|Overall Study||6
10334949|NCT00347360|11471431|FG009|NOT COMPLETED|Overall Study||9
10334950|NCT00347360|11471432|FG010|NOT COMPLETED|Overall Study||5
10334951|NCT00347360|11471433|FG011|NOT COMPLETED|Overall Study||6
10334952|NCT00347360|11471434|FG012|NOT COMPLETED|Overall Study||10
10334953|NCT00347360|11471435|FG013|NOT COMPLETED|Overall Study||8
10334954|NCT00347360|11471436|FG014|NOT COMPLETED|Overall Study||4
10334955|NCT00347438|11471468|FG000|STARTED|Overall Study||18
10334956|NCT00347438|11471468|FG000|COMPLETED|Overall Study||16
10334957|NCT00347438|11471468|FG000|NOT COMPLETED|Overall Study||2
10334958|NCT00347776|11471475|FG000|STARTED|1.5 Month Follow-up||484
10334959|NCT00347776|11471476|FG001|STARTED|1.5 Month Follow-up||483
10334960|NCT00347776|11471477|FG002|STARTED|1.5 Month Follow-up||485
10334961|NCT00347776|11471475|FG000|COMPLETED|1.5 Month Follow-up||470
10334962|NCT00347776|11471476|FG001|COMPLETED|1.5 Month Follow-up|473 had no recurrence.2 were lost to follow-up but were still eligible for follow-up at next visits|475
10334963|NCT00347776|11471477|FG002|COMPLETED|1.5 Month Follow-up|472 had no recurrence.1 was lost to follow-up but was still eligible for follow-up at next visits|473
10334964|NCT00347776|11471475|FG000|NOT COMPLETED|1.5 Month Follow-up||14
10334965|NCT00347776|11471476|FG001|NOT COMPLETED|1.5 Month Follow-up||8
10334966|NCT00347776|11471477|FG002|NOT COMPLETED|1.5 Month Follow-up||12
10334967|NCT00347776|11471475|FG000|STARTED|6 Month Follow-up||470
10334968|NCT00347776|11471476|FG001|STARTED|6 Month Follow-up||475
10334969|NCT00347776|11471477|FG002|STARTED|6 Month Follow-up||473
10334970|NCT00347776|11471475|FG000|COMPLETED|6 Month Follow-up|440 had no recurrence.8 were lost to follow-up but were still eligible for follow-up at next visits|448
10334971|NCT00347776|11471476|FG001|COMPLETED|6 Month Follow-up|459 had no recurrence.3 were lost to follow-up but were still eligible for follow-up at next visits|462
10334972|NCT00347776|11471477|FG002|COMPLETED|6 Month Follow-up|452 had no recurrence.3 were lost to follow-up but were still eligible for follow-up at next visits|455
10334973|NCT00347776|11471475|FG000|NOT COMPLETED|6 Month Follow-up||22
10334974|NCT00347776|11471476|FG001|NOT COMPLETED|6 Month Follow-up||13
10334975|NCT00347776|11471477|FG002|NOT COMPLETED|6 Month Follow-up||18
10334976|NCT00347776|11471475|FG000|STARTED|12 Month Follow-up||448
10334977|NCT00347776|11471476|FG001|STARTED|12 Month Follow-up||462
10334978|NCT00347776|11471477|FG002|STARTED|12 Month Follow-up||455
10334979|NCT00347776|11471475|FG000|COMPLETED|12 Month Follow-up||425
10334980|NCT00347776|11471476|FG001|COMPLETED|12 Month Follow-up||446
10334981|NCT00347776|11471477|FG002|COMPLETED|12 Month Follow-up||436
10334982|NCT00347776|11471475|FG000|NOT COMPLETED|12 Month Follow-up||23
10334983|NCT00347776|11471476|FG001|NOT COMPLETED|12 Month Follow-up||16
10334984|NCT00347776|11471477|FG002|NOT COMPLETED|12 Month Follow-up||19
10334985|NCT00347919|11471488|FG000|STARTED|Overall Study|Safety Population|73
10334986|NCT00347919|11471489|FG001|STARTED|Overall Study|Safety Population|76
10334987|NCT00347919|11471490|FG002|STARTED|Overall Study|Safety Population|40
10334988|NCT00347919|11471488|FG000|COMPLETED|Overall Study||2
10334989|NCT00347919|11471489|FG001|COMPLETED|Overall Study||0
10334990|NCT00347919|11471490|FG002|COMPLETED|Overall Study||2
10334991|NCT00347919|11471488|FG000|NOT COMPLETED|Overall Study||71
10334992|NCT00347919|11471489|FG001|NOT COMPLETED|Overall Study||76
10334993|NCT00347919|11471490|FG002|NOT COMPLETED|Overall Study||38
10334994|NCT00347932|11471502|FG000|STARTED|Overall Study|As Randomized population - received at least one dose of study medication|475
10334995|NCT00347932|11471503|FG001|STARTED|Overall Study|As Randomized Population - received at least one dose of study medication|482
10334996|NCT00347932|11471502|FG000|COMPLETED|Overall Study||444
10334997|NCT00347932|11471503|FG001|COMPLETED|Overall Study||430
10334998|NCT00347932|11471502|FG000|NOT COMPLETED|Overall Study||31
10334999|NCT00347932|11471503|FG001|NOT COMPLETED|Overall Study||52
10335000|NCT00347958|11471509|FG000|STARTED|Overall Study||544
10335001|NCT00347958|11471509|FG000|COMPLETED|Overall Study||540
10335002|NCT00347958|11471509|FG000|NOT COMPLETED|Overall Study||4
10335003|NCT00348140|11471516|FG000|STARTED|Overall Study||487
10335004|NCT00348140|11471517|FG001|STARTED|Overall Study||490
10335005|NCT00348140|11471518|FG002|STARTED|Overall Study||491
10335006|NCT00348140|11471516|FG000|COMPLETED|Overall Study||361
10335007|NCT00348140|11471517|FG001|COMPLETED|Overall Study||351
10335008|NCT00348140|11471518|FG002|COMPLETED|Overall Study||328
10335009|NCT00348140|11471516|FG000|NOT COMPLETED|Overall Study||126
10335010|NCT00348140|11471517|FG001|NOT COMPLETED|Overall Study||139
10335011|NCT00348140|11471518|FG002|NOT COMPLETED|Overall Study||163
10335012|NCT00348205|11471527|FG000|STARTED|Overall Study||80
10335013|NCT00348205|11471527|FG000|COMPLETED|Overall Study||78
10335014|NCT00348205|11471527|FG000|NOT COMPLETED|Overall Study||2
10335015|NCT00348283|11471533|FG000|STARTED|Induction||0
10335016|NCT00348283|11471534|FG001|STARTED|Induction|Subjects received an open- label dose of 80 mg adalimumab at Week 2 (induction dose).|135
10335017|NCT00348283|11471533|FG000|COMPLETED|Induction||0
10335018|NCT00348283|11471534|FG001|COMPLETED|Induction|Subjects provided more than one reason for discontinuing during induction.|129
10335019|NCT00348283|11471533|FG000|NOT COMPLETED|Induction||0
10335020|NCT00348283|11471534|FG001|NOT COMPLETED|Induction||6
10335021|NCT00348283|11471533|FG000|STARTED|Double Blind|At Week 4, subjects were randomized to either adalimumab 40 mg eow or placebo eow.|65
10335022|NCT00348283|11471534|FG001|STARTED|Double Blind|At Week 4, subjects were randomized to either adalimumab 40 mg eow or placebo eow.|64
10335023|NCT00348283|11471533|FG000|COMPLETED|Double Blind||60
10335024|NCT00348283|11471534|FG001|COMPLETED|Double Blind||54
10335025|NCT00348283|11471533|FG000|NOT COMPLETED|Double Blind||5
10335026|NCT00348283|11471534|FG001|NOT COMPLETED|Double Blind||10
10335027|NCT00348283|11471533|FG000|STARTED|Open Label|No comparator was used in the Open Label portion of the study.|0
10335028|NCT00348283|11471534|FG001|STARTED|Open Label|14 subjects completed the Double Blind portion of the study but did not enter the Open Label period.|100
10335029|NCT00348283|11471533|FG000|COMPLETED|Open Label||0
10335030|NCT00348283|11471534|FG001|COMPLETED|Open Label||66
10335031|NCT00348283|11471533|FG000|NOT COMPLETED|Open Label||0
10335032|NCT00348283|11471534|FG001|NOT COMPLETED|Open Label||34
10335033|NCT00348309|11471543|FG000|STARTED|Overall Study||496
10335034|NCT00348309|11471544|FG001|STARTED|Overall Study||494
10335035|NCT00348309|11471545|FG002|STARTED|Overall Study||489
10335036|NCT00348309|11471543|FG000|COMPLETED|Overall Study||362
10335037|NCT00348309|11471544|FG001|COMPLETED|Overall Study||396
10335038|NCT00348309|11471545|FG002|COMPLETED|Overall Study||346
10335039|NCT00348309|11471543|FG000|NOT COMPLETED|Overall Study||134
10335040|NCT00348309|11471544|FG001|NOT COMPLETED|Overall Study||98
10335041|NCT00348309|11471545|FG002|NOT COMPLETED|Overall Study||143
10335042|NCT00348348|11471556|FG000|STARTED|Overall Study|Received at least one drop of study medication (Safety Population)|579
10335043|NCT00348348|11471557|FG001|STARTED|Overall Study|Received at least one drop of study medication(Safety Population)|582
10335044|NCT00348348|11471556|FG000|COMPLETED|Overall Study||554
10335045|NCT00348348|11471557|FG001|COMPLETED|Overall Study||555
10335046|NCT00348348|11471556|FG000|NOT COMPLETED|Overall Study||25
10335047|NCT00348348|11471557|FG001|NOT COMPLETED|Overall Study||27
10335048|NCT00348374|11471565|FG000|STARTED|Overall Study||88
10335049|NCT00348374|11471566|FG001|STARTED|Overall Study||103
10335050|NCT00348374|11471565|FG000|Received Study Treatment|Overall Study||88
10335051|NCT00348374|11471566|FG001|Received Study Treatment|Overall Study||96
10335052|NCT00348374|11471565|FG000|COMPLETED|Overall Study||69
10335053|NCT00348374|11471566|FG001|COMPLETED|Overall Study||71
10335054|NCT00348374|11471565|FG000|NOT COMPLETED|Overall Study||19
10335055|NCT00348374|11471566|FG001|NOT COMPLETED|Overall Study||32
10335056|NCT00348595|11471575|FG000|STARTED|Overall Study||26
10335057|NCT00348595|11471576|FG001|STARTED|Overall Study||34
10335058|NCT00348595|11471575|FG000|COMPLETED|Overall Study||21
10335059|NCT00348595|11471576|FG001|COMPLETED|Overall Study||26
10335060|NCT00348595|11471575|FG000|NOT COMPLETED|Overall Study||5
10335061|NCT00348595|11471576|FG001|NOT COMPLETED|Overall Study||8
10335062|NCT00348673|11471590|FG000|STARTED|Stage 1||6
10335063|NCT00348673|11471591|FG001|STARTED|Stage 1||6
10335064|NCT00348673|11471592|FG002|STARTED|Stage 1||7
10335065|NCT00348673|11471593|FG003|STARTED|Stage 1||6
10335066|NCT00348673|11471594|FG004|STARTED|Stage 1||4
10335067|NCT00348673|11471595|FG005|STARTED|Stage 1||0
10335068|NCT00348673|11471596|FG006|STARTED|Stage 1||0
10335069|NCT00348673|11471597|FG007|STARTED|Stage 1||0
10335070|NCT00348673|11471598|FG008|STARTED|Stage 1||0
10335071|NCT00348673|11471590|FG000|Treated|Stage 1||6
10335072|NCT00348673|11471591|FG001|Treated|Stage 1||6
10335073|NCT00348673|11471592|FG002|Treated|Stage 1||6
10335074|NCT00348673|11471593|FG003|Treated|Stage 1||6
10335075|NCT00348673|11471594|FG004|Treated|Stage 1||4
10335076|NCT00348673|11471595|FG005|Treated|Stage 1||0
10335077|NCT00348673|11471596|FG006|Treated|Stage 1||0
10335078|NCT00348673|11471597|FG007|Treated|Stage 1||0
10335079|NCT00348673|11471598|FG008|Treated|Stage 1||0
10335080|NCT00348673|11471590|FG000|COMPLETED|Stage 1||6
10335081|NCT00348673|11471591|FG001|COMPLETED|Stage 1||6
10335082|NCT00348673|11471592|FG002|COMPLETED|Stage 1||6
10335083|NCT00348673|11471593|FG003|COMPLETED|Stage 1||6
10335084|NCT00348673|11471594|FG004|COMPLETED|Stage 1||4
10335085|NCT00348673|11471595|FG005|COMPLETED|Stage 1||0
10335086|NCT00348673|11471596|FG006|COMPLETED|Stage 1||0
10335087|NCT00348673|11471597|FG007|COMPLETED|Stage 1||0
10335088|NCT00348673|11471598|FG008|COMPLETED|Stage 1||0
10335089|NCT00348673|11471590|FG000|NOT COMPLETED|Stage 1||0
10335090|NCT00348673|11471591|FG001|NOT COMPLETED|Stage 1||0
10335091|NCT00348673|11471592|FG002|NOT COMPLETED|Stage 1||1
10335092|NCT00348673|11471593|FG003|NOT COMPLETED|Stage 1||0
10335093|NCT00348673|11471594|FG004|NOT COMPLETED|Stage 1||0
10335094|NCT00348673|11471595|FG005|NOT COMPLETED|Stage 1||0
10335095|NCT00348673|11471596|FG006|NOT COMPLETED|Stage 1||0
10335096|NCT00348673|11471597|FG007|NOT COMPLETED|Stage 1||0
10335097|NCT00348673|11471598|FG008|NOT COMPLETED|Stage 1||0
10335098|NCT00348673|11471590|FG000|STARTED|Stage 2||0
10335099|NCT00348673|11471591|FG001|STARTED|Stage 2||0
10335100|NCT00348673|11471592|FG002|STARTED|Stage 2||0
10335101|NCT00348673|11471593|FG003|STARTED|Stage 2||0
10335102|NCT00348673|11471594|FG004|STARTED|Stage 2||0
10335103|NCT00348673|11471595|FG005|STARTED|Stage 2||6
10335104|NCT00348673|11471596|FG006|STARTED|Stage 2||6
10335105|NCT00348673|11471597|FG007|STARTED|Stage 2||6
10335106|NCT00348673|11471598|FG008|STARTED|Stage 2||2
10335107|NCT00348673|11471590|FG000|COMPLETED|Stage 2||0
10335108|NCT00348673|11471591|FG001|COMPLETED|Stage 2||0
10335109|NCT00348673|11471592|FG002|COMPLETED|Stage 2||0
10335110|NCT00348673|11471593|FG003|COMPLETED|Stage 2||0
10335111|NCT00348673|11471594|FG004|COMPLETED|Stage 2||0
10335112|NCT00348673|11471595|FG005|COMPLETED|Stage 2||6
10335113|NCT00348673|11471596|FG006|COMPLETED|Stage 2||6
10335114|NCT00348673|11471597|FG007|COMPLETED|Stage 2||6
10335115|NCT00348673|11471598|FG008|COMPLETED|Stage 2||2
10335116|NCT00348673|11471590|FG000|NOT COMPLETED|Stage 2||0
10335117|NCT00348673|11471591|FG001|NOT COMPLETED|Stage 2||0
10335118|NCT00348673|11471592|FG002|NOT COMPLETED|Stage 2||0
10335119|NCT00348673|11471593|FG003|NOT COMPLETED|Stage 2||0
10335120|NCT00348673|11471594|FG004|NOT COMPLETED|Stage 2||0
10335121|NCT00348673|11471595|FG005|NOT COMPLETED|Stage 2||0
10335122|NCT00348673|11471596|FG006|NOT COMPLETED|Stage 2||0
10335123|NCT00348673|11471597|FG007|NOT COMPLETED|Stage 2||0
10335124|NCT00348673|11471598|FG008|NOT COMPLETED|Stage 2||0
10335125|NCT00348686|11471616|FG000|STARTED|Overall Study||315
10335126|NCT00348686|11471616|FG000|COMPLETED|Overall Study||249
10335127|NCT00348686|11471616|FG000|NOT COMPLETED|Overall Study||66
10335128|NCT00348790|11471620|FG000|STARTED|Began Treatment||25
10335129|NCT00348790|11471620|FG000|COMPLETED|Began Treatment||25
10335130|NCT00348790|11471620|FG000|NOT COMPLETED|Began Treatment||0
10335131|NCT00348790|11471620|FG000|STARTED|Completed Treatment||25
10335132|NCT00348790|11471620|FG000|COMPLETED|Completed Treatment||0
10335133|NCT00348790|11471620|FG000|NOT COMPLETED|Completed Treatment||25
10335134|NCT00348816|11471625|FG000|STARTED|Overall Study||20
10335135|NCT00348816|11471625|FG000|COMPLETED|Overall Study||19
10335136|NCT00348816|11471625|FG000|NOT COMPLETED|Overall Study||1
10335137|NCT00348881|11471633|FG000|STARTED|Overall Study||1424
10335138|NCT00348881|11471634|FG001|STARTED|Overall Study||709
10335139|NCT00348881|11471633|FG000|COMPLETED|Overall Study||1407
10809597|NCT03831191|11971474|FG005|NOT COMPLETED|Induction Period (16 Weeks)||0
10809598|NCT03831191|11971475|FG006|NOT COMPLETED|Induction Period (16 Weeks)||0
10809599|NCT03831191|11971476|FG007|NOT COMPLETED|Induction Period (16 Weeks)||0
10809600|NCT03831191|11971477|FG008|NOT COMPLETED|Induction Period (16 Weeks)||0
10335140|NCT00348881|11471634|FG001|COMPLETED|Overall Study||697
10335141|NCT00348881|11471633|FG000|NOT COMPLETED|Overall Study||17
10335142|NCT00348881|11471634|FG001|NOT COMPLETED|Overall Study||12
10335143|NCT00348933|11471644|FG000|STARTED|Overall Study||90
10335144|NCT00348933|11471644|FG000|COMPLETED|Overall Study||65
10335145|NCT00348933|11471644|FG000|NOT COMPLETED|Overall Study||25
10335146|NCT00348946|11471651|FG000|STARTED|Overall Study||46
10335147|NCT00348946|11471652|FG001|STARTED|Overall Study||47
10335148|NCT00348946|11471651|FG000|COMPLETED|Overall Study||35
10335149|NCT00348946|11471652|FG001|COMPLETED|Overall Study||35
10335150|NCT00348946|11471651|FG000|NOT COMPLETED|Overall Study||11
10335151|NCT00348946|11471652|FG001|NOT COMPLETED|Overall Study||12
10335152|NCT00349336|11471662|FG000|STARTED|Overall Study||32
10335153|NCT00349336|11471663|FG001|STARTED|Overall Study||32
10335154|NCT00349336|11471662|FG000|COMPLETED|Overall Study||19
10335155|NCT00349336|11471663|FG001|COMPLETED|Overall Study||18
10335156|NCT00349336|11471662|FG000|NOT COMPLETED|Overall Study||13
10335157|NCT00349336|11471663|FG001|NOT COMPLETED|Overall Study||14
10335158|NCT00349349|11471672|FG000|STARTED|Overall Study||95
10335159|NCT00349349|11471673|FG001|STARTED|Overall Study||112
10335160|NCT00349349|11471674|FG002|STARTED|Overall Study||16
10335161|NCT00349349|11471672|FG000|COMPLETED|Overall Study||42
10335162|NCT00349349|11471673|FG001|COMPLETED|Overall Study||50
10335163|NCT00349349|11471674|FG002|COMPLETED|Overall Study||10
10335164|NCT00349349|11471672|FG000|NOT COMPLETED|Overall Study||53
10335165|NCT00349349|11471673|FG001|NOT COMPLETED|Overall Study||62
10335166|NCT00349349|11471674|FG002|NOT COMPLETED|Overall Study||6
10335167|NCT00349388|11471686|FG000|STARTED|Overall Study|no patients enrolled|0
10335168|NCT00349388|11471687|FG001|STARTED|Overall Study||1
10335169|NCT00349388|11471686|FG000|COMPLETED|Overall Study|no patients enrolled , therefore no patients completed|0
10335170|NCT00349388|11471687|FG001|COMPLETED|Overall Study||1
10335171|NCT00349388|11471686|FG000|NOT COMPLETED|Overall Study||0
10335172|NCT00349388|11471687|FG001|NOT COMPLETED|Overall Study||0
10335173|NCT00349622|11471695|FG000|STARTED|Overall Study||340
10335174|NCT00349622|11471696|FG001|STARTED|Overall Study||173
10335175|NCT00349622|11471695|FG000|COMPLETED|Overall Study||162
10335176|NCT00349622|11471696|FG001|COMPLETED|Overall Study||77
10335177|NCT00349622|11471695|FG000|NOT COMPLETED|Overall Study||178
10335178|NCT00349622|11471696|FG001|NOT COMPLETED|Overall Study||96
10335179|NCT00349713|11471705|FG000|STARTED|Overall Study||20
10335180|NCT00349713|11471706|FG001|STARTED|Overall Study||20
10335181|NCT00349713|11471707|FG002|STARTED|Overall Study||20
10335182|NCT00349713|11471705|FG000|COMPLETED|Overall Study||20
10335183|NCT00349713|11471706|FG001|COMPLETED|Overall Study||20
10335184|NCT00349713|11471707|FG002|COMPLETED|Overall Study||20
10335185|NCT00349713|11471705|FG000|NOT COMPLETED|Overall Study||0
10335186|NCT00349713|11471706|FG001|NOT COMPLETED|Overall Study||0
10335187|NCT00349713|11471707|FG002|NOT COMPLETED|Overall Study||0
10335188|NCT00349752|11471717|FG000|STARTED|Overall Study||87
10335189|NCT00349752|11471718|FG001|STARTED|Overall Study||87
10335190|NCT00349752|11471717|FG000|COMPLETED|Overall Study||28
10335191|NCT00349752|11471718|FG001|COMPLETED|Overall Study||23
10335192|NCT00349752|11471717|FG000|NOT COMPLETED|Overall Study||59
10335193|NCT00349752|11471718|FG001|NOT COMPLETED|Overall Study||64
10335194|NCT00349778|11471724|FG000|STARTED|Overall Study||102
10335195|NCT00349778|11471724|FG000|COMPLETED|Overall Study||102
10335196|NCT00349778|11471724|FG000|NOT COMPLETED|Overall Study||0
10335197|NCT00349908|11471730|FG000|STARTED|Overall Study||10
10457743|NCT01011933|11605560|FG000|COMPLETED|Overall Study|total eligible and evaluable|50
10335198|NCT00349908|11471731|FG001|STARTED|Overall Study||10
10335199|NCT00349908|11471730|FG000|COMPLETED|Overall Study||10
10335200|NCT00349908|11471731|FG001|COMPLETED|Overall Study|9 returned for 30 day follow-up, 7 returned for 6 month and 6/7 had 6 month angiogram|6
10335201|NCT00349908|11471730|FG000|NOT COMPLETED|Overall Study||0
10335202|NCT00349908|11471731|FG001|NOT COMPLETED|Overall Study||4
10457744|NCT01011933|11605560|FG000|NOT COMPLETED|Overall Study||4
10335203|NCT00349921|11471742|FG000|STARTED|First Spinal Injection||10
10335204|NCT00349921|11471743|FG001|STARTED|First Spinal Injection||10
10335205|NCT00349921|11471744|FG002|STARTED|First Spinal Injection||1
10335206|NCT00349921|11471745|FG003|STARTED|First Spinal Injection||1
10335207|NCT00349921|11471742|FG000|COMPLETED|First Spinal Injection||9
10335208|NCT00349921|11471743|FG001|COMPLETED|First Spinal Injection||10
10335209|NCT00349921|11471744|FG002|COMPLETED|First Spinal Injection||0
10335210|NCT00349921|11471745|FG003|COMPLETED|First Spinal Injection||1
10335211|NCT00349921|11471742|FG000|NOT COMPLETED|First Spinal Injection||1
10335212|NCT00349921|11471743|FG001|NOT COMPLETED|First Spinal Injection||0
10335213|NCT00349921|11471744|FG002|NOT COMPLETED|First Spinal Injection||1
10335214|NCT00349921|11471745|FG003|NOT COMPLETED|First Spinal Injection||0
10335215|NCT00349921|11471742|FG000|STARTED|Second Spinal Injection|One patient experienced an adverse event after period one and did not participate in period two|9
10335216|NCT00349921|11471743|FG001|STARTED|Second Spinal Injection||10
10335217|NCT00349921|11471744|FG002|STARTED|Second Spinal Injection||0
10335218|NCT00349921|11471745|FG003|STARTED|Second Spinal Injection||1
10335219|NCT00349921|11471742|FG000|COMPLETED|Second Spinal Injection||9
10335220|NCT00349921|11471743|FG001|COMPLETED|Second Spinal Injection||10
10335221|NCT00349921|11471744|FG002|COMPLETED|Second Spinal Injection||0
10335222|NCT00349921|11471745|FG003|COMPLETED|Second Spinal Injection||1
10707708|NCT02622724|11872407|FG000|NOT COMPLETED|Overall Study||93
10707709|NCT02622724|11872408|FG001|NOT COMPLETED|Overall Study||103
10707710|NCT02623218|11872425|FG000|STARTED|Overall Study||5
10335223|NCT00349921|11471742|FG000|NOT COMPLETED|Second Spinal Injection||0
10335224|NCT00349921|11471743|FG001|NOT COMPLETED|Second Spinal Injection||0
10335225|NCT00349921|11471744|FG002|NOT COMPLETED|Second Spinal Injection||0
10335226|NCT00349921|11471745|FG003|NOT COMPLETED|Second Spinal Injection||0
10335227|NCT00349973|11471756|FG000|STARTED|Overall Study||12
10335228|NCT00349973|11471757|FG001|STARTED|Overall Study||8
10335229|NCT00349973|11471756|FG000|COMPLETED|Overall Study||8
10335230|NCT00349973|11471757|FG001|COMPLETED|Overall Study||5
10335231|NCT00349973|11471756|FG000|NOT COMPLETED|Overall Study||4
10335232|NCT00349973|11471757|FG001|NOT COMPLETED|Overall Study||3
10335233|NCT00350025|11471765|FG000|STARTED|Overall Study||11
10335234|NCT00350025|11471766|FG001|STARTED|Overall Study||30
10335235|NCT00350025|11471765|FG000|COMPLETED|Overall Study||11
10335236|NCT00350025|11471766|FG001|COMPLETED|Overall Study||28
10335237|NCT00350025|11471765|FG000|NOT COMPLETED|Overall Study||0
10335238|NCT00350025|11471766|FG001|NOT COMPLETED|Overall Study||2
10335239|NCT00350142|11471772|FG000|STARTED|Overall Study||20
10335240|NCT00350142|11471772|FG000|COMPLETED|Overall Study||20
10335241|NCT00350142|11471772|FG000|NOT COMPLETED|Overall Study||0
10335242|NCT00350207|11471780|FG000|STARTED|Overall Study||128
10335243|NCT00350207|11471781|FG001|STARTED|Overall Study||134
10335244|NCT00350207|11471782|FG002|STARTED|Overall Study||126
10335245|NCT00350207|11471780|FG000|COMPLETED|Overall Study||120
10335246|NCT00350207|11471781|FG001|COMPLETED|Overall Study||128
10335247|NCT00350207|11471782|FG002|COMPLETED|Overall Study||119
10335248|NCT00350207|11471780|FG000|NOT COMPLETED|Overall Study||8
10335249|NCT00350207|11471781|FG001|NOT COMPLETED|Overall Study||6
10335250|NCT00350207|11471782|FG002|NOT COMPLETED|Overall Study||7
10335251|NCT00350220|11471792|FG000|STARTED|Overall Study||30
10335252|NCT00350220|11471793|FG001|STARTED|Overall Study||30
10335253|NCT00350220|11471792|FG000|COMPLETED|Overall Study||30
10335254|NCT00350220|11471793|FG001|COMPLETED|Overall Study||30
10335255|NCT00350220|11471792|FG000|NOT COMPLETED|Overall Study||0
10335256|NCT00350220|11471793|FG001|NOT COMPLETED|Overall Study||0
10335257|NCT00350272|11471801|FG000|STARTED|Blinded 12 Week Treatment||39
10335258|NCT00350272|11471802|FG001|STARTED|Blinded 12 Week Treatment||37
10335259|NCT00350272|11471801|FG000|COMPLETED|Blinded 12 Week Treatment||30
10335260|NCT00350272|11471802|FG001|COMPLETED|Blinded 12 Week Treatment||35
10335261|NCT00350272|11471801|FG000|NOT COMPLETED|Blinded 12 Week Treatment||9
10335262|NCT00350272|11471802|FG001|NOT COMPLETED|Blinded 12 Week Treatment||2
10335263|NCT00350272|11471801|FG000|STARTED|Open-Label 84 Week Treatment||30
10335264|NCT00350272|11471802|FG001|STARTED|Open-Label 84 Week Treatment||35
10335265|NCT00350272|11471801|FG000|COMPLETED|Open-Label 84 Week Treatment||21
10335266|NCT00350272|11471802|FG001|COMPLETED|Open-Label 84 Week Treatment||27
10335267|NCT00350272|11471801|FG000|NOT COMPLETED|Open-Label 84 Week Treatment||9
10335268|NCT00350272|11471802|FG001|NOT COMPLETED|Open-Label 84 Week Treatment||8
10335269|NCT00350298|11471812|FG000|STARTED|Overall Study||101
10335270|NCT00350298|11471813|FG001|STARTED|Overall Study||99
10335271|NCT00350298|11471812|FG000|COMPLETED|Overall Study||92
10335272|NCT00350298|11471813|FG001|COMPLETED|Overall Study||86
10335273|NCT00350298|11471812|FG000|NOT COMPLETED|Overall Study||9
10335274|NCT00350298|11471813|FG001|NOT COMPLETED|Overall Study||13
10335275|NCT00350337|11471823|FG000|STARTED|Overall Study||22
10335276|NCT00350337|11471824|FG001|STARTED|Overall Study||22
10335277|NCT00350337|11471825|FG002|STARTED|Overall Study||21
10335278|NCT00350337|11471826|FG003|STARTED|Overall Study||21
10707711|NCT02623218|11872426|FG001|STARTED|Overall Study||4
10707712|NCT02623218|11872427|FG002|STARTED|Overall Study||4
10707713|NCT02623218|11872428|FG003|STARTED|Overall Study||4
10335279|NCT00350337|11471823|FG000|COMPLETED|Overall Study||17
10335280|NCT00350337|11471824|FG001|COMPLETED|Overall Study||19
10335281|NCT00350337|11471825|FG002|COMPLETED|Overall Study||18
10335282|NCT00350337|11471826|FG003|COMPLETED|Overall Study||21
10335283|NCT00350337|11471823|FG000|NOT COMPLETED|Overall Study||5
10335284|NCT00350337|11471824|FG001|NOT COMPLETED|Overall Study||3
10335285|NCT00350337|11471825|FG002|NOT COMPLETED|Overall Study||3
10335286|NCT00350337|11471826|FG003|NOT COMPLETED|Overall Study||0
10707714|NCT02623218|11872429|FG004|STARTED|Overall Study||4
10707715|NCT02623218|11872425|FG000|COMPLETED|Overall Study||5
10707716|NCT02623218|11872426|FG001|COMPLETED|Overall Study||3
10335287|NCT00350363|11471837|FG000|STARTED|Overall Study||60
10335288|NCT00350363|11471837|FG000|COMPLETED|Overall Study||60
10335289|NCT00350363|11471837|FG000|NOT COMPLETED|Overall Study||0
10335290|NCT00350402|11471843|FG000|STARTED|Overall Study||21
10335291|NCT00350402|11471844|FG001|STARTED|Overall Study||21
10335292|NCT00350402|11471843|FG000|COMPLETED|Overall Study||20
10335293|NCT00350402|11471844|FG001|COMPLETED|Overall Study||20
10335294|NCT00350402|11471843|FG000|NOT COMPLETED|Overall Study||1
10335295|NCT00350402|11471844|FG001|NOT COMPLETED|Overall Study||1
10335296|NCT00350519|11471858|FG000|STARTED|Overall Study||18
10335297|NCT00350519|11471859|FG001|STARTED|Overall Study||19
10335298|NCT00350519|11471858|FG000|COMPLETED|Overall Study||14
10335299|NCT00350519|11471859|FG001|COMPLETED|Overall Study||13
10335300|NCT00350519|11471858|FG000|NOT COMPLETED|Overall Study||4
10335301|NCT00350519|11471859|FG001|NOT COMPLETED|Overall Study||6
10335302|NCT00350532|11471867|FG000|STARTED|Overall Study||24
10335303|NCT00350532|11471868|FG001|STARTED|Overall Study||19
10335304|NCT00350532|11471867|FG000|COMPLETED|Overall Study||24
10335305|NCT00350532|11471868|FG001|COMPLETED|Overall Study||19
10335306|NCT00350532|11471867|FG000|NOT COMPLETED|Overall Study||0
10335307|NCT00350532|11471868|FG001|NOT COMPLETED|Overall Study||0
10335308|NCT00350545|11471874|FG000|STARTED|Overall Study||37
10335309|NCT00350545|11471874|FG000|COMPLETED|Overall Study||35
10335310|NCT00350545|11471874|FG000|NOT COMPLETED|Overall Study||2
10335311|NCT00350636|11471880|FG000|STARTED|Overall Study||389
10335312|NCT00350636|11471881|FG001|STARTED|Overall Study||400
10335313|NCT00350636|11471880|FG000|COMPLETED|Overall Study||346
10335314|NCT00350636|11471881|FG001|COMPLETED|Overall Study||355
10335315|NCT00350636|11471880|FG000|NOT COMPLETED|Overall Study||43
10335316|NCT00350636|11471881|FG001|NOT COMPLETED|Overall Study||45
10335317|NCT00350727|11471890|FG000|STARTED|Phase I: Dose Escalation||34
10335318|NCT00350727|11471891|FG001|STARTED|Phase I: Dose Escalation||0
10335319|NCT00350727|11471892|FG002|STARTED|Phase I: Dose Escalation||0
10335320|NCT00350727|11471890|FG000|COMPLETED|Phase I: Dose Escalation||0
10335321|NCT00350727|11471891|FG001|COMPLETED|Phase I: Dose Escalation||0
10335322|NCT00350727|11471892|FG002|COMPLETED|Phase I: Dose Escalation||0
10335323|NCT00350727|11471890|FG000|NOT COMPLETED|Phase I: Dose Escalation||34
10335324|NCT00350727|11471891|FG001|NOT COMPLETED|Phase I: Dose Escalation||0
10335325|NCT00350727|11471892|FG002|NOT COMPLETED|Phase I: Dose Escalation||0
10335326|NCT00350727|11471890|FG000|STARTED|Phase II||0
10335327|NCT00350727|11471891|FG001|STARTED|Phase II||19
10335328|NCT00350727|11471892|FG002|STARTED|Phase II||22
10335329|NCT00350727|11471890|FG000|COMPLETED|Phase II||0
10335330|NCT00350727|11471891|FG001|COMPLETED|Phase II||0
10335331|NCT00350727|11471892|FG002|COMPLETED|Phase II||0
10335332|NCT00350727|11471890|FG000|NOT COMPLETED|Phase II||0
10335333|NCT00350727|11471891|FG001|NOT COMPLETED|Phase II||19
10335334|NCT00350727|11471892|FG002|NOT COMPLETED|Phase II||22
10335335|NCT00350779|11471913|FG000|STARTED|Overall Study||170
10335336|NCT00350779|11471914|FG001|STARTED|Overall Study||92
10335337|NCT00350779|11471913|FG000|COMPLETED|Overall Study||148
10335338|NCT00350779|11471914|FG001|COMPLETED|Overall Study||71
10335339|NCT00350779|11471913|FG000|NOT COMPLETED|Overall Study||22
10335340|NCT00350779|11471914|FG001|NOT COMPLETED|Overall Study||21
10335341|NCT00350792|11471922|FG000|STARTED|Overall Study||62
10335342|NCT00350792|11471922|FG000|COMPLETED|Overall Study||29
10335343|NCT00350792|11471922|FG000|NOT COMPLETED|Overall Study||33
10335344|NCT00350870|11471930|FG000|STARTED|Overall Study||27
10335345|NCT00350870|11471931|FG001|STARTED|Overall Study||28
10335346|NCT00350870|11471932|FG002|STARTED|Overall Study||22
10335347|NCT00350870|11471933|FG003|STARTED|Overall Study||22
10707717|NCT02623218|11872427|FG002|COMPLETED|Overall Study||4
10707718|NCT02623218|11872428|FG003|COMPLETED|Overall Study||4
10707719|NCT02623218|11872429|FG004|COMPLETED|Overall Study||4
10707720|NCT02623218|11872425|FG000|NOT COMPLETED|Overall Study||0
10707721|NCT02623218|11872426|FG001|NOT COMPLETED|Overall Study||1
10335348|NCT00350870|11471930|FG000|Had at Least 1 Day of Med|Overall Study||19
10335349|NCT00350870|11471931|FG001|Had at Least 1 Day of Med|Overall Study||24
10335350|NCT00350870|11471932|FG002|Had at Least 1 Day of Med|Overall Study||18
10335351|NCT00350870|11471933|FG003|Had at Least 1 Day of Med|Overall Study||19
10335352|NCT00350870|11471930|FG000|COMPLETED|Overall Study||5
10335353|NCT00350870|11471931|FG001|COMPLETED|Overall Study||11
10335354|NCT00350870|11471932|FG002|COMPLETED|Overall Study||6
10335355|NCT00350870|11471933|FG003|COMPLETED|Overall Study||7
10335356|NCT00350870|11471930|FG000|NOT COMPLETED|Overall Study||22
10335357|NCT00350870|11471931|FG001|NOT COMPLETED|Overall Study||17
10335358|NCT00350870|11471932|FG002|NOT COMPLETED|Overall Study||16
10335359|NCT00350870|11471933|FG003|NOT COMPLETED|Overall Study||15
10335360|NCT00351000|11471943|FG000|STARTED|Overall Study||24
10335361|NCT00351000|11471943|FG000|COMPLETED|Overall Study||21
10335362|NCT00351000|11471943|FG000|NOT COMPLETED|Overall Study||3
10335363|NCT00351039|11471950|FG000|STARTED|Overall Study||8
10335364|NCT00351039|11471950|FG000|COMPLETED|Overall Study|The study was halted before Phase II was initiated.|8
10335365|NCT00351039|11471950|FG000|NOT COMPLETED|Overall Study||0
10335366|NCT00351273|11471958|FG000|STARTED|Overall Study||15
10335367|NCT00351273|11471959|FG001|STARTED|Overall Study||12
10335368|NCT00351273|11471960|FG002|STARTED|Overall Study||15
10335369|NCT00351273|11471958|FG000|COMPLETED|Overall Study||14
10335370|NCT00351273|11471959|FG001|COMPLETED|Overall Study||10
10707722|NCT02623218|11872427|FG002|NOT COMPLETED|Overall Study||0
10707723|NCT02623218|11872428|FG003|NOT COMPLETED|Overall Study||0
10707724|NCT02623218|11872429|FG004|NOT COMPLETED|Overall Study||0
10335371|NCT00351273|11471960|FG002|COMPLETED|Overall Study||10
10335372|NCT00351273|11471958|FG000|NOT COMPLETED|Overall Study||1
10457745|NCT01011946|11605570|FG000|STARTED|Overall Study||36
10457746|NCT01011946|11605570|FG000|COMPLETED|Overall Study||33
10457747|NCT01011946|11605570|FG000|NOT COMPLETED|Overall Study||3
10457748|NCT01012037|11605577|FG000|STARTED|Overall Study||44
10649783|NCT02164383|11809950|FG000|COMPLETED|Overall Study||15
10649784|NCT02164383|11809951|FG001|COMPLETED|Overall Study||14
10457749|NCT01012037|11605578|FG001|STARTED|Overall Study||223
10457750|NCT01012037|11605579|FG002|STARTED|Overall Study||224
10457751|NCT01012037|11605577|FG000|COMPLETED|Overall Study||43
10457752|NCT01012037|11605578|FG001|COMPLETED|Overall Study||207
10457753|NCT01012037|11605579|FG002|COMPLETED|Overall Study||214
10457754|NCT01012037|11605577|FG000|NOT COMPLETED|Overall Study||1
10457755|NCT01012037|11605578|FG001|NOT COMPLETED|Overall Study||16
10457756|NCT01012037|11605579|FG002|NOT COMPLETED|Overall Study||10
10457757|NCT01012089|11605589|FG000|STARTED|Overall Study||6
10457758|NCT01012089|11605589|FG000|COMPLETED|Overall Study||6
10457759|NCT01012089|11605589|FG000|NOT COMPLETED|Overall Study||0
10457760|NCT01012219|11605595|FG000|STARTED|Period 1|Number randomized|36
10457761|NCT01012219|11605595|FG000|COMPLETED|Period 1||35
10457762|NCT01012219|11605595|FG000|NOT COMPLETED|Period 1||1
10457763|NCT01012219|11605595|FG000|STARTED|Period 2|Number who completed Period 1|35
10457764|NCT01012219|11605595|FG000|COMPLETED|Period 2||34
10457765|NCT01012219|11605595|FG000|NOT COMPLETED|Period 2||1
10457766|NCT01012219|11605595|FG000|STARTED|Period 3|of the 36 who started Period 1|20
10457767|NCT01012219|11605595|FG000|COMPLETED|Period 3||20
10457768|NCT01012219|11605595|FG000|NOT COMPLETED|Period 3||0
10457769|NCT01012245|11605606|FG000|STARTED|Overall Study||28812
10457770|NCT01012245|11605606|FG000|COMPLETED|Overall Study|More than 1 discontinuation (DC) reason possible per subject. See outcome measure Reasons for DC.|26385
10457771|NCT01012245|11605606|FG000|NOT COMPLETED|Overall Study||2427
10457772|NCT01012258|11605617|FG000|STARTED|Overall Study||66
10457773|NCT01012258|11605617|FG000|COMPLETED|Overall Study||0
10457774|NCT01012258|11605617|FG000|NOT COMPLETED|Overall Study||66
10457775|NCT01012297|11605624|FG000|STARTED|Overall Study||54
10457776|NCT01012297|11605625|FG001|STARTED|Overall Study||53
10457777|NCT01012297|11605624|FG000|COMPLETED|Overall Study||54
10457778|NCT01012297|11605625|FG001|COMPLETED|Overall Study||53
10457779|NCT01012297|11605624|FG000|NOT COMPLETED|Overall Study||0
10457780|NCT01012297|11605625|FG001|NOT COMPLETED|Overall Study||0
10457781|NCT01012323|11605631|FG000|STARTED|Overall Study||51
10457782|NCT01012323|11605631|FG000|COMPLETED|Overall Study||50
10457783|NCT01012323|11605631|FG000|NOT COMPLETED|Overall Study||1
10457784|NCT01012336|11605635|FG000|STARTED|Overall Study||85
10457785|NCT01012336|11605635|FG000|COMPLETED|Overall Study||85
10457786|NCT01012336|11605635|FG000|NOT COMPLETED|Overall Study||0
10457787|NCT01012362|11605644|FG000|STARTED|Overall Study||9
10457788|NCT01012362|11605645|FG001|STARTED|Overall Study||6
10457789|NCT01012362|11605646|FG002|STARTED|Overall Study||3
10457790|NCT01012362|11605647|FG003|STARTED|Overall Study||4
10457791|NCT01012362|11605648|FG004|STARTED|Overall Study||9
10457792|NCT01012362|11605644|FG000|COMPLETED|Overall Study||9
10457793|NCT01012362|11605645|FG001|COMPLETED|Overall Study||6
10457794|NCT01012362|11605646|FG002|COMPLETED|Overall Study||3
10457795|NCT01012362|11605647|FG003|COMPLETED|Overall Study||4
10457796|NCT01012362|11605648|FG004|COMPLETED|Overall Study||9
10457797|NCT01012362|11605644|FG000|NOT COMPLETED|Overall Study||0
10457798|NCT01012362|11605645|FG001|NOT COMPLETED|Overall Study||0
10457799|NCT01012362|11605646|FG002|NOT COMPLETED|Overall Study||0
10457800|NCT01012362|11605647|FG003|NOT COMPLETED|Overall Study||0
10457801|NCT01012362|11605648|FG004|NOT COMPLETED|Overall Study||0
10457802|NCT01012388|11605664|FG000|STARTED|Overall Study||100
10457803|NCT01012388|11605664|FG000|COMPLETED|Overall Study||100
10457804|NCT01012388|11605664|FG000|NOT COMPLETED|Overall Study||0
10457805|NCT01012440|11605668|FG000|STARTED|Overall Study||5
10457806|NCT01012440|11605668|FG000|COMPLETED|Overall Study||3
10457807|NCT01012440|11605668|FG000|NOT COMPLETED|Overall Study||2
10457808|NCT01012492|11605672|FG000|STARTED|Overall Study||10
10457809|NCT01012492|11605672|FG000|COMPLETED|Overall Study||10
10457810|NCT01012492|11605672|FG000|NOT COMPLETED|Overall Study||0
10457811|NCT01012622|11605676|FG000|STARTED|Overall Study||142
10457812|NCT01012622|11605676|FG000|COMPLETED|Overall Study||111
10457813|NCT01012622|11605676|FG000|NOT COMPLETED|Overall Study||31
10649785|NCT02164383|11809950|FG000|NOT COMPLETED|Overall Study||1
10457814|NCT01012661|11605680|FG000|STARTED|Overall Study||50
10457815|NCT01012661|11605680|FG000|COMPLETED|Overall Study||50
10457816|NCT01012661|11605680|FG000|NOT COMPLETED|Overall Study||0
10457817|NCT01012674|11605686|FG000|STARTED|Overall Study||211
10457818|NCT01012674|11605686|FG000|COMPLETED|Overall Study||187
10457819|NCT01012674|11605686|FG000|NOT COMPLETED|Overall Study||24
10457820|NCT01012713|11605694|FG000|STARTED|Overall Study||30
10457821|NCT01012713|11605694|FG000|COMPLETED|Overall Study||27
10457822|NCT01012713|11605694|FG000|NOT COMPLETED|Overall Study||3
10457823|NCT01012739|11605699|FG000|STARTED|Treatment Period 1||9
10457824|NCT01012739|11605700|FG001|STARTED|Treatment Period 1||8
10457825|NCT01012739|11605701|FG002|STARTED|Treatment Period 1||9
10457826|NCT01012739|11605702|FG003|STARTED|Treatment Period 1||9
10457827|NCT01012739|11605699|FG000|COMPLETED|Treatment Period 1||9
10457828|NCT01012739|11605700|FG001|COMPLETED|Treatment Period 1||8
10457829|NCT01012739|11605701|FG002|COMPLETED|Treatment Period 1||9
10457830|NCT01012739|11605702|FG003|COMPLETED|Treatment Period 1||8
10335373|NCT00351273|11471959|FG001|NOT COMPLETED|Overall Study||2
10335374|NCT00351273|11471960|FG002|NOT COMPLETED|Overall Study||5
10335375|NCT00351299|11471975|FG000|STARTED|Overall Study||25
10707725|NCT02623322|11872444|FG000|STARTED|Overall Study||43
10707726|NCT02623322|11872445|FG001|STARTED|Overall Study||41
10707727|NCT02623322|11872446|FG002|STARTED|Overall Study||40
10707728|NCT02623322|11872444|FG000|COMPLETED|Overall Study||41
10335376|NCT00351299|11471976|FG001|STARTED|Overall Study||28
10335377|NCT00351299|11471975|FG000|COMPLETED|Overall Study||25
10335378|NCT00351299|11471976|FG001|COMPLETED|Overall Study||28
10335379|NCT00351299|11471975|FG000|NOT COMPLETED|Overall Study||0
10335380|NCT00351299|11471976|FG001|NOT COMPLETED|Overall Study||0
10335381|NCT00351351|11471988|FG000|STARTED|Overall Study||34
10335382|NCT00351351|11471989|FG001|STARTED|Overall Study||36
10335383|NCT00351351|11471988|FG000|COMPLETED|Overall Study||25
10335384|NCT00351351|11471989|FG001|COMPLETED|Overall Study||32
10335385|NCT00351351|11471988|FG000|NOT COMPLETED|Overall Study||9
10335386|NCT00351351|11471989|FG001|NOT COMPLETED|Overall Study||4
10335387|NCT00351377|11471995|FG000|STARTED|Overall Study||111
10335388|NCT00351377|11471995|FG000|COMPLETED|Overall Study||104
10335389|NCT00351377|11471995|FG000|NOT COMPLETED|Overall Study||7
10335390|NCT00351416|11472001|FG000|STARTED|Overall Study||6
10335391|NCT00351416|11472002|FG001|STARTED|Overall Study||9
10335392|NCT00351416|11472001|FG000|COMPLETED|Overall Study||6
10335393|NCT00351416|11472002|FG001|COMPLETED|Overall Study||9
10335394|NCT00351416|11472001|FG000|NOT COMPLETED|Overall Study||0
10335395|NCT00351416|11472002|FG001|NOT COMPLETED|Overall Study||0
10335396|NCT00351468|11472008|FG000|STARTED|Overall Study||302
10335397|NCT00351468|11472008|FG000|Subjects From TRA100773A|Overall Study||51
10335398|NCT00351468|11472008|FG000|Subjects From TRA100773B|Overall Study||61
10335399|NCT00351468|11472008|FG000|Subjects From TRA102537 Raise|Overall Study||146
10335400|NCT00351468|11472008|FG000|Subjects From TRA108057 Repeat|Overall Study||43
10335401|NCT00351468|11472008|FG000|Unknown - Not From Previous Trial|Overall Study|Mistakenly enrolled (not in any of the 3 trials) On 50 mg/d eltrombopag for 18 days and withdrawn|1
10335402|NCT00351468|11472008|FG000|COMPLETED|Overall Study||135
10335403|NCT00351468|11472008|FG000|NOT COMPLETED|Overall Study||167
10335404|NCT00351533|11472015|FG000|STARTED|Overall Study||41
10335405|NCT00351533|11472016|FG001|STARTED|Overall Study||49
10335406|NCT00351533|11472015|FG000|COMPLETED|Overall Study|Pts did not undergo BALs if not intubated|39
10335407|NCT00351533|11472016|FG001|COMPLETED|Overall Study|Pts did not undergo BALs if not intubated|44
10335408|NCT00351533|11472015|FG000|NOT COMPLETED|Overall Study||2
10335409|NCT00351533|11472016|FG001|NOT COMPLETED|Overall Study||5
10335410|NCT00351611|11472024|FG000|STARTED|Overall Study||89
10335411|NCT00351611|11472025|FG001|STARTED|Overall Study||98
10335412|NCT00351611|11472024|FG000|Treated|Overall Study||89
10335413|NCT00351611|11472025|FG001|Treated|Overall Study||98
10335414|NCT00351611|11472024|FG000|COMPLETED|Overall Study||75
10335415|NCT00351611|11472025|FG001|COMPLETED|Overall Study||88
10335416|NCT00351611|11472024|FG000|NOT COMPLETED|Overall Study||14
10335417|NCT00351611|11472025|FG001|NOT COMPLETED|Overall Study||10
10335418|NCT00351741|11472033|FG000|STARTED|Overall Study||31
10335419|NCT00351741|11472034|FG001|STARTED|Overall Study||31
10335420|NCT00351741|11472033|FG000|COMPLETED|Overall Study||31
10335421|NCT00351741|11472034|FG001|COMPLETED|Overall Study||31
10335422|NCT00351741|11472033|FG000|NOT COMPLETED|Overall Study||0
10335423|NCT00351741|11472034|FG001|NOT COMPLETED|Overall Study||0
10335424|NCT00351819|11472042|FG000|STARTED|Overall Study||43
10335425|NCT00351819|11472043|FG001|STARTED|Overall Study||41
10335426|NCT00351819|11472042|FG000|COMPLETED|Overall Study||36
10335427|NCT00351819|11472043|FG001|COMPLETED|Overall Study||29
10335428|NCT00351819|11472042|FG000|NOT COMPLETED|Overall Study||7
10335429|NCT00351819|11472043|FG001|NOT COMPLETED|Overall Study||12
10339118|NCT00371397|11476092|FG006|NOT COMPLETED|Session 1||0
10339119|NCT00371397|11476093|FG007|NOT COMPLETED|Session 1||1
10339120|NCT00371397|11476094|FG008|NOT COMPLETED|Session 1||0
10339121|NCT00371397|11476095|FG009|NOT COMPLETED|Session 1||0
10339122|NCT00371397|11476096|FG010|NOT COMPLETED|Session 1||0
10339123|NCT00371397|11476097|FG011|NOT COMPLETED|Session 1||0
10339124|NCT00371397|11476086|FG000|STARTED|Session 2||4
10339125|NCT00371397|11476087|FG001|STARTED|Session 2||7
10339126|NCT00371397|11476088|FG002|STARTED|Session 2||5
10339127|NCT00371397|11476089|FG003|STARTED|Session 2||2
10339128|NCT00371397|11476090|FG004|STARTED|Session 2||3
10339129|NCT00371397|11476091|FG005|STARTED|Session 2||4
10339130|NCT00371397|11476092|FG006|STARTED|Session 2||4
10339131|NCT00371397|11476093|FG007|STARTED|Session 2||4
10339132|NCT00371397|11476094|FG008|STARTED|Session 2||6
10339133|NCT00371397|11476095|FG009|STARTED|Session 2||5
10339134|NCT00371397|11476096|FG010|STARTED|Session 2||4
10339135|NCT00371397|11476097|FG011|STARTED|Session 2||2
10339136|NCT00371397|11476086|FG000|COMPLETED|Session 2||4
10339137|NCT00371397|11476087|FG001|COMPLETED|Session 2||7
10339138|NCT00371397|11476088|FG002|COMPLETED|Session 2||5
10339139|NCT00371397|11476089|FG003|COMPLETED|Session 2||2
10339140|NCT00371397|11476090|FG004|COMPLETED|Session 2||3
10339141|NCT00371397|11476091|FG005|COMPLETED|Session 2||4
10339142|NCT00371397|11476092|FG006|COMPLETED|Session 2||4
10339143|NCT00371397|11476093|FG007|COMPLETED|Session 2||4
10339144|NCT00371397|11476094|FG008|COMPLETED|Session 2||6
10339145|NCT00371397|11476095|FG009|COMPLETED|Session 2||5
10339146|NCT00371397|11476096|FG010|COMPLETED|Session 2||4
10339147|NCT00371397|11476097|FG011|COMPLETED|Session 2||2
10339148|NCT00371397|11476086|FG000|NOT COMPLETED|Session 2||0
10707729|NCT02623322|11872445|FG001|COMPLETED|Overall Study||40
10335430|NCT00351936|11472049|FG000|STARTED|Overall Study||15
10335431|NCT00351936|11472049|FG000|COMPLETED|Overall Study||15
10335432|NCT00351936|11472049|FG000|NOT COMPLETED|Overall Study||0
10335433|NCT00352001|11472054|FG000|STARTED|Overall Study||37
10335434|NCT00352001|11472054|FG000|Azacitidine 75mg/Lenalidomide 5mg-14 Day|Overall Study||3
10335435|NCT00352001|11472054|FG000|Azacitidine 75mg/Lenalidomide 5mg-21 Day|Overall Study||3
10335436|NCT00352001|11472054|FG000|Azacitidine 75mg/Lenalidomide 10mg-14day|Overall Study||3
10335437|NCT00352001|11472054|FG000|COMPLETED|Overall Study||37
10335438|NCT00352001|11472054|FG000|NOT COMPLETED|Overall Study||0
10335439|NCT00352053|11472060|FG000|STARTED|Double-Blind Phase (Through Week 48)||45
10335440|NCT00352053|11472061|FG001|STARTED|Double-Blind Phase (Through Week 48)||42
10335441|NCT00352053|11472060|FG000|COMPLETED|Double-Blind Phase (Through Week 48)||27
10335442|NCT00352053|11472061|FG001|COMPLETED|Double-Blind Phase (Through Week 48)|The 10 participants discontinued for virologic failure enrolled early in the open-label extension.|29
10335443|NCT00352053|11472060|FG000|NOT COMPLETED|Double-Blind Phase (Through Week 48)||18
10335444|NCT00352053|11472061|FG001|NOT COMPLETED|Double-Blind Phase (Through Week 48)||13
10335445|NCT00352053|11472060|FG000|STARTED|First Extension Phase (Weeks 48-144)|3 participants completed the double-blind phase but did not enroll in the 1st extension phase.|24
10335446|NCT00352053|11472061|FG001|STARTED|First Extension Phase (Weeks 48-144)|3 participants completed the double-blind phase but did not enroll in the 1st extension phase.|36
10335447|NCT00352053|11472060|FG000|COMPLETED|First Extension Phase (Weeks 48-144)||12
10335448|NCT00352053|11472061|FG001|COMPLETED|First Extension Phase (Weeks 48-144)||19
10335449|NCT00352053|11472060|FG000|NOT COMPLETED|First Extension Phase (Weeks 48-144)||12
10335450|NCT00352053|11472061|FG001|NOT COMPLETED|First Extension Phase (Weeks 48-144)||17
10335451|NCT00352053|11472060|FG000|STARTED|Second Extension Phase (Weeks 144-240)|3 participants completed the 1st extension phase but did not enroll in the 2nd extension phase.|9
10335452|NCT00352053|11472061|FG001|STARTED|Second Extension Phase (Weeks 144-240)|5 participants completed the 1st extension phase but did not enroll in the 2nd extension phase.|14
10335453|NCT00352053|11472060|FG000|COMPLETED|Second Extension Phase (Weeks 144-240)||4
10335454|NCT00352053|11472061|FG001|COMPLETED|Second Extension Phase (Weeks 144-240)||9
10335455|NCT00352053|11472060|FG000|NOT COMPLETED|Second Extension Phase (Weeks 144-240)||5
10335456|NCT00352053|11472061|FG001|NOT COMPLETED|Second Extension Phase (Weeks 144-240)||5
10335457|NCT00352053|11472060|FG000|STARTED|Third Extension Phase (Weeks 240-294)|3 participants completed the 2nd extension phase but did not enroll in the 3rd extension phase.|1
10335458|NCT00352053|11472061|FG001|STARTED|Third Extension Phase (Weeks 240-294)|5 participants completed the 2nd extension phase but did not enroll in the 3rd extension phase.|4
10335459|NCT00352053|11472060|FG000|COMPLETED|Third Extension Phase (Weeks 240-294)||0
10335460|NCT00352053|11472061|FG001|COMPLETED|Third Extension Phase (Weeks 240-294)||2
10335461|NCT00352053|11472060|FG000|NOT COMPLETED|Third Extension Phase (Weeks 240-294)||1
10335462|NCT00352053|11472061|FG001|NOT COMPLETED|Third Extension Phase (Weeks 240-294)||2
10335463|NCT00352105|11472075|FG000|STARTED|Overall Study||60
10335464|NCT00352105|11472075|FG000|COMPLETED|Overall Study||20
10335465|NCT00352105|11472075|FG000|NOT COMPLETED|Overall Study||40
10335466|NCT00352365|11472079|FG000|STARTED|Induction Therapy||41
10335467|NCT00352365|11472079|FG000|Eligible|Induction Therapy||38
10335468|NCT00352365|11472079|FG000|Eligible and Began Protocol Therapy|Induction Therapy||37
10335469|NCT00352365|11472079|FG000|COMPLETED|Induction Therapy||14
10335470|NCT00352365|11472079|FG000|NOT COMPLETED|Induction Therapy||27
10335471|NCT00352365|11472079|FG000|STARTED|Maintenance Therapy||12
10335472|NCT00352365|11472079|FG000|Eligible and Began Protocol Therapy|Maintenance Therapy||8
10335473|NCT00352365|11472079|FG000|COMPLETED|Maintenance Therapy||0
10335474|NCT00352365|11472079|FG000|NOT COMPLETED|Maintenance Therapy||12
10335475|NCT00352417|11472089|FG000|STARTED|Overall Study||24
10335476|NCT00352417|11472090|FG001|STARTED|Overall Study||26
10335477|NCT00352417|11472089|FG000|COMPLETED|Overall Study||19
10335478|NCT00352417|11472090|FG001|COMPLETED|Overall Study||21
10335479|NCT00352417|11472089|FG000|NOT COMPLETED|Overall Study||5
10335480|NCT00352417|11472090|FG001|NOT COMPLETED|Overall Study||5
10335481|NCT00352612|11472098|FG000|STARTED|Overall Study||100
10335482|NCT00352612|11472099|FG001|STARTED|Overall Study||100
10335483|NCT00352612|11472098|FG000|COMPLETED|Overall Study||100
10335484|NCT00352612|11472099|FG001|COMPLETED|Overall Study||100
10335485|NCT00352612|11472098|FG000|NOT COMPLETED|Overall Study||0
10335486|NCT00352612|11472099|FG001|NOT COMPLETED|Overall Study||0
10335487|NCT00352664|11472107|FG000|STARTED|Overall Study||27
10335488|NCT00352664|11472108|FG001|STARTED|Overall Study||0
10335489|NCT00352664|11472107|FG000|COMPLETED|Overall Study||20
10335490|NCT00352664|11472108|FG001|COMPLETED|Overall Study||0
10335491|NCT00352664|11472107|FG000|NOT COMPLETED|Overall Study||7
10335492|NCT00352664|11472108|FG001|NOT COMPLETED|Overall Study||0
10335493|NCT00352690|11472116|FG000|STARTED|Overall Study||10
10335494|NCT00352690|11472117|FG001|STARTED|Overall Study||0
10335495|NCT00352690|11472116|FG000|COMPLETED|Overall Study||8
10335496|NCT00352690|11472117|FG001|COMPLETED|Overall Study||0
10335497|NCT00352690|11472116|FG000|NOT COMPLETED|Overall Study||2
10335498|NCT00352690|11472117|FG001|NOT COMPLETED|Overall Study||0
10335499|NCT00352755|11472123|FG000|STARTED|Overall Study||18
10335500|NCT00352755|11472123|FG000|COMPLETED|Overall Study||16
10335501|NCT00352755|11472123|FG000|NOT COMPLETED|Overall Study||2
10335502|NCT00352781|11472127|FG000|STARTED|Overall Study||1767
10335503|NCT00352781|11472127|FG000|COMPLETED|Overall Study||884
10335504|NCT00352781|11472127|FG000|NOT COMPLETED|Overall Study||883
10335505|NCT00352794|11472131|FG000|STARTED|Overall Study||40
10335506|NCT00352794|11472131|FG000|COMPLETED|Overall Study||40
10335507|NCT00352794|11472131|FG000|NOT COMPLETED|Overall Study||0
10335508|NCT00352846|11472137|FG000|STARTED|Overall Study||37
10335509|NCT00352846|11472138|FG001|STARTED|Overall Study||37
10335510|NCT00352846|11472137|FG000|COMPLETED|Overall Study||29
10335511|NCT00352846|11472138|FG001|COMPLETED|Overall Study||24
10335512|NCT00352846|11472137|FG000|NOT COMPLETED|Overall Study||8
10335513|NCT00352846|11472138|FG001|NOT COMPLETED|Overall Study||13
10335514|NCT00352885|11472146|FG000|STARTED|Overall Study||9
10335515|NCT00352885|11472147|FG001|STARTED|Overall Study||11
10335516|NCT00352885|11472146|FG000|Completed Cycle 1 of IL-2 Treatment|Overall Study||9
10335517|NCT00352885|11472147|FG001|Completed Cycle 1 of IL-2 Treatment|Overall Study||11
10335518|NCT00352885|11472146|FG000|Completed Cycle 2 of IL-2 Treatment|Overall Study||8
10335519|NCT00352885|11472147|FG001|Completed Cycle 2 of IL-2 Treatment|Overall Study||9
10335520|NCT00352885|11472146|FG000|Completed Cycle 3 of IL-2 Treatment|Overall Study||4
10335521|NCT00352885|11472147|FG001|Completed Cycle 3 of IL-2 Treatment|Overall Study||7
10335522|NCT00352885|11472146|FG000|COMPLETED|Overall Study||3
10335523|NCT00352885|11472147|FG001|COMPLETED|Overall Study||4
10335524|NCT00352885|11472146|FG000|NOT COMPLETED|Overall Study||6
10335525|NCT00352885|11472147|FG001|NOT COMPLETED|Overall Study||7
10335526|NCT00352911|11472155|FG000|STARTED|150mg Twice Daily (14 Days)||16
10335527|NCT00352911|11472156|FG001|STARTED|150mg Twice Daily (14 Days)||3
10335528|NCT00352911|11472155|FG000|COMPLETED|150mg Twice Daily (14 Days)||16
10335529|NCT00352911|11472156|FG001|COMPLETED|150mg Twice Daily (14 Days)||3
10335530|NCT00352911|11472155|FG000|NOT COMPLETED|150mg Twice Daily (14 Days)||0
10335531|NCT00352911|11472156|FG001|NOT COMPLETED|150mg Twice Daily (14 Days)||0
10335532|NCT00352911|11472155|FG000|STARTED|300mg Twice Daily (14 Days)||16
10335533|NCT00352911|11472156|FG001|STARTED|300mg Twice Daily (14 Days)||3
10335534|NCT00352911|11472155|FG000|COMPLETED|300mg Twice Daily (14 Days)||15
10335535|NCT00352911|11472156|FG001|COMPLETED|300mg Twice Daily (14 Days)||3
10335536|NCT00352911|11472155|FG000|NOT COMPLETED|300mg Twice Daily (14 Days)||1
10335537|NCT00352911|11472156|FG001|NOT COMPLETED|300mg Twice Daily (14 Days)||0
10335538|NCT00352976|11472162|FG000|STARTED|Overall Study||83
10335539|NCT00352976|11472162|FG000|COMPLETED|Overall Study||83
10335540|NCT00352976|11472162|FG000|NOT COMPLETED|Overall Study||0
10335541|NCT00353119|11472169|FG000|STARTED|First Intervention Day 0 to Week 12||5
10335542|NCT00353119|11472170|FG001|STARTED|First Intervention Day 0 to Week 12||10
10335543|NCT00353119|11472169|FG000|COMPLETED|First Intervention Day 0 to Week 12||5
10335544|NCT00353119|11472170|FG001|COMPLETED|First Intervention Day 0 to Week 12||10
10707730|NCT02623322|11872446|FG002|COMPLETED|Overall Study||40
10707731|NCT02623322|11872444|FG000|NOT COMPLETED|Overall Study||2
10707732|NCT02623322|11872445|FG001|NOT COMPLETED|Overall Study||1
10707733|NCT02623322|11872446|FG002|NOT COMPLETED|Overall Study||0
10335545|NCT00353119|11472169|FG000|NOT COMPLETED|First Intervention Day 0 to Week 12||0
10335546|NCT00353119|11472170|FG001|NOT COMPLETED|First Intervention Day 0 to Week 12||0
10335547|NCT00353119|11472169|FG000|STARTED|Second Intervention Week 12 to Week 28||5
10335548|NCT00353119|11472170|FG001|STARTED|Second Intervention Week 12 to Week 28||10
10335549|NCT00353119|11472169|FG000|COMPLETED|Second Intervention Week 12 to Week 28||5
10335550|NCT00353119|11472170|FG001|COMPLETED|Second Intervention Week 12 to Week 28||10
10335551|NCT00353119|11472169|FG000|NOT COMPLETED|Second Intervention Week 12 to Week 28||0
10335552|NCT00353119|11472170|FG001|NOT COMPLETED|Second Intervention Week 12 to Week 28||0
10335553|NCT00353262|11472179|FG000|STARTED|Overall Study||36
10335554|NCT00353262|11472179|FG000|COMPLETED|Overall Study||7
10335555|NCT00353262|11472179|FG000|NOT COMPLETED|Overall Study||29
10335556|NCT00353301|11472183|FG000|STARTED|Overall Study||25
10335557|NCT00353301|11472183|FG000|COMPLETED|Overall Study||25
10335558|NCT00353301|11472183|FG000|NOT COMPLETED|Overall Study||0
10335559|NCT00353366|11472187|FG000|STARTED|Overall Study||1439
10335560|NCT00353366|11472187|FG000|COMPLETED|Overall Study||1296
10335561|NCT00353366|11472187|FG000|NOT COMPLETED|Overall Study||143
10335562|NCT00353418|11472193|FG000|STARTED|Overall Study||138
10335563|NCT00353418|11472194|FG001|STARTED|Overall Study||277
10335564|NCT00353418|11472193|FG000|COMPLETED|Overall Study||55
10335565|NCT00353418|11472194|FG001|COMPLETED|Overall Study||119
10335566|NCT00353418|11472193|FG000|NOT COMPLETED|Overall Study||83
10335567|NCT00353418|11472194|FG001|NOT COMPLETED|Overall Study||158
10335568|NCT00353431|11472202|FG000|STARTED|Overall Study||63
10335569|NCT00353431|11472203|FG001|STARTED|Overall Study||67
10335570|NCT00353431|11472202|FG000|COMPLETED|Overall Study||63
10335571|NCT00353431|11472203|FG001|COMPLETED|Overall Study||67
10335572|NCT00353431|11472202|FG000|NOT COMPLETED|Overall Study||0
10335573|NCT00353431|11472203|FG001|NOT COMPLETED|Overall Study||0
10335574|NCT00353496|11472211|FG000|STARTED|Overall Study||101
10335575|NCT00353496|11472212|FG001|STARTED|Overall Study||103
10335576|NCT00353496|11472211|FG000|COMPLETED|Overall Study|Patients who completed specified assessments or met primary efficacy endpoint criteria for an event.|85
10335577|NCT00353496|11472212|FG001|COMPLETED|Overall Study||86
10335578|NCT00353496|11472211|FG000|NOT COMPLETED|Overall Study||16
10335579|NCT00353496|11472212|FG001|NOT COMPLETED|Overall Study||17
10335580|NCT00353522|11472221|FG000|STARTED|Overall Study||89
10335581|NCT00353522|11472222|FG001|STARTED|Overall Study||46
10335582|NCT00353522|11472221|FG000|COMPLETED|Overall Study||74
10335583|NCT00353522|11472222|FG001|COMPLETED|Overall Study||37
10707734|NCT02623335|11872458|FG000|STARTED|Overall Study||223
10335584|NCT00353522|11472221|FG000|NOT COMPLETED|Overall Study||15
10707735|NCT02623335|11872459|FG001|STARTED|Overall Study||223
10335585|NCT00353522|11472222|FG001|NOT COMPLETED|Overall Study||9
10335586|NCT00353652|11472230|FG000|STARTED|First Intervention - 3 Months||15
10335587|NCT00353652|11472231|FG001|STARTED|First Intervention - 3 Months||15
10335588|NCT00353652|11472232|FG002|STARTED|First Intervention - 3 Months||6
10335589|NCT00353652|11472233|FG003|STARTED|First Intervention - 3 Months||7
10335590|NCT00353652|11472234|FG004|STARTED|First Intervention - 3 Months||3
10335591|NCT00353652|11472235|FG005|STARTED|First Intervention - 3 Months||0
10335592|NCT00353652|11472236|FG006|STARTED|First Intervention - 3 Months||1
10335593|NCT00353652|11472237|FG007|STARTED|First Intervention - 3 Months||0
10335594|NCT00353652|11472230|FG000|COMPLETED|First Intervention - 3 Months||12
10335595|NCT00353652|11472231|FG001|COMPLETED|First Intervention - 3 Months||11
10335596|NCT00353652|11472232|FG002|COMPLETED|First Intervention - 3 Months||6
10335597|NCT00353652|11472233|FG003|COMPLETED|First Intervention - 3 Months||7
10335598|NCT00353652|11472234|FG004|COMPLETED|First Intervention - 3 Months||3
10335599|NCT00353652|11472235|FG005|COMPLETED|First Intervention - 3 Months||0
10335600|NCT00353652|11472236|FG006|COMPLETED|First Intervention - 3 Months||1
10335601|NCT00353652|11472237|FG007|COMPLETED|First Intervention - 3 Months||0
10335602|NCT00353652|11472230|FG000|NOT COMPLETED|First Intervention - 3 Months||3
10335603|NCT00353652|11472231|FG001|NOT COMPLETED|First Intervention - 3 Months||4
10335604|NCT00353652|11472232|FG002|NOT COMPLETED|First Intervention - 3 Months||0
10335605|NCT00353652|11472233|FG003|NOT COMPLETED|First Intervention - 3 Months||0
10335606|NCT00353652|11472234|FG004|NOT COMPLETED|First Intervention - 3 Months||0
10335607|NCT00353652|11472235|FG005|NOT COMPLETED|First Intervention - 3 Months||0
10335608|NCT00353652|11472236|FG006|NOT COMPLETED|First Intervention - 3 Months||0
10335609|NCT00353652|11472237|FG007|NOT COMPLETED|First Intervention - 3 Months||0
10335610|NCT00353652|11472230|FG000|STARTED|Second Intervention - 3 Months||12
10335611|NCT00353652|11472231|FG001|STARTED|Second Intervention - 3 Months||11
10335612|NCT00353652|11472232|FG002|STARTED|Second Intervention - 3 Months||6
10335613|NCT00353652|11472233|FG003|STARTED|Second Intervention - 3 Months||7
10335614|NCT00353652|11472234|FG004|STARTED|Second Intervention - 3 Months||3
10335615|NCT00353652|11472235|FG005|STARTED|Second Intervention - 3 Months||0
10335616|NCT00353652|11472236|FG006|STARTED|Second Intervention - 3 Months||1
10335617|NCT00353652|11472237|FG007|STARTED|Second Intervention - 3 Months||0
10335618|NCT00353652|11472230|FG000|COMPLETED|Second Intervention - 3 Months||12
10335619|NCT00353652|11472231|FG001|COMPLETED|Second Intervention - 3 Months||11
10335620|NCT00353652|11472232|FG002|COMPLETED|Second Intervention - 3 Months||6
10335621|NCT00353652|11472233|FG003|COMPLETED|Second Intervention - 3 Months||7
10335622|NCT00353652|11472234|FG004|COMPLETED|Second Intervention - 3 Months||3
10335623|NCT00353652|11472235|FG005|COMPLETED|Second Intervention - 3 Months||0
10335624|NCT00353652|11472236|FG006|COMPLETED|Second Intervention - 3 Months||1
10335625|NCT00353652|11472237|FG007|COMPLETED|Second Intervention - 3 Months||0
10335626|NCT00353652|11472230|FG000|NOT COMPLETED|Second Intervention - 3 Months||0
10335627|NCT00353652|11472231|FG001|NOT COMPLETED|Second Intervention - 3 Months||0
10335628|NCT00353652|11472232|FG002|NOT COMPLETED|Second Intervention - 3 Months||0
10335629|NCT00353652|11472233|FG003|NOT COMPLETED|Second Intervention - 3 Months||0
10335630|NCT00353652|11472234|FG004|NOT COMPLETED|Second Intervention - 3 Months||0
10335631|NCT00353652|11472235|FG005|NOT COMPLETED|Second Intervention - 3 Months||0
10335632|NCT00353652|11472236|FG006|NOT COMPLETED|Second Intervention - 3 Months||0
10335633|NCT00353652|11472237|FG007|NOT COMPLETED|Second Intervention - 3 Months||0
10335634|NCT00353652|11472230|FG000|STARTED|Third Intervention - 3 Months||0
10335635|NCT00353652|11472231|FG001|STARTED|Third Intervention - 3 Months||0
10335636|NCT00353652|11472232|FG002|STARTED|Third Intervention - 3 Months||6
10335637|NCT00353652|11472233|FG003|STARTED|Third Intervention - 3 Months||7
10335638|NCT00353652|11472234|FG004|STARTED|Third Intervention - 3 Months||3
10335639|NCT00353652|11472235|FG005|STARTED|Third Intervention - 3 Months||0
10335640|NCT00353652|11472236|FG006|STARTED|Third Intervention - 3 Months||1
10335641|NCT00353652|11472237|FG007|STARTED|Third Intervention - 3 Months||0
10335642|NCT00353652|11472230|FG000|COMPLETED|Third Intervention - 3 Months||0
10335643|NCT00353652|11472231|FG001|COMPLETED|Third Intervention - 3 Months||0
10335644|NCT00353652|11472232|FG002|COMPLETED|Third Intervention - 3 Months||6
10335645|NCT00353652|11472233|FG003|COMPLETED|Third Intervention - 3 Months||6
10335646|NCT00353652|11472234|FG004|COMPLETED|Third Intervention - 3 Months||3
10335647|NCT00353652|11472235|FG005|COMPLETED|Third Intervention - 3 Months||0
10335648|NCT00353652|11472236|FG006|COMPLETED|Third Intervention - 3 Months||1
10335649|NCT00353652|11472237|FG007|COMPLETED|Third Intervention - 3 Months||0
10335650|NCT00353652|11472230|FG000|NOT COMPLETED|Third Intervention - 3 Months||0
10335651|NCT00353652|11472231|FG001|NOT COMPLETED|Third Intervention - 3 Months||0
10335652|NCT00353652|11472232|FG002|NOT COMPLETED|Third Intervention - 3 Months||0
10335653|NCT00353652|11472233|FG003|NOT COMPLETED|Third Intervention - 3 Months||1
10335654|NCT00353652|11472234|FG004|NOT COMPLETED|Third Intervention - 3 Months||0
10335655|NCT00353652|11472235|FG005|NOT COMPLETED|Third Intervention - 3 Months||0
10335656|NCT00353652|11472236|FG006|NOT COMPLETED|Third Intervention - 3 Months||0
10809601|NCT03831191|11971478|FG009|NOT COMPLETED|Induction Period (16 Weeks)||0
10809602|NCT03831191|11971479|FG010|NOT COMPLETED|Induction Period (16 Weeks)||0
10809603|NCT03831191|11971480|FG011|NOT COMPLETED|Induction Period (16 Weeks)||0
10809604|NCT03831191|11971481|FG012|NOT COMPLETED|Induction Period (16 Weeks)||0
10809605|NCT03831191|11971482|FG013|NOT COMPLETED|Induction Period (16 Weeks)||0
10809606|NCT03831191|11971483|FG014|NOT COMPLETED|Induction Period (16 Weeks)||0
10811211|NCT03770091|11972929|FG001|NOT COMPLETED|Overall Study||0
10335657|NCT00353652|11472237|FG007|NOT COMPLETED|Third Intervention - 3 Months||0
10335658|NCT00353704|11472254|FG000|STARTED|Overall Study||25
10335659|NCT00353704|11472255|FG001|STARTED|Overall Study||25
10335660|NCT00353704|11472254|FG000|COMPLETED|Overall Study||22
10335661|NCT00353704|11472255|FG001|COMPLETED|Overall Study||24
10335662|NCT00353704|11472254|FG000|NOT COMPLETED|Overall Study||3
10335663|NCT00353704|11472255|FG001|NOT COMPLETED|Overall Study||1
10335664|NCT00353795|11472261|FG000|STARTED|Overall Study||179
10335665|NCT00353795|11472261|FG000|COMPLETED|Overall Study||179
10335666|NCT00353795|11472261|FG000|NOT COMPLETED|Overall Study||0
10335667|NCT00353834|11472267|FG000|STARTED|Overall Study||26
10335668|NCT00353834|11472268|FG001|STARTED|Overall Study||27
10335669|NCT00353834|11472267|FG000|COMPLETED|Overall Study||26
10335670|NCT00353834|11472268|FG001|COMPLETED|Overall Study||27
10335671|NCT00353834|11472267|FG000|NOT COMPLETED|Overall Study||0
10335672|NCT00353834|11472268|FG001|NOT COMPLETED|Overall Study||0
10335673|NCT00353873|11472276|FG000|STARTED|Overall Study||153
10335674|NCT00353873|11472277|FG001|STARTED|Overall Study||150
10335675|NCT00353873|11472276|FG000|COMPLETED|Overall Study||147
10335676|NCT00353873|11472277|FG001|COMPLETED|Overall Study||147
10335677|NCT00353873|11472276|FG000|NOT COMPLETED|Overall Study||6
10335678|NCT00353873|11472277|FG001|NOT COMPLETED|Overall Study||3
10335679|NCT00353977|11472283|FG000|STARTED|Overall Study||38
10335680|NCT00353977|11472283|FG000|COMPLETED|Overall Study||38
10335681|NCT00353977|11472283|FG000|NOT COMPLETED|Overall Study||0
10335682|NCT00354029|11472289|FG000|STARTED|Overall Study||43
10335683|NCT00354029|11472290|FG001|STARTED|Overall Study||40
10335684|NCT00354029|11472289|FG000|COMPLETED|Overall Study||39
10335685|NCT00354029|11472290|FG001|COMPLETED|Overall Study||38
10335686|NCT00354029|11472289|FG000|NOT COMPLETED|Overall Study||4
10335687|NCT00354029|11472290|FG001|NOT COMPLETED|Overall Study||2
10335688|NCT00354107|11472296|FG000|STARTED|Overall Study||5
10335689|NCT00354107|11472296|FG000|COMPLETED|Overall Study||0
10335690|NCT00354107|11472296|FG000|NOT COMPLETED|Overall Study||5
10335691|NCT00354159|11472302|FG000|STARTED|Randomized Study Period||202
10335692|NCT00354159|11472303|FG001|STARTED|Randomized Study Period||198
10335693|NCT00354159|11472302|FG000|COMPLETED|Randomized Study Period||180
10335694|NCT00354159|11472303|FG001|COMPLETED|Randomized Study Period||176
10335695|NCT00354159|11472302|FG000|NOT COMPLETED|Randomized Study Period||22
10335696|NCT00354159|11472303|FG001|NOT COMPLETED|Randomized Study Period||22
10335697|NCT00354159|11472302|FG000|STARTED|Long-term Follow-up|Number entering post 12-month non-randomized long-term follow-up period|180
10335698|NCT00354159|11472303|FG001|STARTED|Long-term Follow-up|Number entering post 12-month non-randomized long-term follow-up period|176
10335699|NCT00354159|11472302|FG000|COMPLETED|Long-term Follow-up|All subjects were exited at the time of study closure|0
10335700|NCT00354159|11472303|FG001|COMPLETED|Long-term Follow-up|All subjects were exited at the time of study closure|0
10335701|NCT00354159|11472302|FG000|NOT COMPLETED|Long-term Follow-up||180
10335702|NCT00354159|11472303|FG001|NOT COMPLETED|Long-term Follow-up||176
10335703|NCT00354172|11472316|FG000|STARTED|Overall Study||16
10335704|NCT00354172|11472316|FG000|COMPLETED|Overall Study|1 patient did not reach umbilical cord blood transplant|15
10335705|NCT00354172|11472316|FG000|NOT COMPLETED|Overall Study||1
10335706|NCT00354224|11472320|FG000|STARTED|Overall Study||10
10335707|NCT00354224|11472320|FG000|COMPLETED|Overall Study||10
10335708|NCT00354224|11472320|FG000|NOT COMPLETED|Overall Study||0
10335709|NCT00354341|11472326|FG000|STARTED|Overall Study||88
10335710|NCT00354341|11472327|FG001|STARTED|Overall Study||82
10335711|NCT00354341|11472326|FG000|COMPLETED|Overall Study||85
10335712|NCT00354341|11472327|FG001|COMPLETED|Overall Study||75
10335713|NCT00354341|11472326|FG000|NOT COMPLETED|Overall Study||3
10335714|NCT00354341|11472327|FG001|NOT COMPLETED|Overall Study||7
10335715|NCT00354432|11472337|FG000|STARTED|Overall Study||30
10335716|NCT00354432|11472338|FG001|STARTED|Overall Study||30
10335717|NCT00354432|11472339|FG002|STARTED|Overall Study||30
10335718|NCT00354432|11472340|FG003|STARTED|Overall Study||30
10335719|NCT00354432|11472337|FG000|COMPLETED|Overall Study||24
10335720|NCT00354432|11472338|FG001|COMPLETED|Overall Study||22
10335721|NCT00354432|11472339|FG002|COMPLETED|Overall Study||20
10335722|NCT00354432|11472340|FG003|COMPLETED|Overall Study||20
10335723|NCT00354432|11472337|FG000|NOT COMPLETED|Overall Study||6
10335724|NCT00354432|11472338|FG001|NOT COMPLETED|Overall Study||8
10335725|NCT00354432|11472339|FG002|NOT COMPLETED|Overall Study||10
10335726|NCT00354432|11472340|FG003|NOT COMPLETED|Overall Study||10
10335727|NCT00354484|11472352|FG000|STARTED|Overall Study||142
10335728|NCT00354484|11472353|FG001|STARTED|Overall Study||147
10335729|NCT00354484|11472352|FG000|COMPLETED|Overall Study||138
10335730|NCT00354484|11472353|FG001|COMPLETED|Overall Study||144
10335731|NCT00354484|11472352|FG000|NOT COMPLETED|Overall Study||4
10335732|NCT00354484|11472353|FG001|NOT COMPLETED|Overall Study||3
10335733|NCT00354601|11472359|FG000|STARTED|Overall Study||2
10335734|NCT00354601|11472359|FG000|COMPLETED|Overall Study||0
10335735|NCT00354601|11472359|FG000|NOT COMPLETED|Overall Study||2
10335736|NCT00354614|11472363|FG000|STARTED|Overall Study||81
10335737|NCT00354614|11472363|FG000|COMPLETED|Overall Study||53
10335738|NCT00354614|11472363|FG000|NOT COMPLETED|Overall Study||28
10335739|NCT00354640|11472367|FG000|STARTED|Overall Study||11
10335740|NCT00354640|11472367|FG000|COMPLETED|Overall Study||11
10335741|NCT00354640|11472367|FG000|NOT COMPLETED|Overall Study||0
10335742|NCT00354679|11472371|FG000|STARTED|Overall Study||34
10335743|NCT00354679|11472371|FG000|COMPLETED|Overall Study||33
10335744|NCT00354679|11472371|FG000|NOT COMPLETED|Overall Study||1
10335745|NCT00354744|11472375|FG000|STARTED|Overall Study||109
10335746|NCT00354744|11472375|FG000|COMPLETED|Overall Study||67
10335747|NCT00354744|11472375|FG000|NOT COMPLETED|Overall Study||42
10335748|NCT00354770|11472383|FG000|STARTED|Overall Study||25
10335749|NCT00354770|11472384|FG001|STARTED|Overall Study||25
10335750|NCT00354770|11472383|FG000|COMPLETED|Overall Study||22
10335751|NCT00354770|11472384|FG001|COMPLETED|Overall Study||22
10335752|NCT00354770|11472383|FG000|NOT COMPLETED|Overall Study||3
10335753|NCT00354770|11472384|FG001|NOT COMPLETED|Overall Study||3
10335754|NCT00354887|11472390|FG000|STARTED|Overall Study||30
10335755|NCT00354887|11472390|FG000|COMPLETED|Overall Study||29
10335756|NCT00354887|11472390|FG000|NOT COMPLETED|Overall Study||1
10335757|NCT00354913|11472394|FG000|STARTED|Overall Study||21
10335758|NCT00354913|11472394|FG000|COMPLETED|Overall Study||21
10335759|NCT00354913|11472394|FG000|NOT COMPLETED|Overall Study||0
10335760|NCT00354978|11472398|FG000|STARTED|Overall Study||43
10335761|NCT00354978|11472398|FG000|COMPLETED|Overall Study||43
10335762|NCT00354978|11472398|FG000|NOT COMPLETED|Overall Study||0
10335763|NCT00355030|11472404|FG000|STARTED|Study Period 1 Treatment||46
10335764|NCT00355030|11472405|FG001|STARTED|Study Period 1 Treatment||45
10335765|NCT00355030|11472404|FG000|Received At Least One Dose of Study Drug|Study Period 1 Treatment|1 non-eligible participant received somatropin from previous control group|45
10335766|NCT00355030|11472405|FG001|Received At Least One Dose of Study Drug|Study Period 1 Treatment|2 non-eligible participants received somatropin from previous control group|43
10335767|NCT00355030|11472404|FG000|COMPLETED|Study Period 1 Treatment|Participants from the Netherlands exited the study after Study Period 1.|1
10335768|NCT00355030|11472405|FG001|COMPLETED|Study Period 1 Treatment|Participants from the Netherlands exited the study after Study Period 1.|1
10335769|NCT00355030|11472404|FG000|NOT COMPLETED|Study Period 1 Treatment||45
10335770|NCT00355030|11472405|FG001|NOT COMPLETED|Study Period 1 Treatment||44
10335771|NCT00355030|11472404|FG000|STARTED|Study Period 2 Long Term Follow-Up|Participants from France were given the option to re-consent for Study Period 2.|20
10335772|NCT00355030|11472405|FG001|STARTED|Study Period 2 Long Term Follow-Up|Participants from France were given the option to re-consent for Study Period 2.|19
10335773|NCT00355030|11472404|FG000|COMPLETED|Study Period 2 Long Term Follow-Up||19
10335774|NCT00355030|11472405|FG001|COMPLETED|Study Period 2 Long Term Follow-Up||17
10335775|NCT00355030|11472404|FG000|NOT COMPLETED|Study Period 2 Long Term Follow-Up||1
10335776|NCT00355030|11472405|FG001|NOT COMPLETED|Study Period 2 Long Term Follow-Up||2
10335777|NCT00355056|11472413|FG000|STARTED|Randomization Period||107
10335778|NCT00355056|11472414|FG001|STARTED|Randomization Period||123
10335779|NCT00355056|11472413|FG000|COMPLETED|Randomization Period||103
10335780|NCT00355056|11472414|FG001|COMPLETED|Randomization Period||117
10335781|NCT00355056|11472413|FG000|NOT COMPLETED|Randomization Period||4
10335782|NCT00355056|11472414|FG001|NOT COMPLETED|Randomization Period||6
10335783|NCT00355056|11472413|FG000|STARTED|Optional Patent Foramen Ovale Closure|A sham procedure was not part of this period.|0
10335784|NCT00355056|11472414|FG001|STARTED|Optional Patent Foramen Ovale Closure|Participants who completed Sham Procedure randomization Arm were eligible. 87/103 consented.|87
10335785|NCT00355056|11472413|FG000|COMPLETED|Optional Patent Foramen Ovale Closure||0
10335786|NCT00355056|11472414|FG001|COMPLETED|Optional Patent Foramen Ovale Closure||84
10335787|NCT00355056|11472413|FG000|NOT COMPLETED|Optional Patent Foramen Ovale Closure||0
10335788|NCT00355056|11472414|FG001|NOT COMPLETED|Optional Patent Foramen Ovale Closure||3
10335789|NCT00355082|11472430|FG000|STARTED|Double-Blind (DB) Treatment Phase|112 participants have baseline data; 1 participant did not receive study drug.|113
10335790|NCT00355082|11472431|FG001|STARTED|Double-Blind (DB) Treatment Phase|111 participants have baseline data; 2 participants did not receive study drug.|113
10335791|NCT00355082|11472432|FG002|STARTED|Double-Blind (DB) Treatment Phase||0
10335792|NCT00355082|11472430|FG000|COMPLETED|Double-Blind (DB) Treatment Phase||94
10335793|NCT00355082|11472431|FG001|COMPLETED|Double-Blind (DB) Treatment Phase||79
10335794|NCT00355082|11472432|FG002|COMPLETED|Double-Blind (DB) Treatment Phase||0
10335795|NCT00355082|11472430|FG000|NOT COMPLETED|Double-Blind (DB) Treatment Phase||19
10335796|NCT00355082|11472431|FG001|NOT COMPLETED|Double-Blind (DB) Treatment Phase||34
10335797|NCT00355082|11472432|FG002|NOT COMPLETED|Double-Blind (DB) Treatment Phase||0
10335798|NCT00355082|11472430|FG000|STARTED|Continuation Phase|83 and 101 participants from the 250 and 300 mg groups (DB Phase), respectively, entered the CP.|184
10335799|NCT00355082|11472431|FG001|STARTED|Continuation Phase||0
10335800|NCT00355082|11472432|FG002|STARTED|Continuation Phase|"See Pre-assign. Details for reasons why number starting CP does not equal number completing TP."|11
10335801|NCT00355082|11472430|FG000|COMPLETED|Continuation Phase||160
10335802|NCT00355082|11472431|FG001|COMPLETED|Continuation Phase||0
10335803|NCT00355082|11472432|FG002|COMPLETED|Continuation Phase||8
10335804|NCT00355082|11472430|FG000|NOT COMPLETED|Continuation Phase||24
10335805|NCT00355082|11472431|FG001|NOT COMPLETED|Continuation Phase||0
10335806|NCT00355082|11472432|FG002|NOT COMPLETED|Continuation Phase||3
10335807|NCT00355121|11472446|FG000|STARTED|Overall Study||353
10335808|NCT00355121|11472447|FG001|STARTED|Overall Study||353
10335809|NCT00355121|11472448|FG002|STARTED|Overall Study||175
10335810|NCT00355121|11472446|FG000|COMPLETED|Overall Study||332
10335811|NCT00355121|11472447|FG001|COMPLETED|Overall Study||324
10335812|NCT00355121|11472448|FG002|COMPLETED|Overall Study||170
10335813|NCT00355121|11472446|FG000|NOT COMPLETED|Overall Study||21
10335814|NCT00355121|11472447|FG001|NOT COMPLETED|Overall Study||29
10335815|NCT00355121|11472448|FG002|NOT COMPLETED|Overall Study||5
10335816|NCT00355134|11472464|FG000|STARTED|Core Phase||370
10335817|NCT00355134|11472465|FG001|STARTED|Core Phase||358
10335818|NCT00355134|11472466|FG002|STARTED|Core Phase||355
10335819|NCT00355134|11472467|FG003|STARTED|Core Phase||0
10335820|NCT00355134|11472468|FG004|STARTED|Core Phase||0
10335821|NCT00355134|11472464|FG000|COMPLETED|Core Phase||251
10335822|NCT00355134|11472465|FG001|COMPLETED|Core Phase||272
10335823|NCT00355134|11472466|FG002|COMPLETED|Core Phase||255
10335824|NCT00355134|11472467|FG003|COMPLETED|Core Phase||0
10335825|NCT00355134|11472468|FG004|COMPLETED|Core Phase||0
10335826|NCT00355134|11472464|FG000|NOT COMPLETED|Core Phase||119
10335827|NCT00355134|11472465|FG001|NOT COMPLETED|Core Phase||86
10335828|NCT00355134|11472466|FG002|NOT COMPLETED|Core Phase||100
10335829|NCT00355134|11472467|FG003|NOT COMPLETED|Core Phase||0
10335830|NCT00355134|11472468|FG004|NOT COMPLETED|Core Phase||0
10335831|NCT00355134|11472464|FG000|STARTED|Extension Phase||203
10335832|NCT00355134|11472465|FG001|STARTED|Extension Phase||217
10335833|NCT00355134|11472466|FG002|STARTED|Extension Phase||0
10335834|NCT00355134|11472467|FG003|STARTED|Extension Phase||105
10335835|NCT00355134|11472468|FG004|STARTED|Extension Phase||107
10335836|NCT00355134|11472464|FG000|COMPLETED|Extension Phase||172
10335837|NCT00355134|11472465|FG001|COMPLETED|Extension Phase||180
10335838|NCT00355134|11472466|FG002|COMPLETED|Extension Phase||0
10335839|NCT00355134|11472467|FG003|COMPLETED|Extension Phase||89
10335840|NCT00355134|11472468|FG004|COMPLETED|Extension Phase||88
10335841|NCT00355134|11472464|FG000|NOT COMPLETED|Extension Phase||31
10335842|NCT00355134|11472465|FG001|NOT COMPLETED|Extension Phase||37
10335843|NCT00355134|11472466|FG002|NOT COMPLETED|Extension Phase||0
10335844|NCT00355134|11472467|FG003|NOT COMPLETED|Extension Phase||16
10335845|NCT00355134|11472468|FG004|NOT COMPLETED|Extension Phase||19
10335846|NCT00355147|11472480|FG000|STARTED|Overall Study||87
10335847|NCT00355147|11472481|FG001|STARTED|Overall Study||87
10335848|NCT00355147|11472480|FG000|COMPLETED|Overall Study||69
10335849|NCT00355147|11472481|FG001|COMPLETED|Overall Study||67
10335850|NCT00355147|11472480|FG000|NOT COMPLETED|Overall Study||18
10335851|NCT00355147|11472481|FG001|NOT COMPLETED|Overall Study||20
10335852|NCT00355199|11472493|FG000|STARTED|Overall Study||120
10335853|NCT00355199|11472494|FG001|STARTED|Overall Study||126
10335854|NCT00355199|11472493|FG000|COMPLETED|Overall Study||113
10335855|NCT00355199|11472494|FG001|COMPLETED|Overall Study||122
10335856|NCT00355199|11472493|FG000|NOT COMPLETED|Overall Study||7
10335857|NCT00355199|11472494|FG001|NOT COMPLETED|Overall Study||4
10335858|NCT00355264|11472500|FG000|STARTED|Part 1 (2 Weeks)||12
10335859|NCT00355264|11472500|FG000|COMPLETED|Part 1 (2 Weeks)||12
10335860|NCT00355264|11472500|FG000|NOT COMPLETED|Part 1 (2 Weeks)||0
10707736|NCT02623335|11872458|FG000|T0 Audio Recording (Day of Consultation)|Overall Study||223
10707737|NCT02623335|11872459|FG001|T0 Audio Recording (Day of Consultation)|Overall Study||222
10707738|NCT02623335|11872458|FG000|T1 Survey (24-48 Hours)|Overall Study||216
10707739|NCT02623335|11872459|FG001|T1 Survey (24-48 Hours)|Overall Study||214
10707740|NCT02623335|11872458|FG000|T2 Survey (6-8 Weeks)|Overall Study||199
10707741|NCT02623335|11872459|FG001|T2 Survey (6-8 Weeks)|Overall Study||192
10707742|NCT02623335|11872458|FG000|T3 Survey (12-14 Weeks)|Overall Study||196
10707743|NCT02623335|11872459|FG001|T3 Survey (12-14 Weeks)|Overall Study||187
10707744|NCT02623335|11872458|FG000|COMPLETED|Overall Study||196
10707745|NCT02623335|11872459|FG001|COMPLETED|Overall Study||187
10335861|NCT00355264|11472500|FG000|STARTED|Part 2 (8 Weeks)||12
10335862|NCT00355264|11472500|FG000|COMPLETED|Part 2 (8 Weeks)||12
10335863|NCT00355264|11472500|FG000|NOT COMPLETED|Part 2 (8 Weeks)||0
10335864|NCT00355264|11472500|FG000|STARTED|Part 3 (7 Weeks of Extension)||2
10335865|NCT00355264|11472500|FG000|COMPLETED|Part 3 (7 Weeks of Extension)||2
10335866|NCT00355264|11472500|FG000|NOT COMPLETED|Part 3 (7 Weeks of Extension)||0
10335867|NCT00355264|11472500|FG000|STARTED|Extension (Variable Duration)||12
10335868|NCT00355264|11472500|FG000|COMPLETED|Extension (Variable Duration)||10
10335869|NCT00355264|11472500|FG000|NOT COMPLETED|Extension (Variable Duration)||2
10335870|NCT00355342|11472511|FG000|STARTED|Overall Study||94
10335871|NCT00355342|11472512|FG001|STARTED|Overall Study||92
10707746|NCT02623335|11872458|FG000|NOT COMPLETED|Overall Study||27
10707747|NCT02623335|11872459|FG001|NOT COMPLETED|Overall Study||36
10707748|NCT02623348|11872467|FG000|STARTED|Overall Study||30
10707749|NCT02623348|11872468|FG001|STARTED|Overall Study||30
10707750|NCT02623348|11872467|FG000|3-month Assessment|Overall Study||27
10335872|NCT00355342|11472511|FG000|COMPLETED|Overall Study||55
10335873|NCT00355342|11472512|FG001|COMPLETED|Overall Study||56
10335874|NCT00355342|11472511|FG000|NOT COMPLETED|Overall Study||39
10335875|NCT00355342|11472512|FG001|NOT COMPLETED|Overall Study||36
10335876|NCT00355368|11472520|FG000|STARTED|Overall Study||210
10335877|NCT00355368|11472521|FG001|STARTED|Overall Study||210
10335878|NCT00355368|11472520|FG000|COMPLETED|Overall Study||200
10335879|NCT00355368|11472521|FG001|COMPLETED|Overall Study||201
10335880|NCT00355368|11472520|FG000|NOT COMPLETED|Overall Study||10
10335881|NCT00355368|11472521|FG001|NOT COMPLETED|Overall Study||9
10335882|NCT00355394|11472529|FG000|STARTED|Overall Study||15
10335883|NCT00355394|11472530|FG001|STARTED|Overall Study||16
10335884|NCT00355394|11472529|FG000|COMPLETED|Overall Study||15
10335885|NCT00355394|11472530|FG001|COMPLETED|Overall Study||16
10335886|NCT00355394|11472529|FG000|NOT COMPLETED|Overall Study||0
10335887|NCT00355394|11472530|FG001|NOT COMPLETED|Overall Study||0
10335888|NCT00355472|11472538|FG000|STARTED|Overall Study||16
10335889|NCT00355472|11472538|FG000|COMPLETED|Overall Study||15
10335890|NCT00355472|11472538|FG000|NOT COMPLETED|Overall Study||1
10335891|NCT00355615|11472554|FG000|STARTED|Randomized Double Blind Period||42
10335892|NCT00355615|11472555|FG001|STARTED|Randomized Double Blind Period||44
10335893|NCT00355615|11472556|FG002|STARTED|Randomized Double Blind Period||45
10335894|NCT00355615|11472557|FG003|STARTED|Randomized Double Blind Period||46
10335895|NCT00355615|11472558|FG004|STARTED|Randomized Double Blind Period|open label phase followed the randomized phase|0
10335896|NCT00355615|11472554|FG000|COMPLETED|Randomized Double Blind Period|1 dropped out due to adverse event|41
10335897|NCT00355615|11472555|FG001|COMPLETED|Randomized Double Blind Period||44
10335898|NCT00355615|11472556|FG002|COMPLETED|Randomized Double Blind Period|45 were randomized but 1 never received drug|44
10335899|NCT00355615|11472557|FG003|COMPLETED|Randomized Double Blind Period|1 dropped out due to an adverse event|45
10335900|NCT00355615|11472558|FG004|COMPLETED|Randomized Double Blind Period||0
10335901|NCT00355615|11472554|FG000|NOT COMPLETED|Randomized Double Blind Period||1
10335902|NCT00355615|11472555|FG001|NOT COMPLETED|Randomized Double Blind Period||0
10335903|NCT00355615|11472556|FG002|NOT COMPLETED|Randomized Double Blind Period||1
10335904|NCT00355615|11472557|FG003|NOT COMPLETED|Randomized Double Blind Period||1
10335905|NCT00355615|11472558|FG004|NOT COMPLETED|Randomized Double Blind Period||0
10335906|NCT00355615|11472554|FG000|STARTED|40-week Rosuvastatin Open Label Period||0
10335907|NCT00355615|11472555|FG001|STARTED|40-week Rosuvastatin Open Label Period||0
10335908|NCT00355615|11472556|FG002|STARTED|40-week Rosuvastatin Open Label Period||0
10335909|NCT00355615|11472557|FG003|STARTED|40-week Rosuvastatin Open Label Period||0
10335910|NCT00355615|11472558|FG004|STARTED|40-week Rosuvastatin Open Label Period||173
10335911|NCT00355615|11472554|FG000|COMPLETED|40-week Rosuvastatin Open Label Period||0
10335912|NCT00355615|11472555|FG001|COMPLETED|40-week Rosuvastatin Open Label Period||0
10335913|NCT00355615|11472556|FG002|COMPLETED|40-week Rosuvastatin Open Label Period||0
10335914|NCT00355615|11472557|FG003|COMPLETED|40-week Rosuvastatin Open Label Period||0
10335915|NCT00355615|11472558|FG004|COMPLETED|40-week Rosuvastatin Open Label Period||164
10335916|NCT00355615|11472554|FG000|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
10335917|NCT00355615|11472555|FG001|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
10335918|NCT00355615|11472556|FG002|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
10335919|NCT00355615|11472557|FG003|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
10335920|NCT00355615|11472558|FG004|NOT COMPLETED|40-week Rosuvastatin Open Label Period||9
10335921|NCT00355706|11472571|FG000|STARTED|Overall Study||50
10335922|NCT00355706|11472572|FG001|STARTED|Overall Study||50
10335923|NCT00355706|11472571|FG000|COMPLETED|Overall Study||50
10335924|NCT00355706|11472572|FG001|COMPLETED|Overall Study||50
10335925|NCT00355706|11472571|FG000|NOT COMPLETED|Overall Study||0
10335926|NCT00355706|11472572|FG001|NOT COMPLETED|Overall Study||0
10335927|NCT00355784|11472583|FG000|STARTED|Overall Study||9
10335928|NCT00355784|11472584|FG001|STARTED|Overall Study||8
10335929|NCT00355784|11472585|FG002|STARTED|Overall Study||7
10335930|NCT00355784|11472583|FG000|COMPLETED|Overall Study||9
10335931|NCT00355784|11472584|FG001|COMPLETED|Overall Study||8
10335932|NCT00355784|11472585|FG002|COMPLETED|Overall Study||5
10335933|NCT00355784|11472583|FG000|NOT COMPLETED|Overall Study||0
10335934|NCT00355784|11472584|FG001|NOT COMPLETED|Overall Study||0
10335935|NCT00355784|11472585|FG002|NOT COMPLETED|Overall Study||2
10335936|NCT00355797|11472597|FG000|STARTED|Overall Study||741
10335937|NCT00355797|11472598|FG001|STARTED|Overall Study||369
10335938|NCT00355797|11472599|FG002|STARTED|Overall Study||381
10335939|NCT00355797|11472597|FG000|COMPLETED|Overall Study||501
10335940|NCT00355797|11472598|FG001|COMPLETED|Overall Study||221
10335941|NCT00355797|11472599|FG002|COMPLETED|Overall Study||239
10335942|NCT00355797|11472597|FG000|NOT COMPLETED|Overall Study||240
10335943|NCT00355797|11472598|FG001|NOT COMPLETED|Overall Study||148
10335944|NCT00355797|11472599|FG002|NOT COMPLETED|Overall Study||142
10335945|NCT00355914|11472609|FG000|STARTED|Overall Study||60
10335946|NCT00355914|11472610|FG001|STARTED|Overall Study||60
10335947|NCT00355914|11472609|FG000|COMPLETED|Overall Study||60
10335948|NCT00355914|11472610|FG001|COMPLETED|Overall Study||60
10335949|NCT00355914|11472609|FG000|NOT COMPLETED|Overall Study||0
10335950|NCT00355914|11472610|FG001|NOT COMPLETED|Overall Study||0
10335951|NCT00356031|11472618|FG000|STARTED|Overall Study||20
10335952|NCT00356031|11472618|FG000|COMPLETED|Overall Study||20
10335953|NCT00356031|11472618|FG000|NOT COMPLETED|Overall Study||0
10335954|NCT00356057|11472627|FG000|STARTED|Overall Study||58
10335955|NCT00356057|11472628|FG001|STARTED|Overall Study||61
10335956|NCT00356057|11472629|FG002|STARTED|Overall Study||34
10335957|NCT00356057|11472627|FG000|IMPLANTED|Overall Study||49
10335958|NCT00356057|11472628|FG001|IMPLANTED|Overall Study||52
10335959|NCT00356057|11472629|FG002|IMPLANTED|Overall Study||25
10335960|NCT00356057|11472627|FG000|COMPLETED|Overall Study||45
10335961|NCT00356057|11472628|FG001|COMPLETED|Overall Study||47
10335962|NCT00356057|11472629|FG002|COMPLETED|Overall Study||22
10335963|NCT00356057|11472627|FG000|NOT COMPLETED|Overall Study||13
10335964|NCT00356057|11472628|FG001|NOT COMPLETED|Overall Study||14
10335965|NCT00356057|11472629|FG002|NOT COMPLETED|Overall Study||12
10335966|NCT00356122|11472641|FG000|STARTED|TREATMENT||53
10335967|NCT00356122|11472641|FG000|COMPLETED|TREATMENT||8
10335968|NCT00356122|11472641|FG000|NOT COMPLETED|TREATMENT||45
10335969|NCT00356122|11472641|FG000|STARTED|FOLLOW-UP||53
10335970|NCT00356122|11472641|FG000|COMPLETED|FOLLOW-UP||12
10335971|NCT00356122|11472641|FG000|NOT COMPLETED|FOLLOW-UP||41
10335972|NCT00356135|11472648|FG000|STARTED|Overall Study||47
10335973|NCT00356135|11472649|FG001|STARTED|Overall Study||48
10335974|NCT00356135|11472650|FG002|STARTED|Overall Study||44
10335975|NCT00356135|11472648|FG000|COMPLETED|Overall Study||43
10335976|NCT00356135|11472649|FG001|COMPLETED|Overall Study||46
10335977|NCT00356135|11472650|FG002|COMPLETED|Overall Study||39
10335978|NCT00356135|11472648|FG000|NOT COMPLETED|Overall Study||4
10335979|NCT00356135|11472649|FG001|NOT COMPLETED|Overall Study||2
10335980|NCT00356135|11472650|FG002|NOT COMPLETED|Overall Study||5
10335981|NCT00356148|11472662|FG000|STARTED|Overall Study||189
10335982|NCT00356148|11472663|FG001|STARTED|Overall Study||183
10335983|NCT00356148|11472662|FG000|COMPLETED|Overall Study||187
10335984|NCT00356148|11472663|FG001|COMPLETED|Overall Study||182
10335985|NCT00356148|11472662|FG000|NOT COMPLETED|Overall Study||2
10335986|NCT00356148|11472663|FG001|NOT COMPLETED|Overall Study||1
10335987|NCT00356200|11472672|FG000|STARTED|Cohort 1: 10 ug/ml||5
10335988|NCT00356200|11472673|FG001|STARTED|Cohort 1: 10 ug/ml||0
10335989|NCT00356200|11472672|FG000|COMPLETED|Cohort 1: 10 ug/ml||4
10335990|NCT00356200|11472673|FG001|COMPLETED|Cohort 1: 10 ug/ml||0
10335991|NCT00356200|11472672|FG000|NOT COMPLETED|Cohort 1: 10 ug/ml||1
10335992|NCT00356200|11472673|FG001|NOT COMPLETED|Cohort 1: 10 ug/ml||0
10335993|NCT00356200|11472672|FG000|STARTED|Cohort 2: 100 ug/ml (New Patients)||0
10335994|NCT00356200|11472673|FG001|STARTED|Cohort 2: 100 ug/ml (New Patients)||5
10335995|NCT00356200|11472672|FG000|COMPLETED|Cohort 2: 100 ug/ml (New Patients)||0
10335996|NCT00356200|11472673|FG001|COMPLETED|Cohort 2: 100 ug/ml (New Patients)||3
10335997|NCT00356200|11472672|FG000|NOT COMPLETED|Cohort 2: 100 ug/ml (New Patients)||0
10335998|NCT00356200|11472673|FG001|NOT COMPLETED|Cohort 2: 100 ug/ml (New Patients)||2
10335999|NCT00356265|11472688|FG000|STARTED|Overall Study||7
10336000|NCT00356265|11472689|FG001|STARTED|Overall Study||2
10336001|NCT00356265|11472690|FG002|STARTED|Overall Study||6
10336002|NCT00356265|11472688|FG000|COMPLETED|Overall Study||7
10336003|NCT00356265|11472689|FG001|COMPLETED|Overall Study||2
10336004|NCT00356265|11472690|FG002|COMPLETED|Overall Study||5
10336005|NCT00356265|11472688|FG000|NOT COMPLETED|Overall Study||0
10336006|NCT00356265|11472689|FG001|NOT COMPLETED|Overall Study||0
10336007|NCT00356265|11472690|FG002|NOT COMPLETED|Overall Study||1
10336008|NCT00356278|11472702|FG000|STARTED|Overall Study||53
10336009|NCT00356278|11472703|FG001|STARTED|Overall Study||50
10336010|NCT00356278|11472704|FG002|STARTED|Overall Study||53
10336011|NCT00356278|11472702|FG000|COMPLETED|Overall Study||28
10336012|NCT00356278|11472703|FG001|COMPLETED|Overall Study||35
10336013|NCT00356278|11472704|FG002|COMPLETED|Overall Study||34
10336014|NCT00356278|11472702|FG000|NOT COMPLETED|Overall Study||25
10336015|NCT00356278|11472703|FG001|NOT COMPLETED|Overall Study||15
10336016|NCT00356278|11472704|FG002|NOT COMPLETED|Overall Study||19
10336017|NCT00356304|11472714|FG000|STARTED|Overall Study||26
10336018|NCT00356304|11472715|FG001|STARTED|Overall Study||24
10336019|NCT00356304|11472714|FG000|COMPLETED|Overall Study||24
10336020|NCT00356304|11472715|FG001|COMPLETED|Overall Study||20
10336021|NCT00356304|11472714|FG000|NOT COMPLETED|Overall Study||2
10336022|NCT00356304|11472715|FG001|NOT COMPLETED|Overall Study||4
10336023|NCT00356369|11472723|FG000|STARTED|Active Phase||374
10336024|NCT00356369|11472724|FG001|STARTED|Active Phase||126
10336025|NCT00356369|11472723|FG000|COMPLETED|Active Phase||372
10336026|NCT00356369|11472724|FG001|COMPLETED|Active Phase||125
10336027|NCT00356369|11472723|FG000|NOT COMPLETED|Active Phase||2
10336028|NCT00356369|11472724|FG001|NOT COMPLETED|Active Phase||1
10336029|NCT00356369|11472723|FG000|STARTED|Year 1||364
10336030|NCT00356369|11472724|FG001|STARTED|Year 1||121
10336031|NCT00356369|11472723|FG000|COMPLETED|Year 1||364
10336032|NCT00356369|11472724|FG001|COMPLETED|Year 1||121
10336033|NCT00356369|11472723|FG000|NOT COMPLETED|Year 1||0
10336034|NCT00356369|11472724|FG001|NOT COMPLETED|Year 1||0
10336035|NCT00356369|11472723|FG000|STARTED|Year 2||354
10336036|NCT00356369|11472724|FG001|STARTED|Year 2||117
10336037|NCT00356369|11472723|FG000|COMPLETED|Year 2||354
10336038|NCT00356369|11472724|FG001|COMPLETED|Year 2||117
10336039|NCT00356369|11472723|FG000|NOT COMPLETED|Year 2||0
10336040|NCT00356369|11472724|FG001|NOT COMPLETED|Year 2||0
10336041|NCT00356369|11472723|FG000|STARTED|Year 3||344
10336042|NCT00356369|11472724|FG001|STARTED|Year 3||116
10336043|NCT00356369|11472723|FG000|COMPLETED|Year 3||344
10336044|NCT00356369|11472724|FG001|COMPLETED|Year 3||116
10336045|NCT00356369|11472723|FG000|NOT COMPLETED|Year 3||0
10336046|NCT00356369|11472724|FG001|NOT COMPLETED|Year 3||0
10336047|NCT00356369|11472723|FG000|STARTED|Year 4||317
10336048|NCT00356369|11472724|FG001|STARTED|Year 4||109
10336049|NCT00356369|11472723|FG000|COMPLETED|Year 4||317
10336050|NCT00356369|11472724|FG001|COMPLETED|Year 4||109
10336051|NCT00356369|11472723|FG000|NOT COMPLETED|Year 4||0
10336052|NCT00356369|11472724|FG001|NOT COMPLETED|Year 4||0
10336053|NCT00356369|11472723|FG000|STARTED|Year 5||299
10336054|NCT00356369|11472724|FG001|STARTED|Year 5||105
10336055|NCT00356369|11472723|FG000|COMPLETED|Year 5||299
10336056|NCT00356369|11472724|FG001|COMPLETED|Year 5||105
10336057|NCT00356369|11472723|FG000|NOT COMPLETED|Year 5||0
10336058|NCT00356369|11472724|FG001|NOT COMPLETED|Year 5||0
10336059|NCT00356408|11472734|FG000|STARTED|Overall Study|106 subjects enrolled, however only 103 were included in the Intent to Treat (ITT) population.|103
10336060|NCT00356408|11472734|FG000|COMPLETED|Overall Study||43
10336061|NCT00356408|11472734|FG000|NOT COMPLETED|Overall Study||60
10336062|NCT00356434|11472747|FG000|STARTED|Overall Study||4
10336063|NCT00356434|11472748|FG001|STARTED|Overall Study||7
10336064|NCT00356434|11472747|FG000|COMPLETED|Overall Study||4
10336065|NCT00356434|11472748|FG001|COMPLETED|Overall Study||7
10336066|NCT00356434|11472747|FG000|NOT COMPLETED|Overall Study||0
10336067|NCT00356434|11472748|FG001|NOT COMPLETED|Overall Study||0
10336068|NCT00356525|11472759|FG000|STARTED|Overall Study||14
10336069|NCT00356525|11472760|FG001|STARTED|Overall Study||11
10336070|NCT00356525|11472761|FG002|STARTED|Overall Study||7
10336071|NCT00356525|11472762|FG003|STARTED|Overall Study||9
10336072|NCT00356525|11472759|FG000|COMPLETED|Overall Study||0
10336073|NCT00356525|11472760|FG001|COMPLETED|Overall Study||0
10336074|NCT00356525|11472761|FG002|COMPLETED|Overall Study||0
10336075|NCT00356525|11472762|FG003|COMPLETED|Overall Study||0
10336076|NCT00356525|11472759|FG000|NOT COMPLETED|Overall Study||14
10336077|NCT00356525|11472760|FG001|NOT COMPLETED|Overall Study||11
10336078|NCT00356525|11472761|FG002|NOT COMPLETED|Overall Study||7
10336079|NCT00356525|11472762|FG003|NOT COMPLETED|Overall Study||9
10336080|NCT00356590|11472772|FG000|STARTED|Overall Study||468
10336081|NCT00356590|11472772|FG000|COMPLETED|Overall Study||194
10336082|NCT00356590|11472772|FG000|NOT COMPLETED|Overall Study||274
10336083|NCT00356603|11472778|FG000|STARTED|Overall Study||39
10336084|NCT00356603|11472779|FG001|STARTED|Overall Study||36
10336085|NCT00356603|11472778|FG000|COMPLETED|Overall Study||33
10336086|NCT00356603|11472779|FG001|COMPLETED|Overall Study||33
10336087|NCT00356603|11472778|FG000|NOT COMPLETED|Overall Study||6
10336088|NCT00356603|11472779|FG001|NOT COMPLETED|Overall Study||3
10336089|NCT00356759|11472789|FG000|STARTED|Overall Study||126
10336090|NCT00356759|11472790|FG001|STARTED|Overall Study||124
10336091|NCT00356759|11472789|FG000|COMPLETED|Overall Study||112
10336092|NCT00356759|11472790|FG001|COMPLETED|Overall Study||114
10336093|NCT00356759|11472789|FG000|NOT COMPLETED|Overall Study||14
10336094|NCT00356759|11472790|FG001|NOT COMPLETED|Overall Study||10
10336095|NCT00356811|11472796|FG000|STARTED|Overall Study||57
10336096|NCT00356811|11472796|FG000|COMPLETED|Overall Study||8
10336097|NCT00356811|11472796|FG000|NOT COMPLETED|Overall Study||49
10336098|NCT00356863|11472803|FG000|STARTED|Overall Study||504
10336099|NCT00356863|11472804|FG001|STARTED|Overall Study||520
10336100|NCT00356863|11472803|FG000|COMPLETED|Overall Study||412
10336101|NCT00356863|11472804|FG001|COMPLETED|Overall Study||445
10336102|NCT00356863|11472803|FG000|NOT COMPLETED|Overall Study||92
10336103|NCT00356863|11472804|FG001|NOT COMPLETED|Overall Study||75
10336104|NCT00356889|11472814|FG000|STARTED|Overall Study||56
10336105|NCT00356889|11472814|FG000|COMPLETED|Overall Study||53
10336106|NCT00356889|11472814|FG000|NOT COMPLETED|Overall Study||3
10336107|NCT00356915|11472822|FG000|STARTED|Overall Study||593
10336108|NCT00356915|11472823|FG001|STARTED|Overall Study||590
10336109|NCT00356915|11472824|FG002|STARTED|Overall Study||198
10336110|NCT00356915|11472822|FG000|COMPLETED|Overall Study||517
10336111|NCT00356915|11472823|FG001|COMPLETED|Overall Study||496
10336112|NCT00356915|11472824|FG002|COMPLETED|Overall Study||156
10336113|NCT00356915|11472822|FG000|NOT COMPLETED|Overall Study||76
10336114|NCT00356915|11472823|FG001|NOT COMPLETED|Overall Study||94
10336115|NCT00356915|11472824|FG002|NOT COMPLETED|Overall Study||42
10336116|NCT00356993|11472838|FG000|STARTED|Overall Study||6009
10336117|NCT00356993|11472838|FG000|COMPLETED|Overall Study||2088
10336118|NCT00356993|11472838|FG000|NOT COMPLETED|Overall Study||3921
10336119|NCT00357006|11472845|FG000|STARTED|Overall Study||62
10336120|NCT00357006|11472846|FG001|STARTED|Overall Study||56
10336121|NCT00357006|11472847|FG002|STARTED|Overall Study||62
10336122|NCT00357006|11472845|FG000|COMPLETED|Overall Study||60
10336123|NCT00357006|11472846|FG001|COMPLETED|Overall Study||51
10336124|NCT00357006|11472847|FG002|COMPLETED|Overall Study||59
10336125|NCT00357006|11472845|FG000|NOT COMPLETED|Overall Study||2
10336126|NCT00357006|11472846|FG001|NOT COMPLETED|Overall Study||5
10336127|NCT00357006|11472847|FG002|NOT COMPLETED|Overall Study||3
10336128|NCT00357032|11472855|FG000|STARTED|Overall Study||12
10336129|NCT00357032|11472855|FG000|COMPLETED|Overall Study||12
10336130|NCT00357032|11472855|FG000|NOT COMPLETED|Overall Study||0
10336131|NCT00357097|11472861|FG000|STARTED|Overall Study|199 were randomized. Only 198 took investigational product.|199
10336132|NCT00357097|11472862|FG001|STARTED|Overall Study||67
10336133|NCT00357097|11472861|FG000|COMPLETED|Overall Study||145
10336134|NCT00357097|11472862|FG001|COMPLETED|Overall Study||38
10336135|NCT00357097|11472861|FG000|NOT COMPLETED|Overall Study||54
10336136|NCT00357097|11472862|FG001|NOT COMPLETED|Overall Study||29
10336137|NCT00357110|11472870|FG000|STARTED|Overall Study||6
10336138|NCT00357110|11472871|FG001|STARTED|Overall Study||7
10336139|NCT00357110|11472870|FG000|COMPLETED|Overall Study||1
10336140|NCT00357110|11472871|FG001|COMPLETED|Overall Study||2
10336141|NCT00357110|11472870|FG000|NOT COMPLETED|Overall Study||5
10336142|NCT00357110|11472871|FG001|NOT COMPLETED|Overall Study||5
10336143|NCT00357162|11472877|FG000|STARTED|Overall Study||21
10336144|NCT00357162|11472877|FG000|COMPLETED|Overall Study||21
10336145|NCT00357162|11472877|FG000|NOT COMPLETED|Overall Study||0
10336146|NCT00357214|11472885|FG000|STARTED|Overall Study||43
10336147|NCT00357214|11472886|FG001|STARTED|Overall Study||43
10336148|NCT00357214|11472887|FG002|STARTED|Overall Study||42
10336149|NCT00357214|11472888|FG003|STARTED|Overall Study||43
10336150|NCT00357214|11472885|FG000|COMPLETED|Overall Study||39
10336151|NCT00357214|11472886|FG001|COMPLETED|Overall Study||39
10336152|NCT00357214|11472887|FG002|COMPLETED|Overall Study||42
10336153|NCT00357214|11472888|FG003|COMPLETED|Overall Study||42
10336154|NCT00357214|11472885|FG000|NOT COMPLETED|Overall Study||4
10336155|NCT00357214|11472886|FG001|NOT COMPLETED|Overall Study||4
10336156|NCT00357214|11472887|FG002|NOT COMPLETED|Overall Study||0
10336157|NCT00357214|11472888|FG003|NOT COMPLETED|Overall Study||1
10336158|NCT00357331|11472900|FG000|STARTED|Overall Study||42
10336159|NCT00357331|11472901|FG001|STARTED|Overall Study||41
10336160|NCT00357331|11472900|FG000|COMPLETED|Overall Study||42
10336161|NCT00357331|11472901|FG001|COMPLETED|Overall Study||41
10336162|NCT00357331|11472900|FG000|NOT COMPLETED|Overall Study||0
10336163|NCT00357331|11472901|FG001|NOT COMPLETED|Overall Study||0
10336164|NCT00357370|11472910|FG000|STARTED|Cohort 1||4
10336165|NCT00357370|11472911|FG001|STARTED|Cohort 1||0
10336166|NCT00357370|11472912|FG002|STARTED|Cohort 1||0
10336167|NCT00357370|11472910|FG000|COMPLETED|Cohort 1||4
10336168|NCT00357370|11472911|FG001|COMPLETED|Cohort 1||0
10336169|NCT00357370|11472912|FG002|COMPLETED|Cohort 1||0
10336170|NCT00357370|11472910|FG000|NOT COMPLETED|Cohort 1||0
10336171|NCT00357370|11472911|FG001|NOT COMPLETED|Cohort 1||0
10336172|NCT00357370|11472912|FG002|NOT COMPLETED|Cohort 1||0
10336173|NCT00357370|11472910|FG000|STARTED|Cohort 2||24
10336174|NCT00357370|11472911|FG001|STARTED|Cohort 2||23
10336175|NCT00357370|11472912|FG002|STARTED|Cohort 2||24
10336176|NCT00357370|11472910|FG000|COMPLETED|Cohort 2||22
10336177|NCT00357370|11472911|FG001|COMPLETED|Cohort 2||16
10336178|NCT00357370|11472912|FG002|COMPLETED|Cohort 2||22
10336179|NCT00357370|11472910|FG000|NOT COMPLETED|Cohort 2||2
10336180|NCT00357370|11472911|FG001|NOT COMPLETED|Cohort 2||7
10336181|NCT00357370|11472912|FG002|NOT COMPLETED|Cohort 2||2
10336182|NCT00357396|11472922|FG000|STARTED|Overall Study||6
10336183|NCT00357396|11472923|FG001|STARTED|Overall Study||4
10336184|NCT00357396|11472922|FG000|COMPLETED|Overall Study||5
10336185|NCT00357396|11472923|FG001|COMPLETED|Overall Study||4
10336186|NCT00357396|11472922|FG000|NOT COMPLETED|Overall Study||1
10336187|NCT00357396|11472923|FG001|NOT COMPLETED|Overall Study||0
10336188|NCT00357500|11472928|FG000|STARTED|Overall Study||101
10336189|NCT00357500|11472928|FG000|Began Protocol Therapy|Overall Study|4 pts did not start treatment due either to removal of consent or inability to get insurance.|97
10336190|NCT00357500|11472928|FG000|COMPLETED|Overall Study||24
10336191|NCT00357500|11472928|FG000|NOT COMPLETED|Overall Study||77
10336192|NCT00357552|11472932|FG000|STARTED|Screening|The number of participants who started this period, is the number of participants who screened.|207
10336193|NCT00357552|11472932|FG000|COMPLETED|Screening|The number of participants who completed this period, is the number of participants who enrolled.|123
10336194|NCT00357552|11472932|FG000|NOT COMPLETED|Screening||84
10336195|NCT00357552|11472932|FG000|STARTED|Weeks 0 to 24||123
10336196|NCT00357552|11472932|FG000|COMPLETED|Weeks 0 to 24|One subject died prior to week 24.|122
10336197|NCT00357552|11472932|FG000|NOT COMPLETED|Weeks 0 to 24||1
10336198|NCT00357552|11472932|FG000|STARTED|Weeks 24 to 104||122
10336199|NCT00357552|11472932|FG000|COMPLETED|Weeks 24 to 104||117
10336200|NCT00357552|11472932|FG000|NOT COMPLETED|Weeks 24 to 104||5
10336201|NCT00357656|11472942|FG000|STARTED|Overall Study||31
10336202|NCT00357656|11472943|FG001|STARTED|Overall Study||32
10336203|NCT00357656|11472942|FG000|COMPLETED|Overall Study||31
10336204|NCT00357656|11472943|FG001|COMPLETED|Overall Study||29
10336205|NCT00357656|11472942|FG000|NOT COMPLETED|Overall Study||0
10336206|NCT00357656|11472943|FG001|NOT COMPLETED|Overall Study||3
10336207|NCT00357734|11472961|FG000|STARTED|Overall Study||14
10336208|NCT00357734|11472961|FG000|Patients Received 250 mg of ZD1839|Overall Study||13
10336209|NCT00357734|11472961|FG000|Patient Received 500 mg of ZD1839|Overall Study||1
10336210|NCT00357734|11472961|FG000|COMPLETED|Overall Study||10
10336211|NCT00357734|11472961|FG000|NOT COMPLETED|Overall Study||4
10336212|NCT00357760|11472967|FG000|STARTED|Overall Study||59
10336213|NCT00357760|11472968|FG001|STARTED|Overall Study||35
10336214|NCT00357760|11472967|FG000|Patients Who Started Treatment|Overall Study||57
10336215|NCT00357760|11472968|FG001|Patients Who Started Treatment|Overall Study||34
10336216|NCT00357760|11472967|FG000|Eligible and Treated Patients|Overall Study||57
10336217|NCT00357760|11472968|FG001|Eligible and Treated Patients|Overall Study||32
10336218|NCT00357760|11472967|FG000|Patients Who Undergo Dose Escalation|Overall Study|Only patients who progressed on the low dose (Arm B) had the opportunity to undergo dose escalation.|0
10336219|NCT00357760|11472968|FG001|Patients Who Undergo Dose Escalation|Overall Study||16
10336220|NCT00357760|11472967|FG000|COMPLETED|Overall Study|Patients continued receiving protocol treatment until progressive disease or unacceptable toxicity.|0
10336221|NCT00357760|11472968|FG001|COMPLETED|Overall Study|Patients continued receiving protocol treatment until progressive disease or unacceptable toxicity.|0
10336222|NCT00357760|11472967|FG000|NOT COMPLETED|Overall Study||59
10336223|NCT00357760|11472968|FG001|NOT COMPLETED|Overall Study||35
10336224|NCT00357877|11472976|FG000|STARTED|Overall Study||493
10336225|NCT00357877|11472977|FG001|STARTED|Overall Study||490
10336226|NCT00357877|11472976|FG000|COMPLETED|Overall Study||467
10336227|NCT00357877|11472977|FG001|COMPLETED|Overall Study||460
10336228|NCT00357877|11472976|FG000|NOT COMPLETED|Overall Study||26
10336229|NCT00357877|11472977|FG001|NOT COMPLETED|Overall Study||30
10339149|NCT00371397|11476087|FG001|NOT COMPLETED|Session 2||0
10339150|NCT00371397|11476088|FG002|NOT COMPLETED|Session 2||0
10339151|NCT00371397|11476089|FG003|NOT COMPLETED|Session 2||0
10339152|NCT00371397|11476090|FG004|NOT COMPLETED|Session 2||0
10339153|NCT00371397|11476091|FG005|NOT COMPLETED|Session 2||0
10339154|NCT00371397|11476092|FG006|NOT COMPLETED|Session 2||0
10336230|NCT00357903|11472987|FG000|STARTED|Overall Study||581
10336231|NCT00357903|11472988|FG001|STARTED|Overall Study||58
10336232|NCT00357903|11472987|FG000|COMPLETED|Overall Study||218
10336233|NCT00357903|11472988|FG001|COMPLETED|Overall Study||15
10336234|NCT00357903|11472987|FG000|NOT COMPLETED|Overall Study||363
10336235|NCT00357903|11472988|FG001|NOT COMPLETED|Overall Study||43
10336236|NCT00357955|11472997|FG000|STARTED|Overall Study||64
10336237|NCT00357955|11472998|FG001|STARTED|Overall Study||54
10336238|NCT00357955|11472997|FG000|COMPLETED|Overall Study||58
10336239|NCT00357955|11472998|FG001|COMPLETED|Overall Study||51
10336240|NCT00357955|11472997|FG000|NOT COMPLETED|Overall Study||6
10336241|NCT00357955|11472998|FG001|NOT COMPLETED|Overall Study||3
10336242|NCT00357968|11473006|FG000|STARTED|First Maintenance Dose Phase||102
10336243|NCT00357968|11473007|FG001|STARTED|First Maintenance Dose Phase||99
10336244|NCT00357968|11473006|FG000|Received Loading Dose|First Maintenance Dose Phase||102
10336245|NCT00357968|11473007|FG001|Received Loading Dose|First Maintenance Dose Phase||99
10336246|NCT00357968|11473006|FG000|Percutaneous Coronary Intervention (PCI)|First Maintenance Dose Phase||55
10336247|NCT00357968|11473007|FG001|Percutaneous Coronary Intervention (PCI)|First Maintenance Dose Phase||57
10336248|NCT00357968|11473006|FG000|Started Maintenance Dose|First Maintenance Dose Phase||55
10336249|NCT00357968|11473007|FG001|Started Maintenance Dose|First Maintenance Dose Phase||55
10336250|NCT00357968|11473006|FG000|COMPLETED|First Maintenance Dose Phase||54
10336251|NCT00357968|11473007|FG001|COMPLETED|First Maintenance Dose Phase||55
10336252|NCT00357968|11473006|FG000|NOT COMPLETED|First Maintenance Dose Phase||48
10336253|NCT00357968|11473007|FG001|NOT COMPLETED|First Maintenance Dose Phase||44
10336254|NCT00357968|11473006|FG000|STARTED|Crossover Maintenance Dose Phase|1 subject discontinued study drug-did not take clopidogrel during the 2nd phase but completed study|54
10336255|NCT00357968|11473007|FG001|STARTED|Crossover Maintenance Dose Phase||55
10336256|NCT00357968|11473006|FG000|COMPLETED|Crossover Maintenance Dose Phase||54
10336257|NCT00357968|11473007|FG001|COMPLETED|Crossover Maintenance Dose Phase||55
10336258|NCT00357968|11473006|FG000|NOT COMPLETED|Crossover Maintenance Dose Phase||0
10336259|NCT00357968|11473007|FG001|NOT COMPLETED|Crossover Maintenance Dose Phase||0
10336260|NCT00357994|11473030|FG000|STARTED|Overall Study||37
10336261|NCT00357994|11473031|FG001|STARTED|Overall Study||34
10336262|NCT00357994|11473030|FG000|COMPLETED|Overall Study||35
10336263|NCT00357994|11473031|FG001|COMPLETED|Overall Study||31
10336264|NCT00357994|11473030|FG000|NOT COMPLETED|Overall Study||2
10336265|NCT00357994|11473031|FG001|NOT COMPLETED|Overall Study||3
10336266|NCT00358007|11473037|FG000|STARTED|Overall Study||30
10336267|NCT00358007|11473037|FG000|COMPLETED|Overall Study||28
10336268|NCT00358007|11473037|FG000|NOT COMPLETED|Overall Study||2
10336269|NCT00358150|11473041|FG000|STARTED|Overall Study||26
10336270|NCT00358150|11473041|FG000|COMPLETED|Overall Study||19
10336271|NCT00358150|11473041|FG000|NOT COMPLETED|Overall Study||7
10336272|NCT00358215|11473050|FG000|STARTED|Overall Study||1142
10336273|NCT00358215|11473051|FG001|STARTED|Overall Study||1136
10336274|NCT00358215|11473050|FG000|Received Investigational Product|Overall Study||1140
10336275|NCT00358215|11473051|FG001|Received Investigational Product|Overall Study||1133
10336276|NCT00358215|11473050|FG000|COMPLETED|Overall Study|Participants who completed investigational product|463
10336277|NCT00358215|11473051|FG001|COMPLETED|Overall Study|Participants who completed investigational product|484
10336278|NCT00358215|11473050|FG000|NOT COMPLETED|Overall Study||679
10336279|NCT00358215|11473051|FG001|NOT COMPLETED|Overall Study||652
10336280|NCT00358332|11473061|FG000|STARTED|Overall Study||15
10336281|NCT00358332|11473062|FG001|STARTED|Overall Study||30
10336282|NCT00358332|11473063|FG002|STARTED|Overall Study||30
10336283|NCT00358332|11473064|FG003|STARTED|Overall Study||25
10336284|NCT00358332|11473061|FG000|COMPLETED|Overall Study||15
10336285|NCT00358332|11473062|FG001|COMPLETED|Overall Study||27
10336286|NCT00358332|11473063|FG002|COMPLETED|Overall Study||29
10336287|NCT00358332|11473064|FG003|COMPLETED|Overall Study||25
10336288|NCT00358332|11473061|FG000|NOT COMPLETED|Overall Study||0
10336289|NCT00358332|11473062|FG001|NOT COMPLETED|Overall Study||3
10336290|NCT00358332|11473063|FG002|NOT COMPLETED|Overall Study||1
10336291|NCT00358332|11473064|FG003|NOT COMPLETED|Overall Study||0
10336292|NCT00358436|11473076|FG000|STARTED|Overall Study||600
10336293|NCT00358436|11473077|FG001|STARTED|Overall Study||204
10336294|NCT00358436|11473076|FG000|COMPLETED|Overall Study||446
10336295|NCT00358436|11473077|FG001|COMPLETED|Overall Study||118
10336296|NCT00358436|11473076|FG000|NOT COMPLETED|Overall Study||154
10336297|NCT00358436|11473077|FG001|NOT COMPLETED|Overall Study||86
10336298|NCT00358449|11473088|FG000|STARTED|Overall Study||19
10336299|NCT00358449|11473089|FG001|STARTED|Overall Study||20
10336300|NCT00358449|11473090|FG002|STARTED|Overall Study||20
10336301|NCT00358449|11473088|FG000|COMPLETED|Overall Study||15
10336302|NCT00358449|11473089|FG001|COMPLETED|Overall Study||19
10336303|NCT00358449|11473090|FG002|COMPLETED|Overall Study||18
10336304|NCT00358449|11473088|FG000|NOT COMPLETED|Overall Study||4
10336305|NCT00358449|11473089|FG001|NOT COMPLETED|Overall Study||1
10336306|NCT00358449|11473090|FG002|NOT COMPLETED|Overall Study||2
10336307|NCT00358462|11473102|FG000|STARTED|Overall Study||304
10336308|NCT00358462|11473103|FG001|STARTED|Overall Study||302
10336309|NCT00358462|11473102|FG000|COMPLETED|Overall Study||245
10336310|NCT00358462|11473103|FG001|COMPLETED|Overall Study||238
10336311|NCT00358462|11473102|FG000|NOT COMPLETED|Overall Study||59
10336312|NCT00358462|11473103|FG001|NOT COMPLETED|Overall Study||64
10336313|NCT00358501|11473121|FG000|STARTED|Overall Study||102
10336314|NCT00358501|11473122|FG001|STARTED|Overall Study||32
10336315|NCT00358501|11473121|FG000|COMPLETED|Overall Study||102
10336316|NCT00358501|11473122|FG001|COMPLETED|Overall Study||32
10336317|NCT00358501|11473121|FG000|NOT COMPLETED|Overall Study||0
10707751|NCT02623348|11872468|FG001|3-month Assessment|Overall Study||26
10707752|NCT02623348|11872467|FG000|COMPLETED|Overall Study||27
10707753|NCT02623348|11872468|FG001|COMPLETED|Overall Study||28
10336318|NCT00358501|11473122|FG001|NOT COMPLETED|Overall Study||0
10336319|NCT00358579|11473131|FG000|STARTED|Overall Study||353
10336320|NCT00358579|11473132|FG001|STARTED|Overall Study||374
10336321|NCT00358579|11473131|FG000|COMPLETED|Overall Study||353
10336322|NCT00358579|11473132|FG001|COMPLETED|Overall Study||374
10336323|NCT00358579|11473131|FG000|NOT COMPLETED|Overall Study||0
10336324|NCT00358579|11473132|FG001|NOT COMPLETED|Overall Study||0
10336325|NCT00358644|11473138|FG000|STARTED|Overall Study||55
10336326|NCT00358644|11473138|FG000|COMPLETED|Overall Study||5
10336327|NCT00358644|11473138|FG000|NOT COMPLETED|Overall Study||50
10336328|NCT00358657|11473142|FG000|STARTED|Overall Study||14
10336329|NCT00358657|11473142|FG000|COMPLETED|Overall Study||14
10336330|NCT00358657|11473142|FG000|NOT COMPLETED|Overall Study||0
10336331|NCT00358670|11473148|FG000|STARTED|Overall Study||222
10336332|NCT00358670|11473149|FG001|STARTED|Overall Study||219
10336333|NCT00358670|11473148|FG000|COMPLETED|Overall Study||0
10336334|NCT00358670|11473149|FG001|COMPLETED|Overall Study||0
10336335|NCT00358670|11473148|FG000|NOT COMPLETED|Overall Study||222
10336336|NCT00358670|11473149|FG001|NOT COMPLETED|Overall Study||219
10336337|NCT00358735|11473157|FG000|STARTED|Overall Study||204
10336338|NCT00358735|11473158|FG001|STARTED|Overall Study||207
10336339|NCT00358735|11473157|FG000|Completed Safety|Overall Study||198
10336340|NCT00358735|11473158|FG001|Completed Safety|Overall Study||194
10336341|NCT00358735|11473157|FG000|Not Completed Safety|Overall Study||6
10336342|NCT00358735|11473158|FG001|Not Completed Safety|Overall Study||13
10336343|NCT00358735|11473157|FG000|COMPLETED|Overall Study|Efficacy|196
10336344|NCT00358735|11473158|FG001|COMPLETED|Overall Study|Efficacy|190
10336345|NCT00358735|11473157|FG000|NOT COMPLETED|Overall Study||8
10336346|NCT00358735|11473158|FG001|NOT COMPLETED|Overall Study||17
10336347|NCT00358826|11473168|FG000|STARTED|Core Study||49
10336348|NCT00358826|11473169|FG001|STARTED|Core Study||46
10336349|NCT00358826|11473170|FG002|STARTED|Core Study||44
10336350|NCT00358826|11473171|FG003|STARTED|Core Study||52
10336351|NCT00358826|11473172|FG004|STARTED|Core Study||0
10336352|NCT00358826|11473173|FG005|STARTED|Core Study||0
10336353|NCT00358826|11473174|FG006|STARTED|Core Study||0
10336354|NCT00358826|11473175|FG007|STARTED|Core Study||0
10336355|NCT00358826|11473168|FG000|COMPLETED|Core Study||46
10336356|NCT00358826|11473169|FG001|COMPLETED|Core Study||41
10336357|NCT00358826|11473170|FG002|COMPLETED|Core Study||42
10336358|NCT00358826|11473171|FG003|COMPLETED|Core Study||50
10336359|NCT00358826|11473172|FG004|COMPLETED|Core Study||0
10336360|NCT00358826|11473173|FG005|COMPLETED|Core Study||0
10336361|NCT00358826|11473174|FG006|COMPLETED|Core Study||0
10336362|NCT00358826|11473175|FG007|COMPLETED|Core Study||0
10336363|NCT00358826|11473168|FG000|NOT COMPLETED|Core Study||3
10336364|NCT00358826|11473169|FG001|NOT COMPLETED|Core Study||5
10336365|NCT00358826|11473170|FG002|NOT COMPLETED|Core Study||2
10336366|NCT00358826|11473171|FG003|NOT COMPLETED|Core Study||2
10336367|NCT00358826|11473172|FG004|NOT COMPLETED|Core Study||0
10336368|NCT00358826|11473173|FG005|NOT COMPLETED|Core Study||0
10336369|NCT00358826|11473174|FG006|NOT COMPLETED|Core Study||0
10336370|NCT00358826|11473175|FG007|NOT COMPLETED|Core Study||0
10336371|NCT00358826|11473168|FG000|STARTED|MDCT Substudy||0
10336372|NCT00358826|11473169|FG001|STARTED|MDCT Substudy||0
10336373|NCT00358826|11473170|FG002|STARTED|MDCT Substudy||0
10336374|NCT00358826|11473171|FG003|STARTED|MDCT Substudy||0
10336375|NCT00358826|11473172|FG004|STARTED|MDCT Substudy||25
10336376|NCT00358826|11473173|FG005|STARTED|MDCT Substudy||22
10336377|NCT00358826|11473174|FG006|STARTED|MDCT Substudy||19
10336378|NCT00358826|11473175|FG007|STARTED|MDCT Substudy||27
10336379|NCT00358826|11473168|FG000|COMPLETED|MDCT Substudy||0
10336380|NCT00358826|11473169|FG001|COMPLETED|MDCT Substudy||0
10336381|NCT00358826|11473170|FG002|COMPLETED|MDCT Substudy||0
10336382|NCT00358826|11473171|FG003|COMPLETED|MDCT Substudy||0
10336383|NCT00358826|11473172|FG004|COMPLETED|MDCT Substudy||24
10336384|NCT00358826|11473173|FG005|COMPLETED|MDCT Substudy||20
10336385|NCT00358826|11473174|FG006|COMPLETED|MDCT Substudy||19
10336386|NCT00358826|11473175|FG007|COMPLETED|MDCT Substudy||27
10336387|NCT00358826|11473168|FG000|NOT COMPLETED|MDCT Substudy||0
10336388|NCT00358826|11473169|FG001|NOT COMPLETED|MDCT Substudy||0
10336389|NCT00358826|11473170|FG002|NOT COMPLETED|MDCT Substudy||0
10707754|NCT02623348|11872467|FG000|NOT COMPLETED|Overall Study||3
10707755|NCT02623348|11872468|FG001|NOT COMPLETED|Overall Study||2
10336390|NCT00358826|11473171|FG003|NOT COMPLETED|MDCT Substudy||0
10336391|NCT00358826|11473172|FG004|NOT COMPLETED|MDCT Substudy||1
10336392|NCT00358826|11473173|FG005|NOT COMPLETED|MDCT Substudy||2
10336393|NCT00358826|11473174|FG006|NOT COMPLETED|MDCT Substudy||0
10336394|NCT00358826|11473175|FG007|NOT COMPLETED|MDCT Substudy||0
10336395|NCT00358917|11473191|FG000|STARTED|Overall Study||300
10336396|NCT00358917|11473192|FG001|STARTED|Overall Study||299
10336397|NCT00358917|11473191|FG000|COMPLETED|Overall Study||234
10336398|NCT00358917|11473192|FG001|COMPLETED|Overall Study||230
10707756|NCT02623361|11872476|FG000|STARTED|Overall Study||40
10707757|NCT02623361|11872477|FG001|STARTED|Overall Study||40
10336399|NCT00358917|11473191|FG000|NOT COMPLETED|Overall Study||66
10336400|NCT00358917|11473192|FG001|NOT COMPLETED|Overall Study||69
10336401|NCT00358956|11473200|FG000|STARTED|Overall Study||19
10707758|NCT02623361|11872476|FG000|COMPLETED|Overall Study||40
10336402|NCT00358956|11473200|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|11
10336403|NCT00358956|11473200|FG000|NOT COMPLETED|Overall Study||8
10336404|NCT00359021|11473206|FG000|STARTED|Overall Study||256
10336405|NCT00359021|11473207|FG001|STARTED|Overall Study||247
10336406|NCT00359021|11473206|FG000|COMPLETED|Overall Study||175
10336407|NCT00359021|11473207|FG001|COMPLETED|Overall Study||195
10336408|NCT00359021|11473206|FG000|NOT COMPLETED|Overall Study||81
10336409|NCT00359021|11473207|FG001|NOT COMPLETED|Overall Study||52
10336410|NCT00359073|11473217|FG000|STARTED|Overall Study||12
10336411|NCT00359073|11473218|FG001|STARTED|Overall Study||13
10336412|NCT00359073|11473217|FG000|COMPLETED|Overall Study||8
10336413|NCT00359073|11473218|FG001|COMPLETED|Overall Study||11
10336414|NCT00359073|11473217|FG000|NOT COMPLETED|Overall Study||4
10336415|NCT00359073|11473218|FG001|NOT COMPLETED|Overall Study||2
10336416|NCT00359203|11473228|FG000|STARTED|Overall Study||39
10707759|NCT02623361|11872477|FG001|COMPLETED|Overall Study||38
10707760|NCT02623361|11872476|FG000|NOT COMPLETED|Overall Study||0
10707761|NCT02623361|11872477|FG001|NOT COMPLETED|Overall Study||2
10707762|NCT02623803|11872485|FG000|STARTED|Overall Study||25
10707763|NCT02623803|11872486|FG001|STARTED|Overall Study||23
10336417|NCT00359203|11473229|FG001|STARTED|Overall Study||38
10336418|NCT00359203|11473228|FG000|COMPLETED|Overall Study||39
10336419|NCT00359203|11473229|FG001|COMPLETED|Overall Study||38
10336420|NCT00359203|11473228|FG000|NOT COMPLETED|Overall Study||0
10336421|NCT00359203|11473229|FG001|NOT COMPLETED|Overall Study||0
10336422|NCT00359281|11473244|FG000|STARTED|Overall Study||16
10336423|NCT00359281|11473245|FG001|STARTED|Overall Study||15
10336424|NCT00359281|11473246|FG002|STARTED|Overall Study||10
10336425|NCT00359281|11473247|FG003|STARTED|Overall Study||10
10336426|NCT00359281|11473248|FG004|STARTED|Overall Study||10
10336427|NCT00359281|11473249|FG005|STARTED|Overall Study||15
10336428|NCT00359281|11473250|FG006|STARTED|Overall Study||18
10336429|NCT00359281|11473251|FG007|STARTED|Overall Study||15
10336430|NCT00359281|11473252|FG008|STARTED|Overall Study||20
10336431|NCT00359281|11473244|FG000|COMPLETED|Overall Study||15
10336432|NCT00359281|11473245|FG001|COMPLETED|Overall Study||15
10336433|NCT00359281|11473246|FG002|COMPLETED|Overall Study||10
10336434|NCT00359281|11473247|FG003|COMPLETED|Overall Study||10
10336435|NCT00359281|11473248|FG004|COMPLETED|Overall Study||10
10336436|NCT00359281|11473249|FG005|COMPLETED|Overall Study||15
10336437|NCT00359281|11473250|FG006|COMPLETED|Overall Study||16
10336438|NCT00359281|11473251|FG007|COMPLETED|Overall Study||15
10336439|NCT00359281|11473252|FG008|COMPLETED|Overall Study||20
10336440|NCT00359281|11473244|FG000|NOT COMPLETED|Overall Study||1
10336441|NCT00359281|11473245|FG001|NOT COMPLETED|Overall Study||0
10336442|NCT00359281|11473246|FG002|NOT COMPLETED|Overall Study||0
10336443|NCT00359281|11473247|FG003|NOT COMPLETED|Overall Study||0
10336444|NCT00359281|11473248|FG004|NOT COMPLETED|Overall Study||0
10336445|NCT00359281|11473249|FG005|NOT COMPLETED|Overall Study||0
10336446|NCT00359281|11473250|FG006|NOT COMPLETED|Overall Study||2
10336447|NCT00359281|11473251|FG007|NOT COMPLETED|Overall Study||0
10336448|NCT00359281|11473252|FG008|NOT COMPLETED|Overall Study||0
10336449|NCT00359294|11473284|FG000|STARTED|Overall Study||1
10336450|NCT00359294|11473285|FG001|STARTED|Overall Study||1
10336451|NCT00359294|11473286|FG002|STARTED|Overall Study||3
10336452|NCT00359294|11473287|FG003|STARTED|Overall Study||4
10336453|NCT00359294|11473288|FG004|STARTED|Overall Study||3
10336454|NCT00359294|11473284|FG000|COMPLETED|Overall Study||0
10336455|NCT00359294|11473285|FG001|COMPLETED|Overall Study||0
10336456|NCT00359294|11473286|FG002|COMPLETED|Overall Study||0
10336457|NCT00359294|11473287|FG003|COMPLETED|Overall Study||0
10336458|NCT00359294|11473288|FG004|COMPLETED|Overall Study||0
10336459|NCT00359294|11473284|FG000|NOT COMPLETED|Overall Study||1
10336460|NCT00359294|11473285|FG001|NOT COMPLETED|Overall Study||1
10336461|NCT00359294|11473286|FG002|NOT COMPLETED|Overall Study||3
10336462|NCT00359294|11473287|FG003|NOT COMPLETED|Overall Study||4
10336463|NCT00359294|11473288|FG004|NOT COMPLETED|Overall Study||3
10336464|NCT00359424|11473298|FG000|STARTED|Overall Study||434
10336465|NCT00359424|11473299|FG001|STARTED|Overall Study||222
10336466|NCT00359424|11473298|FG000|90 Day Follow up|Overall Study||343
10707764|NCT02623803|11872485|FG000|COMPLETED|Overall Study||25
10707765|NCT02623803|11872486|FG001|COMPLETED|Overall Study||23
10707766|NCT02623803|11872485|FG000|NOT COMPLETED|Overall Study||0
10336467|NCT00359424|11473299|FG001|90 Day Follow up|Overall Study||172
10336468|NCT00359424|11473298|FG000|180 Day Follow up|Overall Study||325
10336469|NCT00359424|11473299|FG001|180 Day Follow up|Overall Study||167
10336470|NCT00359424|11473298|FG000|270 Day Follow up|Overall Study||313
10336471|NCT00359424|11473299|FG001|270 Day Follow up|Overall Study||159
10336472|NCT00359424|11473298|FG000|COMPLETED|Overall Study||304
10336473|NCT00359424|11473299|FG001|COMPLETED|Overall Study||155
10336474|NCT00359424|11473298|FG000|NOT COMPLETED|Overall Study||130
10707767|NCT02623803|11872486|FG001|NOT COMPLETED|Overall Study||0
10336475|NCT00359424|11473299|FG001|NOT COMPLETED|Overall Study||67
10336476|NCT00359619|11473312|FG000|STARTED|Overall Study||88
10336477|NCT00359619|11473313|FG001|STARTED|Overall Study||50
10336478|NCT00359619|11473314|FG002|STARTED|Overall Study||49
10336479|NCT00359619|11473315|FG003|STARTED|Overall Study||48
10336480|NCT00359619|11473316|FG004|STARTED|Overall Study||48
10336481|NCT00359619|11473317|FG005|STARTED|Overall Study||50
10336482|NCT00359619|11473318|FG006|STARTED|Overall Study||50
10336483|NCT00359619|11473312|FG000|COMPLETED|Overall Study||80
10336484|NCT00359619|11473313|FG001|COMPLETED|Overall Study||45
10336485|NCT00359619|11473314|FG002|COMPLETED|Overall Study||42
10336486|NCT00359619|11473315|FG003|COMPLETED|Overall Study||45
10336487|NCT00359619|11473316|FG004|COMPLETED|Overall Study||45
10336488|NCT00359619|11473317|FG005|COMPLETED|Overall Study||45
10336489|NCT00359619|11473318|FG006|COMPLETED|Overall Study||46
10336490|NCT00359619|11473312|FG000|NOT COMPLETED|Overall Study||8
10336491|NCT00359619|11473313|FG001|NOT COMPLETED|Overall Study||5
10336492|NCT00359619|11473314|FG002|NOT COMPLETED|Overall Study||7
10336493|NCT00359619|11473315|FG003|NOT COMPLETED|Overall Study||3
10336494|NCT00359619|11473316|FG004|NOT COMPLETED|Overall Study||3
10336495|NCT00359619|11473317|FG005|NOT COMPLETED|Overall Study||5
10336496|NCT00359619|11473318|FG006|NOT COMPLETED|Overall Study||4
10336497|NCT00359632|11473336|FG000|STARTED|Overall Study||24
10336498|NCT00359632|11473337|FG001|STARTED|Overall Study||9
10336499|NCT00359632|11473336|FG000|COMPLETED|Overall Study||20
10336500|NCT00359632|11473337|FG001|COMPLETED|Overall Study||9
10336501|NCT00359632|11473336|FG000|NOT COMPLETED|Overall Study||4
10336502|NCT00359632|11473337|FG001|NOT COMPLETED|Overall Study||0
10336503|NCT00359736|11473345|FG000|STARTED|Overall Study||14
10457831|NCT01012739|11605699|FG000|NOT COMPLETED|Treatment Period 1||0
10457832|NCT01012739|11605700|FG001|NOT COMPLETED|Treatment Period 1||0
10457833|NCT01012739|11605701|FG002|NOT COMPLETED|Treatment Period 1||0
10457834|NCT01012739|11605702|FG003|NOT COMPLETED|Treatment Period 1||1
10457835|NCT01012739|11605699|FG000|STARTED|Treatment Period 2||9
10457836|NCT01012739|11605700|FG001|STARTED|Treatment Period 2||8
10457837|NCT01012739|11605701|FG002|STARTED|Treatment Period 2||9
10457838|NCT01012739|11605702|FG003|STARTED|Treatment Period 2||8
10457839|NCT01012739|11605699|FG000|COMPLETED|Treatment Period 2||9
10457840|NCT01012739|11605700|FG001|COMPLETED|Treatment Period 2||8
10457841|NCT01012739|11605701|FG002|COMPLETED|Treatment Period 2||9
10457842|NCT01012739|11605702|FG003|COMPLETED|Treatment Period 2||7
10457843|NCT01012739|11605699|FG000|NOT COMPLETED|Treatment Period 2||0
10457844|NCT01012739|11605700|FG001|NOT COMPLETED|Treatment Period 2||0
10457845|NCT01012739|11605701|FG002|NOT COMPLETED|Treatment Period 2||0
10457846|NCT01012739|11605702|FG003|NOT COMPLETED|Treatment Period 2||1
10457847|NCT01012739|11605699|FG000|STARTED|Treatment Period 3||9
10457848|NCT01012739|11605700|FG001|STARTED|Treatment Period 3||8
10457849|NCT01012739|11605701|FG002|STARTED|Treatment Period 3||9
10457850|NCT01012739|11605702|FG003|STARTED|Treatment Period 3||7
10457851|NCT01012739|11605699|FG000|COMPLETED|Treatment Period 3||9
10457852|NCT01012739|11605700|FG001|COMPLETED|Treatment Period 3||8
10457853|NCT01012739|11605701|FG002|COMPLETED|Treatment Period 3||9
10457854|NCT01012739|11605702|FG003|COMPLETED|Treatment Period 3||7
10457855|NCT01012739|11605699|FG000|NOT COMPLETED|Treatment Period 3||0
10457856|NCT01012739|11605700|FG001|NOT COMPLETED|Treatment Period 3||0
10457857|NCT01012739|11605701|FG002|NOT COMPLETED|Treatment Period 3||0
10457858|NCT01012739|11605702|FG003|NOT COMPLETED|Treatment Period 3||0
10457859|NCT01012739|11605699|FG000|STARTED|Treatment Period 4||9
10457860|NCT01012739|11605700|FG001|STARTED|Treatment Period 4||8
10457861|NCT01012739|11605701|FG002|STARTED|Treatment Period 4||9
10457862|NCT01012739|11605702|FG003|STARTED|Treatment Period 4||7
10457863|NCT01012739|11605699|FG000|COMPLETED|Treatment Period 4||9
10457864|NCT01012739|11605700|FG001|COMPLETED|Treatment Period 4||8
10457865|NCT01012739|11605701|FG002|COMPLETED|Treatment Period 4||9
10457866|NCT01012739|11605702|FG003|COMPLETED|Treatment Period 4||7
10457867|NCT01012739|11605699|FG000|NOT COMPLETED|Treatment Period 4||0
10457868|NCT01012739|11605700|FG001|NOT COMPLETED|Treatment Period 4||0
10457869|NCT01012739|11605701|FG002|NOT COMPLETED|Treatment Period 4||0
10457870|NCT01012739|11605702|FG003|NOT COMPLETED|Treatment Period 4||0
10457871|NCT01012765|11605713|FG000|STARTED|Treatment Period 1||20
10457872|NCT01012765|11605714|FG001|STARTED|Treatment Period 1||21
10457873|NCT01012765|11605715|FG002|STARTED|Treatment Period 1||23
10457874|NCT01012765|11605716|FG003|STARTED|Treatment Period 1||18
10457875|NCT01012765|11605717|FG004|STARTED|Treatment Period 1||22
10457876|NCT01012765|11605718|FG005|STARTED|Treatment Period 1||25
10457877|NCT01012765|11605713|FG000|COMPLETED|Treatment Period 1||17
10457878|NCT01012765|11605714|FG001|COMPLETED|Treatment Period 1||21
10457879|NCT01012765|11605715|FG002|COMPLETED|Treatment Period 1||21
10457880|NCT01012765|11605716|FG003|COMPLETED|Treatment Period 1||15
10457881|NCT01012765|11605717|FG004|COMPLETED|Treatment Period 1||19
10457882|NCT01012765|11605718|FG005|COMPLETED|Treatment Period 1||25
10336504|NCT00359736|11473346|FG001|STARTED|Overall Study||15
10336505|NCT00359736|11473345|FG000|COMPLETED|Overall Study||14
10336506|NCT00359736|11473346|FG001|COMPLETED|Overall Study||15
10336507|NCT00359736|11473345|FG000|NOT COMPLETED|Overall Study||0
10336508|NCT00359736|11473346|FG001|NOT COMPLETED|Overall Study||0
10336509|NCT00359762|11473356|FG000|STARTED|Period II||514
10336510|NCT00359762|11473357|FG001|STARTED|Period II||0
10336511|NCT00359762|11473358|FG002|STARTED|Period II||0
10336512|NCT00359762|11473359|FG003|STARTED|Period II||0
10336513|NCT00359762|11473360|FG004|STARTED|Period II||515
10339155|NCT00371397|11476093|FG007|NOT COMPLETED|Session 2||0
10457883|NCT01012765|11605713|FG000|NOT COMPLETED|Treatment Period 1||3
10457884|NCT01012765|11605714|FG001|NOT COMPLETED|Treatment Period 1||0
10457885|NCT01012765|11605715|FG002|NOT COMPLETED|Treatment Period 1||2
10457886|NCT01012765|11605716|FG003|NOT COMPLETED|Treatment Period 1||3
10457887|NCT01012765|11605717|FG004|NOT COMPLETED|Treatment Period 1||3
10457888|NCT01012765|11605718|FG005|NOT COMPLETED|Treatment Period 1||0
10457889|NCT01012765|11605713|FG000|STARTED|Treatment Period 2||17
10457890|NCT01012765|11605714|FG001|STARTED|Treatment Period 2||21
10457891|NCT01012765|11605715|FG002|STARTED|Treatment Period 2||21
10336514|NCT00359762|11473356|FG000|Intent to Treat (ITT) Safety Population|Period II||508
10336515|NCT00359762|11473357|FG001|Intent to Treat (ITT) Safety Population|Period II||0
10336516|NCT00359762|11473358|FG002|Intent to Treat (ITT) Safety Population|Period II||0
10336517|NCT00359762|11473359|FG003|Intent to Treat (ITT) Safety Population|Period II||0
10336518|NCT00359762|11473360|FG004|Intent to Treat (ITT) Safety Population|Period II||511
10336519|NCT00359762|11473356|FG000|ITT Efficacy Population|Period II||487
10336520|NCT00359762|11473357|FG001|ITT Efficacy Population|Period II||0
10336521|NCT00359762|11473358|FG002|ITT Efficacy Population|Period II||0
10336522|NCT00359762|11473359|FG003|ITT Efficacy Population|Period II||0
10336523|NCT00359762|11473360|FG004|ITT Efficacy Population|Period II||490
10336524|NCT00359762|11473356|FG000|Met Primary Endpoint|Period II||262
10336525|NCT00359762|11473357|FG001|Met Primary Endpoint|Period II||0
10336526|NCT00359762|11473358|FG002|Met Primary Endpoint|Period II||0
10336527|NCT00359762|11473359|FG003|Met Primary Endpoint|Period II||0
10336528|NCT00359762|11473360|FG004|Met Primary Endpoint|Period II||203
10336529|NCT00359762|11473356|FG000|Without Treatment Failure|Period II||124
10336530|NCT00359762|11473357|FG001|Without Treatment Failure|Period II||0
10336531|NCT00359762|11473358|FG002|Without Treatment Failure|Period II||0
10336532|NCT00359762|11473359|FG003|Without Treatment Failure|Period II||0
10336533|NCT00359762|11473360|FG004|Without Treatment Failure|Period II||138
10336534|NCT00359762|11473356|FG000|COMPLETED|Period II||386
10336535|NCT00359762|11473357|FG001|COMPLETED|Period II||0
10336536|NCT00359762|11473358|FG002|COMPLETED|Period II||0
10336537|NCT00359762|11473359|FG003|COMPLETED|Period II||0
10336538|NCT00359762|11473360|FG004|COMPLETED|Period II||341
10336539|NCT00359762|11473356|FG000|NOT COMPLETED|Period II||128
10336540|NCT00359762|11473357|FG001|NOT COMPLETED|Period II||0
10336541|NCT00359762|11473358|FG002|NOT COMPLETED|Period II||0
10336542|NCT00359762|11473359|FG003|NOT COMPLETED|Period II||0
10336543|NCT00359762|11473360|FG004|NOT COMPLETED|Period II||174
10336544|NCT00359762|11473356|FG000|STARTED|Period III||0
10336545|NCT00359762|11473357|FG001|STARTED|Period III||77
10336546|NCT00359762|11473358|FG002|STARTED|Period III||77
10336547|NCT00359762|11473359|FG003|STARTED|Period III||166
10336548|NCT00359762|11473360|FG004|STARTED|Period III||0
10336549|NCT00359762|11473356|FG000|Extension ITT Safety Population|Period III||0
10336550|NCT00359762|11473357|FG001|Extension ITT Safety Population|Period III||74
10336551|NCT00359762|11473358|FG002|Extension ITT Safety Population|Period III||76
10336552|NCT00359762|11473359|FG003|Extension ITT Safety Population|Period III||166
10336553|NCT00359762|11473360|FG004|Extension ITT Safety Population|Period III||0
10336554|NCT00359762|11473356|FG000|Extension ITT Efficacy Population|Period III||0
10336555|NCT00359762|11473357|FG001|Extension ITT Efficacy Population|Period III||73
10336556|NCT00359762|11473358|FG002|Extension ITT Efficacy Population|Period III||75
10336557|NCT00359762|11473359|FG003|Extension ITT Efficacy Population|Period III||164
10336558|NCT00359762|11473360|FG004|Extension ITT Efficacy Population|Period III||0
10336559|NCT00359762|11473356|FG000|COMPLETED|Period III||0
10336560|NCT00359762|11473357|FG001|COMPLETED|Period III||48
10336561|NCT00359762|11473358|FG002|COMPLETED|Period III||47
10336562|NCT00359762|11473359|FG003|COMPLETED|Period III||101
10336563|NCT00359762|11473360|FG004|COMPLETED|Period III||0
10336564|NCT00359762|11473356|FG000|NOT COMPLETED|Period III||0
10336565|NCT00359762|11473357|FG001|NOT COMPLETED|Period III||29
10336566|NCT00359762|11473358|FG002|NOT COMPLETED|Period III||30
10336567|NCT00359762|11473359|FG003|NOT COMPLETED|Period III||65
10336568|NCT00359762|11473360|FG004|NOT COMPLETED|Period III||0
10336569|NCT00359762|11473356|FG000|STARTED|Period I||0
10336570|NCT00359762|11473357|FG001|STARTED|Period I||0
10336571|NCT00359762|11473358|FG002|STARTED|Period I||0
10336572|NCT00359762|11473359|FG003|STARTED|Period I||0
10336573|NCT00359762|11473360|FG004|STARTED|Period I||0
10336574|NCT00359762|11473356|FG000|COMPLETED|Period I||0
10336575|NCT00359762|11473357|FG001|COMPLETED|Period I||0
10336576|NCT00359762|11473358|FG002|COMPLETED|Period I||0
10336577|NCT00359762|11473359|FG003|COMPLETED|Period I||0
10336578|NCT00359762|11473360|FG004|COMPLETED|Period I||0
10336579|NCT00359762|11473356|FG000|NOT COMPLETED|Period I||0
10336580|NCT00359762|11473357|FG001|NOT COMPLETED|Period I||0
10336581|NCT00359762|11473358|FG002|NOT COMPLETED|Period I||0
10336582|NCT00359762|11473359|FG003|NOT COMPLETED|Period I||0
10336583|NCT00359762|11473360|FG004|NOT COMPLETED|Period I||0
10336584|NCT00359788|11473376|FG000|STARTED|Overall Study||173
10336585|NCT00359788|11473377|FG001|STARTED|Overall Study||176
10336586|NCT00359788|11473376|FG000|COMPLETED|Overall Study||150
10336587|NCT00359788|11473377|FG001|COMPLETED|Overall Study||159
10336588|NCT00359788|11473376|FG000|NOT COMPLETED|Overall Study||23
10336589|NCT00359788|11473377|FG001|NOT COMPLETED|Overall Study||17
10336590|NCT00359801|11473385|FG000|STARTED|Overall Study||987
10336591|NCT00359801|11473386|FG001|STARTED|Overall Study||989
10336592|NCT00359801|11473385|FG000|COMPLETED|Overall Study|7 additional subjects had missing data and final status (completed/discontinued) is unknown.|682
10336593|NCT00359801|11473386|FG001|COMPLETED|Overall Study|4 additional subjects had missing data and final status (completed/discontinued) is unknown.|769
10336594|NCT00359801|11473385|FG000|NOT COMPLETED|Overall Study||305
10336595|NCT00359801|11473386|FG001|NOT COMPLETED|Overall Study||220
10336596|NCT00359944|11473395|FG000|STARTED|Overall Study||50
10336597|NCT00359944|11473396|FG001|STARTED|Overall Study||47
10336598|NCT00359944|11473397|FG002|STARTED|Overall Study||57
10336599|NCT00359944|11473395|FG000|COMPLETED|Overall Study||34
10336600|NCT00359944|11473396|FG001|COMPLETED|Overall Study||28
10336601|NCT00359944|11473397|FG002|COMPLETED|Overall Study||38
10336602|NCT00359944|11473395|FG000|NOT COMPLETED|Overall Study||16
10336603|NCT00359944|11473396|FG001|NOT COMPLETED|Overall Study||19
10336604|NCT00359944|11473397|FG002|NOT COMPLETED|Overall Study||19
10336605|NCT00359983|11473408|FG000|STARTED|Year 1 Persistence Follow-up||138
10336606|NCT00359983|11473409|FG001|STARTED|Year 1 Persistence Follow-up||70
10336607|NCT00359983|11473410|FG002|STARTED|Year 1 Persistence Follow-up||62
10336608|NCT00359983|11473408|FG000|COMPLETED|Year 1 Persistence Follow-up||138
10336609|NCT00359983|11473409|FG001|COMPLETED|Year 1 Persistence Follow-up||70
10336610|NCT00359983|11473410|FG002|COMPLETED|Year 1 Persistence Follow-up||62
10336611|NCT00359983|11473408|FG000|NOT COMPLETED|Year 1 Persistence Follow-up||0
10336612|NCT00359983|11473409|FG001|NOT COMPLETED|Year 1 Persistence Follow-up||0
10336613|NCT00359983|11473410|FG002|NOT COMPLETED|Year 1 Persistence Follow-up||0
10336614|NCT00359983|11473408|FG000|STARTED|Year 3 Persistence Follow-up||103
10336615|NCT00359983|11473409|FG001|STARTED|Year 3 Persistence Follow-up||47
10336616|NCT00359983|11473410|FG002|STARTED|Year 3 Persistence Follow-up||51
10336617|NCT00359983|11473408|FG000|COMPLETED|Year 3 Persistence Follow-up||103
10336618|NCT00359983|11473409|FG001|COMPLETED|Year 3 Persistence Follow-up||47
10336619|NCT00359983|11473410|FG002|COMPLETED|Year 3 Persistence Follow-up||51
10336620|NCT00359983|11473408|FG000|NOT COMPLETED|Year 3 Persistence Follow-up||0
10336621|NCT00359983|11473409|FG001|NOT COMPLETED|Year 3 Persistence Follow-up||0
10336622|NCT00359983|11473410|FG002|NOT COMPLETED|Year 3 Persistence Follow-up||0
10336623|NCT00359983|11473408|FG000|STARTED|Year 5 Persistence Follow-up||95
10336624|NCT00359983|11473409|FG001|STARTED|Year 5 Persistence Follow-up||44
10336625|NCT00359983|11473410|FG002|STARTED|Year 5 Persistence Follow-up||42
10336626|NCT00359983|11473408|FG000|COMPLETED|Year 5 Persistence Follow-up||95
10336627|NCT00359983|11473409|FG001|COMPLETED|Year 5 Persistence Follow-up||44
10336628|NCT00359983|11473410|FG002|COMPLETED|Year 5 Persistence Follow-up||42
10336629|NCT00359983|11473408|FG000|NOT COMPLETED|Year 5 Persistence Follow-up||0
10336630|NCT00359983|11473409|FG001|NOT COMPLETED|Year 5 Persistence Follow-up||0
10336631|NCT00359983|11473410|FG002|NOT COMPLETED|Year 5 Persistence Follow-up||0
10336632|NCT00360009|11473421|FG000|STARTED|Overall Study||10
10336633|NCT00360009|11473422|FG001|STARTED|Overall Study||26
10336634|NCT00360009|11473423|FG002|STARTED|Overall Study||26
10336635|NCT00360009|11473421|FG000|COMPLETED|Overall Study||10
10336636|NCT00360009|11473422|FG001|COMPLETED|Overall Study||22
10336637|NCT00360009|11473423|FG002|COMPLETED|Overall Study||23
10336638|NCT00360009|11473421|FG000|NOT COMPLETED|Overall Study||0
10336639|NCT00360009|11473422|FG001|NOT COMPLETED|Overall Study||4
10336640|NCT00360009|11473423|FG002|NOT COMPLETED|Overall Study||3
10336641|NCT00360126|11473431|FG000|STARTED|Overall Study||11
10336642|NCT00360126|11473431|FG000|COMPLETED|Overall Study||11
10336643|NCT00360126|11473431|FG000|NOT COMPLETED|Overall Study||0
10336644|NCT00360230|11473442|FG000|STARTED|Overall Study||90
10336645|NCT00360230|11473443|FG001|STARTED|Overall Study||90
10336646|NCT00360230|11473444|FG002|STARTED|Overall Study||45
10336647|NCT00360230|11473445|FG003|STARTED|Overall Study||90
10336648|NCT00360230|11473446|FG004|STARTED|Overall Study||90
10336649|NCT00360230|11473447|FG005|STARTED|Overall Study||90
10336650|NCT00360230|11473448|FG006|STARTED|Overall Study||45
10336651|NCT00360230|11473442|FG000|COMPLETED|Overall Study||84
10336652|NCT00360230|11473443|FG001|COMPLETED|Overall Study||87
10336653|NCT00360230|11473444|FG002|COMPLETED|Overall Study||42
10336654|NCT00360230|11473445|FG003|COMPLETED|Overall Study||88
10336655|NCT00360230|11473446|FG004|COMPLETED|Overall Study||85
10336656|NCT00360230|11473447|FG005|COMPLETED|Overall Study||86
10336657|NCT00360230|11473448|FG006|COMPLETED|Overall Study||43
10336658|NCT00360230|11473442|FG000|NOT COMPLETED|Overall Study||6
10336659|NCT00360230|11473443|FG001|NOT COMPLETED|Overall Study||3
10336660|NCT00360230|11473444|FG002|NOT COMPLETED|Overall Study||3
10336661|NCT00360230|11473445|FG003|NOT COMPLETED|Overall Study||2
10336662|NCT00360230|11473446|FG004|NOT COMPLETED|Overall Study||5
10336663|NCT00360230|11473447|FG005|NOT COMPLETED|Overall Study||4
10336664|NCT00360230|11473448|FG006|NOT COMPLETED|Overall Study||2
10336665|NCT00360243|11473470|FG000|STARTED|Overall Study||337
10336666|NCT00360243|11473471|FG001|STARTED|Overall Study||363
10336667|NCT00360243|11473472|FG002|STARTED|Overall Study||336
10336668|NCT00360243|11473473|FG003|STARTED|Overall Study||349
10336669|NCT00360243|11473470|FG000|COMPLETED|Overall Study||235
10336670|NCT00360243|11473471|FG001|COMPLETED|Overall Study||243
10336671|NCT00360243|11473472|FG002|COMPLETED|Overall Study||180
10336672|NCT00360243|11473473|FG003|COMPLETED|Overall Study||224
10336673|NCT00360243|11473470|FG000|NOT COMPLETED|Overall Study||102
10336674|NCT00360243|11473471|FG001|NOT COMPLETED|Overall Study||120
10336675|NCT00360243|11473472|FG002|NOT COMPLETED|Overall Study||156
10336676|NCT00360243|11473473|FG003|NOT COMPLETED|Overall Study||125
10336677|NCT00360269|11473485|FG000|STARTED|Overall Study||19
10336678|NCT00360269|11473486|FG001|STARTED|Overall Study||19
10336679|NCT00360269|11473485|FG000|COMPLETED|Overall Study||9
10336680|NCT00360269|11473486|FG001|COMPLETED|Overall Study||7
10336681|NCT00360269|11473485|FG000|NOT COMPLETED|Overall Study||10
10336682|NCT00360269|11473486|FG001|NOT COMPLETED|Overall Study||12
10336683|NCT00360282|11473492|FG000|STARTED|First Intervention||6
10336684|NCT00360282|11473493|FG001|STARTED|First Intervention||8
10336685|NCT00360282|11473494|FG002|STARTED|First Intervention||7
10336686|NCT00360282|11473495|FG003|STARTED|First Intervention||6
10336687|NCT00360282|11473492|FG000|COMPLETED|First Intervention||6
10336688|NCT00360282|11473493|FG001|COMPLETED|First Intervention||8
10336689|NCT00360282|11473494|FG002|COMPLETED|First Intervention||7
10336690|NCT00360282|11473495|FG003|COMPLETED|First Intervention||6
10336691|NCT00360282|11473492|FG000|NOT COMPLETED|First Intervention||0
10336692|NCT00360282|11473493|FG001|NOT COMPLETED|First Intervention||0
10336693|NCT00360282|11473494|FG002|NOT COMPLETED|First Intervention||0
10336694|NCT00360282|11473495|FG003|NOT COMPLETED|First Intervention||0
10336695|NCT00360282|11473492|FG000|STARTED|Washout 1-3 Weeks||6
10336696|NCT00360282|11473493|FG001|STARTED|Washout 1-3 Weeks||8
10336697|NCT00360282|11473494|FG002|STARTED|Washout 1-3 Weeks||7
10336698|NCT00360282|11473495|FG003|STARTED|Washout 1-3 Weeks||6
10336699|NCT00360282|11473492|FG000|COMPLETED|Washout 1-3 Weeks||6
10336700|NCT00360282|11473493|FG001|COMPLETED|Washout 1-3 Weeks||8
10336701|NCT00360282|11473494|FG002|COMPLETED|Washout 1-3 Weeks||6
10336702|NCT00360282|11473495|FG003|COMPLETED|Washout 1-3 Weeks||6
10707768|NCT02623829|11872494|FG000|STARTED|Overall Study||21
10707769|NCT02623829|11872495|FG001|STARTED|Overall Study||21
10707770|NCT02623829|11872494|FG000|COMPLETED|Overall Study||20
10707771|NCT02623829|11872495|FG001|COMPLETED|Overall Study||20
10707772|NCT02623829|11872494|FG000|NOT COMPLETED|Overall Study||1
10707773|NCT02623829|11872495|FG001|NOT COMPLETED|Overall Study||1
10336703|NCT00360282|11473492|FG000|NOT COMPLETED|Washout 1-3 Weeks||0
10336704|NCT00360282|11473493|FG001|NOT COMPLETED|Washout 1-3 Weeks||0
10336705|NCT00360282|11473494|FG002|NOT COMPLETED|Washout 1-3 Weeks||1
10707774|NCT02623855|11872503|FG000|STARTED|Overall Study||56
10707775|NCT02623855|11872504|FG001|STARTED|Overall Study||100
10707776|NCT02623855|11872503|FG000|COMPLETED|Overall Study||46
10707777|NCT02623855|11872504|FG001|COMPLETED|Overall Study||84
10707778|NCT02623855|11872503|FG000|NOT COMPLETED|Overall Study||10
10707779|NCT02623855|11872504|FG001|NOT COMPLETED|Overall Study||16
10707780|NCT02624050|11872512|FG000|STARTED|Overall Study||26
10707781|NCT02624050|11872513|FG001|STARTED|Overall Study||25
10707782|NCT02624050|11872512|FG000|COMPLETED|Overall Study||20
10707783|NCT02624050|11872513|FG001|COMPLETED|Overall Study||25
10707784|NCT02624050|11872512|FG000|NOT COMPLETED|Overall Study||6
10707785|NCT02624050|11872513|FG001|NOT COMPLETED|Overall Study||0
10336706|NCT00360282|11473495|FG003|NOT COMPLETED|Washout 1-3 Weeks||0
10336707|NCT00360282|11473492|FG000|STARTED|Second Intervention||6
10336708|NCT00360282|11473493|FG001|STARTED|Second Intervention||8
10336709|NCT00360282|11473494|FG002|STARTED|Second Intervention||6
10336710|NCT00360282|11473495|FG003|STARTED|Second Intervention||6
10336711|NCT00360282|11473492|FG000|COMPLETED|Second Intervention||6
10336712|NCT00360282|11473493|FG001|COMPLETED|Second Intervention||7
10336713|NCT00360282|11473494|FG002|COMPLETED|Second Intervention||6
10336714|NCT00360282|11473495|FG003|COMPLETED|Second Intervention||6
10707786|NCT02624180|11872521|FG000|STARTED|Overall Study||43
10707787|NCT02624180|11872522|FG001|STARTED|Overall Study||38
10707788|NCT02624180|11872521|FG000|COMPLETED|Overall Study||37
10707789|NCT02624180|11872522|FG001|COMPLETED|Overall Study||34
10707790|NCT02624180|11872521|FG000|NOT COMPLETED|Overall Study||6
10707791|NCT02624180|11872522|FG001|NOT COMPLETED|Overall Study||4
10336715|NCT00360282|11473492|FG000|NOT COMPLETED|Second Intervention||0
10336716|NCT00360282|11473493|FG001|NOT COMPLETED|Second Intervention||1
10336717|NCT00360282|11473494|FG002|NOT COMPLETED|Second Intervention||0
10336718|NCT00360282|11473495|FG003|NOT COMPLETED|Second Intervention||0
10336719|NCT00360308|11473506|FG000|STARTED|Overall Study||247
10336720|NCT00360308|11473507|FG001|STARTED|Overall Study||234
10336721|NCT00360308|11473508|FG002|STARTED|Overall Study||242
10336722|NCT00360308|11473506|FG000|COMPLETED|Overall Study||171
10707792|NCT02624284|11872531|FG000|STARTED|Overall Study||49
10707793|NCT02624284|11872532|FG001|STARTED|Overall Study||53
10707794|NCT02624284|11872533|FG002|STARTED|Overall Study||47
10336723|NCT00360308|11473507|FG001|COMPLETED|Overall Study||155
10336724|NCT00360308|11473508|FG002|COMPLETED|Overall Study||154
10336725|NCT00360308|11473506|FG000|NOT COMPLETED|Overall Study||76
10336726|NCT00360308|11473507|FG001|NOT COMPLETED|Overall Study||79
10336727|NCT00360308|11473508|FG002|NOT COMPLETED|Overall Study||88
10336728|NCT00360334|11473522|FG000|STARTED|Overall Study||118
10336729|NCT00360334|11473523|FG001|STARTED|Overall Study||117
10336730|NCT00360334|11473522|FG000|Full Analysis Set (FAS)|Overall Study|FAS = received ≥ 1 dose of study drug|118
10336731|NCT00360334|11473523|FG001|Full Analysis Set (FAS)|Overall Study|FAS = received ≥ 1 dose of study drug|116
10336732|NCT00360334|11473522|FG000|COMPLETED|Overall Study||99
10336733|NCT00360334|11473523|FG001|COMPLETED|Overall Study||104
10336734|NCT00360334|11473522|FG000|NOT COMPLETED|Overall Study||19
10336735|NCT00360334|11473523|FG001|NOT COMPLETED|Overall Study||13
10336736|NCT00360360|11473529|FG000|STARTED|Overall Study||60
10336737|NCT00360360|11473529|FG000|COMPLETED|Overall Study||54
10336738|NCT00360360|11473529|FG000|NOT COMPLETED|Overall Study||6
10336739|NCT00360399|11473536|FG000|STARTED|Overall Study||114
10336740|NCT00360399|11473537|FG001|STARTED|Overall Study||115
10336741|NCT00360399|11473538|FG002|STARTED|Overall Study||115
10336742|NCT00360399|11473536|FG000|Had Post-randomization Assessment|Overall Study||105
10336743|NCT00360399|11473537|FG001|Had Post-randomization Assessment|Overall Study||106
10336744|NCT00360399|11473538|FG002|Had Post-randomization Assessment|Overall Study||105
10336745|NCT00360399|11473536|FG000|COMPLETED|Overall Study||86
10336746|NCT00360399|11473537|FG001|COMPLETED|Overall Study||79
10336747|NCT00360399|11473538|FG002|COMPLETED|Overall Study||69
10336748|NCT00360399|11473536|FG000|NOT COMPLETED|Overall Study||28
10336749|NCT00360399|11473537|FG001|NOT COMPLETED|Overall Study||36
10336750|NCT00360399|11473538|FG002|NOT COMPLETED|Overall Study||46
10336751|NCT00360412|11473548|FG000|STARTED|Overall Study||333
10336752|NCT00360412|11473549|FG001|STARTED|Overall Study||664
10336753|NCT00360412|11473548|FG000|COMPLETED|Overall Study||0
10336754|NCT00360412|11473549|FG001|COMPLETED|Overall Study||2
10336755|NCT00360412|11473548|FG000|NOT COMPLETED|Overall Study||333
10336756|NCT00360412|11473549|FG001|NOT COMPLETED|Overall Study||662
10336757|NCT00360490|11473557|FG000|STARTED|Overall Study||82
10336758|NCT00360490|11473558|FG001|STARTED|Overall Study||83
10336759|NCT00360490|11473557|FG000|COMPLETED|Overall Study||73
10336760|NCT00360490|11473558|FG001|COMPLETED|Overall Study||72
10336761|NCT00360490|11473557|FG000|NOT COMPLETED|Overall Study||9
10336762|NCT00360490|11473558|FG001|NOT COMPLETED|Overall Study||11
10336763|NCT00360529|11473567|FG000|STARTED|Overall Study||295
10336764|NCT00360529|11473568|FG001|STARTED|Overall Study||295
10336765|NCT00360529|11473569|FG002|STARTED|Overall Study||290
10336766|NCT00360529|11473567|FG000|COMPLETED|Overall Study||234
10336767|NCT00360529|11473568|FG001|COMPLETED|Overall Study||230
10336768|NCT00360529|11473569|FG002|COMPLETED|Overall Study||199
10336769|NCT00360529|11473567|FG000|NOT COMPLETED|Overall Study||61
10336770|NCT00360529|11473568|FG001|NOT COMPLETED|Overall Study||65
10336771|NCT00360529|11473569|FG002|NOT COMPLETED|Overall Study||91
10336772|NCT00360555|11473581|FG000|STARTED|Overall Study||396
10336773|NCT00360555|11473582|FG001|STARTED|Overall Study||393
10336774|NCT00360555|11473583|FG002|STARTED|Overall Study||396
10336775|NCT00360555|11473584|FG003|STARTED|Overall Study||399
10336776|NCT00360555|11473581|FG000|COMPLETED|Overall Study||274
10336777|NCT00360555|11473582|FG001|COMPLETED|Overall Study||259
10336778|NCT00360555|11473583|FG002|COMPLETED|Overall Study||251
10336779|NCT00360555|11473584|FG003|COMPLETED|Overall Study||287
10336780|NCT00360555|11473581|FG000|NOT COMPLETED|Overall Study||122
10336781|NCT00360555|11473582|FG001|NOT COMPLETED|Overall Study||134
10336782|NCT00360555|11473583|FG002|NOT COMPLETED|Overall Study||145
10336783|NCT00360555|11473584|FG003|NOT COMPLETED|Overall Study||112
10336784|NCT00360568|11473596|FG000|STARTED|Overall Study||33
10336785|NCT00360568|11473597|FG001|STARTED|Overall Study||29
10336786|NCT00360568|11473596|FG000|COMPLETED|Overall Study||31
10336787|NCT00360568|11473597|FG001|COMPLETED|Overall Study||24
10336788|NCT00360568|11473596|FG000|NOT COMPLETED|Overall Study||2
10336789|NCT00360568|11473597|FG001|NOT COMPLETED|Overall Study||5
10336790|NCT00360672|11473605|FG000|STARTED|Overall Study||27
10336791|NCT00360672|11473605|FG000|COMPLETED|Overall Study||27
10336792|NCT00360672|11473605|FG000|NOT COMPLETED|Overall Study||0
10336793|NCT00360685|11473611|FG000|STARTED|Overall Study||47
10336794|NCT00360685|11473612|FG001|STARTED|Overall Study||42
10336795|NCT00360685|11473611|FG000|COMPLETED|Overall Study||47
10336796|NCT00360685|11473612|FG001|COMPLETED|Overall Study||42
10336797|NCT00360685|11473611|FG000|NOT COMPLETED|Overall Study||0
10336798|NCT00360685|11473612|FG001|NOT COMPLETED|Overall Study||0
10336799|NCT00360698|11473621|FG000|STARTED|Run-In||0
10336800|NCT00360698|11473622|FG001|STARTED|Run-In||135
10336801|NCT00360698|11473621|FG000|COMPLETED|Run-In||0
10336802|NCT00360698|11473622|FG001|COMPLETED|Run-In|19 patients completed the run-in but were not eligible for randomization in the treatment period|125
10336803|NCT00360698|11473621|FG000|NOT COMPLETED|Run-In||0
10336804|NCT00360698|11473622|FG001|NOT COMPLETED|Run-In||10
10336805|NCT00360698|11473621|FG000|STARTED|Treatment Period||49
10336806|NCT00360698|11473622|FG001|STARTED|Treatment Period||57
10336807|NCT00360698|11473621|FG000|COMPLETED|Treatment Period||48
10336808|NCT00360698|11473622|FG001|COMPLETED|Treatment Period||56
10336809|NCT00360698|11473621|FG000|NOT COMPLETED|Treatment Period||1
10336810|NCT00360698|11473622|FG001|NOT COMPLETED|Treatment Period||1
10336811|NCT00360724|11473630|FG000|STARTED|Overall Study||33
10336812|NCT00360724|11473631|FG001|STARTED|Overall Study||32
10336813|NCT00360724|11473630|FG000|COMPLETED|Overall Study||29
10336814|NCT00360724|11473631|FG001|COMPLETED|Overall Study||28
10336815|NCT00360724|11473630|FG000|NOT COMPLETED|Overall Study||4
10336816|NCT00360724|11473631|FG001|NOT COMPLETED|Overall Study||4
10336817|NCT00360828|11473640|FG000|STARTED|Overall Study||10
10336818|NCT00360828|11473640|FG000|COMPLETED|Overall Study||9
10336819|NCT00360828|11473640|FG000|NOT COMPLETED|Overall Study||1
10336820|NCT00360971|11473646|FG000|STARTED|Overall Study||10
10336821|NCT00360971|11473647|FG001|STARTED|Overall Study||11
10336822|NCT00360971|11473646|FG000|COMPLETED|Overall Study|Subjects with data for planned primary analysis are considered to have completed the study.|10
10336823|NCT00360971|11473647|FG001|COMPLETED|Overall Study|Subjects with data for planned primary analysis are considered to have completed the study.|11
10336824|NCT00360971|11473646|FG000|NOT COMPLETED|Overall Study||0
10336825|NCT00360971|11473647|FG001|NOT COMPLETED|Overall Study||0
10336826|NCT00361140|11473656|FG000|STARTED|Overall Study||40
10336827|NCT00361140|11473657|FG001|STARTED|Overall Study||29
10336828|NCT00361140|11473658|FG002|STARTED|Overall Study||3
10336829|NCT00361140|11473656|FG000|COMPLETED|Overall Study||40
10336830|NCT00361140|11473657|FG001|COMPLETED|Overall Study||29
10336831|NCT00361140|11473658|FG002|COMPLETED|Overall Study||3
10336832|NCT00361140|11473656|FG000|NOT COMPLETED|Overall Study||0
10336833|NCT00361140|11473657|FG001|NOT COMPLETED|Overall Study||0
10336834|NCT00361140|11473658|FG002|NOT COMPLETED|Overall Study||0
10336835|NCT00361218|11473666|FG000|STARTED|Overall Study|met eligibility criteria and enrolled in the study|53
10336836|NCT00361218|11473666|FG000|Completed Baseline Assessment|Overall Study||47
10336837|NCT00361218|11473666|FG000|COMPLETED|Overall Study||30
10336838|NCT00361218|11473666|FG000|NOT COMPLETED|Overall Study||23
10336839|NCT00361231|11473670|FG000|STARTED|Overall Study||35
10336840|NCT00361231|11473670|FG000|COMPLETED|Overall Study||1
10336841|NCT00361231|11473670|FG000|NOT COMPLETED|Overall Study||34
10336842|NCT00361257|11473676|FG000|STARTED|Step 1: Minocycline vs. Placebo||52
10336843|NCT00361257|11473677|FG001|STARTED|Step 1: Minocycline vs. Placebo||55
10336844|NCT00361257|11473676|FG000|COMPLETED|Step 1: Minocycline vs. Placebo||40
10336845|NCT00361257|11473677|FG001|COMPLETED|Step 1: Minocycline vs. Placebo||43
10336846|NCT00361257|11473676|FG000|NOT COMPLETED|Step 1: Minocycline vs. Placebo||12
10336847|NCT00361257|11473677|FG001|NOT COMPLETED|Step 1: Minocycline vs. Placebo||12
10336848|NCT00361257|11473676|FG000|STARTED|Step 2: Minocycline(Open Label) for All|40 participants completed Step 1; however,12 decided not to enroll Step 2,so 40-12=28 started Step 2|28
10336849|NCT00361257|11473677|FG001|STARTED|Step 2: Minocycline(Open Label) for All|43 participants completed Step 1; however, 9 decided not to enroll Step 2,so 43-9=34 started Step 2.|34
10336850|NCT00361257|11473676|FG000|COMPLETED|Step 2: Minocycline(Open Label) for All||13
10336851|NCT00361257|11473677|FG001|COMPLETED|Step 2: Minocycline(Open Label) for All||19
10336852|NCT00361257|11473676|FG000|NOT COMPLETED|Step 2: Minocycline(Open Label) for All||15
10336853|NCT00361257|11473677|FG001|NOT COMPLETED|Step 2: Minocycline(Open Label) for All||15
10336854|NCT00361270|11473689|FG000|STARTED|Overall Study||49
10336855|NCT00361270|11473690|FG001|STARTED|Overall Study||39
10336856|NCT00361270|11473691|FG002|STARTED|Overall Study||35
10336857|NCT00361270|11473692|FG003|STARTED|Overall Study||38
10336858|NCT00361270|11473689|FG000|COMPLETED|Overall Study||25
10336859|NCT00361270|11473690|FG001|COMPLETED|Overall Study||25
10336860|NCT00361270|11473691|FG002|COMPLETED|Overall Study||25
10336861|NCT00361270|11473692|FG003|COMPLETED|Overall Study||25
10336862|NCT00361270|11473689|FG000|NOT COMPLETED|Overall Study||24
10336863|NCT00361270|11473690|FG001|NOT COMPLETED|Overall Study||14
10336864|NCT00361270|11473691|FG002|NOT COMPLETED|Overall Study||10
10336865|NCT00361270|11473692|FG003|NOT COMPLETED|Overall Study||13
10336866|NCT00361283|11473709|FG000|STARTED|Overall Study||108
10336867|NCT00361283|11473709|FG000|COMPLETED|Overall Study||81
10336868|NCT00361283|11473709|FG000|NOT COMPLETED|Overall Study||27
10336869|NCT00361296|11473713|FG000|STARTED|Overall Study||5
10336870|NCT00361296|11473713|FG000|COMPLETED|Overall Study||2
10336871|NCT00361296|11473713|FG000|NOT COMPLETED|Overall Study||3
10336872|NCT00361335|11473722|FG000|STARTED|IV Period: Baseline to E0||129
10336873|NCT00361335|11473723|FG001|STARTED|IV Period: Baseline to E0||128
10336874|NCT00361335|11473724|FG002|STARTED|IV Period: Baseline to E0||128
10336875|NCT00361335|11473725|FG003|STARTED|IV Period: Baseline to E0||129
10336876|NCT00361335|11473726|FG004|STARTED|IV Period: Baseline to E0||129
10336877|NCT00361335|11473727|FG005|STARTED|IV Period: Baseline to E0|"0 in column indicates this reporting group is not relevant to the IV Period."|0
10336878|NCT00361335|11473728|FG006|STARTED|IV Period: Baseline to E0|"0 in column indicates this reporting group is not relevant to the IV Period."|0
10336879|NCT00361335|11473722|FG000|COMPLETED|IV Period: Baseline to E0||109
10336880|NCT00361335|11473723|FG001|COMPLETED|IV Period: Baseline to E0||99
10336881|NCT00361335|11473724|FG002|COMPLETED|IV Period: Baseline to E0||107
10336882|NCT00361335|11473725|FG003|COMPLETED|IV Period: Baseline to E0||102
10336883|NCT00361335|11473726|FG004|COMPLETED|IV Period: Baseline to E0||105
10336884|NCT00361335|11473727|FG005|COMPLETED|IV Period: Baseline to E0||0
10336885|NCT00361335|11473728|FG006|COMPLETED|IV Period: Baseline to E0||0
10336886|NCT00361335|11473722|FG000|NOT COMPLETED|IV Period: Baseline to E0||20
10336887|NCT00361335|11473723|FG001|NOT COMPLETED|IV Period: Baseline to E0||29
10336888|NCT00361335|11473724|FG002|NOT COMPLETED|IV Period: Baseline to E0||21
10336889|NCT00361335|11473725|FG003|NOT COMPLETED|IV Period: Baseline to E0||27
10336890|NCT00361335|11473726|FG004|NOT COMPLETED|IV Period: Baseline to E0||24
10336891|NCT00361335|11473727|FG005|NOT COMPLETED|IV Period: Baseline to E0||0
10336892|NCT00361335|11473728|FG006|NOT COMPLETED|IV Period: Baseline to E0||0
10339156|NCT00371397|11476094|FG008|NOT COMPLETED|Session 2||0
10336893|NCT00361335|11473722|FG000|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|82
10336894|NCT00361335|11473723|FG001|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|59
10336895|NCT00361335|11473724|FG002|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|104
10336896|NCT00361335|11473725|FG003|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|63
10336897|NCT00361335|11473726|FG004|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|3
10336898|NCT00361335|11473727|FG005|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|24
10336899|NCT00361335|11473728|FG006|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|173
10336900|NCT00361335|11473722|FG000|COMPLETED|SC Period: Week E0 to Week E24||80
10336901|NCT00361335|11473723|FG001|COMPLETED|SC Period: Week E0 to Week E24||56
10336902|NCT00361335|11473724|FG002|COMPLETED|SC Period: Week E0 to Week E24||99
10336903|NCT00361335|11473725|FG003|COMPLETED|SC Period: Week E0 to Week E24||59
10336904|NCT00361335|11473726|FG004|COMPLETED|SC Period: Week E0 to Week E24||3
10336905|NCT00361335|11473727|FG005|COMPLETED|SC Period: Week E0 to Week E24||23
10336906|NCT00361335|11473728|FG006|COMPLETED|SC Period: Week E0 to Week E24||164
10336907|NCT00361335|11473722|FG000|NOT COMPLETED|SC Period: Week E0 to Week E24||2
10336908|NCT00361335|11473723|FG001|NOT COMPLETED|SC Period: Week E0 to Week E24||3
10336909|NCT00361335|11473724|FG002|NOT COMPLETED|SC Period: Week E0 to Week E24||5
10336910|NCT00361335|11473725|FG003|NOT COMPLETED|SC Period: Week E0 to Week E24||4
10336911|NCT00361335|11473726|FG004|NOT COMPLETED|SC Period: Week E0 to Week E24||0
10336912|NCT00361335|11473727|FG005|NOT COMPLETED|SC Period: Week E0 to Week E24||1
10707795|NCT02624284|11872531|FG000|COMPLETED|Overall Study||35
10707796|NCT02624284|11872532|FG001|COMPLETED|Overall Study||35
10707797|NCT02624284|11872533|FG002|COMPLETED|Overall Study||36
10707798|NCT02624284|11872531|FG000|NOT COMPLETED|Overall Study||14
10707799|NCT02624284|11872532|FG001|NOT COMPLETED|Overall Study||18
10707800|NCT02624284|11872533|FG002|NOT COMPLETED|Overall Study||11
10707801|NCT02624375|11872541|FG000|STARTED|Overall Study||10
10707802|NCT02624375|11872541|FG000|COMPLETED|Overall Study||10
10707803|NCT02624375|11872541|FG000|NOT COMPLETED|Overall Study||0
10336913|NCT00361335|11473728|FG006|NOT COMPLETED|SC Period: Week E0 to Week E24||9
10336914|NCT00361374|11473747|FG000|STARTED|Overall Study||66
10336915|NCT00361374|11473748|FG001|STARTED|Overall Study||65
10336916|NCT00361374|11473749|FG002|STARTED|Overall Study||65
10336917|NCT00361374|11473747|FG000|COMPLETED|Overall Study||51
10336918|NCT00361374|11473748|FG001|COMPLETED|Overall Study||50
10336919|NCT00361374|11473749|FG002|COMPLETED|Overall Study||53
10336920|NCT00361374|11473747|FG000|NOT COMPLETED|Overall Study||15
10336921|NCT00361374|11473748|FG001|NOT COMPLETED|Overall Study||15
10336922|NCT00361374|11473749|FG002|NOT COMPLETED|Overall Study||12
10336923|NCT00361439|11473759|FG000|STARTED|Overall Study||8
10336924|NCT00361439|11473760|FG001|STARTED|Overall Study||9
10336925|NCT00361439|11473759|FG000|COMPLETED|Overall Study||8
10336926|NCT00361439|11473760|FG001|COMPLETED|Overall Study||9
10336927|NCT00361439|11473759|FG000|NOT COMPLETED|Overall Study||0
10336928|NCT00361439|11473760|FG001|NOT COMPLETED|Overall Study||0
10336929|NCT00361504|11473768|FG000|STARTED|Overall Study|Number of participants who received at least 1 dose of study medication|894
10336930|NCT00361504|11473769|FG001|STARTED|Overall Study|Number of participants who received at least 1 dose of study medication|223
10336931|NCT00361504|11473768|FG000|COMPLETED|Overall Study||413
10336932|NCT00361504|11473769|FG001|COMPLETED|Overall Study||78
10336933|NCT00361504|11473768|FG000|NOT COMPLETED|Overall Study||481
10336934|NCT00361504|11473769|FG001|NOT COMPLETED|Overall Study||145
10336935|NCT00361569|11473779|FG000|STARTED|Overall Study||150
10336936|NCT00361569|11473780|FG001|STARTED|Overall Study||161
10336937|NCT00361569|11473781|FG002|STARTED|Overall Study||155
10336938|NCT00361569|11473782|FG003|STARTED|Overall Study||156
10336939|NCT00361569|11473779|FG000|COMPLETED|Overall Study||138
10336940|NCT00361569|11473780|FG001|COMPLETED|Overall Study||150
10336941|NCT00361569|11473781|FG002|COMPLETED|Overall Study||137
10336942|NCT00361569|11473782|FG003|COMPLETED|Overall Study||135
10336943|NCT00361569|11473779|FG000|NOT COMPLETED|Overall Study||12
10336944|NCT00361569|11473780|FG001|NOT COMPLETED|Overall Study||11
10336945|NCT00361569|11473781|FG002|NOT COMPLETED|Overall Study||18
10336946|NCT00361569|11473782|FG003|NOT COMPLETED|Overall Study||21
10336947|NCT00361595|11473792|FG000|STARTED|Overall Study||35
10707804|NCT02624492|11872548|FG000|STARTED|Overall Study||5
10707805|NCT02624492|11872549|FG001|STARTED|Overall Study||8
10707806|NCT02624492|11872550|FG002|STARTED|Overall Study||8
10336948|NCT00361595|11473792|FG000|COMPLETED|Overall Study||35
10336949|NCT00361595|11473792|FG000|NOT COMPLETED|Overall Study||0
10336950|NCT00361634|11473796|FG000|STARTED|Overall Study||14
10336951|NCT00361634|11473796|FG000|Treated|Overall Study|The safety analysis set consisted of all patients who received at least one dose of etanercept.|13
10336952|NCT00361634|11473796|FG000|COMPLETED|Overall Study||12
10336953|NCT00361634|11473796|FG000|NOT COMPLETED|Overall Study||2
10336954|NCT00361712|11473802|FG000|STARTED|Overall Study||20
10336955|NCT00361712|11473803|FG001|STARTED|Overall Study||21
10336956|NCT00361712|11473802|FG000|COMPLETED|Overall Study||20
10336957|NCT00361712|11473803|FG001|COMPLETED|Overall Study||21
10336958|NCT00361712|11473802|FG000|NOT COMPLETED|Overall Study||0
10707807|NCT02624492|11872548|FG000|COMPLETED|Overall Study||3
10336959|NCT00361712|11473803|FG001|NOT COMPLETED|Overall Study||0
10336960|NCT00361842|11473811|FG000|STARTED|Overall Study||28
10336961|NCT00361842|11473812|FG001|STARTED|Overall Study||35
10336962|NCT00361842|11473811|FG000|COMPLETED|Overall Study||1
10336963|NCT00361842|11473812|FG001|COMPLETED|Overall Study||1
10649786|NCT02164383|11809951|FG001|NOT COMPLETED|Overall Study||0
10649787|NCT02164396|11809960|FG000|STARTED|Overall Study||10
10649788|NCT02164396|11809961|FG001|STARTED|Overall Study||10
10649789|NCT02164396|11809962|FG002|STARTED|Overall Study||10
10649790|NCT02164396|11809960|FG000|COMPLETED|Overall Study||10
10649791|NCT02164396|11809961|FG001|COMPLETED|Overall Study||10
10336964|NCT00361842|11473811|FG000|NOT COMPLETED|Overall Study||27
10336965|NCT00361842|11473812|FG001|NOT COMPLETED|Overall Study||34
10336966|NCT00361972|11473822|FG000|STARTED|Overall Study||8
10336967|NCT00361972|11473823|FG001|STARTED|Overall Study||9
10336968|NCT00361972|11473822|FG000|COMPLETED|Overall Study||8
10336969|NCT00361972|11473823|FG001|COMPLETED|Overall Study||9
10336970|NCT00361972|11473822|FG000|NOT COMPLETED|Overall Study||0
10336971|NCT00361972|11473823|FG001|NOT COMPLETED|Overall Study||0
10336972|NCT00362115|11473837|FG000|STARTED|Overall Study||65
10336973|NCT00362115|11473838|FG001|STARTED|Overall Study|1 participant failed to receive double-blind medication.|65
10336974|NCT00362115|11473839|FG002|STARTED|Overall Study||64
10336975|NCT00362115|11473840|FG003|STARTED|Overall Study|1 participant failed to receive double-blind medication.|63
10336976|NCT00362115|11473841|FG004|STARTED|Overall Study||64
10336977|NCT00362115|11473842|FG005|STARTED|Overall Study|1 participant failed to receive double-blind medication.|64
10336978|NCT00362115|11473843|FG006|STARTED|Overall Study|1 participant failed to receive double-blind medication.|64
10336979|NCT00362115|11473837|FG000|COMPLETED|Overall Study||63
10336980|NCT00362115|11473838|FG001|COMPLETED|Overall Study||59
10336981|NCT00362115|11473839|FG002|COMPLETED|Overall Study||57
10336982|NCT00362115|11473840|FG003|COMPLETED|Overall Study||59
10336983|NCT00362115|11473841|FG004|COMPLETED|Overall Study||57
10336984|NCT00362115|11473842|FG005|COMPLETED|Overall Study||57
10707808|NCT02624492|11872549|FG001|COMPLETED|Overall Study||4
10336985|NCT00362115|11473843|FG006|COMPLETED|Overall Study||52
10336986|NCT00362115|11473837|FG000|NOT COMPLETED|Overall Study||2
10336987|NCT00362115|11473838|FG001|NOT COMPLETED|Overall Study||6
10336988|NCT00362115|11473839|FG002|NOT COMPLETED|Overall Study||7
10336989|NCT00362115|11473840|FG003|NOT COMPLETED|Overall Study||4
10336990|NCT00362115|11473841|FG004|NOT COMPLETED|Overall Study||7
10336991|NCT00362115|11473842|FG005|NOT COMPLETED|Overall Study||7
10336992|NCT00362115|11473843|FG006|NOT COMPLETED|Overall Study||12
10336993|NCT00362128|11473859|FG000|STARTED|Overall Study|Enrollment was initiated in 2007.|2072
10336994|NCT00362128|11473859|FG000|COMPLETED|Overall Study|Enrollment was completed in October 2009.|2072
10336995|NCT00362128|11473859|FG000|NOT COMPLETED|Overall Study||0
10336996|NCT00362180|11473872|FG000|STARTED|Treated Period||4
10336997|NCT00362180|11473873|FG001|STARTED|Treated Period||2
10336998|NCT00362180|11473874|FG002|STARTED|Treated Period||1
10336999|NCT00362180|11473875|FG003|STARTED|Treated Period||0
10337000|NCT00362180|11473876|FG004|STARTED|Treated Period||11
10337001|NCT00362180|11473877|FG005|STARTED|Treated Period||10
10337002|NCT00362180|11473878|FG006|STARTED|Treated Period||6
10337003|NCT00362180|11473879|FG007|STARTED|Treated Period||3
10337004|NCT00362180|11473880|FG008|STARTED|Treated Period||1
10337005|NCT00362180|11473872|FG000|COMPLETED|Treated Period||3
10337006|NCT00362180|11473873|FG001|COMPLETED|Treated Period||2
10337007|NCT00362180|11473874|FG002|COMPLETED|Treated Period||1
10337008|NCT00362180|11473875|FG003|COMPLETED|Treated Period||0
10337009|NCT00362180|11473876|FG004|COMPLETED|Treated Period||11
10337010|NCT00362180|11473877|FG005|COMPLETED|Treated Period||9
10337011|NCT00362180|11473878|FG006|COMPLETED|Treated Period||6
10337012|NCT00362180|11473879|FG007|COMPLETED|Treated Period||2
10337013|NCT00362180|11473880|FG008|COMPLETED|Treated Period||1
10337014|NCT00362180|11473872|FG000|NOT COMPLETED|Treated Period||1
10337015|NCT00362180|11473873|FG001|NOT COMPLETED|Treated Period||0
10337016|NCT00362180|11473874|FG002|NOT COMPLETED|Treated Period||0
10337017|NCT00362180|11473875|FG003|NOT COMPLETED|Treated Period||0
10337018|NCT00362180|11473876|FG004|NOT COMPLETED|Treated Period||0
10337019|NCT00362180|11473877|FG005|NOT COMPLETED|Treated Period||1
10337020|NCT00362180|11473878|FG006|NOT COMPLETED|Treated Period||0
10337021|NCT00362180|11473879|FG007|NOT COMPLETED|Treated Period||1
10337022|NCT00362180|11473880|FG008|NOT COMPLETED|Treated Period||0
10337023|NCT00362180|11473872|FG000|STARTED|20 Week Safety Follow-up||3
10337024|NCT00362180|11473873|FG001|STARTED|20 Week Safety Follow-up||2
10337025|NCT00362180|11473874|FG002|STARTED|20 Week Safety Follow-up||1
10337026|NCT00362180|11473875|FG003|STARTED|20 Week Safety Follow-up||0
10337027|NCT00362180|11473876|FG004|STARTED|20 Week Safety Follow-up||11
10337028|NCT00362180|11473877|FG005|STARTED|20 Week Safety Follow-up||9
10337029|NCT00362180|11473878|FG006|STARTED|20 Week Safety Follow-up|This observational cohort did not include a safety follow-up period.|0
10337030|NCT00362180|11473879|FG007|STARTED|20 Week Safety Follow-up||3
10649792|NCT02164396|11809962|FG002|COMPLETED|Overall Study||10
10649793|NCT02164396|11809960|FG000|NOT COMPLETED|Overall Study||0
10337031|NCT00362180|11473880|FG008|STARTED|20 Week Safety Follow-up||1
10337032|NCT00362180|11473872|FG000|COMPLETED|20 Week Safety Follow-up||3
10337033|NCT00362180|11473873|FG001|COMPLETED|20 Week Safety Follow-up||2
10337034|NCT00362180|11473874|FG002|COMPLETED|20 Week Safety Follow-up||1
10337035|NCT00362180|11473875|FG003|COMPLETED|20 Week Safety Follow-up||0
10337036|NCT00362180|11473876|FG004|COMPLETED|20 Week Safety Follow-up||11
10649794|NCT02164396|11809961|FG001|NOT COMPLETED|Overall Study||0
10337037|NCT00362180|11473877|FG005|COMPLETED|20 Week Safety Follow-up||9
10337038|NCT00362180|11473878|FG006|COMPLETED|20 Week Safety Follow-up||0
10337039|NCT00362180|11473879|FG007|COMPLETED|20 Week Safety Follow-up||3
10337040|NCT00362180|11473880|FG008|COMPLETED|20 Week Safety Follow-up||1
10337041|NCT00362180|11473872|FG000|NOT COMPLETED|20 Week Safety Follow-up||0
10337042|NCT00362180|11473873|FG001|NOT COMPLETED|20 Week Safety Follow-up||0
10337043|NCT00362180|11473874|FG002|NOT COMPLETED|20 Week Safety Follow-up||0
10337044|NCT00362180|11473875|FG003|NOT COMPLETED|20 Week Safety Follow-up||0
10337045|NCT00362180|11473876|FG004|NOT COMPLETED|20 Week Safety Follow-up||0
10337046|NCT00362180|11473877|FG005|NOT COMPLETED|20 Week Safety Follow-up||0
10337047|NCT00362180|11473878|FG006|NOT COMPLETED|20 Week Safety Follow-up||0
10337048|NCT00362180|11473879|FG007|NOT COMPLETED|20 Week Safety Follow-up||0
10337049|NCT00362180|11473880|FG008|NOT COMPLETED|20 Week Safety Follow-up||0
10337050|NCT00362232|11473900|FG000|STARTED|Treatment (12 +/- 2 Days)||1584
10337051|NCT00362232|11473901|FG001|STARTED|Treatment (12 +/- 2 Days)||1564
10337052|NCT00362232|11473900|FG000|Received Treatment|Treatment (12 +/- 2 Days)|Safety population|1526
10337053|NCT00362232|11473901|FG001|Received Treatment|Treatment (12 +/- 2 Days)|Safety population|1508
10337054|NCT00362232|11473900|FG000|COMPLETED|Treatment (12 +/- 2 Days)||1425
10337055|NCT00362232|11473901|FG001|COMPLETED|Treatment (12 +/- 2 Days)||1413
10337056|NCT00362232|11473900|FG000|NOT COMPLETED|Treatment (12 +/- 2 Days)||159
10337057|NCT00362232|11473901|FG001|NOT COMPLETED|Treatment (12 +/- 2 Days)||151
10337058|NCT00362232|11473900|FG000|STARTED|Follow-up (30 (+ 5) Days)||1471
10337059|NCT00362232|11473901|FG001|STARTED|Follow-up (30 (+ 5) Days)||1455
10337060|NCT00362232|11473900|FG000|COMPLETED|Follow-up (30 (+ 5) Days)||1433
10337061|NCT00362232|11473901|FG001|COMPLETED|Follow-up (30 (+ 5) Days)||1416
10337062|NCT00362232|11473900|FG000|NOT COMPLETED|Follow-up (30 (+ 5) Days)||38
10337063|NCT00362232|11473901|FG001|NOT COMPLETED|Follow-up (30 (+ 5) Days)||39
10337064|NCT00362297|11473909|FG000|STARTED|Treatment 1 (Initial Drug Assignment)||16
10337065|NCT00362297|11473910|FG001|STARTED|Treatment 1 (Initial Drug Assignment)||15
10337066|NCT00362297|11473909|FG000|COMPLETED|Treatment 1 (Initial Drug Assignment)||16
10337067|NCT00362297|11473910|FG001|COMPLETED|Treatment 1 (Initial Drug Assignment)||11
10337068|NCT00362297|11473909|FG000|NOT COMPLETED|Treatment 1 (Initial Drug Assignment)||0
10337069|NCT00362297|11473910|FG001|NOT COMPLETED|Treatment 1 (Initial Drug Assignment)||4
10337070|NCT00362297|11473909|FG000|STARTED|Treatment 2||16
10337071|NCT00362297|11473910|FG001|STARTED|Treatment 2||11
10337072|NCT00362297|11473909|FG000|COMPLETED|Treatment 2||16
10337073|NCT00362297|11473910|FG001|COMPLETED|Treatment 2||11
10337074|NCT00362297|11473909|FG000|NOT COMPLETED|Treatment 2||0
10337075|NCT00362297|11473910|FG001|NOT COMPLETED|Treatment 2||0
10337076|NCT00362336|11473919|FG000|STARTED|Overall Study||243
10337077|NCT00362336|11473920|FG001|STARTED|Overall Study||242
10337078|NCT00362336|11473921|FG002|STARTED|Overall Study||137
10337079|NCT00362336|11473919|FG000|COMPLETED|Overall Study||233
10337080|NCT00362336|11473920|FG001|COMPLETED|Overall Study||235
10337081|NCT00362336|11473921|FG002|COMPLETED|Overall Study||134
10337082|NCT00362336|11473919|FG000|NOT COMPLETED|Overall Study||10
10337083|NCT00362336|11473920|FG001|NOT COMPLETED|Overall Study||7
10337084|NCT00362336|11473921|FG002|NOT COMPLETED|Overall Study||3
10337085|NCT00362375|11473938|FG000|STARTED|Overall Study|Number eligible and randomized|161
10337086|NCT00362375|11473939|FG001|STARTED|Overall Study|Number eligible and randomized|152
10337087|NCT00362375|11473938|FG000|COMPLETED|Overall Study|Number completed 6-month follow-up assessment|121
10337088|NCT00362375|11473939|FG001|COMPLETED|Overall Study|Number completed 6-month follow-up assessment|117
10337089|NCT00362375|11473938|FG000|NOT COMPLETED|Overall Study||40
10337090|NCT00362375|11473939|FG001|NOT COMPLETED|Overall Study||35
10337091|NCT00362414|11473945|FG000|STARTED|Overall Study||15
10337092|NCT00362414|11473945|FG000|COMPLETED|Overall Study||12
10337093|NCT00362414|11473945|FG000|NOT COMPLETED|Overall Study||3
10337094|NCT00362440|11473954|FG000|STARTED|Overall Study||5
10337095|NCT00362440|11473955|FG001|STARTED|Overall Study||4
10337096|NCT00362440|11473954|FG000|COMPLETED|Overall Study||3
10337097|NCT00362440|11473955|FG001|COMPLETED|Overall Study||3
10337098|NCT00362440|11473954|FG000|NOT COMPLETED|Overall Study||2
10337099|NCT00362440|11473955|FG001|NOT COMPLETED|Overall Study||1
10337100|NCT00362453|11473963|FG000|STARTED|Overall Study||20
10337101|NCT00362453|11473964|FG001|STARTED|Overall Study||20
10337102|NCT00362453|11473963|FG000|COMPLETED|Overall Study|No patient withdrew from the study (20/20 participants completed follow-ups at 12, 24 and 48 weeks).|20
10337103|NCT00362453|11473964|FG001|COMPLETED|Overall Study|No patient withdrew from the study (20/20 participants completed follow-ups at 12, 24 and 48 weeks).|20
10337104|NCT00362453|11473963|FG000|NOT COMPLETED|Overall Study||0
10337105|NCT00362453|11473964|FG001|NOT COMPLETED|Overall Study||0
10337106|NCT00362466|11473972|FG000|STARTED|Overall Study||2
10337107|NCT00362466|11473973|FG001|STARTED|Overall Study||1
10337108|NCT00362466|11473972|FG000|COMPLETED|Overall Study||2
10337109|NCT00362466|11473973|FG001|COMPLETED|Overall Study||1
10337110|NCT00362466|11473972|FG000|NOT COMPLETED|Overall Study||0
10337111|NCT00362466|11473973|FG001|NOT COMPLETED|Overall Study||0
10337112|NCT00362609|11473981|FG000|STARTED|Overall Study||19
10337113|NCT00362609|11473982|FG001|STARTED|Overall Study||40
10337114|NCT00362609|11473981|FG000|COMPLETED|Overall Study||19
10337115|NCT00362609|11473982|FG001|COMPLETED|Overall Study||38
10337116|NCT00362609|11473981|FG000|NOT COMPLETED|Overall Study||0
10337117|NCT00362609|11473982|FG001|NOT COMPLETED|Overall Study||2
10337118|NCT00362648|11473992|FG000|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|2733
10337119|NCT00362648|11473993|FG001|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|2735
10337120|NCT00362648|11473994|FG002|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|1018
10337121|NCT00362648|11473995|FG003|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|1018
10337122|NCT00362648|11473992|FG000|Vaccinated at Visit 1|Overall Study||2733
10337123|NCT00362648|11473993|FG001|Vaccinated at Visit 1|Overall Study||2735
10337124|NCT00362648|11473994|FG002|Vaccinated at Visit 1|Overall Study||1018
10337125|NCT00362648|11473995|FG003|Vaccinated at Visit 1|Overall Study||1018
10337126|NCT00362648|11473992|FG000|Vaccinated at Visit 2|Overall Study||2657
10337127|NCT00362648|11473993|FG001|Vaccinated at Visit 2|Overall Study||2666
10337128|NCT00362648|11473994|FG002|Vaccinated at Visit 2|Overall Study||1013
10337129|NCT00362648|11473995|FG003|Vaccinated at Visit 2|Overall Study||1009
10337130|NCT00362648|11473992|FG000|Vaccinated at Visit 3|Overall Study||2613
10337131|NCT00362648|11473993|FG001|Vaccinated at Visit 3|Overall Study||2612
10337132|NCT00362648|11473994|FG002|Vaccinated at Visit 3|Overall Study||1009
10337133|NCT00362648|11473995|FG003|Vaccinated at Visit 3|Overall Study||1007
10337134|NCT00362648|11473992|FG000|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|2607
10337135|NCT00362648|11473993|FG001|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|2601
10337136|NCT00362648|11473994|FG002|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|1009
10337137|NCT00362648|11473995|FG003|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|1007
10337138|NCT00362648|11473992|FG000|NOT COMPLETED|Overall Study||126
10337139|NCT00362648|11473993|FG001|NOT COMPLETED|Overall Study||134
10337140|NCT00362648|11473994|FG002|NOT COMPLETED|Overall Study||9
10337141|NCT00362648|11473995|FG003|NOT COMPLETED|Overall Study||11
10337142|NCT00362817|11474009|FG000|STARTED|Overall Study||17
10337143|NCT00362817|11474009|FG000|COMPLETED|Overall Study||17
10337144|NCT00362817|11474009|FG000|NOT COMPLETED|Overall Study||0
10337145|NCT00362882|11474016|FG000|STARTED|Overall Study||40
10337146|NCT00362882|11474017|FG001|STARTED|Overall Study||41
10337147|NCT00362882|11474016|FG000|COMPLETED|Overall Study||40
10337148|NCT00362882|11474017|FG001|COMPLETED|Overall Study||41
10337149|NCT00362882|11474016|FG000|NOT COMPLETED|Overall Study||0
10337150|NCT00362882|11474017|FG001|NOT COMPLETED|Overall Study||0
10337151|NCT00363051|11474025|FG000|STARTED|Overall Study||115
10337152|NCT00363051|11474026|FG001|STARTED|Overall Study||45
10337153|NCT00363051|11474025|FG000|COMPLETED|Overall Study|Patients with documented disease progression per RECIST criteria|77
10337154|NCT00363051|11474026|FG001|COMPLETED|Overall Study||23
10337155|NCT00363051|11474025|FG000|NOT COMPLETED|Overall Study||38
10337156|NCT00363051|11474026|FG001|NOT COMPLETED|Overall Study||22
10337157|NCT00363077|11474036|FG000|STARTED|Overall Study||75
10337158|NCT00363077|11474037|FG001|STARTED|Overall Study||75
10337159|NCT00363077|11474036|FG000|COMPLETED|Overall Study||75
10337160|NCT00363077|11474037|FG001|COMPLETED|Overall Study||75
10337161|NCT00363077|11474036|FG000|NOT COMPLETED|Overall Study||0
10337162|NCT00363077|11474037|FG001|NOT COMPLETED|Overall Study||0
10337163|NCT00363129|11474045|FG000|STARTED|Overall Study||96
10337164|NCT00363129|11474046|FG001|STARTED|Overall Study||93
10337165|NCT00363129|11474045|FG000|COMPLETED|Overall Study||67
10337166|NCT00363129|11474046|FG001|COMPLETED|Overall Study||60
10337167|NCT00363129|11474045|FG000|NOT COMPLETED|Overall Study||29
10337168|NCT00363129|11474046|FG001|NOT COMPLETED|Overall Study||33
10337169|NCT00363142|11474054|FG000|STARTED|Overall Study||140
10337170|NCT00363142|11474055|FG001|STARTED|Overall Study||69
10337171|NCT00363142|11474054|FG000|COMPLETED|Overall Study||133
10337172|NCT00363142|11474055|FG001|COMPLETED|Overall Study||66
10337173|NCT00363142|11474054|FG000|NOT COMPLETED|Overall Study||7
10337174|NCT00363142|11474055|FG001|NOT COMPLETED|Overall Study||3
10337175|NCT00363168|11474066|FG000|STARTED|Overall Study||5
10337176|NCT00363168|11474067|FG001|STARTED|Overall Study||2
10337177|NCT00363168|11474066|FG000|COMPLETED|Overall Study||5
10337178|NCT00363168|11474067|FG001|COMPLETED|Overall Study||2
10337179|NCT00363168|11474066|FG000|NOT COMPLETED|Overall Study||0
10337180|NCT00363168|11474067|FG001|NOT COMPLETED|Overall Study||0
10337181|NCT00363246|11474073|FG000|STARTED|Overall Study||766
10337182|NCT00363246|11474073|FG000|COMPLETED|Overall Study||669
10337183|NCT00363246|11474073|FG000|NOT COMPLETED|Overall Study||97
10337184|NCT00363298|11474080|FG000|STARTED|First Study Week||12
10337185|NCT00363298|11474081|FG001|STARTED|First Study Week||12
10337186|NCT00363298|11474080|FG000|COMPLETED|First Study Week|At end of week 1, 6/12 subjects met Y-BOCS response criterion and began 4-week continuation phase|6
10337187|NCT00363298|11474081|FG001|COMPLETED|First Study Week|At end of week 1, 7/12 subjects met Y-BOCS response criterion and began 4-week continuation phase|7
10337188|NCT00363298|11474080|FG000|NOT COMPLETED|First Study Week||6
10337189|NCT00363298|11474081|FG001|NOT COMPLETED|First Study Week||5
10337190|NCT00363298|11474080|FG000|STARTED|4-week Study Continuation Phase||6
10337191|NCT00363298|11474081|FG001|STARTED|4-week Study Continuation Phase||7
10337192|NCT00363298|11474080|FG000|COMPLETED|4-week Study Continuation Phase||5
10337193|NCT00363298|11474081|FG001|COMPLETED|4-week Study Continuation Phase||7
10337194|NCT00363298|11474080|FG000|NOT COMPLETED|4-week Study Continuation Phase||1
10337195|NCT00363298|11474081|FG001|NOT COMPLETED|4-week Study Continuation Phase||0
10337196|NCT00363311|11474090|FG000|STARTED|Overall Study||155
10337197|NCT00363311|11474091|FG001|STARTED|Overall Study||147
10337198|NCT00363311|11474090|FG000|COMPLETED|Overall Study||79
10337199|NCT00363311|11474091|FG001|COMPLETED|Overall Study||102
10337200|NCT00363311|11474090|FG000|NOT COMPLETED|Overall Study||76
10337201|NCT00363311|11474091|FG001|NOT COMPLETED|Overall Study||45
10337202|NCT00363415|11474099|FG000|STARTED|Overall Study||453
10337203|NCT00363415|11474100|FG001|STARTED|Overall Study||455
10337204|NCT00363415|11474099|FG000|Received at Least One Dose of Study Drug|Overall Study||433
10337205|NCT00363415|11474100|FG001|Received at Least One Dose of Study Drug|Overall Study||447
10337206|NCT00363415|11474099|FG000|COMPLETED|Overall Study||92
10337207|NCT00363415|11474100|FG001|COMPLETED|Overall Study||206
10337208|NCT00363415|11474099|FG000|NOT COMPLETED|Overall Study||361
10337209|NCT00363415|11474100|FG001|NOT COMPLETED|Overall Study||249
10337210|NCT00363467|11474106|FG000|STARTED|Overall Study||3
10337211|NCT00363467|11474106|FG000|COMPLETED|Overall Study||2
10337212|NCT00363467|11474106|FG000|NOT COMPLETED|Overall Study||1
10337213|NCT00363480|11474110|FG000|STARTED|Overall Study||221
10337214|NCT00363480|11474110|FG000|COMPLETED|Overall Study||204
10337215|NCT00363480|11474110|FG000|NOT COMPLETED|Overall Study||17
10337216|NCT00363545|11474116|FG000|STARTED|Overall Study||636
10337217|NCT00363545|11474117|FG001|STARTED|Overall Study||638
10337218|NCT00363545|11474116|FG000|COMPLETED|Overall Study||592
10337219|NCT00363545|11474117|FG001|COMPLETED|Overall Study||581
10337220|NCT00363545|11474116|FG000|NOT COMPLETED|Overall Study||44
10337221|NCT00363545|11474117|FG001|NOT COMPLETED|Overall Study||57
10337222|NCT00363649|11474125|FG000|STARTED|Overall Study||18
10337223|NCT00363649|11474126|FG001|STARTED|Overall Study||16
10337224|NCT00363649|11474125|FG000|Crossed Over to Arm B|Overall Study||9
10337225|NCT00363649|11474126|FG001|Crossed Over to Arm B|Overall Study||0
10337226|NCT00363649|11474125|FG000|Crossed Over to Arm A|Overall Study||0
10337227|NCT00363649|11474126|FG001|Crossed Over to Arm A|Overall Study||12
10337228|NCT00363649|11474125|FG000|Did Not Cross Over|Overall Study||2
10337229|NCT00363649|11474126|FG001|Did Not Cross Over|Overall Study||3
10337230|NCT00363649|11474125|FG000|COMPLETED|Overall Study||11
10337231|NCT00363649|11474126|FG001|COMPLETED|Overall Study||15
10337232|NCT00363649|11474125|FG000|NOT COMPLETED|Overall Study||7
10337233|NCT00363649|11474126|FG001|NOT COMPLETED|Overall Study||1
10339157|NCT00371397|11476095|FG009|NOT COMPLETED|Session 2||0
10339158|NCT00371397|11476096|FG010|NOT COMPLETED|Session 2||0
10339159|NCT00371397|11476097|FG011|NOT COMPLETED|Session 2||0
10339160|NCT00371397|11476086|FG000|STARTED|Session 3||4
10339161|NCT00371397|11476087|FG001|STARTED|Session 3||7
10339162|NCT00371397|11476088|FG002|STARTED|Session 3||5
10339163|NCT00371397|11476089|FG003|STARTED|Session 3||2
10339164|NCT00371397|11476090|FG004|STARTED|Session 3||3
10339165|NCT00371397|11476091|FG005|STARTED|Session 3||4
10339166|NCT00371397|11476092|FG006|STARTED|Session 3||4
10339167|NCT00371397|11476093|FG007|STARTED|Session 3||4
10339168|NCT00371397|11476094|FG008|STARTED|Session 3||6
10339169|NCT00371397|11476095|FG009|STARTED|Session 3||5
10339170|NCT00371397|11476096|FG010|STARTED|Session 3||4
10339171|NCT00371397|11476097|FG011|STARTED|Session 3||2
10339172|NCT00371397|11476086|FG000|COMPLETED|Session 3||4
10339173|NCT00371397|11476087|FG001|COMPLETED|Session 3||7
10339174|NCT00371397|11476088|FG002|COMPLETED|Session 3||5
10339175|NCT00371397|11476089|FG003|COMPLETED|Session 3||2
10339176|NCT00371397|11476090|FG004|COMPLETED|Session 3||3
10339177|NCT00371397|11476091|FG005|COMPLETED|Session 3||4
10339178|NCT00371397|11476092|FG006|COMPLETED|Session 3||4
10339179|NCT00371397|11476093|FG007|COMPLETED|Session 3||4
10339180|NCT00371397|11476094|FG008|COMPLETED|Session 3||6
10339181|NCT00371397|11476095|FG009|COMPLETED|Session 3||5
10339182|NCT00371397|11476096|FG010|COMPLETED|Session 3||4
10339183|NCT00371397|11476097|FG011|COMPLETED|Session 3||2
10339184|NCT00371397|11476086|FG000|NOT COMPLETED|Session 3||0
10339185|NCT00371397|11476087|FG001|NOT COMPLETED|Session 3||0
10339186|NCT00371397|11476088|FG002|NOT COMPLETED|Session 3||0
10339187|NCT00371397|11476089|FG003|NOT COMPLETED|Session 3||0
10339188|NCT00371397|11476090|FG004|NOT COMPLETED|Session 3||0
10339189|NCT00371397|11476091|FG005|NOT COMPLETED|Session 3||0
10339190|NCT00371397|11476092|FG006|NOT COMPLETED|Session 3||0
10339191|NCT00371397|11476093|FG007|NOT COMPLETED|Session 3||0
10339192|NCT00371397|11476094|FG008|NOT COMPLETED|Session 3||0
10339193|NCT00371397|11476095|FG009|NOT COMPLETED|Session 3||0
10339194|NCT00371397|11476096|FG010|NOT COMPLETED|Session 3||0
10339195|NCT00371397|11476097|FG011|NOT COMPLETED|Session 3||0
10339196|NCT00371436|11476105|FG000|STARTED|Overall Study||92
10339197|NCT00371436|11476106|FG001|STARTED|Overall Study||89
10339198|NCT00371436|11476105|FG000|COMPLETED|Overall Study||58
10339199|NCT00371436|11476106|FG001|COMPLETED|Overall Study||68
10339200|NCT00371436|11476105|FG000|NOT COMPLETED|Overall Study||34
10339201|NCT00371436|11476106|FG001|NOT COMPLETED|Overall Study||21
10339202|NCT00371449|11476112|FG000|STARTED|Overall Study||120
10339203|NCT00371449|11476112|FG000|COMPLETED|Overall Study||120
10339204|NCT00371449|11476112|FG000|NOT COMPLETED|Overall Study||0
10339205|NCT00371540|11476120|FG000|STARTED|Overall Study||112
10339206|NCT00371540|11476121|FG001|STARTED|Overall Study||96
10339207|NCT00371540|11476120|FG000|COMPLETED|Overall Study||102
10339208|NCT00371540|11476121|FG001|COMPLETED|Overall Study||87
10339209|NCT00371540|11476120|FG000|NOT COMPLETED|Overall Study||10
10339210|NCT00371540|11476121|FG001|NOT COMPLETED|Overall Study||9
10339211|NCT00371566|11476129|FG000|STARTED|Treatment Phase||36
10339212|NCT00371566|11476130|FG001|STARTED|Treatment Phase||71
10339213|NCT00371566|11476129|FG000|COMPLETED|Treatment Phase||36
10339214|NCT00371566|11476130|FG001|COMPLETED|Treatment Phase|1 screen failure included in the ITT population|68
10339215|NCT00371566|11476129|FG000|NOT COMPLETED|Treatment Phase||0
10339216|NCT00371566|11476130|FG001|NOT COMPLETED|Treatment Phase||3
10337234|NCT00363675|11474132|FG000|STARTED|Overall Study||3
10337235|NCT00363675|11474132|FG000|Completed Testing|Overall Study||3
10337236|NCT00363675|11474132|FG000|COMPLETED|Overall Study||3
10337237|NCT00363675|11474132|FG000|NOT COMPLETED|Overall Study||0
10337238|NCT00363766|11474139|FG000|STARTED|Overall Study||32
10337239|NCT00363766|11474140|FG001|STARTED|Overall Study||20
10337240|NCT00363766|11474139|FG000|COMPLETED|Overall Study||0
10337241|NCT00363766|11474140|FG001|COMPLETED|Overall Study||0
10337242|NCT00363766|11474139|FG000|NOT COMPLETED|Overall Study||32
10337243|NCT00363766|11474140|FG001|NOT COMPLETED|Overall Study||20
10337244|NCT00363779|11474147|FG000|STARTED|Overall Study||5
10337245|NCT00363779|11474147|FG000|COMPLETED|Overall Study||5
10337246|NCT00363779|11474147|FG000|NOT COMPLETED|Overall Study||0
10337247|NCT00363805|11474154|FG000|STARTED|Overall Study||42
10337248|NCT00363805|11474155|FG001|STARTED|Overall Study||63
10337249|NCT00363805|11474156|FG002|STARTED|Overall Study||73
10337250|NCT00363805|11474154|FG000|COMPLETED|Overall Study||38
10337251|NCT00363805|11474155|FG001|COMPLETED|Overall Study||57
10337252|NCT00363805|11474156|FG002|COMPLETED|Overall Study||70
10337253|NCT00363805|11474154|FG000|NOT COMPLETED|Overall Study||4
10337254|NCT00363805|11474155|FG001|NOT COMPLETED|Overall Study||6
10337255|NCT00363805|11474156|FG002|NOT COMPLETED|Overall Study||3
10337256|NCT00363883|11474164|FG000|STARTED|Overall Study||14
10337257|NCT00363883|11474164|FG000|COMPLETED|Overall Study||14
10337258|NCT00363883|11474164|FG000|NOT COMPLETED|Overall Study||0
10337259|NCT00363896|11474170|FG000|STARTED|Overall Study||627
10337260|NCT00363896|11474171|FG001|STARTED|Overall Study||216
10337261|NCT00363896|11474170|FG000|COMPLETED|Overall Study||538
10337262|NCT00363896|11474171|FG001|COMPLETED|Overall Study||169
10337263|NCT00363896|11474170|FG000|NOT COMPLETED|Overall Study||89
10337264|NCT00363896|11474171|FG001|NOT COMPLETED|Overall Study||47
10707809|NCT02624492|11872550|FG002|COMPLETED|Overall Study||3
10707810|NCT02624492|11872548|FG000|NOT COMPLETED|Overall Study||2
10707811|NCT02624492|11872549|FG001|NOT COMPLETED|Overall Study||4
10707812|NCT02624492|11872550|FG002|NOT COMPLETED|Overall Study||5
10707813|NCT02624687|11872560|FG000|STARTED|Overall Study||13
10337273|NCT00364130|11474195|FG000|STARTED|Intervention Period||69
10337274|NCT00364130|11474196|FG001|STARTED|Intervention Period||69
10337275|NCT00364130|11474195|FG000|COMPLETED|Intervention Period||60
10337276|NCT00364130|11474196|FG001|COMPLETED|Intervention Period||61
10337277|NCT00364130|11474195|FG000|NOT COMPLETED|Intervention Period||9
10337278|NCT00364130|11474196|FG001|NOT COMPLETED|Intervention Period||8
10337279|NCT00364130|11474195|FG000|STARTED|Post Intervention Follow-up Period||60
10337280|NCT00364130|11474196|FG001|STARTED|Post Intervention Follow-up Period||61
10337281|NCT00364130|11474195|FG000|COMPLETED|Post Intervention Follow-up Period||55
10337282|NCT00364130|11474196|FG001|COMPLETED|Post Intervention Follow-up Period||50
10337283|NCT00364130|11474195|FG000|NOT COMPLETED|Post Intervention Follow-up Period||5
10337284|NCT00364130|11474196|FG001|NOT COMPLETED|Post Intervention Follow-up Period||11
10337285|NCT00364156|11474206|FG000|STARTED|Overall Study||282
10337286|NCT00364156|11474207|FG001|STARTED|Overall Study||286
10337287|NCT00364156|11474206|FG000|COMPLETED|Overall Study||203
10337288|NCT00364156|11474207|FG001|COMPLETED|Overall Study||205
10337289|NCT00364156|11474206|FG000|NOT COMPLETED|Overall Study||79
10337290|NCT00364156|11474207|FG001|NOT COMPLETED|Overall Study||81
10337291|NCT00364182|11474216|FG000|STARTED|First Intervention||3
10337292|NCT00364182|11474217|FG001|STARTED|First Intervention||22
10337293|NCT00364182|11474218|FG002|STARTED|First Intervention||25
10337294|NCT00364182|11474216|FG000|COMPLETED|First Intervention||0
10337295|NCT00364182|11474217|FG001|COMPLETED|First Intervention||22
10337296|NCT00364182|11474218|FG002|COMPLETED|First Intervention||25
10337297|NCT00364182|11474216|FG000|NOT COMPLETED|First Intervention||3
10337298|NCT00364182|11474217|FG001|NOT COMPLETED|First Intervention||0
10337299|NCT00364182|11474218|FG002|NOT COMPLETED|First Intervention||0
10707814|NCT02624687|11872561|FG001|STARTED|Overall Study||14
10707815|NCT02624687|11872560|FG000|COMPLETED|Overall Study||12
10707816|NCT02624687|11872561|FG001|COMPLETED|Overall Study||12
10337300|NCT00364182|11474216|FG000|STARTED|Second Intervention||0
10337301|NCT00364182|11474217|FG001|STARTED|Second Intervention||22
10337302|NCT00364182|11474218|FG002|STARTED|Second Intervention||25
10337303|NCT00364182|11474216|FG000|Randomized|Second Intervention||0
10337304|NCT00364182|11474217|FG001|Randomized|Second Intervention||22
10337305|NCT00364182|11474218|FG002|Randomized|Second Intervention||25
10707817|NCT02624687|11872560|FG000|NOT COMPLETED|Overall Study||1
10337306|NCT00364182|11474216|FG000|COMPLETED|Second Intervention||0
10337307|NCT00364182|11474217|FG001|COMPLETED|Second Intervention||20
10337308|NCT00364182|11474218|FG002|COMPLETED|Second Intervention||23
10337309|NCT00364182|11474216|FG000|NOT COMPLETED|Second Intervention||0
10337310|NCT00364182|11474217|FG001|NOT COMPLETED|Second Intervention||2
10707818|NCT02624687|11872561|FG001|NOT COMPLETED|Overall Study||2
10337311|NCT00364182|11474218|FG002|NOT COMPLETED|Second Intervention||2
10337312|NCT00364182|11474216|FG000|STARTED|Third Intervention||0
10337313|NCT00364182|11474217|FG001|STARTED|Third Intervention||20
10337314|NCT00364182|11474218|FG002|STARTED|Third Intervention||23
10337315|NCT00364182|11474216|FG000|COMPLETED|Third Intervention||0
10337316|NCT00364182|11474217|FG001|COMPLETED|Third Intervention||19
10337317|NCT00364182|11474218|FG002|COMPLETED|Third Intervention||22
10337318|NCT00364182|11474216|FG000|NOT COMPLETED|Third Intervention||0
10337319|NCT00364182|11474217|FG001|NOT COMPLETED|Third Intervention||1
10337320|NCT00364182|11474218|FG002|NOT COMPLETED|Third Intervention||1
10337321|NCT00364182|11474216|FG000|STARTED|Fourth Intervention||0
10337322|NCT00364182|11474217|FG001|STARTED|Fourth Intervention||19
10337323|NCT00364182|11474218|FG002|STARTED|Fourth Intervention||22
10337324|NCT00364182|11474216|FG000|COMPLETED|Fourth Intervention||0
10457892|NCT01012765|11605716|FG003|STARTED|Treatment Period 2||15
10457893|NCT01012765|11605717|FG004|STARTED|Treatment Period 2||19
10457894|NCT01012765|11605718|FG005|STARTED|Treatment Period 2||25
10457895|NCT01012765|11605713|FG000|COMPLETED|Treatment Period 2||16
10457896|NCT01012765|11605714|FG001|COMPLETED|Treatment Period 2||19
10457897|NCT01012765|11605715|FG002|COMPLETED|Treatment Period 2||18
10457898|NCT01012765|11605716|FG003|COMPLETED|Treatment Period 2||15
10457899|NCT01012765|11605717|FG004|COMPLETED|Treatment Period 2||18
10457900|NCT01012765|11605718|FG005|COMPLETED|Treatment Period 2||24
10457901|NCT01012765|11605713|FG000|NOT COMPLETED|Treatment Period 2||1
10457902|NCT01012765|11605714|FG001|NOT COMPLETED|Treatment Period 2||2
10457903|NCT01012765|11605715|FG002|NOT COMPLETED|Treatment Period 2||3
10457904|NCT01012765|11605716|FG003|NOT COMPLETED|Treatment Period 2||0
10457905|NCT01012765|11605717|FG004|NOT COMPLETED|Treatment Period 2||1
10457906|NCT01012765|11605718|FG005|NOT COMPLETED|Treatment Period 2||1
10457907|NCT01012765|11605713|FG000|STARTED|Treatment Period 3||16
10457908|NCT01012765|11605714|FG001|STARTED|Treatment Period 3||19
10457909|NCT01012765|11605715|FG002|STARTED|Treatment Period 3||18
10457910|NCT01012765|11605716|FG003|STARTED|Treatment Period 3||15
10457911|NCT01012765|11605717|FG004|STARTED|Treatment Period 3||18
10457912|NCT01012765|11605718|FG005|STARTED|Treatment Period 3||24
10457913|NCT01012765|11605713|FG000|COMPLETED|Treatment Period 3||16
10457914|NCT01012765|11605714|FG001|COMPLETED|Treatment Period 3||19
10457915|NCT01012765|11605715|FG002|COMPLETED|Treatment Period 3||18
10457916|NCT01012765|11605716|FG003|COMPLETED|Treatment Period 3||15
10457917|NCT01012765|11605717|FG004|COMPLETED|Treatment Period 3||18
10457918|NCT01012765|11605718|FG005|COMPLETED|Treatment Period 3||24
10457919|NCT01012765|11605713|FG000|NOT COMPLETED|Treatment Period 3||0
10457920|NCT01012765|11605714|FG001|NOT COMPLETED|Treatment Period 3||0
10457921|NCT01012765|11605715|FG002|NOT COMPLETED|Treatment Period 3||0
10457922|NCT01012765|11605716|FG003|NOT COMPLETED|Treatment Period 3||0
10707819|NCT02624700|11872569|FG000|STARTED|Overall Study||9
10707820|NCT02624700|11872570|FG001|STARTED|Overall Study||4
10707821|NCT02624700|11872569|FG000|COMPLETED|Overall Study||9
10707822|NCT02624700|11872570|FG001|COMPLETED|Overall Study||4
10707823|NCT02624700|11872569|FG000|NOT COMPLETED|Overall Study||0
10457923|NCT01012765|11605717|FG004|NOT COMPLETED|Treatment Period 3||0
10457924|NCT01012765|11605718|FG005|NOT COMPLETED|Treatment Period 3||0
10457925|NCT01012921|11605728|FG000|STARTED|Overall Study||57
10457926|NCT01012921|11605729|FG001|STARTED|Overall Study||60
10457927|NCT01012921|11605728|FG000|COMPLETED|Overall Study||47
10457928|NCT01012921|11605729|FG001|COMPLETED|Overall Study||47
10457929|NCT01012921|11605728|FG000|NOT COMPLETED|Overall Study||10
10457930|NCT01012921|11605729|FG001|NOT COMPLETED|Overall Study||13
10457931|NCT01012947|11605740|FG000|STARTED|Overall Study||212
10457932|NCT01012947|11605741|FG001|STARTED|Overall Study||215
10457933|NCT01012947|11605742|FG002|STARTED|Overall Study||241
10457934|NCT01012947|11605743|FG003|STARTED|Overall Study||211
10457935|NCT01012947|11605744|FG004|STARTED|Overall Study||236
10457936|NCT01012947|11605740|FG000|COMPLETED|Overall Study||81
10457937|NCT01012947|11605741|FG001|COMPLETED|Overall Study||80
10457938|NCT01012947|11605742|FG002|COMPLETED|Overall Study||111
10457939|NCT01012947|11605743|FG003|COMPLETED|Overall Study||93
10707824|NCT02624700|11872570|FG001|NOT COMPLETED|Overall Study||0
10707825|NCT02624713|11872580|FG000|STARTED|Overall Study||78
10707826|NCT02624713|11872581|FG001|STARTED|Overall Study||81
10707827|NCT02624713|11872580|FG000|COMPLETED|Overall Study||64
10707828|NCT02624713|11872581|FG001|COMPLETED|Overall Study||81
10707829|NCT02624713|11872580|FG000|NOT COMPLETED|Overall Study||14
10457940|NCT01012947|11605744|FG004|COMPLETED|Overall Study||94
10457941|NCT01012947|11605740|FG000|NOT COMPLETED|Overall Study||131
10457942|NCT01012947|11605741|FG001|NOT COMPLETED|Overall Study||135
10457943|NCT01012947|11605742|FG002|NOT COMPLETED|Overall Study||130
10457944|NCT01012947|11605743|FG003|NOT COMPLETED|Overall Study||118
10457945|NCT01012947|11605744|FG004|NOT COMPLETED|Overall Study||142
10707830|NCT02624713|11872581|FG001|NOT COMPLETED|Overall Study||0
10337325|NCT00364182|11474217|FG001|COMPLETED|Fourth Intervention||19
10337326|NCT00364182|11474218|FG002|COMPLETED|Fourth Intervention||22
10337327|NCT00364182|11474216|FG000|NOT COMPLETED|Fourth Intervention||0
10337328|NCT00364182|11474217|FG001|NOT COMPLETED|Fourth Intervention||0
10457946|NCT01012973|11605758|FG000|STARTED|Overall Study||106
10457947|NCT01012973|11605759|FG001|STARTED|Overall Study||71
10457948|NCT01012973|11605758|FG000|Participants Received Treatment|Overall Study|Safety Population: Participants received treatment|104
10457949|NCT01012973|11605759|FG001|Participants Received Treatment|Overall Study|Safety Population: Participants received treatment|68
10707831|NCT02624791|11872588|FG000|STARTED|Overall Study||2
10337329|NCT00364182|11474218|FG002|NOT COMPLETED|Fourth Intervention||0
10337330|NCT00364286|11474228|FG000|STARTED|Overall Study||17
10337331|NCT00364286|11474228|FG000|COMPLETED|Overall Study||14
10337332|NCT00364286|11474228|FG000|NOT COMPLETED|Overall Study||3
10337333|NCT00364351|11474234|FG000|STARTED|Overall Study|randomised patients|623
10337334|NCT00364351|11474235|FG001|STARTED|Overall Study|randomised patients|617
10337335|NCT00364351|11474234|FG000|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 26 Sep 2008.|31
10337336|NCT00364351|11474235|FG001|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 26 Sep 2008.|34
10337337|NCT00364351|11474234|FG000|NOT COMPLETED|Overall Study||592
10337338|NCT00364351|11474235|FG001|NOT COMPLETED|Overall Study||583
10337339|NCT00364377|11474243|FG000|STARTED|Overall Study||11
10337340|NCT00364377|11474244|FG001|STARTED|Overall Study||11
10337341|NCT00364377|11474243|FG000|COMPLETED|Overall Study||11
10337342|NCT00364377|11474244|FG001|COMPLETED|Overall Study||11
10337343|NCT00364377|11474243|FG000|NOT COMPLETED|Overall Study||0
10337344|NCT00364377|11474244|FG001|NOT COMPLETED|Overall Study||0
10337345|NCT00364533|11474255|FG000|STARTED|Overall Study||77
10337346|NCT00364533|11474256|FG001|STARTED|Overall Study||71
10337347|NCT00364533|11474257|FG002|STARTED|Overall Study||75
10337348|NCT00364533|11474258|FG003|STARTED|Overall Study||67
10337349|NCT00364533|11474259|FG004|STARTED|Overall Study||75
10337350|NCT00364533|11474255|FG000|COMPLETED|Overall Study||35
10337351|NCT00364533|11474256|FG001|COMPLETED|Overall Study||31
10337352|NCT00364533|11474257|FG002|COMPLETED|Overall Study||30
10337353|NCT00364533|11474258|FG003|COMPLETED|Overall Study||36
10337354|NCT00364533|11474259|FG004|COMPLETED|Overall Study||24
10337355|NCT00364533|11474255|FG000|NOT COMPLETED|Overall Study||42
10337356|NCT00364533|11474256|FG001|NOT COMPLETED|Overall Study||40
10337357|NCT00364533|11474257|FG002|NOT COMPLETED|Overall Study||45
10337358|NCT00364533|11474258|FG003|NOT COMPLETED|Overall Study||31
10337359|NCT00364533|11474259|FG004|NOT COMPLETED|Overall Study||51
10337360|NCT00364611|11474273|FG000|STARTED|Overall Study||52
10337361|NCT00364611|11474274|FG001|STARTED|Overall Study||21
10337362|NCT00364611|11474273|FG000|TREATED (SAFTEY POPULATION)|Overall Study|Received at least one dose of study medication|52
10337363|NCT00364611|11474274|FG001|TREATED (SAFTEY POPULATION)|Overall Study|Received at least one dose of study medication|20
10337364|NCT00364611|11474273|FG000|COMPLETED|Overall Study|Ongoing treatment (June 2011-initial analysis). Continued treatment till March 2012 (study closed).|1
10337365|NCT00364611|11474274|FG001|COMPLETED|Overall Study||0
10337366|NCT00364611|11474273|FG000|NOT COMPLETED|Overall Study||51
10337367|NCT00364611|11474274|FG001|NOT COMPLETED|Overall Study||21
10337368|NCT00364793|11474284|FG000|STARTED|Overall Study||15
10337369|NCT00364793|11474285|FG001|STARTED|Overall Study||10
10337370|NCT00364793|11474286|FG002|STARTED|Overall Study||4
10337371|NCT00364793|11474287|FG003|STARTED|Overall Study||8
10337372|NCT00364793|11474284|FG000|COMPLETED|Overall Study||7
10337373|NCT00364793|11474285|FG001|COMPLETED|Overall Study||5
10337374|NCT00364793|11474286|FG002|COMPLETED|Overall Study||0
10337375|NCT00364793|11474287|FG003|COMPLETED|Overall Study||5
10337376|NCT00364793|11474284|FG000|NOT COMPLETED|Overall Study||8
10337377|NCT00364793|11474285|FG001|NOT COMPLETED|Overall Study||5
10337378|NCT00364793|11474286|FG002|NOT COMPLETED|Overall Study||4
10337379|NCT00364793|11474287|FG003|NOT COMPLETED|Overall Study||3
10337380|NCT00364819|11474300|FG000|STARTED|Overall Study||6
10337381|NCT00364819|11474300|FG000|COMPLETED|Overall Study||6
10337382|NCT00364819|11474300|FG000|NOT COMPLETED|Overall Study||0
10337383|NCT00364832|11474313|FG000|STARTED|Core Period||16
10337384|NCT00364832|11474314|FG001|STARTED|Core Period||15
10337385|NCT00364832|11474315|FG002|STARTED|Core Period||15
10337386|NCT00364832|11474316|FG003|STARTED|Core Period||16
10337387|NCT00364832|11474317|FG004|STARTED|Core Period||16
10337388|NCT00364832|11474318|FG005|STARTED|Core Period||12
10337389|NCT00364832|11474319|FG006|STARTED|Core Period||16
10337390|NCT00364832|11474320|FG007|STARTED|Core Period||15
10337391|NCT00364832|11474321|FG008|STARTED|Core Period||16
10337392|NCT00364832|11474322|FG009|STARTED|Core Period||0
10337393|NCT00364832|11474323|FG010|STARTED|Core Period||0
10337394|NCT00364832|11474324|FG011|STARTED|Core Period||0
10337395|NCT00364832|11474313|FG000|COMPLETED|Core Period||14
10337396|NCT00364832|11474314|FG001|COMPLETED|Core Period||13
10337397|NCT00364832|11474315|FG002|COMPLETED|Core Period||14
10337398|NCT00364832|11474316|FG003|COMPLETED|Core Period||15
10337399|NCT00364832|11474317|FG004|COMPLETED|Core Period||16
10707832|NCT02624791|11872589|FG001|STARTED|Overall Study||1
10707833|NCT02624791|11872590|FG002|STARTED|Overall Study||2
10707834|NCT02624791|11872591|FG003|STARTED|Overall Study||2
10707835|NCT02624791|11872592|FG004|STARTED|Overall Study||2
10707836|NCT02624791|11872593|FG005|STARTED|Overall Study||2
10337400|NCT00364832|11474318|FG005|COMPLETED|Core Period||12
10337401|NCT00364832|11474319|FG006|COMPLETED|Core Period||12
10337402|NCT00364832|11474320|FG007|COMPLETED|Core Period||14
10337403|NCT00364832|11474321|FG008|COMPLETED|Core Period||16
10337404|NCT00364832|11474322|FG009|COMPLETED|Core Period||0
10337405|NCT00364832|11474323|FG010|COMPLETED|Core Period||0
10337406|NCT00364832|11474324|FG011|COMPLETED|Core Period||0
10337407|NCT00364832|11474313|FG000|NOT COMPLETED|Core Period||2
10337408|NCT00364832|11474314|FG001|NOT COMPLETED|Core Period||2
10337409|NCT00364832|11474315|FG002|NOT COMPLETED|Core Period||1
10337410|NCT00364832|11474316|FG003|NOT COMPLETED|Core Period||1
10707837|NCT02624791|11872588|FG000|COMPLETED|Overall Study||0
10337411|NCT00364832|11474317|FG004|NOT COMPLETED|Core Period||0
10337412|NCT00364832|11474318|FG005|NOT COMPLETED|Core Period||0
10707838|NCT02624791|11872589|FG001|COMPLETED|Overall Study||1
10707839|NCT02624791|11872590|FG002|COMPLETED|Overall Study||2
10707840|NCT02624791|11872591|FG003|COMPLETED|Overall Study||2
10707841|NCT02624791|11872592|FG004|COMPLETED|Overall Study||2
10707842|NCT02624791|11872593|FG005|COMPLETED|Overall Study||2
10707843|NCT02624791|11872588|FG000|NOT COMPLETED|Overall Study||2
10707844|NCT02624791|11872589|FG001|NOT COMPLETED|Overall Study||0
10707845|NCT02624791|11872590|FG002|NOT COMPLETED|Overall Study||0
10707846|NCT02624791|11872591|FG003|NOT COMPLETED|Overall Study||0
10707847|NCT02624791|11872592|FG004|NOT COMPLETED|Overall Study||0
10707848|NCT02624791|11872593|FG005|NOT COMPLETED|Overall Study||0
10707849|NCT02624843|11872600|FG000|STARTED|Overall Study||107
10707850|NCT02624843|11872601|FG001|STARTED|Overall Study||108
10707851|NCT02624843|11872602|FG002|STARTED|Overall Study||24
10707852|NCT02624843|11872600|FG000|COMPLETED|Overall Study||70
10707853|NCT02624843|11872601|FG001|COMPLETED|Overall Study||72
10707854|NCT02624843|11872602|FG002|COMPLETED|Overall Study||16
10707855|NCT02624843|11872600|FG000|NOT COMPLETED|Overall Study||37
10707856|NCT02624843|11872601|FG001|NOT COMPLETED|Overall Study||36
10707857|NCT02624843|11872602|FG002|NOT COMPLETED|Overall Study||8
10707858|NCT02624986|11872618|FG000|STARTED|Overall Study||2
10707859|NCT02624986|11872619|FG001|STARTED|Overall Study||3
10707860|NCT02624986|11872620|FG002|STARTED|Overall Study||2
10707861|NCT02624986|11872621|FG003|STARTED|Overall Study||3
10707862|NCT02624986|11872622|FG004|STARTED|Overall Study||4
10707863|NCT02624986|11872623|FG005|STARTED|Overall Study||2
10707864|NCT02624986|11872624|FG006|STARTED|Overall Study||4
10707865|NCT02624986|11872625|FG007|STARTED|Overall Study||5
10707866|NCT02624986|11872618|FG000|Received Any Study Treatment|Overall Study||1
10707867|NCT02624986|11872619|FG001|Received Any Study Treatment|Overall Study||3
10707868|NCT02624986|11872620|FG002|Received Any Study Treatment|Overall Study||2
10707869|NCT02624986|11872621|FG003|Received Any Study Treatment|Overall Study||3
10707870|NCT02624986|11872622|FG004|Received Any Study Treatment|Overall Study||4
10707871|NCT02624986|11872623|FG005|Received Any Study Treatment|Overall Study||2
10707872|NCT02624986|11872624|FG006|Received Any Study Treatment|Overall Study||4
10707873|NCT02624986|11872625|FG007|Received Any Study Treatment|Overall Study||5
10707874|NCT02624986|11872618|FG000|COMPLETED|Overall Study||0
10707875|NCT02624986|11872619|FG001|COMPLETED|Overall Study||0
10707876|NCT02624986|11872620|FG002|COMPLETED|Overall Study||0
10707877|NCT02624986|11872621|FG003|COMPLETED|Overall Study||0
10707878|NCT02624986|11872622|FG004|COMPLETED|Overall Study||0
10707879|NCT02624986|11872623|FG005|COMPLETED|Overall Study||0
10707880|NCT02624986|11872624|FG006|COMPLETED|Overall Study||0
10707881|NCT02624986|11872625|FG007|COMPLETED|Overall Study||0
10707882|NCT02624986|11872618|FG000|NOT COMPLETED|Overall Study||2
10707883|NCT02624986|11872619|FG001|NOT COMPLETED|Overall Study||3
10707884|NCT02624986|11872620|FG002|NOT COMPLETED|Overall Study||2
10707885|NCT02624986|11872621|FG003|NOT COMPLETED|Overall Study||3
10707886|NCT02624986|11872622|FG004|NOT COMPLETED|Overall Study||4
10707887|NCT02624986|11872623|FG005|NOT COMPLETED|Overall Study||2
10707888|NCT02624986|11872624|FG006|NOT COMPLETED|Overall Study||4
10707889|NCT02624986|11872625|FG007|NOT COMPLETED|Overall Study||5
10707890|NCT02625181|11872650|FG000|STARTED|Overall Study||1518
10707891|NCT02625181|11872651|FG001|STARTED|Overall Study||12809
10707892|NCT02625181|11872652|FG002|STARTED|Overall Study||12707
10707893|NCT02625181|11872650|FG000|COMPLETED|Overall Study||1518
10707894|NCT02625181|11872651|FG001|COMPLETED|Overall Study||12809
10707895|NCT02625181|11872652|FG002|COMPLETED|Overall Study||12707
10707896|NCT02625181|11872650|FG000|NOT COMPLETED|Overall Study||0
10707897|NCT02625181|11872651|FG001|NOT COMPLETED|Overall Study||0
10707898|NCT02625181|11872652|FG002|NOT COMPLETED|Overall Study||0
10707899|NCT02625207|11872662|FG000|STARTED|Part 1 (6 Days)||11
10707900|NCT02625207|11872663|FG001|STARTED|Part 1 (6 Days)||12
10707901|NCT02625207|11872664|FG002|STARTED|Part 1 (6 Days)||12
10707902|NCT02625207|11872665|FG003|STARTED|Part 1 (6 Days)||12
10707903|NCT02625207|11872662|FG000|COMPLETED|Part 1 (6 Days)||11
10707904|NCT02625207|11872663|FG001|COMPLETED|Part 1 (6 Days)||12
10707905|NCT02625207|11872664|FG002|COMPLETED|Part 1 (6 Days)||12
10707906|NCT02625207|11872665|FG003|COMPLETED|Part 1 (6 Days)||12
10707907|NCT02625207|11872662|FG000|NOT COMPLETED|Part 1 (6 Days)||0
10707908|NCT02625207|11872663|FG001|NOT COMPLETED|Part 1 (6 Days)||0
10707909|NCT02625207|11872664|FG002|NOT COMPLETED|Part 1 (6 Days)||0
10707910|NCT02625207|11872665|FG003|NOT COMPLETED|Part 1 (6 Days)||0
10707911|NCT02625207|11872662|FG000|STARTED|Part 2 (11 Days)||11
10707912|NCT02625207|11872663|FG001|STARTED|Part 2 (11 Days)|Part 2 was conducted only in Cohorts 1 and 3, as pre-specified in protocol.|0
10707913|NCT02625207|11872664|FG002|STARTED|Part 2 (11 Days)||12
10707914|NCT02625207|11872665|FG003|STARTED|Part 2 (11 Days)|Part 2 was conducted only in Cohorts 1 and 3, as pre-specified in protocol.|0
10707915|NCT02625207|11872662|FG000|COMPLETED|Part 2 (11 Days)||11
10707916|NCT02625207|11872663|FG001|COMPLETED|Part 2 (11 Days)||0
10707917|NCT02625207|11872664|FG002|COMPLETED|Part 2 (11 Days)||12
10707918|NCT02625207|11872665|FG003|COMPLETED|Part 2 (11 Days)||0
10707919|NCT02625207|11872662|FG000|NOT COMPLETED|Part 2 (11 Days)||0
10707920|NCT02625207|11872663|FG001|NOT COMPLETED|Part 2 (11 Days)||0
10707921|NCT02625207|11872664|FG002|NOT COMPLETED|Part 2 (11 Days)||0
10707922|NCT02625207|11872665|FG003|NOT COMPLETED|Part 2 (11 Days)||0
10707923|NCT02625220|11872681|FG000|STARTED|Overall Study||170
10707924|NCT02625220|11872681|FG000|COMPLETED|Overall Study||163
10707925|NCT02625220|11872681|FG000|NOT COMPLETED|Overall Study||7
10707926|NCT02625233|11872687|FG000|STARTED|Overall Study||49
10707927|NCT02625233|11872688|FG001|STARTED|Overall Study||56
10707928|NCT02625233|11872687|FG000|COMPLETED|Overall Study||47
10707929|NCT02625233|11872688|FG001|COMPLETED|Overall Study||56
10707930|NCT02625233|11872687|FG000|NOT COMPLETED|Overall Study||2
10707931|NCT02625233|11872688|FG001|NOT COMPLETED|Overall Study||0
10707932|NCT02625259|11872699|FG000|STARTED|First Intervention (Day 1)||11
10707933|NCT02625259|11872700|FG001|STARTED|First Intervention (Day 1)||9
10707934|NCT02625259|11872701|FG002|STARTED|First Intervention (Day 1)||8
10707935|NCT02625259|11872702|FG003|STARTED|First Intervention (Day 1)||10
10707936|NCT02625259|11872703|FG004|STARTED|First Intervention (Day 1)||16
10707937|NCT02625259|11872699|FG000|COMPLETED|First Intervention (Day 1)||9
10707938|NCT02625259|11872700|FG001|COMPLETED|First Intervention (Day 1)||8
10707939|NCT02625259|11872701|FG002|COMPLETED|First Intervention (Day 1)||7
10707940|NCT02625259|11872702|FG003|COMPLETED|First Intervention (Day 1)||9
10707941|NCT02625259|11872703|FG004|COMPLETED|First Intervention (Day 1)||16
10707942|NCT02625259|11872699|FG000|NOT COMPLETED|First Intervention (Day 1)||2
10707943|NCT02625259|11872700|FG001|NOT COMPLETED|First Intervention (Day 1)||1
10337413|NCT00364832|11474319|FG006|NOT COMPLETED|Core Period||4
10337414|NCT00364832|11474320|FG007|NOT COMPLETED|Core Period||1
10337415|NCT00364832|11474321|FG008|NOT COMPLETED|Core Period||0
10337416|NCT00364832|11474322|FG009|NOT COMPLETED|Core Period||0
10337417|NCT00364832|11474323|FG010|NOT COMPLETED|Core Period||0
10337418|NCT00364832|11474324|FG011|NOT COMPLETED|Core Period||0
10337419|NCT00364832|11474313|FG000|STARTED|Extension Year 1||0
10337420|NCT00364832|11474314|FG001|STARTED|Extension Year 1||0
10337421|NCT00364832|11474315|FG002|STARTED|Extension Year 1||0
10337422|NCT00364832|11474316|FG003|STARTED|Extension Year 1||0
10337423|NCT00364832|11474317|FG004|STARTED|Extension Year 1||0
10337424|NCT00364832|11474318|FG005|STARTED|Extension Year 1||0
10337425|NCT00364832|11474319|FG006|STARTED|Extension Year 1||0
10337426|NCT00364832|11474320|FG007|STARTED|Extension Year 1||0
10337427|NCT00364832|11474321|FG008|STARTED|Extension Year 1||0
10337428|NCT00364832|11474322|FG009|STARTED|Extension Year 1|Participants (Cohorts A, D, and G) who completed core, entered extension period (entry optional).|18
10337429|NCT00364832|11474323|FG010|STARTED|Extension Year 1|Participants (Cohorts B, E, and H) who completed core, entered extension period (entry optional).|17
10337430|NCT00364832|11474324|FG011|STARTED|Extension Year 1|Participants (Cohorts C, F, and I) who completed core, entered extension period (entry optional).|27
10337431|NCT00364832|11474313|FG000|COMPLETED|Extension Year 1||0
10337432|NCT00364832|11474314|FG001|COMPLETED|Extension Year 1||0
10337433|NCT00364832|11474315|FG002|COMPLETED|Extension Year 1||0
10337434|NCT00364832|11474316|FG003|COMPLETED|Extension Year 1||0
10337435|NCT00364832|11474317|FG004|COMPLETED|Extension Year 1||0
10337436|NCT00364832|11474318|FG005|COMPLETED|Extension Year 1||0
10337437|NCT00364832|11474319|FG006|COMPLETED|Extension Year 1||0
10337438|NCT00364832|11474320|FG007|COMPLETED|Extension Year 1||0
10337439|NCT00364832|11474321|FG008|COMPLETED|Extension Year 1||0
10337440|NCT00364832|11474322|FG009|COMPLETED|Extension Year 1||14
10337441|NCT00364832|11474323|FG010|COMPLETED|Extension Year 1||15
10337442|NCT00364832|11474324|FG011|COMPLETED|Extension Year 1||17
10337443|NCT00364832|11474313|FG000|NOT COMPLETED|Extension Year 1||0
10337444|NCT00364832|11474314|FG001|NOT COMPLETED|Extension Year 1||0
10337445|NCT00364832|11474315|FG002|NOT COMPLETED|Extension Year 1||0
10337446|NCT00364832|11474316|FG003|NOT COMPLETED|Extension Year 1||0
10337447|NCT00364832|11474317|FG004|NOT COMPLETED|Extension Year 1||0
10457950|NCT01012973|11605758|FG000|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) Population: Participants received treatment with post baseline measurements|103
10548412|NCT01519414|11702219|FG002|STARTED|Pre Cross-over||0
10707944|NCT02625259|11872701|FG002|NOT COMPLETED|First Intervention (Day 1)||1
10337448|NCT00364832|11474318|FG005|NOT COMPLETED|Extension Year 1||0
10337449|NCT00364832|11474319|FG006|NOT COMPLETED|Extension Year 1||0
10337450|NCT00364832|11474320|FG007|NOT COMPLETED|Extension Year 1||0
10337451|NCT00364832|11474321|FG008|NOT COMPLETED|Extension Year 1||0
10707945|NCT02625259|11872702|FG003|NOT COMPLETED|First Intervention (Day 1)||1
10707946|NCT02625259|11872703|FG004|NOT COMPLETED|First Intervention (Day 1)||0
10707947|NCT02625259|11872699|FG000|STARTED|Washout (Day 2 to Day 14)||9
10707948|NCT02625259|11872700|FG001|STARTED|Washout (Day 2 to Day 14)||8
10707949|NCT02625259|11872701|FG002|STARTED|Washout (Day 2 to Day 14)||7
10707950|NCT02625259|11872702|FG003|STARTED|Washout (Day 2 to Day 14)||9
10707951|NCT02625259|11872703|FG004|STARTED|Washout (Day 2 to Day 14)||0
10337452|NCT00364832|11474322|FG009|NOT COMPLETED|Extension Year 1||4
10337453|NCT00364832|11474323|FG010|NOT COMPLETED|Extension Year 1||2
10337454|NCT00364832|11474324|FG011|NOT COMPLETED|Extension Year 1||10
10337455|NCT00364832|11474313|FG000|STARTED|Extension Year 2||0
10337456|NCT00364832|11474314|FG001|STARTED|Extension Year 2||0
10337457|NCT00364832|11474315|FG002|STARTED|Extension Year 2||0
10337458|NCT00364832|11474316|FG003|STARTED|Extension Year 2||0
10337459|NCT00364832|11474317|FG004|STARTED|Extension Year 2||0
10337460|NCT00364832|11474318|FG005|STARTED|Extension Year 2||0
10337461|NCT00364832|11474319|FG006|STARTED|Extension Year 2||0
10337462|NCT00364832|11474320|FG007|STARTED|Extension Year 2||0
10337463|NCT00364832|11474321|FG008|STARTED|Extension Year 2||0
10337464|NCT00364832|11474322|FG009|STARTED|Extension Year 2||14
10337465|NCT00364832|11474323|FG010|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
10649795|NCT02164396|11809962|FG002|NOT COMPLETED|Overall Study||0
10649796|NCT02164422|11809973|FG000|STARTED|Overall Study||25
10649797|NCT02164422|11809974|FG001|STARTED|Overall Study||22
10649798|NCT02164422|11809975|FG002|STARTED|Overall Study||23
10649799|NCT02164422|11809973|FG000|COMPLETED|Overall Study||24
10337466|NCT00364832|11474324|FG011|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
10337467|NCT00364832|11474313|FG000|COMPLETED|Extension Year 2||0
10337468|NCT00364832|11474314|FG001|COMPLETED|Extension Year 2||0
10337469|NCT00364832|11474315|FG002|COMPLETED|Extension Year 2||0
10337470|NCT00364832|11474316|FG003|COMPLETED|Extension Year 2||0
10337471|NCT00364832|11474317|FG004|COMPLETED|Extension Year 2||0
10337472|NCT00364832|11474318|FG005|COMPLETED|Extension Year 2||0
10337473|NCT00364832|11474319|FG006|COMPLETED|Extension Year 2||0
10337474|NCT00364832|11474320|FG007|COMPLETED|Extension Year 2||0
10337475|NCT00364832|11474321|FG008|COMPLETED|Extension Year 2||0
10337476|NCT00364832|11474322|FG009|COMPLETED|Extension Year 2||9
10337477|NCT00364832|11474323|FG010|COMPLETED|Extension Year 2||9
10337478|NCT00364832|11474324|FG011|COMPLETED|Extension Year 2||11
10337479|NCT00364832|11474313|FG000|NOT COMPLETED|Extension Year 2||0
10337480|NCT00364832|11474314|FG001|NOT COMPLETED|Extension Year 2||0
10337481|NCT00364832|11474315|FG002|NOT COMPLETED|Extension Year 2||0
10337482|NCT00364832|11474316|FG003|NOT COMPLETED|Extension Year 2||0
10337483|NCT00364832|11474317|FG004|NOT COMPLETED|Extension Year 2||0
10337484|NCT00364832|11474318|FG005|NOT COMPLETED|Extension Year 2||0
10337485|NCT00364832|11474319|FG006|NOT COMPLETED|Extension Year 2||0
10337486|NCT00364832|11474320|FG007|NOT COMPLETED|Extension Year 2||0
10337487|NCT00364832|11474321|FG008|NOT COMPLETED|Extension Year 2||0
10337488|NCT00364832|11474322|FG009|NOT COMPLETED|Extension Year 2||5
10337489|NCT00364832|11474323|FG010|NOT COMPLETED|Extension Year 2||5
10337490|NCT00364832|11474324|FG011|NOT COMPLETED|Extension Year 2||3
10337491|NCT00364845|11474343|FG000|STARTED|Overall Study||28
10337492|NCT00364845|11474344|FG001|STARTED|Overall Study||23
10337493|NCT00364845|11474343|FG000|COMPLETED|Overall Study|Completed 36-week titration/treatment phase|17
10337494|NCT00364845|11474344|FG001|COMPLETED|Overall Study|Completed 36-week titration/treatment phase|12
10337495|NCT00364845|11474343|FG000|NOT COMPLETED|Overall Study||11
10337496|NCT00364845|11474344|FG001|NOT COMPLETED|Overall Study||11
10337497|NCT00364858|11474352|FG000|STARTED|Overall Study||33
10337498|NCT00364858|11474353|FG001|STARTED|Overall Study||62
10337499|NCT00364858|11474352|FG000|COMPLETED|Overall Study||26
10337500|NCT00364858|11474353|FG001|COMPLETED|Overall Study||40
10337501|NCT00364858|11474352|FG000|NOT COMPLETED|Overall Study||7
10337502|NCT00364858|11474353|FG001|NOT COMPLETED|Overall Study||22
10337503|NCT00364923|11474360|FG000|STARTED|Treatment With Pralatrexate|Received at least one dose of pralatrexate.|111
10337504|NCT00364923|11474360|FG000|COMPLETED|Treatment With Pralatrexate|Treatment duration not limited. After treatment ends, patients attend survival follow-up visits.|107
10337505|NCT00364923|11474360|FG000|NOT COMPLETED|Treatment With Pralatrexate||4
10337506|NCT00364923|11474360|FG000|STARTED|Survival Follow-up, After Pralatrexate|Patients (pts) who stop treatment with pralatrexate are followed for survival|107
10337507|NCT00364923|11474360|FG000|COMPLETED|Survival Follow-up, After Pralatrexate|Pts who completed follow-up either died, were followed for 24 months, or withdrew|83
10337508|NCT00364923|11474360|FG000|NOT COMPLETED|Survival Follow-up, After Pralatrexate||24
10337509|NCT00364949|11474366|FG000|STARTED|Overall Study||31
10337510|NCT00364949|11474367|FG001|STARTED|Overall Study||39
10337511|NCT00364949|11474366|FG000|COMPLETED|Overall Study||31
10337512|NCT00364949|11474367|FG001|COMPLETED|Overall Study||39
10337513|NCT00364949|11474366|FG000|NOT COMPLETED|Overall Study||0
10337514|NCT00364949|11474367|FG001|NOT COMPLETED|Overall Study||0
10337515|NCT00365053|11474373|FG000|STARTED|Overall Study||13
10337516|NCT00365053|11474373|FG000|COMPLETED|Overall Study||13
10337517|NCT00365053|11474373|FG000|NOT COMPLETED|Overall Study||0
10337518|NCT00365105|11474379|FG000|STARTED|Overall Study||129
10337519|NCT00365105|11474380|FG001|STARTED|Overall Study||132
10337520|NCT00365105|11474379|FG000|Eligible|Overall Study||124
10337521|NCT00365105|11474380|FG001|Eligible|Overall Study||124
10337770|NCT00365872|11474562|FG000|STARTED|Overall Study||5
10337522|NCT00365105|11474379|FG000|Eligible With Adverse Event Data|Overall Study||123
10337523|NCT00365105|11474380|FG001|Eligible With Adverse Event Data|Overall Study||124
10337524|NCT00365105|11474379|FG000|COMPLETED|Overall Study||124
10337525|NCT00365105|11474380|FG001|COMPLETED|Overall Study||124
10337526|NCT00365105|11474379|FG000|NOT COMPLETED|Overall Study||5
10337527|NCT00365105|11474380|FG001|NOT COMPLETED|Overall Study||8
10337528|NCT00365144|11474386|FG000|STARTED|Overall Study||36
10337529|NCT00365144|11474386|FG000|COMPLETED|Overall Study||36
10649800|NCT02164422|11809974|FG001|COMPLETED|Overall Study||20
10649801|NCT02164422|11809975|FG002|COMPLETED|Overall Study||23
10649802|NCT02164422|11809973|FG000|NOT COMPLETED|Overall Study||1
10649803|NCT02164422|11809974|FG001|NOT COMPLETED|Overall Study||2
10649804|NCT02164422|11809975|FG002|NOT COMPLETED|Overall Study||0
10649805|NCT02164513|11809986|FG000|STARTED|Overall Study||4151
10649806|NCT02164513|11809987|FG001|STARTED|Overall Study||4134
10649807|NCT02164513|11809988|FG002|STARTED|Overall Study||2070
10337530|NCT00365144|11474386|FG000|NOT COMPLETED|Overall Study||0
10337531|NCT00365209|11474391|FG000|STARTED|Stage 1: Receiving 2g Curcumin||23
10337532|NCT00365209|11474391|FG000|COMPLETED|Stage 1: Receiving 2g Curcumin||21
10337533|NCT00365209|11474391|FG000|NOT COMPLETED|Stage 1: Receiving 2g Curcumin||2
10337534|NCT00365209|11474391|FG000|STARTED|Stage 2: Receiving 4g Curcumin||21
10337535|NCT00365209|11474391|FG000|COMPLETED|Stage 2: Receiving 4g Curcumin||19
10337536|NCT00365209|11474391|FG000|NOT COMPLETED|Stage 2: Receiving 4g Curcumin||2
10337537|NCT00365261|11474398|FG000|STARTED|Overall Study||23
10337538|NCT00365261|11474399|FG001|STARTED|Overall Study||22
10337539|NCT00365261|11474398|FG000|COMPLETED|Overall Study||20
10337540|NCT00365261|11474399|FG001|COMPLETED|Overall Study||19
10337541|NCT00365261|11474398|FG000|NOT COMPLETED|Overall Study||3
10337542|NCT00365261|11474399|FG001|NOT COMPLETED|Overall Study||3
10337543|NCT00365274|11474407|FG000|STARTED|Overall Study||6
10337544|NCT00365274|11474407|FG000|COMPLETED|Overall Study||6
10337545|NCT00365274|11474407|FG000|NOT COMPLETED|Overall Study||0
10337546|NCT00365300|11474413|FG000|STARTED|Open-label Phase||129
10337547|NCT00365300|11474414|FG001|STARTED|Open-label Phase||0
10337548|NCT00365300|11474413|FG000|COMPLETED|Open-label Phase||107
10337549|NCT00365300|11474414|FG001|COMPLETED|Open-label Phase||0
10337550|NCT00365300|11474413|FG000|NOT COMPLETED|Open-label Phase||22
10337551|NCT00365300|11474414|FG001|NOT COMPLETED|Open-label Phase||0
10337552|NCT00365300|11474413|FG000|STARTED|Double-blind Phase||54
10337553|NCT00365300|11474414|FG001|STARTED|Double-blind Phase||54
10337554|NCT00365300|11474413|FG000|COMPLETED|Double-blind Phase||43
10337555|NCT00365300|11474414|FG001|COMPLETED|Double-blind Phase||45
10337556|NCT00365300|11474413|FG000|NOT COMPLETED|Double-blind Phase||11
10337557|NCT00365300|11474414|FG001|NOT COMPLETED|Double-blind Phase||9
10337558|NCT00365352|11474426|FG000|STARTED|Overall Study||97
10337559|NCT00365352|11474427|FG001|STARTED|Overall Study||115
10337560|NCT00365352|11474428|FG002|STARTED|Overall Study||113
10337561|NCT00365352|11474426|FG000|Safety Population|Overall Study||96
10337562|NCT00365352|11474427|FG001|Safety Population|Overall Study||115
10337563|NCT00365352|11474428|FG002|Safety Population|Overall Study||111
10337564|NCT00365352|11474426|FG000|Modified Intent-to-Treat Population|Overall Study||96
10337565|NCT00365352|11474427|FG001|Modified Intent-to-Treat Population|Overall Study||114
10337566|NCT00365352|11474428|FG002|Modified Intent-to-Treat Population|Overall Study||111
10337567|NCT00365352|11474426|FG000|COMPLETED|Overall Study||77
10337568|NCT00365352|11474427|FG001|COMPLETED|Overall Study||104
10337569|NCT00365352|11474428|FG002|COMPLETED|Overall Study||98
10337570|NCT00365352|11474426|FG000|NOT COMPLETED|Overall Study||20
10337571|NCT00365352|11474427|FG001|NOT COMPLETED|Overall Study||11
10337572|NCT00365352|11474428|FG002|NOT COMPLETED|Overall Study||15
10337573|NCT00365365|11474442|FG000|STARTED|Overall Study||78
10337574|NCT00365365|11474443|FG001|STARTED|Overall Study||77
10337575|NCT00365365|11474444|FG002|STARTED|Overall Study||59
10337576|NCT00365365|11474442|FG000|TREATED (SAFETY POPULATION)|Overall Study||78
10337577|NCT00365365|11474443|FG001|TREATED (SAFETY POPULATION)|Overall Study||75
10337578|NCT00365365|11474444|FG002|TREATED (SAFETY POPULATION)|Overall Study||59
10337579|NCT00365365|11474442|FG000|COMPLETED TREATMENT|Overall Study||38
10337580|NCT00365365|11474443|FG001|COMPLETED TREATMENT|Overall Study||36
10337581|NCT00365365|11474444|FG002|COMPLETED TREATMENT|Overall Study||45
10337582|NCT00365365|11474442|FG000|COMPLETED|Overall Study||44
10337583|NCT00365365|11474443|FG001|COMPLETED|Overall Study||41
10337584|NCT00365365|11474444|FG002|COMPLETED|Overall Study||44
10337585|NCT00365365|11474442|FG000|NOT COMPLETED|Overall Study||34
10337586|NCT00365365|11474443|FG001|NOT COMPLETED|Overall Study||36
10337587|NCT00365365|11474444|FG002|NOT COMPLETED|Overall Study||15
10337588|NCT00365378|11474454|FG000|STARTED|Vaccination (Day 1 to Month 7)||1204
10337589|NCT00365378|11474455|FG001|STARTED|Vaccination (Day 1 to Month 7)||1205
10337590|NCT00365378|11474456|FG002|STARTED|Vaccination (Day 1 to Month 7)||0
10337591|NCT00365378|11474454|FG000|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||1193
10337592|NCT00365378|11474455|FG001|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||1198
10337593|NCT00365378|11474456|FG002|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||0
10337594|NCT00365378|11474454|FG000|COMPLETED|Vaccination (Day 1 to Month 7)||993
10337595|NCT00365378|11474455|FG001|COMPLETED|Vaccination (Day 1 to Month 7)||1038
10337596|NCT00365378|11474456|FG002|COMPLETED|Vaccination (Day 1 to Month 7)||0
10337597|NCT00365378|11474454|FG000|NOT COMPLETED|Vaccination (Day 1 to Month 7)||211
10337598|NCT00365378|11474455|FG001|NOT COMPLETED|Vaccination (Day 1 to Month 7)||167
10337599|NCT00365378|11474456|FG002|NOT COMPLETED|Vaccination (Day 1 to Month 7)||0
10337600|NCT00365378|11474454|FG000|STARTED|Follow-up (Month 7 Though Month 48)||993
10337601|NCT00365378|11474455|FG001|STARTED|Follow-up (Month 7 Though Month 48)||1038
10337602|NCT00365378|11474456|FG002|STARTED|Follow-up (Month 7 Though Month 48)||0
10337603|NCT00365378|11474454|FG000|COMPLETED|Follow-up (Month 7 Though Month 48)||835
10337604|NCT00365378|11474455|FG001|COMPLETED|Follow-up (Month 7 Though Month 48)||836
10337605|NCT00365378|11474456|FG002|COMPLETED|Follow-up (Month 7 Though Month 48)||0
10337606|NCT00365378|11474454|FG000|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||158
10337607|NCT00365378|11474455|FG001|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||202
10337608|NCT00365378|11474456|FG002|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||0
10337609|NCT00365378|11474454|FG000|STARTED|Extension||0
10337610|NCT00365378|11474455|FG001|STARTED|Extension||0
10337611|NCT00365378|11474456|FG002|STARTED|Extension||400
10337612|NCT00365378|11474454|FG000|COMPLETED|Extension||0
10337613|NCT00365378|11474455|FG001|COMPLETED|Extension||0
10337614|NCT00365378|11474456|FG002|COMPLETED|Extension||203
10337615|NCT00365378|11474454|FG000|NOT COMPLETED|Extension||0
10337616|NCT00365378|11474455|FG001|NOT COMPLETED|Extension||0
10337617|NCT00365378|11474456|FG002|NOT COMPLETED|Extension||197
10337618|NCT00365391|11474463|FG000|STARTED|Overall Study||27
10337619|NCT00365391|11474463|FG000|COMPLETED|Overall Study||27
10337620|NCT00365391|11474463|FG000|NOT COMPLETED|Overall Study||0
10337621|NCT00365417|11474467|FG000|STARTED|Overall Study||45
10337622|NCT00365417|11474467|FG000|COMPLETED|Overall Study||45
10337623|NCT00365417|11474467|FG000|NOT COMPLETED|Overall Study||0
10337624|NCT00365456|11474472|FG000|STARTED|Trial Period I (12 Months)||407
10337625|NCT00365456|11474473|FG001|STARTED|Trial Period I (12 Months)||0
10337626|NCT00365456|11474472|FG000|COMPLETED|Trial Period I (12 Months)||282
10337627|NCT00365456|11474473|FG001|COMPLETED|Trial Period I (12 Months)||0
10337628|NCT00365456|11474472|FG000|NOT COMPLETED|Trial Period I (12 Months)||125
10337629|NCT00365456|11474473|FG001|NOT COMPLETED|Trial Period I (12 Months)||0
10337630|NCT00365456|11474472|FG000|STARTED|Trial Period II (12 Months)||0
10337631|NCT00365456|11474473|FG001|STARTED|Trial Period II (12 Months)||282
10337632|NCT00365456|11474472|FG000|COMPLETED|Trial Period II (12 Months)||0
10337633|NCT00365456|11474473|FG001|COMPLETED|Trial Period II (12 Months)||268
10337634|NCT00365456|11474472|FG000|NOT COMPLETED|Trial Period II (12 Months)||0
10337635|NCT00365456|11474473|FG001|NOT COMPLETED|Trial Period II (12 Months)||14
10337636|NCT00365456|11474472|FG000|STARTED|Trial Period III (12 Months)||136
10337637|NCT00365456|11474473|FG001|STARTED|Trial Period III (12 Months)||132
10337638|NCT00365456|11474472|FG000|COMPLETED|Trial Period III (12 Months)||118
10337639|NCT00365456|11474473|FG001|COMPLETED|Trial Period III (12 Months)||127
10337640|NCT00365456|11474472|FG000|NOT COMPLETED|Trial Period III (12 Months)||18
10337641|NCT00365456|11474473|FG001|NOT COMPLETED|Trial Period III (12 Months)||5
10337642|NCT00365508|11474481|FG000|STARTED|Overall Study||321
10337643|NCT00365508|11474482|FG001|STARTED|Overall Study||321
10337644|NCT00365508|11474481|FG000|COMPLETED|Overall Study||182
10337645|NCT00365508|11474482|FG001|COMPLETED|Overall Study||167
10337646|NCT00365508|11474481|FG000|NOT COMPLETED|Overall Study||139
10337647|NCT00365508|11474482|FG001|NOT COMPLETED|Overall Study||154
10337648|NCT00365547|11474488|FG000|STARTED|Overall Study||46
10337649|NCT00365547|11474488|FG000|COMPLETED|Overall Study||43
10337650|NCT00365547|11474488|FG000|NOT COMPLETED|Overall Study||3
10337651|NCT00365599|11474495|FG000|STARTED|Overall Study||43
10337652|NCT00365599|11474495|FG000|COMPLETED|Overall Study||43
10337653|NCT00365599|11474495|FG000|NOT COMPLETED|Overall Study||0
10337654|NCT00365716|11474504|FG000|STARTED|Base Study (Day 1 to Month 7)||290
10337655|NCT00365716|11474505|FG001|STARTED|Base Study (Day 1 to Month 7)||284
10337656|NCT00365716|11474506|FG002|STARTED|Base Study (Day 1 to Month 7)||292
10337657|NCT00365716|11474507|FG003|STARTED|Base Study (Day 1 to Month 7)||146
10337658|NCT00365716|11474508|FG004|STARTED|Base Study (Day 1 to Month 7)||146
10337659|NCT00365716|11474509|FG005|STARTED|Base Study (Day 1 to Month 7)||0
10337660|NCT00365716|11474510|FG006|STARTED|Base Study (Day 1 to Month 7)||0
10337661|NCT00365716|11474504|FG000|COMPLETED|Base Study (Day 1 to Month 7)||269
10337662|NCT00365716|11474505|FG001|COMPLETED|Base Study (Day 1 to Month 7)||260
10337663|NCT00365716|11474506|FG002|COMPLETED|Base Study (Day 1 to Month 7)||271
10337664|NCT00365716|11474507|FG003|COMPLETED|Base Study (Day 1 to Month 7)||136
10337665|NCT00365716|11474508|FG004|COMPLETED|Base Study (Day 1 to Month 7)||139
10337666|NCT00365716|11474509|FG005|COMPLETED|Base Study (Day 1 to Month 7)||0
10337667|NCT00365716|11474510|FG006|COMPLETED|Base Study (Day 1 to Month 7)||0
10337668|NCT00365716|11474504|FG000|NOT COMPLETED|Base Study (Day 1 to Month 7)||21
10337669|NCT00365716|11474505|FG001|NOT COMPLETED|Base Study (Day 1 to Month 7)||24
10337670|NCT00365716|11474506|FG002|NOT COMPLETED|Base Study (Day 1 to Month 7)||21
10337671|NCT00365716|11474507|FG003|NOT COMPLETED|Base Study (Day 1 to Month 7)||10
10337672|NCT00365716|11474508|FG004|NOT COMPLETED|Base Study (Day 1 to Month 7)||7
10337673|NCT00365716|11474509|FG005|NOT COMPLETED|Base Study (Day 1 to Month 7)||0
10337674|NCT00365716|11474510|FG006|NOT COMPLETED|Base Study (Day 1 to Month 7)||0
10337675|NCT00365716|11474504|FG000|STARTED|Long Term Follow-up (Month 7 toMonth 36)||269
10337676|NCT00365716|11474505|FG001|STARTED|Long Term Follow-up (Month 7 toMonth 36)||260
10337677|NCT00365716|11474506|FG002|STARTED|Long Term Follow-up (Month 7 toMonth 36)||271
10337678|NCT00365716|11474507|FG003|STARTED|Long Term Follow-up (Month 7 toMonth 36)||136
10337679|NCT00365716|11474508|FG004|STARTED|Long Term Follow-up (Month 7 toMonth 36)||139
10337680|NCT00365716|11474509|FG005|STARTED|Long Term Follow-up (Month 7 toMonth 36)||0
10337681|NCT00365716|11474510|FG006|STARTED|Long Term Follow-up (Month 7 toMonth 36)||0
10337682|NCT00365716|11474504|FG000|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||137
10337683|NCT00365716|11474505|FG001|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||245
10337684|NCT00365716|11474506|FG002|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||251
10337685|NCT00365716|11474507|FG003|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||57
10337686|NCT00365716|11474508|FG004|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||57
10337687|NCT00365716|11474509|FG005|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
10337688|NCT00365716|11474510|FG006|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
10337689|NCT00365716|11474504|FG000|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||132
10337690|NCT00365716|11474505|FG001|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||15
10337691|NCT00365716|11474506|FG002|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||20
10337692|NCT00365716|11474507|FG003|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||79
10337693|NCT00365716|11474508|FG004|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||82
10337694|NCT00365716|11474509|FG005|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
10337695|NCT00365716|11474510|FG006|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
10337696|NCT00365716|11474504|FG000|STARTED|Extension 1||0
10337697|NCT00365716|11474505|FG001|STARTED|Extension 1||0
10337698|NCT00365716|11474506|FG002|STARTED|Extension 1||0
10337699|NCT00365716|11474507|FG003|STARTED|Extension 1||0
10337700|NCT00365716|11474508|FG004|STARTED|Extension 1||0
10337701|NCT00365716|11474509|FG005|STARTED|Extension 1||241
10337702|NCT00365716|11474510|FG006|STARTED|Extension 1||0
10337703|NCT00365716|11474504|FG000|COMPLETED|Extension 1||0
10337704|NCT00365716|11474505|FG001|COMPLETED|Extension 1||0
10337705|NCT00365716|11474506|FG002|COMPLETED|Extension 1||0
10337706|NCT00365716|11474507|FG003|COMPLETED|Extension 1||0
10337707|NCT00365716|11474508|FG004|COMPLETED|Extension 1||0
10337708|NCT00365716|11474509|FG005|COMPLETED|Extension 1||219
10337709|NCT00365716|11474510|FG006|COMPLETED|Extension 1||0
10337710|NCT00365716|11474504|FG000|NOT COMPLETED|Extension 1||0
10337711|NCT00365716|11474505|FG001|NOT COMPLETED|Extension 1||0
10337712|NCT00365716|11474506|FG002|NOT COMPLETED|Extension 1||0
10337713|NCT00365716|11474507|FG003|NOT COMPLETED|Extension 1||0
10337714|NCT00365716|11474508|FG004|NOT COMPLETED|Extension 1||0
10337715|NCT00365716|11474509|FG005|NOT COMPLETED|Extension 1||22
10337716|NCT00365716|11474510|FG006|NOT COMPLETED|Extension 1||0
10337717|NCT00365716|11474504|FG000|STARTED|Extension 2||0
10337718|NCT00365716|11474505|FG001|STARTED|Extension 2||0
10337719|NCT00365716|11474506|FG002|STARTED|Extension 2||0
10337720|NCT00365716|11474507|FG003|STARTED|Extension 2||0
10337721|NCT00365716|11474508|FG004|STARTED|Extension 2||0
10337722|NCT00365716|11474509|FG005|STARTED|Extension 2||0
10337723|NCT00365716|11474510|FG006|STARTED|Extension 2|17 Participants continued into Extension 2 from Extension 1|17
10337724|NCT00365716|11474504|FG000|COMPLETED|Extension 2||0
10337725|NCT00365716|11474505|FG001|COMPLETED|Extension 2||0
10337726|NCT00365716|11474506|FG002|COMPLETED|Extension 2||0
10337727|NCT00365716|11474507|FG003|COMPLETED|Extension 2||0
10337728|NCT00365716|11474508|FG004|COMPLETED|Extension 2||0
10337729|NCT00365716|11474509|FG005|COMPLETED|Extension 2||0
10337730|NCT00365716|11474510|FG006|COMPLETED|Extension 2||7
10337731|NCT00365716|11474504|FG000|NOT COMPLETED|Extension 2||0
10337732|NCT00365716|11474505|FG001|NOT COMPLETED|Extension 2||0
10337733|NCT00365716|11474506|FG002|NOT COMPLETED|Extension 2||0
10337734|NCT00365716|11474507|FG003|NOT COMPLETED|Extension 2||0
10337735|NCT00365716|11474508|FG004|NOT COMPLETED|Extension 2||0
10337736|NCT00365716|11474509|FG005|NOT COMPLETED|Extension 2||0
10337737|NCT00365716|11474510|FG006|NOT COMPLETED|Extension 2||10
10337738|NCT00365768|11474526|FG000|STARTED|Overall Study||24
10337739|NCT00365768|11474527|FG001|STARTED|Overall Study||25
10337740|NCT00365768|11474526|FG000|COMPLETED|Overall Study||24
10337741|NCT00365768|11474527|FG001|COMPLETED|Overall Study||25
10337742|NCT00365768|11474526|FG000|NOT COMPLETED|Overall Study||0
10337743|NCT00365768|11474527|FG001|NOT COMPLETED|Overall Study||0
10337744|NCT00365794|11474533|FG000|STARTED|Overall Study|22 subjects were enrolled since only 20 completed all post treatment measures.|22
10337745|NCT00365794|11474533|FG000|COMPLETED|Overall Study||20
10337746|NCT00365794|11474533|FG000|NOT COMPLETED|Overall Study||2
10337747|NCT00365846|11474538|FG000|STARTED|Overall Study||29
10337748|NCT00365846|11474538|FG000|COMPLETED|Overall Study||28
10337749|NCT00365846|11474538|FG000|NOT COMPLETED|Overall Study||1
10337750|NCT00365859|11474547|FG000|STARTED|Overall Study||86
10337751|NCT00365859|11474548|FG001|STARTED|Overall Study||70
10337752|NCT00365859|11474549|FG002|STARTED|Overall Study||174
10337753|NCT00365859|11474550|FG003|STARTED|Overall Study||330
10337754|NCT00365859|11474547|FG000|Safety Population|Overall Study||86
10337755|NCT00365859|11474548|FG001|Safety Population|Overall Study||70
10337756|NCT00365859|11474549|FG002|Safety Population|Overall Study||174
10337757|NCT00365859|11474550|FG003|Safety Population|Overall Study||330
10337758|NCT00365859|11474547|FG000|Efficacy Population|Overall Study|1 patient was lost to follow-up and 1 not included due to moderate sedation (total=2)|84
10337759|NCT00365859|11474548|FG001|Efficacy Population|Overall Study|1 not included due to increased alanine aminotransferase (ALT) prior to treatment with aripiprazole|69
10337760|NCT00365859|11474549|FG002|Efficacy Population|Overall Study|3 lost to follow-up, 1 not included due to mild increased appetite, 1 to family emergency (total=5)|169
10337761|NCT00365859|11474550|FG003|Efficacy Population|Overall Study||322
10337762|NCT00365859|11474547|FG000|COMPLETED|Overall Study||55
10337763|NCT00365859|11474548|FG001|COMPLETED|Overall Study||37
10337764|NCT00365859|11474549|FG002|COMPLETED|Overall Study||107
10337765|NCT00365859|11474550|FG003|COMPLETED|Overall Study||199
10337766|NCT00365859|11474547|FG000|NOT COMPLETED|Overall Study||31
10337767|NCT00365859|11474548|FG001|NOT COMPLETED|Overall Study||33
10337768|NCT00365859|11474549|FG002|NOT COMPLETED|Overall Study||67
10337769|NCT00365859|11474550|FG003|NOT COMPLETED|Overall Study||131
10337771|NCT00365872|11474563|FG001|STARTED|Overall Study||6
10337772|NCT00365872|11474564|FG002|STARTED|Overall Study||6
10337773|NCT00365872|11474562|FG000|COMPLETED|Overall Study||5
10337774|NCT00365872|11474563|FG001|COMPLETED|Overall Study||6
10337775|NCT00365872|11474564|FG002|COMPLETED|Overall Study||6
10337776|NCT00365872|11474562|FG000|NOT COMPLETED|Overall Study||0
10337777|NCT00365872|11474563|FG001|NOT COMPLETED|Overall Study||0
10337778|NCT00365872|11474564|FG002|NOT COMPLETED|Overall Study||0
10337779|NCT00365976|11474573|FG000|STARTED|Overall Study||33
10337780|NCT00365976|11474574|FG001|STARTED|Overall Study||25
10337781|NCT00365976|11474573|FG000|COMPLETED|Overall Study||32
10337782|NCT00365976|11474574|FG001|COMPLETED|Overall Study||20
10337783|NCT00365976|11474573|FG000|NOT COMPLETED|Overall Study||1
10337784|NCT00365976|11474574|FG001|NOT COMPLETED|Overall Study||5
10337785|NCT00365989|11474580|FG000|STARTED|Overall Study||50
10337786|NCT00365989|11474580|FG000|COMPLETED|Overall Study||48
10337787|NCT00365989|11474580|FG000|NOT COMPLETED|Overall Study||2
10337788|NCT00366028|11474587|FG000|STARTED|Overall Study||889
10337789|NCT00366028|11474588|FG001|STARTED|Overall Study||735
10337790|NCT00366028|11474587|FG000|COMPLETED|Overall Study||889
10337791|NCT00366028|11474588|FG001|COMPLETED|Overall Study||735
10337792|NCT00366028|11474587|FG000|NOT COMPLETED|Overall Study||0
10337793|NCT00366028|11474588|FG001|NOT COMPLETED|Overall Study||0
10337794|NCT00366106|11474596|FG000|STARTED|Overall Study||32
10337795|NCT00366106|11474596|FG000|COMPLETED|Overall Study||32
10337796|NCT00366106|11474596|FG000|NOT COMPLETED|Overall Study||0
10337797|NCT00366249|11474602|FG000|STARTED|Overall Study||553
10337798|NCT00366249|11474603|FG001|STARTED|Overall Study||508
10337799|NCT00366249|11474602|FG000|COMPLETED|Overall Study||422
10337800|NCT00366249|11474603|FG001|COMPLETED|Overall Study||430
10337801|NCT00366249|11474602|FG000|NOT COMPLETED|Overall Study||131
10337802|NCT00366249|11474603|FG001|NOT COMPLETED|Overall Study||78
10337803|NCT00366275|11474609|FG000|STARTED|Overall Study||64
10337804|NCT00366275|11474609|FG000|COMPLETED|Overall Study||58
10337805|NCT00366275|11474609|FG000|NOT COMPLETED|Overall Study||6
10337806|NCT00366301|11474617|FG000|STARTED|Overall Study||124
10337807|NCT00366301|11474618|FG001|STARTED|Overall Study||126
10337808|NCT00366301|11474619|FG002|STARTED|Overall Study||126
10337809|NCT00366301|11474620|FG003|STARTED|Overall Study||124
10337810|NCT00366301|11474617|FG000|Either 6W or 14W CRP Obtained|Overall Study||120
10337811|NCT00366301|11474618|FG001|Either 6W or 14W CRP Obtained|Overall Study||124
10337812|NCT00366301|11474619|FG002|Either 6W or 14W CRP Obtained|Overall Study||124
10337813|NCT00366301|11474620|FG003|Either 6W or 14W CRP Obtained|Overall Study||119
10337814|NCT00366301|11474617|FG000|COMPLETED|Overall Study||116
10337815|NCT00366301|11474618|FG001|COMPLETED|Overall Study||120
10337816|NCT00366301|11474619|FG002|COMPLETED|Overall Study||122
10337817|NCT00366301|11474620|FG003|COMPLETED|Overall Study||116
10337818|NCT00366301|11474617|FG000|NOT COMPLETED|Overall Study||8
10337819|NCT00366301|11474618|FG001|NOT COMPLETED|Overall Study||6
10337820|NCT00366301|11474619|FG002|NOT COMPLETED|Overall Study||4
10337821|NCT00366301|11474620|FG003|NOT COMPLETED|Overall Study||8
10337822|NCT00366340|11474632|FG000|STARTED|Infant Series||301
10337823|NCT00366340|11474633|FG001|STARTED|Infant Series||303
10337824|NCT00366340|11474632|FG000|Vaccinated Dose 1|Infant Series||300
10337825|NCT00366340|11474633|FG001|Vaccinated Dose 1|Infant Series||303
10337826|NCT00366340|11474632|FG000|Vaccinated Dose 2|Infant Series||296
10337827|NCT00366340|11474633|FG001|Vaccinated Dose 2|Infant Series||297
10337828|NCT00366340|11474632|FG000|Vaccinated Dose 3|Infant Series||294
10337829|NCT00366340|11474633|FG001|Vaccinated Dose 3|Infant Series||293
10337830|NCT00366340|11474632|FG000|COMPLETED|Infant Series||293
10337831|NCT00366340|11474633|FG001|COMPLETED|Infant Series||293
10337832|NCT00366340|11474632|FG000|NOT COMPLETED|Infant Series||8
10337833|NCT00366340|11474633|FG001|NOT COMPLETED|Infant Series||10
10337834|NCT00366340|11474632|FG000|STARTED|After the Infant Series||293
10337835|NCT00366340|11474633|FG001|STARTED|After the Infant Series||293
10337836|NCT00366340|11474632|FG000|COMPLETED|After the Infant Series||290
10337837|NCT00366340|11474633|FG001|COMPLETED|After the Infant Series||287
10337838|NCT00366340|11474632|FG000|NOT COMPLETED|After the Infant Series||3
10337839|NCT00366340|11474633|FG001|NOT COMPLETED|After the Infant Series||6
10337840|NCT00366340|11474632|FG000|STARTED|Toddler Dose||290
10337841|NCT00366340|11474633|FG001|STARTED|Toddler Dose||287
10337842|NCT00366340|11474632|FG000|COMPLETED|Toddler Dose||289
10337843|NCT00366340|11474633|FG001|COMPLETED|Toddler Dose||286
10337844|NCT00366340|11474632|FG000|NOT COMPLETED|Toddler Dose||1
10337845|NCT00366340|11474633|FG001|NOT COMPLETED|Toddler Dose||1
10337846|NCT00366444|11474665|FG000|STARTED|Overall Study||102
10337847|NCT00366444|11474666|FG001|STARTED|Overall Study||99
10337848|NCT00366444|11474665|FG000|COMPLETED|Overall Study||101
10337849|NCT00366444|11474666|FG001|COMPLETED|Overall Study||97
10337850|NCT00366444|11474665|FG000|NOT COMPLETED|Overall Study||1
10337851|NCT00366444|11474666|FG001|NOT COMPLETED|Overall Study||2
10337852|NCT00366457|11474672|FG000|STARTED|Overall Study||32
10337853|NCT00366457|11474672|FG000|COMPLETED|Overall Study||30
10337854|NCT00366457|11474672|FG000|NOT COMPLETED|Overall Study||2
10337855|NCT00366535|11474678|FG000|STARTED|First Phase: 12 Weeks||27
10337856|NCT00366535|11474679|FG001|STARTED|First Phase: 12 Weeks||29
10337857|NCT00366535|11474678|FG000|COMPLETED|First Phase: 12 Weeks||24
10337858|NCT00366535|11474679|FG001|COMPLETED|First Phase: 12 Weeks||21
10337859|NCT00366535|11474678|FG000|NOT COMPLETED|First Phase: 12 Weeks||3
10337860|NCT00366535|11474679|FG001|NOT COMPLETED|First Phase: 12 Weeks||8
10337861|NCT00366535|11474678|FG000|STARTED|Washout Period (at Least a Week)||24
10337862|NCT00366535|11474679|FG001|STARTED|Washout Period (at Least a Week)||21
10337863|NCT00366535|11474678|FG000|COMPLETED|Washout Period (at Least a Week)||24
10337864|NCT00366535|11474679|FG001|COMPLETED|Washout Period (at Least a Week)||21
10337865|NCT00366535|11474678|FG000|NOT COMPLETED|Washout Period (at Least a Week)||0
10337866|NCT00366535|11474679|FG001|NOT COMPLETED|Washout Period (at Least a Week)||0
10337867|NCT00366535|11474678|FG000|STARTED|Second Phase: 12 Weeks||24
10337868|NCT00366535|11474679|FG001|STARTED|Second Phase: 12 Weeks||21
10337869|NCT00366535|11474678|FG000|COMPLETED|Second Phase: 12 Weeks||21
10337870|NCT00366535|11474679|FG001|COMPLETED|Second Phase: 12 Weeks||18
10337871|NCT00366535|11474678|FG000|NOT COMPLETED|Second Phase: 12 Weeks||3
10337872|NCT00366535|11474679|FG001|NOT COMPLETED|Second Phase: 12 Weeks||3
10337873|NCT00366548|11474695|FG000|STARTED|Infant Series||250
10337874|NCT00366548|11474696|FG001|STARTED|Infant Series||250
10337875|NCT00366548|11474695|FG000|Vaccinated Dose 1|Infant Series||250
10337876|NCT00366548|11474696|FG001|Vaccinated Dose 1|Infant Series||250
10337877|NCT00366548|11474695|FG000|Vaccinated Dose 2|Infant Series||246
10337878|NCT00366548|11474696|FG001|Vaccinated Dose 2|Infant Series||249
10337879|NCT00366548|11474695|FG000|Vaccinated Dose 3|Infant Series||246
10337880|NCT00366548|11474696|FG001|Vaccinated Dose 3|Infant Series||247
10337881|NCT00366548|11474695|FG000|COMPLETED|Infant Series||246
10337882|NCT00366548|11474696|FG001|COMPLETED|Infant Series||245
10337883|NCT00366548|11474695|FG000|NOT COMPLETED|Infant Series||4
10337884|NCT00366548|11474696|FG001|NOT COMPLETED|Infant Series||5
10337885|NCT00366548|11474695|FG000|STARTED|After Infant Series||246
10337886|NCT00366548|11474696|FG001|STARTED|After Infant Series||245
10337887|NCT00366548|11474695|FG000|COMPLETED|After Infant Series||240
10337888|NCT00366548|11474696|FG001|COMPLETED|After Infant Series||244
10337889|NCT00366548|11474695|FG000|NOT COMPLETED|After Infant Series||6
10337890|NCT00366548|11474696|FG001|NOT COMPLETED|After Infant Series||1
10337891|NCT00366548|11474695|FG000|STARTED|Toddler Dose||240
10337892|NCT00366548|11474696|FG001|STARTED|Toddler Dose||244
10337893|NCT00366548|11474695|FG000|COMPLETED|Toddler Dose||240
10707952|NCT02625259|11872699|FG000|COMPLETED|Washout (Day 2 to Day 14)||9
10707953|NCT02625259|11872700|FG001|COMPLETED|Washout (Day 2 to Day 14)||8
10707954|NCT02625259|11872701|FG002|COMPLETED|Washout (Day 2 to Day 14)||7
10707955|NCT02625259|11872702|FG003|COMPLETED|Washout (Day 2 to Day 14)||9
10707956|NCT02625259|11872703|FG004|COMPLETED|Washout (Day 2 to Day 14)||0
10707957|NCT02625259|11872699|FG000|NOT COMPLETED|Washout (Day 2 to Day 14)||0
10337894|NCT00366548|11474696|FG001|COMPLETED|Toddler Dose||244
10337895|NCT00366548|11474695|FG000|NOT COMPLETED|Toddler Dose||0
10337896|NCT00366548|11474696|FG001|NOT COMPLETED|Toddler Dose||0
10337897|NCT00366626|11474722|FG000|STARTED|Overall Study||38
10337898|NCT00366626|11474723|FG001|STARTED|Overall Study||45
10707958|NCT02625259|11872700|FG001|NOT COMPLETED|Washout (Day 2 to Day 14)||0
10707959|NCT02625259|11872701|FG002|NOT COMPLETED|Washout (Day 2 to Day 14)||0
10707960|NCT02625259|11872702|FG003|NOT COMPLETED|Washout (Day 2 to Day 14)||0
10707961|NCT02625259|11872703|FG004|NOT COMPLETED|Washout (Day 2 to Day 14)||0
10707962|NCT02625259|11872699|FG000|STARTED|Second Intervention (Day 15)||9
10707963|NCT02625259|11872700|FG001|STARTED|Second Intervention (Day 15)||8
10707964|NCT02625259|11872701|FG002|STARTED|Second Intervention (Day 15)||7
10707965|NCT02625259|11872702|FG003|STARTED|Second Intervention (Day 15)||9
10707966|NCT02625259|11872703|FG004|STARTED|Second Intervention (Day 15)||0
10707967|NCT02625259|11872699|FG000|COMPLETED|Second Intervention (Day 15)||9
10707968|NCT02625259|11872700|FG001|COMPLETED|Second Intervention (Day 15)||8
10707969|NCT02625259|11872701|FG002|COMPLETED|Second Intervention (Day 15)||7
10707970|NCT02625259|11872702|FG003|COMPLETED|Second Intervention (Day 15)||9
10707971|NCT02625259|11872703|FG004|COMPLETED|Second Intervention (Day 15)||0
10707972|NCT02625259|11872699|FG000|NOT COMPLETED|Second Intervention (Day 15)||0
10707973|NCT02625259|11872700|FG001|NOT COMPLETED|Second Intervention (Day 15)||0
10707974|NCT02625259|11872701|FG002|NOT COMPLETED|Second Intervention (Day 15)||0
10707975|NCT02625259|11872702|FG003|NOT COMPLETED|Second Intervention (Day 15)||0
10707976|NCT02625259|11872703|FG004|NOT COMPLETED|Second Intervention (Day 15)||0
10707977|NCT02625298|11872720|FG000|STARTED|Overall Study||11
10707978|NCT02625298|11872721|FG001|STARTED|Overall Study||13
10707979|NCT02625298|11872720|FG000|COMPLETED|Overall Study||10
10707980|NCT02625298|11872721|FG001|COMPLETED|Overall Study||13
10707981|NCT02625298|11872720|FG000|NOT COMPLETED|Overall Study||1
10707982|NCT02625298|11872721|FG001|NOT COMPLETED|Overall Study||0
10707983|NCT02625402|11872731|FG000|STARTED|Overall Study||42
10707984|NCT02625402|11872732|FG001|STARTED|Overall Study||37
10707985|NCT02625402|11872731|FG000|COMPLETED|Overall Study||33
10707986|NCT02625402|11872732|FG001|COMPLETED|Overall Study||25
10707987|NCT02625402|11872731|FG000|NOT COMPLETED|Overall Study||9
10707988|NCT02625402|11872732|FG001|NOT COMPLETED|Overall Study||12
10707989|NCT02625428|11872740|FG000|STARTED|Overall Study||20
10707990|NCT02625428|11872741|FG001|STARTED|Overall Study||20
10707991|NCT02625428|11872740|FG000|COMPLETED|Overall Study||20
10707992|NCT02625428|11872741|FG001|COMPLETED|Overall Study||20
10707993|NCT02625428|11872740|FG000|NOT COMPLETED|Overall Study||0
10707994|NCT02625428|11872741|FG001|NOT COMPLETED|Overall Study||0
10337899|NCT00366626|11474722|FG000|COMPLETED|Overall Study||38
10337900|NCT00366626|11474723|FG001|COMPLETED|Overall Study||45
10337901|NCT00366626|11474722|FG000|NOT COMPLETED|Overall Study||0
10337902|NCT00366626|11474723|FG001|NOT COMPLETED|Overall Study||0
10337903|NCT00366678|11474733|FG000|STARTED|Infant Series||304
10337904|NCT00366678|11474734|FG001|STARTED|Infant Series||309
10337905|NCT00366678|11474735|FG002|STARTED|Infant Series||0
10337906|NCT00366678|11474733|FG000|Vaccinated Dose 1|Infant Series||302
10707995|NCT02625545|11872747|FG000|STARTED|Overall Study||45
10707996|NCT02625545|11872747|FG000|3 Month|Overall Study||45
10707997|NCT02625545|11872747|FG000|6 Month|Overall Study||45
10707998|NCT02625545|11872747|FG000|12 Month|Overall Study||45
10707999|NCT02625545|11872747|FG000|COMPLETED|Overall Study||45
10708000|NCT02625545|11872747|FG000|NOT COMPLETED|Overall Study||0
10708001|NCT02625571|11872751|FG000|STARTED|Overall Study||13
10708002|NCT02625571|11872751|FG000|COMPLETED|Overall Study||10
10708003|NCT02625571|11872751|FG000|NOT COMPLETED|Overall Study||3
10708004|NCT02625623|11872757|FG000|STARTED|Overall Study||186
10708005|NCT02625623|11872758|FG001|STARTED|Overall Study||185
10708006|NCT02625623|11872757|FG000|Treated|Overall Study||177
10708007|NCT02625623|11872758|FG001|Treated|Overall Study||184
10708008|NCT02625623|11872757|FG000|COMPLETED|Overall Study||177
10708009|NCT02625623|11872758|FG001|COMPLETED|Overall Study||184
10708010|NCT02625623|11872757|FG000|NOT COMPLETED|Overall Study||9
10708011|NCT02625623|11872758|FG001|NOT COMPLETED|Overall Study||1
10708012|NCT02625844|11872766|FG000|STARTED|Overall Study||110
10708013|NCT02625844|11872766|FG000|COMPLETED|Overall Study||110
10708014|NCT02625844|11872766|FG000|NOT COMPLETED|Overall Study||0
10708015|NCT02625909|11872772|FG000|STARTED|Overall Study||93
10708016|NCT02625909|11872773|FG001|STARTED|Overall Study||95
10708017|NCT02625909|11872772|FG000|COMPLETED|Overall Study||76
10708018|NCT02625909|11872773|FG001|COMPLETED|Overall Study||86
10708019|NCT02625909|11872772|FG000|NOT COMPLETED|Overall Study||17
10708020|NCT02625909|11872773|FG001|NOT COMPLETED|Overall Study||9
10708021|NCT02625922|11872781|FG000|STARTED|Overall Study||14
10708022|NCT02625922|11872782|FG001|STARTED|Overall Study||12
10708023|NCT02625922|11872781|FG000|Completed Treatment Period 1|Overall Study||12
10708024|NCT02625922|11872782|FG001|Completed Treatment Period 1|Overall Study||10
10708025|NCT02625922|11872781|FG000|Completed Treatment Period 2|Overall Study||11
10708026|NCT02625922|11872782|FG001|Completed Treatment Period 2|Overall Study||8
10708027|NCT02625922|11872781|FG000|COMPLETED|Overall Study||12
10708028|NCT02625922|11872782|FG001|COMPLETED|Overall Study||10
10708029|NCT02625922|11872781|FG000|NOT COMPLETED|Overall Study||2
10708030|NCT02625922|11872782|FG001|NOT COMPLETED|Overall Study||2
10708031|NCT02625974|11872793|FG000|STARTED|Overall Study||219
10708032|NCT02625974|11872794|FG001|STARTED|Overall Study||111
10708033|NCT02625974|11872793|FG000|Received Treatment|Overall Study||219
10708034|NCT02625974|11872794|FG001|Received Treatment|Overall Study||111
10708035|NCT02625974|11872793|FG000|COMPLETED|Overall Study||203
10708036|NCT02625974|11872794|FG001|COMPLETED|Overall Study||105
10708037|NCT02625974|11872793|FG000|NOT COMPLETED|Overall Study||16
10708038|NCT02625974|11872794|FG001|NOT COMPLETED|Overall Study||6
10708039|NCT02626000|11872836|FG000|STARTED|Overall Study||36
10708040|NCT02626000|11872836|FG000|COMPLETED|Overall Study||6
10708041|NCT02626000|11872836|FG000|NOT COMPLETED|Overall Study||30
10708042|NCT02626026|11872847|FG000|STARTED|Overall Study||8
10708043|NCT02626026|11872848|FG001|STARTED|Overall Study||2
10708044|NCT02626026|11872849|FG002|STARTED|Overall Study||8
10708045|NCT02626026|11872850|FG003|STARTED|Overall Study||2
10708046|NCT02626026|11872851|FG004|STARTED|Overall Study||17
10708047|NCT02626026|11872852|FG005|STARTED|Overall Study||5
10708048|NCT02626026|11872847|FG000|COMPLETED|Overall Study||8
10708049|NCT02626026|11872848|FG001|COMPLETED|Overall Study||2
10708050|NCT02626026|11872849|FG002|COMPLETED|Overall Study||8
10708051|NCT02626026|11872850|FG003|COMPLETED|Overall Study||2
10708052|NCT02626026|11872851|FG004|COMPLETED|Overall Study||16
10708053|NCT02626026|11872852|FG005|COMPLETED|Overall Study||5
10708054|NCT02626026|11872847|FG000|NOT COMPLETED|Overall Study||0
10708055|NCT02626026|11872848|FG001|NOT COMPLETED|Overall Study||0
10708056|NCT02626026|11872849|FG002|NOT COMPLETED|Overall Study||0
10708057|NCT02626026|11872850|FG003|NOT COMPLETED|Overall Study||0
10708058|NCT02626026|11872851|FG004|NOT COMPLETED|Overall Study||1
10708059|NCT02626026|11872852|FG005|NOT COMPLETED|Overall Study||0
10708060|NCT02626156|11872872|FG000|STARTED|Baseline (Visit 1 to Visit 2)||29
10708061|NCT02626156|11872873|FG001|STARTED|Baseline (Visit 1 to Visit 2)||29
10708062|NCT02626156|11872874|FG002|STARTED|Baseline (Visit 1 to Visit 2)||42
10708063|NCT02626156|11872875|FG003|STARTED|Baseline (Visit 1 to Visit 2)||40
10708064|NCT02626156|11872872|FG000|COMPLETED|Baseline (Visit 1 to Visit 2)||23
10708065|NCT02626156|11872873|FG001|COMPLETED|Baseline (Visit 1 to Visit 2)||22
10708066|NCT02626156|11872874|FG002|COMPLETED|Baseline (Visit 1 to Visit 2)||37
10708067|NCT02626156|11872875|FG003|COMPLETED|Baseline (Visit 1 to Visit 2)||35
10708068|NCT02626156|11872872|FG000|NOT COMPLETED|Baseline (Visit 1 to Visit 2)||6
10708069|NCT02626156|11872873|FG001|NOT COMPLETED|Baseline (Visit 1 to Visit 2)||7
10708070|NCT02626156|11872874|FG002|NOT COMPLETED|Baseline (Visit 1 to Visit 2)||5
10708071|NCT02626156|11872875|FG003|NOT COMPLETED|Baseline (Visit 1 to Visit 2)||5
10708072|NCT02626156|11872872|FG000|STARTED|Study Visit 3||23
10708073|NCT02626156|11872873|FG001|STARTED|Study Visit 3||22
10708074|NCT02626156|11872874|FG002|STARTED|Study Visit 3||37
10708075|NCT02626156|11872875|FG003|STARTED|Study Visit 3||35
10708076|NCT02626156|11872872|FG000|COMPLETED|Study Visit 3||15
10708077|NCT02626156|11872873|FG001|COMPLETED|Study Visit 3||17
10708078|NCT02626156|11872874|FG002|COMPLETED|Study Visit 3||33
10708079|NCT02626156|11872875|FG003|COMPLETED|Study Visit 3||33
10708080|NCT02626156|11872872|FG000|NOT COMPLETED|Study Visit 3||8
10708081|NCT02626156|11872873|FG001|NOT COMPLETED|Study Visit 3||5
10708082|NCT02626156|11872874|FG002|NOT COMPLETED|Study Visit 3||4
10708083|NCT02626156|11872875|FG003|NOT COMPLETED|Study Visit 3||2
10708084|NCT02626156|11872872|FG000|STARTED|Study Visit 4||15
10708085|NCT02626156|11872873|FG001|STARTED|Study Visit 4||17
10708086|NCT02626156|11872874|FG002|STARTED|Study Visit 4||33
10708087|NCT02626156|11872875|FG003|STARTED|Study Visit 4||33
10708088|NCT02626156|11872872|FG000|COMPLETED|Study Visit 4||12
10708089|NCT02626156|11872873|FG001|COMPLETED|Study Visit 4||15
10708090|NCT02626156|11872874|FG002|COMPLETED|Study Visit 4||24
10708091|NCT02626156|11872875|FG003|COMPLETED|Study Visit 4||28
10708092|NCT02626156|11872872|FG000|NOT COMPLETED|Study Visit 4||3
10708093|NCT02626156|11872873|FG001|NOT COMPLETED|Study Visit 4||2
10708094|NCT02626156|11872874|FG002|NOT COMPLETED|Study Visit 4||9
10708095|NCT02626156|11872875|FG003|NOT COMPLETED|Study Visit 4||5
10708096|NCT02626182|11872893|FG000|STARTED|Overall Study||11
10708097|NCT02626182|11872894|FG001|STARTED|Overall Study||3
10708098|NCT02626182|11872893|FG000|COMPLETED|Overall Study||9
10708099|NCT02626182|11872894|FG001|COMPLETED|Overall Study||3
10708100|NCT02626182|11872893|FG000|NOT COMPLETED|Overall Study||2
10708101|NCT02626182|11872894|FG001|NOT COMPLETED|Overall Study||0
10708102|NCT02626611|11872903|FG000|STARTED|Overall Study||20
10708103|NCT02626611|11872904|FG001|STARTED|Overall Study||21
10708104|NCT02626611|11872905|FG002|STARTED|Overall Study||19
10708105|NCT02626611|11872903|FG000|COMPLETED|Overall Study||16
10708106|NCT02626611|11872904|FG001|COMPLETED|Overall Study||20
10708107|NCT02626611|11872905|FG002|COMPLETED|Overall Study||16
10708108|NCT02626611|11872903|FG000|NOT COMPLETED|Overall Study||4
10708109|NCT02626611|11872904|FG001|NOT COMPLETED|Overall Study||1
10708110|NCT02626611|11872905|FG002|NOT COMPLETED|Overall Study||3
10708111|NCT02626780|11872920|FG000|STARTED|Overall Study||7
10708112|NCT02626780|11872920|FG000|Withdrew From Study|Overall Study||3
10708113|NCT02626780|11872920|FG000|COMPLETED|Overall Study||4
10708114|NCT02626780|11872920|FG000|NOT COMPLETED|Overall Study||3
10708115|NCT02626819|11872926|FG000|STARTED|Overall Study||22
10708116|NCT02626819|11872927|FG001|STARTED|Overall Study||23
10708117|NCT02626819|11872926|FG000|COMPLETED|Overall Study||18
10708118|NCT02626819|11872927|FG001|COMPLETED|Overall Study||20
10708119|NCT02626819|11872926|FG000|NOT COMPLETED|Overall Study||4
10708120|NCT02626819|11872927|FG001|NOT COMPLETED|Overall Study||3
10708121|NCT02626910|11872937|FG000|STARTED|Overall Study||23
10708122|NCT02626910|11872938|FG001|STARTED|Overall Study||10
10708123|NCT02626910|11872939|FG002|STARTED|Overall Study||6
10708124|NCT02626910|11872940|FG003|STARTED|Overall Study||10
10708125|NCT02626910|11872937|FG000|COMPLETED|Overall Study||23
10708126|NCT02626910|11872938|FG001|COMPLETED|Overall Study||10
10708127|NCT02626910|11872939|FG002|COMPLETED|Overall Study||6
10708128|NCT02626910|11872940|FG003|COMPLETED|Overall Study||10
10708129|NCT02626910|11872937|FG000|NOT COMPLETED|Overall Study||0
10708130|NCT02626910|11872938|FG001|NOT COMPLETED|Overall Study||0
10708131|NCT02626910|11872939|FG002|NOT COMPLETED|Overall Study||0
10708132|NCT02626910|11872940|FG003|NOT COMPLETED|Overall Study||0
10708133|NCT02627001|11872952|FG000|STARTED|Overall Study||13
10708134|NCT02627001|11872953|FG001|STARTED|Overall Study||14
10708135|NCT02627001|11872952|FG000|COMPLETED|Overall Study||13
10708136|NCT02627001|11872953|FG001|COMPLETED|Overall Study||14
10708137|NCT02627001|11872952|FG000|NOT COMPLETED|Overall Study||0
10708138|NCT02627001|11872953|FG001|NOT COMPLETED|Overall Study||0
10708139|NCT02627118|11872959|FG000|STARTED|Overall Study||10
10708140|NCT02627118|11872959|FG000|COMPLETED|Overall Study||10
10708141|NCT02627118|11872959|FG000|NOT COMPLETED|Overall Study||0
10708142|NCT02627144|11872964|FG000|STARTED|Overall Study||365
10708143|NCT02627144|11872964|FG000|Treated|Overall Study||359
10708144|NCT02627144|11872964|FG000|COMPLETED|Overall Study||0
10708145|NCT02627144|11872964|FG000|NOT COMPLETED|Overall Study||365
10708146|NCT02627495|11872968|FG000|STARTED|Overall Study||9
10708147|NCT02627495|11872968|FG000|COMPLETED|Overall Study||5
10708148|NCT02627495|11872968|FG000|NOT COMPLETED|Overall Study||4
10708149|NCT02627677|11872975|FG000|STARTED|Overall Study||11
10708150|NCT02627677|11872976|FG001|STARTED|Overall Study||21
10708151|NCT02627677|11872977|FG002|STARTED|Overall Study||12
10708152|NCT02627677|11872975|FG000|COMPLETED|Overall Study||0
10708153|NCT02627677|11872976|FG001|COMPLETED|Overall Study||0
10708154|NCT02627677|11872977|FG002|COMPLETED|Overall Study||0
10708155|NCT02627677|11872975|FG000|NOT COMPLETED|Overall Study||11
10708156|NCT02627677|11872976|FG001|NOT COMPLETED|Overall Study||21
10708157|NCT02627677|11872977|FG002|NOT COMPLETED|Overall Study||12
10708158|NCT02627794|11872986|FG000|STARTED|Overall Study||3
10708159|NCT02627794|11872986|FG000|COMPLETED|Overall Study||3
10708160|NCT02627794|11872986|FG000|NOT COMPLETED|Overall Study||0
10708161|NCT02627924|11872993|FG000|STARTED|Overall Study||91
10708162|NCT02627924|11872993|FG000|COMPLETED|Overall Study||79
10708163|NCT02627924|11872993|FG000|NOT COMPLETED|Overall Study||12
10708164|NCT02628028|11873008|FG000|STARTED|Dosing Period||9
10708165|NCT02628028|11873009|FG001|STARTED|Dosing Period||9
10708166|NCT02628028|11873010|FG002|STARTED|Dosing Period||10
10708167|NCT02628028|11873011|FG003|STARTED|Dosing Period||8
10708168|NCT02628028|11873012|FG004|STARTED|Dosing Period||62
10708169|NCT02628028|11873013|FG005|STARTED|Dosing Period||63
10708170|NCT02628028|11873014|FG006|STARTED|Dosing Period||62
10708171|NCT02628028|11873015|FG007|STARTED|Dosing Period||63
10708172|NCT02628028|11873008|FG000|Received at Least 1dose of Study Drug|Dosing Period||9
10708173|NCT02628028|11873009|FG001|Received at Least 1dose of Study Drug|Dosing Period||9
10708174|NCT02628028|11873010|FG002|Received at Least 1dose of Study Drug|Dosing Period||10
10708175|NCT02628028|11873011|FG003|Received at Least 1dose of Study Drug|Dosing Period||8
10708176|NCT02628028|11873012|FG004|Received at Least 1dose of Study Drug|Dosing Period||62
10708177|NCT02628028|11873013|FG005|Received at Least 1dose of Study Drug|Dosing Period||63
10708178|NCT02628028|11873014|FG006|Received at Least 1dose of Study Drug|Dosing Period||62
10708179|NCT02628028|11873015|FG007|Received at Least 1dose of Study Drug|Dosing Period||63
10708180|NCT02628028|11873008|FG000|COMPLETED|Dosing Period||9
10708181|NCT02628028|11873009|FG001|COMPLETED|Dosing Period||9
10708182|NCT02628028|11873010|FG002|COMPLETED|Dosing Period||9
10708183|NCT02628028|11873011|FG003|COMPLETED|Dosing Period||8
10708184|NCT02628028|11873012|FG004|COMPLETED|Dosing Period||46
10708185|NCT02628028|11873013|FG005|COMPLETED|Dosing Period||49
10708186|NCT02628028|11873014|FG006|COMPLETED|Dosing Period||46
10708187|NCT02628028|11873015|FG007|COMPLETED|Dosing Period||48
10708188|NCT02628028|11873008|FG000|NOT COMPLETED|Dosing Period||0
10708189|NCT02628028|11873009|FG001|NOT COMPLETED|Dosing Period||0
10708190|NCT02628028|11873010|FG002|NOT COMPLETED|Dosing Period||1
10708191|NCT02628028|11873011|FG003|NOT COMPLETED|Dosing Period||0
10708192|NCT02628028|11873012|FG004|NOT COMPLETED|Dosing Period||16
10708193|NCT02628028|11873013|FG005|NOT COMPLETED|Dosing Period||14
10708194|NCT02628028|11873014|FG006|NOT COMPLETED|Dosing Period||16
10708195|NCT02628028|11873015|FG007|NOT COMPLETED|Dosing Period||15
10708196|NCT02628028|11873008|FG000|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
10708197|NCT02628028|11873009|FG001|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
10708198|NCT02628028|11873010|FG002|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
10708199|NCT02628028|11873011|FG003|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
10708200|NCT02628028|11873012|FG004|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;42 participants completed part B placebo period,re-randomized to LTE period.|0
10708201|NCT02628028|11873013|FG005|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;14 participants completed part B placebo period,re-randomized to LTE period.|61
10708202|NCT02628028|11873014|FG006|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;14 participants completed part B placebo period,re-randomized to LTE period.|58
10708203|NCT02628028|11873015|FG007|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;14 participants completed part B placebo period,re-randomized to LTE period.|61
10708204|NCT02628028|11873008|FG000|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
10708205|NCT02628028|11873009|FG001|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
10708206|NCT02628028|11873010|FG002|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
10708207|NCT02628028|11873011|FG003|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
10708208|NCT02628028|11873012|FG004|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
10708209|NCT02628028|11873013|FG005|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||14
10708210|NCT02628028|11873014|FG006|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||14
10708211|NCT02628028|11873015|FG007|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||14
10708212|NCT02628028|11873008|FG000|COMPLETED|Long-term Extension (LTE) Period||0
10708213|NCT02628028|11873009|FG001|COMPLETED|Long-term Extension (LTE) Period||0
10708214|NCT02628028|11873010|FG002|COMPLETED|Long-term Extension (LTE) Period||0
10708215|NCT02628028|11873011|FG003|COMPLETED|Long-term Extension (LTE) Period||0
10708216|NCT02628028|11873012|FG004|COMPLETED|Long-term Extension (LTE) Period||0
10708217|NCT02628028|11873013|FG005|COMPLETED|Long-term Extension (LTE) Period||1
10708218|NCT02628028|11873014|FG006|COMPLETED|Long-term Extension (LTE) Period||0
10713949|NCT02683746|11879498|FG001|NOT COMPLETED|Overall Study||14
10337907|NCT00366678|11474734|FG001|Vaccinated Dose 1|Infant Series||309
10337908|NCT00366678|11474735|FG002|Vaccinated Dose 1|Infant Series||0
10337909|NCT00366678|11474733|FG000|Vaccinated Dose 2|Infant Series||295
10337910|NCT00366678|11474734|FG001|Vaccinated Dose 2|Infant Series||304
10337911|NCT00366678|11474735|FG002|Vaccinated Dose 2|Infant Series||0
10337912|NCT00366678|11474733|FG000|Vaccinated Dose 3|Infant Series||291
10337913|NCT00366678|11474734|FG001|Vaccinated Dose 3|Infant Series||302
10337914|NCT00366678|11474735|FG002|Vaccinated Dose 3|Infant Series||0
10337915|NCT00366678|11474733|FG000|COMPLETED|Infant Series||290
10337916|NCT00366678|11474734|FG001|COMPLETED|Infant Series||299
10337917|NCT00366678|11474735|FG002|COMPLETED|Infant Series||0
10337918|NCT00366678|11474733|FG000|NOT COMPLETED|Infant Series||14
10337919|NCT00366678|11474734|FG001|NOT COMPLETED|Infant Series||10
10337920|NCT00366678|11474735|FG002|NOT COMPLETED|Infant Series||0
10337921|NCT00366678|11474733|FG000|STARTED|After Infant||290
10337922|NCT00366678|11474734|FG001|STARTED|After Infant||299
10337923|NCT00366678|11474735|FG002|STARTED|After Infant||0
10337924|NCT00366678|11474733|FG000|COMPLETED|After Infant||273
10337925|NCT00366678|11474734|FG001|COMPLETED|After Infant||289
10337926|NCT00366678|11474735|FG002|COMPLETED|After Infant||0
10337927|NCT00366678|11474733|FG000|NOT COMPLETED|After Infant||17
10337928|NCT00366678|11474734|FG001|NOT COMPLETED|After Infant||10
10337929|NCT00366678|11474735|FG002|NOT COMPLETED|After Infant||0
10337930|NCT00366678|11474733|FG000|STARTED|Toddler Dose||273
10337931|NCT00366678|11474734|FG001|STARTED|Toddler Dose||152
10337932|NCT00366678|11474735|FG002|STARTED|Toddler Dose||137
10337933|NCT00366678|11474733|FG000|COMPLETED|Toddler Dose||268
10337934|NCT00366678|11474734|FG001|COMPLETED|Toddler Dose||151
10337935|NCT00366678|11474735|FG002|COMPLETED|Toddler Dose||137
10337936|NCT00366678|11474733|FG000|NOT COMPLETED|Toddler Dose||5
10337937|NCT00366678|11474734|FG001|NOT COMPLETED|Toddler Dose||1
10337938|NCT00366678|11474735|FG002|NOT COMPLETED|Toddler Dose||0
10337939|NCT00366899|11474782|FG000|STARTED|Infant Series|1 participant was counted twice, 1 participant randomized to 13vPnC, incorrectly received 7vPnC|303
10339217|NCT00371566|11476129|FG000|STARTED|Chemoradiation Phase||36
10337940|NCT00366899|11474783|FG001|STARTED|Infant Series|1 participant randomized to 7vPnC but never vaccinated|303
10337941|NCT00366899|11474782|FG000|Vaccinated Dose 1|Infant Series|2 participants randomized to 13vPnC, incorrectly received 7vPnC|302
10337942|NCT00366899|11474783|FG001|Vaccinated Dose 1|Infant Series||302
10337943|NCT00366899|11474782|FG000|Vaccinated Dose 2|Infant Series|1 participant randomized to 13vPnC, incorrectly received 7vPnC|296
10337944|NCT00366899|11474783|FG001|Vaccinated Dose 2|Infant Series||293
10337945|NCT00366899|11474782|FG000|COMPLETED|Infant Series||294
10337946|NCT00366899|11474783|FG001|COMPLETED|Infant Series||291
10337947|NCT00366899|11474782|FG000|NOT COMPLETED|Infant Series||9
10337948|NCT00366899|11474783|FG001|NOT COMPLETED|Infant Series||12
10337949|NCT00366899|11474782|FG000|STARTED|After Infant Series||294
10337950|NCT00366899|11474783|FG001|STARTED|After Infant Series||291
10337951|NCT00366899|11474782|FG000|COMPLETED|After Infant Series||287
10337952|NCT00366899|11474783|FG001|COMPLETED|After Infant Series||282
10337953|NCT00366899|11474782|FG000|NOT COMPLETED|After Infant Series||7
10337954|NCT00366899|11474783|FG001|NOT COMPLETED|After Infant Series||9
10337955|NCT00366899|11474782|FG000|STARTED|Toddler Dose||287
10337956|NCT00366899|11474783|FG001|STARTED|Toddler Dose||282
10337957|NCT00366899|11474782|FG000|COMPLETED|Toddler Dose||285
10337958|NCT00366899|11474783|FG001|COMPLETED|Toddler Dose||281
10337959|NCT00366899|11474782|FG000|NOT COMPLETED|Toddler Dose||2
10337960|NCT00366899|11474783|FG001|NOT COMPLETED|Toddler Dose||1
10337961|NCT00367016|11474817|FG000|STARTED|Overall Study||3
10337962|NCT00367016|11474818|FG001|STARTED|Overall Study||3
10337963|NCT00367016|11474817|FG000|First Intervention|Overall Study||3
10337964|NCT00367016|11474818|FG001|First Intervention|Overall Study||3
10337965|NCT00367016|11474817|FG000|Second Intervention|Overall Study||3
10337966|NCT00367016|11474818|FG001|Second Intervention|Overall Study||3
10337967|NCT00367016|11474817|FG000|COMPLETED|Overall Study||3
10337968|NCT00367016|11474818|FG001|COMPLETED|Overall Study||3
10337969|NCT00367016|11474817|FG000|NOT COMPLETED|Overall Study||0
10337970|NCT00367016|11474818|FG001|NOT COMPLETED|Overall Study||0
10337971|NCT00367055|11474828|FG000|STARTED|Overall Study||43
10337972|NCT00367055|11474829|FG001|STARTED|Overall Study||41
10337973|NCT00367055|11474828|FG000|COMPLETED|Overall Study||32
10337974|NCT00367055|11474829|FG001|COMPLETED|Overall Study||30
10337975|NCT00367055|11474828|FG000|NOT COMPLETED|Overall Study||11
10337976|NCT00367055|11474829|FG001|NOT COMPLETED|Overall Study||11
10337977|NCT00367133|11474838|FG000|STARTED|2 Years|Number of Eyes|330
10337978|NCT00367133|11474839|FG001|STARTED|2 Years|Number of Eyes|256
10337979|NCT00367133|11474840|FG002|STARTED|2 Years|Number of Eyes|254
10337980|NCT00367133|11474838|FG000|COMPLETED|2 Years||272
10337981|NCT00367133|11474839|FG001|COMPLETED|2 Years||220
10337982|NCT00367133|11474840|FG002|COMPLETED|2 Years||205
10337983|NCT00367133|11474838|FG000|NOT COMPLETED|2 Years||58
10337984|NCT00367133|11474839|FG001|NOT COMPLETED|2 Years||36
10337985|NCT00367133|11474840|FG002|NOT COMPLETED|2 Years||49
10337986|NCT00367133|11474838|FG000|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|143
10337987|NCT00367133|11474839|FG001|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|116
10337988|NCT00367133|11474840|FG002|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|116
10337989|NCT00367133|11474838|FG000|COMPLETED|3 Years||115
10337990|NCT00367133|11474839|FG001|COMPLETED|3 Years||93
10337991|NCT00367133|11474840|FG002|COMPLETED|3 Years||98
10337992|NCT00367133|11474838|FG000|NOT COMPLETED|3 Years||28
10337993|NCT00367133|11474839|FG001|NOT COMPLETED|3 Years||23
10337994|NCT00367133|11474840|FG002|NOT COMPLETED|3 Years||18
10337995|NCT00367237|11474850|FG000|STARTED|Overall Study|Number of subjects randomized|57
10337996|NCT00367237|11474851|FG001|STARTED|Overall Study|Number of subjects randomized|58
10337997|NCT00367237|11474850|FG000|COMPLETED|Overall Study||47
10337998|NCT00367237|11474851|FG001|COMPLETED|Overall Study||47
10337999|NCT00367237|11474850|FG000|NOT COMPLETED|Overall Study||10
10338000|NCT00367237|11474851|FG001|NOT COMPLETED|Overall Study||11
10338001|NCT00367341|11474859|FG000|STARTED|Overall Study||42
10338002|NCT00367341|11474860|FG001|STARTED|Overall Study||40
10338003|NCT00367341|11474859|FG000|COMPLETED|Overall Study||40
10338004|NCT00367341|11474860|FG001|COMPLETED|Overall Study||40
10338005|NCT00367341|11474859|FG000|NOT COMPLETED|Overall Study||2
10338006|NCT00367341|11474860|FG001|NOT COMPLETED|Overall Study||0
10338007|NCT00367380|11474869|FG000|STARTED|Overall Study||6
10338008|NCT00367380|11474870|FG001|STARTED|Overall Study||6
10338009|NCT00367380|11474871|FG002|STARTED|Overall Study||6
10338010|NCT00367380|11474869|FG000|COMPLETED|Overall Study||6
10338011|NCT00367380|11474870|FG001|COMPLETED|Overall Study||6
10338012|NCT00367380|11474871|FG002|COMPLETED|Overall Study||6
10338013|NCT00367380|11474869|FG000|NOT COMPLETED|Overall Study||0
10338014|NCT00367380|11474870|FG001|NOT COMPLETED|Overall Study||0
10338015|NCT00367380|11474871|FG002|NOT COMPLETED|Overall Study||0
10338016|NCT00367432|11474879|FG000|STARTED|First Period (16 Weeks)|Eligible subjects from preceding study N01221 [NCT00280696] entered the First Period of N01222|313
10338017|NCT00367432|11474880|FG001|STARTED|First Period (16 Weeks)||0
10338018|NCT00367432|11474879|FG000|COMPLETED|First Period (16 Weeks)||275
10338019|NCT00367432|11474880|FG001|COMPLETED|First Period (16 Weeks)||0
10338020|NCT00367432|11474879|FG000|NOT COMPLETED|First Period (16 Weeks)||38
10338021|NCT00367432|11474880|FG001|NOT COMPLETED|First Period (16 Weeks)||0
10338022|NCT00367432|11474879|FG000|STARTED|Second Period (up to 54 Months)|275 subjects from N01221 [NCT00280696] completed First Period and entered Second Period of N01222|275
10339218|NCT00371566|11476130|FG001|STARTED|Chemoradiation Phase||68
10338023|NCT00367432|11474880|FG001|STARTED|Second Period (up to 54 Months)|85 subjects from N01020 [NCT00160615] entered Second Period of N01222|85
10338024|NCT00367432|11474879|FG000|COMPLETED|Second Period (up to 54 Months)||188
10338025|NCT00367432|11474880|FG001|COMPLETED|Second Period (up to 54 Months)||69
10338026|NCT00367432|11474879|FG000|NOT COMPLETED|Second Period (up to 54 Months)||87
10338027|NCT00367432|11474880|FG001|NOT COMPLETED|Second Period (up to 54 Months)||16
10338028|NCT00367458|11474886|FG000|STARTED|First Intervention - 8 Weeks||12
10338029|NCT00367458|11474887|FG001|STARTED|First Intervention - 8 Weeks||12
10338030|NCT00367458|11474886|FG000|COMPLETED|First Intervention - 8 Weeks||10
10338031|NCT00367458|11474887|FG001|COMPLETED|First Intervention - 8 Weeks||12
10338032|NCT00367458|11474886|FG000|NOT COMPLETED|First Intervention - 8 Weeks||2
10338033|NCT00367458|11474887|FG001|NOT COMPLETED|First Intervention - 8 Weeks||0
10338034|NCT00367458|11474886|FG000|STARTED|Washout Period - 4-6 Weeks||10
10338035|NCT00367458|11474887|FG001|STARTED|Washout Period - 4-6 Weeks||12
10338036|NCT00367458|11474886|FG000|COMPLETED|Washout Period - 4-6 Weeks||10
10338037|NCT00367458|11474887|FG001|COMPLETED|Washout Period - 4-6 Weeks||12
10338038|NCT00367458|11474886|FG000|NOT COMPLETED|Washout Period - 4-6 Weeks||0
10338039|NCT00367458|11474887|FG001|NOT COMPLETED|Washout Period - 4-6 Weeks||0
10338040|NCT00367458|11474886|FG000|STARTED|Second Intervention - 8 Weeks||10
10338041|NCT00367458|11474887|FG001|STARTED|Second Intervention - 8 Weeks||12
10338042|NCT00367458|11474886|FG000|COMPLETED|Second Intervention - 8 Weeks||10
10338043|NCT00367458|11474887|FG001|COMPLETED|Second Intervention - 8 Weeks||12
10338044|NCT00367458|11474886|FG000|NOT COMPLETED|Second Intervention - 8 Weeks||0
10338045|NCT00367458|11474887|FG001|NOT COMPLETED|Second Intervention - 8 Weeks||0
10338046|NCT00367484|11474893|FG000|STARTED|Overall Study||460
10338047|NCT00367484|11474893|FG000|COMPLETED|Overall Study|Safety population = 460 Intent To Treat (ITT) population = 458|443
10338048|NCT00367484|11474893|FG000|NOT COMPLETED|Overall Study||17
10338049|NCT00367601|11474897|FG000|STARTED|Overall Study||25
10338050|NCT00367601|11474897|FG000|COMPLETED|Overall Study||25
10338051|NCT00367601|11474897|FG000|NOT COMPLETED|Overall Study||0
10338052|NCT00367640|11474906|FG000|STARTED|Overall Study||157
10338053|NCT00367640|11474907|FG001|STARTED|Overall Study||155
10338054|NCT00367640|11474908|FG002|STARTED|Overall Study||160
10338055|NCT00367640|11474909|FG003|STARTED|Overall Study||156
10338056|NCT00367640|11474906|FG000|COMPLETED|Overall Study||139
10338057|NCT00367640|11474907|FG001|COMPLETED|Overall Study||133
10338058|NCT00367640|11474908|FG002|COMPLETED|Overall Study||141
10338059|NCT00367640|11474909|FG003|COMPLETED|Overall Study||146
10338060|NCT00367640|11474906|FG000|NOT COMPLETED|Overall Study||18
10338061|NCT00367640|11474907|FG001|NOT COMPLETED|Overall Study||22
10338062|NCT00367640|11474908|FG002|NOT COMPLETED|Overall Study||19
10338063|NCT00367640|11474909|FG003|NOT COMPLETED|Overall Study||10
10338064|NCT00367679|11474919|FG000|STARTED|Overall Study||35
10338065|NCT00367679|11474919|FG000|COMPLETED|Overall Study||35
10338066|NCT00367679|11474919|FG000|NOT COMPLETED|Overall Study||0
10338067|NCT00367744|11474927|FG000|STARTED|Overall Study||34
10338068|NCT00367744|11474928|FG001|STARTED|Overall Study||37
10338069|NCT00367744|11474927|FG000|COMPLETED|Overall Study||30
10338070|NCT00367744|11474928|FG001|COMPLETED|Overall Study||32
10338071|NCT00367744|11474927|FG000|NOT COMPLETED|Overall Study||4
10338072|NCT00367744|11474928|FG001|NOT COMPLETED|Overall Study||5
10338073|NCT00367770|11474935|FG000|STARTED|Overall Study||37
10338074|NCT00367770|11474935|FG000|COMPLETED|Overall Study||35
10338075|NCT00367770|11474935|FG000|NOT COMPLETED|Overall Study||2
10338076|NCT00367835|11474941|FG000|STARTED|Overall Study||138
10338077|NCT00367835|11474942|FG001|STARTED|Overall Study||79
10338078|NCT00367835|11474941|FG000|COMPLETED|Overall Study||109
10338079|NCT00367835|11474942|FG001|COMPLETED|Overall Study||48
10338080|NCT00367835|11474941|FG000|NOT COMPLETED|Overall Study||29
10338081|NCT00367835|11474942|FG001|NOT COMPLETED|Overall Study||31
10338082|NCT00367991|11474950|FG000|STARTED|Overall Study||29
10338083|NCT00367991|11474951|FG001|STARTED|Overall Study||15
10338084|NCT00367991|11474950|FG000|COMPLETED|Overall Study||27
10338085|NCT00367991|11474951|FG001|COMPLETED|Overall Study||13
10338086|NCT00367991|11474950|FG000|NOT COMPLETED|Overall Study||2
10338087|NCT00367991|11474951|FG001|NOT COMPLETED|Overall Study||2
10338088|NCT00368069|11474959|FG000|STARTED|Overall Study||79
10338089|NCT00368069|11474960|FG001|STARTED|Overall Study||79
10338090|NCT00368069|11474959|FG000|COMPLETED|Overall Study||71
10338091|NCT00368069|11474960|FG001|COMPLETED|Overall Study||72
10338092|NCT00368069|11474959|FG000|NOT COMPLETED|Overall Study||8
10338093|NCT00368069|11474960|FG001|NOT COMPLETED|Overall Study||7
10338094|NCT00368108|11474969|FG000|STARTED|Overall Study|One subject had stopped medication prior to notifying staff. Remaining results will have 250.|251
10338095|NCT00368108|11474970|FG001|STARTED|Overall Study||251
10338096|NCT00368108|11474971|FG002|STARTED|Overall Study||250
10338097|NCT00368108|11474969|FG000|COMPLETED|Overall Study||187
10338098|NCT00368108|11474970|FG001|COMPLETED|Overall Study||198
10338099|NCT00368108|11474971|FG002|COMPLETED|Overall Study||182
10338100|NCT00368108|11474969|FG000|NOT COMPLETED|Overall Study||64
10338101|NCT00368108|11474970|FG001|NOT COMPLETED|Overall Study||53
10338102|NCT00368108|11474971|FG002|NOT COMPLETED|Overall Study||68
10338103|NCT00368251|11474982|FG000|STARTED|Overall Study||18
10338104|NCT00368251|11474983|FG001|STARTED|Overall Study||20
10338105|NCT00368251|11474984|FG002|STARTED|Overall Study||18
10338106|NCT00368251|11474982|FG000|COMPLETED|Overall Study||17
10338107|NCT00368251|11474983|FG001|COMPLETED|Overall Study||20
10338108|NCT00368251|11474984|FG002|COMPLETED|Overall Study||17
10338109|NCT00368251|11474982|FG000|NOT COMPLETED|Overall Study||1
10338110|NCT00368251|11474983|FG001|NOT COMPLETED|Overall Study||0
10338111|NCT00368251|11474984|FG002|NOT COMPLETED|Overall Study||1
10338112|NCT00368277|11474994|FG000|STARTED|Overall Study||457
10338113|NCT00368277|11474995|FG001|STARTED|Overall Study||444
10338114|NCT00368277|11474994|FG000|COMPLETED|Overall Study||344
10338115|NCT00368277|11474995|FG001|COMPLETED|Overall Study||336
10338116|NCT00368277|11474994|FG000|NOT COMPLETED|Overall Study||113
10338117|NCT00368277|11474995|FG001|NOT COMPLETED|Overall Study||108
10338118|NCT00368290|11475003|FG000|STARTED|Overall Study||47
10338119|NCT00368290|11475004|FG001|STARTED|Overall Study||47
10338120|NCT00368290|11475003|FG000|COMPLETED|Overall Study||34
10338121|NCT00368290|11475004|FG001|COMPLETED|Overall Study||37
10338122|NCT00368290|11475003|FG000|NOT COMPLETED|Overall Study||13
10338123|NCT00368290|11475004|FG001|NOT COMPLETED|Overall Study||10
10338124|NCT00368316|11475012|FG000|STARTED|Overall Study||1434
10338125|NCT00368316|11475013|FG001|STARTED|Overall Study||1365
10338126|NCT00368316|11475012|FG000|COMPLETED|Overall Study||1392
10338127|NCT00368316|11475013|FG001|COMPLETED|Overall Study||1319
10338128|NCT00368316|11475012|FG000|NOT COMPLETED|Overall Study||42
10338129|NCT00368316|11475013|FG001|NOT COMPLETED|Overall Study||46
10338130|NCT00368355|11475021|FG000|STARTED|Overall Study||18
10338131|NCT00368355|11475022|FG001|STARTED|Overall Study||28
10338132|NCT00368355|11475021|FG000|COMPLETED|Overall Study||7
10338133|NCT00368355|11475022|FG001|COMPLETED|Overall Study||11
10338134|NCT00368355|11475021|FG000|NOT COMPLETED|Overall Study||11
10338135|NCT00368355|11475022|FG001|NOT COMPLETED|Overall Study||17
10338136|NCT00368459|11475030|FG000|STARTED|Overall Study||21
10338137|NCT00368459|11475031|FG001|STARTED|Overall Study||21
10338138|NCT00368459|11475030|FG000|COMPLETED|Overall Study||19
10338139|NCT00368459|11475031|FG001|COMPLETED|Overall Study||20
10338140|NCT00368459|11475030|FG000|NOT COMPLETED|Overall Study||2
10338141|NCT00368459|11475031|FG001|NOT COMPLETED|Overall Study||1
10338142|NCT00368472|11475037|FG000|STARTED|Overall Study||138
10338143|NCT00368472|11475037|FG000|COMPLETED|Overall Study||33
10338144|NCT00368472|11475037|FG000|NOT COMPLETED|Overall Study||105
10338145|NCT00368537|11475043|FG000|STARTED|Randomization||281
10338146|NCT00368537|11475044|FG001|STARTED|Randomization||269
10338147|NCT00368537|11475043|FG000|COMPLETED|Randomization||268
10338148|NCT00368537|11475044|FG001|COMPLETED|Randomization||263
10457951|NCT01012973|11605759|FG001|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) Population: Participants received treatment with post baseline measurements|68
10457952|NCT01012973|11605758|FG000|Completed Week 24, From FAS|Overall Study||97
10457953|NCT01012973|11605759|FG001|Completed Week 24, From FAS|Overall Study||57
10457954|NCT01012973|11605758|FG000|Completed Week 52, From FAS|Overall Study||91
10457955|NCT01012973|11605759|FG001|Completed Week 52, From FAS|Overall Study||52
10457956|NCT01012973|11605758|FG000|COMPLETED|Overall Study||90
10457957|NCT01012973|11605759|FG001|COMPLETED|Overall Study||52
10457958|NCT01012973|11605758|FG000|NOT COMPLETED|Overall Study||16
10457959|NCT01012973|11605759|FG001|NOT COMPLETED|Overall Study||19
10457960|NCT01012999|11605769|FG000|STARTED|Overall Study||16
10457961|NCT01012999|11605769|FG000|COMPLETED|Overall Study||15
10457962|NCT01012999|11605769|FG000|NOT COMPLETED|Overall Study||1
10457963|NCT01013194|11605775|FG000|STARTED|Overall Study||9
10457964|NCT01013194|11605776|FG001|STARTED|Overall Study||16
10457965|NCT01013194|11605775|FG000|COMPLETED|Overall Study|Consecutive patients|9
10457966|NCT01013194|11605776|FG001|COMPLETED|Overall Study|Retrospectively contemporary matched-pair group|16
10457967|NCT01013194|11605775|FG000|NOT COMPLETED|Overall Study||0
10457968|NCT01013194|11605776|FG001|NOT COMPLETED|Overall Study||0
10457969|NCT01013207|11605786|FG000|STARTED|CPAP Pre Nexus (S9)||50
10457970|NCT01013207|11605786|FG000|COMPLETED|CPAP Pre Nexus (S9)||50
10457971|NCT01013207|11605786|FG000|NOT COMPLETED|CPAP Pre Nexus (S9)||0
10457972|NCT01013207|11605786|FG000|STARTED|Nexus (S9)||50
10457973|NCT01013207|11605786|FG000|COMPLETED|Nexus (S9)||50
10457974|NCT01013207|11605786|FG000|NOT COMPLETED|Nexus (S9)||0
10457975|NCT01013207|11605786|FG000|STARTED|CPAP Post Nexus (S9)||50
10457976|NCT01013207|11605786|FG000|COMPLETED|CPAP Post Nexus (S9)||44
10809607|NCT03831191|11971469|FG000|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
10809608|NCT03831191|11971470|FG001|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
10809609|NCT03831191|11971471|FG002|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
10809610|NCT03831191|11971472|FG003|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
10809611|NCT03831191|11971473|FG004|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|4
10809612|NCT03831191|11971474|FG005|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|5
10811212|NCT03770091|11972930|FG002|NOT COMPLETED|Overall Study||0
10338149|NCT00368537|11475043|FG000|NOT COMPLETED|Randomization||13
10338150|NCT00368537|11475044|FG001|NOT COMPLETED|Randomization||6
10457977|NCT01013207|11605786|FG000|NOT COMPLETED|CPAP Post Nexus (S9)||6
10338151|NCT00368537|11475043|FG000|STARTED|Baseline Participants||268
10338152|NCT00368537|11475044|FG001|STARTED|Baseline Participants||263
10338153|NCT00368537|11475043|FG000|COMPLETED|Baseline Participants||244
10338154|NCT00368537|11475044|FG001|COMPLETED|Baseline Participants||239
10338155|NCT00368537|11475043|FG000|NOT COMPLETED|Baseline Participants||24
10457978|NCT01013285|11605792|FG000|STARTED|Overall Study||70
10457979|NCT01013285|11605793|FG001|STARTED|Overall Study||110
10457980|NCT01013285|11605792|FG000|COMPLETED|Overall Study||22
10457981|NCT01013285|11605793|FG001|COMPLETED|Overall Study||21
10457982|NCT01013285|11605792|FG000|NOT COMPLETED|Overall Study||48
10457983|NCT01013285|11605793|FG001|NOT COMPLETED|Overall Study||89
10457984|NCT01013350|11605800|FG000|STARTED|Overall Study||198
10457985|NCT01013350|11605801|FG001|STARTED|Overall Study||963
10457986|NCT01013350|11605800|FG000|Safety Analysis Set|Overall Study||198
10457987|NCT01013350|11605801|FG001|Safety Analysis Set|Overall Study||950
10457988|NCT01013350|11605800|FG000|COMPLETED|Overall Study||160
10457989|NCT01013350|11605801|FG001|COMPLETED|Overall Study||771
10457990|NCT01013350|11605800|FG000|NOT COMPLETED|Overall Study||38
10457991|NCT01013350|11605801|FG001|NOT COMPLETED|Overall Study||192
10457992|NCT01013597|11605808|FG000|STARTED|Overall Study||13
10457993|NCT01013597|11605808|FG000|COMPLETED|Overall Study||12
10457994|NCT01013597|11605808|FG000|NOT COMPLETED|Overall Study||1
10457995|NCT01013740|11605814|FG000|STARTED|Overall Study|13 participants (par.) experiencing PD in the RP elected to enroll in the optional CP.|37
10457996|NCT01013740|11605815|FG001|STARTED|Overall Study|29 participants experiencing PD in the RP elected to enroll in the optional CP.|75
10457997|NCT01013740|11605814|FG000|Ongoing|Overall Study||0
10457998|NCT01013740|11605815|FG001|Ongoing|Overall Study||0
10457999|NCT01013740|11605814|FG000|COMPLETED|Overall Study|Completion also = 18 mos.of a new anti-cancer therapy initiation +/or progression of disease|26
10458000|NCT01013740|11605815|FG001|COMPLETED|Overall Study|Completion also = 18 mos.of a new anti-cancer therapy initiation +/or progression of disease|56
10458001|NCT01013740|11605814|FG000|NOT COMPLETED|Overall Study||11
10458002|NCT01013740|11605815|FG001|NOT COMPLETED|Overall Study||19
10458003|NCT01013753|11605823|FG000|STARTED|Overall Study|Entered and treated|198
10458004|NCT01013753|11605823|FG000|Received Placebo|Overall Study||125
10458005|NCT01013753|11605823|FG000|Received Olo 2 mcg qd|Overall Study||121
10458006|NCT01013753|11605823|FG000|Received Olo 5 mcg qd|Overall Study||130
10458007|NCT01013753|11605823|FG000|Received Olo 10 mcg qd|Overall Study||127
10458008|NCT01013753|11605823|FG000|Received Olo 20 mcg qd|Overall Study||124
10458009|NCT01013753|11605823|FG000|Received Form 12 mcg Bid|Overall Study||125
10458010|NCT01013753|11605823|FG000|COMPLETED|Overall Study||182
10458011|NCT01013753|11605823|FG000|NOT COMPLETED|Overall Study||16
10458012|NCT01013792|11605839|FG000|STARTED|Overall Study||14
10458013|NCT01013792|11605840|FG001|STARTED|Overall Study||16
10458014|NCT01013792|11605839|FG000|COMPLETED|Overall Study||12
10458015|NCT01013792|11605840|FG001|COMPLETED|Overall Study||11
10458016|NCT01013792|11605839|FG000|NOT COMPLETED|Overall Study||2
10458017|NCT01013792|11605840|FG001|NOT COMPLETED|Overall Study||5
10458018|NCT01013844|11605848|FG000|STARTED|Overall Study||65
10458019|NCT01013844|11605849|FG001|STARTED|Overall Study||65
10458020|NCT01013844|11605848|FG000|COMPLETED|Overall Study||65
10458021|NCT01013844|11605849|FG001|COMPLETED|Overall Study||65
10458022|NCT01013844|11605848|FG000|NOT COMPLETED|Overall Study||0
10458023|NCT01013844|11605849|FG001|NOT COMPLETED|Overall Study||0
10458024|NCT01013870|11605861|FG000|STARTED|Overall Study||28
10458025|NCT01013870|11605862|FG001|STARTED|Overall Study||24
10458026|NCT01013870|11605861|FG000|COMPLETED|Overall Study||27
10458027|NCT01013870|11605862|FG001|COMPLETED|Overall Study||21
10458028|NCT01013870|11605861|FG000|NOT COMPLETED|Overall Study||1
10458029|NCT01013870|11605862|FG001|NOT COMPLETED|Overall Study||3
10458030|NCT01013883|11605870|FG000|STARTED|Overall Study||270
10458031|NCT01013883|11605871|FG001|STARTED|Overall Study||243
10458032|NCT01013883|11605870|FG000|COMPLETED|Overall Study||268
10458033|NCT01013883|11605871|FG001|COMPLETED|Overall Study||241
10458034|NCT01013883|11605870|FG000|NOT COMPLETED|Overall Study||2
10458035|NCT01013883|11605871|FG001|NOT COMPLETED|Overall Study||2
10458036|NCT01013961|11605879|FG000|STARTED|Overall Study||16
10458037|NCT01013961|11605880|FG001|STARTED|Overall Study||15
10458038|NCT01013961|11605879|FG000|COMPLETED|Overall Study||13
10458039|NCT01013961|11605880|FG001|COMPLETED|Overall Study||12
10458040|NCT01013961|11605879|FG000|NOT COMPLETED|Overall Study||3
10458041|NCT01013961|11605880|FG001|NOT COMPLETED|Overall Study||3
10458042|NCT01014013|11605888|FG000|STARTED|Overall Study||135
10458043|NCT01014013|11605889|FG001|STARTED|Overall Study||136
10458044|NCT01014013|11605888|FG000|Adverse Event Reporting|Overall Study|Patients who received at least 1 dose of MK0826 parenteral therapy|132
10458045|NCT01014013|11605889|FG001|Adverse Event Reporting|Overall Study|Patients who received at least 1 dose of Ceftriaxone parenteral therapy|135
10458046|NCT01014013|11605888|FG000|Completed Parenteral Therapy|Overall Study|"Patients completing MK0826 as a single daily dose of 1.0g intravenous~infusion at least 3 days"|87
10458047|NCT01014013|11605889|FG001|Completed Parenteral Therapy|Overall Study|Patients completing Ceftriaxone as a single daily dose of 2.0g intravenous infusion at least 3 days|88
10458048|NCT01014013|11605888|FG000|COMPLETED|Overall Study|Patients who completed 7 days therapy including minimum 3 days of MK0826 parentheral therapy|84
10458049|NCT01014013|11605889|FG001|COMPLETED|Overall Study|Patients who completed 7 days therapy including minimum 3 days of Ceftriaxone parentheral therapy|80
10458050|NCT01014013|11605888|FG000|NOT COMPLETED|Overall Study||51
10458051|NCT01014013|11605889|FG001|NOT COMPLETED|Overall Study||56
10458052|NCT01014091|11605903|FG000|STARTED|Overall Study||7
10458053|NCT01014091|11605904|FG001|STARTED|Overall Study||13
10458054|NCT01014091|11605905|FG002|STARTED|Overall Study||5
10458055|NCT01014091|11605906|FG003|STARTED|Overall Study||15
10458056|NCT01014091|11605907|FG004|STARTED|Overall Study||6
10458057|NCT01014091|11605908|FG005|STARTED|Overall Study||12
10458058|NCT01014091|11605903|FG000|COMPLETED|Overall Study||7
10458059|NCT01014091|11605904|FG001|COMPLETED|Overall Study||13
10458060|NCT01014091|11605905|FG002|COMPLETED|Overall Study||5
10458061|NCT01014091|11605906|FG003|COMPLETED|Overall Study||15
10458062|NCT01014091|11605907|FG004|COMPLETED|Overall Study||6
10458063|NCT01014091|11605908|FG005|COMPLETED|Overall Study||12
10458064|NCT01014091|11605903|FG000|NOT COMPLETED|Overall Study||0
10458065|NCT01014091|11605904|FG001|NOT COMPLETED|Overall Study||0
10458066|NCT01014091|11605905|FG002|NOT COMPLETED|Overall Study||0
10458067|NCT01014091|11605906|FG003|NOT COMPLETED|Overall Study||0
10458068|NCT01014091|11605907|FG004|NOT COMPLETED|Overall Study||0
10458069|NCT01014091|11605908|FG005|NOT COMPLETED|Overall Study||0
10458070|NCT01014143|11605934|FG000|STARTED|First Intervention||10
10458071|NCT01014143|11605935|FG001|STARTED|First Intervention||9
10458072|NCT01014143|11605936|FG002|STARTED|First Intervention||9
10458073|NCT01014143|11605934|FG000|COMPLETED|First Intervention||10
10458074|NCT01014143|11605935|FG001|COMPLETED|First Intervention||9
10458075|NCT01014143|11605936|FG002|COMPLETED|First Intervention||9
10458076|NCT01014143|11605934|FG000|NOT COMPLETED|First Intervention||0
10458077|NCT01014143|11605935|FG001|NOT COMPLETED|First Intervention||0
10458078|NCT01014143|11605936|FG002|NOT COMPLETED|First Intervention||0
10458079|NCT01014143|11605934|FG000|STARTED|Washout Period After 1st Intervention||10
10458080|NCT01014143|11605935|FG001|STARTED|Washout Period After 1st Intervention||9
10458081|NCT01014143|11605936|FG002|STARTED|Washout Period After 1st Intervention||9
10458082|NCT01014143|11605934|FG000|COMPLETED|Washout Period After 1st Intervention||10
10458083|NCT01014143|11605935|FG001|COMPLETED|Washout Period After 1st Intervention||9
10458084|NCT01014143|11605936|FG002|COMPLETED|Washout Period After 1st Intervention||9
10458085|NCT01014143|11605934|FG000|NOT COMPLETED|Washout Period After 1st Intervention||0
10458086|NCT01014143|11605935|FG001|NOT COMPLETED|Washout Period After 1st Intervention||0
10458087|NCT01014143|11605936|FG002|NOT COMPLETED|Washout Period After 1st Intervention||0
10458088|NCT01014143|11605934|FG000|STARTED|Second Intervention||10
10458089|NCT01014143|11605935|FG001|STARTED|Second Intervention||9
10458090|NCT01014143|11605936|FG002|STARTED|Second Intervention||9
10458091|NCT01014143|11605934|FG000|COMPLETED|Second Intervention||8
10458092|NCT01014143|11605935|FG001|COMPLETED|Second Intervention||9
10458093|NCT01014143|11605936|FG002|COMPLETED|Second Intervention||9
10458094|NCT01014143|11605934|FG000|NOT COMPLETED|Second Intervention||2
10458095|NCT01014143|11605935|FG001|NOT COMPLETED|Second Intervention||0
10458096|NCT01014143|11605936|FG002|NOT COMPLETED|Second Intervention||0
10458097|NCT01014143|11605934|FG000|STARTED|Washout After 2nd Intervention||8
10458098|NCT01014143|11605935|FG001|STARTED|Washout After 2nd Intervention||9
10458099|NCT01014143|11605936|FG002|STARTED|Washout After 2nd Intervention||9
10458100|NCT01014143|11605934|FG000|COMPLETED|Washout After 2nd Intervention||8
10458101|NCT01014143|11605935|FG001|COMPLETED|Washout After 2nd Intervention||9
10458102|NCT01014143|11605936|FG002|COMPLETED|Washout After 2nd Intervention||9
10458103|NCT01014143|11605934|FG000|NOT COMPLETED|Washout After 2nd Intervention||0
10458104|NCT01014143|11605935|FG001|NOT COMPLETED|Washout After 2nd Intervention||0
10458105|NCT01014143|11605936|FG002|NOT COMPLETED|Washout After 2nd Intervention||0
10458106|NCT01014143|11605934|FG000|STARTED|Third Intervention||8
10458107|NCT01014143|11605935|FG001|STARTED|Third Intervention||9
10458108|NCT01014143|11605936|FG002|STARTED|Third Intervention||9
10458109|NCT01014143|11605934|FG000|COMPLETED|Third Intervention||8
10458110|NCT01014143|11605935|FG001|COMPLETED|Third Intervention||9
10458111|NCT01014143|11605936|FG002|COMPLETED|Third Intervention||9
10458112|NCT01014143|11605934|FG000|NOT COMPLETED|Third Intervention||0
10458113|NCT01014143|11605935|FG001|NOT COMPLETED|Third Intervention||0
10458114|NCT01014143|11605936|FG002|NOT COMPLETED|Third Intervention||0
10458115|NCT01014169|11605946|FG000|STARTED|Overall Study||65
10458116|NCT01014169|11605947|FG001|STARTED|Overall Study||61
10458117|NCT01014169|11605946|FG000|COMPLETED|Overall Study||58
10458118|NCT01014169|11605947|FG001|COMPLETED|Overall Study||48
10458119|NCT01014169|11605946|FG000|NOT COMPLETED|Overall Study||7
10458120|NCT01014169|11605947|FG001|NOT COMPLETED|Overall Study||13
10458121|NCT01014208|11605955|FG000|STARTED|Overall Study||225
10458122|NCT01014208|11605956|FG001|STARTED|Overall Study||222
10458123|NCT01014208|11605955|FG000|Intent-to-Treat Population|Overall Study||223
10458124|NCT01014208|11605956|FG001|Intent-to-Treat Population|Overall Study||222
10458125|NCT01014208|11605955|FG000|COMPLETED|Overall Study||131
10458126|NCT01014208|11605956|FG001|COMPLETED|Overall Study||122
10458127|NCT01014208|11605955|FG000|NOT COMPLETED|Overall Study||94
10458128|NCT01014208|11605956|FG001|NOT COMPLETED|Overall Study||100
10458129|NCT01014351|11605962|FG000|STARTED|Overall Study||70
10458130|NCT01014351|11605962|FG000|COMPLETED|Overall Study||33
10458131|NCT01014351|11605962|FG000|NOT COMPLETED|Overall Study||37
10458132|NCT01014390|11605966|FG000|STARTED|Overall Study||187
10458133|NCT01014390|11605966|FG000|COMPLETED|Overall Study||177
10458134|NCT01014390|11605966|FG000|NOT COMPLETED|Overall Study||10
10458135|NCT01014403|11605972|FG000|STARTED|Overall Study||34
10458136|NCT01014403|11605973|FG001|STARTED|Overall Study||28
10458137|NCT01014403|11605972|FG000|COMPLETED|Overall Study||34
10458138|NCT01014403|11605973|FG001|COMPLETED|Overall Study||28
10458139|NCT01014403|11605972|FG000|NOT COMPLETED|Overall Study||0
10458140|NCT01014403|11605973|FG001|NOT COMPLETED|Overall Study||0
10458141|NCT01014442|11605981|FG000|STARTED|Overall Study||33
10458142|NCT01014442|11605982|FG001|STARTED|Overall Study||35
10458143|NCT01014442|11605981|FG000|COMPLETED|Overall Study||26
10458144|NCT01014442|11605982|FG001|COMPLETED|Overall Study||16
10458145|NCT01014442|11605981|FG000|NOT COMPLETED|Overall Study||7
10458146|NCT01014442|11605982|FG001|NOT COMPLETED|Overall Study||19
10458147|NCT01014455|11605994|FG000|STARTED|Overall Study||82
10458148|NCT01014455|11605995|FG001|STARTED|Overall Study||87
10458149|NCT01014455|11605994|FG000|COMPLETED|Overall Study||82
10458150|NCT01014455|11605995|FG001|COMPLETED|Overall Study||87
10458151|NCT01014455|11605994|FG000|NOT COMPLETED|Overall Study||0
10458152|NCT01014455|11605995|FG001|NOT COMPLETED|Overall Study||0
10458153|NCT01014533|11606003|FG000|STARTED|Overall Study||29
10458154|NCT01014533|11606004|FG001|STARTED|Overall Study||30
10458155|NCT01014533|11606003|FG000|COMPLETED|Overall Study||24
10458156|NCT01014533|11606004|FG001|COMPLETED|Overall Study||25
10458157|NCT01014533|11606003|FG000|NOT COMPLETED|Overall Study||5
10458158|NCT01014533|11606004|FG001|NOT COMPLETED|Overall Study||5
10458159|NCT01014585|11606015|FG000|STARTED|Overall Study||51
10458160|NCT01014585|11606016|FG001|STARTED|Overall Study||100
10458161|NCT01014585|11606017|FG002|STARTED|Overall Study||60
10458162|NCT01014585|11606018|FG003|STARTED|Overall Study||129
10458163|NCT01014585|11606015|FG000|COMPLETED|Overall Study||31
10458164|NCT01014585|11606016|FG001|COMPLETED|Overall Study||75
10458165|NCT01014585|11606017|FG002|COMPLETED|Overall Study||37
10458166|NCT01014585|11606018|FG003|COMPLETED|Overall Study||99
10458167|NCT01014585|11606015|FG000|NOT COMPLETED|Overall Study||20
10458168|NCT01014585|11606016|FG001|NOT COMPLETED|Overall Study||25
10458169|NCT01014585|11606017|FG002|NOT COMPLETED|Overall Study||23
10458170|NCT01014585|11606018|FG003|NOT COMPLETED|Overall Study||30
10458171|NCT01014624|11606030|FG000|STARTED|Overall Study||29
10458172|NCT01014624|11606031|FG001|STARTED|Overall Study||27
10458173|NCT01014624|11606030|FG000|COMPLETED|Overall Study||27
10458174|NCT01014624|11606031|FG001|COMPLETED|Overall Study||26
10458175|NCT01014624|11606030|FG000|NOT COMPLETED|Overall Study||2
10458176|NCT01014624|11606031|FG001|NOT COMPLETED|Overall Study||1
10458177|NCT01014689|11606041|FG000|STARTED|Overall Study||191
10458178|NCT01014689|11606042|FG001|STARTED|Overall Study||187
10458179|NCT01014689|11606041|FG000|COMPLETED|Overall Study||178
10458180|NCT01014689|11606042|FG001|COMPLETED|Overall Study||174
10458181|NCT01014689|11606041|FG000|NOT COMPLETED|Overall Study||13
10458182|NCT01014689|11606042|FG001|NOT COMPLETED|Overall Study||13
10458183|NCT01014728|11606050|FG000|STARTED|Overall Study||18
10458184|NCT01014728|11606051|FG001|STARTED|Overall Study||15
10458185|NCT01014728|11606050|FG000|COMPLETED|Overall Study||18
10458186|NCT01014728|11606051|FG001|COMPLETED|Overall Study||15
10458187|NCT01014728|11606050|FG000|NOT COMPLETED|Overall Study||0
10458188|NCT01014728|11606051|FG001|NOT COMPLETED|Overall Study||0
10458189|NCT01014741|11606059|FG000|STARTED|Overall Study||105
10458190|NCT01014741|11606060|FG001|STARTED|Overall Study||95
10458191|NCT01014741|11606059|FG000|COMPLETED|Overall Study||94
10458192|NCT01014741|11606060|FG001|COMPLETED|Overall Study||90
10458193|NCT01014741|11606059|FG000|NOT COMPLETED|Overall Study||11
10458194|NCT01014741|11606060|FG001|NOT COMPLETED|Overall Study||5
10458195|NCT01014871|11606066|FG000|STARTED|Overall Study||30
10458196|NCT01014871|11606066|FG000|COMPLETED|Overall Study||30
10458197|NCT01014871|11606066|FG000|NOT COMPLETED|Overall Study||0
10458198|NCT01014910|11606074|FG000|STARTED|Overall Study||80
10458199|NCT01014910|11606075|FG001|STARTED|Overall Study||81
10458200|NCT01014910|11606074|FG000|COMPLETED|Overall Study||80
10458201|NCT01014910|11606075|FG001|COMPLETED|Overall Study||79
10458202|NCT01014910|11606074|FG000|NOT COMPLETED|Overall Study||0
10458203|NCT01014910|11606075|FG001|NOT COMPLETED|Overall Study||2
10458213|NCT01014975|11606152|FG000|STARTED|Overall Study||8
10458214|NCT01014975|11606153|FG001|STARTED|Overall Study||16
10458215|NCT01014975|11606154|FG002|STARTED|Overall Study||16
10458216|NCT01014975|11606152|FG000|COMPLETED|Overall Study||4
10458217|NCT01014975|11606153|FG001|COMPLETED|Overall Study||13
10458218|NCT01014975|11606154|FG002|COMPLETED|Overall Study||10
10458219|NCT01014975|11606152|FG000|NOT COMPLETED|Overall Study||4
10458220|NCT01014975|11606153|FG001|NOT COMPLETED|Overall Study||3
10458221|NCT01014975|11606154|FG002|NOT COMPLETED|Overall Study||6
10458222|NCT01014988|11606168|FG000|STARTED|Overall Study||130
10458223|NCT01014988|11606169|FG001|STARTED|Overall Study||7
10708219|NCT02628028|11873015|FG007|COMPLETED|Long-term Extension (LTE) Period||0
10708220|NCT02628028|11873008|FG000|NOT COMPLETED|Long-term Extension (LTE) Period||0
10708221|NCT02628028|11873009|FG001|NOT COMPLETED|Long-term Extension (LTE) Period||0
10708222|NCT02628028|11873010|FG002|NOT COMPLETED|Long-term Extension (LTE) Period||0
10458224|NCT01014988|11606170|FG002|STARTED|Overall Study||11
10458225|NCT01014988|11606171|FG003|STARTED|Overall Study||12
10458226|NCT01014988|11606172|FG004|STARTED|Overall Study||27
10713950|NCT02683772|11879504|FG000|STARTED|Overall Study||15
10458227|NCT01014988|11606173|FG005|STARTED|Overall Study||14
10458228|NCT01014988|11606168|FG000|COMPLETED|Overall Study||107
10458229|NCT01014988|11606169|FG001|COMPLETED|Overall Study||7
10458230|NCT01014988|11606170|FG002|COMPLETED|Overall Study||9
10458231|NCT01014988|11606171|FG003|COMPLETED|Overall Study||12
10458232|NCT01014988|11606172|FG004|COMPLETED|Overall Study||26
10458233|NCT01014988|11606173|FG005|COMPLETED|Overall Study||11
10458234|NCT01014988|11606168|FG000|NOT COMPLETED|Overall Study||23
10458235|NCT01014988|11606169|FG001|NOT COMPLETED|Overall Study||0
10458236|NCT01014988|11606170|FG002|NOT COMPLETED|Overall Study||2
10458237|NCT01014988|11606171|FG003|NOT COMPLETED|Overall Study||0
10458238|NCT01014988|11606172|FG004|NOT COMPLETED|Overall Study||1
10458239|NCT01014988|11606173|FG005|NOT COMPLETED|Overall Study||3
10458240|NCT01015118|11606197|FG000|STARTED|Overall Study||911
10458241|NCT01015118|11606198|FG001|STARTED|Overall Study||455
10458242|NCT01015118|11606197|FG000|COMPLETED|Overall Study|Patients who completed max trial therapy duration.|242
10458243|NCT01015118|11606198|FG001|COMPLETED|Overall Study|Patients who completed max trial therapy duration.|128
10458244|NCT01015118|11606197|FG000|NOT COMPLETED|Overall Study||669
10458245|NCT01015118|11606198|FG001|NOT COMPLETED|Overall Study||327
10458246|NCT01015131|11606204|FG000|STARTED|Overall Study||44
10458247|NCT01015131|11606204|FG000|COMPLETED|Overall Study||36
10458248|NCT01015131|11606204|FG000|NOT COMPLETED|Overall Study||8
10526199|NCT01380093|11678036|FG004|NOT COMPLETED|Treatment Phase: Washout Period||0
10526200|NCT01380093|11678037|FG005|NOT COMPLETED|Treatment Phase: Washout Period||0
10526201|NCT01380093|11678038|FG006|NOT COMPLETED|Treatment Phase: Washout Period||0
10526202|NCT01380093|11678039|FG007|NOT COMPLETED|Treatment Phase: Washout Period||0
10526203|NCT01380093|11678040|FG008|NOT COMPLETED|Treatment Phase: Washout Period||0
10526204|NCT01380093|11678032|FG000|STARTED|Treatment Phase: Third Intervention||0
10526205|NCT01380093|11678033|FG001|STARTED|Treatment Phase: Third Intervention||0
10526206|NCT01380093|11678034|FG002|STARTED|Treatment Phase: Third Intervention||0
10526207|NCT01380093|11678035|FG003|STARTED|Treatment Phase: Third Intervention||5
10526208|NCT01380093|11678036|FG004|STARTED|Treatment Phase: Third Intervention||6
10526209|NCT01380093|11678037|FG005|STARTED|Treatment Phase: Third Intervention||6
10526210|NCT01380093|11678038|FG006|STARTED|Treatment Phase: Third Intervention||6
10526211|NCT01380093|11678039|FG007|STARTED|Treatment Phase: Third Intervention||6
10526212|NCT01380093|11678040|FG008|STARTED|Treatment Phase: Third Intervention||6
10526213|NCT01380093|11678032|FG000|COMPLETED|Treatment Phase: Third Intervention||0
10526214|NCT01380093|11678033|FG001|COMPLETED|Treatment Phase: Third Intervention||0
10526215|NCT01380093|11678034|FG002|COMPLETED|Treatment Phase: Third Intervention||0
10526216|NCT01380093|11678035|FG003|COMPLETED|Treatment Phase: Third Intervention||5
10526217|NCT01380093|11678036|FG004|COMPLETED|Treatment Phase: Third Intervention||6
10526218|NCT01380093|11678037|FG005|COMPLETED|Treatment Phase: Third Intervention||6
10526219|NCT01380093|11678038|FG006|COMPLETED|Treatment Phase: Third Intervention||6
10526220|NCT01380093|11678039|FG007|COMPLETED|Treatment Phase: Third Intervention||6
10526221|NCT01380093|11678040|FG008|COMPLETED|Treatment Phase: Third Intervention||4
10526222|NCT01380093|11678032|FG000|NOT COMPLETED|Treatment Phase: Third Intervention||0
10526223|NCT01380093|11678033|FG001|NOT COMPLETED|Treatment Phase: Third Intervention||0
10526224|NCT01380093|11678034|FG002|NOT COMPLETED|Treatment Phase: Third Intervention||0
10526225|NCT01380093|11678035|FG003|NOT COMPLETED|Treatment Phase: Third Intervention||0
10526226|NCT01380093|11678036|FG004|NOT COMPLETED|Treatment Phase: Third Intervention||0
10526227|NCT01380093|11678037|FG005|NOT COMPLETED|Treatment Phase: Third Intervention||0
10526228|NCT01380093|11678038|FG006|NOT COMPLETED|Treatment Phase: Third Intervention||0
10526229|NCT01380093|11678039|FG007|NOT COMPLETED|Treatment Phase: Third Intervention||0
10526230|NCT01380093|11678040|FG008|NOT COMPLETED|Treatment Phase: Third Intervention||2
10526231|NCT01380106|11678056|FG000|STARTED|Overall Study||16
10526232|NCT01380106|11678057|FG001|STARTED|Overall Study||17
10526233|NCT01380106|11678056|FG000|COMPLETED|Overall Study||16
10526234|NCT01380106|11678057|FG001|COMPLETED|Overall Study||17
10526235|NCT01380106|11678056|FG000|NOT COMPLETED|Overall Study||0
10526236|NCT01380106|11678057|FG001|NOT COMPLETED|Overall Study||0
10526237|NCT01380145|11678063|FG000|STARTED|Overall Study||13
10526238|NCT01380145|11678063|FG000|COMPLETED|Overall Study||9
10526239|NCT01380145|11678063|FG000|NOT COMPLETED|Overall Study||4
10526240|NCT01380184|11678069|FG000|STARTED|Part 1 (19 Days)||15
10526241|NCT01380184|11678069|FG000|COMPLETED|Part 1 (19 Days)||14
10526242|NCT01380184|11678069|FG000|NOT COMPLETED|Part 1 (19 Days)||1
10526243|NCT01380184|11678069|FG000|STARTED|Washout Period (≥2 Days)||14
10526244|NCT01380184|11678069|FG000|COMPLETED|Washout Period (≥2 Days)||14
10526245|NCT01380184|11678069|FG000|NOT COMPLETED|Washout Period (≥2 Days)||0
10526246|NCT01380184|11678069|FG000|STARTED|Part 2||14
10526247|NCT01380184|11678069|FG000|COMPLETED|Part 2||0
10526248|NCT01380184|11678069|FG000|NOT COMPLETED|Part 2||14
10526249|NCT01380197|11678075|FG000|STARTED|Overall Study||20
10526250|NCT01380197|11678076|FG001|STARTED|Overall Study||20
10526251|NCT01380197|11678075|FG000|COMPLETED|Overall Study||20
10526252|NCT01380197|11678076|FG001|COMPLETED|Overall Study||20
10526253|NCT01380197|11678075|FG000|NOT COMPLETED|Overall Study||0
10526254|NCT01380197|11678076|FG001|NOT COMPLETED|Overall Study||0
10526255|NCT01380327|11678085|FG000|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|30
10526256|NCT01380327|11678086|FG001|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|31
10526257|NCT01380327|11678087|FG002|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|28
10526258|NCT01380327|11678085|FG000|COMPLETED|Overall Study||27
10458249|NCT01015170|11606208|FG000|STARTED|Overall Study||454
10458250|NCT01015170|11606208|FG000|COMPLETED|Overall Study||215
10458251|NCT01015170|11606208|FG000|NOT COMPLETED|Overall Study||239
10458252|NCT01015287|11606216|FG000|STARTED|Overall Study||1996
10458253|NCT01015287|11606217|FG001|STARTED|Overall Study||2037
10458254|NCT01015287|11606216|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1996
10458255|NCT01015287|11606217|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2037
10458256|NCT01015287|11606216|FG000|COMPLETED|Overall Study||1924
10458257|NCT01015287|11606217|FG001|COMPLETED|Overall Study||1958
10458258|NCT01015287|11606216|FG000|NOT COMPLETED|Overall Study||72
10458259|NCT01015287|11606217|FG001|NOT COMPLETED|Overall Study||79
10458260|NCT01015326|11606227|FG000|STARTED|Overall Study||12
10458261|NCT01015326|11606228|FG001|STARTED|Overall Study||20
10458262|NCT01015326|11606227|FG000|COMPLETED|Overall Study||11
10458263|NCT01015326|11606228|FG001|COMPLETED|Overall Study||18
10458264|NCT01015326|11606227|FG000|NOT COMPLETED|Overall Study||1
10458265|NCT01015326|11606228|FG001|NOT COMPLETED|Overall Study||2
10458266|NCT01015443|11606236|FG000|STARTED|Overall Study||191
10458267|NCT01015443|11606237|FG001|STARTED|Overall Study||94
10458268|NCT01015443|11606236|FG000|Treated|Overall Study||191
10458269|NCT01015443|11606237|FG001|Treated|Overall Study||93
10458270|NCT01015443|11606236|FG000|COMPLETED|Overall Study||191
10458271|NCT01015443|11606237|FG001|COMPLETED|Overall Study||94
10458272|NCT01015443|11606236|FG000|NOT COMPLETED|Overall Study||0
10458273|NCT01015443|11606237|FG001|NOT COMPLETED|Overall Study||0
10458274|NCT01015534|11606245|FG000|STARTED|Overall Study||28
10458275|NCT01015534|11606246|FG001|STARTED|Overall Study||27
10458276|NCT01015534|11606245|FG000|COMPLETED|Overall Study||27
10458277|NCT01015534|11606246|FG001|COMPLETED|Overall Study||27
10458278|NCT01015534|11606245|FG000|NOT COMPLETED|Overall Study||1
10458279|NCT01015534|11606246|FG001|NOT COMPLETED|Overall Study||0
10458280|NCT01015560|11606255|FG000|STARTED|Overall Study||44
10458281|NCT01015560|11606255|FG000|Eligible and Analyzable|Overall Study||43
10458282|NCT01015560|11606255|FG000|COMPLETED|Overall Study||41
10458283|NCT01015560|11606255|FG000|NOT COMPLETED|Overall Study||3
10458284|NCT01015586|11606261|FG000|STARTED|Overall Study||21
10458285|NCT01015586|11606262|FG001|STARTED|Overall Study||22
10458286|NCT01015586|11606261|FG000|COMPLETED|Overall Study||14
10458287|NCT01015586|11606262|FG001|COMPLETED|Overall Study||11
10458288|NCT01015586|11606261|FG000|NOT COMPLETED|Overall Study||7
10458289|NCT01015586|11606262|FG001|NOT COMPLETED|Overall Study||11
10458290|NCT01015612|11606268|FG000|STARTED|Overall Study||634
10458291|NCT01015612|11606268|FG000|COMPLETED|Overall Study||481
10458292|NCT01015612|11606268|FG000|NOT COMPLETED|Overall Study||153
10458293|NCT01015638|11606274|FG000|STARTED|Overall Study||17
10458294|NCT01015638|11606275|FG001|STARTED|Overall Study||19
10458295|NCT01015638|11606274|FG000|COMPLETED|Overall Study||16
10458296|NCT01015638|11606275|FG001|COMPLETED|Overall Study||19
10458297|NCT01015638|11606274|FG000|NOT COMPLETED|Overall Study||1
10458298|NCT01015638|11606275|FG001|NOT COMPLETED|Overall Study||0
10458299|NCT01015677|11606284|FG000|STARTED|Overall Study||34
10458300|NCT01015677|11606285|FG001|STARTED|Overall Study||32
10458301|NCT01015677|11606286|FG002|STARTED|Overall Study||33
10458302|NCT01015677|11606284|FG000|COMPLETED|Overall Study||33
10458303|NCT01015677|11606285|FG001|COMPLETED|Overall Study||28
10458304|NCT01015677|11606286|FG002|COMPLETED|Overall Study||33
10458305|NCT01015677|11606284|FG000|NOT COMPLETED|Overall Study||1
10458306|NCT01015677|11606285|FG001|NOT COMPLETED|Overall Study||4
10458307|NCT01015677|11606286|FG002|NOT COMPLETED|Overall Study||0
10458308|NCT01015703|11606299|FG000|STARTED|Overall Study||10
10458309|NCT01015703|11606300|FG001|STARTED|Overall Study||10
10458310|NCT01015703|11606301|FG002|STARTED|Overall Study||10
10458311|NCT01015703|11606302|FG003|STARTED|Overall Study||10
10458312|NCT01015703|11606303|FG004|STARTED|Overall Study||10
10458313|NCT01015703|11606299|FG000|COMPLETED|Overall Study||8
10458314|NCT01015703|11606300|FG001|COMPLETED|Overall Study||9
10458315|NCT01015703|11606301|FG002|COMPLETED|Overall Study||10
10458316|NCT01015703|11606302|FG003|COMPLETED|Overall Study||10
10458317|NCT01015703|11606303|FG004|COMPLETED|Overall Study||10
10458318|NCT01015703|11606299|FG000|NOT COMPLETED|Overall Study||2
10458319|NCT01015703|11606300|FG001|NOT COMPLETED|Overall Study||1
10458320|NCT01015703|11606301|FG002|NOT COMPLETED|Overall Study||0
10458321|NCT01015703|11606302|FG003|NOT COMPLETED|Overall Study||0
10458322|NCT01015703|11606303|FG004|NOT COMPLETED|Overall Study||0
10458323|NCT01015768|11606315|FG000|STARTED|Overall Study||30
10458324|NCT01015768|11606316|FG001|STARTED|Overall Study||30
10458325|NCT01015768|11606315|FG000|COMPLETED|Overall Study||26
10458326|NCT01015768|11606316|FG001|COMPLETED|Overall Study||26
10458327|NCT01015768|11606315|FG000|NOT COMPLETED|Overall Study||4
10458328|NCT01015768|11606316|FG001|NOT COMPLETED|Overall Study||4
10458329|NCT01015781|11606326|FG000|STARTED|Overall Study||150
10458330|NCT01015781|11606327|FG001|STARTED|Overall Study||150
10458331|NCT01015781|11606326|FG000|COMPLETED|Overall Study||113
10458332|NCT01015781|11606327|FG001|COMPLETED|Overall Study||121
10458333|NCT01015781|11606326|FG000|NOT COMPLETED|Overall Study||37
10458334|NCT01015781|11606327|FG001|NOT COMPLETED|Overall Study||29
10458335|NCT01015807|11606336|FG000|STARTED|Overall Study||30
10458336|NCT01015807|11606337|FG001|STARTED|Overall Study||30
10458337|NCT01015807|11606338|FG002|STARTED|Overall Study||30
10458338|NCT01015807|11606336|FG000|COMPLETED|Overall Study||30
10458339|NCT01015807|11606337|FG001|COMPLETED|Overall Study||30
10458340|NCT01015807|11606338|FG002|COMPLETED|Overall Study||30
10458341|NCT01015807|11606336|FG000|NOT COMPLETED|Overall Study||0
10458342|NCT01015807|11606337|FG001|NOT COMPLETED|Overall Study||0
10458343|NCT01015807|11606338|FG002|NOT COMPLETED|Overall Study||0
10458344|NCT01015820|11606348|FG000|STARTED|Overall Study||15
10458345|NCT01015820|11606349|FG001|STARTED|Overall Study||15
10458346|NCT01015820|11606348|FG000|COMPLETED|Overall Study||14
10458347|NCT01015820|11606349|FG001|COMPLETED|Overall Study||15
10458348|NCT01015820|11606348|FG000|NOT COMPLETED|Overall Study||1
10458349|NCT01015820|11606349|FG001|NOT COMPLETED|Overall Study||0
10458350|NCT01015976|11606355|FG000|STARTED|Overall Study||5
10458351|NCT01015976|11606356|FG001|STARTED|Overall Study||5
10458352|NCT01015976|11606355|FG000|COMPLETED|Overall Study||5
10458353|NCT01015976|11606356|FG001|COMPLETED|Overall Study||5
10458354|NCT01015976|11606355|FG000|NOT COMPLETED|Overall Study||0
10458355|NCT01015976|11606356|FG001|NOT COMPLETED|Overall Study||0
10458356|NCT01016015|11606360|FG000|STARTED|Overall Study||178
10458357|NCT01016015|11606360|FG000|COMPLETED|Overall Study||159
10458358|NCT01016015|11606360|FG000|NOT COMPLETED|Overall Study||19
10458359|NCT01016067|11606366|FG000|STARTED|Overall Study||11
10458360|NCT01016067|11606367|FG001|STARTED|Overall Study||12
10458361|NCT01016067|11606366|FG000|COMPLETED|Overall Study||9
10458362|NCT01016067|11606367|FG001|COMPLETED|Overall Study||8
10458363|NCT01016067|11606366|FG000|NOT COMPLETED|Overall Study||2
10458364|NCT01016067|11606367|FG001|NOT COMPLETED|Overall Study||4
10458365|NCT01016106|11606375|FG000|STARTED|Overall Study||17
10458366|NCT01016106|11606376|FG001|STARTED|Overall Study||18
10458367|NCT01016106|11606375|FG000|COMPLETED|Overall Study||17
10458368|NCT01016106|11606376|FG001|COMPLETED|Overall Study||18
10458369|NCT01016106|11606375|FG000|NOT COMPLETED|Overall Study||0
10458370|NCT01016106|11606376|FG001|NOT COMPLETED|Overall Study||0
10458371|NCT01016132|11606382|FG000|STARTED|Overall Study||152
10458372|NCT01016132|11606382|FG000|COMPLETED|Overall Study||151
10458373|NCT01016132|11606382|FG000|NOT COMPLETED|Overall Study||1
10458374|NCT01016262|11606389|FG000|STARTED|Double-blind Phase||41
10458375|NCT01016262|11606390|FG001|STARTED|Double-blind Phase||39
10458376|NCT01016262|11606391|FG002|STARTED|Double-blind Phase||39
10458377|NCT01016262|11606392|FG003|STARTED|Double-blind Phase||0
10458378|NCT01016262|11606393|FG004|STARTED|Double-blind Phase||0
10458379|NCT01016262|11606394|FG005|STARTED|Double-blind Phase||0
10458380|NCT01016262|11606389|FG000|COMPLETED|Double-blind Phase||40
10458381|NCT01016262|11606390|FG001|COMPLETED|Double-blind Phase||38
10458382|NCT01016262|11606391|FG002|COMPLETED|Double-blind Phase||30
10458383|NCT01016262|11606392|FG003|COMPLETED|Double-blind Phase||0
10458384|NCT01016262|11606393|FG004|COMPLETED|Double-blind Phase||0
10458385|NCT01016262|11606394|FG005|COMPLETED|Double-blind Phase||0
10458386|NCT01016262|11606389|FG000|NOT COMPLETED|Double-blind Phase||1
10458387|NCT01016262|11606390|FG001|NOT COMPLETED|Double-blind Phase||1
10458388|NCT01016262|11606391|FG002|NOT COMPLETED|Double-blind Phase||9
10458389|NCT01016262|11606392|FG003|NOT COMPLETED|Double-blind Phase||0
10458390|NCT01016262|11606393|FG004|NOT COMPLETED|Double-blind Phase||0
10458391|NCT01016262|11606394|FG005|NOT COMPLETED|Double-blind Phase||0
10458392|NCT01016262|11606389|FG000|STARTED|Open-Label Phase||0
10458393|NCT01016262|11606390|FG001|STARTED|Open-Label Phase||0
10458394|NCT01016262|11606391|FG002|STARTED|Open-Label Phase||0
10458395|NCT01016262|11606392|FG003|STARTED|Open-Label Phase||44
10458396|NCT01016262|11606393|FG004|STARTED|Open-Label Phase||52
10458397|NCT01016262|11606394|FG005|STARTED|Open-Label Phase||20
10458398|NCT01016262|11606389|FG000|COMPLETED|Open-Label Phase||0
10458399|NCT01016262|11606390|FG001|COMPLETED|Open-Label Phase||0
10458400|NCT01016262|11606391|FG002|COMPLETED|Open-Label Phase||0
10458401|NCT01016262|11606392|FG003|COMPLETED|Open-Label Phase||42
10458402|NCT01016262|11606393|FG004|COMPLETED|Open-Label Phase||50
10458403|NCT01016262|11606394|FG005|COMPLETED|Open-Label Phase||20
10458404|NCT01016262|11606389|FG000|NOT COMPLETED|Open-Label Phase||0
10458405|NCT01016262|11606390|FG001|NOT COMPLETED|Open-Label Phase||0
10458406|NCT01016262|11606391|FG002|NOT COMPLETED|Open-Label Phase||0
10458407|NCT01016262|11606392|FG003|NOT COMPLETED|Open-Label Phase||2
10458408|NCT01016262|11606393|FG004|NOT COMPLETED|Open-Label Phase||2
10458409|NCT01016262|11606394|FG005|NOT COMPLETED|Open-Label Phase||0
10708223|NCT02628028|11873011|FG003|NOT COMPLETED|Long-term Extension (LTE) Period||0
10708224|NCT02628028|11873012|FG004|NOT COMPLETED|Long-term Extension (LTE) Period||0
10708225|NCT02628028|11873013|FG005|NOT COMPLETED|Long-term Extension (LTE) Period||60
10708226|NCT02628028|11873014|FG006|NOT COMPLETED|Long-term Extension (LTE) Period||58
10708227|NCT02628028|11873015|FG007|NOT COMPLETED|Long-term Extension (LTE) Period||61
10708228|NCT02628093|11873039|FG000|STARTED|Overall Study||31
10708229|NCT02628093|11873040|FG001|STARTED|Overall Study||29
10458416|NCT01016483|11606418|FG000|STARTED|Safety Run-in Part||27
10458417|NCT01016483|11606419|FG001|STARTED|Safety Run-in Part||26
10458418|NCT01016483|11606420|FG002|STARTED|Safety Run-in Part||0
10458419|NCT01016483|11606421|FG003|STARTED|Safety Run-in Part||0
10458420|NCT01016483|11606418|FG000|COMPLETED|Safety Run-in Part||27
10458421|NCT01016483|11606419|FG001|COMPLETED|Safety Run-in Part||26
10458422|NCT01016483|11606420|FG002|COMPLETED|Safety Run-in Part||0
10458423|NCT01016483|11606421|FG003|COMPLETED|Safety Run-in Part||0
10458424|NCT01016483|11606418|FG000|NOT COMPLETED|Safety Run-in Part||0
10458425|NCT01016483|11606419|FG001|NOT COMPLETED|Safety Run-in Part||0
10458426|NCT01016483|11606420|FG002|NOT COMPLETED|Safety Run-in Part||0
10458427|NCT01016483|11606421|FG003|NOT COMPLETED|Safety Run-in Part||0
10458428|NCT01016483|11606418|FG000|STARTED|Phase II||0
10458429|NCT01016483|11606419|FG001|STARTED|Phase II||0
10458430|NCT01016483|11606420|FG002|STARTED|Phase II|Subjects presented as randomized (Intention-to-Treat [ITT] Analysis Set).|44
10458431|NCT01016483|11606421|FG003|STARTED|Phase II|Subjects presented as randomized (ITT Analysis Set).|44
10458432|NCT01016483|11606418|FG000|Treated (Safety Analysis Set [SAF])|Phase II||0
10458433|NCT01016483|11606419|FG001|Treated (Safety Analysis Set [SAF])|Phase II||0
10458434|NCT01016483|11606420|FG002|Treated (Safety Analysis Set [SAF])|Phase II|Subjects presented as treated (SAF).|42
10458435|NCT01016483|11606421|FG003|Treated (Safety Analysis Set [SAF])|Phase II|Subjects presented as treated (SAF).|45
10458436|NCT01016483|11606418|FG000|COMPLETED|Phase II||0
10458437|NCT01016483|11606419|FG001|COMPLETED|Phase II||0
10458438|NCT01016483|11606420|FG002|COMPLETED|Phase II||44
10458439|NCT01016483|11606421|FG003|COMPLETED|Phase II||44
10458440|NCT01016483|11606418|FG000|NOT COMPLETED|Phase II||0
10458441|NCT01016483|11606419|FG001|NOT COMPLETED|Phase II||0
10458442|NCT01016483|11606420|FG002|NOT COMPLETED|Phase II||0
10458443|NCT01016483|11606421|FG003|NOT COMPLETED|Phase II||0
10458444|NCT01016600|11606463|FG000|STARTED|Overall Study||9
10458445|NCT01016600|11606464|FG001|STARTED|Overall Study||4
10458446|NCT01016600|11606465|FG002|STARTED|Overall Study||6
10458447|NCT01016600|11606466|FG003|STARTED|Overall Study||12
10458448|NCT01016600|11606463|FG000|COMPLETED|Overall Study||8
10458449|NCT01016600|11606464|FG001|COMPLETED|Overall Study||4
10458450|NCT01016600|11606465|FG002|COMPLETED|Overall Study||6
10458451|NCT01016600|11606466|FG003|COMPLETED|Overall Study||12
10458452|NCT01016600|11606463|FG000|NOT COMPLETED|Overall Study||1
10458453|NCT01016600|11606464|FG001|NOT COMPLETED|Overall Study||0
10458454|NCT01016600|11606465|FG002|NOT COMPLETED|Overall Study||0
10458455|NCT01016600|11606466|FG003|NOT COMPLETED|Overall Study||0
10458456|NCT01016652|11606479|FG000|STARTED|Period 1||25
10458457|NCT01016652|11606480|FG001|STARTED|Period 1||24
10458458|NCT01016652|11606479|FG000|COMPLETED|Period 1||25
10458459|NCT01016652|11606480|FG001|COMPLETED|Period 1||24
10458460|NCT01016652|11606479|FG000|NOT COMPLETED|Period 1||0
10458461|NCT01016652|11606480|FG001|NOT COMPLETED|Period 1||0
10458462|NCT01016652|11606479|FG000|STARTED|Period 2|Crossover study: the completed from period 1 will crossover in period 2 to the opposite arm.|25
10458463|NCT01016652|11606480|FG001|STARTED|Period 2|Crossover study: the completed from period 1 will crossover in period 2 to the opposite arm.|24
10458464|NCT01016652|11606479|FG000|COMPLETED|Period 2||25
10458465|NCT01016652|11606480|FG001|COMPLETED|Period 2||24
10458466|NCT01016652|11606479|FG000|NOT COMPLETED|Period 2||0
10458467|NCT01016652|11606480|FG001|NOT COMPLETED|Period 2||0
10458468|NCT01016678|11606488|FG000|STARTED|Overall Study||20
10458469|NCT01016678|11606489|FG001|STARTED|Overall Study||17
10458470|NCT01016678|11606490|FG002|STARTED|Overall Study||19
10458471|NCT01016678|11606491|FG003|STARTED|Overall Study||19
10458472|NCT01016678|11606492|FG004|STARTED|Overall Study||19
10458473|NCT01016678|11606488|FG000|COMPLETED|Overall Study||18
10458474|NCT01016678|11606489|FG001|COMPLETED|Overall Study||14
10458475|NCT01016678|11606490|FG002|COMPLETED|Overall Study||15
10458476|NCT01016678|11606491|FG003|COMPLETED|Overall Study||19
10458477|NCT01016678|11606492|FG004|COMPLETED|Overall Study||13
10458478|NCT01016678|11606488|FG000|NOT COMPLETED|Overall Study||2
10458479|NCT01016678|11606489|FG001|NOT COMPLETED|Overall Study||3
10458480|NCT01016678|11606490|FG002|NOT COMPLETED|Overall Study||4
10458481|NCT01016678|11606491|FG003|NOT COMPLETED|Overall Study||0
10458482|NCT01016678|11606492|FG004|NOT COMPLETED|Overall Study||6
10458483|NCT01016691|11606513|FG000|STARTED|Overall Study||17
10458484|NCT01016691|11606514|FG001|STARTED|Overall Study||12
10458485|NCT01016691|11606515|FG002|STARTED|Overall Study||18
10458486|NCT01016691|11606513|FG000|COMPLETED|Overall Study||17
10458487|NCT01016691|11606514|FG001|COMPLETED|Overall Study||12
10458488|NCT01016691|11606515|FG002|COMPLETED|Overall Study||18
10458489|NCT01016691|11606513|FG000|NOT COMPLETED|Overall Study||0
10458490|NCT01016691|11606514|FG001|NOT COMPLETED|Overall Study||0
10458491|NCT01016691|11606515|FG002|NOT COMPLETED|Overall Study||0
10458492|NCT01016769|11606527|FG000|STARTED|Overall Study||4
10458493|NCT01016769|11606528|FG001|STARTED|Overall Study||7
10458494|NCT01016769|11606529|FG002|STARTED|Overall Study||7
10458495|NCT01016769|11606530|FG003|STARTED|Overall Study||30
10458496|NCT01016769|11606527|FG000|COMPLETED|Overall Study||3
10458497|NCT01016769|11606528|FG001|COMPLETED|Overall Study||6
10458498|NCT01016769|11606529|FG002|COMPLETED|Overall Study||6
10458499|NCT01016769|11606530|FG003|COMPLETED|Overall Study||30
10458500|NCT01016769|11606527|FG000|NOT COMPLETED|Overall Study||1
10458501|NCT01016769|11606528|FG001|NOT COMPLETED|Overall Study||1
10458502|NCT01016769|11606529|FG002|NOT COMPLETED|Overall Study||1
10458503|NCT01016769|11606530|FG003|NOT COMPLETED|Overall Study||0
10458504|NCT01016834|11606539|FG000|STARTED|Overall Study||242
10458505|NCT01016834|11606539|FG000|COMPLETED|Overall Study||220
10458506|NCT01016834|11606539|FG000|NOT COMPLETED|Overall Study||22
10458507|NCT01016873|11606546|FG000|STARTED|12 Months||75
10458508|NCT01016873|11606547|FG001|STARTED|12 Months||75
10458509|NCT01016873|11606548|FG002|STARTED|12 Months||80
10458510|NCT01016873|11606546|FG000|COMPLETED|12 Months||74
10458511|NCT01016873|11606547|FG001|COMPLETED|12 Months||72
10458512|NCT01016873|11606548|FG002|COMPLETED|12 Months||79
10458513|NCT01016873|11606546|FG000|NOT COMPLETED|12 Months||1
10458514|NCT01016873|11606547|FG001|NOT COMPLETED|12 Months||3
10458515|NCT01016873|11606548|FG002|NOT COMPLETED|12 Months||1
10458516|NCT01016873|11606546|FG000|STARTED|24 Months||74
10458517|NCT01016873|11606547|FG001|STARTED|24 Months||72
10458518|NCT01016873|11606548|FG002|STARTED|24 Months||79
10458519|NCT01016873|11606546|FG000|COMPLETED|24 Months||69
10458520|NCT01016873|11606547|FG001|COMPLETED|24 Months||68
10458521|NCT01016873|11606548|FG002|COMPLETED|24 Months||73
10458522|NCT01016873|11606546|FG000|NOT COMPLETED|24 Months||5
10458523|NCT01016873|11606547|FG001|NOT COMPLETED|24 Months||4
10458524|NCT01016873|11606548|FG002|NOT COMPLETED|24 Months||6
10458525|NCT01016873|11606546|FG000|STARTED|36 Months||69
10458526|NCT01016873|11606547|FG001|STARTED|36 Months||68
10458527|NCT01016873|11606548|FG002|STARTED|36 Months||73
10458528|NCT01016873|11606546|FG000|COMPLETED|36 Months||58
10458529|NCT01016873|11606547|FG001|COMPLETED|36 Months||64
10458530|NCT01016873|11606548|FG002|COMPLETED|36 Months||67
10458531|NCT01016873|11606546|FG000|NOT COMPLETED|36 Months||11
10458532|NCT01016873|11606547|FG001|NOT COMPLETED|36 Months||4
10458533|NCT01016873|11606548|FG002|NOT COMPLETED|36 Months||6
10458534|NCT01016912|11606561|FG000|STARTED|End of Treatment Period||8
10458535|NCT01016912|11606562|FG001|STARTED|End of Treatment Period||9
10458536|NCT01016912|11606563|FG002|STARTED|End of Treatment Period||10
10458537|NCT01016912|11606564|FG003|STARTED|End of Treatment Period||9
10458538|NCT01016912|11606565|FG004|STARTED|End of Treatment Period||9
10458539|NCT01016912|11606561|FG000|Received Treatment|End of Treatment Period||8
10458540|NCT01016912|11606562|FG001|Received Treatment|End of Treatment Period||9
10458541|NCT01016912|11606563|FG002|Received Treatment|End of Treatment Period||10
10458542|NCT01016912|11606564|FG003|Received Treatment|End of Treatment Period||9
10458543|NCT01016912|11606565|FG004|Received Treatment|End of Treatment Period||9
10458544|NCT01016912|11606561|FG000|COMPLETED|End of Treatment Period||8
10458545|NCT01016912|11606562|FG001|COMPLETED|End of Treatment Period||6
10458546|NCT01016912|11606563|FG002|COMPLETED|End of Treatment Period||9
10458547|NCT01016912|11606564|FG003|COMPLETED|End of Treatment Period||5
10458548|NCT01016912|11606565|FG004|COMPLETED|End of Treatment Period||5
10458549|NCT01016912|11606561|FG000|NOT COMPLETED|End of Treatment Period||0
10458550|NCT01016912|11606562|FG001|NOT COMPLETED|End of Treatment Period||3
10458551|NCT01016912|11606563|FG002|NOT COMPLETED|End of Treatment Period||1
10458552|NCT01016912|11606564|FG003|NOT COMPLETED|End of Treatment Period||4
10458553|NCT01016912|11606565|FG004|NOT COMPLETED|End of Treatment Period||4
10458554|NCT01016912|11606561|FG000|STARTED|Follow-up Period||8
10458555|NCT01016912|11606562|FG001|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
10458556|NCT01016912|11606563|FG002|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|10
10458557|NCT01016912|11606564|FG003|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
10458558|NCT01016912|11606565|FG004|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
10458559|NCT01016912|11606561|FG000|COMPLETED|Follow-up Period||8
10458560|NCT01016912|11606562|FG001|COMPLETED|Follow-up Period||9
10458561|NCT01016912|11606563|FG002|COMPLETED|Follow-up Period||9
10458562|NCT01016912|11606564|FG003|COMPLETED|Follow-up Period||8
10458563|NCT01016912|11606565|FG004|COMPLETED|Follow-up Period||9
10458564|NCT01016912|11606561|FG000|NOT COMPLETED|Follow-up Period||0
10458565|NCT01016912|11606562|FG001|NOT COMPLETED|Follow-up Period||0
10458566|NCT01016912|11606563|FG002|NOT COMPLETED|Follow-up Period||1
10458567|NCT01016912|11606564|FG003|NOT COMPLETED|Follow-up Period||1
10458568|NCT01016912|11606565|FG004|NOT COMPLETED|Follow-up Period||0
10458569|NCT01016938|11606597|FG000|STARTED|Overall Study||16
10458570|NCT01016938|11606597|FG000|COMPLETED|Overall Study||7
10458571|NCT01016938|11606597|FG000|NOT COMPLETED|Overall Study||9
10458572|NCT01016964|11606604|FG000|STARTED|Overall Study||21
10458573|NCT01016964|11606605|FG001|STARTED|Overall Study||42
10458574|NCT01016964|11606604|FG000|COMPLETED|Overall Study||18
10458575|NCT01016964|11606605|FG001|COMPLETED|Overall Study||39
10458576|NCT01016964|11606604|FG000|NOT COMPLETED|Overall Study||3
10458577|NCT01016964|11606605|FG001|NOT COMPLETED|Overall Study||3
10458578|NCT01016977|11606613|FG000|STARTED|Overall Study||20
10458579|NCT01016977|11606614|FG001|STARTED|Overall Study||20
10458580|NCT01016977|11606613|FG000|COMPLETED|Overall Study||17
10458581|NCT01016977|11606614|FG001|COMPLETED|Overall Study||18
10708230|NCT02628093|11873039|FG000|COMPLETED|Overall Study||31
10708231|NCT02628093|11873040|FG001|COMPLETED|Overall Study||29
10458582|NCT01016977|11606613|FG000|NOT COMPLETED|Overall Study||3
10458583|NCT01016977|11606614|FG001|NOT COMPLETED|Overall Study||2
10458584|NCT01017003|11606623|FG000|STARTED|Single Dose Colchicine 0.6 mg, Day 1||13
10458585|NCT01017003|11606623|FG000|COMPLETED|Single Dose Colchicine 0.6 mg, Day 1||13
10458586|NCT01017003|11606623|FG000|NOT COMPLETED|Single Dose Colchicine 0.6 mg, Day 1||0
10458587|NCT01017003|11606623|FG000|STARTED|14 Day Washout Period||13
10458588|NCT01017003|11606623|FG000|COMPLETED|14 Day Washout Period||13
10458589|NCT01017003|11606623|FG000|NOT COMPLETED|14 Day Washout Period||0
10458590|NCT01017003|11606623|FG000|STARTED|Colchicine 0.6 mg Twice Daily x 10 Days||13
10458591|NCT01017003|11606623|FG000|COMPLETED|Colchicine 0.6 mg Twice Daily x 10 Days||13
10458592|NCT01017003|11606623|FG000|NOT COMPLETED|Colchicine 0.6 mg Twice Daily x 10 Days||0
10708232|NCT02628093|11873039|FG000|NOT COMPLETED|Overall Study||0
10458593|NCT01017003|11606623|FG000|STARTED|Colchicine 0.6 mg Final Dose||13
10458594|NCT01017003|11606623|FG000|COMPLETED|Colchicine 0.6 mg Final Dose||13
10458595|NCT01017003|11606623|FG000|NOT COMPLETED|Colchicine 0.6 mg Final Dose||0
10458596|NCT01017029|11606631|FG000|STARTED|Overall Study||89
10458597|NCT01017029|11606632|FG001|STARTED|Overall Study||92
10458598|NCT01017029|11606631|FG000|COMPLETED|Overall Study||85
10458599|NCT01017029|11606632|FG001|COMPLETED|Overall Study||90
10458600|NCT01017029|11606631|FG000|NOT COMPLETED|Overall Study||4
10458601|NCT01017029|11606632|FG001|NOT COMPLETED|Overall Study||2
10458602|NCT01017042|11606638|FG000|STARTED|Overall Study||13
10458603|NCT01017042|11606638|FG000|COMPLETED|Overall Study||13
10458604|NCT01017042|11606638|FG000|NOT COMPLETED|Overall Study||0
10458605|NCT01017120|11606649|FG000|STARTED|Overall Study||373
10458606|NCT01017120|11606650|FG001|STARTED|Overall Study||369
10458607|NCT01017120|11606649|FG000|COMPLETED|Overall Study||307
10458608|NCT01017120|11606650|FG001|COMPLETED|Overall Study||334
10458609|NCT01017120|11606649|FG000|NOT COMPLETED|Overall Study||66
10458610|NCT01017120|11606650|FG001|NOT COMPLETED|Overall Study||35
10458611|NCT01017146|11606658|FG000|STARTED|Overall Study||372
10458612|NCT01017146|11606659|FG001|STARTED|Overall Study||372
10458613|NCT01017146|11606658|FG000|COMPLETED|Overall Study||306
10458614|NCT01017146|11606659|FG001|COMPLETED|Overall Study||333
10458615|NCT01017146|11606658|FG000|NOT COMPLETED|Overall Study||66
10458616|NCT01017146|11606659|FG001|NOT COMPLETED|Overall Study||39
10458617|NCT01017237|11606667|FG000|STARTED|Overall Study||10
10458618|NCT01017237|11606668|FG001|STARTED|Overall Study||8
10458619|NCT01017237|11606667|FG000|COMPLETED|Overall Study||5
10458620|NCT01017237|11606668|FG001|COMPLETED|Overall Study||6
10458621|NCT01017237|11606667|FG000|NOT COMPLETED|Overall Study||5
10458622|NCT01017237|11606668|FG001|NOT COMPLETED|Overall Study||2
10458623|NCT01017250|11606677|FG000|STARTED|Overall Study||15
10458624|NCT01017250|11606677|FG000|2-month MRI|Overall Study|1 participant did not return for the 2 month MRI at treating facility. Resides out of state.|14
10458625|NCT01017250|11606677|FG000|COMPLETED|Overall Study||15
10458626|NCT01017250|11606677|FG000|NOT COMPLETED|Overall Study||0
10458627|NCT01017497|11606682|FG000|STARTED|Overall Study||49
10458628|NCT01017497|11606682|FG000|COMPLETED|Overall Study||49
10458629|NCT01017497|11606682|FG000|NOT COMPLETED|Overall Study||0
10458630|NCT01017536|11606690|FG000|STARTED|Overall Study||13
10458631|NCT01017536|11606691|FG001|STARTED|Overall Study||13
10458632|NCT01017536|11606690|FG000|COMPLETED|Overall Study||13
10458633|NCT01017536|11606691|FG001|COMPLETED|Overall Study||13
10458634|NCT01017536|11606690|FG000|NOT COMPLETED|Overall Study||0
10458635|NCT01017536|11606691|FG001|NOT COMPLETED|Overall Study||0
10458636|NCT01017549|11606697|FG000|STARTED|Eligibility Through 6 Month Follow-up||44
10458637|NCT01017549|11606697|FG000|COMPLETED|Eligibility Through 6 Month Follow-up|6 month follow-up complete Oct 2008; data through 6 months and 1 year are published.|43
10458638|NCT01017549|11606697|FG000|NOT COMPLETED|Eligibility Through 6 Month Follow-up||1
10458639|NCT01017549|11606697|FG000|STARTED|One-year Follow-up||43
10458640|NCT01017549|11606697|FG000|COMPLETED|One-year Follow-up||36
10458641|NCT01017549|11606697|FG000|NOT COMPLETED|One-year Follow-up||7
10458642|NCT01017549|11606697|FG000|STARTED|5 Year Follow-up||36
10458643|NCT01017549|11606697|FG000|COMPLETED|5 Year Follow-up||24
10458644|NCT01017549|11606697|FG000|NOT COMPLETED|5 Year Follow-up||12
10458645|NCT01017575|11606706|FG000|STARTED|Overall Study||8
10458646|NCT01017575|11606707|FG001|STARTED|Overall Study||9
10458647|NCT01017575|11606708|FG002|STARTED|Overall Study||8
10458648|NCT01017575|11606709|FG003|STARTED|Overall Study||8
10458649|NCT01017575|11606710|FG004|STARTED|Overall Study||9
10458650|NCT01017575|11606706|FG000|COMPLETED|Overall Study||7
10458651|NCT01017575|11606707|FG001|COMPLETED|Overall Study||7
10458652|NCT01017575|11606708|FG002|COMPLETED|Overall Study||8
10458653|NCT01017575|11606709|FG003|COMPLETED|Overall Study||7
10458654|NCT01017575|11606710|FG004|COMPLETED|Overall Study||6
10458655|NCT01017575|11606706|FG000|NOT COMPLETED|Overall Study||1
10458656|NCT01017575|11606707|FG001|NOT COMPLETED|Overall Study||2
10458657|NCT01017575|11606708|FG002|NOT COMPLETED|Overall Study||0
10458658|NCT01017575|11606709|FG003|NOT COMPLETED|Overall Study||1
10458659|NCT01017575|11606710|FG004|NOT COMPLETED|Overall Study||3
10458660|NCT01017601|11606724|FG000|STARTED|Overall Study||26
10458661|NCT01017601|11606725|FG001|STARTED|Overall Study||24
10458662|NCT01017601|11606724|FG000|COMPLETED|Overall Study||14
10458663|NCT01017601|11606725|FG001|COMPLETED|Overall Study||11
10458664|NCT01017601|11606724|FG000|NOT COMPLETED|Overall Study||12
10458665|NCT01017601|11606725|FG001|NOT COMPLETED|Overall Study||13
10458666|NCT01017653|11606731|FG000|STARTED|Overall Study||16
10458667|NCT01017653|11606731|FG000|COMPLETED|Overall Study||16
10458668|NCT01017653|11606731|FG000|NOT COMPLETED|Overall Study||0
10458669|NCT01017731|11606735|FG000|STARTED|Overall Study||68
10458670|NCT01017731|11606735|FG000|Received at Least 1 Dose of Study Drug|Overall Study||66
10458671|NCT01017731|11606735|FG000|COMPLETED|Overall Study||60
10458672|NCT01017731|11606735|FG000|NOT COMPLETED|Overall Study||8
10458673|NCT01017874|11606742|FG000|STARTED|Overall Study||118
10458674|NCT01017874|11606743|FG001|STARTED|Overall Study||118
10458675|NCT01017874|11606742|FG000|Received at Least 1 Dose of Study Drug|Overall Study||114
10458676|NCT01017874|11606743|FG001|Received at Least 1 Dose of Study Drug|Overall Study||118
10458677|NCT01017874|11606742|FG000|COMPLETED|Overall Study||88
10458678|NCT01017874|11606743|FG001|COMPLETED|Overall Study||92
10458679|NCT01017874|11606742|FG000|NOT COMPLETED|Overall Study||30
10458680|NCT01017874|11606743|FG001|NOT COMPLETED|Overall Study||26
10458681|NCT01017952|11606753|FG000|STARTED|4-week, Open-label Run-In Period||2092
10458682|NCT01017952|11606754|FG001|STARTED|4-week, Open-label Run-In Period||0
10458683|NCT01017952|11606755|FG002|STARTED|4-week, Open-label Run-In Period||0
10458684|NCT01017952|11606756|FG003|STARTED|4-week, Open-label Run-In Period||0
10458685|NCT01017952|11606757|FG004|STARTED|4-week, Open-label Run-In Period||0
10458686|NCT01017952|11606753|FG000|COMPLETED|4-week, Open-label Run-In Period||1633
10458687|NCT01017952|11606754|FG001|COMPLETED|4-week, Open-label Run-In Period||0
10458688|NCT01017952|11606755|FG002|COMPLETED|4-week, Open-label Run-In Period||0
10458689|NCT01017952|11606756|FG003|COMPLETED|4-week, Open-label Run-In Period||0
10458690|NCT01017952|11606757|FG004|COMPLETED|4-week, Open-label Run-In Period||0
10458691|NCT01017952|11606753|FG000|NOT COMPLETED|4-week, Open-label Run-In Period||459
10458692|NCT01017952|11606754|FG001|NOT COMPLETED|4-week, Open-label Run-In Period||0
10458693|NCT01017952|11606755|FG002|NOT COMPLETED|4-week, Open-label Run-In Period||0
10458769|NCT01018186|11606838|FG003|NOT COMPLETED|2-week Run-in Period||0
10458694|NCT01017952|11606756|FG003|NOT COMPLETED|4-week, Open-label Run-In Period||0
10458695|NCT01017952|11606757|FG004|NOT COMPLETED|4-week, Open-label Run-In Period||0
10458696|NCT01017952|11606753|FG000|STARTED|52-week, Double-blind Treatment Period||0
10458697|NCT01017952|11606754|FG001|STARTED|52-week, Double-blind Treatment Period||409
10458698|NCT01017952|11606755|FG002|STARTED|52-week, Double-blind Treatment Period||412
10458699|NCT01017952|11606756|FG003|STARTED|52-week, Double-blind Treatment Period||403
10458700|NCT01017952|11606757|FG004|STARTED|52-week, Double-blind Treatment Period||409
10458701|NCT01017952|11606753|FG000|Completed the Treatment Period|52-week, Double-blind Treatment Period||0
10458702|NCT01017952|11606754|FG001|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|285
10458703|NCT01017952|11606755|FG002|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|305
10458704|NCT01017952|11606756|FG003|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|293
10458705|NCT01017952|11606757|FG004|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|307
10458706|NCT01017952|11606753|FG000|COMPLETED|52-week, Double-blind Treatment Period||0
10458707|NCT01017952|11606754|FG001|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|284
10458708|NCT01017952|11606755|FG002|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|303
10458709|NCT01017952|11606756|FG003|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|291
10458710|NCT01017952|11606757|FG004|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|306
10458711|NCT01017952|11606753|FG000|NOT COMPLETED|52-week, Double-blind Treatment Period||0
10458712|NCT01017952|11606754|FG001|NOT COMPLETED|52-week, Double-blind Treatment Period||125
10458713|NCT01017952|11606755|FG002|NOT COMPLETED|52-week, Double-blind Treatment Period||109
10458714|NCT01017952|11606756|FG003|NOT COMPLETED|52-week, Double-blind Treatment Period||112
10458715|NCT01017952|11606757|FG004|NOT COMPLETED|52-week, Double-blind Treatment Period||103
10458716|NCT01018030|11606770|FG000|STARTED|Overall Study||246
10458717|NCT01018030|11606771|FG001|STARTED|Overall Study||243
10458718|NCT01018030|11606772|FG002|STARTED|Overall Study||252
10458719|NCT01018030|11606770|FG000|COMPLETED|Overall Study||227
10458720|NCT01018030|11606771|FG001|COMPLETED|Overall Study||232
10458721|NCT01018030|11606772|FG002|COMPLETED|Overall Study||239
10458722|NCT01018030|11606770|FG000|NOT COMPLETED|Overall Study||19
10458723|NCT01018030|11606771|FG001|NOT COMPLETED|Overall Study||11
10458724|NCT01018030|11606772|FG002|NOT COMPLETED|Overall Study||13
10458725|NCT01018056|11606785|FG000|STARTED|Overall Study||12
10458726|NCT01018056|11606786|FG001|STARTED|Overall Study||12
10458727|NCT01018056|11606787|FG002|STARTED|Overall Study||6
10458728|NCT01018056|11606785|FG000|COMPLETED|Overall Study||9
10458729|NCT01018056|11606786|FG001|COMPLETED|Overall Study||10
10458730|NCT01018056|11606787|FG002|COMPLETED|Overall Study||5
10458731|NCT01018056|11606785|FG000|NOT COMPLETED|Overall Study||3
10458732|NCT01018056|11606786|FG001|NOT COMPLETED|Overall Study||2
10458733|NCT01018056|11606787|FG002|NOT COMPLETED|Overall Study||1
10458734|NCT01018095|11606800|FG000|STARTED|Overall Study||135
10458735|NCT01018095|11606801|FG001|STARTED|Overall Study||135
10458736|NCT01018095|11606800|FG000|COMPLETED|Overall Study||79
10458737|NCT01018095|11606801|FG001|COMPLETED|Overall Study||73
10458738|NCT01018095|11606800|FG000|NOT COMPLETED|Overall Study||56
10458739|NCT01018095|11606801|FG001|NOT COMPLETED|Overall Study||62
10458740|NCT01018134|11606813|FG000|STARTED|Overall Study||30
10458741|NCT01018134|11606814|FG001|STARTED|Overall Study||31
10458742|NCT01018134|11606815|FG002|STARTED|Overall Study||30
10458743|NCT01018134|11606816|FG003|STARTED|Overall Study|30 enrolled patients, one who did not use the study medication was excluded from all analyses|29
10458744|NCT01018134|11606817|FG004|STARTED|Overall Study||15
10458745|NCT01018134|11606818|FG005|STARTED|Overall Study||15
10458746|NCT01018134|11606813|FG000|COMPLETED|Overall Study||30
10458747|NCT01018134|11606814|FG001|COMPLETED|Overall Study||30
10458748|NCT01018134|11606815|FG002|COMPLETED|Overall Study||29
10458749|NCT01018134|11606816|FG003|COMPLETED|Overall Study||29
10458750|NCT01018134|11606817|FG004|COMPLETED|Overall Study||15
10458751|NCT01018134|11606818|FG005|COMPLETED|Overall Study||15
10458752|NCT01018134|11606813|FG000|NOT COMPLETED|Overall Study||0
10458753|NCT01018134|11606814|FG001|NOT COMPLETED|Overall Study||1
10458754|NCT01018134|11606815|FG002|NOT COMPLETED|Overall Study||1
10458755|NCT01018134|11606816|FG003|NOT COMPLETED|Overall Study||0
10458756|NCT01018134|11606817|FG004|NOT COMPLETED|Overall Study||0
10458757|NCT01018134|11606818|FG005|NOT COMPLETED|Overall Study||0
10458758|NCT01018186|11606835|FG000|STARTED|2-week Run-in Period||617
10458759|NCT01018186|11606836|FG001|STARTED|2-week Run-in Period||0
10458760|NCT01018186|11606837|FG002|STARTED|2-week Run-in Period||0
10458761|NCT01018186|11606838|FG003|STARTED|2-week Run-in Period||0
10458762|NCT01018186|11606835|FG000|COMPLETED|2-week Run-in Period||503
10458763|NCT01018186|11606836|FG001|COMPLETED|2-week Run-in Period||0
10458764|NCT01018186|11606837|FG002|COMPLETED|2-week Run-in Period||0
10458765|NCT01018186|11606838|FG003|COMPLETED|2-week Run-in Period||0
10458766|NCT01018186|11606835|FG000|NOT COMPLETED|2-week Run-in Period||114
10458767|NCT01018186|11606836|FG001|NOT COMPLETED|2-week Run-in Period||0
10458768|NCT01018186|11606837|FG002|NOT COMPLETED|2-week Run-in Period||0
10458770|NCT01018186|11606835|FG000|STARTED|52-week Double-blind Treatment Period||0
10458771|NCT01018186|11606836|FG001|STARTED|52-week Double-blind Treatment Period||201
10458772|NCT01018186|11606837|FG002|STARTED|52-week Double-blind Treatment Period||202
10458773|NCT01018186|11606838|FG003|STARTED|52-week Double-blind Treatment Period||100
10458774|NCT01018186|11606835|FG000|COMPLETED|52-week Double-blind Treatment Period||0
10458775|NCT01018186|11606836|FG001|COMPLETED|52-week Double-blind Treatment Period||161
10458776|NCT01018186|11606837|FG002|COMPLETED|52-week Double-blind Treatment Period||161
10458777|NCT01018186|11606838|FG003|COMPLETED|52-week Double-blind Treatment Period||71
10458778|NCT01018186|11606835|FG000|NOT COMPLETED|52-week Double-blind Treatment Period||0
10458779|NCT01018186|11606836|FG001|NOT COMPLETED|52-week Double-blind Treatment Period||40
10458780|NCT01018186|11606837|FG002|NOT COMPLETED|52-week Double-blind Treatment Period||41
10458781|NCT01018186|11606838|FG003|NOT COMPLETED|52-week Double-blind Treatment Period||29
10458782|NCT01018264|11606852|FG000|STARTED|Overall Study||10
10458783|NCT01018264|11606853|FG001|STARTED|Overall Study||13
10458784|NCT01018264|11606852|FG000|COMPLETED|Overall Study||9
10458785|NCT01018264|11606853|FG001|COMPLETED|Overall Study||12
10458786|NCT01018264|11606852|FG000|NOT COMPLETED|Overall Study||1
10458787|NCT01018264|11606853|FG001|NOT COMPLETED|Overall Study||1
10458788|NCT01018394|11606861|FG000|STARTED|Overall Study||40
10458789|NCT01018394|11606862|FG001|STARTED|Overall Study||41
10458790|NCT01018394|11606861|FG000|COMPLETED|Overall Study||31
10458791|NCT01018394|11606862|FG001|COMPLETED|Overall Study||33
10458792|NCT01018394|11606861|FG000|NOT COMPLETED|Overall Study||9
10458793|NCT01018394|11606862|FG001|NOT COMPLETED|Overall Study||8
10458794|NCT01018420|11606870|FG000|STARTED|Overall Study||15
10458795|NCT01018420|11606871|FG001|STARTED|Overall Study||3
10458796|NCT01018420|11606870|FG000|COMPLETED|Overall Study||15
10458797|NCT01018420|11606871|FG001|COMPLETED|Overall Study||3
10458798|NCT01018420|11606870|FG000|NOT COMPLETED|Overall Study||0
10458799|NCT01018420|11606871|FG001|NOT COMPLETED|Overall Study||0
10458800|NCT01018511|11606898|FG000|STARTED|Overall Study||341
10458801|NCT01018511|11606899|FG001|STARTED|Overall Study||327
10458802|NCT01018511|11606900|FG002|STARTED|Overall Study||339
10458803|NCT01018511|11606901|FG003|STARTED|Overall Study||327
10458804|NCT01018511|11606898|FG000|Randomized and Treated|Overall Study||341
10458805|NCT01018511|11606899|FG001|Randomized and Treated|Overall Study||326
10458806|NCT01018511|11606900|FG002|Randomized and Treated|Overall Study||338
10458807|NCT01018511|11606901|FG003|Randomized and Treated|Overall Study||324
10458808|NCT01018511|11606898|FG000|COMPLETED|Overall Study||315
10458809|NCT01018511|11606899|FG001|COMPLETED|Overall Study||295
10458810|NCT01018511|11606900|FG002|COMPLETED|Overall Study||299
10458811|NCT01018511|11606901|FG003|COMPLETED|Overall Study||294
10458812|NCT01018511|11606898|FG000|NOT COMPLETED|Overall Study||26
10458813|NCT01018511|11606899|FG001|NOT COMPLETED|Overall Study||32
10458814|NCT01018511|11606900|FG002|NOT COMPLETED|Overall Study||40
10458815|NCT01018511|11606901|FG003|NOT COMPLETED|Overall Study||33
10458816|NCT01018680|11606919|FG000|STARTED|Overall Study||260
10458817|NCT01018680|11606920|FG001|STARTED|Overall Study||264
10458818|NCT01018680|11606919|FG000|COMPLETED|Overall Study||199
10458819|NCT01018680|11606920|FG001|COMPLETED|Overall Study||189
10458820|NCT01018680|11606919|FG000|NOT COMPLETED|Overall Study||61
10458821|NCT01018680|11606920|FG001|NOT COMPLETED|Overall Study||75
10458822|NCT01018732|11606929|FG000|STARTED|Overall Study||50
10458823|NCT01018732|11606930|FG001|STARTED|Overall Study||51
10458824|NCT01018732|11606931|FG002|STARTED|Overall Study||54
10458825|NCT01018732|11606929|FG000|COMPLETED|Overall Study||49
10458826|NCT01018732|11606930|FG001|COMPLETED|Overall Study||49
10458827|NCT01018732|11606931|FG002|COMPLETED|Overall Study||50
10458828|NCT01018732|11606929|FG000|NOT COMPLETED|Overall Study||1
10458829|NCT01018732|11606930|FG001|NOT COMPLETED|Overall Study||2
10458830|NCT01018732|11606931|FG002|NOT COMPLETED|Overall Study||4
10458831|NCT01018862|11606942|FG000|STARTED|Overall Study||161
10458832|NCT01018862|11606943|FG001|STARTED|Overall Study||166
10458833|NCT01018862|11606944|FG002|STARTED|Overall Study||162
10458834|NCT01018862|11606942|FG000|COMPLETED|Overall Study||148
10458835|NCT01018862|11606943|FG001|COMPLETED|Overall Study||156
10458836|NCT01018862|11606944|FG002|COMPLETED|Overall Study||146
10458837|NCT01018862|11606942|FG000|NOT COMPLETED|Overall Study||13
10458838|NCT01018862|11606943|FG001|NOT COMPLETED|Overall Study||10
10458839|NCT01018862|11606944|FG002|NOT COMPLETED|Overall Study||16
10458840|NCT01018953|11606952|FG000|STARTED|Overall Study||8
10458841|NCT01018953|11606952|FG000|BIM 23A760 1 mg|Overall Study||3
10458842|NCT01018953|11606952|FG000|BIM 23A760 2 mg|Overall Study||2
10458843|NCT01018953|11606952|FG000|BIM 23A760 4 mg|Overall Study||3
10458844|NCT01018953|11606952|FG000|COMPLETED|Overall Study||0
10458845|NCT01018953|11606952|FG000|NOT COMPLETED|Overall Study||8
10458846|NCT01018979|11606959|FG000|STARTED|Overall Study||7
10458847|NCT01018979|11606960|FG001|STARTED|Overall Study|A total of 20 subjects were randomized.|13
10458848|NCT01018979|11606959|FG000|Received at Least One Dose|Overall Study||7
10458849|NCT01018979|11606960|FG001|Received at Least One Dose|Overall Study||12
10458850|NCT01018979|11606959|FG000|COMPLETED|Overall Study||4
10458851|NCT01018979|11606960|FG001|COMPLETED|Overall Study||3
10458852|NCT01018979|11606959|FG000|NOT COMPLETED|Overall Study||3
10458853|NCT01018979|11606960|FG001|NOT COMPLETED|Overall Study||10
10458854|NCT01018992|11606971|FG000|STARTED|Overall Study||63
10458855|NCT01018992|11606972|FG001|STARTED|Overall Study||65
10458856|NCT01018992|11606971|FG000|COMPLETED|Overall Study||47
10458857|NCT01018992|11606972|FG001|COMPLETED|Overall Study||49
10458858|NCT01018992|11606971|FG000|NOT COMPLETED|Overall Study||16
10458859|NCT01018992|11606972|FG001|NOT COMPLETED|Overall Study||16
10458860|NCT01019135|11606981|FG000|STARTED|Overall Study||55
10458861|NCT01019135|11606982|FG001|STARTED|Overall Study||59
10458862|NCT01019135|11606983|FG002|STARTED|Overall Study||55
10458863|NCT01019135|11606981|FG000|COMPLETED|Overall Study||35
10458864|NCT01019135|11606982|FG001|COMPLETED|Overall Study||40
10458865|NCT01019135|11606983|FG002|COMPLETED|Overall Study||24
10458866|NCT01019135|11606981|FG000|NOT COMPLETED|Overall Study||20
10458867|NCT01019135|11606982|FG001|NOT COMPLETED|Overall Study||19
10458868|NCT01019135|11606983|FG002|NOT COMPLETED|Overall Study||31
10458869|NCT01019252|11606993|FG000|STARTED|Initial CBT for ADHD vs. Wait List|Stratified based on biological sex and clinician-rated severity (CGI score)|24
10458870|NCT01019252|11606994|FG001|STARTED|Initial CBT for ADHD vs. Wait List|Stratified based on biological sex and clinician-rated severity (CGI score)|22
10458871|NCT01019252|11606993|FG000|COMPLETED|Initial CBT for ADHD vs. Wait List||21
10458872|NCT01019252|11606994|FG001|COMPLETED|Initial CBT for ADHD vs. Wait List||22
10458873|NCT01019252|11606993|FG000|NOT COMPLETED|Initial CBT for ADHD vs. Wait List||3
10458874|NCT01019252|11606994|FG001|NOT COMPLETED|Initial CBT for ADHD vs. Wait List||0
10458875|NCT01019252|11606993|FG000|STARTED|Wait List Cross-over to CBT for ADHD|Lost to follow up, did not start treatment following wait list completion (n=3)|21
10458876|NCT01019252|11606994|FG001|STARTED|Wait List Cross-over to CBT for ADHD||22
10458877|NCT01019252|11606993|FG000|COMPLETED|Wait List Cross-over to CBT for ADHD||21
10458878|NCT01019252|11606994|FG001|COMPLETED|Wait List Cross-over to CBT for ADHD||15
10458879|NCT01019252|11606993|FG000|NOT COMPLETED|Wait List Cross-over to CBT for ADHD||0
10458880|NCT01019252|11606994|FG001|NOT COMPLETED|Wait List Cross-over to CBT for ADHD||7
10458881|NCT01019317|11607000|FG000|STARTED|Overall Study||151
10458882|NCT01019317|11607000|FG000|COMPLETED|Overall Study||147
10458883|NCT01019317|11607000|FG000|NOT COMPLETED|Overall Study||4
10458884|NCT01019369|11607006|FG000|STARTED|Overall Study||86
10458885|NCT01019369|11607007|FG001|STARTED|Overall Study||46
10708233|NCT02628093|11873040|FG001|NOT COMPLETED|Overall Study||0
10708234|NCT02628106|11873046|FG000|STARTED|Overall Study||21
10708235|NCT02628106|11873046|FG000|COMPLETED|Overall Study||21
10458886|NCT01019369|11607006|FG000|COMPLETED|Overall Study||76
10458887|NCT01019369|11607007|FG001|COMPLETED|Overall Study||39
10458888|NCT01019369|11607006|FG000|NOT COMPLETED|Overall Study||10
10458889|NCT01019369|11607007|FG001|NOT COMPLETED|Overall Study||7
10458890|NCT01019486|11607017|FG000|STARTED|Overall Study||5
10458891|NCT01019486|11607018|FG001|STARTED|Overall Study||5
10458892|NCT01019486|11607019|FG002|STARTED|Overall Study||16
10458893|NCT01019486|11607017|FG000|COMPLETED|Overall Study||4
10458894|NCT01019486|11607018|FG001|COMPLETED|Overall Study||4
10458895|NCT01019486|11607019|FG002|COMPLETED|Overall Study||15
10458896|NCT01019486|11607017|FG000|NOT COMPLETED|Overall Study||1
10458897|NCT01019486|11607018|FG001|NOT COMPLETED|Overall Study||1
10458898|NCT01019486|11607019|FG002|NOT COMPLETED|Overall Study||1
10458899|NCT01019694|11607031|FG000|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|157
10458900|NCT01019694|11607032|FG001|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|156
10458901|NCT01019694|11607033|FG002|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|157
10458902|NCT01019694|11607031|FG000|COMPLETED|Overall Study||133
10458903|NCT01019694|11607032|FG001|COMPLETED|Overall Study||118
10458904|NCT01019694|11607033|FG002|COMPLETED|Overall Study||110
10458905|NCT01019694|11607031|FG000|NOT COMPLETED|Overall Study||24
10458906|NCT01019694|11607032|FG001|NOT COMPLETED|Overall Study||38
10458907|NCT01019694|11607033|FG002|NOT COMPLETED|Overall Study||47
10458908|NCT01019707|11607041|FG000|STARTED|First Phase||3
10458909|NCT01019707|11607042|FG001|STARTED|First Phase||3
10458910|NCT01019707|11607041|FG000|COMPLETED|First Phase||3
10458911|NCT01019707|11607042|FG001|COMPLETED|First Phase||3
10458912|NCT01019707|11607041|FG000|NOT COMPLETED|First Phase||0
10458913|NCT01019707|11607042|FG001|NOT COMPLETED|First Phase||0
10458914|NCT01019707|11607041|FG000|STARTED|Washout||3
10458915|NCT01019707|11607042|FG001|STARTED|Washout||3
10458916|NCT01019707|11607041|FG000|COMPLETED|Washout||3
10458917|NCT01019707|11607042|FG001|COMPLETED|Washout||1
10458918|NCT01019707|11607041|FG000|NOT COMPLETED|Washout||0
10458919|NCT01019707|11607042|FG001|NOT COMPLETED|Washout||2
10458920|NCT01019707|11607041|FG000|STARTED|Second Phase||3
10458921|NCT01019707|11607042|FG001|STARTED|Second Phase||1
10458922|NCT01019707|11607041|FG000|COMPLETED|Second Phase||3
10458923|NCT01019707|11607042|FG001|COMPLETED|Second Phase||1
10458924|NCT01019707|11607041|FG000|NOT COMPLETED|Second Phase||0
10458925|NCT01019707|11607042|FG001|NOT COMPLETED|Second Phase||0
10458926|NCT01019928|11607050|FG000|STARTED|Period 1||7
10458927|NCT01019928|11607051|FG001|STARTED|Period 1||7
10458928|NCT01019928|11607050|FG000|COMPLETED|Period 1||7
10458929|NCT01019928|11607051|FG001|COMPLETED|Period 1||7
10458930|NCT01019928|11607050|FG000|NOT COMPLETED|Period 1||0
10458931|NCT01019928|11607051|FG001|NOT COMPLETED|Period 1||0
10458932|NCT01019928|11607050|FG000|STARTED|Period 2||7
10458933|NCT01019928|11607051|FG001|STARTED|Period 2||7
10458934|NCT01019928|11607050|FG000|COMPLETED|Period 2||7
10458935|NCT01019928|11607051|FG001|COMPLETED|Period 2|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
10458936|NCT01019928|11607050|FG000|NOT COMPLETED|Period 2||0
10458937|NCT01019928|11607051|FG001|NOT COMPLETED|Period 2||1
10458938|NCT01019928|11607050|FG000|STARTED|Period 3||7
10458939|NCT01019928|11607051|FG001|STARTED|Period 3|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
10458940|NCT01019928|11607050|FG000|COMPLETED|Period 3||7
10458941|NCT01019928|11607051|FG001|COMPLETED|Period 3|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
10458942|NCT01019928|11607050|FG000|NOT COMPLETED|Period 3||0
10458943|NCT01019928|11607051|FG001|NOT COMPLETED|Period 3||0
10458944|NCT01020006|11607060|FG000|STARTED|Overall Study||8
10458945|NCT01020006|11607061|FG001|STARTED|Overall Study||18
10458946|NCT01020006|11607062|FG002|STARTED|Overall Study||16
10458947|NCT01020006|11607060|FG000|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
10458948|NCT01020006|11607061|FG001|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
10458949|NCT01020006|11607062|FG002|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
10458950|NCT01020006|11607060|FG000|NOT COMPLETED|Overall Study||8
10458951|NCT01020006|11607061|FG001|NOT COMPLETED|Overall Study||18
10458952|NCT01020006|11607062|FG002|NOT COMPLETED|Overall Study||16
10458953|NCT01020019|11607072|FG000|STARTED|Overall Study||61
10458954|NCT01020019|11607073|FG001|STARTED|Overall Study||61
10458955|NCT01020019|11607072|FG000|COMPLETED|Overall Study||35
10458956|NCT01020019|11607073|FG001|COMPLETED|Overall Study||32
10458957|NCT01020019|11607072|FG000|NOT COMPLETED|Overall Study||26
10458958|NCT01020019|11607073|FG001|NOT COMPLETED|Overall Study||29
10458959|NCT01020123|11607086|FG000|STARTED|Main Period||93
10458960|NCT01020123|11607087|FG001|STARTED|Main Period||91
10458961|NCT01020123|11607088|FG002|STARTED|Main Period||52
10458962|NCT01020123|11607089|FG003|STARTED|Main Period||40
10458963|NCT01020123|11607090|FG004|STARTED|Main Period||88
10458964|NCT01020123|11607091|FG005|STARTED|Main Period||94
10458965|NCT01020123|11607092|FG006|STARTED|Main Period||72
10458966|NCT01020123|11607086|FG000|COMPLETED|Main Period||76
10458967|NCT01020123|11607087|FG001|COMPLETED|Main Period||77
10458968|NCT01020123|11607088|FG002|COMPLETED|Main Period||44
10458969|NCT01020123|11607089|FG003|COMPLETED|Main Period||33
10458970|NCT01020123|11607090|FG004|COMPLETED|Main Period||77
10458971|NCT01020123|11607091|FG005|COMPLETED|Main Period||83
10458972|NCT01020123|11607092|FG006|COMPLETED|Main Period||61
10458973|NCT01020123|11607086|FG000|NOT COMPLETED|Main Period||17
10458974|NCT01020123|11607087|FG001|NOT COMPLETED|Main Period||14
10458975|NCT01020123|11607088|FG002|NOT COMPLETED|Main Period||8
10458976|NCT01020123|11607089|FG003|NOT COMPLETED|Main Period||7
10458977|NCT01020123|11607090|FG004|NOT COMPLETED|Main Period||11
10458978|NCT01020123|11607091|FG005|NOT COMPLETED|Main Period||11
10458979|NCT01020123|11607092|FG006|NOT COMPLETED|Main Period||11
10458980|NCT01020123|11607086|FG000|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|40
10458981|NCT01020123|11607087|FG001|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|35
10458982|NCT01020123|11607088|FG002|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|19
10458983|NCT01020123|11607089|FG003|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|13
10458984|NCT01020123|11607090|FG004|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|31
10458985|NCT01020123|11607091|FG005|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|38
10458986|NCT01020123|11607092|FG006|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|19
10458987|NCT01020123|11607086|FG000|COMPLETED|Extention Period||37
10458988|NCT01020123|11607087|FG001|COMPLETED|Extention Period||33
10458989|NCT01020123|11607088|FG002|COMPLETED|Extention Period||17
10458990|NCT01020123|11607089|FG003|COMPLETED|Extention Period||12
10458991|NCT01020123|11607090|FG004|COMPLETED|Extention Period||31
10458992|NCT01020123|11607091|FG005|COMPLETED|Extention Period||36
10458993|NCT01020123|11607092|FG006|COMPLETED|Extention Period||18
10458994|NCT01020123|11607086|FG000|NOT COMPLETED|Extention Period||3
10458995|NCT01020123|11607087|FG001|NOT COMPLETED|Extention Period||2
10458996|NCT01020123|11607088|FG002|NOT COMPLETED|Extention Period||2
10458997|NCT01020123|11607089|FG003|NOT COMPLETED|Extention Period||1
10458998|NCT01020123|11607090|FG004|NOT COMPLETED|Extention Period||0
10458999|NCT01020123|11607091|FG005|NOT COMPLETED|Extention Period||2
10459000|NCT01020123|11607092|FG006|NOT COMPLETED|Extention Period||1
10459001|NCT01020305|11607109|FG000|STARTED|Overall Study||5
10459002|NCT01020305|11607109|FG000|COMPLETED|Overall Study||3
10459003|NCT01020305|11607109|FG000|NOT COMPLETED|Overall Study||2
10459004|NCT01020435|11607115|FG000|STARTED|Overall Study||24
10459005|NCT01020435|11607116|FG001|STARTED|Overall Study||27
10459006|NCT01020435|11607115|FG000|COMPLETED|Overall Study||24
10459007|NCT01020435|11607116|FG001|COMPLETED|Overall Study||26
10459008|NCT01020435|11607115|FG000|NOT COMPLETED|Overall Study||0
10459009|NCT01020435|11607116|FG001|NOT COMPLETED|Overall Study||1
10459010|NCT01020448|11607123|FG000|STARTED|Pre-assignment||339
10459011|NCT01020448|11607123|FG000|COMPLETED|Pre-assignment||326
10459012|NCT01020448|11607123|FG000|NOT COMPLETED|Pre-assignment||13
10459013|NCT01020448|11607123|FG000|STARTED|Treatment|One patient was excluded from the safety population as no post-baseline assessment was available|325
10459014|NCT01020448|11607123|FG000|COMPLETED|Treatment||299
10459015|NCT01020448|11607123|FG000|NOT COMPLETED|Treatment||26
10459016|NCT01020474|11607130|FG000|STARTED|Overall Study||54
10459017|NCT01020474|11607131|FG001|STARTED|Overall Study||53
10459018|NCT01020474|11607130|FG000|COMPLETED|Overall Study||44
10459019|NCT01020474|11607131|FG001|COMPLETED|Overall Study||36
10459020|NCT01020474|11607130|FG000|NOT COMPLETED|Overall Study||10
10459021|NCT01020474|11607131|FG001|NOT COMPLETED|Overall Study||17
10459022|NCT01020487|11607140|FG000|STARTED|Part 1||12
10459023|NCT01020487|11607141|FG001|STARTED|Part 1||0
10459024|NCT01020487|11607142|FG002|STARTED|Part 1||0
10459025|NCT01020487|11607140|FG000|COMPLETED|Part 1||12
10459026|NCT01020487|11607141|FG001|COMPLETED|Part 1||0
10459027|NCT01020487|11607142|FG002|COMPLETED|Part 1||0
10459028|NCT01020487|11607140|FG000|NOT COMPLETED|Part 1||0
10459029|NCT01020487|11607141|FG001|NOT COMPLETED|Part 1||0
10459030|NCT01020487|11607142|FG002|NOT COMPLETED|Part 1||0
10459031|NCT01020487|11607140|FG000|STARTED|Part 2 Double-blind Treatment Period||0
10459032|NCT01020487|11607141|FG001|STARTED|Part 2 Double-blind Treatment Period|Includes one participant who enrolled in Part 2 after completing Part 1|18
10459033|NCT01020487|11607142|FG002|STARTED|Part 2 Double-blind Treatment Period|Includes one participant who enrolled in Part 2 after completing Part 1|19
10459034|NCT01020487|11607140|FG000|Received Treatment|Part 2 Double-blind Treatment Period||0
10459035|NCT01020487|11607141|FG001|Received Treatment|Part 2 Double-blind Treatment Period||18
10459036|NCT01020487|11607142|FG002|Received Treatment|Part 2 Double-blind Treatment Period||18
10459037|NCT01020487|11607140|FG000|COMPLETED|Part 2 Double-blind Treatment Period||0
10459038|NCT01020487|11607141|FG001|COMPLETED|Part 2 Double-blind Treatment Period||16
10459039|NCT01020487|11607142|FG002|COMPLETED|Part 2 Double-blind Treatment Period||13
10459040|NCT01020487|11607140|FG000|NOT COMPLETED|Part 2 Double-blind Treatment Period||0
10459041|NCT01020487|11607141|FG001|NOT COMPLETED|Part 2 Double-blind Treatment Period||2
10459042|NCT01020487|11607142|FG002|NOT COMPLETED|Part 2 Double-blind Treatment Period||6
10459043|NCT01020487|11607140|FG000|STARTED|Part 2 Open-label Period||0
10459044|NCT01020487|11607141|FG001|STARTED|Part 2 Open-label Period||16
10459045|NCT01020487|11607142|FG002|STARTED|Part 2 Open-label Period||13
10459046|NCT01020487|11607140|FG000|COMPLETED|Part 2 Open-label Period||0
10459047|NCT01020487|11607141|FG001|COMPLETED|Part 2 Open-label Period||12
10459048|NCT01020487|11607142|FG002|COMPLETED|Part 2 Open-label Period||12
10459049|NCT01020487|11607140|FG000|NOT COMPLETED|Part 2 Open-label Period||0
10459050|NCT01020487|11607141|FG001|NOT COMPLETED|Part 2 Open-label Period||4
10459051|NCT01020487|11607142|FG002|NOT COMPLETED|Part 2 Open-label Period||1
10459052|NCT01020526|11607152|FG000|STARTED|Overall Study||63
10459053|NCT01020526|11607152|FG000|COMPLETED|Overall Study||49
10459054|NCT01020526|11607152|FG000|NOT COMPLETED|Overall Study||14
10459055|NCT01020591|11607158|FG000|STARTED|Overall Study||15
10459056|NCT01020591|11607159|FG001|STARTED|Overall Study||15
10459057|NCT01020591|11607158|FG000|COMPLETED|Overall Study||15
10459058|NCT01020591|11607159|FG001|COMPLETED|Overall Study||15
10459059|NCT01020591|11607158|FG000|NOT COMPLETED|Overall Study||0
10459060|NCT01020591|11607159|FG001|NOT COMPLETED|Overall Study||0
10459061|NCT01020747|11607167|FG000|STARTED|Overall Study||20
10459062|NCT01020747|11607167|FG000|COMPLETED|Overall Study||19
10459063|NCT01020747|11607167|FG000|NOT COMPLETED|Overall Study||1
10459064|NCT01020773|11607174|FG000|STARTED|Overall Study||35
10459065|NCT01020773|11607175|FG001|STARTED|Overall Study||32
10459066|NCT01020773|11607174|FG000|COMPLETED|Overall Study||31
10459067|NCT01020773|11607175|FG001|COMPLETED|Overall Study||29
10459068|NCT01020773|11607174|FG000|NOT COMPLETED|Overall Study||4
10459069|NCT01020773|11607175|FG001|NOT COMPLETED|Overall Study||3
10459070|NCT01020786|11607181|FG000|STARTED|Induction Period||109
10459071|NCT01020786|11607181|FG000|COMPLETED|Induction Period|Completed induction therapy. Completed=starting the maintenance therapy.|60
10459072|NCT01020786|11607181|FG000|NOT COMPLETED|Induction Period||49
10459073|NCT01020786|11607181|FG000|STARTED|Maintenance Period||60
10459074|NCT01020786|11607181|FG000|COMPLETED|Maintenance Period||0
10459075|NCT01020786|11607181|FG000|NOT COMPLETED|Maintenance Period||60
10459076|NCT01020799|11607189|FG000|STARTED|Overall Study||98
10459077|NCT01020799|11607190|FG001|STARTED|Overall Study||99
10459078|NCT01020799|11607191|FG002|STARTED|Overall Study||50
10459079|NCT01020799|11607189|FG000|Patients Received Treatment|Overall Study||96
10459080|NCT01020799|11607190|FG001|Patients Received Treatment|Overall Study||99
10459081|NCT01020799|11607191|FG002|Patients Received Treatment|Overall Study||50
10459082|NCT01020799|11607189|FG000|Full Analysis Set|Overall Study||91
10459083|NCT01020799|11607190|FG001|Full Analysis Set|Overall Study||94
10459084|NCT01020799|11607191|FG002|Full Analysis Set|Overall Study||49
10459085|NCT01020799|11607189|FG000|COMPLETED|Overall Study||79
10459086|NCT01020799|11607190|FG001|COMPLETED|Overall Study||85
10459087|NCT01020799|11607191|FG002|COMPLETED|Overall Study||43
10459088|NCT01020799|11607189|FG000|NOT COMPLETED|Overall Study||19
10459089|NCT01020799|11607190|FG001|NOT COMPLETED|Overall Study||14
10459090|NCT01020799|11607191|FG002|NOT COMPLETED|Overall Study||7
10459091|NCT01020812|11607199|FG000|STARTED|Overall Study||11
10459092|NCT01020812|11607199|FG000|COMPLETED|Overall Study||8
10459093|NCT01020812|11607199|FG000|NOT COMPLETED|Overall Study||3
10459094|NCT01020838|11607203|FG000|STARTED|Overall Study||218
10459095|NCT01020838|11607203|FG000|Safety Analysis Set|Overall Study|Two patients were excluded from this population because injection of florbetaben was not done.|216
10459096|NCT01020838|11607203|FG000|Interim Analysis Set (Primary Efficacy)|Overall Study|Primary efficacy analysis of initial study period (tissue-scan matched regional analysis)|41
10459097|NCT01020838|11607203|FG000|Final Analysis Set (Whole Brain)|Overall Study|Final analysis set comparing PET scans with different histopathological evaluations.|97
10459098|NCT01020838|11607203|FG000|First Annual Repeat Injection|Overall Study|Patients returning for first follow-up administration and PET-scan.|91
10459099|NCT01020838|11607203|FG000|Second Annual Repeat Injection|Overall Study|Patients returning for second follow-up administration and PET-scan.|34
10459100|NCT01020838|11607203|FG000|COMPLETED|Overall Study||35
10459101|NCT01020838|11607203|FG000|NOT COMPLETED|Overall Study||183
10459102|NCT01020877|11607218|FG000|STARTED|First Intervention||19
10459103|NCT01020877|11607219|FG001|STARTED|First Intervention||19
10459104|NCT01020877|11607218|FG000|COMPLETED|First Intervention||19
10459105|NCT01020877|11607219|FG001|COMPLETED|First Intervention||19
10459106|NCT01020877|11607218|FG000|NOT COMPLETED|First Intervention||0
10459107|NCT01020877|11607219|FG001|NOT COMPLETED|First Intervention||0
10459108|NCT01020877|11607218|FG000|STARTED|Washout of 7 Days||19
10459109|NCT01020877|11607219|FG001|STARTED|Washout of 7 Days||19
10459110|NCT01020877|11607218|FG000|COMPLETED|Washout of 7 Days||19
10459111|NCT01020877|11607219|FG001|COMPLETED|Washout of 7 Days||19
10459112|NCT01020877|11607218|FG000|NOT COMPLETED|Washout of 7 Days||0
10459113|NCT01020877|11607219|FG001|NOT COMPLETED|Washout of 7 Days||0
10459114|NCT01020877|11607218|FG000|STARTED|Second Intervention||19
10459115|NCT01020877|11607219|FG001|STARTED|Second Intervention||19
10459116|NCT01020877|11607218|FG000|COMPLETED|Second Intervention||18
10459117|NCT01020877|11607219|FG001|COMPLETED|Second Intervention||19
10459118|NCT01020877|11607218|FG000|NOT COMPLETED|Second Intervention||1
10459119|NCT01020877|11607219|FG001|NOT COMPLETED|Second Intervention||0
10459120|NCT01020981|11607227|FG000|STARTED|Overall Study||150
10459121|NCT01020981|11607228|FG001|STARTED|Overall Study||150
10459122|NCT01020981|11607227|FG000|COMPLETED|Overall Study||66
10459123|NCT01020981|11607228|FG001|COMPLETED|Overall Study||60
10459124|NCT01020981|11607227|FG000|NOT COMPLETED|Overall Study||84
10459125|NCT01020981|11607228|FG001|NOT COMPLETED|Overall Study||90
10459126|NCT01021007|11607238|FG000|STARTED|Overall Study||36
10459127|NCT01021007|11607239|FG001|STARTED|Overall Study||37
10459128|NCT01021007|11607238|FG000|COMPLETED|Overall Study||34
10459129|NCT01021007|11607239|FG001|COMPLETED|Overall Study||33
10459130|NCT01021007|11607238|FG000|NOT COMPLETED|Overall Study||2
10459131|NCT01021007|11607239|FG001|NOT COMPLETED|Overall Study||4
10459132|NCT01021020|11607245|FG000|STARTED|Period I||28
10459133|NCT01021020|11607245|FG000|COMPLETED|Period I|Colchicine(fasted)-subject took Claritin-D 12hour.Colchicine(fed)arm-subject had schedule conflict.|26
10459134|NCT01021020|11607245|FG000|NOT COMPLETED|Period I||2
10459135|NCT01021020|11607245|FG000|STARTED|14 Day Washout Period A||26
10459136|NCT01021020|11607245|FG000|COMPLETED|14 Day Washout Period A|Colchicine/Probenecid-medical investigator dropped due to abnormal check-in lab results.|25
10459137|NCT01021020|11607245|FG000|NOT COMPLETED|14 Day Washout Period A||1
10459138|NCT01021020|11607245|FG000|STARTED|Period II||25
10459139|NCT01021020|11607245|FG000|COMPLETED|Period II||25
10459140|NCT01021020|11607245|FG000|NOT COMPLETED|Period II||0
10459141|NCT01021020|11607245|FG000|STARTED|14 Day Washout Period B||25
10459142|NCT01021020|11607245|FG000|COMPLETED|14 Day Washout Period B||25
10459143|NCT01021020|11607245|FG000|NOT COMPLETED|14 Day Washout Period B||0
10459144|NCT01021020|11607245|FG000|STARTED|Period III||25
10459145|NCT01021020|11607245|FG000|COMPLETED|Period III||25
10459146|NCT01021020|11607245|FG000|NOT COMPLETED|Period III||0
10459147|NCT01021111|11607257|FG000|STARTED|Overall Study||17
10459148|NCT01021111|11607257|FG000|COMPLETED|Overall Study||17
10459149|NCT01021111|11607257|FG000|NOT COMPLETED|Overall Study||0
10459150|NCT01021137|11607265|FG000|STARTED|Overall Study||62
10459151|NCT01021137|11607266|FG001|STARTED|Overall Study||20
10459152|NCT01021137|11607267|FG002|STARTED|Overall Study||11
10459153|NCT01021137|11607268|FG003|STARTED|Overall Study||41
10459154|NCT01021137|11607265|FG000|COMPLETED|Overall Study||52
10459155|NCT01021137|11607266|FG001|COMPLETED|Overall Study||16
10459156|NCT01021137|11607267|FG002|COMPLETED|Overall Study||9
10459157|NCT01021137|11607268|FG003|COMPLETED|Overall Study||32
10459158|NCT01021137|11607265|FG000|NOT COMPLETED|Overall Study||10
10459159|NCT01021137|11607266|FG001|NOT COMPLETED|Overall Study||4
10459160|NCT01021137|11607267|FG002|NOT COMPLETED|Overall Study||2
10459161|NCT01021137|11607268|FG003|NOT COMPLETED|Overall Study||9
10459162|NCT01021215|11607281|FG000|STARTED|Overall Study||60
10459163|NCT01021215|11607282|FG001|STARTED|Overall Study||20
10459164|NCT01021215|11607281|FG000|Received Allocated Intervention|Overall Study||60
10459165|NCT01021215|11607282|FG001|Received Allocated Intervention|Overall Study||20
10459166|NCT01021215|11607281|FG000|COMPLETED|Overall Study||57
10459167|NCT01021215|11607282|FG001|COMPLETED|Overall Study||20
10459168|NCT01021215|11607281|FG000|NOT COMPLETED|Overall Study||3
10459169|NCT01021215|11607282|FG001|NOT COMPLETED|Overall Study||0
10526259|NCT01380327|11678086|FG001|COMPLETED|Overall Study||28
10459170|NCT04525456|11607288|FG000|STARTED|Overall Study||20
10459171|NCT04525456|11607288|FG000|COMPLETED|Overall Study||20
10459172|NCT04525456|11607288|FG000|NOT COMPLETED|Overall Study||0
10459178|NCT04102501|11607299|FG000|STARTED|Overall Study||33
10459179|NCT04102501|11607300|FG001|STARTED|Overall Study||32
10459180|NCT04102501|11607299|FG000|11 Month Visit|Overall Study||25
10459181|NCT04102501|11607300|FG001|11 Month Visit|Overall Study||20
10459182|NCT04102501|11607299|FG000|COMPLETED|Overall Study||25
10459183|NCT04102501|11607300|FG001|COMPLETED|Overall Study||20
10459184|NCT04102501|11607299|FG000|NOT COMPLETED|Overall Study||8
10459185|NCT04102501|11607300|FG001|NOT COMPLETED|Overall Study||12
10459186|NCT04087343|11607310|FG000|STARTED|Overall Study||4
10459187|NCT04087343|11607311|FG001|STARTED|Overall Study||5
10459188|NCT04087343|11607310|FG000|COMPLETED|Overall Study||4
10459189|NCT04087343|11607311|FG001|COMPLETED|Overall Study||5
10459190|NCT04087343|11607310|FG000|NOT COMPLETED|Overall Study||0
10459191|NCT04087343|11607311|FG001|NOT COMPLETED|Overall Study||0
10459192|NCT03656107|11607319|FG000|STARTED|Overall Study||28
10459193|NCT03656107|11607320|FG001|STARTED|Overall Study||28
10459194|NCT03656107|11607319|FG000|COMPLETED|Overall Study||25
10459195|NCT03656107|11607320|FG001|COMPLETED|Overall Study||27
10459196|NCT03656107|11607319|FG000|NOT COMPLETED|Overall Study||3
10459197|NCT03656107|11607320|FG001|NOT COMPLETED|Overall Study||1
10459198|NCT03554850|11607326|FG000|STARTED|Overall Study||201
10459199|NCT03554850|11607326|FG000|COMPLETED|Overall Study||190
10459200|NCT03554850|11607326|FG000|NOT COMPLETED|Overall Study||11
10459201|NCT03426566|11607334|FG000|STARTED|Overall Study||974
10459202|NCT03426566|11607334|FG000|COMPLETED|Overall Study||974
10459203|NCT03426566|11607334|FG000|NOT COMPLETED|Overall Study||0
10459204|NCT03398356|11607343|FG000|STARTED|Before Treatment||15
10459205|NCT03398356|11607344|FG001|STARTED|Before Treatment||21
10459206|NCT03398356|11607345|FG002|STARTED|Before Treatment||11
10459207|NCT03398356|11607343|FG000|COMPLETED|Before Treatment||12
10459208|NCT03398356|11607344|FG001|COMPLETED|Before Treatment||13
10459209|NCT03398356|11607345|FG002|COMPLETED|Before Treatment|only baseline parameters were taken, this group did not participate in the further part of the study|0
10459210|NCT03398356|11607343|FG000|NOT COMPLETED|Before Treatment||3
10459211|NCT03398356|11607344|FG001|NOT COMPLETED|Before Treatment||8
10459212|NCT03398356|11607345|FG002|NOT COMPLETED|Before Treatment||11
10459213|NCT03398356|11607343|FG000|STARTED|After 6 Weeks of Treatment||12
10459214|NCT03398356|11607344|FG001|STARTED|After 6 Weeks of Treatment||13
10459215|NCT03398356|11607345|FG002|STARTED|After 6 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
10459216|NCT03398356|11607343|FG000|COMPLETED|After 6 Weeks of Treatment||12
10459217|NCT03398356|11607344|FG001|COMPLETED|After 6 Weeks of Treatment||11
10459218|NCT03398356|11607345|FG002|COMPLETED|After 6 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
10459219|NCT03398356|11607343|FG000|NOT COMPLETED|After 6 Weeks of Treatment||0
10708236|NCT02628106|11873046|FG000|NOT COMPLETED|Overall Study||0
10708237|NCT02628223|11873052|FG000|STARTED|Overall Study||38
10708238|NCT02628223|11873053|FG001|STARTED|Overall Study||38
10708239|NCT02628223|11873052|FG000|COMPLETED|Overall Study||38
10708240|NCT02628223|11873053|FG001|COMPLETED|Overall Study||36
10708241|NCT02628223|11873052|FG000|NOT COMPLETED|Overall Study||0
10708242|NCT02628223|11873053|FG001|NOT COMPLETED|Overall Study||2
10459220|NCT03398356|11607344|FG001|NOT COMPLETED|After 6 Weeks of Treatment||2
10459221|NCT03398356|11607345|FG002|NOT COMPLETED|After 6 Weeks of Treatment||0
10459222|NCT03398356|11607343|FG000|STARTED|Post 6 Week Period Initial Evaluation|two of the patients were moved from group B, because of intolerance of the higher dose of the drug|14
10459223|NCT03398356|11607344|FG001|STARTED|Post 6 Week Period Initial Evaluation||11
10459224|NCT03398356|11607345|FG002|STARTED|Post 6 Week Period Initial Evaluation||0
10459225|NCT03398356|11607343|FG000|COMPLETED|Post 6 Week Period Initial Evaluation||14
10459226|NCT03398356|11607344|FG001|COMPLETED|Post 6 Week Period Initial Evaluation||11
10459227|NCT03398356|11607345|FG002|COMPLETED|Post 6 Week Period Initial Evaluation||0
10459228|NCT03398356|11607343|FG000|NOT COMPLETED|Post 6 Week Period Initial Evaluation||0
10459229|NCT03398356|11607344|FG001|NOT COMPLETED|Post 6 Week Period Initial Evaluation||0
10459230|NCT03398356|11607345|FG002|NOT COMPLETED|Post 6 Week Period Initial Evaluation||0
10459231|NCT03398356|11607343|FG000|STARTED|After 12 Weeks of Treatment||14
10459232|NCT03398356|11607344|FG001|STARTED|After 12 Weeks of Treatment||11
10459233|NCT03398356|11607345|FG002|STARTED|After 12 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
10459234|NCT03398356|11607343|FG000|COMPLETED|After 12 Weeks of Treatment||14
10459235|NCT03398356|11607344|FG001|COMPLETED|After 12 Weeks of Treatment||11
10459236|NCT03398356|11607345|FG002|COMPLETED|After 12 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
10459237|NCT03398356|11607343|FG000|NOT COMPLETED|After 12 Weeks of Treatment||0
10459238|NCT03398356|11607344|FG001|NOT COMPLETED|After 12 Weeks of Treatment||0
10459239|NCT03398356|11607345|FG002|NOT COMPLETED|After 12 Weeks of Treatment||0
10459240|NCT03398356|11607343|FG000|STARTED|After 15 Weeks of Treatment||14
10459241|NCT03398356|11607344|FG001|STARTED|After 15 Weeks of Treatment||11
10708243|NCT02628236|11873059|FG000|STARTED|Overall Study||14
10708244|NCT02628236|11873059|FG000|COMPLETED|Overall Study||14
10459242|NCT03398356|11607345|FG002|STARTED|After 15 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
10459243|NCT03398356|11607343|FG000|COMPLETED|After 15 Weeks of Treatment||14
10459244|NCT03398356|11607344|FG001|COMPLETED|After 15 Weeks of Treatment||11
10459245|NCT03398356|11607345|FG002|COMPLETED|After 15 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
10459246|NCT03398356|11607343|FG000|NOT COMPLETED|After 15 Weeks of Treatment||0
10459247|NCT03398356|11607344|FG001|NOT COMPLETED|After 15 Weeks of Treatment||0
10459248|NCT03398356|11607345|FG002|NOT COMPLETED|After 15 Weeks of Treatment||0
10459249|NCT03365791|11607353|FG000|STARTED|Overall Study||76
10459250|NCT03365791|11607353|FG000|Full Analysis Set (FAS)|Overall Study||75
10459251|NCT03365791|11607353|FG000|COMPLETED|Overall Study||4
10459252|NCT03365791|11607353|FG000|NOT COMPLETED|Overall Study||72
10526260|NCT01380327|11678087|FG002|COMPLETED|Overall Study||21
10708245|NCT02628236|11873059|FG000|NOT COMPLETED|Overall Study||0
10708246|NCT02628418|11873065|FG000|STARTED|Overall Study||15
10708247|NCT02628418|11873066|FG001|STARTED|Overall Study||15
10708248|NCT02628418|11873065|FG000|COMPLETED|Overall Study||14
10708249|NCT02628418|11873066|FG001|COMPLETED|Overall Study||13
10708250|NCT02628418|11873065|FG000|NOT COMPLETED|Overall Study||1
10526261|NCT01380327|11678085|FG000|NOT COMPLETED|Overall Study||3
10526262|NCT01380327|11678086|FG001|NOT COMPLETED|Overall Study||3
10526263|NCT01380327|11678087|FG002|NOT COMPLETED|Overall Study||7
10526264|NCT01380366|11678095|FG000|STARTED|Overall Study||15
10526265|NCT01380366|11678095|FG000|COMPLETED|Overall Study||15
10526266|NCT01380366|11678095|FG000|NOT COMPLETED|Overall Study||0
10526267|NCT01380379|11678100|FG000|STARTED|Overall Study||9
10526268|NCT01380379|11678100|FG000|COMPLETED|Overall Study||8
10526269|NCT01380379|11678100|FG000|NOT COMPLETED|Overall Study||1
10526270|NCT01380535|11678106|FG000|STARTED|Overall Study||29
10526271|NCT01380535|11678107|FG001|STARTED|Overall Study||31
10526272|NCT01380535|11678106|FG000|Baseline Population|Overall Study||29
10526273|NCT01380535|11678107|FG001|Baseline Population|Overall Study||31
10526274|NCT01380535|11678106|FG000|Safety Population|Overall Study||28
10526275|NCT01380535|11678107|FG001|Safety Population|Overall Study||28
10526276|NCT01380535|11678106|FG000|Intent-to-treat Population|Overall Study||29
10526277|NCT01380535|11678107|FG001|Intent-to-treat Population|Overall Study||24
10526278|NCT01380535|11678106|FG000|COMPLETED|Overall Study||22
10526279|NCT01380535|11678107|FG001|COMPLETED|Overall Study||16
10526280|NCT01380535|11678106|FG000|NOT COMPLETED|Overall Study||7
10526281|NCT01380535|11678107|FG001|NOT COMPLETED|Overall Study||15
10526282|NCT01380639|11678115|FG000|STARTED|Overall Study||42
10526283|NCT01380639|11678116|FG001|STARTED|Overall Study||40
10526284|NCT01380639|11678115|FG000|COMPLETED|Overall Study||36
10526285|NCT01380639|11678116|FG001|COMPLETED|Overall Study||36
10526286|NCT01380639|11678115|FG000|NOT COMPLETED|Overall Study||6
10526287|NCT01380639|11678116|FG001|NOT COMPLETED|Overall Study||4
10526288|NCT01380691|11678122|FG000|STARTED|Period 1||7
10526289|NCT01380691|11678123|FG001|STARTED|Period 1||7
10526290|NCT01380691|11678124|FG002|STARTED|Period 1||7
10526291|NCT01380691|11678125|FG003|STARTED|Period 1||7
10526292|NCT01380691|11678122|FG000|COMPLETED|Period 1||7
10526293|NCT01380691|11678123|FG001|COMPLETED|Period 1||7
10526294|NCT01380691|11678124|FG002|COMPLETED|Period 1||7
10526295|NCT01380691|11678125|FG003|COMPLETED|Period 1||7
10526296|NCT01380691|11678122|FG000|NOT COMPLETED|Period 1||0
10526297|NCT01380691|11678123|FG001|NOT COMPLETED|Period 1||0
10526298|NCT01380691|11678124|FG002|NOT COMPLETED|Period 1||0
10526299|NCT01380691|11678125|FG003|NOT COMPLETED|Period 1||0
10526300|NCT01380691|11678122|FG000|STARTED|Washout (7 Days)||7
10526301|NCT01380691|11678123|FG001|STARTED|Washout (7 Days)||7
10526302|NCT01380691|11678124|FG002|STARTED|Washout (7 Days)||7
10526303|NCT01380691|11678125|FG003|STARTED|Washout (7 Days)||7
10526304|NCT01380691|11678122|FG000|COMPLETED|Washout (7 Days)||7
10526305|NCT01380691|11678123|FG001|COMPLETED|Washout (7 Days)||7
10526306|NCT01380691|11678124|FG002|COMPLETED|Washout (7 Days)||6
10526307|NCT01380691|11678125|FG003|COMPLETED|Washout (7 Days)||6
10526308|NCT01380691|11678122|FG000|NOT COMPLETED|Washout (7 Days)||0
10526309|NCT01380691|11678123|FG001|NOT COMPLETED|Washout (7 Days)||0
10526310|NCT01380691|11678124|FG002|NOT COMPLETED|Washout (7 Days)||1
10526311|NCT01380691|11678125|FG003|NOT COMPLETED|Washout (7 Days)||1
10526312|NCT01380691|11678122|FG000|STARTED|Period 2||7
10526313|NCT01380691|11678123|FG001|STARTED|Period 2||7
10526314|NCT01380691|11678124|FG002|STARTED|Period 2||6
10526315|NCT01380691|11678125|FG003|STARTED|Period 2||6
10526316|NCT01380691|11678122|FG000|COMPLETED|Period 2||7
10526317|NCT01380691|11678123|FG001|COMPLETED|Period 2||7
10526318|NCT01380691|11678124|FG002|COMPLETED|Period 2||6
10526319|NCT01380691|11678125|FG003|COMPLETED|Period 2||6
10526320|NCT01380691|11678122|FG000|NOT COMPLETED|Period 2||0
10526321|NCT01380691|11678123|FG001|NOT COMPLETED|Period 2||0
10708251|NCT02628418|11873066|FG001|NOT COMPLETED|Overall Study||2
10459263|NCT03125148|11607371|FG000|STARTED|Overall Study||9
10459264|NCT03125148|11607372|FG001|STARTED|Overall Study||8
10459265|NCT03125148|11607371|FG000|COMPLETED|Overall Study||9
10459266|NCT03125148|11607372|FG001|COMPLETED|Overall Study||8
10459267|NCT03125148|11607371|FG000|NOT COMPLETED|Overall Study||0
10459268|NCT03125148|11607372|FG001|NOT COMPLETED|Overall Study||0
10459269|NCT02819440|11607380|FG000|STARTED|Overall Study||61
10459270|NCT02819440|11607381|FG001|STARTED|Overall Study||64
10459271|NCT02819440|11607380|FG000|COMPLETED|Overall Study||48
10459272|NCT02819440|11607381|FG001|COMPLETED|Overall Study||52
10459273|NCT02819440|11607380|FG000|NOT COMPLETED|Overall Study||13
10459274|NCT02819440|11607381|FG001|NOT COMPLETED|Overall Study||12
10459275|NCT02782741|11607389|FG000|STARTED|Blinded Treatment Period: up to Week 49||51
10459276|NCT02782741|11607390|FG001|STARTED|Blinded Treatment Period: up to Week 49||49
10459277|NCT02782741|11607389|FG000|Safety Population|Blinded Treatment Period: up to Week 49||51
10459278|NCT02782741|11607390|FG001|Safety Population|Blinded Treatment Period: up to Week 49||49
10459279|NCT02782741|11607389|FG000|COMPLETED|Blinded Treatment Period: up to Week 49||51
10459280|NCT02782741|11607390|FG001|COMPLETED|Blinded Treatment Period: up to Week 49||44
10459281|NCT02782741|11607389|FG000|NOT COMPLETED|Blinded Treatment Period: up to Week 49||0
10459282|NCT02782741|11607390|FG001|NOT COMPLETED|Blinded Treatment Period: up to Week 49||5
10459283|NCT02782741|11607389|FG000|STARTED|Open-label Long-term: Week 50 to 145||51
10459284|NCT02782741|11607390|FG001|STARTED|Open-label Long-term: Week 50 to 145||44
10459285|NCT02782741|11607389|FG000|Safety Population|Open-label Long-term: Week 50 to 145||51
10459286|NCT02782741|11607390|FG001|Safety Population|Open-label Long-term: Week 50 to 145||44
10459287|NCT02782741|11607389|FG000|COMPLETED|Open-label Long-term: Week 50 to 145||0
10459288|NCT02782741|11607390|FG001|COMPLETED|Open-label Long-term: Week 50 to 145||0
10459289|NCT02782741|11607389|FG000|NOT COMPLETED|Open-label Long-term: Week 50 to 145||51
10459290|NCT02782741|11607390|FG001|NOT COMPLETED|Open-label Long-term: Week 50 to 145||44
10459291|NCT02647359|11607402|FG000|STARTED|Stage 1: Double-Masked Period (48 Weeks)||26
10459292|NCT02647359|11607403|FG001|STARTED|Stage 1: Double-Masked Period (48 Weeks)||13
10459293|NCT02647359|11607402|FG000|Received at Least 1 Dose of Study Drug|Stage 1: Double-Masked Period (48 Weeks)||26
10459294|NCT02647359|11607403|FG001|Received at Least 1 Dose of Study Drug|Stage 1: Double-Masked Period (48 Weeks)||13
10459295|NCT02647359|11607402|FG000|COMPLETED|Stage 1: Double-Masked Period (48 Weeks)||22
10459296|NCT02647359|11607403|FG001|COMPLETED|Stage 1: Double-Masked Period (48 Weeks)||12
10459297|NCT02647359|11607402|FG000|NOT COMPLETED|Stage 1: Double-Masked Period (48 Weeks)||4
10459298|NCT02647359|11607403|FG001|NOT COMPLETED|Stage 1: Double-Masked Period (48 Weeks)||1
10459299|NCT02647359|11607402|FG000|STARTED|Stage 2: Open-Label Extension (96 Weeks)||22
10459300|NCT02647359|11607403|FG001|STARTED|Stage 2: Open-Label Extension (96 Weeks)|1 participant completed Stage 1 but did not enter open-label part|11
10459301|NCT02647359|11607402|FG000|COMPLETED|Stage 2: Open-Label Extension (96 Weeks)||12
10459302|NCT02647359|11607403|FG001|COMPLETED|Stage 2: Open-Label Extension (96 Weeks)||7
10459303|NCT02647359|11607402|FG000|NOT COMPLETED|Stage 2: Open-Label Extension (96 Weeks)||10
10459304|NCT02647359|11607403|FG001|NOT COMPLETED|Stage 2: Open-Label Extension (96 Weeks)||4
10459305|NCT02647359|11607402|FG000|STARTED|Open-Label Sub-Study (96 Weeks)|2 participants completed open-label 144-weeks but did not enter open-label sub-study|10
10459306|NCT02647359|11607403|FG001|STARTED|Open-Label Sub-Study (96 Weeks)||7
10459307|NCT02647359|11607402|FG000|COMPLETED|Open-Label Sub-Study (96 Weeks)||2
10459308|NCT02647359|11607403|FG001|COMPLETED|Open-Label Sub-Study (96 Weeks)||3
10459309|NCT02647359|11607402|FG000|NOT COMPLETED|Open-Label Sub-Study (96 Weeks)||8
10459310|NCT02647359|11607403|FG001|NOT COMPLETED|Open-Label Sub-Study (96 Weeks)||4
10459311|NCT02485691|11607415|FG000|STARTED|Overall Study||129
10459312|NCT02485691|11607416|FG001|STARTED|Overall Study||126
10459313|NCT02485691|11607415|FG000|Treated|Overall Study||126
10459314|NCT02485691|11607416|FG001|Treated|Overall Study||124
10459315|NCT02485691|11607415|FG000|COMPLETED|Overall Study||0
10459316|NCT02485691|11607416|FG001|COMPLETED|Overall Study||0
10459317|NCT02485691|11607415|FG000|NOT COMPLETED|Overall Study||129
10459318|NCT02485691|11607416|FG001|NOT COMPLETED|Overall Study||126
10459319|NCT02201251|11607425|FG000|STARTED|Overall Study||28
10459320|NCT02201251|11607426|FG001|STARTED|Overall Study||35
10459321|NCT02201251|11607425|FG000|COMPLETED|Overall Study||24
10459322|NCT02201251|11607426|FG001|COMPLETED|Overall Study||32
10459323|NCT02201251|11607425|FG000|NOT COMPLETED|Overall Study||4
10459324|NCT02201251|11607426|FG001|NOT COMPLETED|Overall Study||3
10459325|NCT02000596|11607435|FG000|STARTED|Cohort 1||2
10459326|NCT02000596|11607436|FG001|STARTED|Cohort 1||0
10459327|NCT02000596|11607437|FG002|STARTED|Cohort 1||0
10459328|NCT02000596|11607435|FG000|COMPLETED|Cohort 1||2
10459329|NCT02000596|11607436|FG001|COMPLETED|Cohort 1||0
10459330|NCT02000596|11607437|FG002|COMPLETED|Cohort 1||0
10459331|NCT02000596|11607435|FG000|NOT COMPLETED|Cohort 1||0
10459332|NCT02000596|11607436|FG001|NOT COMPLETED|Cohort 1||0
10459333|NCT02000596|11607437|FG002|NOT COMPLETED|Cohort 1||0
10459334|NCT02000596|11607435|FG000|STARTED|Cohort 2||0
10459335|NCT02000596|11607436|FG001|STARTED|Cohort 2||0
10459336|NCT02000596|11607437|FG002|STARTED|Cohort 2||2
10459337|NCT02000596|11607435|FG000|COMPLETED|Cohort 2||0
10459338|NCT02000596|11607436|FG001|COMPLETED|Cohort 2||0
10459339|NCT02000596|11607437|FG002|COMPLETED|Cohort 2||2
10459340|NCT02000596|11607435|FG000|NOT COMPLETED|Cohort 2||0
10459341|NCT02000596|11607436|FG001|NOT COMPLETED|Cohort 2||0
10459342|NCT02000596|11607437|FG002|NOT COMPLETED|Cohort 2||0
10459343|NCT00929253|11607447|FG000|STARTED|Overall Study||91
10459344|NCT00929253|11607448|FG001|STARTED|Overall Study||79
10459345|NCT00929253|11607447|FG000|COMPLETED|Overall Study||91
10459346|NCT00929253|11607448|FG001|COMPLETED|Overall Study||79
10459347|NCT00929253|11607447|FG000|NOT COMPLETED|Overall Study||0
10459348|NCT00929253|11607448|FG001|NOT COMPLETED|Overall Study||0
10459349|NCT00657241|11607456|FG000|STARTED|Overall Study||15
10459350|NCT00657241|11607457|FG001|STARTED|Overall Study||15
10459351|NCT00657241|11607456|FG000|COMPLETED|Overall Study||15
10459352|NCT00657241|11607457|FG001|COMPLETED|Overall Study||15
10459353|NCT00657241|11607456|FG000|NOT COMPLETED|Overall Study||0
10459354|NCT00657241|11607457|FG001|NOT COMPLETED|Overall Study||0
10459355|NCT01021293|11607469|FG000|STARTED|Overall Study||550
10459356|NCT01021293|11607470|FG001|STARTED|Overall Study||550
10459357|NCT01021293|11607469|FG000|COMPLETED|Overall Study||538
10459358|NCT01021293|11607470|FG001|COMPLETED|Overall Study||526
10459359|NCT01021293|11607469|FG000|NOT COMPLETED|Overall Study||12
10459360|NCT01021293|11607470|FG001|NOT COMPLETED|Overall Study||24
10459361|NCT01021306|11607481|FG000|STARTED|2 Month (Primary Outcome)||20
10459362|NCT01021306|11607482|FG001|STARTED|2 Month (Primary Outcome)||20
10459363|NCT01021306|11607483|FG002|STARTED|2 Month (Primary Outcome)||19
10459364|NCT01021306|11607484|FG003|STARTED|2 Month (Primary Outcome)||21
10459365|NCT01021306|11607481|FG000|COMPLETED|2 Month (Primary Outcome)||14
10459366|NCT01021306|11607482|FG001|COMPLETED|2 Month (Primary Outcome)||14
10459367|NCT01021306|11607483|FG002|COMPLETED|2 Month (Primary Outcome)||14
10459368|NCT01021306|11607484|FG003|COMPLETED|2 Month (Primary Outcome)||17
10459369|NCT01021306|11607481|FG000|NOT COMPLETED|2 Month (Primary Outcome)||6
10459370|NCT01021306|11607482|FG001|NOT COMPLETED|2 Month (Primary Outcome)||6
10459371|NCT01021306|11607483|FG002|NOT COMPLETED|2 Month (Primary Outcome)||5
10459372|NCT01021306|11607484|FG003|NOT COMPLETED|2 Month (Primary Outcome)||4
10459373|NCT01021306|11607481|FG000|STARTED|6 Month (Follow-up)||14
10459374|NCT01021306|11607482|FG001|STARTED|6 Month (Follow-up)||14
10459375|NCT01021306|11607483|FG002|STARTED|6 Month (Follow-up)||14
10459376|NCT01021306|11607484|FG003|STARTED|6 Month (Follow-up)||17
10459377|NCT01021306|11607481|FG000|COMPLETED|6 Month (Follow-up)||11
10459378|NCT01021306|11607482|FG001|COMPLETED|6 Month (Follow-up)||13
10459379|NCT01021306|11607483|FG002|COMPLETED|6 Month (Follow-up)||14
10459380|NCT01021306|11607484|FG003|COMPLETED|6 Month (Follow-up)||14
10459381|NCT01021306|11607481|FG000|NOT COMPLETED|6 Month (Follow-up)||3
10459382|NCT01021306|11607482|FG001|NOT COMPLETED|6 Month (Follow-up)||1
10459383|NCT01021306|11607483|FG002|NOT COMPLETED|6 Month (Follow-up)||0
10459384|NCT01021306|11607484|FG003|NOT COMPLETED|6 Month (Follow-up)||3
10459385|NCT01021332|11607494|FG000|STARTED|Overall Study|Took ≥ 1 dose of FDC open-label study drug|1066
10459386|NCT01021332|11607494|FG000|Safety Analysis Set (SAF)|Overall Study||1066
10459387|NCT01021332|11607494|FG000|Full Analysis Set (FAS)|Overall Study||1009
10459388|NCT01021332|11607494|FG000|COMPLETED|Overall Study||960
10459389|NCT01021332|11607494|FG000|NOT COMPLETED|Overall Study||106
10459390|NCT01021423|11607502|FG000|STARTED|Overall Study|One participant discontinued treatment (continued in the study) due to an AE|4
10459391|NCT01021423|11607503|FG001|STARTED|Overall Study|One participant discontinued treatment (continued in the study) due to disease progression|5
10459392|NCT01021423|11607502|FG000|COMPLETED|Overall Study||0
10459393|NCT01021423|11607503|FG001|COMPLETED|Overall Study||0
10459394|NCT01021423|11607502|FG000|NOT COMPLETED|Overall Study||4
10459395|NCT01021423|11607503|FG001|NOT COMPLETED|Overall Study||5
10459396|NCT01021553|11607512|FG000|STARTED|Overall Study||27
10459397|NCT01021553|11607513|FG001|STARTED|Overall Study||22
10459398|NCT01021553|11607514|FG002|STARTED|Overall Study||28
10459399|NCT01021553|11607512|FG000|COMPLETED|Overall Study||23
10459400|NCT01021553|11607513|FG001|COMPLETED|Overall Study||17
10459401|NCT01021553|11607514|FG002|COMPLETED|Overall Study||25
10459402|NCT01021553|11607512|FG000|NOT COMPLETED|Overall Study||4
10459403|NCT01021553|11607513|FG001|NOT COMPLETED|Overall Study||5
10459404|NCT01021553|11607514|FG002|NOT COMPLETED|Overall Study||3
10459405|NCT01021618|11607529|FG000|STARTED|Overall Study||44
10459406|NCT01021618|11607530|FG001|STARTED|Overall Study||96
10459407|NCT01021618|11607529|FG000|COMPLETED|Overall Study||44
10459408|NCT01021618|11607530|FG001|COMPLETED|Overall Study||96
10459409|NCT01021618|11607529|FG000|NOT COMPLETED|Overall Study||0
10459410|NCT01021618|11607530|FG001|NOT COMPLETED|Overall Study||0
10459411|NCT01021683|11607536|FG000|STARTED|Overall Study||203
10459412|NCT01021683|11607536|FG000|COMPLETED|Overall Study||132
10459413|NCT01021683|11607536|FG000|NOT COMPLETED|Overall Study||71
10526322|NCT01380691|11678124|FG002|NOT COMPLETED|Period 2||0
10526323|NCT01380691|11678125|FG003|NOT COMPLETED|Period 2||0
10526324|NCT01380730|11678144|FG000|STARTED|Overall Study||78
10526325|NCT01380730|11678145|FG001|STARTED|Overall Study||79
10526326|NCT01380730|11678146|FG002|STARTED|Overall Study||79
10526327|NCT01380730|11678147|FG003|STARTED|Overall Study||79
10526328|NCT01380730|11678148|FG004|STARTED|Overall Study||78
10526329|NCT01380730|11678149|FG005|STARTED|Overall Study||79
10526330|NCT01380730|11678150|FG006|STARTED|Overall Study||79
10526331|NCT01380730|11678151|FG007|STARTED|Overall Study||80
10526332|NCT01380730|11678144|FG000|Received Treatment|Overall Study||78
10526333|NCT01380730|11678145|FG001|Received Treatment|Overall Study|2 participants did not receive treatment but were followed until the end of study|77
10526334|NCT01380730|11678146|FG002|Received Treatment|Overall Study||79
10526335|NCT01380730|11678147|FG003|Received Treatment|Overall Study||79
10526336|NCT01380730|11678148|FG004|Received Treatment|Overall Study||78
10526337|NCT01380730|11678149|FG005|Received Treatment|Overall Study||79
10526338|NCT01380730|11678150|FG006|Received Treatment|Overall Study||79
10526339|NCT01380730|11678151|FG007|Received Treatment|Overall Study||80
10459414|NCT01021748|11607549|FG000|STARTED|Overall Study||6
10459415|NCT01021748|11607550|FG001|STARTED|Overall Study||5
10459416|NCT01021748|11607551|FG002|STARTED|Overall Study||7
10459417|NCT01021748|11607552|FG003|STARTED|Overall Study||7
10459418|NCT01021748|11607553|FG004|STARTED|Overall Study||9
10459419|NCT01021748|11607554|FG005|STARTED|Overall Study||3
10459420|NCT01021748|11607555|FG006|STARTED|Overall Study||3
10459421|NCT01021748|11607556|FG007|STARTED|Overall Study||6
10459422|NCT01021748|11607557|FG008|STARTED|Overall Study||17
10459423|NCT01021748|11607549|FG000|Treated|Overall Study||6
10459424|NCT01021748|11607550|FG001|Treated|Overall Study|One participant was allocated, but not treated.|4
10459425|NCT01021748|11607551|FG002|Treated|Overall Study||7
10459426|NCT01021748|11607552|FG003|Treated|Overall Study||7
10459427|NCT01021748|11607553|FG004|Treated|Overall Study||9
10459428|NCT01021748|11607554|FG005|Treated|Overall Study||3
10459429|NCT01021748|11607555|FG006|Treated|Overall Study||3
10459430|NCT01021748|11607556|FG007|Treated|Overall Study||6
10459431|NCT01021748|11607557|FG008|Treated|Overall Study||17
10459432|NCT01021748|11607549|FG000|COMPLETED|Overall Study||0
10459433|NCT01021748|11607550|FG001|COMPLETED|Overall Study||0
10459434|NCT01021748|11607551|FG002|COMPLETED|Overall Study||0
10459435|NCT01021748|11607552|FG003|COMPLETED|Overall Study||0
10459436|NCT01021748|11607553|FG004|COMPLETED|Overall Study||0
10459437|NCT01021748|11607554|FG005|COMPLETED|Overall Study||0
10459438|NCT01021748|11607555|FG006|COMPLETED|Overall Study||0
10459439|NCT01021748|11607556|FG007|COMPLETED|Overall Study||0
10459440|NCT01021748|11607557|FG008|COMPLETED|Overall Study||1
10459441|NCT01021748|11607549|FG000|NOT COMPLETED|Overall Study||6
10459442|NCT01021748|11607550|FG001|NOT COMPLETED|Overall Study||5
10459443|NCT01021748|11607551|FG002|NOT COMPLETED|Overall Study||7
10459444|NCT01021748|11607552|FG003|NOT COMPLETED|Overall Study||7
10459445|NCT01021748|11607553|FG004|NOT COMPLETED|Overall Study||9
10459446|NCT01021748|11607554|FG005|NOT COMPLETED|Overall Study||3
10459447|NCT01021748|11607555|FG006|NOT COMPLETED|Overall Study||3
10708252|NCT02628600|11873080|FG000|STARTED|Overall Study||73
10708253|NCT02628600|11873081|FG001|STARTED|Overall Study||90
10708254|NCT02628600|11873080|FG000|Participant Discontinued the Study|Overall Study||24
10708255|NCT02628600|11873081|FG001|Participant Discontinued the Study|Overall Study||32
10708256|NCT02628600|11873080|FG000|COMPLETED|Overall Study||49
10708257|NCT02628600|11873081|FG001|COMPLETED|Overall Study||58
10708258|NCT02628600|11873080|FG000|NOT COMPLETED|Overall Study||24
10459448|NCT01021748|11607556|FG007|NOT COMPLETED|Overall Study||6
10459449|NCT01021748|11607557|FG008|NOT COMPLETED|Overall Study||16
10459450|NCT01021761|11607580|FG000|STARTED|Overall Study||42
10459451|NCT01021761|11607581|FG001|STARTED|Overall Study||42
10459452|NCT01021761|11607582|FG002|STARTED|Overall Study||42
10459453|NCT01021761|11607580|FG000|COMPLETED|Overall Study||41
10459454|NCT01021761|11607581|FG001|COMPLETED|Overall Study||38
10708259|NCT02628600|11873081|FG001|NOT COMPLETED|Overall Study||32
10708260|NCT02628743|11873087|FG000|STARTED|Overall Study||131
10708261|NCT02628743|11873087|FG000|COMPLETED|Overall Study||0
10708262|NCT02628743|11873087|FG000|NOT COMPLETED|Overall Study||131
10708263|NCT02628769|11873091|FG000|STARTED|First Intervention||3
10708264|NCT02628769|11873092|FG001|STARTED|First Intervention||3
10708265|NCT02628769|11873091|FG000|COMPLETED|First Intervention||2
10708266|NCT02628769|11873092|FG001|COMPLETED|First Intervention||2
10809613|NCT03831191|11971475|FG006|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|2
10809614|NCT03831191|11971476|FG007|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|4
10809615|NCT03831191|11971477|FG008|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|8
10809616|NCT03831191|11971478|FG009|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|1
10809617|NCT03831191|11971479|FG010|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|4
10809618|NCT03831191|11971480|FG011|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|8
10809619|NCT03831191|11971481|FG012|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|1
10809620|NCT03831191|11971482|FG013|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|1
10809621|NCT03831191|11971483|FG014|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|9
10809622|NCT03831191|11971469|FG000|COMPLETED|Maintenance Period (36 Weeks)||0
10809623|NCT03831191|11971470|FG001|COMPLETED|Maintenance Period (36 Weeks)||0
10809624|NCT03831191|11971471|FG002|COMPLETED|Maintenance Period (36 Weeks)||0
10809625|NCT03831191|11971472|FG003|COMPLETED|Maintenance Period (36 Weeks)||0
10459455|NCT01021761|11607582|FG002|COMPLETED|Overall Study||42
10459456|NCT01021761|11607580|FG000|NOT COMPLETED|Overall Study||1
10459457|NCT01021761|11607581|FG001|NOT COMPLETED|Overall Study||4
10459458|NCT01021761|11607582|FG002|NOT COMPLETED|Overall Study||0
10459459|NCT01021813|11607592|FG000|STARTED|DB Treatment Phase||522
10708267|NCT02628769|11873091|FG000|NOT COMPLETED|First Intervention||1
10708268|NCT02628769|11873092|FG001|NOT COMPLETED|First Intervention||1
10708269|NCT02628769|11873091|FG000|STARTED|Wash Out (28 Days)||2
10708270|NCT02628769|11873092|FG001|STARTED|Wash Out (28 Days)||2
10459460|NCT01021813|11607593|FG001|STARTED|DB Treatment Phase||259
10459461|NCT01021813|11607594|FG002|STARTED|DB Treatment Phase||0
10459462|NCT01021813|11607595|FG003|STARTED|DB Treatment Phase||0
10459463|NCT01021813|11607596|FG004|STARTED|DB Treatment Phase||0
10459464|NCT01021813|11607592|FG000|Treated|DB Treatment Phase||521
10459465|NCT01021813|11607593|FG001|Treated|DB Treatment Phase||258
10459466|NCT01021813|11607594|FG002|Treated|DB Treatment Phase||0
10459467|NCT01021813|11607595|FG003|Treated|DB Treatment Phase||0
10459468|NCT01021813|11607596|FG004|Treated|DB Treatment Phase||0
10459469|NCT01021813|11607592|FG000|COMPLETED|DB Treatment Phase||322
10459470|NCT01021813|11607593|FG001|COMPLETED|DB Treatment Phase||162
10459471|NCT01021813|11607594|FG002|COMPLETED|DB Treatment Phase||0
10459472|NCT01021813|11607595|FG003|COMPLETED|DB Treatment Phase||0
10459473|NCT01021813|11607596|FG004|COMPLETED|DB Treatment Phase||0
10459474|NCT01021813|11607592|FG000|NOT COMPLETED|DB Treatment Phase||200
10459475|NCT01021813|11607593|FG001|NOT COMPLETED|DB Treatment Phase||97
10459476|NCT01021813|11607594|FG002|NOT COMPLETED|DB Treatment Phase||0
10459477|NCT01021813|11607595|FG003|NOT COMPLETED|DB Treatment Phase||0
10459478|NCT01021813|11607596|FG004|NOT COMPLETED|DB Treatment Phase||0
10459479|NCT01021813|11607592|FG000|STARTED|DB Randomized Discontinuation Phase||0
10459480|NCT01021813|11607593|FG001|STARTED|DB Randomized Discontinuation Phase||0
10459481|NCT01021813|11607594|FG002|STARTED|DB Randomized Discontinuation Phase||156
10459482|NCT01021813|11607595|FG003|STARTED|DB Randomized Discontinuation Phase||166
10459483|NCT01021813|11607596|FG004|STARTED|DB Randomized Discontinuation Phase||162
10459484|NCT01021813|11607592|FG000|COMPLETED|DB Randomized Discontinuation Phase||0
10459485|NCT01021813|11607593|FG001|COMPLETED|DB Randomized Discontinuation Phase||0
10459568|NCT01021852|11607623|FG002|NOT COMPLETED|Washout Period-No Drug||0
10459486|NCT01021813|11607594|FG002|COMPLETED|DB Randomized Discontinuation Phase||152
10459487|NCT01021813|11607595|FG003|COMPLETED|DB Randomized Discontinuation Phase||161
10459488|NCT01021813|11607596|FG004|COMPLETED|DB Randomized Discontinuation Phase||157
10459489|NCT01021813|11607592|FG000|NOT COMPLETED|DB Randomized Discontinuation Phase||0
10459490|NCT01021813|11607593|FG001|NOT COMPLETED|DB Randomized Discontinuation Phase||0
10459491|NCT01021813|11607594|FG002|NOT COMPLETED|DB Randomized Discontinuation Phase||4
10459492|NCT01021813|11607595|FG003|NOT COMPLETED|DB Randomized Discontinuation Phase||5
10459493|NCT01021813|11607596|FG004|NOT COMPLETED|DB Randomized Discontinuation Phase||5
10459494|NCT01021852|11607621|FG000|STARTED|Treatment Period 1||40
10459495|NCT01021852|11607622|FG001|STARTED|Treatment Period 1||40
10459496|NCT01021852|11607623|FG002|STARTED|Treatment Period 1||41
10459497|NCT01021852|11607624|FG003|STARTED|Treatment Period 1||40
10459498|NCT01021852|11607625|FG004|STARTED|Treatment Period 1||42
10459499|NCT01021852|11607626|FG005|STARTED|Treatment Period 1||41
10459500|NCT01021852|11607627|FG006|STARTED|Treatment Period 1||41
10459501|NCT01021852|11607628|FG007|STARTED|Treatment Period 1||41
10459502|NCT01021852|11607621|FG000|Treated|Treatment Period 1||40
10459503|NCT01021852|11607622|FG001|Treated|Treatment Period 1||40
10459504|NCT01021852|11607623|FG002|Treated|Treatment Period 1||41
10459505|NCT01021852|11607624|FG003|Treated|Treatment Period 1||38
10459506|NCT01021852|11607625|FG004|Treated|Treatment Period 1||42
10459507|NCT01021852|11607626|FG005|Treated|Treatment Period 1|1 participant discontinued Treatment Period 1 (AE) but continued in Placebo Washout|41
10459508|NCT01021852|11607627|FG006|Treated|Treatment Period 1||41
10459509|NCT01021852|11607628|FG007|Treated|Treatment Period 1||41
10459510|NCT01021852|11607621|FG000|COMPLETED|Treatment Period 1||37
10459511|NCT01021852|11607622|FG001|COMPLETED|Treatment Period 1||39
10459512|NCT01021852|11607623|FG002|COMPLETED|Treatment Period 1||39
10459513|NCT01021852|11607624|FG003|COMPLETED|Treatment Period 1||38
10459514|NCT01021852|11607625|FG004|COMPLETED|Treatment Period 1||39
10459515|NCT01021852|11607626|FG005|COMPLETED|Treatment Period 1||39
10459516|NCT01021852|11607627|FG006|COMPLETED|Treatment Period 1||41
10459517|NCT01021852|11607628|FG007|COMPLETED|Treatment Period 1||40
10459518|NCT01021852|11607621|FG000|NOT COMPLETED|Treatment Period 1||3
10459519|NCT01021852|11607622|FG001|NOT COMPLETED|Treatment Period 1||1
10459520|NCT01021852|11607623|FG002|NOT COMPLETED|Treatment Period 1||2
10459521|NCT01021852|11607624|FG003|NOT COMPLETED|Treatment Period 1||2
10459522|NCT01021852|11607625|FG004|NOT COMPLETED|Treatment Period 1||3
10459523|NCT01021852|11607626|FG005|NOT COMPLETED|Treatment Period 1||2
10459524|NCT01021852|11607627|FG006|NOT COMPLETED|Treatment Period 1||0
10459525|NCT01021852|11607628|FG007|NOT COMPLETED|Treatment Period 1||1
10459526|NCT01021852|11607621|FG000|STARTED|Washout Period-Placebo||37
10459527|NCT01021852|11607622|FG001|STARTED|Washout Period-Placebo||39
10459528|NCT01021852|11607623|FG002|STARTED|Washout Period-Placebo||39
10459529|NCT01021852|11607624|FG003|STARTED|Washout Period-Placebo||38
10459530|NCT01021852|11607625|FG004|STARTED|Washout Period-Placebo|Includes 1 participant that discontinued Treatment Period 1 (AE).|40
10459531|NCT01021852|11607626|FG005|STARTED|Washout Period-Placebo|Excludes 1 participant who completed Treatment Period 1 but missed Placebo Washout|39
10459532|NCT01021852|11607627|FG006|STARTED|Washout Period-Placebo||41
10459533|NCT01021852|11607628|FG007|STARTED|Washout Period-Placebo||40
10459534|NCT01021852|11607621|FG000|COMPLETED|Washout Period-Placebo||37
10459535|NCT01021852|11607622|FG001|COMPLETED|Washout Period-Placebo||39
10459536|NCT01021852|11607623|FG002|COMPLETED|Washout Period-Placebo||39
10459537|NCT01021852|11607624|FG003|COMPLETED|Washout Period-Placebo||37
10459538|NCT01021852|11607625|FG004|COMPLETED|Washout Period-Placebo||39
10459539|NCT01021852|11607626|FG005|COMPLETED|Washout Period-Placebo||38
10459540|NCT01021852|11607627|FG006|COMPLETED|Washout Period-Placebo||40
10459541|NCT01021852|11607628|FG007|COMPLETED|Washout Period-Placebo||40
10459542|NCT01021852|11607621|FG000|NOT COMPLETED|Washout Period-Placebo||0
10459543|NCT01021852|11607622|FG001|NOT COMPLETED|Washout Period-Placebo||0
10459544|NCT01021852|11607623|FG002|NOT COMPLETED|Washout Period-Placebo||0
10459545|NCT01021852|11607624|FG003|NOT COMPLETED|Washout Period-Placebo||1
10459546|NCT01021852|11607625|FG004|NOT COMPLETED|Washout Period-Placebo||1
10459547|NCT01021852|11607626|FG005|NOT COMPLETED|Washout Period-Placebo||1
10459548|NCT01021852|11607627|FG006|NOT COMPLETED|Washout Period-Placebo||1
10459549|NCT01021852|11607628|FG007|NOT COMPLETED|Washout Period-Placebo||0
10459550|NCT01021852|11607621|FG000|STARTED|Washout Period-No Drug|Includes 1 participant who discontinued Treatment Period 1 (AE) and missed Placebo Washout.|38
10459551|NCT01021852|11607622|FG001|STARTED|Washout Period-No Drug||39
10459552|NCT01021852|11607623|FG002|STARTED|Washout Period-No Drug||39
10459553|NCT01021852|11607624|FG003|STARTED|Washout Period-No Drug||37
10459554|NCT01021852|11607625|FG004|STARTED|Washout Period-No Drug||39
10459555|NCT01021852|11607626|FG005|STARTED|Washout Period-No Drug|Includes 1 participant who completed Treatment Period 1 but missed Placebo Washout.|39
10459556|NCT01021852|11607627|FG006|STARTED|Washout Period-No Drug||40
10459557|NCT01021852|11607628|FG007|STARTED|Washout Period-No Drug||40
10459558|NCT01021852|11607621|FG000|COMPLETED|Washout Period-No Drug||37
10459559|NCT01021852|11607622|FG001|COMPLETED|Washout Period-No Drug||39
10459560|NCT01021852|11607623|FG002|COMPLETED|Washout Period-No Drug||39
10459561|NCT01021852|11607624|FG003|COMPLETED|Washout Period-No Drug||37
10459562|NCT01021852|11607625|FG004|COMPLETED|Washout Period-No Drug||39
10459563|NCT01021852|11607626|FG005|COMPLETED|Washout Period-No Drug||38
10459564|NCT01021852|11607627|FG006|COMPLETED|Washout Period-No Drug||40
10459565|NCT01021852|11607628|FG007|COMPLETED|Washout Period-No Drug||40
10459566|NCT01021852|11607621|FG000|NOT COMPLETED|Washout Period-No Drug||1
10459567|NCT01021852|11607622|FG001|NOT COMPLETED|Washout Period-No Drug||0
10459569|NCT01021852|11607624|FG003|NOT COMPLETED|Washout Period-No Drug||0
10459570|NCT01021852|11607625|FG004|NOT COMPLETED|Washout Period-No Drug||0
10459571|NCT01021852|11607626|FG005|NOT COMPLETED|Washout Period-No Drug||1
10459572|NCT01021852|11607627|FG006|NOT COMPLETED|Washout Period-No Drug||0
10459573|NCT01021852|11607628|FG007|NOT COMPLETED|Washout Period-No Drug||0
10459574|NCT01021852|11607621|FG000|STARTED|Treatment Period 2||37
10459575|NCT01021852|11607622|FG001|STARTED|Treatment Period 2||39
10459576|NCT01021852|11607623|FG002|STARTED|Treatment Period 2||39
10459577|NCT01021852|11607624|FG003|STARTED|Treatment Period 2||37
10459578|NCT01021852|11607625|FG004|STARTED|Treatment Period 2||39
10459579|NCT01021852|11607626|FG005|STARTED|Treatment Period 2||38
10459580|NCT01021852|11607627|FG006|STARTED|Treatment Period 2||40
10459581|NCT01021852|11607628|FG007|STARTED|Treatment Period 2||40
10459582|NCT01021852|11607621|FG000|COMPLETED|Treatment Period 2||37
10459583|NCT01021852|11607622|FG001|COMPLETED|Treatment Period 2||38
10459584|NCT01021852|11607623|FG002|COMPLETED|Treatment Period 2||38
10459585|NCT01021852|11607624|FG003|COMPLETED|Treatment Period 2||37
10459586|NCT01021852|11607625|FG004|COMPLETED|Treatment Period 2||37
10459587|NCT01021852|11607626|FG005|COMPLETED|Treatment Period 2||37
10459588|NCT01021852|11607627|FG006|COMPLETED|Treatment Period 2||37
10459589|NCT01021852|11607628|FG007|COMPLETED|Treatment Period 2||38
10459590|NCT01021852|11607621|FG000|NOT COMPLETED|Treatment Period 2||0
10459591|NCT01021852|11607622|FG001|NOT COMPLETED|Treatment Period 2||1
10459592|NCT01021852|11607623|FG002|NOT COMPLETED|Treatment Period 2||1
10459593|NCT01021852|11607624|FG003|NOT COMPLETED|Treatment Period 2||0
10459594|NCT01021852|11607625|FG004|NOT COMPLETED|Treatment Period 2||2
10459595|NCT01021852|11607626|FG005|NOT COMPLETED|Treatment Period 2||1
10459596|NCT01021852|11607627|FG006|NOT COMPLETED|Treatment Period 2||3
10459597|NCT01021852|11607628|FG007|NOT COMPLETED|Treatment Period 2||2
10459598|NCT01021878|11607644|FG000|STARTED|Overall Study||33
10459599|NCT01021878|11607645|FG001|STARTED|Overall Study||27
10459600|NCT01021878|11607644|FG000|Completed Follow-up|Overall Study||17
10459601|NCT01021878|11607645|FG001|Completed Follow-up|Overall Study||17
10459602|NCT01021878|11607644|FG000|COMPLETED|Overall Study||17
10459603|NCT01021878|11607645|FG001|COMPLETED|Overall Study||17
10459604|NCT01021878|11607644|FG000|NOT COMPLETED|Overall Study||16
10459605|NCT01021878|11607645|FG001|NOT COMPLETED|Overall Study||10
10459606|NCT01021956|11607658|FG000|STARTED|Overall Study||3
10459607|NCT01021956|11607659|FG001|STARTED|Overall Study||3
10459608|NCT01021956|11607660|FG002|STARTED|Overall Study||3
10459609|NCT01021956|11607661|FG003|STARTED|Overall Study||1
10459610|NCT01021956|11607658|FG000|COMPLETED|Overall Study||3
10459611|NCT01021956|11607659|FG001|COMPLETED|Overall Study||3
10459612|NCT01021956|11607660|FG002|COMPLETED|Overall Study||3
10459613|NCT01021956|11607661|FG003|COMPLETED|Overall Study||1
10459614|NCT01021956|11607658|FG000|NOT COMPLETED|Overall Study||0
10459615|NCT01021956|11607659|FG001|NOT COMPLETED|Overall Study||0
10459616|NCT01021956|11607660|FG002|NOT COMPLETED|Overall Study||0
10459617|NCT01021956|11607661|FG003|NOT COMPLETED|Overall Study||0
10459618|NCT01022073|11607674|FG000|STARTED|Overall Study||86
10459619|NCT01022073|11607675|FG001|STARTED|Overall Study||70
10459620|NCT01022073|11607674|FG000|COMPLETED|Overall Study||67
10459621|NCT01022073|11607675|FG001|COMPLETED|Overall Study||52
10459622|NCT01022073|11607674|FG000|NOT COMPLETED|Overall Study||19
10459623|NCT01022073|11607675|FG001|NOT COMPLETED|Overall Study||18
10459624|NCT01022112|11607686|FG000|STARTED|Overall Study||82
10459625|NCT01022112|11607687|FG001|STARTED|Overall Study||74
10459626|NCT01022112|11607688|FG002|STARTED|Overall Study||77
10459627|NCT01022112|11607689|FG003|STARTED|Overall Study||75
10459628|NCT01022112|11607690|FG004|STARTED|Overall Study||75
10459629|NCT01022112|11607686|FG000|COMPLETED|Overall Study||79
10459630|NCT01022112|11607687|FG001|COMPLETED|Overall Study||71
10459631|NCT01022112|11607688|FG002|COMPLETED|Overall Study||74
10459632|NCT01022112|11607689|FG003|COMPLETED|Overall Study||72
10459633|NCT01022112|11607690|FG004|COMPLETED|Overall Study||65
10459634|NCT01022112|11607686|FG000|NOT COMPLETED|Overall Study||3
10459635|NCT01022112|11607687|FG001|NOT COMPLETED|Overall Study||3
10459636|NCT01022112|11607688|FG002|NOT COMPLETED|Overall Study||3
10459637|NCT01022112|11607689|FG003|NOT COMPLETED|Overall Study||3
10459638|NCT01022112|11607690|FG004|NOT COMPLETED|Overall Study||10
10459639|NCT01022190|11607702|FG000|STARTED|Overall Study||42
10459640|NCT01022190|11607702|FG000|COMPLETED|Overall Study||42
10459641|NCT01022190|11607702|FG000|NOT COMPLETED|Overall Study||0
10459642|NCT01022203|11607708|FG000|STARTED|PreTreatment Assessment||58
10459643|NCT01022203|11607709|FG001|STARTED|PreTreatment Assessment||56
10459644|NCT01022203|11607708|FG000|COMPLETED|PreTreatment Assessment||58
10459645|NCT01022203|11607709|FG001|COMPLETED|PreTreatment Assessment||56
10459646|NCT01022203|11607708|FG000|NOT COMPLETED|PreTreatment Assessment||0
10459647|NCT01022203|11607709|FG001|NOT COMPLETED|PreTreatment Assessment||0
10459648|NCT01022203|11607708|FG000|STARTED|Post Treatment Assessment||58
10459649|NCT01022203|11607709|FG001|STARTED|Post Treatment Assessment||56
10459650|NCT01022203|11607708|FG000|COMPLETED|Post Treatment Assessment||44
10459651|NCT01022203|11607709|FG001|COMPLETED|Post Treatment Assessment||42
10459652|NCT01022203|11607708|FG000|NOT COMPLETED|Post Treatment Assessment||14
10459653|NCT01022203|11607709|FG001|NOT COMPLETED|Post Treatment Assessment||14
10459654|NCT01022203|11607708|FG000|STARTED|Follow-Up Assessment||44
10459655|NCT01022203|11607709|FG001|STARTED|Follow-Up Assessment||42
10459656|NCT01022203|11607708|FG000|COMPLETED|Follow-Up Assessment||42
10459657|NCT01022203|11607709|FG001|COMPLETED|Follow-Up Assessment||40
10459658|NCT01022203|11607708|FG000|NOT COMPLETED|Follow-Up Assessment||2
10459659|NCT01022203|11607709|FG001|NOT COMPLETED|Follow-Up Assessment||2
10459660|NCT01022242|11607720|FG000|STARTED|Overall Study|71 pat rand to placebo. 1 got incorrect mix of placebo. 70 patients treated with the correct mix.|70
10459661|NCT01022242|11607721|FG001|STARTED|Overall Study|67 pat rand to PXL01. 2 got incorrect mix of PXL01. 65 patients treated with the correct PXL01 mix.|65
10459662|NCT01022242|11607720|FG000|COMPLETED|Overall Study||49
10459663|NCT01022242|11607721|FG001|COMPLETED|Overall Study||46
10459664|NCT01022242|11607720|FG000|NOT COMPLETED|Overall Study||21
10459665|NCT01022242|11607721|FG001|NOT COMPLETED|Overall Study||19
10459666|NCT01022307|11607729|FG000|STARTED|Overall Study||184
10459667|NCT01022307|11607730|FG001|STARTED|Overall Study||28
10459668|NCT01022307|11607729|FG000|COMPLETED|Overall Study||184
10459669|NCT01022307|11607730|FG001|COMPLETED|Overall Study|Some TBI patients could not undergo MR scanning due to contraindications.|24
10459670|NCT01022307|11607729|FG000|NOT COMPLETED|Overall Study||0
10459671|NCT01022307|11607730|FG001|NOT COMPLETED|Overall Study||4
10459672|NCT01022359|11607738|FG000|STARTED|Overall Study||39
10459673|NCT01022359|11607739|FG001|STARTED|Overall Study||41
10459674|NCT01022359|11607738|FG000|COMPLETED|Overall Study||39
10459675|NCT01022359|11607739|FG001|COMPLETED|Overall Study||41
10459676|NCT01022359|11607738|FG000|NOT COMPLETED|Overall Study||0
10459677|NCT01022359|11607739|FG001|NOT COMPLETED|Overall Study||0
10459678|NCT01022424|11607745|FG000|STARTED|Overall Study||13
10459679|NCT01022424|11607745|FG000|COMPLETED|Overall Study||9
10459680|NCT01022424|11607745|FG000|NOT COMPLETED|Overall Study||4
10459681|NCT01022502|11607753|FG000|STARTED|Overall Study|19 used the refined ointment on the right site, 19 used the crude ointment on the left site.|38
10459682|NCT01022502|11607753|FG000|COMPLETED|Overall Study|3 participants withdrew at week 4,5,6,respectively.|35
10459683|NCT01022502|11607753|FG000|NOT COMPLETED|Overall Study||3
10459684|NCT01022567|11607761|FG000|STARTED|Overall Study||273
10459685|NCT01022567|11607762|FG001|STARTED|Overall Study||257
10459686|NCT01022567|11607761|FG000|COMPLETED|Overall Study||272
10459687|NCT01022567|11607762|FG001|COMPLETED|Overall Study||242
10459688|NCT01022567|11607761|FG000|NOT COMPLETED|Overall Study||1
10459689|NCT01022567|11607762|FG001|NOT COMPLETED|Overall Study||15
10459690|NCT01022580|11607770|FG000|STARTED|Overall Study||252
10459691|NCT01022580|11607771|FG001|STARTED|Overall Study||259
10459692|NCT01022580|11607770|FG000|COMPLETED|Overall Study|Survived to discharge|234
10459693|NCT01022580|11607771|FG001|COMPLETED|Overall Study|Survived to discharge.|237
10459694|NCT01022580|11607770|FG000|NOT COMPLETED|Overall Study||18
10459695|NCT01022580|11607771|FG001|NOT COMPLETED|Overall Study||22
10459696|NCT01022762|11607785|FG000|STARTED|Overall Study||218
10459697|NCT01022762|11607786|FG001|STARTED|Overall Study||222
10459698|NCT01022762|11607785|FG000|Exposed to Trial Drug|Overall Study|One participant was not exposed to the treatment due to fulfillment of exclusion criteria|217
10459699|NCT01022762|11607786|FG001|Exposed to Trial Drug|Overall Study|Four participants were not exposed to the treatment due to non-compliance or lost to follow-up|218
10459700|NCT01022762|11607785|FG000|COMPLETED|Overall Study||196
10459701|NCT01022762|11607786|FG001|COMPLETED|Overall Study||194
10459702|NCT01022762|11607785|FG000|NOT COMPLETED|Overall Study||22
10459703|NCT01022762|11607786|FG001|NOT COMPLETED|Overall Study||28
10459704|NCT01022853|11607797|FG000|STARTED|Overall Study|entered and treated|3
10459705|NCT01022853|11607798|FG001|STARTED|Overall Study|entered and treated|4
10459706|NCT01022853|11607799|FG002|STARTED|Overall Study|entered and treated|13
10459707|NCT01022853|11607800|FG003|STARTED|Overall Study|entered and treated|8
10459708|NCT01022853|11607801|FG004|STARTED|Overall Study|entered and treated|2
10459709|NCT01022853|11607797|FG000|COMPLETED|Overall Study||0
10459710|NCT01022853|11607798|FG001|COMPLETED|Overall Study||0
10459711|NCT01022853|11607799|FG002|COMPLETED|Overall Study||0
10459712|NCT01022853|11607800|FG003|COMPLETED|Overall Study||0
10459713|NCT01022853|11607801|FG004|COMPLETED|Overall Study||0
10459714|NCT01022853|11607797|FG000|NOT COMPLETED|Overall Study||3
10459715|NCT01022853|11607798|FG001|NOT COMPLETED|Overall Study||4
10459716|NCT01022853|11607799|FG002|NOT COMPLETED|Overall Study||13
10459717|NCT01022853|11607800|FG003|NOT COMPLETED|Overall Study||8
10459718|NCT01022853|11607801|FG004|NOT COMPLETED|Overall Study||2
10459719|NCT01022996|11607816|FG000|STARTED|Overall Study||57
10459720|NCT01022996|11607816|FG000|COMPLETED|Overall Study||0
10459721|NCT01022996|11607816|FG000|NOT COMPLETED|Overall Study||57
10459722|NCT01023022|11607820|FG000|STARTED|Overall Study|Previous No.: 178 subjects incl. 2 pts who withdraw their approval for processing personal data|176
10459723|NCT01023022|11607820|FG000|COMPLETED|Overall Study||162
10459724|NCT01023022|11607820|FG000|NOT COMPLETED|Overall Study||14
10459725|NCT01023035|11607827|FG000|STARTED|Treatment Period||249
10459726|NCT01023035|11607828|FG001|STARTED|Treatment Period||251
10459727|NCT01023035|11607829|FG002|STARTED|Treatment Period||187
10459728|NCT01023035|11607827|FG000|COMPLETED|Treatment Period||177
10459729|NCT01023035|11607828|FG001|COMPLETED|Treatment Period||166
10459730|NCT01023035|11607829|FG002|COMPLETED|Treatment Period||69
10459731|NCT01023035|11607827|FG000|NOT COMPLETED|Treatment Period||72
10459732|NCT01023035|11607828|FG001|NOT COMPLETED|Treatment Period||85
10459733|NCT01023035|11607829|FG002|NOT COMPLETED|Treatment Period||118
10459734|NCT01023035|11607827|FG000|STARTED|Follow-up Period (up to Week 72)||238
10459735|NCT01023035|11607828|FG001|STARTED|Follow-up Period (up to Week 72)||235
10459736|NCT01023035|11607829|FG002|STARTED|Follow-up Period (up to Week 72)||147
10459737|NCT01023035|11607827|FG000|COMPLETED|Follow-up Period (up to Week 72)||210
10459738|NCT01023035|11607828|FG001|COMPLETED|Follow-up Period (up to Week 72)||207
10459739|NCT01023035|11607829|FG002|COMPLETED|Follow-up Period (up to Week 72)||108
10459740|NCT01023035|11607827|FG000|NOT COMPLETED|Follow-up Period (up to Week 72)||28
10459741|NCT01023035|11607828|FG001|NOT COMPLETED|Follow-up Period (up to Week 72)||28
10459742|NCT01023035|11607829|FG002|NOT COMPLETED|Follow-up Period (up to Week 72)||39
10459743|NCT01023061|11607839|FG000|STARTED|Overall Study||24
10459744|NCT01023061|11607839|FG000|COMPLETED|Overall Study||22
10459745|NCT01023061|11607839|FG000|NOT COMPLETED|Overall Study||2
10459746|NCT01023074|11607846|FG000|STARTED|Overall Study||26
10459747|NCT01023074|11607847|FG001|STARTED|Overall Study||13
10459748|NCT01023074|11607848|FG002|STARTED|Overall Study||13
10459749|NCT01023074|11607846|FG000|COMPLETED|Overall Study||26
10459750|NCT01023074|11607847|FG001|COMPLETED|Overall Study||13
10459751|NCT01023074|11607848|FG002|COMPLETED|Overall Study||13
10459752|NCT01023074|11607846|FG000|NOT COMPLETED|Overall Study||0
10459753|NCT01023074|11607847|FG001|NOT COMPLETED|Overall Study||0
10459754|NCT01023074|11607848|FG002|NOT COMPLETED|Overall Study||0
10459755|NCT01023178|11607863|FG000|STARTED|Overall Study||5
10459756|NCT01023178|11607864|FG001|STARTED|Overall Study||8
10459757|NCT01023178|11607865|FG002|STARTED|Overall Study||7
10459758|NCT01023178|11607863|FG000|COMPLETED|Overall Study||3
10459759|NCT01023178|11607864|FG001|COMPLETED|Overall Study||6
10459760|NCT01023178|11607865|FG002|COMPLETED|Overall Study||4
10459761|NCT01023178|11607863|FG000|NOT COMPLETED|Overall Study||2
10459762|NCT01023178|11607864|FG001|NOT COMPLETED|Overall Study||2
10459763|NCT01023178|11607865|FG002|NOT COMPLETED|Overall Study||3
10459764|NCT01023217|11607875|FG000|STARTED|Overall Study||45
10459765|NCT01023217|11607876|FG001|STARTED|Overall Study||45
10459766|NCT01023217|11607875|FG000|COMPLETED|Overall Study||44
10459767|NCT01023217|11607876|FG001|COMPLETED|Overall Study||45
10459768|NCT01023217|11607875|FG000|NOT COMPLETED|Overall Study||1
10459769|NCT01023217|11607876|FG001|NOT COMPLETED|Overall Study||0
10459770|NCT01023256|11607886|FG000|STARTED|Overall Study||25
10459771|NCT01023256|11607887|FG001|STARTED|Overall Study||22
10459772|NCT01023256|11607888|FG002|STARTED|Overall Study||24
10459773|NCT01023256|11607889|FG003|STARTED|Overall Study||27
10459774|NCT01023256|11607886|FG000|COMPLETED|Overall Study||21
10459775|NCT01023256|11607887|FG001|COMPLETED|Overall Study||19
10459776|NCT01023256|11607888|FG002|COMPLETED|Overall Study||23
10459777|NCT01023256|11607889|FG003|COMPLETED|Overall Study||22
10459778|NCT01023256|11607886|FG000|NOT COMPLETED|Overall Study||4
10459779|NCT01023256|11607887|FG001|NOT COMPLETED|Overall Study||3
10459780|NCT01023256|11607888|FG002|NOT COMPLETED|Overall Study||1
10459781|NCT01023256|11607889|FG003|NOT COMPLETED|Overall Study||5
10459782|NCT01023269|11607902|FG000|STARTED|Overall Study||3
10459783|NCT01023269|11607903|FG001|STARTED|Overall Study||2
10459784|NCT01023269|11607902|FG000|COMPLETED|Overall Study||1
10459785|NCT01023269|11607903|FG001|COMPLETED|Overall Study||2
10459786|NCT01023269|11607902|FG000|NOT COMPLETED|Overall Study||2
10459787|NCT01023269|11607903|FG001|NOT COMPLETED|Overall Study||0
10459788|NCT01023308|11607909|FG000|STARTED|Overall Study||387
10459789|NCT01023308|11607910|FG001|STARTED|Overall Study||381
10459790|NCT01023308|11607909|FG000|COMPLETED|Overall Study|completed all planned cycles of study treatment as per protocol|102
10459791|NCT01023308|11607910|FG001|COMPLETED|Overall Study|completed all planned cycles of study treatment as per protocol|102
10459792|NCT01023308|11607909|FG000|NOT COMPLETED|Overall Study||285
10459793|NCT01023308|11607910|FG001|NOT COMPLETED|Overall Study||279
10459794|NCT01023477|11607918|FG000|STARTED|Overall Study||7
10459795|NCT01023477|11607919|FG001|STARTED|Overall Study||5
10459796|NCT01023477|11607918|FG000|COMPLETED|Overall Study||7
10459797|NCT01023477|11607919|FG001|COMPLETED|Overall Study||5
10459798|NCT01023477|11607918|FG000|NOT COMPLETED|Overall Study||0
10459799|NCT01023477|11607919|FG001|NOT COMPLETED|Overall Study||0
10459800|NCT01023516|11607927|FG000|STARTED|Overall Study||313
10459801|NCT01023516|11607928|FG001|STARTED|Overall Study||302
10459802|NCT01023516|11607927|FG000|COMPLETED|Overall Study||289
10459803|NCT01023516|11607928|FG001|COMPLETED|Overall Study||284
10459804|NCT01023516|11607927|FG000|NOT COMPLETED|Overall Study||24
10459805|NCT01023516|11607928|FG001|NOT COMPLETED|Overall Study||18
10459806|NCT01023568|11607937|FG000|STARTED|Overall Study||45
10459807|NCT01023568|11607938|FG001|STARTED|Overall Study||44
10459808|NCT01023568|11607939|FG002|STARTED|Overall Study||45
10459809|NCT01023568|11607937|FG000|COMPLETED|Overall Study||45
10459810|NCT01023568|11607938|FG001|COMPLETED|Overall Study||44
10459811|NCT01023568|11607939|FG002|COMPLETED|Overall Study||45
10459812|NCT01023568|11607937|FG000|NOT COMPLETED|Overall Study||0
10459813|NCT01023568|11607938|FG001|NOT COMPLETED|Overall Study||0
10459814|NCT01023568|11607939|FG002|NOT COMPLETED|Overall Study||0
10459815|NCT01023581|11607954|FG000|STARTED|Overall Study||109
10459816|NCT01023581|11607955|FG001|STARTED|Overall Study||112
10459817|NCT01023581|11607956|FG002|STARTED|Overall Study||113
10459818|NCT01023581|11607957|FG003|STARTED|Overall Study||114
10459819|NCT01023581|11607958|FG004|STARTED|Overall Study||111
10459820|NCT01023581|11607959|FG005|STARTED|Overall Study||111
10459821|NCT01023581|11607960|FG006|STARTED|Overall Study||114
10459822|NCT01023581|11607954|FG000|Received Study Treatment|Overall Study||106
10459823|NCT01023581|11607955|FG001|Received Study Treatment|Overall Study||112
10459824|NCT01023581|11607956|FG002|Received Study Treatment|Overall Study||110
10459825|NCT01023581|11607957|FG003|Received Study Treatment|Overall Study||109
10459826|NCT01023581|11607958|FG004|Received Study Treatment|Overall Study||111
10459827|NCT01023581|11607959|FG005|Received Study Treatment|Overall Study||106
10459828|NCT01023581|11607960|FG006|Received Study Treatment|Overall Study||114
10459829|NCT01023581|11607954|FG000|COMPLETED|Overall Study|The number of completed patients represents those who completed study drug.|74
10459830|NCT01023581|11607955|FG001|COMPLETED|Overall Study||89
10459831|NCT01023581|11607956|FG002|COMPLETED|Overall Study||71
10459832|NCT01023581|11607957|FG003|COMPLETED|Overall Study||94
10459833|NCT01023581|11607958|FG004|COMPLETED|Overall Study||95
10459834|NCT01023581|11607959|FG005|COMPLETED|Overall Study||92
10459835|NCT01023581|11607960|FG006|COMPLETED|Overall Study||94
10459836|NCT01023581|11607954|FG000|NOT COMPLETED|Overall Study||35
10459837|NCT01023581|11607955|FG001|NOT COMPLETED|Overall Study||23
10459838|NCT01023581|11607956|FG002|NOT COMPLETED|Overall Study||42
10459839|NCT01023581|11607957|FG003|NOT COMPLETED|Overall Study||20
10459840|NCT01023581|11607958|FG004|NOT COMPLETED|Overall Study||16
10459841|NCT01023581|11607959|FG005|NOT COMPLETED|Overall Study||19
10459842|NCT01023581|11607960|FG006|NOT COMPLETED|Overall Study||20
10459843|NCT01023659|11607979|FG000|STARTED|Overall Study||258
10459844|NCT01023659|11607980|FG001|STARTED|Overall Study||365
10459845|NCT01023659|11607981|FG002|STARTED|Overall Study||264
10459846|NCT01023659|11607979|FG000|COMPLETED|Overall Study||185
10459847|NCT01023659|11607980|FG001|COMPLETED|Overall Study||137
10459848|NCT01023659|11607981|FG002|COMPLETED|Overall Study||165
10459849|NCT01023659|11607979|FG000|NOT COMPLETED|Overall Study||73
10459850|NCT01023659|11607980|FG001|NOT COMPLETED|Overall Study||228
10459851|NCT01023659|11607981|FG002|NOT COMPLETED|Overall Study||99
10459852|NCT01023672|11607990|FG000|STARTED|Overall Study||20
10459853|NCT01023672|11607990|FG000|COMPLETED|Overall Study||17
10459854|NCT01023672|11607990|FG000|NOT COMPLETED|Overall Study||3
10459855|NCT01023711|11607994|FG000|STARTED|Overall Study||107
10459856|NCT01023711|11607994|FG000|COMPLETED|Overall Study||107
10459857|NCT01023711|11607994|FG000|NOT COMPLETED|Overall Study||0
10459858|NCT01023724|11608001|FG000|STARTED|Overall Study||25
10459859|NCT01023724|11608002|FG001|STARTED|Overall Study||25
10459860|NCT01023724|11608001|FG000|COMPLETED|Overall Study||21
10459861|NCT01023724|11608002|FG001|COMPLETED|Overall Study||22
10459862|NCT01023724|11608001|FG000|NOT COMPLETED|Overall Study||4
10459863|NCT01023724|11608002|FG001|NOT COMPLETED|Overall Study||3
10459864|NCT01023776|11608008|FG000|STARTED|Overall Study|Subjects received 2 dose of vaccine 0.1 ml in each nostril intra nasally 28 days apart|20
10459865|NCT01023776|11608008|FG000|COMPLETED|Overall Study||20
10459866|NCT01023776|11608008|FG000|NOT COMPLETED|Overall Study||0
10459867|NCT01023789|11608012|FG000|STARTED|30-day Follow-up Visit|Intent-to-treat population (ITT).|812
10459868|NCT01023789|11608012|FG000|COMPLETED|30-day Follow-up Visit||812
10459869|NCT01023789|11608012|FG000|NOT COMPLETED|30-day Follow-up Visit||0
10459870|NCT01023789|11608012|FG000|STARTED|180-day Clinical Follow-up||812
10459871|NCT01023789|11608012|FG000|COMPLETED|180-day Clinical Follow-up||812
10459872|NCT01023789|11608012|FG000|NOT COMPLETED|180-day Clinical Follow-up||0
10459873|NCT01023789|11608012|FG000|STARTED|1 - Year Visit||812
10459874|NCT01023789|11608012|FG000|COMPLETED|1 - Year Visit||812
10459875|NCT01023789|11608012|FG000|NOT COMPLETED|1 - Year Visit||0
10459876|NCT01023789|11608012|FG000|STARTED|2 - Year Visit||812
10459877|NCT01023789|11608012|FG000|COMPLETED|2 - Year Visit||812
10459878|NCT01023789|11608012|FG000|NOT COMPLETED|2 - Year Visit||0
10459879|NCT01023789|11608012|FG000|STARTED|3 - Year Visit||812
10459880|NCT01023789|11608012|FG000|COMPLETED|3 - Year Visit||769
10459881|NCT01023789|11608012|FG000|NOT COMPLETED|3 - Year Visit||43
10459882|NCT01023815|11608020|FG000|STARTED|Pre-randomization Period (Day 1 to 90)|Out of 330 enrolled, 2 patients never received everolimus.|328
10459883|NCT01023815|11608021|FG001|STARTED|Pre-randomization Period (Day 1 to 90)||0
10459884|NCT01023815|11608022|FG002|STARTED|Pre-randomization Period (Day 1 to 90)||0
10459885|NCT01023815|11608023|FG003|STARTED|Pre-randomization Period (Day 1 to 90)||0
10459886|NCT01023815|11608020|FG000|COMPLETED|Pre-randomization Period (Day 1 to 90)||184
10459887|NCT01023815|11608021|FG001|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
10459888|NCT01023815|11608022|FG002|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
10459889|NCT01023815|11608023|FG003|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
10459890|NCT01023815|11608020|FG000|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||144
10459891|NCT01023815|11608021|FG001|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
10459892|NCT01023815|11608022|FG002|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
10459893|NCT01023815|11608023|FG003|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
10459894|NCT01023815|11608020|FG000|STARTED|Randomized Period (Day 90 to Month 12)||0
10459895|NCT01023815|11608021|FG001|STARTED|Randomized Period (Day 90 to Month 12)|Randomized patients to Group A, B and C are also intent to treat population.|45
10459896|NCT01023815|11608022|FG002|STARTED|Randomized Period (Day 90 to Month 12)||68
10459897|NCT01023815|11608023|FG003|STARTED|Randomized Period (Day 90 to Month 12)||71
10459898|NCT01023815|11608020|FG000|COMPLETED|Randomized Period (Day 90 to Month 12)||0
10459899|NCT01023815|11608021|FG001|COMPLETED|Randomized Period (Day 90 to Month 12)||42
10459900|NCT01023815|11608022|FG002|COMPLETED|Randomized Period (Day 90 to Month 12)||60
10459901|NCT01023815|11608023|FG003|COMPLETED|Randomized Period (Day 90 to Month 12)||68
10459902|NCT01023815|11608020|FG000|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||0
10459903|NCT01023815|11608021|FG001|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||3
10459904|NCT01023815|11608022|FG002|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||8
10459905|NCT01023815|11608023|FG003|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||3
10459906|NCT01023841|11608036|FG000|STARTED|Overall Study||48
10459907|NCT01023841|11608037|FG001|STARTED|Overall Study||23
10459908|NCT01023841|11608036|FG000|COMPLETED|Overall Study||47
10459909|NCT01023841|11608037|FG001|COMPLETED|Overall Study||23
10459910|NCT01023841|11608036|FG000|NOT COMPLETED|Overall Study||1
10459911|NCT01023841|11608037|FG001|NOT COMPLETED|Overall Study||0
10459912|NCT01023958|11608043|FG000|STARTED|Overall Study||50
10459913|NCT01023958|11608043|FG000|COMPLETED|Overall Study||0
10459914|NCT01023958|11608043|FG000|NOT COMPLETED|Overall Study||50
10459915|NCT01024010|11608049|FG000|STARTED|Overall Study||48
10459916|NCT01024010|11608050|FG001|STARTED|Overall Study||34
10459917|NCT01024010|11608049|FG000|COMPLETED|Overall Study||48
10459918|NCT01024010|11608050|FG001|COMPLETED|Overall Study||34
10459919|NCT01024010|11608049|FG000|NOT COMPLETED|Overall Study||0
10459920|NCT01024010|11608050|FG001|NOT COMPLETED|Overall Study||0
10459921|NCT01024036|11608058|FG000|STARTED|Blinded Treatment||53
10459922|NCT01024036|11608059|FG001|STARTED|Blinded Treatment||26
10459923|NCT01024036|11608058|FG000|COMPLETED|Blinded Treatment||31
10459924|NCT01024036|11608059|FG001|COMPLETED|Blinded Treatment||6
10459925|NCT01024036|11608058|FG000|NOT COMPLETED|Blinded Treatment||22
10459926|NCT01024036|11608059|FG001|NOT COMPLETED|Blinded Treatment||20
10459927|NCT01024036|11608058|FG000|STARTED|Unblinded Treatment|No participants in this group received treatment during unblinded treatment period|0
10459928|NCT01024036|11608059|FG001|STARTED|Unblinded Treatment|Placebo participants had an option to receive siltuximab in unblinded treatment period|13
10459929|NCT01024036|11608058|FG000|COMPLETED|Unblinded Treatment||0
10459930|NCT01024036|11608059|FG001|COMPLETED|Unblinded Treatment||10
10459931|NCT01024036|11608058|FG000|NOT COMPLETED|Unblinded Treatment||0
10459932|NCT01024036|11608059|FG001|NOT COMPLETED|Unblinded Treatment||3
10459933|NCT01024036|11608058|FG000|STARTED|Follow-Up Period||14
10459934|NCT01024036|11608059|FG001|STARTED|Follow-Up Period||6
10459935|NCT01024036|11608058|FG000|COMPLETED|Follow-Up Period||9
10459936|NCT01024036|11608059|FG001|COMPLETED|Follow-Up Period||3
10459937|NCT01024036|11608058|FG000|NOT COMPLETED|Follow-Up Period||5
10459938|NCT01024036|11608059|FG001|NOT COMPLETED|Follow-Up Period||3
10459939|NCT01024231|11608075|FG000|STARTED|Overall Study||14
10459940|NCT01024231|11608076|FG001|STARTED|Overall Study||17
10459941|NCT01024231|11608077|FG002|STARTED|Overall Study||16
10459942|NCT01024231|11608078|FG003|STARTED|Overall Study||6
10459943|NCT01024231|11608079|FG004|STARTED|Overall Study||17
10459944|NCT01024231|11608080|FG005|STARTED|Overall Study||16
10459945|NCT01024231|11608081|FG006|STARTED|Overall Study||41
10459946|NCT01024231|11608075|FG000|COMPLETED|Overall Study||2
10459947|NCT01024231|11608076|FG001|COMPLETED|Overall Study||2
10708271|NCT02628769|11873091|FG000|COMPLETED|Wash Out (28 Days)||2
10708272|NCT02628769|11873092|FG001|COMPLETED|Wash Out (28 Days)||2
10708273|NCT02628769|11873091|FG000|NOT COMPLETED|Wash Out (28 Days)||0
10459948|NCT01024231|11608077|FG002|COMPLETED|Overall Study||6
10459949|NCT01024231|11608078|FG003|COMPLETED|Overall Study||1
10459950|NCT01024231|11608079|FG004|COMPLETED|Overall Study||0
10459951|NCT01024231|11608080|FG005|COMPLETED|Overall Study||0
10459952|NCT01024231|11608081|FG006|COMPLETED|Overall Study||20
10459953|NCT01024231|11608075|FG000|NOT COMPLETED|Overall Study||12
10459954|NCT01024231|11608076|FG001|NOT COMPLETED|Overall Study||15
10459955|NCT01024231|11608077|FG002|NOT COMPLETED|Overall Study||10
10459956|NCT01024231|11608078|FG003|NOT COMPLETED|Overall Study||5
10459957|NCT01024231|11608079|FG004|NOT COMPLETED|Overall Study||17
10459958|NCT01024231|11608080|FG005|NOT COMPLETED|Overall Study||16
10459959|NCT01024231|11608081|FG006|NOT COMPLETED|Overall Study||21
10708274|NCT02628769|11873092|FG001|NOT COMPLETED|Wash Out (28 Days)||0
10708275|NCT02628769|11873091|FG000|STARTED|Second Intervention||2
10459960|NCT01024244|11608107|FG000|STARTED|Overall Study||22
10459961|NCT01024244|11608108|FG001|STARTED|Overall Study||12
10459962|NCT01024244|11608109|FG002|STARTED|Overall Study||15
10459963|NCT01024244|11608110|FG003|STARTED|Overall Study||14
10459964|NCT01024244|11608111|FG004|STARTED|Overall Study||15
10459965|NCT01024244|11608107|FG000|COMPLETED|Overall Study||5
10459966|NCT01024244|11608108|FG001|COMPLETED|Overall Study||1
10459967|NCT01024244|11608109|FG002|COMPLETED|Overall Study||1
10459968|NCT01024244|11608110|FG003|COMPLETED|Overall Study||1
10459969|NCT01024244|11608111|FG004|COMPLETED|Overall Study||1
10459970|NCT01024244|11608107|FG000|NOT COMPLETED|Overall Study||17
10459971|NCT01024244|11608108|FG001|NOT COMPLETED|Overall Study||11
10459972|NCT01024244|11608109|FG002|NOT COMPLETED|Overall Study||14
10459973|NCT01024244|11608110|FG003|NOT COMPLETED|Overall Study||13
10459974|NCT01024244|11608111|FG004|NOT COMPLETED|Overall Study||14
10459975|NCT01024296|11608123|FG000|STARTED|Overall Study||4
10459976|NCT01024296|11608123|FG000|COMPLETED|Overall Study||4
10459977|NCT01024296|11608123|FG000|NOT COMPLETED|Overall Study||0
10459978|NCT01024309|11608129|FG000|STARTED|Overall Study||35
10459979|NCT01024309|11608130|FG001|STARTED|Overall Study||31
10459980|NCT01024309|11608129|FG000|COMPLETED|Overall Study||27
10459981|NCT01024309|11608130|FG001|COMPLETED|Overall Study||27
10459982|NCT01024309|11608129|FG000|NOT COMPLETED|Overall Study||8
10459983|NCT01024309|11608130|FG001|NOT COMPLETED|Overall Study||4
10459984|NCT01024335|11608138|FG000|STARTED|Overall Study||20
10459985|NCT01024335|11608139|FG001|STARTED|Overall Study||40
10459986|NCT01024335|11608138|FG000|COMPLETED|Overall Study||7
10459987|NCT01024335|11608139|FG001|COMPLETED|Overall Study||14
10459988|NCT01024335|11608138|FG000|NOT COMPLETED|Overall Study||13
10459989|NCT01024335|11608139|FG001|NOT COMPLETED|Overall Study||26
10459990|NCT01024387|11608145|FG000|STARTED|Overall Study||60
10459991|NCT01024387|11608145|FG000|Evaluable for PFS|Overall Study||54
10459992|NCT01024387|11608145|FG000|Evaluable for Response|Overall Study||53
10459993|NCT01024387|11608145|FG000|COMPLETED|Overall Study||0
10459994|NCT01024387|11608145|FG000|NOT COMPLETED|Overall Study||60
10459995|NCT01024465|11608149|FG000|STARTED|Overall Study||26
10459996|NCT01024465|11608149|FG000|COMPLETED|Overall Study||23
10459997|NCT01024465|11608149|FG000|NOT COMPLETED|Overall Study||3
10459998|NCT01024569|11608155|FG000|STARTED|Overall Study||276
10459999|NCT01024569|11608156|FG001|STARTED|Overall Study||279
10460000|NCT01024569|11608155|FG000|COMPLETED|Overall Study||251
10460001|NCT01024569|11608156|FG001|COMPLETED|Overall Study||268
10460002|NCT01024569|11608155|FG000|NOT COMPLETED|Overall Study||25
10460003|NCT01024569|11608156|FG001|NOT COMPLETED|Overall Study||11
10460004|NCT01024686|11608167|FG000|STARTED|Overall Study|July 11, 2010: unexpected adverse event, (1) participant|6
10460005|NCT01024686|11608168|FG001|STARTED|Overall Study||0
10460006|NCT01024686|11608169|FG002|STARTED|Overall Study||0
10460007|NCT01024686|11608167|FG000|COMPLETED|Overall Study||6
10460008|NCT01024686|11608168|FG001|COMPLETED|Overall Study|(0) participants because the clinical trial was terminated prior to enrollment.|0
10460009|NCT01024686|11608169|FG002|COMPLETED|Overall Study|(0) participants because the clinical trial was terminated prior to enrollment.|0
10460010|NCT01024686|11608167|FG000|NOT COMPLETED|Overall Study||0
10460011|NCT01024686|11608168|FG001|NOT COMPLETED|Overall Study||0
10460012|NCT01024686|11608169|FG002|NOT COMPLETED|Overall Study||0
10460013|NCT01024738|11608180|FG000|STARTED|First Intervention:||7
10460014|NCT01024738|11608181|FG001|STARTED|First Intervention:||7
10460015|NCT01024738|11608182|FG002|STARTED|First Intervention:||8
10460016|NCT01024738|11608180|FG000|COMPLETED|First Intervention:||7
10460017|NCT01024738|11608181|FG001|COMPLETED|First Intervention:||7
10460018|NCT01024738|11608182|FG002|COMPLETED|First Intervention:||8
10460019|NCT01024738|11608180|FG000|NOT COMPLETED|First Intervention:||0
10460020|NCT01024738|11608181|FG001|NOT COMPLETED|First Intervention:||0
10460021|NCT01024738|11608182|FG002|NOT COMPLETED|First Intervention:||0
10460022|NCT01024738|11608180|FG000|STARTED|Washout After 1st Intervention||7
10460023|NCT01024738|11608181|FG001|STARTED|Washout After 1st Intervention||7
10460024|NCT01024738|11608182|FG002|STARTED|Washout After 1st Intervention||8
10460025|NCT01024738|11608180|FG000|COMPLETED|Washout After 1st Intervention||7
10460026|NCT01024738|11608181|FG001|COMPLETED|Washout After 1st Intervention||7
10460027|NCT01024738|11608182|FG002|COMPLETED|Washout After 1st Intervention||8
10460028|NCT01024738|11608180|FG000|NOT COMPLETED|Washout After 1st Intervention||0
10460029|NCT01024738|11608181|FG001|NOT COMPLETED|Washout After 1st Intervention||0
10460030|NCT01024738|11608182|FG002|NOT COMPLETED|Washout After 1st Intervention||0
10460031|NCT01024738|11608180|FG000|STARTED|Second Intervention:||7
10460032|NCT01024738|11608181|FG001|STARTED|Second Intervention:||7
10460033|NCT01024738|11608182|FG002|STARTED|Second Intervention:||8
10460034|NCT01024738|11608180|FG000|COMPLETED|Second Intervention:||7
10460035|NCT01024738|11608181|FG001|COMPLETED|Second Intervention:||7
10460036|NCT01024738|11608182|FG002|COMPLETED|Second Intervention:||8
10460037|NCT01024738|11608180|FG000|NOT COMPLETED|Second Intervention:||0
10460038|NCT01024738|11608181|FG001|NOT COMPLETED|Second Intervention:||0
10460039|NCT01024738|11608182|FG002|NOT COMPLETED|Second Intervention:||0
10460040|NCT01024738|11608180|FG000|STARTED|Washout After 2nd Intervention||7
10460041|NCT01024738|11608181|FG001|STARTED|Washout After 2nd Intervention||7
10460042|NCT01024738|11608182|FG002|STARTED|Washout After 2nd Intervention||8
10460043|NCT01024738|11608180|FG000|COMPLETED|Washout After 2nd Intervention||7
10460044|NCT01024738|11608181|FG001|COMPLETED|Washout After 2nd Intervention||7
10460045|NCT01024738|11608182|FG002|COMPLETED|Washout After 2nd Intervention||8
10460046|NCT01024738|11608180|FG000|NOT COMPLETED|Washout After 2nd Intervention||0
10460047|NCT01024738|11608181|FG001|NOT COMPLETED|Washout After 2nd Intervention||0
10460048|NCT01024738|11608182|FG002|NOT COMPLETED|Washout After 2nd Intervention||0
10460049|NCT01024738|11608180|FG000|STARTED|Third Intervention:||7
10460050|NCT01024738|11608181|FG001|STARTED|Third Intervention:||7
10460051|NCT01024738|11608182|FG002|STARTED|Third Intervention:||8
10460052|NCT01024738|11608180|FG000|COMPLETED|Third Intervention:||7
10460053|NCT01024738|11608181|FG001|COMPLETED|Third Intervention:||7
10460054|NCT01024738|11608182|FG002|COMPLETED|Third Intervention:||8
10460055|NCT01024738|11608180|FG000|NOT COMPLETED|Third Intervention:||0
10460056|NCT01024738|11608181|FG001|NOT COMPLETED|Third Intervention:||0
10460057|NCT01024738|11608182|FG002|NOT COMPLETED|Third Intervention:||0
10460058|NCT01024751|11608192|FG000|STARTED|Enrolled Participants||156
10460059|NCT01024751|11608193|FG001|STARTED|Enrolled Participants||156
10460060|NCT01024751|11608192|FG000|COMPLETED|Enrolled Participants||153
10460061|NCT01024751|11608193|FG001|COMPLETED|Enrolled Participants||152
10460062|NCT01024751|11608192|FG000|NOT COMPLETED|Enrolled Participants||3
10460063|NCT01024751|11608193|FG001|NOT COMPLETED|Enrolled Participants||4
10460064|NCT01024751|11608192|FG000|STARTED|Eligible Participants||153
10460065|NCT01024751|11608193|FG001|STARTED|Eligible Participants||152
10460066|NCT01024751|11608192|FG000|COMPLETED|Eligible Participants||153
10460067|NCT01024751|11608193|FG001|COMPLETED|Eligible Participants||149
10460068|NCT01024751|11608192|FG000|NOT COMPLETED|Eligible Participants||0
10460069|NCT01024751|11608193|FG001|NOT COMPLETED|Eligible Participants||3
10460070|NCT01024855|11608199|FG000|STARTED|Overall Study|30 subjects enrolled in a paired/split-eye evaluation; each subject used both study treatments|30
10460071|NCT01024855|11608199|FG000|COMPLETED|Overall Study|One subject of the 30 seen for baseline did not meet the inclusion/exclusion criteria|29
10460072|NCT01024855|11608199|FG000|NOT COMPLETED|Overall Study||1
10460073|NCT01024920|11608206|FG000|STARTED|Overall Study||67
10460074|NCT01024920|11608207|FG001|STARTED|Overall Study||32
10460075|NCT01024920|11608206|FG000|Treated|Overall Study||64
10460076|NCT01024920|11608207|FG001|Treated|Overall Study||32
10460077|NCT01024920|11608206|FG000|COMPLETED|Overall Study||0
10460078|NCT01024920|11608207|FG001|COMPLETED|Overall Study||0
10460079|NCT01024920|11608206|FG000|NOT COMPLETED|Overall Study||67
10460080|NCT01024920|11608207|FG001|NOT COMPLETED|Overall Study||32
10460081|NCT01024946|11608213|FG000|STARTED|Overall Study||11
10460082|NCT01024946|11608213|FG000|COMPLETED|Overall Study||6
10460083|NCT01024946|11608213|FG000|NOT COMPLETED|Overall Study||5
10460084|NCT01024959|11608217|FG000|STARTED|Overall Study||507
10460085|NCT01024959|11608217|FG000|COMPLETED|Overall Study||466
10460086|NCT01024959|11608217|FG000|NOT COMPLETED|Overall Study||41
10460087|NCT01024972|11608228|FG000|STARTED|Overall Study||16
10460088|NCT01024972|11608229|FG001|STARTED|Overall Study||15
10460089|NCT01024972|11608228|FG000|COMPLETED|Overall Study||16
10460090|NCT01024972|11608229|FG001|COMPLETED|Overall Study||15
10460091|NCT01024972|11608228|FG000|NOT COMPLETED|Overall Study||0
10460092|NCT01024972|11608229|FG001|NOT COMPLETED|Overall Study||0
10460093|NCT01025037|11608236|FG000|STARTED|Overall Study||61
10460094|NCT01025037|11608236|FG000|COMPLETED|Overall Study||50
10460095|NCT01025037|11608236|FG000|NOT COMPLETED|Overall Study||11
10460096|NCT01025076|11608240|FG000|STARTED|Overall Study||14
10460097|NCT01025076|11608240|FG000|COMPLETED|Overall Study||14
10460098|NCT01025076|11608240|FG000|NOT COMPLETED|Overall Study||0
10460099|NCT01025154|11608244|FG000|STARTED|Overall Study||59
10460100|NCT01025154|11608244|FG000|COMPLETED|Overall Study||57
10460101|NCT01025154|11608244|FG000|NOT COMPLETED|Overall Study||2
10460102|NCT01025193|11608248|FG000|STARTED|Overall Study||8
10460103|NCT01025193|11608248|FG000|COMPLETED|Overall Study|one patient was transplanted 2 weeks after 8 month belimumab dose and did not receive further doses.|4
10460104|NCT01025193|11608248|FG000|NOT COMPLETED|Overall Study||4
10460105|NCT01025232|11608258|FG000|STARTED|Overall Study||46
10460106|NCT01025232|11608259|FG001|STARTED|Overall Study||42
10460107|NCT01025232|11608258|FG000|COMPLETED|Overall Study||43
10460108|NCT01025232|11608259|FG001|COMPLETED|Overall Study||36
10460109|NCT01025232|11608258|FG000|NOT COMPLETED|Overall Study||3
10460110|NCT01025232|11608259|FG001|NOT COMPLETED|Overall Study||6
10460111|NCT01025284|11608268|FG000|STARTED|Overall Study||38
10460112|NCT01025284|11608269|FG001|STARTED|Overall Study||18
10460113|NCT01025284|11608270|FG002|STARTED|Overall Study||8
10460114|NCT01025284|11608268|FG000|Received at Least 1 Dose of Study Drug|Overall Study||38
10460115|NCT01025284|11608269|FG001|Received at Least 1 Dose of Study Drug|Overall Study||18
10460116|NCT01025284|11608270|FG002|Received at Least 1 Dose of Study Drug|Overall Study||8
10460117|NCT01025284|11608268|FG000|COMPLETED|Overall Study||38
10460118|NCT01025284|11608269|FG001|COMPLETED|Overall Study||16
10460119|NCT01025284|11608270|FG002|COMPLETED|Overall Study||8
10460120|NCT01025284|11608268|FG000|NOT COMPLETED|Overall Study||0
10460121|NCT01025284|11608269|FG001|NOT COMPLETED|Overall Study||2
10460122|NCT01025284|11608270|FG002|NOT COMPLETED|Overall Study||0
10460123|NCT01025336|11608285|FG000|STARTED|Overall Study||130
10460124|NCT01025336|11608286|FG001|STARTED|Overall Study||210
10460125|NCT01025336|11608287|FG002|STARTED|Overall Study||179
10460126|NCT01025336|11608288|FG003|STARTED|Overall Study||221
10460127|NCT01025336|11608289|FG004|STARTED|Overall Study||222
10460128|NCT01025336|11608285|FG000|COMPLETED|Overall Study||130
10460129|NCT01025336|11608286|FG001|COMPLETED|Overall Study||210
10460130|NCT01025336|11608287|FG002|COMPLETED|Overall Study||179
10460131|NCT01025336|11608288|FG003|COMPLETED|Overall Study||219
10460132|NCT01025336|11608289|FG004|COMPLETED|Overall Study||222
10460133|NCT01025336|11608285|FG000|NOT COMPLETED|Overall Study||0
10460134|NCT01025336|11608286|FG001|NOT COMPLETED|Overall Study||0
10460135|NCT01025336|11608287|FG002|NOT COMPLETED|Overall Study||0
10460136|NCT01025336|11608288|FG003|NOT COMPLETED|Overall Study||2
10460137|NCT01025336|11608289|FG004|NOT COMPLETED|Overall Study||0
10460138|NCT01025427|11608313|FG000|STARTED|Overall Study||16
10460139|NCT01025427|11608313|FG000|COMPLETED|Overall Study||16
10460140|NCT01025427|11608313|FG000|NOT COMPLETED|Overall Study||0
10460141|NCT01025453|11608317|FG000|STARTED|Overall Study||37
10460142|NCT01025453|11608317|FG000|COMPLETED|Overall Study||37
10460143|NCT01025453|11608317|FG000|NOT COMPLETED|Overall Study||0
10460144|NCT01025635|11608323|FG000|STARTED|Overall Study||198
10460145|NCT01025635|11608324|FG001|STARTED|Overall Study||203
10460146|NCT01025635|11608323|FG000|COMPLETED|Overall Study||175
10460147|NCT01025635|11608324|FG001|COMPLETED|Overall Study||178
10460148|NCT01025635|11608323|FG000|NOT COMPLETED|Overall Study||23
10460149|NCT01025635|11608324|FG001|NOT COMPLETED|Overall Study||25
10460150|NCT01025752|11608332|FG000|STARTED|Overall Study||62
10460151|NCT01025752|11608333|FG001|STARTED|Overall Study||63
10460152|NCT01025752|11608332|FG000|COMPLETED|Overall Study||54
10460153|NCT01025752|11608333|FG001|COMPLETED|Overall Study||50
10460154|NCT01025752|11608332|FG000|NOT COMPLETED|Overall Study||8
10460155|NCT01025752|11608333|FG001|NOT COMPLETED|Overall Study||13
10460156|NCT01025791|11608342|FG000|STARTED|Period 1||2
10460157|NCT01025791|11608343|FG001|STARTED|Period 1||2
10460158|NCT01025791|11608344|FG002|STARTED|Period 1||2
10460159|NCT01025791|11608345|FG003|STARTED|Period 1||2
10460160|NCT01025791|11608346|FG004|STARTED|Period 1||2
10460161|NCT01025791|11608347|FG005|STARTED|Period 1||2
10460162|NCT01025791|11608348|FG006|STARTED|Period 1||2
10460163|NCT01025791|11608349|FG007|STARTED|Period 1||2
10460164|NCT01025791|11608350|FG008|STARTED|Period 1||2
10460165|NCT01025791|11608351|FG009|STARTED|Period 1||1
10460166|NCT01025791|11608352|FG010|STARTED|Period 1||2
10460167|NCT01025791|11608353|FG011|STARTED|Period 1||1
10460168|NCT01025791|11608354|FG012|STARTED|Period 1||2
10460169|NCT01025791|11608355|FG013|STARTED|Period 1||1
10460170|NCT01025791|11608342|FG000|COMPLETED|Period 1||2
10460171|NCT01025791|11608343|FG001|COMPLETED|Period 1||2
10460172|NCT01025791|11608344|FG002|COMPLETED|Period 1||2
10460173|NCT01025791|11608345|FG003|COMPLETED|Period 1||2
10460174|NCT01025791|11608346|FG004|COMPLETED|Period 1||2
10460175|NCT01025791|11608347|FG005|COMPLETED|Period 1||2
10460176|NCT01025791|11608348|FG006|COMPLETED|Period 1||2
10460177|NCT01025791|11608349|FG007|COMPLETED|Period 1||2
10460178|NCT01025791|11608350|FG008|COMPLETED|Period 1||2
10460179|NCT01025791|11608351|FG009|COMPLETED|Period 1||1
10460180|NCT01025791|11608352|FG010|COMPLETED|Period 1||2
10460181|NCT01025791|11608353|FG011|COMPLETED|Period 1||1
10460182|NCT01025791|11608354|FG012|COMPLETED|Period 1||2
10460183|NCT01025791|11608355|FG013|COMPLETED|Period 1||1
10460184|NCT01025791|11608342|FG000|NOT COMPLETED|Period 1||0
10460185|NCT01025791|11608343|FG001|NOT COMPLETED|Period 1||0
10460186|NCT01025791|11608344|FG002|NOT COMPLETED|Period 1||0
10460187|NCT01025791|11608345|FG003|NOT COMPLETED|Period 1||0
10460188|NCT01025791|11608346|FG004|NOT COMPLETED|Period 1||0
10460189|NCT01025791|11608347|FG005|NOT COMPLETED|Period 1||0
10460190|NCT01025791|11608348|FG006|NOT COMPLETED|Period 1||0
10460191|NCT01025791|11608349|FG007|NOT COMPLETED|Period 1||0
10460192|NCT01025791|11608350|FG008|NOT COMPLETED|Period 1||0
10460193|NCT01025791|11608351|FG009|NOT COMPLETED|Period 1||0
10460194|NCT01025791|11608352|FG010|NOT COMPLETED|Period 1||0
10460195|NCT01025791|11608353|FG011|NOT COMPLETED|Period 1||0
10460196|NCT01025791|11608354|FG012|NOT COMPLETED|Period 1||0
10460197|NCT01025791|11608355|FG013|NOT COMPLETED|Period 1||0
10460198|NCT01025791|11608342|FG000|STARTED|Period 2||2
10460199|NCT01025791|11608343|FG001|STARTED|Period 2||2
10460200|NCT01025791|11608344|FG002|STARTED|Period 2||2
10460201|NCT01025791|11608345|FG003|STARTED|Period 2||2
10460202|NCT01025791|11608346|FG004|STARTED|Period 2||2
10460203|NCT01025791|11608347|FG005|STARTED|Period 2||2
10460204|NCT01025791|11608348|FG006|STARTED|Period 2||2
10460205|NCT01025791|11608349|FG007|STARTED|Period 2||2
10460206|NCT01025791|11608350|FG008|STARTED|Period 2||2
10460207|NCT01025791|11608351|FG009|STARTED|Period 2||1
10460208|NCT01025791|11608352|FG010|STARTED|Period 2||2
10460209|NCT01025791|11608353|FG011|STARTED|Period 2||1
10460210|NCT01025791|11608354|FG012|STARTED|Period 2||2
10460211|NCT01025791|11608355|FG013|STARTED|Period 2||1
10460212|NCT01025791|11608342|FG000|COMPLETED|Period 2||2
10460213|NCT01025791|11608343|FG001|COMPLETED|Period 2||2
10460214|NCT01025791|11608344|FG002|COMPLETED|Period 2||2
10460215|NCT01025791|11608345|FG003|COMPLETED|Period 2||2
10460216|NCT01025791|11608346|FG004|COMPLETED|Period 2||2
10460217|NCT01025791|11608347|FG005|COMPLETED|Period 2||2
10460218|NCT01025791|11608348|FG006|COMPLETED|Period 2||2
10460219|NCT01025791|11608349|FG007|COMPLETED|Period 2||2
10460220|NCT01025791|11608350|FG008|COMPLETED|Period 2||2
10460221|NCT01025791|11608351|FG009|COMPLETED|Period 2||1
10460222|NCT01025791|11608352|FG010|COMPLETED|Period 2||2
10460223|NCT01025791|11608353|FG011|COMPLETED|Period 2||1
10460224|NCT01025791|11608354|FG012|COMPLETED|Period 2||2
10460225|NCT01025791|11608355|FG013|COMPLETED|Period 2||1
10460226|NCT01025791|11608342|FG000|NOT COMPLETED|Period 2||0
10460227|NCT01025791|11608343|FG001|NOT COMPLETED|Period 2||0
10460228|NCT01025791|11608344|FG002|NOT COMPLETED|Period 2||0
10460229|NCT01025791|11608345|FG003|NOT COMPLETED|Period 2||0
10460230|NCT01025791|11608346|FG004|NOT COMPLETED|Period 2||0
10460231|NCT01025791|11608347|FG005|NOT COMPLETED|Period 2||0
10460232|NCT01025791|11608348|FG006|NOT COMPLETED|Period 2||0
10460233|NCT01025791|11608349|FG007|NOT COMPLETED|Period 2||0
10460234|NCT01025791|11608350|FG008|NOT COMPLETED|Period 2||0
10460235|NCT01025791|11608351|FG009|NOT COMPLETED|Period 2||0
10460236|NCT01025791|11608352|FG010|NOT COMPLETED|Period 2||0
10460237|NCT01025791|11608353|FG011|NOT COMPLETED|Period 2||0
10460238|NCT01025791|11608354|FG012|NOT COMPLETED|Period 2||0
10460239|NCT01025791|11608355|FG013|NOT COMPLETED|Period 2||0
10460240|NCT01025791|11608342|FG000|STARTED|Period 3||2
10460241|NCT01025791|11608343|FG001|STARTED|Period 3||2
10460242|NCT01025791|11608344|FG002|STARTED|Period 3||2
10460243|NCT01025791|11608345|FG003|STARTED|Period 3||2
10460244|NCT01025791|11608346|FG004|STARTED|Period 3||2
10460245|NCT01025791|11608347|FG005|STARTED|Period 3||2
10460246|NCT01025791|11608348|FG006|STARTED|Period 3||2
10460247|NCT01025791|11608349|FG007|STARTED|Period 3||2
10460248|NCT01025791|11608350|FG008|STARTED|Period 3||2
10460249|NCT01025791|11608351|FG009|STARTED|Period 3||1
10460250|NCT01025791|11608352|FG010|STARTED|Period 3||2
10460251|NCT01025791|11608353|FG011|STARTED|Period 3||1
10460252|NCT01025791|11608354|FG012|STARTED|Period 3||2
10460253|NCT01025791|11608355|FG013|STARTED|Period 3||1
10460254|NCT01025791|11608342|FG000|COMPLETED|Period 3||2
10460255|NCT01025791|11608343|FG001|COMPLETED|Period 3||2
10460256|NCT01025791|11608344|FG002|COMPLETED|Period 3||2
10460257|NCT01025791|11608345|FG003|COMPLETED|Period 3||2
10460258|NCT01025791|11608346|FG004|COMPLETED|Period 3||2
10460259|NCT01025791|11608347|FG005|COMPLETED|Period 3||2
10460260|NCT01025791|11608348|FG006|COMPLETED|Period 3||2
10460261|NCT01025791|11608349|FG007|COMPLETED|Period 3||2
10460262|NCT01025791|11608350|FG008|COMPLETED|Period 3||2
10460263|NCT01025791|11608351|FG009|COMPLETED|Period 3||1
10460264|NCT01025791|11608352|FG010|COMPLETED|Period 3||2
10460265|NCT01025791|11608353|FG011|COMPLETED|Period 3||1
10460266|NCT01025791|11608354|FG012|COMPLETED|Period 3||2
10460267|NCT01025791|11608355|FG013|COMPLETED|Period 3||1
10460268|NCT01025791|11608342|FG000|NOT COMPLETED|Period 3||0
10460269|NCT01025791|11608343|FG001|NOT COMPLETED|Period 3||0
10460270|NCT01025791|11608344|FG002|NOT COMPLETED|Period 3||0
10460271|NCT01025791|11608345|FG003|NOT COMPLETED|Period 3||0
10460272|NCT01025791|11608346|FG004|NOT COMPLETED|Period 3||0
10460273|NCT01025791|11608347|FG005|NOT COMPLETED|Period 3||0
10460274|NCT01025791|11608348|FG006|NOT COMPLETED|Period 3||0
10460275|NCT01025791|11608349|FG007|NOT COMPLETED|Period 3||0
10460276|NCT01025791|11608350|FG008|NOT COMPLETED|Period 3||0
10460277|NCT01025791|11608351|FG009|NOT COMPLETED|Period 3||0
10460278|NCT01025791|11608352|FG010|NOT COMPLETED|Period 3||0
10460279|NCT01025791|11608353|FG011|NOT COMPLETED|Period 3||0
10460280|NCT01025791|11608354|FG012|NOT COMPLETED|Period 3||0
10460281|NCT01025791|11608355|FG013|NOT COMPLETED|Period 3||0
10460282|NCT01025791|11608342|FG000|STARTED|Period 4||2
10460283|NCT01025791|11608343|FG001|STARTED|Period 4||2
10460284|NCT01025791|11608344|FG002|STARTED|Period 4||2
10460285|NCT01025791|11608345|FG003|STARTED|Period 4||2
10460286|NCT01025791|11608346|FG004|STARTED|Period 4||2
10460287|NCT01025791|11608347|FG005|STARTED|Period 4||2
10460288|NCT01025791|11608348|FG006|STARTED|Period 4||2
10460289|NCT01025791|11608349|FG007|STARTED|Period 4||2
10460290|NCT01025791|11608350|FG008|STARTED|Period 4||2
10460291|NCT01025791|11608351|FG009|STARTED|Period 4||1
10460292|NCT01025791|11608352|FG010|STARTED|Period 4||2
10460293|NCT01025791|11608353|FG011|STARTED|Period 4||1
10460294|NCT01025791|11608354|FG012|STARTED|Period 4||2
10460295|NCT01025791|11608355|FG013|STARTED|Period 4||1
10460296|NCT01025791|11608342|FG000|COMPLETED|Period 4||2
10460297|NCT01025791|11608343|FG001|COMPLETED|Period 4||2
10460298|NCT01025791|11608344|FG002|COMPLETED|Period 4||2
10460299|NCT01025791|11608345|FG003|COMPLETED|Period 4||2
10460300|NCT01025791|11608346|FG004|COMPLETED|Period 4||2
10460301|NCT01025791|11608347|FG005|COMPLETED|Period 4||2
10460302|NCT01025791|11608348|FG006|COMPLETED|Period 4||2
10460303|NCT01025791|11608349|FG007|COMPLETED|Period 4||2
10460304|NCT01025791|11608350|FG008|COMPLETED|Period 4||2
10460305|NCT01025791|11608351|FG009|COMPLETED|Period 4||1
10460306|NCT01025791|11608352|FG010|COMPLETED|Period 4||2
10460307|NCT01025791|11608353|FG011|COMPLETED|Period 4||1
10460308|NCT01025791|11608354|FG012|COMPLETED|Period 4||2
10708276|NCT02628769|11873092|FG001|STARTED|Second Intervention||2
10708277|NCT02628769|11873091|FG000|COMPLETED|Second Intervention||0
10708278|NCT02628769|11873092|FG001|COMPLETED|Second Intervention||1
10708279|NCT02628769|11873091|FG000|NOT COMPLETED|Second Intervention||2
10708280|NCT02628769|11873092|FG001|NOT COMPLETED|Second Intervention||1
10460309|NCT01025791|11608355|FG013|COMPLETED|Period 4||1
10460310|NCT01025791|11608342|FG000|NOT COMPLETED|Period 4||0
10460311|NCT01025791|11608343|FG001|NOT COMPLETED|Period 4||0
10460312|NCT01025791|11608344|FG002|NOT COMPLETED|Period 4||0
10460313|NCT01025791|11608345|FG003|NOT COMPLETED|Period 4||0
10460314|NCT01025791|11608346|FG004|NOT COMPLETED|Period 4||0
10460315|NCT01025791|11608347|FG005|NOT COMPLETED|Period 4||0
10460316|NCT01025791|11608348|FG006|NOT COMPLETED|Period 4||0
10460317|NCT01025791|11608349|FG007|NOT COMPLETED|Period 4||0
10460318|NCT01025791|11608350|FG008|NOT COMPLETED|Period 4||0
10460319|NCT01025791|11608351|FG009|NOT COMPLETED|Period 4||0
10460320|NCT01025791|11608352|FG010|NOT COMPLETED|Period 4||0
10708281|NCT02628873|11873100|FG000|STARTED|First Test (1 Hour)||14
10460321|NCT01025791|11608353|FG011|NOT COMPLETED|Period 4||0
10460322|NCT01025791|11608354|FG012|NOT COMPLETED|Period 4||0
10460323|NCT01025791|11608355|FG013|NOT COMPLETED|Period 4||0
10460324|NCT01025791|11608342|FG000|STARTED|Period 5||2
10460325|NCT01025791|11608343|FG001|STARTED|Period 5||2
10460326|NCT01025791|11608344|FG002|STARTED|Period 5||2
10460327|NCT01025791|11608345|FG003|STARTED|Period 5||2
10460328|NCT01025791|11608346|FG004|STARTED|Period 5||0
10460329|NCT01025791|11608347|FG005|STARTED|Period 5||0
10460330|NCT01025791|11608348|FG006|STARTED|Period 5||0
10460331|NCT01025791|11608349|FG007|STARTED|Period 5||0
10460332|NCT01025791|11608350|FG008|STARTED|Period 5||0
10460333|NCT01025791|11608351|FG009|STARTED|Period 5||0
10460334|NCT01025791|11608352|FG010|STARTED|Period 5||0
10460335|NCT01025791|11608353|FG011|STARTED|Period 5||0
10460336|NCT01025791|11608354|FG012|STARTED|Period 5||0
10460337|NCT01025791|11608355|FG013|STARTED|Period 5||0
10460338|NCT01025791|11608342|FG000|COMPLETED|Period 5||2
10460339|NCT01025791|11608343|FG001|COMPLETED|Period 5||2
10460340|NCT01025791|11608344|FG002|COMPLETED|Period 5||2
10460341|NCT01025791|11608345|FG003|COMPLETED|Period 5||2
10460342|NCT01025791|11608346|FG004|COMPLETED|Period 5||0
10460343|NCT01025791|11608347|FG005|COMPLETED|Period 5||0
10460344|NCT01025791|11608348|FG006|COMPLETED|Period 5||0
10460345|NCT01025791|11608349|FG007|COMPLETED|Period 5||0
10460346|NCT01025791|11608350|FG008|COMPLETED|Period 5||0
10460347|NCT01025791|11608351|FG009|COMPLETED|Period 5||0
10460348|NCT01025791|11608352|FG010|COMPLETED|Period 5||0
10460349|NCT01025791|11608353|FG011|COMPLETED|Period 5||0
10460350|NCT01025791|11608354|FG012|COMPLETED|Period 5||0
10460351|NCT01025791|11608355|FG013|COMPLETED|Period 5||0
10460352|NCT01025791|11608342|FG000|NOT COMPLETED|Period 5||0
10460353|NCT01025791|11608343|FG001|NOT COMPLETED|Period 5||0
10460354|NCT01025791|11608344|FG002|NOT COMPLETED|Period 5||0
10460355|NCT01025791|11608345|FG003|NOT COMPLETED|Period 5||0
10460356|NCT01025791|11608346|FG004|NOT COMPLETED|Period 5||0
10460357|NCT01025791|11608347|FG005|NOT COMPLETED|Period 5||0
10460358|NCT01025791|11608348|FG006|NOT COMPLETED|Period 5||0
10460359|NCT01025791|11608349|FG007|NOT COMPLETED|Period 5||0
10460360|NCT01025791|11608350|FG008|NOT COMPLETED|Period 5||0
10460361|NCT01025791|11608351|FG009|NOT COMPLETED|Period 5||0
10460362|NCT01025791|11608352|FG010|NOT COMPLETED|Period 5||0
10460363|NCT01025791|11608353|FG011|NOT COMPLETED|Period 5||0
10460364|NCT01025791|11608354|FG012|NOT COMPLETED|Period 5||0
10460365|NCT01025791|11608355|FG013|NOT COMPLETED|Period 5||0
10460366|NCT01025817|11608408|FG000|STARTED|Completed Study Medication||309
10460367|NCT01025817|11608409|FG001|STARTED|Completed Study Medication||304
10460368|NCT01025817|11608408|FG000|COMPLETED|Completed Study Medication||204
10460369|NCT01025817|11608409|FG001|COMPLETED|Completed Study Medication||232
10708282|NCT02628873|11873101|FG001|STARTED|First Test (1 Hour)||7
10708283|NCT02628873|11873100|FG000|COMPLETED|First Test (1 Hour)||14
10708284|NCT02628873|11873101|FG001|COMPLETED|First Test (1 Hour)||7
10708285|NCT02628873|11873100|FG000|NOT COMPLETED|First Test (1 Hour)||0
10708286|NCT02628873|11873101|FG001|NOT COMPLETED|First Test (1 Hour)||0
10708287|NCT02628873|11873100|FG000|STARTED|Break (1 Hour)||14
10708288|NCT02628873|11873101|FG001|STARTED|Break (1 Hour)||7
10708289|NCT02628873|11873100|FG000|COMPLETED|Break (1 Hour)||14
10708290|NCT02628873|11873101|FG001|COMPLETED|Break (1 Hour)||6
10708291|NCT02628873|11873100|FG000|NOT COMPLETED|Break (1 Hour)||0
10708292|NCT02628873|11873101|FG001|NOT COMPLETED|Break (1 Hour)||1
10708293|NCT02628873|11873100|FG000|STARTED|Second Test (1 Hour)||14
10708294|NCT02628873|11873101|FG001|STARTED|Second Test (1 Hour)||6
10708295|NCT02628873|11873100|FG000|COMPLETED|Second Test (1 Hour)||13
10708296|NCT02628873|11873101|FG001|COMPLETED|Second Test (1 Hour)||6
10708297|NCT02628873|11873100|FG000|NOT COMPLETED|Second Test (1 Hour)||1
10708298|NCT02628873|11873101|FG001|NOT COMPLETED|Second Test (1 Hour)||0
10708299|NCT02628938|11873110|FG000|STARTED|Overall Study||15
10708300|NCT02628938|11873111|FG001|STARTED|Overall Study||15
10708301|NCT02628938|11873112|FG002|STARTED|Overall Study||15
10708302|NCT02628938|11873110|FG000|COMPLETED|Overall Study||10
10708303|NCT02628938|11873111|FG001|COMPLETED|Overall Study||13
10708304|NCT02628938|11873112|FG002|COMPLETED|Overall Study||11
10708305|NCT02628938|11873110|FG000|NOT COMPLETED|Overall Study||5
10708306|NCT02628938|11873111|FG001|NOT COMPLETED|Overall Study||2
10708307|NCT02628938|11873112|FG002|NOT COMPLETED|Overall Study||4
10708308|NCT02628964|11873122|FG000|STARTED|Overall Study||50
10708309|NCT02628964|11873123|FG001|STARTED|Overall Study||50
10708310|NCT02628964|11873122|FG000|COMPLETED|Overall Study||50
10708311|NCT02628964|11873123|FG001|COMPLETED|Overall Study||49
10708312|NCT02628964|11873122|FG000|NOT COMPLETED|Overall Study||0
10708313|NCT02628964|11873123|FG001|NOT COMPLETED|Overall Study||1
10708314|NCT02629094|11873129|FG000|STARTED|Overall Study||5
10708315|NCT02629094|11873129|FG000|COMPLETED|Overall Study||5
10708316|NCT02629094|11873129|FG000|NOT COMPLETED|Overall Study||0
10708317|NCT02629133|11873135|FG000|STARTED|Overall Study||25
10708318|NCT02629133|11873136|FG001|STARTED|Overall Study||25
10708319|NCT02629133|11873135|FG000|COMPLETED|Overall Study||21
10708320|NCT02629133|11873136|FG001|COMPLETED|Overall Study||23
10708321|NCT02629133|11873135|FG000|NOT COMPLETED|Overall Study||4
10708322|NCT02629133|11873136|FG001|NOT COMPLETED|Overall Study||2
10708323|NCT02629354|11873144|FG000|STARTED|Period 1||18
10708324|NCT02629354|11873145|FG001|STARTED|Period 1||18
10460370|NCT01025817|11608408|FG000|NOT COMPLETED|Completed Study Medication||105
10460371|NCT01025817|11608409|FG001|NOT COMPLETED|Completed Study Medication||72
10460372|NCT01025817|11608408|FG000|STARTED|Completed Study||309
10460373|NCT01025817|11608409|FG001|STARTED|Completed Study||304
10460374|NCT01025817|11608408|FG000|COMPLETED|Completed Study|Completed study phase|293
10460375|NCT01025817|11608409|FG001|COMPLETED|Completed Study|Completed study phase|282
10460376|NCT01025817|11608408|FG000|NOT COMPLETED|Completed Study||16
10708325|NCT02629354|11873144|FG000|COMPLETED|Period 1||18
10708326|NCT02629354|11873145|FG001|COMPLETED|Period 1||18
10460377|NCT01025817|11608409|FG001|NOT COMPLETED|Completed Study||22
10526340|NCT01380730|11678144|FG000|COMPLETED|Overall Study||78
10708327|NCT02629354|11873144|FG000|NOT COMPLETED|Period 1||0
10708328|NCT02629354|11873145|FG001|NOT COMPLETED|Period 1||0
10708329|NCT02629354|11873144|FG000|STARTED|Washout Period||18
10708330|NCT02629354|11873145|FG001|STARTED|Washout Period||18
10708331|NCT02629354|11873144|FG000|COMPLETED|Washout Period||18
10708332|NCT02629354|11873145|FG001|COMPLETED|Washout Period||18
10708333|NCT02629354|11873144|FG000|NOT COMPLETED|Washout Period||0
10460378|NCT01025830|11608415|FG000|STARTED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||8
10460379|NCT01025830|11608416|FG001|STARTED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||12
10460380|NCT01025830|11608415|FG000|COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||8
10460381|NCT01025830|11608416|FG001|COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||12
10460382|NCT01025830|11608415|FG000|NOT COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||0
10460383|NCT01025830|11608416|FG001|NOT COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||0
10460384|NCT01025830|11608415|FG000|STARTED|Washout Period of 30 Days||8
10460385|NCT01025830|11608416|FG001|STARTED|Washout Period of 30 Days||12
10460386|NCT01025830|11608415|FG000|COMPLETED|Washout Period of 30 Days||8
10460387|NCT01025830|11608416|FG001|COMPLETED|Washout Period of 30 Days||12
10460388|NCT01025830|11608415|FG000|NOT COMPLETED|Washout Period of 30 Days||0
10460389|NCT01025830|11608416|FG001|NOT COMPLETED|Washout Period of 30 Days||0
10460390|NCT01025830|11608415|FG000|STARTED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||8
10460391|NCT01025830|11608416|FG001|STARTED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||12
10460392|NCT01025830|11608415|FG000|COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||8
10460393|NCT01025830|11608416|FG001|COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||12
10460394|NCT01025830|11608415|FG000|NOT COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||0
10460395|NCT01025830|11608416|FG001|NOT COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||0
10460396|NCT01025843|11608437|FG000|STARTED|Period 1||2
10460397|NCT01025843|11608438|FG001|STARTED|Period 1||2
10460398|NCT01025843|11608439|FG002|STARTED|Period 1||2
10460399|NCT01025843|11608440|FG003|STARTED|Period 1||2
10460400|NCT01025843|11608441|FG004|STARTED|Period 1||2
10460401|NCT01025843|11608442|FG005|STARTED|Period 1||2
10460402|NCT01025843|11608443|FG006|STARTED|Period 1||2
10460403|NCT01025843|11608444|FG007|STARTED|Period 1||2
10460404|NCT01025843|11608445|FG008|STARTED|Period 1||2
10460405|NCT01025843|11608446|FG009|STARTED|Period 1||2
10460406|NCT01025843|11608437|FG000|COMPLETED|Period 1||2
10460407|NCT01025843|11608438|FG001|COMPLETED|Period 1||2
10460408|NCT01025843|11608439|FG002|COMPLETED|Period 1||2
10460409|NCT01025843|11608440|FG003|COMPLETED|Period 1||2
10460410|NCT01025843|11608441|FG004|COMPLETED|Period 1||2
10460411|NCT01025843|11608442|FG005|COMPLETED|Period 1||2
10460412|NCT01025843|11608443|FG006|COMPLETED|Period 1||2
10460413|NCT01025843|11608444|FG007|COMPLETED|Period 1||2
10460414|NCT01025843|11608445|FG008|COMPLETED|Period 1||2
10460415|NCT01025843|11608446|FG009|COMPLETED|Period 1||2
10460416|NCT01025843|11608437|FG000|NOT COMPLETED|Period 1||0
10460417|NCT01025843|11608438|FG001|NOT COMPLETED|Period 1||0
10460418|NCT01025843|11608439|FG002|NOT COMPLETED|Period 1||0
10460419|NCT01025843|11608440|FG003|NOT COMPLETED|Period 1||0
10460420|NCT01025843|11608441|FG004|NOT COMPLETED|Period 1||0
10460421|NCT01025843|11608442|FG005|NOT COMPLETED|Period 1||0
10460422|NCT01025843|11608443|FG006|NOT COMPLETED|Period 1||0
10460423|NCT01025843|11608444|FG007|NOT COMPLETED|Period 1||0
10460424|NCT01025843|11608445|FG008|NOT COMPLETED|Period 1||0
10460425|NCT01025843|11608446|FG009|NOT COMPLETED|Period 1||0
10460426|NCT01025843|11608437|FG000|STARTED|Washout 1||2
10460427|NCT01025843|11608438|FG001|STARTED|Washout 1||2
10460428|NCT01025843|11608439|FG002|STARTED|Washout 1||2
10460429|NCT01025843|11608440|FG003|STARTED|Washout 1||2
10460430|NCT01025843|11608441|FG004|STARTED|Washout 1||2
10460431|NCT01025843|11608442|FG005|STARTED|Washout 1||2
10460432|NCT01025843|11608443|FG006|STARTED|Washout 1||2
10460433|NCT01025843|11608444|FG007|STARTED|Washout 1||2
10460434|NCT01025843|11608445|FG008|STARTED|Washout 1||2
10460435|NCT01025843|11608446|FG009|STARTED|Washout 1||2
10460436|NCT01025843|11608437|FG000|COMPLETED|Washout 1||2
10460437|NCT01025843|11608438|FG001|COMPLETED|Washout 1||2
10460438|NCT01025843|11608439|FG002|COMPLETED|Washout 1||2
10460439|NCT01025843|11608440|FG003|COMPLETED|Washout 1||2
10460440|NCT01025843|11608441|FG004|COMPLETED|Washout 1||2
10460441|NCT01025843|11608442|FG005|COMPLETED|Washout 1||2
10460442|NCT01025843|11608443|FG006|COMPLETED|Washout 1||2
10460443|NCT01025843|11608444|FG007|COMPLETED|Washout 1||2
10460444|NCT01025843|11608445|FG008|COMPLETED|Washout 1||2
10460445|NCT01025843|11608446|FG009|COMPLETED|Washout 1||2
10460446|NCT01025843|11608437|FG000|NOT COMPLETED|Washout 1||0
10460447|NCT01025843|11608438|FG001|NOT COMPLETED|Washout 1||0
10460448|NCT01025843|11608439|FG002|NOT COMPLETED|Washout 1||0
10460449|NCT01025843|11608440|FG003|NOT COMPLETED|Washout 1||0
10460450|NCT01025843|11608441|FG004|NOT COMPLETED|Washout 1||0
10708334|NCT02629354|11873145|FG001|NOT COMPLETED|Washout Period||0
10708335|NCT02629354|11873144|FG000|STARTED|Period 2||18
10460451|NCT01025843|11608442|FG005|NOT COMPLETED|Washout 1||0
10460452|NCT01025843|11608443|FG006|NOT COMPLETED|Washout 1||0
10460453|NCT01025843|11608444|FG007|NOT COMPLETED|Washout 1||0
10460454|NCT01025843|11608445|FG008|NOT COMPLETED|Washout 1||0
10460455|NCT01025843|11608446|FG009|NOT COMPLETED|Washout 1||0
10460456|NCT01025843|11608437|FG000|STARTED|Period 2||2
10460457|NCT01025843|11608438|FG001|STARTED|Period 2||2
10708336|NCT02629354|11873145|FG001|STARTED|Period 2||18
10460458|NCT01025843|11608439|FG002|STARTED|Period 2||2
10460459|NCT01025843|11608440|FG003|STARTED|Period 2||2
10460460|NCT01025843|11608441|FG004|STARTED|Period 2||2
10460461|NCT01025843|11608442|FG005|STARTED|Period 2||2
10460462|NCT01025843|11608443|FG006|STARTED|Period 2||2
10460463|NCT01025843|11608444|FG007|STARTED|Period 2||2
10460464|NCT01025843|11608445|FG008|STARTED|Period 2||2
10460465|NCT01025843|11608446|FG009|STARTED|Period 2||2
10460466|NCT01025843|11608437|FG000|COMPLETED|Period 2||2
10460467|NCT01025843|11608438|FG001|COMPLETED|Period 2||2
10460468|NCT01025843|11608439|FG002|COMPLETED|Period 2||2
10460469|NCT01025843|11608440|FG003|COMPLETED|Period 2||2
10460470|NCT01025843|11608441|FG004|COMPLETED|Period 2||2
10460471|NCT01025843|11608442|FG005|COMPLETED|Period 2||2
10460472|NCT01025843|11608443|FG006|COMPLETED|Period 2||2
10460473|NCT01025843|11608444|FG007|COMPLETED|Period 2||2
10460474|NCT01025843|11608445|FG008|COMPLETED|Period 2||2
10460475|NCT01025843|11608446|FG009|COMPLETED|Period 2||2
10460476|NCT01025843|11608437|FG000|NOT COMPLETED|Period 2||0
10460477|NCT01025843|11608438|FG001|NOT COMPLETED|Period 2||0
10460478|NCT01025843|11608439|FG002|NOT COMPLETED|Period 2||0
10460479|NCT01025843|11608440|FG003|NOT COMPLETED|Period 2||0
10460480|NCT01025843|11608441|FG004|NOT COMPLETED|Period 2||0
10460481|NCT01025843|11608442|FG005|NOT COMPLETED|Period 2||0
10460482|NCT01025843|11608443|FG006|NOT COMPLETED|Period 2||0
10460483|NCT01025843|11608444|FG007|NOT COMPLETED|Period 2||0
10460484|NCT01025843|11608445|FG008|NOT COMPLETED|Period 2||0
10460485|NCT01025843|11608446|FG009|NOT COMPLETED|Period 2||0
10460486|NCT01025843|11608437|FG000|STARTED|Washout 2||2
10460487|NCT01025843|11608438|FG001|STARTED|Washout 2||2
10460488|NCT01025843|11608439|FG002|STARTED|Washout 2||2
10460489|NCT01025843|11608440|FG003|STARTED|Washout 2||2
10460490|NCT01025843|11608441|FG004|STARTED|Washout 2||2
10460491|NCT01025843|11608442|FG005|STARTED|Washout 2||2
10460492|NCT01025843|11608443|FG006|STARTED|Washout 2||2
10460493|NCT01025843|11608444|FG007|STARTED|Washout 2||2
10460494|NCT01025843|11608445|FG008|STARTED|Washout 2||2
10460495|NCT01025843|11608446|FG009|STARTED|Washout 2||2
10460496|NCT01025843|11608437|FG000|COMPLETED|Washout 2||2
10460497|NCT01025843|11608438|FG001|COMPLETED|Washout 2||2
10460498|NCT01025843|11608439|FG002|COMPLETED|Washout 2||2
10460499|NCT01025843|11608440|FG003|COMPLETED|Washout 2||2
10460500|NCT01025843|11608441|FG004|COMPLETED|Washout 2||2
10460501|NCT01025843|11608442|FG005|COMPLETED|Washout 2||2
10460502|NCT01025843|11608443|FG006|COMPLETED|Washout 2||2
10460503|NCT01025843|11608444|FG007|COMPLETED|Washout 2||2
10460504|NCT01025843|11608445|FG008|COMPLETED|Washout 2||2
10460505|NCT01025843|11608446|FG009|COMPLETED|Washout 2||2
10460506|NCT01025843|11608437|FG000|NOT COMPLETED|Washout 2||0
10460507|NCT01025843|11608438|FG001|NOT COMPLETED|Washout 2||0
10460508|NCT01025843|11608439|FG002|NOT COMPLETED|Washout 2||0
10460509|NCT01025843|11608440|FG003|NOT COMPLETED|Washout 2||0
10460510|NCT01025843|11608441|FG004|NOT COMPLETED|Washout 2||0
10460511|NCT01025843|11608442|FG005|NOT COMPLETED|Washout 2||0
10460512|NCT01025843|11608443|FG006|NOT COMPLETED|Washout 2||0
10460513|NCT01025843|11608444|FG007|NOT COMPLETED|Washout 2||0
10460514|NCT01025843|11608445|FG008|NOT COMPLETED|Washout 2||0
10460515|NCT01025843|11608446|FG009|NOT COMPLETED|Washout 2||0
10460516|NCT01025843|11608437|FG000|STARTED|Period 3||2
10460517|NCT01025843|11608438|FG001|STARTED|Period 3||2
10460518|NCT01025843|11608439|FG002|STARTED|Period 3||2
10460519|NCT01025843|11608440|FG003|STARTED|Period 3||2
10460520|NCT01025843|11608441|FG004|STARTED|Period 3||2
10460521|NCT01025843|11608442|FG005|STARTED|Period 3||2
10460522|NCT01025843|11608443|FG006|STARTED|Period 3||2
10460523|NCT01025843|11608444|FG007|STARTED|Period 3||2
10460524|NCT01025843|11608445|FG008|STARTED|Period 3||2
10460525|NCT01025843|11608446|FG009|STARTED|Period 3||2
10460526|NCT01025843|11608437|FG000|COMPLETED|Period 3||2
10460527|NCT01025843|11608438|FG001|COMPLETED|Period 3||2
10460528|NCT01025843|11608439|FG002|COMPLETED|Period 3||2
10460529|NCT01025843|11608440|FG003|COMPLETED|Period 3||2
10460530|NCT01025843|11608441|FG004|COMPLETED|Period 3||2
10460531|NCT01025843|11608442|FG005|COMPLETED|Period 3||2
10460532|NCT01025843|11608443|FG006|COMPLETED|Period 3||2
10460533|NCT01025843|11608444|FG007|COMPLETED|Period 3||2
10460534|NCT01025843|11608445|FG008|COMPLETED|Period 3||2
10460535|NCT01025843|11608446|FG009|COMPLETED|Period 3||2
10460536|NCT01025843|11608437|FG000|NOT COMPLETED|Period 3||0
10460537|NCT01025843|11608438|FG001|NOT COMPLETED|Period 3||0
10460538|NCT01025843|11608439|FG002|NOT COMPLETED|Period 3||0
10460539|NCT01025843|11608440|FG003|NOT COMPLETED|Period 3||0
10460540|NCT01025843|11608441|FG004|NOT COMPLETED|Period 3||0
10460541|NCT01025843|11608442|FG005|NOT COMPLETED|Period 3||0
10460542|NCT01025843|11608443|FG006|NOT COMPLETED|Period 3||0
10460543|NCT01025843|11608444|FG007|NOT COMPLETED|Period 3||0
10460544|NCT01025843|11608445|FG008|NOT COMPLETED|Period 3||0
10460545|NCT01025843|11608446|FG009|NOT COMPLETED|Period 3||0
10460546|NCT01025843|11608437|FG000|STARTED|Washout 3||2
10460547|NCT01025843|11608438|FG001|STARTED|Washout 3||2
10460548|NCT01025843|11608439|FG002|STARTED|Washout 3||2
10460549|NCT01025843|11608440|FG003|STARTED|Washout 3||2
10460550|NCT01025843|11608441|FG004|STARTED|Washout 3||2
10460551|NCT01025843|11608442|FG005|STARTED|Washout 3||2
10460552|NCT01025843|11608443|FG006|STARTED|Washout 3||2
10460553|NCT01025843|11608444|FG007|STARTED|Washout 3||2
10460554|NCT01025843|11608445|FG008|STARTED|Washout 3||2
10460555|NCT01025843|11608446|FG009|STARTED|Washout 3||2
10460556|NCT01025843|11608437|FG000|COMPLETED|Washout 3||2
10460557|NCT01025843|11608438|FG001|COMPLETED|Washout 3||2
10460558|NCT01025843|11608439|FG002|COMPLETED|Washout 3||2
10460559|NCT01025843|11608440|FG003|COMPLETED|Washout 3||2
10460560|NCT01025843|11608441|FG004|COMPLETED|Washout 3||2
10460561|NCT01025843|11608442|FG005|COMPLETED|Washout 3||2
10460562|NCT01025843|11608443|FG006|COMPLETED|Washout 3||2
10460563|NCT01025843|11608444|FG007|COMPLETED|Washout 3||2
10460564|NCT01025843|11608445|FG008|COMPLETED|Washout 3||2
10460565|NCT01025843|11608446|FG009|COMPLETED|Washout 3||2
10460566|NCT01025843|11608437|FG000|NOT COMPLETED|Washout 3||0
10460567|NCT01025843|11608438|FG001|NOT COMPLETED|Washout 3||0
10460568|NCT01025843|11608439|FG002|NOT COMPLETED|Washout 3||0
10460569|NCT01025843|11608440|FG003|NOT COMPLETED|Washout 3||0
10460570|NCT01025843|11608441|FG004|NOT COMPLETED|Washout 3||0
10460571|NCT01025843|11608442|FG005|NOT COMPLETED|Washout 3||0
10460572|NCT01025843|11608443|FG006|NOT COMPLETED|Washout 3||0
10460573|NCT01025843|11608444|FG007|NOT COMPLETED|Washout 3||0
10460574|NCT01025843|11608445|FG008|NOT COMPLETED|Washout 3||0
10460575|NCT01025843|11608446|FG009|NOT COMPLETED|Washout 3||0
10460576|NCT01025843|11608437|FG000|STARTED|Period 4||2
10460577|NCT01025843|11608438|FG001|STARTED|Period 4||2
10460578|NCT01025843|11608439|FG002|STARTED|Period 4||2
10460579|NCT01025843|11608440|FG003|STARTED|Period 4||2
10460580|NCT01025843|11608441|FG004|STARTED|Period 4||2
10460581|NCT01025843|11608442|FG005|STARTED|Period 4||2
10460582|NCT01025843|11608443|FG006|STARTED|Period 4||2
10460583|NCT01025843|11608444|FG007|STARTED|Period 4||2
10460584|NCT01025843|11608445|FG008|STARTED|Period 4||2
10460585|NCT01025843|11608446|FG009|STARTED|Period 4||2
10460586|NCT01025843|11608437|FG000|COMPLETED|Period 4||2
10460587|NCT01025843|11608438|FG001|COMPLETED|Period 4||2
10460588|NCT01025843|11608439|FG002|COMPLETED|Period 4||2
10460589|NCT01025843|11608440|FG003|COMPLETED|Period 4||2
10460590|NCT01025843|11608441|FG004|COMPLETED|Period 4||2
10460591|NCT01025843|11608442|FG005|COMPLETED|Period 4||2
10460592|NCT01025843|11608443|FG006|COMPLETED|Period 4||2
10460593|NCT01025843|11608444|FG007|COMPLETED|Period 4||2
10460594|NCT01025843|11608445|FG008|COMPLETED|Period 4||2
10460595|NCT01025843|11608446|FG009|COMPLETED|Period 4||2
10460596|NCT01025843|11608437|FG000|NOT COMPLETED|Period 4||0
10460597|NCT01025843|11608438|FG001|NOT COMPLETED|Period 4||0
10460598|NCT01025843|11608439|FG002|NOT COMPLETED|Period 4||0
10460599|NCT01025843|11608440|FG003|NOT COMPLETED|Period 4||0
10460600|NCT01025843|11608441|FG004|NOT COMPLETED|Period 4||0
10460601|NCT01025843|11608442|FG005|NOT COMPLETED|Period 4||0
10460602|NCT01025843|11608443|FG006|NOT COMPLETED|Period 4||0
10460603|NCT01025843|11608444|FG007|NOT COMPLETED|Period 4||0
10460604|NCT01025843|11608445|FG008|NOT COMPLETED|Period 4||0
10460605|NCT01025843|11608446|FG009|NOT COMPLETED|Period 4||0
10460606|NCT01025843|11608437|FG000|STARTED|Washout 4||2
10460607|NCT01025843|11608438|FG001|STARTED|Washout 4||2
10460608|NCT01025843|11608439|FG002|STARTED|Washout 4||2
10460609|NCT01025843|11608440|FG003|STARTED|Washout 4||2
10460610|NCT01025843|11608441|FG004|STARTED|Washout 4||2
10460611|NCT01025843|11608442|FG005|STARTED|Washout 4||2
10460612|NCT01025843|11608443|FG006|STARTED|Washout 4||2
10460613|NCT01025843|11608444|FG007|STARTED|Washout 4||2
10460614|NCT01025843|11608445|FG008|STARTED|Washout 4||2
10460615|NCT01025843|11608446|FG009|STARTED|Washout 4||2
10460616|NCT01025843|11608437|FG000|COMPLETED|Washout 4||2
10460617|NCT01025843|11608438|FG001|COMPLETED|Washout 4||2
10460618|NCT01025843|11608439|FG002|COMPLETED|Washout 4||1
10460619|NCT01025843|11608440|FG003|COMPLETED|Washout 4||1
10460620|NCT01025843|11608441|FG004|COMPLETED|Washout 4||2
10460621|NCT01025843|11608442|FG005|COMPLETED|Washout 4||2
10460622|NCT01025843|11608443|FG006|COMPLETED|Washout 4||2
10460623|NCT01025843|11608444|FG007|COMPLETED|Washout 4||2
10460624|NCT01025843|11608445|FG008|COMPLETED|Washout 4||2
10460625|NCT01025843|11608446|FG009|COMPLETED|Washout 4||2
10460626|NCT01025843|11608437|FG000|NOT COMPLETED|Washout 4||0
10460627|NCT01025843|11608438|FG001|NOT COMPLETED|Washout 4||0
10460628|NCT01025843|11608439|FG002|NOT COMPLETED|Washout 4||1
10460629|NCT01025843|11608440|FG003|NOT COMPLETED|Washout 4||1
10460630|NCT01025843|11608441|FG004|NOT COMPLETED|Washout 4||0
10460631|NCT01025843|11608442|FG005|NOT COMPLETED|Washout 4||0
10460632|NCT01025843|11608443|FG006|NOT COMPLETED|Washout 4||0
10460633|NCT01025843|11608444|FG007|NOT COMPLETED|Washout 4||0
10460634|NCT01025843|11608445|FG008|NOT COMPLETED|Washout 4||0
10460635|NCT01025843|11608446|FG009|NOT COMPLETED|Washout 4||0
10460636|NCT01025843|11608437|FG000|STARTED|Period 5||2
10460637|NCT01025843|11608438|FG001|STARTED|Period 5||2
10460638|NCT01025843|11608439|FG002|STARTED|Period 5||1
10460639|NCT01025843|11608440|FG003|STARTED|Period 5||1
10460640|NCT01025843|11608441|FG004|STARTED|Period 5||2
10460641|NCT01025843|11608442|FG005|STARTED|Period 5||2
10460642|NCT01025843|11608443|FG006|STARTED|Period 5||2
10460643|NCT01025843|11608444|FG007|STARTED|Period 5||2
10460644|NCT01025843|11608445|FG008|STARTED|Period 5||2
10460645|NCT01025843|11608446|FG009|STARTED|Period 5||2
10460646|NCT01025843|11608437|FG000|COMPLETED|Period 5||2
10460647|NCT01025843|11608438|FG001|COMPLETED|Period 5||2
10460648|NCT01025843|11608439|FG002|COMPLETED|Period 5||1
10460649|NCT01025843|11608440|FG003|COMPLETED|Period 5||1
10460650|NCT01025843|11608441|FG004|COMPLETED|Period 5||2
10460651|NCT01025843|11608442|FG005|COMPLETED|Period 5||2
10460652|NCT01025843|11608443|FG006|COMPLETED|Period 5||2
10460653|NCT01025843|11608444|FG007|COMPLETED|Period 5||2
10460654|NCT01025843|11608445|FG008|COMPLETED|Period 5||2
10460655|NCT01025843|11608446|FG009|COMPLETED|Period 5||2
10460656|NCT01025843|11608437|FG000|NOT COMPLETED|Period 5||0
10460657|NCT01025843|11608438|FG001|NOT COMPLETED|Period 5||0
10460658|NCT01025843|11608439|FG002|NOT COMPLETED|Period 5||0
10460659|NCT01025843|11608440|FG003|NOT COMPLETED|Period 5||0
10460660|NCT01025843|11608441|FG004|NOT COMPLETED|Period 5||0
10460661|NCT01025843|11608442|FG005|NOT COMPLETED|Period 5||0
10460662|NCT01025843|11608443|FG006|NOT COMPLETED|Period 5||0
10460663|NCT01025843|11608444|FG007|NOT COMPLETED|Period 5||0
10460664|NCT01025843|11608445|FG008|NOT COMPLETED|Period 5||0
10460665|NCT01025843|11608446|FG009|NOT COMPLETED|Period 5||0
10460669|NCT01026038|11608481|FG000|STARTED|Overall Study||130
10460670|NCT01026038|11608482|FG001|STARTED|Overall Study||65
10460671|NCT01026038|11608483|FG002|STARTED|Overall Study||67
10460672|NCT01026038|11608481|FG000|COMPLETED|Overall Study||129
10460673|NCT01026038|11608482|FG001|COMPLETED|Overall Study||64
10460674|NCT01026038|11608483|FG002|COMPLETED|Overall Study||67
10460675|NCT01026038|11608481|FG000|NOT COMPLETED|Overall Study||1
10460676|NCT01026038|11608482|FG001|NOT COMPLETED|Overall Study||1
10460677|NCT01026038|11608483|FG002|NOT COMPLETED|Overall Study||0
10460678|NCT01026103|11608491|FG000|STARTED|Overall Study||30
10460679|NCT01026103|11608491|FG000|Consented|Overall Study||30
10460680|NCT01026103|11608491|FG000|COMPLETED|Overall Study||28
10460681|NCT01026103|11608491|FG000|NOT COMPLETED|Overall Study||2
10460682|NCT01026142|11608497|FG000|STARTED|Overall Study||224
10460683|NCT01026142|11608498|FG001|STARTED|Overall Study||228
10460684|NCT01026142|11608497|FG000|COMPLETED|Overall Study||52
10460685|NCT01026142|11608498|FG001|COMPLETED|Overall Study||65
10460686|NCT01026142|11608497|FG000|NOT COMPLETED|Overall Study||172
10460687|NCT01026142|11608498|FG001|NOT COMPLETED|Overall Study||163
10460688|NCT01026181|11608507|FG000|STARTED|Overall Study||51
10460689|NCT01026181|11608508|FG001|STARTED|Overall Study||51
10460690|NCT01026181|11608509|FG002|STARTED|Overall Study||48
10460691|NCT01026181|11608507|FG000|COMPLETED|Overall Study||51
10460692|NCT01026181|11608508|FG001|COMPLETED|Overall Study||51
10460693|NCT01026181|11608509|FG002|COMPLETED|Overall Study||48
10460694|NCT01026181|11608507|FG000|NOT COMPLETED|Overall Study||0
10460695|NCT01026181|11608508|FG001|NOT COMPLETED|Overall Study||0
10460696|NCT01026181|11608509|FG002|NOT COMPLETED|Overall Study||0
10460697|NCT01026194|11608519|FG000|STARTED|Period 1：Double Blind Period||101
10460698|NCT01026194|11608520|FG001|STARTED|Period 1：Double Blind Period||103
10460699|NCT01026194|11608519|FG000|COMPLETED|Period 1：Double Blind Period||98
10460700|NCT01026194|11608520|FG001|COMPLETED|Period 1：Double Blind Period||98
10460701|NCT01026194|11608519|FG000|NOT COMPLETED|Period 1：Double Blind Period||3
10460702|NCT01026194|11608520|FG001|NOT COMPLETED|Period 1：Double Blind Period||5
10460703|NCT01026194|11608519|FG000|STARTED|Period 2：Open-label Period||98
10460704|NCT01026194|11608520|FG001|STARTED|Period 2：Open-label Period||98
10460705|NCT01026194|11608519|FG000|COMPLETED|Period 2：Open-label Period||91
10460706|NCT01026194|11608520|FG001|COMPLETED|Period 2：Open-label Period||88
10460707|NCT01026194|11608519|FG000|NOT COMPLETED|Period 2：Open-label Period||7
10460708|NCT01026194|11608520|FG001|NOT COMPLETED|Period 2：Open-label Period||10
10460709|NCT01026324|11608531|FG000|STARTED|Treatment Allocation||5
10460710|NCT01026324|11608532|FG001|STARTED|Treatment Allocation||3
10460711|NCT01026324|11608533|FG002|STARTED|Treatment Allocation||4
10460712|NCT01026324|11608531|FG000|Discontinued Intervention (Toxicity)|Treatment Allocation||1
10460713|NCT01026324|11608532|FG001|Discontinued Intervention (Toxicity)|Treatment Allocation||0
10460714|NCT01026324|11608533|FG002|Discontinued Intervention (Toxicity)|Treatment Allocation||0
10460715|NCT01026324|11608531|FG000|Discontinuted Intervention (Progression)|Treatment Allocation||3
10460716|NCT01026324|11608532|FG001|Discontinuted Intervention (Progression)|Treatment Allocation||3
10460717|NCT01026324|11608533|FG002|Discontinuted Intervention (Progression)|Treatment Allocation||4
10460718|NCT01026324|11608531|FG000|Discontinued Intervention (Withdrew)|Treatment Allocation||1
10460719|NCT01026324|11608532|FG001|Discontinued Intervention (Withdrew)|Treatment Allocation||0
10460720|NCT01026324|11608533|FG002|Discontinued Intervention (Withdrew)|Treatment Allocation||0
10460721|NCT01026324|11608531|FG000|COMPLETED|Treatment Allocation||5
10460722|NCT01026324|11608532|FG001|COMPLETED|Treatment Allocation||3
10460723|NCT01026324|11608533|FG002|COMPLETED|Treatment Allocation||4
10460724|NCT01026324|11608531|FG000|NOT COMPLETED|Treatment Allocation||0
10460725|NCT01026324|11608532|FG001|NOT COMPLETED|Treatment Allocation||0
10460726|NCT01026324|11608533|FG002|NOT COMPLETED|Treatment Allocation||0
10460727|NCT01026324|11608531|FG000|STARTED|Follow up/Survival||5
10460728|NCT01026324|11608532|FG001|STARTED|Follow up/Survival||3
10460729|NCT01026324|11608533|FG002|STARTED|Follow up/Survival||4
10460730|NCT01026324|11608531|FG000|Follow up Discontinuation (Death)|Follow up/Survival||4
10460731|NCT01026324|11608532|FG001|Follow up Discontinuation (Death)|Follow up/Survival||3
10460732|NCT01026324|11608533|FG002|Follow up Discontinuation (Death)|Follow up/Survival||4
10460733|NCT01026324|11608531|FG000|COMPLETED|Follow up/Survival||4
10460734|NCT01026324|11608532|FG001|COMPLETED|Follow up/Survival||3
10460735|NCT01026324|11608533|FG002|COMPLETED|Follow up/Survival||4
10460736|NCT01026324|11608531|FG000|NOT COMPLETED|Follow up/Survival||1
10460737|NCT01026324|11608532|FG001|NOT COMPLETED|Follow up/Survival||0
10460738|NCT01026324|11608533|FG002|NOT COMPLETED|Follow up/Survival||0
10460739|NCT01026389|11608544|FG000|STARTED|Overall Study||93
10460740|NCT01026389|11608545|FG001|STARTED|Overall Study||93
10460741|NCT01026389|11608544|FG000|COMPLETED|Overall Study||88
10460742|NCT01026389|11608545|FG001|COMPLETED|Overall Study||88
10460743|NCT01026389|11608544|FG000|NOT COMPLETED|Overall Study||5
10460744|NCT01026389|11608545|FG001|NOT COMPLETED|Overall Study||5
10460745|NCT01026402|11608568|FG000|STARTED|Overall Study||6
10460746|NCT01026402|11608569|FG001|STARTED|Overall Study||8
10460747|NCT01026402|11608570|FG002|STARTED|Overall Study||33
10460748|NCT01026402|11608571|FG003|STARTED|Overall Study||18
10460749|NCT01026402|11608572|FG004|STARTED|Overall Study||3
10460750|NCT01026402|11608573|FG005|STARTED|Overall Study||5
10460751|NCT01026402|11608574|FG006|STARTED|Overall Study||8
10460752|NCT01026402|11608575|FG007|STARTED|Overall Study||3
10460753|NCT01026402|11608576|FG008|STARTED|Overall Study||7
10460754|NCT01026402|11608577|FG009|STARTED|Overall Study||3
10460755|NCT01026402|11608578|FG010|STARTED|Overall Study||7
10460756|NCT01026402|11608579|FG011|STARTED|Overall Study||8
10460757|NCT01026402|11608580|FG012|STARTED|Overall Study||8
10460758|NCT01026402|11608581|FG013|STARTED|Overall Study||6
10460759|NCT01026402|11608582|FG014|STARTED|Overall Study||3
10460760|NCT01026402|11608583|FG015|STARTED|Overall Study||5
10460761|NCT01026402|11608584|FG016|STARTED|Overall Study||4
10460762|NCT01026402|11608568|FG000|COMPLETED|Overall Study||6
10460763|NCT01026402|11608569|FG001|COMPLETED|Overall Study||8
10460764|NCT01026402|11608570|FG002|COMPLETED|Overall Study||33
10460765|NCT01026402|11608571|FG003|COMPLETED|Overall Study||18
10460766|NCT01026402|11608572|FG004|COMPLETED|Overall Study||3
10460767|NCT01026402|11608573|FG005|COMPLETED|Overall Study||5
10460768|NCT01026402|11608574|FG006|COMPLETED|Overall Study||8
10460769|NCT01026402|11608575|FG007|COMPLETED|Overall Study||3
10460770|NCT01026402|11608576|FG008|COMPLETED|Overall Study||7
10460771|NCT01026402|11608577|FG009|COMPLETED|Overall Study||3
10460772|NCT01026402|11608578|FG010|COMPLETED|Overall Study||7
10460773|NCT01026402|11608579|FG011|COMPLETED|Overall Study||8
10460774|NCT01026402|11608580|FG012|COMPLETED|Overall Study||8
10460775|NCT01026402|11608581|FG013|COMPLETED|Overall Study||6
10460776|NCT01026402|11608582|FG014|COMPLETED|Overall Study||3
10460777|NCT01026402|11608583|FG015|COMPLETED|Overall Study||5
10460778|NCT01026402|11608584|FG016|COMPLETED|Overall Study||4
10460779|NCT01026402|11608568|FG000|NOT COMPLETED|Overall Study||0
10460780|NCT01026402|11608569|FG001|NOT COMPLETED|Overall Study||0
10460781|NCT01026402|11608570|FG002|NOT COMPLETED|Overall Study||0
10460782|NCT01026402|11608571|FG003|NOT COMPLETED|Overall Study||0
10460783|NCT01026402|11608572|FG004|NOT COMPLETED|Overall Study||0
10460784|NCT01026402|11608573|FG005|NOT COMPLETED|Overall Study||0
10460785|NCT01026402|11608574|FG006|NOT COMPLETED|Overall Study||0
10460786|NCT01026402|11608575|FG007|NOT COMPLETED|Overall Study||0
10460787|NCT01026402|11608576|FG008|NOT COMPLETED|Overall Study||0
10460788|NCT01026402|11608577|FG009|NOT COMPLETED|Overall Study||0
10460789|NCT01026402|11608578|FG010|NOT COMPLETED|Overall Study||0
10460790|NCT01026402|11608579|FG011|NOT COMPLETED|Overall Study||0
10460791|NCT01026402|11608580|FG012|NOT COMPLETED|Overall Study||0
10460792|NCT01026402|11608581|FG013|NOT COMPLETED|Overall Study||0
10460793|NCT01026402|11608582|FG014|NOT COMPLETED|Overall Study||0
10460794|NCT01026402|11608583|FG015|NOT COMPLETED|Overall Study||0
10460795|NCT01026402|11608584|FG016|NOT COMPLETED|Overall Study||0
10460796|NCT01026454|11608625|FG000|STARTED|First Intervention||18
10460797|NCT01026454|11608626|FG001|STARTED|First Intervention||14
10460798|NCT01026454|11608625|FG000|COMPLETED|First Intervention||18
10460799|NCT01026454|11608626|FG001|COMPLETED|First Intervention||14
10460800|NCT01026454|11608625|FG000|NOT COMPLETED|First Intervention||0
10460801|NCT01026454|11608626|FG001|NOT COMPLETED|First Intervention||0
10460802|NCT01026454|11608625|FG000|STARTED|Washout||18
10460803|NCT01026454|11608626|FG001|STARTED|Washout||14
10460804|NCT01026454|11608625|FG000|COMPLETED|Washout||18
10460805|NCT01026454|11608626|FG001|COMPLETED|Washout||14
10460806|NCT01026454|11608625|FG000|NOT COMPLETED|Washout||0
10460807|NCT01026454|11608626|FG001|NOT COMPLETED|Washout||0
10460808|NCT01026454|11608625|FG000|STARTED|Second Intervention||17
10460809|NCT01026454|11608626|FG001|STARTED|Second Intervention||14
10460810|NCT01026454|11608625|FG000|COMPLETED|Second Intervention||16
10460811|NCT01026454|11608626|FG001|COMPLETED|Second Intervention||13
10460812|NCT01026454|11608625|FG000|NOT COMPLETED|Second Intervention||1
10460813|NCT01026454|11608626|FG001|NOT COMPLETED|Second Intervention||1
10460814|NCT01026493|11608640|FG000|STARTED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|8
10460815|NCT01026493|11608641|FG001|STARTED|Overall Study||7
10460816|NCT01026493|11608642|FG002|STARTED|Overall Study||9
10460817|NCT01026493|11608643|FG003|STARTED|Overall Study||8
10460818|NCT01026493|11608644|FG004|STARTED|Overall Study||75
10460819|NCT01026493|11608645|FG005|STARTED|Overall Study||76
10460820|NCT01026493|11608646|FG006|STARTED|Overall Study||36
10460821|NCT01026493|11608647|FG007|STARTED|Overall Study||38
10460822|NCT01026493|11608640|FG000|COMPLETED|Overall Study||8
10460823|NCT01026493|11608641|FG001|COMPLETED|Overall Study||6
10460824|NCT01026493|11608642|FG002|COMPLETED|Overall Study||9
10460825|NCT01026493|11608643|FG003|COMPLETED|Overall Study||8
10460826|NCT01026493|11608644|FG004|COMPLETED|Overall Study||73
10460827|NCT01026493|11608645|FG005|COMPLETED|Overall Study||73
10460828|NCT01026493|11608646|FG006|COMPLETED|Overall Study||32
10460829|NCT01026493|11608647|FG007|COMPLETED|Overall Study||37
10460830|NCT01026493|11608640|FG000|NOT COMPLETED|Overall Study||0
10460831|NCT01026493|11608641|FG001|NOT COMPLETED|Overall Study||1
10460832|NCT01026493|11608642|FG002|NOT COMPLETED|Overall Study||0
10460833|NCT01026493|11608643|FG003|NOT COMPLETED|Overall Study||0
10460834|NCT01026493|11608644|FG004|NOT COMPLETED|Overall Study||2
10460835|NCT01026493|11608645|FG005|NOT COMPLETED|Overall Study||3
10460836|NCT01026493|11608646|FG006|NOT COMPLETED|Overall Study||4
10460837|NCT01026493|11608647|FG007|NOT COMPLETED|Overall Study||1
10460838|NCT01026623|11608668|FG000|STARTED|Overall Study||6
10460839|NCT01026623|11608669|FG001|STARTED|Overall Study||5
10460840|NCT01026623|11608670|FG002|STARTED|Overall Study||5
10460841|NCT01026623|11608668|FG000|COMPLETED|Overall Study||6
10460842|NCT01026623|11608669|FG001|COMPLETED|Overall Study||5
10460843|NCT01026623|11608670|FG002|COMPLETED|Overall Study||5
10460844|NCT01026623|11608668|FG000|NOT COMPLETED|Overall Study||0
10460845|NCT01026623|11608669|FG001|NOT COMPLETED|Overall Study||0
10460846|NCT01026623|11608670|FG002|NOT COMPLETED|Overall Study||0
10460847|NCT01026792|11608679|FG000|STARTED|Overall Study||38
10460848|NCT01026792|11608679|FG000|COMPLETED|Overall Study||37
10460849|NCT01026792|11608679|FG000|NOT COMPLETED|Overall Study||1
10460850|NCT01026805|11608683|FG000|STARTED|Overall Study||11
10460851|NCT01026805|11608683|FG000|COMPLETED|Overall Study||11
10460852|NCT01026805|11608683|FG000|NOT COMPLETED|Overall Study||0
10460853|NCT01026818|11608690|FG000|STARTED|Screening Period||583
10460854|NCT01026818|11608691|FG001|STARTED|Screening Period||0
10460855|NCT01026818|11608692|FG002|STARTED|Screening Period||0
10460856|NCT01026818|11608693|FG003|STARTED|Screening Period||0
10460857|NCT01026818|11608690|FG000|COMPLETED|Screening Period||423
10460858|NCT01026818|11608691|FG001|COMPLETED|Screening Period||0
10460859|NCT01026818|11608692|FG002|COMPLETED|Screening Period||0
10460860|NCT01026818|11608693|FG003|COMPLETED|Screening Period||0
10460861|NCT01026818|11608690|FG000|NOT COMPLETED|Screening Period||160
10460862|NCT01026818|11608691|FG001|NOT COMPLETED|Screening Period||0
10460863|NCT01026818|11608692|FG002|NOT COMPLETED|Screening Period||0
10460864|NCT01026818|11608693|FG003|NOT COMPLETED|Screening Period||0
10460865|NCT01026818|11608690|FG000|STARTED|DB Treatment Period (Month 0 - 9)||0
10460866|NCT01026818|11608691|FG001|STARTED|DB Treatment Period (Month 0 - 9)||139
10460867|NCT01026818|11608692|FG002|STARTED|DB Treatment Period (Month 0 - 9)||143
10460868|NCT01026818|11608693|FG003|STARTED|DB Treatment Period (Month 0 - 9)||141
10460869|NCT01026818|11608690|FG000|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||0
10460870|NCT01026818|11608691|FG001|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||139
10460871|NCT01026818|11608692|FG002|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||143
10460872|NCT01026818|11608693|FG003|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||141
10460873|NCT01026818|11608690|FG000|COMPLETED|DB Treatment Period (Month 0 - 9)||0
10460874|NCT01026818|11608691|FG001|COMPLETED|DB Treatment Period (Month 0 - 9)||114
10460875|NCT01026818|11608692|FG002|COMPLETED|DB Treatment Period (Month 0 - 9)||122
10460876|NCT01026818|11608693|FG003|COMPLETED|DB Treatment Period (Month 0 - 9)||115
10460877|NCT01026818|11608690|FG000|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||0
10460878|NCT01026818|11608691|FG001|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||25
10460879|NCT01026818|11608692|FG002|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||21
10460880|NCT01026818|11608693|FG003|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||26
10460881|NCT01026818|11608690|FG000|STARTED|Drug-Free Washout Period (Month 9-10.5)||0
10460882|NCT01026818|11608691|FG001|STARTED|Drug-Free Washout Period (Month 9-10.5)||114
10460883|NCT01026818|11608692|FG002|STARTED|Drug-Free Washout Period (Month 9-10.5)||122
10460884|NCT01026818|11608693|FG003|STARTED|Drug-Free Washout Period (Month 9-10.5)||115
10460885|NCT01026818|11608690|FG000|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||0
10460886|NCT01026818|11608691|FG001|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||105
10460887|NCT01026818|11608692|FG002|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||117
10460888|NCT01026818|11608693|FG003|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||108
10460889|NCT01026818|11608690|FG000|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||0
10460890|NCT01026818|11608691|FG001|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||9
10460891|NCT01026818|11608692|FG002|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||5
10460892|NCT01026818|11608693|FG003|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||7
10460893|NCT01026818|11608690|FG000|STARTED|OL Period (Month 10.5 - 13.5)||0
10460894|NCT01026818|11608691|FG001|STARTED|OL Period (Month 10.5 - 13.5)||105
10460895|NCT01026818|11608692|FG002|STARTED|OL Period (Month 10.5 - 13.5)||117
10460896|NCT01026818|11608693|FG003|STARTED|OL Period (Month 10.5 - 13.5)||108
10460897|NCT01026818|11608690|FG000|COMPLETED|OL Period (Month 10.5 - 13.5)||0
10460898|NCT01026818|11608691|FG001|COMPLETED|OL Period (Month 10.5 - 13.5)||98
10460899|NCT01026818|11608692|FG002|COMPLETED|OL Period (Month 10.5 - 13.5)||112
10460900|NCT01026818|11608693|FG003|COMPLETED|OL Period (Month 10.5 - 13.5)||105
10460901|NCT01026818|11608690|FG000|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||0
10460902|NCT01026818|11608691|FG001|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||7
10460903|NCT01026818|11608692|FG002|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||5
10460904|NCT01026818|11608693|FG003|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||3
10460905|NCT01026831|11608707|FG000|STARTED|Overall Study|randomized|320
10460906|NCT01026831|11608708|FG001|STARTED|Overall Study|randomized|323
10460907|NCT01026831|11608707|FG000|COMPLETED|Overall Study||306
10460908|NCT01026831|11608708|FG001|COMPLETED|Overall Study||312
10460909|NCT01026831|11608707|FG000|NOT COMPLETED|Overall Study||14
10460910|NCT01026831|11608708|FG001|NOT COMPLETED|Overall Study||11
10460911|NCT01026844|11608716|FG000|STARTED|Overall Study||19
10460912|NCT01026844|11608717|FG001|STARTED|Overall Study||8
10460913|NCT01026844|11608716|FG000|COMPLETED|Overall Study||19
10460914|NCT01026844|11608717|FG001|COMPLETED|Overall Study||8
10460915|NCT01026844|11608716|FG000|NOT COMPLETED|Overall Study||0
10460916|NCT01026844|11608717|FG001|NOT COMPLETED|Overall Study||0
10460917|NCT01026909|11608725|FG000|STARTED|Overall Study||1
10460918|NCT01026909|11608726|FG001|STARTED|Overall Study||2
10460919|NCT01026909|11608725|FG000|COMPLETED|Overall Study||1
10460920|NCT01026909|11608726|FG001|COMPLETED|Overall Study||2
10460921|NCT01026909|11608725|FG000|NOT COMPLETED|Overall Study||0
10460922|NCT01026909|11608726|FG001|NOT COMPLETED|Overall Study||0
10460923|NCT01026948|11608732|FG000|STARTED|Overall Study||70
10460924|NCT01026948|11608732|FG000|COMPLETED|Overall Study|8 Women were recalled because of signal loss|62
10460925|NCT01026948|11608732|FG000|NOT COMPLETED|Overall Study||8
10460926|NCT01026974|11608741|FG000|STARTED|Overall Study||16
10460927|NCT01026974|11608742|FG001|STARTED|Overall Study||14
10708337|NCT02629354|11873144|FG000|COMPLETED|Period 2||18
10708338|NCT02629354|11873145|FG001|COMPLETED|Period 2||18
10708339|NCT02629354|11873144|FG000|NOT COMPLETED|Period 2||0
10708340|NCT02629354|11873145|FG001|NOT COMPLETED|Period 2||0
10708341|NCT02629354|11873144|FG000|STARTED|Follow-up||18
10460928|NCT01026974|11608743|FG002|STARTED|Overall Study||41
10460929|NCT01026974|11608744|FG003|STARTED|Overall Study||49
10460930|NCT01026974|11608741|FG000|COMPLETED|Overall Study||15
10460931|NCT01026974|11608742|FG001|COMPLETED|Overall Study||12
10460932|NCT01026974|11608743|FG002|COMPLETED|Overall Study||29
10460933|NCT01026974|11608744|FG003|COMPLETED|Overall Study||46
10460934|NCT01026974|11608741|FG000|NOT COMPLETED|Overall Study||1
10460935|NCT01026974|11608742|FG001|NOT COMPLETED|Overall Study||2
10460936|NCT01026974|11608743|FG002|NOT COMPLETED|Overall Study||12
10460937|NCT01026974|11608744|FG003|NOT COMPLETED|Overall Study||3
10460938|NCT01027000|11608759|FG000|STARTED|Overall Study||68
10460939|NCT01027000|11608759|FG000|COMPLETED|Overall Study||68
10460940|NCT01027000|11608759|FG000|NOT COMPLETED|Overall Study||0
10460941|NCT01027195|11608765|FG000|STARTED|Overall Study||71
10460942|NCT01027195|11608766|FG001|STARTED|Overall Study||69
10460943|NCT01027195|11608765|FG000|COMPLETED|Overall Study||71
10460944|NCT01027195|11608766|FG001|COMPLETED|Overall Study||69
10460945|NCT01027195|11608765|FG000|NOT COMPLETED|Overall Study||0
10460946|NCT01027195|11608766|FG001|NOT COMPLETED|Overall Study||0
10460947|NCT01027273|11608774|FG000|STARTED|Overall Study||301
10460948|NCT01027273|11608775|FG001|STARTED|Overall Study||299
10460949|NCT01027273|11608774|FG000|COMPLETED|Overall Study||242
10460950|NCT01027273|11608775|FG001|COMPLETED|Overall Study||266
10460951|NCT01027273|11608774|FG000|NOT COMPLETED|Overall Study||59
10460952|NCT01027273|11608775|FG001|NOT COMPLETED|Overall Study||33
10460953|NCT01027286|11608783|FG000|STARTED|Overall Study||50
10460954|NCT01027286|11608784|FG001|STARTED|Overall Study||50
10460955|NCT01027286|11608783|FG000|Preoperative|Overall Study||50
10460956|NCT01027286|11608784|FG001|Preoperative|Overall Study||50
10460957|NCT01027286|11608783|FG000|Day of Surgery|Overall Study||50
10460958|NCT01027286|11608784|FG001|Day of Surgery|Overall Study||50
10460959|NCT01027286|11608783|FG000|4 Week Postoperative|Overall Study||49
10460960|NCT01027286|11608784|FG001|4 Week Postoperative|Overall Study||50
10460961|NCT01027286|11608783|FG000|12 Week Postoperative|Overall Study||49
10460962|NCT01027286|11608784|FG001|12 Week Postoperative|Overall Study||49
10460963|NCT01027286|11608783|FG000|COMPLETED|Overall Study||49
10460964|NCT01027286|11608784|FG001|COMPLETED|Overall Study||49
10460965|NCT01027286|11608783|FG000|NOT COMPLETED|Overall Study||1
10460966|NCT01027286|11608784|FG001|NOT COMPLETED|Overall Study||1
10460967|NCT01027351|11608796|FG000|STARTED|Overall Study||29
10708342|NCT02629354|11873145|FG001|STARTED|Follow-up||18
10460968|NCT01027351|11608797|FG001|STARTED|Overall Study||19
10460969|NCT01027351|11608798|FG002|STARTED|Overall Study||14
10460970|NCT01027351|11608799|FG003|STARTED|Overall Study||8
10460971|NCT01027351|11608800|FG004|STARTED|Overall Study||43
10460972|NCT01027351|11608801|FG005|STARTED|Overall Study||50
10460973|NCT01027351|11608796|FG000|COMPLETED|Overall Study||26
10460974|NCT01027351|11608797|FG001|COMPLETED|Overall Study||18
10460975|NCT01027351|11608798|FG002|COMPLETED|Overall Study||13
10460976|NCT01027351|11608799|FG003|COMPLETED|Overall Study||6
10460977|NCT01027351|11608800|FG004|COMPLETED|Overall Study||32
10460978|NCT01027351|11608801|FG005|COMPLETED|Overall Study||45
10460979|NCT01027351|11608796|FG000|NOT COMPLETED|Overall Study||3
10460980|NCT01027351|11608797|FG001|NOT COMPLETED|Overall Study||1
10460981|NCT01027351|11608798|FG002|NOT COMPLETED|Overall Study||1
10460982|NCT01027351|11608799|FG003|NOT COMPLETED|Overall Study||2
10460983|NCT01027351|11608800|FG004|NOT COMPLETED|Overall Study||11
10460984|NCT01027351|11608801|FG005|NOT COMPLETED|Overall Study||5
10526341|NCT01380730|11678145|FG001|COMPLETED|Overall Study||79
10526342|NCT01380730|11678146|FG002|COMPLETED|Overall Study||79
10526343|NCT01380730|11678147|FG003|COMPLETED|Overall Study||79
10526344|NCT01380730|11678148|FG004|COMPLETED|Overall Study||77
10526345|NCT01380730|11678149|FG005|COMPLETED|Overall Study||79
10526346|NCT01380730|11678150|FG006|COMPLETED|Overall Study||79
10526347|NCT01380730|11678151|FG007|COMPLETED|Overall Study||80
10526348|NCT01380730|11678144|FG000|NOT COMPLETED|Overall Study||0
10708343|NCT02629354|11873144|FG000|COMPLETED|Follow-up||18
10526349|NCT01380730|11678145|FG001|NOT COMPLETED|Overall Study||0
10526350|NCT01380730|11678146|FG002|NOT COMPLETED|Overall Study||0
10526351|NCT01380730|11678147|FG003|NOT COMPLETED|Overall Study||0
10526352|NCT01380730|11678148|FG004|NOT COMPLETED|Overall Study||1
10526353|NCT01380730|11678149|FG005|NOT COMPLETED|Overall Study||0
10526354|NCT01380730|11678150|FG006|NOT COMPLETED|Overall Study||0
10526355|NCT01380730|11678151|FG007|NOT COMPLETED|Overall Study||0
10526356|NCT01380743|11678173|FG000|STARTED|Overall Study||6
10526357|NCT01380743|11678174|FG001|STARTED|Overall Study||6
10526358|NCT01380743|11678175|FG002|STARTED|Overall Study||6
10526359|NCT01380743|11678176|FG003|STARTED|Overall Study||7
10526360|NCT01380743|11678173|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
10526361|NCT01380743|11678174|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
10708344|NCT02629354|11873145|FG001|COMPLETED|Follow-up||18
10460985|NCT01027364|11608826|FG000|STARTED|Overall Study||63
10460986|NCT01027364|11608827|FG001|STARTED|Overall Study||29
10460987|NCT01027364|11608828|FG002|STARTED|Overall Study||27
10460988|NCT01027364|11608829|FG003|STARTED|Overall Study|12 total participants in Arm 4 (6 started in Arm 4; 5 joined from Arm 1; 1 joined from Arm 3)|4
10460989|NCT01027364|11608826|FG000|Enrolled in Sequential PK Subgroup|Overall Study||22
10460990|NCT01027364|11608827|FG001|Enrolled in Sequential PK Subgroup|Overall Study||0
10460991|NCT01027364|11608828|FG002|Enrolled in Sequential PK Subgroup|Overall Study||0
10460992|NCT01027364|11608829|FG003|Enrolled in Sequential PK Subgroup|Overall Study||0
10460993|NCT01027364|11608826|FG000|Joined Arm 4 for Surgery Then Returned|Overall Study||5
10460994|NCT01027364|11608827|FG001|Joined Arm 4 for Surgery Then Returned|Overall Study||0
10460995|NCT01027364|11608828|FG002|Joined Arm 4 for Surgery Then Returned|Overall Study||1
10460996|NCT01027364|11608829|FG003|Joined Arm 4 for Surgery Then Returned|Overall Study||0
10460997|NCT01027364|11608826|FG000|Started Arm 4 Then Joined Another Arm|Overall Study||2
10460998|NCT01027364|11608827|FG001|Started Arm 4 Then Joined Another Arm|Overall Study||0
10460999|NCT01027364|11608828|FG002|Started Arm 4 Then Joined Another Arm|Overall Study||0
10461000|NCT01027364|11608829|FG003|Started Arm 4 Then Joined Another Arm|Overall Study||0
10461001|NCT01027364|11608826|FG000|COMPLETED|Overall Study||59
10461002|NCT01027364|11608827|FG001|COMPLETED|Overall Study||27
10461003|NCT01027364|11608828|FG002|COMPLETED|Overall Study||26
10461004|NCT01027364|11608829|FG003|COMPLETED|Overall Study|11 participants total completed Arm 4 (3: compl. Arm 4 only; 7: cont. to Arm 1; 1: cont. to Arm 3)|3
10461005|NCT01027364|11608826|FG000|NOT COMPLETED|Overall Study||4
10461006|NCT01027364|11608827|FG001|NOT COMPLETED|Overall Study||2
10461007|NCT01027364|11608828|FG002|NOT COMPLETED|Overall Study||1
10461008|NCT01027364|11608829|FG003|NOT COMPLETED|Overall Study||1
10461009|NCT01027416|11608857|FG000|STARTED|Overall Study||31
10461010|NCT01027416|11608858|FG001|STARTED|Overall Study||28
10461011|NCT01027416|11608857|FG000|COMPLETED|Overall Study||30
10461012|NCT01027416|11608858|FG001|COMPLETED|Overall Study||23
10461013|NCT01027416|11608857|FG000|NOT COMPLETED|Overall Study||1
10461014|NCT01027416|11608858|FG001|NOT COMPLETED|Overall Study||5
10461015|NCT01027468|11608864|FG000|STARTED|Overall Study||160
10461016|NCT01027468|11608864|FG000|COMPLETED|Overall Study||160
10461017|NCT01027468|11608864|FG000|NOT COMPLETED|Overall Study||0
10461018|NCT01027559|11608871|FG000|STARTED|Overall Study||26
10461019|NCT01027559|11608872|FG001|STARTED|Overall Study||34
10461020|NCT01027559|11608873|FG002|STARTED|Overall Study||31
10461021|NCT01027559|11608871|FG000|COMPLETED|Overall Study||20
10461022|NCT01027559|11608872|FG001|COMPLETED|Overall Study||26
10461023|NCT01027559|11608873|FG002|COMPLETED|Overall Study||22
10461024|NCT01027559|11608871|FG000|NOT COMPLETED|Overall Study||6
10461025|NCT01027559|11608872|FG001|NOT COMPLETED|Overall Study||8
10461026|NCT01027559|11608873|FG002|NOT COMPLETED|Overall Study||9
10461027|NCT01027598|11608884|FG000|STARTED|Overall Study|One patient was enrolled but not treated|134
10461028|NCT01027598|11608885|FG001|STARTED|Overall Study||67
10461029|NCT01027598|11608884|FG000|COMPLETED|Overall Study|Patients remained on treatment until coming off for progression, toxicity or any other reason|0
10461030|NCT01027598|11608885|FG001|COMPLETED|Overall Study|Patients remained on treatment until coming off for progression, toxicity or any other reason|0
10461031|NCT01027598|11608884|FG000|NOT COMPLETED|Overall Study||134
10461032|NCT01027598|11608885|FG001|NOT COMPLETED|Overall Study||67
10461033|NCT01027650|11608899|FG000|STARTED|Overall Study||6
10461034|NCT01027650|11608900|FG001|STARTED|Overall Study||6
10461035|NCT01027650|11608901|FG002|STARTED|Overall Study||6
10461036|NCT01027650|11608902|FG003|STARTED|Overall Study||3
10461037|NCT01027650|11608903|FG004|STARTED|Overall Study||25
10461038|NCT01027650|11608904|FG005|STARTED|Overall Study||26
10461039|NCT01027650|11608905|FG006|STARTED|Overall Study||25
10461040|NCT01027650|11608906|FG007|STARTED|Overall Study||24
10461041|NCT01027650|11608899|FG000|COMPLETED|Overall Study||6
10461042|NCT01027650|11608900|FG001|COMPLETED|Overall Study||6
10461043|NCT01027650|11608901|FG002|COMPLETED|Overall Study||6
10461044|NCT01027650|11608902|FG003|COMPLETED|Overall Study||3
10461045|NCT01027650|11608903|FG004|COMPLETED|Overall Study||23
10461046|NCT01027650|11608904|FG005|COMPLETED|Overall Study||24
10461047|NCT01027650|11608905|FG006|COMPLETED|Overall Study||24
10461048|NCT01027650|11608906|FG007|COMPLETED|Overall Study||24
10461049|NCT01027650|11608899|FG000|NOT COMPLETED|Overall Study||0
10461050|NCT01027650|11608900|FG001|NOT COMPLETED|Overall Study||0
10461051|NCT01027650|11608901|FG002|NOT COMPLETED|Overall Study||0
10461052|NCT01027650|11608902|FG003|NOT COMPLETED|Overall Study||0
10461053|NCT01027650|11608903|FG004|NOT COMPLETED|Overall Study||2
10461054|NCT01027650|11608904|FG005|NOT COMPLETED|Overall Study||2
10461055|NCT01027650|11608905|FG006|NOT COMPLETED|Overall Study||1
10461056|NCT01027650|11608906|FG007|NOT COMPLETED|Overall Study||0
10461057|NCT01027754|11608926|FG000|STARTED|Overall Study||57
10461058|NCT01027754|11608927|FG001|STARTED|Overall Study||55
10461059|NCT01027754|11608926|FG000|COMPLETED|Overall Study||55
10461060|NCT01027754|11608927|FG001|COMPLETED|Overall Study||47
10461061|NCT01027754|11608926|FG000|NOT COMPLETED|Overall Study||2
10461062|NCT01027754|11608927|FG001|NOT COMPLETED|Overall Study||8
10461063|NCT01027780|11608935|FG000|STARTED|Overall Study||105
10461064|NCT01027780|11608936|FG001|STARTED|Overall Study||103
10461065|NCT01027780|11608935|FG000|COMPLETED|Overall Study||105
10461066|NCT01027780|11608936|FG001|COMPLETED|Overall Study||102
10461067|NCT01027780|11608935|FG000|NOT COMPLETED|Overall Study||0
10461068|NCT01027780|11608936|FG001|NOT COMPLETED|Overall Study||1
10461069|NCT01027793|11608945|FG000|STARTED|Overall Study||17
10461070|NCT01027793|11608946|FG001|STARTED|Overall Study||15
10461071|NCT01027793|11608945|FG000|COMPLETED|Overall Study||10
10461072|NCT01027793|11608946|FG001|COMPLETED|Overall Study||12
10461073|NCT01027793|11608945|FG000|NOT COMPLETED|Overall Study||7
10461074|NCT01027793|11608946|FG001|NOT COMPLETED|Overall Study||3
10461075|NCT01027806|11608954|FG000|STARTED|Overall Study||32
10461076|NCT01027806|11608955|FG001|STARTED|Overall Study||32
10461077|NCT01027806|11608954|FG000|COMPLETED|Overall Study||28
10461078|NCT01027806|11608955|FG001|COMPLETED|Overall Study||29
10461079|NCT01027806|11608954|FG000|NOT COMPLETED|Overall Study||4
10461080|NCT01027806|11608955|FG001|NOT COMPLETED|Overall Study||3
10461081|NCT01027819|11608963|FG000|STARTED|Overall Study||40
10461082|NCT01027819|11608964|FG001|STARTED|Overall Study||40
10461083|NCT01027819|11608963|FG000|COMPLETED|Overall Study||40
10461084|NCT01027819|11608964|FG001|COMPLETED|Overall Study||40
10461085|NCT01027819|11608963|FG000|NOT COMPLETED|Overall Study||0
10461086|NCT01027819|11608964|FG001|NOT COMPLETED|Overall Study||0
10461087|NCT01027845|11608972|FG000|STARTED|Primary Vaccination Phase||237
10461088|NCT01027845|11608973|FG001|STARTED|Primary Vaccination Phase||123
10708345|NCT02629354|11873144|FG000|NOT COMPLETED|Follow-up||0
10461089|NCT01027845|11608974|FG002|STARTED|Primary Vaccination Phase|Subjects were not yet assigned to this group at the time of the primary vaccination|0
10461090|NCT01027845|11608975|FG003|STARTED|Primary Vaccination Phase|Subjects were not yet assigned to this group at the time of the primary vaccination|0
10461091|NCT01027845|11608972|FG000|COMPLETED|Primary Vaccination Phase||233
10461092|NCT01027845|11608973|FG001|COMPLETED|Primary Vaccination Phase||122
10461093|NCT01027845|11608974|FG002|COMPLETED|Primary Vaccination Phase||0
10461094|NCT01027845|11608975|FG003|COMPLETED|Primary Vaccination Phase||0
10461095|NCT01027845|11608972|FG000|NOT COMPLETED|Primary Vaccination Phase||4
10461096|NCT01027845|11608973|FG001|NOT COMPLETED|Primary Vaccination Phase||1
10461097|NCT01027845|11608974|FG002|NOT COMPLETED|Primary Vaccination Phase||0
10461098|NCT01027845|11608975|FG003|NOT COMPLETED|Primary Vaccination Phase||0
10461099|NCT01027845|11608972|FG000|STARTED|Booster Vaccination Phase||228
10461100|NCT01027845|11608973|FG001|STARTED|Booster Vaccination Phase|Subjects from this group were assigned to DTPa+Prevenar&DTPa-No Prevenar Groups in the booster phase|0
10461101|NCT01027845|11608974|FG002|STARTED|Booster Vaccination Phase||119
10461102|NCT01027845|11608975|FG003|STARTED|Booster Vaccination Phase||1
10461103|NCT01027845|11608972|FG000|COMPLETED|Booster Vaccination Phase||226
10461104|NCT01027845|11608973|FG001|COMPLETED|Booster Vaccination Phase||0
10461105|NCT01027845|11608974|FG002|COMPLETED|Booster Vaccination Phase||119
10461106|NCT01027845|11608975|FG003|COMPLETED|Booster Vaccination Phase||1
10461107|NCT01027845|11608972|FG000|NOT COMPLETED|Booster Vaccination Phase||2
10461108|NCT01027845|11608973|FG001|NOT COMPLETED|Booster Vaccination Phase||0
10461109|NCT01027845|11608974|FG002|NOT COMPLETED|Booster Vaccination Phase||0
10461110|NCT01027845|11608975|FG003|NOT COMPLETED|Booster Vaccination Phase||0
10461111|NCT01027871|11608987|FG000|STARTED|Overall Study||93
10461112|NCT01027871|11608988|FG001|STARTED|Overall Study||98
10461113|NCT01027871|11608989|FG002|STARTED|Overall Study||98
10461114|NCT01027871|11608987|FG000|Received at Least One Dose of Study Drug|Overall Study||93
10461115|NCT01027871|11608988|FG001|Received at Least One Dose of Study Drug|Overall Study||98
10461116|NCT01027871|11608989|FG002|Received at Least One Dose of Study Drug|Overall Study||97
10461117|NCT01027871|11608987|FG000|COMPLETED|Overall Study||91
10461118|NCT01027871|11608988|FG001|COMPLETED|Overall Study||85
10461119|NCT01027871|11608989|FG002|COMPLETED|Overall Study||91
10461120|NCT01027871|11608987|FG000|NOT COMPLETED|Overall Study||2
10461121|NCT01027871|11608988|FG001|NOT COMPLETED|Overall Study||13
10461122|NCT01027871|11608989|FG002|NOT COMPLETED|Overall Study||7
10461123|NCT01027884|11609004|FG000|STARTED|Overall Study||34
10461124|NCT01027884|11609005|FG001|STARTED|Overall Study||32
10461125|NCT01027884|11609004|FG000|COMPLETED|Overall Study||30
10461126|NCT01027884|11609005|FG001|COMPLETED|Overall Study||25
10461127|NCT01027884|11609004|FG000|NOT COMPLETED|Overall Study||4
10461128|NCT01027884|11609005|FG001|NOT COMPLETED|Overall Study||7
10461129|NCT01027897|11609013|FG000|STARTED|Overall Study||30
10461130|NCT01027897|11609013|FG000|COMPLETED|Overall Study||28
10461131|NCT01027897|11609013|FG000|NOT COMPLETED|Overall Study||2
10461132|NCT01027910|11609019|FG000|STARTED|Overall Study||6
10461133|NCT01027910|11609020|FG001|STARTED|Overall Study||14
10461134|NCT01027910|11609019|FG000|COMPLETED|Overall Study||6
10461135|NCT01027910|11609020|FG001|COMPLETED|Overall Study||14
10461136|NCT01027910|11609019|FG000|NOT COMPLETED|Overall Study||0
10461137|NCT01027910|11609020|FG001|NOT COMPLETED|Overall Study||0
10461138|NCT01027949|11609028|FG000|STARTED|Overall Study||894
10461139|NCT01027949|11609028|FG000|COMPLETED|Overall Study||208
10461140|NCT01027949|11609028|FG000|NOT COMPLETED|Overall Study||686
10461141|NCT01028014|11609038|FG000|STARTED|Overall Study||10
10461142|NCT01028014|11609039|FG001|STARTED|Overall Study||10
10461143|NCT01028014|11609040|FG002|STARTED|Overall Study||10
10461144|NCT01028014|11609041|FG003|STARTED|Overall Study||10
10461145|NCT01028014|11609042|FG004|STARTED|Overall Study||10
10461146|NCT01028014|11609043|FG005|STARTED|Overall Study||6
10461147|NCT01028014|11609038|FG000|COMPLETED|Overall Study||9
10461148|NCT01028014|11609039|FG001|COMPLETED|Overall Study||8
10461149|NCT01028014|11609040|FG002|COMPLETED|Overall Study||10
10461150|NCT01028014|11609041|FG003|COMPLETED|Overall Study||9
10461151|NCT01028014|11609042|FG004|COMPLETED|Overall Study||9
10461152|NCT01028014|11609043|FG005|COMPLETED|Overall Study||4
10461153|NCT01028014|11609038|FG000|NOT COMPLETED|Overall Study||1
10461154|NCT01028014|11609039|FG001|NOT COMPLETED|Overall Study||2
10461155|NCT01028014|11609040|FG002|NOT COMPLETED|Overall Study||0
10461156|NCT01028014|11609041|FG003|NOT COMPLETED|Overall Study||1
10461157|NCT01028014|11609042|FG004|NOT COMPLETED|Overall Study||1
10461158|NCT01028014|11609043|FG005|NOT COMPLETED|Overall Study||2
10461159|NCT01028027|11609059|FG000|STARTED|Overall Study||180
10461160|NCT01028027|11609060|FG001|STARTED|Overall Study||177
10461161|NCT01028027|11609059|FG000|COMPLETED|Overall Study||164
10461162|NCT01028027|11609060|FG001|COMPLETED|Overall Study||164
10461163|NCT01028027|11609059|FG000|NOT COMPLETED|Overall Study||16
10461164|NCT01028027|11609060|FG001|NOT COMPLETED|Overall Study||13
10461165|NCT01028053|11609066|FG000|STARTED|Overall Study||365
10461166|NCT01028053|11609066|FG000|COMPLETED|Overall Study||232
10461167|NCT01028053|11609066|FG000|NOT COMPLETED|Overall Study||133
10461168|NCT01028131|11609076|FG000|STARTED|Overall Study||26
10461169|NCT01028131|11609077|FG001|STARTED|Overall Study||26
10461170|NCT01028131|11609078|FG002|STARTED|Overall Study||28
10461171|NCT01028131|11609079|FG003|STARTED|Overall Study||30
10461172|NCT01028131|11609076|FG000|Completed Intervention/Control Session|Overall Study||26
10461173|NCT01028131|11609077|FG001|Completed Intervention/Control Session|Overall Study||26
10461174|NCT01028131|11609078|FG002|Completed Intervention/Control Session|Overall Study||28
10461175|NCT01028131|11609079|FG003|Completed Intervention/Control Session|Overall Study||30
10461176|NCT01028131|11609076|FG000|COMPLETED|Overall Study||23
10461177|NCT01028131|11609077|FG001|COMPLETED|Overall Study||23
10461178|NCT01028131|11609078|FG002|COMPLETED|Overall Study||22
10461179|NCT01028131|11609079|FG003|COMPLETED|Overall Study||26
10461180|NCT01028131|11609076|FG000|NOT COMPLETED|Overall Study||3
10461181|NCT01028131|11609077|FG001|NOT COMPLETED|Overall Study||3
10461182|NCT01028131|11609078|FG002|NOT COMPLETED|Overall Study||6
10461183|NCT01028131|11609079|FG003|NOT COMPLETED|Overall Study||4
10461184|NCT01028222|11609091|FG000|STARTED|Overall Study||42
10461185|NCT01028222|11609092|FG001|STARTED|Overall Study||13
10461186|NCT01028222|11609091|FG000|Cross Over From DTIC to Nilotinib|Overall Study||0
10461187|NCT01028222|11609092|FG001|Cross Over From DTIC to Nilotinib|Overall Study||10
10461188|NCT01028222|11609091|FG000|COMPLETED|Overall Study||4
10461189|NCT01028222|11609092|FG001|COMPLETED|Overall Study||0
10461190|NCT01028222|11609091|FG000|NOT COMPLETED|Overall Study||38
10461191|NCT01028222|11609092|FG001|NOT COMPLETED|Overall Study||13
10461192|NCT01028352|11609099|FG000|STARTED|Overall Study||35
10461193|NCT01028352|11609099|FG000|COMPLETED|Overall Study||29
10461194|NCT01028352|11609099|FG000|NOT COMPLETED|Overall Study||6
10461195|NCT01028378|11609103|FG000|STARTED|Overall Study|212 participants (249 eyes) with myopia|212
10461196|NCT01028378|11609103|FG000|COMPLETED|Overall Study|195 participants (230 eyes) with myopia|195
10461197|NCT01028378|11609103|FG000|NOT COMPLETED|Overall Study||17
10461198|NCT01028391|11609109|FG000|STARTED|Overall Study||164
10461199|NCT01028391|11609110|FG001|STARTED|Overall Study||153
10461200|NCT01028391|11609109|FG000|COMPLETED|Overall Study||150
10461201|NCT01028391|11609110|FG001|COMPLETED|Overall Study||142
10461202|NCT01028391|11609109|FG000|NOT COMPLETED|Overall Study||14
10461203|NCT01028391|11609110|FG001|NOT COMPLETED|Overall Study||11
10461204|NCT01028560|11609118|FG000|STARTED|Overall Study|4 of 27 withdrew consent immediately after randomization and are excluded from outcome analysis|27
10461205|NCT01028560|11609119|FG001|STARTED|Overall Study|4 of 31 withdrew consent immediately after randomization and are excluded from outcome analysis|31
10461206|NCT01028560|11609118|FG000|Started Study Protocol|Overall Study||23
10461207|NCT01028560|11609119|FG001|Started Study Protocol|Overall Study||27
10461208|NCT01028560|11609118|FG000|COMPLETED|Overall Study||17
10461209|NCT01028560|11609119|FG001|COMPLETED|Overall Study||13
10461210|NCT01028560|11609118|FG000|NOT COMPLETED|Overall Study||10
10461211|NCT01028560|11609119|FG001|NOT COMPLETED|Overall Study||18
10461212|NCT01028651|11609126|FG000|STARTED|Overall Study||13
10461213|NCT01028651|11609126|FG000|COMPLETED|Overall Study||10
10461214|NCT01028651|11609126|FG000|NOT COMPLETED|Overall Study||3
10461215|NCT01028677|11609134|FG000|STARTED|Overall Study||10
10461216|NCT01028677|11609135|FG001|STARTED|Overall Study||7
10461217|NCT01028677|11609134|FG000|COMPLETED|Overall Study||8
10461218|NCT01028677|11609135|FG001|COMPLETED|Overall Study||6
10461219|NCT01028677|11609134|FG000|NOT COMPLETED|Overall Study||2
10461220|NCT01028677|11609135|FG001|NOT COMPLETED|Overall Study||1
10461221|NCT01028820|11609141|FG000|STARTED|Overall Study||13
10461222|NCT01028820|11609141|FG000|COMPLETED|Overall Study||12
10461223|NCT01028820|11609141|FG000|NOT COMPLETED|Overall Study||1
10461224|NCT01028911|11609148|FG000|STARTED|Overall Study||7
10461225|NCT01028911|11609149|FG001|STARTED|Overall Study||2
10461226|NCT01028911|11609148|FG000|COMPLETED|Overall Study||7
10461227|NCT01028911|11609149|FG001|COMPLETED|Overall Study||2
10461228|NCT01028911|11609148|FG000|NOT COMPLETED|Overall Study||0
10461229|NCT01028911|11609149|FG001|NOT COMPLETED|Overall Study||0
10461230|NCT01028937|11609155|FG000|STARTED|Overall Study||6
10461231|NCT01028937|11609155|FG000|COMPLETED|Overall Study||6
10461232|NCT01028937|11609155|FG000|NOT COMPLETED|Overall Study||0
10461233|NCT01029054|11609159|FG000|STARTED|Phase I||4
10461234|NCT01029054|11609160|FG001|STARTED|Phase I||13
10461235|NCT01029054|11609161|FG002|STARTED|Phase I||18
10461236|NCT01029054|11609159|FG000|COMPLETED|Phase I||4
10461237|NCT01029054|11609160|FG001|COMPLETED|Phase I||13
10461238|NCT01029054|11609161|FG002|COMPLETED|Phase I||18
10461239|NCT01029054|11609159|FG000|NOT COMPLETED|Phase I||0
10461240|NCT01029054|11609160|FG001|NOT COMPLETED|Phase I||0
10461241|NCT01029054|11609161|FG002|NOT COMPLETED|Phase I||0
10461242|NCT01029054|11609159|FG000|STARTED|Phase II||0
10461243|NCT01029054|11609160|FG001|STARTED|Phase II||0
10461244|NCT01029054|11609161|FG002|STARTED|Phase II|35 participants were enrolled in Ph I. 18 additional participants were enrolled in Ph II at the MTD.|18
10461245|NCT01029054|11609159|FG000|COMPLETED|Phase II||0
10461246|NCT01029054|11609160|FG001|COMPLETED|Phase II||0
10461247|NCT01029054|11609161|FG002|COMPLETED|Phase II||18
10461248|NCT01029054|11609159|FG000|NOT COMPLETED|Phase II||0
10461249|NCT01029054|11609160|FG001|NOT COMPLETED|Phase II||0
10461250|NCT01029054|11609161|FG002|NOT COMPLETED|Phase II||0
10461251|NCT01029262|11609167|FG000|STARTED|Overall Study||79
10461252|NCT01029262|11609168|FG001|STARTED|Overall Study||160
10461253|NCT01029262|11609167|FG000|COMPLETED|Overall Study||0
10461254|NCT01029262|11609168|FG001|COMPLETED|Overall Study||0
10461255|NCT01029262|11609167|FG000|NOT COMPLETED|Overall Study||79
10461256|NCT01029262|11609168|FG001|NOT COMPLETED|Overall Study||160
10461257|NCT01029340|11609184|FG000|STARTED|Part A Treatment Period||14
10461258|NCT01029340|11609185|FG001|STARTED|Part A Treatment Period||14
10461259|NCT01029340|11609186|FG002|STARTED|Part A Treatment Period||0
10461260|NCT01029340|11609187|FG003|STARTED|Part A Treatment Period||0
10461261|NCT01029340|11609188|FG004|STARTED|Part A Treatment Period||0
10461262|NCT01029340|11609189|FG005|STARTED|Part A Treatment Period||0
10461263|NCT01029340|11609184|FG000|Participants Received Treatment|Part A Treatment Period||14
10461264|NCT01029340|11609185|FG001|Participants Received Treatment|Part A Treatment Period||14
10461265|NCT01029340|11609186|FG002|Participants Received Treatment|Part A Treatment Period||0
10461266|NCT01029340|11609187|FG003|Participants Received Treatment|Part A Treatment Period||0
10461267|NCT01029340|11609188|FG004|Participants Received Treatment|Part A Treatment Period||0
10461268|NCT01029340|11609189|FG005|Participants Received Treatment|Part A Treatment Period||0
10461269|NCT01029340|11609184|FG000|Safety Population|Part A Treatment Period|One excluded because receiving Kogenate FS twice.|13
10461270|NCT01029340|11609185|FG001|Safety Population|Part A Treatment Period||14
10461271|NCT01029340|11609186|FG002|Safety Population|Part A Treatment Period||0
10461272|NCT01029340|11609187|FG003|Safety Population|Part A Treatment Period||0
10461273|NCT01029340|11609188|FG004|Safety Population|Part A Treatment Period||0
10461274|NCT01029340|11609189|FG005|Safety Population|Part A Treatment Period||0
10461275|NCT01029340|11609184|FG000|COMPLETED|Part A Treatment Period||14
10461276|NCT01029340|11609185|FG001|COMPLETED|Part A Treatment Period||14
10461277|NCT01029340|11609186|FG002|COMPLETED|Part A Treatment Period||0
10461278|NCT01029340|11609187|FG003|COMPLETED|Part A Treatment Period||0
10461279|NCT01029340|11609188|FG004|COMPLETED|Part A Treatment Period||0
10461280|NCT01029340|11609189|FG005|COMPLETED|Part A Treatment Period||0
10461281|NCT01029340|11609184|FG000|NOT COMPLETED|Part A Treatment Period||0
10461282|NCT01029340|11609185|FG001|NOT COMPLETED|Part A Treatment Period||0
10461283|NCT01029340|11609186|FG002|NOT COMPLETED|Part A Treatment Period||0
10461284|NCT01029340|11609187|FG003|NOT COMPLETED|Part A Treatment Period||0
10461285|NCT01029340|11609188|FG004|NOT COMPLETED|Part A Treatment Period||0
10461286|NCT01029340|11609189|FG005|NOT COMPLETED|Part A Treatment Period||0
10461287|NCT01029340|11609184|FG000|STARTED|Part A Follow up Period||14
10461288|NCT01029340|11609185|FG001|STARTED|Part A Follow up Period||14
10338156|NCT00368537|11475044|FG001|NOT COMPLETED|Baseline Participants||24
10461289|NCT01029340|11609186|FG002|STARTED|Part A Follow up Period||0
10461290|NCT01029340|11609187|FG003|STARTED|Part A Follow up Period||0
10461291|NCT01029340|11609188|FG004|STARTED|Part A Follow up Period||0
10461292|NCT01029340|11609189|FG005|STARTED|Part A Follow up Period||0
10708346|NCT02629354|11873145|FG001|NOT COMPLETED|Follow-up||0
10708347|NCT02629822|11873151|FG000|STARTED|Base Study||10
10461293|NCT01029340|11609184|FG000|COMPLETED|Part A Follow up Period||14
10461294|NCT01029340|11609185|FG001|COMPLETED|Part A Follow up Period||14
10461295|NCT01029340|11609186|FG002|COMPLETED|Part A Follow up Period||0
10461296|NCT01029340|11609187|FG003|COMPLETED|Part A Follow up Period||0
10461297|NCT01029340|11609188|FG004|COMPLETED|Part A Follow up Period||0
10461298|NCT01029340|11609189|FG005|COMPLETED|Part A Follow up Period||0
10461299|NCT01029340|11609184|FG000|NOT COMPLETED|Part A Follow up Period||0
10461300|NCT01029340|11609185|FG001|NOT COMPLETED|Part A Follow up Period||0
10461301|NCT01029340|11609186|FG002|NOT COMPLETED|Part A Follow up Period||0
10461302|NCT01029340|11609187|FG003|NOT COMPLETED|Part A Follow up Period||0
10461303|NCT01029340|11609188|FG004|NOT COMPLETED|Part A Follow up Period||0
10461304|NCT01029340|11609189|FG005|NOT COMPLETED|Part A Follow up Period||0
10461305|NCT01029340|11609184|FG000|STARTED|Part B Treatment Period||0
10461306|NCT01029340|11609185|FG001|STARTED|Part B Treatment Period||0
10461307|NCT01029340|11609186|FG002|STARTED|Part B Treatment Period|Enrolled 4 participants from Arm 1 and 7 participants from Arm 2|31
10461308|NCT01029340|11609187|FG003|STARTED|Part B Treatment Period|Enrolled 7 participants from Arm 1 and 4 participants from Arm 2|32
10461309|NCT01029340|11609188|FG004|STARTED|Part B Treatment Period||0
10461310|NCT01029340|11609189|FG005|STARTED|Part B Treatment Period||0
10461311|NCT01029340|11609184|FG000|Participants Received Treatment|Part B Treatment Period||0
10461312|NCT01029340|11609185|FG001|Participants Received Treatment|Part B Treatment Period||0
10461313|NCT01029340|11609186|FG002|Participants Received Treatment|Part B Treatment Period||30
10708348|NCT02629822|11873151|FG000|COMPLETED|Base Study||7
10461314|NCT01029340|11609187|FG003|Participants Received Treatment|Part B Treatment Period||32
10461315|NCT01029340|11609188|FG004|Participants Received Treatment|Part B Treatment Period||0
10461316|NCT01029340|11609189|FG005|Participants Received Treatment|Part B Treatment Period||0
10461317|NCT01029340|11609184|FG000|COMPLETED|Part B Treatment Period||0
10461318|NCT01029340|11609185|FG001|COMPLETED|Part B Treatment Period||0
10461319|NCT01029340|11609186|FG002|COMPLETED|Part B Treatment Period||29
10461320|NCT01029340|11609187|FG003|COMPLETED|Part B Treatment Period||32
10461321|NCT01029340|11609188|FG004|COMPLETED|Part B Treatment Period||0
10461322|NCT01029340|11609189|FG005|COMPLETED|Part B Treatment Period||0
10461323|NCT01029340|11609184|FG000|NOT COMPLETED|Part B Treatment Period||0
10461324|NCT01029340|11609185|FG001|NOT COMPLETED|Part B Treatment Period||0
10461325|NCT01029340|11609186|FG002|NOT COMPLETED|Part B Treatment Period||2
10461326|NCT01029340|11609187|FG003|NOT COMPLETED|Part B Treatment Period||0
10461327|NCT01029340|11609188|FG004|NOT COMPLETED|Part B Treatment Period||0
10461328|NCT01029340|11609189|FG005|NOT COMPLETED|Part B Treatment Period||0
10461329|NCT01029340|11609184|FG000|STARTED|Part B Follow up Period||0
10461330|NCT01029340|11609185|FG001|STARTED|Part B Follow up Period||0
10461331|NCT01029340|11609186|FG002|STARTED|Part B Follow up Period||29
10461332|NCT01029340|11609187|FG003|STARTED|Part B Follow up Period||32
10461333|NCT01029340|11609188|FG004|STARTED|Part B Follow up Period||0
10461334|NCT01029340|11609189|FG005|STARTED|Part B Follow up Period||0
10461335|NCT01029340|11609184|FG000|COMPLETED|Part B Follow up Period||0
10461336|NCT01029340|11609185|FG001|COMPLETED|Part B Follow up Period||0
10461337|NCT01029340|11609186|FG002|COMPLETED|Part B Follow up Period||29
10461338|NCT01029340|11609187|FG003|COMPLETED|Part B Follow up Period||32
10461339|NCT01029340|11609188|FG004|COMPLETED|Part B Follow up Period||0
10461340|NCT01029340|11609189|FG005|COMPLETED|Part B Follow up Period||0
10461341|NCT01029340|11609184|FG000|NOT COMPLETED|Part B Follow up Period||0
10461342|NCT01029340|11609185|FG001|NOT COMPLETED|Part B Follow up Period||0
10461343|NCT01029340|11609186|FG002|NOT COMPLETED|Part B Follow up Period||0
10461344|NCT01029340|11609187|FG003|NOT COMPLETED|Part B Follow up Period||0
10461345|NCT01029340|11609188|FG004|NOT COMPLETED|Part B Follow up Period||0
10461346|NCT01029340|11609189|FG005|NOT COMPLETED|Part B Follow up Period||0
10461347|NCT01029340|11609184|FG000|STARTED|Extension Period||0
10461348|NCT01029340|11609185|FG001|STARTED|Extension Period||0
10461349|NCT01029340|11609186|FG002|STARTED|Extension Period||0
10461350|NCT01029340|11609187|FG003|STARTED|Extension Period||0
10461351|NCT01029340|11609188|FG004|STARTED|Extension Period||0
10461352|NCT01029340|11609189|FG005|STARTED|Extension Period||55
10461353|NCT01029340|11609184|FG000|COMPLETED|Extension Period||0
10461354|NCT01029340|11609185|FG001|COMPLETED|Extension Period||0
10461355|NCT01029340|11609186|FG002|COMPLETED|Extension Period||0
10461356|NCT01029340|11609187|FG003|COMPLETED|Extension Period||0
10461357|NCT01029340|11609188|FG004|COMPLETED|Extension Period||0
10461358|NCT01029340|11609189|FG005|COMPLETED|Extension Period||43
10461359|NCT01029340|11609184|FG000|NOT COMPLETED|Extension Period||0
10461360|NCT01029340|11609185|FG001|NOT COMPLETED|Extension Period||0
10461361|NCT01029340|11609186|FG002|NOT COMPLETED|Extension Period||0
10461362|NCT01029340|11609187|FG003|NOT COMPLETED|Extension Period||0
10461363|NCT01029340|11609188|FG004|NOT COMPLETED|Extension Period||0
10461364|NCT01029340|11609189|FG005|NOT COMPLETED|Extension Period||12
10461365|NCT01029340|11609184|FG000|STARTED|Part C Treatment Period||0
10461366|NCT01029340|11609185|FG001|STARTED|Part C Treatment Period||0
10461367|NCT01029340|11609186|FG002|STARTED|Part C Treatment Period||0
10461368|NCT01029340|11609187|FG003|STARTED|Part C Treatment Period||0
10461369|NCT01029340|11609188|FG004|STARTED|Part C Treatment Period||5
10461370|NCT01029340|11609189|FG005|STARTED|Part C Treatment Period||0
10461371|NCT01029340|11609184|FG000|Participants Received Treatment|Part C Treatment Period||0
10461372|NCT01029340|11609185|FG001|Participants Received Treatment|Part C Treatment Period||0
10461373|NCT01029340|11609186|FG002|Participants Received Treatment|Part C Treatment Period||0
10461374|NCT01029340|11609187|FG003|Participants Received Treatment|Part C Treatment Period||0
10461375|NCT01029340|11609188|FG004|Participants Received Treatment|Part C Treatment Period||5
10461376|NCT01029340|11609189|FG005|Participants Received Treatment|Part C Treatment Period||0
10461377|NCT01029340|11609184|FG000|COMPLETED|Part C Treatment Period||0
10461378|NCT01029340|11609185|FG001|COMPLETED|Part C Treatment Period||0
10461379|NCT01029340|11609186|FG002|COMPLETED|Part C Treatment Period||0
10461380|NCT01029340|11609187|FG003|COMPLETED|Part C Treatment Period||0
10461381|NCT01029340|11609188|FG004|COMPLETED|Part C Treatment Period||5
10461382|NCT01029340|11609189|FG005|COMPLETED|Part C Treatment Period||0
10461383|NCT01029340|11609184|FG000|NOT COMPLETED|Part C Treatment Period||0
10461384|NCT01029340|11609185|FG001|NOT COMPLETED|Part C Treatment Period||0
10461385|NCT01029340|11609186|FG002|NOT COMPLETED|Part C Treatment Period||0
10461386|NCT01029340|11609187|FG003|NOT COMPLETED|Part C Treatment Period||0
10461387|NCT01029340|11609188|FG004|NOT COMPLETED|Part C Treatment Period||0
10461388|NCT01029340|11609189|FG005|NOT COMPLETED|Part C Treatment Period||0
10461389|NCT01029340|11609184|FG000|STARTED|Part C Follow up Period||0
10461390|NCT01029340|11609185|FG001|STARTED|Part C Follow up Period||0
10461391|NCT01029340|11609186|FG002|STARTED|Part C Follow up Period||0
10461392|NCT01029340|11609187|FG003|STARTED|Part C Follow up Period||0
10461393|NCT01029340|11609188|FG004|STARTED|Part C Follow up Period||5
10461394|NCT01029340|11609189|FG005|STARTED|Part C Follow up Period||0
10461395|NCT01029340|11609184|FG000|COMPLETED|Part C Follow up Period||0
10461396|NCT01029340|11609185|FG001|COMPLETED|Part C Follow up Period||0
10461397|NCT01029340|11609186|FG002|COMPLETED|Part C Follow up Period||0
10461398|NCT01029340|11609187|FG003|COMPLETED|Part C Follow up Period||0
10461399|NCT01029340|11609188|FG004|COMPLETED|Part C Follow up Period||5
10461400|NCT01029340|11609189|FG005|COMPLETED|Part C Follow up Period||0
10461401|NCT01029340|11609184|FG000|NOT COMPLETED|Part C Follow up Period||0
10461402|NCT01029340|11609185|FG001|NOT COMPLETED|Part C Follow up Period||0
10461403|NCT01029340|11609186|FG002|NOT COMPLETED|Part C Follow up Period||0
10461404|NCT01029340|11609187|FG003|NOT COMPLETED|Part C Follow up Period||0
10461405|NCT01029340|11609188|FG004|NOT COMPLETED|Part C Follow up Period||0
10461406|NCT01029340|11609189|FG005|NOT COMPLETED|Part C Follow up Period||0
10461407|NCT01029353|11609206|FG000|STARTED|Overall Study||148
10461408|NCT01029353|11609207|FG001|STARTED|Overall Study||162
10461409|NCT01029353|11609208|FG002|STARTED|Overall Study||100
10461410|NCT01029353|11609209|FG003|STARTED|Overall Study||119
10461411|NCT01029353|11609206|FG000|Included in ITT Analysis|Overall Study||146
10461412|NCT01029353|11609207|FG001|Included in ITT Analysis|Overall Study||162
10461413|NCT01029353|11609208|FG002|Included in ITT Analysis|Overall Study||100
10461414|NCT01029353|11609209|FG003|Included in ITT Analysis|Overall Study||119
10461415|NCT01029353|11609206|FG000|Reached Network Status|Overall Study||146
10461416|NCT01029353|11609207|FG001|Reached Network Status|Overall Study||162
10461417|NCT01029353|11609208|FG002|Reached Network Status|Overall Study||100
10461418|NCT01029353|11609209|FG003|Reached Network Status|Overall Study||119
10461419|NCT01029353|11609206|FG000|COMPLETED|Overall Study||141
10461420|NCT01029353|11609207|FG001|COMPLETED|Overall Study||154
10461421|NCT01029353|11609208|FG002|COMPLETED|Overall Study||93
10461422|NCT01029353|11609209|FG003|COMPLETED|Overall Study||115
10461423|NCT01029353|11609206|FG000|NOT COMPLETED|Overall Study||7
10461424|NCT01029353|11609207|FG001|NOT COMPLETED|Overall Study||8
10461425|NCT01029353|11609208|FG002|NOT COMPLETED|Overall Study||7
10461426|NCT01029353|11609209|FG003|NOT COMPLETED|Overall Study||4
10461427|NCT01029366|11609221|FG000|STARTED|Overall Study||18
10461428|NCT01029366|11609222|FG001|STARTED|Overall Study||8
10461429|NCT01029366|11609221|FG000|COMPLETED|Overall Study||14
10461430|NCT01029366|11609222|FG001|COMPLETED|Overall Study||6
10461431|NCT01029366|11609221|FG000|NOT COMPLETED|Overall Study||4
10461432|NCT01029366|11609222|FG001|NOT COMPLETED|Overall Study||2
10461433|NCT01029392|11609231|FG000|STARTED|Overall Study||37
10461434|NCT01029392|11609232|FG001|STARTED|Overall Study||38
10461435|NCT01029392|11609231|FG000|COMPLETED|Overall Study||17
10461436|NCT01029392|11609232|FG001|COMPLETED|Overall Study||27
10461437|NCT01029392|11609231|FG000|NOT COMPLETED|Overall Study||20
10461438|NCT01029392|11609232|FG001|NOT COMPLETED|Overall Study||11
10461439|NCT01029405|11609244|FG000|STARTED|Overall Study||36
10461440|NCT01029405|11609245|FG001|STARTED|Overall Study||37
10461441|NCT01029405|11609246|FG002|STARTED|Overall Study||35
10461442|NCT01029405|11609247|FG003|STARTED|Overall Study||37
10461443|NCT01029405|11609244|FG000|COMPLETED|Overall Study||34
10461444|NCT01029405|11609245|FG001|COMPLETED|Overall Study||34
10461445|NCT01029405|11609246|FG002|COMPLETED|Overall Study||31
10461446|NCT01029405|11609247|FG003|COMPLETED|Overall Study||32
10461447|NCT01029405|11609244|FG000|NOT COMPLETED|Overall Study||2
10461448|NCT01029405|11609245|FG001|NOT COMPLETED|Overall Study||3
10461449|NCT01029405|11609246|FG002|NOT COMPLETED|Overall Study||4
10461450|NCT01029405|11609247|FG003|NOT COMPLETED|Overall Study||5
10461451|NCT01029535|11609257|FG000|STARTED|Overall Study||103
10461452|NCT01029535|11609257|FG000|COMPLETED|Overall Study||72
10461453|NCT01029535|11609257|FG000|NOT COMPLETED|Overall Study||31
10461454|NCT01029587|11609262|FG000|STARTED|Overall Study||1
10461455|NCT01029587|11609262|FG000|COMPLETED|Overall Study||1
10461456|NCT01029587|11609262|FG000|NOT COMPLETED|Overall Study||0
10461457|NCT01029652|11609268|FG000|STARTED|Core Study (0-12 Weeks)||115
10461458|NCT01029652|11609269|FG001|STARTED|Core Study (0-12 Weeks)||115
10461459|NCT01029652|11609268|FG000|Full Analysis Set (FAS), Safety Set|Core Study (0-12 Weeks)||113
10461460|NCT01029652|11609269|FG001|Full Analysis Set (FAS), Safety Set|Core Study (0-12 Weeks)||115
10461461|NCT01029652|11609268|FG000|COMPLETED|Core Study (0-12 Weeks)||109
10461462|NCT01029652|11609269|FG001|COMPLETED|Core Study (0-12 Weeks)||105
10461463|NCT01029652|11609268|FG000|NOT COMPLETED|Core Study (0-12 Weeks)||6
10461464|NCT01029652|11609269|FG001|NOT COMPLETED|Core Study (0-12 Weeks)||10
10461465|NCT01029652|11609268|FG000|STARTED|Extension Study 1 (12-24 Weeks)||90
10461466|NCT01029652|11609269|FG001|STARTED|Extension Study 1 (12-24 Weeks)||85
10461467|NCT01029652|11609268|FG000|COMPLETED|Extension Study 1 (12-24 Weeks)||87
10461468|NCT01029652|11609269|FG001|COMPLETED|Extension Study 1 (12-24 Weeks)||80
10461469|NCT01029652|11609268|FG000|NOT COMPLETED|Extension Study 1 (12-24 Weeks)||3
10461470|NCT01029652|11609269|FG001|NOT COMPLETED|Extension Study 1 (12-24 Weeks)||5
10461471|NCT01029652|11609268|FG000|STARTED|Extension Study 2 (25-72 Weeks)||69
10461472|NCT01029652|11609269|FG001|STARTED|Extension Study 2 (25-72 Weeks)||66
10461473|NCT01029652|11609268|FG000|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients re-treated with canakinumab over 72 weeks study duration overall|69
10461474|NCT01029652|11609269|FG001|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients switched to canakinumab from Week 25 - Week 72|39
10461475|NCT01029652|11609268|FG000|COMPLETED|Extension Study 2 (25-72 Weeks)||68
10461476|NCT01029652|11609269|FG001|COMPLETED|Extension Study 2 (25-72 Weeks)||63
10461477|NCT01029652|11609268|FG000|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||1
10461478|NCT01029652|11609269|FG001|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||3
10461479|NCT01029691|11609296|FG000|STARTED|APAP Initiation to Week 1 or Delivery||20
10461480|NCT01029691|11609297|FG001|STARTED|APAP Initiation to Week 1 or Delivery|4 delivered before APAP initiation 7 elected not to have APAP following baseline study|27
10461481|NCT01029691|11609298|FG002|STARTED|APAP Initiation to Week 1 or Delivery||77
10461482|NCT01029691|11609296|FG000|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||20
10461483|NCT01029691|11609297|FG001|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||23
10461484|NCT01029691|11609298|FG002|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||77
10461485|NCT01029691|11609296|FG000|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||20
10461486|NCT01029691|11609297|FG001|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||16
10461487|NCT01029691|11609298|FG002|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||77
10461488|NCT01029691|11609296|FG000|COMPLETED|APAP Initiation to Week 1 or Delivery||20
10461489|NCT01029691|11609297|FG001|COMPLETED|APAP Initiation to Week 1 or Delivery||16
10461490|NCT01029691|11609298|FG002|COMPLETED|APAP Initiation to Week 1 or Delivery||77
10461491|NCT01029691|11609296|FG000|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||0
10461492|NCT01029691|11609297|FG001|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||11
10461493|NCT01029691|11609298|FG002|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||0
10461494|NCT01029691|11609296|FG000|STARTED|Continued APAP to Delivery||20
10461495|NCT01029691|11609297|FG001|STARTED|Continued APAP to Delivery||16
10461496|NCT01029691|11609298|FG002|STARTED|Continued APAP to Delivery||77
10461497|NCT01029691|11609296|FG000|COMPLETED|Continued APAP to Delivery||20
10461498|NCT01029691|11609297|FG001|COMPLETED|Continued APAP to Delivery||16
10461499|NCT01029691|11609298|FG002|COMPLETED|Continued APAP to Delivery||76
10461500|NCT01029691|11609296|FG000|NOT COMPLETED|Continued APAP to Delivery||0
10461501|NCT01029691|11609297|FG001|NOT COMPLETED|Continued APAP to Delivery||0
10461502|NCT01029691|11609298|FG002|NOT COMPLETED|Continued APAP to Delivery||1
10461503|NCT01029704|11609316|FG000|STARTED|Overall Study||5
10461504|NCT01029704|11609317|FG001|STARTED|Overall Study||5
10461505|NCT01029704|11609318|FG002|STARTED|Overall Study||5
10461506|NCT01029704|11609319|FG003|STARTED|Overall Study||5
10461507|NCT01029704|11609320|FG004|STARTED|Overall Study||28
10461508|NCT01029704|11609321|FG005|STARTED|Overall Study||24
10461509|NCT01029704|11609322|FG006|STARTED|Overall Study||23
10461510|NCT01029704|11609323|FG007|STARTED|Overall Study||28
10461511|NCT01029704|11609324|FG008|STARTED|Overall Study||26
10461512|NCT01029704|11609316|FG000|COMPLETED|Overall Study||5
10461513|NCT01029704|11609317|FG001|COMPLETED|Overall Study||5
10461514|NCT01029704|11609318|FG002|COMPLETED|Overall Study||5
10461515|NCT01029704|11609319|FG003|COMPLETED|Overall Study||5
10461516|NCT01029704|11609320|FG004|COMPLETED|Overall Study||23
10461517|NCT01029704|11609321|FG005|COMPLETED|Overall Study||20
10461518|NCT01029704|11609322|FG006|COMPLETED|Overall Study||19
10461519|NCT01029704|11609323|FG007|COMPLETED|Overall Study||22
10461520|NCT01029704|11609324|FG008|COMPLETED|Overall Study||25
10461521|NCT01029704|11609316|FG000|NOT COMPLETED|Overall Study||0
10461522|NCT01029704|11609317|FG001|NOT COMPLETED|Overall Study||0
10461523|NCT01029704|11609318|FG002|NOT COMPLETED|Overall Study||0
10461524|NCT01029704|11609319|FG003|NOT COMPLETED|Overall Study||0
10461525|NCT01029704|11609320|FG004|NOT COMPLETED|Overall Study||5
10461526|NCT01029704|11609321|FG005|NOT COMPLETED|Overall Study||4
10461527|NCT01029704|11609322|FG006|NOT COMPLETED|Overall Study||4
10461528|NCT01029704|11609323|FG007|NOT COMPLETED|Overall Study||6
10461529|NCT01029704|11609324|FG008|NOT COMPLETED|Overall Study||1
10461530|NCT01029730|11609344|FG000|STARTED|Combination Therapy||55
10708349|NCT02629822|11873151|FG000|NOT COMPLETED|Base Study||3
10708350|NCT02629822|11873151|FG000|STARTED|Extension Study|Enrollment in Extension Study was voluntary.|6
10708351|NCT02629822|11873151|FG000|COMPLETED|Extension Study||4
10708352|NCT02629822|11873151|FG000|NOT COMPLETED|Extension Study||2
10708353|NCT02629861|11873159|FG000|STARTED|Overall Study||294
10461531|NCT01029730|11609344|FG000|COMPLETED|Combination Therapy|Patients remained on-study until completing 6 cycles or coming off-treatment for any other reason|39
10461532|NCT01029730|11609344|FG000|NOT COMPLETED|Combination Therapy||16
10461533|NCT01029730|11609344|FG000|STARTED|Maintenance Therapy|Two patients complete study treatment but declined subsequent maintenance therapy|37
10461534|NCT01029730|11609344|FG000|COMPLETED|Maintenance Therapy||14
10461535|NCT01029730|11609344|FG000|NOT COMPLETED|Maintenance Therapy||23
10461536|NCT01029782|11609350|FG000|STARTED|Overall Study||102
10461537|NCT01029782|11609351|FG001|STARTED|Overall Study||104
10461538|NCT01029782|11609350|FG000|COMPLETED|Overall Study||99
10461539|NCT01029782|11609351|FG001|COMPLETED|Overall Study||96
10461540|NCT01029782|11609350|FG000|NOT COMPLETED|Overall Study||3
10461541|NCT01029782|11609351|FG001|NOT COMPLETED|Overall Study||8
10461542|NCT01029795|11609359|FG000|STARTED|Overall Study||16
10461543|NCT01029795|11609360|FG001|STARTED|Overall Study||22
10461544|NCT01029795|11609359|FG000|COMPLETED|Overall Study||0
10461545|NCT01029795|11609360|FG001|COMPLETED|Overall Study||0
10461546|NCT01029795|11609359|FG000|NOT COMPLETED|Overall Study||16
10461547|NCT01029795|11609360|FG001|NOT COMPLETED|Overall Study||22
10461548|NCT01029886|11609368|FG000|STARTED|Overall Study||461
10461549|NCT01029886|11609369|FG001|STARTED|Overall Study||451
10461550|NCT01029886|11609368|FG000|Intent to Treat (ITT)|Overall Study||461
10461551|NCT01029886|11609369|FG001|Intent to Treat (ITT)|Overall Study||450
10461552|NCT01029886|11609368|FG000|COMPLETED|Overall Study||400
10461553|NCT01029886|11609369|FG001|COMPLETED|Overall Study||391
10461554|NCT01029886|11609368|FG000|NOT COMPLETED|Overall Study||61
10461555|NCT01029886|11609369|FG001|NOT COMPLETED|Overall Study||60
10461556|NCT01029912|11609381|FG000|STARTED|Overall Study||14
10461557|NCT01029912|11609382|FG001|STARTED|Overall Study||12
10708354|NCT02629861|11873160|FG001|STARTED|Overall Study||291
10708355|NCT02629861|11873161|FG002|STARTED|Overall Study||290
10461558|NCT01029912|11609381|FG000|COMPLETED|Overall Study||12
10461559|NCT01029912|11609382|FG001|COMPLETED|Overall Study||12
10461560|NCT01029912|11609381|FG000|NOT COMPLETED|Overall Study||2
10461561|NCT01029912|11609382|FG001|NOT COMPLETED|Overall Study||0
10461562|NCT01029925|11609388|FG000|STARTED|Completion of Cycle 1 (28 Days)||7
10461563|NCT01029925|11609388|FG000|COMPLETED|Completion of Cycle 1 (28 Days)||3
10461564|NCT01029925|11609388|FG000|NOT COMPLETED|Completion of Cycle 1 (28 Days)||4
10461565|NCT01029925|11609388|FG000|STARTED|Completion of Cycle 2 (56 Days)||3
10461566|NCT01029925|11609388|FG000|COMPLETED|Completion of Cycle 2 (56 Days)||2
10461567|NCT01029925|11609388|FG000|NOT COMPLETED|Completion of Cycle 2 (56 Days)||1
10461568|NCT01030133|11609394|FG000|STARTED|Overall Study||14
10461569|NCT01030133|11609395|FG001|STARTED|Overall Study||14
10461570|NCT01030133|11609394|FG000|COMPLETED|Overall Study||12
10461571|NCT01030133|11609395|FG001|COMPLETED|Overall Study||12
10461572|NCT01030133|11609394|FG000|NOT COMPLETED|Overall Study||2
10461573|NCT01030133|11609395|FG001|NOT COMPLETED|Overall Study||2
10461574|NCT01030289|11609405|FG000|STARTED|Overall Study||9
10461575|NCT01030289|11609406|FG001|STARTED|Overall Study||10
10461576|NCT01030289|11609405|FG000|COMPLETED|Overall Study||9
10461577|NCT01030289|11609406|FG001|COMPLETED|Overall Study||10
10461578|NCT01030289|11609405|FG000|NOT COMPLETED|Overall Study||0
10461579|NCT01030289|11609406|FG001|NOT COMPLETED|Overall Study||0
10461580|NCT01030406|11609418|FG000|STARTED|Overall Study||10
10461581|NCT01030406|11609419|FG001|STARTED|Overall Study||10
10461582|NCT01030406|11609420|FG002|STARTED|Overall Study||10
10461583|NCT01030406|11609421|FG003|STARTED|Overall Study||10
10461584|NCT01030406|11609422|FG004|STARTED|Overall Study||9
10461585|NCT01030406|11609418|FG000|COMPLETED|Overall Study||10
10461586|NCT01030406|11609419|FG001|COMPLETED|Overall Study||10
10461587|NCT01030406|11609420|FG002|COMPLETED|Overall Study||9
10461588|NCT01030406|11609421|FG003|COMPLETED|Overall Study||9
10461589|NCT01030406|11609422|FG004|COMPLETED|Overall Study||9
10461590|NCT01030406|11609418|FG000|NOT COMPLETED|Overall Study||0
10461591|NCT01030406|11609419|FG001|NOT COMPLETED|Overall Study||0
10461592|NCT01030406|11609420|FG002|NOT COMPLETED|Overall Study||1
10461593|NCT01030406|11609421|FG003|NOT COMPLETED|Overall Study||1
10461594|NCT01030406|11609422|FG004|NOT COMPLETED|Overall Study||0
10461595|NCT01030458|11609436|FG000|STARTED|Overall Study||94
10461596|NCT01030458|11609437|FG001|STARTED|Overall Study||89
10461597|NCT01030458|11609436|FG000|COMPLETED|Overall Study||67
10461598|NCT01030458|11609437|FG001|COMPLETED|Overall Study||57
10461599|NCT01030458|11609436|FG000|NOT COMPLETED|Overall Study||27
10461600|NCT01030458|11609437|FG001|NOT COMPLETED|Overall Study||32
10461601|NCT01030523|11609445|FG000|STARTED|Overall Study||50
10461602|NCT01030523|11609446|FG001|STARTED|Overall Study||51
10461603|NCT01030523|11609445|FG000|COMPLETED|Overall Study||44
10461604|NCT01030523|11609446|FG001|COMPLETED|Overall Study||46
10461605|NCT01030523|11609445|FG000|NOT COMPLETED|Overall Study||6
10461606|NCT01030523|11609446|FG001|NOT COMPLETED|Overall Study||5
10461607|NCT01030536|11609457|FG000|STARTED|Overall Study||7
10461608|NCT01030536|11609458|FG001|STARTED|Overall Study||6
10461609|NCT01030536|11609459|FG002|STARTED|Overall Study||6
10461610|NCT01030536|11609460|FG003|STARTED|Overall Study||3
10461611|NCT01030536|11609461|FG004|STARTED|Overall Study||1
10461612|NCT01030536|11609457|FG000|COMPLETED|Overall Study||0
10461613|NCT01030536|11609458|FG001|COMPLETED|Overall Study||0
10461614|NCT01030536|11609459|FG002|COMPLETED|Overall Study||0
10461615|NCT01030536|11609460|FG003|COMPLETED|Overall Study||0
10461616|NCT01030536|11609461|FG004|COMPLETED|Overall Study||0
10461617|NCT01030536|11609457|FG000|NOT COMPLETED|Overall Study||7
10461618|NCT01030536|11609458|FG001|NOT COMPLETED|Overall Study||6
10461619|NCT01030536|11609459|FG002|NOT COMPLETED|Overall Study||6
10461620|NCT01030536|11609460|FG003|NOT COMPLETED|Overall Study||3
10461621|NCT01030536|11609461|FG004|NOT COMPLETED|Overall Study||1
10461622|NCT01030653|11609479|FG000|STARTED|Loading Dose & First Maintenance Regimen||4
10461623|NCT01030653|11609480|FG001|STARTED|Loading Dose & First Maintenance Regimen||4
10461624|NCT01030653|11609479|FG000|COMPLETED|Loading Dose & First Maintenance Regimen||4
10461625|NCT01030653|11609480|FG001|COMPLETED|Loading Dose & First Maintenance Regimen||4
10461626|NCT01030653|11609479|FG000|NOT COMPLETED|Loading Dose & First Maintenance Regimen||0
10461627|NCT01030653|11609480|FG001|NOT COMPLETED|Loading Dose & First Maintenance Regimen||0
10461628|NCT01030653|11609479|FG000|STARTED|7-Day Washout Period||4
10461629|NCT01030653|11609480|FG001|STARTED|7-Day Washout Period||4
10461630|NCT01030653|11609479|FG000|COMPLETED|7-Day Washout Period||4
10461631|NCT01030653|11609480|FG001|COMPLETED|7-Day Washout Period||4
10461632|NCT01030653|11609479|FG000|NOT COMPLETED|7-Day Washout Period||0
10461633|NCT01030653|11609480|FG001|NOT COMPLETED|7-Day Washout Period||0
10461634|NCT01030653|11609479|FG000|STARTED|Loading Dose & 2nd Maintenance Regimen||4
10461635|NCT01030653|11609480|FG001|STARTED|Loading Dose & 2nd Maintenance Regimen||4
10461636|NCT01030653|11609479|FG000|COMPLETED|Loading Dose & 2nd Maintenance Regimen||4
10461637|NCT01030653|11609480|FG001|COMPLETED|Loading Dose & 2nd Maintenance Regimen||4
10461638|NCT01030653|11609479|FG000|NOT COMPLETED|Loading Dose & 2nd Maintenance Regimen||0
10461639|NCT01030653|11609480|FG001|NOT COMPLETED|Loading Dose & 2nd Maintenance Regimen||0
10461640|NCT01030666|11609489|FG000|STARTED|Overall Study||28
10461641|NCT01030666|11609490|FG001|STARTED|Overall Study||33
10461642|NCT01030666|11609489|FG000|COMPLETED|Overall Study||25
10461643|NCT01030666|11609490|FG001|COMPLETED|Overall Study||31
10461644|NCT01030666|11609489|FG000|NOT COMPLETED|Overall Study||3
10461645|NCT01030666|11609490|FG001|NOT COMPLETED|Overall Study||2
10461646|NCT01030718|11609500|FG000|STARTED|Studies CA180-031 and -036 Combined||30
10461647|NCT01030718|11609501|FG001|STARTED|Studies CA180-031 and -036 Combined||11
10461648|NCT01030718|11609502|FG002|STARTED|Studies CA180-031 and -036 Combined||13
10461649|NCT01030718|11609500|FG000|COMPLETED|Studies CA180-031 and -036 Combined||26
10461650|NCT01030718|11609501|FG001|COMPLETED|Studies CA180-031 and -036 Combined||2
10461651|NCT01030718|11609502|FG002|COMPLETED|Studies CA180-031 and -036 Combined||1
10461652|NCT01030718|11609500|FG000|NOT COMPLETED|Studies CA180-031 and -036 Combined||4
10461653|NCT01030718|11609501|FG001|NOT COMPLETED|Studies CA180-031 and -036 Combined||9
10461654|NCT01030718|11609502|FG002|NOT COMPLETED|Studies CA180-031 and -036 Combined||12
10461655|NCT01030718|11609500|FG000|STARTED|Study CA180-036 Only||29
10461656|NCT01030718|11609501|FG001|STARTED|Study CA180-036 Only||9
10461657|NCT01030718|11609502|FG002|STARTED|Study CA180-036 Only||6
10461658|NCT01030718|11609500|FG000|COMPLETED|Study CA180-036 Only||26
10461659|NCT01030718|11609501|FG001|COMPLETED|Study CA180-036 Only||2
10461660|NCT01030718|11609502|FG002|COMPLETED|Study CA180-036 Only||1
10461661|NCT01030718|11609500|FG000|NOT COMPLETED|Study CA180-036 Only||3
10461662|NCT01030718|11609501|FG001|NOT COMPLETED|Study CA180-036 Only||7
10461663|NCT01030718|11609502|FG002|NOT COMPLETED|Study CA180-036 Only||5
10461664|NCT01030783|11609522|FG000|STARTED|Overall Study||260
10461665|NCT01030783|11609523|FG001|STARTED|Overall Study||257
10461666|NCT01030783|11609522|FG000|COMPLETED|Overall Study||211
10461667|NCT01030783|11609523|FG001|COMPLETED|Overall Study||231
10461668|NCT01030783|11609522|FG000|NOT COMPLETED|Overall Study||49
10461669|NCT01030783|11609523|FG001|NOT COMPLETED|Overall Study||26
10461670|NCT01030822|11609532|FG000|STARTED|Overall Study||100
10461671|NCT01030822|11609533|FG001|STARTED|Overall Study||95
10461672|NCT01030822|11609534|FG002|STARTED|Overall Study||87
10461673|NCT01030822|11609532|FG000|COMPLETED|Overall Study||69
10461674|NCT01030822|11609533|FG001|COMPLETED|Overall Study||71
10461675|NCT01030822|11609534|FG002|COMPLETED|Overall Study||61
10461676|NCT01030822|11609532|FG000|NOT COMPLETED|Overall Study||31
10461677|NCT01030822|11609533|FG001|NOT COMPLETED|Overall Study||24
10461678|NCT01030822|11609534|FG002|NOT COMPLETED|Overall Study||26
10461679|NCT01030861|11609545|FG000|STARTED|Overall Study||44
10461680|NCT01030861|11609546|FG001|STARTED|Overall Study||32
10461681|NCT01030861|11609545|FG000|COMPLETED|Overall Study||44
10461682|NCT01030861|11609546|FG001|COMPLETED|Overall Study||32
10461683|NCT01030861|11609545|FG000|NOT COMPLETED|Overall Study||0
10461684|NCT01030861|11609546|FG001|NOT COMPLETED|Overall Study||0
10461685|NCT01030874|11609554|FG000|STARTED|Overall Study|1 with impaired decision making capacity|178
10461686|NCT01030874|11609555|FG001|STARTED|Overall Study|1 with impaired decision making capacity|178
10461687|NCT01030874|11609554|FG000|COMPLETED|Overall Study||160
10461688|NCT01030874|11609555|FG001|COMPLETED|Overall Study||162
10461689|NCT01030874|11609554|FG000|NOT COMPLETED|Overall Study||18
10461690|NCT01030874|11609555|FG001|NOT COMPLETED|Overall Study||16
10461691|NCT01030952|11609563|FG000|STARTED|Overall Study||51
10461692|NCT01030952|11609564|FG001|STARTED|Overall Study||52
10461693|NCT01030952|11609563|FG000|COMPLETED|Overall Study||49
10461694|NCT01030952|11609564|FG001|COMPLETED|Overall Study||49
10461695|NCT01030952|11609563|FG000|NOT COMPLETED|Overall Study||2
10461696|NCT01030952|11609564|FG001|NOT COMPLETED|Overall Study||3
10461697|NCT01030965|11609576|FG000|STARTED|Overall Study||71
10461698|NCT01030965|11609577|FG001|STARTED|Overall Study||71
10461699|NCT01030965|11609578|FG002|STARTED|Overall Study||72
10461700|NCT01030965|11609579|FG003|STARTED|Overall Study||71
10461701|NCT01030965|11609576|FG000|COMPLETED|Overall Study||67
10461702|NCT01030965|11609577|FG001|COMPLETED|Overall Study||65
10461703|NCT01030965|11609578|FG002|COMPLETED|Overall Study||68
10461704|NCT01030965|11609579|FG003|COMPLETED|Overall Study||64
10461705|NCT01030965|11609576|FG000|NOT COMPLETED|Overall Study||4
10461706|NCT01030965|11609577|FG001|NOT COMPLETED|Overall Study||6
10461707|NCT01030965|11609578|FG002|NOT COMPLETED|Overall Study||4
10461708|NCT01030965|11609579|FG003|NOT COMPLETED|Overall Study||7
10461709|NCT01031004|11609591|FG000|STARTED|Overall Study||25
10461710|NCT01031004|11609592|FG001|STARTED|Overall Study||25
10461711|NCT01031004|11609591|FG000|COMPLETED|Overall Study||24
10461712|NCT01031004|11609592|FG001|COMPLETED|Overall Study||24
10461713|NCT01031004|11609591|FG000|NOT COMPLETED|Overall Study||1
10461714|NCT01031004|11609592|FG001|NOT COMPLETED|Overall Study||1
10461715|NCT01031043|11609598|FG000|STARTED|Overall Study||5
10461716|NCT01031043|11609598|FG000|COMPLETED|Overall Study||4
10461717|NCT01031043|11609598|FG000|NOT COMPLETED|Overall Study||1
10461718|NCT01031069|11609606|FG000|STARTED|Overall Study||129
10461719|NCT01031069|11609607|FG001|STARTED|Overall Study||128
10461720|NCT01031069|11609608|FG002|STARTED|Overall Study||144
10461721|NCT01031069|11609609|FG003|STARTED|Overall Study||145
10461722|NCT01031069|11609606|FG000|COMPLETED|Overall Study||117
10461723|NCT01031069|11609607|FG001|COMPLETED|Overall Study||117
10461724|NCT01031069|11609608|FG002|COMPLETED|Overall Study||103
10461725|NCT01031069|11609609|FG003|COMPLETED|Overall Study||111
10461726|NCT01031069|11609606|FG000|NOT COMPLETED|Overall Study||12
10461727|NCT01031069|11609607|FG001|NOT COMPLETED|Overall Study||11
10461728|NCT01031069|11609608|FG002|NOT COMPLETED|Overall Study||41
10461729|NCT01031069|11609609|FG003|NOT COMPLETED|Overall Study||34
10461730|NCT01031095|11609623|FG000|STARTED|Overall Study||100
10461731|NCT01031095|11609624|FG001|STARTED|Overall Study||100
10461732|NCT01031095|11609623|FG000|COMPLETED|Overall Study||100
10461733|NCT01031095|11609624|FG001|COMPLETED|Overall Study||100
10461734|NCT01031095|11609623|FG000|NOT COMPLETED|Overall Study||0
10461735|NCT01031095|11609624|FG001|NOT COMPLETED|Overall Study||0
10461736|NCT01031134|11609632|FG000|STARTED|Overall Study||114
10461737|NCT01031134|11609633|FG001|STARTED|Overall Study||88
10461738|NCT01031134|11609632|FG000|COMPLETED|Overall Study||103
10461739|NCT01031134|11609633|FG001|COMPLETED|Overall Study||78
10461740|NCT01031134|11609632|FG000|NOT COMPLETED|Overall Study||11
10461741|NCT01031134|11609633|FG001|NOT COMPLETED|Overall Study||10
10461742|NCT01031381|11609639|FG000|STARTED|Overall Study||59
10461743|NCT01031381|11609639|FG000|COMPLETED|Overall Study||50
10461744|NCT01031381|11609639|FG000|NOT COMPLETED|Overall Study||9
10461745|NCT01031420|11609644|FG000|STARTED|Overall Study||54
10461746|NCT01031420|11609644|FG000|COMPLETED|Overall Study||44
10461747|NCT01031420|11609644|FG000|NOT COMPLETED|Overall Study||10
10461748|NCT01031446|11609648|FG000|STARTED|Overall Study||55
10461749|NCT01031446|11609648|FG000|COMPLETED|Overall Study||0
10461750|NCT01031446|11609648|FG000|NOT COMPLETED|Overall Study||55
10461751|NCT01031498|11609657|FG000|STARTED|Overall Study|2 patients were not evaluable in arm 1.|49
10461752|NCT01031498|11609658|FG001|STARTED|Overall Study|3 patients were not evaluable in arm 2|51
10461753|NCT01031498|11609659|FG002|STARTED|Overall Study|2 patients were not evaluable in arm 3.|50
10461754|NCT01031498|11609657|FG000|COMPLETED|Overall Study||47
10461755|NCT01031498|11609658|FG001|COMPLETED|Overall Study||48
10461756|NCT01031498|11609659|FG002|COMPLETED|Overall Study||48
10461757|NCT01031498|11609657|FG000|NOT COMPLETED|Overall Study||2
10461758|NCT01031498|11609658|FG001|NOT COMPLETED|Overall Study||3
10461759|NCT01031498|11609659|FG002|NOT COMPLETED|Overall Study||2
10461760|NCT01031537|11609667|FG000|STARTED|Overall Study||66
10461761|NCT01031537|11609667|FG000|COMPLETED|Overall Study||34
10461762|NCT01031537|11609667|FG000|NOT COMPLETED|Overall Study||32
10461763|NCT01031680|11609673|FG000|STARTED|Overall Study|Of the 460 randomized participants only 455 were included in the full analysis set.|460
10461764|NCT01031680|11609674|FG001|STARTED|Overall Study|Of the 462 randomized participants only 459 were included in the full analysis set.|462
10461765|NCT01031680|11609673|FG000|COMPLETED|Overall Study||403
10461766|NCT01031680|11609674|FG001|COMPLETED|Overall Study||404
10461767|NCT01031680|11609673|FG000|NOT COMPLETED|Overall Study||57
10461768|NCT01031680|11609674|FG001|NOT COMPLETED|Overall Study||58
10461769|NCT01031706|11609682|FG000|STARTED|Overall Study||14
10461770|NCT01031706|11609683|FG001|STARTED|Overall Study||9
10461771|NCT01031706|11609682|FG000|COMPLETED|Overall Study||12
10461772|NCT01031706|11609683|FG001|COMPLETED|Overall Study||8
10461773|NCT01031706|11609682|FG000|NOT COMPLETED|Overall Study||2
10461774|NCT01031706|11609683|FG001|NOT COMPLETED|Overall Study||1
10461775|NCT01031810|11609689|FG000|STARTED|Overall Study||13
10461776|NCT01031810|11609689|FG000|COMPLETED|Overall Study||9
10461777|NCT01031810|11609689|FG000|NOT COMPLETED|Overall Study||4
10461778|NCT01031836|11609701|FG000|STARTED|Stage I||5
10461779|NCT01031836|11609702|FG001|STARTED|Stage I||5
10461780|NCT01031836|11609703|FG002|STARTED|Stage I||5
10461781|NCT01031836|11609704|FG003|STARTED|Stage I||5
10461782|NCT01031836|11609705|FG004|STARTED|Stage I||5
10461783|NCT01031836|11609706|FG005|STARTED|Stage I||5
10461784|NCT01031836|11609701|FG000|COMPLETED|Stage I||4
10461785|NCT01031836|11609702|FG001|COMPLETED|Stage I||3
10461786|NCT01031836|11609703|FG002|COMPLETED|Stage I||5
10461787|NCT01031836|11609704|FG003|COMPLETED|Stage I||5
10461788|NCT01031836|11609705|FG004|COMPLETED|Stage I||5
10461789|NCT01031836|11609706|FG005|COMPLETED|Stage I||4
10461790|NCT01031836|11609701|FG000|NOT COMPLETED|Stage I||1
10461791|NCT01031836|11609702|FG001|NOT COMPLETED|Stage I||2
10461792|NCT01031836|11609703|FG002|NOT COMPLETED|Stage I||0
10461793|NCT01031836|11609704|FG003|NOT COMPLETED|Stage I||0
10461794|NCT01031836|11609705|FG004|NOT COMPLETED|Stage I||0
10461795|NCT01031836|11609706|FG005|NOT COMPLETED|Stage I||1
10461796|NCT01031836|11609701|FG000|STARTED|Stage II|1 patient who completed the study treatment in Stage I did not register in Stage II.|3
10461797|NCT01031836|11609702|FG001|STARTED|Stage II|2 patient who completed the study treatment in Stage I did not register in Stage II.|1
10461798|NCT01031836|11609703|FG002|STARTED|Stage II|1 patient who completed the study treatment in Stage I did not register in Stage II.|4
10461799|NCT01031836|11609704|FG003|STARTED|Stage II|1 patient who completed the study treatment in Stage I did not register in Stage II.|4
10461800|NCT01031836|11609705|FG004|STARTED|Stage II||5
10461801|NCT01031836|11609706|FG005|STARTED|Stage II||4
10461802|NCT01031836|11609701|FG000|COMPLETED|Stage II||1
10461803|NCT01031836|11609702|FG001|COMPLETED|Stage II||1
10461804|NCT01031836|11609703|FG002|COMPLETED|Stage II||2
10461805|NCT01031836|11609704|FG003|COMPLETED|Stage II||1
10461806|NCT01031836|11609705|FG004|COMPLETED|Stage II||3
10461807|NCT01031836|11609706|FG005|COMPLETED|Stage II||3
10461808|NCT01031836|11609701|FG000|NOT COMPLETED|Stage II||2
10461809|NCT01031836|11609702|FG001|NOT COMPLETED|Stage II||0
10461810|NCT01031836|11609703|FG002|NOT COMPLETED|Stage II||2
10461811|NCT01031836|11609704|FG003|NOT COMPLETED|Stage II||3
10461812|NCT01031836|11609705|FG004|NOT COMPLETED|Stage II||2
10461813|NCT01031836|11609706|FG005|NOT COMPLETED|Stage II||1
10461814|NCT01031914|11609720|FG000|STARTED|Overall Study||36
10461815|NCT01031914|11609720|FG000|COMPLETED|Overall Study||36
10461816|NCT01031914|11609720|FG000|NOT COMPLETED|Overall Study||0
10461817|NCT01031953|11609724|FG000|STARTED|Overall Study||11
10461818|NCT01031953|11609724|FG000|COMPLETED|Overall Study||11
10461819|NCT01031953|11609724|FG000|NOT COMPLETED|Overall Study||0
10461820|NCT01031979|11609736|FG000|STARTED|Overall Study|To meet eligibility requirements for randomization, subjects had to reach session 3 w/o dropping.|14
10461821|NCT01031979|11609737|FG001|STARTED|Overall Study|To meet eligibility requirements for randomization, subjects had to reach session 3 w/o dropping.|12
10548413|NCT01519414|11702217|FG000|COMPLETED|Pre Cross-over||52
10461822|NCT01031979|11609736|FG000|Completed Primary Outcome Measure|Overall Study||12
10461823|NCT01031979|11609737|FG001|Completed Primary Outcome Measure|Overall Study||12
10461824|NCT01031979|11609736|FG000|COMPLETED|Overall Study|These are individuals who completed treatment in the study.|9
10461825|NCT01031979|11609737|FG001|COMPLETED|Overall Study|These are individuals who completed treatment in the study.|8
10461826|NCT01031979|11609736|FG000|NOT COMPLETED|Overall Study||5
10461827|NCT01031979|11609737|FG001|NOT COMPLETED|Overall Study||4
10461828|NCT01032018|11609745|FG000|STARTED|Overall Study||77
10461829|NCT01032018|11609746|FG001|STARTED|Overall Study||73
10461830|NCT01032018|11609745|FG000|COMPLETED|Overall Study||71
10461831|NCT01032018|11609746|FG001|COMPLETED|Overall Study||67
10461832|NCT01032018|11609745|FG000|NOT COMPLETED|Overall Study||6
10461833|NCT01032018|11609746|FG001|NOT COMPLETED|Overall Study||6
10461834|NCT01032044|11609754|FG000|STARTED|Overall Study||82
10461835|NCT01032044|11609755|FG001|STARTED|Overall Study||82
10461836|NCT01032044|11609754|FG000|Procedure|Overall Study||74
10461837|NCT01032044|11609755|FG001|Procedure|Overall Study||75
10461838|NCT01032044|11609754|FG000|COMPLETED|Overall Study||57
10461839|NCT01032044|11609755|FG001|COMPLETED|Overall Study||62
10461840|NCT01032044|11609754|FG000|NOT COMPLETED|Overall Study||25
10461841|NCT01032044|11609755|FG001|NOT COMPLETED|Overall Study||20
10461842|NCT01032070|11609763|FG000|STARTED|Overall Study||13
10461843|NCT01032070|11609764|FG001|STARTED|Overall Study||12
10461844|NCT01032070|11609763|FG000|COMPLETED|Overall Study||0
10461845|NCT01032070|11609764|FG001|COMPLETED|Overall Study||0
10461846|NCT01032070|11609763|FG000|NOT COMPLETED|Overall Study||13
10461847|NCT01032070|11609764|FG001|NOT COMPLETED|Overall Study||12
10461848|NCT01032135|11609775|FG000|STARTED|2 Week Randomization||311
10461849|NCT01032135|11609776|FG001|STARTED|2 Week Randomization||93
10461850|NCT01032135|11609777|FG002|STARTED|2 Week Randomization||96
10461851|NCT01032135|11609778|FG003|STARTED|2 Week Randomization||0
10461852|NCT01032135|11609779|FG004|STARTED|2 Week Randomization||0
10461853|NCT01032135|11609780|FG005|STARTED|2 Week Randomization||0
10461854|NCT01032135|11609781|FG006|STARTED|2 Week Randomization||0
10461855|NCT01032135|11609775|FG000|COMPLETED|2 Week Randomization||311
10461856|NCT01032135|11609776|FG001|COMPLETED|2 Week Randomization||93
10461857|NCT01032135|11609777|FG002|COMPLETED|2 Week Randomization||96
10461858|NCT01032135|11609778|FG003|COMPLETED|2 Week Randomization||0
10461859|NCT01032135|11609779|FG004|COMPLETED|2 Week Randomization||0
10461860|NCT01032135|11609780|FG005|COMPLETED|2 Week Randomization||0
10461861|NCT01032135|11609781|FG006|COMPLETED|2 Week Randomization||0
10461862|NCT01032135|11609775|FG000|NOT COMPLETED|2 Week Randomization||0
10461863|NCT01032135|11609776|FG001|NOT COMPLETED|2 Week Randomization||0
10461864|NCT01032135|11609777|FG002|NOT COMPLETED|2 Week Randomization||0
10461865|NCT01032135|11609778|FG003|NOT COMPLETED|2 Week Randomization||0
10461866|NCT01032135|11609779|FG004|NOT COMPLETED|2 Week Randomization||0
10461867|NCT01032135|11609780|FG005|NOT COMPLETED|2 Week Randomization||0
10461868|NCT01032135|11609781|FG006|NOT COMPLETED|2 Week Randomization||0
10461869|NCT01032135|11609775|FG000|STARTED|8 Week Randomization||227
10461870|NCT01032135|11609776|FG001|STARTED|8 Week Randomization||0
10461871|NCT01032135|11609777|FG002|STARTED|8 Week Randomization||0
10461872|NCT01032135|11609778|FG003|STARTED|8 Week Randomization||41
10461873|NCT01032135|11609779|FG004|STARTED|8 Week Randomization||43
10461874|NCT01032135|11609780|FG005|STARTED|8 Week Randomization||48
10461875|NCT01032135|11609781|FG006|STARTED|8 Week Randomization||54
10461876|NCT01032135|11609775|FG000|12 Week Follow up|8 Week Randomization|These participants were'nt included in analyses as they didn't meet criteria for study intervention.|217
10461877|NCT01032135|11609776|FG001|12 Week Follow up|8 Week Randomization||0
10461878|NCT01032135|11609777|FG002|12 Week Follow up|8 Week Randomization||0
10461879|NCT01032135|11609778|FG003|12 Week Follow up|8 Week Randomization||34
10461880|NCT01032135|11609779|FG004|12 Week Follow up|8 Week Randomization||38
10461881|NCT01032135|11609780|FG005|12 Week Follow up|8 Week Randomization||36
10461882|NCT01032135|11609781|FG006|12 Week Follow up|8 Week Randomization||41
10461883|NCT01032135|11609775|FG000|COMPLETED|8 Week Randomization|These participants were'nt included in analyses as they didn't meet criteria for study intervention.|201
10461884|NCT01032135|11609776|FG001|COMPLETED|8 Week Randomization||0
10461885|NCT01032135|11609777|FG002|COMPLETED|8 Week Randomization||0
10461886|NCT01032135|11609778|FG003|COMPLETED|8 Week Randomization||30
10461887|NCT01032135|11609779|FG004|COMPLETED|8 Week Randomization||34
10461888|NCT01032135|11609780|FG005|COMPLETED|8 Week Randomization||31
10461889|NCT01032135|11609781|FG006|COMPLETED|8 Week Randomization||36
10461890|NCT01032135|11609775|FG000|NOT COMPLETED|8 Week Randomization||26
10461891|NCT01032135|11609776|FG001|NOT COMPLETED|8 Week Randomization||0
10461892|NCT01032135|11609777|FG002|NOT COMPLETED|8 Week Randomization||0
10461893|NCT01032135|11609778|FG003|NOT COMPLETED|8 Week Randomization||11
10461894|NCT01032135|11609779|FG004|NOT COMPLETED|8 Week Randomization||9
10461895|NCT01032135|11609780|FG005|NOT COMPLETED|8 Week Randomization||17
10461896|NCT01032135|11609781|FG006|NOT COMPLETED|8 Week Randomization||18
10461897|NCT01032174|11609797|FG000|STARTED|Overall Study||63
10461898|NCT01032174|11609798|FG001|STARTED|Overall Study||60
10461899|NCT01032174|11609797|FG000|COMPLETED|Overall Study||63
10461900|NCT01032174|11609798|FG001|COMPLETED|Overall Study||59
10461901|NCT01032174|11609797|FG000|NOT COMPLETED|Overall Study||0
10461902|NCT01032174|11609798|FG001|NOT COMPLETED|Overall Study||1
10461903|NCT01032200|11609806|FG000|STARTED|Overall Study||26
10461904|NCT01032200|11609807|FG001|STARTED|Overall Study||28
10461905|NCT01032200|11609806|FG000|COMPLETED|Overall Study||22
10461906|NCT01032200|11609807|FG001|COMPLETED|Overall Study||21
10461907|NCT01032200|11609806|FG000|NOT COMPLETED|Overall Study||4
10461908|NCT01032200|11609807|FG001|NOT COMPLETED|Overall Study||7
10461909|NCT01032239|11609815|FG000|STARTED|Overall Study|randomized to ITB arm|31
10461910|NCT01032239|11609816|FG001|STARTED|Overall Study|randomized to BMT arm|29
10461911|NCT01032239|11609815|FG000|Implant|Overall Study|implanted|25
10461912|NCT01032239|11609816|FG001|Implant|Overall Study||0
10461913|NCT01032239|11609815|FG000|COMPLETED|Overall Study||24
10461914|NCT01032239|11609816|FG001|COMPLETED|Overall Study||24
10461915|NCT01032239|11609815|FG000|NOT COMPLETED|Overall Study||7
10461916|NCT01032239|11609816|FG001|NOT COMPLETED|Overall Study||5
10461917|NCT01032291|11609825|FG000|STARTED|Safety Lead-in||8
10461918|NCT01032291|11609826|FG001|STARTED|Safety Lead-in||0
10461919|NCT01032291|11609827|FG002|STARTED|Safety Lead-in||0
10461920|NCT01032291|11609825|FG000|COMPLETED|Safety Lead-in|Participants with disease progression|6
10461921|NCT01032291|11609826|FG001|COMPLETED|Safety Lead-in||0
10461922|NCT01032291|11609827|FG002|COMPLETED|Safety Lead-in||0
10461923|NCT01032291|11609825|FG000|NOT COMPLETED|Safety Lead-in||2
10461924|NCT01032291|11609826|FG001|NOT COMPLETED|Safety Lead-in||0
10461925|NCT01032291|11609827|FG002|NOT COMPLETED|Safety Lead-in||0
10461926|NCT01032291|11609825|FG000|STARTED|Proof of Concept||0
10461927|NCT01032291|11609826|FG001|STARTED|Proof of Concept||22
10461928|NCT01032291|11609827|FG002|STARTED|Proof of Concept||21
10461929|NCT01032291|11609825|FG000|Intent to Treat and Safety Populations|Proof of Concept||0
10461930|NCT01032291|11609826|FG001|Intent to Treat and Safety Populations|Proof of Concept|Participants who took at least one dose of study drug|21
10461931|NCT01032291|11609827|FG002|Intent to Treat and Safety Populations|Proof of Concept|Participants who took at least one dose of study drug|21
10461932|NCT01032291|11609825|FG000|COMPLETED|Proof of Concept||0
10461933|NCT01032291|11609826|FG001|COMPLETED|Proof of Concept|Participants with disease progression|14
10461934|NCT01032291|11609827|FG002|COMPLETED|Proof of Concept|Participants with disease progression|18
10461935|NCT01032291|11609825|FG000|NOT COMPLETED|Proof of Concept||0
10461936|NCT01032291|11609826|FG001|NOT COMPLETED|Proof of Concept||8
10461937|NCT01032291|11609827|FG002|NOT COMPLETED|Proof of Concept||3
10461938|NCT01032330|11609842|FG000|STARTED|Overall Study||183
10461939|NCT01032330|11609843|FG001|STARTED|Overall Study||175
10461940|NCT01032330|11609844|FG002|STARTED|Overall Study||97
10461941|NCT01032330|11609845|FG003|STARTED|Overall Study||104
10461942|NCT01032330|11609842|FG000|COMPLETED|Overall Study||165
10461943|NCT01032330|11609843|FG001|COMPLETED|Overall Study||151
10461944|NCT01032330|11609844|FG002|COMPLETED|Overall Study||87
10461945|NCT01032330|11609845|FG003|COMPLETED|Overall Study||90
10461946|NCT01032330|11609842|FG000|NOT COMPLETED|Overall Study||18
10461947|NCT01032330|11609843|FG001|NOT COMPLETED|Overall Study||24
10461948|NCT01032330|11609844|FG002|NOT COMPLETED|Overall Study||10
10461949|NCT01032330|11609845|FG003|NOT COMPLETED|Overall Study||14
10461950|NCT01032382|11609865|FG000|STARTED|Overall Study||16
10461951|NCT01032382|11609866|FG001|STARTED|Overall Study||14
10461952|NCT01032382|11609865|FG000|COMPLETED|Overall Study||11
10461953|NCT01032382|11609866|FG001|COMPLETED|Overall Study||9
10461954|NCT01032382|11609865|FG000|NOT COMPLETED|Overall Study||5
10461955|NCT01032382|11609866|FG001|NOT COMPLETED|Overall Study||5
10461956|NCT01032538|11609872|FG000|STARTED|Overall Study|Knees|99
10461957|NCT01032538|11609872|FG000|COMPLETED|Overall Study|Knees|99
10461958|NCT01032538|11609872|FG000|NOT COMPLETED|Overall Study||0
10461959|NCT01032629|11609881|FG000|STARTED|Overall Study||1442
10461960|NCT01032629|11609882|FG001|STARTED|Overall Study||1445
10461961|NCT01032629|11609883|FG002|STARTED|Overall Study||1443
10461962|NCT01032629|11609881|FG000|Treated|Overall Study||1441
10461963|NCT01032629|11609882|FG001|Treated|Overall Study||1445
10461964|NCT01032629|11609883|FG002|Treated|Overall Study||1441
10461965|NCT01032629|11609881|FG000|COMPLETED|Overall Study|Participants who died on trial were considered completed|1297
10461966|NCT01032629|11609882|FG001|COMPLETED|Overall Study|Participants who died on trial were considered completed|1344
10461967|NCT01032629|11609883|FG002|COMPLETED|Overall Study|Participants who died on trial were considered completed|1355
10461968|NCT01032629|11609881|FG000|NOT COMPLETED|Overall Study||145
10461969|NCT01032629|11609882|FG001|NOT COMPLETED|Overall Study||101
10461970|NCT01032629|11609883|FG002|NOT COMPLETED|Overall Study||88
10461971|NCT01032694|11609894|FG000|STARTED|Overall Study||20
10461972|NCT01032694|11609895|FG001|STARTED|Overall Study||10
10461973|NCT01032694|11609894|FG000|COMPLETED|Overall Study||20
10461974|NCT01032694|11609895|FG001|COMPLETED|Overall Study||10
10461975|NCT01032694|11609894|FG000|NOT COMPLETED|Overall Study||0
10461976|NCT01032694|11609895|FG001|NOT COMPLETED|Overall Study||0
10461977|NCT01032733|11609903|FG000|STARTED|Overall Study||17
10461978|NCT01032733|11609904|FG001|STARTED|Overall Study||17
10461979|NCT01032733|11609903|FG000|COMPLETED|Overall Study||16
10461980|NCT01032733|11609904|FG001|COMPLETED|Overall Study||16
10461981|NCT01032733|11609903|FG000|NOT COMPLETED|Overall Study||1
10461982|NCT01032733|11609904|FG001|NOT COMPLETED|Overall Study||1
10461983|NCT01032759|11609913|FG000|STARTED|Overall Study||32
10461984|NCT01032759|11609914|FG001|STARTED|Overall Study||31
10461985|NCT01032759|11609913|FG000|Completed 24 Hour Assessment|Overall Study||32
10461986|NCT01032759|11609914|FG001|Completed 24 Hour Assessment|Overall Study||30
10461987|NCT01032759|11609913|FG000|Completed 48 Hour Assessment|Overall Study||31
10461988|NCT01032759|11609914|FG001|Completed 48 Hour Assessment|Overall Study||28
10461989|NCT01032759|11609913|FG000|COMPLETED|Overall Study||31
10461990|NCT01032759|11609914|FG001|COMPLETED|Overall Study||28
10461991|NCT01032759|11609913|FG000|NOT COMPLETED|Overall Study||1
10461992|NCT01032759|11609914|FG001|NOT COMPLETED|Overall Study||3
10461993|NCT01032837|11609924|FG000|STARTED|Overall Study||26
10461994|NCT01032837|11609925|FG001|STARTED|Overall Study||26
10461995|NCT01032837|11609926|FG002|STARTED|Overall Study||25
10461996|NCT01032837|11609927|FG003|STARTED|Overall Study||25
10461997|NCT01032837|11609924|FG000|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|26
10461998|NCT01032837|11609925|FG001|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|26
10461999|NCT01032837|11609926|FG002|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|25
10462000|NCT01032837|11609927|FG003|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|24
10462001|NCT01032837|11609924|FG000|COMPLETED|Overall Study|Represents patients who completed treatment.|26
10462002|NCT01032837|11609925|FG001|COMPLETED|Overall Study|Represents patients who completed treatment.|23
10462003|NCT01032837|11609926|FG002|COMPLETED|Overall Study|Represents patients who completed treatment.|24
10462004|NCT01032837|11609927|FG003|COMPLETED|Overall Study|Represents patients who completed treatment.|22
10462005|NCT01032837|11609924|FG000|NOT COMPLETED|Overall Study||0
10462006|NCT01032837|11609925|FG001|NOT COMPLETED|Overall Study||3
10462007|NCT01032837|11609926|FG002|NOT COMPLETED|Overall Study||1
10462008|NCT01032837|11609927|FG003|NOT COMPLETED|Overall Study||3
10462009|NCT01032850|11609937|FG000|STARTED|Overall Study||15
10462010|NCT01032850|11609937|FG000|COMPLETED|Overall Study||13
10462011|NCT01032850|11609937|FG000|NOT COMPLETED|Overall Study||2
10462012|NCT01032889|11609944|FG000|STARTED|Overall Study||41
10462013|NCT01032889|11609945|FG001|STARTED|Overall Study||43
10462014|NCT01032889|11609946|FG002|STARTED|Overall Study||45
10462015|NCT01032889|11609944|FG000|Received Treatment|Overall Study||41
10462016|NCT01032889|11609945|FG001|Received Treatment|Overall Study||43
10462017|NCT01032889|11609946|FG002|Received Treatment|Overall Study||45
10462018|NCT01032889|11609944|FG000|COMPLETED|Overall Study||33
10462019|NCT01032889|11609945|FG001|COMPLETED|Overall Study||28
10462020|NCT01032889|11609946|FG002|COMPLETED|Overall Study||42
10462021|NCT01032889|11609944|FG000|NOT COMPLETED|Overall Study||8
10462022|NCT01032889|11609945|FG001|NOT COMPLETED|Overall Study||15
10462023|NCT01032889|11609946|FG002|NOT COMPLETED|Overall Study||3
10462024|NCT01032915|11609958|FG000|STARTED|Overall Study||29
10462025|NCT01032915|11609959|FG001|STARTED|Overall Study||31
10462026|NCT01032915|11609960|FG002|STARTED|Overall Study||31
10462027|NCT01032915|11609961|FG003|STARTED|Overall Study||34
10462028|NCT01032915|11609958|FG000|COMPLETED|Overall Study||21
10462029|NCT01032915|11609959|FG001|COMPLETED|Overall Study||20
10462030|NCT01032915|11609960|FG002|COMPLETED|Overall Study||24
10462031|NCT01032915|11609961|FG003|COMPLETED|Overall Study||27
10462032|NCT01032915|11609958|FG000|NOT COMPLETED|Overall Study||8
10462033|NCT01032915|11609959|FG001|NOT COMPLETED|Overall Study||11
10462034|NCT01032915|11609960|FG002|NOT COMPLETED|Overall Study||7
10462035|NCT01032915|11609961|FG003|NOT COMPLETED|Overall Study||7
10462086|NCT01033136|11610027|FG001|NOT COMPLETED|Follow-Up (3 Month)||2
10526362|NCT01380743|11678175|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
10526363|NCT01380743|11678176|FG003|Received at Least 1 Dose of Study Drug|Overall Study||7
10526364|NCT01380743|11678173|FG000|COMPLETED|Overall Study||6
10526365|NCT01380743|11678174|FG001|COMPLETED|Overall Study||6
10526366|NCT01380743|11678175|FG002|COMPLETED|Overall Study||6
10526367|NCT01380743|11678176|FG003|COMPLETED|Overall Study||7
10526368|NCT01380743|11678173|FG000|NOT COMPLETED|Overall Study||0
10526369|NCT01380743|11678174|FG001|NOT COMPLETED|Overall Study||0
10526370|NCT01380743|11678175|FG002|NOT COMPLETED|Overall Study||0
10526371|NCT01380743|11678176|FG003|NOT COMPLETED|Overall Study||0
10526372|NCT01380769|11678188|FG000|STARTED|Overall Study||100
10526373|NCT01380769|11678189|FG001|STARTED|Overall Study||57
10526374|NCT01380769|11678188|FG000|COMPLETED|Overall Study|subjects in ITT with reported date of death, alive with progression, or alive without progression|91
10526375|NCT01380769|11678189|FG001|COMPLETED|Overall Study|subjects in ITT with reported date of death, alive with progression, or alive without progression|43
10526376|NCT01380769|11678188|FG000|NOT COMPLETED|Overall Study||9
10526377|NCT01380769|11678189|FG001|NOT COMPLETED|Overall Study||14
10526378|NCT01380782|11678197|FG000|STARTED|Overall Study||12
10526379|NCT01380782|11678198|FG001|STARTED|Overall Study||10
10526380|NCT01380782|11678199|FG002|STARTED|Overall Study||11
10526381|NCT01380782|11678200|FG003|STARTED|Overall Study||4
10526382|NCT01380782|11678197|FG000|COMPLETED|Overall Study||0
10526383|NCT01380782|11678198|FG001|COMPLETED|Overall Study||0
10526384|NCT01380782|11678199|FG002|COMPLETED|Overall Study||0
10526385|NCT01380782|11678200|FG003|COMPLETED|Overall Study||0
10526386|NCT01380782|11678197|FG000|NOT COMPLETED|Overall Study||12
10526387|NCT01380782|11678198|FG001|NOT COMPLETED|Overall Study||10
10526388|NCT01380782|11678199|FG002|NOT COMPLETED|Overall Study||11
10526389|NCT01380782|11678200|FG003|NOT COMPLETED|Overall Study||4
10526390|NCT01380834|11678214|FG000|STARTED|Overall Study||42
10526391|NCT01380834|11678215|FG001|STARTED|Overall Study||42
10526392|NCT01380834|11678214|FG000|COMPLETED|Overall Study||41
10526393|NCT01380834|11678215|FG001|COMPLETED|Overall Study||42
10526394|NCT01380834|11678214|FG000|NOT COMPLETED|Overall Study||1
10526395|NCT01380834|11678215|FG001|NOT COMPLETED|Overall Study||0
10526396|NCT01380899|11678224|FG000|STARTED|Overall Study||34
10526397|NCT01380899|11678225|FG001|STARTED|Overall Study||33
10526398|NCT01380899|11678226|FG002|STARTED|Overall Study||20
10526399|NCT01380899|11678224|FG000|COMPLETED|Overall Study||34
10526400|NCT01380899|11678225|FG001|COMPLETED|Overall Study||33
10526401|NCT01380899|11678226|FG002|COMPLETED|Overall Study||20
10462036|NCT01032928|11609971|FG000|STARTED|Overall Study||30
10462037|NCT01032928|11609971|FG000|COMPLETED|Overall Study||30
10462038|NCT01032928|11609971|FG000|NOT COMPLETED|Overall Study||0
10462039|NCT01032954|11609982|FG000|STARTED|Overall Study||30
10462040|NCT01032954|11609983|FG001|STARTED|Overall Study||30
10462041|NCT01032954|11609984|FG002|STARTED|Overall Study||30
10462042|NCT01032954|11609982|FG000|COMPLETED|Overall Study||26
10462043|NCT01032954|11609983|FG001|COMPLETED|Overall Study||29
10462044|NCT01032954|11609984|FG002|COMPLETED|Overall Study||30
10462045|NCT01032954|11609982|FG000|NOT COMPLETED|Overall Study||4
10462046|NCT01032954|11609983|FG001|NOT COMPLETED|Overall Study||1
10462047|NCT01032954|11609984|FG002|NOT COMPLETED|Overall Study||0
10462048|NCT01032993|11609994|FG000|STARTED|Overall Study||19
10462049|NCT01032993|11609995|FG001|STARTED|Overall Study||20
10462050|NCT01032993|11609994|FG000|COMPLETED|Overall Study||19
10462051|NCT01032993|11609995|FG001|COMPLETED|Overall Study||20
10462052|NCT01032993|11609994|FG000|NOT COMPLETED|Overall Study||0
10462053|NCT01032993|11609995|FG001|NOT COMPLETED|Overall Study||0
10462054|NCT01033019|11610003|FG000|STARTED|Overall Study||16
10462055|NCT01033019|11610004|FG001|STARTED|Overall Study||8
10462056|NCT01033019|11610003|FG000|COMPLETED|Overall Study||15
10462057|NCT01033019|11610004|FG001|COMPLETED|Overall Study||8
10462058|NCT01033019|11610003|FG000|NOT COMPLETED|Overall Study||1
10462059|NCT01033019|11610004|FG001|NOT COMPLETED|Overall Study||0
10462060|NCT01033071|11610014|FG000|STARTED|Overall Study||355
10462061|NCT01033071|11610015|FG001|STARTED|Overall Study||352
10462062|NCT01033071|11610016|FG002|STARTED|Overall Study||364
10462063|NCT01033071|11610014|FG000|COMPLETED|Overall Study||300
10462064|NCT01033071|11610015|FG001|COMPLETED|Overall Study||275
10462065|NCT01033071|11610016|FG002|COMPLETED|Overall Study||317
10462066|NCT01033071|11610014|FG000|NOT COMPLETED|Overall Study||55
10462067|NCT01033071|11610015|FG001|NOT COMPLETED|Overall Study||77
10462068|NCT01033071|11610016|FG002|NOT COMPLETED|Overall Study||47
10462069|NCT01033136|11610026|FG000|STARTED|Baseline Assessment||36
10462070|NCT01033136|11610027|FG001|STARTED|Baseline Assessment||32
10462071|NCT01033136|11610026|FG000|COMPLETED|Baseline Assessment||30
10462072|NCT01033136|11610027|FG001|COMPLETED|Baseline Assessment||26
10462073|NCT01033136|11610026|FG000|NOT COMPLETED|Baseline Assessment||6
10462074|NCT01033136|11610027|FG001|NOT COMPLETED|Baseline Assessment||6
10462075|NCT01033136|11610026|FG000|STARTED|Post-Treatment (1 Week)||30
10462076|NCT01033136|11610027|FG001|STARTED|Post-Treatment (1 Week)||26
10462077|NCT01033136|11610026|FG000|COMPLETED|Post-Treatment (1 Week)||16
10462078|NCT01033136|11610027|FG001|COMPLETED|Post-Treatment (1 Week)||15
10462079|NCT01033136|11610026|FG000|NOT COMPLETED|Post-Treatment (1 Week)||14
10462080|NCT01033136|11610027|FG001|NOT COMPLETED|Post-Treatment (1 Week)||11
10462081|NCT01033136|11610026|FG000|STARTED|Follow-Up (3 Month)||16
10462082|NCT01033136|11610027|FG001|STARTED|Follow-Up (3 Month)||15
10462083|NCT01033136|11610026|FG000|COMPLETED|Follow-Up (3 Month)||14
10462084|NCT01033136|11610027|FG001|COMPLETED|Follow-Up (3 Month)||13
10462085|NCT01033136|11610026|FG000|NOT COMPLETED|Follow-Up (3 Month)||2
10462087|NCT01033227|11610037|FG000|STARTED|Overall Study||3
10462088|NCT01033227|11610038|FG001|STARTED|Overall Study||2
10462089|NCT01033227|11610037|FG000|COMPLETED|Overall Study||3
10462090|NCT01033227|11610038|FG001|COMPLETED|Overall Study||2
10462091|NCT01033227|11610037|FG000|NOT COMPLETED|Overall Study||0
10462092|NCT01033227|11610038|FG001|NOT COMPLETED|Overall Study||0
10462093|NCT01033240|11610049|FG000|STARTED|Overall Study||55
10462094|NCT01033240|11610050|FG001|STARTED|Overall Study||53
10462095|NCT01033240|11610051|FG002|STARTED|Overall Study||55
10462096|NCT01033240|11610049|FG000|COMPLETED|Overall Study||6
10462097|NCT01033240|11610050|FG001|COMPLETED|Overall Study||3
10462098|NCT01033240|11610051|FG002|COMPLETED|Overall Study||2
10462099|NCT01033240|11610049|FG000|NOT COMPLETED|Overall Study||49
10462100|NCT01033240|11610050|FG001|NOT COMPLETED|Overall Study||50
10462101|NCT01033240|11610051|FG002|NOT COMPLETED|Overall Study||53
10462102|NCT01033383|11610063|FG000|STARTED|Overall Study||20
10462103|NCT01033383|11610064|FG001|STARTED|Overall Study||20
10462104|NCT01033383|11610065|FG002|STARTED|Overall Study||20
10462105|NCT01033383|11610066|FG003|STARTED|Overall Study||20
10462106|NCT01033383|11610063|FG000|COMPLETED|Overall Study||20
10462107|NCT01033383|11610064|FG001|COMPLETED|Overall Study||20
10462108|NCT01033383|11610065|FG002|COMPLETED|Overall Study||20
10462109|NCT01033383|11610066|FG003|COMPLETED|Overall Study||20
10462110|NCT01033383|11610063|FG000|NOT COMPLETED|Overall Study||0
10462111|NCT01033383|11610064|FG001|NOT COMPLETED|Overall Study||0
10462112|NCT01033383|11610065|FG002|NOT COMPLETED|Overall Study||0
10462113|NCT01033383|11610066|FG003|NOT COMPLETED|Overall Study||0
10462114|NCT01033422|11610079|FG000|STARTED|Overall Study||34
10462115|NCT01033422|11610080|FG001|STARTED|Overall Study||32
10462116|NCT01033422|11610081|FG002|STARTED|Overall Study||23
10462117|NCT01033422|11610079|FG000|COMPLETED|Overall Study||33
10462118|NCT01033422|11610080|FG001|COMPLETED|Overall Study||28
10462119|NCT01033422|11610081|FG002|COMPLETED|Overall Study||22
10462120|NCT01033422|11610079|FG000|NOT COMPLETED|Overall Study||1
10462121|NCT01033422|11610080|FG001|NOT COMPLETED|Overall Study||4
10462122|NCT01033422|11610081|FG002|NOT COMPLETED|Overall Study||1
10462123|NCT01033448|11610089|FG000|STARTED|Overall Study||59
10462124|NCT01033448|11610089|FG000|COMPLETED|Overall Study||47
10462125|NCT01033448|11610089|FG000|NOT COMPLETED|Overall Study||12
10462126|NCT01033487|11610095|FG000|STARTED|First Intervention Period||2
10462127|NCT01033487|11610096|FG001|STARTED|First Intervention Period||3
10462128|NCT01033487|11610097|FG002|STARTED|First Intervention Period||2
10708356|NCT02629861|11873159|FG000|Intent to Treat (ITT)|Overall Study||294
10708357|NCT02629861|11873160|FG001|Intent to Treat (ITT)|Overall Study||291
10708358|NCT02629861|11873161|FG002|Intent to Treat (ITT)|Overall Study||290
10462129|NCT01033487|11610098|FG003|STARTED|First Intervention Period||2
10462130|NCT01033487|11610099|FG004|STARTED|First Intervention Period||2
10462131|NCT01033487|11610100|FG005|STARTED|First Intervention Period||2
10462132|NCT01033487|11610101|FG006|STARTED|First Intervention Period||2
10462133|NCT01033487|11610102|FG007|STARTED|First Intervention Period||3
10462134|NCT01033487|11610103|FG008|STARTED|First Intervention Period||2
10462135|NCT01033487|11610104|FG009|STARTED|First Intervention Period||2
10462136|NCT01033487|11610095|FG000|COMPLETED|First Intervention Period||2
10462137|NCT01033487|11610096|FG001|COMPLETED|First Intervention Period||3
10462138|NCT01033487|11610097|FG002|COMPLETED|First Intervention Period||2
10462139|NCT01033487|11610098|FG003|COMPLETED|First Intervention Period||2
10462140|NCT01033487|11610099|FG004|COMPLETED|First Intervention Period||2
10462141|NCT01033487|11610100|FG005|COMPLETED|First Intervention Period||2
10462142|NCT01033487|11610101|FG006|COMPLETED|First Intervention Period||2
10462143|NCT01033487|11610102|FG007|COMPLETED|First Intervention Period||3
10462144|NCT01033487|11610103|FG008|COMPLETED|First Intervention Period||2
10462145|NCT01033487|11610104|FG009|COMPLETED|First Intervention Period||2
10462146|NCT01033487|11610095|FG000|NOT COMPLETED|First Intervention Period||0
10462147|NCT01033487|11610096|FG001|NOT COMPLETED|First Intervention Period||0
10462148|NCT01033487|11610097|FG002|NOT COMPLETED|First Intervention Period||0
10462149|NCT01033487|11610098|FG003|NOT COMPLETED|First Intervention Period||0
10462150|NCT01033487|11610099|FG004|NOT COMPLETED|First Intervention Period||0
10462151|NCT01033487|11610100|FG005|NOT COMPLETED|First Intervention Period||0
10462152|NCT01033487|11610101|FG006|NOT COMPLETED|First Intervention Period||0
10462153|NCT01033487|11610102|FG007|NOT COMPLETED|First Intervention Period||0
10462154|NCT01033487|11610103|FG008|NOT COMPLETED|First Intervention Period||0
10462155|NCT01033487|11610104|FG009|NOT COMPLETED|First Intervention Period||0
10462156|NCT01033487|11610095|FG000|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
10462157|NCT01033487|11610096|FG001|STARTED|Between Period 1 and 2 (At Least 7 Days)||3
10462158|NCT01033487|11610097|FG002|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
10462159|NCT01033487|11610098|FG003|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
10462160|NCT01033487|11610099|FG004|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
10462161|NCT01033487|11610100|FG005|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
10462162|NCT01033487|11610101|FG006|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
10462163|NCT01033487|11610102|FG007|STARTED|Between Period 1 and 2 (At Least 7 Days)||3
10462164|NCT01033487|11610103|FG008|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
10462165|NCT01033487|11610104|FG009|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
10462166|NCT01033487|11610095|FG000|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
10462167|NCT01033487|11610096|FG001|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||3
10462168|NCT01033487|11610097|FG002|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
10462169|NCT01033487|11610098|FG003|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
10462170|NCT01033487|11610099|FG004|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
10462171|NCT01033487|11610100|FG005|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
10462172|NCT01033487|11610101|FG006|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
10462173|NCT01033487|11610102|FG007|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||3
10462174|NCT01033487|11610103|FG008|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
10462175|NCT01033487|11610104|FG009|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
10462176|NCT01033487|11610095|FG000|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
10462177|NCT01033487|11610096|FG001|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
10462178|NCT01033487|11610097|FG002|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
10462179|NCT01033487|11610098|FG003|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
10462180|NCT01033487|11610099|FG004|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
10462181|NCT01033487|11610100|FG005|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
10462182|NCT01033487|11610101|FG006|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
10462183|NCT01033487|11610102|FG007|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
10462184|NCT01033487|11610103|FG008|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
10462185|NCT01033487|11610104|FG009|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
10462186|NCT01033487|11610095|FG000|STARTED|Second Intervention Period||2
10462187|NCT01033487|11610096|FG001|STARTED|Second Intervention Period||3
10462188|NCT01033487|11610097|FG002|STARTED|Second Intervention Period||2
10462189|NCT01033487|11610098|FG003|STARTED|Second Intervention Period||2
10462190|NCT01033487|11610099|FG004|STARTED|Second Intervention Period||2
10462191|NCT01033487|11610100|FG005|STARTED|Second Intervention Period||2
10462192|NCT01033487|11610101|FG006|STARTED|Second Intervention Period||2
10462193|NCT01033487|11610102|FG007|STARTED|Second Intervention Period||3
10462194|NCT01033487|11610103|FG008|STARTED|Second Intervention Period||2
10462195|NCT01033487|11610104|FG009|STARTED|Second Intervention Period||2
10462196|NCT01033487|11610095|FG000|COMPLETED|Second Intervention Period||2
10462197|NCT01033487|11610096|FG001|COMPLETED|Second Intervention Period||3
10462198|NCT01033487|11610097|FG002|COMPLETED|Second Intervention Period||2
10462199|NCT01033487|11610098|FG003|COMPLETED|Second Intervention Period||2
10708359|NCT02629861|11873159|FG000|Safety Population|Overall Study||294
10462200|NCT01033487|11610099|FG004|COMPLETED|Second Intervention Period||2
10462201|NCT01033487|11610100|FG005|COMPLETED|Second Intervention Period||2
10462202|NCT01033487|11610101|FG006|COMPLETED|Second Intervention Period||2
10462203|NCT01033487|11610102|FG007|COMPLETED|Second Intervention Period||3
10462204|NCT01033487|11610103|FG008|COMPLETED|Second Intervention Period||2
10462205|NCT01033487|11610104|FG009|COMPLETED|Second Intervention Period||2
10462206|NCT01033487|11610095|FG000|NOT COMPLETED|Second Intervention Period||0
10462207|NCT01033487|11610096|FG001|NOT COMPLETED|Second Intervention Period||0
10462208|NCT01033487|11610097|FG002|NOT COMPLETED|Second Intervention Period||0
10462209|NCT01033487|11610098|FG003|NOT COMPLETED|Second Intervention Period||0
10462210|NCT01033487|11610099|FG004|NOT COMPLETED|Second Intervention Period||0
10462211|NCT01033487|11610100|FG005|NOT COMPLETED|Second Intervention Period||0
10462212|NCT01033487|11610101|FG006|NOT COMPLETED|Second Intervention Period||0
10462213|NCT01033487|11610102|FG007|NOT COMPLETED|Second Intervention Period||0
10462214|NCT01033487|11610103|FG008|NOT COMPLETED|Second Intervention Period||0
10462215|NCT01033487|11610104|FG009|NOT COMPLETED|Second Intervention Period||0
10462216|NCT01033487|11610095|FG000|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
10462217|NCT01033487|11610096|FG001|STARTED|Between Period 2 and 3 (At Least 7 Days)||3
10462218|NCT01033487|11610097|FG002|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
10462219|NCT01033487|11610098|FG003|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
10462220|NCT01033487|11610099|FG004|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
10462221|NCT01033487|11610100|FG005|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
10462222|NCT01033487|11610101|FG006|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
10462223|NCT01033487|11610102|FG007|STARTED|Between Period 2 and 3 (At Least 7 Days)||3
10462224|NCT01033487|11610103|FG008|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
10708360|NCT02629861|11873160|FG001|Safety Population|Overall Study||291
10708361|NCT02629861|11873161|FG002|Safety Population|Overall Study||289
10708362|NCT02629861|11873159|FG000|Full Analysis Set|Overall Study||290
10708363|NCT02629861|11873160|FG001|Full Analysis Set|Overall Study||288
10708364|NCT02629861|11873161|FG002|Full Analysis Set|Overall Study||287
10708365|NCT02629861|11873159|FG000|COMPLETED|Overall Study||265
10708366|NCT02629861|11873160|FG001|COMPLETED|Overall Study||264
10708367|NCT02629861|11873161|FG002|COMPLETED|Overall Study||262
10708368|NCT02629861|11873159|FG000|NOT COMPLETED|Overall Study||29
10708369|NCT02629861|11873160|FG001|NOT COMPLETED|Overall Study||27
10708370|NCT02629861|11873161|FG002|NOT COMPLETED|Overall Study||28
10708371|NCT02629965|11873169|FG000|STARTED|Period 1||92
10462225|NCT01033487|11610104|FG009|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
10462226|NCT01033487|11610095|FG000|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
10462227|NCT01033487|11610096|FG001|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||3
10462228|NCT01033487|11610097|FG002|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
10462229|NCT01033487|11610098|FG003|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
10462230|NCT01033487|11610099|FG004|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
10462231|NCT01033487|11610100|FG005|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
10462232|NCT01033487|11610101|FG006|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
10462233|NCT01033487|11610102|FG007|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||3
10462234|NCT01033487|11610103|FG008|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
10708372|NCT02629965|11873170|FG001|STARTED|Period 1||92
10708373|NCT02629965|11873169|FG000|COMPLETED|Period 1||88
10708374|NCT02629965|11873170|FG001|COMPLETED|Period 1||90
10708375|NCT02629965|11873169|FG000|NOT COMPLETED|Period 1||4
10708376|NCT02629965|11873170|FG001|NOT COMPLETED|Period 1||2
10708377|NCT02629965|11873169|FG000|STARTED|Period 2||88
10708378|NCT02629965|11873170|FG001|STARTED|Period 2||90
10708379|NCT02629965|11873169|FG000|COMPLETED|Period 2||87
10708380|NCT02629965|11873170|FG001|COMPLETED|Period 2||90
10708381|NCT02629965|11873169|FG000|NOT COMPLETED|Period 2||1
10708382|NCT02629965|11873170|FG001|NOT COMPLETED|Period 2||0
10708383|NCT02629991|11873178|FG000|STARTED|Overall Study||11
10708384|NCT02629991|11873179|FG001|STARTED|Overall Study||12
10708385|NCT02629991|11873178|FG000|COMPLETED|Overall Study||10
10708386|NCT02629991|11873179|FG001|COMPLETED|Overall Study||11
10708387|NCT02629991|11873178|FG000|NOT COMPLETED|Overall Study||1
10708388|NCT02629991|11873179|FG001|NOT COMPLETED|Overall Study||1
10708389|NCT02630017|11873190|FG000|STARTED|Overall Study||13
10708390|NCT02630017|11873191|FG001|STARTED|Overall Study||12
10708391|NCT02630017|11873192|FG002|STARTED|Overall Study||13
10708392|NCT02630017|11873193|FG003|STARTED|Overall Study||13
10708393|NCT02630017|11873190|FG000|COMPLETED|Overall Study||12
10708394|NCT02630017|11873191|FG001|COMPLETED|Overall Study||11
10708395|NCT02630017|11873192|FG002|COMPLETED|Overall Study||11
10708396|NCT02630017|11873193|FG003|COMPLETED|Overall Study||12
10708397|NCT02630017|11873190|FG000|NOT COMPLETED|Overall Study||1
10708398|NCT02630017|11873191|FG001|NOT COMPLETED|Overall Study||1
10708399|NCT02630017|11873192|FG002|NOT COMPLETED|Overall Study||2
10708400|NCT02630017|11873193|FG003|NOT COMPLETED|Overall Study||1
10708401|NCT02630030|11873203|FG000|STARTED|Overall Study||3
10708402|NCT02630030|11873203|FG000|COMPLETED|Overall Study||3
10708403|NCT02630030|11873203|FG000|NOT COMPLETED|Overall Study||0
10708404|NCT02630186|11873207|FG000|STARTED|Overall Study||3
10708405|NCT02630186|11873207|FG000|COMPLETED|Overall Study||2
10708406|NCT02630186|11873207|FG000|NOT COMPLETED|Overall Study||1
10462235|NCT01033487|11610104|FG009|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
10708407|NCT02630251|11873215|FG000|STARTED|Overall Study||2
10708408|NCT02630251|11873216|FG001|STARTED|Overall Study||1
10708409|NCT02630251|11873217|FG002|STARTED|Overall Study||1
10708410|NCT02630251|11873218|FG003|STARTED|Overall Study||1
10708411|NCT02630251|11873215|FG000|COMPLETED|Overall Study||2
10708412|NCT02630251|11873216|FG001|COMPLETED|Overall Study||1
10708413|NCT02630251|11873217|FG002|COMPLETED|Overall Study||0
10708414|NCT02630251|11873218|FG003|COMPLETED|Overall Study||1
10708415|NCT02630251|11873215|FG000|NOT COMPLETED|Overall Study||0
10708416|NCT02630251|11873216|FG001|NOT COMPLETED|Overall Study||0
10708417|NCT02630251|11873217|FG002|NOT COMPLETED|Overall Study||1
10708418|NCT02630251|11873218|FG003|NOT COMPLETED|Overall Study||0
10708425|NCT02630563|11873237|FG000|STARTED|Overall Study||9
10708426|NCT02630563|11873237|FG000|COMPLETED|Overall Study||8
10708427|NCT02630563|11873237|FG000|NOT COMPLETED|Overall Study||1
10708428|NCT02630693|11873244|FG000|STARTED|Overall Study||90
10708429|NCT02630693|11873245|FG001|STARTED|Overall Study||90
10708430|NCT02630693|11873244|FG000|COMPLETED|Overall Study||90
10708431|NCT02630693|11873245|FG001|COMPLETED|Overall Study||89
10708432|NCT02630693|11873244|FG000|NOT COMPLETED|Overall Study||0
10708433|NCT02630693|11873245|FG001|NOT COMPLETED|Overall Study||1
10708434|NCT02630706|11873254|FG000|STARTED|Overall Study||170
10708435|NCT02630706|11873255|FG001|STARTED|Overall Study||169
10708436|NCT02630706|11873256|FG002|STARTED|Overall Study||167
10708437|NCT02630706|11873254|FG000|Treated|Overall Study||170
10708438|NCT02630706|11873255|FG001|Treated|Overall Study||169
10708439|NCT02630706|11873256|FG002|Treated|Overall Study||167
10708440|NCT02630706|11873254|FG000|COMPLETED|Overall Study||163
10708441|NCT02630706|11873255|FG001|COMPLETED|Overall Study||160
10708442|NCT02630706|11873256|FG002|COMPLETED|Overall Study||157
10708443|NCT02630706|11873254|FG000|NOT COMPLETED|Overall Study||7
10708444|NCT02630706|11873255|FG001|NOT COMPLETED|Overall Study||9
10708445|NCT02630706|11873256|FG002|NOT COMPLETED|Overall Study||10
10708446|NCT02630719|11873266|FG000|STARTED|Overall Study||4
10708447|NCT02630719|11873267|FG001|STARTED|Overall Study||6
10708448|NCT02630719|11873266|FG000|COMPLETED|Overall Study||4
10708449|NCT02630719|11873267|FG001|COMPLETED|Overall Study||6
10708450|NCT02630719|11873266|FG000|NOT COMPLETED|Overall Study||0
10708451|NCT02630719|11873267|FG001|NOT COMPLETED|Overall Study||0
10708452|NCT02630953|11873275|FG000|STARTED|6 Month Assessment||97
10708453|NCT02630953|11873276|FG001|STARTED|6 Month Assessment||102
10708454|NCT02630953|11873275|FG000|COMPLETED|6 Month Assessment||83
10462236|NCT01033487|11610095|FG000|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
10462237|NCT01033487|11610096|FG001|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
10462238|NCT01033487|11610097|FG002|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
10462239|NCT01033487|11610098|FG003|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
10462240|NCT01033487|11610099|FG004|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
10462241|NCT01033487|11610100|FG005|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
10462242|NCT01033487|11610101|FG006|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
10462243|NCT01033487|11610102|FG007|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
10462244|NCT01033487|11610103|FG008|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
10462245|NCT01033487|11610104|FG009|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
10462246|NCT01033487|11610095|FG000|STARTED|Third Intervention Period||2
10462247|NCT01033487|11610096|FG001|STARTED|Third Intervention Period||3
10462248|NCT01033487|11610097|FG002|STARTED|Third Intervention Period||2
10462249|NCT01033487|11610098|FG003|STARTED|Third Intervention Period||2
10462250|NCT01033487|11610099|FG004|STARTED|Third Intervention Period||2
10462251|NCT01033487|11610100|FG005|STARTED|Third Intervention Period||2
10462252|NCT01033487|11610101|FG006|STARTED|Third Intervention Period||2
10708455|NCT02630953|11873276|FG001|COMPLETED|6 Month Assessment||70
10708456|NCT02630953|11873275|FG000|NOT COMPLETED|6 Month Assessment||14
10708457|NCT02630953|11873276|FG001|NOT COMPLETED|6 Month Assessment||32
10708458|NCT02630953|11873275|FG000|STARTED|12 Month Assessment||97
10462253|NCT01033487|11610102|FG007|STARTED|Third Intervention Period||3
10462254|NCT01033487|11610103|FG008|STARTED|Third Intervention Period||2
10462255|NCT01033487|11610104|FG009|STARTED|Third Intervention Period||2
10462256|NCT01033487|11610095|FG000|COMPLETED|Third Intervention Period||2
10462257|NCT01033487|11610096|FG001|COMPLETED|Third Intervention Period||3
10462258|NCT01033487|11610097|FG002|COMPLETED|Third Intervention Period||2
10462259|NCT01033487|11610098|FG003|COMPLETED|Third Intervention Period||2
10708459|NCT02630953|11873276|FG001|STARTED|12 Month Assessment||102
10708460|NCT02630953|11873275|FG000|COMPLETED|12 Month Assessment||73
10708461|NCT02630953|11873276|FG001|COMPLETED|12 Month Assessment||64
10708462|NCT02630953|11873275|FG000|NOT COMPLETED|12 Month Assessment||24
10708463|NCT02630953|11873276|FG001|NOT COMPLETED|12 Month Assessment||38
10708464|NCT02630966|11873284|FG000|STARTED|Overall Study||16
10708465|NCT02630966|11873285|FG001|STARTED|Overall Study||18
10708466|NCT02630966|11873284|FG000|COMPLETED|Overall Study||14
10708467|NCT02630966|11873285|FG001|COMPLETED|Overall Study||10
10708468|NCT02630966|11873284|FG000|NOT COMPLETED|Overall Study||2
10708469|NCT02630966|11873285|FG001|NOT COMPLETED|Overall Study||8
10708470|NCT02630992|11873291|FG000|STARTED|Overall Study||112
10708471|NCT02630992|11873291|FG000|COMPLETED|Overall Study||99
10708472|NCT02630992|11873291|FG000|NOT COMPLETED|Overall Study||13
10708473|NCT02631057|11873297|FG000|STARTED|Overall Study||899
10708474|NCT02631057|11873298|FG001|STARTED|Overall Study||3414
10462260|NCT01033487|11610099|FG004|COMPLETED|Third Intervention Period||2
10462261|NCT01033487|11610100|FG005|COMPLETED|Third Intervention Period||2
10462262|NCT01033487|11610101|FG006|COMPLETED|Third Intervention Period||2
10462263|NCT01033487|11610102|FG007|COMPLETED|Third Intervention Period||3
10462264|NCT01033487|11610103|FG008|COMPLETED|Third Intervention Period||2
10462265|NCT01033487|11610104|FG009|COMPLETED|Third Intervention Period||2
10462266|NCT01033487|11610095|FG000|NOT COMPLETED|Third Intervention Period||0
10462267|NCT01033487|11610096|FG001|NOT COMPLETED|Third Intervention Period||0
10462268|NCT01033487|11610097|FG002|NOT COMPLETED|Third Intervention Period||0
10462269|NCT01033487|11610098|FG003|NOT COMPLETED|Third Intervention Period||0
10462270|NCT01033487|11610099|FG004|NOT COMPLETED|Third Intervention Period||0
10462271|NCT01033487|11610100|FG005|NOT COMPLETED|Third Intervention Period||0
10462272|NCT01033487|11610101|FG006|NOT COMPLETED|Third Intervention Period||0
10462273|NCT01033487|11610102|FG007|NOT COMPLETED|Third Intervention Period||0
10462274|NCT01033487|11610103|FG008|NOT COMPLETED|Third Intervention Period||0
10462275|NCT01033487|11610104|FG009|NOT COMPLETED|Third Intervention Period||0
10462276|NCT01033487|11610095|FG000|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
10462277|NCT01033487|11610096|FG001|STARTED|Between Period 3 and 4 (At Least 7 Days)||3
10462278|NCT01033487|11610097|FG002|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
10462279|NCT01033487|11610098|FG003|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
10462280|NCT01033487|11610099|FG004|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
10462281|NCT01033487|11610100|FG005|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
10462282|NCT01033487|11610101|FG006|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
10462283|NCT01033487|11610102|FG007|STARTED|Between Period 3 and 4 (At Least 7 Days)||3
10462284|NCT01033487|11610103|FG008|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
10462285|NCT01033487|11610104|FG009|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
10462286|NCT01033487|11610095|FG000|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
10462287|NCT01033487|11610096|FG001|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||3
10462288|NCT01033487|11610097|FG002|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
10462289|NCT01033487|11610098|FG003|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
10462290|NCT01033487|11610099|FG004|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
10462291|NCT01033487|11610100|FG005|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
10462292|NCT01033487|11610101|FG006|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
10462293|NCT01033487|11610102|FG007|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||3
10462294|NCT01033487|11610103|FG008|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
10462295|NCT01033487|11610104|FG009|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
10462296|NCT01033487|11610095|FG000|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
10462297|NCT01033487|11610096|FG001|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
10462298|NCT01033487|11610097|FG002|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
10462299|NCT01033487|11610098|FG003|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
10462300|NCT01033487|11610099|FG004|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
10462301|NCT01033487|11610100|FG005|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
10462302|NCT01033487|11610101|FG006|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
10462303|NCT01033487|11610102|FG007|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
10462304|NCT01033487|11610103|FG008|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
10462305|NCT01033487|11610104|FG009|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
10462306|NCT01033487|11610095|FG000|STARTED|Fourth Intervention Period||2
10462307|NCT01033487|11610096|FG001|STARTED|Fourth Intervention Period||3
10462308|NCT01033487|11610097|FG002|STARTED|Fourth Intervention Period||2
10462309|NCT01033487|11610098|FG003|STARTED|Fourth Intervention Period||2
10462310|NCT01033487|11610099|FG004|STARTED|Fourth Intervention Period||2
10462311|NCT01033487|11610100|FG005|STARTED|Fourth Intervention Period||2
10462312|NCT01033487|11610101|FG006|STARTED|Fourth Intervention Period||2
10462313|NCT01033487|11610102|FG007|STARTED|Fourth Intervention Period||3
10462314|NCT01033487|11610103|FG008|STARTED|Fourth Intervention Period||2
10708475|NCT02631057|11873297|FG000|COMPLETED|Overall Study||899
10708476|NCT02631057|11873298|FG001|COMPLETED|Overall Study||3414
10708477|NCT02631057|11873297|FG000|NOT COMPLETED|Overall Study||0
10708478|NCT02631057|11873298|FG001|NOT COMPLETED|Overall Study||0
10462315|NCT01033487|11610104|FG009|STARTED|Fourth Intervention Period||2
10462316|NCT01033487|11610095|FG000|COMPLETED|Fourth Intervention Period||2
10462317|NCT01033487|11610096|FG001|COMPLETED|Fourth Intervention Period||3
10462318|NCT01033487|11610097|FG002|COMPLETED|Fourth Intervention Period||2
10462319|NCT01033487|11610098|FG003|COMPLETED|Fourth Intervention Period||2
10462320|NCT01033487|11610099|FG004|COMPLETED|Fourth Intervention Period||2
10462321|NCT01033487|11610100|FG005|COMPLETED|Fourth Intervention Period||2
10462322|NCT01033487|11610101|FG006|COMPLETED|Fourth Intervention Period||2
10462323|NCT01033487|11610102|FG007|COMPLETED|Fourth Intervention Period||3
10462324|NCT01033487|11610103|FG008|COMPLETED|Fourth Intervention Period||1
10462325|NCT01033487|11610104|FG009|COMPLETED|Fourth Intervention Period||2
10462326|NCT01033487|11610095|FG000|NOT COMPLETED|Fourth Intervention Period||0
10462327|NCT01033487|11610096|FG001|NOT COMPLETED|Fourth Intervention Period||0
10462328|NCT01033487|11610097|FG002|NOT COMPLETED|Fourth Intervention Period||0
10462329|NCT01033487|11610098|FG003|NOT COMPLETED|Fourth Intervention Period||0
10462330|NCT01033487|11610099|FG004|NOT COMPLETED|Fourth Intervention Period||0
10708479|NCT02631525|11873306|FG000|STARTED|Overall Study||20
10708480|NCT02631525|11873307|FG001|STARTED|Overall Study||20
10462331|NCT01033487|11610100|FG005|NOT COMPLETED|Fourth Intervention Period||0
10462332|NCT01033487|11610101|FG006|NOT COMPLETED|Fourth Intervention Period||0
10462333|NCT01033487|11610102|FG007|NOT COMPLETED|Fourth Intervention Period||0
10462334|NCT01033487|11610103|FG008|NOT COMPLETED|Fourth Intervention Period||1
10462335|NCT01033487|11610104|FG009|NOT COMPLETED|Fourth Intervention Period||0
10462336|NCT01033487|11610095|FG000|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
10462337|NCT01033487|11610096|FG001|STARTED|Between Period 4 and 5 (At Least 7 Days)||3
10462338|NCT01033487|11610097|FG002|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
10462339|NCT01033487|11610098|FG003|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
10462340|NCT01033487|11610099|FG004|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
10462341|NCT01033487|11610100|FG005|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
10462342|NCT01033487|11610101|FG006|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
10462343|NCT01033487|11610102|FG007|STARTED|Between Period 4 and 5 (At Least 7 Days)||3
10462344|NCT01033487|11610103|FG008|STARTED|Between Period 4 and 5 (At Least 7 Days)||1
10462345|NCT01033487|11610104|FG009|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
10462346|NCT01033487|11610095|FG000|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
10462347|NCT01033487|11610096|FG001|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||3
10462348|NCT01033487|11610097|FG002|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
10462349|NCT01033487|11610098|FG003|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
10462350|NCT01033487|11610099|FG004|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
10462351|NCT01033487|11610100|FG005|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
10462352|NCT01033487|11610101|FG006|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
10462353|NCT01033487|11610102|FG007|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||3
10462354|NCT01033487|11610103|FG008|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||1
10462355|NCT01033487|11610104|FG009|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
10462356|NCT01033487|11610095|FG000|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
10462357|NCT01033487|11610096|FG001|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
10462358|NCT01033487|11610097|FG002|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
10462359|NCT01033487|11610098|FG003|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
10462360|NCT01033487|11610099|FG004|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
10462361|NCT01033487|11610100|FG005|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
10462362|NCT01033487|11610101|FG006|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
10462363|NCT01033487|11610102|FG007|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
10462364|NCT01033487|11610103|FG008|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
10462365|NCT01033487|11610104|FG009|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
10462366|NCT01033487|11610095|FG000|STARTED|Fifth Intervention Period||2
10462367|NCT01033487|11610096|FG001|STARTED|Fifth Intervention Period||3
10462368|NCT01033487|11610097|FG002|STARTED|Fifth Intervention Period||2
10462369|NCT01033487|11610098|FG003|STARTED|Fifth Intervention Period||2
10462370|NCT01033487|11610099|FG004|STARTED|Fifth Intervention Period||2
10462371|NCT01033487|11610100|FG005|STARTED|Fifth Intervention Period||2
10462372|NCT01033487|11610101|FG006|STARTED|Fifth Intervention Period||2
10462373|NCT01033487|11610102|FG007|STARTED|Fifth Intervention Period||3
10462374|NCT01033487|11610103|FG008|STARTED|Fifth Intervention Period||1
10462375|NCT01033487|11610104|FG009|STARTED|Fifth Intervention Period||2
10462376|NCT01033487|11610095|FG000|COMPLETED|Fifth Intervention Period||2
10462377|NCT01033487|11610096|FG001|COMPLETED|Fifth Intervention Period||3
10462378|NCT01033487|11610097|FG002|COMPLETED|Fifth Intervention Period||2
10462379|NCT01033487|11610098|FG003|COMPLETED|Fifth Intervention Period||2
10462380|NCT01033487|11610099|FG004|COMPLETED|Fifth Intervention Period||2
10462381|NCT01033487|11610100|FG005|COMPLETED|Fifth Intervention Period||2
10462382|NCT01033487|11610101|FG006|COMPLETED|Fifth Intervention Period||2
10462383|NCT01033487|11610102|FG007|COMPLETED|Fifth Intervention Period||3
10462384|NCT01033487|11610103|FG008|COMPLETED|Fifth Intervention Period||1
10462385|NCT01033487|11610104|FG009|COMPLETED|Fifth Intervention Period||2
10462386|NCT01033487|11610095|FG000|NOT COMPLETED|Fifth Intervention Period||0
10462387|NCT01033487|11610096|FG001|NOT COMPLETED|Fifth Intervention Period||0
10462388|NCT01033487|11610097|FG002|NOT COMPLETED|Fifth Intervention Period||0
10462389|NCT01033487|11610098|FG003|NOT COMPLETED|Fifth Intervention Period||0
10462390|NCT01033487|11610099|FG004|NOT COMPLETED|Fifth Intervention Period||0
10462391|NCT01033487|11610100|FG005|NOT COMPLETED|Fifth Intervention Period||0
10462392|NCT01033487|11610101|FG006|NOT COMPLETED|Fifth Intervention Period||0
10462393|NCT01033487|11610102|FG007|NOT COMPLETED|Fifth Intervention Period||0
10462394|NCT01033487|11610103|FG008|NOT COMPLETED|Fifth Intervention Period||0
10462395|NCT01033487|11610104|FG009|NOT COMPLETED|Fifth Intervention Period||0
10462396|NCT01033565|11610118|FG000|STARTED|Overall Study||1
10462397|NCT01033565|11610118|FG000|COMPLETED|Overall Study||1
10462398|NCT01033565|11610118|FG000|NOT COMPLETED|Overall Study||0
10462399|NCT01033643|11610127|FG000|STARTED|Overall Study||6
10462400|NCT01033643|11610128|FG001|STARTED|Overall Study||6
10462401|NCT01033643|11610129|FG002|STARTED|Overall Study||6
10462402|NCT01033643|11610130|FG003|STARTED|Overall Study||4
10708481|NCT02631525|11873306|FG000|COMPLETED|Overall Study||20
10708482|NCT02631525|11873307|FG001|COMPLETED|Overall Study||20
10708483|NCT02631525|11873306|FG000|NOT COMPLETED|Overall Study||0
10708484|NCT02631525|11873307|FG001|NOT COMPLETED|Overall Study||0
10462403|NCT01033643|11610131|FG004|STARTED|Overall Study||0
10462404|NCT01033643|11610132|FG005|STARTED|Overall Study||8
10462405|NCT01033643|11610127|FG000|COMPLETED|Overall Study||6
10462406|NCT01033643|11610128|FG001|COMPLETED|Overall Study||3
10462407|NCT01033643|11610129|FG002|COMPLETED|Overall Study||6
10462408|NCT01033643|11610130|FG003|COMPLETED|Overall Study||4
10462409|NCT01033643|11610131|FG004|COMPLETED|Overall Study||0
10462410|NCT01033643|11610132|FG005|COMPLETED|Overall Study||7
10462411|NCT01033643|11610127|FG000|NOT COMPLETED|Overall Study||0
10462412|NCT01033643|11610128|FG001|NOT COMPLETED|Overall Study||3
10462413|NCT01033643|11610129|FG002|NOT COMPLETED|Overall Study||0
10462414|NCT01033643|11610130|FG003|NOT COMPLETED|Overall Study||0
10462415|NCT01033643|11610131|FG004|NOT COMPLETED|Overall Study||0
10462416|NCT01033643|11610132|FG005|NOT COMPLETED|Overall Study||1
10462417|NCT01033734|11610146|FG000|STARTED|Overall Study||8
10462418|NCT01033734|11610146|FG000|COMPLETED|Overall Study||7
10462419|NCT01033734|11610146|FG000|NOT COMPLETED|Overall Study||1
10462420|NCT01033747|11610161|FG000|STARTED|Overall Study||51
10462421|NCT01033747|11610162|FG001|STARTED|Overall Study||19
10462422|NCT01033747|11610161|FG000|COMPLETED|Overall Study||14
10649808|NCT02164513|11809986|FG000|Completed Investigational Product (IP)|Overall Study||3393
10649809|NCT02164513|11809987|FG001|Completed Investigational Product (IP)|Overall Study||3094
10649810|NCT02164513|11809988|FG002|Completed Investigational Product (IP)|Overall Study||1504
10649811|NCT02164513|11809986|FG000|Not Completed IP|Overall Study||758
10649812|NCT02164513|11809987|FG001|Not Completed IP|Overall Study||1040
10462423|NCT01033747|11610162|FG001|COMPLETED|Overall Study||4
10462424|NCT01033747|11610161|FG000|NOT COMPLETED|Overall Study||37
10462425|NCT01033747|11610162|FG001|NOT COMPLETED|Overall Study||15
10462426|NCT01033773|11610168|FG000|STARTED|Overall Study||86
10462427|NCT01033773|11610168|FG000|COMPLETED|Overall Study||51
10462428|NCT01033773|11610168|FG000|NOT COMPLETED|Overall Study||35
10462429|NCT01033825|11610179|FG000|STARTED|Overall Study||51
10462430|NCT01033825|11610180|FG001|STARTED|Overall Study||60
10462431|NCT01033825|11610181|FG002|STARTED|Overall Study||57
10462432|NCT01033825|11610182|FG003|STARTED|Overall Study||48
10462433|NCT01033825|11610183|FG004|STARTED|Overall Study||58
10462434|NCT01033825|11610184|FG005|STARTED|Overall Study||18
10462435|NCT01033825|11610185|FG006|STARTED|Overall Study||18
10462436|NCT01033825|11610179|FG000|COMPLETED|Overall Study||48
10462437|NCT01033825|11610180|FG001|COMPLETED|Overall Study||57
10462438|NCT01033825|11610181|FG002|COMPLETED|Overall Study||55
10462439|NCT01033825|11610182|FG003|COMPLETED|Overall Study||46
10462440|NCT01033825|11610183|FG004|COMPLETED|Overall Study||56
10462441|NCT01033825|11610184|FG005|COMPLETED|Overall Study||18
10462442|NCT01033825|11610185|FG006|COMPLETED|Overall Study||18
10462443|NCT01033825|11610179|FG000|NOT COMPLETED|Overall Study||3
10462444|NCT01033825|11610180|FG001|NOT COMPLETED|Overall Study||3
10462445|NCT01033825|11610181|FG002|NOT COMPLETED|Overall Study||2
10462446|NCT01033825|11610182|FG003|NOT COMPLETED|Overall Study||2
10462447|NCT01033825|11610183|FG004|NOT COMPLETED|Overall Study||2
10462448|NCT01033825|11610184|FG005|NOT COMPLETED|Overall Study||0
10462449|NCT01033825|11610185|FG006|NOT COMPLETED|Overall Study||0
10462450|NCT01033851|11610205|FG000|STARTED|Overall Study||48
10462451|NCT01033851|11610206|FG001|STARTED|Overall Study||41
10462452|NCT01033851|11610205|FG000|COMPLETED|Overall Study||45
10462453|NCT01033851|11610206|FG001|COMPLETED|Overall Study||34
10462454|NCT01033851|11610205|FG000|NOT COMPLETED|Overall Study||3
10462455|NCT01033851|11610206|FG001|NOT COMPLETED|Overall Study||7
10462456|NCT01033864|11610214|FG000|STARTED|Overall Study||12
10462457|NCT01033864|11610215|FG001|STARTED|Overall Study||11
10462458|NCT01033864|11610214|FG000|COMPLETED|Overall Study||12
10462459|NCT01033864|11610215|FG001|COMPLETED|Overall Study||11
10462460|NCT01033864|11610214|FG000|NOT COMPLETED|Overall Study||0
10462461|NCT01033864|11610215|FG001|NOT COMPLETED|Overall Study||0
10462462|NCT01033942|11610224|FG000|STARTED|Overall Study||20
10462463|NCT01033942|11610225|FG001|STARTED|Overall Study||19
10462464|NCT01033942|11610226|FG002|STARTED|Overall Study||19
10462465|NCT01033942|11610224|FG000|COMPLETED|Overall Study||18
10462466|NCT01033942|11610225|FG001|COMPLETED|Overall Study||15
10462467|NCT01033942|11610226|FG002|COMPLETED|Overall Study||18
10462468|NCT01033942|11610224|FG000|NOT COMPLETED|Overall Study||2
10462469|NCT01033942|11610225|FG001|NOT COMPLETED|Overall Study||4
10462470|NCT01033942|11610226|FG002|NOT COMPLETED|Overall Study||1
10462471|NCT01034111|11610236|FG000|STARTED|Overall Study||30
10462472|NCT01034111|11610236|FG000|COMPLETED|Overall Study||30
10462473|NCT01034111|11610236|FG000|NOT COMPLETED|Overall Study||0
10462474|NCT01034137|11610243|FG000|STARTED|Overall Study||106
10462475|NCT01034137|11610244|FG001|STARTED|Overall Study||103
10462476|NCT01034137|11610245|FG002|STARTED|Overall Study||108
10462477|NCT01034137|11610243|FG000|COMPLETED|Overall Study||78
10462478|NCT01034137|11610244|FG001|COMPLETED|Overall Study||81
10462479|NCT01034137|11610245|FG002|COMPLETED|Overall Study||78
10462480|NCT01034137|11610243|FG000|NOT COMPLETED|Overall Study||28
10462481|NCT01034137|11610244|FG001|NOT COMPLETED|Overall Study||22
10462482|NCT01034137|11610245|FG002|NOT COMPLETED|Overall Study||30
10462483|NCT01034163|11610256|FG000|STARTED|Overall Study||27
10462484|NCT01034163|11610257|FG001|STARTED|Overall Study||14
10462485|NCT01034163|11610256|FG000|Untreated (Not in Safety Set)|Overall Study||1
10462486|NCT01034163|11610257|FG001|Untreated (Not in Safety Set)|Overall Study||2
10462487|NCT01034163|11610256|FG000|Safety Set|Overall Study||26
10462488|NCT01034163|11610257|FG001|Safety Set|Overall Study||12
10462489|NCT01034163|11610256|FG000|In Open Label Phase After Unblinding|Overall Study||5
10462490|NCT01034163|11610257|FG001|In Open Label Phase After Unblinding|Overall Study||0
10462491|NCT01034163|11610256|FG000|COMPLETED|Overall Study||0
10462492|NCT01034163|11610257|FG001|COMPLETED|Overall Study||0
10462493|NCT01034163|11610256|FG000|NOT COMPLETED|Overall Study||27
10462494|NCT01034163|11610257|FG001|NOT COMPLETED|Overall Study||14
10462495|NCT01034176|11610265|FG000|STARTED|Overall Study||22
10462496|NCT01034176|11610266|FG001|STARTED|Overall Study||21
10462497|NCT01034176|11610265|FG000|COMPLETED|Overall Study||20
10462498|NCT01034176|11610266|FG001|COMPLETED|Overall Study||19
10462499|NCT01034176|11610265|FG000|NOT COMPLETED|Overall Study||2
10462500|NCT01034176|11610266|FG001|NOT COMPLETED|Overall Study||2
10462501|NCT01034358|11610272|FG000|STARTED|Overall Study||15
10462502|NCT01034358|11610272|FG000|COMPLETED|Overall Study|One patient was found after enrollment to have already received one prior dose of the HPV vaccine.|13
10462503|NCT01034358|11610272|FG000|NOT COMPLETED|Overall Study||2
10462504|NCT01034397|11610278|FG000|STARTED|Overall Study||35
10462505|NCT01034397|11610279|FG001|STARTED|Overall Study||19
10462506|NCT01034397|11610278|FG000|COMPLETED|Overall Study||28
10462507|NCT01034397|11610279|FG001|COMPLETED|Overall Study||17
10462508|NCT01034397|11610278|FG000|NOT COMPLETED|Overall Study||7
10462509|NCT01034397|11610279|FG001|NOT COMPLETED|Overall Study||2
10462510|NCT01034462|11610296|FG000|STARTED|Overall Study||217
10462511|NCT01034462|11610297|FG001|STARTED|Overall Study||217
10462512|NCT01034462|11610296|FG000|COMPLETED|Overall Study||172
10462513|NCT01034462|11610297|FG001|COMPLETED|Overall Study||163
10462514|NCT01034462|11610296|FG000|NOT COMPLETED|Overall Study||45
10462515|NCT01034462|11610297|FG001|NOT COMPLETED|Overall Study||54
10462516|NCT01034527|11610307|FG000|STARTED|Overall Study||307
10462517|NCT01034527|11610308|FG001|STARTED|Overall Study||216
10462518|NCT01034527|11610307|FG000|COMPLETED|Overall Study||307
10462519|NCT01034527|11610308|FG001|COMPLETED|Overall Study||216
10462520|NCT01034527|11610307|FG000|NOT COMPLETED|Overall Study||0
10462521|NCT01034527|11610308|FG001|NOT COMPLETED|Overall Study||0
10462522|NCT01034540|11610316|FG000|STARTED|Overall Study||11
10462523|NCT01034540|11610317|FG001|STARTED|Overall Study||12
10462524|NCT01034540|11610316|FG000|Completed 1st Treatment Intervention|Overall Study||11
10462525|NCT01034540|11610317|FG001|Completed 1st Treatment Intervention|Overall Study||11
10462526|NCT01034540|11610316|FG000|COMPLETED|Overall Study||11
10462527|NCT01034540|11610317|FG001|COMPLETED|Overall Study||11
10462528|NCT01034540|11610316|FG000|NOT COMPLETED|Overall Study||0
10462529|NCT01034540|11610317|FG001|NOT COMPLETED|Overall Study||1
10462530|NCT01034553|11610325|FG000|STARTED|Overall Study||3
10462531|NCT01034553|11610326|FG001|STARTED|Overall Study||4
10462532|NCT01034553|11610327|FG002|STARTED|Overall Study||3
10462533|NCT01034553|11610328|FG003|STARTED|Overall Study||3
10462534|NCT01034553|11610329|FG004|STARTED|Overall Study||6
10462535|NCT01034553|11610330|FG005|STARTED|Overall Study||7
10462536|NCT01034553|11610325|FG000|COMPLETED|Overall Study||3
10462537|NCT01034553|11610326|FG001|COMPLETED|Overall Study||4
10462538|NCT01034553|11610327|FG002|COMPLETED|Overall Study||3
10462539|NCT01034553|11610328|FG003|COMPLETED|Overall Study||3
10462540|NCT01034553|11610329|FG004|COMPLETED|Overall Study||6
10462541|NCT01034553|11610330|FG005|COMPLETED|Overall Study||7
10462542|NCT01034553|11610325|FG000|NOT COMPLETED|Overall Study||0
10462543|NCT01034553|11610326|FG001|NOT COMPLETED|Overall Study||0
10462544|NCT01034553|11610327|FG002|NOT COMPLETED|Overall Study||0
10462545|NCT01034553|11610328|FG003|NOT COMPLETED|Overall Study||0
10462546|NCT01034553|11610329|FG004|NOT COMPLETED|Overall Study||0
10462547|NCT01034553|11610330|FG005|NOT COMPLETED|Overall Study||0
10462548|NCT01034579|11610346|FG000|STARTED|Overall Study||158
10462549|NCT01034579|11610347|FG001|STARTED|Overall Study||166
10462550|NCT01034579|11610346|FG000|COMPLETED|Overall Study||158
10462551|NCT01034579|11610347|FG001|COMPLETED|Overall Study||166
10462552|NCT01034579|11610346|FG000|NOT COMPLETED|Overall Study||0
10462553|NCT01034579|11610347|FG001|NOT COMPLETED|Overall Study||0
10462554|NCT01034592|11610353|FG000|STARTED|Overall Study||2
10462555|NCT01034592|11610353|FG000|COMPLETED|Overall Study||2
10462556|NCT01034592|11610353|FG000|NOT COMPLETED|Overall Study||0
10809626|NCT03831191|11971473|FG004|COMPLETED|Maintenance Period (36 Weeks)||0
10809627|NCT03831191|11971474|FG005|COMPLETED|Maintenance Period (36 Weeks)||0
10809628|NCT03831191|11971475|FG006|COMPLETED|Maintenance Period (36 Weeks)||0
10809629|NCT03831191|11971476|FG007|COMPLETED|Maintenance Period (36 Weeks)||0
10809630|NCT03831191|11971477|FG008|COMPLETED|Maintenance Period (36 Weeks)||0
10809631|NCT03831191|11971478|FG009|COMPLETED|Maintenance Period (36 Weeks)||0
10809632|NCT03831191|11971479|FG010|COMPLETED|Maintenance Period (36 Weeks)||0
10809633|NCT03831191|11971480|FG011|COMPLETED|Maintenance Period (36 Weeks)||1
10809634|NCT03831191|11971481|FG012|COMPLETED|Maintenance Period (36 Weeks)||0
10809635|NCT03831191|11971482|FG013|COMPLETED|Maintenance Period (36 Weeks)||0
10809636|NCT03831191|11971483|FG014|COMPLETED|Maintenance Period (36 Weeks)||0
10809637|NCT03831191|11971469|FG000|NOT COMPLETED|Maintenance Period (36 Weeks)||0
10809638|NCT03831191|11971470|FG001|NOT COMPLETED|Maintenance Period (36 Weeks)||0
10809639|NCT03831191|11971471|FG002|NOT COMPLETED|Maintenance Period (36 Weeks)||0
10809640|NCT03831191|11971472|FG003|NOT COMPLETED|Maintenance Period (36 Weeks)||0
10809641|NCT03831191|11971473|FG004|NOT COMPLETED|Maintenance Period (36 Weeks)||4
10462575|NCT01034657|11610373|FG000|STARTED|Core Phase||34
10462576|NCT01034657|11610374|FG001|STARTED|Core Phase||0
10462577|NCT01034657|11610375|FG002|STARTED|Core Phase||0
10462578|NCT01034657|11610373|FG000|COMPLETED|Core Phase||20
10462579|NCT01034657|11610374|FG001|COMPLETED|Core Phase||0
10462580|NCT01034657|11610375|FG002|COMPLETED|Core Phase||0
10462581|NCT01034657|11610373|FG000|NOT COMPLETED|Core Phase||14
10462582|NCT01034657|11610374|FG001|NOT COMPLETED|Core Phase||0
10462583|NCT01034657|11610375|FG002|NOT COMPLETED|Core Phase||0
10462584|NCT01034657|11610373|FG000|STARTED|Randomized Phase||6
10462585|NCT01034657|11610374|FG001|STARTED|Randomized Phase||6
10462586|NCT01034657|11610375|FG002|STARTED|Randomized Phase||1
10462587|NCT01034657|11610373|FG000|COMPLETED|Randomized Phase||1
10462588|NCT01034657|11610374|FG001|COMPLETED|Randomized Phase||0
10462589|NCT01034657|11610375|FG002|COMPLETED|Randomized Phase||0
10708485|NCT02631538|11873317|FG000|STARTED|Treatment Period (Up to Week 52)||13
10708486|NCT02631538|11873318|FG001|STARTED|Treatment Period (Up to Week 52)||24
10708487|NCT02631538|11873319|FG002|STARTED|Treatment Period (Up to Week 52)||24
10708488|NCT02631538|11873320|FG003|STARTED|Treatment Period (Up to Week 52)||25
10708489|NCT02631538|11873317|FG000|COMPLETED|Treatment Period (Up to Week 52)||9
10462590|NCT01034657|11610373|FG000|NOT COMPLETED|Randomized Phase||5
10462591|NCT01034657|11610374|FG001|NOT COMPLETED|Randomized Phase||6
10462592|NCT01034657|11610375|FG002|NOT COMPLETED|Randomized Phase||1
10462593|NCT01034709|11610387|FG000|STARTED|Overall Study||53
10462594|NCT01034709|11610388|FG001|STARTED|Overall Study||58
10462595|NCT01034709|11610387|FG000|COMPLETED|Overall Study||44
10462596|NCT01034709|11610388|FG001|COMPLETED|Overall Study||42
10462597|NCT01034709|11610387|FG000|NOT COMPLETED|Overall Study||9
10462598|NCT01034709|11610388|FG001|NOT COMPLETED|Overall Study||16
10462599|NCT01035047|11610396|FG000|STARTED|Overall Study||52
10462600|NCT01035047|11610397|FG001|STARTED|Overall Study||53
10462601|NCT01035047|11610396|FG000|COMPLETED|Overall Study||52
10462602|NCT01035047|11610397|FG001|COMPLETED|Overall Study||53
10462603|NCT01035047|11610396|FG000|NOT COMPLETED|Overall Study||0
10462604|NCT01035047|11610397|FG001|NOT COMPLETED|Overall Study||0
10462605|NCT01035060|11610405|FG000|STARTED|Overall Study||39
10462606|NCT01035060|11610406|FG001|STARTED|Overall Study||29
10462607|NCT01035060|11610405|FG000|COMPLETED|Overall Study||15
10462608|NCT01035060|11610406|FG001|COMPLETED|Overall Study||15
10462609|NCT01035060|11610405|FG000|NOT COMPLETED|Overall Study||24
10462610|NCT01035060|11610406|FG001|NOT COMPLETED|Overall Study||14
10462611|NCT01035099|11610414|FG000|STARTED|Overall Study||18
10462612|NCT01035099|11610415|FG001|STARTED|Overall Study||22
10462613|NCT01035099|11610414|FG000|COMPLETED|Overall Study||18
10462614|NCT01035099|11610415|FG001|COMPLETED|Overall Study||22
10462615|NCT01035099|11610414|FG000|NOT COMPLETED|Overall Study||0
10462616|NCT01035099|11610415|FG001|NOT COMPLETED|Overall Study||0
10462617|NCT01035138|11610425|FG000|STARTED|Overall Study||73
10462618|NCT01035138|11610426|FG001|STARTED|Overall Study||60
10462619|NCT01035138|11610427|FG002|STARTED|Overall Study||47
10462620|NCT01035138|11610425|FG000|COMPLETED|Overall Study||0
10462621|NCT01035138|11610426|FG001|COMPLETED|Overall Study||0
10462622|NCT01035138|11610427|FG002|COMPLETED|Overall Study||0
10462623|NCT01035138|11610425|FG000|NOT COMPLETED|Overall Study||73
10462624|NCT01035138|11610426|FG001|NOT COMPLETED|Overall Study||60
10462625|NCT01035138|11610427|FG002|NOT COMPLETED|Overall Study||47
10462626|NCT01035151|11610439|FG000|STARTED|Overall Study||209
10462627|NCT01035151|11610440|FG001|STARTED|Overall Study||200
10462628|NCT01035151|11610439|FG000|COMPLETED|Overall Study||188
10462629|NCT01035151|11610440|FG001|COMPLETED|Overall Study||185
10462630|NCT01035151|11610439|FG000|NOT COMPLETED|Overall Study||21
10462631|NCT01035151|11610440|FG001|NOT COMPLETED|Overall Study||15
10462632|NCT01035229|11610448|FG000|STARTED|Overall Study||362
10462633|NCT01035229|11610449|FG001|STARTED|Overall Study||184
10462634|NCT01035229|11610448|FG000|COMPLETED|Overall Study||0
10462635|NCT01035229|11610449|FG001|COMPLETED|Overall Study||0
10462636|NCT01035229|11610448|FG000|NOT COMPLETED|Overall Study||362
10462637|NCT01035229|11610449|FG001|NOT COMPLETED|Overall Study||184
10462638|NCT01035255|11610459|FG000|STARTED|Overall Study||4209
10649813|NCT02164513|11809988|FG002|Not Completed IP|Overall Study||566
10649814|NCT02164513|11809986|FG000|Withdrew IP (WIP): Adverse Event|Overall Study||249
10649815|NCT02164513|11809987|FG001|Withdrew IP (WIP): Adverse Event|Overall Study||325
10649816|NCT02164513|11809988|FG002|Withdrew IP (WIP): Adverse Event|Overall Study||186
10649817|NCT02164513|11809986|FG000|WIP: Lack of Efficacy|Overall Study||163
10649818|NCT02164513|11809987|FG001|WIP: Lack of Efficacy|Overall Study||313
10649819|NCT02164513|11809988|FG002|WIP: Lack of Efficacy|Overall Study||172
10649820|NCT02164513|11809986|FG000|Withdrew IP: Protocol Deviation|Overall Study||32
10649821|NCT02164513|11809987|FG001|Withdrew IP: Protocol Deviation|Overall Study||41
10649822|NCT02164513|11809988|FG002|Withdrew IP: Protocol Deviation|Overall Study||19
10462639|NCT01035255|11610460|FG001|STARTED|Overall Study||4233
10462640|NCT01035255|11610459|FG000|GCP Violations|Overall Study||18
10462641|NCT01035255|11610460|FG001|GCP Violations|Overall Study||19
10462642|NCT01035255|11610459|FG000|Mis-randomized|Overall Study||4
10462643|NCT01035255|11610460|FG001|Mis-randomized|Overall Study||2
10462644|NCT01035255|11610459|FG000|Full Analysis Set (FAS)|Overall Study|patents with GCP violation and mis-randomized are not included in FAS|4187
10462645|NCT01035255|11610460|FG001|Full Analysis Set (FAS)|Overall Study|patents with GCP violation and mis-randomized are not included in FAS|4212
10462646|NCT01035255|11610459|FG000|COMPLETED|Overall Study||3468
10462647|NCT01035255|11610460|FG001|COMPLETED|Overall Study||3371
10462648|NCT01035255|11610459|FG000|NOT COMPLETED|Overall Study||741
10462649|NCT01035255|11610460|FG001|NOT COMPLETED|Overall Study||862
10462650|NCT01035333|11610466|FG000|STARTED|Overall Study||19
10462651|NCT01035333|11610466|FG000|COMPLETED|Overall Study||9
10462652|NCT01035333|11610466|FG000|NOT COMPLETED|Overall Study||10
10462653|NCT01035346|11610472|FG000|STARTED|Overall Study||7
10462654|NCT01035346|11610473|FG001|STARTED|Overall Study||9
10462655|NCT01035346|11610472|FG000|COMPLETED|Overall Study||7
10462656|NCT01035346|11610473|FG001|COMPLETED|Overall Study||9
10462657|NCT01035346|11610472|FG000|NOT COMPLETED|Overall Study||0
10462658|NCT01035346|11610473|FG001|NOT COMPLETED|Overall Study||0
10462659|NCT01035463|11610481|FG000|STARTED|Overall Study||6
10462660|NCT01035463|11610482|FG001|STARTED|Overall Study||3
10462661|NCT01035463|11610483|FG002|STARTED|Overall Study||6
10462662|NCT01035463|11610484|FG003|STARTED|Overall Study||4
10462663|NCT01035463|11610485|FG004|STARTED|Overall Study||7
10462664|NCT01035463|11610486|FG005|STARTED|Overall Study||33
10462665|NCT01035463|11610481|FG000|COMPLETED|Overall Study||6
10462666|NCT01035463|11610482|FG001|COMPLETED|Overall Study||1
10462667|NCT01035463|11610483|FG002|COMPLETED|Overall Study||1
10462668|NCT01035463|11610484|FG003|COMPLETED|Overall Study||2
10462669|NCT01035463|11610485|FG004|COMPLETED|Overall Study||1
10462670|NCT01035463|11610486|FG005|COMPLETED|Overall Study||15
10462671|NCT01035463|11610481|FG000|NOT COMPLETED|Overall Study||0
10462672|NCT01035463|11610482|FG001|NOT COMPLETED|Overall Study||2
10462673|NCT01035463|11610483|FG002|NOT COMPLETED|Overall Study||5
10462674|NCT01035463|11610484|FG003|NOT COMPLETED|Overall Study||2
10462675|NCT01035463|11610485|FG004|NOT COMPLETED|Overall Study||6
10462676|NCT01035463|11610486|FG005|NOT COMPLETED|Overall Study||18
10462677|NCT01035606|11610496|FG000|STARTED|Overall Study||19
10462678|NCT01035606|11610497|FG001|STARTED|Overall Study||19
10462679|NCT01035606|11610498|FG002|STARTED|Overall Study||11
10462680|NCT01035606|11610496|FG000|COMPLETED|Overall Study||16
10462681|NCT01035606|11610497|FG001|COMPLETED|Overall Study||16
10462682|NCT01035606|11610498|FG002|COMPLETED|Overall Study||7
10462683|NCT01035606|11610496|FG000|NOT COMPLETED|Overall Study||3
10462684|NCT01035606|11610497|FG001|NOT COMPLETED|Overall Study||3
10462685|NCT01035606|11610498|FG002|NOT COMPLETED|Overall Study||4
10462686|NCT01035658|11610510|FG000|STARTED|Overall Study||5
10462687|NCT01035658|11610511|FG001|STARTED|Overall Study||8
10462688|NCT01035658|11610512|FG002|STARTED|Overall Study||3
10462689|NCT01035658|11610513|FG003|STARTED|Overall Study||6
10462690|NCT01035658|11610510|FG000|COMPLETED|Overall Study||5
10462691|NCT01035658|11610511|FG001|COMPLETED|Overall Study||8
10462692|NCT01035658|11610512|FG002|COMPLETED|Overall Study||3
10462693|NCT01035658|11610513|FG003|COMPLETED|Overall Study||6
10462694|NCT01035658|11610510|FG000|NOT COMPLETED|Overall Study||0
10462695|NCT01035658|11610511|FG001|NOT COMPLETED|Overall Study||0
10462696|NCT01035658|11610512|FG002|NOT COMPLETED|Overall Study||0
10462697|NCT01035658|11610513|FG003|NOT COMPLETED|Overall Study||0
10462698|NCT01035749|11610530|FG000|STARTED|Overall Study||66
10462699|NCT01035749|11610531|FG001|STARTED|Overall Study||66
10462700|NCT01035749|11610532|FG002|STARTED|Overall Study||68
10462701|NCT01035749|11610533|FG003|STARTED|Overall Study||110
10462702|NCT01035749|11610530|FG000|COMPLETED|Overall Study||66
10462703|NCT01035749|11610531|FG001|COMPLETED|Overall Study||66
10462704|NCT01035749|11610532|FG002|COMPLETED|Overall Study||68
10462705|NCT01035749|11610533|FG003|COMPLETED|Overall Study||110
10462706|NCT01035749|11610530|FG000|NOT COMPLETED|Overall Study||0
10462707|NCT01035749|11610531|FG001|NOT COMPLETED|Overall Study||0
10462708|NCT01035749|11610532|FG002|NOT COMPLETED|Overall Study||0
10462709|NCT01035749|11610533|FG003|NOT COMPLETED|Overall Study||0
10462710|NCT01035788|11610545|FG000|STARTED|Overall Study|23 couples = 23 Veterans + 23 partners; only data for Veterans will be included for primary outcome.|23
10462711|NCT01035788|11610546|FG001|STARTED|Overall Study|23 couples = 23 Veterans + 23 partners; only data for Veterans will be included for primary outcome.|23
10462712|NCT01035788|11610545|FG000|COMPLETED|Overall Study||17
10462713|NCT01035788|11610546|FG001|COMPLETED|Overall Study||9
10462714|NCT01035788|11610545|FG000|NOT COMPLETED|Overall Study||6
10462715|NCT01035788|11610546|FG001|NOT COMPLETED|Overall Study||14
10462716|NCT01035905|11610554|FG000|STARTED|Overall Study||32
10462717|NCT01035905|11610555|FG001|STARTED|Overall Study||31
10462718|NCT01035905|11610554|FG000|COMPLETED|Overall Study||31
10462719|NCT01035905|11610555|FG001|COMPLETED|Overall Study||30
10462720|NCT01035905|11610554|FG000|NOT COMPLETED|Overall Study||1
10462721|NCT01035905|11610555|FG001|NOT COMPLETED|Overall Study||1
10462722|NCT01036009|11610563|FG000|STARTED|Overall Study||17
10462723|NCT01036009|11610564|FG001|STARTED|Overall Study||26
10462724|NCT01036009|11610563|FG000|COMPLETED|Overall Study||17
10462725|NCT01036009|11610564|FG001|COMPLETED|Overall Study||26
10462726|NCT01036009|11610563|FG000|NOT COMPLETED|Overall Study||0
10462727|NCT01036009|11610564|FG001|NOT COMPLETED|Overall Study||0
10462728|NCT01036022|11610577|FG000|STARTED|Overall Study||15
10462729|NCT01036022|11610578|FG001|STARTED|Overall Study||11
10462730|NCT01036022|11610579|FG002|STARTED|Overall Study||12
10462731|NCT01036022|11610580|FG003|STARTED|Overall Study||12
10462732|NCT01036022|11610581|FG004|STARTED|Overall Study||12
10462733|NCT01036022|11610582|FG005|STARTED|Overall Study||16
10462734|NCT01036022|11610577|FG000|COMPLETED|Overall Study||13
10462735|NCT01036022|11610578|FG001|COMPLETED|Overall Study||7
10462736|NCT01036022|11610579|FG002|COMPLETED|Overall Study||8
10462737|NCT01036022|11610580|FG003|COMPLETED|Overall Study||10
10462738|NCT01036022|11610581|FG004|COMPLETED|Overall Study||9
10462739|NCT01036022|11610582|FG005|COMPLETED|Overall Study||13
10462740|NCT01036022|11610577|FG000|NOT COMPLETED|Overall Study||2
10462741|NCT01036022|11610578|FG001|NOT COMPLETED|Overall Study||4
10462742|NCT01036022|11610579|FG002|NOT COMPLETED|Overall Study||4
10462743|NCT01036022|11610580|FG003|NOT COMPLETED|Overall Study||2
10462744|NCT01036022|11610581|FG004|NOT COMPLETED|Overall Study||3
10462745|NCT01036022|11610582|FG005|NOT COMPLETED|Overall Study||3
10462746|NCT01036165|11610604|FG000|STARTED|Overall Study||103
10462747|NCT01036165|11610604|FG000|COMPLETED|Overall Study||88
10462748|NCT01036165|11610604|FG000|NOT COMPLETED|Overall Study||15
10462749|NCT01036321|11610610|FG000|STARTED|Overall Study||36
10462750|NCT01036321|11610611|FG001|STARTED|Overall Study||35
10462751|NCT01036321|11610610|FG000|COMPLETED|Overall Study||31
10462752|NCT01036321|11610611|FG001|COMPLETED|Overall Study||31
10462753|NCT01036321|11610610|FG000|NOT COMPLETED|Overall Study||5
10462754|NCT01036321|11610611|FG001|NOT COMPLETED|Overall Study||4
10462755|NCT01036438|11610619|FG000|STARTED|Overall Study||101
10462756|NCT01036438|11610620|FG001|STARTED|Overall Study||100
10462757|NCT01036438|11610619|FG000|COMPLETED|Overall Study||91
10462758|NCT01036438|11610620|FG001|COMPLETED|Overall Study||90
10462759|NCT01036438|11610619|FG000|NOT COMPLETED|Overall Study||10
10462760|NCT01036438|11610620|FG001|NOT COMPLETED|Overall Study||10
10462761|NCT01036490|11610628|FG000|STARTED|Overall Study||18
10462762|NCT01036490|11610629|FG001|STARTED|Overall Study||18
10462763|NCT01036490|11610628|FG000|COMPLETED|Overall Study||14
10462764|NCT01036490|11610629|FG001|COMPLETED|Overall Study||18
10462765|NCT01036490|11610628|FG000|NOT COMPLETED|Overall Study||4
10462766|NCT01036490|11610629|FG001|NOT COMPLETED|Overall Study||0
10462767|NCT01036529|11610637|FG000|STARTED|Overall Study||13
10462768|NCT01036529|11610638|FG001|STARTED|Overall Study||15
10462769|NCT01036529|11610637|FG000|Baseline Visit|Overall Study||10
10462770|NCT01036529|11610638|FG001|Baseline Visit|Overall Study||13
10462771|NCT01036529|11610637|FG000|Index Procedure|Overall Study|Index Procedure: Trial Stimulation|10
10462772|NCT01036529|11610638|FG001|Index Procedure|Overall Study|Index Procedure: Surgery|11
10462773|NCT01036529|11610637|FG000|3 Month Follow-up|Overall Study||7
10462774|NCT01036529|11610638|FG001|3 Month Follow-up|Overall Study||9
10462775|NCT01036529|11610637|FG000|6 Month Follow-up|Overall Study||6
10462776|NCT01036529|11610638|FG001|6 Month Follow-up|Overall Study||7
10462777|NCT01036529|11610637|FG000|12 Month Follow-up|Overall Study||4
10462778|NCT01036529|11610638|FG001|12 Month Follow-up|Overall Study||3
10462779|NCT01036529|11610637|FG000|Requested Crossover|Overall Study||1
10462780|NCT01036529|11610638|FG001|Requested Crossover|Overall Study||2
10462781|NCT01036529|11610637|FG000|Crossover to Other Group|Overall Study||1
10462782|NCT01036529|11610638|FG001|Crossover to Other Group|Overall Study||1
10462783|NCT01036529|11610637|FG000|COMPLETED|Overall Study||0
10462784|NCT01036529|11610638|FG001|COMPLETED|Overall Study||0
10462785|NCT01036529|11610637|FG000|NOT COMPLETED|Overall Study||13
10462786|NCT01036529|11610638|FG001|NOT COMPLETED|Overall Study||15
10462787|NCT01036594|11610644|FG000|STARTED|Run-In: Ketoconazole Only (200 mg)||32
10462788|NCT01036594|11610645|FG001|STARTED|Run-In: Ketoconazole Only (200 mg)|Dexamethasone not introduced as treatment option until after Week 12 evaluation|0
10462789|NCT01036594|11610644|FG000|COMPLETED|Run-In: Ketoconazole Only (200 mg)||31
10462790|NCT01036594|11610645|FG001|COMPLETED|Run-In: Ketoconazole Only (200 mg)||0
10462791|NCT01036594|11610644|FG000|NOT COMPLETED|Run-In: Ketoconazole Only (200 mg)||1
10462792|NCT01036594|11610645|FG001|NOT COMPLETED|Run-In: Ketoconazole Only (200 mg)||0
10462793|NCT01036594|11610644|FG000|STARTED|First Treatment Regimen||31
10462794|NCT01036594|11610645|FG001|STARTED|First Treatment Regimen|Dexamethasone not introduced as treatment option until after Week 12 evaluation|0
10462795|NCT01036594|11610644|FG000|COMPLETED|First Treatment Regimen||30
10462796|NCT01036594|11610645|FG001|COMPLETED|First Treatment Regimen||0
10462797|NCT01036594|11610644|FG000|NOT COMPLETED|First Treatment Regimen||1
10462798|NCT01036594|11610645|FG001|NOT COMPLETED|First Treatment Regimen||0
10462799|NCT01036594|11610644|FG000|STARTED|Week 12 Evaluation||30
10462800|NCT01036594|11610645|FG001|STARTED|Week 12 Evaluation|Dexamethasone not introduced as treatment option until after Week 12 evaluation|0
10462801|NCT01036594|11610644|FG000|COMPLETED|Week 12 Evaluation||24
10462802|NCT01036594|11610645|FG001|COMPLETED|Week 12 Evaluation||0
10462803|NCT01036594|11610644|FG000|NOT COMPLETED|Week 12 Evaluation||6
10462804|NCT01036594|11610645|FG001|NOT COMPLETED|Week 12 Evaluation||0
10462805|NCT01036594|11610644|FG000|STARTED|Treatment Regiments Post Week 12||15
10462806|NCT01036594|11610645|FG001|STARTED|Treatment Regiments Post Week 12||9
10462807|NCT01036594|11610644|FG000|COMPLETED|Treatment Regiments Post Week 12||13
10462808|NCT01036594|11610645|FG001|COMPLETED|Treatment Regiments Post Week 12||5
10462809|NCT01036594|11610644|FG000|NOT COMPLETED|Treatment Regiments Post Week 12||2
10462810|NCT01036594|11610645|FG001|NOT COMPLETED|Treatment Regiments Post Week 12||4
10462811|NCT01036724|11610653|FG000|STARTED|Overall Study||52
10462812|NCT01036724|11610654|FG001|STARTED|Overall Study||55
10462813|NCT01036724|11610653|FG000|COMPLETED|Overall Study||46
10462814|NCT01036724|11610654|FG001|COMPLETED|Overall Study||47
10462815|NCT01036724|11610653|FG000|NOT COMPLETED|Overall Study||6
10462816|NCT01036724|11610654|FG001|NOT COMPLETED|Overall Study||8
10462817|NCT01036763|11610660|FG000|STARTED|Overall Study||1264
10462818|NCT01036763|11610660|FG000|COMPLETED|Overall Study||1171
10462819|NCT01036763|11610660|FG000|NOT COMPLETED|Overall Study||93
10462820|NCT01036802|11610666|FG000|STARTED|Overall Study||2
10462821|NCT01036802|11610667|FG001|STARTED|Overall Study||1
10462822|NCT01036802|11610666|FG000|COMPLETED|Overall Study||2
10462823|NCT01036802|11610667|FG001|COMPLETED|Overall Study|Patient was taken off study after 7 months as she required hip replacement surgery.|1
10462824|NCT01036802|11610666|FG000|NOT COMPLETED|Overall Study||0
10462825|NCT01036802|11610667|FG001|NOT COMPLETED|Overall Study||0
10462826|NCT01037088|11610674|FG000|STARTED|Overall Study||39
10462827|NCT01037088|11610674|FG000|Received 3.53% THC|Overall Study||36
10462828|NCT01037088|11610674|FG000|Received 1.29% THC|Overall Study||37
10462829|NCT01037088|11610674|FG000|Received Placebo|Overall Study||38
10462830|NCT01037088|11610674|FG000|COMPLETED|Overall Study||36
10462831|NCT01037088|11610674|FG000|NOT COMPLETED|Overall Study||3
10462832|NCT01037114|11610683|FG000|STARTED|Year 16||49
10462833|NCT01037114|11610683|FG000|COMPLETED|Year 16||49
10462834|NCT01037114|11610683|FG000|NOT COMPLETED|Year 16||0
10462835|NCT01037114|11610683|FG000|STARTED|Year 17||48
10462836|NCT01037114|11610683|FG000|COMPLETED|Year 17||48
10462837|NCT01037114|11610683|FG000|NOT COMPLETED|Year 17||0
10462838|NCT01037114|11610683|FG000|STARTED|Year 18||44
10462839|NCT01037114|11610683|FG000|COMPLETED|Year 18||44
10462840|NCT01037114|11610683|FG000|NOT COMPLETED|Year 18||0
10708490|NCT02631538|11873318|FG001|COMPLETED|Treatment Period (Up to Week 52)||17
10708491|NCT02631538|11873319|FG002|COMPLETED|Treatment Period (Up to Week 52)||19
10708492|NCT02631538|11873320|FG003|COMPLETED|Treatment Period (Up to Week 52)||17
10708493|NCT02631538|11873317|FG000|NOT COMPLETED|Treatment Period (Up to Week 52)||4
10708494|NCT02631538|11873318|FG001|NOT COMPLETED|Treatment Period (Up to Week 52)||7
10708495|NCT02631538|11873319|FG002|NOT COMPLETED|Treatment Period (Up to Week 52)||5
10708496|NCT02631538|11873320|FG003|NOT COMPLETED|Treatment Period (Up to Week 52)||8
10708497|NCT02631538|11873317|FG000|STARTED|General Follow-up (GFU) (Up to Week 68)||9
10708498|NCT02631538|11873318|FG001|STARTED|General Follow-up (GFU) (Up to Week 68)||17
10708499|NCT02631538|11873319|FG002|STARTED|General Follow-up (GFU) (Up to Week 68)||19
10708500|NCT02631538|11873320|FG003|STARTED|General Follow-up (GFU) (Up to Week 68)||17
10708501|NCT02631538|11873317|FG000|COMPLETED|General Follow-up (GFU) (Up to Week 68)||8
10708502|NCT02631538|11873318|FG001|COMPLETED|General Follow-up (GFU) (Up to Week 68)||17
10462841|NCT01037114|11610683|FG000|STARTED|Year 19||45
10462842|NCT01037114|11610683|FG000|COMPLETED|Year 19||45
10462843|NCT01037114|11610683|FG000|NOT COMPLETED|Year 19||0
10462844|NCT01037114|11610683|FG000|STARTED|Year 20||45
10462845|NCT01037114|11610683|FG000|COMPLETED|Year 20|One subject returned at Y20 but did not do lab test because subject met a study exclusion criteria.|44
10462846|NCT01037114|11610683|FG000|NOT COMPLETED|Year 20||1
10462847|NCT01037127|11610689|FG000|STARTED|Overall Study||40
10462848|NCT01037127|11610690|FG001|STARTED|Overall Study||57
10462849|NCT01037127|11610689|FG000|COMPLETED|Overall Study||35
10462850|NCT01037127|11610690|FG001|COMPLETED|Overall Study||36
10462851|NCT01037127|11610689|FG000|NOT COMPLETED|Overall Study||5
10462852|NCT01037127|11610690|FG001|NOT COMPLETED|Overall Study||21
10462853|NCT01037192|11610708|FG000|STARTED|Overall Study||3
10462854|NCT01037192|11610709|FG001|STARTED|Overall Study||1
10462855|NCT01037192|11610708|FG000|COMPLETED|Overall Study||3
10462856|NCT01037192|11610709|FG001|COMPLETED|Overall Study||1
10462857|NCT01037192|11610708|FG000|NOT COMPLETED|Overall Study||0
10462858|NCT01037192|11610709|FG001|NOT COMPLETED|Overall Study||0
10462859|NCT01037218|11610721|FG000|STARTED|Overall Study||147
10462860|NCT01037218|11610722|FG001|STARTED|Overall Study||149
10462861|NCT01037218|11610723|FG002|STARTED|Overall Study||155
10462862|NCT01037218|11610724|FG003|STARTED|Overall Study||150
10462863|NCT01037218|11610721|FG000|Safety Population|Overall Study||147
10462864|NCT01037218|11610722|FG001|Safety Population|Overall Study||148
10462865|NCT01037218|11610723|FG002|Safety Population|Overall Study||154
10462866|NCT01037218|11610724|FG003|Safety Population|Overall Study||150
10462867|NCT01037218|11610721|FG000|mITT Population|Overall Study||141
10462868|NCT01037218|11610722|FG001|mITT Population|Overall Study||140
10462869|NCT01037218|11610723|FG002|mITT Population|Overall Study||147
10462870|NCT01037218|11610724|FG003|mITT Population|Overall Study||141
10462871|NCT01037218|11610721|FG000|COMPLETED|Overall Study||131
10462872|NCT01037218|11610722|FG001|COMPLETED|Overall Study||128
10462873|NCT01037218|11610723|FG002|COMPLETED|Overall Study||134
10462874|NCT01037218|11610724|FG003|COMPLETED|Overall Study||134
10462875|NCT01037218|11610721|FG000|NOT COMPLETED|Overall Study||16
10462876|NCT01037218|11610722|FG001|NOT COMPLETED|Overall Study||21
10462877|NCT01037218|11610723|FG002|NOT COMPLETED|Overall Study||21
10462878|NCT01037218|11610724|FG003|NOT COMPLETED|Overall Study||16
10462879|NCT01037244|11610738|FG000|STARTED|Overall Study||154
10462880|NCT01037244|11610739|FG001|STARTED|Overall Study||152
10462881|NCT01037244|11610740|FG002|STARTED|Overall Study||158
10462882|NCT01037244|11610741|FG003|STARTED|Overall Study||154
10462883|NCT01037244|11610738|FG000|mITT (Modified Intent-to-Treat)|Overall Study||150
10462884|NCT01037244|11610739|FG001|mITT (Modified Intent-to-Treat)|Overall Study||148
10462885|NCT01037244|11610740|FG002|mITT (Modified Intent-to-Treat)|Overall Study||154
10462886|NCT01037244|11610741|FG003|mITT (Modified Intent-to-Treat)|Overall Study||153
10462887|NCT01037244|11610738|FG000|Safety Population|Overall Study|Two subjects randomized to receive placebo inadvertently received udenafil (1 - 50 mg and 1- 150 mg)|155
10462888|NCT01037244|11610739|FG001|Safety Population|Overall Study||150
10462889|NCT01037244|11610740|FG002|Safety Population|Overall Study|Two subjects randomized to receive placebo inadvertently received udenafil (1 - 50 mg and 1- 150 mg)|159
10462890|NCT01037244|11610741|FG003|Safety Population|Overall Study||152
10462891|NCT01037244|11610738|FG000|COMPLETED|Overall Study||141
10708503|NCT02631538|11873319|FG002|COMPLETED|General Follow-up (GFU) (Up to Week 68)||19
10462892|NCT01037244|11610739|FG001|COMPLETED|Overall Study||138
10462893|NCT01037244|11610740|FG002|COMPLETED|Overall Study||144
10462894|NCT01037244|11610741|FG003|COMPLETED|Overall Study||140
10462895|NCT01037244|11610738|FG000|NOT COMPLETED|Overall Study||13
10462896|NCT01037244|11610739|FG001|NOT COMPLETED|Overall Study||14
10462897|NCT01037244|11610740|FG002|NOT COMPLETED|Overall Study||14
10462898|NCT01037244|11610741|FG003|NOT COMPLETED|Overall Study||14
10462899|NCT01037309|11610757|FG000|STARTED|Subcutaneous Cohort 1 - 6||3
10462900|NCT01037309|11610758|FG001|STARTED|Subcutaneous Cohort 1 - 6||3
10462901|NCT01037309|11610759|FG002|STARTED|Subcutaneous Cohort 1 - 6||3
10462902|NCT01037309|11610760|FG003|STARTED|Subcutaneous Cohort 1 - 6||3
10462903|NCT01037309|11610761|FG004|STARTED|Subcutaneous Cohort 1 - 6||3
10462904|NCT01037309|11610762|FG005|STARTED|Subcutaneous Cohort 1 - 6||3
10462905|NCT01037309|11610763|FG006|STARTED|Subcutaneous Cohort 1 - 6||0
10462906|NCT01037309|11610764|FG007|STARTED|Subcutaneous Cohort 1 - 6||0
10462907|NCT01037309|11610765|FG008|STARTED|Subcutaneous Cohort 1 - 6||0
10462908|NCT01037309|11610757|FG000|COMPLETED|Subcutaneous Cohort 1 - 6||3
10462909|NCT01037309|11610758|FG001|COMPLETED|Subcutaneous Cohort 1 - 6||3
10462910|NCT01037309|11610759|FG002|COMPLETED|Subcutaneous Cohort 1 - 6||3
10462911|NCT01037309|11610760|FG003|COMPLETED|Subcutaneous Cohort 1 - 6||3
10462912|NCT01037309|11610761|FG004|COMPLETED|Subcutaneous Cohort 1 - 6||3
10462913|NCT01037309|11610762|FG005|COMPLETED|Subcutaneous Cohort 1 - 6||3
10462914|NCT01037309|11610763|FG006|COMPLETED|Subcutaneous Cohort 1 - 6||0
10462915|NCT01037309|11610764|FG007|COMPLETED|Subcutaneous Cohort 1 - 6||0
10462916|NCT01037309|11610765|FG008|COMPLETED|Subcutaneous Cohort 1 - 6||0
10462917|NCT01037309|11610757|FG000|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
10462918|NCT01037309|11610758|FG001|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
10462919|NCT01037309|11610759|FG002|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
10462920|NCT01037309|11610760|FG003|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
10462921|NCT01037309|11610761|FG004|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
10462922|NCT01037309|11610762|FG005|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
10462923|NCT01037309|11610763|FG006|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
10462924|NCT01037309|11610764|FG007|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
10462925|NCT01037309|11610765|FG008|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
10462926|NCT01037309|11610757|FG000|STARTED|Intravenous Period 7 - 9||0
10462927|NCT01037309|11610758|FG001|STARTED|Intravenous Period 7 - 9||0
10462928|NCT01037309|11610759|FG002|STARTED|Intravenous Period 7 - 9||0
10462929|NCT01037309|11610760|FG003|STARTED|Intravenous Period 7 - 9||0
10462930|NCT01037309|11610761|FG004|STARTED|Intravenous Period 7 - 9||0
10462931|NCT01037309|11610762|FG005|STARTED|Intravenous Period 7 - 9||0
10462932|NCT01037309|11610763|FG006|STARTED|Intravenous Period 7 - 9||3
10462933|NCT01037309|11610764|FG007|STARTED|Intravenous Period 7 - 9||3
10462934|NCT01037309|11610765|FG008|STARTED|Intravenous Period 7 - 9||3
10462935|NCT01037309|11610757|FG000|COMPLETED|Intravenous Period 7 - 9||0
10462936|NCT01037309|11610758|FG001|COMPLETED|Intravenous Period 7 - 9||0
10462937|NCT01037309|11610759|FG002|COMPLETED|Intravenous Period 7 - 9||0
10462938|NCT01037309|11610760|FG003|COMPLETED|Intravenous Period 7 - 9||0
10462939|NCT01037309|11610761|FG004|COMPLETED|Intravenous Period 7 - 9||0
10462940|NCT01037309|11610762|FG005|COMPLETED|Intravenous Period 7 - 9||0
10462941|NCT01037309|11610763|FG006|COMPLETED|Intravenous Period 7 - 9||3
10462942|NCT01037309|11610764|FG007|COMPLETED|Intravenous Period 7 - 9||3
10462943|NCT01037309|11610765|FG008|COMPLETED|Intravenous Period 7 - 9||3
10462944|NCT01037309|11610757|FG000|NOT COMPLETED|Intravenous Period 7 - 9||0
10462945|NCT01037309|11610758|FG001|NOT COMPLETED|Intravenous Period 7 - 9||0
10462946|NCT01037309|11610759|FG002|NOT COMPLETED|Intravenous Period 7 - 9||0
10462947|NCT01037309|11610760|FG003|NOT COMPLETED|Intravenous Period 7 - 9||0
10462948|NCT01037309|11610761|FG004|NOT COMPLETED|Intravenous Period 7 - 9||0
10462949|NCT01037309|11610762|FG005|NOT COMPLETED|Intravenous Period 7 - 9||0
10462950|NCT01037309|11610763|FG006|NOT COMPLETED|Intravenous Period 7 - 9||0
10462951|NCT01037309|11610764|FG007|NOT COMPLETED|Intravenous Period 7 - 9||0
10462952|NCT01037309|11610765|FG008|NOT COMPLETED|Intravenous Period 7 - 9||0
10462953|NCT01037413|11610788|FG000|STARTED|Part A: Skin Testing||25
10462954|NCT01037413|11610789|FG001|STARTED|Part A: Skin Testing||0
10462955|NCT01037413|11610788|FG000|COMPLETED|Part A: Skin Testing||23
10462956|NCT01037413|11610789|FG001|COMPLETED|Part A: Skin Testing||0
10462957|NCT01037413|11610788|FG000|NOT COMPLETED|Part A: Skin Testing||2
10462958|NCT01037413|11610789|FG001|NOT COMPLETED|Part A: Skin Testing||0
10462959|NCT01037413|11610788|FG000|STARTED|Part B: Scar Revision|Participants who tested negative for skin sensitization proceeded to Part B of the study. .|0
10462960|NCT01037413|11610789|FG001|STARTED|Part B: Scar Revision|Participants who completed Part A of the study and were negative for skin sensitization.|23
10462961|NCT01037413|11610788|FG000|Treated|Part B: Scar Revision||0
10462962|NCT01037413|11610789|FG001|Treated|Part B: Scar Revision||22
10462963|NCT01037413|11610788|FG000|COMPLETED|Part B: Scar Revision||0
10462964|NCT01037413|11610789|FG001|COMPLETED|Part B: Scar Revision||21
10462965|NCT01037413|11610788|FG000|NOT COMPLETED|Part B: Scar Revision||0
10462966|NCT01037413|11610789|FG001|NOT COMPLETED|Part B: Scar Revision||2
10462967|NCT01037452|11610806|FG000|STARTED|Overall Study||30
10462968|NCT01037452|11610807|FG001|STARTED|Overall Study||30
10462969|NCT01037452|11610808|FG002|STARTED|Overall Study||30
10462970|NCT01037452|11610809|FG003|STARTED|Overall Study||30
10462971|NCT01037452|11610806|FG000|COMPLETED|Overall Study||30
10462972|NCT01037452|11610807|FG001|COMPLETED|Overall Study||30
10462973|NCT01037452|11610808|FG002|COMPLETED|Overall Study||30
10462974|NCT01037452|11610809|FG003|COMPLETED|Overall Study||30
10462975|NCT01037452|11610806|FG000|NOT COMPLETED|Overall Study||0
10462976|NCT01037452|11610807|FG001|NOT COMPLETED|Overall Study||0
10462977|NCT01037452|11610808|FG002|NOT COMPLETED|Overall Study||0
10462978|NCT01037452|11610809|FG003|NOT COMPLETED|Overall Study||0
10462979|NCT01037790|11610824|FG000|STARTED|Overall Study||63
10462980|NCT01037790|11610825|FG001|STARTED|Overall Study||18
10462981|NCT01037790|11610826|FG002|STARTED|Overall Study||19
10462982|NCT01037790|11610827|FG003|STARTED|Overall Study||30
10462983|NCT01037790|11610828|FG004|STARTED|Overall Study||11
10462984|NCT01037790|11610824|FG000|COMPLETED|Overall Study||63
10462985|NCT01037790|11610825|FG001|COMPLETED|Overall Study||18
10462986|NCT01037790|11610826|FG002|COMPLETED|Overall Study||19
10462987|NCT01037790|11610827|FG003|COMPLETED|Overall Study||30
10462988|NCT01037790|11610828|FG004|COMPLETED|Overall Study||11
10462989|NCT01037790|11610824|FG000|NOT COMPLETED|Overall Study||0
10462990|NCT01037790|11610825|FG001|NOT COMPLETED|Overall Study||0
10462991|NCT01037790|11610826|FG002|NOT COMPLETED|Overall Study||0
10462992|NCT01037790|11610827|FG003|NOT COMPLETED|Overall Study||0
10462993|NCT01037790|11610828|FG004|NOT COMPLETED|Overall Study||0
10462994|NCT01037881|11610847|FG000|STARTED|Overall Study||25
10462995|NCT01037881|11610848|FG001|STARTED|Overall Study||24
10462996|NCT01037881|11610849|FG002|STARTED|Overall Study||25
10462997|NCT01037881|11610850|FG003|STARTED|Overall Study||25
10462998|NCT01037881|11610851|FG004|STARTED|Overall Study||29
10462999|NCT01037881|11610852|FG005|STARTED|Overall Study||30
10463000|NCT01037881|11610853|FG006|STARTED|Overall Study||25
10463001|NCT01037881|11610847|FG000|COMPLETED|Overall Study||19
10463002|NCT01037881|11610848|FG001|COMPLETED|Overall Study||22
10463003|NCT01037881|11610849|FG002|COMPLETED|Overall Study||22
10463004|NCT01037881|11610850|FG003|COMPLETED|Overall Study||24
10463005|NCT01037881|11610851|FG004|COMPLETED|Overall Study||26
10463006|NCT01037881|11610852|FG005|COMPLETED|Overall Study||27
10463007|NCT01037881|11610853|FG006|COMPLETED|Overall Study||23
10463008|NCT01037881|11610847|FG000|NOT COMPLETED|Overall Study||6
10463009|NCT01037881|11610848|FG001|NOT COMPLETED|Overall Study||2
10463010|NCT01037881|11610849|FG002|NOT COMPLETED|Overall Study||3
10463011|NCT01037881|11610850|FG003|NOT COMPLETED|Overall Study||1
10463012|NCT01037881|11610851|FG004|NOT COMPLETED|Overall Study||3
10463013|NCT01037881|11610852|FG005|NOT COMPLETED|Overall Study||3
10463014|NCT01037881|11610853|FG006|NOT COMPLETED|Overall Study||2
10463015|NCT01037985|11610878|FG000|STARTED|Part A: Skin Testing (50 Days)||41
10463016|NCT01037985|11610879|FG001|STARTED|Part A: Skin Testing (50 Days)||0
10463017|NCT01037985|11610878|FG000|COMPLETED|Part A: Skin Testing (50 Days)||37
10463018|NCT01037985|11610879|FG001|COMPLETED|Part A: Skin Testing (50 Days)||0
10463019|NCT01037985|11610878|FG000|NOT COMPLETED|Part A: Skin Testing (50 Days)||4
10463020|NCT01037985|11610879|FG001|NOT COMPLETED|Part A: Skin Testing (50 Days)||0
10463021|NCT01037985|11610878|FG000|STARTED|Part B:Abdominoplasty Surgery (24 Weeks)|Participants who tested negative for skin sensitization proceeded to Part B of the study. .|0
10463022|NCT01037985|11610879|FG001|STARTED|Part B:Abdominoplasty Surgery (24 Weeks)|Participants who completed Part A of the study and were negative for skin sensitization.|37
10463023|NCT01037985|11610878|FG000|Treated|Part B:Abdominoplasty Surgery (24 Weeks)||0
10463024|NCT01037985|11610879|FG001|Treated|Part B:Abdominoplasty Surgery (24 Weeks)||33
10463025|NCT01037985|11610878|FG000|COMPLETED|Part B:Abdominoplasty Surgery (24 Weeks)||0
10463026|NCT01037985|11610879|FG001|COMPLETED|Part B:Abdominoplasty Surgery (24 Weeks)||32
10463027|NCT01037985|11610878|FG000|NOT COMPLETED|Part B:Abdominoplasty Surgery (24 Weeks)||0
10463028|NCT01037985|11610879|FG001|NOT COMPLETED|Part B:Abdominoplasty Surgery (24 Weeks)||5
10463029|NCT01038128|11610889|FG000|STARTED|Overall Study||5
10463030|NCT01038128|11610889|FG000|Baseline Visit|Overall Study||3
10463031|NCT01038128|11610889|FG000|COMPLETED|Overall Study||1
10463032|NCT01038128|11610889|FG000|NOT COMPLETED|Overall Study||4
10463033|NCT01038297|11610898|FG000|STARTED|Part A: Skin Testing Phase (50 Days)||10
10463034|NCT01038297|11610899|FG001|STARTED|Part A: Skin Testing Phase (50 Days)||10
10463035|NCT01038297|11610900|FG002|STARTED|Part A: Skin Testing Phase (50 Days)||10
10463036|NCT01038297|11610898|FG000|COMPLETED|Part A: Skin Testing Phase (50 Days)||9
10463037|NCT01038297|11610899|FG001|COMPLETED|Part A: Skin Testing Phase (50 Days)||10
10463038|NCT01038297|11610900|FG002|COMPLETED|Part A: Skin Testing Phase (50 Days)||10
10463039|NCT01038297|11610898|FG000|NOT COMPLETED|Part A: Skin Testing Phase (50 Days)||1
10463040|NCT01038297|11610899|FG001|NOT COMPLETED|Part A: Skin Testing Phase (50 Days)||0
10463041|NCT01038297|11610900|FG002|NOT COMPLETED|Part A: Skin Testing Phase (50 Days)||0
10463042|NCT01038297|11610898|FG000|STARTED|Part B: Active Dosing Phase (13 Weeks)||9
10463043|NCT01038297|11610899|FG001|STARTED|Part B: Active Dosing Phase (13 Weeks)||10
10463044|NCT01038297|11610900|FG002|STARTED|Part B: Active Dosing Phase (13 Weeks)||10
10463045|NCT01038297|11610898|FG000|COMPLETED|Part B: Active Dosing Phase (13 Weeks)||9
10463046|NCT01038297|11610899|FG001|COMPLETED|Part B: Active Dosing Phase (13 Weeks)||10
10463047|NCT01038297|11610900|FG002|COMPLETED|Part B: Active Dosing Phase (13 Weeks)||10
10463048|NCT01038297|11610898|FG000|NOT COMPLETED|Part B: Active Dosing Phase (13 Weeks)||0
10463049|NCT01038297|11610899|FG001|NOT COMPLETED|Part B: Active Dosing Phase (13 Weeks)||0
10463050|NCT01038297|11610900|FG002|NOT COMPLETED|Part B: Active Dosing Phase (13 Weeks)||0
10463051|NCT01038323|11610920|FG000|STARTED|Overall Study||20
10463052|NCT01038323|11610921|FG001|STARTED|Overall Study||19
10463053|NCT01038323|11610922|FG002|STARTED|Overall Study||19
10463054|NCT01038323|11610920|FG000|COMPLETED|Overall Study||17
10463055|NCT01038323|11610921|FG001|COMPLETED|Overall Study||17
10463056|NCT01038323|11610922|FG002|COMPLETED|Overall Study||15
10463057|NCT01038323|11610920|FG000|NOT COMPLETED|Overall Study||3
10463058|NCT01038323|11610921|FG001|NOT COMPLETED|Overall Study||2
10463059|NCT01038323|11610922|FG002|NOT COMPLETED|Overall Study||4
10463060|NCT01038336|11610933|FG000|STARTED|Overall Study||43
10463061|NCT01038336|11610934|FG001|STARTED|Overall Study||42
10463062|NCT01038336|11610935|FG002|STARTED|Overall Study||44
10463063|NCT01038336|11610933|FG000|COMPLETED|Overall Study||43
10463064|NCT01038336|11610934|FG001|COMPLETED|Overall Study||42
10463065|NCT01038336|11610935|FG002|COMPLETED|Overall Study||44
10463066|NCT01038336|11610933|FG000|NOT COMPLETED|Overall Study||0
10463067|NCT01038336|11610934|FG001|NOT COMPLETED|Overall Study||0
10463068|NCT01038336|11610935|FG002|NOT COMPLETED|Overall Study||0
10463069|NCT01038427|11610951|FG000|STARTED|Overall Study||317
10463070|NCT01038427|11610952|FG001|STARTED|Overall Study||320
10463071|NCT01038427|11610953|FG002|STARTED|Overall Study||158
10463072|NCT01038427|11610951|FG000|Per-Protocol (PPP) Population|Overall Study||306
10463073|NCT01038427|11610952|FG001|Per-Protocol (PPP) Population|Overall Study||307
10463074|NCT01038427|11610953|FG002|Per-Protocol (PPP) Population|Overall Study||150
10463075|NCT01038427|11610951|FG000|Intent-to-Treat (ITT) Population|Overall Study||314
10463076|NCT01038427|11610952|FG001|Intent-to-Treat (ITT) Population|Overall Study||314
10463077|NCT01038427|11610953|FG002|Intent-to-Treat (ITT) Population|Overall Study||156
10463078|NCT01038427|11610951|FG000|COMPLETED|Overall Study||314
10463079|NCT01038427|11610952|FG001|COMPLETED|Overall Study||314
10463080|NCT01038427|11610953|FG002|COMPLETED|Overall Study||154
10463081|NCT01038427|11610951|FG000|NOT COMPLETED|Overall Study||3
10463082|NCT01038427|11610952|FG001|NOT COMPLETED|Overall Study||6
10463083|NCT01038427|11610953|FG002|NOT COMPLETED|Overall Study||4
10463084|NCT01038557|11610964|FG000|STARTED|Overall Study||82
10463085|NCT01038557|11610965|FG001|STARTED|Overall Study||86
10463086|NCT01038557|11610966|FG002|STARTED|Overall Study||86
10463087|NCT01038557|11610964|FG000|COMPLETED|Overall Study||82
10463088|NCT01038557|11610965|FG001|COMPLETED|Overall Study||86
10463089|NCT01038557|11610966|FG002|COMPLETED|Overall Study||86
10463090|NCT01038557|11610964|FG000|NOT COMPLETED|Overall Study||0
10463091|NCT01038557|11610965|FG001|NOT COMPLETED|Overall Study||0
10463092|NCT01038557|11610966|FG002|NOT COMPLETED|Overall Study||0
10463093|NCT01038609|11610979|FG000|STARTED|Overall Study||50
10463094|NCT01038609|11610980|FG001|STARTED|Overall Study||52
10463095|NCT01038609|11610981|FG002|STARTED|Overall Study||49
10463096|NCT01038609|11610982|FG003|STARTED|Overall Study||48
10463097|NCT01038609|11610983|FG004|STARTED|Overall Study||51
10463098|NCT01038609|11610979|FG000|COMPLETED|Overall Study||49
10463099|NCT01038609|11610980|FG001|COMPLETED|Overall Study||51
10463100|NCT01038609|11610981|FG002|COMPLETED|Overall Study||48
10463101|NCT01038609|11610982|FG003|COMPLETED|Overall Study||47
10463102|NCT01038609|11610983|FG004|COMPLETED|Overall Study||50
10463103|NCT01038609|11610979|FG000|NOT COMPLETED|Overall Study||1
10463104|NCT01038609|11610980|FG001|NOT COMPLETED|Overall Study||1
10463105|NCT01038609|11610981|FG002|NOT COMPLETED|Overall Study||1
10463106|NCT01038609|11610982|FG003|NOT COMPLETED|Overall Study||1
10463107|NCT01038609|11610983|FG004|NOT COMPLETED|Overall Study||1
10463108|NCT01038635|11611004|FG000|STARTED|Overall Study||5
10463109|NCT01038635|11611005|FG001|STARTED|Overall Study||3
10463110|NCT01038635|11611006|FG002|STARTED|Overall Study||3
10463111|NCT01038635|11611007|FG003|STARTED|Overall Study||3
10463112|NCT01038635|11611008|FG004|STARTED|Overall Study||4
10463113|NCT01038635|11611009|FG005|STARTED|Overall Study||3
10463114|NCT01038635|11611010|FG006|STARTED|Overall Study||7
10463115|NCT01038635|11611011|FG007|STARTED|Overall Study||20
10463116|NCT01038635|11611012|FG008|STARTED|Overall Study||40
10463117|NCT01038635|11611004|FG000|COMPLETED|Overall Study||3
10463118|NCT01038635|11611005|FG001|COMPLETED|Overall Study||3
10463119|NCT01038635|11611006|FG002|COMPLETED|Overall Study||3
10463120|NCT01038635|11611007|FG003|COMPLETED|Overall Study||3
10463121|NCT01038635|11611008|FG004|COMPLETED|Overall Study||3
10463122|NCT01038635|11611009|FG005|COMPLETED|Overall Study||3
10463123|NCT01038635|11611010|FG006|COMPLETED|Overall Study||5
10463124|NCT01038635|11611011|FG007|COMPLETED|Overall Study||15
10463125|NCT01038635|11611012|FG008|COMPLETED|Overall Study||38
10463126|NCT01038635|11611004|FG000|NOT COMPLETED|Overall Study||2
10463127|NCT01038635|11611005|FG001|NOT COMPLETED|Overall Study||0
10463128|NCT01038635|11611006|FG002|NOT COMPLETED|Overall Study||0
10463129|NCT01038635|11611007|FG003|NOT COMPLETED|Overall Study||0
10463130|NCT01038635|11611008|FG004|NOT COMPLETED|Overall Study||1
10463131|NCT01038635|11611009|FG005|NOT COMPLETED|Overall Study||0
10463132|NCT01038635|11611010|FG006|NOT COMPLETED|Overall Study||2
10463133|NCT01038635|11611011|FG007|NOT COMPLETED|Overall Study||5
10463134|NCT01038635|11611012|FG008|NOT COMPLETED|Overall Study||2
10463135|NCT01038687|11611036|FG000|STARTED|Overall Study||12
10463136|NCT01038687|11611037|FG001|STARTED|Overall Study||11
10463137|NCT01038687|11611038|FG002|STARTED|Overall Study||13
10463138|NCT01038687|11611036|FG000|COMPLETED|Overall Study||12
10463139|NCT01038687|11611037|FG001|COMPLETED|Overall Study||9
10463140|NCT01038687|11611038|FG002|COMPLETED|Overall Study||12
10463141|NCT01038687|11611036|FG000|NOT COMPLETED|Overall Study||0
10463142|NCT01038687|11611037|FG001|NOT COMPLETED|Overall Study||2
10463143|NCT01038687|11611038|FG002|NOT COMPLETED|Overall Study||1
10463144|NCT01038713|11611049|FG000|STARTED|Overall Study||26
10463145|NCT01038713|11611050|FG001|STARTED|Overall Study||20
10463146|NCT01038713|11611051|FG002|STARTED|Overall Study||17
10463147|NCT01038713|11611049|FG000|COMPLETED|Overall Study||21
10463148|NCT01038713|11611050|FG001|COMPLETED|Overall Study||17
10463149|NCT01038713|11611051|FG002|COMPLETED|Overall Study||16
10463150|NCT01038713|11611049|FG000|NOT COMPLETED|Overall Study||5
10463151|NCT01038713|11611050|FG001|NOT COMPLETED|Overall Study||3
10463152|NCT01038713|11611051|FG002|NOT COMPLETED|Overall Study||1
10463153|NCT01038856|11611059|FG000|STARTED|Overall Study||5
10463154|NCT01038856|11611059|FG000|COMPLETED|Overall Study||3
10463155|NCT01038856|11611059|FG000|NOT COMPLETED|Overall Study||2
10463156|NCT01038869|11611065|FG000|STARTED|Overall Study||20
10463157|NCT01038869|11611065|FG000|COMPLETED|Overall Study||13
10463158|NCT01038869|11611065|FG000|NOT COMPLETED|Overall Study||7
10463159|NCT01038921|11611075|FG000|STARTED|Overall Study|19 subjects received melatonin first(10 weeks), washout (6 weeks), placebo second (10 weeks)|19
10463160|NCT01038921|11611076|FG001|STARTED|Overall Study|20 subjects received placebo first (10 weeks), washout (6 weeks), melatonin second ( 10 weeks)|20
10463161|NCT01038921|11611075|FG000|COMPLETED|Overall Study|2 subjects withdrew|17
10463162|NCT01038921|11611076|FG001|COMPLETED|Overall Study||20
10463163|NCT01038921|11611075|FG000|NOT COMPLETED|Overall Study||2
10463164|NCT01038921|11611076|FG001|NOT COMPLETED|Overall Study||0
10463165|NCT01039207|11611082|FG000|STARTED|Overall Study||31
10463166|NCT01039207|11611082|FG000|COMPLETED|Overall Study||31
10463167|NCT01039207|11611082|FG000|NOT COMPLETED|Overall Study||0
10463168|NCT01039376|11611088|FG000|STARTED|Overall Study||240
10463169|NCT01039376|11611089|FG001|STARTED|Overall Study||240
10463170|NCT01039376|11611088|FG000|COMPLETED|Overall Study||110
10463171|NCT01039376|11611089|FG001|COMPLETED|Overall Study||114
10463172|NCT01039376|11611088|FG000|NOT COMPLETED|Overall Study||130
10463173|NCT01039376|11611089|FG001|NOT COMPLETED|Overall Study||126
10463174|NCT01039428|11611098|FG000|STARTED|Overall Study||35
10463175|NCT01039428|11611099|FG001|STARTED|Overall Study||28
10463176|NCT01039428|11611098|FG000|COMPLETED|Overall Study||33
10463177|NCT01039428|11611099|FG001|COMPLETED|Overall Study||28
10463178|NCT01039428|11611098|FG000|NOT COMPLETED|Overall Study||2
10463179|NCT01039428|11611099|FG001|NOT COMPLETED|Overall Study||0
10463180|NCT01039467|11611107|FG000|STARTED|Overall Study||196
10463181|NCT01039467|11611108|FG001|STARTED|Overall Study||189
10463182|NCT01039467|11611107|FG000|COMPLETED|Overall Study||156
10463183|NCT01039467|11611108|FG001|COMPLETED|Overall Study||140
10463184|NCT01039467|11611107|FG000|NOT COMPLETED|Overall Study||40
10463185|NCT01039467|11611108|FG001|NOT COMPLETED|Overall Study||49
10463186|NCT01039519|11611116|FG000|STARTED|Treatment||27
10463187|NCT01039519|11611116|FG000|COMPLETED|Treatment|Reason not completed represents reason for terminating treatment.|0
10463188|NCT01039519|11611116|FG000|NOT COMPLETED|Treatment||27
10463189|NCT01039519|11611116|FG000|STARTED|Survival Follow-up||27
10463190|NCT01039519|11611116|FG000|COMPLETED|Survival Follow-up||0
10463191|NCT01039519|11611116|FG000|NOT COMPLETED|Survival Follow-up||27
10463192|NCT01039584|11611123|FG000|STARTED|Overall Study||246
10463193|NCT01039584|11611124|FG001|STARTED|Overall Study||243
10463194|NCT01039584|11611125|FG002|STARTED|Overall Study||122
10463195|NCT01039584|11611123|FG000|COMPLETED|Overall Study||143
10463196|NCT01039584|11611124|FG001|COMPLETED|Overall Study||146
10463197|NCT01039584|11611125|FG002|COMPLETED|Overall Study||65
10463198|NCT01039584|11611123|FG000|NOT COMPLETED|Overall Study||103
10463199|NCT01039584|11611124|FG001|NOT COMPLETED|Overall Study||97
10463200|NCT01039584|11611125|FG002|NOT COMPLETED|Overall Study||57
10463201|NCT01039675|11611135|FG000|STARTED|Overall Study||9
10463202|NCT01039675|11611136|FG001|STARTED|Overall Study||42
10463203|NCT01039675|11611135|FG000|COMPLETED|Overall Study||9
10463204|NCT01039675|11611136|FG001|COMPLETED|Overall Study||35
10463205|NCT01039675|11611135|FG000|NOT COMPLETED|Overall Study||0
10463206|NCT01039675|11611136|FG001|NOT COMPLETED|Overall Study||7
10463207|NCT01039688|11611145|FG000|STARTED|Overall Study||373
10463208|NCT01039688|11611146|FG001|STARTED|Overall Study||397
10463209|NCT01039688|11611147|FG002|STARTED|Overall Study||186
10463210|NCT01039688|11611145|FG000|COMPLETED|Overall Study||266
10463211|NCT01039688|11611146|FG001|COMPLETED|Overall Study||286
10463212|NCT01039688|11611147|FG002|COMPLETED|Overall Study||106
10463213|NCT01039688|11611145|FG000|NOT COMPLETED|Overall Study||107
10463214|NCT01039688|11611146|FG001|NOT COMPLETED|Overall Study||111
10463215|NCT01039688|11611147|FG002|NOT COMPLETED|Overall Study||80
10463216|NCT01039792|11611160|FG000|STARTED|Overall Study||29
10463217|NCT01039792|11611161|FG001|STARTED|Overall Study||28
10463218|NCT01039792|11611160|FG000|COMPLETED|Overall Study||23
10463219|NCT01039792|11611161|FG001|COMPLETED|Overall Study||27
10463220|NCT01039792|11611160|FG000|NOT COMPLETED|Overall Study||6
10463221|NCT01039792|11611161|FG001|NOT COMPLETED|Overall Study||1
10463222|NCT01040052|11611167|FG000|STARTED|Overall Study||30
10463223|NCT01040052|11611167|FG000|COMPLETED|Overall Study||30
10463224|NCT01040052|11611167|FG000|NOT COMPLETED|Overall Study||0
10463225|NCT01040130|11611171|FG000|STARTED|Overall Study|Number of patients entered and treated|25
10463226|NCT01040130|11611172|FG001|STARTED|Overall Study||25
10463227|NCT01040130|11611173|FG002|STARTED|Overall Study||25
10463228|NCT01040130|11611174|FG003|STARTED|Overall Study||25
10463229|NCT01040130|11611175|FG004|STARTED|Overall Study||25
10463230|NCT01040130|11611176|FG005|STARTED|Overall Study||26
10463231|NCT01040130|11611171|FG000|COMPLETED|Overall Study|Number of patients who did not discontinue from the trial.|22
10463232|NCT01040130|11611172|FG001|COMPLETED|Overall Study||22
10463233|NCT01040130|11611173|FG002|COMPLETED|Overall Study||23
10463234|NCT01040130|11611174|FG003|COMPLETED|Overall Study||20
10463235|NCT01040130|11611175|FG004|COMPLETED|Overall Study||25
10463236|NCT01040130|11611176|FG005|COMPLETED|Overall Study||22
10463237|NCT01040130|11611171|FG000|NOT COMPLETED|Overall Study||3
10463238|NCT01040130|11611172|FG001|NOT COMPLETED|Overall Study||3
10463239|NCT01040130|11611173|FG002|NOT COMPLETED|Overall Study||2
10463240|NCT01040130|11611174|FG003|NOT COMPLETED|Overall Study||5
10463241|NCT01040130|11611175|FG004|NOT COMPLETED|Overall Study||0
10463242|NCT01040130|11611176|FG005|NOT COMPLETED|Overall Study||4
10463243|NCT01040169|11611188|FG000|STARTED|Overall Study||35
10463244|NCT01040169|11611189|FG001|STARTED|Overall Study||44
10463245|NCT01040169|11611188|FG000|COMPLETED|Overall Study||32
10463246|NCT01040169|11611189|FG001|COMPLETED|Overall Study||36
10463247|NCT01040169|11611188|FG000|NOT COMPLETED|Overall Study||3
10463248|NCT01040169|11611189|FG001|NOT COMPLETED|Overall Study||8
10463249|NCT01040208|11611198|FG000|STARTED|Overall Study||45
10463250|NCT01040208|11611199|FG001|STARTED|Overall Study||28
10463251|NCT01040208|11611200|FG002|STARTED|Overall Study||38
10463252|NCT01040208|11611198|FG000|COMPLETED|Overall Study||39
10463253|NCT01040208|11611199|FG001|COMPLETED|Overall Study||15
10463254|NCT01040208|11611200|FG002|COMPLETED|Overall Study||35
10463255|NCT01040208|11611198|FG000|NOT COMPLETED|Overall Study||6
10463256|NCT01040208|11611199|FG001|NOT COMPLETED|Overall Study||13
10463257|NCT01040208|11611200|FG002|NOT COMPLETED|Overall Study||3
10526402|NCT01380899|11678224|FG000|NOT COMPLETED|Overall Study||0
10526403|NCT01380899|11678225|FG001|NOT COMPLETED|Overall Study||0
10526404|NCT01380899|11678226|FG002|NOT COMPLETED|Overall Study||0
10526405|NCT01380990|11678236|FG000|STARTED|Overall Study||20
10526406|NCT01380990|11678237|FG001|STARTED|Overall Study||16
10526407|NCT01380990|11678236|FG000|COMPLETED|Overall Study||19
10526408|NCT01380990|11678237|FG001|COMPLETED|Overall Study||15
10526409|NCT01380990|11678236|FG000|NOT COMPLETED|Overall Study||1
10526410|NCT01380990|11678237|FG001|NOT COMPLETED|Overall Study||1
10526411|NCT01381016|11678249|FG000|STARTED|Overall Study||13
10526412|NCT01381016|11678250|FG001|STARTED|Overall Study||17
10526413|NCT01381016|11678249|FG000|COMPLETED|Overall Study||10
10526414|NCT01381016|11678250|FG001|COMPLETED|Overall Study||11
10526415|NCT01381016|11678249|FG000|NOT COMPLETED|Overall Study||3
10526416|NCT01381016|11678250|FG001|NOT COMPLETED|Overall Study||6
10526417|NCT01381068|11678260|FG000|STARTED|Overall Study||25
10526418|NCT01381068|11678261|FG001|STARTED|Overall Study||24
10526419|NCT01381068|11678260|FG000|COMPLETED|Overall Study||24
10526420|NCT01381068|11678261|FG001|COMPLETED|Overall Study||24
10526421|NCT01381068|11678260|FG000|NOT COMPLETED|Overall Study||1
10526422|NCT01381068|11678261|FG001|NOT COMPLETED|Overall Study||0
10526423|NCT01381120|11678269|FG000|STARTED|Overall Study||50
10526424|NCT01381120|11678270|FG001|STARTED|Overall Study||27
10526425|NCT01381120|11678269|FG000|COMPLETED|Overall Study||39
10526426|NCT01381120|11678270|FG001|COMPLETED|Overall Study||18
10526427|NCT01381120|11678269|FG000|NOT COMPLETED|Overall Study||11
10526428|NCT01381120|11678270|FG001|NOT COMPLETED|Overall Study||9
10526429|NCT01381172|11678278|FG000|STARTED|Overall Study||74
10526430|NCT01381172|11678279|FG001|STARTED|Overall Study||86
10526431|NCT01381172|11678278|FG000|COMPLETED|Overall Study||64
10526432|NCT01381172|11678279|FG001|COMPLETED|Overall Study||73
10526433|NCT01381172|11678278|FG000|NOT COMPLETED|Overall Study||10
10526434|NCT01381172|11678279|FG001|NOT COMPLETED|Overall Study||13
10526435|NCT01381406|11678287|FG000|STARTED|Overall Study||2481
10526436|NCT01381406|11678288|FG001|STARTED|Overall Study||852
10526437|NCT01381406|11678287|FG000|COMPLETED|Overall Study||2481
10526438|NCT01381406|11678288|FG001|COMPLETED|Overall Study||852
10526439|NCT01381406|11678287|FG000|NOT COMPLETED|Overall Study||0
10526440|NCT01381406|11678288|FG001|NOT COMPLETED|Overall Study||0
10526441|NCT01381471|11678294|FG000|STARTED|Overall Study||11060
10526442|NCT01381471|11678294|FG000|COMPLETED|Overall Study||11060
10526443|NCT01381471|11678294|FG000|NOT COMPLETED|Overall Study||0
10526444|NCT01381549|11678301|FG000|STARTED|Overall Study||6
10526445|NCT01381549|11678302|FG001|STARTED|Overall Study||8
10526446|NCT01381549|11678303|FG002|STARTED|Overall Study||6
10526447|NCT01381549|11678301|FG000|COMPLETED|Overall Study||6
10526448|NCT01381549|11678302|FG001|COMPLETED|Overall Study||8
10526449|NCT01381549|11678303|FG002|COMPLETED|Overall Study||5
10526450|NCT01381549|11678301|FG000|NOT COMPLETED|Overall Study||0
10526451|NCT01381549|11678302|FG001|NOT COMPLETED|Overall Study||0
10526452|NCT01381549|11678303|FG002|NOT COMPLETED|Overall Study||1
10526453|NCT01381562|11678315|FG000|STARTED|Overall Study||5
10526454|NCT01381562|11678316|FG001|STARTED|Overall Study||4
10526455|NCT01381562|11678317|FG002|STARTED|Overall Study||5
10526456|NCT01381562|11678315|FG000|COMPLETED|Overall Study||5
10526457|NCT01381562|11678316|FG001|COMPLETED|Overall Study||3
10526458|NCT01381562|11678317|FG002|COMPLETED|Overall Study||5
10526459|NCT01381562|11678315|FG000|NOT COMPLETED|Overall Study||0
10526460|NCT01381562|11678316|FG001|NOT COMPLETED|Overall Study||1
10526461|NCT01381562|11678317|FG002|NOT COMPLETED|Overall Study||0
10526462|NCT01381575|11678328|FG000|STARTED|Overall Study||550
10526463|NCT01381575|11678329|FG001|STARTED|Overall Study||482
10526464|NCT01381575|11678330|FG002|STARTED|Overall Study||415
10526465|NCT01381575|11678328|FG000|COMPLETED|Overall Study||524
10526466|NCT01381575|11678329|FG001|COMPLETED|Overall Study||443
10526467|NCT01381575|11678330|FG002|COMPLETED|Overall Study||395
10526468|NCT01381575|11678328|FG000|NOT COMPLETED|Overall Study||26
10526469|NCT01381575|11678329|FG001|NOT COMPLETED|Overall Study||39
10526470|NCT01381575|11678330|FG002|NOT COMPLETED|Overall Study||20
10526471|NCT01381692|11678341|FG000|STARTED|Overall Study||7
10526472|NCT01381692|11678342|FG001|STARTED|Overall Study||2
10526473|NCT01381692|11678343|FG002|STARTED|Overall Study||0
10526474|NCT01381692|11678344|FG003|STARTED|Overall Study||0
10526475|NCT01381692|11678345|FG004|STARTED|Overall Study||0
10526476|NCT01381692|11678346|FG005|STARTED|Overall Study||0
10463258|NCT01040260|11611215|FG000|STARTED|Overall Study||53
10463259|NCT01040260|11611216|FG001|STARTED|Overall Study||50
10463260|NCT01040260|11611215|FG000|COMPLETED|Overall Study||38
10463261|NCT01040260|11611216|FG001|COMPLETED|Overall Study||39
10463262|NCT01040260|11611215|FG000|NOT COMPLETED|Overall Study||15
10463263|NCT01040260|11611216|FG001|NOT COMPLETED|Overall Study||11
10463264|NCT01040351|11611224|FG000|STARTED|Overall Study|October 2006|55
10463265|NCT01040351|11611225|FG001|STARTED|Overall Study|October 2006|55
10463266|NCT01040351|11611224|FG000|COMPLETED|Overall Study|May 2010|54
10463267|NCT01040351|11611225|FG001|COMPLETED|Overall Study|May 2010|53
10463268|NCT01040351|11611224|FG000|NOT COMPLETED|Overall Study||1
10463269|NCT01040351|11611225|FG001|NOT COMPLETED|Overall Study||2
10463270|NCT01040403|11611231|FG000|STARTED|Overall Study||233
10463271|NCT01040403|11611231|FG000|Completed Olo 5|Overall Study||106
10463272|NCT01040403|11611231|FG000|Completed T+O 1.25/5|Overall Study||105
10463273|NCT01040403|11611231|FG000|Completed T+O 2.5/5|Overall Study||111
10463274|NCT01040403|11611231|FG000|Completed T+O 5/5|Overall Study||106
10463275|NCT01040403|11611231|FG000|Completed Olo 10|Overall Study||109
10463276|NCT01040403|11611231|FG000|Completed T+O 1.25/10|Overall Study||106
10463277|NCT01040403|11611231|FG000|Completed T+O 2.5/10|Overall Study||110
10463278|NCT01040403|11611231|FG000|Completed T+O 5/10|Overall Study||107
10463279|NCT01040403|11611231|FG000|COMPLETED|Overall Study|All treatment periods|213
10463280|NCT01040403|11611231|FG000|NOT COMPLETED|Overall Study||20
10463281|NCT01040689|11611250|FG000|STARTED|Overall Study||27
10463282|NCT01040689|11611251|FG001|STARTED|Overall Study||27
10463283|NCT01040689|11611252|FG002|STARTED|Overall Study||27
10463284|NCT01040689|11611253|FG003|STARTED|Overall Study||27
10463285|NCT01040689|11611250|FG000|COMPLETED|Overall Study||24
10463286|NCT01040689|11611251|FG001|COMPLETED|Overall Study||25
10463287|NCT01040689|11611252|FG002|COMPLETED|Overall Study||23
10463288|NCT01040689|11611253|FG003|COMPLETED|Overall Study||23
10463289|NCT01040689|11611250|FG000|NOT COMPLETED|Overall Study||3
10463290|NCT01040689|11611251|FG001|NOT COMPLETED|Overall Study||2
10463291|NCT01040689|11611252|FG002|NOT COMPLETED|Overall Study||4
10463292|NCT01040689|11611253|FG003|NOT COMPLETED|Overall Study||4
10463293|NCT01040728|11611268|FG000|STARTED|Overall Study||31
10463294|NCT01040728|11611269|FG001|STARTED|Overall Study||30
10463295|NCT01040728|11611270|FG002|STARTED|Overall Study||31
10463296|NCT01040728|11611271|FG003|STARTED|Overall Study||30
10463297|NCT01040728|11611268|FG000|COMPLETED|Overall Study||27
10463298|NCT01040728|11611269|FG001|COMPLETED|Overall Study||19
10463299|NCT01040728|11611270|FG002|COMPLETED|Overall Study||30
10463300|NCT01040728|11611271|FG003|COMPLETED|Overall Study||24
10463301|NCT01040728|11611268|FG000|NOT COMPLETED|Overall Study||4
10463302|NCT01040728|11611269|FG001|NOT COMPLETED|Overall Study||11
10463303|NCT01040728|11611270|FG002|NOT COMPLETED|Overall Study||1
10463304|NCT01040728|11611271|FG003|NOT COMPLETED|Overall Study||6
10463305|NCT01040780|11611289|FG000|STARTED|Overall Study||200
10463306|NCT01040780|11611290|FG001|STARTED|Overall Study||199
10463307|NCT01040780|11611289|FG000|COMPLETED|Overall Study||199
10463308|NCT01040780|11611290|FG001|COMPLETED|Overall Study||196
10463309|NCT01040780|11611289|FG000|NOT COMPLETED|Overall Study||1
10463310|NCT01040780|11611290|FG001|NOT COMPLETED|Overall Study||3
10463311|NCT01040793|11611299|FG000|STARTED|Overall Study|Entered and treated|26
10463312|NCT01040793|11611300|FG001|STARTED|Overall Study||26
10463313|NCT01040793|11611301|FG002|STARTED|Overall Study||26
10463314|NCT01040793|11611302|FG003|STARTED|Overall Study||26
10463315|NCT01040793|11611303|FG004|STARTED|Overall Study||26
10463316|NCT01040793|11611304|FG005|STARTED|Overall Study||27
10463317|NCT01040793|11611299|FG000|COMPLETED|Overall Study||20
10463318|NCT01040793|11611300|FG001|COMPLETED|Overall Study||21
10463319|NCT01040793|11611301|FG002|COMPLETED|Overall Study||23
10463320|NCT01040793|11611302|FG003|COMPLETED|Overall Study||22
10463321|NCT01040793|11611303|FG004|COMPLETED|Overall Study||22
10708504|NCT02631538|11873320|FG003|COMPLETED|General Follow-up (GFU) (Up to Week 68)||16
10708505|NCT02631538|11873317|FG000|NOT COMPLETED|General Follow-up (GFU) (Up to Week 68)||1
10708506|NCT02631538|11873318|FG001|NOT COMPLETED|General Follow-up (GFU) (Up to Week 68)||0
10708507|NCT02631538|11873319|FG002|NOT COMPLETED|General Follow-up (GFU) (Up to Week 68)||0
10708508|NCT02631538|11873320|FG003|NOT COMPLETED|General Follow-up (GFU) (Up to Week 68)||1
10708509|NCT02631551|11873334|FG000|STARTED|Overall Study||302
10708510|NCT02631551|11873335|FG001|STARTED|Overall Study||297
10708511|NCT02631551|11873336|FG002|STARTED|Overall Study||294
10708512|NCT02631551|11873337|FG003|STARTED|Overall Study||287
10708513|NCT02631551|11873334|FG000|COMPLETED|Overall Study||289
10708514|NCT02631551|11873335|FG001|COMPLETED|Overall Study||278
10463322|NCT01040793|11611304|FG005|COMPLETED|Overall Study||26
10463323|NCT01040793|11611299|FG000|NOT COMPLETED|Overall Study||6
10708515|NCT02631551|11873336|FG002|COMPLETED|Overall Study||283
10463324|NCT01040793|11611300|FG001|NOT COMPLETED|Overall Study||5
10463325|NCT01040793|11611301|FG002|NOT COMPLETED|Overall Study||3
10463326|NCT01040793|11611302|FG003|NOT COMPLETED|Overall Study||4
10463327|NCT01040793|11611303|FG004|NOT COMPLETED|Overall Study||4
10463328|NCT01040793|11611304|FG005|NOT COMPLETED|Overall Study||1
10463329|NCT01040819|11611316|FG000|STARTED|Overall Study||13
10463330|NCT01040819|11611317|FG001|STARTED|Overall Study||12
10708516|NCT02631551|11873337|FG003|COMPLETED|Overall Study||276
10463331|NCT01040819|11611316|FG000|COMPLETED|Overall Study||13
10463332|NCT01040819|11611317|FG001|COMPLETED|Overall Study||12
10463333|NCT01040819|11611316|FG000|NOT COMPLETED|Overall Study||0
10463334|NCT01040819|11611317|FG001|NOT COMPLETED|Overall Study||0
10463335|NCT01040832|11611325|FG000|STARTED|Overall Study|One participant was treated with study drug 'Cetuximab Plus EMD 1201081' but was not randomized|54
10463336|NCT01040832|11611326|FG001|STARTED|Overall Study||53
10463337|NCT01040832|11611325|FG000|COMPLETED|Overall Study||8
10463338|NCT01040832|11611326|FG001|COMPLETED|Overall Study||16
10463339|NCT01040832|11611325|FG000|NOT COMPLETED|Overall Study||46
10463340|NCT01040832|11611326|FG001|NOT COMPLETED|Overall Study||37
10463341|NCT01040845|11611334|FG000|STARTED|Overall Study||15
10463342|NCT01040845|11611335|FG001|STARTED|Overall Study||15
10463343|NCT01040845|11611334|FG000|COMPLETED|Overall Study|withdrew consent due to schedule conflict (1); dropped by physician due to positive drug screen (1)|13
10463344|NCT01040845|11611335|FG001|COMPLETED|Overall Study|withdrew consent due to schedule conflict (1)|14
10463345|NCT01040845|11611334|FG000|NOT COMPLETED|Overall Study||2
10463346|NCT01040845|11611335|FG001|NOT COMPLETED|Overall Study||1
10463347|NCT01040858|11611345|FG000|STARTED|Overall Study||59
10463348|NCT01040858|11611346|FG001|STARTED|Overall Study||69
10463349|NCT01040858|11611345|FG000|COMPLETED|Overall Study||50
10463350|NCT01040858|11611346|FG001|COMPLETED|Overall Study||69
10463351|NCT01040858|11611345|FG000|NOT COMPLETED|Overall Study||9
10463352|NCT01040858|11611346|FG001|NOT COMPLETED|Overall Study||0
10463353|NCT01040871|11611357|FG000|STARTED|Overall Study|Intent to Treat, Randomized|84
10463354|NCT01040871|11611358|FG001|STARTED|Overall Study|Intent to Treat, Randomized|80
10463355|NCT01040871|11611357|FG000|COMPLETED|Overall Study||71
10463356|NCT01040871|11611358|FG001|COMPLETED|Overall Study||73
10463357|NCT01040871|11611357|FG000|NOT COMPLETED|Overall Study||13
10463358|NCT01040871|11611358|FG001|NOT COMPLETED|Overall Study||7
10463359|NCT01041209|11611366|FG000|STARTED|Overall Study||60
10463360|NCT01041209|11611367|FG001|STARTED|Overall Study||60
10463361|NCT01041209|11611366|FG000|COMPLETED|Overall Study||60
10463362|NCT01041209|11611367|FG001|COMPLETED|Overall Study||60
10463363|NCT01041209|11611366|FG000|NOT COMPLETED|Overall Study||0
10463364|NCT01041209|11611367|FG001|NOT COMPLETED|Overall Study||0
10463365|NCT01041248|11611374|FG000|STARTED|Overall Study|January 2010|1
10463366|NCT01041248|11611374|FG000|COMPLETED|Overall Study||1
10463367|NCT01041248|11611374|FG000|NOT COMPLETED|Overall Study||0
10463368|NCT01041274|11611381|FG000|STARTED|Overall Study||49
10463369|NCT01041274|11611382|FG001|STARTED|Overall Study||46
10463370|NCT01041274|11611381|FG000|COMPLETED|Overall Study||26
10463371|NCT01041274|11611382|FG001|COMPLETED|Overall Study||25
10463372|NCT01041274|11611381|FG000|NOT COMPLETED|Overall Study||23
10463373|NCT01041274|11611382|FG001|NOT COMPLETED|Overall Study||21
10463374|NCT01041287|11611390|FG000|STARTED|Treatment Period 1 (3 Months)||19
10463375|NCT01041287|11611391|FG001|STARTED|Treatment Period 1 (3 Months)||19
10463376|NCT01041287|11611390|FG000|COMPLETED|Treatment Period 1 (3 Months)||19
10463377|NCT01041287|11611391|FG001|COMPLETED|Treatment Period 1 (3 Months)||19
10463378|NCT01041287|11611390|FG000|NOT COMPLETED|Treatment Period 1 (3 Months)||0
10463379|NCT01041287|11611391|FG001|NOT COMPLETED|Treatment Period 1 (3 Months)||0
10463380|NCT01041287|11611390|FG000|STARTED|Treatment Period 2 (3 Months)||19
10463381|NCT01041287|11611391|FG001|STARTED|Treatment Period 2 (3 Months)||19
10463382|NCT01041287|11611390|FG000|COMPLETED|Treatment Period 2 (3 Months)||16
10463383|NCT01041287|11611391|FG001|COMPLETED|Treatment Period 2 (3 Months)||14
10463384|NCT01041287|11611390|FG000|NOT COMPLETED|Treatment Period 2 (3 Months)||3
10463385|NCT01041287|11611391|FG001|NOT COMPLETED|Treatment Period 2 (3 Months)||5
10463386|NCT01041404|11611399|FG000|STARTED|Overall Study||290
10463387|NCT01041404|11611400|FG001|STARTED|Overall Study||294
10463388|NCT01041404|11611399|FG000|Entered Follow-Up|Overall Study||251
10463389|NCT01041404|11611400|FG001|Entered Follow-Up|Overall Study||251
10463390|NCT01041404|11611399|FG000|Died in Follow-up|Overall Study||199
10463391|NCT01041404|11611400|FG001|Died in Follow-up|Overall Study||200
10463392|NCT01041404|11611399|FG000|Lost to Follow-up|Overall Study||12
10463393|NCT01041404|11611400|FG001|Lost to Follow-up|Overall Study||10
10463394|NCT01041404|11611399|FG000|Alive in Follow-up|Overall Study||40
10463395|NCT01041404|11611400|FG001|Alive in Follow-up|Overall Study||41
10463396|NCT01041404|11611399|FG000|COMPLETED|Overall Study|Summary of withdrawals represents withdrawals from treatment, rather than withdrawals from study.|0
10463480|NCT01042093|11611512|FG003|NOT COMPLETED|Overall Study||4
10463397|NCT01041404|11611400|FG001|COMPLETED|Overall Study|Summary of withdrawals represents withdrawals from treatment, rather than withdrawals from study.|0
10463398|NCT01041404|11611399|FG000|NOT COMPLETED|Overall Study||290
10463399|NCT01041404|11611400|FG001|NOT COMPLETED|Overall Study||294
10463400|NCT01041417|11611411|FG000|STARTED|Overall Study||80
10463401|NCT01041417|11611412|FG001|STARTED|Overall Study||79
10463402|NCT01041417|11611411|FG000|COMPLETED|Overall Study||73
10463403|NCT01041417|11611412|FG001|COMPLETED|Overall Study||76
10463404|NCT01041417|11611411|FG000|NOT COMPLETED|Overall Study||7
10463405|NCT01041417|11611412|FG001|NOT COMPLETED|Overall Study||3
10708517|NCT02631551|11873334|FG000|NOT COMPLETED|Overall Study||13
10708518|NCT02631551|11873335|FG001|NOT COMPLETED|Overall Study||19
10463406|NCT01041495|11611422|FG000|STARTED|Overall Study||16
10463407|NCT01041495|11611423|FG001|STARTED|Overall Study||12
10463408|NCT01041495|11611422|FG000|COMPLETED|Overall Study||12
10463409|NCT01041495|11611423|FG001|COMPLETED|Overall Study||5
10463410|NCT01041495|11611422|FG000|NOT COMPLETED|Overall Study||4
10463411|NCT01041495|11611423|FG001|NOT COMPLETED|Overall Study||7
10463412|NCT01041521|11611431|FG000|STARTED|Overall Study||61
10463413|NCT01041521|11611432|FG001|STARTED|Overall Study||56
10463414|NCT01041521|11611431|FG000|COMPLETED|Overall Study||44
10708519|NCT02631551|11873336|FG002|NOT COMPLETED|Overall Study||11
10463415|NCT01041521|11611432|FG001|COMPLETED|Overall Study||40
10463416|NCT01041521|11611431|FG000|NOT COMPLETED|Overall Study||17
10463417|NCT01041521|11611432|FG001|NOT COMPLETED|Overall Study||16
10463418|NCT01041573|11611442|FG000|STARTED|Overall Study||540
10463419|NCT01041573|11611443|FG001|STARTED|Overall Study||871
10463420|NCT01041573|11611444|FG002|STARTED|Overall Study||394
10463421|NCT01041573|11611445|FG003|STARTED|Overall Study||64
10463422|NCT01041573|11611442|FG000|COMPLETED|Overall Study||535
10463423|NCT01041573|11611443|FG001|COMPLETED|Overall Study||858
10463424|NCT01041573|11611444|FG002|COMPLETED|Overall Study||387
10463425|NCT01041573|11611445|FG003|COMPLETED|Overall Study||62
10463426|NCT01041573|11611442|FG000|NOT COMPLETED|Overall Study||5
10463427|NCT01041573|11611443|FG001|NOT COMPLETED|Overall Study||13
10463428|NCT01041573|11611444|FG002|NOT COMPLETED|Overall Study||7
10463429|NCT01041573|11611445|FG003|NOT COMPLETED|Overall Study||2
10463430|NCT01041638|11611464|FG000|STARTED|Overall Study||105
10463431|NCT01041638|11611464|FG000|COMPLETED|Overall Study||78
10463432|NCT01041638|11611464|FG000|NOT COMPLETED|Overall Study||27
10463433|NCT01041781|11611470|FG000|STARTED|Overall Study||154
10463434|NCT01041781|11611471|FG001|STARTED|Overall Study||158
10463435|NCT01041781|11611470|FG000|COMPLETED|Overall Study||154
10463436|NCT01041781|11611471|FG001|COMPLETED|Overall Study||158
10463437|NCT01041781|11611470|FG000|NOT COMPLETED|Overall Study||0
10463438|NCT01041781|11611471|FG001|NOT COMPLETED|Overall Study||0
10463439|NCT01041859|11611487|FG000|STARTED|Open-Label Titration|Of 460 total enrollment, one subject enrolled twice; this subject's second enrollment is excluded.|459
10463440|NCT01041859|11611488|FG001|STARTED|Open-Label Titration||0
10463441|NCT01041859|11611489|FG002|STARTED|Open-Label Titration||0
10463442|NCT01041859|11611487|FG000|COMPLETED|Open-Label Titration|Of 358 completed subjects, 320 were randomized to the Double-Blind Maintenance Period.|358
10463443|NCT01041859|11611488|FG001|COMPLETED|Open-Label Titration||0
10463444|NCT01041859|11611489|FG002|COMPLETED|Open-Label Titration||0
10463445|NCT01041859|11611487|FG000|NOT COMPLETED|Open-Label Titration||101
10463446|NCT01041859|11611488|FG001|NOT COMPLETED|Open-Label Titration||0
10463447|NCT01041859|11611489|FG002|NOT COMPLETED|Open-Label Titration||0
10463448|NCT01041859|11611487|FG000|STARTED|Double-Blind Maintenance||0
10463449|NCT01041859|11611488|FG001|STARTED|Double-Blind Maintenance|168 were randomized, 2 were not treated (1 randomized in error, 1 withdrew consent).|166
10463450|NCT01041859|11611489|FG002|STARTED|Double-Blind Maintenance|152 randomized, all were treated.|152
10463451|NCT01041859|11611487|FG000|COMPLETED|Double-Blind Maintenance||0
10463452|NCT01041859|11611488|FG001|COMPLETED|Double-Blind Maintenance||120
10463453|NCT01041859|11611489|FG002|COMPLETED|Double-Blind Maintenance||107
10463454|NCT01041859|11611487|FG000|NOT COMPLETED|Double-Blind Maintenance||0
10463455|NCT01041859|11611488|FG001|NOT COMPLETED|Double-Blind Maintenance||46
10463456|NCT01041859|11611489|FG002|NOT COMPLETED|Double-Blind Maintenance||45
10463457|NCT01041976|11611498|FG000|STARTED|Overall Study||42
10463458|NCT01041976|11611499|FG001|STARTED|Overall Study||42
10463459|NCT01041976|11611498|FG000|6 Month Follow-up|Overall Study||39
10463460|NCT01041976|11611499|FG001|6 Month Follow-up|Overall Study||41
10463461|NCT01041976|11611498|FG000|12 Month Follow-up|Overall Study||37
10463462|NCT01041976|11611499|FG001|12 Month Follow-up|Overall Study||38
10463463|NCT01041976|11611498|FG000|18 Month Follow-up|Overall Study||37
10463464|NCT01041976|11611499|FG001|18 Month Follow-up|Overall Study||38
10463465|NCT01041976|11611498|FG000|COMPLETED|Overall Study||37
10463466|NCT01041976|11611499|FG001|COMPLETED|Overall Study||38
10463467|NCT01041976|11611498|FG000|NOT COMPLETED|Overall Study||5
10463468|NCT01041976|11611499|FG001|NOT COMPLETED|Overall Study||4
10463469|NCT01042093|11611509|FG000|STARTED|Overall Study||40
10463470|NCT01042093|11611510|FG001|STARTED|Overall Study||40
10463471|NCT01042093|11611511|FG002|STARTED|Overall Study||40
10463472|NCT01042093|11611512|FG003|STARTED|Overall Study||40
10463473|NCT01042093|11611509|FG000|COMPLETED|Overall Study||38
10463474|NCT01042093|11611510|FG001|COMPLETED|Overall Study||38
10463475|NCT01042093|11611511|FG002|COMPLETED|Overall Study||38
10463476|NCT01042093|11611512|FG003|COMPLETED|Overall Study||36
10463477|NCT01042093|11611509|FG000|NOT COMPLETED|Overall Study||2
10463478|NCT01042093|11611510|FG001|NOT COMPLETED|Overall Study||2
10463479|NCT01042093|11611511|FG002|NOT COMPLETED|Overall Study||2
10463481|NCT01042145|11611527|FG000|STARTED|Overall Study||41
10463482|NCT01042145|11611528|FG001|STARTED|Overall Study||46
10463483|NCT01042145|11611527|FG000|COMPLETED|Overall Study||40
10463484|NCT01042145|11611528|FG001|COMPLETED|Overall Study||45
10463485|NCT01042145|11611527|FG000|NOT COMPLETED|Overall Study||1
10463486|NCT01042145|11611528|FG001|NOT COMPLETED|Overall Study||1
10463487|NCT01042158|11611534|FG000|STARTED|Overall Study||25
10463488|NCT01042158|11611534|FG000|COMPLETED|Overall Study||24
10463489|NCT01042158|11611534|FG000|NOT COMPLETED|Overall Study||1
10463490|NCT01042236|11611538|FG000|STARTED|Treatment Period 1||3
10463491|NCT01042236|11611539|FG001|STARTED|Treatment Period 1||4
10463492|NCT01042236|11611540|FG002|STARTED|Treatment Period 1||3
10463493|NCT01042236|11611541|FG003|STARTED|Treatment Period 1||5
10463494|NCT01042236|11611542|FG004|STARTED|Treatment Period 1||4
10463495|NCT01042236|11611543|FG005|STARTED|Treatment Period 1||3
10463496|NCT01042236|11611538|FG000|COMPLETED|Treatment Period 1||3
10463497|NCT01042236|11611539|FG001|COMPLETED|Treatment Period 1||3
10463498|NCT01042236|11611540|FG002|COMPLETED|Treatment Period 1||3
10463499|NCT01042236|11611541|FG003|COMPLETED|Treatment Period 1||5
10463500|NCT01042236|11611542|FG004|COMPLETED|Treatment Period 1||3
10463501|NCT01042236|11611543|FG005|COMPLETED|Treatment Period 1||3
10463502|NCT01042236|11611538|FG000|NOT COMPLETED|Treatment Period 1||0
10463503|NCT01042236|11611539|FG001|NOT COMPLETED|Treatment Period 1||1
10463504|NCT01042236|11611540|FG002|NOT COMPLETED|Treatment Period 1||0
10463505|NCT01042236|11611541|FG003|NOT COMPLETED|Treatment Period 1||0
10463506|NCT01042236|11611542|FG004|NOT COMPLETED|Treatment Period 1||1
10463507|NCT01042236|11611543|FG005|NOT COMPLETED|Treatment Period 1||0
10463508|NCT01042236|11611538|FG000|STARTED|Treatment Period 2||3
10463509|NCT01042236|11611539|FG001|STARTED|Treatment Period 2||3
10463510|NCT01042236|11611540|FG002|STARTED|Treatment Period 2||3
10463511|NCT01042236|11611541|FG003|STARTED|Treatment Period 2||5
10463512|NCT01042236|11611542|FG004|STARTED|Treatment Period 2||3
10463513|NCT01042236|11611543|FG005|STARTED|Treatment Period 2||3
10463514|NCT01042236|11611538|FG000|COMPLETED|Treatment Period 2||3
10463515|NCT01042236|11611539|FG001|COMPLETED|Treatment Period 2||3
10463516|NCT01042236|11611540|FG002|COMPLETED|Treatment Period 2||3
10463517|NCT01042236|11611541|FG003|COMPLETED|Treatment Period 2||5
10463518|NCT01042236|11611542|FG004|COMPLETED|Treatment Period 2||3
10463519|NCT01042236|11611543|FG005|COMPLETED|Treatment Period 2||3
10463520|NCT01042236|11611538|FG000|NOT COMPLETED|Treatment Period 2||0
10463521|NCT01042236|11611539|FG001|NOT COMPLETED|Treatment Period 2||0
10463522|NCT01042236|11611540|FG002|NOT COMPLETED|Treatment Period 2||0
10463523|NCT01042236|11611541|FG003|NOT COMPLETED|Treatment Period 2||0
10463524|NCT01042236|11611542|FG004|NOT COMPLETED|Treatment Period 2||0
10463525|NCT01042236|11611543|FG005|NOT COMPLETED|Treatment Period 2||0
10463526|NCT01042236|11611538|FG000|STARTED|Treatment Period 3||3
10463527|NCT01042236|11611539|FG001|STARTED|Treatment Period 3||3
10463528|NCT01042236|11611540|FG002|STARTED|Treatment Period 3||3
10463529|NCT01042236|11611541|FG003|STARTED|Treatment Period 3||5
10463530|NCT01042236|11611542|FG004|STARTED|Treatment Period 3||3
10463531|NCT01042236|11611543|FG005|STARTED|Treatment Period 3||3
10463532|NCT01042236|11611538|FG000|COMPLETED|Treatment Period 3||3
10463533|NCT01042236|11611539|FG001|COMPLETED|Treatment Period 3||3
10463534|NCT01042236|11611540|FG002|COMPLETED|Treatment Period 3||3
10463535|NCT01042236|11611541|FG003|COMPLETED|Treatment Period 3||3
10463536|NCT01042236|11611542|FG004|COMPLETED|Treatment Period 3||3
10463537|NCT01042236|11611543|FG005|COMPLETED|Treatment Period 3||3
10463538|NCT01042236|11611538|FG000|NOT COMPLETED|Treatment Period 3||0
10463539|NCT01042236|11611539|FG001|NOT COMPLETED|Treatment Period 3||0
10463540|NCT01042236|11611540|FG002|NOT COMPLETED|Treatment Period 3||0
10463541|NCT01042236|11611541|FG003|NOT COMPLETED|Treatment Period 3||2
10463542|NCT01042236|11611542|FG004|NOT COMPLETED|Treatment Period 3||0
10463543|NCT01042236|11611543|FG005|NOT COMPLETED|Treatment Period 3||0
10463544|NCT01042288|11611551|FG000|STARTED|Overall Study||69
10463545|NCT01042288|11611551|FG000|Maintenance|Overall Study||27
10463546|NCT01042288|11611551|FG000|COMPLETED|Overall Study|Patients remained on maintenance until disease progression, toxicity or other reason to come off|0
10463547|NCT01042288|11611551|FG000|NOT COMPLETED|Overall Study||69
10463548|NCT01042366|11611558|FG000|STARTED|Overall Study||5
10463549|NCT01042366|11611559|FG001|STARTED|Overall Study||6
10463550|NCT01042366|11611560|FG002|STARTED|Overall Study||4
10463551|NCT01042366|11611558|FG000|COMPLETED|Overall Study||5
10463552|NCT01042366|11611559|FG001|COMPLETED|Overall Study||6
10463553|NCT01042366|11611560|FG002|COMPLETED|Overall Study||4
10463554|NCT01042366|11611558|FG000|NOT COMPLETED|Overall Study||0
10463555|NCT01042366|11611559|FG001|NOT COMPLETED|Overall Study||0
10463556|NCT01042366|11611560|FG002|NOT COMPLETED|Overall Study||0
10463557|NCT01042392|11611568|FG000|STARTED|Period II(Randomized,Double Blinded,8wk)||257
10463558|NCT01042392|11611569|FG001|STARTED|Period II(Randomized,Double Blinded,8wk)|This arm is used only in Period III.|0
10463559|NCT01042392|11611570|FG002|STARTED|Period II(Randomized,Double Blinded,8wk)||249
10463560|NCT01042392|11611571|FG003|STARTED|Period II(Randomized,Double Blinded,8wk)|This arm is used only in Period III.|0
10463561|NCT01042392|11611568|FG000|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)|ITT excluded patients from centers where 90% of BP measurements were rounded to 5 or 0|222
10463562|NCT01042392|11611569|FG001|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||0
10463563|NCT01042392|11611570|FG002|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||222
10463564|NCT01042392|11611571|FG003|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||0
10708529|NCT02631772|11873357|FG000|COMPLETED|Overall Study||16
10463565|NCT01042392|11611568|FG000|COMPLETED|Period II(Randomized,Double Blinded,8wk)||247
10463566|NCT01042392|11611569|FG001|COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
10463567|NCT01042392|11611570|FG002|COMPLETED|Period II(Randomized,Double Blinded,8wk)||241
10463568|NCT01042392|11611571|FG003|COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
10463569|NCT01042392|11611568|FG000|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||10
10463570|NCT01042392|11611569|FG001|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
10463571|NCT01042392|11611570|FG002|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||8
10463572|NCT01042392|11611571|FG003|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
10463573|NCT01042392|11611568|FG000|STARTED|Period III (Unblinded,Controlled, 1 Day)||129
10463574|NCT01042392|11611569|FG001|STARTED|Period III (Unblinded,Controlled, 1 Day)||118
10463575|NCT01042392|11611570|FG002|STARTED|Period III (Unblinded,Controlled, 1 Day)||119
10463576|NCT01042392|11611571|FG003|STARTED|Period III (Unblinded,Controlled, 1 Day)||122
10463577|NCT01042392|11611568|FG000|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)|PPMD excluded patients violated protocol instructions for period 3 (duration and treatment intake)|98
10463578|NCT01042392|11611569|FG001|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||73
10463579|NCT01042392|11611570|FG002|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||93
10463580|NCT01042392|11611571|FG003|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||82
10463581|NCT01042392|11611568|FG000|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||127
10463582|NCT01042392|11611569|FG001|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||117
10463583|NCT01042392|11611570|FG002|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||115
10463584|NCT01042392|11611571|FG003|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||121
10463585|NCT01042392|11611568|FG000|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||2
10463586|NCT01042392|11611569|FG001|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||1
10463587|NCT01042392|11611570|FG002|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||4
10463588|NCT01042392|11611571|FG003|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||1
10463589|NCT01042496|11611585|FG000|STARTED|Overall Study||29
10463590|NCT01042496|11611586|FG001|STARTED|Overall Study||33
10463591|NCT01042496|11611585|FG000|COMPLETED|Overall Study||29
10463592|NCT01042496|11611586|FG001|COMPLETED|Overall Study||33
10463593|NCT01042496|11611585|FG000|NOT COMPLETED|Overall Study||0
10463594|NCT01042496|11611586|FG001|NOT COMPLETED|Overall Study||0
10463595|NCT01042509|11611596|FG000|STARTED|Overall Study||15
10463596|NCT01042509|11611596|FG000|COMPLETED|Overall Study||15
10463597|NCT01042509|11611596|FG000|NOT COMPLETED|Overall Study||0
10463598|NCT01042535|11611600|FG000|STARTED|Overall Study||44
10463599|NCT01042535|11611600|FG000|COMPLETED|Overall Study||36
10463600|NCT01042535|11611600|FG000|NOT COMPLETED|Overall Study||8
10463601|NCT01042600|11611606|FG000|STARTED|Overall Study||31
10463602|NCT01042600|11611607|FG001|STARTED|Overall Study||30
10463603|NCT01042600|11611606|FG000|COMPLETED|Overall Study||30
10463604|NCT01042600|11611607|FG001|COMPLETED|Overall Study||30
10463605|NCT01042600|11611606|FG000|NOT COMPLETED|Overall Study||1
10463606|NCT01042600|11611607|FG001|NOT COMPLETED|Overall Study||0
10463607|NCT01042613|11611616|FG000|STARTED|Overall Study||72
10463608|NCT01042613|11611617|FG001|STARTED|Overall Study||74
10463609|NCT01042613|11611616|FG000|COMPLETED|Overall Study||72
10463610|NCT01042613|11611617|FG001|COMPLETED|Overall Study||74
10463611|NCT01042613|11611616|FG000|NOT COMPLETED|Overall Study||0
10463612|NCT01042613|11611617|FG001|NOT COMPLETED|Overall Study||0
10463613|NCT01042678|11611626|FG000|STARTED|Overall Study||6
10463614|NCT01042678|11611627|FG001|STARTED|Overall Study||6
10463615|NCT01042678|11611628|FG002|STARTED|Overall Study||6
10463616|NCT01042678|11611629|FG003|STARTED|Overall Study||0
10463617|NCT01042678|11611630|FG004|STARTED|Overall Study||0
10463618|NCT01042678|11611631|FG005|STARTED|Overall Study||0
10463619|NCT01042678|11611626|FG000|COMPLETED|Overall Study||5
10463620|NCT01042678|11611627|FG001|COMPLETED|Overall Study||6
10463621|NCT01042678|11611628|FG002|COMPLETED|Overall Study||6
10463622|NCT01042678|11611629|FG003|COMPLETED|Overall Study||0
10463623|NCT01042678|11611630|FG004|COMPLETED|Overall Study||0
10463624|NCT01042678|11611631|FG005|COMPLETED|Overall Study||0
10463625|NCT01042678|11611626|FG000|NOT COMPLETED|Overall Study||1
10463626|NCT01042678|11611627|FG001|NOT COMPLETED|Overall Study||0
10463627|NCT01042678|11611628|FG002|NOT COMPLETED|Overall Study||0
10463628|NCT01042678|11611629|FG003|NOT COMPLETED|Overall Study||0
10463629|NCT01042678|11611630|FG004|NOT COMPLETED|Overall Study||0
10463630|NCT01042678|11611631|FG005|NOT COMPLETED|Overall Study||0
10463631|NCT01042795|11611639|FG000|STARTED|Dosing Period - 16 Weeks of Daily Doses||7
10463632|NCT01042795|11611639|FG000|COMPLETED|Dosing Period - 16 Weeks of Daily Doses||2
10463633|NCT01042795|11611639|FG000|NOT COMPLETED|Dosing Period - 16 Weeks of Daily Doses||5
10463634|NCT01042795|11611639|FG000|STARTED|Follow up - 22 Months After Drug Start||2
10463635|NCT01042795|11611639|FG000|COMPLETED|Follow up - 22 Months After Drug Start||0
10463636|NCT01042795|11611639|FG000|NOT COMPLETED|Follow up - 22 Months After Drug Start||2
10463637|NCT01042938|11611645|FG000|STARTED|Overall Study|1 withdrew before radiation; 1 ineligible due to other clinical trial; 1 non-compliance.|17
10463638|NCT01042938|11611646|FG001|STARTED|Overall Study|1 withdrew before radiation; 1 non-compliance.|18
10463639|NCT01042938|11611645|FG000|COMPLETED|Overall Study||14
10463640|NCT01042938|11611646|FG001|COMPLETED|Overall Study||16
10463641|NCT01042938|11611645|FG000|NOT COMPLETED|Overall Study||3
10463642|NCT01042938|11611646|FG001|NOT COMPLETED|Overall Study||2
10463643|NCT01042977|11611656|FG000|STARTED|Overall Study|Of 482 part. 480 were included in full analysis set. Thereof, 1 part. treated but not randomized.|482
10463721|NCT01043185|11611708|FG002|COMPLETED|Period 2 - First Washout Period||3
10463644|NCT01042977|11611657|FG001|STARTED|Overall Study|Of the 483 participants only 482 were included in the full analysis set.|483
10463645|NCT01042977|11611656|FG000|COMPLETED|Overall Study||441
10463646|NCT01042977|11611657|FG001|COMPLETED|Overall Study||428
10463647|NCT01042977|11611656|FG000|NOT COMPLETED|Overall Study||41
10463648|NCT01042977|11611657|FG001|NOT COMPLETED|Overall Study||55
10463649|NCT01043094|11611665|FG000|STARTED|Overall Study||8
10463650|NCT01043094|11611666|FG001|STARTED|Overall Study||8
10463651|NCT01043094|11611665|FG000|COMPLETED|Overall Study||8
10463652|NCT01043094|11611666|FG001|COMPLETED|Overall Study||8
10463653|NCT01043094|11611665|FG000|NOT COMPLETED|Overall Study||0
10463654|NCT01043094|11611666|FG001|NOT COMPLETED|Overall Study||0
10463655|NCT01043133|11611674|FG000|STARTED|Overall Study||75
10463656|NCT01043133|11611675|FG001|STARTED|Overall Study||80
10463657|NCT01043133|11611674|FG000|COMPLETED|Overall Study||74
10463658|NCT01043133|11611675|FG001|COMPLETED|Overall Study||78
10463659|NCT01043133|11611674|FG000|NOT COMPLETED|Overall Study||1
10463660|NCT01043133|11611675|FG001|NOT COMPLETED|Overall Study||2
10463661|NCT01043146|11611687|FG000|STARTED|Overall Study||10
10463662|NCT01043146|11611688|FG001|STARTED|Overall Study||8
10463663|NCT01043146|11611689|FG002|STARTED|Overall Study||8
10463664|NCT01043146|11611690|FG003|STARTED|Overall Study||8
10463665|NCT01043146|11611691|FG004|STARTED|Overall Study||8
10463666|NCT01043146|11611692|FG005|STARTED|Overall Study||8
10463667|NCT01043146|11611687|FG000|COMPLETED|Overall Study||10
10463668|NCT01043146|11611688|FG001|COMPLETED|Overall Study||8
10463669|NCT01043146|11611689|FG002|COMPLETED|Overall Study||8
10463670|NCT01043146|11611690|FG003|COMPLETED|Overall Study||8
10463671|NCT01043146|11611691|FG004|COMPLETED|Overall Study||8
10463672|NCT01043146|11611692|FG005|COMPLETED|Overall Study||8
10463673|NCT01043146|11611687|FG000|NOT COMPLETED|Overall Study||0
10463674|NCT01043146|11611688|FG001|NOT COMPLETED|Overall Study||0
10463675|NCT01043146|11611689|FG002|NOT COMPLETED|Overall Study||0
10463676|NCT01043146|11611690|FG003|NOT COMPLETED|Overall Study||0
10463677|NCT01043146|11611691|FG004|NOT COMPLETED|Overall Study||0
10463678|NCT01043146|11611692|FG005|NOT COMPLETED|Overall Study||0
10463679|NCT01043185|11611706|FG000|STARTED|Period 1 - First Intervention||3
10463680|NCT01043185|11611707|FG001|STARTED|Period 1 - First Intervention||2
10463681|NCT01043185|11611708|FG002|STARTED|Period 1 - First Intervention||3
10463682|NCT01043185|11611709|FG003|STARTED|Period 1 - First Intervention||2
10463683|NCT01043185|11611710|FG004|STARTED|Period 1 - First Intervention||2
10463684|NCT01043185|11611711|FG005|STARTED|Period 1 - First Intervention||3
10463685|NCT01043185|11611712|FG006|STARTED|Period 1 - First Intervention||3
10463686|NCT01043185|11611713|FG007|STARTED|Period 1 - First Intervention||3
10463687|NCT01043185|11611714|FG008|STARTED|Period 1 - First Intervention||3
10463688|NCT01043185|11611715|FG009|STARTED|Period 1 - First Intervention||3
10463689|NCT01043185|11611706|FG000|COMPLETED|Period 1 - First Intervention||3
10463690|NCT01043185|11611707|FG001|COMPLETED|Period 1 - First Intervention||2
10463691|NCT01043185|11611708|FG002|COMPLETED|Period 1 - First Intervention||3
10463692|NCT01043185|11611709|FG003|COMPLETED|Period 1 - First Intervention||2
10463693|NCT01043185|11611710|FG004|COMPLETED|Period 1 - First Intervention||2
10463694|NCT01043185|11611711|FG005|COMPLETED|Period 1 - First Intervention||3
10463695|NCT01043185|11611712|FG006|COMPLETED|Period 1 - First Intervention||3
10463696|NCT01043185|11611713|FG007|COMPLETED|Period 1 - First Intervention||3
10463697|NCT01043185|11611714|FG008|COMPLETED|Period 1 - First Intervention||3
10463698|NCT01043185|11611715|FG009|COMPLETED|Period 1 - First Intervention||3
10463699|NCT01043185|11611706|FG000|NOT COMPLETED|Period 1 - First Intervention||0
10463700|NCT01043185|11611707|FG001|NOT COMPLETED|Period 1 - First Intervention||0
10463701|NCT01043185|11611708|FG002|NOT COMPLETED|Period 1 - First Intervention||0
10463702|NCT01043185|11611709|FG003|NOT COMPLETED|Period 1 - First Intervention||0
10463703|NCT01043185|11611710|FG004|NOT COMPLETED|Period 1 - First Intervention||0
10463704|NCT01043185|11611711|FG005|NOT COMPLETED|Period 1 - First Intervention||0
10463705|NCT01043185|11611712|FG006|NOT COMPLETED|Period 1 - First Intervention||0
10463706|NCT01043185|11611713|FG007|NOT COMPLETED|Period 1 - First Intervention||0
10463707|NCT01043185|11611714|FG008|NOT COMPLETED|Period 1 - First Intervention||0
10463708|NCT01043185|11611715|FG009|NOT COMPLETED|Period 1 - First Intervention||0
10463709|NCT01043185|11611706|FG000|STARTED|Period 2 - First Washout Period||3
10463710|NCT01043185|11611707|FG001|STARTED|Period 2 - First Washout Period||2
10463711|NCT01043185|11611708|FG002|STARTED|Period 2 - First Washout Period||3
10463712|NCT01043185|11611709|FG003|STARTED|Period 2 - First Washout Period||2
10463713|NCT01043185|11611710|FG004|STARTED|Period 2 - First Washout Period||2
10463714|NCT01043185|11611711|FG005|STARTED|Period 2 - First Washout Period||3
10463715|NCT01043185|11611712|FG006|STARTED|Period 2 - First Washout Period||3
10463716|NCT01043185|11611713|FG007|STARTED|Period 2 - First Washout Period||3
10463717|NCT01043185|11611714|FG008|STARTED|Period 2 - First Washout Period||3
10463718|NCT01043185|11611715|FG009|STARTED|Period 2 - First Washout Period||3
10463719|NCT01043185|11611706|FG000|COMPLETED|Period 2 - First Washout Period||3
10463720|NCT01043185|11611707|FG001|COMPLETED|Period 2 - First Washout Period||2
10708520|NCT02631551|11873337|FG003|NOT COMPLETED|Overall Study||11
10708521|NCT02631590|11873347|FG000|STARTED|Overall Study||24
10708522|NCT02631590|11873347|FG000|COMPLETED|Overall Study||24
10708523|NCT02631590|11873347|FG000|NOT COMPLETED|Overall Study||0
10708524|NCT02631746|11873351|FG000|STARTED|Overall Study||3
10708525|NCT02631746|11873351|FG000|COMPLETED|Overall Study||0
10708526|NCT02631746|11873351|FG000|NOT COMPLETED|Overall Study||3
10708527|NCT02631772|11873357|FG000|STARTED|Overall Study||16
10708528|NCT02631772|11873358|FG001|STARTED|Overall Study||16
10463722|NCT01043185|11611709|FG003|COMPLETED|Period 2 - First Washout Period||2
10463723|NCT01043185|11611710|FG004|COMPLETED|Period 2 - First Washout Period||2
10463724|NCT01043185|11611711|FG005|COMPLETED|Period 2 - First Washout Period||3
10463725|NCT01043185|11611712|FG006|COMPLETED|Period 2 - First Washout Period||3
10463726|NCT01043185|11611713|FG007|COMPLETED|Period 2 - First Washout Period||3
10463727|NCT01043185|11611714|FG008|COMPLETED|Period 2 - First Washout Period||3
10463728|NCT01043185|11611715|FG009|COMPLETED|Period 2 - First Washout Period||3
10463729|NCT01043185|11611706|FG000|NOT COMPLETED|Period 2 - First Washout Period||0
10708530|NCT02631772|11873358|FG001|COMPLETED|Overall Study||16
10708531|NCT02631772|11873357|FG000|NOT COMPLETED|Overall Study||0
10463730|NCT01043185|11611707|FG001|NOT COMPLETED|Period 2 - First Washout Period||0
10708532|NCT02631772|11873358|FG001|NOT COMPLETED|Overall Study||0
10713951|NCT02683772|11879505|FG001|STARTED|Overall Study||23
10713952|NCT02683772|11879504|FG000|COMPLETED|Overall Study||15
10463731|NCT01043185|11611708|FG002|NOT COMPLETED|Period 2 - First Washout Period||0
10463732|NCT01043185|11611709|FG003|NOT COMPLETED|Period 2 - First Washout Period||0
10463733|NCT01043185|11611710|FG004|NOT COMPLETED|Period 2 - First Washout Period||0
10463734|NCT01043185|11611711|FG005|NOT COMPLETED|Period 2 - First Washout Period||0
10463735|NCT01043185|11611712|FG006|NOT COMPLETED|Period 2 - First Washout Period||0
10463736|NCT01043185|11611713|FG007|NOT COMPLETED|Period 2 - First Washout Period||0
10463737|NCT01043185|11611714|FG008|NOT COMPLETED|Period 2 - First Washout Period||0
10463738|NCT01043185|11611715|FG009|NOT COMPLETED|Period 2 - First Washout Period||0
10463739|NCT01043185|11611706|FG000|STARTED|Period 3 - Second Intervention||3
10463740|NCT01043185|11611707|FG001|STARTED|Period 3 - Second Intervention||2
10463741|NCT01043185|11611708|FG002|STARTED|Period 3 - Second Intervention||3
10463742|NCT01043185|11611709|FG003|STARTED|Period 3 - Second Intervention||2
10463743|NCT01043185|11611710|FG004|STARTED|Period 3 - Second Intervention||2
10463744|NCT01043185|11611711|FG005|STARTED|Period 3 - Second Intervention||3
10463745|NCT01043185|11611712|FG006|STARTED|Period 3 - Second Intervention||3
10463746|NCT01043185|11611713|FG007|STARTED|Period 3 - Second Intervention||3
10463747|NCT01043185|11611714|FG008|STARTED|Period 3 - Second Intervention||3
10463748|NCT01043185|11611715|FG009|STARTED|Period 3 - Second Intervention||3
10463749|NCT01043185|11611706|FG000|COMPLETED|Period 3 - Second Intervention||3
10463750|NCT01043185|11611707|FG001|COMPLETED|Period 3 - Second Intervention||2
10463751|NCT01043185|11611708|FG002|COMPLETED|Period 3 - Second Intervention||3
10463752|NCT01043185|11611709|FG003|COMPLETED|Period 3 - Second Intervention||2
10463753|NCT01043185|11611710|FG004|COMPLETED|Period 3 - Second Intervention||2
10463754|NCT01043185|11611711|FG005|COMPLETED|Period 3 - Second Intervention||3
10463755|NCT01043185|11611712|FG006|COMPLETED|Period 3 - Second Intervention||3
10463756|NCT01043185|11611713|FG007|COMPLETED|Period 3 - Second Intervention||3
10463757|NCT01043185|11611714|FG008|COMPLETED|Period 3 - Second Intervention||3
10463758|NCT01043185|11611715|FG009|COMPLETED|Period 3 - Second Intervention||3
10463759|NCT01043185|11611706|FG000|NOT COMPLETED|Period 3 - Second Intervention||0
10463760|NCT01043185|11611707|FG001|NOT COMPLETED|Period 3 - Second Intervention||0
10463761|NCT01043185|11611708|FG002|NOT COMPLETED|Period 3 - Second Intervention||0
10463762|NCT01043185|11611709|FG003|NOT COMPLETED|Period 3 - Second Intervention||0
10463763|NCT01043185|11611710|FG004|NOT COMPLETED|Period 3 - Second Intervention||0
10463764|NCT01043185|11611711|FG005|NOT COMPLETED|Period 3 - Second Intervention||0
10463765|NCT01043185|11611712|FG006|NOT COMPLETED|Period 3 - Second Intervention||0
10463766|NCT01043185|11611713|FG007|NOT COMPLETED|Period 3 - Second Intervention||0
10463767|NCT01043185|11611714|FG008|NOT COMPLETED|Period 3 - Second Intervention||0
10463768|NCT01043185|11611715|FG009|NOT COMPLETED|Period 3 - Second Intervention||0
10463769|NCT01043185|11611706|FG000|STARTED|Period 4 - Second Washout Period||3
10463770|NCT01043185|11611707|FG001|STARTED|Period 4 - Second Washout Period||2
10463771|NCT01043185|11611708|FG002|STARTED|Period 4 - Second Washout Period||3
10463772|NCT01043185|11611709|FG003|STARTED|Period 4 - Second Washout Period||2
10463773|NCT01043185|11611710|FG004|STARTED|Period 4 - Second Washout Period||2
10463774|NCT01043185|11611711|FG005|STARTED|Period 4 - Second Washout Period||3
10708533|NCT02631850|11873368|FG000|STARTED|Treatment Period|One participant was withdrawn during treatment because medical records review revealed that the motor deficit was due to an old orthopedic injury and not stroke. This participant had experienced a Transient Ischemic Attack, but no stroke that resulted in lasting neurological motor deficit. 40 participants were thus analyzed for this group in the intent-to-treat analysis even though 41 began treatment.|41
10708534|NCT02631850|11873369|FG001|STARTED|Treatment Period||44
10708535|NCT02631850|11873370|FG002|STARTED|Treatment Period||45
10708536|NCT02631850|11873371|FG003|STARTED|Treatment Period||38
10708537|NCT02631850|11873368|FG000|COMPLETED|Treatment Period||38
10708538|NCT02631850|11873369|FG001|COMPLETED|Treatment Period||38
10463775|NCT01043185|11611712|FG006|STARTED|Period 4 - Second Washout Period||3
10463776|NCT01043185|11611713|FG007|STARTED|Period 4 - Second Washout Period||3
10463777|NCT01043185|11611714|FG008|STARTED|Period 4 - Second Washout Period||3
10463778|NCT01043185|11611715|FG009|STARTED|Period 4 - Second Washout Period||3
10463779|NCT01043185|11611706|FG000|COMPLETED|Period 4 - Second Washout Period||3
10463780|NCT01043185|11611707|FG001|COMPLETED|Period 4 - Second Washout Period||2
10463781|NCT01043185|11611708|FG002|COMPLETED|Period 4 - Second Washout Period||3
10463782|NCT01043185|11611709|FG003|COMPLETED|Period 4 - Second Washout Period||2
10463783|NCT01043185|11611710|FG004|COMPLETED|Period 4 - Second Washout Period||2
10463784|NCT01043185|11611711|FG005|COMPLETED|Period 4 - Second Washout Period||3
10463785|NCT01043185|11611712|FG006|COMPLETED|Period 4 - Second Washout Period||3
10463786|NCT01043185|11611713|FG007|COMPLETED|Period 4 - Second Washout Period||3
10463787|NCT01043185|11611714|FG008|COMPLETED|Period 4 - Second Washout Period||3
10463788|NCT01043185|11611715|FG009|COMPLETED|Period 4 - Second Washout Period||3
10463789|NCT01043185|11611706|FG000|NOT COMPLETED|Period 4 - Second Washout Period||0
10463790|NCT01043185|11611707|FG001|NOT COMPLETED|Period 4 - Second Washout Period||0
10463791|NCT01043185|11611708|FG002|NOT COMPLETED|Period 4 - Second Washout Period||0
10463792|NCT01043185|11611709|FG003|NOT COMPLETED|Period 4 - Second Washout Period||0
10463793|NCT01043185|11611710|FG004|NOT COMPLETED|Period 4 - Second Washout Period||0
10463794|NCT01043185|11611711|FG005|NOT COMPLETED|Period 4 - Second Washout Period||0
10463795|NCT01043185|11611712|FG006|NOT COMPLETED|Period 4 - Second Washout Period||0
10463796|NCT01043185|11611713|FG007|NOT COMPLETED|Period 4 - Second Washout Period||0
10463797|NCT01043185|11611714|FG008|NOT COMPLETED|Period 4 - Second Washout Period||0
10463798|NCT01043185|11611715|FG009|NOT COMPLETED|Period 4 - Second Washout Period||0
10463799|NCT01043185|11611706|FG000|STARTED|Period 5 - Third Intervention||3
10463800|NCT01043185|11611707|FG001|STARTED|Period 5 - Third Intervention||2
10463801|NCT01043185|11611708|FG002|STARTED|Period 5 - Third Intervention||3
10463802|NCT01043185|11611709|FG003|STARTED|Period 5 - Third Intervention||2
10463803|NCT01043185|11611710|FG004|STARTED|Period 5 - Third Intervention||2
10463804|NCT01043185|11611711|FG005|STARTED|Period 5 - Third Intervention||3
10463805|NCT01043185|11611712|FG006|STARTED|Period 5 - Third Intervention||3
10463806|NCT01043185|11611713|FG007|STARTED|Period 5 - Third Intervention||3
10463807|NCT01043185|11611714|FG008|STARTED|Period 5 - Third Intervention||3
10463808|NCT01043185|11611715|FG009|STARTED|Period 5 - Third Intervention||3
10463809|NCT01043185|11611706|FG000|COMPLETED|Period 5 - Third Intervention||3
10463810|NCT01043185|11611707|FG001|COMPLETED|Period 5 - Third Intervention||2
10463811|NCT01043185|11611708|FG002|COMPLETED|Period 5 - Third Intervention||3
10463812|NCT01043185|11611709|FG003|COMPLETED|Period 5 - Third Intervention||2
10463813|NCT01043185|11611710|FG004|COMPLETED|Period 5 - Third Intervention||2
10463814|NCT01043185|11611711|FG005|COMPLETED|Period 5 - Third Intervention||3
10463815|NCT01043185|11611712|FG006|COMPLETED|Period 5 - Third Intervention||3
10463816|NCT01043185|11611713|FG007|COMPLETED|Period 5 - Third Intervention||3
10463817|NCT01043185|11611714|FG008|COMPLETED|Period 5 - Third Intervention||3
10463818|NCT01043185|11611715|FG009|COMPLETED|Period 5 - Third Intervention||3
10463819|NCT01043185|11611706|FG000|NOT COMPLETED|Period 5 - Third Intervention||0
10463820|NCT01043185|11611707|FG001|NOT COMPLETED|Period 5 - Third Intervention||0
10463821|NCT01043185|11611708|FG002|NOT COMPLETED|Period 5 - Third Intervention||0
10463822|NCT01043185|11611709|FG003|NOT COMPLETED|Period 5 - Third Intervention||0
10463823|NCT01043185|11611710|FG004|NOT COMPLETED|Period 5 - Third Intervention||0
10463824|NCT01043185|11611711|FG005|NOT COMPLETED|Period 5 - Third Intervention||0
10463825|NCT01043185|11611712|FG006|NOT COMPLETED|Period 5 - Third Intervention||0
10463826|NCT01043185|11611713|FG007|NOT COMPLETED|Period 5 - Third Intervention||0
10463827|NCT01043185|11611714|FG008|NOT COMPLETED|Period 5 - Third Intervention||0
10463828|NCT01043185|11611715|FG009|NOT COMPLETED|Period 5 - Third Intervention||0
10463829|NCT01043185|11611706|FG000|STARTED|Period 6 - Third Washout Period||3
10463830|NCT01043185|11611707|FG001|STARTED|Period 6 - Third Washout Period||2
10463831|NCT01043185|11611708|FG002|STARTED|Period 6 - Third Washout Period||3
10463832|NCT01043185|11611709|FG003|STARTED|Period 6 - Third Washout Period||2
10463833|NCT01043185|11611710|FG004|STARTED|Period 6 - Third Washout Period||2
10463834|NCT01043185|11611711|FG005|STARTED|Period 6 - Third Washout Period||3
10463835|NCT01043185|11611712|FG006|STARTED|Period 6 - Third Washout Period||3
10463836|NCT01043185|11611713|FG007|STARTED|Period 6 - Third Washout Period||3
10463837|NCT01043185|11611714|FG008|STARTED|Period 6 - Third Washout Period||3
10463838|NCT01043185|11611715|FG009|STARTED|Period 6 - Third Washout Period||3
10463839|NCT01043185|11611706|FG000|COMPLETED|Period 6 - Third Washout Period||3
10463840|NCT01043185|11611707|FG001|COMPLETED|Period 6 - Third Washout Period||2
10463841|NCT01043185|11611708|FG002|COMPLETED|Period 6 - Third Washout Period||3
10463842|NCT01043185|11611709|FG003|COMPLETED|Period 6 - Third Washout Period||2
10463843|NCT01043185|11611710|FG004|COMPLETED|Period 6 - Third Washout Period||2
10463844|NCT01043185|11611711|FG005|COMPLETED|Period 6 - Third Washout Period||3
10463845|NCT01043185|11611712|FG006|COMPLETED|Period 6 - Third Washout Period||3
10463846|NCT01043185|11611713|FG007|COMPLETED|Period 6 - Third Washout Period||3
10463847|NCT01043185|11611714|FG008|COMPLETED|Period 6 - Third Washout Period||2
10463848|NCT01043185|11611715|FG009|COMPLETED|Period 6 - Third Washout Period||3
10463849|NCT01043185|11611706|FG000|NOT COMPLETED|Period 6 - Third Washout Period||0
10463850|NCT01043185|11611707|FG001|NOT COMPLETED|Period 6 - Third Washout Period||0
10463851|NCT01043185|11611708|FG002|NOT COMPLETED|Period 6 - Third Washout Period||0
10463852|NCT01043185|11611709|FG003|NOT COMPLETED|Period 6 - Third Washout Period||0
10463853|NCT01043185|11611710|FG004|NOT COMPLETED|Period 6 - Third Washout Period||0
10463854|NCT01043185|11611711|FG005|NOT COMPLETED|Period 6 - Third Washout Period||0
10463855|NCT01043185|11611712|FG006|NOT COMPLETED|Period 6 - Third Washout Period||0
10463856|NCT01043185|11611713|FG007|NOT COMPLETED|Period 6 - Third Washout Period||0
10463857|NCT01043185|11611714|FG008|NOT COMPLETED|Period 6 - Third Washout Period||1
10463858|NCT01043185|11611715|FG009|NOT COMPLETED|Period 6 - Third Washout Period||0
10463859|NCT01043185|11611706|FG000|STARTED|Period 7 - Fourth Intervention||3
10463860|NCT01043185|11611707|FG001|STARTED|Period 7 - Fourth Intervention||2
10463861|NCT01043185|11611708|FG002|STARTED|Period 7 - Fourth Intervention||3
10463862|NCT01043185|11611709|FG003|STARTED|Period 7 - Fourth Intervention||2
10463863|NCT01043185|11611710|FG004|STARTED|Period 7 - Fourth Intervention||2
10463864|NCT01043185|11611711|FG005|STARTED|Period 7 - Fourth Intervention||3
10463865|NCT01043185|11611712|FG006|STARTED|Period 7 - Fourth Intervention||3
10463866|NCT01043185|11611713|FG007|STARTED|Period 7 - Fourth Intervention||3
10463867|NCT01043185|11611714|FG008|STARTED|Period 7 - Fourth Intervention||2
10463868|NCT01043185|11611715|FG009|STARTED|Period 7 - Fourth Intervention||3
10463869|NCT01043185|11611706|FG000|COMPLETED|Period 7 - Fourth Intervention||3
10463870|NCT01043185|11611707|FG001|COMPLETED|Period 7 - Fourth Intervention||2
10463871|NCT01043185|11611708|FG002|COMPLETED|Period 7 - Fourth Intervention||3
10463872|NCT01043185|11611709|FG003|COMPLETED|Period 7 - Fourth Intervention||2
10463873|NCT01043185|11611710|FG004|COMPLETED|Period 7 - Fourth Intervention||2
10463874|NCT01043185|11611711|FG005|COMPLETED|Period 7 - Fourth Intervention||3
10463875|NCT01043185|11611712|FG006|COMPLETED|Period 7 - Fourth Intervention||3
10463876|NCT01043185|11611713|FG007|COMPLETED|Period 7 - Fourth Intervention||3
10463877|NCT01043185|11611714|FG008|COMPLETED|Period 7 - Fourth Intervention||2
10463878|NCT01043185|11611715|FG009|COMPLETED|Period 7 - Fourth Intervention||3
10463879|NCT01043185|11611706|FG000|NOT COMPLETED|Period 7 - Fourth Intervention||0
10463880|NCT01043185|11611707|FG001|NOT COMPLETED|Period 7 - Fourth Intervention||0
10463881|NCT01043185|11611708|FG002|NOT COMPLETED|Period 7 - Fourth Intervention||0
10463882|NCT01043185|11611709|FG003|NOT COMPLETED|Period 7 - Fourth Intervention||0
10463883|NCT01043185|11611710|FG004|NOT COMPLETED|Period 7 - Fourth Intervention||0
10463884|NCT01043185|11611711|FG005|NOT COMPLETED|Period 7 - Fourth Intervention||0
10463885|NCT01043185|11611712|FG006|NOT COMPLETED|Period 7 - Fourth Intervention||0
10463886|NCT01043185|11611713|FG007|NOT COMPLETED|Period 7 - Fourth Intervention||0
10463887|NCT01043185|11611714|FG008|NOT COMPLETED|Period 7 - Fourth Intervention||0
10463888|NCT01043185|11611715|FG009|NOT COMPLETED|Period 7 - Fourth Intervention||0
10463889|NCT01043393|11611729|FG000|STARTED|Overall Study||12
10463890|NCT01043393|11611730|FG001|STARTED|Overall Study||12
10463891|NCT01043393|11611729|FG000|COMPLETED|Overall Study||12
10463892|NCT01043393|11611730|FG001|COMPLETED|Overall Study||12
10463893|NCT01043393|11611729|FG000|NOT COMPLETED|Overall Study||0
10463894|NCT01043393|11611730|FG001|NOT COMPLETED|Overall Study||0
10463895|NCT01043432|11611740|FG000|STARTED|Overall Study||22
10463896|NCT01043432|11611741|FG001|STARTED|Overall Study||51
10463897|NCT01043432|11611742|FG002|STARTED|Overall Study||12
10463898|NCT01043432|11611743|FG003|STARTED|Overall Study||48
10463899|NCT01043432|11611740|FG000|COMPLETED|Overall Study||22
10463900|NCT01043432|11611741|FG001|COMPLETED|Overall Study||51
10463901|NCT01043432|11611742|FG002|COMPLETED|Overall Study||12
10463902|NCT01043432|11611743|FG003|COMPLETED|Overall Study||48
10463903|NCT01043432|11611740|FG000|NOT COMPLETED|Overall Study||0
10463904|NCT01043432|11611741|FG001|NOT COMPLETED|Overall Study||0
10463905|NCT01043432|11611742|FG002|NOT COMPLETED|Overall Study||0
10463906|NCT01043432|11611743|FG003|NOT COMPLETED|Overall Study||0
10463907|NCT01043523|11611750|FG000|STARTED|Overall Study||52
10463908|NCT01043523|11611750|FG000|Participants With Unenhanced Images|Overall Study||51
10463909|NCT01043523|11611750|FG000|COMPLETED|Overall Study||52
10463910|NCT01043523|11611750|FG000|NOT COMPLETED|Overall Study||0
10463911|NCT01043562|11611758|FG000|STARTED|Overall Study||20
10463912|NCT01043562|11611758|FG000|COMPLETED|Overall Study||20
10463913|NCT01043562|11611758|FG000|NOT COMPLETED|Overall Study||0
10463914|NCT01043640|11611765|FG000|STARTED|Overall Study||46
10463915|NCT01043640|11611765|FG000|COMPLETED|Overall Study||46
10463916|NCT01043640|11611765|FG000|NOT COMPLETED|Overall Study||0
10463917|NCT01043653|11611769|FG000|STARTED|Overall Study||250
10463918|NCT01043653|11611769|FG000|COMPLETED|Overall Study||186
10463919|NCT01043653|11611769|FG000|NOT COMPLETED|Overall Study||64
10463920|NCT01043705|11611776|FG000|STARTED|Overall Study||459
10463921|NCT01043705|11611777|FG001|STARTED|Overall Study||578
10463922|NCT01043705|11611778|FG002|STARTED|Overall Study||578
10463923|NCT01043705|11611776|FG000|COMPLETED|Overall Study||352
10463924|NCT01043705|11611777|FG001|COMPLETED|Overall Study||447
10463925|NCT01043705|11611778|FG002|COMPLETED|Overall Study||498
10463926|NCT01043705|11611776|FG000|NOT COMPLETED|Overall Study||107
10463927|NCT01043705|11611777|FG001|NOT COMPLETED|Overall Study||131
10463928|NCT01043705|11611778|FG002|NOT COMPLETED|Overall Study||80
10463929|NCT01043874|11611786|FG000|STARTED|Overall Study||45
10463930|NCT01043874|11611786|FG000|COMPLETED|Overall Study||39
10463931|NCT01043874|11611786|FG000|NOT COMPLETED|Overall Study||6
10463932|NCT01043926|11611792|FG000|STARTED|Overall Study||8
10463933|NCT01043926|11611793|FG001|STARTED|Overall Study||8
10463934|NCT01043926|11611794|FG002|STARTED|Overall Study||0
10463935|NCT01043926|11611795|FG003|STARTED|Overall Study||0
10463936|NCT01043926|11611792|FG000|COMPLETED|Overall Study||8
10463937|NCT01043926|11611793|FG001|COMPLETED|Overall Study||8
10463938|NCT01043926|11611794|FG002|COMPLETED|Overall Study||0
10463939|NCT01043926|11611795|FG003|COMPLETED|Overall Study||0
10463940|NCT01043926|11611792|FG000|NOT COMPLETED|Overall Study||0
10463941|NCT01043926|11611793|FG001|NOT COMPLETED|Overall Study||0
10463942|NCT01043926|11611794|FG002|NOT COMPLETED|Overall Study||0
10463943|NCT01043926|11611795|FG003|NOT COMPLETED|Overall Study||0
10463944|NCT01043939|11611803|FG000|STARTED|First Intervention||12
10463945|NCT01043939|11611804|FG001|STARTED|First Intervention||12
10463946|NCT01043939|11611803|FG000|COMPLETED|First Intervention||12
10463947|NCT01043939|11611804|FG001|COMPLETED|First Intervention||12
10463948|NCT01043939|11611803|FG000|NOT COMPLETED|First Intervention||0
10463949|NCT01043939|11611804|FG001|NOT COMPLETED|First Intervention||0
10463950|NCT01043939|11611803|FG000|STARTED|Washout Period||12
10463951|NCT01043939|11611804|FG001|STARTED|Washout Period||12
10463952|NCT01043939|11611803|FG000|COMPLETED|Washout Period||12
10463953|NCT01043939|11611804|FG001|COMPLETED|Washout Period||12
10463954|NCT01043939|11611803|FG000|NOT COMPLETED|Washout Period||0
10463955|NCT01043939|11611804|FG001|NOT COMPLETED|Washout Period||0
10463956|NCT01043939|11611803|FG000|STARTED|Second Intervention||12
10463957|NCT01043939|11611804|FG001|STARTED|Second Intervention||12
10463958|NCT01043939|11611803|FG000|COMPLETED|Second Intervention||12
10463959|NCT01043939|11611804|FG001|COMPLETED|Second Intervention||12
10463960|NCT01043939|11611803|FG000|NOT COMPLETED|Second Intervention||0
10463961|NCT01043939|11611804|FG001|NOT COMPLETED|Second Intervention||0
10463962|NCT01044030|11611813|FG000|STARTED|Overall Study||160
10463963|NCT01044030|11611814|FG001|STARTED|Overall Study||166
10463964|NCT01044030|11611813|FG000|COMPLETED|Overall Study||141
10463965|NCT01044030|11611814|FG001|COMPLETED|Overall Study||146
10463966|NCT01044030|11611813|FG000|NOT COMPLETED|Overall Study||19
10463967|NCT01044030|11611814|FG001|NOT COMPLETED|Overall Study||20
10463968|NCT01044212|11611822|FG000|STARTED|Overall Study||35
10463969|NCT01044212|11611823|FG001|STARTED|Overall Study||37
10463970|NCT01044212|11611822|FG000|COMPLETED|Overall Study||30
10463971|NCT01044212|11611823|FG001|COMPLETED|Overall Study||30
10463972|NCT01044212|11611822|FG000|NOT COMPLETED|Overall Study||5
10463973|NCT01044212|11611823|FG001|NOT COMPLETED|Overall Study||7
10463974|NCT01044264|11611832|FG000|STARTED|Overall Study||200
10463975|NCT01044264|11611833|FG001|STARTED|Overall Study||202
10463976|NCT01044264|11611834|FG002|STARTED|Overall Study||200
10463977|NCT01044264|11611832|FG000|COMPLETED|Overall Study||110
10463978|NCT01044264|11611833|FG001|COMPLETED|Overall Study||108
10463979|NCT01044264|11611834|FG002|COMPLETED|Overall Study||108
10463980|NCT01044264|11611832|FG000|NOT COMPLETED|Overall Study||90
10463981|NCT01044264|11611833|FG001|NOT COMPLETED|Overall Study||94
10463982|NCT01044264|11611834|FG002|NOT COMPLETED|Overall Study||92
10463983|NCT01044290|11611845|FG000|STARTED|Randomization||75
10463984|NCT01044290|11611846|FG001|STARTED|Randomization||74
10463985|NCT01044290|11611847|FG002|STARTED|Randomization||72
10463986|NCT01044290|11611845|FG000|Randomized|Randomization||75
10463987|NCT01044290|11611846|FG001|Randomized|Randomization||74
10463988|NCT01044290|11611847|FG002|Randomized|Randomization||72
10463989|NCT01044290|11611845|FG000|COMPLETED|Randomization||75
10463990|NCT01044290|11611846|FG001|COMPLETED|Randomization||74
10463991|NCT01044290|11611847|FG002|COMPLETED|Randomization||72
10463992|NCT01044290|11611845|FG000|NOT COMPLETED|Randomization||0
10463993|NCT01044290|11611846|FG001|NOT COMPLETED|Randomization||0
10463994|NCT01044290|11611847|FG002|NOT COMPLETED|Randomization||0
10463995|NCT01044290|11611845|FG000|STARTED|Follow-up 1||75
10463996|NCT01044290|11611846|FG001|STARTED|Follow-up 1||74
10463997|NCT01044290|11611847|FG002|STARTED|Follow-up 1||72
10463998|NCT01044290|11611845|FG000|Completed F1 Interview|Follow-up 1||61
10463999|NCT01044290|11611846|FG001|Completed F1 Interview|Follow-up 1||60
10464000|NCT01044290|11611847|FG002|Completed F1 Interview|Follow-up 1||61
10464001|NCT01044290|11611845|FG000|COMPLETED|Follow-up 1||70
10464002|NCT01044290|11611846|FG001|COMPLETED|Follow-up 1||69
10464003|NCT01044290|11611847|FG002|COMPLETED|Follow-up 1||71
10464004|NCT01044290|11611845|FG000|NOT COMPLETED|Follow-up 1||5
10464005|NCT01044290|11611846|FG001|NOT COMPLETED|Follow-up 1||5
10464006|NCT01044290|11611847|FG002|NOT COMPLETED|Follow-up 1||1
10464007|NCT01044290|11611845|FG000|STARTED|Follow-Up 2||70
10464008|NCT01044290|11611846|FG001|STARTED|Follow-Up 2||69
10464009|NCT01044290|11611847|FG002|STARTED|Follow-Up 2||71
10464010|NCT01044290|11611845|FG000|Completed F2 Interview|Follow-Up 2||64
10464011|NCT01044290|11611846|FG001|Completed F2 Interview|Follow-Up 2||57
10464012|NCT01044290|11611847|FG002|Completed F2 Interview|Follow-Up 2||64
10464013|NCT01044290|11611845|FG000|COMPLETED|Follow-Up 2||70
10464014|NCT01044290|11611846|FG001|COMPLETED|Follow-Up 2||67
10464015|NCT01044290|11611847|FG002|COMPLETED|Follow-Up 2||69
10464016|NCT01044290|11611845|FG000|NOT COMPLETED|Follow-Up 2||0
10464017|NCT01044290|11611846|FG001|NOT COMPLETED|Follow-Up 2||2
10464018|NCT01044290|11611847|FG002|NOT COMPLETED|Follow-Up 2||2
10464019|NCT01044303|11611865|FG000|STARTED|Overall Study||32
10464020|NCT01044303|11611865|FG000|COMPLETED|Overall Study||30
10464021|NCT01044303|11611865|FG000|NOT COMPLETED|Overall Study||2
10464022|NCT01044433|11611872|FG000|STARTED|Overall Study||44
10464023|NCT01044433|11611872|FG000|COMPLETED|Overall Study||38
10464024|NCT01044433|11611872|FG000|NOT COMPLETED|Overall Study||6
10464025|NCT01044459|11611879|FG000|STARTED|Overall Study||312
10464026|NCT01044459|11611880|FG001|STARTED|Overall Study||293
10464027|NCT01044459|11611879|FG000|COMPLETED|Overall Study||179
10464028|NCT01044459|11611880|FG001|COMPLETED|Overall Study||162
10464029|NCT01044459|11611879|FG000|NOT COMPLETED|Overall Study||133
10464030|NCT01044459|11611880|FG001|NOT COMPLETED|Overall Study||131
10464031|NCT01044498|11611888|FG000|STARTED|Overall Study||23
10464032|NCT01044498|11611889|FG001|STARTED|Overall Study||23
10464033|NCT01044498|11611888|FG000|COMPLETED|Overall Study||20
10464034|NCT01044498|11611889|FG001|COMPLETED|Overall Study||21
10464035|NCT01044498|11611888|FG000|NOT COMPLETED|Overall Study||3
10464036|NCT01044498|11611889|FG001|NOT COMPLETED|Overall Study||2
10464037|NCT01044537|11611902|FG000|STARTED|Overall Study||6
10464038|NCT01044537|11611903|FG001|STARTED|Overall Study||6
10464039|NCT01044537|11611904|FG002|STARTED|Overall Study||6
10464040|NCT01044537|11611905|FG003|STARTED|Overall Study||6
10464041|NCT01044537|11611906|FG004|STARTED|Overall Study||5
10464042|NCT01044537|11611907|FG005|STARTED|Overall Study||5
10464043|NCT01044537|11611908|FG006|STARTED|Overall Study||16
10464044|NCT01044537|11611902|FG000|COMPLETED|Overall Study||6
10464045|NCT01044537|11611903|FG001|COMPLETED|Overall Study||6
10464046|NCT01044537|11611904|FG002|COMPLETED|Overall Study||6
10464047|NCT01044537|11611905|FG003|COMPLETED|Overall Study||6
10464048|NCT01044537|11611906|FG004|COMPLETED|Overall Study||5
10464049|NCT01044537|11611907|FG005|COMPLETED|Overall Study||5
10464050|NCT01044537|11611908|FG006|COMPLETED|Overall Study||16
10464051|NCT01044537|11611902|FG000|NOT COMPLETED|Overall Study||0
10464052|NCT01044537|11611903|FG001|NOT COMPLETED|Overall Study||0
10464053|NCT01044537|11611904|FG002|NOT COMPLETED|Overall Study||0
10464054|NCT01044537|11611905|FG003|NOT COMPLETED|Overall Study||0
10464055|NCT01044537|11611906|FG004|NOT COMPLETED|Overall Study||0
10464056|NCT01044537|11611907|FG005|NOT COMPLETED|Overall Study||0
10464057|NCT01044537|11611908|FG006|NOT COMPLETED|Overall Study||0
10464058|NCT01044576|11611924|FG000|STARTED|Overall Study||200
10464059|NCT01044576|11611924|FG000|COMPLETED|Overall Study||200
10464060|NCT01044576|11611924|FG000|NOT COMPLETED|Overall Study||0
10464061|NCT01044589|11611930|FG000|STARTED|Overall Study||6
10464062|NCT01044589|11611931|FG001|STARTED|Overall Study||7
10464063|NCT01044589|11611930|FG000|COMPLETED|Overall Study||3
10464064|NCT01044589|11611931|FG001|COMPLETED|Overall Study||2
10464065|NCT01044589|11611930|FG000|NOT COMPLETED|Overall Study||3
10464066|NCT01044589|11611931|FG001|NOT COMPLETED|Overall Study||5
10464067|NCT01044693|11611937|FG000|STARTED|Overall Study||3
10464068|NCT01044693|11611938|FG001|STARTED|Overall Study||1
10464069|NCT01044693|11611939|FG002|STARTED|Overall Study||1
10464070|NCT01044693|11611940|FG003|STARTED|Overall Study||1
10464071|NCT01044693|11611941|FG004|STARTED|Overall Study||1
10464072|NCT01044693|11611942|FG005|STARTED|Overall Study||2
10464073|NCT01044693|11611943|FG006|STARTED|Overall Study||1
10464074|NCT01044693|11611944|FG007|STARTED|Overall Study||1
10464075|NCT01044693|11611945|FG008|STARTED|Overall Study||1
10464076|NCT01044693|11611946|FG009|STARTED|Overall Study||1
10464077|NCT01044693|11611947|FG010|STARTED|Overall Study||1
10464078|NCT01044693|11611948|FG011|STARTED|Overall Study||1
10464079|NCT01044693|11611949|FG012|STARTED|Overall Study||2
10464080|NCT01044693|11611950|FG013|STARTED|Overall Study||1
10464081|NCT01044693|11611951|FG014|STARTED|Overall Study||1
10464082|NCT01044693|11611952|FG015|STARTED|Overall Study||1
10464083|NCT01044693|11611937|FG000|COMPLETED|Overall Study||3
10464084|NCT01044693|11611938|FG001|COMPLETED|Overall Study||1
10464085|NCT01044693|11611939|FG002|COMPLETED|Overall Study||1
10464086|NCT01044693|11611940|FG003|COMPLETED|Overall Study||1
10464087|NCT01044693|11611941|FG004|COMPLETED|Overall Study||1
10464088|NCT01044693|11611942|FG005|COMPLETED|Overall Study||2
10464089|NCT01044693|11611943|FG006|COMPLETED|Overall Study||1
10464090|NCT01044693|11611944|FG007|COMPLETED|Overall Study||1
10464091|NCT01044693|11611945|FG008|COMPLETED|Overall Study||1
10464092|NCT01044693|11611946|FG009|COMPLETED|Overall Study||1
10464093|NCT01044693|11611947|FG010|COMPLETED|Overall Study||1
10464094|NCT01044693|11611948|FG011|COMPLETED|Overall Study||1
10464095|NCT01044693|11611949|FG012|COMPLETED|Overall Study||2
10464096|NCT01044693|11611950|FG013|COMPLETED|Overall Study||1
10464097|NCT01044693|11611951|FG014|COMPLETED|Overall Study||1
10464098|NCT01044693|11611952|FG015|COMPLETED|Overall Study||1
10464099|NCT01044693|11611937|FG000|NOT COMPLETED|Overall Study||0
10464100|NCT01044693|11611938|FG001|NOT COMPLETED|Overall Study||0
10464101|NCT01044693|11611939|FG002|NOT COMPLETED|Overall Study||0
10464102|NCT01044693|11611940|FG003|NOT COMPLETED|Overall Study||0
10464103|NCT01044693|11611941|FG004|NOT COMPLETED|Overall Study||0
10464104|NCT01044693|11611942|FG005|NOT COMPLETED|Overall Study||0
10464105|NCT01044693|11611943|FG006|NOT COMPLETED|Overall Study||0
10464106|NCT01044693|11611944|FG007|NOT COMPLETED|Overall Study||0
10464107|NCT01044693|11611945|FG008|NOT COMPLETED|Overall Study||0
10708539|NCT02631850|11873370|FG002|COMPLETED|Treatment Period||41
10708540|NCT02631850|11873371|FG003|COMPLETED|Treatment Period||33
10708541|NCT02631850|11873368|FG000|NOT COMPLETED|Treatment Period||3
10708542|NCT02631850|11873369|FG001|NOT COMPLETED|Treatment Period||6
10708543|NCT02631850|11873370|FG002|NOT COMPLETED|Treatment Period||4
10708544|NCT02631850|11873371|FG003|NOT COMPLETED|Treatment Period||5
10464108|NCT01044693|11611946|FG009|NOT COMPLETED|Overall Study||0
10464109|NCT01044693|11611947|FG010|NOT COMPLETED|Overall Study||0
10464110|NCT01044693|11611948|FG011|NOT COMPLETED|Overall Study||0
10464111|NCT01044693|11611949|FG012|NOT COMPLETED|Overall Study||0
10464112|NCT01044693|11611950|FG013|NOT COMPLETED|Overall Study||0
10464113|NCT01044693|11611951|FG014|NOT COMPLETED|Overall Study||0
10464114|NCT01044693|11611952|FG015|NOT COMPLETED|Overall Study||0
10464115|NCT01044706|11611964|FG000|STARTED|Overall Study||30
10464116|NCT01044706|11611965|FG001|STARTED|Overall Study||30
10464117|NCT01044706|11611964|FG000|COMPLETED|Overall Study||30
10464118|NCT01044706|11611965|FG001|COMPLETED|Overall Study||30
10464119|NCT01044706|11611964|FG000|NOT COMPLETED|Overall Study||0
10464120|NCT01044706|11611965|FG001|NOT COMPLETED|Overall Study||0
10464121|NCT01044732|11611973|FG000|STARTED|Overall Study||222
10464122|NCT01044732|11611974|FG001|STARTED|Overall Study||226
10464123|NCT01044732|11611973|FG000|COMPLETED|Overall Study||173
10464124|NCT01044732|11611974|FG001|COMPLETED|Overall Study||176
10464125|NCT01044732|11611973|FG000|NOT COMPLETED|Overall Study||49
10464126|NCT01044732|11611974|FG001|NOT COMPLETED|Overall Study||50
10464127|NCT01044745|11611982|FG000|STARTED|Overall Study||20
10464128|NCT01044745|11611982|FG000|COMPLETED|Overall Study||18
10464129|NCT01044745|11611982|FG000|NOT COMPLETED|Overall Study||2
10464130|NCT01044758|11611994|FG000|STARTED|Overall Study||12
10464131|NCT01044758|11611995|FG001|STARTED|Overall Study||12
10464132|NCT01044758|11611996|FG002|STARTED|Overall Study||11
10464133|NCT01044758|11611997|FG003|STARTED|Overall Study||12
10464134|NCT01044758|11611998|FG004|STARTED|Overall Study||11
10464135|NCT01044758|11611999|FG005|STARTED|Overall Study||11
10464136|NCT01044758|11612000|FG006|STARTED|Overall Study||27
10464137|NCT01044758|11611994|FG000|COMPLETED|Overall Study||8
10464138|NCT01044758|11611995|FG001|COMPLETED|Overall Study||12
10464139|NCT01044758|11611996|FG002|COMPLETED|Overall Study||7
10708545|NCT02631850|11873368|FG000|STARTED|6 Month Follow up||38
10708546|NCT02631850|11873369|FG001|STARTED|6 Month Follow up||38
10464140|NCT01044758|11611997|FG003|COMPLETED|Overall Study||10
10464141|NCT01044758|11611998|FG004|COMPLETED|Overall Study||9
10464142|NCT01044758|11611999|FG005|COMPLETED|Overall Study||8
10464143|NCT01044758|11612000|FG006|COMPLETED|Overall Study||17
10464144|NCT01044758|11611994|FG000|NOT COMPLETED|Overall Study||4
10464145|NCT01044758|11611995|FG001|NOT COMPLETED|Overall Study||0
10464146|NCT01044758|11611996|FG002|NOT COMPLETED|Overall Study||4
10464147|NCT01044758|11611997|FG003|NOT COMPLETED|Overall Study||2
10464148|NCT01044758|11611998|FG004|NOT COMPLETED|Overall Study||2
10464149|NCT01044758|11611999|FG005|NOT COMPLETED|Overall Study||3
10464150|NCT01044758|11612000|FG006|NOT COMPLETED|Overall Study||10
10464151|NCT01044771|11612019|FG000|STARTED|Overall Study||20
10464152|NCT01044771|11612019|FG000|COMPLETED|Overall Study||20
10464153|NCT01044771|11612019|FG000|NOT COMPLETED|Overall Study||0
10464154|NCT01044862|11612027|FG000|STARTED|Overall Study||299
10464155|NCT01044862|11612028|FG001|STARTED|Overall Study||300
10464156|NCT01044862|11612029|FG002|STARTED|Overall Study||301
10464157|NCT01044862|11612027|FG000|COMPLETED|Overall Study||246
10464158|NCT01044862|11612028|FG001|COMPLETED|Overall Study||251
10464159|NCT01044862|11612029|FG002|COMPLETED|Overall Study||249
10464160|NCT01044862|11612027|FG000|NOT COMPLETED|Overall Study||53
10464161|NCT01044862|11612028|FG001|NOT COMPLETED|Overall Study||49
10464162|NCT01044862|11612029|FG002|NOT COMPLETED|Overall Study||52
10464163|NCT01044966|11612037|FG000|STARTED|Induction Phase||12
10464164|NCT01044966|11612037|FG000|COMPLETED|Induction Phase||12
10464165|NCT01044966|11612037|FG000|NOT COMPLETED|Induction Phase||0
10464166|NCT01044966|11612037|FG000|STARTED|Consolidation Phase||12
10464167|NCT01044966|11612037|FG000|COMPLETED|Consolidation Phase||2
10464168|NCT01044966|11612037|FG000|NOT COMPLETED|Consolidation Phase||10
10464169|NCT01045031|11612044|FG000|STARTED|Overall Study||58
10464170|NCT01045031|11612045|FG001|STARTED|Overall Study||56
10464171|NCT01045031|11612044|FG000|COMPLETED|Overall Study||49
10464172|NCT01045031|11612045|FG001|COMPLETED|Overall Study||50
10464173|NCT01045031|11612044|FG000|NOT COMPLETED|Overall Study||9
10464174|NCT01045031|11612045|FG001|NOT COMPLETED|Overall Study||6
10464175|NCT01045057|11612055|FG000|STARTED|Overall Study||27
10464176|NCT01045057|11612055|FG000|COMPLETED|Overall Study||27
10464177|NCT01045057|11612055|FG000|NOT COMPLETED|Overall Study||0
10464178|NCT01045096|11612064|FG000|STARTED|Overall Study||12
10464179|NCT01045096|11612065|FG001|STARTED|Overall Study||12
10464180|NCT01045096|11612066|FG002|STARTED|Overall Study||12
10464181|NCT01045096|11612064|FG000|Pharmacokinetic Set|Overall Study|All patients with at least one estimable PK parameter for dexlansoprazole on Day 7.|9
10464182|NCT01045096|11612065|FG001|Pharmacokinetic Set|Overall Study||11
10464183|NCT01045096|11612066|FG002|Pharmacokinetic Set|Overall Study||11
10464184|NCT01045096|11612064|FG000|COMPLETED|Overall Study||9
10464185|NCT01045096|11612065|FG001|COMPLETED|Overall Study||12
10464186|NCT01045096|11612066|FG002|COMPLETED|Overall Study||12
10464187|NCT01045096|11612064|FG000|NOT COMPLETED|Overall Study||3
10464188|NCT01045096|11612065|FG001|NOT COMPLETED|Overall Study||0
10464189|NCT01045096|11612066|FG002|NOT COMPLETED|Overall Study||0
10464190|NCT01045122|11612074|FG000|STARTED|Dexmedetomidine Then Propofol||5
10464191|NCT01045122|11612075|FG001|STARTED|Dexmedetomidine Then Propofol||6
10464192|NCT01045122|11612074|FG000|COMPLETED|Dexmedetomidine Then Propofol||5
10464193|NCT01045122|11612075|FG001|COMPLETED|Dexmedetomidine Then Propofol||6
10464194|NCT01045122|11612074|FG000|NOT COMPLETED|Dexmedetomidine Then Propofol||0
10464195|NCT01045122|11612075|FG001|NOT COMPLETED|Dexmedetomidine Then Propofol||0
10464196|NCT01045122|11612074|FG000|STARTED|Propofol Then Dexmedetomidine||5
10464197|NCT01045122|11612075|FG001|STARTED|Propofol Then Dexmedetomidine||6
10464198|NCT01045122|11612074|FG000|COMPLETED|Propofol Then Dexmedetomidine||5
10464199|NCT01045122|11612075|FG001|COMPLETED|Propofol Then Dexmedetomidine||6
10464200|NCT01045122|11612074|FG000|NOT COMPLETED|Propofol Then Dexmedetomidine||0
10464201|NCT01045122|11612075|FG001|NOT COMPLETED|Propofol Then Dexmedetomidine||0
10464202|NCT01045135|11612081|FG000|STARTED|Overall Study||300
10464203|NCT01045135|11612081|FG000|COMPLETED|Overall Study||274
10464204|NCT01045135|11612081|FG000|NOT COMPLETED|Overall Study||26
10464205|NCT01045161|11612090|FG000|STARTED|Part A - 12 Weeks Double Blind Treatment||182
10464206|NCT01045161|11612091|FG001|STARTED|Part A - 12 Weeks Double Blind Treatment||184
10464207|NCT01045161|11612092|FG002|STARTED|Part A - 12 Weeks Double Blind Treatment||178
10464208|NCT01045161|11612090|FG000|COMPLETED|Part A - 12 Weeks Double Blind Treatment||151
10464209|NCT01045161|11612091|FG001|COMPLETED|Part A - 12 Weeks Double Blind Treatment||155
10464210|NCT01045161|11612092|FG002|COMPLETED|Part A - 12 Weeks Double Blind Treatment||148
10464211|NCT01045161|11612090|FG000|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||31
10464212|NCT01045161|11612091|FG001|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||29
10464213|NCT01045161|11612092|FG002|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||30
10464214|NCT01045161|11612090|FG000|STARTED|Part B - 40 Additional Weeks Open Label||147
10464215|NCT01045161|11612091|FG001|STARTED|Part B - 40 Additional Weeks Open Label||154
10464216|NCT01045161|11612092|FG002|STARTED|Part B - 40 Additional Weeks Open Label||147
10464217|NCT01045161|11612090|FG000|COMPLETED|Part B - 40 Additional Weeks Open Label||111
10464218|NCT01045161|11612091|FG001|COMPLETED|Part B - 40 Additional Weeks Open Label||118
10464219|NCT01045161|11612092|FG002|COMPLETED|Part B - 40 Additional Weeks Open Label||115
10464220|NCT01045161|11612090|FG000|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||36
10464221|NCT01045161|11612091|FG001|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||36
10464222|NCT01045161|11612092|FG002|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||32
10464223|NCT01045174|11612111|FG000|STARTED|Overall Study||90
10464224|NCT01045174|11612112|FG001|STARTED|Overall Study||90
10464225|NCT01045174|11612111|FG000|COMPLETED|Overall Study||90
10464226|NCT01045174|11612112|FG001|COMPLETED|Overall Study||90
10464227|NCT01045174|11612111|FG000|NOT COMPLETED|Overall Study||0
10464228|NCT01045174|11612112|FG001|NOT COMPLETED|Overall Study||0
10464229|NCT01045187|11612118|FG000|STARTED|Overall Study||15
10464230|NCT01045187|11612118|FG000|COMPLETED|Overall Study||15
10464231|NCT01045187|11612118|FG000|NOT COMPLETED|Overall Study||0
10464232|NCT01045265|11612122|FG000|STARTED|Overall Study||16
10464233|NCT01045265|11612122|FG000|COMPLETED|Overall Study||16
10464234|NCT01045265|11612122|FG000|NOT COMPLETED|Overall Study||0
10464235|NCT01045421|11612132|FG000|STARTED|Phase 1||1
10464236|NCT01045421|11612133|FG001|STARTED|Phase 1||3
10464237|NCT01045421|11612134|FG002|STARTED|Phase 1||4
10464238|NCT01045421|11612135|FG003|STARTED|Phase 1||12
10464239|NCT01045421|11612136|FG004|STARTED|Phase 1||3
10464240|NCT01045421|11612137|FG005|STARTED|Phase 1||1
10464241|NCT01045421|11612138|FG006|STARTED|Phase 1||0
10464242|NCT01045421|11612139|FG007|STARTED|Phase 1||0
10464243|NCT01045421|11612140|FG008|STARTED|Phase 1||0
10464244|NCT01045421|11612141|FG009|STARTED|Phase 1||0
10464245|NCT01045421|11612142|FG010|STARTED|Phase 1||0
10464246|NCT01045421|11612132|FG000|COMPLETED|Phase 1||1
10464247|NCT01045421|11612133|FG001|COMPLETED|Phase 1||3
10464248|NCT01045421|11612134|FG002|COMPLETED|Phase 1||4
10464249|NCT01045421|11612135|FG003|COMPLETED|Phase 1||11
10464250|NCT01045421|11612136|FG004|COMPLETED|Phase 1||2
10464251|NCT01045421|11612137|FG005|COMPLETED|Phase 1||1
10464252|NCT01045421|11612138|FG006|COMPLETED|Phase 1||0
10464253|NCT01045421|11612139|FG007|COMPLETED|Phase 1||0
10464254|NCT01045421|11612140|FG008|COMPLETED|Phase 1||0
10464255|NCT01045421|11612141|FG009|COMPLETED|Phase 1||0
10464256|NCT01045421|11612142|FG010|COMPLETED|Phase 1||0
10464257|NCT01045421|11612132|FG000|NOT COMPLETED|Phase 1||0
10464258|NCT01045421|11612133|FG001|NOT COMPLETED|Phase 1||0
10464259|NCT01045421|11612134|FG002|NOT COMPLETED|Phase 1||0
10464260|NCT01045421|11612135|FG003|NOT COMPLETED|Phase 1||1
10464261|NCT01045421|11612136|FG004|NOT COMPLETED|Phase 1||1
10464262|NCT01045421|11612137|FG005|NOT COMPLETED|Phase 1||0
10464263|NCT01045421|11612138|FG006|NOT COMPLETED|Phase 1||0
10464264|NCT01045421|11612139|FG007|NOT COMPLETED|Phase 1||0
10464265|NCT01045421|11612140|FG008|NOT COMPLETED|Phase 1||0
10464266|NCT01045421|11612141|FG009|NOT COMPLETED|Phase 1||0
10464267|NCT01045421|11612142|FG010|NOT COMPLETED|Phase 1||0
10464268|NCT01045421|11612132|FG000|STARTED|Phase 2||0
10464269|NCT01045421|11612133|FG001|STARTED|Phase 2||0
10464270|NCT01045421|11612134|FG002|STARTED|Phase 2||0
10464271|NCT01045421|11612135|FG003|STARTED|Phase 2||0
10464272|NCT01045421|11612136|FG004|STARTED|Phase 2||0
10464273|NCT01045421|11612137|FG005|STARTED|Phase 2||0
10464274|NCT01045421|11612138|FG006|STARTED|Phase 2||53
10464275|NCT01045421|11612139|FG007|STARTED|Phase 2||55
10464276|NCT01045421|11612140|FG008|STARTED|Phase 2||55
10464277|NCT01045421|11612141|FG009|STARTED|Phase 2||26
10464278|NCT01045421|11612142|FG010|STARTED|Phase 2||60
10464279|NCT01045421|11612132|FG000|COMPLETED|Phase 2||0
10464280|NCT01045421|11612133|FG001|COMPLETED|Phase 2||0
10464281|NCT01045421|11612134|FG002|COMPLETED|Phase 2||0
10464282|NCT01045421|11612135|FG003|COMPLETED|Phase 2||0
10464283|NCT01045421|11612136|FG004|COMPLETED|Phase 2||0
10464284|NCT01045421|11612137|FG005|COMPLETED|Phase 2||0
10464285|NCT01045421|11612138|FG006|COMPLETED|Phase 2||53
10464286|NCT01045421|11612139|FG007|COMPLETED|Phase 2||50
10464287|NCT01045421|11612140|FG008|COMPLETED|Phase 2||53
10464288|NCT01045421|11612141|FG009|COMPLETED|Phase 2||23
10464289|NCT01045421|11612142|FG010|COMPLETED|Phase 2||58
10464290|NCT01045421|11612132|FG000|NOT COMPLETED|Phase 2||0
10464291|NCT01045421|11612133|FG001|NOT COMPLETED|Phase 2||0
10464292|NCT01045421|11612134|FG002|NOT COMPLETED|Phase 2||0
10464293|NCT01045421|11612135|FG003|NOT COMPLETED|Phase 2||0
10464294|NCT01045421|11612136|FG004|NOT COMPLETED|Phase 2||0
10464295|NCT01045421|11612137|FG005|NOT COMPLETED|Phase 2||0
10464296|NCT01045421|11612138|FG006|NOT COMPLETED|Phase 2||0
10464297|NCT01045421|11612139|FG007|NOT COMPLETED|Phase 2||5
10464298|NCT01045421|11612140|FG008|NOT COMPLETED|Phase 2||2
10464299|NCT01045421|11612141|FG009|NOT COMPLETED|Phase 2||3
10464300|NCT01045421|11612142|FG010|NOT COMPLETED|Phase 2||2
10464301|NCT01045447|11612165|FG000|STARTED|Overall Study||232
10464302|NCT01045447|11612166|FG001|STARTED|Overall Study||233
10464303|NCT01045447|11612165|FG000|Exposed|Overall Study|Two subjects withdrew prior to exposure to trial drug|230
10464304|NCT01045447|11612166|FG001|Exposed|Overall Study||233
10464305|NCT01045447|11612165|FG000|COMPLETED|Overall Study||196
10464306|NCT01045447|11612166|FG001|COMPLETED|Overall Study||205
10464307|NCT01045447|11612165|FG000|NOT COMPLETED|Overall Study||36
10464308|NCT01045447|11612166|FG001|NOT COMPLETED|Overall Study||28
10464309|NCT01045460|11612174|FG000|STARTED|Overall Study||17
10464310|NCT01045460|11612175|FG001|STARTED|Overall Study||18
10464311|NCT01045460|11612174|FG000|COMPLETED|Overall Study||11
10464312|NCT01045460|11612175|FG001|COMPLETED|Overall Study||15
10464313|NCT01045460|11612174|FG000|NOT COMPLETED|Overall Study||6
10464314|NCT01045460|11612175|FG001|NOT COMPLETED|Overall Study||3
10464315|NCT01045499|11612183|FG000|STARTED|Overall Study||137
10464316|NCT01045499|11612183|FG000|COMPLETED|Overall Study||127
10464317|NCT01045499|11612183|FG000|NOT COMPLETED|Overall Study||10
10464318|NCT01045551|11612187|FG000|STARTED|Overall Study||10
10464319|NCT01045551|11612187|FG000|COMPLETED|Overall Study||10
10464320|NCT01045551|11612187|FG000|NOT COMPLETED|Overall Study||0
10464321|NCT01045707|11612194|FG000|STARTED|Main: Week 0 to 26 (NN5401-3590)||266
10464322|NCT01045707|11612195|FG001|STARTED|Main: Week 0 to 26 (NN5401-3590)||264
10464323|NCT01045707|11612194|FG000|Exposed|Main: Week 0 to 26 (NN5401-3590)|One subject withdrew prior to exposure to trial drug|265
10464324|NCT01045707|11612195|FG001|Exposed|Main: Week 0 to 26 (NN5401-3590)|Three subjects withdrew prior to exposure to trial drug|261
10464325|NCT01045707|11612194|FG000|COMPLETED|Main: Week 0 to 26 (NN5401-3590)||219
10464326|NCT01045707|11612195|FG001|COMPLETED|Main: Week 0 to 26 (NN5401-3590)||232
10464327|NCT01045707|11612194|FG000|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3590)||47
10464328|NCT01045707|11612195|FG001|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3590)||32
10464329|NCT01045707|11612194|FG000|STARTED|Extension: Week 27 to 52 (NN5401-3726)|Twenty seven subjects from main trial did not continue into the extension|192
10464330|NCT01045707|11612195|FG001|STARTED|Extension: Week 27 to 52 (NN5401-3726)|Eleven subjects from main trial did not continue into the extension|221
10464331|NCT01045707|11612194|FG000|COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||179
10464332|NCT01045707|11612195|FG001|COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||209
10464333|NCT01045707|11612194|FG000|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||13
10464334|NCT01045707|11612195|FG001|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||12
10464335|NCT01045798|11612203|FG000|STARTED|Overall Study||6
10464336|NCT01045798|11612204|FG001|STARTED|Overall Study||9
10464337|NCT01045798|11612203|FG000|COMPLETED|Overall Study||4
10464338|NCT01045798|11612204|FG001|COMPLETED|Overall Study||5
10464339|NCT01045798|11612203|FG000|NOT COMPLETED|Overall Study||2
10464340|NCT01045798|11612204|FG001|NOT COMPLETED|Overall Study||4
10464341|NCT01045967|11612212|FG000|STARTED|First Intervention||28
10464342|NCT01045967|11612213|FG001|STARTED|First Intervention||28
10464343|NCT01045967|11612212|FG000|COMPLETED|First Intervention||28
10464344|NCT01045967|11612213|FG001|COMPLETED|First Intervention||28
10708547|NCT02631850|11873370|FG002|STARTED|6 Month Follow up||41
10708548|NCT02631850|11873371|FG003|STARTED|6 Month Follow up||33
10708549|NCT02631850|11873368|FG000|COMPLETED|6 Month Follow up||31
10708550|NCT02631850|11873369|FG001|COMPLETED|6 Month Follow up||25
10708551|NCT02631850|11873370|FG002|COMPLETED|6 Month Follow up||35
10708552|NCT02631850|11873371|FG003|COMPLETED|6 Month Follow up||22
10708553|NCT02631850|11873368|FG000|NOT COMPLETED|6 Month Follow up||7
10708554|NCT02631850|11873369|FG001|NOT COMPLETED|6 Month Follow up||13
10708555|NCT02631850|11873370|FG002|NOT COMPLETED|6 Month Follow up||6
10708556|NCT02631850|11873371|FG003|NOT COMPLETED|6 Month Follow up||11
10708557|NCT02631876|11873384|FG000|STARTED|Overall Study||248
10708558|NCT02631876|11873385|FG001|STARTED|Overall Study||118
10708559|NCT02631876|11873384|FG000|Safety Population|Overall Study||243
10708560|NCT02631876|11873385|FG001|Safety Population|Overall Study||109
10708561|NCT02631876|11873384|FG000|COMPLETED|Overall Study||129
10708562|NCT02631876|11873385|FG001|COMPLETED|Overall Study||55
10708563|NCT02631876|11873384|FG000|NOT COMPLETED|Overall Study||119
10708564|NCT02631876|11873385|FG001|NOT COMPLETED|Overall Study||63
10708565|NCT02631954|11873394|FG000|STARTED|Overall Study||12
10708566|NCT02631954|11873395|FG001|STARTED|Overall Study||12
10464345|NCT01045967|11612212|FG000|NOT COMPLETED|First Intervention||0
10464346|NCT01045967|11612213|FG001|NOT COMPLETED|First Intervention||0
10464347|NCT01045967|11612212|FG000|STARTED|Washout of 7 Days||28
10464348|NCT01045967|11612213|FG001|STARTED|Washout of 7 Days||28
10464349|NCT01045967|11612212|FG000|COMPLETED|Washout of 7 Days||28
10464350|NCT01045967|11612213|FG001|COMPLETED|Washout of 7 Days||28
10464351|NCT01045967|11612212|FG000|NOT COMPLETED|Washout of 7 Days||0
10464352|NCT01045967|11612213|FG001|NOT COMPLETED|Washout of 7 Days||0
10464353|NCT01045967|11612212|FG000|STARTED|Second Intervention||28
10464354|NCT01045967|11612213|FG001|STARTED|Second Intervention|Subject was dropped prior to dosing in Period II due to positive drug screen.|28
10464355|NCT01045967|11612212|FG000|COMPLETED|Second Intervention||28
10464356|NCT01045967|11612213|FG001|COMPLETED|Second Intervention||27
10464357|NCT01045967|11612212|FG000|NOT COMPLETED|Second Intervention||0
10464358|NCT01045967|11612213|FG001|NOT COMPLETED|Second Intervention||1
10464359|NCT01045993|11612223|FG000|STARTED|Overall Study||26
10464360|NCT01045993|11612224|FG001|STARTED|Overall Study||5
10464361|NCT01045993|11612225|FG002|STARTED|Overall Study||5
10464362|NCT01045993|11612226|FG003|STARTED|Overall Study||25
10464363|NCT01045993|11612223|FG000|COMPLETED|Overall Study||26
10464364|NCT01045993|11612224|FG001|COMPLETED|Overall Study||4
10464365|NCT01045993|11612225|FG002|COMPLETED|Overall Study||5
10464366|NCT01045993|11612226|FG003|COMPLETED|Overall Study||25
10464367|NCT01045993|11612223|FG000|NOT COMPLETED|Overall Study||0
10464368|NCT01045993|11612224|FG001|NOT COMPLETED|Overall Study||1
10464369|NCT01045993|11612225|FG002|NOT COMPLETED|Overall Study||0
10464370|NCT01045993|11612226|FG003|NOT COMPLETED|Overall Study||0
10464371|NCT01046084|11612238|FG000|STARTED|First Intervention||25
10464372|NCT01046084|11612239|FG001|STARTED|First Intervention||25
10464373|NCT01046084|11612238|FG000|COMPLETED|First Intervention||25
10464374|NCT01046084|11612239|FG001|COMPLETED|First Intervention||25
10464375|NCT01046084|11612238|FG000|NOT COMPLETED|First Intervention||0
10464376|NCT01046084|11612239|FG001|NOT COMPLETED|First Intervention||0
10464377|NCT01046084|11612238|FG000|STARTED|First Washout of 7 Days||25
10464378|NCT01046084|11612239|FG001|STARTED|First Washout of 7 Days||25
10464379|NCT01046084|11612238|FG000|COMPLETED|First Washout of 7 Days||25
10708567|NCT02631954|11873394|FG000|COMPLETED|Overall Study||12
10708568|NCT02631954|11873395|FG001|COMPLETED|Overall Study||12
10708569|NCT02631954|11873394|FG000|NOT COMPLETED|Overall Study||0
10708570|NCT02631954|11873395|FG001|NOT COMPLETED|Overall Study||0
10708571|NCT02632110|11873406|FG000|STARTED|Overall Study||25
10708572|NCT02632110|11873407|FG001|STARTED|Overall Study||25
10464380|NCT01046084|11612239|FG001|COMPLETED|First Washout of 7 Days||25
10464381|NCT01046084|11612238|FG000|NOT COMPLETED|First Washout of 7 Days||0
10464382|NCT01046084|11612239|FG001|NOT COMPLETED|First Washout of 7 Days||0
10464383|NCT01046084|11612238|FG000|STARTED|Second Intervention||25
10464384|NCT01046084|11612239|FG001|STARTED|Second Intervention||25
10464385|NCT01046084|11612238|FG000|COMPLETED|Second Intervention||25
10464386|NCT01046084|11612239|FG001|COMPLETED|Second Intervention||25
10464387|NCT01046084|11612238|FG000|NOT COMPLETED|Second Intervention||0
10464388|NCT01046084|11612239|FG001|NOT COMPLETED|Second Intervention||0
10464389|NCT01046084|11612238|FG000|STARTED|Second Washout of 7 Days||25
10464390|NCT01046084|11612239|FG001|STARTED|Second Washout of 7 Days||25
10464391|NCT01046084|11612238|FG000|COMPLETED|Second Washout of 7 Days||25
10464392|NCT01046084|11612239|FG001|COMPLETED|Second Washout of 7 Days||25
10464393|NCT01046084|11612238|FG000|NOT COMPLETED|Second Washout of 7 Days||0
10464394|NCT01046084|11612239|FG001|NOT COMPLETED|Second Washout of 7 Days||0
10464395|NCT01046084|11612238|FG000|STARTED|Third Intervention||25
10464396|NCT01046084|11612239|FG001|STARTED|Third Intervention||25
10464397|NCT01046084|11612238|FG000|COMPLETED|Third Intervention||25
10464398|NCT01046084|11612239|FG001|COMPLETED|Third Intervention||25
10464399|NCT01046084|11612238|FG000|NOT COMPLETED|Third Intervention||0
10464400|NCT01046084|11612239|FG001|NOT COMPLETED|Third Intervention||0
10464401|NCT01046084|11612238|FG000|STARTED|Third Washout of 7 Days||25
10708573|NCT02632110|11873408|FG002|STARTED|Overall Study||27
10708574|NCT02632110|11873409|FG003|STARTED|Overall Study||27
10708575|NCT02632110|11873410|FG004|STARTED|Overall Study||29
10708576|NCT02632110|11873411|FG005|STARTED|Overall Study||29
10464402|NCT01046084|11612239|FG001|STARTED|Third Washout of 7 Days||25
10464403|NCT01046084|11612238|FG000|COMPLETED|Third Washout of 7 Days||23
10464404|NCT01046084|11612239|FG001|COMPLETED|Third Washout of 7 Days||25
10464405|NCT01046084|11612238|FG000|NOT COMPLETED|Third Washout of 7 Days||2
10464406|NCT01046084|11612239|FG001|NOT COMPLETED|Third Washout of 7 Days||0
10464407|NCT01046084|11612238|FG000|STARTED|Fourth Intervention||23
10464408|NCT01046084|11612239|FG001|STARTED|Fourth Intervention||25
10708577|NCT02632110|11873412|FG006|STARTED|Overall Study||26
10708578|NCT02632110|11873413|FG007|STARTED|Overall Study||26
10464409|NCT01046084|11612238|FG000|COMPLETED|Fourth Intervention||23
10464410|NCT01046084|11612239|FG001|COMPLETED|Fourth Intervention||25
10464411|NCT01046084|11612238|FG000|NOT COMPLETED|Fourth Intervention||0
10464412|NCT01046084|11612239|FG001|NOT COMPLETED|Fourth Intervention||0
10464413|NCT01046110|11612247|FG000|STARTED|Overall Study||229
10464414|NCT01046110|11612248|FG001|STARTED|Overall Study||229
10464415|NCT01046110|11612247|FG000|Exposed|Overall Study|2 subjects were randomised in error and 1 subject did not want to take insulin|226
10464416|NCT01046110|11612248|FG001|Exposed|Overall Study|1 subject was randomised in error|228
10464417|NCT01046110|11612247|FG000|COMPLETED|Overall Study||174
10464418|NCT01046110|11612248|FG001|COMPLETED|Overall Study||174
10464419|NCT01046110|11612247|FG000|NOT COMPLETED|Overall Study||55
10464420|NCT01046110|11612248|FG001|NOT COMPLETED|Overall Study||55
10464421|NCT01046136|11612256|FG000|STARTED|Overall Study||188
10464422|NCT01046136|11612257|FG001|STARTED|Overall Study||190
10464423|NCT01046136|11612256|FG000|COMPLETED|Overall Study||184
10464424|NCT01046136|11612257|FG001|COMPLETED|Overall Study||182
10464425|NCT01046136|11612256|FG000|NOT COMPLETED|Overall Study||4
10464426|NCT01046136|11612257|FG001|NOT COMPLETED|Overall Study||8
10464427|NCT01046253|11612267|FG000|STARTED|First Intervention||25
10464428|NCT01046253|11612268|FG001|STARTED|First Intervention||25
10464429|NCT01046253|11612267|FG000|COMPLETED|First Intervention||25
10464430|NCT01046253|11612268|FG001|COMPLETED|First Intervention||25
10464431|NCT01046253|11612267|FG000|NOT COMPLETED|First Intervention||0
10464432|NCT01046253|11612268|FG001|NOT COMPLETED|First Intervention||0
10464433|NCT01046253|11612267|FG000|STARTED|First Washout of 7 Days||25
10464434|NCT01046253|11612268|FG001|STARTED|First Washout of 7 Days||25
10464435|NCT01046253|11612267|FG000|COMPLETED|First Washout of 7 Days||25
10464436|NCT01046253|11612268|FG001|COMPLETED|First Washout of 7 Days||25
10464437|NCT01046253|11612267|FG000|NOT COMPLETED|First Washout of 7 Days||0
10464438|NCT01046253|11612268|FG001|NOT COMPLETED|First Washout of 7 Days||0
10464439|NCT01046253|11612267|FG000|STARTED|Second Intervention||25
10464440|NCT01046253|11612268|FG001|STARTED|Second Intervention||25
10464441|NCT01046253|11612267|FG000|COMPLETED|Second Intervention||25
10464442|NCT01046253|11612268|FG001|COMPLETED|Second Intervention||23
10464443|NCT01046253|11612267|FG000|NOT COMPLETED|Second Intervention||0
10464444|NCT01046253|11612268|FG001|NOT COMPLETED|Second Intervention||2
10464445|NCT01046253|11612267|FG000|STARTED|Second Washout of 7 Days||25
10464446|NCT01046253|11612268|FG001|STARTED|Second Washout of 7 Days||23
10464447|NCT01046253|11612267|FG000|COMPLETED|Second Washout of 7 Days||25
10464448|NCT01046253|11612268|FG001|COMPLETED|Second Washout of 7 Days||23
10464449|NCT01046253|11612267|FG000|NOT COMPLETED|Second Washout of 7 Days||0
10464450|NCT01046253|11612268|FG001|NOT COMPLETED|Second Washout of 7 Days||0
10464451|NCT01046253|11612267|FG000|STARTED|Third Intervention||25
10464452|NCT01046253|11612268|FG001|STARTED|Third Intervention||23
10464453|NCT01046253|11612267|FG000|COMPLETED|Third Intervention||25
10464454|NCT01046253|11612268|FG001|COMPLETED|Third Intervention||23
10464455|NCT01046253|11612267|FG000|NOT COMPLETED|Third Intervention||0
10464456|NCT01046253|11612268|FG001|NOT COMPLETED|Third Intervention||0
10464457|NCT01046253|11612267|FG000|STARTED|Third Washout of 7 Days||25
10464458|NCT01046253|11612268|FG001|STARTED|Third Washout of 7 Days||23
10464459|NCT01046253|11612267|FG000|COMPLETED|Third Washout of 7 Days||25
10464460|NCT01046253|11612268|FG001|COMPLETED|Third Washout of 7 Days||23
10464461|NCT01046253|11612267|FG000|NOT COMPLETED|Third Washout of 7 Days||0
10464462|NCT01046253|11612268|FG001|NOT COMPLETED|Third Washout of 7 Days||0
10464463|NCT01046253|11612267|FG000|STARTED|Fourth Intervention||25
10464464|NCT01046253|11612268|FG001|STARTED|Fourth Intervention||23
10464465|NCT01046253|11612267|FG000|COMPLETED|Fourth Intervention||25
10464466|NCT01046253|11612268|FG001|COMPLETED|Fourth Intervention||23
10464467|NCT01046253|11612267|FG000|NOT COMPLETED|Fourth Intervention||0
10464468|NCT01046253|11612268|FG001|NOT COMPLETED|Fourth Intervention||0
10464475|NCT01046643|11612292|FG000|STARTED|First Period Treatment or Placebo||9
10464476|NCT01046643|11612293|FG001|STARTED|First Period Treatment or Placebo||7
10464477|NCT01046643|11612294|FG002|STARTED|First Period Treatment or Placebo||7
10464478|NCT01046643|11612295|FG003|STARTED|First Period Treatment or Placebo||7
10464479|NCT01046643|11612292|FG000|COMPLETED|First Period Treatment or Placebo||9
10464480|NCT01046643|11612293|FG001|COMPLETED|First Period Treatment or Placebo||6
10464481|NCT01046643|11612294|FG002|COMPLETED|First Period Treatment or Placebo||7
10464482|NCT01046643|11612295|FG003|COMPLETED|First Period Treatment or Placebo||7
10464483|NCT01046643|11612292|FG000|NOT COMPLETED|First Period Treatment or Placebo||0
10464484|NCT01046643|11612293|FG001|NOT COMPLETED|First Period Treatment or Placebo||1
10464485|NCT01046643|11612294|FG002|NOT COMPLETED|First Period Treatment or Placebo||0
10464486|NCT01046643|11612295|FG003|NOT COMPLETED|First Period Treatment or Placebo||0
10464487|NCT01046643|11612292|FG000|STARTED|Washout Period||9
10464488|NCT01046643|11612293|FG001|STARTED|Washout Period||6
10464489|NCT01046643|11612294|FG002|STARTED|Washout Period||7
10464490|NCT01046643|11612295|FG003|STARTED|Washout Period||7
10464491|NCT01046643|11612292|FG000|COMPLETED|Washout Period||9
10464492|NCT01046643|11612293|FG001|COMPLETED|Washout Period||6
10464493|NCT01046643|11612294|FG002|COMPLETED|Washout Period||7
10464494|NCT01046643|11612295|FG003|COMPLETED|Washout Period||7
10464495|NCT01046643|11612292|FG000|NOT COMPLETED|Washout Period||0
10464496|NCT01046643|11612293|FG001|NOT COMPLETED|Washout Period||0
10464497|NCT01046643|11612294|FG002|NOT COMPLETED|Washout Period||0
10464498|NCT01046643|11612295|FG003|NOT COMPLETED|Washout Period||0
10464499|NCT01046643|11612292|FG000|STARTED|Second Period Treatment or Placebo||9
10464500|NCT01046643|11612293|FG001|STARTED|Second Period Treatment or Placebo||6
10464501|NCT01046643|11612294|FG002|STARTED|Second Period Treatment or Placebo||7
10464502|NCT01046643|11612295|FG003|STARTED|Second Period Treatment or Placebo||7
10464503|NCT01046643|11612292|FG000|COMPLETED|Second Period Treatment or Placebo||9
10464504|NCT01046643|11612293|FG001|COMPLETED|Second Period Treatment or Placebo||6
10464505|NCT01046643|11612294|FG002|COMPLETED|Second Period Treatment or Placebo||7
10464506|NCT01046643|11612295|FG003|COMPLETED|Second Period Treatment or Placebo||7
10464507|NCT01046643|11612292|FG000|NOT COMPLETED|Second Period Treatment or Placebo||0
10464508|NCT01046643|11612293|FG001|NOT COMPLETED|Second Period Treatment or Placebo||0
10464509|NCT01046643|11612294|FG002|NOT COMPLETED|Second Period Treatment or Placebo||0
10464510|NCT01046643|11612295|FG003|NOT COMPLETED|Second Period Treatment or Placebo||0
10464511|NCT01046669|11612307|FG000|STARTED|Overall Study||226
10464512|NCT01046669|11612308|FG001|STARTED|Overall Study||224
10464513|NCT01046669|11612307|FG000|COMPLETED|Overall Study||226
10464514|NCT01046669|11612308|FG001|COMPLETED|Overall Study||223
10464515|NCT01046669|11612307|FG000|NOT COMPLETED|Overall Study||0
10464516|NCT01046669|11612308|FG001|NOT COMPLETED|Overall Study||1
10526477|NCT01381692|11678341|FG000|COMPLETED|Overall Study||6
10526478|NCT01381692|11678342|FG001|COMPLETED|Overall Study||2
10526479|NCT01381692|11678343|FG002|COMPLETED|Overall Study||0
10526480|NCT01381692|11678344|FG003|COMPLETED|Overall Study||0
10526481|NCT01381692|11678345|FG004|COMPLETED|Overall Study||0
10526482|NCT01381692|11678346|FG005|COMPLETED|Overall Study||0
10526483|NCT01381692|11678341|FG000|NOT COMPLETED|Overall Study||1
10526484|NCT01381692|11678342|FG001|NOT COMPLETED|Overall Study||0
10526485|NCT01381692|11678343|FG002|NOT COMPLETED|Overall Study||0
10526486|NCT01381692|11678344|FG003|NOT COMPLETED|Overall Study||0
10526487|NCT01381692|11678345|FG004|NOT COMPLETED|Overall Study||0
10526488|NCT01381692|11678346|FG005|NOT COMPLETED|Overall Study||0
10526489|NCT01381718|11678356|FG000|STARTED|Overall Study||56
10464517|NCT01046682|11612316|FG000|STARTED|Overall Study||20
10464518|NCT01046682|11612317|FG001|STARTED|Overall Study||20
10464519|NCT01046682|11612316|FG000|COMPLETED|Overall Study||18
10464520|NCT01046682|11612317|FG001|COMPLETED|Overall Study||20
10464521|NCT01046682|11612316|FG000|NOT COMPLETED|Overall Study||2
10464522|NCT01046682|11612317|FG001|NOT COMPLETED|Overall Study||0
10464523|NCT01046695|11612325|FG000|STARTED|Overall Study||20
10464524|NCT01046695|11612326|FG001|STARTED|Overall Study||22
10464525|NCT01046695|11612325|FG000|COMPLETED|Overall Study||20
10464526|NCT01046695|11612326|FG001|COMPLETED|Overall Study||20
10464527|NCT01046695|11612325|FG000|NOT COMPLETED|Overall Study||0
10464528|NCT01046695|11612326|FG001|NOT COMPLETED|Overall Study||2
10464529|NCT01046877|11612332|FG000|STARTED|Overall Study||25
10464619|NCT01047345|11612406|FG001|COMPLETED|Extension||0
10464530|NCT01046877|11612332|FG000|Completed on Schedule|Overall Study|Final visit = the earlier of 24 months post-procedure or 12 months after extrusion.|6
10464531|NCT01046877|11612332|FG000|Completed Study Late|Overall Study|One completed (evidencing extrusions) at 23.5 mos. Missed 9 mo visit. Exam not possible at 12 mo.|1
10464532|NCT01046877|11612332|FG000|COMPLETED|Overall Study||7
10464533|NCT01046877|11612332|FG000|NOT COMPLETED|Overall Study||18
10464534|NCT01046903|11612336|FG000|STARTED|Overall Study||503
10464535|NCT01046903|11612336|FG000|COMPLETED|Overall Study||475
10464536|NCT01046903|11612336|FG000|NOT COMPLETED|Overall Study||28
10464537|NCT01047007|11612344|FG000|STARTED|Overall Study||3
10464538|NCT01047007|11612345|FG001|STARTED|Overall Study||6
10464539|NCT01047007|11612346|FG002|STARTED|Overall Study||2
10464540|NCT01047007|11612347|FG003|STARTED|Overall Study||0
10464541|NCT01047007|11612344|FG000|Treated|Overall Study||3
10464542|NCT01047007|11612345|FG001|Treated|Overall Study||6
10464543|NCT01047007|11612346|FG002|Treated|Overall Study||2
10464544|NCT01047007|11612347|FG003|Treated|Overall Study||0
10464545|NCT01047007|11612344|FG000|COMPLETED|Overall Study||1
10464546|NCT01047007|11612345|FG001|COMPLETED|Overall Study||0
10464547|NCT01047007|11612346|FG002|COMPLETED|Overall Study||0
10464548|NCT01047007|11612347|FG003|COMPLETED|Overall Study||0
10464549|NCT01047007|11612344|FG000|NOT COMPLETED|Overall Study||2
10464550|NCT01047007|11612345|FG001|NOT COMPLETED|Overall Study||6
10464551|NCT01047007|11612346|FG002|NOT COMPLETED|Overall Study||2
10464552|NCT01047007|11612347|FG003|NOT COMPLETED|Overall Study||0
10464553|NCT01047189|11612359|FG000|STARTED|Overall Study||13
10464554|NCT01047189|11612360|FG001|STARTED|Overall Study||13
10464555|NCT01047189|11612359|FG000|COMPLETED|Overall Study||9
10464556|NCT01047189|11612360|FG001|COMPLETED|Overall Study||13
10464557|NCT01047189|11612359|FG000|NOT COMPLETED|Overall Study||4
10464558|NCT01047189|11612360|FG001|NOT COMPLETED|Overall Study||0
10464559|NCT01047241|11612366|FG000|STARTED|Overall Study||50
10464560|NCT01047241|11612366|FG000|COMPLETED|Overall Study||50
10464561|NCT01047241|11612366|FG000|NOT COMPLETED|Overall Study||0
10464562|NCT01047293|11612373|FG000|STARTED|Overall Study||4
10464563|NCT01047293|11612374|FG001|STARTED|Overall Study||8
10464564|NCT01047293|11612375|FG002|STARTED|Overall Study||9
10464565|NCT01047293|11612376|FG003|STARTED|Overall Study||26
10464566|NCT01047293|11612373|FG000|COMPLETED|Overall Study||3
10464567|NCT01047293|11612374|FG001|COMPLETED|Overall Study||7
10464568|NCT01047293|11612375|FG002|COMPLETED|Overall Study||9
10464569|NCT01047293|11612376|FG003|COMPLETED|Overall Study||26
10464570|NCT01047293|11612373|FG000|NOT COMPLETED|Overall Study||1
10464571|NCT01047293|11612374|FG001|NOT COMPLETED|Overall Study||1
10464572|NCT01047293|11612375|FG002|NOT COMPLETED|Overall Study||0
10464573|NCT01047293|11612376|FG003|NOT COMPLETED|Overall Study||0
10464574|NCT01047306|11612385|FG000|STARTED|Overall Study||19
10464575|NCT01047306|11612386|FG001|STARTED|Overall Study||6
10464576|NCT01047306|11612385|FG000|Discontinued From the Study|Overall Study||3
10464577|NCT01047306|11612386|FG001|Discontinued From the Study|Overall Study||0
10464578|NCT01047306|11612385|FG000|COMPLETED|Overall Study||16
10464579|NCT01047306|11612386|FG001|COMPLETED|Overall Study||6
10464580|NCT01047306|11612385|FG000|NOT COMPLETED|Overall Study||3
10464581|NCT01047306|11612386|FG001|NOT COMPLETED|Overall Study||0
10464582|NCT01047332|11612396|FG000|STARTED|Overall Study||61
10464583|NCT01047332|11612397|FG001|STARTED|Overall Study||68
10464584|NCT01047332|11612396|FG000|COMPLETED|Overall Study|Alive at final follow-up|4
10464585|NCT01047332|11612397|FG001|COMPLETED|Overall Study|Alive at final follow-up|4
10464586|NCT01047332|11612396|FG000|NOT COMPLETED|Overall Study||57
10464587|NCT01047332|11612397|FG001|NOT COMPLETED|Overall Study||64
10464588|NCT01047345|11612405|FG000|STARTED|Base Study||618
10464589|NCT01047345|11612406|FG001|STARTED|Base Study||306
10464590|NCT01047345|11612407|FG002|STARTED|Base Study||0
10464591|NCT01047345|11612405|FG000|Vaccination 1|Base Study||615
10464592|NCT01047345|11612406|FG001|Vaccination 1|Base Study||306
10464593|NCT01047345|11612407|FG002|Vaccination 1|Base Study||0
10464594|NCT01047345|11612405|FG000|Vaccination 2|Base Study||604
10464595|NCT01047345|11612406|FG001|Vaccination 2|Base Study||304
10464596|NCT01047345|11612407|FG002|Vaccination 2|Base Study||0
10464597|NCT01047345|11612405|FG000|Vaccination 3|Base Study||597
10464598|NCT01047345|11612406|FG001|Vaccination 3|Base Study||300
10464599|NCT01047345|11612407|FG002|Vaccination 3|Base Study||0
10464600|NCT01047345|11612405|FG000|COMPLETED|Base Study|Includes 1 participant for whom completion status is unknown|596
10464601|NCT01047345|11612406|FG001|COMPLETED|Base Study||300
10464602|NCT01047345|11612407|FG002|COMPLETED|Base Study||0
10464603|NCT01047345|11612405|FG000|NOT COMPLETED|Base Study||22
10464604|NCT01047345|11612406|FG001|NOT COMPLETED|Base Study||6
10464605|NCT01047345|11612407|FG002|NOT COMPLETED|Base Study||0
10464606|NCT01047345|11612405|FG000|STARTED|Extension||0
10464607|NCT01047345|11612406|FG001|STARTED|Extension||0
10464608|NCT01047345|11612407|FG002|STARTED|Extension|Not all eligible participants elected to participate in extension|102
10464609|NCT01047345|11612405|FG000|Vaccination 4|Extension||0
10464610|NCT01047345|11612406|FG001|Vaccination 4|Extension||0
10464611|NCT01047345|11612407|FG002|Vaccination 4|Extension||102
10464612|NCT01047345|11612405|FG000|Vaccination 5|Extension||0
10464613|NCT01047345|11612406|FG001|Vaccination 5|Extension||0
10464614|NCT01047345|11612407|FG002|Vaccination 5|Extension||99
10464615|NCT01047345|11612405|FG000|Vaccination 6|Extension||0
10464616|NCT01047345|11612406|FG001|Vaccination 6|Extension||0
10464617|NCT01047345|11612407|FG002|Vaccination 6|Extension|1 participant received 6th vaccination outside the context of study but completed the study.|95
10464618|NCT01047345|11612405|FG000|COMPLETED|Extension||0
10464620|NCT01047345|11612407|FG002|COMPLETED|Extension||96
10464621|NCT01047345|11612405|FG000|NOT COMPLETED|Extension||0
10464622|NCT01047345|11612406|FG001|NOT COMPLETED|Extension||0
10464623|NCT01047345|11612407|FG002|NOT COMPLETED|Extension||6
10464624|NCT01047358|11612415|FG000|STARTED|Overall Study||206
10464625|NCT01047358|11612415|FG000|COMPLETED|Overall Study|At least one safety assessment (Safety Population)|206
10464626|NCT01047358|11612415|FG000|NOT COMPLETED|Overall Study||0
10464627|NCT01047436|11612422|FG000|STARTED|Overall Study||16
10464628|NCT01047436|11612423|FG001|STARTED|Overall Study||15
10464629|NCT01047436|11612422|FG000|COMPLETED|Overall Study||15
10464630|NCT01047436|11612423|FG001|COMPLETED|Overall Study||15
10464631|NCT01047436|11612422|FG000|NOT COMPLETED|Overall Study||1
10464632|NCT01047436|11612423|FG001|NOT COMPLETED|Overall Study||0
10464633|NCT01047475|11612431|FG000|STARTED|Overall Study||34
10464634|NCT01047475|11612432|FG001|STARTED|Overall Study||38
10464635|NCT01047475|11612431|FG000|COMPLETED|Overall Study||29
10464636|NCT01047475|11612432|FG001|COMPLETED|Overall Study||31
10464637|NCT01047475|11612431|FG000|NOT COMPLETED|Overall Study||5
10464638|NCT01047475|11612432|FG001|NOT COMPLETED|Overall Study||7
10464639|NCT01047527|11612441|FG000|STARTED|Overall Study||180
10464640|NCT01047527|11612442|FG001|STARTED|Overall Study||173
10464641|NCT01047527|11612443|FG002|STARTED|Overall Study||172
10464642|NCT01047527|11612441|FG000|8 Weeks|Overall Study||148
10464643|NCT01047527|11612442|FG001|8 Weeks|Overall Study||142
10464644|NCT01047527|11612443|FG002|8 Weeks|Overall Study||138
10464645|NCT01047527|11612441|FG000|24 Weeks|Overall Study||111
10464646|NCT01047527|11612442|FG001|24 Weeks|Overall Study||123
10464647|NCT01047527|11612443|FG002|24 Weeks|Overall Study||119
10464648|NCT01047527|11612441|FG000|COMPLETED|Overall Study||95
10464649|NCT01047527|11612442|FG001|COMPLETED|Overall Study||112
10464650|NCT01047527|11612443|FG002|COMPLETED|Overall Study||107
10464651|NCT01047527|11612441|FG000|NOT COMPLETED|Overall Study||85
10464652|NCT01047527|11612442|FG001|NOT COMPLETED|Overall Study||61
10464653|NCT01047527|11612443|FG002|NOT COMPLETED|Overall Study||65
10464654|NCT01047553|11612454|FG000|STARTED|Overall Study||125
10464655|NCT01047553|11612455|FG001|STARTED|Overall Study||126
10464656|NCT01047553|11612454|FG000|COMPLETED|Overall Study||108
10464657|NCT01047553|11612455|FG001|COMPLETED|Overall Study||117
10464658|NCT01047553|11612454|FG000|NOT COMPLETED|Overall Study||17
10464659|NCT01047553|11612455|FG001|NOT COMPLETED|Overall Study||9
10464660|NCT01047709|11612461|FG000|STARTED|Positional Therapy (1 Night)||9
10464661|NCT01047709|11612462|FG001|STARTED|Positional Therapy (1 Night)||9
10464662|NCT01047709|11612461|FG000|COMPLETED|Positional Therapy (1 Night)||9
10464663|NCT01047709|11612462|FG001|COMPLETED|Positional Therapy (1 Night)||9
10464664|NCT01047709|11612461|FG000|NOT COMPLETED|Positional Therapy (1 Night)||0
10708579|NCT02632110|11873414|FG008|STARTED|Overall Study||30
10464665|NCT01047709|11612462|FG001|NOT COMPLETED|Positional Therapy (1 Night)||0
10464666|NCT01047709|11612461|FG000|STARTED|Control/Positioning ad Lib (1 Night)||9
10464667|NCT01047709|11612462|FG001|STARTED|Control/Positioning ad Lib (1 Night)||9
10464668|NCT01047709|11612461|FG000|COMPLETED|Control/Positioning ad Lib (1 Night)||9
10464669|NCT01047709|11612462|FG001|COMPLETED|Control/Positioning ad Lib (1 Night)||9
10464670|NCT01047709|11612461|FG000|NOT COMPLETED|Control/Positioning ad Lib (1 Night)||0
10464671|NCT01047709|11612462|FG001|NOT COMPLETED|Control/Positioning ad Lib (1 Night)||0
10464672|NCT01047839|11612471|FG000|STARTED|Overall Study||12
10464673|NCT01047839|11612472|FG001|STARTED|Overall Study||29
10464674|NCT01047839|11612473|FG002|STARTED|Overall Study||59
10464675|NCT01047839|11612471|FG000|COMPLETED|Overall Study||10
10464676|NCT01047839|11612472|FG001|COMPLETED|Overall Study||29
10464677|NCT01047839|11612473|FG002|COMPLETED|Overall Study||53
10464678|NCT01047839|11612471|FG000|NOT COMPLETED|Overall Study||2
10464679|NCT01047839|11612472|FG001|NOT COMPLETED|Overall Study||0
10464680|NCT01047839|11612473|FG002|NOT COMPLETED|Overall Study||6
10464681|NCT01048099|11612488|FG000|STARTED|Patients Enrolled and Blood Collected|Patients enrolled|283
10708580|NCT02632110|11873415|FG009|STARTED|Overall Study||30
10464682|NCT01048099|11612488|FG000|COMPLETED|Patients Enrolled and Blood Collected|Patients with circulating tumor cells (CTCs)|226
10464683|NCT01048099|11612488|FG000|NOT COMPLETED|Patients Enrolled and Blood Collected||57
10464684|NCT01048099|11612488|FG000|STARTED|Patients Evaluated by PRO Onc Assay|Patients with CTCs who were evaluated by PRO Onc Assay|226
10464685|NCT01048099|11612488|FG000|COMPLETED|Patients Evaluated by PRO Onc Assay|Patients evaluated by PRO Onc Assay with HER2 overexpression/activation detected|24
10464686|NCT01048099|11612488|FG000|NOT COMPLETED|Patients Evaluated by PRO Onc Assay||202
10464687|NCT01048099|11612488|FG000|STARTED|Pts w/ HER2 Overexpression/Activation|Patients with detected HER2 activation and/or overexpression|24
10708581|NCT02632110|11873406|FG000|COMPLETED|Overall Study||24
10464688|NCT01048099|11612488|FG000|COMPLETED|Pts w/ HER2 Overexpression/Activation|Patients who proceeded to treatment|14
10464689|NCT01048099|11612488|FG000|NOT COMPLETED|Pts w/ HER2 Overexpression/Activation||10
10464690|NCT01048099|11612488|FG000|STARTED|Treatment Per Protocol||14
10464691|NCT01048099|11612488|FG000|COMPLETED|Treatment Per Protocol|Patients continued treatment until disease progression or coming off-study for any other reason|0
10464692|NCT01048099|11612488|FG000|NOT COMPLETED|Treatment Per Protocol||14
10464693|NCT01048242|11612496|FG000|STARTED|Overall Study||12
10464694|NCT01048242|11612497|FG001|STARTED|Overall Study||15
10464695|NCT01048242|11612496|FG000|COMPLETED|Overall Study||8
10464696|NCT01048242|11612497|FG001|COMPLETED|Overall Study||13
10464697|NCT01048242|11612496|FG000|NOT COMPLETED|Overall Study||4
10464698|NCT01048242|11612497|FG001|NOT COMPLETED|Overall Study||2
10464699|NCT01048333|11612503|FG000|STARTED|Treatment Period 1||21
10464700|NCT01048333|11612504|FG001|STARTED|Treatment Period 1||19
10464701|NCT01048333|11612505|FG002|STARTED|Treatment Period 1||16
10464702|NCT01048333|11612506|FG003|STARTED|Treatment Period 1||18
10464703|NCT01048333|11612507|FG004|STARTED|Treatment Period 1||17
10464704|NCT01048333|11612508|FG005|STARTED|Treatment Period 1||18
10464705|NCT01048333|11612503|FG000|COMPLETED|Treatment Period 1||21
10464706|NCT01048333|11612504|FG001|COMPLETED|Treatment Period 1||19
10464707|NCT01048333|11612505|FG002|COMPLETED|Treatment Period 1||16
10464708|NCT01048333|11612506|FG003|COMPLETED|Treatment Period 1||18
10464709|NCT01048333|11612507|FG004|COMPLETED|Treatment Period 1||17
10464710|NCT01048333|11612508|FG005|COMPLETED|Treatment Period 1||18
10464711|NCT01048333|11612503|FG000|NOT COMPLETED|Treatment Period 1||0
10464712|NCT01048333|11612504|FG001|NOT COMPLETED|Treatment Period 1||0
10464713|NCT01048333|11612505|FG002|NOT COMPLETED|Treatment Period 1||0
10464714|NCT01048333|11612506|FG003|NOT COMPLETED|Treatment Period 1||0
10464715|NCT01048333|11612507|FG004|NOT COMPLETED|Treatment Period 1||0
10464716|NCT01048333|11612508|FG005|NOT COMPLETED|Treatment Period 1||0
10464717|NCT01048333|11612503|FG000|STARTED|Wash-Out Period 1 of 2 - 7 Days||21
10464718|NCT01048333|11612504|FG001|STARTED|Wash-Out Period 1 of 2 - 7 Days||19
10464719|NCT01048333|11612505|FG002|STARTED|Wash-Out Period 1 of 2 - 7 Days||16
10464720|NCT01048333|11612506|FG003|STARTED|Wash-Out Period 1 of 2 - 7 Days||18
10464721|NCT01048333|11612507|FG004|STARTED|Wash-Out Period 1 of 2 - 7 Days||17
10464722|NCT01048333|11612508|FG005|STARTED|Wash-Out Period 1 of 2 - 7 Days||18
10464723|NCT01048333|11612503|FG000|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||21
10464724|NCT01048333|11612504|FG001|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||19
10464725|NCT01048333|11612505|FG002|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||16
10464726|NCT01048333|11612506|FG003|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||18
10464727|NCT01048333|11612507|FG004|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||17
10464728|NCT01048333|11612508|FG005|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||18
10464729|NCT01048333|11612503|FG000|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
10464730|NCT01048333|11612504|FG001|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
10464731|NCT01048333|11612505|FG002|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
10464732|NCT01048333|11612506|FG003|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
10464733|NCT01048333|11612507|FG004|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
10464734|NCT01048333|11612508|FG005|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
10464735|NCT01048333|11612503|FG000|STARTED|Treatment Period 2||21
10464736|NCT01048333|11612504|FG001|STARTED|Treatment Period 2||19
10464737|NCT01048333|11612505|FG002|STARTED|Treatment Period 2||16
10464738|NCT01048333|11612506|FG003|STARTED|Treatment Period 2||18
10464739|NCT01048333|11612507|FG004|STARTED|Treatment Period 2||17
10464740|NCT01048333|11612508|FG005|STARTED|Treatment Period 2||18
10464741|NCT01048333|11612503|FG000|COMPLETED|Treatment Period 2||21
10464742|NCT01048333|11612504|FG001|COMPLETED|Treatment Period 2||19
10464743|NCT01048333|11612505|FG002|COMPLETED|Treatment Period 2||16
10464744|NCT01048333|11612506|FG003|COMPLETED|Treatment Period 2||18
10464745|NCT01048333|11612507|FG004|COMPLETED|Treatment Period 2||17
10464746|NCT01048333|11612508|FG005|COMPLETED|Treatment Period 2||18
10464747|NCT01048333|11612503|FG000|NOT COMPLETED|Treatment Period 2||0
10464748|NCT01048333|11612504|FG001|NOT COMPLETED|Treatment Period 2||0
10464749|NCT01048333|11612505|FG002|NOT COMPLETED|Treatment Period 2||0
10464750|NCT01048333|11612506|FG003|NOT COMPLETED|Treatment Period 2||0
10464751|NCT01048333|11612507|FG004|NOT COMPLETED|Treatment Period 2||0
10464752|NCT01048333|11612508|FG005|NOT COMPLETED|Treatment Period 2||0
10464753|NCT01048333|11612503|FG000|STARTED|Wash-Out Period 2 of 2 - 7 Days||21
10464754|NCT01048333|11612504|FG001|STARTED|Wash-Out Period 2 of 2 - 7 Days||19
10464755|NCT01048333|11612505|FG002|STARTED|Wash-Out Period 2 of 2 - 7 Days||16
10464756|NCT01048333|11612506|FG003|STARTED|Wash-Out Period 2 of 2 - 7 Days||18
10464757|NCT01048333|11612507|FG004|STARTED|Wash-Out Period 2 of 2 - 7 Days||17
10464758|NCT01048333|11612508|FG005|STARTED|Wash-Out Period 2 of 2 - 7 Days||18
10464759|NCT01048333|11612503|FG000|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||21
10464760|NCT01048333|11612504|FG001|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
10464761|NCT01048333|11612505|FG002|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||16
10464762|NCT01048333|11612506|FG003|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
10464763|NCT01048333|11612507|FG004|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||17
10464764|NCT01048333|11612508|FG005|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
10464765|NCT01048333|11612503|FG000|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
10464766|NCT01048333|11612504|FG001|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||1
10464767|NCT01048333|11612505|FG002|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
10464768|NCT01048333|11612506|FG003|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
10464769|NCT01048333|11612507|FG004|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
10464770|NCT01048333|11612508|FG005|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
10464771|NCT01048333|11612503|FG000|STARTED|Treatment Period 3||21
10464772|NCT01048333|11612504|FG001|STARTED|Treatment Period 3||18
10464773|NCT01048333|11612505|FG002|STARTED|Treatment Period 3||16
10464774|NCT01048333|11612506|FG003|STARTED|Treatment Period 3||18
10464775|NCT01048333|11612507|FG004|STARTED|Treatment Period 3||17
10464776|NCT01048333|11612508|FG005|STARTED|Treatment Period 3||18
10464777|NCT01048333|11612503|FG000|COMPLETED|Treatment Period 3||21
10464778|NCT01048333|11612504|FG001|COMPLETED|Treatment Period 3||18
10464779|NCT01048333|11612505|FG002|COMPLETED|Treatment Period 3||16
10464780|NCT01048333|11612506|FG003|COMPLETED|Treatment Period 3||18
10464781|NCT01048333|11612507|FG004|COMPLETED|Treatment Period 3||17
10464782|NCT01048333|11612508|FG005|COMPLETED|Treatment Period 3||18
10464783|NCT01048333|11612503|FG000|NOT COMPLETED|Treatment Period 3||0
10464784|NCT01048333|11612504|FG001|NOT COMPLETED|Treatment Period 3||0
10464785|NCT01048333|11612505|FG002|NOT COMPLETED|Treatment Period 3||0
10464786|NCT01048333|11612506|FG003|NOT COMPLETED|Treatment Period 3||0
10464787|NCT01048333|11612507|FG004|NOT COMPLETED|Treatment Period 3||0
10464788|NCT01048333|11612508|FG005|NOT COMPLETED|Treatment Period 3||0
10464789|NCT01048424|11612518|FG000|STARTED|Overall Study||10
10464790|NCT01048424|11612519|FG001|STARTED|Overall Study||10
10464791|NCT01048424|11612518|FG000|COMPLETED|Overall Study||8
10464792|NCT01048424|11612519|FG001|COMPLETED|Overall Study||10
10464793|NCT01048424|11612518|FG000|NOT COMPLETED|Overall Study||2
10464794|NCT01048424|11612519|FG001|NOT COMPLETED|Overall Study||0
10464795|NCT01048502|11612530|FG000|STARTED|Overall Study||24
10464796|NCT01048502|11612531|FG001|STARTED|Overall Study||23
10464797|NCT01048502|11612532|FG002|STARTED|Overall Study||28
10464798|NCT01048502|11612533|FG003|STARTED|Overall Study||25
10464799|NCT01048502|11612530|FG000|COMPLETED|Overall Study||20
10464800|NCT01048502|11612531|FG001|COMPLETED|Overall Study||16
10464801|NCT01048502|11612532|FG002|COMPLETED|Overall Study||23
10464802|NCT01048502|11612533|FG003|COMPLETED|Overall Study||21
10464803|NCT01048502|11612530|FG000|NOT COMPLETED|Overall Study||4
10464804|NCT01048502|11612531|FG001|NOT COMPLETED|Overall Study||7
10464805|NCT01048502|11612532|FG002|NOT COMPLETED|Overall Study||5
10464806|NCT01048502|11612533|FG003|NOT COMPLETED|Overall Study||4
10464807|NCT01048541|11612544|FG000|STARTED|Overall Study||18
10464808|NCT01048541|11612545|FG001|STARTED|Overall Study||19
10464809|NCT01048541|11612544|FG000|COMPLETED|Overall Study||17
10464810|NCT01048541|11612545|FG001|COMPLETED|Overall Study||19
10464811|NCT01048541|11612544|FG000|NOT COMPLETED|Overall Study||1
10464812|NCT01048541|11612545|FG001|NOT COMPLETED|Overall Study||0
10464813|NCT01048593|11612554|FG000|STARTED|Overall Study||3
10464814|NCT01048593|11612555|FG001|STARTED|Overall Study||2
10464815|NCT01048593|11612556|FG002|STARTED|Overall Study||1
10464816|NCT01048593|11612554|FG000|COMPLETED|Overall Study||3
10464817|NCT01048593|11612555|FG001|COMPLETED|Overall Study||2
10464818|NCT01048593|11612556|FG002|COMPLETED|Overall Study||1
10464819|NCT01048593|11612554|FG000|NOT COMPLETED|Overall Study||0
10464820|NCT01048593|11612555|FG001|NOT COMPLETED|Overall Study||0
10464821|NCT01048593|11612556|FG002|NOT COMPLETED|Overall Study||0
10464822|NCT01048606|11612568|FG000|STARTED|Overall Study||28
10464823|NCT01048606|11612569|FG001|STARTED|Overall Study||15
10464824|NCT01048606|11612570|FG002|STARTED|Overall Study||26
10464825|NCT01048606|11612571|FG003|STARTED|Overall Study||10
10464826|NCT01048606|11612568|FG000|COMPLETED|Overall Study||16
10464827|NCT01048606|11612569|FG001|COMPLETED|Overall Study||8
10464828|NCT01048606|11612570|FG002|COMPLETED|Overall Study||16
10464829|NCT01048606|11612571|FG003|COMPLETED|Overall Study||5
10464830|NCT01048606|11612568|FG000|NOT COMPLETED|Overall Study||12
10464831|NCT01048606|11612569|FG001|NOT COMPLETED|Overall Study||7
10464832|NCT01048606|11612570|FG002|NOT COMPLETED|Overall Study||10
10464833|NCT01048606|11612571|FG003|NOT COMPLETED|Overall Study||5
10464834|NCT01048658|11612583|FG000|STARTED|Overall Study||80
10464835|NCT01048658|11612584|FG001|STARTED|Overall Study||80
10464836|NCT01048658|11612583|FG000|COMPLETED|Overall Study||80
10464837|NCT01048658|11612584|FG001|COMPLETED|Overall Study||80
10464838|NCT01048658|11612583|FG000|NOT COMPLETED|Overall Study||0
10464839|NCT01048658|11612584|FG001|NOT COMPLETED|Overall Study||0
10464840|NCT01048671|11612593|FG000|STARTED|Overall Study||66
10464841|NCT01048671|11612594|FG001|STARTED|Overall Study||264
10464842|NCT01048671|11612595|FG002|STARTED|Overall Study||152
10464843|NCT01048671|11612593|FG000|COMPLETED|Overall Study||66
10464844|NCT01048671|11612594|FG001|COMPLETED|Overall Study||263
10464845|NCT01048671|11612595|FG002|COMPLETED|Overall Study||151
10464846|NCT01048671|11612593|FG000|NOT COMPLETED|Overall Study||0
10464847|NCT01048671|11612594|FG001|NOT COMPLETED|Overall Study||1
10464848|NCT01048671|11612595|FG002|NOT COMPLETED|Overall Study||1
10464849|NCT01048697|11612603|FG000|STARTED|Overall Study||18
10464850|NCT01048697|11612603|FG000|COMPLETED|Overall Study||18
10464851|NCT01048697|11612603|FG000|NOT COMPLETED|Overall Study||0
10464852|NCT01048788|11612610|FG000|STARTED|Overall Study||8
10464853|NCT01048788|11612611|FG001|STARTED|Overall Study||30
10464854|NCT01048788|11612612|FG002|STARTED|Overall Study||13
10464855|NCT01048788|11612610|FG000|COMPLETED|Overall Study||3
10464856|NCT01048788|11612611|FG001|COMPLETED|Overall Study||28
10464857|NCT01048788|11612612|FG002|COMPLETED|Overall Study||11
10464858|NCT01048788|11612610|FG000|NOT COMPLETED|Overall Study||5
10464859|NCT01048788|11612611|FG001|NOT COMPLETED|Overall Study||2
10464860|NCT01048788|11612612|FG002|NOT COMPLETED|Overall Study||2
10464861|NCT01048866|11612622|FG000|STARTED|Overall Study||101
10464862|NCT01048866|11612623|FG001|STARTED|Overall Study||97
10464863|NCT01048866|11612622|FG000|COMPLETED|Overall Study||97
10464864|NCT01048866|11612623|FG001|COMPLETED|Overall Study||92
10464865|NCT01048866|11612622|FG000|NOT COMPLETED|Overall Study||4
10464866|NCT01048866|11612623|FG001|NOT COMPLETED|Overall Study||5
10464867|NCT01048879|11612632|FG000|STARTED|Overall Study||1
10464868|NCT01048879|11612633|FG001|STARTED|Overall Study||9
10464869|NCT01048879|11612634|FG002|STARTED|Overall Study||5
10464870|NCT01048879|11612632|FG000|COMPLETED|Overall Study||1
10464871|NCT01048879|11612633|FG001|COMPLETED|Overall Study||9
10464872|NCT01048879|11612634|FG002|COMPLETED|Overall Study||5
10464873|NCT01048879|11612632|FG000|NOT COMPLETED|Overall Study||0
10464874|NCT01048879|11612633|FG001|NOT COMPLETED|Overall Study||0
10464875|NCT01048879|11612634|FG002|NOT COMPLETED|Overall Study||0
10464876|NCT01048905|11612642|FG000|STARTED|Overall Study||13
10464877|NCT01048905|11612642|FG000|COMPLETED|Overall Study||12
10464878|NCT01048905|11612642|FG000|NOT COMPLETED|Overall Study||1
10464879|NCT01048944|11612650|FG000|STARTED|Overall Study||32
10464880|NCT01048944|11612651|FG001|STARTED|Overall Study||38
10464881|NCT01048944|11612652|FG002|STARTED|Overall Study||35
10464882|NCT01048944|11612653|FG003|STARTED|Overall Study||21
10464883|NCT01048944|11612650|FG000|COMPLETED|Overall Study||24
10464884|NCT01048944|11612651|FG001|COMPLETED|Overall Study||28
10464885|NCT01048944|11612652|FG002|COMPLETED|Overall Study||25
10464886|NCT01048944|11612653|FG003|COMPLETED|Overall Study||19
10464887|NCT01048944|11612650|FG000|NOT COMPLETED|Overall Study||8
10464888|NCT01048944|11612651|FG001|NOT COMPLETED|Overall Study||10
10464889|NCT01048944|11612652|FG002|NOT COMPLETED|Overall Study||10
10464890|NCT01048944|11612653|FG003|NOT COMPLETED|Overall Study||2
10464891|NCT01049009|11612665|FG000|STARTED|Treatment Period 1 (12 Weeks)||23
10464892|NCT01049009|11612666|FG001|STARTED|Treatment Period 1 (12 Weeks)||21
10464893|NCT01049009|11612665|FG000|COMPLETED|Treatment Period 1 (12 Weeks)||21
10464894|NCT01049009|11612666|FG001|COMPLETED|Treatment Period 1 (12 Weeks)||18
10464895|NCT01049009|11612665|FG000|NOT COMPLETED|Treatment Period 1 (12 Weeks)||2
10464896|NCT01049009|11612666|FG001|NOT COMPLETED|Treatment Period 1 (12 Weeks)||3
10464897|NCT01049009|11612665|FG000|STARTED|Treatment Period 2 (12 Weeks)||21
10464898|NCT01049009|11612666|FG001|STARTED|Treatment Period 2 (12 Weeks)||18
10464899|NCT01049009|11612665|FG000|COMPLETED|Treatment Period 2 (12 Weeks)||11
10464900|NCT01049009|11612666|FG001|COMPLETED|Treatment Period 2 (12 Weeks)||8
10464901|NCT01049009|11612665|FG000|NOT COMPLETED|Treatment Period 2 (12 Weeks)||10
10464902|NCT01049009|11612666|FG001|NOT COMPLETED|Treatment Period 2 (12 Weeks)||10
10464903|NCT01049217|11612674|FG000|STARTED|Overall Study||183
10464904|NCT01049217|11612675|FG001|STARTED|Overall Study||194
10464905|NCT01049217|11612674|FG000|Treated|Overall Study||183
10464906|NCT01049217|11612675|FG001|Treated|Overall Study||192
10464907|NCT01049217|11612674|FG000|COMPLETED|Overall Study||127
10464908|NCT01049217|11612675|FG001|COMPLETED|Overall Study||131
10464909|NCT01049217|11612674|FG000|NOT COMPLETED|Overall Study||56
10464910|NCT01049217|11612675|FG001|NOT COMPLETED|Overall Study||63
10464911|NCT01049243|11612681|FG000|STARTED|Overall Study||20
10464912|NCT01049243|11612681|FG000|COMPLETED|Overall Study||18
10464913|NCT01049243|11612681|FG000|NOT COMPLETED|Overall Study||2
10464914|NCT01049308|11612686|FG000|STARTED|Evaluation of Cognitive Impairment||251
10464915|NCT01049308|11612686|FG000|COMPLETED|Evaluation of Cognitive Impairment||251
10464916|NCT01049308|11612686|FG000|NOT COMPLETED|Evaluation of Cognitive Impairment||0
10464917|NCT01049308|11612686|FG000|STARTED|Pill Counts||251
10464918|NCT01049308|11612686|FG000|COMPLETED|Pill Counts||168
10464919|NCT01049308|11612686|FG000|NOT COMPLETED|Pill Counts||83
10464920|NCT01049334|11612695|FG000|STARTED|Overall Study||102
10464921|NCT01049334|11612696|FG001|STARTED|Overall Study||102
10464922|NCT01049334|11612695|FG000|COMPLETED|Overall Study||93
10464923|NCT01049334|11612696|FG001|COMPLETED|Overall Study||95
10464924|NCT01049334|11612695|FG000|NOT COMPLETED|Overall Study||9
10464925|NCT01049334|11612696|FG001|NOT COMPLETED|Overall Study||7
10464926|NCT01049360|11612702|FG000|STARTED|Period 1||6
10464927|NCT01049360|11612703|FG001|STARTED|Period 1||6
10464928|NCT01049360|11612704|FG002|STARTED|Period 1||7
10464929|NCT01049360|11612705|FG003|STARTED|Period 1||7
10464930|NCT01049360|11612706|FG004|STARTED|Period 1||7
10464931|NCT01049360|11612707|FG005|STARTED|Period 1||6
10464932|NCT01049360|11612708|FG006|STARTED|Period 1||6
10464933|NCT01049360|11612709|FG007|STARTED|Period 1||6
10464934|NCT01049360|11612710|FG008|STARTED|Period 1||7
10464935|NCT01049360|11612711|FG009|STARTED|Period 1||6
10464936|NCT01049360|11612712|FG010|STARTED|Period 1||6
10464937|NCT01049360|11612713|FG011|STARTED|Period 1||6
10464938|NCT01049360|11612714|FG012|STARTED|Period 1||6
10464939|NCT01049360|11612715|FG013|STARTED|Period 1||7
10464940|NCT01049360|11612716|FG014|STARTED|Period 1||7
10464941|NCT01049360|11612717|FG015|STARTED|Period 1||7
10464942|NCT01049360|11612718|FG016|STARTED|Period 1||6
10464943|NCT01049360|11612719|FG017|STARTED|Period 1||6
10464944|NCT01049360|11612720|FG018|STARTED|Period 1||6
10464945|NCT01049360|11612721|FG019|STARTED|Period 1||7
10464946|NCT01049360|11612702|FG000|COMPLETED|Period 1||6
10464947|NCT01049360|11612703|FG001|COMPLETED|Period 1||5
10464948|NCT01049360|11612704|FG002|COMPLETED|Period 1||7
10464949|NCT01049360|11612705|FG003|COMPLETED|Period 1||6
10464950|NCT01049360|11612706|FG004|COMPLETED|Period 1||7
10464951|NCT01049360|11612707|FG005|COMPLETED|Period 1||6
10464952|NCT01049360|11612708|FG006|COMPLETED|Period 1||6
10464953|NCT01049360|11612709|FG007|COMPLETED|Period 1||4
10464954|NCT01049360|11612710|FG008|COMPLETED|Period 1||5
10464955|NCT01049360|11612711|FG009|COMPLETED|Period 1||6
10464956|NCT01049360|11612712|FG010|COMPLETED|Period 1||5
10464957|NCT01049360|11612713|FG011|COMPLETED|Period 1||6
10464958|NCT01049360|11612714|FG012|COMPLETED|Period 1||4
10464959|NCT01049360|11612715|FG013|COMPLETED|Period 1||6
10464960|NCT01049360|11612716|FG014|COMPLETED|Period 1||7
10464961|NCT01049360|11612717|FG015|COMPLETED|Period 1||7
10464962|NCT01049360|11612718|FG016|COMPLETED|Period 1||5
10464963|NCT01049360|11612719|FG017|COMPLETED|Period 1||6
10464964|NCT01049360|11612720|FG018|COMPLETED|Period 1||5
10464965|NCT01049360|11612721|FG019|COMPLETED|Period 1||7
10464966|NCT01049360|11612702|FG000|NOT COMPLETED|Period 1||0
10464967|NCT01049360|11612703|FG001|NOT COMPLETED|Period 1||1
10464968|NCT01049360|11612704|FG002|NOT COMPLETED|Period 1||0
10464969|NCT01049360|11612705|FG003|NOT COMPLETED|Period 1||1
10464970|NCT01049360|11612706|FG004|NOT COMPLETED|Period 1||0
10464971|NCT01049360|11612707|FG005|NOT COMPLETED|Period 1||0
10464972|NCT01049360|11612708|FG006|NOT COMPLETED|Period 1||0
10464973|NCT01049360|11612709|FG007|NOT COMPLETED|Period 1||2
10464974|NCT01049360|11612710|FG008|NOT COMPLETED|Period 1||2
10464975|NCT01049360|11612711|FG009|NOT COMPLETED|Period 1||0
10708582|NCT02632110|11873407|FG001|COMPLETED|Overall Study||24
10708583|NCT02632110|11873408|FG002|COMPLETED|Overall Study||27
10464976|NCT01049360|11612712|FG010|NOT COMPLETED|Period 1||1
10464977|NCT01049360|11612713|FG011|NOT COMPLETED|Period 1||0
10464978|NCT01049360|11612714|FG012|NOT COMPLETED|Period 1||2
10464979|NCT01049360|11612715|FG013|NOT COMPLETED|Period 1||1
10464980|NCT01049360|11612716|FG014|NOT COMPLETED|Period 1||0
10464981|NCT01049360|11612717|FG015|NOT COMPLETED|Period 1||0
10464982|NCT01049360|11612718|FG016|NOT COMPLETED|Period 1||1
10464983|NCT01049360|11612719|FG017|NOT COMPLETED|Period 1||0
10464984|NCT01049360|11612720|FG018|NOT COMPLETED|Period 1||1
10464985|NCT01049360|11612721|FG019|NOT COMPLETED|Period 1||0
10464986|NCT01049360|11612702|FG000|STARTED|Period 2||6
10464987|NCT01049360|11612703|FG001|STARTED|Period 2||5
10464988|NCT01049360|11612704|FG002|STARTED|Period 2||7
10464989|NCT01049360|11612705|FG003|STARTED|Period 2||6
10464990|NCT01049360|11612706|FG004|STARTED|Period 2||7
10464991|NCT01049360|11612707|FG005|STARTED|Period 2||6
10464992|NCT01049360|11612708|FG006|STARTED|Period 2||6
10464993|NCT01049360|11612709|FG007|STARTED|Period 2||4
10464994|NCT01049360|11612710|FG008|STARTED|Period 2||5
10464995|NCT01049360|11612711|FG009|STARTED|Period 2||6
10464996|NCT01049360|11612712|FG010|STARTED|Period 2||5
10464997|NCT01049360|11612713|FG011|STARTED|Period 2||6
10464998|NCT01049360|11612714|FG012|STARTED|Period 2||4
10464999|NCT01049360|11612715|FG013|STARTED|Period 2||6
10465000|NCT01049360|11612716|FG014|STARTED|Period 2||7
10465001|NCT01049360|11612717|FG015|STARTED|Period 2||7
10465002|NCT01049360|11612718|FG016|STARTED|Period 2||5
10465003|NCT01049360|11612719|FG017|STARTED|Period 2||6
10465004|NCT01049360|11612720|FG018|STARTED|Period 2||5
10465005|NCT01049360|11612721|FG019|STARTED|Period 2||7
10465006|NCT01049360|11612702|FG000|COMPLETED|Period 2||6
10465007|NCT01049360|11612703|FG001|COMPLETED|Period 2||4
10465008|NCT01049360|11612704|FG002|COMPLETED|Period 2||7
10465009|NCT01049360|11612705|FG003|COMPLETED|Period 2||4
10465010|NCT01049360|11612706|FG004|COMPLETED|Period 2||7
10465011|NCT01049360|11612707|FG005|COMPLETED|Period 2||5
10708584|NCT02632110|11873409|FG003|COMPLETED|Overall Study||27
10465012|NCT01049360|11612708|FG006|COMPLETED|Period 2||6
10465013|NCT01049360|11612709|FG007|COMPLETED|Period 2||4
10465014|NCT01049360|11612710|FG008|COMPLETED|Period 2||4
10708585|NCT02632110|11873410|FG004|COMPLETED|Overall Study||28
10465015|NCT01049360|11612711|FG009|COMPLETED|Period 2||6
10465016|NCT01049360|11612712|FG010|COMPLETED|Period 2||5
10465017|NCT01049360|11612713|FG011|COMPLETED|Period 2||6
10465018|NCT01049360|11612714|FG012|COMPLETED|Period 2||4
10465019|NCT01049360|11612715|FG013|COMPLETED|Period 2||6
10465020|NCT01049360|11612716|FG014|COMPLETED|Period 2||5
10465021|NCT01049360|11612717|FG015|COMPLETED|Period 2||6
10465022|NCT01049360|11612718|FG016|COMPLETED|Period 2||5
10465023|NCT01049360|11612719|FG017|COMPLETED|Period 2||6
10465024|NCT01049360|11612720|FG018|COMPLETED|Period 2||5
10465025|NCT01049360|11612721|FG019|COMPLETED|Period 2||5
10465026|NCT01049360|11612702|FG000|NOT COMPLETED|Period 2||0
10465027|NCT01049360|11612703|FG001|NOT COMPLETED|Period 2||1
10465028|NCT01049360|11612704|FG002|NOT COMPLETED|Period 2||0
10708586|NCT02632110|11873411|FG005|COMPLETED|Overall Study||28
10465029|NCT01049360|11612705|FG003|NOT COMPLETED|Period 2||2
10465030|NCT01049360|11612706|FG004|NOT COMPLETED|Period 2||0
10465031|NCT01049360|11612707|FG005|NOT COMPLETED|Period 2||1
10465032|NCT01049360|11612708|FG006|NOT COMPLETED|Period 2||0
10465033|NCT01049360|11612709|FG007|NOT COMPLETED|Period 2||0
10465034|NCT01049360|11612710|FG008|NOT COMPLETED|Period 2||1
10465035|NCT01049360|11612711|FG009|NOT COMPLETED|Period 2||0
10465036|NCT01049360|11612712|FG010|NOT COMPLETED|Period 2||0
10465037|NCT01049360|11612713|FG011|NOT COMPLETED|Period 2||0
10465038|NCT01049360|11612714|FG012|NOT COMPLETED|Period 2||0
10465039|NCT01049360|11612715|FG013|NOT COMPLETED|Period 2||0
10465040|NCT01049360|11612716|FG014|NOT COMPLETED|Period 2||2
10465041|NCT01049360|11612717|FG015|NOT COMPLETED|Period 2||1
10465042|NCT01049360|11612718|FG016|NOT COMPLETED|Period 2||0
10465043|NCT01049360|11612719|FG017|NOT COMPLETED|Period 2||0
10465044|NCT01049360|11612720|FG018|NOT COMPLETED|Period 2||0
10465045|NCT01049360|11612721|FG019|NOT COMPLETED|Period 2||2
10465046|NCT01049360|11612702|FG000|STARTED|Period 3||6
10465047|NCT01049360|11612703|FG001|STARTED|Period 3||4
10465048|NCT01049360|11612704|FG002|STARTED|Period 3||7
10465049|NCT01049360|11612705|FG003|STARTED|Period 3||4
10465050|NCT01049360|11612706|FG004|STARTED|Period 3||7
10465051|NCT01049360|11612707|FG005|STARTED|Period 3||5
10465052|NCT01049360|11612708|FG006|STARTED|Period 3||6
10465053|NCT01049360|11612709|FG007|STARTED|Period 3||4
10465054|NCT01049360|11612710|FG008|STARTED|Period 3||4
10465055|NCT01049360|11612711|FG009|STARTED|Period 3||6
10465056|NCT01049360|11612712|FG010|STARTED|Period 3||5
10465057|NCT01049360|11612713|FG011|STARTED|Period 3||6
10465058|NCT01049360|11612714|FG012|STARTED|Period 3||4
10465059|NCT01049360|11612715|FG013|STARTED|Period 3||6
10465060|NCT01049360|11612716|FG014|STARTED|Period 3||5
10465061|NCT01049360|11612717|FG015|STARTED|Period 3||6
10465062|NCT01049360|11612718|FG016|STARTED|Period 3||5
10465063|NCT01049360|11612719|FG017|STARTED|Period 3||6
10465064|NCT01049360|11612720|FG018|STARTED|Period 3||5
10465065|NCT01049360|11612721|FG019|STARTED|Period 3||5
10465066|NCT01049360|11612702|FG000|COMPLETED|Period 3||6
10465067|NCT01049360|11612703|FG001|COMPLETED|Period 3||4
10465068|NCT01049360|11612704|FG002|COMPLETED|Period 3||7
10465069|NCT01049360|11612705|FG003|COMPLETED|Period 3||4
10465070|NCT01049360|11612706|FG004|COMPLETED|Period 3||7
10465071|NCT01049360|11612707|FG005|COMPLETED|Period 3||5
10465072|NCT01049360|11612708|FG006|COMPLETED|Period 3||6
10465073|NCT01049360|11612709|FG007|COMPLETED|Period 3||4
10465074|NCT01049360|11612710|FG008|COMPLETED|Period 3||4
10465075|NCT01049360|11612711|FG009|COMPLETED|Period 3||6
10465076|NCT01049360|11612712|FG010|COMPLETED|Period 3||5
10465077|NCT01049360|11612713|FG011|COMPLETED|Period 3||6
10465078|NCT01049360|11612714|FG012|COMPLETED|Period 3||4
10465079|NCT01049360|11612715|FG013|COMPLETED|Period 3||6
10465080|NCT01049360|11612716|FG014|COMPLETED|Period 3||5
10465081|NCT01049360|11612717|FG015|COMPLETED|Period 3||6
10465082|NCT01049360|11612718|FG016|COMPLETED|Period 3||5
10465083|NCT01049360|11612719|FG017|COMPLETED|Period 3||6
10465084|NCT01049360|11612720|FG018|COMPLETED|Period 3||5
10465085|NCT01049360|11612721|FG019|COMPLETED|Period 3||5
10465086|NCT01049360|11612702|FG000|NOT COMPLETED|Period 3||0
10465087|NCT01049360|11612703|FG001|NOT COMPLETED|Period 3||0
10465088|NCT01049360|11612704|FG002|NOT COMPLETED|Period 3||0
10465089|NCT01049360|11612705|FG003|NOT COMPLETED|Period 3||0
10465090|NCT01049360|11612706|FG004|NOT COMPLETED|Period 3||0
10465091|NCT01049360|11612707|FG005|NOT COMPLETED|Period 3||0
10465092|NCT01049360|11612708|FG006|NOT COMPLETED|Period 3||0
10465093|NCT01049360|11612709|FG007|NOT COMPLETED|Period 3||0
10465094|NCT01049360|11612710|FG008|NOT COMPLETED|Period 3||0
10465095|NCT01049360|11612711|FG009|NOT COMPLETED|Period 3||0
10465096|NCT01049360|11612712|FG010|NOT COMPLETED|Period 3||0
10465097|NCT01049360|11612713|FG011|NOT COMPLETED|Period 3||0
10465098|NCT01049360|11612714|FG012|NOT COMPLETED|Period 3||0
10465099|NCT01049360|11612715|FG013|NOT COMPLETED|Period 3||0
10465100|NCT01049360|11612716|FG014|NOT COMPLETED|Period 3||0
10465101|NCT01049360|11612717|FG015|NOT COMPLETED|Period 3||0
10465102|NCT01049360|11612718|FG016|NOT COMPLETED|Period 3||0
10465103|NCT01049360|11612719|FG017|NOT COMPLETED|Period 3||0
10465104|NCT01049360|11612720|FG018|NOT COMPLETED|Period 3||0
10465105|NCT01049360|11612721|FG019|NOT COMPLETED|Period 3||0
10465106|NCT01049360|11612702|FG000|STARTED|Period 4||6
10465107|NCT01049360|11612703|FG001|STARTED|Period 4||4
10465108|NCT01049360|11612704|FG002|STARTED|Period 4||7
10465109|NCT01049360|11612705|FG003|STARTED|Period 4||4
10465110|NCT01049360|11612706|FG004|STARTED|Period 4||7
10465111|NCT01049360|11612707|FG005|STARTED|Period 4||5
10465112|NCT01049360|11612708|FG006|STARTED|Period 4||6
10465113|NCT01049360|11612709|FG007|STARTED|Period 4||4
10465114|NCT01049360|11612710|FG008|STARTED|Period 4||4
10465115|NCT01049360|11612711|FG009|STARTED|Period 4||6
10465116|NCT01049360|11612712|FG010|STARTED|Period 4||5
10465117|NCT01049360|11612713|FG011|STARTED|Period 4||6
10465118|NCT01049360|11612714|FG012|STARTED|Period 4||4
10465119|NCT01049360|11612715|FG013|STARTED|Period 4||6
10465120|NCT01049360|11612716|FG014|STARTED|Period 4||5
10465121|NCT01049360|11612717|FG015|STARTED|Period 4||6
10465122|NCT01049360|11612718|FG016|STARTED|Period 4||5
10465123|NCT01049360|11612719|FG017|STARTED|Period 4||6
10465124|NCT01049360|11612720|FG018|STARTED|Period 4||5
10465125|NCT01049360|11612721|FG019|STARTED|Period 4||5
10465126|NCT01049360|11612702|FG000|COMPLETED|Period 4||6
10465127|NCT01049360|11612703|FG001|COMPLETED|Period 4||4
10465128|NCT01049360|11612704|FG002|COMPLETED|Period 4||7
10465129|NCT01049360|11612705|FG003|COMPLETED|Period 4||3
10465130|NCT01049360|11612706|FG004|COMPLETED|Period 4||7
10465131|NCT01049360|11612707|FG005|COMPLETED|Period 4||5
10465132|NCT01049360|11612708|FG006|COMPLETED|Period 4||6
10465133|NCT01049360|11612709|FG007|COMPLETED|Period 4||4
10465134|NCT01049360|11612710|FG008|COMPLETED|Period 4||4
10465135|NCT01049360|11612711|FG009|COMPLETED|Period 4||6
10465136|NCT01049360|11612712|FG010|COMPLETED|Period 4||5
10465137|NCT01049360|11612713|FG011|COMPLETED|Period 4||6
10465138|NCT01049360|11612714|FG012|COMPLETED|Period 4||4
10465139|NCT01049360|11612715|FG013|COMPLETED|Period 4||6
10465140|NCT01049360|11612716|FG014|COMPLETED|Period 4||5
10465141|NCT01049360|11612717|FG015|COMPLETED|Period 4||6
10465142|NCT01049360|11612718|FG016|COMPLETED|Period 4||5
10465143|NCT01049360|11612719|FG017|COMPLETED|Period 4||5
10465144|NCT01049360|11612720|FG018|COMPLETED|Period 4||5
10465145|NCT01049360|11612721|FG019|COMPLETED|Period 4||5
10465146|NCT01049360|11612702|FG000|NOT COMPLETED|Period 4||0
10465147|NCT01049360|11612703|FG001|NOT COMPLETED|Period 4||0
10465148|NCT01049360|11612704|FG002|NOT COMPLETED|Period 4||0
10465149|NCT01049360|11612705|FG003|NOT COMPLETED|Period 4||1
10465150|NCT01049360|11612706|FG004|NOT COMPLETED|Period 4||0
10465151|NCT01049360|11612707|FG005|NOT COMPLETED|Period 4||0
10465152|NCT01049360|11612708|FG006|NOT COMPLETED|Period 4||0
10465153|NCT01049360|11612709|FG007|NOT COMPLETED|Period 4||0
10465154|NCT01049360|11612710|FG008|NOT COMPLETED|Period 4||0
10465155|NCT01049360|11612711|FG009|NOT COMPLETED|Period 4||0
10465156|NCT01049360|11612712|FG010|NOT COMPLETED|Period 4||0
10465157|NCT01049360|11612713|FG011|NOT COMPLETED|Period 4||0
10465158|NCT01049360|11612714|FG012|NOT COMPLETED|Period 4||0
10465159|NCT01049360|11612715|FG013|NOT COMPLETED|Period 4||0
10465160|NCT01049360|11612716|FG014|NOT COMPLETED|Period 4||0
10465161|NCT01049360|11612717|FG015|NOT COMPLETED|Period 4||0
10465162|NCT01049360|11612718|FG016|NOT COMPLETED|Period 4||0
10465163|NCT01049360|11612719|FG017|NOT COMPLETED|Period 4||1
10465164|NCT01049360|11612720|FG018|NOT COMPLETED|Period 4||0
10465165|NCT01049360|11612721|FG019|NOT COMPLETED|Period 4||0
10465166|NCT01049373|11612735|FG000|STARTED|Overall Study||112
10465167|NCT01049373|11612736|FG001|STARTED|Overall Study||109
10465168|NCT01049373|11612735|FG000|COMPLETED|Overall Study||73
10465169|NCT01049373|11612736|FG001|COMPLETED|Overall Study||65
10465170|NCT01049373|11612735|FG000|NOT COMPLETED|Overall Study||39
10465171|NCT01049373|11612736|FG001|NOT COMPLETED|Overall Study||44
10465172|NCT01049412|11612746|FG000|STARTED|Period I||70
10465173|NCT01049412|11612747|FG001|STARTED|Period I||68
10465174|NCT01049412|11612746|FG000|Took at Least One Dose of Study Drug|Period I||69
10465175|NCT01049412|11612747|FG001|Took at Least One Dose of Study Drug|Period I||68
10465176|NCT01049412|11612746|FG000|COMPLETED|Period I||62
10465177|NCT01049412|11612747|FG001|COMPLETED|Period I||55
10465178|NCT01049412|11612746|FG000|NOT COMPLETED|Period I||8
10465179|NCT01049412|11612747|FG001|NOT COMPLETED|Period I||13
10465180|NCT01049412|11612746|FG000|STARTED|Period II||62
10465181|NCT01049412|11612747|FG001|STARTED|Period II||55
10465182|NCT01049412|11612746|FG000|COMPLETED|Period II||58
10465183|NCT01049412|11612747|FG001|COMPLETED|Period II||52
10465184|NCT01049412|11612746|FG000|NOT COMPLETED|Period II||4
10465185|NCT01049412|11612747|FG001|NOT COMPLETED|Period II||3
10465186|NCT01049503|11612761|FG000|STARTED|Overall Study||52
10465187|NCT01049503|11612762|FG001|STARTED|Overall Study||48
10465188|NCT01049503|11612763|FG002|STARTED|Overall Study||56
10465189|NCT01049503|11612764|FG003|STARTED|Overall Study||55
10465190|NCT01049503|11612765|FG004|STARTED|Overall Study||56
10465191|NCT01049503|11612766|FG005|STARTED|Overall Study||48
10465192|NCT01049503|11612761|FG000|COMPLETED|Overall Study||41
10465193|NCT01049503|11612762|FG001|COMPLETED|Overall Study||36
10465194|NCT01049503|11612763|FG002|COMPLETED|Overall Study||32
10465195|NCT01049503|11612764|FG003|COMPLETED|Overall Study||29
10465196|NCT01049503|11612765|FG004|COMPLETED|Overall Study||29
10465197|NCT01049503|11612766|FG005|COMPLETED|Overall Study||40
10465198|NCT01049503|11612761|FG000|NOT COMPLETED|Overall Study||11
10465199|NCT01049503|11612762|FG001|NOT COMPLETED|Overall Study||12
10465200|NCT01049503|11612763|FG002|NOT COMPLETED|Overall Study||24
10465201|NCT01049503|11612764|FG003|NOT COMPLETED|Overall Study||26
10465202|NCT01049503|11612765|FG004|NOT COMPLETED|Overall Study||27
10465203|NCT01049503|11612766|FG005|NOT COMPLETED|Overall Study||8
10708587|NCT02632110|11873412|FG006|COMPLETED|Overall Study||23
10465204|NCT01049581|11612791|FG000|STARTED|Overall Study||13
10465205|NCT01049581|11612792|FG001|STARTED|Overall Study||14
10465206|NCT01049581|11612791|FG000|COMPLETED|Overall Study||11
10465207|NCT01049581|11612792|FG001|COMPLETED|Overall Study||13
10465208|NCT01049581|11612791|FG000|NOT COMPLETED|Overall Study||2
10465209|NCT01049581|11612792|FG001|NOT COMPLETED|Overall Study||1
10465210|NCT01049776|11612801|FG000|STARTED|Overall Study||32
10465211|NCT01049776|11612801|FG000|COMPLETED|Overall Study||12
10465212|NCT01049776|11612801|FG000|NOT COMPLETED|Overall Study||20
10465213|NCT01049802|11612807|FG000|STARTED|Overall Study||20
10465214|NCT01049802|11612808|FG001|STARTED|Overall Study||10
10465215|NCT01049802|11612807|FG000|COMPLETED|Overall Study||20
10708588|NCT02632110|11873413|FG007|COMPLETED|Overall Study||23
10465216|NCT01049802|11612808|FG001|COMPLETED|Overall Study||10
10465217|NCT01049802|11612807|FG000|NOT COMPLETED|Overall Study||0
10465218|NCT01049802|11612808|FG001|NOT COMPLETED|Overall Study||0
10465219|NCT01049919|11612816|FG000|STARTED|Overall Study||117
10465220|NCT01049919|11612817|FG001|STARTED|Overall Study|One participant is counted in both treatment groups due to one leg being randomized to each group.|36
10465221|NCT01049919|11612816|FG000|COMPLETED|Overall Study||65
10465222|NCT01049919|11612817|FG001|COMPLETED|Overall Study|Incl. 11 participants that received crossover treatment after completing 52 week primary follow up.|19
10465223|NCT01049919|11612816|FG000|NOT COMPLETED|Overall Study||52
10465224|NCT01049919|11612817|FG001|NOT COMPLETED|Overall Study||17
10465225|NCT01049945|11612825|FG000|STARTED|Overall Study||3
10465226|NCT01049945|11612826|FG001|STARTED|Overall Study||6
10465227|NCT01049945|11612827|FG002|STARTED|Overall Study||3
10465228|NCT01049945|11612828|FG003|STARTED|Overall Study||6
10465229|NCT01049945|11612829|FG004|STARTED|Overall Study||3
10465230|NCT01049945|11612830|FG005|STARTED|Overall Study||49
10465231|NCT01049945|11612825|FG000|COMPLETED|Overall Study||3
10465232|NCT01049945|11612826|FG001|COMPLETED|Overall Study||6
10465233|NCT01049945|11612827|FG002|COMPLETED|Overall Study||3
10465234|NCT01049945|11612828|FG003|COMPLETED|Overall Study||6
10465235|NCT01049945|11612829|FG004|COMPLETED|Overall Study||3
10465236|NCT01049945|11612830|FG005|COMPLETED|Overall Study||49
10465237|NCT01049945|11612825|FG000|NOT COMPLETED|Overall Study||0
10465238|NCT01049945|11612826|FG001|NOT COMPLETED|Overall Study||0
10465239|NCT01049945|11612827|FG002|NOT COMPLETED|Overall Study||0
10465240|NCT01049945|11612828|FG003|NOT COMPLETED|Overall Study||0
10465241|NCT01049945|11612829|FG004|NOT COMPLETED|Overall Study||0
10465242|NCT01049945|11612830|FG005|NOT COMPLETED|Overall Study||0
10465243|NCT01049984|11612846|FG000|STARTED|Overall Study||163
10465244|NCT01049984|11612847|FG001|STARTED|Overall Study||165
10465245|NCT01049984|11612846|FG000|Safety Population|Overall Study|One patient was randomized but not dosed; omitted from safety population|162
10465246|NCT01049984|11612847|FG001|Safety Population|Overall Study|One patient was randomized but not dosed; omitted from safety population|164
10465247|NCT01049984|11612846|FG000|Modified Intent-to-treat Pop|Overall Study|Took >= 1 dose of study drug and had both baseline and at least 1 post-baseline efficacy assessment|159
10465248|NCT01049984|11612847|FG001|Modified Intent-to-treat Pop|Overall Study|Took >= 1 dose of study drug and had both baseline and at least 1 post-baseline efficacy assessment|162
10465249|NCT01049984|11612846|FG000|COMPLETED|Overall Study||144
10465250|NCT01049984|11612847|FG001|COMPLETED|Overall Study||146
10465251|NCT01049984|11612846|FG000|NOT COMPLETED|Overall Study||19
10465252|NCT01049984|11612847|FG001|NOT COMPLETED|Overall Study||19
10465253|NCT01050062|11612855|FG000|STARTED|Overall Study||1070
10465254|NCT01050062|11612856|FG001|STARTED|Overall Study||355
10465255|NCT01050062|11612855|FG000|COMPLETED|Overall Study||799
10465256|NCT01050062|11612856|FG001|COMPLETED|Overall Study||243
10465257|NCT01050062|11612855|FG000|NOT COMPLETED|Overall Study||271
10465258|NCT01050062|11612856|FG001|NOT COMPLETED|Overall Study||112
10465259|NCT01050153|11612866|FG000|STARTED|Overall Study||25
10465260|NCT01050153|11612867|FG001|STARTED|Overall Study||25
10465261|NCT01050153|11612866|FG000|COMPLETED|Overall Study||25
10465262|NCT01050153|11612867|FG001|COMPLETED|Overall Study||25
10465263|NCT01050153|11612866|FG000|NOT COMPLETED|Overall Study||0
10465264|NCT01050153|11612867|FG001|NOT COMPLETED|Overall Study||0
10465265|NCT01050205|11612875|FG000|STARTED|Overall Study||148
10465266|NCT01050205|11612876|FG001|STARTED|Overall Study||75
10465267|NCT01050205|11612875|FG000|COMPLETED|Overall Study||137
10465268|NCT01050205|11612876|FG001|COMPLETED|Overall Study||71
10465269|NCT01050205|11612875|FG000|NOT COMPLETED|Overall Study||11
10465270|NCT01050205|11612876|FG001|NOT COMPLETED|Overall Study||4
10465271|NCT01050231|11612884|FG000|STARTED|Overall Study||10
10465272|NCT01050231|11612885|FG001|STARTED|Overall Study||10
10465273|NCT01050231|11612884|FG000|COMPLETED|Overall Study||10
10465274|NCT01050231|11612885|FG001|COMPLETED|Overall Study||10
10465275|NCT01050231|11612884|FG000|NOT COMPLETED|Overall Study||0
10465276|NCT01050231|11612885|FG001|NOT COMPLETED|Overall Study||0
10465277|NCT01050257|11612894|FG000|STARTED|Overall Study||50
10465278|NCT01050257|11612895|FG001|STARTED|Overall Study||53
10465279|NCT01050257|11612896|FG002|STARTED|Overall Study||15
10465280|NCT01050257|11612894|FG000|Received Treatment|Overall Study||49
10465281|NCT01050257|11612895|FG001|Received Treatment|Overall Study||50
10465282|NCT01050257|11612896|FG002|Received Treatment|Overall Study||14
10465283|NCT01050257|11612894|FG000|Safety Population: Actual Dose Received|Overall Study||48
10465284|NCT01050257|11612895|FG001|Safety Population: Actual Dose Received|Overall Study|One participant randomized to 100 mg actually received the 200 mg doses.|51
10465285|NCT01050257|11612896|FG002|Safety Population: Actual Dose Received|Overall Study||14
10465286|NCT01050257|11612894|FG000|Intent-to-treat Infected Confirmed|Overall Study||30
10465287|NCT01050257|11612895|FG001|Intent-to-treat Infected Confirmed|Overall Study||32
10465288|NCT01050257|11612896|FG002|Intent-to-treat Infected Confirmed|Overall Study||10
10465289|NCT01050257|11612894|FG000|Switched to Oral Treatment|Overall Study||28
10465290|NCT01050257|11612895|FG001|Switched to Oral Treatment|Overall Study||31
10465291|NCT01050257|11612896|FG002|Switched to Oral Treatment|Overall Study||3
10465292|NCT01050257|11612894|FG000|COMPLETED|Overall Study|Completed 5 days of treatment either IV or Oral|39
10465293|NCT01050257|11612895|FG001|COMPLETED|Overall Study||40
10465294|NCT01050257|11612896|FG002|COMPLETED|Overall Study||8
10465295|NCT01050257|11612894|FG000|NOT COMPLETED|Overall Study||11
10465296|NCT01050257|11612895|FG001|NOT COMPLETED|Overall Study||13
10465297|NCT01050257|11612896|FG002|NOT COMPLETED|Overall Study||7
10465298|NCT01050530|11612906|FG000|STARTED|Overall Study||82
10465299|NCT01050530|11612907|FG001|STARTED|Overall Study||80
10465300|NCT01050530|11612906|FG000|COMPLETED|Overall Study||74
10465301|NCT01050530|11612907|FG001|COMPLETED|Overall Study||70
10465302|NCT01050530|11612906|FG000|NOT COMPLETED|Overall Study||8
10465303|NCT01050530|11612907|FG001|NOT COMPLETED|Overall Study||10
10465304|NCT01050543|11612915|FG000|STARTED|Overall Study|Includes 4 participants who were randomized but discontinued before Treatment Phase.|64
10465305|NCT01050543|11612916|FG001|STARTED|Overall Study|Includes 4 participants who were randomized but discontinued before Treatment Phase.|64
10465306|NCT01050543|11612915|FG000|COMPLETED|Overall Study|Includes 1 participant who started & completed the study but was excluded from Full Analysis Set.|60
10465307|NCT01050543|11612916|FG001|COMPLETED|Overall Study|Includes 1 participant who started & completed the study but was excluded from Full Analysis Set.|60
10465308|NCT01050543|11612915|FG000|NOT COMPLETED|Overall Study||4
10465309|NCT01050543|11612916|FG001|NOT COMPLETED|Overall Study||4
10465310|NCT01050569|11612925|FG000|STARTED|Overall Study||79
10465311|NCT01050569|11612926|FG001|STARTED|Overall Study||76
10465312|NCT01050569|11612927|FG002|STARTED|Overall Study||80
10465313|NCT01050569|11612925|FG000|COMPLETED|Overall Study||41
10465314|NCT01050569|11612926|FG001|COMPLETED|Overall Study||52
10465315|NCT01050569|11612927|FG002|COMPLETED|Overall Study||47
10465316|NCT01050569|11612925|FG000|NOT COMPLETED|Overall Study||38
10465317|NCT01050569|11612926|FG001|NOT COMPLETED|Overall Study||24
10465318|NCT01050569|11612927|FG002|NOT COMPLETED|Overall Study||33
10465319|NCT01050582|11612941|FG000|STARTED|Overall Study||133
10465320|NCT01050582|11612942|FG001|STARTED|Overall Study||51
10465321|NCT01050582|11612941|FG000|COMPLETED|Overall Study||133
10465322|NCT01050582|11612942|FG001|COMPLETED|Overall Study||51
10465323|NCT01050582|11612941|FG000|NOT COMPLETED|Overall Study||0
10465324|NCT01050582|11612942|FG001|NOT COMPLETED|Overall Study||0
10465325|NCT01050634|11612948|FG000|STARTED|Overall Study||980
10465326|NCT01050634|11612948|FG000|Received Treatment|Overall Study||924
10465327|NCT01050634|11612948|FG000|COMPLETED|Overall Study||852
10465328|NCT01050634|11612948|FG000|NOT COMPLETED|Overall Study||128
10465329|NCT01050647|11612954|FG000|STARTED|Overall Study||10
10465330|NCT01050647|11612955|FG001|STARTED|Overall Study||11
10465331|NCT01050647|11612954|FG000|COMPLETED|Overall Study||10
10465332|NCT01050647|11612955|FG001|COMPLETED|Overall Study||11
10465333|NCT01050647|11612954|FG000|NOT COMPLETED|Overall Study||0
10465334|NCT01050647|11612955|FG001|NOT COMPLETED|Overall Study||0
10465335|NCT01050660|11612963|FG000|STARTED|Overall Study||67
10465336|NCT01050660|11612964|FG001|STARTED|Overall Study||69
10465337|NCT01050660|11612963|FG000|COMPLETED|Overall Study||67
10465338|NCT01050660|11612964|FG001|COMPLETED|Overall Study||69
10465339|NCT01050660|11612963|FG000|NOT COMPLETED|Overall Study||0
10465340|NCT01050660|11612964|FG001|NOT COMPLETED|Overall Study||0
10465341|NCT01050673|11612972|FG000|STARTED|Overall Study||21
10465342|NCT01050673|11612973|FG001|STARTED|Overall Study||19
10465343|NCT01050673|11612972|FG000|COMPLETED|Overall Study||17
10649823|NCT02164513|11809986|FG000|WIP (Other): Stopping Criteria Reached|Overall Study||4
10649824|NCT02164513|11809987|FG001|WIP (Other): Stopping Criteria Reached|Overall Study||1
10649825|NCT02164513|11809988|FG002|WIP (Other): Stopping Criteria Reached|Overall Study||2
10465344|NCT01050673|11612973|FG001|COMPLETED|Overall Study||14
10465345|NCT01050673|11612972|FG000|NOT COMPLETED|Overall Study||4
10465346|NCT01050673|11612973|FG001|NOT COMPLETED|Overall Study||5
10465347|NCT01050764|11612979|FG000|STARTED|Overall Study||10
10465348|NCT01050764|11612979|FG000|Received HSCT Graft|Overall Study||8
10465349|NCT01050764|11612979|FG000|Received Infusion of T-reg Cells|Overall Study||7
10465350|NCT01050764|11612979|FG000|Received Infusion of T-con Cells|Overall Study||7
10465351|NCT01050764|11612979|FG000|COMPLETED|Overall Study||7
10465352|NCT01050764|11612979|FG000|NOT COMPLETED|Overall Study||3
10465353|NCT01050790|11612983|FG000|STARTED|Overall Study||17
10465354|NCT01050790|11612983|FG000|COMPLETED|Overall Study||16
10465355|NCT01050790|11612983|FG000|NOT COMPLETED|Overall Study||1
10465356|NCT01050816|11612988|FG000|STARTED|Overall Study||30
10465357|NCT01050816|11612988|FG000|COMPLETED|Overall Study||26
10465358|NCT01050816|11612988|FG000|NOT COMPLETED|Overall Study||4
10465359|NCT01050907|11612992|FG000|STARTED|Overall Study||4
10465360|NCT01050907|11612992|FG000|COMPLETED|Overall Study||4
10465361|NCT01050907|11612992|FG000|NOT COMPLETED|Overall Study||0
10465362|NCT01050946|11612996|FG000|STARTED|Overall Study||1
10465363|NCT01050946|11612996|FG000|COMPLETED|Overall Study|Patient signed consent 2/3/2011. Patient had their transplant 2/15/2011. Patient died 9/2/2011|1
10465364|NCT01050946|11612996|FG000|NOT COMPLETED|Overall Study||0
10465365|NCT01050998|11613006|FG000|STARTED|Overall Study||48
10465366|NCT01050998|11613007|FG001|STARTED|Overall Study||49
10465367|NCT01050998|11613008|FG002|STARTED|Overall Study||49
10465368|NCT01050998|11613009|FG003|STARTED|Overall Study||48
10465369|NCT01050998|11613010|FG004|STARTED|Overall Study||96
10465370|NCT01050998|11613006|FG000|COMPLETED|Overall Study||44
10465371|NCT01050998|11613007|FG001|COMPLETED|Overall Study||47
10465372|NCT01050998|11613008|FG002|COMPLETED|Overall Study||46
10465373|NCT01050998|11613009|FG003|COMPLETED|Overall Study||45
10465374|NCT01050998|11613010|FG004|COMPLETED|Overall Study||82
10465375|NCT01050998|11613006|FG000|NOT COMPLETED|Overall Study||4
10465376|NCT01050998|11613007|FG001|NOT COMPLETED|Overall Study||2
10465377|NCT01050998|11613008|FG002|NOT COMPLETED|Overall Study||3
10465378|NCT01050998|11613009|FG003|NOT COMPLETED|Overall Study||3
10465379|NCT01050998|11613010|FG004|NOT COMPLETED|Overall Study||14
10465380|NCT01051063|11613028|FG000|STARTED|Overall Study||12
10465381|NCT01051063|11613029|FG001|STARTED|Overall Study||5
10465382|NCT01051063|11613028|FG000|COMPLETED|Overall Study||2
10465383|NCT01051063|11613029|FG001|COMPLETED|Overall Study||1
10465384|NCT01051063|11613028|FG000|NOT COMPLETED|Overall Study||10
10465385|NCT01051063|11613029|FG001|NOT COMPLETED|Overall Study||4
10465386|NCT01051310|11613036|FG000|STARTED|Overall Study||18
10465387|NCT01051310|11613036|FG000|COMPLETED|Overall Study||13
10465388|NCT01051310|11613036|FG000|NOT COMPLETED|Overall Study||5
10465389|NCT01051323|11613042|FG000|STARTED|Overall Study||1580
10465390|NCT01051323|11613042|FG000|Received at Least One Dose|Overall Study||1547
10465391|NCT01051323|11613042|FG000|COMPLETED|Overall Study||1041
10465392|NCT01051323|11613042|FG000|NOT COMPLETED|Overall Study||539
10465393|NCT01051349|11613050|FG000|STARTED|Overall Study||410
10465394|NCT01051349|11613050|FG000|COMPLETED|Overall Study||237
10465395|NCT01051349|11613050|FG000|NOT COMPLETED|Overall Study||173
10465396|NCT01051440|11613059|FG000|STARTED|Overall Study||1
10465397|NCT01051440|11613060|FG001|STARTED|Overall Study||1
10465398|NCT01051440|11613059|FG000|COMPLETED|Overall Study||1
10465399|NCT01051440|11613060|FG001|COMPLETED|Overall Study||1
10465400|NCT01051440|11613059|FG000|NOT COMPLETED|Overall Study||0
10465401|NCT01051440|11613060|FG001|NOT COMPLETED|Overall Study||0
10465402|NCT01051466|11613068|FG000|STARTED|Overall Study||32
10465403|NCT01051466|11613069|FG001|STARTED|Overall Study||28
10465404|NCT01051466|11613068|FG000|COMPLETED|Overall Study||24
10465405|NCT01051466|11613069|FG001|COMPLETED|Overall Study||23
10465406|NCT01051466|11613068|FG000|NOT COMPLETED|Overall Study||8
10465407|NCT01051466|11613069|FG001|NOT COMPLETED|Overall Study||5
10465408|NCT01051518|11613079|FG000|STARTED|Overall Study||126
10465409|NCT01051518|11613079|FG000|COMPLETED|Overall Study||53
10465410|NCT01051518|11613079|FG000|NOT COMPLETED|Overall Study||73
10465411|NCT01051557|11613095|FG000|STARTED|Overall Study||4
10465412|NCT01051557|11613096|FG001|STARTED|Overall Study||3
10465413|NCT01051557|11613097|FG002|STARTED|Overall Study||6
10465414|NCT01051557|11613098|FG003|STARTED|Overall Study||3
10465415|NCT01051557|11613099|FG004|STARTED|Overall Study||8
10465416|NCT01051557|11613100|FG005|STARTED|Overall Study||6
10465417|NCT01051557|11613101|FG006|STARTED|Overall Study||6
10465418|NCT01051557|11613095|FG000|COMPLETED|Overall Study||0
10465419|NCT01051557|11613096|FG001|COMPLETED|Overall Study||0
10465420|NCT01051557|11613097|FG002|COMPLETED|Overall Study||0
10465421|NCT01051557|11613098|FG003|COMPLETED|Overall Study||0
10465422|NCT01051557|11613099|FG004|COMPLETED|Overall Study||1
10465423|NCT01051557|11613100|FG005|COMPLETED|Overall Study||0
10465424|NCT01051557|11613101|FG006|COMPLETED|Overall Study||0
10465425|NCT01051557|11613095|FG000|NOT COMPLETED|Overall Study||4
10465426|NCT01051557|11613096|FG001|NOT COMPLETED|Overall Study||3
10465427|NCT01051557|11613097|FG002|NOT COMPLETED|Overall Study||6
10465428|NCT01051557|11613098|FG003|NOT COMPLETED|Overall Study||3
10465429|NCT01051557|11613099|FG004|NOT COMPLETED|Overall Study||7
10465430|NCT01051557|11613100|FG005|NOT COMPLETED|Overall Study||6
10465431|NCT01051557|11613101|FG006|NOT COMPLETED|Overall Study||6
10465432|NCT01051570|11613118|FG000|STARTED|Overall Study||26
10465433|NCT01051570|11613118|FG000|COMPLETED|Overall Study||26
10465434|NCT01051570|11613118|FG000|NOT COMPLETED|Overall Study||0
10465435|NCT01051596|11613122|FG000|STARTED|Overall Study||75
10465436|NCT01051596|11613122|FG000|COMPLETED|Overall Study||75
10465437|NCT01051596|11613122|FG000|NOT COMPLETED|Overall Study||0
10465438|NCT01051661|11613132|FG000|STARTED|Overall Study||610
10465439|NCT01051661|11613133|FG001|STARTED|Overall Study||1438
10465440|NCT01051661|11613134|FG002|STARTED|Overall Study||612
10465441|NCT01051661|11613135|FG003|STARTED|Overall Study||1436
10465442|NCT01051661|11613136|FG004|STARTED|Overall Study||613
10465443|NCT01051661|11613137|FG005|STARTED|Overall Study||1436
10465444|NCT01051661|11613132|FG000|COMPLETED|Overall Study||576
10465445|NCT01051661|11613133|FG001|COMPLETED|Overall Study||1375
10465446|NCT01051661|11613134|FG002|COMPLETED|Overall Study||573
10465447|NCT01051661|11613135|FG003|COMPLETED|Overall Study||1380
10465448|NCT01051661|11613136|FG004|COMPLETED|Overall Study||578
10465449|NCT01051661|11613137|FG005|COMPLETED|Overall Study||1369
10465450|NCT01051661|11613132|FG000|NOT COMPLETED|Overall Study||34
10465451|NCT01051661|11613133|FG001|NOT COMPLETED|Overall Study||63
10465452|NCT01051661|11613134|FG002|NOT COMPLETED|Overall Study||39
10465453|NCT01051661|11613135|FG003|NOT COMPLETED|Overall Study||56
10465454|NCT01051661|11613136|FG004|NOT COMPLETED|Overall Study||35
10465455|NCT01051661|11613137|FG005|NOT COMPLETED|Overall Study||67
10465456|NCT01051739|11613174|FG000|STARTED|Overall Study||120
10465457|NCT01051739|11613175|FG001|STARTED|Overall Study||60
10465458|NCT01051739|11613174|FG000|COMPLETED|Overall Study||92
10465459|NCT01051739|11613175|FG001|COMPLETED|Overall Study||47
10465460|NCT01051739|11613174|FG000|NOT COMPLETED|Overall Study||28
10465461|NCT01051739|11613175|FG001|NOT COMPLETED|Overall Study||13
10465462|NCT01051778|11613183|FG000|STARTED|Overall Study|June 2006|30
10465463|NCT01051778|11613184|FG001|STARTED|Overall Study|June 2006|30
10465464|NCT01051778|11613183|FG000|COMPLETED|Overall Study|November 2009|30
10465465|NCT01051778|11613184|FG001|COMPLETED|Overall Study|November 2009|30
10465466|NCT01051778|11613183|FG000|NOT COMPLETED|Overall Study||0
10465467|NCT01051778|11613184|FG001|NOT COMPLETED|Overall Study||0
10465468|NCT01051791|11613190|FG000|STARTED|Overall Study||13
10465469|NCT01051791|11613190|FG000|COMPLETED|Overall Study||9
10465470|NCT01051791|11613190|FG000|NOT COMPLETED|Overall Study||4
10465471|NCT01051817|11613197|FG000|STARTED|Overall Study||38
10465472|NCT01051817|11613198|FG001|STARTED|Overall Study||35
10465473|NCT01051817|11613197|FG000|COMPLETED|Overall Study||35
10465474|NCT01051817|11613198|FG001|COMPLETED|Overall Study||26
10465475|NCT01051817|11613197|FG000|NOT COMPLETED|Overall Study||3
10465476|NCT01051817|11613198|FG001|NOT COMPLETED|Overall Study||9
10465477|NCT01051856|11613206|FG000|STARTED|Overall Study||33
10465478|NCT01051856|11613207|FG001|STARTED|Overall Study||35
10465479|NCT01051856|11613206|FG000|COMPLETED|Overall Study||32
10465480|NCT01051856|11613207|FG001|COMPLETED|Overall Study||35
10465481|NCT01051856|11613206|FG000|NOT COMPLETED|Overall Study||1
10465482|NCT01051856|11613207|FG001|NOT COMPLETED|Overall Study||0
10465483|NCT01051960|11613213|FG000|STARTED|Overall Study||12
10465484|NCT01051960|11613213|FG000|COMPLETED|Overall Study||11
10465485|NCT01051960|11613213|FG000|NOT COMPLETED|Overall Study||1
10465486|NCT01051986|11613219|FG000|STARTED|Overall Study||112
10465487|NCT01051986|11613220|FG001|STARTED|Overall Study||112
10465488|NCT01051986|11613219|FG000|COMPLETED|Overall Study||107
10465489|NCT01051986|11613220|FG001|COMPLETED|Overall Study||108
10465490|NCT01051986|11613219|FG000|NOT COMPLETED|Overall Study||5
10465491|NCT01051986|11613220|FG001|NOT COMPLETED|Overall Study||4
10465492|NCT01052012|11613232|FG000|STARTED|Overall Study||32
10465493|NCT01052012|11613233|FG001|STARTED|Overall Study||23
10465494|NCT01052012|11613234|FG002|STARTED|Overall Study||30
10465495|NCT01052012|11613235|FG003|STARTED|Overall Study||20
10465496|NCT01052012|11613236|FG004|STARTED|Overall Study||140
10465497|NCT01052012|11613237|FG005|STARTED|Overall Study||86
10465498|NCT01052012|11613232|FG000|COMPLETED|Overall Study||28
10465499|NCT01052012|11613233|FG001|COMPLETED|Overall Study||17
10465500|NCT01052012|11613234|FG002|COMPLETED|Overall Study||30
10465501|NCT01052012|11613235|FG003|COMPLETED|Overall Study||19
10465502|NCT01052012|11613236|FG004|COMPLETED|Overall Study||124
10465503|NCT01052012|11613237|FG005|COMPLETED|Overall Study||76
10465504|NCT01052012|11613232|FG000|NOT COMPLETED|Overall Study||4
10465505|NCT01052012|11613233|FG001|NOT COMPLETED|Overall Study||6
10465506|NCT01052012|11613234|FG002|NOT COMPLETED|Overall Study||0
10465507|NCT01052012|11613235|FG003|NOT COMPLETED|Overall Study||1
10465508|NCT01052012|11613236|FG004|NOT COMPLETED|Overall Study||16
10465509|NCT01052012|11613237|FG005|NOT COMPLETED|Overall Study||10
10465510|NCT01052038|11613254|FG000|STARTED|Overall Study||40
10465511|NCT01052038|11613255|FG001|STARTED|Overall Study||40
10465512|NCT01052038|11613256|FG002|STARTED|Overall Study||40
10465513|NCT01052038|11613254|FG000|COMPLETED|Overall Study||36
10465514|NCT01052038|11613255|FG001|COMPLETED|Overall Study||34
10465515|NCT01052038|11613256|FG002|COMPLETED|Overall Study||36
10465516|NCT01052038|11613254|FG000|NOT COMPLETED|Overall Study||4
10465517|NCT01052038|11613255|FG001|NOT COMPLETED|Overall Study||6
10465518|NCT01052038|11613256|FG002|NOT COMPLETED|Overall Study||4
10465519|NCT01052077|11613266|FG000|STARTED|Phase A||769
10465520|NCT01052077|11613267|FG001|STARTED|Phase A||0
10465521|NCT01052077|11613268|FG002|STARTED|Phase A||0
10465522|NCT01052077|11613269|FG003|STARTED|Phase A||0
10465523|NCT01052077|11613266|FG000|COMPLETED|Phase A||623
10465524|NCT01052077|11613267|FG001|COMPLETED|Phase A||0
10465525|NCT01052077|11613268|FG002|COMPLETED|Phase A||0
10465526|NCT01052077|11613269|FG003|COMPLETED|Phase A||0
10465527|NCT01052077|11613266|FG000|NOT COMPLETED|Phase A||146
10465528|NCT01052077|11613267|FG001|NOT COMPLETED|Phase A||0
10465529|NCT01052077|11613268|FG002|NOT COMPLETED|Phase A||0
10465530|NCT01052077|11613269|FG003|NOT COMPLETED|Phase A||0
10465531|NCT01052077|11613266|FG000|STARTED|Phase B||0
10465532|NCT01052077|11613267|FG001|STARTED|Phase B||185
10465533|NCT01052077|11613268|FG002|STARTED|Phase B||187
10465534|NCT01052077|11613269|FG003|STARTED|Phase B||0
10465535|NCT01052077|11613266|FG000|COMPLETED|Phase B||0
10465536|NCT01052077|11613267|FG001|COMPLETED|Phase B||167
10465537|NCT01052077|11613268|FG002|COMPLETED|Phase B||171
10465538|NCT01052077|11613269|FG003|COMPLETED|Phase B||0
10465539|NCT01052077|11613266|FG000|NOT COMPLETED|Phase B||0
10465540|NCT01052077|11613267|FG001|NOT COMPLETED|Phase B||18
10465541|NCT01052077|11613268|FG002|NOT COMPLETED|Phase B||16
10465542|NCT01052077|11613269|FG003|NOT COMPLETED|Phase B||0
10465543|NCT01052077|11613266|FG000|STARTED|Phase A+||0
10465544|NCT01052077|11613267|FG001|STARTED|Phase A+||0
10465545|NCT01052077|11613268|FG002|STARTED|Phase A+||0
10465546|NCT01052077|11613269|FG003|STARTED|Phase A+||251
10465547|NCT01052077|11613266|FG000|COMPLETED|Phase A+||0
10465548|NCT01052077|11613267|FG001|COMPLETED|Phase A+||0
10465549|NCT01052077|11613268|FG002|COMPLETED|Phase A+||0
10465550|NCT01052077|11613269|FG003|COMPLETED|Phase A+||230
10465551|NCT01052077|11613266|FG000|NOT COMPLETED|Phase A+||0
10465552|NCT01052077|11613267|FG001|NOT COMPLETED|Phase A+||0
10465553|NCT01052077|11613268|FG002|NOT COMPLETED|Phase A+||0
10465554|NCT01052077|11613269|FG003|NOT COMPLETED|Phase A+||21
10465563|NCT01052116|11613287|FG000|STARTED|Overall Study||193
10465564|NCT01052116|11613288|FG001|STARTED|Overall Study||193
10465565|NCT01052116|11613287|FG000|COMPLETED|Overall Study|Completed: defined as having an FEV1 measurement at 24 weeks|179
10465566|NCT01052116|11613288|FG001|COMPLETED|Overall Study|Completed: defined as having an FEV1 measurement at 24 weeks|166
10465567|NCT01052116|11613287|FG000|NOT COMPLETED|Overall Study||14
10465568|NCT01052116|11613288|FG001|NOT COMPLETED|Overall Study||27
10465569|NCT01052207|11613296|FG000|STARTED|Overall Study||60
10465570|NCT01052207|11613297|FG001|STARTED|Overall Study||42
10465571|NCT01052207|11613296|FG000|COMPLETED|Overall Study||60
10465572|NCT01052207|11613297|FG001|COMPLETED|Overall Study||42
10465573|NCT01052207|11613296|FG000|NOT COMPLETED|Overall Study||0
10465574|NCT01052207|11613297|FG001|NOT COMPLETED|Overall Study||0
10465575|NCT01052272|11613307|FG000|STARTED|Overall Study||18
10465576|NCT01052272|11613308|FG001|STARTED|Overall Study||18
10465577|NCT01052272|11613309|FG002|STARTED|Overall Study||18
10465578|NCT01052272|11613310|FG003|STARTED|Overall Study||18
10465579|NCT01052272|11613307|FG000|COMPLETED|Overall Study||13
10465580|NCT01052272|11613308|FG001|COMPLETED|Overall Study||11
10465581|NCT01052272|11613309|FG002|COMPLETED|Overall Study||10
10465582|NCT01052272|11613310|FG003|COMPLETED|Overall Study||11
10465583|NCT01052272|11613307|FG000|NOT COMPLETED|Overall Study||5
10465584|NCT01052272|11613308|FG001|NOT COMPLETED|Overall Study||7
10465585|NCT01052272|11613309|FG002|NOT COMPLETED|Overall Study||8
10465586|NCT01052272|11613310|FG003|NOT COMPLETED|Overall Study||7
10708589|NCT02632110|11873414|FG008|COMPLETED|Overall Study||29
10708590|NCT02632110|11873415|FG009|COMPLETED|Overall Study||29
10708591|NCT02632110|11873406|FG000|NOT COMPLETED|Overall Study||1
10708592|NCT02632110|11873407|FG001|NOT COMPLETED|Overall Study||1
10708593|NCT02632110|11873408|FG002|NOT COMPLETED|Overall Study||0
10708594|NCT02632110|11873409|FG003|NOT COMPLETED|Overall Study||0
10708595|NCT02632110|11873410|FG004|NOT COMPLETED|Overall Study||1
10708596|NCT02632110|11873411|FG005|NOT COMPLETED|Overall Study||1
10708597|NCT02632110|11873412|FG006|NOT COMPLETED|Overall Study||3
10708598|NCT02632110|11873413|FG007|NOT COMPLETED|Overall Study||3
10708599|NCT02632110|11873414|FG008|NOT COMPLETED|Overall Study||1
10708600|NCT02632110|11873415|FG009|NOT COMPLETED|Overall Study||1
10465587|NCT01052428|11613322|FG000|STARTED|Overall Study||19
10465588|NCT01052428|11613323|FG001|STARTED|Overall Study||19
10708601|NCT02632526|11873438|FG000|STARTED|Overall Study||36
10708602|NCT02632526|11873439|FG001|STARTED|Overall Study||12
10708603|NCT02632526|11873440|FG002|STARTED|Overall Study||24
10708604|NCT02632526|11873441|FG003|STARTED|Overall Study||12
10708605|NCT02632526|11873442|FG004|STARTED|Overall Study||4
10465589|NCT01052428|11613322|FG000|COMPLETED|Overall Study||18
10465590|NCT01052428|11613323|FG001|COMPLETED|Overall Study||18
10465591|NCT01052428|11613322|FG000|NOT COMPLETED|Overall Study||1
10465592|NCT01052428|11613323|FG001|NOT COMPLETED|Overall Study||1
10465593|NCT01052480|11613331|FG000|STARTED|Overall Study||49
10465594|NCT01052480|11613332|FG001|STARTED|Overall Study||49
10465595|NCT01052480|11613331|FG000|COMPLETED|Overall Study||41
10465596|NCT01052480|11613332|FG001|COMPLETED|Overall Study||32
10465597|NCT01052480|11613331|FG000|NOT COMPLETED|Overall Study||8
10465598|NCT01052480|11613332|FG001|NOT COMPLETED|Overall Study||17
10465599|NCT01052493|11613338|FG000|STARTED|Intervention 1 (Up to 10 Days)||4
10465600|NCT01052493|11613339|FG001|STARTED|Intervention 1 (Up to 10 Days)||4
10465601|NCT01052493|11613340|FG002|STARTED|Intervention 1 (Up to 10 Days)||4
10465602|NCT01052493|11613338|FG000|COMPLETED|Intervention 1 (Up to 10 Days)||3
10465603|NCT01052493|11613339|FG001|COMPLETED|Intervention 1 (Up to 10 Days)||4
10465604|NCT01052493|11613340|FG002|COMPLETED|Intervention 1 (Up to 10 Days)||4
10465605|NCT01052493|11613338|FG000|NOT COMPLETED|Intervention 1 (Up to 10 Days)||1
10465606|NCT01052493|11613339|FG001|NOT COMPLETED|Intervention 1 (Up to 10 Days)||0
10465607|NCT01052493|11613340|FG002|NOT COMPLETED|Intervention 1 (Up to 10 Days)||0
10465608|NCT01052493|11613338|FG000|STARTED|Washout Period 1 (up to 5 Days)||3
10465609|NCT01052493|11613339|FG001|STARTED|Washout Period 1 (up to 5 Days)||4
10465610|NCT01052493|11613340|FG002|STARTED|Washout Period 1 (up to 5 Days)||4
10465611|NCT01052493|11613338|FG000|COMPLETED|Washout Period 1 (up to 5 Days)||3
10465612|NCT01052493|11613339|FG001|COMPLETED|Washout Period 1 (up to 5 Days)||4
10465613|NCT01052493|11613340|FG002|COMPLETED|Washout Period 1 (up to 5 Days)||4
10465614|NCT01052493|11613338|FG000|NOT COMPLETED|Washout Period 1 (up to 5 Days)||0
10465615|NCT01052493|11613339|FG001|NOT COMPLETED|Washout Period 1 (up to 5 Days)||0
10465616|NCT01052493|11613340|FG002|NOT COMPLETED|Washout Period 1 (up to 5 Days)||0
10526490|NCT01381718|11678357|FG001|STARTED|Overall Study||56
10465617|NCT01052493|11613338|FG000|STARTED|Intervention 2 (up to 10 Days)|Replacement subject recruited|4
10465618|NCT01052493|11613339|FG001|STARTED|Intervention 2 (up to 10 Days)||4
10465619|NCT01052493|11613340|FG002|STARTED|Intervention 2 (up to 10 Days)||4
10465620|NCT01052493|11613338|FG000|COMPLETED|Intervention 2 (up to 10 Days)||4
10465621|NCT01052493|11613339|FG001|COMPLETED|Intervention 2 (up to 10 Days)||4
10465622|NCT01052493|11613340|FG002|COMPLETED|Intervention 2 (up to 10 Days)||4
10465623|NCT01052493|11613338|FG000|NOT COMPLETED|Intervention 2 (up to 10 Days)||0
10465624|NCT01052493|11613339|FG001|NOT COMPLETED|Intervention 2 (up to 10 Days)||0
10465625|NCT01052493|11613340|FG002|NOT COMPLETED|Intervention 2 (up to 10 Days)||0
10465626|NCT01052493|11613338|FG000|STARTED|Washout Period 2 (up to 5 Days)||4
10465627|NCT01052493|11613339|FG001|STARTED|Washout Period 2 (up to 5 Days)||4
10465628|NCT01052493|11613340|FG002|STARTED|Washout Period 2 (up to 5 Days)||4
10465629|NCT01052493|11613338|FG000|COMPLETED|Washout Period 2 (up to 5 Days)||4
10465630|NCT01052493|11613339|FG001|COMPLETED|Washout Period 2 (up to 5 Days)||4
10465631|NCT01052493|11613340|FG002|COMPLETED|Washout Period 2 (up to 5 Days)||4
10465632|NCT01052493|11613338|FG000|NOT COMPLETED|Washout Period 2 (up to 5 Days)||0
10465633|NCT01052493|11613339|FG001|NOT COMPLETED|Washout Period 2 (up to 5 Days)||0
10465634|NCT01052493|11613340|FG002|NOT COMPLETED|Washout Period 2 (up to 5 Days)||0
10465635|NCT01052493|11613338|FG000|STARTED|Intervention 3 (up to 10 Days)||4
10465636|NCT01052493|11613339|FG001|STARTED|Intervention 3 (up to 10 Days)||4
10465637|NCT01052493|11613340|FG002|STARTED|Intervention 3 (up to 10 Days)||4
10465638|NCT01052493|11613338|FG000|COMPLETED|Intervention 3 (up to 10 Days)||4
10465639|NCT01052493|11613339|FG001|COMPLETED|Intervention 3 (up to 10 Days)||4
10465640|NCT01052493|11613340|FG002|COMPLETED|Intervention 3 (up to 10 Days)||4
10465641|NCT01052493|11613338|FG000|NOT COMPLETED|Intervention 3 (up to 10 Days)||0
10465642|NCT01052493|11613339|FG001|NOT COMPLETED|Intervention 3 (up to 10 Days)||0
10465643|NCT01052493|11613340|FG002|NOT COMPLETED|Intervention 3 (up to 10 Days)||0
10465644|NCT01052545|11613355|FG000|STARTED|Overall Study||867
10465645|NCT01052545|11613356|FG001|STARTED|Overall Study||731
10465646|NCT01052545|11613355|FG000|COMPLETED|Overall Study||867
10465647|NCT01052545|11613356|FG001|COMPLETED|Overall Study||731
10465648|NCT01052545|11613355|FG000|NOT COMPLETED|Overall Study||0
10465649|NCT01052545|11613356|FG001|NOT COMPLETED|Overall Study||0
10465650|NCT01052662|11613377|FG000|STARTED|Overall Study|1 subject excluded from Intent-to-treat sample for final analysis due to pharmacy issue.|28
10465651|NCT01052662|11613378|FG001|STARTED|Overall Study|3 subjects excluded from Intent-to-treat sample for final analysis due to pharmacy issue|27
10465652|NCT01052662|11613379|FG002|STARTED|Overall Study|3 subjects excluded from Intent-to-treat sample for final analysis due to pharmacy issue|32
10465653|NCT01052662|11613377|FG000|Stabilization Phase|Overall Study||21
10465654|NCT01052662|11613378|FG001|Stabilization Phase|Overall Study||21
10465655|NCT01052662|11613379|FG002|Stabilization Phase|Overall Study||26
10465656|NCT01052662|11613377|FG000|Discontinuation Phase|Overall Study||6
10465657|NCT01052662|11613378|FG001|Discontinuation Phase|Overall Study||5
10465658|NCT01052662|11613379|FG002|Discontinuation Phase|Overall Study||10
10465659|NCT01052662|11613377|FG000|COMPLETED|Overall Study||6
10465660|NCT01052662|11613378|FG001|COMPLETED|Overall Study||5
10465661|NCT01052662|11613379|FG002|COMPLETED|Overall Study||10
10465662|NCT01052662|11613377|FG000|NOT COMPLETED|Overall Study||22
10465663|NCT01052662|11613378|FG001|NOT COMPLETED|Overall Study||22
10465664|NCT01052662|11613379|FG002|NOT COMPLETED|Overall Study||22
10465665|NCT01052701|11613389|FG000|STARTED|Overall Study||14
10708606|NCT02632526|11873443|FG005|STARTED|Overall Study||8
10708607|NCT02632526|11873438|FG000|COMPLETED|Overall Study||36
10708608|NCT02632526|11873439|FG001|COMPLETED|Overall Study||12
10465666|NCT01052701|11613390|FG001|STARTED|Overall Study||12
10465667|NCT01052701|11613389|FG000|COMPLETED|Overall Study||14
10465668|NCT01052701|11613390|FG001|COMPLETED|Overall Study||12
10465669|NCT01052701|11613389|FG000|NOT COMPLETED|Overall Study||0
10465670|NCT01052701|11613390|FG001|NOT COMPLETED|Overall Study||0
10465671|NCT01052714|11613398|FG000|STARTED|Overall Study||42
10465672|NCT01052714|11613399|FG001|STARTED|Overall Study||62
10465673|NCT01052714|11613400|FG002|STARTED|Overall Study||17
10465674|NCT01052714|11613398|FG000|COMPLETED|Overall Study||17
10465675|NCT01052714|11613399|FG001|COMPLETED|Overall Study||33
10465676|NCT01052714|11613400|FG002|COMPLETED|Overall Study||15
10465677|NCT01052714|11613398|FG000|NOT COMPLETED|Overall Study||25
10465678|NCT01052714|11613399|FG001|NOT COMPLETED|Overall Study||29
10465679|NCT01052714|11613400|FG002|NOT COMPLETED|Overall Study||2
10526491|NCT01381718|11678356|FG000|COMPLETED|Overall Study||51
10526492|NCT01381718|11678357|FG001|COMPLETED|Overall Study||43
10526493|NCT01381718|11678356|FG000|NOT COMPLETED|Overall Study||5
10526494|NCT01381718|11678357|FG001|NOT COMPLETED|Overall Study||13
10526495|NCT01381861|11678363|FG000|STARTED|Overall Study||23
10526496|NCT01381861|11678363|FG000|COMPLETED|Overall Study||23
10526497|NCT01381861|11678363|FG000|NOT COMPLETED|Overall Study||0
10526498|NCT01381874|11678370|FG000|STARTED|Overall Study||102
10526499|NCT01381874|11678371|FG001|STARTED|Overall Study||89
10526500|NCT01381874|11678372|FG002|STARTED|Overall Study||106
10526501|NCT01381874|11678370|FG000|Treated|Overall Study||102
10526502|NCT01381874|11678371|FG001|Treated|Overall Study||87
10526503|NCT01381874|11678372|FG002|Treated|Overall Study||104
10526504|NCT01381874|11678370|FG000|COMPLETED|Overall Study||25
10526505|NCT01381874|11678371|FG001|COMPLETED|Overall Study||26
10526506|NCT01381874|11678372|FG002|COMPLETED|Overall Study||30
10526507|NCT01381874|11678370|FG000|NOT COMPLETED|Overall Study||77
10708609|NCT02632526|11873440|FG002|COMPLETED|Overall Study||24
10708610|NCT02632526|11873441|FG003|COMPLETED|Overall Study||12
10465680|NCT01052779|11613408|FG000|STARTED|Overall Study||80
10465681|NCT01052779|11613409|FG001|STARTED|Overall Study||82
10465682|NCT01052779|11613408|FG000|Received at Least 1 Dose of Study Drug|Overall Study||80
10465683|NCT01052779|11613409|FG001|Received at Least 1 Dose of Study Drug|Overall Study||81
10465684|NCT01052779|11613408|FG000|COMPLETED|Overall Study||75
10465685|NCT01052779|11613409|FG001|COMPLETED|Overall Study||73
10708611|NCT02632526|11873442|FG004|COMPLETED|Overall Study||4
10708612|NCT02632526|11873443|FG005|COMPLETED|Overall Study||8
10708613|NCT02632526|11873438|FG000|NOT COMPLETED|Overall Study||0
10465686|NCT01052779|11613408|FG000|NOT COMPLETED|Overall Study||5
10465687|NCT01052779|11613409|FG001|NOT COMPLETED|Overall Study||9
10465688|NCT01052831|11613417|FG000|STARTED|Overall Study||26
10465689|NCT01052831|11613418|FG001|STARTED|Overall Study||24
10465690|NCT01052831|11613417|FG000|COMPLETED|Overall Study||22
10465691|NCT01052831|11613418|FG001|COMPLETED|Overall Study||23
10465692|NCT01052831|11613417|FG000|NOT COMPLETED|Overall Study||4
10465693|NCT01052831|11613418|FG001|NOT COMPLETED|Overall Study||1
10465694|NCT01052844|11613426|FG000|STARTED|Overall Study||40
10465695|NCT01052844|11613427|FG001|STARTED|Overall Study||40
10465696|NCT01052844|11613426|FG000|COMPLETED|Overall Study||40
10465697|NCT01052844|11613427|FG001|COMPLETED|Overall Study||39
10708614|NCT02632526|11873439|FG001|NOT COMPLETED|Overall Study||0
10465698|NCT01052844|11613426|FG000|NOT COMPLETED|Overall Study||0
10465699|NCT01052844|11613427|FG001|NOT COMPLETED|Overall Study||1
10465700|NCT01052948|11613437|FG000|STARTED|Overall Study||27812
10465701|NCT01052948|11613438|FG001|STARTED|Overall Study||14669
10465702|NCT01052948|11613439|FG002|STARTED|Overall Study||15147
10465703|NCT01052948|11613440|FG003|STARTED|Overall Study||29311
10465704|NCT01052948|11613437|FG000|COMPLETED|Overall Study||27812
10465705|NCT01052948|11613438|FG001|COMPLETED|Overall Study||14669
10465706|NCT01052948|11613439|FG002|COMPLETED|Overall Study||15147
10465707|NCT01052948|11613440|FG003|COMPLETED|Overall Study||29311
10465708|NCT01052948|11613437|FG000|NOT COMPLETED|Overall Study||0
10465709|NCT01052948|11613438|FG001|NOT COMPLETED|Overall Study||0
10465710|NCT01052948|11613439|FG002|NOT COMPLETED|Overall Study||0
10465711|NCT01052948|11613440|FG003|NOT COMPLETED|Overall Study||0
10465712|NCT01053000|11613450|FG000|STARTED|Overall Study||5
10465713|NCT01053000|11613451|FG001|STARTED|Overall Study||5
10465714|NCT01053000|11613450|FG000|COMPLETED|Overall Study||5
10465715|NCT01053000|11613451|FG001|COMPLETED|Overall Study||5
10465716|NCT01053000|11613450|FG000|NOT COMPLETED|Overall Study||0
10465717|NCT01053000|11613451|FG001|NOT COMPLETED|Overall Study||0
10465718|NCT01053013|11613459|FG000|STARTED|Overall Study||24
10465719|NCT01053013|11613460|FG001|STARTED|Overall Study||34
10465720|NCT01053013|11613459|FG000|COMPLETED|Overall Study||24
10465721|NCT01053013|11613460|FG001|COMPLETED|Overall Study||34
10465722|NCT01053013|11613459|FG000|NOT COMPLETED|Overall Study||0
10465723|NCT01053013|11613460|FG001|NOT COMPLETED|Overall Study||0
10465724|NCT01053078|11613564|FG000|STARTED|Overall Study||14
10465725|NCT01053078|11613565|FG001|STARTED|Overall Study||15
10465726|NCT01053078|11613564|FG000|COMPLETED|Overall Study||10
10465727|NCT01053078|11613565|FG001|COMPLETED|Overall Study||12
10465728|NCT01053078|11613564|FG000|NOT COMPLETED|Overall Study||4
10465729|NCT01053078|11613565|FG001|NOT COMPLETED|Overall Study||3
10465730|NCT01053156|11613575|FG000|STARTED|First Intervention (Week 1-12)||33
10465731|NCT01053156|11613576|FG001|STARTED|First Intervention (Week 1-12)||33
10465732|NCT01053156|11613575|FG000|COMPLETED|First Intervention (Week 1-12)||28
10465733|NCT01053156|11613576|FG001|COMPLETED|First Intervention (Week 1-12)||27
10465734|NCT01053156|11613575|FG000|NOT COMPLETED|First Intervention (Week 1-12)||5
10465735|NCT01053156|11613576|FG001|NOT COMPLETED|First Intervention (Week 1-12)||6
10465736|NCT01053156|11613575|FG000|STARTED|Second Intervention (Week 13-24)||28
10465737|NCT01053156|11613576|FG001|STARTED|Second Intervention (Week 13-24)||27
10465738|NCT01053156|11613575|FG000|COMPLETED|Second Intervention (Week 13-24)||26
10465739|NCT01053156|11613576|FG001|COMPLETED|Second Intervention (Week 13-24)||22
10465740|NCT01053156|11613575|FG000|NOT COMPLETED|Second Intervention (Week 13-24)||2
10465741|NCT01053156|11613576|FG001|NOT COMPLETED|Second Intervention (Week 13-24)||5
10465742|NCT01053247|11613588|FG000|STARTED|Overall Study||269
10465743|NCT01053247|11613589|FG001|STARTED|Overall Study||260
10465744|NCT01053247|11613590|FG002|STARTED|Overall Study||264
10465745|NCT01053247|11613588|FG000|COMPLETED|Overall Study||249
10465746|NCT01053247|11613589|FG001|COMPLETED|Overall Study||241
10465747|NCT01053247|11613590|FG002|COMPLETED|Overall Study||236
10465748|NCT01053247|11613588|FG000|NOT COMPLETED|Overall Study||20
10465749|NCT01053247|11613589|FG001|NOT COMPLETED|Overall Study||19
10465750|NCT01053247|11613590|FG002|NOT COMPLETED|Overall Study||28
10465751|NCT01053312|11613598|FG000|STARTED|Overall Study||7
10465752|NCT01053312|11613598|FG000|COMPLETED|Overall Study||7
10465753|NCT01053312|11613598|FG000|NOT COMPLETED|Overall Study||0
10465754|NCT01053429|11613616|FG000|STARTED|Overall Study||3391
10465755|NCT01053429|11613616|FG000|COMPLETED|Overall Study||3018
10465756|NCT01053429|11613616|FG000|NOT COMPLETED|Overall Study||373
10465757|NCT01053507|11613622|FG000|STARTED|Overall Study||11
10465758|NCT01053507|11613623|FG001|STARTED|Overall Study||12
10465759|NCT01053507|11613622|FG000|COMPLETED|Overall Study||8
10465760|NCT01053507|11613623|FG001|COMPLETED|Overall Study||11
10465761|NCT01053507|11613622|FG000|NOT COMPLETED|Overall Study||3
10465762|NCT01053507|11613623|FG001|NOT COMPLETED|Overall Study||1
10465763|NCT01053663|11613632|FG000|STARTED|Overall Study||9
10465764|NCT01053663|11613632|FG000|COMPLETED|Overall Study||3
10465765|NCT01053663|11613632|FG000|NOT COMPLETED|Overall Study||6
10465766|NCT01053741|11613644|FG000|STARTED|1st Intervention||5
10465767|NCT01053741|11613645|FG001|STARTED|1st Intervention||6
10465768|NCT01053741|11613644|FG000|COMPLETED|1st Intervention||5
10465769|NCT01053741|11613645|FG001|COMPLETED|1st Intervention||6
10465770|NCT01053741|11613644|FG000|NOT COMPLETED|1st Intervention||0
10465771|NCT01053741|11613645|FG001|NOT COMPLETED|1st Intervention||0
10465772|NCT01053741|11613644|FG000|STARTED|14 Day Washout||5
10465773|NCT01053741|11613645|FG001|STARTED|14 Day Washout||6
10465774|NCT01053741|11613644|FG000|COMPLETED|14 Day Washout||5
10465775|NCT01053741|11613645|FG001|COMPLETED|14 Day Washout||6
10465776|NCT01053741|11613644|FG000|NOT COMPLETED|14 Day Washout||0
10465777|NCT01053741|11613645|FG001|NOT COMPLETED|14 Day Washout||0
10465778|NCT01053741|11613644|FG000|STARTED|2nd Study Intervention||5
10465779|NCT01053741|11613645|FG001|STARTED|2nd Study Intervention||6
10465780|NCT01053741|11613644|FG000|COMPLETED|2nd Study Intervention||5
10465781|NCT01053741|11613645|FG001|COMPLETED|2nd Study Intervention||5
10465782|NCT01053741|11613644|FG000|NOT COMPLETED|2nd Study Intervention||0
10465783|NCT01053741|11613645|FG001|NOT COMPLETED|2nd Study Intervention||1
10465784|NCT01053819|11613651|FG000|STARTED|Overall Study||6
10465785|NCT01053819|11613651|FG000|COMPLETED|Overall Study||6
10465786|NCT01053819|11613651|FG000|NOT COMPLETED|Overall Study||0
10465787|NCT01053897|11613656|FG000|STARTED|Overall Study||5
10465788|NCT01053897|11613656|FG000|COMPLETED|Overall Study||5
10465789|NCT01053897|11613656|FG000|NOT COMPLETED|Overall Study||0
10465790|NCT01053962|11613671|FG000|STARTED|Pretreatment Period||14
10465791|NCT01053962|11613672|FG001|STARTED|Pretreatment Period||15
10465792|NCT01053962|11613673|FG002|STARTED|Pretreatment Period||16
10465793|NCT01053962|11613674|FG003|STARTED|Pretreatment Period||17
10465794|NCT01053962|11613675|FG004|STARTED|Pretreatment Period||22
10465795|NCT01053962|11613671|FG000|COMPLETED|Pretreatment Period||14
10465796|NCT01053962|11613672|FG001|COMPLETED|Pretreatment Period||14
10465797|NCT01053962|11613673|FG002|COMPLETED|Pretreatment Period||15
10465798|NCT01053962|11613674|FG003|COMPLETED|Pretreatment Period||15
10465799|NCT01053962|11613675|FG004|COMPLETED|Pretreatment Period||20
10465800|NCT01053962|11613671|FG000|NOT COMPLETED|Pretreatment Period||0
10465801|NCT01053962|11613672|FG001|NOT COMPLETED|Pretreatment Period||1
10465802|NCT01053962|11613673|FG002|NOT COMPLETED|Pretreatment Period||1
10465803|NCT01053962|11613674|FG003|NOT COMPLETED|Pretreatment Period||2
10465804|NCT01053962|11613675|FG004|NOT COMPLETED|Pretreatment Period||2
10465805|NCT01053962|11613671|FG000|STARTED|Treatment Period||14
10465806|NCT01053962|11613672|FG001|STARTED|Treatment Period||14
10465807|NCT01053962|11613673|FG002|STARTED|Treatment Period||15
10465808|NCT01053962|11613674|FG003|STARTED|Treatment Period||15
10465809|NCT01053962|11613675|FG004|STARTED|Treatment Period||20
10465810|NCT01053962|11613671|FG000|COMPLETED|Treatment Period||13
10465811|NCT01053962|11613672|FG001|COMPLETED|Treatment Period||14
10465812|NCT01053962|11613673|FG002|COMPLETED|Treatment Period||15
10465813|NCT01053962|11613674|FG003|COMPLETED|Treatment Period||15
10465814|NCT01053962|11613675|FG004|COMPLETED|Treatment Period||17
10465815|NCT01053962|11613671|FG000|NOT COMPLETED|Treatment Period||1
10465816|NCT01053962|11613672|FG001|NOT COMPLETED|Treatment Period||0
10465817|NCT01053962|11613673|FG002|NOT COMPLETED|Treatment Period||0
10465818|NCT01053962|11613674|FG003|NOT COMPLETED|Treatment Period||0
10465819|NCT01053962|11613675|FG004|NOT COMPLETED|Treatment Period||3
10465820|NCT01053962|11613671|FG000|STARTED|Follow-up Period||13
10465821|NCT01053962|11613672|FG001|STARTED|Follow-up Period||14
10465822|NCT01053962|11613673|FG002|STARTED|Follow-up Period||15
10465823|NCT01053962|11613674|FG003|STARTED|Follow-up Period||15
10465824|NCT01053962|11613675|FG004|STARTED|Follow-up Period||17
10465825|NCT01053962|11613671|FG000|COMPLETED|Follow-up Period||13
10465826|NCT01053962|11613672|FG001|COMPLETED|Follow-up Period||14
10465827|NCT01053962|11613673|FG002|COMPLETED|Follow-up Period||15
10465828|NCT01053962|11613674|FG003|COMPLETED|Follow-up Period||15
10465829|NCT01053962|11613675|FG004|COMPLETED|Follow-up Period||17
10465830|NCT01053962|11613671|FG000|NOT COMPLETED|Follow-up Period||0
10465831|NCT01053962|11613672|FG001|NOT COMPLETED|Follow-up Period||0
10465832|NCT01053962|11613673|FG002|NOT COMPLETED|Follow-up Period||0
10465833|NCT01053962|11613674|FG003|NOT COMPLETED|Follow-up Period||0
10465834|NCT01053962|11613675|FG004|NOT COMPLETED|Follow-up Period||0
10465835|NCT01053988|11613697|FG000|STARTED|2-week, Single-blind Run-In Period||1390
10465836|NCT01053988|11613698|FG001|STARTED|2-week, Single-blind Run-In Period||0
10465837|NCT01053988|11613699|FG002|STARTED|2-week, Single-blind Run-In Period||0
10465838|NCT01053988|11613700|FG003|STARTED|2-week, Single-blind Run-In Period||0
10465839|NCT01053988|11613701|FG004|STARTED|2-week, Single-blind Run-In Period||0
10465840|NCT01053988|11613702|FG005|STARTED|2-week, Single-blind Run-In Period||0
10465841|NCT01053988|11613697|FG000|COMPLETED|2-week, Single-blind Run-In Period||1030
10465842|NCT01053988|11613698|FG001|COMPLETED|2-week, Single-blind Run-In Period||0
10465843|NCT01053988|11613699|FG002|COMPLETED|2-week, Single-blind Run-In Period||0
10465844|NCT01053988|11613700|FG003|COMPLETED|2-week, Single-blind Run-In Period||0
10465845|NCT01053988|11613701|FG004|COMPLETED|2-week, Single-blind Run-In Period||0
10465846|NCT01053988|11613702|FG005|COMPLETED|2-week, Single-blind Run-In Period||0
10465847|NCT01053988|11613697|FG000|NOT COMPLETED|2-week, Single-blind Run-In Period||360
10465848|NCT01053988|11613698|FG001|NOT COMPLETED|2-week, Single-blind Run-In Period||0
10465849|NCT01053988|11613699|FG002|NOT COMPLETED|2-week, Single-blind Run-In Period||0
10465850|NCT01053988|11613700|FG003|NOT COMPLETED|2-week, Single-blind Run-In Period||0
10465851|NCT01053988|11613701|FG004|NOT COMPLETED|2-week, Single-blind Run-In Period||0
10465852|NCT01053988|11613702|FG005|NOT COMPLETED|2-week, Single-blind Run-In Period||0
10526508|NCT01381874|11678371|FG001|NOT COMPLETED|Overall Study||63
10465853|NCT01053988|11613697|FG000|STARTED|24-week, Double-blind Treatment Period||0
10465854|NCT01053988|11613698|FG001|STARTED|24-week, Double-blind Treatment Period||207
10465855|NCT01053988|11613699|FG002|STARTED|24-week, Double-blind Treatment Period||206
10465856|NCT01053988|11613700|FG003|STARTED|24-week, Double-blind Treatment Period||205
10465857|NCT01053988|11613701|FG004|STARTED|24-week, Double-blind Treatment Period||206
10465858|NCT01053988|11613702|FG005|STARTED|24-week, Double-blind Treatment Period||206
10465859|NCT01053988|11613697|FG000|COMPLETED|24-week, Double-blind Treatment Period||0
10465860|NCT01053988|11613698|FG001|COMPLETED|24-week, Double-blind Treatment Period||138
10465861|NCT01053988|11613699|FG002|COMPLETED|24-week, Double-blind Treatment Period||145
10465862|NCT01053988|11613700|FG003|COMPLETED|24-week, Double-blind Treatment Period||142
10465863|NCT01053988|11613701|FG004|COMPLETED|24-week, Double-blind Treatment Period||147
10465864|NCT01053988|11613702|FG005|COMPLETED|24-week, Double-blind Treatment Period||151
10465865|NCT01053988|11613697|FG000|NOT COMPLETED|24-week, Double-blind Treatment Period||0
10465866|NCT01053988|11613698|FG001|NOT COMPLETED|24-week, Double-blind Treatment Period||69
10465867|NCT01053988|11613699|FG002|NOT COMPLETED|24-week, Double-blind Treatment Period||61
10465868|NCT01053988|11613700|FG003|NOT COMPLETED|24-week, Double-blind Treatment Period||63
10465869|NCT01053988|11613701|FG004|NOT COMPLETED|24-week, Double-blind Treatment Period||59
10465870|NCT01053988|11613702|FG005|NOT COMPLETED|24-week, Double-blind Treatment Period||55
10465871|NCT01054079|11613714|FG000|STARTED|Overall Study||20
10465872|NCT01054079|11613714|FG000|# Recieved Proper PSA Testing|Overall Study||10
10465873|NCT01054079|11613714|FG000|COMPLETED|Overall Study|while all 20 patients received at least some of the intervention, some did not get proper PSA tests.|20
10465874|NCT01054079|11613714|FG000|NOT COMPLETED|Overall Study||0
10465875|NCT01054144|11613718|FG000|STARTED|Overall Study||27
10465876|NCT01054144|11613718|FG000|COMPLETED|Overall Study||25
10465877|NCT01054144|11613718|FG000|NOT COMPLETED|Overall Study||2
10465878|NCT01054170|11613727|FG000|STARTED|Overall Study||25
10465879|NCT01054170|11613728|FG001|STARTED|Overall Study||27
10465880|NCT01054170|11613727|FG000|COMPLETED|Overall Study||21
10465881|NCT01054170|11613728|FG001|COMPLETED|Overall Study||21
10465882|NCT01054170|11613727|FG000|NOT COMPLETED|Overall Study||4
10465883|NCT01054170|11613728|FG001|NOT COMPLETED|Overall Study||6
10465884|NCT01054183|11613736|FG000|STARTED|Overall Study||10
10465885|NCT01054183|11613737|FG001|STARTED|Overall Study||12
10465886|NCT01054183|11613736|FG000|COMPLETED|Overall Study||10
10465887|NCT01054183|11613737|FG001|COMPLETED|Overall Study||12
10465888|NCT01054183|11613736|FG000|NOT COMPLETED|Overall Study||0
10465889|NCT01054183|11613737|FG001|NOT COMPLETED|Overall Study||0
10465890|NCT01054209|11613745|FG000|STARTED|Overall Study||58
10465891|NCT01054209|11613746|FG001|STARTED|Overall Study||58
10465892|NCT01054209|11613745|FG000|COMPLETED|Overall Study||58
10465893|NCT01054209|11613746|FG001|COMPLETED|Overall Study||58
10465894|NCT01054209|11613745|FG000|NOT COMPLETED|Overall Study||0
10465895|NCT01054209|11613746|FG001|NOT COMPLETED|Overall Study||0
10465896|NCT01054222|11613752|FG000|STARTED|Overall Study||31
10465897|NCT01054222|11613752|FG000|COMPLETED|Overall Study||20
10465898|NCT01054222|11613752|FG000|NOT COMPLETED|Overall Study||11
10465899|NCT01054300|11613758|FG000|STARTED|Period 1||13
10465900|NCT01054300|11613759|FG001|STARTED|Period 1||13
10465901|NCT01054300|11613760|FG002|STARTED|Period 1||13
10465902|NCT01054300|11613761|FG003|STARTED|Period 1||13
10465903|NCT01054300|11613758|FG000|COMPLETED|Period 1|Discontinuation occurred prior to Period 2 dose.|12
10465904|NCT01054300|11613759|FG001|COMPLETED|Period 1||13
10465905|NCT01054300|11613760|FG002|COMPLETED|Period 1||13
10465906|NCT01054300|11613761|FG003|COMPLETED|Period 1||13
10465907|NCT01054300|11613758|FG000|NOT COMPLETED|Period 1||1
10465908|NCT01054300|11613759|FG001|NOT COMPLETED|Period 1||0
10465909|NCT01054300|11613760|FG002|NOT COMPLETED|Period 1||0
10465910|NCT01054300|11613761|FG003|NOT COMPLETED|Period 1||0
10465911|NCT01054300|11613758|FG000|STARTED|Period 2||12
10465912|NCT01054300|11613759|FG001|STARTED|Period 2||13
10465913|NCT01054300|11613760|FG002|STARTED|Period 2||13
10465914|NCT01054300|11613761|FG003|STARTED|Period 2||13
10465915|NCT01054300|11613758|FG000|COMPLETED|Period 2||12
10465916|NCT01054300|11613759|FG001|COMPLETED|Period 2||13
10465917|NCT01054300|11613760|FG002|COMPLETED|Period 2||12
10465918|NCT01054300|11613761|FG003|COMPLETED|Period 2||13
10465919|NCT01054300|11613758|FG000|NOT COMPLETED|Period 2||0
10465920|NCT01054300|11613759|FG001|NOT COMPLETED|Period 2||0
10465921|NCT01054300|11613760|FG002|NOT COMPLETED|Period 2||1
10465922|NCT01054300|11613761|FG003|NOT COMPLETED|Period 2||0
10465923|NCT01054339|11613774|FG000|STARTED|Overall Study||3
10465924|NCT01054339|11613775|FG001|STARTED|Overall Study||3
10465925|NCT01054339|11613776|FG002|STARTED|Overall Study||3
10465926|NCT01054339|11613774|FG000|COMPLETED|Overall Study||3
10465927|NCT01054339|11613775|FG001|COMPLETED|Overall Study||3
10465928|NCT01054339|11613776|FG002|COMPLETED|Overall Study||3
10465929|NCT01054339|11613774|FG000|NOT COMPLETED|Overall Study||0
10465930|NCT01054339|11613775|FG001|NOT COMPLETED|Overall Study||0
10465931|NCT01054339|11613776|FG002|NOT COMPLETED|Overall Study||0
10465932|NCT01054404|11613788|FG000|STARTED|Overall Study||10
10465933|NCT01054404|11613789|FG001|STARTED|Overall Study||13
10465934|NCT01054404|11613788|FG000|COMPLETED|Overall Study||10
10465935|NCT01054404|11613789|FG001|COMPLETED|Overall Study||13
10465936|NCT01054404|11613788|FG000|NOT COMPLETED|Overall Study||0
10465937|NCT01054404|11613789|FG001|NOT COMPLETED|Overall Study||0
10465938|NCT01054443|11613799|FG000|STARTED|Overall Study||5
10465939|NCT01054443|11613800|FG001|STARTED|Overall Study||5
10465940|NCT01054443|11613801|FG002|STARTED|Overall Study||5
10465941|NCT01054443|11613802|FG003|STARTED|Overall Study||5
10465942|NCT01054443|11613799|FG000|COMPLETED|Overall Study||5
10465943|NCT01054443|11613800|FG001|COMPLETED|Overall Study||5
10465944|NCT01054443|11613801|FG002|COMPLETED|Overall Study||5
10465945|NCT01054443|11613802|FG003|COMPLETED|Overall Study||4
10465946|NCT01054443|11613799|FG000|NOT COMPLETED|Overall Study||0
10465947|NCT01054443|11613800|FG001|NOT COMPLETED|Overall Study||0
10465948|NCT01054443|11613801|FG002|NOT COMPLETED|Overall Study||0
10465949|NCT01054443|11613802|FG003|NOT COMPLETED|Overall Study||1
10465950|NCT01054456|11613815|FG000|STARTED|Overall Study||36
10465951|NCT01054456|11613815|FG000|COMPLETED|Overall Study||35
10465952|NCT01054456|11613815|FG000|NOT COMPLETED|Overall Study||1
10465953|NCT01054560|11613821|FG000|STARTED|Overall Study||58
10465954|NCT01054560|11613822|FG001|STARTED|Overall Study||55
10465955|NCT01054560|11613821|FG000|COMPLETED|Overall Study||45
10465956|NCT01054560|11613822|FG001|COMPLETED|Overall Study||27
10465957|NCT01054560|11613821|FG000|NOT COMPLETED|Overall Study||13
10465958|NCT01054560|11613822|FG001|NOT COMPLETED|Overall Study||28
10465959|NCT01054573|11613834|FG000|STARTED|Overall Study||9
10465960|NCT01054573|11613835|FG001|STARTED|Overall Study||32
10465961|NCT01054573|11613836|FG002|STARTED|Overall Study||22
10465962|NCT01054573|11613837|FG003|STARTED|Overall Study||27
10465963|NCT01054573|11613834|FG000|COMPLETED|Overall Study||8
10465964|NCT01054573|11613835|FG001|COMPLETED|Overall Study||28
10465965|NCT01054573|11613836|FG002|COMPLETED|Overall Study||19
10465966|NCT01054573|11613837|FG003|COMPLETED|Overall Study||25
10465967|NCT01054573|11613834|FG000|NOT COMPLETED|Overall Study||1
10465968|NCT01054573|11613835|FG001|NOT COMPLETED|Overall Study||4
10465969|NCT01054573|11613836|FG002|NOT COMPLETED|Overall Study||3
10465970|NCT01054573|11613837|FG003|NOT COMPLETED|Overall Study||2
10465971|NCT01054586|11613860|FG000|STARTED|Overall Study||43
10465972|NCT01054586|11613861|FG001|STARTED|Overall Study||15
10465973|NCT01054586|11613862|FG002|STARTED|Overall Study||8
10465974|NCT01054586|11613863|FG003|STARTED|Overall Study||101
10465975|NCT01054586|11613860|FG000|COMPLETED|Overall Study||43
10465976|NCT01054586|11613861|FG001|COMPLETED|Overall Study||15
10465977|NCT01054586|11613862|FG002|COMPLETED|Overall Study||8
10465978|NCT01054586|11613863|FG003|COMPLETED|Overall Study||101
10465979|NCT01054586|11613860|FG000|NOT COMPLETED|Overall Study||0
10465980|NCT01054586|11613861|FG001|NOT COMPLETED|Overall Study||0
10465981|NCT01054586|11613862|FG002|NOT COMPLETED|Overall Study||0
10465982|NCT01054586|11613863|FG003|NOT COMPLETED|Overall Study||0
10465983|NCT01054599|11613885|FG000|STARTED|Overall Study||13
10465984|NCT01054599|11613886|FG001|STARTED|Overall Study||16
10465985|NCT01054599|11613885|FG000|COMPLETED|Overall Study||9
10465986|NCT01054599|11613886|FG001|COMPLETED|Overall Study||9
10465987|NCT01054599|11613885|FG000|NOT COMPLETED|Overall Study||4
10465988|NCT01054599|11613886|FG001|NOT COMPLETED|Overall Study||7
10465989|NCT01054625|11613895|FG000|STARTED|Overall Study|A total of 31 patients were enrolled, 1 patient died before receiving any zalutumumab|8
10465990|NCT01054625|11613896|FG001|STARTED|Overall Study||12
10465991|NCT01054625|11613897|FG002|STARTED|Overall Study||10
10465992|NCT01054625|11613895|FG000|COMPLETED|Overall Study||6
10465993|NCT01054625|11613896|FG001|COMPLETED|Overall Study||9
10465994|NCT01054625|11613897|FG002|COMPLETED|Overall Study||9
10465995|NCT01054625|11613895|FG000|NOT COMPLETED|Overall Study||2
10465996|NCT01054625|11613896|FG001|NOT COMPLETED|Overall Study||3
10465997|NCT01054625|11613897|FG002|NOT COMPLETED|Overall Study||1
10465998|NCT01054703|11613905|FG000|STARTED|Overall Study||14
10465999|NCT01054703|11613905|FG000|COMPLETED|Overall Study||14
10466000|NCT01054703|11613905|FG000|NOT COMPLETED|Overall Study||0
10466001|NCT01054729|11613913|FG000|STARTED|Overall Study||16
10466002|NCT01054729|11613914|FG001|STARTED|Overall Study||19
10466003|NCT01054729|11613915|FG002|STARTED|Overall Study||15
10466004|NCT01054729|11613916|FG003|STARTED|Overall Study||14
10466005|NCT01054729|11613913|FG000|Randomized and Treated|Overall Study||16
10466006|NCT01054729|11613914|FG001|Randomized and Treated|Overall Study||18
10466007|NCT01054729|11613915|FG002|Randomized and Treated|Overall Study||15
10466008|NCT01054729|11613916|FG003|Randomized and Treated|Overall Study||14
10466009|NCT01054729|11613913|FG000|COMPLETED|Overall Study||12
10466010|NCT01054729|11613914|FG001|COMPLETED|Overall Study||14
10466011|NCT01054729|11613915|FG002|COMPLETED|Overall Study||9
10466012|NCT01054729|11613916|FG003|COMPLETED|Overall Study||11
10466013|NCT01054729|11613913|FG000|NOT COMPLETED|Overall Study||4
10466014|NCT01054729|11613914|FG001|NOT COMPLETED|Overall Study||5
10466015|NCT01054729|11613915|FG002|NOT COMPLETED|Overall Study||6
10466016|NCT01054729|11613916|FG003|NOT COMPLETED|Overall Study||3
10466017|NCT01054742|11613926|FG000|STARTED|Overall Study||2
10466018|NCT01054742|11613926|FG000|COMPLETED|Overall Study||2
10466019|NCT01054742|11613926|FG000|NOT COMPLETED|Overall Study||0
10466020|NCT01054768|11613932|FG000|STARTED|Overall Study||17
10466021|NCT01054768|11613933|FG001|STARTED|Overall Study||20
10466022|NCT01054768|11613932|FG000|COMPLETED|Overall Study||9
10466023|NCT01054768|11613933|FG001|COMPLETED|Overall Study||17
10466024|NCT01054768|11613932|FG000|NOT COMPLETED|Overall Study||8
10466025|NCT01054768|11613933|FG001|NOT COMPLETED|Overall Study||3
10466026|NCT01054820|11613939|FG000|STARTED|Overall Study||123
10466027|NCT01054820|11613939|FG000|COMPLETED|Overall Study||121
10466028|NCT01054820|11613939|FG000|NOT COMPLETED|Overall Study||2
10466029|NCT01054846|11613945|FG000|STARTED|Overall Study||322
10466030|NCT01054846|11613946|FG001|STARTED|Overall Study||68
10466031|NCT01054846|11613945|FG000|COMPLETED|Overall Study||246
10466032|NCT01054846|11613946|FG001|COMPLETED|Overall Study||51
10466033|NCT01054846|11613945|FG000|NOT COMPLETED|Overall Study||76
10466034|NCT01054846|11613946|FG001|NOT COMPLETED|Overall Study||17
10466035|NCT01054885|11613957|FG000|STARTED|2-week, Single-blind Run-In Period||1577
10466036|NCT01054885|11613958|FG001|STARTED|2-week, Single-blind Run-In Period||0
10466037|NCT01054885|11613959|FG002|STARTED|2-week, Single-blind Run-In Period||0
10466038|NCT01054885|11613960|FG003|STARTED|2-week, Single-blind Run-In Period||0
10466039|NCT01054885|11613961|FG004|STARTED|2-week, Single-blind Run-In Period||0
10466040|NCT01054885|11613962|FG005|STARTED|2-week, Single-blind Run-In Period||0
10466041|NCT01054885|11613963|FG006|STARTED|2-week, Single-blind Run-In Period||0
10466042|NCT01054885|11613957|FG000|COMPLETED|2-week, Single-blind Run-In Period||1226
10466043|NCT01054885|11613958|FG001|COMPLETED|2-week, Single-blind Run-In Period||0
10466044|NCT01054885|11613959|FG002|COMPLETED|2-week, Single-blind Run-In Period||0
10466045|NCT01054885|11613960|FG003|COMPLETED|2-week, Single-blind Run-In Period||0
10466046|NCT01054885|11613961|FG004|COMPLETED|2-week, Single-blind Run-In Period||0
10466047|NCT01054885|11613962|FG005|COMPLETED|2-week, Single-blind Run-In Period||0
10466048|NCT01054885|11613963|FG006|COMPLETED|2-week, Single-blind Run-In Period||0
10466049|NCT01054885|11613957|FG000|NOT COMPLETED|2-week, Single-blind Run-In Period||351
10466050|NCT01054885|11613958|FG001|NOT COMPLETED|2-week, Single-blind Run-In Period||0
10466051|NCT01054885|11613959|FG002|NOT COMPLETED|2-week, Single-blind Run-In Period||0
10466052|NCT01054885|11613960|FG003|NOT COMPLETED|2-week, Single-blind Run-In Period||0
10466053|NCT01054885|11613961|FG004|NOT COMPLETED|2-week, Single-blind Run-In Period||0
10466054|NCT01054885|11613962|FG005|NOT COMPLETED|2-week, Single-blind Run-In Period||0
10466055|NCT01054885|11613963|FG006|NOT COMPLETED|2-week, Single-blind Run-In Period||0
10466056|NCT01054885|11613957|FG000|STARTED|24-week, Double-blind Treatment Period||0
10466057|NCT01054885|11613958|FG001|STARTED|24-week, Double-blind Treatment Period||205
10466058|NCT01054885|11613959|FG002|STARTED|24-week, Double-blind Treatment Period||204
10466059|NCT01054885|11613960|FG003|STARTED|24-week, Double-blind Treatment Period||203
10466060|NCT01054885|11613961|FG004|STARTED|24-week, Double-blind Treatment Period||203
10466061|NCT01054885|11613962|FG005|STARTED|24-week, Double-blind Treatment Period||204
10466062|NCT01054885|11613963|FG006|STARTED|24-week, Double-blind Treatment Period||205
10466063|NCT01054885|11613957|FG000|COMPLETED|24-week, Double-blind Treatment Period||0
10466064|NCT01054885|11613958|FG001|COMPLETED|24-week, Double-blind Treatment Period||146
10466065|NCT01054885|11613959|FG002|COMPLETED|24-week, Double-blind Treatment Period||155
10466066|NCT01054885|11613960|FG003|COMPLETED|24-week, Double-blind Treatment Period||160
10466067|NCT01054885|11613961|FG004|COMPLETED|24-week, Double-blind Treatment Period||161
10466068|NCT01054885|11613962|FG005|COMPLETED|24-week, Double-blind Treatment Period||144
10466069|NCT01054885|11613963|FG006|COMPLETED|24-week, Double-blind Treatment Period||158
10466070|NCT01054885|11613957|FG000|NOT COMPLETED|24-week, Double-blind Treatment Period||0
10466071|NCT01054885|11613958|FG001|NOT COMPLETED|24-week, Double-blind Treatment Period||59
10466072|NCT01054885|11613959|FG002|NOT COMPLETED|24-week, Double-blind Treatment Period||49
10466073|NCT01054885|11613960|FG003|NOT COMPLETED|24-week, Double-blind Treatment Period||43
10466074|NCT01054885|11613961|FG004|NOT COMPLETED|24-week, Double-blind Treatment Period||42
10466075|NCT01054885|11613962|FG005|NOT COMPLETED|24-week, Double-blind Treatment Period||60
10466076|NCT01054885|11613963|FG006|NOT COMPLETED|24-week, Double-blind Treatment Period||47
10466077|NCT01054911|11613978|FG000|STARTED|Overall Study||5
10466078|NCT01054911|11613978|FG000|COMPLETED|Overall Study||5
10466079|NCT01054911|11613978|FG000|NOT COMPLETED|Overall Study||0
10466080|NCT01054976|11613984|FG000|STARTED|Overall Study||92
10466081|NCT01054976|11613984|FG000|COMPLETED|Overall Study||57
10466082|NCT01054976|11613984|FG000|NOT COMPLETED|Overall Study||35
10466083|NCT01055028|11613990|FG000|STARTED|Screening||9
10466084|NCT01055028|11613991|FG001|STARTED|Screening||9
10466085|NCT01055028|11613990|FG000|COMPLETED|Screening||8
10466086|NCT01055028|11613991|FG001|COMPLETED|Screening||8
10466087|NCT01055028|11613990|FG000|NOT COMPLETED|Screening||1
10466088|NCT01055028|11613991|FG001|NOT COMPLETED|Screening||1
10466089|NCT01055028|11613990|FG000|STARTED|Treatment Cycles 1 to 3||8
10466090|NCT01055028|11613991|FG001|STARTED|Treatment Cycles 1 to 3||8
10466091|NCT01055028|11613990|FG000|COMPLETED|Treatment Cycles 1 to 3||6
10466092|NCT01055028|11613991|FG001|COMPLETED|Treatment Cycles 1 to 3||5
10466093|NCT01055028|11613990|FG000|NOT COMPLETED|Treatment Cycles 1 to 3||2
10466094|NCT01055028|11613991|FG001|NOT COMPLETED|Treatment Cycles 1 to 3||3
10466095|NCT01055028|11613990|FG000|STARTED|Inter-treatment Period||6
10466096|NCT01055028|11613991|FG001|STARTED|Inter-treatment Period||5
10466097|NCT01055028|11613990|FG000|COMPLETED|Inter-treatment Period||6
10466098|NCT01055028|11613991|FG001|COMPLETED|Inter-treatment Period||2
10466099|NCT01055028|11613990|FG000|NOT COMPLETED|Inter-treatment Period||0
10466100|NCT01055028|11613991|FG001|NOT COMPLETED|Inter-treatment Period||3
10466101|NCT01055028|11613990|FG000|STARTED|Treatment Cycles 4 to 6||6
10466102|NCT01055028|11613991|FG001|STARTED|Treatment Cycles 4 to 6||2
10466103|NCT01055028|11613990|FG000|COMPLETED|Treatment Cycles 4 to 6||6
10466104|NCT01055028|11613991|FG001|COMPLETED|Treatment Cycles 4 to 6||2
10466105|NCT01055028|11613990|FG000|NOT COMPLETED|Treatment Cycles 4 to 6||0
10466106|NCT01055028|11613991|FG001|NOT COMPLETED|Treatment Cycles 4 to 6||0
10466107|NCT01055067|11614001|FG000|STARTED|Overall Study||27
10466108|NCT01055067|11614001|FG000|COMPLETED|Overall Study||27
10466109|NCT01055067|11614001|FG000|NOT COMPLETED|Overall Study||0
10466110|NCT01055132|11614007|FG000|STARTED|Period 1 (5-9 Days)||36
10466111|NCT01055132|11614008|FG001|STARTED|Period 1 (5-9 Days)||33
10466112|NCT01055132|11614007|FG000|COMPLETED|Period 1 (5-9 Days)||35
10466113|NCT01055132|11614008|FG001|COMPLETED|Period 1 (5-9 Days)||33
10466114|NCT01055132|11614007|FG000|NOT COMPLETED|Period 1 (5-9 Days)||1
10466115|NCT01055132|11614008|FG001|NOT COMPLETED|Period 1 (5-9 Days)||0
10466116|NCT01055132|11614007|FG000|STARTED|Period 2 (5-9 Days)||35
10466117|NCT01055132|11614008|FG001|STARTED|Period 2 (5-9 Days)||33
10466118|NCT01055132|11614007|FG000|COMPLETED|Period 2 (5-9 Days)||35
10466119|NCT01055132|11614008|FG001|COMPLETED|Period 2 (5-9 Days)||32
10466120|NCT01055132|11614007|FG000|NOT COMPLETED|Period 2 (5-9 Days)||0
10466121|NCT01055132|11614008|FG001|NOT COMPLETED|Period 2 (5-9 Days)||1
10466122|NCT01055171|11614020|FG000|STARTED|Overall Study|Randomized to receive medication.|29
10466123|NCT01055171|11614021|FG001|STARTED|Overall Study|Randomized to receive placebo.|28
10466124|NCT01055171|11614020|FG000|Retrieval Completion|Overall Study|Received the medication and completed the retrieval session.|25
10466125|NCT01055171|11614021|FG001|Retrieval Completion|Overall Study|Received the sugar pill and completed the retrieval session.|24
10466126|NCT01055171|11614020|FG000|Test Procedure Completion|Overall Study|Received the medication and completed the first test session.|21
10466127|NCT01055171|11614021|FG001|Test Procedure Completion|Overall Study|Received the placebo and completed the first test session.|23
10466128|NCT01055171|11614020|FG000|COMPLETED|Overall Study|Received the medication and completed all visits including the one-week follow-up.|18
10466129|NCT01055171|11614021|FG001|COMPLETED|Overall Study|Received the sugar pill and completed all visits including the one-week follow-up.|21
10466130|NCT01055171|11614020|FG000|NOT COMPLETED|Overall Study||11
10466131|NCT01055171|11614021|FG001|NOT COMPLETED|Overall Study||7
10466132|NCT01055184|11614027|FG000|STARTED|Overall Study||34
10466133|NCT01055184|11614027|FG000|COMPLETED|Overall Study||34
10466134|NCT01055184|11614027|FG000|NOT COMPLETED|Overall Study||0
10466135|NCT01055197|11614033|FG000|STARTED|Overall Study||51
10466136|NCT01055197|11614034|FG001|STARTED|Overall Study||46
10466137|NCT01055197|11614033|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|42
10466138|NCT01055197|11614034|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|44
10466139|NCT01055197|11614033|FG000|NOT COMPLETED|Overall Study||9
10466140|NCT01055197|11614034|FG001|NOT COMPLETED|Overall Study||2
10466141|NCT01055223|11614040|FG000|STARTED|Overall Study||98483
10466142|NCT01055223|11614040|FG000|COMPLETED|Overall Study||98483
10466143|NCT01055223|11614040|FG000|NOT COMPLETED|Overall Study||0
10466144|NCT01055262|11614053|FG000|STARTED|Overall Study||169
10466145|NCT01055262|11614053|FG000|COMPLETED|Overall Study||160
10466146|NCT01055262|11614053|FG000|NOT COMPLETED|Overall Study||9
10466147|NCT01055314|11614059|FG000|STARTED|Overall Study||100
10466148|NCT01055314|11614060|FG001|STARTED|Overall Study||75
10466149|NCT01055314|11614059|FG000|COMPLETED|Overall Study||55
10466150|NCT01055314|11614060|FG001|COMPLETED|Overall Study||37
10466151|NCT01055314|11614059|FG000|NOT COMPLETED|Overall Study||45
10466152|NCT01055314|11614060|FG001|NOT COMPLETED|Overall Study||38
10466153|NCT01055457|11614077|FG000|STARTED|Overall Study||40
10466154|NCT01055457|11614078|FG001|STARTED|Overall Study||40
10466155|NCT01055457|11614079|FG002|STARTED|Overall Study||38
10466156|NCT01055457|11614080|FG003|STARTED|Overall Study||40
10466157|NCT01055457|11614081|FG004|STARTED|Overall Study||41
10466158|NCT01055457|11614082|FG005|STARTED|Overall Study||18
10466159|NCT01055457|11614083|FG006|STARTED|Overall Study||19
10466160|NCT01055457|11614084|FG007|STARTED|Overall Study||19
10466161|NCT01055457|11614085|FG008|STARTED|Overall Study||20
10466162|NCT01055457|11614086|FG009|STARTED|Overall Study||20
10466163|NCT01055457|11614077|FG000|COMPLETED|Overall Study||39
10466164|NCT01055457|11614078|FG001|COMPLETED|Overall Study||39
10466165|NCT01055457|11614079|FG002|COMPLETED|Overall Study||36
10466166|NCT01055457|11614080|FG003|COMPLETED|Overall Study||37
10466167|NCT01055457|11614081|FG004|COMPLETED|Overall Study||38
10466168|NCT01055457|11614082|FG005|COMPLETED|Overall Study||15
10466169|NCT01055457|11614083|FG006|COMPLETED|Overall Study||18
10466170|NCT01055457|11614084|FG007|COMPLETED|Overall Study||18
10466171|NCT01055457|11614085|FG008|COMPLETED|Overall Study||20
10466172|NCT01055457|11614086|FG009|COMPLETED|Overall Study||19
10708615|NCT02632526|11873440|FG002|NOT COMPLETED|Overall Study||0
10466173|NCT01055457|11614077|FG000|NOT COMPLETED|Overall Study||1
10466174|NCT01055457|11614078|FG001|NOT COMPLETED|Overall Study||1
10466175|NCT01055457|11614079|FG002|NOT COMPLETED|Overall Study||2
10466176|NCT01055457|11614080|FG003|NOT COMPLETED|Overall Study||3
10466177|NCT01055457|11614081|FG004|NOT COMPLETED|Overall Study||3
10466178|NCT01055457|11614082|FG005|NOT COMPLETED|Overall Study||3
10466179|NCT01055457|11614083|FG006|NOT COMPLETED|Overall Study||1
10466180|NCT01055457|11614084|FG007|NOT COMPLETED|Overall Study||1
10466181|NCT01055457|11614085|FG008|NOT COMPLETED|Overall Study||0
10466182|NCT01055457|11614086|FG009|NOT COMPLETED|Overall Study||1
10466183|NCT01055496|11614110|FG000|STARTED|Overall Study||48
10466184|NCT01055496|11614111|FG001|STARTED|Overall Study||55
10466185|NCT01055496|11614110|FG000|COMPLETED|Overall Study||33
10466186|NCT01055496|11614111|FG001|COMPLETED|Overall Study||25
10466187|NCT01055496|11614110|FG000|NOT COMPLETED|Overall Study||15
10466188|NCT01055496|11614111|FG001|NOT COMPLETED|Overall Study||30
10466189|NCT01055613|11614140|FG000|STARTED|Overall Study||200
10466190|NCT01055613|11614141|FG001|STARTED|Overall Study||100
10466191|NCT01055613|11614140|FG000|COMPLETED|Overall Study||191
10466192|NCT01055613|11614141|FG001|COMPLETED|Overall Study||96
10466193|NCT01055613|11614140|FG000|NOT COMPLETED|Overall Study||9
10466194|NCT01055613|11614141|FG001|NOT COMPLETED|Overall Study||4
10466195|NCT01055639|11614149|FG000|STARTED|Overall Study||66
10466196|NCT01055639|11614150|FG001|STARTED|Overall Study||60
10466197|NCT01055639|11614149|FG000|COMPLETED|Overall Study||45
10466198|NCT01055639|11614150|FG001|COMPLETED|Overall Study||31
10466199|NCT01055639|11614149|FG000|NOT COMPLETED|Overall Study||21
10466200|NCT01055639|11614150|FG001|NOT COMPLETED|Overall Study||29
10466201|NCT01055704|11614160|FG000|STARTED|Overall Study||16
10466202|NCT01055704|11614161|FG001|STARTED|Overall Study||8
10466203|NCT01055704|11614162|FG002|STARTED|Overall Study||16
10466204|NCT01055704|11614163|FG003|STARTED|Overall Study||8
10466205|NCT01055704|11614160|FG000|COMPLETED|Overall Study||16
10466206|NCT01055704|11614161|FG001|COMPLETED|Overall Study||8
10466207|NCT01055704|11614162|FG002|COMPLETED|Overall Study||16
10466208|NCT01055704|11614163|FG003|COMPLETED|Overall Study||8
10466209|NCT01055704|11614160|FG000|NOT COMPLETED|Overall Study||0
10466210|NCT01055704|11614161|FG001|NOT COMPLETED|Overall Study||0
10466211|NCT01055704|11614162|FG002|NOT COMPLETED|Overall Study||0
10466212|NCT01055704|11614163|FG003|NOT COMPLETED|Overall Study||0
10466213|NCT01055769|11614173|FG000|STARTED|First Intervention||10
10466214|NCT01055769|11614174|FG001|STARTED|First Intervention||10
10466215|NCT01055769|11614173|FG000|COMPLETED|First Intervention||10
10466216|NCT01055769|11614174|FG001|COMPLETED|First Intervention||10
10466217|NCT01055769|11614173|FG000|NOT COMPLETED|First Intervention||0
10466218|NCT01055769|11614174|FG001|NOT COMPLETED|First Intervention||0
10466219|NCT01055769|11614173|FG000|STARTED|Washout Period of Atleast 4 Days||10
10708616|NCT02632526|11873441|FG003|NOT COMPLETED|Overall Study||0
10708617|NCT02632526|11873442|FG004|NOT COMPLETED|Overall Study||0
10708618|NCT02632526|11873443|FG005|NOT COMPLETED|Overall Study||0
10708619|NCT02632552|11873490|FG000|STARTED|Overall Study||80
10466220|NCT01055769|11614174|FG001|STARTED|Washout Period of Atleast 4 Days||10
10466221|NCT01055769|11614173|FG000|COMPLETED|Washout Period of Atleast 4 Days||10
10466222|NCT01055769|11614174|FG001|COMPLETED|Washout Period of Atleast 4 Days||10
10466223|NCT01055769|11614173|FG000|NOT COMPLETED|Washout Period of Atleast 4 Days||0
10466224|NCT01055769|11614174|FG001|NOT COMPLETED|Washout Period of Atleast 4 Days||0
10466225|NCT01055769|11614173|FG000|STARTED|Second Intervention||10
10466226|NCT01055769|11614174|FG001|STARTED|Second Intervention||10
10466227|NCT01055769|11614173|FG000|COMPLETED|Second Intervention||10
10466228|NCT01055769|11614174|FG001|COMPLETED|Second Intervention||10
10466229|NCT01055769|11614173|FG000|NOT COMPLETED|Second Intervention||0
10466230|NCT01055769|11614174|FG001|NOT COMPLETED|Second Intervention||0
10466231|NCT01055782|11614183|FG000|STARTED|Overall Study||555
10466232|NCT01055782|11614184|FG001|STARTED|Overall Study||449
10466233|NCT01055782|11614183|FG000|COMPLETED|Overall Study||555
10466234|NCT01055782|11614184|FG001|COMPLETED|Overall Study||449
10466235|NCT01055782|11614183|FG000|NOT COMPLETED|Overall Study||0
10466236|NCT01055782|11614184|FG001|NOT COMPLETED|Overall Study||0
10466237|NCT01055834|11614194|FG000|STARTED|Treatment Period I||21
10466238|NCT01055834|11614195|FG001|STARTED|Treatment Period I||21
10466239|NCT01055834|11614194|FG000|COMPLETED|Treatment Period I||20
10466240|NCT01055834|11614195|FG001|COMPLETED|Treatment Period I||21
10466241|NCT01055834|11614194|FG000|NOT COMPLETED|Treatment Period I||1
10466242|NCT01055834|11614195|FG001|NOT COMPLETED|Treatment Period I||0
10466243|NCT01055834|11614194|FG000|STARTED|Treatment Period II||20
10466244|NCT01055834|11614195|FG001|STARTED|Treatment Period II||21
10466245|NCT01055834|11614194|FG000|COMPLETED|Treatment Period II||20
10466246|NCT01055834|11614195|FG001|COMPLETED|Treatment Period II||21
10466247|NCT01055834|11614194|FG000|NOT COMPLETED|Treatment Period II||0
10466248|NCT01055834|11614195|FG001|NOT COMPLETED|Treatment Period II||0
10466249|NCT01055834|11614194|FG000|STARTED|Treatment Period III|Participants from Group A did not continue into Period III.|0
10466250|NCT01055834|11614195|FG001|STARTED|Treatment Period III|14 of 21 participants in Group B who were treated in Period II participated in Period III.|14
10466251|NCT01055834|11614194|FG000|COMPLETED|Treatment Period III||0
10466252|NCT01055834|11614195|FG001|COMPLETED|Treatment Period III||14
10466253|NCT01055834|11614194|FG000|NOT COMPLETED|Treatment Period III||0
10466254|NCT01055834|11614195|FG001|NOT COMPLETED|Treatment Period III||0
10466255|NCT01055886|11614206|FG000|STARTED|Overall Study||33
10466256|NCT01055886|11614207|FG001|STARTED|Overall Study||32
10466257|NCT01055886|11614206|FG000|Reached Pre-quit Period|Overall Study|2 withdrawals, 1 lost to contact|30
10466258|NCT01055886|11614207|FG001|Reached Pre-quit Period|Overall Study|1 lost to contact|31
10466259|NCT01055886|11614206|FG000|COMPLETED|Overall Study|This includes those who completed all sessions and those with w/d post quit (missing = smoking).|28
10466260|NCT01055886|11614207|FG001|COMPLETED|Overall Study|This includes those who completed all sessions and those with w/d post quit (missing = smoking).|21
10466261|NCT01055886|11614206|FG000|NOT COMPLETED|Overall Study||5
10466262|NCT01055886|11614207|FG001|NOT COMPLETED|Overall Study||11
10466263|NCT01056016|11614215|FG000|STARTED|Overall Study|22 pediatricians were at 4 practices; practices were unit of randomization|22
10466264|NCT01056016|11614216|FG001|STARTED|Overall Study|27 pediatricians were at 4 practices; practices were unit of randomization|27
10466265|NCT01056016|11614215|FG000|COMPLETED|Overall Study||20
10466266|NCT01056016|11614216|FG001|COMPLETED|Overall Study||26
10466267|NCT01056016|11614215|FG000|NOT COMPLETED|Overall Study||2
10466268|NCT01056016|11614216|FG001|NOT COMPLETED|Overall Study||1
10466269|NCT01056107|11614226|FG000|STARTED|Overall Study||11
10466270|NCT01056107|11614227|FG001|STARTED|Overall Study||11
10466271|NCT01056107|11614228|FG002|STARTED|Overall Study||12
10466272|NCT01056107|11614229|FG003|STARTED|Overall Study||12
10466273|NCT01056107|11614226|FG000|COMPLETED|Overall Study||11
10708620|NCT02632552|11873491|FG001|STARTED|Overall Study||60
10708621|NCT02632552|11873490|FG000|COMPLETED|Overall Study||57
10466274|NCT01056107|11614227|FG001|COMPLETED|Overall Study||10
10466275|NCT01056107|11614228|FG002|COMPLETED|Overall Study||9
10466276|NCT01056107|11614229|FG003|COMPLETED|Overall Study||12
10466277|NCT01056107|11614226|FG000|NOT COMPLETED|Overall Study||0
10466278|NCT01056107|11614227|FG001|NOT COMPLETED|Overall Study||1
10466279|NCT01056107|11614228|FG002|NOT COMPLETED|Overall Study||3
10466280|NCT01056107|11614229|FG003|NOT COMPLETED|Overall Study||0
10466281|NCT01056198|11614241|FG000|STARTED|Overall Study||24
10466282|NCT01056198|11614242|FG001|STARTED|Overall Study||24
10466283|NCT01056198|11614241|FG000|COMPLETED|Overall Study||24
10466284|NCT01056198|11614242|FG001|COMPLETED|Overall Study||24
10466285|NCT01056198|11614241|FG000|NOT COMPLETED|Overall Study||0
10466286|NCT01056198|11614242|FG001|NOT COMPLETED|Overall Study||0
10466287|NCT01056263|11614250|FG000|STARTED|Overall Study||52
10466288|NCT01056263|11614250|FG000|COMPLETED|Overall Study||0
10466289|NCT01056263|11614250|FG000|NOT COMPLETED|Overall Study||52
10466290|NCT01056276|11614256|FG000|STARTED|Treatment Period-Cycles 1-8||18
10466291|NCT01056276|11614257|FG001|STARTED|Treatment Period-Cycles 1-8||41
10466292|NCT01056276|11614256|FG000|COMPLETED|Treatment Period-Cycles 1-8||5
10466293|NCT01056276|11614257|FG001|COMPLETED|Treatment Period-Cycles 1-8||33
10466294|NCT01056276|11614256|FG000|NOT COMPLETED|Treatment Period-Cycles 1-8||13
10466295|NCT01056276|11614257|FG001|NOT COMPLETED|Treatment Period-Cycles 1-8||8
10466296|NCT01056276|11614256|FG000|STARTED|Maintenance Therapy|Original regimen did not include maintenance therapy.|0
10466297|NCT01056276|11614257|FG001|STARTED|Maintenance Therapy|5 patients completed 8 cycles but did not have maintenance therapy.|28
10466298|NCT01056276|11614256|FG000|COMPLETED|Maintenance Therapy||0
10466299|NCT01056276|11614257|FG001|COMPLETED|Maintenance Therapy|14 patients are continuing maintenance therapy.|0
10466300|NCT01056276|11614256|FG000|NOT COMPLETED|Maintenance Therapy||0
10466301|NCT01056276|11614257|FG001|NOT COMPLETED|Maintenance Therapy||28
10466302|NCT01056289|11614268|FG000|STARTED|Open-label Phase||480
10466303|NCT01056289|11614269|FG001|STARTED|Open-label Phase||0
10466304|NCT01056289|11614270|FG002|STARTED|Open-label Phase||0
10466305|NCT01056289|11614271|FG003|STARTED|Open-label Phase||0
10466306|NCT01056289|11614268|FG000|COMPLETED|Open-label Phase|Participants transitioned to Double-blind phase|361
10466307|NCT01056289|11614269|FG001|COMPLETED|Open-label Phase||0
10466308|NCT01056289|11614270|FG002|COMPLETED|Open-label Phase||0
10466309|NCT01056289|11614271|FG003|COMPLETED|Open-label Phase||0
10466310|NCT01056289|11614268|FG000|NOT COMPLETED|Open-label Phase||119
10466311|NCT01056289|11614269|FG001|NOT COMPLETED|Open-label Phase||0
10466312|NCT01056289|11614270|FG002|NOT COMPLETED|Open-label Phase||0
10466313|NCT01056289|11614271|FG003|NOT COMPLETED|Open-label Phase||0
10466314|NCT01056289|11614268|FG000|STARTED|Double-blind Phase||0
10466315|NCT01056289|11614269|FG001|STARTED|Double-blind Phase||73
10466316|NCT01056289|11614270|FG002|STARTED|Double-blind Phase||140
10466317|NCT01056289|11614271|FG003|STARTED|Double-blind Phase||148
10466318|NCT01056289|11614268|FG000|COMPLETED|Double-blind Phase||0
10466319|NCT01056289|11614269|FG001|COMPLETED|Double-blind Phase||69
10466320|NCT01056289|11614270|FG002|COMPLETED|Double-blind Phase||127
10466321|NCT01056289|11614271|FG003|COMPLETED|Double-blind Phase||138
10466322|NCT01056289|11614268|FG000|NOT COMPLETED|Double-blind Phase||0
10466323|NCT01056289|11614269|FG001|NOT COMPLETED|Double-blind Phase||4
10466324|NCT01056289|11614270|FG002|NOT COMPLETED|Double-blind Phase||13
10466325|NCT01056289|11614271|FG003|NOT COMPLETED|Double-blind Phase||10
10466326|NCT01056302|11614281|FG000|STARTED|Overall Study||3
10466327|NCT01056302|11614281|FG000|COMPLETED|Overall Study|The study was completed with 3 datasets from patients who had maxillofacial trauma and were treated|3
10466328|NCT01056302|11614281|FG000|NOT COMPLETED|Overall Study||0
10466329|NCT01056328|11614288|FG000|STARTED|Overall Study||164
10466330|NCT01056328|11614289|FG001|STARTED|Overall Study||160
10466331|NCT01056328|11614288|FG000|COMPLETED|Overall Study||147
10466332|NCT01056328|11614289|FG001|COMPLETED|Overall Study||144
10466333|NCT01056328|11614288|FG000|NOT COMPLETED|Overall Study||17
10466334|NCT01056328|11614289|FG001|NOT COMPLETED|Overall Study||16
10466335|NCT01056341|11614303|FG000|STARTED|Overall Study||55
10466336|NCT01056341|11614304|FG001|STARTED|Overall Study||99
10466337|NCT01056341|11614305|FG002|STARTED|Overall Study||103
10466338|NCT01056341|11614306|FG003|STARTED|Overall Study||101
10466339|NCT01056341|11614307|FG004|STARTED|Overall Study||102
10466340|NCT01056341|11614303|FG000|Interim Analysis|Overall Study||25
10466341|NCT01056341|11614304|FG001|Interim Analysis|Overall Study||41
10466342|NCT01056341|11614305|FG002|Interim Analysis|Overall Study||41
10466343|NCT01056341|11614306|FG003|Interim Analysis|Overall Study||40
10466344|NCT01056341|11614307|FG004|Interim Analysis|Overall Study||43
10466345|NCT01056341|11614303|FG000|COMPLETED|Overall Study||19
10466346|NCT01056341|11614304|FG001|COMPLETED|Overall Study||63
10466347|NCT01056341|11614305|FG002|COMPLETED|Overall Study||88
10466348|NCT01056341|11614306|FG003|COMPLETED|Overall Study||65
10466349|NCT01056341|11614307|FG004|COMPLETED|Overall Study||88
10466350|NCT01056341|11614303|FG000|NOT COMPLETED|Overall Study||36
10466351|NCT01056341|11614304|FG001|NOT COMPLETED|Overall Study||36
10466352|NCT01056341|11614305|FG002|NOT COMPLETED|Overall Study||15
10466353|NCT01056341|11614306|FG003|NOT COMPLETED|Overall Study||36
10466354|NCT01056341|11614307|FG004|NOT COMPLETED|Overall Study||14
10466355|NCT01056380|11614327|FG000|STARTED|Overall Study||37
10466356|NCT01056380|11614328|FG001|STARTED|Overall Study||42
10466357|NCT01056380|11614327|FG000|COMPLETED|Overall Study||35
10466358|NCT01056380|11614328|FG001|COMPLETED|Overall Study||39
10466359|NCT01056380|11614327|FG000|NOT COMPLETED|Overall Study||2
10466360|NCT01056380|11614328|FG001|NOT COMPLETED|Overall Study||3
10466361|NCT01056484|11614338|FG000|STARTED|Randomized Controlled Trial||64
10466362|NCT01056484|11614339|FG001|STARTED|Randomized Controlled Trial||59
10466363|NCT01056484|11614338|FG000|COMPLETED|Randomized Controlled Trial||57
10466364|NCT01056484|11614339|FG001|COMPLETED|Randomized Controlled Trial||58
10466365|NCT01056484|11614338|FG000|NOT COMPLETED|Randomized Controlled Trial||7
10466366|NCT01056484|11614339|FG001|NOT COMPLETED|Randomized Controlled Trial||1
10466367|NCT01056484|11614338|FG000|STARTED|Follow up - Non-randomized|Out of the enrolled experimental subjects (N=64), 57 completed Period 1 and entered into Period 2.|57
10466368|NCT01056484|11614339|FG001|STARTED|Follow up - Non-randomized|Out of the enrolled control subjects (N=59), 58 completed Period 1 and entered into Period 2.|58
10466369|NCT01056484|11614338|FG000|COMPLETED|Follow up - Non-randomized||57
10466370|NCT01056484|11614339|FG001|COMPLETED|Follow up - Non-randomized||56
10466371|NCT01056484|11614338|FG000|NOT COMPLETED|Follow up - Non-randomized||0
10466372|NCT01056484|11614339|FG001|NOT COMPLETED|Follow up - Non-randomized||2
10466373|NCT01056510|11614348|FG000|STARTED|Overall Study||178
10466374|NCT01056510|11614349|FG001|STARTED|Overall Study||179
10466375|NCT01056510|11614348|FG000|COMPLETED|Overall Study||124
10466376|NCT01056510|11614349|FG001|COMPLETED|Overall Study||115
10466377|NCT01056510|11614348|FG000|NOT COMPLETED|Overall Study||54
10466378|NCT01056510|11614349|FG001|NOT COMPLETED|Overall Study||64
10466379|NCT01056523|11614355|FG000|STARTED|Overall Study||4
10466380|NCT01056523|11614356|FG001|STARTED|Overall Study||3
10466381|NCT01056523|11614357|FG002|STARTED|Overall Study||5
10466382|NCT01056523|11614358|FG003|STARTED|Overall Study||6
10466383|NCT01056523|11614359|FG004|STARTED|Overall Study||3
10466384|NCT01056523|11614360|FG005|STARTED|Overall Study||3
10466385|NCT01056523|11614361|FG006|STARTED|Overall Study||5
10466386|NCT01056523|11614355|FG000|COMPLETED|Overall Study||3
10466387|NCT01056523|11614356|FG001|COMPLETED|Overall Study||3
10466388|NCT01056523|11614357|FG002|COMPLETED|Overall Study||3
10466389|NCT01056523|11614358|FG003|COMPLETED|Overall Study||3
10466390|NCT01056523|11614359|FG004|COMPLETED|Overall Study||3
10466391|NCT01056523|11614360|FG005|COMPLETED|Overall Study||3
10466392|NCT01056523|11614361|FG006|COMPLETED|Overall Study||4
10466393|NCT01056523|11614355|FG000|NOT COMPLETED|Overall Study||1
10466394|NCT01056523|11614356|FG001|NOT COMPLETED|Overall Study||0
10466395|NCT01056523|11614357|FG002|NOT COMPLETED|Overall Study||2
10466396|NCT01056523|11614358|FG003|NOT COMPLETED|Overall Study||3
10466397|NCT01056523|11614359|FG004|NOT COMPLETED|Overall Study||0
10466398|NCT01056523|11614360|FG005|NOT COMPLETED|Overall Study||0
10466399|NCT01056523|11614361|FG006|NOT COMPLETED|Overall Study||1
10466400|NCT01056536|11614369|FG000|STARTED|Overall Study||596
10466401|NCT01056536|11614370|FG001|STARTED|Overall Study||356
10466402|NCT01056536|11614371|FG002|STARTED|Overall Study||729
10466403|NCT01056536|11614369|FG000|COMPLETED|Overall Study||394
10466404|NCT01056536|11614370|FG001|COMPLETED|Overall Study||240
10466405|NCT01056536|11614371|FG002|COMPLETED|Overall Study||481
10466406|NCT01056536|11614369|FG000|NOT COMPLETED|Overall Study||202
10466407|NCT01056536|11614370|FG001|NOT COMPLETED|Overall Study||116
10466408|NCT01056536|11614371|FG002|NOT COMPLETED|Overall Study||248
10466409|NCT01056601|11614379|FG000|STARTED|Overall Study||7
10466410|NCT01056601|11614379|FG000|COMPLETED|Overall Study||7
10466411|NCT01056601|11614379|FG000|NOT COMPLETED|Overall Study||0
10466412|NCT01056640|11614385|FG000|STARTED|Overall Study||102
10466413|NCT01056640|11614386|FG001|STARTED|Overall Study||103
10466414|NCT01056640|11614385|FG000|COMPLETED|Overall Study||76
10466415|NCT01056640|11614386|FG001|COMPLETED|Overall Study||91
10466416|NCT01056640|11614385|FG000|NOT COMPLETED|Overall Study||26
10466417|NCT01056640|11614386|FG001|NOT COMPLETED|Overall Study||12
10466418|NCT01056653|11614395|FG000|STARTED|Overall Study||46
10466419|NCT01056653|11614396|FG001|STARTED|Overall Study||23
10466420|NCT01056653|11614397|FG002|STARTED|Overall Study||44
10466421|NCT01056653|11614395|FG000|COMPLETED|Overall Study||46
10466422|NCT01056653|11614396|FG001|COMPLETED|Overall Study||23
10708622|NCT02632552|11873491|FG001|COMPLETED|Overall Study||50
10708623|NCT02632552|11873490|FG000|NOT COMPLETED|Overall Study||23
10466423|NCT01056653|11614397|FG002|COMPLETED|Overall Study|2 were lost to follow-up because one mother left the country and one father was too busy.|42
10466424|NCT01056653|11614395|FG000|NOT COMPLETED|Overall Study||0
10466425|NCT01056653|11614396|FG001|NOT COMPLETED|Overall Study||0
10466426|NCT01056653|11614397|FG002|NOT COMPLETED|Overall Study||2
10466427|NCT01056718|11614406|FG000|STARTED|Overall Study||53
10466428|NCT01056718|11614406|FG000|COMPLETED|Overall Study||50
10466429|NCT01056718|11614406|FG000|NOT COMPLETED|Overall Study||3
10466430|NCT01056822|11614413|FG000|STARTED|Overall Study||47
10708624|NCT02632552|11873491|FG001|NOT COMPLETED|Overall Study||10
10466431|NCT01056822|11614414|FG001|STARTED|Overall Study||42
10466432|NCT01056822|11614413|FG000|Intention-to-treat (ITT) Population: YES|Overall Study||43
10466433|NCT01056822|11614414|FG001|Intention-to-treat (ITT) Population: YES|Overall Study||38
10466434|NCT01056822|11614413|FG000|Intention-to-treat (ITT) Population: NO|Overall Study||4
10466435|NCT01056822|11614414|FG001|Intention-to-treat (ITT) Population: NO|Overall Study||4
10466436|NCT01056822|11614413|FG000|Per-protocol (PP) Population: YES|Overall Study||29
10338157|NCT00368550|11475052|FG000|STARTED|Overall Study||63
10338158|NCT00368550|11475053|FG001|STARTED|Overall Study||71
10466437|NCT01056822|11614414|FG001|Per-protocol (PP) Population: YES|Overall Study||25
10466438|NCT01056822|11614413|FG000|Per-protocol (PP) Population: NO|Overall Study||18
10466439|NCT01056822|11614414|FG001|Per-protocol (PP) Population: NO|Overall Study||17
10466440|NCT01056822|11614413|FG000|Safety (SAF) Population: YES|Overall Study||46
10466441|NCT01056822|11614414|FG001|Safety (SAF) Population: YES|Overall Study||40
10466442|NCT01056822|11614413|FG000|Safety (SAF) Population: NO|Overall Study||1
10466443|NCT01056822|11614414|FG001|Safety (SAF) Population: NO|Overall Study||2
10466444|NCT01056822|11614413|FG000|COMPLETED|Overall Study||39
10466445|NCT01056822|11614414|FG001|COMPLETED|Overall Study||35
10466446|NCT01056822|11614413|FG000|NOT COMPLETED|Overall Study||8
10466447|NCT01056822|11614414|FG001|NOT COMPLETED|Overall Study||7
10466448|NCT01056913|11614421|FG000|STARTED|Overall Study||62
10466449|NCT01056913|11614421|FG000|COMPLETED|Overall Study||62
10466450|NCT01056913|11614421|FG000|NOT COMPLETED|Overall Study||0
10466451|NCT01057017|11614425|FG000|STARTED|Overall Study||5
10708625|NCT02632747|11873500|FG000|STARTED|Treatment Period 1||16
10708626|NCT02632747|11873501|FG001|STARTED|Treatment Period 1||15
10466452|NCT01057017|11614425|FG000|COMPLETED|Overall Study||5
10466453|NCT01057017|11614425|FG000|NOT COMPLETED|Overall Study||0
10466454|NCT01057225|11614429|FG000|STARTED|Overall Study||3
10466455|NCT01057225|11614430|FG001|STARTED|Overall Study||3
10466456|NCT01057225|11614431|FG002|STARTED|Overall Study||6
10466457|NCT01057225|11614432|FG003|STARTED|Overall Study||7
10466458|NCT01057225|11614433|FG004|STARTED|Overall Study||22
10466459|NCT01057225|11614434|FG005|STARTED|Overall Study||23
10466460|NCT01057225|11614429|FG000|COMPLETED|Overall Study||3
10466461|NCT01057225|11614430|FG001|COMPLETED|Overall Study||3
10466462|NCT01057225|11614431|FG002|COMPLETED|Overall Study||6
10466463|NCT01057225|11614432|FG003|COMPLETED|Overall Study||7
10466464|NCT01057225|11614433|FG004|COMPLETED|Overall Study||22
10466465|NCT01057225|11614434|FG005|COMPLETED|Overall Study||23
10466466|NCT01057225|11614429|FG000|NOT COMPLETED|Overall Study||0
10466467|NCT01057225|11614430|FG001|NOT COMPLETED|Overall Study||0
10466468|NCT01057225|11614431|FG002|NOT COMPLETED|Overall Study||0
10466469|NCT01057225|11614432|FG003|NOT COMPLETED|Overall Study||0
10466470|NCT01057225|11614433|FG004|NOT COMPLETED|Overall Study||0
10466471|NCT01057225|11614434|FG005|NOT COMPLETED|Overall Study||0
10466472|NCT01057251|11614449|FG000|STARTED|Overall Study||290
10466473|NCT01057251|11614450|FG001|STARTED|Overall Study|The safety population is 142, as one patient was randomized, but never received study drug.|143
10466474|NCT01057251|11614449|FG000|COMPLETED|Overall Study||262
10466475|NCT01057251|11614450|FG001|COMPLETED|Overall Study||114
10466476|NCT01057251|11614449|FG000|NOT COMPLETED|Overall Study||28
10466477|NCT01057251|11614450|FG001|NOT COMPLETED|Overall Study||29
10466478|NCT01057277|11614456|FG000|STARTED|Overall Study||3
10466479|NCT01057277|11614456|FG000|COMPLETED|Overall Study||3
10466480|NCT01057277|11614456|FG000|NOT COMPLETED|Overall Study||0
10466481|NCT01057381|11614464|FG000|STARTED|Overall Study||26
10466482|NCT01057381|11614465|FG001|STARTED|Overall Study||27
10466483|NCT01057381|11614466|FG002|STARTED|Overall Study||30
10466484|NCT01057381|11614467|FG003|STARTED|Overall Study||26
10466485|NCT01057381|11614464|FG000|COMPLETED|Overall Study||26
10466486|NCT01057381|11614465|FG001|COMPLETED|Overall Study||27
10466487|NCT01057381|11614466|FG002|COMPLETED|Overall Study||30
10466488|NCT01057381|11614467|FG003|COMPLETED|Overall Study||26
10466489|NCT01057381|11614464|FG000|NOT COMPLETED|Overall Study||0
10466490|NCT01057381|11614465|FG001|NOT COMPLETED|Overall Study||0
10708627|NCT02632747|11873500|FG000|COMPLETED|Treatment Period 1||16
10466491|NCT01057381|11614466|FG002|NOT COMPLETED|Overall Study||0
10466492|NCT01057381|11614467|FG003|NOT COMPLETED|Overall Study||0
10466493|NCT01057394|11614477|FG000|STARTED|Overall Study||0
10466494|NCT01057394|11614478|FG001|STARTED|Overall Study|21 enrolled participants|21
10466495|NCT01057394|11614477|FG000|COMPLETED|Overall Study||0
10466496|NCT01057394|11614478|FG001|COMPLETED|Overall Study|19 treated participants|19
10466497|NCT01057394|11614477|FG000|NOT COMPLETED|Overall Study||0
10466498|NCT01057394|11614478|FG001|NOT COMPLETED|Overall Study||2
10466499|NCT01057433|11614482|FG000|STARTED|Overall Study||24
10466500|NCT01057433|11614482|FG000|COMPLETED|Overall Study||23
10466501|NCT01057433|11614482|FG000|NOT COMPLETED|Overall Study||1
10466502|NCT01057589|11614486|FG000|STARTED|Overall Study||66
10466503|NCT01057589|11614486|FG000|COMPLETED|Overall Study||0
10466504|NCT01057589|11614486|FG000|NOT COMPLETED|Overall Study||66
10466505|NCT01057693|11614490|FG000|STARTED|Single-Blind Phase (Up to Week 6)||665
10466506|NCT01057693|11614491|FG001|STARTED|Single-Blind Phase (Up to Week 6)||0
10466507|NCT01057693|11614492|FG002|STARTED|Single-Blind Phase (Up to Week 6)||0
10466508|NCT01057693|11614490|FG000|COMPLETED|Single-Blind Phase (Up to Week 6)||566
10466509|NCT01057693|11614491|FG001|COMPLETED|Single-Blind Phase (Up to Week 6)||0
10466510|NCT01057693|11614492|FG002|COMPLETED|Single-Blind Phase (Up to Week 6)||0
10466511|NCT01057693|11614490|FG000|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||99
10466512|NCT01057693|11614491|FG001|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||0
10466513|NCT01057693|11614492|FG002|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||0
10466514|NCT01057693|11614490|FG000|STARTED|Between Single-Blind and Double-Blind||566
10466515|NCT01057693|11614491|FG001|STARTED|Between Single-Blind and Double-Blind||0
10466516|NCT01057693|11614492|FG002|STARTED|Between Single-Blind and Double-Blind||0
10466517|NCT01057693|11614490|FG000|COMPLETED|Between Single-Blind and Double-Blind||296
10466518|NCT01057693|11614491|FG001|COMPLETED|Between Single-Blind and Double-Blind||0
10466519|NCT01057693|11614492|FG002|COMPLETED|Between Single-Blind and Double-Blind||0
10466520|NCT01057693|11614490|FG000|NOT COMPLETED|Between Single-Blind and Double-Blind||270
10466521|NCT01057693|11614491|FG001|NOT COMPLETED|Between Single-Blind and Double-Blind||0
10466522|NCT01057693|11614492|FG002|NOT COMPLETED|Between Single-Blind and Double-Blind||0
10466523|NCT01057693|11614490|FG000|STARTED|Double-Blind Phase (Week 7 to Week 19)||0
10466524|NCT01057693|11614491|FG001|STARTED|Double-Blind Phase (Week 7 to Week 19)||147
10466525|NCT01057693|11614492|FG002|STARTED|Double-Blind Phase (Week 7 to Week 19)||149
10466526|NCT01057693|11614490|FG000|Treated|Double-Blind Phase (Week 7 to Week 19)||0
10466527|NCT01057693|11614491|FG001|Treated|Double-Blind Phase (Week 7 to Week 19)||147
10466528|NCT01057693|11614492|FG002|Treated|Double-Blind Phase (Week 7 to Week 19)||147
10466529|NCT01057693|11614490|FG000|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||0
10466530|NCT01057693|11614491|FG001|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||125
10466531|NCT01057693|11614492|FG002|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||113
10466532|NCT01057693|11614490|FG000|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||0
10466533|NCT01057693|11614491|FG001|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||22
10466534|NCT01057693|11614492|FG002|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||36
10466535|NCT01057810|11614502|FG000|STARTED|Overall Study||199
10466536|NCT01057810|11614503|FG001|STARTED|Overall Study||399
10466537|NCT01057810|11614502|FG000|COMPLETED|Overall Study||1
10466538|NCT01057810|11614503|FG001|COMPLETED|Overall Study||1
10466539|NCT01057810|11614502|FG000|NOT COMPLETED|Overall Study||198
10466540|NCT01057810|11614503|FG001|NOT COMPLETED|Overall Study||398
10466541|NCT01057862|11614511|FG000|STARTED|Overall Study||5
10466542|NCT01057862|11614512|FG001|STARTED|Overall Study||4
10466543|NCT01057862|11614511|FG000|COMPLETED|Overall Study||4
10466544|NCT01057862|11614512|FG001|COMPLETED|Overall Study||2
10466545|NCT01057862|11614511|FG000|NOT COMPLETED|Overall Study||1
10466546|NCT01057862|11614512|FG001|NOT COMPLETED|Overall Study||2
10466547|NCT01057888|11614521|FG000|STARTED|Overall Study||2504
10466548|NCT01057888|11614522|FG001|STARTED|Overall Study||2406
10466549|NCT01057888|11614523|FG002|STARTED|Overall Study||2494
10466550|NCT01057888|11614521|FG000|COMPLETED|Overall Study||2504
10466551|NCT01057888|11614522|FG001|COMPLETED|Overall Study||2406
10466552|NCT01057888|11614523|FG002|COMPLETED|Overall Study||2494
10466553|NCT01057888|11614521|FG000|NOT COMPLETED|Overall Study||0
10466554|NCT01057888|11614522|FG001|NOT COMPLETED|Overall Study||0
10466555|NCT01057888|11614523|FG002|NOT COMPLETED|Overall Study||0
10466556|NCT01057901|11614531|FG000|STARTED|Overall Study||376
10466557|NCT01057901|11614532|FG001|STARTED|Overall Study||372
10466558|NCT01057901|11614531|FG000|COMPLETED|Overall Study||116
10466559|NCT01057901|11614532|FG001|COMPLETED|Overall Study||126
10466560|NCT01057901|11614531|FG000|NOT COMPLETED|Overall Study||260
10466561|NCT01057901|11614532|FG001|NOT COMPLETED|Overall Study||246
10466562|NCT01058005|11614541|FG000|STARTED|Overall Study||38
10466563|NCT01058005|11614542|FG001|STARTED|Overall Study||25
10466564|NCT01058005|11614543|FG002|STARTED|Overall Study||21
10466565|NCT01058005|11614541|FG000|Dosed With Study Treatment|Overall Study||36
10466566|NCT01058005|11614542|FG001|Dosed With Study Treatment|Overall Study||22
10466567|NCT01058005|11614543|FG002|Dosed With Study Treatment|Overall Study||17
10466568|NCT01058005|11614541|FG000|COMPLETED|Overall Study||0
10466569|NCT01058005|11614542|FG001|COMPLETED|Overall Study||0
10466570|NCT01058005|11614543|FG002|COMPLETED|Overall Study||1
10466571|NCT01058005|11614541|FG000|NOT COMPLETED|Overall Study||38
10466572|NCT01058005|11614542|FG001|NOT COMPLETED|Overall Study||25
10466573|NCT01058005|11614543|FG002|NOT COMPLETED|Overall Study||20
10466574|NCT01058070|11614551|FG000|STARTED|Overall Study||44
10466575|NCT01058070|11614551|FG000|COMPLETED|Overall Study||33
10466576|NCT01058070|11614551|FG000|NOT COMPLETED|Overall Study||11
10466577|NCT01058096|11614558|FG000|STARTED|Double-blind Treatment Phase||154
10466578|NCT01058096|11614559|FG001|STARTED|Double-blind Treatment Phase||158
10466579|NCT01058096|11614558|FG000|COMPLETED|Double-blind Treatment Phase||106
10466580|NCT01058096|11614559|FG001|COMPLETED|Double-blind Treatment Phase||108
10466581|NCT01058096|11614558|FG000|NOT COMPLETED|Double-blind Treatment Phase||48
10466582|NCT01058096|11614559|FG001|NOT COMPLETED|Double-blind Treatment Phase||50
10466583|NCT01058096|11614558|FG000|STARTED|Safety Follow-up|Not all participants continued to Safety Follow-up.|133
10466584|NCT01058096|11614559|FG001|STARTED|Safety Follow-up||134
10466585|NCT01058096|11614558|FG000|COMPLETED|Safety Follow-up||129
10466586|NCT01058096|11614559|FG001|COMPLETED|Safety Follow-up||130
10466587|NCT01058096|11614558|FG000|NOT COMPLETED|Safety Follow-up||4
10466588|NCT01058096|11614559|FG001|NOT COMPLETED|Safety Follow-up||4
10466589|NCT01058239|11614565|FG000|STARTED|Overall Study||7
10466590|NCT01058239|11614565|FG000|COMPLETED|Overall Study||7
10466591|NCT01058239|11614565|FG000|NOT COMPLETED|Overall Study||0
10466592|NCT01058265|11614571|FG000|STARTED|Overall Study||22
10466593|NCT01058265|11614572|FG001|STARTED|Overall Study||25
10466594|NCT01058265|11614571|FG000|COMPLETED|Overall Study||11
10466595|NCT01058265|11614572|FG001|COMPLETED|Overall Study||13
10466596|NCT01058265|11614571|FG000|NOT COMPLETED|Overall Study||11
10466597|NCT01058265|11614572|FG001|NOT COMPLETED|Overall Study||12
10466598|NCT01058304|11614580|FG000|STARTED|Overall Study||159
10466599|NCT01058304|11614581|FG001|STARTED|Overall Study||161
10466600|NCT01058304|11614580|FG000|COMPLETED|Overall Study||132
10466601|NCT01058304|11614581|FG001|COMPLETED|Overall Study||128
10466602|NCT01058304|11614580|FG000|NOT COMPLETED|Overall Study||27
10466603|NCT01058304|11614581|FG001|NOT COMPLETED|Overall Study||33
10526509|NCT01381874|11678372|FG002|NOT COMPLETED|Overall Study||76
10526510|NCT01381900|11678383|FG000|STARTED|Overall Study||226
10526511|NCT01381900|11678384|FG001|STARTED|Overall Study||223
10526512|NCT01381900|11678385|FG002|STARTED|Overall Study||227
10526513|NCT01381900|11678383|FG000|COMPLETED|Overall Study||217
10526514|NCT01381900|11678384|FG001|COMPLETED|Overall Study||214
10526515|NCT01381900|11678385|FG002|COMPLETED|Overall Study||215
10526516|NCT01381900|11678383|FG000|NOT COMPLETED|Overall Study||9
10526517|NCT01381900|11678384|FG001|NOT COMPLETED|Overall Study||9
10526518|NCT01381900|11678385|FG002|NOT COMPLETED|Overall Study||12
10526519|NCT01381926|11678395|FG000|STARTED|Low/High Dose of 1st Treatment (2months)||5
10526520|NCT01381926|11678396|FG001|STARTED|Low/High Dose of 1st Treatment (2months)||5
10526521|NCT01381926|11678395|FG000|COMPLETED|Low/High Dose of 1st Treatment (2months)||3
10526522|NCT01381926|11678396|FG001|COMPLETED|Low/High Dose of 1st Treatment (2months)||4
10526523|NCT01381926|11678395|FG000|NOT COMPLETED|Low/High Dose of 1st Treatment (2months)||2
10526524|NCT01381926|11678396|FG001|NOT COMPLETED|Low/High Dose of 1st Treatment (2months)||1
10526525|NCT01381926|11678395|FG000|STARTED|Low/High Dose of 2nd Treatment (2months)||3
10526526|NCT01381926|11678396|FG001|STARTED|Low/High Dose of 2nd Treatment (2months)||4
10526527|NCT01381926|11678395|FG000|COMPLETED|Low/High Dose of 2nd Treatment (2months)||3
10526528|NCT01381926|11678396|FG001|COMPLETED|Low/High Dose of 2nd Treatment (2months)||4
10526529|NCT01381926|11678395|FG000|NOT COMPLETED|Low/High Dose of 2nd Treatment (2months)||0
10526530|NCT01381926|11678396|FG001|NOT COMPLETED|Low/High Dose of 2nd Treatment (2months)||0
10526531|NCT01381952|11678404|FG000|STARTED|Overall Study||20
10526532|NCT01381952|11678404|FG000|Collected Dose and Image Information|Overall Study||20
10526533|NCT01381952|11678404|FG000|COMPLETED|Overall Study||20
10526534|NCT01381952|11678404|FG000|NOT COMPLETED|Overall Study||0
10526535|NCT01382108|11678412|FG000|STARTED|Overall Study||20
10526536|NCT01382108|11678413|FG001|STARTED|Overall Study||19
10526537|NCT01382108|11678412|FG000|COMPLETED|Overall Study||20
10526538|NCT01382108|11678413|FG001|COMPLETED|Overall Study||19
10526539|NCT01382108|11678412|FG000|NOT COMPLETED|Overall Study||0
10526540|NCT01382108|11678413|FG001|NOT COMPLETED|Overall Study||0
10526541|NCT01382186|11678422|FG000|STARTED|Overall Study||33
10526542|NCT01382186|11678423|FG001|STARTED|Overall Study||819
10526543|NCT01382186|11678422|FG000|COMPLETED|Overall Study||32
10526544|NCT01382186|11678423|FG001|COMPLETED|Overall Study||819
10526545|NCT01382186|11678422|FG000|NOT COMPLETED|Overall Study||1
10526546|NCT01382186|11678423|FG001|NOT COMPLETED|Overall Study||0
10526547|NCT01382212|11678432|FG000|STARTED|Overall Study||13
10526548|NCT01382212|11678432|FG000|COMPLETED|Overall Study||11
10526549|NCT01382212|11678432|FG000|NOT COMPLETED|Overall Study||2
10526550|NCT01382225|11678438|FG000|STARTED|Overall Study||725
10526551|NCT01382225|11678439|FG001|STARTED|Overall Study||729
10526552|NCT01382225|11678438|FG000|COMPLETED|Overall Study||711
10526553|NCT01382225|11678439|FG001|COMPLETED|Overall Study||722
10526554|NCT01382225|11678438|FG000|NOT COMPLETED|Overall Study||14
10526555|NCT01382225|11678439|FG001|NOT COMPLETED|Overall Study||7
10526556|NCT01382251|11678447|FG000|STARTED|Overall Study||123
10526557|NCT01382251|11678448|FG001|STARTED|Overall Study||123
10526558|NCT01382251|11678447|FG000|COMPLETED|Overall Study||102
10526559|NCT01382251|11678448|FG001|COMPLETED|Overall Study||102
10526560|NCT01382251|11678447|FG000|NOT COMPLETED|Overall Study||21
10526561|NCT01382251|11678448|FG001|NOT COMPLETED|Overall Study||21
10526562|NCT01382303|11678455|FG000|STARTED|Overall Study||87
10526563|NCT01382303|11678456|FG001|STARTED|Overall Study||87
10526564|NCT01382303|11678455|FG000|COMPLETED|Overall Study||52
10526565|NCT01382303|11678456|FG001|COMPLETED|Overall Study||70
10526566|NCT01382303|11678455|FG000|NOT COMPLETED|Overall Study||35
10526567|NCT01382303|11678456|FG001|NOT COMPLETED|Overall Study||17
10526568|NCT01382446|11678464|FG000|STARTED|Overall Study||33
10526569|NCT01382446|11678465|FG001|STARTED|Overall Study||33
10526570|NCT01382446|11678464|FG000|COMPLETED|Overall Study||30
10526571|NCT01382446|11678465|FG001|COMPLETED|Overall Study||29
10526572|NCT01382446|11678464|FG000|NOT COMPLETED|Overall Study||3
10526573|NCT01382446|11678465|FG001|NOT COMPLETED|Overall Study||4
10526574|NCT01382602|11678473|FG000|STARTED|Overall Study||93
10526575|NCT01382602|11678474|FG001|STARTED|Overall Study||50
10526576|NCT01382602|11678473|FG000|COMPLETED|Overall Study||93
10526577|NCT01382602|11678474|FG001|COMPLETED|Overall Study||46
10526578|NCT01382602|11678473|FG000|NOT COMPLETED|Overall Study||0
10526579|NCT01382602|11678474|FG001|NOT COMPLETED|Overall Study||4
10526580|NCT01382719|11678484|FG000|STARTED|Overall Study||98
10526581|NCT01382719|11678485|FG001|STARTED|Overall Study||100
10526582|NCT01382719|11678486|FG002|STARTED|Overall Study||100
10466604|NCT01058356|11614587|FG000|STARTED|Overall Study||214
10466605|NCT01058356|11614587|FG000|COMPLETED|Overall Study||172
10466606|NCT01058356|11614587|FG000|NOT COMPLETED|Overall Study||42
10466607|NCT01058395|11614593|FG000|STARTED|Overall Study||7
10466608|NCT01058395|11614594|FG001|STARTED|Overall Study||8
10466609|NCT01058395|11614593|FG000|COMPLETED|Overall Study|Two died, and one was lost to followup.|4
10466610|NCT01058395|11614594|FG001|COMPLETED|Overall Study|One died after enrollment. The patient died in the first 48 hours.|7
10466611|NCT01058395|11614593|FG000|NOT COMPLETED|Overall Study||3
10466612|NCT01058395|11614594|FG001|NOT COMPLETED|Overall Study||1
10466613|NCT01058421|11614602|FG000|STARTED|1 Month Outcomes||59
10466614|NCT01058421|11614603|FG001|STARTED|1 Month Outcomes||61
10466615|NCT01058421|11614602|FG000|COMPLETED|1 Month Outcomes||20
10466616|NCT01058421|11614603|FG001|COMPLETED|1 Month Outcomes||19
10466617|NCT01058421|11614602|FG000|NOT COMPLETED|1 Month Outcomes||39
10466618|NCT01058421|11614603|FG001|NOT COMPLETED|1 Month Outcomes||42
10466619|NCT01058421|11614602|FG000|STARTED|3 Month Outcomes|59 (Subjects started Period 1) minus 10 (deceased subjects during Period 1) = 49 started Period 2.|49
10466620|NCT01058421|11614603|FG001|STARTED|3 Month Outcomes|61 (Subjects started Period 1) minus 6 (deceased subjects during Period 1) = 55 started Period 2.|55
10466621|NCT01058421|11614602|FG000|COMPLETED|3 Month Outcomes||29
10466622|NCT01058421|11614603|FG001|COMPLETED|3 Month Outcomes||29
10466623|NCT01058421|11614602|FG000|NOT COMPLETED|3 Month Outcomes||20
10466624|NCT01058421|11614603|FG001|NOT COMPLETED|3 Month Outcomes||26
10466625|NCT01058421|11614602|FG000|STARTED|6 Month Outcomes|55 (subjects started Period 1) minus 13 (deceased subjects in Periods 1 & 2) = 46 started Period 3.|46
10466626|NCT01058421|11614603|FG001|STARTED|6 Month Outcomes|61 (subjects started Period 1) minus 11 (deceased subjects in Periods 1 & 2) = 50 started Period 3.|50
10466627|NCT01058421|11614602|FG000|COMPLETED|6 Month Outcomes||27
10466628|NCT01058421|11614603|FG001|COMPLETED|6 Month Outcomes||24
10466629|NCT01058421|11614602|FG000|NOT COMPLETED|6 Month Outcomes||19
10466630|NCT01058421|11614603|FG001|NOT COMPLETED|6 Month Outcomes||26
10466631|NCT01058655|11614613|FG000|STARTED|Overall Study||3
10466632|NCT01058655|11614614|FG001|STARTED|Overall Study||3
10466633|NCT01058655|11614615|FG002|STARTED|Overall Study||8
10466634|NCT01058655|11614616|FG003|STARTED|Overall Study||42
10466635|NCT01058655|11614613|FG000|Evaluable|Overall Study||3
10466636|NCT01058655|11614614|FG001|Evaluable|Overall Study||3
10466637|NCT01058655|11614615|FG002|Evaluable|Overall Study||6
10466638|NCT01058655|11614616|FG003|Evaluable|Overall Study||40
10466639|NCT01058655|11614613|FG000|COMPLETED|Overall Study||0
10466640|NCT01058655|11614614|FG001|COMPLETED|Overall Study||0
10466641|NCT01058655|11614615|FG002|COMPLETED|Overall Study||0
10466642|NCT01058655|11614616|FG003|COMPLETED|Overall Study||0
10466643|NCT01058655|11614613|FG000|NOT COMPLETED|Overall Study||3
10466644|NCT01058655|11614614|FG001|NOT COMPLETED|Overall Study||3
10466645|NCT01058655|11614615|FG002|NOT COMPLETED|Overall Study||8
10466646|NCT01058655|11614616|FG003|NOT COMPLETED|Overall Study||42
10466647|NCT01058668|11614630|FG000|STARTED|Double-blind Treatment Phase||161
10466648|NCT01058668|11614631|FG001|STARTED|Double-blind Treatment Phase||167
10466649|NCT01058668|11614632|FG002|STARTED|Double-blind Treatment Phase||169
10466650|NCT01058668|11614630|FG000|COMPLETED|Double-blind Treatment Phase||122
10466651|NCT01058668|11614631|FG001|COMPLETED|Double-blind Treatment Phase||129
10466652|NCT01058668|11614632|FG002|COMPLETED|Double-blind Treatment Phase||119
10466653|NCT01058668|11614630|FG000|NOT COMPLETED|Double-blind Treatment Phase||39
10466654|NCT01058668|11614631|FG001|NOT COMPLETED|Double-blind Treatment Phase||38
10466655|NCT01058668|11614632|FG002|NOT COMPLETED|Double-blind Treatment Phase||50
10466656|NCT01058668|11614630|FG000|STARTED|Safety Follow-up|Not all participants entered the Safety-Follow-up|144
10466657|NCT01058668|11614631|FG001|STARTED|Safety Follow-up||146
10466658|NCT01058668|11614632|FG002|STARTED|Safety Follow-up||148
10466659|NCT01058668|11614630|FG000|COMPLETED|Safety Follow-up||139
10466660|NCT01058668|11614631|FG001|COMPLETED|Safety Follow-up||146
10466661|NCT01058668|11614632|FG002|COMPLETED|Safety Follow-up||141
10466662|NCT01058668|11614630|FG000|NOT COMPLETED|Safety Follow-up||5
10466663|NCT01058668|11614631|FG001|NOT COMPLETED|Safety Follow-up||0
10466664|NCT01058668|11614632|FG002|NOT COMPLETED|Safety Follow-up||7
10466665|NCT01058707|11614647|FG000|STARTED|Overall Study||31
10466666|NCT01058707|11614648|FG001|STARTED|Overall Study||30
10466667|NCT01058707|11614649|FG002|STARTED|Overall Study||33
10466668|NCT01058707|11614650|FG003|STARTED|Overall Study||22
10466669|NCT01058707|11614651|FG004|STARTED|Overall Study||39
10466670|NCT01058707|11614652|FG005|STARTED|Overall Study||17
10466671|NCT01058707|11614653|FG006|STARTED|Overall Study||26
10466672|NCT01058707|11614647|FG000|COMPLETED|Overall Study||0
10466673|NCT01058707|11614648|FG001|COMPLETED|Overall Study||0
10466674|NCT01058707|11614649|FG002|COMPLETED|Overall Study||0
10466675|NCT01058707|11614650|FG003|COMPLETED|Overall Study||0
10466676|NCT01058707|11614651|FG004|COMPLETED|Overall Study||0
10466677|NCT01058707|11614652|FG005|COMPLETED|Overall Study||0
10466678|NCT01058707|11614653|FG006|COMPLETED|Overall Study||0
10466679|NCT01058707|11614647|FG000|NOT COMPLETED|Overall Study||31
10466680|NCT01058707|11614648|FG001|NOT COMPLETED|Overall Study||30
10466681|NCT01058707|11614649|FG002|NOT COMPLETED|Overall Study||33
10466682|NCT01058707|11614650|FG003|NOT COMPLETED|Overall Study||22
10466683|NCT01058707|11614651|FG004|NOT COMPLETED|Overall Study||39
10466684|NCT01058707|11614652|FG005|NOT COMPLETED|Overall Study||17
10466685|NCT01058707|11614653|FG006|NOT COMPLETED|Overall Study||26
10466686|NCT01058863|11614691|FG000|STARTED|Overall Study||72
10526583|NCT01382719|11678487|FG003|STARTED|Overall Study||99
10466687|NCT01058863|11614691|FG000|Safety and ITT Populations|Overall Study|One patient was randomized in error and never received the study drug.|71
10466688|NCT01058863|11614691|FG000|Treated With Albuterol Spiromax® 90 mcg|Overall Study||68
10466689|NCT01058863|11614691|FG000|Treated With Albuterol Spiromax® 180 mcg|Overall Study||68
10466690|NCT01058863|11614691|FG000|Treated With ProAir® HFA 90 mcg|Overall Study||70
10466691|NCT01058863|11614691|FG000|Treated With ProAir® HFA 180 mcg|Overall Study||68
10466692|NCT01058863|11614691|FG000|Treated With Placebo Inhaler|Overall Study||69
10466693|NCT01058863|11614691|FG000|COMPLETED|Overall Study||68
10466694|NCT01058863|11614691|FG000|NOT COMPLETED|Overall Study||4
10466695|NCT01058941|11614706|FG000|STARTED|Overall Study||34
10466696|NCT01058941|11614707|FG001|STARTED|Overall Study||33
10466697|NCT01058941|11614706|FG000|COMPLETED|Overall Study||25
10466698|NCT01058941|11614707|FG001|COMPLETED|Overall Study||22
10466699|NCT01058941|11614706|FG000|NOT COMPLETED|Overall Study||9
10466700|NCT01058941|11614707|FG001|NOT COMPLETED|Overall Study||11
10466701|NCT01058993|11614713|FG000|STARTED|Overall Study||6
10466702|NCT01058993|11614713|FG000|COMPLETED|Overall Study||6
10466703|NCT01058993|11614713|FG000|NOT COMPLETED|Overall Study||0
10466704|NCT01059175|11614719|FG000|STARTED|Overall Study||43
10466705|NCT01059175|11614720|FG001|STARTED|Overall Study||41
10466706|NCT01059175|11614719|FG000|COMPLETED|Overall Study|17 patients deceased 4 additional patients were prematurely exited|22
10466707|NCT01059175|11614720|FG001|COMPLETED|Overall Study|17 patients deceased 3 patients were prematurely exited|21
10466708|NCT01059175|11614719|FG000|NOT COMPLETED|Overall Study||21
10466709|NCT01059175|11614720|FG001|NOT COMPLETED|Overall Study||20
10466710|NCT01059305|11614726|FG000|STARTED|Overall Study||10
10466711|NCT01059305|11614726|FG000|COMPLETED|Overall Study||10
10466712|NCT01059305|11614726|FG000|NOT COMPLETED|Overall Study||0
10466713|NCT01059318|11614730|FG000|STARTED|Core Study (26 Week)|This is safety set and Pharmacodynamic set|24
10466714|NCT01059318|11614730|FG000|Everolimus 2.5 mg for 4 Weeks|Core Study (26 Week)||24
10466715|NCT01059318|11614730|FG000|Everolimus 5 mg for 4 Weeks|Core Study (26 Week)||24
10466716|NCT01059318|11614730|FG000|Everolimus 10 mg for 18 Weeks|Core Study (26 Week)||24
10466717|NCT01059318|11614730|FG000|Pharmacokinetics (PK) Analysis Set|Core Study (26 Week)|For 8 patients plasma rather than whole blood sample was collected, hence excluded from PK set.|16
10466718|NCT01059318|11614730|FG000|COMPLETED|Core Study (26 Week)||20
10466719|NCT01059318|11614730|FG000|NOT COMPLETED|Core Study (26 Week)||4
10466720|NCT01059318|11614730|FG000|STARTED|Extension (36 Week)||20
10466721|NCT01059318|11614730|FG000|COMPLETED|Extension (36 Week)||17
10466722|NCT01059318|11614730|FG000|NOT COMPLETED|Extension (36 Week)||3
10466723|NCT01059344|11614739|FG000|STARTED|Overall Study||140
10466724|NCT01059344|11614740|FG001|STARTED|Overall Study||141
10466725|NCT01059344|11614739|FG000|COMPLETED|Overall Study||118
10466726|NCT01059344|11614740|FG001|COMPLETED|Overall Study||95
10466727|NCT01059344|11614739|FG000|NOT COMPLETED|Overall Study||22
10466728|NCT01059344|11614740|FG001|NOT COMPLETED|Overall Study||46
10466729|NCT01059357|11614748|FG000|STARTED|Overall Study||58
10466730|NCT01059357|11614748|FG000|COMPLETED|Overall Study||54
10466731|NCT01059357|11614748|FG000|NOT COMPLETED|Overall Study||4
10466732|NCT01059435|11614762|FG000|STARTED|Overall Study||14
10466733|NCT01059435|11614763|FG001|STARTED|Overall Study||6
10466734|NCT01059435|11614764|FG002|STARTED|Overall Study||8
10466735|NCT01059435|11614765|FG003|STARTED|Overall Study||9
10466736|NCT01059435|11614766|FG004|STARTED|Overall Study||6
10466737|NCT01059435|11614767|FG005|STARTED|Overall Study||9
10466738|NCT01059435|11614768|FG006|STARTED|Overall Study||6
10466739|NCT01059435|11614769|FG007|STARTED|Overall Study||4
10466740|NCT01059435|11614770|FG008|STARTED|Overall Study||6
10466741|NCT01059435|11614771|FG009|STARTED|Overall Study||6
10466742|NCT01059435|11614762|FG000|Received Study Drug|Overall Study||14
10466743|NCT01059435|11614763|FG001|Received Study Drug|Overall Study||6
10466744|NCT01059435|11614764|FG002|Received Study Drug|Overall Study||6
10466745|NCT01059435|11614765|FG003|Received Study Drug|Overall Study||9
10466746|NCT01059435|11614766|FG004|Received Study Drug|Overall Study||6
10466747|NCT01059435|11614767|FG005|Received Study Drug|Overall Study||9
10466748|NCT01059435|11614768|FG006|Received Study Drug|Overall Study||6
10466749|NCT01059435|11614769|FG007|Received Study Drug|Overall Study||4
10466750|NCT01059435|11614770|FG008|Received Study Drug|Overall Study||6
10466751|NCT01059435|11614771|FG009|Received Study Drug|Overall Study||6
10466752|NCT01059435|11614762|FG000|COMPLETED|Overall Study||14
10466753|NCT01059435|11614763|FG001|COMPLETED|Overall Study||6
10466754|NCT01059435|11614764|FG002|COMPLETED|Overall Study||6
10466755|NCT01059435|11614765|FG003|COMPLETED|Overall Study||9
10466756|NCT01059435|11614766|FG004|COMPLETED|Overall Study||6
10466757|NCT01059435|11614767|FG005|COMPLETED|Overall Study||9
10466758|NCT01059435|11614768|FG006|COMPLETED|Overall Study||6
10466759|NCT01059435|11614769|FG007|COMPLETED|Overall Study||4
10466760|NCT01059435|11614770|FG008|COMPLETED|Overall Study||6
10466761|NCT01059435|11614771|FG009|COMPLETED|Overall Study||6
10466762|NCT01059435|11614762|FG000|NOT COMPLETED|Overall Study||0
10466763|NCT01059435|11614763|FG001|NOT COMPLETED|Overall Study||0
10466764|NCT01059435|11614764|FG002|NOT COMPLETED|Overall Study||2
10466765|NCT01059435|11614765|FG003|NOT COMPLETED|Overall Study||0
10466766|NCT01059435|11614766|FG004|NOT COMPLETED|Overall Study||0
10466767|NCT01059435|11614767|FG005|NOT COMPLETED|Overall Study||0
10466768|NCT01059435|11614768|FG006|NOT COMPLETED|Overall Study||0
10466769|NCT01059435|11614769|FG007|NOT COMPLETED|Overall Study||0
10466770|NCT01059435|11614770|FG008|NOT COMPLETED|Overall Study||0
10466771|NCT01059435|11614771|FG009|NOT COMPLETED|Overall Study||0
10466772|NCT01059526|11614805|FG000|STARTED|Overall Study|ITT population; defined as signing informed consent and meeting all inclusion/ exclusion criteria|41
10466773|NCT01059526|11614806|FG001|STARTED|Overall Study|ITT population; defined as signing informed consent and meeting all inclusion/ exclusion criteria|40
10466859|NCT01059825|11614931|FG006|STARTED|Enrolled, Run-in Period||375
10466774|NCT01059526|11614805|FG000|Treated|Overall Study|Safety population; defined as all patients who received at least 1 treatment dose of KALBITOR|21
10466775|NCT01059526|11614806|FG001|Treated|Overall Study|Safety population; defined as all patients who received at least 1 treatment dose of KALBITOR|23
10466776|NCT01059526|11614805|FG000|COMPLETED|Overall Study||11
10466777|NCT01059526|11614806|FG001|COMPLETED|Overall Study||18
10466778|NCT01059526|11614805|FG000|NOT COMPLETED|Overall Study||30
10466779|NCT01059526|11614806|FG001|NOT COMPLETED|Overall Study||22
10466780|NCT01059539|11614812|FG000|STARTED|Overall Study||403
10466781|NCT01059539|11614812|FG000|COMPLETED|Overall Study||132
10466782|NCT01059539|11614812|FG000|NOT COMPLETED|Overall Study||271
10466783|NCT01059565|11614818|FG000|STARTED|24-Week Randomized Phase||49
10466784|NCT01059565|11614819|FG001|STARTED|24-Week Randomized Phase||52
10466785|NCT01059565|11614818|FG000|Randomized and Treated|24-Week Randomized Phase||48
10466786|NCT01059565|11614819|FG001|Randomized and Treated|24-Week Randomized Phase||52
10466787|NCT01059565|11614818|FG000|COMPLETED|24-Week Randomized Phase||39
10466788|NCT01059565|11614819|FG001|COMPLETED|24-Week Randomized Phase||45
10466789|NCT01059565|11614818|FG000|NOT COMPLETED|24-Week Randomized Phase||10
10466790|NCT01059565|11614819|FG001|NOT COMPLETED|24-Week Randomized Phase||7
10466791|NCT01059565|11614818|FG000|STARTED|24-Week Open-Label Phase||39
10466792|NCT01059565|11614819|FG001|STARTED|24-Week Open-Label Phase||45
10466793|NCT01059565|11614818|FG000|COMPLETED|24-Week Open-Label Phase||34
10466794|NCT01059565|11614819|FG001|COMPLETED|24-Week Open-Label Phase||42
10466795|NCT01059565|11614818|FG000|NOT COMPLETED|24-Week Open-Label Phase||5
10466796|NCT01059565|11614819|FG001|NOT COMPLETED|24-Week Open-Label Phase||3
10466797|NCT01059617|11614831|FG000|STARTED|Overall Study||33
10466798|NCT01059617|11614832|FG001|STARTED|Overall Study||34
10466799|NCT01059617|11614833|FG002|STARTED|Overall Study||33
10466800|NCT01059617|11614834|FG003|STARTED|Overall Study||33
10466801|NCT01059617|11614831|FG000|COMPLETED|Overall Study||26
10466802|NCT01059617|11614832|FG001|COMPLETED|Overall Study||33
10466803|NCT01059617|11614833|FG002|COMPLETED|Overall Study||25
10466804|NCT01059617|11614834|FG003|COMPLETED|Overall Study||27
10466805|NCT01059617|11614831|FG000|NOT COMPLETED|Overall Study||7
10466806|NCT01059617|11614832|FG001|NOT COMPLETED|Overall Study||1
10466807|NCT01059617|11614833|FG002|NOT COMPLETED|Overall Study||8
10466808|NCT01059617|11614834|FG003|NOT COMPLETED|Overall Study||6
10466809|NCT01059630|11614854|FG000|STARTED|Overall Study||209
10466810|NCT01059630|11614855|FG001|STARTED|Overall Study||204
10466811|NCT01059630|11614854|FG000|COMPLETED|Overall Study||82
10466812|NCT01059630|11614855|FG001|COMPLETED|Overall Study||101
10466813|NCT01059630|11614854|FG000|NOT COMPLETED|Overall Study||127
10466814|NCT01059630|11614855|FG001|NOT COMPLETED|Overall Study||103
10466815|NCT01059643|11614861|FG000|STARTED|Overall Study||103
10466816|NCT01059643|11614861|FG000|Received at Least 1 Dose of Study Drug|Overall Study||103
10466817|NCT01059643|11614861|FG000|COMPLETED|Overall Study||97
10466818|NCT01059643|11614861|FG000|NOT COMPLETED|Overall Study||6
10466819|NCT01059682|11614870|FG000|STARTED|Overall Study||474
10466820|NCT01059682|11614871|FG001|STARTED|Overall Study||462
10466821|NCT01059682|11614870|FG000|COMPLETED|Overall Study||464
10466822|NCT01059682|11614871|FG001|COMPLETED|Overall Study||444
10466823|NCT01059682|11614870|FG000|NOT COMPLETED|Overall Study||10
10466824|NCT01059682|11614871|FG001|NOT COMPLETED|Overall Study||18
10466825|NCT01059760|11614879|FG000|STARTED|Overall Study||16
10466826|NCT01059760|11614880|FG001|STARTED|Overall Study||14
10466827|NCT01059760|11614879|FG000|COMPLETED|Overall Study||16
10466828|NCT01059760|11614880|FG001|COMPLETED|Overall Study||14
10466829|NCT01059760|11614879|FG000|NOT COMPLETED|Overall Study||0
10466830|NCT01059760|11614880|FG001|NOT COMPLETED|Overall Study||0
10466831|NCT01059773|11614889|FG000|STARTED|Overall Study||244
10466832|NCT01059773|11614890|FG001|STARTED|Overall Study||245
10466833|NCT01059773|11614889|FG000|COMPLETED|Overall Study|Completed is refering to no Discontinuation of Study Agent Through Week 52|224
10466834|NCT01059773|11614890|FG001|COMPLETED|Overall Study|Completed is refering to no Discontinuation of Study Agent Through Week 52|221
10466835|NCT01059773|11614889|FG000|NOT COMPLETED|Overall Study||20
10466836|NCT01059773|11614890|FG001|NOT COMPLETED|Overall Study||24
10466837|NCT01059799|11614903|FG000|STARTED|Overall Study||289
10466838|NCT01059799|11614904|FG001|STARTED|Overall Study||146
10466839|NCT01059799|11614903|FG000|Exposed|Overall Study|Five subjects withdrew before exposure to trial drug|284
10466840|NCT01059799|11614904|FG001|Exposed|Overall Study||146
10466841|NCT01059799|11614903|FG000|COMPLETED|Overall Study||258
10466842|NCT01059799|11614904|FG001|COMPLETED|Overall Study||136
10466843|NCT01059799|11614903|FG000|NOT COMPLETED|Overall Study||31
10466844|NCT01059799|11614904|FG001|NOT COMPLETED|Overall Study||10
10466845|NCT01059812|11614912|FG000|STARTED|Overall Study||282
10466846|NCT01059812|11614913|FG001|STARTED|Overall Study||142
10466847|NCT01059812|11614912|FG000|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug|279
10466848|NCT01059812|11614913|FG001|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|141
10466849|NCT01059812|11614912|FG000|COMPLETED|Overall Study||245
10466850|NCT01059812|11614913|FG001|COMPLETED|Overall Study||126
10466851|NCT01059812|11614912|FG000|NOT COMPLETED|Overall Study||37
10466852|NCT01059812|11614913|FG001|NOT COMPLETED|Overall Study||16
10466853|NCT01059825|11614925|FG000|STARTED|Enrolled, Run-in Period||0
10466854|NCT01059825|11614926|FG001|STARTED|Enrolled, Run-in Period||0
10466855|NCT01059825|11614927|FG002|STARTED|Enrolled, Run-in Period||0
10466856|NCT01059825|11614928|FG003|STARTED|Enrolled, Run-in Period||0
10466857|NCT01059825|11614929|FG004|STARTED|Enrolled, Run-in Period||0
10466858|NCT01059825|11614930|FG005|STARTED|Enrolled, Run-in Period||0
10466860|NCT01059825|11614925|FG000|COMPLETED|Enrolled, Run-in Period||0
10466861|NCT01059825|11614926|FG001|COMPLETED|Enrolled, Run-in Period||0
10466862|NCT01059825|11614927|FG002|COMPLETED|Enrolled, Run-in Period||0
10466863|NCT01059825|11614928|FG003|COMPLETED|Enrolled, Run-in Period||0
10466864|NCT01059825|11614929|FG004|COMPLETED|Enrolled, Run-in Period||0
10466865|NCT01059825|11614930|FG005|COMPLETED|Enrolled, Run-in Period||0
10466866|NCT01059825|11614931|FG006|COMPLETED|Enrolled, Run-in Period||328
10466867|NCT01059825|11614925|FG000|NOT COMPLETED|Enrolled, Run-in Period||0
10466868|NCT01059825|11614926|FG001|NOT COMPLETED|Enrolled, Run-in Period||0
10466869|NCT01059825|11614927|FG002|NOT COMPLETED|Enrolled, Run-in Period||0
10466870|NCT01059825|11614928|FG003|NOT COMPLETED|Enrolled, Run-in Period||0
10466871|NCT01059825|11614929|FG004|NOT COMPLETED|Enrolled, Run-in Period||0
10466872|NCT01059825|11614930|FG005|NOT COMPLETED|Enrolled, Run-in Period||0
10466873|NCT01059825|11614931|FG006|NOT COMPLETED|Enrolled, Run-in Period||47
10466874|NCT01059825|11614925|FG000|STARTED|Treatment Period|54 participants who completed the run-in period were randomized to this treatment group.|54
10466875|NCT01059825|11614926|FG001|STARTED|Treatment Period|54 participants who completed the run-in period were randomized to this treatment group.|54
10466876|NCT01059825|11614927|FG002|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
10466877|NCT01059825|11614928|FG003|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
10466878|NCT01059825|11614929|FG004|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
10466879|NCT01059825|11614930|FG005|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
10466880|NCT01059825|11614931|FG006|STARTED|Treatment Period|Participants who completed run-in were randomized to 1 of 6 treatment groups.|0
10466881|NCT01059825|11614925|FG000|COMPLETED|Treatment Period||44
10466882|NCT01059825|11614926|FG001|COMPLETED|Treatment Period||50
10466883|NCT01059825|11614927|FG002|COMPLETED|Treatment Period||49
10466884|NCT01059825|11614928|FG003|COMPLETED|Treatment Period||44
10466885|NCT01059825|11614929|FG004|COMPLETED|Treatment Period||47
10466886|NCT01059825|11614930|FG005|COMPLETED|Treatment Period||52
10466887|NCT01059825|11614931|FG006|COMPLETED|Treatment Period||0
10466888|NCT01059825|11614925|FG000|NOT COMPLETED|Treatment Period||10
10466889|NCT01059825|11614926|FG001|NOT COMPLETED|Treatment Period||4
10466890|NCT01059825|11614927|FG002|NOT COMPLETED|Treatment Period||6
10466891|NCT01059825|11614928|FG003|NOT COMPLETED|Treatment Period||11
10466892|NCT01059825|11614929|FG004|NOT COMPLETED|Treatment Period||8
10466893|NCT01059825|11614930|FG005|NOT COMPLETED|Treatment Period||3
10466894|NCT01059825|11614931|FG006|NOT COMPLETED|Treatment Period||0
10466895|NCT01059851|11614949|FG000|STARTED|Overall Study||8
10466896|NCT01059851|11614950|FG001|STARTED|Overall Study||8
10466897|NCT01059851|11614951|FG002|STARTED|Overall Study||0
10466898|NCT01059851|11614952|FG003|STARTED|Overall Study||0
10466899|NCT01059851|11614953|FG004|STARTED|Overall Study||0
10466900|NCT01059851|11614954|FG005|STARTED|Overall Study||0
10466901|NCT01059851|11614949|FG000|COMPLETED|Overall Study||8
10466902|NCT01059851|11614950|FG001|COMPLETED|Overall Study||8
10466903|NCT01059851|11614951|FG002|COMPLETED|Overall Study||0
10466904|NCT01059851|11614952|FG003|COMPLETED|Overall Study||0
10466905|NCT01059851|11614953|FG004|COMPLETED|Overall Study||0
10466906|NCT01059851|11614954|FG005|COMPLETED|Overall Study||0
10466907|NCT01059851|11614949|FG000|NOT COMPLETED|Overall Study||0
10466908|NCT01059851|11614950|FG001|NOT COMPLETED|Overall Study||0
10466909|NCT01059851|11614951|FG002|NOT COMPLETED|Overall Study||0
10466910|NCT01059851|11614952|FG003|NOT COMPLETED|Overall Study||0
10466911|NCT01059851|11614953|FG004|NOT COMPLETED|Overall Study||0
10466912|NCT01059851|11614954|FG005|NOT COMPLETED|Overall Study||0
10466913|NCT01059864|11614964|FG000|STARTED|Open-Label Run-In Phase||111
10466914|NCT01059864|11614965|FG001|STARTED|Open-Label Run-In Phase||0
10466915|NCT01059864|11614966|FG002|STARTED|Open-Label Run-In Phase||0
10466916|NCT01059864|11614964|FG000|COMPLETED|Open-Label Run-In Phase||98
10466917|NCT01059864|11614965|FG001|COMPLETED|Open-Label Run-In Phase||0
10466918|NCT01059864|11614966|FG002|COMPLETED|Open-Label Run-In Phase||0
10466919|NCT01059864|11614964|FG000|NOT COMPLETED|Open-Label Run-In Phase||13
10466920|NCT01059864|11614965|FG001|NOT COMPLETED|Open-Label Run-In Phase||0
10466921|NCT01059864|11614966|FG002|NOT COMPLETED|Open-Label Run-In Phase||0
10466922|NCT01059864|11614964|FG000|STARTED|Double-Blind Treatment Phase||0
10466923|NCT01059864|11614965|FG001|STARTED|Double-Blind Treatment Phase||50
10466924|NCT01059864|11614966|FG002|STARTED|Double-Blind Treatment Phase||48
10466925|NCT01059864|11614964|FG000|Treated|Double-Blind Treatment Phase||0
10466926|NCT01059864|11614965|FG001|Treated|Double-Blind Treatment Phase||50
10466927|NCT01059864|11614966|FG002|Treated|Double-Blind Treatment Phase||47
10466928|NCT01059864|11614964|FG000|COMPLETED|Double-Blind Treatment Phase||0
10466929|NCT01059864|11614965|FG001|COMPLETED|Double-Blind Treatment Phase||47
10466930|NCT01059864|11614966|FG002|COMPLETED|Double-Blind Treatment Phase||45
10466931|NCT01059864|11614964|FG000|NOT COMPLETED|Double-Blind Treatment Phase||0
10466932|NCT01059864|11614965|FG001|NOT COMPLETED|Double-Blind Treatment Phase||3
10466933|NCT01059864|11614966|FG002|NOT COMPLETED|Double-Blind Treatment Phase||3
10466934|NCT01059877|11614975|FG000|STARTED|Overall Study||6
10466935|NCT01059877|11614976|FG001|STARTED|Overall Study||5
10466936|NCT01059877|11614975|FG000|COMPLETED|Overall Study||6
10466937|NCT01059877|11614976|FG001|COMPLETED|Overall Study||3
10466938|NCT01059877|11614975|FG000|NOT COMPLETED|Overall Study||0
10466939|NCT01059877|11614976|FG001|NOT COMPLETED|Overall Study||2
10466940|NCT01059903|11614984|FG000|STARTED|Period 1: First Intervention- 24 Hours||25
10466941|NCT01059903|11614985|FG001|STARTED|Period 1: First Intervention- 24 Hours||25
10466942|NCT01059903|11614984|FG000|COMPLETED|Period 1: First Intervention- 24 Hours||24
10466943|NCT01059903|11614985|FG001|COMPLETED|Period 1: First Intervention- 24 Hours||24
10466944|NCT01059903|11614984|FG000|NOT COMPLETED|Period 1: First Intervention- 24 Hours||1
10466945|NCT01059903|11614985|FG001|NOT COMPLETED|Period 1: First Intervention- 24 Hours||1
10466946|NCT01059903|11614984|FG000|STARTED|Period 2: Washout Period (>= 5 Days)||24
10466947|NCT01059903|11614985|FG001|STARTED|Period 2: Washout Period (>= 5 Days)||24
10466948|NCT01059903|11614984|FG000|COMPLETED|Period 2: Washout Period (>= 5 Days)||24
10466949|NCT01059903|11614985|FG001|COMPLETED|Period 2: Washout Period (>= 5 Days)||24
10466950|NCT01059903|11614984|FG000|NOT COMPLETED|Period 2: Washout Period (>= 5 Days)||0
10466951|NCT01059903|11614985|FG001|NOT COMPLETED|Period 2: Washout Period (>= 5 Days)||0
10466952|NCT01059903|11614984|FG000|STARTED|Period 3: Second Intervention- 24 Hours||24
10466953|NCT01059903|11614985|FG001|STARTED|Period 3: Second Intervention- 24 Hours||24
10466954|NCT01059903|11614984|FG000|Pharmacokinetic Set (PKS)|Period 3: Second Intervention- 24 Hours|Six subjects who fullfilled predefined criteria for patch adhesiveness were excluded from the PKS|18
10466955|NCT01059903|11614985|FG001|Pharmacokinetic Set (PKS)|Period 3: Second Intervention- 24 Hours|Two subjects who fullfilled predefined criteria for patch adhesiveness were excluded from the PKS|22
10466956|NCT01059903|11614984|FG000|COMPLETED|Period 3: Second Intervention- 24 Hours||24
10466957|NCT01059903|11614985|FG001|COMPLETED|Period 3: Second Intervention- 24 Hours||24
10466958|NCT01059903|11614984|FG000|NOT COMPLETED|Period 3: Second Intervention- 24 Hours||0
10466959|NCT01059903|11614985|FG001|NOT COMPLETED|Period 3: Second Intervention- 24 Hours||0
10466960|NCT01059929|11614993|FG000|STARTED|Overall Study||20
10466961|NCT01059929|11614994|FG001|STARTED|Overall Study||21
10466962|NCT01059929|11614993|FG000|COMPLETED|Overall Study||20
10466963|NCT01059929|11614994|FG001|COMPLETED|Overall Study||21
10466964|NCT01059929|11614993|FG000|NOT COMPLETED|Overall Study||0
10466965|NCT01059929|11614994|FG001|NOT COMPLETED|Overall Study||0
10466966|NCT01059994|11615004|FG000|STARTED|Overall Study||3
10466967|NCT01059994|11615005|FG001|STARTED|Overall Study||2
10466968|NCT01059994|11615006|FG002|STARTED|Overall Study||3
10466969|NCT01059994|11615007|FG003|STARTED|Overall Study||4
10466970|NCT01059994|11615004|FG000|COMPLETED|Overall Study||3
10466971|NCT01059994|11615005|FG001|COMPLETED|Overall Study||2
10466972|NCT01059994|11615006|FG002|COMPLETED|Overall Study||3
10466973|NCT01059994|11615007|FG003|COMPLETED|Overall Study||3
10466974|NCT01059994|11615004|FG000|NOT COMPLETED|Overall Study||0
10466975|NCT01059994|11615005|FG001|NOT COMPLETED|Overall Study||0
10466976|NCT01059994|11615006|FG002|NOT COMPLETED|Overall Study||0
10466977|NCT01059994|11615007|FG003|NOT COMPLETED|Overall Study||1
10466978|NCT01060007|11615017|FG000|STARTED|Overall Study||80
10466979|NCT01060007|11615017|FG000|COMPLETED|Overall Study||76
10466980|NCT01060007|11615017|FG000|NOT COMPLETED|Overall Study||4
10466981|NCT01060020|11615024|FG000|STARTED|Overall Study||20
10466982|NCT01060020|11615024|FG000|COMPLETED|Overall Study||20
10466983|NCT01060020|11615024|FG000|NOT COMPLETED|Overall Study||0
10466984|NCT01060059|11615031|FG000|STARTED|Overall Study||444
10466985|NCT01060059|11615032|FG001|STARTED|Overall Study||438
10466986|NCT01060059|11615031|FG000|COMPLETED|Overall Study||377
10466987|NCT01060059|11615032|FG001|COMPLETED|Overall Study||371
10466988|NCT01060059|11615031|FG000|NOT COMPLETED|Overall Study||67
10466989|NCT01060059|11615032|FG001|NOT COMPLETED|Overall Study||67
10466990|NCT01060072|11615042|FG000|STARTED|Overall Study||206
10466991|NCT01060072|11615043|FG001|STARTED|Overall Study||201
10466992|NCT01060072|11615042|FG000|COMPLETED|Overall Study||204
10466993|NCT01060072|11615043|FG001|COMPLETED|Overall Study||196
10466994|NCT01060072|11615042|FG000|NOT COMPLETED|Overall Study||2
10466995|NCT01060072|11615043|FG001|NOT COMPLETED|Overall Study||5
10466996|NCT01060098|11615052|FG000|STARTED|Overall Study||25
10466997|NCT01060098|11615053|FG001|STARTED|Overall Study||15
10466998|NCT01060098|11615054|FG002|STARTED|Overall Study||8
10466999|NCT01060098|11615052|FG000|COMPLETED|Overall Study||25
10467000|NCT01060098|11615053|FG001|COMPLETED|Overall Study||15
10467001|NCT01060098|11615054|FG002|COMPLETED|Overall Study||8
10467002|NCT01060098|11615052|FG000|NOT COMPLETED|Overall Study||0
10467003|NCT01060098|11615053|FG001|NOT COMPLETED|Overall Study||0
10467004|NCT01060098|11615054|FG002|NOT COMPLETED|Overall Study||0
10467005|NCT01060111|11615065|FG000|STARTED|Overall Study||81
10467006|NCT01060111|11615066|FG001|STARTED|Overall Study||84
10467007|NCT01060111|11615067|FG002|STARTED|Overall Study||80
10467008|NCT01060111|11615065|FG000|Treated|Overall Study||81
10467009|NCT01060111|11615066|FG001|Treated|Overall Study||83
10467010|NCT01060111|11615067|FG002|Treated|Overall Study||79
10467011|NCT01060111|11615065|FG000|COMPLETED|Overall Study||54
10467012|NCT01060111|11615066|FG001|COMPLETED|Overall Study||61
10467013|NCT01060111|11615067|FG002|COMPLETED|Overall Study||45
10467014|NCT01060111|11615065|FG000|NOT COMPLETED|Overall Study||27
10467015|NCT01060111|11615066|FG001|NOT COMPLETED|Overall Study||23
10467016|NCT01060111|11615067|FG002|NOT COMPLETED|Overall Study||35
10467017|NCT01060124|11615078|FG000|STARTED|Overall Study||103
10467018|NCT01060124|11615078|FG000|COMPLETED|Overall Study||66
10467019|NCT01060124|11615078|FG000|NOT COMPLETED|Overall Study||37
10467020|NCT01060150|11615082|FG000|STARTED|Overall Study||115
10467021|NCT01060150|11615082|FG000|Treated|Overall Study||113
10467022|NCT01060150|11615082|FG000|COMPLETED|Overall Study||92
10467023|NCT01060150|11615082|FG000|NOT COMPLETED|Overall Study||23
10467024|NCT01060345|11615086|FG000|STARTED|Overall Study||20
10467025|NCT01060345|11615086|FG000|COMPLETED|Overall Study||20
10467026|NCT01060345|11615086|FG000|NOT COMPLETED|Overall Study||0
10467027|NCT01060384|11615090|FG000|STARTED|Overall Study||6
10467028|NCT01060384|11615091|FG001|STARTED|Overall Study||4
10467029|NCT01060384|11615092|FG002|STARTED|Overall Study||0
10467030|NCT01060384|11615093|FG003|STARTED|Overall Study||0
10467031|NCT01060384|11615094|FG004|STARTED|Overall Study||36
10467032|NCT01060384|11615090|FG000|COMPLETED|Overall Study||6
10467033|NCT01060384|11615091|FG001|COMPLETED|Overall Study||3
10467034|NCT01060384|11615092|FG002|COMPLETED|Overall Study||0
10467035|NCT01060384|11615093|FG003|COMPLETED|Overall Study||0
10467036|NCT01060384|11615094|FG004|COMPLETED|Overall Study||34
10467037|NCT01060384|11615090|FG000|NOT COMPLETED|Overall Study||0
10467038|NCT01060384|11615091|FG001|NOT COMPLETED|Overall Study||1
10467039|NCT01060384|11615092|FG002|NOT COMPLETED|Overall Study||0
10467040|NCT01060384|11615093|FG003|NOT COMPLETED|Overall Study||0
10467041|NCT01060384|11615094|FG004|NOT COMPLETED|Overall Study||2
10467042|NCT01060540|11615105|FG000|STARTED|Overall Study||303
10467043|NCT01060540|11615106|FG001|STARTED|Overall Study||298
10467044|NCT01060540|11615105|FG000|COMPLETED|Overall Study||239
10467045|NCT01060540|11615106|FG001|COMPLETED|Overall Study||233
10467046|NCT01060540|11615105|FG000|NOT COMPLETED|Overall Study||64
10467047|NCT01060540|11615106|FG001|NOT COMPLETED|Overall Study||65
10467048|NCT01060553|11615114|FG000|STARTED|Overall Study||15
10467049|NCT01060553|11615115|FG001|STARTED|Overall Study||15
10467050|NCT01060553|11615114|FG000|COMPLETED|Overall Study|5 subjects completed more than half the sessions and midpoint outcome measures were obtained|6
10467051|NCT01060553|11615115|FG001|COMPLETED|Overall Study||5
10467052|NCT01060553|11615114|FG000|NOT COMPLETED|Overall Study||9
10467053|NCT01060553|11615115|FG001|NOT COMPLETED|Overall Study||10
10467054|NCT01060592|11615122|FG000|STARTED|4-6w||35
10467055|NCT01060592|11615123|FG001|STARTED|4-6w||49
10467056|NCT01060592|11615122|FG000|COMPLETED|4-6w||23
10467057|NCT01060592|11615123|FG001|COMPLETED|4-6w||39
10467058|NCT01060592|11615122|FG000|NOT COMPLETED|4-6w||12
10467059|NCT01060592|11615123|FG001|NOT COMPLETED|4-6w||10
10467060|NCT01060592|11615122|FG000|STARTED|12m|For some pts, %EWL were not taken/available in the 4-6w period but were available for the 12m period|35
10467061|NCT01060592|11615123|FG001|STARTED|12m|For some pts, %EWL were not taken/available in the 4-6w period but were available for the 12m period|49
10467062|NCT01060592|11615122|FG000|COMPLETED|12m||35
10467063|NCT01060592|11615123|FG001|COMPLETED|12m|Historic data was not available at 12m for 18 of the historic controls|31
10467064|NCT01060592|11615122|FG000|NOT COMPLETED|12m||0
10467065|NCT01060592|11615123|FG001|NOT COMPLETED|12m||18
10467066|NCT01060670|11615131|FG000|STARTED|Run In||0
10467067|NCT01060670|11615132|FG001|STARTED|Run In||545
10467068|NCT01060670|11615131|FG000|COMPLETED|Run In||0
10467069|NCT01060670|11615132|FG001|COMPLETED|Run In||307
10467070|NCT01060670|11615131|FG000|NOT COMPLETED|Run In||0
10467071|NCT01060670|11615132|FG001|NOT COMPLETED|Run In||238
10467072|NCT01060670|11615131|FG000|STARTED|Treatment Phase||154
10467073|NCT01060670|11615132|FG001|STARTED|Treatment Phase||153
10467074|NCT01060670|11615131|FG000|Healed at End of Treatment Phase|Treatment Phase||79
10467075|NCT01060670|11615132|FG001|Healed at End of Treatment Phase|Treatment Phase||49
10467076|NCT01060670|11615131|FG000|Did Not Heal by Treatment Visit 17|Treatment Phase||49
10467077|NCT01060670|11615132|FG001|Did Not Heal by Treatment Visit 17|Treatment Phase||68
10467078|NCT01060670|11615131|FG000|Withdrew From Treatment|Treatment Phase||26
10467079|NCT01060670|11615132|FG001|Withdrew From Treatment|Treatment Phase||36
10467080|NCT01060670|11615131|FG000|COMPLETED|Treatment Phase||128
10467081|NCT01060670|11615132|FG001|COMPLETED|Treatment Phase||117
10467082|NCT01060670|11615131|FG000|NOT COMPLETED|Treatment Phase||26
10467083|NCT01060670|11615132|FG001|NOT COMPLETED|Treatment Phase||36
10467084|NCT01060670|11615131|FG000|STARTED|Follow up Phase||128
10467085|NCT01060670|11615132|FG001|STARTED|Follow up Phase||117
10467086|NCT01060670|11615131|FG000|Recurrence|Follow up Phase||14
10467087|NCT01060670|11615132|FG001|Recurrence|Follow up Phase||9
10467088|NCT01060670|11615131|FG000|Withdrew From Follow up Phase|Follow up Phase||22
10467089|NCT01060670|11615132|FG001|Withdrew From Follow up Phase|Follow up Phase||35
10467090|NCT01060670|11615131|FG000|COMPLETED|Follow up Phase||106
10467091|NCT01060670|11615132|FG001|COMPLETED|Follow up Phase||82
10467092|NCT01060670|11615131|FG000|NOT COMPLETED|Follow up Phase||22
10467093|NCT01060670|11615132|FG001|NOT COMPLETED|Follow up Phase||35
10467094|NCT01061008|11615142|FG000|STARTED|Overall Study||16
10467095|NCT01061008|11615143|FG001|STARTED|Overall Study||15
10467096|NCT01061008|11615142|FG000|COMPLETED|Overall Study||10
10467097|NCT01061008|11615143|FG001|COMPLETED|Overall Study||9
10467098|NCT01061008|11615142|FG000|NOT COMPLETED|Overall Study||6
10467099|NCT01061008|11615143|FG001|NOT COMPLETED|Overall Study||6
10467100|NCT01061034|11615149|FG000|STARTED|Aspirin||9
10467101|NCT01061034|11615149|FG000|COMPLETED|Aspirin||9
10467102|NCT01061034|11615149|FG000|NOT COMPLETED|Aspirin||0
10467103|NCT01061034|11615149|FG000|STARTED|Aspirin Plus Omeprazole||9
10467104|NCT01061034|11615149|FG000|COMPLETED|Aspirin Plus Omeprazole||9
10467105|NCT01061034|11615149|FG000|NOT COMPLETED|Aspirin Plus Omeprazole||0
10467106|NCT01061177|11615153|FG000|STARTED|Overall Study||1089
10467107|NCT01061177|11615153|FG000|ITT_MR (b2a2 &/or b3a2 +ve Pts Only)|Overall Study||1056
10467108|NCT01061177|11615153|FG000|ITT_CyR (Ph+ Patients Only)|Overall Study||983
10467109|NCT01061177|11615153|FG000|COMPLETED|Overall Study||881
10467110|NCT01061177|11615153|FG000|NOT COMPLETED|Overall Study||208
10467111|NCT01061333|11615157|FG000|STARTED|Period 1: Placebo Run-in||8
10708628|NCT02632747|11873501|FG001|COMPLETED|Treatment Period 1||15
10708629|NCT02632747|11873500|FG000|NOT COMPLETED|Treatment Period 1||0
10708630|NCT02632747|11873501|FG001|NOT COMPLETED|Treatment Period 1||0
10708631|NCT02632747|11873500|FG000|STARTED|Wash-out Period||16
10467112|NCT01061333|11615158|FG001|STARTED|Period 1: Placebo Run-in||8
10467113|NCT01061333|11615157|FG000|COMPLETED|Period 1: Placebo Run-in||8
10467114|NCT01061333|11615158|FG001|COMPLETED|Period 1: Placebo Run-in||8
10467115|NCT01061333|11615157|FG000|NOT COMPLETED|Period 1: Placebo Run-in||0
10467116|NCT01061333|11615158|FG001|NOT COMPLETED|Period 1: Placebo Run-in||0
10467117|NCT01061333|11615157|FG000|STARTED|Period 2: 20-day Washout||8
10467118|NCT01061333|11615158|FG001|STARTED|Period 2: 20-day Washout||8
10467119|NCT01061333|11615157|FG000|COMPLETED|Period 2: 20-day Washout||8
10467120|NCT01061333|11615158|FG001|COMPLETED|Period 2: 20-day Washout||8
10467121|NCT01061333|11615157|FG000|NOT COMPLETED|Period 2: 20-day Washout||0
10467122|NCT01061333|11615158|FG001|NOT COMPLETED|Period 2: 20-day Washout||0
10467123|NCT01061333|11615157|FG000|STARTED|Period 3: Nedocromil-Montelukast X-over||8
10467124|NCT01061333|11615158|FG001|STARTED|Period 3: Nedocromil-Montelukast X-over||8
10467125|NCT01061333|11615157|FG000|COMPLETED|Period 3: Nedocromil-Montelukast X-over||8
10467126|NCT01061333|11615158|FG001|COMPLETED|Period 3: Nedocromil-Montelukast X-over||8
10467127|NCT01061333|11615157|FG000|NOT COMPLETED|Period 3: Nedocromil-Montelukast X-over||0
10467128|NCT01061333|11615158|FG001|NOT COMPLETED|Period 3: Nedocromil-Montelukast X-over||0
10467129|NCT01061333|11615157|FG000|STARTED|Period 4: 20-day Washout||8
10467130|NCT01061333|11615158|FG001|STARTED|Period 4: 20-day Washout||8
10467131|NCT01061333|11615157|FG000|COMPLETED|Period 4: 20-day Washout||8
10467132|NCT01061333|11615158|FG001|COMPLETED|Period 4: 20-day Washout||7
10467133|NCT01061333|11615157|FG000|NOT COMPLETED|Period 4: 20-day Washout||0
10467134|NCT01061333|11615158|FG001|NOT COMPLETED|Period 4: 20-day Washout||1
10467135|NCT01061333|11615157|FG000|STARTED|Period 5: Nedocromil-Montelukast X-over||8
10467136|NCT01061333|11615158|FG001|STARTED|Period 5: Nedocromil-Montelukast X-over||7
10467137|NCT01061333|11615157|FG000|COMPLETED|Period 5: Nedocromil-Montelukast X-over||8
10467138|NCT01061333|11615158|FG001|COMPLETED|Period 5: Nedocromil-Montelukast X-over||7
10467139|NCT01061333|11615157|FG000|NOT COMPLETED|Period 5: Nedocromil-Montelukast X-over||0
10467140|NCT01061333|11615158|FG001|NOT COMPLETED|Period 5: Nedocromil-Montelukast X-over||0
10467141|NCT01061333|11615157|FG000|STARTED|Period 6: 20-day Washout||8
10467142|NCT01061333|11615158|FG001|STARTED|Period 6: 20-day Washout||7
10467143|NCT01061333|11615157|FG000|COMPLETED|Period 6: 20-day Washout||8
10467144|NCT01061333|11615158|FG001|COMPLETED|Period 6: 20-day Washout||7
10467145|NCT01061333|11615157|FG000|NOT COMPLETED|Period 6: 20-day Washout||0
10467146|NCT01061333|11615158|FG001|NOT COMPLETED|Period 6: 20-day Washout||0
10467147|NCT01061333|11615157|FG000|STARTED|Period 7: Mometasone||8
10467148|NCT01061333|11615158|FG001|STARTED|Period 7: Mometasone||7
10467149|NCT01061333|11615157|FG000|COMPLETED|Period 7: Mometasone||8
10467150|NCT01061333|11615158|FG001|COMPLETED|Period 7: Mometasone||7
10467151|NCT01061333|11615157|FG000|NOT COMPLETED|Period 7: Mometasone||0
10467152|NCT01061333|11615158|FG001|NOT COMPLETED|Period 7: Mometasone||0
10467153|NCT01061359|11615169|FG000|STARTED|Overall Study||1972
10467154|NCT01061359|11615169|FG000|COMPLETED|Overall Study|Completed 5 years of follow-up: 668 Disease free and 2 Relapsed|670
10467155|NCT01061359|11615169|FG000|NOT COMPLETED|Overall Study||1302
10467156|NCT01061385|11615175|FG000|STARTED|Overall Study||21
10467157|NCT01061385|11615176|FG001|STARTED|Overall Study||9
10467158|NCT01061385|11615175|FG000|COMPLETED|Overall Study||20
10467159|NCT01061385|11615176|FG001|COMPLETED|Overall Study||8
10467160|NCT01061385|11615175|FG000|NOT COMPLETED|Overall Study||1
10467161|NCT01061385|11615176|FG001|NOT COMPLETED|Overall Study||1
10467162|NCT01061476|11615183|FG000|STARTED|Overall Study||12
10467163|NCT01061476|11615183|FG000|COMPLETED|Overall Study||12
10467164|NCT01061476|11615183|FG000|NOT COMPLETED|Overall Study||0
10467165|NCT01061528|11615189|FG000|STARTED|Overall Study||62
10467166|NCT01061528|11615190|FG001|STARTED|Overall Study||54
10467167|NCT01061528|11615189|FG000|COMPLETED|Overall Study||59
10467168|NCT01061528|11615190|FG001|COMPLETED|Overall Study||52
10467169|NCT01061528|11615189|FG000|NOT COMPLETED|Overall Study||3
10467170|NCT01061528|11615190|FG001|NOT COMPLETED|Overall Study||2
10467171|NCT01061567|11615196|FG000|STARTED|Overall Study||1814
10467172|NCT01061567|11615196|FG000|COMPLETED|Overall Study||1738
10467173|NCT01061567|11615196|FG000|NOT COMPLETED|Overall Study||76
10467174|NCT01061606|11615200|FG000|STARTED|Overall Study||8
10467175|NCT01061606|11615200|FG000|COMPLETED|Overall Study||0
10467176|NCT01061606|11615200|FG000|NOT COMPLETED|Overall Study||8
10467177|NCT01061671|11615206|FG000|STARTED|Overall Study||433
10467178|NCT01061671|11615207|FG001|STARTED|Overall Study||452
10467179|NCT01061671|11615206|FG000|COMPLETED|Overall Study||386
10467180|NCT01061671|11615207|FG001|COMPLETED|Overall Study||397
10467181|NCT01061671|11615206|FG000|NOT COMPLETED|Overall Study||47
10467182|NCT01061671|11615207|FG001|NOT COMPLETED|Overall Study||55
10467183|NCT01061710|11615213|FG000|STARTED|Overall Study||20
10467184|NCT01061710|11615213|FG000|COMPLETED|Overall Study||6
10467185|NCT01061710|11615213|FG000|NOT COMPLETED|Overall Study||14
10467186|NCT01061723|11615223|FG000|STARTED|Overall Study||50
10708632|NCT02632747|11873501|FG001|STARTED|Wash-out Period||15
10708633|NCT02632747|11873500|FG000|COMPLETED|Wash-out Period||15
10708634|NCT02632747|11873501|FG001|COMPLETED|Wash-out Period||15
10708635|NCT02632747|11873500|FG000|NOT COMPLETED|Wash-out Period||1
10467187|NCT01061723|11615224|FG001|STARTED|Overall Study||49
10467188|NCT01061723|11615225|FG002|STARTED|Overall Study||50
10467189|NCT01061723|11615226|FG003|STARTED|Overall Study||52
10467190|NCT01061723|11615227|FG004|STARTED|Overall Study||50
10467191|NCT01061723|11615228|FG005|STARTED|Overall Study||50
10467192|NCT01061723|11615223|FG000|Treated|Overall Study||50
10467193|NCT01061723|11615224|FG001|Treated|Overall Study||49
10467194|NCT01061723|11615225|FG002|Treated|Overall Study||50
10467195|NCT01061723|11615226|FG003|Treated|Overall Study||52
10467196|NCT01061723|11615227|FG004|Treated|Overall Study||50
10467197|NCT01061723|11615228|FG005|Treated|Overall Study||49
10467198|NCT01061723|11615223|FG000|COMPLETED|Overall Study||46
10467199|NCT01061723|11615224|FG001|COMPLETED|Overall Study||43
10467200|NCT01061723|11615225|FG002|COMPLETED|Overall Study||40
10467201|NCT01061723|11615226|FG003|COMPLETED|Overall Study||44
10467202|NCT01061723|11615227|FG004|COMPLETED|Overall Study||47
10467203|NCT01061723|11615228|FG005|COMPLETED|Overall Study||41
10467204|NCT01061723|11615223|FG000|NOT COMPLETED|Overall Study||4
10467205|NCT01061723|11615224|FG001|NOT COMPLETED|Overall Study||6
10467206|NCT01061723|11615225|FG002|NOT COMPLETED|Overall Study||10
10467207|NCT01061723|11615226|FG003|NOT COMPLETED|Overall Study||8
10467208|NCT01061723|11615227|FG004|NOT COMPLETED|Overall Study||3
10467209|NCT01061723|11615228|FG005|NOT COMPLETED|Overall Study||9
10467210|NCT01061736|11615257|FG000|STARTED|Overall Study||50
10467211|NCT01061736|11615258|FG001|STARTED|Overall Study||50
10467212|NCT01061736|11615259|FG002|STARTED|Overall Study||51
10467213|NCT01061736|11615260|FG003|STARTED|Overall Study||51
10467214|NCT01061736|11615261|FG004|STARTED|Overall Study||52
10467215|NCT01061736|11615262|FG005|STARTED|Overall Study||52
10467216|NCT01061736|11615263|FG006|STARTED|Overall Study||84
10467217|NCT01061736|11615264|FG007|STARTED|Overall Study||430
10467218|NCT01061736|11615265|FG008|STARTED|Overall Study||427
10467219|NCT01061736|11615266|FG009|STARTED|Overall Study||428
10467220|NCT01061736|11615257|FG000|Treated|Overall Study||50
10467221|NCT01061736|11615258|FG001|Treated|Overall Study||50
10467222|NCT01061736|11615259|FG002|Treated|Overall Study||51
10467223|NCT01061736|11615260|FG003|Treated|Overall Study||51
10467224|NCT01061736|11615261|FG004|Treated|Overall Study||51
10467225|NCT01061736|11615262|FG005|Treated|Overall Study||52
10467226|NCT01061736|11615263|FG006|Treated|Overall Study||84
10467227|NCT01061736|11615264|FG007|Treated|Overall Study||428
10467228|NCT01061736|11615265|FG008|Treated|Overall Study||426
10467229|NCT01061736|11615266|FG009|Treated|Overall Study||428
10467230|NCT01061736|11615257|FG000|Rescued|Overall Study||0
10467231|NCT01061736|11615258|FG001|Rescued|Overall Study||0
10467232|NCT01061736|11615259|FG002|Rescued|Overall Study||0
10708636|NCT02632747|11873501|FG001|NOT COMPLETED|Wash-out Period||0
10467233|NCT01061736|11615260|FG003|Rescued|Overall Study||0
10467234|NCT01061736|11615261|FG004|Rescued|Overall Study||0
10467235|NCT01061736|11615262|FG005|Rescued|Overall Study||0
10467236|NCT01061736|11615263|FG006|Rescued|Overall Study||0
10467237|NCT01061736|11615264|FG007|Rescued|Overall Study|Included both participants who completed and did not complete the study.|61
10467238|NCT01061736|11615265|FG008|Rescued|Overall Study|Included both participants who completed and did not complete the study.|55
10467239|NCT01061736|11615266|FG009|Rescued|Overall Study|Included both participants who completed and did not complete the study.|168
10467240|NCT01061736|11615257|FG000|COMPLETED|Overall Study||37
10467241|NCT01061736|11615258|FG001|COMPLETED|Overall Study||46
10467242|NCT01061736|11615259|FG002|COMPLETED|Overall Study||45
10467243|NCT01061736|11615260|FG003|COMPLETED|Overall Study||48
10467244|NCT01061736|11615261|FG004|COMPLETED|Overall Study||45
10467245|NCT01061736|11615262|FG005|COMPLETED|Overall Study||49
10467246|NCT01061736|11615263|FG006|COMPLETED|Overall Study||0
10467247|NCT01061736|11615264|FG007|COMPLETED|Overall Study||336
10467248|NCT01061736|11615265|FG008|COMPLETED|Overall Study||330
10467249|NCT01061736|11615266|FG009|COMPLETED|Overall Study||354
10467250|NCT01061736|11615257|FG000|NOT COMPLETED|Overall Study||13
10467251|NCT01061736|11615258|FG001|NOT COMPLETED|Overall Study||4
10467252|NCT01061736|11615259|FG002|NOT COMPLETED|Overall Study||6
10467253|NCT01061736|11615260|FG003|NOT COMPLETED|Overall Study||3
10467254|NCT01061736|11615261|FG004|NOT COMPLETED|Overall Study||7
10467255|NCT01061736|11615262|FG005|NOT COMPLETED|Overall Study||3
10649826|NCT02164513|11809986|FG000|WIP: Study Closed/Terminated|Overall Study||5
10649827|NCT02164513|11809987|FG001|WIP: Study Closed/Terminated|Overall Study||2
10649828|NCT02164513|11809988|FG002|WIP: Study Closed/Terminated|Overall Study||5
10649829|NCT02164513|11809986|FG000|WIP: Lost to Follow-up|Overall Study||21
10649830|NCT02164513|11809987|FG001|WIP: Lost to Follow-up|Overall Study||25
10649831|NCT02164513|11809988|FG002|WIP: Lost to Follow-up|Overall Study||14
10649832|NCT02164513|11809986|FG000|WIP: Investigator Discretion|Overall Study||33
10649833|NCT02164513|11809987|FG001|WIP: Investigator Discretion|Overall Study||36
10649834|NCT02164513|11809988|FG002|WIP: Investigator Discretion|Overall Study||15
10649835|NCT02164513|11809986|FG000|WIP: Withdrawal by Participant|Overall Study||250
10649836|NCT02164513|11809987|FG001|WIP: Withdrawal by Participant|Overall Study||296
10708637|NCT02632747|11873500|FG000|STARTED|Treatment Period 2||15
10467256|NCT01061736|11615263|FG006|NOT COMPLETED|Overall Study||84
10467257|NCT01061736|11615264|FG007|NOT COMPLETED|Overall Study||94
10467258|NCT01061736|11615265|FG008|NOT COMPLETED|Overall Study||97
10467259|NCT01061736|11615266|FG009|NOT COMPLETED|Overall Study||74
10467260|NCT01061775|11615291|FG000|STARTED|Overall Study||19
10467261|NCT01061775|11615291|FG000|COMPLETED|Overall Study||16
10467262|NCT01061775|11615291|FG000|NOT COMPLETED|Overall Study||3
10467263|NCT01061866|11615296|FG000|STARTED|Overall Study||7
10467264|NCT01061866|11615296|FG000|COMPLETED|Overall Study||5
10467265|NCT01061866|11615296|FG000|NOT COMPLETED|Overall Study||2
10467266|NCT01062009|11615304|FG000|STARTED|Overall Study||7
10467267|NCT01062009|11615305|FG001|STARTED|Overall Study||6
10467268|NCT01062009|11615306|FG002|STARTED|Overall Study||6
10467269|NCT01062009|11615307|FG003|STARTED|Overall Study||6
10467270|NCT01062009|11615304|FG000|COMPLETED|Overall Study||6
10467271|NCT01062009|11615305|FG001|COMPLETED|Overall Study||6
10467272|NCT01062009|11615306|FG002|COMPLETED|Overall Study||6
10467273|NCT01062009|11615307|FG003|COMPLETED|Overall Study||6
10467274|NCT01062009|11615304|FG000|NOT COMPLETED|Overall Study||1
10467275|NCT01062009|11615305|FG001|NOT COMPLETED|Overall Study||0
10467276|NCT01062009|11615306|FG002|NOT COMPLETED|Overall Study||0
10467277|NCT01062009|11615307|FG003|NOT COMPLETED|Overall Study||0
10467278|NCT01062061|11615317|FG000|STARTED|Overall Study||754
10467279|NCT01062061|11615317|FG000|COMPLETED|Overall Study||727
10467280|NCT01062061|11615317|FG000|NOT COMPLETED|Overall Study||27
10467281|NCT01062074|11615325|FG000|STARTED|Overall Study||3605
10467282|NCT01062074|11615325|FG000|COMPLETED|Overall Study||3605
10467283|NCT01062074|11615325|FG000|NOT COMPLETED|Overall Study||0
10467284|NCT01062113|11615332|FG000|STARTED|Overall Study||133
10467285|NCT01062113|11615333|FG001|STARTED|Overall Study||64
10467286|NCT01062113|11615334|FG002|STARTED|Overall Study||58
10467287|NCT01062113|11615332|FG000|COMPLETED|Overall Study||93
10467288|NCT01062113|11615333|FG001|COMPLETED|Overall Study||42
10467289|NCT01062113|11615334|FG002|COMPLETED|Overall Study||27
10467290|NCT01062113|11615332|FG000|NOT COMPLETED|Overall Study||40
10467291|NCT01062113|11615333|FG001|NOT COMPLETED|Overall Study||22
10467292|NCT01062113|11615334|FG002|NOT COMPLETED|Overall Study||31
10467293|NCT01062126|11615342|FG000|STARTED|Overall Study||3389
10467294|NCT01062126|11615342|FG000|COMPLETED|Overall Study||2856
10467295|NCT01062126|11615342|FG000|NOT COMPLETED|Overall Study||533
10467296|NCT01062165|11615346|FG000|STARTED|Overall Study||18
10467297|NCT01062165|11615346|FG000|COMPLETED|Overall Study||18
10467298|NCT01062165|11615346|FG000|NOT COMPLETED|Overall Study||0
10467299|NCT01062230|11615350|FG000|STARTED|Overall Study||6
10467300|NCT01062230|11615350|FG000|COMPLETED|Overall Study||6
10467301|NCT01062230|11615350|FG000|NOT COMPLETED|Overall Study||0
10467302|NCT01062256|11615357|FG000|STARTED|Overall Study||55
10467303|NCT01062256|11615358|FG001|STARTED|Overall Study||103
10467304|NCT01062256|11615359|FG002|STARTED|Overall Study||107
10467305|NCT01062256|11615357|FG000|COMPLETED|Overall Study||52
10467306|NCT01062256|11615358|FG001|COMPLETED|Overall Study||96
10467307|NCT01062256|11615359|FG002|COMPLETED|Overall Study||103
10467308|NCT01062256|11615357|FG000|NOT COMPLETED|Overall Study||3
10467309|NCT01062256|11615358|FG001|NOT COMPLETED|Overall Study||7
10467310|NCT01062256|11615359|FG002|NOT COMPLETED|Overall Study||4
10467311|NCT01062269|11615367|FG000|STARTED|Overall Study||42
10467312|NCT01062269|11615367|FG000|COMPLETED|Overall Study||42
10467313|NCT01062269|11615367|FG000|NOT COMPLETED|Overall Study||0
10467314|NCT01062308|11615377|FG000|STARTED|Overall Study||80
10467315|NCT01062308|11615378|FG001|STARTED|Overall Study||82
10467316|NCT01062308|11615377|FG000|COMPLETED|Overall Study||64
10467317|NCT01062308|11615378|FG001|COMPLETED|Overall Study||72
10467318|NCT01062308|11615377|FG000|NOT COMPLETED|Overall Study||16
10467319|NCT01062308|11615378|FG001|NOT COMPLETED|Overall Study||10
10467320|NCT01062555|11615386|FG000|STARTED|Phase 1||266
10467321|NCT01062555|11615387|FG001|STARTED|Phase 1||261
10467322|NCT01062555|11615388|FG002|STARTED|Phase 1||0
10467323|NCT01062555|11615389|FG003|STARTED|Phase 1||0
10467324|NCT01062555|11615386|FG000|COMPLETED|Phase 1||243
10467325|NCT01062555|11615387|FG001|COMPLETED|Phase 1||235
10467326|NCT01062555|11615388|FG002|COMPLETED|Phase 1||0
10467327|NCT01062555|11615389|FG003|COMPLETED|Phase 1||0
10467328|NCT01062555|11615386|FG000|NOT COMPLETED|Phase 1||23
10467329|NCT01062555|11615387|FG001|NOT COMPLETED|Phase 1||26
10467330|NCT01062555|11615388|FG002|NOT COMPLETED|Phase 1||0
10467331|NCT01062555|11615389|FG003|NOT COMPLETED|Phase 1||0
10467332|NCT01062555|11615386|FG000|STARTED|Phase 2||0
10467333|NCT01062555|11615387|FG001|STARTED|Phase 2||0
10467334|NCT01062555|11615388|FG002|STARTED|Phase 2||86
10467335|NCT01062555|11615389|FG003|STARTED|Phase 2||87
10467336|NCT01062555|11615386|FG000|COMPLETED|Phase 2||0
10467337|NCT01062555|11615387|FG001|COMPLETED|Phase 2||0
10467338|NCT01062555|11615388|FG002|COMPLETED|Phase 2||71
10467339|NCT01062555|11615389|FG003|COMPLETED|Phase 2||53
10467340|NCT01062555|11615386|FG000|NOT COMPLETED|Phase 2||0
10467341|NCT01062555|11615387|FG001|NOT COMPLETED|Phase 2||0
10467342|NCT01062555|11615388|FG002|NOT COMPLETED|Phase 2||15
10467343|NCT01062555|11615389|FG003|NOT COMPLETED|Phase 2||34
10467344|NCT01062568|11615401|FG000|STARTED|Overall Study||10
10467345|NCT01062568|11615402|FG001|STARTED|Overall Study||40
10467346|NCT01062568|11615401|FG000|COMPLETED|Overall Study||10
10467347|NCT01062568|11615402|FG001|COMPLETED|Overall Study||40
10467348|NCT01062568|11615401|FG000|NOT COMPLETED|Overall Study||0
10467349|NCT01062568|11615402|FG001|NOT COMPLETED|Overall Study||0
10467350|NCT01062763|11615415|FG000|STARTED|Overall Study|119 randomized.|58
10467351|NCT01062763|11615416|FG001|STARTED|Overall Study||61
10467352|NCT01062763|11615415|FG000|COMPLETED|Overall Study||55
10467353|NCT01062763|11615416|FG001|COMPLETED|Overall Study||57
10467354|NCT01062763|11615415|FG000|NOT COMPLETED|Overall Study||3
10467355|NCT01062763|11615416|FG001|NOT COMPLETED|Overall Study||4
10467356|NCT01062841|11615424|FG000|STARTED|Overall Study||203
10467357|NCT01062841|11615425|FG001|STARTED|Overall Study||215
10467358|NCT01062841|11615424|FG000|COMPLETED|Overall Study||154
10467359|NCT01062841|11615425|FG001|COMPLETED|Overall Study||162
10467360|NCT01062841|11615424|FG000|NOT COMPLETED|Overall Study||49
10467361|NCT01062841|11615425|FG001|NOT COMPLETED|Overall Study||53
10467362|NCT01062893|11615433|FG000|STARTED|Overall Study||41
10467363|NCT01062893|11615434|FG001|STARTED|Overall Study||41
10467364|NCT01062893|11615433|FG000|COMPLETED|Overall Study||27
10467365|NCT01062893|11615434|FG001|COMPLETED|Overall Study||28
10467366|NCT01062893|11615433|FG000|NOT COMPLETED|Overall Study||14
10467367|NCT01062893|11615434|FG001|NOT COMPLETED|Overall Study||13
10467368|NCT01062971|11615442|FG000|STARTED|Overall Study||60
10467369|NCT01062971|11615443|FG001|STARTED|Overall Study||63
10467370|NCT01062971|11615442|FG000|COMPLETED|Overall Study||56
10467371|NCT01062971|11615443|FG001|COMPLETED|Overall Study||56
10467372|NCT01062971|11615442|FG000|NOT COMPLETED|Overall Study||4
10467373|NCT01062971|11615443|FG001|NOT COMPLETED|Overall Study||7
10467374|NCT01063036|11615449|FG000|STARTED|Participants Treated With Study Drug||92
10467375|NCT01063036|11615449|FG000|COMPLETED|Participants Treated With Study Drug||86
10467376|NCT01063036|11615449|FG000|NOT COMPLETED|Participants Treated With Study Drug||6
10467377|NCT01063036|11615449|FG000|STARTED|Post Dosing Follow-up Through 24 Weeks|2 included did not complete treatment; 3 completed treatment but not included (lost to follow-up).|85
10467378|NCT01063036|11615449|FG000|COMPLETED|Post Dosing Follow-up Through 24 Weeks||46
10467379|NCT01063036|11615449|FG000|NOT COMPLETED|Post Dosing Follow-up Through 24 Weeks||39
10467380|NCT01063049|11615456|FG000|STARTED|Overall Study||200
10467381|NCT01063049|11615457|FG001|STARTED|Overall Study||200
10467382|NCT01063049|11615458|FG002|STARTED|Overall Study||200
10467383|NCT01063049|11615456|FG000|COMPLETED|Overall Study||200
10467384|NCT01063049|11615457|FG001|COMPLETED|Overall Study||200
10467385|NCT01063049|11615458|FG002|COMPLETED|Overall Study||200
10467386|NCT01063049|11615456|FG000|NOT COMPLETED|Overall Study||0
10467387|NCT01063049|11615457|FG001|NOT COMPLETED|Overall Study||0
10467388|NCT01063049|11615458|FG002|NOT COMPLETED|Overall Study||0
10467389|NCT01063062|11615468|FG000|STARTED|Overall Study||30
10467390|NCT01063062|11615469|FG001|STARTED|Overall Study||77
10467391|NCT01063062|11615468|FG000|Received Study Drug|Overall Study||29
10467392|NCT01063062|11615469|FG001|Received Study Drug|Overall Study||76
10467393|NCT01063062|11615468|FG000|COMPLETED|Overall Study||22
10467394|NCT01063062|11615469|FG001|COMPLETED|Overall Study||65
10467395|NCT01063062|11615468|FG000|NOT COMPLETED|Overall Study||8
10467396|NCT01063062|11615469|FG001|NOT COMPLETED|Overall Study||12
10467397|NCT01063075|11615476|FG000|STARTED|Overall Study||2
10467398|NCT01063075|11615477|FG001|STARTED|Overall Study||3
10467399|NCT01063075|11615478|FG002|STARTED|Overall Study||14
10467400|NCT01063075|11615479|FG003|STARTED|Overall Study||15
10467401|NCT01063075|11615476|FG000|COMPLETED|Overall Study||1
10467402|NCT01063075|11615477|FG001|COMPLETED|Overall Study||1
10467403|NCT01063075|11615478|FG002|COMPLETED|Overall Study||9
10467404|NCT01063075|11615479|FG003|COMPLETED|Overall Study||14
10467405|NCT01063075|11615476|FG000|NOT COMPLETED|Overall Study||1
10467406|NCT01063075|11615477|FG001|NOT COMPLETED|Overall Study||2
10467407|NCT01063075|11615478|FG002|NOT COMPLETED|Overall Study||5
10467408|NCT01063075|11615479|FG003|NOT COMPLETED|Overall Study||1
10467409|NCT01063153|11615491|FG000|STARTED|Overall Study||33
10467410|NCT01063153|11615492|FG001|STARTED|Overall Study||38
10467411|NCT01063153|11615491|FG000|COMPLETED|Overall Study||31
10467412|NCT01063153|11615492|FG001|COMPLETED|Overall Study||26
10467413|NCT01063153|11615491|FG000|NOT COMPLETED|Overall Study||2
10467414|NCT01063153|11615492|FG001|NOT COMPLETED|Overall Study||12
10467415|NCT01063283|11615504|FG000|STARTED|Cycle 1||20
10467416|NCT01063283|11615505|FG001|STARTED|Cycle 1||0
10467417|NCT01063283|11615506|FG002|STARTED|Cycle 1||0
10467418|NCT01063283|11615504|FG000|COMPLETED|Cycle 1||17
10467419|NCT01063283|11615505|FG001|COMPLETED|Cycle 1||0
10467420|NCT01063283|11615506|FG002|COMPLETED|Cycle 1||0
10467421|NCT01063283|11615504|FG000|NOT COMPLETED|Cycle 1||3
10467422|NCT01063283|11615505|FG001|NOT COMPLETED|Cycle 1||0
10467423|NCT01063283|11615506|FG002|NOT COMPLETED|Cycle 1||0
10467424|NCT01063283|11615504|FG000|STARTED|Randomized Phase (Cycle 2 and Beyond)||0
10467425|NCT01063283|11615505|FG001|STARTED|Randomized Phase (Cycle 2 and Beyond)||6
10467426|NCT01063283|11615506|FG002|STARTED|Randomized Phase (Cycle 2 and Beyond)||11
10467427|NCT01063283|11615504|FG000|COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
10467428|NCT01063283|11615505|FG001|COMPLETED|Randomized Phase (Cycle 2 and Beyond)||6
10467429|NCT01063283|11615506|FG002|COMPLETED|Randomized Phase (Cycle 2 and Beyond)||11
10467430|NCT01063283|11615504|FG000|NOT COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
10467431|NCT01063283|11615505|FG001|NOT COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
10467432|NCT01063283|11615506|FG002|NOT COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
10467433|NCT01063348|11615514|FG000|STARTED|Overall Study||35
10467434|NCT01063348|11615515|FG001|STARTED|Overall Study||31
10467435|NCT01063348|11615514|FG000|COMPLETED|Overall Study||32
10467436|NCT01063348|11615515|FG001|COMPLETED|Overall Study||21
10467437|NCT01063348|11615514|FG000|NOT COMPLETED|Overall Study||3
10467438|NCT01063348|11615515|FG001|NOT COMPLETED|Overall Study||10
10467439|NCT01063595|11615521|FG000|STARTED|Enrolled in Study and Randomized||32
10467440|NCT01063595|11615522|FG001|STARTED|Enrolled in Study and Randomized||31
10467441|NCT01063595|11615521|FG000|Received Treatment|Enrolled in Study and Randomized||31
10467442|NCT01063595|11615522|FG001|Received Treatment|Enrolled in Study and Randomized||29
10467443|NCT01063595|11615521|FG000|COMPLETED|Enrolled in Study and Randomized||31
10467444|NCT01063595|11615522|FG001|COMPLETED|Enrolled in Study and Randomized||29
10467445|NCT01063595|11615521|FG000|NOT COMPLETED|Enrolled in Study and Randomized||1
10467446|NCT01063595|11615522|FG001|NOT COMPLETED|Enrolled in Study and Randomized||2
10467447|NCT01063595|11615521|FG000|STARTED|First Intervention||31
10467448|NCT01063595|11615522|FG001|STARTED|First Intervention||29
10467449|NCT01063595|11615521|FG000|COMPLETED|First Intervention||29
10467450|NCT01063595|11615522|FG001|COMPLETED|First Intervention||24
10467451|NCT01063595|11615521|FG000|NOT COMPLETED|First Intervention||2
10467452|NCT01063595|11615522|FG001|NOT COMPLETED|First Intervention||5
10467453|NCT01063595|11615521|FG000|STARTED|Second Intervention||29
10467454|NCT01063595|11615522|FG001|STARTED|Second Intervention||24
10467455|NCT01063595|11615521|FG000|COMPLETED|Second Intervention||29
10467456|NCT01063595|11615522|FG001|COMPLETED|Second Intervention||24
10467457|NCT01063595|11615521|FG000|NOT COMPLETED|Second Intervention||0
10467458|NCT01063595|11615522|FG001|NOT COMPLETED|Second Intervention||0
10467459|NCT01063712|11615528|FG000|STARTED|Overall Study||29
10467460|NCT01063712|11615528|FG000|COMPLETED|Overall Study||29
10467461|NCT01063712|11615528|FG000|NOT COMPLETED|Overall Study||0
10467462|NCT01063764|11615533|FG000|STARTED|1st Period (From Week 8 to Week 22)||73
10467463|NCT01063764|11615533|FG000|COMPLETED|1st Period (From Week 8 to Week 22)|62 subjects completed the First Period, but 7 of these subjects did not enter the Second Period.|62
10467464|NCT01063764|11615533|FG000|NOT COMPLETED|1st Period (From Week 8 to Week 22)||11
10467465|NCT01063764|11615533|FG000|STARTED|2nd Period (Week 22 to the End of Study)|7 subjects who completed Period 1 did not enter the Second Period.|55
10467466|NCT01063764|11615533|FG000|COMPLETED|2nd Period (Week 22 to the End of Study)||35
10467467|NCT01063764|11615533|FG000|NOT COMPLETED|2nd Period (Week 22 to the End of Study)||20
10467468|NCT01063829|11615541|FG000|STARTED|Overall Study||33
10467469|NCT01063829|11615542|FG001|STARTED|Overall Study||31
10467470|NCT01063829|11615543|FG002|STARTED|Overall Study||34
10467471|NCT01063829|11615544|FG003|STARTED|Overall Study||33
10467472|NCT01063829|11615541|FG000|COMPLETED|Overall Study|Non-completers considered as failure; FAS|17
10467473|NCT01063829|11615542|FG001|COMPLETED|Overall Study|Non-completers considered as failure; FAS|21
10467474|NCT01063829|11615543|FG002|COMPLETED|Overall Study|Non-completers considered as failure; FAS|24
10467475|NCT01063829|11615544|FG003|COMPLETED|Overall Study|Non-completers considered as failure; FAS|12
10467476|NCT01063829|11615541|FG000|NOT COMPLETED|Overall Study||16
10467477|NCT01063829|11615542|FG001|NOT COMPLETED|Overall Study||10
10467478|NCT01063829|11615543|FG002|NOT COMPLETED|Overall Study||10
10467479|NCT01063829|11615544|FG003|NOT COMPLETED|Overall Study||21
10467480|NCT01063855|11615556|FG000|STARTED|Overall Study||245
10467481|NCT01063855|11615557|FG001|STARTED|Overall Study||250
10467482|NCT01063855|11615556|FG000|COMPLETED|Overall Study||208
10467483|NCT01063855|11615557|FG001|COMPLETED|Overall Study||221
10467484|NCT01063855|11615556|FG000|NOT COMPLETED|Overall Study||37
10467485|NCT01063855|11615557|FG001|NOT COMPLETED|Overall Study||29
10467486|NCT01063868|11615569|FG000|STARTED|Overall Study||35
10467487|NCT01063868|11615570|FG001|STARTED|Overall Study||12
10467488|NCT01063868|11615569|FG000|COMPLETED|Overall Study||0
10467489|NCT01063868|11615570|FG001|COMPLETED|Overall Study||0
10467490|NCT01063868|11615569|FG000|NOT COMPLETED|Overall Study||35
10467491|NCT01063868|11615570|FG001|NOT COMPLETED|Overall Study||12
10467492|NCT01063881|11615579|FG000|STARTED|Overall Study||147
10467493|NCT01063881|11615580|FG001|STARTED|Overall Study||125
10467494|NCT01063881|11615581|FG002|STARTED|Overall Study||13
10467495|NCT01063881|11615579|FG000|COMPLETED|Overall Study||92
10467496|NCT01063881|11615580|FG001|COMPLETED|Overall Study||114
10467497|NCT01063881|11615581|FG002|COMPLETED|Overall Study||12
10467498|NCT01063881|11615579|FG000|NOT COMPLETED|Overall Study||55
10467499|NCT01063881|11615580|FG001|NOT COMPLETED|Overall Study||11
10467500|NCT01063881|11615581|FG002|NOT COMPLETED|Overall Study||1
10467501|NCT01063907|11615596|FG000|STARTED|Overall Study||15
10467502|NCT01063907|11615597|FG001|STARTED|Overall Study||80
10467503|NCT01063907|11615596|FG000|COMPLETED|Overall Study||15
10467504|NCT01063907|11615597|FG001|COMPLETED|Overall Study||80
10467505|NCT01063907|11615596|FG000|NOT COMPLETED|Overall Study||0
10467506|NCT01063907|11615597|FG001|NOT COMPLETED|Overall Study||0
10467507|NCT01063972|11615621|FG000|STARTED|Overall Study||310
10467508|NCT01063972|11615622|FG001|STARTED|Overall Study||296
10467509|NCT01063972|11615621|FG000|COMPLETED|Overall Study|Participants who were deceased or incarcerated were excluded.|296
10467510|NCT01063972|11615622|FG001|COMPLETED|Overall Study|Participants who were deceased or incarcerated were excluded.|284
10467511|NCT01063972|11615621|FG000|NOT COMPLETED|Overall Study||14
10467512|NCT01063972|11615622|FG001|NOT COMPLETED|Overall Study||12
10467513|NCT01064076|11615628|FG000|STARTED|Overall Study|321 subjects underwent an implant procedure for the S-ICD System|321
10467514|NCT01064076|11615628|FG000|COMPLETED|Overall Study|303 subjects completed a minimum of 180 days of follow up|303
10467515|NCT01064076|11615628|FG000|NOT COMPLETED|Overall Study||18
10467516|NCT01064167|11615635|FG000|STARTED|Overall Study||130
10467517|NCT01064167|11615636|FG001|STARTED|Overall Study||130
10467518|NCT01064167|11615635|FG000|COMPLETED|Overall Study||116
10467519|NCT01064167|11615636|FG001|COMPLETED|Overall Study||115
10467520|NCT01064167|11615635|FG000|NOT COMPLETED|Overall Study||14
10467521|NCT01064167|11615636|FG001|NOT COMPLETED|Overall Study||15
10467522|NCT01064284|11615644|FG000|STARTED|Overall Study|Taking into account the analyzed patients only|125
10467523|NCT01064284|11615645|FG001|STARTED|Overall Study|Taking into account the analyzed patients only|126
10467524|NCT01064284|11615644|FG000|COMPLETED|Overall Study||107
10467525|NCT01064284|11615645|FG001|COMPLETED|Overall Study||109
10467526|NCT01064284|11615644|FG000|NOT COMPLETED|Overall Study||18
10467527|NCT01064284|11615645|FG001|NOT COMPLETED|Overall Study||17
10467528|NCT01064297|11615655|FG000|STARTED|Overall Study||2567
10467529|NCT01064297|11615656|FG001|STARTED|Overall Study||219
10467530|NCT01064297|11615657|FG002|STARTED|Overall Study||630
10467531|NCT01064297|11615655|FG000|COMPLETED|Overall Study||1776
10467532|NCT01064297|11615656|FG001|COMPLETED|Overall Study||171
10467533|NCT01064297|11615657|FG002|COMPLETED|Overall Study||497
10467534|NCT01064297|11615655|FG000|NOT COMPLETED|Overall Study||791
10467535|NCT01064297|11615656|FG001|NOT COMPLETED|Overall Study||48
10467536|NCT01064297|11615657|FG002|NOT COMPLETED|Overall Study||133
10467537|NCT01064310|11615674|FG000|STARTED|Period 1||82
10467538|NCT01064310|11615675|FG001|STARTED|Period 1||86
10467539|NCT01064310|11615676|FG002|STARTED|Period 1||0
10467540|NCT01064310|11615674|FG000|COMPLETED|Period 1||68
10467541|NCT01064310|11615675|FG001|COMPLETED|Period 1||68
10467542|NCT01064310|11615676|FG002|COMPLETED|Period 1||0
10467543|NCT01064310|11615674|FG000|NOT COMPLETED|Period 1||14
10467544|NCT01064310|11615675|FG001|NOT COMPLETED|Period 1||18
10467545|NCT01064310|11615676|FG002|NOT COMPLETED|Period 1||0
10467546|NCT01064310|11615674|FG000|STARTED|Period 2||68
10467547|NCT01064310|11615675|FG001|STARTED|Period 2||68
10467548|NCT01064310|11615676|FG002|STARTED|Period 2||0
10467549|NCT01064310|11615674|FG000|COMPLETED|Period 2||64
10467550|NCT01064310|11615675|FG001|COMPLETED|Period 2||62
10467551|NCT01064310|11615676|FG002|COMPLETED|Period 2||0
10467552|NCT01064310|11615674|FG000|NOT COMPLETED|Period 2||4
10467553|NCT01064310|11615675|FG001|NOT COMPLETED|Period 2||6
10467554|NCT01064310|11615676|FG002|NOT COMPLETED|Period 2||0
10467555|NCT01064310|11615674|FG000|STARTED|Open Label Pazopinib||0
10467556|NCT01064310|11615675|FG001|STARTED|Open Label Pazopinib||0
10467557|NCT01064310|11615676|FG002|STARTED|Open Label Pazopinib||84
10467558|NCT01064310|11615674|FG000|COMPLETED|Open Label Pazopinib||0
10467559|NCT01064310|11615675|FG001|COMPLETED|Open Label Pazopinib||0
10467560|NCT01064310|11615676|FG002|COMPLETED|Open Label Pazopinib||0
10467561|NCT01064310|11615674|FG000|NOT COMPLETED|Open Label Pazopinib||0
10467562|NCT01064310|11615675|FG001|NOT COMPLETED|Open Label Pazopinib||0
10467563|NCT01064310|11615676|FG002|NOT COMPLETED|Open Label Pazopinib||84
10526584|NCT01382719|11678484|FG000|Subjects Not Dosed|Overall Study||1
10526585|NCT01382719|11678485|FG001|Subjects Not Dosed|Overall Study||0
10526586|NCT01382719|11678486|FG002|Subjects Not Dosed|Overall Study||1
10526587|NCT01382719|11678487|FG003|Subjects Not Dosed|Overall Study||1
10526588|NCT01382719|11678484|FG000|COMPLETED|Overall Study||80
10526589|NCT01382719|11678485|FG001|COMPLETED|Overall Study||81
10526590|NCT01382719|11678486|FG002|COMPLETED|Overall Study||66
10526591|NCT01382719|11678487|FG003|COMPLETED|Overall Study||66
10526592|NCT01382719|11678484|FG000|NOT COMPLETED|Overall Study||18
10526593|NCT01382719|11678485|FG001|NOT COMPLETED|Overall Study||19
10526594|NCT01382719|11678486|FG002|NOT COMPLETED|Overall Study||34
10526595|NCT01382719|11678487|FG003|NOT COMPLETED|Overall Study||33
10526596|NCT01382901|11678499|FG000|STARTED|Overall Study||24
10526597|NCT01382901|11678500|FG001|STARTED|Overall Study||21
10526598|NCT01382901|11678499|FG000|COMPLETED|Overall Study||7
10526599|NCT01382901|11678500|FG001|COMPLETED|Overall Study||7
10526600|NCT01382901|11678499|FG000|NOT COMPLETED|Overall Study||17
10526601|NCT01382901|11678500|FG001|NOT COMPLETED|Overall Study||14
10526602|NCT01382940|11678506|FG000|STARTED|Overall Study||351
10526603|NCT01382940|11678506|FG000|Received Day 1 Infusion|Overall Study||351
10526604|NCT01382940|11678506|FG000|Received Day 15 Infusions|Overall Study||341
10526605|NCT01382940|11678506|FG000|Received Day 168 Infusion|Overall Study||290
10526606|NCT01382940|11678506|FG000|Received Day 182 Infusion|Overall Study||278
10526607|NCT01382940|11678506|FG000|COMPLETED|Overall Study||278
10708638|NCT02632747|11873501|FG001|STARTED|Treatment Period 2||15
10708639|NCT02632747|11873500|FG000|COMPLETED|Treatment Period 2||15
10708640|NCT02632747|11873501|FG001|COMPLETED|Treatment Period 2||15
10526608|NCT01382940|11678506|FG000|NOT COMPLETED|Overall Study||73
10526609|NCT01383005|11678512|FG000|STARTED|Overall Study||34
10526610|NCT01383005|11678513|FG001|STARTED|Overall Study||60
10526611|NCT01383005|11678512|FG000|COMPLETED|Overall Study||34
10526612|NCT01383005|11678513|FG001|COMPLETED|Overall Study||60
10526613|NCT01383005|11678512|FG000|NOT COMPLETED|Overall Study||0
10526614|NCT01383005|11678513|FG001|NOT COMPLETED|Overall Study||0
10526615|NCT01383018|11678519|FG000|STARTED|Overall Study||1457
10708641|NCT02632747|11873500|FG000|NOT COMPLETED|Treatment Period 2||0
10708642|NCT02632747|11873501|FG001|NOT COMPLETED|Treatment Period 2||0
10708643|NCT02632786|11873509|FG000|STARTED|Overall Study||66
10526616|NCT01383018|11678519|FG000|COMPLETED|Overall Study||1082
10526617|NCT01383018|11678519|FG000|NOT COMPLETED|Overall Study||375
10526618|NCT01383096|11678536|FG000|STARTED|First Intervention (8 Days)||19
10526619|NCT01383096|11678537|FG001|STARTED|First Intervention (8 Days)||17
10526620|NCT01383096|11678538|FG002|STARTED|First Intervention (8 Days)||16
10708644|NCT02632786|11873510|FG001|STARTED|Overall Study||63
10809642|NCT03831191|11971474|FG005|NOT COMPLETED|Maintenance Period (36 Weeks)||5
10809643|NCT03831191|11971475|FG006|NOT COMPLETED|Maintenance Period (36 Weeks)||2
10809644|NCT03831191|11971476|FG007|NOT COMPLETED|Maintenance Period (36 Weeks)||4
10809645|NCT03831191|11971477|FG008|NOT COMPLETED|Maintenance Period (36 Weeks)||8
10809646|NCT03831191|11971478|FG009|NOT COMPLETED|Maintenance Period (36 Weeks)||1
10809647|NCT03831191|11971479|FG010|NOT COMPLETED|Maintenance Period (36 Weeks)||4
10809648|NCT03831191|11971480|FG011|NOT COMPLETED|Maintenance Period (36 Weeks)||7
10809649|NCT03831191|11971481|FG012|NOT COMPLETED|Maintenance Period (36 Weeks)||1
10809650|NCT03831191|11971482|FG013|NOT COMPLETED|Maintenance Period (36 Weeks)||1
10809651|NCT03831191|11971483|FG014|NOT COMPLETED|Maintenance Period (36 Weeks)||9
10809652|NCT03831191|11971469|FG000|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
10809653|NCT03831191|11971470|FG001|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
10809654|NCT03831191|11971471|FG002|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
10809655|NCT03831191|11971472|FG003|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
10809656|NCT03831191|11971473|FG004|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
10809657|NCT03831191|11971474|FG005|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
10809658|NCT03831191|11971475|FG006|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
10809659|NCT03831191|11971476|FG007|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
10809660|NCT03831191|11971477|FG008|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
10809661|NCT03831191|11971478|FG009|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
10809662|NCT03831191|11971479|FG010|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
10809663|NCT03831191|11971480|FG011|STARTED|Post-Treatment Follow-Up Period(8 Weeks)|No participant entered the post follow-up period.|0
10809664|NCT03831191|11971481|FG012|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
10809665|NCT03831191|11971482|FG013|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
10809666|NCT03831191|11971483|FG014|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
10809667|NCT03831191|11971469|FG000|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10809668|NCT03831191|11971470|FG001|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10809669|NCT03831191|11971471|FG002|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10809670|NCT03831191|11971472|FG003|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10809671|NCT03831191|11971473|FG004|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10809672|NCT03831191|11971474|FG005|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10809673|NCT03831191|11971475|FG006|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10809674|NCT03831191|11971476|FG007|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10809675|NCT03831191|11971477|FG008|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10809676|NCT03831191|11971478|FG009|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10809677|NCT03831191|11971479|FG010|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10809678|NCT03831191|11971480|FG011|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10809679|NCT03831191|11971481|FG012|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10809680|NCT03831191|11971482|FG013|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10809681|NCT03831191|11971483|FG014|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10809682|NCT03831191|11971469|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10809683|NCT03831191|11971470|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10809684|NCT03831191|11971471|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10809685|NCT03831191|11971472|FG003|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10809686|NCT03831191|11971473|FG004|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10809687|NCT03831191|11971474|FG005|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10809688|NCT03831191|11971475|FG006|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10809689|NCT03831191|11971476|FG007|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10809690|NCT03831191|11971477|FG008|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10809691|NCT03831191|11971478|FG009|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10809692|NCT03831191|11971479|FG010|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10809693|NCT03831191|11971480|FG011|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10809694|NCT03831191|11971481|FG012|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10809695|NCT03831191|11971482|FG013|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10809696|NCT03831191|11971483|FG014|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
10809697|NCT03830281|11971518|FG000|STARTED|Lead-in Period (2 Weeks)||471
10809698|NCT03830281|11971519|FG001|STARTED|Lead-in Period (2 Weeks)||0
10809699|NCT03830281|11971518|FG000|COMPLETED|Lead-in Period (2 Weeks)||432
10809700|NCT03830281|11971519|FG001|COMPLETED|Lead-in Period (2 Weeks)||0
10809701|NCT03830281|11971518|FG000|NOT COMPLETED|Lead-in Period (2 Weeks)||39
10809702|NCT03830281|11971519|FG001|NOT COMPLETED|Lead-in Period (2 Weeks)||0
10809703|NCT03830281|11971518|FG000|STARTED|Treatment Period (16 Weeks)|Pts who completed lead-in period randomized to Humalog or Ultra-Rapid Lispro in treatment period.|217
10809704|NCT03830281|11971519|FG001|STARTED|Treatment Period (16 Weeks)|Pts who completed lead-in period randomized to Humalog or Ultra-Rapid Lispro in treatment period.|215
10708645|NCT02632786|11873509|FG000|Informed Consent Obtained|Overall Study||66
10708646|NCT02632786|11873510|FG001|Informed Consent Obtained|Overall Study||63
10708647|NCT02632786|11873509|FG000|Randomized and Dosed|Overall Study||66
10708648|NCT02632786|11873510|FG001|Randomized and Dosed|Overall Study||63
10708649|NCT02632786|11873509|FG000|COMPLETED|Overall Study||55
10809705|NCT03830281|11971518|FG000|COMPLETED|Treatment Period (16 Weeks)||205
10809706|NCT03830281|11971519|FG001|COMPLETED|Treatment Period (16 Weeks)||198
10809707|NCT03830281|11971518|FG000|NOT COMPLETED|Treatment Period (16 Weeks)||12
10809708|NCT03830281|11971519|FG001|NOT COMPLETED|Treatment Period (16 Weeks)||17
10809709|NCT03828734|11971526|FG000|STARTED|Baseline||32
10809710|NCT03828734|11971527|FG001|STARTED|Baseline||26
10809711|NCT03828734|11971526|FG000|COMPLETED|Baseline||32
10809712|NCT03828734|11971527|FG001|COMPLETED|Baseline||26
10809713|NCT03828734|11971526|FG000|NOT COMPLETED|Baseline||0
10809714|NCT03828734|11971527|FG001|NOT COMPLETED|Baseline||0
10809715|NCT03828734|11971526|FG000|STARTED|Pre-Randomization (1 Week)||32
10809716|NCT03828734|11971527|FG001|STARTED|Pre-Randomization (1 Week)||26
10809717|NCT03828734|11971526|FG000|COMPLETED|Pre-Randomization (1 Week)||29
10809718|NCT03828734|11971527|FG001|COMPLETED|Pre-Randomization (1 Week)||25
10809719|NCT03828734|11971526|FG000|NOT COMPLETED|Pre-Randomization (1 Week)||3
10809720|NCT03828734|11971527|FG001|NOT COMPLETED|Pre-Randomization (1 Week)||1
10809721|NCT03828734|11971526|FG000|STARTED|First Intervention||29
10809722|NCT03828734|11971527|FG001|STARTED|First Intervention||25
10809723|NCT03828734|11971526|FG000|COMPLETED|First Intervention||25
10809724|NCT03828734|11971527|FG001|COMPLETED|First Intervention||25
10809725|NCT03828734|11971526|FG000|NOT COMPLETED|First Intervention||4
10809726|NCT03828734|11971527|FG001|NOT COMPLETED|First Intervention||0
10809727|NCT03828734|11971526|FG000|STARTED|First Washout (1 Week)||25
10809728|NCT03828734|11971527|FG001|STARTED|First Washout (1 Week)||25
10809729|NCT03828734|11971526|FG000|COMPLETED|First Washout (1 Week)||25
10809730|NCT03828734|11971527|FG001|COMPLETED|First Washout (1 Week)||24
10809731|NCT03828734|11971526|FG000|NOT COMPLETED|First Washout (1 Week)||0
10809732|NCT03828734|11971527|FG001|NOT COMPLETED|First Washout (1 Week)||1
10809733|NCT03828734|11971526|FG000|STARTED|Second Intervention||25
10809734|NCT03828734|11971527|FG001|STARTED|Second Intervention||24
10809735|NCT03828734|11971526|FG000|COMPLETED|Second Intervention||25
10809736|NCT03828734|11971527|FG001|COMPLETED|Second Intervention||24
10809737|NCT03828734|11971526|FG000|NOT COMPLETED|Second Intervention||0
10809738|NCT03828734|11971527|FG001|NOT COMPLETED|Second Intervention||0
10809739|NCT03827395|11971535|FG000|STARTED|Overall Study||20
10809740|NCT03827395|11971536|FG001|STARTED|Overall Study||5
10809741|NCT03827395|11971535|FG000|COMPLETED|Overall Study||17
10809742|NCT03827395|11971536|FG001|COMPLETED|Overall Study||3
10809743|NCT03827395|11971535|FG000|NOT COMPLETED|Overall Study||3
10708650|NCT02632786|11873510|FG001|COMPLETED|Overall Study||56
10708651|NCT02632786|11873509|FG000|NOT COMPLETED|Overall Study||11
10708652|NCT02632786|11873510|FG001|NOT COMPLETED|Overall Study||7
10708653|NCT02632812|11873519|FG000|STARTED|Overall Study||12
10708654|NCT02632812|11873520|FG001|STARTED|Overall Study||12
10708655|NCT02632812|11873519|FG000|COMPLETED|Overall Study||12
10708656|NCT02632812|11873520|FG001|COMPLETED|Overall Study||12
10708657|NCT02632812|11873519|FG000|NOT COMPLETED|Overall Study||0
10708658|NCT02632812|11873520|FG001|NOT COMPLETED|Overall Study||0
10708659|NCT02632838|11873528|FG000|STARTED|Overall Study||15
10708660|NCT02632838|11873529|FG001|STARTED|Overall Study||15
10708661|NCT02632838|11873528|FG000|COMPLETED|Overall Study||12
10708662|NCT02632838|11873529|FG001|COMPLETED|Overall Study||13
10809744|NCT03827395|11971536|FG001|NOT COMPLETED|Overall Study||2
10809745|NCT03819218|11971542|FG000|STARTED|Overall Study||7
10809746|NCT03819218|11971542|FG000|COMPLETED|Overall Study||6
10809747|NCT03819218|11971542|FG000|NOT COMPLETED|Overall Study||1
10809748|NCT03818815|11971548|FG000|STARTED|Overall Study||56
10809749|NCT03818815|11971549|FG001|STARTED|Overall Study||47
10809750|NCT03818815|11971548|FG000|COMPLETED|Overall Study||48
10809751|NCT03818815|11971549|FG001|COMPLETED|Overall Study||42
10809752|NCT03818815|11971548|FG000|NOT COMPLETED|Overall Study||8
10809753|NCT03818815|11971549|FG001|NOT COMPLETED|Overall Study||5
10809754|NCT03828487|11971555|FG000|STARTED|Overall Study||8
10809755|NCT03828487|11971555|FG000|COMPLETED|Overall Study||7
10809756|NCT03828487|11971555|FG000|NOT COMPLETED|Overall Study||1
10809757|NCT03828617|11971563|FG000|STARTED|Overall Study||489
10809758|NCT03828617|11971564|FG001|STARTED|Overall Study||490
10809759|NCT03828617|11971565|FG002|STARTED|Overall Study||486
10809760|NCT03828617|11971566|FG003|STARTED|Overall Study||245
10809761|NCT03828617|11971563|FG000|Vaccinated|Overall Study||488
10809762|NCT03828617|11971564|FG001|Vaccinated|Overall Study||489
10809763|NCT03828617|11971565|FG002|Vaccinated|Overall Study||486
10809764|NCT03828617|11971566|FG003|Vaccinated|Overall Study||245
10809765|NCT03828617|11971563|FG000|Safety Population|Overall Study||488
10708663|NCT02632838|11873528|FG000|NOT COMPLETED|Overall Study||3
10809766|NCT03828617|11971564|FG001|Safety Population|Overall Study||489
10809767|NCT03828617|11971565|FG002|Safety Population|Overall Study||486
10809768|NCT03828617|11971566|FG003|Safety Population|Overall Study||245
10809769|NCT03828617|11971563|FG000|Evaluable Immunogenicity Population(EIP)|Overall Study||463
10809770|NCT03828617|11971564|FG001|Evaluable Immunogenicity Population(EIP)|Overall Study||473
10809771|NCT03828617|11971565|FG002|Evaluable Immunogenicity Population(EIP)|Overall Study||456
10809772|NCT03828617|11971566|FG003|Evaluable Immunogenicity Population(EIP)|Overall Study||232
10809773|NCT03828617|11971563|FG000|COMPLETED|Overall Study||465
10809774|NCT03828617|11971564|FG001|COMPLETED|Overall Study||475
10809775|NCT03828617|11971565|FG002|COMPLETED|Overall Study||460
10809776|NCT03828617|11971566|FG003|COMPLETED|Overall Study||235
10708664|NCT02632838|11873529|FG001|NOT COMPLETED|Overall Study||2
10708665|NCT02633020|11873541|FG000|STARTED|Overall Study||19
10708666|NCT02633020|11873542|FG001|STARTED|Overall Study||9
10809777|NCT03828617|11971563|FG000|NOT COMPLETED|Overall Study||24
10809778|NCT03828617|11971564|FG001|NOT COMPLETED|Overall Study||15
10809779|NCT03828617|11971565|FG002|NOT COMPLETED|Overall Study||26
10809780|NCT03828617|11971566|FG003|NOT COMPLETED|Overall Study||10
10809781|NCT03828539|11971577|FG000|STARTED|Overall Study||389
10809782|NCT03828539|11971578|FG001|STARTED|Overall Study||388
10809783|NCT03828539|11971577|FG000|Full Analysis Set (FAS)|Overall Study||388
10809784|NCT03828539|11971578|FG001|Full Analysis Set (FAS)|Overall Study||388
10809785|NCT03828539|11971577|FG000|Safety Analysis Set (SAF)|Overall Study||388
10809786|NCT03828539|11971578|FG001|Safety Analysis Set (SAF)|Overall Study||388
10809787|NCT03828539|11971577|FG000|COMPLETED|Overall Study||373
10809788|NCT03828539|11971578|FG001|COMPLETED|Overall Study||366
10809789|NCT03828539|11971577|FG000|NOT COMPLETED|Overall Study||16
10809790|NCT03828539|11971578|FG001|NOT COMPLETED|Overall Study||22
10809791|NCT03824704|11971584|FG000|STARTED|Overall Study||1
10809792|NCT03824704|11971584|FG000|COMPLETED|Overall Study||0
10809793|NCT03824704|11971584|FG000|NOT COMPLETED|Overall Study||1
10809794|NCT03823937|11971590|FG000|STARTED|Overall Study||30
10809795|NCT03823937|11971591|FG001|STARTED|Overall Study||20
10809796|NCT03823937|11971590|FG000|COMPLETED|Overall Study||30
10809797|NCT03823937|11971591|FG001|COMPLETED|Overall Study||20
10809798|NCT03823937|11971590|FG000|NOT COMPLETED|Overall Study||0
10809799|NCT03823937|11971591|FG001|NOT COMPLETED|Overall Study||0
10809800|NCT03817879|11971599|FG000|STARTED|Overall Study||35
10809801|NCT03817879|11971600|FG001|STARTED|Overall Study||35
10809802|NCT03817879|11971599|FG000|COMPLETED|Overall Study||30
10809803|NCT03817879|11971600|FG001|COMPLETED|Overall Study||22
10809804|NCT03817879|11971599|FG000|NOT COMPLETED|Overall Study||5
10809805|NCT03817879|11971600|FG001|NOT COMPLETED|Overall Study||13
10809806|NCT03811834|11971606|FG000|STARTED|Period 1 ( 7 Days)||7
10809807|NCT03811834|11971606|FG000|COMPLETED|Period 1 ( 7 Days)||6
10526621|NCT01383096|11678536|FG000|COMPLETED|First Intervention (8 Days)||19
10526622|NCT01383096|11678537|FG001|COMPLETED|First Intervention (8 Days)||17
10526623|NCT01383096|11678538|FG002|COMPLETED|First Intervention (8 Days)||16
10526624|NCT01383096|11678536|FG000|NOT COMPLETED|First Intervention (8 Days)||0
10526625|NCT01383096|11678537|FG001|NOT COMPLETED|First Intervention (8 Days)||0
10708667|NCT02633020|11873541|FG000|COMPLETED|Overall Study||18
10708668|NCT02633020|11873542|FG001|COMPLETED|Overall Study||9
10708669|NCT02633020|11873541|FG000|NOT COMPLETED|Overall Study||1
10708670|NCT02633020|11873542|FG001|NOT COMPLETED|Overall Study||0
10708671|NCT02633046|11873548|FG000|STARTED|Overall Study||63
10526626|NCT01383096|11678538|FG002|NOT COMPLETED|First Intervention (8 Days)||0
10526627|NCT01383096|11678536|FG000|STARTED|Second Intervention (8 Days)||19
10526628|NCT01383096|11678537|FG001|STARTED|Second Intervention (8 Days)||17
10526629|NCT01383096|11678538|FG002|STARTED|Second Intervention (8 Days)||16
10526630|NCT01383096|11678536|FG000|COMPLETED|Second Intervention (8 Days)||19
10526631|NCT01383096|11678537|FG001|COMPLETED|Second Intervention (8 Days)||16
10526632|NCT01383096|11678538|FG002|COMPLETED|Second Intervention (8 Days)||14
10526633|NCT01383096|11678536|FG000|NOT COMPLETED|Second Intervention (8 Days)||0
10526634|NCT01383096|11678537|FG001|NOT COMPLETED|Second Intervention (8 Days)||1
10526635|NCT01383096|11678538|FG002|NOT COMPLETED|Second Intervention (8 Days)||2
10526636|NCT01383096|11678536|FG000|STARTED|Third Intervention (8 Days)||19
10526637|NCT01383096|11678537|FG001|STARTED|Third Intervention (8 Days)||16
10526638|NCT01383096|11678538|FG002|STARTED|Third Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
10526639|NCT01383096|11678536|FG000|COMPLETED|Third Intervention (8 Days)||15
10526640|NCT01383096|11678537|FG001|COMPLETED|Third Intervention (8 Days)||12
10526641|NCT01383096|11678538|FG002|COMPLETED|Third Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
10526642|NCT01383096|11678536|FG000|NOT COMPLETED|Third Intervention (8 Days)||4
10526643|NCT01383096|11678537|FG001|NOT COMPLETED|Third Intervention (8 Days)||4
10526644|NCT01383096|11678538|FG002|NOT COMPLETED|Third Intervention (8 Days)||0
10526645|NCT01383096|11678536|FG000|STARTED|Fourth Intervention (8 Days)||15
10526646|NCT01383096|11678537|FG001|STARTED|Fourth Intervention (8 Days)||12
10526647|NCT01383096|11678538|FG002|STARTED|Fourth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
10526648|NCT01383096|11678536|FG000|COMPLETED|Fourth Intervention (8 Days)||13
10526649|NCT01383096|11678537|FG001|COMPLETED|Fourth Intervention (8 Days)||12
10526650|NCT01383096|11678538|FG002|COMPLETED|Fourth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
10526651|NCT01383096|11678536|FG000|NOT COMPLETED|Fourth Intervention (8 Days)||2
10526652|NCT01383096|11678537|FG001|NOT COMPLETED|Fourth Intervention (8 Days)||0
10526653|NCT01383096|11678538|FG002|NOT COMPLETED|Fourth Intervention (8 Days)||0
10526654|NCT01383096|11678536|FG000|STARTED|Fifth Intervention (8 Days)||13
10526655|NCT01383096|11678537|FG001|STARTED|Fifth Intervention (8 Days)|Only 4 interventions in Cohort 2.|0
10526656|NCT01383096|11678538|FG002|STARTED|Fifth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
10526657|NCT01383096|11678536|FG000|COMPLETED|Fifth Intervention (8 Days)||11
10526658|NCT01383096|11678537|FG001|COMPLETED|Fifth Intervention (8 Days)|Only 4 interventions in Cohort 2.|0
10526659|NCT01383096|11678538|FG002|COMPLETED|Fifth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
10708672|NCT02633046|11873548|FG000|Safety Population|Overall Study||63
10708673|NCT02633046|11873548|FG000|COMPLETED|Overall Study||36
10526660|NCT01383096|11678536|FG000|NOT COMPLETED|Fifth Intervention (8 Days)||2
10526661|NCT01383096|11678537|FG001|NOT COMPLETED|Fifth Intervention (8 Days)||0
10526662|NCT01383096|11678538|FG002|NOT COMPLETED|Fifth Intervention (8 Days)||0
10708674|NCT02633046|11873548|FG000|NOT COMPLETED|Overall Study||27
10809808|NCT03811834|11971606|FG000|NOT COMPLETED|Period 1 ( 7 Days)||1
10809809|NCT03811834|11971606|FG000|STARTED|Washout Period (9 Days)||6
10809810|NCT03811834|11971606|FG000|COMPLETED|Washout Period (9 Days)||6
10809811|NCT03811834|11971606|FG000|NOT COMPLETED|Washout Period (9 Days)||0
10809812|NCT03811834|11971606|FG000|STARTED|Period 2 (10 Days)||6
10467749|NCT01064323|11615906|FG000|STARTED|Overall Study||10
10467750|NCT01064323|11615906|FG000|COMPLETED|Overall Study||10
10467751|NCT01064323|11615906|FG000|NOT COMPLETED|Overall Study||0
10467752|NCT01064362|11615912|FG000|STARTED|Overall Study||1559
10467753|NCT01064362|11615913|FG001|STARTED|Overall Study||11883
10467754|NCT01064362|11615912|FG000|COMPLETED|Overall Study||1559
10467755|NCT01064362|11615913|FG001|COMPLETED|Overall Study||11883
10467756|NCT01064362|11615912|FG000|NOT COMPLETED|Overall Study||0
10467757|NCT01064362|11615913|FG001|NOT COMPLETED|Overall Study||0
10467758|NCT01064401|11615921|FG000|STARTED|Overall Study||922
10467759|NCT01064401|11615922|FG001|STARTED|Overall Study||919
10467760|NCT01064401|11615921|FG000|COMPLETED|Overall Study||694
10467761|NCT01064401|11615922|FG001|COMPLETED|Overall Study||724
10467762|NCT01064401|11615921|FG000|NOT COMPLETED|Overall Study||228
10467763|NCT01064401|11615922|FG001|NOT COMPLETED|Overall Study||195
10467764|NCT01064414|11615932|FG000|STARTED|Core Period: Baseline to Week 26||90
10467765|NCT01064414|11615933|FG001|STARTED|Core Period: Baseline to Week 26||90
10467766|NCT01064414|11615934|FG002|STARTED|Core Period: Baseline to Week 26||89
10467767|NCT01064414|11615932|FG000|COMPLETED|Core Period: Baseline to Week 26||77
10467768|NCT01064414|11615933|FG001|COMPLETED|Core Period: Baseline to Week 26||75
10467769|NCT01064414|11615934|FG002|COMPLETED|Core Period: Baseline to Week 26||82
10467770|NCT01064414|11615932|FG000|NOT COMPLETED|Core Period: Baseline to Week 26||13
10467771|NCT01064414|11615933|FG001|NOT COMPLETED|Core Period: Baseline to Week 26||15
10467772|NCT01064414|11615934|FG002|NOT COMPLETED|Core Period: Baseline to Week 26||7
10467773|NCT01064414|11615932|FG000|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext. Reason: other (not specified).|76
10467774|NCT01064414|11615933|FG001|STARTED|Extension Period: Week 26 to Week 52|3 pts completed core but did not enter ext. Reason: other (not specified) (3).|72
10467775|NCT01064414|11615934|FG002|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext. Reason: other (not specified).|81
10467776|NCT01064414|11615932|FG000|COMPLETED|Extension Period: Week 26 to Week 52||64
10467777|NCT01064414|11615933|FG001|COMPLETED|Extension Period: Week 26 to Week 52||67
10467778|NCT01064414|11615934|FG002|COMPLETED|Extension Period: Week 26 to Week 52||76
10467779|NCT01064414|11615932|FG000|NOT COMPLETED|Extension Period: Week 26 to Week 52||12
10467780|NCT01064414|11615933|FG001|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
10467781|NCT01064414|11615934|FG002|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
10467782|NCT01064531|11615947|FG000|STARTED|Overall Study||21
10467783|NCT01064531|11615948|FG001|STARTED|Overall Study||20
10467784|NCT01064531|11615947|FG000|COMPLETED|Overall Study||18
10467785|NCT01064531|11615948|FG001|COMPLETED|Overall Study||13
10467786|NCT01064531|11615947|FG000|NOT COMPLETED|Overall Study||3
10467787|NCT01064531|11615948|FG001|NOT COMPLETED|Overall Study||7
10467788|NCT01064622|11615957|FG000|STARTED|Lead-in Phase I||0
10467789|NCT01064622|11615958|FG001|STARTED|Lead-in Phase I||7
10467790|NCT01064622|11615957|FG000|COMPLETED|Lead-in Phase I||0
10467791|NCT01064622|11615958|FG001|COMPLETED|Lead-in Phase I||7
10467792|NCT01064622|11615957|FG000|NOT COMPLETED|Lead-in Phase I||0
10467793|NCT01064622|11615958|FG001|NOT COMPLETED|Lead-in Phase I||0
10467794|NCT01064622|11615957|FG000|STARTED|Randomized Phase II||55
10467795|NCT01064622|11615958|FG001|STARTED|Randomized Phase II||56
10467796|NCT01064622|11615957|FG000|COMPLETED|Randomized Phase II||53
10467797|NCT01064622|11615958|FG001|COMPLETED|Randomized Phase II||53
10467798|NCT01064622|11615957|FG000|NOT COMPLETED|Randomized Phase II||2
10467799|NCT01064622|11615958|FG001|NOT COMPLETED|Randomized Phase II||3
10467800|NCT01064622|11615957|FG000|STARTED|Crossover of Arm I|Among 53 patients, 45 had disease progression; however 23 elected not to crossover to vismodegib.|22
10467801|NCT01064622|11615958|FG001|STARTED|Crossover of Arm I||0
10467802|NCT01064622|11615957|FG000|COMPLETED|Crossover of Arm I||22
10467803|NCT01064622|11615958|FG001|COMPLETED|Crossover of Arm I||0
10467804|NCT01064622|11615957|FG000|NOT COMPLETED|Crossover of Arm I||0
10467805|NCT01064622|11615958|FG001|NOT COMPLETED|Crossover of Arm I||0
10467806|NCT01064687|11615971|FG000|STARTED|Overall Study||279
10467807|NCT01064687|11615972|FG001|STARTED|Overall Study||280
10467808|NCT01064687|11615973|FG002|STARTED|Overall Study|Of 278 participants randomized to Exenatide, 2 chose not to take study drug.|278
10467809|NCT01064687|11615974|FG003|STARTED|Overall Study||141
10467810|NCT01064687|11615971|FG000|Received at Least 1 Dose of Study Drug|Overall Study||279
10467811|NCT01064687|11615972|FG001|Received at Least 1 Dose of Study Drug|Overall Study||280
10467812|NCT01064687|11615973|FG002|Received at Least 1 Dose of Study Drug|Overall Study||276
10467813|NCT01064687|11615974|FG003|Received at Least 1 Dose of Study Drug|Overall Study||141
10467814|NCT01064687|11615971|FG000|Completed 26 Weeks|Overall Study||260
10467815|NCT01064687|11615972|FG001|Completed 26 Weeks|Overall Study||263
10467816|NCT01064687|11615973|FG002|Completed 26 Weeks|Overall Study||252
10467817|NCT01064687|11615974|FG003|Completed 26 Weeks|Overall Study||124
10467818|NCT01064687|11615971|FG000|COMPLETED|Overall Study||245
10467819|NCT01064687|11615972|FG001|COMPLETED|Overall Study||254
10467820|NCT01064687|11615973|FG002|COMPLETED|Overall Study||237
10467821|NCT01064687|11615974|FG003|COMPLETED|Overall Study||124
10467822|NCT01064687|11615971|FG000|NOT COMPLETED|Overall Study||34
10467823|NCT01064687|11615972|FG001|NOT COMPLETED|Overall Study||26
10467824|NCT01064687|11615973|FG002|NOT COMPLETED|Overall Study||41
10467825|NCT01064687|11615974|FG003|NOT COMPLETED|Overall Study||17
10467826|NCT01064713|11615997|FG000|STARTED|Overall Study||13
10467827|NCT01064713|11615998|FG001|STARTED|Overall Study||4
10467828|NCT01064713|11615997|FG000|COMPLETED|Overall Study||13
10467829|NCT01064713|11615998|FG001|COMPLETED|Overall Study||4
10467830|NCT01064713|11615997|FG000|NOT COMPLETED|Overall Study||0
10467831|NCT01064713|11615998|FG001|NOT COMPLETED|Overall Study||0
10467832|NCT01064739|11616004|FG000|STARTED|Fixed Sodium Study Diet|14 participants consumed the fixed-sodium study diet prior to the fava bean supplement study day.|14
10467833|NCT01064739|11616004|FG000|COMPLETED|Fixed Sodium Study Diet||14
10467834|NCT01064739|11616004|FG000|NOT COMPLETED|Fixed Sodium Study Diet||0
10467835|NCT01064739|11616004|FG000|STARTED|Fixed Sodium Diet + Fava Beans||14
10467836|NCT01064739|11616004|FG000|COMPLETED|Fixed Sodium Diet + Fava Beans|1 participant withdrew with blood in his urine on the fava bean study day.|13
10467837|NCT01064739|11616004|FG000|NOT COMPLETED|Fixed Sodium Diet + Fava Beans||1
10467838|NCT01064830|11616016|FG000|STARTED|Overall Study||10
10467839|NCT01064830|11616017|FG001|STARTED|Overall Study||11
10467840|NCT01064830|11616016|FG000|COMPLETED|Overall Study||8
10467841|NCT01064830|11616017|FG001|COMPLETED|Overall Study||7
10467842|NCT01064830|11616016|FG000|NOT COMPLETED|Overall Study||2
10467843|NCT01064830|11616017|FG001|NOT COMPLETED|Overall Study||4
10467844|NCT01064856|11616027|FG000|STARTED|Double-blind (DB) Period||84
10467845|NCT01064856|11616028|FG001|STARTED|Double-blind (DB) Period||81
10467846|NCT01064856|11616029|FG002|STARTED|Double-blind (DB) Period|This treatment group is not applicable for this period.|0
10467847|NCT01064856|11616030|FG003|STARTED|Double-blind (DB) Period|This treatment group is not applicable for this period.|0
10467848|NCT01064856|11616027|FG000|COMPLETED|Double-blind (DB) Period||82
10467849|NCT01064856|11616028|FG001|COMPLETED|Double-blind (DB) Period||81
10467850|NCT01064856|11616029|FG002|COMPLETED|Double-blind (DB) Period||0
10467851|NCT01064856|11616030|FG003|COMPLETED|Double-blind (DB) Period||0
10467852|NCT01064856|11616027|FG000|NOT COMPLETED|Double-blind (DB) Period||2
10467853|NCT01064856|11616028|FG001|NOT COMPLETED|Double-blind (DB) Period||0
10467854|NCT01064856|11616029|FG002|NOT COMPLETED|Double-blind (DB) Period||0
10467855|NCT01064856|11616030|FG003|NOT COMPLETED|Double-blind (DB) Period||0
10467856|NCT01064856|11616027|FG000|STARTED|Open-label (OL) Period|This treatment group is not applicable for this period.|0
10467857|NCT01064856|11616028|FG001|STARTED|Open-label (OL) Period|This treatment group is not applicable for this period.|0
10467858|NCT01064856|11616029|FG002|STARTED|Open-label (OL) Period||82
10467859|NCT01064856|11616030|FG003|STARTED|Open-label (OL) Period||81
10467860|NCT01064856|11616027|FG000|COMPLETED|Open-label (OL) Period||0
10467861|NCT01064856|11616028|FG001|COMPLETED|Open-label (OL) Period||0
10467862|NCT01064856|11616029|FG002|COMPLETED|Open-label (OL) Period||56
10467863|NCT01064856|11616030|FG003|COMPLETED|Open-label (OL) Period||61
10467864|NCT01064856|11616027|FG000|NOT COMPLETED|Open-label (OL) Period||0
10708675|NCT02633215|11873554|FG000|STARTED|Overall Study||18
10708676|NCT02633215|11873555|FG001|STARTED|Overall Study||18
10708677|NCT02633215|11873554|FG000|COMPLETED|Overall Study||16
10708678|NCT02633215|11873555|FG001|COMPLETED|Overall Study||15
10708679|NCT02633215|11873554|FG000|NOT COMPLETED|Overall Study||2
10467865|NCT01064856|11616028|FG001|NOT COMPLETED|Open-label (OL) Period||0
10467866|NCT01064856|11616029|FG002|NOT COMPLETED|Open-label (OL) Period||26
10467867|NCT01064856|11616030|FG003|NOT COMPLETED|Open-label (OL) Period||20
10467868|NCT01064882|11616040|FG000|STARTED|Overall Study||36
10467869|NCT01064882|11616041|FG001|STARTED|Overall Study||34
10467870|NCT01064882|11616042|FG002|STARTED|Overall Study||34
10467871|NCT01064882|11616040|FG000|COMPLETED|Overall Study||34
10467872|NCT01064882|11616041|FG001|COMPLETED|Overall Study||32
10467873|NCT01064882|11616042|FG002|COMPLETED|Overall Study||32
10467874|NCT01064882|11616040|FG000|NOT COMPLETED|Overall Study||2
10467875|NCT01064882|11616041|FG001|NOT COMPLETED|Overall Study||2
10467876|NCT01064882|11616042|FG002|NOT COMPLETED|Overall Study||2
10467877|NCT01064947|11616050|FG000|STARTED|Overall Study||70
10467878|NCT01064947|11616050|FG000|COMPLETED|Overall Study||29
10467879|NCT01064947|11616050|FG000|NOT COMPLETED|Overall Study||41
10467880|NCT01065350|11616060|FG000|STARTED|Overall Study||43
10467881|NCT01065350|11616061|FG001|STARTED|Overall Study||42
10467882|NCT01065350|11616060|FG000|COMPLETED|Overall Study||43
10467883|NCT01065350|11616061|FG001|COMPLETED|Overall Study||41
10467884|NCT01065350|11616060|FG000|NOT COMPLETED|Overall Study||0
10467885|NCT01065350|11616061|FG001|NOT COMPLETED|Overall Study||1
10467886|NCT01065428|11616069|FG000|STARTED|Overall Study||17
10467887|NCT01065428|11616070|FG001|STARTED|Overall Study||35
10467888|NCT01065428|11616069|FG000|COMPLETED|Overall Study||17
10467889|NCT01065428|11616070|FG001|COMPLETED|Overall Study||35
10467890|NCT01065428|11616069|FG000|NOT COMPLETED|Overall Study||0
10467891|NCT01065428|11616070|FG001|NOT COMPLETED|Overall Study||0
10467892|NCT01065480|11616078|FG000|STARTED|Overall Study||48
10467893|NCT01065480|11616079|FG001|STARTED|Overall Study||43
10467894|NCT01065480|11616078|FG000|COMPLETED|Overall Study||48
10467895|NCT01065480|11616079|FG001|COMPLETED|Overall Study||43
10467896|NCT01065480|11616078|FG000|NOT COMPLETED|Overall Study||0
10467897|NCT01065480|11616079|FG001|NOT COMPLETED|Overall Study||0
10467898|NCT01065506|11616087|FG000|STARTED|Overall Study||64
10467899|NCT01065506|11616088|FG001|STARTED|Overall Study||72
10467900|NCT01065506|11616087|FG000|End of Treatment|Overall Study||44
10467901|NCT01065506|11616088|FG001|End of Treatment|Overall Study||37
10708680|NCT02633215|11873555|FG001|NOT COMPLETED|Overall Study||3
10467902|NCT01065506|11616087|FG000|4-Month Follow-Up|Overall Study||35
10467903|NCT01065506|11616088|FG001|4-Month Follow-Up|Overall Study||34
10467904|NCT01065506|11616087|FG000|COMPLETED|Overall Study||32
10467905|NCT01065506|11616088|FG001|COMPLETED|Overall Study||34
10467906|NCT01065506|11616087|FG000|NOT COMPLETED|Overall Study||32
10467907|NCT01065506|11616088|FG001|NOT COMPLETED|Overall Study||38
10467908|NCT01065558|11616094|FG000|STARTED|Overall Study||5
10467909|NCT01065558|11616094|FG000|COMPLETED|Overall Study||5
10467910|NCT01065558|11616094|FG000|NOT COMPLETED|Overall Study||0
10467911|NCT01065571|11616100|FG000|STARTED|Overall Study||10
10467912|NCT01065571|11616101|FG001|STARTED|Overall Study||5
10467913|NCT01065571|11616100|FG000|COMPLETED|Overall Study||7
10467914|NCT01065571|11616101|FG001|COMPLETED|Overall Study||5
10467915|NCT01065571|11616100|FG000|NOT COMPLETED|Overall Study||3
10467916|NCT01065571|11616101|FG001|NOT COMPLETED|Overall Study||0
10467917|NCT01065597|11616109|FG000|STARTED|Overall Study||13
10467918|NCT01065597|11616109|FG000|COMPLETED|Overall Study||12
10467919|NCT01065597|11616109|FG000|NOT COMPLETED|Overall Study||1
10467920|NCT01065714|11616113|FG000|STARTED|Overall Study|"This was a split body Study. All participants used both Hydrogel and Eucerin"|20
10467921|NCT01065714|11616113|FG000|COMPLETED|Overall Study||20
10467922|NCT01065714|11616113|FG000|NOT COMPLETED|Overall Study||0
10467923|NCT01065766|11616120|FG000|STARTED|Overall Study||4065
10467924|NCT01065766|11616120|FG000|COMPLETED|Overall Study||4033
10467925|NCT01065766|11616120|FG000|NOT COMPLETED|Overall Study||32
10467926|NCT01065844|11616124|FG000|STARTED|Overall Study||15
10467927|NCT01065844|11616124|FG000|COMPLETED|Overall Study||10
10467928|NCT01065844|11616124|FG000|NOT COMPLETED|Overall Study||5
10467929|NCT01066000|11616128|FG000|STARTED|Overall Study||33
10467930|NCT01066000|11616128|FG000|COMPLETED|Overall Study||24
10467931|NCT01066000|11616128|FG000|NOT COMPLETED|Overall Study||9
10467932|NCT01066026|11616132|FG000|STARTED|Overall Study|Each patient was injected with hyaluronic acid in each nasolabial fold (total: 2 injections)|25
10467933|NCT01066026|11616132|FG000|COMPLETED|Overall Study||23
10467934|NCT01066026|11616132|FG000|NOT COMPLETED|Overall Study||2
10467935|NCT01066039|11616138|FG000|STARTED|Overall Study||202
10467936|NCT01066039|11616138|FG000|Treated|Overall Study||200
10467937|NCT01066039|11616138|FG000|COMPLETED|Overall Study||158
10467938|NCT01066039|11616138|FG000|NOT COMPLETED|Overall Study||44
10467939|NCT01066052|11616144|FG000|STARTED|Overall Study||64
10467940|NCT01066052|11616145|FG001|STARTED|Overall Study||51
10467941|NCT01066052|11616144|FG000|Treated|Overall Study||61
10467942|NCT01066052|11616145|FG001|Treated|Overall Study||0
10467943|NCT01066052|11616144|FG000|COMPLETED|Overall Study||61
10467944|NCT01066052|11616145|FG001|COMPLETED|Overall Study||51
10467945|NCT01066052|11616144|FG000|NOT COMPLETED|Overall Study||3
10467946|NCT01066052|11616145|FG001|NOT COMPLETED|Overall Study||0
10467947|NCT01066104|11616152|FG000|STARTED|Overall Study||14
10467948|NCT01066104|11616153|FG001|STARTED|Overall Study||13
10467949|NCT01066104|11616152|FG000|COMPLETED|Overall Study||12
10467950|NCT01066104|11616153|FG001|COMPLETED|Overall Study||12
10467951|NCT01066104|11616152|FG000|NOT COMPLETED|Overall Study||2
10467952|NCT01066104|11616153|FG001|NOT COMPLETED|Overall Study||1
10467953|NCT01066143|11616159|FG000|STARTED|Overall Study||8
10467954|NCT01066143|11616159|FG000|COMPLETED|Overall Study||0
10467955|NCT01066143|11616159|FG000|NOT COMPLETED|Overall Study||8
10467956|NCT01066156|11616163|FG000|STARTED|Overall Study||34
10467957|NCT01066156|11616163|FG000|COMPLETED|Overall Study||24
10467958|NCT01066156|11616163|FG000|NOT COMPLETED|Overall Study||10
10467959|NCT01066364|11616169|FG000|STARTED|Overall Study||25
10467960|NCT01066364|11616170|FG001|STARTED|Overall Study||25
10467961|NCT01066364|11616169|FG000|COMPLETED|Overall Study||22
10467962|NCT01066364|11616170|FG001|COMPLETED|Overall Study||23
10467963|NCT01066364|11616169|FG000|NOT COMPLETED|Overall Study||3
10467964|NCT01066364|11616170|FG001|NOT COMPLETED|Overall Study||2
10467965|NCT01066520|11616179|FG000|STARTED|Overall Study||143
10467966|NCT01066520|11616180|FG001|STARTED|Overall Study||140
10467967|NCT01066520|11616181|FG002|STARTED|Overall Study||137
10467968|NCT01066520|11616179|FG000|COMPLETED|Overall Study||143
10467969|NCT01066520|11616180|FG001|COMPLETED|Overall Study||140
10467970|NCT01066520|11616181|FG002|COMPLETED|Overall Study||137
10467971|NCT01066520|11616179|FG000|NOT COMPLETED|Overall Study||0
10467972|NCT01066520|11616180|FG001|NOT COMPLETED|Overall Study||0
10467973|NCT01066520|11616181|FG002|NOT COMPLETED|Overall Study||0
10467974|NCT01066546|11616189|FG000|STARTED|Overall Study||5
10467975|NCT01066546|11616189|FG000|COMPLETED|Overall Study||0
10467976|NCT01066546|11616189|FG000|NOT COMPLETED|Overall Study||5
10467977|NCT01066585|11616195|FG000|STARTED|Overall Study||211
10467978|NCT01066585|11616196|FG001|STARTED|Overall Study||199
10467979|NCT01066585|11616195|FG000|COMPLETED|Overall Study||210
10467980|NCT01066585|11616196|FG001|COMPLETED|Overall Study||196
10467981|NCT01066585|11616195|FG000|NOT COMPLETED|Overall Study||1
10467982|NCT01066585|11616196|FG001|NOT COMPLETED|Overall Study||3
10467983|NCT01066624|11616205|FG000|STARTED|Overall Study||38
10467984|NCT01066624|11616206|FG001|STARTED|Overall Study||40
10467985|NCT01066624|11616207|FG002|STARTED|Overall Study||39
10467986|NCT01066624|11616205|FG000|COMPLETED|Overall Study||38
10467987|NCT01066624|11616206|FG001|COMPLETED|Overall Study||40
10467988|NCT01066624|11616207|FG002|COMPLETED|Overall Study||39
10467989|NCT01066624|11616205|FG000|NOT COMPLETED|Overall Study||0
10467990|NCT01066624|11616206|FG001|NOT COMPLETED|Overall Study||0
10467991|NCT01066624|11616207|FG002|NOT COMPLETED|Overall Study||0
10467992|NCT01066780|11616215|FG000|STARTED|Overall Study||24
10467993|NCT01066780|11616216|FG001|STARTED|Overall Study||24
10467994|NCT01066780|11616215|FG000|COMPLETED|Overall Study||23
10467995|NCT01066780|11616216|FG001|COMPLETED|Overall Study||23
10467996|NCT01066780|11616215|FG000|NOT COMPLETED|Overall Study||1
10467997|NCT01066780|11616216|FG001|NOT COMPLETED|Overall Study||1
10467998|NCT01066793|11616226|FG000|STARTED|Overall Study||1128
10467999|NCT01066793|11616227|FG001|STARTED|Overall Study||572
10468000|NCT01066793|11616228|FG002|STARTED|Overall Study||484
10468001|NCT01066793|11616229|FG003|STARTED|Overall Study||143
10468002|NCT01066793|11616230|FG004|STARTED|Overall Study||11
10468003|NCT01066793|11616231|FG005|STARTED|Overall Study||5
10468004|NCT01066793|11616226|FG000|COMPLETED|Overall Study||754
10468005|NCT01066793|11616227|FG001|COMPLETED|Overall Study||495
10468006|NCT01066793|11616228|FG002|COMPLETED|Overall Study||369
10468007|NCT01066793|11616229|FG003|COMPLETED|Overall Study||94
10468008|NCT01066793|11616230|FG004|COMPLETED|Overall Study||11
10468009|NCT01066793|11616231|FG005|COMPLETED|Overall Study||4
10468010|NCT01066793|11616226|FG000|NOT COMPLETED|Overall Study||374
10468011|NCT01066793|11616227|FG001|NOT COMPLETED|Overall Study||77
10468012|NCT01066793|11616228|FG002|NOT COMPLETED|Overall Study||115
10468013|NCT01066793|11616229|FG003|NOT COMPLETED|Overall Study||49
10468014|NCT01066793|11616230|FG004|NOT COMPLETED|Overall Study||0
10468015|NCT01066793|11616231|FG005|NOT COMPLETED|Overall Study||1
10468016|NCT01066819|11616252|FG000|STARTED|Overall Study||1006
10468017|NCT01066819|11616253|FG001|STARTED|Overall Study||348
10468018|NCT01066819|11616254|FG002|STARTED|Overall Study||257
10468019|NCT01066819|11616255|FG003|STARTED|Overall Study||25
10468020|NCT01066819|11616256|FG004|STARTED|Overall Study||7
10468021|NCT01066819|11616257|FG005|STARTED|Overall Study||13
10468022|NCT01066819|11616252|FG000|COMPLETED|Overall Study||317
10468023|NCT01066819|11616253|FG001|COMPLETED|Overall Study||177
10468024|NCT01066819|11616254|FG002|COMPLETED|Overall Study||111
10468025|NCT01066819|11616255|FG003|COMPLETED|Overall Study||8
10468026|NCT01066819|11616256|FG004|COMPLETED|Overall Study||3
10468027|NCT01066819|11616257|FG005|COMPLETED|Overall Study||7
10468028|NCT01066819|11616252|FG000|NOT COMPLETED|Overall Study||689
10468029|NCT01066819|11616253|FG001|NOT COMPLETED|Overall Study||171
10468030|NCT01066819|11616254|FG002|NOT COMPLETED|Overall Study||146
10468031|NCT01066819|11616255|FG003|NOT COMPLETED|Overall Study||17
10468032|NCT01066819|11616256|FG004|NOT COMPLETED|Overall Study||4
10468033|NCT01066819|11616257|FG005|NOT COMPLETED|Overall Study||6
10468034|NCT01066871|11616273|FG000|STARTED|Overall Study||20
10468035|NCT01066871|11616274|FG001|STARTED|Overall Study||18
10468036|NCT01066871|11616275|FG002|STARTED|Overall Study||18
10468037|NCT01066871|11616276|FG003|STARTED|Overall Study||18
10468038|NCT01066871|11616273|FG000|COMPLETED|Overall Study||16
10468039|NCT01066871|11616274|FG001|COMPLETED|Overall Study||13
10468040|NCT01066871|11616275|FG002|COMPLETED|Overall Study||12
10468041|NCT01066871|11616276|FG003|COMPLETED|Overall Study||13
10468042|NCT01066871|11616273|FG000|NOT COMPLETED|Overall Study||4
10468043|NCT01066871|11616274|FG001|NOT COMPLETED|Overall Study||5
10468044|NCT01066871|11616275|FG002|NOT COMPLETED|Overall Study||6
10468045|NCT01066871|11616276|FG003|NOT COMPLETED|Overall Study||5
10468046|NCT01066897|11616293|FG000|STARTED|Overall Study||7
10468047|NCT01066897|11616294|FG001|STARTED|Overall Study||9
10468048|NCT01066897|11616293|FG000|COMPLETED|Overall Study||5
10468049|NCT01066897|11616294|FG001|COMPLETED|Overall Study||9
10468050|NCT01066897|11616293|FG000|NOT COMPLETED|Overall Study||2
10708681|NCT02633306|11873561|FG000|STARTED|Overall Study||9
10708682|NCT02633306|11873561|FG000|COMPLETED|Overall Study||6
10468051|NCT01066897|11616294|FG001|NOT COMPLETED|Overall Study||0
10468052|NCT01066923|11616305|FG000|STARTED|Overall Study||28
10468053|NCT01066923|11616306|FG001|STARTED|Overall Study||32
10468054|NCT01066923|11616307|FG002|STARTED|Overall Study||33
10468055|NCT01066923|11616308|FG003|STARTED|Overall Study||31
10468056|NCT01066923|11616305|FG000|Platelet Closure Time|Overall Study||25
10468057|NCT01066923|11616306|FG001|Platelet Closure Time|Overall Study||29
10468058|NCT01066923|11616307|FG002|Platelet Closure Time|Overall Study||25
10468059|NCT01066923|11616308|FG003|Platelet Closure Time|Overall Study||23
10468060|NCT01066923|11616305|FG000|Vascular Function|Overall Study||13
10468061|NCT01066923|11616306|FG001|Vascular Function|Overall Study||14
10468062|NCT01066923|11616307|FG002|Vascular Function|Overall Study||12
10468063|NCT01066923|11616308|FG003|Vascular Function|Overall Study||13
10468064|NCT01066923|11616305|FG000|Activation of Coagulation|Overall Study||0
10468065|NCT01066923|11616306|FG001|Activation of Coagulation|Overall Study||0
10468066|NCT01066923|11616307|FG002|Activation of Coagulation|Overall Study||0
10468067|NCT01066923|11616308|FG003|Activation of Coagulation|Overall Study||0
10468068|NCT01066923|11616305|FG000|Retinal Imaging|Overall Study||0
10468069|NCT01066923|11616306|FG001|Retinal Imaging|Overall Study||0
10468070|NCT01066923|11616307|FG002|Retinal Imaging|Overall Study||0
10468071|NCT01066923|11616308|FG003|Retinal Imaging|Overall Study||0
10468072|NCT01066923|11616305|FG000|COMPLETED|Overall Study||25
10468073|NCT01066923|11616306|FG001|COMPLETED|Overall Study||29
10468074|NCT01066923|11616307|FG002|COMPLETED|Overall Study||25
10468075|NCT01066923|11616308|FG003|COMPLETED|Overall Study||23
10708683|NCT02633306|11873561|FG000|NOT COMPLETED|Overall Study||3
10708684|NCT02633358|11873568|FG000|STARTED|Overall Study||87
10708685|NCT02633358|11873569|FG001|STARTED|Overall Study||54
10708686|NCT02633358|11873568|FG000|COMPLETED|Overall Study||87
10468076|NCT01066923|11616305|FG000|NOT COMPLETED|Overall Study||3
10468077|NCT01066923|11616306|FG001|NOT COMPLETED|Overall Study||3
10468078|NCT01066923|11616307|FG002|NOT COMPLETED|Overall Study||8
10468079|NCT01066923|11616308|FG003|NOT COMPLETED|Overall Study||8
10468080|NCT01066936|11616318|FG000|STARTED|Overall Study||20
10468081|NCT01066936|11616318|FG000|COMPLETED|Overall Study||10
10468082|NCT01066936|11616318|FG000|NOT COMPLETED|Overall Study||10
10468083|NCT01067105|11616324|FG000|STARTED|Overall Study||824
10468084|NCT01067105|11616324|FG000|COMPLETED|Overall Study||683
10468085|NCT01067105|11616324|FG000|NOT COMPLETED|Overall Study||141
10708687|NCT02633358|11873569|FG001|COMPLETED|Overall Study||54
10468086|NCT01067326|11616330|FG000|STARTED|Overall Study||14
10468087|NCT01067326|11616331|FG001|STARTED|Overall Study||8
10468088|NCT01067326|11616330|FG000|COMPLETED|Overall Study||12
10468089|NCT01067326|11616331|FG001|COMPLETED|Overall Study||5
10468090|NCT01067326|11616330|FG000|NOT COMPLETED|Overall Study||2
10468091|NCT01067326|11616331|FG001|NOT COMPLETED|Overall Study||3
10468092|NCT01067339|11616339|FG000|STARTED|Overall Study||31
10468093|NCT01067339|11616340|FG001|STARTED|Overall Study||34
10468094|NCT01067339|11616339|FG000|COMPLETED|Overall Study||25
10468095|NCT01067339|11616340|FG001|COMPLETED|Overall Study||29
10468096|NCT01067339|11616339|FG000|NOT COMPLETED|Overall Study||6
10468097|NCT01067339|11616340|FG001|NOT COMPLETED|Overall Study||5
10468098|NCT01067352|11616349|FG000|STARTED|Overall Study||9
10468099|NCT01067352|11616350|FG001|STARTED|Overall Study||6
10468100|NCT01067352|11616351|FG002|STARTED|Overall Study||10
10468101|NCT01067352|11616349|FG000|COMPLETED|Overall Study||8
10468102|NCT01067352|11616350|FG001|COMPLETED|Overall Study||3
10468103|NCT01067352|11616351|FG002|COMPLETED|Overall Study||9
10468104|NCT01067352|11616349|FG000|NOT COMPLETED|Overall Study||1
10468105|NCT01067352|11616350|FG001|NOT COMPLETED|Overall Study||3
10468106|NCT01067352|11616351|FG002|NOT COMPLETED|Overall Study||1
10468107|NCT01067456|11616361|FG000|STARTED|Overall Study||30
10468108|NCT01067456|11616362|FG001|STARTED|Overall Study||29
10468109|NCT01067456|11616361|FG000|COMPLETED|Overall Study||30
10468110|NCT01067456|11616362|FG001|COMPLETED|Overall Study||29
10468111|NCT01067456|11616361|FG000|NOT COMPLETED|Overall Study||0
10468112|NCT01067456|11616362|FG001|NOT COMPLETED|Overall Study||0
10468113|NCT01067469|11616372|FG000|STARTED|Overall Study||36
10468114|NCT01067469|11616373|FG001|STARTED|Overall Study||35
10468115|NCT01067469|11616372|FG000|90 mg/m^2|Overall Study||0
10468116|NCT01067469|11616373|FG001|90 mg/m^2|Overall Study||12
10468117|NCT01067469|11616372|FG000|75 mg/m^2|Overall Study||0
10468118|NCT01067469|11616373|FG001|75 mg/m^2|Overall Study||21
10468119|NCT01067469|11616372|FG000|COMPLETED|Overall Study||36
10468120|NCT01067469|11616373|FG001|COMPLETED|Overall Study||33
10468121|NCT01067469|11616372|FG000|NOT COMPLETED|Overall Study||0
10468122|NCT01067469|11616373|FG001|NOT COMPLETED|Overall Study||2
10468123|NCT01067508|11616381|FG000|STARTED|Overall Study||10
10468124|NCT01067508|11616382|FG001|STARTED|Overall Study||9
10468125|NCT01067508|11616381|FG000|COMPLETED|Overall Study||10
10468126|NCT01067508|11616382|FG001|COMPLETED|Overall Study||7
10468127|NCT01067508|11616381|FG000|NOT COMPLETED|Overall Study||0
10468128|NCT01067508|11616382|FG001|NOT COMPLETED|Overall Study||2
10468129|NCT01067716|11616391|FG000|STARTED|Overall Study|110 eyes|57
10468130|NCT01067716|11616392|FG001|STARTED|Overall Study|25 eyes|13
10468131|NCT01067716|11616393|FG002|STARTED|Overall Study|15 eyes|9
10468132|NCT01067716|11616391|FG000|COMPLETED|Overall Study|110 eyes|57
10468133|NCT01067716|11616392|FG001|COMPLETED|Overall Study|25 eyes|13
10468134|NCT01067716|11616393|FG002|COMPLETED|Overall Study|15 eyes|9
10468135|NCT01067716|11616391|FG000|NOT COMPLETED|Overall Study||0
10468136|NCT01067716|11616392|FG001|NOT COMPLETED|Overall Study||0
10468137|NCT01067716|11616393|FG002|NOT COMPLETED|Overall Study||0
10468138|NCT01067768|11616403|FG000|STARTED|Overall Study||604
10468139|NCT01067768|11616404|FG001|STARTED|Overall Study||605
10468140|NCT01067768|11616403|FG000|COMPLETED|Overall Study||604
10468141|NCT01067768|11616404|FG001|COMPLETED|Overall Study||605
10468142|NCT01067768|11616403|FG000|NOT COMPLETED|Overall Study||0
10468143|NCT01067768|11616404|FG001|NOT COMPLETED|Overall Study||0
10468144|NCT01067781|11616414|FG000|STARTED|Up to Day 180||203
10468145|NCT01067781|11616415|FG001|STARTED|Up to Day 180||199
10468146|NCT01067781|11616416|FG002|STARTED|Up to Day 180||97
10468147|NCT01067781|11616417|FG003|STARTED|Up to Day 180||101
10468148|NCT01067781|11616414|FG000|COMPLETED|Up to Day 180||173
10468149|NCT01067781|11616415|FG001|COMPLETED|Up to Day 180||168
10468150|NCT01067781|11616416|FG002|COMPLETED|Up to Day 180||89
10468151|NCT01067781|11616417|FG003|COMPLETED|Up to Day 180||89
10468152|NCT01067781|11616414|FG000|NOT COMPLETED|Up to Day 180||30
10468153|NCT01067781|11616415|FG001|NOT COMPLETED|Up to Day 180||31
10468154|NCT01067781|11616416|FG002|NOT COMPLETED|Up to Day 180||8
10468155|NCT01067781|11616417|FG003|NOT COMPLETED|Up to Day 180||12
10468156|NCT01067781|11616414|FG000|STARTED|180 to Day 720||173
10468157|NCT01067781|11616415|FG001|STARTED|180 to Day 720||168
10468158|NCT01067781|11616416|FG002|STARTED|180 to Day 720||89
10468159|NCT01067781|11616417|FG003|STARTED|180 to Day 720||89
10468160|NCT01067781|11616414|FG000|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|3
10468161|NCT01067781|11616415|FG001|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|4
10468162|NCT01067781|11616416|FG002|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|0
10468163|NCT01067781|11616417|FG003|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|0
10468164|NCT01067781|11616414|FG000|NOT COMPLETED|180 to Day 720||170
10468165|NCT01067781|11616415|FG001|NOT COMPLETED|180 to Day 720||164
10468166|NCT01067781|11616416|FG002|NOT COMPLETED|180 to Day 720||89
10468167|NCT01067781|11616417|FG003|NOT COMPLETED|180 to Day 720||89
10468168|NCT01067846|11616431|FG000|STARTED|Overall Study|Due to exclusion prior to group assignment, Study Enrollment will not equal Total # of Participants.|29
10468169|NCT01067846|11616432|FG001|STARTED|Overall Study|Due to exclusion prior to group assignment, Study Enrollment will not equal Total # of Participants.|30
10468170|NCT01067846|11616431|FG000|Completed 3 Tx Sessions|Overall Study|Our final analysis includes these participants.|15
10468171|NCT01067846|11616432|FG001|Completed 3 Tx Sessions|Overall Study|Our final analysis includes these participants.|15
10468172|NCT01067846|11616431|FG000|COMPLETED|Overall Study|Participants that completed all 4 weeks of treatment.|10
10468173|NCT01067846|11616432|FG001|COMPLETED|Overall Study|Participants that completed all 4 weeks of treatment.|11
10468174|NCT01067846|11616431|FG000|NOT COMPLETED|Overall Study||19
10468175|NCT01067846|11616432|FG001|NOT COMPLETED|Overall Study||19
10468176|NCT01067976|11616438|FG000|STARTED|Overall Study|screened and enrolled|446
10468177|NCT01067976|11616438|FG000|Received Treatment|Overall Study|treatment started|426
10468178|NCT01067976|11616438|FG000|Fulfilled Requirements of FAS Population|Overall Study||390
10468179|NCT01067976|11616438|FG000|COMPLETED|Overall Study|study course completed|424
10468180|NCT01067976|11616438|FG000|NOT COMPLETED|Overall Study||22
10468181|NCT01068158|11616458|FG000|STARTED|Overall Study||169
10468182|NCT01068158|11616459|FG001|STARTED|Overall Study||202
10468183|NCT01068158|11616458|FG000|COMPLETED|Overall Study||161
10468184|NCT01068158|11616459|FG001|COMPLETED|Overall Study||198
10468185|NCT01068158|11616458|FG000|NOT COMPLETED|Overall Study||8
10468186|NCT01068158|11616459|FG001|NOT COMPLETED|Overall Study||4
10468187|NCT01068262|11616469|FG000|STARTED|Overall Study||23
10468188|NCT01068262|11616470|FG001|STARTED|Overall Study||9
10468189|NCT01068262|11616471|FG002|STARTED|Overall Study||10
10468190|NCT01068262|11616472|FG003|STARTED|Overall Study||2
10468191|NCT01068262|11616469|FG000|COMPLETED|Overall Study||20
10468192|NCT01068262|11616470|FG001|COMPLETED|Overall Study||8
10468193|NCT01068262|11616471|FG002|COMPLETED|Overall Study||9
10468194|NCT01068262|11616472|FG003|COMPLETED|Overall Study||2
10468195|NCT01068262|11616469|FG000|NOT COMPLETED|Overall Study||3
10468196|NCT01068262|11616470|FG001|NOT COMPLETED|Overall Study||1
10468197|NCT01068262|11616471|FG002|NOT COMPLETED|Overall Study||1
10468198|NCT01068262|11616472|FG003|NOT COMPLETED|Overall Study||0
10468199|NCT01068418|11616485|FG000|STARTED|Overall Study|26 participants found to be eligible|26
10468200|NCT01068418|11616485|FG000|Medication Washout|Overall Study|9 participants were disempaneled during the medication washout phase due to noncompliance or high BP|17
10468201|NCT01068418|11616485|FG000|COMPLETED|Overall Study|14 participants completed all study procedures.|14
10468202|NCT01068418|11616485|FG000|NOT COMPLETED|Overall Study||12
10468203|NCT01068509|11616492|FG000|STARTED|Overall Study||7
10468204|NCT01068509|11616493|FG001|STARTED|Overall Study||29
10468205|NCT01068509|11616494|FG002|STARTED|Overall Study||27
10468206|NCT01068509|11616492|FG000|COMPLETED|Overall Study||1
10468207|NCT01068509|11616493|FG001|COMPLETED|Overall Study||7
10468208|NCT01068509|11616494|FG002|COMPLETED|Overall Study||6
10468209|NCT01068509|11616492|FG000|NOT COMPLETED|Overall Study||6
10468210|NCT01068509|11616493|FG001|NOT COMPLETED|Overall Study||22
10468211|NCT01068509|11616494|FG002|NOT COMPLETED|Overall Study||21
10468212|NCT01068548|11616503|FG000|STARTED|Overall Study||66
10468213|NCT01068548|11616504|FG001|STARTED|Overall Study||63
10468214|NCT01068548|11616503|FG000|COMPLETED|Overall Study||66
10468215|NCT01068548|11616504|FG001|COMPLETED|Overall Study||63
10468216|NCT01068548|11616503|FG000|NOT COMPLETED|Overall Study||0
10468217|NCT01068548|11616504|FG001|NOT COMPLETED|Overall Study||0
10468218|NCT01068600|11616513|FG000|STARTED|Overall Study||159
10468219|NCT01068600|11616514|FG001|STARTED|Overall Study||159
10468220|NCT01068600|11616513|FG000|COMPLETED|Overall Study||148
10468221|NCT01068600|11616514|FG001|COMPLETED|Overall Study||142
10468222|NCT01068600|11616513|FG000|NOT COMPLETED|Overall Study||11
10468223|NCT01068600|11616514|FG001|NOT COMPLETED|Overall Study||17
10468224|NCT01068626|11616522|FG000|STARTED|Overall Study||30
10468225|NCT01068626|11616523|FG001|STARTED|Overall Study||29
10468226|NCT01068626|11616522|FG000|COMPLETED|Overall Study||27
10468227|NCT01068626|11616523|FG001|COMPLETED|Overall Study||27
10468228|NCT01068626|11616522|FG000|NOT COMPLETED|Overall Study||3
10468229|NCT01068626|11616523|FG001|NOT COMPLETED|Overall Study||2
10468230|NCT01068652|11616531|FG000|STARTED|Overall Study||200
10468231|NCT01068652|11616532|FG001|STARTED|Overall Study||203
10708688|NCT02633358|11873568|FG000|NOT COMPLETED|Overall Study||0
10708689|NCT02633358|11873569|FG001|NOT COMPLETED|Overall Study||0
10708690|NCT02633371|11873576|FG000|STARTED|Overall Study||10
10468232|NCT01068652|11616531|FG000|COMPLETED|Overall Study||182
10468233|NCT01068652|11616532|FG001|COMPLETED|Overall Study||188
10468234|NCT01068652|11616531|FG000|NOT COMPLETED|Overall Study||18
10468235|NCT01068652|11616532|FG001|NOT COMPLETED|Overall Study||15
10708691|NCT02633371|11873576|FG000|COMPLETED|Overall Study||7
10708692|NCT02633371|11873576|FG000|NOT COMPLETED|Overall Study||3
10708693|NCT02633488|11873582|FG000|STARTED|Overall Study||6
10708694|NCT02633488|11873583|FG001|STARTED|Overall Study||5
10708695|NCT02633488|11873582|FG000|COMPLETED|Overall Study||6
10468236|NCT01068665|11616540|FG000|STARTED|Overall Study||230
10468237|NCT01068665|11616541|FG001|STARTED|Overall Study||230
10468238|NCT01068665|11616540|FG000|Full Analysis Set|Overall Study|Two subjects were withdrawn because the subjects were randomised in error.|228
10468239|NCT01068665|11616541|FG001|Full Analysis Set|Overall Study|One subject was withdrawn because the subject was randomised in error.|229
10468240|NCT01068665|11616540|FG000|Exposed|Overall Study||228
10468241|NCT01068665|11616541|FG001|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug.|228
10468242|NCT01068665|11616540|FG000|COMPLETED|Overall Study||200
10708696|NCT02633488|11873583|FG001|COMPLETED|Overall Study||5
10708697|NCT02633488|11873582|FG000|NOT COMPLETED|Overall Study||0
10708698|NCT02633488|11873583|FG001|NOT COMPLETED|Overall Study||0
10708699|NCT02633501|11873595|FG000|STARTED|Overall Study||14
10468243|NCT01068665|11616541|FG001|COMPLETED|Overall Study||201
10708700|NCT02633501|11873596|FG001|STARTED|Overall Study||14
10708701|NCT02633501|11873597|FG002|STARTED|Overall Study||62
10708702|NCT02633501|11873598|FG003|STARTED|Overall Study||63
10708703|NCT02633501|11873599|FG004|STARTED|Overall Study||64
10708704|NCT02633501|11873600|FG005|STARTED|Overall Study||63
10708705|NCT02633501|11873595|FG000|COMPLETED|Overall Study||12
10708706|NCT02633501|11873596|FG001|COMPLETED|Overall Study||11
10708707|NCT02633501|11873597|FG002|COMPLETED|Overall Study||55
10708708|NCT02633501|11873598|FG003|COMPLETED|Overall Study||59
10708709|NCT02633501|11873599|FG004|COMPLETED|Overall Study||53
10708710|NCT02633501|11873600|FG005|COMPLETED|Overall Study||48
10708711|NCT02633501|11873595|FG000|NOT COMPLETED|Overall Study||2
10468244|NCT01068665|11616540|FG000|NOT COMPLETED|Overall Study||30
10468245|NCT01068665|11616541|FG001|NOT COMPLETED|Overall Study||29
10468246|NCT01068678|11616549|FG000|STARTED|Overall Study||230
10468247|NCT01068678|11616550|FG001|STARTED|Overall Study||230
10468248|NCT01068678|11616549|FG000|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial product.|227
10468249|NCT01068678|11616550|FG001|Exposed|Overall Study|one subject withdrew prior to exposure to trial product|229
10468250|NCT01068678|11616549|FG000|COMPLETED|Overall Study||192
10468251|NCT01068678|11616550|FG001|COMPLETED|Overall Study||206
10468252|NCT01068678|11616549|FG000|NOT COMPLETED|Overall Study||38
10468253|NCT01068678|11616550|FG001|NOT COMPLETED|Overall Study||24
10468254|NCT01068717|11616556|FG000|STARTED|Period 1: Treatment Schedule Phase 1||7
10468255|NCT01068717|11616557|FG001|STARTED|Period 1: Treatment Schedule Phase 1||6
10468256|NCT01068717|11616558|FG002|STARTED|Period 1: Treatment Schedule Phase 1||7
10468257|NCT01068717|11616559|FG003|STARTED|Period 1: Treatment Schedule Phase 1||7
10468258|NCT01068717|11616556|FG000|COMPLETED|Period 1: Treatment Schedule Phase 1|Patient who withdrew returned for Treatment Periods 3 and 4.|6
10468259|NCT01068717|11616557|FG001|COMPLETED|Period 1: Treatment Schedule Phase 1||6
10468260|NCT01068717|11616558|FG002|COMPLETED|Period 1: Treatment Schedule Phase 1||7
10468261|NCT01068717|11616559|FG003|COMPLETED|Period 1: Treatment Schedule Phase 1||7
10468262|NCT01068717|11616556|FG000|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||1
10468263|NCT01068717|11616557|FG001|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
10468264|NCT01068717|11616558|FG002|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
10468265|NCT01068717|11616559|FG003|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
10468266|NCT01068717|11616556|FG000|STARTED|Period 2: Treatment Schedule Phase 2||6
10468267|NCT01068717|11616557|FG001|STARTED|Period 2: Treatment Schedule Phase 2||6
10468268|NCT01068717|11616558|FG002|STARTED|Period 2: Treatment Schedule Phase 2||7
10468269|NCT01068717|11616559|FG003|STARTED|Period 2: Treatment Schedule Phase 2||7
10468270|NCT01068717|11616556|FG000|COMPLETED|Period 2: Treatment Schedule Phase 2||6
10468271|NCT01068717|11616557|FG001|COMPLETED|Period 2: Treatment Schedule Phase 2||6
10468272|NCT01068717|11616558|FG002|COMPLETED|Period 2: Treatment Schedule Phase 2||7
10468273|NCT01068717|11616559|FG003|COMPLETED|Period 2: Treatment Schedule Phase 2||7
10468274|NCT01068717|11616556|FG000|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
10468275|NCT01068717|11616557|FG001|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
10468276|NCT01068717|11616558|FG002|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
10468277|NCT01068717|11616559|FG003|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
10468278|NCT01068717|11616556|FG000|STARTED|Period 3: Treatment Schedule Phase 3|Patient who withdrew during Treatment Period 1 returned for Treatment Periods 3 and 4.|7
10468279|NCT01068717|11616557|FG001|STARTED|Period 3: Treatment Schedule Phase 3||6
10468280|NCT01068717|11616558|FG002|STARTED|Period 3: Treatment Schedule Phase 3||7
10468281|NCT01068717|11616559|FG003|STARTED|Period 3: Treatment Schedule Phase 3||7
10468282|NCT01068717|11616556|FG000|COMPLETED|Period 3: Treatment Schedule Phase 3||7
10468283|NCT01068717|11616557|FG001|COMPLETED|Period 3: Treatment Schedule Phase 3||6
10468284|NCT01068717|11616558|FG002|COMPLETED|Period 3: Treatment Schedule Phase 3||7
10468285|NCT01068717|11616559|FG003|COMPLETED|Period 3: Treatment Schedule Phase 3||7
10468286|NCT01068717|11616556|FG000|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
10468287|NCT01068717|11616557|FG001|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
10468288|NCT01068717|11616558|FG002|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
10468289|NCT01068717|11616559|FG003|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
10468290|NCT01068717|11616556|FG000|STARTED|Period 4: Treatment Schedule Phase 4|Patient who withdrew during Treatment Period 1 returned for Treatment Periods 3 and 4.|7
10468291|NCT01068717|11616557|FG001|STARTED|Period 4: Treatment Schedule Phase 4||6
10468292|NCT01068717|11616558|FG002|STARTED|Period 4: Treatment Schedule Phase 4||7
10468293|NCT01068717|11616559|FG003|STARTED|Period 4: Treatment Schedule Phase 4||7
10468294|NCT01068717|11616556|FG000|COMPLETED|Period 4: Treatment Schedule Phase 4||7
10468295|NCT01068717|11616557|FG001|COMPLETED|Period 4: Treatment Schedule Phase 4||6
10468296|NCT01068717|11616558|FG002|COMPLETED|Period 4: Treatment Schedule Phase 4||7
10468297|NCT01068717|11616559|FG003|COMPLETED|Period 4: Treatment Schedule Phase 4||7
10468298|NCT01068717|11616556|FG000|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
10468299|NCT01068717|11616557|FG001|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
10468300|NCT01068717|11616558|FG002|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
10708712|NCT02633501|11873596|FG001|NOT COMPLETED|Overall Study||3
10708713|NCT02633501|11873597|FG002|NOT COMPLETED|Overall Study||7
10708714|NCT02633501|11873598|FG003|NOT COMPLETED|Overall Study||4
10708715|NCT02633501|11873599|FG004|NOT COMPLETED|Overall Study||11
10708716|NCT02633501|11873600|FG005|NOT COMPLETED|Overall Study||15
10708717|NCT02633527|11873624|FG000|STARTED|Overall Study||24
10708718|NCT02633527|11873625|FG001|STARTED|Overall Study||48
10468301|NCT01068717|11616559|FG003|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
10468302|NCT01068730|11616573|FG000|STARTED|Period 1||7
10468303|NCT01068730|11616574|FG001|STARTED|Period 1||7
10468304|NCT01068730|11616575|FG002|STARTED|Period 1||7
10468305|NCT01068730|11616576|FG003|STARTED|Period 1||7
10468306|NCT01068730|11616573|FG000|COMPLETED|Period 1||7
10468307|NCT01068730|11616574|FG001|COMPLETED|Period 1||7
10468308|NCT01068730|11616575|FG002|COMPLETED|Period 1||7
10468309|NCT01068730|11616576|FG003|COMPLETED|Period 1||7
10468310|NCT01068730|11616573|FG000|NOT COMPLETED|Period 1||0
10468311|NCT01068730|11616574|FG001|NOT COMPLETED|Period 1||0
10468312|NCT01068730|11616575|FG002|NOT COMPLETED|Period 1||0
10468313|NCT01068730|11616576|FG003|NOT COMPLETED|Period 1||0
10468314|NCT01068730|11616573|FG000|STARTED|Period 2||7
10468315|NCT01068730|11616574|FG001|STARTED|Period 2||7
10468316|NCT01068730|11616575|FG002|STARTED|Period 2||7
10468317|NCT01068730|11616576|FG003|STARTED|Period 2||7
10468318|NCT01068730|11616573|FG000|COMPLETED|Period 2||7
10468319|NCT01068730|11616574|FG001|COMPLETED|Period 2||7
10468320|NCT01068730|11616575|FG002|COMPLETED|Period 2||7
10468321|NCT01068730|11616576|FG003|COMPLETED|Period 2||7
10708719|NCT02633527|11873626|FG002|STARTED|Overall Study||50
10708720|NCT02633527|11873627|FG003|STARTED|Overall Study||49
10708721|NCT02633527|11873628|FG004|STARTED|Overall Study||51
10468322|NCT01068730|11616573|FG000|NOT COMPLETED|Period 2||0
10468323|NCT01068730|11616574|FG001|NOT COMPLETED|Period 2||0
10468324|NCT01068730|11616575|FG002|NOT COMPLETED|Period 2||0
10468325|NCT01068730|11616576|FG003|NOT COMPLETED|Period 2||0
10468326|NCT01068730|11616573|FG000|STARTED|Period 3||7
10468327|NCT01068730|11616574|FG001|STARTED|Period 3||7
10468328|NCT01068730|11616575|FG002|STARTED|Period 3||7
10468329|NCT01068730|11616576|FG003|STARTED|Period 3||7
10468330|NCT01068730|11616573|FG000|COMPLETED|Period 3||6
10468331|NCT01068730|11616574|FG001|COMPLETED|Period 3||7
10468332|NCT01068730|11616575|FG002|COMPLETED|Period 3||7
10468333|NCT01068730|11616576|FG003|COMPLETED|Period 3||7
10468334|NCT01068730|11616573|FG000|NOT COMPLETED|Period 3||1
10468335|NCT01068730|11616574|FG001|NOT COMPLETED|Period 3||0
10468336|NCT01068730|11616575|FG002|NOT COMPLETED|Period 3||0
10468337|NCT01068730|11616576|FG003|NOT COMPLETED|Period 3||0
10468338|NCT01068730|11616573|FG000|STARTED|Period 4||6
10468339|NCT01068730|11616574|FG001|STARTED|Period 4||7
10468340|NCT01068730|11616575|FG002|STARTED|Period 4||7
10468341|NCT01068730|11616576|FG003|STARTED|Period 4||7
10468342|NCT01068730|11616573|FG000|COMPLETED|Period 4||6
10468343|NCT01068730|11616574|FG001|COMPLETED|Period 4||6
10468344|NCT01068730|11616575|FG002|COMPLETED|Period 4||7
10468345|NCT01068730|11616576|FG003|COMPLETED|Period 4||7
10468346|NCT01068730|11616573|FG000|NOT COMPLETED|Period 4||0
10468347|NCT01068730|11616574|FG001|NOT COMPLETED|Period 4||1
10468348|NCT01068730|11616575|FG002|NOT COMPLETED|Period 4||0
10468349|NCT01068730|11616576|FG003|NOT COMPLETED|Period 4||0
10468350|NCT01068743|11616593|FG000|STARTED|Period 1||6
10468351|NCT01068743|11616594|FG001|STARTED|Period 1||6
10468352|NCT01068743|11616595|FG002|STARTED|Period 1||6
10468353|NCT01068743|11616596|FG003|STARTED|Period 1||6
10468354|NCT01068743|11616593|FG000|COMPLETED|Period 1||6
10468355|NCT01068743|11616594|FG001|COMPLETED|Period 1||6
10468356|NCT01068743|11616595|FG002|COMPLETED|Period 1||6
10468357|NCT01068743|11616596|FG003|COMPLETED|Period 1||6
10468358|NCT01068743|11616593|FG000|NOT COMPLETED|Period 1||0
10468359|NCT01068743|11616594|FG001|NOT COMPLETED|Period 1||0
10468360|NCT01068743|11616595|FG002|NOT COMPLETED|Period 1||0
10468361|NCT01068743|11616596|FG003|NOT COMPLETED|Period 1||0
10468362|NCT01068743|11616593|FG000|STARTED|Period 2||6
10468363|NCT01068743|11616594|FG001|STARTED|Period 2||6
10468364|NCT01068743|11616595|FG002|STARTED|Period 2||6
10468365|NCT01068743|11616596|FG003|STARTED|Period 2||6
10468366|NCT01068743|11616593|FG000|COMPLETED|Period 2||6
10468367|NCT01068743|11616594|FG001|COMPLETED|Period 2||6
10468368|NCT01068743|11616595|FG002|COMPLETED|Period 2||6
10468369|NCT01068743|11616596|FG003|COMPLETED|Period 2||6
10468370|NCT01068743|11616593|FG000|NOT COMPLETED|Period 2||0
10468371|NCT01068743|11616594|FG001|NOT COMPLETED|Period 2||0
10468372|NCT01068743|11616595|FG002|NOT COMPLETED|Period 2||0
10468373|NCT01068743|11616596|FG003|NOT COMPLETED|Period 2||0
10468374|NCT01068743|11616593|FG000|STARTED|Period 3||6
10468375|NCT01068743|11616594|FG001|STARTED|Period 3||6
10468376|NCT01068743|11616595|FG002|STARTED|Period 3||6
10468377|NCT01068743|11616596|FG003|STARTED|Period 3||6
10708722|NCT02633527|11873624|FG000|COMPLETED|Overall Study||21
10708723|NCT02633527|11873625|FG001|COMPLETED|Overall Study||37
10708724|NCT02633527|11873626|FG002|COMPLETED|Overall Study||33
10708725|NCT02633527|11873627|FG003|COMPLETED|Overall Study||35
10468378|NCT01068743|11616593|FG000|COMPLETED|Period 3||6
10468379|NCT01068743|11616594|FG001|COMPLETED|Period 3||5
10468380|NCT01068743|11616595|FG002|COMPLETED|Period 3||6
10468381|NCT01068743|11616596|FG003|COMPLETED|Period 3||6
10468382|NCT01068743|11616593|FG000|NOT COMPLETED|Period 3||0
10468383|NCT01068743|11616594|FG001|NOT COMPLETED|Period 3||1
10468384|NCT01068743|11616595|FG002|NOT COMPLETED|Period 3||0
10468385|NCT01068743|11616596|FG003|NOT COMPLETED|Period 3||0
10468386|NCT01068743|11616593|FG000|STARTED|Period 4||6
10468387|NCT01068743|11616594|FG001|STARTED|Period 4||5
10468388|NCT01068743|11616595|FG002|STARTED|Period 4||6
10468389|NCT01068743|11616596|FG003|STARTED|Period 4||6
10468390|NCT01068743|11616593|FG000|COMPLETED|Period 4||6
10468391|NCT01068743|11616594|FG001|COMPLETED|Period 4||5
10468392|NCT01068743|11616595|FG002|COMPLETED|Period 4||6
10468393|NCT01068743|11616596|FG003|COMPLETED|Period 4||6
10468394|NCT01068743|11616593|FG000|NOT COMPLETED|Period 4||0
10468395|NCT01068743|11616594|FG001|NOT COMPLETED|Period 4||0
10468396|NCT01068743|11616595|FG002|NOT COMPLETED|Period 4||0
10468397|NCT01068743|11616596|FG003|NOT COMPLETED|Period 4||0
10468398|NCT01068769|11616609|FG000|STARTED|Overall Study||34
10468399|NCT01068769|11616609|FG000|COMPLETED|Overall Study||33
10468400|NCT01068769|11616609|FG000|NOT COMPLETED|Overall Study||1
10468401|NCT01068821|11616615|FG000|STARTED|Overall Study||31
10468402|NCT01068821|11616616|FG001|STARTED|Overall Study||29
10468403|NCT01068821|11616615|FG000|COMPLETED|Overall Study|1 patient had slide measured, but her patient ID not listed; couldn't do postoperative followup.|30
10468404|NCT01068821|11616616|FG001|COMPLETED|Overall Study||29
10468405|NCT01068821|11616615|FG000|NOT COMPLETED|Overall Study||1
10468406|NCT01068821|11616616|FG001|NOT COMPLETED|Overall Study||0
10468407|NCT01068860|11616632|FG000|STARTED|Overall Study||33
10468408|NCT01068860|11616633|FG001|STARTED|Overall Study||17
10468409|NCT01068860|11616634|FG002|STARTED|Overall Study||33
10468410|NCT01068860|11616635|FG003|STARTED|Overall Study||17
10468411|NCT01068860|11616636|FG004|STARTED|Overall Study||32
10468412|NCT01068860|11616637|FG005|STARTED|Overall Study||16
10468413|NCT01068860|11616638|FG006|STARTED|Overall Study||28
10468414|NCT01068860|11616639|FG007|STARTED|Overall Study||15
10468415|NCT01068860|11616640|FG008|STARTED|Overall Study||28
10468416|NCT01068860|11616641|FG009|STARTED|Overall Study||27
10468417|NCT01068860|11616632|FG000|COMPLETED|Overall Study||33
10468418|NCT01068860|11616633|FG001|COMPLETED|Overall Study||16
10468419|NCT01068860|11616634|FG002|COMPLETED|Overall Study||33
10468420|NCT01068860|11616635|FG003|COMPLETED|Overall Study||16
10468421|NCT01068860|11616636|FG004|COMPLETED|Overall Study||32
10468422|NCT01068860|11616637|FG005|COMPLETED|Overall Study||14
10468423|NCT01068860|11616638|FG006|COMPLETED|Overall Study||28
10468424|NCT01068860|11616639|FG007|COMPLETED|Overall Study||15
10468425|NCT01068860|11616640|FG008|COMPLETED|Overall Study||28
10468426|NCT01068860|11616641|FG009|COMPLETED|Overall Study||23
10468427|NCT01068860|11616632|FG000|NOT COMPLETED|Overall Study||0
10468428|NCT01068860|11616633|FG001|NOT COMPLETED|Overall Study||1
10468429|NCT01068860|11616634|FG002|NOT COMPLETED|Overall Study||0
10468430|NCT01068860|11616635|FG003|NOT COMPLETED|Overall Study||1
10468431|NCT01068860|11616636|FG004|NOT COMPLETED|Overall Study||0
10468432|NCT01068860|11616637|FG005|NOT COMPLETED|Overall Study||2
10468433|NCT01068860|11616638|FG006|NOT COMPLETED|Overall Study||0
10468434|NCT01068860|11616639|FG007|NOT COMPLETED|Overall Study||0
10468435|NCT01068860|11616640|FG008|NOT COMPLETED|Overall Study||0
10468436|NCT01068860|11616641|FG009|NOT COMPLETED|Overall Study||4
10468437|NCT01068873|11616663|FG000|STARTED|Overall Study||1
10468438|NCT01068873|11616663|FG000|COMPLETED|Overall Study||1
10468439|NCT01068873|11616663|FG000|NOT COMPLETED|Overall Study||0
10468440|NCT01068912|11616670|FG000|STARTED|Overall Study||134
10468441|NCT01068912|11616671|FG001|STARTED|Overall Study||195
10468442|NCT01068912|11616672|FG002|STARTED|Overall Study||201
10468443|NCT01068912|11616670|FG000|COMPLETED|Overall Study||123
10468444|NCT01068912|11616671|FG001|COMPLETED|Overall Study||173
10468445|NCT01068912|11616672|FG002|COMPLETED|Overall Study||186
10468446|NCT01068912|11616670|FG000|NOT COMPLETED|Overall Study||11
10468447|NCT01068912|11616671|FG001|NOT COMPLETED|Overall Study||22
10468448|NCT01068912|11616672|FG002|NOT COMPLETED|Overall Study||15
10468449|NCT01068964|11616682|FG000|STARTED|Overall Study||121
10468450|NCT01068964|11616683|FG001|STARTED|Overall Study||114
10468451|NCT01068964|11616682|FG000|COMPLETED|Overall Study||113
10468452|NCT01068964|11616683|FG001|COMPLETED|Overall Study||104
10468453|NCT01068964|11616682|FG000|NOT COMPLETED|Overall Study||8
10468454|NCT01068964|11616683|FG001|NOT COMPLETED|Overall Study||10
10468455|NCT01069003|11616692|FG000|STARTED|Overall Study||399
10468456|NCT01069003|11616693|FG001|STARTED|Overall Study||412
10468457|NCT01069003|11616694|FG002|STARTED|Overall Study||1451
10468458|NCT01069003|11616692|FG000|COMPLETED|Overall Study||353
10468459|NCT01069003|11616693|FG001|COMPLETED|Overall Study||358
10468460|NCT01069003|11616694|FG002|COMPLETED|Overall Study||976
10468461|NCT01069003|11616692|FG000|NOT COMPLETED|Overall Study||46
10468462|NCT01069003|11616693|FG001|NOT COMPLETED|Overall Study||54
10468463|NCT01069003|11616694|FG002|NOT COMPLETED|Overall Study||475
10468464|NCT01069172|11616704|FG000|STARTED|Overall Study|30 eyes|30
10468465|NCT01069172|11616705|FG001|STARTED|Overall Study|30 eyes|30
10468466|NCT01069172|11616704|FG000|COMPLETED|Overall Study|29 eyes|29
10468467|NCT01069172|11616705|FG001|COMPLETED|Overall Study|30 eyes|30
10468468|NCT01069172|11616704|FG000|NOT COMPLETED|Overall Study||1
10468469|NCT01069172|11616705|FG001|NOT COMPLETED|Overall Study||0
10468470|NCT01069185|11616714|FG000|STARTED|Overall Study||47
10468471|NCT01069185|11616715|FG001|STARTED|Overall Study||45
10468472|NCT01069185|11616714|FG000|COMPLETED|Overall Study||47
10468473|NCT01069185|11616715|FG001|COMPLETED|Overall Study||45
10468474|NCT01069185|11616714|FG000|NOT COMPLETED|Overall Study||0
10468475|NCT01069185|11616715|FG001|NOT COMPLETED|Overall Study||0
10468476|NCT01069289|11616723|FG000|STARTED|Overall Study||636
10468477|NCT01069289|11616724|FG001|STARTED|Overall Study||657
10468478|NCT01069289|11616723|FG000|COMPLETED|Overall Study||594
10468479|NCT01069289|11616724|FG001|COMPLETED|Overall Study||601
10468480|NCT01069289|11616723|FG000|NOT COMPLETED|Overall Study||42
10468481|NCT01069289|11616724|FG001|NOT COMPLETED|Overall Study||56
10468482|NCT01069315|11616734|FG000|STARTED|Overall Study||27
10468483|NCT01069315|11616735|FG001|STARTED|Overall Study||30
10468484|NCT01069315|11616736|FG002|STARTED|Overall Study||28
10468485|NCT01069315|11616737|FG003|STARTED|Overall Study||26
10468486|NCT01069315|11616734|FG000|COMPLETED|Overall Study||23
10468487|NCT01069315|11616735|FG001|COMPLETED|Overall Study||24
10468488|NCT01069315|11616736|FG002|COMPLETED|Overall Study||23
10468489|NCT01069315|11616737|FG003|COMPLETED|Overall Study||19
10468490|NCT01069315|11616734|FG000|NOT COMPLETED|Overall Study||4
10468491|NCT01069315|11616735|FG001|NOT COMPLETED|Overall Study||6
10468492|NCT01069315|11616736|FG002|NOT COMPLETED|Overall Study||5
10468493|NCT01069315|11616737|FG003|NOT COMPLETED|Overall Study||7
10468494|NCT01069341|11616751|FG000|STARTED|Overall Study||4
10468495|NCT01069341|11616751|FG000|COMPLETED|Overall Study||3
10468496|NCT01069341|11616751|FG000|NOT COMPLETED|Overall Study||1
10468497|NCT01069354|11616755|FG000|STARTED|Overall Study||102
10708726|NCT02633527|11873628|FG004|COMPLETED|Overall Study||34
10708727|NCT02633527|11873624|FG000|NOT COMPLETED|Overall Study||3
10708728|NCT02633527|11873625|FG001|NOT COMPLETED|Overall Study||11
10468498|NCT01069354|11616755|FG000|COMPLETED|Overall Study|One subject's treatment fold not injected due to adverse event during control fold injection|101
10468499|NCT01069354|11616755|FG000|NOT COMPLETED|Overall Study||1
10468500|NCT01069419|11616763|FG000|STARTED|Overall Study||1117
10468501|NCT01069419|11616763|FG000|Safety Set|Overall Study||1111
10468502|NCT01069419|11616763|FG000|Full Analysis Set|Overall Study||851
10468503|NCT01069419|11616763|FG000|COMPLETED|Overall Study||402
10468504|NCT01069419|11616763|FG000|NOT COMPLETED|Overall Study||715
10468505|NCT01069484|11616769|FG000|STARTED|Overall Study|27 in the stratum with major levator ani muscle defects and 60 in the stratum without such defects.|87
10468506|NCT01069484|11616770|FG001|STARTED|Overall Study|28 in the stratum with major levator ani muscle defects and 60 in the stratum without such defects.|88
10468507|NCT01069484|11616769|FG000|COMPLETED|Overall Study|24 in the stratum with major levator ani muscle defects and 51 in the stratum without such defects.|75
10468508|NCT01069484|11616770|FG001|COMPLETED|Overall Study|27 in the stratum with major levator ani muscle defects and 58 in the stratum without such defects.|85
10468509|NCT01069484|11616769|FG000|NOT COMPLETED|Overall Study||12
10468510|NCT01069484|11616770|FG001|NOT COMPLETED|Overall Study||3
10468511|NCT01069510|11616779|FG000|STARTED|Overall Study||8
10468512|NCT01069510|11616780|FG001|STARTED|Overall Study||7
10468513|NCT01069510|11616779|FG000|COMPLETED|Overall Study||8
10468514|NCT01069510|11616780|FG001|COMPLETED|Overall Study||7
10468515|NCT01069510|11616779|FG000|NOT COMPLETED|Overall Study||0
10468516|NCT01069510|11616780|FG001|NOT COMPLETED|Overall Study||0
10468517|NCT01069523|11616788|FG000|STARTED|Overall Study||13
10468518|NCT01069523|11616789|FG001|STARTED|Overall Study||16
10468519|NCT01069523|11616788|FG000|COMPLETED|Overall Study||9
10468520|NCT01069523|11616789|FG001|COMPLETED|Overall Study||9
10468521|NCT01069523|11616788|FG000|NOT COMPLETED|Overall Study||4
10468522|NCT01069523|11616789|FG001|NOT COMPLETED|Overall Study||7
10468523|NCT01069562|11616799|FG000|STARTED|Overall Study||20
10468524|NCT01069562|11616800|FG001|STARTED|Overall Study||20
10468525|NCT01069562|11616799|FG000|COMPLETED|Overall Study||20
10468526|NCT01069562|11616800|FG001|COMPLETED|Overall Study||20
10468527|NCT01069562|11616799|FG000|NOT COMPLETED|Overall Study||0
10468528|NCT01069562|11616800|FG001|NOT COMPLETED|Overall Study||0
10468529|NCT01069627|11616806|FG000|STARTED|Overall Study||20
10468530|NCT01069627|11616806|FG000|COMPLETED|Overall Study||0
10468531|NCT01069627|11616806|FG000|NOT COMPLETED|Overall Study||20
10468532|NCT01069705|11616810|FG000|STARTED|Overall Study||49
10468533|NCT01069705|11616810|FG000|COMPLETED|Overall Study||46
10468534|NCT01069705|11616810|FG000|NOT COMPLETED|Overall Study||3
10468535|NCT01069900|11616816|FG000|STARTED|Overall Study||305
10468536|NCT01069900|11616817|FG001|STARTED|Overall Study||153
10468537|NCT01069900|11616816|FG000|Treated|Overall Study||301
10468538|NCT01069900|11616817|FG001|Treated|Overall Study||150
10468539|NCT01069900|11616816|FG000|COMPLETED|Overall Study||287
10468540|NCT01069900|11616817|FG001|COMPLETED|Overall Study||149
10468541|NCT01069900|11616816|FG000|NOT COMPLETED|Overall Study||18
10468542|NCT01069900|11616817|FG001|NOT COMPLETED|Overall Study||4
10468543|NCT01069939|11616825|FG000|STARTED|Randomised and Included in the Analyses||213
10468544|NCT01069939|11616826|FG001|STARTED|Randomised and Included in the Analyses||214
10468545|NCT01069939|11616825|FG000|COMPLETED|Randomised and Included in the Analyses||164
10708729|NCT02633527|11873626|FG002|NOT COMPLETED|Overall Study||17
10468546|NCT01069939|11616826|FG001|COMPLETED|Randomised and Included in the Analyses||137
10468547|NCT01069939|11616825|FG000|NOT COMPLETED|Randomised and Included in the Analyses||49
10468548|NCT01069939|11616826|FG001|NOT COMPLETED|Randomised and Included in the Analyses||77
10468549|NCT01069939|11616825|FG000|STARTED|At Data Cut Off Date (26 Feb 2011)||213
10468550|NCT01069939|11616826|FG001|STARTED|At Data Cut Off Date (26 Feb 2011)||214
10468551|NCT01069939|11616825|FG000|COMPLETED|At Data Cut Off Date (26 Feb 2011)||182
10468552|NCT01069939|11616826|FG001|COMPLETED|At Data Cut Off Date (26 Feb 2011)||182
10468553|NCT01069939|11616825|FG000|NOT COMPLETED|At Data Cut Off Date (26 Feb 2011)||31
10468554|NCT01069939|11616826|FG001|NOT COMPLETED|At Data Cut Off Date (26 Feb 2011)||32
10468555|NCT01070043|11616834|FG000|STARTED|Run-In Phase||60
10468556|NCT01070043|11616835|FG001|STARTED|Run-In Phase|This combination therapy arm is used only for double-blind phase.|0
10468557|NCT01070043|11616836|FG002|STARTED|Run-In Phase|This monotherapy (Valsartan 160 mg) treatment arm is used only for double-blind phase.|0
10468558|NCT01070043|11616834|FG000|COMPLETED|Run-In Phase||42
10468559|NCT01070043|11616835|FG001|COMPLETED|Run-In Phase||0
10468560|NCT01070043|11616836|FG002|COMPLETED|Run-In Phase||0
10708730|NCT02633527|11873627|FG003|NOT COMPLETED|Overall Study||14
10708731|NCT02633527|11873628|FG004|NOT COMPLETED|Overall Study||17
10468561|NCT01070043|11616834|FG000|NOT COMPLETED|Run-In Phase||18
10468562|NCT01070043|11616835|FG001|NOT COMPLETED|Run-In Phase||0
10468563|NCT01070043|11616836|FG002|NOT COMPLETED|Run-In Phase||0
10468564|NCT01070043|11616834|FG000|STARTED|Double-Blind Treatment||0
10468565|NCT01070043|11616835|FG001|STARTED|Double-Blind Treatment||21
10468566|NCT01070043|11616836|FG002|STARTED|Double-Blind Treatment||21
10468567|NCT01070043|11616834|FG000|COMPLETED|Double-Blind Treatment||0
10468568|NCT01070043|11616835|FG001|COMPLETED|Double-Blind Treatment||21
10468569|NCT01070043|11616836|FG002|COMPLETED|Double-Blind Treatment||19
10468570|NCT01070043|11616834|FG000|NOT COMPLETED|Double-Blind Treatment||0
10468571|NCT01070043|11616835|FG001|NOT COMPLETED|Double-Blind Treatment||0
10468572|NCT01070043|11616836|FG002|NOT COMPLETED|Double-Blind Treatment||2
10468573|NCT01070095|11616842|FG000|STARTED|Baseline Period||19
10468574|NCT01070095|11616843|FG001|STARTED|Baseline Period||830
10468575|NCT01070095|11616842|FG000|COMPLETED|Baseline Period||18
10468576|NCT01070095|11616843|FG001|COMPLETED|Baseline Period||830
10468577|NCT01070095|11616842|FG000|NOT COMPLETED|Baseline Period||1
10468578|NCT01070095|11616843|FG001|NOT COMPLETED|Baseline Period||0
10468579|NCT01070095|11616842|FG000|STARTED|Intervention Period||18
10468580|NCT01070095|11616843|FG001|STARTED|Intervention Period||890
10468581|NCT01070095|11616842|FG000|COMPLETED|Intervention Period||18
10468582|NCT01070095|11616843|FG001|COMPLETED|Intervention Period||890
10468583|NCT01070095|11616842|FG000|NOT COMPLETED|Intervention Period||0
10468584|NCT01070095|11616843|FG001|NOT COMPLETED|Intervention Period||0
10468585|NCT01070173|11616853|FG000|STARTED|Overall Study||33
10468586|NCT01070173|11616854|FG001|STARTED|Overall Study||8
10468587|NCT01070173|11616855|FG002|STARTED|Overall Study||11
10468588|NCT01070173|11616853|FG000|COMPLETED|Overall Study||33
10468589|NCT01070173|11616854|FG001|COMPLETED|Overall Study||8
10468590|NCT01070173|11616855|FG002|COMPLETED|Overall Study||11
10468591|NCT01070173|11616853|FG000|NOT COMPLETED|Overall Study||0
10468592|NCT01070173|11616854|FG001|NOT COMPLETED|Overall Study||0
10468593|NCT01070173|11616855|FG002|NOT COMPLETED|Overall Study||0
10468594|NCT01070303|11616865|FG000|STARTED|Overall Study||177
10468595|NCT01070303|11616865|FG000|COMPLETED|Overall Study||88
10468596|NCT01070303|11616865|FG000|NOT COMPLETED|Overall Study||89
10468597|NCT01070316|11616875|FG000|STARTED|Main Phase||20
10468598|NCT01070316|11616875|FG000|COMPLETED|Main Phase||20
10468599|NCT01070316|11616875|FG000|NOT COMPLETED|Main Phase||0
10468600|NCT01070316|11616875|FG000|STARTED|Extension Phase|Two participants did not qualify for Extension Phase as defined by protocol|18
10468601|NCT01070316|11616875|FG000|COMPLETED|Extension Phase||14
10468602|NCT01070316|11616875|FG000|NOT COMPLETED|Extension Phase||4
10468603|NCT01070329|11616881|FG000|STARTED|Overall Study||261
10468604|NCT01070329|11616882|FG001|STARTED|Overall Study||266
10468605|NCT01070329|11616881|FG000|COMPLETED|Overall Study||209
10468606|NCT01070329|11616882|FG001|COMPLETED|Overall Study||217
10468607|NCT01070329|11616881|FG000|NOT COMPLETED|Overall Study||52
10468608|NCT01070329|11616882|FG001|NOT COMPLETED|Overall Study||49
10468609|NCT01070381|11616888|FG000|STARTED|Period 1, 1 Week of Wear|One subject could not be dispensed into Period 1 product. Subject started Period 2 wear.|109
10468610|NCT01070381|11616889|FG001|STARTED|Period 1, 1 Week of Wear||107
10468611|NCT01070381|11616888|FG000|COMPLETED|Period 1, 1 Week of Wear|One subject could not continue into Period 2 due to product unavailability.|109
10468612|NCT01070381|11616889|FG001|COMPLETED|Period 1, 1 Week of Wear||107
10468613|NCT01070381|11616888|FG000|NOT COMPLETED|Period 1, 1 Week of Wear||0
10468614|NCT01070381|11616889|FG001|NOT COMPLETED|Period 1, 1 Week of Wear||0
10468615|NCT01070381|11616888|FG000|STARTED|Period 2, 1 Week of Wear||109
10468616|NCT01070381|11616889|FG001|STARTED|Period 2, 1 Week of Wear||107
10468617|NCT01070381|11616888|FG000|COMPLETED|Period 2, 1 Week of Wear||108
10468618|NCT01070381|11616889|FG001|COMPLETED|Period 2, 1 Week of Wear||106
10468619|NCT01070381|11616888|FG000|NOT COMPLETED|Period 2, 1 Week of Wear||1
10468620|NCT01070381|11616889|FG001|NOT COMPLETED|Period 2, 1 Week of Wear||1
10468621|NCT01070394|11616895|FG000|STARTED|Overall Study||40
10468622|NCT01070394|11616895|FG000|COMPLETED|Overall Study||33
10468623|NCT01070394|11616895|FG000|NOT COMPLETED|Overall Study||7
10468624|NCT01070550|11616907|FG000|STARTED|Overall Study||3356
10468625|NCT01070550|11616908|FG001|STARTED|Overall Study||316
10468626|NCT01070550|11616909|FG002|STARTED|Overall Study||744
10468627|NCT01070550|11616910|FG003|STARTED|Overall Study||201
10468628|NCT01070550|11616911|FG004|STARTED|Overall Study||21
10468629|NCT01070550|11616912|FG005|STARTED|Overall Study||42
10468630|NCT01070550|11616907|FG000|COMPLETED|Overall Study||2071
10468631|NCT01070550|11616908|FG001|COMPLETED|Overall Study||254
10468632|NCT01070550|11616909|FG002|COMPLETED|Overall Study||528
10468633|NCT01070550|11616910|FG003|COMPLETED|Overall Study||124
10468634|NCT01070550|11616911|FG004|COMPLETED|Overall Study||20
10468635|NCT01070550|11616912|FG005|COMPLETED|Overall Study||35
10468636|NCT01070550|11616907|FG000|NOT COMPLETED|Overall Study||1285
10468637|NCT01070550|11616908|FG001|NOT COMPLETED|Overall Study||62
10468638|NCT01070550|11616909|FG002|NOT COMPLETED|Overall Study||216
10468639|NCT01070550|11616910|FG003|NOT COMPLETED|Overall Study||77
10468640|NCT01070550|11616911|FG004|NOT COMPLETED|Overall Study||1
10468641|NCT01070550|11616912|FG005|NOT COMPLETED|Overall Study||7
10468642|NCT01070693|11616929|FG000|STARTED|Overall Study||150
10468643|NCT01070693|11616930|FG001|STARTED|Overall Study||149
10468644|NCT01070693|11616929|FG000|COMPLETED|Overall Study||122
10468645|NCT01070693|11616930|FG001|COMPLETED|Overall Study||110
10468646|NCT01070693|11616929|FG000|NOT COMPLETED|Overall Study||28
10468647|NCT01070693|11616930|FG001|NOT COMPLETED|Overall Study||39
10468648|NCT01070771|11616936|FG000|STARTED|Overall Study|September 2008|203
10468649|NCT01070771|11616936|FG000|COMPLETED|Overall Study|August 2012|200
10468650|NCT01070771|11616936|FG000|NOT COMPLETED|Overall Study||3
10526663|NCT01383161|11678577|FG000|STARTED|Overall Study||25
10526664|NCT01383161|11678578|FG001|STARTED|Overall Study||21
10526665|NCT01383161|11678577|FG000|COMPLETED|Overall Study||20
10526666|NCT01383161|11678578|FG001|COMPLETED|Overall Study||17
10526667|NCT01383161|11678577|FG000|NOT COMPLETED|Overall Study||5
10526668|NCT01383161|11678578|FG001|NOT COMPLETED|Overall Study||4
10526669|NCT01383174|11678586|FG000|STARTED|Baseline Assessment||76
10526670|NCT01383174|11678587|FG001|STARTED|Baseline Assessment||75
10526671|NCT01383174|11678586|FG000|COMPLETED|Baseline Assessment|These 76 completed the baseline assessment and continued in the study.|76
10526672|NCT01383174|11678587|FG001|COMPLETED|Baseline Assessment|These 75 completed the baseline assessment and continued in the study.|75
10526673|NCT01383174|11678586|FG000|NOT COMPLETED|Baseline Assessment||0
10526674|NCT01383174|11678587|FG001|NOT COMPLETED|Baseline Assessment||0
10526675|NCT01383174|11678586|FG000|STARTED|3 Month Assessment||76
10526676|NCT01383174|11678587|FG001|STARTED|3 Month Assessment||75
10526677|NCT01383174|11678586|FG000|COMPLETED|3 Month Assessment|These 70 completed the 3 month assessment and continued in the study.|70
10526678|NCT01383174|11678587|FG001|COMPLETED|3 Month Assessment|These 74 completed the 3 month assessment and continued in the study.|74
10526679|NCT01383174|11678586|FG000|NOT COMPLETED|3 Month Assessment||6
10526680|NCT01383174|11678587|FG001|NOT COMPLETED|3 Month Assessment||1
10526681|NCT01383174|11678586|FG000|STARTED|6 Month Assessment|All 76 people were contacted at 6 months;1 person returned and 5 did not return to study at 6 months|76
10526682|NCT01383174|11678587|FG001|STARTED|6 Month Assessment||74
10526683|NCT01383174|11678586|FG000|COMPLETED|6 Month Assessment|These 71 completed the 6 month assessment and completed the study.|71
10526684|NCT01383174|11678587|FG001|COMPLETED|6 Month Assessment|These 73 completed the 6 month assessment and completed the study.|73
10526685|NCT01383174|11678586|FG000|NOT COMPLETED|6 Month Assessment||5
10526686|NCT01383174|11678587|FG001|NOT COMPLETED|6 Month Assessment||1
10529002|NCT01397890|11681409|FG001|Post-baseline Efficacy Data Collected|Overall Study|'Full Analysis Set' used for efficacy analysis|290
10529003|NCT01397890|11681408|FG000|Received Correct Randomized Treatment|Overall Study|'Safety Analysis Set' =287+3-1=289. 3 and 1 pts in respective groups received opposite treatment.|286
10529004|NCT01397890|11681409|FG001|Received Correct Randomized Treatment|Overall Study|'Safety Analysis Set' =291+1-3=289.|287
10529005|NCT01397890|11681408|FG000|COMPLETED|Overall Study||264
10529006|NCT01397890|11681409|FG001|COMPLETED|Overall Study||260
10529007|NCT01397890|11681408|FG000|NOT COMPLETED|Overall Study||23
10529008|NCT01397890|11681409|FG001|NOT COMPLETED|Overall Study||31
10529009|NCT01398059|11681415|FG000|STARTED|Overall Study||4
10529010|NCT01398059|11681416|FG001|STARTED|Overall Study||3
10529011|NCT01398059|11681417|FG002|STARTED|Overall Study||4
10529012|NCT01398059|11681418|FG003|STARTED|Overall Study||2
10529013|NCT01398059|11681419|FG004|STARTED|Overall Study||4
10529014|NCT01398059|11681420|FG005|STARTED|Overall Study||2
10529015|NCT01398059|11681415|FG000|COMPLETED|Overall Study||4
10529016|NCT01398059|11681416|FG001|COMPLETED|Overall Study||3
10529017|NCT01398059|11681417|FG002|COMPLETED|Overall Study||4
10529018|NCT01398059|11681418|FG003|COMPLETED|Overall Study||2
10529019|NCT01398059|11681419|FG004|COMPLETED|Overall Study||4
10529020|NCT01398059|11681420|FG005|COMPLETED|Overall Study||2
10529021|NCT01398059|11681415|FG000|NOT COMPLETED|Overall Study||0
10529022|NCT01398059|11681416|FG001|NOT COMPLETED|Overall Study||0
10529023|NCT01398059|11681417|FG002|NOT COMPLETED|Overall Study||0
10529024|NCT01398059|11681418|FG003|NOT COMPLETED|Overall Study||0
10529025|NCT01398059|11681419|FG004|NOT COMPLETED|Overall Study||0
10529026|NCT01398059|11681420|FG005|NOT COMPLETED|Overall Study||0
10529027|NCT01398176|11681430|FG000|STARTED|Overall Study||26
10529028|NCT01398176|11681431|FG001|STARTED|Overall Study||25
10529029|NCT01398176|11681430|FG000|COMPLETED|Overall Study||23
10529030|NCT01398176|11681431|FG001|COMPLETED|Overall Study||19
10529031|NCT01398176|11681430|FG000|NOT COMPLETED|Overall Study||3
10529032|NCT01398176|11681431|FG001|NOT COMPLETED|Overall Study||6
10529033|NCT01398280|11681439|FG000|STARTED|Overall Study||11
10529034|NCT01398280|11681440|FG001|STARTED|Overall Study||4
10529035|NCT01398280|11681439|FG000|COMPLETED|Overall Study||7
10529036|NCT01398280|11681440|FG001|COMPLETED|Overall Study||4
10529037|NCT01398280|11681439|FG000|NOT COMPLETED|Overall Study||4
10529038|NCT01398280|11681440|FG001|NOT COMPLETED|Overall Study||0
10529039|NCT01398358|11681449|FG000|STARTED|Overall Study||218
10529040|NCT01398358|11681450|FG001|STARTED|Overall Study||224
10529041|NCT01398358|11681451|FG002|STARTED|Overall Study||255
10529042|NCT01398358|11681449|FG000|COMPLETED|Overall Study||203
10529043|NCT01398358|11681450|FG001|COMPLETED|Overall Study||201
10529044|NCT01398358|11681451|FG002|COMPLETED|Overall Study||234
10529045|NCT01398358|11681449|FG000|NOT COMPLETED|Overall Study||15
10529046|NCT01398358|11681450|FG001|NOT COMPLETED|Overall Study||23
10529047|NCT01398358|11681451|FG002|NOT COMPLETED|Overall Study||21
10529048|NCT01398410|11681461|FG000|STARTED|Overall Study|Treated participants (all participants who received at least one dose of rabeprazole).|201
10529049|NCT01398410|11681462|FG001|STARTED|Overall Study||204
10529050|NCT01398410|11681461|FG000|COMPLETED|Overall Study||143
10529051|NCT01398410|11681462|FG001|COMPLETED|Overall Study||148
10529052|NCT01398410|11681461|FG000|NOT COMPLETED|Overall Study||58
10529053|NCT01398410|11681462|FG001|NOT COMPLETED|Overall Study||56
10529054|NCT01398475|11681468|FG000|STARTED|Overall Study||4
10529055|NCT01398475|11681469|FG001|STARTED|Overall Study||3
10529056|NCT01398475|11681470|FG002|STARTED|Overall Study||4
10529057|NCT01398475|11681471|FG003|STARTED|Overall Study||4
10529058|NCT01398475|11681468|FG000|Received First Intervention|Overall Study||4
10468651|NCT01070784|11616943|FG000|STARTED|Overall Study||130
10468652|NCT01070784|11616944|FG001|STARTED|Overall Study||130
10468653|NCT01070784|11616943|FG000|COMPLETED|Overall Study||110
10468654|NCT01070784|11616944|FG001|COMPLETED|Overall Study||112
10468655|NCT01070784|11616943|FG000|NOT COMPLETED|Overall Study||20
10468656|NCT01070784|11616944|FG001|NOT COMPLETED|Overall Study||18
10468657|NCT01070810|11616952|FG000|STARTED|Overall Study||45
10468658|NCT01070810|11616953|FG001|STARTED|Overall Study||43
10468659|NCT01070810|11616952|FG000|COMPLETED|Overall Study||45
10468660|NCT01070810|11616953|FG001|COMPLETED|Overall Study||43
10468661|NCT01070810|11616952|FG000|NOT COMPLETED|Overall Study||0
10468662|NCT01070810|11616953|FG001|NOT COMPLETED|Overall Study||0
10468663|NCT01070888|11616963|FG000|STARTED|First Intervention (14 Days)||2
10468664|NCT01070888|11616964|FG001|STARTED|First Intervention (14 Days)||4
10468665|NCT01070888|11616963|FG000|COMPLETED|First Intervention (14 Days)||2
10468666|NCT01070888|11616964|FG001|COMPLETED|First Intervention (14 Days)||2
10468667|NCT01070888|11616963|FG000|NOT COMPLETED|First Intervention (14 Days)||0
10468668|NCT01070888|11616964|FG001|NOT COMPLETED|First Intervention (14 Days)||2
10468669|NCT01070888|11616963|FG000|STARTED|Washout (14 Days)||2
10468670|NCT01070888|11616964|FG001|STARTED|Washout (14 Days)||2
10468671|NCT01070888|11616963|FG000|COMPLETED|Washout (14 Days)||1
10468672|NCT01070888|11616964|FG001|COMPLETED|Washout (14 Days)||2
10468673|NCT01070888|11616963|FG000|NOT COMPLETED|Washout (14 Days)||1
10468674|NCT01070888|11616964|FG001|NOT COMPLETED|Washout (14 Days)||0
10468675|NCT01070888|11616963|FG000|STARTED|Second Intervention (14 Days)||1
10468676|NCT01070888|11616964|FG001|STARTED|Second Intervention (14 Days)||2
10708732|NCT02633735|11873642|FG000|STARTED|Pre-implementation Phase||788
10708733|NCT02633735|11873643|FG001|STARTED|Pre-implementation Phase||1011
10708734|NCT02633735|11873642|FG000|COMPLETED|Pre-implementation Phase||788
10708735|NCT02633735|11873643|FG001|COMPLETED|Pre-implementation Phase||1011
10708736|NCT02633735|11873642|FG000|NOT COMPLETED|Pre-implementation Phase||0
10708737|NCT02633735|11873643|FG001|NOT COMPLETED|Pre-implementation Phase||0
10708738|NCT02633735|11873642|FG000|STARTED|Implementation Phase||1991
10708739|NCT02633735|11873643|FG001|STARTED|Implementation Phase||2150
10708740|NCT02633735|11873642|FG000|COMPLETED|Implementation Phase||1991
10708741|NCT02633735|11873643|FG001|COMPLETED|Implementation Phase||2150
10468677|NCT01070888|11616963|FG000|COMPLETED|Second Intervention (14 Days)||1
10468678|NCT01070888|11616964|FG001|COMPLETED|Second Intervention (14 Days)||2
10468679|NCT01070888|11616963|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
10468680|NCT01070888|11616964|FG001|NOT COMPLETED|Second Intervention (14 Days)||0
10468681|NCT01070979|11616973|FG000|STARTED|Overall Study||79
10468682|NCT01070979|11616974|FG001|STARTED|Overall Study||85
10468683|NCT01070979|11616975|FG002|STARTED|Overall Study||85
10468684|NCT01070979|11616973|FG000|COMPLETED|Overall Study||68
10468685|NCT01070979|11616974|FG001|COMPLETED|Overall Study||73
10468686|NCT01070979|11616975|FG002|COMPLETED|Overall Study||72
10468687|NCT01070979|11616973|FG000|NOT COMPLETED|Overall Study||11
10468688|NCT01070979|11616974|FG001|NOT COMPLETED|Overall Study||12
10468689|NCT01070979|11616975|FG002|NOT COMPLETED|Overall Study||13
10468690|NCT01071044|11616985|FG000|STARTED|Overall Study||15
10468691|NCT01071044|11616986|FG001|STARTED|Overall Study||11
10468692|NCT01071044|11616985|FG000|COMPLETED|Overall Study||13
10468693|NCT01071044|11616986|FG001|COMPLETED|Overall Study||11
10468694|NCT01071044|11616985|FG000|NOT COMPLETED|Overall Study||2
10468695|NCT01071044|11616986|FG001|NOT COMPLETED|Overall Study||0
10468696|NCT01071070|11616997|FG000|STARTED|Overall Study||108
10468697|NCT01071070|11616998|FG001|STARTED|Overall Study||108
10468698|NCT01071070|11616997|FG000|COMPLETED|Overall Study||104
10468699|NCT01071070|11616998|FG001|COMPLETED|Overall Study||105
10468700|NCT01071070|11616997|FG000|NOT COMPLETED|Overall Study||4
10468701|NCT01071070|11616998|FG001|NOT COMPLETED|Overall Study||3
10468702|NCT01071083|11617009|FG000|STARTED|Overall Study||42
10468703|NCT01071083|11617010|FG001|STARTED|Overall Study||45
10468704|NCT01071083|11617011|FG002|STARTED|Overall Study||17
10468705|NCT01071083|11617012|FG003|STARTED|Overall Study||17
10468706|NCT01071083|11617013|FG004|STARTED|Overall Study||54
10468707|NCT01071083|11617009|FG000|COMPLETED|Overall Study||35
10468708|NCT01071083|11617010|FG001|COMPLETED|Overall Study||43
10468709|NCT01071083|11617011|FG002|COMPLETED|Overall Study||12
10468710|NCT01071083|11617012|FG003|COMPLETED|Overall Study||15
10468711|NCT01071083|11617013|FG004|COMPLETED|Overall Study||46
10468712|NCT01071083|11617009|FG000|NOT COMPLETED|Overall Study||7
10468713|NCT01071083|11617010|FG001|NOT COMPLETED|Overall Study||2
10468714|NCT01071083|11617011|FG002|NOT COMPLETED|Overall Study||5
10468715|NCT01071083|11617012|FG003|NOT COMPLETED|Overall Study||2
10468716|NCT01071083|11617013|FG004|NOT COMPLETED|Overall Study||8
10468717|NCT01071096|11617025|FG000|STARTED|First Intervention (90 Days)||10
10468718|NCT01071096|11617026|FG001|STARTED|First Intervention (90 Days)||10
10468719|NCT01071096|11617025|FG000|COMPLETED|First Intervention (90 Days)||9
10468720|NCT01071096|11617026|FG001|COMPLETED|First Intervention (90 Days)||10
10708742|NCT02633735|11873642|FG000|NOT COMPLETED|Implementation Phase||0
10708743|NCT02633735|11873643|FG001|NOT COMPLETED|Implementation Phase||0
10468721|NCT01071096|11617025|FG000|NOT COMPLETED|First Intervention (90 Days)||1
10468722|NCT01071096|11617026|FG001|NOT COMPLETED|First Intervention (90 Days)||0
10468723|NCT01071096|11617025|FG000|STARTED|Washout Period (30 Days)||9
10468724|NCT01071096|11617026|FG001|STARTED|Washout Period (30 Days)||10
10468725|NCT01071096|11617025|FG000|COMPLETED|Washout Period (30 Days)||9
10468726|NCT01071096|11617026|FG001|COMPLETED|Washout Period (30 Days)||10
10468727|NCT01071096|11617025|FG000|NOT COMPLETED|Washout Period (30 Days)||0
10468728|NCT01071096|11617026|FG001|NOT COMPLETED|Washout Period (30 Days)||0
10468729|NCT01071096|11617025|FG000|STARTED|Second Intervention (90 Days)||9
10468730|NCT01071096|11617026|FG001|STARTED|Second Intervention (90 Days)||10
10468731|NCT01071096|11617025|FG000|COMPLETED|Second Intervention (90 Days)||9
10468732|NCT01071096|11617026|FG001|COMPLETED|Second Intervention (90 Days)||10
10468733|NCT01071096|11617025|FG000|NOT COMPLETED|Second Intervention (90 Days)||0
10468734|NCT01071096|11617026|FG001|NOT COMPLETED|Second Intervention (90 Days)||0
10468735|NCT01071200|11617045|FG000|STARTED|Overall Study||67
10468736|NCT01071200|11617046|FG001|STARTED|Overall Study||66
10468737|NCT01071200|11617045|FG000|COMPLETED|Overall Study||60
10468738|NCT01071200|11617046|FG001|COMPLETED|Overall Study||63
10468739|NCT01071200|11617045|FG000|NOT COMPLETED|Overall Study||7
10468740|NCT01071200|11617046|FG001|NOT COMPLETED|Overall Study||3
10468741|NCT01071252|11617057|FG000|STARTED|Overall Study||29
10468742|NCT01071252|11617058|FG001|STARTED|Overall Study||26
10468743|NCT01071252|11617059|FG002|STARTED|Overall Study||21
10468744|NCT01071252|11617060|FG003|STARTED|Overall Study||27
10468745|NCT01071252|11617061|FG004|STARTED|Overall Study||22
10468746|NCT01071252|11617057|FG000|COMPLETED|Overall Study||14
10468747|NCT01071252|11617058|FG001|COMPLETED|Overall Study||16
10468748|NCT01071252|11617059|FG002|COMPLETED|Overall Study||17
10468749|NCT01071252|11617060|FG003|COMPLETED|Overall Study||20
10468750|NCT01071252|11617061|FG004|COMPLETED|Overall Study||11
10468751|NCT01071252|11617057|FG000|NOT COMPLETED|Overall Study||15
10468752|NCT01071252|11617058|FG001|NOT COMPLETED|Overall Study||10
10468753|NCT01071252|11617059|FG002|NOT COMPLETED|Overall Study||4
10468754|NCT01071252|11617060|FG003|NOT COMPLETED|Overall Study||7
10468755|NCT01071252|11617061|FG004|NOT COMPLETED|Overall Study||11
10468756|NCT01071278|11617073|FG000|STARTED|Overall Study||2390
10468757|NCT01071278|11617073|FG000|COMPLETED|Overall Study||1677
10468758|NCT01071278|11617073|FG000|NOT COMPLETED|Overall Study||713
10468759|NCT01071317|11617081|FG000|STARTED|Overall Study||25
10468760|NCT01071317|11617082|FG001|STARTED|Overall Study||25
10468761|NCT01071317|11617081|FG000|COMPLETED|Overall Study||23
10468762|NCT01071317|11617082|FG001|COMPLETED|Overall Study||23
10468763|NCT01071317|11617081|FG000|NOT COMPLETED|Overall Study||2
10468764|NCT01071317|11617082|FG001|NOT COMPLETED|Overall Study||2
10468765|NCT01071356|11617090|FG000|STARTED|Overall Study||111
10468766|NCT01071356|11617091|FG001|STARTED|Overall Study||106
10468767|NCT01071356|11617090|FG000|COMPLETED|Overall Study||104
10468768|NCT01071356|11617091|FG001|COMPLETED|Overall Study||97
10468769|NCT01071356|11617090|FG000|NOT COMPLETED|Overall Study||7
10468770|NCT01071356|11617091|FG001|NOT COMPLETED|Overall Study||9
10468771|NCT01071395|11617099|FG000|STARTED|Overall Study||36
10468772|NCT01071395|11617100|FG001|STARTED|Overall Study||32
10468773|NCT01071395|11617099|FG000|COMPLETED|Overall Study||31
10468774|NCT01071395|11617100|FG001|COMPLETED|Overall Study||30
10468775|NCT01071395|11617099|FG000|NOT COMPLETED|Overall Study||5
10468776|NCT01071395|11617100|FG001|NOT COMPLETED|Overall Study||2
10468777|NCT01071512|11617106|FG000|STARTED|Overall Study||20
10468778|NCT01071512|11617106|FG000|COMPLETED|Overall Study||15
10468779|NCT01071512|11617106|FG000|NOT COMPLETED|Overall Study||5
10468780|NCT01071538|11617110|FG000|STARTED|Overall Study||15
10468781|NCT01071538|11617110|FG000|COMPLETED|Overall Study||13
10468782|NCT01071538|11617110|FG000|NOT COMPLETED|Overall Study||2
10468783|NCT01071798|11617114|FG000|STARTED|Participants Who Received One Cycle||1653
10468784|NCT01071798|11617114|FG000|Baseline and Safety Analysis Set|Participants Who Received One Cycle||1653
10468785|NCT01071798|11617114|FG000|COMPLETED|Participants Who Received One Cycle||1588
10468786|NCT01071798|11617114|FG000|NOT COMPLETED|Participants Who Received One Cycle||65
10468787|NCT01071798|11617114|FG000|STARTED|Subpopulation Who Received Two Cycles||820
10468788|NCT01071798|11617114|FG000|Baseline and Safety Analysis Set|Subpopulation Who Received Two Cycles||820
10468789|NCT01071798|11617114|FG000|COMPLETED|Subpopulation Who Received Two Cycles||805
10468790|NCT01071798|11617114|FG000|NOT COMPLETED|Subpopulation Who Received Two Cycles||15
10468791|NCT01071915|11617128|FG000|STARTED|Overall Study|Intention to Treat Analysis Set|157
10468792|NCT01071915|11617128|FG000|Full Analysis Set (FAS)|Overall Study||155
10468793|NCT01071915|11617128|FG000|Safety Analysis Set|Overall Study||156
10468794|NCT01071915|11617128|FG000|COMPLETED|Overall Study||148
10468795|NCT01071915|11617128|FG000|NOT COMPLETED|Overall Study||9
10468796|NCT01071954|11617132|FG000|STARTED|Overall Study||66
10468797|NCT01071954|11617132|FG000|Received Treatment|Overall Study||65
10468798|NCT01071954|11617132|FG000|COMPLETED|Overall Study||39
10468799|NCT01071954|11617132|FG000|NOT COMPLETED|Overall Study||27
10468800|NCT01072006|11617140|FG000|STARTED|Overall Study||14
10468801|NCT01072006|11617141|FG001|STARTED|Overall Study||5
10468802|NCT01072006|11617142|FG002|STARTED|Overall Study||0
10468803|NCT01072006|11617143|FG003|STARTED|Overall Study||11
10468804|NCT01072006|11617140|FG000|COMPLETED|Overall Study||14
10468805|NCT01072006|11617141|FG001|COMPLETED|Overall Study||5
10468806|NCT01072006|11617142|FG002|COMPLETED|Overall Study||0
10468807|NCT01072006|11617143|FG003|COMPLETED|Overall Study||11
10468808|NCT01072006|11617140|FG000|NOT COMPLETED|Overall Study||0
10468809|NCT01072006|11617141|FG001|NOT COMPLETED|Overall Study||0
10468810|NCT01072006|11617142|FG002|NOT COMPLETED|Overall Study||0
10468811|NCT01072006|11617143|FG003|NOT COMPLETED|Overall Study||0
10468812|NCT01072032|11617156|FG000|STARTED|Overall Study||13
10468813|NCT01072032|11617157|FG001|STARTED|Overall Study||14
10468814|NCT01072032|11617156|FG000|COMPLETED|Overall Study||5
10468815|NCT01072032|11617157|FG001|COMPLETED|Overall Study||5
10468816|NCT01072032|11617156|FG000|NOT COMPLETED|Overall Study||8
10468817|NCT01072032|11617157|FG001|NOT COMPLETED|Overall Study||9
10468818|NCT01072136|11617166|FG000|STARTED|Overall Study||44
10468819|NCT01072136|11617167|FG001|STARTED|Overall Study||43
10468820|NCT01072136|11617166|FG000|Met All Enrollment Criteria|Overall Study|Some eligibility test results were not available until after randomization.|30
10468821|NCT01072136|11617167|FG001|Met All Enrollment Criteria|Overall Study||25
10468822|NCT01072136|11617166|FG000|COMPLETED|Overall Study||21
10468823|NCT01072136|11617167|FG001|COMPLETED|Overall Study||12
10468824|NCT01072136|11617166|FG000|NOT COMPLETED|Overall Study||23
10468825|NCT01072136|11617167|FG001|NOT COMPLETED|Overall Study||31
10468826|NCT01072149|11617176|FG000|STARTED|Treatment Period 1 (28 Days)||3
10468827|NCT01072149|11617177|FG001|STARTED|Treatment Period 1 (28 Days)||3
10468828|NCT01072149|11617178|FG002|STARTED|Treatment Period 1 (28 Days)||3
10468829|NCT01072149|11617179|FG003|STARTED|Treatment Period 1 (28 Days)||3
10468830|NCT01072149|11617180|FG004|STARTED|Treatment Period 1 (28 Days)||3
10468831|NCT01072149|11617181|FG005|STARTED|Treatment Period 1 (28 Days)||3
10468832|NCT01072149|11617182|FG006|STARTED|Treatment Period 1 (28 Days)||3
10468833|NCT01072149|11617183|FG007|STARTED|Treatment Period 1 (28 Days)||3
10468834|NCT01072149|11617184|FG008|STARTED|Treatment Period 1 (28 Days)||3
10468835|NCT01072149|11617185|FG009|STARTED|Treatment Period 1 (28 Days)||3
10468836|NCT01072149|11617186|FG010|STARTED|Treatment Period 1 (28 Days)||3
10468837|NCT01072149|11617187|FG011|STARTED|Treatment Period 1 (28 Days)||3
10468838|NCT01072149|11617188|FG012|STARTED|Treatment Period 1 (28 Days)||3
10468839|NCT01072149|11617189|FG013|STARTED|Treatment Period 1 (28 Days)||3
10468840|NCT01072149|11617190|FG014|STARTED|Treatment Period 1 (28 Days)||3
10468841|NCT01072149|11617191|FG015|STARTED|Treatment Period 1 (28 Days)||3
10468842|NCT01072149|11617192|FG016|STARTED|Treatment Period 1 (28 Days)||3
10468843|NCT01072149|11617193|FG017|STARTED|Treatment Period 1 (28 Days)||3
10468844|NCT01072149|11617176|FG000|COMPLETED|Treatment Period 1 (28 Days)||3
10468845|NCT01072149|11617177|FG001|COMPLETED|Treatment Period 1 (28 Days)||3
10468846|NCT01072149|11617178|FG002|COMPLETED|Treatment Period 1 (28 Days)||2
10468847|NCT01072149|11617179|FG003|COMPLETED|Treatment Period 1 (28 Days)||3
10468848|NCT01072149|11617180|FG004|COMPLETED|Treatment Period 1 (28 Days)||3
10468849|NCT01072149|11617181|FG005|COMPLETED|Treatment Period 1 (28 Days)||3
10468850|NCT01072149|11617182|FG006|COMPLETED|Treatment Period 1 (28 Days)||3
10468851|NCT01072149|11617183|FG007|COMPLETED|Treatment Period 1 (28 Days)||3
10468852|NCT01072149|11617184|FG008|COMPLETED|Treatment Period 1 (28 Days)||3
10468853|NCT01072149|11617185|FG009|COMPLETED|Treatment Period 1 (28 Days)||3
10468854|NCT01072149|11617186|FG010|COMPLETED|Treatment Period 1 (28 Days)||2
10468855|NCT01072149|11617187|FG011|COMPLETED|Treatment Period 1 (28 Days)||3
10468856|NCT01072149|11617188|FG012|COMPLETED|Treatment Period 1 (28 Days)||3
10468857|NCT01072149|11617189|FG013|COMPLETED|Treatment Period 1 (28 Days)||3
10468858|NCT01072149|11617190|FG014|COMPLETED|Treatment Period 1 (28 Days)||3
10468859|NCT01072149|11617191|FG015|COMPLETED|Treatment Period 1 (28 Days)||3
10468860|NCT01072149|11617192|FG016|COMPLETED|Treatment Period 1 (28 Days)||3
10468861|NCT01072149|11617193|FG017|COMPLETED|Treatment Period 1 (28 Days)||2
10468862|NCT01072149|11617176|FG000|NOT COMPLETED|Treatment Period 1 (28 Days)||0
10468863|NCT01072149|11617177|FG001|NOT COMPLETED|Treatment Period 1 (28 Days)||0
10468864|NCT01072149|11617178|FG002|NOT COMPLETED|Treatment Period 1 (28 Days)||1
10468865|NCT01072149|11617179|FG003|NOT COMPLETED|Treatment Period 1 (28 Days)||0
10468866|NCT01072149|11617180|FG004|NOT COMPLETED|Treatment Period 1 (28 Days)||0
10468867|NCT01072149|11617181|FG005|NOT COMPLETED|Treatment Period 1 (28 Days)||0
10468868|NCT01072149|11617182|FG006|NOT COMPLETED|Treatment Period 1 (28 Days)||0
10468869|NCT01072149|11617183|FG007|NOT COMPLETED|Treatment Period 1 (28 Days)||0
10468870|NCT01072149|11617184|FG008|NOT COMPLETED|Treatment Period 1 (28 Days)||0
10468871|NCT01072149|11617185|FG009|NOT COMPLETED|Treatment Period 1 (28 Days)||0
10468872|NCT01072149|11617186|FG010|NOT COMPLETED|Treatment Period 1 (28 Days)||1
10468873|NCT01072149|11617187|FG011|NOT COMPLETED|Treatment Period 1 (28 Days)||0
10468874|NCT01072149|11617188|FG012|NOT COMPLETED|Treatment Period 1 (28 Days)||0
10468875|NCT01072149|11617189|FG013|NOT COMPLETED|Treatment Period 1 (28 Days)||0
10468876|NCT01072149|11617190|FG014|NOT COMPLETED|Treatment Period 1 (28 Days)||0
10468877|NCT01072149|11617191|FG015|NOT COMPLETED|Treatment Period 1 (28 Days)||0
10468878|NCT01072149|11617192|FG016|NOT COMPLETED|Treatment Period 1 (28 Days)||0
10708744|NCT02633787|11873649|FG000|STARTED|Overall Study||110
10708745|NCT02633787|11873649|FG000|COMPLETED|Overall Study||109
10708746|NCT02633787|11873649|FG000|NOT COMPLETED|Overall Study||1
10708747|NCT02633800|11873655|FG000|STARTED|Overall Study||44
10708748|NCT02633800|11873656|FG001|STARTED|Overall Study||43
10708749|NCT02633800|11873655|FG000|COMPLETED|Overall Study||0
10468879|NCT01072149|11617193|FG017|NOT COMPLETED|Treatment Period 1 (28 Days)||1
10468880|NCT01072149|11617176|FG000|STARTED|Washout Period 1 (14 Days)||3
10468881|NCT01072149|11617177|FG001|STARTED|Washout Period 1 (14 Days)||3
10468882|NCT01072149|11617178|FG002|STARTED|Washout Period 1 (14 Days)||2
10468883|NCT01072149|11617179|FG003|STARTED|Washout Period 1 (14 Days)||3
10468884|NCT01072149|11617180|FG004|STARTED|Washout Period 1 (14 Days)||3
10468885|NCT01072149|11617181|FG005|STARTED|Washout Period 1 (14 Days)||3
10708750|NCT02633800|11873656|FG001|COMPLETED|Overall Study||0
10708751|NCT02633800|11873655|FG000|NOT COMPLETED|Overall Study||44
10468886|NCT01072149|11617182|FG006|STARTED|Washout Period 1 (14 Days)||3
10468887|NCT01072149|11617183|FG007|STARTED|Washout Period 1 (14 Days)||3
10468888|NCT01072149|11617184|FG008|STARTED|Washout Period 1 (14 Days)||3
10468889|NCT01072149|11617185|FG009|STARTED|Washout Period 1 (14 Days)||3
10468890|NCT01072149|11617186|FG010|STARTED|Washout Period 1 (14 Days)||2
10468891|NCT01072149|11617187|FG011|STARTED|Washout Period 1 (14 Days)||3
10468892|NCT01072149|11617188|FG012|STARTED|Washout Period 1 (14 Days)||3
10468893|NCT01072149|11617189|FG013|STARTED|Washout Period 1 (14 Days)||3
10468894|NCT01072149|11617190|FG014|STARTED|Washout Period 1 (14 Days)||3
10468895|NCT01072149|11617191|FG015|STARTED|Washout Period 1 (14 Days)||3
10468896|NCT01072149|11617192|FG016|STARTED|Washout Period 1 (14 Days)||3
10468897|NCT01072149|11617193|FG017|STARTED|Washout Period 1 (14 Days)||2
10468898|NCT01072149|11617176|FG000|COMPLETED|Washout Period 1 (14 Days)||3
10468899|NCT01072149|11617177|FG001|COMPLETED|Washout Period 1 (14 Days)||3
10468900|NCT01072149|11617178|FG002|COMPLETED|Washout Period 1 (14 Days)||2
10468901|NCT01072149|11617179|FG003|COMPLETED|Washout Period 1 (14 Days)||3
10708752|NCT02633800|11873656|FG001|NOT COMPLETED|Overall Study||43
10708753|NCT02633956|11873666|FG000|STARTED|Overall Study||20
10708754|NCT02633956|11873667|FG001|STARTED|Overall Study||21
10708755|NCT02633956|11873668|FG002|STARTED|Overall Study||22
10708756|NCT02633956|11873669|FG003|STARTED|Overall Study||21
10708757|NCT02633956|11873666|FG000|COMPLETED|Overall Study||19
10468902|NCT01072149|11617180|FG004|COMPLETED|Washout Period 1 (14 Days)||3
10468903|NCT01072149|11617181|FG005|COMPLETED|Washout Period 1 (14 Days)||3
10468904|NCT01072149|11617182|FG006|COMPLETED|Washout Period 1 (14 Days)||3
10468905|NCT01072149|11617183|FG007|COMPLETED|Washout Period 1 (14 Days)||3
10468906|NCT01072149|11617184|FG008|COMPLETED|Washout Period 1 (14 Days)||3
10468907|NCT01072149|11617185|FG009|COMPLETED|Washout Period 1 (14 Days)||3
10708758|NCT02633956|11873667|FG001|COMPLETED|Overall Study||19
10708759|NCT02633956|11873668|FG002|COMPLETED|Overall Study||20
10708760|NCT02633956|11873669|FG003|COMPLETED|Overall Study||21
10708761|NCT02633956|11873666|FG000|NOT COMPLETED|Overall Study||1
10708762|NCT02633956|11873667|FG001|NOT COMPLETED|Overall Study||2
10708763|NCT02633956|11873668|FG002|NOT COMPLETED|Overall Study||2
10708764|NCT02633956|11873669|FG003|NOT COMPLETED|Overall Study||0
10708765|NCT02634073|11873683|FG000|STARTED|Overall Study||4
10468908|NCT01072149|11617186|FG010|COMPLETED|Washout Period 1 (14 Days)||2
10468909|NCT01072149|11617187|FG011|COMPLETED|Washout Period 1 (14 Days)||3
10468910|NCT01072149|11617188|FG012|COMPLETED|Washout Period 1 (14 Days)||3
10468911|NCT01072149|11617189|FG013|COMPLETED|Washout Period 1 (14 Days)||3
10468912|NCT01072149|11617190|FG014|COMPLETED|Washout Period 1 (14 Days)||3
10468913|NCT01072149|11617191|FG015|COMPLETED|Washout Period 1 (14 Days)||3
10468914|NCT01072149|11617192|FG016|COMPLETED|Washout Period 1 (14 Days)||3
10468915|NCT01072149|11617193|FG017|COMPLETED|Washout Period 1 (14 Days)||2
10468916|NCT01072149|11617176|FG000|NOT COMPLETED|Washout Period 1 (14 Days)||0
10468917|NCT01072149|11617177|FG001|NOT COMPLETED|Washout Period 1 (14 Days)||0
10468918|NCT01072149|11617178|FG002|NOT COMPLETED|Washout Period 1 (14 Days)||0
10468919|NCT01072149|11617179|FG003|NOT COMPLETED|Washout Period 1 (14 Days)||0
10468920|NCT01072149|11617180|FG004|NOT COMPLETED|Washout Period 1 (14 Days)||0
10468921|NCT01072149|11617181|FG005|NOT COMPLETED|Washout Period 1 (14 Days)||0
10468922|NCT01072149|11617182|FG006|NOT COMPLETED|Washout Period 1 (14 Days)||0
10468923|NCT01072149|11617183|FG007|NOT COMPLETED|Washout Period 1 (14 Days)||0
10468924|NCT01072149|11617184|FG008|NOT COMPLETED|Washout Period 1 (14 Days)||0
10468925|NCT01072149|11617185|FG009|NOT COMPLETED|Washout Period 1 (14 Days)||0
10468926|NCT01072149|11617186|FG010|NOT COMPLETED|Washout Period 1 (14 Days)||0
10468927|NCT01072149|11617187|FG011|NOT COMPLETED|Washout Period 1 (14 Days)||0
10468928|NCT01072149|11617188|FG012|NOT COMPLETED|Washout Period 1 (14 Days)||0
10468929|NCT01072149|11617189|FG013|NOT COMPLETED|Washout Period 1 (14 Days)||0
10468930|NCT01072149|11617190|FG014|NOT COMPLETED|Washout Period 1 (14 Days)||0
10468931|NCT01072149|11617191|FG015|NOT COMPLETED|Washout Period 1 (14 Days)||0
10468932|NCT01072149|11617192|FG016|NOT COMPLETED|Washout Period 1 (14 Days)||0
10468933|NCT01072149|11617193|FG017|NOT COMPLETED|Washout Period 1 (14 Days)||0
10468934|NCT01072149|11617176|FG000|STARTED|Treatment Period 2 (28 Days)||3
10468935|NCT01072149|11617177|FG001|STARTED|Treatment Period 2 (28 Days)||3
10468936|NCT01072149|11617178|FG002|STARTED|Treatment Period 2 (28 Days)||2
10468937|NCT01072149|11617179|FG003|STARTED|Treatment Period 2 (28 Days)||3
10468938|NCT01072149|11617180|FG004|STARTED|Treatment Period 2 (28 Days)||3
10468939|NCT01072149|11617181|FG005|STARTED|Treatment Period 2 (28 Days)||3
10468940|NCT01072149|11617182|FG006|STARTED|Treatment Period 2 (28 Days)||3
10468941|NCT01072149|11617183|FG007|STARTED|Treatment Period 2 (28 Days)||3
10468942|NCT01072149|11617184|FG008|STARTED|Treatment Period 2 (28 Days)||3
10468943|NCT01072149|11617185|FG009|STARTED|Treatment Period 2 (28 Days)||3
10468944|NCT01072149|11617186|FG010|STARTED|Treatment Period 2 (28 Days)||2
10468945|NCT01072149|11617187|FG011|STARTED|Treatment Period 2 (28 Days)||3
10468946|NCT01072149|11617188|FG012|STARTED|Treatment Period 2 (28 Days)||3
10468947|NCT01072149|11617189|FG013|STARTED|Treatment Period 2 (28 Days)||3
10468948|NCT01072149|11617190|FG014|STARTED|Treatment Period 2 (28 Days)||3
10468949|NCT01072149|11617191|FG015|STARTED|Treatment Period 2 (28 Days)||3
10468950|NCT01072149|11617192|FG016|STARTED|Treatment Period 2 (28 Days)||3
10468951|NCT01072149|11617193|FG017|STARTED|Treatment Period 2 (28 Days)||2
10468952|NCT01072149|11617176|FG000|COMPLETED|Treatment Period 2 (28 Days)||3
10708766|NCT02634073|11873684|FG001|STARTED|Overall Study||4
10708767|NCT02634073|11873685|FG002|STARTED|Overall Study||4
10708768|NCT02634073|11873686|FG003|STARTED|Overall Study||4
10708769|NCT02634073|11873683|FG000|COMPLETED|Overall Study||4
10468953|NCT01072149|11617177|FG001|COMPLETED|Treatment Period 2 (28 Days)||2
10468954|NCT01072149|11617178|FG002|COMPLETED|Treatment Period 2 (28 Days)||1
10468955|NCT01072149|11617179|FG003|COMPLETED|Treatment Period 2 (28 Days)||3
10468956|NCT01072149|11617180|FG004|COMPLETED|Treatment Period 2 (28 Days)||3
10468957|NCT01072149|11617181|FG005|COMPLETED|Treatment Period 2 (28 Days)||3
10708770|NCT02634073|11873684|FG001|COMPLETED|Overall Study||4
10708771|NCT02634073|11873685|FG002|COMPLETED|Overall Study||4
10708772|NCT02634073|11873686|FG003|COMPLETED|Overall Study||4
10708773|NCT02634073|11873683|FG000|NOT COMPLETED|Overall Study||0
10708774|NCT02634073|11873684|FG001|NOT COMPLETED|Overall Study||0
10708775|NCT02634073|11873685|FG002|NOT COMPLETED|Overall Study||0
10468958|NCT01072149|11617182|FG006|COMPLETED|Treatment Period 2 (28 Days)||3
10468959|NCT01072149|11617183|FG007|COMPLETED|Treatment Period 2 (28 Days)||2
10468960|NCT01072149|11617184|FG008|COMPLETED|Treatment Period 2 (28 Days)||3
10468961|NCT01072149|11617185|FG009|COMPLETED|Treatment Period 2 (28 Days)||3
10468962|NCT01072149|11617186|FG010|COMPLETED|Treatment Period 2 (28 Days)||2
10468963|NCT01072149|11617187|FG011|COMPLETED|Treatment Period 2 (28 Days)||3
10468964|NCT01072149|11617188|FG012|COMPLETED|Treatment Period 2 (28 Days)||3
10468965|NCT01072149|11617189|FG013|COMPLETED|Treatment Period 2 (28 Days)||3
10468966|NCT01072149|11617190|FG014|COMPLETED|Treatment Period 2 (28 Days)||3
10468967|NCT01072149|11617191|FG015|COMPLETED|Treatment Period 2 (28 Days)||3
10468968|NCT01072149|11617192|FG016|COMPLETED|Treatment Period 2 (28 Days)||3
10468969|NCT01072149|11617193|FG017|COMPLETED|Treatment Period 2 (28 Days)||2
10708776|NCT02634073|11873686|FG003|NOT COMPLETED|Overall Study||0
10708777|NCT02634151|11873698|FG000|STARTED|Overall Study||53
10708778|NCT02634151|11873699|FG001|STARTED|Overall Study||52
10708779|NCT02634151|11873698|FG000|Full Analysis Set|Overall Study||53
10468970|NCT01072149|11617176|FG000|NOT COMPLETED|Treatment Period 2 (28 Days)||0
10468971|NCT01072149|11617177|FG001|NOT COMPLETED|Treatment Period 2 (28 Days)||1
10468972|NCT01072149|11617178|FG002|NOT COMPLETED|Treatment Period 2 (28 Days)||1
10468973|NCT01072149|11617179|FG003|NOT COMPLETED|Treatment Period 2 (28 Days)||0
10468974|NCT01072149|11617180|FG004|NOT COMPLETED|Treatment Period 2 (28 Days)||0
10468975|NCT01072149|11617181|FG005|NOT COMPLETED|Treatment Period 2 (28 Days)||0
10468976|NCT01072149|11617182|FG006|NOT COMPLETED|Treatment Period 2 (28 Days)||0
10468977|NCT01072149|11617183|FG007|NOT COMPLETED|Treatment Period 2 (28 Days)||1
10468978|NCT01072149|11617184|FG008|NOT COMPLETED|Treatment Period 2 (28 Days)||0
10468979|NCT01072149|11617185|FG009|NOT COMPLETED|Treatment Period 2 (28 Days)||0
10468980|NCT01072149|11617186|FG010|NOT COMPLETED|Treatment Period 2 (28 Days)||0
10468981|NCT01072149|11617187|FG011|NOT COMPLETED|Treatment Period 2 (28 Days)||0
10468982|NCT01072149|11617188|FG012|NOT COMPLETED|Treatment Period 2 (28 Days)||0
10468983|NCT01072149|11617189|FG013|NOT COMPLETED|Treatment Period 2 (28 Days)||0
10468984|NCT01072149|11617190|FG014|NOT COMPLETED|Treatment Period 2 (28 Days)||0
10468985|NCT01072149|11617191|FG015|NOT COMPLETED|Treatment Period 2 (28 Days)||0
10468986|NCT01072149|11617192|FG016|NOT COMPLETED|Treatment Period 2 (28 Days)||0
10468987|NCT01072149|11617193|FG017|NOT COMPLETED|Treatment Period 2 (28 Days)||0
10468988|NCT01072149|11617176|FG000|STARTED|Washout Period 2 (14 Days)||3
10468989|NCT01072149|11617177|FG001|STARTED|Washout Period 2 (14 Days)||2
10468990|NCT01072149|11617178|FG002|STARTED|Washout Period 2 (14 Days)||1
10468991|NCT01072149|11617179|FG003|STARTED|Washout Period 2 (14 Days)||3
10468992|NCT01072149|11617180|FG004|STARTED|Washout Period 2 (14 Days)||3
10468993|NCT01072149|11617181|FG005|STARTED|Washout Period 2 (14 Days)||3
10468994|NCT01072149|11617182|FG006|STARTED|Washout Period 2 (14 Days)||3
10468995|NCT01072149|11617183|FG007|STARTED|Washout Period 2 (14 Days)||2
10468996|NCT01072149|11617184|FG008|STARTED|Washout Period 2 (14 Days)||3
10468997|NCT01072149|11617185|FG009|STARTED|Washout Period 2 (14 Days)||3
10468998|NCT01072149|11617186|FG010|STARTED|Washout Period 2 (14 Days)||2
10468999|NCT01072149|11617187|FG011|STARTED|Washout Period 2 (14 Days)||3
10469000|NCT01072149|11617188|FG012|STARTED|Washout Period 2 (14 Days)||3
10469001|NCT01072149|11617189|FG013|STARTED|Washout Period 2 (14 Days)||3
10469002|NCT01072149|11617190|FG014|STARTED|Washout Period 2 (14 Days)||3
10469003|NCT01072149|11617191|FG015|STARTED|Washout Period 2 (14 Days)||3
10469004|NCT01072149|11617192|FG016|STARTED|Washout Period 2 (14 Days)||3
10469005|NCT01072149|11617193|FG017|STARTED|Washout Period 2 (14 Days)||2
10469006|NCT01072149|11617176|FG000|COMPLETED|Washout Period 2 (14 Days)||2
10469007|NCT01072149|11617177|FG001|COMPLETED|Washout Period 2 (14 Days)||2
10469008|NCT01072149|11617178|FG002|COMPLETED|Washout Period 2 (14 Days)||1
10469009|NCT01072149|11617179|FG003|COMPLETED|Washout Period 2 (14 Days)||3
10469010|NCT01072149|11617180|FG004|COMPLETED|Washout Period 2 (14 Days)||3
10469011|NCT01072149|11617181|FG005|COMPLETED|Washout Period 2 (14 Days)||3
10469012|NCT01072149|11617182|FG006|COMPLETED|Washout Period 2 (14 Days)||3
10469013|NCT01072149|11617183|FG007|COMPLETED|Washout Period 2 (14 Days)||2
10469014|NCT01072149|11617184|FG008|COMPLETED|Washout Period 2 (14 Days)||3
10469015|NCT01072149|11617185|FG009|COMPLETED|Washout Period 2 (14 Days)||3
10469016|NCT01072149|11617186|FG010|COMPLETED|Washout Period 2 (14 Days)||2
10469017|NCT01072149|11617187|FG011|COMPLETED|Washout Period 2 (14 Days)||3
10469018|NCT01072149|11617188|FG012|COMPLETED|Washout Period 2 (14 Days)||2
10469019|NCT01072149|11617189|FG013|COMPLETED|Washout Period 2 (14 Days)||3
10469020|NCT01072149|11617190|FG014|COMPLETED|Washout Period 2 (14 Days)||3
10469021|NCT01072149|11617191|FG015|COMPLETED|Washout Period 2 (14 Days)||1
10708780|NCT02634151|11873699|FG001|Full Analysis Set|Overall Study||52
10708781|NCT02634151|11873698|FG000|Safety Set|Overall Study||54
10469022|NCT01072149|11617192|FG016|COMPLETED|Washout Period 2 (14 Days)||3
10469023|NCT01072149|11617193|FG017|COMPLETED|Washout Period 2 (14 Days)||2
10469024|NCT01072149|11617176|FG000|NOT COMPLETED|Washout Period 2 (14 Days)||1
10469025|NCT01072149|11617177|FG001|NOT COMPLETED|Washout Period 2 (14 Days)||0
10469026|NCT01072149|11617178|FG002|NOT COMPLETED|Washout Period 2 (14 Days)||0
10469027|NCT01072149|11617179|FG003|NOT COMPLETED|Washout Period 2 (14 Days)||0
10469028|NCT01072149|11617180|FG004|NOT COMPLETED|Washout Period 2 (14 Days)||0
10469029|NCT01072149|11617181|FG005|NOT COMPLETED|Washout Period 2 (14 Days)||0
10469030|NCT01072149|11617182|FG006|NOT COMPLETED|Washout Period 2 (14 Days)||0
10469031|NCT01072149|11617183|FG007|NOT COMPLETED|Washout Period 2 (14 Days)||0
10469032|NCT01072149|11617184|FG008|NOT COMPLETED|Washout Period 2 (14 Days)||0
10469033|NCT01072149|11617185|FG009|NOT COMPLETED|Washout Period 2 (14 Days)||0
10469034|NCT01072149|11617186|FG010|NOT COMPLETED|Washout Period 2 (14 Days)||0
10469035|NCT01072149|11617187|FG011|NOT COMPLETED|Washout Period 2 (14 Days)||0
10469036|NCT01072149|11617188|FG012|NOT COMPLETED|Washout Period 2 (14 Days)||1
10469037|NCT01072149|11617189|FG013|NOT COMPLETED|Washout Period 2 (14 Days)||0
10469038|NCT01072149|11617190|FG014|NOT COMPLETED|Washout Period 2 (14 Days)||0
10469039|NCT01072149|11617191|FG015|NOT COMPLETED|Washout Period 2 (14 Days)||2
10469040|NCT01072149|11617192|FG016|NOT COMPLETED|Washout Period 2 (14 Days)||0
10469041|NCT01072149|11617193|FG017|NOT COMPLETED|Washout Period 2 (14 Days)||0
10469042|NCT01072149|11617176|FG000|STARTED|Treatment Period 3 (28 Days)||2
10469043|NCT01072149|11617177|FG001|STARTED|Treatment Period 3 (28 Days)||2
10469044|NCT01072149|11617178|FG002|STARTED|Treatment Period 3 (28 Days)||1
10469045|NCT01072149|11617179|FG003|STARTED|Treatment Period 3 (28 Days)||3
10469046|NCT01072149|11617180|FG004|STARTED|Treatment Period 3 (28 Days)||3
10469047|NCT01072149|11617181|FG005|STARTED|Treatment Period 3 (28 Days)||3
10469048|NCT01072149|11617182|FG006|STARTED|Treatment Period 3 (28 Days)||3
10469049|NCT01072149|11617183|FG007|STARTED|Treatment Period 3 (28 Days)||2
10469050|NCT01072149|11617184|FG008|STARTED|Treatment Period 3 (28 Days)||3
10469051|NCT01072149|11617185|FG009|STARTED|Treatment Period 3 (28 Days)||3
10469052|NCT01072149|11617186|FG010|STARTED|Treatment Period 3 (28 Days)||2
10469053|NCT01072149|11617187|FG011|STARTED|Treatment Period 3 (28 Days)||3
10469054|NCT01072149|11617188|FG012|STARTED|Treatment Period 3 (28 Days)||2
10469055|NCT01072149|11617189|FG013|STARTED|Treatment Period 3 (28 Days)||3
10469056|NCT01072149|11617190|FG014|STARTED|Treatment Period 3 (28 Days)||3
10469057|NCT01072149|11617191|FG015|STARTED|Treatment Period 3 (28 Days)||1
10469058|NCT01072149|11617192|FG016|STARTED|Treatment Period 3 (28 Days)||3
10469059|NCT01072149|11617193|FG017|STARTED|Treatment Period 3 (28 Days)||2
10469060|NCT01072149|11617176|FG000|COMPLETED|Treatment Period 3 (28 Days)||2
10469061|NCT01072149|11617177|FG001|COMPLETED|Treatment Period 3 (28 Days)||2
10469062|NCT01072149|11617178|FG002|COMPLETED|Treatment Period 3 (28 Days)||0
10469063|NCT01072149|11617179|FG003|COMPLETED|Treatment Period 3 (28 Days)||3
10469064|NCT01072149|11617180|FG004|COMPLETED|Treatment Period 3 (28 Days)||3
10469065|NCT01072149|11617181|FG005|COMPLETED|Treatment Period 3 (28 Days)||3
10469066|NCT01072149|11617182|FG006|COMPLETED|Treatment Period 3 (28 Days)||3
10469067|NCT01072149|11617183|FG007|COMPLETED|Treatment Period 3 (28 Days)||2
10469068|NCT01072149|11617184|FG008|COMPLETED|Treatment Period 3 (28 Days)||3
10469069|NCT01072149|11617185|FG009|COMPLETED|Treatment Period 3 (28 Days)||3
10469070|NCT01072149|11617186|FG010|COMPLETED|Treatment Period 3 (28 Days)||2
10469071|NCT01072149|11617187|FG011|COMPLETED|Treatment Period 3 (28 Days)||3
10469072|NCT01072149|11617188|FG012|COMPLETED|Treatment Period 3 (28 Days)||2
10469073|NCT01072149|11617189|FG013|COMPLETED|Treatment Period 3 (28 Days)||2
10469074|NCT01072149|11617190|FG014|COMPLETED|Treatment Period 3 (28 Days)||3
10469075|NCT01072149|11617191|FG015|COMPLETED|Treatment Period 3 (28 Days)||1
10469076|NCT01072149|11617192|FG016|COMPLETED|Treatment Period 3 (28 Days)||3
10469077|NCT01072149|11617193|FG017|COMPLETED|Treatment Period 3 (28 Days)||2
10469078|NCT01072149|11617176|FG000|NOT COMPLETED|Treatment Period 3 (28 Days)||0
10469079|NCT01072149|11617177|FG001|NOT COMPLETED|Treatment Period 3 (28 Days)||0
10469080|NCT01072149|11617178|FG002|NOT COMPLETED|Treatment Period 3 (28 Days)||1
10469081|NCT01072149|11617179|FG003|NOT COMPLETED|Treatment Period 3 (28 Days)||0
10469082|NCT01072149|11617180|FG004|NOT COMPLETED|Treatment Period 3 (28 Days)||0
10469083|NCT01072149|11617181|FG005|NOT COMPLETED|Treatment Period 3 (28 Days)||0
10469084|NCT01072149|11617182|FG006|NOT COMPLETED|Treatment Period 3 (28 Days)||0
10469085|NCT01072149|11617183|FG007|NOT COMPLETED|Treatment Period 3 (28 Days)||0
10469086|NCT01072149|11617184|FG008|NOT COMPLETED|Treatment Period 3 (28 Days)||0
10469087|NCT01072149|11617185|FG009|NOT COMPLETED|Treatment Period 3 (28 Days)||0
10469088|NCT01072149|11617186|FG010|NOT COMPLETED|Treatment Period 3 (28 Days)||0
10469089|NCT01072149|11617187|FG011|NOT COMPLETED|Treatment Period 3 (28 Days)||0
10469090|NCT01072149|11617188|FG012|NOT COMPLETED|Treatment Period 3 (28 Days)||0
10469091|NCT01072149|11617189|FG013|NOT COMPLETED|Treatment Period 3 (28 Days)||1
10469092|NCT01072149|11617190|FG014|NOT COMPLETED|Treatment Period 3 (28 Days)||0
10469093|NCT01072149|11617191|FG015|NOT COMPLETED|Treatment Period 3 (28 Days)||0
10469094|NCT01072149|11617192|FG016|NOT COMPLETED|Treatment Period 3 (28 Days)||0
10469095|NCT01072149|11617193|FG017|NOT COMPLETED|Treatment Period 3 (28 Days)||0
10469096|NCT01072188|11617205|FG000|STARTED|Overall Study||22
10469097|NCT01072188|11617206|FG001|STARTED|Overall Study||23
10469098|NCT01072188|11617205|FG000|COMPLETED|Overall Study||22
10469099|NCT01072188|11617206|FG001|COMPLETED|Overall Study||23
10469100|NCT01072188|11617205|FG000|NOT COMPLETED|Overall Study||0
10469101|NCT01072188|11617206|FG001|NOT COMPLETED|Overall Study||0
10469102|NCT01072201|11617214|FG000|STARTED|Overall Study||30
10469103|NCT01072201|11617215|FG001|STARTED|Overall Study||30
10469104|NCT01072201|11617214|FG000|COMPLETED|Overall Study||30
10469105|NCT01072201|11617215|FG001|COMPLETED|Overall Study||29
10469106|NCT01072201|11617214|FG000|NOT COMPLETED|Overall Study||0
10469107|NCT01072201|11617215|FG001|NOT COMPLETED|Overall Study||1
10469108|NCT01072331|11617224|FG000|STARTED|Overall Study||34
10469109|NCT01072331|11617225|FG001|STARTED|Overall Study||33
10469110|NCT01072331|11617226|FG002|STARTED|Overall Study||32
10469111|NCT01072331|11617224|FG000|COMPLETED|Overall Study||34
10469112|NCT01072331|11617225|FG001|COMPLETED|Overall Study||33
10469113|NCT01072331|11617226|FG002|COMPLETED|Overall Study||32
10469114|NCT01072331|11617224|FG000|NOT COMPLETED|Overall Study||0
10469115|NCT01072331|11617225|FG001|NOT COMPLETED|Overall Study||0
10469116|NCT01072331|11617226|FG002|NOT COMPLETED|Overall Study||0
10469117|NCT01072344|11617236|FG000|STARTED|Overall Study||46
10469118|NCT01072344|11617237|FG001|STARTED|Overall Study||47
10469119|NCT01072344|11617236|FG000|COMPLETED|Overall Study||35
10469120|NCT01072344|11617237|FG001|COMPLETED|Overall Study||29
10469121|NCT01072344|11617236|FG000|NOT COMPLETED|Overall Study||11
10469122|NCT01072344|11617237|FG001|NOT COMPLETED|Overall Study||18
10469123|NCT01072357|11617245|FG000|STARTED|Overall Study||15
10469124|NCT01072357|11617246|FG001|STARTED|Overall Study||15
10469125|NCT01072357|11617245|FG000|COMPLETED|Overall Study||15
10469126|NCT01072357|11617246|FG001|COMPLETED|Overall Study||14
10469127|NCT01072357|11617245|FG000|NOT COMPLETED|Overall Study||0
10469128|NCT01072357|11617246|FG001|NOT COMPLETED|Overall Study||1
10469129|NCT01072396|11617254|FG000|STARTED|Period One||63
10469130|NCT01072396|11617255|FG001|STARTED|Period One||63
10469131|NCT01072396|11617254|FG000|COMPLETED|Period One||58
10469132|NCT01072396|11617255|FG001|COMPLETED|Period One||61
10469133|NCT01072396|11617254|FG000|NOT COMPLETED|Period One||5
10469134|NCT01072396|11617255|FG001|NOT COMPLETED|Period One||2
10469135|NCT01072396|11617254|FG000|STARTED|Washout Period||58
10469136|NCT01072396|11617255|FG001|STARTED|Washout Period||61
10469137|NCT01072396|11617254|FG000|COMPLETED|Washout Period||58
10469138|NCT01072396|11617255|FG001|COMPLETED|Washout Period||60
10469139|NCT01072396|11617254|FG000|NOT COMPLETED|Washout Period||0
10469140|NCT01072396|11617255|FG001|NOT COMPLETED|Washout Period||1
10469141|NCT01072396|11617254|FG000|STARTED|Period Two||58
10469142|NCT01072396|11617255|FG001|STARTED|Period Two||60
10469143|NCT01072396|11617254|FG000|COMPLETED|Period Two||57
10469144|NCT01072396|11617255|FG001|COMPLETED|Period Two||57
10469145|NCT01072396|11617254|FG000|NOT COMPLETED|Period Two||1
10469146|NCT01072396|11617255|FG001|NOT COMPLETED|Period Two||3
10469147|NCT01072409|11617261|FG000|STARTED|Overall Study||45
10469148|NCT01072409|11617261|FG000|COMPLETED|Overall Study||38
10469149|NCT01072409|11617261|FG000|NOT COMPLETED|Overall Study||7
10469150|NCT01072448|11617267|FG000|STARTED|Overall Study||163
10469151|NCT01072448|11617268|FG001|STARTED|Overall Study||160
10469152|NCT01072448|11617267|FG000|COMPLETED|Overall Study||144
10469153|NCT01072448|11617268|FG001|COMPLETED|Overall Study||130
10469154|NCT01072448|11617267|FG000|NOT COMPLETED|Overall Study||19
10469155|NCT01072448|11617268|FG001|NOT COMPLETED|Overall Study||30
10469156|NCT01072500|11617276|FG000|STARTED|Overall Study||818
10469157|NCT01072500|11617277|FG001|STARTED|Overall Study||817
10469158|NCT01072500|11617276|FG000|COMPLETED|Overall Study||794
10469159|NCT01072500|11617277|FG001|COMPLETED|Overall Study||803
10469160|NCT01072500|11617276|FG000|NOT COMPLETED|Overall Study||24
10469161|NCT01072500|11617277|FG001|NOT COMPLETED|Overall Study||14
10469162|NCT01072539|11617285|FG000|STARTED|Overall Study||3172
10469163|NCT01072539|11617285|FG000|COMPLETED|Overall Study|Refer to the Safety Analysis Set. Data for completion were not collected.|3169
10469164|NCT01072539|11617285|FG000|NOT COMPLETED|Overall Study||3
10469165|NCT01072617|11617289|FG000|STARTED|Overall Study||8
10469166|NCT01072617|11617289|FG000|COMPLETED|Overall Study||8
10469167|NCT01072617|11617289|FG000|NOT COMPLETED|Overall Study||0
10469168|NCT01072630|11617297|FG000|STARTED|Overall Study||230
10469169|NCT01072630|11617298|FG001|STARTED|Overall Study||232
10469170|NCT01072630|11617299|FG002|STARTED|Overall Study||30
10469171|NCT01072630|11617297|FG000|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|229
10469172|NCT01072630|11617298|FG001|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|231
10469173|NCT01072630|11617299|FG002|Safety Population|Overall Study|Treated participants.|30
10469174|NCT01072630|11617297|FG000|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|224
10469175|NCT01072630|11617298|FG001|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|230
10469176|NCT01072630|11617299|FG002|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|28
10469177|NCT01072630|11617297|FG000|COMPLETED|Overall Study||175
10469178|NCT01072630|11617298|FG001|COMPLETED|Overall Study||172
10469179|NCT01072630|11617299|FG002|COMPLETED|Overall Study||17
10469180|NCT01072630|11617297|FG000|NOT COMPLETED|Overall Study||55
10469181|NCT01072630|11617298|FG001|NOT COMPLETED|Overall Study||60
10469182|NCT01072630|11617299|FG002|NOT COMPLETED|Overall Study||13
10469183|NCT01072643|11617308|FG000|STARTED|Overall Study||4
10469184|NCT01072643|11617308|FG000|COMPLETED|Overall Study||4
10469185|NCT01072643|11617308|FG000|NOT COMPLETED|Overall Study||0
10469186|NCT01072656|11617333|FG000|STARTED|First Intervention||5
10469187|NCT01072656|11617334|FG001|STARTED|First Intervention||4
10469188|NCT01072656|11617333|FG000|COMPLETED|First Intervention||5
10469189|NCT01072656|11617334|FG001|COMPLETED|First Intervention||4
10469190|NCT01072656|11617333|FG000|NOT COMPLETED|First Intervention||0
10469191|NCT01072656|11617334|FG001|NOT COMPLETED|First Intervention||0
10469192|NCT01072656|11617333|FG000|STARTED|Second Intervention||5
10469193|NCT01072656|11617334|FG001|STARTED|Second Intervention||4
10469194|NCT01072656|11617333|FG000|COMPLETED|Second Intervention||5
10469195|NCT01072656|11617334|FG001|COMPLETED|Second Intervention||4
10469196|NCT01072656|11617333|FG000|NOT COMPLETED|Second Intervention||0
10469197|NCT01072656|11617334|FG001|NOT COMPLETED|Second Intervention||0
10469198|NCT01072669|11617343|FG000|STARTED|Overall Study||15
10469199|NCT01072669|11617344|FG001|STARTED|Overall Study||5
10469200|NCT01072669|11617343|FG000|COMPLETED|Overall Study||15
10469201|NCT01072669|11617344|FG001|COMPLETED|Overall Study||5
10469202|NCT01072669|11617343|FG000|NOT COMPLETED|Overall Study||0
10469203|NCT01072669|11617344|FG001|NOT COMPLETED|Overall Study||0
10469204|NCT01072773|11617350|FG000|STARTED|Overall Study||2
10469205|NCT01072773|11617350|FG000|COMPLETED|Overall Study||2
10469206|NCT01072773|11617350|FG000|NOT COMPLETED|Overall Study||0
10469207|NCT01072877|11617359|FG000|STARTED|Overall Study||56
10469208|NCT01072877|11617360|FG001|STARTED|Overall Study||57
10469209|NCT01072877|11617361|FG002|STARTED|Overall Study||51
10469210|NCT01072877|11617362|FG003|STARTED|Overall Study||52
10469211|NCT01072877|11617363|FG004|STARTED|Overall Study||63
10469212|NCT01072877|11617359|FG000|COMPLETED|Overall Study||55
10469213|NCT01072877|11617360|FG001|COMPLETED|Overall Study||56
10469214|NCT01072877|11617361|FG002|COMPLETED|Overall Study||51
10469215|NCT01072877|11617362|FG003|COMPLETED|Overall Study||50
10469216|NCT01072877|11617363|FG004|COMPLETED|Overall Study||63
10469217|NCT01072877|11617359|FG000|NOT COMPLETED|Overall Study||1
10469218|NCT01072877|11617360|FG001|NOT COMPLETED|Overall Study||1
10469219|NCT01072877|11617361|FG002|NOT COMPLETED|Overall Study||0
10469220|NCT01072877|11617362|FG003|NOT COMPLETED|Overall Study||2
10469221|NCT01072877|11617363|FG004|NOT COMPLETED|Overall Study||0
10469222|NCT01072929|11617380|FG000|STARTED|Overall Study||199
10469223|NCT01072929|11617381|FG001|STARTED|Overall Study||201
10469224|NCT01072929|11617382|FG002|STARTED|Overall Study||33
10469225|NCT01072929|11617380|FG000|Safety Population|Overall Study|Treated participants|199
10469226|NCT01072929|11617381|FG001|Safety Population|Overall Study|Treated participants. Three participants were randomized but not treated.|198
10469227|NCT01072929|11617382|FG002|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|32
10469228|NCT01072929|11617380|FG000|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|196
10469229|NCT01072929|11617381|FG001|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|197
10469230|NCT01072929|11617382|FG002|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|31
10469231|NCT01072929|11617380|FG000|COMPLETED|Overall Study||155
10469232|NCT01072929|11617381|FG001|COMPLETED|Overall Study||150
10469233|NCT01072929|11617382|FG002|COMPLETED|Overall Study||24
10469234|NCT01072929|11617380|FG000|NOT COMPLETED|Overall Study||44
10469235|NCT01072929|11617381|FG001|NOT COMPLETED|Overall Study||51
10469236|NCT01072929|11617382|FG002|NOT COMPLETED|Overall Study||9
10469237|NCT01073020|11617395|FG000|STARTED|Overall Study||23
10469238|NCT01073020|11617396|FG001|STARTED|Overall Study||22
10469239|NCT01073020|11617397|FG002|STARTED|Overall Study||22
10469240|NCT01073020|11617398|FG003|STARTED|Overall Study||21
10469241|NCT01073020|11617395|FG000|COMPLETED|Overall Study||16
10469242|NCT01073020|11617396|FG001|COMPLETED|Overall Study||17
10469243|NCT01073020|11617397|FG002|COMPLETED|Overall Study||19
10469244|NCT01073020|11617398|FG003|COMPLETED|Overall Study||19
10469245|NCT01073020|11617395|FG000|NOT COMPLETED|Overall Study||7
10469246|NCT01073020|11617396|FG001|NOT COMPLETED|Overall Study||5
10469247|NCT01073020|11617397|FG002|NOT COMPLETED|Overall Study||3
10469248|NCT01073020|11617398|FG003|NOT COMPLETED|Overall Study||2
10469249|NCT01073163|11617408|FG000|STARTED|Overall Study||54
10469250|NCT01073163|11617408|FG000|Enrolled But Not Treated|Overall Study||1
10469251|NCT01073163|11617408|FG000|Treated With <6 Cycles|Overall Study||4
10469252|NCT01073163|11617408|FG000|Treated With >=6 Cycles|Overall Study||49
10469253|NCT01073163|11617408|FG000|COMPLETED|Overall Study|Patients completed study|51
10469254|NCT01073163|11617408|FG000|NOT COMPLETED|Overall Study||3
10469255|NCT01073267|11617416|FG000|STARTED|Overall Study||4
10469256|NCT01073267|11617416|FG000|COMPLETED|Overall Study||1
10469257|NCT01073267|11617416|FG000|NOT COMPLETED|Overall Study||3
10469258|NCT01073293|11617422|FG000|STARTED|Overall Study||526
10469259|NCT01073293|11617423|FG001|STARTED|Overall Study||528
10469260|NCT01073293|11617422|FG000|COMPLETED|Overall Study||521
10469261|NCT01073293|11617423|FG001|COMPLETED|Overall Study||517
10469262|NCT01073293|11617422|FG000|NOT COMPLETED|Overall Study||5
10469263|NCT01073293|11617423|FG001|NOT COMPLETED|Overall Study||11
10469264|NCT01073449|11617429|FG000|STARTED|Overall Study||3362
10469265|NCT01073449|11617429|FG000|COMPLETED|Overall Study||3362
10469266|NCT01073449|11617429|FG000|NOT COMPLETED|Overall Study||0
10469267|NCT01073462|11617433|FG000|STARTED|Overall Study||67
10469268|NCT01073462|11617433|FG000|COMPLETED|Overall Study||26
10469269|NCT01073462|11617433|FG000|NOT COMPLETED|Overall Study||41
10469270|NCT01073566|11617439|FG000|STARTED|Period 1 (6 Weeks)||19
10469271|NCT01073566|11617440|FG001|STARTED|Period 1 (6 Weeks)||19
10469272|NCT01073566|11617439|FG000|COMPLETED|Period 1 (6 Weeks)||19
10469273|NCT01073566|11617440|FG001|COMPLETED|Period 1 (6 Weeks)||19
10469274|NCT01073566|11617439|FG000|NOT COMPLETED|Period 1 (6 Weeks)||0
10469275|NCT01073566|11617440|FG001|NOT COMPLETED|Period 1 (6 Weeks)||0
10469276|NCT01073566|11617439|FG000|STARTED|Period 2 (6 Weeks)||19
10469277|NCT01073566|11617440|FG001|STARTED|Period 2 (6 Weeks)||19
10469278|NCT01073566|11617439|FG000|COMPLETED|Period 2 (6 Weeks)||18
10469279|NCT01073566|11617440|FG001|COMPLETED|Period 2 (6 Weeks)||19
10469280|NCT01073566|11617439|FG000|NOT COMPLETED|Period 2 (6 Weeks)||1
10469281|NCT01073566|11617440|FG001|NOT COMPLETED|Period 2 (6 Weeks)||0
10469282|NCT01073605|11617449|FG000|STARTED|Overall Study||68
10469283|NCT01073605|11617450|FG001|STARTED|Overall Study||71
10469284|NCT01073605|11617451|FG002|STARTED|Overall Study||69
10469285|NCT01073605|11617449|FG000|Received Treatment|Overall Study||68
10469286|NCT01073605|11617450|FG001|Received Treatment|Overall Study||70
10469287|NCT01073605|11617451|FG002|Received Treatment|Overall Study||68
10469288|NCT01073605|11617449|FG000|COMPLETED|Overall Study|Corresponds to follow-up until final height|6
10469289|NCT01073605|11617450|FG001|COMPLETED|Overall Study|Corresponds to follow-up until final height|4
10469290|NCT01073605|11617451|FG002|COMPLETED|Overall Study|Corresponds to follow-up until final height|8
10469291|NCT01073605|11617449|FG000|NOT COMPLETED|Overall Study||62
10469292|NCT01073605|11617450|FG001|NOT COMPLETED|Overall Study||67
10469293|NCT01073605|11617451|FG002|NOT COMPLETED|Overall Study||61
10469294|NCT01073618|11617459|FG000|STARTED|Overall Study||692
10469295|NCT01073618|11617459|FG000|COMPLETED|Overall Study||385
10469296|NCT01073618|11617459|FG000|NOT COMPLETED|Overall Study||307
10469297|NCT01073631|11617463|FG000|STARTED|Overall Study||543
10469298|NCT01073631|11617463|FG000|COMPLETED|Overall Study||374
10469299|NCT01073631|11617463|FG000|NOT COMPLETED|Overall Study||169
10469300|NCT01073657|11617469|FG000|STARTED|Overall Study||17
10469301|NCT01073657|11617470|FG001|STARTED|Overall Study||16
10469302|NCT01073657|11617469|FG000|COMPLETED|Overall Study||17
10469303|NCT01073657|11617470|FG001|COMPLETED|Overall Study||16
10469304|NCT01073657|11617469|FG000|NOT COMPLETED|Overall Study||0
10469305|NCT01073657|11617470|FG001|NOT COMPLETED|Overall Study||0
10469306|NCT01073865|11617478|FG000|STARTED|Overall Study|Number of patients randomised|109
10469307|NCT01073865|11617479|FG001|STARTED|Overall Study|Number of patients randomised|113
10469308|NCT01073865|11617478|FG000|Received Randomised Treatment|Overall Study|Number of patients received randomised treatment|108
10469309|NCT01073865|11617479|FG001|Received Randomised Treatment|Overall Study|Number of patients received randomised treatment|113
10469310|NCT01073865|11617478|FG000|COMPLETED|Overall Study|Number of patients completed the study|81
10469311|NCT01073865|11617479|FG001|COMPLETED|Overall Study|Number of patients completed the study|74
10469312|NCT01073865|11617478|FG000|NOT COMPLETED|Overall Study||28
10469313|NCT01073865|11617479|FG001|NOT COMPLETED|Overall Study||39
10469314|NCT01073930|11617487|FG000|STARTED|Overall Study||307
10469315|NCT01073930|11617488|FG001|STARTED|Overall Study||301
10469316|NCT01073930|11617487|FG000|Safety Population (Treated)|Overall Study||305
10469317|NCT01073930|11617488|FG001|Safety Population (Treated)|Overall Study||298
10469318|NCT01073930|11617487|FG000|Intent to Treat Population|Overall Study|One treated participant did not have an efficacy assessment performed.|304
10469319|NCT01073930|11617488|FG001|Intent to Treat Population|Overall Study|One treated participant did not have an efficacy assessment performed.|297
10469320|NCT01073930|11617487|FG000|COMPLETED|Overall Study||304
10469321|NCT01073930|11617488|FG001|COMPLETED|Overall Study||295
10469322|NCT01073930|11617487|FG000|NOT COMPLETED|Overall Study||3
10469323|NCT01073930|11617488|FG001|NOT COMPLETED|Overall Study||6
10469324|NCT01073943|11617496|FG000|STARTED|Overall Study||300
10469325|NCT01073943|11617497|FG001|STARTED|Overall Study||303
10469326|NCT01073943|11617496|FG000|Safety Population (Treated)|Overall Study||296
10469327|NCT01073943|11617497|FG001|Safety Population (Treated)|Overall Study||302
10469328|NCT01073943|11617496|FG000|Intent to Treat Population|Overall Study|Two treated participants did not have an efficacy assessment performed.|294
10469329|NCT01073943|11617497|FG001|Intent to Treat Population|Overall Study|Two treated participants did not have an efficacy assessment performed.|300
10469330|NCT01073943|11617496|FG000|COMPLETED|Overall Study||287
10469331|NCT01073943|11617497|FG001|COMPLETED|Overall Study||295
10469332|NCT01073943|11617496|FG000|NOT COMPLETED|Overall Study||13
10469333|NCT01073943|11617497|FG001|NOT COMPLETED|Overall Study||8
10469334|NCT01074008|11617512|FG000|STARTED|Overall Study||8
10469335|NCT01074008|11617513|FG001|STARTED|Overall Study||8
10469336|NCT01074008|11617514|FG002|STARTED|Overall Study||8
10469337|NCT01074008|11617515|FG003|STARTED|Overall Study||8
10469338|NCT01074008|11617516|FG004|STARTED|Overall Study||8
10469339|NCT01074008|11617517|FG005|STARTED|Overall Study||7
10469340|NCT01074008|11617518|FG006|STARTED|Overall Study||8
10469341|NCT01074008|11617519|FG007|STARTED|Overall Study||8
10469342|NCT01074008|11617520|FG008|STARTED|Overall Study||11
10469343|NCT01074008|11617512|FG000|Completed Direct-acting Antiviral Agent|Overall Study||8
10469344|NCT01074008|11617513|FG001|Completed Direct-acting Antiviral Agent|Overall Study||7
10469345|NCT01074008|11617514|FG002|Completed Direct-acting Antiviral Agent|Overall Study||7
10469346|NCT01074008|11617515|FG003|Completed Direct-acting Antiviral Agent|Overall Study||8
10469347|NCT01074008|11617516|FG004|Completed Direct-acting Antiviral Agent|Overall Study||8
10469348|NCT01074008|11617517|FG005|Completed Direct-acting Antiviral Agent|Overall Study||5
10469349|NCT01074008|11617518|FG006|Completed Direct-acting Antiviral Agent|Overall Study||8
10708782|NCT02634151|11873699|FG001|Safety Set|Overall Study||51
10708783|NCT02634151|11873698|FG000|COMPLETED|Overall Study||52
10708784|NCT02634151|11873699|FG001|COMPLETED|Overall Study||50
10708785|NCT02634151|11873698|FG000|NOT COMPLETED|Overall Study||1
10708786|NCT02634151|11873699|FG001|NOT COMPLETED|Overall Study||2
10708787|NCT02634177|11873707|FG000|STARTED|Overall Study||151
10469350|NCT01074008|11617519|FG007|Completed Direct-acting Antiviral Agent|Overall Study||7
10469351|NCT01074008|11617520|FG008|Completed Direct-acting Antiviral Agent|Overall Study||5
10469352|NCT01074008|11617512|FG000|COMPLETED|Overall Study||7
10469353|NCT01074008|11617513|FG001|COMPLETED|Overall Study||5
10469354|NCT01074008|11617514|FG002|COMPLETED|Overall Study||6
10469355|NCT01074008|11617515|FG003|COMPLETED|Overall Study||7
10469356|NCT01074008|11617516|FG004|COMPLETED|Overall Study||6
10469357|NCT01074008|11617517|FG005|COMPLETED|Overall Study||7
10469358|NCT01074008|11617518|FG006|COMPLETED|Overall Study||7
10469359|NCT01074008|11617519|FG007|COMPLETED|Overall Study||8
10469360|NCT01074008|11617520|FG008|COMPLETED|Overall Study||7
10469361|NCT01074008|11617512|FG000|NOT COMPLETED|Overall Study||1
10469362|NCT01074008|11617513|FG001|NOT COMPLETED|Overall Study||3
10469363|NCT01074008|11617514|FG002|NOT COMPLETED|Overall Study||2
10469364|NCT01074008|11617515|FG003|NOT COMPLETED|Overall Study||1
10469365|NCT01074008|11617516|FG004|NOT COMPLETED|Overall Study||2
10469366|NCT01074008|11617517|FG005|NOT COMPLETED|Overall Study||0
10469367|NCT01074008|11617518|FG006|NOT COMPLETED|Overall Study||1
10469368|NCT01074008|11617519|FG007|NOT COMPLETED|Overall Study||0
10469369|NCT01074008|11617520|FG008|NOT COMPLETED|Overall Study||4
10469370|NCT01074034|11617549|FG000|STARTED|Overall Study||211
10469371|NCT01074034|11617549|FG000|COMPLETED|Overall Study||205
10469372|NCT01074034|11617549|FG000|NOT COMPLETED|Overall Study||6
10469373|NCT01074047|11617556|FG000|STARTED|Treatment Phase||241
10469374|NCT01074047|11617557|FG001|STARTED|Treatment Phase||247
10469375|NCT01074047|11617556|FG000|Treated Population|Treatment Phase|5 patients not treated with any drug regimen|236
10469376|NCT01074047|11617557|FG001|Treated Population|Treatment Phase|7 patients not treated with any drug regimen|240
10469377|NCT01074047|11617556|FG000|Safety Population|Treatment Phase|Received at least one dose of study medication and had at least 1 post dose safety assessment|236
10469378|NCT01074047|11617557|FG001|Safety Population|Treatment Phase|Received at least one dose of study medication and had at least 1 post dose safety assessment|235
10469458|NCT01074268|11617638|FG001|NOT COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||7
10469379|NCT01074047|11617556|FG000|Evaluable Population|Treatment Phase|Did not meet criteria for exclusion, received ≥1 cycle of treatment and had ≥ 1 efficacy assessment|179
10469380|NCT01074047|11617557|FG001|Evaluable Population|Treatment Phase|Did not meet criteria for exclusion, received ≥1 cycle of treatment and had ≥ 1 efficacy assessment|191
10469381|NCT01074047|11617556|FG000|COMPLETED|Treatment Phase|Participants who were continuing study treatment at the time of study closure|24
10469382|NCT01074047|11617557|FG001|COMPLETED|Treatment Phase|Participants who were continuing study treatment at the time of study closure|13
10469383|NCT01074047|11617556|FG000|NOT COMPLETED|Treatment Phase||217
10469384|NCT01074047|11617557|FG001|NOT COMPLETED|Treatment Phase||234
10469385|NCT01074047|11617556|FG000|STARTED|Survival Follow-Up Phase||140
10469386|NCT01074047|11617557|FG001|STARTED|Survival Follow-Up Phase||163
10469387|NCT01074047|11617556|FG000|COMPLETED|Survival Follow-Up Phase||16
10469388|NCT01074047|11617557|FG001|COMPLETED|Survival Follow-Up Phase||27
10469389|NCT01074047|11617556|FG000|NOT COMPLETED|Survival Follow-Up Phase||124
10469390|NCT01074047|11617557|FG001|NOT COMPLETED|Survival Follow-Up Phase||136
10469391|NCT01074047|11617556|FG000|STARTED|Extension Phase|2 participants did not enroll in the extension period.|22
10469392|NCT01074047|11617557|FG001|STARTED|Extension Phase||0
10469393|NCT01074047|11617556|FG000|Safety Population|Extension Phase|Participants who enrolled in the extension phase|22
10469394|NCT01074047|11617557|FG001|Safety Population|Extension Phase||0
10469395|NCT01074047|11617556|FG000|COMPLETED|Extension Phase||0
10469396|NCT01074047|11617557|FG001|COMPLETED|Extension Phase||0
10469397|NCT01074047|11617556|FG000|NOT COMPLETED|Extension Phase||22
10469398|NCT01074047|11617557|FG001|NOT COMPLETED|Extension Phase||0
10469399|NCT01074099|11617572|FG000|STARTED|Overall Study||2
10469400|NCT01074099|11617573|FG001|STARTED|Overall Study||3
10469401|NCT01074099|11617572|FG000|COMPLETED|Overall Study||2
10469402|NCT01074099|11617573|FG001|COMPLETED|Overall Study||3
10469403|NCT01074099|11617572|FG000|NOT COMPLETED|Overall Study||0
10469404|NCT01074099|11617573|FG001|NOT COMPLETED|Overall Study||0
10469405|NCT01074125|11617582|FG000|STARTED|Overall Study||51
10469406|NCT01074125|11617583|FG001|STARTED|Overall Study||52
10469407|NCT01074125|11617584|FG002|STARTED|Overall Study||48
10469408|NCT01074125|11617582|FG000|COMPLETED|Overall Study||39
10469409|NCT01074125|11617583|FG001|COMPLETED|Overall Study||47
10469410|NCT01074125|11617584|FG002|COMPLETED|Overall Study||36
10469411|NCT01074125|11617582|FG000|NOT COMPLETED|Overall Study||12
10469412|NCT01074125|11617583|FG001|NOT COMPLETED|Overall Study||5
10469413|NCT01074125|11617584|FG002|NOT COMPLETED|Overall Study||12
10469414|NCT01074164|11617597|FG000|STARTED|Overall Study||7
10469415|NCT01074164|11617598|FG001|STARTED|Overall Study||8
10469416|NCT01074164|11617597|FG000|COMPLETED|Overall Study||4
10469417|NCT01074164|11617598|FG001|COMPLETED|Overall Study||7
10469418|NCT01074164|11617597|FG000|NOT COMPLETED|Overall Study||3
10469419|NCT01074164|11617598|FG001|NOT COMPLETED|Overall Study||1
10469420|NCT01074177|11617604|FG000|STARTED|Overall Study||24
10469421|NCT01074177|11617604|FG000|COMPLETED|Overall Study||24
10469422|NCT01074177|11617604|FG000|NOT COMPLETED|Overall Study||0
10469423|NCT01074216|11617608|FG000|STARTED|Overall Study||54
10469424|NCT01074216|11617608|FG000|COMPLETED|Overall Study||41
10469425|NCT01074216|11617608|FG000|NOT COMPLETED|Overall Study||13
10469426|NCT01074229|11617615|FG000|STARTED|Overall Study||25
10469427|NCT01074229|11617616|FG001|STARTED|Overall Study||25
10469428|NCT01074229|11617617|FG002|STARTED|Overall Study||25
10469429|NCT01074229|11617615|FG000|COMPLETED|Overall Study||23
10469430|NCT01074229|11617616|FG001|COMPLETED|Overall Study||22
10469431|NCT01074229|11617617|FG002|COMPLETED|Overall Study||21
10469432|NCT01074229|11617615|FG000|NOT COMPLETED|Overall Study||2
10469433|NCT01074229|11617616|FG001|NOT COMPLETED|Overall Study||3
10469434|NCT01074229|11617617|FG002|NOT COMPLETED|Overall Study||4
10469435|NCT01074242|11617627|FG000|STARTED|Overall Study||3798
10469436|NCT01074242|11617627|FG000|Received at Least 1 Dose of Vaccine|Overall Study||3395
10469437|NCT01074242|11617627|FG000|COMPLETED|Overall Study||3395
10469438|NCT01074242|11617627|FG000|NOT COMPLETED|Overall Study||403
10469439|NCT01074255|11617631|FG000|STARTED|Overall Study||3141
10469440|NCT01074255|11617631|FG000|Treated|Overall Study||3139
10469441|NCT01074255|11617631|FG000|COMPLETED|Overall Study||3139
10469442|NCT01074255|11617631|FG000|NOT COMPLETED|Overall Study||2
10469443|NCT01074268|11617637|FG000|STARTED|Main: Week 0 to 26 (NN1250-3585)||303
10469444|NCT01074268|11617638|FG001|STARTED|Main: Week 0 to 26 (NN1250-3585)||153
10469445|NCT01074268|11617637|FG000|Full Analysis Set|Main: Week 0 to 26 (NN1250-3585)|One subject was withdrawn because the subject was randomised in error (screening failure)|302
10469446|NCT01074268|11617638|FG001|Full Analysis Set|Main: Week 0 to 26 (NN1250-3585)||153
10469447|NCT01074268|11617637|FG000|Exposed|Main: Week 0 to 26 (NN1250-3585)|Two subjects withdrew prior to exposure to trial drugs|301
10469448|NCT01074268|11617638|FG001|Exposed|Main: Week 0 to 26 (NN1250-3585)|One subject withdrew prior to exposure to trial drugs|152
10469449|NCT01074268|11617637|FG000|COMPLETED|Main: Week 0 to 26 (NN1250-3585)||283
10469450|NCT01074268|11617638|FG001|COMPLETED|Main: Week 0 to 26 (NN1250-3585)||138
10469451|NCT01074268|11617637|FG000|NOT COMPLETED|Main: Week 0 to 26 (NN1250-3585)||20
10469452|NCT01074268|11617638|FG001|NOT COMPLETED|Main: Week 0 to 26 (NN1250-3585)||15
10469453|NCT01074268|11617637|FG000|STARTED|Extension: Week 27 to 52 (NN1250-3725)|Thirty five subjects from main trial did not continue into the extension|248
10469454|NCT01074268|11617638|FG001|STARTED|Extension: Week 27 to 52 (NN1250-3725)|Sixteen subjects from main trial did not continue into the extension|122
10469455|NCT01074268|11617637|FG000|COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||242
10469456|NCT01074268|11617638|FG001|COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||115
10469457|NCT01074268|11617637|FG000|NOT COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||6
10469459|NCT01074307|11617646|FG000|STARTED|Overall Study||66
10469460|NCT01074307|11617647|FG001|STARTED|Overall Study||114
10469461|NCT01074307|11617646|FG000|COMPLETED|Overall Study||44
10469462|NCT01074307|11617647|FG001|COMPLETED|Overall Study||102
10469463|NCT01074307|11617646|FG000|NOT COMPLETED|Overall Study||22
10469464|NCT01074307|11617647|FG001|NOT COMPLETED|Overall Study||12
10469465|NCT01074450|11617655|FG000|STARTED|First Intervention||12
10469466|NCT01074450|11617656|FG001|STARTED|First Intervention||12
10469467|NCT01074450|11617655|FG000|COMPLETED|First Intervention||12
10469468|NCT01074450|11617656|FG001|COMPLETED|First Intervention||10
10469469|NCT01074450|11617655|FG000|NOT COMPLETED|First Intervention||0
10469470|NCT01074450|11617656|FG001|NOT COMPLETED|First Intervention||2
10469471|NCT01074450|11617655|FG000|STARTED|Washout of 7 Days||12
10469472|NCT01074450|11617656|FG001|STARTED|Washout of 7 Days||10
10469473|NCT01074450|11617655|FG000|COMPLETED|Washout of 7 Days||12
10469474|NCT01074450|11617656|FG001|COMPLETED|Washout of 7 Days||10
10469475|NCT01074450|11617655|FG000|NOT COMPLETED|Washout of 7 Days||0
10469476|NCT01074450|11617656|FG001|NOT COMPLETED|Washout of 7 Days||0
10469477|NCT01074450|11617655|FG000|STARTED|Second Intervention||12
10469478|NCT01074450|11617656|FG001|STARTED|Second Intervention||10
10469479|NCT01074450|11617655|FG000|COMPLETED|Second Intervention|Positive Drug Screen at Check in.|11
10469480|NCT01074450|11617656|FG001|COMPLETED|Second Intervention|Influenze Symptoms Present at Check in.|9
10469481|NCT01074450|11617655|FG000|NOT COMPLETED|Second Intervention||1
10469482|NCT01074450|11617656|FG001|NOT COMPLETED|Second Intervention||1
10469483|NCT01074463|11617664|FG000|STARTED|First Intervention||12
10469484|NCT01074463|11617665|FG001|STARTED|First Intervention||12
10469485|NCT01074463|11617664|FG000|COMPLETED|First Intervention||12
10469486|NCT01074463|11617665|FG001|COMPLETED|First Intervention||12
10469487|NCT01074463|11617664|FG000|NOT COMPLETED|First Intervention||0
10469488|NCT01074463|11617665|FG001|NOT COMPLETED|First Intervention||0
10469489|NCT01074463|11617664|FG000|STARTED|Washout of 7 Days||12
10469490|NCT01074463|11617665|FG001|STARTED|Washout of 7 Days||12
10469491|NCT01074463|11617664|FG000|COMPLETED|Washout of 7 Days||12
10469492|NCT01074463|11617665|FG001|COMPLETED|Washout of 7 Days||12
10469493|NCT01074463|11617664|FG000|NOT COMPLETED|Washout of 7 Days||0
10469494|NCT01074463|11617665|FG001|NOT COMPLETED|Washout of 7 Days||0
10469495|NCT01074463|11617664|FG000|STARTED|Second Intervention||12
10469496|NCT01074463|11617665|FG001|STARTED|Second Intervention||12
10469497|NCT01074463|11617664|FG000|COMPLETED|Second Intervention||12
10469498|NCT01074463|11617665|FG001|COMPLETED|Second Intervention||12
10469499|NCT01074463|11617664|FG000|NOT COMPLETED|Second Intervention||0
10469500|NCT01074463|11617665|FG001|NOT COMPLETED|Second Intervention||0
10469501|NCT01074554|11617673|FG000|STARTED|Overall Study||14
10469502|NCT01074554|11617674|FG001|STARTED|Overall Study||15
10469503|NCT01074554|11617673|FG000|COMPLETED|Overall Study||11
10469504|NCT01074554|11617674|FG001|COMPLETED|Overall Study||11
10469505|NCT01074554|11617673|FG000|NOT COMPLETED|Overall Study||3
10469506|NCT01074554|11617674|FG001|NOT COMPLETED|Overall Study||4
10469507|NCT01074658|11617680|FG000|STARTED|Overall Study||1015
10469508|NCT01074658|11617680|FG000|Attempted Implant|Overall Study||996
10469509|NCT01074658|11617680|FG000|COMPLETED|Overall Study||996
10469510|NCT01074658|11617680|FG000|NOT COMPLETED|Overall Study||19
10469511|NCT01074931|11617684|FG000|STARTED|Overall Study||98
10469512|NCT01074931|11617684|FG000|COMPLETED|Overall Study||92
10469513|NCT01074931|11617684|FG000|NOT COMPLETED|Overall Study||6
10469514|NCT01074944|11617692|FG000|STARTED|Lead-in Period (up to 78 Weeks)|LIP conducted to assess randomization criteria of all participants in single reporting arm.|170
10469515|NCT01074944|11617693|FG001|STARTED|Lead-in Period (up to 78 Weeks)||0
10469516|NCT01074944|11617694|FG002|STARTED|Lead-in Period (up to 78 Weeks)||0
10469517|NCT01074944|11617695|FG003|STARTED|Lead-in Period (up to 78 Weeks)||0
10469518|NCT01074944|11617696|FG004|STARTED|Lead-in Period (up to 78 Weeks)||0
10469519|NCT01074944|11617692|FG000|COMPLETED|Lead-in Period (up to 78 Weeks)||157
10469520|NCT01074944|11617693|FG001|COMPLETED|Lead-in Period (up to 78 Weeks)||0
10469521|NCT01074944|11617694|FG002|COMPLETED|Lead-in Period (up to 78 Weeks)||0
10469522|NCT01074944|11617695|FG003|COMPLETED|Lead-in Period (up to 78 Weeks)||0
10469523|NCT01074944|11617696|FG004|COMPLETED|Lead-in Period (up to 78 Weeks)||0
10469524|NCT01074944|11617692|FG000|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||13
10469525|NCT01074944|11617693|FG001|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
10469526|NCT01074944|11617694|FG002|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
10469527|NCT01074944|11617695|FG003|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
10469528|NCT01074944|11617696|FG004|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
10469529|NCT01074944|11617692|FG000|STARTED|Primary Analysis Period (up to 52 Weeks)||0
10469530|NCT01074944|11617693|FG001|STARTED|Primary Analysis Period (up to 52 Weeks)|Participants who were randomized after LIP received treatment in PAP.|65
10469531|NCT01074944|11617694|FG002|STARTED|Primary Analysis Period (up to 52 Weeks)|Participants who were randomized after LIP received treatment in PAP.|66
10469532|NCT01074944|11617695|FG003|STARTED|Primary Analysis Period (up to 52 Weeks)||0
10469533|NCT01074944|11617696|FG004|STARTED|Primary Analysis Period (up to 52 Weeks)||0
10469534|NCT01074944|11617692|FG000|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
10469535|NCT01074944|11617693|FG001|COMPLETED|Primary Analysis Period (up to 52 Weeks)||54
10469536|NCT01074944|11617694|FG002|COMPLETED|Primary Analysis Period (up to 52 Weeks)||60
10469537|NCT01074944|11617695|FG003|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
10469538|NCT01074944|11617696|FG004|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
10469539|NCT01074944|11617692|FG000|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
10469540|NCT01074944|11617693|FG001|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||11
10469541|NCT01074944|11617694|FG002|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||6
10469542|NCT01074944|11617695|FG003|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
10469543|NCT01074944|11617696|FG004|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
10469544|NCT01074944|11617692|FG000|STARTED|Long Term Treatment||0
10469545|NCT01074944|11617693|FG001|STARTED|Long Term Treatment||0
10469546|NCT01074944|11617694|FG002|STARTED|Long Term Treatment||0
10469547|NCT01074944|11617695|FG003|STARTED|Long Term Treatment|Participants who completed PAP (114) including those who considered as treatment failure in PAP (7).|121
10469548|NCT01074944|11617696|FG004|STARTED|Long Term Treatment||0
10469549|NCT01074944|11617692|FG000|COMPLETED|Long Term Treatment||0
10469550|NCT01074944|11617693|FG001|COMPLETED|Long Term Treatment||0
10469551|NCT01074944|11617694|FG002|COMPLETED|Long Term Treatment||0
10469552|NCT01074944|11617695|FG003|COMPLETED|Long Term Treatment||95
10469553|NCT01074944|11617696|FG004|COMPLETED|Long Term Treatment||0
10469554|NCT01074944|11617692|FG000|NOT COMPLETED|Long Term Treatment||0
10469555|NCT01074944|11617693|FG001|NOT COMPLETED|Long Term Treatment||0
10469556|NCT01074944|11617694|FG002|NOT COMPLETED|Long Term Treatment||0
10469557|NCT01074944|11617695|FG003|NOT COMPLETED|Long Term Treatment||26
10469558|NCT01074944|11617696|FG004|NOT COMPLETED|Long Term Treatment||0
10469559|NCT01074944|11617692|FG000|STARTED|Extended Treatment (up to 42 Months)||0
10469560|NCT01074944|11617693|FG001|STARTED|Extended Treatment (up to 42 Months)||0
10469561|NCT01074944|11617694|FG002|STARTED|Extended Treatment (up to 42 Months)||0
10469562|NCT01074944|11617695|FG003|STARTED|Extended Treatment (up to 42 Months)||0
10469563|NCT01074944|11617696|FG004|STARTED|Extended Treatment (up to 42 Months)|Participants who were failed to meet the randomization criteria during the lead-in period.|25
10469564|NCT01074944|11617692|FG000|COMPLETED|Extended Treatment (up to 42 Months)||0
10469565|NCT01074944|11617693|FG001|COMPLETED|Extended Treatment (up to 42 Months)||0
10469566|NCT01074944|11617694|FG002|COMPLETED|Extended Treatment (up to 42 Months)||0
10469567|NCT01074944|11617695|FG003|COMPLETED|Extended Treatment (up to 42 Months)||0
10469568|NCT01074944|11617696|FG004|COMPLETED|Extended Treatment (up to 42 Months)||20
10469569|NCT01074944|11617692|FG000|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
10469570|NCT01074944|11617693|FG001|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
10469571|NCT01074944|11617694|FG002|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
10469572|NCT01074944|11617695|FG003|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
10469573|NCT01074944|11617696|FG004|NOT COMPLETED|Extended Treatment (up to 42 Months)||5
10469574|NCT01075048|11617707|FG000|STARTED|Overall Study||9
10469575|NCT01075048|11617708|FG001|STARTED|Overall Study||60
10469576|NCT01075048|11617709|FG002|STARTED|Overall Study||62
10469577|NCT01075048|11617707|FG000|Did Not Receive Treatment|Overall Study||0
10469578|NCT01075048|11617708|FG001|Did Not Receive Treatment|Overall Study||1
10469579|NCT01075048|11617709|FG002|Did Not Receive Treatment|Overall Study||0
10469580|NCT01075048|11617707|FG000|COMPLETED|Overall Study||0
10469581|NCT01075048|11617708|FG001|COMPLETED|Overall Study||0
10469582|NCT01075048|11617709|FG002|COMPLETED|Overall Study||0
10469583|NCT01075048|11617707|FG000|NOT COMPLETED|Overall Study||9
10469584|NCT01075048|11617708|FG001|NOT COMPLETED|Overall Study||60
10469585|NCT01075048|11617709|FG002|NOT COMPLETED|Overall Study||62
10469586|NCT01075074|11617723|FG000|STARTED|Overall Study||25
10469587|NCT01075074|11617724|FG001|STARTED|Overall Study||25
10469588|NCT01075074|11617725|FG002|STARTED|Overall Study||25
10469589|NCT01075074|11617723|FG000|COMPLETED|Overall Study||24
10469590|NCT01075074|11617724|FG001|COMPLETED|Overall Study||23
10469591|NCT01075074|11617725|FG002|COMPLETED|Overall Study||23
10469592|NCT01075074|11617723|FG000|NOT COMPLETED|Overall Study||1
10469593|NCT01075074|11617724|FG001|NOT COMPLETED|Overall Study||2
10469594|NCT01075074|11617725|FG002|NOT COMPLETED|Overall Study||2
10469595|NCT01075087|11617739|FG000|STARTED|Overall Study||9
10469596|NCT01075087|11617740|FG001|STARTED|Overall Study||10
10469597|NCT01075087|11617739|FG000|COMPLETED|Overall Study||9
10469598|NCT01075087|11617740|FG001|COMPLETED|Overall Study||10
10469599|NCT01075087|11617739|FG000|NOT COMPLETED|Overall Study||0
10469600|NCT01075087|11617740|FG001|NOT COMPLETED|Overall Study||0
10469601|NCT01075100|11617748|FG000|STARTED|Overall Study||49
10469602|NCT01075100|11617749|FG001|STARTED|Overall Study||54
10469603|NCT01075100|11617748|FG000|COMPLETED|Overall Study||0
10469604|NCT01075100|11617749|FG001|COMPLETED|Overall Study||1
10469605|NCT01075100|11617748|FG000|NOT COMPLETED|Overall Study||49
10469606|NCT01075100|11617749|FG001|NOT COMPLETED|Overall Study||53
10469607|NCT01075152|11617759|FG000|STARTED|Overall Study|randomized|88
10469608|NCT01075152|11617760|FG001|STARTED|Overall Study|randomized|89
10469609|NCT01075152|11617759|FG000|COMPLETED|Overall Study||87
10469610|NCT01075152|11617760|FG001|COMPLETED|Overall Study||89
10469611|NCT01075152|11617759|FG000|NOT COMPLETED|Overall Study||1
10469612|NCT01075152|11617760|FG001|NOT COMPLETED|Overall Study||0
10469613|NCT01075178|11617770|FG000|STARTED|Subject Matching|eligible for matching|1148
10469614|NCT01075178|11617771|FG001|STARTED|Subject Matching|eligible for matching|1421
10469615|NCT01075178|11617770|FG000|COMPLETED|Subject Matching|subjects matched|1018
10469616|NCT01075178|11617771|FG001|COMPLETED|Subject Matching|subjects matched|1018
10469617|NCT01075178|11617770|FG000|NOT COMPLETED|Subject Matching||130
10469618|NCT01075178|11617771|FG001|NOT COMPLETED|Subject Matching||403
10469619|NCT01075178|11617770|FG000|STARTED|Subject Chart Review|subjects matched|1018
10469620|NCT01075178|11617771|FG001|STARTED|Subject Chart Review|subjects matched|1018
10469621|NCT01075178|11617770|FG000|COMPLETED|Subject Chart Review|subjects in full analysis set|1009
10469622|NCT01075178|11617771|FG001|COMPLETED|Subject Chart Review|subjects in full analysis set|1009
10469623|NCT01075178|11617770|FG000|NOT COMPLETED|Subject Chart Review||9
10708788|NCT02634177|11873708|FG001|STARTED|Overall Study||153
10708789|NCT02634177|11873707|FG000|COMPLETED|Overall Study||140
10708790|NCT02634177|11873708|FG001|COMPLETED|Overall Study||141
10708791|NCT02634177|11873707|FG000|NOT COMPLETED|Overall Study||11
10708792|NCT02634177|11873708|FG001|NOT COMPLETED|Overall Study||12
10708793|NCT02634320|11873714|FG000|STARTED|Overall Study||51
10469624|NCT01075178|11617771|FG001|NOT COMPLETED|Subject Chart Review||9
10469625|NCT01075191|11617777|FG000|STARTED|Overall Study|65 participants were enrolled; 5 protocol violations were excluded from all analyses except safety.|60
10469626|NCT01075191|11617777|FG000|Discontinued Year 1|Overall Study||7
10469627|NCT01075191|11617777|FG000|Discontinued Year 2|Overall Study||6
10469628|NCT01075191|11617777|FG000|Discontinued Year 3|Overall Study||5
10469629|NCT01075191|11617777|FG000|COMPLETED|Overall Study||42
10708794|NCT02634320|11873714|FG000|COMPLETED|Overall Study||35
10708795|NCT02634320|11873714|FG000|NOT COMPLETED|Overall Study||16
10469630|NCT01075191|11617777|FG000|NOT COMPLETED|Overall Study||18
10469631|NCT01075204|11617781|FG000|STARTED|Overall Study||335
10469632|NCT01075204|11617781|FG000|COMPLETED|Overall Study||335
10469633|NCT01075204|11617781|FG000|NOT COMPLETED|Overall Study||0
10469634|NCT01075217|11617787|FG000|STARTED|Overall Study|88 patients randomized to receive Isovue; 4 of the patients did not meet entry requirements|84
10469635|NCT01075217|11617788|FG001|STARTED|Overall Study|86 patients randomized to receive Visipaque; 1 of the patients did not meet entry requirements|85
10469636|NCT01075217|11617787|FG000|COMPLETED|Overall Study||82
10469637|NCT01075217|11617788|FG001|COMPLETED|Overall Study||84
10469638|NCT01075217|11617787|FG000|NOT COMPLETED|Overall Study||2
10469639|NCT01075217|11617788|FG001|NOT COMPLETED|Overall Study||1
10469640|NCT01075243|11617805|FG000|STARTED|Overall Study||163
10469641|NCT01075243|11617806|FG001|STARTED|Overall Study||158
10469642|NCT01075243|11617807|FG002|STARTED|Overall Study||80
10469643|NCT01075243|11617805|FG000|COMPLETED|Overall Study||157
10469644|NCT01075243|11617806|FG001|COMPLETED|Overall Study||155
10469645|NCT01075243|11617807|FG002|COMPLETED|Overall Study||80
10469646|NCT01075243|11617805|FG000|NOT COMPLETED|Overall Study||6
10469647|NCT01075243|11617806|FG001|NOT COMPLETED|Overall Study||3
10469648|NCT01075243|11617807|FG002|NOT COMPLETED|Overall Study||0
10469649|NCT01075256|11617820|FG000|STARTED|Overall Study||64
10469650|NCT01075256|11617821|FG001|STARTED|Overall Study||66
10469651|NCT01075256|11617822|FG002|STARTED|Overall Study||65
10469652|NCT01075256|11617820|FG000|COMPLETED|Overall Study||63
10469653|NCT01075256|11617821|FG001|COMPLETED|Overall Study||66
10469654|NCT01075256|11617822|FG002|COMPLETED|Overall Study||65
10469655|NCT01075256|11617820|FG000|NOT COMPLETED|Overall Study||1
10469656|NCT01075256|11617821|FG001|NOT COMPLETED|Overall Study||0
10469657|NCT01075256|11617822|FG002|NOT COMPLETED|Overall Study||0
10469658|NCT01075282|11617838|FG000|STARTED|Overall Study||273
10469659|NCT01075282|11617839|FG001|STARTED|Overall Study||272
10469660|NCT01075282|11617840|FG002|STARTED|Overall Study|Of 265 participants randomized to Insulin Glargine, 3 chose not to take study drug.|265
10469661|NCT01075282|11617838|FG000|Received at Least One Dose of Study Drug|Overall Study||273
10469662|NCT01075282|11617839|FG001|Received at Least One Dose of Study Drug|Overall Study||272
10469663|NCT01075282|11617840|FG002|Received at Least One Dose of Study Drug|Overall Study||262
10469664|NCT01075282|11617838|FG000|COMPLETED|Overall Study||242
10469665|NCT01075282|11617839|FG001|COMPLETED|Overall Study||243
10469666|NCT01075282|11617840|FG002|COMPLETED|Overall Study||238
10469667|NCT01075282|11617838|FG000|NOT COMPLETED|Overall Study||31
10469668|NCT01075282|11617839|FG001|NOT COMPLETED|Overall Study||29
10469669|NCT01075282|11617840|FG002|NOT COMPLETED|Overall Study||27
10469670|NCT01075321|11617849|FG000|STARTED|Overall Study||7
10469671|NCT01075321|11617850|FG001|STARTED|Overall Study||9
10469672|NCT01075321|11617851|FG002|STARTED|Overall Study||9
10469673|NCT01075321|11617852|FG003|STARTED|Overall Study||33
10469674|NCT01075321|11617849|FG000|COMPLETED|Overall Study||6
10469675|NCT01075321|11617850|FG001|COMPLETED|Overall Study||9
10469676|NCT01075321|11617851|FG002|COMPLETED|Overall Study||7
10469677|NCT01075321|11617852|FG003|COMPLETED|Overall Study||31
10469678|NCT01075321|11617849|FG000|NOT COMPLETED|Overall Study||1
10469679|NCT01075321|11617850|FG001|NOT COMPLETED|Overall Study||0
10469680|NCT01075321|11617851|FG002|NOT COMPLETED|Overall Study||2
10469681|NCT01075321|11617852|FG003|NOT COMPLETED|Overall Study||2
10469682|NCT01075347|11617866|FG000|STARTED|Overall Study||82
10469683|NCT01075347|11617867|FG001|STARTED|Overall Study||83
10469684|NCT01075347|11617866|FG000|COMPLETED|Overall Study||82
10469685|NCT01075347|11617867|FG001|COMPLETED|Overall Study||83
10469686|NCT01075347|11617866|FG000|NOT COMPLETED|Overall Study||0
10469687|NCT01075347|11617867|FG001|NOT COMPLETED|Overall Study||0
10469688|NCT01075399|11617873|FG000|STARTED|Overall Study|A total of 50 patients were enrolled into the study.|50
10469689|NCT01075399|11617873|FG000|COMPLETED|Overall Study|42 of 50 patients received at least one dose and 39 of 50 patients completed two pre-treatment scan|42
10469690|NCT01075399|11617873|FG000|NOT COMPLETED|Overall Study||8
10469691|NCT01075412|11617879|FG000|STARTED|Overall Study||4
10469692|NCT01075412|11617880|FG001|STARTED|Overall Study||2
10469693|NCT01075412|11617879|FG000|COMPLETED|Overall Study||4
10469694|NCT01075412|11617880|FG001|COMPLETED|Overall Study||1
10469695|NCT01075412|11617879|FG000|NOT COMPLETED|Overall Study||0
10469696|NCT01075412|11617880|FG001|NOT COMPLETED|Overall Study||1
10469697|NCT01075516|11617887|FG000|STARTED|Overall Study||107
10469698|NCT01075516|11617888|FG001|STARTED|Overall Study||102
10469699|NCT01075516|11617887|FG000|COMPLETED|Overall Study||89
10469700|NCT01075516|11617888|FG001|COMPLETED|Overall Study||86
10469701|NCT01075516|11617887|FG000|NOT COMPLETED|Overall Study||18
10469702|NCT01075516|11617888|FG001|NOT COMPLETED|Overall Study||16
10469703|NCT01075646|11617898|FG000|STARTED|Overall Study||33
10469704|NCT01075646|11617899|FG001|STARTED|Overall Study||34
10469705|NCT01075646|11617900|FG002|STARTED|Overall Study||53
10469706|NCT01075646|11617901|FG003|STARTED|Overall Study||46
10469707|NCT01075646|11617898|FG000|COMPLETED|Overall Study||29
10469708|NCT01075646|11617899|FG001|COMPLETED|Overall Study||31
10469709|NCT01075646|11617900|FG002|COMPLETED|Overall Study||52
10469710|NCT01075646|11617901|FG003|COMPLETED|Overall Study||44
10469711|NCT01075646|11617898|FG000|NOT COMPLETED|Overall Study||4
10469712|NCT01075646|11617899|FG001|NOT COMPLETED|Overall Study||3
10469713|NCT01075646|11617900|FG002|NOT COMPLETED|Overall Study||1
10469714|NCT01075646|11617901|FG003|NOT COMPLETED|Overall Study||2
10469715|NCT01075685|11617913|FG000|STARTED|Overall Study||743
10469716|NCT01075685|11617914|FG001|STARTED|Overall Study||414
10469717|NCT01075685|11617913|FG000|Met Inclusion Criteria|Overall Study||734
10469718|NCT01075685|11617914|FG001|Met Inclusion Criteria|Overall Study||413
10469719|NCT01075685|11617913|FG000|Completed Baseline Measures|Overall Study||225
10469720|NCT01075685|11617914|FG001|Completed Baseline Measures|Overall Study||263
10469721|NCT01075685|11617913|FG000|COMPLETED|Overall Study||151
10469722|NCT01075685|11617914|FG001|COMPLETED|Overall Study||188
10469723|NCT01075685|11617913|FG000|NOT COMPLETED|Overall Study||592
10469724|NCT01075685|11617914|FG001|NOT COMPLETED|Overall Study||226
10469725|NCT01075763|11617922|FG000|STARTED|Overall Study||23
10469726|NCT01075763|11617923|FG001|STARTED|Overall Study||19
10469727|NCT01075763|11617922|FG000|COMPLETED|Overall Study||19
10469728|NCT01075763|11617923|FG001|COMPLETED|Overall Study||15
10469729|NCT01075763|11617922|FG000|NOT COMPLETED|Overall Study||4
10469730|NCT01075763|11617923|FG001|NOT COMPLETED|Overall Study||4
10469731|NCT01075815|11617931|FG000|STARTED|Overall Study|Number of participants treated.|40
10469732|NCT01075815|11617932|FG001|STARTED|Overall Study|Number of participants treated.|35
10469733|NCT01075815|11617931|FG000|COMPLETED|Overall Study||30
10469734|NCT01075815|11617932|FG001|COMPLETED|Overall Study||31
10469735|NCT01075815|11617931|FG000|NOT COMPLETED|Overall Study||10
10469736|NCT01075815|11617932|FG001|NOT COMPLETED|Overall Study||4
10469737|NCT01075958|11617938|FG000|STARTED|Overall Study||283
10469738|NCT01075958|11617938|FG000|COMPLETED|Overall Study||239
10469739|NCT01075958|11617938|FG000|NOT COMPLETED|Overall Study||44
10469740|NCT01075971|11617942|FG000|STARTED|Overall Study||52
10469741|NCT01075971|11617942|FG000|COMPLETED|Overall Study||52
10469742|NCT01075971|11617942|FG000|NOT COMPLETED|Overall Study||0
10469743|NCT01075984|11617951|FG000|STARTED|Treatment Phase||10
10469744|NCT01075984|11617952|FG001|STARTED|Treatment Phase||11
10469745|NCT01075984|11617953|FG002|STARTED|Treatment Phase||21
10469746|NCT01075984|11617954|FG003|STARTED|Treatment Phase||24
10469747|NCT01075984|11617955|FG004|STARTED|Treatment Phase||213
10469748|NCT01075984|11617951|FG000|COMPLETED|Treatment Phase||10
10469749|NCT01075984|11617952|FG001|COMPLETED|Treatment Phase||10
10469750|NCT01075984|11617953|FG002|COMPLETED|Treatment Phase||14
10469751|NCT01075984|11617954|FG003|COMPLETED|Treatment Phase||17
10469752|NCT01075984|11617955|FG004|COMPLETED|Treatment Phase||153
10469753|NCT01075984|11617951|FG000|NOT COMPLETED|Treatment Phase||0
10469754|NCT01075984|11617952|FG001|NOT COMPLETED|Treatment Phase||1
10469755|NCT01075984|11617953|FG002|NOT COMPLETED|Treatment Phase||7
10469756|NCT01075984|11617954|FG003|NOT COMPLETED|Treatment Phase||7
10469757|NCT01075984|11617955|FG004|NOT COMPLETED|Treatment Phase||60
10469758|NCT01075984|11617951|FG000|STARTED|Follow-up Phase||10
10469759|NCT01075984|11617952|FG001|STARTED|Follow-up Phase||10
10469760|NCT01075984|11617953|FG002|STARTED|Follow-up Phase|One participant did not start the follow-up phase for reasons unrelated to study procedures.|20
10469761|NCT01075984|11617954|FG003|STARTED|Follow-up Phase|Three participants did not start the follow-up phase: one died and two were lost to follow-up.|21
10469762|NCT01075984|11617955|FG004|STARTED|Follow-up Phase|One participant withdrew consent before the start of the follow-up phase.|212
10469763|NCT01075984|11617951|FG000|COMPLETED|Follow-up Phase||10
10469764|NCT01075984|11617952|FG001|COMPLETED|Follow-up Phase||10
10469765|NCT01075984|11617953|FG002|COMPLETED|Follow-up Phase||19
10469766|NCT01075984|11617954|FG003|COMPLETED|Follow-up Phase||19
10469767|NCT01075984|11617955|FG004|COMPLETED|Follow-up Phase||165
10469768|NCT01075984|11617951|FG000|NOT COMPLETED|Follow-up Phase||0
10469769|NCT01075984|11617952|FG001|NOT COMPLETED|Follow-up Phase||0
10469770|NCT01075984|11617953|FG002|NOT COMPLETED|Follow-up Phase||1
10469771|NCT01075984|11617954|FG003|NOT COMPLETED|Follow-up Phase||2
10469772|NCT01075984|11617955|FG004|NOT COMPLETED|Follow-up Phase||47
10469773|NCT01076010|11617970|FG000|STARTED|Overall Study||161
10469774|NCT01076010|11617971|FG001|STARTED|Overall Study||88
10469775|NCT01076010|11617972|FG002|STARTED|Overall Study||28
10469776|NCT01076010|11617970|FG000|COMPLETED|Overall Study||36
10469777|NCT01076010|11617971|FG001|COMPLETED|Overall Study||49
10469778|NCT01076010|11617972|FG002|COMPLETED|Overall Study||26
10469779|NCT01076010|11617970|FG000|NOT COMPLETED|Overall Study||125
10469780|NCT01076010|11617971|FG001|NOT COMPLETED|Overall Study||39
10469781|NCT01076010|11617972|FG002|NOT COMPLETED|Overall Study||2
10469782|NCT01076036|11617980|FG000|STARTED|Overall Study||10
10469783|NCT01076036|11617980|FG000|# of Procedures|Overall Study||8
10469784|NCT01076036|11617980|FG000|Complete CorPath Procedures|Overall Study||8
10469785|NCT01076036|11617980|FG000|COMPLETED|Overall Study||8
10469786|NCT01076036|11617980|FG000|NOT COMPLETED|Overall Study||2
10526687|NCT01383200|11678595|FG000|STARTED|Overall Study||5
10526688|NCT01383200|11678596|FG001|STARTED|Overall Study||6
10526689|NCT01383200|11678595|FG000|COMPLETED|Overall Study||5
10526690|NCT01383200|11678596|FG001|COMPLETED|Overall Study||6
10526691|NCT01383200|11678595|FG000|NOT COMPLETED|Overall Study||0
10526692|NCT01383200|11678596|FG001|NOT COMPLETED|Overall Study||0
10526693|NCT01383213|11678604|FG000|STARTED|Overall Study||40
10526694|NCT01383213|11678605|FG001|STARTED|Overall Study||41
10526695|NCT01383213|11678604|FG000|COMPLETED|Overall Study||40
10526696|NCT01383213|11678605|FG001|COMPLETED|Overall Study||41
10526697|NCT01383213|11678604|FG000|NOT COMPLETED|Overall Study||0
10708802|NCT02634346|11873731|FG000|STARTED|Overall Study||134
10526698|NCT01383213|11678605|FG001|NOT COMPLETED|Overall Study||0
10526699|NCT01383317|11678613|FG000|STARTED|Overall Study||29
10708803|NCT02634346|11873732|FG001|STARTED|Overall Study||133
10708804|NCT02634346|11873733|FG002|STARTED|Overall Study||134
10526700|NCT01383317|11678614|FG001|STARTED|Overall Study||35
10526701|NCT01383317|11678613|FG000|COMPLETED|Overall Study||26
10526702|NCT01383317|11678614|FG001|COMPLETED|Overall Study||33
10526703|NCT01383317|11678613|FG000|NOT COMPLETED|Overall Study||3
10526704|NCT01383317|11678614|FG001|NOT COMPLETED|Overall Study||2
10526705|NCT01383356|11678620|FG000|STARTED|Period 1|Entered and treated.|29
10526706|NCT01383356|11678621|FG001|STARTED|Period 1|Entered and treated.|29
10708805|NCT02634346|11873731|FG000|COMPLETED|Overall Study||122
10469787|NCT01076049|11617987|FG000|STARTED|Overall Study||52
10469788|NCT01076049|11617988|FG001|STARTED|Overall Study||55
10469789|NCT01076049|11617989|FG002|STARTED|Overall Study||1
10469790|NCT01076049|11617987|FG000|COMPLETED|Overall Study||45
10469791|NCT01076049|11617988|FG001|COMPLETED|Overall Study||52
10469792|NCT01076049|11617989|FG002|COMPLETED|Overall Study||1
10469793|NCT01076049|11617987|FG000|NOT COMPLETED|Overall Study||7
10469794|NCT01076049|11617988|FG001|NOT COMPLETED|Overall Study||3
10469795|NCT01076049|11617989|FG002|NOT COMPLETED|Overall Study||0
10469796|NCT01076075|11618001|FG000|STARTED|Overall Study|3 participants were excluded from safety and efficacy analyses due to one site's non-compliance|213
10469797|NCT01076075|11618002|FG001|STARTED|Overall Study|2 participants were excluded from safety and efficacy analyses due to one site's non-compliance|214
10469798|NCT01076075|11618001|FG000|Completed Phase A|Overall Study||199
10469799|NCT01076075|11618002|FG001|Completed Phase A|Overall Study||189
10469800|NCT01076075|11618001|FG000|COMPLETED|Overall Study||172
10469801|NCT01076075|11618002|FG001|COMPLETED|Overall Study||167
10469802|NCT01076075|11618001|FG000|NOT COMPLETED|Overall Study||41
10469803|NCT01076075|11618002|FG001|NOT COMPLETED|Overall Study||47
10469804|NCT01076088|11618017|FG000|STARTED|Overall Study||122
10469805|NCT01076088|11618018|FG001|STARTED|Overall Study||125
10469806|NCT01076088|11618019|FG002|STARTED|Overall Study||126
10469807|NCT01076088|11618020|FG003|STARTED|Overall Study||124
10469808|NCT01076088|11618021|FG004|STARTED|Overall Study||120
10469809|NCT01076088|11618022|FG005|STARTED|Overall Study||127
10469810|NCT01076088|11618017|FG000|COMPLETED|Overall Study||111
10469811|NCT01076088|11618018|FG001|COMPLETED|Overall Study||107
10469812|NCT01076088|11618019|FG002|COMPLETED|Overall Study||109
10469813|NCT01076088|11618020|FG003|COMPLETED|Overall Study||109
10469814|NCT01076088|11618021|FG004|COMPLETED|Overall Study||104
10469815|NCT01076088|11618022|FG005|COMPLETED|Overall Study||104
10469816|NCT01076088|11618017|FG000|NOT COMPLETED|Overall Study||11
10469817|NCT01076088|11618018|FG001|NOT COMPLETED|Overall Study||18
10469818|NCT01076088|11618019|FG002|NOT COMPLETED|Overall Study||17
10469819|NCT01076088|11618020|FG003|NOT COMPLETED|Overall Study||15
10469820|NCT01076088|11618021|FG004|NOT COMPLETED|Overall Study||16
10469821|NCT01076088|11618022|FG005|NOT COMPLETED|Overall Study||23
10469822|NCT01076153|11618037|FG000|STARTED|Overall Study||760
10469823|NCT01076153|11618037|FG000|COMPLETED|Overall Study||749
10469824|NCT01076153|11618037|FG000|NOT COMPLETED|Overall Study||11
10469825|NCT01076166|11618045|FG000|STARTED|Overall Study||337
10469826|NCT01076166|11618045|FG000|COMPLETED|Overall Study||328
10469827|NCT01076166|11618045|FG000|NOT COMPLETED|Overall Study||9
10469828|NCT01076179|11618052|FG000|STARTED|Overall Study||502
10469829|NCT01076179|11618052|FG000|COMPLETED|Overall Study||501
10469830|NCT01076179|11618052|FG000|NOT COMPLETED|Overall Study||1
10469831|NCT01076192|11618057|FG000|STARTED|Overall Study||547
10469832|NCT01076192|11618057|FG000|COMPLETED|Overall Study||350
10469833|NCT01076192|11618057|FG000|NOT COMPLETED|Overall Study||197
10469834|NCT01076205|11618062|FG000|STARTED|Overall Study||7229
10469835|NCT01076205|11618062|FG000|COMPLETED|Overall Study||1210
10469836|NCT01076205|11618062|FG000|NOT COMPLETED|Overall Study||6019
10469837|NCT01076231|11618082|FG000|STARTED|Overall Study||34
10469838|NCT01076231|11618082|FG000|COMPLETED|Overall Study||0
10469839|NCT01076231|11618082|FG000|NOT COMPLETED|Overall Study||34
10469840|NCT01076244|11618086|FG000|STARTED|Overall Study||46
10469841|NCT01076244|11618086|FG000|COMPLETED|Overall Study||42
10469842|NCT01076244|11618086|FG000|NOT COMPLETED|Overall Study||4
10469843|NCT01076270|11618090|FG000|STARTED|Overall Study||1
10469844|NCT01076270|11618090|FG000|COMPLETED|Overall Study||1
10469845|NCT01076270|11618090|FG000|NOT COMPLETED|Overall Study||0
10469846|NCT01076283|11618096|FG000|STARTED|Overall Study||7
10469847|NCT01076283|11618097|FG001|STARTED|Overall Study||7
10469848|NCT01076283|11618096|FG000|COMPLETED|Overall Study||6
10469849|NCT01076283|11618097|FG001|COMPLETED|Overall Study||7
10469850|NCT01076283|11618096|FG000|NOT COMPLETED|Overall Study||1
10469851|NCT01076283|11618097|FG001|NOT COMPLETED|Overall Study||0
10469852|NCT01076296|11618103|FG000|STARTED|Overall Study||54
10469853|NCT01076296|11618104|FG001|STARTED|Overall Study||196
10469854|NCT01076296|11618105|FG002|STARTED|Overall Study||51
10469855|NCT01076296|11618106|FG003|STARTED|Overall Study||199
10469856|NCT01076296|11618107|FG004|STARTED|Overall Study||59
10469857|NCT01076296|11618108|FG005|STARTED|Overall Study||191
10469858|NCT01076296|11618109|FG006|STARTED|Overall Study||51
10469859|NCT01076296|11618110|FG007|STARTED|Overall Study||199
10469860|NCT01076296|11618103|FG000|COMPLETED|Overall Study||54
10469861|NCT01076296|11618104|FG001|COMPLETED|Overall Study||196
10469862|NCT01076296|11618105|FG002|COMPLETED|Overall Study||51
10469863|NCT01076296|11618106|FG003|COMPLETED|Overall Study||199
10469864|NCT01076296|11618107|FG004|COMPLETED|Overall Study||59
10469865|NCT01076296|11618108|FG005|COMPLETED|Overall Study||191
10469866|NCT01076296|11618109|FG006|COMPLETED|Overall Study||51
10469867|NCT01076296|11618110|FG007|COMPLETED|Overall Study||199
10469868|NCT01076296|11618103|FG000|NOT COMPLETED|Overall Study||0
10469869|NCT01076296|11618104|FG001|NOT COMPLETED|Overall Study||0
10469870|NCT01076296|11618105|FG002|NOT COMPLETED|Overall Study||0
10469871|NCT01076296|11618106|FG003|NOT COMPLETED|Overall Study||0
10469872|NCT01076296|11618107|FG004|NOT COMPLETED|Overall Study||0
10469873|NCT01076296|11618108|FG005|NOT COMPLETED|Overall Study||0
10469874|NCT01076296|11618109|FG006|NOT COMPLETED|Overall Study||0
10469875|NCT01076296|11618110|FG007|NOT COMPLETED|Overall Study||0
10469876|NCT01076335|11618128|FG000|STARTED|Overall Study||40
10469877|NCT01076335|11618128|FG000|COMPLETED|Overall Study||36
10469878|NCT01076335|11618128|FG000|NOT COMPLETED|Overall Study||4
10469879|NCT01076348|11618132|FG000|STARTED|Overall Study||73
10469880|NCT01076348|11618132|FG000|COMPLETED|Overall Study||51
10469881|NCT01076348|11618132|FG000|NOT COMPLETED|Overall Study||22
10469882|NCT01076361|11618136|FG000|STARTED|Overall Study|631 leads were implanted in 370 patients. 22 leads in 21 patients were excluded from analysis.|370
10469883|NCT01076361|11618136|FG000|COMPLETED|Overall Study|Follow-up data was not available for 21 participants (22 leads)|349
10469884|NCT01076361|11618136|FG000|NOT COMPLETED|Overall Study||21
10469885|NCT01076400|11618140|FG000|STARTED|Overall Study||7
10469886|NCT01076400|11618141|FG001|STARTED|Overall Study|No participants were enrolled in Part 2 of the study.|0
10469887|NCT01076400|11618142|FG002|STARTED|Overall Study|No participants were enrolled in Part 2 of the study.|0
10469888|NCT01076400|11618140|FG000|COMPLETED|Overall Study||0
10469889|NCT01076400|11618141|FG001|COMPLETED|Overall Study||0
10469890|NCT01076400|11618142|FG002|COMPLETED|Overall Study||0
10469891|NCT01076400|11618140|FG000|NOT COMPLETED|Overall Study||7
10469892|NCT01076400|11618141|FG001|NOT COMPLETED|Overall Study||0
10469893|NCT01076400|11618142|FG002|NOT COMPLETED|Overall Study||0
10469894|NCT01076452|11618148|FG000|STARTED|Overall Study||147
10469895|NCT01076452|11618149|FG001|STARTED|Overall Study||152
10469896|NCT01076452|11618148|FG000|COMPLETED|Overall Study||123
10469897|NCT01076452|11618149|FG001|COMPLETED|Overall Study||138
10469898|NCT01076452|11618148|FG000|NOT COMPLETED|Overall Study||24
10469899|NCT01076452|11618149|FG001|NOT COMPLETED|Overall Study||14
10469900|NCT01076504|11618155|FG000|STARTED|Overall Study||80
10469901|NCT01076504|11618155|FG000|COMPLETED|Overall Study|Patients remained on study until disease progression or withdrawal for any other reason|0
10469902|NCT01076504|11618155|FG000|NOT COMPLETED|Overall Study||80
10469903|NCT01076543|11618165|FG000|STARTED|Overall Study||8
10469904|NCT01076543|11618166|FG001|STARTED|Overall Study||3
10469905|NCT01076543|11618167|FG002|STARTED|Overall Study||6
10469906|NCT01076543|11618168|FG003|STARTED|Overall Study||39
10469907|NCT01076543|11618169|FG004|STARTED|Overall Study||15
10469908|NCT01076543|11618170|FG005|STARTED|Overall Study||39
10469909|NCT01076543|11618165|FG000|COMPLETED|Overall Study||6
10469910|NCT01076543|11618166|FG001|COMPLETED|Overall Study||3
10469911|NCT01076543|11618167|FG002|COMPLETED|Overall Study||6
10469912|NCT01076543|11618168|FG003|COMPLETED|Overall Study||39
10469913|NCT01076543|11618169|FG004|COMPLETED|Overall Study||15
10469914|NCT01076543|11618170|FG005|COMPLETED|Overall Study||39
10469915|NCT01076543|11618165|FG000|NOT COMPLETED|Overall Study||2
10469916|NCT01076543|11618166|FG001|NOT COMPLETED|Overall Study||0
10469917|NCT01076543|11618167|FG002|NOT COMPLETED|Overall Study||0
10469918|NCT01076543|11618168|FG003|NOT COMPLETED|Overall Study||0
10469919|NCT01076543|11618169|FG004|NOT COMPLETED|Overall Study||0
10469920|NCT01076543|11618170|FG005|NOT COMPLETED|Overall Study||0
10469921|NCT01076647|11618187|FG000|STARTED|Overall Study||233
10469922|NCT01076647|11618188|FG001|STARTED|Overall Study||234
10469923|NCT01076647|11618187|FG000|COMPLETED|Overall Study||208
10469924|NCT01076647|11618188|FG001|COMPLETED|Overall Study||209
10469925|NCT01076647|11618187|FG000|NOT COMPLETED|Overall Study||25
10469926|NCT01076647|11618188|FG001|NOT COMPLETED|Overall Study||25
10469927|NCT01076686|11618198|FG000|STARTED|Overall Study||17
10469928|NCT01076686|11618199|FG001|STARTED|Overall Study||14
10469929|NCT01076686|11618200|FG002|STARTED|Overall Study||32
10469930|NCT01076686|11618201|FG003|STARTED|Overall Study||31
10469931|NCT01076686|11618198|FG000|COMPLETED|Overall Study||17
10469932|NCT01076686|11618199|FG001|COMPLETED|Overall Study||14
10469933|NCT01076686|11618200|FG002|COMPLETED|Overall Study||32
10469934|NCT01076686|11618201|FG003|COMPLETED|Overall Study||31
10469935|NCT01076686|11618198|FG000|NOT COMPLETED|Overall Study||0
10469936|NCT01076686|11618199|FG001|NOT COMPLETED|Overall Study||0
10469937|NCT01076686|11618200|FG002|NOT COMPLETED|Overall Study||0
10469938|NCT01076686|11618201|FG003|NOT COMPLETED|Overall Study||0
10469939|NCT01076959|11618211|FG000|STARTED|Overall Study||7740
10469940|NCT01076959|11618211|FG000|COMPLETED|Overall Study||5490
10469941|NCT01076959|11618211|FG000|NOT COMPLETED|Overall Study||2250
10469942|NCT01076972|11618228|FG000|STARTED|Overall Study||1184
10469943|NCT01076972|11618228|FG000|COMPLETED|Overall Study||1184
10469944|NCT01076972|11618228|FG000|NOT COMPLETED|Overall Study||0
10469945|NCT01076985|11618242|FG000|STARTED|Overall Study||24
10469946|NCT01076985|11618242|FG000|COMPLETED|Overall Study||24
10469947|NCT01076985|11618242|FG000|NOT COMPLETED|Overall Study||0
10469948|NCT01077024|11618250|FG000|STARTED|Overall Study||267
10469949|NCT01077024|11618251|FG001|STARTED|Overall Study||271
10469950|NCT01077024|11618250|FG000|COMPLETED|Overall Study||236
10469951|NCT01077024|11618251|FG001|COMPLETED|Overall Study||243
10469952|NCT01077024|11618250|FG000|NOT COMPLETED|Overall Study||31
10469953|NCT01077024|11618251|FG001|NOT COMPLETED|Overall Study||28
10469954|NCT01077050|11618257|FG000|STARTED|Overall Study||1951
10469955|NCT01077050|11618257|FG000|COMPLETED|Overall Study||1942
10469956|NCT01077050|11618257|FG000|NOT COMPLETED|Overall Study||9
10469957|NCT01077063|11618263|FG000|STARTED|Overall Study||4
10469958|NCT01077063|11618264|FG001|STARTED|Overall Study||3
10469959|NCT01077063|11618263|FG000|COMPLETED|Overall Study||0
10469960|NCT01077063|11618264|FG001|COMPLETED|Overall Study||0
10469961|NCT01077063|11618263|FG000|NOT COMPLETED|Overall Study||4
10469962|NCT01077063|11618264|FG001|NOT COMPLETED|Overall Study||3
10469963|NCT01077076|11618270|FG000|STARTED|First Intervention||5
10469964|NCT01077076|11618271|FG001|STARTED|First Intervention||5
10469965|NCT01077076|11618272|FG002|STARTED|First Intervention||5
10469966|NCT01077076|11618273|FG003|STARTED|First Intervention||5
10469967|NCT01077076|11618274|FG004|STARTED|First Intervention||5
10469968|NCT01077076|11618275|FG005|STARTED|First Intervention||5
10469969|NCT01077076|11618270|FG000|COMPLETED|First Intervention||4
10469970|NCT01077076|11618271|FG001|COMPLETED|First Intervention||5
10469971|NCT01077076|11618272|FG002|COMPLETED|First Intervention||5
10469972|NCT01077076|11618273|FG003|COMPLETED|First Intervention||5
10469973|NCT01077076|11618274|FG004|COMPLETED|First Intervention||5
10469974|NCT01077076|11618275|FG005|COMPLETED|First Intervention||5
10469975|NCT01077076|11618270|FG000|NOT COMPLETED|First Intervention||1
10469976|NCT01077076|11618271|FG001|NOT COMPLETED|First Intervention||0
10469977|NCT01077076|11618272|FG002|NOT COMPLETED|First Intervention||0
10469978|NCT01077076|11618273|FG003|NOT COMPLETED|First Intervention||0
10469979|NCT01077076|11618274|FG004|NOT COMPLETED|First Intervention||0
10469980|NCT01077076|11618275|FG005|NOT COMPLETED|First Intervention||0
10469981|NCT01077076|11618270|FG000|STARTED|Washout Period of 2 Weeks||4
10469982|NCT01077076|11618271|FG001|STARTED|Washout Period of 2 Weeks||5
10469983|NCT01077076|11618272|FG002|STARTED|Washout Period of 2 Weeks||5
10469984|NCT01077076|11618273|FG003|STARTED|Washout Period of 2 Weeks||5
10469985|NCT01077076|11618274|FG004|STARTED|Washout Period of 2 Weeks||5
10469986|NCT01077076|11618275|FG005|STARTED|Washout Period of 2 Weeks||5
10469987|NCT01077076|11618270|FG000|COMPLETED|Washout Period of 2 Weeks||4
10469988|NCT01077076|11618271|FG001|COMPLETED|Washout Period of 2 Weeks||5
10469989|NCT01077076|11618272|FG002|COMPLETED|Washout Period of 2 Weeks||5
10469990|NCT01077076|11618273|FG003|COMPLETED|Washout Period of 2 Weeks||5
10469991|NCT01077076|11618274|FG004|COMPLETED|Washout Period of 2 Weeks||5
10469992|NCT01077076|11618275|FG005|COMPLETED|Washout Period of 2 Weeks||5
10469993|NCT01077076|11618270|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
10469994|NCT01077076|11618271|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
10469995|NCT01077076|11618272|FG002|NOT COMPLETED|Washout Period of 2 Weeks||0
10469996|NCT01077076|11618273|FG003|NOT COMPLETED|Washout Period of 2 Weeks||0
10469997|NCT01077076|11618274|FG004|NOT COMPLETED|Washout Period of 2 Weeks||0
10469998|NCT01077076|11618275|FG005|NOT COMPLETED|Washout Period of 2 Weeks||0
10469999|NCT01077076|11618270|FG000|STARTED|Second Intervention||4
10470000|NCT01077076|11618271|FG001|STARTED|Second Intervention||5
10470001|NCT01077076|11618272|FG002|STARTED|Second Intervention||5
10470002|NCT01077076|11618273|FG003|STARTED|Second Intervention||5
10470003|NCT01077076|11618274|FG004|STARTED|Second Intervention||5
10470004|NCT01077076|11618275|FG005|STARTED|Second Intervention||5
10470005|NCT01077076|11618270|FG000|COMPLETED|Second Intervention||4
10470006|NCT01077076|11618271|FG001|COMPLETED|Second Intervention||5
10470007|NCT01077076|11618272|FG002|COMPLETED|Second Intervention||5
10470008|NCT01077076|11618273|FG003|COMPLETED|Second Intervention||5
10470009|NCT01077076|11618274|FG004|COMPLETED|Second Intervention||5
10470010|NCT01077076|11618275|FG005|COMPLETED|Second Intervention||5
10470011|NCT01077076|11618270|FG000|NOT COMPLETED|Second Intervention||0
10470012|NCT01077076|11618271|FG001|NOT COMPLETED|Second Intervention||0
10470013|NCT01077076|11618272|FG002|NOT COMPLETED|Second Intervention||0
10470014|NCT01077076|11618273|FG003|NOT COMPLETED|Second Intervention||0
10470015|NCT01077076|11618274|FG004|NOT COMPLETED|Second Intervention||0
10470016|NCT01077076|11618275|FG005|NOT COMPLETED|Second Intervention||0
10470017|NCT01077076|11618270|FG000|STARTED|Washout Period of 2 Weeks||4
10470018|NCT01077076|11618271|FG001|STARTED|Washout Period of 2 Weeks||5
10470019|NCT01077076|11618272|FG002|STARTED|Washout Period of 2 Weeks||5
10470020|NCT01077076|11618273|FG003|STARTED|Washout Period of 2 Weeks||5
10470021|NCT01077076|11618274|FG004|STARTED|Washout Period of 2 Weeks||5
10470022|NCT01077076|11618275|FG005|STARTED|Washout Period of 2 Weeks||5
10470023|NCT01077076|11618270|FG000|COMPLETED|Washout Period of 2 Weeks||4
10470024|NCT01077076|11618271|FG001|COMPLETED|Washout Period of 2 Weeks||5
10470025|NCT01077076|11618272|FG002|COMPLETED|Washout Period of 2 Weeks||5
10470026|NCT01077076|11618273|FG003|COMPLETED|Washout Period of 2 Weeks||5
10470027|NCT01077076|11618274|FG004|COMPLETED|Washout Period of 2 Weeks||5
10470028|NCT01077076|11618275|FG005|COMPLETED|Washout Period of 2 Weeks||5
10470029|NCT01077076|11618270|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
10470030|NCT01077076|11618271|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
10470031|NCT01077076|11618272|FG002|NOT COMPLETED|Washout Period of 2 Weeks||0
10470032|NCT01077076|11618273|FG003|NOT COMPLETED|Washout Period of 2 Weeks||0
10470033|NCT01077076|11618274|FG004|NOT COMPLETED|Washout Period of 2 Weeks||0
10470034|NCT01077076|11618275|FG005|NOT COMPLETED|Washout Period of 2 Weeks||0
10470035|NCT01077076|11618270|FG000|STARTED|Third Intervention||4
10470036|NCT01077076|11618271|FG001|STARTED|Third Intervention||5
10470037|NCT01077076|11618272|FG002|STARTED|Third Intervention||5
10470038|NCT01077076|11618273|FG003|STARTED|Third Intervention||5
10470039|NCT01077076|11618274|FG004|STARTED|Third Intervention||5
10470040|NCT01077076|11618275|FG005|STARTED|Third Intervention||5
10470041|NCT01077076|11618270|FG000|COMPLETED|Third Intervention||4
10470042|NCT01077076|11618271|FG001|COMPLETED|Third Intervention||5
10470043|NCT01077076|11618272|FG002|COMPLETED|Third Intervention||5
10470044|NCT01077076|11618273|FG003|COMPLETED|Third Intervention||5
10470045|NCT01077076|11618274|FG004|COMPLETED|Third Intervention||5
10470046|NCT01077076|11618275|FG005|COMPLETED|Third Intervention||4
10470047|NCT01077076|11618270|FG000|NOT COMPLETED|Third Intervention||0
10470048|NCT01077076|11618271|FG001|NOT COMPLETED|Third Intervention||0
10470049|NCT01077076|11618272|FG002|NOT COMPLETED|Third Intervention||0
10470050|NCT01077076|11618273|FG003|NOT COMPLETED|Third Intervention||0
10470051|NCT01077076|11618274|FG004|NOT COMPLETED|Third Intervention||0
10470052|NCT01077076|11618275|FG005|NOT COMPLETED|Third Intervention||1
10470053|NCT01077128|11618283|FG000|STARTED|Overall Study||500
10470054|NCT01077128|11618283|FG000|COMPLETED|Overall Study||433
10470055|NCT01077128|11618283|FG000|NOT COMPLETED|Overall Study||67
10470056|NCT01077154|11618339|FG000|STARTED|Overall Study||2253
10470057|NCT01077154|11618340|FG001|STARTED|Overall Study||2256
10470058|NCT01077154|11618339|FG000|Received Study Drug|Overall Study||2229
10470059|NCT01077154|11618340|FG001|Received Study Drug|Overall Study||2230
10470060|NCT01077154|11618339|FG000|COMPLETED|Overall Study||27
10470061|NCT01077154|11618340|FG001|COMPLETED|Overall Study||28
10470062|NCT01077154|11618339|FG000|NOT COMPLETED|Overall Study||2226
10470063|NCT01077154|11618340|FG001|NOT COMPLETED|Overall Study||2228
10470064|NCT01077193|11618346|FG000|STARTED|Overall Study||44
10470065|NCT01077193|11618346|FG000|COMPLETED|Overall Study||0
10470066|NCT01077193|11618346|FG000|NOT COMPLETED|Overall Study||44
10470067|NCT01077258|11618350|FG000|STARTED|Overall Study||4208
10470068|NCT01077258|11618350|FG000|COMPLETED|Overall Study||1640
10470069|NCT01077258|11618350|FG000|NOT COMPLETED|Overall Study||2568
10470070|NCT01077271|11618367|FG000|STARTED|Overall Study||124
10470071|NCT01077271|11618367|FG000|Participants Treated With Palivizumab|Overall Study||120
10470072|NCT01077271|11618367|FG000|Number of Participants Analyzed|Overall Study||120
10470073|NCT01077271|11618367|FG000|COMPLETED|Overall Study||102
10470074|NCT01077271|11618367|FG000|NOT COMPLETED|Overall Study||22
10470075|NCT01077284|11618382|FG000|STARTED|Overall Study||33
10470076|NCT01077284|11618383|FG001|STARTED|Overall Study||33
10470077|NCT01077284|11618384|FG002|STARTED|Overall Study||33
10470078|NCT01077284|11618382|FG000|COMPLETED|Overall Study||28
10470079|NCT01077284|11618383|FG001|COMPLETED|Overall Study||28
10470080|NCT01077284|11618384|FG002|COMPLETED|Overall Study||30
10470081|NCT01077284|11618382|FG000|NOT COMPLETED|Overall Study||5
10470082|NCT01077284|11618383|FG001|NOT COMPLETED|Overall Study||5
10470083|NCT01077284|11618384|FG002|NOT COMPLETED|Overall Study||3
10470084|NCT01077310|11618394|FG000|STARTED|Overall Study||67
10470085|NCT01077310|11618395|FG001|STARTED|Overall Study||33
10470086|NCT01077310|11618394|FG000|COMPLETED|Overall Study||67
10470087|NCT01077310|11618395|FG001|COMPLETED|Overall Study||33
10470088|NCT01077310|11618394|FG000|NOT COMPLETED|Overall Study||0
10470089|NCT01077310|11618395|FG001|NOT COMPLETED|Overall Study||0
10470090|NCT01077323|11618409|FG000|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|37097
10470091|NCT01077323|11618410|FG001|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|620799
10470092|NCT01077323|11618411|FG002|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|12015600
10470093|NCT01077323|11618409|FG000|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|25719
10470094|NCT01077323|11618410|FG001|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|234536
10470095|NCT01077323|11618411|FG002|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|103511
10470096|NCT01077323|11618409|FG000|NOT COMPLETED|Overall Study||11378
10470097|NCT01077323|11618410|FG001|NOT COMPLETED|Overall Study||386263
10470098|NCT01077323|11618411|FG002|NOT COMPLETED|Overall Study||11912089
10470099|NCT01077362|11618422|FG000|STARTED|Overall Study||104
10470100|NCT01077362|11618423|FG001|STARTED|Overall Study||103
10470101|NCT01077362|11618424|FG002|STARTED|Overall Study||105
10470102|NCT01077362|11618422|FG000|COMPLETED|Overall Study||73
10470103|NCT01077362|11618423|FG001|COMPLETED|Overall Study||84
10470104|NCT01077362|11618424|FG002|COMPLETED|Overall Study||81
10470105|NCT01077362|11618422|FG000|NOT COMPLETED|Overall Study||31
10470106|NCT01077362|11618423|FG001|NOT COMPLETED|Overall Study||19
10470107|NCT01077362|11618424|FG002|NOT COMPLETED|Overall Study||24
10470108|NCT01077375|11618439|FG000|STARTED|Overall Study||21
10470109|NCT01077375|11618440|FG001|STARTED|Overall Study|One randomized patient not taking study drug was excluded from the Double-blind Safety Population.|86
10470110|NCT01077375|11618439|FG000|COMPLETED|Overall Study||11
10470111|NCT01077375|11618440|FG001|COMPLETED|Overall Study||51
10470112|NCT01077375|11618439|FG000|NOT COMPLETED|Overall Study||10
10470113|NCT01077375|11618440|FG001|NOT COMPLETED|Overall Study||35
10470114|NCT01077401|11618450|FG000|STARTED|Overall Study||77
10470115|NCT01077401|11618451|FG001|STARTED|Overall Study||75
10470116|NCT01077401|11618450|FG000|COMPLETED|Overall Study||59
10470117|NCT01077401|11618451|FG001|COMPLETED|Overall Study||54
10470118|NCT01077401|11618450|FG000|NOT COMPLETED|Overall Study||18
10470119|NCT01077401|11618451|FG001|NOT COMPLETED|Overall Study||21
10470120|NCT01077518|11618459|FG000|STARTED|Treatment Phase - no Optional Ofa||173
10470121|NCT01077518|11618460|FG001|STARTED|Treatment Phase - no Optional Ofa||173
10470122|NCT01077518|11618461|FG002|STARTED|Treatment Phase - no Optional Ofa||0
10470123|NCT01077518|11618459|FG000|Completed 5-year Follow-up|Treatment Phase - no Optional Ofa||64
10470124|NCT01077518|11618460|FG001|Completed 5-year Follow-up|Treatment Phase - no Optional Ofa||64
10470125|NCT01077518|11618461|FG002|Completed 5-year Follow-up|Treatment Phase - no Optional Ofa||0
10470126|NCT01077518|11618459|FG000|Safety Population|Treatment Phase - no Optional Ofa||172
10470127|NCT01077518|11618460|FG001|Safety Population|Treatment Phase - no Optional Ofa||170
10470128|NCT01077518|11618461|FG002|Safety Population|Treatment Phase - no Optional Ofa||0
10470129|NCT01077518|11618459|FG000|COMPLETED|Treatment Phase - no Optional Ofa||95
10470130|NCT01077518|11618460|FG001|COMPLETED|Treatment Phase - no Optional Ofa||108
10470131|NCT01077518|11618461|FG002|COMPLETED|Treatment Phase - no Optional Ofa||0
10470132|NCT01077518|11618459|FG000|NOT COMPLETED|Treatment Phase - no Optional Ofa||78
10470133|NCT01077518|11618460|FG001|NOT COMPLETED|Treatment Phase - no Optional Ofa||65
10470134|NCT01077518|11618461|FG002|NOT COMPLETED|Treatment Phase - no Optional Ofa||0
10470135|NCT01077518|11618459|FG000|STARTED|Optional Ofa Phase||0
10470136|NCT01077518|11618460|FG001|STARTED|Optional Ofa Phase||0
10470137|NCT01077518|11618461|FG002|STARTED|Optional Ofa Phase||32
10470138|NCT01077518|11618459|FG000|Completed 5-year Follow-up|Optional Ofa Phase||0
10470139|NCT01077518|11618460|FG001|Completed 5-year Follow-up|Optional Ofa Phase||0
10470140|NCT01077518|11618461|FG002|Completed 5-year Follow-up|Optional Ofa Phase||12
10470141|NCT01077518|11618459|FG000|COMPLETED|Optional Ofa Phase||0
10470142|NCT01077518|11618460|FG001|COMPLETED|Optional Ofa Phase||0
10470143|NCT01077518|11618461|FG002|COMPLETED|Optional Ofa Phase||16
10470144|NCT01077518|11618459|FG000|NOT COMPLETED|Optional Ofa Phase||0
10470145|NCT01077518|11618460|FG001|NOT COMPLETED|Optional Ofa Phase||0
10470146|NCT01077518|11618461|FG002|NOT COMPLETED|Optional Ofa Phase||16
10470147|NCT01077544|11618472|FG000|STARTED|Overall Study||8
10470148|NCT01077544|11618473|FG001|STARTED|Overall Study||7
10470149|NCT01077544|11618472|FG000|COMPLETED|Overall Study||5
10470150|NCT01077544|11618473|FG001|COMPLETED|Overall Study||2
10470151|NCT01077544|11618472|FG000|NOT COMPLETED|Overall Study||3
10470152|NCT01077544|11618473|FG001|NOT COMPLETED|Overall Study||5
10470153|NCT01077596|11618491|FG000|STARTED|Overall Study||350
10470154|NCT01077596|11618492|FG001|STARTED|Overall Study||1050
10470155|NCT01077596|11618493|FG002|STARTED|Overall Study||457
10470156|NCT01077596|11618494|FG003|STARTED|Overall Study||1370
10470157|NCT01077596|11618495|FG004|STARTED|Overall Study||294
10470158|NCT01077596|11618496|FG005|STARTED|Overall Study||882
10470159|NCT01077596|11618497|FG006|STARTED|Overall Study||308
10470160|NCT01077596|11618498|FG007|STARTED|Overall Study||837
10470161|NCT01077596|11618499|FG008|STARTED|Overall Study||2842
10470162|NCT01077596|11618500|FG009|STARTED|Overall Study||28420
10470163|NCT01077596|11618501|FG010|STARTED|Overall Study||2215
10470164|NCT01077596|11618502|FG011|STARTED|Overall Study||22150
10470165|NCT01077596|11618491|FG000|COMPLETED|Overall Study||350
10470166|NCT01077596|11618492|FG001|COMPLETED|Overall Study||1050
10470167|NCT01077596|11618493|FG002|COMPLETED|Overall Study||457
10470168|NCT01077596|11618494|FG003|COMPLETED|Overall Study||1370
10470169|NCT01077596|11618495|FG004|COMPLETED|Overall Study||294
10470170|NCT01077596|11618496|FG005|COMPLETED|Overall Study||882
10470171|NCT01077596|11618497|FG006|COMPLETED|Overall Study||308
10470172|NCT01077596|11618498|FG007|COMPLETED|Overall Study||837
10470173|NCT01077596|11618499|FG008|COMPLETED|Overall Study||2842
10470174|NCT01077596|11618500|FG009|COMPLETED|Overall Study||28420
10470175|NCT01077596|11618501|FG010|COMPLETED|Overall Study||2215
10470176|NCT01077596|11618502|FG011|COMPLETED|Overall Study||22150
10470177|NCT01077596|11618491|FG000|NOT COMPLETED|Overall Study||0
10470178|NCT01077596|11618492|FG001|NOT COMPLETED|Overall Study||0
10470179|NCT01077596|11618493|FG002|NOT COMPLETED|Overall Study||0
10470180|NCT01077596|11618494|FG003|NOT COMPLETED|Overall Study||0
10470181|NCT01077596|11618495|FG004|NOT COMPLETED|Overall Study||0
10470182|NCT01077596|11618496|FG005|NOT COMPLETED|Overall Study||0
10470183|NCT01077596|11618497|FG006|NOT COMPLETED|Overall Study||0
10470184|NCT01077596|11618498|FG007|NOT COMPLETED|Overall Study||0
10470185|NCT01077596|11618499|FG008|NOT COMPLETED|Overall Study||0
10470186|NCT01077596|11618500|FG009|NOT COMPLETED|Overall Study||0
10470187|NCT01077596|11618501|FG010|NOT COMPLETED|Overall Study||0
10470188|NCT01077596|11618502|FG011|NOT COMPLETED|Overall Study||0
10470189|NCT01077622|11618523|FG000|STARTED|Overall Study||10
10470190|NCT01077622|11618523|FG000|COMPLETED|Overall Study||7
10470191|NCT01077622|11618523|FG000|NOT COMPLETED|Overall Study||3
10470192|NCT01077713|11618529|FG000|STARTED|Overall Study||44
10470193|NCT01077713|11618530|FG001|STARTED|Overall Study||42
10470194|NCT01077713|11618529|FG000|COMPLETED|Overall Study||8
10470195|NCT01077713|11618530|FG001|COMPLETED|Overall Study||6
10470196|NCT01077713|11618529|FG000|NOT COMPLETED|Overall Study||36
10470197|NCT01077713|11618530|FG001|NOT COMPLETED|Overall Study||36
10470198|NCT01077739|11618538|FG000|STARTED|Overall Study||25
10470199|NCT01077739|11618539|FG001|STARTED|Overall Study||50
10470200|NCT01077739|11618538|FG000|COMPLETED|Overall Study||20
10470201|NCT01077739|11618539|FG001|COMPLETED|Overall Study||40
10470202|NCT01077739|11618538|FG000|NOT COMPLETED|Overall Study||5
10470203|NCT01077739|11618539|FG001|NOT COMPLETED|Overall Study||10
10470204|NCT01077804|11618545|FG000|STARTED|Overall Study||7585
10470205|NCT01077804|11618545|FG000|COMPLETED|Overall Study||7386
10470206|NCT01077804|11618545|FG000|NOT COMPLETED|Overall Study||199
10470216|NCT01077921|11618596|FG000|STARTED|First Intervention||14
10470217|NCT01077921|11618597|FG001|STARTED|First Intervention||13
10470218|NCT01077921|11618596|FG000|COMPLETED|First Intervention||13
10470219|NCT01077921|11618597|FG001|COMPLETED|First Intervention||12
10470220|NCT01077921|11618596|FG000|NOT COMPLETED|First Intervention||1
10470221|NCT01077921|11618597|FG001|NOT COMPLETED|First Intervention||1
10470222|NCT01077921|11618596|FG000|STARTED|Washout||13
10470223|NCT01077921|11618597|FG001|STARTED|Washout||12
10470224|NCT01077921|11618596|FG000|COMPLETED|Washout||13
10470225|NCT01077921|11618597|FG001|COMPLETED|Washout||10
10470226|NCT01077921|11618596|FG000|NOT COMPLETED|Washout||0
10470227|NCT01077921|11618597|FG001|NOT COMPLETED|Washout||2
10470228|NCT01077921|11618596|FG000|STARTED|Second Intervention||13
10470229|NCT01077921|11618597|FG001|STARTED|Second Intervention||10
10470230|NCT01077921|11618596|FG000|COMPLETED|Second Intervention||13
10470231|NCT01077921|11618597|FG001|COMPLETED|Second Intervention||9
10470232|NCT01077921|11618596|FG000|NOT COMPLETED|Second Intervention||0
10470233|NCT01077921|11618597|FG001|NOT COMPLETED|Second Intervention||1
10470234|NCT01077960|11618604|FG000|STARTED|Overall Study|130 subjects consented to participate, 129 enrolled in the study, and 126 received study drug|126
10470235|NCT01077960|11618604|FG000|COMPLETED|Overall Study|Modified Intent To Treat (ITT) Population|110
10470236|NCT01077960|11618604|FG000|NOT COMPLETED|Overall Study||16
10470237|NCT01077973|11618611|FG000|STARTED|Overall Study||41
10470238|NCT01077973|11618612|FG001|STARTED|Overall Study||79
10470239|NCT01077973|11618613|FG002|STARTED|Overall Study||80
10470240|NCT01077973|11618611|FG000|COMPLETED|Overall Study||41
10470241|NCT01077973|11618612|FG001|COMPLETED|Overall Study||79
10470242|NCT01077973|11618613|FG002|COMPLETED|Overall Study||80
10470243|NCT01077973|11618611|FG000|NOT COMPLETED|Overall Study||0
10470244|NCT01077973|11618612|FG001|NOT COMPLETED|Overall Study||0
10470245|NCT01077973|11618613|FG002|NOT COMPLETED|Overall Study||0
10470246|NCT01078090|11618623|FG000|STARTED|Overall Study||5745
10470247|NCT01078090|11618623|FG000|COMPLETED|Overall Study||1152
10470248|NCT01078090|11618623|FG000|NOT COMPLETED|Overall Study||4593
10470249|NCT01078116|11618641|FG000|STARTED|Overall Study|121 participants were included in analysis (3 were excluded due to missing case report form data).|124
10470250|NCT01078116|11618641|FG000|COMPLETED|Overall Study||76
10470251|NCT01078116|11618641|FG000|NOT COMPLETED|Overall Study||48
10470252|NCT01078155|11618645|FG000|STARTED|Overall Study||131
10470253|NCT01078155|11618645|FG000|COMPLETED|Overall Study||87
10470254|NCT01078155|11618645|FG000|NOT COMPLETED|Overall Study||44
10470255|NCT01078168|11618651|FG000|STARTED|Overall Study||11
10470256|NCT01078168|11618652|FG001|STARTED|Overall Study||11
10470257|NCT01078168|11618651|FG000|COMPLETED|Overall Study||11
10470258|NCT01078168|11618652|FG001|COMPLETED|Overall Study||10
10470259|NCT01078168|11618651|FG000|NOT COMPLETED|Overall Study||0
10470260|NCT01078168|11618652|FG001|NOT COMPLETED|Overall Study||1
10470261|NCT01078207|11618658|FG000|STARTED|Overall Study||100
10470262|NCT01078207|11618658|FG000|COMPLETED|Overall Study||100
10470263|NCT01078207|11618658|FG000|NOT COMPLETED|Overall Study||0
10470264|NCT01078220|11618662|FG000|STARTED|Overall Study||189629
10470265|NCT01078220|11618662|FG000|COMPLETED|Overall Study||189629
10470266|NCT01078220|11618662|FG000|NOT COMPLETED|Overall Study||0
10470267|NCT01078233|11618675|FG000|STARTED|Overall Study||656
10470268|NCT01078233|11618676|FG001|STARTED|Overall Study||296
10470269|NCT01078233|11618677|FG002|STARTED|Overall Study||1681
10470270|NCT01078233|11618678|FG003|STARTED|Overall Study||631
10470271|NCT01078233|11618679|FG004|STARTED|Overall Study||3199
10470272|NCT01078233|11618680|FG005|STARTED|Overall Study||154
10470273|NCT01078233|11618675|FG000|COMPLETED|Overall Study||656
10470274|NCT01078233|11618676|FG001|COMPLETED|Overall Study||296
10470275|NCT01078233|11618677|FG002|COMPLETED|Overall Study||1681
10470276|NCT01078233|11618678|FG003|COMPLETED|Overall Study||631
10470277|NCT01078233|11618679|FG004|COMPLETED|Overall Study||3199
10470278|NCT01078233|11618680|FG005|COMPLETED|Overall Study||154
10470279|NCT01078233|11618675|FG000|NOT COMPLETED|Overall Study||0
10470280|NCT01078233|11618676|FG001|NOT COMPLETED|Overall Study||0
10470281|NCT01078233|11618677|FG002|NOT COMPLETED|Overall Study||0
10470282|NCT01078233|11618678|FG003|NOT COMPLETED|Overall Study||0
10470283|NCT01078233|11618679|FG004|NOT COMPLETED|Overall Study||0
10470284|NCT01078233|11618680|FG005|NOT COMPLETED|Overall Study||0
10470285|NCT01078246|11618695|FG000|STARTED|Overall Study||1041
10470286|NCT01078246|11618696|FG001|STARTED|Overall Study||405
10470287|NCT01078246|11618697|FG002|STARTED|Overall Study||1963
10470288|NCT01078246|11618698|FG003|STARTED|Overall Study||152
10470289|NCT01078246|11618699|FG004|STARTED|Overall Study||3310
10470290|NCT01078246|11618700|FG005|STARTED|Overall Study||231
10470291|NCT01078246|11618701|FG006|STARTED|Overall Study||22
10470292|NCT01078246|11618695|FG000|COMPLETED|Overall Study||1041
10470293|NCT01078246|11618696|FG001|COMPLETED|Overall Study||405
10470294|NCT01078246|11618697|FG002|COMPLETED|Overall Study||1963
10470295|NCT01078246|11618698|FG003|COMPLETED|Overall Study||152
10470296|NCT01078246|11618699|FG004|COMPLETED|Overall Study||3310
10470297|NCT01078246|11618700|FG005|COMPLETED|Overall Study||231
10470298|NCT01078246|11618701|FG006|COMPLETED|Overall Study||22
10470299|NCT01078246|11618695|FG000|NOT COMPLETED|Overall Study||0
10470300|NCT01078246|11618696|FG001|NOT COMPLETED|Overall Study||0
10470301|NCT01078246|11618697|FG002|NOT COMPLETED|Overall Study||0
10470302|NCT01078246|11618698|FG003|NOT COMPLETED|Overall Study||0
10470303|NCT01078246|11618699|FG004|NOT COMPLETED|Overall Study||0
10470304|NCT01078246|11618700|FG005|NOT COMPLETED|Overall Study||0
10470305|NCT01078246|11618701|FG006|NOT COMPLETED|Overall Study||0
10470306|NCT01078298|11618711|FG000|STARTED|Overall Study||256
10470307|NCT01078298|11618712|FG001|STARTED|Overall Study||269
10470308|NCT01078298|11618711|FG000|COMPLETED|Overall Study||175
10470309|NCT01078298|11618712|FG001|COMPLETED|Overall Study||179
10470310|NCT01078298|11618711|FG000|NOT COMPLETED|Overall Study||81
10470311|NCT01078298|11618712|FG001|NOT COMPLETED|Overall Study||90
10470312|NCT01078363|11618720|FG000|STARTED|Overall Study||47
10470313|NCT01078363|11618721|FG001|STARTED|Overall Study||49
10470314|NCT01078363|11618720|FG000|COMPLETED|Overall Study||47
10470315|NCT01078363|11618721|FG001|COMPLETED|Overall Study||49
10470316|NCT01078363|11618720|FG000|NOT COMPLETED|Overall Study||0
10470317|NCT01078363|11618721|FG001|NOT COMPLETED|Overall Study||0
10470318|NCT01078376|11618733|FG000|STARTED|Overall Study||9
10470319|NCT01078376|11618734|FG001|STARTED|Overall Study||9
10470320|NCT01078376|11618735|FG002|STARTED|Overall Study||8
10470321|NCT01078376|11618736|FG003|STARTED|Overall Study||3
10470322|NCT01078376|11618733|FG000|COMPLETED|Overall Study||9
10470323|NCT01078376|11618734|FG001|COMPLETED|Overall Study||9
10470324|NCT01078376|11618735|FG002|COMPLETED|Overall Study||8
10470325|NCT01078376|11618736|FG003|COMPLETED|Overall Study||3
10470326|NCT01078376|11618733|FG000|NOT COMPLETED|Overall Study||0
10470327|NCT01078376|11618734|FG001|NOT COMPLETED|Overall Study||0
10470328|NCT01078376|11618735|FG002|NOT COMPLETED|Overall Study||0
10470329|NCT01078376|11618736|FG003|NOT COMPLETED|Overall Study||0
10470330|NCT01078389|11618751|FG000|STARTED|Overall Study||157
10470331|NCT01078389|11618752|FG001|STARTED|Overall Study||157
10470332|NCT01078389|11618751|FG000|COMPLETED|Overall Study||93
10470333|NCT01078389|11618752|FG001|COMPLETED|Overall Study||90
10470334|NCT01078389|11618751|FG000|NOT COMPLETED|Overall Study||64
10470335|NCT01078389|11618752|FG001|NOT COMPLETED|Overall Study||67
10470336|NCT01078402|11618761|FG000|STARTED|Overall Study||431
10470337|NCT01078402|11618762|FG001|STARTED|Overall Study||124
10470338|NCT01078402|11618763|FG002|STARTED|Overall Study||234
10470339|NCT01078402|11618761|FG000|COMPLETED|Overall Study||324
10470340|NCT01078402|11618762|FG001|COMPLETED|Overall Study||95
10470341|NCT01078402|11618763|FG002|COMPLETED|Overall Study||166
10470342|NCT01078402|11618761|FG000|NOT COMPLETED|Overall Study||107
10470343|NCT01078402|11618762|FG001|NOT COMPLETED|Overall Study||29
10470344|NCT01078402|11618763|FG002|NOT COMPLETED|Overall Study||68
10470345|NCT01078441|11618775|FG000|STARTED|Overall Study||2
10470346|NCT01078441|11618775|FG000|COMPLETED|Overall Study||1
10470347|NCT01078441|11618775|FG000|NOT COMPLETED|Overall Study||1
10470348|NCT01078545|11618779|FG000|STARTED|Overall Study||729
10470349|NCT01078545|11618779|FG000|Intent-to-treat Population|Overall Study||729
10470350|NCT01078545|11618779|FG000|Per Protocol Population|Overall Study||661
10470351|NCT01078545|11618779|FG000|COMPLETED|Overall Study||703
10470352|NCT01078545|11618779|FG000|NOT COMPLETED|Overall Study||26
10470353|NCT01078558|11618786|FG000|STARTED|Overall Study||2836
10470354|NCT01078558|11618787|FG001|STARTED|Overall Study||1127
10470355|NCT01078558|11618788|FG002|STARTED|Overall Study||1957
10470356|NCT01078558|11618786|FG000|Oligoarticular PsA|Overall Study||0
10470357|NCT01078558|11618787|FG001|Oligoarticular PsA|Overall Study||197
10470358|NCT01078558|11618788|FG002|Oligoarticular PsA|Overall Study||0
10470359|NCT01078558|11618786|FG000|COMPLETED|Overall Study||818
10470360|NCT01078558|11618787|FG001|COMPLETED|Overall Study||372
10470361|NCT01078558|11618788|FG002|COMPLETED|Overall Study||596
10470362|NCT01078558|11618786|FG000|NOT COMPLETED|Overall Study||2018
10470363|NCT01078558|11618787|FG001|NOT COMPLETED|Overall Study||755
10470364|NCT01078558|11618788|FG002|NOT COMPLETED|Overall Study||1361
10470365|NCT01078571|11618796|FG000|STARTED|Overall Study||705
10470366|NCT01078571|11618796|FG000|Safety Population|Overall Study||675
10470367|NCT01078571|11618796|FG000|Intent-to-treat (ITT) Population|Overall Study||591
10470368|NCT01078571|11618796|FG000|COMPLETED|Overall Study||590
10470369|NCT01078571|11618796|FG000|NOT COMPLETED|Overall Study||115
10470370|NCT01078584|11618805|FG000|STARTED|Overall Study||7993
10470371|NCT01078584|11618805|FG000|Participants Conducted Visit 2 (3-month)|Overall Study||7125
10470372|NCT01078584|11618805|FG000|Participants Conducted Visit 3 (6-month)|Overall Study||5833
10470373|NCT01078584|11618805|FG000|Participants Conducted Visit 4(12-month)|Overall Study||4983
10470374|NCT01078584|11618805|FG000|COMPLETED|Overall Study||4983
10470375|NCT01078584|11618805|FG000|NOT COMPLETED|Overall Study||3010
10470376|NCT01078623|11618822|FG000|STARTED|Treatment Period 1||6
10470377|NCT01078623|11618823|FG001|STARTED|Treatment Period 1||6
10470378|NCT01078623|11618824|FG002|STARTED|Treatment Period 1||7
10470379|NCT01078623|11618825|FG003|STARTED|Treatment Period 1||6
10470380|NCT01078623|11618826|FG004|STARTED|Treatment Period 1||7
10470381|NCT01078623|11618827|FG005|STARTED|Treatment Period 1||6
10470382|NCT01078623|11618828|FG006|STARTED|Treatment Period 1||7
10470383|NCT01078623|11618829|FG007|STARTED|Treatment Period 1||7
10470384|NCT01078623|11618830|FG008|STARTED|Treatment Period 1||6
10470385|NCT01078623|11618831|FG009|STARTED|Treatment Period 1||7
10470386|NCT01078623|11618832|FG010|STARTED|Treatment Period 1||7
10470387|NCT01078623|11618833|FG011|STARTED|Treatment Period 1||7
10470388|NCT01078623|11618834|FG012|STARTED|Treatment Period 1||7
10470389|NCT01078623|11618835|FG013|STARTED|Treatment Period 1||7
10470390|NCT01078623|11618836|FG014|STARTED|Treatment Period 1||7
10470391|NCT01078623|11618837|FG015|STARTED|Treatment Period 1||7
10470392|NCT01078623|11618838|FG016|STARTED|Treatment Period 1||7
10470393|NCT01078623|11618839|FG017|STARTED|Treatment Period 1||7
10470394|NCT01078623|11618840|FG018|STARTED|Treatment Period 1||7
10470395|NCT01078623|11618841|FG019|STARTED|Treatment Period 1||7
10470396|NCT01078623|11618822|FG000|COMPLETED|Treatment Period 1||5
10470397|NCT01078623|11618823|FG001|COMPLETED|Treatment Period 1||5
10470398|NCT01078623|11618824|FG002|COMPLETED|Treatment Period 1||6
10470399|NCT01078623|11618825|FG003|COMPLETED|Treatment Period 1||6
10470400|NCT01078623|11618826|FG004|COMPLETED|Treatment Period 1||7
10470401|NCT01078623|11618827|FG005|COMPLETED|Treatment Period 1||5
10470402|NCT01078623|11618828|FG006|COMPLETED|Treatment Period 1||6
10470403|NCT01078623|11618829|FG007|COMPLETED|Treatment Period 1||6
10470404|NCT01078623|11618830|FG008|COMPLETED|Treatment Period 1||5
10470405|NCT01078623|11618831|FG009|COMPLETED|Treatment Period 1||6
10470406|NCT01078623|11618832|FG010|COMPLETED|Treatment Period 1||6
10470407|NCT01078623|11618833|FG011|COMPLETED|Treatment Period 1||7
10470408|NCT01078623|11618834|FG012|COMPLETED|Treatment Period 1||7
10470409|NCT01078623|11618835|FG013|COMPLETED|Treatment Period 1||7
10470410|NCT01078623|11618836|FG014|COMPLETED|Treatment Period 1||7
10470411|NCT01078623|11618837|FG015|COMPLETED|Treatment Period 1||7
10470412|NCT01078623|11618838|FG016|COMPLETED|Treatment Period 1||7
10470413|NCT01078623|11618839|FG017|COMPLETED|Treatment Period 1||7
10470414|NCT01078623|11618840|FG018|COMPLETED|Treatment Period 1||7
10470415|NCT01078623|11618841|FG019|COMPLETED|Treatment Period 1||7
10470416|NCT01078623|11618822|FG000|NOT COMPLETED|Treatment Period 1||1
10470417|NCT01078623|11618823|FG001|NOT COMPLETED|Treatment Period 1||1
10470418|NCT01078623|11618824|FG002|NOT COMPLETED|Treatment Period 1||1
10470419|NCT01078623|11618825|FG003|NOT COMPLETED|Treatment Period 1||0
10470420|NCT01078623|11618826|FG004|NOT COMPLETED|Treatment Period 1||0
10470421|NCT01078623|11618827|FG005|NOT COMPLETED|Treatment Period 1||1
10470422|NCT01078623|11618828|FG006|NOT COMPLETED|Treatment Period 1||1
10470423|NCT01078623|11618829|FG007|NOT COMPLETED|Treatment Period 1||1
10470424|NCT01078623|11618830|FG008|NOT COMPLETED|Treatment Period 1||1
10470425|NCT01078623|11618831|FG009|NOT COMPLETED|Treatment Period 1||1
10470426|NCT01078623|11618832|FG010|NOT COMPLETED|Treatment Period 1||1
10470427|NCT01078623|11618833|FG011|NOT COMPLETED|Treatment Period 1||0
10470428|NCT01078623|11618834|FG012|NOT COMPLETED|Treatment Period 1||0
10470429|NCT01078623|11618835|FG013|NOT COMPLETED|Treatment Period 1||0
10470430|NCT01078623|11618836|FG014|NOT COMPLETED|Treatment Period 1||0
10470431|NCT01078623|11618837|FG015|NOT COMPLETED|Treatment Period 1||0
10470432|NCT01078623|11618838|FG016|NOT COMPLETED|Treatment Period 1||0
10470433|NCT01078623|11618839|FG017|NOT COMPLETED|Treatment Period 1||0
10470434|NCT01078623|11618840|FG018|NOT COMPLETED|Treatment Period 1||0
10470435|NCT01078623|11618841|FG019|NOT COMPLETED|Treatment Period 1||0
10470436|NCT01078623|11618822|FG000|STARTED|Treatment Period 2||5
10470437|NCT01078623|11618823|FG001|STARTED|Treatment Period 2||5
10470438|NCT01078623|11618824|FG002|STARTED|Treatment Period 2||6
10470439|NCT01078623|11618825|FG003|STARTED|Treatment Period 2||6
10470440|NCT01078623|11618826|FG004|STARTED|Treatment Period 2||7
10470441|NCT01078623|11618827|FG005|STARTED|Treatment Period 2||5
10470442|NCT01078623|11618828|FG006|STARTED|Treatment Period 2||6
10470443|NCT01078623|11618829|FG007|STARTED|Treatment Period 2||6
10470444|NCT01078623|11618830|FG008|STARTED|Treatment Period 2||5
10470445|NCT01078623|11618831|FG009|STARTED|Treatment Period 2||6
10470446|NCT01078623|11618832|FG010|STARTED|Treatment Period 2||6
10470447|NCT01078623|11618833|FG011|STARTED|Treatment Period 2||7
10470448|NCT01078623|11618834|FG012|STARTED|Treatment Period 2||7
10470449|NCT01078623|11618835|FG013|STARTED|Treatment Period 2||7
10470450|NCT01078623|11618836|FG014|STARTED|Treatment Period 2||7
10470451|NCT01078623|11618837|FG015|STARTED|Treatment Period 2||7
10470452|NCT01078623|11618838|FG016|STARTED|Treatment Period 2||7
10470453|NCT01078623|11618839|FG017|STARTED|Treatment Period 2||7
10470454|NCT01078623|11618840|FG018|STARTED|Treatment Period 2||7
10470455|NCT01078623|11618841|FG019|STARTED|Treatment Period 2||7
10470456|NCT01078623|11618822|FG000|COMPLETED|Treatment Period 2||5
10470457|NCT01078623|11618823|FG001|COMPLETED|Treatment Period 2||5
10470458|NCT01078623|11618824|FG002|COMPLETED|Treatment Period 2||6
10470459|NCT01078623|11618825|FG003|COMPLETED|Treatment Period 2||6
10470460|NCT01078623|11618826|FG004|COMPLETED|Treatment Period 2||7
10470461|NCT01078623|11618827|FG005|COMPLETED|Treatment Period 2||4
10470462|NCT01078623|11618828|FG006|COMPLETED|Treatment Period 2||5
10470463|NCT01078623|11618829|FG007|COMPLETED|Treatment Period 2||6
10470464|NCT01078623|11618830|FG008|COMPLETED|Treatment Period 2||5
10470465|NCT01078623|11618831|FG009|COMPLETED|Treatment Period 2||6
10470466|NCT01078623|11618832|FG010|COMPLETED|Treatment Period 2||6
10708806|NCT02634346|11873732|FG001|COMPLETED|Overall Study||119
10708807|NCT02634346|11873733|FG002|COMPLETED|Overall Study||111
10470467|NCT01078623|11618833|FG011|COMPLETED|Treatment Period 2||7
10470468|NCT01078623|11618834|FG012|COMPLETED|Treatment Period 2||7
10470469|NCT01078623|11618835|FG013|COMPLETED|Treatment Period 2||7
10470470|NCT01078623|11618836|FG014|COMPLETED|Treatment Period 2||7
10470471|NCT01078623|11618837|FG015|COMPLETED|Treatment Period 2||7
10470472|NCT01078623|11618838|FG016|COMPLETED|Treatment Period 2||7
10470473|NCT01078623|11618839|FG017|COMPLETED|Treatment Period 2||7
10470474|NCT01078623|11618840|FG018|COMPLETED|Treatment Period 2||6
10470475|NCT01078623|11618841|FG019|COMPLETED|Treatment Period 2||7
10470476|NCT01078623|11618822|FG000|NOT COMPLETED|Treatment Period 2||0
10470477|NCT01078623|11618823|FG001|NOT COMPLETED|Treatment Period 2||0
10470478|NCT01078623|11618824|FG002|NOT COMPLETED|Treatment Period 2||0
10470479|NCT01078623|11618825|FG003|NOT COMPLETED|Treatment Period 2||0
10470480|NCT01078623|11618826|FG004|NOT COMPLETED|Treatment Period 2||0
10470481|NCT01078623|11618827|FG005|NOT COMPLETED|Treatment Period 2||1
10470482|NCT01078623|11618828|FG006|NOT COMPLETED|Treatment Period 2||1
10470483|NCT01078623|11618829|FG007|NOT COMPLETED|Treatment Period 2||0
10470484|NCT01078623|11618830|FG008|NOT COMPLETED|Treatment Period 2||0
10470485|NCT01078623|11618831|FG009|NOT COMPLETED|Treatment Period 2||0
10470486|NCT01078623|11618832|FG010|NOT COMPLETED|Treatment Period 2||0
10470487|NCT01078623|11618833|FG011|NOT COMPLETED|Treatment Period 2||0
10470488|NCT01078623|11618834|FG012|NOT COMPLETED|Treatment Period 2||0
10470489|NCT01078623|11618835|FG013|NOT COMPLETED|Treatment Period 2||0
10708808|NCT02634346|11873731|FG000|NOT COMPLETED|Overall Study||12
10470490|NCT01078623|11618836|FG014|NOT COMPLETED|Treatment Period 2||0
10470491|NCT01078623|11618837|FG015|NOT COMPLETED|Treatment Period 2||0
10470492|NCT01078623|11618838|FG016|NOT COMPLETED|Treatment Period 2||0
10470493|NCT01078623|11618839|FG017|NOT COMPLETED|Treatment Period 2||0
10470494|NCT01078623|11618840|FG018|NOT COMPLETED|Treatment Period 2||1
10470495|NCT01078623|11618841|FG019|NOT COMPLETED|Treatment Period 2||0
10470496|NCT01078623|11618822|FG000|STARTED|Treatment Period 3||5
10470497|NCT01078623|11618823|FG001|STARTED|Treatment Period 3||5
10470498|NCT01078623|11618824|FG002|STARTED|Treatment Period 3||6
10470499|NCT01078623|11618825|FG003|STARTED|Treatment Period 3||6
10470500|NCT01078623|11618826|FG004|STARTED|Treatment Period 3||7
10470501|NCT01078623|11618827|FG005|STARTED|Treatment Period 3||4
10470502|NCT01078623|11618828|FG006|STARTED|Treatment Period 3||5
10470503|NCT01078623|11618829|FG007|STARTED|Treatment Period 3||6
10470504|NCT01078623|11618830|FG008|STARTED|Treatment Period 3||5
10470505|NCT01078623|11618831|FG009|STARTED|Treatment Period 3||6
10470506|NCT01078623|11618832|FG010|STARTED|Treatment Period 3||6
10470507|NCT01078623|11618833|FG011|STARTED|Treatment Period 3||7
10470508|NCT01078623|11618834|FG012|STARTED|Treatment Period 3||7
10470509|NCT01078623|11618835|FG013|STARTED|Treatment Period 3||7
10470510|NCT01078623|11618836|FG014|STARTED|Treatment Period 3||7
10470511|NCT01078623|11618837|FG015|STARTED|Treatment Period 3||7
10470512|NCT01078623|11618838|FG016|STARTED|Treatment Period 3||7
10470513|NCT01078623|11618839|FG017|STARTED|Treatment Period 3||7
10470514|NCT01078623|11618840|FG018|STARTED|Treatment Period 3||6
10470515|NCT01078623|11618841|FG019|STARTED|Treatment Period 3||7
10470516|NCT01078623|11618822|FG000|COMPLETED|Treatment Period 3||5
10470517|NCT01078623|11618823|FG001|COMPLETED|Treatment Period 3||5
10470518|NCT01078623|11618824|FG002|COMPLETED|Treatment Period 3||6
10470519|NCT01078623|11618825|FG003|COMPLETED|Treatment Period 3||6
10470520|NCT01078623|11618826|FG004|COMPLETED|Treatment Period 3||6
10470521|NCT01078623|11618827|FG005|COMPLETED|Treatment Period 3||4
10470522|NCT01078623|11618828|FG006|COMPLETED|Treatment Period 3||5
10470523|NCT01078623|11618829|FG007|COMPLETED|Treatment Period 3||6
10470524|NCT01078623|11618830|FG008|COMPLETED|Treatment Period 3||5
10470525|NCT01078623|11618831|FG009|COMPLETED|Treatment Period 3||6
10470526|NCT01078623|11618832|FG010|COMPLETED|Treatment Period 3||6
10470527|NCT01078623|11618833|FG011|COMPLETED|Treatment Period 3||7
10470528|NCT01078623|11618834|FG012|COMPLETED|Treatment Period 3||7
10470529|NCT01078623|11618835|FG013|COMPLETED|Treatment Period 3||6
10470530|NCT01078623|11618836|FG014|COMPLETED|Treatment Period 3||7
10470531|NCT01078623|11618837|FG015|COMPLETED|Treatment Period 3||7
10470532|NCT01078623|11618838|FG016|COMPLETED|Treatment Period 3||7
10470533|NCT01078623|11618839|FG017|COMPLETED|Treatment Period 3||7
10470534|NCT01078623|11618840|FG018|COMPLETED|Treatment Period 3||6
10470535|NCT01078623|11618841|FG019|COMPLETED|Treatment Period 3||7
10470536|NCT01078623|11618822|FG000|NOT COMPLETED|Treatment Period 3||0
10470537|NCT01078623|11618823|FG001|NOT COMPLETED|Treatment Period 3||0
10470538|NCT01078623|11618824|FG002|NOT COMPLETED|Treatment Period 3||0
10470539|NCT01078623|11618825|FG003|NOT COMPLETED|Treatment Period 3||0
10470540|NCT01078623|11618826|FG004|NOT COMPLETED|Treatment Period 3||1
10470541|NCT01078623|11618827|FG005|NOT COMPLETED|Treatment Period 3||0
10470542|NCT01078623|11618828|FG006|NOT COMPLETED|Treatment Period 3||0
10470543|NCT01078623|11618829|FG007|NOT COMPLETED|Treatment Period 3||0
10470544|NCT01078623|11618830|FG008|NOT COMPLETED|Treatment Period 3||0
10470545|NCT01078623|11618831|FG009|NOT COMPLETED|Treatment Period 3||0
10470546|NCT01078623|11618832|FG010|NOT COMPLETED|Treatment Period 3||0
10470547|NCT01078623|11618833|FG011|NOT COMPLETED|Treatment Period 3||0
10470548|NCT01078623|11618834|FG012|NOT COMPLETED|Treatment Period 3||0
10470549|NCT01078623|11618835|FG013|NOT COMPLETED|Treatment Period 3||1
10470550|NCT01078623|11618836|FG014|NOT COMPLETED|Treatment Period 3||0
10470551|NCT01078623|11618837|FG015|NOT COMPLETED|Treatment Period 3||0
10470552|NCT01078623|11618838|FG016|NOT COMPLETED|Treatment Period 3||0
10470553|NCT01078623|11618839|FG017|NOT COMPLETED|Treatment Period 3||0
10470554|NCT01078623|11618840|FG018|NOT COMPLETED|Treatment Period 3||0
10470555|NCT01078623|11618841|FG019|NOT COMPLETED|Treatment Period 3||0
10470556|NCT01078623|11618822|FG000|STARTED|Treatment Period 4||5
10470557|NCT01078623|11618823|FG001|STARTED|Treatment Period 4||5
10470558|NCT01078623|11618824|FG002|STARTED|Treatment Period 4||6
10470559|NCT01078623|11618825|FG003|STARTED|Treatment Period 4||6
10470560|NCT01078623|11618826|FG004|STARTED|Treatment Period 4||6
10470561|NCT01078623|11618827|FG005|STARTED|Treatment Period 4||4
10470562|NCT01078623|11618828|FG006|STARTED|Treatment Period 4||5
10470563|NCT01078623|11618829|FG007|STARTED|Treatment Period 4||6
10470564|NCT01078623|11618830|FG008|STARTED|Treatment Period 4||5
10470565|NCT01078623|11618831|FG009|STARTED|Treatment Period 4||6
10470566|NCT01078623|11618832|FG010|STARTED|Treatment Period 4||6
10470567|NCT01078623|11618833|FG011|STARTED|Treatment Period 4||7
10470568|NCT01078623|11618834|FG012|STARTED|Treatment Period 4||7
10470569|NCT01078623|11618835|FG013|STARTED|Treatment Period 4||6
10470570|NCT01078623|11618836|FG014|STARTED|Treatment Period 4||7
10470571|NCT01078623|11618837|FG015|STARTED|Treatment Period 4||7
10470572|NCT01078623|11618838|FG016|STARTED|Treatment Period 4||7
10470573|NCT01078623|11618839|FG017|STARTED|Treatment Period 4||7
10470574|NCT01078623|11618840|FG018|STARTED|Treatment Period 4||6
10470575|NCT01078623|11618841|FG019|STARTED|Treatment Period 4||7
10470576|NCT01078623|11618822|FG000|COMPLETED|Treatment Period 4||5
10470577|NCT01078623|11618823|FG001|COMPLETED|Treatment Period 4||5
10470578|NCT01078623|11618824|FG002|COMPLETED|Treatment Period 4||5
10470579|NCT01078623|11618825|FG003|COMPLETED|Treatment Period 4||6
10470580|NCT01078623|11618826|FG004|COMPLETED|Treatment Period 4||6
10470581|NCT01078623|11618827|FG005|COMPLETED|Treatment Period 4||4
10470582|NCT01078623|11618828|FG006|COMPLETED|Treatment Period 4||5
10470583|NCT01078623|11618829|FG007|COMPLETED|Treatment Period 4||6
10470584|NCT01078623|11618830|FG008|COMPLETED|Treatment Period 4||5
10470585|NCT01078623|11618831|FG009|COMPLETED|Treatment Period 4||6
10470586|NCT01078623|11618832|FG010|COMPLETED|Treatment Period 4||6
10470587|NCT01078623|11618833|FG011|COMPLETED|Treatment Period 4||7
10470588|NCT01078623|11618834|FG012|COMPLETED|Treatment Period 4||7
10470589|NCT01078623|11618835|FG013|COMPLETED|Treatment Period 4||6
10470590|NCT01078623|11618836|FG014|COMPLETED|Treatment Period 4||7
10470591|NCT01078623|11618837|FG015|COMPLETED|Treatment Period 4||6
10470592|NCT01078623|11618838|FG016|COMPLETED|Treatment Period 4||7
10470593|NCT01078623|11618839|FG017|COMPLETED|Treatment Period 4||7
10470594|NCT01078623|11618840|FG018|COMPLETED|Treatment Period 4||6
10470595|NCT01078623|11618841|FG019|COMPLETED|Treatment Period 4||7
10470596|NCT01078623|11618822|FG000|NOT COMPLETED|Treatment Period 4||0
10470597|NCT01078623|11618823|FG001|NOT COMPLETED|Treatment Period 4||0
10470598|NCT01078623|11618824|FG002|NOT COMPLETED|Treatment Period 4||1
10470599|NCT01078623|11618825|FG003|NOT COMPLETED|Treatment Period 4||0
10470600|NCT01078623|11618826|FG004|NOT COMPLETED|Treatment Period 4||0
10470601|NCT01078623|11618827|FG005|NOT COMPLETED|Treatment Period 4||0
10470602|NCT01078623|11618828|FG006|NOT COMPLETED|Treatment Period 4||0
10470603|NCT01078623|11618829|FG007|NOT COMPLETED|Treatment Period 4||0
10470604|NCT01078623|11618830|FG008|NOT COMPLETED|Treatment Period 4||0
10470605|NCT01078623|11618831|FG009|NOT COMPLETED|Treatment Period 4||0
10470606|NCT01078623|11618832|FG010|NOT COMPLETED|Treatment Period 4||0
10470607|NCT01078623|11618833|FG011|NOT COMPLETED|Treatment Period 4||0
10470608|NCT01078623|11618834|FG012|NOT COMPLETED|Treatment Period 4||0
10470609|NCT01078623|11618835|FG013|NOT COMPLETED|Treatment Period 4||0
10470610|NCT01078623|11618836|FG014|NOT COMPLETED|Treatment Period 4||0
10470611|NCT01078623|11618837|FG015|NOT COMPLETED|Treatment Period 4||1
10470612|NCT01078623|11618838|FG016|NOT COMPLETED|Treatment Period 4||0
10470613|NCT01078623|11618839|FG017|NOT COMPLETED|Treatment Period 4||0
10470614|NCT01078623|11618840|FG018|NOT COMPLETED|Treatment Period 4||0
10470615|NCT01078623|11618841|FG019|NOT COMPLETED|Treatment Period 4||0
10470616|NCT01078675|11618855|FG000|STARTED|Overall Study||250
10470617|NCT01078675|11618856|FG001|STARTED|Overall Study||65
10470618|NCT01078675|11618855|FG000|Patients Treated|Overall Study||198
10470619|NCT01078675|11618856|FG001|Patients Treated|Overall Study||0
10470620|NCT01078675|11618855|FG000|COMPLETED|Overall Study||182
10470621|NCT01078675|11618856|FG001|COMPLETED|Overall Study|Healthy siblings did not participate in investigational product administration.|59
10470622|NCT01078675|11618855|FG000|NOT COMPLETED|Overall Study||68
10470623|NCT01078675|11618856|FG001|NOT COMPLETED|Overall Study||6
10470624|NCT01078753|11618864|FG000|STARTED|Treatment Period I||45
10470625|NCT01078753|11618865|FG001|STARTED|Treatment Period I||44
10470626|NCT01078753|11618864|FG000|Full Analysis Set|Treatment Period I|One patient was excluded from the full analysis set due to failure to satisfy the entry criteria.|44
10470627|NCT01078753|11618865|FG001|Full Analysis Set|Treatment Period I||44
10470628|NCT01078753|11618864|FG000|COMPLETED|Treatment Period I||45
10470629|NCT01078753|11618865|FG001|COMPLETED|Treatment Period I||44
10470630|NCT01078753|11618864|FG000|NOT COMPLETED|Treatment Period I||0
10470631|NCT01078753|11618865|FG001|NOT COMPLETED|Treatment Period I||0
10470632|NCT01078753|11618864|FG000|STARTED|Treatment Period II|Desmopressin 120 µg - 4 participants Desmopressin 240 µg - 41 participants|45
10470633|NCT01078753|11618865|FG001|STARTED|Treatment Period II||44
10470634|NCT01078753|11618864|FG000|Full Analysis Set|Treatment Period II|One patient was excluded from the full analysis set due to failure to satisfy the entry criteria.|44
10470635|NCT01078753|11618865|FG001|Full Analysis Set|Treatment Period II||44
10470636|NCT01078753|11618864|FG000|COMPLETED|Treatment Period II||45
10470637|NCT01078753|11618865|FG001|COMPLETED|Treatment Period II||44
10470638|NCT01078753|11618864|FG000|NOT COMPLETED|Treatment Period II||0
10470639|NCT01078753|11618865|FG001|NOT COMPLETED|Treatment Period II||0
10470640|NCT01078805|11618871|FG000|STARTED|Overall Study||4167
10470721|NCT01079143|11618935|FG001|NOT COMPLETED|Overall Study||17
10470641|NCT01078805|11618871|FG000|Took at Least 1 Dose of Study Drug|Overall Study||4085
10470642|NCT01078805|11618871|FG000|Modified Intent-To-Treat|Overall Study|≥1 dose of study drug (SD) and didn't discontinue SD more than 3 consecutive months during treatment|3720
10470643|NCT01078805|11618871|FG000|COMPLETED|Overall Study||2117
10470644|NCT01078805|11618871|FG000|NOT COMPLETED|Overall Study||2050
10470645|NCT01078909|11618880|FG000|STARTED|Overall Study||25
10470646|NCT01078909|11618881|FG001|STARTED|Overall Study||25
10470647|NCT01078909|11618882|FG002|STARTED|Overall Study||25
10470648|NCT01078909|11618883|FG003|STARTED|Overall Study||25
10470649|NCT01078909|11618884|FG004|STARTED|Overall Study||25
10470650|NCT01078909|11618880|FG000|COMPLETED|Overall Study||23
10470651|NCT01078909|11618881|FG001|COMPLETED|Overall Study||21
10470652|NCT01078909|11618882|FG002|COMPLETED|Overall Study||24
10470653|NCT01078909|11618883|FG003|COMPLETED|Overall Study||24
10470654|NCT01078909|11618884|FG004|COMPLETED|Overall Study||23
10470655|NCT01078909|11618880|FG000|NOT COMPLETED|Overall Study||2
10470656|NCT01078909|11618881|FG001|NOT COMPLETED|Overall Study||4
10470657|NCT01078909|11618882|FG002|NOT COMPLETED|Overall Study||1
10470658|NCT01078909|11618883|FG003|NOT COMPLETED|Overall Study||1
10470659|NCT01078909|11618884|FG004|NOT COMPLETED|Overall Study||2
10470660|NCT01078922|11618896|FG000|STARTED|Overall Study||11
10470661|NCT01078922|11618896|FG000|COMPLETED|Overall Study||10
10470662|NCT01078922|11618896|FG000|NOT COMPLETED|Overall Study||1
10470663|NCT01078974|11618901|FG000|STARTED|Overall Study||7
10470664|NCT01078974|11618901|FG000|COMPLETED|Overall Study||4
10470665|NCT01078974|11618901|FG000|NOT COMPLETED|Overall Study||3
10470666|NCT01079130|11618911|FG000|STARTED|Overall Study||85
10470667|NCT01079130|11618912|FG001|STARTED|Overall Study||85
10470668|NCT01079130|11618913|FG002|STARTED|Overall Study||84
10470669|NCT01079130|11618914|FG003|STARTED|Overall Study||86
10470670|NCT01079130|11618915|FG004|STARTED|Overall Study||86
10470671|NCT01079130|11618916|FG005|STARTED|Overall Study||85
10470672|NCT01079130|11618911|FG000|Safety Set: Received Study Drug|Overall Study||84
10470673|NCT01079130|11618912|FG001|Safety Set: Received Study Drug|Overall Study||81
10470674|NCT01079130|11618913|FG002|Safety Set: Received Study Drug|Overall Study||84
10470675|NCT01079130|11618914|FG003|Safety Set: Received Study Drug|Overall Study||85
10470676|NCT01079130|11618915|FG004|Safety Set: Received Study Drug|Overall Study||84
10470677|NCT01079130|11618916|FG005|Safety Set: Received Study Drug|Overall Study||84
10470678|NCT01079130|11618911|FG000|Full Analysis Set (FAS)|Overall Study||84
10470679|NCT01079130|11618912|FG001|Full Analysis Set (FAS)|Overall Study|2 patients (1 in 37.5 µg;1 in 75 µg group) randomized more than once and were excluded from the FAS.|80
10470680|NCT01079130|11618913|FG002|Full Analysis Set (FAS)|Overall Study||83
10470681|NCT01079130|11618914|FG003|Full Analysis Set (FAS)|Overall Study||85
10470682|NCT01079130|11618915|FG004|Full Analysis Set (FAS)|Overall Study||84
10470683|NCT01079130|11618916|FG005|Full Analysis Set (FAS)|Overall Study||84
10470684|NCT01079130|11618911|FG000|COMPLETED|Overall Study||83
10470685|NCT01079130|11618912|FG001|COMPLETED|Overall Study||78
10470686|NCT01079130|11618913|FG002|COMPLETED|Overall Study||83
10470687|NCT01079130|11618914|FG003|COMPLETED|Overall Study||81
10470688|NCT01079130|11618915|FG004|COMPLETED|Overall Study||78
10470689|NCT01079130|11618916|FG005|COMPLETED|Overall Study||80
10470690|NCT01079130|11618911|FG000|NOT COMPLETED|Overall Study||2
10470691|NCT01079130|11618912|FG001|NOT COMPLETED|Overall Study||7
10470692|NCT01079130|11618913|FG002|NOT COMPLETED|Overall Study||1
10470693|NCT01079130|11618914|FG003|NOT COMPLETED|Overall Study||5
10470694|NCT01079130|11618915|FG004|NOT COMPLETED|Overall Study||8
10470695|NCT01079130|11618916|FG005|NOT COMPLETED|Overall Study||5
10470696|NCT01079143|11618934|FG000|STARTED|Overall Study||36
10470697|NCT01079143|11618935|FG001|STARTED|Overall Study||60
10470698|NCT01079143|11618936|FG002|STARTED|Overall Study||39
10470699|NCT01079143|11618937|FG003|STARTED|Overall Study||59
10470700|NCT01079143|11618934|FG000|Exposed|Overall Study||36
10470701|NCT01079143|11618935|FG001|Exposed|Overall Study||60
10470702|NCT01079143|11618936|FG002|Exposed|Overall Study||39
10470703|NCT01079143|11618937|FG003|Exposed|Overall Study||59
10470704|NCT01079143|11618934|FG000|Month 3 (M3) Biopsies|Overall Study||36
10470705|NCT01079143|11618935|FG001|Month 3 (M3) Biopsies|Overall Study|1 patient was excluded due to an IF/TA Grade of III at the M3 Biopsy|59
10470706|NCT01079143|11618936|FG002|Month 3 (M3) Biopsies|Overall Study||39
10470707|NCT01079143|11618937|FG003|Month 3 (M3) Biopsies|Overall Study||59
10470708|NCT01079143|11618934|FG000|Month 12 (M12) Biopsies|Overall Study|Only 26 out of 36 participants in this group had graft biopsy that was eligible for analysis.|26
10470709|NCT01079143|11618935|FG001|Month 12 (M12) Biopsies|Overall Study||43
10470710|NCT01079143|11618936|FG002|Month 12 (M12) Biopsies|Overall Study|Only 32 out of 39 participants in this group had graft biopsy that was eligible for analysis.|32
10470711|NCT01079143|11618937|FG003|Month 12 (M12) Biopsies|Overall Study|Only 53 out of 59 participants in this group had graft biopsy that was eligible for analysis.|53
10470712|NCT01079143|11618934|FG000|M3 and M12 Biopsies|Overall Study|Only 26 out of 36 participants in this group had graft biopsy that was eligible for analysis.|26
10470713|NCT01079143|11618935|FG001|M3 and M12 Biopsies|Overall Study||43
10470714|NCT01079143|11618936|FG002|M3 and M12 Biopsies|Overall Study|Only 32 out of 39 participants in this group had graft biopsy that was eligible for analysis.|32
10470715|NCT01079143|11618937|FG003|M3 and M12 Biopsies|Overall Study|Only 53 out of 59 participants in this group had graft biopsy that was eligible for analysis.|53
10470716|NCT01079143|11618934|FG000|COMPLETED|Overall Study||27
10470717|NCT01079143|11618935|FG001|COMPLETED|Overall Study||43
10470718|NCT01079143|11618936|FG002|COMPLETED|Overall Study||34
10470719|NCT01079143|11618937|FG003|COMPLETED|Overall Study||54
10470720|NCT01079143|11618934|FG000|NOT COMPLETED|Overall Study||9
10470722|NCT01079143|11618936|FG002|NOT COMPLETED|Overall Study||5
10470723|NCT01079143|11618937|FG003|NOT COMPLETED|Overall Study||5
10470724|NCT01079182|11618951|FG000|STARTED|Overall Study||4681
10470725|NCT01079182|11618951|FG000|COMPLETED|Overall Study||1962
10470726|NCT01079182|11618951|FG000|NOT COMPLETED|Overall Study||2719
10470727|NCT01079195|11618955|FG000|STARTED|Overall Study||15873
10470728|NCT01079195|11618955|FG000|COMPLETED|Overall Study||14442
10470729|NCT01079195|11618955|FG000|NOT COMPLETED|Overall Study||1431
10470730|NCT01079234|11618962|FG000|STARTED|Main: Week 0 to 26||164
10470731|NCT01079234|11618963|FG001|STARTED|Main: Week 0 to 26||165
10470732|NCT01079234|11618964|FG002|STARTED|Main: Week 0 to 26||164
10470733|NCT01079234|11618965|FG003|STARTED|Main: Week 0 to 26||0
10470734|NCT01079234|11618962|FG000|Exposed|Main: Week 0 to 26||164
10470735|NCT01079234|11618963|FG001|Exposed|Main: Week 0 to 26||165
10470736|NCT01079234|11618964|FG002|Exposed|Main: Week 0 to 26|Three subjects withdrew prior to exposure to trial drug.|161
10470737|NCT01079234|11618965|FG003|Exposed|Main: Week 0 to 26||0
10470738|NCT01079234|11618962|FG000|COMPLETED|Main: Week 0 to 26||138
10470739|NCT01079234|11618963|FG001|COMPLETED|Main: Week 0 to 26||139
10470740|NCT01079234|11618964|FG002|COMPLETED|Main: Week 0 to 26||152
10470741|NCT01079234|11618965|FG003|COMPLETED|Main: Week 0 to 26||0
10470742|NCT01079234|11618962|FG000|NOT COMPLETED|Main: Week 0 to 26||26
10470743|NCT01079234|11618963|FG001|NOT COMPLETED|Main: Week 0 to 26||26
10470744|NCT01079234|11618964|FG002|NOT COMPLETED|Main: Week 0 to 26||12
10470745|NCT01079234|11618965|FG003|NOT COMPLETED|Main: Week 0 to 26||0
10470746|NCT01079234|11618962|FG000|STARTED|Extension: Week 27 to 52||0
10470747|NCT01079234|11618963|FG001|STARTED|Extension: Week 27 to 52||0
10470748|NCT01079234|11618964|FG002|STARTED|Extension: Week 27 to 52|Nineteen subjects from main trial did not continue into extension trial|133
10470749|NCT01079234|11618965|FG003|STARTED|Extension: Week 27 to 52|Thirty eight subjects did not continue into extension trial.|239
10470750|NCT01079234|11618962|FG000|COMPLETED|Extension: Week 27 to 52||0
10470751|NCT01079234|11618963|FG001|COMPLETED|Extension: Week 27 to 52||0
10470752|NCT01079234|11618964|FG002|COMPLETED|Extension: Week 27 to 52||122
10470753|NCT01079234|11618965|FG003|COMPLETED|Extension: Week 27 to 52||223
10470754|NCT01079234|11618962|FG000|NOT COMPLETED|Extension: Week 27 to 52||0
10470755|NCT01079234|11618963|FG001|NOT COMPLETED|Extension: Week 27 to 52||0
10470756|NCT01079234|11618964|FG002|NOT COMPLETED|Extension: Week 27 to 52||11
10470757|NCT01079234|11618965|FG003|NOT COMPLETED|Extension: Week 27 to 52||16
10470758|NCT01079299|11618976|FG000|STARTED|Overall Study||27
10470759|NCT01079299|11618977|FG001|STARTED|Overall Study||25
10470760|NCT01079299|11618976|FG000|COMPLETED|Overall Study||27
10470761|NCT01079299|11618977|FG001|COMPLETED|Overall Study||25
10470762|NCT01079299|11618976|FG000|NOT COMPLETED|Overall Study||0
10470763|NCT01079299|11618977|FG001|NOT COMPLETED|Overall Study||0
10470764|NCT01079390|11618986|FG000|STARTED|Overall Study||15
10470765|NCT01079390|11618987|FG001|STARTED|Overall Study||15
10470766|NCT01079390|11618988|FG002|STARTED|Overall Study||14
10470767|NCT01079390|11618986|FG000|COMPLETED|Overall Study||10
10470768|NCT01079390|11618987|FG001|COMPLETED|Overall Study||10
10470769|NCT01079390|11618988|FG002|COMPLETED|Overall Study||10
10470770|NCT01079390|11618986|FG000|NOT COMPLETED|Overall Study||5
10470771|NCT01079390|11618987|FG001|NOT COMPLETED|Overall Study||5
10470772|NCT01079390|11618988|FG002|NOT COMPLETED|Overall Study||4
10470773|NCT01079663|11619000|FG000|STARTED|Overall Study||30
10470774|NCT01079663|11619001|FG001|STARTED|Overall Study||30
10470775|NCT01079663|11619000|FG000|COMPLETED|Overall Study||30
10470776|NCT01079663|11619001|FG001|COMPLETED|Overall Study||26
10470777|NCT01079663|11619000|FG000|NOT COMPLETED|Overall Study||0
10470778|NCT01079663|11619001|FG001|NOT COMPLETED|Overall Study||4
10470779|NCT01079741|11619012|FG000|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||3
10470780|NCT01079741|11619013|FG001|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
10470781|NCT01079741|11619014|FG002|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
10470782|NCT01079741|11619015|FG003|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
10470783|NCT01079741|11619016|FG004|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
10470784|NCT01079741|11619012|FG000|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||3
10470785|NCT01079741|11619013|FG001|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
10470786|NCT01079741|11619014|FG002|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
10470787|NCT01079741|11619015|FG003|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
10470788|NCT01079741|11619016|FG004|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
10708809|NCT02634346|11873732|FG001|NOT COMPLETED|Overall Study||14
10708810|NCT02634346|11873733|FG002|NOT COMPLETED|Overall Study||23
10470789|NCT01079741|11619012|FG000|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
10470790|NCT01079741|11619013|FG001|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
10470791|NCT01079741|11619014|FG002|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
10470792|NCT01079741|11619015|FG003|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
10470793|NCT01079741|11619016|FG004|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
10470794|NCT01079741|11619012|FG000|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
10470795|NCT01079741|11619013|FG001|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||4
10470796|NCT01079741|11619014|FG002|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
10470797|NCT01079741|11619015|FG003|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
10470798|NCT01079741|11619016|FG004|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
10470799|NCT01079741|11619012|FG000|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
10470800|NCT01079741|11619013|FG001|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||3
10470801|NCT01079741|11619014|FG002|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
10470802|NCT01079741|11619015|FG003|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
10470803|NCT01079741|11619016|FG004|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
10470804|NCT01079741|11619012|FG000|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
10470805|NCT01079741|11619013|FG001|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||1
10470806|NCT01079741|11619014|FG002|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
10470807|NCT01079741|11619015|FG003|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
10470808|NCT01079741|11619016|FG004|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
10470809|NCT01079741|11619012|FG000|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
10708811|NCT02634580|11873745|FG000|STARTED|Double-blind Treatment Period||10
10470810|NCT01079741|11619013|FG001|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
10470811|NCT01079741|11619014|FG002|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||3
10470812|NCT01079741|11619015|FG003|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
10470813|NCT01079741|11619016|FG004|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
10470814|NCT01079741|11619012|FG000|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
10470815|NCT01079741|11619013|FG001|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
10470816|NCT01079741|11619014|FG002|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
10470817|NCT01079741|11619015|FG003|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
10470818|NCT01079741|11619016|FG004|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
10708812|NCT02634580|11873746|FG001|STARTED|Double-blind Treatment Period||11
10470819|NCT01079741|11619012|FG000|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
10470820|NCT01079741|11619013|FG001|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
10470821|NCT01079741|11619014|FG002|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||3
10470822|NCT01079741|11619015|FG003|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
10470823|NCT01079741|11619016|FG004|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
10470824|NCT01079741|11619012|FG000|STARTED|Phase 2 (Weeks 37-48)||0
10470825|NCT01079741|11619013|FG001|STARTED|Phase 2 (Weeks 37-48)||0
10470826|NCT01079741|11619014|FG002|STARTED|Phase 2 (Weeks 37-48)||0
10470827|NCT01079741|11619015|FG003|STARTED|Phase 2 (Weeks 37-48)||12
10470828|NCT01079741|11619016|FG004|STARTED|Phase 2 (Weeks 37-48)||12
10470829|NCT01079741|11619012|FG000|COMPLETED|Phase 2 (Weeks 37-48)||0
10470830|NCT01079741|11619013|FG001|COMPLETED|Phase 2 (Weeks 37-48)||0
10470831|NCT01079741|11619014|FG002|COMPLETED|Phase 2 (Weeks 37-48)||0
10470832|NCT01079741|11619015|FG003|COMPLETED|Phase 2 (Weeks 37-48)||12
10470833|NCT01079741|11619016|FG004|COMPLETED|Phase 2 (Weeks 37-48)||9
10470834|NCT01079741|11619012|FG000|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
10470835|NCT01079741|11619013|FG001|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
10470836|NCT01079741|11619014|FG002|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
10470837|NCT01079741|11619015|FG003|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
10470838|NCT01079741|11619016|FG004|NOT COMPLETED|Phase 2 (Weeks 37-48)||3
10470839|NCT01079806|11619030|FG000|STARTED|Day 1 to Week 96||120
10470840|NCT01079806|11619031|FG001|STARTED|Day 1 to Week 96||60
10470841|NCT01079806|11619030|FG000|Received Treatment|Day 1 to Week 96||120
10470842|NCT01079806|11619031|FG001|Received Treatment|Day 1 to Week 96||60
10470843|NCT01079806|11619030|FG000|Primary Endpoint Cohort|Day 1 to Week 96||82
10470844|NCT01079806|11619031|FG001|Primary Endpoint Cohort|Day 1 to Week 96||41
10470845|NCT01079806|11619030|FG000|COMPLETED|Day 1 to Week 96||113
10470846|NCT01079806|11619031|FG001|COMPLETED|Day 1 to Week 96||53
10470847|NCT01079806|11619030|FG000|NOT COMPLETED|Day 1 to Week 96||7
10470848|NCT01079806|11619031|FG001|NOT COMPLETED|Day 1 to Week 96||7
10470849|NCT01079806|11619030|FG000|STARTED|Long-term Follow-up: Day 1-End of Study||111
10470850|NCT01079806|11619031|FG001|STARTED|Long-term Follow-up: Day 1-End of Study||58
10470851|NCT01079806|11619030|FG000|COMPLETED|Long-term Follow-up: Day 1-End of Study||92
10470852|NCT01079806|11619031|FG001|COMPLETED|Long-term Follow-up: Day 1-End of Study||43
10470853|NCT01079806|11619030|FG000|NOT COMPLETED|Long-term Follow-up: Day 1-End of Study||19
10470854|NCT01079806|11619031|FG001|NOT COMPLETED|Long-term Follow-up: Day 1-End of Study||15
10470855|NCT01079832|11619039|FG000|STARTED|Overall Study||50
10470856|NCT01079832|11619039|FG000|COMPLETED|Overall Study||49
10470857|NCT01079832|11619039|FG000|NOT COMPLETED|Overall Study||1
10470858|NCT01079936|11619047|FG000|STARTED|Phase I: MTD||16
10470859|NCT01079936|11619048|FG001|STARTED|Phase I: MTD||0
10470860|NCT01079936|11619049|FG002|STARTED|Phase I: MTD||0
10470861|NCT01079936|11619050|FG003|STARTED|Phase I: MTD||0
10470862|NCT01079936|11619051|FG004|STARTED|Phase I: MTD||0
10470863|NCT01079936|11619047|FG000|COMPLETED|Phase I: MTD|The 12 Phase I participants were randomized across 4 dose arms for Phase II.|12
10470864|NCT01079936|11619048|FG001|COMPLETED|Phase I: MTD||0
10470865|NCT01079936|11619049|FG002|COMPLETED|Phase I: MTD||0
10470866|NCT01079936|11619050|FG003|COMPLETED|Phase I: MTD||0
10470867|NCT01079936|11619051|FG004|COMPLETED|Phase I: MTD||0
10470868|NCT01079936|11619047|FG000|NOT COMPLETED|Phase I: MTD||4
10470869|NCT01079936|11619048|FG001|NOT COMPLETED|Phase I: MTD||0
10470870|NCT01079936|11619049|FG002|NOT COMPLETED|Phase I: MTD||0
10470871|NCT01079936|11619050|FG003|NOT COMPLETED|Phase I: MTD||0
10470872|NCT01079936|11619051|FG004|NOT COMPLETED|Phase I: MTD||0
10470873|NCT01079936|11619047|FG000|STARTED|Phase II||0
10470874|NCT01079936|11619048|FG001|STARTED|Phase II||3
10470875|NCT01079936|11619049|FG002|STARTED|Phase II||6
10470876|NCT01079936|11619050|FG003|STARTED|Phase II||24
10470877|NCT01079936|11619051|FG004|STARTED|Phase II||26
10470878|NCT01079936|11619047|FG000|COMPLETED|Phase II||0
10470879|NCT01079936|11619048|FG001|COMPLETED|Phase II||3
10470880|NCT01079936|11619049|FG002|COMPLETED|Phase II||5
10470881|NCT01079936|11619050|FG003|COMPLETED|Phase II||24
10470882|NCT01079936|11619051|FG004|COMPLETED|Phase II||25
10470883|NCT01079936|11619047|FG000|NOT COMPLETED|Phase II||0
10470884|NCT01079936|11619048|FG001|NOT COMPLETED|Phase II||0
10470885|NCT01079936|11619049|FG002|NOT COMPLETED|Phase II||1
10470886|NCT01079936|11619050|FG003|NOT COMPLETED|Phase II||0
10470887|NCT01079936|11619051|FG004|NOT COMPLETED|Phase II||1
10470888|NCT01079949|11619064|FG000|STARTED|Overall Study||46
10470889|NCT01079949|11619065|FG001|STARTED|Overall Study||47
10470890|NCT01079949|11619064|FG000|COMPLETED|Overall Study||31
10470891|NCT01079949|11619065|FG001|COMPLETED|Overall Study||34
10470892|NCT01079949|11619064|FG000|NOT COMPLETED|Overall Study||15
10470893|NCT01079949|11619065|FG001|NOT COMPLETED|Overall Study||13
10470894|NCT01079962|11619073|FG000|STARTED|Overall Study||105
10470895|NCT01079962|11619074|FG001|STARTED|Overall Study||104
10470896|NCT01079962|11619073|FG000|COMPLETED|Overall Study||90
10470897|NCT01079962|11619074|FG001|COMPLETED|Overall Study||89
10470898|NCT01079962|11619073|FG000|NOT COMPLETED|Overall Study||15
10470899|NCT01079962|11619074|FG001|NOT COMPLETED|Overall Study||15
10470900|NCT01079988|11619085|FG000|STARTED|Overall Study||10
10470901|NCT01079988|11619086|FG001|STARTED|Overall Study||1
10470902|NCT01079988|11619087|FG002|STARTED|Overall Study||8
10470903|NCT01079988|11619088|FG003|STARTED|Overall Study||20
10470904|NCT01079988|11619089|FG004|STARTED|Overall Study||2
10470905|NCT01079988|11619085|FG000|COMPLETED|Overall Study||9
10470906|NCT01079988|11619086|FG001|COMPLETED|Overall Study||1
10470907|NCT01079988|11619087|FG002|COMPLETED|Overall Study||8
10470908|NCT01079988|11619088|FG003|COMPLETED|Overall Study||17
10470909|NCT01079988|11619089|FG004|COMPLETED|Overall Study||1
10470910|NCT01079988|11619085|FG000|NOT COMPLETED|Overall Study||1
10470911|NCT01079988|11619086|FG001|NOT COMPLETED|Overall Study||0
10470912|NCT01079988|11619087|FG002|NOT COMPLETED|Overall Study||0
10470913|NCT01079988|11619088|FG003|NOT COMPLETED|Overall Study||3
10470914|NCT01079988|11619089|FG004|NOT COMPLETED|Overall Study||1
10470915|NCT01080118|11619103|FG000|STARTED|Overall Study||15
10470916|NCT01080118|11619104|FG001|STARTED|Overall Study||15
10470917|NCT01080118|11619105|FG002|STARTED|Overall Study||30
10470918|NCT01080118|11619106|FG003|STARTED|Overall Study||30
10470919|NCT01080118|11619103|FG000|COMPLETED|Overall Study||15
10470920|NCT01080118|11619104|FG001|COMPLETED|Overall Study||15
10470921|NCT01080118|11619105|FG002|COMPLETED|Overall Study||30
10470922|NCT01080118|11619106|FG003|COMPLETED|Overall Study||30
10470923|NCT01080118|11619103|FG000|NOT COMPLETED|Overall Study||0
10470924|NCT01080118|11619104|FG001|NOT COMPLETED|Overall Study||0
10470925|NCT01080118|11619105|FG002|NOT COMPLETED|Overall Study||0
10470926|NCT01080118|11619106|FG003|NOT COMPLETED|Overall Study||0
10470927|NCT01080131|11619114|FG000|STARTED|Core Study (0- 12 Weeks)||112
10470928|NCT01080131|11619115|FG001|STARTED|Core Study (0- 12 Weeks)||114
10470929|NCT01080131|11619114|FG000|COMPLETED|Core Study (0- 12 Weeks)||99
10470930|NCT01080131|11619115|FG001|COMPLETED|Core Study (0- 12 Weeks)||103
10470931|NCT01080131|11619114|FG000|NOT COMPLETED|Core Study (0- 12 Weeks)||13
10470932|NCT01080131|11619115|FG001|NOT COMPLETED|Core Study (0- 12 Weeks)||11
10470933|NCT01080131|11619114|FG000|STARTED|Extension Study 1 (12 -24 Weeks)||84
10470934|NCT01080131|11619115|FG001|STARTED|Extension Study 1 (12 -24 Weeks)||76
10470935|NCT01080131|11619114|FG000|COMPLETED|Extension Study 1 (12 -24 Weeks)||78
10470936|NCT01080131|11619115|FG001|COMPLETED|Extension Study 1 (12 -24 Weeks)||72
10470937|NCT01080131|11619114|FG000|NOT COMPLETED|Extension Study 1 (12 -24 Weeks)||6
10470938|NCT01080131|11619115|FG001|NOT COMPLETED|Extension Study 1 (12 -24 Weeks)||4
10470939|NCT01080131|11619114|FG000|STARTED|Extension Study 2 (25-72 Weeks)||72
10470940|NCT01080131|11619115|FG001|STARTED|Extension Study 2 (25-72 Weeks)||65
10470941|NCT01080131|11619114|FG000|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients re-treated with canakinumab at any time during the 72 weeks|62
10470942|NCT01080131|11619115|FG001|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients switched to canakinumab from Week 25 - Week 72|41
10470943|NCT01080131|11619114|FG000|COMPLETED|Extension Study 2 (25-72 Weeks)||64
10470944|NCT01080131|11619115|FG001|COMPLETED|Extension Study 2 (25-72 Weeks)||54
10470945|NCT01080131|11619114|FG000|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||8
10470946|NCT01080131|11619115|FG001|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||11
10470947|NCT01080209|11619146|FG000|STARTED|Overall Study||28
10470948|NCT01080209|11619147|FG001|STARTED|Overall Study||53
10470949|NCT01080209|11619148|FG002|STARTED|Overall Study||33
10470950|NCT01080209|11619149|FG003|STARTED|Overall Study||42
10470951|NCT01080209|11619150|FG004|STARTED|Overall Study||6
10470952|NCT01080209|11619151|FG005|STARTED|Overall Study||2
10470953|NCT01080209|11619152|FG006|STARTED|Overall Study||51
10470954|NCT01080209|11619146|FG000|COMPLETED|Overall Study||22
10470955|NCT01080209|11619147|FG001|COMPLETED|Overall Study||42
10470956|NCT01080209|11619148|FG002|COMPLETED|Overall Study||28
10470957|NCT01080209|11619149|FG003|COMPLETED|Overall Study||37
10470958|NCT01080209|11619150|FG004|COMPLETED|Overall Study||6
10470959|NCT01080209|11619151|FG005|COMPLETED|Overall Study||2
10470960|NCT01080209|11619152|FG006|COMPLETED|Overall Study||44
10470961|NCT01080209|11619146|FG000|NOT COMPLETED|Overall Study||6
10470962|NCT01080209|11619147|FG001|NOT COMPLETED|Overall Study||11
10470963|NCT01080209|11619148|FG002|NOT COMPLETED|Overall Study||5
10470964|NCT01080209|11619149|FG003|NOT COMPLETED|Overall Study||5
10470965|NCT01080209|11619150|FG004|NOT COMPLETED|Overall Study||0
10470966|NCT01080209|11619151|FG005|NOT COMPLETED|Overall Study||0
10470967|NCT01080209|11619152|FG006|NOT COMPLETED|Overall Study||7
10470968|NCT01080248|11619168|FG000|STARTED|Overall Study||2
10470969|NCT01080248|11619168|FG000|COMPLETED|Overall Study||2
10470970|NCT01080248|11619168|FG000|NOT COMPLETED|Overall Study||0
10470971|NCT01080261|11619172|FG000|STARTED|Overall Study||60
10470972|NCT01080261|11619172|FG000|COMPLETED|Overall Study||60
10470973|NCT01080261|11619172|FG000|NOT COMPLETED|Overall Study||0
10470974|NCT01080300|11619178|FG000|STARTED|Overall Study|302 subjects were randomized, but only 300 received study treatment.|300
10470975|NCT01080300|11619179|FG001|STARTED|Overall Study|298 subjects were randomized, but only 295 received study treatment.|295
10470976|NCT01080300|11619178|FG000|COMPLETED|Overall Study||206
10470977|NCT01080300|11619179|FG001|COMPLETED|Overall Study||191
10470978|NCT01080300|11619178|FG000|NOT COMPLETED|Overall Study||94
10470979|NCT01080300|11619179|FG001|NOT COMPLETED|Overall Study||104
10470980|NCT01080326|11619187|FG000|STARTED|Overall Study||7
10470981|NCT01080326|11619187|FG000|COMPLETED|Overall Study||3
10470982|NCT01080326|11619187|FG000|NOT COMPLETED|Overall Study||4
10470991|NCT01080625|11619203|FG000|STARTED|Overall Study||31
10470992|NCT01080625|11619204|FG001|STARTED|Overall Study||33
10470993|NCT01080625|11619205|FG002|STARTED|Overall Study||32
10470994|NCT01080625|11619203|FG000|COMPLETED|Overall Study||31
10470995|NCT01080625|11619204|FG001|COMPLETED|Overall Study||31
10470996|NCT01080625|11619205|FG002|COMPLETED|Overall Study||31
10470997|NCT01080625|11619203|FG000|NOT COMPLETED|Overall Study||0
10470998|NCT01080625|11619204|FG001|NOT COMPLETED|Overall Study||2
10470999|NCT01080625|11619205|FG002|NOT COMPLETED|Overall Study||1
10526707|NCT01383356|11678620|FG000|COMPLETED|Period 1|Completed period 1.|21
10526708|NCT01383356|11678621|FG001|COMPLETED|Period 1|Completed period 1.|23
10526709|NCT01383356|11678620|FG000|NOT COMPLETED|Period 1||8
10526710|NCT01383356|11678621|FG001|NOT COMPLETED|Period 1||6
10526711|NCT01383356|11678620|FG000|STARTED|Washout Period (at Least 35 Days)||21
10526712|NCT01383356|11678621|FG001|STARTED|Washout Period (at Least 35 Days)||23
10526713|NCT01383356|11678620|FG000|COMPLETED|Washout Period (at Least 35 Days)||21
10526714|NCT01383356|11678621|FG001|COMPLETED|Washout Period (at Least 35 Days)||23
10526715|NCT01383356|11678620|FG000|NOT COMPLETED|Washout Period (at Least 35 Days)||0
10526716|NCT01383356|11678621|FG001|NOT COMPLETED|Washout Period (at Least 35 Days)||0
10526717|NCT01383356|11678620|FG000|STARTED|Period 2|Entered and treated.|21
10526718|NCT01383356|11678621|FG001|STARTED|Period 2|Entered and treated.|23
10526719|NCT01383356|11678620|FG000|COMPLETED|Period 2|Completed period 2.|21
10526720|NCT01383356|11678621|FG001|COMPLETED|Period 2|Completed period 2.|23
10526721|NCT01383356|11678620|FG000|NOT COMPLETED|Period 2||0
10526722|NCT01383356|11678621|FG001|NOT COMPLETED|Period 2||0
10526723|NCT01383421|11678627|FG000|STARTED|Overall Study|ITT population: all enrolled participants who received at least 1 dose of study drug.|1025
10526724|NCT01383421|11678627|FG000|COMPLETED|Overall Study||679
10526725|NCT01383421|11678627|FG000|NOT COMPLETED|Overall Study||346
10526726|NCT01383486|11678635|FG000|STARTED|Overall Study|Number of participants who were provided with investigational products|253
10526727|NCT01383486|11678635|FG000|Treated|Overall Study|Number of participants who took any study medication (Safety Population)|237
10526728|NCT01383486|11678635|FG000|COMPLETED|Overall Study|Took any study medication and gave estimated duration of pain (Selection Evaluation Population)|235
10526729|NCT01383486|11678635|FG000|NOT COMPLETED|Overall Study||18
10526730|NCT01383499|11678640|FG000|STARTED|Period 1 (4 Weeks)||27
10526731|NCT01383499|11678641|FG001|STARTED|Period 1 (4 Weeks)||24
10526732|NCT01383499|11678642|FG002|STARTED|Period 1 (4 Weeks)||25
10526733|NCT01383499|11678643|FG003|STARTED|Period 1 (4 Weeks)||25
10526734|NCT01383499|11678640|FG000|COMPLETED|Period 1 (4 Weeks)||26
10526735|NCT01383499|11678641|FG001|COMPLETED|Period 1 (4 Weeks)||24
10526736|NCT01383499|11678642|FG002|COMPLETED|Period 1 (4 Weeks)||25
10526737|NCT01383499|11678643|FG003|COMPLETED|Period 1 (4 Weeks)||25
10526738|NCT01383499|11678640|FG000|NOT COMPLETED|Period 1 (4 Weeks)||1
10526739|NCT01383499|11678641|FG001|NOT COMPLETED|Period 1 (4 Weeks)||0
10526740|NCT01383499|11678642|FG002|NOT COMPLETED|Period 1 (4 Weeks)||0
10526741|NCT01383499|11678643|FG003|NOT COMPLETED|Period 1 (4 Weeks)||0
10526742|NCT01383499|11678640|FG000|STARTED|Period 2 (4 Weeks)||26
10526743|NCT01383499|11678641|FG001|STARTED|Period 2 (4 Weeks)||24
10526744|NCT01383499|11678642|FG002|STARTED|Period 2 (4 Weeks)||25
10526745|NCT01383499|11678643|FG003|STARTED|Period 2 (4 Weeks)||25
10526746|NCT01383499|11678640|FG000|COMPLETED|Period 2 (4 Weeks)||26
10526747|NCT01383499|11678641|FG001|COMPLETED|Period 2 (4 Weeks)||24
10526748|NCT01383499|11678642|FG002|COMPLETED|Period 2 (4 Weeks)||25
10526749|NCT01383499|11678643|FG003|COMPLETED|Period 2 (4 Weeks)||25
10526750|NCT01383499|11678640|FG000|NOT COMPLETED|Period 2 (4 Weeks)||0
10526751|NCT01383499|11678641|FG001|NOT COMPLETED|Period 2 (4 Weeks)||0
10526752|NCT01383499|11678642|FG002|NOT COMPLETED|Period 2 (4 Weeks)||0
10526753|NCT01383499|11678643|FG003|NOT COMPLETED|Period 2 (4 Weeks)||0
10526754|NCT01383499|11678640|FG000|STARTED|Period 3 (4 Weeks)||26
10526755|NCT01383499|11678641|FG001|STARTED|Period 3 (4 Weeks)||24
10526756|NCT01383499|11678642|FG002|STARTED|Period 3 (4 Weeks)||25
10526757|NCT01383499|11678643|FG003|STARTED|Period 3 (4 Weeks)||25
10526758|NCT01383499|11678640|FG000|COMPLETED|Period 3 (4 Weeks)||26
10526759|NCT01383499|11678641|FG001|COMPLETED|Period 3 (4 Weeks)||24
10526760|NCT01383499|11678642|FG002|COMPLETED|Period 3 (4 Weeks)||25
10526761|NCT01383499|11678643|FG003|COMPLETED|Period 3 (4 Weeks)||25
10526762|NCT01383499|11678640|FG000|NOT COMPLETED|Period 3 (4 Weeks)||0
10526763|NCT01383499|11678641|FG001|NOT COMPLETED|Period 3 (4 Weeks)||0
10526764|NCT01383499|11678642|FG002|NOT COMPLETED|Period 3 (4 Weeks)||0
10708813|NCT02634580|11873747|FG002|STARTED|Double-blind Treatment Period||19
10708814|NCT02634580|11873748|FG003|STARTED|Double-blind Treatment Period||21
10526765|NCT01383499|11678643|FG003|NOT COMPLETED|Period 3 (4 Weeks)||0
10526766|NCT01383616|11678658|FG000|STARTED|Overall Study||40
10526767|NCT01383616|11678659|FG001|STARTED|Overall Study||44
10526768|NCT01383616|11678658|FG000|COMPLETED|Overall Study||23
10526769|NCT01383616|11678659|FG001|COMPLETED|Overall Study||21
10526770|NCT01383616|11678658|FG000|NOT COMPLETED|Overall Study||17
10526771|NCT01383616|11678659|FG001|NOT COMPLETED|Overall Study||23
10526772|NCT01383707|11678669|FG000|STARTED|Overall Study||77
10526773|NCT01383707|11678669|FG000|COMPLETED|Overall Study||5
10526774|NCT01383707|11678669|FG000|NOT COMPLETED|Overall Study||72
10526775|NCT01383720|11678673|FG000|STARTED|Overall Study||11
10471000|NCT01080677|11619216|FG000|STARTED|Overall Study||20
10471001|NCT01080677|11619217|FG001|STARTED|Overall Study||20
10471002|NCT01080677|11619218|FG002|STARTED|Overall Study||20
10471003|NCT01080677|11619216|FG000|COMPLETED|Overall Study||20
10471004|NCT01080677|11619217|FG001|COMPLETED|Overall Study||20
10471005|NCT01080677|11619218|FG002|COMPLETED|Overall Study||20
10471006|NCT01080677|11619216|FG000|NOT COMPLETED|Overall Study||0
10471007|NCT01080677|11619217|FG001|NOT COMPLETED|Overall Study||0
10471008|NCT01080677|11619218|FG002|NOT COMPLETED|Overall Study||0
10471009|NCT01080716|11619230|FG000|STARTED|Part 1||14
10471010|NCT01080716|11619231|FG001|STARTED|Part 1||6
10471011|NCT01080716|11619232|FG002|STARTED|Part 1||0
10471012|NCT01080716|11619233|FG003|STARTED|Part 1||0
10471013|NCT01080716|11619230|FG000|COMPLETED|Part 1||13
10471014|NCT01080716|11619231|FG001|COMPLETED|Part 1||6
10471015|NCT01080716|11619232|FG002|COMPLETED|Part 1||0
10471016|NCT01080716|11619233|FG003|COMPLETED|Part 1||0
10471017|NCT01080716|11619230|FG000|NOT COMPLETED|Part 1||1
10471018|NCT01080716|11619231|FG001|NOT COMPLETED|Part 1||0
10471019|NCT01080716|11619232|FG002|NOT COMPLETED|Part 1||0
10471020|NCT01080716|11619233|FG003|NOT COMPLETED|Part 1||0
10471021|NCT01080716|11619230|FG000|STARTED|Part 2||0
10471022|NCT01080716|11619231|FG001|STARTED|Part 2||0
10471023|NCT01080716|11619232|FG002|STARTED|Part 2||10
10471024|NCT01080716|11619233|FG003|STARTED|Part 2||10
10471025|NCT01080716|11619230|FG000|COMPLETED|Part 2||0
10471026|NCT01080716|11619231|FG001|COMPLETED|Part 2||0
10471027|NCT01080716|11619232|FG002|COMPLETED|Part 2||10
10471028|NCT01080716|11619233|FG003|COMPLETED|Part 2||10
10471029|NCT01080716|11619230|FG000|NOT COMPLETED|Part 2||0
10471030|NCT01080716|11619231|FG001|NOT COMPLETED|Part 2||0
10471031|NCT01080716|11619232|FG002|NOT COMPLETED|Part 2||0
10471032|NCT01080716|11619233|FG003|NOT COMPLETED|Part 2||0
10471033|NCT01080794|11619251|FG000|STARTED|Overall Study||20
10471034|NCT01080794|11619252|FG001|STARTED|Overall Study||14
10471035|NCT01080794|11619253|FG002|STARTED|Overall Study||12
10471036|NCT01080794|11619254|FG003|STARTED|Overall Study||15
10471037|NCT01080794|11619251|FG000|COMPLETED|Overall Study||15
10471038|NCT01080794|11619252|FG001|COMPLETED|Overall Study||12
10471039|NCT01080794|11619253|FG002|COMPLETED|Overall Study||10
10471040|NCT01080794|11619254|FG003|COMPLETED|Overall Study||13
10471041|NCT01080794|11619251|FG000|NOT COMPLETED|Overall Study||5
10471042|NCT01080794|11619252|FG001|NOT COMPLETED|Overall Study||2
10471043|NCT01080794|11619253|FG002|NOT COMPLETED|Overall Study||2
10471044|NCT01080794|11619254|FG003|NOT COMPLETED|Overall Study||2
10471045|NCT01080807|11619266|FG000|STARTED|Overall Study|Nine patients randomly assigned to the armodafinil treatment group did not receive study drug.|193
10471046|NCT01080807|11619267|FG001|STARTED|Overall Study|Three patients randomly assigned to the placebo treatment group did not receive study drug.|190
10471047|NCT01080807|11619266|FG000|COMPLETED|Overall Study||158
10471048|NCT01080807|11619267|FG001|COMPLETED|Overall Study||167
10471049|NCT01080807|11619266|FG000|NOT COMPLETED|Overall Study||35
10471050|NCT01080807|11619267|FG001|NOT COMPLETED|Overall Study||23
10471051|NCT01080976|11619275|FG000|STARTED|Overall Study||5
10471052|NCT01080976|11619276|FG001|STARTED|Overall Study||5
10471053|NCT01080976|11619275|FG000|COMPLETED|Overall Study||5
10471054|NCT01080976|11619276|FG001|COMPLETED|Overall Study||5
10471055|NCT01080976|11619275|FG000|NOT COMPLETED|Overall Study||0
10471056|NCT01080976|11619276|FG001|NOT COMPLETED|Overall Study||0
10471057|NCT01081041|11619285|FG000|STARTED|Overall Study||33
10471058|NCT01081041|11619286|FG001|STARTED|Overall Study||81
10471059|NCT01081041|11619287|FG002|STARTED|Overall Study||73
10471060|NCT01081041|11619285|FG000|Received at Least 1 Dose of Study Drug|Overall Study||33
10471061|NCT01081041|11619286|FG001|Received at Least 1 Dose of Study Drug|Overall Study||77
10471062|NCT01081041|11619287|FG002|Received at Least 1 Dose of Study Drug|Overall Study||71
10471063|NCT01081041|11619285|FG000|COMPLETED|Overall Study||33
10471064|NCT01081041|11619286|FG001|COMPLETED|Overall Study||77
10471065|NCT01081041|11619287|FG002|COMPLETED|Overall Study||71
10471066|NCT01081041|11619285|FG000|NOT COMPLETED|Overall Study||0
10471067|NCT01081041|11619286|FG001|NOT COMPLETED|Overall Study||4
10471068|NCT01081041|11619287|FG002|NOT COMPLETED|Overall Study||2
10471069|NCT01081132|11619302|FG000|STARTED|Overall Study||157
10471070|NCT01081132|11619303|FG001|STARTED|Overall Study||157
10471071|NCT01081132|11619302|FG000|COMPLETED|Overall Study||102
10471072|NCT01081132|11619303|FG001|COMPLETED|Overall Study||105
10471073|NCT01081132|11619302|FG000|NOT COMPLETED|Overall Study||55
10471074|NCT01081132|11619303|FG001|NOT COMPLETED|Overall Study||52
10471075|NCT01081145|11619309|FG000|STARTED|Open-Label Phase||528
10471076|NCT01081145|11619310|FG001|STARTED|Open-Label Phase||0
10471077|NCT01081145|11619309|FG000|COMPLETED|Open-Label Phase||316
10471078|NCT01081145|11619310|FG001|COMPLETED|Open-Label Phase||0
10471079|NCT01081145|11619309|FG000|NOT COMPLETED|Open-Label Phase||212
10471080|NCT01081145|11619310|FG001|NOT COMPLETED|Open-Label Phase||0
10471081|NCT01081145|11619309|FG000|STARTED|Double-Blind Randomized-Withdrawal Phase||157
10471082|NCT01081145|11619310|FG001|STARTED|Double-Blind Randomized-Withdrawal Phase||159
10471083|NCT01081145|11619309|FG000|COMPLETED|Double-Blind Randomized-Withdrawal Phase||76
10471084|NCT01081145|11619310|FG001|COMPLETED|Double-Blind Randomized-Withdrawal Phase||53
10471085|NCT01081145|11619309|FG000|NOT COMPLETED|Double-Blind Randomized-Withdrawal Phase||81
10471086|NCT01081145|11619310|FG001|NOT COMPLETED|Double-Blind Randomized-Withdrawal Phase||106
10471087|NCT01081249|11619318|FG000|STARTED|Overall Study||11
10471088|NCT01081249|11619319|FG001|STARTED|Overall Study||7
10471089|NCT01081249|11619318|FG000|First Psychotherapy Appointment (1 Day)|Overall Study||11
10471090|NCT01081249|11619319|FG001|First Psychotherapy Appointment (1 Day)|Overall Study||6
10471091|NCT01081249|11619318|FG000|Washout (5-10 Days)|Overall Study||11
10471092|NCT01081249|11619319|FG001|Washout (5-10 Days)|Overall Study||6
10471093|NCT01081249|11619318|FG000|Second Psychotherapy Appointment (1 Day)|Overall Study||11
10471094|NCT01081249|11619319|FG001|Second Psychotherapy Appointment (1 Day)|Overall Study||6
10471095|NCT01081249|11619318|FG000|COMPLETED|Overall Study||11
10471096|NCT01081249|11619319|FG001|COMPLETED|Overall Study||6
10471097|NCT01081249|11619318|FG000|NOT COMPLETED|Overall Study||0
10471098|NCT01081249|11619319|FG001|NOT COMPLETED|Overall Study||1
10471099|NCT01081301|11619325|FG000|STARTED|Overall Study||36
10471100|NCT01081301|11619325|FG000|COMPLETED|Overall Study||22
10471101|NCT01081301|11619325|FG000|NOT COMPLETED|Overall Study||14
10471102|NCT01081626|11619348|FG000|STARTED|Overall Study||155
10471103|NCT01081626|11619349|FG001|STARTED|Overall Study||155
10471104|NCT01081626|11619348|FG000|Assessed for Efficacy|Overall Study||122
10708815|NCT02634580|11873745|FG000|COMPLETED|Double-blind Treatment Period||9
10708816|NCT02634580|11873746|FG001|COMPLETED|Double-blind Treatment Period||11
10708817|NCT02634580|11873747|FG002|COMPLETED|Double-blind Treatment Period||18
10708818|NCT02634580|11873748|FG003|COMPLETED|Double-blind Treatment Period||20
10708819|NCT02634580|11873745|FG000|NOT COMPLETED|Double-blind Treatment Period||1
10708820|NCT02634580|11873746|FG001|NOT COMPLETED|Double-blind Treatment Period||0
10708821|NCT02634580|11873747|FG002|NOT COMPLETED|Double-blind Treatment Period||1
10708822|NCT02634580|11873748|FG003|NOT COMPLETED|Double-blind Treatment Period||1
10708823|NCT02634580|11873745|FG000|STARTED|Open-label Extension Period||9
10708824|NCT02634580|11873746|FG001|STARTED|Open-label Extension Period||11
10708825|NCT02634580|11873747|FG002|STARTED|Open-label Extension Period||18
10708826|NCT02634580|11873748|FG003|STARTED|Open-label Extension Period|Includes 1 participant who did not complete the double-blind period but had study visits during OLE|21
10708827|NCT02634580|11873745|FG000|Received Open-label Treatment|Open-label Extension Period||9
10708828|NCT02634580|11873746|FG001|Received Open-label Treatment|Open-label Extension Period||11
10708829|NCT02634580|11873747|FG002|Received Open-label Treatment|Open-label Extension Period||18
10708830|NCT02634580|11873748|FG003|Received Open-label Treatment|Open-label Extension Period||20
10708831|NCT02634580|11873745|FG000|COMPLETED|Open-label Extension Period||9
10708832|NCT02634580|11873746|FG001|COMPLETED|Open-label Extension Period||10
10708833|NCT02634580|11873747|FG002|COMPLETED|Open-label Extension Period||18
10708834|NCT02634580|11873748|FG003|COMPLETED|Open-label Extension Period||20
10471105|NCT01081626|11619349|FG001|Assessed for Efficacy|Overall Study||125
10471106|NCT01081626|11619348|FG000|COMPLETED|Overall Study||95
10471107|NCT01081626|11619349|FG001|COMPLETED|Overall Study||94
10471108|NCT01081626|11619348|FG000|NOT COMPLETED|Overall Study||60
10471109|NCT01081626|11619349|FG001|NOT COMPLETED|Overall Study||61
10471110|NCT01081665|11619355|FG000|STARTED|Overall Study||237
10471111|NCT01081665|11619355|FG000|Full Analysis Set|Overall Study||237
10471112|NCT01081665|11619355|FG000|Evaluable Population|Overall Study|Participants with baseline and at least 2 post-baseline parathormone measurements at 24 months.|212
10471113|NCT01081665|11619355|FG000|COMPLETED|Overall Study||142
10471114|NCT01081665|11619355|FG000|NOT COMPLETED|Overall Study||95
10471135|NCT01081769|11619378|FG000|STARTED|Whole Intent-to-Treat||376
10471136|NCT01081769|11619379|FG001|STARTED|Whole Intent-to-Treat||388
10471137|NCT01081769|11619378|FG000|COMPLETED|Whole Intent-to-Treat||352
10471138|NCT01081769|11619379|FG001|COMPLETED|Whole Intent-to-Treat||363
10471139|NCT01081769|11619378|FG000|NOT COMPLETED|Whole Intent-to-Treat||24
10471140|NCT01081769|11619379|FG001|NOT COMPLETED|Whole Intent-to-Treat||25
10471141|NCT01081769|11619378|FG000|STARTED|CORE Intent-To-Treat||352
10471142|NCT01081769|11619379|FG001|STARTED|CORE Intent-To-Treat||363
10471143|NCT01081769|11619378|FG000|COMPLETED|CORE Intent-To-Treat||272
10471144|NCT01081769|11619379|FG001|COMPLETED|CORE Intent-To-Treat||266
10471145|NCT01081769|11619378|FG000|NOT COMPLETED|CORE Intent-To-Treat||80
10471146|NCT01081769|11619379|FG001|NOT COMPLETED|CORE Intent-To-Treat||97
10471147|NCT01081795|11619388|FG000|STARTED|Overall Study||130
10471148|NCT01081795|11619389|FG001|STARTED|Overall Study||130
10471149|NCT01081795|11619390|FG002|STARTED|Overall Study||127
10471150|NCT01081795|11619388|FG000|COMPLETED|Overall Study||97
10471151|NCT01081795|11619389|FG001|COMPLETED|Overall Study||95
10471152|NCT01081795|11619390|FG002|COMPLETED|Overall Study||97
10708835|NCT02634580|11873745|FG000|NOT COMPLETED|Open-label Extension Period||0
10471153|NCT01081795|11619388|FG000|NOT COMPLETED|Overall Study||33
10471154|NCT01081795|11619389|FG001|NOT COMPLETED|Overall Study||35
10471155|NCT01081795|11619390|FG002|NOT COMPLETED|Overall Study||30
10471156|NCT01081834|11619403|FG000|STARTED|Core Period: Baseline to Week 26||192
10471157|NCT01081834|11619404|FG001|STARTED|Core Period: Baseline to Week 26||195
10471158|NCT01081834|11619405|FG002|STARTED|Core Period: Baseline to Week 26||197
10471159|NCT01081834|11619406|FG003|STARTED|Core Period: Baseline to Week 26||47
10471160|NCT01081834|11619407|FG004|STARTED|Core Period: Baseline to Week 26||44
10471161|NCT01081834|11619403|FG000|COMPLETED|Core Period: Baseline to Week 26||160
10471162|NCT01081834|11619404|FG001|COMPLETED|Core Period: Baseline to Week 26||172
10471163|NCT01081834|11619405|FG002|COMPLETED|Core Period: Baseline to Week 26||175
10471164|NCT01081834|11619406|FG003|COMPLETED|Core Period: Baseline to Week 26||40
10471165|NCT01081834|11619407|FG004|COMPLETED|Core Period: Baseline to Week 26||40
10471166|NCT01081834|11619403|FG000|NOT COMPLETED|Core Period: Baseline to Week 26||32
10471167|NCT01081834|11619404|FG001|NOT COMPLETED|Core Period: Baseline to Week 26||23
10471168|NCT01081834|11619405|FG002|NOT COMPLETED|Core Period: Baseline to Week 26||22
10471169|NCT01081834|11619406|FG003|NOT COMPLETED|Core Period: Baseline to Week 26||7
10471170|NCT01081834|11619407|FG004|NOT COMPLETED|Core Period: Baseline to Week 26||4
10471171|NCT01081834|11619403|FG000|STARTED|Extension Period: Week 26 to Week 52|5 pts discontinued on last day of core: lack of efficacy on rescue (2), not specified (NS) (3).|155
10471172|NCT01081834|11619404|FG001|STARTED|Extension Period: Week 26 to Week 52|2 pts discontinued on last day of core: adverse event (AE) (1), protocol violation (PV) (1).|170
10471173|NCT01081834|11619405|FG002|STARTED|Extension Period: Week 26 to Week 52|5 pts discontinued last day of core: AE (1), lost f/u (1), PV (1), NS (1), physician decision (1).|170
10471174|NCT01081834|11619406|FG003|STARTED|Extension Period: Week 26 to Week 52|The treatment duration for the High Glycemic Substudy was 26 weeks only.|0
10471175|NCT01081834|11619407|FG004|STARTED|Extension Period: Week 26 to Week 52|The treatment duration for the High Glycemic Substudy was 26 weeks only.|0
10471176|NCT01081834|11619403|FG000|COMPLETED|Extension Period: Week 26 to Week 52||135
10471177|NCT01081834|11619404|FG001|COMPLETED|Extension Period: Week 26 to Week 52||152
10471178|NCT01081834|11619405|FG002|COMPLETED|Extension Period: Week 26 to Week 52||165
10471179|NCT01081834|11619406|FG003|COMPLETED|Extension Period: Week 26 to Week 52||0
10471180|NCT01081834|11619407|FG004|COMPLETED|Extension Period: Week 26 to Week 52||0
10471181|NCT01081834|11619403|FG000|NOT COMPLETED|Extension Period: Week 26 to Week 52||20
10471182|NCT01081834|11619404|FG001|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
10708836|NCT02634580|11873746|FG001|NOT COMPLETED|Open-label Extension Period||1
10708837|NCT02634580|11873747|FG002|NOT COMPLETED|Open-label Extension Period||0
10708838|NCT02634580|11873748|FG003|NOT COMPLETED|Open-label Extension Period||1
10708839|NCT02634684|11873761|FG000|STARTED|Overall Study||19
10708840|NCT02634684|11873762|FG001|STARTED|Overall Study||19
10708841|NCT02634684|11873763|FG002|STARTED|Overall Study||21
10708842|NCT02634684|11873764|FG003|STARTED|Overall Study||23
10471183|NCT01081834|11619405|FG002|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
10471184|NCT01081834|11619406|FG003|NOT COMPLETED|Extension Period: Week 26 to Week 52||0
10471185|NCT01081834|11619407|FG004|NOT COMPLETED|Extension Period: Week 26 to Week 52||0
10471186|NCT01081873|11619426|FG000|STARTED|Overall Study|3 patients were excluded from this and all analyses due to no available data from Baseline.|2714
10471187|NCT01081873|11619426|FG000|COMPLETED|Overall Study||2416
10471188|NCT01081873|11619426|FG000|NOT COMPLETED|Overall Study||298
10471189|NCT01081912|11619455|FG000|STARTED|Conversion/Titration||510
10471190|NCT01081912|11619456|FG001|STARTED|Conversion/Titration||0
10471191|NCT01081912|11619457|FG002|STARTED|Conversion/Titration||0
10471192|NCT01081912|11619455|FG000|COMPLETED|Conversion/Titration||302
10471193|NCT01081912|11619456|FG001|COMPLETED|Conversion/Titration||0
10471194|NCT01081912|11619457|FG002|COMPLETED|Conversion/Titration||0
10471195|NCT01081912|11619455|FG000|NOT COMPLETED|Conversion/Titration||208
10471196|NCT01081912|11619456|FG001|NOT COMPLETED|Conversion/Titration||0
10471197|NCT01081912|11619457|FG002|NOT COMPLETED|Conversion/Titration||0
10471198|NCT01081912|11619455|FG000|STARTED|Maintenance Treatment||0
10471199|NCT01081912|11619456|FG001|STARTED|Maintenance Treatment||151
10471200|NCT01081912|11619457|FG002|STARTED|Maintenance Treatment||151
10471201|NCT01081912|11619455|FG000|COMPLETED|Maintenance Treatment||0
10471202|NCT01081912|11619456|FG001|COMPLETED|Maintenance Treatment||124
10471203|NCT01081912|11619457|FG002|COMPLETED|Maintenance Treatment||59
10471204|NCT01081912|11619455|FG000|NOT COMPLETED|Maintenance Treatment||0
10471205|NCT01081912|11619456|FG001|NOT COMPLETED|Maintenance Treatment||27
10471206|NCT01081912|11619457|FG002|NOT COMPLETED|Maintenance Treatment||92
10471207|NCT01082081|11619467|FG000|STARTED|Overall Study||121
10471208|NCT01082081|11619468|FG001|STARTED|Overall Study||119
10471209|NCT01082081|11619469|FG002|STARTED|Overall Study||60
10471210|NCT01082081|11619467|FG000|COMPLETED|Overall Study||121
10471211|NCT01082081|11619468|FG001|COMPLETED|Overall Study||118
10471212|NCT01082081|11619469|FG002|COMPLETED|Overall Study||58
10471213|NCT01082081|11619467|FG000|NOT COMPLETED|Overall Study||0
10471214|NCT01082081|11619468|FG001|NOT COMPLETED|Overall Study||1
10471215|NCT01082081|11619469|FG002|NOT COMPLETED|Overall Study||2
10471216|NCT01082159|11619477|FG000|STARTED|Overall Study||55
10471217|NCT01082159|11619477|FG000|COMPLETED|Overall Study||46
10471218|NCT01082159|11619477|FG000|NOT COMPLETED|Overall Study||9
10471219|NCT01082328|11619482|FG000|STARTED|Overall Study||59
10708843|NCT02634684|11873761|FG000|COMPLETED|Overall Study||19
10708844|NCT02634684|11873762|FG001|COMPLETED|Overall Study||19
10708845|NCT02634684|11873763|FG002|COMPLETED|Overall Study||21
10471220|NCT01082328|11619482|FG000|COMPLETED|Overall Study||58
10471221|NCT01082328|11619482|FG000|NOT COMPLETED|Overall Study||1
10471222|NCT01082367|11619488|FG000|STARTED|Double-blind Period||26
10471223|NCT01082367|11619489|FG001|STARTED|Double-blind Period||25
10471224|NCT01082367|11619488|FG000|Stage 1:1st Treatment (tx) Cycle|Double-blind Period||26
10471225|NCT01082367|11619489|FG001|Stage 1:1st Treatment (tx) Cycle|Double-blind Period|1 participant discontinued after cycle 1 due to an SAE|25
10471226|NCT01082367|11619488|FG000|Stage 2:no tx|Double-blind Period||0
10471227|NCT01082367|11619489|FG001|Stage 2:no tx|Double-blind Period||0
10471228|NCT01082367|11619488|FG000|Entered OL TOBI|Double-blind Period||4
10471229|NCT01082367|11619489|FG001|Entered OL TOBI|Double-blind Period||18
10471230|NCT01082367|11619488|FG000|P.A-free,Day 29 w/ no Cross-over|Double-blind Period||9
10471231|NCT01082367|11619489|FG001|P.A-free,Day 29 w/ no Cross-over|Double-blind Period||0
10471232|NCT01082367|11619488|FG000|Stage 3: Cross-over (co) tx|Double-blind Period||13
10471233|NCT01082367|11619489|FG001|Stage 3: Cross-over (co) tx|Double-blind Period||6
10471234|NCT01082367|11619488|FG000|Stage 4:no tx for Patients Not in co|Double-blind Period||0
10471235|NCT01082367|11619489|FG001|Stage 4:no tx for Patients Not in co|Double-blind Period||0
10471236|NCT01082367|11619488|FG000|COMPLETED|Double-blind Period||21
10471237|NCT01082367|11619489|FG001|COMPLETED|Double-blind Period||12
10471238|NCT01082367|11619488|FG000|NOT COMPLETED|Double-blind Period||5
10471239|NCT01082367|11619489|FG001|NOT COMPLETED|Double-blind Period||13
10471240|NCT01082367|11619488|FG000|STARTED|Follow-up (F-U) Period||19
10471241|NCT01082367|11619489|FG001|STARTED|Follow-up (F-U) Period||10
10471242|NCT01082367|11619488|FG000|Treated in F-U|Follow-up (F-U) Period||5
10471243|NCT01082367|11619489|FG001|Treated in F-U|Follow-up (F-U) Period||5
10471244|NCT01082367|11619488|FG000|COMPLETED|Follow-up (F-U) Period||17
10471245|NCT01082367|11619489|FG001|COMPLETED|Follow-up (F-U) Period||9
10471246|NCT01082367|11619488|FG000|NOT COMPLETED|Follow-up (F-U) Period||2
10471247|NCT01082367|11619489|FG001|NOT COMPLETED|Follow-up (F-U) Period||1
10471248|NCT01082380|11619499|FG000|STARTED|Overall Study||6
10471249|NCT01082380|11619499|FG000|COMPLETED|Overall Study||6
10471250|NCT01082380|11619499|FG000|NOT COMPLETED|Overall Study||0
10471251|NCT01082575|11619503|FG000|STARTED|Overall Study||100
10471252|NCT01082575|11619503|FG000|COMPLETED|Overall Study||100
10708846|NCT02634684|11873764|FG003|COMPLETED|Overall Study||23
10708847|NCT02634684|11873761|FG000|NOT COMPLETED|Overall Study||0
10471253|NCT01082575|11619503|FG000|NOT COMPLETED|Overall Study||0
10471254|NCT01082588|11619509|FG000|STARTED|Overall Study||30
10471255|NCT01082588|11619510|FG001|STARTED|Overall Study||30
10471256|NCT01082588|11619509|FG000|COMPLETED|Overall Study||24
10471257|NCT01082588|11619510|FG001|COMPLETED|Overall Study||25
10471258|NCT01082588|11619509|FG000|NOT COMPLETED|Overall Study||6
10471259|NCT01082588|11619510|FG001|NOT COMPLETED|Overall Study||5
10471260|NCT01082614|11619518|FG000|STARTED|Overall Study||23
10471261|NCT01082614|11619519|FG001|STARTED|Overall Study||23
10471262|NCT01082614|11619518|FG000|COMPLETED|Overall Study||20
10471263|NCT01082614|11619519|FG001|COMPLETED|Overall Study||18
10471264|NCT01082614|11619518|FG000|NOT COMPLETED|Overall Study||3
10471265|NCT01082614|11619519|FG001|NOT COMPLETED|Overall Study||5
10471266|NCT01082640|11619528|FG000|STARTED|Overall Study||32
10471267|NCT01082640|11619529|FG001|STARTED|Overall Study||32
10471268|NCT01082640|11619530|FG002|STARTED|Overall Study||32
10471269|NCT01082640|11619528|FG000|COMPLETED|Overall Study||15
10471270|NCT01082640|11619529|FG001|COMPLETED|Overall Study||17
10471271|NCT01082640|11619530|FG002|COMPLETED|Overall Study||24
10471272|NCT01082640|11619528|FG000|NOT COMPLETED|Overall Study||17
10471273|NCT01082640|11619529|FG001|NOT COMPLETED|Overall Study||15
10471274|NCT01082640|11619530|FG002|NOT COMPLETED|Overall Study||8
10471275|NCT01082874|11619545|FG000|STARTED|Overall Study||2499
10471276|NCT01082874|11619546|FG001|STARTED|Overall Study||2510
10471277|NCT01082874|11619547|FG002|STARTED|Overall Study||2499
10471278|NCT01082874|11619548|FG003|STARTED|Overall Study||2502
10471279|NCT01082874|11619545|FG000|COMPLETED|Overall Study||2488
10471280|NCT01082874|11619546|FG001|COMPLETED|Overall Study||2498
10471281|NCT01082874|11619547|FG002|COMPLETED|Overall Study||2488
10471282|NCT01082874|11619548|FG003|COMPLETED|Overall Study||2489
10471283|NCT01082874|11619545|FG000|NOT COMPLETED|Overall Study||11
10471284|NCT01082874|11619546|FG001|NOT COMPLETED|Overall Study||12
10471285|NCT01082874|11619547|FG002|NOT COMPLETED|Overall Study||11
10471286|NCT01082874|11619548|FG003|NOT COMPLETED|Overall Study||13
10471287|NCT01082939|11619558|FG000|STARTED|Overall Study||80
10471288|NCT01082939|11619558|FG000|COMPLETED|Overall Study||80
10471289|NCT01082939|11619558|FG000|NOT COMPLETED|Overall Study||0
10471290|NCT01082952|11619564|FG000|STARTED|Overall Study||6
10471291|NCT01082952|11619565|FG001|STARTED|Overall Study||6
10471292|NCT01082952|11619564|FG000|COMPLETED|Overall Study||6
10471293|NCT01082952|11619565|FG001|COMPLETED|Overall Study||6
10471294|NCT01082952|11619564|FG000|NOT COMPLETED|Overall Study||0
10708848|NCT02634684|11873762|FG001|NOT COMPLETED|Overall Study||0
10708849|NCT02634684|11873763|FG002|NOT COMPLETED|Overall Study||0
10471295|NCT01082952|11619565|FG001|NOT COMPLETED|Overall Study||0
10471296|NCT01082965|11619573|FG000|STARTED|Overall Study||10
10471297|NCT01082965|11619574|FG001|STARTED|Overall Study||8
10471298|NCT01082965|11619573|FG000|COMPLETED|Overall Study||9
10471299|NCT01082965|11619574|FG001|COMPLETED|Overall Study||6
10471300|NCT01082965|11619573|FG000|NOT COMPLETED|Overall Study||1
10471301|NCT01082965|11619574|FG001|NOT COMPLETED|Overall Study||2
10471302|NCT01083121|11619580|FG000|STARTED|Overall Study|Participants who were enrolled in the study|1779
10529059|NCT01398475|11681469|FG001|Received First Intervention|Overall Study||3
10471303|NCT01083121|11619580|FG000|COMPLETED|Overall Study|Participants included in the analysis|1698
10471304|NCT01083121|11619580|FG000|NOT COMPLETED|Overall Study||81
10471305|NCT01083160|11619588|FG000|STARTED|Overall Study||82
10471306|NCT01083160|11619588|FG000|Evaluable Population|Overall Study||71
10471307|NCT01083160|11619588|FG000|COMPLETED|Overall Study||81
10471308|NCT01083160|11619588|FG000|NOT COMPLETED|Overall Study||1
10471309|NCT01083173|11619592|FG000|STARTED|Main Surveillance: Safety Group||595
10471310|NCT01083173|11619593|FG001|STARTED|Main Surveillance: Safety Group||0
10471311|NCT01083173|11619592|FG000|COMPLETED|Main Surveillance: Safety Group||580
10471312|NCT01083173|11619593|FG001|COMPLETED|Main Surveillance: Safety Group||0
10471313|NCT01083173|11619592|FG000|NOT COMPLETED|Main Surveillance: Safety Group||15
10471314|NCT01083173|11619593|FG001|NOT COMPLETED|Main Surveillance: Safety Group||0
10471315|NCT01083173|11619592|FG000|STARTED|Main Surveillance: Effectiveness Group||580
10471316|NCT01083173|11619593|FG001|STARTED|Main Surveillance: Effectiveness Group||0
10471317|NCT01083173|11619592|FG000|COMPLETED|Main Surveillance: Effectiveness Group||198
10471318|NCT01083173|11619593|FG001|COMPLETED|Main Surveillance: Effectiveness Group||0
10471319|NCT01083173|11619592|FG000|NOT COMPLETED|Main Surveillance: Effectiveness Group||382
10471320|NCT01083173|11619593|FG001|NOT COMPLETED|Main Surveillance: Effectiveness Group||0
10471321|NCT01083173|11619592|FG000|STARTED|Long-term Surveillance: Safety Group||0
10471322|NCT01083173|11619593|FG001|STARTED|Long-term Surveillance: Safety Group||595
10471323|NCT01083173|11619592|FG000|COMPLETED|Long-term Surveillance: Safety Group||0
10471324|NCT01083173|11619593|FG001|COMPLETED|Long-term Surveillance: Safety Group||479
10471325|NCT01083173|11619592|FG000|NOT COMPLETED|Long-term Surveillance: Safety Group||0
10471326|NCT01083173|11619593|FG001|NOT COMPLETED|Long-term Surveillance: Safety Group||116
10471327|NCT01083173|11619592|FG000|STARTED|Long-term Surveillance: Effectiveness Gr||0
10471328|NCT01083173|11619593|FG001|STARTED|Long-term Surveillance: Effectiveness Gr||479
10471329|NCT01083173|11619592|FG000|COMPLETED|Long-term Surveillance: Effectiveness Gr||0
10471330|NCT01083173|11619593|FG001|COMPLETED|Long-term Surveillance: Effectiveness Gr||102
10471331|NCT01083173|11619592|FG000|NOT COMPLETED|Long-term Surveillance: Effectiveness Gr||0
10471332|NCT01083173|11619593|FG001|NOT COMPLETED|Long-term Surveillance: Effectiveness Gr||377
10471333|NCT01083186|11619602|FG000|STARTED|Overall Study||500
10471334|NCT01083186|11619602|FG000|COMPLETED|Overall Study||406
10471335|NCT01083186|11619602|FG000|NOT COMPLETED|Overall Study||94
10471336|NCT01083199|11619626|FG000|STARTED|Overall Study||10
10471337|NCT01083199|11619626|FG000|COMPLETED|Overall Study||10
10471338|NCT01083199|11619626|FG000|NOT COMPLETED|Overall Study||0
10338159|NCT00368550|11475052|FG000|COMPLETED|Overall Study||35
10338160|NCT00368550|11475053|FG001|COMPLETED|Overall Study||48
10338161|NCT00368550|11475052|FG000|NOT COMPLETED|Overall Study||28
10471339|NCT01083316|11619631|FG000|STARTED|Overall Study||35
10471340|NCT01083316|11619631|FG000|COMPLETED|Overall Study||32
10471341|NCT01083316|11619631|FG000|NOT COMPLETED|Overall Study||3
10471342|NCT01083368|11619638|FG000|STARTED|Dose Escalation Weeks 1-4||0
10471343|NCT01083368|11619639|FG001|STARTED|Dose Escalation Weeks 1-4||0
10471344|NCT01083368|11619640|FG002|STARTED|Dose Escalation Weeks 1-4||4
10471345|NCT01083368|11619641|FG003|STARTED|Dose Escalation Weeks 1-4||0
10471346|NCT01083368|11619638|FG000|Disease Progression|Dose Escalation Weeks 1-4||0
10471347|NCT01083368|11619639|FG001|Disease Progression|Dose Escalation Weeks 1-4||0
10471348|NCT01083368|11619640|FG002|Disease Progression|Dose Escalation Weeks 1-4||1
10471349|NCT01083368|11619641|FG003|Disease Progression|Dose Escalation Weeks 1-4||0
10471350|NCT01083368|11619638|FG000|COMPLETED|Dose Escalation Weeks 1-4||0
10471351|NCT01083368|11619639|FG001|COMPLETED|Dose Escalation Weeks 1-4||0
10471352|NCT01083368|11619640|FG002|COMPLETED|Dose Escalation Weeks 1-4||4
10471353|NCT01083368|11619641|FG003|COMPLETED|Dose Escalation Weeks 1-4||0
10471354|NCT01083368|11619638|FG000|NOT COMPLETED|Dose Escalation Weeks 1-4||0
10471355|NCT01083368|11619639|FG001|NOT COMPLETED|Dose Escalation Weeks 1-4||0
10471356|NCT01083368|11619640|FG002|NOT COMPLETED|Dose Escalation Weeks 1-4||0
10471357|NCT01083368|11619641|FG003|NOT COMPLETED|Dose Escalation Weeks 1-4||0
10471358|NCT01083368|11619638|FG000|STARTED|Dose Escalation Weeks 5-9||0
10471359|NCT01083368|11619639|FG001|STARTED|Dose Escalation Weeks 5-9||0
10471360|NCT01083368|11619640|FG002|STARTED|Dose Escalation Weeks 5-9|Participant on DL1 did not move to dose level 2 because of disease progression.|1
10471361|NCT01083368|11619641|FG003|STARTED|Dose Escalation Weeks 5-9||6
10471362|NCT01083368|11619638|FG000|COMPLETED|Dose Escalation Weeks 5-9||0
10471363|NCT01083368|11619639|FG001|COMPLETED|Dose Escalation Weeks 5-9||0
10471364|NCT01083368|11619640|FG002|COMPLETED|Dose Escalation Weeks 5-9||1
10471365|NCT01083368|11619641|FG003|COMPLETED|Dose Escalation Weeks 5-9|3 participants on dose level 1 moved to dose level 2, 3 more new participants joined.|6
10471366|NCT01083368|11619638|FG000|NOT COMPLETED|Dose Escalation Weeks 5-9||0
10471367|NCT01083368|11619639|FG001|NOT COMPLETED|Dose Escalation Weeks 5-9||0
10471368|NCT01083368|11619640|FG002|NOT COMPLETED|Dose Escalation Weeks 5-9||0
10471369|NCT01083368|11619641|FG003|NOT COMPLETED|Dose Escalation Weeks 5-9||0
10471370|NCT01083368|11619638|FG000|STARTED|Phase II - Efficacy/Safety||0
10471371|NCT01083368|11619639|FG001|STARTED|Phase II - Efficacy/Safety||0
10471372|NCT01083368|11619640|FG002|STARTED|Phase II - Efficacy/Safety||0
10471373|NCT01083368|11619641|FG003|STARTED|Phase II - Efficacy/Safety||20
10471374|NCT01083368|11619638|FG000|COMPLETED|Phase II - Efficacy/Safety||0
10471375|NCT01083368|11619639|FG001|COMPLETED|Phase II - Efficacy/Safety||0
10471376|NCT01083368|11619640|FG002|COMPLETED|Phase II - Efficacy/Safety||0
10471377|NCT01083368|11619641|FG003|COMPLETED|Phase II - Efficacy/Safety|14 plus 6 participants from previous period|20
10338162|NCT00368550|11475053|FG001|NOT COMPLETED|Overall Study||23
10471378|NCT01083368|11619638|FG000|NOT COMPLETED|Phase II - Efficacy/Safety||0
10471379|NCT01083368|11619639|FG001|NOT COMPLETED|Phase II - Efficacy/Safety||0
10471380|NCT01083368|11619640|FG002|NOT COMPLETED|Phase II - Efficacy/Safety||0
10471381|NCT01083368|11619641|FG003|NOT COMPLETED|Phase II - Efficacy/Safety||0
10471382|NCT01083485|11619651|FG000|STARTED|Overall Study||70
10471383|NCT01083485|11619652|FG001|STARTED|Overall Study||67
10471384|NCT01083485|11619651|FG000|COMPLETED|Overall Study||63
10471385|NCT01083485|11619652|FG001|COMPLETED|Overall Study||64
10471386|NCT01083485|11619651|FG000|NOT COMPLETED|Overall Study||7
10471387|NCT01083485|11619652|FG001|NOT COMPLETED|Overall Study||3
10471388|NCT01083576|11619662|FG000|STARTED|Overall Study||15
10471389|NCT01083576|11619663|FG001|STARTED|Overall Study||15
10471390|NCT01083576|11619662|FG000|COMPLETED|Overall Study||9
10471391|NCT01083576|11619663|FG001|COMPLETED|Overall Study||14
10471392|NCT01083576|11619662|FG000|NOT COMPLETED|Overall Study||6
10471393|NCT01083576|11619663|FG001|NOT COMPLETED|Overall Study||1
10471394|NCT01083602|11619670|FG000|STARTED|Overall Study||55
10471395|NCT01083602|11619670|FG000|COMPLETED|Overall Study||0
10471396|NCT01083602|11619670|FG000|NOT COMPLETED|Overall Study||55
10471397|NCT01083628|11619676|FG000|STARTED|Overall Study||45
10471398|NCT01083628|11619677|FG001|STARTED|Overall Study||40
10471399|NCT01083628|11619676|FG000|COMPLETED|Overall Study||45
10471400|NCT01083628|11619677|FG001|COMPLETED|Overall Study||40
10471401|NCT01083628|11619676|FG000|NOT COMPLETED|Overall Study||0
10471402|NCT01083628|11619677|FG001|NOT COMPLETED|Overall Study||0
10471403|NCT01083641|11619683|FG000|STARTED|Overall Study||17
10471404|NCT01083641|11619683|FG000|COMPLETED|Overall Study||15
10471405|NCT01083641|11619683|FG000|NOT COMPLETED|Overall Study||2
10471406|NCT01083654|11619689|FG000|STARTED|Overall Study||53
10708850|NCT02634684|11873764|FG003|NOT COMPLETED|Overall Study||0
10708851|NCT02634788|11873778|FG000|STARTED|Overall Study||79
10708852|NCT02634788|11873779|FG001|STARTED|Overall Study||81
10708853|NCT02634788|11873780|FG002|STARTED|Overall Study||80
10708854|NCT02634788|11873781|FG003|STARTED|Overall Study||82
10471407|NCT01083654|11619690|FG001|STARTED|Overall Study||50
10471408|NCT01083654|11619689|FG000|COMPLETED|Overall Study||53
10471409|NCT01083654|11619690|FG001|COMPLETED|Overall Study||50
10471410|NCT01083654|11619689|FG000|NOT COMPLETED|Overall Study||0
10471411|NCT01083654|11619690|FG001|NOT COMPLETED|Overall Study||0
10471412|NCT01083667|11619696|FG000|STARTED|Overall Study|enrolled|32
10471413|NCT01083667|11619696|FG000|COMPLETED|Overall Study|22 completed to visit 9, the last visit on study.|22
10471414|NCT01083667|11619696|FG000|NOT COMPLETED|Overall Study||10
10471415|NCT01083680|11619700|FG000|STARTED|Overall Study||4107
10471416|NCT01083680|11619700|FG000|Full Analysis Set (FAS), Efficacy|Overall Study||1621
10471417|NCT01083680|11619700|FG000|COMPLETED|Overall Study||263
10471418|NCT01083680|11619700|FG000|NOT COMPLETED|Overall Study||3844
10471419|NCT01083693|11619707|FG000|STARTED|Overall Study||93
10471420|NCT01083693|11619708|FG001|STARTED|Overall Study||28
10471421|NCT01083693|11619709|FG002|STARTED|Overall Study||40
10471422|NCT01083693|11619707|FG000|COMPLETED|Overall Study||73
10471423|NCT01083693|11619708|FG001|COMPLETED|Overall Study||22
10471424|NCT01083693|11619709|FG002|COMPLETED|Overall Study||33
10471425|NCT01083693|11619707|FG000|NOT COMPLETED|Overall Study||20
10471426|NCT01083693|11619708|FG001|NOT COMPLETED|Overall Study||6
10471427|NCT01083693|11619709|FG002|NOT COMPLETED|Overall Study||7
10471428|NCT01083706|11619721|FG000|STARTED|Overall Study||39
10471429|NCT01083706|11619721|FG000|COMPLETED|Overall Study||39
10471430|NCT01083706|11619721|FG000|NOT COMPLETED|Overall Study||0
10471431|NCT01083732|11619728|FG000|STARTED|Overall Study||6
10471432|NCT01083732|11619729|FG001|STARTED|Overall Study||9
10471433|NCT01083732|11619730|FG002|STARTED|Overall Study||3
10471434|NCT01083732|11619728|FG000|COMPLETED|Overall Study||6
10471435|NCT01083732|11619729|FG001|COMPLETED|Overall Study||9
10471436|NCT01083732|11619730|FG002|COMPLETED|Overall Study||3
10471437|NCT01083732|11619728|FG000|NOT COMPLETED|Overall Study||0
10471438|NCT01083732|11619729|FG001|NOT COMPLETED|Overall Study||0
10471439|NCT01083732|11619730|FG002|NOT COMPLETED|Overall Study||0
10471440|NCT01083758|11619741|FG000|STARTED|Overall Study||31
10471441|NCT01083758|11619741|FG000|COMPLETED|Overall Study||29
10471442|NCT01083758|11619741|FG000|NOT COMPLETED|Overall Study||2
10471443|NCT01083810|11619748|FG000|STARTED|Overall Study||137
10471444|NCT01083810|11619749|FG001|STARTED|Overall Study||92
10471445|NCT01083810|11619750|FG002|STARTED|Overall Study||55
10471446|NCT01083810|11619748|FG000|COMPLETED|Overall Study||72
10471447|NCT01083810|11619749|FG001|COMPLETED|Overall Study||47
10471448|NCT01083810|11619750|FG002|COMPLETED|Overall Study||35
10471449|NCT01083810|11619748|FG000|NOT COMPLETED|Overall Study||65
10471450|NCT01083810|11619749|FG001|NOT COMPLETED|Overall Study||45
10471451|NCT01083810|11619750|FG002|NOT COMPLETED|Overall Study||20
10471452|NCT01083849|11619758|FG000|STARTED|Overall Study||121
10471453|NCT01083849|11619759|FG001|STARTED|Overall Study||638
10471454|NCT01083849|11619758|FG000|COMPLETED|Overall Study||61
10471455|NCT01083849|11619759|FG001|COMPLETED|Overall Study||527
10471456|NCT01083849|11619758|FG000|NOT COMPLETED|Overall Study||60
10471457|NCT01083849|11619759|FG001|NOT COMPLETED|Overall Study||111
10471458|NCT01083901|11619771|FG000|STARTED|Overall Study||13
10471459|NCT01083901|11619772|FG001|STARTED|Overall Study||8
10471460|NCT01083901|11619773|FG002|STARTED|Overall Study||13
10471461|NCT01083901|11619771|FG000|COMPLETED|Overall Study||12
10471462|NCT01083901|11619772|FG001|COMPLETED|Overall Study||6
10471463|NCT01083901|11619773|FG002|COMPLETED|Overall Study||11
10471464|NCT01083901|11619771|FG000|NOT COMPLETED|Overall Study||1
10471465|NCT01083901|11619772|FG001|NOT COMPLETED|Overall Study||2
10471466|NCT01083901|11619773|FG002|NOT COMPLETED|Overall Study||2
10471467|NCT01083979|11619781|FG000|STARTED|Overall Study||1
10471468|NCT01083979|11619781|FG000|COMPLETED|Overall Study||1
10471469|NCT01083979|11619781|FG000|NOT COMPLETED|Overall Study||0
10471470|NCT01084005|11619787|FG000|STARTED|Overall Study||79
10471471|NCT01084005|11619788|FG001|STARTED|Overall Study||162
10471472|NCT01084005|11619787|FG000|COMPLETED|Overall Study||74
10471473|NCT01084005|11619788|FG001|COMPLETED|Overall Study||146
10471474|NCT01084005|11619787|FG000|NOT COMPLETED|Overall Study||5
10471475|NCT01084005|11619788|FG001|NOT COMPLETED|Overall Study||16
10471476|NCT01084083|11619794|FG000|STARTED|Overall Study||90
10471477|NCT01084083|11619794|FG000|Treated|Overall Study|This is the all treated patients for toxicity analysis|89
10471478|NCT01084083|11619794|FG000|Eligible|Overall Study||81
10471479|NCT01084083|11619794|FG000|Eligible and Treated|Overall Study|This is the eligible and treated patients for secondary efficacy endpoints|80
10471480|NCT01084083|11619794|FG000|CR to Induction Therapy|Overall Study||56
10471481|NCT01084083|11619794|FG000|CR and Treated With 5400 cGy IMRT|Overall Study|This is the primary study population for the primary endpoint (24-month PFS).|44
10471482|NCT01084083|11619794|FG000|COMPLETED|Overall Study||78
10471483|NCT01084083|11619794|FG000|NOT COMPLETED|Overall Study||12
10471484|NCT01084135|11619803|FG000|STARTED|12 Week||4
10471485|NCT01084135|11619804|FG001|STARTED|12 Week||4
10471486|NCT01084135|11619803|FG000|COMPLETED|12 Week||4
10471487|NCT01084135|11619804|FG001|COMPLETED|12 Week||4
10471488|NCT01084135|11619803|FG000|NOT COMPLETED|12 Week||0
10471489|NCT01084135|11619804|FG001|NOT COMPLETED|12 Week||0
10471490|NCT01084135|11619803|FG000|STARTED|20 Week||12
10471491|NCT01084135|11619804|FG001|STARTED|20 Week||11
10471492|NCT01084135|11619803|FG000|COMPLETED|20 Week||12
10471493|NCT01084135|11619804|FG001|COMPLETED|20 Week||10
10471494|NCT01084135|11619803|FG000|NOT COMPLETED|20 Week||0
10471495|NCT01084135|11619804|FG001|NOT COMPLETED|20 Week||1
10471496|NCT01084148|11619814|FG000|STARTED|Overall Study||118
10471497|NCT01084148|11619815|FG001|STARTED|Overall Study|Among those 118 patients randomized into V0034 CR 01B vehicle arm, one patient not treated.|118
10471498|NCT01084148|11619814|FG000|Treated Patients|Overall Study||118
10471499|NCT01084148|11619815|FG001|Treated Patients|Overall Study|Patients who received test product at least once|117
10471500|NCT01084148|11619814|FG000|COMPLETED|Overall Study||88
10471501|NCT01084148|11619815|FG001|COMPLETED|Overall Study||102
10471502|NCT01084148|11619814|FG000|NOT COMPLETED|Overall Study||30
10471503|NCT01084148|11619815|FG001|NOT COMPLETED|Overall Study||16
10471504|NCT01084174|11619825|FG000|STARTED|Overall Study||10
10471505|NCT01084174|11619826|FG001|STARTED|Overall Study||11
10471506|NCT01084174|11619825|FG000|COMPLETED|Overall Study||9
10471507|NCT01084174|11619826|FG001|COMPLETED|Overall Study||7
10471508|NCT01084174|11619825|FG000|NOT COMPLETED|Overall Study||1
10471509|NCT01084174|11619826|FG001|NOT COMPLETED|Overall Study||4
10471510|NCT01084239|11619834|FG000|STARTED|Randomization - Index Hospitalization||501
10471511|NCT01084239|11619835|FG001|STARTED|Randomization - Index Hospitalization||499
10471512|NCT01084239|11619834|FG000|COMPLETED|Randomization - Index Hospitalization||501
10471513|NCT01084239|11619835|FG001|COMPLETED|Randomization - Index Hospitalization||499
10471514|NCT01084239|11619834|FG000|NOT COMPLETED|Randomization - Index Hospitalization||0
10471515|NCT01084239|11619835|FG001|NOT COMPLETED|Randomization - Index Hospitalization||0
10471516|NCT01084239|11619834|FG000|STARTED|28-Day Follow-up|All 501 patients enrolled were evaluated for follow-up at 28 days.|501
10471517|NCT01084239|11619835|FG001|STARTED|28-Day Follow-up||499
10471518|NCT01084239|11619834|FG000|COMPLETED|28-Day Follow-up||497
10471519|NCT01084239|11619835|FG001|COMPLETED|28-Day Follow-up||490
10471520|NCT01084239|11619834|FG000|NOT COMPLETED|28-Day Follow-up||4
10471521|NCT01084239|11619835|FG001|NOT COMPLETED|28-Day Follow-up||9
10471522|NCT01084265|11619843|FG000|STARTED|Overall Study||31
10471523|NCT01084265|11619843|FG000|COMPLETED|Overall Study||31
10471524|NCT01084265|11619843|FG000|NOT COMPLETED|Overall Study||0
10471525|NCT01084278|11619852|FG000|STARTED|Overall Study||8
10471526|NCT01084278|11619853|FG001|STARTED|Overall Study||8
10471527|NCT01084278|11619854|FG002|STARTED|Overall Study||8
10471528|NCT01084278|11619855|FG003|STARTED|Overall Study||8
10471529|NCT01084278|11619856|FG004|STARTED|Overall Study||8
10471530|NCT01084278|11619852|FG000|COMPLETED|Overall Study||8
10471531|NCT01084278|11619853|FG001|COMPLETED|Overall Study||8
10471532|NCT01084278|11619854|FG002|COMPLETED|Overall Study||8
10471533|NCT01084278|11619855|FG003|COMPLETED|Overall Study||8
10471534|NCT01084278|11619856|FG004|COMPLETED|Overall Study||8
10471535|NCT01084278|11619852|FG000|NOT COMPLETED|Overall Study||0
10471536|NCT01084278|11619853|FG001|NOT COMPLETED|Overall Study||0
10471537|NCT01084278|11619854|FG002|NOT COMPLETED|Overall Study||0
10471538|NCT01084278|11619855|FG003|NOT COMPLETED|Overall Study||0
10471539|NCT01084278|11619856|FG004|NOT COMPLETED|Overall Study||0
10471540|NCT01084499|11619872|FG000|STARTED|Overall Study|First Intervention (Sequence 1) : Femara (1 Day)|13
10471541|NCT01084499|11619873|FG001|STARTED|Overall Study|First Intervention (Sequence 2) : Peratra (1 Day)|13
10471542|NCT01084499|11619872|FG000|Washout (5 Weeks)|Overall Study||13
10471543|NCT01084499|11619873|FG001|Washout (5 Weeks)|Overall Study||13
10471544|NCT01084499|11619872|FG000|COMPLETED|Overall Study|Second Intervention (Sequence 1) : Peratra (1 Day)|13
10471545|NCT01084499|11619873|FG001|COMPLETED|Overall Study|Second Intervention (Sequence 2) : Femara (1 Day)|13
10471546|NCT01084499|11619872|FG000|NOT COMPLETED|Overall Study||0
10471547|NCT01084499|11619873|FG001|NOT COMPLETED|Overall Study||0
10471548|NCT01084538|11619879|FG000|STARTED|Overall Study||181
10471549|NCT01084538|11619879|FG000|COMPLETED|Overall Study||113
10471550|NCT01084538|11619879|FG000|NOT COMPLETED|Overall Study||68
10471551|NCT01084551|11619886|FG000|STARTED|Overall Study||95
10471552|NCT01084551|11619887|FG001|STARTED|Overall Study||95
10471553|NCT01084551|11619888|FG002|STARTED|Overall Study||94
10471554|NCT01084551|11619886|FG000|COMPLETED|Overall Study||86
10471555|NCT01084551|11619887|FG001|COMPLETED|Overall Study||81
10471556|NCT01084551|11619888|FG002|COMPLETED|Overall Study||86
10471557|NCT01084551|11619886|FG000|NOT COMPLETED|Overall Study||9
10471558|NCT01084551|11619887|FG001|NOT COMPLETED|Overall Study||14
10471559|NCT01084551|11619888|FG002|NOT COMPLETED|Overall Study||8
10471560|NCT01084603|11619896|FG000|STARTED|Baseline||45
10471561|NCT01084603|11619896|FG000|COMPLETED|Baseline||43
10471562|NCT01084603|11619896|FG000|NOT COMPLETED|Baseline||2
10471563|NCT01084603|11619896|FG000|STARTED|NiQuitinTM Lozenge||43
10471564|NCT01084603|11619896|FG000|COMPLETED|NiQuitinTM Lozenge||42
10471565|NCT01084603|11619896|FG000|NOT COMPLETED|NiQuitinTM Lozenge||1
10471566|NCT01084603|11619896|FG000|STARTED|Washout Period 1||42
10471567|NCT01084603|11619896|FG000|COMPLETED|Washout Period 1||42
10471568|NCT01084603|11619896|FG000|NOT COMPLETED|Washout Period 1||0
10471569|NCT01084603|11619896|FG000|STARTED|Nicorette® Gum||42
10471570|NCT01084603|11619896|FG000|COMPLETED|Nicorette® Gum||41
10471571|NCT01084603|11619896|FG000|NOT COMPLETED|Nicorette® Gum||1
10471572|NCT01084603|11619896|FG000|STARTED|Washout Period 2||41
10471573|NCT01084603|11619896|FG000|COMPLETED|Washout Period 2||41
10471574|NCT01084603|11619896|FG000|NOT COMPLETED|Washout Period 2||0
10471575|NCT01084603|11619896|FG000|STARTED|Oral Nicotine 1||41
10471576|NCT01084603|11619896|FG000|COMPLETED|Oral Nicotine 1||40
10471577|NCT01084603|11619896|FG000|NOT COMPLETED|Oral Nicotine 1||1
10471578|NCT01084603|11619896|FG000|STARTED|Washout Period 3||40
10471579|NCT01084603|11619896|FG000|COMPLETED|Washout Period 3||40
10471580|NCT01084603|11619896|FG000|NOT COMPLETED|Washout Period 3||0
10471581|NCT01084603|11619896|FG000|STARTED|Oral Nicotine 2||40
10471582|NCT01084603|11619896|FG000|COMPLETED|Oral Nicotine 2||40
10471583|NCT01084603|11619896|FG000|NOT COMPLETED|Oral Nicotine 2||0
10471584|NCT01084603|11619896|FG000|STARTED|Washout Period 4||40
10471585|NCT01084603|11619896|FG000|COMPLETED|Washout Period 4||39
10471586|NCT01084603|11619896|FG000|NOT COMPLETED|Washout Period 4||1
10471587|NCT01084603|11619896|FG000|STARTED|Oral Nicotine 4||39
10471588|NCT01084603|11619896|FG000|COMPLETED|Oral Nicotine 4||39
10471589|NCT01084603|11619896|FG000|NOT COMPLETED|Oral Nicotine 4||0
10471590|NCT01084655|11619912|FG000|STARTED|Overall Study||6
10471591|NCT01084655|11619913|FG001|STARTED|Overall Study||8
10471592|NCT01084655|11619914|FG002|STARTED|Overall Study||24
10471593|NCT01084655|11619912|FG000|Treated|Overall Study||6
10471594|NCT01084655|11619913|FG001|Treated|Overall Study||8
10471595|NCT01084655|11619914|FG002|Treated|Overall Study||23
10471596|NCT01084655|11619912|FG000|COMPLETED|Overall Study||0
10471597|NCT01084655|11619913|FG001|COMPLETED|Overall Study||2
10471598|NCT01084655|11619914|FG002|COMPLETED|Overall Study||5
10471599|NCT01084655|11619912|FG000|NOT COMPLETED|Overall Study||6
10471600|NCT01084655|11619913|FG001|NOT COMPLETED|Overall Study||6
10708855|NCT02634788|11873778|FG000|COMPLETED|Overall Study||75
10708856|NCT02634788|11873779|FG001|COMPLETED|Overall Study||71
10708857|NCT02634788|11873780|FG002|COMPLETED|Overall Study||75
10471601|NCT01084655|11619914|FG002|NOT COMPLETED|Overall Study||19
10471602|NCT01084668|11619926|FG000|STARTED|Overall Study|Three participants who took Humira prior to study entry have been excluded from the database.|42
10471603|NCT01084668|11619926|FG000|COMPLETED|Overall Study||33
10471604|NCT01084668|11619926|FG000|NOT COMPLETED|Overall Study||9
10471605|NCT01084694|11619934|FG000|STARTED|Overall Study||50
10471606|NCT01084694|11619935|FG001|STARTED|Overall Study||50
10708858|NCT02634788|11873781|FG003|COMPLETED|Overall Study||77
10708859|NCT02634788|11873778|FG000|NOT COMPLETED|Overall Study||4
10708860|NCT02634788|11873779|FG001|NOT COMPLETED|Overall Study||10
10708861|NCT02634788|11873780|FG002|NOT COMPLETED|Overall Study||5
10708862|NCT02634788|11873781|FG003|NOT COMPLETED|Overall Study||5
10708863|NCT02634801|11873794|FG000|STARTED|Treatment Period (Weeks 0 to 24)||54
10708864|NCT02634801|11873795|FG001|STARTED|Treatment Period (Weeks 0 to 24)||54
10708865|NCT02634801|11873796|FG002|STARTED|Treatment Period (Weeks 0 to 24)||54
10471607|NCT01084694|11619934|FG000|COMPLETED|Overall Study||44
10471608|NCT01084694|11619935|FG001|COMPLETED|Overall Study||30
10471609|NCT01084694|11619934|FG000|NOT COMPLETED|Overall Study||6
10471610|NCT01084694|11619935|FG001|NOT COMPLETED|Overall Study||20
10471611|NCT01084707|11619949|FG000|STARTED|Overall Study||40
10471612|NCT01084707|11619949|FG000|COMPLETED|Overall Study||34
10708866|NCT02634801|11873794|FG000|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||54
10708867|NCT02634801|11873795|FG001|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||52
10713953|NCT02683772|11879505|FG001|COMPLETED|Overall Study||23
10471613|NCT01084707|11619949|FG000|NOT COMPLETED|Overall Study||6
10471614|NCT01084759|11619961|FG000|STARTED|Overall Study||16
10471615|NCT01084759|11619961|FG000|COMPLETED|Overall Study||14
10471616|NCT01084759|11619961|FG000|NOT COMPLETED|Overall Study||2
10471617|NCT01084772|11619967|FG000|STARTED|Baseline||68
10471618|NCT01084772|11619968|FG001|STARTED|Baseline||66
10471619|NCT01084772|11619967|FG000|COMPLETED|Baseline||61
10471620|NCT01084772|11619968|FG001|COMPLETED|Baseline||60
10471621|NCT01084772|11619967|FG000|NOT COMPLETED|Baseline||7
10471622|NCT01084772|11619968|FG001|NOT COMPLETED|Baseline||6
10471623|NCT01084772|11619967|FG000|STARTED|3 Months||61
10471624|NCT01084772|11619968|FG001|STARTED|3 Months||60
10471625|NCT01084772|11619967|FG000|COMPLETED|3 Months||58
10471626|NCT01084772|11619968|FG001|COMPLETED|3 Months||58
10471627|NCT01084772|11619967|FG000|NOT COMPLETED|3 Months||3
10708868|NCT02634801|11873796|FG002|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||52
10708869|NCT02634801|11873794|FG000|COMPLETED|Treatment Period (Weeks 0 to 24)||50
10708870|NCT02634801|11873795|FG001|COMPLETED|Treatment Period (Weeks 0 to 24)||23
10471628|NCT01084772|11619968|FG001|NOT COMPLETED|3 Months||2
10471629|NCT01084772|11619967|FG000|STARTED|1 Year||58
10471630|NCT01084772|11619968|FG001|STARTED|1 Year||58
10471631|NCT01084772|11619967|FG000|COMPLETED|1 Year||55
10471632|NCT01084772|11619968|FG001|COMPLETED|1 Year||50
10471633|NCT01084772|11619967|FG000|NOT COMPLETED|1 Year||3
10471634|NCT01084772|11619968|FG001|NOT COMPLETED|1 Year||8
10471635|NCT01084772|11619967|FG000|STARTED|2 Years||55
10471636|NCT01084772|11619968|FG001|STARTED|2 Years||50
10471637|NCT01084772|11619967|FG000|COMPLETED|2 Years||46
10471638|NCT01084772|11619968|FG001|COMPLETED|2 Years||46
10471639|NCT01084772|11619967|FG000|NOT COMPLETED|2 Years||9
10471640|NCT01084772|11619968|FG001|NOT COMPLETED|2 Years||4
10471641|NCT01085006|11619976|FG000|STARTED|Overall Study||50
10471642|NCT01085006|11619977|FG001|STARTED|Overall Study||50
10471643|NCT01085006|11619976|FG000|COMPLETED|Overall Study||50
10471644|NCT01085006|11619977|FG001|COMPLETED|Overall Study||50
10471645|NCT01085006|11619976|FG000|NOT COMPLETED|Overall Study||0
10471646|NCT01085006|11619977|FG001|NOT COMPLETED|Overall Study||0
10471647|NCT01085045|11619983|FG000|STARTED|Part A||122
10471648|NCT01085045|11619983|FG000|GFF MDI 72/9.6mcg|Part A||40
10471649|NCT01085045|11619983|FG000|GFF MDI 36/9.6 µg (PT003)|Part A||42
10471650|NCT01085045|11619983|FG000|GP MDI 36 µg (PT001)|Part A||40
10471651|NCT01085045|11619983|FG000|Spiriva 18 µg|Part A||58
10471652|NCT01085045|11619983|FG000|FF MDI 9.6 µg (PT005)|Part A||20
10471653|NCT01085045|11619983|FG000|FF MDI 7.2 µg (PT005)|Part A||21
10471654|NCT01085045|11619983|FG000|Placebo MDI|Part A||5
10471655|NCT01085045|11619983|FG000|Foradil 12 µg|Part A||14
10471656|NCT01085045|11619983|FG000|COMPLETED|Part A||104
10471657|NCT01085045|11619983|FG000|NOT COMPLETED|Part A||18
10471658|NCT01085045|11619983|FG000|STARTED|Part B||104
10471659|NCT01085045|11619983|FG000|GFF MDI 72/9.6mcg (PT003)|Part B||0
10471660|NCT01085045|11619983|FG000|GFF MDI 36/9.6 µg|Part B||0
10471661|NCT01085045|11619983|FG000|Spiriva 18 µg|Part B||0
10471662|NCT01085045|11619983|FG000|FF MDI 9.6 µg (PT005)|Part B||43
10471663|NCT01085045|11619983|FG000|FF MDI 7.2 µg (PT005)|Part B||43
10471664|NCT01085045|11619983|FG000|Placebo MDI|Part B||47
10471665|NCT01085045|11619983|FG000|Foradil 12 µg|Part B||41
10471666|NCT01085045|11619983|FG000|GP MDI 36 µg (PT001)|Part B||0
10471667|NCT01085045|11619983|FG000|COMPLETED|Part B||89
10471668|NCT01085045|11619983|FG000|NOT COMPLETED|Part B||15
10471669|NCT01085136|11620003|FG000|STARTED|Part A||1154
10471670|NCT01085136|11620004|FG001|STARTED|Part A|Only Afatinib monotherapy administered in Part A|0
10471671|NCT01085136|11620005|FG002|STARTED|Part A||0
10471672|NCT01085136|11620003|FG000|Randomized to Part B|Part A|Discontinued Part A -Randomized to Part B|206
10471673|NCT01085136|11620004|FG001|Randomized to Part B|Part A||0
10471674|NCT01085136|11620005|FG002|Randomized to Part B|Part A||0
10471675|NCT01085136|11620003|FG000|COMPLETED|Part A|Randomized to Part B & completed trial as per protocol, had PD, clinical progression.|831
10471676|NCT01085136|11620004|FG001|COMPLETED|Part A||0
10471677|NCT01085136|11620005|FG002|COMPLETED|Part A||0
10471678|NCT01085136|11620003|FG000|NOT COMPLETED|Part A||323
10471679|NCT01085136|11620004|FG001|NOT COMPLETED|Part A||0
10471680|NCT01085136|11620005|FG002|NOT COMPLETED|Part A||0
10471681|NCT01085136|11620003|FG000|STARTED|Part B|Afatinib monotherapy not administered in Part B|0
10471682|NCT01085136|11620004|FG001|STARTED|Part B||138
10471683|NCT01085136|11620005|FG002|STARTED|Part B||68
10649837|NCT02164513|11809988|FG002|WIP: Withdrawal by Participant|Overall Study||153
10649838|NCT02164513|11809986|FG000|WIP :Did Not Complete Study Treatment|Overall Study||1
10649839|NCT02164513|11809987|FG001|WIP :Did Not Complete Study Treatment|Overall Study||1
10649840|NCT02164513|11809988|FG002|WIP :Did Not Complete Study Treatment|Overall Study||0
10649841|NCT02164513|11809986|FG000|COMPLETED|Overall Study||3714
10649842|NCT02164513|11809987|FG001|COMPLETED|Overall Study||3598
10649843|NCT02164513|11809988|FG002|COMPLETED|Overall Study||1775
10471684|NCT01085136|11620003|FG000|COMPLETED|Part B|Afatinib monotherapy not administered in Part B|0
10649844|NCT02164513|11809986|FG000|NOT COMPLETED|Overall Study||437
10649845|NCT02164513|11809987|FG001|NOT COMPLETED|Overall Study||536
10471685|NCT01085136|11620004|FG001|COMPLETED|Part B|Completed trial as per protocol, had progressive disease, clinical signs or symptoms of progression|87
10471686|NCT01085136|11620005|FG002|COMPLETED|Part B|Completed trial as per protocol, had progressive disease, clinical signs or symptoms of progression|42
10471687|NCT01085136|11620003|FG000|NOT COMPLETED|Part B||0
10471688|NCT01085136|11620004|FG001|NOT COMPLETED|Part B||51
10649846|NCT02164513|11809988|FG002|NOT COMPLETED|Overall Study||295
10649847|NCT02164539|11810003|FG000|STARTED|Treatment Phase A (4 Weeks)||41
10471689|NCT01085136|11620005|FG002|NOT COMPLETED|Part B||26
10649848|NCT02164539|11810004|FG001|STARTED|Treatment Phase A (4 Weeks)||42
10471690|NCT01085201|11620020|FG000|STARTED|Overall Study||18
10471691|NCT01085201|11620021|FG001|STARTED|Overall Study||7
10471692|NCT01085201|11620022|FG002|STARTED|Overall Study||5
10471693|NCT01085201|11620023|FG003|STARTED|Overall Study||6
10471694|NCT01085201|11620024|FG004|STARTED|Overall Study||3
10471695|NCT01085201|11620020|FG000|COMPLETED|Overall Study||15
10471696|NCT01085201|11620021|FG001|COMPLETED|Overall Study||6
10471697|NCT01085201|11620022|FG002|COMPLETED|Overall Study||3
10471698|NCT01085201|11620023|FG003|COMPLETED|Overall Study||6
10471699|NCT01085201|11620024|FG004|COMPLETED|Overall Study||3
10471700|NCT01085201|11620020|FG000|NOT COMPLETED|Overall Study||3
10471701|NCT01085201|11620021|FG001|NOT COMPLETED|Overall Study||1
10708871|NCT02634801|11873796|FG002|COMPLETED|Treatment Period (Weeks 0 to 24)||49
10708872|NCT02634801|11873794|FG000|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||4
10708873|NCT02634801|11873795|FG001|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||31
10708874|NCT02634801|11873796|FG002|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||5
10708875|NCT02634801|11873794|FG000|STARTED|Extension Period (Weeks 24 to 36)|Participants had the option to enter the Extension Period or proceed directly to the Followup Period|48
10708876|NCT02634801|11873795|FG001|STARTED|Extension Period (Weeks 24 to 36)|Participants had the option to enter the Extension Period or proceed directly to the Followup Period|19
10708877|NCT02634801|11873796|FG002|STARTED|Extension Period (Weeks 24 to 36)|Participants had the option to enter the Extension Period or proceed directly to the Followup Period|31
10708878|NCT02634801|11873794|FG000|COMPLETED|Extension Period (Weeks 24 to 36)||45
10708879|NCT02634801|11873795|FG001|COMPLETED|Extension Period (Weeks 24 to 36)||18
10708880|NCT02634801|11873796|FG002|COMPLETED|Extension Period (Weeks 24 to 36)||29
10471702|NCT01085201|11620022|FG002|NOT COMPLETED|Overall Study||2
10471703|NCT01085201|11620023|FG003|NOT COMPLETED|Overall Study||0
10471704|NCT01085201|11620024|FG004|NOT COMPLETED|Overall Study||0
10471705|NCT01085214|11620041|FG000|STARTED|Overall Study||37
10471706|NCT01085214|11620041|FG000|COMPLETED|Overall Study||36
10471707|NCT01085214|11620041|FG000|NOT COMPLETED|Overall Study||1
10471708|NCT01085318|11620047|FG000|STARTED|Overall Study||23
10471709|NCT01085318|11620048|FG001|STARTED|Overall Study||15
10471710|NCT01085318|11620047|FG000|COMPLETED|Overall Study||21
10471711|NCT01085318|11620048|FG001|COMPLETED|Overall Study||15
10471712|NCT01085318|11620047|FG000|NOT COMPLETED|Overall Study||2
10471713|NCT01085318|11620048|FG001|NOT COMPLETED|Overall Study||0
10471714|NCT01085331|11620056|FG000|STARTED|Overall Study||10
10471715|NCT01085331|11620057|FG001|STARTED|Overall Study||6
10471716|NCT01085331|11620056|FG000|COMPLETED|Overall Study||10
10471717|NCT01085331|11620057|FG001|COMPLETED|Overall Study||6
10471718|NCT01085331|11620056|FG000|NOT COMPLETED|Overall Study||0
10471719|NCT01085331|11620057|FG001|NOT COMPLETED|Overall Study||0
10471720|NCT01085344|11620067|FG000|STARTED|Overall Study||56
10471721|NCT01085344|11620067|FG000|COMPLETED|Overall Study||50
10471722|NCT01085344|11620067|FG000|NOT COMPLETED|Overall Study||6
10471723|NCT01085357|11620073|FG000|STARTED|Overall Study||374
10471724|NCT01085357|11620074|FG001|STARTED|Overall Study||131
10471725|NCT01085357|11620073|FG000|COMPLETED|Overall Study||355
10471726|NCT01085357|11620074|FG001|COMPLETED|Overall Study||125
10471727|NCT01085357|11620073|FG000|NOT COMPLETED|Overall Study||19
10471728|NCT01085357|11620074|FG001|NOT COMPLETED|Overall Study||6
10471729|NCT01085500|11620082|FG000|STARTED|Overall Study||26
10471730|NCT01085500|11620083|FG001|STARTED|Overall Study||24
10471731|NCT01085500|11620082|FG000|COMPLETED|Overall Study||26
10471732|NCT01085500|11620083|FG001|COMPLETED|Overall Study||24
10471733|NCT01085500|11620082|FG000|NOT COMPLETED|Overall Study||0
10471734|NCT01085500|11620083|FG001|NOT COMPLETED|Overall Study||0
10471735|NCT01085513|11620091|FG000|STARTED|Phase I - Development Phase||54
10471736|NCT01085513|11620092|FG001|STARTED|Phase I - Development Phase||52
10471737|NCT01085513|11620091|FG000|COMPLETED|Phase I - Development Phase|recruitment was premature terminated|54
10471738|NCT01085513|11620092|FG001|COMPLETED|Phase I - Development Phase||52
10471739|NCT01085513|11620091|FG000|NOT COMPLETED|Phase I - Development Phase||0
10471740|NCT01085513|11620092|FG001|NOT COMPLETED|Phase I - Development Phase||0
10708881|NCT02634801|11873794|FG000|NOT COMPLETED|Extension Period (Weeks 24 to 36)||3
10708882|NCT02634801|11873795|FG001|NOT COMPLETED|Extension Period (Weeks 24 to 36)||1
10708883|NCT02634801|11873796|FG002|NOT COMPLETED|Extension Period (Weeks 24 to 36)||2
10708884|NCT02634801|11873794|FG000|STARTED|Follow-up Period|Participants who discontinued previous periods had option to enter post treatment follow-up period.|41
10708885|NCT02634801|11873795|FG001|STARTED|Follow-up Period|Participants who discontinued previous periods had option to enter post treatment follow-up period.|26
10708886|NCT02634801|11873796|FG002|STARTED|Follow-up Period|Participants who discontinued previous periods had option to enter post treatment follow-up period.|46
10708887|NCT02634801|11873794|FG000|COMPLETED|Follow-up Period||36
10708888|NCT02634801|11873795|FG001|COMPLETED|Follow-up Period||18
10708889|NCT02634801|11873796|FG002|COMPLETED|Follow-up Period||38
10708890|NCT02634801|11873794|FG000|NOT COMPLETED|Follow-up Period||5
10471741|NCT01085513|11620091|FG000|STARTED|Phase II - Validation Phase||21
10471742|NCT01085513|11620092|FG001|STARTED|Phase II - Validation Phase||16
10471743|NCT01085513|11620091|FG000|COMPLETED|Phase II - Validation Phase||21
10471744|NCT01085513|11620092|FG001|COMPLETED|Phase II - Validation Phase||16
10471745|NCT01085513|11620091|FG000|NOT COMPLETED|Phase II - Validation Phase||0
10471746|NCT01085513|11620092|FG001|NOT COMPLETED|Phase II - Validation Phase||0
10471747|NCT01085539|11620098|FG000|STARTED|Sat Secs Off--No Alarm Evaluation||50
10471748|NCT01085539|11620098|FG000|COMPLETED|Sat Secs Off--No Alarm Evaluation||50
10471749|NCT01085539|11620098|FG000|NOT COMPLETED|Sat Secs Off--No Alarm Evaluation||0
10708891|NCT02634801|11873795|FG001|NOT COMPLETED|Follow-up Period||8
10708892|NCT02634801|11873796|FG002|NOT COMPLETED|Follow-up Period||8
10708893|NCT02634814|11873811|FG000|STARTED|Overall Study||32
10708894|NCT02634814|11873812|FG001|STARTED|Overall Study||29
10708895|NCT02634814|11873813|FG002|STARTED|Overall Study||29
10708896|NCT02634814|11873811|FG000|COMPLETED|Overall Study||30
10708897|NCT02634814|11873812|FG001|COMPLETED|Overall Study||23
10708898|NCT02634814|11873813|FG002|COMPLETED|Overall Study||29
10708899|NCT02634814|11873811|FG000|NOT COMPLETED|Overall Study||2
10708900|NCT02634814|11873812|FG001|NOT COMPLETED|Overall Study||6
10708901|NCT02634814|11873813|FG002|NOT COMPLETED|Overall Study||0
10708902|NCT02634983|11873821|FG000|STARTED|Period One (First Treatment, 8-10 Days)||16
10708903|NCT02634983|11873822|FG001|STARTED|Period One (First Treatment, 8-10 Days)||15
10708904|NCT02634983|11873821|FG000|COMPLETED|Period One (First Treatment, 8-10 Days)||16
10708905|NCT02634983|11873822|FG001|COMPLETED|Period One (First Treatment, 8-10 Days)||15
10708906|NCT02634983|11873821|FG000|NOT COMPLETED|Period One (First Treatment, 8-10 Days)||0
10708907|NCT02634983|11873822|FG001|NOT COMPLETED|Period One (First Treatment, 8-10 Days)||0
10708908|NCT02634983|11873821|FG000|STARTED|Washout (Approximately 7-14 Days)||16
10708909|NCT02634983|11873822|FG001|STARTED|Washout (Approximately 7-14 Days)||15
10708910|NCT02634983|11873821|FG000|COMPLETED|Washout (Approximately 7-14 Days)||16
10708911|NCT02634983|11873822|FG001|COMPLETED|Washout (Approximately 7-14 Days)||15
10708912|NCT02634983|11873821|FG000|NOT COMPLETED|Washout (Approximately 7-14 Days)||0
10708913|NCT02634983|11873822|FG001|NOT COMPLETED|Washout (Approximately 7-14 Days)||0
10708914|NCT02634983|11873821|FG000|STARTED|Period 2 (Second Treatment, 8-10 Days)||16
10708915|NCT02634983|11873822|FG001|STARTED|Period 2 (Second Treatment, 8-10 Days)||15
10708916|NCT02634983|11873821|FG000|COMPLETED|Period 2 (Second Treatment, 8-10 Days)||14
10708917|NCT02634983|11873822|FG001|COMPLETED|Period 2 (Second Treatment, 8-10 Days)||15
10708918|NCT02634983|11873821|FG000|NOT COMPLETED|Period 2 (Second Treatment, 8-10 Days)||2
10708919|NCT02634983|11873822|FG001|NOT COMPLETED|Period 2 (Second Treatment, 8-10 Days)||0
10708920|NCT02635035|11873830|FG000|STARTED|Overall Study||17
10708921|NCT02635035|11873831|FG001|STARTED|Overall Study||21
10708922|NCT02635035|11873830|FG000|COMPLETED|Overall Study||17
10708923|NCT02635035|11873831|FG001|COMPLETED|Overall Study||21
10708924|NCT02635035|11873830|FG000|NOT COMPLETED|Overall Study||0
10708925|NCT02635035|11873831|FG001|NOT COMPLETED|Overall Study||0
10708926|NCT02635204|11873839|FG000|STARTED|Overall Study||178
10708927|NCT02635204|11873840|FG001|STARTED|Overall Study||89
10708928|NCT02635204|11873839|FG000|COMPLETED|Overall Study||176
10708929|NCT02635204|11873840|FG001|COMPLETED|Overall Study||88
10708930|NCT02635204|11873839|FG000|NOT COMPLETED|Overall Study||2
10708931|NCT02635204|11873840|FG001|NOT COMPLETED|Overall Study||1
10708932|NCT02635347|11873848|FG000|STARTED|Overall Study||51
10708933|NCT02635347|11873849|FG001|STARTED|Overall Study||70
10708934|NCT02635347|11873848|FG000|Screening|Overall Study||51
10708935|NCT02635347|11873849|FG001|Screening|Overall Study||70
10471750|NCT01085539|11620098|FG000|STARTED|10 Sat Secs--10 Second Alarm Evaluation||50
10471751|NCT01085539|11620098|FG000|COMPLETED|10 Sat Secs--10 Second Alarm Evaluation||50
10471752|NCT01085539|11620098|FG000|NOT COMPLETED|10 Sat Secs--10 Second Alarm Evaluation||0
10471753|NCT01085539|11620098|FG000|STARTED|25 Sat Secs--25 Second Alarm Evaluation||50
10471754|NCT01085539|11620098|FG000|COMPLETED|25 Sat Secs--25 Second Alarm Evaluation||50
10471755|NCT01085539|11620098|FG000|NOT COMPLETED|25 Sat Secs--25 Second Alarm Evaluation||0
10471756|NCT01085539|11620098|FG000|STARTED|50 Sat Secs--50 Second Alarm Evaluation||50
10471757|NCT01085539|11620098|FG000|COMPLETED|50 Sat Secs--50 Second Alarm Evaluation||50
10471758|NCT01085539|11620098|FG000|NOT COMPLETED|50 Sat Secs--50 Second Alarm Evaluation||0
10471759|NCT01085539|11620098|FG000|STARTED|100Sat Secs-100 Second Alarm Evaluation||50
10471760|NCT01085539|11620098|FG000|COMPLETED|100Sat Secs-100 Second Alarm Evaluation||50
10471761|NCT01085539|11620098|FG000|NOT COMPLETED|100Sat Secs-100 Second Alarm Evaluation||0
10471762|NCT01085591|11620105|FG000|STARTED|Overall Study||69
10471763|NCT01085591|11620106|FG001|STARTED|Overall Study||71
10471764|NCT01085591|11620107|FG002|STARTED|Overall Study||70
10471765|NCT01085591|11620105|FG000|Received at Least 1 Dose of Study Drug|Overall Study||68
10471766|NCT01085591|11620106|FG001|Received at Least 1 Dose of Study Drug|Overall Study||69
10471767|NCT01085591|11620107|FG002|Received at Least 1 Dose of Study Drug|Overall Study||70
10471768|NCT01085591|11620105|FG000|COMPLETED|Overall Study||66
10471769|NCT01085591|11620106|FG001|COMPLETED|Overall Study||65
10471770|NCT01085591|11620107|FG002|COMPLETED|Overall Study||63
10471771|NCT01085591|11620105|FG000|NOT COMPLETED|Overall Study||3
10471772|NCT01085591|11620106|FG001|NOT COMPLETED|Overall Study||6
10471773|NCT01085591|11620107|FG002|NOT COMPLETED|Overall Study||7
10471774|NCT01085630|11620118|FG000|STARTED|Overall Study||26
10471775|NCT01085630|11620119|FG001|STARTED|Overall Study||27
10471776|NCT01085630|11620118|FG000|COMPLETED|Overall Study||22
10471777|NCT01085630|11620119|FG001|COMPLETED|Overall Study||27
10471778|NCT01085630|11620118|FG000|NOT COMPLETED|Overall Study||4
10471779|NCT01085630|11620119|FG001|NOT COMPLETED|Overall Study||0
10471780|NCT01085682|11620127|FG000|STARTED|Overall Study||31
10471781|NCT01085682|11620128|FG001|STARTED|Overall Study||28
10471782|NCT01085682|11620127|FG000|COMPLETED|Overall Study||6
10471783|NCT01085682|11620128|FG001|COMPLETED|Overall Study||3
10471784|NCT01085682|11620127|FG000|NOT COMPLETED|Overall Study||25
10471785|NCT01085682|11620128|FG001|NOT COMPLETED|Overall Study||25
10471786|NCT01085734|11620136|FG000|STARTED|Overall Study||15
10471787|NCT01085734|11620137|FG001|STARTED|Overall Study||15
10471788|NCT01085734|11620136|FG000|COMPLETED|Overall Study||14
10471789|NCT01085734|11620137|FG001|COMPLETED|Overall Study||11
10471790|NCT01085734|11620136|FG000|NOT COMPLETED|Overall Study||1
10471791|NCT01085734|11620137|FG001|NOT COMPLETED|Overall Study||4
10471792|NCT01085760|11620148|FG000|STARTED|Overall Study||8
10471793|NCT01085760|11620149|FG001|STARTED|Overall Study||9
10471794|NCT01085760|11620150|FG002|STARTED|Overall Study||9
10471795|NCT01085760|11620151|FG003|STARTED|Overall Study||9
10471796|NCT01085760|11620148|FG000|COMPLETED|Overall Study||7
10471797|NCT01085760|11620149|FG001|COMPLETED|Overall Study||8
10471798|NCT01085760|11620150|FG002|COMPLETED|Overall Study||7
10471799|NCT01085760|11620151|FG003|COMPLETED|Overall Study||6
10471800|NCT01085760|11620148|FG000|NOT COMPLETED|Overall Study||1
10471801|NCT01085760|11620149|FG001|NOT COMPLETED|Overall Study||1
10471802|NCT01085760|11620150|FG002|NOT COMPLETED|Overall Study||2
10471803|NCT01085760|11620151|FG003|NOT COMPLETED|Overall Study||3
10471804|NCT01085786|11620163|FG000|STARTED|Overall Study||123
10471805|NCT01085786|11620164|FG001|STARTED|Overall Study||117
10471806|NCT01085786|11620163|FG000|COMPLETED|Overall Study||123
10471807|NCT01085786|11620164|FG001|COMPLETED|Overall Study||117
10471808|NCT01085786|11620163|FG000|NOT COMPLETED|Overall Study||0
10471809|NCT01085786|11620164|FG001|NOT COMPLETED|Overall Study||0
10471810|NCT01085812|11620170|FG000|STARTED|Open-Label Period||0
10471811|NCT01085812|11620171|FG001|STARTED|Open-Label Period||734
10471812|NCT01085812|11620170|FG000|COMPLETED|Open-Label Period||0
10471813|NCT01085812|11620171|FG001|COMPLETED|Open-Label Period||494
10471814|NCT01085812|11620170|FG000|NOT COMPLETED|Open-Label Period||0
10471815|NCT01085812|11620171|FG001|NOT COMPLETED|Open-Label Period||240
10471816|NCT01085812|11620170|FG000|STARTED|Double-Blind Period||113
10471817|NCT01085812|11620171|FG001|STARTED|Double-Blind Period||235
10471818|NCT01085812|11620170|FG000|COMPLETED|Double-Blind Period||92
10471819|NCT01085812|11620171|FG001|COMPLETED|Double-Blind Period||177
10471820|NCT01085812|11620170|FG000|NOT COMPLETED|Double-Blind Period||21
10471821|NCT01085812|11620171|FG001|NOT COMPLETED|Double-Blind Period||58
10471822|NCT01085812|11620170|FG000|STARTED|Double-blind Intent-to-treat Population||112
10471823|NCT01085812|11620171|FG001|STARTED|Double-blind Intent-to-treat Population||230
10471824|NCT01085812|11620170|FG000|COMPLETED|Double-blind Intent-to-treat Population||92
10471825|NCT01085812|11620171|FG001|COMPLETED|Double-blind Intent-to-treat Population||174
10471826|NCT01085812|11620170|FG000|NOT COMPLETED|Double-blind Intent-to-treat Population||20
10471827|NCT01085812|11620171|FG001|NOT COMPLETED|Double-blind Intent-to-treat Population||56
10471828|NCT01085825|11620180|FG000|STARTED|Overall Study|1st participant enrolled|252
10471829|NCT01085825|11620181|FG001|STARTED|Overall Study||248
10471830|NCT01085825|11620180|FG000|COMPLETED|Overall Study||251
10471831|NCT01085825|11620181|FG001|COMPLETED|Overall Study||247
10471832|NCT01085825|11620180|FG000|NOT COMPLETED|Overall Study||1
10471833|NCT01085825|11620181|FG001|NOT COMPLETED|Overall Study||1
10471834|NCT01085903|11620189|FG000|STARTED|Overall Study||21
10471835|NCT01085903|11620190|FG001|STARTED|Overall Study||4
10471836|NCT01085903|11620191|FG002|STARTED|Overall Study||3
10471837|NCT01085903|11620189|FG000|COMPLETED|Overall Study||21
10471838|NCT01085903|11620190|FG001|COMPLETED|Overall Study||4
10471839|NCT01085903|11620191|FG002|COMPLETED|Overall Study||3
10471840|NCT01085903|11620189|FG000|NOT COMPLETED|Overall Study||0
10471841|NCT01085903|11620190|FG001|NOT COMPLETED|Overall Study||0
10471842|NCT01085903|11620191|FG002|NOT COMPLETED|Overall Study||0
10471843|NCT01085968|11620212|FG000|STARTED|Overall Study||29
10471844|NCT01085968|11620213|FG001|STARTED|Overall Study||25
10471845|NCT01085968|11620212|FG000|COMPLETED|Overall Study||19
10471846|NCT01085968|11620213|FG001|COMPLETED|Overall Study||21
10471847|NCT01085968|11620212|FG000|NOT COMPLETED|Overall Study||10
10471848|NCT01085968|11620213|FG001|NOT COMPLETED|Overall Study||4
10471849|NCT01086033|11620219|FG000|STARTED|Overall Study||566
10471850|NCT01086033|11620219|FG000|COMPLETED|Overall Study||262
10471851|NCT01086033|11620219|FG000|NOT COMPLETED|Overall Study||304
10471852|NCT01086150|11620229|FG000|STARTED|Overall Study||11
10471853|NCT01086150|11620230|FG001|STARTED|Overall Study||27
10471854|NCT01086150|11620231|FG002|STARTED|Overall Study||13
10471855|NCT01086150|11620229|FG000|COMPLETED|Overall Study||11
10471856|NCT01086150|11620230|FG001|COMPLETED|Overall Study||21
10471857|NCT01086150|11620231|FG002|COMPLETED|Overall Study||12
10471858|NCT01086150|11620229|FG000|NOT COMPLETED|Overall Study||0
10471859|NCT01086150|11620230|FG001|NOT COMPLETED|Overall Study||6
10471860|NCT01086150|11620231|FG002|NOT COMPLETED|Overall Study||1
10471861|NCT01086215|11620243|FG000|STARTED|Overall Study||212
10471862|NCT01086215|11620244|FG001|STARTED|Overall Study||201
10471863|NCT01086215|11620245|FG002|STARTED|Overall Study||73
10471864|NCT01086215|11620246|FG003|STARTED|Overall Study||14
10471865|NCT01086215|11620243|FG000|3 Month Follow Up|Overall Study|7 LTF; 4 Deaths|201
10471866|NCT01086215|11620244|FG001|3 Month Follow Up|Overall Study|10 LTF; 4 Deaths|187
10471867|NCT01086215|11620245|FG002|3 Month Follow Up|Overall Study|5 LTF; 4 Deaths|64
10471868|NCT01086215|11620246|FG003|3 Month Follow Up|Overall Study|1 LTF; 0 Deaths|13
10471869|NCT01086215|11620243|FG000|6 Month Follow Up|Overall Study|5 LTF; 4 Deaths|192
10471870|NCT01086215|11620244|FG001|6 Month Follow Up|Overall Study|13 LTF; 2 Deaths|172
10471871|NCT01086215|11620245|FG002|6 Month Follow Up|Overall Study|4 LTF; 0 Deaths|60
10471872|NCT01086215|11620246|FG003|6 Month Follow Up|Overall Study|1 LTF; 0 Deaths|12
10471873|NCT01086215|11620243|FG000|12 Month Follow Up|Overall Study|10 LTF; 6 Deaths|176
10471874|NCT01086215|11620244|FG001|12 Month Follow Up|Overall Study|16 LTF; 2 Deaths|154
10471875|NCT01086215|11620245|FG002|12 Month Follow Up|Overall Study|9 LTF; 4 Deaths|47
10471876|NCT01086215|11620246|FG003|12 Month Follow Up|Overall Study|0 LTF; 1 Death|11
10471877|NCT01086215|11620243|FG000|COMPLETED|Overall Study||176
10471878|NCT01086215|11620244|FG001|COMPLETED|Overall Study||154
10471879|NCT01086215|11620245|FG002|COMPLETED|Overall Study||47
10471880|NCT01086215|11620246|FG003|COMPLETED|Overall Study||11
10471881|NCT01086215|11620243|FG000|NOT COMPLETED|Overall Study||36
10471882|NCT01086215|11620244|FG001|NOT COMPLETED|Overall Study||47
10471883|NCT01086215|11620245|FG002|NOT COMPLETED|Overall Study||26
10471884|NCT01086215|11620246|FG003|NOT COMPLETED|Overall Study||3
10471885|NCT01086228|11620256|FG000|STARTED|8 Month Follow-up|Analysis population|2009
10471886|NCT01086228|11620256|FG000|COMPLETED|8 Month Follow-up||1938
10471887|NCT01086228|11620256|FG000|NOT COMPLETED|8 Month Follow-up||71
10471888|NCT01086228|11620256|FG000|STARTED|1-year Follow-up||1938
10471889|NCT01086228|11620256|FG000|COMPLETED|1-year Follow-up||1894
10471890|NCT01086228|11620256|FG000|NOT COMPLETED|1-year Follow-up||44
10471891|NCT01086228|11620256|FG000|STARTED|2-year Follow-up||1894
10471892|NCT01086228|11620256|FG000|COMPLETED|2-year Follow-up||1834
10471893|NCT01086228|11620256|FG000|NOT COMPLETED|2-year Follow-up||60
10471894|NCT01086228|11620256|FG000|STARTED|3-year Follow-up||1834
10471895|NCT01086228|11620256|FG000|COMPLETED|3-year Follow-up||1767
10471896|NCT01086228|11620256|FG000|NOT COMPLETED|3-year Follow-up||67
10471897|NCT01086228|11620256|FG000|STARTED|4-year Follow-up||1767
10471898|NCT01086228|11620256|FG000|COMPLETED|4-year Follow-up||1664
10471899|NCT01086228|11620256|FG000|NOT COMPLETED|4-year Follow-up||103
10471900|NCT01086228|11620256|FG000|STARTED|5-year Follow-up||1664
10471901|NCT01086228|11620256|FG000|COMPLETED|5-year Follow-up||1012
10471902|NCT01086228|11620256|FG000|NOT COMPLETED|5-year Follow-up||652
10471903|NCT01086358|11620260|FG000|STARTED|First Intervention|30 subjects enrolled.|30
10471904|NCT01086358|11620261|FG001|STARTED|First Intervention|30 subjects enrolled, 1 withdrew before randomization|29
10471905|NCT01086358|11620260|FG000|COMPLETED|First Intervention||21
10471906|NCT01086358|11620261|FG001|COMPLETED|First Intervention||24
10471907|NCT01086358|11620260|FG000|NOT COMPLETED|First Intervention||9
10471908|NCT01086358|11620261|FG001|NOT COMPLETED|First Intervention||5
10471909|NCT01086358|11620260|FG000|STARTED|Second Intervention||21
10471910|NCT01086358|11620261|FG001|STARTED|Second Intervention||24
10471911|NCT01086358|11620260|FG000|COMPLETED|Second Intervention||17
10471912|NCT01086358|11620261|FG001|COMPLETED|Second Intervention||20
10471913|NCT01086358|11620260|FG000|NOT COMPLETED|Second Intervention||4
10471914|NCT01086358|11620261|FG001|NOT COMPLETED|Second Intervention||4
10471915|NCT01086384|11620269|FG000|STARTED|2-week Run-in Period||2183
10471916|NCT01086384|11620270|FG001|STARTED|2-week Run-in Period||0
10471917|NCT01086384|11620271|FG002|STARTED|2-week Run-in Period||0
10471918|NCT01086384|11620269|FG000|COMPLETED|2-week Run-in Period||2020
10471919|NCT01086384|11620270|FG001|COMPLETED|2-week Run-in Period||0
10471920|NCT01086384|11620271|FG002|COMPLETED|2-week Run-in Period||0
10471921|NCT01086384|11620269|FG000|NOT COMPLETED|2-week Run-in Period||163
10471922|NCT01086384|11620270|FG001|NOT COMPLETED|2-week Run-in Period||0
10471923|NCT01086384|11620271|FG002|NOT COMPLETED|2-week Run-in Period||0
10471924|NCT01086384|11620269|FG000|STARTED|Treatment Period||0
10471925|NCT01086384|11620270|FG001|STARTED|Treatment Period||1011
10471926|NCT01086384|11620271|FG002|STARTED|Treatment Period||1009
10471927|NCT01086384|11620269|FG000|COMPLETED|Treatment Period||0
10471928|NCT01086384|11620270|FG001|COMPLETED|Treatment Period||863
10471929|NCT01086384|11620271|FG002|COMPLETED|Treatment Period||885
10471930|NCT01086384|11620269|FG000|NOT COMPLETED|Treatment Period||0
10471931|NCT01086384|11620270|FG001|NOT COMPLETED|Treatment Period||148
10471932|NCT01086384|11620271|FG002|NOT COMPLETED|Treatment Period||124
10526776|NCT01383720|11678673|FG000|Primary Endpoint (Discharge/7 Days)|Overall Study||11
10526777|NCT01383720|11678673|FG000|COMPLETED|Overall Study|Study is continuing to 5 years. All patients are still in the study.|11
10526778|NCT01383720|11678673|FG000|NOT COMPLETED|Overall Study||0
10526779|NCT01383759|11678679|FG000|STARTED|Overall Study||19
10526780|NCT01383759|11678680|FG001|STARTED|Overall Study||1
10526781|NCT01383759|11678679|FG000|COMPLETED|Overall Study||19
10526782|NCT01383759|11678680|FG001|COMPLETED|Overall Study||1
10526783|NCT01383759|11678679|FG000|NOT COMPLETED|Overall Study||0
10526784|NCT01383759|11678680|FG001|NOT COMPLETED|Overall Study||0
10526785|NCT01383928|11678689|FG000|STARTED|Overall Study||7
10526786|NCT01383928|11678690|FG001|STARTED|Overall Study||7
10526787|NCT01383928|11678691|FG002|STARTED|Overall Study||50
10526788|NCT01383928|11678689|FG000|COMPLETED|Overall Study||2
10526789|NCT01383928|11678690|FG001|COMPLETED|Overall Study||0
10526790|NCT01383928|11678691|FG002|COMPLETED|Overall Study||10
10526791|NCT01383928|11678689|FG000|NOT COMPLETED|Overall Study||5
10526792|NCT01383928|11678690|FG001|NOT COMPLETED|Overall Study||7
10526793|NCT01383928|11678691|FG002|NOT COMPLETED|Overall Study||40
10526794|NCT01383954|11678701|FG000|STARTED|Overall Study||52
10526795|NCT01383954|11678701|FG000|Safety Population: Received Treatment|Overall Study||48
10526796|NCT01383954|11678701|FG000|COMPLETED|Overall Study||38
10526797|NCT01383954|11678701|FG000|NOT COMPLETED|Overall Study||14
10526798|NCT01383993|11678708|FG000|STARTED|Overall Study||15
10526799|NCT01383993|11678709|FG001|STARTED|Overall Study||4
10526800|NCT01383993|11678710|FG002|STARTED|Overall Study||2
10526801|NCT01383993|11678708|FG000|COMPLETED|Overall Study||12
10526802|NCT01383993|11678709|FG001|COMPLETED|Overall Study||3
10526803|NCT01383993|11678710|FG002|COMPLETED|Overall Study||1
10526804|NCT01383993|11678708|FG000|NOT COMPLETED|Overall Study||3
10471933|NCT01086410|11620281|FG000|STARTED|Overall Study||58
10471934|NCT01086410|11620282|FG001|STARTED|Overall Study||56
10471935|NCT01086410|11620283|FG002|STARTED|Overall Study||56
10471936|NCT01086410|11620284|FG003|STARTED|Overall Study||15
10471937|NCT01086410|11620281|FG000|COMPLETED|Overall Study||55
10471938|NCT01086410|11620282|FG001|COMPLETED|Overall Study||54
10471939|NCT01086410|11620283|FG002|COMPLETED|Overall Study||55
10471940|NCT01086410|11620284|FG003|COMPLETED|Overall Study||13
10471941|NCT01086410|11620281|FG000|NOT COMPLETED|Overall Study||3
10471942|NCT01086410|11620282|FG001|NOT COMPLETED|Overall Study||2
10471943|NCT01086410|11620283|FG002|NOT COMPLETED|Overall Study||1
10471944|NCT01086410|11620284|FG003|NOT COMPLETED|Overall Study||2
10471945|NCT01086423|11620297|FG000|STARTED|Overall Study||330
10471946|NCT01086423|11620298|FG001|STARTED|Overall Study||324
10471947|NCT01086423|11620299|FG002|STARTED|Overall Study||330
10471948|NCT01086423|11620297|FG000|COMPLETED|Overall Study||320
10471949|NCT01086423|11620298|FG001|COMPLETED|Overall Study||321
10471950|NCT01086423|11620299|FG002|COMPLETED|Overall Study||321
10471951|NCT01086423|11620297|FG000|NOT COMPLETED|Overall Study||10
10471952|NCT01086423|11620298|FG001|NOT COMPLETED|Overall Study||3
10471953|NCT01086423|11620299|FG002|NOT COMPLETED|Overall Study||9
10471954|NCT01086475|11620309|FG000|STARTED|Overall Study||34
10471955|NCT01086475|11620310|FG001|STARTED|Overall Study||33
10471956|NCT01086475|11620309|FG000|COMPLETED|Overall Study||34
10471957|NCT01086475|11620310|FG001|COMPLETED|Overall Study||33
10471958|NCT01086475|11620309|FG000|NOT COMPLETED|Overall Study||0
10471959|NCT01086475|11620310|FG001|NOT COMPLETED|Overall Study||0
10471960|NCT01086540|11620318|FG000|STARTED|Overall Study||29
10471961|NCT01086540|11620319|FG001|STARTED|Overall Study||28
10471962|NCT01086540|11620318|FG000|COMPLETED|Overall Study||23
10471963|NCT01086540|11620319|FG001|COMPLETED|Overall Study||26
10471964|NCT01086540|11620318|FG000|NOT COMPLETED|Overall Study||6
10471965|NCT01086540|11620319|FG001|NOT COMPLETED|Overall Study||2
10471966|NCT01086605|11620327|FG000|STARTED|Overall Study||24
10471967|NCT01086605|11620328|FG001|STARTED|Overall Study||22
10471968|NCT01086605|11620327|FG000|COMPLETED|Overall Study||24
10471969|NCT01086605|11620328|FG001|COMPLETED|Overall Study||22
10471970|NCT01086605|11620327|FG000|NOT COMPLETED|Overall Study||0
10471971|NCT01086605|11620328|FG001|NOT COMPLETED|Overall Study||0
10471972|NCT01086761|11620340|FG000|STARTED|Overall Study||9
10471973|NCT01086761|11620341|FG001|STARTED|Overall Study||7
10471974|NCT01086761|11620342|FG002|STARTED|Overall Study||6
10471975|NCT01086761|11620343|FG003|STARTED|Overall Study||6
10471976|NCT01086761|11620344|FG004|STARTED|Overall Study||4
10471977|NCT01086761|11620345|FG005|STARTED|Overall Study||0
10471978|NCT01086761|11620340|FG000|COMPLETED|Overall Study||9
10471979|NCT01086761|11620341|FG001|COMPLETED|Overall Study||7
10471980|NCT01086761|11620342|FG002|COMPLETED|Overall Study||6
10471981|NCT01086761|11620343|FG003|COMPLETED|Overall Study||6
10471982|NCT01086761|11620344|FG004|COMPLETED|Overall Study||4
10471983|NCT01086761|11620345|FG005|COMPLETED|Overall Study||0
10471984|NCT01086761|11620340|FG000|NOT COMPLETED|Overall Study||0
10471985|NCT01086761|11620341|FG001|NOT COMPLETED|Overall Study||0
10471986|NCT01086761|11620342|FG002|NOT COMPLETED|Overall Study||0
10471987|NCT01086761|11620343|FG003|NOT COMPLETED|Overall Study||0
10471988|NCT01086761|11620344|FG004|NOT COMPLETED|Overall Study||0
10471989|NCT01086761|11620345|FG005|NOT COMPLETED|Overall Study||0
10471990|NCT01086852|11620358|FG000|STARTED|Overall Study||4
10471991|NCT01086852|11620358|FG000|COMPLETED|Overall Study||4
10471992|NCT01086852|11620358|FG000|NOT COMPLETED|Overall Study||0
10471993|NCT01086969|11620366|FG000|STARTED|Overall Study||100
10471994|NCT01086969|11620367|FG001|STARTED|Overall Study||100
10471995|NCT01086969|11620368|FG002|STARTED|Overall Study||100
10471996|NCT01086969|11620366|FG000|COMPLETED|Overall Study||99
10471997|NCT01086969|11620367|FG001|COMPLETED|Overall Study||98
10471998|NCT01086969|11620368|FG002|COMPLETED|Overall Study||100
10471999|NCT01086969|11620366|FG000|NOT COMPLETED|Overall Study||1
10472000|NCT01086969|11620367|FG001|NOT COMPLETED|Overall Study||2
10472001|NCT01086969|11620368|FG002|NOT COMPLETED|Overall Study||0
10472002|NCT01087489|11620376|FG000|STARTED|Overall Study||19
10472003|NCT01087489|11620377|FG001|STARTED|Overall Study||34
10472004|NCT01087489|11620376|FG000|COMPLETED|Overall Study||19
10472005|NCT01087489|11620377|FG001|COMPLETED|Overall Study||31
10472006|NCT01087489|11620376|FG000|NOT COMPLETED|Overall Study||0
10472007|NCT01087489|11620377|FG001|NOT COMPLETED|Overall Study||3
10472008|NCT01087502|11620385|FG000|STARTED|Up to Interim Analysis (Week 12)||123
10472009|NCT01087502|11620386|FG001|STARTED|Up to Interim Analysis (Week 12)||118
10472010|NCT01087502|11620385|FG000|COMPLETED|Up to Interim Analysis (Week 12)||114
10472011|NCT01087502|11620386|FG001|COMPLETED|Up to Interim Analysis (Week 12)||110
10472012|NCT01087502|11620385|FG000|NOT COMPLETED|Up to Interim Analysis (Week 12)||9
10472013|NCT01087502|11620386|FG001|NOT COMPLETED|Up to Interim Analysis (Week 12)||8
10472014|NCT01087502|11620385|FG000|STARTED|Up to Final Analysis (Week 52)||123
10472015|NCT01087502|11620386|FG001|STARTED|Up to Final Analysis (Week 52)||118
10472016|NCT01087502|11620385|FG000|COMPLETED|Up to Final Analysis (Week 52)||90
10472017|NCT01087502|11620386|FG001|COMPLETED|Up to Final Analysis (Week 52)||95
10472018|NCT01087502|11620385|FG000|NOT COMPLETED|Up to Final Analysis (Week 52)||33
10472019|NCT01087502|11620386|FG001|NOT COMPLETED|Up to Final Analysis (Week 52)||23
10472020|NCT01087528|11620394|FG000|STARTED|Overall Study||51
10472021|NCT01087528|11620394|FG000|COMPLETED|Overall Study|withdrawn from the study prior to any procedure|44
10472022|NCT01087528|11620394|FG000|NOT COMPLETED|Overall Study||7
10472023|NCT01087541|11620402|FG000|STARTED|Overall Study||3307
10472024|NCT01087541|11620403|FG001|STARTED|Overall Study||3523
10472025|NCT01087541|11620402|FG000|COMPLETED|Overall Study||3307
10472026|NCT01087541|11620403|FG001|COMPLETED|Overall Study||3523
10472027|NCT01087541|11620402|FG000|NOT COMPLETED|Overall Study||0
10472028|NCT01087541|11620403|FG001|NOT COMPLETED|Overall Study||0
10472029|NCT01087723|11620411|FG000|STARTED|Overall Study|Randomized participants who signed an informed consent form (ICF); Intent-to-treat (ITT) population|1089
10472030|NCT01087723|11620412|FG001|STARTED|Overall Study|Randomized participants who signed an informed consent form (ICF); Intent-to-treat (ITT) population|1109
10472031|NCT01087723|11620411|FG000|Received at Least 1 Dose of Study Drug|Overall Study|Participants who were randomized with signed ICF by treatment actually received; Safety population|1099
10472032|NCT01087723|11620412|FG001|Received at Least 1 Dose of Study Drug|Overall Study|Participants who were randomized with signed ICF by treatment actually received; Safety population|1094
10472033|NCT01087723|11620411|FG000|COMPLETED|Overall Study|Completed 1-year follow-up in the study|1075
10472034|NCT01087723|11620412|FG001|COMPLETED|Overall Study|Completed 1-year follow-up in the study|1089
10472035|NCT01087723|11620411|FG000|NOT COMPLETED|Overall Study||14
10472036|NCT01087723|11620412|FG001|NOT COMPLETED|Overall Study||20
10472037|NCT01087736|11620420|FG000|STARTED|Overall Study||14
10472038|NCT01087736|11620421|FG001|STARTED|Overall Study||16
10472039|NCT01087736|11620420|FG000|COMPLETED|Overall Study||13
10472040|NCT01087736|11620421|FG001|COMPLETED|Overall Study||14
10472041|NCT01087736|11620420|FG000|NOT COMPLETED|Overall Study||1
10472042|NCT01087736|11620421|FG001|NOT COMPLETED|Overall Study||2
10472043|NCT01087762|11620430|FG000|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|107
10472044|NCT01087762|11620431|FG001|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|111
10472045|NCT01087762|11620432|FG002|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|107
10472046|NCT01087762|11620433|FG003|STARTED|Double Blind Period (Weeks 0-24)||0
10472047|NCT01087762|11620434|FG004|STARTED|Double Blind Period (Weeks 0-24)||0
10472048|NCT01087762|11620430|FG000|COMPLETED|Double Blind Period (Weeks 0-24)||95
10472049|NCT01087762|11620431|FG001|COMPLETED|Double Blind Period (Weeks 0-24)||105
10472050|NCT01087762|11620432|FG002|COMPLETED|Double Blind Period (Weeks 0-24)||98
10472051|NCT01087762|11620433|FG003|COMPLETED|Double Blind Period (Weeks 0-24)||0
10472052|NCT01087762|11620434|FG004|COMPLETED|Double Blind Period (Weeks 0-24)||0
10472053|NCT01087762|11620430|FG000|NOT COMPLETED|Double Blind Period (Weeks 0-24)||12
10472054|NCT01087762|11620431|FG001|NOT COMPLETED|Double Blind Period (Weeks 0-24)||6
10472055|NCT01087762|11620432|FG002|NOT COMPLETED|Double Blind Period (Weeks 0-24)||9
10472056|NCT01087762|11620433|FG003|NOT COMPLETED|Double Blind Period (Weeks 0-24)||0
10472057|NCT01087762|11620434|FG004|NOT COMPLETED|Double Blind Period (Weeks 0-24)||0
10472058|NCT01087762|11620430|FG000|STARTED|Open-Label Period (Weeks 48-204)||0
10472059|NCT01087762|11620431|FG001|STARTED|Open-Label Period (Weeks 48-204)||0
10472060|NCT01087762|11620432|FG002|STARTED|Open-Label Period (Weeks 48-204)||0
10472061|NCT01087762|11620433|FG003|STARTED|Open-Label Period (Weeks 48-204)||158
10472062|NCT01087762|11620434|FG004|STARTED|Open-Label Period (Weeks 48-204)||157
10472063|NCT01087762|11620430|FG000|COMPLETED|Open-Label Period (Weeks 48-204)||0
10472064|NCT01087762|11620431|FG001|COMPLETED|Open-Label Period (Weeks 48-204)||0
10472065|NCT01087762|11620432|FG002|COMPLETED|Open-Label Period (Weeks 48-204)||0
10472066|NCT01087762|11620433|FG003|COMPLETED|Open-Label Period (Weeks 48-204)||99
10472067|NCT01087762|11620434|FG004|COMPLETED|Open-Label Period (Weeks 48-204)||100
10472068|NCT01087762|11620430|FG000|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
10472069|NCT01087762|11620431|FG001|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
10472070|NCT01087762|11620432|FG002|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
10472071|NCT01087762|11620433|FG003|NOT COMPLETED|Open-Label Period (Weeks 48-204)||59
10472072|NCT01087762|11620434|FG004|NOT COMPLETED|Open-Label Period (Weeks 48-204)||57
10472073|NCT01087775|11620444|FG000|STARTED|Overall Study||25
10472074|NCT01087775|11620444|FG000|COMPLETED|Overall Study|2 subjects were found to be ineligible for the study|23
10472075|NCT01087775|11620444|FG000|NOT COMPLETED|Overall Study||2
10472076|NCT01087788|11620452|FG000|STARTED|24-weeks Double-blind Period||136
10472077|NCT01087788|11620453|FG001|STARTED|24-weeks Double-blind Period||138
10472078|NCT01087788|11620454|FG002|STARTED|24-weeks Double-blind Period||135
10472079|NCT01087788|11620452|FG000|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|30 subjects left the Placebo group and were re-randomized to CZP 200 mg Q2W on Week 16.|30
10472080|NCT01087788|11620453|FG001|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
10472081|NCT01087788|11620454|FG002|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
10472082|NCT01087788|11620452|FG000|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|29 subjects left the Placebo group and were re-randomized to CZP 400 mg Q4W on Week 16.|29
10472083|NCT01087788|11620453|FG001|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
10472084|NCT01087788|11620454|FG002|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
10472085|NCT01087788|11620452|FG000|COMPLETED|24-weeks Double-blind Period||120
10472086|NCT01087788|11620453|FG001|COMPLETED|24-weeks Double-blind Period||128
10472087|NCT01087788|11620454|FG002|COMPLETED|24-weeks Double-blind Period||120
10472088|NCT01087788|11620452|FG000|NOT COMPLETED|24-weeks Double-blind Period||16
10472089|NCT01087788|11620453|FG001|NOT COMPLETED|24-weeks Double-blind Period||10
10472090|NCT01087788|11620454|FG002|NOT COMPLETED|24-weeks Double-blind Period||15
10472091|NCT01087788|11620452|FG000|STARTED|24-weeks Dose-blind Period||120
10472092|NCT01087788|11620453|FG001|STARTED|24-weeks Dose-blind Period||128
10472093|NCT01087788|11620454|FG002|STARTED|24-weeks Dose-blind Period||120
10472094|NCT01087788|11620452|FG000|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|Sum of subjects re-randomized to CZP 200mg Q2W at week 16 (30 subjects) and at week 24 (30 subjects)|60
10472095|NCT01087788|11620453|FG001|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
10472096|NCT01087788|11620454|FG002|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
10472097|NCT01087788|11620452|FG000|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|Sum of subjects re-randomized to CZP 400mg Q2W at week 16 (29 subjects) and at week 24 (31 subjects)|60
10472098|NCT01087788|11620453|FG001|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
10472099|NCT01087788|11620454|FG002|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
10472100|NCT01087788|11620452|FG000|COMPLETED|24-weeks Dose-blind Period||113
10472101|NCT01087788|11620453|FG001|COMPLETED|24-weeks Dose-blind Period||123
10472102|NCT01087788|11620454|FG002|COMPLETED|24-weeks Dose-blind Period||114
10472103|NCT01087788|11620452|FG000|NOT COMPLETED|24-weeks Dose-blind Period||7
10472104|NCT01087788|11620453|FG001|NOT COMPLETED|24-weeks Dose-blind Period||5
10472105|NCT01087788|11620454|FG002|NOT COMPLETED|24-weeks Dose-blind Period||6
10472106|NCT01087788|11620452|FG000|STARTED|Open-Label Period (OL-P)|2 subj. completed the Dose-Blind Period, then withdrew from the study rather than entering the OL-P.|111
10472107|NCT01087788|11620453|FG001|STARTED|Open-Label Period (OL-P)|2 subj. completed the Dose-Blind Period, then withdrew from the study rather than entering the OL-P.|121
10472108|NCT01087788|11620454|FG002|STARTED|Open-Label Period (OL-P)||114
10472109|NCT01087788|11620452|FG000|COMPLETED|Open-Label Period (OL-P)||81
10472110|NCT01087788|11620453|FG001|COMPLETED|Open-Label Period (OL-P)||97
10472111|NCT01087788|11620454|FG002|COMPLETED|Open-Label Period (OL-P)||86
10472112|NCT01087788|11620452|FG000|NOT COMPLETED|Open-Label Period (OL-P)||30
10472113|NCT01087788|11620453|FG001|NOT COMPLETED|Open-Label Period (OL-P)||24
10472114|NCT01087788|11620454|FG002|NOT COMPLETED|Open-Label Period (OL-P)||28
10472115|NCT01087801|11620465|FG000|STARTED|Overall Study||30
10472116|NCT01087801|11620466|FG001|STARTED|Overall Study||34
10472117|NCT01087801|11620465|FG000|COMPLETED|Overall Study||26
10472118|NCT01087801|11620466|FG001|COMPLETED|Overall Study||29
10472119|NCT01087801|11620465|FG000|NOT COMPLETED|Overall Study||4
10472120|NCT01087801|11620466|FG001|NOT COMPLETED|Overall Study||5
10472121|NCT01087814|11620474|FG000|STARTED|First Intervention (5 Days)||8
10472122|NCT01087814|11620475|FG001|STARTED|First Intervention (5 Days)||7
10472123|NCT01087814|11620474|FG000|COMPLETED|First Intervention (5 Days)||5
10472124|NCT01087814|11620475|FG001|COMPLETED|First Intervention (5 Days)||6
10472125|NCT01087814|11620474|FG000|NOT COMPLETED|First Intervention (5 Days)||3
10472126|NCT01087814|11620475|FG001|NOT COMPLETED|First Intervention (5 Days)||1
10472127|NCT01087814|11620474|FG000|STARTED|Second Intervention (5 Days)||5
10472128|NCT01087814|11620475|FG001|STARTED|Second Intervention (5 Days)||6
10472129|NCT01087814|11620474|FG000|COMPLETED|Second Intervention (5 Days)||4
10472130|NCT01087814|11620475|FG001|COMPLETED|Second Intervention (5 Days)||6
10472131|NCT01087814|11620474|FG000|NOT COMPLETED|Second Intervention (5 Days)||1
10472132|NCT01087814|11620475|FG001|NOT COMPLETED|Second Intervention (5 Days)||0
10472133|NCT01087905|11620489|FG000|STARTED|Overall Study||119
10472134|NCT01087905|11620490|FG001|STARTED|Overall Study||126
10472135|NCT01087905|11620491|FG002|STARTED|Overall Study||123
10472136|NCT01087905|11620492|FG003|STARTED|Overall Study||122
10472137|NCT01087905|11620493|FG004|STARTED|Overall Study||122
10472138|NCT01087905|11620494|FG005|STARTED|Overall Study||127
10472139|NCT01087905|11620495|FG006|STARTED|Overall Study||121
10472140|NCT01087905|11620496|FG007|STARTED|Overall Study||127
10472141|NCT01087905|11620489|FG000|COMPLETED|Overall Study||90
10472142|NCT01087905|11620490|FG001|COMPLETED|Overall Study||94
10472143|NCT01087905|11620491|FG002|COMPLETED|Overall Study||101
10472144|NCT01087905|11620492|FG003|COMPLETED|Overall Study||86
10472145|NCT01087905|11620493|FG004|COMPLETED|Overall Study||91
10472146|NCT01087905|11620494|FG005|COMPLETED|Overall Study||99
10472147|NCT01087905|11620495|FG006|COMPLETED|Overall Study||98
10472148|NCT01087905|11620496|FG007|COMPLETED|Overall Study||98
10472149|NCT01087905|11620489|FG000|NOT COMPLETED|Overall Study||29
10472150|NCT01087905|11620490|FG001|NOT COMPLETED|Overall Study||32
10472151|NCT01087905|11620491|FG002|NOT COMPLETED|Overall Study||22
10472152|NCT01087905|11620492|FG003|NOT COMPLETED|Overall Study||36
10472153|NCT01087905|11620493|FG004|NOT COMPLETED|Overall Study||31
10472154|NCT01087905|11620494|FG005|NOT COMPLETED|Overall Study||28
10472155|NCT01087905|11620495|FG006|NOT COMPLETED|Overall Study||23
10472156|NCT01087905|11620496|FG007|NOT COMPLETED|Overall Study||29
10472157|NCT01087918|11620514|FG000|STARTED|Overall Study||5
10472158|NCT01087918|11620515|FG001|STARTED|Overall Study||4
10472159|NCT01087918|11620514|FG000|COMPLETED|Overall Study||5
10472160|NCT01087918|11620515|FG001|COMPLETED|Overall Study||4
10472161|NCT01087918|11620514|FG000|NOT COMPLETED|Overall Study||0
10472162|NCT01087918|11620515|FG001|NOT COMPLETED|Overall Study||0
10708936|NCT02635347|11873848|FG000|Enrollment|Overall Study||31
10708937|NCT02635347|11873849|FG001|Enrollment|Overall Study||63
10708938|NCT02635347|11873848|FG000|Protocol Completion|Overall Study||22
10472163|NCT01087931|11620527|FG000|STARTED|Overall Study||20
10472164|NCT01087931|11620528|FG001|STARTED|Overall Study||20
10708939|NCT02635347|11873849|FG001|Protocol Completion|Overall Study||63
10708940|NCT02635347|11873848|FG000|Follow up|Overall Study||31
10708941|NCT02635347|11873849|FG001|Follow up|Overall Study||63
10472165|NCT01087931|11620527|FG000|1st Follow up|Overall Study||20
10472166|NCT01087931|11620528|FG001|1st Follow up|Overall Study||19
10472167|NCT01087931|11620527|FG000|Final Follow up|Overall Study||19
10472168|NCT01087931|11620528|FG001|Final Follow up|Overall Study||17
10472169|NCT01087931|11620527|FG000|COMPLETED|Overall Study||20
10472170|NCT01087931|11620528|FG001|COMPLETED|Overall Study||20
10472171|NCT01087931|11620527|FG000|NOT COMPLETED|Overall Study||0
10472172|NCT01087931|11620528|FG001|NOT COMPLETED|Overall Study||0
10472173|NCT01087944|11620534|FG000|STARTED|Period 1 (Week 1-3)||30
10472174|NCT01087944|11620535|FG001|STARTED|Period 1 (Week 1-3)||30
10472175|NCT01087944|11620534|FG000|COMPLETED|Period 1 (Week 1-3)||29
10472176|NCT01087944|11620535|FG001|COMPLETED|Period 1 (Week 1-3)||30
10472177|NCT01087944|11620534|FG000|NOT COMPLETED|Period 1 (Week 1-3)||1
10472178|NCT01087944|11620535|FG001|NOT COMPLETED|Period 1 (Week 1-3)||0
10472179|NCT01087944|11620534|FG000|STARTED|Period 2 (Week 4-6)||29
10472180|NCT01087944|11620535|FG001|STARTED|Period 2 (Week 4-6)||30
10472181|NCT01087944|11620534|FG000|COMPLETED|Period 2 (Week 4-6)||29
10472182|NCT01087944|11620535|FG001|COMPLETED|Period 2 (Week 4-6)||28
10472183|NCT01087944|11620534|FG000|NOT COMPLETED|Period 2 (Week 4-6)||0
10472184|NCT01087944|11620535|FG001|NOT COMPLETED|Period 2 (Week 4-6)||2
10472185|NCT01087957|11620543|FG000|STARTED|Overall Study||253
10472186|NCT01087957|11620544|FG001|STARTED|Overall Study||242
10472187|NCT01087957|11620543|FG000|COMPLETED|Overall Study||212
10472188|NCT01087957|11620544|FG001|COMPLETED|Overall Study||187
10472189|NCT01087957|11620543|FG000|NOT COMPLETED|Overall Study||41
10472190|NCT01087957|11620544|FG001|NOT COMPLETED|Overall Study||55
10472191|NCT01087970|11620550|FG000|STARTED|Overall Study||69
10472192|NCT01087970|11620550|FG000|Received ≥1 Dose of Any Study Drug|Overall Study||69
10472193|NCT01087970|11620550|FG000|Completed 6 Cycles|Overall Study||69
10472194|NCT01087970|11620550|FG000|Efficacy Population|Overall Study|All treated participants excluding those from a noncompliant study site.|58
10472195|NCT01087970|11620550|FG000|Received Carboplatin|Overall Study||63
10472196|NCT01087970|11620550|FG000|COMPLETED|Overall Study||67
10472197|NCT01087970|11620550|FG000|NOT COMPLETED|Overall Study||2
10472198|NCT01087996|11620557|FG000|STARTED|Overall Study||15
10472199|NCT01087996|11620558|FG001|STARTED|Overall Study||15
10472200|NCT01087996|11620557|FG000|COMPLETED|Overall Study||15
10472201|NCT01087996|11620558|FG001|COMPLETED|Overall Study||15
10472202|NCT01087996|11620557|FG000|NOT COMPLETED|Overall Study||0
10472203|NCT01087996|11620558|FG001|NOT COMPLETED|Overall Study||0
10472204|NCT01088048|11620574|FG000|STARTED|Overall Study||51
10472205|NCT01088048|11620575|FG001|STARTED|Overall Study||51
10472206|NCT01088048|11620576|FG002|STARTED|Overall Study||18
10472207|NCT01088048|11620577|FG003|STARTED|Overall Study||18
10472208|NCT01088048|11620578|FG004|STARTED|Overall Study||33
10472209|NCT01088048|11620579|FG005|STARTED|Overall Study||21
10472210|NCT01088048|11620580|FG006|STARTED|Overall Study||12
10472211|NCT01088048|11620581|FG007|STARTED|Overall Study||15
10472212|NCT01088048|11620582|FG008|STARTED|Overall Study||15
10472213|NCT01088048|11620583|FG009|STARTED|Overall Study||7
10472214|NCT01088048|11620574|FG000|Participants With CLL|Overall Study||19
10472215|NCT01088048|11620575|FG001|Participants With CLL|Overall Study||18
10472216|NCT01088048|11620576|FG002|Participants With CLL|Overall Study||0
10472217|NCT01088048|11620577|FG003|Participants With CLL|Overall Study||0
10472218|NCT01088048|11620578|FG004|Participants With CLL|Overall Study||15
10472219|NCT01088048|11620579|FG005|Participants With CLL|Overall Study||21
10472220|NCT01088048|11620580|FG006|Participants With CLL|Overall Study||12
10472221|NCT01088048|11620581|FG007|Participants With CLL|Overall Study||15
10472222|NCT01088048|11620582|FG008|Participants With CLL|Overall Study||14
10472223|NCT01088048|11620583|FG009|Participants With CLL|Overall Study||1
10472224|NCT01088048|11620574|FG000|Participants With Indolent NHL|Overall Study||32
10472225|NCT01088048|11620575|FG001|Participants With Indolent NHL|Overall Study||33
10472226|NCT01088048|11620576|FG002|Participants With Indolent NHL|Overall Study||0
10472227|NCT01088048|11620577|FG003|Participants With Indolent NHL|Overall Study||0
10472228|NCT01088048|11620578|FG004|Participants With Indolent NHL|Overall Study||14
10472229|NCT01088048|11620579|FG005|Participants With Indolent NHL|Overall Study||0
10472230|NCT01088048|11620580|FG006|Participants With Indolent NHL|Overall Study||0
10472231|NCT01088048|11620581|FG007|Participants With Indolent NHL|Overall Study||0
10472232|NCT01088048|11620582|FG008|Participants With Indolent NHL|Overall Study||1
10472233|NCT01088048|11620583|FG009|Participants With Indolent NHL|Overall Study||6
10472234|NCT01088048|11620574|FG000|Participants With MCL|Overall Study||0
10472235|NCT01088048|11620575|FG001|Participants With MCL|Overall Study||0
10472236|NCT01088048|11620576|FG002|Participants With MCL|Overall Study||18
10472237|NCT01088048|11620577|FG003|Participants With MCL|Overall Study||18
10472238|NCT01088048|11620578|FG004|Participants With MCL|Overall Study||4
10472239|NCT01088048|11620579|FG005|Participants With MCL|Overall Study||0
10472240|NCT01088048|11620580|FG006|Participants With MCL|Overall Study||0
10472241|NCT01088048|11620581|FG007|Participants With MCL|Overall Study||0
10472242|NCT01088048|11620582|FG008|Participants With MCL|Overall Study||0
10472243|NCT01088048|11620583|FG009|Participants With MCL|Overall Study||0
10472244|NCT01088048|11620574|FG000|COMPLETED|Overall Study||29
10472245|NCT01088048|11620575|FG001|COMPLETED|Overall Study||24
10472246|NCT01088048|11620576|FG002|COMPLETED|Overall Study||4
10472247|NCT01088048|11620577|FG003|COMPLETED|Overall Study||4
10472248|NCT01088048|11620578|FG004|COMPLETED|Overall Study||16
10472249|NCT01088048|11620579|FG005|COMPLETED|Overall Study||10
10472250|NCT01088048|11620580|FG006|COMPLETED|Overall Study||6
10472251|NCT01088048|11620581|FG007|COMPLETED|Overall Study||10
10472252|NCT01088048|11620582|FG008|COMPLETED|Overall Study||8
10472253|NCT01088048|11620583|FG009|COMPLETED|Overall Study||3
10472254|NCT01088048|11620574|FG000|NOT COMPLETED|Overall Study||22
10472255|NCT01088048|11620575|FG001|NOT COMPLETED|Overall Study||27
10472256|NCT01088048|11620576|FG002|NOT COMPLETED|Overall Study||14
10472257|NCT01088048|11620577|FG003|NOT COMPLETED|Overall Study||14
10472258|NCT01088048|11620578|FG004|NOT COMPLETED|Overall Study||17
10472259|NCT01088048|11620579|FG005|NOT COMPLETED|Overall Study||11
10472260|NCT01088048|11620580|FG006|NOT COMPLETED|Overall Study||6
10472261|NCT01088048|11620581|FG007|NOT COMPLETED|Overall Study||5
10472262|NCT01088048|11620582|FG008|NOT COMPLETED|Overall Study||7
10472263|NCT01088048|11620583|FG009|NOT COMPLETED|Overall Study||4
10472264|NCT01088243|11620618|FG000|STARTED|Overall Study||13
10472265|NCT01088243|11620619|FG001|STARTED|Overall Study||5
10472266|NCT01088243|11620618|FG000|COMPLETED|Overall Study||12
10472267|NCT01088243|11620619|FG001|COMPLETED|Overall Study||5
10472268|NCT01088243|11620618|FG000|NOT COMPLETED|Overall Study||1
10472269|NCT01088243|11620619|FG001|NOT COMPLETED|Overall Study||0
10472270|NCT01088295|11620625|FG000|STARTED|Overall Study||36
10472271|NCT01088295|11620625|FG000|COMPLETED|Overall Study||35
10472272|NCT01088295|11620625|FG000|NOT COMPLETED|Overall Study||1
10472273|NCT01088399|11620632|FG000|STARTED|Overall Study||8716
10472274|NCT01088399|11620633|FG001|STARTED|Overall Study||1655
10472275|NCT01088399|11620634|FG002|STARTED|Overall Study||302
10472276|NCT01088399|11620632|FG000|COMPLETED|Overall Study||1595
10472277|NCT01088399|11620633|FG001|COMPLETED|Overall Study||308
10472278|NCT01088399|11620634|FG002|COMPLETED|Overall Study||21
10472279|NCT01088399|11620632|FG000|NOT COMPLETED|Overall Study||7121
10472280|NCT01088399|11620633|FG001|NOT COMPLETED|Overall Study||1347
10472281|NCT01088399|11620634|FG002|NOT COMPLETED|Overall Study||281
10472282|NCT01088412|11620645|FG000|STARTED|Overall Study||22311
10472283|NCT01088412|11620646|FG001|STARTED|Overall Study||457
10472284|NCT01088412|11620647|FG002|STARTED|Overall Study||77
10472285|NCT01088412|11620645|FG000|Safety Modified Evaluable (SME)|Overall Study||22294
10472286|NCT01088412|11620646|FG001|Safety Modified Evaluable (SME)|Overall Study||456
10472287|NCT01088412|11620647|FG002|Safety Modified Evaluable (SME)|Overall Study||0
10472288|NCT01088412|11620645|FG000|SME With at Least 1 Follow Up (FU)|Overall Study||21178
10472289|NCT01088412|11620646|FG001|SME With at Least 1 Follow Up (FU)|Overall Study||306
10472290|NCT01088412|11620647|FG002|SME With at Least 1 Follow Up (FU)|Overall Study||0
10472291|NCT01088412|11620645|FG000|SME+ >= 1 FU and Unknown Arm|Overall Study||21177
10472292|NCT01088412|11620646|FG001|SME+ >= 1 FU and Unknown Arm|Overall Study||306
10472293|NCT01088412|11620647|FG002|SME+ >= 1 FU and Unknown Arm|Overall Study||40
10472294|NCT01088412|11620645|FG000|SME+ >= 1 FU and No Previous Cancer|Overall Study||20556
10472295|NCT01088412|11620646|FG001|SME+ >= 1 FU and No Previous Cancer|Overall Study||192
10472296|NCT01088412|11620647|FG002|SME+ >= 1 FU and No Previous Cancer|Overall Study||0
10472297|NCT01088412|11620645|FG000|SME+ >= 1 FU and Previous Cancer|Overall Study||622
10472298|NCT01088412|11620646|FG001|SME+ >= 1 FU and Previous Cancer|Overall Study||114
10472299|NCT01088412|11620647|FG002|SME+ >= 1 FU and Previous Cancer|Overall Study||0
10472300|NCT01088412|11620645|FG000|COMPLETED|Overall Study||4294
10472301|NCT01088412|11620646|FG001|COMPLETED|Overall Study||21
10472302|NCT01088412|11620647|FG002|COMPLETED|Overall Study||5
10472303|NCT01088412|11620645|FG000|NOT COMPLETED|Overall Study||18017
10472304|NCT01088412|11620646|FG001|NOT COMPLETED|Overall Study||436
10472305|NCT01088412|11620647|FG002|NOT COMPLETED|Overall Study||72
10472306|NCT01088438|11620660|FG000|STARTED|Overall Study||94
10472307|NCT01088438|11620661|FG001|STARTED|Overall Study||95
10472308|NCT01088438|11620660|FG000|COMPLETED|Overall Study||65
10472309|NCT01088438|11620661|FG001|COMPLETED|Overall Study||59
10472310|NCT01088438|11620660|FG000|NOT COMPLETED|Overall Study||29
10472311|NCT01088438|11620661|FG001|NOT COMPLETED|Overall Study||36
10472312|NCT01088464|11620670|FG000|STARTED|Overall Study||3
10472313|NCT01088464|11620671|FG001|STARTED|Overall Study||6
10472314|NCT01088464|11620672|FG002|STARTED|Overall Study||6
10472315|NCT01088464|11620670|FG000|Received Any Quantity of Study Drug|Overall Study||3
10472316|NCT01088464|11620671|FG001|Received Any Quantity of Study Drug|Overall Study||6
10472317|NCT01088464|11620672|FG002|Received Any Quantity of Study Drug|Overall Study||6
10472318|NCT01088464|11620670|FG000|COMPLETED|Overall Study||3
10472319|NCT01088464|11620671|FG001|COMPLETED|Overall Study||6
10472320|NCT01088464|11620672|FG002|COMPLETED|Overall Study||6
10472321|NCT01088464|11620670|FG000|NOT COMPLETED|Overall Study||0
10472322|NCT01088464|11620671|FG001|NOT COMPLETED|Overall Study||0
10472323|NCT01088464|11620672|FG002|NOT COMPLETED|Overall Study||0
10472324|NCT01088503|11620683|FG000|STARTED|Overall Study||3123
10472325|NCT01088503|11620684|FG001|STARTED|Overall Study||8846
10472326|NCT01088503|11620685|FG002|STARTED|Overall Study||258
10472327|NCT01088503|11620683|FG000|COMPLETED|Overall Study||2941
10472328|NCT01088503|11620684|FG001|COMPLETED|Overall Study||8161
10472329|NCT01088503|11620685|FG002|COMPLETED|Overall Study||241
10472330|NCT01088503|11620683|FG000|NOT COMPLETED|Overall Study||182
10472331|NCT01088503|11620684|FG001|NOT COMPLETED|Overall Study||685
10472332|NCT01088503|11620685|FG002|NOT COMPLETED|Overall Study||17
10472333|NCT01088529|11620693|FG000|STARTED|Overall Study||44
10472334|NCT01088529|11620694|FG001|STARTED|Overall Study||22
10472335|NCT01088529|11620693|FG000|Received Treatment|Overall Study||44
10472336|NCT01088529|11620694|FG001|Received Treatment|Overall Study||21
10472337|NCT01088529|11620693|FG000|COMPLETED|Overall Study||44
10472338|NCT01088529|11620694|FG001|COMPLETED|Overall Study||21
10472339|NCT01088529|11620693|FG000|NOT COMPLETED|Overall Study||0
10472340|NCT01088529|11620694|FG001|NOT COMPLETED|Overall Study||1
10472341|NCT01088646|11620700|FG000|STARTED|Overall Study||25
10472342|NCT01088646|11620700|FG000|COMPLETED|Overall Study||25
10472343|NCT01088646|11620700|FG000|NOT COMPLETED|Overall Study||0
10472344|NCT01088672|11620705|FG000|STARTED|Overall Study||60
10472345|NCT01088672|11620705|FG000|COMPLETED|Overall Study||60
10472346|NCT01088672|11620705|FG000|NOT COMPLETED|Overall Study||0
10472347|NCT01088711|11620713|FG000|STARTED|Overall Study||18
10472348|NCT01088711|11620714|FG001|STARTED|Overall Study||6
10472349|NCT01088711|11620715|FG002|STARTED|Overall Study||6
10472350|NCT01088711|11620716|FG003|STARTED|Overall Study||2
10472351|NCT01088711|11620713|FG000|COMPLETED|Overall Study||18
10472352|NCT01088711|11620714|FG001|COMPLETED|Overall Study||6
10472353|NCT01088711|11620715|FG002|COMPLETED|Overall Study||6
10472354|NCT01088711|11620716|FG003|COMPLETED|Overall Study||2
10472355|NCT01088711|11620713|FG000|NOT COMPLETED|Overall Study||0
10472356|NCT01088711|11620714|FG001|NOT COMPLETED|Overall Study||0
10472357|NCT01088711|11620715|FG002|NOT COMPLETED|Overall Study||0
10472358|NCT01088711|11620716|FG003|NOT COMPLETED|Overall Study||0
10472359|NCT01088984|11620730|FG000|STARTED|Phase 1||5
10472360|NCT01088984|11620731|FG001|STARTED|Phase 1||6
10472361|NCT01088984|11620730|FG000|COMPLETED|Phase 1|completed follow-up up to 12 month from last dose of study drug|0
10472362|NCT01088984|11620731|FG001|COMPLETED|Phase 1|completed follow-up up to 12 month from last dose of study drug|0
10472363|NCT01088984|11620730|FG000|NOT COMPLETED|Phase 1||5
10472364|NCT01088984|11620731|FG001|NOT COMPLETED|Phase 1||6
10472365|NCT01088984|11620730|FG000|STARTED|Phase 2||0
10472366|NCT01088984|11620731|FG001|STARTED|Phase 2||32
10472367|NCT01088984|11620730|FG000|COMPLETED|Phase 2|completed follow-up up to 12 month from last dose of study drug|0
10472368|NCT01088984|11620731|FG001|COMPLETED|Phase 2|completed follow-up up to 12 month from last dose of study drug|0
10472369|NCT01088984|11620730|FG000|NOT COMPLETED|Phase 2||0
10472370|NCT01088984|11620731|FG001|NOT COMPLETED|Phase 2||32
10708942|NCT02635347|11873848|FG000|Analyses|Overall Study||30
10708943|NCT02635347|11873849|FG001|Analyses|Overall Study||63
10708944|NCT02635347|11873848|FG000|COMPLETED|Overall Study||31
10472371|NCT01088997|11620742|FG000|STARTED|Overall Study||7
10472372|NCT01088997|11620743|FG001|STARTED|Overall Study||5
10472373|NCT01088997|11620742|FG000|COMPLETED|Overall Study||4
10472374|NCT01088997|11620743|FG001|COMPLETED|Overall Study||2
10472375|NCT01088997|11620742|FG000|NOT COMPLETED|Overall Study||3
10472376|NCT01088997|11620743|FG001|NOT COMPLETED|Overall Study||3
10472377|NCT01089023|11620752|FG000|STARTED|Overall Study||95
10472378|NCT01089023|11620752|FG000|COMPLETED|Overall Study||88
10472379|NCT01089023|11620752|FG000|NOT COMPLETED|Overall Study||7
10472380|NCT01089062|11620762|FG000|STARTED|Visit 2 (Randomization)||4
10472381|NCT01089062|11620763|FG001|STARTED|Visit 2 (Randomization)||4
10472382|NCT01089062|11620764|FG002|STARTED|Visit 2 (Randomization)||4
10472383|NCT01089062|11620765|FG003|STARTED|Visit 2 (Randomization)||4
10472384|NCT01089062|11620766|FG004|STARTED|Visit 2 (Randomization)||4
10472385|NCT01089062|11620767|FG005|STARTED|Visit 2 (Randomization)||4
10472386|NCT01089062|11620762|FG000|COMPLETED|Visit 2 (Randomization)||3
10472387|NCT01089062|11620763|FG001|COMPLETED|Visit 2 (Randomization)||3
10472388|NCT01089062|11620764|FG002|COMPLETED|Visit 2 (Randomization)||3
10472389|NCT01089062|11620765|FG003|COMPLETED|Visit 2 (Randomization)||4
10472390|NCT01089062|11620766|FG004|COMPLETED|Visit 2 (Randomization)||3
10472391|NCT01089062|11620767|FG005|COMPLETED|Visit 2 (Randomization)||3
10472392|NCT01089062|11620762|FG000|NOT COMPLETED|Visit 2 (Randomization)||1
10472393|NCT01089062|11620763|FG001|NOT COMPLETED|Visit 2 (Randomization)||1
10472394|NCT01089062|11620764|FG002|NOT COMPLETED|Visit 2 (Randomization)||1
10472395|NCT01089062|11620765|FG003|NOT COMPLETED|Visit 2 (Randomization)||0
10472396|NCT01089062|11620766|FG004|NOT COMPLETED|Visit 2 (Randomization)||1
10472397|NCT01089062|11620767|FG005|NOT COMPLETED|Visit 2 (Randomization)||1
10472398|NCT01089062|11620762|FG000|STARTED|Visit 3||3
10472399|NCT01089062|11620763|FG001|STARTED|Visit 3||3
10472400|NCT01089062|11620764|FG002|STARTED|Visit 3||3
10472401|NCT01089062|11620765|FG003|STARTED|Visit 3||4
10472402|NCT01089062|11620766|FG004|STARTED|Visit 3||3
10472403|NCT01089062|11620767|FG005|STARTED|Visit 3||3
10472404|NCT01089062|11620762|FG000|COMPLETED|Visit 3||3
10472405|NCT01089062|11620763|FG001|COMPLETED|Visit 3||3
10472406|NCT01089062|11620764|FG002|COMPLETED|Visit 3||3
10472407|NCT01089062|11620765|FG003|COMPLETED|Visit 3||3
10472408|NCT01089062|11620766|FG004|COMPLETED|Visit 3||3
10472409|NCT01089062|11620767|FG005|COMPLETED|Visit 3||3
10472410|NCT01089062|11620762|FG000|NOT COMPLETED|Visit 3||0
10472411|NCT01089062|11620763|FG001|NOT COMPLETED|Visit 3||0
10472412|NCT01089062|11620764|FG002|NOT COMPLETED|Visit 3||0
10472413|NCT01089062|11620765|FG003|NOT COMPLETED|Visit 3||1
10472414|NCT01089062|11620766|FG004|NOT COMPLETED|Visit 3||0
10472415|NCT01089062|11620767|FG005|NOT COMPLETED|Visit 3||0
10472416|NCT01089062|11620762|FG000|STARTED|Visit 4||3
10708945|NCT02635347|11873849|FG001|COMPLETED|Overall Study||63
10472417|NCT01089062|11620763|FG001|STARTED|Visit 4||3
10472418|NCT01089062|11620764|FG002|STARTED|Visit 4||3
10472419|NCT01089062|11620765|FG003|STARTED|Visit 4||3
10472420|NCT01089062|11620766|FG004|STARTED|Visit 4||3
10472421|NCT01089062|11620767|FG005|STARTED|Visit 4||3
10472422|NCT01089062|11620762|FG000|COMPLETED|Visit 4||3
10472423|NCT01089062|11620763|FG001|COMPLETED|Visit 4||3
10472424|NCT01089062|11620764|FG002|COMPLETED|Visit 4||3
10472425|NCT01089062|11620765|FG003|COMPLETED|Visit 4||3
10472426|NCT01089062|11620766|FG004|COMPLETED|Visit 4||3
10472427|NCT01089062|11620767|FG005|COMPLETED|Visit 4||3
10472428|NCT01089062|11620762|FG000|NOT COMPLETED|Visit 4||0
10472429|NCT01089062|11620763|FG001|NOT COMPLETED|Visit 4||0
10472430|NCT01089062|11620764|FG002|NOT COMPLETED|Visit 4||0
10472431|NCT01089062|11620765|FG003|NOT COMPLETED|Visit 4||0
10472432|NCT01089062|11620766|FG004|NOT COMPLETED|Visit 4||0
10472433|NCT01089062|11620767|FG005|NOT COMPLETED|Visit 4||0
10472434|NCT01089062|11620762|FG000|STARTED|Follow-up Visit (Final Visit)||3
10472435|NCT01089062|11620763|FG001|STARTED|Follow-up Visit (Final Visit)||3
10472436|NCT01089062|11620764|FG002|STARTED|Follow-up Visit (Final Visit)||3
10472437|NCT01089062|11620765|FG003|STARTED|Follow-up Visit (Final Visit)||3
10472438|NCT01089062|11620766|FG004|STARTED|Follow-up Visit (Final Visit)||3
10472439|NCT01089062|11620767|FG005|STARTED|Follow-up Visit (Final Visit)||3
10472440|NCT01089062|11620762|FG000|COMPLETED|Follow-up Visit (Final Visit)||3
10472441|NCT01089062|11620763|FG001|COMPLETED|Follow-up Visit (Final Visit)||3
10472442|NCT01089062|11620764|FG002|COMPLETED|Follow-up Visit (Final Visit)||3
10472443|NCT01089062|11620765|FG003|COMPLETED|Follow-up Visit (Final Visit)||3
10472444|NCT01089062|11620766|FG004|COMPLETED|Follow-up Visit (Final Visit)||3
10472445|NCT01089062|11620767|FG005|COMPLETED|Follow-up Visit (Final Visit)||3
10472446|NCT01089062|11620762|FG000|NOT COMPLETED|Follow-up Visit (Final Visit)||0
10472447|NCT01089062|11620763|FG001|NOT COMPLETED|Follow-up Visit (Final Visit)||0
10472448|NCT01089062|11620764|FG002|NOT COMPLETED|Follow-up Visit (Final Visit)||0
10472449|NCT01089062|11620765|FG003|NOT COMPLETED|Follow-up Visit (Final Visit)||0
10472450|NCT01089062|11620766|FG004|NOT COMPLETED|Follow-up Visit (Final Visit)||0
10472451|NCT01089062|11620767|FG005|NOT COMPLETED|Follow-up Visit (Final Visit)||0
10472452|NCT01089127|11620782|FG000|STARTED|Overall Study||92
10472453|NCT01089127|11620783|FG001|STARTED|Overall Study||91
10472454|NCT01089127|11620784|FG002|STARTED|Overall Study||94
10472455|NCT01089127|11620785|FG003|STARTED|Overall Study||92
10472456|NCT01089127|11620786|FG004|STARTED|Overall Study||92
10472457|NCT01089127|11620787|FG005|STARTED|Overall Study||91
10472458|NCT01089127|11620782|FG000|Exposed to Study Drug|Overall Study|3 randomized patients in this group were not exposed to study treatment.|89
10472459|NCT01089127|11620783|FG001|Exposed to Study Drug|Overall Study|1 randomized patient in this group was not exposed to study treatment.|90
10472460|NCT01089127|11620784|FG002|Exposed to Study Drug|Overall Study||94
10472461|NCT01089127|11620785|FG003|Exposed to Study Drug|Overall Study||92
10472462|NCT01089127|11620786|FG004|Exposed to Study Drug|Overall Study|1 randomized patient in this group was not exposed to study treatment.|91
10472463|NCT01089127|11620787|FG005|Exposed to Study Drug|Overall Study||91
10472464|NCT01089127|11620782|FG000|COMPLETED|Overall Study||84
10472465|NCT01089127|11620783|FG001|COMPLETED|Overall Study||86
10472466|NCT01089127|11620784|FG002|COMPLETED|Overall Study||92
10472467|NCT01089127|11620785|FG003|COMPLETED|Overall Study||91
10472468|NCT01089127|11620786|FG004|COMPLETED|Overall Study||90
10472469|NCT01089127|11620787|FG005|COMPLETED|Overall Study||88
10472470|NCT01089127|11620782|FG000|NOT COMPLETED|Overall Study||8
10472471|NCT01089127|11620783|FG001|NOT COMPLETED|Overall Study||5
10472472|NCT01089127|11620784|FG002|NOT COMPLETED|Overall Study||2
10472473|NCT01089127|11620785|FG003|NOT COMPLETED|Overall Study||1
10472474|NCT01089127|11620786|FG004|NOT COMPLETED|Overall Study||2
10472475|NCT01089127|11620787|FG005|NOT COMPLETED|Overall Study||3
10472476|NCT01089231|11620805|FG000|STARTED|Overall Study||10
10472477|NCT01089231|11620806|FG001|STARTED|Overall Study||10
10472478|NCT01089231|11620807|FG002|STARTED|Overall Study||10
10472479|NCT01089231|11620808|FG003|STARTED|Overall Study||10
10472480|NCT01089231|11620805|FG000|COMPLETED|Overall Study|4 subjects excluded (2 alcohol use / TG level changes; 1 use of not allowed drugs; 1 low RNA yield)|6
10472481|NCT01089231|11620806|FG001|COMPLETED|Overall Study|2 subjects excluded (1 highly elevated TG and TC data; 1 elevated inflammation (CRP level))|8
10472482|NCT01089231|11620807|FG002|COMPLETED|Overall Study|2 subject excluded (1 use of not allowed drugs; 1 low RNA yield)|8
10472483|NCT01089231|11620808|FG003|COMPLETED|Overall Study|1 subject excluded (low RNA yield)|9
10472484|NCT01089231|11620805|FG000|NOT COMPLETED|Overall Study||4
10472485|NCT01089231|11620806|FG001|NOT COMPLETED|Overall Study||2
10472486|NCT01089231|11620807|FG002|NOT COMPLETED|Overall Study||2
10472487|NCT01089231|11620808|FG003|NOT COMPLETED|Overall Study||1
10472488|NCT01089361|11620820|FG000|STARTED|Overall Study||9
10472489|NCT01089361|11620821|FG001|STARTED|Overall Study||10
10472490|NCT01089361|11620820|FG000|COMPLETED|Overall Study||8
10472491|NCT01089361|11620821|FG001|COMPLETED|Overall Study||10
10472492|NCT01089361|11620820|FG000|NOT COMPLETED|Overall Study||1
10472493|NCT01089361|11620821|FG001|NOT COMPLETED|Overall Study||0
10472494|NCT01089413|11620832|FG000|STARTED|Overall Study||201
10472495|NCT01089413|11620832|FG000|Received Bevacizumab in First Line|Overall Study||199
10472496|NCT01089413|11620832|FG000|COMPLETED|Overall Study||0
10472497|NCT01089413|11620832|FG000|NOT COMPLETED|Overall Study||201
10472498|NCT01089504|11620844|FG000|STARTED|Overall Study||8
10472499|NCT01089504|11620845|FG001|STARTED|Overall Study||5
10472500|NCT01089504|11620844|FG000|COMPLETED|Overall Study||5
10472501|NCT01089504|11620845|FG001|COMPLETED|Overall Study||4
10472502|NCT01089504|11620844|FG000|NOT COMPLETED|Overall Study||3
10472503|NCT01089504|11620845|FG001|NOT COMPLETED|Overall Study||1
10472504|NCT01089517|11620854|FG000|STARTED|Overall Study||148
10472505|NCT01089517|11620855|FG001|STARTED|Overall Study||149
10472506|NCT01089517|11620856|FG002|STARTED|Overall Study||152
10472507|NCT01089517|11620854|FG000|COMPLETED|Overall Study||144
10472508|NCT01089517|11620855|FG001|COMPLETED|Overall Study||144
10472509|NCT01089517|11620856|FG002|COMPLETED|Overall Study||147
10472510|NCT01089517|11620854|FG000|NOT COMPLETED|Overall Study||4
10472511|NCT01089517|11620855|FG001|NOT COMPLETED|Overall Study||5
10472512|NCT01089517|11620856|FG002|NOT COMPLETED|Overall Study||5
10472513|NCT01089543|11620868|FG000|STARTED|Overall Study||84
10472514|NCT01089543|11620869|FG001|STARTED|Overall Study||85
10472515|NCT01089543|11620870|FG002|STARTED|Overall Study||84
10472516|NCT01089543|11620871|FG003|STARTED|Overall Study||85
10472517|NCT01089543|11620868|FG000|COMPLETED|Overall Study||81
10472518|NCT01089543|11620869|FG001|COMPLETED|Overall Study||81
10708946|NCT02635347|11873848|FG000|NOT COMPLETED|Overall Study||20
10708947|NCT02635347|11873849|FG001|NOT COMPLETED|Overall Study||7
10708948|NCT02635386|11873861|FG000|STARTED|Overall Study||23
10708949|NCT02635386|11873862|FG001|STARTED|Overall Study||23
10708950|NCT02635386|11873863|FG002|STARTED|Overall Study||22
10708951|NCT02635386|11873864|FG003|STARTED|Overall Study||26
10472519|NCT01089543|11620870|FG002|COMPLETED|Overall Study||81
10472520|NCT01089543|11620871|FG003|COMPLETED|Overall Study||83
10472521|NCT01089543|11620868|FG000|NOT COMPLETED|Overall Study||3
10472522|NCT01089543|11620869|FG001|NOT COMPLETED|Overall Study||4
10472523|NCT01089543|11620870|FG002|NOT COMPLETED|Overall Study||3
10472524|NCT01089543|11620871|FG003|NOT COMPLETED|Overall Study||2
10472525|NCT01089556|11620883|FG000|STARTED|Study Period II (Weeks 1-8)||404
10472526|NCT01089556|11620884|FG001|STARTED|Study Period II (Weeks 1-8)||407
10472527|NCT01089556|11620885|FG002|STARTED|Study Period II (Weeks 1-8)||0
10472528|NCT01089556|11620886|FG003|STARTED|Study Period II (Weeks 1-8)||0
10472529|NCT01089556|11620887|FG004|STARTED|Study Period II (Weeks 1-8)||0
10472530|NCT01089556|11620888|FG005|STARTED|Study Period II (Weeks 1-8)||0
10472531|NCT01089556|11620883|FG000|Safety Population|Study Period II (Weeks 1-8)|Received at least 1 dose of study drug.|401
10472532|NCT01089556|11620884|FG001|Safety Population|Study Period II (Weeks 1-8)|Received at least 1 dose of study drug.|403
10472533|NCT01089556|11620885|FG002|Safety Population|Study Period II (Weeks 1-8)||0
10472534|NCT01089556|11620886|FG003|Safety Population|Study Period II (Weeks 1-8)||0
10472535|NCT01089556|11620887|FG004|Safety Population|Study Period II (Weeks 1-8)||0
10472536|NCT01089556|11620888|FG005|Safety Population|Study Period II (Weeks 1-8)||0
10472537|NCT01089556|11620883|FG000|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||158
10472538|NCT01089556|11620884|FG001|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||205
10472539|NCT01089556|11620885|FG002|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
10472540|NCT01089556|11620886|FG003|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
10472541|NCT01089556|11620887|FG004|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
10472542|NCT01089556|11620888|FG005|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
10472543|NCT01089556|11620883|FG000|COMPLETED|Study Period II (Weeks 1-8)||333
10472544|NCT01089556|11620884|FG001|COMPLETED|Study Period II (Weeks 1-8)||333
10472545|NCT01089556|11620885|FG002|COMPLETED|Study Period II (Weeks 1-8)||0
10472546|NCT01089556|11620886|FG003|COMPLETED|Study Period II (Weeks 1-8)||0
10472547|NCT01089556|11620887|FG004|COMPLETED|Study Period II (Weeks 1-8)||0
10472548|NCT01089556|11620888|FG005|COMPLETED|Study Period II (Weeks 1-8)||0
10472549|NCT01089556|11620883|FG000|NOT COMPLETED|Study Period II (Weeks 1-8)||71
10472550|NCT01089556|11620884|FG001|NOT COMPLETED|Study Period II (Weeks 1-8)||74
10472551|NCT01089556|11620885|FG002|NOT COMPLETED|Study Period II (Weeks 1-8)||0
10472552|NCT01089556|11620886|FG003|NOT COMPLETED|Study Period II (Weeks 1-8)||0
10472553|NCT01089556|11620887|FG004|NOT COMPLETED|Study Period II (Weeks 1-8)||0
10472554|NCT01089556|11620888|FG005|NOT COMPLETED|Study Period II (Weeks 1-8)||0
10472555|NCT01089556|11620883|FG000|STARTED|Study Period III (Weeks 9-16)||0
10472556|NCT01089556|11620884|FG001|STARTED|Study Period III (Weeks 9-16)||0
10472557|NCT01089556|11620885|FG002|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 10 non-responders did not enter SPIII, while 4 responders entered SPIII|74
10472558|NCT01089556|11620886|FG003|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 6 non-responders did not enter SPIII, while 3 responders entered SPIII|75
10472559|NCT01089556|11620887|FG004|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 10 non-responders did not enter SPIII, while 4 responders entered SPIII|95
10472560|NCT01089556|11620888|FG005|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 6 non-responders did not enter SPIII, while 1 responders entered SPIII|99
10472561|NCT01089556|11620883|FG000|Efficacy and Safety Population|Study Period III (Weeks 9-16)||0
10472562|NCT01089556|11620884|FG001|Efficacy and Safety Population|Study Period III (Weeks 9-16)||0
10472563|NCT01089556|11620885|FG002|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|73
10472564|NCT01089556|11620886|FG003|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|75
10472565|NCT01089556|11620887|FG004|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|94
10472566|NCT01089556|11620888|FG005|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|97
10472567|NCT01089556|11620883|FG000|COMPLETED|Study Period III (Weeks 9-16)||0
10472568|NCT01089556|11620884|FG001|COMPLETED|Study Period III (Weeks 9-16)||0
10472569|NCT01089556|11620885|FG002|COMPLETED|Study Period III (Weeks 9-16)||60
10472570|NCT01089556|11620886|FG003|COMPLETED|Study Period III (Weeks 9-16)||66
10472571|NCT01089556|11620887|FG004|COMPLETED|Study Period III (Weeks 9-16)||83
10472572|NCT01089556|11620888|FG005|COMPLETED|Study Period III (Weeks 9-16)||92
10472573|NCT01089556|11620883|FG000|NOT COMPLETED|Study Period III (Weeks 9-16)||0
10472574|NCT01089556|11620884|FG001|NOT COMPLETED|Study Period III (Weeks 9-16)||0
10472575|NCT01089556|11620885|FG002|NOT COMPLETED|Study Period III (Weeks 9-16)||14
10472576|NCT01089556|11620886|FG003|NOT COMPLETED|Study Period III (Weeks 9-16)||9
10708952|NCT02635386|11873865|FG004|STARTED|Overall Study||25
10472577|NCT01089556|11620887|FG004|NOT COMPLETED|Study Period III (Weeks 9-16)||12
10472578|NCT01089556|11620888|FG005|NOT COMPLETED|Study Period III (Weeks 9-16)||7
10472579|NCT01089569|11620903|FG000|STARTED|Overall Study||20
10472580|NCT01089569|11620904|FG001|STARTED|Overall Study||20
10472581|NCT01089569|11620905|FG002|STARTED|Overall Study||20
10472582|NCT01089569|11620903|FG000|COMPLETED|Overall Study||16
10472583|NCT01089569|11620904|FG001|COMPLETED|Overall Study||17
10472584|NCT01089569|11620905|FG002|COMPLETED|Overall Study||16
10472585|NCT01089569|11620903|FG000|NOT COMPLETED|Overall Study||4
10472586|NCT01089569|11620904|FG001|NOT COMPLETED|Overall Study||3
10472587|NCT01089569|11620905|FG002|NOT COMPLETED|Overall Study||4
10472588|NCT01089582|11620913|FG000|STARTED|Overall Study||603
10472589|NCT01089582|11620913|FG000|COMPLETED|Overall Study|1 subject died during the study; 1 subject died following permanent discontinuation from the study.|573
10472590|NCT01089582|11620913|FG000|NOT COMPLETED|Overall Study||30
10472591|NCT01089595|11620919|FG000|STARTED|Overall Study||2
10472592|NCT01089595|11620920|FG001|STARTED|Overall Study||3
10472593|NCT01089595|11620919|FG000|COMPLETED|Overall Study||2
10472594|NCT01089595|11620920|FG001|COMPLETED|Overall Study||3
10472595|NCT01089595|11620919|FG000|NOT COMPLETED|Overall Study||0
10472596|NCT01089595|11620920|FG001|NOT COMPLETED|Overall Study||0
10472597|NCT01089608|11620930|FG000|STARTED|Overall Study||43
10472598|NCT01089608|11620931|FG001|STARTED|Overall Study||50
10472599|NCT01089608|11620930|FG000|COMPLETED|Overall Study||43
10472600|NCT01089608|11620931|FG001|COMPLETED|Overall Study||44
10472601|NCT01089608|11620930|FG000|NOT COMPLETED|Overall Study||0
10472602|NCT01089608|11620931|FG001|NOT COMPLETED|Overall Study||6
10472603|NCT01089647|11620939|FG000|STARTED|Overall Study||17
10472604|NCT01089647|11620940|FG001|STARTED|Overall Study||17
10472605|NCT01089647|11620939|FG000|COMPLETED|Overall Study||13
10472606|NCT01089647|11620940|FG001|COMPLETED|Overall Study||13
10472607|NCT01089647|11620939|FG000|NOT COMPLETED|Overall Study||4
10472608|NCT01089647|11620940|FG001|NOT COMPLETED|Overall Study||4
10472609|NCT01089725|11620951|FG000|STARTED|Overall Study||72
10472610|NCT01089725|11620952|FG001|STARTED|Overall Study||75
10472611|NCT01089725|11620953|FG002|STARTED|Overall Study||65
10472612|NCT01089725|11620954|FG003|STARTED|Overall Study||87
10472613|NCT01089725|11620955|FG004|STARTED|Overall Study||86
10472614|NCT01089725|11620951|FG000|Treated|Overall Study||72
10472615|NCT01089725|11620952|FG001|Treated|Overall Study||74
10472616|NCT01089725|11620953|FG002|Treated|Overall Study||63
10472617|NCT01089725|11620954|FG003|Treated|Overall Study||86
10472618|NCT01089725|11620955|FG004|Treated|Overall Study||84
10472619|NCT01089725|11620951|FG000|COMPLETED|Overall Study||6
10472620|NCT01089725|11620952|FG001|COMPLETED|Overall Study||7
10472621|NCT01089725|11620953|FG002|COMPLETED|Overall Study||4
10472622|NCT01089725|11620954|FG003|COMPLETED|Overall Study||8
10472623|NCT01089725|11620955|FG004|COMPLETED|Overall Study||6
10472624|NCT01089725|11620951|FG000|NOT COMPLETED|Overall Study||66
10472625|NCT01089725|11620952|FG001|NOT COMPLETED|Overall Study||68
10472626|NCT01089725|11620953|FG002|NOT COMPLETED|Overall Study||61
10472627|NCT01089725|11620954|FG003|NOT COMPLETED|Overall Study||79
10472628|NCT01089725|11620955|FG004|NOT COMPLETED|Overall Study||80
10472629|NCT01089751|11620973|FG000|STARTED|Overall Study||163
10472630|NCT01089751|11620974|FG001|STARTED|Overall Study||159
10472631|NCT01089751|11620973|FG000|COMPLETED|Overall Study||129
10472632|NCT01089751|11620974|FG001|COMPLETED|Overall Study||132
10472633|NCT01089751|11620973|FG000|NOT COMPLETED|Overall Study||34
10472634|NCT01089751|11620974|FG001|NOT COMPLETED|Overall Study||27
10472635|NCT01090011|11620980|FG000|STARTED|Overall Study||171
10472636|NCT01090011|11620980|FG000|COMPLETED|Overall Study||0
10472637|NCT01090011|11620980|FG000|NOT COMPLETED|Overall Study||171
10472638|NCT01090050|11620994|FG000|STARTED|Overall Study||16
10472639|NCT01090050|11620995|FG001|STARTED|Overall Study||12
10472640|NCT01090050|11620994|FG000|COMPLETED|Overall Study||15
10338163|NCT00368641|11475061|FG000|STARTED|Overall Study||6
10338164|NCT00368641|11475062|FG001|STARTED|Overall Study||6
10338165|NCT00368641|11475061|FG000|COMPLETED|Overall Study|study was terminated prior to completion of treatment period|0
10338166|NCT00368641|11475062|FG001|COMPLETED|Overall Study|study was terminated prior to completion of treatment period|0
10338167|NCT00368641|11475061|FG000|NOT COMPLETED|Overall Study||6
10338168|NCT00368641|11475062|FG001|NOT COMPLETED|Overall Study||6
10338169|NCT00368745|11475070|FG000|STARTED|Randomized to Double-blind Treatment||57
10338170|NCT00368745|11475071|FG001|STARTED|Randomized to Double-blind Treatment||51
10338171|NCT00368745|11475070|FG000|COMPLETED|Randomized to Double-blind Treatment|One subject did not return following randomization; study drug not dispensed.|56
10339219|NCT00371566|11476129|FG000|COMPLETED|Chemoradiation Phase||31
10472641|NCT01090050|11620995|FG001|COMPLETED|Overall Study||5
10472642|NCT01090050|11620994|FG000|NOT COMPLETED|Overall Study||1
10472643|NCT01090050|11620995|FG001|NOT COMPLETED|Overall Study||7
10472644|NCT01090063|11621005|FG000|STARTED|Screen||28
10472645|NCT01090063|11621005|FG000|COMPLETED|Screen||24
10472646|NCT01090063|11621005|FG000|NOT COMPLETED|Screen||4
10472647|NCT01090063|11621005|FG000|STARTED|Treatment||24
10472648|NCT01090063|11621005|FG000|COMPLETED|Treatment||20
10472649|NCT01090063|11621005|FG000|NOT COMPLETED|Treatment||4
10649849|NCT02164539|11810005|FG002|STARTED|Treatment Phase A (4 Weeks)||40
10472650|NCT01090076|11621021|FG000|STARTED|Overall Study||12
10472651|NCT01090076|11621022|FG001|STARTED|Overall Study||14
10472652|NCT01090076|11621021|FG000|COMPLETED|Overall Study||11
10472653|NCT01090076|11621022|FG001|COMPLETED|Overall Study||12
10472654|NCT01090076|11621021|FG000|NOT COMPLETED|Overall Study||1
10472655|NCT01090076|11621022|FG001|NOT COMPLETED|Overall Study||2
10472656|NCT01090102|11621032|FG000|STARTED|First 12 Weeks||15
10472657|NCT01090102|11621033|FG001|STARTED|First 12 Weeks||18
10472658|NCT01090102|11621032|FG000|COMPLETED|First 12 Weeks||11
10472659|NCT01090102|11621033|FG001|COMPLETED|First 12 Weeks||16
10472660|NCT01090102|11621032|FG000|NOT COMPLETED|First 12 Weeks||4
10472661|NCT01090102|11621033|FG001|NOT COMPLETED|First 12 Weeks||2
10472662|NCT01090102|11621032|FG000|STARTED|Second 12 Weeks||11
10472663|NCT01090102|11621033|FG001|STARTED|Second 12 Weeks||16
10472664|NCT01090102|11621032|FG000|COMPLETED|Second 12 Weeks||11
10472665|NCT01090102|11621033|FG001|COMPLETED|Second 12 Weeks||15
10472666|NCT01090102|11621032|FG000|NOT COMPLETED|Second 12 Weeks||0
10472667|NCT01090102|11621033|FG001|NOT COMPLETED|Second 12 Weeks||1
10472668|NCT01090180|11621041|FG000|STARTED|Overall Study||33
10472669|NCT01090180|11621042|FG001|STARTED|Overall Study||29
10472670|NCT01090180|11621041|FG000|COMPLETED|Overall Study||22
10472671|NCT01090180|11621042|FG001|COMPLETED|Overall Study||21
10472672|NCT01090180|11621041|FG000|NOT COMPLETED|Overall Study||11
10472673|NCT01090180|11621042|FG001|NOT COMPLETED|Overall Study||8
10472674|NCT01090310|11621052|FG000|STARTED|Core Study||29
10472675|NCT01090310|11621053|FG001|STARTED|Core Study||31
10472676|NCT01090310|11621054|FG002|STARTED|Core Study||31
10472677|NCT01090310|11621055|FG003|STARTED|Core Study||34
10472678|NCT01090310|11621052|FG000|COMPLETED|Core Study||21
10472679|NCT01090310|11621053|FG001|COMPLETED|Core Study||20
10472680|NCT01090310|11621054|FG002|COMPLETED|Core Study||24
10472681|NCT01090310|11621055|FG003|COMPLETED|Core Study||27
10472682|NCT01090310|11621052|FG000|NOT COMPLETED|Core Study||8
10472683|NCT01090310|11621053|FG001|NOT COMPLETED|Core Study||11
10472684|NCT01090310|11621054|FG002|NOT COMPLETED|Core Study||7
10472685|NCT01090310|11621055|FG003|NOT COMPLETED|Core Study||7
10472686|NCT01090310|11621052|FG000|STARTED|Extension Study||17
10472687|NCT01090310|11621053|FG001|STARTED|Extension Study||16
10472688|NCT01090310|11621054|FG002|STARTED|Extension Study||16
10472689|NCT01090310|11621055|FG003|STARTED|Extension Study||21
10472690|NCT01090310|11621052|FG000|COMPLETED|Extension Study||3
10472691|NCT01090310|11621053|FG001|COMPLETED|Extension Study||0
10472692|NCT01090310|11621054|FG002|COMPLETED|Extension Study||1
10472693|NCT01090310|11621055|FG003|COMPLETED|Extension Study||1
10472694|NCT01090310|11621052|FG000|NOT COMPLETED|Extension Study||14
10472695|NCT01090310|11621053|FG001|NOT COMPLETED|Extension Study||16
10472696|NCT01090310|11621054|FG002|NOT COMPLETED|Extension Study||15
10472697|NCT01090310|11621055|FG003|NOT COMPLETED|Extension Study||20
10472698|NCT01090323|11621067|FG000|STARTED|Overall Study||132
10472699|NCT01090323|11621068|FG001|STARTED|Overall Study||53
10472700|NCT01090323|11621067|FG000|COMPLETED|Overall Study||43
10472701|NCT01090323|11621068|FG001|COMPLETED|Overall Study||19
10472702|NCT01090323|11621067|FG000|NOT COMPLETED|Overall Study||89
10472703|NCT01090323|11621068|FG001|NOT COMPLETED|Overall Study||34
10472704|NCT01090414|11621078|FG000|STARTED|Parent Studies||191
10472705|NCT01090414|11621079|FG001|STARTED|Parent Studies||241
10472706|NCT01090414|11621080|FG002|STARTED|Parent Studies||64
10472707|NCT01090414|11621081|FG003|STARTED|Parent Studies||18
10472708|NCT01090414|11621078|FG000|COMPLETED|Parent Studies||50
10472709|NCT01090414|11621079|FG001|COMPLETED|Parent Studies||114
10472710|NCT01090414|11621080|FG002|COMPLETED|Parent Studies||43
10472711|NCT01090414|11621081|FG003|COMPLETED|Parent Studies||5
10472712|NCT01090414|11621078|FG000|NOT COMPLETED|Parent Studies||141
10472713|NCT01090414|11621079|FG001|NOT COMPLETED|Parent Studies||127
10472714|NCT01090414|11621080|FG002|NOT COMPLETED|Parent Studies||21
10472715|NCT01090414|11621081|FG003|NOT COMPLETED|Parent Studies||13
10472716|NCT01090414|11621078|FG000|STARTED|Study 101-99|50 participants completed the parent study, but only 48 participants enrolled into Study 101-99.|48
10472717|NCT01090414|11621079|FG001|STARTED|Study 101-99|114 participants completed the parent study, but only 108 participants enrolled into Study 101-99.|108
10472718|NCT01090414|11621080|FG002|STARTED|Study 101-99|43 participants completed the parent study, but only 41 participants enrolled into Study 101-99.|41
10472719|NCT01090414|11621081|FG003|STARTED|Study 101-99||5
10472720|NCT01090414|11621078|FG000|COMPLETED|Study 101-99||0
10472721|NCT01090414|11621079|FG001|COMPLETED|Study 101-99||0
10472722|NCT01090414|11621080|FG002|COMPLETED|Study 101-99||0
10472723|NCT01090414|11621081|FG003|COMPLETED|Study 101-99||0
10472724|NCT01090414|11621078|FG000|NOT COMPLETED|Study 101-99||48
10472725|NCT01090414|11621079|FG001|NOT COMPLETED|Study 101-99||108
10472726|NCT01090414|11621080|FG002|NOT COMPLETED|Study 101-99||41
10472727|NCT01090414|11621081|FG003|NOT COMPLETED|Study 101-99||5
10472728|NCT01090427|11621106|FG000|STARTED|Controlled Period||37
10472729|NCT01090427|11621107|FG001|STARTED|Controlled Period||37
10472730|NCT01090427|11621108|FG002|STARTED|Controlled Period||36
10472731|NCT01090427|11621109|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
10472732|NCT01090427|11621110|FG004|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
10472733|NCT01090427|11621111|FG005|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
10472734|NCT01090427|11621112|FG006|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
10472735|NCT01090427|11621106|FG000|COMPLETED|Controlled Period||37
10472736|NCT01090427|11621107|FG001|COMPLETED|Controlled Period||37
10472737|NCT01090427|11621108|FG002|COMPLETED|Controlled Period||36
10472738|NCT01090427|11621109|FG003|COMPLETED|Controlled Period||0
10472739|NCT01090427|11621110|FG004|COMPLETED|Controlled Period||0
10472740|NCT01090427|11621111|FG005|COMPLETED|Controlled Period||0
10472741|NCT01090427|11621112|FG006|COMPLETED|Controlled Period||0
10472742|NCT01090427|11621106|FG000|NOT COMPLETED|Controlled Period||0
10472743|NCT01090427|11621107|FG001|NOT COMPLETED|Controlled Period||0
10472744|NCT01090427|11621108|FG002|NOT COMPLETED|Controlled Period||0
10472745|NCT01090427|11621109|FG003|NOT COMPLETED|Controlled Period||0
10472746|NCT01090427|11621110|FG004|NOT COMPLETED|Controlled Period||0
10708953|NCT02635386|11873861|FG000|COMPLETED|Overall Study||20
10708954|NCT02635386|11873862|FG001|COMPLETED|Overall Study||17
10708955|NCT02635386|11873863|FG002|COMPLETED|Overall Study||20
10708956|NCT02635386|11873864|FG003|COMPLETED|Overall Study||19
10708957|NCT02635386|11873865|FG004|COMPLETED|Overall Study||16
10708958|NCT02635386|11873861|FG000|NOT COMPLETED|Overall Study||3
10708959|NCT02635386|11873862|FG001|NOT COMPLETED|Overall Study||6
10708960|NCT02635386|11873863|FG002|NOT COMPLETED|Overall Study||2
10708961|NCT02635386|11873864|FG003|NOT COMPLETED|Overall Study||7
10708962|NCT02635386|11873865|FG004|NOT COMPLETED|Overall Study||9
10708963|NCT02635425|11873884|FG000|STARTED|Overall Study||15
10708964|NCT02635425|11873885|FG001|STARTED|Overall Study||15
10708965|NCT02635425|11873884|FG000|COMPLETED|Overall Study||15
10708966|NCT02635425|11873885|FG001|COMPLETED|Overall Study||15
10708967|NCT02635425|11873884|FG000|NOT COMPLETED|Overall Study||0
10708968|NCT02635425|11873885|FG001|NOT COMPLETED|Overall Study||0
10708969|NCT02635542|11873893|FG000|STARTED|Overall Study||50
10708970|NCT02635542|11873894|FG001|STARTED|Overall Study||50
10708971|NCT02635542|11873893|FG000|COMPLETED|Overall Study||50
10708972|NCT02635542|11873894|FG001|COMPLETED|Overall Study||50
10708973|NCT02635542|11873893|FG000|NOT COMPLETED|Overall Study||0
10708974|NCT02635542|11873894|FG001|NOT COMPLETED|Overall Study||0
10708975|NCT02635646|11873902|FG000|STARTED|Overall Study||57
10708976|NCT02635646|11873903|FG001|STARTED|Overall Study||65
10708977|NCT02635646|11873902|FG000|COMPLETED|Overall Study||32
10708978|NCT02635646|11873903|FG001|COMPLETED|Overall Study||39
10708979|NCT02635646|11873902|FG000|NOT COMPLETED|Overall Study||25
10708980|NCT02635646|11873903|FG001|NOT COMPLETED|Overall Study||26
10708981|NCT02635724|11873918|FG000|STARTED|Overall Study||41
10708982|NCT02635724|11873919|FG001|STARTED|Overall Study||26
10708983|NCT02635724|11873920|FG002|STARTED|Overall Study||7
10708984|NCT02635724|11873918|FG000|ITT Population|Overall Study||41
10708985|NCT02635724|11873919|FG001|ITT Population|Overall Study||26
10708986|NCT02635724|11873920|FG002|ITT Population|Overall Study||7
10708987|NCT02635724|11873918|FG000|Safety Population|Overall Study||41
10708988|NCT02635724|11873919|FG001|Safety Population|Overall Study||25
10708989|NCT02635724|11873920|FG002|Safety Population|Overall Study||7
10708990|NCT02635724|11873918|FG000|ITTI Population|Overall Study||28
10708991|NCT02635724|11873919|FG001|ITTI Population|Overall Study||19
10708992|NCT02635724|11873920|FG002|ITTI Population|Overall Study||5
10708993|NCT02635724|11873918|FG000|E-R Population|Overall Study||28
10708994|NCT02635724|11873919|FG001|E-R Population|Overall Study||19
10708995|NCT02635724|11873920|FG002|E-R Population|Overall Study||5
10708996|NCT02635724|11873918|FG000|COMPLETED|Overall Study||41
10708997|NCT02635724|11873919|FG001|COMPLETED|Overall Study||25
10708998|NCT02635724|11873920|FG002|COMPLETED|Overall Study||7
10708999|NCT02635724|11873918|FG000|NOT COMPLETED|Overall Study||0
10709000|NCT02635724|11873919|FG001|NOT COMPLETED|Overall Study||1
10709001|NCT02635724|11873920|FG002|NOT COMPLETED|Overall Study||0
10709002|NCT02635737|11873928|FG000|STARTED|Overall Study||29
10709003|NCT02635737|11873928|FG000|COMPLETED|Overall Study||28
10709004|NCT02635737|11873928|FG000|NOT COMPLETED|Overall Study||1
10709005|NCT02635828|11873932|FG000|STARTED|Overall Study||54
10709006|NCT02635828|11873932|FG000|COMPLETED|Overall Study||40
10709007|NCT02635828|11873932|FG000|NOT COMPLETED|Overall Study||14
10709008|NCT02635880|11873936|FG000|STARTED|Overall Study||32
10709009|NCT02635880|11873936|FG000|COMPLETED|Overall Study||32
10709010|NCT02635880|11873936|FG000|NOT COMPLETED|Overall Study||0
10709011|NCT02635984|11873942|FG000|STARTED|Overall Study||53
10709012|NCT02635984|11873943|FG001|STARTED|Overall Study||55
10472747|NCT01090427|11621111|FG005|NOT COMPLETED|Controlled Period||0
10472748|NCT01090427|11621112|FG006|NOT COMPLETED|Controlled Period||0
10472749|NCT01090427|11621106|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
10472750|NCT01090427|11621107|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
10472751|NCT01090427|11621108|FG002|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
10472752|NCT01090427|11621109|FG003|STARTED|After Controlled Period||19
10472753|NCT01090427|11621110|FG004|STARTED|After Controlled Period||18
10472754|NCT01090427|11621111|FG005|STARTED|After Controlled Period||37
10709013|NCT02635984|11873942|FG000|COMPLETED|Overall Study||50
10709014|NCT02635984|11873943|FG001|COMPLETED|Overall Study||51
10709015|NCT02635984|11873942|FG000|NOT COMPLETED|Overall Study||3
10709016|NCT02635984|11873943|FG001|NOT COMPLETED|Overall Study||4
10709017|NCT02636049|11873949|FG000|STARTED|Overall Study||12
10472755|NCT01090427|11621112|FG006|STARTED|After Controlled Period||36
10709018|NCT02636049|11873949|FG000|Triferic 6 mg IV Over 3 Hours|Overall Study||12
10709019|NCT02636049|11873949|FG000|Triferic 35 Micrograms/kg IV Push|Overall Study||12
10709020|NCT02636049|11873949|FG000|COMPLETED|Overall Study||12
10709021|NCT02636049|11873949|FG000|NOT COMPLETED|Overall Study||0
10709022|NCT02636361|11873955|FG000|STARTED|Period 1||5
10709023|NCT02636361|11873956|FG001|STARTED|Period 1||6
10709024|NCT02636361|11873957|FG002|STARTED|Period 1||5
10709025|NCT02636361|11873958|FG003|STARTED|Period 1||5
10709026|NCT02636361|11873959|FG004|STARTED|Period 1||5
10709027|NCT02636361|11873955|FG000|Received at Least One Dose of Study Drug|Period 1||5
10472756|NCT01090427|11621106|FG000|COMPLETED|After Controlled Period||0
10472757|NCT01090427|11621107|FG001|COMPLETED|After Controlled Period||0
10472758|NCT01090427|11621108|FG002|COMPLETED|After Controlled Period||0
10472759|NCT01090427|11621109|FG003|COMPLETED|After Controlled Period||17
10472760|NCT01090427|11621110|FG004|COMPLETED|After Controlled Period||18
10472761|NCT01090427|11621111|FG005|COMPLETED|After Controlled Period||32
10472762|NCT01090427|11621112|FG006|COMPLETED|After Controlled Period||34
10472763|NCT01090427|11621106|FG000|NOT COMPLETED|After Controlled Period||0
10472764|NCT01090427|11621107|FG001|NOT COMPLETED|After Controlled Period||0
10472765|NCT01090427|11621108|FG002|NOT COMPLETED|After Controlled Period||0
10472766|NCT01090427|11621109|FG003|NOT COMPLETED|After Controlled Period||2
10472767|NCT01090427|11621110|FG004|NOT COMPLETED|After Controlled Period||0
10472768|NCT01090427|11621111|FG005|NOT COMPLETED|After Controlled Period||5
10472769|NCT01090427|11621112|FG006|NOT COMPLETED|After Controlled Period||2
10472770|NCT01090453|11621126|FG000|STARTED|Overall Study||238
10472771|NCT01090453|11621127|FG001|STARTED|Overall Study||242
10472772|NCT01090453|11621126|FG000|COMPLETED|Overall Study||225
10472773|NCT01090453|11621127|FG001|COMPLETED|Overall Study||228
10472774|NCT01090453|11621126|FG000|NOT COMPLETED|Overall Study||13
10472775|NCT01090453|11621127|FG001|NOT COMPLETED|Overall Study||14
10472776|NCT01090479|11621135|FG000|STARTED|Overall Study||50
10472777|NCT01090479|11621136|FG001|STARTED|Overall Study||50
10472778|NCT01090479|11621135|FG000|COMPLETED|Overall Study||50
10472779|NCT01090479|11621136|FG001|COMPLETED|Overall Study||50
10472780|NCT01090479|11621135|FG000|NOT COMPLETED|Overall Study||0
10472781|NCT01090479|11621136|FG001|NOT COMPLETED|Overall Study||0
10472782|NCT01090492|11621150|FG000|STARTED|First Intervention Period (4 Weeks)||27
10472783|NCT01090492|11621151|FG001|STARTED|First Intervention Period (4 Weeks)||29
10472784|NCT01090492|11621152|FG002|STARTED|First Intervention Period (4 Weeks)||29
10472785|NCT01090492|11621153|FG003|STARTED|First Intervention Period (4 Weeks)||28
10472786|NCT01090492|11621154|FG004|STARTED|First Intervention Period (4 Weeks)||33
10472787|NCT01090492|11621155|FG005|STARTED|First Intervention Period (4 Weeks)||32
10472788|NCT01090492|11621156|FG006|STARTED|First Intervention Period (4 Weeks)||32
10472789|NCT01090492|11621157|FG007|STARTED|First Intervention Period (4 Weeks)||33
10472790|NCT01090492|11621150|FG000|COMPLETED|First Intervention Period (4 Weeks)||26
10472791|NCT01090492|11621151|FG001|COMPLETED|First Intervention Period (4 Weeks)||24
10472792|NCT01090492|11621152|FG002|COMPLETED|First Intervention Period (4 Weeks)||26
10472793|NCT01090492|11621153|FG003|COMPLETED|First Intervention Period (4 Weeks)||22
10472794|NCT01090492|11621154|FG004|COMPLETED|First Intervention Period (4 Weeks)||29
10472795|NCT01090492|11621155|FG005|COMPLETED|First Intervention Period (4 Weeks)||30
10472796|NCT01090492|11621156|FG006|COMPLETED|First Intervention Period (4 Weeks)||31
10472797|NCT01090492|11621157|FG007|COMPLETED|First Intervention Period (4 Weeks)||27
10472798|NCT01090492|11621150|FG000|NOT COMPLETED|First Intervention Period (4 Weeks)||1
10472799|NCT01090492|11621151|FG001|NOT COMPLETED|First Intervention Period (4 Weeks)||5
10472800|NCT01090492|11621152|FG002|NOT COMPLETED|First Intervention Period (4 Weeks)||3
10472801|NCT01090492|11621153|FG003|NOT COMPLETED|First Intervention Period (4 Weeks)||6
10472802|NCT01090492|11621154|FG004|NOT COMPLETED|First Intervention Period (4 Weeks)||4
10472803|NCT01090492|11621155|FG005|NOT COMPLETED|First Intervention Period (4 Weeks)||2
10472804|NCT01090492|11621156|FG006|NOT COMPLETED|First Intervention Period (4 Weeks)||1
10472805|NCT01090492|11621157|FG007|NOT COMPLETED|First Intervention Period (4 Weeks)||6
10472806|NCT01090492|11621150|FG000|STARTED|Placebo Washout Period ( 2 Weeks)||26
10472807|NCT01090492|11621151|FG001|STARTED|Placebo Washout Period ( 2 Weeks)||24
10472808|NCT01090492|11621152|FG002|STARTED|Placebo Washout Period ( 2 Weeks)||26
10472809|NCT01090492|11621153|FG003|STARTED|Placebo Washout Period ( 2 Weeks)||22
10472810|NCT01090492|11621154|FG004|STARTED|Placebo Washout Period ( 2 Weeks)||29
10472811|NCT01090492|11621155|FG005|STARTED|Placebo Washout Period ( 2 Weeks)||30
10472812|NCT01090492|11621156|FG006|STARTED|Placebo Washout Period ( 2 Weeks)||31
10472813|NCT01090492|11621157|FG007|STARTED|Placebo Washout Period ( 2 Weeks)||27
10472814|NCT01090492|11621150|FG000|COMPLETED|Placebo Washout Period ( 2 Weeks)||26
10472815|NCT01090492|11621151|FG001|COMPLETED|Placebo Washout Period ( 2 Weeks)||24
10472816|NCT01090492|11621152|FG002|COMPLETED|Placebo Washout Period ( 2 Weeks)||26
10472817|NCT01090492|11621153|FG003|COMPLETED|Placebo Washout Period ( 2 Weeks)||22
10472818|NCT01090492|11621154|FG004|COMPLETED|Placebo Washout Period ( 2 Weeks)||29
10472819|NCT01090492|11621155|FG005|COMPLETED|Placebo Washout Period ( 2 Weeks)||30
10472820|NCT01090492|11621156|FG006|COMPLETED|Placebo Washout Period ( 2 Weeks)||31
10472821|NCT01090492|11621157|FG007|COMPLETED|Placebo Washout Period ( 2 Weeks)||27
10472822|NCT01090492|11621150|FG000|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
10472823|NCT01090492|11621151|FG001|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
10472824|NCT01090492|11621152|FG002|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
10472825|NCT01090492|11621153|FG003|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
10472826|NCT01090492|11621154|FG004|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
10472827|NCT01090492|11621155|FG005|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
10472828|NCT01090492|11621156|FG006|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
10472829|NCT01090492|11621157|FG007|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
10472830|NCT01090492|11621150|FG000|STARTED|Second Intervention Period (4 Weeks)||26
10472831|NCT01090492|11621151|FG001|STARTED|Second Intervention Period (4 Weeks)||24
10472832|NCT01090492|11621152|FG002|STARTED|Second Intervention Period (4 Weeks)||26
10472833|NCT01090492|11621153|FG003|STARTED|Second Intervention Period (4 Weeks)||22
10472834|NCT01090492|11621154|FG004|STARTED|Second Intervention Period (4 Weeks)||29
10472835|NCT01090492|11621155|FG005|STARTED|Second Intervention Period (4 Weeks)||30
10472836|NCT01090492|11621156|FG006|STARTED|Second Intervention Period (4 Weeks)||31
10472837|NCT01090492|11621157|FG007|STARTED|Second Intervention Period (4 Weeks)||27
10472838|NCT01090492|11621150|FG000|COMPLETED|Second Intervention Period (4 Weeks)||25
10472839|NCT01090492|11621151|FG001|COMPLETED|Second Intervention Period (4 Weeks)||22
10472840|NCT01090492|11621152|FG002|COMPLETED|Second Intervention Period (4 Weeks)||24
10472841|NCT01090492|11621153|FG003|COMPLETED|Second Intervention Period (4 Weeks)||22
10472842|NCT01090492|11621154|FG004|COMPLETED|Second Intervention Period (4 Weeks)||27
10472843|NCT01090492|11621155|FG005|COMPLETED|Second Intervention Period (4 Weeks)||29
10472844|NCT01090492|11621156|FG006|COMPLETED|Second Intervention Period (4 Weeks)||22
10472845|NCT01090492|11621157|FG007|COMPLETED|Second Intervention Period (4 Weeks)||25
10472846|NCT01090492|11621150|FG000|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
10472847|NCT01090492|11621151|FG001|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
10472848|NCT01090492|11621152|FG002|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
10472849|NCT01090492|11621153|FG003|NOT COMPLETED|Second Intervention Period (4 Weeks)||0
10472850|NCT01090492|11621154|FG004|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
10472851|NCT01090492|11621155|FG005|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
10472852|NCT01090492|11621156|FG006|NOT COMPLETED|Second Intervention Period (4 Weeks)||9
10472853|NCT01090492|11621157|FG007|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
10472854|NCT01090739|11621176|FG000|STARTED|Enrollment|Subject enrollment = signed informed consent form|207
10472855|NCT01090739|11621176|FG000|COMPLETED|Enrollment||152
10472856|NCT01090739|11621176|FG000|NOT COMPLETED|Enrollment||55
10472857|NCT01090739|11621176|FG000|STARTED|12 Month Follow-up||152
10472858|NCT01090739|11621176|FG000|COMPLETED|12 Month Follow-up||147
10472859|NCT01090739|11621176|FG000|NOT COMPLETED|12 Month Follow-up||5
10472860|NCT01090739|11621176|FG000|STARTED|24 Month Follow-up||147
10472861|NCT01090739|11621176|FG000|COMPLETED|24 Month Follow-up||138
10472862|NCT01090739|11621176|FG000|NOT COMPLETED|24 Month Follow-up||9
10472863|NCT01090739|11621176|FG000|STARTED|36 Month Follow-up||138
10472864|NCT01090739|11621176|FG000|COMPLETED|36 Month Follow-up||115
10472865|NCT01090739|11621176|FG000|NOT COMPLETED|36 Month Follow-up||23
10472866|NCT01090752|11621183|FG000|STARTED|Overall Study||8
10472867|NCT01090752|11621184|FG001|STARTED|Overall Study||8
10472868|NCT01090752|11621183|FG000|COMPLETED|Overall Study||8
10472869|NCT01090752|11621184|FG001|COMPLETED|Overall Study||8
10472870|NCT01090752|11621183|FG000|NOT COMPLETED|Overall Study||0
10472871|NCT01090752|11621184|FG001|NOT COMPLETED|Overall Study||0
10472872|NCT01090765|11621196|FG000|STARTED|Overall Study||3
10472873|NCT01090765|11621197|FG001|STARTED|Overall Study||3
10472874|NCT01090765|11621198|FG002|STARTED|Overall Study||3
10472875|NCT01090765|11621199|FG003|STARTED|Overall Study||2
10472876|NCT01090765|11621200|FG004|STARTED|Overall Study||6
10472877|NCT01090765|11621201|FG005|STARTED|Overall Study||4
10472878|NCT01090765|11621196|FG000|COMPLETED|Overall Study||3
10709028|NCT02636361|11873956|FG001|Received at Least One Dose of Study Drug|Period 1||5
10709029|NCT02636361|11873957|FG002|Received at Least One Dose of Study Drug|Period 1||5
10709030|NCT02636361|11873958|FG003|Received at Least One Dose of Study Drug|Period 1||5
10709031|NCT02636361|11873959|FG004|Received at Least One Dose of Study Drug|Period 1||4
10709032|NCT02636361|11873955|FG000|COMPLETED|Period 1||5
10472879|NCT01090765|11621197|FG001|COMPLETED|Overall Study||3
10472880|NCT01090765|11621198|FG002|COMPLETED|Overall Study||3
10472881|NCT01090765|11621199|FG003|COMPLETED|Overall Study||1
10472882|NCT01090765|11621200|FG004|COMPLETED|Overall Study||4
10472883|NCT01090765|11621201|FG005|COMPLETED|Overall Study||3
10472884|NCT01090765|11621196|FG000|NOT COMPLETED|Overall Study||0
10472885|NCT01090765|11621197|FG001|NOT COMPLETED|Overall Study||0
10472886|NCT01090765|11621198|FG002|NOT COMPLETED|Overall Study||0
10472887|NCT01090765|11621199|FG003|NOT COMPLETED|Overall Study||1
10472888|NCT01090765|11621200|FG004|NOT COMPLETED|Overall Study||2
10472889|NCT01090765|11621201|FG005|NOT COMPLETED|Overall Study||1
10472890|NCT01090921|11621216|FG000|STARTED|Overall Study||50
10472891|NCT01090921|11621216|FG000|COMPLETED|Overall Study||23
10472892|NCT01090921|11621216|FG000|NOT COMPLETED|Overall Study||27
10472893|NCT01090973|11621220|FG000|STARTED|Overall Study||1
10472894|NCT01090973|11621220|FG000|COMPLETED|Overall Study||0
10472895|NCT01090973|11621220|FG000|NOT COMPLETED|Overall Study||1
10472896|NCT01091103|11621224|FG000|STARTED|Overall Study||60
10472897|NCT01091103|11621224|FG000|COMPLETED|Overall Study|Patients on study drug and completed Week 9 visit assessments.|56
10472898|NCT01091103|11621224|FG000|NOT COMPLETED|Overall Study||4
10472899|NCT01091116|11621235|FG000|STARTED|Overall Study||83
10472900|NCT01091116|11621236|FG001|STARTED|Overall Study||88
10472901|NCT01091116|11621237|FG002|STARTED|Overall Study||84
10472902|NCT01091116|11621238|FG003|STARTED|Overall Study||84
10472903|NCT01091116|11621239|FG004|STARTED|Overall Study||84
10472904|NCT01091116|11621235|FG000|COMPLETED|Overall Study||77
10472905|NCT01091116|11621236|FG001|COMPLETED|Overall Study||80
10472906|NCT01091116|11621237|FG002|COMPLETED|Overall Study||73
10472907|NCT01091116|11621238|FG003|COMPLETED|Overall Study||80
10472908|NCT01091116|11621239|FG004|COMPLETED|Overall Study||73
10472909|NCT01091116|11621235|FG000|NOT COMPLETED|Overall Study||6
10472910|NCT01091116|11621236|FG001|NOT COMPLETED|Overall Study||8
10472911|NCT01091116|11621237|FG002|NOT COMPLETED|Overall Study||11
10472912|NCT01091116|11621238|FG003|NOT COMPLETED|Overall Study||4
10472913|NCT01091116|11621239|FG004|NOT COMPLETED|Overall Study||11
10472914|NCT01091155|11621251|FG000|STARTED|Overall Study||288
10472915|NCT01091155|11621251|FG000|COMPLETED|Overall Study||279
10472916|NCT01091155|11621251|FG000|NOT COMPLETED|Overall Study||9
10472917|NCT01091168|11621257|FG000|STARTED|Overall Study||298
10472918|NCT01091168|11621258|FG001|STARTED|Overall Study||296
10472919|NCT01091168|11621257|FG000|COMPLETED|Overall Study||0
10472920|NCT01091168|11621258|FG001|COMPLETED|Overall Study||0
10472921|NCT01091168|11621257|FG000|NOT COMPLETED|Overall Study||298
10472922|NCT01091168|11621258|FG001|NOT COMPLETED|Overall Study||296
10472923|NCT01091246|11621267|FG000|STARTED|Overall Study||1385
10472924|NCT01091246|11621268|FG001|STARTED|Overall Study||464
10472925|NCT01091246|11621269|FG002|STARTED|Overall Study||463
10472926|NCT01091246|11621267|FG000|COMPLETED|Overall Study||1350
10472927|NCT01091246|11621268|FG001|COMPLETED|Overall Study||448
10472928|NCT01091246|11621269|FG002|COMPLETED|Overall Study||450
10472929|NCT01091246|11621267|FG000|NOT COMPLETED|Overall Study||35
10472930|NCT01091246|11621268|FG001|NOT COMPLETED|Overall Study||16
10472931|NCT01091246|11621269|FG002|NOT COMPLETED|Overall Study||13
10472932|NCT01091259|11621279|FG000|STARTED|Overall Study||29
10472933|NCT01091259|11621279|FG000|COMPLETED|Overall Study|Number of patients who had at least 2 cycles of treatments|24
10472934|NCT01091259|11621279|FG000|NOT COMPLETED|Overall Study||5
10472935|NCT01091363|11621285|FG000|STARTED|Overall Study||55
10472936|NCT01091363|11621286|FG001|STARTED|Overall Study||54
10472937|NCT01091363|11621285|FG000|COMPLETED|Overall Study||42
10472938|NCT01091363|11621286|FG001|COMPLETED|Overall Study||37
10472939|NCT01091363|11621285|FG000|NOT COMPLETED|Overall Study||13
10472940|NCT01091363|11621286|FG001|NOT COMPLETED|Overall Study||17
10472941|NCT01091428|11621296|FG000|STARTED|Phase 1||38
10472942|NCT01091428|11621297|FG001|STARTED|Phase 1||11
10472943|NCT01091428|11621298|FG002|STARTED|Phase 1||0
10472944|NCT01091428|11621299|FG003|STARTED|Phase 1||0
10472945|NCT01091428|11621296|FG000|COMPLETED|Phase 1|Completed = participants who completed the treatment.|0
10472946|NCT01091428|11621297|FG001|COMPLETED|Phase 1||0
10472947|NCT01091428|11621298|FG002|COMPLETED|Phase 1||0
10472948|NCT01091428|11621299|FG003|COMPLETED|Phase 1||0
10472949|NCT01091428|11621296|FG000|NOT COMPLETED|Phase 1||38
10472950|NCT01091428|11621297|FG001|NOT COMPLETED|Phase 1||11
10472951|NCT01091428|11621298|FG002|NOT COMPLETED|Phase 1||0
10472952|NCT01091428|11621299|FG003|NOT COMPLETED|Phase 1||0
10472953|NCT01091428|11621296|FG000|STARTED|Phase 2||0
10472954|NCT01091428|11621297|FG001|STARTED|Phase 2||0
10472955|NCT01091428|11621298|FG002|STARTED|Phase 2||73
10472956|NCT01091428|11621299|FG003|STARTED|Phase 2||69
10472957|NCT01091428|11621296|FG000|COMPLETED|Phase 2||0
10472958|NCT01091428|11621297|FG001|COMPLETED|Phase 2||0
10472959|NCT01091428|11621298|FG002|COMPLETED|Phase 2||0
10472960|NCT01091428|11621299|FG003|COMPLETED|Phase 2||0
10472961|NCT01091428|11621296|FG000|NOT COMPLETED|Phase 2||0
10472962|NCT01091428|11621297|FG001|NOT COMPLETED|Phase 2||0
10472963|NCT01091428|11621298|FG002|NOT COMPLETED|Phase 2||73
10472964|NCT01091428|11621299|FG003|NOT COMPLETED|Phase 2||69
10472965|NCT01091454|11621318|FG000|STARTED|Overall Study||48
10472966|NCT01091454|11621318|FG000|COMPLETED|Overall Study||47
10472967|NCT01091454|11621318|FG000|NOT COMPLETED|Overall Study||1
10472968|NCT01091519|11621324|FG000|STARTED|Overall Study||346
10709033|NCT02636361|11873956|FG001|COMPLETED|Period 1||5
10709034|NCT02636361|11873957|FG002|COMPLETED|Period 1||5
10709035|NCT02636361|11873958|FG003|COMPLETED|Period 1||5
10709036|NCT02636361|11873959|FG004|COMPLETED|Period 1||4
10472969|NCT01091519|11621325|FG001|STARTED|Overall Study||435
10472970|NCT01091519|11621324|FG000|Treated|Overall Study||342
10472971|NCT01091519|11621325|FG001|Treated|Overall Study||431
10472972|NCT01091519|11621324|FG000|COMPLETED|Overall Study||291
10472973|NCT01091519|11621325|FG001|COMPLETED|Overall Study||362
10472974|NCT01091519|11621324|FG000|NOT COMPLETED|Overall Study||55
10472975|NCT01091519|11621325|FG001|NOT COMPLETED|Overall Study||73
10472976|NCT01091662|11621333|FG000|STARTED|Overall Study||58
10472977|NCT01091662|11621334|FG001|STARTED|Overall Study||114
10472978|NCT01091662|11621333|FG000|COMPLETED|Overall Study||41
10472979|NCT01091662|11621334|FG001|COMPLETED|Overall Study||80
10472980|NCT01091662|11621333|FG000|NOT COMPLETED|Overall Study||17
10472981|NCT01091662|11621334|FG001|NOT COMPLETED|Overall Study||34
10472982|NCT01091675|11621345|FG000|STARTED|Overall Study|7 patients leave the study due to hypertension, 27 patients withdrew due to lack of efficacy|57
10472983|NCT01091675|11621345|FG000|COMPLETED|Overall Study||23
10472984|NCT01091675|11621345|FG000|NOT COMPLETED|Overall Study||34
10472985|NCT01091948|11621351|FG000|STARTED|Overall Study||37
10472986|NCT01091948|11621352|FG001|STARTED|Overall Study||38
10472987|NCT01091948|11621351|FG000|COMPLETED|Overall Study||37
10472988|NCT01091948|11621352|FG001|COMPLETED|Overall Study||38
10472989|NCT01091948|11621351|FG000|NOT COMPLETED|Overall Study||0
10472990|NCT01091948|11621352|FG001|NOT COMPLETED|Overall Study||0
10472991|NCT01091974|11621363|FG000|STARTED|Overall Study||24
10472992|NCT01091974|11621364|FG001|STARTED|Overall Study||23
10472993|NCT01091974|11621365|FG002|STARTED|Overall Study||25
10472994|NCT01091974|11621366|FG003|STARTED|Overall Study||24
10472995|NCT01091974|11621363|FG000|COMPLETED|Overall Study||19
10472996|NCT01091974|11621364|FG001|COMPLETED|Overall Study||18
10472997|NCT01091974|11621365|FG002|COMPLETED|Overall Study||19
10472998|NCT01091974|11621366|FG003|COMPLETED|Overall Study||17
10472999|NCT01091974|11621363|FG000|NOT COMPLETED|Overall Study||5
10473000|NCT01091974|11621364|FG001|NOT COMPLETED|Overall Study||5
10473001|NCT01091974|11621365|FG002|NOT COMPLETED|Overall Study||6
10473002|NCT01091974|11621366|FG003|NOT COMPLETED|Overall Study||7
10473003|NCT01092182|11621379|FG000|STARTED|Overall Study||15
10709037|NCT02636361|11873955|FG000|NOT COMPLETED|Period 1||0
10473004|NCT01092182|11621380|FG001|STARTED|Overall Study||98
10473005|NCT01092182|11621381|FG002|STARTED|Overall Study||81
10473006|NCT01092182|11621379|FG000|COMPLETED|Overall Study||14
10473007|NCT01092182|11621380|FG001|COMPLETED|Overall Study||80
10473008|NCT01092182|11621381|FG002|COMPLETED|Overall Study||53
10473009|NCT01092182|11621379|FG000|NOT COMPLETED|Overall Study||1
10473010|NCT01092182|11621380|FG001|NOT COMPLETED|Overall Study||18
10473011|NCT01092182|11621381|FG002|NOT COMPLETED|Overall Study||28
10473012|NCT01092195|11621392|FG000|STARTED|Overall Study||23
10473013|NCT01092195|11621393|FG001|STARTED|Overall Study||21
10473014|NCT01092195|11621394|FG002|STARTED|Overall Study||20
10473015|NCT01092195|11621392|FG000|COMPLETED|Overall Study||23
10473016|NCT01092195|11621393|FG001|COMPLETED|Overall Study||21
10473017|NCT01092195|11621394|FG002|COMPLETED|Overall Study||20
10473018|NCT01092195|11621392|FG000|NOT COMPLETED|Overall Study||0
10473019|NCT01092195|11621393|FG001|NOT COMPLETED|Overall Study||0
10473020|NCT01092195|11621394|FG002|NOT COMPLETED|Overall Study||0
10473021|NCT01092338|11621404|FG000|STARTED|Overall Study||22
10473022|NCT01092338|11621405|FG001|STARTED|Overall Study||22
10473023|NCT01092338|11621404|FG000|COMPLETED|Overall Study||21
10473024|NCT01092338|11621405|FG001|COMPLETED|Overall Study||21
10473025|NCT01092338|11621404|FG000|NOT COMPLETED|Overall Study||1
10473026|NCT01092338|11621405|FG001|NOT COMPLETED|Overall Study||1
10473027|NCT01092364|11621414|FG000|STARTED|Overall Study||122
10473028|NCT01092364|11621415|FG001|STARTED|Overall Study||120
10473029|NCT01092364|11621416|FG002|STARTED|Overall Study||123
10473030|NCT01092364|11621414|FG000|COMPLETED|Overall Study||104
10473031|NCT01092364|11621415|FG001|COMPLETED|Overall Study||104
10473032|NCT01092364|11621416|FG002|COMPLETED|Overall Study||105
10473033|NCT01092364|11621414|FG000|NOT COMPLETED|Overall Study||18
10473034|NCT01092364|11621415|FG001|NOT COMPLETED|Overall Study||16
10473035|NCT01092364|11621416|FG002|NOT COMPLETED|Overall Study||18
10473036|NCT01092416|11621424|FG000|STARTED|Enrollment||443
10473037|NCT01092416|11621424|FG000|COMPLETED|Enrollment||440
10473038|NCT01092416|11621424|FG000|NOT COMPLETED|Enrollment||3
10473039|NCT01092416|11621424|FG000|STARTED|30-Day Follow-up||440
10473040|NCT01092416|11621424|FG000|COMPLETED|30-Day Follow-up||430
10473041|NCT01092416|11621424|FG000|NOT COMPLETED|30-Day Follow-up||10
10473042|NCT01092416|11621424|FG000|STARTED|12-Month Follow-up||438
10473043|NCT01092416|11621424|FG000|COMPLETED|12-Month Follow-up||413
10473044|NCT01092416|11621424|FG000|NOT COMPLETED|12-Month Follow-up||25
10473045|NCT01092442|11621433|FG000|STARTED|Overall Study||80
10473046|NCT01092442|11621434|FG001|STARTED|Overall Study||60
10473047|NCT01092442|11621433|FG000|COMPLETED|Overall Study||80
10473048|NCT01092442|11621434|FG001|COMPLETED|Overall Study||60
10473049|NCT01092442|11621433|FG000|NOT COMPLETED|Overall Study||0
10473050|NCT01092442|11621434|FG001|NOT COMPLETED|Overall Study||0
10473051|NCT01092507|11621447|FG000|STARTED|Overall Study||149
10473052|NCT01092507|11621448|FG001|STARTED|Overall Study||150
10473053|NCT01092507|11621447|FG000|COMPLETED|Overall Study||147
10473054|NCT01092507|11621448|FG001|COMPLETED|Overall Study||150
10473055|NCT01092507|11621447|FG000|NOT COMPLETED|Overall Study||2
10473056|NCT01092507|11621448|FG001|NOT COMPLETED|Overall Study||0
10473057|NCT01092546|11621454|FG000|STARTED|Overall Study||16
10473058|NCT01092546|11621454|FG000|COMPLETED|Overall Study||12
10473059|NCT01092546|11621454|FG000|NOT COMPLETED|Overall Study||4
10473060|NCT01092559|11621458|FG000|STARTED|Overall Study||10
10473061|NCT01092559|11621458|FG000|COMPLETED|Overall Study||10
10473062|NCT01092559|11621458|FG000|NOT COMPLETED|Overall Study||0
10473063|NCT01092637|11621464|FG000|STARTED|Overall Study||145
10473064|NCT01092637|11621465|FG001|STARTED|Overall Study||135
10473065|NCT01092637|11621464|FG000|COMPLETED|Overall Study||98
10473066|NCT01092637|11621465|FG001|COMPLETED|Overall Study||86
10473067|NCT01092637|11621464|FG000|NOT COMPLETED|Overall Study||47
10473068|NCT01092637|11621465|FG001|NOT COMPLETED|Overall Study||49
10473069|NCT01092663|11621474|FG000|STARTED|Overall Study||31
10473070|NCT01092663|11621475|FG001|STARTED|Overall Study||30
10473071|NCT01092663|11621474|FG000|COMPLETED|Overall Study||24
10473072|NCT01092663|11621475|FG001|COMPLETED|Overall Study||26
10473073|NCT01092663|11621474|FG000|NOT COMPLETED|Overall Study||7
10473074|NCT01092663|11621475|FG001|NOT COMPLETED|Overall Study||4
10526805|NCT01383993|11678709|FG001|NOT COMPLETED|Overall Study||1
10526806|NCT01383993|11678710|FG002|NOT COMPLETED|Overall Study||1
10526807|NCT01384019|11678721|FG000|STARTED|Overall Study||65
10526808|NCT01384019|11678722|FG001|STARTED|Overall Study||61
10526809|NCT01384019|11678721|FG000|COMPLETED|Overall Study||55
10526810|NCT01384019|11678722|FG001|COMPLETED|Overall Study||55
10526811|NCT01384019|11678721|FG000|NOT COMPLETED|Overall Study||10
10526812|NCT01384019|11678722|FG001|NOT COMPLETED|Overall Study||6
10526813|NCT01384292|11678731|FG000|STARTED|Part A||5
10709038|NCT02636361|11873956|FG001|NOT COMPLETED|Period 1||1
10709039|NCT02636361|11873957|FG002|NOT COMPLETED|Period 1||0
10709040|NCT02636361|11873958|FG003|NOT COMPLETED|Period 1||0
10709041|NCT02636361|11873959|FG004|NOT COMPLETED|Period 1||1
10473075|NCT01092676|11621488|FG000|STARTED|Overall Study||50
10473076|NCT01092676|11621489|FG001|STARTED|Overall Study||49
10473077|NCT01092676|11621488|FG000|COMPLETED|Overall Study||50
10473078|NCT01092676|11621489|FG001|COMPLETED|Overall Study||49
10473079|NCT01092676|11621488|FG000|NOT COMPLETED|Overall Study||0
10473080|NCT01092676|11621489|FG001|NOT COMPLETED|Overall Study||0
10473081|NCT01092702|11621495|FG000|STARTED|Overall Study||32
10473082|NCT01092702|11621495|FG000|COMPLETED|Overall Study||23
10473083|NCT01092702|11621495|FG000|NOT COMPLETED|Overall Study||9
10473084|NCT01092728|11621501|FG000|STARTED|Overall Study||4
10473085|NCT01092728|11621502|FG001|STARTED|Overall Study||14
10473086|NCT01092728|11621501|FG000|COMPLETED|Overall Study||0
10473087|NCT01092728|11621502|FG001|COMPLETED|Overall Study||0
10473088|NCT01092728|11621501|FG000|NOT COMPLETED|Overall Study||4
10473089|NCT01092728|11621502|FG001|NOT COMPLETED|Overall Study||14
10473090|NCT01092767|11621508|FG000|STARTED|Overall Study||50
10473091|NCT01092767|11621508|FG000|COMPLETED|Overall Study||45
10473092|NCT01092767|11621508|FG000|NOT COMPLETED|Overall Study||5
10473093|NCT01092780|11621512|FG000|STARTED|Treatment Period 1||14
10473094|NCT01092780|11621513|FG001|STARTED|Treatment Period 1||15
10473095|NCT01092780|11621514|FG002|STARTED|Treatment Period 1||14
10473096|NCT01092780|11621515|FG003|STARTED|Treatment Period 1||13
10473097|NCT01092780|11621512|FG000|COMPLETED|Treatment Period 1||14
10473098|NCT01092780|11621513|FG001|COMPLETED|Treatment Period 1||15
10473099|NCT01092780|11621514|FG002|COMPLETED|Treatment Period 1||14
10473100|NCT01092780|11621515|FG003|COMPLETED|Treatment Period 1||13
10473101|NCT01092780|11621512|FG000|NOT COMPLETED|Treatment Period 1||0
10473102|NCT01092780|11621513|FG001|NOT COMPLETED|Treatment Period 1||0
10473103|NCT01092780|11621514|FG002|NOT COMPLETED|Treatment Period 1||0
10473104|NCT01092780|11621515|FG003|NOT COMPLETED|Treatment Period 1||0
10473105|NCT01092780|11621512|FG000|STARTED|Washout Period 1||14
10473106|NCT01092780|11621513|FG001|STARTED|Washout Period 1||15
10473107|NCT01092780|11621514|FG002|STARTED|Washout Period 1||14
10473108|NCT01092780|11621515|FG003|STARTED|Washout Period 1||13
10473109|NCT01092780|11621512|FG000|COMPLETED|Washout Period 1||13
10473110|NCT01092780|11621513|FG001|COMPLETED|Washout Period 1||14
10473111|NCT01092780|11621514|FG002|COMPLETED|Washout Period 1||14
10473112|NCT01092780|11621515|FG003|COMPLETED|Washout Period 1||13
10473113|NCT01092780|11621512|FG000|NOT COMPLETED|Washout Period 1||1
10473114|NCT01092780|11621513|FG001|NOT COMPLETED|Washout Period 1||1
10473115|NCT01092780|11621514|FG002|NOT COMPLETED|Washout Period 1||0
10473116|NCT01092780|11621515|FG003|NOT COMPLETED|Washout Period 1||0
10473117|NCT01092780|11621512|FG000|STARTED|Treatment Period 2||13
10473118|NCT01092780|11621513|FG001|STARTED|Treatment Period 2||14
10473119|NCT01092780|11621514|FG002|STARTED|Treatment Period 2||14
10473120|NCT01092780|11621515|FG003|STARTED|Treatment Period 2||13
10473121|NCT01092780|11621512|FG000|COMPLETED|Treatment Period 2||13
10473122|NCT01092780|11621513|FG001|COMPLETED|Treatment Period 2||14
10473123|NCT01092780|11621514|FG002|COMPLETED|Treatment Period 2||14
10473124|NCT01092780|11621515|FG003|COMPLETED|Treatment Period 2||13
10473125|NCT01092780|11621512|FG000|NOT COMPLETED|Treatment Period 2||0
10473126|NCT01092780|11621513|FG001|NOT COMPLETED|Treatment Period 2||0
10473127|NCT01092780|11621514|FG002|NOT COMPLETED|Treatment Period 2||0
10473128|NCT01092780|11621515|FG003|NOT COMPLETED|Treatment Period 2||0
10473129|NCT01092780|11621512|FG000|STARTED|Washout Period 2||13
10473130|NCT01092780|11621513|FG001|STARTED|Washout Period 2||14
10473131|NCT01092780|11621514|FG002|STARTED|Washout Period 2||14
10473132|NCT01092780|11621515|FG003|STARTED|Washout Period 2||13
10473133|NCT01092780|11621512|FG000|COMPLETED|Washout Period 2||13
10473134|NCT01092780|11621513|FG001|COMPLETED|Washout Period 2||13
10473135|NCT01092780|11621514|FG002|COMPLETED|Washout Period 2||13
10473136|NCT01092780|11621515|FG003|COMPLETED|Washout Period 2||13
10473137|NCT01092780|11621512|FG000|NOT COMPLETED|Washout Period 2||0
10473138|NCT01092780|11621513|FG001|NOT COMPLETED|Washout Period 2||1
10473139|NCT01092780|11621514|FG002|NOT COMPLETED|Washout Period 2||1
10473140|NCT01092780|11621515|FG003|NOT COMPLETED|Washout Period 2||0
10473141|NCT01092780|11621512|FG000|STARTED|Treatment Period 3||13
10473142|NCT01092780|11621513|FG001|STARTED|Treatment Period 3||13
10473143|NCT01092780|11621514|FG002|STARTED|Treatment Period 3||13
10473144|NCT01092780|11621515|FG003|STARTED|Treatment Period 3||13
10473145|NCT01092780|11621512|FG000|COMPLETED|Treatment Period 3||13
10473146|NCT01092780|11621513|FG001|COMPLETED|Treatment Period 3||13
10473147|NCT01092780|11621514|FG002|COMPLETED|Treatment Period 3||13
10473148|NCT01092780|11621515|FG003|COMPLETED|Treatment Period 3||13
10709042|NCT02636361|11873955|FG000|STARTED|Period 2||5
10473149|NCT01092780|11621512|FG000|NOT COMPLETED|Treatment Period 3||0
10473150|NCT01092780|11621513|FG001|NOT COMPLETED|Treatment Period 3||0
10473151|NCT01092780|11621514|FG002|NOT COMPLETED|Treatment Period 3||0
10473152|NCT01092780|11621515|FG003|NOT COMPLETED|Treatment Period 3||0
10473153|NCT01092780|11621512|FG000|STARTED|Washout Period 3||13
10473154|NCT01092780|11621513|FG001|STARTED|Washout Period 3||13
10473155|NCT01092780|11621514|FG002|STARTED|Washout Period 3||13
10473156|NCT01092780|11621515|FG003|STARTED|Washout Period 3||13
10473157|NCT01092780|11621512|FG000|COMPLETED|Washout Period 3||13
10473158|NCT01092780|11621513|FG001|COMPLETED|Washout Period 3||13
10473159|NCT01092780|11621514|FG002|COMPLETED|Washout Period 3||13
10709043|NCT02636361|11873956|FG001|STARTED|Period 2||5
10473160|NCT01092780|11621515|FG003|COMPLETED|Washout Period 3||13
10473161|NCT01092780|11621512|FG000|NOT COMPLETED|Washout Period 3||0
10473162|NCT01092780|11621513|FG001|NOT COMPLETED|Washout Period 3||0
10473163|NCT01092780|11621514|FG002|NOT COMPLETED|Washout Period 3||0
10473164|NCT01092780|11621515|FG003|NOT COMPLETED|Washout Period 3||0
10473165|NCT01092780|11621512|FG000|STARTED|Treatment Period 4||13
10473166|NCT01092780|11621513|FG001|STARTED|Treatment Period 4||13
10473167|NCT01092780|11621514|FG002|STARTED|Treatment Period 4||13
10473168|NCT01092780|11621515|FG003|STARTED|Treatment Period 4||13
10473169|NCT01092780|11621512|FG000|COMPLETED|Treatment Period 4||13
10473170|NCT01092780|11621513|FG001|COMPLETED|Treatment Period 4||13
10473171|NCT01092780|11621514|FG002|COMPLETED|Treatment Period 4||13
10473172|NCT01092780|11621515|FG003|COMPLETED|Treatment Period 4||13
10473173|NCT01092780|11621512|FG000|NOT COMPLETED|Treatment Period 4||0
10473174|NCT01092780|11621513|FG001|NOT COMPLETED|Treatment Period 4||0
10473175|NCT01092780|11621514|FG002|NOT COMPLETED|Treatment Period 4||0
10473176|NCT01092780|11621515|FG003|NOT COMPLETED|Treatment Period 4||0
10473177|NCT01092832|11621527|FG000|STARTED|Overall Study||14
10709044|NCT02636361|11873957|FG002|STARTED|Period 2||5
10709045|NCT02636361|11873958|FG003|STARTED|Period 2||5
10709046|NCT02636361|11873959|FG004|STARTED|Period 2||4
10709047|NCT02636361|11873955|FG000|COMPLETED|Period 2||5
10473178|NCT01092832|11621528|FG001|STARTED|Overall Study||8
10473179|NCT01092832|11621527|FG000|COMPLETED|Overall Study||13
10473180|NCT01092832|11621528|FG001|COMPLETED|Overall Study||8
10473181|NCT01092832|11621527|FG000|NOT COMPLETED|Overall Study||1
10473182|NCT01092832|11621528|FG001|NOT COMPLETED|Overall Study||0
10473183|NCT01092910|11621534|FG000|STARTED|Overall Study||57
10473184|NCT01092910|11621534|FG000|4 Month Follow-up|Overall Study||54
10473185|NCT01092910|11621534|FG000|10 Month Follow-up|Overall Study||52
10473186|NCT01092910|11621534|FG000|COMPLETED|Overall Study||52
10473187|NCT01092910|11621534|FG000|NOT COMPLETED|Overall Study||5
10473188|NCT01092923|11621541|FG000|STARTED|Overall Study||10
10473189|NCT01092923|11621542|FG001|STARTED|Overall Study||10
10473190|NCT01092923|11621541|FG000|COMPLETED|Overall Study||10
10473191|NCT01092923|11621542|FG001|COMPLETED|Overall Study||10
10473192|NCT01092923|11621541|FG000|NOT COMPLETED|Overall Study||0
10473193|NCT01092923|11621542|FG001|NOT COMPLETED|Overall Study||0
10473194|NCT01093014|11621552|FG000|STARTED|Overall Study||12
10473195|NCT01093014|11621553|FG001|STARTED|Overall Study||9
10473196|NCT01093014|11621554|FG002|STARTED|Overall Study||12
10473197|NCT01093014|11621552|FG000|COMPLETED|Overall Study||12
10473198|NCT01093014|11621553|FG001|COMPLETED|Overall Study||9
10473199|NCT01093014|11621554|FG002|COMPLETED|Overall Study||12
10473200|NCT01093014|11621552|FG000|NOT COMPLETED|Overall Study||0
10473201|NCT01093014|11621553|FG001|NOT COMPLETED|Overall Study||0
10473202|NCT01093014|11621554|FG002|NOT COMPLETED|Overall Study||0
10473203|NCT01093027|11621567|FG000|STARTED|Visit 1||10
10473204|NCT01093027|11621568|FG001|STARTED|Visit 1||10
10473205|NCT01093027|11621567|FG000|COMPLETED|Visit 1||10
10473206|NCT01093027|11621568|FG001|COMPLETED|Visit 1||10
10473207|NCT01093027|11621567|FG000|NOT COMPLETED|Visit 1||0
10473208|NCT01093027|11621568|FG001|NOT COMPLETED|Visit 1||0
10473209|NCT01093027|11621567|FG000|STARTED|Visit 2||10
10473210|NCT01093027|11621568|FG001|STARTED|Visit 2||10
10473211|NCT01093027|11621567|FG000|COMPLETED|Visit 2||10
10473212|NCT01093027|11621568|FG001|COMPLETED|Visit 2||10
10473213|NCT01093027|11621567|FG000|NOT COMPLETED|Visit 2||0
10473214|NCT01093027|11621568|FG001|NOT COMPLETED|Visit 2||0
10473215|NCT01093183|11621574|FG000|STARTED|Overall Study||19
10473216|NCT01093183|11621575|FG001|STARTED|Overall Study||6
10473217|NCT01093183|11621574|FG000|COMPLETED|Overall Study||18
10473218|NCT01093183|11621575|FG001|COMPLETED|Overall Study||4
10473219|NCT01093183|11621574|FG000|NOT COMPLETED|Overall Study||1
10473220|NCT01093183|11621575|FG001|NOT COMPLETED|Overall Study||2
10473221|NCT01093222|11621579|FG000|STARTED|Overall Study||40
10473222|NCT01093222|11621579|FG000|Eligible and Began Protocol Therapy|Overall Study||34
10473223|NCT01093222|11621579|FG000|COMPLETED|Overall Study||0
10473224|NCT01093222|11621579|FG000|NOT COMPLETED|Overall Study||40
10473225|NCT01093417|11621585|FG000|STARTED|Overall Study||15
10473226|NCT01093417|11621586|FG001|STARTED|Overall Study||30
10473227|NCT01093417|11621585|FG000|COMPLETED|Overall Study||15
10473228|NCT01093417|11621586|FG001|COMPLETED|Overall Study||29
10473229|NCT01093417|11621585|FG000|NOT COMPLETED|Overall Study||0
10473230|NCT01093417|11621586|FG001|NOT COMPLETED|Overall Study||1
10473231|NCT01093469|11621595|FG000|STARTED|Overall Study||13
10473232|NCT01093469|11621596|FG001|STARTED|Overall Study||13
10473233|NCT01093469|11621597|FG002|STARTED|Overall Study||13
10473234|NCT01093469|11621595|FG000|COMPLETED|Overall Study||13
10473235|NCT01093469|11621596|FG001|COMPLETED|Overall Study||13
10709048|NCT02636361|11873956|FG001|COMPLETED|Period 2||5
10473236|NCT01093469|11621597|FG002|COMPLETED|Overall Study||12
10473237|NCT01093469|11621595|FG000|NOT COMPLETED|Overall Study||0
10473238|NCT01093469|11621596|FG001|NOT COMPLETED|Overall Study||0
10473239|NCT01093469|11621597|FG002|NOT COMPLETED|Overall Study||1
10473240|NCT01093482|11621605|FG000|STARTED|Overall Study||8151
10473241|NCT01093482|11621605|FG000|COMPLETED|Overall Study||8151
10473242|NCT01093482|11621605|FG000|NOT COMPLETED|Overall Study||0
10473243|NCT01093521|11621609|FG000|STARTED|Overall Study||20
10473244|NCT01093521|11621609|FG000|COMPLETED|Overall Study||20
10473245|NCT01093521|11621609|FG000|NOT COMPLETED|Overall Study||0
10473246|NCT01093534|11621618|FG000|STARTED|Overall Study||186
10473247|NCT01093534|11621619|FG001|STARTED|Overall Study||183
10709049|NCT02636361|11873957|FG002|COMPLETED|Period 2||5
10473248|NCT01093534|11621620|FG002|STARTED|Overall Study||178
10473249|NCT01093534|11621618|FG000|Received Study Treatment|Overall Study||186
10473250|NCT01093534|11621619|FG001|Received Study Treatment|Overall Study||182
10473251|NCT01093534|11621620|FG002|Received Study Treatment|Overall Study||175
10473252|NCT01093534|11621618|FG000|COMPLETED|Overall Study||176
10473253|NCT01093534|11621619|FG001|COMPLETED|Overall Study||167
10473254|NCT01093534|11621620|FG002|COMPLETED|Overall Study||169
10473255|NCT01093534|11621618|FG000|NOT COMPLETED|Overall Study||10
10473256|NCT01093534|11621619|FG001|NOT COMPLETED|Overall Study||16
10473257|NCT01093534|11621620|FG002|NOT COMPLETED|Overall Study||9
10473258|NCT01093586|11621629|FG000|STARTED|Overall Study||14
10473259|NCT01093586|11621629|FG000|COMPLETED|Overall Study||11
10473260|NCT01093586|11621629|FG000|NOT COMPLETED|Overall Study||3
10473261|NCT01093599|11621635|FG000|STARTED|Overall Study||91
10473262|NCT01093599|11621636|FG001|STARTED|Overall Study||105
10473263|NCT01093599|11621635|FG000|COMPLETED|Overall Study||59
10473264|NCT01093599|11621636|FG001|COMPLETED|Overall Study||59
10473265|NCT01093599|11621635|FG000|NOT COMPLETED|Overall Study||32
10473266|NCT01093599|11621636|FG001|NOT COMPLETED|Overall Study||46
10473267|NCT01093625|11621644|FG000|STARTED|Baseline and Dispensed||49
10473268|NCT01093625|11621645|FG001|STARTED|Baseline and Dispensed||49
10473269|NCT01093625|11621644|FG000|COMPLETED|Baseline and Dispensed||47
10473270|NCT01093625|11621645|FG001|COMPLETED|Baseline and Dispensed||49
10473271|NCT01093625|11621644|FG000|NOT COMPLETED|Baseline and Dispensed||2
10473272|NCT01093625|11621645|FG001|NOT COMPLETED|Baseline and Dispensed||0
10473273|NCT01093625|11621644|FG000|STARTED|2-Week Visit||47
10473274|NCT01093625|11621645|FG001|STARTED|2-Week Visit||49
10473275|NCT01093625|11621644|FG000|COMPLETED|2-Week Visit||46
10473276|NCT01093625|11621645|FG001|COMPLETED|2-Week Visit||49
10473277|NCT01093625|11621644|FG000|NOT COMPLETED|2-Week Visit||1
10473278|NCT01093625|11621645|FG001|NOT COMPLETED|2-Week Visit||0
10473279|NCT01093625|11621644|FG000|STARTED|1-Month Visit||46
10473280|NCT01093625|11621645|FG001|STARTED|1-Month Visit||49
10473281|NCT01093625|11621644|FG000|COMPLETED|1-Month Visit||44
10473282|NCT01093625|11621645|FG001|COMPLETED|1-Month Visit||49
10473283|NCT01093625|11621644|FG000|NOT COMPLETED|1-Month Visit||2
10473284|NCT01093625|11621645|FG001|NOT COMPLETED|1-Month Visit||0
10473285|NCT01093625|11621644|FG000|STARTED|3-Month Visit||44
10473286|NCT01093625|11621645|FG001|STARTED|3-Month Visit||49
10473287|NCT01093625|11621644|FG000|COMPLETED|3-Month Visit||42
10473288|NCT01093625|11621645|FG001|COMPLETED|3-Month Visit||49
10473289|NCT01093625|11621644|FG000|NOT COMPLETED|3-Month Visit||2
10473290|NCT01093625|11621645|FG001|NOT COMPLETED|3-Month Visit||0
10473291|NCT01093625|11621644|FG000|STARTED|6-Month Visit||42
10473292|NCT01093625|11621645|FG001|STARTED|6-Month Visit||49
10473293|NCT01093625|11621644|FG000|COMPLETED|6-Month Visit||34
10473294|NCT01093625|11621645|FG001|COMPLETED|6-Month Visit||40
10473295|NCT01093625|11621644|FG000|NOT COMPLETED|6-Month Visit||8
10473296|NCT01093625|11621645|FG001|NOT COMPLETED|6-Month Visit||9
10473297|NCT01093625|11621644|FG000|STARTED|1-Year Visit||34
10473298|NCT01093625|11621645|FG001|STARTED|1-Year Visit||40
10473299|NCT01093625|11621644|FG000|COMPLETED|1-Year Visit||29
10473300|NCT01093625|11621645|FG001|COMPLETED|1-Year Visit||37
10473301|NCT01093625|11621644|FG000|NOT COMPLETED|1-Year Visit||5
10473302|NCT01093625|11621645|FG001|NOT COMPLETED|1-Year Visit||3
10473303|NCT01093651|11621653|FG000|STARTED|Overall Study||10
10473304|NCT01093651|11621654|FG001|STARTED|Overall Study||10
10473305|NCT01093651|11621653|FG000|COMPLETED|Overall Study||10
10473306|NCT01093651|11621654|FG001|COMPLETED|Overall Study||10
10473307|NCT01093651|11621653|FG000|NOT COMPLETED|Overall Study||0
10473308|NCT01093651|11621654|FG001|NOT COMPLETED|Overall Study||0
10473309|NCT01093690|11621662|FG000|STARTED|Overall Study||83
10473310|NCT01093690|11621663|FG001|STARTED|Overall Study||79
10473311|NCT01093690|11621662|FG000|COMPLETED|Overall Study||83
10473312|NCT01093690|11621663|FG001|COMPLETED|Overall Study||79
10473313|NCT01093690|11621662|FG000|NOT COMPLETED|Overall Study||0
10473314|NCT01093690|11621663|FG001|NOT COMPLETED|Overall Study||0
10473315|NCT01093755|11621671|FG000|STARTED|Overall Study||16
10473316|NCT01093755|11621672|FG001|STARTED|Overall Study||14
10473317|NCT01093755|11621671|FG000|COMPLETED|Overall Study||13
10473318|NCT01093755|11621672|FG001|COMPLETED|Overall Study||10
10473319|NCT01093755|11621671|FG000|NOT COMPLETED|Overall Study||3
10473320|NCT01093755|11621672|FG001|NOT COMPLETED|Overall Study||4
10473321|NCT01093794|11621678|FG000|STARTED|Treatment Period 1||7
10473322|NCT01093794|11621679|FG001|STARTED|Treatment Period 1||7
10473323|NCT01093794|11621680|FG002|STARTED|Treatment Period 1||7
10473324|NCT01093794|11621681|FG003|STARTED|Treatment Period 1||7
10473325|NCT01093794|11621678|FG000|COMPLETED|Treatment Period 1||7
10473326|NCT01093794|11621679|FG001|COMPLETED|Treatment Period 1||7
10473327|NCT01093794|11621680|FG002|COMPLETED|Treatment Period 1||7
10473328|NCT01093794|11621681|FG003|COMPLETED|Treatment Period 1||7
10473329|NCT01093794|11621678|FG000|NOT COMPLETED|Treatment Period 1||0
10473330|NCT01093794|11621679|FG001|NOT COMPLETED|Treatment Period 1||0
10473331|NCT01093794|11621680|FG002|NOT COMPLETED|Treatment Period 1||0
10473332|NCT01093794|11621681|FG003|NOT COMPLETED|Treatment Period 1||0
10473333|NCT01093794|11621678|FG000|STARTED|Treatment Period 2||7
10473334|NCT01093794|11621679|FG001|STARTED|Treatment Period 2||7
10473335|NCT01093794|11621680|FG002|STARTED|Treatment Period 2|After period 1, one participant was discontinued by the investigator due to a protocol deviation.|6
10473336|NCT01093794|11621681|FG003|STARTED|Treatment Period 2||7
10473337|NCT01093794|11621678|FG000|COMPLETED|Treatment Period 2||7
10473338|NCT01093794|11621679|FG001|COMPLETED|Treatment Period 2||7
10473339|NCT01093794|11621680|FG002|COMPLETED|Treatment Period 2||6
10473340|NCT01093794|11621681|FG003|COMPLETED|Treatment Period 2||7
10473341|NCT01093794|11621678|FG000|NOT COMPLETED|Treatment Period 2||0
10473342|NCT01093794|11621679|FG001|NOT COMPLETED|Treatment Period 2||0
10473343|NCT01093794|11621680|FG002|NOT COMPLETED|Treatment Period 2||0
10473344|NCT01093794|11621681|FG003|NOT COMPLETED|Treatment Period 2||0
10473345|NCT01093794|11621678|FG000|STARTED|Treatment Period 3||7
10473346|NCT01093794|11621679|FG001|STARTED|Treatment Period 3||7
10473347|NCT01093794|11621680|FG002|STARTED|Treatment Period 3||6
10473348|NCT01093794|11621681|FG003|STARTED|Treatment Period 3||7
10473349|NCT01093794|11621678|FG000|COMPLETED|Treatment Period 3||7
10473350|NCT01093794|11621679|FG001|COMPLETED|Treatment Period 3||7
10473351|NCT01093794|11621680|FG002|COMPLETED|Treatment Period 3||6
10473352|NCT01093794|11621681|FG003|COMPLETED|Treatment Period 3||7
10473353|NCT01093794|11621678|FG000|NOT COMPLETED|Treatment Period 3||0
10473354|NCT01093794|11621679|FG001|NOT COMPLETED|Treatment Period 3||0
10473355|NCT01093794|11621680|FG002|NOT COMPLETED|Treatment Period 3||0
10473356|NCT01093794|11621681|FG003|NOT COMPLETED|Treatment Period 3||0
10473357|NCT01093794|11621678|FG000|STARTED|Treatment Period 4||7
10473358|NCT01093794|11621679|FG001|STARTED|Treatment Period 4||7
10473359|NCT01093794|11621680|FG002|STARTED|Treatment Period 4||6
10473360|NCT01093794|11621681|FG003|STARTED|Treatment Period 4||7
10473361|NCT01093794|11621678|FG000|COMPLETED|Treatment Period 4||7
10473362|NCT01093794|11621679|FG001|COMPLETED|Treatment Period 4||7
10473363|NCT01093794|11621680|FG002|COMPLETED|Treatment Period 4||6
10473364|NCT01093794|11621681|FG003|COMPLETED|Treatment Period 4||7
10473365|NCT01093794|11621678|FG000|NOT COMPLETED|Treatment Period 4||0
10473366|NCT01093794|11621679|FG001|NOT COMPLETED|Treatment Period 4||0
10473367|NCT01093794|11621680|FG002|NOT COMPLETED|Treatment Period 4||0
10473368|NCT01093794|11621681|FG003|NOT COMPLETED|Treatment Period 4||0
10473369|NCT01093885|11621691|FG000|STARTED|Overall Study||15
10473370|NCT01093885|11621691|FG000|COMPLETED|Overall Study||10
10473371|NCT01093885|11621691|FG000|NOT COMPLETED|Overall Study||5
10473372|NCT01093976|11621696|FG000|STARTED|Overall Study||14
10473373|NCT01093976|11621696|FG000|COMPLETED|Overall Study||14
10473374|NCT01093976|11621696|FG000|NOT COMPLETED|Overall Study||0
10709050|NCT02636361|11873958|FG003|COMPLETED|Period 2||5
10709051|NCT02636361|11873959|FG004|COMPLETED|Period 2||4
10709052|NCT02636361|11873955|FG000|NOT COMPLETED|Period 2||0
10709053|NCT02636361|11873956|FG001|NOT COMPLETED|Period 2||0
10709054|NCT02636361|11873957|FG002|NOT COMPLETED|Period 2||0
10709055|NCT02636361|11873958|FG003|NOT COMPLETED|Period 2||0
10709056|NCT02636361|11873959|FG004|NOT COMPLETED|Period 2||0
10709057|NCT02636361|11873955|FG000|STARTED|Period 3||5
10709058|NCT02636361|11873956|FG001|STARTED|Period 3||5
10709059|NCT02636361|11873957|FG002|STARTED|Period 3||5
10709060|NCT02636361|11873958|FG003|STARTED|Period 3||5
10709061|NCT02636361|11873959|FG004|STARTED|Period 3||4
10473375|NCT01094106|11621702|FG000|STARTED|Overall Study||33
10473376|NCT01094106|11621703|FG001|STARTED|Overall Study||34
10473377|NCT01094106|11621702|FG000|COMPLETED|Overall Study||33
10473378|NCT01094106|11621703|FG001|COMPLETED|Overall Study||34
10473379|NCT01094106|11621702|FG000|NOT COMPLETED|Overall Study||0
10473380|NCT01094106|11621703|FG001|NOT COMPLETED|Overall Study||0
10473381|NCT01094119|11621711|FG000|STARTED|Overall Study||34
10473382|NCT01094119|11621712|FG001|STARTED|Overall Study||36
10473383|NCT01094119|11621711|FG000|COMPLETED|Overall Study||32
10473384|NCT01094119|11621712|FG001|COMPLETED|Overall Study||32
10473385|NCT01094119|11621711|FG000|NOT COMPLETED|Overall Study||2
10473386|NCT01094119|11621712|FG001|NOT COMPLETED|Overall Study||4
10473387|NCT01094171|11621718|FG000|STARTED|Overall Study||400
10473388|NCT01094171|11621718|FG000|COMPLETED|Overall Study||390
10473389|NCT01094171|11621718|FG000|NOT COMPLETED|Overall Study||10
10473390|NCT01094184|11621724|FG000|STARTED|Overall Study||36
10473391|NCT01094184|11621725|FG001|STARTED|Overall Study||13
10709062|NCT02636361|11873955|FG000|COMPLETED|Period 3||5
10709063|NCT02636361|11873956|FG001|COMPLETED|Period 3||5
10709064|NCT02636361|11873957|FG002|COMPLETED|Period 3||5
10709065|NCT02636361|11873958|FG003|COMPLETED|Period 3||5
10473392|NCT01094184|11621724|FG000|COMPLETED|Overall Study||1
10473393|NCT01094184|11621725|FG001|COMPLETED|Overall Study||2
10473394|NCT01094184|11621724|FG000|NOT COMPLETED|Overall Study||35
10473395|NCT01094184|11621725|FG001|NOT COMPLETED|Overall Study||11
10473396|NCT01094288|11621739|FG000|STARTED|Overall Study||6
10473397|NCT01094288|11621740|FG001|STARTED|Overall Study||15
10473398|NCT01094288|11621741|FG002|STARTED|Overall Study||5
10473399|NCT01094288|11621742|FG003|STARTED|Overall Study||3
10473400|NCT01094288|11621743|FG004|STARTED|Overall Study||2
10473401|NCT01094288|11621744|FG005|STARTED|Overall Study||4
10473402|NCT01094288|11621745|FG006|STARTED|Overall Study||2
10473403|NCT01094288|11621746|FG007|STARTED|Overall Study||4
10473404|NCT01094288|11621739|FG000|COMPLETED|Overall Study|Completed=Completed Treatment|4
10473405|NCT01094288|11621740|FG001|COMPLETED|Overall Study||5
10473406|NCT01094288|11621741|FG002|COMPLETED|Overall Study||1
10473407|NCT01094288|11621742|FG003|COMPLETED|Overall Study||1
10473408|NCT01094288|11621743|FG004|COMPLETED|Overall Study||2
10473409|NCT01094288|11621744|FG005|COMPLETED|Overall Study||4
10473410|NCT01094288|11621745|FG006|COMPLETED|Overall Study||2
10473411|NCT01094288|11621746|FG007|COMPLETED|Overall Study||2
10473412|NCT01094288|11621739|FG000|NOT COMPLETED|Overall Study||2
10709066|NCT02636361|11873959|FG004|COMPLETED|Period 3||4
10709067|NCT02636361|11873955|FG000|NOT COMPLETED|Period 3||0
10473413|NCT01094288|11621740|FG001|NOT COMPLETED|Overall Study||10
10473414|NCT01094288|11621741|FG002|NOT COMPLETED|Overall Study||4
10473415|NCT01094288|11621742|FG003|NOT COMPLETED|Overall Study||2
10473416|NCT01094288|11621743|FG004|NOT COMPLETED|Overall Study||0
10473417|NCT01094288|11621744|FG005|NOT COMPLETED|Overall Study||0
10473418|NCT01094288|11621745|FG006|NOT COMPLETED|Overall Study||0
10473419|NCT01094288|11621746|FG007|NOT COMPLETED|Overall Study||2
10473420|NCT01094301|11621768|FG000|STARTED|Trial Stage||28
10473421|NCT01094301|11621768|FG000|Subjects Who Received Smartpatch Lead|Trial Stage||28
10473422|NCT01094301|11621768|FG000|COMPLETED|Trial Stage||27
10473423|NCT01094301|11621768|FG000|NOT COMPLETED|Trial Stage||1
10473424|NCT01094301|11621768|FG000|STARTED|Implant Stage||13
10473425|NCT01094301|11621768|FG000|Met Criteria for Implant Stage|Implant Stage||7
10473426|NCT01094301|11621768|FG000|Subjects Who Received SPR IPG|Implant Stage||5
10473427|NCT01094301|11621768|FG000|COMPLETED|Implant Stage||5
10473428|NCT01094301|11621768|FG000|NOT COMPLETED|Implant Stage||8
10473429|NCT01094522|11621776|FG000|STARTED|Overall Study||20
10473430|NCT01094522|11621777|FG001|STARTED|Overall Study||20
10473431|NCT01094522|11621776|FG000|COMPLETED|Overall Study||20
10473432|NCT01094522|11621777|FG001|COMPLETED|Overall Study||20
10473433|NCT01094522|11621776|FG000|NOT COMPLETED|Overall Study||0
10473434|NCT01094522|11621777|FG001|NOT COMPLETED|Overall Study||0
10473435|NCT01094548|11621786|FG000|STARTED|Overall Study||17
10473436|NCT01094548|11621787|FG001|STARTED|Overall Study||17
10473437|NCT01094548|11621786|FG000|COMPLETED|Overall Study||17
10473438|NCT01094548|11621787|FG001|COMPLETED|Overall Study||17
10473439|NCT01094548|11621786|FG000|NOT COMPLETED|Overall Study||0
10473440|NCT01094548|11621787|FG001|NOT COMPLETED|Overall Study||0
10473441|NCT01094574|11621801|FG000|STARTED|Overall Study||1
10473442|NCT01094574|11621802|FG001|STARTED|Overall Study||1
10473443|NCT01094574|11621803|FG002|STARTED|Overall Study||2
10473444|NCT01094574|11621804|FG003|STARTED|Overall Study||2
10473445|NCT01094574|11621805|FG004|STARTED|Overall Study||2
10473446|NCT01094574|11621806|FG005|STARTED|Overall Study||2
10473447|NCT01094574|11621801|FG000|COMPLETED|Overall Study||1
10473448|NCT01094574|11621802|FG001|COMPLETED|Overall Study||1
10473449|NCT01094574|11621803|FG002|COMPLETED|Overall Study||2
10473450|NCT01094574|11621804|FG003|COMPLETED|Overall Study||2
10473451|NCT01094574|11621805|FG004|COMPLETED|Overall Study||2
10473452|NCT01094574|11621806|FG005|COMPLETED|Overall Study||2
10473453|NCT01094574|11621801|FG000|NOT COMPLETED|Overall Study||0
10473454|NCT01094574|11621802|FG001|NOT COMPLETED|Overall Study||0
10473455|NCT01094574|11621803|FG002|NOT COMPLETED|Overall Study||0
10473456|NCT01094574|11621804|FG003|NOT COMPLETED|Overall Study||0
10473457|NCT01094574|11621805|FG004|NOT COMPLETED|Overall Study||0
10473458|NCT01094574|11621806|FG005|NOT COMPLETED|Overall Study||0
10473459|NCT01094704|11621819|FG000|STARTED|Overall Study||8
10473460|NCT01094704|11621820|FG001|STARTED|Overall Study||8
10473461|NCT01094704|11621819|FG000|COMPLETED|Overall Study||8
10473462|NCT01094704|11621820|FG001|COMPLETED|Overall Study||8
10473463|NCT01094704|11621819|FG000|NOT COMPLETED|Overall Study||0
10473464|NCT01094704|11621820|FG001|NOT COMPLETED|Overall Study||0
10473465|NCT01094717|11621828|FG000|STARTED|Overall Study||3
10473466|NCT01094717|11621829|FG001|STARTED|Overall Study||10
10473467|NCT01094717|11621828|FG000|COMPLETED|Overall Study||3
10473468|NCT01094717|11621829|FG001|COMPLETED|Overall Study||10
10473469|NCT01094717|11621828|FG000|NOT COMPLETED|Overall Study||0
10473470|NCT01094717|11621829|FG001|NOT COMPLETED|Overall Study||0
10473471|NCT01094730|11621845|FG000|STARTED|Period 1 (14 Days)||92
10473472|NCT01094730|11621846|FG001|STARTED|Period 1 (14 Days)||88
10473473|NCT01094730|11621845|FG000|COMPLETED|Period 1 (14 Days)||90
10473474|NCT01094730|11621846|FG001|COMPLETED|Period 1 (14 Days)||86
10473475|NCT01094730|11621845|FG000|NOT COMPLETED|Period 1 (14 Days)||2
10473476|NCT01094730|11621846|FG001|NOT COMPLETED|Period 1 (14 Days)||2
10473477|NCT01094730|11621845|FG000|STARTED|Period 2 (14 Days)||90
10473478|NCT01094730|11621846|FG001|STARTED|Period 2 (14 Days)||86
10473479|NCT01094730|11621845|FG000|COMPLETED|Period 2 (14 Days)||87
10473480|NCT01094730|11621846|FG001|COMPLETED|Period 2 (14 Days)||84
10473481|NCT01094730|11621845|FG000|NOT COMPLETED|Period 2 (14 Days)||3
10473482|NCT01094730|11621846|FG001|NOT COMPLETED|Period 2 (14 Days)||2
10473483|NCT01094743|11621853|FG000|STARTED|Period 1||52
10473484|NCT01094743|11621853|FG000|COMPLETED|Period 1||50
10473485|NCT01094743|11621853|FG000|NOT COMPLETED|Period 1||2
10473486|NCT01094743|11621853|FG000|STARTED|Period 2||50
10473487|NCT01094743|11621853|FG000|COMPLETED|Period 2||50
10473488|NCT01094743|11621853|FG000|NOT COMPLETED|Period 2||0
10473489|NCT01094808|11621861|FG000|STARTED|Overall Study||21
10473490|NCT01094808|11621862|FG001|STARTED|Overall Study||20
10473491|NCT01094808|11621863|FG002|STARTED|Overall Study||21
10473492|NCT01094808|11621861|FG000|COMPLETED|Overall Study||20
10473493|NCT01094808|11621862|FG001|COMPLETED|Overall Study||19
10473494|NCT01094808|11621863|FG002|COMPLETED|Overall Study||21
10473495|NCT01094808|11621861|FG000|NOT COMPLETED|Overall Study||1
10473496|NCT01094808|11621862|FG001|NOT COMPLETED|Overall Study||1
10473497|NCT01094808|11621863|FG002|NOT COMPLETED|Overall Study||0
10473498|NCT01094886|11621871|FG000|STARTED|Overall Study||53
10473499|NCT01094886|11621871|FG000|COMPLETED|Overall Study||46
10473500|NCT01094886|11621871|FG000|NOT COMPLETED|Overall Study||7
10473501|NCT01095094|11621875|FG000|STARTED|Overall Study||19
10473502|NCT01095094|11621875|FG000|COMPLETED|Overall Study||16
10473503|NCT01095094|11621875|FG000|NOT COMPLETED|Overall Study||3
10473504|NCT01095497|11621881|FG000|STARTED|Intravenous CINRYZE||14
10473505|NCT01095497|11621882|FG001|STARTED|Intravenous CINRYZE||12
10473506|NCT01095497|11621881|FG000|COMPLETED|Intravenous CINRYZE||13
10473507|NCT01095497|11621882|FG001|COMPLETED|Intravenous CINRYZE||12
10473508|NCT01095497|11621881|FG000|NOT COMPLETED|Intravenous CINRYZE||1
10473509|NCT01095497|11621882|FG001|NOT COMPLETED|Intravenous CINRYZE||0
10473510|NCT01095497|11621881|FG000|STARTED|Subcutaneous CINRYZE||13
10473511|NCT01095497|11621882|FG001|STARTED|Subcutaneous CINRYZE||12
10473512|NCT01095497|11621881|FG000|COMPLETED|Subcutaneous CINRYZE||12
10473513|NCT01095497|11621882|FG001|COMPLETED|Subcutaneous CINRYZE||12
10473514|NCT01095497|11621881|FG000|NOT COMPLETED|Subcutaneous CINRYZE||1
10473515|NCT01095497|11621882|FG001|NOT COMPLETED|Subcutaneous CINRYZE||0
10473516|NCT01095510|11621896|FG000|STARTED|Overall Study||3
10473517|NCT01095510|11621897|FG001|STARTED|Overall Study||0
10473518|NCT01095510|11621898|FG002|STARTED|Overall Study||3
10473519|NCT01095510|11621899|FG003|STARTED|Overall Study||3
10473520|NCT01095510|11621896|FG000|COMPLETED|Overall Study||3
10473521|NCT01095510|11621897|FG001|COMPLETED|Overall Study||0
10473522|NCT01095510|11621898|FG002|COMPLETED|Overall Study||3
10473523|NCT01095510|11621899|FG003|COMPLETED|Overall Study||3
10473524|NCT01095510|11621896|FG000|NOT COMPLETED|Overall Study||0
10473525|NCT01095510|11621897|FG001|NOT COMPLETED|Overall Study||0
10473526|NCT01095510|11621898|FG002|NOT COMPLETED|Overall Study||0
10473527|NCT01095510|11621899|FG003|NOT COMPLETED|Overall Study||0
10473528|NCT01095653|11621910|FG000|STARTED|Overall Study||132
10473529|NCT01095653|11621911|FG001|STARTED|Overall Study||128
10473530|NCT01095653|11621912|FG002|STARTED|Overall Study||133
10473531|NCT01095653|11621910|FG000|COMPLETED|Overall Study||113
10473532|NCT01095653|11621911|FG001|COMPLETED|Overall Study||113
10473533|NCT01095653|11621912|FG002|COMPLETED|Overall Study||117
10473534|NCT01095653|11621910|FG000|NOT COMPLETED|Overall Study||19
10473535|NCT01095653|11621911|FG001|NOT COMPLETED|Overall Study||15
10473536|NCT01095653|11621912|FG002|NOT COMPLETED|Overall Study||16
10473537|NCT01095666|11621923|FG000|STARTED|Overall Study||145
10473538|NCT01095666|11621924|FG001|STARTED|Overall Study||147
10473539|NCT01095666|11621925|FG002|STARTED|Overall Study||152
10473540|NCT01095666|11621923|FG000|COMPLETED|Overall Study||128
10473541|NCT01095666|11621924|FG001|COMPLETED|Overall Study||136
10473542|NCT01095666|11621925|FG002|COMPLETED|Overall Study||145
10473543|NCT01095666|11621923|FG000|NOT COMPLETED|Overall Study||17
10473544|NCT01095666|11621924|FG001|NOT COMPLETED|Overall Study||11
10473545|NCT01095666|11621925|FG002|NOT COMPLETED|Overall Study||7
10473546|NCT01095757|11621933|FG000|STARTED|Overall Study||45
10473547|NCT01095757|11621933|FG000|COMPLETED|Overall Study||45
10473548|NCT01095757|11621933|FG000|NOT COMPLETED|Overall Study||0
10473549|NCT01095796|11621940|FG000|STARTED|Overall Study||353
10473550|NCT01095796|11621941|FG001|STARTED|Overall Study||354
10473551|NCT01095796|11621940|FG000|COMPLETED|Overall Study||58
10473552|NCT01095796|11621941|FG001|COMPLETED|Overall Study||65
10473553|NCT01095796|11621940|FG000|NOT COMPLETED|Overall Study||295
10473554|NCT01095796|11621941|FG001|NOT COMPLETED|Overall Study||289
10473555|NCT01095835|11621950|FG000|STARTED|Overall Study||51
10473556|NCT01095835|11621951|FG001|STARTED|Overall Study||52
10473557|NCT01095835|11621952|FG002|STARTED|Overall Study||25
10473558|NCT01095835|11621950|FG000|COMPLETED|Overall Study||41
10473559|NCT01095835|11621951|FG001|COMPLETED|Overall Study||40
10473560|NCT01095835|11621952|FG002|COMPLETED|Overall Study||17
10473561|NCT01095835|11621950|FG000|NOT COMPLETED|Overall Study||10
10473562|NCT01095835|11621951|FG001|NOT COMPLETED|Overall Study||12
10473563|NCT01095835|11621952|FG002|NOT COMPLETED|Overall Study||8
10473564|NCT01095887|11621961|FG000|STARTED|Overall Study||6
10473565|NCT01095887|11621961|FG000|COMPLETED|Overall Study||6
10473566|NCT01095887|11621961|FG000|NOT COMPLETED|Overall Study||0
10473567|NCT01095978|11621965|FG000|STARTED|Overall Study||2822
10473568|NCT01095978|11621965|FG000|COMPLETED|Overall Study||2819
10473569|NCT01095978|11621965|FG000|NOT COMPLETED|Overall Study||3
10473570|NCT01096017|11621971|FG000|STARTED|Treatment Period 1||12
10473571|NCT01096017|11621972|FG001|STARTED|Treatment Period 1||12
10473572|NCT01096017|11621971|FG000|COMPLETED|Treatment Period 1||12
10473573|NCT01096017|11621972|FG001|COMPLETED|Treatment Period 1||12
10473574|NCT01096017|11621971|FG000|NOT COMPLETED|Treatment Period 1||0
10473575|NCT01096017|11621972|FG001|NOT COMPLETED|Treatment Period 1||0
10473576|NCT01096017|11621971|FG000|STARTED|Washout 1 - 14 Days||12
10473577|NCT01096017|11621972|FG001|STARTED|Washout 1 - 14 Days||12
10473578|NCT01096017|11621971|FG000|COMPLETED|Washout 1 - 14 Days||12
10473579|NCT01096017|11621972|FG001|COMPLETED|Washout 1 - 14 Days||12
10473580|NCT01096017|11621971|FG000|NOT COMPLETED|Washout 1 - 14 Days||0
10473581|NCT01096017|11621972|FG001|NOT COMPLETED|Washout 1 - 14 Days||0
10473582|NCT01096017|11621971|FG000|STARTED|Treatment Period 2||12
10473583|NCT01096017|11621972|FG001|STARTED|Treatment Period 2||12
10473584|NCT01096017|11621971|FG000|COMPLETED|Treatment Period 2||11
10473585|NCT01096017|11621972|FG001|COMPLETED|Treatment Period 2||11
10473586|NCT01096017|11621971|FG000|NOT COMPLETED|Treatment Period 2||1
10473587|NCT01096017|11621972|FG001|NOT COMPLETED|Treatment Period 2||1
10473588|NCT01096056|11621980|FG000|STARTED|Overall Study||20
10473589|NCT01096056|11621981|FG001|STARTED|Overall Study||20
10473590|NCT01096056|11621980|FG000|Completed at Day 42|Overall Study||20
10473591|NCT01096056|11621981|FG001|Completed at Day 42|Overall Study||20
10473592|NCT01096056|11621980|FG000|COMPLETED|Overall Study||20
10473593|NCT01096056|11621981|FG001|COMPLETED|Overall Study||19
10473594|NCT01096056|11621980|FG000|NOT COMPLETED|Overall Study||0
10473595|NCT01096056|11621981|FG001|NOT COMPLETED|Overall Study||1
10473596|NCT01096160|11621997|FG000|STARTED|Overall Study||6
10473597|NCT01096160|11621998|FG001|STARTED|Overall Study||2
10473598|NCT01096160|11621999|FG002|STARTED|Overall Study||6
10473599|NCT01096160|11622000|FG003|STARTED|Overall Study||2
10473600|NCT01096160|11622001|FG004|STARTED|Overall Study||6
10473601|NCT01096160|11622002|FG005|STARTED|Overall Study||2
10473602|NCT01096160|11622003|FG006|STARTED|Overall Study||6
10473603|NCT01096160|11622004|FG007|STARTED|Overall Study||2
10473604|NCT01096160|11622005|FG008|STARTED|Overall Study||6
10473605|NCT01096160|11622006|FG009|STARTED|Overall Study||2
10473606|NCT01096160|11621997|FG000|COMPLETED|Overall Study||6
10473607|NCT01096160|11621998|FG001|COMPLETED|Overall Study||2
10473608|NCT01096160|11621999|FG002|COMPLETED|Overall Study||5
10473609|NCT01096160|11622000|FG003|COMPLETED|Overall Study||2
10473610|NCT01096160|11622001|FG004|COMPLETED|Overall Study||5
10473611|NCT01096160|11622002|FG005|COMPLETED|Overall Study||2
10473612|NCT01096160|11622003|FG006|COMPLETED|Overall Study||4
10473613|NCT01096160|11622004|FG007|COMPLETED|Overall Study||2
10473614|NCT01096160|11622005|FG008|COMPLETED|Overall Study||4
10473615|NCT01096160|11622006|FG009|COMPLETED|Overall Study||1
10473616|NCT01096160|11621997|FG000|NOT COMPLETED|Overall Study||0
10473617|NCT01096160|11621998|FG001|NOT COMPLETED|Overall Study||0
10473618|NCT01096160|11621999|FG002|NOT COMPLETED|Overall Study||1
10473619|NCT01096160|11622000|FG003|NOT COMPLETED|Overall Study||0
10473620|NCT01096160|11622001|FG004|NOT COMPLETED|Overall Study||1
10473621|NCT01096160|11622002|FG005|NOT COMPLETED|Overall Study||0
10473622|NCT01096160|11622003|FG006|NOT COMPLETED|Overall Study||2
10473623|NCT01096160|11622004|FG007|NOT COMPLETED|Overall Study||0
10473624|NCT01096160|11622005|FG008|NOT COMPLETED|Overall Study||2
10473625|NCT01096160|11622006|FG009|NOT COMPLETED|Overall Study||1
10473626|NCT01096186|11622041|FG000|STARTED|Overall Study||617
10473627|NCT01096186|11622041|FG000|COMPLETED|Overall Study||567
10473628|NCT01096186|11622041|FG000|NOT COMPLETED|Overall Study||50
10473629|NCT01096290|11622047|FG000|STARTED|Overall Study||9
10473630|NCT01096290|11622048|FG001|STARTED|Overall Study||14
10473631|NCT01096290|11622047|FG000|COMPLETED|Overall Study||9
10473632|NCT01096290|11622048|FG001|COMPLETED|Overall Study||14
10473633|NCT01096290|11622047|FG000|NOT COMPLETED|Overall Study||0
10473634|NCT01096290|11622048|FG001|NOT COMPLETED|Overall Study||0
10473635|NCT01096316|11622056|FG000|STARTED|Overall Study||102
10473636|NCT01096316|11622057|FG001|STARTED|Overall Study||103
10473637|NCT01096316|11622056|FG000|COMPLETED|Overall Study||87
10473638|NCT01096316|11622057|FG001|COMPLETED|Overall Study||94
10473639|NCT01096316|11622056|FG000|NOT COMPLETED|Overall Study||15
10473640|NCT01096316|11622057|FG001|NOT COMPLETED|Overall Study||9
10473641|NCT01096342|11622063|FG000|STARTED|Overall Study||16
10473642|NCT01096342|11622063|FG000|COMPLETED|Overall Study||15
10473643|NCT01096342|11622063|FG000|NOT COMPLETED|Overall Study||1
10473644|NCT01096446|11622069|FG000|STARTED|Overall Study||12
10473645|NCT01096446|11622070|FG001|STARTED|Overall Study||10
10473646|NCT01096446|11622069|FG000|COMPLETED|Overall Study|One infant was SGA; one infant had a congenital anomaly; and one discontinued medical management|9
10473647|NCT01096446|11622070|FG001|COMPLETED|Overall Study||10
10473648|NCT01096446|11622069|FG000|NOT COMPLETED|Overall Study||3
10473649|NCT01096446|11622070|FG001|NOT COMPLETED|Overall Study||0
10473650|NCT01096550|11622077|FG000|STARTED|Overall Study||170
10473651|NCT01096550|11622078|FG001|STARTED|Overall Study||175
10473652|NCT01096550|11622077|FG000|COMPLETED|Overall Study||133
10473653|NCT01096550|11622078|FG001|COMPLETED|Overall Study||146
10473654|NCT01096550|11622077|FG000|NOT COMPLETED|Overall Study||37
10473655|NCT01096550|11622078|FG001|NOT COMPLETED|Overall Study||29
10473656|NCT01096589|11622088|FG000|STARTED|Overall Study||22
10473657|NCT01096589|11622089|FG001|STARTED|Overall Study||20
10473658|NCT01096589|11622090|FG002|STARTED|Overall Study||22
10473659|NCT01096589|11622091|FG003|STARTED|Overall Study||18
10473660|NCT01096589|11622088|FG000|COMPLETED|Overall Study||18
10473661|NCT01096589|11622089|FG001|COMPLETED|Overall Study||18
10473662|NCT01096589|11622090|FG002|COMPLETED|Overall Study||18
10473663|NCT01096589|11622091|FG003|COMPLETED|Overall Study||15
10473664|NCT01096589|11622088|FG000|NOT COMPLETED|Overall Study||4
10473665|NCT01096589|11622089|FG001|NOT COMPLETED|Overall Study||2
10473666|NCT01096589|11622090|FG002|NOT COMPLETED|Overall Study||4
10473667|NCT01096589|11622091|FG003|NOT COMPLETED|Overall Study||3
10473668|NCT01096667|11622110|FG000|STARTED|Overall Study||39
10473669|NCT01096667|11622111|FG001|STARTED|Overall Study||39
10473670|NCT01096667|11622112|FG002|STARTED|Overall Study||38
10473671|NCT01096667|11622113|FG003|STARTED|Overall Study||39
10473672|NCT01096667|11622114|FG004|STARTED|Overall Study||39
10473673|NCT01096667|11622110|FG000|Treated|Overall Study||38
10473674|NCT01096667|11622111|FG001|Treated|Overall Study||39
10473675|NCT01096667|11622112|FG002|Treated|Overall Study||38
10473676|NCT01096667|11622113|FG003|Treated|Overall Study||39
10473677|NCT01096667|11622114|FG004|Treated|Overall Study||39
10473678|NCT01096667|11622110|FG000|COMPLETED|Overall Study||36
10473679|NCT01096667|11622111|FG001|COMPLETED|Overall Study||37
10473680|NCT01096667|11622112|FG002|COMPLETED|Overall Study||36
10473681|NCT01096667|11622113|FG003|COMPLETED|Overall Study||36
10473682|NCT01096667|11622114|FG004|COMPLETED|Overall Study||39
10473683|NCT01096667|11622110|FG000|NOT COMPLETED|Overall Study||3
10473684|NCT01096667|11622111|FG001|NOT COMPLETED|Overall Study||2
10473685|NCT01096667|11622112|FG002|NOT COMPLETED|Overall Study||2
10473686|NCT01096667|11622113|FG003|NOT COMPLETED|Overall Study||3
10473687|NCT01096667|11622114|FG004|NOT COMPLETED|Overall Study||0
10473688|NCT01096680|11622132|FG000|STARTED|Overall Study||27
10473689|NCT01096680|11622133|FG001|STARTED|Overall Study||27
10473690|NCT01096680|11622134|FG002|STARTED|Overall Study||27
10473691|NCT01096680|11622135|FG003|STARTED|Overall Study||27
10473692|NCT01096680|11622136|FG004|STARTED|Overall Study||27
10473693|NCT01096680|11622132|FG000|COMPLETED|Overall Study||27
10473694|NCT01096680|11622133|FG001|COMPLETED|Overall Study||27
10473695|NCT01096680|11622134|FG002|COMPLETED|Overall Study||27
10473696|NCT01096680|11622135|FG003|COMPLETED|Overall Study||27
10473697|NCT01096680|11622136|FG004|COMPLETED|Overall Study||27
10473698|NCT01096680|11622132|FG000|NOT COMPLETED|Overall Study||0
10473699|NCT01096680|11622133|FG001|NOT COMPLETED|Overall Study||0
10473700|NCT01096680|11622134|FG002|NOT COMPLETED|Overall Study||0
10473701|NCT01096680|11622135|FG003|NOT COMPLETED|Overall Study||0
10473702|NCT01096680|11622136|FG004|NOT COMPLETED|Overall Study||0
10473703|NCT01096771|11622150|FG000|STARTED|Overall Study||7
10473704|NCT01096771|11622151|FG001|STARTED|Overall Study||7
10473705|NCT01096771|11622150|FG000|COMPLETED|Overall Study||7
10473706|NCT01096771|11622151|FG001|COMPLETED|Overall Study||7
10473707|NCT01096771|11622150|FG000|NOT COMPLETED|Overall Study||0
10473708|NCT01096771|11622151|FG001|NOT COMPLETED|Overall Study||0
10473709|NCT01096784|11622159|FG000|STARTED|Overall Study||61
10473710|NCT01096784|11622160|FG001|STARTED|Overall Study||60
10473711|NCT01096784|11622159|FG000|COMPLETED|Overall Study||46
10473712|NCT01096784|11622160|FG001|COMPLETED|Overall Study||46
10473713|NCT01096784|11622159|FG000|NOT COMPLETED|Overall Study||15
10473714|NCT01096784|11622160|FG001|NOT COMPLETED|Overall Study||14
10473715|NCT01096810|11622168|FG000|STARTED|Overall Study||20
10473716|NCT01096810|11622168|FG000|COMPLETED|Overall Study||20
10473717|NCT01096810|11622168|FG000|NOT COMPLETED|Overall Study||0
10473718|NCT01096823|11622174|FG000|STARTED|Overall Study||14
10473719|NCT01096823|11622175|FG001|STARTED|Overall Study||16
10473720|NCT01096823|11622174|FG000|COMPLETED|Overall Study||11
10473721|NCT01096823|11622175|FG001|COMPLETED|Overall Study||15
10473722|NCT01096823|11622174|FG000|NOT COMPLETED|Overall Study||3
10473723|NCT01096823|11622175|FG001|NOT COMPLETED|Overall Study||1
10473724|NCT01096849|11622184|FG000|STARTED|Overall Study||22
10473725|NCT01096849|11622185|FG001|STARTED|Overall Study||76
10473726|NCT01096849|11622186|FG002|STARTED|Overall Study||47
10473727|NCT01096849|11622184|FG000|COMPLETED|Overall Study||20
10473728|NCT01096849|11622185|FG001|COMPLETED|Overall Study||64
10473729|NCT01096849|11622186|FG002|COMPLETED|Overall Study||41
10473730|NCT01096849|11622184|FG000|NOT COMPLETED|Overall Study||2
10473731|NCT01096849|11622185|FG001|NOT COMPLETED|Overall Study||12
10473732|NCT01096849|11622186|FG002|NOT COMPLETED|Overall Study||6
10473733|NCT01096875|11622196|FG000|STARTED|Overall Study||30
10473734|NCT01096875|11622197|FG001|STARTED|Overall Study||30
10473735|NCT01096875|11622196|FG000|COMPLETED|Overall Study||30
10473736|NCT01096875|11622197|FG001|COMPLETED|Overall Study||29
10473737|NCT01096875|11622196|FG000|NOT COMPLETED|Overall Study||0
10473738|NCT01096875|11622197|FG001|NOT COMPLETED|Overall Study||1
10473739|NCT01096992|11622210|FG000|STARTED|Overall Study||6
10473740|NCT01096992|11622211|FG001|STARTED|Overall Study||3
10473741|NCT01096992|11622212|FG002|STARTED|Overall Study||6
10473742|NCT01096992|11622213|FG003|STARTED|Overall Study||6
10473743|NCT01096992|11622214|FG004|STARTED|Overall Study||30
10473744|NCT01096992|11622210|FG000|COMPLETED|Overall Study||6
10473745|NCT01096992|11622211|FG001|COMPLETED|Overall Study||3
10473746|NCT01096992|11622212|FG002|COMPLETED|Overall Study||6
10473747|NCT01096992|11622213|FG003|COMPLETED|Overall Study||6
10473748|NCT01096992|11622214|FG004|COMPLETED|Overall Study||30
10473749|NCT01096992|11622210|FG000|NOT COMPLETED|Overall Study||0
10473750|NCT01096992|11622211|FG001|NOT COMPLETED|Overall Study||0
10473751|NCT01096992|11622212|FG002|NOT COMPLETED|Overall Study||0
10473752|NCT01096992|11622213|FG003|NOT COMPLETED|Overall Study||0
10473753|NCT01096992|11622214|FG004|NOT COMPLETED|Overall Study||0
10473754|NCT01097044|11622229|FG000|STARTED|Overall Study||39
10473755|NCT01097044|11622230|FG001|STARTED|Overall Study||38
10473756|NCT01097044|11622229|FG000|COMPLETED|Overall Study||34
10473757|NCT01097044|11622230|FG001|COMPLETED|Overall Study||33
10473758|NCT01097044|11622229|FG000|NOT COMPLETED|Overall Study||5
10473759|NCT01097044|11622230|FG001|NOT COMPLETED|Overall Study||5
10473760|NCT01097057|11622238|FG000|STARTED|Overall Study||20
10473761|NCT01097057|11622238|FG000|COMPLETED|Overall Study||17
10473762|NCT01097057|11622238|FG000|NOT COMPLETED|Overall Study||3
10473763|NCT01097304|11622242|FG000|STARTED|Overall Study||36
10473764|NCT01097304|11622242|FG000|COMPLETED|Overall Study||29
10473765|NCT01097304|11622242|FG000|NOT COMPLETED|Overall Study||7
10473766|NCT01097330|11622249|FG000|STARTED|Overall Study||7
10473767|NCT01097330|11622250|FG001|STARTED|Overall Study||5
10473768|NCT01097330|11622249|FG000|COMPLETED|Overall Study||0
10473769|NCT01097330|11622250|FG001|COMPLETED|Overall Study||0
10473770|NCT01097330|11622249|FG000|NOT COMPLETED|Overall Study||7
10473771|NCT01097330|11622250|FG001|NOT COMPLETED|Overall Study||5
10473772|NCT01097343|11622256|FG000|STARTED|First Intervention- 30 Days||25
10473773|NCT01097343|11622257|FG001|STARTED|First Intervention- 30 Days||25
10473774|NCT01097343|11622256|FG000|COMPLETED|First Intervention- 30 Days||25
10473775|NCT01097343|11622257|FG001|COMPLETED|First Intervention- 30 Days||25
10473776|NCT01097343|11622256|FG000|NOT COMPLETED|First Intervention- 30 Days||0
10473777|NCT01097343|11622257|FG001|NOT COMPLETED|First Intervention- 30 Days||0
10473778|NCT01097343|11622256|FG000|STARTED|Second Intervention- 30 Days||25
10473779|NCT01097343|11622257|FG001|STARTED|Second Intervention- 30 Days||25
10473780|NCT01097343|11622256|FG000|COMPLETED|Second Intervention- 30 Days||25
10473781|NCT01097343|11622257|FG001|COMPLETED|Second Intervention- 30 Days||25
10473782|NCT01097343|11622256|FG000|NOT COMPLETED|Second Intervention- 30 Days||0
10473783|NCT01097343|11622257|FG001|NOT COMPLETED|Second Intervention- 30 Days||0
10473784|NCT01097395|11622265|FG000|STARTED|Overall Study||17
10473785|NCT01097395|11622266|FG001|STARTED|Overall Study||18
10473786|NCT01097395|11622265|FG000|COMPLETED|Overall Study||14
10473787|NCT01097395|11622266|FG001|COMPLETED|Overall Study||14
10473788|NCT01097395|11622265|FG000|NOT COMPLETED|Overall Study||3
10473789|NCT01097395|11622266|FG001|NOT COMPLETED|Overall Study||4
10473790|NCT01097421|11622272|FG000|STARTED|Overall Study||328
10473791|NCT01097421|11622272|FG000|COMPLETED|Overall Study||314
10473792|NCT01097421|11622272|FG000|NOT COMPLETED|Overall Study||14
10473793|NCT01097460|11622276|FG000|STARTED|Overall Study||16
10473794|NCT01097460|11622276|FG000|COMPLETED|Overall Study||16
10473795|NCT01097460|11622276|FG000|NOT COMPLETED|Overall Study||0
10473796|NCT01097577|11622282|FG000|STARTED|Overall Study||67
10473797|NCT01097577|11622283|FG001|STARTED|Overall Study||63
10473798|NCT01097577|11622282|FG000|COMPLETED|Overall Study||67
10473799|NCT01097577|11622283|FG001|COMPLETED|Overall Study||62
10473800|NCT01097577|11622282|FG000|NOT COMPLETED|Overall Study||0
10473801|NCT01097577|11622283|FG001|NOT COMPLETED|Overall Study||1
10473802|NCT01097616|11622292|FG000|STARTED|Double-Blind (DB) Treatment (TRT) Phase||254
10473803|NCT01097616|11622293|FG001|STARTED|Double-Blind (DB) Treatment (TRT) Phase||383
10473804|NCT01097616|11622294|FG002|STARTED|Double-Blind (DB) Treatment (TRT) Phase||385
10473805|NCT01097616|11622295|FG003|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
10473806|NCT01097616|11622296|FG004|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
10473807|NCT01097616|11622297|FG005|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
10473808|NCT01097616|11622298|FG006|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
10473809|NCT01097616|11622299|FG007|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
10473810|NCT01097616|11622292|FG000|Treated|Double-Blind (DB) Treatment (TRT) Phase||254
10473811|NCT01097616|11622293|FG001|Treated|Double-Blind (DB) Treatment (TRT) Phase||383
10473812|NCT01097616|11622294|FG002|Treated|Double-Blind (DB) Treatment (TRT) Phase||384
10473813|NCT01097616|11622295|FG003|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
10473814|NCT01097616|11622296|FG004|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
10473815|NCT01097616|11622297|FG005|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
10473816|NCT01097616|11622298|FG006|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
10473817|NCT01097616|11622299|FG007|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
10473818|NCT01097616|11622292|FG000|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|100 continued into EXT, 128 continued directly into RO, 2 did not continue into either Phase|230
10473819|NCT01097616|11622293|FG001|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|172 continued into EXT, 172 continued directly into RO, 1 did not continue into either Phase|345
10473820|NCT01097616|11622294|FG002|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|151 continued into EXT, 186 continued directly into RO, 4 did not continue into either Phase|341
10473821|NCT01097616|11622295|FG003|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
10473822|NCT01097616|11622296|FG004|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
10473823|NCT01097616|11622297|FG005|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
10473824|NCT01097616|11622298|FG006|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
10473825|NCT01097616|11622299|FG007|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
10473826|NCT01097616|11622292|FG000|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||24
10473827|NCT01097616|11622293|FG001|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||38
10473828|NCT01097616|11622294|FG002|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||44
10473829|NCT01097616|11622295|FG003|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
10473830|NCT01097616|11622296|FG004|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
10473831|NCT01097616|11622297|FG005|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
10473832|NCT01097616|11622298|FG006|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
10473833|NCT01097616|11622299|FG007|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
10473834|NCT01097616|11622292|FG000|STARTED|Optional DB EXT Phase||100
10473835|NCT01097616|11622293|FG001|STARTED|Optional DB EXT Phase||172
10473836|NCT01097616|11622294|FG002|STARTED|Optional DB EXT Phase||151
10473837|NCT01097616|11622295|FG003|STARTED|Optional DB EXT Phase||0
10473838|NCT01097616|11622296|FG004|STARTED|Optional DB EXT Phase||0
10473839|NCT01097616|11622297|FG005|STARTED|Optional DB EXT Phase||0
10473840|NCT01097616|11622298|FG006|STARTED|Optional DB EXT Phase||0
10473841|NCT01097616|11622299|FG007|STARTED|Optional DB EXT Phase||0
10473842|NCT01097616|11622292|FG000|COMPLETED|Optional DB EXT Phase|All 85 continued into RO|85
10473843|NCT01097616|11622293|FG001|COMPLETED|Optional DB EXT Phase|All 151 continued into RO|151
10473844|NCT01097616|11622294|FG002|COMPLETED|Optional DB EXT Phase|All 141 continued into RO|141
10473845|NCT01097616|11622295|FG003|COMPLETED|Optional DB EXT Phase||0
10473846|NCT01097616|11622296|FG004|COMPLETED|Optional DB EXT Phase||0
10473847|NCT01097616|11622297|FG005|COMPLETED|Optional DB EXT Phase||0
10473848|NCT01097616|11622298|FG006|COMPLETED|Optional DB EXT Phase||0
10473849|NCT01097616|11622299|FG007|COMPLETED|Optional DB EXT Phase||0
10473850|NCT01097616|11622292|FG000|NOT COMPLETED|Optional DB EXT Phase||15
10473851|NCT01097616|11622293|FG001|NOT COMPLETED|Optional DB EXT Phase||21
10473852|NCT01097616|11622294|FG002|NOT COMPLETED|Optional DB EXT Phase||10
10473853|NCT01097616|11622295|FG003|NOT COMPLETED|Optional DB EXT Phase||0
10473854|NCT01097616|11622296|FG004|NOT COMPLETED|Optional DB EXT Phase||0
10473855|NCT01097616|11622297|FG005|NOT COMPLETED|Optional DB EXT Phase||0
10473856|NCT01097616|11622298|FG006|NOT COMPLETED|Optional DB EXT Phase||0
10473857|NCT01097616|11622299|FG007|NOT COMPLETED|Optional DB EXT Phase||0
10473858|NCT01097616|11622292|FG000|STARTED|DB RO Phase||0
10473859|NCT01097616|11622293|FG001|STARTED|DB RO Phase||0
10473860|NCT01097616|11622294|FG002|STARTED|DB RO Phase||0
10473861|NCT01097616|11622295|FG003|STARTED|DB RO Phase||101
10473862|NCT01097616|11622296|FG004|STARTED|DB RO Phase|1 was randomized to this group but actually received suvorexant LD during RO|112
10473863|NCT01097616|11622297|FG005|STARTED|DB RO Phase|1 entered RO but was not treated during RO|161
10473864|NCT01097616|11622298|FG006|STARTED|DB RO Phase||162
10473865|NCT01097616|11622299|FG007|STARTED|DB RO Phase||327
10473866|NCT01097616|11622292|FG000|COMPLETED|DB RO Phase||0
10473867|NCT01097616|11622293|FG001|COMPLETED|DB RO Phase||0
10473868|NCT01097616|11622294|FG002|COMPLETED|DB RO Phase||0
10473869|NCT01097616|11622295|FG003|COMPLETED|DB RO Phase||100
10473870|NCT01097616|11622296|FG004|COMPLETED|DB RO Phase||111
10473871|NCT01097616|11622297|FG005|COMPLETED|DB RO Phase||159
10473872|NCT01097616|11622298|FG006|COMPLETED|DB RO Phase||161
10473873|NCT01097616|11622299|FG007|COMPLETED|DB RO Phase||326
10473874|NCT01097616|11622292|FG000|NOT COMPLETED|DB RO Phase||0
10473875|NCT01097616|11622293|FG001|NOT COMPLETED|DB RO Phase||0
10473876|NCT01097616|11622294|FG002|NOT COMPLETED|DB RO Phase||0
10473877|NCT01097616|11622295|FG003|NOT COMPLETED|DB RO Phase||1
10473878|NCT01097616|11622296|FG004|NOT COMPLETED|DB RO Phase||1
10473879|NCT01097616|11622297|FG005|NOT COMPLETED|DB RO Phase||2
10473880|NCT01097616|11622298|FG006|NOT COMPLETED|DB RO Phase||1
10473881|NCT01097616|11622299|FG007|NOT COMPLETED|DB RO Phase||1
10473882|NCT01097629|11622328|FG000|STARTED|Double-Blind (DB) Treatment (TRT) Phase||240
10473883|NCT01097629|11622329|FG001|STARTED|Double-Blind (DB) Treatment (TRT) Phase||392
10473969|NCT01097707|11622399|FG001|COMPLETED|Overall Study||37
10473884|NCT01097629|11622330|FG002|STARTED|Double-Blind (DB) Treatment (TRT) Phase||387
10473885|NCT01097629|11622331|FG003|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
10473886|NCT01097629|11622332|FG004|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
10473887|NCT01097629|11622333|FG005|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
10473888|NCT01097629|11622334|FG006|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
10473889|NCT01097629|11622335|FG007|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
10473890|NCT01097629|11622328|FG000|Treated|Double-Blind (DB) Treatment (TRT) Phase||239
10473891|NCT01097629|11622329|FG001|Treated|Double-Blind (DB) Treatment (TRT) Phase||387
10473892|NCT01097629|11622330|FG002|Treated|Double-Blind (DB) Treatment (TRT) Phase||383
10473893|NCT01097629|11622331|FG003|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
10473894|NCT01097629|11622332|FG004|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
10473895|NCT01097629|11622333|FG005|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
10473896|NCT01097629|11622334|FG006|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
10473897|NCT01097629|11622335|FG007|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
10473898|NCT01097629|11622328|FG000|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||205
10473899|NCT01097629|11622329|FG001|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|2 did not continue into RO|346
10473900|NCT01097629|11622330|FG002|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|3 did not continue into RO|330
10473901|NCT01097629|11622331|FG003|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
10473902|NCT01097629|11622332|FG004|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
10473903|NCT01097629|11622333|FG005|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
10473904|NCT01097629|11622334|FG006|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
10473905|NCT01097629|11622335|FG007|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
10473906|NCT01097629|11622328|FG000|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||35
10473907|NCT01097629|11622329|FG001|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||46
10473908|NCT01097629|11622330|FG002|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||57
10473909|NCT01097629|11622331|FG003|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
10473910|NCT01097629|11622332|FG004|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
10473911|NCT01097629|11622333|FG005|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
10473912|NCT01097629|11622334|FG006|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
10473913|NCT01097629|11622335|FG007|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
10473914|NCT01097629|11622328|FG000|STARTED|DB RO Phase||0
10473915|NCT01097629|11622329|FG001|STARTED|DB RO Phase||0
10473916|NCT01097629|11622330|FG002|STARTED|DB RO Phase||0
10473917|NCT01097629|11622331|FG003|STARTED|DB RO Phase||97
10473918|NCT01097629|11622332|FG004|STARTED|DB RO Phase||108
10473919|NCT01097629|11622333|FG005|STARTED|DB RO Phase||173
10473920|NCT01097629|11622334|FG006|STARTED|DB RO Phase||171
10473921|NCT01097629|11622335|FG007|STARTED|DB RO Phase||327
10473922|NCT01097629|11622328|FG000|COMPLETED|DB RO Phase||0
10473923|NCT01097629|11622329|FG001|COMPLETED|DB RO Phase||0
10473924|NCT01097629|11622330|FG002|COMPLETED|DB RO Phase||0
10473925|NCT01097629|11622331|FG003|COMPLETED|DB RO Phase||96
10473926|NCT01097629|11622332|FG004|COMPLETED|DB RO Phase||108
10473927|NCT01097629|11622333|FG005|COMPLETED|DB RO Phase||172
10473928|NCT01097629|11622334|FG006|COMPLETED|DB RO Phase||168
10473929|NCT01097629|11622335|FG007|COMPLETED|DB RO Phase||326
10473930|NCT01097629|11622328|FG000|NOT COMPLETED|DB RO Phase||0
10473931|NCT01097629|11622329|FG001|NOT COMPLETED|DB RO Phase||0
10473932|NCT01097629|11622330|FG002|NOT COMPLETED|DB RO Phase||0
10473933|NCT01097629|11622331|FG003|NOT COMPLETED|DB RO Phase||1
10473934|NCT01097629|11622332|FG004|NOT COMPLETED|DB RO Phase||0
10473935|NCT01097629|11622333|FG005|NOT COMPLETED|DB RO Phase||1
10473936|NCT01097629|11622334|FG006|NOT COMPLETED|DB RO Phase||3
10473937|NCT01097629|11622335|FG007|NOT COMPLETED|DB RO Phase||1
10473938|NCT01097642|11622360|FG000|STARTED|Overall Study||15
10473939|NCT01097642|11622361|FG001|STARTED|Overall Study||25
10473940|NCT01097642|11622360|FG000|COMPLETED|Overall Study||15
10473941|NCT01097642|11622361|FG001|COMPLETED|Overall Study||25
10473942|NCT01097642|11622360|FG000|NOT COMPLETED|Overall Study||0
10473943|NCT01097642|11622361|FG001|NOT COMPLETED|Overall Study||0
10473944|NCT01097655|11622367|FG000|STARTED|Overall Study||3049
10473945|NCT01097655|11622367|FG000|COMPLETED|Overall Study|participants included for analysis|3039
10473946|NCT01097655|11622367|FG000|NOT COMPLETED|Overall Study||10
10473947|NCT01097668|11622373|FG000|STARTED|Overall Study||21
10473948|NCT01097668|11622374|FG001|STARTED|Overall Study||22
10473949|NCT01097668|11622373|FG000|Week 20|Overall Study|Patient evaluability time point = week 20|21
10473950|NCT01097668|11622374|FG001|Week 20|Overall Study|Patient evaluability time point = week 20|22
10473951|NCT01097668|11622373|FG000|Week 48|Overall Study||19
10473952|NCT01097668|11622374|FG001|Week 48|Overall Study||20
10473953|NCT01097668|11622373|FG000|COMPLETED|Overall Study||19
10473954|NCT01097668|11622374|FG001|COMPLETED|Overall Study||20
10473955|NCT01097668|11622373|FG000|NOT COMPLETED|Overall Study||2
10473956|NCT01097668|11622374|FG001|NOT COMPLETED|Overall Study||2
10473957|NCT01097694|11622386|FG000|STARTED|Overall Study||32
10473958|NCT01097694|11622387|FG001|STARTED|Overall Study||30
10473959|NCT01097694|11622386|FG000|COMPLETED|Overall Study||24
10473960|NCT01097694|11622387|FG001|COMPLETED|Overall Study||26
10473961|NCT01097694|11622386|FG000|NOT COMPLETED|Overall Study||8
10473962|NCT01097694|11622387|FG001|NOT COMPLETED|Overall Study||4
10473963|NCT01097707|11622398|FG000|STARTED|Overall Study||83
10473964|NCT01097707|11622399|FG001|STARTED|Overall Study||80
10473965|NCT01097707|11622400|FG002|STARTED|Overall Study||82
10473966|NCT01097707|11622401|FG003|STARTED|Overall Study||84
10473967|NCT01097707|11622402|FG004|STARTED|Overall Study||85
10473968|NCT01097707|11622398|FG000|COMPLETED|Overall Study||39
10473970|NCT01097707|11622400|FG002|COMPLETED|Overall Study||37
10473971|NCT01097707|11622401|FG003|COMPLETED|Overall Study||40
10473972|NCT01097707|11622402|FG004|COMPLETED|Overall Study||35
10473973|NCT01097707|11622398|FG000|NOT COMPLETED|Overall Study||44
10473974|NCT01097707|11622399|FG001|NOT COMPLETED|Overall Study||43
10473975|NCT01097707|11622400|FG002|NOT COMPLETED|Overall Study||45
10473976|NCT01097707|11622401|FG003|NOT COMPLETED|Overall Study||44
10473977|NCT01097707|11622402|FG004|NOT COMPLETED|Overall Study||50
10473978|NCT01097785|11622416|FG000|STARTED|Cycle 1 (30 Days)||6
10473979|NCT01097785|11622417|FG001|STARTED|Cycle 1 (30 Days)||6
10473980|NCT01097785|11622416|FG000|COMPLETED|Cycle 1 (30 Days)||6
10473981|NCT01097785|11622417|FG001|COMPLETED|Cycle 1 (30 Days)||6
10473982|NCT01097785|11622416|FG000|NOT COMPLETED|Cycle 1 (30 Days)||0
10473983|NCT01097785|11622417|FG001|NOT COMPLETED|Cycle 1 (30 Days)||0
10473984|NCT01097785|11622416|FG000|STARTED|Washout (2 Weeks)||6
10473985|NCT01097785|11622417|FG001|STARTED|Washout (2 Weeks)||6
10473986|NCT01097785|11622416|FG000|COMPLETED|Washout (2 Weeks)||6
10473987|NCT01097785|11622417|FG001|COMPLETED|Washout (2 Weeks)||6
10473988|NCT01097785|11622416|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10473989|NCT01097785|11622417|FG001|NOT COMPLETED|Washout (2 Weeks)||0
10473990|NCT01097785|11622416|FG000|STARTED|Cycle 3 (30 Days)||6
10473991|NCT01097785|11622417|FG001|STARTED|Cycle 3 (30 Days)||6
10473992|NCT01097785|11622416|FG000|COMPLETED|Cycle 3 (30 Days)||6
10473993|NCT01097785|11622417|FG001|COMPLETED|Cycle 3 (30 Days)||6
10473994|NCT01097785|11622416|FG000|NOT COMPLETED|Cycle 3 (30 Days)||0
10473995|NCT01097785|11622417|FG001|NOT COMPLETED|Cycle 3 (30 Days)||0
10473996|NCT01097863|11622427|FG000|STARTED|Overall Study||90
10473997|NCT01097863|11622428|FG001|STARTED|Overall Study||98
10473998|NCT01097863|11622429|FG002|STARTED|Overall Study||91
10473999|NCT01097863|11622427|FG000|COMPLETED|Overall Study||89
10474000|NCT01097863|11622428|FG001|COMPLETED|Overall Study||98
10474001|NCT01097863|11622429|FG002|COMPLETED|Overall Study||89
10474002|NCT01097863|11622427|FG000|NOT COMPLETED|Overall Study||1
10474003|NCT01097863|11622428|FG001|NOT COMPLETED|Overall Study||0
10474004|NCT01097863|11622429|FG002|NOT COMPLETED|Overall Study||2
10474005|NCT01097915|11622440|FG000|STARTED|Overall Study||50
10474006|NCT01097915|11622441|FG001|STARTED|Overall Study||70
10474007|NCT01097915|11622442|FG002|STARTED|Overall Study||50
10474008|NCT01097915|11622440|FG000|COMPLETED|Overall Study||27
10474009|NCT01097915|11622441|FG001|COMPLETED|Overall Study||28
10474010|NCT01097915|11622442|FG002|COMPLETED|Overall Study||20
10474011|NCT01097915|11622440|FG000|NOT COMPLETED|Overall Study||23
10474012|NCT01097915|11622441|FG001|NOT COMPLETED|Overall Study||42
10474013|NCT01097915|11622442|FG002|NOT COMPLETED|Overall Study||30
10474014|NCT01098006|11622461|FG000|STARTED|Overall Study||7
10474015|NCT01098006|11622462|FG001|STARTED|Overall Study||11
10474016|NCT01098006|11622463|FG002|STARTED|Overall Study||60
10474017|NCT01098006|11622464|FG003|STARTED|Overall Study||21
10474018|NCT01098006|11622461|FG000|COMPLETED|Overall Study||7
10474019|NCT01098006|11622462|FG001|COMPLETED|Overall Study||11
10474020|NCT01098006|11622463|FG002|COMPLETED|Overall Study||60
10474021|NCT01098006|11622464|FG003|COMPLETED|Overall Study||21
10474022|NCT01098006|11622461|FG000|NOT COMPLETED|Overall Study||0
10474023|NCT01098006|11622462|FG001|NOT COMPLETED|Overall Study||0
10474024|NCT01098006|11622463|FG002|NOT COMPLETED|Overall Study||0
10474025|NCT01098006|11622464|FG003|NOT COMPLETED|Overall Study||0
10474026|NCT01098097|11622474|FG000|STARTED|Overall Study||963
10474027|NCT01098097|11622474|FG000|COMPLETED|Overall Study|Participants completing the study received at least 12 weeks of treatment|881
10474028|NCT01098097|11622474|FG000|NOT COMPLETED|Overall Study||82
10474029|NCT01098162|11622478|FG000|STARTED|Overall Study||573
10474030|NCT01098162|11622478|FG000|COMPLETED|Overall Study||461
10474031|NCT01098162|11622478|FG000|NOT COMPLETED|Overall Study||112
10474032|NCT01098240|11622482|FG000|STARTED|Open-Label Phase||297
10474033|NCT01098240|11622483|FG001|STARTED|Open-Label Phase||0
10474034|NCT01098240|11622484|FG002|STARTED|Open-Label Phase||0
10474035|NCT01098240|11622482|FG000|COMPLETED|Open-Label Phase||162
10474036|NCT01098240|11622483|FG001|COMPLETED|Open-Label Phase||0
10474037|NCT01098240|11622484|FG002|COMPLETED|Open-Label Phase||0
10474038|NCT01098240|11622482|FG000|NOT COMPLETED|Open-Label Phase||135
10474039|NCT01098240|11622483|FG001|NOT COMPLETED|Open-Label Phase||0
10474040|NCT01098240|11622484|FG002|NOT COMPLETED|Open-Label Phase||0
10474041|NCT01098240|11622482|FG000|STARTED|Double-Blind Phase||0
10474042|NCT01098240|11622483|FG001|STARTED|Double-Blind Phase||77
10474043|NCT01098240|11622484|FG002|STARTED|Double-Blind Phase||85
10474044|NCT01098240|11622482|FG000|COMPLETED|Double-Blind Phase||0
10474045|NCT01098240|11622483|FG001|COMPLETED|Double-Blind Phase||60
10474046|NCT01098240|11622484|FG002|COMPLETED|Double-Blind Phase||63
10474047|NCT01098240|11622482|FG000|NOT COMPLETED|Double-Blind Phase||0
10474048|NCT01098240|11622483|FG001|NOT COMPLETED|Double-Blind Phase||17
10474049|NCT01098240|11622484|FG002|NOT COMPLETED|Double-Blind Phase||22
10474050|NCT01098253|11622493|FG000|STARTED|Overall Study||94
10474051|NCT01098253|11622494|FG001|STARTED|Overall Study||88
10474052|NCT01098253|11622493|FG000|COMPLETED|Overall Study||92
10474053|NCT01098253|11622494|FG001|COMPLETED|Overall Study||88
10474054|NCT01098253|11622493|FG000|NOT COMPLETED|Overall Study||2
10474055|NCT01098253|11622494|FG001|NOT COMPLETED|Overall Study||0
10474056|NCT01098266|11622502|FG000|STARTED|Overall Study||200
10474057|NCT01098266|11622503|FG001|STARTED|Overall Study||200
10474058|NCT01098266|11622502|FG000|COMPLETED|Overall Study||193
10474059|NCT01098266|11622503|FG001|COMPLETED|Overall Study||193
10474060|NCT01098266|11622502|FG000|NOT COMPLETED|Overall Study||7
10474061|NCT01098266|11622503|FG001|NOT COMPLETED|Overall Study||7
10474062|NCT01098305|11622511|FG000|STARTED|Overall Study||119
10474063|NCT01098305|11622512|FG001|STARTED|Overall Study||118
10474064|NCT01098305|11622511|FG000|COMPLETED|Overall Study||88
10474065|NCT01098305|11622512|FG001|COMPLETED|Overall Study||85
10474066|NCT01098305|11622511|FG000|NOT COMPLETED|Overall Study||31
10474067|NCT01098305|11622512|FG001|NOT COMPLETED|Overall Study||33
10474068|NCT01098318|11622521|FG000|STARTED|Overall Study||20
10474069|NCT01098318|11622522|FG001|STARTED|Overall Study||19
10474070|NCT01098318|11622523|FG002|STARTED|Overall Study||18
10474071|NCT01098318|11622521|FG000|COMPLETED|Overall Study||17
10474072|NCT01098318|11622522|FG001|COMPLETED|Overall Study||12
10474073|NCT01098318|11622523|FG002|COMPLETED|Overall Study||15
10474074|NCT01098318|11622521|FG000|NOT COMPLETED|Overall Study||3
10474075|NCT01098318|11622522|FG001|NOT COMPLETED|Overall Study||7
10474076|NCT01098318|11622523|FG002|NOT COMPLETED|Overall Study||3
10474077|NCT01098422|11622531|FG000|STARTED|Overall Study||10
10474078|NCT01098422|11622531|FG000|COMPLETED|Overall Study||9
10474079|NCT01098422|11622531|FG000|NOT COMPLETED|Overall Study||1
10474080|NCT01098461|11622539|FG000|STARTED|Treatment Period (TP) (16 Weeks)||53
10474081|NCT01098461|11622540|FG001|STARTED|Treatment Period (TP) (16 Weeks)||52
10474082|NCT01098461|11622541|FG002|STARTED|Treatment Period (TP) (16 Weeks)||54
10474083|NCT01098461|11622542|FG003|STARTED|Treatment Period (TP) (16 Weeks)||53
10474084|NCT01098461|11622539|FG000|COMPLETED|Treatment Period (TP) (16 Weeks)||41
10474085|NCT01098461|11622540|FG001|COMPLETED|Treatment Period (TP) (16 Weeks)||45
10474086|NCT01098461|11622541|FG002|COMPLETED|Treatment Period (TP) (16 Weeks)||53
10474087|NCT01098461|11622542|FG003|COMPLETED|Treatment Period (TP) (16 Weeks)||50
10474088|NCT01098461|11622539|FG000|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||12
10474089|NCT01098461|11622540|FG001|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||7
10474090|NCT01098461|11622541|FG002|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||1
10474091|NCT01098461|11622542|FG003|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||3
10474092|NCT01098461|11622539|FG000|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|52
10474093|NCT01098461|11622540|FG001|STARTED|Follow-up (FU) Period (8 Weeks)||52
10474094|NCT01098461|11622541|FG002|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|53
10474095|NCT01098461|11622542|FG003|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|52
10474096|NCT01098461|11622539|FG000|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
10474097|NCT01098461|11622540|FG001|COMPLETED|Follow-up (FU) Period (8 Weeks)||49
10474098|NCT01098461|11622541|FG002|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
10474099|NCT01098461|11622542|FG003|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
10474100|NCT01098461|11622539|FG000|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||0
10474101|NCT01098461|11622540|FG001|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||3
10474102|NCT01098461|11622541|FG002|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||1
10474103|NCT01098461|11622542|FG003|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||0
10474104|NCT01098474|11622559|FG000|STARTED|Active Phase||50
10474105|NCT01098474|11622560|FG001|STARTED|Active Phase||50
10474106|NCT01098474|11622561|FG002|STARTED|Active Phase||50
10474107|NCT01098474|11622562|FG003|STARTED|Active Phase||49
10474108|NCT01098474|11622563|FG004|STARTED|Active Phase||52
10474109|NCT01098474|11622564|FG005|STARTED|Active Phase||49
10474110|NCT01098474|11622559|FG000|COMPLETED|Active Phase||48
10474111|NCT01098474|11622560|FG001|COMPLETED|Active Phase||49
10474112|NCT01098474|11622561|FG002|COMPLETED|Active Phase||45
10474113|NCT01098474|11622562|FG003|COMPLETED|Active Phase||49
10474114|NCT01098474|11622563|FG004|COMPLETED|Active Phase||52
10474115|NCT01098474|11622564|FG005|COMPLETED|Active Phase||49
10474116|NCT01098474|11622559|FG000|NOT COMPLETED|Active Phase||2
10474117|NCT01098474|11622560|FG001|NOT COMPLETED|Active Phase||1
10474118|NCT01098474|11622561|FG002|NOT COMPLETED|Active Phase||5
10474119|NCT01098474|11622562|FG003|NOT COMPLETED|Active Phase||0
10474120|NCT01098474|11622563|FG004|NOT COMPLETED|Active Phase||0
10474121|NCT01098474|11622564|FG005|NOT COMPLETED|Active Phase||0
10474122|NCT01098474|11622559|FG000|STARTED|Follow Up Phase||48
10474123|NCT01098474|11622560|FG001|STARTED|Follow Up Phase||49
10474124|NCT01098474|11622561|FG002|STARTED|Follow Up Phase||45
10474125|NCT01098474|11622562|FG003|STARTED|Follow Up Phase||49
10474126|NCT01098474|11622563|FG004|STARTED|Follow Up Phase||52
10474127|NCT01098474|11622564|FG005|STARTED|Follow Up Phase||49
10474128|NCT01098474|11622559|FG000|COMPLETED|Follow Up Phase||48
10474129|NCT01098474|11622560|FG001|COMPLETED|Follow Up Phase||49
10474130|NCT01098474|11622561|FG002|COMPLETED|Follow Up Phase||45
10474131|NCT01098474|11622562|FG003|COMPLETED|Follow Up Phase||47
10474132|NCT01098474|11622563|FG004|COMPLETED|Follow Up Phase||50
10474133|NCT01098474|11622564|FG005|COMPLETED|Follow Up Phase||44
10474134|NCT01098474|11622559|FG000|NOT COMPLETED|Follow Up Phase||0
10474135|NCT01098474|11622560|FG001|NOT COMPLETED|Follow Up Phase||0
10474136|NCT01098474|11622561|FG002|NOT COMPLETED|Follow Up Phase||0
10474137|NCT01098474|11622562|FG003|NOT COMPLETED|Follow Up Phase||2
10474138|NCT01098474|11622563|FG004|NOT COMPLETED|Follow Up Phase||2
10474139|NCT01098474|11622564|FG005|NOT COMPLETED|Follow Up Phase||5
10526814|NCT01384292|11678732|FG001|STARTED|Part A||5
10526815|NCT01384292|11678733|FG002|STARTED|Part A||4
10526816|NCT01384292|11678731|FG000|COMPLETED|Part A||5
10526817|NCT01384292|11678732|FG001|COMPLETED|Part A||5
10526818|NCT01384292|11678733|FG002|COMPLETED|Part A||4
10526819|NCT01384292|11678731|FG000|NOT COMPLETED|Part A||0
10526820|NCT01384292|11678732|FG001|NOT COMPLETED|Part A||0
10526821|NCT01384292|11678733|FG002|NOT COMPLETED|Part A||0
10526822|NCT01384292|11678731|FG000|STARTED|Part B||3
10526823|NCT01384292|11678732|FG001|STARTED|Part B||6
10526824|NCT01384292|11678733|FG002|STARTED|Part B||0
10526825|NCT01384292|11678731|FG000|COMPLETED|Part B||2
10526826|NCT01384292|11678732|FG001|COMPLETED|Part B||6
10526827|NCT01384292|11678733|FG002|COMPLETED|Part B||0
10526828|NCT01384292|11678731|FG000|NOT COMPLETED|Part B||1
10526829|NCT01384292|11678732|FG001|NOT COMPLETED|Part B||0
10526830|NCT01384292|11678733|FG002|NOT COMPLETED|Part B||0
10526831|NCT01384539|11678745|FG000|STARTED|Overall Study||64
10526832|NCT01384539|11678746|FG001|STARTED|Overall Study||64
10526833|NCT01384539|11678745|FG000|COMPLETED|Overall Study||58
10526834|NCT01384539|11678746|FG001|COMPLETED|Overall Study||57
10526835|NCT01384539|11678745|FG000|NOT COMPLETED|Overall Study||6
10526836|NCT01384539|11678746|FG001|NOT COMPLETED|Overall Study||7
10526837|NCT01384591|11678755|FG000|STARTED|Overall Study||2
10526838|NCT01384591|11678756|FG001|STARTED|Overall Study||2
10526839|NCT01384591|11678757|FG002|STARTED|Overall Study||2
10526840|NCT01384591|11678755|FG000|COMPLETED|Overall Study||2
10526841|NCT01384591|11678756|FG001|COMPLETED|Overall Study||2
10526842|NCT01384591|11678757|FG002|COMPLETED|Overall Study||2
10526843|NCT01384591|11678755|FG000|NOT COMPLETED|Overall Study||0
10526844|NCT01384591|11678756|FG001|NOT COMPLETED|Overall Study||0
10526845|NCT01384591|11678757|FG002|NOT COMPLETED|Overall Study||0
10526846|NCT01384734|11678770|FG000|STARTED|Overall Study||50
10526847|NCT01384734|11678771|FG001|STARTED|Overall Study||49
10526848|NCT01384734|11678772|FG002|STARTED|Overall Study||51
10526849|NCT01384734|11678773|FG003|STARTED|Overall Study||50
10526850|NCT01384734|11678774|FG004|STARTED|Overall Study||51
10526851|NCT01384734|11678770|FG000|COMPLETED|Overall Study||33
10526852|NCT01384734|11678771|FG001|COMPLETED|Overall Study||25
10526853|NCT01384734|11678772|FG002|COMPLETED|Overall Study||28
10526854|NCT01384734|11678773|FG003|COMPLETED|Overall Study||22
10526855|NCT01384734|11678774|FG004|COMPLETED|Overall Study||22
10526856|NCT01384734|11678770|FG000|NOT COMPLETED|Overall Study||17
10526857|NCT01384734|11678771|FG001|NOT COMPLETED|Overall Study||24
10526858|NCT01384734|11678772|FG002|NOT COMPLETED|Overall Study||23
10526859|NCT01384734|11678773|FG003|NOT COMPLETED|Overall Study||28
10526860|NCT01384734|11678774|FG004|NOT COMPLETED|Overall Study||29
10526861|NCT01384760|11678785|FG000|STARTED|Overall Study||61
10526862|NCT01384760|11678786|FG001|STARTED|Overall Study||43
10526863|NCT01384760|11678785|FG000|Randomized|Overall Study||61
10526864|NCT01384760|11678786|FG001|Randomized|Overall Study||43
10526865|NCT01384760|11678785|FG000|COMPLETED|Overall Study||45
10526866|NCT01384760|11678786|FG001|COMPLETED|Overall Study||37
10526867|NCT01384760|11678785|FG000|NOT COMPLETED|Overall Study||16
10526868|NCT01384760|11678786|FG001|NOT COMPLETED|Overall Study||6
10526869|NCT01384877|11678794|FG000|STARTED|Treatment 1||17
10526870|NCT01384877|11678795|FG001|STARTED|Treatment 1||15
10526871|NCT01384877|11678794|FG000|COMPLETED|Treatment 1||17
10526872|NCT01384877|11678795|FG001|COMPLETED|Treatment 1||15
10526873|NCT01384877|11678794|FG000|NOT COMPLETED|Treatment 1||0
10526874|NCT01384877|11678795|FG001|NOT COMPLETED|Treatment 1||0
10526875|NCT01384877|11678794|FG000|STARTED|Treatment 2|1 Patient died between treatment periods|16
10526876|NCT01384877|11678795|FG001|STARTED|Treatment 2|2 Patients died between treatment periods|13
10526877|NCT01384877|11678794|FG000|COMPLETED|Treatment 2||14
10526878|NCT01384877|11678795|FG001|COMPLETED|Treatment 2||11
10474140|NCT01098487|11622588|FG000|STARTED|Overall Study||162
10474141|NCT01098487|11622588|FG000|COMPLETED|Overall Study||118
10474142|NCT01098487|11622588|FG000|NOT COMPLETED|Overall Study||44
10474143|NCT01098500|11622592|FG000|STARTED|Overall Study||3800
10474144|NCT01098500|11622592|FG000|COMPLETED|Overall Study||3800
10474145|NCT01098500|11622592|FG000|NOT COMPLETED|Overall Study||0
10474146|NCT01098539|11622598|FG000|STARTED|Overall Study||249
10474147|NCT01098539|11622599|FG001|STARTED|Overall Study||246
10474148|NCT01098539|11622598|FG000|COMPLETED|Overall Study||198
10474149|NCT01098539|11622599|FG001|COMPLETED|Overall Study||178
10474150|NCT01098539|11622598|FG000|NOT COMPLETED|Overall Study||51
10474151|NCT01098539|11622599|FG001|NOT COMPLETED|Overall Study||68
10474152|NCT01098578|11622605|FG000|STARTED|Overall Study||20
10474153|NCT01098578|11622605|FG000|COMPLETED|Overall Study||20
10474154|NCT01098578|11622605|FG000|NOT COMPLETED|Overall Study||0
10474155|NCT01098747|11622615|FG000|STARTED|Overall Study||48
10474156|NCT01098747|11622616|FG001|STARTED|Overall Study||95
10474157|NCT01098747|11622617|FG002|STARTED|Overall Study||86
10474158|NCT01098747|11622618|FG003|STARTED|Overall Study||87
10474159|NCT01098747|11622615|FG000|COMPLETED|Overall Study||48
10474160|NCT01098747|11622616|FG001|COMPLETED|Overall Study||95
10474161|NCT01098747|11622617|FG002|COMPLETED|Overall Study||86
10474162|NCT01098747|11622618|FG003|COMPLETED|Overall Study||87
10474163|NCT01098747|11622615|FG000|NOT COMPLETED|Overall Study||0
10474164|NCT01098747|11622616|FG001|NOT COMPLETED|Overall Study||0
10474165|NCT01098747|11622617|FG002|NOT COMPLETED|Overall Study||0
10474166|NCT01098747|11622618|FG003|NOT COMPLETED|Overall Study||0
10474167|NCT01098812|11622630|FG000|STARTED|Overall Study||95
10474168|NCT01098812|11622631|FG001|STARTED|Overall Study||102
10474169|NCT01098812|11622632|FG002|STARTED|Overall Study||72
10474170|NCT01098812|11622630|FG000|COMPLETED|Overall Study||93
10474171|NCT01098812|11622631|FG001|COMPLETED|Overall Study||101
10474172|NCT01098812|11622632|FG002|COMPLETED|Overall Study||71
10474173|NCT01098812|11622630|FG000|NOT COMPLETED|Overall Study||2
10474174|NCT01098812|11622631|FG001|NOT COMPLETED|Overall Study||1
10474175|NCT01098812|11622632|FG002|NOT COMPLETED|Overall Study||1
10474176|NCT01098851|11622641|FG000|STARTED|Overall Study||11
10474177|NCT01098851|11622642|FG001|STARTED|Overall Study||10
10474178|NCT01098851|11622641|FG000|COMPLETED|Overall Study||10
10474179|NCT01098851|11622642|FG001|COMPLETED|Overall Study||10
10474180|NCT01098851|11622641|FG000|NOT COMPLETED|Overall Study||1
10474181|NCT01098851|11622642|FG001|NOT COMPLETED|Overall Study||0
10474182|NCT01099111|11622653|FG000|STARTED|Overall Study||50
10474183|NCT01099111|11622654|FG001|STARTED|Overall Study||50
10474184|NCT01099111|11622655|FG002|STARTED|Overall Study||46
10474185|NCT01099111|11622656|FG003|STARTED|Overall Study||29
10474186|NCT01099111|11622657|FG004|STARTED|Overall Study||50
10474187|NCT01099111|11622653|FG000|COMPLETED|Overall Study|5 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
10474188|NCT01099111|11622654|FG001|COMPLETED|Overall Study|3 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
10474189|NCT01099111|11622655|FG002|COMPLETED|Overall Study|2 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|46
10474190|NCT01099111|11622656|FG003|COMPLETED|Overall Study||29
10474191|NCT01099111|11622657|FG004|COMPLETED|Overall Study|6 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
10474192|NCT01099111|11622653|FG000|NOT COMPLETED|Overall Study||0
10474193|NCT01099111|11622654|FG001|NOT COMPLETED|Overall Study||0
10474194|NCT01099111|11622655|FG002|NOT COMPLETED|Overall Study||0
10474195|NCT01099111|11622656|FG003|NOT COMPLETED|Overall Study||0
10474196|NCT01099111|11622657|FG004|NOT COMPLETED|Overall Study||0
10474197|NCT01099202|11622671|FG000|STARTED|Overall Study||55
10474198|NCT01099202|11622672|FG001|STARTED|Overall Study||54
10474199|NCT01099202|11622671|FG000|COMPLETED|Overall Study||55
10474200|NCT01099202|11622672|FG001|COMPLETED|Overall Study||54
10474201|NCT01099202|11622671|FG000|NOT COMPLETED|Overall Study||0
10474202|NCT01099202|11622672|FG001|NOT COMPLETED|Overall Study||0
10474203|NCT01099215|11622681|FG000|STARTED|Overall Study||11
10474204|NCT01099215|11622682|FG001|STARTED|Overall Study||10
10474205|NCT01099215|11622681|FG000|COMPLETED|Overall Study||10
10474206|NCT01099215|11622682|FG001|COMPLETED|Overall Study||9
10474207|NCT01099215|11622681|FG000|NOT COMPLETED|Overall Study||1
10474208|NCT01099215|11622682|FG001|NOT COMPLETED|Overall Study||1
10474209|NCT01099267|11622688|FG000|STARTED|MDS-003 Study|This information duplicates results in NCT00065156.|148
10474210|NCT01099267|11622688|FG000|COMPLETED|MDS-003 Study||24
10474211|NCT01099267|11622688|FG000|NOT COMPLETED|MDS-003 Study||124
10474212|NCT01099267|11622688|FG000|STARTED|MDS-009 Extension Follow-up|Participants from MDS-003 (including some who did not complete) at sites participating in MDS-009.|54
10474213|NCT01099267|11622688|FG000|Informed Consent Given|MDS-009 Extension Follow-up||33
10474214|NCT01099267|11622688|FG000|Other Source of Follow-up Info Used|MDS-009 Extension Follow-up|Social Security Death Index, public records, verbal reports from health providers and next of kin.|21
10474215|NCT01099267|11622688|FG000|COMPLETED|MDS-009 Extension Follow-up||54
10474216|NCT01099267|11622688|FG000|NOT COMPLETED|MDS-009 Extension Follow-up||0
10474217|NCT01099358|11622692|FG000|STARTED|Overall Study||4
10474218|NCT01099358|11622693|FG001|STARTED|Overall Study||6
10474219|NCT01099358|11622694|FG002|STARTED|Overall Study||21
10474220|NCT01099358|11622695|FG003|STARTED|Overall Study||16
10474221|NCT01099358|11622692|FG000|Received at Least One Dose of Study Drug|Overall Study||3
10474222|NCT01099358|11622693|FG001|Received at Least One Dose of Study Drug|Overall Study||6
10526879|NCT01384877|11678794|FG000|NOT COMPLETED|Treatment 2||2
10474223|NCT01099358|11622694|FG002|Received at Least One Dose of Study Drug|Overall Study||20
10474224|NCT01099358|11622695|FG003|Received at Least One Dose of Study Drug|Overall Study||15
10474225|NCT01099358|11622692|FG000|COMPLETED|Overall Study||1
10474226|NCT01099358|11622693|FG001|COMPLETED|Overall Study||5
10474227|NCT01099358|11622694|FG002|COMPLETED|Overall Study||13
10474228|NCT01099358|11622695|FG003|COMPLETED|Overall Study||12
10474229|NCT01099358|11622692|FG000|NOT COMPLETED|Overall Study||3
10474230|NCT01099358|11622693|FG001|NOT COMPLETED|Overall Study||1
10474231|NCT01099358|11622694|FG002|NOT COMPLETED|Overall Study||8
10474232|NCT01099358|11622695|FG003|NOT COMPLETED|Overall Study||4
10474233|NCT01099397|11622706|FG000|STARTED|Overall Study||39
10474234|NCT01099397|11622706|FG000|COMPLETED|Overall Study||26
10474235|NCT01099397|11622706|FG000|NOT COMPLETED|Overall Study||13
10474236|NCT01099449|11622714|FG000|STARTED|Overall Study||118
10474237|NCT01099449|11622715|FG001|STARTED|Overall Study||119
10474238|NCT01099449|11622716|FG002|STARTED|Overall Study||116
10474239|NCT01099449|11622714|FG000|COMPLETED|Overall Study||118
10474240|NCT01099449|11622715|FG001|COMPLETED|Overall Study||119
10474241|NCT01099449|11622716|FG002|COMPLETED|Overall Study||116
10474242|NCT01099449|11622714|FG000|NOT COMPLETED|Overall Study||0
10474243|NCT01099449|11622715|FG001|NOT COMPLETED|Overall Study||0
10474244|NCT01099449|11622716|FG002|NOT COMPLETED|Overall Study||0
10474245|NCT01099475|11622739|FG000|STARTED|Overall Study||10
10474246|NCT01099475|11622740|FG001|STARTED|Overall Study||10
10474247|NCT01099475|11622739|FG000|COMPLETED|Overall Study||10
10474248|NCT01099475|11622740|FG001|COMPLETED|Overall Study||10
10474249|NCT01099475|11622739|FG000|NOT COMPLETED|Overall Study||0
10474250|NCT01099475|11622740|FG001|NOT COMPLETED|Overall Study||0
10474251|NCT01099579|11622749|FG000|STARTED|Stage 1 (ATV Powder Formulation)||21
10474252|NCT01099579|11622750|FG001|STARTED|Stage 1 (ATV Powder Formulation)||19
10474253|NCT01099579|11622751|FG002|STARTED|Stage 1 (ATV Powder Formulation)||16
10474254|NCT01099579|11622749|FG000|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|17
10474255|NCT01099579|11622750|FG001|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|14
10474256|NCT01099579|11622751|FG002|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|15
10474257|NCT01099579|11622749|FG000|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||4
10474258|NCT01099579|11622750|FG001|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||5
10474259|NCT01099579|11622751|FG002|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||1
10474260|NCT01099579|11622749|FG000|STARTED|Stage 2 (ATV Capsule)||16
10474261|NCT01099579|11622750|FG001|STARTED|Stage 2 (ATV Capsule)||14
10474262|NCT01099579|11622751|FG002|STARTED|Stage 2 (ATV Capsule)||15
10474263|NCT01099579|11622749|FG000|COMPLETED|Stage 2 (ATV Capsule)||10
10474264|NCT01099579|11622750|FG001|COMPLETED|Stage 2 (ATV Capsule)||9
10474265|NCT01099579|11622751|FG002|COMPLETED|Stage 2 (ATV Capsule)||9
10474266|NCT01099579|11622749|FG000|NOT COMPLETED|Stage 2 (ATV Capsule)||6
10474267|NCT01099579|11622750|FG001|NOT COMPLETED|Stage 2 (ATV Capsule)||5
10474268|NCT01099579|11622751|FG002|NOT COMPLETED|Stage 2 (ATV Capsule)||6
10474269|NCT01099618|11622764|FG000|STARTED|Overall Study||17
10474270|NCT01099618|11622765|FG001|STARTED|Overall Study||16
10474271|NCT01099618|11622766|FG002|STARTED|Overall Study||15
10709068|NCT02636361|11873956|FG001|NOT COMPLETED|Period 3||0
10709069|NCT02636361|11873957|FG002|NOT COMPLETED|Period 3||0
10474272|NCT01099618|11622764|FG000|COMPLETED|Overall Study||17
10474273|NCT01099618|11622765|FG001|COMPLETED|Overall Study||16
10474274|NCT01099618|11622766|FG002|COMPLETED|Overall Study||15
10474275|NCT01099618|11622764|FG000|NOT COMPLETED|Overall Study||0
10474276|NCT01099618|11622765|FG001|NOT COMPLETED|Overall Study||0
10474277|NCT01099618|11622766|FG002|NOT COMPLETED|Overall Study||0
10474278|NCT01099631|11622780|FG000|STARTED|Overall Study||6
10474279|NCT01099631|11622781|FG001|STARTED|Overall Study||3
10474280|NCT01099631|11622782|FG002|STARTED|Overall Study||3
10474281|NCT01099631|11622783|FG003|STARTED|Overall Study||3
10474282|NCT01099631|11622784|FG004|STARTED|Overall Study||3
10474283|NCT01099631|11622785|FG005|STARTED|Overall Study||4
10474284|NCT01099631|11622780|FG000|COMPLETED|Overall Study||6
10474285|NCT01099631|11622781|FG001|COMPLETED|Overall Study||3
10474286|NCT01099631|11622782|FG002|COMPLETED|Overall Study||3
10474287|NCT01099631|11622783|FG003|COMPLETED|Overall Study||3
10474288|NCT01099631|11622784|FG004|COMPLETED|Overall Study||3
10474289|NCT01099631|11622785|FG005|COMPLETED|Overall Study||4
10474290|NCT01099631|11622780|FG000|NOT COMPLETED|Overall Study||0
10474291|NCT01099631|11622781|FG001|NOT COMPLETED|Overall Study||0
10474292|NCT01099631|11622782|FG002|NOT COMPLETED|Overall Study||0
10474293|NCT01099631|11622783|FG003|NOT COMPLETED|Overall Study||0
10709070|NCT02636361|11873958|FG003|NOT COMPLETED|Period 3||0
10709071|NCT02636361|11873959|FG004|NOT COMPLETED|Period 3||0
10709072|NCT02636361|11873955|FG000|STARTED|Period 4||5
10474294|NCT01099631|11622784|FG004|NOT COMPLETED|Overall Study||0
10474295|NCT01099631|11622785|FG005|NOT COMPLETED|Overall Study||0
10474296|NCT01099709|11622805|FG000|STARTED|Period 1||42
10474297|NCT01099709|11622806|FG001|STARTED|Period 1||43
10474298|NCT01099709|11622805|FG000|COMPLETED|Period 1||41
10474299|NCT01099709|11622806|FG001|COMPLETED|Period 1||41
10474300|NCT01099709|11622805|FG000|NOT COMPLETED|Period 1||1
10474301|NCT01099709|11622806|FG001|NOT COMPLETED|Period 1||2
10474302|NCT01099709|11622805|FG000|STARTED|Period 2||41
10474303|NCT01099709|11622806|FG001|STARTED|Period 2||41
10474304|NCT01099709|11622805|FG000|COMPLETED|Period 2||41
10474305|NCT01099709|11622806|FG001|COMPLETED|Period 2||41
10474306|NCT01099709|11622805|FG000|NOT COMPLETED|Period 2||0
10474307|NCT01099709|11622806|FG001|NOT COMPLETED|Period 2||0
10709073|NCT02636361|11873956|FG001|STARTED|Period 4||5
10474308|NCT01099761|11622817|FG000|STARTED|Overall Study||9
10474309|NCT01099761|11622818|FG001|STARTED|Overall Study||9
10474310|NCT01099761|11622819|FG002|STARTED|Overall Study|Study terminated prior to enrolling cohort 3|0
10474311|NCT01099761|11622820|FG003|STARTED|Overall Study||6
10474312|NCT01099761|11622817|FG000|COMPLETED|Overall Study||9
10474313|NCT01099761|11622818|FG001|COMPLETED|Overall Study||9
10474314|NCT01099761|11622819|FG002|COMPLETED|Overall Study||0
10474315|NCT01099761|11622820|FG003|COMPLETED|Overall Study||6
10474316|NCT01099761|11622817|FG000|NOT COMPLETED|Overall Study||0
10474317|NCT01099761|11622818|FG001|NOT COMPLETED|Overall Study||0
10474318|NCT01099761|11622819|FG002|NOT COMPLETED|Overall Study||0
10474319|NCT01099761|11622820|FG003|NOT COMPLETED|Overall Study||0
10474320|NCT01099774|11622831|FG000|STARTED|Overall Study||302
10474321|NCT01099774|11622832|FG001|STARTED|Overall Study||295
10474322|NCT01099774|11622831|FG000|COMPLETED|Overall Study||296
10474323|NCT01099774|11622832|FG001|COMPLETED|Overall Study||289
10474324|NCT01099774|11622831|FG000|NOT COMPLETED|Overall Study||6
10474325|NCT01099774|11622832|FG001|NOT COMPLETED|Overall Study||6
10474326|NCT01099917|11622838|FG000|STARTED|Overall Study||45
10474327|NCT01099917|11622838|FG000|COMPLETED|Overall Study||18
10474328|NCT01099917|11622838|FG000|NOT COMPLETED|Overall Study||27
10474329|NCT01099969|11622846|FG000|STARTED|Overall Study||15
10474330|NCT01099969|11622847|FG001|STARTED|Overall Study||15
10474331|NCT01099969|11622848|FG002|STARTED|Overall Study||15
10474332|NCT01099969|11622849|FG003|STARTED|Overall Study||15
10474333|NCT01099969|11622846|FG000|COMPLETED|Overall Study||15
10474334|NCT01099969|11622847|FG001|COMPLETED|Overall Study||15
10474335|NCT01099969|11622848|FG002|COMPLETED|Overall Study||15
10474336|NCT01099969|11622849|FG003|COMPLETED|Overall Study||15
10474337|NCT01099969|11622846|FG000|NOT COMPLETED|Overall Study||0
10474338|NCT01099969|11622847|FG001|NOT COMPLETED|Overall Study||0
10474339|NCT01099969|11622848|FG002|NOT COMPLETED|Overall Study||0
10474340|NCT01099969|11622849|FG003|NOT COMPLETED|Overall Study||0
10474341|NCT01100034|11622859|FG000|STARTED|Overall Study||72
10474342|NCT01100034|11622859|FG000|COMPLETED|Overall Study||29
10474343|NCT01100034|11622859|FG000|NOT COMPLETED|Overall Study||43
10474344|NCT01100073|11622863|FG000|STARTED|Overall Study|Baseline (Visit 1)|1699
10474345|NCT01100073|11622863|FG000|COMPLETED|Overall Study|End of study (Visit 3)|1599
10474346|NCT01100073|11622863|FG000|NOT COMPLETED|Overall Study||100
10474347|NCT01100086|11622867|FG000|STARTED|Period 1||43
10474348|NCT01100086|11622868|FG001|STARTED|Period 1||41
10474349|NCT01100086|11622867|FG000|COMPLETED|Period 1||42
10474350|NCT01100086|11622868|FG001|COMPLETED|Period 1||41
10474351|NCT01100086|11622867|FG000|NOT COMPLETED|Period 1||1
10474352|NCT01100086|11622868|FG001|NOT COMPLETED|Period 1||0
10474353|NCT01100086|11622867|FG000|STARTED|Period 2||42
10474354|NCT01100086|11622868|FG001|STARTED|Period 2||41
10474355|NCT01100086|11622867|FG000|COMPLETED|Period 2||42
10474356|NCT01100086|11622868|FG001|COMPLETED|Period 2||41
10474357|NCT01100086|11622867|FG000|NOT COMPLETED|Period 2||0
10474358|NCT01100086|11622868|FG001|NOT COMPLETED|Period 2||0
10474359|NCT01100112|11622874|FG000|STARTED|Overall Study||60
10474360|NCT01100112|11622874|FG000|COMPLETED|Overall Study||52
10474361|NCT01100112|11622874|FG000|NOT COMPLETED|Overall Study||8
10474362|NCT01100242|11622878|FG000|STARTED|Overall Study||17
10474363|NCT01100242|11622878|FG000|COMPLETED|Overall Study||17
10474364|NCT01100242|11622878|FG000|NOT COMPLETED|Overall Study||0
10474365|NCT01100255|11622884|FG000|STARTED|Overall Study||8
10474366|NCT01100255|11622885|FG001|STARTED|Overall Study||7
10709074|NCT02636361|11873957|FG002|STARTED|Period 4||5
10709075|NCT02636361|11873958|FG003|STARTED|Period 4||5
10709076|NCT02636361|11873959|FG004|STARTED|Period 4||4
10709077|NCT02636361|11873955|FG000|COMPLETED|Period 4||5
10709078|NCT02636361|11873956|FG001|COMPLETED|Period 4||5
10709079|NCT02636361|11873957|FG002|COMPLETED|Period 4||5
10709080|NCT02636361|11873958|FG003|COMPLETED|Period 4||4
10709081|NCT02636361|11873959|FG004|COMPLETED|Period 4||4
10709082|NCT02636361|11873955|FG000|NOT COMPLETED|Period 4||0
10474367|NCT01100255|11622884|FG000|COMPLETED|Overall Study||8
10474368|NCT01100255|11622885|FG001|COMPLETED|Overall Study||7
10474369|NCT01100255|11622884|FG000|NOT COMPLETED|Overall Study||0
10474370|NCT01100255|11622885|FG001|NOT COMPLETED|Overall Study||0
10474371|NCT01100268|11622891|FG000|STARTED|Overall Study||4
10709083|NCT02636361|11873956|FG001|NOT COMPLETED|Period 4||0
10474372|NCT01100268|11622891|FG000|COMPLETED|Overall Study||4
10474373|NCT01100268|11622891|FG000|NOT COMPLETED|Overall Study||0
10709084|NCT02636361|11873957|FG002|NOT COMPLETED|Period 4||0
10709085|NCT02636361|11873958|FG003|NOT COMPLETED|Period 4||1
10474374|NCT01100307|11622897|FG000|STARTED|Double Masked Phase (Up to Week 24)||123
10474375|NCT01100307|11622898|FG001|STARTED|Double Masked Phase (Up to Week 24)||120
10474376|NCT01100307|11622897|FG000|COMPLETED|Double Masked Phase (Up to Week 24)||117
10474377|NCT01100307|11622898|FG001|COMPLETED|Double Masked Phase (Up to Week 24)||116
10474378|NCT01100307|11622897|FG000|NOT COMPLETED|Double Masked Phase (Up to Week 24)||6
10474379|NCT01100307|11622898|FG001|NOT COMPLETED|Double Masked Phase (Up to Week 24)||4
10474380|NCT01100307|11622897|FG000|STARTED|Open Phase (Week 24 up to Week 54)|One participant discontinued from the study due to adverse event before study drug administration.|116
10474381|NCT01100307|11622898|FG001|STARTED|Open Phase (Week 24 up to Week 54)|Four participants did not enter to the open phase after completing the double masked phase.|112
10474382|NCT01100307|11622897|FG000|COMPLETED|Open Phase (Week 24 up to Week 54)||110
10709086|NCT02636361|11873959|FG004|NOT COMPLETED|Period 4||0
10709087|NCT02636361|11873955|FG000|STARTED|Period 5||5
10709088|NCT02636361|11873956|FG001|STARTED|Period 5||5
10474383|NCT01100307|11622898|FG001|COMPLETED|Open Phase (Week 24 up to Week 54)||99
10474384|NCT01100307|11622897|FG000|NOT COMPLETED|Open Phase (Week 24 up to Week 54)||6
10474385|NCT01100307|11622898|FG001|NOT COMPLETED|Open Phase (Week 24 up to Week 54)||13
10474386|NCT01100320|11622906|FG000|STARTED|Period 1||43
10474387|NCT01100320|11622907|FG001|STARTED|Period 1||45
10474388|NCT01100320|11622906|FG000|COMPLETED|Period 1||38
10474389|NCT01100320|11622907|FG001|COMPLETED|Period 1||38
10474390|NCT01100320|11622906|FG000|NOT COMPLETED|Period 1||5
10474391|NCT01100320|11622907|FG001|NOT COMPLETED|Period 1||7
10474392|NCT01100320|11622906|FG000|STARTED|Period 2||38
10474393|NCT01100320|11622907|FG001|STARTED|Period 2||38
10474394|NCT01100320|11622906|FG000|COMPLETED|Period 2||37
10474395|NCT01100320|11622907|FG001|COMPLETED|Period 2||37
10474396|NCT01100320|11622906|FG000|NOT COMPLETED|Period 2||1
10474397|NCT01100320|11622907|FG001|NOT COMPLETED|Period 2||1
10474398|NCT01100437|11622913|FG000|STARTED|Screening||4
10474399|NCT01100437|11622914|FG001|STARTED|Screening||2
10474400|NCT01100437|11622915|FG002|STARTED|Screening||8
10474401|NCT01100437|11622913|FG000|COMPLETED|Screening||4
10474402|NCT01100437|11622914|FG001|COMPLETED|Screening||2
10474403|NCT01100437|11622915|FG002|COMPLETED|Screening||8
10474404|NCT01100437|11622913|FG000|NOT COMPLETED|Screening||0
10474405|NCT01100437|11622914|FG001|NOT COMPLETED|Screening||0
10474406|NCT01100437|11622915|FG002|NOT COMPLETED|Screening||0
10474407|NCT01100437|11622913|FG000|STARTED|Titration/Stabilization||4
10474408|NCT01100437|11622914|FG001|STARTED|Titration/Stabilization||2
10474409|NCT01100437|11622915|FG002|STARTED|Titration/Stabilization||8
10474410|NCT01100437|11622913|FG000|COMPLETED|Titration/Stabilization||4
10474411|NCT01100437|11622914|FG001|COMPLETED|Titration/Stabilization||2
10474412|NCT01100437|11622915|FG002|COMPLETED|Titration/Stabilization||2
10474413|NCT01100437|11622913|FG000|NOT COMPLETED|Titration/Stabilization||0
10474414|NCT01100437|11622914|FG001|NOT COMPLETED|Titration/Stabilization||0
10474415|NCT01100437|11622915|FG002|NOT COMPLETED|Titration/Stabilization||6
10474416|NCT01100437|11622913|FG000|STARTED|Maintenance||4
10474417|NCT01100437|11622914|FG001|STARTED|Maintenance||2
10474418|NCT01100437|11622915|FG002|STARTED|Maintenance||2
10474419|NCT01100437|11622913|FG000|COMPLETED|Maintenance||4
10474420|NCT01100437|11622914|FG001|COMPLETED|Maintenance||2
10474421|NCT01100437|11622915|FG002|COMPLETED|Maintenance||0
10474422|NCT01100437|11622913|FG000|NOT COMPLETED|Maintenance||0
10474423|NCT01100437|11622914|FG001|NOT COMPLETED|Maintenance||0
10474424|NCT01100437|11622915|FG002|NOT COMPLETED|Maintenance||2
10474425|NCT01100437|11622913|FG000|STARTED|Treatment 1||4
10474426|NCT01100437|11622914|FG001|STARTED|Treatment 1||2
10474427|NCT01100437|11622915|FG002|STARTED|Treatment 1||0
10474428|NCT01100437|11622913|FG000|COMPLETED|Treatment 1||4
10474429|NCT01100437|11622914|FG001|COMPLETED|Treatment 1||2
10474430|NCT01100437|11622915|FG002|COMPLETED|Treatment 1||0
10474431|NCT01100437|11622913|FG000|NOT COMPLETED|Treatment 1||0
10474432|NCT01100437|11622914|FG001|NOT COMPLETED|Treatment 1||0
10474433|NCT01100437|11622915|FG002|NOT COMPLETED|Treatment 1||0
10474434|NCT01100437|11622913|FG000|STARTED|Washout (4 Days)||4
10474435|NCT01100437|11622914|FG001|STARTED|Washout (4 Days)||2
10474436|NCT01100437|11622915|FG002|STARTED|Washout (4 Days)||0
10474437|NCT01100437|11622913|FG000|COMPLETED|Washout (4 Days)||4
10474438|NCT01100437|11622914|FG001|COMPLETED|Washout (4 Days)||2
10474439|NCT01100437|11622915|FG002|COMPLETED|Washout (4 Days)||0
10474440|NCT01100437|11622913|FG000|NOT COMPLETED|Washout (4 Days)||0
10474441|NCT01100437|11622914|FG001|NOT COMPLETED|Washout (4 Days)||0
10474442|NCT01100437|11622915|FG002|NOT COMPLETED|Washout (4 Days)||0
10474443|NCT01100437|11622913|FG000|STARTED|Treatment 2||4
10474444|NCT01100437|11622914|FG001|STARTED|Treatment 2||2
10474445|NCT01100437|11622915|FG002|STARTED|Treatment 2||0
10474446|NCT01100437|11622913|FG000|COMPLETED|Treatment 2||4
10474447|NCT01100437|11622914|FG001|COMPLETED|Treatment 2||2
10474448|NCT01100437|11622915|FG002|COMPLETED|Treatment 2||0
10474449|NCT01100437|11622913|FG000|NOT COMPLETED|Treatment 2||0
10474450|NCT01100437|11622914|FG001|NOT COMPLETED|Treatment 2||0
10474451|NCT01100437|11622915|FG002|NOT COMPLETED|Treatment 2||0
10474452|NCT01100502|11622926|FG000|STARTED|Overall Study||165
10474453|NCT01100502|11622927|FG001|STARTED|Overall Study||164
10474454|NCT01100502|11622926|FG000|COMPLETED|Overall Study|Completed due to study closure by sponsor|89
10474455|NCT01100502|11622927|FG001|COMPLETED|Overall Study|Completed due to study closure by sponsor|70
10474456|NCT01100502|11622926|FG000|NOT COMPLETED|Overall Study||76
10474457|NCT01100502|11622927|FG001|NOT COMPLETED|Overall Study||94
10474458|NCT01100528|11622933|FG000|STARTED|Overall Study||38
10649850|NCT02164539|11810006|FG003|STARTED|Treatment Phase A (4 Weeks)||46
10474459|NCT01100528|11622933|FG000|COMPLETED|Overall Study||35
10474460|NCT01100528|11622933|FG000|NOT COMPLETED|Overall Study||3
10649851|NCT02164539|11810007|FG004|STARTED|Treatment Phase A (4 Weeks)||85
10649852|NCT02164539|11810008|FG005|STARTED|Treatment Phase A (4 Weeks)||84
10649853|NCT02164539|11810009|FG006|STARTED|Treatment Phase A (4 Weeks)||0
10649854|NCT02164539|11810003|FG000|COMPLETED|Treatment Phase A (4 Weeks)||39
10649855|NCT02164539|11810004|FG001|COMPLETED|Treatment Phase A (4 Weeks)||42
10474461|NCT01100567|11622939|FG000|STARTED|Overall Study||50
10474462|NCT01100567|11622940|FG001|STARTED|Overall Study||51
10474463|NCT01100567|11622939|FG000|COMPLETED|Overall Study||38
10474464|NCT01100567|11622940|FG001|COMPLETED|Overall Study||35
10474465|NCT01100567|11622939|FG000|NOT COMPLETED|Overall Study||12
10474466|NCT01100567|11622940|FG001|NOT COMPLETED|Overall Study||16
10474467|NCT01100606|11622946|FG000|STARTED|First Treatment Period||8
10649856|NCT02164539|11810005|FG002|COMPLETED|Treatment Phase A (4 Weeks)||39
10474468|NCT01100606|11622947|FG001|STARTED|First Treatment Period||7
10474469|NCT01100606|11622946|FG000|COMPLETED|First Treatment Period|Due to difficulty with syringe nurser,1 participant completed study with apple sauce,not apple juice|8
10474470|NCT01100606|11622947|FG001|COMPLETED|First Treatment Period||7
10474471|NCT01100606|11622946|FG000|NOT COMPLETED|First Treatment Period||0
10474472|NCT01100606|11622947|FG001|NOT COMPLETED|First Treatment Period||0
10474473|NCT01100606|11622946|FG000|STARTED|Second Treatment Period||8
10474474|NCT01100606|11622947|FG001|STARTED|Second Treatment Period||7
10474475|NCT01100606|11622946|FG000|COMPLETED|Second Treatment Period|Due to intolerance to apple sauce & apple juice,1 participant completed study with banana-based food|8
10474476|NCT01100606|11622947|FG001|COMPLETED|Second Treatment Period|Due to difficulty with syringe nurser, 1 participant completed study using apple sauce|7
10474477|NCT01100606|11622946|FG000|NOT COMPLETED|Second Treatment Period||0
10474478|NCT01100606|11622947|FG001|NOT COMPLETED|Second Treatment Period||0
10474479|NCT01100723|11622957|FG000|STARTED|Overall Study||92
10474480|NCT01100723|11622957|FG000|6 Month Analysis|Overall Study|85 subjects had laboratory data at the 6 month analysis and were compared to their baseline data.|85
10474481|NCT01100723|11622957|FG000|COMPLETED|Overall Study|78 subjects had laboratory data at the 12 month analysis and were compared to their baseline data.|78
10474482|NCT01100723|11622957|FG000|NOT COMPLETED|Overall Study||14
10474483|NCT01100762|11622962|FG000|STARTED|Overall Study||10
10474484|NCT01100762|11622962|FG000|COMPLETED|Overall Study||10
10474485|NCT01100762|11622962|FG000|NOT COMPLETED|Overall Study||0
10474486|NCT01100853|11622970|FG000|STARTED|Overall Study||51
10474487|NCT01100853|11622971|FG001|STARTED|Overall Study||49
10474488|NCT01100853|11622970|FG000|COMPLETED|Overall Study||24
10474489|NCT01100853|11622971|FG001|COMPLETED|Overall Study||26
10474490|NCT01100853|11622970|FG000|NOT COMPLETED|Overall Study||27
10474491|NCT01100853|11622971|FG001|NOT COMPLETED|Overall Study||23
10474492|NCT01100931|11622979|FG000|STARTED|Phase I||22
10474493|NCT01100931|11622980|FG001|STARTED|Phase I||0
10474494|NCT01100931|11622979|FG000|COMPLETED|Phase I||22
10474495|NCT01100931|11622980|FG001|COMPLETED|Phase I||0
10474496|NCT01100931|11622979|FG000|NOT COMPLETED|Phase I||0
10474497|NCT01100931|11622980|FG001|NOT COMPLETED|Phase I||0
10474498|NCT01100931|11622979|FG000|STARTED|Phase II||0
10474499|NCT01100931|11622980|FG001|STARTED|Phase II||19
10474500|NCT01100931|11622979|FG000|COMPLETED|Phase II||0
10474501|NCT01100931|11622980|FG001|COMPLETED|Phase II||19
10474502|NCT01100931|11622979|FG000|NOT COMPLETED|Phase II||0
10474503|NCT01100931|11622980|FG001|NOT COMPLETED|Phase II||0
10474504|NCT01100944|11622987|FG000|STARTED|Dose Escalation Phase 1 Dose Level 1||6
10474505|NCT01100944|11622988|FG001|STARTED|Dose Escalation Phase 1 Dose Level 1||0
10474506|NCT01100944|11622989|FG002|STARTED|Dose Escalation Phase 1 Dose Level 1||0
10474507|NCT01100944|11622987|FG000|COMPLETED|Dose Escalation Phase 1 Dose Level 1||2
10474508|NCT01100944|11622988|FG001|COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
10474509|NCT01100944|11622989|FG002|COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
10474510|NCT01100944|11622987|FG000|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||4
10474511|NCT01100944|11622988|FG001|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
10474512|NCT01100944|11622989|FG002|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
10474513|NCT01100944|11622987|FG000|STARTED|Dose Escalation Phase 1 Dose Level 2||0
10474514|NCT01100944|11622988|FG001|STARTED|Dose Escalation Phase 1 Dose Level 2||2
10474515|NCT01100944|11622989|FG002|STARTED|Dose Escalation Phase 1 Dose Level 2||0
10474516|NCT01100944|11622987|FG000|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
10474517|NCT01100944|11622988|FG001|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
10474518|NCT01100944|11622989|FG002|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
10474519|NCT01100944|11622987|FG000|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
10474520|NCT01100944|11622988|FG001|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||2
10474521|NCT01100944|11622989|FG002|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
10474522|NCT01100944|11622987|FG000|STARTED|Expansion Phase - Phase 2||0
10474523|NCT01100944|11622988|FG001|STARTED|Expansion Phase - Phase 2||0
10474524|NCT01100944|11622989|FG002|STARTED|Expansion Phase - Phase 2||18
10474525|NCT01100944|11622987|FG000|COMPLETED|Expansion Phase - Phase 2||0
10474526|NCT01100944|11622988|FG001|COMPLETED|Expansion Phase - Phase 2||0
10474527|NCT01100944|11622989|FG002|COMPLETED|Expansion Phase - Phase 2||18
10474528|NCT01100944|11622987|FG000|NOT COMPLETED|Expansion Phase - Phase 2||0
10474529|NCT01100944|11622988|FG001|NOT COMPLETED|Expansion Phase - Phase 2||0
10474530|NCT01100944|11622989|FG002|NOT COMPLETED|Expansion Phase - Phase 2||0
10474531|NCT01101022|11623012|FG000|STARTED|Overall Study||79
10474532|NCT01101022|11623013|FG001|STARTED|Overall Study||80
10474533|NCT01101022|11623012|FG000|COMPLETED|Overall Study||62
10474534|NCT01101022|11623013|FG001|COMPLETED|Overall Study||53
10474535|NCT01101022|11623012|FG000|NOT COMPLETED|Overall Study||17
10474536|NCT01101022|11623013|FG001|NOT COMPLETED|Overall Study||27
10474537|NCT01101035|11623021|FG000|STARTED|Overall Study||3101
10474538|NCT01101035|11623022|FG001|STARTED|Overall Study||3097
10474539|NCT01101035|11623021|FG000|COMPLETED|Overall Study||1704
10474540|NCT01101035|11623022|FG001|COMPLETED|Overall Study||1706
10474541|NCT01101035|11623021|FG000|NOT COMPLETED|Overall Study||1397
10474542|NCT01101035|11623022|FG001|NOT COMPLETED|Overall Study||1391
10474543|NCT01101061|11623034|FG000|STARTED|Overall Study||6
10474544|NCT01101061|11623035|FG001|STARTED|Overall Study||6
10474545|NCT01101061|11623036|FG002|STARTED|Overall Study||7
10474546|NCT01101061|11623037|FG003|STARTED|Overall Study||6
10474547|NCT01101061|11623038|FG004|STARTED|Overall Study||2
10474548|NCT01101061|11623039|FG005|STARTED|Overall Study||4
10474549|NCT01101061|11623034|FG000|Received Study Drug|Overall Study||6
10474550|NCT01101061|11623035|FG001|Received Study Drug|Overall Study||6
10474551|NCT01101061|11623036|FG002|Received Study Drug|Overall Study||6
10474552|NCT01101061|11623037|FG003|Received Study Drug|Overall Study||6
10474553|NCT01101061|11623038|FG004|Received Study Drug|Overall Study||2
10474554|NCT01101061|11623039|FG005|Received Study Drug|Overall Study||4
10474555|NCT01101061|11623034|FG000|COMPLETED|Overall Study||6
10474556|NCT01101061|11623035|FG001|COMPLETED|Overall Study||6
10474557|NCT01101061|11623036|FG002|COMPLETED|Overall Study||6
10474558|NCT01101061|11623037|FG003|COMPLETED|Overall Study||6
10474559|NCT01101061|11623038|FG004|COMPLETED|Overall Study||2
10474560|NCT01101061|11623039|FG005|COMPLETED|Overall Study||4
10474561|NCT01101061|11623034|FG000|NOT COMPLETED|Overall Study||0
10474562|NCT01101061|11623035|FG001|NOT COMPLETED|Overall Study||0
10474563|NCT01101061|11623036|FG002|NOT COMPLETED|Overall Study||1
10474564|NCT01101061|11623037|FG003|NOT COMPLETED|Overall Study||0
10474565|NCT01101061|11623038|FG004|NOT COMPLETED|Overall Study||0
10474566|NCT01101061|11623039|FG005|NOT COMPLETED|Overall Study||0
10474567|NCT01101100|11623057|FG000|STARTED|Overall Study||181
10474568|NCT01101100|11623057|FG000|COMPLETED|Overall Study||126
10474569|NCT01101100|11623057|FG000|NOT COMPLETED|Overall Study||55
10474570|NCT01101165|11623062|FG000|STARTED|Period 1||47
10474571|NCT01101165|11623063|FG001|STARTED|Period 1||45
10474572|NCT01101165|11623062|FG000|COMPLETED|Period 1||45
10474573|NCT01101165|11623063|FG001|COMPLETED|Period 1||40
10709089|NCT02636361|11873957|FG002|STARTED|Period 5||5
10709090|NCT02636361|11873958|FG003|STARTED|Period 5||4
10709091|NCT02636361|11873959|FG004|STARTED|Period 5||4
10709092|NCT02636361|11873955|FG000|COMPLETED|Period 5||5
10474574|NCT01101165|11623062|FG000|NOT COMPLETED|Period 1||2
10474575|NCT01101165|11623063|FG001|NOT COMPLETED|Period 1||5
10474576|NCT01101165|11623062|FG000|STARTED|Period 2||45
10474577|NCT01101165|11623063|FG001|STARTED|Period 2||40
10474578|NCT01101165|11623062|FG000|COMPLETED|Period 2||41
10474579|NCT01101165|11623063|FG001|COMPLETED|Period 2||39
10474580|NCT01101165|11623062|FG000|NOT COMPLETED|Period 2||4
10474581|NCT01101165|11623063|FG001|NOT COMPLETED|Period 2||1
10474582|NCT01101178|11623069|FG000|STARTED|Period 1||40
10474583|NCT01101178|11623070|FG001|STARTED|Period 1||39
10474584|NCT01101178|11623069|FG000|COMPLETED|Period 1||36
10474585|NCT01101178|11623070|FG001|COMPLETED|Period 1||35
10474586|NCT01101178|11623069|FG000|NOT COMPLETED|Period 1||4
10474587|NCT01101178|11623070|FG001|NOT COMPLETED|Period 1||4
10474588|NCT01101178|11623069|FG000|STARTED|Period 2||36
10474589|NCT01101178|11623070|FG001|STARTED|Period 2||35
10474590|NCT01101178|11623069|FG000|COMPLETED|Period 2||36
10474591|NCT01101178|11623070|FG001|COMPLETED|Period 2||34
10474592|NCT01101178|11623069|FG000|NOT COMPLETED|Period 2||0
10474593|NCT01101178|11623070|FG001|NOT COMPLETED|Period 2||1
10474594|NCT01101191|11623077|FG000|STARTED|Period 1||42
10474595|NCT01101191|11623078|FG001|STARTED|Period 1||42
10474596|NCT01101191|11623077|FG000|COMPLETED|Period 1||40
10474597|NCT01101191|11623078|FG001|COMPLETED|Period 1||40
10474598|NCT01101191|11623077|FG000|NOT COMPLETED|Period 1||2
10474599|NCT01101191|11623078|FG001|NOT COMPLETED|Period 1||2
10474600|NCT01101191|11623077|FG000|STARTED|Period 2||40
10474601|NCT01101191|11623078|FG001|STARTED|Period 2||40
10474602|NCT01101191|11623077|FG000|COMPLETED|Period 2||40
10474603|NCT01101191|11623078|FG001|COMPLETED|Period 2||40
10474604|NCT01101191|11623077|FG000|NOT COMPLETED|Period 2||0
10474605|NCT01101191|11623078|FG001|NOT COMPLETED|Period 2||0
10474606|NCT01101308|11623085|FG000|STARTED|Period 1||27
10474607|NCT01101308|11623086|FG001|STARTED|Period 1||28
10474608|NCT01101308|11623085|FG000|COMPLETED|Period 1||24
10474609|NCT01101308|11623086|FG001|COMPLETED|Period 1||27
10474610|NCT01101308|11623085|FG000|NOT COMPLETED|Period 1||3
10474611|NCT01101308|11623086|FG001|NOT COMPLETED|Period 1||1
10474612|NCT01101308|11623085|FG000|STARTED|Period 2||24
10474613|NCT01101308|11623086|FG001|STARTED|Period 2||27
10474614|NCT01101308|11623085|FG000|COMPLETED|Period 2||24
10474615|NCT01101308|11623086|FG001|COMPLETED|Period 2||27
10474616|NCT01101308|11623085|FG000|NOT COMPLETED|Period 2||0
10709093|NCT02636361|11873956|FG001|COMPLETED|Period 5||5
10474617|NCT01101308|11623086|FG001|NOT COMPLETED|Period 2||0
10474618|NCT01101321|11623093|FG000|STARTED|Period 1||30
10474619|NCT01101321|11623094|FG001|STARTED|Period 1||28
10709094|NCT02636361|11873957|FG002|COMPLETED|Period 5||5
10709095|NCT02636361|11873958|FG003|COMPLETED|Period 5||4
10709096|NCT02636361|11873959|FG004|COMPLETED|Period 5||4
10474620|NCT01101321|11623093|FG000|COMPLETED|Period 1||26
10474621|NCT01101321|11623094|FG001|COMPLETED|Period 1||24
10474622|NCT01101321|11623093|FG000|NOT COMPLETED|Period 1||4
10474623|NCT01101321|11623094|FG001|NOT COMPLETED|Period 1||4
10474624|NCT01101321|11623093|FG000|STARTED|Period 2||26
10474625|NCT01101321|11623094|FG001|STARTED|Period 2||24
10474626|NCT01101321|11623093|FG000|COMPLETED|Period 2||26
10474627|NCT01101321|11623094|FG001|COMPLETED|Period 2||24
10474628|NCT01101321|11623093|FG000|NOT COMPLETED|Period 2||0
10474629|NCT01101321|11623094|FG001|NOT COMPLETED|Period 2||0
10474630|NCT01101334|11623102|FG000|STARTED|Overall Study||45
10474631|NCT01101334|11623103|FG001|STARTED|Overall Study||45
10474632|NCT01101334|11623102|FG000|Received Study Treatment|Overall Study||44
10474633|NCT01101334|11623103|FG001|Received Study Treatment|Overall Study||45
10474634|NCT01101334|11623102|FG000|COMPLETED|Overall Study||0
10709097|NCT02636361|11873955|FG000|NOT COMPLETED|Period 5||0
10474635|NCT01101334|11623103|FG001|COMPLETED|Overall Study||0
10474636|NCT01101334|11623102|FG000|NOT COMPLETED|Overall Study||45
10474637|NCT01101334|11623103|FG001|NOT COMPLETED|Overall Study||45
10474638|NCT01101477|11623112|FG000|STARTED|Overall Study||49
10474639|NCT01101477|11623113|FG001|STARTED|Overall Study||49
10474640|NCT01101477|11623114|FG002|STARTED|Overall Study||46
10474641|NCT01101477|11623112|FG000|COMPLETED|Overall Study||44
10474642|NCT01101477|11623113|FG001|COMPLETED|Overall Study||46
10474643|NCT01101477|11623114|FG002|COMPLETED|Overall Study||45
10474644|NCT01101477|11623112|FG000|NOT COMPLETED|Overall Study||5
10474645|NCT01101477|11623113|FG001|NOT COMPLETED|Overall Study||3
10474646|NCT01101477|11623114|FG002|NOT COMPLETED|Overall Study||1
10474647|NCT01101542|11623122|FG000|STARTED|Year 3 Surveillance Period||105
10474648|NCT01101542|11623122|FG000|COMPLETED|Year 3 Surveillance Period||94
10474649|NCT01101542|11623122|FG000|NOT COMPLETED|Year 3 Surveillance Period||11
10474650|NCT01101542|11623122|FG000|STARTED|Year 4 Surveillance Period||569
10474651|NCT01101542|11623122|FG000|COMPLETED|Year 4 Surveillance Period||282
10474652|NCT01101542|11623122|FG000|NOT COMPLETED|Year 4 Surveillance Period||287
10474653|NCT01101542|11623122|FG000|STARTED|Year 5 Surveillance Period||809
10474654|NCT01101542|11623122|FG000|COMPLETED|Year 5 Surveillance Period||668
10474655|NCT01101542|11623122|FG000|NOT COMPLETED|Year 5 Surveillance Period||141
10474656|NCT01101542|11623122|FG000|STARTED|Year 6 Surveillance Period||3091
10474657|NCT01101542|11623122|FG000|COMPLETED|Year 6 Surveillance Period||2100
10474658|NCT01101542|11623122|FG000|NOT COMPLETED|Year 6 Surveillance Period||991
10474659|NCT01101750|11623126|FG000|STARTED|Overall Study||25
10474660|NCT01101750|11623126|FG000|COMPLETED|Overall Study||9
10474661|NCT01101750|11623126|FG000|NOT COMPLETED|Overall Study||16
10474662|NCT01101841|11623132|FG000|STARTED|Overall Study||285
10474663|NCT01101841|11623133|FG001|STARTED|Overall Study||285
10474664|NCT01101841|11623132|FG000|COMPLETED|Overall Study||235
10474665|NCT01101841|11623133|FG001|COMPLETED|Overall Study||218
10474666|NCT01101841|11623132|FG000|NOT COMPLETED|Overall Study||50
10474667|NCT01101841|11623133|FG001|NOT COMPLETED|Overall Study||67
10474668|NCT01101867|11623142|FG000|STARTED|Overall Study||63
10474669|NCT01101867|11623143|FG001|STARTED|Overall Study||63
10474670|NCT01101867|11623142|FG000|COMPLETED|Overall Study||62
10474671|NCT01101867|11623143|FG001|COMPLETED|Overall Study||59
10474672|NCT01101867|11623142|FG000|NOT COMPLETED|Overall Study||1
10474673|NCT01101867|11623143|FG001|NOT COMPLETED|Overall Study||4
10474674|NCT01101880|11623153|FG000|STARTED|Overall Study||50
10474675|NCT01101880|11623153|FG000|COMPLETED|Overall Study||50
10474676|NCT01101880|11623153|FG000|NOT COMPLETED|Overall Study||0
10474677|NCT01101958|11623159|FG000|STARTED|Overall Study||62
10474678|NCT01101958|11623160|FG001|STARTED|Overall Study||34
10474679|NCT01101958|11623159|FG000|COMPLETED|Overall Study||51
10474680|NCT01101958|11623160|FG001|COMPLETED|Overall Study||29
10474681|NCT01101958|11623159|FG000|NOT COMPLETED|Overall Study||11
10474682|NCT01101958|11623160|FG001|NOT COMPLETED|Overall Study||5
10474683|NCT01101971|11623166|FG000|STARTED|Overall Study||45
10474684|NCT01101971|11623166|FG000|COMPLETED|Overall Study||45
10474685|NCT01101971|11623166|FG000|NOT COMPLETED|Overall Study||0
10474686|NCT01101997|11623170|FG000|STARTED|Overall Study||60
10474687|NCT01101997|11623170|FG000|COMPLETED|Overall Study||58
10474688|NCT01101997|11623170|FG000|NOT COMPLETED|Overall Study||2
10474689|NCT01102218|11623178|FG000|STARTED|Overall Study||24
10474690|NCT01102218|11623179|FG001|STARTED|Overall Study||24
10474691|NCT01102218|11623178|FG000|COMPLETED|Overall Study||13
10474692|NCT01102218|11623179|FG001|COMPLETED|Overall Study||14
10474693|NCT01102218|11623178|FG000|NOT COMPLETED|Overall Study||11
10474694|NCT01102218|11623179|FG001|NOT COMPLETED|Overall Study||10
10474695|NCT01102231|11623185|FG000|STARTED|Overall Study||106
10474696|NCT01102231|11623185|FG000|COMPLETED|Overall Study||91
10474697|NCT01102231|11623185|FG000|NOT COMPLETED|Overall Study||15
10474698|NCT01102257|11623192|FG000|STARTED|Overall Study||9
10474699|NCT01102257|11623193|FG001|STARTED|Overall Study||9
10474700|NCT01102257|11623192|FG000|COMPLETED|Overall Study|2 withdrew from the study d/t adverse events. 1 had shortness of breath and the other had chest pain|7
10474701|NCT01102257|11623193|FG001|COMPLETED|Overall Study||9
10474702|NCT01102257|11623192|FG000|NOT COMPLETED|Overall Study||2
10474703|NCT01102257|11623193|FG001|NOT COMPLETED|Overall Study||0
10474704|NCT01102270|11623199|FG000|STARTED|Overall Study||8
10474705|NCT01102270|11623200|FG001|STARTED|Overall Study||9
10474706|NCT01102270|11623199|FG000|COMPLETED|Overall Study||8
10474707|NCT01102270|11623200|FG001|COMPLETED|Overall Study||9
10474708|NCT01102270|11623199|FG000|NOT COMPLETED|Overall Study||0
10474709|NCT01102270|11623200|FG001|NOT COMPLETED|Overall Study||0
10474710|NCT01102374|11623208|FG000|STARTED|Overall Study||55
10474711|NCT01102374|11623209|FG001|STARTED|Overall Study||52
10474712|NCT01102374|11623208|FG000|COMPLETED|Overall Study||39
10474713|NCT01102374|11623209|FG001|COMPLETED|Overall Study||33
10474714|NCT01102374|11623208|FG000|NOT COMPLETED|Overall Study||16
10474715|NCT01102374|11623209|FG001|NOT COMPLETED|Overall Study||19
10474716|NCT01102413|11623217|FG000|STARTED|Overall Study||233
10474717|NCT01102413|11623218|FG001|STARTED|Overall Study||118
10474718|NCT01102413|11623217|FG000|COMPLETED|Overall Study||208
10474719|NCT01102413|11623218|FG001|COMPLETED|Overall Study||106
10474720|NCT01102413|11623217|FG000|NOT COMPLETED|Overall Study||25
10474721|NCT01102413|11623218|FG001|NOT COMPLETED|Overall Study||12
10474722|NCT01102426|11623226|FG000|STARTED|Overall Study||171
10474723|NCT01102426|11623227|FG001|STARTED|Overall Study||84
10474724|NCT01102426|11623226|FG000|COMPLETED|Overall Study||6
10474725|NCT01102426|11623227|FG001|COMPLETED|Overall Study||3
10474726|NCT01102426|11623226|FG000|NOT COMPLETED|Overall Study||165
10474727|NCT01102426|11623227|FG001|NOT COMPLETED|Overall Study||81
10474728|NCT01102491|11623235|FG000|STARTED|Overall Study||71
10474729|NCT01102491|11623236|FG001|STARTED|Overall Study||71
10474730|NCT01102491|11623235|FG000|COMPLETED|Overall Study|11 patient excluded|60
10474731|NCT01102491|11623236|FG001|COMPLETED|Overall Study|12 patients were excluded|59
10474732|NCT01102491|11623235|FG000|NOT COMPLETED|Overall Study||11
10474733|NCT01102491|11623236|FG001|NOT COMPLETED|Overall Study||12
10474734|NCT01102738|11623242|FG000|STARTED|Overall Study||369
10474735|NCT01102738|11623242|FG000|COMPLETED|Overall Study||369
10474736|NCT01102738|11623242|FG000|NOT COMPLETED|Overall Study||0
10474737|NCT01102764|11623248|FG000|STARTED|Overall Study||64
10474738|NCT01102764|11623249|FG001|STARTED|Overall Study||68
10474739|NCT01102764|11623248|FG000|COMPLETED|Overall Study||43
10474740|NCT01102764|11623249|FG001|COMPLETED|Overall Study||55
10474741|NCT01102764|11623248|FG000|NOT COMPLETED|Overall Study||21
10474742|NCT01102764|11623249|FG001|NOT COMPLETED|Overall Study||13
10474743|NCT01102777|11623257|FG000|STARTED|Overall Study||84
10474744|NCT01102777|11623258|FG001|STARTED|Overall Study||155
10474745|NCT01102777|11623257|FG000|COMPLETED|Overall Study||75
10474746|NCT01102777|11623258|FG001|COMPLETED|Overall Study||139
10474747|NCT01102777|11623257|FG000|NOT COMPLETED|Overall Study||9
10474748|NCT01102777|11623258|FG001|NOT COMPLETED|Overall Study||16
10474749|NCT01102803|11623267|FG000|STARTED|Baseline to Post-Treatment||14
10474750|NCT01102803|11623268|FG001|STARTED|Baseline to Post-Treatment||15
10474751|NCT01102803|11623267|FG000|COMPLETED|Baseline to Post-Treatment||11
10474752|NCT01102803|11623268|FG001|COMPLETED|Baseline to Post-Treatment||15
10474753|NCT01102803|11623267|FG000|NOT COMPLETED|Baseline to Post-Treatment||3
10474754|NCT01102803|11623268|FG001|NOT COMPLETED|Baseline to Post-Treatment||0
10474755|NCT01102803|11623267|FG000|STARTED|Post to Follow-Up||11
10474756|NCT01102803|11623268|FG001|STARTED|Post to Follow-Up||15
10474757|NCT01102803|11623267|FG000|COMPLETED|Post to Follow-Up||10
10474758|NCT01102803|11623268|FG001|COMPLETED|Post to Follow-Up||12
10474759|NCT01102803|11623267|FG000|NOT COMPLETED|Post to Follow-Up||1
10474760|NCT01102803|11623268|FG001|NOT COMPLETED|Post to Follow-Up||3
10474761|NCT01102894|11623276|FG000|STARTED|Overall Study||10
10474762|NCT01102894|11623276|FG000|COMPLETED|Overall Study||10
10474763|NCT01102894|11623276|FG000|NOT COMPLETED|Overall Study||0
10474764|NCT01102972|11623284|FG000|STARTED|Overall Study|"297 PAR enrolled. 1 PAR withdrew before taking investigational product and didn't start the study."|199
10474765|NCT01102972|11623285|FG001|STARTED|Overall Study|"297 PAR enrolled. 1 PAR withdrew before taking investigational product and didn't start the study."|97
10474766|NCT01102972|11623284|FG000|Completed Week 24|Overall Study||180
10474767|NCT01102972|11623285|FG001|Completed Week 24|Overall Study||88
10474768|NCT01102972|11623284|FG000|COMPLETED|Overall Study|These participants completed Study Week 48.|170
10474769|NCT01102972|11623285|FG001|COMPLETED|Overall Study|These participants completed Study Week 48.|83
10474770|NCT01102972|11623284|FG000|NOT COMPLETED|Overall Study||29
10474771|NCT01102972|11623285|FG001|NOT COMPLETED|Overall Study||14
10474772|NCT01103063|11623293|FG000|STARTED|Overall Study||1446
10474773|NCT01103063|11623294|FG001|STARTED|Overall Study||1445
10474774|NCT01103063|11623293|FG000|COMPLETED|Overall Study||969
10474775|NCT01103063|11623294|FG001|COMPLETED|Overall Study||1024
10474776|NCT01103063|11623293|FG000|NOT COMPLETED|Overall Study||477
10474777|NCT01103063|11623294|FG001|NOT COMPLETED|Overall Study||421
10474778|NCT01103141|11623304|FG000|STARTED|Overall Study||67
10474779|NCT01103141|11623305|FG001|STARTED|Overall Study||76
10474780|NCT01103141|11623304|FG000|COMPLETED|Overall Study||65
10474781|NCT01103141|11623305|FG001|COMPLETED|Overall Study||74
10474782|NCT01103141|11623304|FG000|NOT COMPLETED|Overall Study||2
10474783|NCT01103141|11623305|FG001|NOT COMPLETED|Overall Study||2
10474784|NCT01103232|11623313|FG000|STARTED|Overall Study||13
10474785|NCT01103232|11623314|FG001|STARTED|Overall Study||13
10474786|NCT01103232|11623313|FG000|COMPLETED|Overall Study||12
10474787|NCT01103232|11623314|FG001|COMPLETED|Overall Study||11
10474788|NCT01103232|11623313|FG000|NOT COMPLETED|Overall Study||1
10474789|NCT01103232|11623314|FG001|NOT COMPLETED|Overall Study||2
10474790|NCT01103245|11623324|FG000|STARTED|Overall Study||13
10474791|NCT01103245|11623325|FG001|STARTED|Overall Study||7
10474792|NCT01103245|11623326|FG002|STARTED|Overall Study||12
10474793|NCT01103245|11623327|FG003|STARTED|Overall Study||6
10474794|NCT01103245|11623324|FG000|COMPLETED|Overall Study||10
10474795|NCT01103245|11623325|FG001|COMPLETED|Overall Study||5
10474796|NCT01103245|11623326|FG002|COMPLETED|Overall Study||8
10474797|NCT01103245|11623327|FG003|COMPLETED|Overall Study||6
10474798|NCT01103245|11623324|FG000|NOT COMPLETED|Overall Study||3
10474799|NCT01103245|11623325|FG001|NOT COMPLETED|Overall Study||2
10474800|NCT01103245|11623326|FG002|NOT COMPLETED|Overall Study||4
10474801|NCT01103245|11623327|FG003|NOT COMPLETED|Overall Study||0
10474802|NCT01103271|11623339|FG000|STARTED|Overall Study||11
10474803|NCT01103271|11623340|FG001|STARTED|Overall Study||9
10474804|NCT01103271|11623339|FG000|COMPLETED|Overall Study||10
10474805|NCT01103271|11623340|FG001|COMPLETED|Overall Study||5
10474806|NCT01103271|11623339|FG000|NOT COMPLETED|Overall Study||1
10474807|NCT01103271|11623340|FG001|NOT COMPLETED|Overall Study||4
10474808|NCT01103284|11623349|FG000|STARTED|Overall Study||236
10474809|NCT01103284|11623350|FG001|STARTED|Overall Study||239
10474810|NCT01103284|11623349|FG000|Treated|Overall Study||236
10474811|NCT01103284|11623350|FG001|Treated|Overall Study||238
10526880|NCT01384877|11678795|FG001|NOT COMPLETED|Treatment 2||2
10474812|NCT01103284|11623349|FG000|At Least One Post-baseline Visit (FAS)|Overall Study|Patients reaching this milestone were included in the Full Analysis Set (FAS) population|233
10474813|NCT01103284|11623350|FG001|At Least One Post-baseline Visit (FAS)|Overall Study|Patients reaching this milestone were included in the Full Analysis Set (FAS)|235
10474814|NCT01103284|11623349|FG000|COMPLETED|Overall Study||194
10474815|NCT01103284|11623350|FG001|COMPLETED|Overall Study||195
10474816|NCT01103284|11623349|FG000|NOT COMPLETED|Overall Study||42
10474817|NCT01103284|11623350|FG001|NOT COMPLETED|Overall Study||44
10474818|NCT01103323|11623358|FG000|STARTED|Without/Before Drug Switch||505
10474819|NCT01103323|11623359|FG001|STARTED|Without/Before Drug Switch||255
10474820|NCT01103323|11623358|FG000|Participants Received Treatment|Without/Before Drug Switch||500
10474821|NCT01103323|11623359|FG001|Participants Received Treatment|Without/Before Drug Switch||253
10474822|NCT01103323|11623358|FG000|COMPLETED|Without/Before Drug Switch||429
10474823|NCT01103323|11623359|FG001|COMPLETED|Without/Before Drug Switch||237
10474824|NCT01103323|11623358|FG000|NOT COMPLETED|Without/Before Drug Switch||76
10474825|NCT01103323|11623359|FG001|NOT COMPLETED|Without/Before Drug Switch||18
10474826|NCT01103323|11623358|FG000|STARTED|Switched From Placebo to Regorafenib||0
10474827|NCT01103323|11623359|FG001|STARTED|Switched From Placebo to Regorafenib|Participants in the placebo+BSC group switched to Regorafenib treatment after unblinding.|4
10474828|NCT01103323|11623358|FG000|COMPLETED|Switched From Placebo to Regorafenib||0
10474829|NCT01103323|11623359|FG001|COMPLETED|Switched From Placebo to Regorafenib||3
10474830|NCT01103323|11623358|FG000|NOT COMPLETED|Switched From Placebo to Regorafenib||0
10474831|NCT01103323|11623359|FG001|NOT COMPLETED|Switched From Placebo to Regorafenib||1
10474832|NCT01103362|11623366|FG000|STARTED|Overall Study||596
10474833|NCT01103362|11623366|FG000|COMPLETED|Overall Study||0
10474834|NCT01103362|11623366|FG000|NOT COMPLETED|Overall Study||596
10474835|NCT01103414|11623375|FG000|STARTED|Overall Study||72
10474836|NCT01103414|11623376|FG001|STARTED|Overall Study||71
10474837|NCT01103414|11623377|FG002|STARTED|Overall Study||71
10474838|NCT01103414|11623378|FG003|STARTED|Overall Study||71
10474839|NCT01103414|11623379|FG004|STARTED|Overall Study||71
10474840|NCT01103414|11623375|FG000|COMPLETED|Overall Study||59
10474841|NCT01103414|11623376|FG001|COMPLETED|Overall Study||62
10474842|NCT01103414|11623377|FG002|COMPLETED|Overall Study||56
10474843|NCT01103414|11623378|FG003|COMPLETED|Overall Study||64
10474844|NCT01103414|11623379|FG004|COMPLETED|Overall Study||56
10474845|NCT01103414|11623375|FG000|NOT COMPLETED|Overall Study||13
10474846|NCT01103414|11623376|FG001|NOT COMPLETED|Overall Study||9
10474847|NCT01103414|11623377|FG002|NOT COMPLETED|Overall Study||15
10474848|NCT01103414|11623378|FG003|NOT COMPLETED|Overall Study||7
10474849|NCT01103414|11623379|FG004|NOT COMPLETED|Overall Study||15
10474850|NCT01103440|11623393|FG000|STARTED|Overall Study||18
10474851|NCT01103440|11623394|FG001|STARTED|Overall Study||18
10474852|NCT01103440|11623393|FG000|COMPLETED|Overall Study||18
10474853|NCT01103440|11623394|FG001|COMPLETED|Overall Study||18
10474854|NCT01103440|11623393|FG000|NOT COMPLETED|Overall Study||0
10474855|NCT01103440|11623394|FG001|NOT COMPLETED|Overall Study||0
10474856|NCT01103466|11623400|FG000|STARTED|First Period (14 +/- 3 Days)||12
10474857|NCT01103466|11623401|FG001|STARTED|First Period (14 +/- 3 Days)||12
10474858|NCT01103466|11623402|FG002|STARTED|First Period (14 +/- 3 Days)||13
10474859|NCT01103466|11623400|FG000|COMPLETED|First Period (14 +/- 3 Days)||10
10474860|NCT01103466|11623401|FG001|COMPLETED|First Period (14 +/- 3 Days)||12
10474861|NCT01103466|11623402|FG002|COMPLETED|First Period (14 +/- 3 Days)||13
10474862|NCT01103466|11623400|FG000|NOT COMPLETED|First Period (14 +/- 3 Days)||2
10474863|NCT01103466|11623401|FG001|NOT COMPLETED|First Period (14 +/- 3 Days)||0
10474864|NCT01103466|11623402|FG002|NOT COMPLETED|First Period (14 +/- 3 Days)||0
10474865|NCT01103466|11623400|FG000|STARTED|Second Period (14 +/- 3 Days)||15
10474866|NCT01103466|11623401|FG001|STARTED|Second Period (14 +/- 3 Days)||13
10474867|NCT01103466|11623402|FG002|STARTED|Second Period (14 +/- 3 Days)||7
10474868|NCT01103466|11623400|FG000|COMPLETED|Second Period (14 +/- 3 Days)||13
10474869|NCT01103466|11623401|FG001|COMPLETED|Second Period (14 +/- 3 Days)||11
10474870|NCT01103466|11623402|FG002|COMPLETED|Second Period (14 +/- 3 Days)||6
10474871|NCT01103466|11623400|FG000|NOT COMPLETED|Second Period (14 +/- 3 Days)||2
10474872|NCT01103466|11623401|FG001|NOT COMPLETED|Second Period (14 +/- 3 Days)||2
10709098|NCT02636361|11873956|FG001|NOT COMPLETED|Period 5||0
10709099|NCT02636361|11873957|FG002|NOT COMPLETED|Period 5||0
10474873|NCT01103466|11623402|FG002|NOT COMPLETED|Second Period (14 +/- 3 Days)||1
10474874|NCT01103466|11623400|FG000|STARTED|Third Period (14 +/- 3 Days)||8
10474875|NCT01103466|11623401|FG001|STARTED|Third Period (14 +/- 3 Days)||8
10474876|NCT01103466|11623402|FG002|STARTED|Third Period (14 +/- 3 Days)||14
10474877|NCT01103466|11623400|FG000|COMPLETED|Third Period (14 +/- 3 Days)||6
10474878|NCT01103466|11623401|FG001|COMPLETED|Third Period (14 +/- 3 Days)||8
10474879|NCT01103466|11623402|FG002|COMPLETED|Third Period (14 +/- 3 Days)||13
10474880|NCT01103466|11623400|FG000|NOT COMPLETED|Third Period (14 +/- 3 Days)||2
10474881|NCT01103466|11623401|FG001|NOT COMPLETED|Third Period (14 +/- 3 Days)||0
10474882|NCT01103466|11623402|FG002|NOT COMPLETED|Third Period (14 +/- 3 Days)||1
10474883|NCT01103479|11623413|FG000|STARTED|Overall Study||168
10474884|NCT01103479|11623414|FG001|STARTED|Overall Study||210
10474885|NCT01103479|11623415|FG002|STARTED|Overall Study||188
10474886|NCT01103479|11623413|FG000|COMPLETED|Overall Study||163
10474887|NCT01103479|11623414|FG001|COMPLETED|Overall Study||201
10474888|NCT01103479|11623415|FG002|COMPLETED|Overall Study||174
10709100|NCT02636361|11873958|FG003|NOT COMPLETED|Period 5||0
10709101|NCT02636361|11873959|FG004|NOT COMPLETED|Period 5||0
10474889|NCT01103479|11623413|FG000|NOT COMPLETED|Overall Study||5
10474890|NCT01103479|11623414|FG001|NOT COMPLETED|Overall Study||9
10474891|NCT01103479|11623415|FG002|NOT COMPLETED|Overall Study||14
10474892|NCT01103492|11623424|FG000|STARTED|Overall Study||1
10474893|NCT01103492|11623424|FG000|COMPLETED|Overall Study||1
10474894|NCT01103492|11623424|FG000|NOT COMPLETED|Overall Study||0
10474895|NCT01103505|11623430|FG000|STARTED|Overall Study||763
10474896|NCT01103505|11623431|FG001|STARTED|Overall Study||757
10474897|NCT01103505|11623430|FG000|COMPLETED|Overall Study||739
10474898|NCT01103505|11623431|FG001|COMPLETED|Overall Study||737
10474899|NCT01103505|11623430|FG000|NOT COMPLETED|Overall Study||24
10474900|NCT01103505|11623431|FG001|NOT COMPLETED|Overall Study||20
10474901|NCT01103713|11623445|FG000|STARTED|Overall Study||168
10474902|NCT01103713|11623445|FG000|COMPLETED|Overall Study||155
10474903|NCT01103713|11623445|FG000|NOT COMPLETED|Overall Study||13
10474904|NCT01103778|11623452|FG000|STARTED|Overall Study||11
10474905|NCT01103778|11623452|FG000|COMPLETED|Overall Study||8
10474906|NCT01103778|11623452|FG000|NOT COMPLETED|Overall Study||3
10474907|NCT01103934|11623460|FG000|STARTED|Overall Study||17
10474908|NCT01103934|11623461|FG001|STARTED|Overall Study||18
10474909|NCT01103934|11623460|FG000|COMPLETED|Overall Study||17
10474910|NCT01103934|11623461|FG001|COMPLETED|Overall Study||18
10474911|NCT01103934|11623460|FG000|NOT COMPLETED|Overall Study||0
10474912|NCT01103934|11623461|FG001|NOT COMPLETED|Overall Study||0
10474913|NCT01103960|11623469|FG000|STARTED|Overall Study|Randomised and treated.|164
10474914|NCT01103960|11623470|FG001|STARTED|Overall Study|Randomised and treated.|160
10474915|NCT01103960|11623469|FG000|COMPLETED|Overall Study|Completed study medication.|159
10474916|NCT01103960|11623470|FG001|COMPLETED|Overall Study|Completed study medication.|158
10474917|NCT01103960|11623469|FG000|NOT COMPLETED|Overall Study||5
10474918|NCT01103960|11623470|FG001|NOT COMPLETED|Overall Study||2
10474919|NCT01103973|11623478|FG000|STARTED|Overall Study||51
10474920|NCT01103973|11623479|FG001|STARTED|Overall Study||46
10474921|NCT01103973|11623478|FG000|COMPLETED|Overall Study||51
10474922|NCT01103973|11623479|FG001|COMPLETED|Overall Study||46
10474923|NCT01103973|11623478|FG000|NOT COMPLETED|Overall Study||0
10474924|NCT01103973|11623479|FG001|NOT COMPLETED|Overall Study||0
10474925|NCT01104025|11623485|FG000|STARTED|Treatment Period||31
10474926|NCT01104025|11623485|FG000|COMPLETED|Treatment Period||25
10474927|NCT01104025|11623485|FG000|NOT COMPLETED|Treatment Period||6
10474928|NCT01104025|11623485|FG000|STARTED|Follow up Until BMT OR 6 Months||25
10474929|NCT01104025|11623485|FG000|COMPLETED|Follow up Until BMT OR 6 Months||22
10474930|NCT01104025|11623485|FG000|NOT COMPLETED|Follow up Until BMT OR 6 Months||3
10474931|NCT01104025|11623485|FG000|STARTED|Follow up Until Day 100 Post BMT|only 11 participants proceeded to BMT; 14 did not|11
10474932|NCT01104025|11623485|FG000|COMPLETED|Follow up Until Day 100 Post BMT||9
10474933|NCT01104025|11623485|FG000|NOT COMPLETED|Follow up Until Day 100 Post BMT||2
10474934|NCT01104090|11623491|FG000|STARTED|Overall Study||25
10474935|NCT01104090|11623492|FG001|STARTED|Overall Study||25
10474936|NCT01104090|11623491|FG000|COMPLETED|Overall Study||25
10474937|NCT01104090|11623492|FG001|COMPLETED|Overall Study||25
10474938|NCT01104090|11623491|FG000|NOT COMPLETED|Overall Study||0
10474939|NCT01104090|11623492|FG001|NOT COMPLETED|Overall Study||0
10474940|NCT01104103|11623502|FG000|STARTED|Overall Study||243
10474941|NCT01104103|11623503|FG001|STARTED|Overall Study||224
10474942|NCT01104103|11623502|FG000|COMPLETED|Overall Study||243
10709102|NCT02636595|11873973|FG000|STARTED|Overall Study||121
10709103|NCT02636595|11873973|FG000|COMPLETED|Overall Study||119
10709104|NCT02636595|11873973|FG000|NOT COMPLETED|Overall Study||2
10709105|NCT02636608|11873977|FG000|STARTED|Overall Study||244
10709106|NCT02636608|11873977|FG000|Received Treatment|Overall Study||243
10709107|NCT02636608|11873977|FG000|COMPLETED|Overall Study||233
10474943|NCT01104103|11623503|FG001|COMPLETED|Overall Study||224
10474944|NCT01104103|11623502|FG000|NOT COMPLETED|Overall Study||0
10474945|NCT01104103|11623503|FG001|NOT COMPLETED|Overall Study||0
10709108|NCT02636608|11873977|FG000|NOT COMPLETED|Overall Study||11
10709109|NCT02636699|11873986|FG000|STARTED|Overall Study||238
10474946|NCT01104155|11623511|FG000|STARTED|Overall Study||63
10474947|NCT01104155|11623512|FG001|STARTED|Overall Study||60
10474948|NCT01104155|11623511|FG000|COMPLETED|Overall Study||38
10474949|NCT01104155|11623512|FG001|COMPLETED|Overall Study||42
10474950|NCT01104155|11623511|FG000|NOT COMPLETED|Overall Study||25
10474951|NCT01104155|11623512|FG001|NOT COMPLETED|Overall Study||18
10474952|NCT01104207|11623520|FG000|STARTED|Overall Study||35
10474953|NCT01104207|11623521|FG001|STARTED|Overall Study||35
10474954|NCT01104207|11623520|FG000|COMPLETED|Overall Study||32
10474955|NCT01104207|11623521|FG001|COMPLETED|Overall Study||32
10474956|NCT01104207|11623520|FG000|NOT COMPLETED|Overall Study||3
10474957|NCT01104207|11623521|FG001|NOT COMPLETED|Overall Study||3
10474958|NCT01104246|11623527|FG000|STARTED|Overall Study||40
10474959|NCT01104246|11623527|FG000|Baseline Characteristics Measured|Overall Study||35
10474960|NCT01104246|11623527|FG000|COMPLETED|Overall Study||35
10474961|NCT01104246|11623527|FG000|NOT COMPLETED|Overall Study||5
10526881|NCT01385098|11678801|FG000|STARTED|Overall Study||37
10526882|NCT01385098|11678801|FG000|COMPLETED|Overall Study|14 subjects did not complete. 4 subjects loss to follow-up & 10 subjects could not tolerate suppl.|23
10526883|NCT01385098|11678801|FG000|NOT COMPLETED|Overall Study||14
10526884|NCT01385137|11678809|FG000|STARTED|Evaluable at Baseline||131
10526885|NCT01385137|11678810|FG001|STARTED|Evaluable at Baseline||131
10526886|NCT01385137|11678809|FG000|COMPLETED|Evaluable at Baseline||122
10709110|NCT02636699|11873987|FG001|STARTED|Overall Study||118
10474962|NCT01104285|11623533|FG000|STARTED|Overall Study||112
10474963|NCT01104285|11623534|FG001|STARTED|Overall Study||86
10474964|NCT01104285|11623533|FG000|COMPLETED|Overall Study||112
10474965|NCT01104285|11623534|FG001|COMPLETED|Overall Study||86
10474966|NCT01104285|11623533|FG000|NOT COMPLETED|Overall Study||0
10474967|NCT01104285|11623534|FG001|NOT COMPLETED|Overall Study||0
10474968|NCT01104311|11623542|FG000|STARTED|Overall Study||66
10474969|NCT01104311|11623543|FG001|STARTED|Overall Study||66
10474970|NCT01104311|11623542|FG000|COMPLETED|Overall Study||56
10474971|NCT01104311|11623543|FG001|COMPLETED|Overall Study||54
10474972|NCT01104311|11623542|FG000|NOT COMPLETED|Overall Study||10
10474973|NCT01104311|11623543|FG001|NOT COMPLETED|Overall Study||12
10474974|NCT01104376|11623553|FG000|STARTED|Overall Study||89
10474975|NCT01104376|11623553|FG000|COMPLETED|Overall Study||61
10474976|NCT01104376|11623553|FG000|NOT COMPLETED|Overall Study||28
10474977|NCT01104402|11623559|FG000|STARTED|Overall Study||132
10474978|NCT01104402|11623560|FG001|STARTED|Overall Study||135
10474979|NCT01104402|11623559|FG000|COMPLETED|Overall Study||111
10474980|NCT01104402|11623560|FG001|COMPLETED|Overall Study||102
10474981|NCT01104402|11623559|FG000|NOT COMPLETED|Overall Study||21
10474982|NCT01104402|11623560|FG001|NOT COMPLETED|Overall Study||33
10474983|NCT01104415|11623566|FG000|STARTED|Core Phase||15
10474984|NCT01104415|11623567|FG001|STARTED|Core Phase||0
10474985|NCT01104415|11623566|FG000|COMPLETED|Core Phase||14
10474986|NCT01104415|11623567|FG001|COMPLETED|Core Phase||0
10474987|NCT01104415|11623566|FG000|NOT COMPLETED|Core Phase||1
10474988|NCT01104415|11623567|FG001|NOT COMPLETED|Core Phase||0
10474989|NCT01104415|11623566|FG000|STARTED|Extension Period||0
10474990|NCT01104415|11623567|FG001|STARTED|Extension Period|Out of 14 participants who completed Core Phase, 3 were not eligible to enter the Extension Period.|11
10474991|NCT01104415|11623566|FG000|COMPLETED|Extension Period||0
10474992|NCT01104415|11623567|FG001|COMPLETED|Extension Period||0
10474993|NCT01104415|11623566|FG000|NOT COMPLETED|Extension Period||0
10474994|NCT01104415|11623567|FG001|NOT COMPLETED|Extension Period||11
10474995|NCT01104493|11623576|FG000|STARTED|Overall Study||240
10474996|NCT01104493|11623577|FG001|STARTED|Overall Study||60
10474997|NCT01104493|11623576|FG000|COMPLETED|Overall Study||240
10474998|NCT01104493|11623577|FG001|COMPLETED|Overall Study||58
10474999|NCT01104493|11623576|FG000|NOT COMPLETED|Overall Study||0
10475000|NCT01104493|11623577|FG001|NOT COMPLETED|Overall Study||2
10475001|NCT01104545|11623586|FG000|STARTED|Overall Study||8
10475002|NCT01104545|11623587|FG001|STARTED|Overall Study||8
10475003|NCT01104545|11623588|FG002|STARTED|Overall Study|1 participant received 0.50 mg of MK-3614 or placebo in Periods 3 and 4 instead of planned 0.75 mg|8
10475004|NCT01104545|11623586|FG000|COMPLETED|Overall Study||8
10475005|NCT01104545|11623587|FG001|COMPLETED|Overall Study|Participant discontinued after receiving 0.75 mg MK-3614 in Period 1|7
10475006|NCT01104545|11623588|FG002|COMPLETED|Overall Study|Participants discontinued after receiving MK-3614 0.75 mg (Period 1)and placebo (Period 2)|6
10475007|NCT01104545|11623586|FG000|NOT COMPLETED|Overall Study||0
10475008|NCT01104545|11623587|FG001|NOT COMPLETED|Overall Study||1
10475009|NCT01104545|11623588|FG002|NOT COMPLETED|Overall Study||2
10475010|NCT01104558|11623633|FG000|STARTED|Overall Study||100
10475011|NCT01104558|11623633|FG000|COMPLETED|Overall Study||83
10475012|NCT01104558|11623633|FG000|NOT COMPLETED|Overall Study||17
10475013|NCT01104584|11623637|FG000|STARTED|Overall Study|screened and enrolled|460
10475014|NCT01104584|11623637|FG000|Received Treatment|Overall Study|treatment started|439
10475015|NCT01104584|11623637|FG000|Fulfilled Requirements of FAS Population|Overall Study||397
10475016|NCT01104584|11623637|FG000|COMPLETED|Overall Study|study course completed|437
10475017|NCT01104584|11623637|FG000|NOT COMPLETED|Overall Study||23
10475018|NCT01104636|11623659|FG000|STARTED|Overall Study||1177
10475019|NCT01104636|11623659|FG000|COMPLETED|Overall Study||999
10475020|NCT01104636|11623659|FG000|NOT COMPLETED|Overall Study||178
10475021|NCT01104662|11623671|FG000|STARTED|Overall Study||20
10475022|NCT01104662|11623672|FG001|STARTED|Overall Study||21
10475023|NCT01104662|11623673|FG002|STARTED|Overall Study||5
10475024|NCT01104662|11623674|FG003|STARTED|Overall Study||4
10475025|NCT01104662|11623675|FG004|STARTED|Overall Study||15
10475026|NCT01104662|11623676|FG005|STARTED|Overall Study||16
10475027|NCT01104662|11623677|FG006|STARTED|Overall Study||5
10475028|NCT01104662|11623678|FG007|STARTED|Overall Study||6
10475029|NCT01104662|11623671|FG000|Received at Least 1 Dose of Study Drug|Overall Study||17
10475030|NCT01104662|11623672|FG001|Received at Least 1 Dose of Study Drug|Overall Study||17
10475031|NCT01104662|11623673|FG002|Received at Least 1 Dose of Study Drug|Overall Study||4
10709111|NCT02636699|11873986|FG000|COMPLETED|Overall Study||213
10709112|NCT02636699|11873987|FG001|COMPLETED|Overall Study||107
10709113|NCT02636699|11873986|FG000|NOT COMPLETED|Overall Study||25
10709114|NCT02636699|11873987|FG001|NOT COMPLETED|Overall Study||11
10475032|NCT01104662|11623674|FG003|Received at Least 1 Dose of Study Drug|Overall Study||4
10475033|NCT01104662|11623675|FG004|Received at Least 1 Dose of Study Drug|Overall Study||15
10475034|NCT01104662|11623676|FG005|Received at Least 1 Dose of Study Drug|Overall Study||15
10475035|NCT01104662|11623677|FG006|Received at Least 1 Dose of Study Drug|Overall Study||5
10475036|NCT01104662|11623678|FG007|Received at Least 1 Dose of Study Drug|Overall Study||6
10475037|NCT01104662|11623671|FG000|COMPLETED|Overall Study||10
10475038|NCT01104662|11623672|FG001|COMPLETED|Overall Study||11
10475039|NCT01104662|11623673|FG002|COMPLETED|Overall Study||4
10475040|NCT01104662|11623674|FG003|COMPLETED|Overall Study||3
10475041|NCT01104662|11623675|FG004|COMPLETED|Overall Study||14
10475042|NCT01104662|11623676|FG005|COMPLETED|Overall Study||12
10475043|NCT01104662|11623677|FG006|COMPLETED|Overall Study||5
10475044|NCT01104662|11623678|FG007|COMPLETED|Overall Study||6
10475045|NCT01104662|11623671|FG000|NOT COMPLETED|Overall Study||10
10475046|NCT01104662|11623672|FG001|NOT COMPLETED|Overall Study||10
10475047|NCT01104662|11623673|FG002|NOT COMPLETED|Overall Study||1
10475048|NCT01104662|11623674|FG003|NOT COMPLETED|Overall Study||1
10475049|NCT01104662|11623675|FG004|NOT COMPLETED|Overall Study||1
10475050|NCT01104662|11623676|FG005|NOT COMPLETED|Overall Study||4
10475051|NCT01104662|11623677|FG006|NOT COMPLETED|Overall Study||0
10475052|NCT01104662|11623678|FG007|NOT COMPLETED|Overall Study||0
10475053|NCT01104701|11623701|FG000|STARTED|Overall Study||30
10475054|NCT01104701|11623702|FG001|STARTED|Overall Study||30
10475055|NCT01104701|11623703|FG002|STARTED|Overall Study||31
10475056|NCT01104701|11623704|FG003|STARTED|Overall Study||30
10475057|NCT01104701|11623701|FG000|COMPLETED|Overall Study||30
10475058|NCT01104701|11623702|FG001|COMPLETED|Overall Study||27
10475059|NCT01104701|11623703|FG002|COMPLETED|Overall Study||29
10475060|NCT01104701|11623704|FG003|COMPLETED|Overall Study||28
10475061|NCT01104701|11623701|FG000|NOT COMPLETED|Overall Study||0
10475062|NCT01104701|11623702|FG001|NOT COMPLETED|Overall Study||3
10475063|NCT01104701|11623703|FG002|NOT COMPLETED|Overall Study||2
10475064|NCT01104701|11623704|FG003|NOT COMPLETED|Overall Study||2
10475065|NCT01104766|11623718|FG000|STARTED|Overall Study||153
10475066|NCT01104766|11623719|FG001|STARTED|Overall Study||155
10475067|NCT01104766|11623720|FG002|STARTED|Overall Study||157
10475068|NCT01104766|11623721|FG003|STARTED|Overall Study||152
10475069|NCT01104766|11623718|FG000|COMPLETED|Overall Study||95
10475070|NCT01104766|11623719|FG001|COMPLETED|Overall Study||104
10475071|NCT01104766|11623720|FG002|COMPLETED|Overall Study||97
10475072|NCT01104766|11623721|FG003|COMPLETED|Overall Study||114
10475073|NCT01104766|11623718|FG000|NOT COMPLETED|Overall Study||58
10475074|NCT01104766|11623719|FG001|NOT COMPLETED|Overall Study||51
10475075|NCT01104766|11623720|FG002|NOT COMPLETED|Overall Study||60
10475076|NCT01104766|11623721|FG003|NOT COMPLETED|Overall Study||38
10475077|NCT01104779|11623734|FG000|STARTED|Overall Study||147
10475078|NCT01104779|11623735|FG001|STARTED|Overall Study||151
10475079|NCT01104779|11623736|FG002|STARTED|Overall Study||148
10475080|NCT01104779|11623734|FG000|COMPLETED|Overall Study||88
10475081|NCT01104779|11623735|FG001|COMPLETED|Overall Study||96
10475082|NCT01104779|11623736|FG002|COMPLETED|Overall Study||86
10475083|NCT01104779|11623734|FG000|NOT COMPLETED|Overall Study||59
10475084|NCT01104779|11623735|FG001|NOT COMPLETED|Overall Study||55
10475085|NCT01104779|11623736|FG002|NOT COMPLETED|Overall Study||62
10475086|NCT01104792|11623744|FG000|STARTED|Overall Study||752
10475087|NCT01104792|11623744|FG000|COMPLETED|Overall Study||226
10475088|NCT01104792|11623744|FG000|NOT COMPLETED|Overall Study||526
10475089|NCT01104870|11623751|FG000|STARTED|Overall Study||11
10475090|NCT01104870|11623752|FG001|STARTED|Overall Study||19
10475091|NCT01104870|11623753|FG002|STARTED|Overall Study||20
10475092|NCT01104870|11623751|FG000|COMPLETED|Overall Study||10
10475093|NCT01104870|11623752|FG001|COMPLETED|Overall Study||18
10475094|NCT01104870|11623753|FG002|COMPLETED|Overall Study||18
10475095|NCT01104870|11623751|FG000|NOT COMPLETED|Overall Study||1
10475096|NCT01104870|11623752|FG001|NOT COMPLETED|Overall Study||1
10475097|NCT01104870|11623753|FG002|NOT COMPLETED|Overall Study||2
10475098|NCT01105065|11623761|FG000|STARTED|Overall Study||23
10475099|NCT01105065|11623761|FG000|COMPLETED|Overall Study||17
10475100|NCT01105065|11623761|FG000|NOT COMPLETED|Overall Study||6
10475101|NCT01105091|11623769|FG000|STARTED|Overall Study||20
10475102|NCT01105091|11623770|FG001|STARTED|Overall Study||10
10475103|NCT01105091|11623769|FG000|COMPLETED|Overall Study||18
10475104|NCT01105091|11623770|FG001|COMPLETED|Overall Study||10
10475105|NCT01105091|11623769|FG000|NOT COMPLETED|Overall Study||2
10475106|NCT01105091|11623770|FG001|NOT COMPLETED|Overall Study||0
10475107|NCT01105117|11623780|FG000|STARTED|Overall Study||1
10475108|NCT01105117|11623781|FG001|STARTED|Overall Study||1
10475109|NCT01105117|11623780|FG000|COMPLETED|Overall Study||1
10475110|NCT01105117|11623781|FG001|COMPLETED|Overall Study||1
10475111|NCT01105117|11623780|FG000|NOT COMPLETED|Overall Study||0
10475112|NCT01105117|11623781|FG001|NOT COMPLETED|Overall Study||0
10475113|NCT01105130|11623790|FG000|STARTED|Overall Study||48
10475114|NCT01105130|11623791|FG001|STARTED|Overall Study||45
10475115|NCT01105130|11623792|FG002|STARTED|Overall Study||47
10475116|NCT01105130|11623790|FG000|COMPLETED|Overall Study||38
10475117|NCT01105130|11623791|FG001|COMPLETED|Overall Study||34
10475118|NCT01105130|11623792|FG002|COMPLETED|Overall Study||37
10475119|NCT01105130|11623790|FG000|NOT COMPLETED|Overall Study||10
10475120|NCT01105130|11623791|FG001|NOT COMPLETED|Overall Study||11
10475121|NCT01105130|11623792|FG002|NOT COMPLETED|Overall Study||10
10475122|NCT01105247|11623802|FG000|STARTED|Overall Study||116
10475123|NCT01105247|11623803|FG001|STARTED|Overall Study||16
10475124|NCT01105247|11623802|FG000|COMPLETED|Overall Study||79
10475125|NCT01105247|11623803|FG001|COMPLETED|Overall Study||16
10475126|NCT01105247|11623802|FG000|NOT COMPLETED|Overall Study||37
10475127|NCT01105247|11623803|FG001|NOT COMPLETED|Overall Study||0
10475128|NCT01105312|11623817|FG000|STARTED|Overall Study||16
10475129|NCT01105312|11623818|FG001|STARTED|Overall Study||6
10475130|NCT01105312|11623819|FG002|STARTED|Overall Study||6
10475131|NCT01105312|11623817|FG000|COMPLETED|Overall Study||13
10475132|NCT01105312|11623818|FG001|COMPLETED|Overall Study||6
10475133|NCT01105312|11623819|FG002|COMPLETED|Overall Study||6
10475134|NCT01105312|11623817|FG000|NOT COMPLETED|Overall Study||3
10475135|NCT01105312|11623818|FG001|NOT COMPLETED|Overall Study||0
10475136|NCT01105312|11623819|FG002|NOT COMPLETED|Overall Study||0
10475137|NCT01105377|11623829|FG000|STARTED|Overall Study||24
10475138|NCT01105377|11623830|FG001|STARTED|Overall Study||23
10475139|NCT01105377|11623829|FG000|COMPLETED|Overall Study||24
10475140|NCT01105377|11623830|FG001|COMPLETED|Overall Study||22
10475141|NCT01105377|11623829|FG000|NOT COMPLETED|Overall Study||0
10475142|NCT01105377|11623830|FG001|NOT COMPLETED|Overall Study||1
10475143|NCT01105533|11623836|FG000|STARTED|Overall Study||1
10475144|NCT01105533|11623837|FG001|STARTED|Overall Study||1
10475145|NCT01105533|11623838|FG002|STARTED|Overall Study||3
10475146|NCT01105533|11623839|FG003|STARTED|Overall Study||3
10475147|NCT01105533|11623840|FG004|STARTED|Overall Study||7
10475148|NCT01105533|11623841|FG005|STARTED|Overall Study||7
10475149|NCT01105533|11623842|FG006|STARTED|Overall Study||8
10475150|NCT01105533|11623843|FG007|STARTED|Overall Study||4
10475151|NCT01105533|11623844|FG008|STARTED|Overall Study||12
10475152|NCT01105533|11623836|FG000|COMPLETED|Overall Study||0
10475153|NCT01105533|11623837|FG001|COMPLETED|Overall Study||0
10475154|NCT01105533|11623838|FG002|COMPLETED|Overall Study||0
10475155|NCT01105533|11623839|FG003|COMPLETED|Overall Study||0
10475156|NCT01105533|11623840|FG004|COMPLETED|Overall Study||0
10475157|NCT01105533|11623841|FG005|COMPLETED|Overall Study||0
10475158|NCT01105533|11623842|FG006|COMPLETED|Overall Study||0
10475159|NCT01105533|11623843|FG007|COMPLETED|Overall Study||0
10475160|NCT01105533|11623844|FG008|COMPLETED|Overall Study||0
10475161|NCT01105533|11623836|FG000|NOT COMPLETED|Overall Study||1
10475162|NCT01105533|11623837|FG001|NOT COMPLETED|Overall Study||1
10475163|NCT01105533|11623838|FG002|NOT COMPLETED|Overall Study||3
10475164|NCT01105533|11623839|FG003|NOT COMPLETED|Overall Study||3
10475165|NCT01105533|11623840|FG004|NOT COMPLETED|Overall Study||7
10475166|NCT01105533|11623841|FG005|NOT COMPLETED|Overall Study||7
10475167|NCT01105533|11623842|FG006|NOT COMPLETED|Overall Study||8
10475168|NCT01105533|11623843|FG007|NOT COMPLETED|Overall Study||4
10475169|NCT01105533|11623844|FG008|NOT COMPLETED|Overall Study||12
10475170|NCT01105650|11623860|FG000|STARTED|Overall Study||3
10475171|NCT01105650|11623861|FG001|STARTED|Overall Study||3
10475172|NCT01105650|11623862|FG002|STARTED|Overall Study||7
10475173|NCT01105650|11623863|FG003|STARTED|Overall Study|Arm 3 was determined to be successful, thus eliminating the need to test Arm 4.|0
10475174|NCT01105650|11623860|FG000|COMPLETED|Overall Study||3
10475175|NCT01105650|11623861|FG001|COMPLETED|Overall Study||3
10475176|NCT01105650|11623862|FG002|COMPLETED|Overall Study||7
10475177|NCT01105650|11623863|FG003|COMPLETED|Overall Study||0
10475178|NCT01105650|11623860|FG000|NOT COMPLETED|Overall Study||0
10475179|NCT01105650|11623861|FG001|NOT COMPLETED|Overall Study||0
10475180|NCT01105650|11623862|FG002|NOT COMPLETED|Overall Study||0
10475181|NCT01105650|11623863|FG003|NOT COMPLETED|Overall Study||0
10475182|NCT01105702|11623871|FG000|STARTED|Overall Study||28
10475183|NCT01105702|11623871|FG000|COMPLETED|Overall Study||10
10475184|NCT01105702|11623871|FG000|NOT COMPLETED|Overall Study||18
10475185|NCT01105754|11623879|FG000|STARTED|Overall Study||319
10475186|NCT01105754|11623880|FG001|STARTED|Overall Study||319
10475187|NCT01105754|11623879|FG000|COMPLETED|Overall Study||304
10475188|NCT01105754|11623880|FG001|COMPLETED|Overall Study||307
10475189|NCT01105754|11623879|FG000|NOT COMPLETED|Overall Study||15
10475190|NCT01105754|11623880|FG001|NOT COMPLETED|Overall Study||12
10475191|NCT01105767|11623889|FG000|STARTED|Overall Study||9315
10475192|NCT01105767|11623890|FG001|STARTED|Overall Study||10864
10475193|NCT01105767|11623891|FG002|STARTED|Overall Study||10030
10475194|NCT01105767|11623889|FG000|COMPLETED|Overall Study||8155
10475195|NCT01105767|11623890|FG001|COMPLETED|Overall Study||9250
10475196|NCT01105767|11623891|FG002|COMPLETED|Overall Study||8846
10475197|NCT01105767|11623889|FG000|NOT COMPLETED|Overall Study||1160
10475198|NCT01105767|11623890|FG001|NOT COMPLETED|Overall Study||1614
10475199|NCT01105767|11623891|FG002|NOT COMPLETED|Overall Study||1184
10475200|NCT01105936|11623899|FG000|STARTED|Period 1||8
10475201|NCT01105936|11623900|FG001|STARTED|Period 1||8
10475202|NCT01105936|11623901|FG002|STARTED|Period 1||7
10475203|NCT01105936|11623902|FG003|STARTED|Period 1||8
10475204|NCT01105936|11623899|FG000|COMPLETED|Period 1||8
10475205|NCT01105936|11623900|FG001|COMPLETED|Period 1||8
10475206|NCT01105936|11623901|FG002|COMPLETED|Period 1||7
10475207|NCT01105936|11623902|FG003|COMPLETED|Period 1||7
10475208|NCT01105936|11623899|FG000|NOT COMPLETED|Period 1||0
10475209|NCT01105936|11623900|FG001|NOT COMPLETED|Period 1||0
10475210|NCT01105936|11623901|FG002|NOT COMPLETED|Period 1||0
10475211|NCT01105936|11623902|FG003|NOT COMPLETED|Period 1||1
10475212|NCT01105936|11623899|FG000|STARTED|Wash-out Period 1||8
10475213|NCT01105936|11623900|FG001|STARTED|Wash-out Period 1||8
10475214|NCT01105936|11623901|FG002|STARTED|Wash-out Period 1||7
10475215|NCT01105936|11623902|FG003|STARTED|Wash-out Period 1||7
10475216|NCT01105936|11623899|FG000|COMPLETED|Wash-out Period 1||8
10475217|NCT01105936|11623900|FG001|COMPLETED|Wash-out Period 1||8
10475218|NCT01105936|11623901|FG002|COMPLETED|Wash-out Period 1||7
10475219|NCT01105936|11623902|FG003|COMPLETED|Wash-out Period 1||7
10475220|NCT01105936|11623899|FG000|NOT COMPLETED|Wash-out Period 1||0
10475221|NCT01105936|11623900|FG001|NOT COMPLETED|Wash-out Period 1||0
10475222|NCT01105936|11623901|FG002|NOT COMPLETED|Wash-out Period 1||0
10475223|NCT01105936|11623902|FG003|NOT COMPLETED|Wash-out Period 1||0
10475224|NCT01105936|11623899|FG000|STARTED|Period 2||8
10475225|NCT01105936|11623900|FG001|STARTED|Period 2||8
10475226|NCT01105936|11623901|FG002|STARTED|Period 2||7
10475227|NCT01105936|11623902|FG003|STARTED|Period 2||7
10475228|NCT01105936|11623899|FG000|COMPLETED|Period 2||7
10475229|NCT01105936|11623900|FG001|COMPLETED|Period 2||8
10475230|NCT01105936|11623901|FG002|COMPLETED|Period 2||7
10475231|NCT01105936|11623902|FG003|COMPLETED|Period 2||7
10475232|NCT01105936|11623899|FG000|NOT COMPLETED|Period 2||1
10475233|NCT01105936|11623900|FG001|NOT COMPLETED|Period 2||0
10475234|NCT01105936|11623901|FG002|NOT COMPLETED|Period 2||0
10475235|NCT01105936|11623902|FG003|NOT COMPLETED|Period 2||0
10475236|NCT01105936|11623899|FG000|STARTED|Wash-out Period 2||7
10475237|NCT01105936|11623900|FG001|STARTED|Wash-out Period 2||8
10475238|NCT01105936|11623901|FG002|STARTED|Wash-out Period 2||7
10475239|NCT01105936|11623902|FG003|STARTED|Wash-out Period 2||7
10475240|NCT01105936|11623899|FG000|COMPLETED|Wash-out Period 2||7
10475241|NCT01105936|11623900|FG001|COMPLETED|Wash-out Period 2||8
10475242|NCT01105936|11623901|FG002|COMPLETED|Wash-out Period 2||7
10475243|NCT01105936|11623902|FG003|COMPLETED|Wash-out Period 2||7
10475244|NCT01105936|11623899|FG000|NOT COMPLETED|Wash-out Period 2||0
10475245|NCT01105936|11623900|FG001|NOT COMPLETED|Wash-out Period 2||0
10475246|NCT01105936|11623901|FG002|NOT COMPLETED|Wash-out Period 2||0
10475247|NCT01105936|11623902|FG003|NOT COMPLETED|Wash-out Period 2||0
10475248|NCT01105936|11623899|FG000|STARTED|Period 3||7
10475249|NCT01105936|11623900|FG001|STARTED|Period 3||8
10475250|NCT01105936|11623901|FG002|STARTED|Period 3||7
10475251|NCT01105936|11623902|FG003|STARTED|Period 3||7
10475252|NCT01105936|11623899|FG000|COMPLETED|Period 3||7
10475253|NCT01105936|11623900|FG001|COMPLETED|Period 3||6
10475254|NCT01105936|11623901|FG002|COMPLETED|Period 3||7
10475255|NCT01105936|11623902|FG003|COMPLETED|Period 3||7
10475256|NCT01105936|11623899|FG000|NOT COMPLETED|Period 3||0
10475257|NCT01105936|11623900|FG001|NOT COMPLETED|Period 3||2
10475258|NCT01105936|11623901|FG002|NOT COMPLETED|Period 3||0
10475259|NCT01105936|11623902|FG003|NOT COMPLETED|Period 3||0
10475260|NCT01105975|11623921|FG000|STARTED|Overall Study||40
10475261|NCT01105975|11623922|FG001|STARTED|Overall Study||39
10475262|NCT01105975|11623923|FG002|STARTED|Overall Study||42
10475263|NCT01105975|11623924|FG003|STARTED|Overall Study||38
10475264|NCT01105975|11623925|FG004|STARTED|Overall Study||41
10475265|NCT01105975|11623926|FG005|STARTED|Overall Study||35
10475266|NCT01105975|11623927|FG006|STARTED|Overall Study||42
10475267|NCT01105975|11623928|FG007|STARTED|Overall Study||40
10475268|NCT01105975|11623929|FG008|STARTED|Overall Study||40
10475269|NCT01105975|11623930|FG009|STARTED|Overall Study||41
10475270|NCT01105975|11623921|FG000|Took at Least One Dose of Study Drug|Overall Study||40
10475271|NCT01105975|11623922|FG001|Took at Least One Dose of Study Drug|Overall Study||38
10475272|NCT01105975|11623923|FG002|Took at Least One Dose of Study Drug|Overall Study||40
10475273|NCT01105975|11623924|FG003|Took at Least One Dose of Study Drug|Overall Study||38
10475274|NCT01105975|11623925|FG004|Took at Least One Dose of Study Drug|Overall Study||41
10475275|NCT01105975|11623926|FG005|Took at Least One Dose of Study Drug|Overall Study||35
10475276|NCT01105975|11623927|FG006|Took at Least One Dose of Study Drug|Overall Study||41
10475277|NCT01105975|11623928|FG007|Took at Least One Dose of Study Drug|Overall Study||40
10475278|NCT01105975|11623929|FG008|Took at Least One Dose of Study Drug|Overall Study||39
10475279|NCT01105975|11623930|FG009|Took at Least One Dose of Study Drug|Overall Study||41
10475280|NCT01105975|11623921|FG000|COMPLETED|Overall Study||35
10475281|NCT01105975|11623922|FG001|COMPLETED|Overall Study||34
10475282|NCT01105975|11623923|FG002|COMPLETED|Overall Study||32
10475283|NCT01105975|11623924|FG003|COMPLETED|Overall Study||36
10475284|NCT01105975|11623925|FG004|COMPLETED|Overall Study||35
10475285|NCT01105975|11623926|FG005|COMPLETED|Overall Study||30
10475286|NCT01105975|11623927|FG006|COMPLETED|Overall Study||34
10475287|NCT01105975|11623928|FG007|COMPLETED|Overall Study||33
10475288|NCT01105975|11623929|FG008|COMPLETED|Overall Study||34
10475289|NCT01105975|11623930|FG009|COMPLETED|Overall Study||32
10475290|NCT01105975|11623921|FG000|NOT COMPLETED|Overall Study||5
10475291|NCT01105975|11623922|FG001|NOT COMPLETED|Overall Study||5
10475292|NCT01105975|11623923|FG002|NOT COMPLETED|Overall Study||10
10475293|NCT01105975|11623924|FG003|NOT COMPLETED|Overall Study||2
10475294|NCT01105975|11623925|FG004|NOT COMPLETED|Overall Study||6
10475295|NCT01105975|11623926|FG005|NOT COMPLETED|Overall Study||5
10475296|NCT01105975|11623927|FG006|NOT COMPLETED|Overall Study||8
10475297|NCT01105975|11623928|FG007|NOT COMPLETED|Overall Study||7
10475298|NCT01105975|11623929|FG008|NOT COMPLETED|Overall Study||6
10475299|NCT01105975|11623930|FG009|NOT COMPLETED|Overall Study||9
10475300|NCT01106014|11623973|FG000|STARTED|Overall Study||574
10475301|NCT01106014|11623974|FG001|STARTED|Overall Study||582
10475302|NCT01106014|11623973|FG000|COMPLETED|Overall Study||289
10475303|NCT01106014|11623974|FG001|COMPLETED|Overall Study||252
10475304|NCT01106014|11623973|FG000|NOT COMPLETED|Overall Study||285
10475305|NCT01106014|11623974|FG001|NOT COMPLETED|Overall Study||330
10475306|NCT01106027|11623980|FG000|STARTED|Overall Study||2
10475307|NCT01106027|11623980|FG000|COMPLETED|Overall Study||1
10475308|NCT01106027|11623980|FG000|NOT COMPLETED|Overall Study||1
10475309|NCT01106040|11623984|FG000|STARTED|Overall Study||163
10475310|NCT01106040|11623984|FG000|COMPLETED|Overall Study||152
10475311|NCT01106040|11623984|FG000|NOT COMPLETED|Overall Study||11
10475312|NCT01106092|11623993|FG000|STARTED|Overall Study||78
10475313|NCT01106092|11623994|FG001|STARTED|Overall Study||78
10475314|NCT01106092|11623995|FG002|STARTED|Overall Study||78
10475315|NCT01106092|11623996|FG003|STARTED|Overall Study||78
10475316|NCT01106092|11623993|FG000|COMPLETED|Overall Study||78
10475317|NCT01106092|11623994|FG001|COMPLETED|Overall Study||78
10475318|NCT01106092|11623995|FG002|COMPLETED|Overall Study||78
10475319|NCT01106092|11623996|FG003|COMPLETED|Overall Study||77
10475320|NCT01106092|11623993|FG000|NOT COMPLETED|Overall Study||0
10475321|NCT01106092|11623994|FG001|NOT COMPLETED|Overall Study||0
10475322|NCT01106092|11623995|FG002|NOT COMPLETED|Overall Study||0
10475323|NCT01106092|11623996|FG003|NOT COMPLETED|Overall Study||1
10475324|NCT01106157|11624008|FG000|STARTED|Overall Study||17
10475325|NCT01106157|11624009|FG001|STARTED|Overall Study||8
10475326|NCT01106157|11624008|FG000|COMPLETED|Overall Study||16
10475327|NCT01106157|11624009|FG001|COMPLETED|Overall Study||8
10475328|NCT01106157|11624008|FG000|NOT COMPLETED|Overall Study||1
10475329|NCT01106157|11624009|FG001|NOT COMPLETED|Overall Study||0
10475330|NCT01106248|11624015|FG000|STARTED|Overall Study||26
10475331|NCT01106248|11624015|FG000|COMPLETED|Overall Study||23
10475332|NCT01106248|11624015|FG000|NOT COMPLETED|Overall Study||3
10475333|NCT01106287|11624023|FG000|STARTED|Overall Study|One participant that discontinued the study due to a pre-treatment adverse event was replaced.|4
10475334|NCT01106287|11624024|FG001|STARTED|Overall Study||3
10475335|NCT01106287|11624025|FG002|STARTED|Overall Study||3
10475336|NCT01106287|11624026|FG003|STARTED|Overall Study||3
10475337|NCT01106287|11624023|FG000|COMPLETED|Overall Study||3
10475338|NCT01106287|11624024|FG001|COMPLETED|Overall Study||3
10475339|NCT01106287|11624025|FG002|COMPLETED|Overall Study||3
10475340|NCT01106287|11624026|FG003|COMPLETED|Overall Study||3
10475341|NCT01106287|11624023|FG000|NOT COMPLETED|Overall Study||1
10475342|NCT01106287|11624024|FG001|NOT COMPLETED|Overall Study||0
10475343|NCT01106287|11624025|FG002|NOT COMPLETED|Overall Study||0
10475344|NCT01106287|11624026|FG003|NOT COMPLETED|Overall Study||0
10475345|NCT01106326|11624040|FG000|STARTED|Overall Study||30
10475346|NCT01106326|11624040|FG000|COMPLETED|Overall Study||28
10475347|NCT01106326|11624040|FG000|NOT COMPLETED|Overall Study||2
10475348|NCT01106352|11624051|FG000|STARTED|Overall Study||7
10475349|NCT01106352|11624052|FG001|STARTED|Overall Study||3
10475350|NCT01106352|11624053|FG002|STARTED|Overall Study||7
10475351|NCT01106352|11624054|FG003|STARTED|Overall Study||36
10475352|NCT01106352|11624055|FG004|STARTED|Overall Study||17
10475353|NCT01106352|11624051|FG000|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|7
10475354|NCT01106352|11624052|FG001|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|3
10475355|NCT01106352|11624053|FG002|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|7
10475356|NCT01106352|11624054|FG003|Started Dose Escalation|Overall Study||0
10475357|NCT01106352|11624055|FG004|Started Dose Escalation|Overall Study||0
10475358|NCT01106352|11624051|FG000|Completed Dose Escalation|Overall Study||6
10475359|NCT01106352|11624052|FG001|Completed Dose Escalation|Overall Study||3
10475360|NCT01106352|11624053|FG002|Completed Dose Escalation|Overall Study||5
10475361|NCT01106352|11624054|FG003|Completed Dose Escalation|Overall Study||0
10475362|NCT01106352|11624055|FG004|Completed Dose Escalation|Overall Study||0
10475363|NCT01106352|11624051|FG000|Started Safety Cohort|Overall Study||0
10475364|NCT01106352|11624052|FG001|Started Safety Cohort|Overall Study||0
10475365|NCT01106352|11624053|FG002|Started Safety Cohort|Overall Study||0
10475366|NCT01106352|11624054|FG003|Started Safety Cohort|Overall Study||36
10475367|NCT01106352|11624055|FG004|Started Safety Cohort|Overall Study||17
10475368|NCT01106352|11624051|FG000|Treated Safety Cohort|Overall Study||0
10475369|NCT01106352|11624052|FG001|Treated Safety Cohort|Overall Study||0
10475370|NCT01106352|11624053|FG002|Treated Safety Cohort|Overall Study||0
10475371|NCT01106352|11624054|FG003|Treated Safety Cohort|Overall Study|Number of subjects for safety analysis set.|33
10475372|NCT01106352|11624055|FG004|Treated Safety Cohort|Overall Study|Number of subjects for safety analysis set.|13
10475373|NCT01106352|11624051|FG000|Completed Safety Cohort|Overall Study||0
10475374|NCT01106352|11624052|FG001|Completed Safety Cohort|Overall Study||0
10475375|NCT01106352|11624053|FG002|Completed Safety Cohort|Overall Study||0
10475376|NCT01106352|11624054|FG003|Completed Safety Cohort|Overall Study||23
10475377|NCT01106352|11624055|FG004|Completed Safety Cohort|Overall Study||9
10475378|NCT01106352|11624051|FG000|COMPLETED|Overall Study||6
10475379|NCT01106352|11624052|FG001|COMPLETED|Overall Study||3
10475380|NCT01106352|11624053|FG002|COMPLETED|Overall Study||5
10475381|NCT01106352|11624054|FG003|COMPLETED|Overall Study|This group is only applicable for Safety cohort period.|23
10475382|NCT01106352|11624055|FG004|COMPLETED|Overall Study|This group is only applicable for Safety cohort period.|9
10475383|NCT01106352|11624051|FG000|NOT COMPLETED|Overall Study||1
10475384|NCT01106352|11624052|FG001|NOT COMPLETED|Overall Study||0
10475385|NCT01106352|11624053|FG002|NOT COMPLETED|Overall Study||2
10475386|NCT01106352|11624054|FG003|NOT COMPLETED|Overall Study||13
10475387|NCT01106352|11624055|FG004|NOT COMPLETED|Overall Study||8
10475388|NCT01106391|11624071|FG000|STARTED|Overall Study||60
10475389|NCT01106391|11624071|FG000|COMPLETED|Overall Study||60
10475390|NCT01106391|11624071|FG000|NOT COMPLETED|Overall Study||0
10475391|NCT01106404|11624077|FG000|STARTED|Period I (First 6 Weeks)||36
10475392|NCT01106404|11624078|FG001|STARTED|Period I (First 6 Weeks)||40
10475393|NCT01106404|11624077|FG000|COMPLETED|Period I (First 6 Weeks)||33
10475394|NCT01106404|11624078|FG001|COMPLETED|Period I (First 6 Weeks)||38
10475395|NCT01106404|11624077|FG000|NOT COMPLETED|Period I (First 6 Weeks)||3
10475396|NCT01106404|11624078|FG001|NOT COMPLETED|Period I (First 6 Weeks)||2
10475397|NCT01106404|11624077|FG000|STARTED|Period II (Second 6 Weeks)||33
10475398|NCT01106404|11624078|FG001|STARTED|Period II (Second 6 Weeks)||38
10475399|NCT01106404|11624077|FG000|COMPLETED|Period II (Second 6 Weeks)||33
10475400|NCT01106404|11624078|FG001|COMPLETED|Period II (Second 6 Weeks)||38
10475401|NCT01106404|11624077|FG000|NOT COMPLETED|Period II (Second 6 Weeks)||0
10475402|NCT01106404|11624078|FG001|NOT COMPLETED|Period II (Second 6 Weeks)||0
10475403|NCT01106430|11624092|FG000|STARTED|Overall Study||133
10475404|NCT01106430|11624093|FG001|STARTED|Overall Study||134
10475405|NCT01106430|11624092|FG000|COMPLETED|Overall Study||100
10475406|NCT01106430|11624093|FG001|COMPLETED|Overall Study||101
10475407|NCT01106430|11624092|FG000|NOT COMPLETED|Overall Study||33
10475408|NCT01106430|11624093|FG001|NOT COMPLETED|Overall Study||33
10475409|NCT01106456|11624101|FG000|STARTED|Overall Study||243
10475410|NCT01106456|11624102|FG001|STARTED|Overall Study||220
10475411|NCT01106456|11624101|FG000|COMPLETED|Overall Study||140
10475412|NCT01106456|11624102|FG001|COMPLETED|Overall Study||96
10475413|NCT01106456|11624101|FG000|NOT COMPLETED|Overall Study||103
10475414|NCT01106456|11624102|FG001|NOT COMPLETED|Overall Study||124
10475415|NCT01106586|11624110|FG000|STARTED|Overall Study||353
10475416|NCT01106586|11624111|FG001|STARTED|Overall Study||355
10475417|NCT01106586|11624110|FG000|COMPLETED|Overall Study||68
10475418|NCT01106586|11624111|FG001|COMPLETED|Overall Study||70
10475419|NCT01106586|11624110|FG000|NOT COMPLETED|Overall Study||285
10475420|NCT01106586|11624111|FG001|NOT COMPLETED|Overall Study||285
10475421|NCT01106625|11624120|FG000|STARTED|Core Period: Baseline to Week 26||156
10475422|NCT01106625|11624121|FG001|STARTED|Core Period: Baseline to Week 26||157
10475423|NCT01106625|11624122|FG002|STARTED|Core Period: Baseline to Week 26||156
10475424|NCT01106625|11624120|FG000|COMPLETED|Core Period: Baseline to Week 26||123
10475425|NCT01106625|11624121|FG001|COMPLETED|Core Period: Baseline to Week 26||129
10475426|NCT01106625|11624122|FG002|COMPLETED|Core Period: Baseline to Week 26||129
10475427|NCT01106625|11624120|FG000|NOT COMPLETED|Core Period: Baseline to Week 26||33
10475428|NCT01106625|11624121|FG001|NOT COMPLETED|Core Period: Baseline to Week 26||28
10475429|NCT01106625|11624122|FG002|NOT COMPLETED|Core Period: Baseline to Week 26||27
10475430|NCT01106625|11624120|FG000|STARTED|Extension Period: Week 26 to Week 52|4 pts discontinued last day of core: physician decision (1), noncompliance (1), not specified (2).|119
10475431|NCT01106625|11624121|FG001|STARTED|Extension Period: Week 26 to Week 52|2 pts discontinued last day of core: adverse event (1), not specified (1).|127
10475432|NCT01106625|11624122|FG002|STARTED|Extension Period: Week 26 to Week 52|1 pt discontinued last day of core: withdrawal by subject (1).|128
10475433|NCT01106625|11624120|FG000|COMPLETED|Extension Period: Week 26 to Week 52||90
10475434|NCT01106625|11624121|FG001|COMPLETED|Extension Period: Week 26 to Week 52||109
10475435|NCT01106625|11624122|FG002|COMPLETED|Extension Period: Week 26 to Week 52||111
10475436|NCT01106625|11624120|FG000|NOT COMPLETED|Extension Period: Week 26 to Week 52||29
10475437|NCT01106625|11624121|FG001|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
10475438|NCT01106625|11624122|FG002|NOT COMPLETED|Extension Period: Week 26 to Week 52||17
10475439|NCT01106651|11624136|FG000|STARTED|Overall Study||237
10475440|NCT01106651|11624137|FG001|STARTED|Overall Study||241
10475441|NCT01106651|11624138|FG002|STARTED|Overall Study||236
10475442|NCT01106651|11624136|FG000|COMPLETED|Overall Study||158
10475443|NCT01106651|11624137|FG001|COMPLETED|Overall Study||184
10475444|NCT01106651|11624138|FG002|COMPLETED|Overall Study||178
10475445|NCT01106651|11624136|FG000|NOT COMPLETED|Overall Study||79
10475446|NCT01106651|11624137|FG001|NOT COMPLETED|Overall Study||57
10475447|NCT01106651|11624138|FG002|NOT COMPLETED|Overall Study||58
10475448|NCT01106677|11624153|FG000|STARTED|Core Period: Baseline to Week 26||183
10475449|NCT01106677|11624154|FG001|STARTED|Core Period: Baseline to Week 26||368
10475450|NCT01106677|11624155|FG002|STARTED|Core Period: Baseline to Week 26||367
10475451|NCT01106677|11624156|FG003|STARTED|Core Period: Baseline to Week 26||366
10475452|NCT01106677|11624153|FG000|COMPLETED|Core Period: Baseline to Week 26||155
10475453|NCT01106677|11624154|FG001|COMPLETED|Core Period: Baseline to Week 26||322
10475454|NCT01106677|11624155|FG002|COMPLETED|Core Period: Baseline to Week 26||323
10475455|NCT01106677|11624156|FG003|COMPLETED|Core Period: Baseline to Week 26||319
10475456|NCT01106677|11624153|FG000|NOT COMPLETED|Core Period: Baseline to Week 26||28
10475457|NCT01106677|11624154|FG001|NOT COMPLETED|Core Period: Baseline to Week 26||46
10475458|NCT01106677|11624155|FG002|NOT COMPLETED|Core Period: Baseline to Week 26||44
10475459|NCT01106677|11624156|FG003|NOT COMPLETED|Core Period: Baseline to Week 26||47
10475460|NCT01106677|11624153|FG000|STARTED|Extension Period: Week 26 to Week 52|2 pts completed core but did not enter ext: protcol violation(1), lost to f/u(1).|153
10475461|NCT01106677|11624154|FG001|STARTED|Extension Period: Week 26 to Week 52|6 pts completed core but did not enter ext: not specified(5), withdrawal by subject(1).|316
10475462|NCT01106677|11624155|FG002|STARTED|Extension Period: Week 26 to Week 52|2 pts completed core but did not enter ext: not specified(1), withdrawal by subject(1).|321
10709115|NCT02636712|11873993|FG000|STARTED|Overall Study||10
10709116|NCT02636712|11873993|FG000|COMPLETED|Overall Study||10
10709117|NCT02636712|11873993|FG000|NOT COMPLETED|Overall Study||0
10475463|NCT01106677|11624156|FG003|STARTED|Extension Period: Week 26 to Week 52|6 pts completed core but did not enter ext: not specified(3), physician decision(2), lost to f/u(1).|313
10475464|NCT01106677|11624153|FG000|COMPLETED|Extension Period: Week 26 to Week 52||138
10475465|NCT01106677|11624154|FG001|COMPLETED|Extension Period: Week 26 to Week 52||298
10475466|NCT01106677|11624155|FG002|COMPLETED|Extension Period: Week 26 to Week 52||299
10475467|NCT01106677|11624156|FG003|COMPLETED|Extension Period: Week 26 to Week 52||285
10475468|NCT01106677|11624153|FG000|NOT COMPLETED|Extension Period: Week 26 to Week 52||15
10475469|NCT01106677|11624154|FG001|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
10475470|NCT01106677|11624155|FG002|NOT COMPLETED|Extension Period: Week 26 to Week 52||22
10526887|NCT01385137|11678810|FG001|COMPLETED|Evaluable at Baseline||127
10475471|NCT01106677|11624156|FG003|NOT COMPLETED|Extension Period: Week 26 to Week 52||28
10475472|NCT01106690|11624176|FG000|STARTED|Core Period: Baseline to Week 26||115
10475473|NCT01106690|11624177|FG001|STARTED|Core Period: Baseline to Week 26||113
10475474|NCT01106690|11624178|FG002|STARTED|Core Period: Baseline to Week 26||114
10475475|NCT01106690|11624176|FG000|COMPLETED|Core Period: Baseline to Week 26||91
10475476|NCT01106690|11624177|FG001|COMPLETED|Core Period: Baseline to Week 26||104
10475477|NCT01106690|11624178|FG002|COMPLETED|Core Period: Baseline to Week 26||101
10475478|NCT01106690|11624176|FG000|NOT COMPLETED|Core Period: Baseline to Week 26||24
10475479|NCT01106690|11624177|FG001|NOT COMPLETED|Core Period: Baseline to Week 26||9
10475480|NCT01106690|11624178|FG002|NOT COMPLETED|Core Period: Baseline to Week 26||13
10475481|NCT01106690|11624176|FG000|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext: physician decision(1).|90
10475482|NCT01106690|11624177|FG001|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext: physician decision(1).|103
10475483|NCT01106690|11624178|FG002|STARTED|Extension Period: Week 26 to Week 52|5 pts completed core but did not exter ext: lost to f/u(1), not spec(2), AE(1), eGFR criteria(1).|96
10475484|NCT01106690|11624176|FG000|COMPLETED|Extension Period: Week 26 to Week 52||78
10475485|NCT01106690|11624177|FG001|COMPLETED|Extension Period: Week 26 to Week 52||96
10475486|NCT01106690|11624178|FG002|COMPLETED|Extension Period: Week 26 to Week 52||89
10475487|NCT01106690|11624176|FG000|NOT COMPLETED|Extension Period: Week 26 to Week 52||12
10475488|NCT01106690|11624177|FG001|NOT COMPLETED|Extension Period: Week 26 to Week 52||7
10475489|NCT01106690|11624178|FG002|NOT COMPLETED|Extension Period: Week 26 to Week 52||7
10475490|NCT01106833|11624191|FG000|STARTED|Overall Study||74
10475491|NCT01106833|11624192|FG001|STARTED|Overall Study||77
10475492|NCT01106833|11624191|FG000|COMPLETED|Overall Study||74
10475493|NCT01106833|11624192|FG001|COMPLETED|Overall Study||77
10475494|NCT01106833|11624191|FG000|NOT COMPLETED|Overall Study||0
10475495|NCT01106833|11624192|FG001|NOT COMPLETED|Overall Study||0
10475496|NCT01106846|11624200|FG000|STARTED|Overall Study||12
10475497|NCT01106846|11624201|FG001|STARTED|Overall Study||10
10475498|NCT01106846|11624200|FG000|COMPLETED|Overall Study||12
10709118|NCT02636725|11873998|FG000|STARTED|Baseline||33
10709119|NCT02636725|11873998|FG000|COMPLETED|Baseline||30
10709120|NCT02636725|11873998|FG000|NOT COMPLETED|Baseline||3
10475499|NCT01106846|11624201|FG001|COMPLETED|Overall Study||9
10475500|NCT01106846|11624200|FG000|NOT COMPLETED|Overall Study||0
10475501|NCT01106846|11624201|FG001|NOT COMPLETED|Overall Study||1
10475502|NCT01106859|11624207|FG000|STARTED|Overall Study|Intent to treat population and safety population are the same (40 participants)|40
10475503|NCT01106859|11624207|FG000|COMPLETED|Overall Study||40
10475504|NCT01106859|11624207|FG000|NOT COMPLETED|Overall Study||0
10475505|NCT01106898|11624218|FG000|STARTED|Overall Study||100
10475506|NCT01106898|11624218|FG000|COMPLETED|Overall Study||94
10475507|NCT01106898|11624218|FG000|NOT COMPLETED|Overall Study||6
10475508|NCT01106911|11624222|FG000|STARTED|Overall Study||1085
10475509|NCT01106911|11624222|FG000|COMPLETED|Overall Study||1080
10475510|NCT01106911|11624222|FG000|NOT COMPLETED|Overall Study||5
10475511|NCT01106950|11624226|FG000|STARTED|Overall Study||15
10475512|NCT01106950|11624226|FG000|COMPLETED|Overall Study||15
10475513|NCT01106950|11624226|FG000|NOT COMPLETED|Overall Study||0
10475514|NCT01106976|11624232|FG000|STARTED|Overall Study||67
10475515|NCT01106976|11624232|FG000|COMPLETED|Overall Study||59
10475516|NCT01106976|11624232|FG000|NOT COMPLETED|Overall Study||8
10709121|NCT02636725|11873998|FG000|STARTED|Post-Baseline Imaging Assessment||30
10709122|NCT02636725|11873998|FG000|COMPLETED|Post-Baseline Imaging Assessment||30
10709123|NCT02636725|11873998|FG000|NOT COMPLETED|Post-Baseline Imaging Assessment||0
10709124|NCT02636868|11874005|FG000|STARTED|Overall Study||73
10709125|NCT02636868|11874006|FG001|STARTED|Overall Study||76
10709126|NCT02636868|11874007|FG002|STARTED|Overall Study||72
10709127|NCT02636868|11874005|FG000|COMPLETED|Overall Study||73
10709128|NCT02636868|11874006|FG001|COMPLETED|Overall Study||75
10709129|NCT02636868|11874007|FG002|COMPLETED|Overall Study||70
10709130|NCT02636868|11874005|FG000|NOT COMPLETED|Overall Study||0
10709131|NCT02636868|11874006|FG001|NOT COMPLETED|Overall Study||1
10709132|NCT02636868|11874007|FG002|NOT COMPLETED|Overall Study||2
10709133|NCT02636907|11874015|FG000|STARTED|Autoinjector Assessment Period|Assigned to treatment.|77
10709134|NCT02636907|11874015|FG000|COMPLETED|Autoinjector Assessment Period|Completed autoinjector assessment period (Day 50).|73
10709135|NCT02636907|11874015|FG000|NOT COMPLETED|Autoinjector Assessment Period||4
10709136|NCT02636907|11874015|FG000|STARTED|Extension Phase||72
10709137|NCT02636907|11874015|FG000|COMPLETED|Extension Phase||62
10475517|NCT01107015|11624240|FG000|STARTED|Overall Study||62
10475518|NCT01107015|11624241|FG001|STARTED|Overall Study||38
10475519|NCT01107015|11624242|FG002|STARTED|Overall Study||33
10475520|NCT01107015|11624243|FG003|STARTED|Overall Study||80
10475521|NCT01107015|11624240|FG000|COMPLETED|Overall Study||56
10475522|NCT01107015|11624241|FG001|COMPLETED|Overall Study||23
10475523|NCT01107015|11624242|FG002|COMPLETED|Overall Study||22
10475524|NCT01107015|11624243|FG003|COMPLETED|Overall Study||62
10475525|NCT01107015|11624240|FG000|NOT COMPLETED|Overall Study||6
10475526|NCT01107015|11624241|FG001|NOT COMPLETED|Overall Study||15
10475527|NCT01107015|11624242|FG002|NOT COMPLETED|Overall Study||11
10709138|NCT02636907|11874015|FG000|NOT COMPLETED|Extension Phase||10
10709139|NCT02637037|11874021|FG000|STARTED|Overall Study||40
10709140|NCT02637037|11874022|FG001|STARTED|Overall Study||40
10709141|NCT02637037|11874021|FG000|COMPLETED|Overall Study||36
10709142|NCT02637037|11874022|FG001|COMPLETED|Overall Study||39
10709143|NCT02637037|11874021|FG000|NOT COMPLETED|Overall Study||4
10475528|NCT01107015|11624243|FG003|NOT COMPLETED|Overall Study||18
10475529|NCT01107197|11624255|FG000|STARTED|Overall Study||99
10475530|NCT01107197|11624256|FG001|STARTED|Overall Study||101
10475531|NCT01107197|11624255|FG000|COMPLETED|Overall Study|Included in intention-to-treat efficacy analyses (per-protocol analyses were based on 67 patients )|79
10475532|NCT01107197|11624256|FG001|COMPLETED|Overall Study|Included in intention-to-treat efficacy analyses (per-protocol analyses were based on 64 patients )|78
10475533|NCT01107197|11624255|FG000|NOT COMPLETED|Overall Study||20
10475534|NCT01107197|11624256|FG001|NOT COMPLETED|Overall Study||23
10475535|NCT01107353|11624264|FG000|STARTED|Overall Study||20
10475536|NCT01107353|11624265|FG001|STARTED|Overall Study||20
10475537|NCT01107353|11624264|FG000|COMPLETED|Overall Study||19
10475538|NCT01107353|11624265|FG001|COMPLETED|Overall Study||20
10475539|NCT01107353|11624264|FG000|NOT COMPLETED|Overall Study||1
10475540|NCT01107353|11624265|FG001|NOT COMPLETED|Overall Study||0
10475541|NCT01107379|11624271|FG000|STARTED|Overall Study||203
10475542|NCT01107379|11624271|FG000|COMPLETED|Overall Study||182
10475543|NCT01107379|11624271|FG000|NOT COMPLETED|Overall Study||21
10475544|NCT01107392|11624277|FG000|STARTED|Overall Study||158
10475545|NCT01107392|11624278|FG001|STARTED|Overall Study||157
10475546|NCT01107392|11624277|FG000|COMPLETED|Overall Study||153
10475547|NCT01107392|11624278|FG001|COMPLETED|Overall Study||154
10475548|NCT01107392|11624277|FG000|NOT COMPLETED|Overall Study||5
10475549|NCT01107392|11624278|FG001|NOT COMPLETED|Overall Study||3
10475550|NCT01107405|11624289|FG000|STARTED|Overall Study||21
10475551|NCT01107405|11624290|FG001|STARTED|Overall Study||20
10475552|NCT01107405|11624291|FG002|STARTED|Overall Study||20
10475553|NCT01107405|11624292|FG003|STARTED|Overall Study||20
10475554|NCT01107405|11624293|FG004|STARTED|Overall Study||20
10475555|NCT01107405|11624289|FG000|COMPLETED|Overall Study||19
10475556|NCT01107405|11624290|FG001|COMPLETED|Overall Study||19
10475557|NCT01107405|11624291|FG002|COMPLETED|Overall Study||18
10475558|NCT01107405|11624292|FG003|COMPLETED|Overall Study||17
10475559|NCT01107405|11624293|FG004|COMPLETED|Overall Study||17
10475560|NCT01107405|11624289|FG000|NOT COMPLETED|Overall Study||2
10475561|NCT01107405|11624290|FG001|NOT COMPLETED|Overall Study||1
10475562|NCT01107405|11624291|FG002|NOT COMPLETED|Overall Study||2
10475563|NCT01107405|11624292|FG003|NOT COMPLETED|Overall Study||3
10475564|NCT01107405|11624293|FG004|NOT COMPLETED|Overall Study||3
10475565|NCT01107418|11624309|FG000|STARTED|Overall Study||52
10475566|NCT01107418|11624309|FG000|COMPLETED|Overall Study||0
10475567|NCT01107418|11624309|FG000|NOT COMPLETED|Overall Study||52
10475568|NCT01107444|11624326|FG000|STARTED|Overall Study||120
10475569|NCT01107444|11624327|FG001|STARTED|Overall Study||60
10475570|NCT01107444|11624326|FG000|Received At Least 1 Dose of Study Drug|Overall Study||114
10475571|NCT01107444|11624327|FG001|Received At Least 1 Dose of Study Drug|Overall Study||48
10475572|NCT01107444|11624326|FG000|COMPLETED|Overall Study||112
10475573|NCT01107444|11624327|FG001|COMPLETED|Overall Study||47
10475574|NCT01107444|11624326|FG000|NOT COMPLETED|Overall Study||8
10475575|NCT01107444|11624327|FG001|NOT COMPLETED|Overall Study||13
10475576|NCT01107457|11624341|FG000|STARTED|Part A||27
10475577|NCT01107457|11624342|FG001|STARTED|Part A||28
10475578|NCT01107457|11624343|FG002|STARTED|Part A||30
10475579|NCT01107457|11624344|FG003|STARTED|Part A||29
10475580|NCT01107457|11624345|FG004|STARTED|Part A||28
10475581|NCT01107457|11624346|FG005|STARTED|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
10475582|NCT01107457|11624341|FG000|Received at Least 1 Dose of Study Drug|Part A||27
10475583|NCT01107457|11624342|FG001|Received at Least 1 Dose of Study Drug|Part A||28
10475584|NCT01107457|11624343|FG002|Received at Least 1 Dose of Study Drug|Part A||30
10475585|NCT01107457|11624344|FG003|Received at Least 1 Dose of Study Drug|Part A||29
10475586|NCT01107457|11624345|FG004|Received at Least 1 Dose of Study Drug|Part A||28
10475587|NCT01107457|11624346|FG005|Received at Least 1 Dose of Study Drug|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
10475588|NCT01107457|11624341|FG000|COMPLETED|Part A||22
10475589|NCT01107457|11624342|FG001|COMPLETED|Part A||21
10475590|NCT01107457|11624343|FG002|COMPLETED|Part A||29
10475591|NCT01107457|11624344|FG003|COMPLETED|Part A||26
10475592|NCT01107457|11624345|FG004|COMPLETED|Part A||27
10475593|NCT01107457|11624346|FG005|COMPLETED|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
10475594|NCT01107457|11624341|FG000|NOT COMPLETED|Part A||5
10475595|NCT01107457|11624342|FG001|NOT COMPLETED|Part A||7
10475596|NCT01107457|11624343|FG002|NOT COMPLETED|Part A||1
10475597|NCT01107457|11624344|FG003|NOT COMPLETED|Part A||3
10475598|NCT01107457|11624345|FG004|NOT COMPLETED|Part A||1
10475599|NCT01107457|11624346|FG005|NOT COMPLETED|Part A||0
10475600|NCT01107457|11624341|FG000|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
10475601|NCT01107457|11624342|FG001|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
10475602|NCT01107457|11624343|FG002|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
10475603|NCT01107457|11624344|FG003|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
10475604|NCT01107457|11624345|FG004|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
10475605|NCT01107457|11624346|FG005|STARTED|Part B and C|80 and 120 mg ixekizumab were administered during Part B and C.|120
10475606|NCT01107457|11624341|FG000|Completed Part B (Week 240)|Part B and C||0
10475607|NCT01107457|11624342|FG001|Completed Part B (Week 240)|Part B and C||0
10475608|NCT01107457|11624343|FG002|Completed Part B (Week 240)|Part B and C||0
10475609|NCT01107457|11624344|FG003|Completed Part B (Week 240)|Part B and C||0
10475610|NCT01107457|11624345|FG004|Completed Part B (Week 240)|Part B and C||0
10475611|NCT01107457|11624346|FG005|Completed Part B (Week 240)|Part B and C||74
10475612|NCT01107457|11624341|FG000|Completed Part C|Part B and C||0
10475613|NCT01107457|11624342|FG001|Completed Part C|Part B and C||0
10475614|NCT01107457|11624343|FG002|Completed Part C|Part B and C||0
10475615|NCT01107457|11624344|FG003|Completed Part C|Part B and C||0
10475616|NCT01107457|11624345|FG004|Completed Part C|Part B and C||0
10475617|NCT01107457|11624346|FG005|Completed Part C|Part B and C|Part C was stopped once ixekizumab became available through marketing authorization.|0
10475618|NCT01107457|11624341|FG000|Post Treatment Safety Visits|Part B and C||0
10475619|NCT01107457|11624342|FG001|Post Treatment Safety Visits|Part B and C||0
10475620|NCT01107457|11624343|FG002|Post Treatment Safety Visits|Part B and C||0
10475621|NCT01107457|11624344|FG003|Post Treatment Safety Visits|Part B and C||0
10475622|NCT01107457|11624345|FG004|Post Treatment Safety Visits|Part B and C||0
10475623|NCT01107457|11624346|FG005|Post Treatment Safety Visits|Part B and C|Only participants with neutropenia entered the post treatment safety visits.|6
10475624|NCT01107457|11624341|FG000|COMPLETED|Part B and C||0
10475625|NCT01107457|11624342|FG001|COMPLETED|Part B and C||0
10475626|NCT01107457|11624343|FG002|COMPLETED|Part B and C||0
10475627|NCT01107457|11624344|FG003|COMPLETED|Part B and C||0
10475628|NCT01107457|11624345|FG004|COMPLETED|Part B and C||0
10475629|NCT01107457|11624346|FG005|COMPLETED|Part B and C|No participants completed the study as Part C was stopped.|0
10475630|NCT01107457|11624341|FG000|NOT COMPLETED|Part B and C||0
10475631|NCT01107457|11624342|FG001|NOT COMPLETED|Part B and C||0
10475632|NCT01107457|11624343|FG002|NOT COMPLETED|Part B and C||0
10475633|NCT01107457|11624344|FG003|NOT COMPLETED|Part B and C||0
10475634|NCT01107457|11624345|FG004|NOT COMPLETED|Part B and C||0
10475635|NCT01107457|11624346|FG005|NOT COMPLETED|Part B and C||120
10475636|NCT01107535|11624364|FG000|STARTED|Overall Study||82
10475637|NCT01107535|11624364|FG000|Number of Participants Analyzed|Overall Study||82
10475638|NCT01107535|11624364|FG000|COMPLETED|Overall Study||77
10475639|NCT01107535|11624364|FG000|NOT COMPLETED|Overall Study||5
10475640|NCT01107665|11624368|FG000|STARTED|Overall Study||60
10475641|NCT01107665|11624368|FG000|COMPLETED|Overall Study||11
10475642|NCT01107665|11624368|FG000|NOT COMPLETED|Overall Study||49
10475643|NCT01107730|11624377|FG000|STARTED|Overall Study||11
10709144|NCT02637037|11874022|FG001|NOT COMPLETED|Overall Study||1
10709145|NCT02637063|11874043|FG000|STARTED|Overall Study||67
10709146|NCT02637063|11874044|FG001|STARTED|Overall Study||68
10709147|NCT02637063|11874045|FG002|STARTED|Overall Study||68
10709148|NCT02637063|11874043|FG000|COMPLETED|Overall Study||62
10709149|NCT02637063|11874044|FG001|COMPLETED|Overall Study||64
10709150|NCT02637063|11874045|FG002|COMPLETED|Overall Study||62
10709151|NCT02637063|11874043|FG000|NOT COMPLETED|Overall Study||5
10709152|NCT02637063|11874044|FG001|NOT COMPLETED|Overall Study||4
10709153|NCT02637063|11874045|FG002|NOT COMPLETED|Overall Study||6
10709154|NCT02637076|11874055|FG000|STARTED|Overall Study||2
10475644|NCT01107730|11624378|FG001|STARTED|Overall Study||11
10475645|NCT01107730|11624379|FG002|STARTED|Overall Study||11
10475646|NCT01107730|11624377|FG000|COMPLETED|Overall Study||11
10475647|NCT01107730|11624378|FG001|COMPLETED|Overall Study||11
10475648|NCT01107730|11624379|FG002|COMPLETED|Overall Study||11
10475649|NCT01107730|11624377|FG000|NOT COMPLETED|Overall Study||0
10475650|NCT01107730|11624378|FG001|NOT COMPLETED|Overall Study||0
10475651|NCT01107730|11624379|FG002|NOT COMPLETED|Overall Study||0
10475652|NCT01107743|11624387|FG000|STARTED|Overall Study||1291
10475653|NCT01107743|11624387|FG000|COMPLETED|Overall Study||1245
10475654|NCT01107743|11624387|FG000|NOT COMPLETED|Overall Study||46
10475655|NCT01107834|11624438|FG000|STARTED|Overall Study||30
10475656|NCT01107834|11624439|FG001|STARTED|Overall Study||30
10475657|NCT01107834|11624438|FG000|COMPLETED|Overall Study||30
10475658|NCT01107834|11624439|FG001|COMPLETED|Overall Study||30
10475659|NCT01107834|11624438|FG000|NOT COMPLETED|Overall Study||0
10475660|NCT01107834|11624439|FG001|NOT COMPLETED|Overall Study||0
10475661|NCT01107886|11624447|FG000|STARTED|Overall Study|Randomized subjects|8280
10475662|NCT01107886|11624448|FG001|STARTED|Overall Study|Randomized subjects|8212
10475663|NCT01107886|11624447|FG000|COMPLETED|Overall Study|Completed subjects|8078
10475664|NCT01107886|11624448|FG001|COMPLETED|Overall Study|Completed subjects|7998
10475665|NCT01107886|11624447|FG000|NOT COMPLETED|Overall Study||202
10475666|NCT01107886|11624448|FG001|NOT COMPLETED|Overall Study||214
10475667|NCT01107899|11624457|FG000|STARTED|Overall Study||10
10475668|NCT01107899|11624458|FG001|STARTED|Overall Study||10
10475669|NCT01107899|11624459|FG002|STARTED|Overall Study||9
10475670|NCT01107899|11624457|FG000|Received at Least One Dose of Study Drug|Overall Study||10
10475671|NCT01107899|11624458|FG001|Received at Least One Dose of Study Drug|Overall Study||10
10475672|NCT01107899|11624459|FG002|Received at Least One Dose of Study Drug|Overall Study||8
10475673|NCT01107899|11624457|FG000|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|5
10709155|NCT02637076|11874056|FG001|STARTED|Overall Study||15
10709156|NCT02637076|11874055|FG000|COMPLETED|Overall Study||1
10475674|NCT01107899|11624458|FG001|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|10
10475675|NCT01107899|11624459|FG002|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|6
10526888|NCT01385137|11678809|FG000|NOT COMPLETED|Evaluable at Baseline||9
10709157|NCT02637076|11874056|FG001|COMPLETED|Overall Study||10
10709158|NCT02637076|11874055|FG000|NOT COMPLETED|Overall Study||1
10709159|NCT02637076|11874056|FG001|NOT COMPLETED|Overall Study||5
10475676|NCT01107899|11624457|FG000|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|5
10475677|NCT01107899|11624458|FG001|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|10
10475678|NCT01107899|11624459|FG002|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|6
10475679|NCT01107899|11624457|FG000|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|5
10475680|NCT01107899|11624458|FG001|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|10
10475681|NCT01107899|11624459|FG002|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|4
10475682|NCT01107899|11624457|FG000|COMPLETED|Overall Study||5
10475683|NCT01107899|11624458|FG001|COMPLETED|Overall Study||10
10475684|NCT01107899|11624459|FG002|COMPLETED|Overall Study||5
10475685|NCT01107899|11624457|FG000|NOT COMPLETED|Overall Study||5
10475686|NCT01107899|11624458|FG001|NOT COMPLETED|Overall Study||0
10475687|NCT01107899|11624459|FG002|NOT COMPLETED|Overall Study||4
10475688|NCT01107912|11624474|FG000|STARTED|Period 1||73
10475689|NCT01107912|11624475|FG001|STARTED|Period 1||0
10475690|NCT01107912|11624476|FG002|STARTED|Period 1||0
10475691|NCT01107912|11624477|FG003|STARTED|Period 1||0
10475692|NCT01107912|11624478|FG004|STARTED|Period 1||82
10475693|NCT01107912|11624479|FG005|STARTED|Period 1||0
10475694|NCT01107912|11624474|FG000|Received at Least 1 Dose of Study Drug|Period 1||73
10475695|NCT01107912|11624475|FG001|Received at Least 1 Dose of Study Drug|Period 1||0
10475696|NCT01107912|11624476|FG002|Received at Least 1 Dose of Study Drug|Period 1||0
10475697|NCT01107912|11624477|FG003|Received at Least 1 Dose of Study Drug|Period 1||0
10475698|NCT01107912|11624478|FG004|Received at Least 1 Dose of Study Drug|Period 1||82
10475699|NCT01107912|11624479|FG005|Received at Least 1 Dose of Study Drug|Period 1||0
10475700|NCT01107912|11624474|FG000|COMPLETED|Period 1||72
10475701|NCT01107912|11624475|FG001|COMPLETED|Period 1||0
10475702|NCT01107912|11624476|FG002|COMPLETED|Period 1||0
10475703|NCT01107912|11624477|FG003|COMPLETED|Period 1||0
10475704|NCT01107912|11624478|FG004|COMPLETED|Period 1||79
10475705|NCT01107912|11624479|FG005|COMPLETED|Period 1||0
10475706|NCT01107912|11624474|FG000|NOT COMPLETED|Period 1||1
10475707|NCT01107912|11624475|FG001|NOT COMPLETED|Period 1||0
10475708|NCT01107912|11624476|FG002|NOT COMPLETED|Period 1||0
10475709|NCT01107912|11624477|FG003|NOT COMPLETED|Period 1||0
10475710|NCT01107912|11624478|FG004|NOT COMPLETED|Period 1||3
10475711|NCT01107912|11624479|FG005|NOT COMPLETED|Period 1||0
10475712|NCT01107912|11624474|FG000|STARTED|Period 2|Participants switched to either 10 mg prasugrel or 75 mg clopidogrel in Period 2.|0
10475713|NCT01107912|11624475|FG001|STARTED|Period 2||36
10475714|NCT01107912|11624476|FG002|STARTED|Period 2||36
10475715|NCT01107912|11624477|FG003|STARTED|Period 2||41
10475716|NCT01107912|11624478|FG004|STARTED|Period 2|Participants switched to either 5 mg prasugrel or 75 mg clopidogrel in Period 2.|0
10475717|NCT01107912|11624479|FG005|STARTED|Period 2||38
10475718|NCT01107912|11624474|FG000|COMPLETED|Period 2||0
10475719|NCT01107912|11624475|FG001|COMPLETED|Period 2||36
10475720|NCT01107912|11624476|FG002|COMPLETED|Period 2||35
10475721|NCT01107912|11624477|FG003|COMPLETED|Period 2||41
10475722|NCT01107912|11624478|FG004|COMPLETED|Period 2||0
10475723|NCT01107912|11624479|FG005|COMPLETED|Period 2||38
10475724|NCT01107912|11624474|FG000|NOT COMPLETED|Period 2||0
10475725|NCT01107912|11624475|FG001|NOT COMPLETED|Period 2||0
10475726|NCT01107912|11624476|FG002|NOT COMPLETED|Period 2||1
10475727|NCT01107912|11624477|FG003|NOT COMPLETED|Period 2||0
10475728|NCT01107912|11624478|FG004|NOT COMPLETED|Period 2||0
10475729|NCT01107912|11624479|FG005|NOT COMPLETED|Period 2||0
10475730|NCT01107912|11624474|FG000|STARTED|Period 3||0
10475731|NCT01107912|11624475|FG001|STARTED|Period 3|Participants who received 75 mg clopidogrel in Period 2 received 10 mg prasugrel in Period 3|35
10475732|NCT01107912|11624476|FG002|STARTED|Period 3|Participants who received 10 mg prasugrel in Period 2 received 75 mg clopidogrel in Period 3|36
10475733|NCT01107912|11624477|FG003|STARTED|Period 3|Participants who received 75 mg clopidogrel in Period 2 received 5 mg prasugrel in Period 3|38
10475734|NCT01107912|11624478|FG004|STARTED|Period 3||0
10475735|NCT01107912|11624479|FG005|STARTED|Period 3|Participants who received 5 mg prasugrel in Period 2 received 75 mg clopidogrel in Period 3|41
10475736|NCT01107912|11624474|FG000|COMPLETED|Period 3||0
10475737|NCT01107912|11624475|FG001|COMPLETED|Period 3||34
10475738|NCT01107912|11624476|FG002|COMPLETED|Period 3||35
10475739|NCT01107912|11624477|FG003|COMPLETED|Period 3||37
10475740|NCT01107912|11624478|FG004|COMPLETED|Period 3||0
10475741|NCT01107912|11624479|FG005|COMPLETED|Period 3||41
10475742|NCT01107912|11624474|FG000|NOT COMPLETED|Period 3||0
10475743|NCT01107912|11624475|FG001|NOT COMPLETED|Period 3||1
10475744|NCT01107912|11624476|FG002|NOT COMPLETED|Period 3||1
10475745|NCT01107912|11624477|FG003|NOT COMPLETED|Period 3||1
10475746|NCT01107912|11624478|FG004|NOT COMPLETED|Period 3||0
10475747|NCT01107912|11624479|FG005|NOT COMPLETED|Period 3||0
10475748|NCT01107925|11624498|FG000|STARTED|Period 1-Randomization up Through Day 12||34
10475749|NCT01107925|11624499|FG001|STARTED|Period 1-Randomization up Through Day 12||0
10475750|NCT01107925|11624500|FG002|STARTED|Period 1-Randomization up Through Day 12||0
10475751|NCT01107925|11624501|FG003|STARTED|Period 1-Randomization up Through Day 12||0
10475752|NCT01107925|11624502|FG004|STARTED|Period 1-Randomization up Through Day 12||38
10475753|NCT01107925|11624503|FG005|STARTED|Period 1-Randomization up Through Day 12||0
10475754|NCT01107925|11624498|FG000|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||34
10475755|NCT01107925|11624499|FG001|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
10475756|NCT01107925|11624500|FG002|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
10475757|NCT01107925|11624501|FG003|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
10475758|NCT01107925|11624502|FG004|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||38
10475759|NCT01107925|11624503|FG005|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
10475760|NCT01107925|11624498|FG000|COMPLETED|Period 1-Randomization up Through Day 12||33
10475761|NCT01107925|11624499|FG001|COMPLETED|Period 1-Randomization up Through Day 12||0
10475762|NCT01107925|11624500|FG002|COMPLETED|Period 1-Randomization up Through Day 12||0
10475763|NCT01107925|11624501|FG003|COMPLETED|Period 1-Randomization up Through Day 12||0
10475764|NCT01107925|11624502|FG004|COMPLETED|Period 1-Randomization up Through Day 12||37
10475765|NCT01107925|11624503|FG005|COMPLETED|Period 1-Randomization up Through Day 12||0
10475766|NCT01107925|11624498|FG000|NOT COMPLETED|Period 1-Randomization up Through Day 12||1
10475767|NCT01107925|11624499|FG001|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
10475768|NCT01107925|11624500|FG002|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
10475769|NCT01107925|11624501|FG003|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
10475770|NCT01107925|11624502|FG004|NOT COMPLETED|Period 1-Randomization up Through Day 12||1
10475771|NCT01107925|11624503|FG005|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
10475772|NCT01107925|11624498|FG000|STARTED|Period 2|5 mg prasugrel (Period 1, LBW treatment) switched to 10 mg prasugrel or 75 mg clopidogrel (Period 2)|0
10475773|NCT01107925|11624499|FG001|STARTED|Period 2||16
10475774|NCT01107925|11624500|FG002|STARTED|Period 2||17
10475775|NCT01107925|11624501|FG003|STARTED|Period 2||20
10475776|NCT01107925|11624502|FG004|STARTED|Period 2|10 mg prasugrel (Period 1, HBW treatment) switched to 5 mg prasugrel or 75 mg clopidogrel (Period 2)|0
10475777|NCT01107925|11624503|FG005|STARTED|Period 2||17
10475778|NCT01107925|11624498|FG000|Took at Least 1 Dose of Study Drug|Period 2||0
10475779|NCT01107925|11624499|FG001|Took at Least 1 Dose of Study Drug|Period 2||16
10475780|NCT01107925|11624500|FG002|Took at Least 1 Dose of Study Drug|Period 2||17
10475781|NCT01107925|11624501|FG003|Took at Least 1 Dose of Study Drug|Period 2||20
10475782|NCT01107925|11624502|FG004|Took at Least 1 Dose of Study Drug|Period 2||0
10475783|NCT01107925|11624503|FG005|Took at Least 1 Dose of Study Drug|Period 2||17
10475784|NCT01107925|11624498|FG000|COMPLETED|Period 2||0
10475785|NCT01107925|11624499|FG001|COMPLETED|Period 2||15
10475786|NCT01107925|11624500|FG002|COMPLETED|Period 2||17
10475787|NCT01107925|11624501|FG003|COMPLETED|Period 2||20
10475788|NCT01107925|11624502|FG004|COMPLETED|Period 2||0
10475789|NCT01107925|11624503|FG005|COMPLETED|Period 2||16
10475790|NCT01107925|11624498|FG000|NOT COMPLETED|Period 2||0
10475791|NCT01107925|11624499|FG001|NOT COMPLETED|Period 2||1
10475792|NCT01107925|11624500|FG002|NOT COMPLETED|Period 2||0
10475793|NCT01107925|11624501|FG003|NOT COMPLETED|Period 2||0
10475794|NCT01107925|11624502|FG004|NOT COMPLETED|Period 2||0
10475795|NCT01107925|11624503|FG005|NOT COMPLETED|Period 2||1
10475796|NCT01107925|11624498|FG000|STARTED|Period 3||0
10475871|NCT01108237|11624603|FG001|NOT COMPLETED|Overall Study||17
10475797|NCT01107925|11624499|FG001|STARTED|Period 3|75 mg clopidogrel (Period 2, LBW treatment sequence) crossed over to 10 mg prasugrel (Period 3).|17
10475798|NCT01107925|11624500|FG002|STARTED|Period 3|10 mg prasugrel (Period 2, LBW treatment sequence) crossed over to 75 mg clopidogrel (Period 3).|15
10475799|NCT01107925|11624501|FG003|STARTED|Period 3|75 mg clopidogrel (Period 2, HBW treatment sequence) crossed over to 5 mg prasugrel (Period 3).|16
10475800|NCT01107925|11624502|FG004|STARTED|Period 3||0
10475801|NCT01107925|11624503|FG005|STARTED|Period 3|5 mg prasugrel (Period 2, HBW treatment sequence) crossed over to 75 mg clopidogrel (Period 3).|20
10475802|NCT01107925|11624498|FG000|Took at Least 1 Dose of Study Drug|Period 3||0
10475803|NCT01107925|11624499|FG001|Took at Least 1 Dose of Study Drug|Period 3||17
10475804|NCT01107925|11624500|FG002|Took at Least 1 Dose of Study Drug|Period 3||15
10475805|NCT01107925|11624501|FG003|Took at Least 1 Dose of Study Drug|Period 3||16
10475806|NCT01107925|11624502|FG004|Took at Least 1 Dose of Study Drug|Period 3||0
10475807|NCT01107925|11624503|FG005|Took at Least 1 Dose of Study Drug|Period 3||20
10475808|NCT01107925|11624498|FG000|COMPLETED|Period 3||0
10475809|NCT01107925|11624499|FG001|COMPLETED|Period 3||17
10475810|NCT01107925|11624500|FG002|COMPLETED|Period 3||15
10475811|NCT01107925|11624501|FG003|COMPLETED|Period 3||16
10709160|NCT02637141|11874065|FG000|STARTED|Overall Study||22
10709161|NCT02637141|11874066|FG001|STARTED|Overall Study||22
10709162|NCT02637141|11874067|FG002|STARTED|Overall Study||20
10709163|NCT02637141|11874065|FG000|Received Study Drug|Overall Study||22
10475812|NCT01107925|11624502|FG004|COMPLETED|Period 3||0
10475813|NCT01107925|11624503|FG005|COMPLETED|Period 3||20
10475814|NCT01107925|11624498|FG000|NOT COMPLETED|Period 3||0
10475815|NCT01107925|11624499|FG001|NOT COMPLETED|Period 3||0
10475816|NCT01107925|11624500|FG002|NOT COMPLETED|Period 3||0
10475817|NCT01107925|11624501|FG003|NOT COMPLETED|Period 3||0
10475818|NCT01107925|11624502|FG004|NOT COMPLETED|Period 3||0
10475819|NCT01107925|11624503|FG005|NOT COMPLETED|Period 3||0
10475820|NCT01107964|11624533|FG000|STARTED|Overall Study||13
10475821|NCT01107964|11624534|FG001|STARTED|Overall Study||14
10475822|NCT01107964|11624533|FG000|COMPLETED|Overall Study||12
10475823|NCT01107964|11624534|FG001|COMPLETED|Overall Study||13
10475824|NCT01107964|11624533|FG000|NOT COMPLETED|Overall Study||1
10475825|NCT01107964|11624534|FG001|NOT COMPLETED|Overall Study||1
10475826|NCT01108003|11624542|FG000|STARTED|Overall Study||4
10475827|NCT01108003|11624543|FG001|STARTED|Overall Study||3
10475828|NCT01108003|11624542|FG000|COMPLETED|Overall Study||4
10475829|NCT01108003|11624543|FG001|COMPLETED|Overall Study||3
10475830|NCT01108003|11624542|FG000|NOT COMPLETED|Overall Study||0
10475831|NCT01108003|11624543|FG001|NOT COMPLETED|Overall Study||0
10475832|NCT01108068|11624551|FG000|STARTED|Overall Study||10
10475833|NCT01108068|11624552|FG001|STARTED|Overall Study||16
10709164|NCT02637141|11874066|FG001|Received Study Drug|Overall Study||21
10709165|NCT02637141|11874067|FG002|Received Study Drug|Overall Study||19
10709166|NCT02637141|11874065|FG000|COMPLETED|Overall Study||20
10709167|NCT02637141|11874066|FG001|COMPLETED|Overall Study||20
10709168|NCT02637141|11874067|FG002|COMPLETED|Overall Study||19
10709169|NCT02637141|11874065|FG000|NOT COMPLETED|Overall Study||2
10709170|NCT02637141|11874066|FG001|NOT COMPLETED|Overall Study||2
10709171|NCT02637141|11874067|FG002|NOT COMPLETED|Overall Study||1
10475834|NCT01108068|11624551|FG000|COMPLETED|Overall Study|Only 5 individuals were recruited into the Lithium treatment arm|4
10475835|NCT01108068|11624552|FG001|COMPLETED|Overall Study||16
10475836|NCT01108068|11624551|FG000|NOT COMPLETED|Overall Study||6
10475837|NCT01108068|11624552|FG001|NOT COMPLETED|Overall Study||0
10475838|NCT01108081|11624563|FG000|STARTED|Overall Study||46
10475839|NCT01108081|11624564|FG001|STARTED|Overall Study||42
10475840|NCT01108081|11624565|FG002|STARTED|Overall Study||38
10475841|NCT01108081|11624566|FG003|STARTED|Overall Study||43
10475842|NCT01108081|11624563|FG000|COMPLETED|Overall Study||44
10475843|NCT01108081|11624564|FG001|COMPLETED|Overall Study||40
10475844|NCT01108081|11624565|FG002|COMPLETED|Overall Study||38
10475845|NCT01108081|11624566|FG003|COMPLETED|Overall Study||39
10475846|NCT01108081|11624563|FG000|NOT COMPLETED|Overall Study||2
10475847|NCT01108081|11624564|FG001|NOT COMPLETED|Overall Study||2
10475848|NCT01108081|11624565|FG002|NOT COMPLETED|Overall Study||0
10475849|NCT01108081|11624566|FG003|NOT COMPLETED|Overall Study||4
10475850|NCT01108094|11624580|FG000|STARTED|Overall Study||12
10475851|NCT01108094|11624581|FG001|STARTED|Overall Study||3
10475852|NCT01108094|11624582|FG002|STARTED|Overall Study||4
10475853|NCT01108094|11624583|FG003|STARTED|Overall Study||10
10475854|NCT01108094|11624580|FG000|COMPLETED|Overall Study||9
10475855|NCT01108094|11624581|FG001|COMPLETED|Overall Study||3
10475856|NCT01108094|11624582|FG002|COMPLETED|Overall Study||4
10475857|NCT01108094|11624583|FG003|COMPLETED|Overall Study||10
10475858|NCT01108094|11624580|FG000|NOT COMPLETED|Overall Study||3
10475859|NCT01108094|11624581|FG001|NOT COMPLETED|Overall Study||0
10475860|NCT01108094|11624582|FG002|NOT COMPLETED|Overall Study||0
10475861|NCT01108094|11624583|FG003|NOT COMPLETED|Overall Study||0
10475862|NCT01108185|11624596|FG000|STARTED|Overall Study||3181
10475863|NCT01108185|11624596|FG000|Per Protocol Population|Overall Study||3181
10475864|NCT01108185|11624596|FG000|COMPLETED|Overall Study||3154
10475865|NCT01108185|11624596|FG000|NOT COMPLETED|Overall Study||27
10475866|NCT01108237|11624602|FG000|STARTED|Overall Study|78 subjects were consented with intent to treat, however, 73 had surgery.|73
10475867|NCT01108237|11624603|FG001|STARTED|Overall Study||101
10475868|NCT01108237|11624602|FG000|COMPLETED|Overall Study|66 subjects underwent surgery per the protocol, however, only 64 met the primary end point.|64
10475869|NCT01108237|11624603|FG001|COMPLETED|Overall Study||84
10475870|NCT01108237|11624602|FG000|NOT COMPLETED|Overall Study||9
10475872|NCT01108263|11624611|FG000|STARTED|Overall Study||2
10475873|NCT01108263|11624612|FG001|STARTED|Overall Study||3
10475874|NCT01108263|11624611|FG000|COMPLETED|Overall Study||2
10475875|NCT01108263|11624612|FG001|COMPLETED|Overall Study||2
10475876|NCT01108263|11624611|FG000|NOT COMPLETED|Overall Study||0
10475877|NCT01108263|11624612|FG001|NOT COMPLETED|Overall Study||1
10475878|NCT01108341|11624618|FG000|STARTED|Overall Study||50
10475879|NCT01108341|11624618|FG000|Safety Set (Enrolled and Treated)|Overall Study||49
10475880|NCT01108341|11624618|FG000|COMPLETED|Overall Study||45
10475881|NCT01108341|11624618|FG000|NOT COMPLETED|Overall Study||5
10475882|NCT01108406|11624622|FG000|STARTED|Overall Study||22
10475883|NCT01108406|11624622|FG000|COMPLETED|Overall Study||22
10475884|NCT01108406|11624622|FG000|NOT COMPLETED|Overall Study||0
10475885|NCT01108445|11624630|FG000|STARTED|Overall Study||57
10475886|NCT01108445|11624631|FG001|STARTED|Overall Study||51
10475887|NCT01108445|11624630|FG000|COMPLETED|Overall Study||1
10475888|NCT01108445|11624631|FG001|COMPLETED|Overall Study||2
10475889|NCT01108445|11624630|FG000|NOT COMPLETED|Overall Study||56
10475890|NCT01108445|11624631|FG001|NOT COMPLETED|Overall Study||49
10475891|NCT01108458|11624637|FG000|STARTED|Overall Study||1
10475892|NCT01108458|11624637|FG000|COMPLETED|Overall Study||0
10475893|NCT01108458|11624637|FG000|NOT COMPLETED|Overall Study||1
10475894|NCT01108510|11624643|FG000|STARTED|Overall Study||349
10709172|NCT02637232|11874075|FG000|STARTED|Overall Study||301
10709173|NCT02637232|11874075|FG000|COMPLETED|Overall Study||246
10475895|NCT01108510|11624644|FG001|STARTED|Overall Study||349
10475896|NCT01108510|11624643|FG000|COMPLETED|Overall Study||70
10475897|NCT01108510|11624644|FG001|COMPLETED|Overall Study||81
10475898|NCT01108510|11624643|FG000|NOT COMPLETED|Overall Study||279
10475899|NCT01108510|11624644|FG001|NOT COMPLETED|Overall Study||268
10475900|NCT01108718|11624652|FG000|STARTED|Received First Intervention (2 Months)||5
10475901|NCT01108718|11624653|FG001|STARTED|Received First Intervention (2 Months)||7
10475902|NCT01108718|11624652|FG000|COMPLETED|Received First Intervention (2 Months)||5
10475903|NCT01108718|11624653|FG001|COMPLETED|Received First Intervention (2 Months)||7
10475904|NCT01108718|11624652|FG000|NOT COMPLETED|Received First Intervention (2 Months)||0
10475905|NCT01108718|11624653|FG001|NOT COMPLETED|Received First Intervention (2 Months)||0
10526889|NCT01385137|11678810|FG001|NOT COMPLETED|Evaluable at Baseline||4
10475906|NCT01108718|11624652|FG000|STARTED|Received Second Intervention (2 Months)|Used control mattress was delivered to participant at crossover causing her to withdraw.|5
10475907|NCT01108718|11624653|FG001|STARTED|Received Second Intervention (2 Months)||7
10475908|NCT01108718|11624652|FG000|COMPLETED|Received Second Intervention (2 Months)||4
10475909|NCT01108718|11624653|FG001|COMPLETED|Received Second Intervention (2 Months)||7
10475910|NCT01108718|11624652|FG000|NOT COMPLETED|Received Second Intervention (2 Months)||1
10475911|NCT01108718|11624653|FG001|NOT COMPLETED|Received Second Intervention (2 Months)||0
10475912|NCT01108731|11624660|FG000|STARTED|Overall Study||17
10475913|NCT01108731|11624661|FG001|STARTED|Overall Study||17
10475914|NCT01108731|11624660|FG000|COMPLETED|Overall Study||13
10475915|NCT01108731|11624661|FG001|COMPLETED|Overall Study||13
10475916|NCT01108731|11624660|FG000|NOT COMPLETED|Overall Study||4
10475917|NCT01108731|11624661|FG001|NOT COMPLETED|Overall Study||4
10475918|NCT01108757|11624669|FG000|STARTED|Overall Study||26
10475919|NCT01108757|11624670|FG001|STARTED|Overall Study||26
10475920|NCT01108757|11624669|FG000|COMPLETED|Overall Study||26
10475921|NCT01108757|11624670|FG001|COMPLETED|Overall Study||26
10475922|NCT01108757|11624669|FG000|NOT COMPLETED|Overall Study||0
10475923|NCT01108757|11624670|FG001|NOT COMPLETED|Overall Study||0
10475924|NCT01108796|11624680|FG000|STARTED|Overall Study||774
10475925|NCT01108796|11624681|FG001|STARTED|Overall Study||1067
10475926|NCT01108796|11624680|FG000|COMPLETED|Overall Study||767
10475927|NCT01108796|11624681|FG001|COMPLETED|Overall Study||1060
10475928|NCT01108796|11624680|FG000|NOT COMPLETED|Overall Study||7
10475929|NCT01108796|11624681|FG001|NOT COMPLETED|Overall Study||7
10475930|NCT01108809|11624689|FG000|STARTED|Overall Study||295
10475931|NCT01108809|11624689|FG000|COMPLETED|Overall Study||291
10475932|NCT01108809|11624689|FG000|NOT COMPLETED|Overall Study||4
10475933|NCT01108835|11624696|FG000|STARTED|Overall Study||90
10475934|NCT01108835|11624697|FG001|STARTED|Overall Study||90
10475935|NCT01108835|11624696|FG000|COMPLETED|Overall Study||73
10475936|NCT01108835|11624697|FG001|COMPLETED|Overall Study||69
10475937|NCT01108835|11624696|FG000|NOT COMPLETED|Overall Study||17
10475938|NCT01108835|11624697|FG001|NOT COMPLETED|Overall Study||21
10475939|NCT01109056|11624706|FG000|STARTED|Overall Study||57
10475940|NCT01109056|11624707|FG001|STARTED|Overall Study||58
10475941|NCT01109056|11624706|FG000|COMPLETED|Overall Study||50
10475942|NCT01109056|11624707|FG001|COMPLETED|Overall Study||53
10475943|NCT01109056|11624706|FG000|NOT COMPLETED|Overall Study||7
10475944|NCT01109056|11624707|FG001|NOT COMPLETED|Overall Study||5
10475945|NCT01109069|11624713|FG000|STARTED|Overall Study||199
10475946|NCT01109069|11624713|FG000|COMPLETED|Overall Study||106
10475947|NCT01109069|11624713|FG000|NOT COMPLETED|Overall Study||93
10475948|NCT01109108|11624720|FG000|STARTED|Overall Study||4035
10475949|NCT01109108|11624721|FG001|STARTED|Overall Study||4755
10475950|NCT01109108|11624720|FG000|COMPLETED|Overall Study||4035
10475951|NCT01109108|11624721|FG001|COMPLETED|Overall Study||4755
10709174|NCT02637232|11874075|FG000|NOT COMPLETED|Overall Study||55
10475952|NCT01109108|11624720|FG000|NOT COMPLETED|Overall Study||0
10475953|NCT01109108|11624721|FG001|NOT COMPLETED|Overall Study||0
10475954|NCT01109147|11624730|FG000|STARTED|Overall Study||17
10475955|NCT01109147|11624731|FG001|STARTED|Overall Study||14
10475956|NCT01109147|11624732|FG002|STARTED|Overall Study||36
10475957|NCT01109147|11624730|FG000|COMPLETED|Overall Study|2 have been excluded of the results|15
10475958|NCT01109147|11624731|FG001|COMPLETED|Overall Study|3 have been excluded of the results|11
10475959|NCT01109147|11624732|FG002|COMPLETED|Overall Study|10 have been excluded of the results|26
10475960|NCT01109147|11624730|FG000|NOT COMPLETED|Overall Study||2
10475961|NCT01109147|11624731|FG001|NOT COMPLETED|Overall Study||3
10475962|NCT01109147|11624732|FG002|NOT COMPLETED|Overall Study||10
10475963|NCT01109173|11624744|FG000|STARTED|Overall Study||851
10475964|NCT01109173|11624745|FG001|STARTED|Overall Study||845
10475965|NCT01109173|11624746|FG002|STARTED|Overall Study||211
10475966|NCT01109173|11624747|FG003|STARTED|Overall Study||213
10475967|NCT01109173|11624744|FG000|COMPLETED|Overall Study||763
10475968|NCT01109173|11624745|FG001|COMPLETED|Overall Study||759
10475969|NCT01109173|11624746|FG002|COMPLETED|Overall Study||110
10475970|NCT01109173|11624747|FG003|COMPLETED|Overall Study||120
10475971|NCT01109173|11624744|FG000|NOT COMPLETED|Overall Study||88
10475972|NCT01109173|11624745|FG001|NOT COMPLETED|Overall Study||86
10475973|NCT01109173|11624746|FG002|NOT COMPLETED|Overall Study||101
10475974|NCT01109173|11624747|FG003|NOT COMPLETED|Overall Study||93
10475975|NCT01109316|11624763|FG000|STARTED|Study Period 1||22
10475976|NCT01109316|11624764|FG001|STARTED|Study Period 1||22
10475977|NCT01109316|11624765|FG002|STARTED|Study Period 1||22
10475978|NCT01109316|11624766|FG003|STARTED|Study Period 1||22
10475979|NCT01109316|11624767|FG004|STARTED|Study Period 1||22
10475980|NCT01109316|11624768|FG005|STARTED|Study Period 1||22
10475981|NCT01109316|11624763|FG000|Received at Least One Dose of Study Drug|Study Period 1||22
10475982|NCT01109316|11624764|FG001|Received at Least One Dose of Study Drug|Study Period 1||22
10475983|NCT01109316|11624765|FG002|Received at Least One Dose of Study Drug|Study Period 1||22
10475984|NCT01109316|11624766|FG003|Received at Least One Dose of Study Drug|Study Period 1||22
10475985|NCT01109316|11624767|FG004|Received at Least One Dose of Study Drug|Study Period 1||22
10475986|NCT01109316|11624768|FG005|Received at Least One Dose of Study Drug|Study Period 1||20
10475987|NCT01109316|11624763|FG000|COMPLETED|Study Period 1||22
10475988|NCT01109316|11624764|FG001|COMPLETED|Study Period 1||22
10475989|NCT01109316|11624765|FG002|COMPLETED|Study Period 1||19
10475990|NCT01109316|11624766|FG003|COMPLETED|Study Period 1||21
10475991|NCT01109316|11624767|FG004|COMPLETED|Study Period 1||20
10475992|NCT01109316|11624768|FG005|COMPLETED|Study Period 1||20
10475993|NCT01109316|11624763|FG000|NOT COMPLETED|Study Period 1||0
10475994|NCT01109316|11624764|FG001|NOT COMPLETED|Study Period 1||0
10475995|NCT01109316|11624765|FG002|NOT COMPLETED|Study Period 1||3
10475996|NCT01109316|11624766|FG003|NOT COMPLETED|Study Period 1||1
10475997|NCT01109316|11624767|FG004|NOT COMPLETED|Study Period 1||2
10475998|NCT01109316|11624768|FG005|NOT COMPLETED|Study Period 1||2
10475999|NCT01109316|11624763|FG000|STARTED|Study Period 2||22
10476000|NCT01109316|11624764|FG001|STARTED|Study Period 2||22
10476001|NCT01109316|11624765|FG002|STARTED|Study Period 2||19
10476002|NCT01109316|11624766|FG003|STARTED|Study Period 2||21
10476003|NCT01109316|11624767|FG004|STARTED|Study Period 2||20
10476004|NCT01109316|11624768|FG005|STARTED|Study Period 2||20
10476005|NCT01109316|11624763|FG000|COMPLETED|Study Period 2||21
10476006|NCT01109316|11624764|FG001|COMPLETED|Study Period 2||21
10476007|NCT01109316|11624765|FG002|COMPLETED|Study Period 2||18
10476008|NCT01109316|11624766|FG003|COMPLETED|Study Period 2||20
10476009|NCT01109316|11624767|FG004|COMPLETED|Study Period 2||20
10476010|NCT01109316|11624768|FG005|COMPLETED|Study Period 2||19
10476011|NCT01109316|11624763|FG000|NOT COMPLETED|Study Period 2||1
10476012|NCT01109316|11624764|FG001|NOT COMPLETED|Study Period 2||1
10476013|NCT01109316|11624765|FG002|NOT COMPLETED|Study Period 2||1
10476014|NCT01109316|11624766|FG003|NOT COMPLETED|Study Period 2||1
10476015|NCT01109316|11624767|FG004|NOT COMPLETED|Study Period 2||0
10476016|NCT01109316|11624768|FG005|NOT COMPLETED|Study Period 2||1
10476017|NCT01109316|11624763|FG000|STARTED|Study Period 3||21
10476018|NCT01109316|11624764|FG001|STARTED|Study Period 3||21
10476019|NCT01109316|11624765|FG002|STARTED|Study Period 3||18
10476020|NCT01109316|11624766|FG003|STARTED|Study Period 3||20
10476021|NCT01109316|11624767|FG004|STARTED|Study Period 3||20
10476022|NCT01109316|11624768|FG005|STARTED|Study Period 3||19
10476023|NCT01109316|11624763|FG000|COMPLETED|Study Period 3||20
10476024|NCT01109316|11624764|FG001|COMPLETED|Study Period 3||21
10476025|NCT01109316|11624765|FG002|COMPLETED|Study Period 3||18
10476026|NCT01109316|11624766|FG003|COMPLETED|Study Period 3||20
10476027|NCT01109316|11624767|FG004|COMPLETED|Study Period 3||18
10476028|NCT01109316|11624768|FG005|COMPLETED|Study Period 3||19
10476029|NCT01109316|11624763|FG000|NOT COMPLETED|Study Period 3||1
10476030|NCT01109316|11624764|FG001|NOT COMPLETED|Study Period 3||0
10476031|NCT01109316|11624765|FG002|NOT COMPLETED|Study Period 3||0
10476032|NCT01109316|11624766|FG003|NOT COMPLETED|Study Period 3||0
10476033|NCT01109316|11624767|FG004|NOT COMPLETED|Study Period 3||2
10476034|NCT01109316|11624768|FG005|NOT COMPLETED|Study Period 3||0
10476035|NCT01109381|11624776|FG000|STARTED|Overall Study||33
10476036|NCT01109381|11624776|FG000|COMPLETED|Overall Study||31
10476037|NCT01109381|11624776|FG000|NOT COMPLETED|Overall Study||2
10476038|NCT01109524|11624782|FG000|STARTED|Overall Study||60
10476039|NCT01109524|11624782|FG000|COMPLETED|Overall Study||3
10476040|NCT01109524|11624782|FG000|NOT COMPLETED|Overall Study||57
10526890|NCT01385137|11678809|FG000|STARTED|Evaluable for Primary Endpoint||131
10526891|NCT01385137|11678810|FG001|STARTED|Evaluable for Primary Endpoint||131
10526892|NCT01385137|11678809|FG000|COMPLETED|Evaluable for Primary Endpoint||102
10526893|NCT01385137|11678810|FG001|COMPLETED|Evaluable for Primary Endpoint||107
10526894|NCT01385137|11678809|FG000|NOT COMPLETED|Evaluable for Primary Endpoint||29
10526895|NCT01385137|11678810|FG001|NOT COMPLETED|Evaluable for Primary Endpoint||24
10526896|NCT01385189|11678821|FG000|STARTED|Overall Study||12
10526897|NCT01385189|11678822|FG001|STARTED|Overall Study||12
10526898|NCT01385189|11678823|FG002|STARTED|Overall Study||4
10526899|NCT01385189|11678824|FG003|STARTED|Overall Study||4
10526900|NCT01385189|11678825|FG004|STARTED|Overall Study||8
10526901|NCT01385189|11678821|FG000|COMPLETED|Overall Study||11
10526902|NCT01385189|11678822|FG001|COMPLETED|Overall Study||11
10526903|NCT01385189|11678823|FG002|COMPLETED|Overall Study||4
10526904|NCT01385189|11678824|FG003|COMPLETED|Overall Study||3
10526905|NCT01385189|11678825|FG004|COMPLETED|Overall Study||6
10526906|NCT01385189|11678821|FG000|NOT COMPLETED|Overall Study||1
10526907|NCT01385189|11678822|FG001|NOT COMPLETED|Overall Study||1
10526908|NCT01385189|11678823|FG002|NOT COMPLETED|Overall Study||0
10526909|NCT01385189|11678824|FG003|NOT COMPLETED|Overall Study||1
10526910|NCT01385189|11678825|FG004|NOT COMPLETED|Overall Study||2
10526911|NCT01385202|11678844|FG000|STARTED|Overall Study|Per protocol, enrolled subjects were defined as those who signed inform consent form.|172
10526912|NCT01385202|11678844|FG000|Study Catheter Inserted|Overall Study||161
10526913|NCT01385202|11678844|FG000|Undergoing Ablation|Overall Study||160
10526914|NCT01385202|11678844|FG000|COMPLETED|Overall Study||154
10526915|NCT01385202|11678844|FG000|NOT COMPLETED|Overall Study||18
10526916|NCT01385293|11678850|FG000|STARTED|Overall Study||30
10526917|NCT01385293|11678850|FG000|COMPLETED|Overall Study||30
10526918|NCT01385293|11678850|FG000|NOT COMPLETED|Overall Study||0
10526919|NCT01385306|11678854|FG000|STARTED|Overall Study||6
10526920|NCT01385306|11678854|FG000|COMPLETED|Overall Study||6
10526921|NCT01385306|11678854|FG000|NOT COMPLETED|Overall Study||0
10526922|NCT01385371|11678860|FG000|STARTED|Overall Study||752
10526923|NCT01385371|11678861|FG001|STARTED|Overall Study||749
10526924|NCT01385371|11678860|FG000|COMPLETED|Overall Study||603
10526925|NCT01385371|11678861|FG001|COMPLETED|Overall Study||652
10526926|NCT01385371|11678860|FG000|NOT COMPLETED|Overall Study||149
10526927|NCT01385371|11678861|FG001|NOT COMPLETED|Overall Study||97
10476041|NCT01109576|11624786|FG000|STARTED|Overall Study||13
10476042|NCT01109576|11624786|FG000|COMPLETED|Overall Study||12
10476043|NCT01109576|11624786|FG000|NOT COMPLETED|Overall Study||1
10476044|NCT01109602|11624793|FG000|STARTED|Overall Study||14
10476045|NCT01109602|11624794|FG001|STARTED|Overall Study||23
10476046|NCT01109602|11624795|FG002|STARTED|Overall Study||10
10476047|NCT01109602|11624793|FG000|COMPLETED|Overall Study||13
10476048|NCT01109602|11624794|FG001|COMPLETED|Overall Study||21
10476049|NCT01109602|11624795|FG002|COMPLETED|Overall Study||9
10476050|NCT01109602|11624793|FG000|NOT COMPLETED|Overall Study||1
10476051|NCT01109602|11624794|FG001|NOT COMPLETED|Overall Study||2
10476052|NCT01109602|11624795|FG002|NOT COMPLETED|Overall Study||1
10476053|NCT01109849|11624804|FG000|STARTED|Initial Randomization: ADHD Treatment||50
10476054|NCT01109849|11624805|FG001|STARTED|Initial Randomization: ADHD Treatment||180
10476055|NCT01109849|11624806|FG002|STARTED|Initial Randomization: ADHD Treatment||0
10476056|NCT01109849|11624807|FG003|STARTED|Initial Randomization: ADHD Treatment||0
10476057|NCT01109849|11624808|FG004|STARTED|Initial Randomization: ADHD Treatment||0
10476058|NCT01109849|11624804|FG000|COMPLETED|Initial Randomization: ADHD Treatment||32
10476059|NCT01109849|11624805|FG001|COMPLETED|Initial Randomization: ADHD Treatment||131
10476060|NCT01109849|11624806|FG002|COMPLETED|Initial Randomization: ADHD Treatment||0
10476061|NCT01109849|11624807|FG003|COMPLETED|Initial Randomization: ADHD Treatment||0
10476062|NCT01109849|11624808|FG004|COMPLETED|Initial Randomization: ADHD Treatment||0
10476063|NCT01109849|11624804|FG000|NOT COMPLETED|Initial Randomization: ADHD Treatment||18
10476064|NCT01109849|11624805|FG001|NOT COMPLETED|Initial Randomization: ADHD Treatment||49
10476065|NCT01109849|11624806|FG002|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
10476066|NCT01109849|11624807|FG003|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
10476067|NCT01109849|11624808|FG004|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
10476068|NCT01109849|11624804|FG000|STARTED|Adaptive Randomization: Weight Recovery||0
10476069|NCT01109849|11624805|FG001|STARTED|Adaptive Randomization: Weight Recovery||0
10476070|NCT01109849|11624806|FG002|STARTED|Adaptive Randomization: Weight Recovery||24
10476071|NCT01109849|11624807|FG003|STARTED|Adaptive Randomization: Weight Recovery||23
10476072|NCT01109849|11624808|FG004|STARTED|Adaptive Randomization: Weight Recovery||25
10476073|NCT01109849|11624804|FG000|COMPLETED|Adaptive Randomization: Weight Recovery||0
10476074|NCT01109849|11624805|FG001|COMPLETED|Adaptive Randomization: Weight Recovery||0
10476075|NCT01109849|11624806|FG002|COMPLETED|Adaptive Randomization: Weight Recovery||23
10476076|NCT01109849|11624807|FG003|COMPLETED|Adaptive Randomization: Weight Recovery||20
10476077|NCT01109849|11624808|FG004|COMPLETED|Adaptive Randomization: Weight Recovery||24
10476078|NCT01109849|11624804|FG000|NOT COMPLETED|Adaptive Randomization: Weight Recovery||0
10476079|NCT01109849|11624805|FG001|NOT COMPLETED|Adaptive Randomization: Weight Recovery||0
10476080|NCT01109849|11624806|FG002|NOT COMPLETED|Adaptive Randomization: Weight Recovery||1
10476081|NCT01109849|11624807|FG003|NOT COMPLETED|Adaptive Randomization: Weight Recovery||3
10476082|NCT01109849|11624808|FG004|NOT COMPLETED|Adaptive Randomization: Weight Recovery||1
10476083|NCT01109940|11624832|FG000|STARTED|Overall Study||21
10476084|NCT01109940|11624833|FG001|STARTED|Overall Study||8
10476085|NCT01109940|11624834|FG002|STARTED|Overall Study||7
10476086|NCT01109940|11624835|FG003|STARTED|Overall Study||3
10476087|NCT01109940|11624832|FG000|COMPLETED|Overall Study||13
10476088|NCT01109940|11624833|FG001|COMPLETED|Overall Study||6
10476089|NCT01109940|11624834|FG002|COMPLETED|Overall Study||6
10476090|NCT01109940|11624835|FG003|COMPLETED|Overall Study||3
10476091|NCT01109940|11624832|FG000|NOT COMPLETED|Overall Study||8
10476092|NCT01109940|11624833|FG001|NOT COMPLETED|Overall Study||2
10476093|NCT01109940|11624834|FG002|NOT COMPLETED|Overall Study||1
10476094|NCT01109940|11624835|FG003|NOT COMPLETED|Overall Study||0
10476095|NCT01109979|11624847|FG000|STARTED|Overall Study||12
10476096|NCT01109979|11624848|FG001|STARTED|Overall Study||12
10476097|NCT01109979|11624847|FG000|COMPLETED|Overall Study||10
10476098|NCT01109979|11624848|FG001|COMPLETED|Overall Study||11
10476099|NCT01109979|11624847|FG000|NOT COMPLETED|Overall Study||2
10476100|NCT01109979|11624848|FG001|NOT COMPLETED|Overall Study||1
10476101|NCT01109992|11624856|FG000|STARTED|Overall Study||11
10476102|NCT01109992|11624857|FG001|STARTED|Overall Study||32
10476103|NCT01109992|11624856|FG000|Subjects Enrolled|Overall Study||11
10476104|NCT01109992|11624857|FG001|Subjects Enrolled|Overall Study||32
10476105|NCT01109992|11624856|FG000|COMPLETED|Overall Study||11
10476106|NCT01109992|11624857|FG001|COMPLETED|Overall Study||30
10476107|NCT01109992|11624856|FG000|NOT COMPLETED|Overall Study||0
10476108|NCT01109992|11624857|FG001|NOT COMPLETED|Overall Study||2
10476109|NCT01110005|11624868|FG000|STARTED|Overall Study||157
10476110|NCT01110005|11624869|FG001|STARTED|Overall Study||161
10476111|NCT01110005|11624868|FG000|COMPLETED|Overall Study||153
10476112|NCT01110005|11624869|FG001|COMPLETED|Overall Study||156
10476113|NCT01110005|11624868|FG000|NOT COMPLETED|Overall Study||4
10476114|NCT01110005|11624869|FG001|NOT COMPLETED|Overall Study||5
10476115|NCT01110135|11624875|FG000|STARTED|Overall Study||43
10476116|NCT01110135|11624875|FG000|COMPLETED|Overall Study||34
10476117|NCT01110135|11624875|FG000|NOT COMPLETED|Overall Study||9
10476118|NCT01110187|11624881|FG000|STARTED|Overall Study||7
10476119|NCT01110187|11624882|FG001|STARTED|Overall Study||4
10476120|NCT01110187|11624881|FG000|COMPLETED|Overall Study|completed 7 day treatment|7
10476121|NCT01110187|11624882|FG001|COMPLETED|Overall Study|completed 7 day treatment|4
10476122|NCT01110187|11624881|FG000|NOT COMPLETED|Overall Study||0
10476123|NCT01110187|11624882|FG001|NOT COMPLETED|Overall Study||0
10476124|NCT01110200|11624892|FG000|STARTED|Overall Study||314
10476125|NCT01110200|11624893|FG001|STARTED|Overall Study||325
10476126|NCT01110200|11624892|FG000|COMPLETED|Overall Study||208
10476127|NCT01110200|11624893|FG001|COMPLETED|Overall Study||204
10476128|NCT01110200|11624892|FG000|NOT COMPLETED|Overall Study||106
10476129|NCT01110200|11624893|FG001|NOT COMPLETED|Overall Study||121
10476130|NCT01110239|11624903|FG000|STARTED|Sham Preconditioning||7
10476131|NCT01110239|11624904|FG001|STARTED|Sham Preconditioning||14
10476132|NCT01110239|11624905|FG002|STARTED|Sham Preconditioning||7
10476133|NCT01110239|11624906|FG003|STARTED|Sham Preconditioning||6
10476134|NCT01110239|11624903|FG000|COMPLETED|Sham Preconditioning||7
10476135|NCT01110239|11624904|FG001|COMPLETED|Sham Preconditioning||14
10476136|NCT01110239|11624905|FG002|COMPLETED|Sham Preconditioning||6
10476137|NCT01110239|11624906|FG003|COMPLETED|Sham Preconditioning||6
10476138|NCT01110239|11624903|FG000|NOT COMPLETED|Sham Preconditioning||0
10476139|NCT01110239|11624904|FG001|NOT COMPLETED|Sham Preconditioning||0
10476140|NCT01110239|11624905|FG002|NOT COMPLETED|Sham Preconditioning||1
10476141|NCT01110239|11624906|FG003|NOT COMPLETED|Sham Preconditioning||0
10476142|NCT01110239|11624903|FG000|STARTED|5 Min Ischemia||0
10476143|NCT01110239|11624904|FG001|STARTED|5 Min Ischemia||14
10476144|NCT01110239|11624905|FG002|STARTED|5 Min Ischemia||0
10476145|NCT01110239|11624906|FG003|STARTED|5 Min Ischemia||0
10476146|NCT01110239|11624903|FG000|COMPLETED|5 Min Ischemia||0
10476147|NCT01110239|11624904|FG001|COMPLETED|5 Min Ischemia||0
10476148|NCT01110239|11624905|FG002|COMPLETED|5 Min Ischemia||0
10476149|NCT01110239|11624906|FG003|COMPLETED|5 Min Ischemia||0
10476150|NCT01110239|11624903|FG000|NOT COMPLETED|5 Min Ischemia||0
10476151|NCT01110239|11624904|FG001|NOT COMPLETED|5 Min Ischemia||14
10476152|NCT01110239|11624905|FG002|NOT COMPLETED|5 Min Ischemia||0
10476153|NCT01110239|11624906|FG003|NOT COMPLETED|5 Min Ischemia||0
10476154|NCT01110239|11624903|FG000|STARTED|7.5 Min Ischemia||0
10476155|NCT01110239|11624904|FG001|STARTED|7.5 Min Ischemia||0
10476156|NCT01110239|11624905|FG002|STARTED|7.5 Min Ischemia||7
10476157|NCT01110239|11624906|FG003|STARTED|7.5 Min Ischemia||0
10476158|NCT01110239|11624903|FG000|COMPLETED|7.5 Min Ischemia||0
10476159|NCT01110239|11624904|FG001|COMPLETED|7.5 Min Ischemia||0
10476160|NCT01110239|11624905|FG002|COMPLETED|7.5 Min Ischemia||6
10476161|NCT01110239|11624906|FG003|COMPLETED|7.5 Min Ischemia||0
10476162|NCT01110239|11624903|FG000|NOT COMPLETED|7.5 Min Ischemia||0
10476163|NCT01110239|11624904|FG001|NOT COMPLETED|7.5 Min Ischemia||0
10476164|NCT01110239|11624905|FG002|NOT COMPLETED|7.5 Min Ischemia||1
10476165|NCT01110239|11624906|FG003|NOT COMPLETED|7.5 Min Ischemia||0
10476166|NCT01110239|11624903|FG000|STARTED|10 Min Ischemia||0
10476167|NCT01110239|11624904|FG001|STARTED|10 Min Ischemia||0
10476168|NCT01110239|11624905|FG002|STARTED|10 Min Ischemia||0
10476169|NCT01110239|11624906|FG003|STARTED|10 Min Ischemia||6
10476170|NCT01110239|11624903|FG000|COMPLETED|10 Min Ischemia||0
10476171|NCT01110239|11624904|FG001|COMPLETED|10 Min Ischemia||0
10476172|NCT01110239|11624905|FG002|COMPLETED|10 Min Ischemia||0
10476173|NCT01110239|11624906|FG003|COMPLETED|10 Min Ischemia||6
10476174|NCT01110239|11624903|FG000|NOT COMPLETED|10 Min Ischemia||0
10476175|NCT01110239|11624904|FG001|NOT COMPLETED|10 Min Ischemia||0
10476176|NCT01110239|11624905|FG002|NOT COMPLETED|10 Min Ischemia||0
10476177|NCT01110239|11624906|FG003|NOT COMPLETED|10 Min Ischemia||0
10476178|NCT01110252|11624917|FG000|STARTED|Pre-procedure (Stem Cells Infusion)||4
10476179|NCT01110252|11624917|FG000|COMPLETED|Pre-procedure (Stem Cells Infusion)||4
10476180|NCT01110252|11624917|FG000|NOT COMPLETED|Pre-procedure (Stem Cells Infusion)||0
10476181|NCT01110252|11624917|FG000|STARTED|Post-procedure (Stem Cells Infusion)||4
10476182|NCT01110252|11624917|FG000|COMPLETED|Post-procedure (Stem Cells Infusion)||4
10476183|NCT01110252|11624917|FG000|NOT COMPLETED|Post-procedure (Stem Cells Infusion)||0
10476184|NCT01110330|11624925|FG000|STARTED|Overall Study||119
10476185|NCT01110330|11624926|FG001|STARTED|Overall Study||230
10476186|NCT01110330|11624927|FG002|STARTED|Overall Study||234
10476187|NCT01110330|11624925|FG000|Positive Baseline Culture Set|Overall Study||56
10476188|NCT01110330|11624926|FG001|Positive Baseline Culture Set|Overall Study||111
10476189|NCT01110330|11624927|FG002|Positive Baseline Culture Set|Overall Study||114
10476190|NCT01110330|11624925|FG000|COMPLETED|Overall Study||104
10476191|NCT01110330|11624926|FG001|COMPLETED|Overall Study||207
10476192|NCT01110330|11624927|FG002|COMPLETED|Overall Study||208
10476193|NCT01110330|11624925|FG000|NOT COMPLETED|Overall Study||15
10476194|NCT01110330|11624926|FG001|NOT COMPLETED|Overall Study||23
10476195|NCT01110330|11624927|FG002|NOT COMPLETED|Overall Study||26
10476196|NCT01110382|11624937|FG000|STARTED|Overall Study||31
10476197|NCT01110382|11624938|FG001|STARTED|Overall Study||10
10476198|NCT01110382|11624937|FG000|COMPLETED|Overall Study||31
10476199|NCT01110382|11624938|FG001|COMPLETED|Overall Study||8
10476200|NCT01110382|11624937|FG000|NOT COMPLETED|Overall Study||0
10476201|NCT01110382|11624938|FG001|NOT COMPLETED|Overall Study||2
10476202|NCT01110395|11624944|FG000|STARTED|Overall Study||15
10476203|NCT01110395|11624944|FG000|COMPLETED|Overall Study||15
10476204|NCT01110395|11624944|FG000|NOT COMPLETED|Overall Study||0
10476205|NCT01110408|11624950|FG000|STARTED|Overall Study||31
10476206|NCT01110408|11624951|FG001|STARTED|Overall Study||10
10476207|NCT01110408|11624950|FG000|COMPLETED|Overall Study||30
10476208|NCT01110408|11624951|FG001|COMPLETED|Overall Study||10
10476209|NCT01110408|11624950|FG000|NOT COMPLETED|Overall Study||1
10476210|NCT01110408|11624951|FG001|NOT COMPLETED|Overall Study||0
10476211|NCT01110421|11624959|FG000|STARTED|Overall Study||5
10476212|NCT01110421|11624960|FG001|STARTED|Overall Study||2
10526928|NCT01385566|11678873|FG000|STARTED|Overall Study||52
10526929|NCT01385566|11678874|FG001|STARTED|Overall Study||34
10476213|NCT01110421|11624959|FG000|COMPLETED|Overall Study|Includes 1 participant who discontinued study drug due to an adverse event of empyema on Days 9-13.|5
10476214|NCT01110421|11624960|FG001|COMPLETED|Overall Study||2
10476215|NCT01110421|11624959|FG000|NOT COMPLETED|Overall Study||0
10476216|NCT01110421|11624960|FG001|NOT COMPLETED|Overall Study||0
10476217|NCT01110434|11624968|FG000|STARTED|Overall Study||40
10476218|NCT01110434|11624969|FG001|STARTED|Overall Study||26
10476219|NCT01110434|11624968|FG000|COMPLETED|Overall Study||29
10476220|NCT01110434|11624969|FG001|COMPLETED|Overall Study||20
10476221|NCT01110434|11624968|FG000|NOT COMPLETED|Overall Study||11
10476222|NCT01110434|11624969|FG001|NOT COMPLETED|Overall Study||6
10476223|NCT01110499|11624983|FG000|STARTED|Overall Study||14
10476224|NCT01110499|11624984|FG001|STARTED|Overall Study||14
10476225|NCT01110499|11624985|FG002|STARTED|Overall Study||14
10476226|NCT01110499|11624986|FG003|STARTED|Overall Study||14
10476227|NCT01110499|11624987|FG004|STARTED|Overall Study||14
10476228|NCT01110499|11624988|FG005|STARTED|Overall Study||14
10476229|NCT01110499|11624989|FG006|STARTED|Overall Study||39
10476230|NCT01110499|11624990|FG007|STARTED|Overall Study||40
10476231|NCT01110499|11624983|FG000|COMPLETED|Overall Study||14
10476232|NCT01110499|11624984|FG001|COMPLETED|Overall Study||14
10476233|NCT01110499|11624985|FG002|COMPLETED|Overall Study||14
10476234|NCT01110499|11624986|FG003|COMPLETED|Overall Study||14
10476235|NCT01110499|11624987|FG004|COMPLETED|Overall Study||14
10476236|NCT01110499|11624988|FG005|COMPLETED|Overall Study||14
10476237|NCT01110499|11624989|FG006|COMPLETED|Overall Study||39
10476238|NCT01110499|11624990|FG007|COMPLETED|Overall Study||40
10476239|NCT01110499|11624983|FG000|NOT COMPLETED|Overall Study||0
10476240|NCT01110499|11624984|FG001|NOT COMPLETED|Overall Study||0
10476241|NCT01110499|11624985|FG002|NOT COMPLETED|Overall Study||0
10476242|NCT01110499|11624986|FG003|NOT COMPLETED|Overall Study||0
10476243|NCT01110499|11624987|FG004|NOT COMPLETED|Overall Study||0
10476244|NCT01110499|11624988|FG005|NOT COMPLETED|Overall Study||0
10476245|NCT01110499|11624989|FG006|NOT COMPLETED|Overall Study||0
10476246|NCT01110499|11624990|FG007|NOT COMPLETED|Overall Study||0
10476250|NCT01110707|11625016|FG000|STARTED|Overall Study||63
10476251|NCT01110707|11625017|FG001|STARTED|Overall Study||68
10476252|NCT01110707|11625016|FG000|COMPLETED|Overall Study||63
10476253|NCT01110707|11625017|FG001|COMPLETED|Overall Study||65
10476254|NCT01110707|11625016|FG000|NOT COMPLETED|Overall Study||0
10476255|NCT01110707|11625017|FG001|NOT COMPLETED|Overall Study||3
10476256|NCT01110876|11625026|FG000|STARTED|Overall Study|One received 400 mg Erlotinib dose as result of enzyme inducing anticonvulsants (EIACs)|13
10476257|NCT01110876|11625027|FG001|STARTED|Overall Study||5
10476258|NCT01110876|11625026|FG000|COMPLETED|Overall Study||13
10476259|NCT01110876|11625027|FG001|COMPLETED|Overall Study||5
10476260|NCT01110876|11625026|FG000|NOT COMPLETED|Overall Study||0
10476261|NCT01110876|11625027|FG001|NOT COMPLETED|Overall Study||0
10476262|NCT01110915|11625036|FG000|STARTED|Overall Study|Subjects being randomized to the MRI group.|177
10476263|NCT01110915|11625037|FG001|STARTED|Overall Study|Subjects being randomized to the Control group.|86
10476264|NCT01110915|11625036|FG000|COMPLETED|Overall Study|Subjects completing at least 4 months of follow-up.|167
10476265|NCT01110915|11625037|FG001|COMPLETED|Overall Study|Subjects completing at least 4 months of follow-up.|84
10476266|NCT01110915|11625036|FG000|NOT COMPLETED|Overall Study||10
10476267|NCT01110915|11625037|FG001|NOT COMPLETED|Overall Study||2
10476268|NCT01110967|11625044|FG000|STARTED|Overall Study||40
10476269|NCT01110967|11625044|FG000|Surgery|Overall Study||40
10476270|NCT01110967|11625044|FG000|1 Month Follow up|Overall Study||26
10476271|NCT01110967|11625044|FG000|3 Months Follow up|Overall Study||28
10476272|NCT01110967|11625044|FG000|6 Months Follow up|Overall Study||24
10476273|NCT01110967|11625044|FG000|12 Months Follow up|Overall Study||31
10476274|NCT01110967|11625044|FG000|COMPLETED|Overall Study||31
10476275|NCT01110967|11625044|FG000|NOT COMPLETED|Overall Study||9
10476276|NCT01111058|11625050|FG000|STARTED|Overall Study||28
10476277|NCT01111058|11625051|FG001|STARTED|Overall Study||24
10476278|NCT01111058|11625050|FG000|COMPLETED|Overall Study||28
10476279|NCT01111058|11625051|FG001|COMPLETED|Overall Study||24
10476280|NCT01111058|11625050|FG000|NOT COMPLETED|Overall Study||0
10476281|NCT01111058|11625051|FG001|NOT COMPLETED|Overall Study||0
10709175|NCT02637323|11874081|FG000|STARTED|Overall Study||63
10476282|NCT01111123|11625059|FG000|STARTED|Open- Label Phase||55
10476283|NCT01111123|11625060|FG001|STARTED|Open- Label Phase||0
10476284|NCT01111123|11625059|FG000|COMPLETED|Open- Label Phase||41
10476285|NCT01111123|11625060|FG001|COMPLETED|Open- Label Phase||0
10476286|NCT01111123|11625059|FG000|NOT COMPLETED|Open- Label Phase||14
10476287|NCT01111123|11625060|FG001|NOT COMPLETED|Open- Label Phase||0
10476288|NCT01111123|11625059|FG000|STARTED|Maintenance Phase||21
10709176|NCT02637323|11874082|FG001|STARTED|Overall Study||18
10709177|NCT02637323|11874081|FG000|COMPLETED|Overall Study||61
10476289|NCT01111123|11625060|FG001|STARTED|Maintenance Phase||20
10476290|NCT01111123|11625059|FG000|COMPLETED|Maintenance Phase||21
10476291|NCT01111123|11625060|FG001|COMPLETED|Maintenance Phase||18
10476292|NCT01111123|11625059|FG000|NOT COMPLETED|Maintenance Phase||0
10476293|NCT01111123|11625060|FG001|NOT COMPLETED|Maintenance Phase||2
10476294|NCT01111149|11625071|FG000|STARTED|Overall Study||9
10476295|NCT01111149|11625072|FG001|STARTED|Overall Study||6
10476296|NCT01111149|11625073|FG002|STARTED|Overall Study||9
10476297|NCT01111149|11625071|FG000|COMPLETED|Overall Study||7
10476298|NCT01111149|11625072|FG001|COMPLETED|Overall Study||5
10476299|NCT01111149|11625073|FG002|COMPLETED|Overall Study||5
10476300|NCT01111149|11625071|FG000|NOT COMPLETED|Overall Study||2
10476301|NCT01111149|11625072|FG001|NOT COMPLETED|Overall Study||1
10476302|NCT01111149|11625073|FG002|NOT COMPLETED|Overall Study||4
10476303|NCT01111162|11625081|FG000|STARTED|Overall Study||120
10476304|NCT01111162|11625081|FG000|COMPLETED|Overall Study||120
10476305|NCT01111162|11625081|FG000|NOT COMPLETED|Overall Study||0
10476306|NCT01111240|11625086|FG000|STARTED|Overall Study||4635
10476307|NCT01111240|11625086|FG000|COMPLETED|Overall Study||3569
10476308|NCT01111240|11625086|FG000|NOT COMPLETED|Overall Study||1066
10476309|NCT01111292|11625092|FG000|STARTED|Randomization||3
10476310|NCT01111292|11625093|FG001|STARTED|Randomization||2
10476311|NCT01111292|11625092|FG000|COMPLETED|Randomization||3
10476312|NCT01111292|11625093|FG001|COMPLETED|Randomization||2
10476313|NCT01111292|11625092|FG000|NOT COMPLETED|Randomization||0
10476314|NCT01111292|11625093|FG001|NOT COMPLETED|Randomization||0
10476315|NCT01111292|11625092|FG000|STARTED|Treatment||3
10476316|NCT01111292|11625093|FG001|STARTED|Treatment||2
10476317|NCT01111292|11625092|FG000|COMPLETED|Treatment||2
10476318|NCT01111292|11625093|FG001|COMPLETED|Treatment||1
10476319|NCT01111292|11625092|FG000|NOT COMPLETED|Treatment||1
10476320|NCT01111292|11625093|FG001|NOT COMPLETED|Treatment||1
10476321|NCT01111292|11625092|FG000|STARTED|Post Treatment Biopsy||2
10476322|NCT01111292|11625093|FG001|STARTED|Post Treatment Biopsy||1
10476323|NCT01111292|11625092|FG000|COMPLETED|Post Treatment Biopsy||2
10476324|NCT01111292|11625093|FG001|COMPLETED|Post Treatment Biopsy||1
10476325|NCT01111292|11625092|FG000|NOT COMPLETED|Post Treatment Biopsy||0
10476326|NCT01111292|11625093|FG001|NOT COMPLETED|Post Treatment Biopsy||0
10476327|NCT01111292|11625092|FG000|STARTED|Follow-Up||2
10476328|NCT01111292|11625093|FG001|STARTED|Follow-Up||1
10476329|NCT01111292|11625092|FG000|COMPLETED|Follow-Up||2
10476330|NCT01111292|11625093|FG001|COMPLETED|Follow-Up||1
10476331|NCT01111292|11625092|FG000|NOT COMPLETED|Follow-Up||0
10476332|NCT01111292|11625093|FG001|NOT COMPLETED|Follow-Up||0
10476333|NCT01111318|11625103|FG000|STARTED|Overall Study||12
10476334|NCT01111318|11625104|FG001|STARTED|Overall Study||8
10476335|NCT01111318|11625105|FG002|STARTED|Overall Study||8
10476336|NCT01111318|11625106|FG003|STARTED|Overall Study||8
10476337|NCT01111318|11625103|FG000|COMPLETED|Overall Study||12
10476338|NCT01111318|11625104|FG001|COMPLETED|Overall Study||8
10476339|NCT01111318|11625105|FG002|COMPLETED|Overall Study||8
10476340|NCT01111318|11625106|FG003|COMPLETED|Overall Study||8
10476341|NCT01111318|11625103|FG000|NOT COMPLETED|Overall Study||0
10476342|NCT01111318|11625104|FG001|NOT COMPLETED|Overall Study||0
10476343|NCT01111318|11625105|FG002|NOT COMPLETED|Overall Study||0
10476344|NCT01111318|11625106|FG003|NOT COMPLETED|Overall Study||0
10476345|NCT01111331|11625116|FG000|STARTED|Overall Study||9
10476346|NCT01111331|11625117|FG001|STARTED|Overall Study||9
10476347|NCT01111331|11625116|FG000|COMPLETED|Overall Study||9
10476348|NCT01111331|11625117|FG001|COMPLETED|Overall Study||9
10476349|NCT01111331|11625116|FG000|NOT COMPLETED|Overall Study||0
10476350|NCT01111331|11625117|FG001|NOT COMPLETED|Overall Study||0
10476351|NCT01111370|11625127|FG000|STARTED|Overall Study||60
10476352|NCT01111370|11625127|FG000|COMPLETED|Overall Study||58
10476353|NCT01111370|11625127|FG000|NOT COMPLETED|Overall Study||2
10476354|NCT01111461|11625131|FG000|STARTED|Overall Study||133
10476355|NCT01111461|11625131|FG000|COMPLETED|Overall Study|On treatment at data cut-off or on treatment until disease progression|82
10476356|NCT01111461|11625131|FG000|NOT COMPLETED|Overall Study||51
10476357|NCT01111474|11625135|FG000|STARTED|Overall Study|593 teeth from 74 participants: 296 teeth treated with cyanoacrylate and 297 teeth with LILT|74
10476358|NCT01111474|11625135|FG000|COMPLETED|Overall Study|434 teeth from 62 participants: 218 teeth teated with cyanoacrylate and 216 teeth with LILT|62
10476359|NCT01111474|11625135|FG000|NOT COMPLETED|Overall Study||12
10476360|NCT01111526|11625141|FG000|STARTED|Overall Study||4
10476361|NCT01111526|11625142|FG001|STARTED|Overall Study||8
10476362|NCT01111526|11625143|FG002|STARTED|Overall Study||10
10476363|NCT01111526|11625141|FG000|COMPLETED|Overall Study||4
10476364|NCT01111526|11625142|FG001|COMPLETED|Overall Study||7
10476365|NCT01111526|11625143|FG002|COMPLETED|Overall Study||8
10476366|NCT01111526|11625141|FG000|NOT COMPLETED|Overall Study||0
10476367|NCT01111526|11625142|FG001|NOT COMPLETED|Overall Study||1
10476368|NCT01111526|11625143|FG002|NOT COMPLETED|Overall Study||2
10476369|NCT01111539|11625147|FG000|STARTED|Phase B (Day 1 to Week 8)||211
10476370|NCT01111539|11625148|FG001|STARTED|Phase B (Day 1 to Week 8)||0
10476371|NCT01111539|11625149|FG002|STARTED|Phase B (Day 1 to Week 8)||0
10476372|NCT01111539|11625150|FG003|STARTED|Phase B (Day 1 to Week 8)||0
10476373|NCT01111539|11625151|FG004|STARTED|Phase B (Day 1 to Week 8)||0
10476374|NCT01111539|11625147|FG000|COMPLETED|Phase B (Day 1 to Week 8)||129
10476375|NCT01111539|11625148|FG001|COMPLETED|Phase B (Day 1 to Week 8)||0
10476376|NCT01111539|11625149|FG002|COMPLETED|Phase B (Day 1 to Week 8)||0
10476377|NCT01111539|11625150|FG003|COMPLETED|Phase B (Day 1 to Week 8)||0
10476378|NCT01111539|11625151|FG004|COMPLETED|Phase B (Day 1 to Week 8)||0
10476379|NCT01111539|11625147|FG000|NOT COMPLETED|Phase B (Day 1 to Week 8)||82
10476380|NCT01111539|11625148|FG001|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
10476381|NCT01111539|11625149|FG002|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
10476382|NCT01111539|11625150|FG003|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
10476383|NCT01111539|11625151|FG004|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
10476384|NCT01111539|11625147|FG000|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||0
10476385|NCT01111539|11625148|FG001|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||45
10476386|NCT01111539|11625149|FG002|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||28
10476387|NCT01111539|11625150|FG003|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||28
10476388|NCT01111539|11625151|FG004|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||28
10476389|NCT01111539|11625147|FG000|Intent-to-treat (ITT) Sample|Phase B+ and Phase C (Weeks 9 to 14)||0
10476390|NCT01111539|11625148|FG001|Intent-to-treat (ITT) Sample|Phase B+ and Phase C (Weeks 9 to 14)||45
10476391|NCT01111539|11625149|FG002|Intent-to-treat (ITT) Sample|Phase B+ and Phase C (Weeks 9 to 14)||28
10476392|NCT01111539|11625150|FG003|Intent-to-treat (ITT) Sample|Phase B+ and Phase C (Weeks 9 to 14)||27
10476393|NCT01111539|11625151|FG004|Intent-to-treat (ITT) Sample|Phase B+ and Phase C (Weeks 9 to 14)||28
10476394|NCT01111539|11625147|FG000|Safety Sample|Phase B+ and Phase C (Weeks 9 to 14)||0
10476395|NCT01111539|11625148|FG001|Safety Sample|Phase B+ and Phase C (Weeks 9 to 14)||45
10476396|NCT01111539|11625149|FG002|Safety Sample|Phase B+ and Phase C (Weeks 9 to 14)||28
10476397|NCT01111539|11625150|FG003|Safety Sample|Phase B+ and Phase C (Weeks 9 to 14)||27
10476398|NCT01111539|11625151|FG004|Safety Sample|Phase B+ and Phase C (Weeks 9 to 14)||28
10476399|NCT01111539|11625147|FG000|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||0
10476400|NCT01111539|11625148|FG001|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||38
10476401|NCT01111539|11625149|FG002|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||22
10476402|NCT01111539|11625150|FG003|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||20
10476403|NCT01111539|11625151|FG004|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||18
10476404|NCT01111539|11625147|FG000|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||0
10476405|NCT01111539|11625148|FG001|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||7
10476406|NCT01111539|11625149|FG002|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||6
10476407|NCT01111539|11625150|FG003|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||8
10476408|NCT01111539|11625151|FG004|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||10
10476409|NCT01111552|11625161|FG000|STARTED|Phase B (Day 1 to Week 8)||237
10476410|NCT01111552|11625162|FG001|STARTED|Phase B (Day 1 to Week 8)||0
10476411|NCT01111552|11625163|FG002|STARTED|Phase B (Day 1 to Week 8)||0
10476412|NCT01111552|11625164|FG003|STARTED|Phase B (Day 1 to Week 8)||0
10476413|NCT01111552|11625165|FG004|STARTED|Phase B (Day 1 to Week 8)||0
10476414|NCT01111552|11625161|FG000|COMPLETED|Phase B (Day 1 to Week 8)||120
10476415|NCT01111552|11625162|FG001|COMPLETED|Phase B (Day 1 to Week 8)||0
10476416|NCT01111552|11625163|FG002|COMPLETED|Phase B (Day 1 to Week 8)||0
10476417|NCT01111552|11625164|FG003|COMPLETED|Phase B (Day 1 to Week 8)||0
10476418|NCT01111552|11625165|FG004|COMPLETED|Phase B (Day 1 to Week 8)||0
10476419|NCT01111552|11625161|FG000|NOT COMPLETED|Phase B (Day 1 to Week 8)||117
10476420|NCT01111552|11625162|FG001|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
10476421|NCT01111552|11625163|FG002|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
10476422|NCT01111552|11625164|FG003|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
10476423|NCT01111552|11625165|FG004|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
10476424|NCT01111552|11625161|FG000|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||0
10476425|NCT01111552|11625162|FG001|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||54
10476426|NCT01111552|11625163|FG002|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||22
10476427|NCT01111552|11625164|FG003|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||21
10476428|NCT01111552|11625165|FG004|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||23
10476429|NCT01111552|11625161|FG000|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||0
10476430|NCT01111552|11625162|FG001|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||45
10476431|NCT01111552|11625163|FG002|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||17
10476432|NCT01111552|11625164|FG003|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||17
10476433|NCT01111552|11625165|FG004|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||18
10476434|NCT01111552|11625161|FG000|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||0
10476435|NCT01111552|11625162|FG001|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||9
10476436|NCT01111552|11625163|FG002|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||5
10476437|NCT01111552|11625164|FG003|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||4
10476438|NCT01111552|11625165|FG004|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||5
10476439|NCT01111604|11625178|FG000|STARTED|Overall Study||54
10476440|NCT01111604|11625179|FG001|STARTED|Overall Study||52
10476441|NCT01111604|11625180|FG002|STARTED|Overall Study||52
10476442|NCT01111604|11625178|FG000|Received at Least One Dose of Study Drug|Overall Study||49
10476443|NCT01111604|11625179|FG001|Received at Least One Dose of Study Drug|Overall Study||52
10476444|NCT01111604|11625180|FG002|Received at Least One Dose of Study Drug|Overall Study||52
10476445|NCT01111604|11625178|FG000|COMPLETED|Overall Study||46
10476446|NCT01111604|11625179|FG001|COMPLETED|Overall Study||52
10476447|NCT01111604|11625180|FG002|COMPLETED|Overall Study||49
10476448|NCT01111604|11625178|FG000|NOT COMPLETED|Overall Study||8
10476449|NCT01111604|11625179|FG001|NOT COMPLETED|Overall Study||0
10476450|NCT01111604|11625180|FG002|NOT COMPLETED|Overall Study||3
10476451|NCT01111825|11625210|FG000|STARTED|Overall Study||8
10476452|NCT01111825|11625211|FG001|STARTED|Overall Study||6
10476453|NCT01111825|11625212|FG002|STARTED|Overall Study||37
10476454|NCT01111825|11625213|FG003|STARTED|Overall Study||48
10476455|NCT01111825|11625210|FG000|COMPLETED|Overall Study||5
10476456|NCT01111825|11625211|FG001|COMPLETED|Overall Study||5
10476457|NCT01111825|11625212|FG002|COMPLETED|Overall Study||29
10476458|NCT01111825|11625213|FG003|COMPLETED|Overall Study||27
10476459|NCT01111825|11625210|FG000|NOT COMPLETED|Overall Study||3
10476460|NCT01111825|11625211|FG001|NOT COMPLETED|Overall Study||1
10476461|NCT01111825|11625212|FG002|NOT COMPLETED|Overall Study||8
10476462|NCT01111825|11625213|FG003|NOT COMPLETED|Overall Study||21
10476463|NCT01111838|11625223|FG000|STARTED|Overall Study||22
10476464|NCT01111838|11625223|FG000|COMPLETED|Overall Study||15
10476465|NCT01111838|11625223|FG000|NOT COMPLETED|Overall Study||7
10476466|NCT01111851|11625229|FG000|STARTED|Overall Study||8
10476467|NCT01111851|11625230|FG001|STARTED|Overall Study||8
10476468|NCT01111851|11625229|FG000|COMPLETED|Overall Study||6
10476469|NCT01111851|11625230|FG001|COMPLETED|Overall Study||8
10476470|NCT01111851|11625229|FG000|NOT COMPLETED|Overall Study||2
10476471|NCT01111851|11625230|FG001|NOT COMPLETED|Overall Study||0
10476472|NCT01112059|11625238|FG000|STARTED|Overall Study||20
10476473|NCT01112059|11625239|FG001|STARTED|Overall Study||20
10476474|NCT01112059|11625238|FG000|COMPLETED|Overall Study||19
10476475|NCT01112059|11625239|FG001|COMPLETED|Overall Study||20
10476476|NCT01112059|11625238|FG000|NOT COMPLETED|Overall Study||1
10476477|NCT01112059|11625239|FG001|NOT COMPLETED|Overall Study||0
10476478|NCT01112228|11625248|FG000|STARTED|Overall Study||600
10476479|NCT01112228|11625248|FG000|COMPLETED|Overall Study||600
10476480|NCT01112228|11625248|FG000|NOT COMPLETED|Overall Study||0
10476481|NCT01112241|11625254|FG000|STARTED|Overall Study||17
10476482|NCT01112241|11625254|FG000|COMPLETED|Overall Study||17
10476483|NCT01112241|11625254|FG000|NOT COMPLETED|Overall Study||0
10476484|NCT01112267|11625260|FG000|STARTED|Overall Study||126
10476485|NCT01112267|11625261|FG001|STARTED|Overall Study||122
10476486|NCT01112267|11625260|FG000|Treated|Overall Study||125
10476487|NCT01112267|11625261|FG001|Treated|Overall Study||120
10476488|NCT01112267|11625260|FG000|COMPLETED|Overall Study||92
10476489|NCT01112267|11625261|FG001|COMPLETED|Overall Study||104
10476490|NCT01112267|11625260|FG000|NOT COMPLETED|Overall Study||34
10476491|NCT01112267|11625261|FG001|NOT COMPLETED|Overall Study||18
10476492|NCT01112293|11625267|FG000|STARTED|Overall Study||14
10476493|NCT01112293|11625267|FG000|COMPLETED|Overall Study||14
10476494|NCT01112293|11625267|FG000|NOT COMPLETED|Overall Study||0
10476495|NCT01112358|11625273|FG000|STARTED|Overall Study||25
10476496|NCT01112358|11625274|FG001|STARTED|Overall Study||33
10476497|NCT01112358|11625273|FG000|COMPLETED|Overall Study||25
10476498|NCT01112358|11625274|FG001|COMPLETED|Overall Study||33
10476499|NCT01112358|11625273|FG000|NOT COMPLETED|Overall Study||0
10476500|NCT01112358|11625274|FG001|NOT COMPLETED|Overall Study||0
10476501|NCT01112514|11625280|FG000|STARTED|Overall Study||4
10476502|NCT01112514|11625280|FG000|COMPLETED|Overall Study||3
10476503|NCT01112514|11625280|FG000|NOT COMPLETED|Overall Study||1
10476504|NCT01112579|11625286|FG000|STARTED|Overall Study||42
10476505|NCT01112579|11625287|FG001|STARTED|Overall Study||24
10476506|NCT01112579|11625286|FG000|COMPLETED|Overall Study||41
10476507|NCT01112579|11625287|FG001|COMPLETED|Overall Study||21
10476508|NCT01112579|11625286|FG000|NOT COMPLETED|Overall Study||1
10476509|NCT01112579|11625287|FG001|NOT COMPLETED|Overall Study||3
10476510|NCT01112670|11625293|FG000|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||8
10476511|NCT01112670|11625294|FG001|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
10476512|NCT01112670|11625295|FG002|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||7
10476513|NCT01112670|11625296|FG003|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
10476514|NCT01112670|11625297|FG004|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||6
10476515|NCT01112670|11625298|FG005|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
10476516|NCT01112670|11625293|FG000|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||7
10476517|NCT01112670|11625294|FG001|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
10476518|NCT01112670|11625295|FG002|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||6
10476519|NCT01112670|11625296|FG003|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
10476520|NCT01112670|11625297|FG004|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||5
10476521|NCT01112670|11625298|FG005|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
10476522|NCT01112670|11625293|FG000|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
10476523|NCT01112670|11625294|FG001|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
10476524|NCT01112670|11625295|FG002|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
10476525|NCT01112670|11625296|FG003|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
10476526|NCT01112670|11625297|FG004|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
10476527|NCT01112670|11625298|FG005|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
10476528|NCT01112670|11625293|FG000|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
10476529|NCT01112670|11625294|FG001|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||3
10476530|NCT01112670|11625295|FG002|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
10476531|NCT01112670|11625296|FG003|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||4
10476532|NCT01112670|11625297|FG004|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
10476533|NCT01112670|11625298|FG005|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||5
10476534|NCT01112670|11625293|FG000|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
10476535|NCT01112670|11625294|FG001|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||3
10476536|NCT01112670|11625295|FG002|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
10476537|NCT01112670|11625296|FG003|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||4
10476538|NCT01112670|11625297|FG004|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
10476539|NCT01112670|11625298|FG005|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||5
10476540|NCT01112670|11625293|FG000|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
10476541|NCT01112670|11625294|FG001|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
10476542|NCT01112670|11625295|FG002|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
10476543|NCT01112670|11625296|FG003|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
10476544|NCT01112670|11625297|FG004|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
10476545|NCT01112670|11625298|FG005|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
10476546|NCT01112683|11625307|FG000|STARTED|Overall Study||19
10476547|NCT01112683|11625308|FG001|STARTED|Overall Study||20
10476548|NCT01112683|11625307|FG000|COMPLETED|Overall Study||18
10476549|NCT01112683|11625308|FG001|COMPLETED|Overall Study||19
10476550|NCT01112683|11625307|FG000|NOT COMPLETED|Overall Study||1
10476551|NCT01112683|11625308|FG001|NOT COMPLETED|Overall Study||1
10476552|NCT01112696|11625314|FG000|STARTED|Overall Study||100
10476553|NCT01112696|11625314|FG000|COMPLETED|Overall Study||98
10476554|NCT01112696|11625314|FG000|NOT COMPLETED|Overall Study||2
10476555|NCT01112735|11625321|FG000|STARTED|Overall Study||20
10476556|NCT01112735|11625322|FG001|STARTED|Overall Study||20
10476557|NCT01112735|11625321|FG000|COMPLETED|Overall Study||20
10476558|NCT01112735|11625322|FG001|COMPLETED|Overall Study||20
10476559|NCT01112735|11625321|FG000|NOT COMPLETED|Overall Study||0
10476560|NCT01112735|11625322|FG001|NOT COMPLETED|Overall Study||0
10476561|NCT01112865|11625328|FG000|STARTED|First Intervention||59
10476562|NCT01112865|11625329|FG001|STARTED|First Intervention||61
10476563|NCT01112865|11625328|FG000|COMPLETED|First Intervention||59
10476564|NCT01112865|11625329|FG001|COMPLETED|First Intervention||61
10476565|NCT01112865|11625328|FG000|NOT COMPLETED|First Intervention||0
10476566|NCT01112865|11625329|FG001|NOT COMPLETED|First Intervention||0
10476567|NCT01112865|11625328|FG000|STARTED|Second Intervention||59
10476568|NCT01112865|11625329|FG001|STARTED|Second Intervention||61
10476569|NCT01112865|11625328|FG000|COMPLETED|Second Intervention||59
10476570|NCT01112865|11625329|FG001|COMPLETED|Second Intervention||61
10476571|NCT01112865|11625328|FG000|NOT COMPLETED|Second Intervention||0
10476572|NCT01112865|11625329|FG001|NOT COMPLETED|Second Intervention||0
10476573|NCT01112917|11625335|FG000|STARTED|Overall Study||96
10476574|NCT01112917|11625336|FG001|STARTED|Overall Study||53
10476575|NCT01112917|11625335|FG000|COMPLETED|Overall Study||89
10476576|NCT01112917|11625336|FG001|COMPLETED|Overall Study||38
10476577|NCT01112917|11625335|FG000|NOT COMPLETED|Overall Study||7
10476578|NCT01112917|11625336|FG001|NOT COMPLETED|Overall Study||15
10476579|NCT01112982|11625340|FG000|STARTED|Overall Study||74
10476580|NCT01112982|11625340|FG000|COMPLETED|Overall Study||72
10476581|NCT01112982|11625340|FG000|NOT COMPLETED|Overall Study||2
10476582|NCT01113008|11625349|FG000|STARTED|Overall Study||133
10476583|NCT01113008|11625350|FG001|STARTED|Overall Study||133
10476584|NCT01113008|11625349|FG000|COMPLETED|Overall Study||133
10476585|NCT01113008|11625350|FG001|COMPLETED|Overall Study||133
10476586|NCT01113008|11625349|FG000|NOT COMPLETED|Overall Study||0
10476587|NCT01113008|11625350|FG001|NOT COMPLETED|Overall Study||0
10476588|NCT01113385|11625356|FG000|STARTED|Overall Study||7
10476589|NCT01113385|11625356|FG000|COMPLETED|Overall Study||7
10476590|NCT01113385|11625356|FG000|NOT COMPLETED|Overall Study||0
10476591|NCT01113398|11625360|FG000|STARTED|Overall Study||36
10476592|NCT01113398|11625360|FG000|COMPLETED|Overall Study|Completed= Discontinued study drug due to disease progression, death, toxicity or any other reason|36
10476593|NCT01113398|11625360|FG000|NOT COMPLETED|Overall Study||0
10476594|NCT01113463|11625364|FG000|STARTED|Overall Study||17
10476595|NCT01113463|11625364|FG000|COMPLETED|Overall Study||12
10476596|NCT01113463|11625364|FG000|NOT COMPLETED|Overall Study||5
10476597|NCT01113502|11625373|FG000|STARTED|Overall Study||4
10476598|NCT01113502|11625374|FG001|STARTED|Overall Study||3
10476599|NCT01113502|11625375|FG002|STARTED|Overall Study||7
10476600|NCT01113502|11625376|FG003|STARTED|Overall Study||9
10476601|NCT01113502|11625377|FG004|STARTED|Overall Study||21
10476602|NCT01113502|11625373|FG000|COMPLETED|Overall Study||3
10476603|NCT01113502|11625374|FG001|COMPLETED|Overall Study||3
10476604|NCT01113502|11625375|FG002|COMPLETED|Overall Study||3
10476605|NCT01113502|11625376|FG003|COMPLETED|Overall Study||6
10476606|NCT01113502|11625377|FG004|COMPLETED|Overall Study||21
10476607|NCT01113502|11625373|FG000|NOT COMPLETED|Overall Study||1
10476608|NCT01113502|11625374|FG001|NOT COMPLETED|Overall Study||0
10476609|NCT01113502|11625375|FG002|NOT COMPLETED|Overall Study||4
10476610|NCT01113502|11625376|FG003|NOT COMPLETED|Overall Study||3
10476611|NCT01113502|11625377|FG004|NOT COMPLETED|Overall Study||0
10476612|NCT01113541|11625390|FG000|STARTED|Overall Study||13
10476613|NCT01113541|11625390|FG000|COMPLETED|Overall Study||0
10476614|NCT01113541|11625390|FG000|NOT COMPLETED|Overall Study||13
10476615|NCT01113580|11625396|FG000|STARTED|Overall Study||60
10476616|NCT01113580|11625397|FG001|STARTED|Overall Study||60
10476617|NCT01113580|11625396|FG000|COMPLETED|Overall Study||59
10476618|NCT01113580|11625397|FG001|COMPLETED|Overall Study||60
10476619|NCT01113580|11625396|FG000|NOT COMPLETED|Overall Study||1
10476620|NCT01113580|11625397|FG001|NOT COMPLETED|Overall Study||0
10476621|NCT01113632|11625405|FG000|STARTED|Overall Study||33
10476622|NCT01113632|11625406|FG001|STARTED|Overall Study||44
10476623|NCT01113632|11625405|FG000|COMPLETED|Overall Study||2
10476624|NCT01113632|11625406|FG001|COMPLETED|Overall Study||19
10476625|NCT01113632|11625405|FG000|NOT COMPLETED|Overall Study||31
10476626|NCT01113632|11625406|FG001|NOT COMPLETED|Overall Study||25
10476627|NCT01113710|11625412|FG000|STARTED|Overall Study|See Additional Study Description for further information regarding withdrawal due to Adverse Event.|687
10476628|NCT01113710|11625412|FG000|COMPLETED|Overall Study|"Discontinued reasons for Other are listed in the Participant Flow."|418
10476629|NCT01113710|11625412|FG000|NOT COMPLETED|Overall Study||269
10476630|NCT01113723|11625418|FG000|STARTED|Overall Study||70
10476631|NCT01113723|11625419|FG001|STARTED|Overall Study||70
10476632|NCT01113723|11625418|FG000|COMPLETED|Overall Study||70
10476633|NCT01113723|11625419|FG001|COMPLETED|Overall Study||70
10476634|NCT01113723|11625418|FG000|NOT COMPLETED|Overall Study||0
10476635|NCT01113723|11625419|FG001|NOT COMPLETED|Overall Study||0
10476636|NCT01113749|11625429|FG000|STARTED|Overall Study||127
10476637|NCT01113749|11625430|FG001|STARTED|Overall Study||129
10476638|NCT01113749|11625429|FG000|COMPLETED|Overall Study||126
10476639|NCT01113749|11625430|FG001|COMPLETED|Overall Study||127
10476640|NCT01113749|11625429|FG000|NOT COMPLETED|Overall Study||1
10476641|NCT01113749|11625430|FG001|NOT COMPLETED|Overall Study||2
10476642|NCT01113801|11625440|FG000|STARTED|Overall Study||103
10476643|NCT01113801|11625441|FG001|STARTED|Overall Study||105
10476644|NCT01113801|11625442|FG002|STARTED|Overall Study||103
10476645|NCT01113801|11625443|FG003|STARTED|Overall Study||106
10476646|NCT01113801|11625440|FG000|Received at Least One Dose of Drug|Overall Study||103
10476647|NCT01113801|11625441|FG001|Received at Least One Dose of Drug|Overall Study||105
10476648|NCT01113801|11625442|FG002|Received at Least One Dose of Drug|Overall Study||103
10476649|NCT01113801|11625443|FG003|Received at Least One Dose of Drug|Overall Study||105
10476650|NCT01113801|11625440|FG000|COMPLETED|Overall Study||62
10476651|NCT01113801|11625441|FG001|COMPLETED|Overall Study||65
10476652|NCT01113801|11625442|FG002|COMPLETED|Overall Study||66
10476653|NCT01113801|11625443|FG003|COMPLETED|Overall Study||65
10476654|NCT01113801|11625440|FG000|NOT COMPLETED|Overall Study||41
10476655|NCT01113801|11625441|FG001|NOT COMPLETED|Overall Study||40
10476656|NCT01113801|11625442|FG002|NOT COMPLETED|Overall Study||37
10476657|NCT01113801|11625443|FG003|NOT COMPLETED|Overall Study||41
10476658|NCT01113879|11625455|FG000|STARTED|Period 1: Block 1||7
10476659|NCT01113879|11625456|FG001|STARTED|Period 1: Block 1||2
10476660|NCT01113879|11625455|FG000|COMPLETED|Period 1: Block 1||5
10476661|NCT01113879|11625456|FG001|COMPLETED|Period 1: Block 1||2
10476662|NCT01113879|11625455|FG000|NOT COMPLETED|Period 1: Block 1||2
10476663|NCT01113879|11625456|FG001|NOT COMPLETED|Period 1: Block 1||0
10476664|NCT01113879|11625455|FG000|STARTED|Period 2: Block 2||5
10476665|NCT01113879|11625456|FG001|STARTED|Period 2: Block 2||2
10476666|NCT01113879|11625455|FG000|COMPLETED|Period 2: Block 2||5
10476667|NCT01113879|11625456|FG001|COMPLETED|Period 2: Block 2||2
10476668|NCT01113879|11625455|FG000|NOT COMPLETED|Period 2: Block 2||0
10476669|NCT01113879|11625456|FG001|NOT COMPLETED|Period 2: Block 2||0
10476670|NCT01113892|11625466|FG000|STARTED|Overall Study||101
10476671|NCT01113892|11625467|FG001|STARTED|Overall Study||106
10476672|NCT01113892|11625466|FG000|COMPLETED|Overall Study||87
10476673|NCT01113892|11625467|FG001|COMPLETED|Overall Study||90
10476674|NCT01113892|11625466|FG000|NOT COMPLETED|Overall Study||14
10476675|NCT01113892|11625467|FG001|NOT COMPLETED|Overall Study||16
10476676|NCT01113931|11625475|FG000|STARTED|Overall Study||247
10476677|NCT01113931|11625476|FG001|STARTED|Overall Study||248
10476678|NCT01113931|11625475|FG000|Safety Population|Overall Study|1 subject did not take any study medication|246
10476679|NCT01113931|11625476|FG001|Safety Population|Overall Study||248
10476680|NCT01113931|11625475|FG000|mITT Population|Overall Study||188
10476681|NCT01113931|11625476|FG001|mITT Population|Overall Study||190
10476682|NCT01113931|11625475|FG000|COMPLETED|Overall Study||228
10476683|NCT01113931|11625476|FG001|COMPLETED|Overall Study||231
10476684|NCT01113931|11625475|FG000|NOT COMPLETED|Overall Study||19
10476685|NCT01113931|11625476|FG001|NOT COMPLETED|Overall Study||17
10476686|NCT01113983|11625484|FG000|STARTED|Overall Study||37
10476687|NCT01113983|11625485|FG001|STARTED|Overall Study||27
10476688|NCT01113983|11625484|FG000|COMPLETED|Overall Study||12
10476689|NCT01113983|11625485|FG001|COMPLETED|Overall Study||10
10476690|NCT01113983|11625484|FG000|NOT COMPLETED|Overall Study||25
10476691|NCT01113983|11625485|FG001|NOT COMPLETED|Overall Study||17
10476692|NCT01114334|11625493|FG000|STARTED|Overall Study||88
10476693|NCT01114334|11625494|FG001|STARTED|Overall Study||80
10476694|NCT01114334|11625493|FG000|COMPLETED|Overall Study||67
10476695|NCT01114334|11625494|FG001|COMPLETED|Overall Study||58
10476696|NCT01114334|11625493|FG000|NOT COMPLETED|Overall Study||21
10476697|NCT01114334|11625494|FG001|NOT COMPLETED|Overall Study||22
10476698|NCT01114360|11625501|FG000|STARTED|Intervention 1 (4 Weeks)||18
10476699|NCT01114360|11625502|FG001|STARTED|Intervention 1 (4 Weeks)||19
10476700|NCT01114360|11625501|FG000|COMPLETED|Intervention 1 (4 Weeks)||18
10476701|NCT01114360|11625502|FG001|COMPLETED|Intervention 1 (4 Weeks)||18
10476702|NCT01114360|11625501|FG000|NOT COMPLETED|Intervention 1 (4 Weeks)||0
10476703|NCT01114360|11625502|FG001|NOT COMPLETED|Intervention 1 (4 Weeks)||1
10476704|NCT01114360|11625501|FG000|STARTED|Intervention 2 (4 Weeks)||18
10476705|NCT01114360|11625502|FG001|STARTED|Intervention 2 (4 Weeks)||18
10476706|NCT01114360|11625501|FG000|COMPLETED|Intervention 2 (4 Weeks)||18
10476707|NCT01114360|11625502|FG001|COMPLETED|Intervention 2 (4 Weeks)||18
10476708|NCT01114360|11625501|FG000|NOT COMPLETED|Intervention 2 (4 Weeks)||0
10476709|NCT01114360|11625502|FG001|NOT COMPLETED|Intervention 2 (4 Weeks)||0
10476710|NCT01114373|11625522|FG000|STARTED|Intervention 1 (4 Weeks)||21
10476711|NCT01114373|11625523|FG001|STARTED|Intervention 1 (4 Weeks)||19
10476712|NCT01114373|11625522|FG000|COMPLETED|Intervention 1 (4 Weeks)||18
10476713|NCT01114373|11625523|FG001|COMPLETED|Intervention 1 (4 Weeks)||19
10476714|NCT01114373|11625522|FG000|NOT COMPLETED|Intervention 1 (4 Weeks)||3
10476715|NCT01114373|11625523|FG001|NOT COMPLETED|Intervention 1 (4 Weeks)||0
10476716|NCT01114373|11625522|FG000|STARTED|Intervention 2 (4 Weeks)||18
10476717|NCT01114373|11625523|FG001|STARTED|Intervention 2 (4 Weeks)||19
10476718|NCT01114373|11625522|FG000|COMPLETED|Intervention 2 (4 Weeks)||18
10476719|NCT01114373|11625523|FG001|COMPLETED|Intervention 2 (4 Weeks)||18
10476720|NCT01114373|11625522|FG000|NOT COMPLETED|Intervention 2 (4 Weeks)||0
10476721|NCT01114373|11625523|FG001|NOT COMPLETED|Intervention 2 (4 Weeks)||1
10476722|NCT01114438|11625533|FG000|STARTED|Overall Study||45
10476723|NCT01114438|11625533|FG000|COMPLETED|Overall Study||31
10476724|NCT01114438|11625533|FG000|NOT COMPLETED|Overall Study||14
10476725|NCT01114503|11625542|FG000|STARTED|Overall Study||2
10476726|NCT01114503|11625542|FG000|COMPLETED|Overall Study||2
10476727|NCT01114503|11625542|FG000|NOT COMPLETED|Overall Study||0
10476728|NCT01114516|11625548|FG000|STARTED|Overall Study||26
10476729|NCT01114516|11625549|FG001|STARTED|Overall Study||27
10476730|NCT01114516|11625548|FG000|COMPLETED|Overall Study||24
10476731|NCT01114516|11625549|FG001|COMPLETED|Overall Study||26
10476732|NCT01114516|11625548|FG000|NOT COMPLETED|Overall Study||2
10476733|NCT01114516|11625549|FG001|NOT COMPLETED|Overall Study||1
10476734|NCT01114529|11625558|FG000|STARTED|Completed Study Medication at Month 24|Randomized set - 360 Full analysis set - 353 Safety analysis set -346*|353
10476735|NCT01114529|11625559|FG001|STARTED|Completed Study Medication at Month 24|Randomized set -231 Full analysis set -231 Safety analysis set -238**|231
10709178|NCT02637323|11874082|FG001|COMPLETED|Overall Study||17
10709179|NCT02637323|11874081|FG000|NOT COMPLETED|Overall Study||2
10709180|NCT02637323|11874082|FG001|NOT COMPLETED|Overall Study||1
10709181|NCT02637427|11874091|FG000|STARTED|Overall Study||27
10476736|NCT01114529|11625560|FG002|STARTED|Completed Study Medication at Month 24|Randomized set-125 Full analysis set -125 Safety analysis set -121***|125
10476737|NCT01114529|11625558|FG000|COMPLETED|Completed Study Medication at Month 24|completed at month 24|229
10476738|NCT01114529|11625559|FG001|COMPLETED|Completed Study Medication at Month 24|completed at month 24|190
10476739|NCT01114529|11625560|FG002|COMPLETED|Completed Study Medication at Month 24|completed at month 24|93
10476740|NCT01114529|11625558|FG000|NOT COMPLETED|Completed Study Medication at Month 24||124
10476741|NCT01114529|11625559|FG001|NOT COMPLETED|Completed Study Medication at Month 24||41
10476742|NCT01114529|11625560|FG002|NOT COMPLETED|Completed Study Medication at Month 24||32
10476743|NCT01114529|11625558|FG000|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|353
10476744|NCT01114529|11625559|FG001|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|231
10476745|NCT01114529|11625560|FG002|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|125
10476746|NCT01114529|11625558|FG000|COMPLETED|Completed Study Phase at Month 24|at month 24|313
10476747|NCT01114529|11625559|FG001|COMPLETED|Completed Study Phase at Month 24|at month 24|215
10476748|NCT01114529|11625560|FG002|COMPLETED|Completed Study Phase at Month 24|at month 24|111
10476749|NCT01114529|11625558|FG000|NOT COMPLETED|Completed Study Phase at Month 24||40
10476750|NCT01114529|11625559|FG001|NOT COMPLETED|Completed Study Phase at Month 24||16
10476751|NCT01114529|11625560|FG002|NOT COMPLETED|Completed Study Phase at Month 24||14
10476752|NCT01114555|11625570|FG000|STARTED|Overall Study||34
10476753|NCT01114555|11625570|FG000|COMPLETED|Overall Study||34
10476754|NCT01114555|11625570|FG000|NOT COMPLETED|Overall Study||0
10476755|NCT01114581|11625576|FG000|STARTED|Overall Study||19
10476756|NCT01114581|11625577|FG001|STARTED|Overall Study||19
10476757|NCT01114581|11625576|FG000|COMPLETED|Overall Study||19
10476758|NCT01114581|11625577|FG001|COMPLETED|Overall Study||19
10476759|NCT01114581|11625576|FG000|NOT COMPLETED|Overall Study||0
10476760|NCT01114581|11625577|FG001|NOT COMPLETED|Overall Study||0
10476761|NCT01114620|11625583|FG000|STARTED|Overall Study||50
10476762|NCT01114620|11625583|FG000|COMPLETED|Overall Study||50
10476763|NCT01114620|11625583|FG000|NOT COMPLETED|Overall Study||0
10476764|NCT01114646|11625589|FG000|STARTED|Overall Study||66
10476765|NCT01114646|11625590|FG001|STARTED|Overall Study||64
10476766|NCT01114646|11625589|FG000|COMPLETED|Overall Study||63
10476767|NCT01114646|11625590|FG001|COMPLETED|Overall Study||62
10476768|NCT01114646|11625589|FG000|NOT COMPLETED|Overall Study||3
10476769|NCT01114646|11625590|FG001|NOT COMPLETED|Overall Study||2
10476770|NCT01114672|11625598|FG000|STARTED|Overall Study||25
10476771|NCT01114672|11625599|FG001|STARTED|Overall Study||25
10476772|NCT01114672|11625598|FG000|COMPLETED|Overall Study||21
10476773|NCT01114672|11625599|FG001|COMPLETED|Overall Study||23
10476774|NCT01114672|11625598|FG000|NOT COMPLETED|Overall Study||4
10476775|NCT01114672|11625599|FG001|NOT COMPLETED|Overall Study||2
10476776|NCT01114724|11625605|FG000|STARTED|Overall Study||50
10476777|NCT01114724|11625605|FG000|COMPLETED|Overall Study||40
10476778|NCT01114724|11625605|FG000|NOT COMPLETED|Overall Study||10
10476779|NCT01114737|11625612|FG000|STARTED|Randomized Treatment Period||108
10709182|NCT02637427|11874092|FG001|STARTED|Overall Study||30
10709183|NCT02637427|11874091|FG000|COMPLETED|Overall Study||27
10476780|NCT01114737|11625613|FG001|STARTED|Randomized Treatment Period||98
10476781|NCT01114737|11625612|FG000|COMPLETED|Randomized Treatment Period||105
10476782|NCT01114737|11625613|FG001|COMPLETED|Randomized Treatment Period||97
10476783|NCT01114737|11625612|FG000|NOT COMPLETED|Randomized Treatment Period||3
10476784|NCT01114737|11625613|FG001|NOT COMPLETED|Randomized Treatment Period||1
10476785|NCT01114737|11625612|FG000|STARTED|Open-Label Treatment Period|One subject did not receive a single dose of the study drug|105
10476786|NCT01114737|11625613|FG001|STARTED|Open-Label Treatment Period|Two subjects did not receive a single dose of the study drug|97
10476787|NCT01114737|11625612|FG000|COMPLETED|Open-Label Treatment Period||100
10476788|NCT01114737|11625613|FG001|COMPLETED|Open-Label Treatment Period||95
10476789|NCT01114737|11625612|FG000|NOT COMPLETED|Open-Label Treatment Period||5
10476790|NCT01114737|11625613|FG001|NOT COMPLETED|Open-Label Treatment Period||2
10476791|NCT01114828|11625632|FG000|STARTED|Overall Study||19
10476792|NCT01114828|11625633|FG001|STARTED|Overall Study||21
10476793|NCT01114828|11625632|FG000|COMPLETED|Overall Study||16
10476794|NCT01114828|11625633|FG001|COMPLETED|Overall Study||17
10476795|NCT01114828|11625632|FG000|NOT COMPLETED|Overall Study||3
10476796|NCT01114828|11625633|FG001|NOT COMPLETED|Overall Study||4
10476797|NCT01114880|11625641|FG000|STARTED|Period 1 (Week 0 to Week 12)||229
10476798|NCT01114880|11625642|FG001|STARTED|Period 1 (Week 0 to Week 12)||115
10476799|NCT01114880|11625641|FG000|COMPLETED|Period 1 (Week 0 to Week 12)||224
10476800|NCT01114880|11625642|FG001|COMPLETED|Period 1 (Week 0 to Week 12)||113
10476801|NCT01114880|11625641|FG000|NOT COMPLETED|Period 1 (Week 0 to Week 12)||5
10476802|NCT01114880|11625642|FG001|NOT COMPLETED|Period 1 (Week 0 to Week 12)||2
10476803|NCT01114880|11625641|FG000|STARTED|Period 2 (Week 12 to Week 24)||224
10476804|NCT01114880|11625642|FG001|STARTED|Period 2 (Week 12 to Week 24)||113
10476805|NCT01114880|11625641|FG000|COMPLETED|Period 2 (Week 12 to Week 24)||221
10476806|NCT01114880|11625642|FG001|COMPLETED|Period 2 (Week 12 to Week 24)||111
10476807|NCT01114880|11625641|FG000|NOT COMPLETED|Period 2 (Week 12 to Week 24)||3
10476808|NCT01114880|11625642|FG001|NOT COMPLETED|Period 2 (Week 12 to Week 24)||2
10476809|NCT01114893|11625655|FG000|STARTED|Overall Study||14
10476810|NCT01114893|11625656|FG001|STARTED|Overall Study||14
10476811|NCT01114893|11625657|FG002|STARTED|Overall Study||14
10476812|NCT01114893|11625658|FG003|STARTED|Overall Study||13
10476813|NCT01114893|11625659|FG004|STARTED|Overall Study||12
10476814|NCT01114893|11625655|FG000|COMPLETED|Overall Study||14
10476815|NCT01114893|11625656|FG001|COMPLETED|Overall Study||14
10476816|NCT01114893|11625657|FG002|COMPLETED|Overall Study||14
10476817|NCT01114893|11625658|FG003|COMPLETED|Overall Study||13
10476818|NCT01114893|11625659|FG004|COMPLETED|Overall Study||12
10476819|NCT01114893|11625655|FG000|NOT COMPLETED|Overall Study||0
10476820|NCT01114893|11625656|FG001|NOT COMPLETED|Overall Study||0
10476821|NCT01114893|11625657|FG002|NOT COMPLETED|Overall Study||0
10476822|NCT01114893|11625658|FG003|NOT COMPLETED|Overall Study||0
10476823|NCT01114893|11625659|FG004|NOT COMPLETED|Overall Study||0
10476824|NCT01114945|11625675|FG000|STARTED|Overall Study||30
10476825|NCT01114945|11625676|FG001|STARTED|Overall Study||30
10476826|NCT01114945|11625677|FG002|STARTED|Overall Study||30
10476827|NCT01114945|11625678|FG003|STARTED|Overall Study||31
10476828|NCT01114945|11625675|FG000|COMPLETED|Overall Study||30
10476829|NCT01114945|11625676|FG001|COMPLETED|Overall Study||30
10476830|NCT01114945|11625677|FG002|COMPLETED|Overall Study||30
10476831|NCT01114945|11625678|FG003|COMPLETED|Overall Study||31
10476832|NCT01114945|11625675|FG000|NOT COMPLETED|Overall Study||0
10476833|NCT01114945|11625676|FG001|NOT COMPLETED|Overall Study||0
10476834|NCT01114945|11625677|FG002|NOT COMPLETED|Overall Study||0
10476835|NCT01114945|11625678|FG003|NOT COMPLETED|Overall Study||0
10476836|NCT01114971|11625692|FG000|STARTED|Overall Study||25
10476837|NCT01114971|11625693|FG001|STARTED|Overall Study||25
10476838|NCT01114971|11625694|FG002|STARTED|Overall Study||25
10476839|NCT01114971|11625692|FG000|COMPLETED|Overall Study||25
10476840|NCT01114971|11625693|FG001|COMPLETED|Overall Study||25
10476841|NCT01114971|11625694|FG002|COMPLETED|Overall Study||25
10476842|NCT01114971|11625692|FG000|NOT COMPLETED|Overall Study||0
10476843|NCT01114971|11625693|FG001|NOT COMPLETED|Overall Study||0
10476844|NCT01114971|11625694|FG002|NOT COMPLETED|Overall Study||0
10476845|NCT01114997|11625705|FG000|STARTED|Overall Study||11
10476846|NCT01114997|11625706|FG001|STARTED|Overall Study||10
10476847|NCT01114997|11625707|FG002|STARTED|Overall Study||11
10476848|NCT01114997|11625705|FG000|COMPLETED|Overall Study||11
10476849|NCT01114997|11625706|FG001|COMPLETED|Overall Study||10
10476850|NCT01114997|11625707|FG002|COMPLETED|Overall Study||11
10476851|NCT01114997|11625705|FG000|NOT COMPLETED|Overall Study||0
10476852|NCT01114997|11625706|FG001|NOT COMPLETED|Overall Study||0
10476853|NCT01114997|11625707|FG002|NOT COMPLETED|Overall Study||0
10476854|NCT01115101|11625718|FG000|STARTED|Overall Study||113
10476855|NCT01115101|11625719|FG001|STARTED|Overall Study||126
10476856|NCT01115101|11625718|FG000|COMPLETED|Overall Study||113
10476857|NCT01115101|11625719|FG001|COMPLETED|Overall Study||126
10476858|NCT01115101|11625718|FG000|NOT COMPLETED|Overall Study||0
10476859|NCT01115101|11625719|FG001|NOT COMPLETED|Overall Study||0
10476860|NCT01115166|11625725|FG000|STARTED|Overall Study||10
10476861|NCT01115166|11625725|FG000|COMPLETED|Overall Study||10
10476862|NCT01115166|11625725|FG000|NOT COMPLETED|Overall Study||0
10476863|NCT01115231|11625731|FG000|STARTED|Overall Study||133
10476864|NCT01115231|11625732|FG001|STARTED|Overall Study||90
10476865|NCT01115231|11625731|FG000|COMPLETED|Overall Study||133
10476866|NCT01115231|11625732|FG001|COMPLETED|Overall Study||90
10476867|NCT01115231|11625731|FG000|NOT COMPLETED|Overall Study||0
10476868|NCT01115231|11625732|FG001|NOT COMPLETED|Overall Study||0
10476869|NCT01115309|11625739|FG000|STARTED|Procedure Safety (1-Month)||175
10476870|NCT01115309|11625739|FG000|COMPLETED|Procedure Safety (1-Month)||172
10476871|NCT01115309|11625739|FG000|NOT COMPLETED|Procedure Safety (1-Month)||3
10476872|NCT01115309|11625739|FG000|STARTED|Long-term Follow-up||50
10476873|NCT01115309|11625739|FG000|6-Month Follow-up|Long-term Follow-up||46
10476874|NCT01115309|11625739|FG000|12-Month Follow-up|Long-term Follow-up||44
10476875|NCT01115309|11625739|FG000|COMPLETED|Long-term Follow-up||44
10476876|NCT01115309|11625739|FG000|NOT COMPLETED|Long-term Follow-up||6
10476877|NCT01115452|11625744|FG000|STARTED|Overall Study||32
10476878|NCT01115452|11625744|FG000|COMPLETED|Overall Study||32
10476879|NCT01115452|11625744|FG000|NOT COMPLETED|Overall Study||0
10476880|NCT01115491|11625752|FG000|STARTED|Overall Study||32
10476881|NCT01115491|11625752|FG000|COMPLETED|Overall Study||2
10476882|NCT01115491|11625752|FG000|NOT COMPLETED|Overall Study||30
10476883|NCT01115517|11625758|FG000|STARTED|Overall Study||18
10476884|NCT01115517|11625759|FG001|STARTED|Overall Study||21
10476885|NCT01115517|11625758|FG000|COMPLETED|Overall Study||14
10476886|NCT01115517|11625759|FG001|COMPLETED|Overall Study||16
10476887|NCT01115517|11625758|FG000|NOT COMPLETED|Overall Study||4
10476888|NCT01115517|11625759|FG001|NOT COMPLETED|Overall Study||5
10526930|NCT01385566|11678875|FG002|STARTED|Overall Study||34
10526931|NCT01385566|11678876|FG003|STARTED|Overall Study||35
10526932|NCT01385566|11678877|FG004|STARTED|Overall Study||34
10526933|NCT01385566|11678878|FG005|STARTED|Overall Study||34
10526934|NCT01385566|11678873|FG000|COMPLETED|Overall Study||51
10526935|NCT01385566|11678874|FG001|COMPLETED|Overall Study||34
10526936|NCT01385566|11678875|FG002|COMPLETED|Overall Study||34
10526937|NCT01385566|11678876|FG003|COMPLETED|Overall Study||34
10526938|NCT01385566|11678877|FG004|COMPLETED|Overall Study||34
10526939|NCT01385566|11678878|FG005|COMPLETED|Overall Study||34
10526940|NCT01385566|11678873|FG000|NOT COMPLETED|Overall Study||1
10526941|NCT01385566|11678874|FG001|NOT COMPLETED|Overall Study||0
10526942|NCT01385566|11678875|FG002|NOT COMPLETED|Overall Study||0
10526943|NCT01385566|11678876|FG003|NOT COMPLETED|Overall Study||1
10526944|NCT01385566|11678877|FG004|NOT COMPLETED|Overall Study||0
10526945|NCT01385566|11678878|FG005|NOT COMPLETED|Overall Study||0
10526946|NCT01385579|11678896|FG000|STARTED|Overall Study||98
10526947|NCT01385579|11678897|FG001|STARTED|Overall Study||104
10526948|NCT01385579|11678896|FG000|COMPLETED|Overall Study||98
10526949|NCT01385579|11678897|FG001|COMPLETED|Overall Study||104
10526950|NCT01385579|11678896|FG000|NOT COMPLETED|Overall Study||0
10526951|NCT01385579|11678897|FG001|NOT COMPLETED|Overall Study||0
10526952|NCT01385644|11678905|FG000|STARTED|Overall Study||4
10526953|NCT01385644|11678906|FG001|STARTED|Overall Study||4
10526954|NCT01385644|11678905|FG000|COMPLETED|Overall Study||4
10526955|NCT01385644|11678906|FG001|COMPLETED|Overall Study||4
10526956|NCT01385644|11678905|FG000|NOT COMPLETED|Overall Study||0
10526957|NCT01385644|11678906|FG001|NOT COMPLETED|Overall Study||0
10526958|NCT01385696|11678912|FG000|STARTED|Overall Study||66
10526959|NCT01385696|11678913|FG001|STARTED|Overall Study|1 patient used Handihaler® once only, Genuair® zero times, & was excluded from the safety population|64
10526960|NCT01385696|11678912|FG000|COMPLETED|Overall Study||66
10526961|NCT01385696|11678913|FG001|COMPLETED|Overall Study||64
10526962|NCT01385696|11678912|FG000|NOT COMPLETED|Overall Study||0
10526963|NCT01385696|11678913|FG001|NOT COMPLETED|Overall Study||0
10526964|NCT01385748|11678923|FG000|STARTED|Overall Study||56
10526965|NCT01385748|11678924|FG001|STARTED|Overall Study||65
10526966|NCT01385748|11678925|FG002|STARTED|Overall Study||62
10526967|NCT01385748|11678923|FG000|COMPLETED|Overall Study||41
10526968|NCT01385748|11678924|FG001|COMPLETED|Overall Study||51
10526969|NCT01385748|11678925|FG002|COMPLETED|Overall Study||49
10526970|NCT01385748|11678923|FG000|NOT COMPLETED|Overall Study||15
10526971|NCT01385748|11678924|FG001|NOT COMPLETED|Overall Study||14
10526972|NCT01385748|11678925|FG002|NOT COMPLETED|Overall Study||13
10709184|NCT02637427|11874092|FG001|COMPLETED|Overall Study||30
10709185|NCT02637427|11874091|FG000|NOT COMPLETED|Overall Study||0
10526973|NCT01385995|11678939|FG000|STARTED|Period 1, 2 Months||25
10526974|NCT01385995|11678940|FG001|STARTED|Period 1, 2 Months||25
10526975|NCT01385995|11678939|FG000|COMPLETED|Period 1, 2 Months||24
10526976|NCT01385995|11678940|FG001|COMPLETED|Period 1, 2 Months||25
10526977|NCT01385995|11678939|FG000|NOT COMPLETED|Period 1, 2 Months||1
10526978|NCT01385995|11678940|FG001|NOT COMPLETED|Period 1, 2 Months||0
10526979|NCT01385995|11678939|FG000|STARTED|Washout Period, 1 Month||24
10526980|NCT01385995|11678940|FG001|STARTED|Washout Period, 1 Month||25
10526981|NCT01385995|11678939|FG000|COMPLETED|Washout Period, 1 Month||24
10526982|NCT01385995|11678940|FG001|COMPLETED|Washout Period, 1 Month||25
10526983|NCT01385995|11678939|FG000|NOT COMPLETED|Washout Period, 1 Month||0
10526984|NCT01385995|11678940|FG001|NOT COMPLETED|Washout Period, 1 Month||0
10526985|NCT01385995|11678939|FG000|STARTED|Period 2, 2 Months||24
10526986|NCT01385995|11678940|FG001|STARTED|Period 2, 2 Months||25
10526987|NCT01385995|11678939|FG000|COMPLETED|Period 2, 2 Months||24
10526988|NCT01385995|11678940|FG001|COMPLETED|Period 2, 2 Months||25
10526989|NCT01385995|11678939|FG000|NOT COMPLETED|Period 2, 2 Months||0
10526990|NCT01385995|11678940|FG001|NOT COMPLETED|Period 2, 2 Months||0
10526991|NCT01386008|11678948|FG000|STARTED|Overall Study||20
10526992|NCT01386008|11678948|FG000|COMPLETED|Overall Study||0
10526993|NCT01386008|11678948|FG000|NOT COMPLETED|Overall Study||20
10526994|NCT01386528|11678952|FG000|STARTED|Overall Study||13
10526995|NCT01386528|11678952|FG000|COMPLETED|Overall Study||13
10526996|NCT01386528|11678952|FG000|NOT COMPLETED|Overall Study||0
10526997|NCT01386554|11678959|FG000|STARTED|Overall Study||4
10526998|NCT01386554|11678960|FG001|STARTED|Overall Study||35
10476889|NCT01115556|11625767|FG000|STARTED|Overall Study||7
10476890|NCT01115556|11625768|FG001|STARTED|Overall Study||2
10476891|NCT01115556|11625767|FG000|COMPLETED|Overall Study||7
10476892|NCT01115556|11625768|FG001|COMPLETED|Overall Study||2
10476893|NCT01115556|11625767|FG000|NOT COMPLETED|Overall Study||0
10476894|NCT01115556|11625768|FG001|NOT COMPLETED|Overall Study||0
10476895|NCT01115569|11625776|FG000|STARTED|Conversion/Titration Phase||638
10476896|NCT01115569|11625777|FG001|STARTED|Conversion/Titration Phase||0
10476897|NCT01115569|11625776|FG000|COMPLETED|Conversion/Titration Phase||424
10476898|NCT01115569|11625777|FG001|COMPLETED|Conversion/Titration Phase||0
10476899|NCT01115569|11625776|FG000|NOT COMPLETED|Conversion/Titration Phase||214
10476900|NCT01115569|11625777|FG001|NOT COMPLETED|Conversion/Titration Phase||0
10476901|NCT01115569|11625776|FG000|STARTED|Maintenance Phase||0
10476902|NCT01115569|11625777|FG001|STARTED|Maintenance Phase||424
10476903|NCT01115569|11625776|FG000|COMPLETED|Maintenance Phase||0
10476904|NCT01115569|11625777|FG001|COMPLETED|Maintenance Phase||285
10476905|NCT01115569|11625776|FG000|NOT COMPLETED|Maintenance Phase||0
10476906|NCT01115569|11625777|FG001|NOT COMPLETED|Maintenance Phase||139
10476907|NCT01115582|11625782|FG000|STARTED|Overall Study||16
10476908|NCT01115582|11625782|FG000|COMPLETED|Overall Study||16
10476909|NCT01115582|11625782|FG000|NOT COMPLETED|Overall Study||0
10476910|NCT01115660|11625788|FG000|STARTED|Overall Study||20
10476911|NCT01115660|11625789|FG001|STARTED|Overall Study||10
10476912|NCT01115660|11625788|FG000|COMPLETED|Overall Study||19
10476913|NCT01115660|11625789|FG001|COMPLETED|Overall Study||10
10476914|NCT01115660|11625788|FG000|NOT COMPLETED|Overall Study||1
10476915|NCT01115660|11625789|FG001|NOT COMPLETED|Overall Study||0
10476916|NCT01115673|11625798|FG000|STARTED|Overall Study||239
10476917|NCT01115673|11625799|FG001|STARTED|Overall Study||241
10476918|NCT01115673|11625800|FG002|STARTED|Overall Study||60
10476919|NCT01115673|11625798|FG000|COMPLETED|Overall Study||239
10476920|NCT01115673|11625799|FG001|COMPLETED|Overall Study||241
10476921|NCT01115673|11625800|FG002|COMPLETED|Overall Study||60
10476922|NCT01115673|11625798|FG000|NOT COMPLETED|Overall Study||0
10476923|NCT01115673|11625799|FG001|NOT COMPLETED|Overall Study||0
10476924|NCT01115673|11625800|FG002|NOT COMPLETED|Overall Study||0
10476925|NCT01115738|11625811|FG000|STARTED|Overall Study||110
10476926|NCT01115738|11625812|FG001|STARTED|Overall Study||83
10476927|NCT01115738|11625813|FG002|STARTED|Overall Study||89
10476928|NCT01115738|11625811|FG000|Received Any Treatment|Overall Study||109
10476929|NCT01115738|11625812|FG001|Received Any Treatment|Overall Study||79
10476930|NCT01115738|11625813|FG002|Received Any Treatment|Overall Study||88
10476931|NCT01115738|11625811|FG000|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|52
10476932|NCT01115738|11625812|FG001|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|47
10476933|NCT01115738|11625813|FG002|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|50
10476934|NCT01115738|11625811|FG000|COMPLETED|Overall Study||85
10476935|NCT01115738|11625812|FG001|COMPLETED|Overall Study||62
10476936|NCT01115738|11625813|FG002|COMPLETED|Overall Study||62
10476937|NCT01115738|11625811|FG000|NOT COMPLETED|Overall Study||25
10476938|NCT01115738|11625812|FG001|NOT COMPLETED|Overall Study||21
10476939|NCT01115738|11625813|FG002|NOT COMPLETED|Overall Study||27
10476940|NCT01115803|11625836|FG000|STARTED|Overall Study||4
10476941|NCT01115803|11625837|FG001|STARTED|Overall Study||5
10476942|NCT01115803|11625838|FG002|STARTED|Overall Study||3
10476943|NCT01115803|11625839|FG003|STARTED|Overall Study||5
10476944|NCT01115803|11625840|FG004|STARTED|Overall Study||3
10476945|NCT01115803|11625841|FG005|STARTED|Overall Study||3
10476946|NCT01115803|11625842|FG006|STARTED|Overall Study||6
10476947|NCT01115803|11625836|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
10476948|NCT01115803|11625837|FG001|Received at Least 1 Dose of Study Drug|Overall Study||5
10476949|NCT01115803|11625838|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
10476950|NCT01115803|11625839|FG003|Received at Least 1 Dose of Study Drug|Overall Study||5
10476951|NCT01115803|11625840|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3
10476952|NCT01115803|11625841|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3
10476953|NCT01115803|11625842|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
10476954|NCT01115803|11625836|FG000|COMPLETED|Overall Study||4
10476955|NCT01115803|11625837|FG001|COMPLETED|Overall Study||5
10476956|NCT01115803|11625838|FG002|COMPLETED|Overall Study||2
10476957|NCT01115803|11625839|FG003|COMPLETED|Overall Study||5
10476958|NCT01115803|11625840|FG004|COMPLETED|Overall Study||3
10476959|NCT01115803|11625841|FG005|COMPLETED|Overall Study||3
10476960|NCT01115803|11625842|FG006|COMPLETED|Overall Study||4
10476961|NCT01115803|11625836|FG000|NOT COMPLETED|Overall Study||0
10476962|NCT01115803|11625837|FG001|NOT COMPLETED|Overall Study||0
10476963|NCT01115803|11625838|FG002|NOT COMPLETED|Overall Study||1
10476964|NCT01115803|11625839|FG003|NOT COMPLETED|Overall Study||0
10476965|NCT01115803|11625840|FG004|NOT COMPLETED|Overall Study||0
10476966|NCT01115803|11625841|FG005|NOT COMPLETED|Overall Study||0
10476967|NCT01115803|11625842|FG006|NOT COMPLETED|Overall Study||2
10476968|NCT01115855|11625865|FG000|STARTED|Overall Study||111
10476969|NCT01115855|11625866|FG001|STARTED|Overall Study||110
10476970|NCT01115855|11625865|FG000|COMPLETED|Overall Study||75
10476971|NCT01115855|11625866|FG001|COMPLETED|Overall Study||74
10476972|NCT01115855|11625865|FG000|NOT COMPLETED|Overall Study||36
10476973|NCT01115855|11625866|FG001|NOT COMPLETED|Overall Study||36
10476974|NCT01115933|11625872|FG000|STARTED|Overall Study||65
10476975|NCT01115933|11625872|FG000|COMPLETED|Overall Study||64
10476976|NCT01115933|11625872|FG000|NOT COMPLETED|Overall Study||1
10476977|NCT01115998|11625931|FG000|STARTED|Overall Study||17
10476978|NCT01115998|11625932|FG001|STARTED|Overall Study||17
10709186|NCT02637427|11874092|FG001|NOT COMPLETED|Overall Study||0
10709187|NCT02637557|11874102|FG000|STARTED|Overall Study||71
10709188|NCT02637557|11874103|FG001|STARTED|Overall Study||71
10709189|NCT02637557|11874104|FG002|STARTED|Overall Study||71
10709190|NCT02637557|11874105|FG003|STARTED|Overall Study||69
10709191|NCT02637557|11874102|FG000|COMPLETED|Overall Study||63
10709192|NCT02637557|11874103|FG001|COMPLETED|Overall Study||66
10709193|NCT02637557|11874104|FG002|COMPLETED|Overall Study||62
10709194|NCT02637557|11874105|FG003|COMPLETED|Overall Study||62
10476979|NCT01115998|11625931|FG000|COMPLETED|Overall Study||11
10476980|NCT01115998|11625932|FG001|COMPLETED|Overall Study||11
10476981|NCT01115998|11625931|FG000|NOT COMPLETED|Overall Study||6
10476982|NCT01115998|11625932|FG001|NOT COMPLETED|Overall Study||6
10476983|NCT01116024|11625938|FG000|STARTED|Overall Study|148 subjects left operating room with the device implanted and were included in the analysis.|148
10476984|NCT01116024|11625938|FG000|COMPLETED|Overall Study|Patient Enrollment stop date|96
10476985|NCT01116024|11625938|FG000|NOT COMPLETED|Overall Study||52
10476986|NCT01116037|11625964|FG000|STARTED|Overall Study||26
10476987|NCT01116037|11625964|FG000|COMPLETED|Overall Study||1
10476988|NCT01116037|11625964|FG000|NOT COMPLETED|Overall Study||25
10476989|NCT01116102|11625976|FG000|STARTED|Overall Study||2
10476990|NCT01116102|11625977|FG001|STARTED|Overall Study||3
10476991|NCT01116102|11625978|FG002|STARTED|Overall Study||3
10476992|NCT01116102|11625979|FG003|STARTED|Overall Study||3
10476993|NCT01116102|11625980|FG004|STARTED|Overall Study||2
10709195|NCT02637557|11874102|FG000|NOT COMPLETED|Overall Study||8
10709196|NCT02637557|11874103|FG001|NOT COMPLETED|Overall Study||5
10476994|NCT01116102|11625981|FG005|STARTED|Overall Study||2
10476995|NCT01116102|11625982|FG006|STARTED|Overall Study||2
10476996|NCT01116102|11625983|FG007|STARTED|Overall Study||3
10476997|NCT01116102|11625976|FG000|COMPLETED|Overall Study||2
10476998|NCT01116102|11625977|FG001|COMPLETED|Overall Study||3
10476999|NCT01116102|11625978|FG002|COMPLETED|Overall Study||3
10477000|NCT01116102|11625979|FG003|COMPLETED|Overall Study||3
10477001|NCT01116102|11625980|FG004|COMPLETED|Overall Study||2
10477002|NCT01116102|11625981|FG005|COMPLETED|Overall Study||2
10477003|NCT01116102|11625982|FG006|COMPLETED|Overall Study||2
10477004|NCT01116102|11625983|FG007|COMPLETED|Overall Study||3
10477005|NCT01116102|11625976|FG000|NOT COMPLETED|Overall Study||0
10477006|NCT01116102|11625977|FG001|NOT COMPLETED|Overall Study||0
10477007|NCT01116102|11625978|FG002|NOT COMPLETED|Overall Study||0
10477008|NCT01116102|11625979|FG003|NOT COMPLETED|Overall Study||0
10477009|NCT01116102|11625980|FG004|NOT COMPLETED|Overall Study||0
10477010|NCT01116102|11625981|FG005|NOT COMPLETED|Overall Study||0
10477011|NCT01116102|11625982|FG006|NOT COMPLETED|Overall Study||0
10477012|NCT01116102|11625983|FG007|NOT COMPLETED|Overall Study||0
10477013|NCT01116401|11626001|FG000|STARTED|Overall Study||29
10477014|NCT01116401|11626001|FG000|COMPLETED|Overall Study||29
10477015|NCT01116401|11626001|FG000|NOT COMPLETED|Overall Study||0
10477016|NCT01116427|11626007|FG000|STARTED|Core Phase||44
10477017|NCT01116427|11626008|FG001|STARTED|Core Phase||21
10477018|NCT01116427|11626007|FG000|COMPLETED|Core Phase||39
10477019|NCT01116427|11626008|FG001|COMPLETED|Core Phase||20
10477020|NCT01116427|11626007|FG000|NOT COMPLETED|Core Phase||5
10477021|NCT01116427|11626008|FG001|NOT COMPLETED|Core Phase||1
10477022|NCT01116427|11626007|FG000|STARTED|Extension Phase|One participant that completed core phase did not meet eligibility for Extension Phase|38
10477023|NCT01116427|11626008|FG001|STARTED|Extension Phase||20
10477024|NCT01116427|11626007|FG000|COMPLETED|Extension Phase||29
10477025|NCT01116427|11626008|FG001|COMPLETED|Extension Phase||18
10477026|NCT01116427|11626007|FG000|NOT COMPLETED|Extension Phase||9
10477027|NCT01116427|11626008|FG001|NOT COMPLETED|Extension Phase||2
10477028|NCT01116440|11626020|FG000|STARTED|Treatment||11
10477029|NCT01116440|11626021|FG001|STARTED|Treatment||16
10477030|NCT01116440|11626020|FG000|COMPLETED|Treatment||8
10477031|NCT01116440|11626021|FG001|COMPLETED|Treatment||9
10477032|NCT01116440|11626020|FG000|NOT COMPLETED|Treatment||3
10477033|NCT01116440|11626021|FG001|NOT COMPLETED|Treatment||7
10709197|NCT02637557|11874104|FG002|NOT COMPLETED|Overall Study||9
10709198|NCT02637557|11874105|FG003|NOT COMPLETED|Overall Study||7
10709199|NCT02637804|11874117|FG000|STARTED|First Intervention (1 Week)||27
10477034|NCT01116440|11626020|FG000|STARTED|Withdrawal||8
10477035|NCT01116440|11626021|FG001|STARTED|Withdrawal||9
10477036|NCT01116440|11626020|FG000|COMPLETED|Withdrawal||8
10477037|NCT01116440|11626021|FG001|COMPLETED|Withdrawal||7
10477038|NCT01116440|11626020|FG000|NOT COMPLETED|Withdrawal||0
10477039|NCT01116440|11626021|FG001|NOT COMPLETED|Withdrawal||2
10477040|NCT01116440|11626020|FG000|STARTED|Follow-up||8
10477041|NCT01116440|11626021|FG001|STARTED|Follow-up||7
10477042|NCT01116440|11626020|FG000|COMPLETED|Follow-up||8
10477043|NCT01116440|11626021|FG001|COMPLETED|Follow-up||5
10477044|NCT01116440|11626020|FG000|NOT COMPLETED|Follow-up||0
10477045|NCT01116440|11626021|FG001|NOT COMPLETED|Follow-up||2
10477046|NCT01116466|11626029|FG000|STARTED|Overall Study||5
10477047|NCT01116466|11626029|FG000|COMPLETED|Overall Study||5
10477048|NCT01116466|11626029|FG000|NOT COMPLETED|Overall Study||0
10477049|NCT01116544|11626036|FG000|STARTED|Overall Study||23
10709200|NCT02637804|11874118|FG001|STARTED|First Intervention (1 Week)||28
10709201|NCT02637804|11874119|FG002|STARTED|First Intervention (1 Week)||25
10477050|NCT01116544|11626037|FG001|STARTED|Overall Study||23
10477051|NCT01116544|11626036|FG000|COMPLETED|Overall Study||21
10477052|NCT01116544|11626037|FG001|COMPLETED|Overall Study||22
10477053|NCT01116544|11626036|FG000|NOT COMPLETED|Overall Study||2
10477054|NCT01116544|11626037|FG001|NOT COMPLETED|Overall Study||1
10477055|NCT01116661|11626043|FG000|STARTED|Overall Study||199
10477056|NCT01116661|11626043|FG000|COMPLETED|Overall Study||197
10477057|NCT01116661|11626043|FG000|NOT COMPLETED|Overall Study||2
10477058|NCT01116687|11626047|FG000|STARTED|Overall Study||37
10477059|NCT01116687|11626047|FG000|COMPLETED|Overall Study||33
10477060|NCT01116687|11626047|FG000|NOT COMPLETED|Overall Study||4
10477061|NCT01116739|11626053|FG000|STARTED|Overall Study||1056
10477062|NCT01116739|11626054|FG001|STARTED|Overall Study||1004
10477063|NCT01116739|11626053|FG000|COMPLETED|Overall Study||926
10477064|NCT01116739|11626054|FG001|COMPLETED|Overall Study||868
10477065|NCT01116739|11626053|FG000|NOT COMPLETED|Overall Study||130
10477066|NCT01116739|11626054|FG001|NOT COMPLETED|Overall Study||136
10477067|NCT01116882|11626062|FG000|STARTED|30-day||2774
10477068|NCT01116882|11626063|FG001|STARTED|30-day||917
10477069|NCT01116882|11626062|FG000|COMPLETED|30-day||2706
10477070|NCT01116882|11626063|FG001|COMPLETED|30-day||886
10477071|NCT01116882|11626062|FG000|NOT COMPLETED|30-day||68
10477072|NCT01116882|11626063|FG001|NOT COMPLETED|30-day||31
10477073|NCT01116882|11626062|FG000|STARTED|12-month||2706
10477074|NCT01116882|11626063|FG001|STARTED|12-month||886
10477075|NCT01116882|11626062|FG000|COMPLETED|12-month||2439
10477076|NCT01116882|11626063|FG001|COMPLETED|12-month||787
10477077|NCT01116882|11626062|FG000|NOT COMPLETED|12-month||267
10477078|NCT01116882|11626063|FG001|NOT COMPLETED|12-month||99
10477079|NCT01116895|11626076|FG000|STARTED|Overall Study||16
10477080|NCT01116895|11626077|FG001|STARTED|Overall Study||15
10477081|NCT01116895|11626078|FG002|STARTED|Overall Study||18
10477082|NCT01116895|11626079|FG003|STARTED|Overall Study||14
10477083|NCT01116895|11626076|FG000|COMPLETED|Overall Study||12
10477084|NCT01116895|11626077|FG001|COMPLETED|Overall Study||8
10477085|NCT01116895|11626078|FG002|COMPLETED|Overall Study||14
10477086|NCT01116895|11626079|FG003|COMPLETED|Overall Study||11
10477087|NCT01116895|11626076|FG000|NOT COMPLETED|Overall Study||4
10477088|NCT01116895|11626077|FG001|NOT COMPLETED|Overall Study||7
10477089|NCT01116895|11626078|FG002|NOT COMPLETED|Overall Study||4
10477090|NCT01116895|11626079|FG003|NOT COMPLETED|Overall Study||3
10477091|NCT01116921|11626091|FG000|STARTED|Overall Study||53
10477092|NCT01116921|11626092|FG001|STARTED|Overall Study||50
10477093|NCT01116921|11626091|FG000|COMPLETED|Overall Study||53
10477094|NCT01116921|11626092|FG001|COMPLETED|Overall Study||50
10477095|NCT01116921|11626091|FG000|NOT COMPLETED|Overall Study||0
10477096|NCT01116921|11626092|FG001|NOT COMPLETED|Overall Study||0
10477097|NCT01116934|11626100|FG000|STARTED|Overall Study||8
10477098|NCT01116934|11626101|FG001|STARTED|Overall Study||9
10477099|NCT01116934|11626100|FG000|COMPLETED|Overall Study||8
10477100|NCT01116934|11626101|FG001|COMPLETED|Overall Study||9
10477101|NCT01116934|11626100|FG000|NOT COMPLETED|Overall Study||0
10477102|NCT01116934|11626101|FG001|NOT COMPLETED|Overall Study||0
10477103|NCT01116986|11626139|FG000|STARTED|Overall Study||24
10477104|NCT01116986|11626140|FG001|STARTED|Overall Study||19
10477105|NCT01116986|11626141|FG002|STARTED|Overall Study||18
10477106|NCT01116986|11626142|FG003|STARTED|Overall Study||22
10477107|NCT01116986|11626143|FG004|STARTED|Overall Study||24
10477108|NCT01116986|11626144|FG005|STARTED|Overall Study||22
10477109|NCT01116986|11626145|FG006|STARTED|Overall Study||22
10477110|NCT01116986|11626146|FG007|STARTED|Overall Study||22
10477111|NCT01116986|11626147|FG008|STARTED|Overall Study||20
10477112|NCT01116986|11626148|FG009|STARTED|Overall Study||23
10477113|NCT01116986|11626149|FG010|STARTED|Overall Study||19
10477114|NCT01116986|11626150|FG011|STARTED|Overall Study||20
10477115|NCT01116986|11626151|FG012|STARTED|Overall Study||17
10477116|NCT01116986|11626152|FG013|STARTED|Overall Study||19
10709202|NCT02637804|11874120|FG003|STARTED|First Intervention (1 Week)||26
10477117|NCT01116986|11626153|FG014|STARTED|Overall Study||17
10477118|NCT01116986|11626154|FG015|STARTED|Overall Study||21
10477119|NCT01116986|11626155|FG016|STARTED|Overall Study||16
10477120|NCT01116986|11626156|FG017|STARTED|Overall Study||24
10477121|NCT01116986|11626157|FG018|STARTED|Overall Study||23
10477122|NCT01116986|11626158|FG019|STARTED|Overall Study||15
10477123|NCT01116986|11626159|FG020|STARTED|Overall Study||24
10477124|NCT01116986|11626160|FG021|STARTED|Overall Study||20
10477125|NCT01116986|11626161|FG022|STARTED|Overall Study||23
10477126|NCT01116986|11626162|FG023|STARTED|Overall Study||21
10477127|NCT01116986|11626163|FG024|STARTED|Overall Study||18
10477128|NCT01116986|11626164|FG025|STARTED|Overall Study||19
10477129|NCT01116986|11626165|FG026|STARTED|Overall Study||18
10477130|NCT01116986|11626166|FG027|STARTED|Overall Study||19
10477131|NCT01116986|11626167|FG028|STARTED|Overall Study||17
10477132|NCT01116986|11626168|FG029|STARTED|Overall Study||17
10477133|NCT01116986|11626169|FG030|STARTED|Overall Study||17
10477134|NCT01116986|11626170|FG031|STARTED|Overall Study||17
10477135|NCT01116986|11626139|FG000|COMPLETED|Overall Study||22
10477136|NCT01116986|11626140|FG001|COMPLETED|Overall Study||16
10477137|NCT01116986|11626141|FG002|COMPLETED|Overall Study||16
10477138|NCT01116986|11626142|FG003|COMPLETED|Overall Study||20
10477139|NCT01116986|11626143|FG004|COMPLETED|Overall Study||20
10477140|NCT01116986|11626144|FG005|COMPLETED|Overall Study||20
10477141|NCT01116986|11626145|FG006|COMPLETED|Overall Study||20
10477142|NCT01116986|11626146|FG007|COMPLETED|Overall Study||20
10477143|NCT01116986|11626147|FG008|COMPLETED|Overall Study||19
10477144|NCT01116986|11626148|FG009|COMPLETED|Overall Study||19
10477145|NCT01116986|11626149|FG010|COMPLETED|Overall Study||18
10477146|NCT01116986|11626150|FG011|COMPLETED|Overall Study||20
10477147|NCT01116986|11626151|FG012|COMPLETED|Overall Study||16
10477148|NCT01116986|11626152|FG013|COMPLETED|Overall Study||16
10477149|NCT01116986|11626153|FG014|COMPLETED|Overall Study||17
10477150|NCT01116986|11626154|FG015|COMPLETED|Overall Study||15
10477151|NCT01116986|11626155|FG016|COMPLETED|Overall Study||13
10477152|NCT01116986|11626156|FG017|COMPLETED|Overall Study||19
10477153|NCT01116986|11626157|FG018|COMPLETED|Overall Study||20
10477154|NCT01116986|11626158|FG019|COMPLETED|Overall Study||13
10477155|NCT01116986|11626159|FG020|COMPLETED|Overall Study||22
10477156|NCT01116986|11626160|FG021|COMPLETED|Overall Study||18
10477157|NCT01116986|11626161|FG022|COMPLETED|Overall Study||19
10477158|NCT01116986|11626162|FG023|COMPLETED|Overall Study||19
10477159|NCT01116986|11626163|FG024|COMPLETED|Overall Study||15
10477160|NCT01116986|11626164|FG025|COMPLETED|Overall Study||19
10477161|NCT01116986|11626165|FG026|COMPLETED|Overall Study||14
10477162|NCT01116986|11626166|FG027|COMPLETED|Overall Study||18
10477163|NCT01116986|11626167|FG028|COMPLETED|Overall Study||17
10477164|NCT01116986|11626168|FG029|COMPLETED|Overall Study||17
10477165|NCT01116986|11626169|FG030|COMPLETED|Overall Study||16
10477166|NCT01116986|11626170|FG031|COMPLETED|Overall Study||14
10477167|NCT01116986|11626139|FG000|NOT COMPLETED|Overall Study||2
10477168|NCT01116986|11626140|FG001|NOT COMPLETED|Overall Study||3
10477169|NCT01116986|11626141|FG002|NOT COMPLETED|Overall Study||2
10477170|NCT01116986|11626142|FG003|NOT COMPLETED|Overall Study||2
10477171|NCT01116986|11626143|FG004|NOT COMPLETED|Overall Study||4
10477172|NCT01116986|11626144|FG005|NOT COMPLETED|Overall Study||2
10477173|NCT01116986|11626145|FG006|NOT COMPLETED|Overall Study||2
10477174|NCT01116986|11626146|FG007|NOT COMPLETED|Overall Study||2
10477175|NCT01116986|11626147|FG008|NOT COMPLETED|Overall Study||1
10477176|NCT01116986|11626148|FG009|NOT COMPLETED|Overall Study||4
10477177|NCT01116986|11626149|FG010|NOT COMPLETED|Overall Study||1
10477178|NCT01116986|11626150|FG011|NOT COMPLETED|Overall Study||0
10477179|NCT01116986|11626151|FG012|NOT COMPLETED|Overall Study||1
10477180|NCT01116986|11626152|FG013|NOT COMPLETED|Overall Study||3
10477181|NCT01116986|11626153|FG014|NOT COMPLETED|Overall Study||0
10477182|NCT01116986|11626154|FG015|NOT COMPLETED|Overall Study||6
10477183|NCT01116986|11626155|FG016|NOT COMPLETED|Overall Study||3
10477184|NCT01116986|11626156|FG017|NOT COMPLETED|Overall Study||5
10477185|NCT01116986|11626157|FG018|NOT COMPLETED|Overall Study||3
10477186|NCT01116986|11626158|FG019|NOT COMPLETED|Overall Study||2
10477187|NCT01116986|11626159|FG020|NOT COMPLETED|Overall Study||2
10477188|NCT01116986|11626160|FG021|NOT COMPLETED|Overall Study||2
10477189|NCT01116986|11626161|FG022|NOT COMPLETED|Overall Study||4
10477190|NCT01116986|11626162|FG023|NOT COMPLETED|Overall Study||2
10477191|NCT01116986|11626163|FG024|NOT COMPLETED|Overall Study||3
10477192|NCT01116986|11626164|FG025|NOT COMPLETED|Overall Study||0
10477193|NCT01116986|11626165|FG026|NOT COMPLETED|Overall Study||4
10477194|NCT01116986|11626166|FG027|NOT COMPLETED|Overall Study||1
10477195|NCT01116986|11626167|FG028|NOT COMPLETED|Overall Study||0
10477196|NCT01116986|11626168|FG029|NOT COMPLETED|Overall Study||0
10477197|NCT01116986|11626169|FG030|NOT COMPLETED|Overall Study||1
10477198|NCT01116986|11626170|FG031|NOT COMPLETED|Overall Study||3
10477199|NCT01117012|11626192|FG000|STARTED|Overall Study||89
10477200|NCT01117012|11626193|FG001|STARTED|Overall Study||103
10477201|NCT01117012|11626192|FG000|COMPLETED|Overall Study||81
10477202|NCT01117012|11626193|FG001|COMPLETED|Overall Study||98
10477203|NCT01117012|11626192|FG000|NOT COMPLETED|Overall Study||8
10477204|NCT01117012|11626193|FG001|NOT COMPLETED|Overall Study||5
10477205|NCT01117051|11626201|FG000|STARTED|Overall Study||86
10477206|NCT01117051|11626202|FG001|STARTED|Overall Study||88
10477207|NCT01117051|11626201|FG000|COMPLETED|Overall Study||73
10477208|NCT01117051|11626202|FG001|COMPLETED|Overall Study||77
10477209|NCT01117051|11626201|FG000|NOT COMPLETED|Overall Study||13
10477210|NCT01117051|11626202|FG001|NOT COMPLETED|Overall Study||11
10477211|NCT01117090|11626209|FG000|STARTED|Overall Study||47
10477212|NCT01117090|11626209|FG000|COMPLETED|Overall Study||47
10477213|NCT01117090|11626209|FG000|NOT COMPLETED|Overall Study||0
10477214|NCT01117181|11626222|FG000|STARTED|Overall Study||29
10477215|NCT01117181|11626223|FG001|STARTED|Overall Study||31
10477216|NCT01117181|11626222|FG000|COMPLETED|Overall Study||28
10477217|NCT01117181|11626223|FG001|COMPLETED|Overall Study||29
10477218|NCT01117181|11626222|FG000|NOT COMPLETED|Overall Study||1
10477219|NCT01117181|11626223|FG001|NOT COMPLETED|Overall Study||2
10477220|NCT01117311|11626231|FG000|STARTED|Lead-in Mixed Meal 1||3
10477221|NCT01117311|11626232|FG001|STARTED|Lead-in Mixed Meal 1||4
10477222|NCT01117311|11626231|FG000|COMPLETED|Lead-in Mixed Meal 1||3
10477223|NCT01117311|11626232|FG001|COMPLETED|Lead-in Mixed Meal 1||4
10477224|NCT01117311|11626231|FG000|NOT COMPLETED|Lead-in Mixed Meal 1||0
10477225|NCT01117311|11626232|FG001|NOT COMPLETED|Lead-in Mixed Meal 1||0
10477226|NCT01117311|11626231|FG000|STARTED|First Intervention - Mixed Meal 2||3
10477227|NCT01117311|11626232|FG001|STARTED|First Intervention - Mixed Meal 2||4
10477228|NCT01117311|11626231|FG000|COMPLETED|First Intervention - Mixed Meal 2||3
10477229|NCT01117311|11626232|FG001|COMPLETED|First Intervention - Mixed Meal 2||4
10477230|NCT01117311|11626231|FG000|NOT COMPLETED|First Intervention - Mixed Meal 2||0
10477231|NCT01117311|11626232|FG001|NOT COMPLETED|First Intervention - Mixed Meal 2||0
10477232|NCT01117311|11626231|FG000|STARTED|Second Intervention - Mixed Meal 3||3
10477233|NCT01117311|11626232|FG001|STARTED|Second Intervention - Mixed Meal 3||4
10649857|NCT02164539|11810006|FG003|COMPLETED|Treatment Phase A (4 Weeks)||44
10649858|NCT02164539|11810007|FG004|COMPLETED|Treatment Phase A (4 Weeks)||82
10649859|NCT02164539|11810008|FG005|COMPLETED|Treatment Phase A (4 Weeks)||83
10649860|NCT02164539|11810009|FG006|COMPLETED|Treatment Phase A (4 Weeks)||0
10649861|NCT02164539|11810003|FG000|NOT COMPLETED|Treatment Phase A (4 Weeks)||2
10649862|NCT02164539|11810004|FG001|NOT COMPLETED|Treatment Phase A (4 Weeks)||0
10649863|NCT02164539|11810005|FG002|NOT COMPLETED|Treatment Phase A (4 Weeks)||1
10649864|NCT02164539|11810006|FG003|NOT COMPLETED|Treatment Phase A (4 Weeks)||2
10649865|NCT02164539|11810007|FG004|NOT COMPLETED|Treatment Phase A (4 Weeks)||3
10477234|NCT01117311|11626231|FG000|COMPLETED|Second Intervention - Mixed Meal 3||3
10477235|NCT01117311|11626232|FG001|COMPLETED|Second Intervention - Mixed Meal 3||4
10477236|NCT01117311|11626231|FG000|NOT COMPLETED|Second Intervention - Mixed Meal 3||0
10477237|NCT01117311|11626232|FG001|NOT COMPLETED|Second Intervention - Mixed Meal 3||0
10477238|NCT01117337|11626240|FG000|STARTED|Overall Study|52 pateints on inguinal hernia were randomized to mesh fixation group|52
10477239|NCT01117337|11626241|FG001|STARTED|Overall Study||52
10477240|NCT01117337|11626240|FG000|Underwent Surgery|Overall Study|52 patients underwent surgery|52
10477241|NCT01117337|11626241|FG001|Underwent Surgery|Overall Study||52
10477242|NCT01117337|11626240|FG000|COMPLETED|Overall Study|48 completed one year follow-up. 4 lost to follow-up.|48
10477243|NCT01117337|11626241|FG001|COMPLETED|Overall Study||52
10477244|NCT01117337|11626240|FG000|NOT COMPLETED|Overall Study||4
10477245|NCT01117337|11626241|FG001|NOT COMPLETED|Overall Study||0
10477246|NCT01117350|11626249|FG000|STARTED|Comparative Period|STARTED: randomized|489
10477247|NCT01117350|11626250|FG001|STARTED|Comparative Period||489
10477248|NCT01117350|11626249|FG000|TREATED = Safety Population|Comparative Period|Safety population: all randomized and treated patients (received at least one dose)|484
10477249|NCT01117350|11626250|FG001|TREATED = Safety Population|Comparative Period||481
10477250|NCT01117350|11626249|FG000|mITT Population|Comparative Period|modified Intent-To-Treat population: treated patients with at least one efficacy post-baseline value|474
10477251|NCT01117350|11626250|FG001|mITT Population|Comparative Period||470
10477252|NCT01117350|11626249|FG000|COMPLETED|Comparative Period||447
10477253|NCT01117350|11626250|FG001|COMPLETED|Comparative Period||414
10477254|NCT01117350|11626249|FG000|NOT COMPLETED|Comparative Period||42
10477255|NCT01117350|11626250|FG001|NOT COMPLETED|Comparative Period||75
10477256|NCT01117350|11626249|FG000|STARTED|Extension Period||0
10477257|NCT01117350|11626250|FG001|STARTED|Extension Period|STARTED: patients having completed the comparative period and eligible for the extension period|210
10477258|NCT01117350|11626249|FG000|TREATED = Safety Population (Extension)|Extension Period||0
10477259|NCT01117350|11626250|FG001|TREATED = Safety Population (Extension)|Extension Period|Safety population (extension): treated with insulin glargine during the extension period|160
10477260|NCT01117350|11626249|FG000|mITT Population (Extension)|Extension Period||0
10477261|NCT01117350|11626250|FG001|mITT Population (Extension)|Extension Period|mITT (extension): treated patients with at least 1 efficacy value both at entry and during extension|154
10477262|NCT01117350|11626249|FG000|COMPLETED|Extension Period||0
10477263|NCT01117350|11626250|FG001|COMPLETED|Extension Period||147
10477264|NCT01117350|11626249|FG000|NOT COMPLETED|Extension Period||0
10477265|NCT01117350|11626250|FG001|NOT COMPLETED|Extension Period||63
10477266|NCT01117428|11626265|FG000|STARTED|Overall Study|"0.4 mg/kg=1~0.75 mg/kg=1~1.5 mg/kg=3~3 mg/kg=3~6 mg/kg=3~9 mg/kg=6~12 mg/kg=3"|20
10477267|NCT01117428|11626266|FG001|STARTED|Overall Study||29
10477268|NCT01117428|11626267|FG002|STARTED|Overall Study||13
10477269|NCT01117428|11626268|FG003|STARTED|Overall Study||12
10477270|NCT01117428|11626269|FG004|STARTED|Overall Study||17
10477271|NCT01117428|11626270|FG005|STARTED|Overall Study||20
10477272|NCT01117428|11626265|FG000|COMPLETED|Overall Study||0
10477273|NCT01117428|11626266|FG001|COMPLETED|Overall Study||0
10477274|NCT01117428|11626267|FG002|COMPLETED|Overall Study||0
10477275|NCT01117428|11626268|FG003|COMPLETED|Overall Study||0
10477276|NCT01117428|11626269|FG004|COMPLETED|Overall Study||0
10477277|NCT01117428|11626270|FG005|COMPLETED|Overall Study||0
10477278|NCT01117428|11626265|FG000|NOT COMPLETED|Overall Study||20
10477279|NCT01117428|11626266|FG001|NOT COMPLETED|Overall Study||29
10477280|NCT01117428|11626267|FG002|NOT COMPLETED|Overall Study||13
10477281|NCT01117428|11626268|FG003|NOT COMPLETED|Overall Study||12
10477282|NCT01117428|11626269|FG004|NOT COMPLETED|Overall Study||17
10477283|NCT01117428|11626270|FG005|NOT COMPLETED|Overall Study||20
10477284|NCT01117454|11626288|FG000|STARTED|Overall Study||6
10477285|NCT01117454|11626289|FG001|STARTED|Overall Study||8
10477286|NCT01117454|11626288|FG000|COMPLETED|Overall Study||6
10477287|NCT01117454|11626289|FG001|COMPLETED|Overall Study||7
10477288|NCT01117454|11626288|FG000|NOT COMPLETED|Overall Study||0
10477289|NCT01117454|11626289|FG001|NOT COMPLETED|Overall Study||1
10477290|NCT01117480|11626295|FG000|STARTED|Overall Study||1013
10477291|NCT01117480|11626295|FG000|COMPLETED|Overall Study||985
10477292|NCT01117480|11626295|FG000|NOT COMPLETED|Overall Study||28
10477293|NCT01117623|11626307|FG000|STARTED|Overall Study||3
10477294|NCT01117623|11626308|FG001|STARTED|Overall Study||8
10477295|NCT01117623|11626309|FG002|STARTED|Overall Study||11
10477296|NCT01117623|11626310|FG003|STARTED|Overall Study||6
10477297|NCT01117623|11626311|FG004|STARTED|Overall Study||10
10477298|NCT01117623|11626312|FG005|STARTED|Overall Study||16
10339220|NCT00371566|11476130|FG001|COMPLETED|Chemoradiation Phase||65
10477299|NCT01117623|11626313|FG006|STARTED|Overall Study||6
10477300|NCT01117623|11626314|FG007|STARTED|Overall Study||26
10477301|NCT01117623|11626307|FG000|ITT Efficacy Analysis Population|Overall Study||3
10477302|NCT01117623|11626308|FG001|ITT Efficacy Analysis Population|Overall Study||8
10338172|NCT00368745|11475071|FG001|COMPLETED|Randomized to Double-blind Treatment|One subject did not want to participate in study.|50
10338173|NCT00368745|11475070|FG000|NOT COMPLETED|Randomized to Double-blind Treatment||1
10338174|NCT00368745|11475071|FG001|NOT COMPLETED|Randomized to Double-blind Treatment||1
10338175|NCT00368745|11475070|FG000|STARTED|Double-blind Treatment Period||56
10338176|NCT00368745|11475071|FG001|STARTED|Double-blind Treatment Period||50
10338177|NCT00368745|11475070|FG000|COMPLETED|Double-blind Treatment Period||30
10338178|NCT00368745|11475071|FG001|COMPLETED|Double-blind Treatment Period||19
10338179|NCT00368745|11475070|FG000|NOT COMPLETED|Double-blind Treatment Period||26
10338180|NCT00368745|11475071|FG001|NOT COMPLETED|Double-blind Treatment Period||31
10338181|NCT00368849|11475077|FG000|STARTED|Overall Study||10
10338182|NCT00368849|11475078|FG001|STARTED|Overall Study||10
10338183|NCT00368849|11475077|FG000|COMPLETED|Overall Study||10
10338184|NCT00368849|11475078|FG001|COMPLETED|Overall Study||8
10709203|NCT02637804|11874117|FG000|COMPLETED|First Intervention (1 Week)||27
10709204|NCT02637804|11874118|FG001|COMPLETED|First Intervention (1 Week)||28
10709205|NCT02637804|11874119|FG002|COMPLETED|First Intervention (1 Week)||25
10709206|NCT02637804|11874120|FG003|COMPLETED|First Intervention (1 Week)||26
10709207|NCT02637804|11874117|FG000|NOT COMPLETED|First Intervention (1 Week)||0
10709208|NCT02637804|11874118|FG001|NOT COMPLETED|First Intervention (1 Week)||0
10709209|NCT02637804|11874119|FG002|NOT COMPLETED|First Intervention (1 Week)||0
10709210|NCT02637804|11874120|FG003|NOT COMPLETED|First Intervention (1 Week)||0
10709211|NCT02637804|11874117|FG000|STARTED|Second Intervention (1 Week)||27
10709212|NCT02637804|11874118|FG001|STARTED|Second Intervention (1 Week)||28
10709213|NCT02637804|11874119|FG002|STARTED|Second Intervention (1 Week)||25
10709214|NCT02637804|11874120|FG003|STARTED|Second Intervention (1 Week)||26
10709215|NCT02637804|11874117|FG000|COMPLETED|Second Intervention (1 Week)||27
10709216|NCT02637804|11874118|FG001|COMPLETED|Second Intervention (1 Week)||28
10709217|NCT02637804|11874119|FG002|COMPLETED|Second Intervention (1 Week)||25
10709218|NCT02637804|11874120|FG003|COMPLETED|Second Intervention (1 Week)||26
10709219|NCT02637804|11874117|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
10709220|NCT02637804|11874118|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
10709221|NCT02637804|11874119|FG002|NOT COMPLETED|Second Intervention (1 Week)||0
10709222|NCT02637804|11874120|FG003|NOT COMPLETED|Second Intervention (1 Week)||0
10709223|NCT02637856|11874137|FG000|STARTED|Main Study (Baseline to Week 100)||608
10709224|NCT02637856|11874138|FG001|STARTED|Main Study (Baseline to Week 100)||0
10709225|NCT02637856|11874137|FG000|COMPLETED|Main Study (Baseline to Week 100)||389
10709226|NCT02637856|11874138|FG001|COMPLETED|Main Study (Baseline to Week 100)||0
10709227|NCT02637856|11874137|FG000|NOT COMPLETED|Main Study (Baseline to Week 100)||219
10709228|NCT02637856|11874138|FG001|NOT COMPLETED|Main Study (Baseline to Week 100)||0
10709229|NCT02637856|11874137|FG000|STARTED|Sub-Study (Week 72 to Week 100)||0
10709230|NCT02637856|11874138|FG001|STARTED|Sub-Study (Week 72 to Week 100)||129
10709231|NCT02637856|11874137|FG000|COMPLETED|Sub-Study (Week 72 to Week 100)||0
10709232|NCT02637856|11874138|FG001|COMPLETED|Sub-Study (Week 72 to Week 100)||125
10709233|NCT02637856|11874137|FG000|NOT COMPLETED|Sub-Study (Week 72 to Week 100)||0
10709234|NCT02637856|11874138|FG001|NOT COMPLETED|Sub-Study (Week 72 to Week 100)||4
10709235|NCT02637895|11874146|FG000|STARTED|Overall Study||21
10338185|NCT00368849|11475077|FG000|NOT COMPLETED|Overall Study||0
10338186|NCT00368849|11475078|FG001|NOT COMPLETED|Overall Study||2
10338187|NCT00368875|11475085|FG000|STARTED|Overall Study||6
10338188|NCT00368875|11475086|FG001|STARTED|Overall Study||48
10338189|NCT00368875|11475085|FG000|COMPLETED|Overall Study||0
10338190|NCT00368875|11475086|FG001|COMPLETED|Overall Study||0
10338191|NCT00368875|11475085|FG000|NOT COMPLETED|Overall Study||6
10338192|NCT00368875|11475086|FG001|NOT COMPLETED|Overall Study||48
10338193|NCT00368927|11475094|FG000|STARTED|Overall Study||31
10338194|NCT00368927|11475095|FG001|STARTED|Overall Study||30
10338195|NCT00368927|11475094|FG000|COMPLETED|Overall Study||26
10338196|NCT00368927|11475095|FG001|COMPLETED|Overall Study||27
10338197|NCT00368927|11475094|FG000|NOT COMPLETED|Overall Study||5
10338198|NCT00368927|11475095|FG001|NOT COMPLETED|Overall Study||3
10338199|NCT00368940|11475103|FG000|STARTED|Intention-to-Treat||37
10338200|NCT00368940|11475104|FG001|STARTED|Intention-to-Treat||37
10338201|NCT00368940|11475103|FG000|COMPLETED|Intention-to-Treat||37
10338202|NCT00368940|11475104|FG001|COMPLETED|Intention-to-Treat||37
10338203|NCT00368940|11475103|FG000|NOT COMPLETED|Intention-to-Treat||0
10338204|NCT00368940|11475104|FG001|NOT COMPLETED|Intention-to-Treat||0
10338205|NCT00368940|11475103|FG000|STARTED|Completed 12-wk Treatment||37
10338206|NCT00368940|11475104|FG001|STARTED|Completed 12-wk Treatment||37
10338207|NCT00368940|11475103|FG000|COMPLETED|Completed 12-wk Treatment||31
10338208|NCT00368940|11475104|FG001|COMPLETED|Completed 12-wk Treatment||32
10338209|NCT00368940|11475103|FG000|NOT COMPLETED|Completed 12-wk Treatment||6
10338210|NCT00368940|11475104|FG001|NOT COMPLETED|Completed 12-wk Treatment||5
10709236|NCT02637895|11874147|FG001|STARTED|Overall Study||20
10709237|NCT02637895|11874146|FG000|COMPLETED|Overall Study||15
10709238|NCT02637895|11874147|FG001|COMPLETED|Overall Study||17
10709239|NCT02637895|11874146|FG000|NOT COMPLETED|Overall Study||6
10709240|NCT02637895|11874147|FG001|NOT COMPLETED|Overall Study||3
10709241|NCT02637999|11874157|FG000|STARTED|Overall Study||8
10709242|NCT02637999|11874158|FG001|STARTED|Overall Study||8
10709243|NCT02637999|11874159|FG002|STARTED|Overall Study||8
10709244|NCT02637999|11874157|FG000|COMPLETED|Overall Study||7
10709245|NCT02637999|11874158|FG001|COMPLETED|Overall Study||6
10338211|NCT00368966|11475113|FG000|STARTED|Infant Series||315
10338212|NCT00368966|11475114|FG001|STARTED|Infant Series||304
10338213|NCT00368966|11475113|FG000|Vaccinated Dose 1|Infant Series||314
10338214|NCT00368966|11475114|FG001|Vaccinated Dose 1|Infant Series|1 randomized to 7vPnC but given 13vPnC vaccine; 1 was withdrawn before receiving 7vPnC vaccine|302
10338215|NCT00368966|11475113|FG000|Vaccinated Dose 2|Infant Series|1 randomized but incorrectly given 7vPnC|307
10338216|NCT00368966|11475114|FG001|Vaccinated Dose 2|Infant Series||298
10338217|NCT00368966|11475113|FG000|Vaccinated Dose 3|Infant Series||301
10338218|NCT00368966|11475114|FG001|Vaccinated Dose 3|Infant Series|1 randomized but incorrectly given 13vPnC|296
10338219|NCT00368966|11475113|FG000|COMPLETED|Infant Series||299
10338220|NCT00368966|11475114|FG001|COMPLETED|Infant Series||294
10477303|NCT01117623|11626309|FG002|ITT Efficacy Analysis Population|Overall Study||11
10709246|NCT02637999|11874159|FG002|COMPLETED|Overall Study||6
10709247|NCT02637999|11874157|FG000|NOT COMPLETED|Overall Study||1
10709248|NCT02637999|11874158|FG001|NOT COMPLETED|Overall Study||2
10709249|NCT02637999|11874159|FG002|NOT COMPLETED|Overall Study||2
10709250|NCT02638012|11874167|FG000|STARTED|Overall Study||8
10709251|NCT02638012|11874167|FG000|COMPLETED|Overall Study||7
10709252|NCT02638012|11874167|FG000|NOT COMPLETED|Overall Study||1
10709253|NCT02638051|11874173|FG000|STARTED|Overall Study||130
10709254|NCT02638051|11874174|FG001|STARTED|Overall Study||130
10709255|NCT02638051|11874173|FG000|COMPLETED|Overall Study||130
10709256|NCT02638051|11874174|FG001|COMPLETED|Overall Study||130
10709257|NCT02638051|11874173|FG000|NOT COMPLETED|Overall Study||0
10477304|NCT01117623|11626310|FG003|ITT Efficacy Analysis Population|Overall Study||5
10477305|NCT01117623|11626311|FG004|ITT Efficacy Analysis Population|Overall Study||10
10477306|NCT01117623|11626312|FG005|ITT Efficacy Analysis Population|Overall Study||16
10477307|NCT01117623|11626313|FG006|ITT Efficacy Analysis Population|Overall Study||6
10477308|NCT01117623|11626314|FG007|ITT Efficacy Analysis Population|Overall Study||22
10477309|NCT01117623|11626307|FG000|PK Population|Overall Study||3
10477310|NCT01117623|11626308|FG001|PK Population|Overall Study||8
10477311|NCT01117623|11626309|FG002|PK Population|Overall Study||10
10477312|NCT01117623|11626310|FG003|PK Population|Overall Study||6
10477313|NCT01117623|11626311|FG004|PK Population|Overall Study||10
10477314|NCT01117623|11626312|FG005|PK Population|Overall Study||14
10477315|NCT01117623|11626313|FG006|PK Population|Overall Study||6
10477316|NCT01117623|11626314|FG007|PK Population|Overall Study||24
10477317|NCT01117623|11626307|FG000|COMPLETED|Overall Study||0
10477318|NCT01117623|11626308|FG001|COMPLETED|Overall Study||0
10477319|NCT01117623|11626309|FG002|COMPLETED|Overall Study||0
10477320|NCT01117623|11626310|FG003|COMPLETED|Overall Study||0
10477321|NCT01117623|11626311|FG004|COMPLETED|Overall Study||0
10477322|NCT01117623|11626312|FG005|COMPLETED|Overall Study||0
10477323|NCT01117623|11626313|FG006|COMPLETED|Overall Study||0
10477324|NCT01117623|11626314|FG007|COMPLETED|Overall Study||0
10477325|NCT01117623|11626307|FG000|NOT COMPLETED|Overall Study||3
10477326|NCT01117623|11626308|FG001|NOT COMPLETED|Overall Study||8
10477327|NCT01117623|11626309|FG002|NOT COMPLETED|Overall Study||11
10477328|NCT01117623|11626310|FG003|NOT COMPLETED|Overall Study||6
10477329|NCT01117623|11626311|FG004|NOT COMPLETED|Overall Study||10
10477330|NCT01117623|11626312|FG005|NOT COMPLETED|Overall Study||16
10477331|NCT01117623|11626313|FG006|NOT COMPLETED|Overall Study||6
10477332|NCT01117623|11626314|FG007|NOT COMPLETED|Overall Study||26
10477333|NCT01117727|11626334|FG000|STARTED|Overall Study||1
10477334|NCT01117727|11626334|FG000|COMPLETED|Overall Study||1
10477335|NCT01117727|11626334|FG000|NOT COMPLETED|Overall Study||0
10477336|NCT01117766|11626339|FG000|STARTED|First Intervention||14
10477337|NCT01117766|11626340|FG001|STARTED|First Intervention||17
10477338|NCT01117766|11626339|FG000|Received Treatment|First Intervention||14
10477339|NCT01117766|11626340|FG001|Received Treatment|First Intervention||17
10477340|NCT01117766|11626339|FG000|COMPLETED|First Intervention||13
10477341|NCT01117766|11626340|FG001|COMPLETED|First Intervention||16
10477342|NCT01117766|11626339|FG000|NOT COMPLETED|First Intervention||1
10477343|NCT01117766|11626340|FG001|NOT COMPLETED|First Intervention||1
10477344|NCT01117766|11626339|FG000|STARTED|Washout Period||13
10477345|NCT01117766|11626340|FG001|STARTED|Washout Period||16
10477346|NCT01117766|11626339|FG000|COMPLETED|Washout Period||13
10477347|NCT01117766|11626340|FG001|COMPLETED|Washout Period||14
10477348|NCT01117766|11626339|FG000|NOT COMPLETED|Washout Period||0
10477349|NCT01117766|11626340|FG001|NOT COMPLETED|Washout Period||2
10477350|NCT01117766|11626339|FG000|STARTED|Second Intervention||13
10477351|NCT01117766|11626340|FG001|STARTED|Second Intervention||14
10477352|NCT01117766|11626339|FG000|COMPLETED|Second Intervention||11
10477353|NCT01117766|11626340|FG001|COMPLETED|Second Intervention||9
10477354|NCT01117766|11626339|FG000|NOT COMPLETED|Second Intervention||2
10477355|NCT01117766|11626340|FG001|NOT COMPLETED|Second Intervention||5
10477356|NCT01117792|11626346|FG000|STARTED|Overall Study||55
10477357|NCT01117792|11626346|FG000|COMPLETED|Overall Study||51
10477358|NCT01117792|11626346|FG000|NOT COMPLETED|Overall Study||4
10477359|NCT01117857|11626350|FG000|STARTED|Overall Study||22
10477360|NCT01117857|11626350|FG000|COMPLETED|Overall Study||13
10477361|NCT01117857|11626350|FG000|NOT COMPLETED|Overall Study||9
10477362|NCT01117870|11626356|FG000|STARTED|Overall Study||15
10477363|NCT01117870|11626357|FG001|STARTED|Overall Study||16
10477364|NCT01117870|11626356|FG000|COMPLETED|Overall Study|One did not receive the allocated intervention; (degenerate spine/inability to place needle).|14
10709258|NCT02638051|11874174|FG001|NOT COMPLETED|Overall Study||0
10709259|NCT02638103|11874184|FG000|STARTED|Overall Study||419
10709260|NCT02638103|11874185|FG001|STARTED|Overall Study||526
10709261|NCT02638103|11874186|FG002|STARTED|Overall Study||420
10709262|NCT02638103|11874187|FG003|STARTED|Overall Study||525
10477365|NCT01117870|11626357|FG001|COMPLETED|Overall Study||16
10477366|NCT01117870|11626356|FG000|NOT COMPLETED|Overall Study||1
10477367|NCT01117870|11626357|FG001|NOT COMPLETED|Overall Study||0
10477368|NCT01117948|11626369|FG000|STARTED|Double Blind||111
10477369|NCT01117948|11626370|FG001|STARTED|Double Blind||108
10477370|NCT01117948|11626369|FG000|COMPLETED|Double Blind||93
10477371|NCT01117948|11626370|FG001|COMPLETED|Double Blind||98
10477372|NCT01117948|11626369|FG000|NOT COMPLETED|Double Blind||18
10477373|NCT01117948|11626370|FG001|NOT COMPLETED|Double Blind||10
10477374|NCT01117948|11626369|FG000|STARTED|Open Label||93
10477375|NCT01117948|11626370|FG001|STARTED|Open Label||98
10477376|NCT01117948|11626369|FG000|COMPLETED|Open Label||41
10477377|NCT01117948|11626370|FG001|COMPLETED|Open Label||51
10477378|NCT01117948|11626369|FG000|NOT COMPLETED|Open Label||52
10477379|NCT01117948|11626370|FG001|NOT COMPLETED|Open Label||47
10477380|NCT01117987|11626378|FG000|STARTED|Overall Study||66
10477381|NCT01117987|11626379|FG001|STARTED|Overall Study||78
10477382|NCT01117987|11626378|FG000|COMPLETED|Overall Study||5
10477383|NCT01117987|11626379|FG001|COMPLETED|Overall Study||4
10477384|NCT01117987|11626378|FG000|NOT COMPLETED|Overall Study||61
10477385|NCT01117987|11626379|FG001|NOT COMPLETED|Overall Study||74
10477386|NCT01118052|11626385|FG000|STARTED|Overall Study||22
10477387|NCT01118052|11626385|FG000|COMPLETED|Overall Study||20
10477388|NCT01118052|11626385|FG000|NOT COMPLETED|Overall Study||2
10477389|NCT01118091|11626397|FG000|STARTED|Overall Study|2pts were randomized to Arm 2, were not able to grow cell product, were treated with Arm 1 regimen.|7
10477390|NCT01118091|11626398|FG001|STARTED|Overall Study||5
10477391|NCT01118091|11626397|FG000|COMPLETED|Overall Study|Continued from above: These 2 pts are only represented in Arm 1 (and not Arm 2).|7
10477392|NCT01118091|11626398|FG001|COMPLETED|Overall Study||5
10477393|NCT01118091|11626397|FG000|NOT COMPLETED|Overall Study||0
10477394|NCT01118091|11626398|FG001|NOT COMPLETED|Overall Study||0
10477395|NCT01118117|11626406|FG000|STARTED|Overall Study||261
10477396|NCT01118117|11626407|FG001|STARTED|Overall Study||15
10477397|NCT01118117|11626406|FG000|COMPLETED|Overall Study||240
10477398|NCT01118117|11626407|FG001|COMPLETED|Overall Study||15
10477399|NCT01118117|11626406|FG000|NOT COMPLETED|Overall Study||21
10477400|NCT01118117|11626407|FG001|NOT COMPLETED|Overall Study||0
10477401|NCT01118143|11626415|FG000|STARTED|Overall Study||64
10477402|NCT01118143|11626416|FG001|STARTED|Overall Study||69
10477403|NCT01118143|11626415|FG000|COMPLETED|Overall Study||62
10477404|NCT01118143|11626416|FG001|COMPLETED|Overall Study||64
10477405|NCT01118143|11626415|FG000|NOT COMPLETED|Overall Study||2
10477406|NCT01118143|11626416|FG001|NOT COMPLETED|Overall Study||5
10477407|NCT01118221|11626426|FG000|STARTED|Overall Study||14
10477408|NCT01118221|11626427|FG001|STARTED|Overall Study||11
10477409|NCT01118221|11626426|FG000|COMPLETED|Overall Study||11
10477410|NCT01118221|11626427|FG001|COMPLETED|Overall Study||10
10477411|NCT01118221|11626426|FG000|NOT COMPLETED|Overall Study||3
10477412|NCT01118221|11626427|FG001|NOT COMPLETED|Overall Study||1
10477413|NCT01118273|11626443|FG000|STARTED|Overall Study||27
10477414|NCT01118273|11626444|FG001|STARTED|Overall Study||27
10477415|NCT01118273|11626445|FG002|STARTED|Overall Study||27
10477416|NCT01118273|11626446|FG003|STARTED|Overall Study||27
10477417|NCT01118273|11626447|FG004|STARTED|Overall Study||27
10477418|NCT01118273|11626448|FG005|STARTED|Overall Study||27
10477419|NCT01118273|11626443|FG000|COMPLETED|Overall Study||27
10477420|NCT01118273|11626444|FG001|COMPLETED|Overall Study||27
10477421|NCT01118273|11626445|FG002|COMPLETED|Overall Study||27
10477422|NCT01118273|11626446|FG003|COMPLETED|Overall Study||27
10477423|NCT01118273|11626447|FG004|COMPLETED|Overall Study||27
10477424|NCT01118273|11626448|FG005|COMPLETED|Overall Study||27
10477425|NCT01118273|11626443|FG000|NOT COMPLETED|Overall Study||0
10477426|NCT01118273|11626444|FG001|NOT COMPLETED|Overall Study||0
10477427|NCT01118273|11626445|FG002|NOT COMPLETED|Overall Study||0
10477428|NCT01118273|11626446|FG003|NOT COMPLETED|Overall Study||0
10477429|NCT01118273|11626447|FG004|NOT COMPLETED|Overall Study||0
10477430|NCT01118273|11626448|FG005|NOT COMPLETED|Overall Study||0
10477431|NCT01118299|11626464|FG000|STARTED|Overall Study||68
10477432|NCT01118299|11626465|FG001|STARTED|Overall Study||29
10477433|NCT01118299|11626464|FG000|COMPLETED|Overall Study||45
10477434|NCT01118299|11626465|FG001|COMPLETED|Overall Study||0
10477435|NCT01118299|11626464|FG000|NOT COMPLETED|Overall Study||23
10477436|NCT01118299|11626465|FG001|NOT COMPLETED|Overall Study||29
10477437|NCT01118312|11626472|FG000|STARTED|Overall Study||189
10477438|NCT01118312|11626473|FG001|STARTED|Overall Study||199
10477439|NCT01118312|11626472|FG000|COMPLETED|Overall Study||155
10477440|NCT01118312|11626473|FG001|COMPLETED|Overall Study||164
10477441|NCT01118312|11626472|FG000|NOT COMPLETED|Overall Study||34
10477442|NCT01118312|11626473|FG001|NOT COMPLETED|Overall Study||35
10477443|NCT01118325|11626482|FG000|STARTED|Overall Study||50
10477444|NCT01118325|11626483|FG001|STARTED|Overall Study||43
10477445|NCT01118325|11626484|FG002|STARTED|Overall Study||46
10477446|NCT01118325|11626482|FG000|COMPLETED|Overall Study||49
10477447|NCT01118325|11626483|FG001|COMPLETED|Overall Study||43
10477448|NCT01118325|11626484|FG002|COMPLETED|Overall Study||45
10477449|NCT01118325|11626482|FG000|NOT COMPLETED|Overall Study||1
10477450|NCT01118325|11626483|FG001|NOT COMPLETED|Overall Study||0
10477451|NCT01118325|11626484|FG002|NOT COMPLETED|Overall Study||1
10477452|NCT01118338|11626507|FG000|STARTED|Overall Study||185
10477453|NCT01118338|11626508|FG001|STARTED|Overall Study||183
10477454|NCT01118338|11626507|FG000|COMPLETED|Overall Study||182
10477455|NCT01118338|11626508|FG001|COMPLETED|Overall Study||174
10477456|NCT01118338|11626507|FG000|NOT COMPLETED|Overall Study||3
10477457|NCT01118338|11626508|FG001|NOT COMPLETED|Overall Study||9
10477458|NCT01118351|11626514|FG000|STARTED|Overall Study||19
10477459|NCT01118351|11626514|FG000|COMPLETED|Overall Study||15
10477460|NCT01118351|11626514|FG000|NOT COMPLETED|Overall Study||4
10477461|NCT01118377|11626518|FG000|STARTED|Overall Study||45
10477462|NCT01118377|11626518|FG000|COMPLETED|Overall Study||3
10477463|NCT01118377|11626518|FG000|NOT COMPLETED|Overall Study||42
10477464|NCT01118455|11626524|FG000|STARTED|Baseline [Visits 1 & 2]||66
10477465|NCT01118455|11626525|FG001|STARTED|Baseline [Visits 1 & 2]||69
10477466|NCT01118455|11626524|FG000|Actual Patients Treated|Baseline [Visits 1 & 2]||65
10477467|NCT01118455|11626525|FG001|Actual Patients Treated|Baseline [Visits 1 & 2]||69
10477468|NCT01118455|11626524|FG000|COMPLETED|Baseline [Visits 1 & 2]||65
10477469|NCT01118455|11626525|FG001|COMPLETED|Baseline [Visits 1 & 2]||69
10477470|NCT01118455|11626524|FG000|NOT COMPLETED|Baseline [Visits 1 & 2]||1
10477471|NCT01118455|11626525|FG001|NOT COMPLETED|Baseline [Visits 1 & 2]||0
10477472|NCT01118455|11626524|FG000|STARTED|Treatment Phase (VNS/AED) [Visits 3-10]||65
10477473|NCT01118455|11626525|FG001|STARTED|Treatment Phase (VNS/AED) [Visits 3-10]||69
10477474|NCT01118455|11626524|FG000|COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||65
10709263|NCT02638103|11874184|FG000|Safety Analysis Set|Overall Study||418
10709264|NCT02638103|11874185|FG001|Safety Analysis Set|Overall Study||526
10709265|NCT02638103|11874186|FG002|Safety Analysis Set|Overall Study||419
10477475|NCT01118455|11626525|FG001|COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||69
10477476|NCT01118455|11626524|FG000|NOT COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||0
10477477|NCT01118455|11626525|FG001|NOT COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||0
10477478|NCT01118520|11626542|FG000|STARTED|Overall Study||73
10477479|NCT01118520|11626543|FG001|STARTED|Overall Study||72
10477480|NCT01118520|11626544|FG002|STARTED|Overall Study||79
10477481|NCT01118520|11626542|FG000|COMPLETED|Overall Study||53
10477482|NCT01118520|11626543|FG001|COMPLETED|Overall Study||49
10477483|NCT01118520|11626544|FG002|COMPLETED|Overall Study||59
10477484|NCT01118520|11626542|FG000|NOT COMPLETED|Overall Study||20
10477485|NCT01118520|11626543|FG001|NOT COMPLETED|Overall Study||23
10477486|NCT01118520|11626544|FG002|NOT COMPLETED|Overall Study||20
10477487|NCT01118624|11626552|FG000|STARTED|Overall Study||22
10477488|NCT01118624|11626552|FG000|COMPLETED|Overall Study||0
10477489|NCT01118624|11626552|FG000|NOT COMPLETED|Overall Study||22
10477490|NCT01118663|11626558|FG000|STARTED|Overall Study||7
10477491|NCT01118663|11626559|FG001|STARTED|Overall Study||10
10477492|NCT01118663|11626558|FG000|COMPLETED|Overall Study||5
10477493|NCT01118663|11626559|FG001|COMPLETED|Overall Study||8
10477494|NCT01118663|11626558|FG000|NOT COMPLETED|Overall Study||2
10477495|NCT01118663|11626559|FG001|NOT COMPLETED|Overall Study||2
10477496|NCT01118715|11626567|FG000|STARTED|Overall Study||68
10477497|NCT01118715|11626568|FG001|STARTED|Overall Study||60
10477498|NCT01118715|11626567|FG000|COMPLETED|Overall Study||68
10477499|NCT01118715|11626568|FG001|COMPLETED|Overall Study||60
10477500|NCT01118715|11626567|FG000|NOT COMPLETED|Overall Study||0
10477501|NCT01118715|11626568|FG001|NOT COMPLETED|Overall Study||0
10477502|NCT01118728|11626595|FG000|STARTED|Overall Study||223
10477503|NCT01118728|11626595|FG000|COMPLETED|Overall Study||0
10477504|NCT01118728|11626595|FG000|NOT COMPLETED|Overall Study||223
10477505|NCT01118741|11626601|FG000|STARTED|Overall Study||9
10477506|NCT01118741|11626602|FG001|STARTED|Overall Study||10
10477507|NCT01118741|11626601|FG000|COMPLETED|Overall Study||9
10477508|NCT01118741|11626602|FG001|COMPLETED|Overall Study||10
10477509|NCT01118741|11626601|FG000|NOT COMPLETED|Overall Study||0
10477510|NCT01118741|11626602|FG001|NOT COMPLETED|Overall Study||0
10477511|NCT01118780|11626612|FG000|STARTED|Overall Study||151
10477512|NCT01118780|11626613|FG001|STARTED|Overall Study||140
10477513|NCT01118780|11626612|FG000|COMPLETED|Overall Study||115
10477514|NCT01118780|11626613|FG001|COMPLETED|Overall Study||105
10477515|NCT01118780|11626612|FG000|NOT COMPLETED|Overall Study||36
10477516|NCT01118780|11626613|FG001|NOT COMPLETED|Overall Study||35
10477517|NCT01118845|11626622|FG000|STARTED|Overall Study||59
10477518|NCT01118845|11626622|FG000|COMPLETED|Overall Study||17
10477519|NCT01118845|11626622|FG000|NOT COMPLETED|Overall Study||42
10477520|NCT01118949|11626626|FG000|STARTED|Overall Study||49
10477521|NCT01118949|11626626|FG000|COMPLETED|Overall Study||40
10477522|NCT01118949|11626626|FG000|NOT COMPLETED|Overall Study||9
10477523|NCT01118962|11626630|FG000|STARTED|Overall Study||39
10477524|NCT01118962|11626630|FG000|COMPLETED|Overall Study||29
10477525|NCT01118962|11626630|FG000|NOT COMPLETED|Overall Study||10
10477526|NCT01118975|11626636|FG000|STARTED|Overall Study||9
10477527|NCT01118975|11626637|FG001|STARTED|Overall Study||3
10477528|NCT01118975|11626636|FG000|COMPLETED|Overall Study||9
10477529|NCT01118975|11626637|FG001|COMPLETED|Overall Study||2
10709266|NCT02638103|11874187|FG003|Safety Analysis Set|Overall Study||525
10477530|NCT01118975|11626636|FG000|NOT COMPLETED|Overall Study||0
10477531|NCT01118975|11626637|FG001|NOT COMPLETED|Overall Study||1
10477532|NCT01118988|11626646|FG000|STARTED|Overall Study||16
10477533|NCT01118988|11626647|FG001|STARTED|Overall Study||4
10477534|NCT01118988|11626648|FG002|STARTED|Overall Study||7
10477535|NCT01118988|11626646|FG000|COMPLETED|Overall Study||11
10477536|NCT01118988|11626647|FG001|COMPLETED|Overall Study||3
10477537|NCT01118988|11626648|FG002|COMPLETED|Overall Study||3
10477538|NCT01118988|11626646|FG000|NOT COMPLETED|Overall Study||5
10477539|NCT01118988|11626647|FG001|NOT COMPLETED|Overall Study||1
10477540|NCT01118988|11626648|FG002|NOT COMPLETED|Overall Study||4
10477541|NCT01119001|11626655|FG000|STARTED|Overall Study||13
10477542|NCT01119001|11626655|FG000|COMPLETED|Overall Study||11
10477543|NCT01119001|11626655|FG000|NOT COMPLETED|Overall Study||2
10477544|NCT01119040|11626661|FG000|STARTED|Overall Study||1
10477545|NCT01119040|11626661|FG000|COMPLETED|Overall Study||0
10477546|NCT01119040|11626661|FG000|NOT COMPLETED|Overall Study||1
10477547|NCT01119105|11626668|FG000|STARTED|Overall Study||70
10477548|NCT01119105|11626669|FG001|STARTED|Overall Study||72
10477549|NCT01119105|11626670|FG002|STARTED|Overall Study||68
10477550|NCT01119105|11626668|FG000|COMPLETED|Overall Study||66
10477551|NCT01119105|11626669|FG001|COMPLETED|Overall Study||66
10477552|NCT01119105|11626670|FG002|COMPLETED|Overall Study||60
10477553|NCT01119105|11626668|FG000|NOT COMPLETED|Overall Study||4
10477554|NCT01119105|11626669|FG001|NOT COMPLETED|Overall Study||6
10477555|NCT01119105|11626670|FG002|NOT COMPLETED|Overall Study||8
10477556|NCT01119118|11626678|FG000|STARTED|Overall Study||6
10477557|NCT01119118|11626678|FG000|COMPLETED|Overall Study||5
10477558|NCT01119118|11626678|FG000|NOT COMPLETED|Overall Study||1
10477559|NCT01119131|11626685|FG000|STARTED|Overall Study||10
10477560|NCT01119131|11626686|FG001|STARTED|Overall Study||28
10477561|NCT01119131|11626687|FG002|STARTED|Overall Study||30
10477562|NCT01119131|11626685|FG000|COMPLETED|Overall Study||8
10477563|NCT01119131|11626686|FG001|COMPLETED|Overall Study||27
10477564|NCT01119131|11626687|FG002|COMPLETED|Overall Study||24
10477565|NCT01119131|11626685|FG000|NOT COMPLETED|Overall Study||2
10477566|NCT01119131|11626686|FG001|NOT COMPLETED|Overall Study||1
10477567|NCT01119131|11626687|FG002|NOT COMPLETED|Overall Study||6
10477568|NCT01119222|11626695|FG000|STARTED|Overall Study||5
10477569|NCT01119222|11626696|FG001|STARTED|Overall Study||5
10477570|NCT01119222|11626697|FG002|STARTED|Overall Study||5
10477571|NCT01119222|11626698|FG003|STARTED|Overall Study||4
10477572|NCT01119222|11626695|FG000|COMPLETED|Overall Study||5
10477573|NCT01119222|11626696|FG001|COMPLETED|Overall Study||5
10477574|NCT01119222|11626697|FG002|COMPLETED|Overall Study||5
10477575|NCT01119222|11626698|FG003|COMPLETED|Overall Study||4
10477576|NCT01119222|11626695|FG000|NOT COMPLETED|Overall Study||0
10477577|NCT01119222|11626696|FG001|NOT COMPLETED|Overall Study||0
10477578|NCT01119222|11626697|FG002|NOT COMPLETED|Overall Study||0
10477579|NCT01119222|11626698|FG003|NOT COMPLETED|Overall Study||0
10477580|NCT01119248|11626711|FG000|STARTED|Overall Study||120
10477581|NCT01119248|11626711|FG000|COMPLETED|Overall Study||115
10477582|NCT01119248|11626711|FG000|NOT COMPLETED|Overall Study||5
10477583|NCT01119287|11626722|FG000|STARTED|Overall Study||26
10477584|NCT01119287|11626723|FG001|STARTED|Overall Study||24
10477585|NCT01119287|11626724|FG002|STARTED|Overall Study||26
10477586|NCT01119287|11626725|FG003|STARTED|Overall Study||31
10477587|NCT01119287|11626726|FG004|STARTED|Overall Study||31
10477588|NCT01119287|11626727|FG005|STARTED|Overall Study||32
10477589|NCT01119287|11626722|FG000|COMPLETED|Overall Study||26
10477590|NCT01119287|11626723|FG001|COMPLETED|Overall Study||24
10477591|NCT01119287|11626724|FG002|COMPLETED|Overall Study||24
10477592|NCT01119287|11626725|FG003|COMPLETED|Overall Study||29
10477593|NCT01119287|11626726|FG004|COMPLETED|Overall Study||30
10477594|NCT01119287|11626727|FG005|COMPLETED|Overall Study||32
10477595|NCT01119287|11626722|FG000|NOT COMPLETED|Overall Study||0
10477596|NCT01119287|11626723|FG001|NOT COMPLETED|Overall Study||0
10477597|NCT01119287|11626724|FG002|NOT COMPLETED|Overall Study||2
10477598|NCT01119287|11626725|FG003|NOT COMPLETED|Overall Study||2
10477599|NCT01119287|11626726|FG004|NOT COMPLETED|Overall Study||1
10477600|NCT01119287|11626727|FG005|NOT COMPLETED|Overall Study||0
10477601|NCT01119443|11626741|FG000|STARTED|Up-titration Period (10 Days)||14
10477602|NCT01119443|11626742|FG001|STARTED|Up-titration Period (10 Days)||14
10477603|NCT01119443|11626741|FG000|COMPLETED|Up-titration Period (10 Days)||14
10477604|NCT01119443|11626742|FG001|COMPLETED|Up-titration Period (10 Days)||14
10477605|NCT01119443|11626741|FG000|NOT COMPLETED|Up-titration Period (10 Days)||0
10477606|NCT01119443|11626742|FG001|NOT COMPLETED|Up-titration Period (10 Days)||0
10477607|NCT01119443|11626741|FG000|STARTED|Crossover Period 1 (5 Days)||14
10477608|NCT01119443|11626742|FG001|STARTED|Crossover Period 1 (5 Days)||14
10477609|NCT01119443|11626741|FG000|COMPLETED|Crossover Period 1 (5 Days)||14
10477610|NCT01119443|11626742|FG001|COMPLETED|Crossover Period 1 (5 Days)||13
10477611|NCT01119443|11626741|FG000|NOT COMPLETED|Crossover Period 1 (5 Days)||0
10477612|NCT01119443|11626742|FG001|NOT COMPLETED|Crossover Period 1 (5 Days)||1
10477613|NCT01119443|11626741|FG000|STARTED|Crossover Period 2 (5 Days)||14
10477614|NCT01119443|11626742|FG001|STARTED|Crossover Period 2 (5 Days)||13
10477615|NCT01119443|11626741|FG000|COMPLETED|Crossover Period 2 (5 Days)||14
10477616|NCT01119443|11626742|FG001|COMPLETED|Crossover Period 2 (5 Days)||13
10477617|NCT01119443|11626741|FG000|NOT COMPLETED|Crossover Period 2 (5 Days)||0
10477618|NCT01119443|11626742|FG001|NOT COMPLETED|Crossover Period 2 (5 Days)||0
10477619|NCT01119443|11626741|FG000|STARTED|Crossover Period 3 (5 Days)||14
10477620|NCT01119443|11626742|FG001|STARTED|Crossover Period 3 (5 Days)||13
10477621|NCT01119443|11626741|FG000|COMPLETED|Crossover Period 3 (5 Days)||14
10477622|NCT01119443|11626742|FG001|COMPLETED|Crossover Period 3 (5 Days)||13
10477623|NCT01119443|11626741|FG000|NOT COMPLETED|Crossover Period 3 (5 Days)||0
10477624|NCT01119443|11626742|FG001|NOT COMPLETED|Crossover Period 3 (5 Days)||0
10709267|NCT02638103|11874184|FG000|Full Analysis Set (FAS)|Overall Study||416
10709268|NCT02638103|11874185|FG001|Full Analysis Set (FAS)|Overall Study||520
10477625|NCT01119443|11626741|FG000|STARTED|Crossover Period 4 (5 Days)||14
10477626|NCT01119443|11626742|FG001|STARTED|Crossover Period 4 (5 Days)||13
10477627|NCT01119443|11626741|FG000|COMPLETED|Crossover Period 4 (5 Days)||14
10477628|NCT01119443|11626742|FG001|COMPLETED|Crossover Period 4 (5 Days)||13
10477629|NCT01119443|11626741|FG000|NOT COMPLETED|Crossover Period 4 (5 Days)||0
10477630|NCT01119443|11626742|FG001|NOT COMPLETED|Crossover Period 4 (5 Days)||0
10477631|NCT01119443|11626741|FG000|STARTED|Down-titration Period (1 Day)||14
10477632|NCT01119443|11626742|FG001|STARTED|Down-titration Period (1 Day)||13
10477633|NCT01119443|11626741|FG000|COMPLETED|Down-titration Period (1 Day)||14
10477634|NCT01119443|11626742|FG001|COMPLETED|Down-titration Period (1 Day)||13
10477635|NCT01119443|11626741|FG000|NOT COMPLETED|Down-titration Period (1 Day)||0
10477636|NCT01119443|11626742|FG001|NOT COMPLETED|Down-titration Period (1 Day)||0
10477637|NCT01119443|11626741|FG000|STARTED|End of Study (All Patients)||14
10477638|NCT01119443|11626742|FG001|STARTED|End of Study (All Patients)||14
10477639|NCT01119443|11626741|FG000|COMPLETED|End of Study (All Patients)||14
10477640|NCT01119443|11626742|FG001|COMPLETED|End of Study (All Patients)||14
10477641|NCT01119443|11626741|FG000|NOT COMPLETED|End of Study (All Patients)||0
10477642|NCT01119443|11626742|FG001|NOT COMPLETED|End of Study (All Patients)||0
10477643|NCT01119456|11626759|FG000|STARTED|Overall Study||7
10477644|NCT01119456|11626760|FG001|STARTED|Overall Study||3
10477645|NCT01119456|11626761|FG002|STARTED|Overall Study||3
10477646|NCT01119456|11626762|FG003|STARTED|Overall Study||13
10477647|NCT01119456|11626763|FG004|STARTED|Overall Study||4
10477648|NCT01119456|11626764|FG005|STARTED|Overall Study||3
10477649|NCT01119456|11626765|FG006|STARTED|Overall Study||3
10477650|NCT01119456|11626766|FG007|STARTED|Overall Study||3
10477651|NCT01119456|11626759|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7
10477652|NCT01119456|11626760|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
10477653|NCT01119456|11626761|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
10477654|NCT01119456|11626762|FG003|Received at Least 1 Dose of Study Drug|Overall Study||13
10477655|NCT01119456|11626763|FG004|Received at Least 1 Dose of Study Drug|Overall Study||4
10477656|NCT01119456|11626764|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3
10477657|NCT01119456|11626765|FG006|Received at Least 1 Dose of Study Drug|Overall Study||3
10477658|NCT01119456|11626766|FG007|Received at Least 1 Dose of Study Drug|Overall Study||3
10477659|NCT01119456|11626759|FG000|COMPLETED|Overall Study||7
10477660|NCT01119456|11626760|FG001|COMPLETED|Overall Study||3
10477661|NCT01119456|11626761|FG002|COMPLETED|Overall Study||3
10477662|NCT01119456|11626762|FG003|COMPLETED|Overall Study||13
10477663|NCT01119456|11626763|FG004|COMPLETED|Overall Study||4
10477664|NCT01119456|11626764|FG005|COMPLETED|Overall Study||3
10477665|NCT01119456|11626765|FG006|COMPLETED|Overall Study||3
10477666|NCT01119456|11626766|FG007|COMPLETED|Overall Study||3
10477667|NCT01119456|11626759|FG000|NOT COMPLETED|Overall Study||0
10477668|NCT01119456|11626760|FG001|NOT COMPLETED|Overall Study||0
10477669|NCT01119456|11626761|FG002|NOT COMPLETED|Overall Study||0
10477670|NCT01119456|11626762|FG003|NOT COMPLETED|Overall Study||0
10477671|NCT01119456|11626763|FG004|NOT COMPLETED|Overall Study||0
10477672|NCT01119456|11626764|FG005|NOT COMPLETED|Overall Study||0
10477673|NCT01119456|11626765|FG006|NOT COMPLETED|Overall Study||0
10477674|NCT01119456|11626766|FG007|NOT COMPLETED|Overall Study||0
10477675|NCT01119508|11626791|FG000|STARTED|Overall Study||64
10477676|NCT01119508|11626791|FG000|Received Four Induction Doses|Overall Study||45
10477677|NCT01119508|11626791|FG000|Received Fifth Consolidation Dose week12|Overall Study||32
10477678|NCT01119508|11626791|FG000|COMPLETED|Overall Study||5
10477679|NCT01119508|11626791|FG000|NOT COMPLETED|Overall Study||59
10477680|NCT01119625|11626797|FG000|STARTED|Overall Study||118
10477681|NCT01119625|11626798|FG001|STARTED|Overall Study||120
10477682|NCT01119625|11626797|FG000|COMPLETED|Overall Study||115
10477683|NCT01119625|11626798|FG001|COMPLETED|Overall Study||116
10477684|NCT01119625|11626797|FG000|NOT COMPLETED|Overall Study||3
10477685|NCT01119625|11626798|FG001|NOT COMPLETED|Overall Study||4
10477686|NCT01119703|11626806|FG000|STARTED|Overall Study||30
10477687|NCT01119703|11626807|FG001|STARTED|Overall Study||144
10477688|NCT01119703|11626806|FG000|COMPLETED|Overall Study||30
10477689|NCT01119703|11626807|FG001|COMPLETED|Overall Study||143
10477690|NCT01119703|11626806|FG000|NOT COMPLETED|Overall Study||0
10477691|NCT01119703|11626807|FG001|NOT COMPLETED|Overall Study||1
10477692|NCT01119716|11626812|FG000|STARTED|Overall Study||4658
10477693|NCT01119716|11626812|FG000|COMPLETED|Overall Study||4658
10477694|NCT01119716|11626812|FG000|NOT COMPLETED|Overall Study||0
10477695|NCT01119755|11626820|FG000|STARTED|Overall Study||80
10477696|NCT01119755|11626820|FG000|COMPLETED|Overall Study||80
10477697|NCT01119755|11626820|FG000|NOT COMPLETED|Overall Study||0
10477698|NCT01119768|11626826|FG000|STARTED|Treatment Period||154
10477699|NCT01119768|11626827|FG001|STARTED|Treatment Period||151
10477700|NCT01119768|11626826|FG000|COMPLETED|Treatment Period||136
10477701|NCT01119768|11626827|FG001|COMPLETED|Treatment Period||126
10477702|NCT01119768|11626826|FG000|NOT COMPLETED|Treatment Period||18
10477703|NCT01119768|11626827|FG001|NOT COMPLETED|Treatment Period||25
10709269|NCT02638103|11874186|FG002|Full Analysis Set (FAS)|Overall Study||419
10477704|NCT01119768|11626826|FG000|STARTED|Follow-up||136
10477705|NCT01119768|11626827|FG001|STARTED|Follow-up||124
10477706|NCT01119768|11626826|FG000|COMPLETED|Follow-up||135
10477707|NCT01119768|11626827|FG001|COMPLETED|Follow-up||122
10477708|NCT01119768|11626826|FG000|NOT COMPLETED|Follow-up||1
10477709|NCT01119768|11626827|FG001|NOT COMPLETED|Follow-up||2
10477710|NCT01119794|11626833|FG000|STARTED|Overall Study||10
10477711|NCT01119794|11626833|FG000|COMPLETED|Overall Study||10
10477712|NCT01119794|11626833|FG000|NOT COMPLETED|Overall Study||0
10477713|NCT01119846|11626840|FG000|STARTED|Overall Study||13
10477714|NCT01119846|11626841|FG001|STARTED|Overall Study||4
10477715|NCT01119846|11626842|FG002|STARTED|Overall Study||83
10477716|NCT01119846|11626840|FG000|COMPLETED|Overall Study||11
10477717|NCT01119846|11626841|FG001|COMPLETED|Overall Study||4
10477718|NCT01119846|11626842|FG002|COMPLETED|Overall Study||72
10477719|NCT01119846|11626840|FG000|NOT COMPLETED|Overall Study||2
10477720|NCT01119846|11626841|FG001|NOT COMPLETED|Overall Study||0
10477721|NCT01119846|11626842|FG002|NOT COMPLETED|Overall Study||11
10477722|NCT01119859|11626879|FG000|STARTED|Overall Study||163
10477723|NCT01119859|11626880|FG001|STARTED|Overall Study||163
10477724|NCT01119859|11626879|FG000|COMPLETED|Overall Study||139
10477725|NCT01119859|11626880|FG001|COMPLETED|Overall Study||133
10477726|NCT01119859|11626879|FG000|NOT COMPLETED|Overall Study||24
10477727|NCT01119859|11626880|FG001|NOT COMPLETED|Overall Study||30
10477728|NCT01119898|11626888|FG000|STARTED|Overall Study||131
10477729|NCT01119898|11626889|FG001|STARTED|Overall Study||129
10477730|NCT01119898|11626888|FG000|Received Study Drug (mITT)|Overall Study||130
10477731|NCT01119898|11626889|FG001|Received Study Drug (mITT)|Overall Study||129
10477732|NCT01119898|11626888|FG000|COMPLETED|Overall Study||123
10477733|NCT01119898|11626889|FG001|COMPLETED|Overall Study||117
10477734|NCT01119898|11626888|FG000|NOT COMPLETED|Overall Study||8
10477735|NCT01119898|11626889|FG001|NOT COMPLETED|Overall Study||12
10477736|NCT01119937|11626897|FG000|STARTED|Overall Study||123
10477737|NCT01119937|11626898|FG001|STARTED|Overall Study||40
10477738|NCT01119937|11626897|FG000|COMPLETED|Overall Study||104
10477739|NCT01119937|11626898|FG001|COMPLETED|Overall Study||33
10477740|NCT01119937|11626897|FG000|NOT COMPLETED|Overall Study||19
10477741|NCT01119937|11626898|FG001|NOT COMPLETED|Overall Study||7
10477742|NCT01119950|11626904|FG000|STARTED|Overall Study|These participants were randomized to 2 different treatment sequences during period 1 and 2.|388
10477743|NCT01119950|11626904|FG000|NVA237 12.5 ug q.d.|Overall Study|5 randomized and 2 misrandomized patients did not receive study drug, 80 completed, 9 discontinued.|96
10477744|NCT01119950|11626904|FG000|NVA237 25 ug q.d.|Overall Study|3 randomized participants did not receive study drug, 91 completed treatment, 5 discontinued.|99
10477745|NCT01119950|11626904|FG000|NVA237 12.5 ug b.i.d.|Overall Study|4 randomized participants did not receive study drug, 93 completed treatment, 2 discontinued.|99
10477746|NCT01119950|11626904|FG000|NVA237 50 ug q.d.|Overall Study|4 randomized participants did not receive study drug, 89 completed treatment, 3 discontinued.|96
10477747|NCT01119950|11626904|FG000|NVA237 25 ug b.i.d.|Overall Study|4 randomized participants did not receive study drug, 89 completed treatment, 7 discontinued.|100
10477748|NCT01119950|11626904|FG000|NVA237 100 ug q.d.|Overall Study|2 randomized participants did not receive study drug, 92 completed treatment, 4 discontinued.|98
10477749|NCT01119950|11626904|FG000|NVA237 50 ug b.i.d.|Overall Study|6 randomized and 1 misrandomized patients did not receive study drug, 82 completed, 5 discontinued.|94
10477750|NCT01119950|11626904|FG000|Placebo|Overall Study|3 randomized participants did not receive study drug, 82 completed treatment, 5 discontinued.|94
10477751|NCT01119950|11626904|FG000|COMPLETED|Overall Study|These participants completed both periods 1 and 2|341
10477752|NCT01119950|11626904|FG000|NOT COMPLETED|Overall Study||47
10477753|NCT01119963|11626932|FG000|STARTED|Overall Study||74
10477754|NCT01119963|11626933|FG001|STARTED|Overall Study||78
10477755|NCT01119963|11626932|FG000|COMPLETED|Overall Study||73
10477756|NCT01119963|11626933|FG001|COMPLETED|Overall Study||77
10477757|NCT01119963|11626932|FG000|NOT COMPLETED|Overall Study||1
10477758|NCT01119963|11626933|FG001|NOT COMPLETED|Overall Study||1
10477759|NCT01120028|11626945|FG000|STARTED|Period 1: Alemtuzumab or Basiliximab||426
10477760|NCT01120028|11626946|FG001|STARTED|Period 1: Alemtuzumab or Basiliximab||426
10477761|NCT01120028|11626947|FG002|STARTED|Period 1: Alemtuzumab or Basiliximab||0
10477762|NCT01120028|11626948|FG003|STARTED|Period 1: Alemtuzumab or Basiliximab||0
10477763|NCT01120028|11626945|FG000|COMPLETED|Period 1: Alemtuzumab or Basiliximab||412
10477764|NCT01120028|11626946|FG001|COMPLETED|Period 1: Alemtuzumab or Basiliximab||403
10477765|NCT01120028|11626947|FG002|COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
10477766|NCT01120028|11626948|FG003|COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
10477767|NCT01120028|11626945|FG000|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||14
10477768|NCT01120028|11626946|FG001|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||23
10477769|NCT01120028|11626947|FG002|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
10477770|NCT01120028|11626948|FG003|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
10477771|NCT01120028|11626945|FG000|STARTED|Period 2: Tacrolimus or Sirolimus||0
10477772|NCT01120028|11626946|FG001|STARTED|Period 2: Tacrolimus or Sirolimus||0
10477773|NCT01120028|11626947|FG002|STARTED|Period 2: Tacrolimus or Sirolimus||197
10477774|NCT01120028|11626948|FG003|STARTED|Period 2: Tacrolimus or Sirolimus||197
10477775|NCT01120028|11626945|FG000|COMPLETED|Period 2: Tacrolimus or Sirolimus||0
10477776|NCT01120028|11626946|FG001|COMPLETED|Period 2: Tacrolimus or Sirolimus||0
10477777|NCT01120028|11626947|FG002|COMPLETED|Period 2: Tacrolimus or Sirolimus||197
10477778|NCT01120028|11626948|FG003|COMPLETED|Period 2: Tacrolimus or Sirolimus||197
10477779|NCT01120028|11626945|FG000|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
10477780|NCT01120028|11626946|FG001|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
10477781|NCT01120028|11626947|FG002|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
10477782|NCT01120028|11626948|FG003|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
10477783|NCT01120067|11626961|FG000|STARTED|Overall Study||12
10477784|NCT01120067|11626962|FG001|STARTED|Overall Study||11
10477785|NCT01120067|11626961|FG000|COMPLETED|Overall Study||7
10477786|NCT01120067|11626962|FG001|COMPLETED|Overall Study||10
10477787|NCT01120067|11626961|FG000|NOT COMPLETED|Overall Study||5
10477788|NCT01120067|11626962|FG001|NOT COMPLETED|Overall Study||1
10477789|NCT01120093|11626968|FG000|STARTED|Treatment Period 1||18
10477790|NCT01120093|11626969|FG001|STARTED|Treatment Period 1||14
10477791|NCT01120093|11626970|FG002|STARTED|Treatment Period 1||17
10477792|NCT01120093|11626971|FG003|STARTED|Treatment Period 1||14
10477793|NCT01120093|11626972|FG004|STARTED|Treatment Period 1||16
10477794|NCT01120093|11626968|FG000|COMPLETED|Treatment Period 1||18
10477795|NCT01120093|11626969|FG001|COMPLETED|Treatment Period 1||13
10477796|NCT01120093|11626970|FG002|COMPLETED|Treatment Period 1||16
10477797|NCT01120093|11626971|FG003|COMPLETED|Treatment Period 1||14
10477798|NCT01120093|11626972|FG004|COMPLETED|Treatment Period 1||15
10477799|NCT01120093|11626968|FG000|NOT COMPLETED|Treatment Period 1||0
10477800|NCT01120093|11626969|FG001|NOT COMPLETED|Treatment Period 1||1
10477801|NCT01120093|11626970|FG002|NOT COMPLETED|Treatment Period 1||1
10477802|NCT01120093|11626971|FG003|NOT COMPLETED|Treatment Period 1||0
10477803|NCT01120093|11626972|FG004|NOT COMPLETED|Treatment Period 1||1
10477804|NCT01120093|11626968|FG000|STARTED|Treatment Period 2||18
10477805|NCT01120093|11626969|FG001|STARTED|Treatment Period 2||13
10477806|NCT01120093|11626970|FG002|STARTED|Treatment Period 2||16
10477807|NCT01120093|11626971|FG003|STARTED|Treatment Period 2||14
10477808|NCT01120093|11626972|FG004|STARTED|Treatment Period 2||15
10477809|NCT01120093|11626968|FG000|COMPLETED|Treatment Period 2||18
10477810|NCT01120093|11626969|FG001|COMPLETED|Treatment Period 2||13
10477811|NCT01120093|11626970|FG002|COMPLETED|Treatment Period 2||16
10477812|NCT01120093|11626971|FG003|COMPLETED|Treatment Period 2||13
10477813|NCT01120093|11626972|FG004|COMPLETED|Treatment Period 2||14
10477814|NCT01120093|11626968|FG000|NOT COMPLETED|Treatment Period 2||0
10477815|NCT01120093|11626969|FG001|NOT COMPLETED|Treatment Period 2||0
10477816|NCT01120093|11626970|FG002|NOT COMPLETED|Treatment Period 2||0
10477817|NCT01120093|11626971|FG003|NOT COMPLETED|Treatment Period 2||1
10477818|NCT01120093|11626972|FG004|NOT COMPLETED|Treatment Period 2||1
10477819|NCT01120093|11626968|FG000|STARTED|Treatment Period 3||18
10477820|NCT01120093|11626969|FG001|STARTED|Treatment Period 3||13
10477821|NCT01120093|11626970|FG002|STARTED|Treatment Period 3||16
10477822|NCT01120093|11626971|FG003|STARTED|Treatment Period 3||13
10477823|NCT01120093|11626972|FG004|STARTED|Treatment Period 3||14
10477824|NCT01120093|11626968|FG000|COMPLETED|Treatment Period 3||18
10477825|NCT01120093|11626969|FG001|COMPLETED|Treatment Period 3||13
10477826|NCT01120093|11626970|FG002|COMPLETED|Treatment Period 3||15
10477827|NCT01120093|11626971|FG003|COMPLETED|Treatment Period 3||12
10477828|NCT01120093|11626972|FG004|COMPLETED|Treatment Period 3||13
10477829|NCT01120093|11626968|FG000|NOT COMPLETED|Treatment Period 3||0
10477830|NCT01120093|11626969|FG001|NOT COMPLETED|Treatment Period 3||0
10477831|NCT01120093|11626970|FG002|NOT COMPLETED|Treatment Period 3||1
10477832|NCT01120093|11626971|FG003|NOT COMPLETED|Treatment Period 3||1
10477833|NCT01120093|11626972|FG004|NOT COMPLETED|Treatment Period 3||1
10477834|NCT01120093|11626968|FG000|STARTED|Treatment Period 4||18
10477835|NCT01120093|11626969|FG001|STARTED|Treatment Period 4||13
10477836|NCT01120093|11626970|FG002|STARTED|Treatment Period 4||15
10477837|NCT01120093|11626971|FG003|STARTED|Treatment Period 4||12
10477838|NCT01120093|11626972|FG004|STARTED|Treatment Period 4||13
10477839|NCT01120093|11626968|FG000|COMPLETED|Treatment Period 4||17
10477840|NCT01120093|11626969|FG001|COMPLETED|Treatment Period 4||13
10477841|NCT01120093|11626970|FG002|COMPLETED|Treatment Period 4||15
10477842|NCT01120093|11626971|FG003|COMPLETED|Treatment Period 4||12
10477843|NCT01120093|11626972|FG004|COMPLETED|Treatment Period 4||13
10477844|NCT01120093|11626968|FG000|NOT COMPLETED|Treatment Period 4||1
10477845|NCT01120093|11626969|FG001|NOT COMPLETED|Treatment Period 4||0
10477846|NCT01120093|11626970|FG002|NOT COMPLETED|Treatment Period 4||0
10477847|NCT01120093|11626971|FG003|NOT COMPLETED|Treatment Period 4||0
10477848|NCT01120093|11626972|FG004|NOT COMPLETED|Treatment Period 4||0
10477849|NCT01120093|11626968|FG000|STARTED|Treatment Period 5||17
10477850|NCT01120093|11626969|FG001|STARTED|Treatment Period 5||13
10709270|NCT02638103|11874187|FG003|Full Analysis Set (FAS)|Overall Study||523
10709271|NCT02638103|11874184|FG000|COMPLETED|Overall Study||313
10709272|NCT02638103|11874185|FG001|COMPLETED|Overall Study||408
10709273|NCT02638103|11874186|FG002|COMPLETED|Overall Study||335
10477851|NCT01120093|11626970|FG002|STARTED|Treatment Period 5||15
10477852|NCT01120093|11626971|FG003|STARTED|Treatment Period 5||12
10477853|NCT01120093|11626972|FG004|STARTED|Treatment Period 5||13
10477854|NCT01120093|11626968|FG000|COMPLETED|Treatment Period 5||17
10477855|NCT01120093|11626969|FG001|COMPLETED|Treatment Period 5||12
10477856|NCT01120093|11626970|FG002|COMPLETED|Treatment Period 5||15
10709274|NCT02638103|11874187|FG003|COMPLETED|Overall Study||383
10477857|NCT01120093|11626971|FG003|COMPLETED|Treatment Period 5||11
10477858|NCT01120093|11626972|FG004|COMPLETED|Treatment Period 5||13
10477859|NCT01120093|11626968|FG000|NOT COMPLETED|Treatment Period 5||0
10477860|NCT01120093|11626969|FG001|NOT COMPLETED|Treatment Period 5||1
10477861|NCT01120093|11626970|FG002|NOT COMPLETED|Treatment Period 5||0
10477862|NCT01120093|11626971|FG003|NOT COMPLETED|Treatment Period 5||1
10477863|NCT01120093|11626972|FG004|NOT COMPLETED|Treatment Period 5||0
10477864|NCT01120184|11626987|FG000|STARTED|Overall Study||365
10477865|NCT01120184|11626988|FG001|STARTED|Overall Study||367
10477866|NCT01120184|11626989|FG002|STARTED|Overall Study||363
10477867|NCT01120184|11626987|FG000|Treated|Overall Study||355
10477868|NCT01120184|11626988|FG001|Treated|Overall Study||365
10477869|NCT01120184|11626989|FG002|Treated|Overall Study||360
10477870|NCT01120184|11626987|FG000|COMPLETED|Overall Study||0
10477871|NCT01120184|11626988|FG001|COMPLETED|Overall Study||0
10477872|NCT01120184|11626989|FG002|COMPLETED|Overall Study||0
10477873|NCT01120184|11626987|FG000|NOT COMPLETED|Overall Study||365
10477874|NCT01120184|11626988|FG001|NOT COMPLETED|Overall Study||367
10477875|NCT01120184|11626989|FG002|NOT COMPLETED|Overall Study||363
10477876|NCT01120197|11626999|FG000|STARTED|Overall Study||47
10477877|NCT01120197|11627000|FG001|STARTED|Overall Study||42
10477878|NCT01120197|11626999|FG000|COMPLETED|Overall Study||38
10477879|NCT01120197|11627000|FG001|COMPLETED|Overall Study||32
10477880|NCT01120197|11626999|FG000|NOT COMPLETED|Overall Study||9
10477881|NCT01120197|11627000|FG001|NOT COMPLETED|Overall Study||10
10477882|NCT01120210|11627009|FG000|STARTED|MAIN INFUSION||16
10477883|NCT01120210|11627010|FG001|STARTED|MAIN INFUSION||46
10477884|NCT01120210|11627009|FG000|COMPLETED|MAIN INFUSION||15
10477885|NCT01120210|11627010|FG001|COMPLETED|MAIN INFUSION||45
10477886|NCT01120210|11627009|FG000|NOT COMPLETED|MAIN INFUSION||1
10709275|NCT02638103|11874184|FG000|NOT COMPLETED|Overall Study||106
10709276|NCT02638103|11874185|FG001|NOT COMPLETED|Overall Study||118
10709277|NCT02638103|11874186|FG002|NOT COMPLETED|Overall Study||85
10709278|NCT02638103|11874187|FG003|NOT COMPLETED|Overall Study||142
10709279|NCT02638168|11874205|FG000|STARTED|Overall Study||3
10709280|NCT02638168|11874206|FG001|STARTED|Overall Study||0
10477887|NCT01120210|11627010|FG001|NOT COMPLETED|MAIN INFUSION||1
10477888|NCT01120210|11627009|FG000|STARTED|18-HOUR EXTENDED INFUSION SUBSTUDY||3
10477889|NCT01120210|11627010|FG001|STARTED|18-HOUR EXTENDED INFUSION SUBSTUDY||7
10477890|NCT01120210|11627009|FG000|COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||3
10477891|NCT01120210|11627010|FG001|COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||7
10477892|NCT01120210|11627009|FG000|NOT COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||0
10477893|NCT01120210|11627010|FG001|NOT COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||0
10477894|NCT01120223|11627016|FG000|STARTED|Overall Study||78
10477895|NCT01120223|11627016|FG000|COMPLETED|Overall Study||74
10477896|NCT01120223|11627016|FG000|NOT COMPLETED|Overall Study||4
10477897|NCT01120236|11627022|FG000|STARTED|Overall Study||105
10477898|NCT01120236|11627023|FG001|STARTED|Overall Study||106
10477899|NCT01120236|11627022|FG000|Ineligble|Overall Study||0
10477900|NCT01120236|11627023|FG001|Ineligble|Overall Study|Patient ineligible due to no demonstable radiographic metastasis and is excluded from all analyses.|1
10477901|NCT01120236|11627022|FG000|COMPLETED|Overall Study||105
10477902|NCT01120236|11627023|FG001|COMPLETED|Overall Study||105
10477903|NCT01120236|11627022|FG000|NOT COMPLETED|Overall Study||0
10477904|NCT01120236|11627023|FG001|NOT COMPLETED|Overall Study||1
10526999|NCT01386554|11678961|FG002|STARTED|Overall Study||21
10527000|NCT01386554|11678959|FG000|COMPLETED|Overall Study||1
10527001|NCT01386554|11678960|FG001|COMPLETED|Overall Study||26
10527002|NCT01386554|11678961|FG002|COMPLETED|Overall Study||15
10527003|NCT01386554|11678959|FG000|NOT COMPLETED|Overall Study||3
10527004|NCT01386554|11678960|FG001|NOT COMPLETED|Overall Study||9
10527005|NCT01386554|11678961|FG002|NOT COMPLETED|Overall Study||6
10527006|NCT01386606|11678975|FG000|STARTED|Overall Study||16
10527007|NCT01386606|11678976|FG001|STARTED|Overall Study||14
10527008|NCT01386606|11678977|FG002|STARTED|Overall Study||16
10527009|NCT01386606|11678978|FG003|STARTED|Overall Study||14
10527010|NCT01386606|11678975|FG000|COMPLETED|Overall Study||12
10527011|NCT01386606|11678976|FG001|COMPLETED|Overall Study||10
10527012|NCT01386606|11678977|FG002|COMPLETED|Overall Study||13
10527013|NCT01386606|11678978|FG003|COMPLETED|Overall Study||13
10527014|NCT01386606|11678975|FG000|NOT COMPLETED|Overall Study||4
10527015|NCT01386606|11678976|FG001|NOT COMPLETED|Overall Study||4
10527016|NCT01386606|11678977|FG002|NOT COMPLETED|Overall Study||3
10527017|NCT01386606|11678978|FG003|NOT COMPLETED|Overall Study||1
10527018|NCT01386632|11678994|FG000|STARTED|Overall Study||25
10527019|NCT01386632|11678995|FG001|STARTED|Overall Study||25
10527020|NCT01386632|11678994|FG000|COMPLETED|Overall Study||20
10527021|NCT01386632|11678995|FG001|COMPLETED|Overall Study||21
10527022|NCT01386632|11678994|FG000|NOT COMPLETED|Overall Study||5
10527023|NCT01386632|11678995|FG001|NOT COMPLETED|Overall Study||4
10527024|NCT01386645|11679004|FG000|STARTED|Overall Study||18
10527025|NCT01386645|11679005|FG001|STARTED|Overall Study||19
10527026|NCT01386645|11679006|FG002|STARTED|Overall Study||19
10527027|NCT01386645|11679004|FG000|COMPLETED|Overall Study||18
10527028|NCT01386645|11679005|FG001|COMPLETED|Overall Study||18
10527029|NCT01386645|11679006|FG002|COMPLETED|Overall Study||17
10527030|NCT01386645|11679004|FG000|NOT COMPLETED|Overall Study||0
10527031|NCT01386645|11679005|FG001|NOT COMPLETED|Overall Study||1
10527032|NCT01386645|11679006|FG002|NOT COMPLETED|Overall Study||2
10527033|NCT01386788|11679014|FG000|STARTED|Overall Study||102
10527034|NCT01386788|11679014|FG000|COMPLETED|Overall Study||100
10709281|NCT02638168|11874205|FG000|COMPLETED|Overall Study||3
10527035|NCT01386788|11679014|FG000|NOT COMPLETED|Overall Study||2
10527036|NCT01386944|11679018|FG000|STARTED|Overall Study||102
10527037|NCT01386944|11679018|FG000|COMPLETED|Overall Study||46
10527038|NCT01386944|11679018|FG000|NOT COMPLETED|Overall Study||56
10527039|NCT01386970|11679024|FG000|STARTED|Overall Study||20
10527040|NCT01386970|11679025|FG001|STARTED|Overall Study||23
10527041|NCT01386970|11679024|FG000|COMPLETED|Overall Study||16
10527042|NCT01386970|11679025|FG001|COMPLETED|Overall Study||21
10527043|NCT01386970|11679024|FG000|NOT COMPLETED|Overall Study||4
10527044|NCT01386970|11679025|FG001|NOT COMPLETED|Overall Study||2
10527045|NCT01386983|11679035|FG000|STARTED|Overall Study||264
10709282|NCT02638168|11874206|FG001|COMPLETED|Overall Study||0
10477905|NCT01120275|11627037|FG000|STARTED|Overall Study||36
10477906|NCT01120275|11627037|FG000|Eligible and Treated|Overall Study||32
10477907|NCT01120275|11627037|FG000|COMPLETED|Overall Study||0
10477908|NCT01120275|11627037|FG000|NOT COMPLETED|Overall Study||36
10477909|NCT01120379|11627042|FG000|STARTED|One Year Timepoint||5020
10477910|NCT01120379|11627042|FG000|COMPLETED|One Year Timepoint||4742
10477911|NCT01120379|11627042|FG000|NOT COMPLETED|One Year Timepoint||278
10477912|NCT01120379|11627042|FG000|STARTED|Two Year Timepoint||4742
10477913|NCT01120379|11627042|FG000|COMPLETED|Two Year Timepoint||4505
10477914|NCT01120379|11627042|FG000|NOT COMPLETED|Two Year Timepoint||237
10477915|NCT01120379|11627042|FG000|STARTED|Three Year Timepoint||4505
10477916|NCT01120379|11627042|FG000|COMPLETED|Three Year Timepoint||4291
10477917|NCT01120379|11627042|FG000|NOT COMPLETED|Three Year Timepoint||214
10477918|NCT01120379|11627042|FG000|STARTED|Four Year Timepoint||4291
10477919|NCT01120379|11627042|FG000|COMPLETED|Four Year Timepoint||3923
10477920|NCT01120379|11627042|FG000|NOT COMPLETED|Four Year Timepoint||368
10477921|NCT01120405|11627048|FG000|STARTED|Overall Study||298
10477922|NCT01120405|11627049|FG001|STARTED|Overall Study||302
10477923|NCT01120405|11627048|FG000|COMPLETED|Overall Study||271
10477924|NCT01120405|11627049|FG001|COMPLETED|Overall Study||269
10477925|NCT01120405|11627048|FG000|NOT COMPLETED|Overall Study||27
10477926|NCT01120405|11627049|FG001|NOT COMPLETED|Overall Study||33
10477927|NCT01120600|11627059|FG000|STARTED|Overall Study||147
10477928|NCT01120600|11627060|FG001|STARTED|Overall Study||147
10477929|NCT01120600|11627059|FG000|Treated|Overall Study||146
10477930|NCT01120600|11627060|FG001|Treated|Overall Study||146
10477931|NCT01120600|11627059|FG000|COMPLETED|Overall Study||128
10477932|NCT01120600|11627060|FG001|COMPLETED|Overall Study||115
10477933|NCT01120600|11627059|FG000|NOT COMPLETED|Overall Study||19
10477934|NCT01120600|11627060|FG001|NOT COMPLETED|Overall Study||32
10477935|NCT01120626|11627068|FG000|STARTED|Overall Study||20
10477936|NCT01120626|11627069|FG001|STARTED|Overall Study||22
10477937|NCT01120626|11627068|FG000|COMPLETED|Overall Study||19
10477938|NCT01120626|11627069|FG001|COMPLETED|Overall Study||22
10477939|NCT01120626|11627068|FG000|NOT COMPLETED|Overall Study||1
10477940|NCT01120626|11627069|FG001|NOT COMPLETED|Overall Study||0
10477941|NCT01120639|11627079|FG000|STARTED|Overall Study||6
10477942|NCT01120639|11627080|FG001|STARTED|Overall Study||6
10477943|NCT01120639|11627081|FG002|STARTED|Overall Study||6
10477944|NCT01120639|11627082|FG003|STARTED|Overall Study||12
10477945|NCT01120639|11627079|FG000|COMPLETED|Overall Study||6
10477946|NCT01120639|11627080|FG001|COMPLETED|Overall Study||6
10477947|NCT01120639|11627081|FG002|COMPLETED|Overall Study||6
10477948|NCT01120639|11627082|FG003|COMPLETED|Overall Study||12
10477949|NCT01120639|11627079|FG000|NOT COMPLETED|Overall Study||0
10477950|NCT01120639|11627080|FG001|NOT COMPLETED|Overall Study||0
10477951|NCT01120639|11627081|FG002|NOT COMPLETED|Overall Study||0
10477952|NCT01120639|11627082|FG003|NOT COMPLETED|Overall Study||0
10477953|NCT01120691|11627095|FG000|STARTED|Overall Study||741
10477954|NCT01120691|11627096|FG001|STARTED|Overall Study||741
10477955|NCT01120691|11627097|FG002|STARTED|Overall Study||742
10477956|NCT01120691|11627095|FG000|Full Analysis Set (FAS)|Overall Study||736
10477957|NCT01120691|11627096|FG001|Full Analysis Set (FAS)|Overall Study||739
10477958|NCT01120691|11627097|FG002|Full Analysis Set (FAS)|Overall Study||739
10477959|NCT01120691|11627095|FG000|Safety Set (SAF)|Overall Study||736
10709283|NCT02638168|11874205|FG000|NOT COMPLETED|Overall Study||0
10709284|NCT02638168|11874206|FG001|NOT COMPLETED|Overall Study||0
10709285|NCT02638207|11874213|FG000|STARTED|Overall Study||35
10477960|NCT01120691|11627096|FG001|Safety Set (SAF)|Overall Study||740
10477961|NCT01120691|11627097|FG002|Safety Set (SAF)|Overall Study||739
10477962|NCT01120691|11627095|FG000|Modified Safety Set (mSAF)|Overall Study||729
10477963|NCT01120691|11627096|FG001|Modified Safety Set (mSAF)|Overall Study||740
10477964|NCT01120691|11627097|FG002|Modified Safety Set (mSAF)|Overall Study||737
10477965|NCT01120691|11627095|FG000|Modified Full Analysis Set (mFAS)|Overall Study||729
10477966|NCT01120691|11627096|FG001|Modified Full Analysis Set (mFAS)|Overall Study||739
10477967|NCT01120691|11627097|FG002|Modified Full Analysis Set (mFAS)|Overall Study||737
10477968|NCT01120691|11627095|FG000|COMPLETED|Overall Study||570
10477969|NCT01120691|11627096|FG001|COMPLETED|Overall Study||538
10477970|NCT01120691|11627097|FG002|COMPLETED|Overall Study||559
10477971|NCT01120691|11627095|FG000|NOT COMPLETED|Overall Study||171
10477972|NCT01120691|11627096|FG001|NOT COMPLETED|Overall Study||203
10477973|NCT01120691|11627097|FG002|NOT COMPLETED|Overall Study||183
10477974|NCT01120704|11627141|FG000|STARTED|Overall Study||13
10477975|NCT01120704|11627142|FG001|STARTED|Overall Study||17
10477976|NCT01120704|11627143|FG002|STARTED|Overall Study||14
10477977|NCT01120704|11627144|FG003|STARTED|Overall Study||19
10477978|NCT01120704|11627145|FG004|STARTED|Overall Study||16
10477979|NCT01120704|11627146|FG005|STARTED|Overall Study||19
10649866|NCT02164539|11810008|FG005|NOT COMPLETED|Treatment Phase A (4 Weeks)||1
10649867|NCT02164539|11810009|FG006|NOT COMPLETED|Treatment Phase A (4 Weeks)||0
10649868|NCT02164539|11810003|FG000|STARTED|Treatment Phase B (1 Week)||0
10649869|NCT02164539|11810004|FG001|STARTED|Treatment Phase B (1 Week)||0
10649870|NCT02164539|11810005|FG002|STARTED|Treatment Phase B (1 Week)||0
10709286|NCT02638207|11874214|FG001|STARTED|Overall Study||69
10477980|NCT01120704|11627147|FG006|STARTED|Overall Study||15
10709287|NCT02638207|11874215|FG002|STARTED|Overall Study||38
10477981|NCT01120704|11627148|FG007|STARTED|Overall Study||15
10477982|NCT01120704|11627149|FG008|STARTED|Overall Study||22
10477983|NCT01120704|11627150|FG009|STARTED|Overall Study||20
10477984|NCT01120704|11627151|FG010|STARTED|Overall Study||17
10477985|NCT01120704|11627152|FG011|STARTED|Overall Study||16
10477986|NCT01120704|11627153|FG012|STARTED|Overall Study||17
10477987|NCT01120704|11627154|FG013|STARTED|Overall Study||19
10477988|NCT01120704|11627155|FG014|STARTED|Overall Study||18
10477989|NCT01120704|11627156|FG015|STARTED|Overall Study||18
10477990|NCT01120704|11627157|FG016|STARTED|Overall Study||14
10477991|NCT01120704|11627158|FG017|STARTED|Overall Study||16
10477992|NCT01120704|11627159|FG018|STARTED|Overall Study||17
10477993|NCT01120704|11627160|FG019|STARTED|Overall Study||18
10477994|NCT01120704|11627161|FG020|STARTED|Overall Study||17
10477995|NCT01120704|11627162|FG021|STARTED|Overall Study||16
10477996|NCT01120704|11627163|FG022|STARTED|Overall Study||21
10477997|NCT01120704|11627164|FG023|STARTED|Overall Study||16
10477998|NCT01120704|11627165|FG024|STARTED|Overall Study||18
10477999|NCT01120704|11627166|FG025|STARTED|Overall Study||14
10478000|NCT01120704|11627167|FG026|STARTED|Overall Study||18
10478001|NCT01120704|11627168|FG027|STARTED|Overall Study||18
10709288|NCT02638207|11874213|FG000|COMPLETED|Overall Study||28
10709289|NCT02638207|11874214|FG001|COMPLETED|Overall Study||61
10709290|NCT02638207|11874215|FG002|COMPLETED|Overall Study||34
10709291|NCT02638207|11874213|FG000|NOT COMPLETED|Overall Study||7
10709292|NCT02638207|11874214|FG001|NOT COMPLETED|Overall Study||8
10709293|NCT02638207|11874215|FG002|NOT COMPLETED|Overall Study||4
10709294|NCT02638259|11874227|FG000|STARTED|Treatment Period 1||186
10709295|NCT02638259|11874228|FG001|STARTED|Treatment Period 1||190
10709296|NCT02638259|11874227|FG000|COMPLETED|Treatment Period 1||181
10709297|NCT02638259|11874228|FG001|COMPLETED|Treatment Period 1||172
10709298|NCT02638259|11874227|FG000|NOT COMPLETED|Treatment Period 1||5
10709299|NCT02638259|11874228|FG001|NOT COMPLETED|Treatment Period 1||18
10709300|NCT02638259|11874227|FG000|STARTED|Treatment Period 2|6 patients did not proceed to TP2 (3 not eligible, 2 consent withdrawal, 1 IP delay)|175
10709301|NCT02638259|11874228|FG001|STARTED|Treatment Period 2|6 patients did not proceed to TP2 (4 not eligible, 1 consent withdrawal, 1 adverse event).|166
10709302|NCT02638259|11874227|FG000|COMPLETED|Treatment Period 2||169
10709303|NCT02638259|11874228|FG001|COMPLETED|Treatment Period 2||155
10709304|NCT02638259|11874227|FG000|NOT COMPLETED|Treatment Period 2||6
10709305|NCT02638259|11874228|FG001|NOT COMPLETED|Treatment Period 2||11
10709306|NCT02638337|11874240|FG000|STARTED|Overall Study||316
10709307|NCT02638337|11874241|FG001|STARTED|Overall Study||315
10709308|NCT02638337|11874240|FG000|Received Treatment|Overall Study||313
10709309|NCT02638337|11874241|FG001|Received Treatment|Overall Study||315
10709310|NCT02638337|11874240|FG000|COMPLETED|Overall Study||283
10709311|NCT02638337|11874241|FG001|COMPLETED|Overall Study||279
10709312|NCT02638337|11874240|FG000|NOT COMPLETED|Overall Study||33
10709313|NCT02638337|11874241|FG001|NOT COMPLETED|Overall Study||36
10709314|NCT02638493|11874250|FG000|STARTED|Overall Study|Two men were not able to provide semen samples, and thus were replaced|10
10709315|NCT02638493|11874251|FG001|STARTED|Overall Study||8
10709316|NCT02638493|11874252|FG002|STARTED|Overall Study||8
10478002|NCT01120704|11627169|FG028|STARTED|Overall Study||19
10478003|NCT01120704|11627170|FG029|STARTED|Overall Study||15
10478004|NCT01120704|11627171|FG030|STARTED|Overall Study||14
10478005|NCT01120704|11627172|FG031|STARTED|Overall Study||18
10478006|NCT01120704|11627141|FG000|COMPLETED|Overall Study||10
10478007|NCT01120704|11627142|FG001|COMPLETED|Overall Study||13
10478008|NCT01120704|11627143|FG002|COMPLETED|Overall Study||13
10478009|NCT01120704|11627144|FG003|COMPLETED|Overall Study||15
10478010|NCT01120704|11627145|FG004|COMPLETED|Overall Study||14
10478011|NCT01120704|11627146|FG005|COMPLETED|Overall Study||18
10478012|NCT01120704|11627147|FG006|COMPLETED|Overall Study||12
10478013|NCT01120704|11627148|FG007|COMPLETED|Overall Study||13
10478014|NCT01120704|11627149|FG008|COMPLETED|Overall Study||19
10478015|NCT01120704|11627150|FG009|COMPLETED|Overall Study||19
10478016|NCT01120704|11627151|FG010|COMPLETED|Overall Study||16
10478017|NCT01120704|11627152|FG011|COMPLETED|Overall Study||14
10478018|NCT01120704|11627153|FG012|COMPLETED|Overall Study||14
10478019|NCT01120704|11627154|FG013|COMPLETED|Overall Study||15
10478020|NCT01120704|11627155|FG014|COMPLETED|Overall Study||17
10478021|NCT01120704|11627156|FG015|COMPLETED|Overall Study||16
10478022|NCT01120704|11627157|FG016|COMPLETED|Overall Study||13
10478023|NCT01120704|11627158|FG017|COMPLETED|Overall Study||16
10478024|NCT01120704|11627159|FG018|COMPLETED|Overall Study||15
10478025|NCT01120704|11627160|FG019|COMPLETED|Overall Study||15
10478026|NCT01120704|11627161|FG020|COMPLETED|Overall Study||14
10478027|NCT01120704|11627162|FG021|COMPLETED|Overall Study||16
10478028|NCT01120704|11627163|FG022|COMPLETED|Overall Study||17
10478029|NCT01120704|11627164|FG023|COMPLETED|Overall Study||13
10478030|NCT01120704|11627165|FG024|COMPLETED|Overall Study||16
10478031|NCT01120704|11627166|FG025|COMPLETED|Overall Study||14
10478032|NCT01120704|11627167|FG026|COMPLETED|Overall Study||15
10478033|NCT01120704|11627168|FG027|COMPLETED|Overall Study||16
10478034|NCT01120704|11627169|FG028|COMPLETED|Overall Study||14
10709317|NCT02638493|11874250|FG000|COMPLETED|Overall Study||8
10709318|NCT02638493|11874251|FG001|COMPLETED|Overall Study||8
10478035|NCT01120704|11627170|FG029|COMPLETED|Overall Study||12
10709319|NCT02638493|11874252|FG002|COMPLETED|Overall Study||8
10478036|NCT01120704|11627171|FG030|COMPLETED|Overall Study||12
10478037|NCT01120704|11627172|FG031|COMPLETED|Overall Study||17
10478038|NCT01120704|11627141|FG000|NOT COMPLETED|Overall Study||3
10478039|NCT01120704|11627142|FG001|NOT COMPLETED|Overall Study||4
10478040|NCT01120704|11627143|FG002|NOT COMPLETED|Overall Study||1
10478041|NCT01120704|11627144|FG003|NOT COMPLETED|Overall Study||4
10478042|NCT01120704|11627145|FG004|NOT COMPLETED|Overall Study||2
10478043|NCT01120704|11627146|FG005|NOT COMPLETED|Overall Study||1
10478044|NCT01120704|11627147|FG006|NOT COMPLETED|Overall Study||3
10478045|NCT01120704|11627148|FG007|NOT COMPLETED|Overall Study||2
10478046|NCT01120704|11627149|FG008|NOT COMPLETED|Overall Study||3
10478047|NCT01120704|11627150|FG009|NOT COMPLETED|Overall Study||1
10478048|NCT01120704|11627151|FG010|NOT COMPLETED|Overall Study||1
10478049|NCT01120704|11627152|FG011|NOT COMPLETED|Overall Study||2
10478050|NCT01120704|11627153|FG012|NOT COMPLETED|Overall Study||3
10478051|NCT01120704|11627154|FG013|NOT COMPLETED|Overall Study||4
10478052|NCT01120704|11627155|FG014|NOT COMPLETED|Overall Study||1
10478053|NCT01120704|11627156|FG015|NOT COMPLETED|Overall Study||2
10478054|NCT01120704|11627157|FG016|NOT COMPLETED|Overall Study||1
10478055|NCT01120704|11627158|FG017|NOT COMPLETED|Overall Study||0
10478056|NCT01120704|11627159|FG018|NOT COMPLETED|Overall Study||2
10478057|NCT01120704|11627160|FG019|NOT COMPLETED|Overall Study||3
10478058|NCT01120704|11627161|FG020|NOT COMPLETED|Overall Study||3
10478059|NCT01120704|11627162|FG021|NOT COMPLETED|Overall Study||0
10478060|NCT01120704|11627163|FG022|NOT COMPLETED|Overall Study||4
10478061|NCT01120704|11627164|FG023|NOT COMPLETED|Overall Study||3
10478062|NCT01120704|11627165|FG024|NOT COMPLETED|Overall Study||2
10478063|NCT01120704|11627166|FG025|NOT COMPLETED|Overall Study||0
10478064|NCT01120704|11627167|FG026|NOT COMPLETED|Overall Study||3
10478065|NCT01120704|11627168|FG027|NOT COMPLETED|Overall Study||2
10478066|NCT01120704|11627169|FG028|NOT COMPLETED|Overall Study||5
10478067|NCT01120704|11627170|FG029|NOT COMPLETED|Overall Study||3
10478068|NCT01120704|11627171|FG030|NOT COMPLETED|Overall Study||2
10478069|NCT01120704|11627172|FG031|NOT COMPLETED|Overall Study||1
10478070|NCT01120717|11627188|FG000|STARTED|Overall Study||226
10478071|NCT01120717|11627189|FG001|STARTED|Overall Study||113
10478072|NCT01120717|11627188|FG000|Safety Population: Received Study Drug|Overall Study||225
10478073|NCT01120717|11627189|FG001|Safety Population: Received Study Drug|Overall Study||113
10478074|NCT01120717|11627188|FG000|COMPLETED|Overall Study||194
10478075|NCT01120717|11627189|FG001|COMPLETED|Overall Study||89
10478076|NCT01120717|11627188|FG000|NOT COMPLETED|Overall Study||32
10478077|NCT01120717|11627189|FG001|NOT COMPLETED|Overall Study||24
10478078|NCT01120756|11627197|FG000|STARTED|Overall Study||21
10478079|NCT01120756|11627198|FG001|STARTED|Overall Study||14
10478080|NCT01120756|11627197|FG000|COMPLETED|Overall Study||20
10478081|NCT01120756|11627198|FG001|COMPLETED|Overall Study||13
10478082|NCT01120756|11627197|FG000|NOT COMPLETED|Overall Study||1
10478083|NCT01120756|11627198|FG001|NOT COMPLETED|Overall Study||1
10478084|NCT01120782|11627204|FG000|STARTED|Overall Study||45
10478085|NCT01120782|11627204|FG000|COMPLETED|Overall Study||34
10478086|NCT01120782|11627204|FG000|NOT COMPLETED|Overall Study||11
10478087|NCT01120808|11627208|FG000|STARTED|Overall Study||136
10478088|NCT01120808|11627208|FG000|COMPLETED|Overall Study||90
10478089|NCT01120808|11627208|FG000|NOT COMPLETED|Overall Study||46
10478090|NCT01120834|11627212|FG000|STARTED|Overall Study||18
10478091|NCT01120834|11627212|FG000|COMPLETED|Overall Study||18
10478092|NCT01120834|11627212|FG000|NOT COMPLETED|Overall Study||0
10478093|NCT01120899|11627216|FG000|STARTED|Overall Study||6
10478094|NCT01120899|11627216|FG000|Month 6|Overall Study||5
10478095|NCT01120899|11627216|FG000|Month 12|Overall Study||3
10478096|NCT01120899|11627216|FG000|Month 18|Overall Study||3
10478097|NCT01120899|11627216|FG000|COMPLETED|Overall Study||3
10478098|NCT01120899|11627216|FG000|NOT COMPLETED|Overall Study||3
10478099|NCT01120990|11627220|FG000|STARTED|Overall Study||51
10478100|NCT01120990|11627220|FG000|COMPLETED|Overall Study||51
10478101|NCT01120990|11627220|FG000|NOT COMPLETED|Overall Study||0
10478102|NCT01121146|11627226|FG000|STARTED|Overall Study||116
10478103|NCT01121146|11627227|FG001|STARTED|Overall Study||114
10478104|NCT01121146|11627226|FG000|COMPLETED|Overall Study|The 90 hips include those that were not revised and had a minimum 9-year questionnaire or radiograph|90
10478105|NCT01121146|11627227|FG001|COMPLETED|Overall Study|The 72 hips include those that were not revised and had a minimum 9-year questionnaire or radiograph|72
10478106|NCT01121146|11627226|FG000|NOT COMPLETED|Overall Study||26
10478107|NCT01121146|11627227|FG001|NOT COMPLETED|Overall Study||42
10478108|NCT01121172|11627236|FG000|STARTED|Overall Study||90
10478109|NCT01121172|11627237|FG001|STARTED|Overall Study||90
10478110|NCT01121172|11627236|FG000|COMPLETED|Overall Study||90
10478111|NCT01121172|11627237|FG001|COMPLETED|Overall Study||90
10478112|NCT01121172|11627236|FG000|NOT COMPLETED|Overall Study||0
10478113|NCT01121172|11627237|FG001|NOT COMPLETED|Overall Study||0
10478114|NCT01121185|11627246|FG000|STARTED|Overall Study||7
10478115|NCT01121185|11627247|FG001|STARTED|Overall Study||6
10478116|NCT01121185|11627246|FG000|Infused|Overall Study||7
10478117|NCT01121185|11627247|FG001|Infused|Overall Study|Excluded medical condition identified in one subject after randomization but before study infusion.|5
10478118|NCT01121185|11627246|FG000|Transplanted|Overall Study|One subject initiated the first study infusion, but transplant surgery was subsequently cancelled.|6
10478119|NCT01121185|11627247|FG001|Transplanted|Overall Study||5
10478120|NCT01121185|11627246|FG000|COMPLETED|Overall Study||6
10478121|NCT01121185|11627247|FG001|COMPLETED|Overall Study||5
10478122|NCT01121185|11627246|FG000|NOT COMPLETED|Overall Study||1
10478123|NCT01121185|11627247|FG001|NOT COMPLETED|Overall Study||1
10478124|NCT01121211|11627255|FG000|STARTED|Overall Study||43
10478125|NCT01121211|11627256|FG001|STARTED|Overall Study||47
10478126|NCT01121211|11627255|FG000|COMPLETED|Overall Study||32
10478127|NCT01121211|11627256|FG001|COMPLETED|Overall Study||35
10478128|NCT01121211|11627255|FG000|NOT COMPLETED|Overall Study||11
10478129|NCT01121211|11627256|FG001|NOT COMPLETED|Overall Study||12
10478136|NCT01121250|11627276|FG000|STARTED|Overall Study||76
10478137|NCT01121250|11627277|FG001|STARTED|Overall Study||76
10478138|NCT01121250|11627278|FG002|STARTED|Overall Study||76
10478139|NCT01121250|11627276|FG000|COMPLETED|Overall Study||76
10478140|NCT01121250|11627277|FG001|COMPLETED|Overall Study||76
10478141|NCT01121250|11627278|FG002|COMPLETED|Overall Study||75
10478142|NCT01121250|11627276|FG000|NOT COMPLETED|Overall Study||0
10478143|NCT01121250|11627277|FG001|NOT COMPLETED|Overall Study||0
10478144|NCT01121250|11627278|FG002|NOT COMPLETED|Overall Study||1
10478145|NCT01121263|11627288|FG000|STARTED|Overall Study||200
10478146|NCT01121263|11627289|FG001|STARTED|Overall Study||98
10478147|NCT01121263|11627288|FG000|COMPLETED|Overall Study||175
10478148|NCT01121263|11627289|FG001|COMPLETED|Overall Study||83
10478149|NCT01121263|11627288|FG000|NOT COMPLETED|Overall Study||25
10478150|NCT01121263|11627289|FG001|NOT COMPLETED|Overall Study||15
10478151|NCT01121393|11627299|FG000|STARTED|Overall Study|Randomised|242
10478152|NCT01121393|11627300|FG001|STARTED|Overall Study|Randomised|122
10478153|NCT01121393|11627299|FG000|Treated|Overall Study|Treated|239
10478154|NCT01121393|11627300|FG001|Treated|Overall Study|Treated|113
10478155|NCT01121393|11627299|FG000|COMPLETED|Overall Study|At the time of data cut-off for last-patient out (07 December 2017)|0
10478156|NCT01121393|11627300|FG001|COMPLETED|Overall Study|Completed 6 courses of chemotherapy|38
10478157|NCT01121393|11627299|FG000|NOT COMPLETED|Overall Study||242
10478158|NCT01121393|11627300|FG001|NOT COMPLETED|Overall Study||84
10478159|NCT01121406|11627314|FG000|STARTED|Overall Study||55
10478160|NCT01121406|11627315|FG001|STARTED|Overall Study|24 patients switched to Volasertib (BI 6727) due to disease progression or occurrence of toxicity|55
10478161|NCT01121406|11627314|FG000|COMPLETED|Overall Study||0
10478162|NCT01121406|11627315|FG001|COMPLETED|Overall Study||0
10478163|NCT01121406|11627314|FG000|NOT COMPLETED|Overall Study||55
10478164|NCT01121406|11627315|FG001|NOT COMPLETED|Overall Study||55
10478165|NCT01121484|11627326|FG000|STARTED|Overall Study||218
10478166|NCT01121484|11627327|FG001|STARTED|Overall Study||221
10478167|NCT01121484|11627326|FG000|Treated|Overall Study||217
10478168|NCT01121484|11627327|FG001|Treated|Overall Study||217
10478169|NCT01121484|11627326|FG000|COMPLETED|Overall Study||185
10478170|NCT01121484|11627327|FG001|COMPLETED|Overall Study||178
10478171|NCT01121484|11627326|FG000|NOT COMPLETED|Overall Study||33
10478172|NCT01121484|11627327|FG001|NOT COMPLETED|Overall Study||43
10478173|NCT01121536|11627333|FG000|STARTED|Overall Study||867
10478174|NCT01121536|11627333|FG000|Safety Population|Overall Study|Participants treated|863
10478175|NCT01121536|11627333|FG000|Full Analysis Population|Overall Study|Treated participants who had at least 1 post-baseline efficacy assessment.|859
10478176|NCT01121536|11627333|FG000|COMPLETED|Overall Study|One participant 'completed' early due to study closeout.|506
10478177|NCT01121536|11627333|FG000|NOT COMPLETED|Overall Study||361
10478178|NCT01121549|11627337|FG000|STARTED|Overall Study||378
10478179|NCT01121549|11627337|FG000|COMPLETED|Overall Study||31
10478180|NCT01121549|11627337|FG000|NOT COMPLETED|Overall Study||347
10478181|NCT01121562|11627341|FG000|STARTED|Overall Study||12
10478182|NCT01121562|11627341|FG000|COMPLETED|Overall Study||0
10478183|NCT01121562|11627341|FG000|NOT COMPLETED|Overall Study||12
10478184|NCT01121575|11627351|FG000|STARTED|Overall Study||14
10478185|NCT01121575|11627352|FG001|STARTED|Overall Study||6
10478186|NCT01121575|11627353|FG002|STARTED|Overall Study||7
10478187|NCT01121575|11627354|FG003|STARTED|Overall Study||6
10478188|NCT01121575|11627355|FG004|STARTED|Overall Study||25
10478189|NCT01121575|11627356|FG005|STARTED|Overall Study||12
10478190|NCT01121575|11627351|FG000|Treated|Overall Study||14
10478191|NCT01121575|11627352|FG001|Treated|Overall Study||6
10478192|NCT01121575|11627353|FG002|Treated|Overall Study||7
10478193|NCT01121575|11627354|FG003|Treated|Overall Study||6
10478194|NCT01121575|11627355|FG004|Treated|Overall Study||25
10478195|NCT01121575|11627356|FG005|Treated|Overall Study||12
10478196|NCT01121575|11627351|FG000|COMPLETED|Overall Study||0
10478197|NCT01121575|11627352|FG001|COMPLETED|Overall Study||0
10709320|NCT02638493|11874250|FG000|NOT COMPLETED|Overall Study||2
10709321|NCT02638493|11874251|FG001|NOT COMPLETED|Overall Study||0
10709322|NCT02638493|11874252|FG002|NOT COMPLETED|Overall Study||0
10709323|NCT02638597|11874262|FG000|STARTED|Overall Study||8
10709324|NCT02638597|11874263|FG001|STARTED|Overall Study||8
10709325|NCT02638597|11874262|FG000|COMPLETED|Overall Study||4
10709326|NCT02638597|11874263|FG001|COMPLETED|Overall Study||3
10478198|NCT01121575|11627353|FG002|COMPLETED|Overall Study||0
10478199|NCT01121575|11627354|FG003|COMPLETED|Overall Study||0
10478200|NCT01121575|11627355|FG004|COMPLETED|Overall Study||0
10478201|NCT01121575|11627356|FG005|COMPLETED|Overall Study||0
10478202|NCT01121575|11627351|FG000|NOT COMPLETED|Overall Study||14
10478203|NCT01121575|11627352|FG001|NOT COMPLETED|Overall Study||6
10478204|NCT01121575|11627353|FG002|NOT COMPLETED|Overall Study||7
10478205|NCT01121575|11627354|FG003|NOT COMPLETED|Overall Study||6
10478206|NCT01121575|11627355|FG004|NOT COMPLETED|Overall Study||25
10478207|NCT01121575|11627356|FG005|NOT COMPLETED|Overall Study||12
10478208|NCT01121666|11627377|FG000|STARTED|Overall Study||249
10478209|NCT01121666|11627378|FG001|STARTED|Overall Study||123
10478210|NCT01121666|11627377|FG000|COMPLETED|Overall Study||220
10709327|NCT02638597|11874262|FG000|NOT COMPLETED|Overall Study||4
10478211|NCT01121666|11627378|FG001|COMPLETED|Overall Study||113
10478212|NCT01121666|11627377|FG000|NOT COMPLETED|Overall Study||29
10478213|NCT01121666|11627378|FG001|NOT COMPLETED|Overall Study||10
10478214|NCT01121757|11627386|FG000|STARTED|First Drug||6
10478215|NCT01121757|11627387|FG001|STARTED|First Drug||3
10478216|NCT01121757|11627386|FG000|COMPLETED|First Drug|Completed a minimum of 4 cycles of Azacitidine.|5
10478217|NCT01121757|11627387|FG001|COMPLETED|First Drug|Completed a minimum of 4 cycles of Lenalidomide|1
10478218|NCT01121757|11627386|FG000|NOT COMPLETED|First Drug||1
10478219|NCT01121757|11627387|FG001|NOT COMPLETED|First Drug||2
10478220|NCT01121757|11627386|FG000|STARTED|Second Drug|1 subject did not start drug 2 due to disease progression|4
10478221|NCT01121757|11627387|FG001|STARTED|Second Drug||1
10478222|NCT01121757|11627386|FG000|COMPLETED|Second Drug||4
10478223|NCT01121757|11627387|FG001|COMPLETED|Second Drug||1
10478224|NCT01121757|11627386|FG000|NOT COMPLETED|Second Drug||0
10478225|NCT01121757|11627387|FG001|NOT COMPLETED|Second Drug||0
10478226|NCT01121757|11627386|FG000|STARTED|Combination|2 subjects did not start combination drug. 1 elected surgery 1 had a complete response after drug 2.|2
10478227|NCT01121757|11627387|FG001|STARTED|Combination||1
10478228|NCT01121757|11627386|FG000|COMPLETED|Combination||0
10478229|NCT01121757|11627387|FG001|COMPLETED|Combination||0
10478230|NCT01121757|11627386|FG000|NOT COMPLETED|Combination||2
10478231|NCT01121757|11627387|FG001|NOT COMPLETED|Combination||1
10478232|NCT01121900|11627395|FG000|STARTED|First Intervention Period||13
10478233|NCT01121900|11627396|FG001|STARTED|First Intervention Period||13
10478234|NCT01121900|11627395|FG000|COMPLETED|First Intervention Period||12
10478235|NCT01121900|11627396|FG001|COMPLETED|First Intervention Period||12
10478236|NCT01121900|11627395|FG000|NOT COMPLETED|First Intervention Period||1
10478237|NCT01121900|11627396|FG001|NOT COMPLETED|First Intervention Period||1
10478238|NCT01121900|11627395|FG000|STARTED|Washout Period of 7 Days||12
10478239|NCT01121900|11627396|FG001|STARTED|Washout Period of 7 Days||12
10478240|NCT01121900|11627395|FG000|COMPLETED|Washout Period of 7 Days||12
10478241|NCT01121900|11627396|FG001|COMPLETED|Washout Period of 7 Days||11
10478242|NCT01121900|11627395|FG000|NOT COMPLETED|Washout Period of 7 Days||0
10478243|NCT01121900|11627396|FG001|NOT COMPLETED|Washout Period of 7 Days||1
10478244|NCT01121900|11627395|FG000|STARTED|Second Intervention Period||12
10478245|NCT01121900|11627396|FG001|STARTED|Second Intervention Period||11
10478246|NCT01121900|11627395|FG000|COMPLETED|Second Intervention Period||12
10478247|NCT01121900|11627396|FG001|COMPLETED|Second Intervention Period||11
10478248|NCT01121900|11627395|FG000|NOT COMPLETED|Second Intervention Period||0
10478249|NCT01121900|11627396|FG001|NOT COMPLETED|Second Intervention Period||0
10478250|NCT01121913|11627402|FG000|STARTED|First Intervention Period||6
10478251|NCT01121913|11627403|FG001|STARTED|First Intervention Period||6
10478252|NCT01121913|11627404|FG002|STARTED|First Intervention Period||6
10478253|NCT01121913|11627405|FG003|STARTED|First Intervention Period||6
10478254|NCT01121913|11627402|FG000|COMPLETED|First Intervention Period||6
10478255|NCT01121913|11627403|FG001|COMPLETED|First Intervention Period||6
10478256|NCT01121913|11627404|FG002|COMPLETED|First Intervention Period||5
10478257|NCT01121913|11627405|FG003|COMPLETED|First Intervention Period||6
10478258|NCT01121913|11627402|FG000|NOT COMPLETED|First Intervention Period||0
10478259|NCT01121913|11627403|FG001|NOT COMPLETED|First Intervention Period||0
10478260|NCT01121913|11627404|FG002|NOT COMPLETED|First Intervention Period||1
10478261|NCT01121913|11627405|FG003|NOT COMPLETED|First Intervention Period||0
10478262|NCT01121913|11627402|FG000|STARTED|First Washout Period||6
10478263|NCT01121913|11627403|FG001|STARTED|First Washout Period||6
10478264|NCT01121913|11627404|FG002|STARTED|First Washout Period||5
10478265|NCT01121913|11627405|FG003|STARTED|First Washout Period||6
10478266|NCT01121913|11627402|FG000|COMPLETED|First Washout Period||5
10478267|NCT01121913|11627403|FG001|COMPLETED|First Washout Period||6
10478268|NCT01121913|11627404|FG002|COMPLETED|First Washout Period||5
10478269|NCT01121913|11627405|FG003|COMPLETED|First Washout Period||6
10478270|NCT01121913|11627402|FG000|NOT COMPLETED|First Washout Period||1
10478271|NCT01121913|11627403|FG001|NOT COMPLETED|First Washout Period||0
10478272|NCT01121913|11627404|FG002|NOT COMPLETED|First Washout Period||0
10478273|NCT01121913|11627405|FG003|NOT COMPLETED|First Washout Period||0
10478274|NCT01121913|11627402|FG000|STARTED|Second Intervention Period||5
10478275|NCT01121913|11627403|FG001|STARTED|Second Intervention Period||6
10478276|NCT01121913|11627404|FG002|STARTED|Second Intervention Period||5
10478277|NCT01121913|11627405|FG003|STARTED|Second Intervention Period||6
10478278|NCT01121913|11627402|FG000|COMPLETED|Second Intervention Period||5
10478279|NCT01121913|11627403|FG001|COMPLETED|Second Intervention Period||6
10478280|NCT01121913|11627404|FG002|COMPLETED|Second Intervention Period||4
10478281|NCT01121913|11627405|FG003|COMPLETED|Second Intervention Period||6
10478282|NCT01121913|11627402|FG000|NOT COMPLETED|Second Intervention Period||0
10478283|NCT01121913|11627403|FG001|NOT COMPLETED|Second Intervention Period||0
10478284|NCT01121913|11627404|FG002|NOT COMPLETED|Second Intervention Period||1
10478285|NCT01121913|11627405|FG003|NOT COMPLETED|Second Intervention Period||0
10478286|NCT01121913|11627402|FG000|STARTED|Second Washout Period||5
10478287|NCT01121913|11627403|FG001|STARTED|Second Washout Period||6
10478288|NCT01121913|11627404|FG002|STARTED|Second Washout Period||4
10478289|NCT01121913|11627405|FG003|STARTED|Second Washout Period||6
10478290|NCT01121913|11627402|FG000|COMPLETED|Second Washout Period||5
10478291|NCT01121913|11627403|FG001|COMPLETED|Second Washout Period||6
10478292|NCT01121913|11627404|FG002|COMPLETED|Second Washout Period||3
10478293|NCT01121913|11627405|FG003|COMPLETED|Second Washout Period||6
10478294|NCT01121913|11627402|FG000|NOT COMPLETED|Second Washout Period||0
10478295|NCT01121913|11627403|FG001|NOT COMPLETED|Second Washout Period||0
10478296|NCT01121913|11627404|FG002|NOT COMPLETED|Second Washout Period||1
10478297|NCT01121913|11627405|FG003|NOT COMPLETED|Second Washout Period||0
10478298|NCT01121913|11627402|FG000|STARTED|Third Intervention Period||5
10478299|NCT01121913|11627403|FG001|STARTED|Third Intervention Period||6
10478300|NCT01121913|11627404|FG002|STARTED|Third Intervention Period||3
10478301|NCT01121913|11627405|FG003|STARTED|Third Intervention Period||6
10478302|NCT01121913|11627402|FG000|COMPLETED|Third Intervention Period||5
10478303|NCT01121913|11627403|FG001|COMPLETED|Third Intervention Period||6
10478304|NCT01121913|11627404|FG002|COMPLETED|Third Intervention Period||3
10478305|NCT01121913|11627405|FG003|COMPLETED|Third Intervention Period||6
10478306|NCT01121913|11627402|FG000|NOT COMPLETED|Third Intervention Period||0
10478307|NCT01121913|11627403|FG001|NOT COMPLETED|Third Intervention Period||0
10478308|NCT01121913|11627404|FG002|NOT COMPLETED|Third Intervention Period||0
10478309|NCT01121913|11627405|FG003|NOT COMPLETED|Third Intervention Period||0
10478310|NCT01121913|11627402|FG000|STARTED|Third Washout Period||5
10478311|NCT01121913|11627403|FG001|STARTED|Third Washout Period||6
10478312|NCT01121913|11627404|FG002|STARTED|Third Washout Period||3
10478313|NCT01121913|11627405|FG003|STARTED|Third Washout Period||6
10478314|NCT01121913|11627402|FG000|COMPLETED|Third Washout Period||4
10478315|NCT01121913|11627403|FG001|COMPLETED|Third Washout Period||6
10478316|NCT01121913|11627404|FG002|COMPLETED|Third Washout Period||3
10478317|NCT01121913|11627405|FG003|COMPLETED|Third Washout Period||6
10478318|NCT01121913|11627402|FG000|NOT COMPLETED|Third Washout Period||1
10478319|NCT01121913|11627403|FG001|NOT COMPLETED|Third Washout Period||0
10478320|NCT01121913|11627404|FG002|NOT COMPLETED|Third Washout Period||0
10478321|NCT01121913|11627405|FG003|NOT COMPLETED|Third Washout Period||0
10478322|NCT01121913|11627402|FG000|STARTED|Fourth Intervention Period||4
10478323|NCT01121913|11627403|FG001|STARTED|Fourth Intervention Period||6
10478324|NCT01121913|11627404|FG002|STARTED|Fourth Intervention Period||3
10478325|NCT01121913|11627405|FG003|STARTED|Fourth Intervention Period||6
10478326|NCT01121913|11627402|FG000|COMPLETED|Fourth Intervention Period||4
10478327|NCT01121913|11627403|FG001|COMPLETED|Fourth Intervention Period||6
10478328|NCT01121913|11627404|FG002|COMPLETED|Fourth Intervention Period||3
10478329|NCT01121913|11627405|FG003|COMPLETED|Fourth Intervention Period||6
10478330|NCT01121913|11627402|FG000|NOT COMPLETED|Fourth Intervention Period||0
10478331|NCT01121913|11627403|FG001|NOT COMPLETED|Fourth Intervention Period||0
10478332|NCT01121913|11627404|FG002|NOT COMPLETED|Fourth Intervention Period||0
10478333|NCT01121913|11627405|FG003|NOT COMPLETED|Fourth Intervention Period||0
10478334|NCT01121926|11627415|FG000|STARTED|First Intervention Period||15
10478335|NCT01121926|11627416|FG001|STARTED|First Intervention Period||15
10478336|NCT01121926|11627415|FG000|COMPLETED|First Intervention Period||14
10478337|NCT01121926|11627416|FG001|COMPLETED|First Intervention Period||15
10478338|NCT01121926|11627415|FG000|NOT COMPLETED|First Intervention Period||1
10478339|NCT01121926|11627416|FG001|NOT COMPLETED|First Intervention Period||0
10478340|NCT01121926|11627415|FG000|STARTED|Washout Period||14
10478341|NCT01121926|11627416|FG001|STARTED|Washout Period||15
10478342|NCT01121926|11627415|FG000|COMPLETED|Washout Period||14
10478343|NCT01121926|11627416|FG001|COMPLETED|Washout Period||13
10478344|NCT01121926|11627415|FG000|NOT COMPLETED|Washout Period||0
10478345|NCT01121926|11627416|FG001|NOT COMPLETED|Washout Period||2
10478346|NCT01121926|11627415|FG000|STARTED|Second Intervention Period||14
10478347|NCT01121926|11627416|FG001|STARTED|Second Intervention Period||13
10478348|NCT01121926|11627415|FG000|COMPLETED|Second Intervention Period||14
10478349|NCT01121926|11627416|FG001|COMPLETED|Second Intervention Period||13
10478350|NCT01121926|11627415|FG000|NOT COMPLETED|Second Intervention Period||0
10478351|NCT01121926|11627416|FG001|NOT COMPLETED|Second Intervention Period||0
10478352|NCT01121939|11627422|FG000|STARTED|Overall Study||43
10478353|NCT01121939|11627422|FG000|COMPLETED|Overall Study|Patients remained on-study until disease progression or unacceptable toxicity occurred.|0
10478354|NCT01121939|11627422|FG000|NOT COMPLETED|Overall Study||43
10478355|NCT01121991|11627429|FG000|STARTED|Overall Study|Number of participants treated|52
10478356|NCT01121991|11627429|FG000|COMPLETED|Overall Study||46
10478357|NCT01121991|11627429|FG000|NOT COMPLETED|Overall Study||6
10478358|NCT01122030|11627440|FG000|STARTED|Overall Study||18
10478359|NCT01122030|11627441|FG001|STARTED|Overall Study||9
10478360|NCT01122030|11627442|FG002|STARTED|Overall Study||9
10478361|NCT01122030|11627443|FG003|STARTED|Overall Study||9
10478362|NCT01122030|11627444|FG004|STARTED|Overall Study||9
10478363|NCT01122030|11627445|FG005|STARTED|Overall Study||9
10478364|NCT01122030|11627446|FG006|STARTED|Overall Study||9
10478365|NCT01122030|11627440|FG000|Received Treatment|Overall Study||18
10478366|NCT01122030|11627441|FG001|Received Treatment|Overall Study||9
10478367|NCT01122030|11627442|FG002|Received Treatment|Overall Study||9
10478368|NCT01122030|11627443|FG003|Received Treatment|Overall Study||9
10478369|NCT01122030|11627444|FG004|Received Treatment|Overall Study||9
10478370|NCT01122030|11627445|FG005|Received Treatment|Overall Study||9
10478371|NCT01122030|11627446|FG006|Received Treatment|Overall Study||9
10478372|NCT01122030|11627440|FG000|COMPLETED|Overall Study||18
10478373|NCT01122030|11627441|FG001|COMPLETED|Overall Study||9
10478374|NCT01122030|11627442|FG002|COMPLETED|Overall Study||9
10478375|NCT01122030|11627443|FG003|COMPLETED|Overall Study||9
10478376|NCT01122030|11627444|FG004|COMPLETED|Overall Study||9
10478377|NCT01122030|11627445|FG005|COMPLETED|Overall Study||9
10478378|NCT01122030|11627446|FG006|COMPLETED|Overall Study||9
10478379|NCT01122030|11627440|FG000|NOT COMPLETED|Overall Study||0
10478380|NCT01122030|11627441|FG001|NOT COMPLETED|Overall Study||0
10478381|NCT01122030|11627442|FG002|NOT COMPLETED|Overall Study||0
10478382|NCT01122030|11627443|FG003|NOT COMPLETED|Overall Study||0
10478383|NCT01122030|11627444|FG004|NOT COMPLETED|Overall Study||0
10478384|NCT01122030|11627445|FG005|NOT COMPLETED|Overall Study||0
10478385|NCT01122030|11627446|FG006|NOT COMPLETED|Overall Study||0
10478386|NCT01122108|11627468|FG000|STARTED|Overall Study||21
10478387|NCT01122108|11627469|FG001|STARTED|Overall Study||21
10478388|NCT01122108|11627468|FG000|COMPLETED|Overall Study||21
10478389|NCT01122108|11627469|FG001|COMPLETED|Overall Study||21
10478390|NCT01122108|11627468|FG000|NOT COMPLETED|Overall Study||0
10478391|NCT01122108|11627469|FG001|NOT COMPLETED|Overall Study||0
10478392|NCT01122160|11627477|FG000|STARTED|First Intervention (7 Days)||6
10478393|NCT01122160|11627478|FG001|STARTED|First Intervention (7 Days)||5
10478394|NCT01122160|11627477|FG000|COMPLETED|First Intervention (7 Days)||6
10478395|NCT01122160|11627478|FG001|COMPLETED|First Intervention (7 Days)||5
10478396|NCT01122160|11627477|FG000|NOT COMPLETED|First Intervention (7 Days)||0
10478397|NCT01122160|11627478|FG001|NOT COMPLETED|First Intervention (7 Days)||0
10478398|NCT01122160|11627477|FG000|STARTED|Washout (7-14 Days)||6
10709328|NCT02638597|11874263|FG001|NOT COMPLETED|Overall Study||5
10709329|NCT02638623|11874273|FG000|STARTED|Overall Study||27
10709330|NCT02638623|11874274|FG001|STARTED|Overall Study||25
10709331|NCT02638623|11874273|FG000|COMPLETED|Overall Study||20
10709332|NCT02638623|11874274|FG001|COMPLETED|Overall Study||19
10478399|NCT01122160|11627478|FG001|STARTED|Washout (7-14 Days)||5
10478400|NCT01122160|11627477|FG000|COMPLETED|Washout (7-14 Days)||6
10478401|NCT01122160|11627478|FG001|COMPLETED|Washout (7-14 Days)||5
10478402|NCT01122160|11627477|FG000|NOT COMPLETED|Washout (7-14 Days)||0
10478403|NCT01122160|11627478|FG001|NOT COMPLETED|Washout (7-14 Days)||0
10478404|NCT01122160|11627477|FG000|STARTED|Second Intervention (7 Days)||6
10478405|NCT01122160|11627478|FG001|STARTED|Second Intervention (7 Days)||5
10478406|NCT01122160|11627477|FG000|COMPLETED|Second Intervention (7 Days)||6
10478407|NCT01122160|11627478|FG001|COMPLETED|Second Intervention (7 Days)||5
10478408|NCT01122160|11627477|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
10478409|NCT01122160|11627478|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
10478410|NCT01122173|11627484|FG000|STARTED|Overall Study||150
10478411|NCT01122173|11627484|FG000|COMPLETED|Overall Study||141
10478412|NCT01122173|11627484|FG000|NOT COMPLETED|Overall Study||9
10478413|NCT01122238|11627505|FG000|STARTED|Overall Study||30
10478414|NCT01122238|11627506|FG001|STARTED|Overall Study||37
10478415|NCT01122238|11627507|FG002|STARTED|Overall Study||33
10478416|NCT01122238|11627508|FG003|STARTED|Overall Study||33
10478417|NCT01122238|11627509|FG004|STARTED|Overall Study||33
10478418|NCT01122238|11627510|FG005|STARTED|Overall Study||32
10478419|NCT01122238|11627511|FG006|STARTED|Overall Study||35
10478420|NCT01122238|11627512|FG007|STARTED|Overall Study||32
10478421|NCT01122238|11627513|FG008|STARTED|Overall Study||32
10478422|NCT01122238|11627514|FG009|STARTED|Overall Study||34
10478423|NCT01122238|11627515|FG010|STARTED|Overall Study||32
10478424|NCT01122238|11627516|FG011|STARTED|Overall Study||33
10478425|NCT01122238|11627517|FG012|STARTED|Overall Study||30
10478426|NCT01122238|11627518|FG013|STARTED|Overall Study||32
10478427|NCT01122238|11627519|FG014|STARTED|Overall Study||28
10478428|NCT01122238|11627520|FG015|STARTED|Overall Study||31
10478429|NCT01122238|11627505|FG000|COMPLETED|Overall Study||28
10478430|NCT01122238|11627506|FG001|COMPLETED|Overall Study||36
10478431|NCT01122238|11627507|FG002|COMPLETED|Overall Study||28
10478432|NCT01122238|11627508|FG003|COMPLETED|Overall Study||33
10478433|NCT01122238|11627509|FG004|COMPLETED|Overall Study||33
10478434|NCT01122238|11627510|FG005|COMPLETED|Overall Study||31
10478435|NCT01122238|11627511|FG006|COMPLETED|Overall Study||34
10478436|NCT01122238|11627512|FG007|COMPLETED|Overall Study||32
10478437|NCT01122238|11627513|FG008|COMPLETED|Overall Study||31
10478438|NCT01122238|11627514|FG009|COMPLETED|Overall Study||33
10478439|NCT01122238|11627515|FG010|COMPLETED|Overall Study||32
10478440|NCT01122238|11627516|FG011|COMPLETED|Overall Study||31
10478441|NCT01122238|11627517|FG012|COMPLETED|Overall Study||28
10478442|NCT01122238|11627518|FG013|COMPLETED|Overall Study||31
10478443|NCT01122238|11627519|FG014|COMPLETED|Overall Study||28
10478444|NCT01122238|11627520|FG015|COMPLETED|Overall Study||31
10478445|NCT01122238|11627505|FG000|NOT COMPLETED|Overall Study||2
10478446|NCT01122238|11627506|FG001|NOT COMPLETED|Overall Study||1
10478447|NCT01122238|11627507|FG002|NOT COMPLETED|Overall Study||5
10478448|NCT01122238|11627508|FG003|NOT COMPLETED|Overall Study||0
10478449|NCT01122238|11627509|FG004|NOT COMPLETED|Overall Study||0
10478450|NCT01122238|11627510|FG005|NOT COMPLETED|Overall Study||1
10478451|NCT01122238|11627511|FG006|NOT COMPLETED|Overall Study||1
10478452|NCT01122238|11627512|FG007|NOT COMPLETED|Overall Study||0
10478453|NCT01122238|11627513|FG008|NOT COMPLETED|Overall Study||1
10478454|NCT01122238|11627514|FG009|NOT COMPLETED|Overall Study||1
10478455|NCT01122238|11627515|FG010|NOT COMPLETED|Overall Study||0
10478456|NCT01122238|11627516|FG011|NOT COMPLETED|Overall Study||2
10478457|NCT01122238|11627517|FG012|NOT COMPLETED|Overall Study||2
10478458|NCT01122238|11627518|FG013|NOT COMPLETED|Overall Study||1
10709333|NCT02638623|11874273|FG000|NOT COMPLETED|Overall Study||7
10478459|NCT01122238|11627519|FG014|NOT COMPLETED|Overall Study||0
10478460|NCT01122238|11627520|FG015|NOT COMPLETED|Overall Study||0
10478461|NCT01122264|11627537|FG000|STARTED|Overall Study||252
10478462|NCT01122264|11627538|FG001|STARTED|Overall Study||257
10478463|NCT01122264|11627539|FG002|STARTED|Overall Study||261
10478464|NCT01122264|11627537|FG000|Received at Least 1 Dose of Study Drug|Overall Study||250
10478465|NCT01122264|11627538|FG001|Received at Least 1 Dose of Study Drug|Overall Study||257
10478466|NCT01122264|11627539|FG002|Received at Least 1 Dose of Study Drug|Overall Study||260
10478467|NCT01122264|11627537|FG000|COMPLETED|Overall Study||220
10478468|NCT01122264|11627538|FG001|COMPLETED|Overall Study||228
10478469|NCT01122264|11627539|FG002|COMPLETED|Overall Study||214
10478470|NCT01122264|11627537|FG000|NOT COMPLETED|Overall Study||32
10478471|NCT01122264|11627538|FG001|NOT COMPLETED|Overall Study||29
10478472|NCT01122264|11627539|FG002|NOT COMPLETED|Overall Study||47
10478473|NCT01122316|11627551|FG000|STARTED|Overall Study||10
10478474|NCT01122316|11627551|FG000|COMPLETED|Overall Study||8
10478475|NCT01122316|11627551|FG000|NOT COMPLETED|Overall Study||2
10478476|NCT01122394|11627557|FG000|STARTED|Overall Study||66
10478477|NCT01122394|11627558|FG001|STARTED|Overall Study||74
10478478|NCT01122394|11627557|FG000|COMPLETED|Overall Study||63
10478479|NCT01122394|11627558|FG001|COMPLETED|Overall Study||70
10478480|NCT01122394|11627557|FG000|NOT COMPLETED|Overall Study||3
10709334|NCT02638623|11874274|FG001|NOT COMPLETED|Overall Study||6
10709335|NCT02638948|11874284|FG000|STARTED|Overall Study||75
10709336|NCT02638948|11874285|FG001|STARTED|Overall Study||73
10709337|NCT02638948|11874286|FG002|STARTED|Overall Study||73
10709338|NCT02638948|11874287|FG003|STARTED|Overall Study||26
10709339|NCT02638948|11874284|FG000|COMPLETED|Overall Study||66
10709340|NCT02638948|11874285|FG001|COMPLETED|Overall Study||62
10709341|NCT02638948|11874286|FG002|COMPLETED|Overall Study||66
10709342|NCT02638948|11874287|FG003|COMPLETED|Overall Study||18
10709343|NCT02638948|11874284|FG000|NOT COMPLETED|Overall Study||9
10709344|NCT02638948|11874285|FG001|NOT COMPLETED|Overall Study||11
10709345|NCT02638948|11874286|FG002|NOT COMPLETED|Overall Study||7
10709346|NCT02638948|11874287|FG003|NOT COMPLETED|Overall Study||8
10709347|NCT02638974|11874302|FG000|STARTED|Overall Study||26
10709348|NCT02638974|11874303|FG001|STARTED|Overall Study||25
10478481|NCT01122394|11627558|FG001|NOT COMPLETED|Overall Study||4
10478482|NCT01122446|11627568|FG000|STARTED|Overall Study||25
10478483|NCT01122446|11627569|FG001|STARTED|Overall Study||25
10478484|NCT01122446|11627568|FG000|COMPLETED|Overall Study||25
10478485|NCT01122446|11627569|FG001|COMPLETED|Overall Study||25
10478486|NCT01122446|11627568|FG000|NOT COMPLETED|Overall Study||0
10478487|NCT01122446|11627569|FG001|NOT COMPLETED|Overall Study||0
10478488|NCT01122576|11627578|FG000|STARTED|Pre-Cataract Surgery||26
10478489|NCT01122576|11627579|FG001|STARTED|Pre-Cataract Surgery||26
10478490|NCT01122576|11627580|FG002|STARTED|Pre-Cataract Surgery||26
10478491|NCT01122576|11627578|FG000|COMPLETED|Pre-Cataract Surgery||26
10478492|NCT01122576|11627579|FG001|COMPLETED|Pre-Cataract Surgery||25
10478493|NCT01122576|11627580|FG002|COMPLETED|Pre-Cataract Surgery||24
10478494|NCT01122576|11627578|FG000|NOT COMPLETED|Pre-Cataract Surgery||0
10478495|NCT01122576|11627579|FG001|NOT COMPLETED|Pre-Cataract Surgery||1
10478496|NCT01122576|11627580|FG002|NOT COMPLETED|Pre-Cataract Surgery||2
10478497|NCT01122576|11627578|FG000|STARTED|Post-Cataract Surgery||26
10478498|NCT01122576|11627579|FG001|STARTED|Post-Cataract Surgery||25
10478499|NCT01122576|11627580|FG002|STARTED|Post-Cataract Surgery||24
10478500|NCT01122576|11627578|FG000|COMPLETED|Post-Cataract Surgery||26
10478501|NCT01122576|11627579|FG001|COMPLETED|Post-Cataract Surgery||25
10478502|NCT01122576|11627580|FG002|COMPLETED|Post-Cataract Surgery||22
10478503|NCT01122576|11627578|FG000|NOT COMPLETED|Post-Cataract Surgery||0
10478504|NCT01122576|11627579|FG001|NOT COMPLETED|Post-Cataract Surgery||0
10478505|NCT01122576|11627580|FG002|NOT COMPLETED|Post-Cataract Surgery||2
10478506|NCT01122680|11627591|FG000|STARTED|Period 1 (4 Weeks)|Entered this study period.|29
10478507|NCT01122680|11627592|FG001|STARTED|Period 1 (4 Weeks)|Entered this study period.|26
10478508|NCT01122680|11627593|FG002|STARTED|Period 1 (4 Weeks)|Entered this study period.|26
10478509|NCT01122680|11627594|FG003|STARTED|Period 1 (4 Weeks)|Entered this study period.|24
10478510|NCT01122680|11627591|FG000|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|26
10478511|NCT01122680|11627592|FG001|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|25
10478512|NCT01122680|11627593|FG002|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|26
10478513|NCT01122680|11627594|FG003|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|24
10478514|NCT01122680|11627591|FG000|NOT COMPLETED|Period 1 (4 Weeks)||3
10478515|NCT01122680|11627592|FG001|NOT COMPLETED|Period 1 (4 Weeks)||1
10478516|NCT01122680|11627593|FG002|NOT COMPLETED|Period 1 (4 Weeks)||0
10478517|NCT01122680|11627594|FG003|NOT COMPLETED|Period 1 (4 Weeks)||0
10478518|NCT01122680|11627591|FG000|STARTED|Period 2 (4 Weeks)|Entered this study period.|26
10478519|NCT01122680|11627592|FG001|STARTED|Period 2 (4 Weeks)|Entered this study period.|25
10478520|NCT01122680|11627593|FG002|STARTED|Period 2 (4 Weeks)|Entered this study period.|26
10478521|NCT01122680|11627594|FG003|STARTED|Period 2 (4 Weeks)|Entered this study period.|24
10478522|NCT01122680|11627591|FG000|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|25
10478523|NCT01122680|11627592|FG001|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|25
10709349|NCT02638974|11874302|FG000|COMPLETED|Overall Study||23
10709350|NCT02638974|11874303|FG001|COMPLETED|Overall Study||22
10709351|NCT02638974|11874302|FG000|NOT COMPLETED|Overall Study||3
10478524|NCT01122680|11627593|FG002|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|26
10478525|NCT01122680|11627594|FG003|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|23
10478526|NCT01122680|11627591|FG000|NOT COMPLETED|Period 2 (4 Weeks)||1
10478527|NCT01122680|11627592|FG001|NOT COMPLETED|Period 2 (4 Weeks)||0
10478528|NCT01122680|11627593|FG002|NOT COMPLETED|Period 2 (4 Weeks)||0
10478529|NCT01122680|11627594|FG003|NOT COMPLETED|Period 2 (4 Weeks)||1
10478530|NCT01122680|11627591|FG000|STARTED|Period 3 (4 Weeks)|Entered this study period.|25
10478531|NCT01122680|11627592|FG001|STARTED|Period 3 (4 Weeks)|Entered this study period.|25
10478532|NCT01122680|11627593|FG002|STARTED|Period 3 (4 Weeks)|Entered this study period.|26
10478533|NCT01122680|11627594|FG003|STARTED|Period 3 (4 Weeks)|Entered this study period.|23
10478534|NCT01122680|11627591|FG000|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|24
10478535|NCT01122680|11627592|FG001|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|24
10478536|NCT01122680|11627593|FG002|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|26
10478537|NCT01122680|11627594|FG003|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|23
10478538|NCT01122680|11627591|FG000|NOT COMPLETED|Period 3 (4 Weeks)||1
10478539|NCT01122680|11627592|FG001|NOT COMPLETED|Period 3 (4 Weeks)||1
10478540|NCT01122680|11627593|FG002|NOT COMPLETED|Period 3 (4 Weeks)||0
10478541|NCT01122680|11627594|FG003|NOT COMPLETED|Period 3 (4 Weeks)||0
10478542|NCT01122849|11627607|FG000|STARTED|Overall Study||20
10478543|NCT01122849|11627608|FG001|STARTED|Overall Study||21
10478544|NCT01122849|11627609|FG002|STARTED|Overall Study||20
10478545|NCT01122849|11627607|FG000|COMPLETED|Overall Study||20
10478546|NCT01122849|11627608|FG001|COMPLETED|Overall Study||21
10478547|NCT01122849|11627609|FG002|COMPLETED|Overall Study||20
10478548|NCT01122849|11627607|FG000|NOT COMPLETED|Overall Study||0
10478549|NCT01122849|11627608|FG001|NOT COMPLETED|Overall Study||0
10478550|NCT01122849|11627609|FG002|NOT COMPLETED|Overall Study||0
10478551|NCT01122862|11627627|FG000|STARTED|Period 1||8
10478552|NCT01122862|11627628|FG001|STARTED|Period 1||8
10478553|NCT01122862|11627629|FG002|STARTED|Period 1||7
10478554|NCT01122862|11627627|FG000|COMPLETED|Period 1||8
10478555|NCT01122862|11627628|FG001|COMPLETED|Period 1||7
10478556|NCT01122862|11627629|FG002|COMPLETED|Period 1||7
10478557|NCT01122862|11627627|FG000|NOT COMPLETED|Period 1||0
10478558|NCT01122862|11627628|FG001|NOT COMPLETED|Period 1||1
10478559|NCT01122862|11627629|FG002|NOT COMPLETED|Period 1||0
10478560|NCT01122862|11627627|FG000|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|8
10478561|NCT01122862|11627628|FG001|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|7
10478562|NCT01122862|11627629|FG002|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|7
10478563|NCT01122862|11627627|FG000|COMPLETED|Period 2||8
10478564|NCT01122862|11627628|FG001|COMPLETED|Period 2||7
10478565|NCT01122862|11627629|FG002|COMPLETED|Period 2||6
10478566|NCT01122862|11627627|FG000|NOT COMPLETED|Period 2||0
10478567|NCT01122862|11627628|FG001|NOT COMPLETED|Period 2||0
10478568|NCT01122862|11627629|FG002|NOT COMPLETED|Period 2||1
10478569|NCT01122862|11627627|FG000|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|6
10478570|NCT01122862|11627628|FG001|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|7
10478571|NCT01122862|11627629|FG002|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|8
10478572|NCT01122862|11627627|FG000|COMPLETED|Period 3||6
10478573|NCT01122862|11627628|FG001|COMPLETED|Period 3||7
10478574|NCT01122862|11627629|FG002|COMPLETED|Period 3||8
10478575|NCT01122862|11627627|FG000|NOT COMPLETED|Period 3||0
10478576|NCT01122862|11627628|FG001|NOT COMPLETED|Period 3||0
10478577|NCT01122862|11627629|FG002|NOT COMPLETED|Period 3||0
10478578|NCT01122901|11627640|FG000|STARTED|Overall Study||40
10478579|NCT01122901|11627641|FG001|STARTED|Overall Study||7
10478580|NCT01122901|11627640|FG000|COMPLETED|Overall Study||40
10478581|NCT01122901|11627641|FG001|COMPLETED|Overall Study||7
10478582|NCT01122901|11627640|FG000|NOT COMPLETED|Overall Study||0
10478583|NCT01122901|11627641|FG001|NOT COMPLETED|Overall Study||0
10478584|NCT01122927|11627652|FG000|STARTED|Period 1 - Conversion Phase||297
10478585|NCT01122927|11627653|FG001|STARTED|Period 1 - Conversion Phase||0
10478586|NCT01122927|11627652|FG000|COMPLETED|Period 1 - Conversion Phase||283
10478587|NCT01122927|11627653|FG001|COMPLETED|Period 1 - Conversion Phase||0
10478588|NCT01122927|11627652|FG000|NOT COMPLETED|Period 1 - Conversion Phase||14
10478589|NCT01122927|11627653|FG001|NOT COMPLETED|Period 1 - Conversion Phase||0
10478590|NCT01122927|11627652|FG000|STARTED|Period 2- Open-label Treatment Phase||0
10478591|NCT01122927|11627653|FG001|STARTED|Period 2- Open-label Treatment Phase|362 were de novo participants and 148 had rolled over from study NCT01149655.|510
10478592|NCT01122927|11627652|FG000|COMPLETED|Period 2- Open-label Treatment Phase||0
10478593|NCT01122927|11627653|FG001|COMPLETED|Period 2- Open-label Treatment Phase|De novo participants who completed Month 24 visit or rolled over from study NCT01149655.|198
10478594|NCT01122927|11627652|FG000|NOT COMPLETED|Period 2- Open-label Treatment Phase||0
10478595|NCT01122927|11627653|FG001|NOT COMPLETED|Period 2- Open-label Treatment Phase||312
10478596|NCT01123070|11627667|FG000|STARTED|Part A Cohort 1 Open Label Period||3
10478597|NCT01123070|11627668|FG001|STARTED|Part A Cohort 1 Open Label Period||0
10478598|NCT01123070|11627669|FG002|STARTED|Part A Cohort 1 Open Label Period||0
10478599|NCT01123070|11627670|FG003|STARTED|Part A Cohort 1 Open Label Period||0
10478600|NCT01123070|11627667|FG000|COMPLETED|Part A Cohort 1 Open Label Period||3
10478601|NCT01123070|11627668|FG001|COMPLETED|Part A Cohort 1 Open Label Period||0
10478602|NCT01123070|11627669|FG002|COMPLETED|Part A Cohort 1 Open Label Period||0
10478603|NCT01123070|11627670|FG003|COMPLETED|Part A Cohort 1 Open Label Period||0
10478604|NCT01123070|11627667|FG000|NOT COMPLETED|Part A Cohort 1 Open Label Period||0
10478605|NCT01123070|11627668|FG001|NOT COMPLETED|Part A Cohort 1 Open Label Period||0
10478606|NCT01123070|11627669|FG002|NOT COMPLETED|Part A Cohort 1 Open Label Period||0
10478607|NCT01123070|11627670|FG003|NOT COMPLETED|Part A Cohort 1 Open Label Period||0
10478608|NCT01123070|11627667|FG000|STARTED|Part A Cohort 2 Open Label Period||0
10478609|NCT01123070|11627668|FG001|STARTED|Part A Cohort 2 Open Label Period||3
10478610|NCT01123070|11627669|FG002|STARTED|Part A Cohort 2 Open Label Period||0
10478611|NCT01123070|11627670|FG003|STARTED|Part A Cohort 2 Open Label Period||0
10478612|NCT01123070|11627667|FG000|COMPLETED|Part A Cohort 2 Open Label Period||0
10478613|NCT01123070|11627668|FG001|COMPLETED|Part A Cohort 2 Open Label Period||3
10478614|NCT01123070|11627669|FG002|COMPLETED|Part A Cohort 2 Open Label Period||0
10478615|NCT01123070|11627670|FG003|COMPLETED|Part A Cohort 2 Open Label Period||0
10478616|NCT01123070|11627667|FG000|NOT COMPLETED|Part A Cohort 2 Open Label Period||0
10478617|NCT01123070|11627668|FG001|NOT COMPLETED|Part A Cohort 2 Open Label Period||0
10478618|NCT01123070|11627669|FG002|NOT COMPLETED|Part A Cohort 2 Open Label Period||0
10478619|NCT01123070|11627670|FG003|NOT COMPLETED|Part A Cohort 2 Open Label Period||0
10478620|NCT01123070|11627667|FG000|STARTED|Part B Double Blind Period||0
10478621|NCT01123070|11627668|FG001|STARTED|Part B Double Blind Period||0
10478622|NCT01123070|11627669|FG002|STARTED|Part B Double Blind Period||25
10478623|NCT01123070|11627670|FG003|STARTED|Part B Double Blind Period||23
10478624|NCT01123070|11627667|FG000|COMPLETED|Part B Double Blind Period||0
10478625|NCT01123070|11627668|FG001|COMPLETED|Part B Double Blind Period||0
10478626|NCT01123070|11627669|FG002|COMPLETED|Part B Double Blind Period||21
10478627|NCT01123070|11627670|FG003|COMPLETED|Part B Double Blind Period||20
10478628|NCT01123070|11627667|FG000|NOT COMPLETED|Part B Double Blind Period||0
10478629|NCT01123070|11627668|FG001|NOT COMPLETED|Part B Double Blind Period||0
10478630|NCT01123070|11627669|FG002|NOT COMPLETED|Part B Double Blind Period||4
10478631|NCT01123070|11627670|FG003|NOT COMPLETED|Part B Double Blind Period||3
10478632|NCT01123083|11627683|FG000|STARTED|Overall Study||61
10478633|NCT01123083|11627684|FG001|STARTED|Overall Study||118
10478634|NCT01123083|11627683|FG000|COMPLETED|Overall Study||50
10478635|NCT01123083|11627684|FG001|COMPLETED|Overall Study||103
10478636|NCT01123083|11627683|FG000|NOT COMPLETED|Overall Study||11
10478637|NCT01123083|11627684|FG001|NOT COMPLETED|Overall Study||15
10478638|NCT01123148|11627690|FG000|STARTED|Overall Study||14
10478639|NCT01123148|11627690|FG000|BCI Calibration >50% Accuracy|Overall Study||13
10478640|NCT01123148|11627690|FG000|COMPLETED|Overall Study||12
10478641|NCT01123148|11627690|FG000|NOT COMPLETED|Overall Study||2
10478642|NCT01123161|11627696|FG000|STARTED|Overall Study||57
10478643|NCT01123161|11627697|FG001|STARTED|Overall Study||63
10478644|NCT01123161|11627696|FG000|COMPLETED|Overall Study||55
10478645|NCT01123161|11627697|FG001|COMPLETED|Overall Study||63
10478646|NCT01123161|11627696|FG000|NOT COMPLETED|Overall Study||2
10478647|NCT01123161|11627697|FG001|NOT COMPLETED|Overall Study||0
10478648|NCT01123200|11627706|FG000|STARTED|Overall Study||1
10478649|NCT01123200|11627706|FG000|COMPLETED|Overall Study||0
10478650|NCT01123200|11627706|FG000|NOT COMPLETED|Overall Study||1
10478651|NCT01123356|11627710|FG000|STARTED|Overall Study||21
10478652|NCT01123356|11627710|FG000|COMPLETED|Overall Study||14
10478653|NCT01123356|11627710|FG000|NOT COMPLETED|Overall Study||7
10478654|NCT01123382|11627717|FG000|STARTED|Overall Study||13
10478655|NCT01123382|11627718|FG001|STARTED|Overall Study||12
10478656|NCT01123382|11627717|FG000|Received Intervention|Overall Study||12
10478657|NCT01123382|11627718|FG001|Received Intervention|Overall Study||10
10478658|NCT01123382|11627717|FG000|COMPLETED|Overall Study||11
10478659|NCT01123382|11627718|FG001|COMPLETED|Overall Study||6
10478660|NCT01123382|11627717|FG000|NOT COMPLETED|Overall Study||2
10478661|NCT01123382|11627718|FG001|NOT COMPLETED|Overall Study||6
10478662|NCT01123395|11627724|FG000|STARTED|Period 1||8
10478663|NCT01123395|11627725|FG001|STARTED|Period 1||8
10478664|NCT01123395|11627724|FG000|COMPLETED|Period 1||8
10478665|NCT01123395|11627725|FG001|COMPLETED|Period 1||8
10478666|NCT01123395|11627724|FG000|NOT COMPLETED|Period 1||0
10478667|NCT01123395|11627725|FG001|NOT COMPLETED|Period 1||0
10478668|NCT01123395|11627724|FG000|STARTED|Washout Period of 14 Days||8
10478669|NCT01123395|11627725|FG001|STARTED|Washout Period of 14 Days||8
10478670|NCT01123395|11627724|FG000|COMPLETED|Washout Period of 14 Days||8
10478671|NCT01123395|11627725|FG001|COMPLETED|Washout Period of 14 Days||7
10478672|NCT01123395|11627724|FG000|NOT COMPLETED|Washout Period of 14 Days||0
10478673|NCT01123395|11627725|FG001|NOT COMPLETED|Washout Period of 14 Days||1
10478674|NCT01123395|11627724|FG000|STARTED|Period 2||8
10478675|NCT01123395|11627725|FG001|STARTED|Period 2||7
10478676|NCT01123395|11627724|FG000|COMPLETED|Period 2||8
10478677|NCT01123395|11627725|FG001|COMPLETED|Period 2||7
10478678|NCT01123395|11627724|FG000|NOT COMPLETED|Period 2||0
10478679|NCT01123395|11627725|FG001|NOT COMPLETED|Period 2||0
10478680|NCT01123512|11627733|FG000|STARTED|Overall Study||153
10478681|NCT01123512|11627734|FG001|STARTED|Overall Study||147
10478682|NCT01123512|11627733|FG000|COMPLETED|Overall Study||127
10478683|NCT01123512|11627734|FG001|COMPLETED|Overall Study||126
10478684|NCT01123512|11627733|FG000|NOT COMPLETED|Overall Study||26
10478685|NCT01123512|11627734|FG001|NOT COMPLETED|Overall Study||21
10478686|NCT01123642|11627740|FG000|STARTED|Overall Study||345
10478687|NCT01123642|11627740|FG000|COMPLETED|Overall Study||277
10478688|NCT01123642|11627740|FG000|NOT COMPLETED|Overall Study||68
10478689|NCT01123655|11627747|FG000|STARTED|Overall Study||10
10478690|NCT01123655|11627748|FG001|STARTED|Overall Study||4
10478691|NCT01123655|11627749|FG002|STARTED|Overall Study||8
10478692|NCT01123655|11627747|FG000|COMPLETED|Overall Study||9
10478693|NCT01123655|11627748|FG001|COMPLETED|Overall Study||3
10478694|NCT01123655|11627749|FG002|COMPLETED|Overall Study||7
10478695|NCT01123655|11627747|FG000|NOT COMPLETED|Overall Study||1
10478696|NCT01123655|11627748|FG001|NOT COMPLETED|Overall Study||1
10478697|NCT01123655|11627749|FG002|NOT COMPLETED|Overall Study||1
10478698|NCT01123889|11627757|FG000|STARTED|Overall Study||5
10478699|NCT01123889|11627758|FG001|STARTED|Overall Study||7
10478700|NCT01123889|11627757|FG000|COMPLETED|Overall Study||2
10478701|NCT01123889|11627758|FG001|COMPLETED|Overall Study||6
10478702|NCT01123889|11627757|FG000|NOT COMPLETED|Overall Study||3
10478703|NCT01123889|11627758|FG001|NOT COMPLETED|Overall Study||1
10478704|NCT01123928|11627766|FG000|STARTED|Overall Study||212
10478705|NCT01123928|11627767|FG001|STARTED|Overall Study||222
10478706|NCT01123928|11627766|FG000|COMPLETED|Overall Study||212
10478707|NCT01123928|11627767|FG001|COMPLETED|Overall Study||222
10478708|NCT01123928|11627766|FG000|NOT COMPLETED|Overall Study||0
10478709|NCT01123928|11627767|FG001|NOT COMPLETED|Overall Study||0
10478710|NCT01123941|11627775|FG000|STARTED|Overall Study||25
10478711|NCT01123941|11627776|FG001|STARTED|Overall Study||25
10478712|NCT01123941|11627775|FG000|COMPLETED|Overall Study||23
10478713|NCT01123941|11627776|FG001|COMPLETED|Overall Study||24
10478714|NCT01123941|11627775|FG000|NOT COMPLETED|Overall Study||2
10478715|NCT01123941|11627776|FG001|NOT COMPLETED|Overall Study||1
10478716|NCT01123980|11627784|FG000|STARTED|Overall Study||261
10478717|NCT01123980|11627785|FG001|STARTED|Overall Study||260
10478718|NCT01123980|11627784|FG000|COMPLETED|Overall Study||242
10478719|NCT01123980|11627785|FG001|COMPLETED|Overall Study||236
10478720|NCT01123980|11627784|FG000|NOT COMPLETED|Overall Study||19
10478721|NCT01123980|11627785|FG001|NOT COMPLETED|Overall Study||24
10478722|NCT01124006|11627794|FG000|STARTED|Overall Study||10
10478723|NCT01124006|11627795|FG001|STARTED|Overall Study||10
10478724|NCT01124006|11627796|FG002|STARTED|Overall Study||4
10478725|NCT01124006|11627794|FG000|COMPLETED|Overall Study||7
10478726|NCT01124006|11627795|FG001|COMPLETED|Overall Study||8
10709352|NCT02638974|11874303|FG001|NOT COMPLETED|Overall Study||3
10709353|NCT02639052|11874309|FG000|STARTED|Overall Study||35
10709354|NCT02639052|11874309|FG000|Visit 1 (Baseline)|Overall Study||35
10709355|NCT02639052|11874309|FG000|Visit 2 (1-week Follow-up)|Overall Study||35
10478727|NCT01124006|11627796|FG002|COMPLETED|Overall Study||2
10478728|NCT01124006|11627794|FG000|NOT COMPLETED|Overall Study||3
10478729|NCT01124006|11627795|FG001|NOT COMPLETED|Overall Study||2
10478730|NCT01124006|11627796|FG002|NOT COMPLETED|Overall Study||2
10478731|NCT01124045|11627806|FG000|STARTED|Overall Study||39
10478732|NCT01124045|11627807|FG001|STARTED|Overall Study||40
10478733|NCT01124045|11627806|FG000|COMPLETED|Overall Study||39
10478734|NCT01124045|11627807|FG001|COMPLETED|Overall Study||37
10478735|NCT01124045|11627806|FG000|NOT COMPLETED|Overall Study||0
10478736|NCT01124045|11627807|FG001|NOT COMPLETED|Overall Study||3
10478737|NCT01124097|11627817|FG000|STARTED|Overall Study||60
10478738|NCT01124097|11627818|FG001|STARTED|Overall Study||60
10478739|NCT01124097|11627819|FG002|STARTED|Overall Study||60
10478740|NCT01124097|11627820|FG003|STARTED|Overall Study||60
10478741|NCT01124097|11627817|FG000|Safety Population|Overall Study||60
10478742|NCT01124097|11627818|FG001|Safety Population|Overall Study||60
10478743|NCT01124097|11627819|FG002|Safety Population|Overall Study||60
10478744|NCT01124097|11627820|FG003|Safety Population|Overall Study||60
10478745|NCT01124097|11627817|FG000|Efficacy Population|Overall Study||52
10478746|NCT01124097|11627818|FG001|Efficacy Population|Overall Study||53
10478747|NCT01124097|11627819|FG002|Efficacy Population|Overall Study||53
10478748|NCT01124097|11627820|FG003|Efficacy Population|Overall Study||51
10478749|NCT01124097|11627817|FG000|COMPLETED|Overall Study||26
10478750|NCT01124097|11627818|FG001|COMPLETED|Overall Study||38
10478751|NCT01124097|11627819|FG002|COMPLETED|Overall Study||40
10478752|NCT01124097|11627820|FG003|COMPLETED|Overall Study||46
10478753|NCT01124097|11627817|FG000|NOT COMPLETED|Overall Study||34
10478754|NCT01124097|11627818|FG001|NOT COMPLETED|Overall Study||22
10478755|NCT01124097|11627819|FG002|NOT COMPLETED|Overall Study||20
10478756|NCT01124097|11627820|FG003|NOT COMPLETED|Overall Study||14
10478757|NCT01124149|11627830|FG000|STARTED|Acute Phase||722
10478758|NCT01124149|11627830|FG000|COMPLETED|Acute Phase||639
10478759|NCT01124149|11627830|FG000|NOT COMPLETED|Acute Phase||83
10478760|NCT01124149|11627830|FG000|STARTED|Maintenance Phase||469
10478761|NCT01124149|11627830|FG000|COMPLETED|Maintenance Phase||373
10478762|NCT01124149|11627830|FG000|NOT COMPLETED|Maintenance Phase||96
10478763|NCT01124162|11627839|FG000|STARTED|First Intervention||40
10478764|NCT01124162|11627840|FG001|STARTED|First Intervention||40
10478765|NCT01124162|11627839|FG000|COMPLETED|First Intervention||38
10478766|NCT01124162|11627840|FG001|COMPLETED|First Intervention||40
10478767|NCT01124162|11627839|FG000|NOT COMPLETED|First Intervention||2
10478768|NCT01124162|11627840|FG001|NOT COMPLETED|First Intervention||0
10478769|NCT01124162|11627839|FG000|STARTED|Washout of 7 Days||38
10478770|NCT01124162|11627840|FG001|STARTED|Washout of 7 Days||40
10478771|NCT01124162|11627839|FG000|COMPLETED|Washout of 7 Days||37
10478772|NCT01124162|11627840|FG001|COMPLETED|Washout of 7 Days||40
10478773|NCT01124162|11627839|FG000|NOT COMPLETED|Washout of 7 Days||1
10478774|NCT01124162|11627840|FG001|NOT COMPLETED|Washout of 7 Days||0
10478775|NCT01124162|11627839|FG000|STARTED|Second Intervention||37
10478776|NCT01124162|11627840|FG001|STARTED|Second Intervention||40
10478777|NCT01124162|11627839|FG000|COMPLETED|Second Intervention||37
10478778|NCT01124162|11627840|FG001|COMPLETED|Second Intervention||40
10478779|NCT01124162|11627839|FG000|NOT COMPLETED|Second Intervention||0
10478780|NCT01124162|11627840|FG001|NOT COMPLETED|Second Intervention||0
10478781|NCT01124175|11627848|FG000|STARTED|First Intervention||40
10478782|NCT01124175|11627849|FG001|STARTED|First Intervention||40
10478783|NCT01124175|11627848|FG000|COMPLETED|First Intervention||40
10478784|NCT01124175|11627849|FG001|COMPLETED|First Intervention||40
10478785|NCT01124175|11627848|FG000|NOT COMPLETED|First Intervention||0
10478786|NCT01124175|11627849|FG001|NOT COMPLETED|First Intervention||0
10478787|NCT01124175|11627848|FG000|STARTED|Washout of 7 Days||40
10478788|NCT01124175|11627849|FG001|STARTED|Washout of 7 Days||40
10478789|NCT01124175|11627848|FG000|COMPLETED|Washout of 7 Days||40
10478790|NCT01124175|11627849|FG001|COMPLETED|Washout of 7 Days||38
10478791|NCT01124175|11627848|FG000|NOT COMPLETED|Washout of 7 Days||0
10478792|NCT01124175|11627849|FG001|NOT COMPLETED|Washout of 7 Days||2
10478793|NCT01124175|11627848|FG000|STARTED|Second Intervention||40
10478794|NCT01124175|11627849|FG001|STARTED|Second Intervention||38
10478795|NCT01124175|11627848|FG000|COMPLETED|Second Intervention||40
10478796|NCT01124175|11627849|FG001|COMPLETED|Second Intervention||38
10478797|NCT01124175|11627848|FG000|NOT COMPLETED|Second Intervention||0
10478798|NCT01124175|11627849|FG001|NOT COMPLETED|Second Intervention||0
10478799|NCT01124188|11627857|FG000|STARTED|Overall Study||68
10478800|NCT01124188|11627858|FG001|STARTED|Overall Study||71
10478801|NCT01124188|11627857|FG000|COMPLETED|Overall Study||60
10478802|NCT01124188|11627858|FG001|COMPLETED|Overall Study||65
10478803|NCT01124188|11627857|FG000|NOT COMPLETED|Overall Study||8
10478804|NCT01124188|11627858|FG001|NOT COMPLETED|Overall Study||6
10478805|NCT01124292|11627867|FG000|STARTED|Overall Study||16
10478806|NCT01124292|11627868|FG001|STARTED|Overall Study||24
10478807|NCT01124292|11627869|FG002|STARTED|Overall Study||21
10478808|NCT01124292|11627867|FG000|COMPLETED|Overall Study||14
10478809|NCT01124292|11627868|FG001|COMPLETED|Overall Study||9
10478810|NCT01124292|11627869|FG002|COMPLETED|Overall Study||11
10478811|NCT01124292|11627867|FG000|NOT COMPLETED|Overall Study||2
10478812|NCT01124292|11627868|FG001|NOT COMPLETED|Overall Study||15
10478813|NCT01124292|11627869|FG002|NOT COMPLETED|Overall Study||10
10478814|NCT01124305|11627882|FG000|STARTED|Overall Study||34
10478815|NCT01124305|11627883|FG001|STARTED|Overall Study||36
10478816|NCT01124305|11627882|FG000|COMPLETED|Overall Study||26
10478817|NCT01124305|11627883|FG001|COMPLETED|Overall Study||26
10478818|NCT01124305|11627882|FG000|NOT COMPLETED|Overall Study||8
10478819|NCT01124305|11627883|FG001|NOT COMPLETED|Overall Study||10
10478820|NCT01124370|11627889|FG000|STARTED|Overall Study|Underwent implant attempt|57
10478821|NCT01124370|11627889|FG000|Successfully Implanted|Overall Study||50
10478822|NCT01124370|11627889|FG000|Therapy Initiated|Overall Study||48
10478823|NCT01124370|11627889|FG000|3 Month Visit|Overall Study|Defines evaluable population|47
10478824|NCT01124370|11627889|FG000|COMPLETED|Overall Study|Completed 2 year post-implant follow-up|37
10478825|NCT01124370|11627889|FG000|NOT COMPLETED|Overall Study||20
10478826|NCT01124422|11627895|FG000|STARTED|4-Week Open-label Run-in Phase||338
10478827|NCT01124422|11627896|FG001|STARTED|4-Week Open-label Run-in Phase||0
10478828|NCT01124422|11627897|FG002|STARTED|4-Week Open-label Run-in Phase||0
10478829|NCT01124422|11627895|FG000|COMPLETED|4-Week Open-label Run-in Phase||255
10478830|NCT01124422|11627896|FG001|COMPLETED|4-Week Open-label Run-in Phase||0
10478831|NCT01124422|11627897|FG002|COMPLETED|4-Week Open-label Run-in Phase||0
10478832|NCT01124422|11627895|FG000|NOT COMPLETED|4-Week Open-label Run-in Phase||83
10478833|NCT01124422|11627896|FG001|NOT COMPLETED|4-Week Open-label Run-in Phase||0
10478834|NCT01124422|11627897|FG002|NOT COMPLETED|4-Week Open-label Run-in Phase||0
10478835|NCT01124422|11627895|FG000|STARTED|4-Week Double-blind Treatment Phase||0
10478836|NCT01124422|11627896|FG001|STARTED|4-Week Double-blind Treatment Phase||131
10478837|NCT01124422|11627897|FG002|STARTED|4-Week Double-blind Treatment Phase||124
10478838|NCT01124422|11627895|FG000|COMPLETED|4-Week Double-blind Treatment Phase||0
10478839|NCT01124422|11627896|FG001|COMPLETED|4-Week Double-blind Treatment Phase||120
10478840|NCT01124422|11627897|FG002|COMPLETED|4-Week Double-blind Treatment Phase||115
10478841|NCT01124422|11627895|FG000|NOT COMPLETED|4-Week Double-blind Treatment Phase||0
10478842|NCT01124422|11627896|FG001|NOT COMPLETED|4-Week Double-blind Treatment Phase||11
10478843|NCT01124422|11627897|FG002|NOT COMPLETED|4-Week Double-blind Treatment Phase||9
10478844|NCT01124448|11627906|FG000|STARTED|Overall Study||25
10478845|NCT01124448|11627907|FG001|STARTED|Overall Study||15
10709356|NCT02639052|11874309|FG000|Visit 3 (1-month Follow-up)|Overall Study||35
10338221|NCT00368966|11475113|FG000|NOT COMPLETED|Infant Series||16
10338222|NCT00368966|11475114|FG001|NOT COMPLETED|Infant Series||10
10338223|NCT00368966|11475113|FG000|STARTED|After Infant||299
10338224|NCT00368966|11475114|FG001|STARTED|After Infant||294
10338225|NCT00368966|11475113|FG000|COMPLETED|After Infant||293
10338226|NCT00368966|11475114|FG001|COMPLETED|After Infant||289
10478846|NCT01124448|11627906|FG000|COMPLETED|Overall Study||23
10478847|NCT01124448|11627907|FG001|COMPLETED|Overall Study||12
10478848|NCT01124448|11627906|FG000|NOT COMPLETED|Overall Study||2
10478849|NCT01124448|11627907|FG001|NOT COMPLETED|Overall Study||3
10478850|NCT01124604|11627915|FG000|STARTED|Overall Study||60
10478851|NCT01124604|11627916|FG001|STARTED|Overall Study||31
10478852|NCT01124604|11627915|FG000|COMPLETED|Overall Study||45
10478853|NCT01124604|11627916|FG001|COMPLETED|Overall Study||29
10478854|NCT01124604|11627915|FG000|NOT COMPLETED|Overall Study||15
10478855|NCT01124604|11627916|FG001|NOT COMPLETED|Overall Study||2
10478856|NCT01124617|11627924|FG000|STARTED|Overall Study||60
10478857|NCT01124617|11627925|FG001|STARTED|Overall Study||31
10478858|NCT01124617|11627924|FG000|COMPLETED|Overall Study||41
10478859|NCT01124617|11627925|FG001|COMPLETED|Overall Study||25
10478860|NCT01124617|11627924|FG000|NOT COMPLETED|Overall Study||19
10478861|NCT01124617|11627925|FG001|NOT COMPLETED|Overall Study||6
10478862|NCT01124643|11627931|FG000|STARTED|Overall Study||35
10478863|NCT01124643|11627931|FG000|COMPLETED|Overall Study||34
10478864|NCT01124643|11627931|FG000|NOT COMPLETED|Overall Study||1
10478865|NCT01124734|11627935|FG000|STARTED|Overall Study||17
10478866|NCT01124734|11627935|FG000|Completion of Course 1 Cycle 1|Overall Study|All 17 participants successfully completed Course 1 Cycle 1|17
10478867|NCT01124734|11627935|FG000|Initiation of Course 1 Cycle 2|Overall Study||17
10478868|NCT01124734|11627935|FG000|COMPLETED|Overall Study|Closed to accrual|0
10478869|NCT01124734|11627935|FG000|NOT COMPLETED|Overall Study||17
10478870|NCT01124786|11627946|FG000|STARTED|Overall Study||182
10478871|NCT01124786|11627947|FG001|STARTED|Overall Study||185
10478872|NCT01124786|11627946|FG000|Intent-to-Treat (ITT) Population|Overall Study|All randomized patients (pts)|182
10478873|NCT01124786|11627947|FG001|Intent-to-Treat (ITT) Population|Overall Study||185
10478874|NCT01124786|11627946|FG000|Safety Population|Overall Study|All pts who received at least one dose of study drug|179
10478875|NCT01124786|11627947|FG001|Safety Population|Overall Study||181
10478876|NCT01124786|11627946|FG000|Tumor Evaluable Population|Overall Study|All pts with measurable/evaluable tumor at baseline per RECIST and have received ≥ one dose of drug|178
10478877|NCT01124786|11627947|FG001|Tumor Evaluable Population|Overall Study||180
10478878|NCT01124786|11627946|FG000|COMPLETED|Overall Study||178
10478879|NCT01124786|11627947|FG001|COMPLETED|Overall Study||180
10478880|NCT01124786|11627946|FG000|NOT COMPLETED|Overall Study||4
10478881|NCT01124786|11627947|FG001|NOT COMPLETED|Overall Study||5
10478882|NCT01124838|11627955|FG000|STARTED|Overall Study||130
10478883|NCT01124838|11627956|FG001|STARTED|Overall Study||131
10478884|NCT01124838|11627955|FG000|Enrolled in Main Study|Overall Study||114
10478885|NCT01124838|11627956|FG001|Enrolled in Main Study|Overall Study||115
10478886|NCT01124838|11627955|FG000|Enrolled in Japan Sub-study|Overall Study||16
10478887|NCT01124838|11627956|FG001|Enrolled in Japan Sub-study|Overall Study||16
10478888|NCT01124838|11627955|FG000|COMPLETED|Overall Study||112
10478889|NCT01124838|11627956|FG001|COMPLETED|Overall Study||116
10478890|NCT01124838|11627955|FG000|NOT COMPLETED|Overall Study||18
10478891|NCT01124838|11627956|FG001|NOT COMPLETED|Overall Study||15
10478892|NCT01124864|11627970|FG000|STARTED|Overall Study||28
10478893|NCT01124864|11627971|FG001|STARTED|Overall Study||35
10478894|NCT01124864|11627972|FG002|STARTED|Overall Study||34
10478895|NCT01124864|11627973|FG003|STARTED|Overall Study||22
10478896|NCT01124864|11627974|FG004|STARTED|Overall Study||31
10478897|NCT01124864|11627975|FG005|STARTED|Overall Study||3
10709357|NCT02639052|11874309|FG000|Visit 4 (3-month Follow-up)|Overall Study||34
10709358|NCT02639052|11874309|FG000|COMPLETED|Overall Study||34
10709359|NCT02639052|11874309|FG000|NOT COMPLETED|Overall Study||1
10709360|NCT02639182|11874317|FG000|STARTED|Overall Study||67
10709361|NCT02639182|11874318|FG001|STARTED|Overall Study||66
10709362|NCT02639182|11874317|FG000|Treated|Overall Study||66
10709363|NCT02639182|11874318|FG001|Treated|Overall Study||65
10709364|NCT02639182|11874317|FG000|COMPLETED|Overall Study||0
10478898|NCT01124864|11627970|FG000|COMPLETED|Overall Study||0
10478899|NCT01124864|11627971|FG001|COMPLETED|Overall Study||0
10478900|NCT01124864|11627972|FG002|COMPLETED|Overall Study||0
10478901|NCT01124864|11627973|FG003|COMPLETED|Overall Study|1 patient ongoing at time of data cut-off 30-Jul-2013|1
10478902|NCT01124864|11627974|FG004|COMPLETED|Overall Study|1 patient ongoing at time of data cut-off 30-Jul-2013|1
10478903|NCT01124864|11627975|FG005|COMPLETED|Overall Study||0
10478904|NCT01124864|11627970|FG000|NOT COMPLETED|Overall Study||28
10478905|NCT01124864|11627971|FG001|NOT COMPLETED|Overall Study||35
10478906|NCT01124864|11627972|FG002|NOT COMPLETED|Overall Study||34
10478907|NCT01124864|11627973|FG003|NOT COMPLETED|Overall Study||21
10478908|NCT01124864|11627974|FG004|NOT COMPLETED|Overall Study||30
10478909|NCT01124864|11627975|FG005|NOT COMPLETED|Overall Study||3
10478910|NCT01124916|11627993|FG000|STARTED|Overall Study||38
10478911|NCT01124916|11627994|FG001|STARTED|Overall Study||40
10478912|NCT01124916|11627993|FG000|COMPLETED|Overall Study||35
10478913|NCT01124916|11627994|FG001|COMPLETED|Overall Study||38
10478914|NCT01124916|11627993|FG000|NOT COMPLETED|Overall Study||3
10478915|NCT01124916|11627994|FG001|NOT COMPLETED|Overall Study||2
10478916|NCT01124955|11628002|FG000|STARTED|Overall Study||40
10478917|NCT01124955|11628003|FG001|STARTED|Overall Study||40
10478918|NCT01124955|11628002|FG000|COMPLETED|Overall Study||40
10478919|NCT01124955|11628003|FG001|COMPLETED|Overall Study||40
10709365|NCT02639182|11874318|FG001|COMPLETED|Overall Study||0
10709366|NCT02639182|11874317|FG000|NOT COMPLETED|Overall Study||67
10709367|NCT02639182|11874318|FG001|NOT COMPLETED|Overall Study||66
10709368|NCT02639247|11874326|FG000|STARTED|Overall Study||182
10478920|NCT01124955|11628002|FG000|NOT COMPLETED|Overall Study||0
10478921|NCT01124955|11628003|FG001|NOT COMPLETED|Overall Study||0
10478922|NCT01125046|11628009|FG000|STARTED|First 6 Months of Treatment||50
10709369|NCT02639247|11874327|FG001|STARTED|Overall Study||151
10709370|NCT02639247|11874326|FG000|COMPLETED|Overall Study||177
10709371|NCT02639247|11874327|FG001|COMPLETED|Overall Study||149
10709372|NCT02639247|11874326|FG000|NOT COMPLETED|Overall Study||5
10478923|NCT01125046|11628009|FG000|COMPLETED|First 6 Months of Treatment||36
10478924|NCT01125046|11628009|FG000|NOT COMPLETED|First 6 Months of Treatment||14
10478925|NCT01125046|11628009|FG000|STARTED|Continued Treatment After 6 Months||36
10478926|NCT01125046|11628009|FG000|COMPLETED|Continued Treatment After 6 Months||33
10478927|NCT01125046|11628009|FG000|NOT COMPLETED|Continued Treatment After 6 Months||3
10478928|NCT01125046|11628009|FG000|STARTED|Follow-up/Data Cut Off Point||49
10478929|NCT01125046|11628009|FG000|COMPLETED|Follow-up/Data Cut Off Point||16
10478930|NCT01125046|11628009|FG000|NOT COMPLETED|Follow-up/Data Cut Off Point||33
10478931|NCT01125098|11628015|FG000|STARTED|Overall Study||91
10478932|NCT01125098|11628016|FG001|STARTED|Overall Study||90
10478933|NCT01125098|11628015|FG000|COMPLETED|Overall Study||88
10478934|NCT01125098|11628016|FG001|COMPLETED|Overall Study||90
10478935|NCT01125098|11628015|FG000|NOT COMPLETED|Overall Study||3
10478936|NCT01125098|11628016|FG001|NOT COMPLETED|Overall Study||0
10478937|NCT01125163|11628024|FG000|STARTED|Overall Study||76
10478938|NCT01125163|11628025|FG001|STARTED|Overall Study||74
10478939|NCT01125163|11628024|FG000|COMPLETED|Overall Study||76
10478940|NCT01125163|11628025|FG001|COMPLETED|Overall Study||74
10478941|NCT01125163|11628024|FG000|NOT COMPLETED|Overall Study||0
10478942|NCT01125163|11628025|FG001|NOT COMPLETED|Overall Study||0
10478943|NCT01125189|11628035|FG000|STARTED|Treatment Period||159
10478944|NCT01125189|11628036|FG001|STARTED|Treatment Period||158
10478945|NCT01125189|11628037|FG002|STARTED|Treatment Period||78
10478946|NCT01125189|11628035|FG000|COMPLETED|Treatment Period||128
10478947|NCT01125189|11628036|FG001|COMPLETED|Treatment Period||123
10478948|NCT01125189|11628037|FG002|COMPLETED|Treatment Period||37
10478949|NCT01125189|11628035|FG000|NOT COMPLETED|Treatment Period||31
10478950|NCT01125189|11628036|FG001|NOT COMPLETED|Treatment Period||35
10478951|NCT01125189|11628037|FG002|NOT COMPLETED|Treatment Period||41
10478952|NCT01125189|11628035|FG000|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|152
10478953|NCT01125189|11628036|FG001|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|153
10478954|NCT01125189|11628037|FG002|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|74
10478955|NCT01125189|11628035|FG000|COMPLETED|Follow up Period||132
10478956|NCT01125189|11628036|FG001|COMPLETED|Follow up Period||138
10478957|NCT01125189|11628037|FG002|COMPLETED|Follow up Period||58
10478958|NCT01125189|11628035|FG000|NOT COMPLETED|Follow up Period||20
10478959|NCT01125189|11628036|FG001|NOT COMPLETED|Follow up Period||15
10478960|NCT01125189|11628037|FG002|NOT COMPLETED|Follow up Period||16
10478961|NCT01125202|11628050|FG000|STARTED|Overall Study||93
10478962|NCT01125202|11628051|FG001|STARTED|Overall Study||86
10478963|NCT01125202|11628050|FG000|COMPLETED|Overall Study||81
10478964|NCT01125202|11628051|FG001|COMPLETED|Overall Study||79
10478965|NCT01125202|11628050|FG000|NOT COMPLETED|Overall Study||12
10478966|NCT01125202|11628051|FG001|NOT COMPLETED|Overall Study||7
10478967|NCT01125293|11628063|FG000|STARTED|Overall Study||3
10478968|NCT01125293|11628064|FG001|STARTED|Overall Study||3
10478969|NCT01125293|11628065|FG002|STARTED|Overall Study||4
10478970|NCT01125293|11628066|FG003|STARTED|Overall Study||3
10478971|NCT01125293|11628067|FG004|STARTED|Overall Study|Per protocol, a 10 patient expansion cohort is used to confirm the MTD determined in Stage B .|10
10478972|NCT01125293|11628068|FG005|STARTED|Overall Study||23
10478973|NCT01125293|11628063|FG000|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study||3
10478974|NCT01125293|11628064|FG001|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study||3
10478975|NCT01125293|11628065|FG002|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study||3
10478976|NCT01125293|11628066|FG003|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study||3
10478977|NCT01125293|11628067|FG004|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study|The Phase I dose expansion cohort was not evaluated for cycle 1 dose-limiting toxicity.|0
10478978|NCT01125293|11628068|FG005|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study|The Phase II cohort was not evaluated for cycle 1 dose-limiting toxicity.|0
10478979|NCT01125293|11628063|FG000|COMPLETED|Overall Study||0
10478980|NCT01125293|11628064|FG001|COMPLETED|Overall Study||0
10478981|NCT01125293|11628065|FG002|COMPLETED|Overall Study||0
10478982|NCT01125293|11628066|FG003|COMPLETED|Overall Study||0
10478983|NCT01125293|11628067|FG004|COMPLETED|Overall Study||0
10478984|NCT01125293|11628068|FG005|COMPLETED|Overall Study||0
10478985|NCT01125293|11628063|FG000|NOT COMPLETED|Overall Study||3
10478986|NCT01125293|11628064|FG001|NOT COMPLETED|Overall Study||3
10478987|NCT01125293|11628065|FG002|NOT COMPLETED|Overall Study||4
10478988|NCT01125293|11628066|FG003|NOT COMPLETED|Overall Study||3
10478989|NCT01125293|11628067|FG004|NOT COMPLETED|Overall Study||10
10478990|NCT01125293|11628068|FG005|NOT COMPLETED|Overall Study||23
10478991|NCT01125358|11628089|FG000|STARTED|Overall Study||21
10478992|NCT01125358|11628090|FG001|STARTED|Overall Study||21
10478993|NCT01125358|11628091|FG002|STARTED|Overall Study||20
10478994|NCT01125358|11628092|FG003|STARTED|Overall Study||20
10478995|NCT01125358|11628089|FG000|Received at Least 1 Dose of Study Drug|Overall Study||21
10478996|NCT01125358|11628090|FG001|Received at Least 1 Dose of Study Drug|Overall Study||21
10478997|NCT01125358|11628091|FG002|Received at Least 1 Dose of Study Drug|Overall Study||20
10478998|NCT01125358|11628092|FG003|Received at Least 1 Dose of Study Drug|Overall Study||20
10478999|NCT01125358|11628089|FG000|Placebo Responder|Overall Study||1
10479000|NCT01125358|11628090|FG001|Placebo Responder|Overall Study||0
10479001|NCT01125358|11628091|FG002|Placebo Responder|Overall Study||0
10479002|NCT01125358|11628092|FG003|Placebo Responder|Overall Study||0
10479003|NCT01125358|11628089|FG000|COMPLETED|Overall Study||9
10479004|NCT01125358|11628090|FG001|COMPLETED|Overall Study||17
10479005|NCT01125358|11628091|FG002|COMPLETED|Overall Study||11
10479006|NCT01125358|11628092|FG003|COMPLETED|Overall Study||12
10709373|NCT02639247|11874327|FG001|NOT COMPLETED|Overall Study||2
10709374|NCT02639286|11874335|FG000|STARTED|Overall Study||3
10479007|NCT01125358|11628089|FG000|NOT COMPLETED|Overall Study||12
10479008|NCT01125358|11628090|FG001|NOT COMPLETED|Overall Study||4
10479009|NCT01125358|11628091|FG002|NOT COMPLETED|Overall Study||9
10479010|NCT01125358|11628092|FG003|NOT COMPLETED|Overall Study||8
10527046|NCT01386983|11679036|FG001|STARTED|Overall Study||68
10527047|NCT01386983|11679035|FG000|COMPLETED|Overall Study||264
10527048|NCT01386983|11679036|FG001|COMPLETED|Overall Study||68
10527049|NCT01386983|11679035|FG000|NOT COMPLETED|Overall Study||0
10527050|NCT01386983|11679036|FG001|NOT COMPLETED|Overall Study||0
10527051|NCT01387022|11679044|FG000|STARTED|Overall Study||29
10527052|NCT01387022|11679045|FG001|STARTED|Overall Study||30
10527053|NCT01387022|11679044|FG000|COMPLETED|Overall Study||28
10527054|NCT01387022|11679045|FG001|COMPLETED|Overall Study||26
10527055|NCT01387022|11679044|FG000|NOT COMPLETED|Overall Study||1
10527056|NCT01387022|11679045|FG001|NOT COMPLETED|Overall Study||4
10527057|NCT01387074|11679051|FG000|STARTED|Overall Study||108
10527058|NCT01387074|11679051|FG000|COMPLETED|Overall Study||100
10527059|NCT01387074|11679051|FG000|NOT COMPLETED|Overall Study||8
10527060|NCT01387139|11679057|FG000|STARTED|Overall Study||99
10527061|NCT01387139|11679058|FG001|STARTED|Overall Study||84
10527062|NCT01387139|11679057|FG000|COMPLETED|Overall Study||99
10527063|NCT01387139|11679058|FG001|COMPLETED|Overall Study||84
10527064|NCT01387139|11679057|FG000|NOT COMPLETED|Overall Study||0
10527065|NCT01387139|11679058|FG001|NOT COMPLETED|Overall Study||0
10527066|NCT01387178|11679066|FG000|STARTED|Overall Study||11582
10527067|NCT01387178|11679067|FG001|STARTED|Overall Study||10641
10527068|NCT01387178|11679066|FG000|COMPLETED|Overall Study||11582
10527069|NCT01387178|11679067|FG001|COMPLETED|Overall Study||10641
10527070|NCT01387178|11679066|FG000|NOT COMPLETED|Overall Study||0
10527071|NCT01387178|11679067|FG001|NOT COMPLETED|Overall Study||0
10527072|NCT01387230|11679077|FG000|STARTED|Overall Study||68
10527073|NCT01387230|11679078|FG001|STARTED|Overall Study||69
10527074|NCT01387230|11679079|FG002|STARTED|Overall Study||69
10527075|NCT01387230|11679077|FG000|COMPLETED|Overall Study||50
10527076|NCT01387230|11679078|FG001|COMPLETED|Overall Study||62
10527077|NCT01387230|11679079|FG002|COMPLETED|Overall Study||56
10527078|NCT01387230|11679077|FG000|NOT COMPLETED|Overall Study||18
10527079|NCT01387230|11679078|FG001|NOT COMPLETED|Overall Study||7
10527080|NCT01387230|11679079|FG002|NOT COMPLETED|Overall Study||13
10527081|NCT01387269|11679089|FG000|STARTED|Overall Study||323
10527082|NCT01387269|11679090|FG001|STARTED|Overall Study||161
10527083|NCT01387269|11679089|FG000|ITT Population|Overall Study||323
10527084|NCT01387269|11679090|FG001|ITT Population|Overall Study||161
10527085|NCT01387269|11679089|FG000|MITT Population|Overall Study||284
10527086|NCT01387269|11679090|FG001|MITT Population|Overall Study||141
10527087|NCT01387269|11679089|FG000|Safety Population|Overall Study||320
10527088|NCT01387269|11679090|FG001|Safety Population|Overall Study||161
10527089|NCT01387269|11679089|FG000|COMPLETED|Overall Study||231
10527090|NCT01387269|11679090|FG001|COMPLETED|Overall Study||121
10527091|NCT01387269|11679089|FG000|NOT COMPLETED|Overall Study||92
10527092|NCT01387269|11679090|FG001|NOT COMPLETED|Overall Study||40
10527093|NCT01387282|11679098|FG000|STARTED|Overall Study||330
10527094|NCT01387282|11679099|FG001|STARTED|Overall Study||165
10527095|NCT01387282|11679098|FG000|ITT Population|Overall Study||330
10527096|NCT01387282|11679099|FG001|ITT Population|Overall Study||165
10527097|NCT01387282|11679098|FG000|MITT Population|Overall Study||268
10527098|NCT01387282|11679099|FG001|MITT Population|Overall Study||136
10527099|NCT01387282|11679098|FG000|Safety Population|Overall Study||330
10527100|NCT01387282|11679099|FG001|Safety Population|Overall Study||161
10527101|NCT01387282|11679098|FG000|COMPLETED|Overall Study||233
10527102|NCT01387282|11679099|FG001|COMPLETED|Overall Study||118
10527103|NCT01387282|11679098|FG000|NOT COMPLETED|Overall Study||97
10527104|NCT01387282|11679099|FG001|NOT COMPLETED|Overall Study||47
10527105|NCT01387347|11679107|FG000|STARTED|Overall Study||36
10527106|NCT01387347|11679108|FG001|STARTED|Overall Study||36
10527107|NCT01387347|11679107|FG000|COMPLETED|Overall Study||34
10527108|NCT01387347|11679108|FG001|COMPLETED|Overall Study||35
10527109|NCT01387347|11679107|FG000|NOT COMPLETED|Overall Study||2
10527110|NCT01387347|11679108|FG001|NOT COMPLETED|Overall Study||1
10527111|NCT01387464|11679120|FG000|STARTED|Overall Study||30
10527112|NCT01387464|11679121|FG001|STARTED|Overall Study||30
10527113|NCT01387464|11679120|FG000|Safety Population|Overall Study||30
10527114|NCT01387464|11679121|FG001|Safety Population|Overall Study||29
10527115|NCT01387464|11679120|FG000|Per-Protocol Population|Overall Study|Safety subjects who completed surgery|29
10527116|NCT01387464|11679121|FG001|Per-Protocol Population|Overall Study||29
10527117|NCT01387464|11679120|FG000|COMPLETED|Overall Study||29
10527118|NCT01387464|11679121|FG001|COMPLETED|Overall Study||29
10527119|NCT01387464|11679120|FG000|NOT COMPLETED|Overall Study||1
10527120|NCT01387464|11679121|FG001|NOT COMPLETED|Overall Study||1
10527121|NCT01387516|11679131|FG000|STARTED|Overall Study||80
10527122|NCT01387516|11679132|FG001|STARTED|Overall Study||68
10527123|NCT01387516|11679133|FG002|STARTED|Overall Study||79
10527124|NCT01387516|11679134|FG003|STARTED|Overall Study||69
10527125|NCT01387516|11679131|FG000|COMPLETED|Overall Study||75
10527126|NCT01387516|11679132|FG001|COMPLETED|Overall Study||63
10527127|NCT01387516|11679133|FG002|COMPLETED|Overall Study||75
10527128|NCT01387516|11679134|FG003|COMPLETED|Overall Study||65
10479011|NCT04733664|11628102|FG000|STARTED|Overall Study||10
10479012|NCT04733664|11628102|FG000|COMPLETED|Overall Study||10
10479013|NCT04733664|11628102|FG000|NOT COMPLETED|Overall Study||0
10479014|NCT04573322|11628110|FG000|STARTED|Overall Study||6
10479015|NCT04573322|11628111|FG001|STARTED|Overall Study||6
10479016|NCT04573322|11628112|FG002|STARTED|Overall Study||7
10479017|NCT04573322|11628113|FG003|STARTED|Overall Study||6
10479018|NCT04573322|11628110|FG000|COMPLETED|Overall Study||5
10479019|NCT04573322|11628111|FG001|COMPLETED|Overall Study||4
10479020|NCT04573322|11628112|FG002|COMPLETED|Overall Study||5
10479021|NCT04573322|11628113|FG003|COMPLETED|Overall Study||3
10479022|NCT04573322|11628110|FG000|NOT COMPLETED|Overall Study||1
10479023|NCT04573322|11628111|FG001|NOT COMPLETED|Overall Study||2
10479024|NCT04573322|11628112|FG002|NOT COMPLETED|Overall Study||2
10479025|NCT04573322|11628113|FG003|NOT COMPLETED|Overall Study||3
10479036|NCT04374565|11628132|FG000|STARTED|Overall Study||29
10479037|NCT04374565|11628132|FG000|COMPLETED|Overall Study||29
10479038|NCT04374565|11628132|FG000|NOT COMPLETED|Overall Study||0
10479039|NCT04364737|11628138|FG000|STARTED|Overall Study||468
10479040|NCT04364737|11628139|FG001|STARTED|Overall Study||473
10479041|NCT04364737|11628138|FG000|COMPLETED|Overall Study||463
10479042|NCT04364737|11628139|FG001|COMPLETED|Overall Study||463
10479043|NCT04364737|11628138|FG000|NOT COMPLETED|Overall Study||5
10479044|NCT04364737|11628139|FG001|NOT COMPLETED|Overall Study||10
10479045|NCT04354155|11628145|FG000|STARTED|Overall Study||40
10479046|NCT04354155|11628145|FG000|COMPLETED|Overall Study||38
10479047|NCT04354155|11628145|FG000|NOT COMPLETED|Overall Study||2
10479048|NCT04085367|11628151|FG000|STARTED|Overall Study||364
10479049|NCT04085367|11628152|FG001|STARTED|Overall Study||193
10479050|NCT04085367|11628151|FG000|COMPLETED|Overall Study||344
10479051|NCT04085367|11628152|FG001|COMPLETED|Overall Study||185
10479052|NCT04085367|11628151|FG000|NOT COMPLETED|Overall Study||20
10479053|NCT04085367|11628152|FG001|NOT COMPLETED|Overall Study||8
10479054|NCT03884270|11628158|FG000|STARTED|Overall Study||23
10479055|NCT03884270|11628158|FG000|COMPLETED|Overall Study||22
10479056|NCT03884270|11628158|FG000|NOT COMPLETED|Overall Study||1
10479057|NCT03621696|11628166|FG000|STARTED|Overall Study||21
10479058|NCT03621696|11628167|FG001|STARTED|Overall Study||31
10479059|NCT03621696|11628168|FG002|STARTED|Overall Study||6
10479060|NCT03621696|11628169|FG003|STARTED|Overall Study||5
10479061|NCT03621696|11628166|FG000|COMPLETED|Overall Study||20
10479062|NCT03621696|11628167|FG001|COMPLETED|Overall Study||30
10479063|NCT03621696|11628168|FG002|COMPLETED|Overall Study||4
10479064|NCT03621696|11628169|FG003|COMPLETED|Overall Study||0
10479065|NCT03621696|11628166|FG000|NOT COMPLETED|Overall Study||1
10479066|NCT03621696|11628167|FG001|NOT COMPLETED|Overall Study||1
10479067|NCT03621696|11628168|FG002|NOT COMPLETED|Overall Study||2
10479068|NCT03621696|11628169|FG003|NOT COMPLETED|Overall Study||5
10479069|NCT03544268|11628179|FG000|STARTED|Overall Study||5
10479070|NCT03544268|11628180|FG001|STARTED|Overall Study||15
10479071|NCT03544268|11628179|FG000|COMPLETED|Overall Study||3
10479072|NCT03544268|11628180|FG001|COMPLETED|Overall Study||15
10479073|NCT03544268|11628179|FG000|NOT COMPLETED|Overall Study||2
10479074|NCT03544268|11628180|FG001|NOT COMPLETED|Overall Study||0
10479075|NCT03421197|11628190|FG000|STARTED|Overall Study||105
10479076|NCT03421197|11628191|FG001|STARTED|Overall Study||107
10479077|NCT03421197|11628192|FG002|STARTED|Overall Study||107
10479078|NCT03421197|11628193|FG003|STARTED|Overall Study||107
10479079|NCT03421197|11628190|FG000|COMPLETED|Overall Study||67
10479080|NCT03421197|11628191|FG001|COMPLETED|Overall Study||68
10479081|NCT03421197|11628192|FG002|COMPLETED|Overall Study||56
10479082|NCT03421197|11628193|FG003|COMPLETED|Overall Study||62
10479083|NCT03421197|11628190|FG000|NOT COMPLETED|Overall Study||38
10479084|NCT03421197|11628191|FG001|NOT COMPLETED|Overall Study||39
10479085|NCT03421197|11628192|FG002|NOT COMPLETED|Overall Study||51
10479086|NCT03421197|11628193|FG003|NOT COMPLETED|Overall Study||45
10479087|NCT03371108|11628205|FG000|STARTED|Safety Analysis Set||284
10479088|NCT03371108|11628206|FG001|STARTED|Safety Analysis Set||283
10479089|NCT03371108|11628205|FG000|COMPLETED|Safety Analysis Set||281
10479090|NCT03371108|11628206|FG001|COMPLETED|Safety Analysis Set||282
10479091|NCT03371108|11628205|FG000|NOT COMPLETED|Safety Analysis Set||3
10479092|NCT03371108|11628206|FG001|NOT COMPLETED|Safety Analysis Set||1
10479093|NCT03371108|11628205|FG000|STARTED|Completers||281
10479094|NCT03371108|11628206|FG001|STARTED|Completers||282
10479095|NCT03371108|11628205|FG000|COMPLETED|Completers||259
10479096|NCT03371108|11628206|FG001|COMPLETED|Completers||256
10479097|NCT03371108|11628205|FG000|NOT COMPLETED|Completers||22
10479098|NCT03371108|11628206|FG001|NOT COMPLETED|Completers||26
10479099|NCT03112993|11628214|FG000|STARTED|Overall Study||19
10479100|NCT03112993|11628215|FG001|STARTED|Overall Study||21
10479101|NCT03112993|11628214|FG000|COMPLETED|Overall Study||19
10479102|NCT03112993|11628215|FG001|COMPLETED|Overall Study||21
10479103|NCT03112993|11628214|FG000|NOT COMPLETED|Overall Study||0
10479104|NCT03112993|11628215|FG001|NOT COMPLETED|Overall Study||0
10479105|NCT03088137|11628225|FG000|STARTED|Overall Study||55
10479106|NCT03088137|11628226|FG001|STARTED|Overall Study||55
10479107|NCT03088137|11628225|FG000|COMPLETED|Overall Study||55
10479108|NCT03088137|11628226|FG001|COMPLETED|Overall Study||55
10479109|NCT03088137|11628225|FG000|NOT COMPLETED|Overall Study||0
10479110|NCT03088137|11628226|FG001|NOT COMPLETED|Overall Study||0
10479111|NCT03038438|11628232|FG000|STARTED|Overall Study||200
10479112|NCT03038438|11628232|FG000|30-Day Follow-Up|Overall Study||198
10479113|NCT03038438|11628232|FG000|6-Month Follow-up|Overall Study||193
10479114|NCT03038438|11628232|FG000|12-Month Follow-up|Overall Study||191
10479115|NCT03038438|11628232|FG000|24-Month Follow-up|Overall Study||148
10479116|NCT03038438|11628232|FG000|COMPLETED|Overall Study||148
10479117|NCT03038438|11628232|FG000|NOT COMPLETED|Overall Study||52
10527129|NCT01387516|11679131|FG000|NOT COMPLETED|Overall Study||5
10527130|NCT01387516|11679132|FG001|NOT COMPLETED|Overall Study||5
10527131|NCT01387516|11679133|FG002|NOT COMPLETED|Overall Study||4
10527132|NCT01387516|11679134|FG003|NOT COMPLETED|Overall Study||4
10527133|NCT01387542|11679144|FG000|STARTED|Overall Study||40
10527134|NCT01387542|11679144|FG000|Treated|Overall Study||38
10527135|NCT01387542|11679144|FG000|COMPLETED|Overall Study||32
10527136|NCT01387542|11679144|FG000|NOT COMPLETED|Overall Study||8
10527137|NCT01387581|11679151|FG000|STARTED|Overall Study||108
10527138|NCT01387581|11679152|FG001|STARTED|Overall Study||107
10527139|NCT01387581|11679153|FG002|STARTED|Overall Study||12
10527140|NCT01387581|11679151|FG000|COMPLETED|Overall Study||101
10527141|NCT01387581|11679152|FG001|COMPLETED|Overall Study||101
10527142|NCT01387581|11679153|FG002|COMPLETED|Overall Study||9
10527143|NCT01387581|11679151|FG000|NOT COMPLETED|Overall Study||7
10527144|NCT01387581|11679152|FG001|NOT COMPLETED|Overall Study||6
10527145|NCT01387581|11679153|FG002|NOT COMPLETED|Overall Study||3
10527146|NCT01387594|11679163|FG000|STARTED|Overall Study||10
10527147|NCT01387594|11679164|FG001|STARTED|Overall Study||39
10527148|NCT01387594|11679163|FG000|COMPLETED|Overall Study||10
10527149|NCT01387594|11679164|FG001|COMPLETED|Overall Study||36
10527150|NCT01387594|11679163|FG000|NOT COMPLETED|Overall Study||0
10527151|NCT01387594|11679164|FG001|NOT COMPLETED|Overall Study||3
10527152|NCT01387607|11679175|FG000|STARTED|Overall Study||173
10527153|NCT01387607|11679176|FG001|STARTED|Overall Study||170
10527154|NCT01387607|11679175|FG000|Received Treatment|Overall Study||170
10527155|NCT01387607|11679176|FG001|Received Treatment|Overall Study||164
10527156|NCT01387607|11679175|FG000|COMPLETED|Overall Study||122
10527157|NCT01387607|11679176|FG001|COMPLETED|Overall Study||125
10527158|NCT01387607|11679175|FG000|NOT COMPLETED|Overall Study||51
10527159|NCT01387607|11679176|FG001|NOT COMPLETED|Overall Study||45
10527160|NCT01387672|11679188|FG000|STARTED|Overall Study||39
10527161|NCT01387672|11679189|FG001|STARTED|Overall Study||38
10527162|NCT01387672|11679190|FG002|STARTED|Overall Study||38
10527163|NCT01387672|11679191|FG003|STARTED|Overall Study||39
10527164|NCT01387672|11679192|FG004|STARTED|Overall Study||38
10527165|NCT01387672|11679193|FG005|STARTED|Overall Study||37
10527166|NCT01387672|11679188|FG000|COMPLETED|Overall Study||32
10527167|NCT01387672|11679189|FG001|COMPLETED|Overall Study||31
10527168|NCT01387672|11679190|FG002|COMPLETED|Overall Study||33
10527169|NCT01387672|11679191|FG003|COMPLETED|Overall Study||35
10527170|NCT01387672|11679192|FG004|COMPLETED|Overall Study||34
10527171|NCT01387672|11679193|FG005|COMPLETED|Overall Study||37
10527172|NCT01387672|11679188|FG000|NOT COMPLETED|Overall Study||7
10527173|NCT01387672|11679189|FG001|NOT COMPLETED|Overall Study||7
10527174|NCT01387672|11679190|FG002|NOT COMPLETED|Overall Study||5
10527175|NCT01387672|11679191|FG003|NOT COMPLETED|Overall Study||4
10527176|NCT01387672|11679192|FG004|NOT COMPLETED|Overall Study||4
10527177|NCT01387672|11679193|FG005|NOT COMPLETED|Overall Study||0
10527178|NCT01387737|11679210|FG000|STARTED|Overall Study||584
10527179|NCT01387737|11679211|FG001|STARTED|Overall Study||715
10527180|NCT01387737|11679210|FG000|COMPLETED|Overall Study||532
10527181|NCT01387737|11679211|FG001|COMPLETED|Overall Study||641
10527182|NCT01387737|11679210|FG000|NOT COMPLETED|Overall Study||52
10527183|NCT01387737|11679211|FG001|NOT COMPLETED|Overall Study||74
10527184|NCT01387789|11679217|FG000|STARTED|Overall Study||71
10527185|NCT01387789|11679217|FG000|COMPLETED|Overall Study||63
10527186|NCT01387789|11679217|FG000|NOT COMPLETED|Overall Study||8
10527187|NCT01387815|11679223|FG000|STARTED|Overall Study||302
10527188|NCT01387815|11679224|FG001|STARTED|Overall Study||293
10527189|NCT01387815|11679223|FG000|COMPLETED|Overall Study||162
10527190|NCT01387815|11679224|FG001|COMPLETED|Overall Study||189
10527191|NCT01387815|11679223|FG000|NOT COMPLETED|Overall Study||140
10527192|NCT01387815|11679224|FG001|NOT COMPLETED|Overall Study||104
10527193|NCT01387932|11679232|FG000|STARTED|Randomized and Treated||118
10527194|NCT01387932|11679233|FG001|STARTED|Randomized and Treated||117
10527195|NCT01387932|11679232|FG000|COMPLETED|Randomized and Treated||111
10527196|NCT01387932|11679233|FG001|COMPLETED|Randomized and Treated||113
10527197|NCT01387932|11679232|FG000|NOT COMPLETED|Randomized and Treated||7
10527198|NCT01387932|11679233|FG001|NOT COMPLETED|Randomized and Treated||4
10527199|NCT01387932|11679232|FG000|STARTED|Completion of TACE Cycle||111
10527200|NCT01387932|11679233|FG001|STARTED|Completion of TACE Cycle||113
10527201|NCT01387932|11679232|FG000|COMPLETED|Completion of TACE Cycle||111
10527202|NCT01387932|11679233|FG001|COMPLETED|Completion of TACE Cycle||113
10527203|NCT01387932|11679232|FG000|NOT COMPLETED|Completion of TACE Cycle||0
10527204|NCT01387932|11679233|FG001|NOT COMPLETED|Completion of TACE Cycle||0
10527205|NCT01387932|11679232|FG000|STARTED|Survival Follow-up||111
10479118|NCT02951481|11628238|FG000|STARTED|Overall Study||231
10479119|NCT02951481|11628239|FG001|STARTED|Overall Study||172
10479120|NCT02951481|11628238|FG000|COMPLETED|Overall Study||231
10479121|NCT02951481|11628239|FG001|COMPLETED|Overall Study||172
10479122|NCT02951481|11628238|FG000|NOT COMPLETED|Overall Study||0
10479123|NCT02951481|11628239|FG001|NOT COMPLETED|Overall Study||0
10479124|NCT02451943|11628247|FG000|STARTED|Overall Study||258
10479125|NCT02451943|11628248|FG001|STARTED|Overall Study||251
10479126|NCT02451943|11628247|FG000|Received at Least One Dose of Study Drug|Overall Study||257
10479127|NCT02451943|11628248|FG001|Received at Least One Dose of Study Drug|Overall Study||249
10479128|NCT02451943|11628247|FG000|Leiomyosarcoma (LMS) Population|Overall Study||119
10479129|NCT02451943|11628248|FG001|Leiomyosarcoma (LMS) Population|Overall Study||115
10479130|NCT02451943|11628247|FG000|COMPLETED|Overall Study||238
10479131|NCT02451943|11628248|FG001|COMPLETED|Overall Study||227
10479132|NCT02451943|11628247|FG000|NOT COMPLETED|Overall Study||20
10709375|NCT02639286|11874336|FG001|STARTED|Overall Study||2
10709376|NCT02639286|11874335|FG000|COMPLETED|Overall Study||3
10709377|NCT02639286|11874336|FG001|COMPLETED|Overall Study||2
10709378|NCT02639286|11874335|FG000|NOT COMPLETED|Overall Study||0
10709379|NCT02639286|11874336|FG001|NOT COMPLETED|Overall Study||0
10709380|NCT02639338|11874344|FG000|STARTED|Overall Study||110
10709381|NCT02639338|11874345|FG001|STARTED|Overall Study||110
10709382|NCT02639338|11874344|FG000|COMPLETED|Overall Study||106
10709383|NCT02639338|11874345|FG001|COMPLETED|Overall Study||105
10479133|NCT02451943|11628248|FG001|NOT COMPLETED|Overall Study||24
10479134|NCT02198794|11628254|FG000|STARTED|Part A: Open-Label (158 Weeks)||337
10479135|NCT02198794|11628255|FG001|STARTED|Part A: Open-Label (158 Weeks)||0
10709384|NCT02639338|11874344|FG000|NOT COMPLETED|Overall Study||4
10709385|NCT02639338|11874345|FG001|NOT COMPLETED|Overall Study||5
10709386|NCT02639351|11874356|FG000|STARTED|Overall Study||16
10709387|NCT02639351|11874357|FG001|STARTED|Overall Study||16
10709388|NCT02639351|11874358|FG002|STARTED|Overall Study||16
10709389|NCT02639351|11874359|FG003|STARTED|Overall Study||16
10709390|NCT02639351|11874360|FG004|STARTED|Overall Study||16
10709391|NCT02639351|11874356|FG000|COMPLETED|Overall Study||16
10709392|NCT02639351|11874357|FG001|COMPLETED|Overall Study||16
10479136|NCT02198794|11628256|FG002|STARTED|Part A: Open-Label (158 Weeks)||0
10479137|NCT02198794|11628257|FG003|STARTED|Part A: Open-Label (158 Weeks)||0
10479138|NCT02198794|11628254|FG000|Received at Least 1 Dose of Study Drug|Part A: Open-Label (158 Weeks)||337
10479139|NCT02198794|11628255|FG001|Received at Least 1 Dose of Study Drug|Part A: Open-Label (158 Weeks)||0
10479140|NCT02198794|11628256|FG002|Received at Least 1 Dose of Study Drug|Part A: Open-Label (158 Weeks)||0
10479141|NCT02198794|11628257|FG003|Received at Least 1 Dose of Study Drug|Part A: Open-Label (158 Weeks)||0
10479142|NCT02198794|11628254|FG000|Intent-to-Treat (ITT) Population|Part A: Open-Label (158 Weeks)||337
10479143|NCT02198794|11628255|FG001|Intent-to-Treat (ITT) Population|Part A: Open-Label (158 Weeks)||0
10479144|NCT02198794|11628256|FG002|Intent-to-Treat (ITT) Population|Part A: Open-Label (158 Weeks)||0
10479145|NCT02198794|11628257|FG003|Intent-to-Treat (ITT) Population|Part A: Open-Label (158 Weeks)||0
10479146|NCT02198794|11628254|FG000|Participants Who Participated in Part A But Not in Part B|Part A: Open-Label (158 Weeks)||195
10479147|NCT02198794|11628255|FG001|Participants Who Participated in Part A But Not in Part B|Part A: Open-Label (158 Weeks)||0
10479148|NCT02198794|11628256|FG002|Participants Who Participated in Part A But Not in Part B|Part A: Open-Label (158 Weeks)||0
10479149|NCT02198794|11628257|FG003|Participants Who Participated in Part A But Not in Part B|Part A: Open-Label (158 Weeks)||0
10479150|NCT02198794|11628254|FG000|Participants Who Agreed to Continue in Part B|Part A: Open-Label (158 Weeks)||142
10479151|NCT02198794|11628255|FG001|Participants Who Agreed to Continue in Part B|Part A: Open-Label (158 Weeks)||0
10479152|NCT02198794|11628256|FG002|Participants Who Agreed to Continue in Part B|Part A: Open-Label (158 Weeks)||0
10479153|NCT02198794|11628257|FG003|Participants Who Agreed to Continue in Part B|Part A: Open-Label (158 Weeks)||0
10479154|NCT02198794|11628254|FG000|COMPLETED|Part A: Open-Label (158 Weeks)||32
10479155|NCT02198794|11628255|FG001|COMPLETED|Part A: Open-Label (158 Weeks)||0
10479156|NCT02198794|11628256|FG002|COMPLETED|Part A: Open-Label (158 Weeks)||0
10479157|NCT02198794|11628257|FG003|COMPLETED|Part A: Open-Label (158 Weeks)||0
10479158|NCT02198794|11628254|FG000|NOT COMPLETED|Part A: Open-Label (158 Weeks)||305
10479159|NCT02198794|11628255|FG001|NOT COMPLETED|Part A: Open-Label (158 Weeks)||0
10479160|NCT02198794|11628256|FG002|NOT COMPLETED|Part A: Open-Label (158 Weeks)||0
10479161|NCT02198794|11628257|FG003|NOT COMPLETED|Part A: Open-Label (158 Weeks)||0
10479162|NCT02198794|11628254|FG000|STARTED|Part B: Randomized (13 Weeks)||0
10479163|NCT02198794|11628255|FG001|STARTED|Part B: Randomized (13 Weeks)|Participants of Part A who agreed to participate in Part B|71
10479164|NCT02198794|11628256|FG002|STARTED|Part B: Randomized (13 Weeks)|Participants of Part A who agreed to participate in Part B|71
10479165|NCT02198794|11628257|FG003|STARTED|Part B: Randomized (13 Weeks)||0
10479166|NCT02198794|11628254|FG000|Randomized Withdrawal mITT Population|Part B: Randomized (13 Weeks)||0
10479167|NCT02198794|11628255|FG001|Randomized Withdrawal mITT Population|Part B: Randomized (13 Weeks)||63
10479168|NCT02198794|11628256|FG002|Randomized Withdrawal mITT Population|Part B: Randomized (13 Weeks)||65
10479169|NCT02198794|11628257|FG003|Randomized Withdrawal mITT Population|Part B: Randomized (13 Weeks)||0
10479170|NCT02198794|11628254|FG000|COMPLETED|Part B: Randomized (13 Weeks)||0
10709393|NCT02639351|11874358|FG002|COMPLETED|Overall Study||16
10709394|NCT02639351|11874359|FG003|COMPLETED|Overall Study||16
10709395|NCT02639351|11874360|FG004|COMPLETED|Overall Study||16
10709396|NCT02639351|11874356|FG000|NOT COMPLETED|Overall Study||0
10709397|NCT02639351|11874357|FG001|NOT COMPLETED|Overall Study||0
10709398|NCT02639351|11874358|FG002|NOT COMPLETED|Overall Study||0
10709399|NCT02639351|11874359|FG003|NOT COMPLETED|Overall Study||0
10709400|NCT02639351|11874360|FG004|NOT COMPLETED|Overall Study||0
10709401|NCT02639429|11874376|FG000|STARTED|Overall Study||113
10709402|NCT02639429|11874377|FG001|STARTED|Overall Study||123
10709403|NCT02639429|11874376|FG000|COMPLETED|Overall Study||113
10709404|NCT02639429|11874377|FG001|COMPLETED|Overall Study||123
10709405|NCT02639429|11874376|FG000|NOT COMPLETED|Overall Study||0
10709406|NCT02639429|11874377|FG001|NOT COMPLETED|Overall Study||0
10709407|NCT02639494|11874383|FG000|STARTED|Overall Study||20
10709408|NCT02639494|11874383|FG000|COMPLETED|Overall Study||20
10709409|NCT02639494|11874383|FG000|NOT COMPLETED|Overall Study||0
10709410|NCT02639637|11874390|FG000|STARTED|Overall Study||7
10709411|NCT02639637|11874391|FG001|STARTED|Overall Study||6
10709412|NCT02639637|11874392|FG002|STARTED|Overall Study||2
10709413|NCT02639637|11874393|FG003|STARTED|Overall Study||3
10709414|NCT02639637|11874390|FG000|COMPLETED|Overall Study||7
10709415|NCT02639637|11874391|FG001|COMPLETED|Overall Study||6
10709416|NCT02639637|11874392|FG002|COMPLETED|Overall Study||2
10709417|NCT02639637|11874393|FG003|COMPLETED|Overall Study||3
10709418|NCT02639637|11874390|FG000|NOT COMPLETED|Overall Study||0
10709419|NCT02639637|11874391|FG001|NOT COMPLETED|Overall Study||0
10709420|NCT02639637|11874392|FG002|NOT COMPLETED|Overall Study||0
10709421|NCT02639637|11874393|FG003|NOT COMPLETED|Overall Study||0
10709422|NCT02639884|11874409|FG000|STARTED|Overall Study||51
10709423|NCT02639884|11874409|FG000|COMPLETED|Overall Study||47
10709424|NCT02639884|11874409|FG000|NOT COMPLETED|Overall Study||4
10709425|NCT02640053|11874416|FG000|STARTED|Overall Study||21
10479171|NCT02198794|11628255|FG001|COMPLETED|Part B: Randomized (13 Weeks)||66
10479172|NCT02198794|11628256|FG002|COMPLETED|Part B: Randomized (13 Weeks)||68
10479173|NCT02198794|11628257|FG003|COMPLETED|Part B: Randomized (13 Weeks)||0
10479174|NCT02198794|11628254|FG000|NOT COMPLETED|Part B: Randomized (13 Weeks)||0
10479175|NCT02198794|11628255|FG001|NOT COMPLETED|Part B: Randomized (13 Weeks)||5
10479176|NCT02198794|11628256|FG002|NOT COMPLETED|Part B: Randomized (13 Weeks)||3
10479177|NCT02198794|11628257|FG003|NOT COMPLETED|Part B: Randomized (13 Weeks)||0
10479178|NCT02198794|11628254|FG000|STARTED|Part C: Safety Assessment (52 Weeks)||0
10479179|NCT02198794|11628255|FG001|STARTED|Part C: Safety Assessment (52 Weeks)||0
10479180|NCT02198794|11628256|FG002|STARTED|Part C: Safety Assessment (52 Weeks)||0
10479181|NCT02198794|11628257|FG003|STARTED|Part C: Safety Assessment (52 Weeks)||80
10479182|NCT02198794|11628254|FG000|COMPLETED|Part C: Safety Assessment (52 Weeks)||0
10479183|NCT02198794|11628255|FG001|COMPLETED|Part C: Safety Assessment (52 Weeks)||0
10479184|NCT02198794|11628256|FG002|COMPLETED|Part C: Safety Assessment (52 Weeks)||0
10479185|NCT02198794|11628257|FG003|COMPLETED|Part C: Safety Assessment (52 Weeks)||73
10479186|NCT02198794|11628254|FG000|NOT COMPLETED|Part C: Safety Assessment (52 Weeks)||0
10479187|NCT02198794|11628255|FG001|NOT COMPLETED|Part C: Safety Assessment (52 Weeks)||0
10479188|NCT02198794|11628256|FG002|NOT COMPLETED|Part C: Safety Assessment (52 Weeks)||0
10479189|NCT02198794|11628257|FG003|NOT COMPLETED|Part C: Safety Assessment (52 Weeks)||7
10479190|NCT01877655|11628268|FG000|STARTED|Overall Study||263
10479191|NCT01877655|11628269|FG001|STARTED|Overall Study||251
10479192|NCT01877655|11628268|FG000|Received Treatment|Overall Study||255
10479193|NCT01877655|11628269|FG001|Received Treatment|Overall Study||246
10479194|NCT01877655|11628268|FG000|COMPLETED|Overall Study||165
10479195|NCT01877655|11628269|FG001|COMPLETED|Overall Study||154
10479196|NCT01877655|11628268|FG000|NOT COMPLETED|Overall Study||98
10479197|NCT01877655|11628269|FG001|NOT COMPLETED|Overall Study||97
10479198|NCT00308685|11628277|FG000|STARTED|Overall Study||50
10709426|NCT02640053|11874417|FG001|STARTED|Overall Study||21
10709427|NCT02640053|11874416|FG000|COMPLETED|Overall Study||17
10709428|NCT02640053|11874417|FG001|COMPLETED|Overall Study||17
10709429|NCT02640053|11874416|FG000|NOT COMPLETED|Overall Study||4
10709430|NCT02640053|11874417|FG001|NOT COMPLETED|Overall Study||4
10709431|NCT02640157|11874426|FG000|STARTED|Overall Study|Intent-to-treat population: all participants who received at least 1 dose of study drug|233
10709432|NCT02640157|11874427|FG001|STARTED|Overall Study||116
10709433|NCT02640157|11874428|FG002|STARTED|Overall Study|Intent-to-treat population: all participants who received at least 1 dose of study drug|157
10709434|NCT02640157|11874426|FG000|Received Study Drug|Overall Study||233
10479199|NCT00308685|11628278|FG001|STARTED|Overall Study||45
10479200|NCT00308685|11628277|FG000|Received at Least 1 Dose of Study Drug|Overall Study||50
10479201|NCT00308685|11628278|FG001|Received at Least 1 Dose of Study Drug|Overall Study||45
10479202|NCT00308685|11628277|FG000|COMPLETED|Overall Study||47
10709435|NCT02640157|11874427|FG001|Received Study Drug|Overall Study|One participant in Arm B was randomized in error and never dispensed study drug.|115
10709436|NCT02640157|11874428|FG002|Received Study Drug|Overall Study||157
10709437|NCT02640157|11874426|FG000|Completed Study Drug|Overall Study||225
10709438|NCT02640157|11874427|FG001|Completed Study Drug|Overall Study||112
10709439|NCT02640157|11874428|FG002|Completed Study Drug|Overall Study||154
10709440|NCT02640157|11874426|FG000|Discontinued Study Drug|Overall Study||8
10709441|NCT02640157|11874427|FG001|Discontinued Study Drug|Overall Study||3
10709442|NCT02640157|11874428|FG002|Discontinued Study Drug|Overall Study||3
10709443|NCT02640157|11874426|FG000|COMPLETED|Overall Study||220
10479203|NCT00308685|11628278|FG001|COMPLETED|Overall Study||40
10479204|NCT00308685|11628277|FG000|NOT COMPLETED|Overall Study||3
10479205|NCT00308685|11628278|FG001|NOT COMPLETED|Overall Study||5
10479206|NCT01125514|11628284|FG000|STARTED|Treatment Period 1 (Day 1 - Day 7)|Randomized and safety population|37
10479207|NCT01125514|11628284|FG000|COMPLETED|Treatment Period 1 (Day 1 - Day 7)||35
10479208|NCT01125514|11628284|FG000|NOT COMPLETED|Treatment Period 1 (Day 1 - Day 7)||2
10479209|NCT01125514|11628284|FG000|STARTED|Treatment Period 2 (Day 8 - Day 17)||35
10479210|NCT01125514|11628284|FG000|Pharmacokinetic (PK) Analysis Set|Treatment Period 2 (Day 8 - Day 17)||33
10479211|NCT01125514|11628284|FG000|Pharmacodynamics (PD) Analysis Set|Treatment Period 2 (Day 8 - Day 17)||33
10479212|NCT01125514|11628284|FG000|COMPLETED|Treatment Period 2 (Day 8 - Day 17)||32
10479213|NCT01125514|11628284|FG000|NOT COMPLETED|Treatment Period 2 (Day 8 - Day 17)||3
10479214|NCT01125514|11628284|FG000|STARTED|Treatment Period2(Day9-Day27) and Day 28||32
10479215|NCT01125514|11628284|FG000|COMPLETED|Treatment Period2(Day9-Day27) and Day 28||28
10479216|NCT01125514|11628284|FG000|NOT COMPLETED|Treatment Period2(Day9-Day27) and Day 28||4
10479217|NCT01125566|11628300|FG000|STARTED|Patients Before the Switch (26Apr2013)||339
10479218|NCT01125566|11628301|FG001|STARTED|Patients Before the Switch (26Apr2013)||169
10479219|NCT01125566|11628302|FG002|STARTED|Patients Before the Switch (26Apr2013)||0
10479220|NCT01125566|11628300|FG000|Treated|Patients Before the Switch (26Apr2013)||337
10479221|NCT01125566|11628301|FG001|Treated|Patients Before the Switch (26Apr2013)||169
10479222|NCT01125566|11628302|FG002|Treated|Patients Before the Switch (26Apr2013)||0
10479223|NCT01125566|11628300|FG000|COMPLETED|Patients Before the Switch (26Apr2013)||74
10479224|NCT01125566|11628301|FG001|COMPLETED|Patients Before the Switch (26Apr2013)||0
10479225|NCT01125566|11628302|FG002|COMPLETED|Patients Before the Switch (26Apr2013)||0
10479226|NCT01125566|11628300|FG000|NOT COMPLETED|Patients Before the Switch (26Apr2013)||265
10479227|NCT01125566|11628301|FG001|NOT COMPLETED|Patients Before the Switch (26Apr2013)||169
10479228|NCT01125566|11628302|FG002|NOT COMPLETED|Patients Before the Switch (26Apr2013)||0
10479229|NCT01125566|11628300|FG000|STARTED|Patients Who Switched From AV to TV||0
10479230|NCT01125566|11628301|FG001|STARTED|Patients Who Switched From AV to TV||0
10479231|NCT01125566|11628302|FG002|STARTED|Patients Who Switched From AV to TV||75
10479232|NCT01125566|11628300|FG000|COMPLETED|Patients Who Switched From AV to TV||0
10479233|NCT01125566|11628301|FG001|COMPLETED|Patients Who Switched From AV to TV||0
10479234|NCT01125566|11628302|FG002|COMPLETED|Patients Who Switched From AV to TV||2
10479235|NCT01125566|11628300|FG000|NOT COMPLETED|Patients Who Switched From AV to TV||0
10479236|NCT01125566|11628301|FG001|NOT COMPLETED|Patients Who Switched From AV to TV||0
10479237|NCT01125566|11628302|FG002|NOT COMPLETED|Patients Who Switched From AV to TV||73
10479238|NCT01125605|11628309|FG000|STARTED|Overall Study|started = had baseline values|325
10479239|NCT01125605|11628309|FG000|Safety|Overall Study|1 patient was only analysed for safety|326
10479240|NCT01125605|11628309|FG000|COMPLETED|Overall Study||325
10479241|NCT01125605|11628309|FG000|NOT COMPLETED|Overall Study||0
10479242|NCT01125722|11628328|FG000|STARTED|Overall Study||37
10479243|NCT01125722|11628329|FG001|STARTED|Overall Study||37
10479244|NCT01125722|11628328|FG000|COMPLETED|Overall Study||34
10479245|NCT01125722|11628329|FG001|COMPLETED|Overall Study||36
10479246|NCT01125722|11628328|FG000|NOT COMPLETED|Overall Study||3
10479247|NCT01125722|11628329|FG001|NOT COMPLETED|Overall Study||1
10479248|NCT01125748|11628337|FG000|STARTED|Overall Study||88
10479249|NCT01125748|11628338|FG001|STARTED|Overall Study||88
10479250|NCT01125748|11628337|FG000|COMPLETED|Overall Study||78
10479251|NCT01125748|11628338|FG001|COMPLETED|Overall Study||74
10479252|NCT01125748|11628337|FG000|NOT COMPLETED|Overall Study||10
10479253|NCT01125748|11628338|FG001|NOT COMPLETED|Overall Study||14
10479254|NCT01125774|11628346|FG000|STARTED|Overall Study|Randomized|3018
10479255|NCT01125774|11628347|FG001|STARTED|Overall Study|Randomized|1502
10479256|NCT01125774|11628348|FG002|STARTED|Overall Study|Unique participants randomized|22
10479257|NCT01125774|11628349|FG003|STARTED|Overall Study|Unique participants randomized|6
10479258|NCT01125774|11628346|FG000|Treated|Overall Study||2638
10479259|NCT01125774|11628347|FG001|Treated|Overall Study|1 mistakenly took telcagepant and is included with telcagepant group for adverse event analysis|1322
10479260|NCT01125774|11628348|FG002|Treated|Overall Study|Received telcagepant|21
10479261|NCT01125774|11628349|FG003|Treated|Overall Study||5
10479262|NCT01125774|11628346|FG000|COMPLETED|Overall Study||1893
10479263|NCT01125774|11628347|FG001|COMPLETED|Overall Study||948
10479264|NCT01125774|11628348|FG002|COMPLETED|Overall Study|"Completed study at least once while treated with telcagepant (otherwise counted Not Completed)"|13
10479265|NCT01125774|11628349|FG003|COMPLETED|Overall Study|Completed study at least once|3
10479266|NCT01125774|11628346|FG000|NOT COMPLETED|Overall Study||1125
10479267|NCT01125774|11628347|FG001|NOT COMPLETED|Overall Study||554
10479268|NCT01125774|11628348|FG002|NOT COMPLETED|Overall Study||9
10479269|NCT01125774|11628349|FG003|NOT COMPLETED|Overall Study||3
10479270|NCT01125800|11628360|FG000|STARTED|Phase I||11
10479271|NCT01125800|11628361|FG001|STARTED|Phase I||16
10479272|NCT01125800|11628362|FG002|STARTED|Phase I||11
10479273|NCT01125800|11628363|FG003|STARTED|Phase I||21
10479274|NCT01125800|11628364|FG004|STARTED|Phase I|None of participants were enrolled to this treatment in this period.|0
10479275|NCT01125800|11628360|FG000|COMPLETED|Phase I||3
10479276|NCT01125800|11628361|FG001|COMPLETED|Phase I||7
10479277|NCT01125800|11628362|FG002|COMPLETED|Phase I||7
10479278|NCT01125800|11628363|FG003|COMPLETED|Phase I||10
10479279|NCT01125800|11628364|FG004|COMPLETED|Phase I||0
10479280|NCT01125800|11628360|FG000|NOT COMPLETED|Phase I||8
10479281|NCT01125800|11628361|FG001|NOT COMPLETED|Phase I||9
10479282|NCT01125800|11628362|FG002|NOT COMPLETED|Phase I||4
10479283|NCT01125800|11628363|FG003|NOT COMPLETED|Phase I||11
10479284|NCT01125800|11628364|FG004|NOT COMPLETED|Phase I||0
10479285|NCT01125800|11628360|FG000|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
10479286|NCT01125800|11628361|FG001|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
10479287|NCT01125800|11628362|FG002|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
10479288|NCT01125800|11628363|FG003|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|1
10479289|NCT01125800|11628364|FG004|STARTED|Phase II|Additional participants were enrolled to this treatment in this period.|16
10479290|NCT01125800|11628360|FG000|COMPLETED|Phase II||0
10479291|NCT01125800|11628361|FG001|COMPLETED|Phase II||0
10479292|NCT01125800|11628362|FG002|COMPLETED|Phase II||0
10479293|NCT01125800|11628363|FG003|COMPLETED|Phase II||0
10479294|NCT01125800|11628364|FG004|COMPLETED|Phase II||5
10479295|NCT01125800|11628360|FG000|NOT COMPLETED|Phase II||0
10479296|NCT01125800|11628361|FG001|NOT COMPLETED|Phase II||0
10479297|NCT01125800|11628362|FG002|NOT COMPLETED|Phase II||0
10479298|NCT01125800|11628363|FG003|NOT COMPLETED|Phase II||1
10479299|NCT01125800|11628364|FG004|NOT COMPLETED|Phase II||11
10479300|NCT01125813|11628379|FG000|STARTED|Overall Study||36
10479301|NCT01125813|11628379|FG000|COMPLETED|Overall Study||30
10479302|NCT01125813|11628379|FG000|NOT COMPLETED|Overall Study||6
10479303|NCT01125917|11628383|FG000|STARTED|Overall Study||354
10479304|NCT01125917|11628383|FG000|COMPLETED|Overall Study||15
10479305|NCT01125917|11628383|FG000|NOT COMPLETED|Overall Study||339
10479306|NCT01125930|11628389|FG000|STARTED|Overall Study||22
10479307|NCT01125930|11628390|FG001|STARTED|Overall Study||46
10479308|NCT01125930|11628389|FG000|COMPLETED|Overall Study||21
10479309|NCT01125930|11628390|FG001|COMPLETED|Overall Study||36
10479310|NCT01125930|11628389|FG000|NOT COMPLETED|Overall Study||1
10479311|NCT01125930|11628390|FG001|NOT COMPLETED|Overall Study||10
10479312|NCT01126060|11628414|FG000|STARTED|Overall Study||40
10479313|NCT01126060|11628415|FG001|STARTED|Overall Study||40
10479314|NCT01126060|11628414|FG000|COMPLETED|Overall Study||40
10479315|NCT01126060|11628415|FG001|COMPLETED|Overall Study||38
10479316|NCT01126060|11628414|FG000|NOT COMPLETED|Overall Study||0
10479317|NCT01126060|11628415|FG001|NOT COMPLETED|Overall Study||2
10479318|NCT01126099|11628423|FG000|STARTED|Double Blind Phase||11
10479319|NCT01126099|11628424|FG001|STARTED|Double Blind Phase||9
10479320|NCT01126099|11628423|FG000|COMPLETED|Double Blind Phase||7
10709444|NCT02640157|11874427|FG001|COMPLETED|Overall Study||111
10709445|NCT02640157|11874428|FG002|COMPLETED|Overall Study||147
10709446|NCT02640157|11874426|FG000|NOT COMPLETED|Overall Study||13
10709447|NCT02640157|11874427|FG001|NOT COMPLETED|Overall Study||5
10709448|NCT02640157|11874428|FG002|NOT COMPLETED|Overall Study||10
10709449|NCT02640235|11874439|FG000|STARTED|Overall Study||131
10709450|NCT02640235|11874440|FG001|STARTED|Overall Study||129
10709451|NCT02640235|11874439|FG000|COMPLETED|Overall Study||117
10709452|NCT02640235|11874440|FG001|COMPLETED|Overall Study||115
10709453|NCT02640235|11874439|FG000|NOT COMPLETED|Overall Study||14
10709454|NCT02640235|11874440|FG001|NOT COMPLETED|Overall Study||14
10709455|NCT02640404|11874448|FG000|STARTED|Overall Study||112
10709456|NCT02640404|11874449|FG001|STARTED|Overall Study||112
10709457|NCT02640404|11874448|FG000|COMPLETED|Overall Study||110
10479321|NCT01126099|11628424|FG001|COMPLETED|Double Blind Phase||7
10479322|NCT01126099|11628423|FG000|NOT COMPLETED|Double Blind Phase||4
10479323|NCT01126099|11628424|FG001|NOT COMPLETED|Double Blind Phase||2
10479324|NCT01126099|11628423|FG000|STARTED|Open-label Extension|2 in the Prazosin arm of the Double Blind Phase elected not to enter the Open-Label extension|5
10479325|NCT01126099|11628424|FG001|STARTED|Open-label Extension||7
10479326|NCT01126099|11628423|FG000|COMPLETED|Open-label Extension||4
10479327|NCT01126099|11628424|FG001|COMPLETED|Open-label Extension||6
10479328|NCT01126099|11628423|FG000|NOT COMPLETED|Open-label Extension||1
10479329|NCT01126099|11628424|FG001|NOT COMPLETED|Open-label Extension||1
10479330|NCT01126268|11628430|FG000|STARTED|Overall Study||38
10479331|NCT01126268|11628430|FG000|COMPLETED|Overall Study||37
10479332|NCT01126268|11628430|FG000|NOT COMPLETED|Overall Study||1
10479333|NCT01126359|11628434|FG000|STARTED|First Intervention (20-minutes)||5
10479334|NCT01126359|11628435|FG001|STARTED|First Intervention (20-minutes)||6
10479335|NCT01126359|11628434|FG000|COMPLETED|First Intervention (20-minutes)||5
10479336|NCT01126359|11628435|FG001|COMPLETED|First Intervention (20-minutes)||5
10479337|NCT01126359|11628434|FG000|NOT COMPLETED|First Intervention (20-minutes)||0
10479338|NCT01126359|11628435|FG001|NOT COMPLETED|First Intervention (20-minutes)||1
10479339|NCT01126359|11628434|FG000|STARTED|Dressing Replacement/Healing (48-hours)||5
10479340|NCT01126359|11628435|FG001|STARTED|Dressing Replacement/Healing (48-hours)||5
10479341|NCT01126359|11628434|FG000|COMPLETED|Dressing Replacement/Healing (48-hours)||5
10479342|NCT01126359|11628435|FG001|COMPLETED|Dressing Replacement/Healing (48-hours)||5
10479343|NCT01126359|11628434|FG000|NOT COMPLETED|Dressing Replacement/Healing (48-hours)||0
10709458|NCT02640404|11874449|FG001|COMPLETED|Overall Study||112
10709459|NCT02640404|11874448|FG000|NOT COMPLETED|Overall Study||2
10709460|NCT02640404|11874449|FG001|NOT COMPLETED|Overall Study||0
10709461|NCT02640482|11874457|FG000|STARTED|Overall Study||202
10479344|NCT01126359|11628435|FG001|NOT COMPLETED|Dressing Replacement/Healing (48-hours)||0
10479345|NCT01126359|11628434|FG000|STARTED|Second Intervention (20-minutes)||5
10479346|NCT01126359|11628435|FG001|STARTED|Second Intervention (20-minutes)||5
10709462|NCT02640482|11874458|FG001|STARTED|Overall Study||100
10709463|NCT02640482|11874457|FG000|COMPLETED|Overall Study||199
10709464|NCT02640482|11874458|FG001|COMPLETED|Overall Study||100
10709465|NCT02640482|11874457|FG000|NOT COMPLETED|Overall Study||3
10709466|NCT02640482|11874458|FG001|NOT COMPLETED|Overall Study||0
10709467|NCT02640547|11874464|FG000|STARTED|Overall Study||394
10479347|NCT01126359|11628434|FG000|COMPLETED|Second Intervention (20-minutes)||5
10479348|NCT01126359|11628435|FG001|COMPLETED|Second Intervention (20-minutes)||5
10479349|NCT01126359|11628434|FG000|NOT COMPLETED|Second Intervention (20-minutes)||0
10479350|NCT01126359|11628435|FG001|NOT COMPLETED|Second Intervention (20-minutes)||0
10479351|NCT01126424|11628451|FG000|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|3
10479352|NCT01126424|11628452|FG001|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
10479353|NCT01126424|11628453|FG002|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|5
10479354|NCT01126424|11628454|FG003|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|6
10479355|NCT01126424|11628455|FG004|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
10479356|NCT01126424|11628456|FG005|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
10479357|NCT01126424|11628451|FG000|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|3
10479358|NCT01126424|11628452|FG001|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
10479359|NCT01126424|11628453|FG002|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
10479360|NCT01126424|11628454|FG003|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
10479361|NCT01126424|11628455|FG004|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
10479362|NCT01126424|11628456|FG005|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
10479363|NCT01126424|11628451|FG000|COMPLETED|Overall Study||3
10479364|NCT01126424|11628452|FG001|COMPLETED|Overall Study||4
10479365|NCT01126424|11628453|FG002|COMPLETED|Overall Study||4
10479366|NCT01126424|11628454|FG003|COMPLETED|Overall Study||3
10479367|NCT01126424|11628455|FG004|COMPLETED|Overall Study||2
10479368|NCT01126424|11628456|FG005|COMPLETED|Overall Study||4
10479369|NCT01126424|11628451|FG000|NOT COMPLETED|Overall Study||0
10479370|NCT01126424|11628452|FG001|NOT COMPLETED|Overall Study||0
10479371|NCT01126424|11628453|FG002|NOT COMPLETED|Overall Study||1
10479372|NCT01126424|11628454|FG003|NOT COMPLETED|Overall Study||3
10479373|NCT01126424|11628455|FG004|NOT COMPLETED|Overall Study||2
10479374|NCT01126424|11628456|FG005|NOT COMPLETED|Overall Study||0
10479375|NCT01126437|11628467|FG000|STARTED|Overall Study||5741
10479376|NCT01126437|11628468|FG001|STARTED|Overall Study||5729
10479377|NCT01126437|11628469|FG002|STARTED|Overall Study||5713
10479378|NCT01126437|11628467|FG000|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4400
10479379|NCT01126437|11628468|FG001|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4399
10479380|NCT01126437|11628469|FG002|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4400
10479381|NCT01126437|11628467|FG000|NOT COMPLETED|Overall Study||1341
10479382|NCT01126437|11628468|FG001|NOT COMPLETED|Overall Study||1330
10479383|NCT01126437|11628469|FG002|NOT COMPLETED|Overall Study||1313
10479384|NCT01126541|11628480|FG000|STARTED|Overall Study||70
10479385|NCT01126541|11628481|FG001|STARTED|Overall Study||73
10479386|NCT01126541|11628482|FG002|STARTED|Overall Study||81
10479387|NCT01126541|11628480|FG000|COMPLETED|Overall Study||60
10479388|NCT01126541|11628481|FG001|COMPLETED|Overall Study||61
10479389|NCT01126541|11628482|FG002|COMPLETED|Overall Study||55
10479390|NCT01126541|11628480|FG000|NOT COMPLETED|Overall Study||10
10479391|NCT01126541|11628481|FG001|NOT COMPLETED|Overall Study||12
10479392|NCT01126541|11628482|FG002|NOT COMPLETED|Overall Study||26
10479393|NCT01126580|11628495|FG000|STARTED|Overall Study||269
10709468|NCT02640547|11874464|FG000|COMPLETED|Overall Study||383
10709469|NCT02640547|11874464|FG000|NOT COMPLETED|Overall Study||11
10479394|NCT01126580|11628496|FG001|STARTED|Overall Study||270
10479395|NCT01126580|11628497|FG002|STARTED|Overall Study||268
10479396|NCT01126580|11628495|FG000|Received at Least 1 Dose of Study Drug|Overall Study||269
10479397|NCT01126580|11628496|FG001|Received at Least 1 Dose of Study Drug|Overall Study||270
10479398|NCT01126580|11628497|FG002|Received at Least 1 Dose of Study Drug|Overall Study||268
10479399|NCT01126580|11628495|FG000|Completed 26 Weeks|Overall Study||233
10479400|NCT01126580|11628496|FG001|Completed 26 Weeks|Overall Study||242
10479401|NCT01126580|11628497|FG002|Completed 26 Weeks|Overall Study||226
10479402|NCT01126580|11628495|FG000|COMPLETED|Overall Study||220
10479403|NCT01126580|11628496|FG001|COMPLETED|Overall Study||218
10479404|NCT01126580|11628497|FG002|COMPLETED|Overall Study||213
10479405|NCT01126580|11628495|FG000|NOT COMPLETED|Overall Study||49
10479406|NCT01126580|11628496|FG001|NOT COMPLETED|Overall Study||52
10709470|NCT02640612|11874479|FG000|STARTED|Overall Study||225
10479407|NCT01126580|11628497|FG002|NOT COMPLETED|Overall Study||55
10479408|NCT01126593|11628509|FG000|STARTED|Overall Study||33
10479409|NCT01126593|11628510|FG001|STARTED|Overall Study||29
10479410|NCT01126593|11628511|FG002|STARTED|Overall Study||34
10479411|NCT01126593|11628509|FG000|COMPLETED|Overall Study||29
10479412|NCT01126593|11628510|FG001|COMPLETED|Overall Study||27
10479413|NCT01126593|11628511|FG002|COMPLETED|Overall Study||32
10479414|NCT01126593|11628509|FG000|NOT COMPLETED|Overall Study||4
10479415|NCT01126593|11628510|FG001|NOT COMPLETED|Overall Study||2
10479416|NCT01126593|11628511|FG002|NOT COMPLETED|Overall Study||2
10479417|NCT01126619|11628519|FG000|STARTED|Overall Study||103
10479418|NCT01126619|11628519|FG000|COMPLETED|Overall Study|The completed population was used for all effectiveness analyses.|86
10479419|NCT01126619|11628519|FG000|NOT COMPLETED|Overall Study||17
10479420|NCT01126671|11628527|FG000|STARTED|Overall Study||26
10479421|NCT01126671|11628528|FG001|STARTED|Overall Study||30
10479422|NCT01126671|11628527|FG000|COMPLETED|Overall Study||24
10479423|NCT01126671|11628528|FG001|COMPLETED|Overall Study||29
10479424|NCT01126671|11628527|FG000|NOT COMPLETED|Overall Study||2
10479425|NCT01126671|11628528|FG001|NOT COMPLETED|Overall Study||1
10479426|NCT01126723|11628538|FG000|STARTED|Overall Study||35
10479427|NCT01126723|11628539|FG001|STARTED|Overall Study||31
10479428|NCT01126723|11628538|FG000|COMPLETED|Overall Study||29
10479429|NCT01126723|11628539|FG001|COMPLETED|Overall Study||28
10479430|NCT01126723|11628538|FG000|NOT COMPLETED|Overall Study||6
10479431|NCT01126723|11628539|FG001|NOT COMPLETED|Overall Study||3
10479432|NCT01127061|11628547|FG000|STARTED|Overall Study||67
10479433|NCT01127061|11628548|FG001|STARTED|Overall Study||69
10479434|NCT01127061|11628547|FG000|COMPLETED|Overall Study||57
10479435|NCT01127061|11628548|FG001|COMPLETED|Overall Study||56
10479436|NCT01127061|11628547|FG000|NOT COMPLETED|Overall Study||10
10479437|NCT01127061|11628548|FG001|NOT COMPLETED|Overall Study||13
10479438|NCT01127087|11628556|FG000|STARTED|Overall Study||8
10479439|NCT01127087|11628557|FG001|STARTED|Overall Study||2
10479440|NCT01127087|11628556|FG000|COMPLETED|Overall Study||8
10479441|NCT01127087|11628557|FG001|COMPLETED|Overall Study||2
10479442|NCT01127087|11628556|FG000|NOT COMPLETED|Overall Study||0
10479443|NCT01127087|11628557|FG001|NOT COMPLETED|Overall Study||0
10479444|NCT01127139|11628565|FG000|STARTED|Overall Study||3828
10479445|NCT01127139|11628565|FG000|Number of Participants Analyzed|Overall Study||3828
10479446|NCT01127139|11628565|FG000|COMPLETED|Overall Study||3771
10479447|NCT01127139|11628565|FG000|NOT COMPLETED|Overall Study||57
10479448|NCT01127165|11628574|FG000|STARTED|Overall Study||65
10479449|NCT01127165|11628575|FG001|STARTED|Overall Study||60
10479450|NCT01127165|11628574|FG000|COMPLETED|Overall Study||49
10479451|NCT01127165|11628575|FG001|COMPLETED|Overall Study||41
10479452|NCT01127165|11628574|FG000|NOT COMPLETED|Overall Study||16
10479453|NCT01127165|11628575|FG001|NOT COMPLETED|Overall Study||19
10479454|NCT01127321|11628586|FG000|STARTED|Overall Study||3
10479455|NCT01127321|11628587|FG001|STARTED|Overall Study||1
10479456|NCT01127321|11628588|FG002|STARTED|Overall Study||1
10479457|NCT01127321|11628589|FG003|STARTED|Overall Study||7
10479458|NCT01127321|11628590|FG004|STARTED|Overall Study||5
10479459|NCT01127321|11628586|FG000|COMPLETED|Overall Study||3
10479460|NCT01127321|11628587|FG001|COMPLETED|Overall Study||1
10479461|NCT01127321|11628588|FG002|COMPLETED|Overall Study||1
10479462|NCT01127321|11628589|FG003|COMPLETED|Overall Study||7
10479463|NCT01127321|11628590|FG004|COMPLETED|Overall Study||5
10479464|NCT01127321|11628586|FG000|NOT COMPLETED|Overall Study||0
10479465|NCT01127321|11628587|FG001|NOT COMPLETED|Overall Study||0
10479466|NCT01127321|11628588|FG002|NOT COMPLETED|Overall Study||0
10479467|NCT01127321|11628589|FG003|NOT COMPLETED|Overall Study||0
10479468|NCT01127321|11628590|FG004|NOT COMPLETED|Overall Study||0
10479469|NCT01127373|11628602|FG000|STARTED|Overall Study||116
10479470|NCT01127373|11628602|FG000|COMPLETED|Overall Study||104
10479471|NCT01127373|11628602|FG000|NOT COMPLETED|Overall Study||12
10479472|NCT01127438|11628612|FG000|STARTED|Overall Study||25
10709471|NCT02640612|11874480|FG001|STARTED|Overall Study||103
10709472|NCT02640612|11874481|FG002|STARTED|Overall Study||102
10709473|NCT02640612|11874479|FG000|COMPLETED|Overall Study||203
10709474|NCT02640612|11874480|FG001|COMPLETED|Overall Study||89
10709475|NCT02640612|11874481|FG002|COMPLETED|Overall Study||96
10709476|NCT02640612|11874479|FG000|NOT COMPLETED|Overall Study||22
10709477|NCT02640612|11874480|FG001|NOT COMPLETED|Overall Study||14
10709478|NCT02640612|11874481|FG002|NOT COMPLETED|Overall Study||6
10709479|NCT02640716|11874491|FG000|STARTED|Overall Study||30
10479473|NCT01127438|11628613|FG001|STARTED|Overall Study||25
10479474|NCT01127438|11628614|FG002|STARTED|Overall Study||26
10479475|NCT01127438|11628615|FG003|STARTED|Overall Study||24
10479476|NCT01127438|11628616|FG004|STARTED|Overall Study||28
10479477|NCT01127438|11628617|FG005|STARTED|Overall Study||25
10479478|NCT01127438|11628612|FG000|COMPLETED|Overall Study||25
10479479|NCT01127438|11628613|FG001|COMPLETED|Overall Study||25
10527206|NCT01387932|11679233|FG001|STARTED|Survival Follow-up||113
10709480|NCT02640716|11874492|FG001|STARTED|Overall Study||30
10709481|NCT02640716|11874491|FG000|Training Completion|Overall Study||27
10709482|NCT02640716|11874492|FG001|Training Completion|Overall Study||27
10479480|NCT01127438|11628614|FG002|COMPLETED|Overall Study|(n=25) One subject randomized to the approved dose group received a lower dose in error.|26
10479481|NCT01127438|11628615|FG003|COMPLETED|Overall Study|(n=25) One subject randomized to the approved dose group received a lower dose in error.|24
10709483|NCT02640716|11874491|FG000|COMPLETED|Overall Study||23
10709484|NCT02640716|11874492|FG001|COMPLETED|Overall Study||21
10709485|NCT02640716|11874491|FG000|NOT COMPLETED|Overall Study||7
10479482|NCT01127438|11628616|FG004|COMPLETED|Overall Study||28
10479483|NCT01127438|11628617|FG005|COMPLETED|Overall Study||25
10479484|NCT01127438|11628612|FG000|NOT COMPLETED|Overall Study||0
10479485|NCT01127438|11628613|FG001|NOT COMPLETED|Overall Study||0
10479486|NCT01127438|11628614|FG002|NOT COMPLETED|Overall Study||0
10479487|NCT01127438|11628615|FG003|NOT COMPLETED|Overall Study||0
10479488|NCT01127438|11628616|FG004|NOT COMPLETED|Overall Study||0
10479489|NCT01127438|11628617|FG005|NOT COMPLETED|Overall Study||0
10479490|NCT01127581|11628629|FG000|STARTED|Overall Study||678
10479491|NCT01127581|11628630|FG001|STARTED|Overall Study||680
10479492|NCT01127581|11628629|FG000|COMPLETED|Overall Study||678
10479493|NCT01127581|11628630|FG001|COMPLETED|Overall Study||680
10479494|NCT01127581|11628629|FG000|NOT COMPLETED|Overall Study||0
10479495|NCT01127581|11628630|FG001|NOT COMPLETED|Overall Study||0
10479496|NCT01127607|11628638|FG000|STARTED|Phase I (Within Subjects)||14
10479497|NCT01127607|11628639|FG001|STARTED|Phase I (Within Subjects)||13
10479498|NCT01127607|11628638|FG000|COMPLETED|Phase I (Within Subjects)||14
10479499|NCT01127607|11628639|FG001|COMPLETED|Phase I (Within Subjects)||13
10479500|NCT01127607|11628638|FG000|NOT COMPLETED|Phase I (Within Subjects)||0
10479501|NCT01127607|11628639|FG001|NOT COMPLETED|Phase I (Within Subjects)||0
10479502|NCT01127607|11628638|FG000|STARTED|Phase II (Between Subjects)||14
10479503|NCT01127607|11628639|FG001|STARTED|Phase II (Between Subjects)||13
10479504|NCT01127607|11628638|FG000|COMPLETED|Phase II (Between Subjects)||13
10479505|NCT01127607|11628639|FG001|COMPLETED|Phase II (Between Subjects)||11
10479506|NCT01127607|11628638|FG000|NOT COMPLETED|Phase II (Between Subjects)||1
10479507|NCT01127607|11628639|FG001|NOT COMPLETED|Phase II (Between Subjects)||2
10479508|NCT01127633|11628664|FG000|STARTED|Overall Study||723
10479509|NCT01127633|11628665|FG001|STARTED|Overall Study||734
10479510|NCT01127633|11628664|FG000|Received at Least 1 Dose of Study Drug|Overall Study||723
10479511|NCT01127633|11628665|FG001|Received at Least 1 Dose of Study Drug|Overall Study||734
10479512|NCT01127633|11628664|FG000|COMPLETED|Overall Study||70
10479513|NCT01127633|11628665|FG001|COMPLETED|Overall Study||61
10479514|NCT01127633|11628664|FG000|NOT COMPLETED|Overall Study||653
10479515|NCT01127633|11628665|FG001|NOT COMPLETED|Overall Study||673
10527207|NCT01387932|11679232|FG000|COMPLETED|Survival Follow-up||27
10527208|NCT01387932|11679233|FG001|COMPLETED|Survival Follow-up||23
10527209|NCT01387932|11679232|FG000|NOT COMPLETED|Survival Follow-up||84
10527210|NCT01387932|11679233|FG001|NOT COMPLETED|Survival Follow-up||90
10527211|NCT01388166|11679241|FG000|STARTED|Overall Study||1253
10527212|NCT01388166|11679241|FG000|COMPLETED|Overall Study||1194
10527213|NCT01388166|11679241|FG000|NOT COMPLETED|Overall Study||59
10527214|NCT01388335|11679245|FG000|STARTED|Period 1||13
10527215|NCT01388335|11679245|FG000|Received at Least 1 Dose of Study Drug|Period 1||13
10527216|NCT01388335|11679245|FG000|COMPLETED|Period 1||12
10527217|NCT01388335|11679245|FG000|NOT COMPLETED|Period 1||1
10527218|NCT01388335|11679245|FG000|STARTED|Period 2||12
10527219|NCT01388335|11679245|FG000|Received at Least 1 Dose of Study Drug|Period 2||12
10527220|NCT01388335|11679245|FG000|COMPLETED|Period 2|Only 6 participants who completed Period 2 entered Safety Extension.|9
10527221|NCT01388335|11679245|FG000|NOT COMPLETED|Period 2||3
10527222|NCT01388335|11679245|FG000|STARTED|Safety Extension|Six completed Period 2 and 1 participant who discontinued Period 2 entered Safety Extension.|7
10527223|NCT01388335|11679245|FG000|COMPLETED|Safety Extension||0
10527224|NCT01388335|11679245|FG000|NOT COMPLETED|Safety Extension||7
10527225|NCT01388361|11679260|FG000|STARTED|Overall Study||236
10527226|NCT01388361|11679261|FG001|STARTED|Overall Study||88
10527227|NCT01388361|11679262|FG002|STARTED|Overall Study||89
10527228|NCT01388361|11679260|FG000|Exposed|Overall Study|Two subjects withdrew prior to exposure to IDeg during NN1250-3948|234
10527229|NCT01388361|11679261|FG001|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug.|87
10527230|NCT01388361|11679262|FG002|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug.|86
10527231|NCT01388361|11679260|FG000|COMPLETED|Overall Study||224
10527232|NCT01388361|11679261|FG001|COMPLETED|Overall Study||76
10527233|NCT01388361|11679262|FG002|COMPLETED|Overall Study||75
10527234|NCT01388361|11679260|FG000|NOT COMPLETED|Overall Study||12
10527235|NCT01388361|11679261|FG001|NOT COMPLETED|Overall Study||12
10527236|NCT01388361|11679262|FG002|NOT COMPLETED|Overall Study||14
10527237|NCT01388478|11679270|FG000|STARTED|Overall Study||20
10527238|NCT01388478|11679270|FG000|COMPLETED|Overall Study||15
10527239|NCT01388478|11679270|FG000|NOT COMPLETED|Overall Study||5
10527240|NCT01388530|11679274|FG000|STARTED|Overall Study||25
10527241|NCT01388530|11679274|FG000|COMPLETED|Overall Study||20
10527242|NCT01388530|11679274|FG000|NOT COMPLETED|Overall Study||5
10527243|NCT01388543|11679280|FG000|STARTED|Day 7, Primary End Point||15
10527244|NCT01388543|11679281|FG001|STARTED|Day 7, Primary End Point||16
10527245|NCT01388543|11679280|FG000|COMPLETED|Day 7, Primary End Point||15
10527246|NCT01388543|11679281|FG001|COMPLETED|Day 7, Primary End Point||16
10527247|NCT01388543|11679280|FG000|NOT COMPLETED|Day 7, Primary End Point||0
10527248|NCT01388543|11679281|FG001|NOT COMPLETED|Day 7, Primary End Point||0
10527249|NCT01388543|11679280|FG000|STARTED|Day 14||15
10479516|NCT01127646|11628673|FG000|STARTED|Overall Study||15
10479517|NCT01127646|11628674|FG001|STARTED|Overall Study||8
10479518|NCT01127646|11628673|FG000|COMPLETED|Overall Study||14
10709486|NCT02640716|11874492|FG001|NOT COMPLETED|Overall Study||9
10709487|NCT02640755|11874500|FG000|STARTED|Single Dose Period (Day 1 - 8)||3
10709488|NCT02640755|11874501|FG001|STARTED|Single Dose Period (Day 1 - 8)||1
10709489|NCT02640755|11874500|FG000|COMPLETED|Single Dose Period (Day 1 - 8)||3
10709490|NCT02640755|11874501|FG001|COMPLETED|Single Dose Period (Day 1 - 8)||1
10709491|NCT02640755|11874500|FG000|NOT COMPLETED|Single Dose Period (Day 1 - 8)||0
10709492|NCT02640755|11874501|FG001|NOT COMPLETED|Single Dose Period (Day 1 - 8)||0
10709493|NCT02640755|11874500|FG000|STARTED|Multiple Dose Period (Day 8 - EoS)||3
10479519|NCT01127646|11628674|FG001|COMPLETED|Overall Study||7
10479520|NCT01127646|11628673|FG000|NOT COMPLETED|Overall Study||1
10479521|NCT01127646|11628674|FG001|NOT COMPLETED|Overall Study||1
10479522|NCT01127659|11628688|FG000|STARTED|Overall Study||22
10479523|NCT01127659|11628689|FG001|STARTED|Overall Study||22
10479524|NCT01127659|11628690|FG002|STARTED|Overall Study||12
10709494|NCT02640755|11874501|FG001|STARTED|Multiple Dose Period (Day 8 - EoS)||1
10709495|NCT02640755|11874500|FG000|COMPLETED|Multiple Dose Period (Day 8 - EoS)||1
10709496|NCT02640755|11874501|FG001|COMPLETED|Multiple Dose Period (Day 8 - EoS)||0
10709497|NCT02640755|11874500|FG000|NOT COMPLETED|Multiple Dose Period (Day 8 - EoS)||2
10709498|NCT02640755|11874501|FG001|NOT COMPLETED|Multiple Dose Period (Day 8 - EoS)||1
10479525|NCT01127659|11628691|FG003|STARTED|Overall Study||10
10479526|NCT01127659|11628692|FG004|STARTED|Overall Study||50
10479527|NCT01127659|11628693|FG005|STARTED|Overall Study||21
10479528|NCT01127659|11628688|FG000|COMPLETED|Overall Study||20
10479529|NCT01127659|11628689|FG001|COMPLETED|Overall Study||14
10479530|NCT01127659|11628690|FG002|COMPLETED|Overall Study||10
10479531|NCT01127659|11628691|FG003|COMPLETED|Overall Study||6
10479532|NCT01127659|11628692|FG004|COMPLETED|Overall Study||50
10479533|NCT01127659|11628693|FG005|COMPLETED|Overall Study||21
10479534|NCT01127659|11628688|FG000|NOT COMPLETED|Overall Study||2
10479535|NCT01127659|11628689|FG001|NOT COMPLETED|Overall Study||8
10479536|NCT01127659|11628690|FG002|NOT COMPLETED|Overall Study||2
10479537|NCT01127659|11628691|FG003|NOT COMPLETED|Overall Study||4
10479538|NCT01127659|11628692|FG004|NOT COMPLETED|Overall Study||0
10479539|NCT01127659|11628693|FG005|NOT COMPLETED|Overall Study||0
10479540|NCT01127737|11628709|FG000|STARTED|Overall Study||37
10479541|NCT01127737|11628710|FG001|STARTED|Overall Study||38
10479542|NCT01127737|11628709|FG000|COMPLETED|Overall Study||37
10479543|NCT01127737|11628710|FG001|COMPLETED|Overall Study||38
10479544|NCT01127737|11628709|FG000|NOT COMPLETED|Overall Study||0
10479545|NCT01127737|11628710|FG001|NOT COMPLETED|Overall Study||0
10479546|NCT01127763|11628716|FG000|STARTED|Overall Study||25
10479547|NCT01127763|11628716|FG000|COMPLETED|Overall Study|Patients off study due to disease progression were considered to have completed the study.|20
10479548|NCT01127763|11628716|FG000|NOT COMPLETED|Overall Study||5
10479549|NCT01127893|11628724|FG000|STARTED|Overall Study||1
10479550|NCT01127893|11628724|FG000|COMPLETED|Overall Study||0
10479551|NCT01127893|11628724|FG000|NOT COMPLETED|Overall Study||1
10479552|NCT01128049|11628731|FG000|STARTED|Overall Study||5
10479553|NCT01128049|11628732|FG001|STARTED|Overall Study||5
10479554|NCT01128049|11628733|FG002|STARTED|Overall Study||5
10479555|NCT01128049|11628731|FG000|COMPLETED|Overall Study||5
10479556|NCT01128049|11628732|FG001|COMPLETED|Overall Study||5
10479557|NCT01128049|11628733|FG002|COMPLETED|Overall Study||5
10479558|NCT01128049|11628731|FG000|NOT COMPLETED|Overall Study||0
10479559|NCT01128049|11628732|FG001|NOT COMPLETED|Overall Study||0
10479560|NCT01128049|11628733|FG002|NOT COMPLETED|Overall Study||0
10479561|NCT01128153|11628743|FG000|STARTED|Overall Study|Randomised|129
10479562|NCT01128153|11628744|FG001|STARTED|Overall Study|Randomised|128
10479563|NCT01128153|11628743|FG000|Full Analysis Set|Overall Study|Received at least 1 dose of investigational product during 24 week blinded period|127
10479564|NCT01128153|11628744|FG001|Full Analysis Set|Overall Study|Received at least 1 dose of investigational product during 24 week blinded period|128
10479565|NCT01128153|11628743|FG000|COMPLETED|Overall Study|Completed 24 weeks|113
10479566|NCT01128153|11628744|FG001|COMPLETED|Overall Study|Completed 24 weeks|113
10479567|NCT01128153|11628743|FG000|NOT COMPLETED|Overall Study||16
10479568|NCT01128153|11628744|FG001|NOT COMPLETED|Overall Study||15
10479569|NCT01128179|11628752|FG000|STARTED|Overall Study||23
10479570|NCT01128179|11628753|FG001|STARTED|Overall Study||12
10479571|NCT01128179|11628752|FG000|COMPLETED|Overall Study||21
10479572|NCT01128179|11628753|FG001|COMPLETED|Overall Study||12
10479573|NCT01128179|11628752|FG000|NOT COMPLETED|Overall Study||2
10479574|NCT01128179|11628753|FG001|NOT COMPLETED|Overall Study||0
10479575|NCT01128192|11628761|FG000|STARTED|Overall Study||19
10479576|NCT01128192|11628762|FG001|STARTED|Overall Study||19
10479577|NCT01128192|11628763|FG002|STARTED|Overall Study||7
10479578|NCT01128192|11628761|FG000|COMPLETED|Overall Study||19
10479579|NCT01128192|11628762|FG001|COMPLETED|Overall Study||19
10479580|NCT01128192|11628763|FG002|COMPLETED|Overall Study||7
10479581|NCT01128192|11628761|FG000|NOT COMPLETED|Overall Study||0
10479582|NCT01128192|11628762|FG001|NOT COMPLETED|Overall Study||0
10479583|NCT01128192|11628763|FG002|NOT COMPLETED|Overall Study||0
10479584|NCT01128244|11628774|FG000|STARTED|Overall Study||13
10479585|NCT01128244|11628774|FG000|COMPLETED|Overall Study||10
10479586|NCT01128244|11628774|FG000|NOT COMPLETED|Overall Study||3
10479587|NCT01128270|11628782|FG000|STARTED|Environment Chloral Hydrate and DCA (1A)||7
10479588|NCT01128270|11628782|FG000|COMPLETED|Environment Chloral Hydrate and DCA (1A)||7
10479589|NCT01128270|11628782|FG000|NOT COMPLETED|Environment Chloral Hydrate and DCA (1A)||0
10479590|NCT01128270|11628782|FG000|STARTED|Environmental Chloral Hydrate (1B)|Per the suggestion from Heather, periods are not in chronological order, but defined by treatment.|8
10479591|NCT01128270|11628782|FG000|COMPLETED|Environmental Chloral Hydrate (1B)||8
10479592|NCT01128270|11628782|FG000|NOT COMPLETED|Environmental Chloral Hydrate (1B)||0
10479593|NCT01128270|11628782|FG000|STARTED|Therapeutic Chloral Hydrate and DCA (2A)||8
10479594|NCT01128270|11628782|FG000|COMPLETED|Therapeutic Chloral Hydrate and DCA (2A)||8
10479595|NCT01128270|11628782|FG000|NOT COMPLETED|Therapeutic Chloral Hydrate and DCA (2A)||0
10479596|NCT01128270|11628782|FG000|STARTED|Therapeutic Chloral Hydrate (2B)||8
10479597|NCT01128270|11628782|FG000|COMPLETED|Therapeutic Chloral Hydrate (2B)||8
10479598|NCT01128270|11628782|FG000|NOT COMPLETED|Therapeutic Chloral Hydrate (2B)||0
10479599|NCT01128296|11628794|FG000|STARTED|Overall Study||1
10479600|NCT01128296|11628795|FG001|STARTED|Overall Study||1
10479601|NCT01128296|11628796|FG002|STARTED|Overall Study||1
10479602|NCT01128296|11628797|FG003|STARTED|Overall Study||1
10479603|NCT01128296|11628798|FG004|STARTED|Overall Study||1
10479604|NCT01128296|11628799|FG005|STARTED|Overall Study||26
10479605|NCT01128296|11628794|FG000|COMPLETED|Overall Study||1
10479606|NCT01128296|11628795|FG001|COMPLETED|Overall Study||1
10479607|NCT01128296|11628796|FG002|COMPLETED|Overall Study||1
10479608|NCT01128296|11628797|FG003|COMPLETED|Overall Study||1
10479609|NCT01128296|11628798|FG004|COMPLETED|Overall Study||1
10479610|NCT01128296|11628799|FG005|COMPLETED|Overall Study||21
10479611|NCT01128296|11628794|FG000|NOT COMPLETED|Overall Study||0
10479612|NCT01128296|11628795|FG001|NOT COMPLETED|Overall Study||0
10479613|NCT01128296|11628796|FG002|NOT COMPLETED|Overall Study||0
10479614|NCT01128296|11628797|FG003|NOT COMPLETED|Overall Study||0
10479615|NCT01128296|11628798|FG004|NOT COMPLETED|Overall Study||0
10479616|NCT01128296|11628799|FG005|NOT COMPLETED|Overall Study||5
10479617|NCT01128361|11628812|FG000|STARTED|Overall Study||39
10479618|NCT01128361|11628813|FG001|STARTED|Overall Study||37
10479619|NCT01128361|11628812|FG000|COMPLETED|Overall Study||34
10479620|NCT01128361|11628813|FG001|COMPLETED|Overall Study||34
10479621|NCT01128361|11628812|FG000|NOT COMPLETED|Overall Study||5
10479622|NCT01128361|11628813|FG001|NOT COMPLETED|Overall Study||3
10479623|NCT01128387|11628821|FG000|STARTED|Overall Study||5
10709499|NCT02640807|11874511|FG000|STARTED|Overall Study||9
10709500|NCT02640807|11874512|FG001|STARTED|Overall Study||8
10709501|NCT02640807|11874513|FG002|STARTED|Overall Study||10
10709502|NCT02640807|11874511|FG000|COMPLETED|Overall Study||9
10709503|NCT02640807|11874512|FG001|COMPLETED|Overall Study||8
10709504|NCT02640807|11874513|FG002|COMPLETED|Overall Study||10
10479624|NCT01128387|11628822|FG001|STARTED|Overall Study||6
10479625|NCT01128387|11628821|FG000|COMPLETED|Overall Study||5
10479626|NCT01128387|11628822|FG001|COMPLETED|Overall Study||5
10479627|NCT01128387|11628821|FG000|NOT COMPLETED|Overall Study||0
10479628|NCT01128387|11628822|FG001|NOT COMPLETED|Overall Study||1
10479629|NCT01128400|11628831|FG000|STARTED|Overall Study||8
10479630|NCT01128400|11628832|FG001|STARTED|Overall Study||9
10479631|NCT01128400|11628833|FG002|STARTED|Overall Study||23
10479632|NCT01128400|11628831|FG000|COMPLETED|Overall Study||6
10709505|NCT02640807|11874511|FG000|NOT COMPLETED|Overall Study||0
10709506|NCT02640807|11874512|FG001|NOT COMPLETED|Overall Study||0
10709507|NCT02640807|11874513|FG002|NOT COMPLETED|Overall Study||0
10709508|NCT02641067|11874523|FG000|STARTED|Overall Study||8
10709509|NCT02641067|11874524|FG001|STARTED|Overall Study||8
10709510|NCT02641067|11874523|FG000|COMPLETED|Overall Study||8
10709511|NCT02641067|11874524|FG001|COMPLETED|Overall Study||8
10709512|NCT02641067|11874523|FG000|NOT COMPLETED|Overall Study||0
10709513|NCT02641067|11874524|FG001|NOT COMPLETED|Overall Study||0
10479633|NCT01128400|11628832|FG001|COMPLETED|Overall Study||8
10479634|NCT01128400|11628833|FG002|COMPLETED|Overall Study||7
10479635|NCT01128400|11628831|FG000|NOT COMPLETED|Overall Study||2
10479636|NCT01128400|11628832|FG001|NOT COMPLETED|Overall Study||1
10479637|NCT01128400|11628833|FG002|NOT COMPLETED|Overall Study||16
10479638|NCT01128413|11628843|FG000|STARTED|Overall Study||11
10479639|NCT01128413|11628844|FG001|STARTED|Overall Study||11
10479640|NCT01128413|11628843|FG000|COMPLETED|Overall Study||7
10479641|NCT01128413|11628844|FG001|COMPLETED|Overall Study||10
10479642|NCT01128413|11628843|FG000|NOT COMPLETED|Overall Study||4
10479643|NCT01128413|11628844|FG001|NOT COMPLETED|Overall Study||1
10479644|NCT01128426|11628850|FG000|STARTED|Overall Study||53902
10479645|NCT01128426|11628850|FG000|COMPLETED|Overall Study||53902
10479646|NCT01128426|11628850|FG000|NOT COMPLETED|Overall Study||0
10479647|NCT01128543|11628856|FG000|STARTED|Overall Study||29
10479648|NCT01128543|11628856|FG000|COMPLETED|Overall Study||25
10479649|NCT01128543|11628856|FG000|NOT COMPLETED|Overall Study||4
10479650|NCT01128569|11628860|FG000|STARTED|Treatment Period 1||9
10479651|NCT01128569|11628861|FG001|STARTED|Treatment Period 1||8
10479652|NCT01128569|11628862|FG002|STARTED|Treatment Period 1||9
10479653|NCT01128569|11628863|FG003|STARTED|Treatment Period 1||8
10479654|NCT01128569|11628864|FG004|STARTED|Treatment Period 1||9
10479655|NCT01128569|11628865|FG005|STARTED|Treatment Period 1||9
10479656|NCT01128569|11628860|FG000|COMPLETED|Treatment Period 1||9
10709514|NCT02641080|11874532|FG000|STARTED|Overall Study||40
10479657|NCT01128569|11628861|FG001|COMPLETED|Treatment Period 1||8
10709515|NCT02641080|11874533|FG001|STARTED|Overall Study||40
10709516|NCT02641080|11874532|FG000|COMPLETED|Overall Study||38
10709517|NCT02641080|11874533|FG001|COMPLETED|Overall Study||33
10709518|NCT02641080|11874532|FG000|NOT COMPLETED|Overall Study||2
10479658|NCT01128569|11628862|FG002|COMPLETED|Treatment Period 1||9
10479659|NCT01128569|11628863|FG003|COMPLETED|Treatment Period 1||8
10479660|NCT01128569|11628864|FG004|COMPLETED|Treatment Period 1||9
10479661|NCT01128569|11628865|FG005|COMPLETED|Treatment Period 1||9
10479662|NCT01128569|11628860|FG000|NOT COMPLETED|Treatment Period 1||0
10479663|NCT01128569|11628861|FG001|NOT COMPLETED|Treatment Period 1||0
10479664|NCT01128569|11628862|FG002|NOT COMPLETED|Treatment Period 1||0
10479665|NCT01128569|11628863|FG003|NOT COMPLETED|Treatment Period 1||0
10479666|NCT01128569|11628864|FG004|NOT COMPLETED|Treatment Period 1||0
10479667|NCT01128569|11628865|FG005|NOT COMPLETED|Treatment Period 1||0
10479668|NCT01128569|11628860|FG000|STARTED|Washout Period 1||9
10479669|NCT01128569|11628861|FG001|STARTED|Washout Period 1||8
10479670|NCT01128569|11628862|FG002|STARTED|Washout Period 1||9
10479671|NCT01128569|11628863|FG003|STARTED|Washout Period 1||8
10479672|NCT01128569|11628864|FG004|STARTED|Washout Period 1||9
10479673|NCT01128569|11628865|FG005|STARTED|Washout Period 1||9
10479674|NCT01128569|11628860|FG000|COMPLETED|Washout Period 1||9
10479675|NCT01128569|11628861|FG001|COMPLETED|Washout Period 1||8
10479676|NCT01128569|11628862|FG002|COMPLETED|Washout Period 1||8
10479677|NCT01128569|11628863|FG003|COMPLETED|Washout Period 1||8
10479678|NCT01128569|11628864|FG004|COMPLETED|Washout Period 1||9
10479679|NCT01128569|11628865|FG005|COMPLETED|Washout Period 1||9
10479680|NCT01128569|11628860|FG000|NOT COMPLETED|Washout Period 1||0
10479681|NCT01128569|11628861|FG001|NOT COMPLETED|Washout Period 1||0
10479682|NCT01128569|11628862|FG002|NOT COMPLETED|Washout Period 1||1
10479683|NCT01128569|11628863|FG003|NOT COMPLETED|Washout Period 1||0
10479684|NCT01128569|11628864|FG004|NOT COMPLETED|Washout Period 1||0
10479685|NCT01128569|11628865|FG005|NOT COMPLETED|Washout Period 1||0
10479686|NCT01128569|11628860|FG000|STARTED|Treatment Period 2||9
10479687|NCT01128569|11628861|FG001|STARTED|Treatment Period 2||8
10479688|NCT01128569|11628862|FG002|STARTED|Treatment Period 2||8
10479689|NCT01128569|11628863|FG003|STARTED|Treatment Period 2||8
10479690|NCT01128569|11628864|FG004|STARTED|Treatment Period 2||9
10479691|NCT01128569|11628865|FG005|STARTED|Treatment Period 2||9
10479692|NCT01128569|11628860|FG000|COMPLETED|Treatment Period 2||9
10479693|NCT01128569|11628861|FG001|COMPLETED|Treatment Period 2||7
10479694|NCT01128569|11628862|FG002|COMPLETED|Treatment Period 2||8
10479695|NCT01128569|11628863|FG003|COMPLETED|Treatment Period 2||8
10479696|NCT01128569|11628864|FG004|COMPLETED|Treatment Period 2||9
10479697|NCT01128569|11628865|FG005|COMPLETED|Treatment Period 2||9
10479698|NCT01128569|11628860|FG000|NOT COMPLETED|Treatment Period 2||0
10479699|NCT01128569|11628861|FG001|NOT COMPLETED|Treatment Period 2||1
10479700|NCT01128569|11628862|FG002|NOT COMPLETED|Treatment Period 2||0
10479701|NCT01128569|11628863|FG003|NOT COMPLETED|Treatment Period 2||0
10479702|NCT01128569|11628864|FG004|NOT COMPLETED|Treatment Period 2||0
10479703|NCT01128569|11628865|FG005|NOT COMPLETED|Treatment Period 2||0
10479704|NCT01128569|11628860|FG000|STARTED|Washout Period 2||9
10479705|NCT01128569|11628861|FG001|STARTED|Washout Period 2||7
10479706|NCT01128569|11628862|FG002|STARTED|Washout Period 2||8
10479707|NCT01128569|11628863|FG003|STARTED|Washout Period 2||8
10479708|NCT01128569|11628864|FG004|STARTED|Washout Period 2||9
10479709|NCT01128569|11628865|FG005|STARTED|Washout Period 2||9
10479710|NCT01128569|11628860|FG000|COMPLETED|Washout Period 2||9
10479711|NCT01128569|11628861|FG001|COMPLETED|Washout Period 2||7
10479712|NCT01128569|11628862|FG002|COMPLETED|Washout Period 2||8
10479713|NCT01128569|11628863|FG003|COMPLETED|Washout Period 2||8
10479714|NCT01128569|11628864|FG004|COMPLETED|Washout Period 2||9
10479715|NCT01128569|11628865|FG005|COMPLETED|Washout Period 2||9
10479716|NCT01128569|11628860|FG000|NOT COMPLETED|Washout Period 2||0
10479717|NCT01128569|11628861|FG001|NOT COMPLETED|Washout Period 2||0
10479718|NCT01128569|11628862|FG002|NOT COMPLETED|Washout Period 2||0
10479719|NCT01128569|11628863|FG003|NOT COMPLETED|Washout Period 2||0
10479720|NCT01128569|11628864|FG004|NOT COMPLETED|Washout Period 2||0
10479721|NCT01128569|11628865|FG005|NOT COMPLETED|Washout Period 2||0
10479722|NCT01128569|11628860|FG000|STARTED|Treatment Period 3||9
10479723|NCT01128569|11628861|FG001|STARTED|Treatment Period 3||7
10479724|NCT01128569|11628862|FG002|STARTED|Treatment Period 3||8
10479725|NCT01128569|11628863|FG003|STARTED|Treatment Period 3||8
10479726|NCT01128569|11628864|FG004|STARTED|Treatment Period 3||9
10479727|NCT01128569|11628865|FG005|STARTED|Treatment Period 3||9
10479728|NCT01128569|11628860|FG000|COMPLETED|Treatment Period 3||9
10479729|NCT01128569|11628861|FG001|COMPLETED|Treatment Period 3||7
10479730|NCT01128569|11628862|FG002|COMPLETED|Treatment Period 3||8
10479731|NCT01128569|11628863|FG003|COMPLETED|Treatment Period 3||8
10479732|NCT01128569|11628864|FG004|COMPLETED|Treatment Period 3||9
10479733|NCT01128569|11628865|FG005|COMPLETED|Treatment Period 3||9
10479734|NCT01128569|11628860|FG000|NOT COMPLETED|Treatment Period 3||0
10479735|NCT01128569|11628861|FG001|NOT COMPLETED|Treatment Period 3||0
10479736|NCT01128569|11628862|FG002|NOT COMPLETED|Treatment Period 3||0
10479737|NCT01128569|11628863|FG003|NOT COMPLETED|Treatment Period 3||0
10479738|NCT01128569|11628864|FG004|NOT COMPLETED|Treatment Period 3||0
10479739|NCT01128569|11628865|FG005|NOT COMPLETED|Treatment Period 3||0
10479740|NCT01128595|11628873|FG000|STARTED|Treatment Period 1||7
10479741|NCT01128595|11628874|FG001|STARTED|Treatment Period 1||6
10479742|NCT01128595|11628875|FG002|STARTED|Treatment Period 1||7
10479743|NCT01128595|11628876|FG003|STARTED|Treatment Period 1||7
10479744|NCT01128595|11628873|FG000|COMPLETED|Treatment Period 1||7
10479745|NCT01128595|11628874|FG001|COMPLETED|Treatment Period 1||6
10479746|NCT01128595|11628875|FG002|COMPLETED|Treatment Period 1||7
10479747|NCT01128595|11628876|FG003|COMPLETED|Treatment Period 1||7
10479748|NCT01128595|11628873|FG000|NOT COMPLETED|Treatment Period 1||0
10479749|NCT01128595|11628874|FG001|NOT COMPLETED|Treatment Period 1||0
10479750|NCT01128595|11628875|FG002|NOT COMPLETED|Treatment Period 1||0
10479751|NCT01128595|11628876|FG003|NOT COMPLETED|Treatment Period 1||0
10479752|NCT01128595|11628873|FG000|STARTED|Washout Period 1||7
10479753|NCT01128595|11628874|FG001|STARTED|Washout Period 1||6
10479754|NCT01128595|11628875|FG002|STARTED|Washout Period 1||7
10479755|NCT01128595|11628876|FG003|STARTED|Washout Period 1||7
10479756|NCT01128595|11628873|FG000|COMPLETED|Washout Period 1||7
10479757|NCT01128595|11628874|FG001|COMPLETED|Washout Period 1||6
10479758|NCT01128595|11628875|FG002|COMPLETED|Washout Period 1||7
10479759|NCT01128595|11628876|FG003|COMPLETED|Washout Period 1||7
10479760|NCT01128595|11628873|FG000|NOT COMPLETED|Washout Period 1||0
10479761|NCT01128595|11628874|FG001|NOT COMPLETED|Washout Period 1||0
10479762|NCT01128595|11628875|FG002|NOT COMPLETED|Washout Period 1||0
10479763|NCT01128595|11628876|FG003|NOT COMPLETED|Washout Period 1||0
10479764|NCT01128595|11628873|FG000|STARTED|Treatment Period 2||7
10479765|NCT01128595|11628874|FG001|STARTED|Treatment Period 2||6
10479766|NCT01128595|11628875|FG002|STARTED|Treatment Period 2||7
10479767|NCT01128595|11628876|FG003|STARTED|Treatment Period 2||7
10479768|NCT01128595|11628873|FG000|COMPLETED|Treatment Period 2||7
10479769|NCT01128595|11628874|FG001|COMPLETED|Treatment Period 2||6
10479770|NCT01128595|11628875|FG002|COMPLETED|Treatment Period 2||7
10479771|NCT01128595|11628876|FG003|COMPLETED|Treatment Period 2||7
10479772|NCT01128595|11628873|FG000|NOT COMPLETED|Treatment Period 2||0
10479773|NCT01128595|11628874|FG001|NOT COMPLETED|Treatment Period 2||0
10479774|NCT01128595|11628875|FG002|NOT COMPLETED|Treatment Period 2||0
10479775|NCT01128595|11628876|FG003|NOT COMPLETED|Treatment Period 2||0
10479776|NCT01128595|11628873|FG000|STARTED|Washout Period 2||7
10479777|NCT01128595|11628874|FG001|STARTED|Washout Period 2||6
10479778|NCT01128595|11628875|FG002|STARTED|Washout Period 2||7
10479779|NCT01128595|11628876|FG003|STARTED|Washout Period 2||7
10479780|NCT01128595|11628873|FG000|COMPLETED|Washout Period 2||7
10479781|NCT01128595|11628874|FG001|COMPLETED|Washout Period 2||6
10479782|NCT01128595|11628875|FG002|COMPLETED|Washout Period 2||7
10479783|NCT01128595|11628876|FG003|COMPLETED|Washout Period 2||7
10479784|NCT01128595|11628873|FG000|NOT COMPLETED|Washout Period 2||0
10479785|NCT01128595|11628874|FG001|NOT COMPLETED|Washout Period 2||0
10479786|NCT01128595|11628875|FG002|NOT COMPLETED|Washout Period 2||0
10479787|NCT01128595|11628876|FG003|NOT COMPLETED|Washout Period 2||0
10479788|NCT01128595|11628873|FG000|STARTED|Treatment Period 3||7
10479789|NCT01128595|11628874|FG001|STARTED|Treatment Period 3||6
10479790|NCT01128595|11628875|FG002|STARTED|Treatment Period 3||7
10479791|NCT01128595|11628876|FG003|STARTED|Treatment Period 3||7
10479792|NCT01128595|11628873|FG000|COMPLETED|Treatment Period 3||7
10479793|NCT01128595|11628874|FG001|COMPLETED|Treatment Period 3||5
10479794|NCT01128595|11628875|FG002|COMPLETED|Treatment Period 3||7
10479795|NCT01128595|11628876|FG003|COMPLETED|Treatment Period 3||7
10479796|NCT01128595|11628873|FG000|NOT COMPLETED|Treatment Period 3||0
10479797|NCT01128595|11628874|FG001|NOT COMPLETED|Treatment Period 3||1
10479798|NCT01128595|11628875|FG002|NOT COMPLETED|Treatment Period 3||0
10479799|NCT01128595|11628876|FG003|NOT COMPLETED|Treatment Period 3||0
10479800|NCT01128595|11628873|FG000|STARTED|Washout Period 3||7
10479801|NCT01128595|11628874|FG001|STARTED|Washout Period 3||5
10479802|NCT01128595|11628875|FG002|STARTED|Washout Period 3||7
10479803|NCT01128595|11628876|FG003|STARTED|Washout Period 3||7
10649871|NCT02164539|11810006|FG003|STARTED|Treatment Phase B (1 Week)||0
10649872|NCT02164539|11810007|FG004|STARTED|Treatment Phase B (1 Week)||166
10649873|NCT02164539|11810008|FG005|STARTED|Treatment Phase B (1 Week)||0
10649874|NCT02164539|11810009|FG006|STARTED|Treatment Phase B (1 Week)||163
10649875|NCT02164539|11810003|FG000|COMPLETED|Treatment Phase B (1 Week)||0
10649876|NCT02164539|11810004|FG001|COMPLETED|Treatment Phase B (1 Week)||0
10649877|NCT02164539|11810005|FG002|COMPLETED|Treatment Phase B (1 Week)||0
10649878|NCT02164539|11810006|FG003|COMPLETED|Treatment Phase B (1 Week)||0
10649879|NCT02164539|11810007|FG004|COMPLETED|Treatment Phase B (1 Week)||163
10649880|NCT02164539|11810008|FG005|COMPLETED|Treatment Phase B (1 Week)||0
10649881|NCT02164539|11810009|FG006|COMPLETED|Treatment Phase B (1 Week)||162
10649882|NCT02164539|11810003|FG000|NOT COMPLETED|Treatment Phase B (1 Week)||0
10649883|NCT02164539|11810004|FG001|NOT COMPLETED|Treatment Phase B (1 Week)||0
10649884|NCT02164539|11810005|FG002|NOT COMPLETED|Treatment Phase B (1 Week)||0
10649885|NCT02164539|11810006|FG003|NOT COMPLETED|Treatment Phase B (1 Week)||0
10649886|NCT02164539|11810007|FG004|NOT COMPLETED|Treatment Phase B (1 Week)||3
10649887|NCT02164539|11810008|FG005|NOT COMPLETED|Treatment Phase B (1 Week)||0
10649888|NCT02164539|11810009|FG006|NOT COMPLETED|Treatment Phase B (1 Week)||1
10479804|NCT01128595|11628873|FG000|COMPLETED|Washout Period 3||7
10479805|NCT01128595|11628874|FG001|COMPLETED|Washout Period 3||5
10479806|NCT01128595|11628875|FG002|COMPLETED|Washout Period 3||7
10479807|NCT01128595|11628876|FG003|COMPLETED|Washout Period 3||7
10479808|NCT01128595|11628873|FG000|NOT COMPLETED|Washout Period 3||0
10479809|NCT01128595|11628874|FG001|NOT COMPLETED|Washout Period 3||0
10649889|NCT02164539|11810003|FG000|STARTED|Treatment Phase C (1 Week)||79
10479810|NCT01128595|11628875|FG002|NOT COMPLETED|Washout Period 3||0
10479811|NCT01128595|11628876|FG003|NOT COMPLETED|Washout Period 3||0
10479812|NCT01128595|11628873|FG000|STARTED|Treatment Period 4||7
10479813|NCT01128595|11628874|FG001|STARTED|Treatment Period 4||5
10479814|NCT01128595|11628875|FG002|STARTED|Treatment Period 4||7
10479815|NCT01128595|11628876|FG003|STARTED|Treatment Period 4||7
10479816|NCT01128595|11628873|FG000|COMPLETED|Treatment Period 4||7
10479817|NCT01128595|11628874|FG001|COMPLETED|Treatment Period 4||5
10479818|NCT01128595|11628875|FG002|COMPLETED|Treatment Period 4||7
10479819|NCT01128595|11628876|FG003|COMPLETED|Treatment Period 4||7
10479820|NCT01128595|11628873|FG000|NOT COMPLETED|Treatment Period 4||0
10479821|NCT01128595|11628874|FG001|NOT COMPLETED|Treatment Period 4||0
10479822|NCT01128595|11628875|FG002|NOT COMPLETED|Treatment Period 4||0
10479823|NCT01128595|11628876|FG003|NOT COMPLETED|Treatment Period 4||0
10479824|NCT01128621|11628889|FG000|STARTED|Part A: GSK1292263 300 mg||6
10479825|NCT01128621|11628890|FG001|STARTED|Part A: GSK1292263 300 mg||0
10479826|NCT01128621|11628889|FG000|COMPLETED|Part A: GSK1292263 300 mg||6
10479827|NCT01128621|11628890|FG001|COMPLETED|Part A: GSK1292263 300 mg||0
10479828|NCT01128621|11628889|FG000|NOT COMPLETED|Part A: GSK1292263 300 mg||0
10479829|NCT01128621|11628890|FG001|NOT COMPLETED|Part A: GSK1292263 300 mg||0
10479830|NCT01128621|11628889|FG000|STARTED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
10479831|NCT01128621|11628890|FG001|STARTED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||67
10479832|NCT01128621|11628889|FG000|COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
10479833|NCT01128621|11628890|FG001|COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||65
10479834|NCT01128621|11628889|FG000|NOT COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
10479835|NCT01128621|11628890|FG001|NOT COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||2
10479836|NCT01128738|11628914|FG000|STARTED|First Treatment Phase (TP)||78
10479837|NCT01128738|11628915|FG001|STARTED|First Treatment Phase (TP)||74
10479838|NCT01128738|11628914|FG000|COMPLETED|First Treatment Phase (TP)||74
10479839|NCT01128738|11628915|FG001|COMPLETED|First Treatment Phase (TP)||73
10479840|NCT01128738|11628914|FG000|NOT COMPLETED|First Treatment Phase (TP)||4
10479841|NCT01128738|11628915|FG001|NOT COMPLETED|First Treatment Phase (TP)||1
10479842|NCT01128738|11628914|FG000|STARTED|Second TP|Only participants who received a second treatment entered this phase.|34
10479843|NCT01128738|11628915|FG001|STARTED|Second TP|Only participants who received a second treatment entered this phase.|66
10479844|NCT01128738|11628914|FG000|COMPLETED|Second TP||34
10479845|NCT01128738|11628915|FG001|COMPLETED|Second TP||63
10479846|NCT01128738|11628914|FG000|NOT COMPLETED|Second TP||0
10479847|NCT01128738|11628915|FG001|NOT COMPLETED|Second TP||3
10479848|NCT01128829|11628922|FG000|STARTED|Overall Study||6
10479849|NCT01128829|11628923|FG001|STARTED|Overall Study||11
10479850|NCT01128829|11628922|FG000|COMPLETED|Overall Study||6
10479851|NCT01128829|11628923|FG001|COMPLETED|Overall Study||11
10479852|NCT01128829|11628922|FG000|NOT COMPLETED|Overall Study||0
10479853|NCT01128829|11628923|FG001|NOT COMPLETED|Overall Study||0
10479854|NCT01128842|11628927|FG000|STARTED|Overall Study||7
10479855|NCT01128842|11628927|FG000|COMPLETED|Overall Study||0
10479856|NCT01128842|11628927|FG000|NOT COMPLETED|Overall Study||7
10479857|NCT01128894|11628934|FG000|STARTED|Overall Study||404
10479858|NCT01128894|11628935|FG001|STARTED|Overall Study||408
10479859|NCT01128894|11628934|FG000|COMPLETED|Overall Study||346
10479860|NCT01128894|11628935|FG001|COMPLETED|Overall Study||340
10479861|NCT01128894|11628934|FG000|NOT COMPLETED|Overall Study||58
10479862|NCT01128894|11628935|FG001|NOT COMPLETED|Overall Study||68
10479863|NCT01128946|11628941|FG000|STARTED|Period I||20
10479864|NCT01128946|11628942|FG001|STARTED|Period I||21
10479865|NCT01128946|11628943|FG002|STARTED|Period I||21
10479866|NCT01128946|11628944|FG003|STARTED|Period I||21
10479867|NCT01128946|11628941|FG000|COMPLETED|Period I||20
10479868|NCT01128946|11628942|FG001|COMPLETED|Period I||20
10479869|NCT01128946|11628943|FG002|COMPLETED|Period I||20
10479870|NCT01128946|11628944|FG003|COMPLETED|Period I||20
10479871|NCT01128946|11628941|FG000|NOT COMPLETED|Period I||0
10479872|NCT01128946|11628942|FG001|NOT COMPLETED|Period I||1
10479873|NCT01128946|11628943|FG002|NOT COMPLETED|Period I||1
10479874|NCT01128946|11628944|FG003|NOT COMPLETED|Period I||1
10479875|NCT01128946|11628941|FG000|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
10479876|NCT01128946|11628942|FG001|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
10479877|NCT01128946|11628943|FG002|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
10479878|NCT01128946|11628944|FG003|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
10479879|NCT01128946|11628941|FG000|COMPLETED|Period II||20
10479880|NCT01128946|11628942|FG001|COMPLETED|Period II||19
10479881|NCT01128946|11628943|FG002|COMPLETED|Period II||20
10479882|NCT01128946|11628944|FG003|COMPLETED|Period II||19
10479883|NCT01128946|11628941|FG000|NOT COMPLETED|Period II||0
10479884|NCT01128946|11628942|FG001|NOT COMPLETED|Period II||1
10479885|NCT01128946|11628943|FG002|NOT COMPLETED|Period II||0
10479886|NCT01128946|11628944|FG003|NOT COMPLETED|Period II||1
10479887|NCT01128946|11628941|FG000|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|20
10479888|NCT01128946|11628942|FG001|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|19
10479889|NCT01128946|11628943|FG002|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|20
10479890|NCT01128946|11628944|FG003|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|19
10479891|NCT01128946|11628941|FG000|COMPLETED|Period III||19
10479892|NCT01128946|11628942|FG001|COMPLETED|Period III||19
10479893|NCT01128946|11628943|FG002|COMPLETED|Period III||20
10479894|NCT01128946|11628944|FG003|COMPLETED|Period III||19
10479895|NCT01128946|11628941|FG000|NOT COMPLETED|Period III||1
10479896|NCT01128946|11628942|FG001|NOT COMPLETED|Period III||0
10479897|NCT01128946|11628943|FG002|NOT COMPLETED|Period III||0
10479898|NCT01128946|11628944|FG003|NOT COMPLETED|Period III||0
10479899|NCT01128946|11628941|FG000|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
10479900|NCT01128946|11628942|FG001|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|20
10479901|NCT01128946|11628943|FG002|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
10479902|NCT01128946|11628944|FG003|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
10479903|NCT01128946|11628941|FG000|COMPLETED|Period IV||19
10479904|NCT01128946|11628942|FG001|COMPLETED|Period IV||20
10479905|NCT01128946|11628943|FG002|COMPLETED|Period IV||19
10479906|NCT01128946|11628944|FG003|COMPLETED|Period IV||19
10479907|NCT01128946|11628941|FG000|NOT COMPLETED|Period IV||0
10479908|NCT01128946|11628942|FG001|NOT COMPLETED|Period IV||0
10479909|NCT01128946|11628943|FG002|NOT COMPLETED|Period IV||0
10479910|NCT01128946|11628944|FG003|NOT COMPLETED|Period IV||0
10479911|NCT01128959|11628955|FG000|STARTED|Lead in Period||108
10479912|NCT01128959|11628955|FG000|COMPLETED|Lead in Period||105
10479913|NCT01128959|11628955|FG000|NOT COMPLETED|Lead in Period||3
10479914|NCT01128959|11628955|FG000|STARTED|Treatment Period||105
10479915|NCT01128959|11628955|FG000|COMPLETED|Treatment Period||101
10479916|NCT01128959|11628955|FG000|NOT COMPLETED|Treatment Period||4
10479917|NCT01128972|11628961|FG000|STARTED|Period I||7
10479918|NCT01128972|11628962|FG001|STARTED|Period I||7
10479919|NCT01128972|11628963|FG002|STARTED|Period I||7
10479920|NCT01128972|11628964|FG003|STARTED|Period I||7
10479921|NCT01128972|11628965|FG004|STARTED|Period I||8
10479922|NCT01128972|11628961|FG000|COMPLETED|Period I||7
10479923|NCT01128972|11628962|FG001|COMPLETED|Period I||7
10479924|NCT01128972|11628963|FG002|COMPLETED|Period I||7
10479925|NCT01128972|11628964|FG003|COMPLETED|Period I||7
10479926|NCT01128972|11628965|FG004|COMPLETED|Period I||8
10479927|NCT01128972|11628961|FG000|NOT COMPLETED|Period I||0
10479928|NCT01128972|11628962|FG001|NOT COMPLETED|Period I||0
10479929|NCT01128972|11628963|FG002|NOT COMPLETED|Period I||0
10479930|NCT01128972|11628964|FG003|NOT COMPLETED|Period I||0
10479931|NCT01128972|11628965|FG004|NOT COMPLETED|Period I||0
10479932|NCT01128972|11628961|FG000|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
10479933|NCT01128972|11628962|FG001|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
10479934|NCT01128972|11628963|FG002|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
10479935|NCT01128972|11628964|FG003|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|8
10479936|NCT01128972|11628965|FG004|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
10479937|NCT01128972|11628961|FG000|COMPLETED|Period II||7
10479938|NCT01128972|11628962|FG001|COMPLETED|Period II||7
10479939|NCT01128972|11628963|FG002|COMPLETED|Period II||7
10479940|NCT01128972|11628964|FG003|COMPLETED|Period II||8
10479941|NCT01128972|11628965|FG004|COMPLETED|Period II||7
10479942|NCT01128972|11628961|FG000|NOT COMPLETED|Period II||0
10479943|NCT01128972|11628962|FG001|NOT COMPLETED|Period II||0
10479944|NCT01128972|11628963|FG002|NOT COMPLETED|Period II||0
10479945|NCT01128972|11628964|FG003|NOT COMPLETED|Period II||0
10479946|NCT01128972|11628965|FG004|NOT COMPLETED|Period II||0
10479947|NCT01128972|11628961|FG000|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
10479948|NCT01128972|11628962|FG001|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
10479949|NCT01128972|11628963|FG002|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|8
10479950|NCT01128972|11628964|FG003|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
10479951|NCT01128972|11628965|FG004|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
10479952|NCT01128972|11628961|FG000|COMPLETED|Period III||7
10479953|NCT01128972|11628962|FG001|COMPLETED|Period III||7
10479954|NCT01128972|11628963|FG002|COMPLETED|Period III||8
10479955|NCT01128972|11628964|FG003|COMPLETED|Period III||7
10479956|NCT01128972|11628965|FG004|COMPLETED|Period III||7
10479957|NCT01128972|11628961|FG000|NOT COMPLETED|Period III||0
10479958|NCT01128972|11628962|FG001|NOT COMPLETED|Period III||0
10479959|NCT01128972|11628963|FG002|NOT COMPLETED|Period III||0
10479960|NCT01128972|11628964|FG003|NOT COMPLETED|Period III||0
10479961|NCT01128972|11628965|FG004|NOT COMPLETED|Period III||0
10479962|NCT01128972|11628961|FG000|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
10479963|NCT01128972|11628962|FG001|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|8
10479964|NCT01128972|11628963|FG002|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
10479965|NCT01128972|11628964|FG003|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
10479966|NCT01128972|11628965|FG004|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
10479967|NCT01128972|11628961|FG000|COMPLETED|Period IV||7
10479968|NCT01128972|11628962|FG001|COMPLETED|Period IV||8
10709519|NCT02641080|11874533|FG001|NOT COMPLETED|Overall Study||7
10709520|NCT02641249|11874539|FG000|STARTED|Overall Study||19
10479969|NCT01128972|11628963|FG002|COMPLETED|Period IV||7
10479970|NCT01128972|11628964|FG003|COMPLETED|Period IV||7
10479971|NCT01128972|11628965|FG004|COMPLETED|Period IV||7
10479972|NCT01128972|11628961|FG000|NOT COMPLETED|Period IV||0
10479973|NCT01128972|11628962|FG001|NOT COMPLETED|Period IV||0
10479974|NCT01128972|11628963|FG002|NOT COMPLETED|Period IV||0
10479975|NCT01128972|11628964|FG003|NOT COMPLETED|Period IV||0
10479976|NCT01128972|11628965|FG004|NOT COMPLETED|Period IV||0
10479977|NCT01128972|11628961|FG000|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|8
10479978|NCT01128972|11628962|FG001|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
10479979|NCT01128972|11628963|FG002|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
10479980|NCT01128972|11628964|FG003|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
10479981|NCT01128972|11628965|FG004|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
10479982|NCT01128972|11628961|FG000|COMPLETED|Period V||8
10479983|NCT01128972|11628962|FG001|COMPLETED|Period V||7
10479984|NCT01128972|11628963|FG002|COMPLETED|Period V||7
10479985|NCT01128972|11628964|FG003|COMPLETED|Period V||7
10479986|NCT01128972|11628965|FG004|COMPLETED|Period V||7
10479987|NCT01128972|11628961|FG000|NOT COMPLETED|Period V||0
10479988|NCT01128972|11628962|FG001|NOT COMPLETED|Period V||0
10479989|NCT01128972|11628963|FG002|NOT COMPLETED|Period V||0
10479990|NCT01128972|11628964|FG003|NOT COMPLETED|Period V||0
10479991|NCT01128972|11628965|FG004|NOT COMPLETED|Period V||0
10479992|NCT01129024|11628983|FG000|STARTED|Overall Study||19
10479993|NCT01129024|11628983|FG000|COMPLETED|Overall Study||0
10479994|NCT01129024|11628983|FG000|NOT COMPLETED|Overall Study||19
10479995|NCT01129102|11628990|FG000|STARTED|Overall Study||110
10479996|NCT01129102|11628991|FG001|STARTED|Overall Study||50
10479997|NCT01129102|11628992|FG002|STARTED|Overall Study||55
10479998|NCT01129102|11628990|FG000|COMPLETED|Overall Study||102
10479999|NCT01129102|11628991|FG001|COMPLETED|Overall Study||44
10480000|NCT01129102|11628992|FG002|COMPLETED|Overall Study||48
10480001|NCT01129102|11628990|FG000|NOT COMPLETED|Overall Study||8
10480002|NCT01129102|11628991|FG001|NOT COMPLETED|Overall Study||6
10480003|NCT01129102|11628992|FG002|NOT COMPLETED|Overall Study||7
10480004|NCT01129115|11629003|FG000|STARTED|Overall Study||25
10480005|NCT01129115|11629004|FG001|STARTED|Overall Study||25
10480006|NCT01129115|11629005|FG002|STARTED|Overall Study||27
10480007|NCT01129115|11629006|FG003|STARTED|Overall Study||24
10480008|NCT01129115|11629003|FG000|COMPLETED|Overall Study||23
10480009|NCT01129115|11629004|FG001|COMPLETED|Overall Study||18
10480010|NCT01129115|11629005|FG002|COMPLETED|Overall Study||21
10480011|NCT01129115|11629006|FG003|COMPLETED|Overall Study||15
10480012|NCT01129115|11629003|FG000|NOT COMPLETED|Overall Study||2
10480013|NCT01129115|11629004|FG001|NOT COMPLETED|Overall Study||7
10480014|NCT01129115|11629005|FG002|NOT COMPLETED|Overall Study||6
10480015|NCT01129115|11629006|FG003|NOT COMPLETED|Overall Study||9
10809813|NCT03811834|11971606|FG000|COMPLETED|Period 2 (10 Days)||6
10480016|NCT01129128|11629019|FG000|STARTED|Overall Study||22
10480017|NCT01129128|11629020|FG001|STARTED|Overall Study||22
10480018|NCT01129128|11629021|FG002|STARTED|Overall Study||23
10480019|NCT01129128|11629019|FG000|COMPLETED|Overall Study||19
10480020|NCT01129128|11629020|FG001|COMPLETED|Overall Study||18
10480021|NCT01129128|11629021|FG002|COMPLETED|Overall Study||19
10480022|NCT01129128|11629019|FG000|NOT COMPLETED|Overall Study||3
10480023|NCT01129128|11629020|FG001|NOT COMPLETED|Overall Study||4
10480024|NCT01129128|11629021|FG002|NOT COMPLETED|Overall Study||4
10480025|NCT01129141|11629031|FG000|STARTED|Overall Study||101
10480026|NCT01129141|11629032|FG001|STARTED|Overall Study||104
10480027|NCT01129141|11629031|FG000|COMPLETED|Overall Study||86
10480028|NCT01129141|11629032|FG001|COMPLETED|Overall Study||91
10480029|NCT01129141|11629031|FG000|NOT COMPLETED|Overall Study||15
10480030|NCT01129141|11629032|FG001|NOT COMPLETED|Overall Study||13
10480031|NCT01129206|11629038|FG000|STARTED|Overall Study||6
10480032|NCT01129206|11629038|FG000|COMPLETED|Overall Study||6
10480033|NCT01129206|11629038|FG000|NOT COMPLETED|Overall Study||0
10480034|NCT01129245|11629047|FG000|STARTED|Control Cycle (no Celecoxib or Placebo)||10
10480035|NCT01129245|11629048|FG001|STARTED|Control Cycle (no Celecoxib or Placebo)||10
10480036|NCT01129245|11629047|FG000|COMPLETED|Control Cycle (no Celecoxib or Placebo)||10
10709521|NCT02641249|11874539|FG000|COMPLETED|Overall Study||15
10709522|NCT02641249|11874539|FG000|NOT COMPLETED|Overall Study||4
10709523|NCT02641353|11874544|FG000|STARTED|Overall Study||5
10709524|NCT02641353|11874545|FG001|STARTED|Overall Study||5
10709525|NCT02641353|11874546|FG002|STARTED|Overall Study||6
10709526|NCT02641353|11874547|FG003|STARTED|Overall Study||6
10709527|NCT02641353|11874548|FG004|STARTED|Overall Study||6
10709528|NCT02641353|11874549|FG005|STARTED|Overall Study||6
10709529|NCT02641353|11874544|FG000|COMPLETED|Overall Study||5
10709530|NCT02641353|11874545|FG001|COMPLETED|Overall Study||5
10809814|NCT03811834|11971606|FG000|NOT COMPLETED|Period 2 (10 Days)||0
10480037|NCT01129245|11629048|FG001|COMPLETED|Control Cycle (no Celecoxib or Placebo)||10
10709531|NCT02641353|11874546|FG002|COMPLETED|Overall Study||6
10709532|NCT02641353|11874547|FG003|COMPLETED|Overall Study||6
10709533|NCT02641353|11874548|FG004|COMPLETED|Overall Study||6
10709534|NCT02641353|11874549|FG005|COMPLETED|Overall Study||6
10709535|NCT02641353|11874544|FG000|NOT COMPLETED|Overall Study||0
10480038|NCT01129245|11629047|FG000|NOT COMPLETED|Control Cycle (no Celecoxib or Placebo)||0
10480039|NCT01129245|11629048|FG001|NOT COMPLETED|Control Cycle (no Celecoxib or Placebo)||0
10480040|NCT01129245|11629047|FG000|STARTED|Treatment Cycle 1||10
10480041|NCT01129245|11629048|FG001|STARTED|Treatment Cycle 1||10
10480042|NCT01129245|11629047|FG000|COMPLETED|Treatment Cycle 1||10
10480043|NCT01129245|11629048|FG001|COMPLETED|Treatment Cycle 1||10
10480044|NCT01129245|11629047|FG000|NOT COMPLETED|Treatment Cycle 1||0
10480045|NCT01129245|11629048|FG001|NOT COMPLETED|Treatment Cycle 1||0
10480046|NCT01129245|11629047|FG000|STARTED|Washout Cycle||10
10480047|NCT01129245|11629048|FG001|STARTED|Washout Cycle||10
10480048|NCT01129245|11629047|FG000|COMPLETED|Washout Cycle||10
10480049|NCT01129245|11629048|FG001|COMPLETED|Washout Cycle||10
10480050|NCT01129245|11629047|FG000|NOT COMPLETED|Washout Cycle||0
10480051|NCT01129245|11629048|FG001|NOT COMPLETED|Washout Cycle||0
10480052|NCT01129245|11629047|FG000|STARTED|Treatment Cycle 2||10
10480053|NCT01129245|11629048|FG001|STARTED|Treatment Cycle 2||10
10480054|NCT01129245|11629047|FG000|COMPLETED|Treatment Cycle 2||10
10480055|NCT01129245|11629048|FG001|COMPLETED|Treatment Cycle 2||10
10480056|NCT01129245|11629047|FG000|NOT COMPLETED|Treatment Cycle 2||0
10480057|NCT01129245|11629048|FG001|NOT COMPLETED|Treatment Cycle 2||0
10480058|NCT01129284|11629060|FG000|STARTED|Overall Study||5
10480059|NCT01129284|11629061|FG001|STARTED|Overall Study||5
10480060|NCT01129284|11629062|FG002|STARTED|Overall Study||5
10480061|NCT01129284|11629060|FG000|COMPLETED|Overall Study||3
10480062|NCT01129284|11629061|FG001|COMPLETED|Overall Study||5
10480063|NCT01129284|11629062|FG002|COMPLETED|Overall Study||4
10480064|NCT01129284|11629060|FG000|NOT COMPLETED|Overall Study||2
10480065|NCT01129284|11629061|FG001|NOT COMPLETED|Overall Study||0
10480066|NCT01129284|11629062|FG002|NOT COMPLETED|Overall Study||1
10480067|NCT01129336|11629072|FG000|STARTED|Overall Study||15
10709536|NCT02641353|11874545|FG001|NOT COMPLETED|Overall Study||0
10709537|NCT02641353|11874546|FG002|NOT COMPLETED|Overall Study||0
10709538|NCT02641353|11874547|FG003|NOT COMPLETED|Overall Study||0
10709539|NCT02641353|11874548|FG004|NOT COMPLETED|Overall Study||0
10709540|NCT02641353|11874549|FG005|NOT COMPLETED|Overall Study||0
10709541|NCT02641379|11874571|FG000|STARTED|Overall Study||142
10709542|NCT02641379|11874572|FG001|STARTED|Overall Study||152
10709543|NCT02641379|11874573|FG002|STARTED|Overall Study||78
10709544|NCT02641379|11874574|FG003|STARTED|Overall Study||156
10709545|NCT02641379|11874575|FG004|STARTED|Overall Study||17
10709546|NCT02641379|11874576|FG005|STARTED|Overall Study||36
10709547|NCT02641379|11874577|FG006|STARTED|Overall Study||25
10709548|NCT02641379|11874578|FG007|STARTED|Overall Study||20
10709549|NCT02641379|11874579|FG008|STARTED|Overall Study||42
10709550|NCT02641379|11874580|FG009|STARTED|Overall Study||45
10709551|NCT02641379|11874581|FG010|STARTED|Overall Study||8
10709552|NCT02641379|11874571|FG000|COMPLETED|Overall Study||107
10709553|NCT02641379|11874572|FG001|COMPLETED|Overall Study||101
10709554|NCT02641379|11874573|FG002|COMPLETED|Overall Study||7
10709555|NCT02641379|11874574|FG003|COMPLETED|Overall Study||139
10709556|NCT02641379|11874575|FG004|COMPLETED|Overall Study||0
10709557|NCT02641379|11874576|FG005|COMPLETED|Overall Study||20
10709558|NCT02641379|11874577|FG006|COMPLETED|Overall Study||12
10709559|NCT02641379|11874578|FG007|COMPLETED|Overall Study||1
10709560|NCT02641379|11874579|FG008|COMPLETED|Overall Study||36
10709561|NCT02641379|11874580|FG009|COMPLETED|Overall Study||36
10709562|NCT02641379|11874581|FG010|COMPLETED|Overall Study||0
10709563|NCT02641379|11874571|FG000|NOT COMPLETED|Overall Study||35
10709564|NCT02641379|11874572|FG001|NOT COMPLETED|Overall Study||51
10709565|NCT02641379|11874573|FG002|NOT COMPLETED|Overall Study||71
10709566|NCT02641379|11874574|FG003|NOT COMPLETED|Overall Study||17
10709567|NCT02641379|11874575|FG004|NOT COMPLETED|Overall Study||17
10709568|NCT02641379|11874576|FG005|NOT COMPLETED|Overall Study||16
10709569|NCT02641379|11874577|FG006|NOT COMPLETED|Overall Study||13
10709570|NCT02641379|11874578|FG007|NOT COMPLETED|Overall Study||19
10709571|NCT02641379|11874579|FG008|NOT COMPLETED|Overall Study||6
10480068|NCT01129336|11629073|FG001|STARTED|Overall Study||29
10480069|NCT01129336|11629072|FG000|Completed Treatment|Overall Study||1
10480070|NCT01129336|11629073|FG001|Completed Treatment|Overall Study||3
10480071|NCT01129336|11629072|FG000|COMPLETED|Overall Study|Completed indicates Completed Study as per protocol.|3
10480072|NCT01129336|11629073|FG001|COMPLETED|Overall Study|Completed indicates Completed Study as per protocol.|13
10480073|NCT01129336|11629072|FG000|NOT COMPLETED|Overall Study||12
10480074|NCT01129336|11629073|FG001|NOT COMPLETED|Overall Study||16
10709572|NCT02641379|11874580|FG009|NOT COMPLETED|Overall Study||9
10709573|NCT02641379|11874581|FG010|NOT COMPLETED|Overall Study||8
10709574|NCT02641392|11874613|FG000|STARTED|Overall Study||4
10709575|NCT02641392|11874614|FG001|STARTED|Overall Study||13
10709576|NCT02641392|11874615|FG002|STARTED|Overall Study||293
10709577|NCT02641392|11874613|FG000|COMPLETED|Overall Study||0
10709578|NCT02641392|11874614|FG001|COMPLETED|Overall Study||0
10709579|NCT02641392|11874615|FG002|COMPLETED|Overall Study||0
10709580|NCT02641392|11874613|FG000|NOT COMPLETED|Overall Study||4
10709581|NCT02641392|11874614|FG001|NOT COMPLETED|Overall Study||13
10480075|NCT01129440|11629081|FG000|STARTED|Overall Study||297
10480076|NCT01129440|11629082|FG001|STARTED|Overall Study||300
10480077|NCT01129440|11629081|FG000|12 Month Follow-up|Overall Study||249
10480078|NCT01129440|11629082|FG001|12 Month Follow-up|Overall Study||256
10480079|NCT01129440|11629081|FG000|24 Month Follow-up|Overall Study||239
10480080|NCT01129440|11629082|FG001|24 Month Follow-up|Overall Study||258
10480081|NCT01129440|11629081|FG000|COMPLETED|Overall Study||246
10480082|NCT01129440|11629082|FG001|COMPLETED|Overall Study||258
10480083|NCT01129440|11629081|FG000|NOT COMPLETED|Overall Study||51
10480084|NCT01129440|11629082|FG001|NOT COMPLETED|Overall Study||42
10480085|NCT01129531|11629092|FG000|STARTED|Treatment Cycle 1||84
10480086|NCT01129531|11629093|FG001|STARTED|Treatment Cycle 1||84
10480087|NCT01129531|11629094|FG002|STARTED|Treatment Cycle 1||126
10480088|NCT01129531|11629092|FG000|COMPLETED|Treatment Cycle 1||80
10480089|NCT01129531|11629093|FG001|COMPLETED|Treatment Cycle 1||78
10480090|NCT01129531|11629094|FG002|COMPLETED|Treatment Cycle 1||110
10480091|NCT01129531|11629092|FG000|NOT COMPLETED|Treatment Cycle 1||4
10480092|NCT01129531|11629093|FG001|NOT COMPLETED|Treatment Cycle 1||6
10480093|NCT01129531|11629094|FG002|NOT COMPLETED|Treatment Cycle 1||16
10480094|NCT01129531|11629092|FG000|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|94
10480095|NCT01129531|11629093|FG001|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|95
10480096|NCT01129531|11629094|FG002|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|79
10480097|NCT01129531|11629092|FG000|COMPLETED|Treatment Cycle 2||88
10480098|NCT01129531|11629093|FG001|COMPLETED|Treatment Cycle 2||92
10480099|NCT01129531|11629094|FG002|COMPLETED|Treatment Cycle 2||74
10480100|NCT01129531|11629092|FG000|NOT COMPLETED|Treatment Cycle 2||6
10480101|NCT01129531|11629093|FG001|NOT COMPLETED|Treatment Cycle 2||3
10338227|NCT00368966|11475113|FG000|NOT COMPLETED|After Infant||6
10338228|NCT00368966|11475114|FG001|NOT COMPLETED|After Infant||5
10338229|NCT00368966|11475113|FG000|STARTED|Toddler Dose||293
10338230|NCT00368966|11475114|FG001|STARTED|Toddler Dose||289
10338231|NCT00368966|11475113|FG000|COMPLETED|Toddler Dose||292
10338232|NCT00368966|11475114|FG001|COMPLETED|Toddler Dose||286
10338233|NCT00368966|11475113|FG000|NOT COMPLETED|Toddler Dose||1
10480102|NCT01129531|11629094|FG002|NOT COMPLETED|Treatment Cycle 2||5
10480103|NCT01129557|11629109|FG000|STARTED|Overall Study||15
10480104|NCT01129557|11629110|FG001|STARTED|Overall Study||17
10480105|NCT01129557|11629111|FG002|STARTED|Overall Study||14
10480106|NCT01129557|11629109|FG000|COMPLETED|Overall Study||11
10480107|NCT01129557|11629110|FG001|COMPLETED|Overall Study||12
10480108|NCT01129557|11629111|FG002|COMPLETED|Overall Study||10
10480109|NCT01129557|11629109|FG000|NOT COMPLETED|Overall Study||4
10480110|NCT01129557|11629110|FG001|NOT COMPLETED|Overall Study||5
10480111|NCT01129557|11629111|FG002|NOT COMPLETED|Overall Study||4
10480112|NCT01129583|11629132|FG000|STARTED|Overall Study||9
10480113|NCT01129583|11629133|FG001|STARTED|Overall Study||9
10480114|NCT01129583|11629132|FG000|COMPLETED|Overall Study||6
10480115|NCT01129583|11629133|FG001|COMPLETED|Overall Study||7
10480116|NCT01129583|11629132|FG000|NOT COMPLETED|Overall Study||3
10480117|NCT01129583|11629133|FG001|NOT COMPLETED|Overall Study||2
10480118|NCT01129609|11629139|FG000|STARTED|Overall Study||20
10480119|NCT01129609|11629139|FG000|COMPLETED|Overall Study||18
10480120|NCT01129609|11629139|FG000|NOT COMPLETED|Overall Study||2
10480121|NCT01129622|11629143|FG000|STARTED|Overall Study||16
10480122|NCT01129622|11629143|FG000|COMPLETED|Overall Study||14
10480123|NCT01129622|11629143|FG000|NOT COMPLETED|Overall Study||2
10480124|NCT01129765|11629148|FG000|STARTED|Overall Study||30
10480125|NCT01129765|11629148|FG000|COMPLETED|Overall Study||30
10480126|NCT01129765|11629148|FG000|NOT COMPLETED|Overall Study||0
10480127|NCT01129778|11629152|FG000|STARTED|Overall Study||22
10480128|NCT01129778|11629152|FG000|COMPLETED|Overall Study||15
10480129|NCT01129778|11629152|FG000|NOT COMPLETED|Overall Study||7
10480130|NCT01129804|11629158|FG000|STARTED|Overall Study||96
10480131|NCT01129804|11629159|FG001|STARTED|Overall Study||97
10480132|NCT01129804|11629158|FG000|COMPLETED|Overall Study||64
10480133|NCT01129804|11629159|FG001|COMPLETED|Overall Study||66
10480134|NCT01129804|11629158|FG000|NOT COMPLETED|Overall Study||32
10480135|NCT01129804|11629159|FG001|NOT COMPLETED|Overall Study||31
10480136|NCT01129882|11629165|FG000|STARTED|Overall Study||709
10480137|NCT01129882|11629165|FG000|Received at Least 1 Dose of Study Drug|Overall Study||709
10480138|NCT01129882|11629165|FG000|COMPLETED|Overall Study||431
10480139|NCT01129882|11629165|FG000|NOT COMPLETED|Overall Study||278
10480140|NCT01129921|11629171|FG000|STARTED|Prior to Sham Cross-over, 6-12 Weeks||20
10480141|NCT01129921|11629172|FG001|STARTED|Prior to Sham Cross-over, 6-12 Weeks||20
10480142|NCT01129921|11629171|FG000|COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||20
10480143|NCT01129921|11629172|FG001|COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||20
10480144|NCT01129921|11629171|FG000|NOT COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||0
10480145|NCT01129921|11629172|FG001|NOT COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||0
10480146|NCT01129921|11629171|FG000|STARTED|After Sham Cross-over to Mild, One Year||20
10480147|NCT01129921|11629172|FG001|STARTED|After Sham Cross-over to Mild, One Year||20
10480148|NCT01129921|11629171|FG000|COMPLETED|After Sham Cross-over to Mild, One Year|All 20 completed Wk 6-12 Intent to Treat analysis. Eighteen reported Year 1 outcomes.|18
10480149|NCT01129921|11629172|FG001|COMPLETED|After Sham Cross-over to Mild, One Year|All 20 completed Wk 6-12 Intent to Treat analysis prior to x-over. After x-over 13 reported Year 1.|13
10480150|NCT01129921|11629171|FG000|NOT COMPLETED|After Sham Cross-over to Mild, One Year||2
10338234|NCT00368966|11475114|FG001|NOT COMPLETED|Toddler Dose||3
10480151|NCT01129921|11629172|FG001|NOT COMPLETED|After Sham Cross-over to Mild, One Year||7
10480152|NCT01129960|11629186|FG000|STARTED|Overall Study||84
10480153|NCT01129960|11629187|FG001|STARTED|Overall Study||83
10709582|NCT02641392|11874615|FG002|NOT COMPLETED|Overall Study||293
10709583|NCT02641522|11874623|FG000|STARTED|Overall Study||10
10709584|NCT02641522|11874623|FG000|COMPLETED|Overall Study||10
10480154|NCT01129960|11629188|FG002|STARTED|Overall Study||82
10480155|NCT01129960|11629189|FG003|STARTED|Overall Study||83
10480156|NCT01129960|11629186|FG000|Safety|Overall Study||84
10480157|NCT01129960|11629187|FG001|Safety|Overall Study||83
10480158|NCT01129960|11629188|FG002|Safety|Overall Study|One subject was randomized to placebo, but was dispensed in error with an ESL 800 mg kit at DB Visit|83
10480159|NCT01129960|11629189|FG003|Safety|Overall Study||82
10480160|NCT01129960|11629186|FG000|Intent-to-Treat|Overall Study||84
10480161|NCT01129960|11629187|FG001|Intent-to-Treat|Overall Study||83
10480162|NCT01129960|11629188|FG002|Intent-to-Treat|Overall Study||82
10480163|NCT01129960|11629189|FG003|Intent-to-Treat|Overall Study||83
10480164|NCT01129960|11629186|FG000|Per-Protocol|Overall Study||34
10480165|NCT01129960|11629187|FG001|Per-Protocol|Overall Study||52
10480166|NCT01129960|11629188|FG002|Per-Protocol|Overall Study||49
10480167|NCT01129960|11629189|FG003|Per-Protocol|Overall Study||55
10480168|NCT01129960|11629186|FG000|Full Analysis Set (FAS|Overall Study||71
10480169|NCT01129960|11629187|FG001|Full Analysis Set (FAS|Overall Study||67
10480170|NCT01129960|11629188|FG002|Full Analysis Set (FAS|Overall Study||68
10480171|NCT01129960|11629189|FG003|Full Analysis Set (FAS|Overall Study||71
10480172|NCT01129960|11629186|FG000|COMPLETED|Overall Study||54
10480173|NCT01129960|11629187|FG001|COMPLETED|Overall Study||61
10480174|NCT01129960|11629188|FG002|COMPLETED|Overall Study||56
10480175|NCT01129960|11629189|FG003|COMPLETED|Overall Study||70
10480176|NCT01129960|11629186|FG000|NOT COMPLETED|Overall Study||30
10480177|NCT01129960|11629187|FG001|NOT COMPLETED|Overall Study||22
10480178|NCT01129960|11629188|FG002|NOT COMPLETED|Overall Study||26
10480179|NCT01129960|11629189|FG003|NOT COMPLETED|Overall Study||13
10480180|NCT01130051|11629199|FG000|STARTED|Period 1||8
10480181|NCT01130051|11629200|FG001|STARTED|Period 1||8
10480182|NCT01130051|11629199|FG000|COMPLETED|Period 1||8
10480183|NCT01130051|11629200|FG001|COMPLETED|Period 1||8
10480184|NCT01130051|11629199|FG000|NOT COMPLETED|Period 1||0
10480185|NCT01130051|11629200|FG001|NOT COMPLETED|Period 1||0
10480186|NCT01130051|11629199|FG000|STARTED|Washout Period of 14 Days||8
10480187|NCT01130051|11629200|FG001|STARTED|Washout Period of 14 Days||8
10480188|NCT01130051|11629199|FG000|COMPLETED|Washout Period of 14 Days||7
10480189|NCT01130051|11629200|FG001|COMPLETED|Washout Period of 14 Days||6
10480190|NCT01130051|11629199|FG000|NOT COMPLETED|Washout Period of 14 Days||1
10480191|NCT01130051|11629200|FG001|NOT COMPLETED|Washout Period of 14 Days||2
10480192|NCT01130051|11629199|FG000|STARTED|Period 2||7
10480193|NCT01130051|11629200|FG001|STARTED|Period 2||6
10480194|NCT01130051|11629199|FG000|COMPLETED|Period 2||7
10480195|NCT01130051|11629200|FG001|COMPLETED|Period 2||6
10480196|NCT01130051|11629199|FG000|NOT COMPLETED|Period 2||0
10480197|NCT01130051|11629200|FG001|NOT COMPLETED|Period 2||0
10480198|NCT01130103|11629208|FG000|STARTED|Randomized Treatment||19
10480199|NCT01130103|11629209|FG001|STARTED|Randomized Treatment||18
10480200|NCT01130103|11629208|FG000|COMPLETED|Randomized Treatment||13
10480201|NCT01130103|11629209|FG001|COMPLETED|Randomized Treatment||13
10480202|NCT01130103|11629208|FG000|NOT COMPLETED|Randomized Treatment||6
10480203|NCT01130103|11629209|FG001|NOT COMPLETED|Randomized Treatment||5
10480204|NCT01130103|11629208|FG000|STARTED|Maintenance Treatment||13
10480205|NCT01130103|11629209|FG001|STARTED|Maintenance Treatment||13
10480206|NCT01130103|11629208|FG000|COMPLETED|Maintenance Treatment||11
10480207|NCT01130103|11629209|FG001|COMPLETED|Maintenance Treatment||11
10480208|NCT01130103|11629208|FG000|NOT COMPLETED|Maintenance Treatment||2
10480209|NCT01130103|11629209|FG001|NOT COMPLETED|Maintenance Treatment||2
10480210|NCT01130168|11629215|FG000|STARTED|Period 1||6
10480211|NCT01130168|11629216|FG001|STARTED|Period 1||7
10480212|NCT01130168|11629217|FG002|STARTED|Period 1||6
10480213|NCT01130168|11629218|FG003|STARTED|Period 1||8
10480214|NCT01130168|11629219|FG004|STARTED|Period 1||5
10480215|NCT01130168|11629220|FG005|STARTED|Period 1||6
10480216|NCT01130168|11629215|FG000|COMPLETED|Period 1||6
10480217|NCT01130168|11629216|FG001|COMPLETED|Period 1||6
10480218|NCT01130168|11629217|FG002|COMPLETED|Period 1||5
10480219|NCT01130168|11629218|FG003|COMPLETED|Period 1||5
10480220|NCT01130168|11629219|FG004|COMPLETED|Period 1||5
10480221|NCT01130168|11629220|FG005|COMPLETED|Period 1||6
10480222|NCT01130168|11629215|FG000|NOT COMPLETED|Period 1||0
10480223|NCT01130168|11629216|FG001|NOT COMPLETED|Period 1||1
10480224|NCT01130168|11629217|FG002|NOT COMPLETED|Period 1||1
10480225|NCT01130168|11629218|FG003|NOT COMPLETED|Period 1||3
10480226|NCT01130168|11629219|FG004|NOT COMPLETED|Period 1||0
10480227|NCT01130168|11629220|FG005|NOT COMPLETED|Period 1||0
10480228|NCT01130168|11629215|FG000|STARTED|Period 2||6
10480229|NCT01130168|11629216|FG001|STARTED|Period 2||6
10480230|NCT01130168|11629217|FG002|STARTED|Period 2||5
10709585|NCT02641522|11874623|FG000|NOT COMPLETED|Overall Study||0
10480231|NCT01130168|11629218|FG003|STARTED|Period 2||5
10480232|NCT01130168|11629219|FG004|STARTED|Period 2||5
10480233|NCT01130168|11629220|FG005|STARTED|Period 2||6
10480234|NCT01130168|11629215|FG000|COMPLETED|Period 2||6
10480235|NCT01130168|11629216|FG001|COMPLETED|Period 2||6
10480236|NCT01130168|11629217|FG002|COMPLETED|Period 2||5
10709586|NCT02641561|11874631|FG000|STARTED|Overall Study||48
10709587|NCT02641561|11874632|FG001|STARTED|Overall Study||48
10480237|NCT01130168|11629218|FG003|COMPLETED|Period 2||5
10480238|NCT01130168|11629219|FG004|COMPLETED|Period 2||5
10480239|NCT01130168|11629220|FG005|COMPLETED|Period 2||6
10480240|NCT01130168|11629215|FG000|NOT COMPLETED|Period 2||0
10480241|NCT01130168|11629216|FG001|NOT COMPLETED|Period 2||0
10480242|NCT01130168|11629217|FG002|NOT COMPLETED|Period 2||0
10480243|NCT01130168|11629218|FG003|NOT COMPLETED|Period 2||0
10480244|NCT01130168|11629219|FG004|NOT COMPLETED|Period 2||0
10480245|NCT01130168|11629220|FG005|NOT COMPLETED|Period 2||0
10480246|NCT01130168|11629215|FG000|STARTED|Period 3||6
10480247|NCT01130168|11629216|FG001|STARTED|Period 3||6
10480248|NCT01130168|11629217|FG002|STARTED|Period 3||5
10480249|NCT01130168|11629218|FG003|STARTED|Period 3||5
10480250|NCT01130168|11629219|FG004|STARTED|Period 3||5
10480251|NCT01130168|11629220|FG005|STARTED|Period 3||6
10480252|NCT01130168|11629215|FG000|COMPLETED|Period 3||6
10480253|NCT01130168|11629216|FG001|COMPLETED|Period 3||6
10480254|NCT01130168|11629217|FG002|COMPLETED|Period 3||5
10480255|NCT01130168|11629218|FG003|COMPLETED|Period 3||5
10480256|NCT01130168|11629219|FG004|COMPLETED|Period 3||5
10480257|NCT01130168|11629220|FG005|COMPLETED|Period 3||6
10480258|NCT01130168|11629215|FG000|NOT COMPLETED|Period 3||0
10480259|NCT01130168|11629216|FG001|NOT COMPLETED|Period 3||0
10480260|NCT01130168|11629217|FG002|NOT COMPLETED|Period 3||0
10480261|NCT01130168|11629218|FG003|NOT COMPLETED|Period 3||0
10480262|NCT01130168|11629219|FG004|NOT COMPLETED|Period 3||0
10480263|NCT01130168|11629220|FG005|NOT COMPLETED|Period 3||0
10480264|NCT01130272|11629234|FG000|STARTED|Overall Study||107
10480265|NCT01130272|11629235|FG001|STARTED|Overall Study||173
10480266|NCT01130272|11629236|FG002|STARTED|Overall Study||169
10480267|NCT01130272|11629237|FG003|STARTED|Overall Study||171
10480268|NCT01130272|11629238|FG004|STARTED|Overall Study||169
10480269|NCT01130272|11629234|FG000|Safety Analysis Set: as Randomized|Overall Study||105
10480270|NCT01130272|11629235|FG001|Safety Analysis Set: as Randomized|Overall Study||171
10480271|NCT01130272|11629236|FG002|Safety Analysis Set: as Randomized|Overall Study||166
10480272|NCT01130272|11629237|FG003|Safety Analysis Set: as Randomized|Overall Study||167
10480273|NCT01130272|11629238|FG004|Safety Analysis Set: as Randomized|Overall Study||162
10480274|NCT01130272|11629234|FG000|Safety Analysis Set: Highest Dose Level|Overall Study|105 total represents 1 patient in from Placebo arm; 1 patient out to 200 mg arm.|105
10480275|NCT01130272|11629235|FG001|Safety Analysis Set: Highest Dose Level|Overall Study|170 total represents 2 patients in from Placebo arm; 3 patients out to 200 mg arm.|170
10480276|NCT01130272|11629236|FG002|Safety Analysis Set: Highest Dose Level|Overall Study|165 total represents 1 patient out to 200 mg arm.|165
10480277|NCT01130272|11629237|FG003|Safety Analysis Set: Highest Dose Level|Overall Study|172 total represents 1 patient in from 5 mg; 3 patients in from 25 mg;1 patient in from 100 mg arms.|172
10480278|NCT01130272|11629238|FG004|Safety Analysis Set: Highest Dose Level|Overall Study|159 total represents 2 patients out to 25 mg arm; 1 patient out to 5 mg arm.|159
10480279|NCT01130272|11629234|FG000|COMPLETED|Overall Study||48
10480280|NCT01130272|11629235|FG001|COMPLETED|Overall Study||131
10480281|NCT01130272|11629236|FG002|COMPLETED|Overall Study||121
10480282|NCT01130272|11629237|FG003|COMPLETED|Overall Study||103
10480283|NCT01130272|11629238|FG004|COMPLETED|Overall Study||117
10480284|NCT01130272|11629234|FG000|NOT COMPLETED|Overall Study||59
10480285|NCT01130272|11629235|FG001|NOT COMPLETED|Overall Study||42
10480286|NCT01130272|11629236|FG002|NOT COMPLETED|Overall Study||48
10480287|NCT01130272|11629237|FG003|NOT COMPLETED|Overall Study||68
10480288|NCT01130272|11629238|FG004|NOT COMPLETED|Overall Study||52
10480289|NCT01130337|11629250|FG000|STARTED|Overall Study||36
10480290|NCT01130337|11629250|FG000|COMPLETED|Overall Study||22
10480291|NCT01130337|11629250|FG000|NOT COMPLETED|Overall Study||14
10480292|NCT01130493|11629254|FG000|STARTED|Open-label Dose Conversion to IPX066|During the open-label dose conversion to IPX066, all subjects received IPX066|110
10480293|NCT01130493|11629255|FG001|STARTED|Open-label Dose Conversion to IPX066||0
10480294|NCT01130493|11629256|FG002|STARTED|Open-label Dose Conversion to IPX066||0
10480295|NCT01130493|11629254|FG000|COMPLETED|Open-label Dose Conversion to IPX066||91
10480296|NCT01130493|11629255|FG001|COMPLETED|Open-label Dose Conversion to IPX066||0
10480297|NCT01130493|11629256|FG002|COMPLETED|Open-label Dose Conversion to IPX066||0
10480298|NCT01130493|11629254|FG000|NOT COMPLETED|Open-label Dose Conversion to IPX066||19
10480299|NCT01130493|11629255|FG001|NOT COMPLETED|Open-label Dose Conversion to IPX066||0
10480377|NCT01130740|11629292|FG001|NOT COMPLETED|Overall Study||15
10480300|NCT01130493|11629256|FG002|NOT COMPLETED|Open-label Dose Conversion to IPX066||0
10480301|NCT01130493|11629254|FG000|STARTED|Part 1: Double-blind Treatment Period 1|91 subjects completed IPX066 dose conversion and were then randomized to the two treatment sequences|0
10480302|NCT01130493|11629255|FG001|STARTED|Part 1: Double-blind Treatment Period 1|48 were randomized to IPX066-CLE double-blind treatment sequence|48
10480303|NCT01130493|11629256|FG002|STARTED|Part 1: Double-blind Treatment Period 1|43 were randomized to CLE-IPX066 double-blind treatment sequence|43
10480304|NCT01130493|11629254|FG000|COMPLETED|Part 1: Double-blind Treatment Period 1||0
10480305|NCT01130493|11629255|FG001|COMPLETED|Part 1: Double-blind Treatment Period 1||46
10480306|NCT01130493|11629256|FG002|COMPLETED|Part 1: Double-blind Treatment Period 1||43
10480307|NCT01130493|11629254|FG000|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||0
10480308|NCT01130493|11629255|FG001|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||2
10480309|NCT01130493|11629256|FG002|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||0
10480310|NCT01130493|11629254|FG000|STARTED|Part 1: Open-Label IPX066 Washout||0
10480311|NCT01130493|11629255|FG001|STARTED|Part 1: Open-Label IPX066 Washout||46
10480312|NCT01130493|11629256|FG002|STARTED|Part 1: Open-Label IPX066 Washout||43
10480313|NCT01130493|11629254|FG000|COMPLETED|Part 1: Open-Label IPX066 Washout||0
10480314|NCT01130493|11629255|FG001|COMPLETED|Part 1: Open-Label IPX066 Washout||45
10480315|NCT01130493|11629256|FG002|COMPLETED|Part 1: Open-Label IPX066 Washout||41
10480316|NCT01130493|11629254|FG000|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||0
10480317|NCT01130493|11629255|FG001|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||1
10480318|NCT01130493|11629256|FG002|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||2
10480319|NCT01130493|11629254|FG000|STARTED|Part 1: Double-blind Treatment Period 2||0
10480320|NCT01130493|11629255|FG001|STARTED|Part 1: Double-blind Treatment Period 2||45
10480321|NCT01130493|11629256|FG002|STARTED|Part 1: Double-blind Treatment Period 2||41
10480322|NCT01130493|11629254|FG000|COMPLETED|Part 1: Double-blind Treatment Period 2||0
10480323|NCT01130493|11629255|FG001|COMPLETED|Part 1: Double-blind Treatment Period 2||45
10480324|NCT01130493|11629256|FG002|COMPLETED|Part 1: Double-blind Treatment Period 2||39
10480325|NCT01130493|11629254|FG000|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||0
10480326|NCT01130493|11629255|FG001|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||0
10480327|NCT01130493|11629256|FG002|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||2
10480328|NCT01130493|11629254|FG000|STARTED|Part 2: OLE||0
10480329|NCT01130493|11629255|FG001|STARTED|Part 2: OLE|All subjects received IPX066 during OLE|39
10480330|NCT01130493|11629256|FG002|STARTED|Part 2: OLE|No subjects received CLE during OLE|35
10480331|NCT01130493|11629254|FG000|COMPLETED|Part 2: OLE||0
10480332|NCT01130493|11629255|FG001|COMPLETED|Part 2: OLE||36
10480333|NCT01130493|11629256|FG002|COMPLETED|Part 2: OLE||30
10480334|NCT01130493|11629254|FG000|NOT COMPLETED|Part 2: OLE||0
10480335|NCT01130493|11629255|FG001|NOT COMPLETED|Part 2: OLE||3
10480336|NCT01130493|11629256|FG002|NOT COMPLETED|Part 2: OLE||5
10480337|NCT01130532|11629270|FG000|STARTED|Period III (Weeks 0-12)||207
10480338|NCT01130532|11629271|FG001|STARTED|Period III (Weeks 0-12)||207
10480339|NCT01130532|11629272|FG002|STARTED|Period III (Weeks 0-12)||209
10480340|NCT01130532|11629273|FG003|STARTED|Period III (Weeks 0-12)||0
10480341|NCT01130532|11629270|FG000|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||205
10480342|NCT01130532|11629271|FG001|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||205
10480343|NCT01130532|11629272|FG002|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||207
10480344|NCT01130532|11629273|FG003|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||0
10480345|NCT01130532|11629270|FG000|COMPLETED|Period III (Weeks 0-12)||186
10480346|NCT01130532|11629271|FG001|COMPLETED|Period III (Weeks 0-12)||189
10480347|NCT01130532|11629272|FG002|COMPLETED|Period III (Weeks 0-12)||190
10480348|NCT01130532|11629273|FG003|COMPLETED|Period III (Weeks 0-12)||0
10480349|NCT01130532|11629270|FG000|NOT COMPLETED|Period III (Weeks 0-12)||21
10480350|NCT01130532|11629271|FG001|NOT COMPLETED|Period III (Weeks 0-12)||18
10480351|NCT01130532|11629272|FG002|NOT COMPLETED|Period III (Weeks 0-12)||19
10480352|NCT01130532|11629273|FG003|NOT COMPLETED|Period III (Weeks 0-12)||0
10480353|NCT01130532|11629270|FG000|STARTED|Period IV (Weeks 13-16)||0
10480354|NCT01130532|11629271|FG001|STARTED|Period IV (Weeks 13-16)||0
10480355|NCT01130532|11629272|FG002|STARTED|Period IV (Weeks 13-16)||0
10480356|NCT01130532|11629273|FG003|STARTED|Period IV (Weeks 13-16)|Three participants who completed Period III chose not to continue into Period IV.|562
10480357|NCT01130532|11629270|FG000|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
10480358|NCT01130532|11629271|FG001|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
10480359|NCT01130532|11629272|FG002|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
10480360|NCT01130532|11629273|FG003|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||546
10480361|NCT01130532|11629270|FG000|COMPLETED|Period IV (Weeks 13-16)||0
10480362|NCT01130532|11629271|FG001|COMPLETED|Period IV (Weeks 13-16)||0
10480363|NCT01130532|11629272|FG002|COMPLETED|Period IV (Weeks 13-16)||0
10480364|NCT01130532|11629273|FG003|COMPLETED|Period IV (Weeks 13-16)||552
10480365|NCT01130532|11629270|FG000|NOT COMPLETED|Period IV (Weeks 13-16)||0
10480366|NCT01130532|11629271|FG001|NOT COMPLETED|Period IV (Weeks 13-16)||0
10480367|NCT01130532|11629272|FG002|NOT COMPLETED|Period IV (Weeks 13-16)||0
10480368|NCT01130532|11629273|FG003|NOT COMPLETED|Period IV (Weeks 13-16)||10
10480369|NCT01130597|11629285|FG000|STARTED|Overall Study||63
10480370|NCT01130597|11629285|FG000|COMPLETED|Overall Study||56
10480371|NCT01130597|11629285|FG000|NOT COMPLETED|Overall Study||7
10480372|NCT01130740|11629291|FG000|STARTED|Overall Study||149
10480373|NCT01130740|11629292|FG001|STARTED|Overall Study||151
10480374|NCT01130740|11629291|FG000|COMPLETED|Overall Study||137
10480375|NCT01130740|11629292|FG001|COMPLETED|Overall Study||136
10480376|NCT01130740|11629291|FG000|NOT COMPLETED|Overall Study||12
10480378|NCT01130831|11629298|FG000|STARTED|Overall Study||66
10480379|NCT01130831|11629298|FG000|COMPLETED|Overall Study||52
10480380|NCT01130831|11629298|FG000|NOT COMPLETED|Overall Study||14
10480381|NCT01130844|11629317|FG000|STARTED|Overall Study||21
10480382|NCT01130844|11629318|FG001|STARTED|Overall Study||22
10480383|NCT01130844|11629319|FG002|STARTED|Overall Study||9
10480384|NCT01130844|11629317|FG000|COMPLETED|Overall Study||21
10480385|NCT01130844|11629318|FG001|COMPLETED|Overall Study||22
10480386|NCT01130844|11629319|FG002|COMPLETED|Overall Study||9
10480387|NCT01130844|11629317|FG000|NOT COMPLETED|Overall Study||0
10480388|NCT01130844|11629318|FG001|NOT COMPLETED|Overall Study||0
10480389|NCT01130844|11629319|FG002|NOT COMPLETED|Overall Study||0
10480390|NCT01130883|11629330|FG000|STARTED|Overall Study||3130
10480391|NCT01130883|11629330|FG000|Participants Analyzed|Overall Study||3128
10480392|NCT01130883|11629330|FG000|COMPLETED|Overall Study||3120
10480393|NCT01130883|11629330|FG000|NOT COMPLETED|Overall Study||10
10480394|NCT01130896|11629334|FG000|STARTED|Overall Study||1509
10480395|NCT01130896|11629334|FG000|COMPLETED|Overall Study||1509
10480396|NCT01130896|11629334|FG000|NOT COMPLETED|Overall Study||0
10480397|NCT01130974|11629340|FG000|STARTED|Overall Study||100
10480398|NCT01130974|11629341|FG001|STARTED|Overall Study||100
10480399|NCT01130974|11629340|FG000|COMPLETED|Overall Study||85
10480400|NCT01130974|11629341|FG001|COMPLETED|Overall Study||87
10480401|NCT01130974|11629340|FG000|NOT COMPLETED|Overall Study||15
10480402|NCT01130974|11629341|FG001|NOT COMPLETED|Overall Study||13
10480403|NCT01131052|11629350|FG000|STARTED|Overall Study||75
10480404|NCT01131052|11629351|FG001|STARTED|Overall Study||75
10480405|NCT01131052|11629350|FG000|COMPLETED|Overall Study||75
10480406|NCT01131052|11629351|FG001|COMPLETED|Overall Study||75
10480407|NCT01131052|11629350|FG000|NOT COMPLETED|Overall Study||0
10480408|NCT01131052|11629351|FG001|NOT COMPLETED|Overall Study||0
10480409|NCT01131065|11629357|FG000|STARTED|Overall Study||15
10480410|NCT01131065|11629357|FG000|COMPLETED|Overall Study||15
10480411|NCT01131065|11629357|FG000|NOT COMPLETED|Overall Study||0
10480412|NCT01131078|11629364|FG000|STARTED|Overall Study||101
10480413|NCT01131078|11629365|FG001|STARTED|Overall Study||102
10480414|NCT01131078|11629366|FG002|STARTED|Overall Study||103
10480415|NCT01131078|11629364|FG000|COMPLETED|Overall Study||0
10480416|NCT01131078|11629365|FG001|COMPLETED|Overall Study||1
10480417|NCT01131078|11629366|FG002|COMPLETED|Overall Study||1
10480418|NCT01131078|11629364|FG000|NOT COMPLETED|Overall Study||101
10480419|NCT01131078|11629365|FG001|NOT COMPLETED|Overall Study||101
10480420|NCT01131078|11629366|FG002|NOT COMPLETED|Overall Study||102
10480421|NCT01131104|11629376|FG000|STARTED|Overall Study||345
10480422|NCT01131104|11629376|FG000|Study Set|Overall Study||344
10480423|NCT01131104|11629376|FG000|Adjudication-Confirmed NAION Set|Overall Study||279
10480424|NCT01131104|11629376|FG000|30-Day Analysis Set|Overall Study||24
10480425|NCT01131104|11629376|FG000|42-Day Analysis Set|Overall Study||28
10480426|NCT01131104|11629376|FG000|12-Month Analysis Set|Overall Study||26
10480427|NCT01131104|11629376|FG000|COMPLETED|Overall Study||332
10480428|NCT01131104|11629376|FG000|NOT COMPLETED|Overall Study||13
10480429|NCT01131130|11629380|FG000|STARTED|Period 1 - Baseline||118
10480430|NCT01131130|11629380|FG000|COMPLETED|Period 1 - Baseline|Participant was discontinued 1 day following dispensing and not reported in result tables|117
10480431|NCT01131130|11629380|FG000|NOT COMPLETED|Period 1 - Baseline||1
10480432|NCT01131130|11629380|FG000|STARTED|Period 2 - Crossover||117
10480433|NCT01131130|11629380|FG000|COMPLETED|Period 2 - Crossover||117
10480434|NCT01131130|11629380|FG000|NOT COMPLETED|Period 2 - Crossover||0
10480435|NCT01131130|11629380|FG000|STARTED|Period 3- Crossover||117
10480436|NCT01131130|11629380|FG000|COMPLETED|Period 3- Crossover||116
10480437|NCT01131130|11629380|FG000|NOT COMPLETED|Period 3- Crossover||1
10480444|NCT01131260|11629399|FG000|STARTED|Overall Study||5532
10480445|NCT01131260|11629400|FG001|STARTED|Overall Study||5576
10480446|NCT01131260|11629399|FG000|COMPLETED|Overall Study||5488
10480447|NCT01131260|11629400|FG001|COMPLETED|Overall Study||5529
10480448|NCT01131260|11629399|FG000|NOT COMPLETED|Overall Study||44
10480449|NCT01131260|11629400|FG001|NOT COMPLETED|Overall Study||47
10480450|NCT01131299|11629408|FG000|STARTED|Overall Study||42
10480451|NCT01131299|11629409|FG001|STARTED|Overall Study||44
10480452|NCT01131299|11629408|FG000|COMPLETED|Overall Study||38
10480453|NCT01131299|11629409|FG001|COMPLETED|Overall Study||37
10480454|NCT01131299|11629408|FG000|NOT COMPLETED|Overall Study||4
10480455|NCT01131299|11629409|FG001|NOT COMPLETED|Overall Study||7
10480456|NCT01131312|11629417|FG000|STARTED|Overall Study||1839
10480457|NCT01131312|11629418|FG001|STARTED|Overall Study||1385
10480458|NCT01131312|11629419|FG002|STARTED|Overall Study||1836
10480459|NCT01131312|11629417|FG000|COMPLETED|Overall Study||1414
10480460|NCT01131312|11629418|FG001|COMPLETED|Overall Study||1156
10480461|NCT01131312|11629419|FG002|COMPLETED|Overall Study||1485
10480462|NCT01131312|11629417|FG000|NOT COMPLETED|Overall Study||425
10480463|NCT01131312|11629418|FG001|NOT COMPLETED|Overall Study||229
10480464|NCT01131312|11629419|FG002|NOT COMPLETED|Overall Study||351
10480465|NCT01131325|11629427|FG000|STARTED|Overall Study||3
10480466|NCT01131325|11629427|FG000|COMPLETED|Overall Study||0
10480467|NCT01131325|11629427|FG000|NOT COMPLETED|Overall Study||3
10480468|NCT01131351|11629433|FG000|STARTED|Overall Study||5
10480469|NCT01131351|11629434|FG001|STARTED|Overall Study||5
10480470|NCT01131351|11629433|FG000|COMPLETED|Overall Study||5
10480471|NCT01131351|11629434|FG001|COMPLETED|Overall Study||2
10480472|NCT01131351|11629433|FG000|NOT COMPLETED|Overall Study||0
10480473|NCT01131351|11629434|FG001|NOT COMPLETED|Overall Study||3
10480474|NCT01131494|11629440|FG000|STARTED|Overall Study||17
10480475|NCT01131494|11629440|FG000|COMPLETED|Overall Study||15
10480476|NCT01131494|11629440|FG000|NOT COMPLETED|Overall Study||2
10527250|NCT01388543|11679281|FG001|STARTED|Day 14||16
10527251|NCT01388543|11679280|FG000|COMPLETED|Day 14||14
10527252|NCT01388543|11679281|FG001|COMPLETED|Day 14||12
10527253|NCT01388543|11679280|FG000|NOT COMPLETED|Day 14||1
10527254|NCT01388543|11679281|FG001|NOT COMPLETED|Day 14||4
10527255|NCT01388647|11679289|FG000|STARTED|Overall Study||6
10527256|NCT01388647|11679290|FG001|STARTED|Overall Study||6
10527257|NCT01388647|11679289|FG000|COMPLETED|Overall Study|one subject ended study treatment due to adverse events|5
10527258|NCT01388647|11679290|FG001|COMPLETED|Overall Study|two subjects ended study treatment due to adverse events|4
10480477|NCT01131507|11629445|FG000|STARTED|Overall Study||15
10480478|NCT01131507|11629445|FG000|COMPLETED|Overall Study||12
10480479|NCT01131507|11629445|FG000|NOT COMPLETED|Overall Study||3
10480480|NCT01131520|11629451|FG000|STARTED|Overall Study||180
10480481|NCT01131520|11629452|FG001|STARTED|Overall Study||180
10480482|NCT01131520|11629451|FG000|COMPLETED|Overall Study||179
10480483|NCT01131520|11629452|FG001|COMPLETED|Overall Study||176
10480484|NCT01131520|11629451|FG000|NOT COMPLETED|Overall Study||1
10480485|NCT01131520|11629452|FG001|NOT COMPLETED|Overall Study||4
10480486|NCT01131585|11629460|FG000|STARTED|Overall Study||85
10480487|NCT01131585|11629461|FG001|STARTED|Overall Study||43
10480488|NCT01131585|11629460|FG000|COMPLETED|Overall Study||0
10480489|NCT01131585|11629461|FG001|COMPLETED|Overall Study||0
10480490|NCT01131585|11629460|FG000|NOT COMPLETED|Overall Study||85
10480491|NCT01131585|11629461|FG001|NOT COMPLETED|Overall Study||43
10480492|NCT01131676|11629470|FG000|STARTED|Discontinuation From Treatment|Randomised|2337
10480493|NCT01131676|11629471|FG001|STARTED|Discontinuation From Treatment|Randomised|2347
10480494|NCT01131676|11629472|FG002|STARTED|Discontinuation From Treatment|Randomised|2344
10480495|NCT01131676|11629470|FG000|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1650
10480496|NCT01131676|11629471|FG001|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1790
10480497|NCT01131676|11629472|FG002|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1800
10480498|NCT01131676|11629470|FG000|NOT COMPLETED|Discontinuation From Treatment||687
10480499|NCT01131676|11629471|FG001|NOT COMPLETED|Discontinuation From Treatment||557
10480500|NCT01131676|11629472|FG002|NOT COMPLETED|Discontinuation From Treatment||544
10480501|NCT01131676|11629470|FG000|STARTED|Discontinuation From Study (Treated Set)||2333
10480502|NCT01131676|11629471|FG001|STARTED|Discontinuation From Study (Treated Set)||2345
10480503|NCT01131676|11629472|FG002|STARTED|Discontinuation From Study (Treated Set)||2342
10480504|NCT01131676|11629470|FG000|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2316
10480505|NCT01131676|11629471|FG001|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2324
10480506|NCT01131676|11629472|FG002|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2327
10480507|NCT01131676|11629470|FG000|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2266
10480508|NCT01131676|11629471|FG001|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2264
10480509|NCT01131676|11629472|FG002|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2279
10480510|NCT01131676|11629470|FG000|NOT COMPLETED|Discontinuation From Study (Treated Set)||67
10480511|NCT01131676|11629471|FG001|NOT COMPLETED|Discontinuation From Study (Treated Set)||81
10480512|NCT01131676|11629472|FG002|NOT COMPLETED|Discontinuation From Study (Treated Set)||63
10480513|NCT01132118|11629483|FG000|STARTED|First Intervention (8 Weeks)||15
10480514|NCT01132118|11629484|FG001|STARTED|First Intervention (8 Weeks)||15
10480515|NCT01132118|11629483|FG000|COMPLETED|First Intervention (8 Weeks)||12
10480516|NCT01132118|11629484|FG001|COMPLETED|First Intervention (8 Weeks)||12
10480517|NCT01132118|11629483|FG000|NOT COMPLETED|First Intervention (8 Weeks)||3
10480518|NCT01132118|11629484|FG001|NOT COMPLETED|First Intervention (8 Weeks)||3
10480519|NCT01132118|11629483|FG000|STARTED|Second Intervention (8 Weeks)||12
10480520|NCT01132118|11629484|FG001|STARTED|Second Intervention (8 Weeks)||12
10480521|NCT01132118|11629483|FG000|COMPLETED|Second Intervention (8 Weeks)||12
10480522|NCT01132118|11629484|FG001|COMPLETED|Second Intervention (8 Weeks)||11
10480523|NCT01132118|11629483|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||0
10480524|NCT01132118|11629484|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||1
10480525|NCT01132144|11629492|FG000|STARTED|Overall Study||79
10480526|NCT01132144|11629493|FG001|STARTED|Overall Study||79
10480527|NCT01132144|11629492|FG000|COMPLETED|Overall Study||79
10480528|NCT01132144|11629493|FG001|COMPLETED|Overall Study||79
10480529|NCT01132144|11629492|FG000|NOT COMPLETED|Overall Study||0
10480530|NCT01132144|11629493|FG001|NOT COMPLETED|Overall Study||0
10480531|NCT01132313|11629513|FG000|STARTED|Overall Study||17
10480532|NCT01132313|11629514|FG001|STARTED|Overall Study||17
10480533|NCT01132313|11629515|FG002|STARTED|Overall Study||81
10480534|NCT01132313|11629516|FG003|STARTED|Overall Study||80
10480535|NCT01132313|11629517|FG004|STARTED|Overall Study||79
10480536|NCT01132313|11629518|FG005|STARTED|Overall Study||79
10480537|NCT01132313|11629519|FG006|STARTED|Overall Study||49
10480538|NCT01132313|11629520|FG007|STARTED|Overall Study||32
10480539|NCT01132313|11629521|FG008|STARTED|Overall Study||26
10480540|NCT01132313|11629522|FG009|STARTED|Overall Study||25
10480541|NCT01132313|11629523|FG010|STARTED|Overall Study||1
10480542|NCT01132313|11629524|FG011|STARTED|Overall Study||2
10480543|NCT01132313|11629513|FG000|COMPLETED|Overall Study||14
10480544|NCT01132313|11629514|FG001|COMPLETED|Overall Study||17
10480545|NCT01132313|11629515|FG002|COMPLETED|Overall Study||61
10480546|NCT01132313|11629516|FG003|COMPLETED|Overall Study||48
10480547|NCT01132313|11629517|FG004|COMPLETED|Overall Study||34
10480548|NCT01132313|11629518|FG005|COMPLETED|Overall Study||54
10480549|NCT01132313|11629519|FG006|COMPLETED|Overall Study||19
10480550|NCT01132313|11629520|FG007|COMPLETED|Overall Study||24
10480551|NCT01132313|11629521|FG008|COMPLETED|Overall Study||5
10480552|NCT01132313|11629522|FG009|COMPLETED|Overall Study||5
10480553|NCT01132313|11629523|FG010|COMPLETED|Overall Study||0
10480554|NCT01132313|11629524|FG011|COMPLETED|Overall Study||2
10480555|NCT01132313|11629513|FG000|NOT COMPLETED|Overall Study||3
10480556|NCT01132313|11629514|FG001|NOT COMPLETED|Overall Study||0
10480557|NCT01132313|11629515|FG002|NOT COMPLETED|Overall Study||20
10480558|NCT01132313|11629516|FG003|NOT COMPLETED|Overall Study||32
10480559|NCT01132313|11629517|FG004|NOT COMPLETED|Overall Study||45
10480560|NCT01132313|11629518|FG005|NOT COMPLETED|Overall Study||25
10480561|NCT01132313|11629519|FG006|NOT COMPLETED|Overall Study||30
10480562|NCT01132313|11629520|FG007|NOT COMPLETED|Overall Study||8
10480563|NCT01132313|11629521|FG008|NOT COMPLETED|Overall Study||21
10480564|NCT01132313|11629522|FG009|NOT COMPLETED|Overall Study||20
10480565|NCT01132313|11629523|FG010|NOT COMPLETED|Overall Study||1
10480566|NCT01132313|11629524|FG011|NOT COMPLETED|Overall Study||0
10480567|NCT01132326|11629555|FG000|STARTED|Overall Study||350
10480568|NCT01132326|11629555|FG000|COMPLETED|Overall Study||132
10480569|NCT01132326|11629555|FG000|NOT COMPLETED|Overall Study||218
10480570|NCT01132378|11629559|FG000|STARTED|Overall Study||40
10480571|NCT01132378|11629559|FG000|COMPLETED|Overall Study||40
10480572|NCT01132378|11629559|FG000|NOT COMPLETED|Overall Study||0
10480573|NCT01132482|11629566|FG000|STARTED|Overall Study||13
10480574|NCT01132482|11629567|FG001|STARTED|Overall Study||6
10480575|NCT01132482|11629566|FG000|COMPLETED|Overall Study||12
10480576|NCT01132482|11629567|FG001|COMPLETED|Overall Study||6
10480577|NCT01132482|11629566|FG000|NOT COMPLETED|Overall Study||1
10480578|NCT01132482|11629567|FG001|NOT COMPLETED|Overall Study||0
10480579|NCT01132495|11629577|FG000|STARTED|Overall Study||447
10480580|NCT01132495|11629578|FG001|STARTED|Overall Study||441
10480581|NCT01132495|11629579|FG002|STARTED|Overall Study||166
10480582|NCT01132495|11629580|FG003|STARTED|Overall Study||116
10480583|NCT01132495|11629577|FG000|COMPLETED|Overall Study||407
10480584|NCT01132495|11629578|FG001|COMPLETED|Overall Study||403
10480585|NCT01132495|11629579|FG002|COMPLETED|Overall Study||146
10480586|NCT01132495|11629580|FG003|COMPLETED|Overall Study||104
10480587|NCT01132495|11629577|FG000|NOT COMPLETED|Overall Study||40
10480588|NCT01132495|11629578|FG001|NOT COMPLETED|Overall Study||38
10480589|NCT01132495|11629579|FG002|NOT COMPLETED|Overall Study||20
10480590|NCT01132495|11629580|FG003|NOT COMPLETED|Overall Study||12
10480591|NCT01132508|11629591|FG000|STARTED|Overall Study||33
10480592|NCT01132508|11629591|FG000|Treated at Baseline|Overall Study||33
10480593|NCT01132508|11629591|FG000|6 Weeks|Overall Study||33
10480594|NCT01132508|11629591|FG000|12 Weeks|Overall Study||33
10480595|NCT01132508|11629591|FG000|26 Weeks|Overall Study||33
10480596|NCT01132508|11629591|FG000|52 Weeks|Overall Study||30
10480597|NCT01132508|11629591|FG000|78 Weeks|Overall Study||28
10480598|NCT01132508|11629591|FG000|104 Weeks|Overall Study||27
10480599|NCT01132508|11629591|FG000|COMPLETED|Overall Study||24
10480600|NCT01132508|11629591|FG000|NOT COMPLETED|Overall Study||9
10480601|NCT01132547|11629597|FG000|STARTED|Overall Study||9
10480602|NCT01132547|11629598|FG001|STARTED|Overall Study||13
10480603|NCT01132547|11629597|FG000|COMPLETED|Overall Study||5
10480604|NCT01132547|11629598|FG001|COMPLETED|Overall Study||12
10480605|NCT01132547|11629597|FG000|NOT COMPLETED|Overall Study||4
10480606|NCT01132547|11629598|FG001|NOT COMPLETED|Overall Study||1
10480607|NCT01132612|11629607|FG000|STARTED|Overall Study||46
10480608|NCT01132612|11629608|FG001|STARTED|Overall Study||42
10480609|NCT01132612|11629609|FG002|STARTED|Overall Study||187
10480610|NCT01132612|11629607|FG000|COMPLETED|Overall Study||6
10480611|NCT01132612|11629608|FG001|COMPLETED|Overall Study||7
10480612|NCT01132612|11629609|FG002|COMPLETED|Overall Study||17
10480613|NCT01132612|11629607|FG000|NOT COMPLETED|Overall Study||40
10480614|NCT01132612|11629608|FG001|NOT COMPLETED|Overall Study||35
10480615|NCT01132612|11629609|FG002|NOT COMPLETED|Overall Study||170
10480616|NCT01132651|11629619|FG000|STARTED|Overall Study||4
10480617|NCT01132651|11629620|FG001|STARTED|Overall Study||5
10480618|NCT01132651|11629619|FG000|COMPLETED|Overall Study||3
10480619|NCT01132651|11629620|FG001|COMPLETED|Overall Study||4
10480620|NCT01132651|11629619|FG000|NOT COMPLETED|Overall Study||1
10480621|NCT01132651|11629620|FG001|NOT COMPLETED|Overall Study||1
10480622|NCT01132664|11629631|FG000|STARTED|Phase lb||5
10480623|NCT01132664|11629632|FG001|STARTED|Phase lb||12
10480624|NCT01132664|11629633|FG002|STARTED|Phase lb||0
10480625|NCT01132664|11629634|FG003|STARTED|Phase lb||0
10480626|NCT01132664|11629635|FG004|STARTED|Phase lb||0
10480627|NCT01132664|11629631|FG000|COMPLETED|Phase lb||0
10480628|NCT01132664|11629632|FG001|COMPLETED|Phase lb||0
10480629|NCT01132664|11629633|FG002|COMPLETED|Phase lb||0
10480630|NCT01132664|11629634|FG003|COMPLETED|Phase lb||0
10480631|NCT01132664|11629635|FG004|COMPLETED|Phase lb||0
10480632|NCT01132664|11629631|FG000|NOT COMPLETED|Phase lb||5
10480633|NCT01132664|11629632|FG001|NOT COMPLETED|Phase lb||12
10480634|NCT01132664|11629633|FG002|NOT COMPLETED|Phase lb||0
10480635|NCT01132664|11629634|FG003|NOT COMPLETED|Phase lb||0
10480636|NCT01132664|11629635|FG004|NOT COMPLETED|Phase lb||0
10480637|NCT01132664|11629631|FG000|STARTED|Phase ll||0
10480638|NCT01132664|11629632|FG001|STARTED|Phase ll||0
10480639|NCT01132664|11629633|FG002|STARTED|Phase ll|Of the 50 patients, 8 were from phase lb & were eligible for inclusion in Phase II|50
10480640|NCT01132664|11629634|FG003|STARTED|Phase ll||0
10480641|NCT01132664|11629635|FG004|STARTED|Phase ll||0
10480642|NCT01132664|11629631|FG000|COMPLETED|Phase ll||0
10480643|NCT01132664|11629632|FG001|COMPLETED|Phase ll||0
10480644|NCT01132664|11629633|FG002|COMPLETED|Phase ll||0
10480645|NCT01132664|11629634|FG003|COMPLETED|Phase ll||0
10480646|NCT01132664|11629635|FG004|COMPLETED|Phase ll||0
10480647|NCT01132664|11629631|FG000|NOT COMPLETED|Phase ll||0
10480648|NCT01132664|11629632|FG001|NOT COMPLETED|Phase ll||0
10480649|NCT01132664|11629633|FG002|NOT COMPLETED|Phase ll||50
10480650|NCT01132664|11629634|FG003|NOT COMPLETED|Phase ll||0
10480651|NCT01132664|11629635|FG004|NOT COMPLETED|Phase ll||0
10480652|NCT01132664|11629631|FG000|STARTED|BM Cohort||0
10480653|NCT01132664|11629632|FG001|STARTED|BM Cohort||0
10480654|NCT01132664|11629633|FG002|STARTED|BM Cohort||0
10480655|NCT01132664|11629634|FG003|STARTED|BM Cohort||3
10480656|NCT01132664|11629635|FG004|STARTED|BM Cohort||6
10480657|NCT01132664|11629631|FG000|COMPLETED|BM Cohort||0
10480658|NCT01132664|11629632|FG001|COMPLETED|BM Cohort||0
10480659|NCT01132664|11629633|FG002|COMPLETED|BM Cohort||0
10480660|NCT01132664|11629634|FG003|COMPLETED|BM Cohort||0
10480661|NCT01132664|11629635|FG004|COMPLETED|BM Cohort||0
10480662|NCT01132664|11629631|FG000|NOT COMPLETED|BM Cohort||0
10480663|NCT01132664|11629632|FG001|NOT COMPLETED|BM Cohort||0
10480664|NCT01132664|11629633|FG002|NOT COMPLETED|BM Cohort||0
10480665|NCT01132664|11629634|FG003|NOT COMPLETED|BM Cohort||3
10480666|NCT01132664|11629635|FG004|NOT COMPLETED|BM Cohort||6
10480667|NCT01132690|11629649|FG000|STARTED|Overall Study||6
10480668|NCT01132690|11629650|FG001|STARTED|Overall Study||5
10480669|NCT01132690|11629649|FG000|COMPLETED|Overall Study||6
10480670|NCT01132690|11629650|FG001|COMPLETED|Overall Study||5
10480671|NCT01132690|11629649|FG000|NOT COMPLETED|Overall Study||0
10480672|NCT01132690|11629650|FG001|NOT COMPLETED|Overall Study||0
10480673|NCT01132755|11629656|FG000|STARTED|Overall Study||112
10480674|NCT01132755|11629656|FG000|COMPLETED|Overall Study||70
10480675|NCT01132755|11629656|FG000|NOT COMPLETED|Overall Study||42
10480676|NCT01132807|11629660|FG000|STARTED|Initial ABVD Treatment (2 Cycles)||15
10480677|NCT01132807|11629661|FG001|STARTED|Initial ABVD Treatment (2 Cycles)||135
10480678|NCT01132807|11629662|FG002|STARTED|Initial ABVD Treatment (2 Cycles)||14
10480679|NCT01132807|11629660|FG000|COMPLETED|Initial ABVD Treatment (2 Cycles)||0
10480680|NCT01132807|11629661|FG001|COMPLETED|Initial ABVD Treatment (2 Cycles)||135
10480681|NCT01132807|11629662|FG002|COMPLETED|Initial ABVD Treatment (2 Cycles)||14
10480682|NCT01132807|11629660|FG000|NOT COMPLETED|Initial ABVD Treatment (2 Cycles)||15
10480683|NCT01132807|11629661|FG001|NOT COMPLETED|Initial ABVD Treatment (2 Cycles)||0
10480684|NCT01132807|11629662|FG002|NOT COMPLETED|Initial ABVD Treatment (2 Cycles)||0
10480685|NCT01132807|11629660|FG000|STARTED|Post-Cycle 2 PET Assessment||0
10480686|NCT01132807|11629661|FG001|STARTED|Post-Cycle 2 PET Assessment||135
10480687|NCT01132807|11629662|FG002|STARTED|Post-Cycle 2 PET Assessment||14
10480688|NCT01132807|11629660|FG000|COMPLETED|Post-Cycle 2 PET Assessment||0
10480689|NCT01132807|11629661|FG001|COMPLETED|Post-Cycle 2 PET Assessment||135
10480690|NCT01132807|11629662|FG002|COMPLETED|Post-Cycle 2 PET Assessment||14
10480691|NCT01132807|11629660|FG000|NOT COMPLETED|Post-Cycle 2 PET Assessment||0
10480692|NCT01132807|11629661|FG001|NOT COMPLETED|Post-Cycle 2 PET Assessment||0
10480693|NCT01132807|11629662|FG002|NOT COMPLETED|Post-Cycle 2 PET Assessment||0
10480694|NCT01132820|11629670|FG000|STARTED|Overall Study||53
10480695|NCT01132820|11629670|FG000|COMPLETED|Overall Study||48
10480696|NCT01132820|11629670|FG000|NOT COMPLETED|Overall Study||5
10480697|NCT01132846|11629677|FG000|STARTED|Overall Study||122
10480698|NCT01132846|11629678|FG001|STARTED|Overall Study||119
10480699|NCT01132846|11629679|FG002|STARTED|Overall Study||119
10480700|NCT01132846|11629677|FG000|COMPLETED|Overall Study||106
10480701|NCT01132846|11629678|FG001|COMPLETED|Overall Study||101
10480702|NCT01132846|11629679|FG002|COMPLETED|Overall Study||108
10480703|NCT01132846|11629677|FG000|NOT COMPLETED|Overall Study||16
10480704|NCT01132846|11629678|FG001|NOT COMPLETED|Overall Study||18
10480705|NCT01132846|11629679|FG002|NOT COMPLETED|Overall Study||11
10480706|NCT01133067|11629689|FG000|STARTED|Overall Study||200
10480707|NCT01133067|11629689|FG000|COMPLETED|Overall Study||61
10480708|NCT01133067|11629689|FG000|NOT COMPLETED|Overall Study||139
10480709|NCT01133158|11629693|FG000|STARTED|Overall Study||60
10480710|NCT01133158|11629693|FG000|COMPLETED|Overall Study||43
10480711|NCT01133158|11629693|FG000|NOT COMPLETED|Overall Study||17
10480712|NCT01133171|11629702|FG000|STARTED|Overall Study||25
10480713|NCT01133171|11629703|FG001|STARTED|Overall Study||27
10480714|NCT01133171|11629704|FG002|STARTED|Overall Study||25
10480715|NCT01133171|11629702|FG000|COMPLETED|Overall Study||24
10480716|NCT01133171|11629703|FG001|COMPLETED|Overall Study||25
10480717|NCT01133171|11629704|FG002|COMPLETED|Overall Study||25
10480718|NCT01133171|11629702|FG000|NOT COMPLETED|Overall Study||1
10480719|NCT01133171|11629703|FG001|NOT COMPLETED|Overall Study||2
10480720|NCT01133171|11629704|FG002|NOT COMPLETED|Overall Study||0
10480721|NCT01133275|11629712|FG000|STARTED|Overall Study||28
10480722|NCT01133275|11629712|FG000|COMPLETED|Overall Study||26
10480723|NCT01133275|11629712|FG000|NOT COMPLETED|Overall Study||2
10527259|NCT01388647|11679289|FG000|NOT COMPLETED|Overall Study||1
10527260|NCT01388647|11679290|FG001|NOT COMPLETED|Overall Study||2
10527261|NCT01388777|11679297|FG000|STARTED|Overall Study||1
10527262|NCT01388777|11679297|FG000|Cryoablation|Overall Study||1
10527263|NCT01388777|11679297|FG000|COMPLETED|Overall Study||1
10527264|NCT01388777|11679297|FG000|NOT COMPLETED|Overall Study||0
10527265|NCT01388790|11679301|FG000|STARTED|Overall Study||40
10527266|NCT01388790|11679301|FG000|COMPLETED|Overall Study||32
10527267|NCT01388790|11679301|FG000|NOT COMPLETED|Overall Study||8
10527268|NCT01388816|11679309|FG000|STARTED|Overall Study||45
10527269|NCT01388816|11679310|FG001|STARTED|Overall Study||43
10527270|NCT01388816|11679311|FG002|STARTED|Overall Study||44
10527271|NCT01388816|11679312|FG003|STARTED|Overall Study||44
10527272|NCT01388816|11679309|FG000|COMPLETED|Overall Study||43
10527273|NCT01388816|11679310|FG001|COMPLETED|Overall Study||39
10527274|NCT01388816|11679311|FG002|COMPLETED|Overall Study||41
10527275|NCT01388816|11679312|FG003|COMPLETED|Overall Study||44
10527276|NCT01388816|11679309|FG000|NOT COMPLETED|Overall Study||2
10527277|NCT01388816|11679310|FG001|NOT COMPLETED|Overall Study||4
10527278|NCT01388816|11679311|FG002|NOT COMPLETED|Overall Study||3
10480724|NCT01133379|11629719|FG000|STARTED|Overall Study||58
10480725|NCT01133379|11629720|FG001|STARTED|Overall Study||58
10480726|NCT01133379|11629721|FG002|STARTED|Overall Study||58
10480727|NCT01133379|11629719|FG000|COMPLETED|Overall Study||57
10480728|NCT01133379|11629720|FG001|COMPLETED|Overall Study||56
10480729|NCT01133379|11629721|FG002|COMPLETED|Overall Study||56
10480730|NCT01133379|11629719|FG000|NOT COMPLETED|Overall Study||1
10480731|NCT01133379|11629720|FG001|NOT COMPLETED|Overall Study||2
10480732|NCT01133379|11629721|FG002|NOT COMPLETED|Overall Study||2
10480733|NCT01133392|11629731|FG000|STARTED|First Intervention (1 Day )||20
10480734|NCT01133392|11629732|FG001|STARTED|First Intervention (1 Day )||18
10480735|NCT01133392|11629731|FG000|COMPLETED|First Intervention (1 Day )||20
10480736|NCT01133392|11629732|FG001|COMPLETED|First Intervention (1 Day )||18
10480737|NCT01133392|11629731|FG000|NOT COMPLETED|First Intervention (1 Day )||0
10480738|NCT01133392|11629732|FG001|NOT COMPLETED|First Intervention (1 Day )||0
10480739|NCT01133392|11629731|FG000|STARTED|Interval Between Dosing (4-7 Days)||20
10480740|NCT01133392|11629732|FG001|STARTED|Interval Between Dosing (4-7 Days)||18
10480741|NCT01133392|11629731|FG000|COMPLETED|Interval Between Dosing (4-7 Days)||20
10480742|NCT01133392|11629732|FG001|COMPLETED|Interval Between Dosing (4-7 Days)||17
10480743|NCT01133392|11629731|FG000|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
10480744|NCT01133392|11629732|FG001|NOT COMPLETED|Interval Between Dosing (4-7 Days)||1
10480745|NCT01133392|11629731|FG000|STARTED|Second Intervention (1 Day)||20
10480746|NCT01133392|11629732|FG001|STARTED|Second Intervention (1 Day)||17
10480747|NCT01133392|11629731|FG000|COMPLETED|Second Intervention (1 Day)||20
10480748|NCT01133392|11629732|FG001|COMPLETED|Second Intervention (1 Day)||17
10480749|NCT01133392|11629731|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10480750|NCT01133392|11629732|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10480751|NCT01133392|11629731|FG000|STARTED|Interval Between Dosing (4-7 Days)||20
10480752|NCT01133392|11629732|FG001|STARTED|Interval Between Dosing (4-7 Days)||17
10480753|NCT01133392|11629731|FG000|COMPLETED|Interval Between Dosing (4-7 Days)||20
10480754|NCT01133392|11629732|FG001|COMPLETED|Interval Between Dosing (4-7 Days)||17
10480755|NCT01133392|11629731|FG000|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
10480756|NCT01133392|11629732|FG001|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
10480757|NCT01133392|11629731|FG000|STARTED|Third Intervention (1 Day)||20
10480758|NCT01133392|11629732|FG001|STARTED|Third Intervention (1 Day)||17
10480759|NCT01133392|11629731|FG000|COMPLETED|Third Intervention (1 Day)||20
10480760|NCT01133392|11629732|FG001|COMPLETED|Third Intervention (1 Day)||17
10480761|NCT01133392|11629731|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
10480762|NCT01133392|11629732|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
10480763|NCT01133392|11629731|FG000|STARTED|Interval Between Dosing (4-7 Days)||20
10480764|NCT01133392|11629732|FG001|STARTED|Interval Between Dosing (4-7 Days)||17
10480765|NCT01133392|11629731|FG000|COMPLETED|Interval Between Dosing (4-7 Days)||20
10480766|NCT01133392|11629732|FG001|COMPLETED|Interval Between Dosing (4-7 Days)||16
10480767|NCT01133392|11629731|FG000|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
10480768|NCT01133392|11629732|FG001|NOT COMPLETED|Interval Between Dosing (4-7 Days)||1
10480769|NCT01133392|11629731|FG000|STARTED|Fourth Intervention (1 Day)||20
10480770|NCT01133392|11629732|FG001|STARTED|Fourth Intervention (1 Day)||16
10480771|NCT01133392|11629731|FG000|COMPLETED|Fourth Intervention (1 Day)||20
10480772|NCT01133392|11629732|FG001|COMPLETED|Fourth Intervention (1 Day)||16
10480773|NCT01133392|11629731|FG000|NOT COMPLETED|Fourth Intervention (1 Day)||0
10480774|NCT01133392|11629732|FG001|NOT COMPLETED|Fourth Intervention (1 Day)||0
10480775|NCT01133405|11629748|FG000|STARTED|Period 1||3
10480776|NCT01133405|11629749|FG001|STARTED|Period 1||6
10480777|NCT01133405|11629750|FG002|STARTED|Period 1||5
10480778|NCT01133405|11629751|FG003|STARTED|Period 1||5
10480779|NCT01133405|11629752|FG004|STARTED|Period 1||3
10480780|NCT01133405|11629753|FG005|STARTED|Period 1||5
10480781|NCT01133405|11629754|FG006|STARTED|Period 1||5
10480782|NCT01133405|11629755|FG007|STARTED|Period 1||2
10480783|NCT01133405|11629756|FG008|STARTED|Period 1||4
10480784|NCT01133405|11629757|FG009|STARTED|Period 1||2
10480785|NCT01133405|11629748|FG000|Safety Analysis Population|Period 1|One discontinued from study after randomization but before any study procedures.|2
10480786|NCT01133405|11629749|FG001|Safety Analysis Population|Period 1||6
10480787|NCT01133405|11629750|FG002|Safety Analysis Population|Period 1||5
10480788|NCT01133405|11629751|FG003|Safety Analysis Population|Period 1||5
10480789|NCT01133405|11629752|FG004|Safety Analysis Population|Period 1||3
10480790|NCT01133405|11629753|FG005|Safety Analysis Population|Period 1||5
10480791|NCT01133405|11629754|FG006|Safety Analysis Population|Period 1||5
10480792|NCT01133405|11629755|FG007|Safety Analysis Population|Period 1||2
10480793|NCT01133405|11629756|FG008|Safety Analysis Population|Period 1||4
10480794|NCT01133405|11629757|FG009|Safety Analysis Population|Period 1||2
10480795|NCT01133405|11629748|FG000|Received at Least 1 Dose of Drug|Period 1||2
10480796|NCT01133405|11629749|FG001|Received at Least 1 Dose of Drug|Period 1||4
10480797|NCT01133405|11629750|FG002|Received at Least 1 Dose of Drug|Period 1||4
10480798|NCT01133405|11629751|FG003|Received at Least 1 Dose of Drug|Period 1||3
10480799|NCT01133405|11629752|FG004|Received at Least 1 Dose of Drug|Period 1||3
10480800|NCT01133405|11629753|FG005|Received at Least 1 Dose of Drug|Period 1||4
10480801|NCT01133405|11629754|FG006|Received at Least 1 Dose of Drug|Period 1||4
10480802|NCT01133405|11629755|FG007|Received at Least 1 Dose of Drug|Period 1||2
10480803|NCT01133405|11629756|FG008|Received at Least 1 Dose of Drug|Period 1||4
10480804|NCT01133405|11629757|FG009|Received at Least 1 Dose of Drug|Period 1||2
10480805|NCT01133405|11629748|FG000|COMPLETED|Period 1||2
10480806|NCT01133405|11629749|FG001|COMPLETED|Period 1||3
10480807|NCT01133405|11629750|FG002|COMPLETED|Period 1||4
10480808|NCT01133405|11629751|FG003|COMPLETED|Period 1||1
10480809|NCT01133405|11629752|FG004|COMPLETED|Period 1||3
10480810|NCT01133405|11629753|FG005|COMPLETED|Period 1||3
10480811|NCT01133405|11629754|FG006|COMPLETED|Period 1||4
10480812|NCT01133405|11629755|FG007|COMPLETED|Period 1||2
10480813|NCT01133405|11629756|FG008|COMPLETED|Period 1||4
10480814|NCT01133405|11629757|FG009|COMPLETED|Period 1||2
10480815|NCT01133405|11629748|FG000|NOT COMPLETED|Period 1||1
10480816|NCT01133405|11629749|FG001|NOT COMPLETED|Period 1||3
10480817|NCT01133405|11629750|FG002|NOT COMPLETED|Period 1||1
10480818|NCT01133405|11629751|FG003|NOT COMPLETED|Period 1||4
10480819|NCT01133405|11629752|FG004|NOT COMPLETED|Period 1||0
10480820|NCT01133405|11629753|FG005|NOT COMPLETED|Period 1||2
10480821|NCT01133405|11629754|FG006|NOT COMPLETED|Period 1||1
10480822|NCT01133405|11629755|FG007|NOT COMPLETED|Period 1||0
10480823|NCT01133405|11629756|FG008|NOT COMPLETED|Period 1||0
10480824|NCT01133405|11629757|FG009|NOT COMPLETED|Period 1||0
10480825|NCT01133405|11629748|FG000|STARTED|Period 2||2
10480826|NCT01133405|11629749|FG001|STARTED|Period 2|One participant started and received 15 mg LY2886721 only in period 2.|4
10480827|NCT01133405|11629750|FG002|STARTED|Period 2||4
10480828|NCT01133405|11629751|FG003|STARTED|Period 2|Two participants started and received 25 mg LY2886721 only in period 2.|3
10480829|NCT01133405|11629752|FG004|STARTED|Period 2||3
10480830|NCT01133405|11629753|FG005|STARTED|Period 2|One participant started and received 25 mg LY2886721 only in period 2.|4
10480831|NCT01133405|11629754|FG006|STARTED|Period 2|Cohort C was planned only for single period.|0
10480832|NCT01133405|11629755|FG007|STARTED|Period 2|Cohort C was planned only for single period.|0
10480833|NCT01133405|11629756|FG008|STARTED|Period 2|Cohort D was planned only for single period.|0
10480834|NCT01133405|11629757|FG009|STARTED|Period 2|Cohort D was planned only for single period.|0
10480835|NCT01133405|11629748|FG000|Received at Least 1 Dose of Study Drug|Period 2||2
10480836|NCT01133405|11629749|FG001|Received at Least 1 Dose of Study Drug|Period 2||4
10480837|NCT01133405|11629750|FG002|Received at Least 1 Dose of Study Drug|Period 2||4
10480838|NCT01133405|11629751|FG003|Received at Least 1 Dose of Study Drug|Period 2||3
10480839|NCT01133405|11629752|FG004|Received at Least 1 Dose of Study Drug|Period 2||3
10480840|NCT01133405|11629753|FG005|Received at Least 1 Dose of Study Drug|Period 2||4
10480841|NCT01133405|11629754|FG006|Received at Least 1 Dose of Study Drug|Period 2||0
10480842|NCT01133405|11629755|FG007|Received at Least 1 Dose of Study Drug|Period 2||0
10480843|NCT01133405|11629756|FG008|Received at Least 1 Dose of Study Drug|Period 2||0
10480844|NCT01133405|11629757|FG009|Received at Least 1 Dose of Study Drug|Period 2||0
10480845|NCT01133405|11629748|FG000|COMPLETED|Period 2||2
10480846|NCT01133405|11629749|FG001|COMPLETED|Period 2||3
10480847|NCT01133405|11629750|FG002|COMPLETED|Period 2||3
10480848|NCT01133405|11629751|FG003|COMPLETED|Period 2||2
10480849|NCT01133405|11629752|FG004|COMPLETED|Period 2||3
10480850|NCT01133405|11629753|FG005|COMPLETED|Period 2||2
10480851|NCT01133405|11629754|FG006|COMPLETED|Period 2||0
10480852|NCT01133405|11629755|FG007|COMPLETED|Period 2||0
10480853|NCT01133405|11629756|FG008|COMPLETED|Period 2||0
10480854|NCT01133405|11629757|FG009|COMPLETED|Period 2||0
10480855|NCT01133405|11629748|FG000|NOT COMPLETED|Period 2||0
10480856|NCT01133405|11629749|FG001|NOT COMPLETED|Period 2||1
10480857|NCT01133405|11629750|FG002|NOT COMPLETED|Period 2||1
10480858|NCT01133405|11629751|FG003|NOT COMPLETED|Period 2||1
10480859|NCT01133405|11629752|FG004|NOT COMPLETED|Period 2||0
10480860|NCT01133405|11629753|FG005|NOT COMPLETED|Period 2||2
10480861|NCT01133405|11629754|FG006|NOT COMPLETED|Period 2||0
10480862|NCT01133405|11629755|FG007|NOT COMPLETED|Period 2||0
10480863|NCT01133405|11629756|FG008|NOT COMPLETED|Period 2||0
10480864|NCT01133405|11629757|FG009|NOT COMPLETED|Period 2||0
10480865|NCT01133405|11629748|FG000|STARTED|Period 3||2
10480866|NCT01133405|11629749|FG001|STARTED|Period 3|One participant started and received placebo only in period 3.|4
10480867|NCT01133405|11629750|FG002|STARTED|Period 3|One participant started and received 35 mg LY2886721 only in period 3.|4
10480868|NCT01133405|11629751|FG003|STARTED|Period 3||2
10480869|NCT01133405|11629752|FG004|STARTED|Period 3||3
10480870|NCT01133405|11629753|FG005|STARTED|Period 3||2
10480871|NCT01133405|11629754|FG006|STARTED|Period 3||0
10480872|NCT01133405|11629755|FG007|STARTED|Period 3||0
10480873|NCT01133405|11629756|FG008|STARTED|Period 3||0
10480874|NCT01133405|11629757|FG009|STARTED|Period 3||0
10480875|NCT01133405|11629748|FG000|Received at Least 1 Dose of Study Drug|Period 3||2
10480876|NCT01133405|11629749|FG001|Received at Least 1 Dose of Study Drug|Period 3||4
10480877|NCT01133405|11629750|FG002|Received at Least 1 Dose of Study Drug|Period 3||4
10480878|NCT01133405|11629751|FG003|Received at Least 1 Dose of Study Drug|Period 3||2
10480879|NCT01133405|11629752|FG004|Received at Least 1 Dose of Study Drug|Period 3||3
10480880|NCT01133405|11629753|FG005|Received at Least 1 Dose of Study Drug|Period 3||2
10480881|NCT01133405|11629754|FG006|Received at Least 1 Dose of Study Drug|Period 3||0
10480882|NCT01133405|11629755|FG007|Received at Least 1 Dose of Study Drug|Period 3||0
10480883|NCT01133405|11629756|FG008|Received at Least 1 Dose of Study Drug|Period 3||0
10480884|NCT01133405|11629757|FG009|Received at Least 1 Dose of Study Drug|Period 3||0
10480885|NCT01133405|11629748|FG000|COMPLETED|Period 3||2
10480886|NCT01133405|11629749|FG001|COMPLETED|Period 3||4
10480887|NCT01133405|11629750|FG002|COMPLETED|Period 3||4
10480888|NCT01133405|11629751|FG003|COMPLETED|Period 3||2
10480889|NCT01133405|11629752|FG004|COMPLETED|Period 3||3
10480890|NCT01133405|11629753|FG005|COMPLETED|Period 3||2
10480891|NCT01133405|11629754|FG006|COMPLETED|Period 3||0
10480892|NCT01133405|11629755|FG007|COMPLETED|Period 3||0
10480893|NCT01133405|11629756|FG008|COMPLETED|Period 3||0
10480894|NCT01133405|11629757|FG009|COMPLETED|Period 3||0
10480895|NCT01133405|11629748|FG000|NOT COMPLETED|Period 3||0
10480896|NCT01133405|11629749|FG001|NOT COMPLETED|Period 3||0
10480897|NCT01133405|11629750|FG002|NOT COMPLETED|Period 3||0
10480898|NCT01133405|11629751|FG003|NOT COMPLETED|Period 3||0
10480899|NCT01133405|11629752|FG004|NOT COMPLETED|Period 3||0
10480900|NCT01133405|11629753|FG005|NOT COMPLETED|Period 3||0
10480901|NCT01133405|11629754|FG006|NOT COMPLETED|Period 3||0
10480902|NCT01133405|11629755|FG007|NOT COMPLETED|Period 3||0
10480903|NCT01133405|11629756|FG008|NOT COMPLETED|Period 3||0
10480904|NCT01133405|11629757|FG009|NOT COMPLETED|Period 3||0
10480905|NCT01133418|11629789|FG000|STARTED|Overall Study||34
10480906|NCT01133418|11629790|FG001|STARTED|Overall Study||38
10480907|NCT01133418|11629789|FG000|COMPLETED|Overall Study||29
10480908|NCT01133418|11629790|FG001|COMPLETED|Overall Study||32
10480909|NCT01133418|11629789|FG000|NOT COMPLETED|Overall Study||5
10480910|NCT01133418|11629790|FG001|NOT COMPLETED|Overall Study||6
10480911|NCT01133522|11629806|FG000|STARTED|Overall Study||10
10480912|NCT01133522|11629807|FG001|STARTED|Overall Study||7
10480913|NCT01133522|11629808|FG002|STARTED|Overall Study||6
10480914|NCT01133522|11629809|FG003|STARTED|Overall Study||7
10480915|NCT01133522|11629810|FG004|STARTED|Overall Study||7
10480916|NCT01133522|11629811|FG005|STARTED|Overall Study||6
10480917|NCT01133522|11629812|FG006|STARTED|Overall Study||2
10480918|NCT01133522|11629813|FG007|STARTED|Overall Study||9
10480919|NCT01133522|11629814|FG008|STARTED|Overall Study||2
10480920|NCT01133522|11629815|FG009|STARTED|Overall Study||4
10480921|NCT01133522|11629806|FG000|Received Treatment|Overall Study||10
10480922|NCT01133522|11629807|FG001|Received Treatment|Overall Study||6
10480923|NCT01133522|11629808|FG002|Received Treatment|Overall Study||6
10480924|NCT01133522|11629809|FG003|Received Treatment|Overall Study||6
10480925|NCT01133522|11629810|FG004|Received Treatment|Overall Study||6
10480926|NCT01133522|11629811|FG005|Received Treatment|Overall Study||6
10480927|NCT01133522|11629812|FG006|Received Treatment|Overall Study||2
10480928|NCT01133522|11629813|FG007|Received Treatment|Overall Study||9
10480929|NCT01133522|11629814|FG008|Received Treatment|Overall Study||2
10480930|NCT01133522|11629815|FG009|Received Treatment|Overall Study||4
10480931|NCT01133522|11629806|FG000|COMPLETED|Overall Study||10
10480932|NCT01133522|11629807|FG001|COMPLETED|Overall Study||6
10480933|NCT01133522|11629808|FG002|COMPLETED|Overall Study||6
10480934|NCT01133522|11629809|FG003|COMPLETED|Overall Study||6
10480935|NCT01133522|11629810|FG004|COMPLETED|Overall Study||6
10480936|NCT01133522|11629811|FG005|COMPLETED|Overall Study||6
10480937|NCT01133522|11629812|FG006|COMPLETED|Overall Study||2
10480938|NCT01133522|11629813|FG007|COMPLETED|Overall Study||9
10480939|NCT01133522|11629814|FG008|COMPLETED|Overall Study||2
10480940|NCT01133522|11629815|FG009|COMPLETED|Overall Study||4
10480941|NCT01133522|11629806|FG000|NOT COMPLETED|Overall Study||0
10480942|NCT01133522|11629807|FG001|NOT COMPLETED|Overall Study||1
10480943|NCT01133522|11629808|FG002|NOT COMPLETED|Overall Study||0
10480944|NCT01133522|11629809|FG003|NOT COMPLETED|Overall Study||1
10480945|NCT01133522|11629810|FG004|NOT COMPLETED|Overall Study||1
10480946|NCT01133522|11629811|FG005|NOT COMPLETED|Overall Study||0
10480947|NCT01133522|11629812|FG006|NOT COMPLETED|Overall Study||0
10480948|NCT01133522|11629813|FG007|NOT COMPLETED|Overall Study||0
10480949|NCT01133522|11629814|FG008|NOT COMPLETED|Overall Study||0
10480950|NCT01133522|11629815|FG009|NOT COMPLETED|Overall Study||0
10480951|NCT01133626|11629847|FG000|STARTED|Overall Study||50
10480952|NCT01133626|11629848|FG001|STARTED|Overall Study||46
10480953|NCT01133626|11629849|FG002|STARTED|Overall Study||11
10480954|NCT01133626|11629847|FG000|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|50
10480955|NCT01133626|11629848|FG001|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|46
10480956|NCT01133626|11629849|FG002|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|11
10480957|NCT01133626|11629847|FG000|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|48
10480958|NCT01133626|11629848|FG001|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|41
10480959|NCT01133626|11629849|FG002|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|9
10709588|NCT02641561|11874633|FG002|STARTED|Overall Study||48
10709589|NCT02641561|11874634|FG003|STARTED|Overall Study||48
10709590|NCT02641561|11874631|FG000|COMPLETED|Overall Study||48
10709591|NCT02641561|11874632|FG001|COMPLETED|Overall Study||48
10480960|NCT01133626|11629847|FG000|COMPLETED|Overall Study||49
10480961|NCT01133626|11629848|FG001|COMPLETED|Overall Study||41
10480962|NCT01133626|11629849|FG002|COMPLETED|Overall Study||9
10480963|NCT01133626|11629847|FG000|NOT COMPLETED|Overall Study||1
10480964|NCT01133626|11629848|FG001|NOT COMPLETED|Overall Study||5
10480965|NCT01133626|11629849|FG002|NOT COMPLETED|Overall Study||2
10480966|NCT01133665|11629857|FG000|STARTED|Overall Study||42
10480967|NCT01133665|11629857|FG000|COMPLETED|Overall Study||40
10709592|NCT02641561|11874633|FG002|COMPLETED|Overall Study||48
10709593|NCT02641561|11874634|FG003|COMPLETED|Overall Study||48
10480968|NCT01133665|11629857|FG000|NOT COMPLETED|Overall Study||2
10480969|NCT01133678|11629863|FG000|STARTED|Overall Study||25
10480970|NCT01133678|11629864|FG001|STARTED|Overall Study||25
10480971|NCT01133678|11629863|FG000|COMPLETED|Overall Study||24
10709594|NCT02641561|11874631|FG000|NOT COMPLETED|Overall Study||0
10480972|NCT01133678|11629864|FG001|COMPLETED|Overall Study||24
10480973|NCT01133678|11629863|FG000|NOT COMPLETED|Overall Study||1
10480974|NCT01133678|11629864|FG001|NOT COMPLETED|Overall Study||1
10480975|NCT01133704|11629872|FG000|STARTED|Overall Study||65
10480976|NCT01133704|11629873|FG001|STARTED|Overall Study||33
10480977|NCT01133704|11629872|FG000|COMPLETED|Overall Study|(including 3 year follow-up)|16
10480978|NCT01133704|11629873|FG001|COMPLETED|Overall Study|(including 3 year follow-up)|7
10480979|NCT01133704|11629872|FG000|NOT COMPLETED|Overall Study||49
10480980|NCT01133704|11629873|FG001|NOT COMPLETED|Overall Study||26
10480981|NCT01133756|11629882|FG000|STARTED|Overall Study||2
10480982|NCT01133756|11629883|FG001|STARTED|Overall Study||3
10480983|NCT01133756|11629884|FG002|STARTED|Overall Study||2
10480984|NCT01133756|11629882|FG000|Completed 6 Cycles|Overall Study|One participant completed 6 cycles and remained in the study until 18 Sep 2012.|1
10480985|NCT01133756|11629883|FG001|Completed 6 Cycles|Overall Study||0
10480986|NCT01133756|11629884|FG002|Completed 6 Cycles|Overall Study||0
10480987|NCT01133756|11629882|FG000|COMPLETED|Overall Study||0
10480988|NCT01133756|11629883|FG001|COMPLETED|Overall Study||0
10480989|NCT01133756|11629884|FG002|COMPLETED|Overall Study||0
10480990|NCT01133756|11629882|FG000|NOT COMPLETED|Overall Study||2
10480991|NCT01133756|11629883|FG001|NOT COMPLETED|Overall Study||3
10480992|NCT01133756|11629884|FG002|NOT COMPLETED|Overall Study||2
10480993|NCT01133821|11629894|FG000|STARTED|Overall Study||45
10480994|NCT01133821|11629895|FG001|STARTED|Overall Study||47
10480995|NCT01133821|11629894|FG000|COMPLETED|Overall Study||27
10480996|NCT01133821|11629895|FG001|COMPLETED|Overall Study||28
10480997|NCT01133821|11629894|FG000|NOT COMPLETED|Overall Study||18
10480998|NCT01133821|11629895|FG001|NOT COMPLETED|Overall Study||19
10480999|NCT01133847|11629904|FG000|STARTED|Active Treatment Phase (Weeks 1-16)||78
10481000|NCT01133847|11629905|FG001|STARTED|Active Treatment Phase (Weeks 1-16)||74
10481001|NCT01133847|11629906|FG002|STARTED|Active Treatment Phase (Weeks 1-16)||70
10481002|NCT01133847|11629904|FG000|COMPLETED|Active Treatment Phase (Weeks 1-16)||73
10481003|NCT01133847|11629905|FG001|COMPLETED|Active Treatment Phase (Weeks 1-16)||73
10481004|NCT01133847|11629906|FG002|COMPLETED|Active Treatment Phase (Weeks 1-16)||67
10481005|NCT01133847|11629904|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||5
10481006|NCT01133847|11629905|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||1
10481007|NCT01133847|11629906|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||3
10481008|NCT01133847|11629904|FG000|STARTED|Follow-Up Phase||73
10481009|NCT01133847|11629905|FG001|STARTED|Follow-Up Phase||73
10481010|NCT01133847|11629906|FG002|STARTED|Follow-Up Phase||67
10481011|NCT01133847|11629904|FG000|COMPLETED|Follow-Up Phase||72
10481012|NCT01133847|11629905|FG001|COMPLETED|Follow-Up Phase||70
10481013|NCT01133847|11629906|FG002|COMPLETED|Follow-Up Phase||60
10481014|NCT01133847|11629904|FG000|NOT COMPLETED|Follow-Up Phase||1
10481015|NCT01133847|11629905|FG001|NOT COMPLETED|Follow-Up Phase||3
10481016|NCT01133847|11629906|FG002|NOT COMPLETED|Follow-Up Phase||7
10481017|NCT01133860|11629915|FG000|STARTED|Overall Study||12
10481018|NCT01133860|11629915|FG000|COMPLETED|Overall Study||12
10481019|NCT01133860|11629915|FG000|NOT COMPLETED|Overall Study||0
10481020|NCT01133977|11629925|FG000|STARTED|Overall Study|Treated|3
10481021|NCT01133977|11629926|FG001|STARTED|Overall Study|Treated|7
10481022|NCT01133977|11629927|FG002|STARTED|Overall Study|Treated|6
10481023|NCT01133977|11629928|FG003|STARTED|Overall Study|Treated|42
10481024|NCT01133977|11629929|FG004|STARTED|Overall Study|Treated|39
10709595|NCT02641561|11874632|FG001|NOT COMPLETED|Overall Study||0
10709596|NCT02641561|11874633|FG002|NOT COMPLETED|Overall Study||0
10481025|NCT01133977|11629925|FG000|COMPLETED|Overall Study||0
10481026|NCT01133977|11629926|FG001|COMPLETED|Overall Study||0
10481027|NCT01133977|11629927|FG002|COMPLETED|Overall Study||0
10481028|NCT01133977|11629928|FG003|COMPLETED|Overall Study||3
10481029|NCT01133977|11629929|FG004|COMPLETED|Overall Study||1
10481030|NCT01133977|11629925|FG000|NOT COMPLETED|Overall Study||3
10481031|NCT01133977|11629926|FG001|NOT COMPLETED|Overall Study||7
10481032|NCT01133977|11629927|FG002|NOT COMPLETED|Overall Study||6
10481033|NCT01133977|11629928|FG003|NOT COMPLETED|Overall Study||39
10481034|NCT01133977|11629929|FG004|NOT COMPLETED|Overall Study||38
10481035|NCT01134016|11629944|FG000|STARTED|Overall Study||13
10481036|NCT01134016|11629944|FG000|COMPLETED|Overall Study||10
10481037|NCT01134016|11629944|FG000|NOT COMPLETED|Overall Study||3
10481038|NCT01134042|11629980|FG000|STARTED|Overall Study||194
10481039|NCT01134042|11629981|FG001|STARTED|Overall Study||197
10481040|NCT01134042|11629982|FG002|STARTED|Overall Study||195
10481041|NCT01134042|11629980|FG000|COMPLETED|Overall Study||146
10481042|NCT01134042|11629981|FG001|COMPLETED|Overall Study||169
10709597|NCT02641561|11874634|FG003|NOT COMPLETED|Overall Study||0
10481043|NCT01134042|11629982|FG002|COMPLETED|Overall Study||161
10481044|NCT01134042|11629980|FG000|NOT COMPLETED|Overall Study||48
10481045|NCT01134042|11629981|FG001|NOT COMPLETED|Overall Study||28
10481046|NCT01134042|11629982|FG002|NOT COMPLETED|Overall Study||34
10481047|NCT01134055|11629998|FG000|STARTED|Overall Study||73
10481048|NCT01134055|11629999|FG001|STARTED|Overall Study||72
10481049|NCT01134055|11630000|FG002|STARTED|Overall Study||74
10481050|NCT01134055|11630001|FG003|STARTED|Overall Study||73
10481051|NCT01134055|11630002|FG004|STARTED|Overall Study||73
10481052|NCT01134055|11630003|FG005|STARTED|Overall Study||72
10481053|NCT01134055|11630004|FG006|STARTED|Overall Study||73
10481054|NCT01134055|11629998|FG000|COMPLETED|Overall Study||65
10481055|NCT01134055|11629999|FG001|COMPLETED|Overall Study||66
10481056|NCT01134055|11630000|FG002|COMPLETED|Overall Study||71
10709598|NCT02641587|11874647|FG000|STARTED|Confinement Period||80
10481057|NCT01134055|11630001|FG003|COMPLETED|Overall Study||67
10481058|NCT01134055|11630002|FG004|COMPLETED|Overall Study||67
10481059|NCT01134055|11630003|FG005|COMPLETED|Overall Study||65
10481060|NCT01134055|11630004|FG006|COMPLETED|Overall Study||62
10481061|NCT01134055|11629998|FG000|NOT COMPLETED|Overall Study||8
10481062|NCT01134055|11629999|FG001|NOT COMPLETED|Overall Study||6
10481063|NCT01134055|11630000|FG002|NOT COMPLETED|Overall Study||3
10481064|NCT01134055|11630001|FG003|NOT COMPLETED|Overall Study||6
10481065|NCT01134055|11630002|FG004|NOT COMPLETED|Overall Study||6
10481066|NCT01134055|11630003|FG005|NOT COMPLETED|Overall Study||7
10481067|NCT01134055|11630004|FG006|NOT COMPLETED|Overall Study||11
10481068|NCT01134081|11630026|FG000|STARTED|Overall Study||44
10481069|NCT01134081|11630026|FG000|COMPLETED|Overall Study||44
10481070|NCT01134081|11630026|FG000|NOT COMPLETED|Overall Study||0
10481071|NCT01134107|11630036|FG000|STARTED|Period 1-First Treatment Intervention||67
10481072|NCT01134107|11630037|FG001|STARTED|Period 1-First Treatment Intervention||66
10481073|NCT01134107|11630036|FG000|Received at Least One Dose of Study Drug|Period 1-First Treatment Intervention||66
10481074|NCT01134107|11630037|FG001|Received at Least One Dose of Study Drug|Period 1-First Treatment Intervention||66
10481075|NCT01134107|11630036|FG000|COMPLETED|Period 1-First Treatment Intervention||61
10481076|NCT01134107|11630037|FG001|COMPLETED|Period 1-First Treatment Intervention||61
10481077|NCT01134107|11630036|FG000|NOT COMPLETED|Period 1-First Treatment Intervention||6
10481078|NCT01134107|11630037|FG001|NOT COMPLETED|Period 1-First Treatment Intervention||5
10481079|NCT01134107|11630036|FG000|STARTED|Period 2-Second Treatment Intervention||61
10481080|NCT01134107|11630037|FG001|STARTED|Period 2-Second Treatment Intervention||61
10481081|NCT01134107|11630036|FG000|COMPLETED|Period 2-Second Treatment Intervention||57
10481082|NCT01134107|11630037|FG001|COMPLETED|Period 2-Second Treatment Intervention||61
10481083|NCT01134107|11630036|FG000|NOT COMPLETED|Period 2-Second Treatment Intervention||4
10481084|NCT01134107|11630037|FG001|NOT COMPLETED|Period 2-Second Treatment Intervention||0
10481085|NCT01134198|11630045|FG000|STARTED|Phase 1||16
10481086|NCT01134198|11630046|FG001|STARTED|Phase 1||13
10481087|NCT01134198|11630045|FG000|COMPLETED|Phase 1||9
10481088|NCT01134198|11630046|FG001|COMPLETED|Phase 1||11
10481089|NCT01134198|11630045|FG000|NOT COMPLETED|Phase 1||7
10481090|NCT01134198|11630046|FG001|NOT COMPLETED|Phase 1||2
10481091|NCT01134198|11630045|FG000|STARTED|Phase 2||9
10481092|NCT01134198|11630046|FG001|STARTED|Phase 2||11
10481093|NCT01134198|11630045|FG000|COMPLETED|Phase 2||9
10481094|NCT01134198|11630046|FG001|COMPLETED|Phase 2||7
10481095|NCT01134198|11630045|FG000|NOT COMPLETED|Phase 2||0
10481096|NCT01134198|11630046|FG001|NOT COMPLETED|Phase 2||4
10481097|NCT01134263|11630057|FG000|STARTED|Overall Study||164
10481098|NCT01134263|11630058|FG001|STARTED|Overall Study||163
10481099|NCT01134263|11630059|FG002|STARTED|Overall Study||163
10481100|NCT01134263|11630060|FG003|STARTED|Overall Study||168
10481101|NCT01134263|11630061|FG004|STARTED|Overall Study||57
10481102|NCT01134263|11630057|FG000|Received Vaccination 1|Overall Study||163
10481103|NCT01134263|11630058|FG001|Received Vaccination 1|Overall Study||162
10481104|NCT01134263|11630059|FG002|Received Vaccination 1|Overall Study||163
10481105|NCT01134263|11630060|FG003|Received Vaccination 1|Overall Study||167
10481106|NCT01134263|11630061|FG004|Received Vaccination 1|Overall Study||57
10481107|NCT01134263|11630057|FG000|Received Vaccination 2|Overall Study||151
10481108|NCT01134263|11630058|FG001|Received Vaccination 2|Overall Study||152
10481109|NCT01134263|11630059|FG002|Received Vaccination 2|Overall Study||139
10481110|NCT01134263|11630060|FG003|Received Vaccination 2|Overall Study||154
10481111|NCT01134263|11630061|FG004|Received Vaccination 2|Overall Study||53
10481112|NCT01134263|11630057|FG000|Received Vaccination 3|Overall Study||140
10481113|NCT01134263|11630058|FG001|Received Vaccination 3|Overall Study||145
10481114|NCT01134263|11630059|FG002|Received Vaccination 3|Overall Study||134
10481115|NCT01134263|11630060|FG003|Received Vaccination 3|Overall Study||151
10481116|NCT01134263|11630061|FG004|Received Vaccination 3|Overall Study||49
10481117|NCT01134263|11630057|FG000|Safety Population|Overall Study||163
10481118|NCT01134263|11630058|FG001|Safety Population|Overall Study||161
10481119|NCT01134263|11630059|FG002|Safety Population|Overall Study|1 participant randomized to the Phase III Lot 2 group, received Phase III Lot 3 vaccination.|164
10481120|NCT01134263|11630060|FG003|Safety Population|Overall Study||167
10481121|NCT01134263|11630061|FG004|Safety Population|Overall Study||57
10481122|NCT01134263|11630057|FG000|COMPLETED|Overall Study||140
10481123|NCT01134263|11630058|FG001|COMPLETED|Overall Study||143
10481124|NCT01134263|11630059|FG002|COMPLETED|Overall Study||134
10481125|NCT01134263|11630060|FG003|COMPLETED|Overall Study||149
10481126|NCT01134263|11630061|FG004|COMPLETED|Overall Study||48
10709599|NCT02641587|11874648|FG001|STARTED|Confinement Period||40
10709600|NCT02641587|11874647|FG000|COMPLETED|Confinement Period||77
10481127|NCT01134263|11630057|FG000|NOT COMPLETED|Overall Study||24
10481128|NCT01134263|11630058|FG001|NOT COMPLETED|Overall Study||20
10481129|NCT01134263|11630059|FG002|NOT COMPLETED|Overall Study||29
10481130|NCT01134263|11630060|FG003|NOT COMPLETED|Overall Study||19
10481131|NCT01134263|11630061|FG004|NOT COMPLETED|Overall Study||9
10481132|NCT01134276|11630081|FG000|STARTED|Overall Study||104
10481133|NCT01134276|11630082|FG001|STARTED|Overall Study||107
10481134|NCT01134276|11630081|FG000|COMPLETED|Overall Study||104
10481135|NCT01134276|11630082|FG001|COMPLETED|Overall Study||107
10481136|NCT01134276|11630081|FG000|NOT COMPLETED|Overall Study||0
10481137|NCT01134276|11630082|FG001|NOT COMPLETED|Overall Study||0
10481138|NCT01134315|11630093|FG000|STARTED|Overall Study||21
10481139|NCT01134315|11630094|FG001|STARTED|Overall Study||40
10709601|NCT02641587|11874648|FG001|COMPLETED|Confinement Period||39
10709602|NCT02641587|11874647|FG000|NOT COMPLETED|Confinement Period||3
10709603|NCT02641587|11874648|FG001|NOT COMPLETED|Confinement Period||1
10709604|NCT02641587|11874647|FG000|STARTED|Ambulatory Period||77
10709605|NCT02641587|11874648|FG001|STARTED|Ambulatory Period||39
10709606|NCT02641587|11874647|FG000|COMPLETED|Ambulatory Period||76
10709607|NCT02641587|11874648|FG001|COMPLETED|Ambulatory Period||39
10709608|NCT02641587|11874647|FG000|NOT COMPLETED|Ambulatory Period||1
10709609|NCT02641587|11874648|FG001|NOT COMPLETED|Ambulatory Period||0
10709610|NCT02641691|11874661|FG000|STARTED|Overall Study||20
10709611|NCT02641691|11874661|FG000|COMPLETED|Overall Study||20
10709612|NCT02641691|11874661|FG000|NOT COMPLETED|Overall Study||0
10709613|NCT02641730|11874674|FG000|STARTED|Placebo Controlled Period (Week 0 - 16)||53
10709614|NCT02641730|11874675|FG001|STARTED|Placebo Controlled Period (Week 0 - 16)||0
10709615|NCT02641730|11874676|FG002|STARTED|Placebo Controlled Period (Week 0 - 16)||0
10709616|NCT02641730|11874677|FG003|STARTED|Placebo Controlled Period (Week 0 - 16)||54
10709617|NCT02641730|11874678|FG004|STARTED|Placebo Controlled Period (Week 0 - 16)||52
10709618|NCT02641730|11874674|FG000|COMPLETED|Placebo Controlled Period (Week 0 - 16)||51
10709619|NCT02641730|11874675|FG001|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
10709620|NCT02641730|11874676|FG002|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
10709621|NCT02641730|11874677|FG003|COMPLETED|Placebo Controlled Period (Week 0 - 16)||53
10709622|NCT02641730|11874678|FG004|COMPLETED|Placebo Controlled Period (Week 0 - 16)||50
10709623|NCT02641730|11874674|FG000|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||2
10709624|NCT02641730|11874675|FG001|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
10709625|NCT02641730|11874676|FG002|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
10709626|NCT02641730|11874677|FG003|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||1
10481140|NCT01134315|11630093|FG000|COMPLETED|Overall Study|Completed study drug treatment during the observational study (ie, prior to study termination).|12
10481141|NCT01134315|11630094|FG001|COMPLETED|Overall Study|Completed study drug treatment during the observational study (ie, prior to study termination).|21
10481142|NCT01134315|11630093|FG000|NOT COMPLETED|Overall Study||9
10709627|NCT02641730|11874678|FG004|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||2
10709628|NCT02641730|11874674|FG000|STARTED|After Controlled Period (Week 16 - 52)||0
10709629|NCT02641730|11874675|FG001|STARTED|After Controlled Period (Week 16 - 52)||25
10709630|NCT02641730|11874676|FG002|STARTED|After Controlled Period (Week 16 - 52)||26
10709631|NCT02641730|11874677|FG003|STARTED|After Controlled Period (Week 16 - 52)||53
10709632|NCT02641730|11874678|FG004|STARTED|After Controlled Period (Week 16 - 52)||50
10709633|NCT02641730|11874674|FG000|COMPLETED|After Controlled Period (Week 16 - 52)||0
10709634|NCT02641730|11874675|FG001|COMPLETED|After Controlled Period (Week 16 - 52)||21
10481143|NCT01134315|11630094|FG001|NOT COMPLETED|Overall Study||19
10481144|NCT01134328|11630104|FG000|STARTED|Overall Study||21
10481145|NCT01134328|11630105|FG001|STARTED|Overall Study||21
10481146|NCT01134328|11630106|FG002|STARTED|Overall Study||20
10481147|NCT01134328|11630107|FG003|STARTED|Overall Study||21
10481148|NCT01134328|11630104|FG000|COMPLETED|Overall Study||19
10481149|NCT01134328|11630105|FG001|COMPLETED|Overall Study||18
10481150|NCT01134328|11630106|FG002|COMPLETED|Overall Study||17
10481151|NCT01134328|11630107|FG003|COMPLETED|Overall Study||17
10481152|NCT01134328|11630104|FG000|NOT COMPLETED|Overall Study||2
10481153|NCT01134328|11630105|FG001|NOT COMPLETED|Overall Study||3
10481154|NCT01134328|11630106|FG002|NOT COMPLETED|Overall Study||3
10481155|NCT01134328|11630107|FG003|NOT COMPLETED|Overall Study||4
10481156|NCT01134393|11630117|FG000|STARTED|Overall Study|Entered and treated.|501
10481157|NCT01134393|11630117|FG000|COMPLETED|Overall Study|Completed trial medication.|449
10481158|NCT01134393|11630117|FG000|NOT COMPLETED|Overall Study||52
10481159|NCT01134510|11630124|FG000|STARTED|Overall Study|Transplant Day; Infusion #1 C1 esterase inhibitor vs Placebo|10
10481160|NCT01134510|11630125|FG001|STARTED|Overall Study|Transplant Day; Infusion #1 C1 esterase inhibitor vs Placebo|10
10481161|NCT01134510|11630124|FG000|Day 2|Overall Study|Infusion #2 C1 esterase inhibitor vs Placebo|10
10481162|NCT01134510|11630125|FG001|Day 2|Overall Study|Infusion #2 C1 esterase inhibitor vs Placebo|10
10481163|NCT01134510|11630124|FG000|Week 2|Overall Study|Infusion #3 C1 esterase inhibitor vs Placebo|10
10481164|NCT01134510|11630125|FG001|Week 2|Overall Study|Infusion #3 C1 esterase inhibitor vs Placebo|10
10481165|NCT01134510|11630124|FG000|Week 2|Overall Study|Infusion #4 C1 esterase inhibitor vs Placebo|10
10481166|NCT01134510|11630125|FG001|Week 2|Overall Study|Infusion #4 C1 esterase inhibitor vs Placebo|10
10481167|NCT01134510|11630124|FG000|Week 3|Overall Study|Infusion #5 C1 esterase inhibitor vs Placebo|10
10481168|NCT01134510|11630125|FG001|Week 3|Overall Study|Infusion #5 C1 esterase inhibitor vs Placebo|10
10481169|NCT01134510|11630124|FG000|Week 3|Overall Study|Infusion #6 C1 esterase inhibitor vs Placebo|10
10481170|NCT01134510|11630125|FG001|Week 3|Overall Study|Infusion #6 C1 esterase inhibitor vs Placebo|10
10481171|NCT01134510|11630124|FG000|Week 4|Overall Study|Infusion #7 C1 esterase inhibitor vs Placebo|10
10481172|NCT01134510|11630125|FG001|Week 4|Overall Study|Infusion #7 C1 esterase inhibitor vs Placebo|10
10481173|NCT01134510|11630124|FG000|Week 4|Overall Study|Infusion #8 C1 esterase inhibitor vs Placebo|10
10481174|NCT01134510|11630125|FG001|Week 4|Overall Study|Infusion #8 C1 esterase inhibitor vs Placebo|10
10481175|NCT01134510|11630124|FG000|Month 1|Overall Study||10
10481176|NCT01134510|11630125|FG001|Month 1|Overall Study||10
10481177|NCT01134510|11630124|FG000|Month 3|Overall Study||10
10481178|NCT01134510|11630125|FG001|Month 3|Overall Study||9
10709635|NCT02641730|11874676|FG002|COMPLETED|After Controlled Period (Week 16 - 52)||24
10709636|NCT02641730|11874677|FG003|COMPLETED|After Controlled Period (Week 16 - 52)||45
10709637|NCT02641730|11874678|FG004|COMPLETED|After Controlled Period (Week 16 - 52)||44
10481179|NCT01134510|11630124|FG000|COMPLETED|Overall Study||10
10481180|NCT01134510|11630125|FG001|COMPLETED|Overall Study||9
10481181|NCT01134510|11630124|FG000|NOT COMPLETED|Overall Study||0
10481182|NCT01134510|11630125|FG001|NOT COMPLETED|Overall Study||1
10481183|NCT01129011|11630136|FG000|STARTED|Overall Study|Safety, Intent-to-Treat population|210
10481184|NCT01129011|11630137|FG001|STARTED|Overall Study|Safety, Intent-to-Treat population|210
10481185|NCT01129011|11630136|FG000|COMPLETED|Overall Study||151
10481186|NCT01129011|11630137|FG001|COMPLETED|Overall Study||153
10481187|NCT01129011|11630136|FG000|NOT COMPLETED|Overall Study||59
10481188|NCT01129011|11630137|FG001|NOT COMPLETED|Overall Study||57
10481189|NCT01134549|11630148|FG000|STARTED|Overall Study||8
10481190|NCT01134549|11630149|FG001|STARTED|Overall Study||6
10481191|NCT01134549|11630150|FG002|STARTED|Overall Study||6
10481192|NCT01134549|11630151|FG003|STARTED|Overall Study||6
10481193|NCT01134549|11630152|FG004|STARTED|Overall Study||6
10481194|NCT01134549|11630148|FG000|COMPLETED|Overall Study||8
10481195|NCT01134549|11630149|FG001|COMPLETED|Overall Study||6
10481196|NCT01134549|11630150|FG002|COMPLETED|Overall Study||6
10481197|NCT01134549|11630151|FG003|COMPLETED|Overall Study||6
10481198|NCT01134549|11630152|FG004|COMPLETED|Overall Study||6
10481199|NCT01134549|11630148|FG000|NOT COMPLETED|Overall Study||0
10481200|NCT01134549|11630149|FG001|NOT COMPLETED|Overall Study||0
10481201|NCT01134549|11630150|FG002|NOT COMPLETED|Overall Study||0
10481202|NCT01134549|11630151|FG003|NOT COMPLETED|Overall Study||0
10481203|NCT01134549|11630152|FG004|NOT COMPLETED|Overall Study||0
10481204|NCT01134562|11630174|FG000|STARTED|Overall Study||4
10481205|NCT01134562|11630175|FG001|STARTED|Overall Study||4
10481206|NCT01134562|11630176|FG002|STARTED|Overall Study||4
10481207|NCT01134562|11630177|FG003|STARTED|Overall Study||8
10481208|NCT01134562|11630178|FG004|STARTED|Overall Study||8
10481209|NCT01134562|11630174|FG000|COMPLETED|Overall Study||4
10481210|NCT01134562|11630175|FG001|COMPLETED|Overall Study||3
10481211|NCT01134562|11630176|FG002|COMPLETED|Overall Study||4
10481212|NCT01134562|11630177|FG003|COMPLETED|Overall Study||8
10481213|NCT01134562|11630178|FG004|COMPLETED|Overall Study||8
10481214|NCT01134562|11630174|FG000|NOT COMPLETED|Overall Study||0
10481215|NCT01134562|11630175|FG001|NOT COMPLETED|Overall Study||1
10481216|NCT01134562|11630176|FG002|NOT COMPLETED|Overall Study||0
10481217|NCT01134562|11630177|FG003|NOT COMPLETED|Overall Study||0
10481218|NCT01134562|11630178|FG004|NOT COMPLETED|Overall Study||0
10481219|NCT01134575|11630201|FG000|STARTED|Overall Study||3
10481220|NCT01134575|11630202|FG001|STARTED|Overall Study||45
10481221|NCT01134575|11630203|FG002|STARTED|Overall Study||42
10481222|NCT01134575|11630201|FG000|COMPLETED|Overall Study||3
10481223|NCT01134575|11630202|FG001|COMPLETED|Overall Study||45
10481224|NCT01134575|11630203|FG002|COMPLETED|Overall Study||42
10481225|NCT01134575|11630201|FG000|NOT COMPLETED|Overall Study||0
10481226|NCT01134575|11630202|FG001|NOT COMPLETED|Overall Study||0
10481227|NCT01134575|11630203|FG002|NOT COMPLETED|Overall Study||0
10481228|NCT01134627|11630213|FG000|STARTED|Overall Study|Number of participants treated.|149
10481229|NCT01134627|11630214|FG001|STARTED|Overall Study|Number of participants treated.|155
10481230|NCT01134627|11630213|FG000|COMPLETED|Overall Study||80
10481231|NCT01134627|11630214|FG001|COMPLETED|Overall Study||88
10481232|NCT01134627|11630213|FG000|NOT COMPLETED|Overall Study||69
10481233|NCT01134627|11630214|FG001|NOT COMPLETED|Overall Study||67
10481234|NCT01134705|11630222|FG000|STARTED|Overall Study||236
10481235|NCT01134705|11630223|FG001|STARTED|Overall Study||238
10481236|NCT01134705|11630222|FG000|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment.|232
10481237|NCT01134705|11630223|FG001|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment.|234
10481238|NCT01134705|11630222|FG000|COMPLETED|Overall Study||221
10481239|NCT01134705|11630223|FG001|COMPLETED|Overall Study||216
10481240|NCT01134705|11630222|FG000|NOT COMPLETED|Overall Study||15
10481241|NCT01134705|11630223|FG001|NOT COMPLETED|Overall Study||22
10481242|NCT01134731|11630232|FG000|STARTED|Overall Study||23
10481243|NCT01134731|11630233|FG001|STARTED|Overall Study||21
10481244|NCT01134731|11630234|FG002|STARTED|Overall Study||10
10481245|NCT01134731|11630232|FG000|COMPLETED|Overall Study||10
10481246|NCT01134731|11630233|FG001|COMPLETED|Overall Study||10
10481247|NCT01134731|11630234|FG002|COMPLETED|Overall Study||2
10481248|NCT01134731|11630232|FG000|NOT COMPLETED|Overall Study||13
10481249|NCT01134731|11630233|FG001|NOT COMPLETED|Overall Study||11
10481250|NCT01134731|11630234|FG002|NOT COMPLETED|Overall Study||8
10481251|NCT01134783|11630245|FG000|STARTED|Overall Study||224
10481252|NCT01134783|11630246|FG001|STARTED|Overall Study||217
10481253|NCT01134783|11630245|FG000|COMPLETED|Overall Study||188
10481254|NCT01134783|11630246|FG001|COMPLETED|Overall Study||180
10481255|NCT01134783|11630245|FG000|NOT COMPLETED|Overall Study||36
10481256|NCT01134783|11630246|FG001|NOT COMPLETED|Overall Study||37
10481257|NCT01134887|11630260|FG000|STARTED|Overall Study||9
10481258|NCT01134887|11630261|FG001|STARTED|Overall Study||11
10481259|NCT01134887|11630262|FG002|STARTED|Overall Study||5
10481260|NCT01134887|11630263|FG003|STARTED|Overall Study||5
10481261|NCT01134887|11630260|FG000|COMPLETED|Overall Study||9
10481262|NCT01134887|11630261|FG001|COMPLETED|Overall Study|Four patients in the Veteran-Control arm did not have two clinic visits videotaped and left study.|7
10481263|NCT01134887|11630262|FG002|COMPLETED|Overall Study||5
10481264|NCT01134887|11630263|FG003|COMPLETED|Overall Study||5
10481265|NCT01134887|11630260|FG000|NOT COMPLETED|Overall Study||0
10481266|NCT01134887|11630261|FG001|NOT COMPLETED|Overall Study||4
10481267|NCT01134887|11630262|FG002|NOT COMPLETED|Overall Study||0
10481268|NCT01134887|11630263|FG003|NOT COMPLETED|Overall Study||0
10481269|NCT01134900|11630273|FG000|STARTED|Overall Study||200
10481270|NCT01134900|11630274|FG001|STARTED|Overall Study||196
10481271|NCT01134900|11630273|FG000|COMPLETED|Overall Study||200
10481272|NCT01134900|11630274|FG001|COMPLETED|Overall Study||196
10481273|NCT01134900|11630273|FG000|NOT COMPLETED|Overall Study||0
10481274|NCT01134900|11630274|FG001|NOT COMPLETED|Overall Study||0
10481275|NCT01134939|11630288|FG000|STARTED|Overall Study||59
10481276|NCT01134939|11630289|FG001|STARTED|Overall Study||42
10481277|NCT01134939|11630290|FG002|STARTED|Overall Study||51
10481278|NCT01134939|11630291|FG003|STARTED|Overall Study||46
10481279|NCT01134939|11630292|FG004|STARTED|Overall Study||33
10481280|NCT01134939|11630293|FG005|STARTED|Overall Study||14
10481281|NCT01134939|11630294|FG006|STARTED|Overall Study||19
10481282|NCT01134939|11630295|FG007|STARTED|Overall Study||1
10481283|NCT01134939|11630288|FG000|COMPLETED|Overall Study||42
10481284|NCT01134939|11630289|FG001|COMPLETED|Overall Study||24
10481285|NCT01134939|11630290|FG002|COMPLETED|Overall Study||41
10481286|NCT01134939|11630291|FG003|COMPLETED|Overall Study||32
10481287|NCT01134939|11630292|FG004|COMPLETED|Overall Study||23
10481288|NCT01134939|11630293|FG005|COMPLETED|Overall Study||5
10481289|NCT01134939|11630294|FG006|COMPLETED|Overall Study||10
10481290|NCT01134939|11630295|FG007|COMPLETED|Overall Study||1
10481291|NCT01134939|11630288|FG000|NOT COMPLETED|Overall Study||17
10481292|NCT01134939|11630289|FG001|NOT COMPLETED|Overall Study||18
10481293|NCT01134939|11630290|FG002|NOT COMPLETED|Overall Study||10
10481294|NCT01134939|11630291|FG003|NOT COMPLETED|Overall Study||14
10481295|NCT01134939|11630292|FG004|NOT COMPLETED|Overall Study||10
10481296|NCT01134939|11630293|FG005|NOT COMPLETED|Overall Study||9
10481297|NCT01134939|11630294|FG006|NOT COMPLETED|Overall Study||9
10481298|NCT01134939|11630295|FG007|NOT COMPLETED|Overall Study||0
10481299|NCT01134952|11630309|FG000|STARTED|Overall Study||11
10481300|NCT01134952|11630309|FG000|COMPLETED|Overall Study||11
10481301|NCT01134952|11630309|FG000|NOT COMPLETED|Overall Study||0
10481302|NCT01135017|11630319|FG000|STARTED|Overall Study||55
10481303|NCT01135017|11630320|FG001|STARTED|Overall Study||57
10481304|NCT01135017|11630319|FG000|Treated|Overall Study||55
10481305|NCT01135017|11630320|FG001|Treated|Overall Study||57
10481306|NCT01135017|11630319|FG000|Evaluable for Efficacy|Overall Study||55
10481307|NCT01135017|11630320|FG001|Evaluable for Efficacy|Overall Study|Two participants did not have interrogation of the pacemaker after randomization|55
10481308|NCT01135017|11630319|FG000|COMPLETED|Overall Study|The study was terminated after enrolled participants completed the study period as per protocol|49
10481309|NCT01135017|11630320|FG001|COMPLETED|Overall Study|The study was terminated after enrolled participants completed the study period as per protocol|45
10481310|NCT01135017|11630319|FG000|NOT COMPLETED|Overall Study||6
10481311|NCT01135017|11630320|FG001|NOT COMPLETED|Overall Study||12
10481312|NCT01135069|11630329|FG000|STARTED|Overall Study||205
10481313|NCT01135069|11630330|FG001|STARTED|Overall Study||209
10481314|NCT01135069|11630331|FG002|STARTED|Overall Study||66
10481315|NCT01135069|11630329|FG000|COMPLETED|Overall Study||169
10481316|NCT01135069|11630330|FG001|COMPLETED|Overall Study||177
10481317|NCT01135069|11630331|FG002|COMPLETED|Overall Study||56
10481318|NCT01135069|11630329|FG000|NOT COMPLETED|Overall Study||36
10481319|NCT01135069|11630330|FG001|NOT COMPLETED|Overall Study||32
10481320|NCT01135069|11630331|FG002|NOT COMPLETED|Overall Study||10
10481321|NCT01135095|11630339|FG000|STARTED|Overall Study||101
10481322|NCT01135095|11630339|FG000|COMPLETED|Overall Study||101
10481323|NCT01135095|11630339|FG000|NOT COMPLETED|Overall Study||0
10481324|NCT01135186|11630343|FG000|STARTED|Overall Study||9
10481325|NCT01135186|11630343|FG000|COMPLETED|Overall Study||9
10481326|NCT01135186|11630343|FG000|NOT COMPLETED|Overall Study||0
10481327|NCT01135329|11630349|FG000|STARTED|Overall Study||15
10481328|NCT01135329|11630349|FG000|COMPLETED|Overall Study||15
10481329|NCT01135329|11630349|FG000|NOT COMPLETED|Overall Study||0
10481330|NCT01135368|11630354|FG000|STARTED|Overall Study||506
10481331|NCT01135368|11630354|FG000|COMPLETED|Overall Study||255
10709638|NCT02641730|11874674|FG000|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0
10709639|NCT02641730|11874675|FG001|NOT COMPLETED|After Controlled Period (Week 16 - 52)||4
10709640|NCT02641730|11874676|FG002|NOT COMPLETED|After Controlled Period (Week 16 - 52)||2
10709641|NCT02641730|11874677|FG003|NOT COMPLETED|After Controlled Period (Week 16 - 52)||8
10709642|NCT02641730|11874678|FG004|NOT COMPLETED|After Controlled Period (Week 16 - 52)||6
10709643|NCT02641730|11874674|FG000|STARTED|Observational Period (Week 60 - Week 84)||0
10709644|NCT02641730|11874675|FG001|STARTED|Observational Period (Week 60 - Week 84)||21
10709645|NCT02641730|11874676|FG002|STARTED|Observational Period (Week 60 - Week 84)||24
10709646|NCT02641730|11874677|FG003|STARTED|Observational Period (Week 60 - Week 84)||45
10709647|NCT02641730|11874678|FG004|STARTED|Observational Period (Week 60 - Week 84)||44
10709648|NCT02641730|11874674|FG000|COMPLETED|Observational Period (Week 60 - Week 84)||0
10481332|NCT01135368|11630354|FG000|NOT COMPLETED|Overall Study||251
10481333|NCT01135381|11630396|FG000|STARTED|Overall Study||189
10481334|NCT01135381|11630397|FG001|STARTED|Overall Study||185
10481335|NCT01135381|11630398|FG002|STARTED|Overall Study||69
10481336|NCT01135381|11630399|FG003|STARTED|Overall Study||68
10481337|NCT01135381|11630396|FG000|COMPLETED|Overall Study||168
10481338|NCT01135381|11630397|FG001|COMPLETED|Overall Study||178
10481339|NCT01135381|11630398|FG002|COMPLETED|Overall Study||65
10481340|NCT01135381|11630399|FG003|COMPLETED|Overall Study||67
10481341|NCT01135381|11630396|FG000|NOT COMPLETED|Overall Study||21
10481342|NCT01135381|11630397|FG001|NOT COMPLETED|Overall Study||7
10709649|NCT02641730|11874675|FG001|COMPLETED|Observational Period (Week 60 - Week 84)||21
10709650|NCT02641730|11874676|FG002|COMPLETED|Observational Period (Week 60 - Week 84)||24
10709651|NCT02641730|11874677|FG003|COMPLETED|Observational Period (Week 60 - Week 84)||45
10709652|NCT02641730|11874678|FG004|COMPLETED|Observational Period (Week 60 - Week 84)||43
10709653|NCT02641730|11874674|FG000|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
10709654|NCT02641730|11874675|FG001|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
10709655|NCT02641730|11874676|FG002|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
10481343|NCT01135381|11630398|FG002|NOT COMPLETED|Overall Study||4
10481344|NCT01135381|11630399|FG003|NOT COMPLETED|Overall Study||1
10481345|NCT01135394|11630409|FG000|STARTED|Screening||114
10481346|NCT01135394|11630409|FG000|COMPLETED|Screening||81
10481347|NCT01135394|11630409|FG000|NOT COMPLETED|Screening||33
10481348|NCT01135394|11630409|FG000|STARTED|Baseline Assessment||81
10481349|NCT01135394|11630409|FG000|COMPLETED|Baseline Assessment||66
10481350|NCT01135394|11630409|FG000|NOT COMPLETED|Baseline Assessment||15
10481351|NCT01135394|11630409|FG000|STARTED|Study Treatment||66
10481352|NCT01135394|11630409|FG000|COMPLETED|Study Treatment||62
10481353|NCT01135394|11630409|FG000|NOT COMPLETED|Study Treatment||4
10481354|NCT01135420|11630415|FG000|STARTED|Overall Study||199
10481355|NCT01135420|11630416|FG001|STARTED|Overall Study||207
10481356|NCT01135420|11630415|FG000|COMPLETED|Overall Study||155
10481357|NCT01135420|11630416|FG001|COMPLETED|Overall Study||175
10481358|NCT01135420|11630415|FG000|NOT COMPLETED|Overall Study||44
10481359|NCT01135420|11630416|FG001|NOT COMPLETED|Overall Study||32
10481360|NCT01135498|11630422|FG000|STARTED|Overall Study||90
10481361|NCT01135498|11630422|FG000|COMPLETED|Overall Study||0
10481362|NCT01135498|11630422|FG000|NOT COMPLETED|Overall Study||90
10481363|NCT01135511|11630436|FG000|STARTED|Overall Study||41
10481364|NCT01135511|11630437|FG001|STARTED|Overall Study||42
10481365|NCT01135511|11630438|FG002|STARTED|Overall Study||41
10481366|NCT01135511|11630439|FG003|STARTED|Overall Study||40
10481367|NCT01135511|11630440|FG004|STARTED|Overall Study||39
10481368|NCT01135511|11630441|FG005|STARTED|Overall Study||21
10481369|NCT01135511|11630442|FG006|STARTED|Overall Study||19
10481370|NCT01135511|11630443|FG007|STARTED|Overall Study||21
10481371|NCT01135511|11630444|FG008|STARTED|Overall Study||21
10481372|NCT01135511|11630436|FG000|COMPLETED|Overall Study||41
10481373|NCT01135511|11630437|FG001|COMPLETED|Overall Study||39
10481374|NCT01135511|11630438|FG002|COMPLETED|Overall Study||33
10481375|NCT01135511|11630439|FG003|COMPLETED|Overall Study||37
10481376|NCT01135511|11630440|FG004|COMPLETED|Overall Study||38
10481377|NCT01135511|11630441|FG005|COMPLETED|Overall Study||20
10481378|NCT01135511|11630442|FG006|COMPLETED|Overall Study||18
10481379|NCT01135511|11630443|FG007|COMPLETED|Overall Study||20
10481380|NCT01135511|11630444|FG008|COMPLETED|Overall Study||20
10481381|NCT01135511|11630436|FG000|NOT COMPLETED|Overall Study||0
10481382|NCT01135511|11630437|FG001|NOT COMPLETED|Overall Study||3
10481383|NCT01135511|11630438|FG002|NOT COMPLETED|Overall Study||8
10481384|NCT01135511|11630439|FG003|NOT COMPLETED|Overall Study||3
10481385|NCT01135511|11630440|FG004|NOT COMPLETED|Overall Study||1
10481386|NCT01135511|11630441|FG005|NOT COMPLETED|Overall Study||1
10481387|NCT01135511|11630442|FG006|NOT COMPLETED|Overall Study||1
10481388|NCT01135511|11630443|FG007|NOT COMPLETED|Overall Study||1
10481389|NCT01135511|11630444|FG008|NOT COMPLETED|Overall Study||1
10481390|NCT01135524|11630464|FG000|STARTED|Overall Study||196
10481391|NCT01135524|11630464|FG000|COMPLETED|Overall Study||0
10481392|NCT01135524|11630464|FG000|NOT COMPLETED|Overall Study||196
10481393|NCT01135537|11630468|FG000|STARTED|Overall Study||30
10481394|NCT01135537|11630468|FG000|COMPLETED|Overall Study||17
10481395|NCT01135537|11630468|FG000|NOT COMPLETED|Overall Study||13
10481396|NCT01135914|11630475|FG000|STARTED|Overall Study||78
10481397|NCT01135914|11630476|FG001|STARTED|Overall Study||80
10481398|NCT01135914|11630477|FG002|STARTED|Overall Study||81
10481399|NCT01135914|11630475|FG000|Intent to Treat (ITT) Population|Overall Study||73
10481400|NCT01135914|11630476|FG001|Intent to Treat (ITT) Population|Overall Study||75
10481401|NCT01135914|11630477|FG002|Intent to Treat (ITT) Population|Overall Study||72
10481402|NCT01135914|11630475|FG000|Safety Population|Overall Study||73
10481403|NCT01135914|11630476|FG001|Safety Population|Overall Study||75
10481404|NCT01135914|11630477|FG002|Safety Population|Overall Study||74
10481405|NCT01135914|11630475|FG000|COMPLETED|Overall Study||74
10481406|NCT01135914|11630476|FG001|COMPLETED|Overall Study||75
10481407|NCT01135914|11630477|FG002|COMPLETED|Overall Study||59
10481408|NCT01135914|11630475|FG000|NOT COMPLETED|Overall Study||4
10481409|NCT01135914|11630476|FG001|NOT COMPLETED|Overall Study||5
10481410|NCT01135914|11630477|FG002|NOT COMPLETED|Overall Study||22
10481411|NCT01135992|11630485|FG000|STARTED|Overall Study||143
10481412|NCT01135992|11630485|FG000|Exposed|Overall Study|One subject was withdrawn before being exposed.|142
10481413|NCT01135992|11630485|FG000|Full Analysis Set|Overall Study||129
10481414|NCT01135992|11630485|FG000|COMPLETED|Overall Study||122
10481415|NCT01135992|11630485|FG000|NOT COMPLETED|Overall Study||21
10481416|NCT01136174|11630493|FG000|STARTED|Overall Study||12
10481417|NCT01136174|11630494|FG001|STARTED|Overall Study||6
10481418|NCT01136174|11630495|FG002|STARTED|Overall Study||8
10481419|NCT01136174|11630496|FG003|STARTED|Overall Study||24
10481420|NCT01136174|11630493|FG000|COMPLETED|Overall Study||12
10481421|NCT01136174|11630494|FG001|COMPLETED|Overall Study||6
10481422|NCT01136174|11630495|FG002|COMPLETED|Overall Study||8
10481423|NCT01136174|11630496|FG003|COMPLETED|Overall Study||20
10481424|NCT01136174|11630493|FG000|NOT COMPLETED|Overall Study||0
10481425|NCT01136174|11630494|FG001|NOT COMPLETED|Overall Study||0
10481426|NCT01136174|11630495|FG002|NOT COMPLETED|Overall Study||0
10481427|NCT01136174|11630496|FG003|NOT COMPLETED|Overall Study||4
10481428|NCT01136226|11630515|FG000|STARTED|Overall Study||42
10481429|NCT01136226|11630515|FG000|COMPLETED|Overall Study||29
10481430|NCT01136226|11630515|FG000|NOT COMPLETED|Overall Study||13
10481431|NCT01136291|11630522|FG000|STARTED|Overall Study||40
10481432|NCT01136291|11630523|FG001|STARTED|Overall Study||42
10481433|NCT01136291|11630522|FG000|Follow|Overall Study||40
10481434|NCT01136291|11630523|FG001|Follow|Overall Study||42
10481435|NCT01136291|11630522|FG000|COMPLETED|Overall Study||39
10481436|NCT01136291|11630523|FG001|COMPLETED|Overall Study||41
10481437|NCT01136291|11630522|FG000|NOT COMPLETED|Overall Study||1
10481438|NCT01136291|11630523|FG001|NOT COMPLETED|Overall Study||1
10481439|NCT01136356|11630529|FG000|STARTED|First Intervention||6
10481440|NCT01136356|11630530|FG001|STARTED|First Intervention||6
10481441|NCT01136356|11630529|FG000|COMPLETED|First Intervention||6
10481442|NCT01136356|11630530|FG001|COMPLETED|First Intervention||6
10481443|NCT01136356|11630529|FG000|NOT COMPLETED|First Intervention||0
10481444|NCT01136356|11630530|FG001|NOT COMPLETED|First Intervention||0
10481445|NCT01136356|11630529|FG000|STARTED|First 18-day Withdrawal||6
10481446|NCT01136356|11630530|FG001|STARTED|First 18-day Withdrawal||6
10481447|NCT01136356|11630529|FG000|COMPLETED|First 18-day Withdrawal||2
10481448|NCT01136356|11630530|FG001|COMPLETED|First 18-day Withdrawal||6
10481449|NCT01136356|11630529|FG000|NOT COMPLETED|First 18-day Withdrawal||4
10481450|NCT01136356|11630530|FG001|NOT COMPLETED|First 18-day Withdrawal||0
10481451|NCT01136356|11630529|FG000|STARTED|Second Intervention||2
10481452|NCT01136356|11630530|FG001|STARTED|Second Intervention||6
10481453|NCT01136356|11630529|FG000|COMPLETED|Second Intervention||2
10481454|NCT01136356|11630530|FG001|COMPLETED|Second Intervention||6
10481455|NCT01136356|11630529|FG000|NOT COMPLETED|Second Intervention||0
10481456|NCT01136356|11630530|FG001|NOT COMPLETED|Second Intervention||0
10481457|NCT01136356|11630529|FG000|STARTED|Second 18-day Withdrawal||2
10481458|NCT01136356|11630530|FG001|STARTED|Second 18-day Withdrawal||6
10481459|NCT01136356|11630529|FG000|COMPLETED|Second 18-day Withdrawal||2
10481460|NCT01136356|11630530|FG001|COMPLETED|Second 18-day Withdrawal||5
10481461|NCT01136356|11630529|FG000|NOT COMPLETED|Second 18-day Withdrawal||0
10481462|NCT01136356|11630530|FG001|NOT COMPLETED|Second 18-day Withdrawal||1
10481463|NCT01136382|11630537|FG000|STARTED|Overall Study||152
10481464|NCT01136382|11630538|FG001|STARTED|Overall Study||152
10481465|NCT01136382|11630537|FG000|COMPLETED|Overall Study||92
10481466|NCT01136382|11630538|FG001|COMPLETED|Overall Study||121
10481467|NCT01136382|11630537|FG000|NOT COMPLETED|Overall Study||60
10481468|NCT01136382|11630538|FG001|NOT COMPLETED|Overall Study||31
10481469|NCT01136408|11630547|FG000|STARTED|Overall Study||46
10481470|NCT01136408|11630548|FG001|STARTED|Overall Study||58
10481471|NCT01136408|11630549|FG002|STARTED|Overall Study||62
10481472|NCT01136408|11630547|FG000|COMPLETED|Overall Study||41
10481473|NCT01136408|11630548|FG001|COMPLETED|Overall Study||49
10481474|NCT01136408|11630549|FG002|COMPLETED|Overall Study||57
10481475|NCT01136408|11630547|FG000|NOT COMPLETED|Overall Study||5
10481476|NCT01136408|11630548|FG001|NOT COMPLETED|Overall Study||9
10481477|NCT01136408|11630549|FG002|NOT COMPLETED|Overall Study||5
10481478|NCT01136486|11630561|FG000|STARTED|Overall Study||56
10481479|NCT01136486|11630561|FG000|COMPLETED|Overall Study||56
10481480|NCT01136486|11630561|FG000|NOT COMPLETED|Overall Study||0
10481481|NCT01136655|11630565|FG000|STARTED|BUD 160/FM 2.25 (1 Dose)||54
10481482|NCT01136655|11630565|FG000|COMPLETED|BUD 160/FM 2.25 (1 Dose)||54
10481483|NCT01136655|11630565|FG000|NOT COMPLETED|BUD 160/FM 2.25 (1 Dose)||0
10481484|NCT01136655|11630565|FG000|STARTED|Washout After BUD 160/FM 2.25 (7 Days)||54
10481485|NCT01136655|11630565|FG000|COMPLETED|Washout After BUD 160/FM 2.25 (7 Days)||53
10481486|NCT01136655|11630565|FG000|NOT COMPLETED|Washout After BUD 160/FM 2.25 (7 Days)||1
10481487|NCT01136655|11630565|FG000|STARTED|BUD 160/FM 4.5 (1 Dose)||53
10481488|NCT01136655|11630565|FG000|COMPLETED|BUD 160/FM 4.5 (1 Dose)||53
10481489|NCT01136655|11630565|FG000|NOT COMPLETED|BUD 160/FM 4.5 (1 Dose)||0
10481490|NCT01136655|11630565|FG000|STARTED|Washout After BUD 160/FM 4.5 (7 Days)||53
10481491|NCT01136655|11630565|FG000|COMPLETED|Washout After BUD 160/FM 4.5 (7 Days)||52
10481492|NCT01136655|11630565|FG000|NOT COMPLETED|Washout After BUD 160/FM 4.5 (7 Days)||1
10481493|NCT01136655|11630565|FG000|STARTED|BUD 160/FM 9.0 (1 Dose)||53
10481494|NCT01136655|11630565|FG000|COMPLETED|BUD 160/FM 9.0 (1 Dose)||53
10481495|NCT01136655|11630565|FG000|NOT COMPLETED|BUD 160/FM 9.0 (1 Dose)||0
10481496|NCT01136655|11630565|FG000|STARTED|Washout After BUD 160/FM 9.0 (7 Days)||53
10481497|NCT01136655|11630565|FG000|COMPLETED|Washout After BUD 160/FM 9.0 (7 Days)||51
10481498|NCT01136655|11630565|FG000|NOT COMPLETED|Washout After BUD 160/FM 9.0 (7 Days)||2
10481499|NCT01136655|11630565|FG000|STARTED|BUD 160 (1 Dose)||51
10481500|NCT01136655|11630565|FG000|COMPLETED|BUD 160 (1 Dose)||51
10481501|NCT01136655|11630565|FG000|NOT COMPLETED|BUD 160 (1 Dose)||0
10481502|NCT01136655|11630565|FG000|STARTED|Washout After BUD 160 (7 Days)||51
10481503|NCT01136655|11630565|FG000|COMPLETED|Washout After BUD 160 (7 Days)||51
10481504|NCT01136655|11630565|FG000|NOT COMPLETED|Washout After BUD 160 (7 Days)||0
10481505|NCT01136655|11630565|FG000|STARTED|BUD 160/ Foradil 12.0 (1 Dose)||50
10481506|NCT01136655|11630565|FG000|COMPLETED|BUD 160/ Foradil 12.0 (1 Dose)||50
10481507|NCT01136655|11630565|FG000|NOT COMPLETED|BUD 160/ Foradil 12.0 (1 Dose)||0
10481508|NCT01136655|11630565|FG000|STARTED|Washout After BUD 160/ Foradil (7 Days)||50
10481509|NCT01136655|11630565|FG000|COMPLETED|Washout After BUD 160/ Foradil (7 Days)||50
10481510|NCT01136655|11630565|FG000|NOT COMPLETED|Washout After BUD 160/ Foradil (7 Days)||0
10527279|NCT01388816|11679312|FG003|NOT COMPLETED|Overall Study||0
10481511|NCT01136733|11630585|FG000|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|7
10481512|NCT01136733|11630586|FG001|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|11
10709656|NCT02641730|11874677|FG003|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
10709657|NCT02641730|11874678|FG004|NOT COMPLETED|Observational Period (Week 60 - Week 84)||1
10709658|NCT02641834|11874694|FG000|STARTED|Overall Study||60
10709659|NCT02641834|11874695|FG001|STARTED|Overall Study||58
10481513|NCT01136733|11630587|FG002|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|2
10481514|NCT01136733|11630588|FG003|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|0
10481515|NCT01136733|11630589|FG004|STARTED|Phase 1b||0
10481516|NCT01136733|11630590|FG005|STARTED|Phase 1b||0
10481517|NCT01136733|11630591|FG006|STARTED|Phase 1b||0
10481518|NCT01136733|11630585|FG000|COMPLETED|Phase 1b||6
10481519|NCT01136733|11630586|FG001|COMPLETED|Phase 1b||6
10481520|NCT01136733|11630587|FG002|COMPLETED|Phase 1b||0
10481521|NCT01136733|11630588|FG003|COMPLETED|Phase 1b||0
10481522|NCT01136733|11630589|FG004|COMPLETED|Phase 1b||0
10481523|NCT01136733|11630590|FG005|COMPLETED|Phase 1b||0
10481524|NCT01136733|11630591|FG006|COMPLETED|Phase 1b||0
10481525|NCT01136733|11630585|FG000|NOT COMPLETED|Phase 1b||1
10481526|NCT01136733|11630586|FG001|NOT COMPLETED|Phase 1b||5
10481527|NCT01136733|11630587|FG002|NOT COMPLETED|Phase 1b||2
10481528|NCT01136733|11630588|FG003|NOT COMPLETED|Phase 1b||0
10481529|NCT01136733|11630589|FG004|NOT COMPLETED|Phase 1b||0
10481530|NCT01136733|11630590|FG005|NOT COMPLETED|Phase 1b||0
10481531|NCT01136733|11630591|FG006|NOT COMPLETED|Phase 1b||0
10481532|NCT01136733|11630585|FG000|STARTED|Phase 2||0
10481533|NCT01136733|11630586|FG001|STARTED|Phase 2||0
10481534|NCT01136733|11630587|FG002|STARTED|Phase 2||0
10481535|NCT01136733|11630588|FG003|STARTED|Phase 2||0
10481536|NCT01136733|11630589|FG004|STARTED|Phase 2|Participants in Phase 2 did not participate in Phase 1b.|51
10481537|NCT01136733|11630590|FG005|STARTED|Phase 2|Participants in Phase 2 did not participate in Phase 1b.|52
10481538|NCT01136733|11630591|FG006|STARTED|Phase 2|Participants in Phase 2 did not participate in Phase 1b.|50
10481539|NCT01136733|11630585|FG000|COMPLETED|Phase 2||0
10481540|NCT01136733|11630586|FG001|COMPLETED|Phase 2||0
10481541|NCT01136733|11630587|FG002|COMPLETED|Phase 2||0
10481542|NCT01136733|11630588|FG003|COMPLETED|Phase 2||0
10481543|NCT01136733|11630589|FG004|COMPLETED|Phase 2||0
10481544|NCT01136733|11630590|FG005|COMPLETED|Phase 2||0
10481545|NCT01136733|11630591|FG006|COMPLETED|Phase 2||0
10481546|NCT01136733|11630585|FG000|NOT COMPLETED|Phase 2||0
10481547|NCT01136733|11630586|FG001|NOT COMPLETED|Phase 2||0
10481548|NCT01136733|11630587|FG002|NOT COMPLETED|Phase 2||0
10481549|NCT01136733|11630588|FG003|NOT COMPLETED|Phase 2||0
10481550|NCT01136733|11630589|FG004|NOT COMPLETED|Phase 2||51
10481551|NCT01136733|11630590|FG005|NOT COMPLETED|Phase 2||52
10481552|NCT01136733|11630591|FG006|NOT COMPLETED|Phase 2||50
10481553|NCT01136746|11630623|FG000|STARTED|Overall Study||9
10481554|NCT01136746|11630624|FG001|STARTED|Overall Study||7
10481555|NCT01136746|11630623|FG000|COMPLETED|Overall Study||6
10481556|NCT01136746|11630624|FG001|COMPLETED|Overall Study||4
10481557|NCT01136746|11630623|FG000|NOT COMPLETED|Overall Study||3
10481558|NCT01136746|11630624|FG001|NOT COMPLETED|Overall Study||3
10481559|NCT01136772|11630632|FG000|STARTED|Overall Study||157
10481560|NCT01136772|11630633|FG001|STARTED|Overall Study||154
10481561|NCT01136772|11630632|FG000|Safety Population|Overall Study|Includes all randomized participants who received at least one dose of the injectable medication|147
10481562|NCT01136772|11630633|FG001|Safety Population|Overall Study|Includes all randomized participants who received at least one dose of the injectable medication|147
10481563|NCT01136772|11630632|FG000|COMPLETED|Overall Study||41
10481564|NCT01136772|11630633|FG001|COMPLETED|Overall Study||44
10481565|NCT01136772|11630632|FG000|NOT COMPLETED|Overall Study||116
10481566|NCT01136772|11630633|FG001|NOT COMPLETED|Overall Study||110
10481567|NCT01136785|11630641|FG000|STARTED|Overall Study||15
10481568|NCT01136785|11630642|FG001|STARTED|Overall Study||7
10481569|NCT01136785|11630641|FG000|COMPLETED|Overall Study||13
10481570|NCT01136785|11630642|FG001|COMPLETED|Overall Study||6
10481571|NCT01136785|11630641|FG000|NOT COMPLETED|Overall Study||2
10481572|NCT01136785|11630642|FG001|NOT COMPLETED|Overall Study||1
10481573|NCT01136798|11630654|FG000|STARTED|Overall Study||10
10481574|NCT01136798|11630655|FG001|STARTED|Overall Study||8
10481575|NCT01136798|11630654|FG000|COMPLETED|Overall Study||10
10481576|NCT01136798|11630655|FG001|COMPLETED|Overall Study||8
10481577|NCT01136798|11630654|FG000|NOT COMPLETED|Overall Study||0
10481578|NCT01136798|11630655|FG001|NOT COMPLETED|Overall Study||0
10481579|NCT01136876|11630663|FG000|STARTED|Overall Study||28
10481580|NCT01136876|11630664|FG001|STARTED|Overall Study||29
10481581|NCT01136876|11630663|FG000|COMPLETED|Overall Study||23
10481582|NCT01136876|11630664|FG001|COMPLETED|Overall Study||18
10481583|NCT01136876|11630663|FG000|NOT COMPLETED|Overall Study||5
10481584|NCT01136876|11630664|FG001|NOT COMPLETED|Overall Study||11
10481585|NCT01136915|11630674|FG000|STARTED|Overall Study||8
10481586|NCT01136915|11630675|FG001|STARTED|Overall Study||7
10481587|NCT01136915|11630674|FG000|COMPLETED|Overall Study||6
10481588|NCT01136915|11630675|FG001|COMPLETED|Overall Study||6
10481589|NCT01136915|11630674|FG000|NOT COMPLETED|Overall Study||2
10481590|NCT01136915|11630675|FG001|NOT COMPLETED|Overall Study||1
10481591|NCT01136954|11630685|FG000|STARTED|Overall Study||72
10481592|NCT01136954|11630686|FG001|STARTED|Overall Study||72
10481593|NCT01136954|11630685|FG000|COMPLETED|Overall Study||48
10481594|NCT01136954|11630686|FG001|COMPLETED|Overall Study||51
10481595|NCT01136954|11630685|FG000|NOT COMPLETED|Overall Study||24
10481596|NCT01136954|11630686|FG001|NOT COMPLETED|Overall Study||21
10481597|NCT01137006|11630700|FG000|STARTED|Overall Study||3
10481598|NCT01137006|11630701|FG001|STARTED|Overall Study||3
10481599|NCT01137006|11630702|FG002|STARTED|Overall Study||8
10481600|NCT01137006|11630703|FG003|STARTED|Overall Study||3
10481601|NCT01137006|11630704|FG004|STARTED|Overall Study||3
10481602|NCT01137006|11630705|FG005|STARTED|Overall Study||4
10481603|NCT01137006|11630706|FG006|STARTED|Overall Study||3
10481604|NCT01137006|11630700|FG000|Completed at Least 1 Treatment Cycle|Overall Study||3
10481605|NCT01137006|11630701|FG001|Completed at Least 1 Treatment Cycle|Overall Study||3
10481606|NCT01137006|11630702|FG002|Completed at Least 1 Treatment Cycle|Overall Study||8
10481607|NCT01137006|11630703|FG003|Completed at Least 1 Treatment Cycle|Overall Study||3
10481608|NCT01137006|11630704|FG004|Completed at Least 1 Treatment Cycle|Overall Study||3
10481609|NCT01137006|11630705|FG005|Completed at Least 1 Treatment Cycle|Overall Study||4
10481610|NCT01137006|11630706|FG006|Completed at Least 1 Treatment Cycle|Overall Study||3
10481611|NCT01137006|11630700|FG000|COMPLETED|Overall Study||3
10481612|NCT01137006|11630701|FG001|COMPLETED|Overall Study||3
10481613|NCT01137006|11630702|FG002|COMPLETED|Overall Study||8
10481614|NCT01137006|11630703|FG003|COMPLETED|Overall Study||3
10481615|NCT01137006|11630704|FG004|COMPLETED|Overall Study||3
10481616|NCT01137006|11630705|FG005|COMPLETED|Overall Study||4
10481617|NCT01137006|11630706|FG006|COMPLETED|Overall Study||3
10481618|NCT01137006|11630700|FG000|NOT COMPLETED|Overall Study||0
10481619|NCT01137006|11630701|FG001|NOT COMPLETED|Overall Study||0
10481620|NCT01137006|11630702|FG002|NOT COMPLETED|Overall Study||0
10481621|NCT01137006|11630703|FG003|NOT COMPLETED|Overall Study||0
10481622|NCT01137006|11630704|FG004|NOT COMPLETED|Overall Study||0
10481623|NCT01137006|11630705|FG005|NOT COMPLETED|Overall Study||0
10481624|NCT01137006|11630706|FG006|NOT COMPLETED|Overall Study||0
10481625|NCT01137032|11630723|FG000|STARTED|Overall Study||19
10481626|NCT01137032|11630723|FG000|COMPLETED|Overall Study||19
10481627|NCT01137032|11630723|FG000|NOT COMPLETED|Overall Study||0
10481628|NCT01137071|11630727|FG000|STARTED|Overall Study|all patients considered eligible were included on the study|29
10481629|NCT01137071|11630727|FG000|COMPLETED|Overall Study|Of the eligible patients|15
10481630|NCT01137071|11630727|FG000|NOT COMPLETED|Overall Study||14
10481631|NCT01137110|11630738|FG000|STARTED|Overall Study||35
10481632|NCT01137110|11630739|FG001|STARTED|Overall Study||49
10481633|NCT01137110|11630738|FG000|COMPLETED|Overall Study||34
10481634|NCT01137110|11630739|FG001|COMPLETED|Overall Study||49
10481635|NCT01137110|11630738|FG000|NOT COMPLETED|Overall Study||1
10481636|NCT01137110|11630739|FG001|NOT COMPLETED|Overall Study||0
10481637|NCT01137292|11630745|FG000|STARTED|Overall Study||177
10481638|NCT01137292|11630745|FG000|COMPLETED|Overall Study||123
10481639|NCT01137292|11630745|FG000|NOT COMPLETED|Overall Study||54
10481640|NCT01137370|11630751|FG000|STARTED|Overall Study||116
10481641|NCT01137370|11630752|FG001|STARTED|Overall Study||87
10481642|NCT01137370|11630751|FG000|COMPLETED|Overall Study||116
10481643|NCT01137370|11630752|FG001|COMPLETED|Overall Study||87
10481644|NCT01137370|11630751|FG000|NOT COMPLETED|Overall Study||0
10481645|NCT01137370|11630752|FG001|NOT COMPLETED|Overall Study||0
10481646|NCT01137396|11630760|FG000|STARTED|Overall Study||30
10709660|NCT02641834|11874694|FG000|COMPLETED|Overall Study||50
10709661|NCT02641834|11874695|FG001|COMPLETED|Overall Study||50
10709662|NCT02641834|11874694|FG000|NOT COMPLETED|Overall Study||10
10481647|NCT01137396|11630761|FG001|STARTED|Overall Study||27
10481648|NCT01137396|11630760|FG000|COMPLETED|Overall Study||22
10481649|NCT01137396|11630761|FG001|COMPLETED|Overall Study||25
10481650|NCT01137396|11630760|FG000|NOT COMPLETED|Overall Study||8
10481651|NCT01137396|11630761|FG001|NOT COMPLETED|Overall Study||2
10481652|NCT01137474|11630771|FG000|STARTED|Overall Study||311
10481653|NCT01137474|11630772|FG001|STARTED|Overall Study||166
10481654|NCT01137474|11630773|FG002|STARTED|Overall Study||165
10481655|NCT01137474|11630774|FG003|STARTED|Overall Study||302
10481656|NCT01137474|11630771|FG000|Received Treatment|Overall Study||311
10481657|NCT01137474|11630772|FG001|Received Treatment|Overall Study||166
10481658|NCT01137474|11630773|FG002|Received Treatment|Overall Study||165
10481659|NCT01137474|11630774|FG003|Received Treatment|Overall Study||302
10481660|NCT01137474|11630771|FG000|COMPLETED|Overall Study||287
10481661|NCT01137474|11630772|FG001|COMPLETED|Overall Study||154
10481662|NCT01137474|11630773|FG002|COMPLETED|Overall Study||158
10709663|NCT02641834|11874695|FG001|NOT COMPLETED|Overall Study||8
10481663|NCT01137474|11630774|FG003|COMPLETED|Overall Study||281
10481664|NCT01137474|11630771|FG000|NOT COMPLETED|Overall Study||24
10481665|NCT01137474|11630772|FG001|NOT COMPLETED|Overall Study||12
10481666|NCT01137474|11630773|FG002|NOT COMPLETED|Overall Study||7
10481667|NCT01137474|11630774|FG003|NOT COMPLETED|Overall Study||21
10481668|NCT01137539|11630784|FG000|STARTED|Overall Study||50
10481669|NCT01137539|11630784|FG000|COMPLETED|Overall Study||50
10481670|NCT01137539|11630784|FG000|NOT COMPLETED|Overall Study||0
10481671|NCT01137578|11630788|FG000|STARTED|Overall Study||77
10481672|NCT01137578|11630789|FG001|STARTED|Overall Study||14
10481673|NCT01137578|11630790|FG002|STARTED|Overall Study||43
10481674|NCT01137578|11630788|FG000|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|61
10481675|NCT01137578|11630789|FG001|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|12
10481676|NCT01137578|11630790|FG002|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|37
10481677|NCT01137578|11630788|FG000|NOT COMPLETED|Overall Study||16
10481678|NCT01137578|11630789|FG001|NOT COMPLETED|Overall Study||2
10481679|NCT01137578|11630790|FG002|NOT COMPLETED|Overall Study||6
10481680|NCT01137604|11630822|FG000|STARTED|Overall Study|39 participants were randomized but 1 participant died prior to receiving treatment.|38
10481681|NCT01137604|11630823|FG001|STARTED|Overall Study||42
10481682|NCT01137604|11630824|FG002|STARTED|Overall Study||39
10481683|NCT01137604|11630825|FG003|STARTED|Overall Study||32
10481684|NCT01137604|11630822|FG000|Disease Progression|Overall Study||34
10481685|NCT01137604|11630823|FG001|Disease Progression|Overall Study||29
10481686|NCT01137604|11630824|FG002|Disease Progression|Overall Study||25
10481687|NCT01137604|11630825|FG003|Disease Progression|Overall Study||21
10481688|NCT01137604|11630822|FG000|Treatment Ongoing at Data Cutoff|Overall Study||2
10481689|NCT01137604|11630823|FG001|Treatment Ongoing at Data Cutoff|Overall Study||3
10481690|NCT01137604|11630824|FG002|Treatment Ongoing at Data Cutoff|Overall Study||1
10481691|NCT01137604|11630825|FG003|Treatment Ongoing at Data Cutoff|Overall Study||0
10481692|NCT01137604|11630822|FG000|COMPLETED|Overall Study|Participants with disease progression and treatment ongoing at data cutoff (19 Mar 2013)|36
10481693|NCT01137604|11630823|FG001|COMPLETED|Overall Study||32
10481694|NCT01137604|11630824|FG002|COMPLETED|Overall Study||26
10481695|NCT01137604|11630825|FG003|COMPLETED|Overall Study||21
10481696|NCT01137604|11630822|FG000|NOT COMPLETED|Overall Study||2
10481697|NCT01137604|11630823|FG001|NOT COMPLETED|Overall Study||10
10481698|NCT01137604|11630824|FG002|NOT COMPLETED|Overall Study||13
10481699|NCT01137604|11630825|FG003|NOT COMPLETED|Overall Study||11
10481700|NCT01137682|11630838|FG000|STARTED|Overall Study||65
10481701|NCT01137682|11630839|FG001|STARTED|Overall Study||65
10481702|NCT01137682|11630840|FG002|STARTED|Overall Study||68
10481703|NCT01137682|11630838|FG000|Not Treated|Overall Study||2
10481704|NCT01137682|11630839|FG001|Not Treated|Overall Study||2
10481705|NCT01137682|11630840|FG002|Not Treated|Overall Study||1
10481706|NCT01137682|11630838|FG000|Treated|Overall Study||63
10481707|NCT01137682|11630839|FG001|Treated|Overall Study||63
10481708|NCT01137682|11630840|FG002|Treated|Overall Study||67
10481709|NCT01137682|11630838|FG000|Completed 24-Week Core Phase|Overall Study||59
10709664|NCT02641912|11874704|FG000|STARTED|Overall Study||53
10709665|NCT02641912|11874705|FG001|STARTED|Overall Study||47
10709666|NCT02641912|11874704|FG000|COMPLETED|Overall Study||53
10709667|NCT02641912|11874705|FG001|COMPLETED|Overall Study||47
10709668|NCT02641912|11874704|FG000|NOT COMPLETED|Overall Study||0
10709669|NCT02641912|11874705|FG001|NOT COMPLETED|Overall Study||0
10709670|NCT02642159|11874717|FG000|STARTED|Overall Study|Randomized|276
10709671|NCT02642159|11874718|FG001|STARTED|Overall Study|Randomized|137
10481710|NCT01137682|11630839|FG001|Completed 24-Week Core Phase|Overall Study||57
10481711|NCT01137682|11630840|FG002|Completed 24-Week Core Phase|Overall Study||65
10481712|NCT01137682|11630838|FG000|Not Continuing Into Extension|Overall Study||2
10481713|NCT01137682|11630839|FG001|Not Continuing Into Extension|Overall Study||3
10481714|NCT01137682|11630840|FG002|Not Continuing Into Extension|Overall Study||2
10481715|NCT01137682|11630838|FG000|Continuing Into Extension|Overall Study||57
10481716|NCT01137682|11630839|FG001|Continuing Into Extension|Overall Study||54
10481717|NCT01137682|11630840|FG002|Continuing Into Extension|Overall Study||63
10481718|NCT01137682|11630838|FG000|Safety Set - CORE|Overall Study|2 patients never received drug.|63
10481719|NCT01137682|11630839|FG001|Safety Set - CORE|Overall Study|2 patients never received drug. 1 patient had no post baseline safety assement.|62
10481720|NCT01137682|11630840|FG002|Safety Set - CORE|Overall Study|2 patients never received drug.|66
10481721|NCT01137682|11630838|FG000|Safety Set - Extension|Overall Study||57
10481722|NCT01137682|11630839|FG001|Safety Set - Extension|Overall Study||54
10709672|NCT02642159|11874717|FG000|Treated (Safety Population)|Overall Study||275
10709673|NCT02642159|11874718|FG001|Treated (Safety Population)|Overall Study||137
10709674|NCT02642159|11874717|FG000|ITT Population|Overall Study||273
10709675|NCT02642159|11874718|FG001|ITT Population|Overall Study||136
10709676|NCT02642159|11874717|FG000|ITT: Intent to Prescribe Fenofibrate|Overall Study|Fenofibrate was only 'intended to prescribe' in the Alirocumab arm but not actually administered.|47
10709677|NCT02642159|11874718|FG001|ITT: Intent to Prescribe Fenofibrate|Overall Study||24
10709678|NCT02642159|11874717|FG000|COMPLETED|Overall Study||245
10709679|NCT02642159|11874718|FG001|COMPLETED|Overall Study||129
10709680|NCT02642159|11874717|FG000|NOT COMPLETED|Overall Study||31
10481723|NCT01137682|11630840|FG002|Safety Set - Extension|Overall Study|1 patient did not receive study treatment|62
10481724|NCT01137682|11630838|FG000|COMPLETED|Overall Study||28
10481725|NCT01137682|11630839|FG001|COMPLETED|Overall Study||25
10481726|NCT01137682|11630840|FG002|COMPLETED|Overall Study||34
10481727|NCT01137682|11630838|FG000|NOT COMPLETED|Overall Study||37
10481728|NCT01137682|11630839|FG001|NOT COMPLETED|Overall Study||40
10481729|NCT01137682|11630840|FG002|NOT COMPLETED|Overall Study||34
10481730|NCT01137786|11630854|FG000|STARTED|Overall Study||25
10481731|NCT01137786|11630855|FG001|STARTED|Overall Study||24
10481732|NCT01137786|11630854|FG000|COMPLETED|Overall Study||24
10481733|NCT01137786|11630855|FG001|COMPLETED|Overall Study||21
10481734|NCT01137786|11630854|FG000|NOT COMPLETED|Overall Study||1
10481735|NCT01137786|11630855|FG001|NOT COMPLETED|Overall Study||3
10481736|NCT01137812|11630865|FG000|STARTED|Overall Study||377
10481737|NCT01137812|11630866|FG001|STARTED|Overall Study||378
10481738|NCT01137812|11630865|FG000|COMPLETED|Overall Study||254
10481739|NCT01137812|11630866|FG001|COMPLETED|Overall Study||210
10481740|NCT01137812|11630865|FG000|NOT COMPLETED|Overall Study||123
10481741|NCT01137812|11630866|FG001|NOT COMPLETED|Overall Study||168
10481742|NCT01137890|11630874|FG000|STARTED|Overall Study||14
10481743|NCT01137890|11630875|FG001|STARTED|Overall Study||5
10481744|NCT01137890|11630874|FG000|COMPLETED|Overall Study||8
10481745|NCT01137890|11630875|FG001|COMPLETED|Overall Study||2
10481746|NCT01137890|11630874|FG000|NOT COMPLETED|Overall Study||6
10481747|NCT01137890|11630875|FG001|NOT COMPLETED|Overall Study||3
10481748|NCT01138007|11630930|FG000|STARTED|Overall Study||187
10481749|NCT01138007|11630931|FG001|STARTED|Overall Study||190
10481750|NCT01138007|11630932|FG002|STARTED|Overall Study||192
10481751|NCT01138007|11630930|FG000|COMPLETED|Overall Study||165
10481752|NCT01138007|11630931|FG001|COMPLETED|Overall Study||160
10481753|NCT01138007|11630932|FG002|COMPLETED|Overall Study||144
10481754|NCT01138007|11630930|FG000|NOT COMPLETED|Overall Study||22
10481755|NCT01138007|11630931|FG001|NOT COMPLETED|Overall Study||30
10481756|NCT01138007|11630932|FG002|NOT COMPLETED|Overall Study||48
10481757|NCT01138046|11630942|FG000|STARTED|Overall Study||12
10481758|NCT01138046|11630942|FG000|COMPLETED|Overall Study||6
10481759|NCT01138046|11630942|FG000|NOT COMPLETED|Overall Study||6
10481760|NCT01138098|11630948|FG000|STARTED|Overall Study||95
10481761|NCT01138098|11630949|FG001|STARTED|Overall Study||90
10481762|NCT01138098|11630948|FG000|COMPLETED|Overall Study||95
10481763|NCT01138098|11630949|FG001|COMPLETED|Overall Study||90
10481764|NCT01138098|11630948|FG000|NOT COMPLETED|Overall Study||0
10481765|NCT01138098|11630949|FG001|NOT COMPLETED|Overall Study||0
10481766|NCT01138111|11630955|FG000|STARTED|Overall Study||45
10481767|NCT01138111|11630955|FG000|COMPLETED|Overall Study||36
10481768|NCT01138111|11630955|FG000|NOT COMPLETED|Overall Study||9
10481769|NCT01138124|11630988|FG000|STARTED|Overall Study||3149
10481770|NCT01138124|11630989|FG001|STARTED|Overall Study||30026
10481771|NCT01138124|11630990|FG002|STARTED|Overall Study||1981
10481772|NCT01138124|11630991|FG003|STARTED|Overall Study||19046
10481773|NCT01138124|11630988|FG000|COMPLETED|Overall Study||3149
10481774|NCT01138124|11630989|FG001|COMPLETED|Overall Study||30026
10481775|NCT01138124|11630990|FG002|COMPLETED|Overall Study||1981
10481776|NCT01138124|11630991|FG003|COMPLETED|Overall Study||19046
10481777|NCT01138124|11630988|FG000|NOT COMPLETED|Overall Study||0
10481778|NCT01138124|11630989|FG001|NOT COMPLETED|Overall Study||0
10481779|NCT01138124|11630990|FG002|NOT COMPLETED|Overall Study||0
10481780|NCT01138124|11630991|FG003|NOT COMPLETED|Overall Study||0
10481781|NCT01138150|11631001|FG000|STARTED|Overall Study||18
10481782|NCT01138150|11631002|FG001|STARTED|Overall Study||18
10481783|NCT01138150|11631001|FG000|COMPLETED|Overall Study||17
10481784|NCT01138150|11631002|FG001|COMPLETED|Overall Study||17
10481785|NCT01138150|11631001|FG000|NOT COMPLETED|Overall Study||1
10481786|NCT01138150|11631002|FG001|NOT COMPLETED|Overall Study||1
10481787|NCT01138475|11631021|FG000|STARTED|Overall Study||16
10481788|NCT01138475|11631022|FG001|STARTED|Overall Study||16
10481789|NCT01138475|11631023|FG002|STARTED|Overall Study||17
10481790|NCT01138475|11631021|FG000|COMPLETED|Overall Study||16
10481791|NCT01138475|11631022|FG001|COMPLETED|Overall Study||16
10481792|NCT01138475|11631023|FG002|COMPLETED|Overall Study||17
10481793|NCT01138475|11631021|FG000|NOT COMPLETED|Overall Study||0
10481794|NCT01138475|11631022|FG001|NOT COMPLETED|Overall Study||0
10481795|NCT01138475|11631023|FG002|NOT COMPLETED|Overall Study||0
10481796|NCT01138501|11631037|FG000|STARTED|Overall Study|Two subjects withdrew consent after being enrolled but before receiving any trial product.|65
10481797|NCT01138501|11631037|FG000|Exposed|Overall Study||63
10481798|NCT01138501|11631037|FG000|COMPLETED|Overall Study||60
10481799|NCT01138501|11631037|FG000|NOT COMPLETED|Overall Study||5
10481800|NCT01138514|11631044|FG000|STARTED|Overall Study||522
10481801|NCT01138514|11631045|FG001|STARTED|Overall Study||516
10481802|NCT01138514|11631046|FG002|STARTED|Overall Study||517
10481803|NCT01138514|11631044|FG000|COMPLETED|Overall Study||474
10481804|NCT01138514|11631045|FG001|COMPLETED|Overall Study||463
10481805|NCT01138514|11631046|FG002|COMPLETED|Overall Study||424
10481806|NCT01138514|11631044|FG000|NOT COMPLETED|Overall Study||48
10481807|NCT01138514|11631045|FG001|NOT COMPLETED|Overall Study||53
10481808|NCT01138514|11631046|FG002|NOT COMPLETED|Overall Study||93
10481809|NCT01138657|11631057|FG000|STARTED|Overall Study||120
10481810|NCT01138657|11631058|FG001|STARTED|Overall Study||119
10481811|NCT01138657|11631057|FG000|Enrolled in Main Study|Overall Study||112
10481812|NCT01138657|11631058|FG001|Enrolled in Main Study|Overall Study||111
10481813|NCT01138657|11631057|FG000|Enrolled in Japan Sub-study|Overall Study||8
10481814|NCT01138657|11631058|FG001|Enrolled in Japan Sub-study|Overall Study||8
10481815|NCT01138657|11631057|FG000|COMPLETED|Overall Study||112
10481816|NCT01138657|11631058|FG001|COMPLETED|Overall Study||101
10481817|NCT01138657|11631057|FG000|NOT COMPLETED|Overall Study||8
10481818|NCT01138657|11631058|FG001|NOT COMPLETED|Overall Study||18
10481819|NCT01138735|11631068|FG000|STARTED|Overall Study||142
10481820|NCT01138735|11631069|FG001|STARTED|Overall Study||143
10481821|NCT01138735|11631068|FG000|COMPLETED|Overall Study||134
10481822|NCT01138735|11631069|FG001|COMPLETED|Overall Study||126
10481823|NCT01138735|11631068|FG000|NOT COMPLETED|Overall Study||8
10481824|NCT01138735|11631069|FG001|NOT COMPLETED|Overall Study||17
10481825|NCT01138826|11631075|FG000|STARTED|First Intervention Period||3
10481826|NCT01138826|11631076|FG001|STARTED|First Intervention Period||3
10481827|NCT01138826|11631077|FG002|STARTED|First Intervention Period||3
10481828|NCT01138826|11631078|FG003|STARTED|First Intervention Period||3
10481829|NCT01138826|11631079|FG004|STARTED|First Intervention Period||3
10481830|NCT01138826|11631080|FG005|STARTED|First Intervention Period||3
10481831|NCT01138826|11631075|FG000|COMPLETED|First Intervention Period||3
10481832|NCT01138826|11631076|FG001|COMPLETED|First Intervention Period||3
10481833|NCT01138826|11631077|FG002|COMPLETED|First Intervention Period||3
10481834|NCT01138826|11631078|FG003|COMPLETED|First Intervention Period||3
10481835|NCT01138826|11631079|FG004|COMPLETED|First Intervention Period||3
10481836|NCT01138826|11631080|FG005|COMPLETED|First Intervention Period||3
10481837|NCT01138826|11631075|FG000|NOT COMPLETED|First Intervention Period||0
10481838|NCT01138826|11631076|FG001|NOT COMPLETED|First Intervention Period||0
10481839|NCT01138826|11631077|FG002|NOT COMPLETED|First Intervention Period||0
10481840|NCT01138826|11631078|FG003|NOT COMPLETED|First Intervention Period||0
10481841|NCT01138826|11631079|FG004|NOT COMPLETED|First Intervention Period||0
10481842|NCT01138826|11631080|FG005|NOT COMPLETED|First Intervention Period||0
10481843|NCT01138826|11631075|FG000|STARTED|Washout Period I (of 16 Days)||3
10481844|NCT01138826|11631076|FG001|STARTED|Washout Period I (of 16 Days)||3
10481845|NCT01138826|11631077|FG002|STARTED|Washout Period I (of 16 Days)||3
10481846|NCT01138826|11631078|FG003|STARTED|Washout Period I (of 16 Days)||3
10481847|NCT01138826|11631079|FG004|STARTED|Washout Period I (of 16 Days)||3
10481848|NCT01138826|11631080|FG005|STARTED|Washout Period I (of 16 Days)||3
10481849|NCT01138826|11631075|FG000|COMPLETED|Washout Period I (of 16 Days)||2
10481850|NCT01138826|11631076|FG001|COMPLETED|Washout Period I (of 16 Days)||2
10481851|NCT01138826|11631077|FG002|COMPLETED|Washout Period I (of 16 Days)||3
10481852|NCT01138826|11631078|FG003|COMPLETED|Washout Period I (of 16 Days)||3
10481853|NCT01138826|11631079|FG004|COMPLETED|Washout Period I (of 16 Days)||2
10481854|NCT01138826|11631080|FG005|COMPLETED|Washout Period I (of 16 Days)||3
10481855|NCT01138826|11631075|FG000|NOT COMPLETED|Washout Period I (of 16 Days)||1
10481856|NCT01138826|11631076|FG001|NOT COMPLETED|Washout Period I (of 16 Days)||1
10481857|NCT01138826|11631077|FG002|NOT COMPLETED|Washout Period I (of 16 Days)||0
10481858|NCT01138826|11631078|FG003|NOT COMPLETED|Washout Period I (of 16 Days)||0
10481859|NCT01138826|11631079|FG004|NOT COMPLETED|Washout Period I (of 16 Days)||1
10481860|NCT01138826|11631080|FG005|NOT COMPLETED|Washout Period I (of 16 Days)||0
10481861|NCT01138826|11631075|FG000|STARTED|Second Intervention Period||2
10481862|NCT01138826|11631076|FG001|STARTED|Second Intervention Period||2
10481863|NCT01138826|11631077|FG002|STARTED|Second Intervention Period||3
10481864|NCT01138826|11631078|FG003|STARTED|Second Intervention Period||3
10481865|NCT01138826|11631079|FG004|STARTED|Second Intervention Period||2
10481866|NCT01138826|11631080|FG005|STARTED|Second Intervention Period||3
10481867|NCT01138826|11631075|FG000|COMPLETED|Second Intervention Period||2
10481868|NCT01138826|11631076|FG001|COMPLETED|Second Intervention Period||2
10481869|NCT01138826|11631077|FG002|COMPLETED|Second Intervention Period||3
10481870|NCT01138826|11631078|FG003|COMPLETED|Second Intervention Period||3
10481871|NCT01138826|11631079|FG004|COMPLETED|Second Intervention Period||2
10481872|NCT01138826|11631080|FG005|COMPLETED|Second Intervention Period||3
10481873|NCT01138826|11631075|FG000|NOT COMPLETED|Second Intervention Period||0
10481874|NCT01138826|11631076|FG001|NOT COMPLETED|Second Intervention Period||0
10481875|NCT01138826|11631077|FG002|NOT COMPLETED|Second Intervention Period||0
10481876|NCT01138826|11631078|FG003|NOT COMPLETED|Second Intervention Period||0
10481877|NCT01138826|11631079|FG004|NOT COMPLETED|Second Intervention Period||0
10481878|NCT01138826|11631080|FG005|NOT COMPLETED|Second Intervention Period||0
10481879|NCT01138826|11631075|FG000|STARTED|Washout Period II (of 16 Days)||2
10481880|NCT01138826|11631076|FG001|STARTED|Washout Period II (of 16 Days)||2
10481881|NCT01138826|11631077|FG002|STARTED|Washout Period II (of 16 Days)||3
10481882|NCT01138826|11631078|FG003|STARTED|Washout Period II (of 16 Days)||3
10481883|NCT01138826|11631079|FG004|STARTED|Washout Period II (of 16 Days)||2
10481884|NCT01138826|11631080|FG005|STARTED|Washout Period II (of 16 Days)||3
10481885|NCT01138826|11631075|FG000|COMPLETED|Washout Period II (of 16 Days)||2
10481886|NCT01138826|11631076|FG001|COMPLETED|Washout Period II (of 16 Days)||2
10481887|NCT01138826|11631077|FG002|COMPLETED|Washout Period II (of 16 Days)||3
10481888|NCT01138826|11631078|FG003|COMPLETED|Washout Period II (of 16 Days)||3
10481889|NCT01138826|11631079|FG004|COMPLETED|Washout Period II (of 16 Days)||2
10481890|NCT01138826|11631080|FG005|COMPLETED|Washout Period II (of 16 Days)||3
10481891|NCT01138826|11631075|FG000|NOT COMPLETED|Washout Period II (of 16 Days)||0
10481892|NCT01138826|11631076|FG001|NOT COMPLETED|Washout Period II (of 16 Days)||0
10481893|NCT01138826|11631077|FG002|NOT COMPLETED|Washout Period II (of 16 Days)||0
10481894|NCT01138826|11631078|FG003|NOT COMPLETED|Washout Period II (of 16 Days)||0
10481895|NCT01138826|11631079|FG004|NOT COMPLETED|Washout Period II (of 16 Days)||0
10481896|NCT01138826|11631080|FG005|NOT COMPLETED|Washout Period II (of 16 Days)||0
10481897|NCT01138826|11631075|FG000|STARTED|Third Intervention Period||2
10481898|NCT01138826|11631076|FG001|STARTED|Third Intervention Period||2
10481899|NCT01138826|11631077|FG002|STARTED|Third Intervention Period||3
10481900|NCT01138826|11631078|FG003|STARTED|Third Intervention Period||3
10481901|NCT01138826|11631079|FG004|STARTED|Third Intervention Period||2
10481902|NCT01138826|11631080|FG005|STARTED|Third Intervention Period||3
10481903|NCT01138826|11631075|FG000|COMPLETED|Third Intervention Period||2
10481904|NCT01138826|11631076|FG001|COMPLETED|Third Intervention Period||2
10481905|NCT01138826|11631077|FG002|COMPLETED|Third Intervention Period||3
10481906|NCT01138826|11631078|FG003|COMPLETED|Third Intervention Period||3
10481907|NCT01138826|11631079|FG004|COMPLETED|Third Intervention Period||2
10481908|NCT01138826|11631080|FG005|COMPLETED|Third Intervention Period||3
10481909|NCT01138826|11631075|FG000|NOT COMPLETED|Third Intervention Period||0
10481910|NCT01138826|11631076|FG001|NOT COMPLETED|Third Intervention Period||0
10481911|NCT01138826|11631077|FG002|NOT COMPLETED|Third Intervention Period||0
10481912|NCT01138826|11631078|FG003|NOT COMPLETED|Third Intervention Period||0
10481913|NCT01138826|11631079|FG004|NOT COMPLETED|Third Intervention Period||0
10481914|NCT01138826|11631080|FG005|NOT COMPLETED|Third Intervention Period||0
10481915|NCT01138917|11631088|FG000|STARTED|Overall Study||101
10481916|NCT01138917|11631088|FG000|COMPLETED|Overall Study||77
10481917|NCT01138917|11631088|FG000|NOT COMPLETED|Overall Study||24
10481918|NCT01138969|11631098|FG000|STARTED|Overall Study||83
10481919|NCT01138969|11631099|FG001|STARTED|Overall Study||82
10481920|NCT01138969|11631098|FG000|COMPLETED|Overall Study||83
10481921|NCT01138969|11631099|FG001|COMPLETED|Overall Study||82
10481922|NCT01138969|11631098|FG000|NOT COMPLETED|Overall Study||0
10481923|NCT01138969|11631099|FG001|NOT COMPLETED|Overall Study||0
10481924|NCT01138995|11631107|FG000|STARTED|Overall Study||98
10481925|NCT01138995|11631108|FG001|STARTED|Overall Study||99
10481926|NCT01138995|11631107|FG000|COMPLETED|Overall Study||88
10481927|NCT01138995|11631108|FG001|COMPLETED|Overall Study||74
10481928|NCT01138995|11631107|FG000|NOT COMPLETED|Overall Study||10
10481929|NCT01138995|11631108|FG001|NOT COMPLETED|Overall Study||25
10527280|NCT01388907|11679327|FG000|STARTED|Overall Study||33
10527281|NCT01388907|11679328|FG001|STARTED|Overall Study||28
10527282|NCT01388907|11679327|FG000|COMPLETED|Overall Study||31
10527283|NCT01388907|11679328|FG001|COMPLETED|Overall Study||28
10527284|NCT01388907|11679327|FG000|NOT COMPLETED|Overall Study||2
10527285|NCT01388907|11679328|FG001|NOT COMPLETED|Overall Study||0
10527286|NCT01388946|11679338|FG000|STARTED|Overall Study||55
10527287|NCT01388946|11679339|FG001|STARTED|Overall Study||55
10527288|NCT01388946|11679338|FG000|COMPLETED|Overall Study||49
10527289|NCT01388946|11679339|FG001|COMPLETED|Overall Study||52
10527290|NCT01388946|11679338|FG000|NOT COMPLETED|Overall Study||6
10527291|NCT01388946|11679339|FG001|NOT COMPLETED|Overall Study||3
10527292|NCT01388985|11679347|FG000|STARTED|Overall Study|1 participant (from the 250 enrolled) did not receive any vaccination because of consent withdrawal.|249
10527293|NCT01388985|11679348|FG001|STARTED|Overall Study|1 participant (from the 250 enrolled) did not receive any vaccination because of consent withdrawal.|249
10527294|NCT01388985|11679347|FG000|Primary Vaccination Period|Overall Study||231
10527295|NCT01388985|11679348|FG001|Primary Vaccination Period|Overall Study||238
10527296|NCT01388985|11679347|FG000|COMPLETED|Overall Study|From those 200, 15 were excluded from the per protocol analysis.|200
10527297|NCT01388985|11679348|FG001|COMPLETED|Overall Study|From those 200, 28 were excluded from the per protocol analysis.|211
10527298|NCT01388985|11679347|FG000|NOT COMPLETED|Overall Study||49
10527299|NCT01388985|11679348|FG001|NOT COMPLETED|Overall Study||38
10527300|NCT01389076|11679354|FG000|STARTED|Overall Study||22
10527301|NCT01389076|11679354|FG000|COMPLETED|Overall Study||22
10527302|NCT01389076|11679354|FG000|NOT COMPLETED|Overall Study||0
10527303|NCT01389102|11679364|FG000|STARTED|Overall Study||75
10527304|NCT01389102|11679365|FG001|STARTED|Overall Study||76
10527305|NCT01389102|11679366|FG002|STARTED|Overall Study||77
10527306|NCT01389102|11679367|FG003|STARTED|Overall Study||76
10527307|NCT01389102|11679368|FG004|STARTED|Overall Study||74
10527308|NCT01389102|11679369|FG005|STARTED|Overall Study||76
10527309|NCT01389102|11679364|FG000|COMPLETED|Overall Study||57
10527310|NCT01389102|11679365|FG001|COMPLETED|Overall Study||64
10527311|NCT01389102|11679366|FG002|COMPLETED|Overall Study||58
10527312|NCT01389102|11679367|FG003|COMPLETED|Overall Study||69
10527313|NCT01389102|11679368|FG004|COMPLETED|Overall Study||61
10527314|NCT01389102|11679369|FG005|COMPLETED|Overall Study||68
10527315|NCT01389102|11679364|FG000|NOT COMPLETED|Overall Study||18
10527316|NCT01389102|11679365|FG001|NOT COMPLETED|Overall Study||12
10527317|NCT01389102|11679366|FG002|NOT COMPLETED|Overall Study||19
10527318|NCT01389102|11679367|FG003|NOT COMPLETED|Overall Study||7
10527319|NCT01389102|11679368|FG004|NOT COMPLETED|Overall Study||13
10527320|NCT01389102|11679369|FG005|NOT COMPLETED|Overall Study||8
10527321|NCT01389128|11679391|FG000|STARTED|Overall Study||40
10527322|NCT01389128|11679392|FG001|STARTED|Overall Study||40
10527323|NCT01389128|11679391|FG000|COMPLETED|Overall Study||35
10527324|NCT01389128|11679392|FG001|COMPLETED|Overall Study||34
10527325|NCT01389128|11679391|FG000|NOT COMPLETED|Overall Study||5
10527326|NCT01389128|11679392|FG001|NOT COMPLETED|Overall Study||6
10527327|NCT01389232|11679402|FG000|STARTED|Overall Study||100
10527328|NCT01389232|11679402|FG000|COMPLETED|Overall Study||81
10527329|NCT01389232|11679402|FG000|NOT COMPLETED|Overall Study||19
10527330|NCT01389245|11679416|FG000|STARTED|Overall Study||42
10527331|NCT01389245|11679416|FG000|COMPLETED|Overall Study||27
10527332|NCT01389245|11679416|FG000|NOT COMPLETED|Overall Study||15
10527333|NCT01389258|11679420|FG000|STARTED|Overall Study||45
10481933|NCT01139021|11631128|FG000|STARTED|Overall Study||152
10481934|NCT01139021|11631129|FG001|STARTED|Overall Study||153
10481935|NCT01139021|11631130|FG002|STARTED|Overall Study||67
10481936|NCT01139021|11631131|FG003|STARTED|Overall Study||19
10481937|NCT01139021|11631132|FG004|STARTED|Overall Study||116
10481938|NCT01139021|11631133|FG005|STARTED|Overall Study||1
10481939|NCT01139021|11631128|FG000|COMPLETED|Overall Study||151
10481940|NCT01139021|11631129|FG001|COMPLETED|Overall Study||153
10481941|NCT01139021|11631130|FG002|COMPLETED|Overall Study||67
10481942|NCT01139021|11631131|FG003|COMPLETED|Overall Study||18
10481943|NCT01139021|11631132|FG004|COMPLETED|Overall Study||107
10481944|NCT01139021|11631133|FG005|COMPLETED|Overall Study||1
10481945|NCT01139021|11631128|FG000|NOT COMPLETED|Overall Study||1
10481946|NCT01139021|11631129|FG001|NOT COMPLETED|Overall Study||0
10481947|NCT01139021|11631130|FG002|NOT COMPLETED|Overall Study||0
10481948|NCT01139021|11631131|FG003|NOT COMPLETED|Overall Study||1
10481949|NCT01139021|11631132|FG004|NOT COMPLETED|Overall Study||9
10481950|NCT01139021|11631133|FG005|NOT COMPLETED|Overall Study||0
10481954|NCT01139164|11631158|FG000|STARTED|Overall Study||4
10481955|NCT01139164|11631159|FG001|STARTED|Overall Study||67
10481956|NCT01139164|11631160|FG002|STARTED|Overall Study||7
10481957|NCT01139164|11631158|FG000|COMPLETED|Overall Study||4
10481958|NCT01139164|11631159|FG001|COMPLETED|Overall Study||65
10481959|NCT01139164|11631160|FG002|COMPLETED|Overall Study||7
10481960|NCT01139164|11631158|FG000|NOT COMPLETED|Overall Study||0
10481961|NCT01139164|11631159|FG001|NOT COMPLETED|Overall Study||2
10481962|NCT01139164|11631160|FG002|NOT COMPLETED|Overall Study||0
10481963|NCT01139190|11631170|FG000|STARTED|Overall Study||38
10481964|NCT01139190|11631171|FG001|STARTED|Overall Study||39
10481965|NCT01139190|11631170|FG000|COMPLETED|Overall Study||38
10481966|NCT01139190|11631171|FG001|COMPLETED|Overall Study||38
10481967|NCT01139190|11631170|FG000|NOT COMPLETED|Overall Study||0
10481968|NCT01139190|11631171|FG001|NOT COMPLETED|Overall Study||1
10481969|NCT01139411|11631179|FG000|STARTED|Overall Study||26
10481970|NCT01139411|11631180|FG001|STARTED|Overall Study||23
10481971|NCT01139411|11631179|FG000|COMPLETED|Overall Study||24
10481972|NCT01139411|11631180|FG001|COMPLETED|Overall Study||19
10481973|NCT01139411|11631179|FG000|NOT COMPLETED|Overall Study||2
10481974|NCT01139411|11631180|FG001|NOT COMPLETED|Overall Study||4
10481975|NCT01139450|11631191|FG000|STARTED|Overall Study||302
10481976|NCT01139450|11631192|FG001|STARTED|Overall Study||297
10481977|NCT01139450|11631193|FG002|STARTED|Overall Study||300
10481978|NCT01139450|11631191|FG000|COMPLETED|Overall Study||275
10481979|NCT01139450|11631192|FG001|COMPLETED|Overall Study||272
10481980|NCT01139450|11631193|FG002|COMPLETED|Overall Study||262
10481981|NCT01139450|11631191|FG000|NOT COMPLETED|Overall Study||27
10481982|NCT01139450|11631192|FG001|NOT COMPLETED|Overall Study||25
10709681|NCT02642159|11874718|FG001|NOT COMPLETED|Overall Study||8
10709682|NCT02642237|11874727|FG000|STARTED|Overall Study||15
10709683|NCT02642237|11874728|FG001|STARTED|Overall Study||15
10481983|NCT01139450|11631193|FG002|NOT COMPLETED|Overall Study||38
10481984|NCT01139515|11631201|FG000|STARTED|First Intervention Period||4
10481985|NCT01139515|11631202|FG001|STARTED|First Intervention Period||4
10481986|NCT01139515|11631203|FG002|STARTED|First Intervention Period||4
10481987|NCT01139515|11631204|FG003|STARTED|First Intervention Period||4
10481988|NCT01139515|11631201|FG000|COMPLETED|First Intervention Period||4
10481989|NCT01139515|11631202|FG001|COMPLETED|First Intervention Period||4
10481990|NCT01139515|11631203|FG002|COMPLETED|First Intervention Period||4
10481991|NCT01139515|11631204|FG003|COMPLETED|First Intervention Period||4
10481992|NCT01139515|11631201|FG000|NOT COMPLETED|First Intervention Period||0
10481993|NCT01139515|11631202|FG001|NOT COMPLETED|First Intervention Period||0
10481994|NCT01139515|11631203|FG002|NOT COMPLETED|First Intervention Period||0
10481995|NCT01139515|11631204|FG003|NOT COMPLETED|First Intervention Period||0
10481996|NCT01139515|11631201|FG000|STARTED|Washout Period I (46hrs)||4
10481997|NCT01139515|11631202|FG001|STARTED|Washout Period I (46hrs)||4
10481998|NCT01139515|11631203|FG002|STARTED|Washout Period I (46hrs)||4
10481999|NCT01139515|11631204|FG003|STARTED|Washout Period I (46hrs)||4
10709684|NCT02642237|11874727|FG000|COMPLETED|Overall Study||15
10709685|NCT02642237|11874728|FG001|COMPLETED|Overall Study||15
10709686|NCT02642237|11874727|FG000|NOT COMPLETED|Overall Study||0
10709687|NCT02642237|11874728|FG001|NOT COMPLETED|Overall Study||0
10709688|NCT02642393|11874736|FG000|STARTED|Overall Study||149
10709689|NCT02642393|11874737|FG001|STARTED|Overall Study||149
10709690|NCT02642393|11874736|FG000|COMPLETED|Overall Study|"Participants who completed the study:~On-drug: 31; In-person off-drug:13; By telephone off-drug: 6"|50
10482000|NCT01139515|11631201|FG000|COMPLETED|Washout Period I (46hrs)||4
10482001|NCT01139515|11631202|FG001|COMPLETED|Washout Period I (46hrs)||4
10482002|NCT01139515|11631203|FG002|COMPLETED|Washout Period I (46hrs)||4
10482003|NCT01139515|11631204|FG003|COMPLETED|Washout Period I (46hrs)||4
10482004|NCT01139515|11631201|FG000|NOT COMPLETED|Washout Period I (46hrs)||0
10482005|NCT01139515|11631202|FG001|NOT COMPLETED|Washout Period I (46hrs)||0
10482006|NCT01139515|11631203|FG002|NOT COMPLETED|Washout Period I (46hrs)||0
10482007|NCT01139515|11631204|FG003|NOT COMPLETED|Washout Period I (46hrs)||0
10482008|NCT01139515|11631201|FG000|STARTED|Second Intervention Period||4
10482009|NCT01139515|11631202|FG001|STARTED|Second Intervention Period||4
10482010|NCT01139515|11631203|FG002|STARTED|Second Intervention Period||4
10482011|NCT01139515|11631204|FG003|STARTED|Second Intervention Period||4
10482012|NCT01139515|11631201|FG000|COMPLETED|Second Intervention Period||4
10482013|NCT01139515|11631202|FG001|COMPLETED|Second Intervention Period||4
10482014|NCT01139515|11631203|FG002|COMPLETED|Second Intervention Period||4
10482015|NCT01139515|11631204|FG003|COMPLETED|Second Intervention Period||4
10482016|NCT01139515|11631201|FG000|NOT COMPLETED|Second Intervention Period||0
10709691|NCT02642393|11874737|FG001|COMPLETED|Overall Study|"Participants who completed the study:~On-drug: 40; In-person off-drug: 16; By telephone off-drug: 1"|57
10709692|NCT02642393|11874736|FG000|NOT COMPLETED|Overall Study||99
10482017|NCT01139515|11631202|FG001|NOT COMPLETED|Second Intervention Period||0
10482018|NCT01139515|11631203|FG002|NOT COMPLETED|Second Intervention Period||0
10482019|NCT01139515|11631204|FG003|NOT COMPLETED|Second Intervention Period||0
10482020|NCT01139515|11631201|FG000|STARTED|Washout Period 2 (46 Hrs)||4
10482021|NCT01139515|11631202|FG001|STARTED|Washout Period 2 (46 Hrs)||4
10482022|NCT01139515|11631203|FG002|STARTED|Washout Period 2 (46 Hrs)||4
10482023|NCT01139515|11631204|FG003|STARTED|Washout Period 2 (46 Hrs)||4
10482024|NCT01139515|11631201|FG000|COMPLETED|Washout Period 2 (46 Hrs)||4
10482025|NCT01139515|11631202|FG001|COMPLETED|Washout Period 2 (46 Hrs)||4
10482026|NCT01139515|11631203|FG002|COMPLETED|Washout Period 2 (46 Hrs)||4
10482027|NCT01139515|11631204|FG003|COMPLETED|Washout Period 2 (46 Hrs)||4
10482028|NCT01139515|11631201|FG000|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
10482029|NCT01139515|11631202|FG001|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
10482030|NCT01139515|11631203|FG002|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
10482031|NCT01139515|11631204|FG003|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
10482032|NCT01139515|11631201|FG000|STARTED|Third Intervention Period||4
10482033|NCT01139515|11631202|FG001|STARTED|Third Intervention Period||4
10482034|NCT01139515|11631203|FG002|STARTED|Third Intervention Period||4
10482035|NCT01139515|11631204|FG003|STARTED|Third Intervention Period||4
10482036|NCT01139515|11631201|FG000|COMPLETED|Third Intervention Period||4
10482037|NCT01139515|11631202|FG001|COMPLETED|Third Intervention Period||4
10482038|NCT01139515|11631203|FG002|COMPLETED|Third Intervention Period||4
10482039|NCT01139515|11631204|FG003|COMPLETED|Third Intervention Period||4
10482040|NCT01139515|11631201|FG000|NOT COMPLETED|Third Intervention Period||0
10482041|NCT01139515|11631202|FG001|NOT COMPLETED|Third Intervention Period||0
10482042|NCT01139515|11631203|FG002|NOT COMPLETED|Third Intervention Period||0
10482043|NCT01139515|11631204|FG003|NOT COMPLETED|Third Intervention Period||0
10482044|NCT01139515|11631201|FG000|STARTED|Washout Period 3 (46 Hrs)||4
10482045|NCT01139515|11631202|FG001|STARTED|Washout Period 3 (46 Hrs)||4
10482046|NCT01139515|11631203|FG002|STARTED|Washout Period 3 (46 Hrs)||4
10482047|NCT01139515|11631204|FG003|STARTED|Washout Period 3 (46 Hrs)||4
10482048|NCT01139515|11631201|FG000|COMPLETED|Washout Period 3 (46 Hrs)||4
10482049|NCT01139515|11631202|FG001|COMPLETED|Washout Period 3 (46 Hrs)||4
10482050|NCT01139515|11631203|FG002|COMPLETED|Washout Period 3 (46 Hrs)||4
10482051|NCT01139515|11631204|FG003|COMPLETED|Washout Period 3 (46 Hrs)||4
10482052|NCT01139515|11631201|FG000|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
10482053|NCT01139515|11631202|FG001|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
10482054|NCT01139515|11631203|FG002|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
10482055|NCT01139515|11631204|FG003|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
10482056|NCT01139515|11631201|FG000|STARTED|Fourth Intervention Period||4
10482057|NCT01139515|11631202|FG001|STARTED|Fourth Intervention Period||4
10482058|NCT01139515|11631203|FG002|STARTED|Fourth Intervention Period||4
10482059|NCT01139515|11631204|FG003|STARTED|Fourth Intervention Period||4
10482060|NCT01139515|11631201|FG000|COMPLETED|Fourth Intervention Period||4
10482061|NCT01139515|11631202|FG001|COMPLETED|Fourth Intervention Period||4
10482062|NCT01139515|11631203|FG002|COMPLETED|Fourth Intervention Period||4
10482063|NCT01139515|11631204|FG003|COMPLETED|Fourth Intervention Period||4
10482064|NCT01139515|11631201|FG000|NOT COMPLETED|Fourth Intervention Period||0
10482065|NCT01139515|11631202|FG001|NOT COMPLETED|Fourth Intervention Period||0
10482066|NCT01139515|11631203|FG002|NOT COMPLETED|Fourth Intervention Period||0
10482067|NCT01139515|11631204|FG003|NOT COMPLETED|Fourth Intervention Period||0
10482068|NCT01139580|11631216|FG000|STARTED|Overall Study||181
10482069|NCT01139580|11631217|FG001|STARTED|Overall Study||182
10482070|NCT01139580|11631216|FG000|COMPLETED|Overall Study||158
10482071|NCT01139580|11631217|FG001|COMPLETED|Overall Study||164
10482072|NCT01139580|11631216|FG000|NOT COMPLETED|Overall Study||23
10482073|NCT01139580|11631217|FG001|NOT COMPLETED|Overall Study||18
10482074|NCT01139658|11631225|FG000|STARTED|Overall Study||747
10482075|NCT01139658|11631226|FG001|STARTED|Overall Study||929
10482076|NCT01139658|11631225|FG000|COMPLETED|Overall Study||691
10482077|NCT01139658|11631226|FG001|COMPLETED|Overall Study||816
10482078|NCT01139658|11631225|FG000|NOT COMPLETED|Overall Study||56
10482079|NCT01139658|11631226|FG001|NOT COMPLETED|Overall Study||113
10482080|NCT01139762|11631234|FG000|STARTED|Washout and Placebo Lead-In Period||1070
10482081|NCT01139762|11631235|FG001|STARTED|Washout and Placebo Lead-In Period||0
10482082|NCT01139762|11631236|FG002|STARTED|Washout and Placebo Lead-In Period||0
10482083|NCT01139762|11631234|FG000|COMPLETED|Washout and Placebo Lead-In Period||696
10338235|NCT00368979|11475147|FG000|STARTED|Overall Study||185
10338236|NCT00368979|11475148|FG001|STARTED|Overall Study||193
10338237|NCT00368979|11475147|FG000|COMPLETED|Overall Study||160
10338238|NCT00368979|11475148|FG001|COMPLETED|Overall Study||163
10338239|NCT00368979|11475147|FG000|NOT COMPLETED|Overall Study||25
10338240|NCT00368979|11475148|FG001|NOT COMPLETED|Overall Study||30
10338241|NCT00368992|11475154|FG000|STARTED|Overall Study||110
10338242|NCT00368992|11475154|FG000|COMPLETED|Overall Study||0
10338243|NCT00368992|11475154|FG000|NOT COMPLETED|Overall Study||110
10338244|NCT00369122|11475159|FG000|STARTED|Overall Study||60
10338245|NCT00369122|11475159|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|49
10482084|NCT01139762|11631235|FG001|COMPLETED|Washout and Placebo Lead-In Period||0
10482085|NCT01139762|11631236|FG002|COMPLETED|Washout and Placebo Lead-In Period||0
10482086|NCT01139762|11631234|FG000|NOT COMPLETED|Washout and Placebo Lead-In Period||374
10482087|NCT01139762|11631235|FG001|NOT COMPLETED|Washout and Placebo Lead-In Period||0
10482088|NCT01139762|11631236|FG002|NOT COMPLETED|Washout and Placebo Lead-In Period||0
10482089|NCT01139762|11631234|FG000|STARTED|Double-Blind Randomized Active Treatment||0
10482090|NCT01139762|11631235|FG001|STARTED|Double-Blind Randomized Active Treatment||346
10482091|NCT01139762|11631236|FG002|STARTED|Double-Blind Randomized Active Treatment||350
10482092|NCT01139762|11631234|FG000|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||0
10482093|NCT01139762|11631235|FG001|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||345
10482094|NCT01139762|11631236|FG002|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||350
10709693|NCT02642393|11874737|FG001|NOT COMPLETED|Overall Study||92
10709694|NCT02642432|11874743|FG000|STARTED|Overall Study||146
10709695|NCT02642432|11874743|FG000|COMPLETED|Overall Study||138
10482095|NCT01139762|11631234|FG000|COMPLETED|Double-Blind Randomized Active Treatment||0
10482096|NCT01139762|11631235|FG001|COMPLETED|Double-Blind Randomized Active Treatment||306
10482097|NCT01139762|11631236|FG002|COMPLETED|Double-Blind Randomized Active Treatment||286
10482098|NCT01139762|11631234|FG000|NOT COMPLETED|Double-Blind Randomized Active Treatment||0
10482099|NCT01139762|11631235|FG001|NOT COMPLETED|Double-Blind Randomized Active Treatment||40
10482100|NCT01139762|11631236|FG002|NOT COMPLETED|Double-Blind Randomized Active Treatment||64
10482101|NCT01139775|11631246|FG000|STARTED|Overall Study||14
10482102|NCT01139775|11631247|FG001|STARTED|Overall Study||39
10482103|NCT01139775|11631248|FG002|STARTED|Overall Study||23
10482104|NCT01139775|11631246|FG000|Received at Least 1 Dose of Study Drug|Overall Study||14
10482105|NCT01139775|11631247|FG001|Received at Least 1 Dose of Study Drug|Overall Study||39
10482106|NCT01139775|11631248|FG002|Received at Least 1 Dose of Study Drug|Overall Study||22
10482107|NCT01139775|11631246|FG000|COMPLETED|Overall Study||13
10482108|NCT01139775|11631247|FG001|COMPLETED|Overall Study||26
10482109|NCT01139775|11631248|FG002|COMPLETED|Overall Study||17
10482110|NCT01139775|11631246|FG000|NOT COMPLETED|Overall Study||1
10482111|NCT01139775|11631247|FG001|NOT COMPLETED|Overall Study||13
10482112|NCT01139775|11631248|FG002|NOT COMPLETED|Overall Study||6
10482113|NCT01139801|11631260|FG000|STARTED|Overall Study||25
10482114|NCT01139801|11631261|FG001|STARTED|Overall Study||25
10482115|NCT01139801|11631260|FG000|COMPLETED|Overall Study||25
10482116|NCT01139801|11631261|FG001|COMPLETED|Overall Study||25
10482117|NCT01139801|11631260|FG000|NOT COMPLETED|Overall Study||0
10482118|NCT01139801|11631261|FG001|NOT COMPLETED|Overall Study||0
10482119|NCT01139814|11631267|FG000|STARTED|Overall Study||181
10482120|NCT01139814|11631267|FG000|COMPLETED|Overall Study||181
10482121|NCT01139814|11631267|FG000|NOT COMPLETED|Overall Study||0
10482122|NCT01139879|11631272|FG000|STARTED|Overall Study||10
10482123|NCT01139879|11631272|FG000|COMPLETED|Overall Study||10
10482124|NCT01139879|11631272|FG000|NOT COMPLETED|Overall Study||0
10482125|NCT01140061|11631288|FG000|STARTED|Part I|Includes 1 replacement participant|7
10482126|NCT01140061|11631289|FG001|STARTED|Part I||2
10482127|NCT01140061|11631290|FG002|STARTED|Part I||0
10482128|NCT01140061|11631291|FG003|STARTED|Part I||0
10482129|NCT01140061|11631292|FG004|STARTED|Part I||0
10482130|NCT01140061|11631293|FG005|STARTED|Part I||0
10482131|NCT01140061|11631294|FG006|STARTED|Part I||0
10482132|NCT01140061|11631295|FG007|STARTED|Part I||0
10482133|NCT01140061|11631296|FG008|STARTED|Part I||0
10482134|NCT01140061|11631297|FG009|STARTED|Part I||0
10482135|NCT01140061|11631288|FG000|COMPLETED|Part I||6
10482136|NCT01140061|11631289|FG001|COMPLETED|Part I||2
10482137|NCT01140061|11631290|FG002|COMPLETED|Part I||0
10482138|NCT01140061|11631291|FG003|COMPLETED|Part I||0
10482139|NCT01140061|11631292|FG004|COMPLETED|Part I||0
10482140|NCT01140061|11631293|FG005|COMPLETED|Part I||0
10482141|NCT01140061|11631294|FG006|COMPLETED|Part I||0
10482142|NCT01140061|11631295|FG007|COMPLETED|Part I||0
10482143|NCT01140061|11631296|FG008|COMPLETED|Part I||0
10482144|NCT01140061|11631297|FG009|COMPLETED|Part I||0
10482145|NCT01140061|11631288|FG000|NOT COMPLETED|Part I||1
10482146|NCT01140061|11631289|FG001|NOT COMPLETED|Part I||0
10482147|NCT01140061|11631290|FG002|NOT COMPLETED|Part I||0
10482148|NCT01140061|11631291|FG003|NOT COMPLETED|Part I||0
10482149|NCT01140061|11631292|FG004|NOT COMPLETED|Part I||0
10482150|NCT01140061|11631293|FG005|NOT COMPLETED|Part I||0
10482151|NCT01140061|11631294|FG006|NOT COMPLETED|Part I||0
10482152|NCT01140061|11631295|FG007|NOT COMPLETED|Part I||0
10482153|NCT01140061|11631296|FG008|NOT COMPLETED|Part I||0
10482154|NCT01140061|11631297|FG009|NOT COMPLETED|Part I||0
10482155|NCT01140061|11631288|FG000|STARTED|Part II||0
10482156|NCT01140061|11631289|FG001|STARTED|Part II||0
10482157|NCT01140061|11631290|FG002|STARTED|Part II||6
10482158|NCT01140061|11631291|FG003|STARTED|Part II||2
10482159|NCT01140061|11631292|FG004|STARTED|Part II||6
10482160|NCT01140061|11631293|FG005|STARTED|Part II||2
10482161|NCT01140061|11631294|FG006|STARTED|Part II||6
10482162|NCT01140061|11631295|FG007|STARTED|Part II||2
10482163|NCT01140061|11631296|FG008|STARTED|Part II||0
10482164|NCT01140061|11631297|FG009|STARTED|Part II||0
10482165|NCT01140061|11631288|FG000|COMPLETED|Part II||0
10482166|NCT01140061|11631289|FG001|COMPLETED|Part II||0
10709696|NCT02642432|11874743|FG000|NOT COMPLETED|Overall Study||8
10709697|NCT02642536|11874749|FG000|STARTED|Overall Study||21
10482167|NCT01140061|11631290|FG002|COMPLETED|Part II||6
10482168|NCT01140061|11631291|FG003|COMPLETED|Part II||2
10482169|NCT01140061|11631292|FG004|COMPLETED|Part II||6
10482170|NCT01140061|11631293|FG005|COMPLETED|Part II||2
10482171|NCT01140061|11631294|FG006|COMPLETED|Part II||6
10482172|NCT01140061|11631295|FG007|COMPLETED|Part II||2
10482173|NCT01140061|11631296|FG008|COMPLETED|Part II||0
10482174|NCT01140061|11631297|FG009|COMPLETED|Part II||0
10482175|NCT01140061|11631288|FG000|NOT COMPLETED|Part II||0
10709698|NCT02642536|11874750|FG001|STARTED|Overall Study||23
10709699|NCT02642536|11874749|FG000|COMPLETED|Overall Study||19
10709700|NCT02642536|11874750|FG001|COMPLETED|Overall Study||18
10482176|NCT01140061|11631289|FG001|NOT COMPLETED|Part II||0
10482177|NCT01140061|11631290|FG002|NOT COMPLETED|Part II||0
10482178|NCT01140061|11631291|FG003|NOT COMPLETED|Part II||0
10482179|NCT01140061|11631292|FG004|NOT COMPLETED|Part II||0
10482180|NCT01140061|11631293|FG005|NOT COMPLETED|Part II||0
10482181|NCT01140061|11631294|FG006|NOT COMPLETED|Part II||0
10482182|NCT01140061|11631295|FG007|NOT COMPLETED|Part II||0
10482183|NCT01140061|11631296|FG008|NOT COMPLETED|Part II||0
10482184|NCT01140061|11631297|FG009|NOT COMPLETED|Part II||0
10482185|NCT01140061|11631288|FG000|STARTED|Part III||0
10482186|NCT01140061|11631289|FG001|STARTED|Part III||0
10482187|NCT01140061|11631290|FG002|STARTED|Part III||0
10482188|NCT01140061|11631291|FG003|STARTED|Part III||0
10482189|NCT01140061|11631292|FG004|STARTED|Part III||0
10482190|NCT01140061|11631293|FG005|STARTED|Part III||0
10482191|NCT01140061|11631294|FG006|STARTED|Part III||0
10482192|NCT01140061|11631295|FG007|STARTED|Part III||0
10482193|NCT01140061|11631296|FG008|STARTED|Part III||7
10482194|NCT01140061|11631297|FG009|STARTED|Part III|Includes 1 replacement participant|2
10482195|NCT01140061|11631288|FG000|COMPLETED|Part III||0
10482196|NCT01140061|11631289|FG001|COMPLETED|Part III||0
10482197|NCT01140061|11631290|FG002|COMPLETED|Part III||0
10482198|NCT01140061|11631291|FG003|COMPLETED|Part III||0
10482199|NCT01140061|11631292|FG004|COMPLETED|Part III||0
10482200|NCT01140061|11631293|FG005|COMPLETED|Part III||0
10482201|NCT01140061|11631294|FG006|COMPLETED|Part III||0
10482202|NCT01140061|11631295|FG007|COMPLETED|Part III||0
10482203|NCT01140061|11631296|FG008|COMPLETED|Part III||7
10482204|NCT01140061|11631297|FG009|COMPLETED|Part III||2
10482205|NCT01140061|11631288|FG000|NOT COMPLETED|Part III||0
10482206|NCT01140061|11631289|FG001|NOT COMPLETED|Part III||0
10482207|NCT01140061|11631290|FG002|NOT COMPLETED|Part III||0
10482208|NCT01140061|11631291|FG003|NOT COMPLETED|Part III||0
10482209|NCT01140061|11631292|FG004|NOT COMPLETED|Part III||0
10482210|NCT01140061|11631293|FG005|NOT COMPLETED|Part III||0
10482211|NCT01140061|11631294|FG006|NOT COMPLETED|Part III||0
10482212|NCT01140061|11631295|FG007|NOT COMPLETED|Part III||0
10482213|NCT01140061|11631296|FG008|NOT COMPLETED|Part III||0
10482214|NCT01140061|11631297|FG009|NOT COMPLETED|Part III||0
10482215|NCT01140061|11631288|FG000|STARTED|Extension||0
10482216|NCT01140061|11631289|FG001|STARTED|Extension||0
10482217|NCT01140061|11631290|FG002|STARTED|Extension||0
10482218|NCT01140061|11631291|FG003|STARTED|Extension||0
10482219|NCT01140061|11631292|FG004|STARTED|Extension||0
10482220|NCT01140061|11631293|FG005|STARTED|Extension||0
10482221|NCT01140061|11631294|FG006|STARTED|Extension||0
10482222|NCT01140061|11631295|FG007|STARTED|Extension||0
10482223|NCT01140061|11631296|FG008|STARTED|Extension||7
10482224|NCT01140061|11631297|FG009|STARTED|Extension||2
10482225|NCT01140061|11631288|FG000|COMPLETED|Extension||0
10482226|NCT01140061|11631289|FG001|COMPLETED|Extension||0
10482227|NCT01140061|11631290|FG002|COMPLETED|Extension||0
10482228|NCT01140061|11631291|FG003|COMPLETED|Extension||0
10482229|NCT01140061|11631292|FG004|COMPLETED|Extension||0
10482230|NCT01140061|11631293|FG005|COMPLETED|Extension||0
10482231|NCT01140061|11631294|FG006|COMPLETED|Extension||0
10482232|NCT01140061|11631295|FG007|COMPLETED|Extension||0
10482233|NCT01140061|11631296|FG008|COMPLETED|Extension||7
10482234|NCT01140061|11631297|FG009|COMPLETED|Extension||1
10482235|NCT01140061|11631288|FG000|NOT COMPLETED|Extension||0
10482236|NCT01140061|11631289|FG001|NOT COMPLETED|Extension||0
10482237|NCT01140061|11631290|FG002|NOT COMPLETED|Extension||0
10482238|NCT01140061|11631291|FG003|NOT COMPLETED|Extension||0
10482239|NCT01140061|11631292|FG004|NOT COMPLETED|Extension||0
10482240|NCT01140061|11631293|FG005|NOT COMPLETED|Extension||0
10482241|NCT01140061|11631294|FG006|NOT COMPLETED|Extension||0
10482242|NCT01140061|11631295|FG007|NOT COMPLETED|Extension||0
10482243|NCT01140061|11631296|FG008|NOT COMPLETED|Extension||0
10482244|NCT01140061|11631297|FG009|NOT COMPLETED|Extension||1
10482245|NCT01140191|11631312|FG000|STARTED|Overall Study||1
10482246|NCT01140191|11631312|FG000|COMPLETED|Overall Study||1
10482247|NCT01140191|11631312|FG000|NOT COMPLETED|Overall Study||0
10482248|NCT01140295|11631318|FG000|STARTED|Overall Study||17
10482249|NCT01140295|11631319|FG001|STARTED|Overall Study||16
10482250|NCT01140295|11631318|FG000|COMPLETED|Overall Study||16
10482251|NCT01140295|11631319|FG001|COMPLETED|Overall Study||14
10709701|NCT02642536|11874749|FG000|NOT COMPLETED|Overall Study||2
10709702|NCT02642536|11874750|FG001|NOT COMPLETED|Overall Study||5
10482252|NCT01140295|11631318|FG000|NOT COMPLETED|Overall Study||1
10482253|NCT01140295|11631319|FG001|NOT COMPLETED|Overall Study||2
10482254|NCT01140347|11631329|FG000|STARTED|Overall Study||283
10482255|NCT01140347|11631330|FG001|STARTED|Overall Study||282
10482256|NCT01140347|11631329|FG000|Received at Least 1 Dose of Study Drug|Overall Study||277
10482257|NCT01140347|11631330|FG001|Received at Least 1 Dose of Study Drug|Overall Study||276
10482258|NCT01140347|11631329|FG000|COMPLETED|Overall Study||265
10482259|NCT01140347|11631330|FG001|COMPLETED|Overall Study||268
10482260|NCT01140347|11631329|FG000|NOT COMPLETED|Overall Study||18
10482261|NCT01140347|11631330|FG001|NOT COMPLETED|Overall Study||14
10482262|NCT01140360|11631336|FG000|STARTED|Overall Study||21
10482263|NCT01140360|11631336|FG000|COMPLETED|Overall Study||15
10482264|NCT01140360|11631336|FG000|NOT COMPLETED|Overall Study||6
10482265|NCT01140477|11631342|FG000|STARTED|Overall Study||153
10482266|NCT01140477|11631343|FG001|STARTED|Overall Study||76
10482267|NCT01140477|11631342|FG000|COMPLETED|Overall Study||145
10482268|NCT01140477|11631343|FG001|COMPLETED|Overall Study||70
10482269|NCT01140477|11631342|FG000|NOT COMPLETED|Overall Study||8
10482270|NCT01140477|11631343|FG001|NOT COMPLETED|Overall Study||6
10482271|NCT01140503|11631349|FG000|STARTED|Overall Study||5
10482272|NCT01140503|11631349|FG000|COMPLETED|Overall Study||4
10482273|NCT01140503|11631349|FG000|NOT COMPLETED|Overall Study||1
10482274|NCT01140568|11631353|FG000|STARTED|Overall Study||38
10482275|NCT01140568|11631353|FG000|Screen Fail|Overall Study||4
10482276|NCT01140568|11631353|FG000|Treated With Study Drug|Overall Study||34
10482277|NCT01140568|11631353|FG000|COMPLETED|Overall Study||2
10482278|NCT01140568|11631353|FG000|NOT COMPLETED|Overall Study||36
10482279|NCT01140646|11631357|FG000|STARTED|Overall Study||43
10482280|NCT01140646|11631357|FG000|COMPLETED|Overall Study||34
10482281|NCT01140646|11631357|FG000|NOT COMPLETED|Overall Study||9
10482282|NCT01140815|11631363|FG000|STARTED|Overall Study||25
10482283|NCT01140815|11631364|FG001|STARTED|Overall Study||25
10482284|NCT01140815|11631363|FG000|COMPLETED|Overall Study||25
10482285|NCT01140815|11631364|FG001|COMPLETED|Overall Study||25
10482286|NCT01140815|11631363|FG000|NOT COMPLETED|Overall Study||0
10482287|NCT01140815|11631364|FG001|NOT COMPLETED|Overall Study||0
10482288|NCT01140880|11631374|FG000|STARTED|Overall Study||70
10482289|NCT01140880|11631375|FG001|STARTED|Overall Study||100
10482290|NCT01140880|11631374|FG000|COMPLETED|Overall Study||56
10482291|NCT01140880|11631375|FG001|COMPLETED|Overall Study||56
10482292|NCT01140880|11631374|FG000|NOT COMPLETED|Overall Study||14
10482293|NCT01140880|11631375|FG001|NOT COMPLETED|Overall Study||44
10482294|NCT01140906|11631385|FG000|STARTED|Overall Study||158
10482295|NCT01140906|11631386|FG001|STARTED|Overall Study||151
10482296|NCT01140906|11631387|FG002|STARTED|Overall Study||151
10482297|NCT01140906|11631388|FG003|STARTED|Overall Study||147
10482298|NCT01140906|11631385|FG000|COMPLETED|Overall Study||133
10482299|NCT01140906|11631386|FG001|COMPLETED|Overall Study||117
10482300|NCT01140906|11631387|FG002|COMPLETED|Overall Study||125
10482301|NCT01140906|11631388|FG003|COMPLETED|Overall Study||131
10482302|NCT01140906|11631385|FG000|NOT COMPLETED|Overall Study||25
10482303|NCT01140906|11631386|FG001|NOT COMPLETED|Overall Study||34
10482304|NCT01140906|11631387|FG002|NOT COMPLETED|Overall Study||26
10482305|NCT01140906|11631388|FG003|NOT COMPLETED|Overall Study||16
10482306|NCT01141049|11631400|FG000|STARTED|Overall Study||19
10482307|NCT01141049|11631401|FG001|STARTED|Overall Study||21
10482308|NCT01141049|11631400|FG000|COMPLETED|Overall Study||14
10482309|NCT01141049|11631401|FG001|COMPLETED|Overall Study||13
10482310|NCT01141049|11631400|FG000|NOT COMPLETED|Overall Study||5
10482311|NCT01141049|11631401|FG001|NOT COMPLETED|Overall Study||8
10482312|NCT01141075|11631407|FG000|STARTED|Cycle 1||11
10482313|NCT01141075|11631407|FG000|Received at Least 1 Dose of Study Drug|Cycle 1||11
10482314|NCT01141075|11631407|FG000|COMPLETED|Cycle 1||11
10482315|NCT01141075|11631407|FG000|NOT COMPLETED|Cycle 1||0
10482316|NCT01141075|11631407|FG000|STARTED|Cycle 2||11
10482317|NCT01141075|11631407|FG000|Received at Least 1 Dose of Study Drug|Cycle 2||11
10482318|NCT01141075|11631407|FG000|COMPLETED|Cycle 2||11
10482319|NCT01141075|11631407|FG000|NOT COMPLETED|Cycle 2||0
10482320|NCT01141205|11631413|FG000|STARTED|Overall Study||18
10482321|NCT01141205|11631414|FG001|STARTED|Overall Study||5
10482322|NCT01141205|11631413|FG000|COMPLETED|Overall Study||15
10482323|NCT01141205|11631414|FG001|COMPLETED|Overall Study||3
10482324|NCT01141205|11631413|FG000|NOT COMPLETED|Overall Study||3
10482325|NCT01141205|11631414|FG001|NOT COMPLETED|Overall Study||2
10482326|NCT01141283|11631424|FG000|STARTED|Overall Study||290
10482327|NCT01141283|11631424|FG000|COMPLETED|Overall Study||202
10482328|NCT01141283|11631424|FG000|NOT COMPLETED|Overall Study||88
10482329|NCT01141374|11631431|FG000|STARTED|Overall Study||26
10482330|NCT01141374|11631432|FG001|STARTED|Overall Study||27
10482331|NCT01141374|11631433|FG002|STARTED|Overall Study||22
10482332|NCT01141374|11631431|FG000|COMPLETED|Overall Study||26
10482333|NCT01141374|11631432|FG001|COMPLETED|Overall Study||27
10482334|NCT01141374|11631433|FG002|COMPLETED|Overall Study||22
10482335|NCT01141374|11631431|FG000|NOT COMPLETED|Overall Study||0
10482336|NCT01141374|11631432|FG001|NOT COMPLETED|Overall Study||0
10482337|NCT01141374|11631433|FG002|NOT COMPLETED|Overall Study||0
10482338|NCT01141478|11631445|FG000|STARTED|Overall Study||4
10482339|NCT01141478|11631446|FG001|STARTED|Overall Study||4
10482340|NCT01141478|11631445|FG000|COMPLETED|Overall Study||3
10482341|NCT01141478|11631446|FG001|COMPLETED|Overall Study||3
10482342|NCT01141478|11631445|FG000|NOT COMPLETED|Overall Study||1
10482343|NCT01141478|11631446|FG001|NOT COMPLETED|Overall Study||1
10482344|NCT01141491|11631454|FG000|STARTED|Overall Study||68
10482345|NCT01141491|11631455|FG001|STARTED|Overall Study||68
10482346|NCT01141491|11631454|FG000|COMPLETED|Overall Study||20
10482347|NCT01141491|11631455|FG001|COMPLETED|Overall Study||21
10482348|NCT01141491|11631454|FG000|NOT COMPLETED|Overall Study||48
10482349|NCT01141491|11631455|FG001|NOT COMPLETED|Overall Study||47
10482350|NCT01141569|11631461|FG000|STARTED|Overall Study||12
10482351|NCT01141569|11631461|FG000|COMPLETED|Overall Study||12
10482352|NCT01141569|11631461|FG000|NOT COMPLETED|Overall Study||0
10482353|NCT01141595|11631465|FG000|STARTED|Overall Study||10
10482354|NCT01141595|11631465|FG000|COMPLETED|Overall Study||8
10482355|NCT01141595|11631465|FG000|NOT COMPLETED|Overall Study||2
10482356|NCT01141608|11631471|FG000|STARTED|Overall Study||152
10482357|NCT01141608|11631472|FG001|STARTED|Overall Study||150
10482358|NCT01141608|11631471|FG000|COMPLETED|Overall Study||152
10482359|NCT01141608|11631472|FG001|COMPLETED|Overall Study||150
10482360|NCT01141608|11631471|FG000|NOT COMPLETED|Overall Study||0
10482361|NCT01141608|11631472|FG001|NOT COMPLETED|Overall Study||0
10482362|NCT01141647|11631478|FG000|STARTED|Overall Study||213
10482363|NCT01141647|11631478|FG000|COMPLETED|Overall Study||167
10482364|NCT01141647|11631478|FG000|NOT COMPLETED|Overall Study||46
10482365|NCT01141660|11631489|FG000|STARTED|Overall Study||71
10482366|NCT01141660|11631490|FG001|STARTED|Overall Study||60
10482367|NCT01141660|11631489|FG000|COMPLETED|Overall Study||71
10482368|NCT01141660|11631490|FG001|COMPLETED|Overall Study||48
10482369|NCT01141660|11631489|FG000|NOT COMPLETED|Overall Study||0
10482370|NCT01141660|11631490|FG001|NOT COMPLETED|Overall Study||12
10482371|NCT01141725|11631496|FG000|STARTED|Overall Study||3
10482372|NCT01141725|11631497|FG001|STARTED|Overall Study||33
10482373|NCT01141725|11631498|FG002|STARTED|Overall Study||3
10482374|NCT01141725|11631496|FG000|COMPLETED|Overall Study||3
10482375|NCT01141725|11631497|FG001|COMPLETED|Overall Study||33
10482376|NCT01141725|11631498|FG002|COMPLETED|Overall Study||3
10482377|NCT01141725|11631496|FG000|NOT COMPLETED|Overall Study||0
10482378|NCT01141725|11631497|FG001|NOT COMPLETED|Overall Study||0
10482379|NCT01141725|11631498|FG002|NOT COMPLETED|Overall Study||0
10482380|NCT01141907|11631507|FG000|STARTED|Overall Study||6
10482381|NCT01141907|11631508|FG001|STARTED|Overall Study||5
10482382|NCT01141907|11631507|FG000|COMPLETED|Overall Study||6
10482383|NCT01141907|11631508|FG001|COMPLETED|Overall Study||5
10482384|NCT01141907|11631507|FG000|NOT COMPLETED|Overall Study||0
10482385|NCT01141907|11631508|FG001|NOT COMPLETED|Overall Study||0
10482386|NCT01142089|11631516|FG000|STARTED|Overall Study||65
10482387|NCT01142089|11631517|FG001|STARTED|Overall Study||199
10482388|NCT01142089|11631516|FG000|COMPLETED|Overall Study||53
10482389|NCT01142089|11631517|FG001|COMPLETED|Overall Study||178
10482390|NCT01142089|11631516|FG000|NOT COMPLETED|Overall Study||12
10482391|NCT01142089|11631517|FG001|NOT COMPLETED|Overall Study||21
10482392|NCT01142115|11631523|FG000|STARTED|First Intervention||21
10482393|NCT01142115|11631524|FG001|STARTED|First Intervention||20
10482394|NCT01142115|11631523|FG000|COMPLETED|First Intervention||19
10482395|NCT01142115|11631524|FG001|COMPLETED|First Intervention||19
10482396|NCT01142115|11631523|FG000|NOT COMPLETED|First Intervention||2
10482397|NCT01142115|11631524|FG001|NOT COMPLETED|First Intervention||1
10482398|NCT01142115|11631523|FG000|STARTED|Second Intervention||19
10482399|NCT01142115|11631524|FG001|STARTED|Second Intervention||19
10482400|NCT01142115|11631523|FG000|COMPLETED|Second Intervention||19
10482401|NCT01142115|11631524|FG001|COMPLETED|Second Intervention||19
10482402|NCT01142115|11631523|FG000|NOT COMPLETED|Second Intervention||0
10482403|NCT01142115|11631524|FG001|NOT COMPLETED|Second Intervention||0
10482404|NCT01142193|11631531|FG000|STARTED|Overall Study||124
10482405|NCT01142193|11631532|FG001|STARTED|Overall Study||125
10482406|NCT01142193|11631531|FG000|COMPLETED|Overall Study||103
10482407|NCT01142193|11631532|FG001|COMPLETED|Overall Study||114
10482408|NCT01142193|11631531|FG000|NOT COMPLETED|Overall Study||21
10482409|NCT01142193|11631532|FG001|NOT COMPLETED|Overall Study||11
10482410|NCT01142232|11631543|FG000|STARTED|Overall Study||3
10482411|NCT01142232|11631544|FG001|STARTED|Overall Study||4
10482412|NCT01142232|11631545|FG002|STARTED|Overall Study||3
10482413|NCT01142232|11631546|FG003|STARTED|Overall Study||6
10482414|NCT01142232|11631547|FG004|STARTED|Overall Study||44
10482415|NCT01142232|11631543|FG000|COMPLETED|Overall Study||0
10482416|NCT01142232|11631544|FG001|COMPLETED|Overall Study||0
10482417|NCT01142232|11631545|FG002|COMPLETED|Overall Study||0
10482418|NCT01142232|11631546|FG003|COMPLETED|Overall Study||1
10482419|NCT01142232|11631547|FG004|COMPLETED|Overall Study||10
10482420|NCT01142232|11631543|FG000|NOT COMPLETED|Overall Study||3
10482421|NCT01142232|11631544|FG001|NOT COMPLETED|Overall Study||4
10482422|NCT01142232|11631545|FG002|NOT COMPLETED|Overall Study||3
10482423|NCT01142232|11631546|FG003|NOT COMPLETED|Overall Study||5
10482424|NCT01142232|11631547|FG004|NOT COMPLETED|Overall Study||34
10482425|NCT01142297|11631559|FG000|STARTED|Overall Study||24
10482426|NCT01142297|11631559|FG000|COMPLETED|Overall Study||18
10482427|NCT01142297|11631559|FG000|NOT COMPLETED|Overall Study||6
10482428|NCT01142310|11631568|FG000|STARTED|Overall Study||26
10482429|NCT01142310|11631569|FG001|STARTED|Overall Study||28
10482430|NCT01142310|11631568|FG000|COMPLETED|Overall Study||17
10482431|NCT01142310|11631569|FG001|COMPLETED|Overall Study||16
10482432|NCT01142310|11631568|FG000|NOT COMPLETED|Overall Study||9
10482433|NCT01142310|11631569|FG001|NOT COMPLETED|Overall Study||12
10482434|NCT01142323|11631575|FG000|STARTED|Overall Study||8
10482435|NCT01142323|11631575|FG000|COMPLETED|Overall Study||8
10482436|NCT01142323|11631575|FG000|NOT COMPLETED|Overall Study||0
10482437|NCT01142336|11631583|FG000|STARTED|Overall Study||26
10482438|NCT01142336|11631584|FG001|STARTED|Overall Study||23
10482439|NCT01142336|11631583|FG000|COMPLETED|Overall Study||25
10482440|NCT01142336|11631584|FG001|COMPLETED|Overall Study||21
10482441|NCT01142336|11631583|FG000|NOT COMPLETED|Overall Study||1
10482442|NCT01142336|11631584|FG001|NOT COMPLETED|Overall Study||2
10482443|NCT01142466|11631595|FG000|STARTED|Overall Study||15
10482444|NCT01142466|11631596|FG001|STARTED|Overall Study||15
10482445|NCT01142466|11631595|FG000|COMPLETED|Overall Study||12
10482446|NCT01142466|11631596|FG001|COMPLETED|Overall Study||13
10482447|NCT01142466|11631595|FG000|NOT COMPLETED|Overall Study||3
10482448|NCT01142466|11631596|FG001|NOT COMPLETED|Overall Study||2
10482449|NCT01142661|11631602|FG000|STARTED|Overall Study||9
10482450|NCT01142661|11631602|FG000|COMPLETED|Overall Study||5
10482451|NCT01142661|11631602|FG000|NOT COMPLETED|Overall Study||4
10482452|NCT01142726|11631609|FG000|STARTED|Treatment Phase: Day 1 Through Month 12||119
10482453|NCT01142726|11631610|FG001|STARTED|Treatment Phase: Day 1 Through Month 12||116
10482454|NCT01142726|11631611|FG002|STARTED|Treatment Phase: Day 1 Through Month 12||116
10482455|NCT01142726|11631609|FG000|COMPLETED|Treatment Phase: Day 1 Through Month 12||103
10482456|NCT01142726|11631610|FG001|COMPLETED|Treatment Phase: Day 1 Through Month 12||91
10482457|NCT01142726|11631611|FG002|COMPLETED|Treatment Phase: Day 1 Through Month 12||96
10482458|NCT01142726|11631609|FG000|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||16
10482459|NCT01142726|11631610|FG001|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||25
10482460|NCT01142726|11631611|FG002|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||20
10482461|NCT01142726|11631609|FG000|STARTED|Withdrawal Phase: Months 12 up to 24||84
10482462|NCT01142726|11631610|FG001|STARTED|Withdrawal Phase: Months 12 up to 24||66
10482463|NCT01142726|11631611|FG002|STARTED|Withdrawal Phase: Months 12 up to 24||75
10482464|NCT01142726|11631609|FG000|COMPLETED|Withdrawal Phase: Months 12 up to 24||14
10482465|NCT01142726|11631610|FG001|COMPLETED|Withdrawal Phase: Months 12 up to 24||10
10482466|NCT01142726|11631611|FG002|COMPLETED|Withdrawal Phase: Months 12 up to 24||17
10482467|NCT01142726|11631609|FG000|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||70
10482468|NCT01142726|11631610|FG001|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||56
10482469|NCT01142726|11631611|FG002|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||58
10482470|NCT01142726|11631609|FG000|STARTED|Re-Exposure Phase: Months 24 up to 30||55
10482471|NCT01142726|11631610|FG001|STARTED|Re-Exposure Phase: Months 24 up to 30||48
10482472|NCT01142726|11631611|FG002|STARTED|Re-Exposure Phase: Months 24 up to 30||43
10482473|NCT01142726|11631609|FG000|COMPLETED|Re-Exposure Phase: Months 24 up to 30||54
10482474|NCT01142726|11631610|FG001|COMPLETED|Re-Exposure Phase: Months 24 up to 30||46
10482475|NCT01142726|11631611|FG002|COMPLETED|Re-Exposure Phase: Months 24 up to 30||40
10482476|NCT01142726|11631609|FG000|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||1
10482477|NCT01142726|11631610|FG001|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||2
10482478|NCT01142726|11631611|FG002|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||3
10482479|NCT01142791|11631627|FG000|STARTED|Overall Study||115
10482480|NCT01142791|11631628|FG001|STARTED|Overall Study|6 participants receiving only 1 sonication were included only in adverse events reporting.|6
10482481|NCT01142791|11631627|FG000|Safety|Overall Study||115
10482482|NCT01142791|11631628|FG001|Safety|Overall Study|Safety data only was reported for 6 participants receiving only 1 sonication.|6
10482483|NCT01142791|11631627|FG000|COMPLETED|Overall Study||108
10482484|NCT01142791|11631628|FG001|COMPLETED|Overall Study||0
10482485|NCT01142791|11631627|FG000|NOT COMPLETED|Overall Study||7
10482486|NCT01142791|11631628|FG001|NOT COMPLETED|Overall Study||6
10482487|NCT01142908|11631634|FG000|STARTED|Overall Study||215
10482488|NCT01142908|11631635|FG001|STARTED|Overall Study||213
10482489|NCT01142908|11631634|FG000|6 Month f/u|Overall Study||188
10482490|NCT01142908|11631635|FG001|6 Month f/u|Overall Study||196
10482491|NCT01142908|11631634|FG000|COMPLETED|Overall Study||183
10482492|NCT01142908|11631635|FG001|COMPLETED|Overall Study||191
10482493|NCT01142908|11631634|FG000|NOT COMPLETED|Overall Study||32
10482494|NCT01142908|11631635|FG001|NOT COMPLETED|Overall Study||22
10482495|NCT01142947|11631641|FG000|STARTED|Overall Study||362
10482496|NCT01142947|11631641|FG000|COMPLETED|Overall Study||244
10482497|NCT01142947|11631641|FG000|NOT COMPLETED|Overall Study||118
10482501|NCT01143051|11631655|FG000|STARTED|Visit 1||4
10482502|NCT01143051|11631656|FG001|STARTED|Visit 1||4
10482503|NCT01143051|11631657|FG002|STARTED|Visit 1||4
10482504|NCT01143051|11631658|FG003|STARTED|Visit 1||4
10482505|NCT01143051|11631659|FG004|STARTED|Visit 1||4
10482506|NCT01143051|11631660|FG005|STARTED|Visit 1||4
10482507|NCT01143051|11631655|FG000|COMPLETED|Visit 1||4
10482508|NCT01143051|11631656|FG001|COMPLETED|Visit 1||4
10482509|NCT01143051|11631657|FG002|COMPLETED|Visit 1||4
10482510|NCT01143051|11631658|FG003|COMPLETED|Visit 1||4
10482511|NCT01143051|11631659|FG004|COMPLETED|Visit 1||4
10709703|NCT02642575|11874756|FG000|STARTED|Overall Study||67
10709704|NCT02642575|11874756|FG000|COMPLETED|Overall Study||67
10709705|NCT02642575|11874756|FG000|NOT COMPLETED|Overall Study||0
10713811|NCT02682420|11879330|FG000|COMPLETED|Overall Study|Note: 63 participants completed the 6-month visit. The study was discontinued prematurely due to company acquisition and therefore, many participants did not complete their 12-month visit.|63
10713812|NCT02682420|11879330|FG000|NOT COMPLETED|Overall Study||37
10713813|NCT02682498|11879343|FG000|STARTED|Overall Study||18
10713814|NCT02682498|11879344|FG001|STARTED|Overall Study||20
10713815|NCT02682498|11879343|FG000|COMPLETED|Overall Study||18
10713816|NCT02682498|11879344|FG001|COMPLETED|Overall Study||20
10713817|NCT02682498|11879343|FG000|NOT COMPLETED|Overall Study||0
10482512|NCT01143051|11631660|FG005|COMPLETED|Visit 1||4
10482513|NCT01143051|11631655|FG000|NOT COMPLETED|Visit 1||0
10482514|NCT01143051|11631656|FG001|NOT COMPLETED|Visit 1||0
10482515|NCT01143051|11631657|FG002|NOT COMPLETED|Visit 1||0
10482516|NCT01143051|11631658|FG003|NOT COMPLETED|Visit 1||0
10482517|NCT01143051|11631659|FG004|NOT COMPLETED|Visit 1||0
10482518|NCT01143051|11631660|FG005|NOT COMPLETED|Visit 1||0
10482519|NCT01143051|11631655|FG000|STARTED|3-14 Day Washout||4
10482520|NCT01143051|11631656|FG001|STARTED|3-14 Day Washout||4
10482521|NCT01143051|11631657|FG002|STARTED|3-14 Day Washout||4
10482522|NCT01143051|11631658|FG003|STARTED|3-14 Day Washout||4
10482523|NCT01143051|11631659|FG004|STARTED|3-14 Day Washout||4
10482524|NCT01143051|11631660|FG005|STARTED|3-14 Day Washout||4
10482525|NCT01143051|11631655|FG000|COMPLETED|3-14 Day Washout||4
10482526|NCT01143051|11631656|FG001|COMPLETED|3-14 Day Washout||4
10482527|NCT01143051|11631657|FG002|COMPLETED|3-14 Day Washout||3
10482528|NCT01143051|11631658|FG003|COMPLETED|3-14 Day Washout||4
10482529|NCT01143051|11631659|FG004|COMPLETED|3-14 Day Washout||4
10482530|NCT01143051|11631660|FG005|COMPLETED|3-14 Day Washout||4
10482531|NCT01143051|11631655|FG000|NOT COMPLETED|3-14 Day Washout||0
10482532|NCT01143051|11631656|FG001|NOT COMPLETED|3-14 Day Washout||0
10482533|NCT01143051|11631657|FG002|NOT COMPLETED|3-14 Day Washout||1
10482534|NCT01143051|11631658|FG003|NOT COMPLETED|3-14 Day Washout||0
10482535|NCT01143051|11631659|FG004|NOT COMPLETED|3-14 Day Washout||0
10482536|NCT01143051|11631660|FG005|NOT COMPLETED|3-14 Day Washout||0
10482537|NCT01143051|11631655|FG000|STARTED|Visit 2||4
10482538|NCT01143051|11631656|FG001|STARTED|Visit 2||4
10482539|NCT01143051|11631657|FG002|STARTED|Visit 2||3
10482540|NCT01143051|11631658|FG003|STARTED|Visit 2||4
10482541|NCT01143051|11631659|FG004|STARTED|Visit 2||4
10482542|NCT01143051|11631660|FG005|STARTED|Visit 2||4
10482543|NCT01143051|11631655|FG000|COMPLETED|Visit 2||4
10482544|NCT01143051|11631656|FG001|COMPLETED|Visit 2||4
10482545|NCT01143051|11631657|FG002|COMPLETED|Visit 2||3
10482546|NCT01143051|11631658|FG003|COMPLETED|Visit 2||4
10482547|NCT01143051|11631659|FG004|COMPLETED|Visit 2||4
10482548|NCT01143051|11631660|FG005|COMPLETED|Visit 2||4
10482549|NCT01143051|11631655|FG000|NOT COMPLETED|Visit 2||0
10482550|NCT01143051|11631656|FG001|NOT COMPLETED|Visit 2||0
10482551|NCT01143051|11631657|FG002|NOT COMPLETED|Visit 2||0
10482552|NCT01143051|11631658|FG003|NOT COMPLETED|Visit 2||0
10482553|NCT01143051|11631659|FG004|NOT COMPLETED|Visit 2||0
10482554|NCT01143051|11631660|FG005|NOT COMPLETED|Visit 2||0
10482555|NCT01143051|11631655|FG000|STARTED|3-14 Day Washout||4
10482556|NCT01143051|11631656|FG001|STARTED|3-14 Day Washout||4
10482557|NCT01143051|11631657|FG002|STARTED|3-14 Day Washout||3
10482558|NCT01143051|11631658|FG003|STARTED|3-14 Day Washout||4
10482559|NCT01143051|11631659|FG004|STARTED|3-14 Day Washout||4
10482560|NCT01143051|11631660|FG005|STARTED|3-14 Day Washout||4
10482561|NCT01143051|11631655|FG000|COMPLETED|3-14 Day Washout||4
10482562|NCT01143051|11631656|FG001|COMPLETED|3-14 Day Washout||4
10482563|NCT01143051|11631657|FG002|COMPLETED|3-14 Day Washout||3
10482564|NCT01143051|11631658|FG003|COMPLETED|3-14 Day Washout||4
10713818|NCT02682498|11879344|FG001|NOT COMPLETED|Overall Study||0
10713819|NCT02682563|11879353|FG000|STARTED|Overall Study||24
10713820|NCT02682563|11879354|FG001|STARTED|Overall Study||20
10713821|NCT02682563|11879353|FG000|COMPLETED|Overall Study||24
10482565|NCT01143051|11631659|FG004|COMPLETED|3-14 Day Washout||4
10482566|NCT01143051|11631660|FG005|COMPLETED|3-14 Day Washout||3
10482567|NCT01143051|11631655|FG000|NOT COMPLETED|3-14 Day Washout||0
10482568|NCT01143051|11631656|FG001|NOT COMPLETED|3-14 Day Washout||0
10482569|NCT01143051|11631657|FG002|NOT COMPLETED|3-14 Day Washout||0
10482570|NCT01143051|11631658|FG003|NOT COMPLETED|3-14 Day Washout||0
10482571|NCT01143051|11631659|FG004|NOT COMPLETED|3-14 Day Washout||0
10482572|NCT01143051|11631660|FG005|NOT COMPLETED|3-14 Day Washout||1
10482573|NCT01143051|11631655|FG000|STARTED|Visit 3||4
10482574|NCT01143051|11631656|FG001|STARTED|Visit 3||4
10482575|NCT01143051|11631657|FG002|STARTED|Visit 3||3
10482576|NCT01143051|11631658|FG003|STARTED|Visit 3||4
10482577|NCT01143051|11631659|FG004|STARTED|Visit 3||4
10482578|NCT01143051|11631660|FG005|STARTED|Visit 3||3
10482579|NCT01143051|11631655|FG000|COMPLETED|Visit 3||4
10482580|NCT01143051|11631656|FG001|COMPLETED|Visit 3||4
10482581|NCT01143051|11631657|FG002|COMPLETED|Visit 3||3
10482582|NCT01143051|11631658|FG003|COMPLETED|Visit 3||4
10482583|NCT01143051|11631659|FG004|COMPLETED|Visit 3||4
10482584|NCT01143051|11631660|FG005|COMPLETED|Visit 3||3
10482585|NCT01143051|11631655|FG000|NOT COMPLETED|Visit 3||0
10482586|NCT01143051|11631656|FG001|NOT COMPLETED|Visit 3||0
10482587|NCT01143051|11631657|FG002|NOT COMPLETED|Visit 3||0
10482588|NCT01143051|11631658|FG003|NOT COMPLETED|Visit 3||0
10482589|NCT01143051|11631659|FG004|NOT COMPLETED|Visit 3||0
10482590|NCT01143051|11631660|FG005|NOT COMPLETED|Visit 3||0
10482591|NCT01143077|11631673|FG000|STARTED|Overall Study||74
10482592|NCT01143077|11631674|FG001|STARTED|Overall Study||88
10482593|NCT01143077|11631675|FG002|STARTED|Overall Study||82
10482594|NCT01143077|11631673|FG000|COMPLETED|Overall Study||58
10482595|NCT01143077|11631674|FG001|COMPLETED|Overall Study||73
10482596|NCT01143077|11631675|FG002|COMPLETED|Overall Study||67
10482597|NCT01143077|11631673|FG000|NOT COMPLETED|Overall Study||16
10482598|NCT01143077|11631674|FG001|NOT COMPLETED|Overall Study||15
10482599|NCT01143077|11631675|FG002|NOT COMPLETED|Overall Study||15
10482600|NCT01143090|11631683|FG000|STARTED|Overall Study||149
10482601|NCT01143090|11631683|FG000|COMPLETED|Overall Study||98
10482602|NCT01143090|11631683|FG000|NOT COMPLETED|Overall Study||51
10482603|NCT01143142|11631689|FG000|STARTED|Overall Study||36
10482604|NCT01143142|11631690|FG001|STARTED|Overall Study||34
10482605|NCT01143142|11631689|FG000|COMPLETED|Overall Study||36
10482606|NCT01143142|11631690|FG001|COMPLETED|Overall Study||34
10482607|NCT01143142|11631689|FG000|NOT COMPLETED|Overall Study||0
10482608|NCT01143142|11631690|FG001|NOT COMPLETED|Overall Study||0
10482609|NCT01143181|11631700|FG000|STARTED|Overall Study||30
10482610|NCT01143181|11631701|FG001|STARTED|Overall Study||38
10482611|NCT01143181|11631702|FG002|STARTED|Overall Study||102
10482612|NCT01143181|11631703|FG003|STARTED|Overall Study||40
10482613|NCT01143181|11631700|FG000|COMPLETED|Overall Study||14
10482614|NCT01143181|11631701|FG001|COMPLETED|Overall Study||22
10482615|NCT01143181|11631702|FG002|COMPLETED|Overall Study||58
10482616|NCT01143181|11631703|FG003|COMPLETED|Overall Study||17
10482617|NCT01143181|11631700|FG000|NOT COMPLETED|Overall Study||16
10482618|NCT01143181|11631701|FG001|NOT COMPLETED|Overall Study||16
10482619|NCT01143181|11631702|FG002|NOT COMPLETED|Overall Study||44
10482620|NCT01143181|11631703|FG003|NOT COMPLETED|Overall Study||23
10482621|NCT01143207|11631713|FG000|STARTED|Overall Study||26
10482622|NCT01143207|11631713|FG000|COMPLETED|Overall Study||24
10482623|NCT01143207|11631713|FG000|NOT COMPLETED|Overall Study||2
10482624|NCT01143259|11631719|FG000|STARTED|Overall Study||136
10482625|NCT01143259|11631720|FG001|STARTED|Overall Study||138
10482626|NCT01143259|11631719|FG000|COMPLETED|Overall Study||113
10482627|NCT01143259|11631720|FG001|COMPLETED|Overall Study||118
10482628|NCT01143259|11631719|FG000|NOT COMPLETED|Overall Study||23
10482629|NCT01143259|11631720|FG001|NOT COMPLETED|Overall Study||20
10482630|NCT01143272|11631728|FG000|STARTED|Overall Study||246
10482631|NCT01143272|11631729|FG001|STARTED|Overall Study||231
10482632|NCT01143272|11631728|FG000|COMPLETED|Overall Study||246
10482633|NCT01143272|11631729|FG001|COMPLETED|Overall Study||231
10482634|NCT01143272|11631728|FG000|NOT COMPLETED|Overall Study||0
10482635|NCT01143272|11631729|FG001|NOT COMPLETED|Overall Study||0
10482636|NCT01143324|11631735|FG000|STARTED|Overall Study||252
10482637|NCT01143324|11631735|FG000|COMPLETED|Overall Study||233
10482638|NCT01143324|11631735|FG000|NOT COMPLETED|Overall Study||19
10482639|NCT01143337|11631741|FG000|STARTED|Overall Study||49
10482640|NCT01143337|11631742|FG001|STARTED|Overall Study||50
10482641|NCT01143337|11631743|FG002|STARTED|Overall Study||13
10482642|NCT01143337|11631741|FG000|COMPLETED|Overall Study||39
10482643|NCT01143337|11631742|FG001|COMPLETED|Overall Study||39
10482644|NCT01143337|11631743|FG002|COMPLETED|Overall Study|Frequency of this arm AE was higher than assumption before study initiation.|1
10482645|NCT01143337|11631741|FG000|NOT COMPLETED|Overall Study||10
10482646|NCT01143337|11631742|FG001|NOT COMPLETED|Overall Study||11
10482647|NCT01143337|11631743|FG002|NOT COMPLETED|Overall Study||12
10482648|NCT01143389|11631751|FG000|STARTED|Overall Study||253
10482649|NCT01143389|11631752|FG001|STARTED|Overall Study||257
10482650|NCT01143389|11631751|FG000|COMPLETED|Overall Study||227
10482651|NCT01143389|11631752|FG001|COMPLETED|Overall Study||232
10482652|NCT01143389|11631751|FG000|NOT COMPLETED|Overall Study||26
10482653|NCT01143389|11631752|FG001|NOT COMPLETED|Overall Study||25
10482654|NCT01143402|11631761|FG000|STARTED|Overall Study||51
10482655|NCT01143402|11631762|FG001|STARTED|Overall Study||50
10482656|NCT01143402|11631763|FG002|STARTED|Overall Study||19
10482657|NCT01143402|11631761|FG000|COMPLETED|Overall Study||50
10482658|NCT01143402|11631762|FG001|COMPLETED|Overall Study||49
10482659|NCT01143402|11631763|FG002|COMPLETED|Overall Study||18
10482660|NCT01143402|11631761|FG000|NOT COMPLETED|Overall Study||1
10482661|NCT01143402|11631762|FG001|NOT COMPLETED|Overall Study||1
10482662|NCT01143402|11631763|FG002|NOT COMPLETED|Overall Study||1
10482663|NCT01143610|11631772|FG000|STARTED|Overall Study||7
10482664|NCT01143610|11631773|FG001|STARTED|Overall Study||8
10482665|NCT01143610|11631772|FG000|COMPLETED|Overall Study||7
10482666|NCT01143610|11631773|FG001|COMPLETED|Overall Study||8
10482667|NCT01143610|11631772|FG000|NOT COMPLETED|Overall Study||0
10482668|NCT01143610|11631773|FG001|NOT COMPLETED|Overall Study||0
10482669|NCT01143636|11631782|FG000|STARTED|Overall Study||6
10482670|NCT01143636|11631783|FG001|STARTED|Overall Study||5
10482671|NCT01143636|11631784|FG002|STARTED|Overall Study||8
10482672|NCT01143636|11631785|FG003|STARTED|Overall Study||7
10482673|NCT01143636|11631782|FG000|COMPLETED|Overall Study||5
10482674|NCT01143636|11631783|FG001|COMPLETED|Overall Study||4
10482675|NCT01143636|11631784|FG002|COMPLETED|Overall Study||8
10482676|NCT01143636|11631785|FG003|COMPLETED|Overall Study||7
10482677|NCT01143636|11631782|FG000|NOT COMPLETED|Overall Study||1
10482678|NCT01143636|11631783|FG001|NOT COMPLETED|Overall Study||1
10482679|NCT01143636|11631784|FG002|NOT COMPLETED|Overall Study||0
10482680|NCT01143636|11631785|FG003|NOT COMPLETED|Overall Study||0
10482681|NCT01143649|11631800|FG000|STARTED|Overall Study||7
10482682|NCT01143649|11631801|FG001|STARTED|Overall Study||7
10482683|NCT01143649|11631802|FG002|STARTED|Overall Study||10
10482684|NCT01143649|11631803|FG003|STARTED|Overall Study||10
10482685|NCT01143649|11631804|FG004|STARTED|Overall Study||5
10482686|NCT01143649|11631805|FG005|STARTED|Overall Study||5
10482687|NCT01143649|11631800|FG000|COMPLETED|Overall Study||7
10482688|NCT01143649|11631801|FG001|COMPLETED|Overall Study||7
10482689|NCT01143649|11631802|FG002|COMPLETED|Overall Study||10
10482690|NCT01143649|11631803|FG003|COMPLETED|Overall Study||10
10482691|NCT01143649|11631804|FG004|COMPLETED|Overall Study||4
10482692|NCT01143649|11631805|FG005|COMPLETED|Overall Study||3
10482693|NCT01143649|11631800|FG000|NOT COMPLETED|Overall Study||0
10482694|NCT01143649|11631801|FG001|NOT COMPLETED|Overall Study||0
10482695|NCT01143649|11631802|FG002|NOT COMPLETED|Overall Study||0
10482696|NCT01143649|11631803|FG003|NOT COMPLETED|Overall Study||0
10482697|NCT01143649|11631804|FG004|NOT COMPLETED|Overall Study||1
10482698|NCT01143649|11631805|FG005|NOT COMPLETED|Overall Study||2
10482699|NCT01143688|11631819|FG000|STARTED|Overall Study||39
10482700|NCT01143688|11631819|FG000|COMPLETED|Overall Study||39
10482701|NCT01143688|11631819|FG000|NOT COMPLETED|Overall Study||0
10482702|NCT01143701|11631831|FG000|STARTED|Overall Study||258
10482703|NCT01143701|11631832|FG001|STARTED|Overall Study||319
10482704|NCT01143701|11631831|FG000|COMPLETED|Overall Study|Number of patients for whom at least one set of post-baseline parent-ratings were collected|235
10482705|NCT01143701|11631832|FG001|COMPLETED|Overall Study|Number of patients for whom at least one set of post-baseline parent-ratings were collected|287
10482706|NCT01143701|11631831|FG000|NOT COMPLETED|Overall Study||23
10482707|NCT01143701|11631832|FG001|NOT COMPLETED|Overall Study||32
10482708|NCT01143714|11631840|FG000|STARTED|Overall Study||29
10482709|NCT01143714|11631841|FG001|STARTED|Overall Study||28
10482710|NCT01143714|11631840|FG000|COMPLETED|Overall Study||22
10482711|NCT01143714|11631841|FG001|COMPLETED|Overall Study||25
10482712|NCT01143714|11631840|FG000|NOT COMPLETED|Overall Study||7
10482713|NCT01143714|11631841|FG001|NOT COMPLETED|Overall Study||3
10482714|NCT01143727|11631849|FG000|STARTED|Overall Study||9
10482715|NCT01143727|11631850|FG001|STARTED|Overall Study||8
10482716|NCT01143727|11631849|FG000|COMPLETED|Overall Study||9
10482717|NCT01143727|11631850|FG001|COMPLETED|Overall Study||8
10482718|NCT01143727|11631849|FG000|NOT COMPLETED|Overall Study||0
10482719|NCT01143727|11631850|FG001|NOT COMPLETED|Overall Study||0
10482720|NCT01143766|11631858|FG000|STARTED|Overall Study||25
10482721|NCT01143766|11631859|FG001|STARTED|Overall Study||31
10482722|NCT01143766|11631858|FG000|COMPLETED|Overall Study||25
10482723|NCT01143766|11631859|FG001|COMPLETED|Overall Study||31
10482724|NCT01143766|11631858|FG000|NOT COMPLETED|Overall Study||0
10482725|NCT01143766|11631859|FG001|NOT COMPLETED|Overall Study||0
10482726|NCT01143792|11631870|FG000|STARTED|Overall Study||93
10482727|NCT01143792|11631871|FG001|STARTED|Overall Study||86
10482728|NCT01143792|11631872|FG002|STARTED|Overall Study||91
10482729|NCT01143792|11631870|FG000|COMPLETED|Overall Study||93
10482730|NCT01143792|11631871|FG001|COMPLETED|Overall Study||86
10482731|NCT01143792|11631872|FG002|COMPLETED|Overall Study||91
10482732|NCT01143792|11631870|FG000|NOT COMPLETED|Overall Study||0
10482733|NCT01143792|11631871|FG001|NOT COMPLETED|Overall Study||0
10482734|NCT01143792|11631872|FG002|NOT COMPLETED|Overall Study||0
10482735|NCT01143818|11631891|FG000|STARTED|Overall Study|A total of 1053 participants were enrolled but only 1049 received study drug.|1049
10482736|NCT01143818|11631891|FG000|COMPLETED|Overall Study||799
10482737|NCT01143818|11631891|FG000|NOT COMPLETED|Overall Study||250
10482738|NCT01143870|11631898|FG000|STARTED|Overall Study||58
10482739|NCT01143870|11631899|FG001|STARTED|Overall Study||58
10482740|NCT01143870|11631900|FG002|STARTED|Overall Study||61
10482741|NCT01143870|11631898|FG000|Post-intervention Survey|Overall Study||53
10482742|NCT01143870|11631899|FG001|Post-intervention Survey|Overall Study||50
10482743|NCT01143870|11631900|FG002|Post-intervention Survey|Overall Study||61
10482744|NCT01143870|11631898|FG000|Had Available 6-month A1C|Overall Study||27
10482745|NCT01143870|11631899|FG001|Had Available 6-month A1C|Overall Study||29
10482746|NCT01143870|11631900|FG002|Had Available 6-month A1C|Overall Study||31
10482747|NCT01143870|11631898|FG000|A1C Imputed|Overall Study||31
10482748|NCT01143870|11631899|FG001|A1C Imputed|Overall Study||29
10482749|NCT01143870|11631900|FG002|A1C Imputed|Overall Study||30
10482750|NCT01143870|11631898|FG000|COMPLETED|Overall Study||58
10482751|NCT01143870|11631899|FG001|COMPLETED|Overall Study||58
10482752|NCT01143870|11631900|FG002|COMPLETED|Overall Study||61
10482753|NCT01143870|11631898|FG000|NOT COMPLETED|Overall Study||0
10482754|NCT01143870|11631899|FG001|NOT COMPLETED|Overall Study||0
10482755|NCT01143870|11631900|FG002|NOT COMPLETED|Overall Study||0
10482756|NCT01143883|11631910|FG000|STARTED|Overall Study||55
10482757|NCT01143883|11631911|FG001|STARTED|Overall Study||55
10482758|NCT01143883|11631910|FG000|COMPLETED|Overall Study||55
10482759|NCT01143883|11631911|FG001|COMPLETED|Overall Study||55
10482760|NCT01143883|11631910|FG000|NOT COMPLETED|Overall Study||0
10482761|NCT01143883|11631911|FG001|NOT COMPLETED|Overall Study||0
10482762|NCT01143896|11631919|FG000|STARTED|Overall Study||156
10482763|NCT01143896|11631920|FG001|STARTED|Overall Study||153
10482764|NCT01143896|11631919|FG000|COMPLETED|Overall Study||114
10482765|NCT01143896|11631920|FG001|COMPLETED|Overall Study||128
10482766|NCT01143896|11631919|FG000|NOT COMPLETED|Overall Study||42
10482767|NCT01143896|11631920|FG001|NOT COMPLETED|Overall Study||25
10482768|NCT01144026|11631929|FG000|STARTED|Overall Study||10
10482769|NCT01144026|11631930|FG001|STARTED|Overall Study||5
10482770|NCT01144026|11631929|FG000|COMPLETED|Overall Study||10
10482771|NCT01144026|11631930|FG001|COMPLETED|Overall Study||5
10482772|NCT01144026|11631929|FG000|NOT COMPLETED|Overall Study||0
10482773|NCT01144026|11631930|FG001|NOT COMPLETED|Overall Study||0
10482774|NCT01144052|11631938|FG000|STARTED|Overall Study||10
10482775|NCT01144052|11631939|FG001|STARTED|Overall Study||9
10482776|NCT01144052|11631938|FG000|COMPLETED|Overall Study||9
10482777|NCT01144052|11631939|FG001|COMPLETED|Overall Study||8
10482778|NCT01144052|11631938|FG000|NOT COMPLETED|Overall Study||1
10482779|NCT01144052|11631939|FG001|NOT COMPLETED|Overall Study||1
10482780|NCT01144143|11631950|FG000|STARTED|Overall Study||8
10482781|NCT01144143|11631951|FG001|STARTED|Overall Study||4
10482782|NCT01144143|11631952|FG002|STARTED|Overall Study||4
10482783|NCT01144143|11631950|FG000|COMPLETED|Overall Study||8
10482784|NCT01144143|11631951|FG001|COMPLETED|Overall Study||4
10482785|NCT01144143|11631952|FG002|COMPLETED|Overall Study||4
10482786|NCT01144143|11631950|FG000|NOT COMPLETED|Overall Study||0
10482787|NCT01144143|11631951|FG001|NOT COMPLETED|Overall Study||0
10482788|NCT01144143|11631952|FG002|NOT COMPLETED|Overall Study||0
10482789|NCT01144182|11631966|FG000|STARTED|Overall Study||68
10482790|NCT01144182|11631967|FG001|STARTED|Overall Study||68
10482791|NCT01144182|11631966|FG000|COMPLETED|Overall Study||51
10482792|NCT01144182|11631967|FG001|COMPLETED|Overall Study||47
10482793|NCT01144182|11631966|FG000|NOT COMPLETED|Overall Study||17
10482794|NCT01144182|11631967|FG001|NOT COMPLETED|Overall Study||21
10482795|NCT01144286|11631978|FG000|STARTED|Overall Study||57
10482796|NCT01144286|11631979|FG001|STARTED|Overall Study||58
10482797|NCT01144286|11631980|FG002|STARTED|Overall Study||58
10482798|NCT01144286|11631981|FG003|STARTED|Overall Study||56
10482799|NCT01144286|11631978|FG000|COMPLETED|Overall Study||57
10482800|NCT01144286|11631979|FG001|COMPLETED|Overall Study||58
10482801|NCT01144286|11631980|FG002|COMPLETED|Overall Study||58
10482802|NCT01144286|11631981|FG003|COMPLETED|Overall Study||56
10482803|NCT01144286|11631978|FG000|NOT COMPLETED|Overall Study||0
10482804|NCT01144286|11631979|FG001|NOT COMPLETED|Overall Study||0
10482805|NCT01144286|11631980|FG002|NOT COMPLETED|Overall Study||0
10482806|NCT01144286|11631981|FG003|NOT COMPLETED|Overall Study||0
10482807|NCT01144299|11631993|FG000|STARTED|Overall Study||60
10482808|NCT01144299|11631994|FG001|STARTED|Overall Study||54
10482809|NCT01144299|11631993|FG000|COMPLETED|Overall Study||58
10482810|NCT01144299|11631994|FG001|COMPLETED|Overall Study||54
10482811|NCT01144299|11631993|FG000|NOT COMPLETED|Overall Study||2
10482812|NCT01144299|11631994|FG001|NOT COMPLETED|Overall Study||0
10482813|NCT01144338|11632002|FG000|STARTED|Overall Study||7396
10482814|NCT01144338|11632003|FG001|STARTED|Overall Study||7356
10482815|NCT01144338|11632002|FG000|COMPLETED|Overall Study||7093
10482816|NCT01144338|11632003|FG001|COMPLETED|Overall Study||7094
10482817|NCT01144338|11632002|FG000|NOT COMPLETED|Overall Study||303
10482818|NCT01144338|11632003|FG001|NOT COMPLETED|Overall Study||262
10482819|NCT01144364|11632011|FG000|STARTED|Induction Phase||234
10482820|NCT01144364|11632012|FG001|STARTED|Induction Phase||0
10482821|NCT01144364|11632013|FG002|STARTED|Induction Phase||0
10482822|NCT01144364|11632011|FG000|COMPLETED|Induction Phase||202
10482823|NCT01144364|11632012|FG001|COMPLETED|Induction Phase||0
10482824|NCT01144364|11632013|FG002|COMPLETED|Induction Phase||0
10482825|NCT01144364|11632011|FG000|NOT COMPLETED|Induction Phase||32
10482826|NCT01144364|11632012|FG001|NOT COMPLETED|Induction Phase||0
10482827|NCT01144364|11632013|FG002|NOT COMPLETED|Induction Phase||0
10482828|NCT01144364|11632011|FG000|STARTED|Follow-Up/Maintenance Phase||0
10482829|NCT01144364|11632012|FG001|STARTED|Follow-Up/Maintenance Phase||101
10482830|NCT01144364|11632013|FG002|STARTED|Follow-Up/Maintenance Phase||101
10482831|NCT01144364|11632011|FG000|COMPLETED|Follow-Up/Maintenance Phase||0
10482832|NCT01144364|11632012|FG001|COMPLETED|Follow-Up/Maintenance Phase||66
10482833|NCT01144364|11632013|FG002|COMPLETED|Follow-Up/Maintenance Phase||60
10482834|NCT01144364|11632011|FG000|NOT COMPLETED|Follow-Up/Maintenance Phase||0
10482835|NCT01144364|11632012|FG001|NOT COMPLETED|Follow-Up/Maintenance Phase||35
10482836|NCT01144364|11632013|FG002|NOT COMPLETED|Follow-Up/Maintenance Phase||41
10482837|NCT01144377|11632028|FG000|STARTED|52 Week Treatment Period||31
10482838|NCT01144377|11632029|FG001|STARTED|52 Week Treatment Period||30
10482839|NCT01144377|11632030|FG002|STARTED|52 Week Treatment Period||30
10482840|NCT01144377|11632031|FG003|STARTED|52 Week Treatment Period||26
10482841|NCT01144377|11632032|FG004|STARTED|52 Week Treatment Period||37
10482842|NCT01144377|11632028|FG000|Received at Least One Dose of Study Drug|52 Week Treatment Period||31
10482843|NCT01144377|11632029|FG001|Received at Least One Dose of Study Drug|52 Week Treatment Period||30
10482844|NCT01144377|11632030|FG002|Received at Least One Dose of Study Drug|52 Week Treatment Period||30
10482845|NCT01144377|11632031|FG003|Received at Least One Dose of Study Drug|52 Week Treatment Period||25
10482846|NCT01144377|11632032|FG004|Received at Least One Dose of Study Drug|52 Week Treatment Period||37
10482847|NCT01144377|11632028|FG000|COMPLETED|52 Week Treatment Period||26
10482848|NCT01144377|11632029|FG001|COMPLETED|52 Week Treatment Period||29
10482849|NCT01144377|11632030|FG002|COMPLETED|52 Week Treatment Period||25
10482850|NCT01144377|11632031|FG003|COMPLETED|52 Week Treatment Period||22
10482851|NCT01144377|11632032|FG004|COMPLETED|52 Week Treatment Period||34
10482852|NCT01144377|11632028|FG000|NOT COMPLETED|52 Week Treatment Period||5
10482853|NCT01144377|11632029|FG001|NOT COMPLETED|52 Week Treatment Period||1
10482854|NCT01144377|11632030|FG002|NOT COMPLETED|52 Week Treatment Period||5
10482855|NCT01144377|11632031|FG003|NOT COMPLETED|52 Week Treatment Period||4
10482856|NCT01144377|11632032|FG004|NOT COMPLETED|52 Week Treatment Period||3
10482857|NCT01144377|11632028|FG000|STARTED|12 Week Safety Follow-up Period||26
10482858|NCT01144377|11632029|FG001|STARTED|12 Week Safety Follow-up Period||29
10482859|NCT01144377|11632030|FG002|STARTED|12 Week Safety Follow-up Period||25
10482860|NCT01144377|11632031|FG003|STARTED|12 Week Safety Follow-up Period||22
10482861|NCT01144377|11632032|FG004|STARTED|12 Week Safety Follow-up Period||34
10482862|NCT01144377|11632028|FG000|COMPLETED|12 Week Safety Follow-up Period|Of the 26 participants who completed this Period, 22 continued to the Optional 40 Week follow-up.|26
10482863|NCT01144377|11632029|FG001|COMPLETED|12 Week Safety Follow-up Period|Of the 29 participants who completed this Period, 25 continued to the Optional 40 Week follow-up.|29
10482864|NCT01144377|11632030|FG002|COMPLETED|12 Week Safety Follow-up Period|Of the 25 participants who completed this Period, 23 continued to the Optional 40 Week follow-up.|25
10482865|NCT01144377|11632031|FG003|COMPLETED|12 Week Safety Follow-up Period|Of the 22 participants who completed this Period, 3 continued to the Optional 40 Week follow-up.|22
10482866|NCT01144377|11632032|FG004|COMPLETED|12 Week Safety Follow-up Period|Of the 34 participants who completed this Period, 23 continued to the Optional 40 Week follow-up.|34
10482867|NCT01144377|11632028|FG000|NOT COMPLETED|12 Week Safety Follow-up Period||0
10482868|NCT01144377|11632029|FG001|NOT COMPLETED|12 Week Safety Follow-up Period||0
10482869|NCT01144377|11632030|FG002|NOT COMPLETED|12 Week Safety Follow-up Period||0
10482870|NCT01144377|11632031|FG003|NOT COMPLETED|12 Week Safety Follow-up Period||0
10482871|NCT01144377|11632032|FG004|NOT COMPLETED|12 Week Safety Follow-up Period||0
10482872|NCT01144377|11632028|FG000|STARTED|Optional 40 Week Safety Follow-up Period||22
10482873|NCT01144377|11632029|FG001|STARTED|Optional 40 Week Safety Follow-up Period||25
10482874|NCT01144377|11632030|FG002|STARTED|Optional 40 Week Safety Follow-up Period||23
10482875|NCT01144377|11632031|FG003|STARTED|Optional 40 Week Safety Follow-up Period||3
10482876|NCT01144377|11632032|FG004|STARTED|Optional 40 Week Safety Follow-up Period||23
10482877|NCT01144377|11632028|FG000|COMPLETED|Optional 40 Week Safety Follow-up Period||21
10482878|NCT01144377|11632029|FG001|COMPLETED|Optional 40 Week Safety Follow-up Period||24
10482879|NCT01144377|11632030|FG002|COMPLETED|Optional 40 Week Safety Follow-up Period||23
10482880|NCT01144377|11632031|FG003|COMPLETED|Optional 40 Week Safety Follow-up Period||3
10649890|NCT02164539|11810004|FG001|STARTED|Treatment Phase C (1 Week)||0
10649891|NCT02164539|11810005|FG002|STARTED|Treatment Phase C (1 Week)||0
10649892|NCT02164539|11810006|FG003|STARTED|Treatment Phase C (1 Week)||0
10649893|NCT02164539|11810007|FG004|STARTED|Treatment Phase C (1 Week)||84
10649894|NCT02164539|11810008|FG005|STARTED|Treatment Phase C (1 Week)||82
10649895|NCT02164539|11810009|FG006|STARTED|Treatment Phase C (1 Week)||80
10649896|NCT02164539|11810003|FG000|COMPLETED|Treatment Phase C (1 Week)||78
10482881|NCT01144377|11632032|FG004|COMPLETED|Optional 40 Week Safety Follow-up Period||21
10482882|NCT01144377|11632028|FG000|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||1
10482883|NCT01144377|11632029|FG001|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||1
10482884|NCT01144377|11632030|FG002|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||0
10482885|NCT01144377|11632031|FG003|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||0
10482886|NCT01144377|11632032|FG004|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||2
10482887|NCT01144403|11632046|FG000|STARTED|Overall Study||8
10482888|NCT01144403|11632046|FG000|COMPLETED|Overall Study||3
10482889|NCT01144403|11632046|FG000|NOT COMPLETED|Overall Study||5
10482890|NCT01144442|11632051|FG000|STARTED|Overall Study||10
10482891|NCT01144442|11632051|FG000|COMPLETED|Overall Study||10
10482892|NCT01144442|11632051|FG000|NOT COMPLETED|Overall Study||0
10482893|NCT01144455|11632058|FG000|STARTED|Overall Study||69
10482894|NCT01144455|11632059|FG001|STARTED|Overall Study||71
10482895|NCT01144455|11632060|FG002|STARTED|Overall Study||74
10482896|NCT01144455|11632058|FG000|COMPLETED|Overall Study||19
10482897|NCT01144455|11632059|FG001|COMPLETED|Overall Study||29
10482898|NCT01144455|11632060|FG002|COMPLETED|Overall Study||38
10482899|NCT01144455|11632058|FG000|NOT COMPLETED|Overall Study||50
10482900|NCT01144455|11632059|FG001|NOT COMPLETED|Overall Study||42
10482901|NCT01144455|11632060|FG002|NOT COMPLETED|Overall Study||36
10482902|NCT01144494|11632068|FG000|STARTED|Overall Study||15
10482903|NCT01144494|11632069|FG001|STARTED|Overall Study||18
10482904|NCT01144494|11632068|FG000|COMPLETED|Overall Study||15
10482905|NCT01144494|11632069|FG001|COMPLETED|Overall Study||14
10482906|NCT01144494|11632068|FG000|NOT COMPLETED|Overall Study||0
10482907|NCT01144494|11632069|FG001|NOT COMPLETED|Overall Study||4
10482908|NCT01144598|11632080|FG000|STARTED|Overall Study||356
10482909|NCT01144598|11632080|FG000|Analysis Population|Overall Study||356
10482910|NCT01144598|11632080|FG000|COMPLETED|Overall Study||356
10482911|NCT01144598|11632080|FG000|NOT COMPLETED|Overall Study||0
10482912|NCT01144624|11632087|FG000|STARTED|Overall Study||7
10482913|NCT01144624|11632088|FG001|STARTED|Overall Study||7
10482914|NCT01144624|11632089|FG002|STARTED|Overall Study||6
10482915|NCT01144624|11632087|FG000|Received Treatment|Overall Study||7
10482916|NCT01144624|11632088|FG001|Received Treatment|Overall Study||7
10482917|NCT01144624|11632089|FG002|Received Treatment|Overall Study||6
10482918|NCT01144624|11632087|FG000|Completed Treatment|Overall Study|One patient died after completing the full course of study treatment.|7
10482919|NCT01144624|11632088|FG001|Completed Treatment|Overall Study||7
10482920|NCT01144624|11632089|FG002|Completed Treatment|Overall Study|Two patients died during the dosing period. Death was not a reason for treatment discontinuation.|6
10482921|NCT01144624|11632087|FG000|COMPLETED|Overall Study|One patient died during the study. Death was not a reason for treatment or study discontinuation.|7
10482922|NCT01144624|11632088|FG001|COMPLETED|Overall Study||7
10482923|NCT01144624|11632089|FG002|COMPLETED|Overall Study|Two patients died during the study. Death was not a reason for treatment or study discontinuation.|6
10482924|NCT01144624|11632087|FG000|NOT COMPLETED|Overall Study||0
10482925|NCT01144624|11632088|FG001|NOT COMPLETED|Overall Study||0
10482926|NCT01144624|11632089|FG002|NOT COMPLETED|Overall Study||0
10482927|NCT01144637|11632101|FG000|STARTED|Overall Study||999
10482928|NCT01144637|11632102|FG001|STARTED|Overall Study||1005
10482929|NCT01144637|11632103|FG002|STARTED|Overall Study||999
10482930|NCT01144637|11632104|FG003|STARTED|Overall Study||1002
10482931|NCT01144637|11632101|FG000|COMPLETED|Overall Study||925
10482932|NCT01144637|11632102|FG001|COMPLETED|Overall Study||929
10482933|NCT01144637|11632103|FG002|COMPLETED|Overall Study||939
10482934|NCT01144637|11632104|FG003|COMPLETED|Overall Study||946
10482935|NCT01144637|11632101|FG000|NOT COMPLETED|Overall Study||74
10482936|NCT01144637|11632102|FG001|NOT COMPLETED|Overall Study||76
10482937|NCT01144637|11632103|FG002|NOT COMPLETED|Overall Study||60
10482938|NCT01144637|11632104|FG003|NOT COMPLETED|Overall Study||56
10482939|NCT01144663|11632118|FG000|STARTED|Primary Vaccination Phase||528
10482940|NCT01144663|11632119|FG001|STARTED|Primary Vaccination Phase||524
10482941|NCT01144663|11632120|FG002|STARTED|Primary Vaccination Phase||516
10482942|NCT01144663|11632121|FG003|STARTED|Primary Vaccination Phase||527
10482943|NCT01144663|11632118|FG000|COMPLETED|Primary Vaccination Phase||508
10482944|NCT01144663|11632119|FG001|COMPLETED|Primary Vaccination Phase||517
10482945|NCT01144663|11632120|FG002|COMPLETED|Primary Vaccination Phase||508
10482946|NCT01144663|11632121|FG003|COMPLETED|Primary Vaccination Phase||509
10482947|NCT01144663|11632118|FG000|NOT COMPLETED|Primary Vaccination Phase||20
10482948|NCT01144663|11632119|FG001|NOT COMPLETED|Primary Vaccination Phase||7
10482949|NCT01144663|11632120|FG002|NOT COMPLETED|Primary Vaccination Phase||8
10482950|NCT01144663|11632121|FG003|NOT COMPLETED|Primary Vaccination Phase||18
10482951|NCT01144663|11632118|FG000|STARTED|Booster Vaccination Phase||497
10482952|NCT01144663|11632119|FG001|STARTED|Booster Vaccination Phase||511
10482953|NCT01144663|11632120|FG002|STARTED|Booster Vaccination Phase||503
10482954|NCT01144663|11632121|FG003|STARTED|Booster Vaccination Phase||506
10482955|NCT01144663|11632118|FG000|COMPLETED|Booster Vaccination Phase||494
10482956|NCT01144663|11632119|FG001|COMPLETED|Booster Vaccination Phase||509
10482957|NCT01144663|11632120|FG002|COMPLETED|Booster Vaccination Phase||498
10482958|NCT01144663|11632121|FG003|COMPLETED|Booster Vaccination Phase||505
10482959|NCT01144663|11632118|FG000|NOT COMPLETED|Booster Vaccination Phase||3
10482960|NCT01144663|11632119|FG001|NOT COMPLETED|Booster Vaccination Phase||2
10482961|NCT01144663|11632120|FG002|NOT COMPLETED|Booster Vaccination Phase||5
10482962|NCT01144663|11632121|FG003|NOT COMPLETED|Booster Vaccination Phase||1
10482963|NCT01144663|11632118|FG000|STARTED|Extended Safety Follow-Up (ESFU)||497
10482964|NCT01144663|11632119|FG001|STARTED|Extended Safety Follow-Up (ESFU)||511
10482965|NCT01144663|11632120|FG002|STARTED|Extended Safety Follow-Up (ESFU)||503
10482966|NCT01144663|11632121|FG003|STARTED|Extended Safety Follow-Up (ESFU)||506
10482967|NCT01144663|11632118|FG000|COMPLETED|Extended Safety Follow-Up (ESFU)||492
10482968|NCT01144663|11632119|FG001|COMPLETED|Extended Safety Follow-Up (ESFU)||502
10482969|NCT01144663|11632120|FG002|COMPLETED|Extended Safety Follow-Up (ESFU)||496
10482970|NCT01144663|11632121|FG003|COMPLETED|Extended Safety Follow-Up (ESFU)||505
10482971|NCT01144663|11632118|FG000|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||5
10482972|NCT01144663|11632119|FG001|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||9
10482973|NCT01144663|11632120|FG002|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||7
10482974|NCT01144663|11632121|FG003|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||1
10482975|NCT01144715|11632133|FG000|STARTED|Overall Study||51
10482976|NCT01144715|11632134|FG001|STARTED|Overall Study||48
10482977|NCT01144715|11632133|FG000|COMPLETED|Overall Study||47
10482978|NCT01144715|11632134|FG001|COMPLETED|Overall Study||45
10482979|NCT01144715|11632133|FG000|NOT COMPLETED|Overall Study||4
10482980|NCT01144715|11632134|FG001|NOT COMPLETED|Overall Study||3
10482981|NCT01144949|11632142|FG000|STARTED|Overall Study||119
10482982|NCT01144949|11632143|FG001|STARTED|Overall Study||120
10482983|NCT01144949|11632142|FG000|COMPLETED|Overall Study||108
10482984|NCT01144949|11632143|FG001|COMPLETED|Overall Study||106
10482985|NCT01144949|11632142|FG000|NOT COMPLETED|Overall Study||11
10482986|NCT01144949|11632143|FG001|NOT COMPLETED|Overall Study||14
10482987|NCT01145001|11632153|FG000|STARTED|Overall Study||36
10482988|NCT01145001|11632154|FG001|STARTED|Overall Study||37
10482989|NCT01145001|11632155|FG002|STARTED|Overall Study||44
10482990|NCT01145001|11632156|FG003|STARTED|Overall Study||37
10482991|NCT01145001|11632153|FG000|COMPLETED|Overall Study||28
10482992|NCT01145001|11632154|FG001|COMPLETED|Overall Study||31
10482993|NCT01145001|11632155|FG002|COMPLETED|Overall Study||39
10482994|NCT01145001|11632156|FG003|COMPLETED|Overall Study||31
10482995|NCT01145001|11632153|FG000|NOT COMPLETED|Overall Study||8
10482996|NCT01145001|11632154|FG001|NOT COMPLETED|Overall Study||6
10482997|NCT01145001|11632155|FG002|NOT COMPLETED|Overall Study||5
10482998|NCT01145001|11632156|FG003|NOT COMPLETED|Overall Study||6
10527334|NCT01389258|11679420|FG000|COMPLETED|Overall Study||40
10527335|NCT01389258|11679420|FG000|NOT COMPLETED|Overall Study||5
10527336|NCT01389284|11679427|FG000|STARTED|Overall Study||120
10527337|NCT01389284|11679428|FG001|STARTED|Overall Study||120
10527338|NCT01389284|11679429|FG002|STARTED|Overall Study||60
10527339|NCT01389284|11679427|FG000|COMPLETED|Overall Study||120
10527340|NCT01389284|11679428|FG001|COMPLETED|Overall Study||120
10527341|NCT01389284|11679429|FG002|COMPLETED|Overall Study||60
10527342|NCT01389284|11679427|FG000|NOT COMPLETED|Overall Study||0
10527343|NCT01389284|11679428|FG001|NOT COMPLETED|Overall Study||0
10527344|NCT01389284|11679429|FG002|NOT COMPLETED|Overall Study||0
10527345|NCT01389323|11679437|FG000|STARTED|Treatment Period (up to 48 Weeks)||246
10527346|NCT01389323|11679437|FG000|COMPLETED|Treatment Period (up to 48 Weeks)||151
10527347|NCT01389323|11679437|FG000|NOT COMPLETED|Treatment Period (up to 48 Weeks)||95
10527348|NCT01389323|11679437|FG000|STARTED|Follow-up Period (up to 48 Weeks)|Out of 246 participants who entered the treatment period, 221 continued in the follow-up period.|221
10527349|NCT01389323|11679437|FG000|COMPLETED|Follow-up Period (up to 48 Weeks)||184
10527350|NCT01389323|11679437|FG000|NOT COMPLETED|Follow-up Period (up to 48 Weeks)||37
10527351|NCT01389596|11679451|FG000|STARTED|Overall Study||104
10527352|NCT01389596|11679452|FG001|STARTED|Overall Study||97
10527353|NCT01389596|11679453|FG002|STARTED|Overall Study||94
10527354|NCT01389596|11679451|FG000|COMPLETED|Overall Study||94
10527355|NCT01389596|11679452|FG001|COMPLETED|Overall Study||81
10527356|NCT01389596|11679453|FG002|COMPLETED|Overall Study||84
10527357|NCT01389596|11679451|FG000|NOT COMPLETED|Overall Study||10
10527358|NCT01389596|11679452|FG001|NOT COMPLETED|Overall Study||16
10527359|NCT01389596|11679453|FG002|NOT COMPLETED|Overall Study||10
10527360|NCT01389752|11679461|FG000|STARTED|Study Period 1||11
10527361|NCT01389752|11679462|FG001|STARTED|Study Period 1||11
10527362|NCT01389752|11679461|FG000|COMPLETED|Study Period 1||11
10709706|NCT02642614|11874764|FG000|STARTED|Overall Study||30
10709707|NCT02642614|11874765|FG001|STARTED|Overall Study||30
10709708|NCT02642614|11874766|FG002|STARTED|Overall Study||30
10527363|NCT01389752|11679462|FG001|COMPLETED|Study Period 1||9
10527364|NCT01389752|11679461|FG000|NOT COMPLETED|Study Period 1||0
10527365|NCT01389752|11679462|FG001|NOT COMPLETED|Study Period 1||2
10527366|NCT01389752|11679461|FG000|STARTED|Study Period 2||11
10527367|NCT01389752|11679462|FG001|STARTED|Study Period 2||9
10527368|NCT01389752|11679461|FG000|COMPLETED|Study Period 2||10
10709709|NCT02642614|11874767|FG003|STARTED|Overall Study||30
10709710|NCT02642614|11874764|FG000|COMPLETED|Overall Study||27
10709711|NCT02642614|11874765|FG001|COMPLETED|Overall Study||28
10709712|NCT02642614|11874766|FG002|COMPLETED|Overall Study||28
10527369|NCT01389752|11679462|FG001|COMPLETED|Study Period 2||9
10527370|NCT01389752|11679461|FG000|NOT COMPLETED|Study Period 2||1
10527371|NCT01389752|11679462|FG001|NOT COMPLETED|Study Period 2||0
10527372|NCT01389765|11679469|FG000|STARTED|First Intervention (Day 1)||12
10527373|NCT01389765|11679470|FG001|STARTED|First Intervention (Day 1)||12
10709713|NCT02642614|11874767|FG003|COMPLETED|Overall Study||28
10527374|NCT01389765|11679469|FG000|COMPLETED|First Intervention (Day 1)||12
10527375|NCT01389765|11679470|FG001|COMPLETED|First Intervention (Day 1)||12
10527376|NCT01389765|11679469|FG000|NOT COMPLETED|First Intervention (Day 1)||0
10527377|NCT01389765|11679470|FG001|NOT COMPLETED|First Intervention (Day 1)||0
10709714|NCT02642614|11874764|FG000|NOT COMPLETED|Overall Study||3
10527378|NCT01389765|11679469|FG000|STARTED|Washout Period (7 Days)||12
10527379|NCT01389765|11679470|FG001|STARTED|Washout Period (7 Days)||12
10527380|NCT01389765|11679469|FG000|COMPLETED|Washout Period (7 Days)||12
10527381|NCT01389765|11679470|FG001|COMPLETED|Washout Period (7 Days)||12
10527382|NCT01389765|11679469|FG000|NOT COMPLETED|Washout Period (7 Days)||0
10527383|NCT01389765|11679470|FG001|NOT COMPLETED|Washout Period (7 Days)||0
10527384|NCT01389765|11679469|FG000|STARTED|Second Intervention (Day 1)||12
10527385|NCT01389765|11679470|FG001|STARTED|Second Intervention (Day 1)||12
10709715|NCT02642614|11874765|FG001|NOT COMPLETED|Overall Study||2
10482999|NCT01145053|11632166|FG000|STARTED|Overall Study||341
10483000|NCT01145053|11632166|FG000|COMPLETED|Overall Study||248
10483001|NCT01145053|11632166|FG000|NOT COMPLETED|Overall Study||93
10483002|NCT01145066|11632173|FG000|STARTED|Overall Study||26
10483003|NCT01145066|11632174|FG001|STARTED|Overall Study||20
10483004|NCT01145066|11632175|FG002|STARTED|Overall Study||25
10483005|NCT01145066|11632173|FG000|COMPLETED|Overall Study||22
10483006|NCT01145066|11632174|FG001|COMPLETED|Overall Study||16
10483007|NCT01145066|11632175|FG002|COMPLETED|Overall Study||21
10483008|NCT01145066|11632173|FG000|NOT COMPLETED|Overall Study||4
10483009|NCT01145066|11632174|FG001|NOT COMPLETED|Overall Study||4
10483010|NCT01145066|11632175|FG002|NOT COMPLETED|Overall Study||4
10483011|NCT01145183|11632187|FG000|STARTED|Overall Study||21
10483012|NCT01145183|11632188|FG001|STARTED|Overall Study||26
10483013|NCT01145183|11632189|FG002|STARTED|Overall Study||19
10483014|NCT01145183|11632190|FG003|STARTED|Overall Study||10
10483015|NCT01145183|11632187|FG000|COMPLETED|Overall Study||21
10483016|NCT01145183|11632188|FG001|COMPLETED|Overall Study||26
10483017|NCT01145183|11632189|FG002|COMPLETED|Overall Study||19
10483018|NCT01145183|11632190|FG003|COMPLETED|Overall Study||10
10483019|NCT01145183|11632187|FG000|NOT COMPLETED|Overall Study||0
10483020|NCT01145183|11632188|FG001|NOT COMPLETED|Overall Study||0
10483021|NCT01145183|11632189|FG002|NOT COMPLETED|Overall Study||0
10483022|NCT01145183|11632190|FG003|NOT COMPLETED|Overall Study||0
10483023|NCT01145222|11632204|FG000|STARTED|Overall Study||40
10483024|NCT01145222|11632205|FG001|STARTED|Overall Study||40
10483025|NCT01145222|11632206|FG002|STARTED|Overall Study||41
10483026|NCT01145222|11632207|FG003|STARTED|Overall Study||41
10483027|NCT01145222|11632204|FG000|Safety Population|Overall Study||40
10483028|NCT01145222|11632205|FG001|Safety Population|Overall Study||40
10483029|NCT01145222|11632206|FG002|Safety Population|Overall Study||40
10483030|NCT01145222|11632207|FG003|Safety Population|Overall Study||41
10483031|NCT01145222|11632204|FG000|Intention to Treat (ITT) Population|Overall Study||40
10483032|NCT01145222|11632205|FG001|Intention to Treat (ITT) Population|Overall Study||40
10483033|NCT01145222|11632206|FG002|Intention to Treat (ITT) Population|Overall Study||40
10483034|NCT01145222|11632207|FG003|Intention to Treat (ITT) Population|Overall Study||40
10483035|NCT01145222|11632204|FG000|COMPLETED|Overall Study||40
10483036|NCT01145222|11632205|FG001|COMPLETED|Overall Study||40
10483037|NCT01145222|11632206|FG002|COMPLETED|Overall Study||40
10483038|NCT01145222|11632207|FG003|COMPLETED|Overall Study||40
10483039|NCT01145222|11632204|FG000|NOT COMPLETED|Overall Study||0
10483040|NCT01145222|11632205|FG001|NOT COMPLETED|Overall Study||0
10483041|NCT01145222|11632206|FG002|NOT COMPLETED|Overall Study||1
10483042|NCT01145222|11632207|FG003|NOT COMPLETED|Overall Study||1
10483043|NCT01145352|11632217|FG000|STARTED|Overall Study||113
10483044|NCT01145352|11632217|FG000|COMPLETED|Overall Study||102
10483045|NCT01145352|11632217|FG000|NOT COMPLETED|Overall Study||11
10483046|NCT01145391|11632223|FG000|STARTED|Overall Study||293
10483047|NCT01145391|11632224|FG001|STARTED|Overall Study||298
10483048|NCT01145391|11632223|FG000|9 Months Post-randomization|Overall Study||293
10483049|NCT01145391|11632224|FG001|9 Months Post-randomization|Overall Study||298
10483050|NCT01145391|11632223|FG000|COMPLETED|Overall Study||293
10483051|NCT01145391|11632224|FG001|COMPLETED|Overall Study||298
10483052|NCT01145391|11632223|FG000|NOT COMPLETED|Overall Study||0
10483053|NCT01145391|11632224|FG001|NOT COMPLETED|Overall Study||0
10483054|NCT01145417|11632234|FG000|STARTED|Overall Study||108
10483055|NCT01145417|11632235|FG001|STARTED|Overall Study||109
10483056|NCT01145417|11632234|FG000|COMPLETED|Overall Study||67
10483057|NCT01145417|11632235|FG001|COMPLETED|Overall Study||62
10483058|NCT01145417|11632234|FG000|NOT COMPLETED|Overall Study||41
10483059|NCT01145417|11632235|FG001|NOT COMPLETED|Overall Study||47
10483060|NCT01145482|11632243|FG000|STARTED|First Intervention (1 Day)||6
10483061|NCT01145482|11632244|FG001|STARTED|First Intervention (1 Day)||6
10483062|NCT01145482|11632243|FG000|COMPLETED|First Intervention (1 Day)||6
10483063|NCT01145482|11632244|FG001|COMPLETED|First Intervention (1 Day)||5
10483064|NCT01145482|11632243|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10483065|NCT01145482|11632244|FG001|NOT COMPLETED|First Intervention (1 Day)||1
10483066|NCT01145482|11632243|FG000|STARTED|Second Intervention (1 Day)||5
10483067|NCT01145482|11632244|FG001|STARTED|Second Intervention (1 Day)||6
10483068|NCT01145482|11632243|FG000|COMPLETED|Second Intervention (1 Day)||5
10709716|NCT02642614|11874766|FG002|NOT COMPLETED|Overall Study||2
10483069|NCT01145482|11632244|FG001|COMPLETED|Second Intervention (1 Day)||6
10483070|NCT01145482|11632243|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10483071|NCT01145482|11632244|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10483072|NCT01145508|11632252|FG000|STARTED|Overall Study||7
10483073|NCT01145508|11632253|FG001|STARTED|Overall Study||3
10483074|NCT01145508|11632252|FG000|Treated|Overall Study||6
10483075|NCT01145508|11632253|FG001|Treated|Overall Study||2
10483076|NCT01145508|11632252|FG000|COMPLETED|Overall Study||2
10483077|NCT01145508|11632253|FG001|COMPLETED|Overall Study||1
10483078|NCT01145508|11632252|FG000|NOT COMPLETED|Overall Study||5
10483079|NCT01145508|11632253|FG001|NOT COMPLETED|Overall Study||2
10483080|NCT01145547|11632259|FG000|STARTED|Overall Study||4
10483081|NCT01145547|11632260|FG001|STARTED|Overall Study||3
10483082|NCT01145547|11632259|FG000|COMPLETED|Overall Study||4
10483083|NCT01145547|11632260|FG001|COMPLETED|Overall Study||3
10483084|NCT01145547|11632259|FG000|NOT COMPLETED|Overall Study||0
10483085|NCT01145547|11632260|FG001|NOT COMPLETED|Overall Study||0
10483086|NCT01145560|11632269|FG000|STARTED|Overall Study||100
10483087|NCT01145560|11632270|FG001|STARTED|Overall Study||100
10483088|NCT01145560|11632271|FG002|STARTED|Overall Study||100
10483089|NCT01145560|11632269|FG000|Received Treatment|Overall Study||99
10483090|NCT01145560|11632270|FG001|Received Treatment|Overall Study||98
10483091|NCT01145560|11632271|FG002|Received Treatment|Overall Study||99
10483092|NCT01145560|11632269|FG000|Completed Treatment|Overall Study|9 patients died during the treatment period without completing the full course of treatment.|69
10483093|NCT01145560|11632270|FG001|Completed Treatment|Overall Study|8 patients died during the treatment period without completing the full course of treatment.|85
10483094|NCT01145560|11632271|FG002|Completed Treatment|Overall Study|7 patients died during the treatment period without completing the full course of treatment.|78
10483095|NCT01145560|11632269|FG000|COMPLETED|Overall Study|20 patients died during the study. Death was not a reason for treatment or study discontinuation.|96
10483096|NCT01145560|11632270|FG001|COMPLETED|Overall Study|33 patients died during the study. Death was not a reason for treatment or study discontinuation.|96
10483097|NCT01145560|11632271|FG002|COMPLETED|Overall Study|27 patients died during the study. Death was not a reason for treatment or study discontinuation.|98
10483098|NCT01145560|11632269|FG000|NOT COMPLETED|Overall Study||4
10483099|NCT01145560|11632270|FG001|NOT COMPLETED|Overall Study||4
10483100|NCT01145560|11632271|FG002|NOT COMPLETED|Overall Study||2
10483101|NCT01145625|11632281|FG000|STARTED|Overall Study||161
10483102|NCT01145625|11632282|FG001|STARTED|Overall Study||161
10483103|NCT01145625|11632281|FG000|COMPLETED|Overall Study||137
10483104|NCT01145625|11632282|FG001|COMPLETED|Overall Study||130
10483105|NCT01145625|11632281|FG000|NOT COMPLETED|Overall Study||24
10483106|NCT01145625|11632282|FG001|NOT COMPLETED|Overall Study||31
10483107|NCT01145638|11632290|FG000|STARTED|Overall Study||231
10483108|NCT01145638|11632291|FG001|STARTED|Overall Study||119
10483109|NCT01145638|11632290|FG000|COMPLETED|Overall Study||141
10483110|NCT01145638|11632291|FG001|COMPLETED|Overall Study||62
10483111|NCT01145638|11632290|FG000|NOT COMPLETED|Overall Study||90
10483112|NCT01145638|11632291|FG001|NOT COMPLETED|Overall Study||57
10483113|NCT01145755|11632300|FG000|STARTED|Overall Study||40
10483114|NCT01145755|11632301|FG001|STARTED|Overall Study||47
10483115|NCT01145755|11632302|FG002|STARTED|Overall Study||44
10483116|NCT01145755|11632300|FG000|COMPLETED|Overall Study||20
10483117|NCT01145755|11632301|FG001|COMPLETED|Overall Study||19
10483118|NCT01145755|11632302|FG002|COMPLETED|Overall Study||19
10483119|NCT01145755|11632300|FG000|NOT COMPLETED|Overall Study||20
10709717|NCT02642614|11874767|FG003|NOT COMPLETED|Overall Study||2
10709718|NCT02642627|11874780|FG000|STARTED|Overall Study||42
10709719|NCT02642627|11874780|FG000|COMPLETED|Overall Study||39
10709720|NCT02642627|11874780|FG000|NOT COMPLETED|Overall Study||3
10709721|NCT02642653|11874787|FG000|STARTED|Overall Study||14
10709722|NCT02642653|11874788|FG001|STARTED|Overall Study||16
10709723|NCT02642653|11874787|FG000|COMPLETED|Overall Study||12
10709724|NCT02642653|11874788|FG001|COMPLETED|Overall Study||16
10709725|NCT02642653|11874787|FG000|NOT COMPLETED|Overall Study||2
10709726|NCT02642653|11874788|FG001|NOT COMPLETED|Overall Study||0
10709727|NCT02642679|11874794|FG000|STARTED|Overall Study||19
10709728|NCT02642679|11874794|FG000|COMPLETED|Overall Study||16
10709729|NCT02642679|11874794|FG000|NOT COMPLETED|Overall Study||3
10709730|NCT02642835|11874798|FG000|STARTED|Overall Study||48
10709731|NCT02642835|11874798|FG000|COMPLETED|Overall Study||48
10709732|NCT02642835|11874798|FG000|NOT COMPLETED|Overall Study||0
10709733|NCT02642952|11874804|FG000|STARTED|Overall Study||21
10709734|NCT02642952|11874805|FG001|STARTED|Overall Study||30
10709735|NCT02642952|11874804|FG000|COMPLETED|Overall Study||19
10709736|NCT02642952|11874805|FG001|COMPLETED|Overall Study||25
10709737|NCT02642952|11874804|FG000|NOT COMPLETED|Overall Study||2
10709738|NCT02642952|11874805|FG001|NOT COMPLETED|Overall Study||5
10709739|NCT02642991|11874811|FG000|STARTED|First Intervention||22
10709740|NCT02642991|11874812|FG001|STARTED|First Intervention||22
10483120|NCT01145755|11632301|FG001|NOT COMPLETED|Overall Study||28
10483121|NCT01145755|11632302|FG002|NOT COMPLETED|Overall Study||25
10483122|NCT01145833|11632312|FG000|STARTED|Overall Study||25
10483123|NCT01145833|11632313|FG001|STARTED|Overall Study||25
10483124|NCT01145833|11632312|FG000|COMPLETED|Overall Study||22
10483125|NCT01145833|11632313|FG001|COMPLETED|Overall Study||25
10483126|NCT01145833|11632312|FG000|NOT COMPLETED|Overall Study||3
10483127|NCT01145833|11632313|FG001|NOT COMPLETED|Overall Study||0
10483128|NCT01145885|11632319|FG000|STARTED|Overall Study||7
10483129|NCT01145885|11632319|FG000|COMPLETED|Overall Study||0
10483130|NCT01145885|11632319|FG000|NOT COMPLETED|Overall Study||7
10483131|NCT01145898|11632331|FG000|STARTED|6-month Treatment||12
10483132|NCT01145898|11632332|FG001|STARTED|6-month Treatment||44
10483133|NCT01145898|11632331|FG000|COMPLETED|6-month Treatment||12
10709741|NCT02642991|11874811|FG000|COMPLETED|First Intervention||22
10709742|NCT02642991|11874812|FG001|COMPLETED|First Intervention||22
10709743|NCT02642991|11874811|FG000|NOT COMPLETED|First Intervention||0
10709744|NCT02642991|11874812|FG001|NOT COMPLETED|First Intervention||0
10709745|NCT02642991|11874811|FG000|STARTED|Second Intervention||22
10709746|NCT02642991|11874812|FG001|STARTED|Second Intervention||22
10709747|NCT02642991|11874811|FG000|COMPLETED|Second Intervention||22
10483134|NCT01145898|11632332|FG001|COMPLETED|6-month Treatment||44
10483135|NCT01145898|11632331|FG000|NOT COMPLETED|6-month Treatment||0
10483136|NCT01145898|11632332|FG001|NOT COMPLETED|6-month Treatment||0
10483137|NCT01145898|11632331|FG000|STARTED|3-year Treatment||12
10483138|NCT01145898|11632332|FG001|STARTED|3-year Treatment||44
10483139|NCT01145898|11632331|FG000|COMPLETED|3-year Treatment||9
10483140|NCT01145898|11632332|FG001|COMPLETED|3-year Treatment||28
10483141|NCT01145898|11632331|FG000|NOT COMPLETED|3-year Treatment||3
10483142|NCT01145898|11632332|FG001|NOT COMPLETED|3-year Treatment||16
10483143|NCT01146054|11632337|FG000|STARTED|Overall Study||59
10483144|NCT01146054|11632337|FG000|COMPLETED|Overall Study||49
10483145|NCT01146054|11632337|FG000|NOT COMPLETED|Overall Study||10
10483149|NCT01146288|11632348|FG000|STARTED|First Intervention(1 Day)||7
10483150|NCT01146288|11632349|FG001|STARTED|First Intervention(1 Day)||6
10483151|NCT01146288|11632348|FG000|COMPLETED|First Intervention(1 Day)||7
10483152|NCT01146288|11632349|FG001|COMPLETED|First Intervention(1 Day)||5
10483153|NCT01146288|11632348|FG000|NOT COMPLETED|First Intervention(1 Day)||0
10483154|NCT01146288|11632349|FG001|NOT COMPLETED|First Intervention(1 Day)||1
10483155|NCT01146288|11632348|FG000|STARTED|Second Intervention (1 Day)||7
10483156|NCT01146288|11632349|FG001|STARTED|Second Intervention (1 Day)||5
10483157|NCT01146288|11632348|FG000|COMPLETED|Second Intervention (1 Day)||7
10483158|NCT01146288|11632349|FG001|COMPLETED|Second Intervention (1 Day)||5
10483159|NCT01146288|11632348|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10483160|NCT01146288|11632349|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10483161|NCT01146379|11632360|FG000|STARTED|Overall Study||21
10483162|NCT01146379|11632361|FG001|STARTED|Overall Study||22
10483163|NCT01146379|11632362|FG002|STARTED|Overall Study||21
10483164|NCT01146379|11632363|FG003|STARTED|Overall Study||21
10483165|NCT01146379|11632360|FG000|COMPLETED|Overall Study||20
10483166|NCT01146379|11632361|FG001|COMPLETED|Overall Study||21
10483167|NCT01146379|11632362|FG002|COMPLETED|Overall Study||21
10338246|NCT00369122|11475159|FG000|NOT COMPLETED|Overall Study||11
10338247|NCT00369161|11475165|FG000|STARTED|Overall Study|"Started indicates randomized and safety population."|109
10483168|NCT01146379|11632363|FG003|COMPLETED|Overall Study||20
10483169|NCT01146379|11632360|FG000|NOT COMPLETED|Overall Study||1
10483170|NCT01146379|11632361|FG001|NOT COMPLETED|Overall Study||1
10483171|NCT01146379|11632362|FG002|NOT COMPLETED|Overall Study||0
10483172|NCT01146379|11632363|FG003|NOT COMPLETED|Overall Study||1
10483173|NCT01146457|11632378|FG000|STARTED|Overall Study||19
10483174|NCT01146457|11632379|FG001|STARTED|Overall Study||17
10483175|NCT01146457|11632380|FG002|STARTED|Overall Study||21
10483176|NCT01146457|11632381|FG003|STARTED|Overall Study||13
10483177|NCT01146457|11632382|FG004|STARTED|Overall Study||13
10483178|NCT01146457|11632378|FG000|COMPLETED|Overall Study||19
10483179|NCT01146457|11632379|FG001|COMPLETED|Overall Study||17
10483180|NCT01146457|11632380|FG002|COMPLETED|Overall Study||20
10483181|NCT01146457|11632381|FG003|COMPLETED|Overall Study||13
10483182|NCT01146457|11632382|FG004|COMPLETED|Overall Study||13
10483183|NCT01146457|11632378|FG000|NOT COMPLETED|Overall Study||0
10483184|NCT01146457|11632379|FG001|NOT COMPLETED|Overall Study||0
10483185|NCT01146457|11632380|FG002|NOT COMPLETED|Overall Study||1
10483186|NCT01146457|11632381|FG003|NOT COMPLETED|Overall Study||0
10483187|NCT01146457|11632382|FG004|NOT COMPLETED|Overall Study||0
10483188|NCT01146496|11632396|FG000|STARTED|Overall Study||114168
10483189|NCT01146496|11632397|FG001|STARTED|Overall Study||109693
10483190|NCT01146496|11632396|FG000|COMPLETED|Overall Study||114168
10483191|NCT01146496|11632397|FG001|COMPLETED|Overall Study||109693
10483192|NCT01146496|11632396|FG000|NOT COMPLETED|Overall Study||0
10483193|NCT01146496|11632397|FG001|NOT COMPLETED|Overall Study||0
10483194|NCT01146561|11632404|FG000|STARTED|Overall Study||2
10483195|NCT01146561|11632404|FG000|COMPLETED|Overall Study||0
10483196|NCT01146561|11632404|FG000|NOT COMPLETED|Overall Study||2
10483197|NCT01146600|11632410|FG000|STARTED|Period 1 (Weeks 1 & 2)||13
10483198|NCT01146600|11632411|FG001|STARTED|Period 1 (Weeks 1 & 2)||10
10483199|NCT01146600|11632410|FG000|COMPLETED|Period 1 (Weeks 1 & 2)||10
10483200|NCT01146600|11632411|FG001|COMPLETED|Period 1 (Weeks 1 & 2)||10
10483201|NCT01146600|11632410|FG000|NOT COMPLETED|Period 1 (Weeks 1 & 2)||3
10483202|NCT01146600|11632411|FG001|NOT COMPLETED|Period 1 (Weeks 1 & 2)||0
10483203|NCT01146600|11632410|FG000|STARTED|Washout (Week 3)||10
10483204|NCT01146600|11632411|FG001|STARTED|Washout (Week 3)||10
10483205|NCT01146600|11632410|FG000|COMPLETED|Washout (Week 3)||10
10483206|NCT01146600|11632411|FG001|COMPLETED|Washout (Week 3)||10
10483207|NCT01146600|11632410|FG000|NOT COMPLETED|Washout (Week 3)||0
10483208|NCT01146600|11632411|FG001|NOT COMPLETED|Washout (Week 3)||0
10483209|NCT01146600|11632410|FG000|STARTED|Period 2 (Weeks 4 & 5)||10
10483210|NCT01146600|11632411|FG001|STARTED|Period 2 (Weeks 4 & 5)||10
10483211|NCT01146600|11632410|FG000|COMPLETED|Period 2 (Weeks 4 & 5)||10
10483212|NCT01146600|11632411|FG001|COMPLETED|Period 2 (Weeks 4 & 5)||10
10483213|NCT01146600|11632410|FG000|NOT COMPLETED|Period 2 (Weeks 4 & 5)||0
10483214|NCT01146600|11632411|FG001|NOT COMPLETED|Period 2 (Weeks 4 & 5)||0
10483215|NCT01146613|11632420|FG000|STARTED|Overall Study||99
10483216|NCT01146613|11632421|FG001|STARTED|Overall Study||101
10483217|NCT01146613|11632420|FG000|COMPLETED|Overall Study||92
10483218|NCT01146613|11632421|FG001|COMPLETED|Overall Study||89
10483219|NCT01146613|11632420|FG000|NOT COMPLETED|Overall Study||7
10483220|NCT01146613|11632421|FG001|NOT COMPLETED|Overall Study||12
10483221|NCT01146665|11632429|FG000|STARTED|Overall Study||18
10483222|NCT01146665|11632430|FG001|STARTED|Overall Study||26
10483223|NCT01146665|11632429|FG000|1-month Post-ED Discharge (Follow-up)|Overall Study||9
10483224|NCT01146665|11632430|FG001|1-month Post-ED Discharge (Follow-up)|Overall Study||12
10483225|NCT01146665|11632429|FG000|3-month Post-ED Discharge (Follow-up)|Overall Study||8
10483226|NCT01146665|11632430|FG001|3-month Post-ED Discharge (Follow-up)|Overall Study||10
10483227|NCT01146665|11632429|FG000|COMPLETED|Overall Study||8
10483228|NCT01146665|11632430|FG001|COMPLETED|Overall Study||10
10483229|NCT01146665|11632429|FG000|NOT COMPLETED|Overall Study||10
10483230|NCT01146665|11632430|FG001|NOT COMPLETED|Overall Study||16
10483231|NCT01146704|11632447|FG000|STARTED|Overall Study||16
10483232|NCT01146704|11632448|FG001|STARTED|Overall Study||15
10483233|NCT01146704|11632447|FG000|COMPLETED|Overall Study||16
10483234|NCT01146704|11632448|FG001|COMPLETED|Overall Study||15
10483235|NCT01146704|11632447|FG000|NOT COMPLETED|Overall Study||0
10483236|NCT01146704|11632448|FG001|NOT COMPLETED|Overall Study||0
10483237|NCT01146782|11632454|FG000|STARTED|Screening Cohort||367
10483238|NCT01146782|11632454|FG000|COMPLETED|Screening Cohort||146
10483239|NCT01146782|11632454|FG000|NOT COMPLETED|Screening Cohort||221
10483240|NCT01146782|11632454|FG000|STARTED|Safety Cohort||146
10483241|NCT01146782|11632454|FG000|COMPLETED|Safety Cohort||63
10483242|NCT01146782|11632454|FG000|NOT COMPLETED|Safety Cohort||83
10483243|NCT01146782|11632454|FG000|STARTED|Primary Endpoint Cohort|63 Subjects in the Primary Endpoint Cohort|63
10483244|NCT01146782|11632454|FG000|COMPLETED|Primary Endpoint Cohort|57 Subjects in the Primary Endpoint Cohort completed the 28 day study|57
10483245|NCT01146782|11632454|FG000|NOT COMPLETED|Primary Endpoint Cohort||6
10483246|NCT01146795|11632459|FG000|STARTED|Overall Study||32
10483247|NCT01146795|11632459|FG000|COMPLETED|Overall Study||12
10709748|NCT02642991|11874812|FG001|COMPLETED|Second Intervention||22
10709749|NCT02642991|11874811|FG000|NOT COMPLETED|Second Intervention||0
10709750|NCT02642991|11874812|FG001|NOT COMPLETED|Second Intervention||0
10709751|NCT02643004|11874821|FG000|STARTED|First Intervention (One Week)||35
10709752|NCT02643004|11874822|FG001|STARTED|First Intervention (One Week)||35
10709753|NCT02643004|11874821|FG000|COMPLETED|First Intervention (One Week)||35
10709754|NCT02643004|11874822|FG001|COMPLETED|First Intervention (One Week)||35
10709755|NCT02643004|11874821|FG000|NOT COMPLETED|First Intervention (One Week)||0
10709756|NCT02643004|11874822|FG001|NOT COMPLETED|First Intervention (One Week)||0
10709757|NCT02643004|11874821|FG000|STARTED|Second Intervention (One Week)||35
10709758|NCT02643004|11874822|FG001|STARTED|Second Intervention (One Week)||35
10709759|NCT02643004|11874821|FG000|COMPLETED|Second Intervention (One Week)||35
10709760|NCT02643004|11874822|FG001|COMPLETED|Second Intervention (One Week)||35
10483248|NCT01146795|11632459|FG000|NOT COMPLETED|Overall Study||20
10483249|NCT01146808|11632463|FG000|STARTED|Overall Study||16
10483250|NCT01146808|11632463|FG000|COMPLETED|Overall Study||16
10483251|NCT01146808|11632463|FG000|NOT COMPLETED|Overall Study||0
10483252|NCT01146834|11632472|FG000|STARTED|Overall Study||20
10483253|NCT01146834|11632473|FG001|STARTED|Overall Study||4
10483254|NCT01146834|11632474|FG002|STARTED|Overall Study||23
10483255|NCT01146834|11632475|FG003|STARTED|Overall Study||0
10483256|NCT01146834|11632476|FG004|STARTED|Overall Study||0
10483257|NCT01146834|11632472|FG000|COMPLETED|Overall Study||17
10483258|NCT01146834|11632473|FG001|COMPLETED|Overall Study||4
10483259|NCT01146834|11632474|FG002|COMPLETED|Overall Study||21
10483260|NCT01146834|11632475|FG003|COMPLETED|Overall Study||0
10483261|NCT01146834|11632476|FG004|COMPLETED|Overall Study||0
10483262|NCT01146834|11632472|FG000|NOT COMPLETED|Overall Study||3
10483263|NCT01146834|11632473|FG001|NOT COMPLETED|Overall Study||0
10483264|NCT01146834|11632474|FG002|NOT COMPLETED|Overall Study||2
10483265|NCT01146834|11632475|FG003|NOT COMPLETED|Overall Study||0
10483266|NCT01146834|11632476|FG004|NOT COMPLETED|Overall Study||0
10483267|NCT01146860|11632490|FG000|STARTED|Overall Study||194
10483268|NCT01146860|11632491|FG001|STARTED|Overall Study||192
10483269|NCT01146860|11632490|FG000|COMPLETED|Overall Study||194
10483270|NCT01146860|11632491|FG001|COMPLETED|Overall Study||191
10483271|NCT01146860|11632490|FG000|NOT COMPLETED|Overall Study||0
10483272|NCT01146860|11632491|FG001|NOT COMPLETED|Overall Study||1
10483273|NCT01146873|11632499|FG000|STARTED|Overall Study||148
10709761|NCT02643004|11874821|FG000|NOT COMPLETED|Second Intervention (One Week)||0
10709762|NCT02643004|11874822|FG001|NOT COMPLETED|Second Intervention (One Week)||0
10709763|NCT02643082|11874828|FG000|STARTED|Period 1||10
10709764|NCT02643082|11874829|FG001|STARTED|Period 1||10
10709765|NCT02643082|11874828|FG000|COMPLETED|Period 1||9
10709766|NCT02643082|11874829|FG001|COMPLETED|Period 1||10
10709767|NCT02643082|11874828|FG000|NOT COMPLETED|Period 1||1
10483274|NCT01146873|11632500|FG001|STARTED|Overall Study||150
10483275|NCT01146873|11632499|FG000|COMPLETED|Overall Study||148
10483276|NCT01146873|11632500|FG001|COMPLETED|Overall Study||144
10483277|NCT01146873|11632499|FG000|NOT COMPLETED|Overall Study||0
10483278|NCT01146873|11632500|FG001|NOT COMPLETED|Overall Study||6
10483279|NCT01146912|11632513|FG000|STARTED|Overall Study||4607
10483280|NCT01146912|11632514|FG001|STARTED|Overall Study||4606
10483281|NCT01146912|11632515|FG002|STARTED|Overall Study||593
10709768|NCT02643082|11874829|FG001|NOT COMPLETED|Period 1||0
10709769|NCT02643082|11874828|FG000|STARTED|Washout||9
10709770|NCT02643082|11874829|FG001|STARTED|Washout||10
10709771|NCT02643082|11874828|FG000|COMPLETED|Washout||9
10709772|NCT02643082|11874829|FG001|COMPLETED|Washout||10
10483282|NCT01146912|11632516|FG003|STARTED|Overall Study||594
10483283|NCT01146912|11632517|FG004|STARTED|Overall Study||1821
10483284|NCT01146912|11632518|FG005|STARTED|Overall Study||1821
10483285|NCT01146912|11632519|FG006|STARTED|Overall Study||1820
10483286|NCT01146912|11632520|FG007|STARTED|Overall Study||14675
10483287|NCT01146912|11632513|FG000|COMPLETED|Overall Study||3790
10483288|NCT01146912|11632514|FG001|COMPLETED|Overall Study||3784
10483289|NCT01146912|11632515|FG002|COMPLETED|Overall Study||576
10483290|NCT01146912|11632516|FG003|COMPLETED|Overall Study||577
10483291|NCT01146912|11632517|FG004|COMPLETED|Overall Study||1780
10483292|NCT01146912|11632518|FG005|COMPLETED|Overall Study||1760
10483293|NCT01146912|11632519|FG006|COMPLETED|Overall Study||1764
10483294|NCT01146912|11632520|FG007|COMPLETED|Overall Study|Parents are considered subjects but outcomes are on child level|14675
10483295|NCT01146912|11632513|FG000|NOT COMPLETED|Overall Study||817
10483296|NCT01146912|11632514|FG001|NOT COMPLETED|Overall Study||822
10483297|NCT01146912|11632515|FG002|NOT COMPLETED|Overall Study||17
10483298|NCT01146912|11632516|FG003|NOT COMPLETED|Overall Study||17
10483299|NCT01146912|11632517|FG004|NOT COMPLETED|Overall Study||41
10483300|NCT01146912|11632518|FG005|NOT COMPLETED|Overall Study||61
10483301|NCT01146912|11632519|FG006|NOT COMPLETED|Overall Study||56
10483302|NCT01146912|11632520|FG007|NOT COMPLETED|Overall Study||0
10483303|NCT01146951|11632541|FG000|STARTED|Overall Study||29
10483304|NCT01146951|11632542|FG001|STARTED|Overall Study||30
10483305|NCT01146951|11632541|FG000|COMPLETED|Overall Study||25
10483306|NCT01146951|11632542|FG001|COMPLETED|Overall Study||29
10483307|NCT01146951|11632541|FG000|NOT COMPLETED|Overall Study||4
10483308|NCT01146951|11632542|FG001|NOT COMPLETED|Overall Study||1
10483309|NCT01147055|11632548|FG000|STARTED|First Intervention Period||15
10483310|NCT01147055|11632549|FG001|STARTED|First Intervention Period||0
10483311|NCT01147055|11632548|FG000|COMPLETED|First Intervention Period||14
10483312|NCT01147055|11632549|FG001|COMPLETED|First Intervention Period||0
10483313|NCT01147055|11632548|FG000|NOT COMPLETED|First Intervention Period||1
10483314|NCT01147055|11632549|FG001|NOT COMPLETED|First Intervention Period||0
10483315|NCT01147055|11632548|FG000|STARTED|Washout Period (at Least 14 Days)||14
10483316|NCT01147055|11632549|FG001|STARTED|Washout Period (at Least 14 Days)||0
10483317|NCT01147055|11632548|FG000|COMPLETED|Washout Period (at Least 14 Days)||14
10483318|NCT01147055|11632549|FG001|COMPLETED|Washout Period (at Least 14 Days)||0
10483319|NCT01147055|11632548|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10483320|NCT01147055|11632549|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10483321|NCT01147055|11632548|FG000|STARTED|Second Intervention Period||0
10483322|NCT01147055|11632549|FG001|STARTED|Second Intervention Period||14
10483323|NCT01147055|11632548|FG000|COMPLETED|Second Intervention Period||0
10483324|NCT01147055|11632549|FG001|COMPLETED|Second Intervention Period||14
10483325|NCT01147055|11632548|FG000|NOT COMPLETED|Second Intervention Period||0
10483326|NCT01147055|11632549|FG001|NOT COMPLETED|Second Intervention Period||0
10483327|NCT01147068|11632562|FG000|STARTED|Subjects That Received 1st Dose||60
10483328|NCT01147068|11632563|FG001|STARTED|Subjects That Received 1st Dose||57
10483329|NCT01147068|11632564|FG002|STARTED|Subjects That Received 1st Dose||55
10483330|NCT01147068|11632565|FG003|STARTED|Subjects That Received 1st Dose||56
10483331|NCT01147068|11632566|FG004|STARTED|Subjects That Received 1st Dose||56
10483332|NCT01147068|11632567|FG005|STARTED|Subjects That Received 1st Dose||53
10483333|NCT01147068|11632568|FG006|STARTED|Subjects That Received 1st Dose||55
10483334|NCT01147068|11632562|FG000|COMPLETED|Subjects That Received 1st Dose||60
10483335|NCT01147068|11632563|FG001|COMPLETED|Subjects That Received 1st Dose||57
10483336|NCT01147068|11632564|FG002|COMPLETED|Subjects That Received 1st Dose||55
10483337|NCT01147068|11632565|FG003|COMPLETED|Subjects That Received 1st Dose||56
10483338|NCT01147068|11632566|FG004|COMPLETED|Subjects That Received 1st Dose||56
10483339|NCT01147068|11632567|FG005|COMPLETED|Subjects That Received 1st Dose||53
10483340|NCT01147068|11632568|FG006|COMPLETED|Subjects That Received 1st Dose||55
10483341|NCT01147068|11632562|FG000|NOT COMPLETED|Subjects That Received 1st Dose||0
10483342|NCT01147068|11632563|FG001|NOT COMPLETED|Subjects That Received 1st Dose||0
10483343|NCT01147068|11632564|FG002|NOT COMPLETED|Subjects That Received 1st Dose||0
10483344|NCT01147068|11632565|FG003|NOT COMPLETED|Subjects That Received 1st Dose||0
10483345|NCT01147068|11632566|FG004|NOT COMPLETED|Subjects That Received 1st Dose||0
10483346|NCT01147068|11632567|FG005|NOT COMPLETED|Subjects That Received 1st Dose||0
10483347|NCT01147068|11632568|FG006|NOT COMPLETED|Subjects That Received 1st Dose||0
10483348|NCT01147068|11632562|FG000|STARTED|Subjects That Received 2nd Dose||60
10483349|NCT01147068|11632563|FG001|STARTED|Subjects That Received 2nd Dose||57
10483350|NCT01147068|11632564|FG002|STARTED|Subjects That Received 2nd Dose||55
10483351|NCT01147068|11632565|FG003|STARTED|Subjects That Received 2nd Dose||56
10483352|NCT01147068|11632566|FG004|STARTED|Subjects That Received 2nd Dose||56
10483353|NCT01147068|11632567|FG005|STARTED|Subjects That Received 2nd Dose||53
10483354|NCT01147068|11632568|FG006|STARTED|Subjects That Received 2nd Dose||55
10483355|NCT01147068|11632562|FG000|COMPLETED|Subjects That Received 2nd Dose||59
10483356|NCT01147068|11632563|FG001|COMPLETED|Subjects That Received 2nd Dose||52
10483357|NCT01147068|11632564|FG002|COMPLETED|Subjects That Received 2nd Dose||52
10483358|NCT01147068|11632565|FG003|COMPLETED|Subjects That Received 2nd Dose||56
10483359|NCT01147068|11632566|FG004|COMPLETED|Subjects That Received 2nd Dose||55
10483360|NCT01147068|11632567|FG005|COMPLETED|Subjects That Received 2nd Dose||51
10483361|NCT01147068|11632568|FG006|COMPLETED|Subjects That Received 2nd Dose||55
10483362|NCT01147068|11632562|FG000|NOT COMPLETED|Subjects That Received 2nd Dose||1
10483363|NCT01147068|11632563|FG001|NOT COMPLETED|Subjects That Received 2nd Dose||5
10483364|NCT01147068|11632564|FG002|NOT COMPLETED|Subjects That Received 2nd Dose||3
10483365|NCT01147068|11632565|FG003|NOT COMPLETED|Subjects That Received 2nd Dose||0
10483366|NCT01147068|11632566|FG004|NOT COMPLETED|Subjects That Received 2nd Dose||1
10483367|NCT01147068|11632567|FG005|NOT COMPLETED|Subjects That Received 2nd Dose||2
10483368|NCT01147068|11632568|FG006|NOT COMPLETED|Subjects That Received 2nd Dose||0
10483369|NCT01147068|11632562|FG000|STARTED|Subjects That Completed Safety Follow-up|Participants were eligible for follow-up regardless of number of doses received.|60
10483370|NCT01147068|11632563|FG001|STARTED|Subjects That Completed Safety Follow-up|One subject was ineligible, one subject did not complete the study, and the other data is unknown.|57
10483371|NCT01147068|11632564|FG002|STARTED|Subjects That Completed Safety Follow-up|Data on three subjects is unknown.|55
10483372|NCT01147068|11632565|FG003|STARTED|Subjects That Completed Safety Follow-up||56
10483373|NCT01147068|11632566|FG004|STARTED|Subjects That Completed Safety Follow-up|Data for one subject is unknown.|56
10483374|NCT01147068|11632567|FG005|STARTED|Subjects That Completed Safety Follow-up|One subject was lost to follow up and one subject did not complete the study.|53
10483375|NCT01147068|11632568|FG006|STARTED|Subjects That Completed Safety Follow-up||55
10483376|NCT01147068|11632562|FG000|COMPLETED|Subjects That Completed Safety Follow-up||59
10483377|NCT01147068|11632563|FG001|COMPLETED|Subjects That Completed Safety Follow-up||56
10483378|NCT01147068|11632564|FG002|COMPLETED|Subjects That Completed Safety Follow-up||55
10483379|NCT01147068|11632565|FG003|COMPLETED|Subjects That Completed Safety Follow-up||54
10483380|NCT01147068|11632566|FG004|COMPLETED|Subjects That Completed Safety Follow-up||56
10483381|NCT01147068|11632567|FG005|COMPLETED|Subjects That Completed Safety Follow-up||52
10483382|NCT01147068|11632568|FG006|COMPLETED|Subjects That Completed Safety Follow-up||54
10483383|NCT01147068|11632562|FG000|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
10483384|NCT01147068|11632563|FG001|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
10483385|NCT01147068|11632564|FG002|NOT COMPLETED|Subjects That Completed Safety Follow-up||0
10483386|NCT01147068|11632565|FG003|NOT COMPLETED|Subjects That Completed Safety Follow-up||2
10483387|NCT01147068|11632566|FG004|NOT COMPLETED|Subjects That Completed Safety Follow-up||0
10483388|NCT01147068|11632567|FG005|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
10483389|NCT01147068|11632568|FG006|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
10483390|NCT01147107|11632586|FG000|STARTED|Overall Study||39
10483391|NCT01147107|11632587|FG001|STARTED|Overall Study||41
10483392|NCT01147107|11632586|FG000|COMPLETED|Overall Study||33
10483393|NCT01147107|11632587|FG001|COMPLETED|Overall Study||40
10483394|NCT01147107|11632586|FG000|NOT COMPLETED|Overall Study||6
10483395|NCT01147107|11632587|FG001|NOT COMPLETED|Overall Study||1
10483396|NCT01147172|11632593|FG000|STARTED|Overall Study||100
10483397|NCT01147172|11632593|FG000|COMPLETED|Overall Study||96
10483398|NCT01147172|11632593|FG000|NOT COMPLETED|Overall Study||4
10483399|NCT01147250|11632601|FG000|STARTED|Overall Study||3034
10483400|NCT01147250|11632602|FG001|STARTED|Overall Study||3034
10483401|NCT01147250|11632601|FG000|Treated|Overall Study||3032
10483402|NCT01147250|11632602|FG001|Treated|Overall Study||3031
10483403|NCT01147250|11632601|FG000|COMPLETED|Overall Study||2924
10483404|NCT01147250|11632602|FG001|COMPLETED|Overall Study||2929
10483405|NCT01147250|11632601|FG000|NOT COMPLETED|Overall Study||110
10483406|NCT01147250|11632602|FG001|NOT COMPLETED|Overall Study||105
10483407|NCT01147302|11632610|FG000|STARTED|Overall Study||9
10483408|NCT01147302|11632611|FG001|STARTED|Overall Study||9
10483409|NCT01147302|11632610|FG000|COMPLETED|Overall Study||9
10483410|NCT01147302|11632611|FG001|COMPLETED|Overall Study||9
10483411|NCT01147302|11632610|FG000|NOT COMPLETED|Overall Study||0
10483412|NCT01147302|11632611|FG001|NOT COMPLETED|Overall Study||0
10483413|NCT01147341|11632619|FG000|STARTED|Double Blind Period||27
10483414|NCT01147341|11632620|FG001|STARTED|Double Blind Period||10
10483415|NCT01147341|11632619|FG000|COMPLETED|Double Blind Period||26
10483416|NCT01147341|11632620|FG001|COMPLETED|Double Blind Period||8
10483417|NCT01147341|11632619|FG000|NOT COMPLETED|Double Blind Period||1
10483418|NCT01147341|11632620|FG001|NOT COMPLETED|Double Blind Period||2
10483419|NCT01147341|11632619|FG000|STARTED|Open Label Period||26
10483420|NCT01147341|11632620|FG001|STARTED|Open Label Period||8
10483421|NCT01147341|11632619|FG000|COMPLETED|Open Label Period||22
10483422|NCT01147341|11632620|FG001|COMPLETED|Open Label Period||8
10483423|NCT01147341|11632619|FG000|NOT COMPLETED|Open Label Period||4
10483424|NCT01147341|11632620|FG001|NOT COMPLETED|Open Label Period||0
10483425|NCT01147380|11632628|FG000|STARTED|Overall Study||6
10483426|NCT01147380|11632629|FG001|STARTED|Overall Study||12
10483427|NCT01147380|11632628|FG000|COMPLETED|Overall Study||6
10483428|NCT01147380|11632629|FG001|COMPLETED|Overall Study||12
10483429|NCT01147380|11632628|FG000|NOT COMPLETED|Overall Study||0
10483430|NCT01147380|11632629|FG001|NOT COMPLETED|Overall Study||0
10483431|NCT01147406|11632643|FG000|STARTED|Overall Study||6
10483432|NCT01147406|11632644|FG001|STARTED|Overall Study||12
10483433|NCT01147406|11632645|FG002|STARTED|Overall Study||1
10483434|NCT01147406|11632646|FG003|STARTED|Overall Study||6
10483435|NCT01147406|11632647|FG004|STARTED|Overall Study||6
10483436|NCT01147406|11632648|FG005|STARTED|Overall Study||10
10483437|NCT01147406|11632643|FG000|COMPLETED|Overall Study||6
10483438|NCT01147406|11632644|FG001|COMPLETED|Overall Study||12
10483439|NCT01147406|11632645|FG002|COMPLETED|Overall Study||1
10483440|NCT01147406|11632646|FG003|COMPLETED|Overall Study||6
10483441|NCT01147406|11632647|FG004|COMPLETED|Overall Study||6
10483442|NCT01147406|11632648|FG005|COMPLETED|Overall Study||10
10483443|NCT01147406|11632643|FG000|NOT COMPLETED|Overall Study||0
10483444|NCT01147406|11632644|FG001|NOT COMPLETED|Overall Study||0
10483445|NCT01147406|11632645|FG002|NOT COMPLETED|Overall Study||0
10483446|NCT01147406|11632646|FG003|NOT COMPLETED|Overall Study||0
10483447|NCT01147406|11632647|FG004|NOT COMPLETED|Overall Study||0
10483448|NCT01147406|11632648|FG005|NOT COMPLETED|Overall Study||0
10483449|NCT01147458|11632663|FG000|STARTED|First Intervention||48
10483450|NCT01147458|11632664|FG001|STARTED|First Intervention||47
10483451|NCT01147458|11632665|FG002|STARTED|First Intervention||47
10483452|NCT01147458|11632666|FG003|STARTED|First Intervention||48
10483453|NCT01147458|11632663|FG000|COMPLETED|First Intervention||34
10483454|NCT01147458|11632664|FG001|COMPLETED|First Intervention||31
10483455|NCT01147458|11632665|FG002|COMPLETED|First Intervention||35
10483456|NCT01147458|11632666|FG003|COMPLETED|First Intervention||34
10483457|NCT01147458|11632663|FG000|NOT COMPLETED|First Intervention||14
10483458|NCT01147458|11632664|FG001|NOT COMPLETED|First Intervention||16
10483459|NCT01147458|11632665|FG002|NOT COMPLETED|First Intervention||12
10483460|NCT01147458|11632666|FG003|NOT COMPLETED|First Intervention||14
10483461|NCT01147458|11632663|FG000|STARTED|Washout Period of 2 Weeks||34
10483462|NCT01147458|11632664|FG001|STARTED|Washout Period of 2 Weeks||31
10483463|NCT01147458|11632665|FG002|STARTED|Washout Period of 2 Weeks||35
10483464|NCT01147458|11632666|FG003|STARTED|Washout Period of 2 Weeks||34
10483465|NCT01147458|11632663|FG000|COMPLETED|Washout Period of 2 Weeks||34
10483466|NCT01147458|11632664|FG001|COMPLETED|Washout Period of 2 Weeks||31
10483467|NCT01147458|11632665|FG002|COMPLETED|Washout Period of 2 Weeks||35
10483468|NCT01147458|11632666|FG003|COMPLETED|Washout Period of 2 Weeks||34
10483469|NCT01147458|11632663|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
10483470|NCT01147458|11632664|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
10483471|NCT01147458|11632665|FG002|NOT COMPLETED|Washout Period of 2 Weeks||0
10483472|NCT01147458|11632666|FG003|NOT COMPLETED|Washout Period of 2 Weeks||0
10483473|NCT01147458|11632663|FG000|STARTED|Second Intervention||34
10483474|NCT01147458|11632664|FG001|STARTED|Second Intervention||31
10483475|NCT01147458|11632665|FG002|STARTED|Second Intervention||35
10483476|NCT01147458|11632666|FG003|STARTED|Second Intervention||34
10483477|NCT01147458|11632663|FG000|COMPLETED|Second Intervention||25
10483478|NCT01147458|11632664|FG001|COMPLETED|Second Intervention||24
10483479|NCT01147458|11632665|FG002|COMPLETED|Second Intervention||27
10483480|NCT01147458|11632666|FG003|COMPLETED|Second Intervention||30
10483481|NCT01147458|11632663|FG000|NOT COMPLETED|Second Intervention||9
10483482|NCT01147458|11632664|FG001|NOT COMPLETED|Second Intervention||7
10483483|NCT01147458|11632665|FG002|NOT COMPLETED|Second Intervention||8
10483484|NCT01147458|11632666|FG003|NOT COMPLETED|Second Intervention||4
10483485|NCT01147471|11632680|FG000|STARTED|Through Initial Hospital Discharge||13
10483486|NCT01147471|11632681|FG001|STARTED|Through Initial Hospital Discharge||11
10483487|NCT01147471|11632680|FG000|COMPLETED|Through Initial Hospital Discharge||13
10483488|NCT01147471|11632681|FG001|COMPLETED|Through Initial Hospital Discharge||11
10483489|NCT01147471|11632680|FG000|NOT COMPLETED|Through Initial Hospital Discharge||0
10483490|NCT01147471|11632681|FG001|NOT COMPLETED|Through Initial Hospital Discharge||0
10483491|NCT01147471|11632680|FG000|STARTED|Post-discharge Follow Up (Approx 2 Wks)||13
10483492|NCT01147471|11632681|FG001|STARTED|Post-discharge Follow Up (Approx 2 Wks)||11
10483493|NCT01147471|11632680|FG000|COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||13
10483494|NCT01147471|11632681|FG001|COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||8
10483495|NCT01147471|11632680|FG000|NOT COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||0
10483496|NCT01147471|11632681|FG001|NOT COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||3
10483497|NCT01147471|11632680|FG000|STARTED|3 Month Follow Up||13
10483498|NCT01147471|11632681|FG001|STARTED|3 Month Follow Up||8
10483499|NCT01147471|11632680|FG000|COMPLETED|3 Month Follow Up||12
10483500|NCT01147471|11632681|FG001|COMPLETED|3 Month Follow Up||6
10483501|NCT01147471|11632680|FG000|NOT COMPLETED|3 Month Follow Up||1
10483502|NCT01147471|11632681|FG001|NOT COMPLETED|3 Month Follow Up||2
10483503|NCT01147471|11632680|FG000|STARTED|6 Month Follow Up||12
10483504|NCT01147471|11632681|FG001|STARTED|6 Month Follow Up||6
10483505|NCT01147471|11632680|FG000|COMPLETED|6 Month Follow Up||8
10483506|NCT01147471|11632681|FG001|COMPLETED|6 Month Follow Up||4
10483507|NCT01147471|11632680|FG000|NOT COMPLETED|6 Month Follow Up||4
10483508|NCT01147471|11632681|FG001|NOT COMPLETED|6 Month Follow Up||2
10483509|NCT01147497|11632689|FG000|STARTED|Overall Study||37
10483510|NCT01147497|11632690|FG001|STARTED|Overall Study||36
10483511|NCT01147497|11632689|FG000|COMPLETED|Overall Study||35
10483512|NCT01147497|11632690|FG001|COMPLETED|Overall Study||36
10483513|NCT01147497|11632689|FG000|NOT COMPLETED|Overall Study||2
10483514|NCT01147497|11632690|FG001|NOT COMPLETED|Overall Study||0
10483515|NCT01147601|11632698|FG000|STARTED|Overall Study||5
10483516|NCT01147601|11632699|FG001|STARTED|Overall Study||1
10483517|NCT01147601|11632698|FG000|COMPLETED|Overall Study||2
10483518|NCT01147601|11632699|FG001|COMPLETED|Overall Study||1
10483519|NCT01147601|11632698|FG000|NOT COMPLETED|Overall Study||3
10483520|NCT01147601|11632699|FG001|NOT COMPLETED|Overall Study||0
10483521|NCT01147627|11632708|FG000|STARTED|Overall Study||142
10483522|NCT01147627|11632709|FG001|STARTED|Overall Study||138
10483523|NCT01147627|11632710|FG002|STARTED|Overall Study||136
10483524|NCT01147627|11632708|FG000|COMPLETED|Overall Study||110
10483525|NCT01147627|11632709|FG001|COMPLETED|Overall Study||114
10483526|NCT01147627|11632710|FG002|COMPLETED|Overall Study||118
10483527|NCT01147627|11632708|FG000|NOT COMPLETED|Overall Study||32
10483528|NCT01147627|11632709|FG001|NOT COMPLETED|Overall Study||24
10483529|NCT01147627|11632710|FG002|NOT COMPLETED|Overall Study||18
10483530|NCT01147640|11632720|FG000|STARTED|Overall Study||83
10483531|NCT01147640|11632721|FG001|STARTED|Overall Study||39
10483532|NCT01147640|11632720|FG000|COMPLETED|Overall Study||78
10483533|NCT01147640|11632721|FG001|COMPLETED|Overall Study||38
10483534|NCT01147640|11632720|FG000|NOT COMPLETED|Overall Study||5
10483535|NCT01147640|11632721|FG001|NOT COMPLETED|Overall Study||1
10483536|NCT01147744|11632734|FG000|STARTED|Overall Study||100
10483537|NCT01147744|11632735|FG001|STARTED|Overall Study||99
10483538|NCT01147744|11632736|FG002|STARTED|Overall Study||100
10483539|NCT01147744|11632737|FG003|STARTED|Overall Study||100
10483540|NCT01147744|11632738|FG004|STARTED|Overall Study||101
10483541|NCT01147744|11632739|FG005|STARTED|Overall Study||103
10483542|NCT01147744|11632740|FG006|STARTED|Overall Study||97
10483543|NCT01147744|11632734|FG000|COMPLETED|Overall Study||71
10483544|NCT01147744|11632735|FG001|COMPLETED|Overall Study||76
10483545|NCT01147744|11632736|FG002|COMPLETED|Overall Study||82
10483546|NCT01147744|11632737|FG003|COMPLETED|Overall Study||82
10483547|NCT01147744|11632738|FG004|COMPLETED|Overall Study||76
10483548|NCT01147744|11632739|FG005|COMPLETED|Overall Study||83
10483549|NCT01147744|11632740|FG006|COMPLETED|Overall Study||78
10483550|NCT01147744|11632734|FG000|NOT COMPLETED|Overall Study||29
10483551|NCT01147744|11632735|FG001|NOT COMPLETED|Overall Study||23
10483552|NCT01147744|11632736|FG002|NOT COMPLETED|Overall Study||18
10483553|NCT01147744|11632737|FG003|NOT COMPLETED|Overall Study||18
10483554|NCT01147744|11632738|FG004|NOT COMPLETED|Overall Study||25
10483555|NCT01147744|11632739|FG005|NOT COMPLETED|Overall Study||20
10483556|NCT01147744|11632740|FG006|NOT COMPLETED|Overall Study||19
10483557|NCT01147809|11632768|FG000|STARTED|Phase I (168 Days)||3
10483558|NCT01147809|11632769|FG001|STARTED|Phase I (168 Days)||9
10483559|NCT01147809|11632770|FG002|STARTED|Phase I (168 Days)||4
10483560|NCT01147809|11632771|FG003|STARTED|Phase I (168 Days)||10
10483561|NCT01147809|11632772|FG004|STARTED|Phase I (168 Days)||0
10483562|NCT01147809|11632773|FG005|STARTED|Phase I (168 Days)||0
10483563|NCT01147809|11632768|FG000|COMPLETED|Phase I (168 Days)||2
10483564|NCT01147809|11632769|FG001|COMPLETED|Phase I (168 Days)||8
10483565|NCT01147809|11632770|FG002|COMPLETED|Phase I (168 Days)||2
10483566|NCT01147809|11632771|FG003|COMPLETED|Phase I (168 Days)||5
10483567|NCT01147809|11632772|FG004|COMPLETED|Phase I (168 Days)||0
10483568|NCT01147809|11632773|FG005|COMPLETED|Phase I (168 Days)||0
10483569|NCT01147809|11632768|FG000|NOT COMPLETED|Phase I (168 Days)||1
10483570|NCT01147809|11632769|FG001|NOT COMPLETED|Phase I (168 Days)||1
10483571|NCT01147809|11632770|FG002|NOT COMPLETED|Phase I (168 Days)||2
10483572|NCT01147809|11632771|FG003|NOT COMPLETED|Phase I (168 Days)||5
10483573|NCT01147809|11632772|FG004|NOT COMPLETED|Phase I (168 Days)||0
10483574|NCT01147809|11632773|FG005|NOT COMPLETED|Phase I (168 Days)||0
10483575|NCT01147809|11632768|FG000|STARTED|Phase II (168 Days)||0
10483576|NCT01147809|11632769|FG001|STARTED|Phase II (168 Days)||0
10483577|NCT01147809|11632770|FG002|STARTED|Phase II (168 Days)||0
10483578|NCT01147809|11632771|FG003|STARTED|Phase II (168 Days)||0
10483579|NCT01147809|11632772|FG004|STARTED|Phase II (168 Days)||23
10483580|NCT01147809|11632773|FG005|STARTED|Phase II (168 Days)||52
10483581|NCT01147809|11632768|FG000|Ongoing|Phase II (168 Days)||0
10483582|NCT01147809|11632769|FG001|Ongoing|Phase II (168 Days)||0
10483583|NCT01147809|11632770|FG002|Ongoing|Phase II (168 Days)||0
10483584|NCT01147809|11632771|FG003|Ongoing|Phase II (168 Days)||0
10483585|NCT01147809|11632772|FG004|Ongoing|Phase II (168 Days)||1
10483586|NCT01147809|11632773|FG005|Ongoing|Phase II (168 Days)||0
10483587|NCT01147809|11632768|FG000|COMPLETED|Phase II (168 Days)||0
10483588|NCT01147809|11632769|FG001|COMPLETED|Phase II (168 Days)||0
10483589|NCT01147809|11632770|FG002|COMPLETED|Phase II (168 Days)||0
10483590|NCT01147809|11632771|FG003|COMPLETED|Phase II (168 Days)||0
10483591|NCT01147809|11632772|FG004|COMPLETED|Phase II (168 Days)||7
10483592|NCT01147809|11632773|FG005|COMPLETED|Phase II (168 Days)||19
10483593|NCT01147809|11632768|FG000|NOT COMPLETED|Phase II (168 Days)||0
10483594|NCT01147809|11632769|FG001|NOT COMPLETED|Phase II (168 Days)||0
10483595|NCT01147809|11632770|FG002|NOT COMPLETED|Phase II (168 Days)||0
10483596|NCT01147809|11632771|FG003|NOT COMPLETED|Phase II (168 Days)||0
10483597|NCT01147809|11632772|FG004|NOT COMPLETED|Phase II (168 Days)||16
10483598|NCT01147809|11632773|FG005|NOT COMPLETED|Phase II (168 Days)||33
10483599|NCT01147848|11632790|FG000|STARTED|Run-in Period||1564
10483600|NCT01147848|11632791|FG001|STARTED|Run-in Period||0
10483601|NCT01147848|11632792|FG002|STARTED|Run-in Period||0
10483602|NCT01147848|11632790|FG000|COMPLETED|Run-in Period||806
10483603|NCT01147848|11632791|FG001|COMPLETED|Run-in Period||0
10483604|NCT01147848|11632792|FG002|COMPLETED|Run-in Period||0
10483605|NCT01147848|11632790|FG000|NOT COMPLETED|Run-in Period||758
10483606|NCT01147848|11632791|FG001|NOT COMPLETED|Run-in Period||0
10483607|NCT01147848|11632792|FG002|NOT COMPLETED|Run-in Period||0
10483608|NCT01147848|11632790|FG000|STARTED|Randomized Phase||0
10483609|NCT01147848|11632791|FG001|STARTED|Randomized Phase||403
10483610|NCT01147848|11632792|FG002|STARTED|Randomized Phase||403
10483611|NCT01147848|11632790|FG000|COMPLETED|Randomized Phase||0
10483612|NCT01147848|11632791|FG001|COMPLETED|Randomized Phase||358
10483613|NCT01147848|11632792|FG002|COMPLETED|Randomized Phase||357
10483614|NCT01147848|11632790|FG000|NOT COMPLETED|Randomized Phase||0
10483615|NCT01147848|11632791|FG001|NOT COMPLETED|Randomized Phase||45
10483616|NCT01147848|11632792|FG002|NOT COMPLETED|Randomized Phase||46
10483617|NCT01147874|11632799|FG000|STARTED|Overall Study||1013
10483618|NCT01147874|11632799|FG000|COMPLETED|Overall Study||946
10483619|NCT01147874|11632799|FG000|NOT COMPLETED|Overall Study||67
10483620|NCT01147900|11632806|FG000|STARTED|At Year 8.5||54
10483621|NCT01147900|11632807|FG001|STARTED|At Year 8.5||60
10483622|NCT01147900|11632808|FG002|STARTED|At Year 8.5||66
10483623|NCT01147900|11632806|FG000|COMPLETED|At Year 8.5||54
10483624|NCT01147900|11632807|FG001|COMPLETED|At Year 8.5||60
10483625|NCT01147900|11632808|FG002|COMPLETED|At Year 8.5||66
10483626|NCT01147900|11632806|FG000|NOT COMPLETED|At Year 8.5||0
10483627|NCT01147900|11632807|FG001|NOT COMPLETED|At Year 8.5||0
10483628|NCT01147900|11632808|FG002|NOT COMPLETED|At Year 8.5||0
10483629|NCT01147900|11632806|FG000|STARTED|At Year 10|At Year 10, a total of 177 subjects (out of the 180 planned) were enrolled|55
10483630|NCT01147900|11632807|FG001|STARTED|At Year 10||60
10483631|NCT01147900|11632808|FG002|STARTED|At Year 10|At Year 10, a total of 177 subjects (out of the 180 planned) were enrolled.|62
10483632|NCT01147900|11632806|FG000|COMPLETED|At Year 10||55
10483633|NCT01147900|11632807|FG001|COMPLETED|At Year 10||59
10483634|NCT01147900|11632808|FG002|COMPLETED|At Year 10||62
10483635|NCT01147900|11632806|FG000|NOT COMPLETED|At Year 10||0
10483636|NCT01147900|11632807|FG001|NOT COMPLETED|At Year 10||1
10483637|NCT01147900|11632808|FG002|NOT COMPLETED|At Year 10||0
10483638|NCT01147926|11632818|FG000|STARTED|Overall Study||187
10483639|NCT01147926|11632819|FG001|STARTED|Overall Study||187
10483640|NCT01147926|11632818|FG000|COMPLETED|Overall Study||160
10483641|NCT01147926|11632819|FG001|COMPLETED|Overall Study||158
10483642|NCT01147926|11632818|FG000|NOT COMPLETED|Overall Study||27
10483643|NCT01147926|11632819|FG001|NOT COMPLETED|Overall Study||29
10483644|NCT01148017|11632829|FG000|STARTED|Overall Study||214
10483645|NCT01148017|11632830|FG001|STARTED|Overall Study||121
10483646|NCT01148017|11632831|FG002|STARTED|Overall Study||53
10483647|NCT01148017|11632832|FG003|STARTED|Overall Study||45
10483648|NCT01148017|11632829|FG000|COMPLETED|Overall Study||134
10483649|NCT01148017|11632830|FG001|COMPLETED|Overall Study||87
10483650|NCT01148017|11632831|FG002|COMPLETED|Overall Study||53
10483651|NCT01148017|11632832|FG003|COMPLETED|Overall Study||45
10483652|NCT01148017|11632829|FG000|NOT COMPLETED|Overall Study||80
10483653|NCT01148017|11632830|FG001|NOT COMPLETED|Overall Study||34
10483654|NCT01148017|11632831|FG002|NOT COMPLETED|Overall Study||0
10483655|NCT01148017|11632832|FG003|NOT COMPLETED|Overall Study||0
10483656|NCT01148225|11632843|FG000|STARTED|Overall Study||424
10483657|NCT01148225|11632843|FG000|COMPLETED|Overall Study||239
10483658|NCT01148225|11632843|FG000|NOT COMPLETED|Overall Study||185
10483659|NCT01148420|11632850|FG000|STARTED|Overall Study||48
10483660|NCT01148420|11632850|FG000|COMPLETED|Overall Study||48
10483661|NCT01148420|11632850|FG000|NOT COMPLETED|Overall Study||0
10483662|NCT01148459|11632857|FG000|STARTED|Overall Study||99
10483663|NCT01148459|11632858|FG001|STARTED|Overall Study||101
10483664|NCT01148459|11632857|FG000|COMPLETED|Overall Study||87
10483665|NCT01148459|11632858|FG001|COMPLETED|Overall Study||90
10483666|NCT01148459|11632857|FG000|NOT COMPLETED|Overall Study||12
10483667|NCT01148459|11632858|FG001|NOT COMPLETED|Overall Study||11
10483668|NCT01148511|11632866|FG000|STARTED|Exposed to Study Drug||99
10483669|NCT01148511|11632867|FG001|STARTED|Exposed to Study Drug|Patients were not randomized to this group until the Randomized Period.|0
10483670|NCT01148511|11632868|FG002|STARTED|Exposed to Study Drug|Patients were not randomized to this group until the Randomized Period.|0
10483671|NCT01148511|11632866|FG000|COMPLETED|Exposed to Study Drug||93
10483672|NCT01148511|11632867|FG001|COMPLETED|Exposed to Study Drug||0
10483673|NCT01148511|11632868|FG002|COMPLETED|Exposed to Study Drug||0
10483674|NCT01148511|11632866|FG000|NOT COMPLETED|Exposed to Study Drug||6
10483675|NCT01148511|11632867|FG001|NOT COMPLETED|Exposed to Study Drug||0
10483676|NCT01148511|11632868|FG002|NOT COMPLETED|Exposed to Study Drug||0
10483677|NCT01148511|11632866|FG000|STARTED|Randomized|All patients were randomized into the Treat and Extend and the Treat and Observe treatment groups.|0
10709773|NCT02643082|11874828|FG000|NOT COMPLETED|Washout||0
10709774|NCT02643082|11874829|FG001|NOT COMPLETED|Washout||0
10709775|NCT02643082|11874828|FG000|STARTED|Period 2||9
10709776|NCT02643082|11874829|FG001|STARTED|Period 2||10
10709777|NCT02643082|11874828|FG000|COMPLETED|Period 2||9
10709778|NCT02643082|11874829|FG001|COMPLETED|Period 2||10
10709779|NCT02643082|11874828|FG000|NOT COMPLETED|Period 2||0
10709780|NCT02643082|11874829|FG001|NOT COMPLETED|Period 2||0
10709781|NCT02643095|11874836|FG000|STARTED|Overall Study||22
10709782|NCT02643095|11874836|FG000|COMPLETED|Overall Study||21
10709783|NCT02643095|11874836|FG000|NOT COMPLETED|Overall Study||1
10709784|NCT02643199|11874840|FG000|STARTED|Overall Study||90
10709785|NCT02643199|11874840|FG000|COMPLETED|Overall Study||90
10709786|NCT02643199|11874840|FG000|NOT COMPLETED|Overall Study||0
10709787|NCT02643225|11874846|FG000|STARTED|Overall Study||40
10709788|NCT02643225|11874847|FG001|STARTED|Overall Study||40
10709789|NCT02643225|11874846|FG000|COMPLETED|Overall Study||40
10483678|NCT01148511|11632867|FG001|STARTED|Randomized||48
10483679|NCT01148511|11632868|FG002|STARTED|Randomized||45
10483680|NCT01148511|11632866|FG000|COMPLETED|Randomized||0
10483681|NCT01148511|11632867|FG001|COMPLETED|Randomized||38
10483682|NCT01148511|11632868|FG002|COMPLETED|Randomized||39
10483683|NCT01148511|11632866|FG000|NOT COMPLETED|Randomized||0
10483684|NCT01148511|11632867|FG001|NOT COMPLETED|Randomized||10
10483685|NCT01148511|11632868|FG002|NOT COMPLETED|Randomized||6
10483686|NCT01148524|11632884|FG000|STARTED|Overall Study||49
10709790|NCT02643225|11874847|FG001|COMPLETED|Overall Study||40
10709791|NCT02643225|11874846|FG000|NOT COMPLETED|Overall Study||0
10709792|NCT02643225|11874847|FG001|NOT COMPLETED|Overall Study||0
10709793|NCT02643251|11874856|FG000|STARTED|Overall Study||69
10709794|NCT02643251|11874857|FG001|STARTED|Overall Study||69
10709795|NCT02643251|11874856|FG000|COMPLETED|Overall Study||58
10709796|NCT02643251|11874857|FG001|COMPLETED|Overall Study||67
10709797|NCT02643251|11874856|FG000|NOT COMPLETED|Overall Study||11
10709798|NCT02643251|11874857|FG001|NOT COMPLETED|Overall Study||2
10709799|NCT02643355|11874865|FG000|STARTED|Overall Study||34
10709800|NCT02643355|11874866|FG001|STARTED|Overall Study||35
10709801|NCT02643355|11874865|FG000|COMPLETED|Overall Study||33
10483687|NCT01148524|11632885|FG001|STARTED|Overall Study||95
10483688|NCT01148524|11632886|FG002|STARTED|Overall Study||53
10483689|NCT01148524|11632887|FG003|STARTED|Overall Study||102
10483690|NCT01148524|11632888|FG004|STARTED|Overall Study||57
10483691|NCT01148524|11632889|FG005|STARTED|Overall Study||106
10483692|NCT01148524|11632890|FG006|STARTED|Overall Study||153
10483693|NCT01148524|11632891|FG007|STARTED|Overall Study||51
10483694|NCT01148524|11632892|FG008|STARTED|Overall Study||151
10483695|NCT01148524|11632884|FG000|COMPLETED|Overall Study||49
10483696|NCT01148524|11632885|FG001|COMPLETED|Overall Study||95
10483697|NCT01148524|11632886|FG002|COMPLETED|Overall Study||53
10483698|NCT01148524|11632887|FG003|COMPLETED|Overall Study||102
10709802|NCT02643355|11874866|FG001|COMPLETED|Overall Study||30
10709803|NCT02643355|11874865|FG000|NOT COMPLETED|Overall Study||1
10709804|NCT02643355|11874866|FG001|NOT COMPLETED|Overall Study||5
10483699|NCT01148524|11632888|FG004|COMPLETED|Overall Study||57
10483700|NCT01148524|11632889|FG005|COMPLETED|Overall Study||106
10483701|NCT01148524|11632890|FG006|COMPLETED|Overall Study||153
10483702|NCT01148524|11632891|FG007|COMPLETED|Overall Study||51
10483703|NCT01148524|11632892|FG008|COMPLETED|Overall Study||151
10483704|NCT01148524|11632884|FG000|NOT COMPLETED|Overall Study||0
10483705|NCT01148524|11632885|FG001|NOT COMPLETED|Overall Study||0
10483706|NCT01148524|11632886|FG002|NOT COMPLETED|Overall Study||0
10483707|NCT01148524|11632887|FG003|NOT COMPLETED|Overall Study||0
10483708|NCT01148524|11632888|FG004|NOT COMPLETED|Overall Study||0
10483709|NCT01148524|11632889|FG005|NOT COMPLETED|Overall Study||0
10483710|NCT01148524|11632890|FG006|NOT COMPLETED|Overall Study||0
10483711|NCT01148524|11632891|FG007|NOT COMPLETED|Overall Study||0
10483712|NCT01148524|11632892|FG008|NOT COMPLETED|Overall Study||0
10483713|NCT01148537|11632915|FG000|STARTED|Overall Study||44
10483714|NCT01148537|11632916|FG001|STARTED|Overall Study||44
10483715|NCT01148537|11632917|FG002|STARTED|Overall Study||44
10483716|NCT01148537|11632915|FG000|COMPLETED|Overall Study||41
10483717|NCT01148537|11632916|FG001|COMPLETED|Overall Study||44
10483718|NCT01148537|11632917|FG002|COMPLETED|Overall Study||41
10483719|NCT01148537|11632915|FG000|NOT COMPLETED|Overall Study||3
10483720|NCT01148537|11632916|FG001|NOT COMPLETED|Overall Study||0
10483721|NCT01148537|11632917|FG002|NOT COMPLETED|Overall Study||3
10483722|NCT01148563|11632928|FG000|STARTED|Overall Study||69
10483723|NCT01148563|11632929|FG001|STARTED|Overall Study||67
10483724|NCT01148563|11632928|FG000|COMPLETED|Overall Study||40
10483725|NCT01148563|11632929|FG001|COMPLETED|Overall Study||37
10483726|NCT01148563|11632928|FG000|NOT COMPLETED|Overall Study||29
10483727|NCT01148563|11632929|FG001|NOT COMPLETED|Overall Study||30
10483728|NCT01148693|11632938|FG000|STARTED|Overall Study||70
10483729|NCT01148693|11632939|FG001|STARTED|Overall Study||67
10483730|NCT01148693|11632938|FG000|COMPLETED|Overall Study||57
10483731|NCT01148693|11632939|FG001|COMPLETED|Overall Study||57
10483732|NCT01148693|11632938|FG000|NOT COMPLETED|Overall Study||13
10483733|NCT01148693|11632939|FG001|NOT COMPLETED|Overall Study||10
10483734|NCT01148745|11632945|FG000|STARTED|Overall Study||15
10483735|NCT01148745|11632945|FG000|COMPLETED|Overall Study||15
10483736|NCT01148745|11632945|FG000|NOT COMPLETED|Overall Study||0
10483737|NCT01148771|11632953|FG000|STARTED|First Intervention||6
10483738|NCT01148771|11632954|FG001|STARTED|First Intervention||6
10483739|NCT01148771|11632953|FG000|COMPLETED|First Intervention||6
10483740|NCT01148771|11632954|FG001|COMPLETED|First Intervention||6
10483741|NCT01148771|11632953|FG000|NOT COMPLETED|First Intervention||0
10483742|NCT01148771|11632954|FG001|NOT COMPLETED|First Intervention||0
10483743|NCT01148771|11632953|FG000|STARTED|Washout Period||6
10483744|NCT01148771|11632954|FG001|STARTED|Washout Period||6
10483745|NCT01148771|11632953|FG000|COMPLETED|Washout Period||6
10483746|NCT01148771|11632954|FG001|COMPLETED|Washout Period||5
10483747|NCT01148771|11632953|FG000|NOT COMPLETED|Washout Period||0
10483748|NCT01148771|11632954|FG001|NOT COMPLETED|Washout Period||1
10483749|NCT01148771|11632953|FG000|STARTED|Second Intervention||6
10483750|NCT01148771|11632954|FG001|STARTED|Second Intervention||5
10483751|NCT01148771|11632953|FG000|COMPLETED|Second Intervention||6
10483752|NCT01148771|11632954|FG001|COMPLETED|Second Intervention||5
10483753|NCT01148771|11632953|FG000|NOT COMPLETED|Second Intervention||0
10483754|NCT01148771|11632954|FG001|NOT COMPLETED|Second Intervention||0
10483755|NCT01148810|11632966|FG000|STARTED|Overall Study||8
10483756|NCT01148810|11632967|FG001|STARTED|Overall Study||10
10483757|NCT01148810|11632966|FG000|COMPLETED|Overall Study||7
10483758|NCT01148810|11632967|FG001|COMPLETED|Overall Study||5
10483759|NCT01148810|11632966|FG000|NOT COMPLETED|Overall Study||1
10709805|NCT02643394|11874874|FG000|STARTED|Overall Study||55
10709806|NCT02643394|11874875|FG001|STARTED|Overall Study||55
10709807|NCT02643394|11874874|FG000|COMPLETED|Overall Study||51
10483760|NCT01148810|11632967|FG001|NOT COMPLETED|Overall Study||5
10483761|NCT01148836|11632976|FG000|STARTED|Overall Study|Enrollment completed|8
10483762|NCT01148836|11632977|FG001|STARTED|Overall Study||10
10483763|NCT01148836|11632976|FG000|COMPLETED|Overall Study|Enrollment completed|7
10709808|NCT02643394|11874875|FG001|COMPLETED|Overall Study||50
10709809|NCT02643394|11874874|FG000|NOT COMPLETED|Overall Study||4
10483764|NCT01148836|11632977|FG001|COMPLETED|Overall Study||8
10483765|NCT01148836|11632976|FG000|NOT COMPLETED|Overall Study||1
10483766|NCT01148836|11632977|FG001|NOT COMPLETED|Overall Study||2
10483767|NCT01148862|11632983|FG000|STARTED|First Intervention||25
10483768|NCT01148862|11632984|FG001|STARTED|First Intervention||25
10483769|NCT01148862|11632983|FG000|COMPLETED|First Intervention||25
10483770|NCT01148862|11632984|FG001|COMPLETED|First Intervention||25
10483771|NCT01148862|11632983|FG000|NOT COMPLETED|First Intervention||0
10483772|NCT01148862|11632984|FG001|NOT COMPLETED|First Intervention||0
10483773|NCT01148862|11632983|FG000|STARTED|Washout Period of 2 Weeks||25
10483774|NCT01148862|11632984|FG001|STARTED|Washout Period of 2 Weeks||25
10483775|NCT01148862|11632983|FG000|COMPLETED|Washout Period of 2 Weeks||25
10483776|NCT01148862|11632984|FG001|COMPLETED|Washout Period of 2 Weeks||25
10483777|NCT01148862|11632983|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
10483778|NCT01148862|11632984|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
10483779|NCT01148862|11632983|FG000|STARTED|Second Intervention||25
10483780|NCT01148862|11632984|FG001|STARTED|Second Intervention||25
10483781|NCT01148862|11632983|FG000|COMPLETED|Second Intervention||25
10483782|NCT01148862|11632984|FG001|COMPLETED|Second Intervention||23
10483783|NCT01148862|11632983|FG000|NOT COMPLETED|Second Intervention||0
10483784|NCT01148862|11632984|FG001|NOT COMPLETED|Second Intervention||2
10483785|NCT01148940|11632992|FG000|STARTED|Overall Study||7
10483786|NCT01148940|11632993|FG001|STARTED|Overall Study||27
10483787|NCT01148940|11632994|FG002|STARTED|Overall Study||0
10483788|NCT01148940|11632992|FG000|COMPLETED|Overall Study||7
10483789|NCT01148940|11632993|FG001|COMPLETED|Overall Study||27
10483790|NCT01148940|11632994|FG002|COMPLETED|Overall Study||0
10483791|NCT01148940|11632992|FG000|NOT COMPLETED|Overall Study||0
10483792|NCT01148940|11632993|FG001|NOT COMPLETED|Overall Study||0
10483793|NCT01148940|11632994|FG002|NOT COMPLETED|Overall Study||0
10483794|NCT01148979|11633004|FG000|STARTED|Overall Study||13
10483795|NCT01148979|11633005|FG001|STARTED|Overall Study||16
10483796|NCT01148979|11633004|FG000|COMPLETED|Overall Study||13
10483797|NCT01148979|11633005|FG001|COMPLETED|Overall Study||15
10483798|NCT01148979|11633004|FG000|NOT COMPLETED|Overall Study||0
10483799|NCT01148979|11633005|FG001|NOT COMPLETED|Overall Study||1
10483800|NCT01149057|11633011|FG000|STARTED|Overall Study||145
10483801|NCT01149057|11633011|FG000|COMPLETED|Overall Study||88
10483802|NCT01149057|11633011|FG000|NOT COMPLETED|Overall Study||57
10483803|NCT01149096|11633017|FG000|STARTED|Overall Study||6
10483804|NCT01149096|11633018|FG001|STARTED|Overall Study||7
10483805|NCT01149096|11633017|FG000|COMPLETED|Overall Study||6
10483806|NCT01149096|11633018|FG001|COMPLETED|Overall Study||6
10483807|NCT01149096|11633017|FG000|NOT COMPLETED|Overall Study||0
10483808|NCT01149096|11633018|FG001|NOT COMPLETED|Overall Study||1
10483809|NCT01149148|11633027|FG000|STARTED|Overall Study||12
10483810|NCT01149148|11633028|FG001|STARTED|Overall Study||13
10483811|NCT01149148|11633027|FG000|COMPLETED|Overall Study||10
10483812|NCT01149148|11633028|FG001|COMPLETED|Overall Study||11
10483813|NCT01149148|11633027|FG000|NOT COMPLETED|Overall Study||2
10483814|NCT01149148|11633028|FG001|NOT COMPLETED|Overall Study||2
10483815|NCT01149343|11633039|FG000|STARTED|Overall Study||20
10483816|NCT01149343|11633040|FG001|STARTED|Overall Study||24
10483817|NCT01149343|11633041|FG002|STARTED|Overall Study||22
10483818|NCT01149343|11633042|FG003|STARTED|Overall Study||40
10483819|NCT01149343|11633039|FG000|COMPLETED|Overall Study||0
10483820|NCT01149343|11633040|FG001|COMPLETED|Overall Study||0
10483821|NCT01149343|11633041|FG002|COMPLETED|Overall Study||0
10483822|NCT01149343|11633042|FG003|COMPLETED|Overall Study||0
10483823|NCT01149343|11633039|FG000|NOT COMPLETED|Overall Study||20
10483824|NCT01149343|11633040|FG001|NOT COMPLETED|Overall Study||24
10483825|NCT01149343|11633041|FG002|NOT COMPLETED|Overall Study||22
10483826|NCT01149343|11633042|FG003|NOT COMPLETED|Overall Study||40
10483827|NCT01149369|11633058|FG000|STARTED|Overall Study||63
10483828|NCT01149369|11633059|FG001|STARTED|Overall Study||63
10483829|NCT01149369|11633058|FG000|COMPLETED|Overall Study||57
10483830|NCT01149369|11633059|FG001|COMPLETED|Overall Study||60
10483831|NCT01149369|11633058|FG000|NOT COMPLETED|Overall Study||6
10483832|NCT01149369|11633059|FG001|NOT COMPLETED|Overall Study||3
10483833|NCT01149421|11633068|FG000|STARTED|Overall Study||251
10483834|NCT01149421|11633069|FG001|STARTED|Overall Study||254
10483835|NCT01149421|11633070|FG002|STARTED|Overall Study||250
10483836|NCT01149421|11633068|FG000|Received at Least One Dose of Study Drug|Overall Study||251
10483837|NCT01149421|11633069|FG001|Received at Least One Dose of Study Drug|Overall Study||254
10483838|NCT01149421|11633070|FG002|Received at Least One Dose of Study Drug|Overall Study||250
10483839|NCT01149421|11633068|FG000|COMPLETED|Overall Study||199
10483840|NCT01149421|11633069|FG001|COMPLETED|Overall Study||225
10483841|NCT01149421|11633070|FG002|COMPLETED|Overall Study||206
10483842|NCT01149421|11633068|FG000|NOT COMPLETED|Overall Study||52
10483843|NCT01149421|11633069|FG001|NOT COMPLETED|Overall Study||29
10483844|NCT01149421|11633070|FG002|NOT COMPLETED|Overall Study||44
10483845|NCT01149434|11633080|FG000|STARTED|Overall Study||4
10483846|NCT01149434|11633081|FG001|STARTED|Overall Study||15
10483847|NCT01149434|11633080|FG000|COMPLETED|Overall Study||4
10483848|NCT01149434|11633081|FG001|COMPLETED|Overall Study||10
10483849|NCT01149434|11633080|FG000|NOT COMPLETED|Overall Study||0
10483850|NCT01149434|11633081|FG001|NOT COMPLETED|Overall Study||5
10483851|NCT01149460|11633090|FG000|STARTED|Overall Study||18
10483852|NCT01149460|11633091|FG001|STARTED|Overall Study||18
10483853|NCT01149460|11633090|FG000|COMPLETED|Overall Study||18
10483854|NCT01149460|11633091|FG001|COMPLETED|Overall Study||16
10483855|NCT01149460|11633090|FG000|NOT COMPLETED|Overall Study||0
10483856|NCT01149460|11633091|FG001|NOT COMPLETED|Overall Study||2
10483857|NCT01149473|11633099|FG000|STARTED|First Intervention||40
10483858|NCT01149473|11633100|FG001|STARTED|First Intervention||40
10483859|NCT01149473|11633099|FG000|COMPLETED|First Intervention||39
10483860|NCT01149473|11633100|FG001|COMPLETED|First Intervention||39
10483861|NCT01149473|11633099|FG000|NOT COMPLETED|First Intervention||1
10483862|NCT01149473|11633100|FG001|NOT COMPLETED|First Intervention||1
10483863|NCT01149473|11633099|FG000|STARTED|Washout of 7 Days||39
10483864|NCT01149473|11633100|FG001|STARTED|Washout of 7 Days||39
10483865|NCT01149473|11633099|FG000|COMPLETED|Washout of 7 Days||38
10483866|NCT01149473|11633100|FG001|COMPLETED|Washout of 7 Days||38
10483867|NCT01149473|11633099|FG000|NOT COMPLETED|Washout of 7 Days||1
10483868|NCT01149473|11633100|FG001|NOT COMPLETED|Washout of 7 Days||1
10483869|NCT01149473|11633099|FG000|STARTED|Second Intervention||38
10483870|NCT01149473|11633100|FG001|STARTED|Second Intervention||38
10483871|NCT01149473|11633099|FG000|COMPLETED|Second Intervention||38
10483872|NCT01149473|11633100|FG001|COMPLETED|Second Intervention||38
10483873|NCT01149473|11633099|FG000|NOT COMPLETED|Second Intervention||0
10483874|NCT01149473|11633100|FG001|NOT COMPLETED|Second Intervention||0
10483875|NCT01149486|11633108|FG000|STARTED|First Intervention||10
10483876|NCT01149486|11633109|FG001|STARTED|First Intervention||10
10483877|NCT01149486|11633108|FG000|COMPLETED|First Intervention||10
10483878|NCT01149486|11633109|FG001|COMPLETED|First Intervention||9
10483879|NCT01149486|11633108|FG000|NOT COMPLETED|First Intervention||0
10483880|NCT01149486|11633109|FG001|NOT COMPLETED|First Intervention||1
10483881|NCT01149486|11633108|FG000|STARTED|Washout of 7 Days||10
10483882|NCT01149486|11633109|FG001|STARTED|Washout of 7 Days||9
10483883|NCT01149486|11633108|FG000|COMPLETED|Washout of 7 Days||10
10483884|NCT01149486|11633109|FG001|COMPLETED|Washout of 7 Days||9
10483885|NCT01149486|11633108|FG000|NOT COMPLETED|Washout of 7 Days||0
10483886|NCT01149486|11633109|FG001|NOT COMPLETED|Washout of 7 Days||0
10483887|NCT01149486|11633108|FG000|STARTED|Second Intervention||10
10483888|NCT01149486|11633109|FG001|STARTED|Second Intervention||9
10483889|NCT01149486|11633108|FG000|COMPLETED|Second Intervention||10
10483890|NCT01149486|11633109|FG001|COMPLETED|Second Intervention||9
10483891|NCT01149486|11633108|FG000|NOT COMPLETED|Second Intervention||0
10483892|NCT01149486|11633109|FG001|NOT COMPLETED|Second Intervention||0
10483893|NCT01149512|11633115|FG000|STARTED|Overall Study||178
10483894|NCT01149512|11633115|FG000|COMPLETED|Overall Study||178
10483895|NCT01149512|11633115|FG000|NOT COMPLETED|Overall Study||0
10483896|NCT01149538|11633121|FG000|STARTED|Overall Study||31
10483897|NCT01149538|11633122|FG001|STARTED|Overall Study||29
10483898|NCT01149538|11633121|FG000|COMPLETED|Overall Study||26
10483899|NCT01149538|11633122|FG001|COMPLETED|Overall Study||25
10483900|NCT01149538|11633121|FG000|NOT COMPLETED|Overall Study||5
10483901|NCT01149538|11633122|FG001|NOT COMPLETED|Overall Study||4
10483902|NCT01149616|11633130|FG000|STARTED|Overall Study||41
10483903|NCT01149616|11633131|FG001|STARTED|Overall Study||41
10483904|NCT01149616|11633130|FG000|COMPLETED|Overall Study||41
10483905|NCT01149616|11633131|FG001|COMPLETED|Overall Study||41
10483906|NCT01149616|11633130|FG000|NOT COMPLETED|Overall Study||0
10483907|NCT01149616|11633131|FG001|NOT COMPLETED|Overall Study||0
10483908|NCT01149655|11633141|FG000|STARTED|Period 1 - Conversion Phase||186
10483909|NCT01149655|11633142|FG001|STARTED|Period 1 - Conversion Phase||0
10483910|NCT01149655|11633143|FG002|STARTED|Period 1 - Conversion Phase||0
10483911|NCT01149655|11633144|FG003|STARTED|Period 1 - Conversion Phase||0
10483912|NCT01149655|11633141|FG000|COMPLETED|Period 1 - Conversion Phase||168
10483913|NCT01149655|11633142|FG001|COMPLETED|Period 1 - Conversion Phase||0
10483914|NCT01149655|11633143|FG002|COMPLETED|Period 1 - Conversion Phase||0
10483915|NCT01149655|11633144|FG003|COMPLETED|Period 1 - Conversion Phase||0
10483916|NCT01149655|11633141|FG000|NOT COMPLETED|Period 1 - Conversion Phase||18
10483917|NCT01149655|11633142|FG001|NOT COMPLETED|Period 1 - Conversion Phase||0
10483918|NCT01149655|11633143|FG002|NOT COMPLETED|Period 1 - Conversion Phase||0
10483919|NCT01149655|11633144|FG003|NOT COMPLETED|Period 1 - Conversion Phase||0
10483920|NCT01149655|11633141|FG000|STARTED|Period 2-Stabilization Phase||0
10483921|NCT01149655|11633142|FG001|STARTED|Period 2-Stabilization Phase||183
10483922|NCT01149655|11633143|FG002|STARTED|Period 2-Stabilization Phase||0
10483923|NCT01149655|11633144|FG003|STARTED|Period 2-Stabilization Phase||0
10483924|NCT01149655|11633141|FG000|COMPLETED|Period 2-Stabilization Phase||0
10483925|NCT01149655|11633142|FG001|COMPLETED|Period 2-Stabilization Phase||146
10483926|NCT01149655|11633143|FG002|COMPLETED|Period 2-Stabilization Phase||0
10483927|NCT01149655|11633144|FG003|COMPLETED|Period 2-Stabilization Phase||0
10483928|NCT01149655|11633141|FG000|NOT COMPLETED|Period 2-Stabilization Phase||0
10483929|NCT01149655|11633142|FG001|NOT COMPLETED|Period 2-Stabilization Phase||37
10483930|NCT01149655|11633143|FG002|NOT COMPLETED|Period 2-Stabilization Phase||0
10483931|NCT01149655|11633144|FG003|NOT COMPLETED|Period 2-Stabilization Phase||0
10483932|NCT01149655|11633141|FG000|STARTED|Period 3-DB Maintenance Phase||0
10483933|NCT01149655|11633142|FG001|STARTED|Period 3-DB Maintenance Phase||0
10483934|NCT01149655|11633143|FG002|STARTED|Period 3-DB Maintenance Phase||98
10483935|NCT01149655|11633144|FG003|STARTED|Period 3-DB Maintenance Phase||48
10483936|NCT01149655|11633141|FG000|COMPLETED|Period 3-DB Maintenance Phase||0
10483937|NCT01149655|11633142|FG001|COMPLETED|Period 3-DB Maintenance Phase||0
10483938|NCT01149655|11633143|FG002|COMPLETED|Period 3-DB Maintenance Phase||15
10483939|NCT01149655|11633144|FG003|COMPLETED|Period 3-DB Maintenance Phase||6
10483940|NCT01149655|11633141|FG000|NOT COMPLETED|Period 3-DB Maintenance Phase||0
10483941|NCT01149655|11633142|FG001|NOT COMPLETED|Period 3-DB Maintenance Phase||0
10483942|NCT01149655|11633143|FG002|NOT COMPLETED|Period 3-DB Maintenance Phase||83
10483943|NCT01149655|11633144|FG003|NOT COMPLETED|Period 3-DB Maintenance Phase||42
10483944|NCT01149681|11633152|FG000|STARTED|Overall Study||12
10483945|NCT01149681|11633152|FG000|COMPLETED|Overall Study||0
10483946|NCT01149681|11633152|FG000|NOT COMPLETED|Overall Study||12
10483947|NCT01149733|11633159|FG000|STARTED|Overall Study||16
10483948|NCT01149733|11633160|FG001|STARTED|Overall Study||16
10483949|NCT01149733|11633159|FG000|COMPLETED|Overall Study||16
10483950|NCT01149733|11633160|FG001|COMPLETED|Overall Study||16
10483951|NCT01149733|11633159|FG000|NOT COMPLETED|Overall Study||0
10483952|NCT01149733|11633160|FG001|NOT COMPLETED|Overall Study||0
10483953|NCT01149759|11633166|FG000|STARTED|Overall Study||9
10483954|NCT01149759|11633166|FG000|COMPLETED|Overall Study||9
10483955|NCT01149759|11633166|FG000|NOT COMPLETED|Overall Study||0
10483956|NCT01149772|11633172|FG000|STARTED|Overall Study||180
10483957|NCT01149772|11633173|FG001|STARTED|Overall Study||122
10483958|NCT01149772|11633172|FG000|COMPLETED|Overall Study||132
10483959|NCT01149772|11633173|FG001|COMPLETED|Overall Study||101
10483960|NCT01149772|11633172|FG000|NOT COMPLETED|Overall Study||48
10483961|NCT01149772|11633173|FG001|NOT COMPLETED|Overall Study||21
10483962|NCT01149785|11633181|FG000|STARTED|First Intervention||15
10483963|NCT01149785|11633182|FG001|STARTED|First Intervention||0
10483964|NCT01149785|11633181|FG000|COMPLETED|First Intervention||15
10483965|NCT01149785|11633182|FG001|COMPLETED|First Intervention||0
10483966|NCT01149785|11633181|FG000|NOT COMPLETED|First Intervention||0
10483967|NCT01149785|11633182|FG001|NOT COMPLETED|First Intervention||0
10483968|NCT01149785|11633181|FG000|STARTED|Washout Period of at Least 14 Days||15
10483969|NCT01149785|11633182|FG001|STARTED|Washout Period of at Least 14 Days||0
10483970|NCT01149785|11633181|FG000|COMPLETED|Washout Period of at Least 14 Days||15
10483971|NCT01149785|11633182|FG001|COMPLETED|Washout Period of at Least 14 Days||0
10483972|NCT01149785|11633181|FG000|NOT COMPLETED|Washout Period of at Least 14 Days||0
10483973|NCT01149785|11633182|FG001|NOT COMPLETED|Washout Period of at Least 14 Days||0
10483974|NCT01149785|11633181|FG000|STARTED|Second Intervention||0
10483975|NCT01149785|11633182|FG001|STARTED|Second Intervention||15
10483976|NCT01149785|11633181|FG000|COMPLETED|Second Intervention||0
10483977|NCT01149785|11633182|FG001|COMPLETED|Second Intervention||15
10483978|NCT01149785|11633181|FG000|NOT COMPLETED|Second Intervention||0
10483979|NCT01149785|11633182|FG001|NOT COMPLETED|Second Intervention||0
10483980|NCT01149863|11633188|FG000|STARTED|Overall Study||34
10483981|NCT01149863|11633188|FG000|COMPLETED|Overall Study||31
10483982|NCT01149863|11633188|FG000|NOT COMPLETED|Overall Study||3
10483983|NCT01149876|11633196|FG000|STARTED|Overall Study||21
10483984|NCT01149876|11633197|FG001|STARTED|Overall Study||20
10483985|NCT01149876|11633198|FG002|STARTED|Overall Study||21
10483986|NCT01149876|11633199|FG003|STARTED|Overall Study||18
10483987|NCT01149876|11633196|FG000|COMPLETED|Overall Study||20
10483988|NCT01149876|11633197|FG001|COMPLETED|Overall Study||20
10483989|NCT01149876|11633198|FG002|COMPLETED|Overall Study||20
10483990|NCT01149876|11633199|FG003|COMPLETED|Overall Study||18
10483991|NCT01149876|11633196|FG000|NOT COMPLETED|Overall Study||1
10483992|NCT01149876|11633197|FG001|NOT COMPLETED|Overall Study||0
10483993|NCT01149876|11633198|FG002|NOT COMPLETED|Overall Study||1
10483994|NCT01149876|11633199|FG003|NOT COMPLETED|Overall Study||0
10483995|NCT01150097|11633213|FG000|STARTED|Months 24 to 36 Post-transplantation||106
10483996|NCT01150097|11633214|FG001|STARTED|Months 24 to 36 Post-transplantation||51
10483997|NCT01150097|11633215|FG002|STARTED|Months 24 to 36 Post-transplantation||125
10483998|NCT01150097|11633213|FG000|COMPLETED|Months 24 to 36 Post-transplantation||96
10483999|NCT01150097|11633214|FG001|COMPLETED|Months 24 to 36 Post-transplantation||49
10484000|NCT01150097|11633215|FG002|COMPLETED|Months 24 to 36 Post-transplantation||117
10484001|NCT01150097|11633213|FG000|NOT COMPLETED|Months 24 to 36 Post-transplantation||10
10484002|NCT01150097|11633214|FG001|NOT COMPLETED|Months 24 to 36 Post-transplantation||2
10484003|NCT01150097|11633215|FG002|NOT COMPLETED|Months 24 to 36 Post-transplantation||8
10484004|NCT01150097|11633213|FG000|STARTED|Months 24 to 48 Post-transplantation||106
10484005|NCT01150097|11633214|FG001|STARTED|Months 24 to 48 Post-transplantation||51
10484006|NCT01150097|11633215|FG002|STARTED|Months 24 to 48 Post-transplantation||0
10484007|NCT01150097|11633213|FG000|COMPLETED|Months 24 to 48 Post-transplantation||95
10484008|NCT01150097|11633214|FG001|COMPLETED|Months 24 to 48 Post-transplantation||47
10484009|NCT01150097|11633215|FG002|COMPLETED|Months 24 to 48 Post-transplantation||0
10484010|NCT01150097|11633213|FG000|NOT COMPLETED|Months 24 to 48 Post-transplantation||11
10484011|NCT01150097|11633214|FG001|NOT COMPLETED|Months 24 to 48 Post-transplantation||4
10484012|NCT01150097|11633215|FG002|NOT COMPLETED|Months 24 to 48 Post-transplantation||0
10484013|NCT01150123|11633243|FG000|STARTED|Overall Study||40
10484014|NCT01150123|11633244|FG001|STARTED|Overall Study||40
10484015|NCT01150123|11633245|FG002|STARTED|Overall Study||39
10484016|NCT01150123|11633246|FG003|STARTED|Overall Study||40
10484017|NCT01150123|11633247|FG004|STARTED|Overall Study||40
10484018|NCT01150123|11633248|FG005|STARTED|Overall Study||40
10484019|NCT01150123|11633249|FG006|STARTED|Overall Study||39
10484020|NCT01150123|11633250|FG007|STARTED|Overall Study||40
10484021|NCT01150123|11633251|FG008|STARTED|Overall Study||20
10484022|NCT01150123|11633252|FG009|STARTED|Overall Study||40
10484023|NCT01150123|11633253|FG010|STARTED|Overall Study||40
10484024|NCT01150123|11633254|FG011|STARTED|Overall Study||40
10484025|NCT01150123|11633255|FG012|STARTED|Overall Study||40
10484026|NCT01150123|11633256|FG013|STARTED|Overall Study||40
10484027|NCT01150123|11633257|FG014|STARTED|Overall Study||40
10484028|NCT01150123|11633258|FG015|STARTED|Overall Study||40
10484029|NCT01150123|11633259|FG016|STARTED|Overall Study||40
10484030|NCT01150123|11633260|FG017|STARTED|Overall Study||20
10484031|NCT01150123|11633243|FG000|COMPLETED|Overall Study||37
10484032|NCT01150123|11633244|FG001|COMPLETED|Overall Study||38
10484033|NCT01150123|11633245|FG002|COMPLETED|Overall Study||35
10484034|NCT01150123|11633246|FG003|COMPLETED|Overall Study||37
10484035|NCT01150123|11633247|FG004|COMPLETED|Overall Study||37
10484036|NCT01150123|11633248|FG005|COMPLETED|Overall Study||34
10484037|NCT01150123|11633249|FG006|COMPLETED|Overall Study||39
10484038|NCT01150123|11633250|FG007|COMPLETED|Overall Study||37
10484039|NCT01150123|11633251|FG008|COMPLETED|Overall Study||15
10484040|NCT01150123|11633252|FG009|COMPLETED|Overall Study||39
10484041|NCT01150123|11633253|FG010|COMPLETED|Overall Study||38
10484042|NCT01150123|11633254|FG011|COMPLETED|Overall Study||39
10484043|NCT01150123|11633255|FG012|COMPLETED|Overall Study||37
10484044|NCT01150123|11633256|FG013|COMPLETED|Overall Study||40
10484045|NCT01150123|11633257|FG014|COMPLETED|Overall Study||40
10484046|NCT01150123|11633258|FG015|COMPLETED|Overall Study||39
10484047|NCT01150123|11633259|FG016|COMPLETED|Overall Study||40
10484048|NCT01150123|11633260|FG017|COMPLETED|Overall Study||19
10484049|NCT01150123|11633243|FG000|NOT COMPLETED|Overall Study||3
10484050|NCT01150123|11633244|FG001|NOT COMPLETED|Overall Study||2
10484051|NCT01150123|11633245|FG002|NOT COMPLETED|Overall Study||4
10484052|NCT01150123|11633246|FG003|NOT COMPLETED|Overall Study||3
10484053|NCT01150123|11633247|FG004|NOT COMPLETED|Overall Study||3
10484054|NCT01150123|11633248|FG005|NOT COMPLETED|Overall Study||6
10484055|NCT01150123|11633249|FG006|NOT COMPLETED|Overall Study||0
10484056|NCT01150123|11633250|FG007|NOT COMPLETED|Overall Study||3
10484057|NCT01150123|11633251|FG008|NOT COMPLETED|Overall Study||5
10484058|NCT01150123|11633252|FG009|NOT COMPLETED|Overall Study||1
10484059|NCT01150123|11633253|FG010|NOT COMPLETED|Overall Study||2
10484060|NCT01150123|11633254|FG011|NOT COMPLETED|Overall Study||1
10484061|NCT01150123|11633255|FG012|NOT COMPLETED|Overall Study||3
10484062|NCT01150123|11633256|FG013|NOT COMPLETED|Overall Study||0
10484063|NCT01150123|11633257|FG014|NOT COMPLETED|Overall Study||0
10484064|NCT01150123|11633258|FG015|NOT COMPLETED|Overall Study||1
10484065|NCT01150123|11633259|FG016|NOT COMPLETED|Overall Study||0
10484066|NCT01150123|11633260|FG017|NOT COMPLETED|Overall Study||1
10484067|NCT01150357|11633320|FG000|STARTED|Dose Response Phase (Phase 1)||108
10484068|NCT01150357|11633321|FG001|STARTED|Dose Response Phase (Phase 1)||54
10484069|NCT01150357|11633322|FG002|STARTED|Dose Response Phase (Phase 1)||105
10484070|NCT01150357|11633320|FG000|COMPLETED|Dose Response Phase (Phase 1)||107
10484071|NCT01150357|11633321|FG001|COMPLETED|Dose Response Phase (Phase 1)||51
10484072|NCT01150357|11633322|FG002|COMPLETED|Dose Response Phase (Phase 1)||102
10484073|NCT01150357|11633320|FG000|NOT COMPLETED|Dose Response Phase (Phase 1)||1
10484074|NCT01150357|11633321|FG001|NOT COMPLETED|Dose Response Phase (Phase 1)||3
10484075|NCT01150357|11633322|FG002|NOT COMPLETED|Dose Response Phase (Phase 1)||3
10484076|NCT01150357|11633320|FG000|STARTED|Placebo-controlled Withdrawal (Phase 2)||107
10484077|NCT01150357|11633321|FG001|STARTED|Placebo-controlled Withdrawal (Phase 2)||51
10484078|NCT01150357|11633322|FG002|STARTED|Placebo-controlled Withdrawal (Phase 2)||102
10484079|NCT01150357|11633320|FG000|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
10484080|NCT01150357|11633321|FG001|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||30
10484081|NCT01150357|11633322|FG002|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
10484082|NCT01150357|11633320|FG000|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
10484083|NCT01150357|11633321|FG001|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||30
10484084|NCT01150357|11633322|FG002|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||49
10484085|NCT01150357|11633320|FG000|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||57
10484086|NCT01150357|11633321|FG001|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||21
10484087|NCT01150357|11633322|FG002|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||52
10484088|NCT01150357|11633320|FG000|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||54
10484089|NCT01150357|11633321|FG001|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||21
10484090|NCT01150357|11633322|FG002|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||51
10484091|NCT01150357|11633320|FG000|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||104
10484092|NCT01150357|11633321|FG001|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||51
10484093|NCT01150357|11633322|FG002|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||100
10484094|NCT01150357|11633320|FG000|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||3
10484095|NCT01150357|11633321|FG001|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||0
10484096|NCT01150357|11633322|FG002|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||2
10484097|NCT01150461|11633344|FG000|STARTED|Overall Study||11
10484098|NCT01150461|11633345|FG001|STARTED|Overall Study||9
10484099|NCT01150461|11633344|FG000|COMPLETED|Overall Study||11
10484100|NCT01150461|11633345|FG001|COMPLETED|Overall Study||9
10484101|NCT01150461|11633344|FG000|NOT COMPLETED|Overall Study||0
10484102|NCT01150461|11633345|FG001|NOT COMPLETED|Overall Study||0
10484103|NCT01150474|11633353|FG000|STARTED|Overall Study||51
10484104|NCT01150474|11633354|FG001|STARTED|Overall Study||52
10484105|NCT01150474|11633353|FG000|COMPLETED|Overall Study||41
10484106|NCT01150474|11633354|FG001|COMPLETED|Overall Study||49
10484107|NCT01150474|11633353|FG000|NOT COMPLETED|Overall Study||10
10484108|NCT01150474|11633354|FG001|NOT COMPLETED|Overall Study||3
10484109|NCT01150500|11633360|FG000|STARTED|Overall Study||65
10484110|NCT01150500|11633360|FG000|COMPLETED|Overall Study||0
10484111|NCT01150500|11633360|FG000|NOT COMPLETED|Overall Study||65
10527386|NCT01389765|11679469|FG000|COMPLETED|Second Intervention (Day 1)||12
10527387|NCT01389765|11679470|FG001|COMPLETED|Second Intervention (Day 1)||12
10527388|NCT01389765|11679469|FG000|NOT COMPLETED|Second Intervention (Day 1)||0
10527389|NCT01389765|11679470|FG001|NOT COMPLETED|Second Intervention (Day 1)||0
10527390|NCT01389856|11679478|FG000|STARTED|Overall Study|Randomized and treated. An additional 2 patients were randomized but not treated.|13
10527391|NCT01389856|11679479|FG001|STARTED|Overall Study|Randomized and treated.|8
10527392|NCT01389856|11679478|FG000|COMPLETED|Overall Study||13
10527393|NCT01389856|11679479|FG001|COMPLETED|Overall Study||8
10527394|NCT01389856|11679478|FG000|NOT COMPLETED|Overall Study||0
10527395|NCT01389856|11679479|FG001|NOT COMPLETED|Overall Study||0
10527396|NCT01389882|11679487|FG000|STARTED|Overall Study||13
10527397|NCT01389882|11679488|FG001|STARTED|Overall Study||11
10527398|NCT01389882|11679487|FG000|COMPLETED|Overall Study||12
10527399|NCT01389882|11679488|FG001|COMPLETED|Overall Study||7
10527400|NCT01389882|11679487|FG000|NOT COMPLETED|Overall Study||1
10527401|NCT01389882|11679488|FG001|NOT COMPLETED|Overall Study||4
10527402|NCT01389973|11679494|FG000|STARTED|Overall Study||20
10527403|NCT01389973|11679494|FG000|COMPLETED|Overall Study||0
10527404|NCT01389973|11679494|FG000|NOT COMPLETED|Overall Study||20
10527405|NCT01390038|11679498|FG000|STARTED|Overall Study||157
10527406|NCT01390038|11679498|FG000|COMPLETED|Overall Study||149
10527407|NCT01390038|11679498|FG000|NOT COMPLETED|Overall Study||8
10527408|NCT01390064|11679504|FG000|STARTED|Overall Study||3
10527409|NCT01390064|11679505|FG001|STARTED|Overall Study||3
10527410|NCT01390064|11679504|FG000|COMPLETED|Overall Study||3
10527411|NCT01390064|11679505|FG001|COMPLETED|Overall Study||3
10527412|NCT01390064|11679504|FG000|NOT COMPLETED|Overall Study||0
10527413|NCT01390064|11679505|FG001|NOT COMPLETED|Overall Study||0
10527414|NCT01390077|11679511|FG000|STARTED|Overall Study||8
10527415|NCT01390077|11679511|FG000|Treatment|Overall Study||7
10527416|NCT01390077|11679511|FG000|COMPLETED|Overall Study||7
10527417|NCT01390077|11679511|FG000|NOT COMPLETED|Overall Study||1
10527418|NCT01390220|11679520|FG000|STARTED|Test Dose Phase||292
10527419|NCT01390220|11679521|FG001|STARTED|Test Dose Phase|This arm not applicable in TDP.|0
10527420|NCT01390220|11679522|FG002|STARTED|Test Dose Phase|This arm not applicable in TDP.|0
10527421|NCT01390220|11679520|FG000|COMPLETED|Test Dose Phase||201
10527422|NCT01390220|11679521|FG001|COMPLETED|Test Dose Phase||0
10527423|NCT01390220|11679522|FG002|COMPLETED|Test Dose Phase||0
10527424|NCT01390220|11679520|FG000|NOT COMPLETED|Test Dose Phase||91
10527425|NCT01390220|11679521|FG001|NOT COMPLETED|Test Dose Phase||0
10527426|NCT01390220|11679522|FG002|NOT COMPLETED|Test Dose Phase||0
10527427|NCT01390220|11679520|FG000|STARTED|Comparative Phase|This arm not applicable in CP|0
10527428|NCT01390220|11679521|FG001|STARTED|Comparative Phase||134
10527429|NCT01390220|11679522|FG002|STARTED|Comparative Phase||67
10527430|NCT01390220|11679520|FG000|COMPLETED|Comparative Phase|This arm not applicable in CP|0
10527431|NCT01390220|11679521|FG001|COMPLETED|Comparative Phase||133
10527432|NCT01390220|11679522|FG002|COMPLETED|Comparative Phase||67
10527433|NCT01390220|11679520|FG000|NOT COMPLETED|Comparative Phase||0
10527434|NCT01390220|11679521|FG001|NOT COMPLETED|Comparative Phase||1
10527435|NCT01390220|11679522|FG002|NOT COMPLETED|Comparative Phase||0
10527436|NCT01390233|11679534|FG000|STARTED|Overall Study||35
10527437|NCT01390233|11679535|FG001|STARTED|Overall Study||31
10527438|NCT01390233|11679536|FG002|STARTED|Overall Study||36
10527439|NCT01390233|11679534|FG000|COMPLETED|Overall Study||30
10527440|NCT01390233|11679535|FG001|COMPLETED|Overall Study||29
10527441|NCT01390233|11679536|FG002|COMPLETED|Overall Study||30
10527442|NCT01390233|11679534|FG000|NOT COMPLETED|Overall Study||5
10527443|NCT01390233|11679535|FG001|NOT COMPLETED|Overall Study||2
10527444|NCT01390233|11679536|FG002|NOT COMPLETED|Overall Study||6
10527445|NCT01390246|11679546|FG000|STARTED|Overall Study||30
10527446|NCT01390246|11679547|FG001|STARTED|Overall Study||35
10527447|NCT01390246|11679546|FG000|Visit 2: Quit Day|Overall Study||24
10527448|NCT01390246|11679547|FG001|Visit 2: Quit Day|Overall Study||24
10527449|NCT01390246|11679546|FG000|Visit 6: End of Treatment|Overall Study||15
10527450|NCT01390246|11679547|FG001|Visit 6: End of Treatment|Overall Study||15
10527451|NCT01390246|11679546|FG000|Visit 7: 36-38 Weeks Gestation|Overall Study||10
10527452|NCT01390246|11679547|FG001|Visit 7: 36-38 Weeks Gestation|Overall Study||10
10527453|NCT01390246|11679546|FG000|COMPLETED|Overall Study||10
10527454|NCT01390246|11679547|FG001|COMPLETED|Overall Study||10
10527455|NCT01390246|11679546|FG000|NOT COMPLETED|Overall Study||20
10527456|NCT01390246|11679547|FG001|NOT COMPLETED|Overall Study||25
10527457|NCT01390259|11679553|FG000|STARTED|Overall Study||5
10527458|NCT01390259|11679554|FG001|STARTED|Overall Study||6
10527459|NCT01390259|11679553|FG000|COMPLETED|Overall Study||5
10527460|NCT01390259|11679554|FG001|COMPLETED|Overall Study||6
10527461|NCT01390259|11679553|FG000|NOT COMPLETED|Overall Study||0
10527462|NCT01390259|11679554|FG001|NOT COMPLETED|Overall Study||0
10527463|NCT01390272|11679561|FG000|STARTED|Overall Study||192
10527464|NCT01390272|11679562|FG001|STARTED|Overall Study||193
10527465|NCT01390272|11679561|FG000|6 Month Follow up|Overall Study|30 of 192 participants in the Titration Intervention group had missing blood pressure measurement|162
10484112|NCT01150760|11633366|FG000|STARTED|Overall Study||3525
10484113|NCT01150760|11633367|FG001|STARTED|Overall Study||3525
10484114|NCT01150760|11633366|FG000|COMPLETED|Overall Study||3525
10484115|NCT01150760|11633367|FG001|COMPLETED|Overall Study||3525
10484116|NCT01150760|11633366|FG000|NOT COMPLETED|Overall Study||0
10484117|NCT01150760|11633367|FG001|NOT COMPLETED|Overall Study||0
10484118|NCT01150838|11633378|FG000|STARTED|Overall Study||19
10484119|NCT01150838|11633379|FG001|STARTED|Overall Study||26
10484120|NCT01150838|11633380|FG002|STARTED|Overall Study||24
10484121|NCT01150838|11633381|FG003|STARTED|Overall Study||15
10484122|NCT01150838|11633382|FG004|STARTED|Overall Study||16
10484123|NCT01150838|11633383|FG005|STARTED|Overall Study||2
10484124|NCT01150838|11633378|FG000|COMPLETED|Overall Study||19
10484125|NCT01150838|11633379|FG001|COMPLETED|Overall Study||26
10484126|NCT01150838|11633380|FG002|COMPLETED|Overall Study||24
10484127|NCT01150838|11633381|FG003|COMPLETED|Overall Study||15
10484128|NCT01150838|11633382|FG004|COMPLETED|Overall Study||16
10484129|NCT01150838|11633383|FG005|COMPLETED|Overall Study||2
10484130|NCT01150838|11633378|FG000|NOT COMPLETED|Overall Study||0
10484131|NCT01150838|11633379|FG001|NOT COMPLETED|Overall Study||0
10484132|NCT01150838|11633380|FG002|NOT COMPLETED|Overall Study||0
10484133|NCT01150838|11633381|FG003|NOT COMPLETED|Overall Study||0
10484134|NCT01150838|11633382|FG004|NOT COMPLETED|Overall Study||0
10484135|NCT01150838|11633383|FG005|NOT COMPLETED|Overall Study||0
10484136|NCT01150903|11633393|FG000|STARTED|Overall Study||24708
10484137|NCT01150903|11633394|FG001|STARTED|Overall Study||74124
10484138|NCT01150903|11633393|FG000|COMPLETED|Overall Study||24708
10484139|NCT01150903|11633394|FG001|COMPLETED|Overall Study||74124
10484140|NCT01150903|11633393|FG000|NOT COMPLETED|Overall Study||0
10484141|NCT01150903|11633394|FG001|NOT COMPLETED|Overall Study||0
10484142|NCT01150981|11633402|FG000|STARTED|Overall Study||20
10484143|NCT01150981|11633403|FG001|STARTED|Overall Study||15
10484144|NCT01150981|11633402|FG000|COMPLETED|Overall Study||16
10484145|NCT01150981|11633403|FG001|COMPLETED|Overall Study||13
10484146|NCT01150981|11633402|FG000|NOT COMPLETED|Overall Study||4
10484147|NCT01150981|11633403|FG001|NOT COMPLETED|Overall Study||2
10484148|NCT01151020|11633409|FG000|STARTED|Overall Study||110
10484149|NCT01151020|11633409|FG000|30-day|Overall Study||110
10484150|NCT01151020|11633409|FG000|COMPLETED|Overall Study||56
10484151|NCT01151020|11633409|FG000|NOT COMPLETED|Overall Study||54
10484152|NCT01151046|11633415|FG000|STARTED|Overall Study||59
10484153|NCT01151046|11633416|FG001|STARTED|Overall Study||59
10484154|NCT01151046|11633415|FG000|COMPLETED|Overall Study||56
10484155|NCT01151046|11633416|FG001|COMPLETED|Overall Study||59
10484156|NCT01151046|11633415|FG000|NOT COMPLETED|Overall Study||3
10484157|NCT01151046|11633416|FG001|NOT COMPLETED|Overall Study||0
10484158|NCT01151085|11633426|FG000|STARTED|Overall Study||1002
10484159|NCT01151085|11633426|FG000|COMPLETED|Overall Study||946
10484160|NCT01151085|11633426|FG000|NOT COMPLETED|Overall Study||56
10484161|NCT01151098|11633437|FG000|STARTED|Overall Study|Extension Safety Population|189
10484162|NCT01151098|11633437|FG000|COMPLETED|Overall Study||72
10484163|NCT01151098|11633437|FG000|NOT COMPLETED|Overall Study||117
10484164|NCT01151137|11633443|FG000|STARTED|Overall Study||1617
10484165|NCT01151137|11633444|FG001|STARTED|Overall Study||1619
10484166|NCT01151137|11633443|FG000|Treated|Overall Study|One participant randomized to the placebo group received Dronedarone for 7 days by mistake|1610
10484167|NCT01151137|11633444|FG001|Treated|Overall Study||1613
10484168|NCT01151137|11633443|FG000|Discontinued Treatment|Overall Study||171
10484169|NCT01151137|11633444|FG001|Discontinued Treatment|Overall Study||342
10484170|NCT01151137|11633443|FG000|COMPLETED|Overall Study||1601
10484171|NCT01151137|11633444|FG001|COMPLETED|Overall Study||1591
10484172|NCT01151137|11633443|FG000|NOT COMPLETED|Overall Study||16
10484173|NCT01151137|11633444|FG001|NOT COMPLETED|Overall Study||28
10484174|NCT01151189|11633452|FG000|STARTED|Overall Study||326
10484175|NCT01151189|11633453|FG001|STARTED|Overall Study||324
10484176|NCT01151189|11633452|FG000|Received Vaccine|Overall Study||325
10484177|NCT01151189|11633453|FG001|Received Vaccine|Overall Study||324
10484178|NCT01151189|11633452|FG000|COMPLETED|Overall Study||311
10484179|NCT01151189|11633453|FG001|COMPLETED|Overall Study||314
10484180|NCT01151189|11633452|FG000|NOT COMPLETED|Overall Study||15
10484181|NCT01151189|11633453|FG001|NOT COMPLETED|Overall Study||10
10484182|NCT01151215|11633462|FG000|STARTED|Overall Study||120
10484183|NCT01151215|11633463|FG001|STARTED|Overall Study||118
10484184|NCT01151215|11633464|FG002|STARTED|Overall Study||121
10484185|NCT01151215|11633462|FG000|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|100
10484186|NCT01151215|11633463|FG001|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|95
10484187|NCT01151215|11633464|FG002|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|102
10484188|NCT01151215|11633462|FG000|NOT COMPLETED|Overall Study||20
10484189|NCT01151215|11633463|FG001|NOT COMPLETED|Overall Study||23
10484190|NCT01151215|11633464|FG002|NOT COMPLETED|Overall Study||19
10484191|NCT01151280|11633472|FG000|STARTED|Overall Study||10
10484192|NCT01151280|11633472|FG000|COMPLETED|Overall Study||6
10484193|NCT01151280|11633472|FG000|NOT COMPLETED|Overall Study||4
10484194|NCT01151345|11633476|FG000|STARTED|First Intervention Period||13
10484195|NCT01151345|11633477|FG001|STARTED|First Intervention Period||13
10484196|NCT01151345|11633476|FG000|Treated|First Intervention Period||13
10484197|NCT01151345|11633477|FG001|Treated|First Intervention Period||12
10484198|NCT01151345|11633476|FG000|COMPLETED|First Intervention Period||13
10484199|NCT01151345|11633477|FG001|COMPLETED|First Intervention Period||12
10484200|NCT01151345|11633476|FG000|NOT COMPLETED|First Intervention Period||0
10484201|NCT01151345|11633477|FG001|NOT COMPLETED|First Intervention Period||1
10484202|NCT01151345|11633476|FG000|STARTED|Wash-out Period (7 Days)||13
10484203|NCT01151345|11633477|FG001|STARTED|Wash-out Period (7 Days)||12
10484204|NCT01151345|11633476|FG000|COMPLETED|Wash-out Period (7 Days)||13
10484205|NCT01151345|11633477|FG001|COMPLETED|Wash-out Period (7 Days)||12
10484206|NCT01151345|11633476|FG000|NOT COMPLETED|Wash-out Period (7 Days)||0
10484207|NCT01151345|11633477|FG001|NOT COMPLETED|Wash-out Period (7 Days)||0
10484208|NCT01151345|11633476|FG000|STARTED|Second Intervention Period||13
10484209|NCT01151345|11633477|FG001|STARTED|Second Intervention Period||12
10484210|NCT01151345|11633476|FG000|COMPLETED|Second Intervention Period||13
10484211|NCT01151345|11633477|FG001|COMPLETED|Second Intervention Period||12
10484212|NCT01151345|11633476|FG000|NOT COMPLETED|Second Intervention Period||0
10484213|NCT01151345|11633477|FG001|NOT COMPLETED|Second Intervention Period||0
10484214|NCT01151371|11633486|FG000|STARTED|Overall Study||149
10484215|NCT01151371|11633487|FG001|STARTED|Overall Study||150
10484216|NCT01151371|11633488|FG002|STARTED|Overall Study||153
10484217|NCT01151371|11633486|FG000|COMPLETED|Overall Study||144
10484218|NCT01151371|11633487|FG001|COMPLETED|Overall Study||149
10484219|NCT01151371|11633488|FG002|COMPLETED|Overall Study||146
10484220|NCT01151371|11633486|FG000|NOT COMPLETED|Overall Study||5
10484221|NCT01151371|11633487|FG001|NOT COMPLETED|Overall Study||1
10484222|NCT01151371|11633488|FG002|NOT COMPLETED|Overall Study||7
10484223|NCT01151410|11633498|FG000|STARTED|Overall Study||104
10484224|NCT01151410|11633499|FG001|STARTED|Overall Study||104
10484225|NCT01151410|11633498|FG000|Safety Set (SAF)|Overall Study||105
10484226|NCT01151410|11633499|FG001|Safety Set (SAF)|Overall Study|Number of patients in SAF differed due to kit dispensing error in 1 patient at Visit 12|103
10484227|NCT01151410|11633498|FG000|COMPLETED|Overall Study||93
10484228|NCT01151410|11633499|FG001|COMPLETED|Overall Study||89
10484229|NCT01151410|11633498|FG000|NOT COMPLETED|Overall Study||11
10484230|NCT01151410|11633499|FG001|NOT COMPLETED|Overall Study||15
10484231|NCT01151423|11633507|FG000|STARTED|Overall Study||36
10484232|NCT01151423|11633508|FG001|STARTED|Overall Study||39
10484233|NCT01151423|11633507|FG000|Received Study Drug|Overall Study||35
10484234|NCT01151423|11633508|FG001|Received Study Drug|Overall Study||37
10484235|NCT01151423|11633507|FG000|COMPLETED|Overall Study||20
10484236|NCT01151423|11633508|FG001|COMPLETED|Overall Study||21
10484237|NCT01151423|11633507|FG000|NOT COMPLETED|Overall Study||16
10484238|NCT01151423|11633508|FG001|NOT COMPLETED|Overall Study||18
10484239|NCT01151436|11633514|FG000|STARTED|Overall Study||77
10484240|NCT01151436|11633514|FG000|COMPLETED|Overall Study||76
10484241|NCT01151436|11633514|FG000|NOT COMPLETED|Overall Study||1
10484242|NCT01151449|11633518|FG000|STARTED|Overall Study||6
10484243|NCT01151449|11633518|FG000|COMPLETED|Overall Study||6
10484244|NCT01151449|11633518|FG000|NOT COMPLETED|Overall Study||0
10484245|NCT01151540|11633522|FG000|STARTED|Overall Study||54
10484246|NCT01151540|11633522|FG000|COMPLETED|Overall Study||41
10484247|NCT01151540|11633522|FG000|NOT COMPLETED|Overall Study||13
10484248|NCT01151579|11633528|FG000|STARTED|Overall Study||58
10484249|NCT01151579|11633529|FG001|STARTED|Overall Study||31
10484250|NCT01151579|11633528|FG000|COMPLETED|Overall Study||46
10484251|NCT01151579|11633529|FG001|COMPLETED|Overall Study||24
10484252|NCT01151579|11633528|FG000|NOT COMPLETED|Overall Study||12
10484253|NCT01151579|11633529|FG001|NOT COMPLETED|Overall Study||7
10484254|NCT01151618|11633535|FG000|STARTED|Overall Study||22
10484255|NCT01151618|11633535|FG000|COMPLETED|Overall Study||13
10484256|NCT01151618|11633535|FG000|NOT COMPLETED|Overall Study||9
10484257|NCT01151761|11633539|FG000|STARTED|Overall Study||2
10484258|NCT01151761|11633539|FG000|COMPLETED|Overall Study||2
10484259|NCT01151761|11633539|FG000|NOT COMPLETED|Overall Study||0
10484260|NCT01151813|11633543|FG000|STARTED|Period 1||8
10484261|NCT01151813|11633544|FG001|STARTED|Period 1||7
10484262|NCT01151813|11633543|FG000|COMPLETED|Period 1||8
10484263|NCT01151813|11633544|FG001|COMPLETED|Period 1||7
10484264|NCT01151813|11633543|FG000|NOT COMPLETED|Period 1||0
10484265|NCT01151813|11633544|FG001|NOT COMPLETED|Period 1||0
10484266|NCT01151813|11633543|FG000|STARTED|Period 2||8
10484267|NCT01151813|11633544|FG001|STARTED|Period 2||7
10484268|NCT01151813|11633543|FG000|COMPLETED|Period 2||8
10484269|NCT01151813|11633544|FG001|COMPLETED|Period 2||7
10484270|NCT01151813|11633543|FG000|NOT COMPLETED|Period 2||0
10484271|NCT01151813|11633544|FG001|NOT COMPLETED|Period 2||0
10484272|NCT01151852|11633553|FG000|STARTED|Overall Study||41
10484273|NCT01151852|11633554|FG001|STARTED|Overall Study||40
10484274|NCT01151852|11633553|FG000|COMPLETED|Overall Study||41
10484275|NCT01151852|11633554|FG001|COMPLETED|Overall Study||40
10484276|NCT01151852|11633553|FG000|NOT COMPLETED|Overall Study||0
10484277|NCT01151852|11633554|FG001|NOT COMPLETED|Overall Study||0
10484278|NCT01152021|11633562|FG000|STARTED|Overall Study||8
10484279|NCT01152021|11633563|FG001|STARTED|Overall Study||7
10484280|NCT01152021|11633562|FG000|COMPLETED|Overall Study||2
10484281|NCT01152021|11633563|FG001|COMPLETED|Overall Study||1
10484282|NCT01152021|11633562|FG000|NOT COMPLETED|Overall Study||6
10484283|NCT01152021|11633563|FG001|NOT COMPLETED|Overall Study||6
10484284|NCT01152112|11633573|FG000|STARTED|Overall Study||42
10484285|NCT01152112|11633574|FG001|STARTED|Overall Study||32
10484286|NCT01152112|11633573|FG000|COMPLETED|Overall Study||42
10484287|NCT01152112|11633574|FG001|COMPLETED|Overall Study||32
10484288|NCT01152112|11633573|FG000|NOT COMPLETED|Overall Study||0
10484289|NCT01152112|11633574|FG001|NOT COMPLETED|Overall Study||0
10484290|NCT01152190|11633582|FG000|STARTED|Overall Study||50
10484291|NCT01152190|11633583|FG001|STARTED|Overall Study||47
10484292|NCT01152190|11633582|FG000|Received at Least 1 Dose of Study Drug|Overall Study||50
10484293|NCT01152190|11633583|FG001|Received at Least 1 Dose of Study Drug|Overall Study||47
10484294|NCT01152190|11633582|FG000|COMPLETED|Overall Study||45
10484295|NCT01152190|11633583|FG001|COMPLETED|Overall Study||39
10484296|NCT01152190|11633582|FG000|NOT COMPLETED|Overall Study||5
10484297|NCT01152190|11633583|FG001|NOT COMPLETED|Overall Study||8
10484298|NCT01152294|11633591|FG000|STARTED|Overall Study||213
10484299|NCT01152294|11633592|FG001|STARTED|Overall Study||188
10484300|NCT01152294|11633591|FG000|COMPLETED|Overall Study||213
10484301|NCT01152294|11633592|FG001|COMPLETED|Overall Study||188
10484302|NCT01152294|11633591|FG000|NOT COMPLETED|Overall Study||0
10484303|NCT01152294|11633592|FG001|NOT COMPLETED|Overall Study||0
10484304|NCT01152307|11633600|FG000|STARTED|Overall Study||191
10484305|NCT01152307|11633601|FG001|STARTED|Overall Study||214
10484306|NCT01152307|11633600|FG000|COMPLETED|Overall Study||191
10484307|NCT01152307|11633601|FG001|COMPLETED|Overall Study||214
10484308|NCT01152307|11633600|FG000|NOT COMPLETED|Overall Study||0
10484309|NCT01152307|11633601|FG001|NOT COMPLETED|Overall Study||0
10484310|NCT01152359|11633609|FG000|STARTED|Overall Study||105
10484311|NCT01152359|11633610|FG001|STARTED|Overall Study||102
10484312|NCT01152359|11633609|FG000|COMPLETED|Overall Study||81
10484313|NCT01152359|11633610|FG001|COMPLETED|Overall Study||80
10484314|NCT01152359|11633609|FG000|NOT COMPLETED|Overall Study||24
10484315|NCT01152359|11633610|FG001|NOT COMPLETED|Overall Study||22
10484316|NCT01152385|11633620|FG000|STARTED|Overall Study||55
10484317|NCT01152385|11633621|FG001|STARTED|Overall Study||58
10484318|NCT01152385|11633622|FG002|STARTED|Overall Study||56
10484319|NCT01152385|11633623|FG003|STARTED|Overall Study||55
10484320|NCT01152385|11633620|FG000|COMPLETED|Overall Study||46
10484321|NCT01152385|11633621|FG001|COMPLETED|Overall Study||52
10484322|NCT01152385|11633622|FG002|COMPLETED|Overall Study||51
10484323|NCT01152385|11633623|FG003|COMPLETED|Overall Study||50
10484324|NCT01152385|11633620|FG000|NOT COMPLETED|Overall Study||9
10484325|NCT01152385|11633621|FG001|NOT COMPLETED|Overall Study||6
10484326|NCT01152385|11633622|FG002|NOT COMPLETED|Overall Study||5
10484327|NCT01152385|11633623|FG003|NOT COMPLETED|Overall Study||5
10484328|NCT01152437|11633640|FG000|STARTED|Overall Study|randomised|36
10484329|NCT01152437|11633641|FG001|STARTED|Overall Study|randomised|15
10484330|NCT01152437|11633642|FG002|STARTED|Overall Study|entered|43
10484331|NCT01152437|11633640|FG000|COMPLETED|Overall Study||0
10484332|NCT01152437|11633641|FG001|COMPLETED|Overall Study||0
10484333|NCT01152437|11633642|FG002|COMPLETED|Overall Study||0
10484334|NCT01152437|11633640|FG000|NOT COMPLETED|Overall Study||36
10484335|NCT01152437|11633641|FG001|NOT COMPLETED|Overall Study||15
10484336|NCT01152437|11633642|FG002|NOT COMPLETED|Overall Study||43
10484337|NCT01152450|11633652|FG000|STARTED|Period 1 (4 Weeks)||15
10484338|NCT01152450|11633653|FG001|STARTED|Period 1 (4 Weeks)||16
10484339|NCT01152450|11633654|FG002|STARTED|Period 1 (4 Weeks)||17
10484340|NCT01152450|11633655|FG003|STARTED|Period 1 (4 Weeks)||15
10484341|NCT01152450|11633656|FG004|STARTED|Period 1 (4 Weeks)||18
10484342|NCT01152450|11633657|FG005|STARTED|Period 1 (4 Weeks)||13
10484343|NCT01152450|11633652|FG000|COMPLETED|Period 1 (4 Weeks)||15
10484344|NCT01152450|11633653|FG001|COMPLETED|Period 1 (4 Weeks)||15
10484345|NCT01152450|11633654|FG002|COMPLETED|Period 1 (4 Weeks)||16
10484346|NCT01152450|11633655|FG003|COMPLETED|Period 1 (4 Weeks)||15
10484347|NCT01152450|11633656|FG004|COMPLETED|Period 1 (4 Weeks)||16
10484348|NCT01152450|11633657|FG005|COMPLETED|Period 1 (4 Weeks)||12
10484349|NCT01152450|11633652|FG000|NOT COMPLETED|Period 1 (4 Weeks)||0
10484350|NCT01152450|11633653|FG001|NOT COMPLETED|Period 1 (4 Weeks)||1
10484351|NCT01152450|11633654|FG002|NOT COMPLETED|Period 1 (4 Weeks)||1
10484352|NCT01152450|11633655|FG003|NOT COMPLETED|Period 1 (4 Weeks)||0
10484353|NCT01152450|11633656|FG004|NOT COMPLETED|Period 1 (4 Weeks)||2
10484354|NCT01152450|11633657|FG005|NOT COMPLETED|Period 1 (4 Weeks)||1
10484355|NCT01152450|11633652|FG000|STARTED|Period 2 (4 Weeks)||15
10484356|NCT01152450|11633653|FG001|STARTED|Period 2 (4 Weeks)||15
10484357|NCT01152450|11633654|FG002|STARTED|Period 2 (4 Weeks)||16
10484358|NCT01152450|11633655|FG003|STARTED|Period 2 (4 Weeks)||15
10484359|NCT01152450|11633656|FG004|STARTED|Period 2 (4 Weeks)||16
10484360|NCT01152450|11633657|FG005|STARTED|Period 2 (4 Weeks)||12
10484361|NCT01152450|11633652|FG000|COMPLETED|Period 2 (4 Weeks)||15
10484362|NCT01152450|11633653|FG001|COMPLETED|Period 2 (4 Weeks)||15
10484363|NCT01152450|11633654|FG002|COMPLETED|Period 2 (4 Weeks)||16
10484364|NCT01152450|11633655|FG003|COMPLETED|Period 2 (4 Weeks)||15
10484365|NCT01152450|11633656|FG004|COMPLETED|Period 2 (4 Weeks)||16
10484366|NCT01152450|11633657|FG005|COMPLETED|Period 2 (4 Weeks)||12
10484367|NCT01152450|11633652|FG000|NOT COMPLETED|Period 2 (4 Weeks)||0
10484368|NCT01152450|11633653|FG001|NOT COMPLETED|Period 2 (4 Weeks)||0
10484369|NCT01152450|11633654|FG002|NOT COMPLETED|Period 2 (4 Weeks)||0
10484370|NCT01152450|11633655|FG003|NOT COMPLETED|Period 2 (4 Weeks)||0
10484371|NCT01152450|11633656|FG004|NOT COMPLETED|Period 2 (4 Weeks)||0
10484372|NCT01152450|11633657|FG005|NOT COMPLETED|Period 2 (4 Weeks)||0
10484373|NCT01152450|11633652|FG000|STARTED|Period 3 (4 Weeks)||15
10484374|NCT01152450|11633653|FG001|STARTED|Period 3 (4 Weeks)||15
10484375|NCT01152450|11633654|FG002|STARTED|Period 3 (4 Weeks)||16
10484376|NCT01152450|11633655|FG003|STARTED|Period 3 (4 Weeks)||15
10484377|NCT01152450|11633656|FG004|STARTED|Period 3 (4 Weeks)||16
10484378|NCT01152450|11633657|FG005|STARTED|Period 3 (4 Weeks)||12
10484379|NCT01152450|11633652|FG000|COMPLETED|Period 3 (4 Weeks)||15
10484380|NCT01152450|11633653|FG001|COMPLETED|Period 3 (4 Weeks)||15
10484381|NCT01152450|11633654|FG002|COMPLETED|Period 3 (4 Weeks)||16
10484382|NCT01152450|11633655|FG003|COMPLETED|Period 3 (4 Weeks)||15
10484383|NCT01152450|11633656|FG004|COMPLETED|Period 3 (4 Weeks)||16
10484384|NCT01152450|11633657|FG005|COMPLETED|Period 3 (4 Weeks)||12
10484385|NCT01152450|11633652|FG000|NOT COMPLETED|Period 3 (4 Weeks)||0
10484386|NCT01152450|11633653|FG001|NOT COMPLETED|Period 3 (4 Weeks)||0
10484387|NCT01152450|11633654|FG002|NOT COMPLETED|Period 3 (4 Weeks)||0
10484388|NCT01152450|11633655|FG003|NOT COMPLETED|Period 3 (4 Weeks)||0
10484389|NCT01152450|11633656|FG004|NOT COMPLETED|Period 3 (4 Weeks)||0
10484390|NCT01152450|11633657|FG005|NOT COMPLETED|Period 3 (4 Weeks)||0
10484391|NCT01152515|11633667|FG000|STARTED|Overall Study||25
10484392|NCT01152515|11633668|FG001|STARTED|Overall Study||25
10484393|NCT01152515|11633667|FG000|COMPLETED|Overall Study||25
10484394|NCT01152515|11633668|FG001|COMPLETED|Overall Study||25
10484395|NCT01152515|11633667|FG000|NOT COMPLETED|Overall Study||0
10484396|NCT01152515|11633668|FG001|NOT COMPLETED|Overall Study||0
10484397|NCT01152554|11633676|FG000|STARTED|Overall Study||610
10484398|NCT01152554|11633677|FG001|STARTED|Overall Study||203
10484399|NCT01152554|11633676|FG000|Received Treatment|Overall Study||607
10484400|NCT01152554|11633677|FG001|Received Treatment|Overall Study||201
10484401|NCT01152554|11633676|FG000|COMPLETED|Overall Study||276
10484402|NCT01152554|11633677|FG001|COMPLETED|Overall Study||92
10484403|NCT01152554|11633676|FG000|NOT COMPLETED|Overall Study||334
10484404|NCT01152554|11633677|FG001|NOT COMPLETED|Overall Study||111
10484405|NCT01152580|11633685|FG000|STARTED|Overall Study||5
10484406|NCT01152580|11633686|FG001|STARTED|Overall Study||14
10484407|NCT01152580|11633685|FG000|COMPLETED|Overall Study||5
10484408|NCT01152580|11633686|FG001|COMPLETED|Overall Study||13
10484409|NCT01152580|11633685|FG000|NOT COMPLETED|Overall Study||0
10484410|NCT01152580|11633686|FG001|NOT COMPLETED|Overall Study||1
10484411|NCT01152697|11633692|FG000|STARTED|Overall Study||30
10484412|NCT01152697|11633692|FG000|COMPLETED|Overall Study||11
10484413|NCT01152697|11633692|FG000|NOT COMPLETED|Overall Study||19
10484414|NCT01152788|11633698|FG000|STARTED|Overall Study||32
10484415|NCT01152788|11633699|FG001|STARTED|Overall Study||32
10484416|NCT01152788|11633698|FG000|COMPLETED|Overall Study||32
10484417|NCT01152788|11633699|FG001|COMPLETED|Overall Study||28
10484418|NCT01152788|11633698|FG000|NOT COMPLETED|Overall Study||0
10484419|NCT01152788|11633699|FG001|NOT COMPLETED|Overall Study||4
10484420|NCT01152814|11633705|FG000|STARTED|Overall Study||64
10484421|NCT01152814|11633705|FG000|COMPLETED|Overall Study||62
10484422|NCT01152814|11633705|FG000|NOT COMPLETED|Overall Study||2
10484423|NCT01152996|11633709|FG000|STARTED|Overall Study||1075
10484424|NCT01152996|11633709|FG000|Treated|Overall Study||1073
10484425|NCT01152996|11633709|FG000|COMPLETED|Overall Study||538
10484426|NCT01152996|11633709|FG000|NOT COMPLETED|Overall Study||537
10484427|NCT01153009|11633717|FG000|STARTED|Overall Study||161
10484428|NCT01153009|11633718|FG001|STARTED|Overall Study||147
10484429|NCT01153009|11633719|FG002|STARTED|Overall Study||154
10484430|NCT01153009|11633720|FG003|STARTED|Overall Study||152
10484431|NCT01153009|11633717|FG000|Treated|Overall Study||159
10484432|NCT01153009|11633718|FG001|Treated|Overall Study||147
10484433|NCT01153009|11633719|FG002|Treated|Overall Study||154
10484434|NCT01153009|11633720|FG003|Treated|Overall Study||150
10484435|NCT01153009|11633717|FG000|COMPLETED|Overall Study||129
10484436|NCT01153009|11633718|FG001|COMPLETED|Overall Study||113
10484437|NCT01153009|11633719|FG002|COMPLETED|Overall Study||113
10484438|NCT01153009|11633720|FG003|COMPLETED|Overall Study||115
10484439|NCT01153009|11633717|FG000|NOT COMPLETED|Overall Study||32
10484440|NCT01153009|11633718|FG001|NOT COMPLETED|Overall Study||34
10484441|NCT01153009|11633719|FG002|NOT COMPLETED|Overall Study||41
10484442|NCT01153009|11633720|FG003|NOT COMPLETED|Overall Study||37
10484443|NCT01153269|11633730|FG000|STARTED|Overall Study||33
10484444|NCT01153269|11633730|FG000|Participants Analyzed|Overall Study||33
10484445|NCT01153269|11633730|FG000|COMPLETED|Overall Study||31
10484446|NCT01153269|11633730|FG000|NOT COMPLETED|Overall Study||2
10484447|NCT01153321|11633739|FG000|STARTED|Overall Study||22
10484448|NCT01153321|11633740|FG001|STARTED|Overall Study||22
10484449|NCT01153321|11633739|FG000|COMPLETED|Overall Study||21
10484450|NCT01153321|11633740|FG001|COMPLETED|Overall Study||19
10484451|NCT01153321|11633739|FG000|NOT COMPLETED|Overall Study||1
10484452|NCT01153321|11633740|FG001|NOT COMPLETED|Overall Study||3
10484453|NCT01153347|11633750|FG000|STARTED|Overall Study||160
10484454|NCT01153347|11633751|FG001|STARTED|Overall Study||160
10484455|NCT01153347|11633752|FG002|STARTED|Overall Study||160
10484456|NCT01153347|11633753|FG003|STARTED|Overall Study||161
10484457|NCT01153347|11633750|FG000|Received Treatment|Overall Study||160
10484458|NCT01153347|11633751|FG001|Received Treatment|Overall Study||158
10484459|NCT01153347|11633752|FG002|Received Treatment|Overall Study||158
10484460|NCT01153347|11633753|FG003|Received Treatment|Overall Study||160
10484461|NCT01153347|11633750|FG000|COMPLETED|Overall Study||127
10484462|NCT01153347|11633751|FG001|COMPLETED|Overall Study||116
10484463|NCT01153347|11633752|FG002|COMPLETED|Overall Study||110
10484464|NCT01153347|11633753|FG003|COMPLETED|Overall Study||129
10484465|NCT01153347|11633750|FG000|NOT COMPLETED|Overall Study||33
10484466|NCT01153347|11633751|FG001|NOT COMPLETED|Overall Study||44
10484467|NCT01153347|11633752|FG002|NOT COMPLETED|Overall Study||50
10484468|NCT01153347|11633753|FG003|NOT COMPLETED|Overall Study||32
10484469|NCT01153425|11633765|FG000|STARTED|Overall Study||16
10484470|NCT01153425|11633766|FG001|STARTED|Overall Study||17
10484471|NCT01153425|11633765|FG000|COMPLETED|Overall Study||13
10484472|NCT01153425|11633766|FG001|COMPLETED|Overall Study||14
10484473|NCT01153425|11633765|FG000|NOT COMPLETED|Overall Study||3
10484474|NCT01153425|11633766|FG001|NOT COMPLETED|Overall Study||3
10484475|NCT01153503|11633776|FG000|STARTED|Overall Study||25
10484476|NCT01153503|11633777|FG001|STARTED|Overall Study||25
10484477|NCT01153503|11633778|FG002|STARTED|Overall Study||25
10484478|NCT01153503|11633776|FG000|COMPLETED|Overall Study||25
10484479|NCT01153503|11633777|FG001|COMPLETED|Overall Study||24
10484480|NCT01153503|11633778|FG002|COMPLETED|Overall Study||25
10484481|NCT01153503|11633776|FG000|NOT COMPLETED|Overall Study||0
10484482|NCT01153503|11633777|FG001|NOT COMPLETED|Overall Study||1
10484483|NCT01153503|11633778|FG002|NOT COMPLETED|Overall Study||0
10484484|NCT01153516|11633788|FG000|STARTED|Overall Study||12
10484485|NCT01153516|11633789|FG001|STARTED|Overall Study||10
10484486|NCT01153516|11633788|FG000|COMPLETED|Overall Study||10
10484487|NCT01153516|11633789|FG001|COMPLETED|Overall Study||10
10484488|NCT01153516|11633788|FG000|NOT COMPLETED|Overall Study||2
10484489|NCT01153516|11633789|FG001|NOT COMPLETED|Overall Study||0
10484490|NCT01153581|11633795|FG000|STARTED|Overall Study||109
10484491|NCT01153581|11633795|FG000|COMPLETED|Overall Study||109
10484492|NCT01153581|11633795|FG000|NOT COMPLETED|Overall Study||0
10484493|NCT01153620|11633807|FG000|STARTED|Overall Study||30
10484494|NCT01153620|11633808|FG001|STARTED|Overall Study|30 patients (31 wounds)|30
10484495|NCT01153620|11633807|FG000|COMPLETED|Overall Study||30
10484496|NCT01153620|11633808|FG001|COMPLETED|Overall Study|30 patients (31 wounds)|30
10484497|NCT01153620|11633807|FG000|NOT COMPLETED|Overall Study||0
10484498|NCT01153620|11633808|FG001|NOT COMPLETED|Overall Study||0
10484499|NCT01153633|11633816|FG000|STARTED|Overall Study||17
10484500|NCT01153633|11633817|FG001|STARTED|Overall Study||17
10484501|NCT01153633|11633816|FG000|COMPLETED|Overall Study||13
10484502|NCT01153633|11633817|FG001|COMPLETED|Overall Study||13
10484503|NCT01153633|11633816|FG000|NOT COMPLETED|Overall Study||4
10484504|NCT01153633|11633817|FG001|NOT COMPLETED|Overall Study||4
10484505|NCT01153672|11633825|FG000|STARTED|Overall Study||8
10484506|NCT01153672|11633825|FG000|COMPLETED|Overall Study||6
10484507|NCT01153672|11633825|FG000|NOT COMPLETED|Overall Study||2
10484508|NCT01153685|11633831|FG000|STARTED|Overall Study||50
10484509|NCT01153685|11633832|FG001|STARTED|Overall Study||70
10484510|NCT01153685|11633831|FG000|COMPLETED|Overall Study||50
10484511|NCT01153685|11633832|FG001|COMPLETED|Overall Study||70
10484512|NCT01153685|11633831|FG000|NOT COMPLETED|Overall Study||0
10484513|NCT01153685|11633832|FG001|NOT COMPLETED|Overall Study||0
10484514|NCT01153698|11633838|FG000|STARTED|Overall Study|Entered and treated.|168
10484515|NCT01153698|11633838|FG000|COMPLETED|Overall Study|Completed Pradaxa treatment.|139
10484516|NCT01153698|11633838|FG000|NOT COMPLETED|Overall Study||29
10484517|NCT01153711|11633843|FG000|STARTED|Overall Study||32
10484518|NCT01153711|11633843|FG000|COMPLETED|Overall Study||32
10484519|NCT01153711|11633843|FG000|NOT COMPLETED|Overall Study||0
10484520|NCT01153724|11633849|FG000|STARTED|Treatment Period 1||35
10484521|NCT01153724|11633849|FG000|COMPLETED|Treatment Period 1||34
10484522|NCT01153724|11633849|FG000|NOT COMPLETED|Treatment Period 1||1
10484523|NCT01153724|11633849|FG000|STARTED|Treatment Period 2||34
10484524|NCT01153724|11633849|FG000|COMPLETED|Treatment Period 2||32
10484525|NCT01153724|11633849|FG000|NOT COMPLETED|Treatment Period 2||2
10484526|NCT01153763|11633855|FG000|STARTED|Overall Study||92
10484527|NCT01153763|11633855|FG000|COMPLETED|Overall Study||71
10484528|NCT01153763|11633855|FG000|NOT COMPLETED|Overall Study||21
10484529|NCT01153815|11633861|FG000|STARTED|Overall Study||83
10484530|NCT01153815|11633862|FG001|STARTED|Overall Study||87
10484531|NCT01153815|11633861|FG000|COMPLETED|Overall Study||74
10484532|NCT01153815|11633862|FG001|COMPLETED|Overall Study||82
10484533|NCT01153815|11633861|FG000|NOT COMPLETED|Overall Study||9
10484534|NCT01153815|11633862|FG001|NOT COMPLETED|Overall Study||5
10484535|NCT01153841|11633870|FG000|STARTED|Overall Study||199
10484536|NCT01153841|11633871|FG001|STARTED|Overall Study||99
10484537|NCT01153841|11633870|FG000|COMPLETED|Overall Study||193
10484538|NCT01153841|11633871|FG001|COMPLETED|Overall Study||99
10484539|NCT01153841|11633870|FG000|NOT COMPLETED|Overall Study||6
10484540|NCT01153841|11633871|FG001|NOT COMPLETED|Overall Study||0
10484541|NCT01153893|11633879|FG000|STARTED|Overall Study|Issues with the informed consent obtained from one child led to related data not used in this report|68
10484542|NCT01153893|11633880|FG001|STARTED|Overall Study||36
10484543|NCT01153893|11633879|FG000|COMPLETED|Overall Study|Number of subjects who completed the follow-up visit at Month 1.|67
10484544|NCT01153893|11633880|FG001|COMPLETED|Overall Study|Number of subjects who completed the follow-up visit at Month 3.|36
10484545|NCT01153893|11633879|FG000|NOT COMPLETED|Overall Study||1
10484546|NCT01153893|11633880|FG001|NOT COMPLETED|Overall Study||0
10484547|NCT01153958|11633888|FG000|STARTED|Overall Study||66
10484548|NCT01153958|11633889|FG001|STARTED|Overall Study||67
10484549|NCT01153958|11633888|FG000|COMPLETED|Overall Study||30
10484550|NCT01153958|11633889|FG001|COMPLETED|Overall Study||35
10484551|NCT01153958|11633888|FG000|NOT COMPLETED|Overall Study||36
10484552|NCT01153958|11633889|FG001|NOT COMPLETED|Overall Study||32
10484553|NCT01153971|11633895|FG000|STARTED|Induction Phase (Months 1 to 7 of Study)||47
10484554|NCT01153971|11633895|FG000|COMPLETED|Induction Phase (Months 1 to 7 of Study)||44
10484555|NCT01153971|11633895|FG000|NOT COMPLETED|Induction Phase (Months 1 to 7 of Study)||3
10484556|NCT01153971|11633895|FG000|STARTED|Maintenance Phase (Months 8-16 of Study)||44
10484557|NCT01153971|11633895|FG000|COMPLETED|Maintenance Phase (Months 8-16 of Study)||41
10484558|NCT01153971|11633895|FG000|NOT COMPLETED|Maintenance Phase (Months 8-16 of Study)||3
10484559|NCT01153971|11633895|FG000|STARTED|Follow-up (Months 17-40 of Study)||41
10484560|NCT01153971|11633895|FG000|COMPLETED|Follow-up (Months 17-40 of Study)||37
10484561|NCT01153971|11633895|FG000|NOT COMPLETED|Follow-up (Months 17-40 of Study)||4
10484562|NCT01153984|11633899|FG000|STARTED|Overall Study||23
10484563|NCT01153984|11633899|FG000|COMPLETED|Overall Study||21
10484564|NCT01153984|11633899|FG000|NOT COMPLETED|Overall Study||2
10484565|NCT01154010|11633905|FG000|STARTED|Overall Study||9
10484566|NCT01154010|11633906|FG001|STARTED|Overall Study||9
10484567|NCT01154010|11633905|FG000|COMPLETED|Overall Study||9
10484568|NCT01154010|11633906|FG001|COMPLETED|Overall Study||8
10484569|NCT01154010|11633905|FG000|NOT COMPLETED|Overall Study||0
10484570|NCT01154010|11633906|FG001|NOT COMPLETED|Overall Study||1
10484571|NCT01154088|11633915|FG000|STARTED|Overall Study||390
10484572|NCT01154088|11633916|FG001|STARTED|Overall Study||390
10484573|NCT01154088|11633917|FG002|STARTED|Overall Study||390
10484574|NCT01154088|11633915|FG000|COMPLETED|Overall Study||386
10484575|NCT01154088|11633916|FG001|COMPLETED|Overall Study||384
10484576|NCT01154088|11633917|FG002|COMPLETED|Overall Study||383
10484577|NCT01154088|11633915|FG000|NOT COMPLETED|Overall Study||4
10484578|NCT01154088|11633916|FG001|NOT COMPLETED|Overall Study||6
10484579|NCT01154088|11633917|FG002|NOT COMPLETED|Overall Study||7
10484580|NCT01154101|11633931|FG000|STARTED|Overall Study||7
10484581|NCT01154101|11633932|FG001|STARTED|Overall Study||9
10484582|NCT01154101|11633933|FG002|STARTED|Overall Study||12
10484583|NCT01154101|11633934|FG003|STARTED|Overall Study||11
10484584|NCT01154101|11633935|FG004|STARTED|Overall Study||1
10484585|NCT01154101|11633931|FG000|COMPLETED|Overall Study||7
10484586|NCT01154101|11633932|FG001|COMPLETED|Overall Study||5
10484587|NCT01154101|11633933|FG002|COMPLETED|Overall Study||9
10484588|NCT01154101|11633934|FG003|COMPLETED|Overall Study||9
10484589|NCT01154101|11633935|FG004|COMPLETED|Overall Study||0
10484590|NCT01154101|11633931|FG000|NOT COMPLETED|Overall Study||0
10484591|NCT01154101|11633932|FG001|NOT COMPLETED|Overall Study||4
10484592|NCT01154101|11633933|FG002|NOT COMPLETED|Overall Study||3
10484593|NCT01154101|11633934|FG003|NOT COMPLETED|Overall Study||2
10484594|NCT01154101|11633935|FG004|NOT COMPLETED|Overall Study||1
10484595|NCT01154127|11633954|FG000|STARTED|Period 1 (21 Days)||55
10484596|NCT01154127|11633955|FG001|STARTED|Period 1 (21 Days)||53
10484597|NCT01154127|11633954|FG000|COMPLETED|Period 1 (21 Days)||52
10484598|NCT01154127|11633955|FG001|COMPLETED|Period 1 (21 Days)||47
10649897|NCT02164539|11810004|FG001|COMPLETED|Treatment Phase C (1 Week)||0
10649898|NCT02164539|11810005|FG002|COMPLETED|Treatment Phase C (1 Week)||0
10649899|NCT02164539|11810006|FG003|COMPLETED|Treatment Phase C (1 Week)||0
10649900|NCT02164539|11810007|FG004|COMPLETED|Treatment Phase C (1 Week)||84
10649901|NCT02164539|11810008|FG005|COMPLETED|Treatment Phase C (1 Week)||82
10484599|NCT01154127|11633954|FG000|NOT COMPLETED|Period 1 (21 Days)||3
10484600|NCT01154127|11633955|FG001|NOT COMPLETED|Period 1 (21 Days)||6
10484601|NCT01154127|11633954|FG000|STARTED|Washout (14 - 28 Days)||52
10484602|NCT01154127|11633955|FG001|STARTED|Washout (14 - 28 Days)||47
10484603|NCT01154127|11633954|FG000|COMPLETED|Washout (14 - 28 Days)||49
10484604|NCT01154127|11633955|FG001|COMPLETED|Washout (14 - 28 Days)||47
10484605|NCT01154127|11633954|FG000|NOT COMPLETED|Washout (14 - 28 Days)||3
10649902|NCT02164539|11810009|FG006|COMPLETED|Treatment Phase C (1 Week)||78
10484606|NCT01154127|11633955|FG001|NOT COMPLETED|Washout (14 - 28 Days)||0
10484607|NCT01154127|11633954|FG000|STARTED|Period 2 (21 Days)||49
10484608|NCT01154127|11633955|FG001|STARTED|Period 2 (21 Days)||47
10484609|NCT01154127|11633954|FG000|COMPLETED|Period 2 (21 Days)||49
10484610|NCT01154127|11633955|FG001|COMPLETED|Period 2 (21 Days)||46
10484611|NCT01154127|11633954|FG000|NOT COMPLETED|Period 2 (21 Days)||0
10484612|NCT01154127|11633955|FG001|NOT COMPLETED|Period 2 (21 Days)||1
10484613|NCT01154140|11633963|FG000|STARTED|Overall Study||172
10484614|NCT01154140|11633964|FG001|STARTED|Overall Study||171
10484615|NCT01154140|11633963|FG000|Treated|Overall Study||171
10484616|NCT01154140|11633964|FG001|Treated|Overall Study||169
10484617|NCT01154140|11633963|FG000|COMPLETED|Overall Study||81
10484618|NCT01154140|11633964|FG001|COMPLETED|Overall Study||69
10484619|NCT01154140|11633963|FG000|NOT COMPLETED|Overall Study||91
10484620|NCT01154140|11633964|FG001|NOT COMPLETED|Overall Study||102
10484621|NCT01154153|11633972|FG000|STARTED|Overall Study||71
10484622|NCT01154153|11633973|FG001|STARTED|Overall Study||69
10484623|NCT01154153|11633972|FG000|COMPLETED|Overall Study||66
10484624|NCT01154153|11633973|FG001|COMPLETED|Overall Study||66
10484625|NCT01154153|11633972|FG000|NOT COMPLETED|Overall Study||5
10484626|NCT01154153|11633973|FG001|NOT COMPLETED|Overall Study||3
10484627|NCT01154166|11633981|FG000|STARTED|Overall Study||169
10484628|NCT01154166|11633982|FG001|STARTED|Overall Study||175
10484629|NCT01154166|11633981|FG000|COMPLETED|Overall Study||135
10484630|NCT01154166|11633982|FG001|COMPLETED|Overall Study||163
10484631|NCT01154166|11633981|FG000|NOT COMPLETED|Overall Study||34
10484632|NCT01154166|11633982|FG001|NOT COMPLETED|Overall Study||12
10484633|NCT01154192|11633991|FG000|STARTED|Overall Study||14
10484634|NCT01154192|11633992|FG001|STARTED|Overall Study||10
10484635|NCT01154192|11633993|FG002|STARTED|Overall Study||0
10484636|NCT01154192|11633991|FG000|COMPLETED|Overall Study||14
10484637|NCT01154192|11633992|FG001|COMPLETED|Overall Study||10
10484638|NCT01154192|11633993|FG002|COMPLETED|Overall Study||0
10484639|NCT01154192|11633991|FG000|NOT COMPLETED|Overall Study||0
10484640|NCT01154192|11633992|FG001|NOT COMPLETED|Overall Study||0
10484641|NCT01154192|11633993|FG002|NOT COMPLETED|Overall Study||0
10484642|NCT01154218|11634002|FG000|STARTED|First Intervention Period||9
10484643|NCT01154218|11634003|FG001|STARTED|First Intervention Period||9
10484644|NCT01154218|11634004|FG002|STARTED|First Intervention Period||9
10484645|NCT01154218|11634005|FG003|STARTED|First Intervention Period||9
10484646|NCT01154218|11634002|FG000|COMPLETED|First Intervention Period||9
10484647|NCT01154218|11634003|FG001|COMPLETED|First Intervention Period||9
10484648|NCT01154218|11634004|FG002|COMPLETED|First Intervention Period||9
10484649|NCT01154218|11634005|FG003|COMPLETED|First Intervention Period||9
10484650|NCT01154218|11634002|FG000|NOT COMPLETED|First Intervention Period||0
10484651|NCT01154218|11634003|FG001|NOT COMPLETED|First Intervention Period||0
10484652|NCT01154218|11634004|FG002|NOT COMPLETED|First Intervention Period||0
10484653|NCT01154218|11634005|FG003|NOT COMPLETED|First Intervention Period||0
10484654|NCT01154218|11634002|FG000|STARTED|Washout Period (at Least 14 Days)||9
10484655|NCT01154218|11634003|FG001|STARTED|Washout Period (at Least 14 Days)||9
10484656|NCT01154218|11634004|FG002|STARTED|Washout Period (at Least 14 Days)||9
10484657|NCT01154218|11634005|FG003|STARTED|Washout Period (at Least 14 Days)||9
10484658|NCT01154218|11634002|FG000|COMPLETED|Washout Period (at Least 14 Days)||9
10484659|NCT01154218|11634003|FG001|COMPLETED|Washout Period (at Least 14 Days)||9
10484660|NCT01154218|11634004|FG002|COMPLETED|Washout Period (at Least 14 Days)||9
10484661|NCT01154218|11634005|FG003|COMPLETED|Washout Period (at Least 14 Days)||9
10484662|NCT01154218|11634002|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10484663|NCT01154218|11634003|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10484664|NCT01154218|11634004|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10484665|NCT01154218|11634005|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10484666|NCT01154218|11634002|FG000|STARTED|Second Intervention Period||9
10484667|NCT01154218|11634003|FG001|STARTED|Second Intervention Period||9
10484668|NCT01154218|11634004|FG002|STARTED|Second Intervention Period||9
10484669|NCT01154218|11634005|FG003|STARTED|Second Intervention Period||9
10484670|NCT01154218|11634002|FG000|COMPLETED|Second Intervention Period||9
10484671|NCT01154218|11634003|FG001|COMPLETED|Second Intervention Period||9
10484672|NCT01154218|11634004|FG002|COMPLETED|Second Intervention Period||9
10484673|NCT01154218|11634005|FG003|COMPLETED|Second Intervention Period||9
10484674|NCT01154218|11634002|FG000|NOT COMPLETED|Second Intervention Period||0
10484675|NCT01154218|11634003|FG001|NOT COMPLETED|Second Intervention Period||0
10484676|NCT01154218|11634004|FG002|NOT COMPLETED|Second Intervention Period||0
10484677|NCT01154218|11634005|FG003|NOT COMPLETED|Second Intervention Period||0
10709810|NCT02643394|11874875|FG001|NOT COMPLETED|Overall Study||5
10709811|NCT02643459|11874883|FG000|STARTED|Overall Study||7901
10709812|NCT02643459|11874884|FG001|STARTED|Overall Study||8900
10484678|NCT01154218|11634002|FG000|STARTED|Washout Period (at Least 14 Days)||9
10484679|NCT01154218|11634003|FG001|STARTED|Washout Period (at Least 14 Days)||9
10709813|NCT02643459|11874883|FG000|COMPLETED|Overall Study||7901
10484680|NCT01154218|11634004|FG002|STARTED|Washout Period (at Least 14 Days)||9
10484681|NCT01154218|11634005|FG003|STARTED|Washout Period (at Least 14 Days)||9
10484682|NCT01154218|11634002|FG000|COMPLETED|Washout Period (at Least 14 Days)||9
10484683|NCT01154218|11634003|FG001|COMPLETED|Washout Period (at Least 14 Days)||9
10484684|NCT01154218|11634004|FG002|COMPLETED|Washout Period (at Least 14 Days)||9
10709814|NCT02643459|11874884|FG001|COMPLETED|Overall Study||8900
10484685|NCT01154218|11634005|FG003|COMPLETED|Washout Period (at Least 14 Days)||9
10709815|NCT02643459|11874883|FG000|NOT COMPLETED|Overall Study||0
10709816|NCT02643459|11874884|FG001|NOT COMPLETED|Overall Study||0
10484686|NCT01154218|11634002|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10484687|NCT01154218|11634003|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10484688|NCT01154218|11634004|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10484689|NCT01154218|11634005|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10484690|NCT01154218|11634002|FG000|STARTED|Third Intervention Period||9
10649903|NCT02164539|11810003|FG000|NOT COMPLETED|Treatment Phase C (1 Week)||1
10649904|NCT02164539|11810004|FG001|NOT COMPLETED|Treatment Phase C (1 Week)||0
10649905|NCT02164539|11810005|FG002|NOT COMPLETED|Treatment Phase C (1 Week)||0
10649906|NCT02164539|11810006|FG003|NOT COMPLETED|Treatment Phase C (1 Week)||0
10649907|NCT02164539|11810007|FG004|NOT COMPLETED|Treatment Phase C (1 Week)||0
10649908|NCT02164539|11810008|FG005|NOT COMPLETED|Treatment Phase C (1 Week)||0
10649909|NCT02164539|11810009|FG006|NOT COMPLETED|Treatment Phase C (1 Week)||2
10649910|NCT02164721|11810024|FG000|STARTED|Overall Study||30
10484691|NCT01154218|11634003|FG001|STARTED|Third Intervention Period||9
10484692|NCT01154218|11634004|FG002|STARTED|Third Intervention Period||9
10484693|NCT01154218|11634005|FG003|STARTED|Third Intervention Period||9
10484694|NCT01154218|11634002|FG000|COMPLETED|Third Intervention Period||9
10484695|NCT01154218|11634003|FG001|COMPLETED|Third Intervention Period||8
10484696|NCT01154218|11634004|FG002|COMPLETED|Third Intervention Period||9
10484697|NCT01154218|11634005|FG003|COMPLETED|Third Intervention Period||9
10484698|NCT01154218|11634002|FG000|NOT COMPLETED|Third Intervention Period||0
10484699|NCT01154218|11634003|FG001|NOT COMPLETED|Third Intervention Period||1
10484700|NCT01154218|11634004|FG002|NOT COMPLETED|Third Intervention Period||0
10484701|NCT01154218|11634005|FG003|NOT COMPLETED|Third Intervention Period||0
10484702|NCT01154218|11634002|FG000|STARTED|Washout Period (at Least 14 Days)||9
10484703|NCT01154218|11634003|FG001|STARTED|Washout Period (at Least 14 Days)||8
10484704|NCT01154218|11634004|FG002|STARTED|Washout Period (at Least 14 Days)||9
10484705|NCT01154218|11634005|FG003|STARTED|Washout Period (at Least 14 Days)||9
10484706|NCT01154218|11634002|FG000|COMPLETED|Washout Period (at Least 14 Days)||9
10484707|NCT01154218|11634003|FG001|COMPLETED|Washout Period (at Least 14 Days)||8
10484708|NCT01154218|11634004|FG002|COMPLETED|Washout Period (at Least 14 Days)||9
10484709|NCT01154218|11634005|FG003|COMPLETED|Washout Period (at Least 14 Days)||8
10484710|NCT01154218|11634002|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10484711|NCT01154218|11634003|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10484712|NCT01154218|11634004|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10484713|NCT01154218|11634005|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||1
10484714|NCT01154218|11634002|FG000|STARTED|Fourth Intervention Period||9
10484715|NCT01154218|11634003|FG001|STARTED|Fourth Intervention Period||8
10484716|NCT01154218|11634004|FG002|STARTED|Fourth Intervention Period||9
10484717|NCT01154218|11634005|FG003|STARTED|Fourth Intervention Period||8
10484718|NCT01154218|11634002|FG000|COMPLETED|Fourth Intervention Period||8
10484719|NCT01154218|11634003|FG001|COMPLETED|Fourth Intervention Period||8
10484720|NCT01154218|11634004|FG002|COMPLETED|Fourth Intervention Period||9
10484721|NCT01154218|11634005|FG003|COMPLETED|Fourth Intervention Period||8
10484722|NCT01154218|11634002|FG000|NOT COMPLETED|Fourth Intervention Period||1
10484723|NCT01154218|11634003|FG001|NOT COMPLETED|Fourth Intervention Period||0
10484724|NCT01154218|11634004|FG002|NOT COMPLETED|Fourth Intervention Period||0
10484725|NCT01154218|11634005|FG003|NOT COMPLETED|Fourth Intervention Period||0
10484726|NCT01154231|11634015|FG000|STARTED|Overall Study||314
10484727|NCT01154231|11634015|FG000|COMPLETED|Overall Study||312
10484728|NCT01154231|11634015|FG000|NOT COMPLETED|Overall Study||2
10484729|NCT01154283|11634021|FG000|STARTED|0-6 Weeks||14
10484730|NCT01154283|11634022|FG001|STARTED|0-6 Weeks||14
10484731|NCT01154283|11634021|FG000|COMPLETED|0-6 Weeks||7
10484732|NCT01154283|11634022|FG001|COMPLETED|0-6 Weeks||11
10484733|NCT01154283|11634021|FG000|NOT COMPLETED|0-6 Weeks||7
10484734|NCT01154283|11634022|FG001|NOT COMPLETED|0-6 Weeks||3
10484735|NCT01154283|11634021|FG000|STARTED|7-12 Weeks||7
10484736|NCT01154283|11634022|FG001|STARTED|7-12 Weeks||11
10484737|NCT01154283|11634021|FG000|COMPLETED|7-12 Weeks||6
10484738|NCT01154283|11634022|FG001|COMPLETED|7-12 Weeks||10
10484739|NCT01154283|11634021|FG000|NOT COMPLETED|7-12 Weeks||1
10484740|NCT01154283|11634022|FG001|NOT COMPLETED|7-12 Weeks||1
10484741|NCT01154296|11634030|FG000|STARTED|Randomization and Intervention||2505
10484742|NCT01154296|11634031|FG001|STARTED|Randomization and Intervention||2507
10484743|NCT01154296|11634030|FG000|COMPLETED|Randomization and Intervention||2500
10484744|NCT01154296|11634031|FG001|COMPLETED|Randomization and Intervention||2505
10484745|NCT01154296|11634030|FG000|NOT COMPLETED|Randomization and Intervention||5
10484746|NCT01154296|11634031|FG001|NOT COMPLETED|Randomization and Intervention||2
10484747|NCT01154296|11634030|FG000|STARTED|6-month Follow-up||2505
10484748|NCT01154296|11634031|FG001|STARTED|6-month Follow-up||2507
10484749|NCT01154296|11634030|FG000|COMPLETED|6-month Follow-up||2177
10484750|NCT01154296|11634031|FG001|COMPLETED|6-month Follow-up||2179
10484751|NCT01154296|11634030|FG000|NOT COMPLETED|6-month Follow-up||328
10484752|NCT01154296|11634031|FG001|NOT COMPLETED|6-month Follow-up||328
10484753|NCT01154322|11634037|FG000|STARTED|Overall Study||16
10649911|NCT02164721|11810024|FG000|COMPLETED|Overall Study||30
10649912|NCT02164721|11810024|FG000|NOT COMPLETED|Overall Study||0
10649913|NCT02164864|11810032|FG000|STARTED|Overall Study|Started are the Randomised/entered patients.|981
10649914|NCT02164864|11810033|FG001|STARTED|Overall Study|Started are the Randomised/entered patients.|763
10709817|NCT02643472|11874893|FG000|STARTED|Overall Study||150
10484754|NCT01154322|11634037|FG000|COMPLETED|Overall Study||14
10484755|NCT01154322|11634037|FG000|NOT COMPLETED|Overall Study||2
10484756|NCT01154452|11634046|FG000|STARTED|Phase Ib||6
10484757|NCT01154452|11634047|FG001|STARTED|Phase Ib||4
10484758|NCT01154452|11634048|FG002|STARTED|Phase Ib||0
10484759|NCT01154452|11634049|FG003|STARTED|Phase Ib||0
10484760|NCT01154452|11634046|FG000|COMPLETED|Phase Ib||3
10484761|NCT01154452|11634047|FG001|COMPLETED|Phase Ib||3
10484762|NCT01154452|11634048|FG002|COMPLETED|Phase Ib||0
10484763|NCT01154452|11634049|FG003|COMPLETED|Phase Ib||0
10484764|NCT01154452|11634046|FG000|NOT COMPLETED|Phase Ib||3
10484765|NCT01154452|11634047|FG001|NOT COMPLETED|Phase Ib||1
10484766|NCT01154452|11634048|FG002|NOT COMPLETED|Phase Ib||0
10484767|NCT01154452|11634049|FG003|NOT COMPLETED|Phase Ib||0
10484768|NCT01154452|11634046|FG000|STARTED|Phase II||0
10484769|NCT01154452|11634047|FG001|STARTED|Phase II||0
10484770|NCT01154452|11634048|FG002|STARTED|Phase II||35
10484771|NCT01154452|11634049|FG003|STARTED|Phase II||33
10484772|NCT01154452|11634046|FG000|COMPLETED|Phase II||0
10484773|NCT01154452|11634047|FG001|COMPLETED|Phase II||0
10484774|NCT01154452|11634048|FG002|COMPLETED|Phase II||30
10484775|NCT01154452|11634049|FG003|COMPLETED|Phase II||27
10484776|NCT01154452|11634046|FG000|NOT COMPLETED|Phase II||0
10484777|NCT01154452|11634047|FG001|NOT COMPLETED|Phase II||0
10484778|NCT01154452|11634048|FG002|NOT COMPLETED|Phase II||5
10484779|NCT01154452|11634049|FG003|NOT COMPLETED|Phase II||6
10484780|NCT01154634|11634066|FG000|STARTED|Period 1 - First Intervention||4
10484781|NCT01154634|11634067|FG001|STARTED|Period 1 - First Intervention||7
10484782|NCT01154634|11634068|FG002|STARTED|Period 1 - First Intervention||4
10484783|NCT01154634|11634069|FG003|STARTED|Period 1 - First Intervention||5
10484784|NCT01154634|11634066|FG000|COMPLETED|Period 1 - First Intervention||4
10484785|NCT01154634|11634067|FG001|COMPLETED|Period 1 - First Intervention||7
10484786|NCT01154634|11634068|FG002|COMPLETED|Period 1 - First Intervention||4
10484787|NCT01154634|11634069|FG003|COMPLETED|Period 1 - First Intervention||5
10484788|NCT01154634|11634066|FG000|NOT COMPLETED|Period 1 - First Intervention||0
10484789|NCT01154634|11634067|FG001|NOT COMPLETED|Period 1 - First Intervention||0
10484790|NCT01154634|11634068|FG002|NOT COMPLETED|Period 1 - First Intervention||0
10484791|NCT01154634|11634069|FG003|NOT COMPLETED|Period 1 - First Intervention||0
10484792|NCT01154634|11634066|FG000|STARTED|Period 2 - Washout||4
10484793|NCT01154634|11634067|FG001|STARTED|Period 2 - Washout||7
10484794|NCT01154634|11634068|FG002|STARTED|Period 2 - Washout||4
10484795|NCT01154634|11634069|FG003|STARTED|Period 2 - Washout||5
10484796|NCT01154634|11634066|FG000|COMPLETED|Period 2 - Washout||4
10484797|NCT01154634|11634067|FG001|COMPLETED|Period 2 - Washout||7
10484798|NCT01154634|11634068|FG002|COMPLETED|Period 2 - Washout||4
10484799|NCT01154634|11634069|FG003|COMPLETED|Period 2 - Washout||5
10484800|NCT01154634|11634066|FG000|NOT COMPLETED|Period 2 - Washout||0
10484801|NCT01154634|11634067|FG001|NOT COMPLETED|Period 2 - Washout||0
10484802|NCT01154634|11634068|FG002|NOT COMPLETED|Period 2 - Washout||0
10484803|NCT01154634|11634069|FG003|NOT COMPLETED|Period 2 - Washout||0
10484804|NCT01154634|11634066|FG000|STARTED|Period 3- Second Intervention||4
10484805|NCT01154634|11634067|FG001|STARTED|Period 3- Second Intervention||7
10484806|NCT01154634|11634068|FG002|STARTED|Period 3- Second Intervention||4
10484807|NCT01154634|11634069|FG003|STARTED|Period 3- Second Intervention||5
10484808|NCT01154634|11634066|FG000|COMPLETED|Period 3- Second Intervention||4
10484809|NCT01154634|11634067|FG001|COMPLETED|Period 3- Second Intervention||7
10484810|NCT01154634|11634068|FG002|COMPLETED|Period 3- Second Intervention||4
10484811|NCT01154634|11634069|FG003|COMPLETED|Period 3- Second Intervention||5
10484812|NCT01154634|11634066|FG000|NOT COMPLETED|Period 3- Second Intervention||0
10484813|NCT01154634|11634067|FG001|NOT COMPLETED|Period 3- Second Intervention||0
10484814|NCT01154634|11634068|FG002|NOT COMPLETED|Period 3- Second Intervention||0
10484815|NCT01154634|11634069|FG003|NOT COMPLETED|Period 3- Second Intervention||0
10484816|NCT01154634|11634066|FG000|STARTED|Period 4 - Washout||4
10484817|NCT01154634|11634067|FG001|STARTED|Period 4 - Washout||7
10484818|NCT01154634|11634068|FG002|STARTED|Period 4 - Washout||4
10484819|NCT01154634|11634069|FG003|STARTED|Period 4 - Washout||5
10484820|NCT01154634|11634066|FG000|COMPLETED|Period 4 - Washout||4
10484821|NCT01154634|11634067|FG001|COMPLETED|Period 4 - Washout||7
10484822|NCT01154634|11634068|FG002|COMPLETED|Period 4 - Washout||4
10484823|NCT01154634|11634069|FG003|COMPLETED|Period 4 - Washout||5
10484824|NCT01154634|11634066|FG000|NOT COMPLETED|Period 4 - Washout||0
10484825|NCT01154634|11634067|FG001|NOT COMPLETED|Period 4 - Washout||0
10484826|NCT01154634|11634068|FG002|NOT COMPLETED|Period 4 - Washout||0
10484827|NCT01154634|11634069|FG003|NOT COMPLETED|Period 4 - Washout||0
10484828|NCT01154634|11634066|FG000|STARTED|Period 5 - Third Intervention||4
10484829|NCT01154634|11634067|FG001|STARTED|Period 5 - Third Intervention||7
10484830|NCT01154634|11634068|FG002|STARTED|Period 5 - Third Intervention||4
10484831|NCT01154634|11634069|FG003|STARTED|Period 5 - Third Intervention||5
10484832|NCT01154634|11634066|FG000|COMPLETED|Period 5 - Third Intervention||4
10484833|NCT01154634|11634067|FG001|COMPLETED|Period 5 - Third Intervention||7
10484834|NCT01154634|11634068|FG002|COMPLETED|Period 5 - Third Intervention||4
10484835|NCT01154634|11634069|FG003|COMPLETED|Period 5 - Third Intervention||5
10484836|NCT01154634|11634066|FG000|NOT COMPLETED|Period 5 - Third Intervention||0
10484837|NCT01154634|11634067|FG001|NOT COMPLETED|Period 5 - Third Intervention||0
10484838|NCT01154634|11634068|FG002|NOT COMPLETED|Period 5 - Third Intervention||0
10484839|NCT01154634|11634069|FG003|NOT COMPLETED|Period 5 - Third Intervention||0
10709818|NCT02643472|11874894|FG001|STARTED|Overall Study||150
10709819|NCT02643472|11874893|FG000|COMPLETED|Overall Study||123
10709820|NCT02643472|11874894|FG001|COMPLETED|Overall Study|One participant completed CESD-10 but not other measures at 12 months; n=115 for other measures.|116
10709821|NCT02643472|11874893|FG000|NOT COMPLETED|Overall Study||27
10709822|NCT02643472|11874894|FG001|NOT COMPLETED|Overall Study||34
10484840|NCT01154634|11634066|FG000|STARTED|Period 6 - Washout||4
10484841|NCT01154634|11634067|FG001|STARTED|Period 6 - Washout||7
10484842|NCT01154634|11634068|FG002|STARTED|Period 6 - Washout||4
10484843|NCT01154634|11634069|FG003|STARTED|Period 6 - Washout||5
10484844|NCT01154634|11634066|FG000|COMPLETED|Period 6 - Washout||4
10484845|NCT01154634|11634067|FG001|COMPLETED|Period 6 - Washout||7
10484846|NCT01154634|11634068|FG002|COMPLETED|Period 6 - Washout||4
10484847|NCT01154634|11634069|FG003|COMPLETED|Period 6 - Washout||5
10484848|NCT01154634|11634066|FG000|NOT COMPLETED|Period 6 - Washout||0
10484849|NCT01154634|11634067|FG001|NOT COMPLETED|Period 6 - Washout||0
10484850|NCT01154634|11634068|FG002|NOT COMPLETED|Period 6 - Washout||0
10484851|NCT01154634|11634069|FG003|NOT COMPLETED|Period 6 - Washout||0
10484852|NCT01154634|11634066|FG000|STARTED|Period 7 - Fourth Intervention||4
10484853|NCT01154634|11634067|FG001|STARTED|Period 7 - Fourth Intervention||7
10484854|NCT01154634|11634068|FG002|STARTED|Period 7 - Fourth Intervention||4
10484855|NCT01154634|11634069|FG003|STARTED|Period 7 - Fourth Intervention||5
10484856|NCT01154634|11634066|FG000|COMPLETED|Period 7 - Fourth Intervention||4
10484857|NCT01154634|11634067|FG001|COMPLETED|Period 7 - Fourth Intervention||7
10484858|NCT01154634|11634068|FG002|COMPLETED|Period 7 - Fourth Intervention||4
10484859|NCT01154634|11634069|FG003|COMPLETED|Period 7 - Fourth Intervention||5
10484860|NCT01154634|11634066|FG000|NOT COMPLETED|Period 7 - Fourth Intervention||0
10484861|NCT01154634|11634067|FG001|NOT COMPLETED|Period 7 - Fourth Intervention||0
10484862|NCT01154634|11634068|FG002|NOT COMPLETED|Period 7 - Fourth Intervention||0
10484863|NCT01154634|11634069|FG003|NOT COMPLETED|Period 7 - Fourth Intervention||0
10484864|NCT01154673|11634081|FG000|STARTED|Overall Study||16
10484865|NCT01154673|11634082|FG001|STARTED|Overall Study||16
10484866|NCT01154673|11634081|FG000|COMPLETED|Overall Study||14
10484867|NCT01154673|11634082|FG001|COMPLETED|Overall Study||16
10484868|NCT01154673|11634081|FG000|NOT COMPLETED|Overall Study||2
10484869|NCT01154673|11634082|FG001|NOT COMPLETED|Overall Study||0
10484870|NCT01154699|11634090|FG000|STARTED|First Intervention (4 Weeks)||13
10709823|NCT02643615|11874904|FG000|STARTED|Overall Study||9
10709824|NCT02643615|11874905|FG001|STARTED|Overall Study||11
10709825|NCT02643615|11874904|FG000|COMPLETED|Overall Study||9
10709826|NCT02643615|11874905|FG001|COMPLETED|Overall Study||11
10484871|NCT01154699|11634091|FG001|STARTED|First Intervention (4 Weeks)||8
10484872|NCT01154699|11634090|FG000|Subjects With Asthma Only|First Intervention (4 Weeks)||7
10484873|NCT01154699|11634091|FG001|Subjects With Asthma Only|First Intervention (4 Weeks)||6
10484874|NCT01154699|11634090|FG000|Subjects With Asthma + OSA|First Intervention (4 Weeks)||6
10484875|NCT01154699|11634091|FG001|Subjects With Asthma + OSA|First Intervention (4 Weeks)||2
10484876|NCT01154699|11634090|FG000|COMPLETED|First Intervention (4 Weeks)||13
10484877|NCT01154699|11634091|FG001|COMPLETED|First Intervention (4 Weeks)||8
10484878|NCT01154699|11634090|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
10484879|NCT01154699|11634091|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
10484880|NCT01154699|11634090|FG000|STARTED|Washout Period (4 Weeks)||13
10484881|NCT01154699|11634091|FG001|STARTED|Washout Period (4 Weeks)||8
10709827|NCT02643615|11874904|FG000|NOT COMPLETED|Overall Study||0
10484882|NCT01154699|11634090|FG000|Subjects With Asthma Only|Washout Period (4 Weeks)||7
10484883|NCT01154699|11634091|FG001|Subjects With Asthma Only|Washout Period (4 Weeks)||6
10484884|NCT01154699|11634090|FG000|Subjects With Asthma + OSA|Washout Period (4 Weeks)||6
10484885|NCT01154699|11634091|FG001|Subjects With Asthma + OSA|Washout Period (4 Weeks)||2
10484886|NCT01154699|11634090|FG000|COMPLETED|Washout Period (4 Weeks)||13
10484887|NCT01154699|11634091|FG001|COMPLETED|Washout Period (4 Weeks)||8
10484888|NCT01154699|11634090|FG000|NOT COMPLETED|Washout Period (4 Weeks)||0
10484889|NCT01154699|11634091|FG001|NOT COMPLETED|Washout Period (4 Weeks)||0
10484890|NCT01154699|11634090|FG000|STARTED|Second Intervention||13
10709828|NCT02643615|11874905|FG001|NOT COMPLETED|Overall Study||0
10709829|NCT02643628|11874914|FG000|STARTED|Overall Study||21
10484891|NCT01154699|11634091|FG001|STARTED|Second Intervention||8
10484892|NCT01154699|11634090|FG000|Subjects With Asthma Only|Second Intervention||7
10484893|NCT01154699|11634091|FG001|Subjects With Asthma Only|Second Intervention||6
10484894|NCT01154699|11634090|FG000|Subjects With Asthma + OSA|Second Intervention||6
10484895|NCT01154699|11634091|FG001|Subjects With Asthma + OSA|Second Intervention||2
10484896|NCT01154699|11634090|FG000|COMPLETED|Second Intervention||13
10484897|NCT01154699|11634091|FG001|COMPLETED|Second Intervention||8
10484898|NCT01154699|11634090|FG000|NOT COMPLETED|Second Intervention||0
10484899|NCT01154699|11634091|FG001|NOT COMPLETED|Second Intervention||0
10484900|NCT01154751|11634099|FG000|STARTED|6-month Follow-up||109
10484901|NCT01154751|11634099|FG000|COMPLETED|6-month Follow-up||98
10484902|NCT01154751|11634099|FG000|NOT COMPLETED|6-month Follow-up||11
10484903|NCT01154751|11634099|FG000|STARTED|1-year Follow-up||98
10484904|NCT01154751|11634099|FG000|COMPLETED|1-year Follow-up||93
10484905|NCT01154751|11634099|FG000|NOT COMPLETED|1-year Follow-up||5
10484906|NCT01154751|11634099|FG000|STARTED|2-year Follow-up||93
10484907|NCT01154751|11634099|FG000|COMPLETED|2-year Follow-up||83
10484908|NCT01154751|11634099|FG000|NOT COMPLETED|2-year Follow-up||10
10484909|NCT01154751|11634099|FG000|STARTED|3-year Follow-up||83
10484910|NCT01154751|11634099|FG000|COMPLETED|3-year Follow-up||34
10484911|NCT01154751|11634099|FG000|NOT COMPLETED|3-year Follow-up||49
10484912|NCT01154816|11634115|FG000|STARTED|Overall Study||20
10484913|NCT01154816|11634116|FG001|STARTED|Overall Study||12
10484914|NCT01154816|11634117|FG002|STARTED|Overall Study||10
10484915|NCT01154816|11634118|FG003|STARTED|Overall Study||10
10484916|NCT01154816|11634119|FG004|STARTED|Overall Study||10
10484917|NCT01154816|11634120|FG005|STARTED|Overall Study||8
10484918|NCT01154816|11634121|FG006|STARTED|Overall Study||6
10484919|NCT01154816|11634122|FG007|STARTED|Overall Study||7
10484920|NCT01154816|11634123|FG008|STARTED|Overall Study||10
10484921|NCT01154816|11634124|FG009|STARTED|Overall Study||10
10484922|NCT01154816|11634125|FG010|STARTED|Overall Study||11
10484923|NCT01154816|11634126|FG011|STARTED|Overall Study||4
10484924|NCT01154816|11634115|FG000|COMPLETED|Overall Study||0
10484925|NCT01154816|11634116|FG001|COMPLETED|Overall Study||2
10484926|NCT01154816|11634117|FG002|COMPLETED|Overall Study||0
10484927|NCT01154816|11634118|FG003|COMPLETED|Overall Study||0
10484928|NCT01154816|11634119|FG004|COMPLETED|Overall Study||0
10484929|NCT01154816|11634120|FG005|COMPLETED|Overall Study||0
10484930|NCT01154816|11634121|FG006|COMPLETED|Overall Study||0
10484931|NCT01154816|11634122|FG007|COMPLETED|Overall Study||0
10484932|NCT01154816|11634123|FG008|COMPLETED|Overall Study||1
10484933|NCT01154816|11634124|FG009|COMPLETED|Overall Study||0
10484934|NCT01154816|11634125|FG010|COMPLETED|Overall Study||0
10484935|NCT01154816|11634126|FG011|COMPLETED|Overall Study||0
10484936|NCT01154816|11634115|FG000|NOT COMPLETED|Overall Study||20
10484937|NCT01154816|11634116|FG001|NOT COMPLETED|Overall Study||10
10484938|NCT01154816|11634117|FG002|NOT COMPLETED|Overall Study||10
10484939|NCT01154816|11634118|FG003|NOT COMPLETED|Overall Study||10
10484940|NCT01154816|11634119|FG004|NOT COMPLETED|Overall Study||10
10484941|NCT01154816|11634120|FG005|NOT COMPLETED|Overall Study||8
10484942|NCT01154816|11634121|FG006|NOT COMPLETED|Overall Study||6
10484943|NCT01154816|11634122|FG007|NOT COMPLETED|Overall Study||7
10484944|NCT01154816|11634123|FG008|NOT COMPLETED|Overall Study||9
10484945|NCT01154816|11634124|FG009|NOT COMPLETED|Overall Study||10
10484946|NCT01154816|11634125|FG010|NOT COMPLETED|Overall Study||11
10484947|NCT01154816|11634126|FG011|NOT COMPLETED|Overall Study||4
10484948|NCT01154985|11634157|FG000|STARTED|Overall Study|Randomized|75
10484949|NCT01154985|11634158|FG001|STARTED|Overall Study|Randomized|82
10484950|NCT01154985|11634159|FG002|STARTED|Overall Study|Randomized|86
10484951|NCT01154985|11634157|FG000|Full Analysis Set|Overall Study|Received at least one dose of study medication|75
10484952|NCT01154985|11634158|FG001|Full Analysis Set|Overall Study|Received at least one dose of study medication|82
10484953|NCT01154985|11634159|FG002|Full Analysis Set|Overall Study|Received at least one dose of study medication|86
10484954|NCT01154985|11634157|FG000|Valid Biopsy -Baseline and Month 12.5|Overall Study||60
10484955|NCT01154985|11634158|FG001|Valid Biopsy -Baseline and Month 12.5|Overall Study||62
10484956|NCT01154985|11634159|FG002|Valid Biopsy -Baseline and Month 12.5|Overall Study||68
10484957|NCT01154985|11634157|FG000|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|55
10484958|NCT01154985|11634158|FG001|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|55
10484959|NCT01154985|11634159|FG002|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|64
10484960|NCT01154985|11634157|FG000|COMPLETED|Overall Study||58
10484961|NCT01154985|11634158|FG001|COMPLETED|Overall Study||55
10484962|NCT01154985|11634159|FG002|COMPLETED|Overall Study||68
10484963|NCT01154985|11634157|FG000|NOT COMPLETED|Overall Study||17
10484964|NCT01154985|11634158|FG001|NOT COMPLETED|Overall Study||27
10484965|NCT01154985|11634159|FG002|NOT COMPLETED|Overall Study||18
10484966|NCT01155011|11634169|FG000|STARTED|Baseline to 6 Months||151
10484967|NCT01155011|11634170|FG001|STARTED|Baseline to 6 Months||156
10484968|NCT01155011|11634169|FG000|COMPLETED|Baseline to 6 Months||129
10484969|NCT01155011|11634170|FG001|COMPLETED|Baseline to 6 Months||131
10484970|NCT01155011|11634169|FG000|NOT COMPLETED|Baseline to 6 Months||22
10484971|NCT01155011|11634170|FG001|NOT COMPLETED|Baseline to 6 Months||25
10484972|NCT01155011|11634169|FG000|STARTED|6 to 12 Months||129
10484973|NCT01155011|11634170|FG001|STARTED|6 to 12 Months||131
10484974|NCT01155011|11634169|FG000|COMPLETED|6 to 12 Months||120
10484975|NCT01155011|11634170|FG001|COMPLETED|6 to 12 Months||121
10484976|NCT01155011|11634169|FG000|NOT COMPLETED|6 to 12 Months||9
10484977|NCT01155011|11634170|FG001|NOT COMPLETED|6 to 12 Months||10
10484978|NCT01155024|11634180|FG000|STARTED|First Socket Intervention Fitting||5
10484979|NCT01155024|11634181|FG001|STARTED|First Socket Intervention Fitting||5
10484980|NCT01155024|11634180|FG000|COMPLETED|First Socket Intervention Fitting||5
10484981|NCT01155024|11634181|FG001|COMPLETED|First Socket Intervention Fitting||5
10484982|NCT01155024|11634180|FG000|NOT COMPLETED|First Socket Intervention Fitting||0
10484983|NCT01155024|11634181|FG001|NOT COMPLETED|First Socket Intervention Fitting||0
10484984|NCT01155024|11634180|FG000|STARTED|Second Socket Intervention Fitting||5
10484985|NCT01155024|11634181|FG001|STARTED|Second Socket Intervention Fitting||5
10484986|NCT01155024|11634180|FG000|COMPLETED|Second Socket Intervention Fitting||5
10484987|NCT01155024|11634181|FG001|COMPLETED|Second Socket Intervention Fitting||5
10484988|NCT01155024|11634180|FG000|NOT COMPLETED|Second Socket Intervention Fitting||0
10484989|NCT01155024|11634181|FG001|NOT COMPLETED|Second Socket Intervention Fitting||0
10484990|NCT01155024|11634180|FG000|STARTED|Direct Manufactured Socket 3 Month Trial||0
10484991|NCT01155024|11634181|FG001|STARTED|Direct Manufactured Socket 3 Month Trial||10
10484992|NCT01155024|11634180|FG000|COMPLETED|Direct Manufactured Socket 3 Month Trial||0
10484993|NCT01155024|11634181|FG001|COMPLETED|Direct Manufactured Socket 3 Month Trial||4
10484994|NCT01155024|11634180|FG000|NOT COMPLETED|Direct Manufactured Socket 3 Month Trial||0
10484995|NCT01155024|11634181|FG001|NOT COMPLETED|Direct Manufactured Socket 3 Month Trial||6
10484996|NCT01155050|11634192|FG000|STARTED|Overall Study||50
10484997|NCT01155050|11634193|FG001|STARTED|Overall Study||51
10484998|NCT01155050|11634194|FG002|STARTED|Overall Study||52
10484999|NCT01155050|11634195|FG003|STARTED|Overall Study||49
10485000|NCT01155050|11634192|FG000|COMPLETED|Overall Study||35
10485001|NCT01155050|11634193|FG001|COMPLETED|Overall Study||31
10485002|NCT01155050|11634194|FG002|COMPLETED|Overall Study||33
10485003|NCT01155050|11634195|FG003|COMPLETED|Overall Study||27
10485004|NCT01155050|11634192|FG000|NOT COMPLETED|Overall Study||15
10485005|NCT01155050|11634193|FG001|NOT COMPLETED|Overall Study||20
10485006|NCT01155050|11634194|FG002|NOT COMPLETED|Overall Study||19
10485007|NCT01155050|11634195|FG003|NOT COMPLETED|Overall Study||22
10485008|NCT01155063|11634205|FG000|STARTED|Overall Study||89
10485009|NCT01155063|11634205|FG000|COMPLETED|Overall Study||0
10485010|NCT01155063|11634205|FG000|NOT COMPLETED|Overall Study||89
10485011|NCT01155141|11634209|FG000|STARTED|Overall Study||16
10485012|NCT01155141|11634209|FG000|COMPLETED|Overall Study||14
10485013|NCT01155141|11634209|FG000|NOT COMPLETED|Overall Study||2
10485014|NCT01155154|11634216|FG000|STARTED|Overall Study||25
10485015|NCT01155154|11634217|FG001|STARTED|Overall Study||24
10485016|NCT01155154|11634218|FG002|STARTED|Overall Study||24
10485017|NCT01155154|11634216|FG000|COMPLETED|Overall Study||25
10485018|NCT01155154|11634217|FG001|COMPLETED|Overall Study||24
10485019|NCT01155154|11634218|FG002|COMPLETED|Overall Study||24
10485020|NCT01155154|11634216|FG000|NOT COMPLETED|Overall Study||0
10485021|NCT01155154|11634217|FG001|NOT COMPLETED|Overall Study||0
10485022|NCT01155154|11634218|FG002|NOT COMPLETED|Overall Study||0
10485023|NCT01155167|11634228|FG000|STARTED|Overall Study||43
10485024|NCT01155167|11634229|FG001|STARTED|Overall Study||43
10485025|NCT01155167|11634228|FG000|COMPLETED|Overall Study||40
10485026|NCT01155167|11634229|FG001|COMPLETED|Overall Study||43
10485027|NCT01155167|11634228|FG000|NOT COMPLETED|Overall Study||3
10485028|NCT01155167|11634229|FG001|NOT COMPLETED|Overall Study||0
10485029|NCT01155180|11634237|FG000|STARTED|Overall Study||18
10485030|NCT01155180|11634238|FG001|STARTED|Overall Study||6
10485031|NCT01155180|11634237|FG000|COMPLETED|Overall Study||18
10485032|NCT01155180|11634238|FG001|COMPLETED|Overall Study||6
10485033|NCT01155180|11634237|FG000|NOT COMPLETED|Overall Study||0
10485034|NCT01155180|11634238|FG001|NOT COMPLETED|Overall Study||0
10485035|NCT01155193|11634248|FG000|STARTED|Overall Study||10924
10485036|NCT01155193|11634249|FG001|STARTED|Overall Study||3818
10485037|NCT01155193|11634250|FG002|STARTED|Overall Study||2260
10485038|NCT01155193|11634251|FG003|STARTED|Overall Study||13802
10485039|NCT01155193|11634248|FG000|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|10686
10485040|NCT01155193|11634249|FG001|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|3805
10485041|NCT01155193|11634250|FG002|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|2248
10485042|NCT01155193|11634251|FG003|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|13711
10485043|NCT01155193|11634248|FG000|NOT COMPLETED|Overall Study||238
10485044|NCT01155193|11634249|FG001|NOT COMPLETED|Overall Study||13
10485045|NCT01155193|11634250|FG002|NOT COMPLETED|Overall Study||12
10485046|NCT01155193|11634251|FG003|NOT COMPLETED|Overall Study||91
10485047|NCT01155219|11634268|FG000|STARTED|Overall Study||77
10485048|NCT01155219|11634269|FG001|STARTED|Overall Study||73
10485049|NCT01155219|11634268|FG000|COMPLETED|Overall Study||73
10485050|NCT01155219|11634269|FG001|COMPLETED|Overall Study||70
10485051|NCT01155219|11634268|FG000|NOT COMPLETED|Overall Study||4
10485052|NCT01155219|11634269|FG001|NOT COMPLETED|Overall Study||3
10485053|NCT01155284|11634277|FG000|STARTED|Overall Study||47
10485054|NCT01155284|11634278|FG001|STARTED|Overall Study||23
10485055|NCT01155284|11634277|FG000|COMPLETED|Overall Study||40
10485056|NCT01155284|11634278|FG001|COMPLETED|Overall Study||18
10485057|NCT01155284|11634277|FG000|NOT COMPLETED|Overall Study||7
10485058|NCT01155284|11634278|FG001|NOT COMPLETED|Overall Study||5
10485059|NCT01155323|11634286|FG000|STARTED|First Intervention||60
10485060|NCT01155323|11634287|FG001|STARTED|First Intervention||58
10485061|NCT01155323|11634286|FG000|COMPLETED|First Intervention||59
10485062|NCT01155323|11634287|FG001|COMPLETED|First Intervention||57
10485063|NCT01155323|11634286|FG000|NOT COMPLETED|First Intervention||1
10485064|NCT01155323|11634287|FG001|NOT COMPLETED|First Intervention||1
10485065|NCT01155323|11634286|FG000|STARTED|Second Intervention||59
10485066|NCT01155323|11634287|FG001|STARTED|Second Intervention||57
10485067|NCT01155323|11634286|FG000|COMPLETED|Second Intervention||58
10485068|NCT01155323|11634287|FG001|COMPLETED|Second Intervention||56
10485069|NCT01155323|11634286|FG000|NOT COMPLETED|Second Intervention||1
10709830|NCT02643628|11874915|FG001|STARTED|Overall Study||23
10709831|NCT02643628|11874914|FG000|COMPLETED|Overall Study||20
10709832|NCT02643628|11874915|FG001|COMPLETED|Overall Study||17
10709833|NCT02643628|11874914|FG000|NOT COMPLETED|Overall Study||1
10709834|NCT02643628|11874915|FG001|NOT COMPLETED|Overall Study||6
10709835|NCT02643693|11874923|FG000|STARTED|Overall Study||4
10709836|NCT02643693|11874924|FG001|STARTED|Overall Study||4
10485070|NCT01155323|11634287|FG001|NOT COMPLETED|Second Intervention||1
10485071|NCT01155336|11634295|FG000|STARTED|Overall Study|We did not complete the study.|0
10485072|NCT01155336|11634296|FG001|STARTED|Overall Study|We did not complete the study.|4
10485073|NCT01155336|11634295|FG000|COMPLETED|Overall Study|We did not complete the study.|0
10485074|NCT01155336|11634296|FG001|COMPLETED|Overall Study|We did not complete the study.|4
10485075|NCT01155336|11634295|FG000|NOT COMPLETED|Overall Study||0
10485076|NCT01155336|11634296|FG001|NOT COMPLETED|Overall Study||0
10485077|NCT01155466|11634307|FG000|STARTED|Overall Study||156
10485078|NCT01155466|11634308|FG001|STARTED|Overall Study||155
10485079|NCT01155466|11634309|FG002|STARTED|Overall Study||156
10485080|NCT01155466|11634310|FG003|STARTED|Overall Study||155
10485081|NCT01155466|11634311|FG004|STARTED|Overall Study||156
10485082|NCT01155466|11634307|FG000|Treated|Overall Study||154
10485083|NCT01155466|11634308|FG001|Treated|Overall Study||153
10485084|NCT01155466|11634309|FG002|Treated|Overall Study||153
10485085|NCT01155466|11634310|FG003|Treated|Overall Study||155
10485086|NCT01155466|11634311|FG004|Treated|Overall Study||154
10485087|NCT01155466|11634307|FG000|COMPLETED|Overall Study|Completed treatment phase|134
10485088|NCT01155466|11634308|FG001|COMPLETED|Overall Study|Completed treatment phase|130
10485089|NCT01155466|11634309|FG002|COMPLETED|Overall Study|Completed treatment phase|136
10485090|NCT01155466|11634310|FG003|COMPLETED|Overall Study|Completed treatment phase|134
10485091|NCT01155466|11634311|FG004|COMPLETED|Overall Study|Completed treatment phase|129
10485092|NCT01155466|11634307|FG000|NOT COMPLETED|Overall Study||22
10485093|NCT01155466|11634308|FG001|NOT COMPLETED|Overall Study||25
10485094|NCT01155466|11634309|FG002|NOT COMPLETED|Overall Study||20
10485095|NCT01155466|11634310|FG003|NOT COMPLETED|Overall Study||21
10485096|NCT01155466|11634311|FG004|NOT COMPLETED|Overall Study||27
10485097|NCT01155479|11634328|FG000|STARTED|Part I||204
10485098|NCT01155479|11634329|FG001|STARTED|Part I||204
10485099|NCT01155479|11634330|FG002|STARTED|Part I||206
10485100|NCT01155479|11634331|FG003|STARTED|Part I||204
10485101|NCT01155479|11634332|FG004|STARTED|Part I||204
10485102|NCT01155479|11634328|FG000|Treated|Part I||200
10485103|NCT01155479|11634329|FG001|Treated|Part I||202
10485104|NCT01155479|11634330|FG002|Treated|Part I||204
10485105|NCT01155479|11634331|FG003|Treated|Part I||198
10485106|NCT01155479|11634332|FG004|Treated|Part I||203
10485107|NCT01155479|11634328|FG000|COMPLETED|Part I||166
10485108|NCT01155479|11634329|FG001|COMPLETED|Part I||177
10485109|NCT01155479|11634330|FG002|COMPLETED|Part I||167
10485110|NCT01155479|11634331|FG003|COMPLETED|Part I||177
10485111|NCT01155479|11634332|FG004|COMPLETED|Part I||181
10485112|NCT01155479|11634328|FG000|NOT COMPLETED|Part I||38
10485113|NCT01155479|11634329|FG001|NOT COMPLETED|Part I||27
10485114|NCT01155479|11634330|FG002|NOT COMPLETED|Part I||39
10485115|NCT01155479|11634331|FG003|NOT COMPLETED|Part I||27
10485116|NCT01155479|11634332|FG004|NOT COMPLETED|Part I||23
10485117|NCT01155479|11634328|FG000|STARTED|Part II||166
10485118|NCT01155479|11634329|FG001|STARTED|Part II||177
10485119|NCT01155479|11634330|FG002|STARTED|Part II||167
10709837|NCT02643693|11874925|FG002|STARTED|Overall Study||4
10485120|NCT01155479|11634331|FG003|STARTED|Part II||177
10485121|NCT01155479|11634332|FG004|STARTED|Part II||181
10485122|NCT01155479|11634328|FG000|COMPLETED|Part II||107
10485123|NCT01155479|11634329|FG001|COMPLETED|Part II||116
10485124|NCT01155479|11634330|FG002|COMPLETED|Part II||109
10485125|NCT01155479|11634331|FG003|COMPLETED|Part II||127
10485126|NCT01155479|11634332|FG004|COMPLETED|Part II||126
10485127|NCT01155479|11634328|FG000|NOT COMPLETED|Part II||59
10709838|NCT02643693|11874926|FG003|STARTED|Overall Study||4
10709839|NCT02643693|11874927|FG004|STARTED|Overall Study||4
10485128|NCT01155479|11634329|FG001|NOT COMPLETED|Part II||61
10485129|NCT01155479|11634330|FG002|NOT COMPLETED|Part II||58
10485130|NCT01155479|11634331|FG003|NOT COMPLETED|Part II||50
10485131|NCT01155479|11634332|FG004|NOT COMPLETED|Part II||55
10485132|NCT01155531|11634364|FG000|STARTED|Overall Study||10
10485133|NCT01155531|11634365|FG001|STARTED|Overall Study||10
10485134|NCT01155531|11634366|FG002|STARTED|Overall Study||10
10485135|NCT01155531|11634367|FG003|STARTED|Overall Study||10
10485136|NCT01155531|11634364|FG000|COMPLETED|Overall Study||9
10485137|NCT01155531|11634365|FG001|COMPLETED|Overall Study||10
10485138|NCT01155531|11634366|FG002|COMPLETED|Overall Study||8
10485139|NCT01155531|11634367|FG003|COMPLETED|Overall Study||9
10485140|NCT01155531|11634364|FG000|NOT COMPLETED|Overall Study||1
10485141|NCT01155531|11634365|FG001|NOT COMPLETED|Overall Study||0
10485142|NCT01155531|11634366|FG002|NOT COMPLETED|Overall Study||2
10485143|NCT01155531|11634367|FG003|NOT COMPLETED|Overall Study||1
10485144|NCT01155570|11634377|FG000|STARTED|Overall Study|Safety Analysis Population|734
10485145|NCT01155570|11634377|FG000|Efficacy Analysis Population|Overall Study|5 received Humira off-label, 21 did not receive Humira after the first administration|708
10485146|NCT01155570|11634377|FG000|COMPLETED|Overall Study||592
10485147|NCT01155570|11634377|FG000|NOT COMPLETED|Overall Study||142
10485148|NCT01155583|11634392|FG000|STARTED|Phase I||3
10485149|NCT01155583|11634393|FG001|STARTED|Phase I||3
10485150|NCT01155583|11634394|FG002|STARTED|Phase I||4
10485151|NCT01155583|11634395|FG003|STARTED|Phase I||6
10485152|NCT01155583|11634396|FG004|STARTED|Phase I||7
10485153|NCT01155583|11634397|FG005|STARTED|Phase I||0
10485154|NCT01155583|11634398|FG006|STARTED|Phase I||3
10485155|NCT01155583|11634399|FG007|STARTED|Phase I||8
10485156|NCT01155583|11634400|FG008|STARTED|Phase I||0
10485157|NCT01155583|11634392|FG000|COMPLETED|Phase I||3
10485158|NCT01155583|11634393|FG001|COMPLETED|Phase I||3
10485159|NCT01155583|11634394|FG002|COMPLETED|Phase I||4
10485160|NCT01155583|11634395|FG003|COMPLETED|Phase I||6
10485161|NCT01155583|11634396|FG004|COMPLETED|Phase I||6
10485162|NCT01155583|11634397|FG005|COMPLETED|Phase I||0
10485163|NCT01155583|11634398|FG006|COMPLETED|Phase I||3
10485164|NCT01155583|11634399|FG007|COMPLETED|Phase I||5
10485165|NCT01155583|11634400|FG008|COMPLETED|Phase I||0
10485166|NCT01155583|11634392|FG000|NOT COMPLETED|Phase I||0
10485167|NCT01155583|11634393|FG001|NOT COMPLETED|Phase I||0
10485168|NCT01155583|11634394|FG002|NOT COMPLETED|Phase I||0
10485169|NCT01155583|11634395|FG003|NOT COMPLETED|Phase I||0
10485170|NCT01155583|11634396|FG004|NOT COMPLETED|Phase I||1
10485171|NCT01155583|11634397|FG005|NOT COMPLETED|Phase I||0
10485172|NCT01155583|11634398|FG006|NOT COMPLETED|Phase I||0
10485173|NCT01155583|11634399|FG007|NOT COMPLETED|Phase I||3
10485174|NCT01155583|11634400|FG008|NOT COMPLETED|Phase I||0
10485175|NCT01155583|11634392|FG000|STARTED|Phase II - Expansion Phase||0
10485176|NCT01155583|11634393|FG001|STARTED|Phase II - Expansion Phase||0
10485177|NCT01155583|11634394|FG002|STARTED|Phase II - Expansion Phase||0
10485178|NCT01155583|11634395|FG003|STARTED|Phase II - Expansion Phase||0
10485179|NCT01155583|11634396|FG004|STARTED|Phase II - Expansion Phase||0
10485180|NCT01155583|11634397|FG005|STARTED|Phase II - Expansion Phase||0
10485181|NCT01155583|11634398|FG006|STARTED|Phase II - Expansion Phase||0
10485182|NCT01155583|11634399|FG007|STARTED|Phase II - Expansion Phase||0
10485183|NCT01155583|11634400|FG008|STARTED|Phase II - Expansion Phase||11
10485184|NCT01155583|11634392|FG000|COMPLETED|Phase II - Expansion Phase||0
10485185|NCT01155583|11634393|FG001|COMPLETED|Phase II - Expansion Phase||0
10485186|NCT01155583|11634394|FG002|COMPLETED|Phase II - Expansion Phase||0
10485187|NCT01155583|11634395|FG003|COMPLETED|Phase II - Expansion Phase||0
10485188|NCT01155583|11634396|FG004|COMPLETED|Phase II - Expansion Phase||0
10485189|NCT01155583|11634397|FG005|COMPLETED|Phase II - Expansion Phase||0
10485190|NCT01155583|11634398|FG006|COMPLETED|Phase II - Expansion Phase||0
10485191|NCT01155583|11634399|FG007|COMPLETED|Phase II - Expansion Phase||0
10485192|NCT01155583|11634400|FG008|COMPLETED|Phase II - Expansion Phase||11
10485193|NCT01155583|11634392|FG000|NOT COMPLETED|Phase II - Expansion Phase||0
10485194|NCT01155583|11634393|FG001|NOT COMPLETED|Phase II - Expansion Phase||0
10485195|NCT01155583|11634394|FG002|NOT COMPLETED|Phase II - Expansion Phase||0
10485196|NCT01155583|11634395|FG003|NOT COMPLETED|Phase II - Expansion Phase||0
10485197|NCT01155583|11634396|FG004|NOT COMPLETED|Phase II - Expansion Phase||0
10485198|NCT01155583|11634397|FG005|NOT COMPLETED|Phase II - Expansion Phase||0
10485199|NCT01155583|11634398|FG006|NOT COMPLETED|Phase II - Expansion Phase||0
10485200|NCT01155583|11634399|FG007|NOT COMPLETED|Phase II - Expansion Phase||0
10485201|NCT01155583|11634400|FG008|NOT COMPLETED|Phase II - Expansion Phase||0
10527466|NCT01390272|11679562|FG001|6 Month Follow up|Overall Study|22 of 193 in the LPN control group had missing blood pressure measurement|171
10527467|NCT01390272|11679561|FG000|12 Month Follow up|Overall Study|53 of 192 participants in the Titration Intervention group had missing measurement|139
10527468|NCT01390272|11679562|FG001|12 Month Follow up|Overall Study|34 of 193 in the LPN control group had missing blood pressure measurement|159
10527469|NCT01390272|11679561|FG000|18 Month Follow up|Overall Study|37 of 192 participants in the Titration Intervention group had missing blood pressure measurement|155
10527470|NCT01390272|11679562|FG001|18 Month Follow up|Overall Study|33 of 193 in the LPN control group had missing blood pressure measurement|160
10527471|NCT01390272|11679561|FG000|COMPLETED|Overall Study||175
10527472|NCT01390272|11679562|FG001|COMPLETED|Overall Study||178
10527473|NCT01390272|11679561|FG000|NOT COMPLETED|Overall Study||17
10527474|NCT01390272|11679562|FG001|NOT COMPLETED|Overall Study||15
10527475|NCT01390298|11679568|FG000|STARTED|Overall Study||55
10527476|NCT01390298|11679568|FG000|COMPLETED|Overall Study||31
10527477|NCT01390298|11679568|FG000|NOT COMPLETED|Overall Study||24
10527478|NCT01390389|11679574|FG000|STARTED|Overall Study||10
10527479|NCT01390389|11679575|FG001|STARTED|Overall Study||9
10527480|NCT01390389|11679574|FG000|COMPLETED|Overall Study||6
10527481|NCT01390389|11679575|FG001|COMPLETED|Overall Study||8
10527482|NCT01390389|11679574|FG000|NOT COMPLETED|Overall Study||4
10527483|NCT01390389|11679575|FG001|NOT COMPLETED|Overall Study||1
10529060|NCT01398475|11681470|FG002|Received First Intervention|Overall Study||4
10529061|NCT01398475|11681471|FG003|Received First Intervention|Overall Study||4
10529062|NCT01398475|11681468|FG000|Received Second Intervention|Overall Study||4
10529063|NCT01398475|11681469|FG001|Received Second Intervention|Overall Study||3
10485202|NCT01155661|11634416|FG000|STARTED|Overall Study||608
10485203|NCT01155661|11634416|FG000|COMPLETED|Overall Study||328
10485204|NCT01155661|11634416|FG000|NOT COMPLETED|Overall Study||280
10485205|NCT01155726|11634422|FG000|STARTED|Period 1, 3 Days (Masked)||24
10485206|NCT01155726|11634423|FG001|STARTED|Period 1, 3 Days (Masked)||20
10485207|NCT01155726|11634424|FG002|STARTED|Period 1, 3 Days (Masked)||30
10485208|NCT01155726|11634425|FG003|STARTED|Period 1, 3 Days (Masked)||25
10485209|NCT01155726|11634422|FG000|COMPLETED|Period 1, 3 Days (Masked)||23
10485210|NCT01155726|11634423|FG001|COMPLETED|Period 1, 3 Days (Masked)||20
10485211|NCT01155726|11634424|FG002|COMPLETED|Period 1, 3 Days (Masked)||28
10485212|NCT01155726|11634425|FG003|COMPLETED|Period 1, 3 Days (Masked)||25
10485213|NCT01155726|11634422|FG000|NOT COMPLETED|Period 1, 3 Days (Masked)||1
10485214|NCT01155726|11634423|FG001|NOT COMPLETED|Period 1, 3 Days (Masked)||0
10485215|NCT01155726|11634424|FG002|NOT COMPLETED|Period 1, 3 Days (Masked)||2
10485216|NCT01155726|11634425|FG003|NOT COMPLETED|Period 1, 3 Days (Masked)||0
10485217|NCT01155726|11634422|FG000|STARTED|Period 2, 3 Days (Unmask) or (Partial)||23
10485218|NCT01155726|11634423|FG001|STARTED|Period 2, 3 Days (Unmask) or (Partial)||20
10485219|NCT01155726|11634424|FG002|STARTED|Period 2, 3 Days (Unmask) or (Partial)||28
10485220|NCT01155726|11634425|FG003|STARTED|Period 2, 3 Days (Unmask) or (Partial)||25
10485221|NCT01155726|11634422|FG000|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||23
10485222|NCT01155726|11634423|FG001|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||20
10485223|NCT01155726|11634424|FG002|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||28
10485224|NCT01155726|11634425|FG003|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||25
10485225|NCT01155726|11634422|FG000|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
10485226|NCT01155726|11634423|FG001|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
10485227|NCT01155726|11634424|FG002|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
10485228|NCT01155726|11634425|FG003|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
10485229|NCT01155778|11634450|FG000|STARTED|Overall Study||4
10485230|NCT01155778|11634451|FG001|STARTED|Overall Study||4
10485231|NCT01155778|11634452|FG002|STARTED|Overall Study||4
10485232|NCT01155778|11634450|FG000|COMPLETED|Overall Study||4
10485233|NCT01155778|11634451|FG001|COMPLETED|Overall Study||4
10485234|NCT01155778|11634452|FG002|COMPLETED|Overall Study||4
10485235|NCT01155778|11634450|FG000|NOT COMPLETED|Overall Study||0
10485236|NCT01155778|11634451|FG001|NOT COMPLETED|Overall Study||0
10485237|NCT01155778|11634452|FG002|NOT COMPLETED|Overall Study||0
10485238|NCT01155830|11634463|FG000|STARTED|Overall Study||0
10485239|NCT01155830|11634464|FG001|STARTED|Overall Study||0
10485240|NCT01155830|11634465|FG002|STARTED|Overall Study||21
10485241|NCT01155830|11634463|FG000|COMPLETED|Overall Study||0
10485242|NCT01155830|11634464|FG001|COMPLETED|Overall Study||0
10485243|NCT01155830|11634465|FG002|COMPLETED|Overall Study||21
10485244|NCT01155830|11634463|FG000|NOT COMPLETED|Overall Study||0
10485245|NCT01155830|11634464|FG001|NOT COMPLETED|Overall Study||0
10485246|NCT01155830|11634465|FG002|NOT COMPLETED|Overall Study||0
10485247|NCT01155869|11634475|FG000|STARTED|Overall Study||3
10485248|NCT01155869|11634476|FG001|STARTED|Overall Study||4
10485249|NCT01155869|11634475|FG000|COMPLETED|Overall Study||0
10485250|NCT01155869|11634476|FG001|COMPLETED|Overall Study||3
10485251|NCT01155869|11634475|FG000|NOT COMPLETED|Overall Study||3
10485252|NCT01155869|11634476|FG001|NOT COMPLETED|Overall Study||1
10485253|NCT01155999|11634484|FG000|STARTED|Overall Study||146
10485254|NCT01155999|11634485|FG001|STARTED|Overall Study||140
10485255|NCT01155999|11634484|FG000|COMPLETED|Overall Study||139
10485256|NCT01155999|11634485|FG001|COMPLETED|Overall Study||136
10485257|NCT01155999|11634484|FG000|NOT COMPLETED|Overall Study||7
10485258|NCT01155999|11634485|FG001|NOT COMPLETED|Overall Study||4
10709840|NCT02643693|11874928|FG005|STARTED|Overall Study||4
10709841|NCT02643693|11874923|FG000|COMPLETED|Overall Study||2
10709842|NCT02643693|11874924|FG001|COMPLETED|Overall Study||2
10485259|NCT01156012|11634493|FG000|STARTED|Overall Study||213
10709843|NCT02643693|11874925|FG002|COMPLETED|Overall Study||3
10709844|NCT02643693|11874926|FG003|COMPLETED|Overall Study||4
10709845|NCT02643693|11874927|FG004|COMPLETED|Overall Study||4
10709846|NCT02643693|11874928|FG005|COMPLETED|Overall Study||3
10709847|NCT02643693|11874923|FG000|NOT COMPLETED|Overall Study||2
10709848|NCT02643693|11874924|FG001|NOT COMPLETED|Overall Study||2
10709849|NCT02643693|11874925|FG002|NOT COMPLETED|Overall Study||1
10709850|NCT02643693|11874926|FG003|NOT COMPLETED|Overall Study||0
10709851|NCT02643693|11874927|FG004|NOT COMPLETED|Overall Study||0
10709852|NCT02643693|11874928|FG005|NOT COMPLETED|Overall Study||1
10485260|NCT01156012|11634494|FG001|STARTED|Overall Study||189
10485261|NCT01156012|11634493|FG000|COMPLETED|Overall Study||206
10485262|NCT01156012|11634494|FG001|COMPLETED|Overall Study||186
10485263|NCT01156012|11634493|FG000|NOT COMPLETED|Overall Study||7
10485264|NCT01156012|11634494|FG001|NOT COMPLETED|Overall Study||3
10485265|NCT01156051|11634502|FG000|STARTED|Overall Study||12
10485266|NCT01156051|11634503|FG001|STARTED|Overall Study||17
10485267|NCT01156051|11634502|FG000|COMPLETED|Overall Study||11
10485268|NCT01156051|11634503|FG001|COMPLETED|Overall Study||16
10485269|NCT01156051|11634502|FG000|NOT COMPLETED|Overall Study||1
10485270|NCT01156051|11634503|FG001|NOT COMPLETED|Overall Study||1
10485271|NCT01156116|11634511|FG000|STARTED|Overall Study||26
10485272|NCT01156116|11634512|FG001|STARTED|Overall Study||13
10485273|NCT01156116|11634511|FG000|COMPLETED|Overall Study||21
10485274|NCT01156116|11634512|FG001|COMPLETED|Overall Study||12
10485275|NCT01156116|11634511|FG000|NOT COMPLETED|Overall Study||5
10485276|NCT01156116|11634512|FG001|NOT COMPLETED|Overall Study||1
10709853|NCT02643849|11874936|FG000|STARTED|Overall Study||107
10709854|NCT02643849|11874936|FG000|COMPLETED|Overall Study||82
10709855|NCT02643849|11874936|FG000|NOT COMPLETED|Overall Study||25
10709856|NCT02643862|11874942|FG000|STARTED|Overall Study||36
10709857|NCT02643862|11874943|FG001|STARTED|Overall Study||12
10709858|NCT02643862|11874942|FG000|COMPLETED|Overall Study||36
10709859|NCT02643862|11874943|FG001|COMPLETED|Overall Study||12
10485277|NCT01156142|11634520|FG000|STARTED|Overall Study||77
10485278|NCT01156142|11634521|FG001|STARTED|Overall Study||78
10485279|NCT01156142|11634520|FG000|COMPLETED|Overall Study||69
10485280|NCT01156142|11634521|FG001|COMPLETED|Overall Study||71
10485281|NCT01156142|11634520|FG000|NOT COMPLETED|Overall Study||8
10485282|NCT01156142|11634521|FG001|NOT COMPLETED|Overall Study||7
10485283|NCT01156311|11634529|FG000|STARTED|2-Month Monotherapy Period||59
10485284|NCT01156311|11634530|FG001|STARTED|2-Month Monotherapy Period||49
10485285|NCT01156311|11634531|FG002|STARTED|2-Month Monotherapy Period||0
10485286|NCT01156311|11634532|FG003|STARTED|2-Month Monotherapy Period||0
10485287|NCT01156311|11634529|FG000|COMPLETED|2-Month Monotherapy Period||57
10485288|NCT01156311|11634530|FG001|COMPLETED|2-Month Monotherapy Period||47
10485289|NCT01156311|11634531|FG002|COMPLETED|2-Month Monotherapy Period||0
10485290|NCT01156311|11634532|FG003|COMPLETED|2-Month Monotherapy Period||0
10485291|NCT01156311|11634529|FG000|NOT COMPLETED|2-Month Monotherapy Period||2
10485292|NCT01156311|11634530|FG001|NOT COMPLETED|2-Month Monotherapy Period||2
10485293|NCT01156311|11634531|FG002|NOT COMPLETED|2-Month Monotherapy Period||0
10485294|NCT01156311|11634532|FG003|NOT COMPLETED|2-Month Monotherapy Period||0
10485295|NCT01156311|11634529|FG000|STARTED|6-month Add-on Therapy Period||0
10485296|NCT01156311|11634530|FG001|STARTED|6-month Add-on Therapy Period||0
10485297|NCT01156311|11634531|FG002|STARTED|6-month Add-on Therapy Period||57
10485298|NCT01156311|11634532|FG003|STARTED|6-month Add-on Therapy Period||47
10485299|NCT01156311|11634529|FG000|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||0
10485300|NCT01156311|11634530|FG001|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||0
10485301|NCT01156311|11634531|FG002|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||45
10485302|NCT01156311|11634532|FG003|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||38
10485303|NCT01156311|11634529|FG000|COMPLETED|6-month Add-on Therapy Period||0
10485304|NCT01156311|11634530|FG001|COMPLETED|6-month Add-on Therapy Period||0
10485305|NCT01156311|11634531|FG002|COMPLETED|6-month Add-on Therapy Period||45
10485306|NCT01156311|11634532|FG003|COMPLETED|6-month Add-on Therapy Period||37
10485307|NCT01156311|11634529|FG000|NOT COMPLETED|6-month Add-on Therapy Period||0
10485308|NCT01156311|11634530|FG001|NOT COMPLETED|6-month Add-on Therapy Period||0
10485309|NCT01156311|11634531|FG002|NOT COMPLETED|6-month Add-on Therapy Period||12
10485310|NCT01156311|11634532|FG003|NOT COMPLETED|6-month Add-on Therapy Period||10
10485311|NCT01156363|11634543|FG000|STARTED|Overall Study||86
10485312|NCT01156363|11634543|FG000|COMPLETED|Overall Study||64
10485313|NCT01156363|11634543|FG000|NOT COMPLETED|Overall Study||22
10485314|NCT01156376|11634557|FG000|STARTED|Overall Study||27
10485315|NCT01156376|11634558|FG001|STARTED|Overall Study||26
10485316|NCT01156376|11634559|FG002|STARTED|Overall Study||27
10485317|NCT01156376|11634557|FG000|COMPLETED|Overall Study||26
10485318|NCT01156376|11634558|FG001|COMPLETED|Overall Study||26
10485319|NCT01156376|11634559|FG002|COMPLETED|Overall Study||23
10485320|NCT01156376|11634557|FG000|NOT COMPLETED|Overall Study||1
10485321|NCT01156376|11634558|FG001|NOT COMPLETED|Overall Study||0
10485322|NCT01156376|11634559|FG002|NOT COMPLETED|Overall Study||4
10485323|NCT01156480|11634569|FG000|STARTED|Overall Study||0
10485324|NCT01156480|11634570|FG001|STARTED|Overall Study||2
10485325|NCT01156480|11634569|FG000|COMPLETED|Overall Study||0
10485326|NCT01156480|11634570|FG001|COMPLETED|Overall Study||1
10485327|NCT01156480|11634569|FG000|NOT COMPLETED|Overall Study||0
10485328|NCT01156480|11634570|FG001|NOT COMPLETED|Overall Study||1
10485329|NCT01156532|11634578|FG000|STARTED|Overall Study||30
10485330|NCT01156532|11634578|FG000|COMPLETED|Overall Study||28
10485331|NCT01156532|11634578|FG000|NOT COMPLETED|Overall Study||2
10485332|NCT01156571|11634584|FG000|STARTED|Overall Study|ITT: defined as all patients randomized.|5581
10485333|NCT01156571|11634585|FG001|STARTED|Overall Study|ITT: defined as all patients randomized.|5564
10485334|NCT01156571|11634584|FG000|COMPLETED|Overall Study|Completed = ITT patients who completed scheduled visits or developed a primary endpoint event|5564
10485335|NCT01156571|11634585|FG001|COMPLETED|Overall Study|Completed = ITT patients who completed scheduled visits or developed a primary endpoint event|5545
10485336|NCT01156571|11634584|FG000|NOT COMPLETED|Overall Study||17
10485337|NCT01156571|11634585|FG001|NOT COMPLETED|Overall Study||19
10485338|NCT01156597|11634593|FG000|STARTED|Overall Study||16
10485339|NCT01156597|11634594|FG001|STARTED|Overall Study||14
10485340|NCT01156597|11634593|FG000|COMPLETED|Overall Study||13
10485341|NCT01156597|11634594|FG001|COMPLETED|Overall Study||13
10485342|NCT01156597|11634593|FG000|NOT COMPLETED|Overall Study||3
10485343|NCT01156597|11634594|FG001|NOT COMPLETED|Overall Study||1
10485344|NCT01156675|11634604|FG000|STARTED|Overall Study||107
10485345|NCT01156675|11634605|FG001|STARTED|Overall Study||106
10485346|NCT01156675|11634606|FG002|STARTED|Overall Study||2
10485347|NCT01156675|11634604|FG000|COMPLETED|Overall Study||73
10485348|NCT01156675|11634605|FG001|COMPLETED|Overall Study||81
10485349|NCT01156675|11634606|FG002|COMPLETED|Overall Study||0
10485350|NCT01156675|11634604|FG000|NOT COMPLETED|Overall Study||34
10485351|NCT01156675|11634605|FG001|NOT COMPLETED|Overall Study||25
10709860|NCT02643862|11874942|FG000|NOT COMPLETED|Overall Study||0
10709861|NCT02643862|11874943|FG001|NOT COMPLETED|Overall Study||0
10485352|NCT01156675|11634606|FG002|NOT COMPLETED|Overall Study||2
10485353|NCT01156701|11634615|FG000|STARTED|Overall Study||257
10485354|NCT01156701|11634616|FG001|STARTED|Overall Study||1007
10485355|NCT01156701|11634617|FG002|STARTED|Overall Study||163716
10485356|NCT01156701|11634618|FG003|STARTED|Overall Study||6725
10485357|NCT01156701|11634615|FG000|COMPLETED|Overall Study||257
10485358|NCT01156701|11634616|FG001|COMPLETED|Overall Study||1007
10485359|NCT01156701|11634617|FG002|COMPLETED|Overall Study||163716
10485360|NCT01156701|11634618|FG003|COMPLETED|Overall Study||6725
10485361|NCT01156701|11634615|FG000|NOT COMPLETED|Overall Study||0
10485362|NCT01156701|11634616|FG001|NOT COMPLETED|Overall Study||0
10485363|NCT01156701|11634617|FG002|NOT COMPLETED|Overall Study||0
10485364|NCT01156701|11634618|FG003|NOT COMPLETED|Overall Study||0
10485365|NCT01156714|11634631|FG000|STARTED|Overall Study||20
10485366|NCT01156714|11634632|FG001|STARTED|Overall Study||19
10485367|NCT01156714|11634633|FG002|STARTED|Overall Study||20
10485368|NCT01156714|11634631|FG000|COMPLETED|Overall Study||11
10485369|NCT01156714|11634632|FG001|COMPLETED|Overall Study||15
10485370|NCT01156714|11634633|FG002|COMPLETED|Overall Study||17
10485371|NCT01156714|11634631|FG000|NOT COMPLETED|Overall Study||9
10485372|NCT01156714|11634632|FG001|NOT COMPLETED|Overall Study||4
10485373|NCT01156714|11634633|FG002|NOT COMPLETED|Overall Study||3
10485374|NCT01156792|11634644|FG000|STARTED|Overall Study||162
10485375|NCT01156792|11634644|FG000|COMPLETED|Overall Study||93
10485376|NCT01156792|11634644|FG000|NOT COMPLETED|Overall Study||69
10485377|NCT01156805|11634661|FG000|STARTED|Overall Study||237
10485378|NCT01156805|11634662|FG001|STARTED|Overall Study||272
10485379|NCT01156805|11634661|FG000|COMPLETED|Overall Study||181
10485380|NCT01156805|11634662|FG001|COMPLETED|Overall Study||216
10485381|NCT01156805|11634661|FG000|NOT COMPLETED|Overall Study||56
10485382|NCT01156805|11634662|FG001|NOT COMPLETED|Overall Study||56
10485383|NCT01156844|11634672|FG000|STARTED|Overall Study|Randomized participants.|48
10485384|NCT01156844|11634673|FG001|STARTED|Overall Study||48
10485385|NCT01156844|11634674|FG002|STARTED|Overall Study||48
10485386|NCT01156844|11634675|FG003|STARTED|Overall Study||47
10485387|NCT01156844|11634672|FG000|PD & Safety Sets: Received Study Drug|Overall Study|PD=Pharmacodynamic|48
10485388|NCT01156844|11634673|FG001|PD & Safety Sets: Received Study Drug|Overall Study||47
10485389|NCT01156844|11634674|FG002|PD & Safety Sets: Received Study Drug|Overall Study||48
10485390|NCT01156844|11634675|FG003|PD & Safety Sets: Received Study Drug|Overall Study||46
10485391|NCT01156844|11634672|FG000|COMPLETED|Overall Study||46
10485392|NCT01156844|11634673|FG001|COMPLETED|Overall Study||46
10485393|NCT01156844|11634674|FG002|COMPLETED|Overall Study||42
10485394|NCT01156844|11634675|FG003|COMPLETED|Overall Study||41
10485395|NCT01156844|11634672|FG000|NOT COMPLETED|Overall Study||2
10485396|NCT01156844|11634673|FG001|NOT COMPLETED|Overall Study||2
10485397|NCT01156844|11634674|FG002|NOT COMPLETED|Overall Study||6
10485398|NCT01156844|11634675|FG003|NOT COMPLETED|Overall Study||6
10485399|NCT01156987|11634690|FG000|STARTED|Overall Study||8
10485400|NCT01156987|11634691|FG001|STARTED|Overall Study||23
10485401|NCT01156987|11634690|FG000|COMPLETED|Overall Study||8
10485402|NCT01156987|11634691|FG001|COMPLETED|Overall Study||12
10485403|NCT01156987|11634690|FG000|NOT COMPLETED|Overall Study||0
10485404|NCT01156987|11634691|FG001|NOT COMPLETED|Overall Study||11
10485405|NCT01157065|11634699|FG000|STARTED|Overall Study||38
10485406|NCT01157065|11634700|FG001|STARTED|Overall Study||11
10485407|NCT01157065|11634699|FG000|COMPLETED|Overall Study||38
10485408|NCT01157065|11634700|FG001|COMPLETED|Overall Study||10
10485409|NCT01157065|11634699|FG000|NOT COMPLETED|Overall Study||0
10485410|NCT01157065|11634700|FG001|NOT COMPLETED|Overall Study||1
10485411|NCT01157078|11634708|FG000|STARTED|Overall Study||159
10485412|NCT01157078|11634709|FG001|STARTED|Overall Study||160
10485413|NCT01157078|11634708|FG000|Received Treatment|Overall Study||157
10485414|NCT01157078|11634709|FG001|Received Treatment|Overall Study||159
10485415|NCT01157078|11634708|FG000|COMPLETED|Overall Study||124
10485416|NCT01157078|11634709|FG001|COMPLETED|Overall Study||124
10485417|NCT01157078|11634708|FG000|NOT COMPLETED|Overall Study||35
10485418|NCT01157078|11634709|FG001|NOT COMPLETED|Overall Study||36
10485419|NCT01157117|11634718|FG000|STARTED|Overall Study||28
10485420|NCT01157117|11634719|FG001|STARTED|Overall Study||29
10485421|NCT01157117|11634720|FG002|STARTED|Overall Study||20
10485422|NCT01157117|11634718|FG000|Began Omalizumab or Placebo Dosing|Overall Study||27
10485423|NCT01157117|11634719|FG001|Began Omalizumab or Placebo Dosing|Overall Study||28
10485424|NCT01157117|11634720|FG002|Began Omalizumab or Placebo Dosing|Overall Study||0
10485425|NCT01157117|11634718|FG000|Began Milk OIT Dosing at Month 4|Overall Study||27
10485426|NCT01157117|11634719|FG001|Began Milk OIT Dosing at Month 4|Overall Study||28
10485427|NCT01157117|11634720|FG002|Began Milk OIT Dosing at Month 4|Overall Study||0
10485428|NCT01157117|11634718|FG000|Reached Milk OIT Maintenance Dosing|Overall Study||26
10485429|NCT01157117|11634719|FG001|Reached Milk OIT Maintenance Dosing|Overall Study||26
10485430|NCT01157117|11634720|FG002|Reached Milk OIT Maintenance Dosing|Overall Study||0
10485431|NCT01157117|11634718|FG000|Unblinded at Month 16|Overall Study||26
10485432|NCT01157117|11634719|FG001|Unblinded at Month 16|Overall Study||26
10485433|NCT01157117|11634720|FG002|Unblinded at Month 16|Overall Study||0
10485434|NCT01157117|11634718|FG000|Completed Month 28 Desensitization OFC|Overall Study||26
10485435|NCT01157117|11634719|FG001|Completed Month 28 Desensitization OFC|Overall Study||24
10485436|NCT01157117|11634720|FG002|Completed Month 28 Desensitization OFC|Overall Study||0
10485437|NCT01157117|11634718|FG000|Discontinued Milk OIT at Month 30|Overall Study||24
10485438|NCT01157117|11634719|FG001|Discontinued Milk OIT at Month 30|Overall Study||20
10485439|NCT01157117|11634720|FG002|Discontinued Milk OIT at Month 30|Overall Study||0
10485440|NCT01157117|11634718|FG000|Completed Month 32 Tolerance OFC|Overall Study||24
10485441|NCT01157117|11634719|FG001|Completed Month 32 Tolerance OFC|Overall Study||20
10485442|NCT01157117|11634720|FG002|Completed Month 32 Tolerance OFC|Overall Study||0
10485443|NCT01157117|11634718|FG000|Completed Final Month 38 Study Visit|Overall Study||19
10485444|NCT01157117|11634719|FG001|Completed Final Month 38 Study Visit|Overall Study||18
10485445|NCT01157117|11634720|FG002|Completed Final Month 38 Study Visit|Overall Study||3
10485446|NCT01157117|11634718|FG000|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|19
10485447|NCT01157117|11634719|FG001|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|18
10485448|NCT01157117|11634720|FG002|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|5
10485449|NCT01157117|11634718|FG000|NOT COMPLETED|Overall Study||9
10485450|NCT01157117|11634719|FG001|NOT COMPLETED|Overall Study||11
10485451|NCT01157117|11634720|FG002|NOT COMPLETED|Overall Study||15
10485452|NCT01157169|11634730|FG000|STARTED|First Intervention||20
10485453|NCT01157169|11634731|FG001|STARTED|First Intervention||20
10485454|NCT01157169|11634730|FG000|COMPLETED|First Intervention||16
10485455|NCT01157169|11634731|FG001|COMPLETED|First Intervention||18
10485456|NCT01157169|11634730|FG000|NOT COMPLETED|First Intervention||4
10485457|NCT01157169|11634731|FG001|NOT COMPLETED|First Intervention||2
10485458|NCT01157169|11634730|FG000|STARTED|Washout of 10 Days||16
10485459|NCT01157169|11634731|FG001|STARTED|Washout of 10 Days||18
10485460|NCT01157169|11634730|FG000|COMPLETED|Washout of 10 Days||16
10485461|NCT01157169|11634731|FG001|COMPLETED|Washout of 10 Days||18
10485462|NCT01157169|11634730|FG000|NOT COMPLETED|Washout of 10 Days||0
10485463|NCT01157169|11634731|FG001|NOT COMPLETED|Washout of 10 Days||0
10485464|NCT01157169|11634730|FG000|STARTED|Second Intervention||16
10485465|NCT01157169|11634731|FG001|STARTED|Second Intervention||18
10485466|NCT01157169|11634730|FG000|COMPLETED|Second Intervention||16
10485467|NCT01157169|11634731|FG001|COMPLETED|Second Intervention||17
10485468|NCT01157169|11634730|FG000|NOT COMPLETED|Second Intervention||0
10485469|NCT01157169|11634731|FG001|NOT COMPLETED|Second Intervention||1
10485470|NCT01157182|11634739|FG000|STARTED|First Intervention||18
10485471|NCT01157182|11634740|FG001|STARTED|First Intervention||18
10485472|NCT01157182|11634739|FG000|COMPLETED|First Intervention||18
10485473|NCT01157182|11634740|FG001|COMPLETED|First Intervention||18
10485474|NCT01157182|11634739|FG000|NOT COMPLETED|First Intervention||0
10485475|NCT01157182|11634740|FG001|NOT COMPLETED|First Intervention||0
10485476|NCT01157182|11634739|FG000|STARTED|Washout of 28 Days||18
10485477|NCT01157182|11634740|FG001|STARTED|Washout of 28 Days||18
10485478|NCT01157182|11634739|FG000|COMPLETED|Washout of 28 Days||16
10485479|NCT01157182|11634740|FG001|COMPLETED|Washout of 28 Days||18
10485480|NCT01157182|11634739|FG000|NOT COMPLETED|Washout of 28 Days||2
10485481|NCT01157182|11634740|FG001|NOT COMPLETED|Washout of 28 Days||0
10485482|NCT01157182|11634739|FG000|STARTED|Second Intervention||16
10485483|NCT01157182|11634740|FG001|STARTED|Second Intervention||18
10485484|NCT01157182|11634739|FG000|COMPLETED|Second Intervention||16
10485485|NCT01157182|11634740|FG001|COMPLETED|Second Intervention||18
10485486|NCT01157182|11634739|FG000|NOT COMPLETED|Second Intervention||0
10485487|NCT01157182|11634740|FG001|NOT COMPLETED|Second Intervention||0
10485488|NCT01157234|11634748|FG000|STARTED|Overall Study||15
10485489|NCT01157234|11634749|FG001|STARTED|Overall Study||15
10485490|NCT01157234|11634748|FG000|COMPLETED|Overall Study||14
10485491|NCT01157234|11634749|FG001|COMPLETED|Overall Study||15
10485492|NCT01157234|11634748|FG000|NOT COMPLETED|Overall Study||1
10485493|NCT01157234|11634749|FG001|NOT COMPLETED|Overall Study||0
10485494|NCT01157351|11634764|FG000|STARTED|Overall Study||230
10485495|NCT01157351|11634765|FG001|STARTED|Overall Study||220
10485496|NCT01157351|11634764|FG000|Treated|Overall Study||226
10485497|NCT01157351|11634765|FG001|Treated|Overall Study||218
10485498|NCT01157351|11634764|FG000|COMPLETED|Overall Study||93
10709862|NCT02643875|11874949|FG000|STARTED|Overall Study||36
10709863|NCT02643875|11874949|FG000|Received 0.75|Overall Study||36
10709864|NCT02643875|11874949|FG000|Received 1.75 D|Overall Study||36
10709865|NCT02643875|11874949|FG000|COMPLETED|Overall Study||28
10709866|NCT02643875|11874949|FG000|NOT COMPLETED|Overall Study||8
10709867|NCT02643979|11874956|FG000|STARTED|Overall Study||11
10709868|NCT02643979|11874957|FG001|STARTED|Overall Study||11
10485499|NCT01157351|11634765|FG001|COMPLETED|Overall Study||88
10485500|NCT01157351|11634764|FG000|NOT COMPLETED|Overall Study||137
10485501|NCT01157351|11634765|FG001|NOT COMPLETED|Overall Study||132
10485502|NCT01157364|11634777|FG000|STARTED|Overall Study||15
10485503|NCT01157364|11634778|FG001|STARTED|Overall Study||21
10485504|NCT01157364|11634779|FG002|STARTED|Overall Study||21
10485505|NCT01157364|11634780|FG003|STARTED|Overall Study||18
10485506|NCT01157364|11634781|FG004|STARTED|Overall Study||11
10485507|NCT01157364|11634782|FG005|STARTED|Overall Study||23
10485508|NCT01157364|11634777|FG000|COMPLETED|Overall Study||13
10485509|NCT01157364|11634778|FG001|COMPLETED|Overall Study||17
10485510|NCT01157364|11634779|FG002|COMPLETED|Overall Study||17
10485511|NCT01157364|11634780|FG003|COMPLETED|Overall Study||16
10485512|NCT01157364|11634781|FG004|COMPLETED|Overall Study||9
10485513|NCT01157364|11634782|FG005|COMPLETED|Overall Study||22
10485514|NCT01157364|11634777|FG000|NOT COMPLETED|Overall Study||2
10709869|NCT02643979|11874956|FG000|COMPLETED|Overall Study||11
10709870|NCT02643979|11874957|FG001|COMPLETED|Overall Study||11
10709871|NCT02643979|11874956|FG000|NOT COMPLETED|Overall Study||0
10485515|NCT01157364|11634778|FG001|NOT COMPLETED|Overall Study||4
10485516|NCT01157364|11634779|FG002|NOT COMPLETED|Overall Study||4
10485517|NCT01157364|11634780|FG003|NOT COMPLETED|Overall Study||2
10485518|NCT01157364|11634781|FG004|NOT COMPLETED|Overall Study||2
10485519|NCT01157364|11634782|FG005|NOT COMPLETED|Overall Study||1
10485520|NCT01157377|11634803|FG000|STARTED|Overall Study||23
10485521|NCT01157377|11634804|FG001|STARTED|Overall Study||23
10485522|NCT01157377|11634805|FG002|STARTED|Overall Study||27
10485523|NCT01157377|11634806|FG003|STARTED|Overall Study||15
10485524|NCT01157377|11634807|FG004|STARTED|Overall Study||20
10485525|NCT01157377|11634808|FG005|STARTED|Overall Study||19
10485526|NCT01157377|11634809|FG006|STARTED|Overall Study||29
10485527|NCT01157377|11634803|FG000|COMPLETED|Overall Study||21
10485528|NCT01157377|11634804|FG001|COMPLETED|Overall Study||20
10485529|NCT01157377|11634805|FG002|COMPLETED|Overall Study||26
10485530|NCT01157377|11634806|FG003|COMPLETED|Overall Study||14
10485531|NCT01157377|11634807|FG004|COMPLETED|Overall Study||18
10485532|NCT01157377|11634808|FG005|COMPLETED|Overall Study||16
10485533|NCT01157377|11634809|FG006|COMPLETED|Overall Study||27
10485534|NCT01157377|11634803|FG000|NOT COMPLETED|Overall Study||2
10485535|NCT01157377|11634804|FG001|NOT COMPLETED|Overall Study||3
10485536|NCT01157377|11634805|FG002|NOT COMPLETED|Overall Study||1
10485537|NCT01157377|11634806|FG003|NOT COMPLETED|Overall Study||1
10485538|NCT01157377|11634807|FG004|NOT COMPLETED|Overall Study||2
10485539|NCT01157377|11634808|FG005|NOT COMPLETED|Overall Study||3
10485540|NCT01157377|11634809|FG006|NOT COMPLETED|Overall Study||2
10485541|NCT01157416|11634827|FG000|STARTED|Overall Study||17
10485542|NCT01157416|11634828|FG001|STARTED|Overall Study||16
10485543|NCT01157416|11634827|FG000|COMPLETED|Overall Study||15
10485544|NCT01157416|11634828|FG001|COMPLETED|Overall Study||16
10485545|NCT01157416|11634827|FG000|NOT COMPLETED|Overall Study||2
10485546|NCT01157416|11634828|FG001|NOT COMPLETED|Overall Study||0
10485547|NCT01157429|11634836|FG000|STARTED|Overall Study||12
10485548|NCT01157429|11634837|FG001|STARTED|Overall Study||12
10485549|NCT01157429|11634836|FG000|COMPLETED|Overall Study||8
10485550|NCT01157429|11634837|FG001|COMPLETED|Overall Study||8
10485551|NCT01157429|11634836|FG000|NOT COMPLETED|Overall Study||4
10485552|NCT01157429|11634837|FG001|NOT COMPLETED|Overall Study||4
10485553|NCT01157676|11634845|FG000|STARTED|Enrollment||174
10485554|NCT01157676|11634846|FG001|STARTED|Enrollment||176
10485555|NCT01157676|11634845|FG000|COMPLETED|Enrollment||174
10485556|NCT01157676|11634846|FG001|COMPLETED|Enrollment||176
10485557|NCT01157676|11634845|FG000|NOT COMPLETED|Enrollment||0
10485558|NCT01157676|11634846|FG001|NOT COMPLETED|Enrollment||0
10485559|NCT01157676|11634845|FG000|STARTED|Randomization||174
10485560|NCT01157676|11634846|FG001|STARTED|Randomization||176
10485561|NCT01157676|11634845|FG000|COMPLETED|Randomization||153
10485562|NCT01157676|11634846|FG001|COMPLETED|Randomization||159
10485563|NCT01157676|11634845|FG000|NOT COMPLETED|Randomization||21
10485564|NCT01157676|11634846|FG001|NOT COMPLETED|Randomization||17
10485565|NCT01157676|11634845|FG000|STARTED|Surgery||153
10485566|NCT01157676|11634846|FG001|STARTED|Surgery||159
10485567|NCT01157676|11634845|FG000|COMPLETED|Surgery||152
10485568|NCT01157676|11634846|FG001|COMPLETED|Surgery|advanced disease=2, inadequate visualization=1, inability to tolerate position=1, colonic mass=1.|150
10485569|NCT01157676|11634845|FG000|NOT COMPLETED|Surgery||1
10485570|NCT01157676|11634846|FG001|NOT COMPLETED|Surgery||9
10485571|NCT01157845|11634858|FG000|STARTED|Overall Study||165
10485572|NCT01157845|11634858|FG000|COMPLETED|Overall Study||130
10485573|NCT01157845|11634858|FG000|NOT COMPLETED|Overall Study||35
10485574|NCT01157897|11634866|FG000|STARTED|Overall Study||10
10485575|NCT01157897|11634867|FG001|STARTED|Overall Study||10
10485576|NCT01157897|11634868|FG002|STARTED|Overall Study||10
10485577|NCT01157897|11634869|FG003|STARTED|Overall Study||6
10485578|NCT01157897|11634866|FG000|COMPLETED|Overall Study||8
10485579|NCT01157897|11634867|FG001|COMPLETED|Overall Study||8
10485580|NCT01157897|11634868|FG002|COMPLETED|Overall Study||10
10485581|NCT01157897|11634869|FG003|COMPLETED|Overall Study||5
10485582|NCT01157897|11634866|FG000|NOT COMPLETED|Overall Study||2
10485583|NCT01157897|11634867|FG001|NOT COMPLETED|Overall Study||2
10485584|NCT01157897|11634868|FG002|NOT COMPLETED|Overall Study||0
10485585|NCT01157897|11634869|FG003|NOT COMPLETED|Overall Study||1
10485586|NCT01158118|11634881|FG000|STARTED|Overall Study||24
10485587|NCT01158118|11634882|FG001|STARTED|Overall Study||24
10485588|NCT01158118|11634881|FG000|COMPLETED|Overall Study||23
10485589|NCT01158118|11634882|FG001|COMPLETED|Overall Study||21
10485590|NCT01158118|11634881|FG000|NOT COMPLETED|Overall Study||1
10485591|NCT01158118|11634882|FG001|NOT COMPLETED|Overall Study||3
10485592|NCT01158157|11634888|FG000|STARTED|Overall Study|61 subjects screened; 25 subjects were vaccinated; 36 subjects were not eligible.|25
10485593|NCT01158157|11634888|FG000|COMPLETED|Overall Study||25
10485594|NCT01158157|11634888|FG000|NOT COMPLETED|Overall Study||0
10485595|NCT01158222|11634892|FG000|STARTED|Overall Study||37
10485596|NCT01158222|11634892|FG000|COMPLETED|Overall Study||20
10485597|NCT01158222|11634892|FG000|NOT COMPLETED|Overall Study||17
10485598|NCT01158261|11634896|FG000|STARTED|Overall Study||300
10485599|NCT01158261|11634896|FG000|COMPLETED|Overall Study||283
10485600|NCT01158261|11634896|FG000|NOT COMPLETED|Overall Study||17
10485601|NCT01158378|11634902|FG000|STARTED|Overall Study||124
10485602|NCT01158378|11634903|FG001|STARTED|Overall Study||126
10485603|NCT01158378|11634902|FG000|COMPLETED|Overall Study||114
10485604|NCT01158378|11634903|FG001|COMPLETED|Overall Study||117
10485605|NCT01158378|11634902|FG000|NOT COMPLETED|Overall Study||10
10485606|NCT01158378|11634903|FG001|NOT COMPLETED|Overall Study||9
10485607|NCT01158404|11634918|FG000|STARTED|Overall Study||3
10485608|NCT01158404|11634919|FG001|STARTED|Overall Study||4
10485609|NCT01158404|11634920|FG002|STARTED|Overall Study||3
10485610|NCT01158404|11634921|FG003|STARTED|Overall Study||3
10485611|NCT01158404|11634922|FG004|STARTED|Overall Study||6
10485612|NCT01158404|11634923|FG005|STARTED|Overall Study||5
10485613|NCT01158404|11634924|FG006|STARTED|Overall Study||3
10485614|NCT01158404|11634925|FG007|STARTED|Overall Study||8
10485615|NCT01158404|11634918|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
10485616|NCT01158404|11634919|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4
10485617|NCT01158404|11634920|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
10485618|NCT01158404|11634921|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
10485619|NCT01158404|11634922|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
10709872|NCT02643979|11874957|FG001|NOT COMPLETED|Overall Study||0
10709873|NCT02644096|11874965|FG000|STARTED|Overall Study||93
10709874|NCT02644096|11874966|FG001|STARTED|Overall Study||82
10709875|NCT02644096|11874965|FG000|2 Week Interview|Overall Study|Not done in control group|0
10709876|NCT02644096|11874966|FG001|2 Week Interview|Overall Study||68
10709877|NCT02644096|11874965|FG000|10 Week Interview|Overall Study|Not done in control group|0
10709878|NCT02644096|11874966|FG001|10 Week Interview|Overall Study||59
10709879|NCT02644096|11874965|FG000|12 Week SF-36 Questionnaire|Overall Study||68
10709880|NCT02644096|11874966|FG001|12 Week SF-36 Questionnaire|Overall Study||59
10709881|NCT02644096|11874965|FG000|9 Month SF-36 Questionnaire|Overall Study||65
10709882|NCT02644096|11874966|FG001|9 Month SF-36 Questionnaire|Overall Study||57
10709883|NCT02644096|11874965|FG000|COMPLETED|Overall Study||65
10709884|NCT02644096|11874966|FG001|COMPLETED|Overall Study||57
10709885|NCT02644096|11874965|FG000|NOT COMPLETED|Overall Study||28
10709886|NCT02644096|11874966|FG001|NOT COMPLETED|Overall Study||25
10485620|NCT01158404|11634923|FG005|Received at Least 1 Dose of Study Drug|Overall Study||5
10485621|NCT01158404|11634924|FG006|Received at Least 1 Dose of Study Drug|Overall Study||3
10485622|NCT01158404|11634925|FG007|Received at Least 1 Dose of Study Drug|Overall Study||8
10485623|NCT01158404|11634918|FG000|COMPLETED|Overall Study||3
10485624|NCT01158404|11634919|FG001|COMPLETED|Overall Study||3
10485625|NCT01158404|11634920|FG002|COMPLETED|Overall Study||3
10485626|NCT01158404|11634921|FG003|COMPLETED|Overall Study||3
10485627|NCT01158404|11634922|FG004|COMPLETED|Overall Study||3
10485628|NCT01158404|11634923|FG005|COMPLETED|Overall Study||4
10485629|NCT01158404|11634924|FG006|COMPLETED|Overall Study||2
10485630|NCT01158404|11634925|FG007|COMPLETED|Overall Study||6
10485631|NCT01158404|11634918|FG000|NOT COMPLETED|Overall Study||0
10485632|NCT01158404|11634919|FG001|NOT COMPLETED|Overall Study||1
10485633|NCT01158404|11634920|FG002|NOT COMPLETED|Overall Study||0
10485634|NCT01158404|11634921|FG003|NOT COMPLETED|Overall Study||0
10485635|NCT01158404|11634922|FG004|NOT COMPLETED|Overall Study||3
10485636|NCT01158404|11634923|FG005|NOT COMPLETED|Overall Study||1
10485637|NCT01158404|11634924|FG006|NOT COMPLETED|Overall Study||1
10485638|NCT01158404|11634925|FG007|NOT COMPLETED|Overall Study||2
10485639|NCT01158521|11634945|FG000|STARTED|Overall Study||25
10485640|NCT01158521|11634945|FG000|COMPLETED|Overall Study||25
10485641|NCT01158521|11634945|FG000|NOT COMPLETED|Overall Study||0
10485642|NCT01158534|11634951|FG000|STARTED|Overall Study||17
10485643|NCT01158534|11634951|FG000|COMPLETED|Overall Study|All three pts that did not complete study had some treatment|14
10485644|NCT01158534|11634951|FG000|NOT COMPLETED|Overall Study||3
10485645|NCT01158573|11634959|FG000|STARTED|Overall Study|Aimed to recruit 160 from July 2010 to May 2013. Each subject studied on one time point only|30
10485646|NCT01158573|11634960|FG001|STARTED|Overall Study||30
10485647|NCT01158573|11634961|FG002|STARTED|Overall Study||29
10485648|NCT01158573|11634962|FG003|STARTED|Overall Study||28
10485649|NCT01158573|11634959|FG000|COMPLETED|Overall Study|Study completed at 117 subjects.|30
10485650|NCT01158573|11634960|FG001|COMPLETED|Overall Study||30
10485651|NCT01158573|11634961|FG002|COMPLETED|Overall Study||29
10485652|NCT01158573|11634962|FG003|COMPLETED|Overall Study||28
10485653|NCT01158573|11634959|FG000|NOT COMPLETED|Overall Study||0
10485654|NCT01158573|11634960|FG001|NOT COMPLETED|Overall Study||0
10485655|NCT01158573|11634961|FG002|NOT COMPLETED|Overall Study||0
10485656|NCT01158573|11634962|FG003|NOT COMPLETED|Overall Study||0
10485657|NCT01158651|11634972|FG000|STARTED|Overall Study||23
10485658|NCT01158651|11634972|FG000|COMPLETED|Overall Study||22
10485659|NCT01158651|11634972|FG000|NOT COMPLETED|Overall Study||1
10485660|NCT01158703|11634978|FG000|STARTED|Overall Study||12
10485661|NCT01158703|11634979|FG001|STARTED|Overall Study||8
10485662|NCT01158703|11634978|FG000|COMPLETED|Overall Study||12
10485663|NCT01158703|11634979|FG001|COMPLETED|Overall Study||8
10485664|NCT01158703|11634978|FG000|NOT COMPLETED|Overall Study||0
10485665|NCT01158703|11634979|FG001|NOT COMPLETED|Overall Study||0
10485666|NCT01158716|11634987|FG000|STARTED|Overall Study||48
10485667|NCT01158716|11634988|FG001|STARTED|Overall Study||48
10485668|NCT01158716|11634987|FG000|COMPLETED|Overall Study||47
10485669|NCT01158716|11634988|FG001|COMPLETED|Overall Study||47
10709887|NCT02644109|11874974|FG000|STARTED|Overall Study||24
10709888|NCT02644109|11874975|FG001|STARTED|Overall Study||28
10709889|NCT02644109|11874974|FG000|COMPLETED|Overall Study||24
10709890|NCT02644109|11874975|FG001|COMPLETED|Overall Study||24
10709891|NCT02644109|11874974|FG000|NOT COMPLETED|Overall Study||0
10485670|NCT01158716|11634987|FG000|NOT COMPLETED|Overall Study||1
10485671|NCT01158716|11634988|FG001|NOT COMPLETED|Overall Study||1
10485672|NCT01158820|11634996|FG000|STARTED|Overall Study||25
10485673|NCT01158820|11634997|FG001|STARTED|Overall Study||25
10485674|NCT01158820|11634996|FG000|COMPLETED|Overall Study||25
10485675|NCT01158820|11634997|FG001|COMPLETED|Overall Study||25
10485676|NCT01158820|11634996|FG000|NOT COMPLETED|Overall Study||0
10485677|NCT01158820|11634997|FG001|NOT COMPLETED|Overall Study||0
10485678|NCT01158885|11635004|FG000|STARTED|Treatment Course 1||2
10485679|NCT01158885|11635004|FG000|COMPLETED|Treatment Course 1||2
10485680|NCT01158885|11635004|FG000|NOT COMPLETED|Treatment Course 1||0
10485681|NCT01158885|11635004|FG000|STARTED|Treatment Course 2|Neither of the patients that were treated on Treatment Course 1 were eligible to proceed to Course 2|0
10485682|NCT01158885|11635004|FG000|COMPLETED|Treatment Course 2||0
10485683|NCT01158885|11635004|FG000|NOT COMPLETED|Treatment Course 2||0
10485684|NCT01158924|11635010|FG000|STARTED|Overall Study||14
10485685|NCT01158924|11635011|FG001|STARTED|Overall Study||26
10485686|NCT01158924|11635010|FG000|COMPLETED|Overall Study||13
10485687|NCT01158924|11635011|FG001|COMPLETED|Overall Study||23
10485688|NCT01158924|11635010|FG000|NOT COMPLETED|Overall Study||1
10485689|NCT01158924|11635011|FG001|NOT COMPLETED|Overall Study||3
10485690|NCT01158950|11635017|FG000|STARTED|1st Intervention (1 Day)||13
10485691|NCT01158950|11635018|FG001|STARTED|1st Intervention (1 Day)||13
10485692|NCT01158950|11635017|FG000|Data Collected|1st Intervention (1 Day)||12
10485693|NCT01158950|11635018|FG001|Data Collected|1st Intervention (1 Day)||11
10485694|NCT01158950|11635017|FG000|COMPLETED|1st Intervention (1 Day)||12
10485695|NCT01158950|11635018|FG001|COMPLETED|1st Intervention (1 Day)||11
10485696|NCT01158950|11635017|FG000|NOT COMPLETED|1st Intervention (1 Day)||1
10485697|NCT01158950|11635018|FG001|NOT COMPLETED|1st Intervention (1 Day)||2
10485698|NCT01158950|11635017|FG000|STARTED|Washout (1 Week)||12
10485699|NCT01158950|11635018|FG001|STARTED|Washout (1 Week)||11
10485700|NCT01158950|11635017|FG000|COMPLETED|Washout (1 Week)||12
10485701|NCT01158950|11635018|FG001|COMPLETED|Washout (1 Week)||11
10485702|NCT01158950|11635017|FG000|NOT COMPLETED|Washout (1 Week)||0
10485703|NCT01158950|11635018|FG001|NOT COMPLETED|Washout (1 Week)||0
10485704|NCT01158950|11635017|FG000|STARTED|2nd Intervention (1 Day)||12
10485705|NCT01158950|11635018|FG001|STARTED|2nd Intervention (1 Day)||11
10485706|NCT01158950|11635017|FG000|COMPLETED|2nd Intervention (1 Day)||12
10485707|NCT01158950|11635018|FG001|COMPLETED|2nd Intervention (1 Day)||11
10485708|NCT01158950|11635017|FG000|NOT COMPLETED|2nd Intervention (1 Day)||0
10485709|NCT01158950|11635018|FG001|NOT COMPLETED|2nd Intervention (1 Day)||0
10485710|NCT01158976|11635025|FG000|STARTED|Overall Study||43
10485711|NCT01158976|11635026|FG001|STARTED|Overall Study||21
10485712|NCT01158976|11635025|FG000|COMPLETED|Overall Study||34
10485713|NCT01158976|11635026|FG001|COMPLETED|Overall Study||17
10485714|NCT01158976|11635025|FG000|NOT COMPLETED|Overall Study||9
10485715|NCT01158976|11635026|FG001|NOT COMPLETED|Overall Study||4
10485716|NCT01159015|11635034|FG000|STARTED|Overall Study||357
10485717|NCT01159015|11635035|FG001|STARTED|Overall Study||177
10485718|NCT01159015|11635034|FG000|COMPLETED|Overall Study||339
10485719|NCT01159015|11635035|FG001|COMPLETED|Overall Study||170
10485720|NCT01159015|11635034|FG000|NOT COMPLETED|Overall Study||18
10485721|NCT01159015|11635035|FG001|NOT COMPLETED|Overall Study||7
10485722|NCT01159054|11635041|FG000|STARTED|Overall Study||22
10485723|NCT01159054|11635041|FG000|COMPLETED|Overall Study||2
10485724|NCT01159054|11635041|FG000|NOT COMPLETED|Overall Study||20
10485725|NCT01159067|11635045|FG000|STARTED|Overall Study||1
10485726|NCT01159067|11635045|FG000|COMPLETED|Overall Study||1
10485727|NCT01159067|11635045|FG000|NOT COMPLETED|Overall Study||0
10485728|NCT01159171|11635049|FG000|STARTED|Overall Study||50
10485729|NCT01159171|11635049|FG000|COMPLETED|Overall Study||0
10485730|NCT01159171|11635049|FG000|NOT COMPLETED|Overall Study||50
10485731|NCT01159262|11635057|FG000|STARTED|Overall Study||14
10485732|NCT01159262|11635058|FG001|STARTED|Overall Study||14
10485733|NCT01159262|11635059|FG002|STARTED|Overall Study||8
10485734|NCT01159262|11635057|FG000|COMPLETED|Overall Study||14
10485735|NCT01159262|11635058|FG001|COMPLETED|Overall Study||14
10485736|NCT01159262|11635059|FG002|COMPLETED|Overall Study||8
10485737|NCT01159262|11635057|FG000|NOT COMPLETED|Overall Study||0
10485738|NCT01159262|11635058|FG001|NOT COMPLETED|Overall Study||0
10485739|NCT01159262|11635059|FG002|NOT COMPLETED|Overall Study||0
10485740|NCT01159431|11635069|FG000|STARTED|Overall Study||25
10485741|NCT01159431|11635070|FG001|STARTED|Overall Study||25
10485742|NCT01159431|11635069|FG000|COMPLETED|Overall Study||23
10485743|NCT01159431|11635070|FG001|COMPLETED|Overall Study||19
10485744|NCT01159431|11635069|FG000|NOT COMPLETED|Overall Study||2
10485745|NCT01159431|11635070|FG001|NOT COMPLETED|Overall Study||6
10485746|NCT01159535|11635086|FG000|STARTED|Overall Study||103
10485747|NCT01159535|11635087|FG001|STARTED|Overall Study||88
10485748|NCT01159535|11635088|FG002|STARTED|Overall Study||95
10485749|NCT01159535|11635086|FG000|COMPLETED|Overall Study||79
10485750|NCT01159535|11635087|FG001|COMPLETED|Overall Study||64
10485751|NCT01159535|11635088|FG002|COMPLETED|Overall Study||64
10485752|NCT01159535|11635086|FG000|NOT COMPLETED|Overall Study||24
10485753|NCT01159535|11635087|FG001|NOT COMPLETED|Overall Study||24
10485754|NCT01159535|11635088|FG002|NOT COMPLETED|Overall Study||31
10485755|NCT01159574|11635096|FG000|STARTED|Treatment Phase||121
10485756|NCT01159574|11635096|FG000|COMPLETED|Treatment Phase||100
10485757|NCT01159574|11635096|FG000|NOT COMPLETED|Treatment Phase||21
10485758|NCT01159574|11635096|FG000|STARTED|Follow Up Phase||112
10485759|NCT01159574|11635096|FG000|COMPLETED|Follow Up Phase|Completion defined as those that are no longer in long term follow up due to death.|92
10485760|NCT01159574|11635096|FG000|NOT COMPLETED|Follow Up Phase||20
10485761|NCT01159600|11635108|FG000|STARTED|Overall Study||207
10485762|NCT01159600|11635109|FG001|STARTED|Overall Study||217
10485763|NCT01159600|11635110|FG002|STARTED|Overall Study||214
10485764|NCT01159600|11635111|FG003|STARTED|Overall Study||69
10485765|NCT01159600|11635112|FG004|STARTED|Overall Study||225
10485766|NCT01159600|11635113|FG005|STARTED|Overall Study||226
10485767|NCT01159600|11635114|FG006|STARTED|Overall Study||218
10485768|NCT01159600|11635115|FG007|STARTED|Overall Study||103
10485769|NCT01159600|11635108|FG000|COMPLETED|Overall Study||186
10485770|NCT01159600|11635109|FG001|COMPLETED|Overall Study||209
10485771|NCT01159600|11635110|FG002|COMPLETED|Overall Study||196
10485772|NCT01159600|11635111|FG003|COMPLETED|Overall Study||58
10485773|NCT01159600|11635112|FG004|COMPLETED|Overall Study||201
10485774|NCT01159600|11635113|FG005|COMPLETED|Overall Study||208
10485775|NCT01159600|11635114|FG006|COMPLETED|Overall Study||199
10485776|NCT01159600|11635115|FG007|COMPLETED|Overall Study||85
10485777|NCT01159600|11635108|FG000|NOT COMPLETED|Overall Study||21
10485778|NCT01159600|11635109|FG001|NOT COMPLETED|Overall Study||8
10485779|NCT01159600|11635110|FG002|NOT COMPLETED|Overall Study||18
10485780|NCT01159600|11635111|FG003|NOT COMPLETED|Overall Study||11
10485781|NCT01159600|11635112|FG004|NOT COMPLETED|Overall Study||24
10485782|NCT01159600|11635113|FG005|NOT COMPLETED|Overall Study||18
10485783|NCT01159600|11635114|FG006|NOT COMPLETED|Overall Study||19
10485784|NCT01159600|11635115|FG007|NOT COMPLETED|Overall Study||18
10485785|NCT01159665|11635140|FG000|STARTED|Overall Study||9
10485786|NCT01159665|11635141|FG001|STARTED|Overall Study||9
10485787|NCT01159665|11635142|FG002|STARTED|Overall Study||8
10485788|NCT01159665|11635143|FG003|STARTED|Overall Study||4
10485789|NCT01159665|11635144|FG004|STARTED|Overall Study||4
10485790|NCT01159665|11635145|FG005|STARTED|Overall Study||4
10485791|NCT01159665|11635140|FG000|COMPLETED|Overall Study||9
10485792|NCT01159665|11635141|FG001|COMPLETED|Overall Study||8
10485793|NCT01159665|11635142|FG002|COMPLETED|Overall Study||8
10485794|NCT01159665|11635143|FG003|COMPLETED|Overall Study||4
10485795|NCT01159665|11635144|FG004|COMPLETED|Overall Study||4
10485796|NCT01159665|11635145|FG005|COMPLETED|Overall Study||4
10485797|NCT01159665|11635140|FG000|NOT COMPLETED|Overall Study||0
10485798|NCT01159665|11635141|FG001|NOT COMPLETED|Overall Study||1
10485799|NCT01159665|11635142|FG002|NOT COMPLETED|Overall Study||0
10485800|NCT01159665|11635143|FG003|NOT COMPLETED|Overall Study||0
10485801|NCT01159665|11635144|FG004|NOT COMPLETED|Overall Study||0
10485802|NCT01159665|11635145|FG005|NOT COMPLETED|Overall Study||0
10485803|NCT01159691|11635159|FG000|STARTED|Overall Study||76
10485804|NCT01159691|11635159|FG000|COMPLETED|Overall Study|Multiple discontinuation reasons were possible.|54
10485805|NCT01159691|11635159|FG000|NOT COMPLETED|Overall Study||22
10485806|NCT01159743|11635165|FG000|STARTED|Overall Study||237
10485807|NCT01159743|11635166|FG001|STARTED|Overall Study||109
10485808|NCT01159743|11635165|FG000|COMPLETED|Overall Study||237
10485809|NCT01159743|11635166|FG001|COMPLETED|Overall Study||109
10485810|NCT01159743|11635165|FG000|NOT COMPLETED|Overall Study||0
10485811|NCT01159743|11635166|FG001|NOT COMPLETED|Overall Study||0
10485812|NCT01159769|11635172|FG000|STARTED|Overall Study||215
10485813|NCT01159769|11635172|FG000|COMPLETED|Overall Study||214
10485814|NCT01159769|11635172|FG000|NOT COMPLETED|Overall Study||1
10485815|NCT01159912|11635179|FG000|STARTED|Overall Study||115
10485816|NCT01159912|11635180|FG001|STARTED|Overall Study||114
10485817|NCT01159912|11635181|FG002|STARTED|Overall Study||114
10485818|NCT01159912|11635179|FG000|COMPLETED|Overall Study||75
10485819|NCT01159912|11635180|FG001|COMPLETED|Overall Study||92
10485820|NCT01159912|11635181|FG002|COMPLETED|Overall Study||88
10485821|NCT01159912|11635179|FG000|NOT COMPLETED|Overall Study||40
10485822|NCT01159912|11635180|FG001|NOT COMPLETED|Overall Study||22
10485823|NCT01159912|11635181|FG002|NOT COMPLETED|Overall Study||26
10485824|NCT01159938|11635192|FG000|STARTED|First Study Period||26
10485825|NCT01159938|11635193|FG001|STARTED|First Study Period||11
10485826|NCT01159938|11635194|FG002|STARTED|First Study Period||11
10485827|NCT01159938|11635195|FG003|STARTED|First Study Period||12
10485828|NCT01159938|11635196|FG004|STARTED|First Study Period||12
10485829|NCT01159938|11635192|FG000|Received at Least 1 Dose of Study Drug|First Study Period||0
10485830|NCT01159938|11635193|FG001|Received at Least 1 Dose of Study Drug|First Study Period||11
10485831|NCT01159938|11635194|FG002|Received at Least 1 Dose of Study Drug|First Study Period||11
10485832|NCT01159938|11635195|FG003|Received at Least 1 Dose of Study Drug|First Study Period||12
10485833|NCT01159938|11635196|FG004|Received at Least 1 Dose of Study Drug|First Study Period||12
10485834|NCT01159938|11635192|FG000|Safety and Efficacy Analysis Population|First Study Period|One healthy participant completed study but was excluded from analyses (major protocol violation).|25
10485835|NCT01159938|11635193|FG001|Safety and Efficacy Analysis Population|First Study Period||11
10485836|NCT01159938|11635194|FG002|Safety and Efficacy Analysis Population|First Study Period|Microalbuminuria relaxed with protocol amendment. T2DM albuminuria participant included in analyses.|11
10485837|NCT01159938|11635195|FG003|Safety and Efficacy Analysis Population|First Study Period||12
10485838|NCT01159938|11635196|FG004|Safety and Efficacy Analysis Population|First Study Period||12
10485839|NCT01159938|11635192|FG000|COMPLETED|First Study Period||26
10485840|NCT01159938|11635193|FG001|COMPLETED|First Study Period||11
10485841|NCT01159938|11635194|FG002|COMPLETED|First Study Period||10
10485842|NCT01159938|11635195|FG003|COMPLETED|First Study Period||12
10485843|NCT01159938|11635196|FG004|COMPLETED|First Study Period||12
10485844|NCT01159938|11635192|FG000|NOT COMPLETED|First Study Period||0
10485845|NCT01159938|11635193|FG001|NOT COMPLETED|First Study Period||0
10485846|NCT01159938|11635194|FG002|NOT COMPLETED|First Study Period||1
10485847|NCT01159938|11635195|FG003|NOT COMPLETED|First Study Period||0
10485848|NCT01159938|11635196|FG004|NOT COMPLETED|First Study Period||0
10485849|NCT01159938|11635192|FG000|STARTED|Second Study Period||0
10485850|NCT01159938|11635193|FG001|STARTED|Second Study Period||11
10485851|NCT01159938|11635194|FG002|STARTED|Second Study Period||10
10485852|NCT01159938|11635195|FG003|STARTED|Second Study Period||12
10485853|NCT01159938|11635196|FG004|STARTED|Second Study Period||12
10485854|NCT01159938|11635192|FG000|COMPLETED|Second Study Period||0
10485855|NCT01159938|11635193|FG001|COMPLETED|Second Study Period||11
10485856|NCT01159938|11635194|FG002|COMPLETED|Second Study Period||10
10485857|NCT01159938|11635195|FG003|COMPLETED|Second Study Period||12
10485858|NCT01159938|11635196|FG004|COMPLETED|Second Study Period||12
10485859|NCT01159938|11635192|FG000|NOT COMPLETED|Second Study Period||0
10485860|NCT01159938|11635193|FG001|NOT COMPLETED|Second Study Period||0
10485861|NCT01159938|11635194|FG002|NOT COMPLETED|Second Study Period||0
10485862|NCT01159938|11635195|FG003|NOT COMPLETED|Second Study Period||0
10485863|NCT01159938|11635196|FG004|NOT COMPLETED|Second Study Period||0
10485864|NCT01160198|11635220|FG000|STARTED|Overall Study||89
10485865|NCT01160198|11635221|FG001|STARTED|Overall Study||91
10485866|NCT01160198|11635222|FG002|STARTED|Overall Study||90
10485867|NCT01160198|11635220|FG000|COMPLETED|Overall Study||87
10485868|NCT01160198|11635221|FG001|COMPLETED|Overall Study||88
10485869|NCT01160198|11635222|FG002|COMPLETED|Overall Study||89
10485870|NCT01160198|11635220|FG000|NOT COMPLETED|Overall Study||2
10485871|NCT01160198|11635221|FG001|NOT COMPLETED|Overall Study||3
10485872|NCT01160198|11635222|FG002|NOT COMPLETED|Overall Study||1
10485873|NCT01160237|11635233|FG000|STARTED|Overall Study||4
10485874|NCT01160237|11635234|FG001|STARTED|Overall Study||3
10485875|NCT01160237|11635235|FG002|STARTED|Overall Study||0
10485876|NCT01160237|11635233|FG000|COMPLETED|Overall Study||4
10485877|NCT01160237|11635234|FG001|COMPLETED|Overall Study||3
10485878|NCT01160237|11635235|FG002|COMPLETED|Overall Study||0
10485879|NCT01160237|11635233|FG000|NOT COMPLETED|Overall Study||0
10485880|NCT01160237|11635234|FG001|NOT COMPLETED|Overall Study||0
10485881|NCT01160237|11635235|FG002|NOT COMPLETED|Overall Study||0
10485882|NCT01160289|11635248|FG000|STARTED|Screening, Washout, and Lead-In Period||894
10485883|NCT01160289|11635249|FG001|STARTED|Screening, Washout, and Lead-In Period||0
10485884|NCT01160289|11635250|FG002|STARTED|Screening, Washout, and Lead-In Period||0
10485885|NCT01160289|11635251|FG003|STARTED|Screening, Washout, and Lead-In Period||0
10485886|NCT01160289|11635252|FG004|STARTED|Screening, Washout, and Lead-In Period||0
10485887|NCT01160289|11635253|FG005|STARTED|Screening, Washout, and Lead-In Period||0
10485888|NCT01160289|11635248|FG000|COMPLETED|Screening, Washout, and Lead-In Period||410
10485889|NCT01160289|11635249|FG001|COMPLETED|Screening, Washout, and Lead-In Period||0
10485890|NCT01160289|11635250|FG002|COMPLETED|Screening, Washout, and Lead-In Period||0
10485891|NCT01160289|11635251|FG003|COMPLETED|Screening, Washout, and Lead-In Period||0
10485892|NCT01160289|11635252|FG004|COMPLETED|Screening, Washout, and Lead-In Period||0
10485893|NCT01160289|11635253|FG005|COMPLETED|Screening, Washout, and Lead-In Period||0
10485894|NCT01160289|11635248|FG000|NOT COMPLETED|Screening, Washout, and Lead-In Period||484
10485895|NCT01160289|11635249|FG001|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
10485896|NCT01160289|11635250|FG002|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
10485897|NCT01160289|11635251|FG003|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
10485898|NCT01160289|11635252|FG004|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
10485899|NCT01160289|11635253|FG005|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
10485900|NCT01160289|11635248|FG000|STARTED|Post-Randomization Period||0
10485901|NCT01160289|11635249|FG001|STARTED|Post-Randomization Period||85
10485902|NCT01160289|11635250|FG002|STARTED|Post-Randomization Period||97
10485903|NCT01160289|11635251|FG003|STARTED|Post-Randomization Period||52
10485904|NCT01160289|11635252|FG004|STARTED|Post-Randomization Period||89
10485905|NCT01160289|11635253|FG005|STARTED|Post-Randomization Period||87
10485906|NCT01160289|11635248|FG000|Received at Least 1 Dose of Study Drug|Post-Randomization Period||0
10485907|NCT01160289|11635249|FG001|Received at Least 1 Dose of Study Drug|Post-Randomization Period||85
10485908|NCT01160289|11635250|FG002|Received at Least 1 Dose of Study Drug|Post-Randomization Period||97
10485909|NCT01160289|11635251|FG003|Received at Least 1 Dose of Study Drug|Post-Randomization Period||52
10485910|NCT01160289|11635252|FG004|Received at Least 1 Dose of Study Drug|Post-Randomization Period||89
10485911|NCT01160289|11635253|FG005|Received at Least 1 Dose of Study Drug|Post-Randomization Period||87
10485912|NCT01160289|11635248|FG000|COMPLETED|Post-Randomization Period||0
10485913|NCT01160289|11635249|FG001|COMPLETED|Post-Randomization Period||65
10485914|NCT01160289|11635250|FG002|COMPLETED|Post-Randomization Period||73
10485915|NCT01160289|11635251|FG003|COMPLETED|Post-Randomization Period||31
10485916|NCT01160289|11635252|FG004|COMPLETED|Post-Randomization Period||80
10485917|NCT01160289|11635253|FG005|COMPLETED|Post-Randomization Period||73
10485918|NCT01160289|11635248|FG000|NOT COMPLETED|Post-Randomization Period||0
10485919|NCT01160289|11635249|FG001|NOT COMPLETED|Post-Randomization Period||20
10485920|NCT01160289|11635250|FG002|NOT COMPLETED|Post-Randomization Period||24
10485921|NCT01160289|11635251|FG003|NOT COMPLETED|Post-Randomization Period||21
10485922|NCT01160289|11635252|FG004|NOT COMPLETED|Post-Randomization Period||9
10485923|NCT01160289|11635253|FG005|NOT COMPLETED|Post-Randomization Period||14
10485924|NCT01160354|11635269|FG000|STARTED|Overall Study||3
10485925|NCT01160354|11635270|FG001|STARTED|Overall Study||4
10485926|NCT01160354|11635271|FG002|STARTED|Overall Study||15
10485927|NCT01160354|11635269|FG000|COMPLETED|Overall Study||3
10485928|NCT01160354|11635270|FG001|COMPLETED|Overall Study||3
10485929|NCT01160354|11635271|FG002|COMPLETED|Overall Study||14
10485930|NCT01160354|11635269|FG000|NOT COMPLETED|Overall Study||0
10485931|NCT01160354|11635270|FG001|NOT COMPLETED|Overall Study||1
10485932|NCT01160354|11635271|FG002|NOT COMPLETED|Overall Study||1
10485933|NCT01160380|11635281|FG000|STARTED|Overall Study||25
10485934|NCT01160380|11635282|FG001|STARTED|Overall Study||25
10485935|NCT01160380|11635281|FG000|COMPLETED|Overall Study||17
10485936|NCT01160380|11635282|FG001|COMPLETED|Overall Study||20
10485937|NCT01160380|11635281|FG000|NOT COMPLETED|Overall Study||8
10485938|NCT01160380|11635282|FG001|NOT COMPLETED|Overall Study||5
10485939|NCT01160445|11635290|FG000|STARTED|Overall Study||7
10485940|NCT01160445|11635291|FG001|STARTED|Overall Study||2
10485941|NCT01160445|11635290|FG000|COMPLETED|Overall Study||7
10649915|NCT02164864|11810034|FG002|STARTED|Overall Study|Started are the Randomised/entered patients.|981
10649916|NCT02164864|11810032|FG000|COMPLETED|Overall Study||886
10649917|NCT02164864|11810033|FG001|COMPLETED|Overall Study||703
10649918|NCT02164864|11810034|FG002|COMPLETED|Overall Study||849
10649919|NCT02164864|11810032|FG000|NOT COMPLETED|Overall Study||95
10649920|NCT02164864|11810033|FG001|NOT COMPLETED|Overall Study||60
10485942|NCT01160445|11635291|FG001|COMPLETED|Overall Study||2
10485943|NCT01160445|11635290|FG000|NOT COMPLETED|Overall Study||0
10485944|NCT01160445|11635291|FG001|NOT COMPLETED|Overall Study||0
10485945|NCT01160458|11635297|FG000|STARTED|Overall Study||20
10709892|NCT02644109|11874975|FG001|NOT COMPLETED|Overall Study||4
10709893|NCT02644122|11874981|FG000|STARTED|Overall Study||1
10709894|NCT02644122|11874981|FG000|COMPLETED|Overall Study||0
10709895|NCT02644122|11874981|FG000|NOT COMPLETED|Overall Study||1
10709896|NCT02644278|11874990|FG000|STARTED|Overall Study||3
10709897|NCT02644278|11874991|FG001|STARTED|Overall Study||3
10709898|NCT02644278|11874992|FG002|STARTED|Overall Study||6
10485946|NCT01160458|11635297|FG000|COMPLETED|Overall Study||20
10485947|NCT01160458|11635297|FG000|NOT COMPLETED|Overall Study||0
10485948|NCT01160484|11635301|FG000|STARTED|Overall Study||40
10485949|NCT01160484|11635301|FG000|COMPLETED|Overall Study||22
10485950|NCT01160484|11635301|FG000|NOT COMPLETED|Overall Study||18
10485951|NCT01160614|11635307|FG000|STARTED|Overall Study||5
10485952|NCT01160614|11635308|FG001|STARTED|Overall Study||25
10485953|NCT01160614|11635307|FG000|COMPLETED|Overall Study||5
10485954|NCT01160614|11635308|FG001|COMPLETED|Overall Study||23
10485955|NCT01160614|11635307|FG000|NOT COMPLETED|Overall Study||0
10649921|NCT02164864|11810034|FG002|NOT COMPLETED|Overall Study||132
10649922|NCT02164916|11810047|FG000|STARTED|Overall Study||52
10649923|NCT02164916|11810048|FG001|STARTED|Overall Study||54
10649924|NCT02164916|11810047|FG000|Eligible|Overall Study||50
10649925|NCT02164916|11810048|FG001|Eligible|Overall Study||49
10649926|NCT02164916|11810047|FG000|Cross-over to Arm II|Overall Study|Following disease progression on Arm 1. Note: these patients are also counted in 'Not Completed'.|24
10709899|NCT02644278|11874993|FG003|STARTED|Overall Study||3
10709900|NCT02644278|11874990|FG000|COMPLETED|Overall Study||3
10709901|NCT02644278|11874991|FG001|COMPLETED|Overall Study||3
10649927|NCT02164916|11810048|FG001|Cross-over to Arm II|Overall Study||0
10649928|NCT02164916|11810047|FG000|COMPLETED|Overall Study||0
10709902|NCT02644278|11874992|FG002|COMPLETED|Overall Study||6
10485956|NCT01160614|11635308|FG001|NOT COMPLETED|Overall Study||2
10485957|NCT01160640|11635334|FG000|STARTED|Overall Study||117
10485958|NCT01160640|11635335|FG001|STARTED|Overall Study||116
10485959|NCT01160640|11635334|FG000|COMPLETED|Overall Study||113
10485960|NCT01160640|11635335|FG001|COMPLETED|Overall Study||110
10485961|NCT01160640|11635334|FG000|NOT COMPLETED|Overall Study||4
10485962|NCT01160640|11635335|FG001|NOT COMPLETED|Overall Study||6
10485963|NCT01160744|11635347|FG000|STARTED|Overall Study||71
10485964|NCT01160744|11635348|FG001|STARTED|Overall Study||69
10485965|NCT01160744|11635349|FG002|STARTED|Overall Study||69
10485966|NCT01160744|11635350|FG003|STARTED|Overall Study||71
10485967|NCT01160744|11635347|FG000|Received Study Drug|Overall Study||69
10485968|NCT01160744|11635348|FG001|Received Study Drug|Overall Study||67
10485969|NCT01160744|11635349|FG002|Received Study Drug|Overall Study||63
10485970|NCT01160744|11635350|FG003|Received Study Drug|Overall Study||71
10485971|NCT01160744|11635347|FG000|COMPLETED|Overall Study||60
10485972|NCT01160744|11635348|FG001|COMPLETED|Overall Study||64
10485973|NCT01160744|11635349|FG002|COMPLETED|Overall Study||62
10485974|NCT01160744|11635350|FG003|COMPLETED|Overall Study||67
10485975|NCT01160744|11635347|FG000|NOT COMPLETED|Overall Study||11
10485976|NCT01160744|11635348|FG001|NOT COMPLETED|Overall Study||5
10485977|NCT01160744|11635349|FG002|NOT COMPLETED|Overall Study||7
10485978|NCT01160744|11635350|FG003|NOT COMPLETED|Overall Study||4
10485979|NCT01160770|11635362|FG000|STARTED|Overall Study||267
10485980|NCT01160770|11635362|FG000|COMPLETED|Overall Study||188
10485981|NCT01160770|11635362|FG000|NOT COMPLETED|Overall Study||79
10485982|NCT01160822|11635373|FG000|STARTED|Overall Study||6
10485983|NCT01160822|11635374|FG001|STARTED|Overall Study||7
10485984|NCT01160822|11635375|FG002|STARTED|Overall Study||6
10485985|NCT01160822|11635376|FG003|STARTED|Overall Study||5
10485986|NCT01160822|11635377|FG004|STARTED|Overall Study||45
10485987|NCT01160822|11635378|FG005|STARTED|Overall Study||47
10485988|NCT01160822|11635379|FG006|STARTED|Overall Study||53
10485989|NCT01160822|11635373|FG000|COMPLETED|Overall Study||6
10485990|NCT01160822|11635374|FG001|COMPLETED|Overall Study||7
10485991|NCT01160822|11635375|FG002|COMPLETED|Overall Study||6
10485992|NCT01160822|11635376|FG003|COMPLETED|Overall Study||5
10485993|NCT01160822|11635377|FG004|COMPLETED|Overall Study||36
10485994|NCT01160822|11635378|FG005|COMPLETED|Overall Study||40
10485995|NCT01160822|11635379|FG006|COMPLETED|Overall Study||44
10485996|NCT01160822|11635373|FG000|NOT COMPLETED|Overall Study||0
10485997|NCT01160822|11635374|FG001|NOT COMPLETED|Overall Study||0
10485998|NCT01160822|11635375|FG002|NOT COMPLETED|Overall Study||0
10485999|NCT01160822|11635376|FG003|NOT COMPLETED|Overall Study||0
10486000|NCT01160822|11635377|FG004|NOT COMPLETED|Overall Study||9
10486001|NCT01160822|11635378|FG005|NOT COMPLETED|Overall Study||7
10486002|NCT01160822|11635379|FG006|NOT COMPLETED|Overall Study||9
10486003|NCT01160848|11635398|FG000|STARTED|Overall Study||12
10486004|NCT01160848|11635399|FG001|STARTED|Overall Study||8
10486005|NCT01160848|11635398|FG000|COMPLETED|Overall Study||12
10486006|NCT01160848|11635399|FG001|COMPLETED|Overall Study||8
10486007|NCT01160848|11635398|FG000|NOT COMPLETED|Overall Study||0
10486008|NCT01160848|11635399|FG001|NOT COMPLETED|Overall Study||0
10486009|NCT01161043|11635409|FG000|STARTED|Overall Study||83
10486010|NCT01161043|11635409|FG000|COMPLETED|Overall Study||80
10486011|NCT01161043|11635409|FG000|NOT COMPLETED|Overall Study||3
10486012|NCT01161121|11635413|FG000|STARTED|Overall Study||46
10486013|NCT01161121|11635413|FG000|COMPLETED|Overall Study||46
10486014|NCT01161121|11635413|FG000|NOT COMPLETED|Overall Study||0
10486015|NCT01161160|11635424|FG000|STARTED|Overall Study||76
10486016|NCT01161160|11635425|FG001|STARTED|Overall Study||75
10486017|NCT01161160|11635426|FG002|STARTED|Overall Study||58
10486018|NCT01161160|11635424|FG000|COMPLETED|Overall Study||76
10486019|NCT01161160|11635425|FG001|COMPLETED|Overall Study||75
10486020|NCT01161160|11635426|FG002|COMPLETED|Overall Study||58
10486021|NCT01161160|11635424|FG000|NOT COMPLETED|Overall Study||0
10486022|NCT01161160|11635425|FG001|NOT COMPLETED|Overall Study||0
10486023|NCT01161160|11635426|FG002|NOT COMPLETED|Overall Study||0
10486024|NCT01161173|11635434|FG000|STARTED|Overall Study||347
10486025|NCT01161173|11635434|FG000|COMPLETED|Overall Study||0
10486026|NCT01161173|11635434|FG000|NOT COMPLETED|Overall Study||347
10649929|NCT02164916|11810048|FG001|COMPLETED|Overall Study||0
10649930|NCT02164916|11810047|FG000|NOT COMPLETED|Overall Study||52
10649931|NCT02164916|11810048|FG001|NOT COMPLETED|Overall Study||54
10486027|NCT01161225|11635441|FG000|STARTED|Overall Study||59
10486028|NCT01161225|11635442|FG001|STARTED|Overall Study||53
10486029|NCT01161225|11635443|FG002|STARTED|Overall Study||14
10486030|NCT01161225|11635441|FG000|COMPLETED|Overall Study||45
10486031|NCT01161225|11635442|FG001|COMPLETED|Overall Study||44
10486032|NCT01161225|11635443|FG002|COMPLETED|Overall Study||12
10486033|NCT01161225|11635441|FG000|NOT COMPLETED|Overall Study||14
10486034|NCT01161225|11635442|FG001|NOT COMPLETED|Overall Study||9
10486035|NCT01161225|11635443|FG002|NOT COMPLETED|Overall Study||2
10486036|NCT01161329|11635457|FG000|STARTED|Overall Study||33
10486037|NCT01161329|11635458|FG001|STARTED|Overall Study||34
10486038|NCT01161329|11635457|FG000|COMPLETED|Overall Study||29
10486039|NCT01161329|11635458|FG001|COMPLETED|Overall Study||24
10486040|NCT01161329|11635457|FG000|NOT COMPLETED|Overall Study||4
10486041|NCT01161329|11635458|FG001|NOT COMPLETED|Overall Study||10
10486042|NCT01161407|11635467|FG000|STARTED|Overall Study||6
10486043|NCT01161407|11635468|FG001|STARTED|Overall Study||6
10486044|NCT01161407|11635467|FG000|COMPLETED|Overall Study||3
10486045|NCT01161407|11635468|FG001|COMPLETED|Overall Study||5
10649932|NCT02164929|11810063|FG000|STARTED|Overall Study||4
10649933|NCT02164929|11810064|FG001|STARTED|Overall Study||3
10709903|NCT02644278|11874993|FG003|COMPLETED|Overall Study||3
10709904|NCT02644278|11874990|FG000|NOT COMPLETED|Overall Study||0
10709905|NCT02644278|11874991|FG001|NOT COMPLETED|Overall Study||0
10649934|NCT02164929|11810065|FG002|STARTED|Overall Study||5
10649935|NCT02164929|11810066|FG003|STARTED|Overall Study||4
10649936|NCT02164929|11810063|FG000|COMPLETED|Overall Study||3
10649937|NCT02164929|11810064|FG001|COMPLETED|Overall Study||3
10649938|NCT02164929|11810065|FG002|COMPLETED|Overall Study||4
10649939|NCT02164929|11810066|FG003|COMPLETED|Overall Study||2
10649940|NCT02164929|11810063|FG000|NOT COMPLETED|Overall Study||1
10649941|NCT02164929|11810064|FG001|NOT COMPLETED|Overall Study||0
10649942|NCT02164929|11810065|FG002|NOT COMPLETED|Overall Study||1
10649943|NCT02164929|11810066|FG003|NOT COMPLETED|Overall Study||2
10649944|NCT02164981|11810079|FG000|STARTED|Started||23
10649945|NCT02164981|11810080|FG001|STARTED|Started||19
10486046|NCT01161407|11635467|FG000|NOT COMPLETED|Overall Study||3
10486047|NCT01161407|11635468|FG001|NOT COMPLETED|Overall Study||1
10486048|NCT01161420|11635474|FG000|STARTED|Inspire Therapy||126
10486049|NCT01161420|11635474|FG000|COMPLETED|Inspire Therapy||124
10486050|NCT01161420|11635474|FG000|NOT COMPLETED|Inspire Therapy||2
10486051|NCT01161420|11635474|FG000|STARTED|Withdrawal Study - Maintenance||23
10486052|NCT01161420|11635474|FG000|COMPLETED|Withdrawal Study - Maintenance||23
10486053|NCT01161420|11635474|FG000|NOT COMPLETED|Withdrawal Study - Maintenance||0
10486054|NCT01161420|11635474|FG000|STARTED|Withdrawal Study - Withdrawal||23
10486055|NCT01161420|11635474|FG000|COMPLETED|Withdrawal Study - Withdrawal||23
10486056|NCT01161420|11635474|FG000|NOT COMPLETED|Withdrawal Study - Withdrawal||0
10486057|NCT01161446|11635486|FG000|STARTED|Overall Study||116
10486058|NCT01161446|11635487|FG001|STARTED|Overall Study||114
10486059|NCT01161446|11635486|FG000|COMPLETED|Overall Study||98
10486060|NCT01161446|11635487|FG001|COMPLETED|Overall Study||99
10486061|NCT01161446|11635486|FG000|NOT COMPLETED|Overall Study||18
10486062|NCT01161446|11635487|FG001|NOT COMPLETED|Overall Study||15
10486063|NCT01161472|11635493|FG000|STARTED|First Intervention Period||5
10709906|NCT02644278|11874992|FG002|NOT COMPLETED|Overall Study||0
10709907|NCT02644278|11874993|FG003|NOT COMPLETED|Overall Study||0
10709908|NCT02644343|11875003|FG000|STARTED|Overall Study||40
10709909|NCT02644343|11875003|FG000|COMPLETED|Overall Study||39
10709910|NCT02644343|11875003|FG000|NOT COMPLETED|Overall Study||1
10709911|NCT02644356|11875007|FG000|STARTED|Overall Study||51
10709912|NCT02644356|11875007|FG000|COMPLETED|Overall Study|49 of the 51 consented subjects completed pre-post knowledge testing (96%)|49
10709913|NCT02644356|11875007|FG000|NOT COMPLETED|Overall Study||2
10709914|NCT02644668|11875014|FG000|STARTED|Overall Study||26
10709915|NCT02644668|11875015|FG001|STARTED|Overall Study||24
10709916|NCT02644668|11875016|FG002|STARTED|Overall Study||20
10709917|NCT02644668|11875014|FG000|COMPLETED|Overall Study||24
10809815|NCT03806127|11971621|FG000|STARTED|Overall Study||111
10809816|NCT03806127|11971622|FG001|STARTED|Overall Study||111
10486064|NCT01161472|11635494|FG001|STARTED|First Intervention Period||5
10486065|NCT01161472|11635495|FG002|STARTED|First Intervention Period||5
10486066|NCT01161472|11635496|FG003|STARTED|First Intervention Period||5
10486067|NCT01161472|11635493|FG000|Treated|First Intervention Period||5
10809817|NCT03806127|11971621|FG000|COMPLETED|Overall Study||90
10486068|NCT01161472|11635494|FG001|Treated|First Intervention Period||5
10486069|NCT01161472|11635495|FG002|Treated|First Intervention Period||5
10486070|NCT01161472|11635496|FG003|Treated|First Intervention Period||5
10486071|NCT01161472|11635493|FG000|COMPLETED|First Intervention Period||5
10486072|NCT01161472|11635494|FG001|COMPLETED|First Intervention Period||5
10649946|NCT02164981|11810081|FG002|STARTED|Started||18
10809818|NCT03806127|11971622|FG001|COMPLETED|Overall Study||99
10809819|NCT03806127|11971621|FG000|NOT COMPLETED|Overall Study||21
10809820|NCT03806127|11971622|FG001|NOT COMPLETED|Overall Study||12
10649947|NCT02164981|11810079|FG000|COMPLETED|Started||18
10709918|NCT02644668|11875015|FG001|COMPLETED|Overall Study||24
10709919|NCT02644668|11875016|FG002|COMPLETED|Overall Study||17
10709920|NCT02644668|11875014|FG000|NOT COMPLETED|Overall Study||2
10709921|NCT02644668|11875015|FG001|NOT COMPLETED|Overall Study||0
10809821|NCT03827473|11971630|FG000|STARTED|Overall Study||1
10486073|NCT01161472|11635495|FG002|COMPLETED|First Intervention Period||5
10486074|NCT01161472|11635496|FG003|COMPLETED|First Intervention Period||5
10486075|NCT01161472|11635493|FG000|NOT COMPLETED|First Intervention Period||0
10486076|NCT01161472|11635494|FG001|NOT COMPLETED|First Intervention Period||0
10486077|NCT01161472|11635495|FG002|NOT COMPLETED|First Intervention Period||0
10486078|NCT01161472|11635496|FG003|NOT COMPLETED|First Intervention Period||0
10709922|NCT02644668|11875016|FG002|NOT COMPLETED|Overall Study||3
10486079|NCT01161472|11635493|FG000|STARTED|Washout Period (At Least 3 to 6 Days)||5
10486080|NCT01161472|11635494|FG001|STARTED|Washout Period (At Least 3 to 6 Days)||5
10486081|NCT01161472|11635495|FG002|STARTED|Washout Period (At Least 3 to 6 Days)||5
10649948|NCT02164981|11810080|FG001|COMPLETED|Started||16
10649949|NCT02164981|11810081|FG002|COMPLETED|Started||18
10649950|NCT02164981|11810079|FG000|NOT COMPLETED|Started||5
10649951|NCT02164981|11810080|FG001|NOT COMPLETED|Started||3
10649952|NCT02164981|11810081|FG002|NOT COMPLETED|Started||0
10649953|NCT02164981|11810079|FG000|STARTED|Phase 1 (Day 0 - Day 14)||18
10649954|NCT02164981|11810080|FG001|STARTED|Phase 1 (Day 0 - Day 14)||16
10649955|NCT02164981|11810081|FG002|STARTED|Phase 1 (Day 0 - Day 14)||18
10649956|NCT02164981|11810079|FG000|COMPLETED|Phase 1 (Day 0 - Day 14)||18
10649957|NCT02164981|11810080|FG001|COMPLETED|Phase 1 (Day 0 - Day 14)||14
10649958|NCT02164981|11810081|FG002|COMPLETED|Phase 1 (Day 0 - Day 14)||18
10649959|NCT02164981|11810079|FG000|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||0
10649960|NCT02164981|11810080|FG001|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||2
10649961|NCT02164981|11810081|FG002|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||0
10649962|NCT02164981|11810079|FG000|STARTED|Phase 2 (Day 14 - Day 28)||18
10649963|NCT02164981|11810080|FG001|STARTED|Phase 2 (Day 14 - Day 28)||14
10649964|NCT02164981|11810081|FG002|STARTED|Phase 2 (Day 14 - Day 28)||18
10649965|NCT02164981|11810079|FG000|COMPLETED|Phase 2 (Day 14 - Day 28)||16
10649966|NCT02164981|11810080|FG001|COMPLETED|Phase 2 (Day 14 - Day 28)||12
10649967|NCT02164981|11810081|FG002|COMPLETED|Phase 2 (Day 14 - Day 28)||18
10649968|NCT02164981|11810079|FG000|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||2
10649969|NCT02164981|11810080|FG001|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||2
10649970|NCT02164981|11810081|FG002|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||0
10649971|NCT02165072|11810102|FG000|STARTED|Overall Study||30
10649972|NCT02165072|11810102|FG000|COMPLETED|Overall Study||30
10649973|NCT02165072|11810102|FG000|NOT COMPLETED|Overall Study||0
10654448|NCT02202980|11815247|FG006|STARTED|Overall Study||15
10654449|NCT02202980|11815248|FG007|STARTED|Overall Study||15
10486082|NCT01161472|11635496|FG003|STARTED|Washout Period (At Least 3 to 6 Days)||5
10486083|NCT01161472|11635493|FG000|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
10486084|NCT01161472|11635494|FG001|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
10486085|NCT01161472|11635495|FG002|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
10486086|NCT01161472|11635496|FG003|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
10486087|NCT01161472|11635493|FG000|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
10486088|NCT01161472|11635494|FG001|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
10486089|NCT01161472|11635495|FG002|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
10486090|NCT01161472|11635496|FG003|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
10486091|NCT01161472|11635493|FG000|STARTED|Second Intervention Period||5
10486092|NCT01161472|11635494|FG001|STARTED|Second Intervention Period||5
10486093|NCT01161472|11635495|FG002|STARTED|Second Intervention Period||5
10486094|NCT01161472|11635496|FG003|STARTED|Second Intervention Period||5
10486095|NCT01161472|11635493|FG000|COMPLETED|Second Intervention Period||5
10486096|NCT01161472|11635494|FG001|COMPLETED|Second Intervention Period||5
10486097|NCT01161472|11635495|FG002|COMPLETED|Second Intervention Period||5
10486098|NCT01161472|11635496|FG003|COMPLETED|Second Intervention Period||5
10486099|NCT01161472|11635493|FG000|NOT COMPLETED|Second Intervention Period||0
10486100|NCT01161472|11635494|FG001|NOT COMPLETED|Second Intervention Period||0
10486101|NCT01161472|11635495|FG002|NOT COMPLETED|Second Intervention Period||0
10486102|NCT01161472|11635496|FG003|NOT COMPLETED|Second Intervention Period||0
10486103|NCT01161472|11635493|FG000|STARTED|Washout Period (At Least 3 to 6 Days)||5
10486104|NCT01161472|11635494|FG001|STARTED|Washout Period (At Least 3 to 6 Days)||5
10486105|NCT01161472|11635495|FG002|STARTED|Washout Period (At Least 3 to 6 Days)||5
10486106|NCT01161472|11635496|FG003|STARTED|Washout Period (At Least 3 to 6 Days)||5
10486107|NCT01161472|11635493|FG000|COMPLETED|Washout Period (At Least 3 to 6 Days)||4
10486108|NCT01161472|11635494|FG001|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
10486109|NCT01161472|11635495|FG002|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
10486110|NCT01161472|11635496|FG003|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
10654450|NCT02202980|11815249|FG008|STARTED|Overall Study||18
10654451|NCT02202980|11815250|FG009|STARTED|Overall Study||17
10654452|NCT02202980|11815251|FG010|STARTED|Overall Study||19
10654453|NCT02202980|11815252|FG011|STARTED|Overall Study||28
10654454|NCT02202980|11815253|FG012|STARTED|Overall Study||30
10654455|NCT02202980|11815254|FG013|STARTED|Overall Study||4
10654456|NCT02202980|11815241|FG000|COMPLETED|Overall Study||13
10654457|NCT02202980|11815242|FG001|COMPLETED|Overall Study||24
10654458|NCT02202980|11815243|FG002|COMPLETED|Overall Study||17
10654459|NCT02202980|11815244|FG003|COMPLETED|Overall Study||28
10709923|NCT02645019|11875031|FG000|STARTED|Overall Study||13
10486111|NCT01161472|11635493|FG000|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||1
10486112|NCT01161472|11635494|FG001|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
10486113|NCT01161472|11635495|FG002|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
10486114|NCT01161472|11635496|FG003|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
10486115|NCT01161472|11635493|FG000|STARTED|Third Intervention Period||4
10486116|NCT01161472|11635494|FG001|STARTED|Third Intervention Period||5
10486117|NCT01161472|11635495|FG002|STARTED|Third Intervention Period||5
10486118|NCT01161472|11635496|FG003|STARTED|Third Intervention Period||5
10486119|NCT01161472|11635493|FG000|COMPLETED|Third Intervention Period||4
10486120|NCT01161472|11635494|FG001|COMPLETED|Third Intervention Period||5
10486121|NCT01161472|11635495|FG002|COMPLETED|Third Intervention Period||5
10486122|NCT01161472|11635496|FG003|COMPLETED|Third Intervention Period||5
10486123|NCT01161472|11635493|FG000|NOT COMPLETED|Third Intervention Period||0
10486124|NCT01161472|11635494|FG001|NOT COMPLETED|Third Intervention Period||0
10486125|NCT01161472|11635495|FG002|NOT COMPLETED|Third Intervention Period||0
10486126|NCT01161472|11635496|FG003|NOT COMPLETED|Third Intervention Period||0
10486127|NCT01161472|11635493|FG000|STARTED|Washout Period (At Least 3 to 6 Days)||4
10486128|NCT01161472|11635494|FG001|STARTED|Washout Period (At Least 3 to 6 Days)||5
10486129|NCT01161472|11635495|FG002|STARTED|Washout Period (At Least 3 to 6 Days)||5
10486130|NCT01161472|11635496|FG003|STARTED|Washout Period (At Least 3 to 6 Days)||5
10486131|NCT01161472|11635493|FG000|COMPLETED|Washout Period (At Least 3 to 6 Days)||4
10486132|NCT01161472|11635494|FG001|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
10486133|NCT01161472|11635495|FG002|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
10486134|NCT01161472|11635496|FG003|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
10486135|NCT01161472|11635493|FG000|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
10486136|NCT01161472|11635494|FG001|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
10486137|NCT01161472|11635495|FG002|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
10486138|NCT01161472|11635496|FG003|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
10486139|NCT01161472|11635493|FG000|STARTED|Fourth Intervention Period||4
10486140|NCT01161472|11635494|FG001|STARTED|Fourth Intervention Period||5
10486141|NCT01161472|11635495|FG002|STARTED|Fourth Intervention Period||5
10486142|NCT01161472|11635496|FG003|STARTED|Fourth Intervention Period||5
10486143|NCT01161472|11635493|FG000|COMPLETED|Fourth Intervention Period||4
10486144|NCT01161472|11635494|FG001|COMPLETED|Fourth Intervention Period||5
10486145|NCT01161472|11635495|FG002|COMPLETED|Fourth Intervention Period||5
10486146|NCT01161472|11635496|FG003|COMPLETED|Fourth Intervention Period||5
10486147|NCT01161472|11635493|FG000|NOT COMPLETED|Fourth Intervention Period||0
10486148|NCT01161472|11635494|FG001|NOT COMPLETED|Fourth Intervention Period||0
10486149|NCT01161472|11635495|FG002|NOT COMPLETED|Fourth Intervention Period||0
10486150|NCT01161472|11635496|FG003|NOT COMPLETED|Fourth Intervention Period||0
10486151|NCT01161498|11635508|FG000|STARTED|Overall Study||3
10486152|NCT01161498|11635509|FG001|STARTED|Overall Study||2
10486153|NCT01161498|11635508|FG000|COMPLETED|Overall Study||3
10486154|NCT01161498|11635509|FG001|COMPLETED|Overall Study||1
10486155|NCT01161498|11635508|FG000|NOT COMPLETED|Overall Study||0
10486156|NCT01161498|11635509|FG001|NOT COMPLETED|Overall Study||1
10709924|NCT02645019|11875032|FG001|STARTED|Overall Study||15
10709925|NCT02645019|11875033|FG002|STARTED|Overall Study||15
10709926|NCT02645019|11875034|FG003|STARTED|Overall Study||33
10709927|NCT02645019|11875035|FG004|STARTED|Overall Study||24
10709928|NCT02645019|11875031|FG000|COMPLETED|Overall Study||13
10709929|NCT02645019|11875032|FG001|COMPLETED|Overall Study||15
10709930|NCT02645019|11875033|FG002|COMPLETED|Overall Study||15
10709931|NCT02645019|11875034|FG003|COMPLETED|Overall Study||33
10709932|NCT02645019|11875035|FG004|COMPLETED|Overall Study||24
10709933|NCT02645019|11875031|FG000|NOT COMPLETED|Overall Study||0
10709934|NCT02645019|11875032|FG001|NOT COMPLETED|Overall Study||0
10709935|NCT02645019|11875033|FG002|NOT COMPLETED|Overall Study||0
10709936|NCT02645019|11875034|FG003|NOT COMPLETED|Overall Study||0
10709937|NCT02645019|11875035|FG004|NOT COMPLETED|Overall Study||0
10709938|NCT02645123|11875050|FG000|STARTED|Overall Study||25
10709939|NCT02645123|11875051|FG001|STARTED|Overall Study||25
10709940|NCT02645123|11875052|FG002|STARTED|Overall Study||25
10709941|NCT02645123|11875050|FG000|COMPLETED|Overall Study||25
10709942|NCT02645123|11875051|FG001|COMPLETED|Overall Study||25
10709943|NCT02645123|11875052|FG002|COMPLETED|Overall Study||25
10709944|NCT02645123|11875050|FG000|NOT COMPLETED|Overall Study||0
10709945|NCT02645123|11875051|FG001|NOT COMPLETED|Overall Study||0
10709946|NCT02645123|11875052|FG002|NOT COMPLETED|Overall Study||0
10709947|NCT02645253|11875064|FG000|STARTED|Overall Study||7
10809822|NCT03827473|11971631|FG001|STARTED|Overall Study||0
10809823|NCT03827473|11971630|FG000|COMPLETED|Overall Study||0
10809824|NCT03827473|11971631|FG001|COMPLETED|Overall Study||0
10486157|NCT01161524|11635517|FG000|STARTED|Core Study (23 Weeks)||85
10486158|NCT01161524|11635518|FG001|STARTED|Core Study (23 Weeks)||48
10486159|NCT01161524|11635519|FG002|STARTED|Core Study (23 Weeks)||0
10486160|NCT01161524|11635517|FG000|COMPLETED|Core Study (23 Weeks)||76
10709948|NCT02645253|11875065|FG001|STARTED|Overall Study||7
10809825|NCT03827473|11971630|FG000|NOT COMPLETED|Overall Study||1
10486161|NCT01161524|11635518|FG001|COMPLETED|Core Study (23 Weeks)||43
10709949|NCT02645253|11875066|FG002|STARTED|Overall Study||7
10486162|NCT01161524|11635519|FG002|COMPLETED|Core Study (23 Weeks)||0
10486163|NCT01161524|11635517|FG000|NOT COMPLETED|Core Study (23 Weeks)||9
10486164|NCT01161524|11635518|FG001|NOT COMPLETED|Core Study (23 Weeks)||5
10486165|NCT01161524|11635519|FG002|NOT COMPLETED|Core Study (23 Weeks)||0
10486166|NCT01161524|11635517|FG000|STARTED|Extension Phase (Approximately 83 Weeks)||0
10486167|NCT01161524|11635518|FG001|STARTED|Extension Phase (Approximately 83 Weeks)||0
10486168|NCT01161524|11635519|FG002|STARTED|Extension Phase (Approximately 83 Weeks)||114
10486169|NCT01161524|11635517|FG000|COMPLETED|Extension Phase (Approximately 83 Weeks)||0
10486170|NCT01161524|11635518|FG001|COMPLETED|Extension Phase (Approximately 83 Weeks)||0
10486171|NCT01161524|11635519|FG002|COMPLETED|Extension Phase (Approximately 83 Weeks)||90
10486172|NCT01161524|11635517|FG000|NOT COMPLETED|Extension Phase (Approximately 83 Weeks)||0
10486173|NCT01161524|11635518|FG001|NOT COMPLETED|Extension Phase (Approximately 83 Weeks)||0
10486174|NCT01161524|11635519|FG002|NOT COMPLETED|Extension Phase (Approximately 83 Weeks)||24
10486175|NCT01161537|11635528|FG000|STARTED|Part A||8
10486176|NCT01161537|11635528|FG000|COMPLETED|Part A||8
10486177|NCT01161537|11635528|FG000|NOT COMPLETED|Part A||0
10486178|NCT01161537|11635528|FG000|STARTED|Part B|4 subjects from Part A continued in Part B of the study.|9
10486179|NCT01161537|11635528|FG000|COMPLETED|Part B||7
10486180|NCT01161537|11635528|FG000|NOT COMPLETED|Part B||2
10486181|NCT01161563|11635539|FG000|STARTED|Overall Study||63
10486182|NCT01161563|11635540|FG001|STARTED|Overall Study||55
10486183|NCT01161563|11635539|FG000|COMPLETED|Overall Study||58
10486184|NCT01161563|11635540|FG001|COMPLETED|Overall Study||49
10486185|NCT01161563|11635539|FG000|NOT COMPLETED|Overall Study||5
10486186|NCT01161563|11635540|FG001|NOT COMPLETED|Overall Study||6
10486187|NCT01161628|11635546|FG000|STARTED|Overall Study||25
10486188|NCT01161628|11635546|FG000|COMPLETED|Overall Study||17
10486189|NCT01161628|11635546|FG000|NOT COMPLETED|Overall Study||8
10486190|NCT01161771|11635550|FG000|STARTED|Overall Study||32
10486191|NCT01161771|11635550|FG000|COMPLETED|Overall Study||32
10486192|NCT01161771|11635550|FG000|NOT COMPLETED|Overall Study||0
10527484|NCT01390402|11679585|FG000|STARTED|Overall Study||6
10527485|NCT01390402|11679585|FG000|COMPLETED|Overall Study||1
10527486|NCT01390402|11679585|FG000|NOT COMPLETED|Overall Study||5
10527487|NCT01390428|11679595|FG000|STARTED|Overall Study||8
10527488|NCT01390428|11679596|FG001|STARTED|Overall Study||8
10527489|NCT01390428|11679597|FG002|STARTED|Overall Study||9
10527490|NCT01390428|11679598|FG003|STARTED|Overall Study||9
10527491|NCT01390428|11679599|FG004|STARTED|Overall Study||8
10527492|NCT01390428|11679600|FG005|STARTED|Overall Study||8
10527493|NCT01390428|11679595|FG000|COMPLETED|Overall Study||8
10527494|NCT01390428|11679596|FG001|COMPLETED|Overall Study||8
10527495|NCT01390428|11679597|FG002|COMPLETED|Overall Study||8
10527496|NCT01390428|11679598|FG003|COMPLETED|Overall Study||9
10527497|NCT01390428|11679599|FG004|COMPLETED|Overall Study||7
10527498|NCT01390428|11679600|FG005|COMPLETED|Overall Study||8
10527499|NCT01390428|11679595|FG000|NOT COMPLETED|Overall Study||0
10527500|NCT01390428|11679596|FG001|NOT COMPLETED|Overall Study||0
10527501|NCT01390428|11679597|FG002|NOT COMPLETED|Overall Study||1
10527502|NCT01390428|11679598|FG003|NOT COMPLETED|Overall Study||0
10527503|NCT01390428|11679599|FG004|NOT COMPLETED|Overall Study||1
10527504|NCT01390428|11679600|FG005|NOT COMPLETED|Overall Study||0
10527505|NCT01390441|11679619|FG000|STARTED|Treatment Period||23
10527506|NCT01390441|11679620|FG001|STARTED|Treatment Period||22
10527507|NCT01390441|11679621|FG002|STARTED|Treatment Period||18
10527508|NCT01390441|11679622|FG003|STARTED|Treatment Period||19
10527509|NCT01390441|11679623|FG004|STARTED|Treatment Period||18
10527510|NCT01390441|11679619|FG000|COMPLETED|Treatment Period||22
10527511|NCT01390441|11679620|FG001|COMPLETED|Treatment Period||21
10527512|NCT01390441|11679621|FG002|COMPLETED|Treatment Period||8
10527513|NCT01390441|11679622|FG003|COMPLETED|Treatment Period||6
10527514|NCT01390441|11679623|FG004|COMPLETED|Treatment Period||7
10527515|NCT01390441|11679619|FG000|NOT COMPLETED|Treatment Period||1
10527516|NCT01390441|11679620|FG001|NOT COMPLETED|Treatment Period||1
10527517|NCT01390441|11679621|FG002|NOT COMPLETED|Treatment Period||10
10527518|NCT01390441|11679622|FG003|NOT COMPLETED|Treatment Period||13
10527519|NCT01390441|11679623|FG004|NOT COMPLETED|Treatment Period||11
10527520|NCT01390441|11679619|FG000|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|15
10527521|NCT01390441|11679620|FG001|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|13
10527522|NCT01390441|11679621|FG002|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|1
10527523|NCT01390441|11679622|FG003|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|1
10527524|NCT01390441|11679623|FG004|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|3
10527525|NCT01390441|11679619|FG000|COMPLETED|Extension Period||12
10527526|NCT01390441|11679620|FG001|COMPLETED|Extension Period||12
10527527|NCT01390441|11679621|FG002|COMPLETED|Extension Period||1
10527528|NCT01390441|11679622|FG003|COMPLETED|Extension Period||0
10527529|NCT01390441|11679623|FG004|COMPLETED|Extension Period||3
10527530|NCT01390441|11679619|FG000|NOT COMPLETED|Extension Period||3
10527531|NCT01390441|11679620|FG001|NOT COMPLETED|Extension Period||1
10527532|NCT01390441|11679621|FG002|NOT COMPLETED|Extension Period||0
10527533|NCT01390441|11679622|FG003|NOT COMPLETED|Extension Period||1
10527534|NCT01390441|11679623|FG004|NOT COMPLETED|Extension Period||0
10527535|NCT01390584|11679663|FG000|STARTED|Step 1: Induction Tx (ABVD Then PET/CT)||4
10486193|NCT01161862|11635556|FG000|STARTED|Overall Study||12
10486194|NCT01161862|11635557|FG001|STARTED|Overall Study||12
10486195|NCT01161862|11635556|FG000|COMPLETED|Overall Study||12
10486196|NCT01161862|11635557|FG001|COMPLETED|Overall Study||12
10486197|NCT01161862|11635556|FG000|NOT COMPLETED|Overall Study||0
10486198|NCT01161862|11635557|FG001|NOT COMPLETED|Overall Study||0
10486199|NCT01162005|11635568|FG000|STARTED|Overall Study||44
10486200|NCT01162005|11635569|FG001|STARTED|Overall Study||33
10486201|NCT01162005|11635568|FG000|COMPLETED|Overall Study||44
10486202|NCT01162005|11635569|FG001|COMPLETED|Overall Study||33
10486203|NCT01162005|11635568|FG000|NOT COMPLETED|Overall Study||0
10486204|NCT01162005|11635569|FG001|NOT COMPLETED|Overall Study||0
10486205|NCT01162096|11635577|FG000|STARTED|Overall Study||34
10486206|NCT01162096|11635577|FG000|COMPLETED|Overall Study||34
10486207|NCT01162096|11635577|FG000|NOT COMPLETED|Overall Study||0
10486208|NCT01162122|11635584|FG000|STARTED|Overall Study||3552
10486209|NCT01162122|11635585|FG001|STARTED|Overall Study||3552
10486210|NCT01162122|11635584|FG000|Vaccinated|Overall Study||3541
10486211|NCT01162122|11635585|FG001|Vaccinated|Overall Study||3541
10486212|NCT01162122|11635584|FG000|COMPLETED|Overall Study||3361
10486213|NCT01162122|11635585|FG001|COMPLETED|Overall Study||3356
10486214|NCT01162122|11635584|FG000|NOT COMPLETED|Overall Study||191
10486215|NCT01162122|11635585|FG001|NOT COMPLETED|Overall Study||196
10486216|NCT01162135|11635594|FG000|STARTED|Overall Study||16
10486217|NCT01162135|11635594|FG000|COMPLETED|Overall Study||13
10486218|NCT01162135|11635594|FG000|NOT COMPLETED|Overall Study||3
10486219|NCT01162239|11635602|FG000|STARTED|Treatment Phase||55
10486220|NCT01162239|11635603|FG001|STARTED|Treatment Phase||54
10486221|NCT01162239|11635604|FG002|STARTED|Treatment Phase||52
10486222|NCT01162239|11635605|FG003|STARTED|Treatment Phase||55
10486223|NCT01162239|11635602|FG000|Week 12|Treatment Phase||50
10486224|NCT01162239|11635603|FG001|Week 12|Treatment Phase||51
10486225|NCT01162239|11635604|FG002|Week 12|Treatment Phase||49
10486226|NCT01162239|11635605|FG003|Week 12|Treatment Phase||53
10486227|NCT01162239|11635602|FG000|Week 24|Treatment Phase||51
10486228|NCT01162239|11635603|FG001|Week 24|Treatment Phase||48
10486229|NCT01162239|11635604|FG002|Week 24|Treatment Phase||48
10486230|NCT01162239|11635605|FG003|Week 24|Treatment Phase||50
10486231|NCT01162239|11635602|FG000|Week 52|Treatment Phase||49
10486232|NCT01162239|11635603|FG001|Week 52|Treatment Phase||47
10486233|NCT01162239|11635604|FG002|Week 52|Treatment Phase||48
10486234|NCT01162239|11635605|FG003|Week 52|Treatment Phase||50
10486235|NCT01162239|11635602|FG000|COMPLETED|Treatment Phase||49
10486236|NCT01162239|11635603|FG001|COMPLETED|Treatment Phase||47
10486237|NCT01162239|11635604|FG002|COMPLETED|Treatment Phase||48
10486238|NCT01162239|11635605|FG003|COMPLETED|Treatment Phase||50
10486239|NCT01162239|11635602|FG000|NOT COMPLETED|Treatment Phase||6
10486240|NCT01162239|11635603|FG001|NOT COMPLETED|Treatment Phase||7
10486241|NCT01162239|11635604|FG002|NOT COMPLETED|Treatment Phase||4
10486242|NCT01162239|11635605|FG003|NOT COMPLETED|Treatment Phase||5
10486243|NCT01162239|11635602|FG000|STARTED|Extended Follow-up||47
10486244|NCT01162239|11635603|FG001|STARTED|Extended Follow-up||45
10486245|NCT01162239|11635604|FG002|STARTED|Extended Follow-up||45
10486246|NCT01162239|11635605|FG003|STARTED|Extended Follow-up||47
10486247|NCT01162239|11635602|FG000|COMPLETED|Extended Follow-up||39
10486248|NCT01162239|11635603|FG001|COMPLETED|Extended Follow-up||32
10486249|NCT01162239|11635604|FG002|COMPLETED|Extended Follow-up||37
10486250|NCT01162239|11635605|FG003|COMPLETED|Extended Follow-up||41
10486251|NCT01162239|11635602|FG000|NOT COMPLETED|Extended Follow-up||8
10486252|NCT01162239|11635603|FG001|NOT COMPLETED|Extended Follow-up||13
10486253|NCT01162239|11635604|FG002|NOT COMPLETED|Extended Follow-up||8
10486254|NCT01162239|11635605|FG003|NOT COMPLETED|Extended Follow-up||6
10486255|NCT01162317|11635618|FG000|STARTED|Overall Study||30
10486256|NCT01162317|11635619|FG001|STARTED|Overall Study||30
10486257|NCT01162317|11635618|FG000|COMPLETED|Overall Study||27
10486258|NCT01162317|11635619|FG001|COMPLETED|Overall Study||28
10486259|NCT01162317|11635618|FG000|NOT COMPLETED|Overall Study||3
10486260|NCT01162317|11635619|FG001|NOT COMPLETED|Overall Study||2
10486261|NCT01162343|11635625|FG000|STARTED|Overall Study||498
10486262|NCT01162343|11635625|FG000|COMPLETED|Overall Study||406
10486263|NCT01162343|11635625|FG000|NOT COMPLETED|Overall Study||92
10486264|NCT01162421|11635631|FG000|STARTED|Overall Study||37
10486265|NCT01162421|11635632|FG001|STARTED|Overall Study||40
10486266|NCT01162421|11635631|FG000|COMPLETED|Overall Study||29
10486267|NCT01162421|11635632|FG001|COMPLETED|Overall Study||27
10486268|NCT01162421|11635631|FG000|NOT COMPLETED|Overall Study||8
10486269|NCT01162421|11635632|FG001|NOT COMPLETED|Overall Study||13
10486270|NCT01162473|11635640|FG000|STARTED|Overall Study||8
10486271|NCT01162473|11635641|FG001|STARTED|Overall Study||17
10486272|NCT01162473|11635640|FG000|COMPLETED|Overall Study||6
10486273|NCT01162473|11635641|FG001|COMPLETED|Overall Study||12
10486274|NCT01162473|11635640|FG000|NOT COMPLETED|Overall Study||2
10486275|NCT01162473|11635641|FG001|NOT COMPLETED|Overall Study||5
10486276|NCT01162486|11635652|FG000|STARTED|Overall Study||8
10486277|NCT01162486|11635653|FG001|STARTED|Overall Study||6
10486278|NCT01162486|11635654|FG002|STARTED|Overall Study||6
10486279|NCT01162486|11635655|FG003|STARTED|Overall Study||7
10486280|NCT01162486|11635656|FG004|STARTED|Overall Study||6
10486281|NCT01162486|11635652|FG000|Took at Least One Dose Study Drug|Overall Study||8
10486282|NCT01162486|11635653|FG001|Took at Least One Dose Study Drug|Overall Study||6
10486283|NCT01162486|11635654|FG002|Took at Least One Dose Study Drug|Overall Study||6
10486284|NCT01162486|11635655|FG003|Took at Least One Dose Study Drug|Overall Study||7
10486285|NCT01162486|11635656|FG004|Took at Least One Dose Study Drug|Overall Study||6
10486286|NCT01162486|11635652|FG000|COMPLETED|Overall Study||6
10486287|NCT01162486|11635653|FG001|COMPLETED|Overall Study||6
10486288|NCT01162486|11635654|FG002|COMPLETED|Overall Study||5
10486289|NCT01162486|11635655|FG003|COMPLETED|Overall Study||6
10486290|NCT01162486|11635656|FG004|COMPLETED|Overall Study||6
10486291|NCT01162486|11635652|FG000|NOT COMPLETED|Overall Study||2
10486292|NCT01162486|11635653|FG001|NOT COMPLETED|Overall Study||0
10486293|NCT01162486|11635654|FG002|NOT COMPLETED|Overall Study||1
10486294|NCT01162486|11635655|FG003|NOT COMPLETED|Overall Study||1
10486295|NCT01162486|11635656|FG004|NOT COMPLETED|Overall Study||0
10486296|NCT01162499|11635672|FG000|STARTED|Intervention 1 (4 Hours)||3
10486297|NCT01162499|11635673|FG001|STARTED|Intervention 1 (4 Hours)||4
10486298|NCT01162499|11635672|FG000|Received Intervention|Intervention 1 (4 Hours)||3
10486299|NCT01162499|11635673|FG001|Received Intervention|Intervention 1 (4 Hours)||3
10486300|NCT01162499|11635672|FG000|COMPLETED|Intervention 1 (4 Hours)||3
10486301|NCT01162499|11635673|FG001|COMPLETED|Intervention 1 (4 Hours)||3
10486302|NCT01162499|11635672|FG000|NOT COMPLETED|Intervention 1 (4 Hours)||0
10486303|NCT01162499|11635673|FG001|NOT COMPLETED|Intervention 1 (4 Hours)||1
10486304|NCT01162499|11635672|FG000|STARTED|Intervention 2 (4 Hours)||3
10486305|NCT01162499|11635673|FG001|STARTED|Intervention 2 (4 Hours)||3
10486306|NCT01162499|11635672|FG000|COMPLETED|Intervention 2 (4 Hours)||3
10486307|NCT01162499|11635673|FG001|COMPLETED|Intervention 2 (4 Hours)||3
10486308|NCT01162499|11635672|FG000|NOT COMPLETED|Intervention 2 (4 Hours)||0
10486309|NCT01162499|11635673|FG001|NOT COMPLETED|Intervention 2 (4 Hours)||0
10486310|NCT01162551|11635681|FG000|STARTED|Overall Study|2 subjects were enrolled but withdrew before receiving any study treatment|3
10486311|NCT01162551|11635681|FG000|COMPLETED|Overall Study||3
10486312|NCT01162551|11635681|FG000|NOT COMPLETED|Overall Study||0
10486313|NCT01162733|11635687|FG000|STARTED|Overall Study||49
10486314|NCT01162733|11635688|FG001|STARTED|Overall Study||50
10486315|NCT01162733|11635687|FG000|COMPLETED|Overall Study||22
10486316|NCT01162733|11635688|FG001|COMPLETED|Overall Study||25
10486317|NCT01162733|11635687|FG000|NOT COMPLETED|Overall Study||27
10486318|NCT01162733|11635688|FG001|NOT COMPLETED|Overall Study||25
10486319|NCT01162863|11635697|FG000|STARTED|Overall Study||18
10486320|NCT01162863|11635698|FG001|STARTED|Overall Study||17
10486321|NCT01162863|11635699|FG002|STARTED|Overall Study||17
10486322|NCT01162863|11635697|FG000|COMPLETED|Overall Study||17
10486323|NCT01162863|11635698|FG001|COMPLETED|Overall Study||16
10486324|NCT01162863|11635699|FG002|COMPLETED|Overall Study||17
10486325|NCT01162863|11635697|FG000|NOT COMPLETED|Overall Study||1
10486326|NCT01162863|11635698|FG001|NOT COMPLETED|Overall Study||1
10486327|NCT01162863|11635699|FG002|NOT COMPLETED|Overall Study||0
10486328|NCT01163032|11635710|FG000|STARTED|Randomization Phase||42
10486329|NCT01163032|11635711|FG001|STARTED|Randomization Phase||42
10486330|NCT01163032|11635712|FG002|STARTED|Randomization Phase|Not applicable for Randomized Phase|0
10486331|NCT01163032|11635710|FG000|COMPLETED|Randomization Phase||32
10486332|NCT01163032|11635711|FG001|COMPLETED|Randomization Phase||30
10486333|NCT01163032|11635712|FG002|COMPLETED|Randomization Phase|Not applicable for Randomized Phase|0
10709950|NCT02645253|11875067|FG003|STARTED|Overall Study||6
10709951|NCT02645253|11875064|FG000|COMPLETED|Overall Study||7
10709952|NCT02645253|11875065|FG001|COMPLETED|Overall Study||7
10709953|NCT02645253|11875066|FG002|COMPLETED|Overall Study||7
10709954|NCT02645253|11875067|FG003|COMPLETED|Overall Study||6
10709955|NCT02645253|11875064|FG000|NOT COMPLETED|Overall Study||0
10709956|NCT02645253|11875065|FG001|NOT COMPLETED|Overall Study||0
10709957|NCT02645253|11875066|FG002|NOT COMPLETED|Overall Study||0
10709958|NCT02645253|11875067|FG003|NOT COMPLETED|Overall Study||0
10709959|NCT02645409|11875084|FG000|STARTED|Overall Study||14
10709960|NCT02645409|11875085|FG001|STARTED|Overall Study|It was decided to not continue with the Radical Nephrectomy arm of the study.|0
10486334|NCT01163032|11635710|FG000|NOT COMPLETED|Randomization Phase||10
10486335|NCT01163032|11635711|FG001|NOT COMPLETED|Randomization Phase||12
10486336|NCT01163032|11635712|FG002|NOT COMPLETED|Randomization Phase||0
10486337|NCT01163032|11635710|FG000|STARTED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
10709961|NCT02645409|11875084|FG000|COMPLETED|Overall Study||10
10709962|NCT02645409|11875085|FG001|COMPLETED|Overall Study||0
10486425|NCT01163604|11635835|FG001|STARTED|Overall Study|August 2010|56
10486338|NCT01163032|11635711|FG001|STARTED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
10486339|NCT01163032|11635712|FG002|STARTED|Open Label Extension Phase|3 randomized patients rolled into extension (2 randomized to tasimelteon and one to placebo)|55
10486340|NCT01163032|11635710|FG000|COMPLETED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
10486341|NCT01163032|11635711|FG001|COMPLETED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
10486342|NCT01163032|11635712|FG002|COMPLETED|Open Label Extension Phase||39
10486343|NCT01163032|11635710|FG000|NOT COMPLETED|Open Label Extension Phase||0
10486344|NCT01163032|11635711|FG001|NOT COMPLETED|Open Label Extension Phase||0
10486345|NCT01163032|11635712|FG002|NOT COMPLETED|Open Label Extension Phase||16
10486346|NCT01163097|11635723|FG000|STARTED|Overall Study|15 subjects were successfully titrated and entered the palifermin treatment|20
10486347|NCT01163097|11635724|FG001|STARTED|Overall Study||16
10486348|NCT01163097|11635725|FG002|STARTED|Overall Study||8
10486349|NCT01163097|11635723|FG000|COMPLETED|Overall Study||14
10486350|NCT01163097|11635724|FG001|COMPLETED|Overall Study||16
10486351|NCT01163097|11635725|FG002|COMPLETED|Overall Study||8
10486352|NCT01163097|11635723|FG000|NOT COMPLETED|Overall Study||6
10486353|NCT01163097|11635724|FG001|NOT COMPLETED|Overall Study||0
10486354|NCT01163097|11635725|FG002|NOT COMPLETED|Overall Study||0
10486355|NCT01163149|11635738|FG000|STARTED|Primary Treatment Period||7
10486356|NCT01163149|11635739|FG001|STARTED|Primary Treatment Period||6
10486357|NCT01163149|11635740|FG002|STARTED|Primary Treatment Period||6
10486358|NCT01163149|11635738|FG000|COMPLETED|Primary Treatment Period||7
10486359|NCT01163149|11635739|FG001|COMPLETED|Primary Treatment Period||6
10486360|NCT01163149|11635740|FG002|COMPLETED|Primary Treatment Period||6
10486361|NCT01163149|11635738|FG000|NOT COMPLETED|Primary Treatment Period||0
10486362|NCT01163149|11635739|FG001|NOT COMPLETED|Primary Treatment Period||0
10486363|NCT01163149|11635740|FG002|NOT COMPLETED|Primary Treatment Period||0
10486364|NCT01163149|11635738|FG000|STARTED|Extension Treatment Period||7
10486365|NCT01163149|11635739|FG001|STARTED|Extension Treatment Period||6
10486366|NCT01163149|11635740|FG002|STARTED|Extension Treatment Period||6
10486367|NCT01163149|11635738|FG000|COMPLETED|Extension Treatment Period||5
10486368|NCT01163149|11635739|FG001|COMPLETED|Extension Treatment Period||5
10486369|NCT01163149|11635740|FG002|COMPLETED|Extension Treatment Period||4
10486370|NCT01163149|11635738|FG000|NOT COMPLETED|Extension Treatment Period||2
10486371|NCT01163149|11635739|FG001|NOT COMPLETED|Extension Treatment Period||1
10486372|NCT01163149|11635740|FG002|NOT COMPLETED|Extension Treatment Period||2
10486373|NCT01163162|11635762|FG000|STARTED|Overall Study||16
10486374|NCT01163162|11635762|FG000|COMPLETED|Overall Study||16
10486375|NCT01163162|11635762|FG000|NOT COMPLETED|Overall Study||0
10486376|NCT01163214|11635768|FG000|STARTED|Overall Study||79
10486377|NCT01163214|11635769|FG001|STARTED|Overall Study||81
10486378|NCT01163214|11635768|FG000|COMPLETED|Overall Study||79
10486379|NCT01163214|11635769|FG001|COMPLETED|Overall Study||81
10486380|NCT01163214|11635768|FG000|NOT COMPLETED|Overall Study||0
10486381|NCT01163214|11635769|FG001|NOT COMPLETED|Overall Study||0
10486382|NCT01163253|11635777|FG000|STARTED|Overall Study||2281
10486383|NCT01163253|11635778|FG001|STARTED|Overall Study||586
10486384|NCT01163253|11635777|FG000|COMPLETED|Overall Study||0
10486385|NCT01163253|11635778|FG001|COMPLETED|Overall Study||0
10486386|NCT01163253|11635777|FG000|NOT COMPLETED|Overall Study||2281
10486387|NCT01163253|11635778|FG001|NOT COMPLETED|Overall Study||586
10486388|NCT01163266|11635787|FG000|STARTED|Overall Study||157
10486389|NCT01163266|11635788|FG001|STARTED|Overall Study||155
10486390|NCT01163266|11635789|FG002|STARTED|Overall Study||150
10486391|NCT01163266|11635787|FG000|Treated|Overall Study||157
10486392|NCT01163266|11635788|FG001|Treated|Overall Study||155
10486393|NCT01163266|11635789|FG002|Treated|Overall Study||150
10486394|NCT01163266|11635787|FG000|COMPLETED|Overall Study||139
10486395|NCT01163266|11635788|FG001|COMPLETED|Overall Study||124
10486396|NCT01163266|11635789|FG002|COMPLETED|Overall Study||122
10486397|NCT01163266|11635787|FG000|NOT COMPLETED|Overall Study||18
10486398|NCT01163266|11635788|FG001|NOT COMPLETED|Overall Study||31
10486399|NCT01163266|11635789|FG002|NOT COMPLETED|Overall Study||28
10486400|NCT01163279|11635799|FG000|STARTED|Overall Study||10
10486401|NCT01163279|11635800|FG001|STARTED|Overall Study||9
10486402|NCT01163279|11635799|FG000|COMPLETED|Overall Study||8
10486403|NCT01163279|11635800|FG001|COMPLETED|Overall Study||9
10486404|NCT01163279|11635799|FG000|NOT COMPLETED|Overall Study||2
10486405|NCT01163279|11635800|FG001|NOT COMPLETED|Overall Study||0
10486406|NCT01163292|11635809|FG000|STARTED|Overall Study||106
10486407|NCT01163292|11635810|FG001|STARTED|Overall Study||114
10486408|NCT01163292|11635809|FG000|COMPLETED|Overall Study||65
10486409|NCT01163292|11635810|FG001|COMPLETED|Overall Study||92
10486410|NCT01163292|11635809|FG000|NOT COMPLETED|Overall Study||41
10486411|NCT01163292|11635810|FG001|NOT COMPLETED|Overall Study||22
10486412|NCT01163318|11635816|FG000|STARTED|Overall Study||552
10486413|NCT01163318|11635816|FG000|COMPLETED|Overall Study||284
10486414|NCT01163318|11635816|FG000|NOT COMPLETED|Overall Study||268
10486415|NCT01163461|11635820|FG000|STARTED|Overall Study||14
10486416|NCT01163461|11635821|FG001|STARTED|Overall Study||14
10486417|NCT01163461|11635820|FG000|COMPLETED|Overall Study||14
10486418|NCT01163461|11635821|FG001|COMPLETED|Overall Study||14
10486419|NCT01163461|11635820|FG000|NOT COMPLETED|Overall Study||0
10486420|NCT01163461|11635821|FG001|NOT COMPLETED|Overall Study||0
10486421|NCT01163474|11635825|FG000|STARTED|Overall Study||40
10486422|NCT01163474|11635825|FG000|COMPLETED|Overall Study||24
10486423|NCT01163474|11635825|FG000|NOT COMPLETED|Overall Study||16
10486424|NCT01163604|11635834|FG000|STARTED|Overall Study|August 2010|58
10486426|NCT01163604|11635834|FG000|COMPLETED|Overall Study|August 2011|58
10486427|NCT01163604|11635835|FG001|COMPLETED|Overall Study|August 2011|56
10486428|NCT01163604|11635834|FG000|NOT COMPLETED|Overall Study||0
10486429|NCT01163604|11635835|FG001|NOT COMPLETED|Overall Study||0
10486430|NCT01163617|11635841|FG000|STARTED|Phase A (User Experience), Weeks 0 and 2||19
10486431|NCT01163617|11635842|FG001|STARTED|Phase A (User Experience), Weeks 0 and 2||23
10486432|NCT01163617|11635843|FG002|STARTED|Phase A (User Experience), Weeks 0 and 2||21
10486433|NCT01163617|11635844|FG003|STARTED|Phase A (User Experience), Weeks 0 and 2||21
10486434|NCT01163617|11635845|FG004|STARTED|Phase A (User Experience), Weeks 0 and 2||0
10486435|NCT01163617|11635846|FG005|STARTED|Phase A (User Experience), Weeks 0 and 2||0
10486436|NCT01163617|11635847|FG006|STARTED|Phase A (User Experience), Weeks 0 and 2||0
10486437|NCT01163617|11635848|FG007|STARTED|Phase A (User Experience), Weeks 0 and 2||0
10486438|NCT01163617|11635841|FG000|COMPLETED|Phase A (User Experience), Weeks 0 and 2||19
10486439|NCT01163617|11635842|FG001|COMPLETED|Phase A (User Experience), Weeks 0 and 2||21
10486440|NCT01163617|11635843|FG002|COMPLETED|Phase A (User Experience), Weeks 0 and 2||20
10486441|NCT01163617|11635844|FG003|COMPLETED|Phase A (User Experience), Weeks 0 and 2||21
10486442|NCT01163617|11635845|FG004|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
10486443|NCT01163617|11635846|FG005|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
10486444|NCT01163617|11635847|FG006|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
10486445|NCT01163617|11635848|FG007|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
10486446|NCT01163617|11635841|FG000|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
10486447|NCT01163617|11635842|FG001|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||2
10486448|NCT01163617|11635843|FG002|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||1
10486449|NCT01163617|11635844|FG003|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
10486450|NCT01163617|11635845|FG004|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
10486451|NCT01163617|11635846|FG005|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
10486452|NCT01163617|11635847|FG006|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
10486453|NCT01163617|11635848|FG007|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
10486454|NCT01163617|11635841|FG000|STARTED|Phase B (Injection Time), Week 4||0
10486455|NCT01163617|11635842|FG001|STARTED|Phase B (Injection Time), Week 4||0
10486456|NCT01163617|11635843|FG002|STARTED|Phase B (Injection Time), Week 4||0
10486457|NCT01163617|11635844|FG003|STARTED|Phase B (Injection Time), Week 4||0
10486458|NCT01163617|11635845|FG004|STARTED|Phase B (Injection Time), Week 4||18
10486459|NCT01163617|11635846|FG005|STARTED|Phase B (Injection Time), Week 4||27
10486460|NCT01163617|11635847|FG006|STARTED|Phase B (Injection Time), Week 4||16
10486461|NCT01163617|11635848|FG007|STARTED|Phase B (Injection Time), Week 4||20
10486462|NCT01163617|11635841|FG000|COMPLETED|Phase B (Injection Time), Week 4||0
10486463|NCT01163617|11635842|FG001|COMPLETED|Phase B (Injection Time), Week 4||0
10486464|NCT01163617|11635843|FG002|COMPLETED|Phase B (Injection Time), Week 4||0
10486465|NCT01163617|11635844|FG003|COMPLETED|Phase B (Injection Time), Week 4||0
10486466|NCT01163617|11635845|FG004|COMPLETED|Phase B (Injection Time), Week 4||18
10486467|NCT01163617|11635846|FG005|COMPLETED|Phase B (Injection Time), Week 4||27
10486468|NCT01163617|11635847|FG006|COMPLETED|Phase B (Injection Time), Week 4||16
10486469|NCT01163617|11635848|FG007|COMPLETED|Phase B (Injection Time), Week 4||20
10486470|NCT01163617|11635841|FG000|NOT COMPLETED|Phase B (Injection Time), Week 4||0
10486471|NCT01163617|11635842|FG001|NOT COMPLETED|Phase B (Injection Time), Week 4||0
10486472|NCT01163617|11635843|FG002|NOT COMPLETED|Phase B (Injection Time), Week 4||0
10486473|NCT01163617|11635844|FG003|NOT COMPLETED|Phase B (Injection Time), Week 4||0
10486474|NCT01163617|11635845|FG004|NOT COMPLETED|Phase B (Injection Time), Week 4||0
10486475|NCT01163617|11635846|FG005|NOT COMPLETED|Phase B (Injection Time), Week 4||0
10486476|NCT01163617|11635847|FG006|NOT COMPLETED|Phase B (Injection Time), Week 4||0
10486477|NCT01163617|11635848|FG007|NOT COMPLETED|Phase B (Injection Time), Week 4||0
10486478|NCT01163643|11635874|FG000|STARTED|Overall Study||68
10486479|NCT01163643|11635875|FG001|STARTED|Overall Study||37
10486480|NCT01163643|11635876|FG002|STARTED|Overall Study||35
10486481|NCT01163643|11635877|FG003|STARTED|Overall Study||74
10486482|NCT01163643|11635878|FG004|STARTED|Overall Study||69
10486483|NCT01163643|11635879|FG005|STARTED|Overall Study||73
10486484|NCT01163643|11635874|FG000|COMPLETED|Overall Study||62
10486485|NCT01163643|11635875|FG001|COMPLETED|Overall Study||35
10486486|NCT01163643|11635876|FG002|COMPLETED|Overall Study||33
10486487|NCT01163643|11635877|FG003|COMPLETED|Overall Study||69
10486488|NCT01163643|11635878|FG004|COMPLETED|Overall Study||61
10486489|NCT01163643|11635879|FG005|COMPLETED|Overall Study||66
10486490|NCT01163643|11635874|FG000|NOT COMPLETED|Overall Study||6
10486491|NCT01163643|11635875|FG001|NOT COMPLETED|Overall Study||2
10486492|NCT01163643|11635876|FG002|NOT COMPLETED|Overall Study||2
10486493|NCT01163643|11635877|FG003|NOT COMPLETED|Overall Study||5
10486494|NCT01163643|11635878|FG004|NOT COMPLETED|Overall Study||8
10486495|NCT01163643|11635879|FG005|NOT COMPLETED|Overall Study||7
10486496|NCT01163656|11635895|FG000|STARTED|Overall Study||33
10486497|NCT01163656|11635896|FG001|STARTED|Overall Study||33
10486498|NCT01163656|11635895|FG000|COMPLETED|Overall Study||30
10486499|NCT01163656|11635896|FG001|COMPLETED|Overall Study||30
10486500|NCT01163656|11635895|FG000|NOT COMPLETED|Overall Study||3
10486501|NCT01163656|11635896|FG001|NOT COMPLETED|Overall Study||3
10486502|NCT01163721|11635904|FG000|STARTED|Overall Study||39
10486503|NCT01163721|11635905|FG001|STARTED|Overall Study||41
10486504|NCT01163721|11635904|FG000|COMPLETED|Overall Study||31
10486505|NCT01163721|11635905|FG001|COMPLETED|Overall Study||29
10486506|NCT01163721|11635904|FG000|NOT COMPLETED|Overall Study||8
10486507|NCT01163721|11635905|FG001|NOT COMPLETED|Overall Study||12
10486508|NCT01163747|11635913|FG000|STARTED|Overall Study||31
10486509|NCT01163747|11635914|FG001|STARTED|Overall Study||60
10486510|NCT01163747|11635913|FG000|Per Protocol Population|Overall Study|Participants who received at least 1 dose of study treatment excluding major protocol violators.|27
10486511|NCT01163747|11635914|FG001|Per Protocol Population|Overall Study|Participants who received at least 1 dose of study treatment excluding major protocol violators.|54
10486512|NCT01163747|11635913|FG000|COMPLETED|Overall Study||25
10486513|NCT01163747|11635914|FG001|COMPLETED|Overall Study||49
10486514|NCT01163747|11635913|FG000|NOT COMPLETED|Overall Study||6
10486515|NCT01163747|11635914|FG001|NOT COMPLETED|Overall Study||11
10486516|NCT01163760|11635920|FG000|STARTED|Period 1 (Fit)||12
10486517|NCT01163760|11635921|FG001|STARTED|Period 1 (Fit)||13
10486518|NCT01163760|11635922|FG002|STARTED|Period 1 (Fit)||13
10486519|NCT01163760|11635923|FG003|STARTED|Period 1 (Fit)||12
10486520|NCT01163760|11635920|FG000|COMPLETED|Period 1 (Fit)||12
10486521|NCT01163760|11635921|FG001|COMPLETED|Period 1 (Fit)||13
10486522|NCT01163760|11635922|FG002|COMPLETED|Period 1 (Fit)||13
10486523|NCT01163760|11635923|FG003|COMPLETED|Period 1 (Fit)||12
10486524|NCT01163760|11635920|FG000|NOT COMPLETED|Period 1 (Fit)||0
10486525|NCT01163760|11635921|FG001|NOT COMPLETED|Period 1 (Fit)||0
10486526|NCT01163760|11635922|FG002|NOT COMPLETED|Period 1 (Fit)||0
10486527|NCT01163760|11635923|FG003|NOT COMPLETED|Period 1 (Fit)||0
10486528|NCT01163760|11635920|FG000|STARTED|Period 2 (Follow-up)||12
10486529|NCT01163760|11635921|FG001|STARTED|Period 2 (Follow-up)||13
10486530|NCT01163760|11635922|FG002|STARTED|Period 2 (Follow-up)||13
10486531|NCT01163760|11635923|FG003|STARTED|Period 2 (Follow-up)||12
10486532|NCT01163760|11635920|FG000|COMPLETED|Period 2 (Follow-up)||12
10486533|NCT01163760|11635921|FG001|COMPLETED|Period 2 (Follow-up)||13
10486534|NCT01163760|11635922|FG002|COMPLETED|Period 2 (Follow-up)||13
10486535|NCT01163760|11635923|FG003|COMPLETED|Period 2 (Follow-up)||12
10486536|NCT01163760|11635920|FG000|NOT COMPLETED|Period 2 (Follow-up)||0
10486537|NCT01163760|11635921|FG001|NOT COMPLETED|Period 2 (Follow-up)||0
10486538|NCT01163760|11635922|FG002|NOT COMPLETED|Period 2 (Follow-up)||0
10486539|NCT01163760|11635923|FG003|NOT COMPLETED|Period 2 (Follow-up)||0
10486540|NCT01163760|11635920|FG000|STARTED|Period 3 (Fit)||12
10486541|NCT01163760|11635921|FG001|STARTED|Period 3 (Fit)||13
10486542|NCT01163760|11635922|FG002|STARTED|Period 3 (Fit)||13
10486543|NCT01163760|11635923|FG003|STARTED|Period 3 (Fit)||12
10486544|NCT01163760|11635920|FG000|COMPLETED|Period 3 (Fit)||12
10486545|NCT01163760|11635921|FG001|COMPLETED|Period 3 (Fit)||13
10486546|NCT01163760|11635922|FG002|COMPLETED|Period 3 (Fit)||13
10486547|NCT01163760|11635923|FG003|COMPLETED|Period 3 (Fit)||12
10486548|NCT01163760|11635920|FG000|NOT COMPLETED|Period 3 (Fit)||0
10486549|NCT01163760|11635921|FG001|NOT COMPLETED|Period 3 (Fit)||0
10486550|NCT01163760|11635922|FG002|NOT COMPLETED|Period 3 (Fit)||0
10486551|NCT01163760|11635923|FG003|NOT COMPLETED|Period 3 (Fit)||0
10486552|NCT01163760|11635920|FG000|STARTED|Period 4 (Follow-up)||12
10486553|NCT01163760|11635921|FG001|STARTED|Period 4 (Follow-up)||13
10486554|NCT01163760|11635922|FG002|STARTED|Period 4 (Follow-up)||13
10486555|NCT01163760|11635923|FG003|STARTED|Period 4 (Follow-up)||12
10486556|NCT01163760|11635920|FG000|COMPLETED|Period 4 (Follow-up)||12
10486557|NCT01163760|11635921|FG001|COMPLETED|Period 4 (Follow-up)||13
10486558|NCT01163760|11635922|FG002|COMPLETED|Period 4 (Follow-up)||13
10486559|NCT01163760|11635923|FG003|COMPLETED|Period 4 (Follow-up)||12
10486560|NCT01163760|11635920|FG000|NOT COMPLETED|Period 4 (Follow-up)||0
10486561|NCT01163760|11635921|FG001|NOT COMPLETED|Period 4 (Follow-up)||0
10486562|NCT01163760|11635922|FG002|NOT COMPLETED|Period 4 (Follow-up)||0
10486563|NCT01163760|11635923|FG003|NOT COMPLETED|Period 4 (Follow-up)||0
10486564|NCT01163786|11635931|FG000|STARTED|Treatment With Bortezomib||17
10486565|NCT01163786|11635931|FG000|Completed 1st Cycle|Treatment With Bortezomib||17
10486566|NCT01163786|11635931|FG000|Completed 2nd Cycle|Treatment With Bortezomib|One patient completed cycle 2 but missed one dose of Bortezomib.|14
10486567|NCT01163786|11635931|FG000|COMPLETED|Treatment With Bortezomib||14
10486568|NCT01163786|11635931|FG000|NOT COMPLETED|Treatment With Bortezomib||3
10486569|NCT01163786|11635931|FG000|STARTED|Completed Follow up (Visit 9 and 10)||14
10486570|NCT01163786|11635931|FG000|Completed Week 12 Follow up (Visit 9)|Completed Follow up (Visit 9 and 10)||14
10486571|NCT01163786|11635931|FG000|Completed Week 18 Follow up (Visit 10)|Completed Follow up (Visit 9 and 10)||13
10486572|NCT01163786|11635931|FG000|COMPLETED|Completed Follow up (Visit 9 and 10)||13
10486573|NCT01163786|11635931|FG000|NOT COMPLETED|Completed Follow up (Visit 9 and 10)||1
10486574|NCT01163851|11635937|FG000|STARTED|Overall Study||13
10486575|NCT01163851|11635938|FG001|STARTED|Overall Study||12
10486576|NCT01163851|11635937|FG000|Treated|Overall Study||12
10486577|NCT01163851|11635938|FG001|Treated|Overall Study||12
10486578|NCT01163851|11635937|FG000|COMPLETED|Overall Study||12
10486579|NCT01163851|11635938|FG001|COMPLETED|Overall Study||11
10486580|NCT01163851|11635937|FG000|NOT COMPLETED|Overall Study||1
10486581|NCT01163851|11635938|FG001|NOT COMPLETED|Overall Study||1
10486582|NCT01163916|11635947|FG000|STARTED|Overall Study||126
10486583|NCT01163916|11635948|FG001|STARTED|Overall Study||35
10486584|NCT01163916|11635949|FG002|STARTED|Overall Study||91
10486585|NCT01163916|11635947|FG000|Safety Population|Overall Study|One patient discontinued prior to receiving treatment with adalimumab due to absence of medication.|125
10486586|NCT01163916|11635948|FG001|Safety Population|Overall Study||35
10486587|NCT01163916|11635949|FG002|Safety Population|Overall Study||91
10486588|NCT01163916|11635947|FG000|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|96
10486589|NCT01163916|11635948|FG001|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|31
10486590|NCT01163916|11635949|FG002|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|71
10486591|NCT01163916|11635947|FG000|NOT COMPLETED|Overall Study||30
10486592|NCT01163916|11635948|FG001|NOT COMPLETED|Overall Study||4
10486593|NCT01163916|11635949|FG002|NOT COMPLETED|Overall Study||20
10486594|NCT01163955|11635964|FG000|STARTED|Overall Study||26
10486595|NCT01163955|11635965|FG001|STARTED|Overall Study||30
10486596|NCT01163955|11635964|FG000|COMPLETED|Overall Study||26
10486597|NCT01163955|11635965|FG001|COMPLETED|Overall Study||26
10486598|NCT01163955|11635964|FG000|NOT COMPLETED|Overall Study||0
10486599|NCT01163955|11635965|FG001|NOT COMPLETED|Overall Study||4
10486600|NCT01164007|11635971|FG000|STARTED|Overall Study||40
10486601|NCT01164007|11635971|FG000|Treated|Overall Study||37
10486602|NCT01164007|11635971|FG000|COMPLETED|Overall Study||0
10486603|NCT01164007|11635971|FG000|NOT COMPLETED|Overall Study||40
10486604|NCT01164098|11635977|FG000|STARTED|Overall Study||15
10486605|NCT01164098|11635978|FG001|STARTED|Overall Study||15
10486606|NCT01164098|11635977|FG000|COMPLETED|Overall Study||15
10486607|NCT01164098|11635978|FG001|COMPLETED|Overall Study||15
10486608|NCT01164098|11635977|FG000|NOT COMPLETED|Overall Study||0
10486609|NCT01164098|11635978|FG001|NOT COMPLETED|Overall Study||0
10486610|NCT01164137|11635986|FG000|STARTED|Overall Study||80
10486611|NCT01164137|11635987|FG001|STARTED|Overall Study||76
10486612|NCT01164137|11635986|FG000|COMPLETED|Overall Study||77
10486613|NCT01164137|11635987|FG001|COMPLETED|Overall Study||76
10486614|NCT01164137|11635986|FG000|NOT COMPLETED|Overall Study||3
10486615|NCT01164137|11635987|FG001|NOT COMPLETED|Overall Study||0
10486616|NCT01164475|11635995|FG000|STARTED|Overall Study||30
10486617|NCT01164475|11635996|FG001|STARTED|Overall Study||31
10486618|NCT01164475|11635995|FG000|COMPLETED|Overall Study||28
10486619|NCT01164475|11635996|FG001|COMPLETED|Overall Study||29
10486620|NCT01164475|11635995|FG000|NOT COMPLETED|Overall Study||2
10486621|NCT01164475|11635996|FG001|NOT COMPLETED|Overall Study||2
10486622|NCT01164501|11636005|FG000|STARTED|Overall Study||321
10486623|NCT01164501|11636006|FG001|STARTED|Overall Study||98
10486624|NCT01164501|11636007|FG002|STARTED|Overall Study||322
10486625|NCT01164501|11636005|FG000|COMPLETED|Overall Study||278
10486626|NCT01164501|11636006|FG001|COMPLETED|Overall Study||88
10486627|NCT01164501|11636007|FG002|COMPLETED|Overall Study||280
10486628|NCT01164501|11636005|FG000|NOT COMPLETED|Overall Study||43
10486629|NCT01164501|11636006|FG001|NOT COMPLETED|Overall Study||10
10486630|NCT01164501|11636007|FG002|NOT COMPLETED|Overall Study||42
10486631|NCT01164579|11636020|FG000|STARTED|Overall Study||36
10486632|NCT01164579|11636021|FG001|STARTED|Overall Study||36
10486633|NCT01164579|11636022|FG002|STARTED|Overall Study||37
10486634|NCT01164579|11636020|FG000|COMPLETED|Overall Study||28
10486635|NCT01164579|11636021|FG001|COMPLETED|Overall Study||27
10709963|NCT02645409|11875084|FG000|NOT COMPLETED|Overall Study||4
10709964|NCT02645409|11875085|FG001|NOT COMPLETED|Overall Study||0
10709965|NCT02645617|11875090|FG000|STARTED|Overall Study||12
10709966|NCT02645617|11875090|FG000|COMPLETED|Overall Study||12
10709967|NCT02645617|11875090|FG000|NOT COMPLETED|Overall Study||0
10709968|NCT02645760|11875096|FG000|STARTED|Overall Study||19
10486636|NCT01164579|11636022|FG002|COMPLETED|Overall Study||21
10486637|NCT01164579|11636020|FG000|NOT COMPLETED|Overall Study||8
10486638|NCT01164579|11636021|FG001|NOT COMPLETED|Overall Study||9
10486639|NCT01164579|11636022|FG002|NOT COMPLETED|Overall Study||16
10486640|NCT01164644|11636033|FG000|STARTED|Overall Study||12
10486641|NCT01164644|11636034|FG001|STARTED|Overall Study||14
10486642|NCT01164644|11636033|FG000|COMPLETED|Overall Study||9
10486643|NCT01164644|11636034|FG001|COMPLETED|Overall Study||13
10486644|NCT01164644|11636033|FG000|NOT COMPLETED|Overall Study||3
10486645|NCT01164644|11636034|FG001|NOT COMPLETED|Overall Study||1
10486646|NCT01164722|11636042|FG000|STARTED|Overall Study||60
10486647|NCT01164722|11636043|FG001|STARTED|Overall Study||60
10486648|NCT01164722|11636042|FG000|COMPLETED|Overall Study||42
10486649|NCT01164722|11636043|FG001|COMPLETED|Overall Study||45
10486650|NCT01164722|11636042|FG000|NOT COMPLETED|Overall Study||18
10486651|NCT01164722|11636043|FG001|NOT COMPLETED|Overall Study||15
10486652|NCT01164865|11636051|FG000|STARTED|Overall Study||39
10486653|NCT01164865|11636052|FG001|STARTED|Overall Study||39
10486654|NCT01164865|11636051|FG000|COMPLETED|Overall Study||37
10486655|NCT01164865|11636052|FG001|COMPLETED|Overall Study||38
10486656|NCT01164865|11636051|FG000|NOT COMPLETED|Overall Study||2
10486657|NCT01164865|11636052|FG001|NOT COMPLETED|Overall Study||1
10486658|NCT01164891|11636058|FG000|STARTED|Overall Study||7
10486659|NCT01164891|11636058|FG000|COMPLETED|Overall Study||1
10486660|NCT01164891|11636058|FG000|NOT COMPLETED|Overall Study||6
10486661|NCT01164956|11636063|FG000|STARTED|Overall Study||1
10486662|NCT01164956|11636064|FG001|STARTED|Overall Study||1
10486663|NCT01164956|11636065|FG002|STARTED|Overall Study||1
10486664|NCT01164956|11636063|FG000|Evaluable for pedsFACIT-F Score Change|Overall Study||0
10486665|NCT01164956|11636064|FG001|Evaluable for pedsFACIT-F Score Change|Overall Study||1
10486666|NCT01164956|11636065|FG002|Evaluable for pedsFACIT-F Score Change|Overall Study||0
10486667|NCT01164956|11636063|FG000|COMPLETED|Overall Study||0
10709969|NCT02645760|11875097|FG001|STARTED|Overall Study||19
10709970|NCT02645760|11875096|FG000|COMPLETED|Overall Study||19
10709971|NCT02645760|11875097|FG001|COMPLETED|Overall Study||19
10709972|NCT02645760|11875096|FG000|NOT COMPLETED|Overall Study||0
10709973|NCT02645760|11875097|FG001|NOT COMPLETED|Overall Study||0
10709974|NCT02646124|11875106|FG000|STARTED|Overall Study||57
10709975|NCT02646124|11875107|FG001|STARTED|Overall Study||57
10809826|NCT03827473|11971631|FG001|NOT COMPLETED|Overall Study||0
10809827|NCT03826914|11971639|FG000|STARTED|Overall Study||35
10809828|NCT03826914|11971640|FG001|STARTED|Overall Study||34
10809829|NCT03826914|11971639|FG000|COMPLETED|Overall Study||34
10809830|NCT03826914|11971640|FG001|COMPLETED|Overall Study||33
10809831|NCT03826914|11971639|FG000|NOT COMPLETED|Overall Study||1
10809832|NCT03826914|11971640|FG001|NOT COMPLETED|Overall Study||1
10809833|NCT03812328|11971651|FG000|STARTED|Overall Study||55
10809834|NCT03812328|11971652|FG001|STARTED|Overall Study||63
10486668|NCT01164956|11636064|FG001|COMPLETED|Overall Study||1
10486669|NCT01164956|11636065|FG002|COMPLETED|Overall Study||0
10809835|NCT03812328|11971653|FG002|STARTED|Overall Study||89
10809836|NCT03812328|11971651|FG000|Modified Intent-to-Treat (mITT) Population|Overall Study||48
10809837|NCT03812328|11971652|FG001|Modified Intent-to-Treat (mITT) Population|Overall Study||61
10486670|NCT01164956|11636063|FG000|NOT COMPLETED|Overall Study||1
10486671|NCT01164956|11636064|FG001|NOT COMPLETED|Overall Study||0
10709976|NCT02646124|11875106|FG000|COMPLETED|Overall Study||57
10709977|NCT02646124|11875107|FG001|COMPLETED|Overall Study||55
10709978|NCT02646124|11875106|FG000|NOT COMPLETED|Overall Study||0
10809838|NCT03812328|11971653|FG002|Modified Intent-to-Treat (mITT) Population|Overall Study||84
10809839|NCT03812328|11971651|FG000|Safety Population|Overall Study||55
10809840|NCT03812328|11971652|FG001|Safety Population|Overall Study||63
10809841|NCT03812328|11971653|FG002|Safety Population|Overall Study||88
10486672|NCT01164956|11636065|FG002|NOT COMPLETED|Overall Study||1
10486673|NCT01165021|11636073|FG000|STARTED|Overall Study||19
10486674|NCT01165021|11636073|FG000|≥1 Dose Chemo|Overall Study||19
10486675|NCT01165021|11636073|FG000|≥1 Dose Chemo, Baseline, Cy 3 Assessment|Overall Study||17
10486676|NCT01165021|11636073|FG000|3 Cycles of Chemo, Then Surgery|Overall Study||15
10486677|NCT01165021|11636073|FG000|COMPLETED|Overall Study||18
10486678|NCT01165021|11636073|FG000|NOT COMPLETED|Overall Study||1
10486679|NCT01165047|11636077|FG000|STARTED|Overall Study||10
10486680|NCT01165047|11636077|FG000|COMPLETED|Overall Study||10
10486681|NCT01165047|11636077|FG000|NOT COMPLETED|Overall Study||0
10486682|NCT01165112|11636081|FG000|STARTED|Overall Study||48
10486683|NCT01165112|11636081|FG000|COMPLETED|Overall Study||48
10486684|NCT01165112|11636081|FG000|NOT COMPLETED|Overall Study||0
10486685|NCT01165138|11636088|FG000|STARTED|Overall Study||0
10486686|NCT01165138|11636089|FG001|STARTED|Overall Study||203
10486687|NCT01165138|11636090|FG002|STARTED|Overall Study||205
10486688|NCT01165138|11636091|FG003|STARTED|Overall Study||201
10486689|NCT01165138|11636088|FG000|COMPLETED|Overall Study||0
10486690|NCT01165138|11636089|FG001|COMPLETED|Overall Study||151
10486691|NCT01165138|11636090|FG002|COMPLETED|Overall Study||185
10486692|NCT01165138|11636091|FG003|COMPLETED|Overall Study||179
10486693|NCT01165138|11636088|FG000|NOT COMPLETED|Overall Study||0
10486694|NCT01165138|11636089|FG001|NOT COMPLETED|Overall Study||52
10486695|NCT01165138|11636090|FG002|NOT COMPLETED|Overall Study||20
10486696|NCT01165138|11636091|FG003|NOT COMPLETED|Overall Study||22
10486697|NCT01165177|11636101|FG000|STARTED|Overall Study||7695
10486698|NCT01165177|11636102|FG001|STARTED|Overall Study||7710
10486699|NCT01165177|11636101|FG000|COMPLETED|Overall Study||6773
10486700|NCT01165177|11636102|FG001|COMPLETED|Overall Study||6808
10486701|NCT01165177|11636101|FG000|NOT COMPLETED|Overall Study||922
10486702|NCT01165177|11636102|FG001|NOT COMPLETED|Overall Study||902
10486703|NCT01165203|11636118|FG000|STARTED|Active Phase||74
10486704|NCT01165203|11636119|FG001|STARTED|Active Phase||49
10486705|NCT01165203|11636118|FG000|COMPLETED|Active Phase||69
10486706|NCT01165203|11636119|FG001|COMPLETED|Active Phase||47
10486707|NCT01165203|11636118|FG000|NOT COMPLETED|Active Phase||5
10486708|NCT01165203|11636119|FG001|NOT COMPLETED|Active Phase||2
10486709|NCT01165203|11636118|FG000|STARTED|Extended Safety Follow-up Phase||74
10486710|NCT01165203|11636119|FG001|STARTED|Extended Safety Follow-up Phase||49
10486711|NCT01165203|11636118|FG000|COMPLETED|Extended Safety Follow-up Phase||67
10486712|NCT01165203|11636119|FG001|COMPLETED|Extended Safety Follow-up Phase||45
10486713|NCT01165203|11636118|FG000|NOT COMPLETED|Extended Safety Follow-up Phase||7
10486714|NCT01165203|11636119|FG001|NOT COMPLETED|Extended Safety Follow-up Phase||4
10486715|NCT01165216|11636134|FG000|STARTED|Overall Study|Participants who received any study drug|8
10486716|NCT01165216|11636135|FG001|STARTED|Overall Study|Participants who received any study drug|7
10486717|NCT01165216|11636134|FG000|Received at Least 1 Dose of Ipilimumab|Overall Study||6
10486718|NCT01165216|11636135|FG001|Received at Least 1 Dose of Ipilimumab|Overall Study||6
10486719|NCT01165216|11636134|FG000|COMPLETED|Overall Study|Completed=still on study drug|0
10486720|NCT01165216|11636135|FG001|COMPLETED|Overall Study|Completed=still on study drug|0
10486721|NCT01165216|11636134|FG000|NOT COMPLETED|Overall Study||8
10486722|NCT01165216|11636135|FG001|NOT COMPLETED|Overall Study||7
10486723|NCT01165229|11636145|FG000|STARTED|Overall Study||6950
10486724|NCT01165229|11636146|FG001|STARTED|Overall Study||6950
10486725|NCT01165229|11636145|FG000|COMPLETED|Overall Study||5770
10486726|NCT01165229|11636146|FG001|COMPLETED|Overall Study||5760
10486727|NCT01165229|11636145|FG000|NOT COMPLETED|Overall Study||1180
10809842|NCT03812328|11971651|FG000|COMPLETED|Overall Study||55
10486728|NCT01165229|11636146|FG001|NOT COMPLETED|Overall Study||1190
10486729|NCT01165242|11636185|FG000|STARTED|Overall Study||337
10486730|NCT01165242|11636186|FG001|STARTED|Overall Study||336
10809843|NCT03812328|11971652|FG001|COMPLETED|Overall Study||60
10486731|NCT01165242|11636187|FG002|STARTED|Overall Study||338
10486732|NCT01165242|11636185|FG000|COMPLETED|Overall Study||327
10486733|NCT01165242|11636186|FG001|COMPLETED|Overall Study||326
10486734|NCT01165242|11636187|FG002|COMPLETED|Overall Study||324
10486735|NCT01165242|11636185|FG000|NOT COMPLETED|Overall Study||10
10486736|NCT01165242|11636186|FG001|NOT COMPLETED|Overall Study||10
10486737|NCT01165242|11636187|FG002|NOT COMPLETED|Overall Study||14
10486738|NCT01165281|11636199|FG000|STARTED|Overall Study||168
10486739|NCT01165281|11636200|FG001|STARTED|Overall Study||172
10486740|NCT01165281|11636199|FG000|COMPLETED|Overall Study||110
10486741|NCT01165281|11636200|FG001|COMPLETED|Overall Study||121
10486742|NCT01165281|11636199|FG000|NOT COMPLETED|Overall Study||58
10486743|NCT01165281|11636200|FG001|NOT COMPLETED|Overall Study||51
10486744|NCT01165307|11636208|FG000|STARTED|Overall Study||33
10486745|NCT01165307|11636209|FG001|STARTED|Overall Study||34
10486746|NCT01165307|11636208|FG000|COMPLETED|Overall Study||19
10486747|NCT01165307|11636209|FG001|COMPLETED|Overall Study||31
10486748|NCT01165307|11636208|FG000|NOT COMPLETED|Overall Study||14
10486749|NCT01165307|11636209|FG001|NOT COMPLETED|Overall Study||3
10486750|NCT01165320|11636217|FG000|STARTED|Overall Study||12
10486751|NCT01165320|11636218|FG001|STARTED|Overall Study||8
10486752|NCT01165320|11636219|FG002|STARTED|Overall Study|No participants with esophageal candidiasis were identified for inclusion in the study|0
10486753|NCT01165320|11636217|FG000|COMPLETED|Overall Study||9
10486754|NCT01165320|11636218|FG001|COMPLETED|Overall Study||4
10486755|NCT01165320|11636219|FG002|COMPLETED|Overall Study||0
10486756|NCT01165320|11636217|FG000|NOT COMPLETED|Overall Study||3
10486757|NCT01165320|11636218|FG001|NOT COMPLETED|Overall Study||4
10486758|NCT01165320|11636219|FG002|NOT COMPLETED|Overall Study||0
10486759|NCT01165541|11636225|FG000|STARTED|Quetiapine XR Monotherapy||20
10486760|NCT01165541|11636225|FG000|COMPLETED|Quetiapine XR Monotherapy||16
10486761|NCT01165541|11636225|FG000|NOT COMPLETED|Quetiapine XR Monotherapy||4
10486762|NCT01165541|11636225|FG000|STARTED|Quetiapine XR and Mirtazepine||16
10486763|NCT01165541|11636225|FG000|COMPLETED|Quetiapine XR and Mirtazepine||11
10486764|NCT01165541|11636225|FG000|NOT COMPLETED|Quetiapine XR and Mirtazepine||5
10486765|NCT01165554|11636231|FG000|STARTED|Overall Study|This was the number of subjects that started the study.|203
10486766|NCT01165554|11636231|FG000|COMPLETED|Overall Study||180
10486767|NCT01165554|11636231|FG000|NOT COMPLETED|Overall Study||23
10486768|NCT01165684|11636240|FG000|STARTED|Overall Study||201
10486769|NCT01165684|11636241|FG001|STARTED|Overall Study||200
10486770|NCT01165684|11636240|FG000|Exposed|Overall Study|3 subjects withdrew prior to exposure to trial drug|198
10486771|NCT01165684|11636241|FG001|Exposed|Overall Study|1 subject withdrew prior to exposure to trial drug|199
10486772|NCT01165684|11636240|FG000|COMPLETED|Overall Study||173
10486773|NCT01165684|11636241|FG001|COMPLETED|Overall Study||148
10486774|NCT01165684|11636240|FG000|NOT COMPLETED|Overall Study||28
10486775|NCT01165684|11636241|FG001|NOT COMPLETED|Overall Study||52
10486776|NCT01165775|11636247|FG000|STARTED|Overall Study||17
10486777|NCT01165775|11636247|FG000|COMPLETED|Overall Study||15
10486778|NCT01165775|11636247|FG000|NOT COMPLETED|Overall Study||2
10486779|NCT01165840|11636255|FG000|STARTED|Overall Study||36
10486780|NCT01165840|11636255|FG000|COMPLETED|Overall Study||36
10486781|NCT01165840|11636255|FG000|NOT COMPLETED|Overall Study||0
10486782|NCT01165983|11636261|FG000|STARTED|Overall Study||51
10486783|NCT01165983|11636262|FG001|STARTED|Overall Study||49
10486784|NCT01165983|11636261|FG000|COMPLETED|Overall Study||46
10486785|NCT01165983|11636262|FG001|COMPLETED|Overall Study||42
10486786|NCT01165983|11636261|FG000|NOT COMPLETED|Overall Study||5
10486787|NCT01165983|11636262|FG001|NOT COMPLETED|Overall Study||7
10486788|NCT01165996|11636270|FG000|STARTED|Overall Study||25
10486789|NCT01165996|11636270|FG000|Induction Phase|Overall Study||25
10486790|NCT01165996|11636270|FG000|Maintenance Phase|Overall Study||23
10486791|NCT01165996|11636270|FG000|COMPLETED|Overall Study||23
10486792|NCT01165996|11636270|FG000|NOT COMPLETED|Overall Study||2
10486793|NCT01166126|11636275|FG000|STARTED|Overall Study||4
10486794|NCT01166126|11636275|FG000|COMPLETED|Overall Study||4
10486795|NCT01166126|11636275|FG000|NOT COMPLETED|Overall Study||0
10486796|NCT01166139|11636279|FG000|STARTED|Overall Study||10
10486797|NCT01166139|11636279|FG000|COMPLETED|Overall Study||7
10486798|NCT01166139|11636279|FG000|NOT COMPLETED|Overall Study||3
10486799|NCT01166230|11636285|FG000|STARTED|Overall Study||280
10486800|NCT01166230|11636286|FG001|STARTED|Overall Study||271
10486801|NCT01166230|11636285|FG000|COMPLETED|Overall Study||261
10486802|NCT01166230|11636286|FG001|COMPLETED|Overall Study||255
10486803|NCT01166230|11636285|FG000|NOT COMPLETED|Overall Study||19
10486804|NCT01166230|11636286|FG001|NOT COMPLETED|Overall Study||16
10486805|NCT01166282|11636294|FG000|STARTED|Double-blind Period||15
10486806|NCT01166282|11636295|FG001|STARTED|Double-blind Period||31
10486807|NCT01166282|11636296|FG002|STARTED|Double-blind Period||0
10486808|NCT01166282|11636294|FG000|COMPLETED|Double-blind Period||15
10486809|NCT01166282|11636295|FG001|COMPLETED|Double-blind Period||31
10486810|NCT01166282|11636296|FG002|COMPLETED|Double-blind Period||0
10486811|NCT01166282|11636294|FG000|NOT COMPLETED|Double-blind Period||0
10486812|NCT01166282|11636295|FG001|NOT COMPLETED|Double-blind Period||0
10486813|NCT01166282|11636296|FG002|NOT COMPLETED|Double-blind Period||0
10486814|NCT01166282|11636294|FG000|STARTED|Open-label Period||0
10486815|NCT01166282|11636295|FG001|STARTED|Open-label Period||0
10486816|NCT01166282|11636296|FG002|STARTED|Open-label Period||46
10486817|NCT01166282|11636294|FG000|COMPLETED|Open-label Period||0
10486818|NCT01166282|11636295|FG001|COMPLETED|Open-label Period||0
10486819|NCT01166282|11636296|FG002|COMPLETED|Open-label Period||29
10486820|NCT01166282|11636294|FG000|NOT COMPLETED|Open-label Period||0
10486821|NCT01166282|11636295|FG001|NOT COMPLETED|Open-label Period||0
10486822|NCT01166282|11636296|FG002|NOT COMPLETED|Open-label Period||17
10486823|NCT01166347|11636306|FG000|STARTED|Overall Study||297
10486824|NCT01166347|11636307|FG001|STARTED|Overall Study||149
10486825|NCT01166347|11636306|FG000|COMPLETED|Overall Study||295
10486826|NCT01166347|11636307|FG001|COMPLETED|Overall Study||148
10486827|NCT01166347|11636306|FG000|NOT COMPLETED|Overall Study||2
10486828|NCT01166347|11636307|FG001|NOT COMPLETED|Overall Study||1
10486829|NCT01166373|11636317|FG000|STARTED|Overall Study||95
10486830|NCT01166373|11636318|FG001|STARTED|Overall Study||91
10486831|NCT01166373|11636319|FG002|STARTED|Overall Study||91
10486832|NCT01166373|11636320|FG003|STARTED|Overall Study||97
10486833|NCT01166373|11636317|FG000|Completed OPTIMAL Year 2 Visit|Overall Study||81
10486834|NCT01166373|11636318|FG001|Completed OPTIMAL Year 2 Visit|Overall Study||80
10486835|NCT01166373|11636319|FG002|Completed OPTIMAL Year 2 Visit|Overall Study||79
10486836|NCT01166373|11636320|FG003|Completed OPTIMAL Year 2 Visit|Overall Study||87
10486837|NCT01166373|11636317|FG000|Randomized to Video|Overall Study||32
10486838|NCT01166373|11636318|FG001|Randomized to Video|Overall Study||43
10486839|NCT01166373|11636319|FG002|Randomized to Video|Overall Study||38
10486840|NCT01166373|11636320|FG003|Randomized to Video|Overall Study||40
10486841|NCT01166373|11636317|FG000|Randomized to No Video|Overall Study||45
10486842|NCT01166373|11636318|FG001|Randomized to No Video|Overall Study||30
10486843|NCT01166373|11636319|FG002|Randomized to No Video|Overall Study||34
10486844|NCT01166373|11636320|FG003|Randomized to No Video|Overall Study||42
10486845|NCT01166373|11636317|FG000|Consented to Participate E-OPTIMAL|Overall Study||72
10486846|NCT01166373|11636318|FG001|Consented to Participate E-OPTIMAL|Overall Study||66
10486847|NCT01166373|11636319|FG002|Consented to Participate E-OPTIMAL|Overall Study||69
10486848|NCT01166373|11636320|FG003|Consented to Participate E-OPTIMAL|Overall Study||78
10486849|NCT01166373|11636317|FG000|Completed E-OPTIMAL Year 3 Visit|Overall Study||70
10486850|NCT01166373|11636318|FG001|Completed E-OPTIMAL Year 3 Visit|Overall Study||66
10486851|NCT01166373|11636319|FG002|Completed E-OPTIMAL Year 3 Visit|Overall Study||66
10486852|NCT01166373|11636320|FG003|Completed E-OPTIMAL Year 3 Visit|Overall Study||77
10486853|NCT01166373|11636317|FG000|Completed E-OPTIMAL Year 4 Visit|Overall Study||67
10486854|NCT01166373|11636318|FG001|Completed E-OPTIMAL Year 4 Visit|Overall Study||61
10486855|NCT01166373|11636319|FG002|Completed E-OPTIMAL Year 4 Visit|Overall Study||63
10486856|NCT01166373|11636320|FG003|Completed E-OPTIMAL Year 4 Visit|Overall Study||68
10486857|NCT01166373|11636317|FG000|Completed E-OPTIMAL Year 5 Visit|Overall Study||62
10486858|NCT01166373|11636318|FG001|Completed E-OPTIMAL Year 5 Visit|Overall Study||56
10486859|NCT01166373|11636319|FG002|Completed E-OPTIMAL Year 5 Visit|Overall Study||62
10486860|NCT01166373|11636320|FG003|Completed E-OPTIMAL Year 5 Visit|Overall Study||64
10486861|NCT01166373|11636317|FG000|COMPLETED|Overall Study||90
10486862|NCT01166373|11636318|FG001|COMPLETED|Overall Study||87
10486863|NCT01166373|11636319|FG002|COMPLETED|Overall Study||87
10486864|NCT01166373|11636320|FG003|COMPLETED|Overall Study||92
10486865|NCT01166373|11636317|FG000|NOT COMPLETED|Overall Study||5
10486866|NCT01166373|11636318|FG001|NOT COMPLETED|Overall Study||4
10486867|NCT01166373|11636319|FG002|NOT COMPLETED|Overall Study||4
10486868|NCT01166373|11636320|FG003|NOT COMPLETED|Overall Study||5
10486869|NCT01166438|11636334|FG000|STARTED|Double-blind Phase: 1st 6 Months||122
10486870|NCT01166438|11636335|FG001|STARTED|Double-blind Phase: 1st 6 Months||127
10486871|NCT01166438|11636334|FG000|Treated|Double-blind Phase: 1st 6 Months||121
10486872|NCT01166438|11636335|FG001|Treated|Double-blind Phase: 1st 6 Months||126
10486873|NCT01166438|11636334|FG000|COMPLETED|Double-blind Phase: 1st 6 Months|Completion of 12 month follow-up visit|113
10486874|NCT01166438|11636335|FG001|COMPLETED|Double-blind Phase: 1st 6 Months|Completion of 12 month follow-up visit|118
10486875|NCT01166438|11636334|FG000|NOT COMPLETED|Double-blind Phase: 1st 6 Months||9
10486876|NCT01166438|11636335|FG001|NOT COMPLETED|Double-blind Phase: 1st 6 Months||9
10486877|NCT01166438|11636334|FG000|STARTED|Off Treatment Follow-up Phase||85
10486878|NCT01166438|11636335|FG001|STARTED|Off Treatment Follow-up Phase||89
10486879|NCT01166438|11636334|FG000|COMPLETED|Off Treatment Follow-up Phase||51
10486880|NCT01166438|11636335|FG001|COMPLETED|Off Treatment Follow-up Phase||33
10486881|NCT01166438|11636334|FG000|NOT COMPLETED|Off Treatment Follow-up Phase||34
10486882|NCT01166438|11636335|FG001|NOT COMPLETED|Off Treatment Follow-up Phase||56
10486883|NCT01166568|11636345|FG000|STARTED|Deferred Implantation- Randomized||0
10486884|NCT01166568|11636346|FG001|STARTED|Deferred Implantation- Randomized||0
10486885|NCT01166568|11636347|FG002|STARTED|Deferred Implantation- Randomized||16
10486886|NCT01166568|11636345|FG000|COMPLETED|Deferred Implantation- Randomized||0
10486887|NCT01166568|11636346|FG001|COMPLETED|Deferred Implantation- Randomized||0
10486888|NCT01166568|11636347|FG002|COMPLETED|Deferred Implantation- Randomized|From the randomized sub-study control group (n=16), 1 subject withdrew during the observation phase|15
10486889|NCT01166568|11636345|FG000|NOT COMPLETED|Deferred Implantation- Randomized||0
10486890|NCT01166568|11636346|FG001|NOT COMPLETED|Deferred Implantation- Randomized||0
10486891|NCT01166568|11636347|FG002|NOT COMPLETED|Deferred Implantation- Randomized||1
10486892|NCT01166568|11636345|FG000|STARTED|Implantation- Nonrandomized & Randomized||288
10486893|NCT01166568|11636346|FG001|STARTED|Implantation- Nonrandomized & Randomized||33
10486894|NCT01166568|11636347|FG002|STARTED|Implantation- Nonrandomized & Randomized|15 subjects completed the observation phase and 9 subjects (17 eyes) proceeded with implantation.|9
10486895|NCT01166568|11636345|FG000|COMPLETED|Implantation- Nonrandomized & Randomized||274
10486896|NCT01166568|11636346|FG001|COMPLETED|Implantation- Nonrandomized & Randomized||32
10548414|NCT01519414|11702218|FG001|COMPLETED|Pre Cross-over||26
10486897|NCT01166568|11636347|FG002|COMPLETED|Implantation- Nonrandomized & Randomized|(1) Primary eye implanted only subject withdrew consent after implantation of the device.|8
10486898|NCT01166568|11636345|FG000|NOT COMPLETED|Implantation- Nonrandomized & Randomized||14
10486899|NCT01166568|11636346|FG001|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1
10486900|NCT01166568|11636347|FG002|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1
10486901|NCT01166646|11636355|FG000|STARTED|Overall Study||21
10486902|NCT01166646|11636356|FG001|STARTED|Overall Study||22
10486903|NCT01166646|11636355|FG000|COMPLETED|Overall Study||20
10486904|NCT01166646|11636356|FG001|COMPLETED|Overall Study||21
10486905|NCT01166646|11636355|FG000|NOT COMPLETED|Overall Study||1
10486906|NCT01166646|11636356|FG001|NOT COMPLETED|Overall Study||1
10486907|NCT01166659|11636362|FG000|STARTED|Overall Study||48
10486908|NCT01166659|11636362|FG000|COMPLETED|Overall Study||35
10486909|NCT01166659|11636362|FG000|NOT COMPLETED|Overall Study||13
10486910|NCT01166750|11636369|FG000|STARTED|Overall Study||10
10486911|NCT01166750|11636370|FG001|STARTED|Overall Study||13
10486912|NCT01166750|11636369|FG000|COMPLETED|Overall Study||9
10486913|NCT01166750|11636370|FG001|COMPLETED|Overall Study||13
10486914|NCT01166750|11636369|FG000|NOT COMPLETED|Overall Study||1
10486915|NCT01166750|11636370|FG001|NOT COMPLETED|Overall Study||0
10486916|NCT01166763|11636376|FG000|STARTED|Overall Study||30
10486917|NCT01166763|11636376|FG000|COMPLETED|Overall Study||27
10486918|NCT01166763|11636376|FG000|NOT COMPLETED|Overall Study||3
10486919|NCT01166945|11636382|FG000|STARTED|Randomized||51
10486920|NCT01166945|11636383|FG001|STARTED|Randomized||47
10486921|NCT01166945|11636382|FG000|COMPLETED|Randomized||47
10486922|NCT01166945|11636383|FG001|COMPLETED|Randomized||43
10486923|NCT01166945|11636382|FG000|NOT COMPLETED|Randomized||4
10486924|NCT01166945|11636383|FG001|NOT COMPLETED|Randomized||4
10486925|NCT01166945|11636382|FG000|STARTED|Day 5||47
10486926|NCT01166945|11636383|FG001|STARTED|Day 5||43
10486927|NCT01166945|11636382|FG000|COMPLETED|Day 5||47
10486928|NCT01166945|11636383|FG001|COMPLETED|Day 5||43
10486929|NCT01166945|11636382|FG000|NOT COMPLETED|Day 5||0
10486930|NCT01166945|11636383|FG001|NOT COMPLETED|Day 5||0
10486931|NCT01166945|11636382|FG000|STARTED|Day 10||47
10486932|NCT01166945|11636383|FG001|STARTED|Day 10||43
10486933|NCT01166945|11636382|FG000|COMPLETED|Day 10||44
10486934|NCT01166945|11636383|FG001|COMPLETED|Day 10||41
10486935|NCT01166945|11636382|FG000|NOT COMPLETED|Day 10||3
10486936|NCT01166945|11636383|FG001|NOT COMPLETED|Day 10||2
10486937|NCT01166945|11636382|FG000|STARTED|Day 15||44
10486938|NCT01166945|11636383|FG001|STARTED|Day 15||41
10486939|NCT01166945|11636382|FG000|COMPLETED|Day 15||42
10486940|NCT01166945|11636383|FG001|COMPLETED|Day 15||40
10486941|NCT01166945|11636382|FG000|NOT COMPLETED|Day 15||2
10486942|NCT01166945|11636383|FG001|NOT COMPLETED|Day 15||1
10486943|NCT01166945|11636382|FG000|STARTED|Day 20||42
10486944|NCT01166945|11636383|FG001|STARTED|Day 20||40
10486945|NCT01166945|11636382|FG000|COMPLETED|Day 20||42
10486946|NCT01166945|11636383|FG001|COMPLETED|Day 20||40
10486947|NCT01166945|11636382|FG000|NOT COMPLETED|Day 20||0
10486948|NCT01166945|11636383|FG001|NOT COMPLETED|Day 20||0
10486949|NCT01166945|11636382|FG000|STARTED|Day 30||42
10486950|NCT01166945|11636383|FG001|STARTED|Day 30||40
10486951|NCT01166945|11636382|FG000|COMPLETED|Day 30||38
10486952|NCT01166945|11636383|FG001|COMPLETED|Day 30||37
10486953|NCT01166945|11636382|FG000|NOT COMPLETED|Day 30||4
10486954|NCT01166945|11636383|FG001|NOT COMPLETED|Day 30||3
10486955|NCT01166958|11636393|FG000|STARTED|Overall Study||13
10486956|NCT01166958|11636394|FG001|STARTED|Overall Study||13
10486957|NCT01166958|11636393|FG000|COMPLETED|Overall Study||12
10486958|NCT01166958|11636394|FG001|COMPLETED|Overall Study||13
10486959|NCT01166958|11636393|FG000|NOT COMPLETED|Overall Study||1
10486960|NCT01166958|11636394|FG001|NOT COMPLETED|Overall Study||0
10486961|NCT01166971|11636402|FG000|STARTED|Overall Study||33
10486962|NCT01166971|11636403|FG001|STARTED|Overall Study||31
10486963|NCT01166971|11636402|FG000|COMPLETED|Overall Study||32
10486964|NCT01166971|11636403|FG001|COMPLETED|Overall Study||30
10486965|NCT01166971|11636402|FG000|NOT COMPLETED|Overall Study||1
10486966|NCT01166971|11636403|FG001|NOT COMPLETED|Overall Study||1
10486967|NCT01166984|11636414|FG000|STARTED|Overall Study||5
10486968|NCT01166984|11636415|FG001|STARTED|Overall Study||5
10486969|NCT01166984|11636416|FG002|STARTED|Overall Study||5
10486970|NCT01166984|11636417|FG003|STARTED|Overall Study||5
10486971|NCT01166984|11636418|FG004|STARTED|Overall Study||5
10486972|NCT01166984|11636414|FG000|COMPLETED|Overall Study||5
10486973|NCT01166984|11636415|FG001|COMPLETED|Overall Study||5
10486974|NCT01166984|11636416|FG002|COMPLETED|Overall Study||5
10486975|NCT01166984|11636417|FG003|COMPLETED|Overall Study||5
10486976|NCT01166984|11636418|FG004|COMPLETED|Overall Study||5
10486977|NCT01166984|11636414|FG000|NOT COMPLETED|Overall Study||0
10486978|NCT01166984|11636415|FG001|NOT COMPLETED|Overall Study||0
10486979|NCT01166984|11636416|FG002|NOT COMPLETED|Overall Study||0
10486980|NCT01166984|11636417|FG003|NOT COMPLETED|Overall Study||0
10486981|NCT01166984|11636418|FG004|NOT COMPLETED|Overall Study||0
10486982|NCT01166997|11636442|FG000|STARTED|Overall Study||29
10486983|NCT01166997|11636443|FG001|STARTED|Overall Study||30
10486984|NCT01166997|11636442|FG000|COMPLETED|Overall Study||27
10486985|NCT01166997|11636443|FG001|COMPLETED|Overall Study||30
10486986|NCT01166997|11636442|FG000|NOT COMPLETED|Overall Study||2
10486987|NCT01166997|11636443|FG001|NOT COMPLETED|Overall Study||0
10486988|NCT01167023|11636453|FG000|STARTED|Overall Study||0
10486989|NCT01167023|11636454|FG001|STARTED|Overall Study||21
10486990|NCT01167023|11636455|FG002|STARTED|Overall Study||41
10486991|NCT01167023|11636453|FG000|Received at Least 1 Dose of Study Drug|Overall Study||0
10486992|NCT01167023|11636454|FG001|Received at Least 1 Dose of Study Drug|Overall Study||19
10486993|NCT01167023|11636455|FG002|Received at Least 1 Dose of Study Drug|Overall Study||41
10486994|NCT01167023|11636453|FG000|COMPLETED|Overall Study||0
10486995|NCT01167023|11636454|FG001|COMPLETED|Overall Study||18
10486996|NCT01167023|11636455|FG002|COMPLETED|Overall Study||39
10486997|NCT01167023|11636453|FG000|NOT COMPLETED|Overall Study||0
10486998|NCT01167023|11636454|FG001|NOT COMPLETED|Overall Study||3
10486999|NCT01167023|11636455|FG002|NOT COMPLETED|Overall Study||2
10487000|NCT01167140|11636461|FG000|STARTED|Overall Study||42
10487001|NCT01167140|11636461|FG000|COMPLETED|Overall Study||41
10487002|NCT01167140|11636461|FG000|NOT COMPLETED|Overall Study||1
10487003|NCT01167153|11636467|FG000|STARTED|Overall Study||282
10487004|NCT01167153|11636468|FG001|STARTED|Overall Study||282
10487005|NCT01167153|11636467|FG000|Intention to Treat (ITT)|Overall Study||272
10487006|NCT01167153|11636468|FG001|Intention to Treat (ITT)|Overall Study||268
10487007|NCT01167153|11636467|FG000|COMPLETED|Overall Study||264
10487008|NCT01167153|11636468|FG001|COMPLETED|Overall Study||249
10487009|NCT01167153|11636467|FG000|NOT COMPLETED|Overall Study||18
10487010|NCT01167153|11636468|FG001|NOT COMPLETED|Overall Study||33
10487011|NCT01167179|11636476|FG000|STARTED|Overall Study||80
10487012|NCT01167179|11636477|FG001|STARTED|Overall Study||80
10487013|NCT01167179|11636476|FG000|COMPLETED|Overall Study||65
10487014|NCT01167179|11636477|FG001|COMPLETED|Overall Study||59
10487015|NCT01167179|11636476|FG000|NOT COMPLETED|Overall Study||15
10487016|NCT01167179|11636477|FG001|NOT COMPLETED|Overall Study||21
10487017|NCT01167192|11636483|FG000|STARTED|Overall Study||10
10487018|NCT01167192|11636483|FG000|COMPLETED|Overall Study||6
10487019|NCT01167192|11636483|FG000|NOT COMPLETED|Overall Study||4
10487020|NCT01167257|11636489|FG000|STARTED|Overall Study||31
10649974|NCT02165111|11810108|FG000|STARTED|Overall Study||40
10649975|NCT02165111|11810109|FG001|STARTED|Overall Study||40
10649976|NCT02165111|11810108|FG000|COMPLETED|Overall Study||40
10649977|NCT02165111|11810109|FG001|COMPLETED|Overall Study||40
10487021|NCT01167257|11636490|FG001|STARTED|Overall Study||31
10487022|NCT01167257|11636489|FG000|COMPLETED|Overall Study||28
10487023|NCT01167257|11636490|FG001|COMPLETED|Overall Study||28
10487024|NCT01167257|11636489|FG000|NOT COMPLETED|Overall Study||3
10487025|NCT01167257|11636490|FG001|NOT COMPLETED|Overall Study||3
10487026|NCT01167426|11636500|FG000|STARTED|Overall Study||148
10487027|NCT01167426|11636500|FG000|COMPLETED|Overall Study||138
10487028|NCT01167426|11636500|FG000|NOT COMPLETED|Overall Study||10
10487029|NCT01167452|11636505|FG000|STARTED|Overall Study||36
10487030|NCT01167452|11636505|FG000|COMPLETED|Overall Study||36
10487031|NCT01167452|11636505|FG000|NOT COMPLETED|Overall Study||0
10487032|NCT01167504|11636510|FG000|STARTED|Overall Study||15
10487033|NCT01167504|11636510|FG000|COMPLETED|Overall Study||12
10487034|NCT01167504|11636510|FG000|NOT COMPLETED|Overall Study||3
10487035|NCT01167569|11636516|FG000|STARTED|Overall Study||28
10487036|NCT01167569|11636517|FG001|STARTED|Overall Study||29
10487037|NCT01167569|11636516|FG000|COMPLETED|Overall Study||27
10487038|NCT01167569|11636517|FG001|COMPLETED|Overall Study||27
10487039|NCT01167569|11636516|FG000|NOT COMPLETED|Overall Study||1
10487040|NCT01167569|11636517|FG001|NOT COMPLETED|Overall Study||2
10487041|NCT01167582|11636527|FG000|STARTED|Overall Study||55
10487042|NCT01167582|11636528|FG001|STARTED|Overall Study||55
10487043|NCT01167582|11636527|FG000|COMPLETED|Overall Study||55
10487044|NCT01167582|11636528|FG001|COMPLETED|Overall Study||54
10487045|NCT01167582|11636527|FG000|NOT COMPLETED|Overall Study||0
10487046|NCT01167582|11636528|FG001|NOT COMPLETED|Overall Study||1
10487047|NCT01167595|11636536|FG000|STARTED|Overall Study||522
10487048|NCT01167595|11636537|FG001|STARTED|Overall Study||537
10487049|NCT01167595|11636536|FG000|COMPLETED|Overall Study||522
10487050|NCT01167595|11636537|FG001|COMPLETED|Overall Study||537
10487051|NCT01167595|11636536|FG000|NOT COMPLETED|Overall Study||0
10487052|NCT01167595|11636537|FG001|NOT COMPLETED|Overall Study||0
10487053|NCT01167608|11636543|FG000|STARTED|Overall Study||883
10487054|NCT01167608|11636543|FG000|COMPLETED|Overall Study||769
10649978|NCT02165111|11810108|FG000|NOT COMPLETED|Overall Study||0
10487055|NCT01167608|11636543|FG000|NOT COMPLETED|Overall Study||114
10487056|NCT01167634|11636552|FG000|STARTED|Overall Study||33
10487057|NCT01167634|11636553|FG001|STARTED|Overall Study||33
10487058|NCT01167634|11636554|FG002|STARTED|Overall Study||33
10487059|NCT01167634|11636555|FG003|STARTED|Overall Study||33
10487060|NCT01167634|11636552|FG000|COMPLETED|Overall Study||31
10487061|NCT01167634|11636553|FG001|COMPLETED|Overall Study||29
10487062|NCT01167634|11636554|FG002|COMPLETED|Overall Study||30
10487063|NCT01167634|11636555|FG003|COMPLETED|Overall Study||29
10487064|NCT01167634|11636552|FG000|NOT COMPLETED|Overall Study||2
10487065|NCT01167634|11636553|FG001|NOT COMPLETED|Overall Study||4
10487066|NCT01167634|11636554|FG002|NOT COMPLETED|Overall Study||3
10487067|NCT01167634|11636555|FG003|NOT COMPLETED|Overall Study||4
10527536|NCT01390584|11679664|FG001|STARTED|Step 1: Induction Tx (ABVD Then PET/CT)||1
10527537|NCT01390584|11679665|FG002|STARTED|Step 1: Induction Tx (ABVD Then PET/CT)||1
10527538|NCT01390584|11679663|FG000|COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||4
10527539|NCT01390584|11679664|FG001|COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||1
10527540|NCT01390584|11679665|FG002|COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||0
10527541|NCT01390584|11679663|FG000|NOT COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||0
10527542|NCT01390584|11679664|FG001|NOT COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||0
10527543|NCT01390584|11679665|FG002|NOT COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||1
10527544|NCT01390584|11679663|FG000|STARTED|Step 2: ABVD or BEACOPP Then INRT||4
10527545|NCT01390584|11679664|FG001|STARTED|Step 2: ABVD or BEACOPP Then INRT||1
10527546|NCT01390584|11679665|FG002|STARTED|Step 2: ABVD or BEACOPP Then INRT||0
10527547|NCT01390584|11679663|FG000|COMPLETED|Step 2: ABVD or BEACOPP Then INRT||4
10527548|NCT01390584|11679664|FG001|COMPLETED|Step 2: ABVD or BEACOPP Then INRT||1
10527549|NCT01390584|11679665|FG002|COMPLETED|Step 2: ABVD or BEACOPP Then INRT||0
10527550|NCT01390584|11679663|FG000|NOT COMPLETED|Step 2: ABVD or BEACOPP Then INRT||0
10527551|NCT01390584|11679664|FG001|NOT COMPLETED|Step 2: ABVD or BEACOPP Then INRT||0
10527552|NCT01390584|11679665|FG002|NOT COMPLETED|Step 2: ABVD or BEACOPP Then INRT||0
10527553|NCT01390649|11679674|FG000|STARTED|Overall Study|Subjects treated with Privigen|57
10527554|NCT01390649|11679674|FG000|COMPLETED|Overall Study||56
10527555|NCT01390649|11679674|FG000|NOT COMPLETED|Overall Study||1
10527556|NCT01390779|11679678|FG000|STARTED|Overall Study||33
10527557|NCT01390779|11679678|FG000|COMPLETED|Overall Study||32
10527558|NCT01390779|11679678|FG000|NOT COMPLETED|Overall Study||1
10527559|NCT01390818|11679697|FG000|STARTED|Overall Study||3
10527560|NCT01390818|11679698|FG001|STARTED|Overall Study||3
10527561|NCT01390818|11679699|FG002|STARTED|Overall Study||3
10527562|NCT01390818|11679700|FG003|STARTED|Overall Study||4
10527563|NCT01390818|11679701|FG004|STARTED|Overall Study||4
10527564|NCT01390818|11679702|FG005|STARTED|Overall Study||3
10527565|NCT01390818|11679703|FG006|STARTED|Overall Study||19
10527566|NCT01390818|11679704|FG007|STARTED|Overall Study||14
10527567|NCT01390818|11679705|FG008|STARTED|Overall Study||3
10527568|NCT01390818|11679706|FG009|STARTED|Overall Study||3
10527569|NCT01390818|11679707|FG010|STARTED|Overall Study||4
10527570|NCT01390818|11679708|FG011|STARTED|Overall Study||26
10527571|NCT01390818|11679709|FG012|STARTED|Overall Study||24
10527572|NCT01390818|11679710|FG013|STARTED|Overall Study||18
10527573|NCT01390818|11679711|FG014|STARTED|Overall Study||15
10527574|NCT01390818|11679697|FG000|COMPLETED|Overall Study||3
10649979|NCT02165111|11810109|FG001|NOT COMPLETED|Overall Study||0
10649980|NCT02165124|11810117|FG000|STARTED|Overall Study||20
10649981|NCT02165124|11810117|FG000|COMPLETED|Overall Study||15
10649982|NCT02165124|11810117|FG000|NOT COMPLETED|Overall Study||5
10649983|NCT02165202|11810123|FG000|STARTED|Oral Phase|Participants Enrolled in the study|91
10649984|NCT02165202|11810124|FG001|STARTED|Oral Phase|Participants Enrolled in the study|45
10649985|NCT02165202|11810123|FG000|COMPLETED|Oral Phase||80
10649986|NCT02165202|11810124|FG001|COMPLETED|Oral Phase||42
10649987|NCT02165202|11810123|FG000|NOT COMPLETED|Oral Phase||11
10487074|NCT01167829|11636574|FG000|STARTED|Overall Study||12
10487075|NCT01167829|11636574|FG000|COMPLETED|Overall Study||12
10487076|NCT01167829|11636574|FG000|NOT COMPLETED|Overall Study||0
10487077|NCT01167881|11636582|FG000|STARTED|Overall Study||769
10487078|NCT01167881|11636583|FG001|STARTED|Overall Study||780
10487079|NCT01167881|11636582|FG000|Completed After 2 Years Treatment|Overall Study||95
10487080|NCT01167881|11636583|FG001|Completed After 2 Years Treatment|Overall Study||127
10487081|NCT01167881|11636582|FG000|Completed After 4 Years Treatment|Overall Study||515
10487082|NCT01167881|11636583|FG001|Completed After 4 Years Treatment|Overall Study||462
10487083|NCT01167881|11636582|FG000|COMPLETED|Overall Study||610
10487084|NCT01167881|11636583|FG001|COMPLETED|Overall Study||589
10487085|NCT01167881|11636582|FG000|NOT COMPLETED|Overall Study||159
10487086|NCT01167881|11636583|FG001|NOT COMPLETED|Overall Study||191
10487087|NCT01167907|11636591|FG000|STARTED|Overall Study||17
10487088|NCT01167907|11636592|FG001|STARTED|Overall Study||15
10487089|NCT01167907|11636591|FG000|COMPLETED|Overall Study||15
10487090|NCT01167907|11636592|FG001|COMPLETED|Overall Study||14
10487091|NCT01167907|11636591|FG000|NOT COMPLETED|Overall Study||2
10487092|NCT01167907|11636592|FG001|NOT COMPLETED|Overall Study||1
10487093|NCT01168024|11636600|FG000|STARTED|Overall Study|13 tx/3 controls. Roll-ins occurred for product training, several more treatment cases than control.|13
10487094|NCT01168024|11636601|FG001|STARTED|Overall Study||3
10487095|NCT01168024|11636600|FG000|COMPLETED|Overall Study||13
10487096|NCT01168024|11636601|FG001|COMPLETED|Overall Study||3
10487097|NCT01168024|11636600|FG000|NOT COMPLETED|Overall Study||0
10487098|NCT01168024|11636601|FG001|NOT COMPLETED|Overall Study||0
10487099|NCT01168232|11636607|FG000|STARTED|Overall Study||42
10487100|NCT01168232|11636607|FG000|COMPLETED|Overall Study|Eligible and treated patients|34
10487101|NCT01168232|11636607|FG000|NOT COMPLETED|Overall Study||8
10487102|NCT01168349|11636611|FG000|STARTED|Overall Study||1055
10487103|NCT01168349|11636611|FG000|COMPLETED|Overall Study||754
10487104|NCT01168349|11636611|FG000|NOT COMPLETED|Overall Study||301
10487105|NCT01168401|11636642|FG000|STARTED|Overall Study||10
10487106|NCT01168401|11636643|FG001|STARTED|Overall Study||10
10487107|NCT01168401|11636644|FG002|STARTED|Overall Study||10
10487108|NCT01168401|11636645|FG003|STARTED|Overall Study||9
10487109|NCT01168401|11636646|FG004|STARTED|Overall Study||9
10487110|NCT01168401|11636647|FG005|STARTED|Overall Study||9
10487111|NCT01168401|11636648|FG006|STARTED|Overall Study||10
10487112|NCT01168401|11636649|FG007|STARTED|Overall Study||10
10487113|NCT01168401|11636650|FG008|STARTED|Overall Study||9
10487114|NCT01168401|11636651|FG009|STARTED|Overall Study||8
10487115|NCT01168401|11636652|FG010|STARTED|Overall Study||8
10487116|NCT01168401|11636642|FG000|COMPLETED|Overall Study||9
10487117|NCT01168401|11636643|FG001|COMPLETED|Overall Study||9
10487118|NCT01168401|11636644|FG002|COMPLETED|Overall Study||8
10487119|NCT01168401|11636645|FG003|COMPLETED|Overall Study||7
10487120|NCT01168401|11636646|FG004|COMPLETED|Overall Study||9
10487121|NCT01168401|11636647|FG005|COMPLETED|Overall Study||9
10487122|NCT01168401|11636648|FG006|COMPLETED|Overall Study||10
10487123|NCT01168401|11636649|FG007|COMPLETED|Overall Study||10
10487124|NCT01168401|11636650|FG008|COMPLETED|Overall Study||9
10487125|NCT01168401|11636651|FG009|COMPLETED|Overall Study||8
10709979|NCT02646124|11875107|FG001|NOT COMPLETED|Overall Study||2
10487126|NCT01168401|11636652|FG010|COMPLETED|Overall Study||8
10487127|NCT01168401|11636642|FG000|NOT COMPLETED|Overall Study||1
10487128|NCT01168401|11636643|FG001|NOT COMPLETED|Overall Study||1
10487129|NCT01168401|11636644|FG002|NOT COMPLETED|Overall Study||2
10487130|NCT01168401|11636645|FG003|NOT COMPLETED|Overall Study||2
10487131|NCT01168401|11636646|FG004|NOT COMPLETED|Overall Study||0
10487132|NCT01168401|11636647|FG005|NOT COMPLETED|Overall Study||0
10487133|NCT01168401|11636648|FG006|NOT COMPLETED|Overall Study||0
10487134|NCT01168401|11636649|FG007|NOT COMPLETED|Overall Study||0
10487135|NCT01168401|11636650|FG008|NOT COMPLETED|Overall Study||0
10487136|NCT01168401|11636651|FG009|NOT COMPLETED|Overall Study||0
10487137|NCT01168401|11636652|FG010|NOT COMPLETED|Overall Study||0
10487138|NCT01168427|11636676|FG000|STARTED|Overall Study||66
10487139|NCT01168427|11636676|FG000|COMPLETED|Overall Study||65
10487140|NCT01168427|11636676|FG000|NOT COMPLETED|Overall Study||1
10487141|NCT01168596|11636682|FG000|STARTED|Overall Study||16
10487142|NCT01168596|11636683|FG001|STARTED|Overall Study||14
10487143|NCT01168596|11636682|FG000|COMPLETED|Overall Study||13
10709980|NCT02646332|11875115|FG000|STARTED|Overall Study||124
10487144|NCT01168596|11636683|FG001|COMPLETED|Overall Study||13
10487145|NCT01168596|11636682|FG000|NOT COMPLETED|Overall Study||3
10487146|NCT01168596|11636683|FG001|NOT COMPLETED|Overall Study||1
10487147|NCT01168674|11636689|FG000|STARTED|Overall Study||25
10487148|NCT01168674|11636690|FG001|STARTED|Overall Study||24
10487149|NCT01168674|11636689|FG000|COMPLETED|Overall Study||25
10487150|NCT01168674|11636690|FG001|COMPLETED|Overall Study||24
10487151|NCT01168674|11636689|FG000|NOT COMPLETED|Overall Study||0
10487152|NCT01168674|11636690|FG001|NOT COMPLETED|Overall Study||0
10487153|NCT01168687|11636699|FG000|STARTED|Overall Study||23
10487154|NCT01168687|11636700|FG001|STARTED|Overall Study||23
10487155|NCT01168687|11636699|FG000|COMPLETED|Overall Study||23
10487156|NCT01168687|11636700|FG001|COMPLETED|Overall Study||23
10487157|NCT01168687|11636699|FG000|NOT COMPLETED|Overall Study||0
10487158|NCT01168687|11636700|FG001|NOT COMPLETED|Overall Study||0
10487159|NCT01168726|11636709|FG000|STARTED|Overall Study||111
10487160|NCT01168726|11636710|FG001|STARTED|Overall Study||121
10487161|NCT01168726|11636711|FG002|STARTED|Overall Study||133
10487162|NCT01168726|11636709|FG000|COMPLETED|Overall Study||103
10487163|NCT01168726|11636710|FG001|COMPLETED|Overall Study||112
10487164|NCT01168726|11636711|FG002|COMPLETED|Overall Study||128
10487165|NCT01168726|11636709|FG000|NOT COMPLETED|Overall Study||8
10487166|NCT01168726|11636710|FG001|NOT COMPLETED|Overall Study||9
10487167|NCT01168726|11636711|FG002|NOT COMPLETED|Overall Study||5
10487168|NCT01168856|11636721|FG000|STARTED|Overall Study||176
10487169|NCT01168856|11636722|FG001|STARTED|Overall Study||558
10487170|NCT01168856|11636721|FG000|COMPLETED|Overall Study||158
10487171|NCT01168856|11636722|FG001|COMPLETED|Overall Study||215
10487172|NCT01168856|11636721|FG000|NOT COMPLETED|Overall Study||18
10487173|NCT01168856|11636722|FG001|NOT COMPLETED|Overall Study||343
10487174|NCT01168908|11636735|FG000|STARTED|Double Blind, Placebo Controlled||10
10487175|NCT01168908|11636736|FG001|STARTED|Double Blind, Placebo Controlled||10
10487176|NCT01168908|11636735|FG000|COMPLETED|Double Blind, Placebo Controlled||7
10487177|NCT01168908|11636736|FG001|COMPLETED|Double Blind, Placebo Controlled||8
10487178|NCT01168908|11636735|FG000|NOT COMPLETED|Double Blind, Placebo Controlled||3
10487179|NCT01168908|11636736|FG001|NOT COMPLETED|Double Blind, Placebo Controlled||2
10487180|NCT01168908|11636735|FG000|STARTED|Open Label||7
10487181|NCT01168908|11636736|FG001|STARTED|Open Label||8
10487182|NCT01168908|11636735|FG000|COMPLETED|Open Label||6
10487183|NCT01168908|11636736|FG001|COMPLETED|Open Label||7
10487184|NCT01168908|11636735|FG000|NOT COMPLETED|Open Label||1
10487185|NCT01168908|11636736|FG001|NOT COMPLETED|Open Label||1
10487186|NCT01168934|11636742|FG000|STARTED|First Intervention Period||7
10487187|NCT01168934|11636743|FG001|STARTED|First Intervention Period||7
10487188|NCT01168934|11636742|FG000|COMPLETED|First Intervention Period||7
10487189|NCT01168934|11636743|FG001|COMPLETED|First Intervention Period||7
10487190|NCT01168934|11636742|FG000|NOT COMPLETED|First Intervention Period||0
10487191|NCT01168934|11636743|FG001|NOT COMPLETED|First Intervention Period||0
10487192|NCT01168934|11636742|FG000|STARTED|Washout Period (at Least 14 Days)||7
10487193|NCT01168934|11636743|FG001|STARTED|Washout Period (at Least 14 Days)||7
10487194|NCT01168934|11636742|FG000|COMPLETED|Washout Period (at Least 14 Days)||7
10487195|NCT01168934|11636743|FG001|COMPLETED|Washout Period (at Least 14 Days)||7
10487196|NCT01168934|11636742|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10487197|NCT01168934|11636743|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10487198|NCT01168934|11636742|FG000|STARTED|Second Intervention Period||7
10487199|NCT01168934|11636743|FG001|STARTED|Second Intervention Period||7
10487200|NCT01168934|11636742|FG000|COMPLETED|Second Intervention Period||7
10487201|NCT01168934|11636743|FG001|COMPLETED|Second Intervention Period||7
10487202|NCT01168934|11636742|FG000|NOT COMPLETED|Second Intervention Period||0
10487203|NCT01168934|11636743|FG001|NOT COMPLETED|Second Intervention Period||0
10487204|NCT01168973|11636752|FG000|STARTED|Overall Study||628
10487205|NCT01168973|11636753|FG001|STARTED|Overall Study||625
10487206|NCT01168973|11636752|FG000|Received Any Quantity of Any Study Drug|Overall Study||624
10487207|NCT01168973|11636753|FG001|Received Any Quantity of Any Study Drug|Overall Study|Three participants randomized to placebo and docetaxel received 1 dose of ramucirumab in error.|621
10487208|NCT01168973|11636752|FG000|COMPLETED|Overall Study||15
10487209|NCT01168973|11636753|FG001|COMPLETED|Overall Study||14
10487210|NCT01168973|11636752|FG000|NOT COMPLETED|Overall Study||613
10487211|NCT01168973|11636753|FG001|NOT COMPLETED|Overall Study||611
10487212|NCT01168986|11636762|FG000|STARTED|Overall Study||20
10487213|NCT01168986|11636763|FG001|STARTED|Overall Study||21
10487214|NCT01168986|11636764|FG002|STARTED|Overall Study||21
10487215|NCT01168986|11636762|FG000|COMPLETED|Overall Study||18
10487216|NCT01168986|11636763|FG001|COMPLETED|Overall Study||20
10487217|NCT01168986|11636764|FG002|COMPLETED|Overall Study||21
10487218|NCT01168986|11636762|FG000|NOT COMPLETED|Overall Study||2
10487219|NCT01168986|11636763|FG001|NOT COMPLETED|Overall Study||1
10487220|NCT01168986|11636764|FG002|NOT COMPLETED|Overall Study||0
10487221|NCT01168999|11636776|FG000|STARTED|Overall Study||28
10487222|NCT01168999|11636777|FG001|STARTED|Overall Study||27
10487223|NCT01168999|11636778|FG002|STARTED|Overall Study||27
10487224|NCT01168999|11636779|FG003|STARTED|Overall Study||28
10487225|NCT01168999|11636776|FG000|COMPLETED|Overall Study||26
10487226|NCT01168999|11636777|FG001|COMPLETED|Overall Study||26
10487227|NCT01168999|11636778|FG002|COMPLETED|Overall Study||27
10487228|NCT01168999|11636779|FG003|COMPLETED|Overall Study||28
10487229|NCT01168999|11636776|FG000|NOT COMPLETED|Overall Study||2
10487230|NCT01168999|11636777|FG001|NOT COMPLETED|Overall Study||1
10487231|NCT01168999|11636778|FG002|NOT COMPLETED|Overall Study||0
10487232|NCT01168999|11636779|FG003|NOT COMPLETED|Overall Study||0
10487233|NCT01169038|11636789|FG000|STARTED|Overall Study||15
10487234|NCT01169038|11636789|FG000|COMPLETED|Overall Study||8
10487235|NCT01169038|11636789|FG000|NOT COMPLETED|Overall Study||7
10487236|NCT01169064|11636795|FG000|STARTED|Overall Study||239
10487237|NCT01169064|11636796|FG001|STARTED|Overall Study||236
10487238|NCT01169064|11636795|FG000|COMPLETED|Overall Study||239
10487239|NCT01169064|11636796|FG001|COMPLETED|Overall Study||236
10487240|NCT01169064|11636795|FG000|NOT COMPLETED|Overall Study||0
10487241|NCT01169064|11636796|FG001|NOT COMPLETED|Overall Study||0
10487242|NCT01169103|11636806|FG000|STARTED|Overall Study||11
10487243|NCT01169103|11636807|FG001|STARTED|Overall Study||11
10487244|NCT01169103|11636806|FG000|COMPLETED|Overall Study||5
10487245|NCT01169103|11636807|FG001|COMPLETED|Overall Study||7
10487246|NCT01169103|11636806|FG000|NOT COMPLETED|Overall Study||6
10487247|NCT01169103|11636807|FG001|NOT COMPLETED|Overall Study||4
10487248|NCT01169311|11636813|FG000|STARTED|Overall Study||27
10487249|NCT01169311|11636813|FG000|COMPLETED|Overall Study||27
10487250|NCT01169311|11636813|FG000|NOT COMPLETED|Overall Study||0
10487251|NCT01169337|11636821|FG000|STARTED|Overall Study||44
10487252|NCT01169337|11636822|FG001|STARTED|Overall Study||90
10487253|NCT01169337|11636823|FG002|STARTED|Overall Study||92
10487254|NCT01169337|11636821|FG000|Received Treatment/Observation|Overall Study||44
10487255|NCT01169337|11636822|FG001|Received Treatment/Observation|Overall Study||88
10487256|NCT01169337|11636823|FG002|Received Treatment/Observation|Overall Study||86
10487257|NCT01169337|11636821|FG000|COMPLETED|Overall Study||0
10487258|NCT01169337|11636822|FG001|COMPLETED|Overall Study||0
10487259|NCT01169337|11636823|FG002|COMPLETED|Overall Study||86
10487260|NCT01169337|11636821|FG000|NOT COMPLETED|Overall Study||44
10487261|NCT01169337|11636822|FG001|NOT COMPLETED|Overall Study||90
10487262|NCT01169337|11636823|FG002|NOT COMPLETED|Overall Study||6
10487263|NCT01169350|11636831|FG000|STARTED|Overall Study||8
10487264|NCT01169350|11636831|FG000|COMPLETED|Overall Study||3
10487265|NCT01169350|11636831|FG000|NOT COMPLETED|Overall Study||5
10487266|NCT01169467|11636837|FG000|STARTED|Overall Study||44
10487267|NCT01169467|11636838|FG001|STARTED|Overall Study||40
10487268|NCT01169467|11636837|FG000|COMPLETED|Overall Study||37
10487269|NCT01169467|11636838|FG001|COMPLETED|Overall Study||36
10487270|NCT01169467|11636837|FG000|NOT COMPLETED|Overall Study||7
10487271|NCT01169467|11636838|FG001|NOT COMPLETED|Overall Study||4
10487272|NCT01169493|11636850|FG000|STARTED|Period 1 (6 Months)||2
10487273|NCT01169493|11636851|FG001|STARTED|Period 1 (6 Months)||4
10487274|NCT01169493|11636852|FG002|STARTED|Period 1 (6 Months)||5
10487275|NCT01169493|11636853|FG003|STARTED|Period 1 (6 Months)||0
10487276|NCT01169493|11636854|FG004|STARTED|Period 1 (6 Months)||0
10487277|NCT01169493|11636855|FG005|STARTED|Period 1 (6 Months)||5
10487278|NCT01169493|11636850|FG000|COMPLETED|Period 1 (6 Months)||2
10487279|NCT01169493|11636851|FG001|COMPLETED|Period 1 (6 Months)||3
10487280|NCT01169493|11636852|FG002|COMPLETED|Period 1 (6 Months)||3
10487281|NCT01169493|11636853|FG003|COMPLETED|Period 1 (6 Months)||0
10487282|NCT01169493|11636854|FG004|COMPLETED|Period 1 (6 Months)||0
10487283|NCT01169493|11636855|FG005|COMPLETED|Period 1 (6 Months)||2
10487284|NCT01169493|11636850|FG000|NOT COMPLETED|Period 1 (6 Months)||0
10487285|NCT01169493|11636851|FG001|NOT COMPLETED|Period 1 (6 Months)||1
10487286|NCT01169493|11636852|FG002|NOT COMPLETED|Period 1 (6 Months)||2
10487287|NCT01169493|11636853|FG003|NOT COMPLETED|Period 1 (6 Months)||0
10487288|NCT01169493|11636854|FG004|NOT COMPLETED|Period 1 (6 Months)||0
10487289|NCT01169493|11636855|FG005|NOT COMPLETED|Period 1 (6 Months)||3
10487290|NCT01169493|11636850|FG000|STARTED|Period 2 (6 Months)||2
10487291|NCT01169493|11636851|FG001|STARTED|Period 2 (6 Months)||3
10487292|NCT01169493|11636852|FG002|STARTED|Period 2 (6 Months)||3
10487293|NCT01169493|11636853|FG003|STARTED|Period 2 (6 Months)||0
10487294|NCT01169493|11636854|FG004|STARTED|Period 2 (6 Months)||0
10487295|NCT01169493|11636855|FG005|STARTED|Period 2 (6 Months)||2
10487296|NCT01169493|11636850|FG000|COMPLETED|Period 2 (6 Months)||2
10487297|NCT01169493|11636851|FG001|COMPLETED|Period 2 (6 Months)||3
10487298|NCT01169493|11636852|FG002|COMPLETED|Period 2 (6 Months)||3
10487299|NCT01169493|11636853|FG003|COMPLETED|Period 2 (6 Months)||0
10487300|NCT01169493|11636854|FG004|COMPLETED|Period 2 (6 Months)||0
10487301|NCT01169493|11636855|FG005|COMPLETED|Period 2 (6 Months)||2
10487302|NCT01169493|11636850|FG000|NOT COMPLETED|Period 2 (6 Months)||0
10487303|NCT01169493|11636851|FG001|NOT COMPLETED|Period 2 (6 Months)||0
10487304|NCT01169493|11636852|FG002|NOT COMPLETED|Period 2 (6 Months)||0
10487305|NCT01169493|11636853|FG003|NOT COMPLETED|Period 2 (6 Months)||0
10487306|NCT01169493|11636854|FG004|NOT COMPLETED|Period 2 (6 Months)||0
10487307|NCT01169493|11636855|FG005|NOT COMPLETED|Period 2 (6 Months)||0
10487308|NCT01169493|11636850|FG000|STARTED|Period 3 (6 Months)||2
10487309|NCT01169493|11636851|FG001|STARTED|Period 3 (6 Months)||3
10487310|NCT01169493|11636852|FG002|STARTED|Period 3 (6 Months)||3
10487311|NCT01169493|11636853|FG003|STARTED|Period 3 (6 Months)||0
10487312|NCT01169493|11636854|FG004|STARTED|Period 3 (6 Months)||0
10487313|NCT01169493|11636855|FG005|STARTED|Period 3 (6 Months)||2
10487314|NCT01169493|11636850|FG000|COMPLETED|Period 3 (6 Months)||2
10487315|NCT01169493|11636851|FG001|COMPLETED|Period 3 (6 Months)||1
10487316|NCT01169493|11636852|FG002|COMPLETED|Period 3 (6 Months)||2
10487317|NCT01169493|11636853|FG003|COMPLETED|Period 3 (6 Months)||0
10487318|NCT01169493|11636854|FG004|COMPLETED|Period 3 (6 Months)||0
10487319|NCT01169493|11636855|FG005|COMPLETED|Period 3 (6 Months)||2
10487320|NCT01169493|11636850|FG000|NOT COMPLETED|Period 3 (6 Months)||0
10487321|NCT01169493|11636851|FG001|NOT COMPLETED|Period 3 (6 Months)||2
10487322|NCT01169493|11636852|FG002|NOT COMPLETED|Period 3 (6 Months)||1
10487323|NCT01169493|11636853|FG003|NOT COMPLETED|Period 3 (6 Months)||0
10487324|NCT01169493|11636854|FG004|NOT COMPLETED|Period 3 (6 Months)||0
10487325|NCT01169493|11636855|FG005|NOT COMPLETED|Period 3 (6 Months)||0
10487326|NCT01169519|11636863|FG000|STARTED|Overall Study|This was a pre-post study, All patients receiving a baseline assessment, also received sildenafil.|21
10487327|NCT01169519|11636863|FG000|COMPLETED|Overall Study||21
10487328|NCT01169519|11636863|FG000|NOT COMPLETED|Overall Study||0
10487329|NCT01169532|11636875|FG000|STARTED|Overall Study||16
10487330|NCT01169532|11636875|FG000|COMPLETED|Overall Study||15
10487331|NCT01169532|11636875|FG000|NOT COMPLETED|Overall Study||1
10487332|NCT01169558|11636879|FG000|STARTED|Overall Study||162
10487333|NCT01169558|11636879|FG000|COMPLETED|Overall Study||6
10487334|NCT01169558|11636879|FG000|NOT COMPLETED|Overall Study||156
10487335|NCT01169636|11636888|FG000|STARTED|Overall Study||3
10487336|NCT01169636|11636889|FG001|STARTED|Overall Study||6
10487337|NCT01169636|11636890|FG002|STARTED|Overall Study||20
10487338|NCT01169636|11636891|FG003|STARTED|Overall Study||13
10487339|NCT01169636|11636892|FG004|STARTED|Overall Study||14
10487340|NCT01169636|11636888|FG000|COMPLETED|Overall Study||3
10487341|NCT01169636|11636889|FG001|COMPLETED|Overall Study||6
10487342|NCT01169636|11636890|FG002|COMPLETED|Overall Study||17
10487343|NCT01169636|11636891|FG003|COMPLETED|Overall Study||12
10487344|NCT01169636|11636892|FG004|COMPLETED|Overall Study||11
10487345|NCT01169636|11636888|FG000|NOT COMPLETED|Overall Study||0
10487346|NCT01169636|11636889|FG001|NOT COMPLETED|Overall Study||0
10487347|NCT01169636|11636890|FG002|NOT COMPLETED|Overall Study||3
10487348|NCT01169636|11636891|FG003|NOT COMPLETED|Overall Study||1
10487349|NCT01169636|11636892|FG004|NOT COMPLETED|Overall Study||3
10487350|NCT01169649|11636902|FG000|STARTED|Overall Study||11
10487351|NCT01169649|11636902|FG000|COMPLETED|Overall Study||8
10487352|NCT01169649|11636902|FG000|NOT COMPLETED|Overall Study||3
10487353|NCT01169675|11636911|FG000|STARTED|Overall Study||20
10487354|NCT01169675|11636912|FG001|STARTED|Overall Study||3
10487355|NCT01169675|11636913|FG002|STARTED|Overall Study||7
10487356|NCT01169675|11636914|FG003|STARTED|Overall Study||17
10487357|NCT01169675|11636915|FG004|STARTED|Overall Study||6
10487358|NCT01169675|11636911|FG000|COMPLETED|Overall Study||0
10487359|NCT01169675|11636912|FG001|COMPLETED|Overall Study||0
10487360|NCT01169675|11636913|FG002|COMPLETED|Overall Study||0
10487361|NCT01169675|11636914|FG003|COMPLETED|Overall Study||0
10487362|NCT01169675|11636915|FG004|COMPLETED|Overall Study||0
10487363|NCT01169675|11636911|FG000|NOT COMPLETED|Overall Study||20
10487364|NCT01169675|11636912|FG001|NOT COMPLETED|Overall Study||3
10487365|NCT01169675|11636913|FG002|NOT COMPLETED|Overall Study||7
10487366|NCT01169675|11636914|FG003|NOT COMPLETED|Overall Study||17
10487367|NCT01169675|11636915|FG004|NOT COMPLETED|Overall Study||6
10487368|NCT01169701|11636929|FG000|STARTED|Overall Study||36
10487369|NCT01169701|11636930|FG001|STARTED|Overall Study||35
10487370|NCT01169701|11636929|FG000|Safety Set|Overall Study||36
10487371|NCT01169701|11636930|FG001|Safety Set|Overall Study||35
10487372|NCT01169701|11636929|FG000|Intent to Treat (ITT) Set|Overall Study||32
10487373|NCT01169701|11636930|FG001|Intent to Treat (ITT) Set|Overall Study||28
10487374|NCT01169701|11636929|FG000|COMPLETED|Overall Study||31
10487375|NCT01169701|11636930|FG001|COMPLETED|Overall Study||25
10487376|NCT01169701|11636929|FG000|NOT COMPLETED|Overall Study||5
10487377|NCT01169701|11636930|FG001|NOT COMPLETED|Overall Study||10
10709981|NCT02646332|11875116|FG001|STARTED|Overall Study||124
10709982|NCT02646332|11875115|FG000|COMPLETED|Overall Study||124
10709983|NCT02646332|11875116|FG001|COMPLETED|Overall Study||121
10709984|NCT02646332|11875115|FG000|NOT COMPLETED|Overall Study||0
10709985|NCT02646332|11875116|FG001|NOT COMPLETED|Overall Study||3
10487378|NCT01169779|11636938|FG000|STARTED|Overall Study|Randomized.|195
10487379|NCT01169779|11636939|FG001|STARTED|Overall Study||196
10487380|NCT01169779|11636938|FG000|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|194
10487381|NCT01169779|11636939|FG001|Treated/Safety Population|Overall Study||196
10487382|NCT01169779|11636938|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|193
10487383|NCT01169779|11636939|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||195
10487384|NCT01169779|11636938|FG000|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal test was performed.|130
10487385|NCT01169779|11636939|FG001|Subgroup for Standardized Meal Test|Overall Study||121
10487386|NCT01169779|11636938|FG000|COMPLETED|Overall Study||184
10487387|NCT01169779|11636939|FG001|COMPLETED|Overall Study||179
10487388|NCT01169779|11636938|FG000|NOT COMPLETED|Overall Study||11
10487389|NCT01169779|11636939|FG001|NOT COMPLETED|Overall Study||17
10487390|NCT01169844|11636947|FG000|STARTED|Overall Study||19
10487391|NCT01169844|11636948|FG001|STARTED|Overall Study||9
10487392|NCT01169844|11636947|FG000|COMPLETED|Overall Study||14
10487393|NCT01169844|11636948|FG001|COMPLETED|Overall Study||8
10487394|NCT01169844|11636947|FG000|NOT COMPLETED|Overall Study||5
10487395|NCT01169844|11636948|FG001|NOT COMPLETED|Overall Study||1
10487396|NCT01169987|11636954|FG000|STARTED|Overall Study||191
10487397|NCT01169987|11636954|FG000|COMPLETED|Overall Study||160
10487398|NCT01169987|11636954|FG000|NOT COMPLETED|Overall Study||31
10487399|NCT01170039|11636966|FG000|STARTED|Overall Study||37
10487400|NCT01170039|11636967|FG001|STARTED|Overall Study||39
10487401|NCT01170039|11636966|FG000|COMPLETED|Overall Study||29
10487402|NCT01170039|11636967|FG001|COMPLETED|Overall Study||33
10487403|NCT01170039|11636966|FG000|NOT COMPLETED|Overall Study||8
10487404|NCT01170039|11636967|FG001|NOT COMPLETED|Overall Study||6
10487405|NCT01170065|11636976|FG000|STARTED|Overall Study||37
10487406|NCT01170065|11636977|FG001|STARTED|Overall Study||126
10487407|NCT01170065|11636978|FG002|STARTED|Overall Study||35
10487408|NCT01170065|11636976|FG000|COMPLETED|Overall Study|Planned observation time is from first trial drug intake to follow-up visit|9
10487409|NCT01170065|11636977|FG001|COMPLETED|Overall Study|Planned observation time is from first trial drug intake to follow-up visit|34
10487410|NCT01170065|11636978|FG002|COMPLETED|Overall Study|Planned observation time is from first trial drug intake to follow-up visit|9
10487411|NCT01170065|11636976|FG000|NOT COMPLETED|Overall Study||28
10487412|NCT01170065|11636977|FG001|NOT COMPLETED|Overall Study||92
10487413|NCT01170065|11636978|FG002|NOT COMPLETED|Overall Study||26
10487414|NCT01170091|11636986|FG000|STARTED|Overall Study||651
10487415|NCT01170091|11636986|FG000|COMPLETED|Overall Study||627
10487416|NCT01170091|11636986|FG000|NOT COMPLETED|Overall Study||24
10487417|NCT01170117|11636992|FG000|STARTED|Overall Study||77
10487418|NCT01170117|11636993|FG001|STARTED|Overall Study||75
10487419|NCT01170117|11636992|FG000|COMPLETED|Overall Study||47
10487420|NCT01170117|11636993|FG001|COMPLETED|Overall Study||55
10487421|NCT01170117|11636992|FG000|NOT COMPLETED|Overall Study||30
10709986|NCT02646371|11875124|FG000|STARTED|Overall Study||34
10709987|NCT02646371|11875125|FG001|STARTED|Overall Study||33
10487422|NCT01170117|11636993|FG001|NOT COMPLETED|Overall Study||20
10487423|NCT01170208|11637002|FG000|STARTED|Overall Study||20
10487424|NCT01170208|11637003|FG001|STARTED|Overall Study||20
10487425|NCT01170208|11637004|FG002|STARTED|Overall Study||6
10487426|NCT01170208|11637002|FG000|COMPLETED|Overall Study||14
10487427|NCT01170208|11637003|FG001|COMPLETED|Overall Study||20
10487428|NCT01170208|11637004|FG002|COMPLETED|Overall Study||4
10487429|NCT01170208|11637002|FG000|NOT COMPLETED|Overall Study||6
10487430|NCT01170208|11637003|FG001|NOT COMPLETED|Overall Study||0
10487431|NCT01170208|11637004|FG002|NOT COMPLETED|Overall Study||2
10487432|NCT01170221|11637017|FG000|STARTED|Overall Study||332
10487433|NCT01170221|11637018|FG001|STARTED|Overall Study||335
10487434|NCT01170221|11637017|FG000|COMPLETED|Overall Study||299
10487435|NCT01170221|11637018|FG001|COMPLETED|Overall Study||307
10487436|NCT01170221|11637017|FG000|NOT COMPLETED|Overall Study||33
10487437|NCT01170221|11637018|FG001|NOT COMPLETED|Overall Study||28
10487438|NCT01170247|11637026|FG000|STARTED|Overall Study||2
10487439|NCT01170247|11637027|FG001|STARTED|Overall Study||1
10487440|NCT01170247|11637026|FG000|COMPLETED|Overall Study||2
10487441|NCT01170247|11637027|FG001|COMPLETED|Overall Study||1
10487442|NCT01170247|11637026|FG000|NOT COMPLETED|Overall Study||0
10487443|NCT01170247|11637027|FG001|NOT COMPLETED|Overall Study||0
10487444|NCT01170273|11637035|FG000|STARTED|Overall Study||64
10487445|NCT01170273|11637036|FG001|STARTED|Overall Study||66
10487446|NCT01170273|11637035|FG000|COMPLETED|Overall Study||56
10487447|NCT01170273|11637036|FG001|COMPLETED|Overall Study||57
10487448|NCT01170273|11637035|FG000|NOT COMPLETED|Overall Study||8
10487449|NCT01170273|11637036|FG001|NOT COMPLETED|Overall Study||9
10487450|NCT01170364|11637044|FG000|STARTED|Overall Study||8
10487451|NCT01170364|11637045|FG001|STARTED|Overall Study||6
10487452|NCT01170364|11637044|FG000|COMPLETED|Overall Study||4
10487453|NCT01170364|11637045|FG001|COMPLETED|Overall Study|One participant was unable to begin the second testing period due to scheduling conflicts.|5
10487454|NCT01170364|11637044|FG000|NOT COMPLETED|Overall Study||4
10487455|NCT01170364|11637045|FG001|NOT COMPLETED|Overall Study||1
10487456|NCT01170390|11637053|FG000|STARTED|Oral Contraceptives||32
10487457|NCT01170390|11637054|FG001|STARTED|Oral Contraceptives||0
10487458|NCT01170390|11637055|FG002|STARTED|Oral Contraceptives||0
10487459|NCT01170390|11637053|FG000|COMPLETED|Oral Contraceptives||31
10487460|NCT01170390|11637054|FG001|COMPLETED|Oral Contraceptives||0
10487461|NCT01170390|11637055|FG002|COMPLETED|Oral Contraceptives||0
10487462|NCT01170390|11637053|FG000|NOT COMPLETED|Oral Contraceptives||1
10487463|NCT01170390|11637054|FG001|NOT COMPLETED|Oral Contraceptives||0
10487464|NCT01170390|11637055|FG002|NOT COMPLETED|Oral Contraceptives||0
10487465|NCT01170390|11637053|FG000|STARTED|Randomized Treatment||0
10487466|NCT01170390|11637054|FG001|STARTED|Randomized Treatment||17
10487467|NCT01170390|11637055|FG002|STARTED|Randomized Treatment||15
10487468|NCT01170390|11637053|FG000|COMPLETED|Randomized Treatment||0
10487469|NCT01170390|11637054|FG001|COMPLETED|Randomized Treatment||16
10487470|NCT01170390|11637055|FG002|COMPLETED|Randomized Treatment||15
10487471|NCT01170390|11637053|FG000|NOT COMPLETED|Randomized Treatment||0
10487472|NCT01170390|11637054|FG001|NOT COMPLETED|Randomized Treatment||1
10487473|NCT01170390|11637055|FG002|NOT COMPLETED|Randomized Treatment||0
10487474|NCT01170533|11637063|FG000|STARTED|Omeprazole Cross-over||20
10487475|NCT01170533|11637064|FG001|STARTED|Omeprazole Cross-over||0
10487476|NCT01170533|11637063|FG000|COMPLETED|Omeprazole Cross-over||20
10487477|NCT01170533|11637064|FG001|COMPLETED|Omeprazole Cross-over||0
10487478|NCT01170533|11637063|FG000|NOT COMPLETED|Omeprazole Cross-over||0
10487479|NCT01170533|11637064|FG001|NOT COMPLETED|Omeprazole Cross-over||0
10487480|NCT01170533|11637063|FG000|STARTED|Pantoprazole Cross-over||0
10487481|NCT01170533|11637064|FG001|STARTED|Pantoprazole Cross-over|15 participants continued from omeprazole cross-over; the remaining 5 were new participants|20
10487482|NCT01170533|11637063|FG000|COMPLETED|Pantoprazole Cross-over||0
10487483|NCT01170533|11637064|FG001|COMPLETED|Pantoprazole Cross-over||20
10709988|NCT02646371|11875124|FG000|COMPLETED|Overall Study||34
10709989|NCT02646371|11875125|FG001|COMPLETED|Overall Study||33
10709990|NCT02646371|11875124|FG000|NOT COMPLETED|Overall Study||0
10709991|NCT02646371|11875125|FG001|NOT COMPLETED|Overall Study||0
10809844|NCT03812328|11971653|FG002|COMPLETED|Overall Study||88
10809845|NCT03812328|11971651|FG000|NOT COMPLETED|Overall Study||0
10487484|NCT01170533|11637063|FG000|NOT COMPLETED|Pantoprazole Cross-over||0
10487485|NCT01170533|11637064|FG001|NOT COMPLETED|Pantoprazole Cross-over||0
10487486|NCT01170546|11637078|FG000|STARTED|Overall Study||7
10487487|NCT01170546|11637079|FG001|STARTED|Overall Study||7
10487488|NCT01170546|11637080|FG002|STARTED|Overall Study||6
10487489|NCT01170546|11637081|FG003|STARTED|Overall Study||8
10487490|NCT01170546|11637078|FG000|COMPLETED|Overall Study||7
10487491|NCT01170546|11637079|FG001|COMPLETED|Overall Study||7
10487492|NCT01170546|11637080|FG002|COMPLETED|Overall Study||6
10487493|NCT01170546|11637081|FG003|COMPLETED|Overall Study||8
10487494|NCT01170546|11637078|FG000|NOT COMPLETED|Overall Study||0
10487495|NCT01170546|11637079|FG001|NOT COMPLETED|Overall Study||0
10487496|NCT01170546|11637080|FG002|NOT COMPLETED|Overall Study||0
10487497|NCT01170546|11637081|FG003|NOT COMPLETED|Overall Study||0
10487498|NCT01170598|11637091|FG000|STARTED|Overall Study||35
10487499|NCT01170598|11637091|FG000|COMPLETED|Overall Study||29
10487500|NCT01170598|11637091|FG000|NOT COMPLETED|Overall Study||6
10487501|NCT01170663|11637097|FG000|STARTED|Overall Study|Participant was included in ramucirumab (IMC-1121B)/paclitaxel treatment arm (safety population).|330
10487502|NCT01170663|11637098|FG001|STARTED|Overall Study|Participant was included in the placebo/paclitaxel treatment arm (intent-to-treat (ITT) population).|335
10487503|NCT01170663|11637097|FG000|Received Any Treatment (Safety Pop)|Overall Study||327
10487504|NCT01170663|11637098|FG001|Received Any Treatment (Safety Pop)|Overall Study||329
10487505|NCT01170663|11637097|FG000|COMPLETED|Overall Study||316
10487506|NCT01170663|11637098|FG001|COMPLETED|Overall Study||315
10487507|NCT01170663|11637097|FG000|NOT COMPLETED|Overall Study||14
10487508|NCT01170663|11637098|FG001|NOT COMPLETED|Overall Study||20
10809846|NCT03812328|11971652|FG001|NOT COMPLETED|Overall Study||3
10487509|NCT01170715|11637104|FG000|STARTED|Overall Study||21
10709992|NCT02646423|11875133|FG000|STARTED|Overall Study||742
10487510|NCT01170715|11637104|FG000|COMPLETED|Overall Study||14
10487511|NCT01170715|11637104|FG000|NOT COMPLETED|Overall Study||7
10487512|NCT01170754|11637110|FG000|STARTED|Overall Study||66
10487513|NCT01170754|11637111|FG001|STARTED|Overall Study||70
10487514|NCT01170754|11637110|FG000|COMPLETED|Overall Study||66
10487515|NCT01170754|11637111|FG001|COMPLETED|Overall Study||70
10487516|NCT01170754|11637110|FG000|NOT COMPLETED|Overall Study||0
10487517|NCT01170754|11637111|FG001|NOT COMPLETED|Overall Study||0
10487518|NCT01170884|11637121|FG000|STARTED|Overall Study||59
10487519|NCT01170884|11637122|FG001|STARTED|Overall Study||62
10487520|NCT01170884|11637121|FG000|COMPLETED|Overall Study||54
10487521|NCT01170884|11637122|FG001|COMPLETED|Overall Study||60
10487522|NCT01170884|11637121|FG000|NOT COMPLETED|Overall Study||5
10487523|NCT01170884|11637122|FG001|NOT COMPLETED|Overall Study||2
10487524|NCT01170949|11637130|FG000|STARTED|Overall Study||50
10487525|NCT01170949|11637131|FG001|STARTED|Overall Study||26
10487526|NCT01170949|11637130|FG000|COMPLETED|Overall Study||43
10487527|NCT01170949|11637131|FG001|COMPLETED|Overall Study||22
10487528|NCT01170949|11637130|FG000|NOT COMPLETED|Overall Study||7
10487529|NCT01170949|11637131|FG001|NOT COMPLETED|Overall Study||4
10487530|NCT01170962|11637140|FG000|STARTED|Treatment Period||203
10487531|NCT01170962|11637141|FG001|STARTED|Treatment Period||199
10487532|NCT01170962|11637142|FG002|STARTED|Treatment Period||17
10487533|NCT01170962|11637140|FG000|No PDR|Treatment Period||145
10487534|NCT01170962|11637141|FG001|No PDR|Treatment Period||127
10487535|NCT01170962|11637142|FG002|No PDR|Treatment Period||17
10487536|NCT01170962|11637140|FG000|PDR -Randomized to 24 Weeks pegIFNα--2a|Treatment Period||30
10487537|NCT01170962|11637141|FG001|PDR -Randomized to 24 Weeks pegIFNα--2a|Treatment Period||36
10487538|NCT01170962|11637142|FG002|PDR -Randomized to 24 Weeks pegIFNα--2a|Treatment Period||0
10487539|NCT01170962|11637140|FG000|PDR -Randomized to 48 Weeks Follow--up|Treatment Period||28
10487540|NCT01170962|11637141|FG001|PDR -Randomized to 48 Weeks Follow--up|Treatment Period||36
10487541|NCT01170962|11637142|FG002|PDR -Randomized to 48 Weeks Follow--up|Treatment Period||0
10487542|NCT01170962|11637140|FG000|COMPLETED|Treatment Period||76
10487543|NCT01170962|11637141|FG001|COMPLETED|Treatment Period||88
10487544|NCT01170962|11637142|FG002|COMPLETED|Treatment Period||5
10487545|NCT01170962|11637140|FG000|NOT COMPLETED|Treatment Period||127
10487546|NCT01170962|11637141|FG001|NOT COMPLETED|Treatment Period||111
10487547|NCT01170962|11637142|FG002|NOT COMPLETED|Treatment Period||12
10487548|NCT01170962|11637140|FG000|STARTED|Follow up Period|Out of 203 participants who entered the treatment period, 198 continued in the follow-up period.|198
10487549|NCT01170962|11637141|FG001|STARTED|Follow up Period|Out of 199 participants who entered the treatment period, 192 continued in the follow-up period.|192
10487632|NCT01171989|11637276|FG002|STARTED|Overall Study||121
10487550|NCT01170962|11637142|FG002|STARTED|Follow up Period|Out of 17 participants who entered the treatment period, 15 continued in the follow-up period.|15
10487551|NCT01170962|11637140|FG000|COMPLETED|Follow up Period||159
10487552|NCT01170962|11637141|FG001|COMPLETED|Follow up Period||165
10487553|NCT01170962|11637142|FG002|COMPLETED|Follow up Period||9
10487554|NCT01170962|11637140|FG000|NOT COMPLETED|Follow up Period||39
10487555|NCT01170962|11637141|FG001|NOT COMPLETED|Follow up Period||27
10487556|NCT01170962|11637142|FG002|NOT COMPLETED|Follow up Period||6
10487557|NCT01171118|11637159|FG000|STARTED|Overall Study||10
10487558|NCT01171118|11637159|FG000|COMPLETED|Overall Study||10
10487559|NCT01171118|11637159|FG000|NOT COMPLETED|Overall Study||0
10487560|NCT01171183|11637171|FG000|STARTED|Residential Facility (Weeks 1-2)|Those who were admitted to the residential facility and received at least one dose of study med.|15
10487561|NCT01171183|11637172|FG001|STARTED|Residential Facility (Weeks 1-2)|Subjects receiving at least one dose of study med. One did not due to BP outside study parameters.|16
10487562|NCT01171183|11637171|FG000|COMPLETED|Residential Facility (Weeks 1-2)||13
10487563|NCT01171183|11637172|FG001|COMPLETED|Residential Facility (Weeks 1-2)||10
10487564|NCT01171183|11637171|FG000|NOT COMPLETED|Residential Facility (Weeks 1-2)||2
10487565|NCT01171183|11637172|FG001|NOT COMPLETED|Residential Facility (Weeks 1-2)||6
10487566|NCT01171183|11637171|FG000|STARTED|Outpatient Participation (Weeks 3-10)|One subject completed the residential stay but withdrew prior to starting the outpatient phase.|12
10487567|NCT01171183|11637172|FG001|STARTED|Outpatient Participation (Weeks 3-10)|One subject completed the residential stay but was discharged due to protocol noncompliance.|9
10487568|NCT01171183|11637171|FG000|COMPLETED|Outpatient Participation (Weeks 3-10)||2
10487569|NCT01171183|11637172|FG001|COMPLETED|Outpatient Participation (Weeks 3-10)||4
10487570|NCT01171183|11637171|FG000|NOT COMPLETED|Outpatient Participation (Weeks 3-10)||10
10487571|NCT01171183|11637172|FG001|NOT COMPLETED|Outpatient Participation (Weeks 3-10)||5
10487572|NCT01171521|11637178|FG000|STARTED|Overall Study||6
10487573|NCT01171521|11637178|FG000|COMPLETED|Overall Study||0
10487574|NCT01171521|11637178|FG000|NOT COMPLETED|Overall Study||6
10487575|NCT01171612|11637182|FG000|STARTED|Overall Study||483
10487576|NCT01171612|11637182|FG000|COMPLETED|Overall Study||432
10487577|NCT01171612|11637182|FG000|NOT COMPLETED|Overall Study||51
10487578|NCT01171625|11637189|FG000|STARTED|Overall Study||283
10487579|NCT01171625|11637189|FG000|Subjects Implanted With Device|Overall Study||258
10487580|NCT01171625|11637189|FG000|COMPLETED|Overall Study||103
10487581|NCT01171625|11637189|FG000|NOT COMPLETED|Overall Study||180
10487582|NCT01171677|11637203|FG000|STARTED|Overall Study||17
10487583|NCT01171677|11637204|FG001|STARTED|Overall Study||15
10487584|NCT01171677|11637203|FG000|COMPLETED|Overall Study||11
10487585|NCT01171677|11637204|FG001|COMPLETED|Overall Study||12
10487586|NCT01171677|11637203|FG000|NOT COMPLETED|Overall Study||6
10487587|NCT01171677|11637204|FG001|NOT COMPLETED|Overall Study||3
10487588|NCT01171690|11637212|FG000|STARTED|Overall Study||5
10487589|NCT01171690|11637213|FG001|STARTED|Overall Study||5
10487590|NCT01171690|11637212|FG000|COMPLETED|Overall Study||5
10487591|NCT01171690|11637213|FG001|COMPLETED|Overall Study||5
10487592|NCT01171690|11637212|FG000|NOT COMPLETED|Overall Study||0
10487593|NCT01171690|11637213|FG001|NOT COMPLETED|Overall Study||0
10487594|NCT01171794|11637221|FG000|STARTED|Overall Study||47
10487595|NCT01171794|11637222|FG001|STARTED|Overall Study||42
10487596|NCT01171794|11637221|FG000|COMPLETED|Overall Study||44
10487597|NCT01171794|11637222|FG001|COMPLETED|Overall Study||42
10487598|NCT01171794|11637221|FG000|NOT COMPLETED|Overall Study||3
10487599|NCT01171794|11637222|FG001|NOT COMPLETED|Overall Study||0
10487600|NCT01171820|11637230|FG000|STARTED|Overall Study||106
10487601|NCT01171820|11637231|FG001|STARTED|Overall Study||218
10487602|NCT01171820|11637230|FG000|COMPLETED|Overall Study||100
10487603|NCT01171820|11637231|FG001|COMPLETED|Overall Study||212
10487604|NCT01171820|11637230|FG000|NOT COMPLETED|Overall Study||6
10487605|NCT01171820|11637231|FG001|NOT COMPLETED|Overall Study||6
10487606|NCT01171924|11637239|FG000|STARTED|Overall Study||23
10487607|NCT01171924|11637240|FG001|STARTED|Overall Study||23
10487608|NCT01171924|11637239|FG000|COMPLETED|Overall Study||0
10487609|NCT01171924|11637240|FG001|COMPLETED|Overall Study||0
10487610|NCT01171924|11637239|FG000|NOT COMPLETED|Overall Study||23
10487611|NCT01171924|11637240|FG001|NOT COMPLETED|Overall Study||23
10487612|NCT01171963|11637248|FG000|STARTED|Overall Study||1666
10487613|NCT01171963|11637249|FG001|STARTED|Overall Study||1667
10487614|NCT01171963|11637248|FG000|COMPLETED|Overall Study||1518
10487615|NCT01171963|11637249|FG001|COMPLETED|Overall Study||1499
10487616|NCT01171963|11637248|FG000|NOT COMPLETED|Overall Study||148
10487617|NCT01171963|11637249|FG001|NOT COMPLETED|Overall Study||168
10487618|NCT01171976|11637261|FG000|STARTED|Overall Study||121
10487619|NCT01171976|11637262|FG001|STARTED|Overall Study||128
10487620|NCT01171976|11637263|FG002|STARTED|Overall Study||123
10487621|NCT01171976|11637261|FG000|Safety Set|Overall Study|Include 4 from PRN and 3 from TE alone who got laser treatment, exclude 2 with no laser treatment.|126
10487622|NCT01171976|11637262|FG001|Safety Set|Overall Study|Exclude 1 who did not get drug and 3 got laser treatment, include 2 from 1st arm with no laser|126
10487623|NCT01171976|11637263|FG002|Safety Set|Overall Study|Exclude 1 who did not get drug and 4 got laser treatment|118
10487624|NCT01171976|11637261|FG000|COMPLETED|Overall Study||107
10487625|NCT01171976|11637262|FG001|COMPLETED|Overall Study||117
10487626|NCT01171976|11637263|FG002|COMPLETED|Overall Study||108
10487627|NCT01171976|11637261|FG000|NOT COMPLETED|Overall Study||14
10487628|NCT01171976|11637262|FG001|NOT COMPLETED|Overall Study||11
10487629|NCT01171976|11637263|FG002|NOT COMPLETED|Overall Study||15
10487630|NCT01171989|11637274|FG000|STARTED|Overall Study||137
10487631|NCT01171989|11637275|FG001|STARTED|Overall Study||133
10487633|NCT01171989|11637274|FG000|COMPLETED|Overall Study||137
10487634|NCT01171989|11637275|FG001|COMPLETED|Overall Study||133
10487635|NCT01171989|11637276|FG002|COMPLETED|Overall Study||120
10487636|NCT01171989|11637274|FG000|NOT COMPLETED|Overall Study||0
10487637|NCT01171989|11637275|FG001|NOT COMPLETED|Overall Study||0
10487638|NCT01171989|11637276|FG002|NOT COMPLETED|Overall Study||1
10487639|NCT01172067|11637286|FG000|STARTED|Overall Study||200
10487640|NCT01172067|11637287|FG001|STARTED|Overall Study||200
10487641|NCT01172067|11637286|FG000|COMPLETED|Overall Study||153
10487642|NCT01172067|11637287|FG001|COMPLETED|Overall Study||163
10487643|NCT01172067|11637286|FG000|NOT COMPLETED|Overall Study||47
10487644|NCT01172067|11637287|FG001|NOT COMPLETED|Overall Study||37
10487645|NCT01172145|11637295|FG000|STARTED|Overall Study||11
10487646|NCT01172145|11637296|FG001|STARTED|Overall Study||11
10487647|NCT01172145|11637295|FG000|COMPLETED|Overall Study||11
10487648|NCT01172145|11637296|FG001|COMPLETED|Overall Study||11
10487649|NCT01172145|11637295|FG000|NOT COMPLETED|Overall Study||0
10487650|NCT01172145|11637296|FG001|NOT COMPLETED|Overall Study||0
10487651|NCT01172184|11637302|FG000|STARTED|Overall Study||111
10487652|NCT01172184|11637302|FG000|COMPLETED|Overall Study||111
10487653|NCT01172184|11637302|FG000|NOT COMPLETED|Overall Study||0
10487654|NCT01172197|11637308|FG000|STARTED|Overall Study||7
10487655|NCT01172197|11637309|FG001|STARTED|Overall Study||7
10487656|NCT01172197|11637308|FG000|COMPLETED|Overall Study||7
10487657|NCT01172197|11637309|FG001|COMPLETED|Overall Study||7
10487658|NCT01172197|11637308|FG000|NOT COMPLETED|Overall Study||0
10487659|NCT01172197|11637309|FG001|NOT COMPLETED|Overall Study||0
10487660|NCT01172275|11637317|FG000|STARTED|Overall Study||5
10487661|NCT01172275|11637318|FG001|STARTED|Overall Study||6
10487662|NCT01172275|11637317|FG000|COMPLETED|Overall Study||3
10487663|NCT01172275|11637318|FG001|COMPLETED|Overall Study||6
10487664|NCT01172275|11637317|FG000|NOT COMPLETED|Overall Study||2
10487665|NCT01172275|11637318|FG001|NOT COMPLETED|Overall Study||0
10487666|NCT01172288|11637326|FG000|STARTED|Overall Study||17
10487667|NCT01172288|11637327|FG001|STARTED|Overall Study||14
10487668|NCT01172288|11637326|FG000|COMPLETED|Overall Study||16
10487669|NCT01172288|11637327|FG001|COMPLETED|Overall Study||13
10487670|NCT01172288|11637326|FG000|NOT COMPLETED|Overall Study||1
10487671|NCT01172288|11637327|FG001|NOT COMPLETED|Overall Study||1
10487672|NCT01172353|11637335|FG000|STARTED|Overall Study||150
10487673|NCT01172353|11637336|FG001|STARTED|Overall Study||151
10487674|NCT01172353|11637335|FG000|COMPLETED|Overall Study||150
10487675|NCT01172353|11637336|FG001|COMPLETED|Overall Study||151
10487676|NCT01172353|11637335|FG000|NOT COMPLETED|Overall Study||0
10487677|NCT01172353|11637336|FG001|NOT COMPLETED|Overall Study||0
10487678|NCT01172418|11637344|FG000|STARTED|Overall Study||100
10487679|NCT01172418|11637345|FG001|STARTED|Overall Study||100
10487680|NCT01172418|11637344|FG000|COMPLETED|Overall Study||100
10487681|NCT01172418|11637345|FG001|COMPLETED|Overall Study||100
10487682|NCT01172418|11637344|FG000|NOT COMPLETED|Overall Study||0
10487683|NCT01172418|11637345|FG001|NOT COMPLETED|Overall Study||0
10487684|NCT01172522|11637355|FG000|STARTED|Overall Study||15
10487685|NCT01172522|11637356|FG001|STARTED|Overall Study||15
10487686|NCT01172522|11637355|FG000|COMPLETED|Overall Study||15
10487687|NCT01172522|11637356|FG001|COMPLETED|Overall Study||15
10487688|NCT01172522|11637355|FG000|NOT COMPLETED|Overall Study||0
10487689|NCT01172522|11637356|FG001|NOT COMPLETED|Overall Study||0
10487690|NCT01172535|11637361|FG000|STARTED|Overall Study||97
10487691|NCT01172535|11637361|FG000|COMPLETED|Overall Study||89
10487692|NCT01172535|11637361|FG000|NOT COMPLETED|Overall Study||8
10487693|NCT01172600|11637370|FG000|STARTED|Overall Study||39
10487694|NCT01172600|11637371|FG001|STARTED|Overall Study||39
10487695|NCT01172600|11637370|FG000|COMPLETED|Overall Study||39
10487696|NCT01172600|11637371|FG001|COMPLETED|Overall Study||39
10487697|NCT01172600|11637370|FG000|NOT COMPLETED|Overall Study||0
10709993|NCT02646423|11875134|FG001|STARTED|Overall Study||743
10709994|NCT02646423|11875133|FG000|COMPLETED|Overall Study||735
10487698|NCT01172600|11637371|FG001|NOT COMPLETED|Overall Study||0
10487699|NCT01172639|11637382|FG000|STARTED|Overall Study||98
10487700|NCT01172639|11637383|FG001|STARTED|Overall Study||98
10487701|NCT01172639|11637384|FG002|STARTED|Overall Study||93
10487702|NCT01172639|11637385|FG003|STARTED|Overall Study||43
10487703|NCT01172639|11637386|FG004|STARTED|Overall Study||47
10487704|NCT01172639|11637382|FG000|Week 16|Overall Study||94
10487705|NCT01172639|11637383|FG001|Week 16|Overall Study||96
10487706|NCT01172639|11637384|FG002|Week 16|Overall Study||91
10487707|NCT01172639|11637385|FG003|Week 16|Overall Study||39
10487708|NCT01172639|11637386|FG004|Week 16|Overall Study||47
10487709|NCT01172639|11637382|FG000|Week 52|Overall Study||89
10487710|NCT01172639|11637383|FG001|Week 52|Overall Study||89
10487711|NCT01172639|11637384|FG002|Week 52|Overall Study||88
10487712|NCT01172639|11637385|FG003|Week 52|Overall Study||38
10487713|NCT01172639|11637386|FG004|Week 52|Overall Study||45
10487714|NCT01172639|11637382|FG000|COMPLETED|Overall Study||85
10487715|NCT01172639|11637383|FG001|COMPLETED|Overall Study||87
10487716|NCT01172639|11637384|FG002|COMPLETED|Overall Study||77
10487717|NCT01172639|11637385|FG003|COMPLETED|Overall Study||32
10487718|NCT01172639|11637386|FG004|COMPLETED|Overall Study||41
10487719|NCT01172639|11637382|FG000|NOT COMPLETED|Overall Study||13
10487720|NCT01172639|11637383|FG001|NOT COMPLETED|Overall Study||11
10487721|NCT01172639|11637384|FG002|NOT COMPLETED|Overall Study||16
10487722|NCT01172639|11637385|FG003|NOT COMPLETED|Overall Study||11
10487723|NCT01172639|11637386|FG004|NOT COMPLETED|Overall Study||6
10487724|NCT01172808|11637402|FG000|STARTED|Overall Study|Entered and Treated|269
10487725|NCT01172808|11637403|FG001|STARTED|Overall Study|Entered and Treated|262
10487726|NCT01172808|11637404|FG002|STARTED|Overall Study|Entered and Treated|264
10487727|NCT01172808|11637405|FG003|STARTED|Overall Study|Entered and Treated|275
10487728|NCT01172808|11637402|FG000|COMPLETED|Overall Study||248
10487729|NCT01172808|11637403|FG001|COMPLETED|Overall Study||249
10487730|NCT01172808|11637404|FG002|COMPLETED|Overall Study||241
10487731|NCT01172808|11637405|FG003|COMPLETED|Overall Study||260
10487732|NCT01172808|11637402|FG000|NOT COMPLETED|Overall Study||21
10487733|NCT01172808|11637403|FG001|NOT COMPLETED|Overall Study||13
10487734|NCT01172808|11637404|FG002|NOT COMPLETED|Overall Study||23
10487735|NCT01172808|11637405|FG003|NOT COMPLETED|Overall Study||15
10487736|NCT01172821|11637419|FG000|STARTED|Overall Study|Entered and Treated|254
10487737|NCT01172821|11637420|FG001|STARTED|Overall Study|Entered and Treated|257
10487738|NCT01172821|11637421|FG002|STARTED|Overall Study|Entered and Treated|253
10487739|NCT01172821|11637422|FG003|STARTED|Overall Study|Entered and Treated|266
10487740|NCT01172821|11637419|FG000|COMPLETED|Overall Study||240
10487741|NCT01172821|11637420|FG001|COMPLETED|Overall Study||245
10487742|NCT01172821|11637421|FG002|COMPLETED|Overall Study||240
10487743|NCT01172821|11637422|FG003|COMPLETED|Overall Study||249
10487744|NCT01172821|11637419|FG000|NOT COMPLETED|Overall Study||14
10487745|NCT01172821|11637420|FG001|NOT COMPLETED|Overall Study||12
10487746|NCT01172821|11637421|FG002|NOT COMPLETED|Overall Study||13
10487747|NCT01172821|11637422|FG003|NOT COMPLETED|Overall Study||17
10487748|NCT01172847|11637432|FG000|STARTED|Overall Study||24
10487749|NCT01172847|11637432|FG000|Oseltamivir|Overall Study||24
10487750|NCT01172847|11637432|FG000|Rimantadine|Overall Study||22
10487751|NCT01172847|11637432|FG000|Oseltamivir + Rimantadine|Overall Study||21
10487752|NCT01172847|11637432|FG000|COMPLETED|Overall Study||21
10487753|NCT01172847|11637432|FG000|NOT COMPLETED|Overall Study||3
10487754|NCT01172873|11637444|FG000|STARTED|Overall Study||11
10487755|NCT01172873|11637445|FG001|STARTED|Overall Study||5
10487756|NCT01172873|11637444|FG000|COMPLETED|Overall Study||8
10487757|NCT01172873|11637445|FG001|COMPLETED|Overall Study||3
10487758|NCT01172873|11637444|FG000|NOT COMPLETED|Overall Study||3
10487759|NCT01172873|11637445|FG001|NOT COMPLETED|Overall Study||2
10487760|NCT01172938|11637454|FG000|STARTED|Placebo-controlled Phase (Week 0-24)||168
10487761|NCT01172938|11637455|FG001|STARTED|Placebo-controlled Phase (Week 0-24)||168
10487762|NCT01172938|11637456|FG002|STARTED|Placebo-controlled Phase (Week 0-24)||168
10487763|NCT01172938|11637457|FG003|STARTED|Placebo-controlled Phase (Week 0-24)||0
10487764|NCT01172938|11637458|FG004|STARTED|Placebo-controlled Phase (Week 0-24)||0
10487765|NCT01172938|11637459|FG005|STARTED|Placebo-controlled Phase (Week 0-24)||0
10487766|NCT01172938|11637460|FG006|STARTED|Placebo-controlled Phase (Week 0-24)||0
10487767|NCT01172938|11637461|FG007|STARTED|Placebo-controlled Phase (Week 0-24)||0
10487768|NCT01172938|11637462|FG008|STARTED|Placebo-controlled Phase (Week 0-24)||0
10487769|NCT01172938|11637454|FG000|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
10487770|NCT01172938|11637455|FG001|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
10487771|NCT01172938|11637456|FG002|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
10487772|NCT01172938|11637457|FG003|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
10487773|NCT01172938|11637458|FG004|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
10487774|NCT01172938|11637459|FG005|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
10487775|NCT01172938|11637460|FG006|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
10487776|NCT01172938|11637461|FG007|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
10487777|NCT01172938|11637462|FG008|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
10487778|NCT01172938|11637454|FG000|Completed Week 16|Placebo-controlled Phase (Week 0-24)||158
10527575|NCT01390818|11679698|FG001|COMPLETED|Overall Study||3
10709995|NCT02646423|11875134|FG001|COMPLETED|Overall Study||735
10487779|NCT01172938|11637455|FG001|Completed Week 16|Placebo-controlled Phase (Week 0-24)||158
10487780|NCT01172938|11637456|FG002|Completed Week 16|Placebo-controlled Phase (Week 0-24)||154
10487781|NCT01172938|11637457|FG003|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
10487782|NCT01172938|11637458|FG004|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
10487783|NCT01172938|11637459|FG005|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
10487784|NCT01172938|11637460|FG006|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
10487785|NCT01172938|11637461|FG007|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
10487786|NCT01172938|11637462|FG008|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
10487787|NCT01172938|11637454|FG000|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|Five participants who escaped early did not complete Week 24|107
10487788|NCT01172938|11637455|FG001|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|Six participants who escaped early did not complete Week 24|78
10487789|NCT01172938|11637456|FG002|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||58
10487790|NCT01172938|11637457|FG003|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
10487791|NCT01172938|11637458|FG004|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
10487792|NCT01172938|11637459|FG005|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
10487793|NCT01172938|11637460|FG006|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
10487794|NCT01172938|11637461|FG007|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
10487795|NCT01172938|11637462|FG008|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
10487796|NCT01172938|11637454|FG000|COMPLETED|Placebo-controlled Phase (Week 0-24)|One participant who completed Week 24 did not enter the active treatment phase|150
10487797|NCT01172938|11637455|FG001|COMPLETED|Placebo-controlled Phase (Week 0-24)||146
10487798|NCT01172938|11637456|FG002|COMPLETED|Placebo-controlled Phase (Week 0-24)||148
10487799|NCT01172938|11637457|FG003|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
10487800|NCT01172938|11637458|FG004|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
10487801|NCT01172938|11637459|FG005|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
10487802|NCT01172938|11637460|FG006|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
10487803|NCT01172938|11637461|FG007|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
10487804|NCT01172938|11637462|FG008|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
10487805|NCT01172938|11637454|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||18
10487806|NCT01172938|11637455|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||22
10487807|NCT01172938|11637456|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||20
10487808|NCT01172938|11637457|FG003|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
10487809|NCT01172938|11637458|FG004|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
10487810|NCT01172938|11637459|FG005|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
10487811|NCT01172938|11637460|FG006|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
10487812|NCT01172938|11637461|FG007|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
10527576|NCT01390818|11679699|FG002|COMPLETED|Overall Study||3
10487813|NCT01172938|11637462|FG008|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
10487814|NCT01172938|11637454|FG000|STARTED|Active Treatment Phase (Weeks 25-52)||0
10487815|NCT01172938|11637455|FG001|STARTED|Active Treatment Phase (Weeks 25-52)|Ten participants who completed Week 24 did not enter the active treatment phase|136
10487816|NCT01172938|11637456|FG002|STARTED|Active Treatment Phase (Weeks 25-52)|Three participants who completed Week 24 did not enter the active treatment phase|145
10487817|NCT01172938|11637457|FG003|STARTED|Active Treatment Phase (Weeks 25-52)|One participant who escaped early and completed Week 24 did not enter the active treatment phase|51
10487818|NCT01172938|11637458|FG004|STARTED|Active Treatment Phase (Weeks 25-52)||23
10487819|NCT01172938|11637459|FG005|STARTED|Active Treatment Phase (Weeks 25-52)|One participant who escaped early and completed Week 24 did not enter the active treatment phase|49
10487820|NCT01172938|11637460|FG006|STARTED|Active Treatment Phase (Weeks 25-52)||24
10487821|NCT01172938|11637461|FG007|STARTED|Active Treatment Phase (Weeks 25-52)||0
10487822|NCT01172938|11637462|FG008|STARTED|Active Treatment Phase (Weeks 25-52)||0
10487823|NCT01172938|11637454|FG000|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
10487824|NCT01172938|11637455|FG001|COMPLETED|Active Treatment Phase (Weeks 25-52)||124
10487825|NCT01172938|11637456|FG002|COMPLETED|Active Treatment Phase (Weeks 25-52)||130
10487826|NCT01172938|11637457|FG003|COMPLETED|Active Treatment Phase (Weeks 25-52)||44
10487827|NCT01172938|11637458|FG004|COMPLETED|Active Treatment Phase (Weeks 25-52)||19
10487828|NCT01172938|11637459|FG005|COMPLETED|Active Treatment Phase (Weeks 25-52)||34
10487829|NCT01172938|11637460|FG006|COMPLETED|Active Treatment Phase (Weeks 25-52)||22
10487830|NCT01172938|11637461|FG007|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
10487831|NCT01172938|11637462|FG008|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
10487832|NCT01172938|11637454|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
10487833|NCT01172938|11637455|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||12
10487834|NCT01172938|11637456|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||15
10487835|NCT01172938|11637457|FG003|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||7
10487836|NCT01172938|11637458|FG004|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||4
10487837|NCT01172938|11637459|FG005|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||15
10487838|NCT01172938|11637460|FG006|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||2
10487839|NCT01172938|11637461|FG007|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
10487840|NCT01172938|11637462|FG008|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
10487841|NCT01172938|11637454|FG000|STARTED|Active-Treatment Phase (Weeks 52-104)||0
10487842|NCT01172938|11637455|FG001|STARTED|Active-Treatment Phase (Weeks 52-104)|Six participants who completed Week 52 did not enter the next year of active treatment phase|118
10487843|NCT01172938|11637456|FG002|STARTED|Active-Treatment Phase (Weeks 52-104)|Nine participants who completed Week 52 did not enter the next year of active treatment phase|121
10487844|NCT01172938|11637457|FG003|STARTED|Active-Treatment Phase (Weeks 52-104)||0
10487845|NCT01172938|11637458|FG004|STARTED|Active-Treatment Phase (Weeks 52-104)||0
10487846|NCT01172938|11637459|FG005|STARTED|Active-Treatment Phase (Weeks 52-104)||0
10487847|NCT01172938|11637460|FG006|STARTED|Active-Treatment Phase (Weeks 52-104)||0
10487848|NCT01172938|11637461|FG007|STARTED|Active-Treatment Phase (Weeks 52-104)||61
10487849|NCT01172938|11637462|FG008|STARTED|Active-Treatment Phase (Weeks 52-104)||49
10487850|NCT01172938|11637454|FG000|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
10487851|NCT01172938|11637455|FG001|COMPLETED|Active-Treatment Phase (Weeks 52-104)||95
10487852|NCT01172938|11637456|FG002|COMPLETED|Active-Treatment Phase (Weeks 52-104)||100
10527577|NCT01390818|11679700|FG003|COMPLETED|Overall Study||4
10487853|NCT01172938|11637457|FG003|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
10487854|NCT01172938|11637458|FG004|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
10487855|NCT01172938|11637459|FG005|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
10487856|NCT01172938|11637460|FG006|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
10487857|NCT01172938|11637461|FG007|COMPLETED|Active-Treatment Phase (Weeks 52-104)||46
10487858|NCT01172938|11637462|FG008|COMPLETED|Active-Treatment Phase (Weeks 52-104)||45
10487859|NCT01172938|11637454|FG000|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
10487860|NCT01172938|11637455|FG001|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||23
10487861|NCT01172938|11637456|FG002|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||21
10487862|NCT01172938|11637457|FG003|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
10487863|NCT01172938|11637458|FG004|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
10487864|NCT01172938|11637459|FG005|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
10487865|NCT01172938|11637460|FG006|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
10487866|NCT01172938|11637461|FG007|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||15
10487867|NCT01172938|11637462|FG008|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||4
10487868|NCT01172938|11637454|FG000|STARTED|Active-Treatment Phase Weeks (104-156)||0
10487869|NCT01172938|11637455|FG001|STARTED|Active-Treatment Phase Weeks (104-156)||95
10487870|NCT01172938|11637456|FG002|STARTED|Active-Treatment Phase Weeks (104-156)||100
10487871|NCT01172938|11637457|FG003|STARTED|Active-Treatment Phase Weeks (104-156)||0
10487872|NCT01172938|11637458|FG004|STARTED|Active-Treatment Phase Weeks (104-156)||0
10487873|NCT01172938|11637459|FG005|STARTED|Active-Treatment Phase Weeks (104-156)||0
10487874|NCT01172938|11637460|FG006|STARTED|Active-Treatment Phase Weeks (104-156)||0
10487875|NCT01172938|11637461|FG007|STARTED|Active-Treatment Phase Weeks (104-156)||46
10487876|NCT01172938|11637462|FG008|STARTED|Active-Treatment Phase Weeks (104-156)||45
10487877|NCT01172938|11637454|FG000|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
10487878|NCT01172938|11637455|FG001|COMPLETED|Active-Treatment Phase Weeks (104-156)||84
10487879|NCT01172938|11637456|FG002|COMPLETED|Active-Treatment Phase Weeks (104-156)||93
10487880|NCT01172938|11637457|FG003|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
10487881|NCT01172938|11637458|FG004|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
10487882|NCT01172938|11637459|FG005|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
10487883|NCT01172938|11637460|FG006|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
10487884|NCT01172938|11637461|FG007|COMPLETED|Active-Treatment Phase Weeks (104-156)||41
10487885|NCT01172938|11637462|FG008|COMPLETED|Active-Treatment Phase Weeks (104-156)||41
10487886|NCT01172938|11637454|FG000|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
10487887|NCT01172938|11637455|FG001|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||11
10487888|NCT01172938|11637456|FG002|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||7
10487889|NCT01172938|11637457|FG003|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
10487890|NCT01172938|11637458|FG004|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
10487891|NCT01172938|11637459|FG005|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
10487892|NCT01172938|11637460|FG006|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
10487893|NCT01172938|11637461|FG007|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||5
10487894|NCT01172938|11637462|FG008|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||4
10487895|NCT01172938|11637454|FG000|STARTED|Active-Treatment Phase (Weeks 156-208)||0
10487896|NCT01172938|11637455|FG001|STARTED|Active-Treatment Phase (Weeks 156-208)||84
10487897|NCT01172938|11637456|FG002|STARTED|Active-Treatment Phase (Weeks 156-208)||93
10487898|NCT01172938|11637457|FG003|STARTED|Active-Treatment Phase (Weeks 156-208)||0
10487899|NCT01172938|11637458|FG004|STARTED|Active-Treatment Phase (Weeks 156-208)||0
10809847|NCT03812328|11971653|FG002|NOT COMPLETED|Overall Study||1
10809848|NCT03808688|11971663|FG000|STARTED|Overall Study||99
10809849|NCT03808688|11971664|FG001|STARTED|Overall Study||161
10809850|NCT03808688|11971663|FG000|COMPLETED|Overall Study||81
10809851|NCT03808688|11971664|FG001|COMPLETED|Overall Study||138
10809852|NCT03808688|11971663|FG000|NOT COMPLETED|Overall Study||18
10809853|NCT03808688|11971664|FG001|NOT COMPLETED|Overall Study||23
10487900|NCT01172938|11637459|FG005|STARTED|Active-Treatment Phase (Weeks 156-208)||0
10487901|NCT01172938|11637460|FG006|STARTED|Active-Treatment Phase (Weeks 156-208)||0
10487902|NCT01172938|11637461|FG007|STARTED|Active-Treatment Phase (Weeks 156-208)||41
10809860|NCT03822182|11971687|FG000|STARTED|Overall Study||26
10809861|NCT03822182|11971688|FG001|STARTED|Overall Study||25
10487903|NCT01172938|11637462|FG008|STARTED|Active-Treatment Phase (Weeks 156-208)||41
10487904|NCT01172938|11637454|FG000|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
10487905|NCT01172938|11637455|FG001|COMPLETED|Active-Treatment Phase (Weeks 156-208)||75
10487906|NCT01172938|11637456|FG002|COMPLETED|Active-Treatment Phase (Weeks 156-208)||88
10487907|NCT01172938|11637457|FG003|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
10487908|NCT01172938|11637458|FG004|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
10487909|NCT01172938|11637459|FG005|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
10487910|NCT01172938|11637460|FG006|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
10487911|NCT01172938|11637461|FG007|COMPLETED|Active-Treatment Phase (Weeks 156-208)||32
10487912|NCT01172938|11637462|FG008|COMPLETED|Active-Treatment Phase (Weeks 156-208)||34
10487913|NCT01172938|11637454|FG000|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
10487914|NCT01172938|11637455|FG001|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||9
10487915|NCT01172938|11637456|FG002|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||5
10487916|NCT01172938|11637457|FG003|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
10487917|NCT01172938|11637458|FG004|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
10487918|NCT01172938|11637459|FG005|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
10487919|NCT01172938|11637460|FG006|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
10487920|NCT01172938|11637461|FG007|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||9
10487921|NCT01172938|11637462|FG008|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||7
10487922|NCT01172938|11637454|FG000|STARTED|Active-Treatment Phase (Weeks 208-260)||0
10487923|NCT01172938|11637455|FG001|STARTED|Active-Treatment Phase (Weeks 208-260)||75
10487924|NCT01172938|11637456|FG002|STARTED|Active-Treatment Phase (Weeks 208-260)||88
10487925|NCT01172938|11637457|FG003|STARTED|Active-Treatment Phase (Weeks 208-260)||0
10487926|NCT01172938|11637458|FG004|STARTED|Active-Treatment Phase (Weeks 208-260)||0
10487927|NCT01172938|11637459|FG005|STARTED|Active-Treatment Phase (Weeks 208-260)||0
10487928|NCT01172938|11637460|FG006|STARTED|Active-Treatment Phase (Weeks 208-260)||0
10487929|NCT01172938|11637461|FG007|STARTED|Active-Treatment Phase (Weeks 208-260)||32
10487930|NCT01172938|11637462|FG008|STARTED|Active-Treatment Phase (Weeks 208-260)||34
10487931|NCT01172938|11637454|FG000|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
10487932|NCT01172938|11637455|FG001|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
10487933|NCT01172938|11637456|FG002|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
10487934|NCT01172938|11637457|FG003|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
10487935|NCT01172938|11637458|FG004|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
10487936|NCT01172938|11637459|FG005|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
10487937|NCT01172938|11637460|FG006|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
10487938|NCT01172938|11637461|FG007|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||25
10487939|NCT01172938|11637462|FG008|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
10487940|NCT01172938|11637454|FG000|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
10487941|NCT01172938|11637455|FG001|COMPLETED|Active-Treatment Phase (Weeks 208-260)||72
10487942|NCT01172938|11637456|FG002|COMPLETED|Active-Treatment Phase (Weeks 208-260)||80
10487943|NCT01172938|11637457|FG003|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
10487944|NCT01172938|11637458|FG004|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
10487945|NCT01172938|11637459|FG005|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
10487946|NCT01172938|11637460|FG006|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
10487947|NCT01172938|11637461|FG007|COMPLETED|Active-Treatment Phase (Weeks 208-260)||29
10709996|NCT02646423|11875133|FG000|NOT COMPLETED|Overall Study||7
10709997|NCT02646423|11875134|FG001|NOT COMPLETED|Overall Study||8
10487948|NCT01172938|11637462|FG008|COMPLETED|Active-Treatment Phase (Weeks 208-260)||32
10487949|NCT01172938|11637454|FG000|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
10487950|NCT01172938|11637455|FG001|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||3
10487951|NCT01172938|11637456|FG002|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||8
10487952|NCT01172938|11637457|FG003|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
10487953|NCT01172938|11637458|FG004|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
10487954|NCT01172938|11637459|FG005|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
10487955|NCT01172938|11637460|FG006|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
10487956|NCT01172938|11637461|FG007|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||3
10487957|NCT01172938|11637462|FG008|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||2
10487958|NCT01173016|11637480|FG000|STARTED|Overall Study||11
10487959|NCT01173016|11637480|FG000|COMPLETED|Overall Study||10
10487960|NCT01173016|11637480|FG000|NOT COMPLETED|Overall Study||1
10487961|NCT01173029|11637486|FG000|STARTED|Overall Study||61
10487962|NCT01173029|11637487|FG001|STARTED|Overall Study||31
10487963|NCT01173029|11637486|FG000|COMPLETED|Overall Study||61
10487964|NCT01173029|11637487|FG001|COMPLETED|Overall Study||31
10487965|NCT01173029|11637486|FG000|NOT COMPLETED|Overall Study||0
10487966|NCT01173029|11637487|FG001|NOT COMPLETED|Overall Study||0
10487967|NCT01173055|11637504|FG000|STARTED|Period 1 - Day 1 to 49||10
10487968|NCT01173055|11637505|FG001|STARTED|Period 1 - Day 1 to 49||12
10487969|NCT01173055|11637504|FG000|COMPLETED|Period 1 - Day 1 to 49||8
10487970|NCT01173055|11637505|FG001|COMPLETED|Period 1 - Day 1 to 49||10
10487971|NCT01173055|11637504|FG000|NOT COMPLETED|Period 1 - Day 1 to 49||2
10487972|NCT01173055|11637505|FG001|NOT COMPLETED|Period 1 - Day 1 to 49||2
10487973|NCT01173055|11637504|FG000|STARTED|Placebo Washout Period - Day 50 to 63||8
10487974|NCT01173055|11637505|FG001|STARTED|Placebo Washout Period - Day 50 to 63||10
10487975|NCT01173055|11637504|FG000|COMPLETED|Placebo Washout Period - Day 50 to 63||8
10487976|NCT01173055|11637505|FG001|COMPLETED|Placebo Washout Period - Day 50 to 63||10
10487977|NCT01173055|11637504|FG000|NOT COMPLETED|Placebo Washout Period - Day 50 to 63||0
10487978|NCT01173055|11637505|FG001|NOT COMPLETED|Placebo Washout Period - Day 50 to 63||0
10487979|NCT01173055|11637504|FG000|STARTED|Period 2 - Day 64 to 112||8
10487980|NCT01173055|11637505|FG001|STARTED|Period 2 - Day 64 to 112||10
10487981|NCT01173055|11637504|FG000|COMPLETED|Period 2 - Day 64 to 112||8
10487982|NCT01173055|11637505|FG001|COMPLETED|Period 2 - Day 64 to 112||9
10487983|NCT01173055|11637504|FG000|NOT COMPLETED|Period 2 - Day 64 to 112||0
10487984|NCT01173055|11637505|FG001|NOT COMPLETED|Period 2 - Day 64 to 112||1
10487985|NCT01173120|11637511|FG000|STARTED|Overall Study||62
10487986|NCT01173120|11637511|FG000|Switched Back to Main Study|Overall Study||57
10487987|NCT01173120|11637511|FG000|Discontinued ACP Substudy and Main Study|Overall Study||5
10487988|NCT01173120|11637511|FG000|COMPLETED|Overall Study||0
10487989|NCT01173120|11637511|FG000|NOT COMPLETED|Overall Study||62
10487990|NCT01173159|11637517|FG000|STARTED|Overall Study||10
10487991|NCT01173159|11637517|FG000|COMPLETED|Overall Study||10
10487992|NCT01173159|11637517|FG000|NOT COMPLETED|Overall Study||0
10487993|NCT01173211|11637527|FG000|STARTED|Overall Study||48
10487994|NCT01173211|11637528|FG001|STARTED|Overall Study||45
10709998|NCT02646449|11875142|FG000|STARTED|Overall Study||4
10709999|NCT02646449|11875143|FG001|STARTED|Overall Study||3
10710000|NCT02646449|11875142|FG000|COMPLETED|Overall Study||4
10710001|NCT02646449|11875143|FG001|COMPLETED|Overall Study||3
10487995|NCT01173211|11637529|FG002|STARTED|Overall Study||46
10487996|NCT01173211|11637530|FG003|STARTED|Overall Study||15
10487997|NCT01173211|11637531|FG004|STARTED|Overall Study||16
10487998|NCT01173211|11637532|FG005|STARTED|Overall Study||13
10487999|NCT01173211|11637527|FG000|COMPLETED|Overall Study||46
10488000|NCT01173211|11637528|FG001|COMPLETED|Overall Study||44
10488001|NCT01173211|11637529|FG002|COMPLETED|Overall Study||44
10488002|NCT01173211|11637530|FG003|COMPLETED|Overall Study||15
10488003|NCT01173211|11637531|FG004|COMPLETED|Overall Study||16
10488004|NCT01173211|11637532|FG005|COMPLETED|Overall Study||13
10488005|NCT01173211|11637527|FG000|NOT COMPLETED|Overall Study||2
10488006|NCT01173211|11637528|FG001|NOT COMPLETED|Overall Study||1
10488007|NCT01173211|11637529|FG002|NOT COMPLETED|Overall Study||2
10488008|NCT01173211|11637530|FG003|NOT COMPLETED|Overall Study||0
10488009|NCT01173211|11637531|FG004|NOT COMPLETED|Overall Study||0
10488010|NCT01173211|11637532|FG005|NOT COMPLETED|Overall Study||0
10488011|NCT01173471|11637550|FG000|STARTED|Overall Study|Randomized|6
10488012|NCT01173471|11637551|FG001|STARTED|Overall Study|Randomized|7
10488013|NCT01173471|11637552|FG002|STARTED|Overall Study|Randomized|18
10488014|NCT01173471|11637553|FG003|STARTED|Overall Study|Randomized|19
10488015|NCT01173471|11637550|FG000|Received Treatment|Overall Study||6
10488016|NCT01173471|11637551|FG001|Received Treatment|Overall Study||7
10488017|NCT01173471|11637552|FG002|Received Treatment|Overall Study||18
10488018|NCT01173471|11637553|FG003|Received Treatment|Overall Study||19
10488019|NCT01173471|11637550|FG000|Completed Treatment|Overall Study||4
10488020|NCT01173471|11637551|FG001|Completed Treatment|Overall Study||7
10488021|NCT01173471|11637552|FG002|Completed Treatment|Overall Study||15
10488022|NCT01173471|11637553|FG003|Completed Treatment|Overall Study||18
10488023|NCT01173471|11637550|FG000|COMPLETED|Overall Study|Completed study|4
10488024|NCT01173471|11637551|FG001|COMPLETED|Overall Study|Completed study|7
10488025|NCT01173471|11637552|FG002|COMPLETED|Overall Study|Completed study|15
10488026|NCT01173471|11637553|FG003|COMPLETED|Overall Study|Completed study|18
10488027|NCT01173471|11637550|FG000|NOT COMPLETED|Overall Study||2
10488028|NCT01173471|11637551|FG001|NOT COMPLETED|Overall Study||0
10488029|NCT01173471|11637552|FG002|NOT COMPLETED|Overall Study||3
10488030|NCT01173471|11637553|FG003|NOT COMPLETED|Overall Study||1
10488031|NCT01173523|11637565|FG000|STARTED|Overall Study||13
10488032|NCT01173523|11637566|FG001|STARTED|Overall Study||12
10488033|NCT01173523|11637565|FG000|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
10488034|NCT01173523|11637566|FG001|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
10488035|NCT01173523|11637565|FG000|NOT COMPLETED|Overall Study||13
10488036|NCT01173523|11637566|FG001|NOT COMPLETED|Overall Study||12
10488037|NCT01173601|11637576|FG000|STARTED|Confirmation (CF) Phase, 3 Weeks||1416
10488038|NCT01173601|11637577|FG001|STARTED|Confirmation (CF) Phase, 3 Weeks||0
10488039|NCT01173601|11637578|FG002|STARTED|Confirmation (CF) Phase, 3 Weeks||0
10488040|NCT01173601|11637579|FG003|STARTED|Confirmation (CF) Phase, 3 Weeks||0
10488041|NCT01173601|11637580|FG004|STARTED|Confirmation (CF) Phase, 3 Weeks||0
10488042|NCT01173601|11637576|FG000|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase had the option to enter the DC phase.|21
10488043|NCT01173601|11637577|FG001|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
10488044|NCT01173601|11637578|FG002|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
10488045|NCT01173601|11637579|FG003|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
10488046|NCT01173601|11637580|FG004|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
10488047|NCT01173601|11637576|FG000|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the AT Phase.|1328
10488048|NCT01173601|11637577|FG001|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
10488049|NCT01173601|11637578|FG002|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
10488050|NCT01173601|11637579|FG003|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
10488051|NCT01173601|11637580|FG004|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
10488052|NCT01173601|11637576|FG000|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||88
10488053|NCT01173601|11637577|FG001|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
10488054|NCT01173601|11637578|FG002|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
10488055|NCT01173601|11637579|FG003|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
10488056|NCT01173601|11637580|FG004|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
10488057|NCT01173601|11637576|FG000|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
10488058|NCT01173601|11637577|FG001|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||231
10488059|NCT01173601|11637578|FG002|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||230
10488060|NCT01173601|11637579|FG003|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||240
10488061|NCT01173601|11637580|FG004|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||627
10488062|NCT01173601|11637576|FG000|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
10488063|NCT01173601|11637577|FG001|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the taper DC Phase.|100
10488064|NCT01173601|11637578|FG002|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the taper DC Phase.|107
10488065|NCT01173601|11637579|FG003|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
10488066|NCT01173601|11637580|FG004|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
10488067|NCT01173601|11637576|FG000|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
10488068|NCT01173601|11637577|FG001|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|100
10488069|NCT01173601|11637578|FG002|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|108
10488070|NCT01173601|11637579|FG003|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|221
10488071|NCT01173601|11637580|FG004|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|586
10488072|NCT01173601|11637576|FG000|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
10488073|NCT01173601|11637577|FG001|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||196
10488074|NCT01173601|11637578|FG002|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||197
10488075|NCT01173601|11637579|FG003|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||210
10488076|NCT01173601|11637580|FG004|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||559
10488077|NCT01173601|11637576|FG000|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
10488078|NCT01173601|11637577|FG001|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
10488079|NCT01173601|11637578|FG002|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||33
10488080|NCT01173601|11637579|FG003|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||30
10488081|NCT01173601|11637580|FG004|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||68
10488082|NCT01173653|11637600|FG000|STARTED|Overall Study||109
10488083|NCT01173653|11637601|FG001|STARTED|Overall Study||90
10488084|NCT01173653|11637600|FG000|COMPLETED|Overall Study||56
10488085|NCT01173653|11637601|FG001|COMPLETED|Overall Study||49
10488086|NCT01173653|11637600|FG000|NOT COMPLETED|Overall Study||53
10488087|NCT01173653|11637601|FG001|NOT COMPLETED|Overall Study||41
10488088|NCT01173679|11637607|FG000|STARTED|Overall Study||10
10488089|NCT01173679|11637607|FG000|COMPLETED|Overall Study||9
10488090|NCT01173679|11637607|FG000|NOT COMPLETED|Overall Study||1
10488091|NCT01173692|11637614|FG000|STARTED|Overall Study||22
10488092|NCT01173692|11637615|FG001|STARTED|Overall Study||25
10488093|NCT01173692|11637614|FG000|COMPLETED|Overall Study||20
10488094|NCT01173692|11637615|FG001|COMPLETED|Overall Study||20
10488095|NCT01173692|11637614|FG000|NOT COMPLETED|Overall Study||2
10488096|NCT01173692|11637615|FG001|NOT COMPLETED|Overall Study||5
10488097|NCT01173718|11637621|FG000|STARTED|Overall Study||138
10488098|NCT01173718|11637621|FG000|COMPLETED|Overall Study||94
10488099|NCT01173718|11637621|FG000|NOT COMPLETED|Overall Study||44
10488100|NCT01173848|11637627|FG000|STARTED|Overall Study||8
10488101|NCT01173848|11637628|FG001|STARTED|Overall Study||11
10488102|NCT01173848|11637627|FG000|COMPLETED|Overall Study||4
10488103|NCT01173848|11637628|FG001|COMPLETED|Overall Study||3
10488104|NCT01173848|11637627|FG000|NOT COMPLETED|Overall Study||4
10488105|NCT01173848|11637628|FG001|NOT COMPLETED|Overall Study||8
10488106|NCT01173874|11637635|FG000|STARTED|Overall Study||56
10488107|NCT01173874|11637636|FG001|STARTED|Overall Study||64
10488108|NCT01173874|11637635|FG000|COMPLETED|Overall Study||33
10488109|NCT01173874|11637636|FG001|COMPLETED|Overall Study||41
10488110|NCT01173874|11637635|FG000|NOT COMPLETED|Overall Study||23
10488111|NCT01173874|11637636|FG001|NOT COMPLETED|Overall Study||23
10527578|NCT01390818|11679701|FG004|COMPLETED|Overall Study||4
10527579|NCT01390818|11679702|FG005|COMPLETED|Overall Study||3
10527580|NCT01390818|11679703|FG006|COMPLETED|Overall Study||19
10527581|NCT01390818|11679704|FG007|COMPLETED|Overall Study||14
10527582|NCT01390818|11679705|FG008|COMPLETED|Overall Study||3
10527583|NCT01390818|11679706|FG009|COMPLETED|Overall Study||3
10527584|NCT01390818|11679707|FG010|COMPLETED|Overall Study||4
10527585|NCT01390818|11679708|FG011|COMPLETED|Overall Study||26
10527586|NCT01390818|11679709|FG012|COMPLETED|Overall Study||24
10527587|NCT01390818|11679710|FG013|COMPLETED|Overall Study||18
10527588|NCT01390818|11679711|FG014|COMPLETED|Overall Study||15
10527589|NCT01390818|11679697|FG000|NOT COMPLETED|Overall Study||0
10527590|NCT01390818|11679698|FG001|NOT COMPLETED|Overall Study||0
10527591|NCT01390818|11679699|FG002|NOT COMPLETED|Overall Study||0
10527592|NCT01390818|11679700|FG003|NOT COMPLETED|Overall Study||0
10527593|NCT01390818|11679701|FG004|NOT COMPLETED|Overall Study||0
10527594|NCT01390818|11679702|FG005|NOT COMPLETED|Overall Study||0
10527595|NCT01390818|11679703|FG006|NOT COMPLETED|Overall Study||0
10527596|NCT01390818|11679704|FG007|NOT COMPLETED|Overall Study||0
10527597|NCT01390818|11679705|FG008|NOT COMPLETED|Overall Study||0
10527598|NCT01390818|11679706|FG009|NOT COMPLETED|Overall Study||0
10527599|NCT01390818|11679707|FG010|NOT COMPLETED|Overall Study||0
10527600|NCT01390818|11679708|FG011|NOT COMPLETED|Overall Study||0
10527601|NCT01390818|11679709|FG012|NOT COMPLETED|Overall Study||0
10527602|NCT01390818|11679710|FG013|NOT COMPLETED|Overall Study||0
10527603|NCT01390818|11679711|FG014|NOT COMPLETED|Overall Study||0
10527604|NCT01390844|11679815|FG000|STARTED|Treatment Phase||133
10527605|NCT01390844|11679816|FG001|STARTED|Treatment Phase||65
10527606|NCT01390844|11679817|FG002|STARTED|Treatment Phase||57
10527607|NCT01390844|11679818|FG003|STARTED|Treatment Phase||27
10527608|NCT01390844|11679815|FG000|Followed Good Clinical Practice (GCP)|Treatment Phase||133
10527609|NCT01390844|11679816|FG001|Followed Good Clinical Practice (GCP)|Treatment Phase||65
10527610|NCT01390844|11679817|FG002|Followed Good Clinical Practice (GCP)|Treatment Phase||47
10527611|NCT01390844|11679818|FG003|Followed Good Clinical Practice (GCP)|Treatment Phase||24
10527612|NCT01390844|11679815|FG000|COMPLETED|Treatment Phase||93
10527613|NCT01390844|11679816|FG001|COMPLETED|Treatment Phase||37
10527614|NCT01390844|11679817|FG002|COMPLETED|Treatment Phase||26
10527615|NCT01390844|11679818|FG003|COMPLETED|Treatment Phase||8
10527616|NCT01390844|11679815|FG000|NOT COMPLETED|Treatment Phase||40
10527617|NCT01390844|11679816|FG001|NOT COMPLETED|Treatment Phase||28
10527618|NCT01390844|11679817|FG002|NOT COMPLETED|Treatment Phase||31
10527619|NCT01390844|11679818|FG003|NOT COMPLETED|Treatment Phase||19
10527620|NCT01390844|11679815|FG000|STARTED|Follow-Up Phase||93
10527621|NCT01390844|11679816|FG001|STARTED|Follow-Up Phase||37
10527622|NCT01390844|11679817|FG002|STARTED|Follow-Up Phase||26
10527623|NCT01390844|11679818|FG003|STARTED|Follow-Up Phase||8
10527624|NCT01390844|11679815|FG000|COMPLETED|Follow-Up Phase||92
10527625|NCT01390844|11679816|FG001|COMPLETED|Follow-Up Phase||36
10527626|NCT01390844|11679817|FG002|COMPLETED|Follow-Up Phase||25
10527627|NCT01390844|11679818|FG003|COMPLETED|Follow-Up Phase||8
10527628|NCT01390844|11679815|FG000|NOT COMPLETED|Follow-Up Phase||1
10527629|NCT01390844|11679816|FG001|NOT COMPLETED|Follow-Up Phase||1
10527630|NCT01390844|11679817|FG002|NOT COMPLETED|Follow-Up Phase||1
10527631|NCT01390844|11679818|FG003|NOT COMPLETED|Follow-Up Phase||0
10527632|NCT01390857|11679828|FG000|STARTED|Overall Study||379
10527633|NCT01390857|11679828|FG000|COMPLETED|Overall Study||369
10527634|NCT01390857|11679828|FG000|NOT COMPLETED|Overall Study||10
10527635|NCT01390870|11679832|FG000|STARTED|Overall Study||400
10527636|NCT01390870|11679832|FG000|COMPLETED|Overall Study||400
10527637|NCT01390870|11679832|FG000|NOT COMPLETED|Overall Study||0
10527638|NCT01390909|11679842|FG000|STARTED|Overall Study||3454
10527639|NCT01390909|11679843|FG001|STARTED|Overall Study||3552
10527640|NCT01390909|11679844|FG002|STARTED|Overall Study||3552
10527641|NCT01390909|11679845|FG003|STARTED|Overall Study||602
10527642|NCT01390909|11679846|FG004|STARTED|Overall Study||613
10527643|NCT01390909|11679847|FG005|STARTED|Overall Study||613
10527644|NCT01390909|11679842|FG000|Participants in Subgroup|Overall Study||0
10527645|NCT01390909|11679843|FG001|Participants in Subgroup|Overall Study||3454
10527646|NCT01390909|11679844|FG002|Participants in Subgroup|Overall Study||0
10527647|NCT01390909|11679845|FG003|Participants in Subgroup|Overall Study||0
10527648|NCT01390909|11679846|FG004|Participants in Subgroup|Overall Study||602
10527649|NCT01390909|11679847|FG005|Participants in Subgroup|Overall Study||0
10527650|NCT01390909|11679842|FG000|COMPLETED|Overall Study||3454
10527651|NCT01390909|11679843|FG001|COMPLETED|Overall Study||3552
10527652|NCT01390909|11679844|FG002|COMPLETED|Overall Study||3552
10527653|NCT01390909|11679845|FG003|COMPLETED|Overall Study||602
10527654|NCT01390909|11679846|FG004|COMPLETED|Overall Study||613
10527655|NCT01390909|11679847|FG005|COMPLETED|Overall Study||613
10527656|NCT01390909|11679842|FG000|NOT COMPLETED|Overall Study||0
10527657|NCT01390909|11679843|FG001|NOT COMPLETED|Overall Study||0
10527658|NCT01390909|11679844|FG002|NOT COMPLETED|Overall Study||0
10527659|NCT01390909|11679845|FG003|NOT COMPLETED|Overall Study||0
10527660|NCT01390909|11679846|FG004|NOT COMPLETED|Overall Study||0
10527661|NCT01390909|11679847|FG005|NOT COMPLETED|Overall Study||0
10527662|NCT01390948|11679868|FG000|STARTED|Overall Study||59
10527663|NCT01390948|11679869|FG001|STARTED|Overall Study||62
10527664|NCT01390948|11679870|FG002|STARTED|Overall Study||3
10527665|NCT01390948|11679868|FG000|Treated|Overall Study||56
10527666|NCT01390948|11679869|FG001|Treated|Overall Study||60
10527667|NCT01390948|11679870|FG002|Treated|Overall Study||3
10488112|NCT01174004|11637644|FG000|STARTED|Overall Study||94
10488113|NCT01174004|11637645|FG001|STARTED|Overall Study||105
10488114|NCT01174004|11637644|FG000|COMPLETED|Overall Study||87
10488115|NCT01174004|11637645|FG001|COMPLETED|Overall Study||89
10488116|NCT01174004|11637644|FG000|NOT COMPLETED|Overall Study||7
10488117|NCT01174004|11637645|FG001|NOT COMPLETED|Overall Study||16
10488118|NCT01174030|11637656|FG000|STARTED|Overall Study||53
10488119|NCT01174030|11637657|FG001|STARTED|Overall Study||54
10488120|NCT01174030|11637658|FG002|STARTED|Overall Study||54
10488121|NCT01174030|11637659|FG003|STARTED|Overall Study||55
10488122|NCT01174030|11637660|FG004|STARTED|Overall Study||53
10488123|NCT01174030|11637656|FG000|COMPLETED|Overall Study||51
10488124|NCT01174030|11637657|FG001|COMPLETED|Overall Study||52
10488125|NCT01174030|11637658|FG002|COMPLETED|Overall Study||52
10488126|NCT01174030|11637659|FG003|COMPLETED|Overall Study||53
10488127|NCT01174030|11637660|FG004|COMPLETED|Overall Study||52
10488128|NCT01174030|11637656|FG000|NOT COMPLETED|Overall Study||2
10488129|NCT01174030|11637657|FG001|NOT COMPLETED|Overall Study||2
10488130|NCT01174030|11637658|FG002|NOT COMPLETED|Overall Study||2
10488131|NCT01174030|11637659|FG003|NOT COMPLETED|Overall Study||2
10488132|NCT01174030|11637660|FG004|NOT COMPLETED|Overall Study||1
10488133|NCT01174043|11637672|FG000|STARTED|Overall Study||11
10488134|NCT01174043|11637672|FG000|COMPLETED|Overall Study||0
10488135|NCT01174043|11637672|FG000|NOT COMPLETED|Overall Study||11
10488136|NCT01174082|11637678|FG000|STARTED|Overall Study||1
10488137|NCT01174082|11637679|FG001|STARTED|Overall Study||1
10488138|NCT01174082|11637678|FG000|COMPLETED|Overall Study||1
10488139|NCT01174082|11637679|FG001|COMPLETED|Overall Study||1
10488140|NCT01174082|11637678|FG000|NOT COMPLETED|Overall Study||0
10488141|NCT01174082|11637679|FG001|NOT COMPLETED|Overall Study||0
10488142|NCT01174160|11637687|FG000|STARTED|Overall Study||61
10488143|NCT01174160|11637688|FG001|STARTED|Overall Study||62
10488144|NCT01174160|11637687|FG000|Discontinued Pre Dose|Overall Study||6
10488145|NCT01174160|11637688|FG001|Discontinued Pre Dose|Overall Study||6
10488146|NCT01174160|11637687|FG000|Dosed|Overall Study||55
10488147|NCT01174160|11637688|FG001|Dosed|Overall Study||56
10488148|NCT01174160|11637687|FG000|Discontinued Post Dose|Overall Study||2
10488149|NCT01174160|11637688|FG001|Discontinued Post Dose|Overall Study||0
10488150|NCT01174160|11637687|FG000|COMPLETED|Overall Study||53
10488151|NCT01174160|11637688|FG001|COMPLETED|Overall Study||56
10488152|NCT01174160|11637687|FG000|NOT COMPLETED|Overall Study||8
10488153|NCT01174160|11637688|FG001|NOT COMPLETED|Overall Study||6
10488154|NCT01174173|11637694|FG000|STARTED|Overall Study||11
10488155|NCT01174173|11637694|FG000|COMPLETED|Overall Study||10
10488156|NCT01174173|11637694|FG000|NOT COMPLETED|Overall Study||1
10488157|NCT01174186|11637701|FG000|STARTED|Overall Study|Patients were included over three years|15
10488158|NCT01174186|11637702|FG001|STARTED|Overall Study||15
10488159|NCT01174186|11637701|FG000|COMPLETED|Overall Study||15
10488160|NCT01174186|11637702|FG001|COMPLETED|Overall Study||12
10488161|NCT01174186|11637701|FG000|NOT COMPLETED|Overall Study||0
10488162|NCT01174186|11637702|FG001|NOT COMPLETED|Overall Study||3
10488163|NCT01174238|11637708|FG000|STARTED|Overall Study||38
10488164|NCT01174238|11637708|FG000|Participants That Underwent FLT-PET Scan|Overall Study||6
10488165|NCT01174238|11637708|FG000|COMPLETED|Overall Study||36
10488166|NCT01174238|11637708|FG000|NOT COMPLETED|Overall Study||2
10488167|NCT01174264|11637718|FG000|STARTED|Single Dose Pharmacokinetics||23
10488168|NCT01174264|11637719|FG001|STARTED|Single Dose Pharmacokinetics||20
10488169|NCT01174264|11637720|FG002|STARTED|Single Dose Pharmacokinetics||20
10488170|NCT01174264|11637718|FG000|COMPLETED|Single Dose Pharmacokinetics||22
10488171|NCT01174264|11637719|FG001|COMPLETED|Single Dose Pharmacokinetics||20
10488172|NCT01174264|11637720|FG002|COMPLETED|Single Dose Pharmacokinetics||18
10488173|NCT01174264|11637718|FG000|NOT COMPLETED|Single Dose Pharmacokinetics||1
10488174|NCT01174264|11637719|FG001|NOT COMPLETED|Single Dose Pharmacokinetics||0
10488175|NCT01174264|11637720|FG002|NOT COMPLETED|Single Dose Pharmacokinetics||2
10710002|NCT02646449|11875142|FG000|NOT COMPLETED|Overall Study||0
10710003|NCT02646449|11875143|FG001|NOT COMPLETED|Overall Study||0
10710004|NCT02646566|11875152|FG000|STARTED|Overall Study||237
10710005|NCT02646566|11875153|FG001|STARTED|Overall Study||230
10710006|NCT02646566|11875154|FG002|STARTED|Overall Study||235
10710007|NCT02646566|11875152|FG000|COMPLETED|Overall Study||231
10710008|NCT02646566|11875153|FG001|COMPLETED|Overall Study||226
10710009|NCT02646566|11875154|FG002|COMPLETED|Overall Study||230
10488176|NCT01174264|11637718|FG000|STARTED|Steady-state Pharmacokinetics|Includes 22 patients from period 1 fasting arm and 9 patients from period 1 high-fat arm|31
10488177|NCT01174264|11637719|FG001|STARTED|Steady-state Pharmacokinetics|Patients in period 2 were randomized to fasting vs. fed state only.|0
10488178|NCT01174264|11637720|FG002|STARTED|Steady-state Pharmacokinetics|Includes 11 patients from period 1 high-fat arm and 18 patients from period 1 low-fat arm|29
10488179|NCT01174264|11637718|FG000|COMPLETED|Steady-state Pharmacokinetics||25
10488180|NCT01174264|11637719|FG001|COMPLETED|Steady-state Pharmacokinetics||0
10488181|NCT01174264|11637720|FG002|COMPLETED|Steady-state Pharmacokinetics||27
10488182|NCT01174264|11637718|FG000|NOT COMPLETED|Steady-state Pharmacokinetics||6
10488183|NCT01174264|11637719|FG001|NOT COMPLETED|Steady-state Pharmacokinetics||0
10488184|NCT01174264|11637720|FG002|NOT COMPLETED|Steady-state Pharmacokinetics||2
10488185|NCT01174342|11637728|FG000|STARTED|Overall Study||30
10488186|NCT01174342|11637728|FG000|COMPLETED|Overall Study||26
10710010|NCT02646566|11875152|FG000|NOT COMPLETED|Overall Study||6
10710011|NCT02646566|11875153|FG001|NOT COMPLETED|Overall Study||4
10710012|NCT02646566|11875154|FG002|NOT COMPLETED|Overall Study||5
10488187|NCT01174342|11637728|FG000|NOT COMPLETED|Overall Study||4
10488188|NCT01174446|11637732|FG000|STARTED|Part 1 -Pharmacokinetic Crossover||14
10488189|NCT01174446|11637733|FG001|STARTED|Part 1 -Pharmacokinetic Crossover||14
10488190|NCT01174446|11637734|FG002|STARTED|Part 1 -Pharmacokinetic Crossover||0
10488191|NCT01174446|11637735|FG003|STARTED|Part 1 -Pharmacokinetic Crossover||0
10488192|NCT01174446|11637732|FG000|COMPLETED|Part 1 -Pharmacokinetic Crossover|BAX326 was mistakenly infused for second PK infusion (ie should have been BeneFIX) for 1 participant|14
10488193|NCT01174446|11637733|FG001|COMPLETED|Part 1 -Pharmacokinetic Crossover||14
10488194|NCT01174446|11637734|FG002|COMPLETED|Part 1 -Pharmacokinetic Crossover||0
10488195|NCT01174446|11637735|FG003|COMPLETED|Part 1 -Pharmacokinetic Crossover||0
10488196|NCT01174446|11637732|FG000|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
10488197|NCT01174446|11637733|FG001|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
10488198|NCT01174446|11637734|FG002|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
10488199|NCT01174446|11637735|FG003|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
10488200|NCT01174446|11637732|FG000|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|In Study Part 2 all 14 participants received Prophylaxis|14
10488201|NCT01174446|11637733|FG001|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|In Study Part 2 all 14 participants received Prophylaxis|14
10488202|NCT01174446|11637734|FG002|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|This group only participated in Study Part 2|31
10488203|NCT01174446|11637735|FG003|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|This group only participated in Study Part 2|14
10488204|NCT01174446|11637732|FG000|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
10488205|NCT01174446|11637733|FG001|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
10488206|NCT01174446|11637734|FG002|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||29
10488207|NCT01174446|11637735|FG003|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
10488208|NCT01174446|11637732|FG000|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
10488209|NCT01174446|11637733|FG001|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
10488210|NCT01174446|11637734|FG002|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||2
10488211|NCT01174446|11637735|FG003|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
10488212|NCT01174446|11637732|FG000|STARTED|Part 3 -Pharmacokinetic BAX326 Only|Includes all participants who completed Part 1|14
10488213|NCT01174446|11637733|FG001|STARTED|Part 3 -Pharmacokinetic BAX326 Only|Includes all participants who completed Part 1|14
10488214|NCT01174446|11637734|FG002|STARTED|Part 3 -Pharmacokinetic BAX326 Only||0
10488215|NCT01174446|11637735|FG003|STARTED|Part 3 -Pharmacokinetic BAX326 Only||0
10488216|NCT01174446|11637732|FG000|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||13
10488217|NCT01174446|11637733|FG001|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||13
10488218|NCT01174446|11637734|FG002|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
10488219|NCT01174446|11637735|FG003|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
10488220|NCT01174446|11637732|FG000|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||1
10488221|NCT01174446|11637733|FG001|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||1
10710013|NCT02646618|11875164|FG000|STARTED|Overall Study||167
10710014|NCT02646618|11875165|FG001|STARTED|Overall Study||162
10488222|NCT01174446|11637734|FG002|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
10488297|NCT01175135|11637879|FG000|Treated|Overall Study||74
10488223|NCT01174446|11637735|FG003|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
10488224|NCT01174459|11637782|FG000|STARTED|Overall Study|Registered patients|571
10488225|NCT01174459|11637782|FG000|COMPLETED|Overall Study|Case report form (CRF) collected|566
10488226|NCT01174459|11637782|FG000|NOT COMPLETED|Overall Study||5
10488227|NCT01174550|11637788|FG000|STARTED|Overall Study||5007
10488228|NCT01174550|11637789|FG001|STARTED|Overall Study||4996
10488229|NCT01174550|11637788|FG000|COMPLETED|Overall Study||3737
10488230|NCT01174550|11637789|FG001|COMPLETED|Overall Study||4123
10488231|NCT01174550|11637788|FG000|NOT COMPLETED|Overall Study||1270
10488232|NCT01174550|11637789|FG001|NOT COMPLETED|Overall Study||873
10488233|NCT01174576|11637795|FG000|STARTED|Overall Study|All participants received all interventions without exception.|16
10488234|NCT01174576|11637795|FG000|COMPLETED|Overall Study||16
10488235|NCT01174576|11637795|FG000|NOT COMPLETED|Overall Study||0
10488236|NCT01174784|11637808|FG000|STARTED|Overall Study||88
10488237|NCT01174784|11637808|FG000|COMPLETED|Overall Study|While 88 subjects did complete the procedure, 4 were considered screen failures post-procedure.|84
10488238|NCT01174784|11637808|FG000|NOT COMPLETED|Overall Study||4
10488239|NCT01174823|11637815|FG000|STARTED|Overall Study||122
10488240|NCT01174823|11637816|FG001|STARTED|Overall Study||123
10488241|NCT01174823|11637815|FG000|COMPLETED|Overall Study||115
10488242|NCT01174823|11637816|FG001|COMPLETED|Overall Study||119
10488243|NCT01174823|11637815|FG000|NOT COMPLETED|Overall Study||7
10488244|NCT01174823|11637816|FG001|NOT COMPLETED|Overall Study||4
10488245|NCT01175005|11637822|FG000|STARTED|Overall Study||62
10488246|NCT01175005|11637822|FG000|COMPLETED|Overall Study||62
10488247|NCT01175005|11637822|FG000|NOT COMPLETED|Overall Study||0
10488248|NCT01175018|11637829|FG000|STARTED|Overall Study||15
10488249|NCT01175018|11637830|FG001|STARTED|Overall Study||15
10488250|NCT01175018|11637829|FG000|COMPLETED|Overall Study||12
10488251|NCT01175018|11637830|FG001|COMPLETED|Overall Study||14
10488252|NCT01175018|11637829|FG000|NOT COMPLETED|Overall Study||3
10488253|NCT01175018|11637830|FG001|NOT COMPLETED|Overall Study||1
10488254|NCT01175031|11637838|FG000|STARTED|Overall Study||45
10488255|NCT01175031|11637838|FG000|COMPLETED|Overall Study||45
10488256|NCT01175031|11637838|FG000|NOT COMPLETED|Overall Study||0
10488257|NCT01175083|11637852|FG000|STARTED|Primary Epoch||50
10488258|NCT01175083|11637853|FG001|STARTED|Primary Epoch||50
10710015|NCT02646618|11875164|FG000|6 Month Follow-up|Overall Study||152
10710016|NCT02646618|11875165|FG001|6 Month Follow-up|Overall Study||150
10710017|NCT02646618|11875164|FG000|COMPLETED|Overall Study||157
10488259|NCT01175083|11637854|FG002|STARTED|Primary Epoch||50
10488260|NCT01175083|11637855|FG003|STARTED|Primary Epoch||50
10488261|NCT01175083|11637856|FG004|STARTED|Primary Epoch||50
10488262|NCT01175083|11637857|FG005|STARTED|Primary Epoch||50
10488263|NCT01175083|11637852|FG000|COMPLETED|Primary Epoch||50
10710018|NCT02646618|11875165|FG001|COMPLETED|Overall Study||148
10710019|NCT02646618|11875164|FG000|NOT COMPLETED|Overall Study||10
10710020|NCT02646618|11875165|FG001|NOT COMPLETED|Overall Study||14
10710021|NCT02646761|11875175|FG000|STARTED|Overall Study||18
10710022|NCT02646761|11875176|FG001|STARTED|Overall Study||20
10710023|NCT02646761|11875175|FG000|Subject Withdrew Before Baseline|Overall Study||5
10488264|NCT01175083|11637853|FG001|COMPLETED|Primary Epoch||50
10710024|NCT02646761|11875176|FG001|Subject Withdrew Before Baseline|Overall Study||8
10710025|NCT02646761|11875175|FG000|Baseline Assessment|Overall Study||13
10710026|NCT02646761|11875176|FG001|Baseline Assessment|Overall Study||12
10488265|NCT01175083|11637854|FG002|COMPLETED|Primary Epoch||50
10488266|NCT01175083|11637855|FG003|COMPLETED|Primary Epoch||50
10488267|NCT01175083|11637856|FG004|COMPLETED|Primary Epoch||50
10488268|NCT01175083|11637857|FG005|COMPLETED|Primary Epoch||47
10488269|NCT01175083|11637852|FG000|NOT COMPLETED|Primary Epoch||0
10488270|NCT01175083|11637853|FG001|NOT COMPLETED|Primary Epoch||0
10488271|NCT01175083|11637854|FG002|NOT COMPLETED|Primary Epoch||0
10488272|NCT01175083|11637855|FG003|NOT COMPLETED|Primary Epoch||0
10488273|NCT01175083|11637856|FG004|NOT COMPLETED|Primary Epoch||0
10488274|NCT01175083|11637857|FG005|NOT COMPLETED|Primary Epoch||3
10488275|NCT01175083|11637852|FG000|STARTED|Booster Epoch|One subject died between both Epochs and hence did not participate in the Booster Epoch.|49
10488276|NCT01175083|11637853|FG001|STARTED|Booster Epoch|One subject died between both Epochs and hence did not participate in the Booster Epoch.|49
10488277|NCT01175083|11637854|FG002|STARTED|Booster Epoch||50
10488278|NCT01175083|11637855|FG003|STARTED|Booster Epoch||50
10488279|NCT01175083|11637856|FG004|STARTED|Booster Epoch|No subjects participated in the Booster Epoch, as no booster dose was planned per protocol.|0
10488280|NCT01175083|11637857|FG005|STARTED|Booster Epoch|No subjects participated in the Booster Epoch, as no booster dose was planned per protocol.|0
10488281|NCT01175083|11637852|FG000|COMPLETED|Booster Epoch||49
10488282|NCT01175083|11637853|FG001|COMPLETED|Booster Epoch||49
10488283|NCT01175083|11637854|FG002|COMPLETED|Booster Epoch||49
10488284|NCT01175083|11637855|FG003|COMPLETED|Booster Epoch||49
10488285|NCT01175083|11637856|FG004|COMPLETED|Booster Epoch||0
10488286|NCT01175083|11637857|FG005|COMPLETED|Booster Epoch||0
10488287|NCT01175083|11637852|FG000|NOT COMPLETED|Booster Epoch||0
10488288|NCT01175083|11637853|FG001|NOT COMPLETED|Booster Epoch||0
10488289|NCT01175083|11637854|FG002|NOT COMPLETED|Booster Epoch||1
10488290|NCT01175083|11637855|FG003|NOT COMPLETED|Booster Epoch||1
10488291|NCT01175083|11637856|FG004|NOT COMPLETED|Booster Epoch||0
10488292|NCT01175083|11637857|FG005|NOT COMPLETED|Booster Epoch||0
10488293|NCT01175135|11637879|FG000|STARTED|Overall Study||74
10488294|NCT01175135|11637880|FG001|STARTED|Overall Study||74
10488295|NCT01175135|11637881|FG002|STARTED|Overall Study||37
10488296|NCT01175135|11637882|FG003|STARTED|Overall Study||74
10488298|NCT01175135|11637880|FG001|Treated|Overall Study||74
10488299|NCT01175135|11637881|FG002|Treated|Overall Study||36
10488300|NCT01175135|11637882|FG003|Treated|Overall Study||74
10488301|NCT01175135|11637879|FG000|Analyzed for Efficacy|Overall Study||74
10488302|NCT01175135|11637880|FG001|Analyzed for Efficacy|Overall Study||73
10488303|NCT01175135|11637881|FG002|Analyzed for Efficacy|Overall Study||34
10488304|NCT01175135|11637882|FG003|Analyzed for Efficacy|Overall Study||73
10488305|NCT01175135|11637879|FG000|COMPLETED|Overall Study||58
10710027|NCT02646761|11875175|FG000|5-week Assessment|Overall Study||12
10710028|NCT02646761|11875176|FG001|5-week Assessment|Overall Study||10
10710029|NCT02646761|11875175|FG000|COMPLETED|Overall Study||10
10710030|NCT02646761|11875176|FG001|COMPLETED|Overall Study||10
10710031|NCT02646761|11875175|FG000|NOT COMPLETED|Overall Study||8
10710032|NCT02646761|11875176|FG001|NOT COMPLETED|Overall Study||10
10488306|NCT01175135|11637880|FG001|COMPLETED|Overall Study||52
10488307|NCT01175135|11637881|FG002|COMPLETED|Overall Study||25
10488308|NCT01175135|11637882|FG003|COMPLETED|Overall Study||60
10488309|NCT01175135|11637879|FG000|NOT COMPLETED|Overall Study||16
10488310|NCT01175135|11637880|FG001|NOT COMPLETED|Overall Study||22
10488311|NCT01175135|11637881|FG002|NOT COMPLETED|Overall Study||12
10488312|NCT01175135|11637882|FG003|NOT COMPLETED|Overall Study||14
10488313|NCT01175148|11637894|FG000|STARTED|Overall Study||30
10488314|NCT01175148|11637895|FG001|STARTED|Overall Study||30
10488315|NCT01175148|11637894|FG000|COMPLETED|Overall Study||30
10488316|NCT01175148|11637895|FG001|COMPLETED|Overall Study||30
10710033|NCT02646826|11875186|FG000|STARTED|Overall Study||21
10710034|NCT02646826|11875187|FG001|STARTED|Overall Study||22
10710035|NCT02646826|11875188|FG002|STARTED|Overall Study||21
10488317|NCT01175148|11637894|FG000|NOT COMPLETED|Overall Study||0
10488318|NCT01175148|11637895|FG001|NOT COMPLETED|Overall Study||0
10488319|NCT01175213|11637904|FG000|STARTED|IGSC, 10%/rHuPH20||63
10488320|NCT01175213|11637905|FG001|STARTED|IGSC, 10%/rHuPH20|3 participants treated IV with IGIV,10% without rHuPH20 throughout the study.|3
10488321|NCT01175213|11637904|FG000|COMPLETED|IGSC, 10%/rHuPH20||48
10488322|NCT01175213|11637905|FG001|COMPLETED|IGSC, 10%/rHuPH20||3
10488323|NCT01175213|11637904|FG000|NOT COMPLETED|IGSC, 10%/rHuPH20||15
10488324|NCT01175213|11637905|FG001|NOT COMPLETED|IGSC, 10%/rHuPH20||0
10710036|NCT02646826|11875189|FG003|STARTED|Overall Study||22
10710037|NCT02646826|11875186|FG000|COMPLETED|Overall Study||19
10710038|NCT02646826|11875187|FG001|COMPLETED|Overall Study||22
10488325|NCT01175213|11637904|FG000|STARTED|Safety Follow-up||48
10488326|NCT01175213|11637905|FG001|STARTED|Safety Follow-up||3
10488327|NCT01175213|11637904|FG000|COMPLETED|Safety Follow-up||47
10488328|NCT01175213|11637905|FG001|COMPLETED|Safety Follow-up||3
10488329|NCT01175213|11637904|FG000|NOT COMPLETED|Safety Follow-up||1
10488330|NCT01175213|11637905|FG001|NOT COMPLETED|Safety Follow-up||0
10488331|NCT01175226|11637916|FG000|STARTED|Overall Study||155
10488332|NCT01175226|11637917|FG001|STARTED|Overall Study||145
10488333|NCT01175226|11637916|FG000|COMPLETED|Overall Study||144
10488334|NCT01175226|11637917|FG001|COMPLETED|Overall Study||140
10488335|NCT01175226|11637916|FG000|NOT COMPLETED|Overall Study||11
10488336|NCT01175226|11637917|FG001|NOT COMPLETED|Overall Study||5
10488337|NCT01175317|11637925|FG000|STARTED|Overall Study||27
10488338|NCT01175317|11637926|FG001|STARTED|Overall Study||31
10488339|NCT01175317|11637925|FG000|COMPLETED|Overall Study||27
10488340|NCT01175317|11637926|FG001|COMPLETED|Overall Study||31
10488341|NCT01175317|11637925|FG000|NOT COMPLETED|Overall Study||0
10488342|NCT01175317|11637926|FG001|NOT COMPLETED|Overall Study||0
10488343|NCT01175343|11637932|FG000|STARTED|Overall Study||44
10488344|NCT01175343|11637932|FG000|COMPLETED|Overall Study||44
10488345|NCT01175343|11637932|FG000|NOT COMPLETED|Overall Study||0
10488346|NCT01175369|11637938|FG000|STARTED|Overall Study||265
10488347|NCT01175369|11637939|FG001|STARTED|Overall Study||265
10488348|NCT01175369|11637938|FG000|COMPLETED|Overall Study||263
10488349|NCT01175369|11637939|FG001|COMPLETED|Overall Study||260
10488350|NCT01175369|11637938|FG000|NOT COMPLETED|Overall Study||2
10488351|NCT01175369|11637939|FG001|NOT COMPLETED|Overall Study||5
10488352|NCT01175382|11637948|FG000|STARTED|Overall Study||71
10488353|NCT01175382|11637949|FG001|STARTED|Overall Study||68
10488354|NCT01175382|11637950|FG002|STARTED|Overall Study||65
10488355|NCT01175382|11637948|FG000|COMPLETED|Overall Study||63
10488356|NCT01175382|11637949|FG001|COMPLETED|Overall Study||61
10488357|NCT01175382|11637950|FG002|COMPLETED|Overall Study||59
10488358|NCT01175382|11637948|FG000|NOT COMPLETED|Overall Study||8
10488359|NCT01175382|11637949|FG001|NOT COMPLETED|Overall Study||7
10488360|NCT01175382|11637950|FG002|NOT COMPLETED|Overall Study||6
10488361|NCT01175395|11637958|FG000|STARTED|Overall Study||10
10488362|NCT01175395|11637958|FG000|COMPLETED|Overall Study||10
10488363|NCT01175395|11637958|FG000|NOT COMPLETED|Overall Study||0
10488364|NCT01175434|11637964|FG000|STARTED|Overall Study||48
10488365|NCT01175434|11637965|FG001|STARTED|Overall Study||51
10488366|NCT01175434|11637964|FG000|COMPLETED|Overall Study||48
10488367|NCT01175434|11637965|FG001|COMPLETED|Overall Study||51
10488368|NCT01175434|11637964|FG000|NOT COMPLETED|Overall Study||0
10488369|NCT01175434|11637965|FG001|NOT COMPLETED|Overall Study||0
10488370|NCT01175473|11637973|FG000|STARTED|Overall Study|Randomized and treated.|77
10488371|NCT01175473|11637974|FG001|STARTED|Overall Study||71
10488372|NCT01175473|11637973|FG000|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|77
10488373|NCT01175473|11637974|FG001|Safety Population|Overall Study||71
10488374|NCT01175473|11637973|FG000|Pharmacodynamic (PD) Population|Overall Study|All patients who received at least 1 dose; had baseline and at least 1 post-baseline PD assessment.|75
10488375|NCT01175473|11637974|FG001|Pharmacodynamic (PD) Population|Overall Study||68
10488376|NCT01175473|11637973|FG000|COMPLETED|Overall Study||75
10488377|NCT01175473|11637974|FG001|COMPLETED|Overall Study||69
10488378|NCT01175473|11637973|FG000|NOT COMPLETED|Overall Study||2
10488379|NCT01175473|11637974|FG001|NOT COMPLETED|Overall Study||2
10488380|NCT01175590|11637982|FG000|STARTED|Overall Study||347
10488381|NCT01175590|11637983|FG001|STARTED|Overall Study||171
10488382|NCT01175590|11637982|FG000|Modified Intent to Treat Population|Overall Study||212
10488383|NCT01175590|11637983|FG001|Modified Intent to Treat Population|Overall Study||87
10488384|NCT01175590|11637982|FG000|Safety Population|Overall Study||344
10488385|NCT01175590|11637983|FG001|Safety Population|Overall Study||170
10488386|NCT01175590|11637982|FG000|COMPLETED|Overall Study||335
10488387|NCT01175590|11637983|FG001|COMPLETED|Overall Study||161
10488388|NCT01175590|11637982|FG000|NOT COMPLETED|Overall Study||12
10488389|NCT01175590|11637983|FG001|NOT COMPLETED|Overall Study||10
10488390|NCT01175668|11637992|FG000|STARTED|Overall Study||34
10488391|NCT01175668|11637993|FG001|STARTED|Overall Study||34
10488392|NCT01175668|11637992|FG000|COMPLETED|Overall Study||32
10488393|NCT01175668|11637993|FG001|COMPLETED|Overall Study||34
10488394|NCT01175668|11637992|FG000|NOT COMPLETED|Overall Study||2
10488395|NCT01175668|11637993|FG001|NOT COMPLETED|Overall Study||0
10488396|NCT01175707|11638001|FG000|STARTED|Overall Study||40
10649988|NCT02165202|11810124|FG001|NOT COMPLETED|Oral Phase||3
10649989|NCT02165202|11810123|FG000|STARTED|Injection Phase|Participants who received at least one injection.|80
10649990|NCT02165202|11810124|FG001|STARTED|Injection Phase|Participants who received at least one injection.|42
10649991|NCT02165202|11810123|FG000|COMPLETED|Injection Phase||70
10649992|NCT02165202|11810124|FG001|COMPLETED|Injection Phase||36
10488397|NCT01175707|11638002|FG001|STARTED|Overall Study||40
10488398|NCT01175707|11638001|FG000|COMPLETED|Overall Study||36
10488399|NCT01175707|11638002|FG001|COMPLETED|Overall Study||34
10488400|NCT01175707|11638001|FG000|NOT COMPLETED|Overall Study||4
10488401|NCT01175707|11638002|FG001|NOT COMPLETED|Overall Study||6
10488402|NCT01175798|11638011|FG000|STARTED|Overall Study||34
10488403|NCT01175798|11638012|FG001|STARTED|Overall Study||62
10488404|NCT01175798|11638011|FG000|COMPLETED|Overall Study||27
10488405|NCT01175798|11638012|FG001|COMPLETED|Overall Study||41
10488406|NCT01175798|11638011|FG000|NOT COMPLETED|Overall Study||7
10488407|NCT01175798|11638012|FG001|NOT COMPLETED|Overall Study||21
10488408|NCT01175811|11638020|FG000|STARTED|Overall Study||199
10488409|NCT01175811|11638021|FG001|STARTED|Overall Study||203
10488410|NCT01175811|11638020|FG000|Received at Least 1 Dose of Study Drug|Overall Study||197
10488411|NCT01175811|11638021|FG001|Received at Least 1 Dose of Study Drug|Overall Study||202
10488412|NCT01175811|11638020|FG000|COMPLETED|Overall Study||183
10488413|NCT01175811|11638021|FG001|COMPLETED|Overall Study||189
10488414|NCT01175811|11638020|FG000|NOT COMPLETED|Overall Study||16
10488415|NCT01175811|11638021|FG001|NOT COMPLETED|Overall Study||14
10488416|NCT01175824|11638029|FG000|STARTED|Overall Study||236
10488417|NCT01175824|11638030|FG001|STARTED|Overall Study||242
10488418|NCT01175824|11638029|FG000|Received at Least 1 Dose of Study Drug|Overall Study||236
10488419|NCT01175824|11638030|FG001|Received at Least 1 Dose of Study Drug|Overall Study||240
10488420|NCT01175824|11638029|FG000|COMPLETED|Overall Study||220
10488421|NCT01175824|11638030|FG001|COMPLETED|Overall Study||220
10488422|NCT01175824|11638029|FG000|NOT COMPLETED|Overall Study||16
10488423|NCT01175824|11638030|FG001|NOT COMPLETED|Overall Study||22
10488424|NCT01175850|11638038|FG000|STARTED|IN.PACT SFA I Phase||99
10488425|NCT01175850|11638039|FG001|STARTED|IN.PACT SFA I Phase||51
10488426|NCT01175850|11638038|FG000|COMPLETED|IN.PACT SFA I Phase||88
10488427|NCT01175850|11638039|FG001|COMPLETED|IN.PACT SFA I Phase||49
10488428|NCT01175850|11638038|FG000|NOT COMPLETED|IN.PACT SFA I Phase||11
10488429|NCT01175850|11638039|FG001|NOT COMPLETED|IN.PACT SFA I Phase||2
10488430|NCT01175850|11638038|FG000|STARTED|IN.PACT SFA II Phase||121
10488431|NCT01175850|11638039|FG001|STARTED|IN.PACT SFA II Phase||60
10488432|NCT01175850|11638038|FG000|COMPLETED|IN.PACT SFA II Phase||109
10488433|NCT01175850|11638039|FG001|COMPLETED|IN.PACT SFA II Phase||55
10488434|NCT01175850|11638038|FG000|NOT COMPLETED|IN.PACT SFA II Phase||12
10488435|NCT01175850|11638039|FG001|NOT COMPLETED|IN.PACT SFA II Phase||5
10488436|NCT01175902|11638048|FG000|STARTED|Overall Study||22
10488437|NCT01175902|11638049|FG001|STARTED|Overall Study||22
10488438|NCT01175902|11638048|FG000|COMPLETED|Overall Study||22
10488439|NCT01175902|11638049|FG001|COMPLETED|Overall Study||22
10488440|NCT01175902|11638048|FG000|NOT COMPLETED|Overall Study||0
10488441|NCT01175902|11638049|FG001|NOT COMPLETED|Overall Study||0
10488442|NCT01175980|11638057|FG000|STARTED|Overall Study||30
10488443|NCT01175980|11638057|FG000|COMPLETED|Overall Study||30
10488444|NCT01175980|11638057|FG000|NOT COMPLETED|Overall Study||0
10488445|NCT01176032|11638063|FG000|STARTED|Overall Study|"Started indicates randomized and safety population"|37
10488446|NCT01176032|11638064|FG001|STARTED|Overall Study||37
10488447|NCT01176032|11638063|FG000|Intention-to-treat (ITT) Population|Overall Study||32
10488448|NCT01176032|11638064|FG001|Intention-to-treat (ITT) Population|Overall Study||37
10488449|NCT01176032|11638063|FG000|COMPLETED|Overall Study||31
10488450|NCT01176032|11638064|FG001|COMPLETED|Overall Study||36
10488451|NCT01176032|11638063|FG000|NOT COMPLETED|Overall Study||6
10488452|NCT01176032|11638064|FG001|NOT COMPLETED|Overall Study||1
10488453|NCT01176058|11638077|FG000|STARTED|Overall Study||9
10488454|NCT01176058|11638078|FG001|STARTED|Overall Study||8
10488455|NCT01176058|11638077|FG000|COMPLETED|Overall Study||5
10488456|NCT01176058|11638078|FG001|COMPLETED|Overall Study||5
10488457|NCT01176058|11638077|FG000|NOT COMPLETED|Overall Study||4
10488458|NCT01176058|11638078|FG001|NOT COMPLETED|Overall Study||3
10488459|NCT01176240|11638088|FG000|STARTED|Study 306A||24
10488460|NCT01176240|11638089|FG001|STARTED|Study 306A||27
10488461|NCT01176240|11638088|FG000|COMPLETED|Study 306A||21
10488462|NCT01176240|11638089|FG001|COMPLETED|Study 306A||24
10488463|NCT01176240|11638088|FG000|NOT COMPLETED|Study 306A||3
10488464|NCT01176240|11638089|FG001|NOT COMPLETED|Study 306A||3
10488465|NCT01176240|11638088|FG000|STARTED|Study 306B||89
10488466|NCT01176240|11638089|FG001|STARTED|Study 306B||85
10488467|NCT01176240|11638088|FG000|Took at Least 1 Dose of Study Drug|Study 306B|Two randomized patients discontinued before receiving study drug.|87
10488468|NCT01176240|11638089|FG001|Took at Least 1 Dose of Study Drug|Study 306B|One randomized patient discontinued before receiving study drug.|84
10488469|NCT01176240|11638088|FG000|1 wk of Stable Dosing and Visit 4|Study 306B||69
10488470|NCT01176240|11638089|FG001|1 wk of Stable Dosing and Visit 4|Study 306B||78
10488471|NCT01176240|11638088|FG000|2 wk of Stable Dosing and Visit 5|Study 306B||68
10488472|NCT01176240|11638089|FG001|2 wk of Stable Dosing and Visit 5|Study 306B||75
10488473|NCT01176240|11638088|FG000|4 wk of Stable Dosing and Visit 6|Study 306B||67
10488474|NCT01176240|11638089|FG001|4 wk of Stable Dosing and Visit 6|Study 306B||73
10488475|NCT01176240|11638088|FG000|COMPLETED|Study 306B||63
10488476|NCT01176240|11638089|FG001|COMPLETED|Study 306B||68
10488477|NCT01176240|11638088|FG000|NOT COMPLETED|Study 306B||26
10488478|NCT01176240|11638089|FG001|NOT COMPLETED|Study 306B||17
10488479|NCT01176266|11638095|FG000|STARTED|Overall Study||69
10488480|NCT01176266|11638095|FG000|COMPLETED|Overall Study||60
10488481|NCT01176266|11638095|FG000|NOT COMPLETED|Overall Study||9
10488482|NCT01176292|11638105|FG000|STARTED|Overall Study||71
10488483|NCT01176292|11638106|FG001|STARTED|Overall Study||71
10488484|NCT01176292|11638105|FG000|COMPLETED|Overall Study||66
10488485|NCT01176292|11638106|FG001|COMPLETED|Overall Study||62
10488486|NCT01176292|11638105|FG000|NOT COMPLETED|Overall Study||5
10488487|NCT01176292|11638106|FG001|NOT COMPLETED|Overall Study||9
10488488|NCT01176435|11638115|FG000|STARTED|Overall Study||15
10488489|NCT01176435|11638116|FG001|STARTED|Overall Study||15
10488490|NCT01176435|11638117|FG002|STARTED|Overall Study||15
10488491|NCT01176435|11638115|FG000|COMPLETED|Overall Study||15
10488492|NCT01176435|11638116|FG001|COMPLETED|Overall Study||15
10488493|NCT01176435|11638117|FG002|COMPLETED|Overall Study||15
10488494|NCT01176435|11638115|FG000|NOT COMPLETED|Overall Study||0
10488495|NCT01176435|11638116|FG001|NOT COMPLETED|Overall Study||0
10488496|NCT01176435|11638117|FG002|NOT COMPLETED|Overall Study||0
10488497|NCT01176448|11638125|FG000|STARTED|Overall Study||6
10488498|NCT01176448|11638125|FG000|COMPLETED|Overall Study||6
10488499|NCT01176448|11638125|FG000|NOT COMPLETED|Overall Study||0
10488500|NCT01176565|11638135|FG000|STARTED|Overall Study||500
10488501|NCT01176565|11638136|FG001|STARTED|Overall Study||500
10488502|NCT01176565|11638135|FG000|COMPLETED|Overall Study||480
10488503|NCT01176565|11638136|FG001|COMPLETED|Overall Study||481
10488504|NCT01176565|11638135|FG000|NOT COMPLETED|Overall Study||20
10488505|NCT01176565|11638136|FG001|NOT COMPLETED|Overall Study||19
10488506|NCT01176591|11638144|FG000|STARTED|Session 1||10
10488507|NCT01176591|11638145|FG001|STARTED|Session 1||3
10488508|NCT01176591|11638144|FG000|COMPLETED|Session 1||10
10488509|NCT01176591|11638145|FG001|COMPLETED|Session 1||3
10488510|NCT01176591|11638144|FG000|NOT COMPLETED|Session 1||0
10488511|NCT01176591|11638145|FG001|NOT COMPLETED|Session 1||0
10488512|NCT01176591|11638144|FG000|STARTED|Session 2||10
10488513|NCT01176591|11638145|FG001|STARTED|Session 2||3
10488514|NCT01176591|11638144|FG000|COMPLETED|Session 2||10
10488515|NCT01176591|11638145|FG001|COMPLETED|Session 2||3
10488516|NCT01176591|11638144|FG000|NOT COMPLETED|Session 2||0
10488517|NCT01176591|11638145|FG001|NOT COMPLETED|Session 2||0
10488518|NCT01176617|11638155|FG000|STARTED|1 - 6 Months (Ron-randomized)||0
10488519|NCT01176617|11638156|FG001|STARTED|1 - 6 Months (Ron-randomized)||0
10488520|NCT01176617|11638157|FG002|STARTED|1 - 6 Months (Ron-randomized)||38
10488521|NCT01176617|11638155|FG000|COMPLETED|1 - 6 Months (Ron-randomized)||0
10488522|NCT01176617|11638156|FG001|COMPLETED|1 - 6 Months (Ron-randomized)||0
10488523|NCT01176617|11638157|FG002|COMPLETED|1 - 6 Months (Ron-randomized)||38
10488524|NCT01176617|11638155|FG000|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
10488525|NCT01176617|11638156|FG001|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
10488526|NCT01176617|11638157|FG002|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
10488527|NCT01176617|11638155|FG000|STARTED|6 - 12 Months (Randomized)||18
10488528|NCT01176617|11638156|FG001|STARTED|6 - 12 Months (Randomized)||20
10488529|NCT01176617|11638157|FG002|STARTED|6 - 12 Months (Randomized)||0
10488530|NCT01176617|11638155|FG000|COMPLETED|6 - 12 Months (Randomized)||13
10488531|NCT01176617|11638156|FG001|COMPLETED|6 - 12 Months (Randomized)||20
10488532|NCT01176617|11638157|FG002|COMPLETED|6 - 12 Months (Randomized)||0
10488533|NCT01176617|11638155|FG000|NOT COMPLETED|6 - 12 Months (Randomized)||5
10488534|NCT01176617|11638156|FG001|NOT COMPLETED|6 - 12 Months (Randomized)||0
10488535|NCT01176617|11638157|FG002|NOT COMPLETED|6 - 12 Months (Randomized)||0
10488536|NCT01176773|11638165|FG000|STARTED|Overall Study||62
10488537|NCT01176773|11638165|FG000|COMPLETED|Overall Study||59
10488538|NCT01176773|11638165|FG000|NOT COMPLETED|Overall Study||3
10488539|NCT01176877|11638170|FG000|STARTED|Overall Study||40
10488540|NCT01176877|11638170|FG000|COMPLETED|Overall Study||31
10488541|NCT01176877|11638170|FG000|NOT COMPLETED|Overall Study||9
10488542|NCT01176916|11638175|FG000|STARTED|Overall Study||564
10488543|NCT01176916|11638175|FG000|Treated|Overall Study||558
10488544|NCT01176916|11638175|FG000|Assigne But Not Treated|Overall Study||6
10488545|NCT01176916|11638175|FG000|COMPLETED|Overall Study||397
10488546|NCT01176916|11638175|FG000|NOT COMPLETED|Overall Study||167
10488547|NCT01176955|11638181|FG000|STARTED|Overall Study||10
10488548|NCT01176955|11638182|FG001|STARTED|Overall Study||10
10488549|NCT01176955|11638181|FG000|COMPLETED|Overall Study||7
10488550|NCT01176955|11638182|FG001|COMPLETED|Overall Study||8
10488551|NCT01176955|11638181|FG000|NOT COMPLETED|Overall Study||3
10488552|NCT01176955|11638182|FG001|NOT COMPLETED|Overall Study||2
10488553|NCT01176968|11638193|FG000|STARTED|Overall Study||506
10488554|NCT01176968|11638194|FG001|STARTED|Overall Study||506
10488555|NCT01176968|11638193|FG000|Treated|Overall Study||505
10488556|NCT01176968|11638194|FG001|Treated|Overall Study||505
10488557|NCT01176968|11638193|FG000|COMPLETED|Overall Study||422
10488558|NCT01176968|11638194|FG001|COMPLETED|Overall Study||424
10488559|NCT01176968|11638193|FG000|NOT COMPLETED|Overall Study||84
10488560|NCT01176968|11638194|FG001|NOT COMPLETED|Overall Study||82
10488561|NCT01176981|11638200|FG000|STARTED|Overall Study||6
10488562|NCT01176981|11638200|FG000|COMPLETED|Overall Study||6
10488563|NCT01176981|11638200|FG000|NOT COMPLETED|Overall Study||0
10488564|NCT01177007|11638204|FG000|STARTED|Overall Study||50
10488565|NCT01177007|11638204|FG000|Completed First Y90 Treatment|Overall Study||50
10488566|NCT01177007|11638204|FG000|Completed First Clinical and Imaging|Overall Study||43
10488567|NCT01177007|11638204|FG000|COMPLETED|Overall Study||12
10488568|NCT01177007|11638204|FG000|NOT COMPLETED|Overall Study||38
10488569|NCT01177059|11638210|FG000|STARTED|Overall Study||68
10488570|NCT01177059|11638210|FG000|COMPLETED|Overall Study||18
10488571|NCT01177059|11638210|FG000|NOT COMPLETED|Overall Study||50
10488572|NCT01177098|11638216|FG000|STARTED|Overall Study||278
10488573|NCT01177098|11638217|FG001|STARTED|Overall Study||283
10488574|NCT01177098|11638216|FG000|COMPLETED|Overall Study||269
10488575|NCT01177098|11638217|FG001|COMPLETED|Overall Study||271
10488576|NCT01177098|11638216|FG000|NOT COMPLETED|Overall Study||9
10488577|NCT01177098|11638217|FG001|NOT COMPLETED|Overall Study||12
10488578|NCT01177137|11638226|FG000|STARTED|Overall Study||51
10488579|NCT01177137|11638227|FG001|STARTED|Overall Study||51
10488580|NCT01177137|11638228|FG002|STARTED|Overall Study||49
10488581|NCT01177137|11638226|FG000|COMPLETED|Overall Study||41
10488582|NCT01177137|11638227|FG001|COMPLETED|Overall Study||41
10488583|NCT01177137|11638228|FG002|COMPLETED|Overall Study||47
10488584|NCT01177137|11638226|FG000|NOT COMPLETED|Overall Study||10
10488585|NCT01177137|11638227|FG001|NOT COMPLETED|Overall Study||10
10488586|NCT01177137|11638228|FG002|NOT COMPLETED|Overall Study||2
10488587|NCT01177189|11638241|FG000|STARTED|Overall Study||42
10488588|NCT01177189|11638242|FG001|STARTED|Overall Study||45
10488589|NCT01177189|11638241|FG000|COMPLETED|Overall Study||42
10488590|NCT01177189|11638242|FG001|COMPLETED|Overall Study||45
10488591|NCT01177189|11638241|FG000|NOT COMPLETED|Overall Study||0
10488592|NCT01177189|11638242|FG001|NOT COMPLETED|Overall Study||0
10488593|NCT01177228|11638252|FG000|STARTED|Overall Study||9
10488594|NCT01177228|11638253|FG001|STARTED|Overall Study||13
10488595|NCT01177228|11638254|FG002|STARTED|Overall Study||14
10488596|NCT01177228|11638255|FG003|STARTED|Overall Study||11
10488597|NCT01177228|11638252|FG000|Received Treatment|Overall Study||9
10488598|NCT01177228|11638253|FG001|Received Treatment|Overall Study||12
10488599|NCT01177228|11638254|FG002|Received Treatment|Overall Study||14
10488600|NCT01177228|11638255|FG003|Received Treatment|Overall Study||11
10488601|NCT01177228|11638252|FG000|COMPLETED|Overall Study||8
10488602|NCT01177228|11638253|FG001|COMPLETED|Overall Study||11
10488603|NCT01177228|11638254|FG002|COMPLETED|Overall Study||14
10488604|NCT01177228|11638255|FG003|COMPLETED|Overall Study||11
10488605|NCT01177228|11638252|FG000|NOT COMPLETED|Overall Study||1
10488606|NCT01177228|11638253|FG001|NOT COMPLETED|Overall Study||2
10488607|NCT01177228|11638254|FG002|NOT COMPLETED|Overall Study||0
10488608|NCT01177228|11638255|FG003|NOT COMPLETED|Overall Study||0
10488609|NCT01177293|11638270|FG000|STARTED|First Intervention Period||7
10488610|NCT01177293|11638271|FG001|STARTED|First Intervention Period||7
10488611|NCT01177293|11638270|FG000|COMPLETED|First Intervention Period||7
10488612|NCT01177293|11638271|FG001|COMPLETED|First Intervention Period||7
10488613|NCT01177293|11638270|FG000|NOT COMPLETED|First Intervention Period||0
10488614|NCT01177293|11638271|FG001|NOT COMPLETED|First Intervention Period||0
10488615|NCT01177293|11638270|FG000|STARTED|Washout Period (of 14 Days)||7
10488616|NCT01177293|11638271|FG001|STARTED|Washout Period (of 14 Days)||7
10488617|NCT01177293|11638270|FG000|COMPLETED|Washout Period (of 14 Days)||7
10488618|NCT01177293|11638271|FG001|COMPLETED|Washout Period (of 14 Days)||6
10488619|NCT01177293|11638270|FG000|NOT COMPLETED|Washout Period (of 14 Days)||0
10488620|NCT01177293|11638271|FG001|NOT COMPLETED|Washout Period (of 14 Days)||1
10488621|NCT01177293|11638270|FG000|STARTED|Second Intervention Period||7
10488622|NCT01177293|11638271|FG001|STARTED|Second Intervention Period||6
10488623|NCT01177293|11638270|FG000|COMPLETED|Second Intervention Period||7
10488624|NCT01177293|11638271|FG001|COMPLETED|Second Intervention Period||6
10488625|NCT01177293|11638270|FG000|NOT COMPLETED|Second Intervention Period||0
10488626|NCT01177293|11638271|FG001|NOT COMPLETED|Second Intervention Period||0
10488627|NCT01177384|11638279|FG000|STARTED|Overall Study||191
10488628|NCT01177384|11638280|FG001|STARTED|Overall Study|Includes the second randomization of a participant|190
10488629|NCT01177384|11638279|FG000|COMPLETED|Overall Study||177
10488630|NCT01177384|11638280|FG001|COMPLETED|Overall Study||164
10488631|NCT01177384|11638279|FG000|NOT COMPLETED|Overall Study||14
10488632|NCT01177384|11638280|FG001|NOT COMPLETED|Overall Study||26
10488633|NCT01177410|11638289|FG000|STARTED|Overall Study||51
10488634|NCT01177410|11638290|FG001|STARTED|Overall Study||47
10488635|NCT01177410|11638291|FG002|STARTED|Overall Study||50
10488636|NCT01177410|11638289|FG000|COMPLETED|Overall Study||50
10488637|NCT01177410|11638290|FG001|COMPLETED|Overall Study||40
10488638|NCT01177410|11638291|FG002|COMPLETED|Overall Study||45
10488639|NCT01177410|11638289|FG000|NOT COMPLETED|Overall Study||1
10488640|NCT01177410|11638290|FG001|NOT COMPLETED|Overall Study||7
10488641|NCT01177410|11638291|FG002|NOT COMPLETED|Overall Study||5
10488642|NCT01177553|11638301|FG000|STARTED|Overall Study||3
10488643|NCT01177553|11638302|FG001|STARTED|Overall Study||2
10488644|NCT01177553|11638301|FG000|COMPLETED|Overall Study|data as of March 2009|2
10488645|NCT01177553|11638302|FG001|COMPLETED|Overall Study|data as of March 2009|2
10488646|NCT01177553|11638301|FG000|NOT COMPLETED|Overall Study||1
10488647|NCT01177553|11638302|FG001|NOT COMPLETED|Overall Study||0
10488648|NCT01177670|11638308|FG000|STARTED|Overall Study||169
10488649|NCT01177670|11638308|FG000|COMPLETED|Overall Study||0
10488650|NCT01177670|11638308|FG000|NOT COMPLETED|Overall Study||169
10488651|NCT01177709|11638312|FG000|STARTED|Overall Study||12
10488652|NCT01177709|11638312|FG000|COMPLETED|Overall Study||12
10488653|NCT01177709|11638312|FG000|NOT COMPLETED|Overall Study||0
10488654|NCT01177722|11638320|FG000|STARTED|Overall Study|A Batch B participant got Batch A vaccine data analyses was according to actual vaccine administered|344
10488655|NCT01177722|11638321|FG001|STARTED|Overall Study|A randomized participant got Batch A vaccine, analyses was according to actual vaccine administered.|344
10488656|NCT01177722|11638322|FG002|STARTED|Overall Study||342
10488657|NCT01177722|11638323|FG003|STARTED|Overall Study||345
10488658|NCT01177722|11638320|FG000|COMPLETED|Overall Study||331
10488659|NCT01177722|11638321|FG001|COMPLETED|Overall Study||334
10488660|NCT01177722|11638322|FG002|COMPLETED|Overall Study||333
10488661|NCT01177722|11638323|FG003|COMPLETED|Overall Study||338
10488662|NCT01177722|11638320|FG000|NOT COMPLETED|Overall Study||13
10488663|NCT01177722|11638321|FG001|NOT COMPLETED|Overall Study||10
10488664|NCT01177722|11638322|FG002|NOT COMPLETED|Overall Study||9
10488665|NCT01177722|11638323|FG003|NOT COMPLETED|Overall Study||7
10488666|NCT01177735|11638334|FG000|STARTED|Overall Study||71
10488667|NCT01177735|11638334|FG000|COMPLETED|Overall Study||0
10488668|NCT01177735|11638334|FG000|NOT COMPLETED|Overall Study||71
10488669|NCT01177787|11638338|FG000|STARTED|Clinical Efficacy of Cryolipolysis||28
10488670|NCT01177787|11638338|FG000|COMPLETED|Clinical Efficacy of Cryolipolysis||28
10488671|NCT01177787|11638338|FG000|NOT COMPLETED|Clinical Efficacy of Cryolipolysis||0
10488672|NCT01177787|11638338|FG000|STARTED|Cryolipolysis on Thigh||28
10488673|NCT01177787|11638338|FG000|COMPLETED|Cryolipolysis on Thigh||14
10488674|NCT01177787|11638338|FG000|NOT COMPLETED|Cryolipolysis on Thigh||14
10488675|NCT01177800|11638352|FG000|STARTED|Overall Study||84
10488676|NCT01177800|11638353|FG001|STARTED|Overall Study||45
10488677|NCT01177800|11638352|FG000|COMPLETED|Overall Study||74
10488678|NCT01177800|11638353|FG001|COMPLETED|Overall Study||40
10488679|NCT01177800|11638352|FG000|NOT COMPLETED|Overall Study||10
10488680|NCT01177800|11638353|FG001|NOT COMPLETED|Overall Study||5
10488681|NCT01177813|11638364|FG000|STARTED|Overall Study||228
10488682|NCT01177813|11638365|FG001|STARTED|Overall Study||224
10488683|NCT01177813|11638366|FG002|STARTED|Overall Study||224
10488684|NCT01177813|11638367|FG003|STARTED|Overall Study||223
10488685|NCT01177813|11638368|FG004|STARTED|Overall Study||87
10488686|NCT01177813|11638364|FG000|COMPLETED|Overall Study||187
10488687|NCT01177813|11638365|FG001|COMPLETED|Overall Study||206
10488688|NCT01177813|11638366|FG002|COMPLETED|Overall Study||204
10488689|NCT01177813|11638367|FG003|COMPLETED|Overall Study||206
10488690|NCT01177813|11638368|FG004|COMPLETED|Overall Study||78
10488691|NCT01177813|11638364|FG000|NOT COMPLETED|Overall Study||41
10488692|NCT01177813|11638365|FG001|NOT COMPLETED|Overall Study||18
10488693|NCT01177813|11638366|FG002|NOT COMPLETED|Overall Study||20
10488694|NCT01177813|11638367|FG003|NOT COMPLETED|Overall Study||17
10488695|NCT01177813|11638368|FG004|NOT COMPLETED|Overall Study||9
10488696|NCT01177943|11638382|FG000|STARTED|First Intervention||21
10488697|NCT01177943|11638383|FG001|STARTED|First Intervention||21
10488698|NCT01177943|11638382|FG000|COMPLETED|First Intervention||19
10488699|NCT01177943|11638383|FG001|COMPLETED|First Intervention||21
10488700|NCT01177943|11638382|FG000|NOT COMPLETED|First Intervention||2
10488701|NCT01177943|11638383|FG001|NOT COMPLETED|First Intervention||0
10488702|NCT01177943|11638382|FG000|STARTED|Second Intervention||19
10488703|NCT01177943|11638383|FG001|STARTED|Second Intervention||21
10488704|NCT01177943|11638382|FG000|COMPLETED|Second Intervention||19
10488705|NCT01177943|11638383|FG001|COMPLETED|Second Intervention||21
10488706|NCT01177943|11638382|FG000|NOT COMPLETED|Second Intervention||0
10488707|NCT01177943|11638383|FG001|NOT COMPLETED|Second Intervention||0
10488708|NCT01177956|11638389|FG000|STARTED|Overall Study||68
10488709|NCT01177956|11638389|FG000|COMPLETED|Overall Study||68
10488710|NCT01177956|11638389|FG000|NOT COMPLETED|Overall Study||0
10488711|NCT01177969|11638396|FG000|STARTED|Overall Study||19
10488712|NCT01177969|11638397|FG001|STARTED|Overall Study||14
10488713|NCT01177969|11638396|FG000|COMPLETED|Overall Study||16
10488714|NCT01177969|11638397|FG001|COMPLETED|Overall Study||11
10488715|NCT01177969|11638396|FG000|NOT COMPLETED|Overall Study||3
10488716|NCT01177969|11638397|FG001|NOT COMPLETED|Overall Study||3
10488717|NCT01178073|11638406|FG000|STARTED|Overall Study||302
10488718|NCT01178073|11638407|FG001|STARTED|Overall Study||152
10488719|NCT01178073|11638408|FG002|STARTED|Overall Study||151
10488720|NCT01178073|11638406|FG000|COMPLETED|Overall Study||240
10488721|NCT01178073|11638407|FG001|COMPLETED|Overall Study||108
10488722|NCT01178073|11638408|FG002|COMPLETED|Overall Study||105
10488723|NCT01178073|11638406|FG000|NOT COMPLETED|Overall Study||62
10488724|NCT01178073|11638407|FG001|NOT COMPLETED|Overall Study||44
10488725|NCT01178073|11638408|FG002|NOT COMPLETED|Overall Study||46
10488726|NCT01178086|11638419|FG000|STARTED|Overall Study|Safety analysis set: participants who received at least one dose of rituximab.|681
10488727|NCT01178086|11638419|FG000|Effectiveness Analysis Set (EAS)|Overall Study|who received at least 1 dose of rituximab and had data from baseline and at least 1 follow-up visit.|661
10488728|NCT01178086|11638419|FG000|COMPLETED|Overall Study||349
10488729|NCT01178086|11638419|FG000|NOT COMPLETED|Overall Study||332
10488730|NCT01178099|11638429|FG000|STARTED|Overall Study||13
10488731|NCT01178099|11638430|FG001|STARTED|Overall Study||13
10488732|NCT01178099|11638429|FG000|COMPLETED|Overall Study||13
10488733|NCT01178099|11638430|FG001|COMPLETED|Overall Study||12
10488734|NCT01178099|11638429|FG000|NOT COMPLETED|Overall Study||0
10488735|NCT01178099|11638430|FG001|NOT COMPLETED|Overall Study||1
10488736|NCT01178125|11638440|FG000|STARTED|Overall Study|Number enrolled.|2858
10488737|NCT01178125|11638440|FG000|Safety Population|Overall Study|Received at least 1 dose of DR-102.|2765
10488738|NCT01178125|11638440|FG000|Intent to Treat (ITT) Population|Overall Study|Completed at least one 28-day cycle of investigational product.|2607
10488739|NCT01178125|11638440|FG000|Pregnancy ITT (PITT) Population|Overall Study|Participants in the ITT population between the ages of 18 and 35, inclusive.|2401
10488740|NCT01178125|11638440|FG000|COMPLETED|Overall Study||1680
10488741|NCT01178125|11638440|FG000|NOT COMPLETED|Overall Study||1178
10488742|NCT01178138|11638449|FG000|STARTED|Overall Study||24
10488743|NCT01178138|11638449|FG000|Completed 6 Sessions|Overall Study||1
10488744|NCT01178138|11638449|FG000|Completed 5 Sessions|Overall Study||1
10488745|NCT01178138|11638449|FG000|Completed 3 Sessions|Overall Study||1
10488746|NCT01178138|11638449|FG000|COMPLETED|Overall Study||1
10488747|NCT01178138|11638449|FG000|NOT COMPLETED|Overall Study||23
10488748|NCT01178216|11638458|FG000|STARTED|Overall Study||41
10488749|NCT01178216|11638458|FG000|COMPLETED|Overall Study||39
10488750|NCT01178216|11638458|FG000|NOT COMPLETED|Overall Study||2
10488751|NCT01178268|11638464|FG000|STARTED|Overall Study||367
10488752|NCT01178268|11638465|FG001|STARTED|Overall Study||121
10488753|NCT01178268|11638464|FG000|COMPLETED|Overall Study||360
10488754|NCT01178268|11638465|FG001|COMPLETED|Overall Study||120
10488755|NCT01178268|11638464|FG000|NOT COMPLETED|Overall Study||7
10488756|NCT01178268|11638465|FG001|NOT COMPLETED|Overall Study||1
10488757|NCT01178281|11638474|FG000|STARTED|Overall Study||168
10488758|NCT01178281|11638475|FG001|STARTED|Overall Study||84
10488759|NCT01178281|11638476|FG002|STARTED|Overall Study||15
10488760|NCT01178281|11638474|FG000|Received Study Drug|Overall Study||167
10488761|NCT01178281|11638475|FG001|Received Study Drug|Overall Study||83
10488762|NCT01178281|11638476|FG002|Received Study Drug|Overall Study||15
10488763|NCT01178281|11638474|FG000|COMPLETED|Overall Study||168
10488764|NCT01178281|11638475|FG001|COMPLETED|Overall Study||84
10488765|NCT01178281|11638476|FG002|COMPLETED|Overall Study||15
10488766|NCT01178281|11638474|FG000|NOT COMPLETED|Overall Study||0
10488767|NCT01178281|11638475|FG001|NOT COMPLETED|Overall Study||0
10488768|NCT01178281|11638476|FG002|NOT COMPLETED|Overall Study||0
10488769|NCT01178294|11638486|FG000|STARTED|Overall Study|25 subjects enrolled under OBI-1-301 + 4 subjects enrolled under expanded access OBI-1-301a.|29
10488770|NCT01178294|11638486|FG000|COMPLETED|Overall Study||18
10488771|NCT01178294|11638486|FG000|NOT COMPLETED|Overall Study||11
10488772|NCT01178333|11638493|FG000|STARTED|Overall Study||71
10488773|NCT01178333|11638494|FG001|STARTED|Overall Study||284
10488774|NCT01178333|11638495|FG002|STARTED|Overall Study||87
10488775|NCT01178333|11638493|FG000|COMPLETED|Overall Study||71
10488776|NCT01178333|11638494|FG001|COMPLETED|Overall Study||284
10488777|NCT01178333|11638495|FG002|COMPLETED|Overall Study||87
10488778|NCT01178333|11638493|FG000|NOT COMPLETED|Overall Study||0
10488779|NCT01178333|11638494|FG001|NOT COMPLETED|Overall Study||0
10488780|NCT01178333|11638495|FG002|NOT COMPLETED|Overall Study||0
10488781|NCT01178385|11638507|FG000|STARTED|Overall Study||24
10488782|NCT01178385|11638508|FG001|STARTED|Overall Study||21
10488783|NCT01178385|11638507|FG000|COMPLETED|Overall Study||22
10488784|NCT01178385|11638508|FG001|COMPLETED|Overall Study||21
10488785|NCT01178385|11638507|FG000|NOT COMPLETED|Overall Study||2
10488786|NCT01178385|11638508|FG001|NOT COMPLETED|Overall Study||0
10488787|NCT01178411|11638514|FG000|STARTED|Overall Study||60
10488788|NCT01178411|11638514|FG000|COMPLETED|Overall Study||0
10488789|NCT01178411|11638514|FG000|NOT COMPLETED|Overall Study||60
10488790|NCT01178528|11638521|FG000|STARTED|Overall Study||41
10488791|NCT01178528|11638522|FG001|STARTED|Overall Study||38
10488792|NCT01178528|11638523|FG002|STARTED|Overall Study||42
10488793|NCT01178528|11638521|FG000|COMPLETED|Overall Study||41
10488794|NCT01178528|11638522|FG001|COMPLETED|Overall Study||38
10488795|NCT01178528|11638523|FG002|COMPLETED|Overall Study||42
10488796|NCT01178528|11638521|FG000|NOT COMPLETED|Overall Study||0
10488797|NCT01178528|11638522|FG001|NOT COMPLETED|Overall Study||0
10488798|NCT01178528|11638523|FG002|NOT COMPLETED|Overall Study||0
10488799|NCT01178671|11638534|FG000|STARTED|Overall Study||18
10488800|NCT01178671|11638535|FG001|STARTED|Overall Study||18
10488801|NCT01178671|11638534|FG000|COMPLETED|Overall Study||6
10488802|NCT01178671|11638535|FG001|COMPLETED|Overall Study||3
10488803|NCT01178671|11638534|FG000|NOT COMPLETED|Overall Study||12
10488804|NCT01178671|11638535|FG001|NOT COMPLETED|Overall Study||15
10488805|NCT01178762|11638541|FG000|STARTED|Overall Study||42
10710039|NCT02646826|11875188|FG002|COMPLETED|Overall Study||20
10710040|NCT02646826|11875189|FG003|COMPLETED|Overall Study||21
10710041|NCT02646826|11875186|FG000|NOT COMPLETED|Overall Study||2
10710042|NCT02646826|11875187|FG001|NOT COMPLETED|Overall Study||0
10710043|NCT02646826|11875188|FG002|NOT COMPLETED|Overall Study||1
10710044|NCT02646826|11875189|FG003|NOT COMPLETED|Overall Study||1
10710045|NCT02646891|11875209|FG000|STARTED|Overall Study||6
10710046|NCT02646891|11875210|FG001|STARTED|Overall Study||12
10710047|NCT02646891|11875211|FG002|STARTED|Overall Study||12
10488806|NCT01178762|11638541|FG000|COMPLETED|Overall Study||27
10488807|NCT01178762|11638541|FG000|NOT COMPLETED|Overall Study||15
10488808|NCT01178827|11638548|FG000|STARTED|Overall Study||6
10488809|NCT01178827|11638549|FG001|STARTED|Overall Study||10
10488810|NCT01178827|11638550|FG002|STARTED|Overall Study||4
10488811|NCT01178827|11638548|FG000|COMPLETED|Overall Study||6
10488812|NCT01178827|11638549|FG001|COMPLETED|Overall Study||10
10488813|NCT01178827|11638550|FG002|COMPLETED|Overall Study||4
10488814|NCT01178827|11638548|FG000|NOT COMPLETED|Overall Study||0
10488815|NCT01178827|11638549|FG001|NOT COMPLETED|Overall Study||0
10488816|NCT01178827|11638550|FG002|NOT COMPLETED|Overall Study||0
10488817|NCT01178853|11638560|FG000|STARTED|Period 1 (Warfarin Titration)||24
10488818|NCT01178853|11638561|FG001|STARTED|Period 1 (Warfarin Titration)||24
10488819|NCT01178853|11638560|FG000|COMPLETED|Period 1 (Warfarin Titration)||23
10488820|NCT01178853|11638561|FG001|COMPLETED|Period 1 (Warfarin Titration)||22
10488821|NCT01178853|11638560|FG000|NOT COMPLETED|Period 1 (Warfarin Titration)||1
10488822|NCT01178853|11638561|FG001|NOT COMPLETED|Period 1 (Warfarin Titration)||2
10488823|NCT01178853|11638560|FG000|STARTED|Period 2 (Warfarin + Study Drug)||23
10710048|NCT02646891|11875212|FG003|STARTED|Overall Study||6
10710049|NCT02646891|11875213|FG004|STARTED|Overall Study||12
10488824|NCT01178853|11638561|FG001|STARTED|Period 2 (Warfarin + Study Drug)||22
10710050|NCT02646891|11875214|FG005|STARTED|Overall Study||12
10488825|NCT01178853|11638560|FG000|COMPLETED|Period 2 (Warfarin + Study Drug)||22
10488826|NCT01178853|11638561|FG001|COMPLETED|Period 2 (Warfarin + Study Drug)||22
10488827|NCT01178853|11638560|FG000|NOT COMPLETED|Period 2 (Warfarin + Study Drug)||1
10488828|NCT01178853|11638561|FG001|NOT COMPLETED|Period 2 (Warfarin + Study Drug)||0
10488829|NCT01178853|11638560|FG000|STARTED|Period 3 (Warfarin Titration)||22
10488830|NCT01178853|11638561|FG001|STARTED|Period 3 (Warfarin Titration)||22
10488831|NCT01178853|11638560|FG000|COMPLETED|Period 3 (Warfarin Titration)||21
10488832|NCT01178853|11638561|FG001|COMPLETED|Period 3 (Warfarin Titration)||22
10488833|NCT01178853|11638560|FG000|NOT COMPLETED|Period 3 (Warfarin Titration)||1
10488834|NCT01178853|11638561|FG001|NOT COMPLETED|Period 3 (Warfarin Titration)||0
10710051|NCT02646891|11875215|FG006|STARTED|Overall Study||139
10488835|NCT01178853|11638560|FG000|STARTED|Period 4 (Warfarin + Study Drug)||21
10488836|NCT01178853|11638561|FG001|STARTED|Period 4 (Warfarin + Study Drug)||22
10488837|NCT01178853|11638560|FG000|COMPLETED|Period 4 (Warfarin + Study Drug)||21
10488838|NCT01178853|11638561|FG001|COMPLETED|Period 4 (Warfarin + Study Drug)||19
10488839|NCT01178853|11638560|FG000|NOT COMPLETED|Period 4 (Warfarin + Study Drug)||0
10488840|NCT01178853|11638561|FG001|NOT COMPLETED|Period 4 (Warfarin + Study Drug)||3
10488841|NCT01178944|11638567|FG000|STARTED|Overall Study||35
10488842|NCT01178944|11638567|FG000|COMPLETED|Overall Study||35
10488843|NCT01178944|11638567|FG000|NOT COMPLETED|Overall Study||0
10488844|NCT01179048|11638573|FG000|STARTED|Overall Study||4668
10488845|NCT01179048|11638574|FG001|STARTED|Overall Study||4672
10488846|NCT01179048|11638573|FG000|COMPLETED|Overall Study||4529
10488847|NCT01179048|11638574|FG001|COMPLETED|Overall Study||4513
10488848|NCT01179048|11638573|FG000|NOT COMPLETED|Overall Study||139
10488849|NCT01179048|11638574|FG001|NOT COMPLETED|Overall Study||159
10488850|NCT01179113|11638582|FG000|STARTED|Overall Study||17
10488851|NCT01179113|11638583|FG001|STARTED|Overall Study||16
10488852|NCT01179113|11638582|FG000|COMPLETED|Overall Study||17
10488853|NCT01179113|11638583|FG001|COMPLETED|Overall Study||16
10488854|NCT01179113|11638582|FG000|NOT COMPLETED|Overall Study||0
10488855|NCT01179113|11638583|FG001|NOT COMPLETED|Overall Study||0
10488856|NCT01179191|11638589|FG000|STARTED|Titration Phase (up to 6 Weeks)||684
10488857|NCT01179191|11638589|FG000|COMPLETED|Titration Phase (up to 6 Weeks)||351
10488858|NCT01179191|11638589|FG000|NOT COMPLETED|Titration Phase (up to 6 Weeks)||333
10488859|NCT01179191|11638589|FG000|STARTED|Maintenance Phase (8 Weeks)||351
10488860|NCT01179191|11638589|FG000|COMPLETED|Maintenance Phase (8 Weeks)||234
10488861|NCT01179191|11638589|FG000|NOT COMPLETED|Maintenance Phase (8 Weeks)||117
10488862|NCT01179217|11638595|FG000|STARTED|Overall Study||152
10488863|NCT01179217|11638596|FG001|STARTED|Overall Study||78
10488864|NCT01179217|11638595|FG000|COMPLETED|Overall Study||97
10488865|NCT01179217|11638596|FG001|COMPLETED|Overall Study||59
10488866|NCT01179217|11638595|FG000|NOT COMPLETED|Overall Study||55
10488867|NCT01179217|11638596|FG001|NOT COMPLETED|Overall Study||19
10488868|NCT01179334|11638606|FG000|STARTED|Treatment Period||12
10488869|NCT01179334|11638607|FG001|STARTED|Treatment Period||6
10488870|NCT01179334|11638606|FG000|Participants Received Treatment|Treatment Period||12
10488871|NCT01179334|11638607|FG001|Participants Received Treatment|Treatment Period||6
10488872|NCT01179334|11638606|FG000|COMPLETED|Treatment Period||11
10488873|NCT01179334|11638607|FG001|COMPLETED|Treatment Period||6
10488874|NCT01179334|11638606|FG000|NOT COMPLETED|Treatment Period||1
10488875|NCT01179334|11638607|FG001|NOT COMPLETED|Treatment Period||0
10488876|NCT01179334|11638606|FG000|STARTED|Long-term Extension (LTE) Period||11
10488877|NCT01179334|11638607|FG001|STARTED|Long-term Extension (LTE) Period||6
10488878|NCT01179334|11638606|FG000|COMPLETED|Long-term Extension (LTE) Period|LTE phase was terminated by sponsor|0
10488879|NCT01179334|11638607|FG001|COMPLETED|Long-term Extension (LTE) Period|LTE phase was terminated by sponsor|0
10488880|NCT01179334|11638606|FG000|NOT COMPLETED|Long-term Extension (LTE) Period||11
10488881|NCT01179334|11638607|FG001|NOT COMPLETED|Long-term Extension (LTE) Period||6
10488882|NCT01179347|11638615|FG000|STARTED|Double-blind Period (12 Weeks)|Entered and treated in double-blind period.|155
10488924|NCT01179568|11638649|FG000|NOT COMPLETED|Overall Study||28
10488883|NCT01179347|11638616|FG001|STARTED|Double-blind Period (12 Weeks)|Entered and treated in double-blind period.|308
10488884|NCT01179347|11638615|FG000|COMPLETED|Double-blind Period (12 Weeks)|Completed double-blind period.|147
10488885|NCT01179347|11638616|FG001|COMPLETED|Double-blind Period (12 Weeks)|Completed double-blind period.|294
10488886|NCT01179347|11638615|FG000|NOT COMPLETED|Double-blind Period (12 Weeks)||8
10488887|NCT01179347|11638616|FG001|NOT COMPLETED|Double-blind Period (12 Weeks)||14
10488888|NCT01179347|11638615|FG000|STARTED|Open-label Period (12 Weeks)|Treated in open-label period.|147
10488889|NCT01179347|11638616|FG001|STARTED|Open-label Period (12 Weeks)|Treated in open-label period.|294
10488890|NCT01179347|11638615|FG000|COMPLETED|Open-label Period (12 Weeks)|Completed open-label period.|132
10488891|NCT01179347|11638616|FG001|COMPLETED|Open-label Period (12 Weeks)|Completed open-label period.|278
10488892|NCT01179347|11638615|FG000|NOT COMPLETED|Open-label Period (12 Weeks)||15
10488893|NCT01179347|11638616|FG001|NOT COMPLETED|Open-label Period (12 Weeks)||16
10527668|NCT01390948|11679868|FG000|COMPLETED|Overall Study||44
10527669|NCT01390948|11679869|FG001|COMPLETED|Overall Study||44
10527670|NCT01390948|11679870|FG002|COMPLETED|Overall Study||2
10527671|NCT01390948|11679868|FG000|NOT COMPLETED|Overall Study||15
10527672|NCT01390948|11679869|FG001|NOT COMPLETED|Overall Study||18
10527673|NCT01390948|11679870|FG002|NOT COMPLETED|Overall Study||1
10527674|NCT01391000|11679879|FG000|STARTED|Overall Study||35
10527675|NCT01391000|11679880|FG001|STARTED|Overall Study||35
10527676|NCT01391000|11679879|FG000|COMPLETED|Overall Study||33
10527677|NCT01391000|11679880|FG001|COMPLETED|Overall Study||35
10527678|NCT01391000|11679879|FG000|NOT COMPLETED|Overall Study||2
10527679|NCT01391000|11679880|FG001|NOT COMPLETED|Overall Study||0
10527680|NCT01391013|11679888|FG000|STARTED|Overall Study||15
10710052|NCT02646891|11875216|FG007|STARTED|Overall Study||140
10527681|NCT01391013|11679889|FG001|STARTED|Overall Study||15
10527682|NCT01391013|11679888|FG000|COMPLETED|Overall Study||15
10710053|NCT02646891|11875217|FG008|STARTED|Overall Study||140
10527683|NCT01391013|11679889|FG001|COMPLETED|Overall Study||15
10649993|NCT02165202|11810123|FG000|NOT COMPLETED|Injection Phase||10
10649994|NCT02165202|11810124|FG001|NOT COMPLETED|Injection Phase||6
10649995|NCT02165384|11810130|FG000|STARTED|Overall Study||199
10649996|NCT02165384|11810130|FG000|COMPLETED|Overall Study||199
10649997|NCT02165384|11810130|FG000|NOT COMPLETED|Overall Study||0
10649998|NCT02165397|11810137|FG000|STARTED|Overall Study||75
10649999|NCT02165397|11810138|FG001|STARTED|Overall Study||75
10650000|NCT02165397|11810139|FG002|STARTED|Overall Study||31
10650001|NCT02165397|11810137|FG000|COMPLETED|Overall Study||61
10650002|NCT02165397|11810138|FG001|COMPLETED|Overall Study||56
10650003|NCT02165397|11810139|FG002|COMPLETED|Overall Study||21
10650004|NCT02165397|11810137|FG000|NOT COMPLETED|Overall Study||14
10650005|NCT02165397|11810138|FG001|NOT COMPLETED|Overall Study||19
10488894|NCT01179477|11638624|FG000|STARTED|Overall Study||1930
10488895|NCT01179477|11638624|FG000|COMPLETED|Overall Study||843
10488896|NCT01179477|11638624|FG000|NOT COMPLETED|Overall Study||1087
10488897|NCT01179490|11638628|FG000|STARTED|Overall Study||5
10488898|NCT01179490|11638628|FG000|COMPLETED|Overall Study||5
10488899|NCT01179490|11638628|FG000|NOT COMPLETED|Overall Study||0
10488900|NCT01179516|11638635|FG000|STARTED|Overall Study||160
10488901|NCT01179516|11638636|FG001|STARTED|Overall Study||157
10488902|NCT01179516|11638637|FG002|STARTED|Overall Study||152
10488903|NCT01179516|11638635|FG000|Treated|Overall Study||160
10488904|NCT01179516|11638636|FG001|Treated|Overall Study||154
10488905|NCT01179516|11638637|FG002|Treated|Overall Study||151
10488906|NCT01179516|11638635|FG000|COMPLETED|Overall Study||133
10488907|NCT01179516|11638636|FG001|COMPLETED|Overall Study||131
10488908|NCT01179516|11638637|FG002|COMPLETED|Overall Study||121
10488909|NCT01179516|11638635|FG000|NOT COMPLETED|Overall Study||27
10488910|NCT01179516|11638636|FG001|NOT COMPLETED|Overall Study||26
10488911|NCT01179516|11638637|FG002|NOT COMPLETED|Overall Study||31
10488912|NCT01179568|11638649|FG000|STARTED|Overall Study||101
10488913|NCT01179568|11638650|FG001|STARTED|Overall Study||99
10488914|NCT01179568|11638651|FG002|STARTED|Overall Study||99
10488915|NCT01179568|11638652|FG003|STARTED|Overall Study||96
10488916|NCT01179568|11638649|FG000|Completed Week 12 Assessment|Overall Study||69
10488917|NCT01179568|11638650|FG001|Completed Week 12 Assessment|Overall Study||69
10488918|NCT01179568|11638651|FG002|Completed Week 12 Assessment|Overall Study||76
10488919|NCT01179568|11638652|FG003|Completed Week 12 Assessment|Overall Study||75
10488920|NCT01179568|11638649|FG000|COMPLETED|Overall Study||73
10488921|NCT01179568|11638650|FG001|COMPLETED|Overall Study||61
10488922|NCT01179568|11638651|FG002|COMPLETED|Overall Study||76
10710054|NCT02646891|11875218|FG009|STARTED|Overall Study||139
10710055|NCT02646891|11875209|FG000|Received at Least 1 Dose|Overall Study||6
10710056|NCT02646891|11875210|FG001|Received at Least 1 Dose|Overall Study||12
10710057|NCT02646891|11875211|FG002|Received at Least 1 Dose|Overall Study||12
10710058|NCT02646891|11875212|FG003|Received at Least 1 Dose|Overall Study||6
10710059|NCT02646891|11875213|FG004|Received at Least 1 Dose|Overall Study||12
10710060|NCT02646891|11875214|FG005|Received at Least 1 Dose|Overall Study||12
10710061|NCT02646891|11875215|FG006|Received at Least 1 Dose|Overall Study||139
10710062|NCT02646891|11875216|FG007|Received at Least 1 Dose|Overall Study|One participant was randomized but determined to be ineligible pre-vaccination.|139
10710063|NCT02646891|11875217|FG008|Received at Least 1 Dose|Overall Study||140
10710064|NCT02646891|11875218|FG009|Received at Least 1 Dose|Overall Study||139
10710065|NCT02646891|11875209|FG000|COMPLETED|Overall Study||4
10710066|NCT02646891|11875210|FG001|COMPLETED|Overall Study||11
10710067|NCT02646891|11875211|FG002|COMPLETED|Overall Study||11
10488923|NCT01179568|11638652|FG003|COMPLETED|Overall Study||76
10488925|NCT01179568|11638650|FG001|NOT COMPLETED|Overall Study||38
10488926|NCT01179568|11638651|FG002|NOT COMPLETED|Overall Study||23
10488927|NCT01179568|11638652|FG003|NOT COMPLETED|Overall Study||20
10488928|NCT01179672|11638667|FG000|STARTED|Overall Study||203
10488929|NCT01179672|11638668|FG001|STARTED|Overall Study||202
10488930|NCT01179672|11638667|FG000|Received at Least 1 Dose of Study Drug|Overall Study||202
10650006|NCT02165397|11810139|FG002|NOT COMPLETED|Overall Study||10
10650007|NCT02165462|11810149|FG000|STARTED|Overall Study||17
10650008|NCT02165462|11810149|FG000|COMPLETED|Overall Study||17
10650009|NCT02165462|11810149|FG000|NOT COMPLETED|Overall Study||0
10650010|NCT02165605|11810153|FG000|STARTED|Overall Study||28
10710068|NCT02646891|11875212|FG003|COMPLETED|Overall Study||6
10710069|NCT02646891|11875213|FG004|COMPLETED|Overall Study||12
10710070|NCT02646891|11875214|FG005|COMPLETED|Overall Study||12
10710071|NCT02646891|11875215|FG006|COMPLETED|Overall Study||130
10710072|NCT02646891|11875216|FG007|COMPLETED|Overall Study||127
10710073|NCT02646891|11875217|FG008|COMPLETED|Overall Study||130
10710074|NCT02646891|11875218|FG009|COMPLETED|Overall Study||134
10710075|NCT02646891|11875209|FG000|NOT COMPLETED|Overall Study||2
10710076|NCT02646891|11875210|FG001|NOT COMPLETED|Overall Study||1
10710077|NCT02646891|11875211|FG002|NOT COMPLETED|Overall Study||1
10710078|NCT02646891|11875212|FG003|NOT COMPLETED|Overall Study||0
10710079|NCT02646891|11875213|FG004|NOT COMPLETED|Overall Study||0
10710080|NCT02646891|11875214|FG005|NOT COMPLETED|Overall Study||0
10710081|NCT02646891|11875215|FG006|NOT COMPLETED|Overall Study||9
10710082|NCT02646891|11875216|FG007|NOT COMPLETED|Overall Study||13
10710083|NCT02646891|11875217|FG008|NOT COMPLETED|Overall Study||10
10710084|NCT02646891|11875218|FG009|NOT COMPLETED|Overall Study||5
10710085|NCT02646917|11875254|FG000|STARTED|Overall Study||21
10710086|NCT02646917|11875255|FG001|STARTED|Overall Study||20
10710087|NCT02646917|11875254|FG000|COMPLETED|Overall Study||21
10710088|NCT02646917|11875255|FG001|COMPLETED|Overall Study||20
10710089|NCT02646917|11875254|FG000|NOT COMPLETED|Overall Study||0
10710090|NCT02646917|11875255|FG001|NOT COMPLETED|Overall Study||0
10710091|NCT02647203|11875268|FG000|STARTED|12 Month Follow-up||173
10710092|NCT02647203|11875269|FG001|STARTED|12 Month Follow-up||172
10488931|NCT01179672|11638668|FG001|Received at Least 1 Dose of Study Drug|Overall Study||202
10488932|NCT01179672|11638667|FG000|Entered Taper|Overall Study||181
10488933|NCT01179672|11638668|FG001|Entered Taper|Overall Study||177
10488934|NCT01179672|11638667|FG000|COMPLETED|Overall Study||173
10488935|NCT01179672|11638668|FG001|COMPLETED|Overall Study||176
10488936|NCT01179672|11638667|FG000|NOT COMPLETED|Overall Study||30
10488937|NCT01179672|11638668|FG001|NOT COMPLETED|Overall Study||26
10488938|NCT01179919|11638678|FG000|STARTED|Overall Study||21
10488939|NCT01179919|11638678|FG000|COMPLETED|Overall Study||19
10488940|NCT01179919|11638678|FG000|NOT COMPLETED|Overall Study||2
10488941|NCT01179984|11638682|FG000|STARTED|Overall Study||76
10488942|NCT01179984|11638682|FG000|COMPLETED|Overall Study||58
10488943|NCT01179984|11638682|FG000|NOT COMPLETED|Overall Study||18
10488944|NCT01180036|11638689|FG000|STARTED|Overall Study||65
10488945|NCT01180036|11638690|FG001|STARTED|Overall Study||65
10488946|NCT01180036|11638689|FG000|COMPLETED|Overall Study||65
10488947|NCT01180036|11638690|FG001|COMPLETED|Overall Study||65
10488948|NCT01180036|11638689|FG000|NOT COMPLETED|Overall Study||0
10488949|NCT01180036|11638690|FG001|NOT COMPLETED|Overall Study||0
10488950|NCT01180049|11638700|FG000|STARTED|Overall Study||53
10488951|NCT01180049|11638701|FG001|STARTED|Overall Study||48
10488952|NCT01180049|11638700|FG000|COMPLETED|Overall Study||0
10488953|NCT01180049|11638701|FG001|COMPLETED|Overall Study||0
10488954|NCT01180049|11638700|FG000|NOT COMPLETED|Overall Study||53
10488955|NCT01180049|11638701|FG001|NOT COMPLETED|Overall Study||48
10488956|NCT01180127|11638711|FG000|STARTED|Overall Study||10
10488957|NCT01180127|11638712|FG001|STARTED|Overall Study||11
10488958|NCT01180127|11638713|FG002|STARTED|Overall Study||10
10488959|NCT01180127|11638714|FG003|STARTED|Overall Study||10
10488960|NCT01180127|11638711|FG000|COMPLETED|Overall Study||8
10488961|NCT01180127|11638712|FG001|COMPLETED|Overall Study||11
10488962|NCT01180127|11638713|FG002|COMPLETED|Overall Study||9
10488963|NCT01180127|11638714|FG003|COMPLETED|Overall Study||9
10488964|NCT01180127|11638711|FG000|NOT COMPLETED|Overall Study||2
10488965|NCT01180127|11638712|FG001|NOT COMPLETED|Overall Study||0
10488966|NCT01180127|11638713|FG002|NOT COMPLETED|Overall Study||1
10488967|NCT01180127|11638714|FG003|NOT COMPLETED|Overall Study||1
10488968|NCT01180244|11638730|FG000|STARTED|Overall Study|Number of enrolled patients initially randomized to active treatment group|45
10488969|NCT01180244|11638731|FG001|STARTED|Overall Study|Number of enrolled patients initially randomized to placebo group|46
10488970|NCT01180244|11638730|FG000|Received Treatment|Overall Study|Number of patients in the active treatment group that received at least one study treatment|40
10488971|NCT01180244|11638731|FG001|Received Treatment|Overall Study|Number of patients in the placebo group that received at least one sham treatment|45
10488972|NCT01180244|11638730|FG000|COMPLETED|Overall Study|Number of active treatment patients who completed all study visits and are evaluable|39
10488973|NCT01180244|11638731|FG001|COMPLETED|Overall Study|Number of placebo group patients who completed all study visits and are evaluable|38
10488974|NCT01180244|11638730|FG000|NOT COMPLETED|Overall Study||6
10488975|NCT01180244|11638731|FG001|NOT COMPLETED|Overall Study||8
10488976|NCT01180296|11638739|FG000|STARTED|Overall Study||20
10488977|NCT01180296|11638740|FG001|STARTED|Overall Study||16
10488978|NCT01180296|11638739|FG000|COMPLETED|Overall Study||19
10488979|NCT01180296|11638740|FG001|COMPLETED|Overall Study||14
10488980|NCT01180296|11638739|FG000|NOT COMPLETED|Overall Study||1
10488981|NCT01180296|11638740|FG001|NOT COMPLETED|Overall Study||2
10488982|NCT01180400|11638750|FG000|STARTED|Overall Study||147
10488983|NCT01180400|11638751|FG001|STARTED|Overall Study||148
10488984|NCT01180400|11638750|FG000|Received Treatment|Overall Study||147
10488985|NCT01180400|11638751|FG001|Received Treatment|Overall Study||146
10488986|NCT01180400|11638750|FG000|COMPLETED|Overall Study||122
10488987|NCT01180400|11638751|FG001|COMPLETED|Overall Study||121
10488988|NCT01180400|11638750|FG000|NOT COMPLETED|Overall Study||25
10488989|NCT01180400|11638751|FG001|NOT COMPLETED|Overall Study||27
10488990|NCT01180478|11638759|FG000|STARTED|Overall Study||484
10488991|NCT01180478|11638760|FG001|STARTED|Overall Study||481
10488992|NCT01180478|11638759|FG000|COMPLETED|Overall Study||303
10488993|NCT01180478|11638760|FG001|COMPLETED|Overall Study||293
10488994|NCT01180478|11638759|FG000|NOT COMPLETED|Overall Study||181
10488995|NCT01180478|11638760|FG001|NOT COMPLETED|Overall Study||188
10488996|NCT01180647|11638770|FG000|STARTED|Overall Study||17
10488997|NCT01180647|11638771|FG001|STARTED|Overall Study||17
10488998|NCT01180647|11638770|FG000|COMPLETED|Overall Study||12
10488999|NCT01180647|11638771|FG001|COMPLETED|Overall Study||11
10489000|NCT01180647|11638770|FG000|NOT COMPLETED|Overall Study||5
10710093|NCT02647203|11875268|FG000|COMPLETED|12 Month Follow-up||148
10710094|NCT02647203|11875269|FG001|COMPLETED|12 Month Follow-up||149
10710095|NCT02647203|11875268|FG000|NOT COMPLETED|12 Month Follow-up||25
10710096|NCT02647203|11875269|FG001|NOT COMPLETED|12 Month Follow-up||23
10489001|NCT01180647|11638771|FG001|NOT COMPLETED|Overall Study||6
10489002|NCT01180660|11638779|FG000|STARTED|Overall Study||25
10489003|NCT01180660|11638780|FG001|STARTED|Overall Study||26
10489004|NCT01180660|11638779|FG000|COMPLETED|Overall Study||24
10489005|NCT01180660|11638780|FG001|COMPLETED|Overall Study||26
10489006|NCT01180660|11638779|FG000|NOT COMPLETED|Overall Study||1
10489007|NCT01180660|11638780|FG001|NOT COMPLETED|Overall Study||0
10489008|NCT01180777|11638786|FG000|STARTED|Overall Study||92
10489009|NCT01180777|11638786|FG000|COMPLETED|Overall Study||80
10489010|NCT01180777|11638786|FG000|NOT COMPLETED|Overall Study||12
10489011|NCT01180790|11638799|FG000|STARTED|Overall Study||16
10710097|NCT02647203|11875268|FG000|STARTED|24 Month Follow-up||148
10710098|NCT02647203|11875269|FG001|STARTED|24 Month Follow-up||149
10489012|NCT01180790|11638800|FG001|STARTED|Overall Study||16
10489013|NCT01180790|11638801|FG002|STARTED|Overall Study||17
10489014|NCT01180790|11638802|FG003|STARTED|Overall Study||15
10489015|NCT01180790|11638803|FG004|STARTED|Overall Study||19
10489016|NCT01180790|11638804|FG005|STARTED|Overall Study||20
10489017|NCT01180790|11638805|FG006|STARTED|Overall Study||19
10489018|NCT01180790|11638799|FG000|COMPLETED|Overall Study||7
10489019|NCT01180790|11638800|FG001|COMPLETED|Overall Study||11
10489020|NCT01180790|11638801|FG002|COMPLETED|Overall Study||4
10489021|NCT01180790|11638802|FG003|COMPLETED|Overall Study||6
10489022|NCT01180790|11638803|FG004|COMPLETED|Overall Study||14
10489023|NCT01180790|11638804|FG005|COMPLETED|Overall Study||13
10489024|NCT01180790|11638805|FG006|COMPLETED|Overall Study||18
10489025|NCT01180790|11638799|FG000|NOT COMPLETED|Overall Study||9
10489026|NCT01180790|11638800|FG001|NOT COMPLETED|Overall Study||5
10489027|NCT01180790|11638801|FG002|NOT COMPLETED|Overall Study||13
10489028|NCT01180790|11638802|FG003|NOT COMPLETED|Overall Study||9
10489029|NCT01180790|11638803|FG004|NOT COMPLETED|Overall Study||5
10489030|NCT01180790|11638804|FG005|NOT COMPLETED|Overall Study||7
10489031|NCT01180790|11638805|FG006|NOT COMPLETED|Overall Study||1
10489032|NCT01180894|11638851|FG000|STARTED|Overall Study||75
10489033|NCT01180894|11638852|FG001|STARTED|Overall Study||75
10489034|NCT01180894|11638851|FG000|COMPLETED|Overall Study||75
10489035|NCT01180894|11638852|FG001|COMPLETED|Overall Study||75
10489036|NCT01180894|11638851|FG000|NOT COMPLETED|Overall Study||0
10489037|NCT01180894|11638852|FG001|NOT COMPLETED|Overall Study||0
10489038|NCT01180985|11638860|FG000|STARTED|Period 1 (7 +/- Days)||27
10489039|NCT01180985|11638861|FG001|STARTED|Period 1 (7 +/- Days)||26
10489040|NCT01180985|11638860|FG000|COMPLETED|Period 1 (7 +/- Days)||27
10489041|NCT01180985|11638861|FG001|COMPLETED|Period 1 (7 +/- Days)||26
10489042|NCT01180985|11638860|FG000|NOT COMPLETED|Period 1 (7 +/- Days)||0
10489043|NCT01180985|11638861|FG001|NOT COMPLETED|Period 1 (7 +/- Days)||0
10489044|NCT01180985|11638860|FG000|STARTED|Period 2 (7 +/- 1 Days)||27
10489045|NCT01180985|11638861|FG001|STARTED|Period 2 (7 +/- 1 Days)||26
10489046|NCT01180985|11638860|FG000|COMPLETED|Period 2 (7 +/- 1 Days)||26
10489047|NCT01180985|11638861|FG001|COMPLETED|Period 2 (7 +/- 1 Days)||26
10489048|NCT01180985|11638860|FG000|NOT COMPLETED|Period 2 (7 +/- 1 Days)||1
10489049|NCT01180985|11638861|FG001|NOT COMPLETED|Period 2 (7 +/- 1 Days)||0
10489050|NCT01180998|11638871|FG000|STARTED|Overall Study||67
10489051|NCT01180998|11638872|FG001|STARTED|Overall Study||72
10489052|NCT01180998|11638873|FG002|STARTED|Overall Study||61
10489053|NCT01180998|11638871|FG000|COMPLETED|Overall Study||63
10710099|NCT02647203|11875268|FG000|COMPLETED|24 Month Follow-up||142
10710100|NCT02647203|11875269|FG001|COMPLETED|24 Month Follow-up||138
10710101|NCT02647203|11875268|FG000|NOT COMPLETED|24 Month Follow-up||6
10710102|NCT02647203|11875269|FG001|NOT COMPLETED|24 Month Follow-up||11
10710103|NCT02647281|11875284|FG000|STARTED|Single-Ascending Dose(Part 1-62 Days)||8
10710104|NCT02647281|11875285|FG001|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
10710105|NCT02647281|11875286|FG002|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
10710106|NCT02647281|11875287|FG003|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
10710107|NCT02647281|11875288|FG004|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
10710108|NCT02647281|11875289|FG005|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
10710109|NCT02647281|11875290|FG006|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
10710110|NCT02647281|11875291|FG007|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
10710111|NCT02647281|11875292|FG008|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
10489054|NCT01180998|11638872|FG001|COMPLETED|Overall Study||68
10489055|NCT01180998|11638873|FG002|COMPLETED|Overall Study||51
10489056|NCT01180998|11638871|FG000|NOT COMPLETED|Overall Study||4
10489057|NCT01180998|11638872|FG001|NOT COMPLETED|Overall Study||4
10489058|NCT01180998|11638873|FG002|NOT COMPLETED|Overall Study||10
10489059|NCT01181011|11638882|FG000|STARTED|Overall Study||28
10489060|NCT01181011|11638882|FG000|Received Telmisartan 80mg|Overall Study||27
10489061|NCT01181011|11638882|FG000|Received Telmisartan 80mg,Amlodipine 5mg|Overall Study||27
10489062|NCT01181011|11638882|FG000|Received Amlodipine 5mg|Overall Study||26
10489063|NCT01181011|11638882|FG000|COMPLETED|Overall Study||25
10489064|NCT01181011|11638882|FG000|NOT COMPLETED|Overall Study||3
10489065|NCT01181050|11638893|FG000|STARTED|Overall Study||41
10489066|NCT01181050|11638894|FG001|STARTED|Overall Study||22
10489067|NCT01181050|11638893|FG000|COMPLETED|Overall Study||41
10489068|NCT01181050|11638894|FG001|COMPLETED|Overall Study||22
10489069|NCT01181050|11638893|FG000|NOT COMPLETED|Overall Study||0
10489070|NCT01181050|11638894|FG001|NOT COMPLETED|Overall Study||0
10489071|NCT01181076|11638902|FG000|STARTED|Overall Study||59
10710112|NCT02647281|11875284|FG000|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||8
10710113|NCT02647281|11875285|FG001|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
10710114|NCT02647281|11875286|FG002|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
10489072|NCT01181076|11638903|FG001|STARTED|Overall Study||60
10489073|NCT01181076|11638902|FG000|COMPLETED|Overall Study||40
10489074|NCT01181076|11638903|FG001|COMPLETED|Overall Study|As determined|48
10489075|NCT01181076|11638902|FG000|NOT COMPLETED|Overall Study||19
10489076|NCT01181076|11638903|FG001|NOT COMPLETED|Overall Study||12
10489077|NCT01181102|11638911|FG000|STARTED|Overall Study||360
10489078|NCT01181102|11638912|FG001|STARTED|Overall Study||356
10489079|NCT01181102|11638911|FG000|Safety Analysis Set|Overall Study||354
10489080|NCT01181102|11638912|FG001|Safety Analysis Set|Overall Study||349
10489081|NCT01181102|11638911|FG000|Efficacy Analysis Population|Overall Study||299
10489082|NCT01181102|11638912|FG001|Efficacy Analysis Population|Overall Study||295
10489083|NCT01181102|11638911|FG000|COMPLETED|Overall Study||309
10489084|NCT01181102|11638912|FG001|COMPLETED|Overall Study||310
10489085|NCT01181102|11638911|FG000|NOT COMPLETED|Overall Study||51
10489086|NCT01181102|11638912|FG001|NOT COMPLETED|Overall Study||46
10489087|NCT01181128|11638921|FG000|STARTED|Overall Study||118
10489088|NCT01181128|11638922|FG001|STARTED|Overall Study||24
10489089|NCT01181128|11638923|FG002|STARTED|Overall Study||23
10489090|NCT01181128|11638921|FG000|Pharmacokinetic (PK) Subgroup|Overall Study||30
10489091|NCT01181128|11638922|FG001|Pharmacokinetic (PK) Subgroup|Overall Study||0
10489092|NCT01181128|11638923|FG002|Pharmacokinetic (PK) Subgroup|Overall Study||0
10489093|NCT01181128|11638921|FG000|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|8
10489094|NCT01181128|11638922|FG001|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|1
10489095|NCT01181128|11638923|FG002|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|0
10489096|NCT01181128|11638921|FG000|COMPLETED|Overall Study||112
10489097|NCT01181128|11638922|FG001|COMPLETED|Overall Study||19
10489098|NCT01181128|11638923|FG002|COMPLETED|Overall Study||22
10489099|NCT01181128|11638921|FG000|NOT COMPLETED|Overall Study||6
10489100|NCT01181128|11638922|FG001|NOT COMPLETED|Overall Study||5
10489101|NCT01181128|11638923|FG002|NOT COMPLETED|Overall Study||1
10489102|NCT01181141|11638945|FG000|STARTED|Overall Study||62
10489103|NCT01181141|11638946|FG001|STARTED|Overall Study||30
10489104|NCT01181141|11638945|FG000|Safety Analysis Population|Overall Study||59
10489105|NCT01181141|11638946|FG001|Safety Analysis Population|Overall Study||29
10489106|NCT01181141|11638945|FG000|COMPLETED|Overall Study||50
10489107|NCT01181141|11638946|FG001|COMPLETED|Overall Study||26
10489108|NCT01181141|11638945|FG000|NOT COMPLETED|Overall Study||12
10489109|NCT01181141|11638946|FG001|NOT COMPLETED|Overall Study||4
10489110|NCT01181167|11638954|FG000|STARTED|Overall Study||307
10489111|NCT01181167|11638955|FG001|STARTED|Overall Study||303
10489112|NCT01181167|11638954|FG000|Efficacy Analysis Population|Overall Study||255
10489113|NCT01181167|11638955|FG001|Efficacy Analysis Population|Overall Study||248
10489114|NCT01181167|11638954|FG000|COMPLETED|Overall Study||284
10489115|NCT01181167|11638955|FG001|COMPLETED|Overall Study||271
10489116|NCT01181167|11638954|FG000|NOT COMPLETED|Overall Study||23
10489117|NCT01181167|11638955|FG001|NOT COMPLETED|Overall Study||32
10489118|NCT01181258|11638961|FG000|STARTED|Overall Study||16
10489119|NCT01181258|11638961|FG000|COMPLETED|Overall Study||16
10489120|NCT01181258|11638961|FG000|NOT COMPLETED|Overall Study||0
10489121|NCT01181271|11638965|FG000|STARTED|Autologous Transplant||42
10489122|NCT01181271|11638965|FG000|COMPLETED|Autologous Transplant||42
10489123|NCT01181271|11638965|FG000|NOT COMPLETED|Autologous Transplant||0
10489124|NCT01181271|11638965|FG000|STARTED|Evaluation for Allogeneic Transplant||42
10710115|NCT02647281|11875287|FG003|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
10710116|NCT02647281|11875288|FG004|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
10710117|NCT02647281|11875289|FG005|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
10489125|NCT01181271|11638965|FG000|COMPLETED|Evaluation for Allogeneic Transplant||29
10489126|NCT01181271|11638965|FG000|NOT COMPLETED|Evaluation for Allogeneic Transplant||13
10489127|NCT01181271|11638965|FG000|STARTED|Allogeneic Transplant||29
10489128|NCT01181271|11638965|FG000|COMPLETED|Allogeneic Transplant||29
10489129|NCT01181271|11638965|FG000|NOT COMPLETED|Allogeneic Transplant||0
10489130|NCT01181323|11638973|FG000|STARTED|Overall Study||124
10489131|NCT01181323|11638974|FG001|STARTED|Overall Study||124
10489132|NCT01181323|11638975|FG002|STARTED|Overall Study||124
10489133|NCT01181323|11638976|FG003|STARTED|Overall Study||125
10489134|NCT01181323|11638973|FG000|COMPLETED|Overall Study||123
10489135|NCT01181323|11638974|FG001|COMPLETED|Overall Study||121
10489136|NCT01181323|11638975|FG002|COMPLETED|Overall Study||123
10489137|NCT01181323|11638976|FG003|COMPLETED|Overall Study||122
10489138|NCT01181323|11638973|FG000|NOT COMPLETED|Overall Study||1
10489139|NCT01181323|11638974|FG001|NOT COMPLETED|Overall Study||3
10489140|NCT01181323|11638975|FG002|NOT COMPLETED|Overall Study||1
10489141|NCT01181323|11638976|FG003|NOT COMPLETED|Overall Study||3
10489142|NCT01181349|11638998|FG000|STARTED|Overall Study||350
10489143|NCT01181349|11638998|FG000|COMPLETED|Overall Study||350
10489144|NCT01181349|11638998|FG000|NOT COMPLETED|Overall Study||0
10489145|NCT01181479|11639006|FG000|STARTED|Subjects Receive AG200-15 or Lessina||1129
10489146|NCT01181479|11639007|FG001|STARTED|Subjects Receive AG200-15 or Lessina||375
10489147|NCT01181479|11639008|FG002|STARTED|Subjects Receive AG200-15 or Lessina|"This column is a subset of the Lessina completers in the Lessina (Cycles 1-6) column."|0
10489148|NCT01181479|11639006|FG000|COMPLETED|Subjects Receive AG200-15 or Lessina||485
10489149|NCT01181479|11639007|FG001|COMPLETED|Subjects Receive AG200-15 or Lessina||249
10489150|NCT01181479|11639008|FG002|COMPLETED|Subjects Receive AG200-15 or Lessina||0
10489151|NCT01181479|11639006|FG000|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||644
10489152|NCT01181479|11639007|FG001|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||126
10489153|NCT01181479|11639008|FG002|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||0
10489154|NCT01181479|11639006|FG000|STARTED|Crossover Subjects Recieve AG200-15||0
10489155|NCT01181479|11639007|FG001|STARTED|Crossover Subjects Recieve AG200-15||0
10489156|NCT01181479|11639008|FG002|STARTED|Crossover Subjects Recieve AG200-15|"This column is a subset of the Lessina completers in the Lessina (Cycles 1-6) column."|249
10489157|NCT01181479|11639006|FG000|COMPLETED|Crossover Subjects Recieve AG200-15||0
10489158|NCT01181479|11639007|FG001|COMPLETED|Crossover Subjects Recieve AG200-15||0
10489159|NCT01181479|11639008|FG002|COMPLETED|Crossover Subjects Recieve AG200-15||150
10489160|NCT01181479|11639006|FG000|NOT COMPLETED|Crossover Subjects Recieve AG200-15||0
10489161|NCT01181479|11639007|FG001|NOT COMPLETED|Crossover Subjects Recieve AG200-15||0
10489162|NCT01181479|11639008|FG002|NOT COMPLETED|Crossover Subjects Recieve AG200-15||99
10489163|NCT01181492|11639023|FG000|STARTED|Overall Study||103
10489164|NCT01181492|11639024|FG001|STARTED|Overall Study||66
10489165|NCT01181492|11639025|FG002|STARTED|Overall Study||7
10489166|NCT01181492|11639023|FG000|COMPLETED|Overall Study||103
10489167|NCT01181492|11639024|FG001|COMPLETED|Overall Study||66
10489168|NCT01181492|11639025|FG002|COMPLETED|Overall Study||7
10489169|NCT01181492|11639023|FG000|NOT COMPLETED|Overall Study||0
10489170|NCT01181492|11639024|FG001|NOT COMPLETED|Overall Study||0
10489171|NCT01181492|11639025|FG002|NOT COMPLETED|Overall Study||0
10489172|NCT01181531|11639035|FG000|STARTED|Overall Study|Subjects are randomized after washout.|157
10489173|NCT01181531|11639036|FG001|STARTED|Overall Study|Subjects are randomized after washout.|155
10489174|NCT01181531|11639035|FG000|Received Investigational Product|Overall Study||155
10489175|NCT01181531|11639036|FG001|Received Investigational Product|Overall Study||153
10489176|NCT01181531|11639035|FG000|COMPLETED|Overall Study||96
10489177|NCT01181531|11639036|FG001|COMPLETED|Overall Study||102
10489178|NCT01181531|11639035|FG000|NOT COMPLETED|Overall Study||61
10489179|NCT01181531|11639036|FG001|NOT COMPLETED|Overall Study||53
10489180|NCT01181596|11639042|FG000|STARTED|Overall Study||31
10489181|NCT01181596|11639042|FG000|COMPLETED|Overall Study||31
10489182|NCT01181596|11639042|FG000|NOT COMPLETED|Overall Study||0
10489183|NCT01181609|11639047|FG000|STARTED|Overall Study||54
10489184|NCT01181609|11639047|FG000|COMPLETED|Overall Study||1
10489185|NCT01181609|11639047|FG000|NOT COMPLETED|Overall Study||53
10489186|NCT01181674|11639054|FG000|STARTED|Overall Study||28
10489187|NCT01181674|11639055|FG001|STARTED|Overall Study||27
10489188|NCT01181674|11639056|FG002|STARTED|Overall Study||28
10489189|NCT01181674|11639054|FG000|COMPLETED|Overall Study||28
10489190|NCT01181674|11639055|FG001|COMPLETED|Overall Study||27
10489191|NCT01181674|11639056|FG002|COMPLETED|Overall Study|28 included in analyses|26
10489192|NCT01181674|11639054|FG000|NOT COMPLETED|Overall Study||0
10489193|NCT01181674|11639055|FG001|NOT COMPLETED|Overall Study||0
10489194|NCT01181674|11639056|FG002|NOT COMPLETED|Overall Study||2
10489195|NCT01181726|11639066|FG000|STARTED|First Intervention||20
10489196|NCT01181726|11639067|FG001|STARTED|First Intervention||20
10489197|NCT01181726|11639066|FG000|COMPLETED|First Intervention||19
10489198|NCT01181726|11639067|FG001|COMPLETED|First Intervention||20
10489199|NCT01181726|11639066|FG000|NOT COMPLETED|First Intervention||1
10489200|NCT01181726|11639067|FG001|NOT COMPLETED|First Intervention||0
10489201|NCT01181726|11639066|FG000|STARTED|Washout of 28 Days||19
10489202|NCT01181726|11639067|FG001|STARTED|Washout of 28 Days||20
10489203|NCT01181726|11639066|FG000|COMPLETED|Washout of 28 Days||19
10489204|NCT01181726|11639067|FG001|COMPLETED|Washout of 28 Days||20
10489205|NCT01181726|11639066|FG000|NOT COMPLETED|Washout of 28 Days||0
10489206|NCT01181726|11639067|FG001|NOT COMPLETED|Washout of 28 Days||0
10489207|NCT01181726|11639066|FG000|STARTED|Second Intervention||19
10489208|NCT01181726|11639067|FG001|STARTED|Second Intervention||20
10489209|NCT01181726|11639066|FG000|COMPLETED|Second Intervention||19
10489210|NCT01181726|11639067|FG001|COMPLETED|Second Intervention||20
10489211|NCT01181726|11639066|FG000|NOT COMPLETED|Second Intervention||0
10489212|NCT01181726|11639067|FG001|NOT COMPLETED|Second Intervention||0
10489213|NCT01181804|11639077|FG000|STARTED|Period 1, Fed (Part 1)||30
10489214|NCT01181804|11639078|FG001|STARTED|Period 1, Fed (Part 1)||30
10489215|NCT01181804|11639079|FG002|STARTED|Period 1, Fed (Part 1)||0
10489216|NCT01181804|11639080|FG003|STARTED|Period 1, Fed (Part 1)||0
10489217|NCT01181804|11639077|FG000|COMPLETED|Period 1, Fed (Part 1)||30
10489218|NCT01181804|11639078|FG001|COMPLETED|Period 1, Fed (Part 1)||30
10489219|NCT01181804|11639079|FG002|COMPLETED|Period 1, Fed (Part 1)||0
10489220|NCT01181804|11639080|FG003|COMPLETED|Period 1, Fed (Part 1)||0
10489221|NCT01181804|11639077|FG000|NOT COMPLETED|Period 1, Fed (Part 1)||0
10489222|NCT01181804|11639078|FG001|NOT COMPLETED|Period 1, Fed (Part 1)||0
10489223|NCT01181804|11639079|FG002|NOT COMPLETED|Period 1, Fed (Part 1)||0
10489224|NCT01181804|11639080|FG003|NOT COMPLETED|Period 1, Fed (Part 1)||0
10489225|NCT01181804|11639077|FG000|STARTED|Period 2, Fed (Part 1)||30
10489226|NCT01181804|11639078|FG001|STARTED|Period 2, Fed (Part 1)||30
10489227|NCT01181804|11639079|FG002|STARTED|Period 2, Fed (Part 1)||0
10489228|NCT01181804|11639080|FG003|STARTED|Period 2, Fed (Part 1)||0
10489229|NCT01181804|11639077|FG000|COMPLETED|Period 2, Fed (Part 1)||30
10489230|NCT01181804|11639078|FG001|COMPLETED|Period 2, Fed (Part 1)||30
10489231|NCT01181804|11639079|FG002|COMPLETED|Period 2, Fed (Part 1)||0
10489232|NCT01181804|11639080|FG003|COMPLETED|Period 2, Fed (Part 1)||0
10489233|NCT01181804|11639077|FG000|NOT COMPLETED|Period 2, Fed (Part 1)||0
10710118|NCT02647281|11875290|FG006|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
10710119|NCT02647281|11875291|FG007|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
10710120|NCT02647281|11875292|FG008|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
10489234|NCT01181804|11639078|FG001|NOT COMPLETED|Period 2, Fed (Part 1)||0
10489235|NCT01181804|11639079|FG002|NOT COMPLETED|Period 2, Fed (Part 1)||0
10489236|NCT01181804|11639080|FG003|NOT COMPLETED|Period 2, Fed (Part 1)||0
10489237|NCT01181804|11639077|FG000|STARTED|Period 3, Fasted (Part 2)||0
10489238|NCT01181804|11639078|FG001|STARTED|Period 3, Fasted (Part 2)||0
10489239|NCT01181804|11639079|FG002|STARTED|Period 3, Fasted (Part 2)||59
10489240|NCT01181804|11639080|FG003|STARTED|Period 3, Fasted (Part 2)||58
10489241|NCT01181804|11639077|FG000|COMPLETED|Period 3, Fasted (Part 2)||0
10489242|NCT01181804|11639078|FG001|COMPLETED|Period 3, Fasted (Part 2)||0
10489243|NCT01181804|11639079|FG002|COMPLETED|Period 3, Fasted (Part 2)||59
10489244|NCT01181804|11639080|FG003|COMPLETED|Period 3, Fasted (Part 2)||58
10489245|NCT01181804|11639077|FG000|NOT COMPLETED|Period 3, Fasted (Part 2)||0
10489246|NCT01181804|11639078|FG001|NOT COMPLETED|Period 3, Fasted (Part 2)||0
10489247|NCT01181804|11639079|FG002|NOT COMPLETED|Period 3, Fasted (Part 2)||0
10489248|NCT01181804|11639080|FG003|NOT COMPLETED|Period 3, Fasted (Part 2)||0
10489249|NCT01181804|11639077|FG000|STARTED|Period 4, Fasted (Part 2)||0
10489250|NCT01181804|11639078|FG001|STARTED|Period 4, Fasted (Part 2)||0
10489251|NCT01181804|11639079|FG002|STARTED|Period 4, Fasted (Part 2)||59
10489252|NCT01181804|11639080|FG003|STARTED|Period 4, Fasted (Part 2)||58
10489253|NCT01181804|11639077|FG000|COMPLETED|Period 4, Fasted (Part 2)||0
10489254|NCT01181804|11639078|FG001|COMPLETED|Period 4, Fasted (Part 2)||0
10489255|NCT01181804|11639079|FG002|COMPLETED|Period 4, Fasted (Part 2)||58
10489256|NCT01181804|11639080|FG003|COMPLETED|Period 4, Fasted (Part 2)||58
10489257|NCT01181804|11639077|FG000|NOT COMPLETED|Period 4, Fasted (Part 2)||0
10489258|NCT01181804|11639078|FG001|NOT COMPLETED|Period 4, Fasted (Part 2)||0
10489259|NCT01181804|11639079|FG002|NOT COMPLETED|Period 4, Fasted (Part 2)||1
10489260|NCT01181804|11639080|FG003|NOT COMPLETED|Period 4, Fasted (Part 2)||0
10489261|NCT01181895|11639093|FG000|STARTED|Overall Study||116
10489262|NCT01181895|11639094|FG001|STARTED|Overall Study||115
10489263|NCT01181895|11639095|FG002|STARTED|Overall Study||116
10489264|NCT01181895|11639093|FG000|COMPLETED|Overall Study||99
10489265|NCT01181895|11639094|FG001|COMPLETED|Overall Study||101
10489266|NCT01181895|11639095|FG002|COMPLETED|Overall Study||98
10489267|NCT01181895|11639093|FG000|NOT COMPLETED|Overall Study||17
10489268|NCT01181895|11639094|FG001|NOT COMPLETED|Overall Study||14
10489269|NCT01181895|11639095|FG002|NOT COMPLETED|Overall Study||18
10489270|NCT01181947|11639103|FG000|STARTED|Overall Study||100
10489271|NCT01181947|11639103|FG000|COMPLETED|Overall Study||100
10489272|NCT01181947|11639103|FG000|NOT COMPLETED|Overall Study||0
10489273|NCT01181986|11639110|FG000|STARTED|Phase 1||19
10489274|NCT01181986|11639111|FG001|STARTED|Phase 1||23
10489275|NCT01181986|11639112|FG002|STARTED|Phase 1||34
10489276|NCT01181986|11639110|FG000|Saline+Exenatide|Phase 1|N/A for this arm|0
10489277|NCT01181986|11639111|FG001|Saline+Exenatide|Phase 1|N/A for this arm|0
10489278|NCT01181986|11639112|FG002|Saline+Exenatide|Phase 1||32
10489279|NCT01181986|11639110|FG000|Saline+Placebo|Phase 1|N/A for this arm|0
10489280|NCT01181986|11639111|FG001|Saline+Placebo|Phase 1|N/A for this arm|0
10489281|NCT01181986|11639112|FG002|Saline+Placebo|Phase 1||33
10489282|NCT01181986|11639110|FG000|Exendin-9+Exenatide|Phase 1|N/A for this arm|0
10489283|NCT01181986|11639111|FG001|Exendin-9+Exenatide|Phase 1|N/A for this arm|0
10489284|NCT01181986|11639112|FG002|Exendin-9+Exenatide|Phase 1||33
10489285|NCT01181986|11639110|FG000|COMPLETED|Phase 1||18
10489286|NCT01181986|11639111|FG001|COMPLETED|Phase 1||22
10489287|NCT01181986|11639112|FG002|COMPLETED|Phase 1||32
10489288|NCT01181986|11639110|FG000|NOT COMPLETED|Phase 1||1
10489289|NCT01181986|11639111|FG001|NOT COMPLETED|Phase 1||1
10489290|NCT01181986|11639112|FG002|NOT COMPLETED|Phase 1||2
10489291|NCT01181986|11639110|FG000|STARTED|Phase 2||18
10489292|NCT01181986|11639111|FG001|STARTED|Phase 2||22
10489293|NCT01181986|11639112|FG002|STARTED|Phase 2|N/A for Sub-study 2|0
10489294|NCT01181986|11639110|FG000|COMPLETED|Phase 2||18
10489295|NCT01181986|11639111|FG001|COMPLETED|Phase 2||18
10489296|NCT01181986|11639112|FG002|COMPLETED|Phase 2||0
10489297|NCT01181986|11639110|FG000|NOT COMPLETED|Phase 2||0
10489298|NCT01181986|11639111|FG001|NOT COMPLETED|Phase 2||4
10489299|NCT01181986|11639112|FG002|NOT COMPLETED|Phase 2||0
10489300|NCT01182103|11639128|FG000|STARTED|Overall Study||48
10710121|NCT02647281|11875284|FG000|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
10489301|NCT01182103|11639129|FG001|STARTED|Overall Study||62
10489302|NCT01182103|11639128|FG000|COMPLETED|Overall Study||48
10489303|NCT01182103|11639129|FG001|COMPLETED|Overall Study||62
10489304|NCT01182103|11639128|FG000|NOT COMPLETED|Overall Study||0
10489305|NCT01182103|11639129|FG001|NOT COMPLETED|Overall Study||0
10489306|NCT01182181|11639140|FG000|STARTED|First Intervention||11
10489307|NCT01182181|11639141|FG001|STARTED|First Intervention||11
10489308|NCT01182181|11639140|FG000|COMPLETED|First Intervention||10
10489309|NCT01182181|11639141|FG001|COMPLETED|First Intervention||11
10489310|NCT01182181|11639140|FG000|NOT COMPLETED|First Intervention||1
10489311|NCT01182181|11639141|FG001|NOT COMPLETED|First Intervention||0
10489312|NCT01182181|11639140|FG000|STARTED|Washout of 21 Days||10
10489313|NCT01182181|11639141|FG001|STARTED|Washout of 21 Days||11
10489314|NCT01182181|11639140|FG000|COMPLETED|Washout of 21 Days||10
10489315|NCT01182181|11639141|FG001|COMPLETED|Washout of 21 Days||10
10489316|NCT01182181|11639140|FG000|NOT COMPLETED|Washout of 21 Days||0
10489317|NCT01182181|11639141|FG001|NOT COMPLETED|Washout of 21 Days||1
10489318|NCT01182181|11639140|FG000|STARTED|Second Intervention||10
10489319|NCT01182181|11639141|FG001|STARTED|Second Intervention||10
10489320|NCT01182181|11639140|FG000|COMPLETED|Second Intervention||10
10489321|NCT01182181|11639141|FG001|COMPLETED|Second Intervention||10
10489322|NCT01182181|11639140|FG000|NOT COMPLETED|Second Intervention||0
10489323|NCT01182181|11639141|FG001|NOT COMPLETED|Second Intervention||0
10489324|NCT01182194|11639149|FG000|STARTED|First Intervention||16
10489325|NCT01182194|11639150|FG001|STARTED|First Intervention||16
10489326|NCT01182194|11639149|FG000|COMPLETED|First Intervention||16
10489327|NCT01182194|11639150|FG001|COMPLETED|First Intervention||16
10489328|NCT01182194|11639149|FG000|NOT COMPLETED|First Intervention||0
10489329|NCT01182194|11639150|FG001|NOT COMPLETED|First Intervention||0
10489330|NCT01182194|11639149|FG000|STARTED|Washout of 28 Days||16
10489331|NCT01182194|11639150|FG001|STARTED|Washout of 28 Days||16
10489332|NCT01182194|11639149|FG000|COMPLETED|Washout of 28 Days||15
10489333|NCT01182194|11639150|FG001|COMPLETED|Washout of 28 Days||16
10489334|NCT01182194|11639149|FG000|NOT COMPLETED|Washout of 28 Days||1
10489335|NCT01182194|11639150|FG001|NOT COMPLETED|Washout of 28 Days||0
10489336|NCT01182194|11639149|FG000|STARTED|Second Intervention||15
10489337|NCT01182194|11639150|FG001|STARTED|Second Intervention||16
10489338|NCT01182194|11639149|FG000|COMPLETED|Second Intervention||15
10489339|NCT01182194|11639150|FG001|COMPLETED|Second Intervention||16
10489340|NCT01182194|11639149|FG000|NOT COMPLETED|Second Intervention||0
10489341|NCT01182194|11639150|FG001|NOT COMPLETED|Second Intervention||0
10489342|NCT01182207|11639158|FG000|STARTED|First Intervention||18
10489343|NCT01182207|11639159|FG001|STARTED|First Intervention||15
10489344|NCT01182207|11639158|FG000|COMPLETED|First Intervention||18
10489345|NCT01182207|11639159|FG001|COMPLETED|First Intervention||14
10489346|NCT01182207|11639158|FG000|NOT COMPLETED|First Intervention||0
10489347|NCT01182207|11639159|FG001|NOT COMPLETED|First Intervention||1
10489348|NCT01182207|11639158|FG000|STARTED|Washout of 28 Days||18
10489349|NCT01182207|11639159|FG001|STARTED|Washout of 28 Days||14
10489350|NCT01182207|11639158|FG000|COMPLETED|Washout of 28 Days||18
10489351|NCT01182207|11639159|FG001|COMPLETED|Washout of 28 Days||14
10489352|NCT01182207|11639158|FG000|NOT COMPLETED|Washout of 28 Days||0
10489353|NCT01182207|11639159|FG001|NOT COMPLETED|Washout of 28 Days||0
10489354|NCT01182207|11639158|FG000|STARTED|Second Intervention||18
10489355|NCT01182207|11639159|FG001|STARTED|Second Intervention||14
10489356|NCT01182207|11639158|FG000|COMPLETED|Second Intervention||17
10489357|NCT01182207|11639159|FG001|COMPLETED|Second Intervention||14
10489358|NCT01182207|11639158|FG000|NOT COMPLETED|Second Intervention||1
10489359|NCT01182207|11639159|FG001|NOT COMPLETED|Second Intervention||0
10489360|NCT01182285|11639165|FG000|STARTED|First Intervention Week 1-10||13
10489361|NCT01182285|11639166|FG001|STARTED|First Intervention Week 1-10||0
10489362|NCT01182285|11639167|FG002|STARTED|First Intervention Week 1-10||0
10489363|NCT01182285|11639165|FG000|COMPLETED|First Intervention Week 1-10||10
10489364|NCT01182285|11639166|FG001|COMPLETED|First Intervention Week 1-10||0
10489365|NCT01182285|11639167|FG002|COMPLETED|First Intervention Week 1-10||0
10489366|NCT01182285|11639165|FG000|NOT COMPLETED|First Intervention Week 1-10||3
10489367|NCT01182285|11639166|FG001|NOT COMPLETED|First Intervention Week 1-10||0
10489368|NCT01182285|11639167|FG002|NOT COMPLETED|First Intervention Week 1-10||0
10489369|NCT01182285|11639165|FG000|STARTED|Second Intervention Week 11-17||0
10489370|NCT01182285|11639166|FG001|STARTED|Second Intervention Week 11-17||0
10489371|NCT01182285|11639167|FG002|STARTED|Second Intervention Week 11-17||0
10489372|NCT01182285|11639165|FG000|COMPLETED|Second Intervention Week 11-17||0
10489373|NCT01182285|11639166|FG001|COMPLETED|Second Intervention Week 11-17||0
10489374|NCT01182285|11639167|FG002|COMPLETED|Second Intervention Week 11-17||0
10489375|NCT01182285|11639165|FG000|NOT COMPLETED|Second Intervention Week 11-17||0
10489376|NCT01182285|11639166|FG001|NOT COMPLETED|Second Intervention Week 11-17||0
10489377|NCT01182285|11639167|FG002|NOT COMPLETED|Second Intervention Week 11-17||0
10489378|NCT01182285|11639165|FG000|STARTED|Third Intervention Week 11-52||0
10489379|NCT01182285|11639166|FG001|STARTED|Third Intervention Week 11-52||0
10489380|NCT01182285|11639167|FG002|STARTED|Third Intervention Week 11-52|2 subj. taken off study after completing ph 1: 1 due to a negative uptake scan & one off due to PD.|8
10489381|NCT01182285|11639165|FG000|COMPLETED|Third Intervention Week 11-52||0
10489382|NCT01182285|11639166|FG001|COMPLETED|Third Intervention Week 11-52||0
10489383|NCT01182285|11639167|FG002|COMPLETED|Third Intervention Week 11-52||0
10489384|NCT01182285|11639165|FG000|NOT COMPLETED|Third Intervention Week 11-52||0
10489385|NCT01182285|11639166|FG001|NOT COMPLETED|Third Intervention Week 11-52||0
10489386|NCT01182285|11639167|FG002|NOT COMPLETED|Third Intervention Week 11-52||8
10489387|NCT01182298|11639174|FG000|STARTED|Overall Study||10
10489388|NCT01182298|11639174|FG000|COMPLETED|Overall Study||4
10489389|NCT01182298|11639174|FG000|NOT COMPLETED|Overall Study||6
10489390|NCT01182337|11639180|FG000|STARTED|Overall Study||22
10489391|NCT01182337|11639181|FG001|STARTED|Overall Study||9
10489392|NCT01182337|11639180|FG000|COMPLETED|Overall Study||19
10489393|NCT01182337|11639181|FG001|COMPLETED|Overall Study||7
10489394|NCT01182337|11639180|FG000|NOT COMPLETED|Overall Study||3
10489395|NCT01182337|11639181|FG001|NOT COMPLETED|Overall Study||2
10489396|NCT01182350|11639188|FG000|STARTED|Overall Study||30
10489397|NCT01182350|11639189|FG001|STARTED|Overall Study||14
10489398|NCT01182350|11639190|FG002|STARTED|Overall Study||3
10489399|NCT01182350|11639191|FG003|STARTED|Overall Study||3
10489400|NCT01182350|11639192|FG004|STARTED|Overall Study||3
10489401|NCT01182350|11639188|FG000|Underwent Stereotactic Biopsy|Overall Study||30
10489402|NCT01182350|11639189|FG001|Underwent Stereotactic Biopsy|Overall Study||14
10489403|NCT01182350|11639190|FG002|Underwent Stereotactic Biopsy|Overall Study||3
10489404|NCT01182350|11639191|FG003|Underwent Stereotactic Biopsy|Overall Study||3
10489405|NCT01182350|11639192|FG004|Underwent Stereotactic Biopsy|Overall Study||0
10489406|NCT01182350|11639188|FG000|Started Assigned Chemoradiation|Overall Study||27
10489407|NCT01182350|11639189|FG001|Started Assigned Chemoradiation|Overall Study||14
10489408|NCT01182350|11639190|FG002|Started Assigned Chemoradiation|Overall Study||2
10489409|NCT01182350|11639191|FG003|Started Assigned Chemoradiation|Overall Study||2
10489410|NCT01182350|11639192|FG004|Started Assigned Chemoradiation|Overall Study||0
10489411|NCT01182350|11639188|FG000|COMPLETED|Overall Study||3
10489412|NCT01182350|11639189|FG001|COMPLETED|Overall Study||0
10489413|NCT01182350|11639190|FG002|COMPLETED|Overall Study||0
10489414|NCT01182350|11639191|FG003|COMPLETED|Overall Study||0
10489415|NCT01182350|11639192|FG004|COMPLETED|Overall Study||0
10489416|NCT01182350|11639188|FG000|NOT COMPLETED|Overall Study||27
10489417|NCT01182350|11639189|FG001|NOT COMPLETED|Overall Study||14
10489418|NCT01182350|11639190|FG002|NOT COMPLETED|Overall Study||3
10489419|NCT01182350|11639191|FG003|NOT COMPLETED|Overall Study||3
10489420|NCT01182350|11639192|FG004|NOT COMPLETED|Overall Study||3
10489421|NCT01182376|11639210|FG000|STARTED|Overall Study||15
10489422|NCT01182376|11639211|FG001|STARTED|Overall Study||18
10489423|NCT01182376|11639210|FG000|COMPLETED|Overall Study||4
10489424|NCT01182376|11639211|FG001|COMPLETED|Overall Study||13
10338248|NCT00369161|11475166|FG001|STARTED|Overall Study||119
10338249|NCT00369161|11475165|FG000|Intention to Treat (ITT)|Overall Study||107
10338250|NCT00369161|11475166|FG001|Intention to Treat (ITT)|Overall Study||117
10338251|NCT00369161|11475165|FG000|COMPLETED|Overall Study||82
10338252|NCT00369161|11475166|FG001|COMPLETED|Overall Study||95
10338253|NCT00369161|11475165|FG000|NOT COMPLETED|Overall Study||27
10338254|NCT00369161|11475166|FG001|NOT COMPLETED|Overall Study||24
10338255|NCT00369226|11475174|FG000|STARTED|Phase I (45 Days)||13
10489425|NCT01182376|11639210|FG000|NOT COMPLETED|Overall Study||11
10489426|NCT01182376|11639211|FG001|NOT COMPLETED|Overall Study||5
10489427|NCT01182415|11639217|FG000|STARTED|Overall Study||30
10489428|NCT01182415|11639217|FG000|COMPLETED|Overall Study||29
10489429|NCT01182415|11639217|FG000|NOT COMPLETED|Overall Study||1
10489430|NCT01182428|11639223|FG000|STARTED|Overall Study||304
10489431|NCT01182428|11639224|FG001|STARTED|Overall Study||151
10489432|NCT01182428|11639223|FG000|COMPLETED|Overall Study||293
10489433|NCT01182428|11639224|FG001|COMPLETED|Overall Study||150
10489434|NCT01182428|11639223|FG000|NOT COMPLETED|Overall Study||11
10489435|NCT01182428|11639224|FG001|NOT COMPLETED|Overall Study||1
10489436|NCT01182441|11639232|FG000|STARTED|Overall Study||269
10489437|NCT01182441|11639233|FG001|STARTED|Overall Study||138
10489438|NCT01182441|11639232|FG000|COMPLETED|Overall Study||49
10489439|NCT01182441|11639233|FG001|COMPLETED|Overall Study||19
10710122|NCT02647281|11875285|FG001|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
10710123|NCT02647281|11875286|FG002|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
10710124|NCT02647281|11875287|FG003|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
10710125|NCT02647281|11875288|FG004|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
10710126|NCT02647281|11875289|FG005|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
10489440|NCT01182441|11639232|FG000|NOT COMPLETED|Overall Study||220
10489441|NCT01182441|11639233|FG001|NOT COMPLETED|Overall Study||119
10489442|NCT01182480|11639239|FG000|STARTED|Overall Study||47
10489443|NCT01182480|11639239|FG000|COMPLETED|Overall Study||47
10489444|NCT01182480|11639239|FG000|NOT COMPLETED|Overall Study||0
10489445|NCT01182493|11639245|FG000|STARTED|Overall Study||168
10489446|NCT01182493|11639246|FG001|STARTED|Overall Study||163
10489447|NCT01182493|11639245|FG000|COMPLETED|Overall Study||152
10489448|NCT01182493|11639246|FG001|COMPLETED|Overall Study||156
10489449|NCT01182493|11639245|FG000|NOT COMPLETED|Overall Study||16
10489450|NCT01182493|11639246|FG001|NOT COMPLETED|Overall Study||7
10489451|NCT01182675|11639254|FG000|STARTED|Overall Study||7
10338256|NCT00369226|11475175|FG001|STARTED|Phase I (45 Days)||0
10339221|NCT00371566|11476129|FG000|NOT COMPLETED|Chemoradiation Phase||5
10489452|NCT01182675|11639255|FG001|STARTED|Overall Study||0
10489453|NCT01182675|11639254|FG000|COMPLETED|Overall Study||7
10489454|NCT01182675|11639255|FG001|COMPLETED|Overall Study||0
10489455|NCT01182675|11639254|FG000|NOT COMPLETED|Overall Study||0
10489456|NCT01182675|11639255|FG001|NOT COMPLETED|Overall Study||0
10489457|NCT01182805|11639263|FG000|STARTED|Overall Study||50
10489458|NCT01182805|11639263|FG000|COMPLETED|Overall Study||50
10489459|NCT01182805|11639263|FG000|NOT COMPLETED|Overall Study||0
10489460|NCT01182844|11639271|FG000|STARTED|Overall Study||15
10489461|NCT01182844|11639272|FG001|STARTED|Overall Study||15
10489462|NCT01182844|11639271|FG000|COMPLETED|Overall Study||15
10489463|NCT01182844|11639272|FG001|COMPLETED|Overall Study||13
10489464|NCT01182844|11639271|FG000|NOT COMPLETED|Overall Study||0
10489465|NCT01182844|11639272|FG001|NOT COMPLETED|Overall Study||2
10489466|NCT01183013|11639285|FG000|STARTED|Overall Study||131
10710127|NCT02647281|11875290|FG006|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
10710128|NCT02647281|11875291|FG007|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
10489467|NCT01183013|11639286|FG001|STARTED|Overall Study||140
10489468|NCT01183013|11639287|FG002|STARTED|Overall Study||138
10489469|NCT01183013|11639288|FG003|STARTED|Overall Study||135
10489470|NCT01183013|11639289|FG004|STARTED|Overall Study||126
10489471|NCT01183013|11639290|FG005|STARTED|Overall Study||133
10489472|NCT01183013|11639291|FG006|STARTED|Overall Study||133
10489473|NCT01183013|11639285|FG000|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|86
10489474|NCT01183013|11639286|FG001|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|101
10489475|NCT01183013|11639287|FG002|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|97
10489476|NCT01183013|11639288|FG003|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|105
10489477|NCT01183013|11639289|FG004|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|90
10489478|NCT01183013|11639290|FG005|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|88
10489479|NCT01183013|11639291|FG006|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|96
10489480|NCT01183013|11639285|FG000|NOT COMPLETED|Overall Study||45
10489481|NCT01183013|11639286|FG001|NOT COMPLETED|Overall Study||39
10489482|NCT01183013|11639287|FG002|NOT COMPLETED|Overall Study||41
10489483|NCT01183013|11639288|FG003|NOT COMPLETED|Overall Study||30
10489484|NCT01183013|11639289|FG004|NOT COMPLETED|Overall Study||36
10489485|NCT01183013|11639290|FG005|NOT COMPLETED|Overall Study||45
10489486|NCT01183013|11639291|FG006|NOT COMPLETED|Overall Study||37
10489487|NCT01183065|11639308|FG000|STARTED|Overall Study||13
10489488|NCT01183065|11639308|FG000|COMPLETED|Overall Study||12
10489489|NCT01183065|11639308|FG000|NOT COMPLETED|Overall Study||1
10489490|NCT01183104|11639314|FG000|STARTED|Overall Study||153
10489491|NCT01183104|11639315|FG001|STARTED|Overall Study||152
10489492|NCT01183104|11639314|FG000|Received Study Drug|Overall Study||148
10489493|NCT01183104|11639315|FG001|Received Study Drug|Overall Study||143
10489494|NCT01183104|11639314|FG000|Continued Treatment for 12 Weeks|Overall Study||143
10489495|NCT01183104|11639315|FG001|Continued Treatment for 12 Weeks|Overall Study||129
10489496|NCT01183104|11639314|FG000|Completed 52-week Treatment|Overall Study||119
10489497|NCT01183104|11639315|FG001|Completed 52-week Treatment|Overall Study||111
10489498|NCT01183104|11639314|FG000|Enrolled in Extension Study|Overall Study||80
10489499|NCT01183104|11639315|FG001|Enrolled in Extension Study|Overall Study||61
10489500|NCT01183104|11639314|FG000|COMPLETED|Overall Study||76
10489501|NCT01183104|11639315|FG001|COMPLETED|Overall Study||60
10489502|NCT01183104|11639314|FG000|NOT COMPLETED|Overall Study||77
10489503|NCT01183104|11639315|FG001|NOT COMPLETED|Overall Study||92
10489504|NCT01183143|11639321|FG000|STARTED|Overall Study||215
10489505|NCT01183143|11639321|FG000|Intention to Treat (ITT) Population|Overall Study|ITT=Subjects who received at least 1 dose of the investigational medicinal product (IMP).|204
10489506|NCT01183143|11639321|FG000|COMPLETED|Overall Study||65
10489507|NCT01183143|11639321|FG000|NOT COMPLETED|Overall Study||150
10489508|NCT01183169|11639329|FG000|STARTED|Main Phase||121
10489509|NCT01183169|11639330|FG001|STARTED|Main Phase||115
10489510|NCT01183169|11639331|FG002|STARTED|Main Phase||59
10489511|NCT01183169|11639332|FG003|STARTED|Main Phase||55
10489512|NCT01183169|11639333|FG004|STARTED|Main Phase||109
10489513|NCT01183169|11639334|FG005|STARTED|Main Phase||0
10489514|NCT01183169|11639335|FG006|STARTED|Main Phase||0
10489515|NCT01183169|11639329|FG000|Completed Treatment|Main Phase||72
10489516|NCT01183169|11639330|FG001|Completed Treatment|Main Phase||78
10489517|NCT01183169|11639331|FG002|Completed Treatment|Main Phase||17
10489518|NCT01183169|11639332|FG003|Completed Treatment|Main Phase||17
10489519|NCT01183169|11639333|FG004|Completed Treatment|Main Phase||77
10489520|NCT01183169|11639334|FG005|Completed Treatment|Main Phase||0
10489521|NCT01183169|11639335|FG006|Completed Treatment|Main Phase||0
10489522|NCT01183169|11639329|FG000|Switched to ALV|Main Phase||0
10489523|NCT01183169|11639330|FG001|Switched to ALV|Main Phase||0
10489524|NCT01183169|11639331|FG002|Switched to ALV|Main Phase||35
10489525|NCT01183169|11639332|FG003|Switched to ALV|Main Phase||30
10489526|NCT01183169|11639333|FG004|Switched to ALV|Main Phase||0
10489527|NCT01183169|11639334|FG005|Switched to ALV|Main Phase||0
10489528|NCT01183169|11639335|FG006|Switched to ALV|Main Phase||0
10489529|NCT01183169|11639329|FG000|COMPLETED|Main Phase||94
10489530|NCT01183169|11639330|FG001|COMPLETED|Main Phase||93
10489531|NCT01183169|11639331|FG002|COMPLETED|Main Phase||18
10489532|NCT01183169|11639332|FG003|COMPLETED|Main Phase||18
10489533|NCT01183169|11639333|FG004|COMPLETED|Main Phase||83
10489534|NCT01183169|11639334|FG005|COMPLETED|Main Phase||0
10489535|NCT01183169|11639335|FG006|COMPLETED|Main Phase||0
10489536|NCT01183169|11639329|FG000|NOT COMPLETED|Main Phase||27
10489537|NCT01183169|11639330|FG001|NOT COMPLETED|Main Phase||22
10489538|NCT01183169|11639331|FG002|NOT COMPLETED|Main Phase||41
10489539|NCT01183169|11639332|FG003|NOT COMPLETED|Main Phase||37
10489540|NCT01183169|11639333|FG004|NOT COMPLETED|Main Phase||26
10489541|NCT01183169|11639334|FG005|NOT COMPLETED|Main Phase||0
10489542|NCT01183169|11639335|FG006|NOT COMPLETED|Main Phase||0
10489543|NCT01183169|11639329|FG000|STARTED|Post-switch Phase|Not a post-switch group|0
10489544|NCT01183169|11639330|FG001|STARTED|Post-switch Phase|Not a post-switch group|0
10489545|NCT01183169|11639331|FG002|STARTED|Post-switch Phase|Not a post-switch group|0
10489546|NCT01183169|11639332|FG003|STARTED|Post-switch Phase|Not a post-switch group|0
10489547|NCT01183169|11639333|FG004|STARTED|Post-switch Phase|Not a post-switch group|0
10489548|NCT01183169|11639334|FG005|STARTED|Post-switch Phase|Participants in Treatment C1 who switched to active ALV|35
10489549|NCT01183169|11639335|FG006|STARTED|Post-switch Phase|Participants in Treatment C2 who switched to active ALV|30
10489550|NCT01183169|11639329|FG000|Completed Treatment|Post-switch Phase||0
10489551|NCT01183169|11639330|FG001|Completed Treatment|Post-switch Phase||0
10489552|NCT01183169|11639331|FG002|Completed Treatment|Post-switch Phase||0
10489553|NCT01183169|11639332|FG003|Completed Treatment|Post-switch Phase||0
10489554|NCT01183169|11639333|FG004|Completed Treatment|Post-switch Phase||0
10489555|NCT01183169|11639334|FG005|Completed Treatment|Post-switch Phase||12
10489556|NCT01183169|11639335|FG006|Completed Treatment|Post-switch Phase||13
10489557|NCT01183169|11639329|FG000|COMPLETED|Post-switch Phase||0
10489558|NCT01183169|11639330|FG001|COMPLETED|Post-switch Phase||0
10489559|NCT01183169|11639331|FG002|COMPLETED|Post-switch Phase||0
10489560|NCT01183169|11639332|FG003|COMPLETED|Post-switch Phase||0
10489561|NCT01183169|11639333|FG004|COMPLETED|Post-switch Phase||0
10489562|NCT01183169|11639334|FG005|COMPLETED|Post-switch Phase||21
10489563|NCT01183169|11639335|FG006|COMPLETED|Post-switch Phase||21
10489564|NCT01183169|11639329|FG000|NOT COMPLETED|Post-switch Phase||0
10489565|NCT01183169|11639330|FG001|NOT COMPLETED|Post-switch Phase||0
10489566|NCT01183169|11639331|FG002|NOT COMPLETED|Post-switch Phase||0
10489567|NCT01183169|11639332|FG003|NOT COMPLETED|Post-switch Phase||0
10489568|NCT01183169|11639333|FG004|NOT COMPLETED|Post-switch Phase||0
10489569|NCT01183169|11639334|FG005|NOT COMPLETED|Post-switch Phase||14
10489570|NCT01183169|11639335|FG006|NOT COMPLETED|Post-switch Phase||9
10489571|NCT01183234|11639355|FG000|STARTED|First Intervention||14
10489572|NCT01183234|11639356|FG001|STARTED|First Intervention||14
10489573|NCT01183234|11639355|FG000|COMPLETED|First Intervention||13
10489574|NCT01183234|11639356|FG001|COMPLETED|First Intervention||14
10489575|NCT01183234|11639355|FG000|NOT COMPLETED|First Intervention||1
10489576|NCT01183234|11639356|FG001|NOT COMPLETED|First Intervention||0
10489577|NCT01183234|11639355|FG000|STARTED|Washout||13
10489578|NCT01183234|11639356|FG001|STARTED|Washout||14
10489579|NCT01183234|11639355|FG000|COMPLETED|Washout||13
10489580|NCT01183234|11639356|FG001|COMPLETED|Washout||14
10489581|NCT01183234|11639355|FG000|NOT COMPLETED|Washout||0
10489582|NCT01183234|11639356|FG001|NOT COMPLETED|Washout||0
10489583|NCT01183234|11639355|FG000|STARTED|Second Intervention||13
10489584|NCT01183234|11639356|FG001|STARTED|Second Intervention||14
10489585|NCT01183234|11639355|FG000|COMPLETED|Second Intervention||13
10489586|NCT01183234|11639356|FG001|COMPLETED|Second Intervention||14
10489587|NCT01183234|11639355|FG000|NOT COMPLETED|Second Intervention||0
10489588|NCT01183234|11639356|FG001|NOT COMPLETED|Second Intervention||0
10489589|NCT01183260|11639364|FG000|STARTED|Overall Study||14
10489590|NCT01183260|11639365|FG001|STARTED|Overall Study||11
10489591|NCT01183260|11639364|FG000|COMPLETED|Overall Study||10
10489592|NCT01183260|11639365|FG001|COMPLETED|Overall Study||9
10489593|NCT01183260|11639364|FG000|NOT COMPLETED|Overall Study||4
10489594|NCT01183260|11639365|FG001|NOT COMPLETED|Overall Study||2
10489595|NCT01183312|11639373|FG000|STARTED|First Intervention Day||5
10489596|NCT01183312|11639374|FG001|STARTED|First Intervention Day||5
10489597|NCT01183312|11639373|FG000|COMPLETED|First Intervention Day||5
10489598|NCT01183312|11639374|FG001|COMPLETED|First Intervention Day||5
10489599|NCT01183312|11639373|FG000|NOT COMPLETED|First Intervention Day||0
10489600|NCT01183312|11639374|FG001|NOT COMPLETED|First Intervention Day||0
10489601|NCT01183312|11639373|FG000|STARTED|Washout Period of at Least 1 Week||5
10489602|NCT01183312|11639374|FG001|STARTED|Washout Period of at Least 1 Week||5
10489603|NCT01183312|11639373|FG000|COMPLETED|Washout Period of at Least 1 Week||5
10489604|NCT01183312|11639374|FG001|COMPLETED|Washout Period of at Least 1 Week||5
10489605|NCT01183312|11639373|FG000|NOT COMPLETED|Washout Period of at Least 1 Week||0
10489606|NCT01183312|11639374|FG001|NOT COMPLETED|Washout Period of at Least 1 Week||0
10489607|NCT01183312|11639373|FG000|STARTED|Second Intervention Day||5
10489608|NCT01183312|11639374|FG001|STARTED|Second Intervention Day||5
10489609|NCT01183312|11639373|FG000|COMPLETED|Second Intervention Day||5
10489610|NCT01183312|11639374|FG001|COMPLETED|Second Intervention Day||5
10489611|NCT01183312|11639373|FG000|NOT COMPLETED|Second Intervention Day||0
10489612|NCT01183312|11639374|FG001|NOT COMPLETED|Second Intervention Day||0
10489613|NCT01183390|11639382|FG000|STARTED|First Intervention||11
10489614|NCT01183390|11639383|FG001|STARTED|First Intervention||11
10489615|NCT01183390|11639382|FG000|COMPLETED|First Intervention||11
10489616|NCT01183390|11639383|FG001|COMPLETED|First Intervention||10
10489617|NCT01183390|11639382|FG000|NOT COMPLETED|First Intervention||0
10489618|NCT01183390|11639383|FG001|NOT COMPLETED|First Intervention||1
10489619|NCT01183390|11639382|FG000|STARTED|Washout of 21 Days||11
10489620|NCT01183390|11639383|FG001|STARTED|Washout of 21 Days||10
10489621|NCT01183390|11639382|FG000|COMPLETED|Washout of 21 Days||11
10489622|NCT01183390|11639383|FG001|COMPLETED|Washout of 21 Days||10
10489623|NCT01183390|11639382|FG000|NOT COMPLETED|Washout of 21 Days||0
10489624|NCT01183390|11639383|FG001|NOT COMPLETED|Washout of 21 Days||0
10489625|NCT01183390|11639382|FG000|STARTED|Second Intervention||11
10489626|NCT01183390|11639383|FG001|STARTED|Second Intervention||10
10489627|NCT01183390|11639382|FG000|COMPLETED|Second Intervention||11
10489628|NCT01183390|11639383|FG001|COMPLETED|Second Intervention||10
10489629|NCT01183390|11639382|FG000|NOT COMPLETED|Second Intervention||0
10489630|NCT01183390|11639383|FG001|NOT COMPLETED|Second Intervention||0
10489631|NCT01183481|11639389|FG000|STARTED|Overall Study||19
10489632|NCT01183481|11639389|FG000|COMPLETED|Overall Study||19
10489633|NCT01183481|11639389|FG000|NOT COMPLETED|Overall Study||0
10489634|NCT01183533|11639394|FG000|STARTED|Overall Study|Between Oct 2010 and Oct 2013.|40
10489635|NCT01183533|11639394|FG000|COMPLETED|Overall Study|- all pre-planned 40 patients received the study medication.|40
10489636|NCT01183533|11639394|FG000|NOT COMPLETED|Overall Study||0
10489637|NCT01183546|11639398|FG000|STARTED|Overall Study||53
10489638|NCT01183546|11639398|FG000|COMPLETED|Overall Study||53
10489639|NCT01183546|11639398|FG000|NOT COMPLETED|Overall Study||0
10489640|NCT01183559|11639403|FG000|STARTED|Overall Study||9
10489641|NCT01183559|11639403|FG000|COMPLETED|Overall Study||9
10489642|NCT01183559|11639403|FG000|NOT COMPLETED|Overall Study||0
10489643|NCT01183650|11639410|FG000|STARTED|Overall Study||12
10489644|NCT01183650|11639411|FG001|STARTED|Overall Study||12
10489645|NCT01183650|11639410|FG000|COMPLETED|Overall Study||12
10489646|NCT01183650|11639411|FG001|COMPLETED|Overall Study||12
10489647|NCT01183650|11639410|FG000|NOT COMPLETED|Overall Study||0
10489648|NCT01183650|11639411|FG001|NOT COMPLETED|Overall Study||0
10489649|NCT01183689|11639420|FG000|STARTED|Overall Study||202
10489650|NCT01183689|11639421|FG001|STARTED|Overall Study||200
10489651|NCT01183689|11639422|FG002|STARTED|Overall Study||197
10489652|NCT01183689|11639420|FG000|Month 4 Visit|Overall Study||197
10489653|NCT01183689|11639421|FG001|Month 4 Visit|Overall Study||192
10489654|NCT01183689|11639422|FG002|Month 4 Visit|Overall Study||187
10489655|NCT01183689|11639420|FG000|Year 1 Visit|Overall Study||187
10489656|NCT01183689|11639421|FG001|Year 1 Visit|Overall Study||172
10489657|NCT01183689|11639422|FG002|Year 1 Visit|Overall Study||183
10489658|NCT01183689|11639420|FG000|Year 2 Visit|Overall Study||178
10489659|NCT01183689|11639421|FG001|Year 2 Visit|Overall Study||172
10489660|NCT01183689|11639422|FG002|Year 2 Visit|Overall Study||174
10489661|NCT01183689|11639420|FG000|Year 3 Visit|Overall Study||139
10489662|NCT01183689|11639421|FG001|Year 3 Visit|Overall Study||125
10489663|NCT01183689|11639422|FG002|Year 3 Visit|Overall Study||126
10489664|NCT01183689|11639420|FG000|Year 4 Visit|Overall Study||38
10489665|NCT01183689|11639421|FG001|Year 4 Visit|Overall Study||33
10489666|NCT01183689|11639422|FG002|Year 4 Visit|Overall Study||30
10489667|NCT01183689|11639420|FG000|COMPLETED|Overall Study||202
10489668|NCT01183689|11639421|FG001|COMPLETED|Overall Study||200
10489669|NCT01183689|11639422|FG002|COMPLETED|Overall Study||197
10489670|NCT01183689|11639420|FG000|NOT COMPLETED|Overall Study||0
10489671|NCT01183689|11639421|FG001|NOT COMPLETED|Overall Study||0
10489672|NCT01183689|11639422|FG002|NOT COMPLETED|Overall Study||0
10489673|NCT01183728|11639432|FG000|STARTED|Overall Study||12
10489674|NCT01183728|11639432|FG000|COMPLETED|Overall Study||12
10489675|NCT01183728|11639432|FG000|NOT COMPLETED|Overall Study||0
10489676|NCT01183780|11639438|FG000|STARTED|Overall Study||536
10489677|NCT01183780|11639439|FG001|STARTED|Overall Study||536
10489678|NCT01183780|11639438|FG000|Received at Least 1 Dose of Study Drug|Overall Study||528
10489679|NCT01183780|11639439|FG001|Received at Least 1 Dose of Study Drug|Overall Study||529
10489680|NCT01183780|11639438|FG000|COMPLETED|Overall Study||505
10489681|NCT01183780|11639439|FG001|COMPLETED|Overall Study||511
10489682|NCT01183780|11639438|FG000|NOT COMPLETED|Overall Study||31
10489683|NCT01183780|11639439|FG001|NOT COMPLETED|Overall Study||25
10489684|NCT01183858|11639447|FG000|STARTED|Overall Study||154
10489685|NCT01183858|11639448|FG001|STARTED|Overall Study||159
10489686|NCT01183858|11639447|FG000|Safety Population|Overall Study||154
10710129|NCT02647281|11875292|FG008|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
10710130|NCT02647281|11875284|FG000|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
10489687|NCT01183858|11639448|FG001|Safety Population|Overall Study||158
10489688|NCT01183858|11639447|FG000|COMPLETED|Overall Study||1
10489689|NCT01183858|11639448|FG001|COMPLETED|Overall Study||3
10489690|NCT01183858|11639447|FG000|NOT COMPLETED|Overall Study||153
10489691|NCT01183858|11639448|FG001|NOT COMPLETED|Overall Study||156
10489692|NCT01183923|11639454|FG000|STARTED|Intervention 1 (7 Days)||1
10489693|NCT01183923|11639455|FG001|STARTED|Intervention 1 (7 Days)||0
10489694|NCT01183923|11639454|FG000|COMPLETED|Intervention 1 (7 Days)||1
10489695|NCT01183923|11639455|FG001|COMPLETED|Intervention 1 (7 Days)||0
10489696|NCT01183923|11639454|FG000|NOT COMPLETED|Intervention 1 (7 Days)||0
10489697|NCT01183923|11639455|FG001|NOT COMPLETED|Intervention 1 (7 Days)||0
10489698|NCT01183923|11639454|FG000|STARTED|Washout (14 Days)||1
10489699|NCT01183923|11639455|FG001|STARTED|Washout (14 Days)||0
10489700|NCT01183923|11639454|FG000|COMPLETED|Washout (14 Days)||1
10489701|NCT01183923|11639455|FG001|COMPLETED|Washout (14 Days)||0
10489702|NCT01183923|11639454|FG000|NOT COMPLETED|Washout (14 Days)||0
10489703|NCT01183923|11639455|FG001|NOT COMPLETED|Washout (14 Days)||0
10489704|NCT01183923|11639454|FG000|STARTED|Intervention 2 (7 Days)||1
10489705|NCT01183923|11639455|FG001|STARTED|Intervention 2 (7 Days)||0
10489706|NCT01183923|11639454|FG000|COMPLETED|Intervention 2 (7 Days)||1
10489707|NCT01183923|11639455|FG001|COMPLETED|Intervention 2 (7 Days)||0
10489708|NCT01183923|11639454|FG000|NOT COMPLETED|Intervention 2 (7 Days)||0
10489709|NCT01183923|11639455|FG001|NOT COMPLETED|Intervention 2 (7 Days)||0
10489710|NCT01183975|11639460|FG000|STARTED|Overall Study||517
10489711|NCT01183975|11639460|FG000|COMPLETED|Overall Study||444
10489712|NCT01183975|11639460|FG000|NOT COMPLETED|Overall Study||73
10489713|NCT01184014|11639466|FG000|STARTED|Overall Study||35
10489714|NCT01184014|11639467|FG001|STARTED|Overall Study||37
10489715|NCT01184014|11639466|FG000|COMPLETED|Overall Study||30
10489716|NCT01184014|11639467|FG001|COMPLETED|Overall Study||31
10710131|NCT02647281|11875285|FG001|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
10710132|NCT02647281|11875286|FG002|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
10710133|NCT02647281|11875287|FG003|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
10489717|NCT01184014|11639466|FG000|NOT COMPLETED|Overall Study||5
10489718|NCT01184014|11639467|FG001|NOT COMPLETED|Overall Study||6
10489719|NCT01184053|11639473|FG000|STARTED|Overall Study||3
10489720|NCT01184053|11639473|FG000|COMPLETED|Overall Study||0
10489721|NCT01184053|11639473|FG000|NOT COMPLETED|Overall Study||3
10489722|NCT01184079|11639480|FG000|STARTED|Overall Study||111
10489723|NCT01184079|11639481|FG001|STARTED|Overall Study||109
10489724|NCT01184079|11639480|FG000|Dose 2|Overall Study||110
10489725|NCT01184079|11639481|FG001|Dose 2|Overall Study||108
10489726|NCT01184079|11639480|FG000|Dose 3|Overall Study||101
10489727|NCT01184079|11639481|FG001|Dose 3|Overall Study||107
10489728|NCT01184079|11639480|FG000|Final Blood Draw|Overall Study||97
10489729|NCT01184079|11639481|FG001|Final Blood Draw|Overall Study||107
10489730|NCT01184079|11639480|FG000|COMPLETED|Overall Study||97
10489731|NCT01184079|11639481|FG001|COMPLETED|Overall Study||107
10489732|NCT01184079|11639480|FG000|NOT COMPLETED|Overall Study||14
10489733|NCT01184079|11639481|FG001|NOT COMPLETED|Overall Study||2
10489734|NCT01184118|11639489|FG000|STARTED|Overall Study||36
10489735|NCT01184118|11639489|FG000|FP MDI 1,760 mcg/Day (16 Weeks)|Overall Study||18
10489736|NCT01184118|11639489|FG000|FP MDI 880 mcg/Day (2 Weeks)|Overall Study||18
10489737|NCT01184118|11639489|FG000|FP MDI as Indicated (2 Weeks)|Overall Study||18
10489738|NCT01184118|11639489|FG000|COMPLETED|Overall Study||18
10489739|NCT01184118|11639489|FG000|NOT COMPLETED|Overall Study||18
10489740|NCT01184326|11639496|FG000|STARTED|Overall Study||3
10489741|NCT01184326|11639497|FG001|STARTED|Overall Study||6
10489742|NCT01184326|11639498|FG002|STARTED|Overall Study||14
10489743|NCT01184326|11639496|FG000|COMPLETED|Overall Study||0
10489744|NCT01184326|11639497|FG001|COMPLETED|Overall Study||0
10489745|NCT01184326|11639498|FG002|COMPLETED|Overall Study||0
10489746|NCT01184326|11639496|FG000|NOT COMPLETED|Overall Study||3
10489747|NCT01184326|11639497|FG001|NOT COMPLETED|Overall Study||6
10489748|NCT01184326|11639498|FG002|NOT COMPLETED|Overall Study||14
10489749|NCT01184417|11639511|FG000|STARTED|Overall Study||51
10489750|NCT01184417|11639512|FG001|STARTED|Overall Study||51
10489751|NCT01184417|11639511|FG000|COMPLETED|Overall Study||51
10489752|NCT01184417|11639512|FG001|COMPLETED|Overall Study||51
10489753|NCT01184417|11639511|FG000|NOT COMPLETED|Overall Study||0
10489754|NCT01184417|11639512|FG001|NOT COMPLETED|Overall Study||0
10489755|NCT01184508|11639520|FG000|STARTED|Overall Study||45
10489756|NCT01184508|11639521|FG001|STARTED|Overall Study||42
10489757|NCT01184508|11639520|FG000|Received at Least 1 Dose of Study Drug|Overall Study||45
10489758|NCT01184508|11639521|FG001|Received at Least 1 Dose of Study Drug|Overall Study||41
10489759|NCT01184508|11639520|FG000|COMPLETED|Overall Study||29
10489760|NCT01184508|11639521|FG001|COMPLETED|Overall Study||27
10489761|NCT01184508|11639520|FG000|NOT COMPLETED|Overall Study||16
10489762|NCT01184508|11639521|FG001|NOT COMPLETED|Overall Study||15
10489763|NCT01184755|11639531|FG000|STARTED|Overall Study||126
10489764|NCT01184755|11639532|FG001|STARTED|Overall Study||65
10489765|NCT01184755|11639533|FG002|STARTED|Overall Study||62
10489766|NCT01184755|11639531|FG000|COMPLETED|Overall Study||101
10489767|NCT01184755|11639532|FG001|COMPLETED|Overall Study||54
10489768|NCT01184755|11639533|FG002|COMPLETED|Overall Study||56
10489769|NCT01184755|11639531|FG000|NOT COMPLETED|Overall Study||25
10489770|NCT01184755|11639532|FG001|NOT COMPLETED|Overall Study||11
10489771|NCT01184755|11639533|FG002|NOT COMPLETED|Overall Study||6
10489772|NCT01184846|11639541|FG000|STARTED|Overall Study||28
10489773|NCT01184846|11639541|FG000|COMPLETED|Overall Study||25
10489774|NCT01184846|11639541|FG000|NOT COMPLETED|Overall Study||3
10489775|NCT01184859|11639552|FG000|STARTED|Period 1: Single Dose||23
10489776|NCT01184859|11639553|FG001|STARTED|Period 1: Single Dose||25
10489777|NCT01184859|11639554|FG002|STARTED|Period 1: Single Dose||22
10489778|NCT01184859|11639555|FG003|STARTED|Period 1: Single Dose||22
10489779|NCT01184859|11639556|FG004|STARTED|Period 1: Single Dose||24
10489780|NCT01184859|11639552|FG000|Full Analysis Set (FAS)|Period 1: Single Dose||23
10489781|NCT01184859|11639553|FG001|Full Analysis Set (FAS)|Period 1: Single Dose|2 participants disqualified due to no post-baseline primary efficacy data, and/or 'other'.|23
10489782|NCT01184859|11639554|FG002|Full Analysis Set (FAS)|Period 1: Single Dose||22
10489783|NCT01184859|11639555|FG003|Full Analysis Set (FAS)|Period 1: Single Dose|1 participant disqualified due to major entry criteria violation|21
10489784|NCT01184859|11639556|FG004|Full Analysis Set (FAS)|Period 1: Single Dose||24
10489785|NCT01184859|11639552|FG000|Per Protocol (PP)|Period 1: Single Dose||23
10489786|NCT01184859|11639553|FG001|Per Protocol (PP)|Period 1: Single Dose||23
10489787|NCT01184859|11639554|FG002|Per Protocol (PP)|Period 1: Single Dose||22
10489788|NCT01184859|11639555|FG003|Per Protocol (PP)|Period 1: Single Dose||21
10489789|NCT01184859|11639556|FG004|Per Protocol (PP)|Period 1: Single Dose|1 additional participant disqualified due to 'other'.|23
10489790|NCT01184859|11639552|FG000|COMPLETED|Period 1: Single Dose||23
10489791|NCT01184859|11639553|FG001|COMPLETED|Period 1: Single Dose||23
10489792|NCT01184859|11639554|FG002|COMPLETED|Period 1: Single Dose||22
10489793|NCT01184859|11639555|FG003|COMPLETED|Period 1: Single Dose||22
10489794|NCT01184859|11639556|FG004|COMPLETED|Period 1: Single Dose||23
10489795|NCT01184859|11639552|FG000|NOT COMPLETED|Period 1: Single Dose||0
10489796|NCT01184859|11639553|FG001|NOT COMPLETED|Period 1: Single Dose||2
10489797|NCT01184859|11639554|FG002|NOT COMPLETED|Period 1: Single Dose||0
10489798|NCT01184859|11639555|FG003|NOT COMPLETED|Period 1: Single Dose||0
10489799|NCT01184859|11639556|FG004|NOT COMPLETED|Period 1: Single Dose||1
10489800|NCT01184859|11639552|FG000|STARTED|Washout Period||23
10489801|NCT01184859|11639553|FG001|STARTED|Washout Period||23
10489802|NCT01184859|11639554|FG002|STARTED|Washout Period||22
10489803|NCT01184859|11639555|FG003|STARTED|Washout Period||22
10489804|NCT01184859|11639556|FG004|STARTED|Washout Period||23
10489805|NCT01184859|11639552|FG000|COMPLETED|Washout Period||23
10489806|NCT01184859|11639553|FG001|COMPLETED|Washout Period||23
10489807|NCT01184859|11639554|FG002|COMPLETED|Washout Period||22
10489808|NCT01184859|11639555|FG003|COMPLETED|Washout Period||22
10489809|NCT01184859|11639556|FG004|COMPLETED|Washout Period||23
10489810|NCT01184859|11639552|FG000|NOT COMPLETED|Washout Period||0
10489811|NCT01184859|11639553|FG001|NOT COMPLETED|Washout Period||0
10489812|NCT01184859|11639554|FG002|NOT COMPLETED|Washout Period||0
10489813|NCT01184859|11639555|FG003|NOT COMPLETED|Washout Period||0
10489814|NCT01184859|11639556|FG004|NOT COMPLETED|Washout Period||0
10338257|NCT00369226|11475174|FG000|COMPLETED|Phase I (45 Days)|Once MTD established, additional 10 patients were accrued at MTD to better estimate toxicity.|13
10338258|NCT00369226|11475175|FG001|COMPLETED|Phase I (45 Days)||0
10338259|NCT00369226|11475174|FG000|NOT COMPLETED|Phase I (45 Days)||0
10338260|NCT00369226|11475175|FG001|NOT COMPLETED|Phase I (45 Days)||0
10338261|NCT00369226|11475174|FG000|STARTED|Phase II (45 Days)||0
10489815|NCT01184859|11639552|FG000|STARTED|Period 2: Daily Dose for 28 Days||23
10489816|NCT01184859|11639553|FG001|STARTED|Period 2: Daily Dose for 28 Days||23
10489817|NCT01184859|11639554|FG002|STARTED|Period 2: Daily Dose for 28 Days||22
10489818|NCT01184859|11639555|FG003|STARTED|Period 2: Daily Dose for 28 Days||22
10489819|NCT01184859|11639556|FG004|STARTED|Period 2: Daily Dose for 28 Days||23
10489820|NCT01184859|11639552|FG000|COMPLETED|Period 2: Daily Dose for 28 Days||22
10489821|NCT01184859|11639553|FG001|COMPLETED|Period 2: Daily Dose for 28 Days||23
10489822|NCT01184859|11639554|FG002|COMPLETED|Period 2: Daily Dose for 28 Days||22
10489823|NCT01184859|11639555|FG003|COMPLETED|Period 2: Daily Dose for 28 Days||22
10489824|NCT01184859|11639556|FG004|COMPLETED|Period 2: Daily Dose for 28 Days||22
10489825|NCT01184859|11639552|FG000|NOT COMPLETED|Period 2: Daily Dose for 28 Days||1
10489826|NCT01184859|11639553|FG001|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
10489827|NCT01184859|11639554|FG002|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
10489828|NCT01184859|11639555|FG003|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
10489829|NCT01184859|11639556|FG004|NOT COMPLETED|Period 2: Daily Dose for 28 Days||1
10489830|NCT01184872|11639575|FG000|STARTED|Overall Study|"Started indicates randomized and full analysis set."|81
10489831|NCT01184872|11639576|FG001|STARTED|Overall Study||39
10489832|NCT01184872|11639575|FG000|Safety Set|Overall Study|One patient randomized to Daptomycin received Vancomycin.|80
10489833|NCT01184872|11639576|FG001|Safety Set|Overall Study||40
10489834|NCT01184872|11639575|FG000|Clinical Evaluable Set (CES)|Overall Study||73
10489835|NCT01184872|11639576|FG001|Clinical Evaluable Set (CES)|Overall Study||30
10489836|NCT01184872|11639575|FG000|Microbiologically Evaluable Set (MES)|Overall Study||65
10489837|NCT01184872|11639576|FG001|Microbiologically Evaluable Set (MES)|Overall Study||27
10489838|NCT01184872|11639575|FG000|COMPLETED|Overall Study||71
10489839|NCT01184872|11639576|FG001|COMPLETED|Overall Study||31
10489840|NCT01184872|11639575|FG000|NOT COMPLETED|Overall Study||10
10489841|NCT01184872|11639576|FG001|NOT COMPLETED|Overall Study||8
10489842|NCT01184885|11639582|FG000|STARTED|Overall Study||7
10489843|NCT01184885|11639582|FG000|COMPLETED|Overall Study||7
10489844|NCT01184885|11639582|FG000|NOT COMPLETED|Overall Study||0
10489845|NCT01184898|11639587|FG000|STARTED|Overall Study||36
10489846|NCT01184898|11639587|FG000|COMPLETED|Overall Study||36
10489847|NCT01184898|11639587|FG000|NOT COMPLETED|Overall Study||0
10489848|NCT01184989|11639591|FG000|STARTED|Overall Study|Treated Patients|112
10489849|NCT01184989|11639591|FG000|COMPLETED|Overall Study||100
10489850|NCT01184989|11639591|FG000|NOT COMPLETED|Overall Study||12
10489851|NCT01185028|11639595|FG000|STARTED|Overall Study||8
10489852|NCT01185028|11639595|FG000|COMPLETED|Overall Study||4
10489853|NCT01185028|11639595|FG000|NOT COMPLETED|Overall Study||4
10489854|NCT01185080|11639602|FG000|STARTED|Overall Study||50
10489855|NCT01185080|11639603|FG001|STARTED|Overall Study||16
10489856|NCT01185080|11639604|FG002|STARTED|Overall Study||17
10489857|NCT01185080|11639602|FG000|COMPLETED|Overall Study||49
10489858|NCT01185080|11639603|FG001|COMPLETED|Overall Study||15
10489859|NCT01185080|11639604|FG002|COMPLETED|Overall Study||16
10489860|NCT01185080|11639602|FG000|NOT COMPLETED|Overall Study||1
10489861|NCT01185080|11639603|FG001|NOT COMPLETED|Overall Study||1
10489862|NCT01185080|11639604|FG002|NOT COMPLETED|Overall Study||1
10489863|NCT01185171|11639612|FG000|STARTED|Induction Chemotherapy||59
10489864|NCT01185171|11639612|FG000|COMPLETED|Induction Chemotherapy||57
10489865|NCT01185171|11639612|FG000|NOT COMPLETED|Induction Chemotherapy||2
10489866|NCT01185171|11639612|FG000|STARTED|Concurrent Chemo and Radiation Treatment||69
10489867|NCT01185171|11639612|FG000|COMPLETED|Concurrent Chemo and Radiation Treatment||66
10489868|NCT01185171|11639612|FG000|NOT COMPLETED|Concurrent Chemo and Radiation Treatment||3
10489869|NCT01185171|11639612|FG000|STARTED|Maintenance||60
10489870|NCT01185171|11639612|FG000|COMPLETED|Maintenance||48
10489871|NCT01185171|11639612|FG000|NOT COMPLETED|Maintenance||12
10489872|NCT01185249|11639616|FG000|STARTED|Overall Study|Total number of patients consented to participate.|66
10489873|NCT01185249|11639616|FG000|COMPLETED|Overall Study|Data was analyzed for patients with three consecutive days of data.|24
10489874|NCT01185249|11639616|FG000|NOT COMPLETED|Overall Study||42
10489875|NCT01185288|11639623|FG000|STARTED|Overall Study||154
10489876|NCT01185288|11639624|FG001|STARTED|Overall Study||155
10489877|NCT01185288|11639623|FG000|COMPLETED|Overall Study||135
10489878|NCT01185288|11639624|FG001|COMPLETED|Overall Study||139
10489879|NCT01185288|11639623|FG000|NOT COMPLETED|Overall Study||19
10489880|NCT01185288|11639624|FG001|NOT COMPLETED|Overall Study||16
10489881|NCT01185301|11639634|FG000|STARTED|Overall Study||98
10489882|NCT01185301|11639635|FG001|STARTED|Overall Study||100
10489883|NCT01185301|11639636|FG002|STARTED|Overall Study||99
10489884|NCT01185301|11639637|FG003|STARTED|Overall Study||98
10489885|NCT01185301|11639634|FG000|COMPLETED|Overall Study||83
10489886|NCT01185301|11639635|FG001|COMPLETED|Overall Study||93
10489887|NCT01185301|11639636|FG002|COMPLETED|Overall Study||93
10489888|NCT01185301|11639637|FG003|COMPLETED|Overall Study||89
10489889|NCT01185301|11639634|FG000|NOT COMPLETED|Overall Study||15
10489890|NCT01185301|11639635|FG001|NOT COMPLETED|Overall Study||7
10489891|NCT01185301|11639636|FG002|NOT COMPLETED|Overall Study||6
10489892|NCT01185301|11639637|FG003|NOT COMPLETED|Overall Study||9
10527684|NCT01391013|11679888|FG000|NOT COMPLETED|Overall Study||0
10527685|NCT01391013|11679889|FG001|NOT COMPLETED|Overall Study||0
10527686|NCT01391130|11679897|FG000|STARTED|Overall Study||73
10527687|NCT01391130|11679898|FG001|STARTED|Overall Study||37
10527688|NCT01391130|11679897|FG000|Received At Least One Dose of Study Drug|Overall Study||72
10527689|NCT01391130|11679898|FG001|Received At Least One Dose of Study Drug|Overall Study||36
10527690|NCT01391130|11679897|FG000|COMPLETED|Overall Study||67
10527691|NCT01391130|11679898|FG001|COMPLETED|Overall Study||31
10527692|NCT01391130|11679897|FG000|NOT COMPLETED|Overall Study||6
10527693|NCT01391130|11679898|FG001|NOT COMPLETED|Overall Study||6
10527694|NCT01391273|11679906|FG000|STARTED|Overall Study||88
10527695|NCT01391273|11679907|FG001|STARTED|Overall Study||85
10527696|NCT01391273|11679906|FG000|COMPLETED|Overall Study||84
10527697|NCT01391273|11679907|FG001|COMPLETED|Overall Study||83
10527698|NCT01391273|11679906|FG000|NOT COMPLETED|Overall Study||4
10527699|NCT01391273|11679907|FG001|NOT COMPLETED|Overall Study||2
10527700|NCT01391286|11679915|FG000|STARTED|Overall Study||18
10527701|NCT01391286|11679916|FG001|STARTED|Overall Study||18
10527702|NCT01391286|11679915|FG000|COMPLETED|Overall Study||18
10527703|NCT01391286|11679916|FG001|COMPLETED|Overall Study||18
10527704|NCT01391286|11679915|FG000|NOT COMPLETED|Overall Study||0
10527705|NCT01391286|11679916|FG001|NOT COMPLETED|Overall Study||0
10527706|NCT01391299|11679925|FG000|STARTED|Overall Study||57
10527707|NCT01391299|11679926|FG001|STARTED|Overall Study||60
10527708|NCT01391299|11679927|FG002|STARTED|Overall Study||58
10527709|NCT01391299|11679925|FG000|COMPLETED|Overall Study||57
10527710|NCT01391299|11679926|FG001|COMPLETED|Overall Study||59
10527711|NCT01391299|11679927|FG002|COMPLETED|Overall Study||56
10527712|NCT01391299|11679925|FG000|NOT COMPLETED|Overall Study||0
10527713|NCT01391299|11679926|FG001|NOT COMPLETED|Overall Study||1
10527714|NCT01391299|11679927|FG002|NOT COMPLETED|Overall Study||2
10527715|NCT01391312|11679937|FG000|STARTED|Overall Study||20
10527716|NCT01391312|11679938|FG001|STARTED|Overall Study||20
10527717|NCT01391312|11679937|FG000|COMPLETED|Overall Study||18
10527718|NCT01391312|11679938|FG001|COMPLETED|Overall Study||19
10527719|NCT01391312|11679937|FG000|NOT COMPLETED|Overall Study||2
10527720|NCT01391312|11679938|FG001|NOT COMPLETED|Overall Study||1
10527721|NCT01391325|11679944|FG000|STARTED|Overall Study||1732
10527722|NCT01391325|11679944|FG000|COMPLETED|Overall Study||1238
10527723|NCT01391325|11679944|FG000|NOT COMPLETED|Overall Study||494
10527724|NCT01391364|11679950|FG000|STARTED|Overall Study||222
10527725|NCT01391364|11679951|FG001|STARTED|Overall Study||216
10527726|NCT01391364|11679950|FG000|COMPLETED|Overall Study||217
10527727|NCT01391364|11679951|FG001|COMPLETED|Overall Study||214
10527728|NCT01391364|11679950|FG000|NOT COMPLETED|Overall Study||5
10527729|NCT01391364|11679951|FG001|NOT COMPLETED|Overall Study||2
10527730|NCT01391468|11679959|FG000|STARTED|Overall Study||24
10527731|NCT01391468|11679960|FG001|STARTED|Overall Study||23
10527732|NCT01391468|11679959|FG000|COMPLETED|Overall Study||18
10527733|NCT01391468|11679960|FG001|COMPLETED|Overall Study||21
10527734|NCT01391468|11679959|FG000|NOT COMPLETED|Overall Study||6
10527735|NCT01391468|11679960|FG001|NOT COMPLETED|Overall Study||2
10527736|NCT01391507|11679975|FG000|STARTED|Overall Study||10
10527737|NCT01391507|11679976|FG001|STARTED|Overall Study||8
10527738|NCT01391507|11679977|FG002|STARTED|Overall Study||6
10527739|NCT01391507|11679978|FG003|STARTED|Overall Study||12
10527740|NCT01391507|11679975|FG000|COMPLETED|Overall Study||6
10527741|NCT01391507|11679976|FG001|COMPLETED|Overall Study||4
10527742|NCT01391507|11679977|FG002|COMPLETED|Overall Study||2
10527743|NCT01391507|11679978|FG003|COMPLETED|Overall Study||5
10527744|NCT01391507|11679975|FG000|NOT COMPLETED|Overall Study||4
10527745|NCT01391507|11679976|FG001|NOT COMPLETED|Overall Study||4
10527746|NCT01391507|11679977|FG002|NOT COMPLETED|Overall Study||4
10527747|NCT01391507|11679978|FG003|NOT COMPLETED|Overall Study||7
10527748|NCT01391546|11679990|FG000|STARTED|Overall Study||177
10527749|NCT01391546|11679991|FG001|STARTED|Overall Study||177
10527750|NCT01391546|11679990|FG000|Vaccinated|Overall Study||176
10527751|NCT01391546|11679991|FG001|Vaccinated|Overall Study||177
10527752|NCT01391546|11679990|FG000|COMPLETED|Overall Study||176
10527753|NCT01391546|11679991|FG001|COMPLETED|Overall Study||177
10527754|NCT01391546|11679990|FG000|NOT COMPLETED|Overall Study||1
10527755|NCT01391546|11679991|FG001|NOT COMPLETED|Overall Study||0
10527756|NCT01391559|11679998|FG000|STARTED|First Intervention||10
10527757|NCT01391559|11679999|FG001|STARTED|First Intervention||10
10527758|NCT01391559|11679998|FG000|COMPLETED|First Intervention||10
10527759|NCT01391559|11679999|FG001|COMPLETED|First Intervention||10
10527760|NCT01391559|11679998|FG000|NOT COMPLETED|First Intervention||0
10527761|NCT01391559|11679999|FG001|NOT COMPLETED|First Intervention||0
10489893|NCT01185340|11639650|FG000|STARTED|Confirmation (CF) Phase, 3 Weeks||1056
10489894|NCT01185340|11639651|FG001|STARTED|Confirmation (CF) Phase, 3 Weeks||0
10489895|NCT01185340|11639652|FG002|STARTED|Confirmation (CF) Phase, 3 Weeks||0
10489896|NCT01185340|11639653|FG003|STARTED|Confirmation (CF) Phase, 3 Weeks||0
10489897|NCT01185340|11639650|FG000|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase early had the option to enter the DC Phase.|18
10489898|NCT01185340|11639651|FG001|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
10489899|NCT01185340|11639652|FG002|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
10489900|NCT01185340|11639653|FG003|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
10489901|NCT01185340|11639650|FG000|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the Adjunctive Treatment (AT) Phase.|968
10489902|NCT01185340|11639651|FG001|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
10489903|NCT01185340|11639652|FG002|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
10489904|NCT01185340|11639653|FG003|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
10489905|NCT01185340|11639650|FG000|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||88
10489906|NCT01185340|11639651|FG001|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
10489907|NCT01185340|11639652|FG002|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
10489908|NCT01185340|11639653|FG003|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
10489909|NCT01185340|11639650|FG000|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
10489910|NCT01185340|11639651|FG001|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||230
10489911|NCT01185340|11639652|FG002|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||219
10489912|NCT01185340|11639653|FG003|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||519
10489913|NCT01185340|11639650|FG000|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
10489914|NCT01185340|11639651|FG001|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|206
10489915|NCT01185340|11639652|FG002|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|204
10489916|NCT01185340|11639653|FG003|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|483
10489917|NCT01185340|11639650|FG000|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
10710134|NCT02647281|11875288|FG004|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
10710135|NCT02647281|11875289|FG005|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
10710136|NCT02647281|11875290|FG006|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
10710137|NCT02647281|11875291|FG007|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
10489918|NCT01185340|11639651|FG001|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||195
10489919|NCT01185340|11639652|FG002|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||186
10489920|NCT01185340|11639653|FG003|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||458
10489921|NCT01185340|11639650|FG000|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
10489922|NCT01185340|11639651|FG001|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
10489923|NCT01185340|11639652|FG002|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||33
10489924|NCT01185340|11639653|FG003|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||61
10489925|NCT01185353|11639670|FG000|STARTED|Part A (Weeks 0 Through 12)||49
10489926|NCT01185353|11639671|FG001|STARTED|Part A (Weeks 0 Through 12)||52
10489927|NCT01185353|11639672|FG002|STARTED|Part A (Weeks 0 Through 12)||52
10489928|NCT01185353|11639673|FG003|STARTED|Part A (Weeks 0 Through 12)||50
10489929|NCT01185353|11639674|FG004|STARTED|Part A (Weeks 0 Through 12)||98
10489930|NCT01185353|11639675|FG005|STARTED|Part A (Weeks 0 Through 12)||0
10489931|NCT01185353|11639676|FG006|STARTED|Part A (Weeks 0 Through 12)||0
10489932|NCT01185353|11639677|FG007|STARTED|Part A (Weeks 0 Through 12)||0
10489933|NCT01185353|11639678|FG008|STARTED|Part A (Weeks 0 Through 12)||0
10489934|NCT01185353|11639679|FG009|STARTED|Part A (Weeks 0 Through 12)||0
10489935|NCT01185353|11639670|FG000|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||49
10489936|NCT01185353|11639671|FG001|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||52
10489937|NCT01185353|11639672|FG002|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||52
10489938|NCT01185353|11639673|FG003|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||50
10489939|NCT01185353|11639674|FG004|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||98
10489940|NCT01185353|11639675|FG005|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
10489941|NCT01185353|11639676|FG006|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
10489942|NCT01185353|11639677|FG007|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
10489943|NCT01185353|11639678|FG008|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
10489944|NCT01185353|11639679|FG009|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
10489945|NCT01185353|11639670|FG000|COMPLETED|Part A (Weeks 0 Through 12)||44
10489946|NCT01185353|11639671|FG001|COMPLETED|Part A (Weeks 0 Through 12)||51
10489947|NCT01185353|11639672|FG002|COMPLETED|Part A (Weeks 0 Through 12)||50
10489948|NCT01185353|11639673|FG003|COMPLETED|Part A (Weeks 0 Through 12)||49
10489949|NCT01185353|11639674|FG004|COMPLETED|Part A (Weeks 0 Through 12)||82
10489950|NCT01185353|11639675|FG005|COMPLETED|Part A (Weeks 0 Through 12)||0
10489951|NCT01185353|11639676|FG006|COMPLETED|Part A (Weeks 0 Through 12)||0
10710138|NCT02647281|11875292|FG008|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
10710139|NCT02647281|11875284|FG000|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
10710140|NCT02647281|11875285|FG001|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
10489952|NCT01185353|11639677|FG007|COMPLETED|Part A (Weeks 0 Through 12)||0
10489953|NCT01185353|11639678|FG008|COMPLETED|Part A (Weeks 0 Through 12)||0
10489954|NCT01185353|11639679|FG009|COMPLETED|Part A (Weeks 0 Through 12)||0
10489955|NCT01185353|11639670|FG000|NOT COMPLETED|Part A (Weeks 0 Through 12)||5
10489956|NCT01185353|11639671|FG001|NOT COMPLETED|Part A (Weeks 0 Through 12)||1
10489957|NCT01185353|11639672|FG002|NOT COMPLETED|Part A (Weeks 0 Through 12)||2
10489958|NCT01185353|11639673|FG003|NOT COMPLETED|Part A (Weeks 0 Through 12)||1
10489959|NCT01185353|11639674|FG004|NOT COMPLETED|Part A (Weeks 0 Through 12)||16
10489960|NCT01185353|11639675|FG005|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
10489961|NCT01185353|11639676|FG006|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
10489962|NCT01185353|11639677|FG007|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
10489963|NCT01185353|11639678|FG008|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
10489964|NCT01185353|11639679|FG009|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
10489965|NCT01185353|11639670|FG000|STARTED|Part B (Weeks 12 Through 24)||0
10489966|NCT01185353|11639671|FG001|STARTED|Part B (Weeks 12 Through 24)||51
10489967|NCT01185353|11639672|FG002|STARTED|Part B (Weeks 12 Through 24)||50
10489968|NCT01185353|11639673|FG003|STARTED|Part B (Weeks 12 Through 24)||49
10489969|NCT01185353|11639674|FG004|STARTED|Part B (Weeks 12 Through 24)||0
10489970|NCT01185353|11639675|FG005|STARTED|Part B (Weeks 12 Through 24)||63
10489971|NCT01185353|11639676|FG006|STARTED|Part B (Weeks 12 Through 24)||63
10489972|NCT01185353|11639677|FG007|STARTED|Part B (Weeks 12 Through 24)||0
10489973|NCT01185353|11639678|FG008|STARTED|Part B (Weeks 12 Through 24)||0
10489974|NCT01185353|11639679|FG009|STARTED|Part B (Weeks 12 Through 24)||0
10489975|NCT01185353|11639670|FG000|COMPLETED|Part B (Weeks 12 Through 24)||0
10489976|NCT01185353|11639671|FG001|COMPLETED|Part B (Weeks 12 Through 24)||50
10489977|NCT01185353|11639672|FG002|COMPLETED|Part B (Weeks 12 Through 24)||48
10489978|NCT01185353|11639673|FG003|COMPLETED|Part B (Weeks 12 Through 24)||45
10489979|NCT01185353|11639674|FG004|COMPLETED|Part B (Weeks 12 Through 24)||0
10489980|NCT01185353|11639675|FG005|COMPLETED|Part B (Weeks 12 Through 24)||59
10489981|NCT01185353|11639676|FG006|COMPLETED|Part B (Weeks 12 Through 24)||57
10489982|NCT01185353|11639677|FG007|COMPLETED|Part B (Weeks 12 Through 24)||0
10489983|NCT01185353|11639678|FG008|COMPLETED|Part B (Weeks 12 Through 24)||0
10338262|NCT00369226|11475175|FG001|STARTED|Phase II (45 Days)||32
10338263|NCT00369226|11475174|FG000|COMPLETED|Phase II (45 Days)||0
10489984|NCT01185353|11639679|FG009|COMPLETED|Part B (Weeks 12 Through 24)||0
10489985|NCT01185353|11639670|FG000|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
10489986|NCT01185353|11639671|FG001|NOT COMPLETED|Part B (Weeks 12 Through 24)||1
10489987|NCT01185353|11639672|FG002|NOT COMPLETED|Part B (Weeks 12 Through 24)||2
10489988|NCT01185353|11639673|FG003|NOT COMPLETED|Part B (Weeks 12 Through 24)||4
10489989|NCT01185353|11639674|FG004|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
10489990|NCT01185353|11639675|FG005|NOT COMPLETED|Part B (Weeks 12 Through 24)||4
10489991|NCT01185353|11639676|FG006|NOT COMPLETED|Part B (Weeks 12 Through 24)||6
10489992|NCT01185353|11639677|FG007|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
10489993|NCT01185353|11639678|FG008|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
10489994|NCT01185353|11639679|FG009|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
10489995|NCT01185353|11639670|FG000|STARTED|Part C (Weeks 24 Through 76)||0
10489996|NCT01185353|11639671|FG001|STARTED|Part C (Weeks 24 Through 76)||0
10489997|NCT01185353|11639672|FG002|STARTED|Part C (Weeks 24 Through 76)||0
10489998|NCT01185353|11639673|FG003|STARTED|Part C (Weeks 24 Through 76)||0
10489999|NCT01185353|11639674|FG004|STARTED|Part C (Weeks 24 Through 76)||0
10490000|NCT01185353|11639675|FG005|STARTED|Part C (Weeks 24 Through 76)||0
10490001|NCT01185353|11639676|FG006|STARTED|Part C (Weeks 24 Through 76)||0
10490002|NCT01185353|11639677|FG007|STARTED|Part C (Weeks 24 Through 76)||108
10490003|NCT01185353|11639678|FG008|STARTED|Part C (Weeks 24 Through 76)||61
10490004|NCT01185353|11639679|FG009|STARTED|Part C (Weeks 24 Through 76)||32
10490005|NCT01185353|11639670|FG000|COMPLETED|Part C (Weeks 24 Through 76)||0
10490006|NCT01185353|11639671|FG001|COMPLETED|Part C (Weeks 24 Through 76)||0
10490007|NCT01185353|11639672|FG002|COMPLETED|Part C (Weeks 24 Through 76)||0
10490008|NCT01185353|11639673|FG003|COMPLETED|Part C (Weeks 24 Through 76)||0
10490009|NCT01185353|11639674|FG004|COMPLETED|Part C (Weeks 24 Through 76)||0
10490010|NCT01185353|11639675|FG005|COMPLETED|Part C (Weeks 24 Through 76)||0
10490011|NCT01185353|11639676|FG006|COMPLETED|Part C (Weeks 24 Through 76)||0
10490012|NCT01185353|11639677|FG007|COMPLETED|Part C (Weeks 24 Through 76)||92
10490013|NCT01185353|11639678|FG008|COMPLETED|Part C (Weeks 24 Through 76)||53
10490014|NCT01185353|11639679|FG009|COMPLETED|Part C (Weeks 24 Through 76)||24
10490015|NCT01185353|11639670|FG000|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
10490016|NCT01185353|11639671|FG001|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
10490017|NCT01185353|11639672|FG002|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
10490018|NCT01185353|11639673|FG003|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
10490019|NCT01185353|11639674|FG004|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
10710141|NCT02647281|11875286|FG002|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
10710142|NCT02647281|11875287|FG003|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
10338264|NCT00369226|11475175|FG001|COMPLETED|Phase II (45 Days)|This includes 10 patients treated at candidate MTD in Phase I.|32
10490020|NCT01185353|11639675|FG005|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
10490021|NCT01185353|11639676|FG006|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
10490022|NCT01185353|11639677|FG007|NOT COMPLETED|Part C (Weeks 24 Through 76)||16
10710143|NCT02647281|11875288|FG004|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
10710144|NCT02647281|11875289|FG005|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6
10490023|NCT01185353|11639678|FG008|NOT COMPLETED|Part C (Weeks 24 Through 76)||8
10490024|NCT01185353|11639679|FG009|NOT COMPLETED|Part C (Weeks 24 Through 76)||8
10490025|NCT01185353|11639670|FG000|STARTED|Part D (Weeks 76 Through 128)||0
10490026|NCT01185353|11639671|FG001|STARTED|Part D (Weeks 76 Through 128)||0
10490027|NCT01185353|11639672|FG002|STARTED|Part D (Weeks 76 Through 128)||0
10490028|NCT01185353|11639673|FG003|STARTED|Part D (Weeks 76 Through 128)||0
10490029|NCT01185353|11639674|FG004|STARTED|Part D (Weeks 76 Through 128)||0
10490030|NCT01185353|11639675|FG005|STARTED|Part D (Weeks 76 Through 128)||0
10490031|NCT01185353|11639676|FG006|STARTED|Part D (Weeks 76 Through 128)||0
10490032|NCT01185353|11639677|FG007|STARTED|Part D (Weeks 76 Through 128)||79
10490033|NCT01185353|11639678|FG008|STARTED|Part D (Weeks 76 Through 128)||47
10490034|NCT01185353|11639679|FG009|STARTED|Part D (Weeks 76 Through 128)||18
10490035|NCT01185353|11639670|FG000|COMPLETED|Part D (Weeks 76 Through 128)||0
10490036|NCT01185353|11639671|FG001|COMPLETED|Part D (Weeks 76 Through 128)||0
10490037|NCT01185353|11639672|FG002|COMPLETED|Part D (Weeks 76 Through 128)||0
10490038|NCT01185353|11639673|FG003|COMPLETED|Part D (Weeks 76 Through 128)||0
10490039|NCT01185353|11639674|FG004|COMPLETED|Part D (Weeks 76 Through 128)||0
10490040|NCT01185353|11639675|FG005|COMPLETED|Part D (Weeks 76 Through 128)||0
10490041|NCT01185353|11639676|FG006|COMPLETED|Part D (Weeks 76 Through 128)||0
10490042|NCT01185353|11639677|FG007|COMPLETED|Part D (Weeks 76 Through 128)||76
10490043|NCT01185353|11639678|FG008|COMPLETED|Part D (Weeks 76 Through 128)||40
10490044|NCT01185353|11639679|FG009|COMPLETED|Part D (Weeks 76 Through 128)||17
10490045|NCT01185353|11639670|FG000|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
10490046|NCT01185353|11639671|FG001|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
10490047|NCT01185353|11639672|FG002|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
10490048|NCT01185353|11639673|FG003|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
10490049|NCT01185353|11639674|FG004|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
10490050|NCT01185353|11639675|FG005|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
10490051|NCT01185353|11639676|FG006|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
10650011|NCT02165605|11810153|FG000|COMPLETED|Overall Study||28
10650012|NCT02165605|11810153|FG000|NOT COMPLETED|Overall Study||0
10650013|NCT02165722|11810162|FG000|STARTED|Overall Study||1971
10650014|NCT02165722|11810163|FG001|STARTED|Overall Study||2202
10650015|NCT02165722|11810162|FG000|COMPLETED|Overall Study|Started and completed participants reflect the longitudinal analytic data set of patients used|1971
10650016|NCT02165722|11810163|FG001|COMPLETED|Overall Study|Started and completed participants reflect the longitudinal analytic data set of patients used|2202
10650017|NCT02165722|11810162|FG000|NOT COMPLETED|Overall Study||0
10650018|NCT02165722|11810163|FG001|NOT COMPLETED|Overall Study||0
10650019|NCT02165735|11810177|FG000|STARTED|Overall Study||180
10490052|NCT01185353|11639677|FG007|NOT COMPLETED|Part D (Weeks 76 Through 128)||3
10490053|NCT01185353|11639678|FG008|NOT COMPLETED|Part D (Weeks 76 Through 128)||7
10490054|NCT01185353|11639679|FG009|NOT COMPLETED|Part D (Weeks 76 Through 128)||1
10490055|NCT01185366|11639720|FG000|STARTED|First Line Therapy||38
10490056|NCT01185366|11639721|FG001|STARTED|First Line Therapy||34
10490057|NCT01185366|11639720|FG000|Received 1st Drug|First Line Therapy||36
10490058|NCT01185366|11639721|FG001|Received 1st Drug|First Line Therapy||33
10490059|NCT01185366|11639720|FG000|COMPLETED|First Line Therapy||35
10490060|NCT01185366|11639721|FG001|COMPLETED|First Line Therapy||33
10490061|NCT01185366|11639720|FG000|NOT COMPLETED|First Line Therapy||3
10490062|NCT01185366|11639721|FG001|NOT COMPLETED|First Line Therapy||1
10490063|NCT01185366|11639720|FG000|STARTED|Crossover to Second Line Therapy||35
10490064|NCT01185366|11639721|FG001|STARTED|Crossover to Second Line Therapy||33
10490065|NCT01185366|11639720|FG000|Received Crossover Drug|Crossover to Second Line Therapy||21
10490066|NCT01185366|11639721|FG001|Received Crossover Drug|Crossover to Second Line Therapy||23
10490067|NCT01185366|11639720|FG000|COMPLETED|Crossover to Second Line Therapy||21
10490068|NCT01185366|11639721|FG001|COMPLETED|Crossover to Second Line Therapy||23
10490069|NCT01185366|11639720|FG000|NOT COMPLETED|Crossover to Second Line Therapy||14
10490070|NCT01185366|11639721|FG001|NOT COMPLETED|Crossover to Second Line Therapy||10
10490071|NCT01185509|11639731|FG000|STARTED|Overall Study||11
10490072|NCT01185509|11639732|FG001|STARTED|Overall Study||20
10490073|NCT01185509|11639731|FG000|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
10490074|NCT01185509|11639732|FG001|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
10490075|NCT01185509|11639731|FG000|NOT COMPLETED|Overall Study||11
10490076|NCT01185509|11639732|FG001|NOT COMPLETED|Overall Study||20
10490077|NCT01185522|11639739|FG000|STARTED|Overall Study||693
10490078|NCT01185522|11639739|FG000|COMPLETED|Overall Study||585
10490079|NCT01185522|11639739|FG000|NOT COMPLETED|Overall Study||108
10490080|NCT01185548|11639744|FG000|STARTED|Period 1 : Tolbutamide||4
10490081|NCT01185548|11639744|FG000|COMPLETED|Period 1 : Tolbutamide||4
10490082|NCT01185548|11639744|FG000|NOT COMPLETED|Period 1 : Tolbutamide||0
10490083|NCT01185548|11639744|FG000|STARTED|Period 2: Tasisulam and Tolbutamide||4
10490084|NCT01185548|11639744|FG000|COMPLETED|Period 2: Tasisulam and Tolbutamide||2
10490085|NCT01185548|11639744|FG000|NOT COMPLETED|Period 2: Tasisulam and Tolbutamide||2
10490086|NCT01185548|11639744|FG000|STARTED|Period 3: Tasisulam and Tolbutamide||2
10490087|NCT01185548|11639744|FG000|COMPLETED|Period 3: Tasisulam and Tolbutamide||2
10490088|NCT01185548|11639744|FG000|NOT COMPLETED|Period 3: Tasisulam and Tolbutamide||0
10490089|NCT01185561|11639759|FG000|STARTED|Overall Study||36
10490090|NCT01185561|11639760|FG001|STARTED|Overall Study||38
10490091|NCT01185561|11639759|FG000|COMPLETED|Overall Study||34
10490092|NCT01185561|11639760|FG001|COMPLETED|Overall Study||26
10490093|NCT01185561|11639759|FG000|NOT COMPLETED|Overall Study||2
10490094|NCT01185561|11639760|FG001|NOT COMPLETED|Overall Study||12
10490095|NCT01185600|11639768|FG000|STARTED|Overall Study||73
10490096|NCT01185600|11639769|FG001|STARTED|Overall Study||104
10490097|NCT01185600|11639768|FG000|COMPLETED|Overall Study||41
10490098|NCT01185600|11639769|FG001|COMPLETED|Overall Study||59
10490099|NCT01185600|11639768|FG000|NOT COMPLETED|Overall Study||32
10490100|NCT01185600|11639769|FG001|NOT COMPLETED|Overall Study||45
10490101|NCT01185639|11639778|FG000|STARTED|Overall Study||29
10490102|NCT01185639|11639778|FG000|COMPLETED|Overall Study||27
10490103|NCT01185639|11639778|FG000|NOT COMPLETED|Overall Study||2
10490104|NCT01185704|11639784|FG000|STARTED|Overall Study||68
10490105|NCT01185704|11639785|FG001|STARTED|Overall Study||68
10490106|NCT01185704|11639784|FG000|Treated|Overall Study||65
10490107|NCT01185704|11639785|FG001|Treated|Overall Study||65
10490108|NCT01185704|11639784|FG000|COMPLETED|Overall Study||55
10490109|NCT01185704|11639785|FG001|COMPLETED|Overall Study||60
10490110|NCT01185704|11639784|FG000|NOT COMPLETED|Overall Study||13
10490111|NCT01185704|11639785|FG001|NOT COMPLETED|Overall Study||8
10490112|NCT01185782|11639793|FG000|STARTED|Overall Study||129
10490113|NCT01185782|11639794|FG001|STARTED|Overall Study||136
10490114|NCT01185782|11639793|FG000|Treated|Overall Study||129
10490115|NCT01185782|11639794|FG001|Treated|Overall Study||132
10490116|NCT01185782|11639793|FG000|COMPLETED|Overall Study||123
10490117|NCT01185782|11639794|FG001|COMPLETED|Overall Study||125
10490118|NCT01185782|11639793|FG000|NOT COMPLETED|Overall Study||6
10490119|NCT01185782|11639794|FG001|NOT COMPLETED|Overall Study||11
10490120|NCT01185821|11639805|FG000|STARTED|Overall Study||33
10490121|NCT01185821|11639806|FG001|STARTED|Overall Study||29
10490122|NCT01185821|11639807|FG002|STARTED|Overall Study||43
10490123|NCT01185821|11639808|FG003|STARTED|Overall Study||29
10490124|NCT01185821|11639809|FG004|STARTED|Overall Study||50
10490125|NCT01185821|11639805|FG000|Patients With Washout|Overall Study||33
10490126|NCT01185821|11639806|FG001|Patients With Washout|Overall Study||29
10490127|NCT01185821|11639807|FG002|Patients With Washout|Overall Study||39
10490128|NCT01185821|11639808|FG003|Patients With Washout|Overall Study||29
10490129|NCT01185821|11639809|FG004|Patients With Washout|Overall Study||33
10490130|NCT01185821|11639805|FG000|Patients Without Washout|Overall Study||0
10490131|NCT01185821|11639806|FG001|Patients Without Washout|Overall Study||0
10490132|NCT01185821|11639807|FG002|Patients Without Washout|Overall Study||4
10490133|NCT01185821|11639808|FG003|Patients Without Washout|Overall Study||0
10490134|NCT01185821|11639809|FG004|Patients Without Washout|Overall Study||17
10490135|NCT01185821|11639805|FG000|Patients on Placebo in Core|Overall Study||8
10490136|NCT01185821|11639806|FG001|Patients on Placebo in Core|Overall Study||7
10490137|NCT01185821|11639807|FG002|Patients on Placebo in Core|Overall Study||9
10490138|NCT01185821|11639808|FG003|Patients on Placebo in Core|Overall Study||8
10490139|NCT01185821|11639809|FG004|Patients on Placebo in Core|Overall Study||2
10490140|NCT01185821|11639805|FG000|COMPLETED|Overall Study||26
10490141|NCT01185821|11639806|FG001|COMPLETED|Overall Study||20
10490142|NCT01185821|11639807|FG002|COMPLETED|Overall Study||33
10490143|NCT01185821|11639808|FG003|COMPLETED|Overall Study||23
10490144|NCT01185821|11639809|FG004|COMPLETED|Overall Study||26
10490145|NCT01185821|11639805|FG000|NOT COMPLETED|Overall Study||7
10490146|NCT01185821|11639806|FG001|NOT COMPLETED|Overall Study||9
10490147|NCT01185821|11639807|FG002|NOT COMPLETED|Overall Study||10
10490148|NCT01185821|11639808|FG003|NOT COMPLETED|Overall Study||6
10490149|NCT01185821|11639809|FG004|NOT COMPLETED|Overall Study||24
10490150|NCT01185834|11639823|FG000|STARTED|Overall Study||118
10490151|NCT01185834|11639823|FG000|COMPLETED|Overall Study||104
10490152|NCT01185834|11639823|FG000|NOT COMPLETED|Overall Study||14
10490153|NCT01185964|11639830|FG000|STARTED|Phase 1b and Phase 2||15
10490154|NCT01185964|11639831|FG001|STARTED|Phase 1b and Phase 2||66
10490155|NCT01185964|11639832|FG002|STARTED|Phase 1b and Phase 2||67
10490156|NCT01185964|11639833|FG003|STARTED|Phase 1b and Phase 2||0
10490157|NCT01185964|11639830|FG000|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||15
10490158|NCT01185964|11639831|FG001|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||64
10490159|NCT01185964|11639832|FG002|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||65
10490160|NCT01185964|11639833|FG003|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||0
10490161|NCT01185964|11639830|FG000|COMPLETED|Phase 1b and Phase 2||13
10490162|NCT01185964|11639831|FG001|COMPLETED|Phase 1b and Phase 2||56
10490163|NCT01185964|11639832|FG002|COMPLETED|Phase 1b and Phase 2||58
10490164|NCT01185964|11639833|FG003|COMPLETED|Phase 1b and Phase 2||0
10490165|NCT01185964|11639830|FG000|NOT COMPLETED|Phase 1b and Phase 2||2
10490166|NCT01185964|11639831|FG001|NOT COMPLETED|Phase 1b and Phase 2||10
10490167|NCT01185964|11639832|FG002|NOT COMPLETED|Phase 1b and Phase 2||9
10490168|NCT01185964|11639833|FG003|NOT COMPLETED|Phase 1b and Phase 2||0
10490169|NCT01185964|11639830|FG000|STARTED|Optional Olaratumab Monotherapy on Dox||0
10490170|NCT01185964|11639831|FG001|STARTED|Optional Olaratumab Monotherapy on Dox||0
10490171|NCT01185964|11639832|FG002|STARTED|Optional Olaratumab Monotherapy on Dox||0
10490172|NCT01185964|11639833|FG003|STARTED|Optional Olaratumab Monotherapy on Dox|Participants with disease progression after treatment received olaratumab.|30
10490173|NCT01185964|11639830|FG000|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
10490174|NCT01185964|11639831|FG001|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
10490175|NCT01185964|11639832|FG002|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
10490176|NCT01185964|11639833|FG003|COMPLETED|Optional Olaratumab Monotherapy on Dox||25
10490177|NCT01185964|11639830|FG000|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
10490178|NCT01185964|11639831|FG001|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
10490179|NCT01185964|11639832|FG002|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
10490180|NCT01185964|11639833|FG003|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||5
10490181|NCT01186250|11639851|FG000|STARTED|Overall Study||9
10490182|NCT01186250|11639852|FG001|STARTED|Overall Study||9
10490183|NCT01186250|11639851|FG000|COMPLETED|Overall Study||8
10490184|NCT01186250|11639852|FG001|COMPLETED|Overall Study||9
10490185|NCT01186250|11639851|FG000|NOT COMPLETED|Overall Study||1
10490186|NCT01186250|11639852|FG001|NOT COMPLETED|Overall Study||0
10490187|NCT01186328|11639858|FG000|STARTED|Overall Study||6
10490188|NCT01186328|11639859|FG001|STARTED|Overall Study||0
10490189|NCT01186328|11639860|FG002|STARTED|Overall Study||0
10490190|NCT01186328|11639858|FG000|COMPLETED|Overall Study||5
10490191|NCT01186328|11639859|FG001|COMPLETED|Overall Study||0
10490192|NCT01186328|11639860|FG002|COMPLETED|Overall Study||0
10490193|NCT01186328|11639858|FG000|NOT COMPLETED|Overall Study||1
10490194|NCT01186328|11639859|FG001|NOT COMPLETED|Overall Study||0
10490195|NCT01186328|11639860|FG002|NOT COMPLETED|Overall Study||0
10490196|NCT01186406|11639865|FG000|STARTED|Overall Study||41
10490197|NCT01186406|11639865|FG000|COMPLETED|Overall Study||41
10490198|NCT01186406|11639865|FG000|NOT COMPLETED|Overall Study||0
10490199|NCT01186419|11639871|FG000|STARTED|Overall Study||24
10490200|NCT01186419|11639872|FG001|STARTED|Overall Study||27
10490201|NCT01186419|11639871|FG000|COMPLETED|Overall Study||17
10490202|NCT01186419|11639872|FG001|COMPLETED|Overall Study||18
10490203|NCT01186419|11639871|FG000|NOT COMPLETED|Overall Study||7
10490204|NCT01186419|11639872|FG001|NOT COMPLETED|Overall Study||9
10490205|NCT01186458|11639877|FG000|STARTED|Overall Study||4
10490206|NCT01186458|11639877|FG000|COMPLETED|Overall Study||3
10490207|NCT01186458|11639877|FG000|NOT COMPLETED|Overall Study||1
10490208|NCT01186562|11639883|FG000|STARTED|Overall Study||54
10490209|NCT01186562|11639884|FG001|STARTED|Overall Study||29
10490210|NCT01186562|11639883|FG000|COMPLETED|Overall Study||50
10490211|NCT01186562|11639884|FG001|COMPLETED|Overall Study||27
10490212|NCT01186562|11639883|FG000|NOT COMPLETED|Overall Study||4
10490213|NCT01186562|11639884|FG001|NOT COMPLETED|Overall Study||2
10490214|NCT01186692|11639890|FG000|STARTED|Overall Study||131
10490215|NCT01186692|11639890|FG000|COMPLETED|Overall Study||99
10490216|NCT01186692|11639890|FG000|NOT COMPLETED|Overall Study||32
10490217|NCT01186705|11639898|FG000|STARTED|Overall Study||1
10490218|NCT01186705|11639898|FG000|COMPLETED|Overall Study||1
10490219|NCT01186705|11639898|FG000|NOT COMPLETED|Overall Study||0
10490220|NCT01186744|11639908|FG000|STARTED|Overall Study||218
10490221|NCT01186744|11639909|FG001|STARTED|Overall Study||157
10490222|NCT01186744|11639910|FG002|STARTED|Overall Study||31
10490223|NCT01186744|11639911|FG003|STARTED|Overall Study||82
10490224|NCT01186744|11639912|FG004|STARTED|Overall Study||45
10490225|NCT01186744|11639913|FG005|STARTED|Overall Study||133
10490226|NCT01186744|11639908|FG000|COMPLETED|Overall Study||10
10490227|NCT01186744|11639909|FG001|COMPLETED|Overall Study||5
10490228|NCT01186744|11639910|FG002|COMPLETED|Overall Study||25
10490229|NCT01186744|11639911|FG003|COMPLETED|Overall Study||70
10490230|NCT01186744|11639912|FG004|COMPLETED|Overall Study||39
10490231|NCT01186744|11639913|FG005|COMPLETED|Overall Study||107
10490232|NCT01186744|11639908|FG000|NOT COMPLETED|Overall Study||208
10490233|NCT01186744|11639909|FG001|NOT COMPLETED|Overall Study||152
10490234|NCT01186744|11639910|FG002|NOT COMPLETED|Overall Study||6
10490235|NCT01186744|11639911|FG003|NOT COMPLETED|Overall Study||12
10490236|NCT01186744|11639912|FG004|NOT COMPLETED|Overall Study||6
10490237|NCT01186744|11639913|FG005|NOT COMPLETED|Overall Study||26
10490238|NCT01186770|11639952|FG000|STARTED|Overall Study||201
10490239|NCT01186770|11639953|FG001|STARTED|Overall Study||202
10490240|NCT01186770|11639954|FG002|STARTED|Overall Study||200
10490241|NCT01186770|11639955|FG003|STARTED|Overall Study||201
10490242|NCT01186770|11639952|FG000|Intent-to-treat (ITT Population)|Overall Study||201
10490243|NCT01186770|11639953|FG001|Intent-to-treat (ITT Population)|Overall Study||201
10490244|NCT01186770|11639954|FG002|Intent-to-treat (ITT Population)|Overall Study||200
10490245|NCT01186770|11639955|FG003|Intent-to-treat (ITT Population)|Overall Study||201
10490246|NCT01186770|11639952|FG000|COMPLETED|Overall Study||160
10490247|NCT01186770|11639953|FG001|COMPLETED|Overall Study||156
10490248|NCT01186770|11639954|FG002|COMPLETED|Overall Study||148
10490249|NCT01186770|11639955|FG003|COMPLETED|Overall Study||143
10490250|NCT01186770|11639952|FG000|NOT COMPLETED|Overall Study||41
10490251|NCT01186770|11639953|FG001|NOT COMPLETED|Overall Study||46
10490252|NCT01186770|11639954|FG002|NOT COMPLETED|Overall Study||52
10490253|NCT01186770|11639955|FG003|NOT COMPLETED|Overall Study||58
10490254|NCT01186796|11639967|FG000|STARTED|Overall Study||14
10490255|NCT01186796|11639968|FG001|STARTED|Overall Study|1 subject was randomized but withdrew before study interventions.|16
10490256|NCT01186796|11639967|FG000|COMPLETED|Overall Study||10
10490257|NCT01186796|11639968|FG001|COMPLETED|Overall Study||14
10490258|NCT01186796|11639967|FG000|NOT COMPLETED|Overall Study||4
10490259|NCT01186796|11639968|FG001|NOT COMPLETED|Overall Study||2
10490260|NCT01186809|11639974|FG000|STARTED|Overall Study||73
10490261|NCT01186809|11639974|FG000|COMPLETED|Overall Study||43
10490262|NCT01186809|11639974|FG000|NOT COMPLETED|Overall Study||30
10490263|NCT01186939|11639978|FG000|STARTED|Overall Study||40
10490264|NCT01186939|11639978|FG000|COMPLETED|Overall Study||0
10490265|NCT01186939|11639978|FG000|NOT COMPLETED|Overall Study||40
10490266|NCT01186978|11639982|FG000|STARTED|Overall Study||63
10490267|NCT01186978|11639982|FG000|COMPLETED|Overall Study||62
10490268|NCT01186978|11639982|FG000|NOT COMPLETED|Overall Study||1
10490269|NCT01187004|11639988|FG000|STARTED|Overall Study||20
10490270|NCT01187004|11639989|FG001|STARTED|Overall Study||144
10490271|NCT01187004|11639988|FG000|COMPLETED|Overall Study||20
10490272|NCT01187004|11639989|FG001|COMPLETED|Overall Study||144
10490273|NCT01187004|11639988|FG000|NOT COMPLETED|Overall Study||0
10490274|NCT01187004|11639989|FG001|NOT COMPLETED|Overall Study||0
10490275|NCT01187017|11639996|FG000|STARTED|Overall Study||1
10490276|NCT01187017|11639996|FG000|COMPLETED|Overall Study||1
10490277|NCT01187017|11639996|FG000|NOT COMPLETED|Overall Study||0
10490278|NCT01187043|11640007|FG000|STARTED|Overall Study||12
10490279|NCT01187043|11640008|FG001|STARTED|Overall Study||10
10490280|NCT01187043|11640009|FG002|STARTED|Overall Study||12
10490281|NCT01187043|11640010|FG003|STARTED|Overall Study||12
10490282|NCT01187043|11640011|FG004|STARTED|Overall Study||12
10490283|NCT01187043|11640007|FG000|COMPLETED|Overall Study||11
10490284|NCT01187043|11640008|FG001|COMPLETED|Overall Study||10
10490285|NCT01187043|11640009|FG002|COMPLETED|Overall Study||8
10490286|NCT01187043|11640010|FG003|COMPLETED|Overall Study||12
10490287|NCT01187043|11640011|FG004|COMPLETED|Overall Study||10
10490288|NCT01187043|11640007|FG000|NOT COMPLETED|Overall Study||1
10490289|NCT01187043|11640008|FG001|NOT COMPLETED|Overall Study||0
10490290|NCT01187043|11640009|FG002|NOT COMPLETED|Overall Study||4
10490291|NCT01187043|11640010|FG003|NOT COMPLETED|Overall Study||0
10490292|NCT01187043|11640011|FG004|NOT COMPLETED|Overall Study||2
10490293|NCT01187095|11640025|FG000|STARTED|Overall Study||153
10490294|NCT01187095|11640026|FG001|STARTED|Overall Study||142
10490295|NCT01187095|11640025|FG000|COMPLETED|Overall Study||108
10490296|NCT01187095|11640026|FG001|COMPLETED|Overall Study||108
10490297|NCT01187095|11640025|FG000|NOT COMPLETED|Overall Study||45
10490298|NCT01187095|11640026|FG001|NOT COMPLETED|Overall Study||34
10490299|NCT01187329|11640034|FG000|STARTED|Overall Study||50
10490300|NCT01187329|11640035|FG001|STARTED|Overall Study||50
10490301|NCT01187329|11640034|FG000|COMPLETED|Overall Study||49
10490302|NCT01187329|11640035|FG001|COMPLETED|Overall Study||48
10490303|NCT01187329|11640034|FG000|NOT COMPLETED|Overall Study||1
10490304|NCT01187329|11640035|FG001|NOT COMPLETED|Overall Study||2
10490305|NCT01187355|11640043|FG000|STARTED|Overall Study||294
10490306|NCT01187355|11640044|FG001|STARTED|Overall Study||297
10490307|NCT01187355|11640043|FG000|COMPLETED|Overall Study||276
10490308|NCT01187355|11640044|FG001|COMPLETED|Overall Study||277
10490309|NCT01187355|11640043|FG000|NOT COMPLETED|Overall Study||18
10490310|NCT01187355|11640044|FG001|NOT COMPLETED|Overall Study||20
10490311|NCT01187381|11640050|FG000|STARTED|Overall Study||250
10490312|NCT01187381|11640050|FG000|COMPLETED|Overall Study|A participant completed study when the trastuzumab treatment was discontinued.|250
10490313|NCT01187381|11640050|FG000|NOT COMPLETED|Overall Study||0
10490314|NCT01187407|11640058|FG000|STARTED|Confirmation (CF) Phase, 3 Weeks||1480
10490315|NCT01187407|11640059|FG001|STARTED|Confirmation (CF) Phase, 3 Weeks||0
10490316|NCT01187407|11640060|FG002|STARTED|Confirmation (CF) Phase, 3 Weeks||0
10490317|NCT01187407|11640061|FG003|STARTED|Confirmation (CF) Phase, 3 Weeks||0
10490318|NCT01187407|11640062|FG004|STARTED|Confirmation (CF) Phase, 3 Weeks||0
10490319|NCT01187407|11640058|FG000|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase early had the option to enter the DC Phase.|25
10490320|NCT01187407|11640059|FG001|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
10490321|NCT01187407|11640060|FG002|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
10490322|NCT01187407|11640061|FG003|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
10490323|NCT01187407|11640062|FG004|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
10490324|NCT01187407|11640058|FG000|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the Adjunctive Treatment (AT) Phase.|1390
10710145|NCT02647281|11875290|FG006|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6
10710146|NCT02647281|11875291|FG007|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6
10710147|NCT02647281|11875292|FG008|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||5
10710148|NCT02647281|11875284|FG000|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
10710149|NCT02647281|11875285|FG001|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
10490325|NCT01187407|11640059|FG001|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
10490326|NCT01187407|11640060|FG002|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
10490327|NCT01187407|11640061|FG003|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
10490328|NCT01187407|11640062|FG004|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
10490329|NCT01187407|11640058|FG000|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||90
10490330|NCT01187407|11640059|FG001|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
10490331|NCT01187407|11640060|FG002|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
10490332|NCT01187407|11640061|FG003|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
10490333|NCT01187407|11640062|FG004|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
10490334|NCT01187407|11640058|FG000|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
10490335|NCT01187407|11640059|FG001|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||232
10490336|NCT01187407|11640060|FG002|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||226
10490337|NCT01187407|11640061|FG003|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||231
10490338|NCT01187407|11640062|FG004|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||701
10490339|NCT01187407|11640058|FG000|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
10490424|NCT01188421|11640194|FG000|STARTED|Overall Study||31
10490425|NCT01188421|11640195|FG001|STARTED|Overall Study||36
10490340|NCT01187407|11640059|FG001|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|212
10490341|NCT01187407|11640060|FG002|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|215
10490342|NCT01187407|11640061|FG003|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|220
10490343|NCT01187407|11640062|FG004|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|660
10490344|NCT01187407|11640058|FG000|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
10490345|NCT01187407|11640059|FG001|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||196
10490346|NCT01187407|11640060|FG002|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||191
10490347|NCT01187407|11640061|FG003|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||202
10490348|NCT01187407|11640062|FG004|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||626
10490349|NCT01187407|11640058|FG000|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
10490350|NCT01187407|11640059|FG001|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||36
10490351|NCT01187407|11640060|FG002|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
10490352|NCT01187407|11640061|FG003|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||29
10490353|NCT01187407|11640062|FG004|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||75
10490354|NCT01187446|11640081|FG000|STARTED|Overall Study||14
10490355|NCT01187446|11640082|FG001|STARTED|Overall Study||14
10490356|NCT01187446|11640081|FG000|COMPLETED|Overall Study||14
10490357|NCT01187446|11640082|FG001|COMPLETED|Overall Study||13
10490358|NCT01187446|11640081|FG000|NOT COMPLETED|Overall Study||0
10490359|NCT01187446|11640082|FG001|NOT COMPLETED|Overall Study||1
10490360|NCT01187498|11640090|FG000|STARTED|Overall Study||73
10490361|NCT01187498|11640091|FG001|STARTED|Overall Study||70
10490362|NCT01187498|11640090|FG000|COMPLETED|Overall Study||64
10490363|NCT01187498|11640091|FG001|COMPLETED|Overall Study||60
10490364|NCT01187498|11640090|FG000|NOT COMPLETED|Overall Study||9
10490365|NCT01187498|11640091|FG001|NOT COMPLETED|Overall Study||10
10490366|NCT01187511|11640099|FG000|STARTED|Overall Study||22
10490367|NCT01187511|11640100|FG001|STARTED|Overall Study||22
10490368|NCT01187511|11640099|FG000|COMPLETED|Overall Study||14
10490369|NCT01187511|11640100|FG001|COMPLETED|Overall Study||21
10490370|NCT01187511|11640099|FG000|NOT COMPLETED|Overall Study||8
10490371|NCT01187511|11640100|FG001|NOT COMPLETED|Overall Study||1
10490372|NCT01187550|11640108|FG000|STARTED|Overall Study||183
10490373|NCT01187550|11640109|FG001|STARTED|Overall Study||30
10490374|NCT01187550|11640108|FG000|Treated|Overall Study||175
10490375|NCT01187550|11640109|FG001|Treated|Overall Study||30
10490376|NCT01187550|11640108|FG000|COMPLETED|Overall Study||169
10490377|NCT01187550|11640109|FG001|COMPLETED|Overall Study||29
10490378|NCT01187550|11640108|FG000|NOT COMPLETED|Overall Study||14
10490379|NCT01187550|11640109|FG001|NOT COMPLETED|Overall Study||1
10490380|NCT01187771|11640117|FG000|STARTED|Overall Study||28
10490381|NCT01187771|11640118|FG001|STARTED|Overall Study||21
10490382|NCT01187771|11640117|FG000|COMPLETED|Overall Study||25
10490383|NCT01187771|11640118|FG001|COMPLETED|Overall Study||18
10490384|NCT01187771|11640117|FG000|NOT COMPLETED|Overall Study||3
10490385|NCT01187771|11640118|FG001|NOT COMPLETED|Overall Study||3
10490386|NCT01187901|11640128|FG000|STARTED|Overall Study||46
10490387|NCT01187901|11640129|FG001|STARTED|Overall Study||46
10490388|NCT01187901|11640128|FG000|COMPLETED|Overall Study||37
10490389|NCT01187901|11640129|FG001|COMPLETED|Overall Study||36
10490390|NCT01187901|11640128|FG000|NOT COMPLETED|Overall Study||9
10490391|NCT01187901|11640129|FG001|NOT COMPLETED|Overall Study||10
10490392|NCT01187914|11640135|FG000|STARTED|Overall Study||40
10490393|NCT01187914|11640135|FG000|COMPLETED|Overall Study||40
10490394|NCT01187914|11640135|FG000|NOT COMPLETED|Overall Study||0
10490395|NCT01187953|11640141|FG000|STARTED|Overall Study||268
10490396|NCT01187953|11640142|FG001|STARTED|Overall Study||275
10490397|NCT01187953|11640141|FG000|Dosed|Overall Study||266
10490398|NCT01187953|11640142|FG001|Dosed|Overall Study||271
10490399|NCT01187953|11640141|FG000|COMPLETED|Overall Study||253
10490400|NCT01187953|11640142|FG001|COMPLETED|Overall Study||254
10490401|NCT01187953|11640141|FG000|NOT COMPLETED|Overall Study||15
10490402|NCT01187953|11640142|FG001|NOT COMPLETED|Overall Study||21
10490403|NCT01188109|11640148|FG000|STARTED|Overall Study||22
10490404|NCT01188109|11640148|FG000|COMPLETED|Overall Study||22
10490405|NCT01188109|11640148|FG000|NOT COMPLETED|Overall Study||0
10490406|NCT01188226|11640152|FG000|STARTED|Overall Study||10
10490407|NCT01188226|11640152|FG000|COMPLETED|Overall Study||6
10490408|NCT01188226|11640152|FG000|NOT COMPLETED|Overall Study||4
10490409|NCT01188343|11640169|FG000|STARTED|Overall Study||102
10490410|NCT01188343|11640170|FG001|STARTED|Overall Study||219
10490411|NCT01188343|11640171|FG002|STARTED|Overall Study||221
10490412|NCT01188343|11640169|FG000|COMPLETED|Overall Study||101
10490413|NCT01188343|11640170|FG001|COMPLETED|Overall Study||193
10490414|NCT01188343|11640171|FG002|COMPLETED|Overall Study||220
10490415|NCT01188343|11640169|FG000|NOT COMPLETED|Overall Study||1
10490416|NCT01188343|11640170|FG001|NOT COMPLETED|Overall Study||26
10490417|NCT01188343|11640171|FG002|NOT COMPLETED|Overall Study||1
10490418|NCT01188369|11640184|FG000|STARTED|Overall Study||10
10490419|NCT01188369|11640185|FG001|STARTED|Overall Study||10
10490420|NCT01188369|11640184|FG000|COMPLETED|Overall Study||10
10490421|NCT01188369|11640185|FG001|COMPLETED|Overall Study||10
10490422|NCT01188369|11640184|FG000|NOT COMPLETED|Overall Study||0
10490423|NCT01188369|11640185|FG001|NOT COMPLETED|Overall Study||0
10490426|NCT01188421|11640196|FG002|STARTED|Overall Study||36
10490427|NCT01188421|11640194|FG000|COMPLETED|Overall Study||28
10490428|NCT01188421|11640195|FG001|COMPLETED|Overall Study||26
10490429|NCT01188421|11640196|FG002|COMPLETED|Overall Study||22
10490430|NCT01188421|11640194|FG000|NOT COMPLETED|Overall Study||3
10490431|NCT01188421|11640195|FG001|NOT COMPLETED|Overall Study||10
10490432|NCT01188421|11640196|FG002|NOT COMPLETED|Overall Study||14
10490433|NCT01188447|11640204|FG000|STARTED|Overall Study||4034
10490434|NCT01188447|11640204|FG000|COMPLETED|Overall Study||4034
10490435|NCT01188447|11640204|FG000|NOT COMPLETED|Overall Study||0
10490436|NCT01188460|11640211|FG000|STARTED|Overall Study||25
10490437|NCT01188460|11640212|FG001|STARTED|Overall Study||23
10490438|NCT01188460|11640211|FG000|COMPLETED|Overall Study||25
10490439|NCT01188460|11640212|FG001|COMPLETED|Overall Study||23
10490440|NCT01188460|11640211|FG000|NOT COMPLETED|Overall Study||0
10490441|NCT01188460|11640212|FG001|NOT COMPLETED|Overall Study||0
10490442|NCT01188499|11640223|FG000|STARTED|Overall Study||24
10490443|NCT01188499|11640224|FG001|STARTED|Overall Study||83
10490444|NCT01188499|11640225|FG002|STARTED|Overall Study||33
10490445|NCT01188499|11640226|FG003|STARTED|Overall Study||18
10490446|NCT01188499|11640227|FG004|STARTED|Overall Study||18
10490447|NCT01188499|11640223|FG000|COMPLETED|Overall Study||24
10490448|NCT01188499|11640224|FG001|COMPLETED|Overall Study||83
10490449|NCT01188499|11640225|FG002|COMPLETED|Overall Study||33
10490450|NCT01188499|11640226|FG003|COMPLETED|Overall Study||18
10490451|NCT01188499|11640227|FG004|COMPLETED|Overall Study||18
10490452|NCT01188499|11640223|FG000|NOT COMPLETED|Overall Study||0
10490453|NCT01188499|11640224|FG001|NOT COMPLETED|Overall Study||0
10490454|NCT01188499|11640225|FG002|NOT COMPLETED|Overall Study||0
10490455|NCT01188499|11640226|FG003|NOT COMPLETED|Overall Study||0
10490456|NCT01188499|11640227|FG004|NOT COMPLETED|Overall Study||0
10490457|NCT01188538|11640241|FG000|STARTED|Overall Study||20
10490458|NCT01188538|11640242|FG001|STARTED|Overall Study||20
10490459|NCT01188538|11640241|FG000|COMPLETED|Overall Study||20
10490460|NCT01188538|11640242|FG001|COMPLETED|Overall Study||19
10490461|NCT01188538|11640241|FG000|NOT COMPLETED|Overall Study||0
10490462|NCT01188538|11640242|FG001|NOT COMPLETED|Overall Study||1
10490463|NCT01188551|11640254|FG000|STARTED|Overall Study||25
10490464|NCT01188551|11640255|FG001|STARTED|Overall Study||25
10490465|NCT01188551|11640256|FG002|STARTED|Overall Study||25
10490466|NCT01188551|11640257|FG003|STARTED|Overall Study||25
10490467|NCT01188551|11640254|FG000|COMPLETED|Overall Study||24
10490468|NCT01188551|11640255|FG001|COMPLETED|Overall Study||25
10490469|NCT01188551|11640256|FG002|COMPLETED|Overall Study||25
10490470|NCT01188551|11640257|FG003|COMPLETED|Overall Study||25
10490471|NCT01188551|11640254|FG000|NOT COMPLETED|Overall Study||1
10490472|NCT01188551|11640255|FG001|NOT COMPLETED|Overall Study||0
10490473|NCT01188551|11640256|FG002|NOT COMPLETED|Overall Study||0
10490474|NCT01188551|11640257|FG003|NOT COMPLETED|Overall Study||0
10650020|NCT02165735|11810178|FG001|STARTED|Overall Study||180
10490475|NCT01188564|11640269|FG000|STARTED|Double-blind Phase||44
10490476|NCT01188564|11640270|FG001|STARTED|Double-blind Phase||31
10490477|NCT01188564|11640269|FG000|COMPLETED|Double-blind Phase||43
10490478|NCT01188564|11640270|FG001|COMPLETED|Double-blind Phase||31
10490479|NCT01188564|11640269|FG000|NOT COMPLETED|Double-blind Phase||1
10490480|NCT01188564|11640270|FG001|NOT COMPLETED|Double-blind Phase||0
10490481|NCT01188564|11640269|FG000|STARTED|Open Label Phase|Not all Double-Blind Phase participants went on to Open Label Phase|24
10490482|NCT01188564|11640270|FG001|STARTED|Open Label Phase|Not all Double Blind Phase participants went on to Open Label Phase|20
10490483|NCT01188564|11640269|FG000|COMPLETED|Open Label Phase||24
10490484|NCT01188564|11640270|FG001|COMPLETED|Open Label Phase||20
10490485|NCT01188564|11640269|FG000|NOT COMPLETED|Open Label Phase||0
10490486|NCT01188564|11640270|FG001|NOT COMPLETED|Open Label Phase||0
10490487|NCT01188577|11640278|FG000|STARTED|Visit 1||11
10490488|NCT01188577|11640279|FG001|STARTED|Visit 1||12
10490489|NCT01188577|11640278|FG000|COMPLETED|Visit 1||11
10490490|NCT01188577|11640279|FG001|COMPLETED|Visit 1||12
10490491|NCT01188577|11640278|FG000|NOT COMPLETED|Visit 1||0
10490492|NCT01188577|11640279|FG001|NOT COMPLETED|Visit 1||0
10490493|NCT01188577|11640278|FG000|STARTED|3-14 Day Washout||11
10490494|NCT01188577|11640279|FG001|STARTED|3-14 Day Washout||12
10490495|NCT01188577|11640278|FG000|COMPLETED|3-14 Day Washout||11
10490496|NCT01188577|11640279|FG001|COMPLETED|3-14 Day Washout||12
10490497|NCT01188577|11640278|FG000|NOT COMPLETED|3-14 Day Washout||0
10490498|NCT01188577|11640279|FG001|NOT COMPLETED|3-14 Day Washout||0
10490499|NCT01188577|11640278|FG000|STARTED|Visit 2||11
10490500|NCT01188577|11640279|FG001|STARTED|Visit 2||12
10490501|NCT01188577|11640278|FG000|COMPLETED|Visit 2||11
10490502|NCT01188577|11640279|FG001|COMPLETED|Visit 2||12
10490503|NCT01188577|11640278|FG000|NOT COMPLETED|Visit 2||0
10490504|NCT01188577|11640279|FG001|NOT COMPLETED|Visit 2||0
10490505|NCT01188603|11640285|FG000|STARTED|Overall Study||24
10490506|NCT01188603|11640285|FG000|COMPLETED|Overall Study||24
10490507|NCT01188603|11640285|FG000|NOT COMPLETED|Overall Study||0
10490508|NCT01188655|11640289|FG000|STARTED|Overall Study||89
10490509|NCT01188655|11640289|FG000|COMPLETED|Overall Study||76
10490510|NCT01188655|11640289|FG000|NOT COMPLETED|Overall Study||13
10490511|NCT01188668|11640293|FG000|STARTED|Period 1: ARIP Alone||38
10490512|NCT01188668|11640293|FG000|COMPLETED|Period 1: ARIP Alone||36
10490513|NCT01188668|11640293|FG000|NOT COMPLETED|Period 1: ARIP Alone||2
10490514|NCT01188668|11640293|FG000|STARTED|Period 2: Coadministration ARIP + DVS SR||36
10490515|NCT01188668|11640293|FG000|COMPLETED|Period 2: Coadministration ARIP + DVS SR||33
10490516|NCT01188668|11640293|FG000|NOT COMPLETED|Period 2: Coadministration ARIP + DVS SR||3
10490517|NCT01188681|11640304|FG000|STARTED|Overall Study||6
10490518|NCT01188681|11640305|FG001|STARTED|Overall Study||6
10490519|NCT01188681|11640306|FG002|STARTED|Overall Study|33 patients enrolled, 32 patients treated. One patient had bladder cancer and was not treated.|33
10490520|NCT01188681|11640307|FG003|STARTED|Overall Study|34 patients enrolled, 33 patients treated. One patient withdrew consent and was not treated.|34
10490521|NCT01188681|11640304|FG000|COMPLETED|Overall Study||6
10490522|NCT01188681|11640305|FG001|COMPLETED|Overall Study||6
10490523|NCT01188681|11640306|FG002|COMPLETED|Overall Study||32
10490524|NCT01188681|11640307|FG003|COMPLETED|Overall Study||33
10490525|NCT01188681|11640304|FG000|NOT COMPLETED|Overall Study||0
10490526|NCT01188681|11640305|FG001|NOT COMPLETED|Overall Study||0
10490527|NCT01188681|11640306|FG002|NOT COMPLETED|Overall Study||1
10490528|NCT01188681|11640307|FG003|NOT COMPLETED|Overall Study||1
10490529|NCT01188694|11640324|FG000|STARTED|Overall Study||15
10490530|NCT01188694|11640325|FG001|STARTED|Overall Study||16
10490531|NCT01188694|11640326|FG002|STARTED|Overall Study||11
10490532|NCT01188694|11640324|FG000|COMPLETED|Overall Study||10
10490533|NCT01188694|11640325|FG001|COMPLETED|Overall Study||15
10490534|NCT01188694|11640326|FG002|COMPLETED|Overall Study||10
10490535|NCT01188694|11640324|FG000|NOT COMPLETED|Overall Study||5
10490536|NCT01188694|11640325|FG001|NOT COMPLETED|Overall Study||1
10490537|NCT01188694|11640326|FG002|NOT COMPLETED|Overall Study||1
10490538|NCT01188772|11640338|FG000|STARTED|Overall Study||48
10490539|NCT01188772|11640339|FG001|STARTED|Overall Study||48
10490540|NCT01188772|11640340|FG002|STARTED|Overall Study||26
10490541|NCT01188772|11640341|FG003|STARTED|Overall Study||25
10490542|NCT01188772|11640338|FG000|Randomized and Treated|Overall Study||48
10490543|NCT01188772|11640339|FG001|Randomized and Treated|Overall Study||47
10490544|NCT01188772|11640340|FG002|Randomized and Treated|Overall Study||26
10490545|NCT01188772|11640341|FG003|Randomized and Treated|Overall Study||25
10490546|NCT01188772|11640338|FG000|COMPLETED|Overall Study||43
10490547|NCT01188772|11640339|FG001|COMPLETED|Overall Study||45
10490548|NCT01188772|11640340|FG002|COMPLETED|Overall Study||15
10490549|NCT01188772|11640341|FG003|COMPLETED|Overall Study||24
10490550|NCT01188772|11640338|FG000|NOT COMPLETED|Overall Study||5
10490551|NCT01188772|11640339|FG001|NOT COMPLETED|Overall Study||3
10490552|NCT01188772|11640340|FG002|NOT COMPLETED|Overall Study||11
10490553|NCT01188772|11640341|FG003|NOT COMPLETED|Overall Study||1
10490554|NCT01188811|11640356|FG000|STARTED|Overall Study||28
10490555|NCT01188811|11640357|FG001|STARTED|Overall Study||26
10490556|NCT01188811|11640356|FG000|COMPLETED|Overall Study||22
10490557|NCT01188811|11640357|FG001|COMPLETED|Overall Study||24
10490558|NCT01188811|11640356|FG000|NOT COMPLETED|Overall Study||6
10490559|NCT01188811|11640357|FG001|NOT COMPLETED|Overall Study||2
10490560|NCT01188876|11640363|FG000|STARTED|Overall Study||50
10490561|NCT01188876|11640363|FG000|COMPLETED|Overall Study||50
10490562|NCT01188876|11640363|FG000|NOT COMPLETED|Overall Study||0
10490563|NCT01188928|11640371|FG000|STARTED|Overall Study||482
10490564|NCT01188928|11640372|FG001|STARTED|Overall Study||479
10490565|NCT01188928|11640373|FG002|STARTED|Overall Study||96
10490566|NCT01188928|11640374|FG003|STARTED|Overall Study||95
10490567|NCT01188928|11640371|FG000|COMPLETED|Overall Study||444
10490568|NCT01188928|11640372|FG001|COMPLETED|Overall Study||417
10490569|NCT01188928|11640373|FG002|COMPLETED|Overall Study||82
10490570|NCT01188928|11640374|FG003|COMPLETED|Overall Study||77
10490571|NCT01188928|11640371|FG000|NOT COMPLETED|Overall Study||38
10490572|NCT01188928|11640372|FG001|NOT COMPLETED|Overall Study||62
10490573|NCT01188928|11640373|FG002|NOT COMPLETED|Overall Study||14
10490574|NCT01188928|11640374|FG003|NOT COMPLETED|Overall Study||18
10490575|NCT01188967|11640386|FG000|STARTED|Overall Study||10
10490576|NCT01188967|11640387|FG001|STARTED|Overall Study||8
10490577|NCT01188967|11640386|FG000|COMPLETED|Overall Study||5
10490578|NCT01188967|11640387|FG001|COMPLETED|Overall Study||4
10490579|NCT01188967|11640386|FG000|NOT COMPLETED|Overall Study||5
10490580|NCT01188967|11640387|FG001|NOT COMPLETED|Overall Study||4
10490581|NCT01189032|11640398|FG000|STARTED|Overall Study||94
10490582|NCT01189032|11640399|FG001|STARTED|Overall Study||96
10490583|NCT01189032|11640400|FG002|STARTED|Overall Study||96
10490584|NCT01189032|11640398|FG000|COMPLETED|Overall Study||89
10490585|NCT01189032|11640399|FG001|COMPLETED|Overall Study||89
10490586|NCT01189032|11640400|FG002|COMPLETED|Overall Study||90
10490587|NCT01189032|11640398|FG000|NOT COMPLETED|Overall Study||5
10490588|NCT01189032|11640399|FG001|NOT COMPLETED|Overall Study||7
10490589|NCT01189032|11640400|FG002|NOT COMPLETED|Overall Study||6
10490590|NCT01189110|11640410|FG000|STARTED|Overall Study|September, 2010|64
10490591|NCT01189110|11640411|FG001|STARTED|Overall Study||61
10490592|NCT01189110|11640410|FG000|COMPLETED|Overall Study|February, 2011|64
10490593|NCT01189110|11640411|FG001|COMPLETED|Overall Study||61
10490594|NCT01189110|11640410|FG000|NOT COMPLETED|Overall Study||0
10490595|NCT01189110|11640411|FG001|NOT COMPLETED|Overall Study||0
10490596|NCT01189123|11640419|FG000|STARTED|Overall Study||52
10490597|NCT01189123|11640420|FG001|STARTED|Overall Study||53
10490598|NCT01189123|11640419|FG000|COMPLETED|Overall Study||50
10490599|NCT01189123|11640420|FG001|COMPLETED|Overall Study||47
10490600|NCT01189123|11640419|FG000|NOT COMPLETED|Overall Study||2
10490601|NCT01189123|11640420|FG001|NOT COMPLETED|Overall Study||6
10490602|NCT01189136|11640428|FG000|STARTED|Overall Study||42
10490603|NCT01189136|11640429|FG001|STARTED|Overall Study||42
10490604|NCT01189136|11640428|FG000|COMPLETED|Overall Study||42
10490605|NCT01189136|11640429|FG001|COMPLETED|Overall Study||42
10490606|NCT01189136|11640428|FG000|NOT COMPLETED|Overall Study||0
10490607|NCT01189136|11640429|FG001|NOT COMPLETED|Overall Study||0
10490608|NCT01189201|11640435|FG000|STARTED|Overall Study||42
10490609|NCT01189201|11640435|FG000|Received Empa/Linagliptin FDC A1(Fasted)|Overall Study||42
10490610|NCT01189201|11640435|FG000|Rec. Empa/Linagliptin Ind.Tablet(Fasted)|Overall Study||41
10490611|NCT01189201|11640435|FG000|Received Empa/Linagliptin FDC A1 (Fed)|Overall Study||18
10490612|NCT01189201|11640435|FG000|Received Empa/Linagliptin FDC A3(Fasted)|Overall Study||24
10490613|NCT01189201|11640435|FG000|COMPLETED|Overall Study||41
10490614|NCT01189201|11640435|FG000|NOT COMPLETED|Overall Study||1
10490615|NCT01189240|11640450|FG000|STARTED|Overall Study||4
10490616|NCT01189240|11640451|FG001|STARTED|Overall Study||6
10490617|NCT01189240|11640452|FG002|STARTED|Overall Study||3
10490618|NCT01189240|11640450|FG000|COMPLETED|Overall Study||4
10490619|NCT01189240|11640451|FG001|COMPLETED|Overall Study||6
10490620|NCT01189240|11640452|FG002|COMPLETED|Overall Study||3
10490621|NCT01189240|11640450|FG000|NOT COMPLETED|Overall Study||0
10490622|NCT01189240|11640451|FG001|NOT COMPLETED|Overall Study||0
10490623|NCT01189240|11640452|FG002|NOT COMPLETED|Overall Study||0
10490624|NCT01189266|11640465|FG000|STARTED|Overall Study||6
10490625|NCT01189266|11640466|FG001|STARTED|Overall Study||6
10490626|NCT01189266|11640467|FG002|STARTED|Overall Study||67
10490627|NCT01189266|11640465|FG000|COMPLETED|Overall Study||0
10490628|NCT01189266|11640466|FG001|COMPLETED|Overall Study||0
10490629|NCT01189266|11640467|FG002|COMPLETED|Overall Study||2
10490630|NCT01189266|11640465|FG000|NOT COMPLETED|Overall Study||6
10490631|NCT01189266|11640466|FG001|NOT COMPLETED|Overall Study||6
10490632|NCT01189266|11640467|FG002|NOT COMPLETED|Overall Study||65
10490633|NCT01189279|11640479|FG000|STARTED|Overall Study||14
10490634|NCT01189279|11640480|FG001|STARTED|Overall Study||14
10490635|NCT01189279|11640481|FG002|STARTED|Overall Study||14
10490636|NCT01189279|11640479|FG000|COMPLETED|Overall Study||13
10490637|NCT01189279|11640480|FG001|COMPLETED|Overall Study||14
10490638|NCT01189279|11640481|FG002|COMPLETED|Overall Study||13
10490639|NCT01189279|11640479|FG000|NOT COMPLETED|Overall Study||1
10490640|NCT01189279|11640480|FG001|NOT COMPLETED|Overall Study||0
10490641|NCT01189279|11640481|FG002|NOT COMPLETED|Overall Study||1
10490642|NCT01189292|11640491|FG000|STARTED|Intention to Treat Analysis||76
10490643|NCT01189292|11640492|FG001|STARTED|Intention to Treat Analysis||76
10490644|NCT01189292|11640491|FG000|COMPLETED|Intention to Treat Analysis||76
10490645|NCT01189292|11640492|FG001|COMPLETED|Intention to Treat Analysis||76
10490646|NCT01189292|11640491|FG000|NOT COMPLETED|Intention to Treat Analysis||0
10490647|NCT01189292|11640492|FG001|NOT COMPLETED|Intention to Treat Analysis||0
10490648|NCT01189292|11640491|FG000|STARTED|Per Protocol Analysis||76
10490649|NCT01189292|11640492|FG001|STARTED|Per Protocol Analysis||76
10490650|NCT01189292|11640491|FG000|COMPLETED|Per Protocol Analysis||65
10490651|NCT01189292|11640492|FG001|COMPLETED|Per Protocol Analysis||60
10490652|NCT01189292|11640491|FG000|NOT COMPLETED|Per Protocol Analysis||11
10490653|NCT01189292|11640492|FG001|NOT COMPLETED|Per Protocol Analysis||16
10490654|NCT01189370|11640498|FG000|STARTED|Dose Level 1||25
10490655|NCT01189370|11640499|FG001|STARTED|Dose Level 1||0
10490656|NCT01189370|11640500|FG002|STARTED|Dose Level 1||0
10490657|NCT01189370|11640498|FG000|COMPLETED|Dose Level 1||16
10490658|NCT01189370|11640499|FG001|COMPLETED|Dose Level 1||0
10490659|NCT01189370|11640500|FG002|COMPLETED|Dose Level 1||0
10490660|NCT01189370|11640498|FG000|NOT COMPLETED|Dose Level 1||9
10490661|NCT01189370|11640499|FG001|NOT COMPLETED|Dose Level 1||0
10490662|NCT01189370|11640500|FG002|NOT COMPLETED|Dose Level 1||0
10490663|NCT01189370|11640498|FG000|STARTED|Dose Level 2||0
10490664|NCT01189370|11640499|FG001|STARTED|Dose Level 2||16
10490665|NCT01189370|11640500|FG002|STARTED|Dose Level 2||0
10490666|NCT01189370|11640498|FG000|COMPLETED|Dose Level 2||0
10490667|NCT01189370|11640499|FG001|COMPLETED|Dose Level 2||12
10490668|NCT01189370|11640500|FG002|COMPLETED|Dose Level 2||0
10490669|NCT01189370|11640498|FG000|NOT COMPLETED|Dose Level 2||0
10490670|NCT01189370|11640499|FG001|NOT COMPLETED|Dose Level 2||4
10490671|NCT01189370|11640500|FG002|NOT COMPLETED|Dose Level 2||0
10490672|NCT01189370|11640498|FG000|STARTED|Dose Level 3||0
10490673|NCT01189370|11640499|FG001|STARTED|Dose Level 3||0
10490674|NCT01189370|11640500|FG002|STARTED|Dose Level 3||12
10490675|NCT01189370|11640498|FG000|COMPLETED|Dose Level 3||0
10490676|NCT01189370|11640499|FG001|COMPLETED|Dose Level 3||0
10490677|NCT01189370|11640500|FG002|COMPLETED|Dose Level 3||6
10490678|NCT01189370|11640498|FG000|NOT COMPLETED|Dose Level 3||0
10490679|NCT01189370|11640499|FG001|NOT COMPLETED|Dose Level 3||0
10490680|NCT01189370|11640500|FG002|NOT COMPLETED|Dose Level 3||6
10490681|NCT01189409|11640509|FG000|STARTED|First 3 Weeks||37
10490682|NCT01189409|11640510|FG001|STARTED|First 3 Weeks||33
10490683|NCT01189409|11640509|FG000|COMPLETED|First 3 Weeks||19
10490684|NCT01189409|11640510|FG001|COMPLETED|First 3 Weeks||23
10490685|NCT01189409|11640509|FG000|NOT COMPLETED|First 3 Weeks||18
10490686|NCT01189409|11640510|FG001|NOT COMPLETED|First 3 Weeks||10
10490687|NCT01189409|11640509|FG000|STARTED|Second 3 Weeks (Switch to 2nd Treatment)||19
10490688|NCT01189409|11640510|FG001|STARTED|Second 3 Weeks (Switch to 2nd Treatment)||23
10490689|NCT01189409|11640509|FG000|COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||13
10490690|NCT01189409|11640510|FG001|COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||15
10490691|NCT01189409|11640509|FG000|NOT COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||6
10490692|NCT01189409|11640510|FG001|NOT COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||8
10490693|NCT01189461|11640523|FG000|STARTED|Overall Study||46
10490694|NCT01189461|11640523|FG000|COMPLETED|Overall Study||12
10490695|NCT01189461|11640523|FG000|NOT COMPLETED|Overall Study||34
10490696|NCT01189487|11640527|FG000|STARTED|Overall Study|Treated participants|47
10490697|NCT01189487|11640527|FG000|COMPLETED|Overall Study||44
10490698|NCT01189487|11640527|FG000|NOT COMPLETED|Overall Study||3
10490699|NCT01189500|11640531|FG000|STARTED|Period 1: TAMOX Alone||30
10490700|NCT01189500|11640531|FG000|COMPLETED|Period 1: TAMOX Alone||29
10490701|NCT01189500|11640531|FG000|NOT COMPLETED|Period 1: TAMOX Alone||1
10490702|NCT01189500|11640531|FG000|STARTED|Period 2: Coadministration TAMOX+DVS SR||29
10490703|NCT01189500|11640531|FG000|COMPLETED|Period 2: Coadministration TAMOX+DVS SR||28
10490704|NCT01189500|11640531|FG000|NOT COMPLETED|Period 2: Coadministration TAMOX+DVS SR||1
10490705|NCT01189604|11640545|FG000|STARTED|Overall Study||21
10490706|NCT01189604|11640546|FG001|STARTED|Overall Study||21
10490707|NCT01189604|11640547|FG002|STARTED|Overall Study||20
10490708|NCT01189604|11640548|FG003|STARTED|Overall Study||20
10490709|NCT01189604|11640549|FG004|STARTED|Overall Study||20
10490710|NCT01189604|11640550|FG005|STARTED|Overall Study||11
10490711|NCT01189604|11640551|FG006|STARTED|Overall Study||10
10490712|NCT01189604|11640545|FG000|Administered Study Drug|Overall Study||20
10490713|NCT01189604|11640546|FG001|Administered Study Drug|Overall Study||20
10490714|NCT01189604|11640547|FG002|Administered Study Drug|Overall Study||20
10490715|NCT01189604|11640548|FG003|Administered Study Drug|Overall Study||20
10490716|NCT01189604|11640549|FG004|Administered Study Drug|Overall Study||20
10490717|NCT01189604|11640550|FG005|Administered Study Drug|Overall Study||10
10490718|NCT01189604|11640551|FG006|Administered Study Drug|Overall Study||10
10490719|NCT01189604|11640545|FG000|COMPLETED|Overall Study||20
10490720|NCT01189604|11640546|FG001|COMPLETED|Overall Study||20
10490721|NCT01189604|11640547|FG002|COMPLETED|Overall Study||20
10490722|NCT01189604|11640548|FG003|COMPLETED|Overall Study||20
10490723|NCT01189604|11640549|FG004|COMPLETED|Overall Study||18
10490724|NCT01189604|11640550|FG005|COMPLETED|Overall Study||10
10490725|NCT01189604|11640551|FG006|COMPLETED|Overall Study||9
10490726|NCT01189604|11640545|FG000|NOT COMPLETED|Overall Study||1
10490727|NCT01189604|11640546|FG001|NOT COMPLETED|Overall Study||1
10490728|NCT01189604|11640547|FG002|NOT COMPLETED|Overall Study||0
10490729|NCT01189604|11640548|FG003|NOT COMPLETED|Overall Study||0
10490730|NCT01189604|11640549|FG004|NOT COMPLETED|Overall Study||2
10490731|NCT01189604|11640550|FG005|NOT COMPLETED|Overall Study||1
10490732|NCT01189604|11640551|FG006|NOT COMPLETED|Overall Study||1
10490733|NCT01189617|11640569|FG000|STARTED|Overall Study||35
10490734|NCT01189617|11640570|FG001|STARTED|Overall Study||35
10490735|NCT01189617|11640569|FG000|COMPLETED|Overall Study||35
10490736|NCT01189617|11640570|FG001|COMPLETED|Overall Study||35
10490737|NCT01189617|11640569|FG000|NOT COMPLETED|Overall Study||0
10490738|NCT01189617|11640570|FG001|NOT COMPLETED|Overall Study||0
10490739|NCT01189747|11640578|FG000|STARTED|Overall Study||222
10490740|NCT01189747|11640579|FG001|STARTED|Overall Study||224
10490741|NCT01189747|11640578|FG000|COMPLETED|Overall Study||210
10490742|NCT01189747|11640579|FG001|COMPLETED|Overall Study||206
10490743|NCT01189747|11640578|FG000|NOT COMPLETED|Overall Study||12
10490744|NCT01189747|11640579|FG001|NOT COMPLETED|Overall Study||18
10490745|NCT01189760|11640588|FG000|STARTED|Overall Study||305
10490746|NCT01189760|11640589|FG001|STARTED|Overall Study||306
10490747|NCT01189760|11640590|FG002|STARTED|Overall Study||306
10490748|NCT01189760|11640588|FG000|COMPLETED|Overall Study||291
10490749|NCT01189760|11640589|FG001|COMPLETED|Overall Study||283
10490750|NCT01189760|11640590|FG002|COMPLETED|Overall Study||255
10490751|NCT01189760|11640588|FG000|NOT COMPLETED|Overall Study||14
10490752|NCT01189760|11640589|FG001|NOT COMPLETED|Overall Study||23
10490753|NCT01189760|11640590|FG002|NOT COMPLETED|Overall Study||51
10490754|NCT01189812|11640600|FG000|STARTED|Overall Study||40
10490755|NCT01189812|11640601|FG001|STARTED|Overall Study||40
10490756|NCT01189812|11640600|FG000|COMPLETED|Overall Study||32
10490757|NCT01189812|11640601|FG001|COMPLETED|Overall Study||32
10490758|NCT01189812|11640600|FG000|NOT COMPLETED|Overall Study||8
10490759|NCT01189812|11640601|FG001|NOT COMPLETED|Overall Study||8
10490760|NCT01189890|11640609|FG000|STARTED|Overall Study||241
10490761|NCT01189890|11640610|FG001|STARTED|Overall Study|3 randomized glimepiride participants did not receive study drug.|239
10490762|NCT01189890|11640609|FG000|COMPLETED|Overall Study||204
10490763|NCT01189890|11640610|FG001|COMPLETED|Overall Study||200
10490764|NCT01189890|11640609|FG000|NOT COMPLETED|Overall Study||37
10490765|NCT01189890|11640610|FG001|NOT COMPLETED|Overall Study||39
10490766|NCT01190007|11640616|FG000|STARTED|Overall Study|Treated|159
10490767|NCT01190007|11640616|FG000|COMPLETED|Overall Study||145
10490768|NCT01190007|11640616|FG000|NOT COMPLETED|Overall Study||14
10490769|NCT01190020|11640622|FG000|STARTED|Overall Study||29
10490770|NCT01190020|11640623|FG001|STARTED|Overall Study||12
10490771|NCT01190020|11640622|FG000|COMPLETED|Overall Study||22
10490772|NCT01190020|11640623|FG001|COMPLETED|Overall Study||12
10490773|NCT01190020|11640622|FG000|NOT COMPLETED|Overall Study||7
10490774|NCT01190020|11640623|FG001|NOT COMPLETED|Overall Study||0
10490775|NCT01190085|11640632|FG000|STARTED|Overall Study||13
10490776|NCT01190085|11640633|FG001|STARTED|Overall Study||14
10490777|NCT01190085|11640634|FG002|STARTED|Overall Study||18
10490778|NCT01190085|11640632|FG000|COMPLETED|Overall Study||13
10490779|NCT01190085|11640633|FG001|COMPLETED|Overall Study||14
10490780|NCT01190085|11640634|FG002|COMPLETED|Overall Study||18
10490781|NCT01190085|11640632|FG000|NOT COMPLETED|Overall Study||0
10490782|NCT01190085|11640633|FG001|NOT COMPLETED|Overall Study||0
10490783|NCT01190085|11640634|FG002|NOT COMPLETED|Overall Study||0
10490784|NCT01190098|11640644|FG000|STARTED|Overall Study||42
10490785|NCT01190098|11640645|FG001|STARTED|Overall Study||10
10490786|NCT01190098|11640644|FG000|COMPLETED|Overall Study||39
10490787|NCT01190098|11640645|FG001|COMPLETED|Overall Study||8
10490788|NCT01190098|11640644|FG000|NOT COMPLETED|Overall Study||3
10490789|NCT01190098|11640645|FG001|NOT COMPLETED|Overall Study||2
10490790|NCT01190124|11640654|FG000|STARTED|Overall Study||107
10490791|NCT01190124|11640655|FG001|STARTED|Overall Study||24
10490792|NCT01190124|11640656|FG002|STARTED|Overall Study||20
10490793|NCT01190124|11640654|FG000|COMPLETED|Overall Study||90
10490794|NCT01190124|11640655|FG001|COMPLETED|Overall Study||24
10490795|NCT01190124|11640656|FG002|COMPLETED|Overall Study||19
10490796|NCT01190124|11640654|FG000|NOT COMPLETED|Overall Study||17
10490797|NCT01190124|11640655|FG001|NOT COMPLETED|Overall Study||0
10490798|NCT01190124|11640656|FG002|NOT COMPLETED|Overall Study||1
10490799|NCT01190150|11640669|FG000|STARTED|First Treatment|Randomized, as well as Safety and PK populations|11
10490800|NCT01190150|11640670|FG001|STARTED|First Treatment|Randomized, as well as Safety and PK populations|9
10490801|NCT01190150|11640669|FG000|COMPLETED|First Treatment||10
10490802|NCT01190150|11640670|FG001|COMPLETED|First Treatment||9
10490803|NCT01190150|11640669|FG000|NOT COMPLETED|First Treatment||1
10490804|NCT01190150|11640670|FG001|NOT COMPLETED|First Treatment||0
10490805|NCT01190150|11640669|FG000|STARTED|Washout||10
10490806|NCT01190150|11640670|FG001|STARTED|Washout||9
10490807|NCT01190150|11640669|FG000|COMPLETED|Washout||10
10490808|NCT01190150|11640670|FG001|COMPLETED|Washout||7
10490809|NCT01190150|11640669|FG000|NOT COMPLETED|Washout||0
10490810|NCT01190150|11640670|FG001|NOT COMPLETED|Washout||2
10490811|NCT01190150|11640669|FG000|STARTED|Second Treatment||10
10490812|NCT01190150|11640670|FG001|STARTED|Second Treatment||7
10490813|NCT01190150|11640669|FG000|COMPLETED|Second Treatment||10
10490814|NCT01190150|11640670|FG001|COMPLETED|Second Treatment||7
10490815|NCT01190150|11640669|FG000|NOT COMPLETED|Second Treatment||0
10490816|NCT01190150|11640670|FG001|NOT COMPLETED|Second Treatment||0
10490817|NCT01190176|11640676|FG000|STARTED|Overall Study||32
10490818|NCT01190176|11640676|FG000|COMPLETED|Overall Study||30
10490819|NCT01190176|11640676|FG000|NOT COMPLETED|Overall Study||2
10490820|NCT01190189|11640680|FG000|STARTED|Overall Study||137
10490821|NCT01190189|11640680|FG000|COMPLETED|Overall Study||131
10490822|NCT01190189|11640680|FG000|NOT COMPLETED|Overall Study||6
10490823|NCT01190215|11640686|FG000|STARTED|Up to Day 28||38
10490824|NCT01190215|11640687|FG001|STARTED|Up to Day 28||39
10490825|NCT01190215|11640686|FG000|COMPLETED|Up to Day 28||38
10490826|NCT01190215|11640687|FG001|COMPLETED|Up to Day 28||39
10490827|NCT01190215|11640686|FG000|NOT COMPLETED|Up to Day 28||0
10490828|NCT01190215|11640687|FG001|NOT COMPLETED|Up to Day 28||0
10490829|NCT01190215|11640686|FG000|STARTED|Up to Month 6||38
10490830|NCT01190215|11640687|FG001|STARTED|Up to Month 6||39
10490831|NCT01190215|11640686|FG000|COMPLETED|Up to Month 6||36
10490832|NCT01190215|11640687|FG001|COMPLETED|Up to Month 6||39
10490833|NCT01190215|11640686|FG000|NOT COMPLETED|Up to Month 6||2
10490834|NCT01190215|11640687|FG001|NOT COMPLETED|Up to Month 6||0
10490835|NCT01190410|11640695|FG000|STARTED|Overall Study||4
10490836|NCT01190410|11640696|FG001|STARTED|Overall Study||12
10490837|NCT01190410|11640695|FG000|Re-Induction|Overall Study||0
10490838|NCT01190410|11640696|FG001|Re-Induction|Overall Study||2
10490839|NCT01190410|11640695|FG000|COMPLETED|Overall Study||3
10490840|NCT01190410|11640696|FG001|COMPLETED|Overall Study||3
10490841|NCT01190410|11640695|FG000|NOT COMPLETED|Overall Study||1
10490842|NCT01190410|11640696|FG001|NOT COMPLETED|Overall Study||9
10490843|NCT01190436|11640708|FG000|STARTED|Overall Study||125
10490844|NCT01190436|11640708|FG000|COMPLETED|Overall Study||86
10490845|NCT01190436|11640708|FG000|NOT COMPLETED|Overall Study||39
10490846|NCT01190449|11640715|FG000|STARTED|Overall Study||15
10490847|NCT01190449|11640716|FG001|STARTED|Overall Study||36
10490848|NCT01190449|11640715|FG000|COMPLETED|Overall Study||15
10490849|NCT01190449|11640716|FG001|COMPLETED|Overall Study||32
10490850|NCT01190449|11640715|FG000|NOT COMPLETED|Overall Study||0
10490851|NCT01190449|11640716|FG001|NOT COMPLETED|Overall Study||4
10490852|NCT01190475|11640725|FG000|STARTED|Overall Study||2
10490853|NCT01190475|11640726|FG001|STARTED|Overall Study||2
10490854|NCT01190475|11640727|FG002|STARTED|Overall Study||2
10490855|NCT01190475|11640725|FG000|COMPLETED|Overall Study||2
10490856|NCT01190475|11640726|FG001|COMPLETED|Overall Study||2
10490857|NCT01190475|11640727|FG002|COMPLETED|Overall Study||1
10490858|NCT01190475|11640725|FG000|NOT COMPLETED|Overall Study||0
10490859|NCT01190475|11640726|FG001|NOT COMPLETED|Overall Study||0
10490860|NCT01190475|11640727|FG002|NOT COMPLETED|Overall Study||1
10490861|NCT01190514|11640737|FG000|STARTED|First Intervention (Period 1)||11
10490862|NCT01190514|11640738|FG001|STARTED|First Intervention (Period 1)||10
10490863|NCT01190514|11640739|FG002|STARTED|First Intervention (Period 1)||10
10490864|NCT01190514|11640740|FG003|STARTED|First Intervention (Period 1)||10
10490865|NCT01190514|11640737|FG000|COMPLETED|First Intervention (Period 1)|Discontinued participant received treatment A of sequence ABCD.|10
10490866|NCT01190514|11640738|FG001|COMPLETED|First Intervention (Period 1)||10
10490867|NCT01190514|11640739|FG002|COMPLETED|First Intervention (Period 1)||10
10490868|NCT01190514|11640740|FG003|COMPLETED|First Intervention (Period 1)||10
10490869|NCT01190514|11640737|FG000|NOT COMPLETED|First Intervention (Period 1)||1
10490870|NCT01190514|11640738|FG001|NOT COMPLETED|First Intervention (Period 1)||0
10490871|NCT01190514|11640739|FG002|NOT COMPLETED|First Intervention (Period 1)||0
10490872|NCT01190514|11640740|FG003|NOT COMPLETED|First Intervention (Period 1)||0
10490873|NCT01190514|11640737|FG000|STARTED|Second Intervention (Period 2)|Period 2 received treatment B|10
10490874|NCT01190514|11640738|FG001|STARTED|Second Intervention (Period 2)|Period 2 received treatment A|10
10490875|NCT01190514|11640739|FG002|STARTED|Second Intervention (Period 2)|Period 2 received treatment D|10
10490876|NCT01190514|11640740|FG003|STARTED|Second Intervention (Period 2)|Period 2 received treatment C|10
10490877|NCT01190514|11640737|FG000|COMPLETED|Second Intervention (Period 2)||10
10490878|NCT01190514|11640738|FG001|COMPLETED|Second Intervention (Period 2)||10
10490879|NCT01190514|11640739|FG002|COMPLETED|Second Intervention (Period 2)||10
10490880|NCT01190514|11640740|FG003|COMPLETED|Second Intervention (Period 2)||10
10490881|NCT01190514|11640737|FG000|NOT COMPLETED|Second Intervention (Period 2)||0
10490882|NCT01190514|11640738|FG001|NOT COMPLETED|Second Intervention (Period 2)||0
10490883|NCT01190514|11640739|FG002|NOT COMPLETED|Second Intervention (Period 2)||0
10490884|NCT01190514|11640740|FG003|NOT COMPLETED|Second Intervention (Period 2)||0
10490885|NCT01190514|11640737|FG000|STARTED|Third Intervention (Period 3)|Period 3 received treatment C|10
10490886|NCT01190514|11640738|FG001|STARTED|Third Intervention (Period 3)|Period 3 received treatment D|10
10490887|NCT01190514|11640739|FG002|STARTED|Third Intervention (Period 3)|Period 3 received treatment A|10
10490888|NCT01190514|11640740|FG003|STARTED|Third Intervention (Period 3)|Period 3 received treatment B|10
10490889|NCT01190514|11640737|FG000|COMPLETED|Third Intervention (Period 3)|Discontinued participant received treatments ABC of sequence ABCD.|9
10490890|NCT01190514|11640738|FG001|COMPLETED|Third Intervention (Period 3)||10
10490891|NCT01190514|11640739|FG002|COMPLETED|Third Intervention (Period 3)||10
10490892|NCT01190514|11640740|FG003|COMPLETED|Third Intervention (Period 3)||10
10490893|NCT01190514|11640737|FG000|NOT COMPLETED|Third Intervention (Period 3)||1
10490894|NCT01190514|11640738|FG001|NOT COMPLETED|Third Intervention (Period 3)||0
10490895|NCT01190514|11640739|FG002|NOT COMPLETED|Third Intervention (Period 3)||0
10490896|NCT01190514|11640740|FG003|NOT COMPLETED|Third Intervention (Period 3)||0
10490897|NCT01190514|11640737|FG000|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment D|9
10490898|NCT01190514|11640738|FG001|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment C|10
10490899|NCT01190514|11640739|FG002|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment B|10
10490900|NCT01190514|11640740|FG003|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment A|10
10490901|NCT01190514|11640737|FG000|COMPLETED|Fourth Intervention (Period 4)||9
10490902|NCT01190514|11640738|FG001|COMPLETED|Fourth Intervention (Period 4)||10
10490903|NCT01190514|11640739|FG002|COMPLETED|Fourth Intervention (Period 4)||10
10490904|NCT01190514|11640740|FG003|COMPLETED|Fourth Intervention (Period 4)||10
10490905|NCT01190514|11640737|FG000|NOT COMPLETED|Fourth Intervention (Period 4)||0
10490906|NCT01190514|11640738|FG001|NOT COMPLETED|Fourth Intervention (Period 4)||0
10490907|NCT01190514|11640739|FG002|NOT COMPLETED|Fourth Intervention (Period 4)||0
10490908|NCT01190514|11640740|FG003|NOT COMPLETED|Fourth Intervention (Period 4)||0
10527762|NCT01391559|11679998|FG000|STARTED|Second Intervention||10
10527763|NCT01391559|11679999|FG001|STARTED|Second Intervention||10
10527764|NCT01391559|11679998|FG000|COMPLETED|Second Intervention||10
10527765|NCT01391559|11679999|FG001|COMPLETED|Second Intervention||10
10527766|NCT01391559|11679998|FG000|NOT COMPLETED|Second Intervention||0
10527767|NCT01391559|11679999|FG001|NOT COMPLETED|Second Intervention||0
10527768|NCT01391611|11680005|FG000|STARTED|Overall Study||25
10527769|NCT01391611|11680005|FG000|COMPLETED|Overall Study||3
10527770|NCT01391611|11680005|FG000|NOT COMPLETED|Overall Study||22
10527771|NCT01391663|11680013|FG000|STARTED|Overall Study||12
10527772|NCT01391663|11680014|FG001|STARTED|Overall Study||12
10527773|NCT01391663|11680015|FG002|STARTED|Overall Study||12
10527774|NCT01391663|11680016|FG003|STARTED|Overall Study||12
10527775|NCT01391663|11680013|FG000|COMPLETED|Overall Study||12
10527776|NCT01391663|11680014|FG001|COMPLETED|Overall Study||12
10710150|NCT02647281|11875286|FG002|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
10710151|NCT02647281|11875287|FG003|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
10710152|NCT02647281|11875288|FG004|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
10710153|NCT02647281|11875289|FG005|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
10710154|NCT02647281|11875290|FG006|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
10710155|NCT02647281|11875291|FG007|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
10710156|NCT02647281|11875292|FG008|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||1
10710157|NCT02647320|11875326|FG000|STARTED|Overall Study||46
10710158|NCT02647320|11875327|FG001|STARTED|Overall Study||46
10710159|NCT02647320|11875328|FG002|STARTED|Overall Study||69
10710160|NCT02647320|11875329|FG003|STARTED|Overall Study||68
10710161|NCT02647320|11875330|FG004|STARTED|Overall Study||69
10710162|NCT02647320|11875326|FG000|Inadvertently Randomized|Overall Study||0
10490909|NCT01190527|11640750|FG000|STARTED|Overall Study||42
10490910|NCT01190527|11640750|FG000|COMPLETED|Overall Study||42
10490911|NCT01190527|11640750|FG000|NOT COMPLETED|Overall Study||0
10490912|NCT01190566|11640756|FG000|STARTED|Overall Study||6
10490913|NCT01190566|11640757|FG001|STARTED|Overall Study||42
10490914|NCT01190566|11640756|FG000|COMPLETED|Overall Study||6
10490915|NCT01190566|11640757|FG001|COMPLETED|Overall Study||42
10490916|NCT01190566|11640756|FG000|NOT COMPLETED|Overall Study||0
10490917|NCT01190566|11640757|FG001|NOT COMPLETED|Overall Study||0
10490918|NCT01190813|11640766|FG000|STARTED|Overall Study||90
10490919|NCT01190813|11640767|FG001|STARTED|Overall Study||49
10490920|NCT01190813|11640766|FG000|2-week Phone Call|Overall Study|2 missed, 1 dropped|87
10490921|NCT01190813|11640767|FG001|2-week Phone Call|Overall Study|1 missed, 0 dropped|48
10490922|NCT01190813|11640766|FG000|4-week Visit|Overall Study|0 missed, 1 dropped|88
10490923|NCT01190813|11640767|FG001|4-week Visit|Overall Study|1 missed, 1 dropped|47
10809897|NCT03822377|11971745|FG001|STARTED|Overall Study||65
10490924|NCT01190813|11640766|FG000|7-week Phone Call|Overall Study|3 missed, 0 dropped|85
10490925|NCT01190813|11640767|FG001|7-week Phone Call|Overall Study|2 missed, 0 dropped|46
10490926|NCT01190813|11640766|FG000|10-week Visit|Overall Study|0 missed, 0 dropped|88
10490927|NCT01190813|11640767|FG001|10-week Visit|Overall Study|0 dropped, 0 missed|48
10490928|NCT01190813|11640766|FG000|13-week Phone Call|Overall Study|6 missed, 0 dropped|82
10490929|NCT01190813|11640767|FG001|13-week Phone Call|Overall Study|0 dropped, 0 missed|48
10490930|NCT01190813|11640766|FG000|16-week Visit|Overall Study|1 dropped|87
10490931|NCT01190813|11640767|FG001|16-week Visit|Overall Study|2 dropped|46
10490932|NCT01190813|11640766|FG000|18-week Visit (Masked Primary)|Overall Study|0 dropped|87
10490933|NCT01190813|11640767|FG001|18-week Visit (Masked Primary)|Overall Study|1 dropped|45
10490934|NCT01190813|11640766|FG000|23-week Phone Call|Overall Study|4 missed, 1 dropped|82
10490935|NCT01190813|11640767|FG001|23-week Phone Call|Overall Study|4 missed, 0 dropped|41
10490936|NCT01190813|11640766|FG000|26-week Visit|Overall Study|0 missed, 0 dropped|86
10490937|NCT01190813|11640767|FG001|26-week Visit|Overall Study|0 missed, 0 dropped|45
10490938|NCT01190813|11640766|FG000|COMPLETED|Overall Study||86
10490939|NCT01190813|11640767|FG001|COMPLETED|Overall Study||45
10490940|NCT01190813|11640766|FG000|NOT COMPLETED|Overall Study||4
10710163|NCT02647320|11875327|FG001|Inadvertently Randomized|Overall Study||0
10710164|NCT02647320|11875328|FG002|Inadvertently Randomized|Overall Study||0
10710165|NCT02647320|11875329|FG003|Inadvertently Randomized|Overall Study||1
10490941|NCT01190813|11640767|FG001|NOT COMPLETED|Overall Study||4
10490942|NCT01190839|11640775|FG000|STARTED|Overall Study||150
10490943|NCT01190839|11640776|FG001|STARTED|Overall Study||147
10490944|NCT01190839|11640775|FG000|Treated|Overall Study||148
10490945|NCT01190839|11640776|FG001|Treated|Overall Study||143
10490946|NCT01190839|11640775|FG000|COMPLETED|Overall Study||0
10490947|NCT01190839|11640776|FG001|COMPLETED|Overall Study||0
10490948|NCT01190839|11640775|FG000|NOT COMPLETED|Overall Study||150
10490949|NCT01190839|11640776|FG001|NOT COMPLETED|Overall Study||147
10490950|NCT01190865|11640784|FG000|STARTED|Overall Study||28
10490951|NCT01190865|11640784|FG000|COMPLETED|Overall Study||25
10490952|NCT01190865|11640784|FG000|NOT COMPLETED|Overall Study||3
10490953|NCT01190878|11640792|FG000|STARTED|Overall Study||40
10490954|NCT01190878|11640793|FG001|STARTED|Overall Study||45
10490955|NCT01190878|11640794|FG002|STARTED|Overall Study||42
10490956|NCT01190878|11640795|FG003|STARTED|Overall Study||42
10490957|NCT01190878|11640792|FG000|COMPLETED|Overall Study||37
10490958|NCT01190878|11640793|FG001|COMPLETED|Overall Study||42
10490959|NCT01190878|11640794|FG002|COMPLETED|Overall Study||37
10490960|NCT01190878|11640795|FG003|COMPLETED|Overall Study||22
10490961|NCT01190878|11640792|FG000|NOT COMPLETED|Overall Study||3
10490962|NCT01190878|11640793|FG001|NOT COMPLETED|Overall Study||3
10490963|NCT01190878|11640794|FG002|NOT COMPLETED|Overall Study||5
10490964|NCT01190878|11640795|FG003|NOT COMPLETED|Overall Study||20
10490965|NCT01190891|11640807|FG000|STARTED|Overall Study||52
10490966|NCT01190891|11640808|FG001|STARTED|Overall Study||52
10490967|NCT01190891|11640807|FG000|COMPLETED|Overall Study||46
10490968|NCT01190891|11640808|FG001|COMPLETED|Overall Study||52
10490969|NCT01190891|11640807|FG000|NOT COMPLETED|Overall Study||6
10490970|NCT01190891|11640808|FG001|NOT COMPLETED|Overall Study||0
10809862|NCT03822182|11971689|FG002|STARTED|Overall Study||27
10809863|NCT03822182|11971687|FG000|COMPLETED|Overall Study||26
10809864|NCT03822182|11971688|FG001|COMPLETED|Overall Study||24
10809865|NCT03822182|11971689|FG002|COMPLETED|Overall Study||26
10809866|NCT03822182|11971687|FG000|NOT COMPLETED|Overall Study||0
10809867|NCT03822182|11971688|FG001|NOT COMPLETED|Overall Study||1
10809868|NCT03822182|11971689|FG002|NOT COMPLETED|Overall Study||1
10809869|NCT03822416|11971700|FG000|STARTED|Overall Study||19
10809870|NCT03822416|11971701|FG001|STARTED|Overall Study||19
10809871|NCT03822416|11971700|FG000|COMPLETED|Overall Study||18
10809872|NCT03822416|11971701|FG001|COMPLETED|Overall Study||18
10809873|NCT03822416|11971700|FG000|NOT COMPLETED|Overall Study||1
10809874|NCT03822416|11971701|FG001|NOT COMPLETED|Overall Study||1
10809875|NCT03809104|11971707|FG000|STARTED|Overall Study||43
10809876|NCT03809104|11971707|FG000|COMPLETED|Overall Study||40
10809877|NCT03809104|11971707|FG000|NOT COMPLETED|Overall Study||3
10809878|NCT03807089|11971713|FG000|STARTED|Overall Study||101
10809879|NCT03807089|11971714|FG001|STARTED|Overall Study||93
10809880|NCT03807089|11971713|FG000|COMPLETED|Overall Study||101
10710166|NCT02647320|11875330|FG004|Inadvertently Randomized|Overall Study||0
10710167|NCT02647320|11875326|FG000|Safety Set|Overall Study||43
10710168|NCT02647320|11875327|FG001|Safety Set|Overall Study||44
10710169|NCT02647320|11875328|FG002|Safety Set|Overall Study||68
10809881|NCT03807089|11971714|FG001|COMPLETED|Overall Study||93
10809882|NCT03807089|11971713|FG000|NOT COMPLETED|Overall Study||0
10809883|NCT03807089|11971714|FG001|NOT COMPLETED|Overall Study||0
10809884|NCT03806231|11971722|FG000|STARTED|Overall Study||4
10809885|NCT03806231|11971723|FG001|STARTED|Overall Study||4
10809886|NCT03806231|11971722|FG000|COMPLETED|Overall Study||2
10809887|NCT03806231|11971723|FG001|COMPLETED|Overall Study||4
10809888|NCT03806231|11971722|FG000|NOT COMPLETED|Overall Study||2
10809889|NCT03806231|11971723|FG001|NOT COMPLETED|Overall Study||0
10809890|NCT03804710|11971731|FG000|STARTED|Overall Study||75
10809891|NCT03804710|11971732|FG001|STARTED|Overall Study||74
10809892|NCT03804710|11971731|FG000|COMPLETED|Overall Study||73
10809893|NCT03804710|11971732|FG001|COMPLETED|Overall Study||69
10809894|NCT03804710|11971731|FG000|NOT COMPLETED|Overall Study||2
10809895|NCT03804710|11971732|FG001|NOT COMPLETED|Overall Study||5
10809896|NCT03822377|11971744|FG000|STARTED|Overall Study||65
10809898|NCT03822377|11971744|FG000|COMPLETED|Overall Study||65
10809899|NCT03822377|11971745|FG001|COMPLETED|Overall Study||65
10809900|NCT03822377|11971744|FG000|NOT COMPLETED|Overall Study||0
10809901|NCT03822377|11971745|FG001|NOT COMPLETED|Overall Study||0
10809902|NCT03820388|11971756|FG000|STARTED|Overall Study||25
10809903|NCT03820388|11971757|FG001|STARTED|Overall Study||25
10809904|NCT03820388|11971758|FG002|STARTED|Overall Study||25
10809905|NCT03820388|11971756|FG000|COMPLETED|Overall Study||25
10809906|NCT03820388|11971757|FG001|COMPLETED|Overall Study||25
10809907|NCT03820388|11971758|FG002|COMPLETED|Overall Study||25
10809908|NCT03820388|11971756|FG000|NOT COMPLETED|Overall Study||0
10809909|NCT03820388|11971757|FG001|NOT COMPLETED|Overall Study||0
10809910|NCT03820388|11971758|FG002|NOT COMPLETED|Overall Study||0
10809911|NCT03816696|11971766|FG000|STARTED|Period 1 (Up to Day 5)||16
10809912|NCT03816696|11971766|FG000|COMPLETED|Period 1 (Up to Day 5)||16
10809913|NCT03816696|11971766|FG000|NOT COMPLETED|Period 1 (Up to Day 5)||0
10809914|NCT03816696|11971766|FG000|STARTED|Wash Out Period (Days 6 to 9)||16
10809915|NCT03816696|11971766|FG000|COMPLETED|Wash Out Period (Days 6 to 9)||16
10809916|NCT03816696|11971766|FG000|NOT COMPLETED|Wash Out Period (Days 6 to 9)||0
10809917|NCT03816696|11971766|FG000|STARTED|Period 2 (Up to Day 7)||16
10809918|NCT03816696|11971766|FG000|COMPLETED|Period 2 (Up to Day 7)||16
10809919|NCT03816696|11971766|FG000|NOT COMPLETED|Period 2 (Up to Day 7)||0
10809920|NCT03816696|11971766|FG000|STARTED|Period 3 (Up to Day 11)||16
10809921|NCT03816696|11971766|FG000|COMPLETED|Period 3 (Up to Day 11)||16
10809922|NCT03816696|11971766|FG000|NOT COMPLETED|Period 3 (Up to Day 11)||0
10809923|NCT03821064|11971776|FG000|STARTED|Overall Study||11
10809924|NCT03821064|11971776|FG000|COMPLETED|Overall Study||10
10809925|NCT03821064|11971776|FG000|NOT COMPLETED|Overall Study||1
10809926|NCT03820544|11971782|FG000|STARTED|Overall Study||2
10809927|NCT03820544|11971783|FG001|STARTED|Overall Study||2
10809928|NCT03820544|11971782|FG000|COMPLETED|Overall Study||2
10809929|NCT03820544|11971783|FG001|COMPLETED|Overall Study||2
10809930|NCT03820544|11971782|FG000|NOT COMPLETED|Overall Study||0
10809931|NCT03820544|11971783|FG001|NOT COMPLETED|Overall Study||0
10809932|NCT03820024|11971791|FG000|STARTED|Overall Study||19
10809933|NCT03820024|11971792|FG001|STARTED|Overall Study||20
10809934|NCT03820024|11971791|FG000|COMPLETED|Overall Study||18
10809935|NCT03820024|11971792|FG001|COMPLETED|Overall Study||18
10809936|NCT03820024|11971791|FG000|NOT COMPLETED|Overall Study||1
10809937|NCT03820024|11971792|FG001|NOT COMPLETED|Overall Study||2
10809938|NCT03807544|11971798|FG000|STARTED|Overall Study||17
10809939|NCT03807544|11971798|FG000|COMPLETED|Overall Study||17
10809940|NCT03807544|11971798|FG000|NOT COMPLETED|Overall Study||0
10710170|NCT02647320|11875329|FG003|Safety Set|Overall Study||68
10710171|NCT02647320|11875330|FG004|Safety Set|Overall Study||69
10710172|NCT02647320|11875326|FG000|Modified Intent-to-Treat Set (mITT)|Overall Study||40
10809941|NCT03809182|11971805|FG000|STARTED|Overall Study||20
10809942|NCT03809182|11971806|FG001|STARTED|Overall Study||20
10809943|NCT03809182|11971805|FG000|COMPLETED|Overall Study||20
10809944|NCT03809182|11971806|FG001|COMPLETED|Overall Study||20
10809945|NCT03809182|11971805|FG000|NOT COMPLETED|Overall Study||0
10809946|NCT03809182|11971806|FG001|NOT COMPLETED|Overall Study||0
10809947|NCT03816761|11971817|FG000|STARTED|First Treatment Period (7 Days)||4
10809948|NCT03816761|11971818|FG001|STARTED|First Treatment Period (7 Days)||4
10809949|NCT03816761|11971819|FG002|STARTED|First Treatment Period (7 Days)||4
10809950|NCT03816761|11971820|FG003|STARTED|First Treatment Period (7 Days)||4
10491061|NCT01191008|11640849|FG000|STARTED|Overall Study||633
10491062|NCT01191008|11640849|FG000|COMPLETED|Overall Study||618
10491063|NCT01191008|11640849|FG000|NOT COMPLETED|Overall Study||15
10491064|NCT01191086|11640853|FG000|STARTED|Overall Study||210
10491065|NCT01191086|11640853|FG000|COMPLETED|Overall Study||148
10491066|NCT01191086|11640853|FG000|NOT COMPLETED|Overall Study||62
10491067|NCT01191190|11640857|FG000|STARTED|Overall Study||21
10491068|NCT01191190|11640857|FG000|COMPLETED|Overall Study||20
10491069|NCT01191190|11640857|FG000|NOT COMPLETED|Overall Study||1
10491070|NCT01191242|11640861|FG000|STARTED|Overall Study||31
10491071|NCT01191242|11640861|FG000|COMPLETED|Overall Study||31
10491072|NCT01191242|11640861|FG000|NOT COMPLETED|Overall Study||0
10491073|NCT01191255|11640869|FG000|STARTED|Safety Assessment Period|3 subjects were assigned to receive KRX-0502 but didn't receive a single dose|149
10710173|NCT02647320|11875327|FG001|Modified Intent-to-Treat Set (mITT)|Overall Study||38
10809951|NCT03816761|11971821|FG004|STARTED|First Treatment Period (7 Days)||4
10809952|NCT03816761|11971822|FG005|STARTED|First Treatment Period (7 Days)||4
10491074|NCT01191255|11640870|FG001|STARTED|Safety Assessment Period||292
10491075|NCT01191255|11640871|FG002|STARTED|Safety Assessment Period||0
10491076|NCT01191255|11640872|FG003|STARTED|Safety Assessment Period||0
10491077|NCT01191255|11640869|FG000|Safety Population|Safety Assessment Period||149
10491078|NCT01191255|11640870|FG001|Safety Population|Safety Assessment Period||289
10491079|NCT01191255|11640871|FG002|Safety Population|Safety Assessment Period||0
10491080|NCT01191255|11640872|FG003|Safety Population|Safety Assessment Period||0
10491081|NCT01191255|11640869|FG000|COMPLETED|Safety Assessment Period||111
10491082|NCT01191255|11640870|FG001|COMPLETED|Safety Assessment Period||193
10491083|NCT01191255|11640871|FG002|COMPLETED|Safety Assessment Period||0
10491084|NCT01191255|11640872|FG003|COMPLETED|Safety Assessment Period||0
10491085|NCT01191255|11640869|FG000|NOT COMPLETED|Safety Assessment Period||38
10491086|NCT01191255|11640870|FG001|NOT COMPLETED|Safety Assessment Period||99
10491087|NCT01191255|11640871|FG002|NOT COMPLETED|Safety Assessment Period||0
10491088|NCT01191255|11640872|FG003|NOT COMPLETED|Safety Assessment Period||0
10491089|NCT01191255|11640869|FG000|STARTED|Efficacy Assessment Period||0
10491090|NCT01191255|11640870|FG001|STARTED|Efficacy Assessment Period||0
10491091|NCT01191255|11640871|FG002|STARTED|Efficacy Assessment Period||96
10491092|NCT01191255|11640872|FG003|STARTED|Efficacy Assessment Period||96
10491093|NCT01191255|11640869|FG000|COMPLETED|Efficacy Assessment Period||0
10491094|NCT01191255|11640870|FG001|COMPLETED|Efficacy Assessment Period||0
10491095|NCT01191255|11640871|FG002|COMPLETED|Efficacy Assessment Period||70
10491096|NCT01191255|11640872|FG003|COMPLETED|Efficacy Assessment Period||90
10491097|NCT01191255|11640869|FG000|NOT COMPLETED|Efficacy Assessment Period||0
10491098|NCT01191255|11640870|FG001|NOT COMPLETED|Efficacy Assessment Period||0
10491099|NCT01191255|11640871|FG002|NOT COMPLETED|Efficacy Assessment Period||26
10491100|NCT01191255|11640872|FG003|NOT COMPLETED|Efficacy Assessment Period||6
10491101|NCT01191268|11640885|FG000|STARTED|Overall Study||295
10491102|NCT01191268|11640886|FG001|STARTED|Overall Study||293
10491103|NCT01191268|11640887|FG002|STARTED|Overall Study||296
10491104|NCT01191268|11640885|FG000|Received at Least One Dose of Study Drug|Overall Study||295
10491105|NCT01191268|11640886|FG001|Received at Least One Dose of Study Drug|Overall Study||293
10491106|NCT01191268|11640887|FG002|Received at Least One Dose of Study Drug|Overall Study||296
10491107|NCT01191268|11640885|FG000|COMPLETED|Overall Study||237
10491108|NCT01191268|11640886|FG001|COMPLETED|Overall Study||238
10491109|NCT01191268|11640887|FG002|COMPLETED|Overall Study||244
10491110|NCT01191268|11640885|FG000|NOT COMPLETED|Overall Study||58
10491111|NCT01191268|11640886|FG001|NOT COMPLETED|Overall Study||55
10491112|NCT01191268|11640887|FG002|NOT COMPLETED|Overall Study||52
10491113|NCT01191320|11640899|FG000|STARTED|Overall Study||43
10491114|NCT01191320|11640900|FG001|STARTED|Overall Study||38
10491115|NCT01191320|11640901|FG002|STARTED|Overall Study||38
10491116|NCT01191320|11640899|FG000|COMPLETED|Overall Study||36
10491117|NCT01191320|11640900|FG001|COMPLETED|Overall Study||32
10491118|NCT01191320|11640901|FG002|COMPLETED|Overall Study||31
10491119|NCT01191320|11640899|FG000|NOT COMPLETED|Overall Study||7
10491120|NCT01191320|11640900|FG001|NOT COMPLETED|Overall Study||6
10491121|NCT01191320|11640901|FG002|NOT COMPLETED|Overall Study||7
10491122|NCT01191333|11640911|FG000|STARTED|Overall Study||81
10491123|NCT01191333|11640912|FG001|STARTED|Overall Study||83
10491124|NCT01191333|11640911|FG000|COMPLETED|Overall Study||60
10491125|NCT01191333|11640912|FG001|COMPLETED|Overall Study||65
10491126|NCT01191333|11640911|FG000|NOT COMPLETED|Overall Study||21
10491127|NCT01191333|11640912|FG001|NOT COMPLETED|Overall Study||18
10491128|NCT01191398|11640921|FG000|STARTED|Overall Study||17
10491129|NCT01191398|11640922|FG001|STARTED|Overall Study||17
10491130|NCT01191398|11640923|FG002|STARTED|Overall Study||18
10491131|NCT01191398|11640921|FG000|COMPLETED|Overall Study||17
10491132|NCT01191398|11640922|FG001|COMPLETED|Overall Study||17
10491133|NCT01191398|11640923|FG002|COMPLETED|Overall Study||18
10491134|NCT01191398|11640921|FG000|NOT COMPLETED|Overall Study||0
10491135|NCT01191398|11640922|FG001|NOT COMPLETED|Overall Study||0
10491136|NCT01191398|11640923|FG002|NOT COMPLETED|Overall Study||0
10491137|NCT01191411|11640934|FG000|STARTED|Overall Study||1593
10491138|NCT01191411|11640935|FG001|STARTED|Overall Study||479
10491139|NCT01191411|11640936|FG002|STARTED|Overall Study||3898
10491140|NCT01191411|11640934|FG000|COMPLETED|Overall Study||648
10491141|NCT01191411|11640935|FG001|COMPLETED|Overall Study||118
10491142|NCT01191411|11640936|FG002|COMPLETED|Overall Study||471
10491143|NCT01191411|11640934|FG000|NOT COMPLETED|Overall Study||945
10491144|NCT01191411|11640935|FG001|NOT COMPLETED|Overall Study||361
10491145|NCT01191411|11640936|FG002|NOT COMPLETED|Overall Study||3427
10491146|NCT01191476|11640947|FG000|STARTED|Overall Study||112
10491147|NCT01191476|11640948|FG001|STARTED|Overall Study|Data was not collected for 1 subject for baseline characteristics or the full analysis set.|111
10491148|NCT01191476|11640949|FG002|STARTED|Overall Study|Data was not collected for 1 subject for baseline characteristics or the full analysis set.|111
10491149|NCT01191476|11640947|FG000|COMPLETED|Overall Study||109
10491150|NCT01191476|11640948|FG001|COMPLETED|Overall Study||107
10491151|NCT01191476|11640949|FG002|COMPLETED|Overall Study||111
10491152|NCT01191476|11640947|FG000|NOT COMPLETED|Overall Study||3
10491153|NCT01191476|11640948|FG001|NOT COMPLETED|Overall Study||4
10491154|NCT01191476|11640949|FG002|NOT COMPLETED|Overall Study||0
10491155|NCT01191541|11640961|FG000|STARTED|All the Patients||30
10491156|NCT01191541|11640962|FG001|STARTED|All the Patients||35
10491157|NCT01191541|11640961|FG000|COMPLETED|All the Patients||30
10491158|NCT01191541|11640962|FG001|COMPLETED|All the Patients||35
10491159|NCT01191541|11640961|FG000|NOT COMPLETED|All the Patients||0
10491160|NCT01191541|11640962|FG001|NOT COMPLETED|All the Patients||0
10491161|NCT01191541|11640961|FG000|STARTED|the Randomized Patients||30
10491162|NCT01191541|11640962|FG001|STARTED|the Randomized Patients||35
10491163|NCT01191541|11640961|FG000|COMPLETED|the Randomized Patients||30
10491164|NCT01191541|11640962|FG001|COMPLETED|the Randomized Patients||35
10491165|NCT01191541|11640961|FG000|NOT COMPLETED|the Randomized Patients||0
10491166|NCT01191541|11640962|FG001|NOT COMPLETED|the Randomized Patients||0
10491167|NCT01191723|11640978|FG000|STARTED|Overall Study||9
10491168|NCT01191723|11640979|FG001|STARTED|Overall Study||9
10491169|NCT01191723|11640980|FG002|STARTED|Overall Study||9
10491170|NCT01191723|11640981|FG003|STARTED|Overall Study||9
10491171|NCT01191723|11640982|FG004|STARTED|Overall Study||9
10491172|NCT01191723|11640983|FG005|STARTED|Overall Study||9
10491173|NCT01191723|11640978|FG000|COMPLETED|Overall Study||9
10491174|NCT01191723|11640979|FG001|COMPLETED|Overall Study||9
10491175|NCT01191723|11640980|FG002|COMPLETED|Overall Study||9
10491176|NCT01191723|11640981|FG003|COMPLETED|Overall Study||9
10491177|NCT01191723|11640982|FG004|COMPLETED|Overall Study||9
10491178|NCT01191723|11640983|FG005|COMPLETED|Overall Study||9
10491179|NCT01191723|11640978|FG000|NOT COMPLETED|Overall Study||0
10491180|NCT01191723|11640979|FG001|NOT COMPLETED|Overall Study||0
10491181|NCT01191723|11640980|FG002|NOT COMPLETED|Overall Study||0
10491182|NCT01191723|11640981|FG003|NOT COMPLETED|Overall Study||0
10491183|NCT01191723|11640982|FG004|NOT COMPLETED|Overall Study||0
10491184|NCT01191723|11640983|FG005|NOT COMPLETED|Overall Study||0
10491185|NCT01191736|11640999|FG000|STARTED|Overall Study||51
10491186|NCT01191736|11641000|FG001|STARTED|Overall Study||47
10491187|NCT01191736|11641001|FG002|STARTED|Overall Study||49
10491188|NCT01191736|11641002|FG003|STARTED|Overall Study||46
10491189|NCT01191736|11641003|FG004|STARTED|Overall Study||48
10491190|NCT01191736|11641004|FG005|STARTED|Overall Study||50
10491191|NCT01191736|11641005|FG006|STARTED|Overall Study||45
10491192|NCT01191736|11640999|FG000|COMPLETED|Overall Study||51
10491193|NCT01191736|11641000|FG001|COMPLETED|Overall Study||47
10491194|NCT01191736|11641001|FG002|COMPLETED|Overall Study||49
10491195|NCT01191736|11641002|FG003|COMPLETED|Overall Study||46
10491196|NCT01191736|11641003|FG004|COMPLETED|Overall Study||48
10491197|NCT01191736|11641004|FG005|COMPLETED|Overall Study||50
10491198|NCT01191736|11641005|FG006|COMPLETED|Overall Study||45
10491199|NCT01191736|11640999|FG000|NOT COMPLETED|Overall Study||0
10491200|NCT01191736|11641000|FG001|NOT COMPLETED|Overall Study||0
10491201|NCT01191736|11641001|FG002|NOT COMPLETED|Overall Study||0
10491202|NCT01191736|11641002|FG003|NOT COMPLETED|Overall Study||0
10491203|NCT01191736|11641003|FG004|NOT COMPLETED|Overall Study||0
10491204|NCT01191736|11641004|FG005|NOT COMPLETED|Overall Study||0
10491205|NCT01191736|11641005|FG006|NOT COMPLETED|Overall Study||0
10491206|NCT01191749|11641021|FG000|STARTED|Overall Study||7
10491207|NCT01191749|11641021|FG000|COMPLETED|Overall Study||7
10491208|NCT01191749|11641021|FG000|NOT COMPLETED|Overall Study||0
10491209|NCT01191762|11641027|FG000|STARTED|Overall Study||15
10491210|NCT01191762|11641028|FG001|STARTED|Overall Study||15
10491211|NCT01191762|11641027|FG000|COMPLETED|Overall Study|One subject dropped out on the 3rd treatment day because of gastrointestinal complaints.|14
10491212|NCT01191762|11641028|FG001|COMPLETED|Overall Study||15
10491213|NCT01191762|11641027|FG000|NOT COMPLETED|Overall Study||1
10710174|NCT02647320|11875328|FG002|Modified Intent-to-Treat Set (mITT)|Overall Study||61
10809953|NCT03816761|11971817|FG000|COMPLETED|First Treatment Period (7 Days)||4
10809954|NCT03816761|11971818|FG001|COMPLETED|First Treatment Period (7 Days)||4
10491214|NCT01191762|11641028|FG001|NOT COMPLETED|Overall Study||0
10491215|NCT01191788|11641036|FG000|STARTED|Overall Study||140
10491216|NCT01191788|11641037|FG001|STARTED|Overall Study||159
10491217|NCT01191788|11641036|FG000|COMPLETED|Overall Study|Completed 3-month followup|119
10491218|NCT01191788|11641037|FG001|COMPLETED|Overall Study|Completed 3-month followup|137
10491219|NCT01191788|11641036|FG000|NOT COMPLETED|Overall Study||21
10491220|NCT01191788|11641037|FG001|NOT COMPLETED|Overall Study||22
10491221|NCT01191801|11641046|FG000|STARTED|Overall Study||356
10491222|NCT01191801|11641047|FG001|STARTED|Overall Study||355
10491223|NCT01191801|11641046|FG000|COMPLETED|Overall Study||40
10491224|NCT01191801|11641047|FG001|COMPLETED|Overall Study||18
10491225|NCT01191801|11641046|FG000|NOT COMPLETED|Overall Study||316
10491226|NCT01191801|11641047|FG001|NOT COMPLETED|Overall Study||337
10491227|NCT01191827|11641055|FG000|STARTED|Overall Study||20
10491228|NCT01191827|11641056|FG001|STARTED|Overall Study||20
10491229|NCT01191827|11641055|FG000|COMPLETED|Overall Study||20
10710175|NCT02647320|11875329|FG003|Modified Intent-to-Treat Set (mITT)|Overall Study||62
10710176|NCT02647320|11875330|FG004|Modified Intent-to-Treat Set (mITT)|Overall Study||62
10491230|NCT01191827|11641056|FG001|COMPLETED|Overall Study||20
10491231|NCT01191827|11641055|FG000|NOT COMPLETED|Overall Study||0
10491232|NCT01191827|11641056|FG001|NOT COMPLETED|Overall Study||0
10491233|NCT01191840|11641064|FG000|STARTED|Overall Study||254
10491234|NCT01191840|11641065|FG001|STARTED|Overall Study||255
10491235|NCT01191840|11641064|FG000|COMPLETED|Overall Study||240
10491236|NCT01191840|11641065|FG001|COMPLETED|Overall Study||240
10491237|NCT01191840|11641064|FG000|NOT COMPLETED|Overall Study||14
10491238|NCT01191840|11641065|FG001|NOT COMPLETED|Overall Study||15
10491239|NCT01191944|11641073|FG000|STARTED|Overall Study|Treated titration/maintenance|234
10491240|NCT01191944|11641074|FG001|STARTED|Overall Study|Treated titration/maintenance|239
10491241|NCT01191944|11641073|FG000|COMPLETED|Overall Study|Completed titration/maintenance|217
10491242|NCT01191944|11641074|FG001|COMPLETED|Overall Study|Completed titration/maintenance|220
10710177|NCT02647320|11875326|FG000|COMPLETED|Overall Study||34
10491243|NCT01191944|11641073|FG000|NOT COMPLETED|Overall Study||17
10491244|NCT01191944|11641074|FG001|NOT COMPLETED|Overall Study||19
10491245|NCT01192022|11641084|FG000|STARTED|Overall Study||114
10491246|NCT01192022|11641085|FG001|STARTED|Overall Study||110
10491247|NCT01192022|11641086|FG002|STARTED|Overall Study||8
10491248|NCT01192022|11641087|FG003|STARTED|Overall Study||9
10491249|NCT01192022|11641088|FG004|STARTED|Overall Study||12
10491250|NCT01192022|11641084|FG000|Safety Population-Received Treatment|Overall Study||114
10491251|NCT01192022|11641085|FG001|Safety Population-Received Treatment|Overall Study||109
10710178|NCT02647320|11875327|FG001|COMPLETED|Overall Study||35
10710179|NCT02647320|11875328|FG002|COMPLETED|Overall Study||54
10710180|NCT02647320|11875329|FG003|COMPLETED|Overall Study||58
10710181|NCT02647320|11875330|FG004|COMPLETED|Overall Study||52
10491252|NCT01192022|11641086|FG002|Safety Population-Received Treatment|Overall Study||8
10491253|NCT01192022|11641087|FG003|Safety Population-Received Treatment|Overall Study||9
10491254|NCT01192022|11641088|FG004|Safety Population-Received Treatment|Overall Study||12
10491255|NCT01192022|11641084|FG000|COMPLETED|Overall Study||101
10491256|NCT01192022|11641085|FG001|COMPLETED|Overall Study||99
10491257|NCT01192022|11641086|FG002|COMPLETED|Overall Study||7
10491258|NCT01192022|11641087|FG003|COMPLETED|Overall Study||7
10491259|NCT01192022|11641088|FG004|COMPLETED|Overall Study||11
10491260|NCT01192022|11641084|FG000|NOT COMPLETED|Overall Study||13
10491261|NCT01192022|11641085|FG001|NOT COMPLETED|Overall Study||11
10491262|NCT01192022|11641086|FG002|NOT COMPLETED|Overall Study||1
10491263|NCT01192022|11641087|FG003|NOT COMPLETED|Overall Study||2
10491264|NCT01192022|11641088|FG004|NOT COMPLETED|Overall Study||1
10491265|NCT01192100|11641099|FG000|STARTED|Overall Study||6
10491266|NCT01192100|11641100|FG001|STARTED|Overall Study||4
10491267|NCT01192100|11641101|FG002|STARTED|Overall Study||3
10491268|NCT01192100|11641102|FG003|STARTED|Overall Study||4
10491269|NCT01192100|11641103|FG004|STARTED|Overall Study||3
10491270|NCT01192100|11641104|FG005|STARTED|Overall Study||2
10491271|NCT01192100|11641099|FG000|Began 1st Intervention Week|Overall Study||6
10491272|NCT01192100|11641100|FG001|Began 1st Intervention Week|Overall Study||4
10491273|NCT01192100|11641101|FG002|Began 1st Intervention Week|Overall Study||3
10491274|NCT01192100|11641102|FG003|Began 1st Intervention Week|Overall Study||4
10491275|NCT01192100|11641103|FG004|Began 1st Intervention Week|Overall Study||3
10491276|NCT01192100|11641104|FG005|Began 1st Intervention Week|Overall Study||2
10491277|NCT01192100|11641099|FG000|Began 2nd Intervention Week|Overall Study||6
10491278|NCT01192100|11641100|FG001|Began 2nd Intervention Week|Overall Study||4
10491279|NCT01192100|11641101|FG002|Began 2nd Intervention Week|Overall Study||3
10491280|NCT01192100|11641102|FG003|Began 2nd Intervention Week|Overall Study||3
10491281|NCT01192100|11641103|FG004|Began 2nd Intervention Week|Overall Study||2
10491282|NCT01192100|11641104|FG005|Began 2nd Intervention Week|Overall Study||2
10491283|NCT01192100|11641099|FG000|Began 3rd Intervention Week|Overall Study||6
10491284|NCT01192100|11641100|FG001|Began 3rd Intervention Week|Overall Study||4
10491285|NCT01192100|11641101|FG002|Began 3rd Intervention Week|Overall Study||3
10491286|NCT01192100|11641102|FG003|Began 3rd Intervention Week|Overall Study||3
10491287|NCT01192100|11641103|FG004|Began 3rd Intervention Week|Overall Study||2
10491288|NCT01192100|11641104|FG005|Began 3rd Intervention Week|Overall Study||2
10491289|NCT01192100|11641099|FG000|COMPLETED|Overall Study||6
10491290|NCT01192100|11641100|FG001|COMPLETED|Overall Study||4
10491291|NCT01192100|11641101|FG002|COMPLETED|Overall Study||3
10491292|NCT01192100|11641102|FG003|COMPLETED|Overall Study||3
10491293|NCT01192100|11641103|FG004|COMPLETED|Overall Study||2
10491294|NCT01192100|11641104|FG005|COMPLETED|Overall Study||2
10491295|NCT01192100|11641099|FG000|NOT COMPLETED|Overall Study||0
10491296|NCT01192100|11641100|FG001|NOT COMPLETED|Overall Study||0
10491297|NCT01192100|11641101|FG002|NOT COMPLETED|Overall Study||0
10491298|NCT01192100|11641102|FG003|NOT COMPLETED|Overall Study||1
10491299|NCT01192100|11641103|FG004|NOT COMPLETED|Overall Study||1
10491300|NCT01192100|11641104|FG005|NOT COMPLETED|Overall Study||0
10491301|NCT01192126|11641114|FG000|STARTED|First Intervention (1 Week)||51
10491302|NCT01192126|11641115|FG001|STARTED|First Intervention (1 Week)||51
10491303|NCT01192126|11641114|FG000|COMPLETED|First Intervention (1 Week)||49
10491304|NCT01192126|11641115|FG001|COMPLETED|First Intervention (1 Week)||50
10491305|NCT01192126|11641114|FG000|NOT COMPLETED|First Intervention (1 Week)||2
10491306|NCT01192126|11641115|FG001|NOT COMPLETED|First Intervention (1 Week)||1
10491307|NCT01192126|11641114|FG000|STARTED|Second Intervention (1 Week)||49
10491308|NCT01192126|11641115|FG001|STARTED|Second Intervention (1 Week)||50
10491309|NCT01192126|11641114|FG000|COMPLETED|Second Intervention (1 Week)||49
10491310|NCT01192126|11641115|FG001|COMPLETED|Second Intervention (1 Week)||50
10491311|NCT01192126|11641114|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
10491312|NCT01192126|11641115|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
10491313|NCT01192139|11641121|FG000|STARTED|Period 1||5
10491314|NCT01192139|11641122|FG001|STARTED|Period 1||5
10491315|NCT01192139|11641123|FG002|STARTED|Period 1||5
10491316|NCT01192139|11641124|FG003|STARTED|Period 1||5
10491317|NCT01192139|11641125|FG004|STARTED|Period 1||5
10491318|NCT01192139|11641126|FG005|STARTED|Period 1||5
10491319|NCT01192139|11641121|FG000|COMPLETED|Period 1||5
10491320|NCT01192139|11641122|FG001|COMPLETED|Period 1||5
10491321|NCT01192139|11641123|FG002|COMPLETED|Period 1||5
10491322|NCT01192139|11641124|FG003|COMPLETED|Period 1||5
10710182|NCT02647320|11875326|FG000|NOT COMPLETED|Overall Study||12
10491323|NCT01192139|11641125|FG004|COMPLETED|Period 1||5
10491324|NCT01192139|11641126|FG005|COMPLETED|Period 1||5
10491325|NCT01192139|11641121|FG000|NOT COMPLETED|Period 1||0
10491326|NCT01192139|11641122|FG001|NOT COMPLETED|Period 1||0
10491327|NCT01192139|11641123|FG002|NOT COMPLETED|Period 1||0
10491328|NCT01192139|11641124|FG003|NOT COMPLETED|Period 1||0
10491329|NCT01192139|11641125|FG004|NOT COMPLETED|Period 1||0
10491330|NCT01192139|11641126|FG005|NOT COMPLETED|Period 1||0
10491331|NCT01192139|11641121|FG000|STARTED|Period 2||5
10491332|NCT01192139|11641122|FG001|STARTED|Period 2||5
10491333|NCT01192139|11641123|FG002|STARTED|Period 2||5
10491334|NCT01192139|11641124|FG003|STARTED|Period 2||5
10491335|NCT01192139|11641125|FG004|STARTED|Period 2||5
10491336|NCT01192139|11641126|FG005|STARTED|Period 2||5
10491337|NCT01192139|11641121|FG000|COMPLETED|Period 2||5
10491338|NCT01192139|11641122|FG001|COMPLETED|Period 2||5
10491339|NCT01192139|11641123|FG002|COMPLETED|Period 2||5
10491340|NCT01192139|11641124|FG003|COMPLETED|Period 2||5
10491341|NCT01192139|11641125|FG004|COMPLETED|Period 2||5
10491342|NCT01192139|11641126|FG005|COMPLETED|Period 2||5
10491343|NCT01192139|11641121|FG000|NOT COMPLETED|Period 2||0
10491344|NCT01192139|11641122|FG001|NOT COMPLETED|Period 2||0
10491345|NCT01192139|11641123|FG002|NOT COMPLETED|Period 2||0
10491346|NCT01192139|11641124|FG003|NOT COMPLETED|Period 2||0
10491347|NCT01192139|11641125|FG004|NOT COMPLETED|Period 2||0
10491348|NCT01192139|11641126|FG005|NOT COMPLETED|Period 2||0
10491349|NCT01192139|11641121|FG000|STARTED|Period 3||5
10491350|NCT01192139|11641122|FG001|STARTED|Period 3||5
10491351|NCT01192139|11641123|FG002|STARTED|Period 3||5
10491352|NCT01192139|11641124|FG003|STARTED|Period 3||5
10491353|NCT01192139|11641125|FG004|STARTED|Period 3||5
10491354|NCT01192139|11641126|FG005|STARTED|Period 3||5
10491355|NCT01192139|11641121|FG000|COMPLETED|Period 3||5
10491356|NCT01192139|11641122|FG001|COMPLETED|Period 3||5
10710183|NCT02647320|11875327|FG001|NOT COMPLETED|Overall Study||11
10710184|NCT02647320|11875328|FG002|NOT COMPLETED|Overall Study||15
10710185|NCT02647320|11875329|FG003|NOT COMPLETED|Overall Study||10
10491357|NCT01192139|11641123|FG002|COMPLETED|Period 3||5
10491358|NCT01192139|11641124|FG003|COMPLETED|Period 3||5
10491359|NCT01192139|11641125|FG004|COMPLETED|Period 3||5
10491360|NCT01192139|11641126|FG005|COMPLETED|Period 3||5
10491361|NCT01192139|11641121|FG000|NOT COMPLETED|Period 3||0
10491362|NCT01192139|11641122|FG001|NOT COMPLETED|Period 3||0
10710186|NCT02647320|11875330|FG004|NOT COMPLETED|Overall Study||17
10491363|NCT01192139|11641123|FG002|NOT COMPLETED|Period 3||0
10491364|NCT01192139|11641124|FG003|NOT COMPLETED|Period 3||0
10491365|NCT01192139|11641125|FG004|NOT COMPLETED|Period 3||0
10491366|NCT01192139|11641126|FG005|NOT COMPLETED|Period 3||0
10491367|NCT01192152|11641134|FG000|STARTED|Period 1||15
10491368|NCT01192152|11641135|FG001|STARTED|Period 1||15
10491369|NCT01192152|11641134|FG000|COMPLETED|Period 1||15
10491370|NCT01192152|11641135|FG001|COMPLETED|Period 1||14
10491371|NCT01192152|11641134|FG000|NOT COMPLETED|Period 1||0
10491372|NCT01192152|11641135|FG001|NOT COMPLETED|Period 1||1
10491373|NCT01192152|11641134|FG000|STARTED|Period 2||15
10491374|NCT01192152|11641135|FG001|STARTED|Period 2||14
10491375|NCT01192152|11641134|FG000|COMPLETED|Period 2||15
10491376|NCT01192152|11641135|FG001|COMPLETED|Period 2||14
10491377|NCT01192152|11641134|FG000|NOT COMPLETED|Period 2||0
10491378|NCT01192152|11641135|FG001|NOT COMPLETED|Period 2||0
10491379|NCT01192152|11641134|FG000|STARTED|Period 3||15
10491380|NCT01192152|11641135|FG001|STARTED|Period 3||0
10491381|NCT01192152|11641134|FG000|COMPLETED|Period 3||14
10491382|NCT01192152|11641135|FG001|COMPLETED|Period 3||0
10491383|NCT01192152|11641134|FG000|NOT COMPLETED|Period 3||1
10491384|NCT01192152|11641135|FG001|NOT COMPLETED|Period 3||0
10491385|NCT01192178|11641145|FG000|STARTED|Overall Study||171
10491386|NCT01192178|11641146|FG001|STARTED|Overall Study||168
10491387|NCT01192178|11641145|FG000|COMPLETED|Overall Study||147
10491388|NCT01192178|11641146|FG001|COMPLETED|Overall Study||145
10491389|NCT01192178|11641145|FG000|NOT COMPLETED|Overall Study||24
10491390|NCT01192178|11641146|FG001|NOT COMPLETED|Overall Study||23
10491391|NCT01192191|11641156|FG000|STARTED|Overall Study||60
10491392|NCT01192191|11641157|FG001|STARTED|Overall Study||127
10491393|NCT01192191|11641156|FG000|COMPLETED|Overall Study||49
10491394|NCT01192191|11641157|FG001|COMPLETED|Overall Study||106
10491395|NCT01192191|11641156|FG000|NOT COMPLETED|Overall Study||11
10491396|NCT01192191|11641157|FG001|NOT COMPLETED|Overall Study||21
10491397|NCT01192204|11641165|FG000|STARTED|Overall Study||23
10491398|NCT01192204|11641166|FG001|STARTED|Overall Study||18
10491399|NCT01192204|11641165|FG000|COMPLETED|Overall Study||22
10491400|NCT01192204|11641166|FG001|COMPLETED|Overall Study||18
10491401|NCT01192204|11641165|FG000|NOT COMPLETED|Overall Study||1
10491402|NCT01192204|11641166|FG001|NOT COMPLETED|Overall Study||0
10491403|NCT01192282|11641176|FG000|STARTED|Overall Study||156
10491404|NCT01192282|11641176|FG000|COMPLETED|Overall Study||156
10491405|NCT01192282|11641176|FG000|NOT COMPLETED|Overall Study||0
10491406|NCT01192295|11641191|FG000|STARTED|Overall Study||27
10491407|NCT01192295|11641192|FG001|STARTED|Overall Study||128
10710187|NCT02647346|11875344|FG000|STARTED|Overall Study||132
10710188|NCT02647346|11875344|FG000|COMPLETED|Overall Study||129
10710189|NCT02647346|11875344|FG000|NOT COMPLETED|Overall Study||3
10710190|NCT02647645|11875350|FG000|STARTED|Overall Study||11
10710191|NCT02647645|11875351|FG001|STARTED|Overall Study||10
10710192|NCT02647645|11875350|FG000|COMPLETED|Overall Study||9
10710193|NCT02647645|11875351|FG001|COMPLETED|Overall Study||9
10710194|NCT02647645|11875350|FG000|NOT COMPLETED|Overall Study||2
10710195|NCT02647645|11875351|FG001|NOT COMPLETED|Overall Study||1
10710196|NCT02647658|11875359|FG000|STARTED|Overall Study||1207
10491408|NCT01192295|11641191|FG000|COMPLETED|Overall Study||17
10491409|NCT01192295|11641192|FG001|COMPLETED|Overall Study||105
10491410|NCT01192295|11641191|FG000|NOT COMPLETED|Overall Study||10
10491411|NCT01192295|11641192|FG001|NOT COMPLETED|Overall Study||23
10491412|NCT01192347|11641200|FG000|STARTED|Overall Study||175
10491413|NCT01192347|11641200|FG000|COMPLETED|Overall Study||163
10491414|NCT01192347|11641200|FG000|NOT COMPLETED|Overall Study||12
10491415|NCT01192399|11641204|FG000|STARTED|Overall Study||29
10491416|NCT01192399|11641204|FG000|COMPLETED|Overall Study||27
10491417|NCT01192399|11641204|FG000|NOT COMPLETED|Overall Study||2
10491418|NCT01192412|11641210|FG000|STARTED|Overall Study||497
10491419|NCT01192412|11641211|FG001|STARTED|Overall Study||490
10491420|NCT01192412|11641210|FG000|COMPLETED|Overall Study||493
10491421|NCT01192412|11641211|FG001|COMPLETED|Overall Study||488
10491422|NCT01192412|11641210|FG000|NOT COMPLETED|Overall Study||4
10491423|NCT01192412|11641211|FG001|NOT COMPLETED|Overall Study||2
10491424|NCT01192516|11641220|FG000|STARTED|Overall Study|Indicates number of people initially randomized to group|66
10491425|NCT01192516|11641221|FG001|STARTED|Overall Study|Indicates number of people initially randomized to group|66
10491426|NCT01192516|11641222|FG002|STARTED|Overall Study|Indicates number of people initially randomized to group|63
10491427|NCT01192516|11641220|FG000|COMPLETED|Overall Study||46
10491428|NCT01192516|11641221|FG001|COMPLETED|Overall Study||49
10491429|NCT01192516|11641222|FG002|COMPLETED|Overall Study||55
10491430|NCT01192516|11641220|FG000|NOT COMPLETED|Overall Study||20
10491431|NCT01192516|11641221|FG001|NOT COMPLETED|Overall Study||17
10491432|NCT01192516|11641222|FG002|NOT COMPLETED|Overall Study||8
10491433|NCT01192542|11641234|FG000|STARTED|Period 1||18
10491434|NCT01192542|11641235|FG001|STARTED|Period 1||20
10491435|NCT01192542|11641234|FG000|COMPLETED|Period 1||18
10491436|NCT01192542|11641235|FG001|COMPLETED|Period 1||20
10491437|NCT01192542|11641234|FG000|NOT COMPLETED|Period 1||0
10491438|NCT01192542|11641235|FG001|NOT COMPLETED|Period 1||0
10491439|NCT01192542|11641234|FG000|STARTED|Period 2||18
10491440|NCT01192542|11641235|FG001|STARTED|Period 2||20
10491441|NCT01192542|11641234|FG000|COMPLETED|Period 2||18
10491442|NCT01192542|11641235|FG001|COMPLETED|Period 2||20
10491443|NCT01192542|11641234|FG000|NOT COMPLETED|Period 2||0
10491444|NCT01192542|11641235|FG001|NOT COMPLETED|Period 2||0
10491445|NCT01192815|11641243|FG000|STARTED|Overall Study||2
10491446|NCT01192815|11641243|FG000|COMPLETED|Overall Study||0
10491447|NCT01192815|11641243|FG000|NOT COMPLETED|Overall Study||2
10491448|NCT01192828|11641247|FG000|STARTED|Overall Study||14
10491449|NCT01192828|11641247|FG000|COMPLETED|Overall Study||14
10491450|NCT01192828|11641247|FG000|NOT COMPLETED|Overall Study||0
10491451|NCT01193010|11641255|FG000|STARTED|Overall Study||20
10491452|NCT01193010|11641256|FG001|STARTED|Overall Study||20
10491453|NCT01193010|11641255|FG000|COMPLETED|Overall Study||17
10491454|NCT01193010|11641256|FG001|COMPLETED|Overall Study||20
10491455|NCT01193010|11641255|FG000|NOT COMPLETED|Overall Study||3
10491456|NCT01193010|11641256|FG001|NOT COMPLETED|Overall Study||0
10491457|NCT01193049|11641262|FG000|STARTED|Period 1: Placebo Run-In||5
10491458|NCT01193049|11641263|FG001|STARTED|Period 1: Placebo Run-In||6
10491459|NCT01193049|11641262|FG000|COMPLETED|Period 1: Placebo Run-In||5
10491460|NCT01193049|11641263|FG001|COMPLETED|Period 1: Placebo Run-In||6
10491461|NCT01193049|11641262|FG000|NOT COMPLETED|Period 1: Placebo Run-In||0
10491462|NCT01193049|11641263|FG001|NOT COMPLETED|Period 1: Placebo Run-In||0
10491463|NCT01193049|11641262|FG000|STARTED|Washout 1 : 21 Day Washout||5
10491464|NCT01193049|11641263|FG001|STARTED|Washout 1 : 21 Day Washout||6
10491465|NCT01193049|11641262|FG000|COMPLETED|Washout 1 : 21 Day Washout||5
10491466|NCT01193049|11641263|FG001|COMPLETED|Washout 1 : 21 Day Washout||6
10491467|NCT01193049|11641262|FG000|NOT COMPLETED|Washout 1 : 21 Day Washout||0
10491468|NCT01193049|11641263|FG001|NOT COMPLETED|Washout 1 : 21 Day Washout||0
10491469|NCT01193049|11641262|FG000|STARTED|Period 2 : Double Blind Crossover||5
10491470|NCT01193049|11641263|FG001|STARTED|Period 2 : Double Blind Crossover||6
10491471|NCT01193049|11641262|FG000|COMPLETED|Period 2 : Double Blind Crossover||5
10650021|NCT02165735|11810177|FG000|COMPLETED|Overall Study||164
10650022|NCT02165735|11810178|FG001|COMPLETED|Overall Study||166
10650023|NCT02165735|11810177|FG000|NOT COMPLETED|Overall Study||16
10650024|NCT02165735|11810178|FG001|NOT COMPLETED|Overall Study||14
10650025|NCT02165761|11810186|FG000|STARTED|Overall Study||23
10650026|NCT02165761|11810187|FG001|STARTED|Overall Study||19
10650027|NCT02165761|11810186|FG000|COMPLETED|Overall Study||4
10650028|NCT02165761|11810187|FG001|COMPLETED|Overall Study||5
10650029|NCT02165761|11810186|FG000|NOT COMPLETED|Overall Study||19
10650030|NCT02165761|11810187|FG001|NOT COMPLETED|Overall Study||14
10650031|NCT02165826|11810196|FG000|STARTED|Main Treatment Period||441
10491472|NCT01193049|11641263|FG001|COMPLETED|Period 2 : Double Blind Crossover||6
10491473|NCT01193049|11641262|FG000|NOT COMPLETED|Period 2 : Double Blind Crossover||0
10491474|NCT01193049|11641263|FG001|NOT COMPLETED|Period 2 : Double Blind Crossover||0
10491475|NCT01193049|11641262|FG000|STARTED|Washout 2 : 21 Day Washout||5
10491476|NCT01193049|11641263|FG001|STARTED|Washout 2 : 21 Day Washout||6
10491477|NCT01193049|11641262|FG000|COMPLETED|Washout 2 : 21 Day Washout||5
10491478|NCT01193049|11641263|FG001|COMPLETED|Washout 2 : 21 Day Washout||6
10491479|NCT01193049|11641262|FG000|NOT COMPLETED|Washout 2 : 21 Day Washout||0
10491480|NCT01193049|11641263|FG001|NOT COMPLETED|Washout 2 : 21 Day Washout||0
10491481|NCT01193049|11641262|FG000|STARTED|Period 3 : Double Blind Crossover||5
10491482|NCT01193049|11641263|FG001|STARTED|Period 3 : Double Blind Crossover||6
10491483|NCT01193049|11641262|FG000|COMPLETED|Period 3 : Double Blind Crossover||5
10650032|NCT02165826|11810197|FG001|STARTED|Main Treatment Period||439
10491484|NCT01193049|11641263|FG001|COMPLETED|Period 3 : Double Blind Crossover||6
10491485|NCT01193049|11641262|FG000|NOT COMPLETED|Period 3 : Double Blind Crossover||0
10491486|NCT01193049|11641263|FG001|NOT COMPLETED|Period 3 : Double Blind Crossover||0
10491487|NCT01193101|11641273|FG000|STARTED|Overall Study||100
10491488|NCT01193101|11641274|FG001|STARTED|Overall Study||101
10491489|NCT01193101|11641275|FG002|STARTED|Overall Study||96
10491490|NCT01193101|11641276|FG003|STARTED|Overall Study||92
10491491|NCT01193101|11641273|FG000|Full Analysis Set|Overall Study||100
10491492|NCT01193101|11641274|FG001|Full Analysis Set|Overall Study||101
10491493|NCT01193101|11641275|FG002|Full Analysis Set|Overall Study||96
10491494|NCT01193101|11641276|FG003|Full Analysis Set|Overall Study||92
10491495|NCT01193101|11641273|FG000|Placebo Withdrawal Set|Overall Study||95
10491496|NCT01193101|11641274|FG001|Placebo Withdrawal Set|Overall Study||94
10491497|NCT01193101|11641275|FG002|Placebo Withdrawal Set|Overall Study||93
10491498|NCT01193101|11641276|FG003|Placebo Withdrawal Set|Overall Study||80
10491499|NCT01193101|11641273|FG000|COMPLETED|Overall Study||95
10491500|NCT01193101|11641274|FG001|COMPLETED|Overall Study||94
10491501|NCT01193101|11641275|FG002|COMPLETED|Overall Study||93
10491502|NCT01193101|11641276|FG003|COMPLETED|Overall Study||80
10491503|NCT01193101|11641273|FG000|NOT COMPLETED|Overall Study||5
10491504|NCT01193101|11641274|FG001|NOT COMPLETED|Overall Study||7
10491505|NCT01193101|11641275|FG002|NOT COMPLETED|Overall Study||3
10491506|NCT01193101|11641276|FG003|NOT COMPLETED|Overall Study||12
10491507|NCT01193114|11641288|FG000|STARTED|Overall Study||30
10491508|NCT01193114|11641289|FG001|STARTED|Overall Study||30
10491509|NCT01193114|11641288|FG000|COMPLETED|Overall Study||30
10491510|NCT01193114|11641289|FG001|COMPLETED|Overall Study||30
10491511|NCT01193114|11641288|FG000|NOT COMPLETED|Overall Study||0
10491512|NCT01193114|11641289|FG001|NOT COMPLETED|Overall Study||0
10491513|NCT01193127|11641299|FG000|STARTED|Randomized||57
10491514|NCT01193127|11641300|FG001|STARTED|Randomized||54
10491515|NCT01193127|11641301|FG002|STARTED|Randomized||55
10491516|NCT01193127|11641302|FG003|STARTED|Randomized||57
10491517|NCT01193127|11641299|FG000|COMPLETED|Randomized||57
10491518|NCT01193127|11641300|FG001|COMPLETED|Randomized||54
10491519|NCT01193127|11641301|FG002|COMPLETED|Randomized||55
10491520|NCT01193127|11641302|FG003|COMPLETED|Randomized||56
10491521|NCT01193127|11641299|FG000|NOT COMPLETED|Randomized||0
10491522|NCT01193127|11641300|FG001|NOT COMPLETED|Randomized||0
10491523|NCT01193127|11641301|FG002|NOT COMPLETED|Randomized||0
10491524|NCT01193127|11641302|FG003|NOT COMPLETED|Randomized||1
10491525|NCT01193127|11641299|FG000|STARTED|Treated||57
10491526|NCT01193127|11641300|FG001|STARTED|Treated||54
10491527|NCT01193127|11641301|FG002|STARTED|Treated||55
10491528|NCT01193127|11641302|FG003|STARTED|Treated||56
10491529|NCT01193127|11641299|FG000|COMPLETED|Treated||57
10491530|NCT01193127|11641300|FG001|COMPLETED|Treated||54
10491531|NCT01193127|11641301|FG002|COMPLETED|Treated||55
10491532|NCT01193127|11641302|FG003|COMPLETED|Treated||55
10491533|NCT01193127|11641299|FG000|NOT COMPLETED|Treated||0
10491534|NCT01193127|11641300|FG001|NOT COMPLETED|Treated||0
10491535|NCT01193127|11641301|FG002|NOT COMPLETED|Treated||0
10491536|NCT01193127|11641302|FG003|NOT COMPLETED|Treated||1
10491537|NCT01193153|11641314|FG000|STARTED|Open-label Lead in Period||667
10491538|NCT01193153|11641315|FG001|STARTED|Open-label Lead in Period||0
10491539|NCT01193153|11641314|FG000|COMPLETED|Open-label Lead in Period||432
10491540|NCT01193153|11641315|FG001|COMPLETED|Open-label Lead in Period||0
10491541|NCT01193153|11641314|FG000|NOT COMPLETED|Open-label Lead in Period||235
10491542|NCT01193153|11641315|FG001|NOT COMPLETED|Open-label Lead in Period||0
10491543|NCT01193153|11641314|FG000|STARTED|Open-label Stabilization Period||432
10491544|NCT01193153|11641315|FG001|STARTED|Open-label Stabilization Period||0
10491545|NCT01193153|11641314|FG000|COMPLETED|Open-label Stabilization Period||334
10491546|NCT01193153|11641315|FG001|COMPLETED|Open-label Stabilization Period||0
10491547|NCT01193153|11641314|FG000|NOT COMPLETED|Open-label Stabilization Period||98
10491548|NCT01193153|11641315|FG001|NOT COMPLETED|Open-label Stabilization Period||0
10491549|NCT01193153|11641314|FG000|STARTED|Double Blind Relapse Prevention Period||164
10491550|NCT01193153|11641315|FG001|STARTED|Double Blind Relapse Prevention Period||170
10491551|NCT01193153|11641314|FG000|COMPLETED|Double Blind Relapse Prevention Period||100
10491552|NCT01193153|11641315|FG001|COMPLETED|Double Blind Relapse Prevention Period||65
10491553|NCT01193153|11641314|FG000|NOT COMPLETED|Double Blind Relapse Prevention Period||64
10491554|NCT01193153|11641315|FG001|NOT COMPLETED|Double Blind Relapse Prevention Period||105
10491555|NCT01193218|11641329|FG000|STARTED|0-12 Weeks|It is actually placebo group|109
10491556|NCT01193218|11641330|FG001|STARTED|0-12 Weeks|It is actually N/A|0
10491557|NCT01193218|11641331|FG002|STARTED|0-12 Weeks|It is actually empa 5mg group|110
10491558|NCT01193218|11641332|FG003|STARTED|0-12 Weeks|It is actually N/A|0
10491559|NCT01193218|11641333|FG004|STARTED|0-12 Weeks||109
10491560|NCT01193218|11641334|FG005|STARTED|0-12 Weeks||109
10491561|NCT01193218|11641335|FG006|STARTED|0-12 Weeks|It is actually empa 50mg group|110
10491562|NCT01193218|11641336|FG007|STARTED|0-12 Weeks|It is actually N/A|0
10491563|NCT01193218|11641329|FG000|COMPLETED|0-12 Weeks||100
10491564|NCT01193218|11641330|FG001|COMPLETED|0-12 Weeks||0
10491565|NCT01193218|11641331|FG002|COMPLETED|0-12 Weeks||107
10491566|NCT01193218|11641332|FG003|COMPLETED|0-12 Weeks||0
10491567|NCT01193218|11641333|FG004|COMPLETED|0-12 Weeks||108
10491568|NCT01193218|11641334|FG005|COMPLETED|0-12 Weeks||106
10491569|NCT01193218|11641335|FG006|COMPLETED|0-12 Weeks||107
10491570|NCT01193218|11641336|FG007|COMPLETED|0-12 Weeks||0
10491571|NCT01193218|11641329|FG000|NOT COMPLETED|0-12 Weeks||9
10491572|NCT01193218|11641330|FG001|NOT COMPLETED|0-12 Weeks||0
10491573|NCT01193218|11641331|FG002|NOT COMPLETED|0-12 Weeks||3
10491574|NCT01193218|11641332|FG003|NOT COMPLETED|0-12 Weeks||0
10491575|NCT01193218|11641333|FG004|NOT COMPLETED|0-12 Weeks||1
10491576|NCT01193218|11641334|FG005|NOT COMPLETED|0-12 Weeks||3
10491577|NCT01193218|11641335|FG006|NOT COMPLETED|0-12 Weeks||3
10491578|NCT01193218|11641336|FG007|NOT COMPLETED|0-12 Weeks||0
10491579|NCT01193218|11641329|FG000|STARTED|12-52 Weeks||50
10491580|NCT01193218|11641330|FG001|STARTED|12-52 Weeks||50
10491581|NCT01193218|11641331|FG002|STARTED|12-52 Weeks||54
10491582|NCT01193218|11641332|FG003|STARTED|12-52 Weeks||53
10491583|NCT01193218|11641333|FG004|STARTED|12-52 Weeks||108
10491584|NCT01193218|11641334|FG005|STARTED|12-52 Weeks||106
10491585|NCT01193218|11641335|FG006|STARTED|12-52 Weeks||54
10491586|NCT01193218|11641336|FG007|STARTED|12-52 Weeks||53
10491587|NCT01193218|11641329|FG000|COMPLETED|12-52 Weeks||45
10491588|NCT01193218|11641330|FG001|COMPLETED|12-52 Weeks||50
10491589|NCT01193218|11641331|FG002|COMPLETED|12-52 Weeks||50
10491590|NCT01193218|11641332|FG003|COMPLETED|12-52 Weeks||50
10491591|NCT01193218|11641333|FG004|COMPLETED|12-52 Weeks||104
10491592|NCT01193218|11641334|FG005|COMPLETED|12-52 Weeks||101
10491593|NCT01193218|11641335|FG006|COMPLETED|12-52 Weeks||51
10491594|NCT01193218|11641336|FG007|COMPLETED|12-52 Weeks||49
10491595|NCT01193218|11641329|FG000|NOT COMPLETED|12-52 Weeks||5
10491596|NCT01193218|11641330|FG001|NOT COMPLETED|12-52 Weeks||0
10491597|NCT01193218|11641331|FG002|NOT COMPLETED|12-52 Weeks||4
10491598|NCT01193218|11641332|FG003|NOT COMPLETED|12-52 Weeks||3
10491599|NCT01193218|11641333|FG004|NOT COMPLETED|12-52 Weeks||4
10491600|NCT01193218|11641334|FG005|NOT COMPLETED|12-52 Weeks||5
10491601|NCT01193218|11641335|FG006|NOT COMPLETED|12-52 Weeks||3
10491602|NCT01193218|11641336|FG007|NOT COMPLETED|12-52 Weeks||4
10491603|NCT01193244|11641354|FG000|STARTED|Overall Study||779
10491604|NCT01193244|11641355|FG001|STARTED|Overall Study||781
10491605|NCT01193244|11641354|FG000|Treated|Overall Study|Participants who continued to receive Placebo after unblinding.|770
10710197|NCT02647658|11875360|FG001|STARTED|Overall Study||1093
10710198|NCT02647658|11875359|FG000|6 Month Assessment|Overall Study||658
10491606|NCT01193244|11641355|FG001|Treated|Overall Study|Participants randomized to receive Placebo but crossed-over to receive Orteronel after unblinding.|784
10491607|NCT01193244|11641354|FG000|COMPLETED|Overall Study||391
10491608|NCT01193244|11641355|FG001|COMPLETED|Overall Study||391
10491609|NCT01193244|11641354|FG000|NOT COMPLETED|Overall Study||388
10491610|NCT01193244|11641355|FG001|NOT COMPLETED|Overall Study||390
10491611|NCT01193257|11641363|FG000|STARTED|Overall Study||365
10491612|NCT01193257|11641364|FG001|STARTED|Overall Study||734
10491613|NCT01193257|11641363|FG000|Treated|Overall Study||363
10491614|NCT01193257|11641364|FG001|Treated|Overall Study||732
10491615|NCT01193257|11641363|FG000|COMPLETED|Overall Study||0
10491616|NCT01193257|11641364|FG001|COMPLETED|Overall Study||0
10491617|NCT01193257|11641363|FG000|NOT COMPLETED|Overall Study||365
10491618|NCT01193257|11641364|FG001|NOT COMPLETED|Overall Study||734
10491619|NCT01193283|11641370|FG000|STARTED|Overall Study||22
10491620|NCT01193283|11641370|FG000|COMPLETED|Overall Study||21
10491621|NCT01193283|11641370|FG000|NOT COMPLETED|Overall Study||1
10491622|NCT01193335|11641376|FG000|STARTED|Infant Series||100
10491623|NCT01193335|11641377|FG001|STARTED|Infant Series||100
10491624|NCT01193335|11641376|FG000|COMPLETED|Infant Series||100
10491625|NCT01193335|11641377|FG001|COMPLETED|Infant Series||100
10491626|NCT01193335|11641376|FG000|NOT COMPLETED|Infant Series||0
10491627|NCT01193335|11641377|FG001|NOT COMPLETED|Infant Series||0
10491628|NCT01193335|11641376|FG000|STARTED|After Infant Series||100
10491629|NCT01193335|11641377|FG001|STARTED|After Infant Series||100
10491630|NCT01193335|11641376|FG000|COMPLETED|After Infant Series||99
10491631|NCT01193335|11641377|FG001|COMPLETED|After Infant Series||97
10491632|NCT01193335|11641376|FG000|NOT COMPLETED|After Infant Series||1
10491633|NCT01193335|11641377|FG001|NOT COMPLETED|After Infant Series||3
10491634|NCT01193335|11641376|FG000|STARTED|Toddler Dose||99
10491635|NCT01193335|11641377|FG001|STARTED|Toddler Dose||97
10491636|NCT01193335|11641376|FG000|COMPLETED|Toddler Dose||99
10491637|NCT01193335|11641377|FG001|COMPLETED|Toddler Dose||97
10491638|NCT01193335|11641376|FG000|NOT COMPLETED|Toddler Dose||0
10491639|NCT01193335|11641377|FG001|NOT COMPLETED|Toddler Dose||0
10491640|NCT01193335|11641376|FG000|STARTED|1-Year Follow-up||99
10491641|NCT01193335|11641377|FG001|STARTED|1-Year Follow-up||97
10491642|NCT01193335|11641376|FG000|COMPLETED|1-Year Follow-up||88
10491643|NCT01193335|11641377|FG001|COMPLETED|1-Year Follow-up||88
10491644|NCT01193335|11641376|FG000|NOT COMPLETED|1-Year Follow-up||11
10491645|NCT01193335|11641377|FG001|NOT COMPLETED|1-Year Follow-up||9
10491646|NCT01193335|11641376|FG000|STARTED|2-Year Follow-up||88
10491647|NCT01193335|11641377|FG001|STARTED|2-Year Follow-up||88
10491648|NCT01193335|11641376|FG000|COMPLETED|2-Year Follow-up||81
10491649|NCT01193335|11641377|FG001|COMPLETED|2-Year Follow-up||80
10491650|NCT01193335|11641376|FG000|NOT COMPLETED|2-Year Follow-up||7
10491651|NCT01193335|11641377|FG001|NOT COMPLETED|2-Year Follow-up||8
10491652|NCT01193348|11641399|FG000|STARTED|Screening Period||27
10491653|NCT01193348|11641399|FG000|COMPLETED|Screening Period||22
10491654|NCT01193348|11641399|FG000|NOT COMPLETED|Screening Period||5
10491655|NCT01193348|11641399|FG000|STARTED|Treatment Period (26 Weeks)||22
10491656|NCT01193348|11641399|FG000|COMPLETED|Treatment Period (26 Weeks)||19
10491657|NCT01193348|11641399|FG000|NOT COMPLETED|Treatment Period (26 Weeks)||3
10491658|NCT01193348|11641399|FG000|STARTED|Extension Treatment Period||17
10710199|NCT02647658|11875360|FG001|6 Month Assessment|Overall Study||635
10710200|NCT02647658|11875359|FG000|COMPLETED|Overall Study||1192
10710201|NCT02647658|11875360|FG001|COMPLETED|Overall Study||1069
10491659|NCT01193348|11641399|FG000|COMPLETED|Extension Treatment Period||16
10491660|NCT01193348|11641399|FG000|NOT COMPLETED|Extension Treatment Period||1
10491661|NCT01193348|11641399|FG000|STARTED|Post Treatment Period (Patients Who Disc||10
10491662|NCT01193348|11641399|FG000|COMPLETED|Post Treatment Period (Patients Who Disc||8
10491663|NCT01193348|11641399|FG000|NOT COMPLETED|Post Treatment Period (Patients Who Disc||2
10491664|NCT01193517|11641411|FG000|STARTED|Overall Study||3
10491665|NCT01193517|11641412|FG001|STARTED|Overall Study||12
10491666|NCT01193517|11641413|FG002|STARTED|Overall Study||11
10491667|NCT01193517|11641411|FG000|COMPLETED|Overall Study||2
10491668|NCT01193517|11641412|FG001|COMPLETED|Overall Study||12
10491669|NCT01193517|11641413|FG002|COMPLETED|Overall Study||11
10491670|NCT01193517|11641411|FG000|NOT COMPLETED|Overall Study||1
10491671|NCT01193517|11641412|FG001|NOT COMPLETED|Overall Study||0
10491672|NCT01193517|11641413|FG002|NOT COMPLETED|Overall Study||0
10491673|NCT01193582|11641426|FG000|STARTED|Vaccination Series||100
10491674|NCT01193582|11641427|FG001|STARTED|Vaccination Series||101
10491675|NCT01193582|11641428|FG002|STARTED|Vaccination Series||125
10491676|NCT01193582|11641429|FG003|STARTED|Vaccination Series||180
10491677|NCT01193582|11641426|FG000|Vaccinated Dose 1|Vaccination Series||100
10491678|NCT01193582|11641427|FG001|Vaccinated Dose 1|Vaccination Series||100
10491679|NCT01193582|11641428|FG002|Vaccinated Dose 1|Vaccination Series||125
10491680|NCT01193582|11641429|FG003|Vaccinated Dose 1|Vaccination Series||180
10491681|NCT01193582|11641426|FG000|Vaccinated Dose 2|Vaccination Series||92
10491682|NCT01193582|11641427|FG001|Vaccinated Dose 2|Vaccination Series||91
10491683|NCT01193582|11641428|FG002|Vaccinated Dose 2|Vaccination Series||118
10491684|NCT01193582|11641429|FG003|Vaccinated Dose 2|Vaccination Series||0
10491685|NCT01193582|11641426|FG000|Vaccinated Dose 3|Vaccination Series||90
10491686|NCT01193582|11641427|FG001|Vaccinated Dose 3|Vaccination Series||89
10491687|NCT01193582|11641428|FG002|Vaccinated Dose 3|Vaccination Series||0
10491688|NCT01193582|11641429|FG003|Vaccinated Dose 3|Vaccination Series||0
10491689|NCT01193582|11641426|FG000|Vaccinated Dose 4|Vaccination Series||90
10491690|NCT01193582|11641427|FG001|Vaccinated Dose 4|Vaccination Series||0
10491691|NCT01193582|11641428|FG002|Vaccinated Dose 4|Vaccination Series||0
10491692|NCT01193582|11641429|FG003|Vaccinated Dose 4|Vaccination Series||0
10491693|NCT01193582|11641426|FG000|COMPLETED|Vaccination Series||89
10491694|NCT01193582|11641427|FG001|COMPLETED|Vaccination Series||88
10491695|NCT01193582|11641428|FG002|COMPLETED|Vaccination Series||117
10491696|NCT01193582|11641429|FG003|COMPLETED|Vaccination Series||177
10491697|NCT01193582|11641426|FG000|NOT COMPLETED|Vaccination Series||11
10491698|NCT01193582|11641427|FG001|NOT COMPLETED|Vaccination Series||13
10491699|NCT01193582|11641428|FG002|NOT COMPLETED|Vaccination Series||8
10491700|NCT01193582|11641429|FG003|NOT COMPLETED|Vaccination Series||3
10491701|NCT01193582|11641426|FG000|STARTED|12 Month Follow-up||89
10491702|NCT01193582|11641427|FG001|STARTED|12 Month Follow-up||88
10491703|NCT01193582|11641428|FG002|STARTED|12 Month Follow-up||117
10491704|NCT01193582|11641429|FG003|STARTED|12 Month Follow-up||177
10491705|NCT01193582|11641426|FG000|COMPLETED|12 Month Follow-up||83
10491706|NCT01193582|11641427|FG001|COMPLETED|12 Month Follow-up||88
10491707|NCT01193582|11641428|FG002|COMPLETED|12 Month Follow-up||113
10491708|NCT01193582|11641429|FG003|COMPLETED|12 Month Follow-up||166
10491709|NCT01193582|11641426|FG000|NOT COMPLETED|12 Month Follow-up||6
10491710|NCT01193582|11641427|FG001|NOT COMPLETED|12 Month Follow-up||0
10491711|NCT01193582|11641428|FG002|NOT COMPLETED|12 Month Follow-up||4
10491712|NCT01193582|11641429|FG003|NOT COMPLETED|12 Month Follow-up||11
10491713|NCT01193608|11641447|FG000|STARTED|Overall Study||6
10491714|NCT01193608|11641448|FG001|STARTED|Overall Study||6
10491715|NCT01193608|11641449|FG002|STARTED|Overall Study||16
10491716|NCT01193608|11641450|FG003|STARTED|Overall Study||17
10491717|NCT01193608|11641451|FG004|STARTED|Overall Study||24
10491718|NCT01193608|11641452|FG005|STARTED|Overall Study||19
10491719|NCT01193608|11641447|FG000|COMPLETED|Overall Study||6
10491720|NCT01193608|11641448|FG001|COMPLETED|Overall Study||4
10491721|NCT01193608|11641449|FG002|COMPLETED|Overall Study||14
10491722|NCT01193608|11641450|FG003|COMPLETED|Overall Study||14
10491723|NCT01193608|11641451|FG004|COMPLETED|Overall Study||19
10491724|NCT01193608|11641452|FG005|COMPLETED|Overall Study||17
10491725|NCT01193608|11641447|FG000|NOT COMPLETED|Overall Study||0
10491726|NCT01193608|11641448|FG001|NOT COMPLETED|Overall Study||2
10491727|NCT01193608|11641449|FG002|NOT COMPLETED|Overall Study||2
10491728|NCT01193608|11641450|FG003|NOT COMPLETED|Overall Study||3
10491729|NCT01193608|11641451|FG004|NOT COMPLETED|Overall Study||5
10491730|NCT01193608|11641452|FG005|NOT COMPLETED|Overall Study||2
10491731|NCT01193660|11641474|FG000|STARTED|Overall Study||35
10491732|NCT01193660|11641475|FG001|STARTED|Overall Study||36
10491733|NCT01193660|11641476|FG002|STARTED|Overall Study||34
10491734|NCT01193660|11641474|FG000|COMPLETED|Overall Study||31
10491735|NCT01193660|11641475|FG001|COMPLETED|Overall Study||33
10491736|NCT01193660|11641476|FG002|COMPLETED|Overall Study||32
10491737|NCT01193660|11641474|FG000|NOT COMPLETED|Overall Study||4
10491738|NCT01193660|11641475|FG001|NOT COMPLETED|Overall Study||3
10491739|NCT01193660|11641476|FG002|NOT COMPLETED|Overall Study||2
10491740|NCT01193686|11641486|FG000|STARTED|Overall Study||15
10491741|NCT01193686|11641487|FG001|STARTED|Overall Study||9
10491742|NCT01193686|11641486|FG000|Completed Baseline Assessment|Overall Study||15
10491743|NCT01193686|11641487|FG001|Completed Baseline Assessment|Overall Study||9
10491744|NCT01193686|11641486|FG000|Completed Mentor Training|Overall Study||9
10491745|NCT01193686|11641487|FG001|Completed Mentor Training|Overall Study|Not applicable. Recipients were not required to complete training.|0
10491746|NCT01193686|11641486|FG000|Completed Visits and Final Assessment|Overall Study||8
10491747|NCT01193686|11641487|FG001|Completed Visits and Final Assessment|Overall Study||8
10491748|NCT01193686|11641486|FG000|COMPLETED|Overall Study||8
10491749|NCT01193686|11641487|FG001|COMPLETED|Overall Study||8
10491750|NCT01193686|11641486|FG000|NOT COMPLETED|Overall Study||7
10491751|NCT01193686|11641487|FG001|NOT COMPLETED|Overall Study||1
10491752|NCT01193868|11641494|FG000|STARTED|Overall Study||6
10491753|NCT01193868|11641494|FG000|COMPLETED|Overall Study||6
10491754|NCT01193868|11641494|FG000|NOT COMPLETED|Overall Study||0
10491755|NCT01193907|11641502|FG000|STARTED|Overall Study||22
10491756|NCT01193907|11641503|FG001|STARTED|Overall Study||22
10491757|NCT01193907|11641504|FG002|STARTED|Overall Study||22
10491758|NCT01193907|11641505|FG003|STARTED|Overall Study||22
10491759|NCT01193907|11641502|FG000|COMPLETED|Overall Study||21
10491760|NCT01193907|11641503|FG001|COMPLETED|Overall Study||22
10491761|NCT01193907|11641504|FG002|COMPLETED|Overall Study||22
10491762|NCT01193907|11641505|FG003|COMPLETED|Overall Study||21
10491763|NCT01193907|11641502|FG000|NOT COMPLETED|Overall Study||1
10491764|NCT01193907|11641503|FG001|NOT COMPLETED|Overall Study||0
10491765|NCT01193907|11641504|FG002|NOT COMPLETED|Overall Study||0
10491766|NCT01193907|11641505|FG003|NOT COMPLETED|Overall Study||1
10491767|NCT01193920|11641525|FG000|STARTED|Overall Study||40
10491768|NCT01193920|11641526|FG001|STARTED|Overall Study||20
10491769|NCT01193920|11641527|FG002|STARTED|Overall Study||80
10491770|NCT01193920|11641528|FG003|STARTED|Overall Study||80
10491771|NCT01193920|11641529|FG004|STARTED|Overall Study||80
10491772|NCT01193920|11641530|FG005|STARTED|Overall Study||80
10491773|NCT01193920|11641531|FG006|STARTED|Overall Study||80
10491774|NCT01193920|11641532|FG007|STARTED|Overall Study||80
10491775|NCT01193920|11641533|FG008|STARTED|Overall Study||76
10491776|NCT01193920|11641534|FG009|STARTED|Overall Study||81
10491777|NCT01193920|11641525|FG000|COMPLETED|Overall Study||37
10491778|NCT01193920|11641526|FG001|COMPLETED|Overall Study||20
10491779|NCT01193920|11641527|FG002|COMPLETED|Overall Study||74
10491780|NCT01193920|11641528|FG003|COMPLETED|Overall Study||76
10491781|NCT01193920|11641529|FG004|COMPLETED|Overall Study||74
10491782|NCT01193920|11641530|FG005|COMPLETED|Overall Study||76
10491783|NCT01193920|11641531|FG006|COMPLETED|Overall Study||74
10491784|NCT01193920|11641532|FG007|COMPLETED|Overall Study||76
10491785|NCT01193920|11641533|FG008|COMPLETED|Overall Study||71
10491786|NCT01193920|11641534|FG009|COMPLETED|Overall Study||74
10491787|NCT01193920|11641525|FG000|NOT COMPLETED|Overall Study||3
10491788|NCT01193920|11641526|FG001|NOT COMPLETED|Overall Study||0
10491789|NCT01193920|11641527|FG002|NOT COMPLETED|Overall Study||6
10491790|NCT01193920|11641528|FG003|NOT COMPLETED|Overall Study||4
10491791|NCT01193920|11641529|FG004|NOT COMPLETED|Overall Study||6
10491792|NCT01193920|11641530|FG005|NOT COMPLETED|Overall Study||4
10491793|NCT01193920|11641531|FG006|NOT COMPLETED|Overall Study||6
10491794|NCT01193920|11641532|FG007|NOT COMPLETED|Overall Study||4
10491795|NCT01193920|11641533|FG008|NOT COMPLETED|Overall Study||5
10491796|NCT01193920|11641534|FG009|NOT COMPLETED|Overall Study||7
10491797|NCT01194089|11641559|FG000|STARTED|Overall Study||42
10491798|NCT01194089|11641560|FG001|STARTED|Overall Study||47
10491799|NCT01194089|11641559|FG000|COMPLETED|Overall Study||42
10491800|NCT01194089|11641560|FG001|COMPLETED|Overall Study||47
10491801|NCT01194089|11641559|FG000|NOT COMPLETED|Overall Study||0
10491802|NCT01194089|11641560|FG001|NOT COMPLETED|Overall Study||0
10491803|NCT01194154|11641568|FG000|STARTED|Overall Study||117
10491804|NCT01194154|11641569|FG001|STARTED|Overall Study||124
10491805|NCT01194154|11641568|FG000|Full Analysis Set|Overall Study||115
10491806|NCT01194154|11641569|FG001|Full Analysis Set|Overall Study||120
10491807|NCT01194154|11641568|FG000|Safety Analysis Set|Overall Study|3 participants randomized to placebo but received MIRCERA and included in MIRCERA arm (as treated).|118
10491808|NCT01194154|11641569|FG001|Safety Analysis Set|Overall Study|3 participants randomized to placebo but received MIRCERA and included in MIRCERA arm (as treated).|117
10491809|NCT01194154|11641568|FG000|COMPLETED|Overall Study||68
10491810|NCT01194154|11641569|FG001|COMPLETED|Overall Study||91
10491811|NCT01194154|11641568|FG000|NOT COMPLETED|Overall Study||49
10491812|NCT01194154|11641569|FG001|NOT COMPLETED|Overall Study||33
10491813|NCT01194245|11641582|FG000|STARTED|Titration Period (4 to 6 Weeks)||135
10491814|NCT01194245|11641583|FG001|STARTED|Titration Period (4 to 6 Weeks)||0
10491815|NCT01194245|11641584|FG002|STARTED|Titration Period (4 to 6 Weeks)||0
10491816|NCT01194245|11641585|FG003|STARTED|Titration Period (4 to 6 Weeks)||0
10491817|NCT01194245|11641586|FG004|STARTED|Titration Period (4 to 6 Weeks)||0
10710202|NCT02647658|11875359|FG000|NOT COMPLETED|Overall Study||15
10710203|NCT02647658|11875360|FG001|NOT COMPLETED|Overall Study||24
10491818|NCT01194245|11641582|FG000|COMPLETED|Titration Period (4 to 6 Weeks)|Participants that completed the Titration Period were randomized to Treatment Period 1.|117
10491819|NCT01194245|11641583|FG001|COMPLETED|Titration Period (4 to 6 Weeks)||0
10491820|NCT01194245|11641584|FG002|COMPLETED|Titration Period (4 to 6 Weeks)||0
10491821|NCT01194245|11641585|FG003|COMPLETED|Titration Period (4 to 6 Weeks)||0
10491822|NCT01194245|11641586|FG004|COMPLETED|Titration Period (4 to 6 Weeks)||0
10491823|NCT01194245|11641582|FG000|NOT COMPLETED|Titration Period (4 to 6 Weeks)||18
10491824|NCT01194245|11641583|FG001|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
10491825|NCT01194245|11641584|FG002|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
10491826|NCT01194245|11641585|FG003|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
10710204|NCT02647788|11875368|FG000|STARTED|Overall Study||70
10710205|NCT02647788|11875369|FG001|STARTED|Overall Study||70
10710206|NCT02647788|11875368|FG000|COMPLETED|Overall Study||54
10710207|NCT02647788|11875369|FG001|COMPLETED|Overall Study||57
10710208|NCT02647788|11875368|FG000|NOT COMPLETED|Overall Study||16
10491827|NCT01194245|11641586|FG004|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
10491828|NCT01194245|11641582|FG000|STARTED|Treatment Period 1 (Weeks 0 to 12)||0
10491829|NCT01194245|11641583|FG001|STARTED|Treatment Period 1 (Weeks 0 to 12)||29
10491830|NCT01194245|11641584|FG002|STARTED|Treatment Period 1 (Weeks 0 to 12)||28
10491831|NCT01194245|11641585|FG003|STARTED|Treatment Period 1 (Weeks 0 to 12)||30
10491832|NCT01194245|11641586|FG004|STARTED|Treatment Period 1 (Weeks 0 to 12)||30
10491833|NCT01194245|11641582|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||0
10491834|NCT01194245|11641583|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||29
10491835|NCT01194245|11641584|FG002|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||28
10491836|NCT01194245|11641585|FG003|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||30
10491837|NCT01194245|11641586|FG004|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||30
10491838|NCT01194245|11641582|FG000|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
10491839|NCT01194245|11641583|FG001|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||29
10491840|NCT01194245|11641584|FG002|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||27
10491841|NCT01194245|11641585|FG003|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||29
10491842|NCT01194245|11641586|FG004|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||28
10491843|NCT01194245|11641582|FG000|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
10491844|NCT01194245|11641583|FG001|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
10491845|NCT01194245|11641584|FG002|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||1
10491846|NCT01194245|11641585|FG003|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||1
10491847|NCT01194245|11641586|FG004|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||2
10491848|NCT01194245|11641582|FG000|STARTED|Treatment Period 2 (Weeks 12 to 24)||0
10491849|NCT01194245|11641583|FG001|STARTED|Treatment Period 2 (Weeks 12 to 24)||29
10491850|NCT01194245|11641584|FG002|STARTED|Treatment Period 2 (Weeks 12 to 24)||27
10491851|NCT01194245|11641585|FG003|STARTED|Treatment Period 2 (Weeks 12 to 24)||29
10491852|NCT01194245|11641586|FG004|STARTED|Treatment Period 2 (Weeks 12 to 24)||28
10491853|NCT01194245|11641582|FG000|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
10491854|NCT01194245|11641583|FG001|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||29
10491855|NCT01194245|11641584|FG002|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||27
10491856|NCT01194245|11641585|FG003|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||29
10491857|NCT01194245|11641586|FG004|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||28
10491858|NCT01194245|11641582|FG000|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
10491859|NCT01194245|11641583|FG001|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
10491860|NCT01194245|11641584|FG002|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
10491861|NCT01194245|11641585|FG003|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
10491862|NCT01194245|11641586|FG004|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
10491863|NCT01194258|11641595|FG000|STARTED|Titration Period||132
10491864|NCT01194258|11641596|FG001|STARTED|Titration Period||0
10491865|NCT01194258|11641597|FG002|STARTED|Titration Period||0
10491866|NCT01194258|11641598|FG003|STARTED|Titration Period||0
10491867|NCT01194258|11641599|FG004|STARTED|Titration Period||0
10491868|NCT01194258|11641595|FG000|COMPLETED|Titration Period||121
10491869|NCT01194258|11641596|FG001|COMPLETED|Titration Period||0
10491870|NCT01194258|11641597|FG002|COMPLETED|Titration Period||0
10491871|NCT01194258|11641598|FG003|COMPLETED|Titration Period||0
10491872|NCT01194258|11641599|FG004|COMPLETED|Titration Period||0
10491873|NCT01194258|11641595|FG000|NOT COMPLETED|Titration Period||11
10491874|NCT01194258|11641596|FG001|NOT COMPLETED|Titration Period||0
10491875|NCT01194258|11641597|FG002|NOT COMPLETED|Titration Period||0
10491876|NCT01194258|11641598|FG003|NOT COMPLETED|Titration Period||0
10491877|NCT01194258|11641599|FG004|NOT COMPLETED|Titration Period||0
10491878|NCT01194258|11641595|FG000|STARTED|Period 1 (12 Weeks)|Participants were randomized to the Insulin lispro or an Analog-PH20 group after titration.|0
10491879|NCT01194258|11641596|FG001|STARTED|Period 1 (12 Weeks)|After the titration phase, 29 participants were randomized to the Insulin lispro/Lispro-PH20 group.|29
10491880|NCT01194258|11641597|FG002|STARTED|Period 1 (12 Weeks)|After the titration phase, 30 participants were randomized to the Lispro-PH20/Insulin lispro group.|30
10491881|NCT01194258|11641598|FG003|STARTED|Period 1 (12 Weeks)|After the titration phase, 29 participants were randomized to the Insulin lispro/Aspart-PH20 group.|29
10491882|NCT01194258|11641599|FG004|STARTED|Period 1 (12 Weeks)|After the titration phase, 33 participants were randomized to the Aspart-PH20/Insulin lispro group.|33
10491883|NCT01194258|11641595|FG000|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||0
10491884|NCT01194258|11641596|FG001|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||29
10491885|NCT01194258|11641597|FG002|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||30
10491886|NCT01194258|11641598|FG003|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||29
10491887|NCT01194258|11641599|FG004|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||33
10491888|NCT01194258|11641595|FG000|COMPLETED|Period 1 (12 Weeks)||0
10491889|NCT01194258|11641596|FG001|COMPLETED|Period 1 (12 Weeks)||29
10491890|NCT01194258|11641597|FG002|COMPLETED|Period 1 (12 Weeks)||30
10491891|NCT01194258|11641598|FG003|COMPLETED|Period 1 (12 Weeks)||29
10491892|NCT01194258|11641599|FG004|COMPLETED|Period 1 (12 Weeks)||32
10491893|NCT01194258|11641595|FG000|NOT COMPLETED|Period 1 (12 Weeks)||0
10491894|NCT01194258|11641596|FG001|NOT COMPLETED|Period 1 (12 Weeks)||0
10710209|NCT02647788|11875369|FG001|NOT COMPLETED|Overall Study||13
10710210|NCT02647866|11875380|FG000|STARTED|Overall Study||9
10710211|NCT02647866|11875381|FG001|STARTED|Overall Study||10
10710212|NCT02647866|11875382|FG002|STARTED|Overall Study||9
10491895|NCT01194258|11641597|FG002|NOT COMPLETED|Period 1 (12 Weeks)||0
10491896|NCT01194258|11641598|FG003|NOT COMPLETED|Period 1 (12 Weeks)||0
10491897|NCT01194258|11641599|FG004|NOT COMPLETED|Period 1 (12 Weeks)||1
10491898|NCT01194258|11641595|FG000|STARTED|Period 2 (12 Weeks)||0
10491899|NCT01194258|11641596|FG001|STARTED|Period 2 (12 Weeks)||29
10491900|NCT01194258|11641597|FG002|STARTED|Period 2 (12 Weeks)||30
10491901|NCT01194258|11641598|FG003|STARTED|Period 2 (12 Weeks)||29
10491902|NCT01194258|11641599|FG004|STARTED|Period 2 (12 Weeks)||32
10491903|NCT01194258|11641595|FG000|COMPLETED|Period 2 (12 Weeks)||0
10491904|NCT01194258|11641596|FG001|COMPLETED|Period 2 (12 Weeks)||27
10491905|NCT01194258|11641597|FG002|COMPLETED|Period 2 (12 Weeks)||29
10491906|NCT01194258|11641598|FG003|COMPLETED|Period 2 (12 Weeks)||29
10491907|NCT01194258|11641599|FG004|COMPLETED|Period 2 (12 Weeks)||30
10491908|NCT01194258|11641595|FG000|NOT COMPLETED|Period 2 (12 Weeks)||0
10491909|NCT01194258|11641596|FG001|NOT COMPLETED|Period 2 (12 Weeks)||2
10491910|NCT01194258|11641597|FG002|NOT COMPLETED|Period 2 (12 Weeks)||1
10491911|NCT01194258|11641598|FG003|NOT COMPLETED|Period 2 (12 Weeks)||0
10491912|NCT01194258|11641599|FG004|NOT COMPLETED|Period 2 (12 Weeks)||2
10491913|NCT01194271|11641610|FG000|STARTED|Overall Study||19
10491914|NCT01194271|11641610|FG000|COMPLETED|Overall Study||16
10491915|NCT01194271|11641610|FG000|NOT COMPLETED|Overall Study||3
10491916|NCT01194297|11641616|FG000|STARTED|Overall Study||2
10491917|NCT01194297|11641617|FG001|STARTED|Overall Study||1
10491918|NCT01194297|11641616|FG000|COMPLETED|Overall Study||2
10491919|NCT01194297|11641617|FG001|COMPLETED|Overall Study||1
10491920|NCT01194297|11641616|FG000|NOT COMPLETED|Overall Study||0
10491921|NCT01194297|11641617|FG001|NOT COMPLETED|Overall Study||0
10491922|NCT01194414|11641625|FG000|STARTED|24 Weeks Double Blind Period||631
10491923|NCT01194414|11641626|FG001|STARTED|24 Weeks Double Blind Period||631
10491924|NCT01194414|11641627|FG002|STARTED|24 Weeks Double Blind Period||0
10491925|NCT01194414|11641628|FG003|STARTED|24 Weeks Double Blind Period||0
10491926|NCT01194414|11641625|FG000|Per Protocol Population|24 Weeks Double Blind Period||558
10491927|NCT01194414|11641626|FG001|Per Protocol Population|24 Weeks Double Blind Period||537
10491928|NCT01194414|11641627|FG002|Per Protocol Population|24 Weeks Double Blind Period||0
10491929|NCT01194414|11641628|FG003|Per Protocol Population|24 Weeks Double Blind Period||0
10491930|NCT01194414|11641625|FG000|COMPLETED|24 Weeks Double Blind Period||572
10491931|NCT01194414|11641626|FG001|COMPLETED|24 Weeks Double Blind Period||564
10491932|NCT01194414|11641627|FG002|COMPLETED|24 Weeks Double Blind Period||0
10491933|NCT01194414|11641628|FG003|COMPLETED|24 Weeks Double Blind Period||0
10491934|NCT01194414|11641625|FG000|NOT COMPLETED|24 Weeks Double Blind Period||59
10491935|NCT01194414|11641626|FG001|NOT COMPLETED|24 Weeks Double Blind Period||67
10491936|NCT01194414|11641627|FG002|NOT COMPLETED|24 Weeks Double Blind Period||0
10491937|NCT01194414|11641628|FG003|NOT COMPLETED|24 Weeks Double Blind Period||0
10491938|NCT01194414|11641625|FG000|STARTED|72 Weeks Open Label Extension||524
10491939|NCT01194414|11641626|FG001|STARTED|72 Weeks Open Label Extension||377
10491940|NCT01194414|11641627|FG002|STARTED|72 Weeks Open Label Extension||48
10491941|NCT01194414|11641628|FG003|STARTED|72 Weeks Open Label Extension||186
10491942|NCT01194414|11641625|FG000|COMPLETED|72 Weeks Open Label Extension||445
10491943|NCT01194414|11641626|FG001|COMPLETED|72 Weeks Open Label Extension||311
10491944|NCT01194414|11641627|FG002|COMPLETED|72 Weeks Open Label Extension||40
10491945|NCT01194414|11641628|FG003|COMPLETED|72 Weeks Open Label Extension||160
10491946|NCT01194414|11641625|FG000|NOT COMPLETED|72 Weeks Open Label Extension||79
10491947|NCT01194414|11641626|FG001|NOT COMPLETED|72 Weeks Open Label Extension||66
10491948|NCT01194414|11641627|FG002|NOT COMPLETED|72 Weeks Open Label Extension||8
10491949|NCT01194414|11641628|FG003|NOT COMPLETED|72 Weeks Open Label Extension||26
10491950|NCT01194440|11641640|FG000|STARTED|Baseline (First Dose)||59
10491951|NCT01194440|11641640|FG000|COMPLETED|Baseline (First Dose)||52
10710213|NCT02647866|11875383|FG003|STARTED|Overall Study||21
10710214|NCT02647866|11875384|FG004|STARTED|Overall Study||17
10710215|NCT02647866|11875380|FG000|Completed Induction Therapy|Overall Study|Subjects received KHK4083 1.0 mg/kg for 12 weeks|8
10491952|NCT01194440|11641640|FG000|NOT COMPLETED|Baseline (First Dose)||7
10491953|NCT01194440|11641640|FG000|STARTED|6-months (2nd Dose)||52
10491954|NCT01194440|11641640|FG000|COMPLETED|6-months (2nd Dose)||48
10491955|NCT01194440|11641640|FG000|NOT COMPLETED|6-months (2nd Dose)||4
10491956|NCT01194453|11641647|FG000|STARTED|Overall Study||144
10491957|NCT01194453|11641648|FG001|STARTED|Overall Study||144
10491958|NCT01194453|11641647|FG000|COMPLETED|Overall Study||127
10491959|NCT01194453|11641648|FG001|COMPLETED|Overall Study||127
10491960|NCT01194453|11641647|FG000|NOT COMPLETED|Overall Study||17
10491961|NCT01194453|11641648|FG001|NOT COMPLETED|Overall Study||17
10491962|NCT01194466|11641654|FG000|STARTED|Overall Study||14
10710216|NCT02647866|11875381|FG001|Completed Induction Therapy|Overall Study|Subjects received KHK4083 3.0 mg/kg for 12 weeks|9
10710217|NCT02647866|11875382|FG002|Completed Induction Therapy|Overall Study|Subjects received KHK4083 10.0 mg/kg for 12 weeks|8
10710218|NCT02647866|11875383|FG003|Completed Induction Therapy|Overall Study|Subjects received the maximum tolerated dose of KHK4083 10.0 mg/kg for 12 weeks|19
10491963|NCT01194466|11641655|FG001|STARTED|Overall Study||14
10710219|NCT02647866|11875384|FG004|Completed Induction Therapy|Overall Study|Subjects received Placebo for 12 weeks|17
10710220|NCT02647866|11875380|FG000|Completed Induction Therapy Follow-Up|Overall Study||5
10710221|NCT02647866|11875381|FG001|Completed Induction Therapy Follow-Up|Overall Study||1
10710222|NCT02647866|11875382|FG002|Completed Induction Therapy Follow-Up|Overall Study||2
10710223|NCT02647866|11875383|FG003|Completed Induction Therapy Follow-Up|Overall Study||0
10491964|NCT01194466|11641656|FG002|STARTED|Overall Study||13
10491965|NCT01194466|11641654|FG000|COMPLETED|Overall Study||14
10491966|NCT01194466|11641655|FG001|COMPLETED|Overall Study||14
10491967|NCT01194466|11641656|FG002|COMPLETED|Overall Study||13
10491968|NCT01194466|11641654|FG000|NOT COMPLETED|Overall Study||0
10491969|NCT01194466|11641655|FG001|NOT COMPLETED|Overall Study||0
10491970|NCT01194466|11641656|FG002|NOT COMPLETED|Overall Study||0
10491971|NCT01194479|11641666|FG000|STARTED|Overall Study||3
10491972|NCT01194479|11641667|FG001|STARTED|Overall Study||4
10491973|NCT01194479|11641668|FG002|STARTED|Overall Study||2
10491974|NCT01194479|11641669|FG003|STARTED|Overall Study||5
10491975|NCT01194479|11641666|FG000|Cross-over at Second Visit|Overall Study||3
10491976|NCT01194479|11641667|FG001|Cross-over at Second Visit|Overall Study||4
10491977|NCT01194479|11641668|FG002|Cross-over at Second Visit|Overall Study||2
10491978|NCT01194479|11641669|FG003|Cross-over at Second Visit|Overall Study||5
10491979|NCT01194479|11641666|FG000|COMPLETED|Overall Study||3
10491980|NCT01194479|11641667|FG001|COMPLETED|Overall Study||4
10491981|NCT01194479|11641668|FG002|COMPLETED|Overall Study||2
10491982|NCT01194479|11641669|FG003|COMPLETED|Overall Study||5
10491983|NCT01194479|11641666|FG000|NOT COMPLETED|Overall Study||0
10491984|NCT01194479|11641667|FG001|NOT COMPLETED|Overall Study||0
10491985|NCT01194479|11641668|FG002|NOT COMPLETED|Overall Study||0
10491986|NCT01194479|11641669|FG003|NOT COMPLETED|Overall Study||0
10491987|NCT01194531|11641681|FG000|STARTED|Overall Study||29
10491988|NCT01194531|11641682|FG001|STARTED|Overall Study||30
10491989|NCT01194531|11641681|FG000|COMPLETED|Overall Study||24
10491990|NCT01194531|11641682|FG001|COMPLETED|Overall Study||27
10491991|NCT01194531|11641681|FG000|NOT COMPLETED|Overall Study||5
10491992|NCT01194531|11641682|FG001|NOT COMPLETED|Overall Study||3
10491993|NCT01194674|11641688|FG000|STARTED|Overall Study||2
10491994|NCT01194674|11641688|FG000|COMPLETED|Overall Study||2
10491995|NCT01194674|11641688|FG000|NOT COMPLETED|Overall Study||0
10491996|NCT01194804|11641693|FG000|STARTED|Overall Study||27
10491997|NCT01194804|11641693|FG000|COMPLETED|Overall Study||26
10491998|NCT01194804|11641693|FG000|NOT COMPLETED|Overall Study||1
10491999|NCT01194830|11641699|FG000|STARTED|Overall Study||124
10492000|NCT01194830|11641700|FG001|STARTED|Overall Study||110
10492001|NCT01194830|11641699|FG000|COMPLETED|Overall Study||88
10492002|NCT01194830|11641700|FG001|COMPLETED|Overall Study||83
10492003|NCT01194830|11641699|FG000|NOT COMPLETED|Overall Study||36
10492004|NCT01194830|11641700|FG001|NOT COMPLETED|Overall Study||27
10492005|NCT01194869|11641706|FG000|STARTED|Overall Study||25
10492006|NCT01194869|11641706|FG000|COMPLETED|Overall Study||21
10492007|NCT01194869|11641706|FG000|NOT COMPLETED|Overall Study||4
10492008|NCT01194973|11641710|FG000|STARTED|Screening Period||44
10492009|NCT01194973|11641710|FG000|COMPLETED|Screening Period||41
10492010|NCT01194973|11641710|FG000|NOT COMPLETED|Screening Period||3
10492011|NCT01194973|11641710|FG000|STARTED|26 Week Treatment Period||41
10492012|NCT01194973|11641710|FG000|COMPLETED|26 Week Treatment Period||38
10492013|NCT01194973|11641710|FG000|NOT COMPLETED|26 Week Treatment Period||3
10492014|NCT01194999|11641714|FG000|STARTED|Overall Study||132
10492015|NCT01194999|11641714|FG000|COMPLETED|Overall Study||115
10492016|NCT01194999|11641714|FG000|NOT COMPLETED|Overall Study||17
10492017|NCT01195025|11641718|FG000|STARTED|First Intervention A||2
10492018|NCT01195025|11641719|FG001|STARTED|First Intervention A||3
10492019|NCT01195025|11641720|FG002|STARTED|First Intervention A||2
10492020|NCT01195025|11641721|FG003|STARTED|First Intervention A||2
10492021|NCT01195025|11641722|FG004|STARTED|First Intervention A||1
10492022|NCT01195025|11641718|FG000|COMPLETED|First Intervention A||2
10492023|NCT01195025|11641719|FG001|COMPLETED|First Intervention A||3
10492024|NCT01195025|11641720|FG002|COMPLETED|First Intervention A||2
10492025|NCT01195025|11641721|FG003|COMPLETED|First Intervention A||2
10492026|NCT01195025|11641722|FG004|COMPLETED|First Intervention A||1
10492027|NCT01195025|11641718|FG000|NOT COMPLETED|First Intervention A||0
10492028|NCT01195025|11641719|FG001|NOT COMPLETED|First Intervention A||0
10492029|NCT01195025|11641720|FG002|NOT COMPLETED|First Intervention A||0
10492030|NCT01195025|11641721|FG003|NOT COMPLETED|First Intervention A||0
10492031|NCT01195025|11641722|FG004|NOT COMPLETED|First Intervention A||0
10492032|NCT01195025|11641718|FG000|STARTED|Second Intervention B||2
10492033|NCT01195025|11641719|FG001|STARTED|Second Intervention B||3
10492034|NCT01195025|11641720|FG002|STARTED|Second Intervention B||2
10492035|NCT01195025|11641721|FG003|STARTED|Second Intervention B||2
10492036|NCT01195025|11641722|FG004|STARTED|Second Intervention B||1
10492037|NCT01195025|11641718|FG000|COMPLETED|Second Intervention B||2
10492038|NCT01195025|11641719|FG001|COMPLETED|Second Intervention B||3
10492039|NCT01195025|11641720|FG002|COMPLETED|Second Intervention B||2
10492040|NCT01195025|11641721|FG003|COMPLETED|Second Intervention B||2
10492041|NCT01195025|11641722|FG004|COMPLETED|Second Intervention B||1
10492042|NCT01195025|11641718|FG000|NOT COMPLETED|Second Intervention B||0
10492043|NCT01195025|11641719|FG001|NOT COMPLETED|Second Intervention B||0
10492044|NCT01195025|11641720|FG002|NOT COMPLETED|Second Intervention B||0
10492045|NCT01195025|11641721|FG003|NOT COMPLETED|Second Intervention B||0
10492046|NCT01195025|11641722|FG004|NOT COMPLETED|Second Intervention B||0
10492047|NCT01195025|11641718|FG000|STARTED|Third Intervention C||2
10492048|NCT01195025|11641719|FG001|STARTED|Third Intervention C||3
10492049|NCT01195025|11641720|FG002|STARTED|Third Intervention C||2
10492050|NCT01195025|11641721|FG003|STARTED|Third Intervention C||2
10492051|NCT01195025|11641722|FG004|STARTED|Third Intervention C||1
10492052|NCT01195025|11641718|FG000|COMPLETED|Third Intervention C||2
10492053|NCT01195025|11641719|FG001|COMPLETED|Third Intervention C||3
10492054|NCT01195025|11641720|FG002|COMPLETED|Third Intervention C||2
10492055|NCT01195025|11641721|FG003|COMPLETED|Third Intervention C||2
10492056|NCT01195025|11641722|FG004|COMPLETED|Third Intervention C||1
10492057|NCT01195025|11641718|FG000|NOT COMPLETED|Third Intervention C||0
10492058|NCT01195025|11641719|FG001|NOT COMPLETED|Third Intervention C||0
10492059|NCT01195025|11641720|FG002|NOT COMPLETED|Third Intervention C||0
10492060|NCT01195025|11641721|FG003|NOT COMPLETED|Third Intervention C||0
10492061|NCT01195025|11641722|FG004|NOT COMPLETED|Third Intervention C||0
10492062|NCT01195090|11641730|FG000|STARTED|Overall Study||60
10492063|NCT01195090|11641731|FG001|STARTED|Overall Study||60
10492064|NCT01195090|11641730|FG000|COMPLETED|Overall Study||54
10492065|NCT01195090|11641731|FG001|COMPLETED|Overall Study||52
10492066|NCT01195090|11641730|FG000|NOT COMPLETED|Overall Study||6
10492067|NCT01195090|11641731|FG001|NOT COMPLETED|Overall Study||8
10492068|NCT01195103|11641740|FG000|STARTED|Overall Study||6
10492069|NCT01195103|11641741|FG001|STARTED|Overall Study||2
10492070|NCT01195103|11641742|FG002|STARTED|Overall Study||5
10492071|NCT01195103|11641740|FG000|COMPLETED|Overall Study|One patient withdrew after randomization but before received study drug.|5
10492072|NCT01195103|11641741|FG001|COMPLETED|Overall Study||2
10492073|NCT01195103|11641742|FG002|COMPLETED|Overall Study||5
10492074|NCT01195103|11641740|FG000|NOT COMPLETED|Overall Study||1
10492075|NCT01195103|11641741|FG001|NOT COMPLETED|Overall Study||0
10492076|NCT01195103|11641742|FG002|NOT COMPLETED|Overall Study||0
10492077|NCT01195116|11641752|FG000|STARTED|Overall Study||21
10492078|NCT01195116|11641753|FG001|STARTED|Overall Study||20
10492079|NCT01195116|11641752|FG000|COMPLETED|Overall Study||21
10492080|NCT01195116|11641753|FG001|COMPLETED|Overall Study||20
10492081|NCT01195116|11641752|FG000|NOT COMPLETED|Overall Study||0
10492082|NCT01195116|11641753|FG001|NOT COMPLETED|Overall Study||0
10492083|NCT01195272|11641759|FG000|STARTED|Overall Study||21
10492084|NCT01195272|11641759|FG000|COMPLETED|Overall Study||17
10492085|NCT01195272|11641759|FG000|NOT COMPLETED|Overall Study||4
10492086|NCT01195363|11641765|FG000|STARTED|Overall Study||15
10492087|NCT01195363|11641766|FG001|STARTED|Overall Study||13
10492088|NCT01195363|11641765|FG000|COMPLETED|Overall Study||4
10492089|NCT01195363|11641766|FG001|COMPLETED|Overall Study||4
10492090|NCT01195363|11641765|FG000|NOT COMPLETED|Overall Study||11
10492091|NCT01195363|11641766|FG001|NOT COMPLETED|Overall Study||9
10492092|NCT01195415|11641772|FG000|STARTED|Overall Study||25
10492093|NCT01195415|11641772|FG000|COMPLETED|Overall Study||23
10492094|NCT01195415|11641772|FG000|NOT COMPLETED|Overall Study||2
10492095|NCT01195467|11641776|FG000|STARTED|Overall Study||40
10492096|NCT01195467|11641776|FG000|COMPLETED|Overall Study||30
10492097|NCT01195467|11641776|FG000|NOT COMPLETED|Overall Study||10
10492098|NCT01195545|11641780|FG000|STARTED|Overall Study||20
10492099|NCT01195545|11641780|FG000|COMPLETED|Overall Study||16
10492100|NCT01195545|11641780|FG000|NOT COMPLETED|Overall Study||4
10492101|NCT01195584|11641787|FG000|STARTED|Overall Study||20
10492102|NCT01195584|11641788|FG001|STARTED|Overall Study||25
10492103|NCT01195584|11641789|FG002|STARTED|Overall Study||27
10492104|NCT01195584|11641787|FG000|COMPLETED|Overall Study||20
10492105|NCT01195584|11641788|FG001|COMPLETED|Overall Study||25
10492106|NCT01195584|11641789|FG002|COMPLETED|Overall Study||27
10492107|NCT01195584|11641787|FG000|NOT COMPLETED|Overall Study||0
10492108|NCT01195584|11641788|FG001|NOT COMPLETED|Overall Study||0
10492109|NCT01195584|11641789|FG002|NOT COMPLETED|Overall Study||0
10492110|NCT01195597|11641799|FG000|STARTED|Overall Study||40
10492111|NCT01195597|11641799|FG000|COMPLETED|Overall Study||27
10492112|NCT01195597|11641799|FG000|NOT COMPLETED|Overall Study||13
10492113|NCT01195623|11641805|FG000|STARTED|Overall Study|166 legs total operated|148
10492114|NCT01195623|11641806|FG001|STARTED|Overall Study|177 legs total operated|145
10492115|NCT01195623|11641805|FG000|COMPLETED|Overall Study|127 legs|113
10492116|NCT01195623|11641806|FG001|COMPLETED|Overall Study|129 legs|108
10492117|NCT01195623|11641805|FG000|NOT COMPLETED|Overall Study||35
10492118|NCT01195623|11641806|FG001|NOT COMPLETED|Overall Study||37
10492119|NCT01195636|11641814|FG000|STARTED|First Intervention (3 Weeks)||35
10492120|NCT01195636|11641815|FG001|STARTED|First Intervention (3 Weeks)||35
10492121|NCT01195636|11641814|FG000|Received at Least 1 Dose of Drug|First Intervention (3 Weeks)||33
10492122|NCT01195636|11641815|FG001|Received at Least 1 Dose of Drug|First Intervention (3 Weeks)||35
10492123|NCT01195636|11641814|FG000|COMPLETED|First Intervention (3 Weeks)||30
10492124|NCT01195636|11641815|FG001|COMPLETED|First Intervention (3 Weeks)||32
10492125|NCT01195636|11641814|FG000|NOT COMPLETED|First Intervention (3 Weeks)||5
10492126|NCT01195636|11641815|FG001|NOT COMPLETED|First Intervention (3 Weeks)||3
10492127|NCT01195636|11641814|FG000|STARTED|Washout Period (2 Weeks)||30
10492128|NCT01195636|11641815|FG001|STARTED|Washout Period (2 Weeks)||32
10492129|NCT01195636|11641814|FG000|COMPLETED|Washout Period (2 Weeks)||28
10492130|NCT01195636|11641815|FG001|COMPLETED|Washout Period (2 Weeks)||29
10492131|NCT01195636|11641814|FG000|NOT COMPLETED|Washout Period (2 Weeks)||2
10492132|NCT01195636|11641815|FG001|NOT COMPLETED|Washout Period (2 Weeks)||3
10492133|NCT01195636|11641814|FG000|STARTED|Second Intervention (3 Weeks)||28
10492134|NCT01195636|11641815|FG001|STARTED|Second Intervention (3 Weeks)||29
10492135|NCT01195636|11641814|FG000|COMPLETED|Second Intervention (3 Weeks)||27
10492136|NCT01195636|11641815|FG001|COMPLETED|Second Intervention (3 Weeks)||27
10492137|NCT01195636|11641814|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||1
10492138|NCT01195636|11641815|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||2
10492139|NCT01195662|11641824|FG000|STARTED|Double Blind Treatment Period||224
10492140|NCT01195662|11641825|FG001|STARTED|Double Blind Treatment Period||225
10492141|NCT01195662|11641826|FG002|STARTED|Double Blind Treatment Period||133
10492142|NCT01195662|11641824|FG000|COMPLETED|Double Blind Treatment Period||202
10492143|NCT01195662|11641825|FG001|COMPLETED|Double Blind Treatment Period||211
10492144|NCT01195662|11641826|FG002|COMPLETED|Double Blind Treatment Period||119
10492145|NCT01195662|11641824|FG000|NOT COMPLETED|Double Blind Treatment Period||22
10492146|NCT01195662|11641825|FG001|NOT COMPLETED|Double Blind Treatment Period||14
10492147|NCT01195662|11641826|FG002|NOT COMPLETED|Double Blind Treatment Period||14
10492148|NCT01195662|11641824|FG000|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|1 participant discontinued drug but remained in study and entered Follow-Up.|203
10492149|NCT01195662|11641825|FG001|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|2 participants completed treatment period but chose not to enter follow up period.|209
10492150|NCT01195662|11641826|FG002|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|1 participant discontinued drug but remained in the study and entered the follow up period.|120
10492151|NCT01195662|11641824|FG000|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||200
10492152|NCT01195662|11641825|FG001|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||209
10492153|NCT01195662|11641826|FG002|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||119
10492154|NCT01195662|11641824|FG000|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||3
10492155|NCT01195662|11641825|FG001|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||0
10492156|NCT01195662|11641826|FG002|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||1
10492157|NCT01195675|11641835|FG000|STARTED|Overall Study||30
10492158|NCT01195675|11641835|FG000|Received Empa 25mg|Overall Study||28
10492159|NCT01195675|11641835|FG000|Received Empa 200mg|Overall Study||30
10492160|NCT01195675|11641835|FG000|Received Moxifloxacin|Overall Study||29
10492161|NCT01195675|11641835|FG000|Received Placebo 1|Overall Study||29
10492162|NCT01195675|11641835|FG000|Received Placebo 2|Overall Study||28
10492163|NCT01195675|11641835|FG000|COMPLETED|Overall Study||27
10492164|NCT01195675|11641835|FG000|NOT COMPLETED|Overall Study||3
10492165|NCT01195701|11641852|FG000|STARTED|Overall Study||10
10492166|NCT01195701|11641853|FG001|STARTED|Overall Study||25
10492167|NCT01195701|11641852|FG000|COMPLETED|Overall Study||10
10492168|NCT01195701|11641853|FG001|COMPLETED|Overall Study||20
10492169|NCT01195701|11641852|FG000|NOT COMPLETED|Overall Study||0
10492170|NCT01195701|11641853|FG001|NOT COMPLETED|Overall Study||5
10527777|NCT01391663|11680015|FG002|COMPLETED|Overall Study||11
10527778|NCT01391663|11680016|FG003|COMPLETED|Overall Study||12
10527779|NCT01391663|11680013|FG000|NOT COMPLETED|Overall Study||0
10527780|NCT01391663|11680014|FG001|NOT COMPLETED|Overall Study||0
10527781|NCT01391663|11680015|FG002|NOT COMPLETED|Overall Study||1
10527782|NCT01391663|11680016|FG003|NOT COMPLETED|Overall Study||0
10527783|NCT01391793|11680028|FG000|STARTED|Overall Study||271
10527784|NCT01391793|11680029|FG001|STARTED|Overall Study||275
10527785|NCT01391793|11680028|FG000|Had a Positive Urine Culture|Overall Study||197
10527786|NCT01391793|11680029|FG001|Had a Positive Urine Culture|Overall Study||188
10527787|NCT01391793|11680028|FG000|COMPLETED|Overall Study||124
10527788|NCT01391793|11680029|FG001|COMPLETED|Overall Study||131
10527789|NCT01391793|11680028|FG000|NOT COMPLETED|Overall Study||147
10527790|NCT01391793|11680029|FG001|NOT COMPLETED|Overall Study||144
10527791|NCT01391819|11680035|FG000|STARTED|Overall Study||2116
10527792|NCT01391819|11680035|FG000|COMPLETED|Overall Study||1714
10527793|NCT01391819|11680035|FG000|NOT COMPLETED|Overall Study||402
10527794|NCT01391832|11680044|FG000|STARTED|Overall Study||49
10527795|NCT01391832|11680045|FG001|STARTED|Overall Study||54
10527796|NCT01391832|11680044|FG000|1 Month Follow-Up|Overall Study||30
10527797|NCT01391832|11680045|FG001|1 Month Follow-Up|Overall Study||31
10527798|NCT01391832|11680044|FG000|3 Month Follow-Up|Overall Study||28
10527799|NCT01391832|11680045|FG001|3 Month Follow-Up|Overall Study||29
10527800|NCT01391832|11680044|FG000|COMPLETED|Overall Study||28
10527801|NCT01391832|11680045|FG001|COMPLETED|Overall Study||31
10527802|NCT01391832|11680044|FG000|NOT COMPLETED|Overall Study||21
10527803|NCT01391832|11680045|FG001|NOT COMPLETED|Overall Study||23
10527804|NCT01391858|11680053|FG000|STARTED|Overall Study||25
10527805|NCT01391858|11680054|FG001|STARTED|Overall Study||24
10527806|NCT01391858|11680053|FG000|COMPLETED|Overall Study||23
10527807|NCT01391858|11680054|FG001|COMPLETED|Overall Study||24
10527808|NCT01391858|11680053|FG000|NOT COMPLETED|Overall Study||2
10527809|NCT01391858|11680054|FG001|NOT COMPLETED|Overall Study||0
10527810|NCT01392053|11680062|FG000|STARTED|Overall Study||23
10527811|NCT01392053|11680063|FG001|STARTED|Overall Study||23
10527812|NCT01392053|11680062|FG000|COMPLETED|Overall Study||23
10527813|NCT01392053|11680063|FG001|COMPLETED|Overall Study||23
10527814|NCT01392053|11680062|FG000|NOT COMPLETED|Overall Study||0
10527815|NCT01392053|11680063|FG001|NOT COMPLETED|Overall Study||0
10527816|NCT01392183|11680071|FG000|STARTED|First Drug Administration||35
10527817|NCT01392183|11680072|FG001|STARTED|First Drug Administration||34
10527818|NCT01392183|11680071|FG000|Eligible to Cross Over to 2nd Drug|First Drug Administration||29
10527819|NCT01392183|11680072|FG001|Eligible to Cross Over to 2nd Drug|First Drug Administration||31
10527820|NCT01392183|11680071|FG000|COMPLETED|First Drug Administration||21
10527821|NCT01392183|11680072|FG001|COMPLETED|First Drug Administration||15
10527822|NCT01392183|11680071|FG000|NOT COMPLETED|First Drug Administration||14
10527823|NCT01392183|11680072|FG001|NOT COMPLETED|First Drug Administration||19
10527824|NCT01392183|11680071|FG000|STARTED|Second Drug Administration||21
10527825|NCT01392183|11680072|FG001|STARTED|Second Drug Administration||15
10527826|NCT01392183|11680071|FG000|Treatment Ended: Progression|Second Drug Administration||18
10527827|NCT01392183|11680072|FG001|Treatment Ended: Progression|Second Drug Administration||11
10492171|NCT01195779|11641873|FG000|STARTED|Overall Study||0
10492172|NCT01195779|11641874|FG001|STARTED|Overall Study||0
10492173|NCT01195779|11641875|FG002|STARTED|Overall Study||0
10492174|NCT01195779|11641876|FG003|STARTED|Overall Study||0
10492175|NCT01195779|11641877|FG004|STARTED|Overall Study||1
10492176|NCT01195779|11641878|FG005|STARTED|Overall Study||0
10492177|NCT01195779|11641879|FG006|STARTED|Overall Study||0
10492178|NCT01195779|11641880|FG007|STARTED|Overall Study||1
10492179|NCT01195779|11641881|FG008|STARTED|Overall Study||0
10492180|NCT01195779|11641882|FG009|STARTED|Overall Study||0
10492181|NCT01195779|11641883|FG010|STARTED|Overall Study||0
10492182|NCT01195779|11641884|FG011|STARTED|Overall Study||1
10492183|NCT01195779|11641885|FG012|STARTED|Overall Study||0
10492184|NCT01195779|11641886|FG013|STARTED|Overall Study||1
10492185|NCT01195779|11641873|FG000|COMPLETED|Overall Study||0
10492186|NCT01195779|11641874|FG001|COMPLETED|Overall Study||0
10492187|NCT01195779|11641875|FG002|COMPLETED|Overall Study||0
10492188|NCT01195779|11641876|FG003|COMPLETED|Overall Study||0
10492189|NCT01195779|11641877|FG004|COMPLETED|Overall Study||1
10492190|NCT01195779|11641878|FG005|COMPLETED|Overall Study||0
10492191|NCT01195779|11641879|FG006|COMPLETED|Overall Study||0
10492192|NCT01195779|11641880|FG007|COMPLETED|Overall Study||1
10492193|NCT01195779|11641881|FG008|COMPLETED|Overall Study||0
10492194|NCT01195779|11641882|FG009|COMPLETED|Overall Study||0
10492195|NCT01195779|11641883|FG010|COMPLETED|Overall Study||0
10492196|NCT01195779|11641884|FG011|COMPLETED|Overall Study||1
10492197|NCT01195779|11641885|FG012|COMPLETED|Overall Study||0
10492198|NCT01195779|11641886|FG013|COMPLETED|Overall Study||1
10492199|NCT01195779|11641873|FG000|NOT COMPLETED|Overall Study||0
10492200|NCT01195779|11641874|FG001|NOT COMPLETED|Overall Study||0
10492201|NCT01195779|11641875|FG002|NOT COMPLETED|Overall Study||0
10492202|NCT01195779|11641876|FG003|NOT COMPLETED|Overall Study||0
10492203|NCT01195779|11641877|FG004|NOT COMPLETED|Overall Study||0
10492204|NCT01195779|11641878|FG005|NOT COMPLETED|Overall Study||0
10492205|NCT01195779|11641879|FG006|NOT COMPLETED|Overall Study||0
10492206|NCT01195779|11641880|FG007|NOT COMPLETED|Overall Study||0
10492207|NCT01195779|11641881|FG008|NOT COMPLETED|Overall Study||0
10492208|NCT01195779|11641882|FG009|NOT COMPLETED|Overall Study||0
10492209|NCT01195779|11641883|FG010|NOT COMPLETED|Overall Study||0
10492210|NCT01195779|11641884|FG011|NOT COMPLETED|Overall Study||0
10492211|NCT01195779|11641885|FG012|NOT COMPLETED|Overall Study||0
10492212|NCT01195779|11641886|FG013|NOT COMPLETED|Overall Study||0
10492213|NCT01195831|11641918|FG000|STARTED|Overall Study||120
10492214|NCT01195831|11641919|FG001|STARTED|Overall Study||124
10492215|NCT01195831|11641918|FG000|COMPLETED|Overall Study||112
10492216|NCT01195831|11641919|FG001|COMPLETED|Overall Study||114
10492217|NCT01195831|11641918|FG000|NOT COMPLETED|Overall Study||8
10492218|NCT01195831|11641919|FG001|NOT COMPLETED|Overall Study||10
10492219|NCT01195844|11641925|FG000|STARTED|Overall Study||230
10492220|NCT01195844|11641925|FG000|COMPLETED|Overall Study||190
10492221|NCT01195844|11641925|FG000|NOT COMPLETED|Overall Study||40
10492222|NCT01195883|11641941|FG000|STARTED|Overall Study||553
10492223|NCT01195883|11641942|FG001|STARTED|Overall Study||549
10492224|NCT01195883|11641941|FG000|COMPLETED|Overall Study||534
10492225|NCT01195883|11641942|FG001|COMPLETED|Overall Study||523
10492226|NCT01195883|11641941|FG000|NOT COMPLETED|Overall Study||19
10492227|NCT01195883|11641942|FG001|NOT COMPLETED|Overall Study||26
10492228|NCT01195922|11641948|FG000|STARTED|Overall Study||16
10492229|NCT01195922|11641948|FG000|COMPLETED|Overall Study||16
10492230|NCT01195922|11641948|FG000|NOT COMPLETED|Overall Study||0
10492231|NCT01195948|11641955|FG000|STARTED|Overall Study||10
10492232|NCT01195948|11641956|FG001|STARTED|Overall Study||10
10492233|NCT01195948|11641957|FG002|STARTED|Overall Study||11
10492234|NCT01195948|11641955|FG000|Week 24|Overall Study||10
10492235|NCT01195948|11641956|FG001|Week 24|Overall Study||10
10492236|NCT01195948|11641957|FG002|Week 24|Overall Study||10
10492237|NCT01195948|11641955|FG000|COMPLETED|Overall Study||10
10492238|NCT01195948|11641956|FG001|COMPLETED|Overall Study||9
10492239|NCT01195948|11641957|FG002|COMPLETED|Overall Study||9
10492240|NCT01195948|11641955|FG000|NOT COMPLETED|Overall Study||0
10492241|NCT01195948|11641956|FG001|NOT COMPLETED|Overall Study||1
10492242|NCT01195948|11641957|FG002|NOT COMPLETED|Overall Study||2
10492243|NCT01196026|11641974|FG000|STARTED|Overall Study||10
10492244|NCT01196026|11641975|FG001|STARTED|Overall Study||44
10492245|NCT01196026|11641976|FG002|STARTED|Overall Study||23
10492246|NCT01196026|11641977|FG003|STARTED|Overall Study||10
10492247|NCT01196026|11641978|FG004|STARTED|Overall Study||43
10492248|NCT01196026|11641979|FG005|STARTED|Overall Study||24
10492249|NCT01196026|11641974|FG000|Completed at Day 28|Overall Study||9
10492250|NCT01196026|11641975|FG001|Completed at Day 28|Overall Study||41
10492251|NCT01196026|11641976|FG002|Completed at Day 28|Overall Study||23
10492252|NCT01196026|11641977|FG003|Completed at Day 28|Overall Study||10
10492253|NCT01196026|11641978|FG004|Completed at Day 28|Overall Study||42
10492254|NCT01196026|11641979|FG005|Completed at Day 28|Overall Study||24
10492255|NCT01196026|11641974|FG000|COMPLETED|Overall Study||9
10492256|NCT01196026|11641975|FG001|COMPLETED|Overall Study||36
10492257|NCT01196026|11641976|FG002|COMPLETED|Overall Study||23
10492258|NCT01196026|11641977|FG003|COMPLETED|Overall Study||10
10492259|NCT01196026|11641978|FG004|COMPLETED|Overall Study||42
10492260|NCT01196026|11641979|FG005|COMPLETED|Overall Study||24
10492261|NCT01196026|11641974|FG000|NOT COMPLETED|Overall Study||1
10492262|NCT01196026|11641975|FG001|NOT COMPLETED|Overall Study||8
10492263|NCT01196026|11641976|FG002|NOT COMPLETED|Overall Study||0
10492264|NCT01196026|11641977|FG003|NOT COMPLETED|Overall Study||0
10492265|NCT01196026|11641978|FG004|NOT COMPLETED|Overall Study||1
10492266|NCT01196026|11641979|FG005|NOT COMPLETED|Overall Study||0
10492267|NCT01196052|11641995|FG000|STARTED|Overall Study||153
10492268|NCT01196052|11641995|FG000|Received Trastuzumab Emtansine|Overall Study||148
10492269|NCT01196052|11641995|FG000|COMPLETED|Overall Study||130
10492270|NCT01196052|11641995|FG000|NOT COMPLETED|Overall Study||23
10492271|NCT01196078|11642001|FG000|STARTED|Overall Study||57
10492272|NCT01196078|11642002|FG001|STARTED|Overall Study||57
10492273|NCT01196078|11642001|FG000|COMPLETED|Overall Study||24
10492274|NCT01196078|11642002|FG001|COMPLETED|Overall Study||20
10492275|NCT01196078|11642001|FG000|NOT COMPLETED|Overall Study||33
10492276|NCT01196078|11642002|FG001|NOT COMPLETED|Overall Study||37
10492277|NCT01196091|11642011|FG000|STARTED|Overall Study||387
10492278|NCT01196091|11642012|FG001|STARTED|Overall Study||389
10492279|NCT01196091|11642013|FG002|STARTED|Overall Study||388
10492280|NCT01196091|11642011|FG000|Received at Least 1 Dose of Study Drug|Overall Study||386
10492281|NCT01196091|11642012|FG001|Received at Least 1 Dose of Study Drug|Overall Study||389
10492282|NCT01196091|11642013|FG002|Received at Least 1 Dose of Study Drug|Overall Study||387
10492283|NCT01196091|11642011|FG000|ITT-Received Drug and Excluded Sites|Overall Study||381
10492284|NCT01196091|11642012|FG001|ITT-Received Drug and Excluded Sites|Overall Study||378
10492285|NCT01196091|11642013|FG002|ITT-Received Drug and Excluded Sites|Overall Study||379
10492286|NCT01196091|11642011|FG000|Follow-Up|Overall Study||103
10492287|NCT01196091|11642012|FG001|Follow-Up|Overall Study||105
10492288|NCT01196091|11642013|FG002|Follow-Up|Overall Study||128
10492289|NCT01196091|11642011|FG000|COMPLETED|Overall Study||299
10492290|NCT01196091|11642012|FG001|COMPLETED|Overall Study||291
10492291|NCT01196091|11642013|FG002|COMPLETED|Overall Study||284
10492292|NCT01196091|11642011|FG000|NOT COMPLETED|Overall Study||88
10492293|NCT01196091|11642012|FG001|NOT COMPLETED|Overall Study||98
10492294|NCT01196091|11642013|FG002|NOT COMPLETED|Overall Study||104
10492295|NCT01196104|11642028|FG000|STARTED|Overall Study||19
10492296|NCT01196104|11642029|FG001|STARTED|Overall Study||20
10492297|NCT01196104|11642028|FG000|COMPLETED|Overall Study||15
10492298|NCT01196104|11642029|FG001|COMPLETED|Overall Study||15
10492299|NCT01196104|11642028|FG000|NOT COMPLETED|Overall Study||4
10492300|NCT01196104|11642029|FG001|NOT COMPLETED|Overall Study||5
10492301|NCT01196117|11642037|FG000|STARTED|Placebo, Then CPAP||18
10492302|NCT01196117|11642038|FG001|STARTED|Placebo, Then CPAP||0
10492303|NCT01196117|11642037|FG000|COMPLETED|Placebo, Then CPAP||18
10492304|NCT01196117|11642038|FG001|COMPLETED|Placebo, Then CPAP||0
10492305|NCT01196117|11642037|FG000|NOT COMPLETED|Placebo, Then CPAP||0
10492306|NCT01196117|11642038|FG001|NOT COMPLETED|Placebo, Then CPAP||0
10492307|NCT01196117|11642037|FG000|STARTED|CPAP||0
10492308|NCT01196117|11642038|FG001|STARTED|CPAP||18
10492309|NCT01196117|11642037|FG000|COMPLETED|CPAP||0
10492310|NCT01196117|11642038|FG001|COMPLETED|CPAP||18
10492311|NCT01196117|11642037|FG000|NOT COMPLETED|CPAP||0
10492312|NCT01196117|11642038|FG001|NOT COMPLETED|CPAP||0
10492313|NCT01196377|11642052|FG000|STARTED|Overall Study||4
10492314|NCT01196377|11642053|FG001|STARTED|Overall Study||4
10492315|NCT01196377|11642054|FG002|STARTED|Overall Study||4
10492316|NCT01196377|11642055|FG003|STARTED|Overall Study||4
10492317|NCT01196377|11642052|FG000|COMPLETED|Overall Study||4
10492318|NCT01196377|11642053|FG001|COMPLETED|Overall Study||4
10492319|NCT01196377|11642054|FG002|COMPLETED|Overall Study||4
10492320|NCT01196377|11642055|FG003|COMPLETED|Overall Study||4
10492321|NCT01196377|11642052|FG000|NOT COMPLETED|Overall Study||0
10492322|NCT01196377|11642053|FG001|NOT COMPLETED|Overall Study||0
10492323|NCT01196377|11642054|FG002|NOT COMPLETED|Overall Study||0
10492324|NCT01196377|11642055|FG003|NOT COMPLETED|Overall Study||0
10492325|NCT01196416|11642065|FG000|STARTED|Overall Study||14
10492326|NCT01196416|11642065|FG000|COMPLETED|Overall Study||12
10492327|NCT01196416|11642065|FG000|NOT COMPLETED|Overall Study||2
10492328|NCT01196429|11642071|FG000|STARTED|Overall Study||45
10492329|NCT01196429|11642072|FG001|STARTED|Overall Study||45
10492330|NCT01196429|11642071|FG000|COMPLETED|Overall Study||42
10492331|NCT01196429|11642072|FG001|COMPLETED|Overall Study||45
10492332|NCT01196429|11642071|FG000|NOT COMPLETED|Overall Study||3
10492333|NCT01196429|11642072|FG001|NOT COMPLETED|Overall Study||0
10492334|NCT01196442|11642080|FG000|STARTED|Overall Study||39
10492335|NCT01196442|11642080|FG000|COMPLETED|Overall Study||39
10492336|NCT01196442|11642080|FG000|NOT COMPLETED|Overall Study||0
10492337|NCT01196533|11642085|FG000|STARTED|Overall Study||94
10492338|NCT01196533|11642085|FG000|COMPLETED|Overall Study||94
10492339|NCT01196533|11642085|FG000|NOT COMPLETED|Overall Study||0
10492340|NCT01196741|11642091|FG000|STARTED|Overall Study||71
10492341|NCT01196741|11642092|FG001|STARTED|Overall Study||36
10492342|NCT01196741|11642091|FG000|COMPLETED|Overall Study||11
10492343|NCT01196741|11642092|FG001|COMPLETED|Overall Study||8
10492344|NCT01196741|11642091|FG000|NOT COMPLETED|Overall Study||60
10492345|NCT01196741|11642092|FG001|NOT COMPLETED|Overall Study||28
10492346|NCT01196793|11642098|FG000|STARTED|Overall Study||108
10492347|NCT01196793|11642098|FG000|COMPLETED|Overall Study||108
10492348|NCT01196793|11642098|FG000|NOT COMPLETED|Overall Study||0
10492349|NCT01196819|11642104|FG000|STARTED|Overall Study||231
10492350|NCT01196819|11642105|FG001|STARTED|Overall Study||227
10492351|NCT01196819|11642104|FG000|COMPLETED|Overall Study||225
10492352|NCT01196819|11642105|FG001|COMPLETED|Overall Study||227
10492353|NCT01196819|11642104|FG000|NOT COMPLETED|Overall Study||6
10492354|NCT01196819|11642105|FG001|NOT COMPLETED|Overall Study||0
10492355|NCT01196871|11642117|FG000|STARTED|Stage 1: Period 1||5
10492356|NCT01196871|11642118|FG001|STARTED|Stage 1: Period 1||3
10492357|NCT01196871|11642119|FG002|STARTED|Stage 1: Period 1||4
10492358|NCT01196871|11642120|FG003|STARTED|Stage 1: Period 1|Zero participants noted since these participants started in Stage 2|0
10492359|NCT01196871|11642121|FG004|STARTED|Stage 1: Period 1|Zero participants noted since these participants started in Stage 2|0
10492360|NCT01196871|11642122|FG005|STARTED|Stage 1: Period 1|Zero participants noted since these participants started in Stage 2|0
10492361|NCT01196871|11642117|FG000|PK Population|Stage 1: Period 1||5
10492362|NCT01196871|11642118|FG001|PK Population|Stage 1: Period 1||3
10492363|NCT01196871|11642119|FG002|PK Population|Stage 1: Period 1||4
10492364|NCT01196871|11642120|FG003|PK Population|Stage 1: Period 1||0
10492365|NCT01196871|11642121|FG004|PK Population|Stage 1: Period 1||0
10492366|NCT01196871|11642122|FG005|PK Population|Stage 1: Period 1||0
10492367|NCT01196871|11642117|FG000|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||5
10492368|NCT01196871|11642118|FG001|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||3
10492369|NCT01196871|11642119|FG002|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||4
10492370|NCT01196871|11642120|FG003|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0
10492371|NCT01196871|11642121|FG004|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0
10492372|NCT01196871|11642122|FG005|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0
10492373|NCT01196871|11642117|FG000|COMPLETED|Stage 1: Period 1||5
10492374|NCT01196871|11642118|FG001|COMPLETED|Stage 1: Period 1||3
10492375|NCT01196871|11642119|FG002|COMPLETED|Stage 1: Period 1||4
10492376|NCT01196871|11642120|FG003|COMPLETED|Stage 1: Period 1||0
10492377|NCT01196871|11642121|FG004|COMPLETED|Stage 1: Period 1||0
10492378|NCT01196871|11642122|FG005|COMPLETED|Stage 1: Period 1||0
10492379|NCT01196871|11642117|FG000|NOT COMPLETED|Stage 1: Period 1||0
10492380|NCT01196871|11642118|FG001|NOT COMPLETED|Stage 1: Period 1||0
10492381|NCT01196871|11642119|FG002|NOT COMPLETED|Stage 1: Period 1||0
10492382|NCT01196871|11642120|FG003|NOT COMPLETED|Stage 1: Period 1||0
10492383|NCT01196871|11642121|FG004|NOT COMPLETED|Stage 1: Period 1||0
10492384|NCT01196871|11642122|FG005|NOT COMPLETED|Stage 1: Period 1||0
10492385|NCT01196871|11642117|FG000|STARTED|Stage 1: Period 2||5
10492386|NCT01196871|11642118|FG001|STARTED|Stage 1: Period 2||3
10492387|NCT01196871|11642119|FG002|STARTED|Stage 1: Period 2||4
10492388|NCT01196871|11642120|FG003|STARTED|Stage 1: Period 2|Zero participants noted since these participants started in Stage 2|0
10492389|NCT01196871|11642121|FG004|STARTED|Stage 1: Period 2|Zero participants noted since these participants started in Stage 2|0
10492390|NCT01196871|11642122|FG005|STARTED|Stage 1: Period 2|Zero participants noted since these participants started in Stage 2|0
10492391|NCT01196871|11642117|FG000|PK Population|Stage 1: Period 2||5
10492392|NCT01196871|11642118|FG001|PK Population|Stage 1: Period 2||3
10492393|NCT01196871|11642119|FG002|PK Population|Stage 1: Period 2||4
10492394|NCT01196871|11642120|FG003|PK Population|Stage 1: Period 2||0
10492395|NCT01196871|11642121|FG004|PK Population|Stage 1: Period 2||0
10492396|NCT01196871|11642122|FG005|PK Population|Stage 1: Period 2||0
10492397|NCT01196871|11642117|FG000|COMPLETED|Stage 1: Period 2||5
10492398|NCT01196871|11642118|FG001|COMPLETED|Stage 1: Period 2||3
10492399|NCT01196871|11642119|FG002|COMPLETED|Stage 1: Period 2||4
10492400|NCT01196871|11642120|FG003|COMPLETED|Stage 1: Period 2||0
10492401|NCT01196871|11642121|FG004|COMPLETED|Stage 1: Period 2||0
10492402|NCT01196871|11642122|FG005|COMPLETED|Stage 1: Period 2||0
10492403|NCT01196871|11642117|FG000|NOT COMPLETED|Stage 1: Period 2||0
10492404|NCT01196871|11642118|FG001|NOT COMPLETED|Stage 1: Period 2||0
10492405|NCT01196871|11642119|FG002|NOT COMPLETED|Stage 1: Period 2||0
10492406|NCT01196871|11642120|FG003|NOT COMPLETED|Stage 1: Period 2||0
10492407|NCT01196871|11642121|FG004|NOT COMPLETED|Stage 1: Period 2||0
10492408|NCT01196871|11642122|FG005|NOT COMPLETED|Stage 1: Period 2||0
10492409|NCT01196871|11642117|FG000|STARTED|Stage 1: Period 3||5
10492410|NCT01196871|11642118|FG001|STARTED|Stage 1: Period 3||3
10492411|NCT01196871|11642119|FG002|STARTED|Stage 1: Period 3||4
10492412|NCT01196871|11642120|FG003|STARTED|Stage 1: Period 3|Zero participants noted since these participants started in Stage 2|0
10492413|NCT01196871|11642121|FG004|STARTED|Stage 1: Period 3|Zero participants noted since these participants started in Stage 2|0
10492414|NCT01196871|11642122|FG005|STARTED|Stage 1: Period 3|Zero participants noted since these participants started in Stage 2|0
10492415|NCT01196871|11642117|FG000|COMPLETED|Stage 1: Period 3||5
10492416|NCT01196871|11642118|FG001|COMPLETED|Stage 1: Period 3||3
10492417|NCT01196871|11642119|FG002|COMPLETED|Stage 1: Period 3||4
10492418|NCT01196871|11642120|FG003|COMPLETED|Stage 1: Period 3||0
10492419|NCT01196871|11642121|FG004|COMPLETED|Stage 1: Period 3||0
10492420|NCT01196871|11642122|FG005|COMPLETED|Stage 1: Period 3||0
10492421|NCT01196871|11642117|FG000|NOT COMPLETED|Stage 1: Period 3||0
10492422|NCT01196871|11642118|FG001|NOT COMPLETED|Stage 1: Period 3||0
10492423|NCT01196871|11642119|FG002|NOT COMPLETED|Stage 1: Period 3||0
10492424|NCT01196871|11642120|FG003|NOT COMPLETED|Stage 1: Period 3||0
10492425|NCT01196871|11642121|FG004|NOT COMPLETED|Stage 1: Period 3||0
10492426|NCT01196871|11642122|FG005|NOT COMPLETED|Stage 1: Period 3||0
10492427|NCT01196871|11642117|FG000|STARTED|Stage 2: Period 1|Zero participants noted because participants had completed Stage 1|0
10492428|NCT01196871|11642118|FG001|STARTED|Stage 2: Period 1|Zero participants noted because participants had completed Stage 1|0
10492429|NCT01196871|11642119|FG002|STARTED|Stage 2: Period 1|Zero participants noted because participants had completed Stage 1|0
10492430|NCT01196871|11642120|FG003|STARTED|Stage 2: Period 1|Both participants re-enrolled into Stage 2 after completing Stage 1|2
10492431|NCT01196871|11642121|FG004|STARTED|Stage 2: Period 1|One participant re-enrolled into Stage 2 after completing Stage 1|5
10492432|NCT01196871|11642122|FG005|STARTED|Stage 2: Period 1||4
10492433|NCT01196871|11642117|FG000|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0
10492434|NCT01196871|11642118|FG001|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0
10492435|NCT01196871|11642119|FG002|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0
10492436|NCT01196871|11642120|FG003|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||2
10492437|NCT01196871|11642121|FG004|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||5
10492438|NCT01196871|11642122|FG005|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||4
10492439|NCT01196871|11642117|FG000|PK Population|Stage 2: Period 1||0
10492440|NCT01196871|11642118|FG001|PK Population|Stage 2: Period 1||0
10492441|NCT01196871|11642119|FG002|PK Population|Stage 2: Period 1||0
10492442|NCT01196871|11642120|FG003|PK Population|Stage 2: Period 1||1
10492443|NCT01196871|11642121|FG004|PK Population|Stage 2: Period 1||5
10492444|NCT01196871|11642122|FG005|PK Population|Stage 2: Period 1||4
10492445|NCT01196871|11642117|FG000|COMPLETED|Stage 2: Period 1||0
10492446|NCT01196871|11642118|FG001|COMPLETED|Stage 2: Period 1||0
10492447|NCT01196871|11642119|FG002|COMPLETED|Stage 2: Period 1||0
10492448|NCT01196871|11642120|FG003|COMPLETED|Stage 2: Period 1||2
10492449|NCT01196871|11642121|FG004|COMPLETED|Stage 2: Period 1||5
10492450|NCT01196871|11642122|FG005|COMPLETED|Stage 2: Period 1||4
10492451|NCT01196871|11642117|FG000|NOT COMPLETED|Stage 2: Period 1||0
10492452|NCT01196871|11642118|FG001|NOT COMPLETED|Stage 2: Period 1||0
10492453|NCT01196871|11642119|FG002|NOT COMPLETED|Stage 2: Period 1||0
10492454|NCT01196871|11642120|FG003|NOT COMPLETED|Stage 2: Period 1||0
10492455|NCT01196871|11642121|FG004|NOT COMPLETED|Stage 2: Period 1||0
10492456|NCT01196871|11642122|FG005|NOT COMPLETED|Stage 2: Period 1||0
10492457|NCT01196871|11642117|FG000|STARTED|Stage 2: Period 2|Zero participants noted because participants had completed Stage 1|0
10492458|NCT01196871|11642118|FG001|STARTED|Stage 2: Period 2|Zero participants noted because participants had completed Stage 1|0
10492459|NCT01196871|11642119|FG002|STARTED|Stage 2: Period 2|Zero participants noted because participants had completed Stage 1|0
10492460|NCT01196871|11642120|FG003|STARTED|Stage 2: Period 2|One participant switched agalsidase dose from 0.5 mg/kg in Period 1 to 1.0 mg/kg in Period 2|1
10492461|NCT01196871|11642121|FG004|STARTED|Stage 2: Period 2|One participant switched agalsidase dose from 0.5 mg/kg in Period 1 to 1.0 mg/kg in Period 2|6
10492462|NCT01196871|11642122|FG005|STARTED|Stage 2: Period 2||4
10492463|NCT01196871|11642117|FG000|PK Population|Stage 2: Period 2||0
10492464|NCT01196871|11642118|FG001|PK Population|Stage 2: Period 2||0
10492465|NCT01196871|11642119|FG002|PK Population|Stage 2: Period 2||0
10492466|NCT01196871|11642120|FG003|PK Population|Stage 2: Period 2||1
10492467|NCT01196871|11642121|FG004|PK Population|Stage 2: Period 2||6
10492468|NCT01196871|11642122|FG005|PK Population|Stage 2: Period 2||4
10492469|NCT01196871|11642117|FG000|COMPLETED|Stage 2: Period 2||0
10492470|NCT01196871|11642118|FG001|COMPLETED|Stage 2: Period 2||0
10492471|NCT01196871|11642119|FG002|COMPLETED|Stage 2: Period 2||0
10492472|NCT01196871|11642120|FG003|COMPLETED|Stage 2: Period 2||1
10492473|NCT01196871|11642121|FG004|COMPLETED|Stage 2: Period 2||6
10492474|NCT01196871|11642122|FG005|COMPLETED|Stage 2: Period 2||4
10492475|NCT01196871|11642117|FG000|NOT COMPLETED|Stage 2: Period 2||0
10492476|NCT01196871|11642118|FG001|NOT COMPLETED|Stage 2: Period 2||0
10492477|NCT01196871|11642119|FG002|NOT COMPLETED|Stage 2: Period 2||0
10492478|NCT01196871|11642120|FG003|NOT COMPLETED|Stage 2: Period 2||0
10492479|NCT01196871|11642121|FG004|NOT COMPLETED|Stage 2: Period 2||0
10492480|NCT01196871|11642122|FG005|NOT COMPLETED|Stage 2: Period 2||0
10492481|NCT01196923|11642145|FG000|STARTED|Overall Study||20
10492482|NCT01196923|11642145|FG000|COMPLETED|Overall Study||20
10492483|NCT01196923|11642145|FG000|NOT COMPLETED|Overall Study||0
10492484|NCT01196975|11642154|FG000|STARTED|Overall Study||423
10492485|NCT01196975|11642155|FG001|STARTED|Overall Study||424
10492486|NCT01196975|11642156|FG002|STARTED|Overall Study||425
10492487|NCT01196975|11642157|FG003|STARTED|Overall Study||213
10492488|NCT01196975|11642158|FG004|STARTED|Overall Study||218
10492489|NCT01196975|11642154|FG000|COMPLETED|Overall Study||408
10492490|NCT01196975|11642155|FG001|COMPLETED|Overall Study||415
10492491|NCT01196975|11642156|FG002|COMPLETED|Overall Study||420
10492492|NCT01196975|11642157|FG003|COMPLETED|Overall Study||207
10492493|NCT01196975|11642158|FG004|COMPLETED|Overall Study||205
10492494|NCT01196975|11642154|FG000|NOT COMPLETED|Overall Study||15
10492495|NCT01196975|11642155|FG001|NOT COMPLETED|Overall Study||9
10492496|NCT01196975|11642156|FG002|NOT COMPLETED|Overall Study||5
10492497|NCT01196975|11642157|FG003|NOT COMPLETED|Overall Study||6
10492498|NCT01196975|11642158|FG004|NOT COMPLETED|Overall Study||13
10492499|NCT01196988|11642197|FG000|STARTED|Overall Study||915
10492500|NCT01196988|11642198|FG001|STARTED|Overall Study||912
10492501|NCT01196988|11642199|FG002|STARTED|Overall Study||911
10492502|NCT01196988|11642200|FG003|STARTED|Overall Study||277
10492503|NCT01196988|11642197|FG000|COMPLETED|Overall Study||891
10492504|NCT01196988|11642198|FG001|COMPLETED|Overall Study||880
10492505|NCT01196988|11642199|FG002|COMPLETED|Overall Study||886
10492506|NCT01196988|11642200|FG003|COMPLETED|Overall Study||276
10492507|NCT01196988|11642197|FG000|NOT COMPLETED|Overall Study||24
10492508|NCT01196988|11642198|FG001|NOT COMPLETED|Overall Study||32
10492509|NCT01196988|11642199|FG002|NOT COMPLETED|Overall Study||25
10492510|NCT01196988|11642200|FG003|NOT COMPLETED|Overall Study||1
10492511|NCT01197300|11642213|FG000|STARTED|Overall Study||10
10492512|NCT01197300|11642214|FG001|STARTED|Overall Study||15
10492513|NCT01197300|11642213|FG000|COMPLETED|Overall Study||10
10492514|NCT01197300|11642214|FG001|COMPLETED|Overall Study||13
10492515|NCT01197300|11642213|FG000|NOT COMPLETED|Overall Study||0
10492516|NCT01197300|11642214|FG001|NOT COMPLETED|Overall Study||2
10492517|NCT01197326|11642222|FG000|STARTED|Overall Study||205
10492518|NCT01197326|11642223|FG001|STARTED|Overall Study||209
10492519|NCT01197326|11642222|FG000|COMPLETED|Overall Study||205
10809955|NCT03816761|11971819|FG002|COMPLETED|First Treatment Period (7 Days)||4
10809956|NCT03816761|11971820|FG003|COMPLETED|First Treatment Period (7 Days)||4
10809957|NCT03816761|11971821|FG004|COMPLETED|First Treatment Period (7 Days)||4
10809958|NCT03816761|11971822|FG005|COMPLETED|First Treatment Period (7 Days)||3
10809959|NCT03816761|11971817|FG000|NOT COMPLETED|First Treatment Period (7 Days)||0
10809960|NCT03816761|11971818|FG001|NOT COMPLETED|First Treatment Period (7 Days)||0
10809961|NCT03816761|11971819|FG002|NOT COMPLETED|First Treatment Period (7 Days)||0
10809962|NCT03816761|11971820|FG003|NOT COMPLETED|First Treatment Period (7 Days)||0
10809963|NCT03816761|11971821|FG004|NOT COMPLETED|First Treatment Period (7 Days)||0
10809964|NCT03816761|11971822|FG005|NOT COMPLETED|First Treatment Period (7 Days)||1
10809965|NCT03816761|11971817|FG000|STARTED|Second Treatment Period (7 Days)||4
10809966|NCT03816761|11971818|FG001|STARTED|Second Treatment Period (7 Days)||4
10809967|NCT03816761|11971819|FG002|STARTED|Second Treatment Period (7 Days)||4
10809968|NCT03816761|11971820|FG003|STARTED|Second Treatment Period (7 Days)||4
10809969|NCT03816761|11971821|FG004|STARTED|Second Treatment Period (7 Days)||4
10809970|NCT03816761|11971822|FG005|STARTED|Second Treatment Period (7 Days)||3
10809971|NCT03816761|11971817|FG000|COMPLETED|Second Treatment Period (7 Days)||4
10492520|NCT01197326|11642223|FG001|COMPLETED|Overall Study||209
10492521|NCT01197326|11642222|FG000|NOT COMPLETED|Overall Study||0
10492522|NCT01197326|11642223|FG001|NOT COMPLETED|Overall Study||0
10492523|NCT01197378|11642231|FG000|STARTED|Overall Study||60
10492524|NCT01197378|11642231|FG000|Received Treatment|Overall Study||59
10492525|NCT01197378|11642231|FG000|COMPLETED|Overall Study||53
10492526|NCT01197378|11642231|FG000|NOT COMPLETED|Overall Study||7
10492527|NCT01197417|11642237|FG000|STARTED|Overall Study||104
10492528|NCT01197417|11642238|FG001|STARTED|Overall Study||104
10492529|NCT01197417|11642237|FG000|Received Study Drug|Overall Study||101
10492530|NCT01197417|11642238|FG001|Received Study Drug|Overall Study||103
10492531|NCT01197417|11642237|FG000|COMPLETED|Overall Study||96
10492532|NCT01197417|11642238|FG001|COMPLETED|Overall Study||86
10492533|NCT01197417|11642237|FG000|NOT COMPLETED|Overall Study||8
10492534|NCT01197417|11642238|FG001|NOT COMPLETED|Overall Study||18
10492535|NCT01197456|11642246|FG000|STARTED|Overall Study||171
10492536|NCT01197456|11642247|FG001|STARTED|Overall Study||61
10492537|NCT01197456|11642246|FG000|COMPLETED|Overall Study||171
10492538|NCT01197456|11642247|FG001|COMPLETED|Overall Study||61
10492539|NCT01197456|11642246|FG000|NOT COMPLETED|Overall Study||0
10492540|NCT01197456|11642247|FG001|NOT COMPLETED|Overall Study||0
10492541|NCT01197495|11642255|FG000|STARTED|Overall Study||157
10492542|NCT01197495|11642256|FG001|STARTED|Overall Study||56
10492543|NCT01197495|11642255|FG000|COMPLETED|Overall Study||144
10492544|NCT01197495|11642256|FG001|COMPLETED|Overall Study||49
10492545|NCT01197495|11642255|FG000|NOT COMPLETED|Overall Study||13
10492546|NCT01197495|11642256|FG001|NOT COMPLETED|Overall Study||7
10492547|NCT01197508|11642266|FG000|STARTED|Overall Study||174
10492548|NCT01197508|11642267|FG001|STARTED|Overall Study||174
10492549|NCT01197508|11642268|FG002|STARTED|Overall Study||174
10492550|NCT01197508|11642269|FG003|STARTED|Overall Study||174
10492551|NCT01197508|11642266|FG000|Received Treatment|Overall Study||174
10492552|NCT01197508|11642267|FG001|Received Treatment|Overall Study||174
10492553|NCT01197508|11642268|FG002|Received Treatment|Overall Study||171
10492554|NCT01197508|11642269|FG003|Received Treatment|Overall Study||174
10492555|NCT01197508|11642266|FG000|COMPLETED|Overall Study||151
10492556|NCT01197508|11642267|FG001|COMPLETED|Overall Study||144
10492557|NCT01197508|11642268|FG002|COMPLETED|Overall Study||125
10492558|NCT01197508|11642269|FG003|COMPLETED|Overall Study||158
10492559|NCT01197508|11642266|FG000|NOT COMPLETED|Overall Study||23
10492560|NCT01197508|11642267|FG001|NOT COMPLETED|Overall Study||30
10492561|NCT01197508|11642268|FG002|NOT COMPLETED|Overall Study||49
10492562|NCT01197508|11642269|FG003|NOT COMPLETED|Overall Study||16
10492563|NCT01197521|11642282|FG000|STARTED|Overall Study|Patients who received treatment|310
10492564|NCT01197521|11642283|FG001|STARTED|Overall Study|Patients who received treatment|304
10492565|NCT01197521|11642284|FG002|STARTED|Overall Study|Patients who received treatment|304
10492566|NCT01197521|11642282|FG000|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled|1
10492567|NCT01197521|11642283|FG001|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/other|2
10492568|NCT01197521|11642284|FG002|Randomised But Did Not Receive Treatment|Overall Study|Adverse event/eligibility criteria not fulfilled|2
10492569|NCT01197521|11642282|FG000|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|207
10492570|NCT01197521|11642283|FG001|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|191
10492571|NCT01197521|11642284|FG002|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|161
10492572|NCT01197521|11642282|FG000|NOT COMPLETED|Overall Study||103
10492573|NCT01197521|11642283|FG001|NOT COMPLETED|Overall Study||113
10492574|NCT01197521|11642284|FG002|NOT COMPLETED|Overall Study||143
10492575|NCT01197534|11642298|FG000|STARTED|Overall Study|Patients who received treatment|308
10492576|NCT01197534|11642299|FG001|STARTED|Overall Study|Patients who received treatment|298
10492577|NCT01197534|11642300|FG002|STARTED|Overall Study|Patients who received treatment|302
10492578|NCT01197534|11642298|FG000|Randomised But Did Not Receive Treatment|Overall Study||0
10492579|NCT01197534|11642299|FG001|Randomised But Did Not Receive Treatment|Overall Study|Adverse event / Other|2
10548415|NCT01519414|11702219|FG002|COMPLETED|Pre Cross-over||0
10492580|NCT01197534|11642300|FG002|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled / Severe non-compliance to protocol|3
10492581|NCT01197534|11642298|FG000|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|174
10492582|NCT01197534|11642299|FG001|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|168
10492583|NCT01197534|11642300|FG002|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|129
10492584|NCT01197534|11642298|FG000|NOT COMPLETED|Overall Study||134
10492585|NCT01197534|11642299|FG001|NOT COMPLETED|Overall Study||130
10650033|NCT02165826|11810198|FG002|STARTED|Main Treatment Period||443
10650034|NCT02165826|11810196|FG000|Safety Analysis Set: Received Study Drug|Main Treatment Period||441
10650035|NCT02165826|11810197|FG001|Safety Analysis Set: Received Study Drug|Main Treatment Period||437
10650036|NCT02165826|11810198|FG002|Safety Analysis Set: Received Study Drug|Main Treatment Period||443
10650037|NCT02165826|11810196|FG000|COMPLETED|Main Treatment Period||360
10650038|NCT02165826|11810197|FG001|COMPLETED|Main Treatment Period||349
10650039|NCT02165826|11810198|FG002|COMPLETED|Main Treatment Period||334
10650040|NCT02165826|11810196|FG000|NOT COMPLETED|Main Treatment Period||81
10650041|NCT02165826|11810197|FG001|NOT COMPLETED|Main Treatment Period||90
10492586|NCT01197534|11642300|FG002|NOT COMPLETED|Overall Study||173
10492587|NCT01197547|11642311|FG000|STARTED|Overall Study||1014
10492588|NCT01197547|11642311|FG000|COMPLETED|Overall Study|992 Intent-To-Treat (ITT) 931 evaluable subjects|992
10492589|NCT01197547|11642311|FG000|NOT COMPLETED|Overall Study||22
10492590|NCT01197560|11642317|FG000|STARTED|Overall Study|This is the intent to treat population|54
10492591|NCT01197560|11642318|FG001|STARTED|Overall Study|This is the intent to treat population|57
10492592|NCT01197560|11642317|FG000|Received ≥ One Dose Study Drug|Overall Study||54
10492593|NCT01197560|11642318|FG001|Received ≥ One Dose Study Drug|Overall Study||55
10492594|NCT01197560|11642317|FG000|Lenalidomide Crossover|Overall Study||0
10492595|NCT01197560|11642318|FG001|Lenalidomide Crossover|Overall Study||29
10492596|NCT01197560|11642317|FG000|Discontinued Treatment After ≥ 6 Cycles|Overall Study||14
10492597|NCT01197560|11642318|FG001|Discontinued Treatment After ≥ 6 Cycles|Overall Study||0
10492598|NCT01197560|11642317|FG000|COMPLETED|Overall Study||0
10492599|NCT01197560|11642318|FG001|COMPLETED|Overall Study||4
10492600|NCT01197560|11642317|FG000|NOT COMPLETED|Overall Study||54
10492601|NCT01197560|11642318|FG001|NOT COMPLETED|Overall Study||53
10492602|NCT01197573|11642329|FG000|STARTED|Overall Study||33
10492603|NCT01197573|11642330|FG001|STARTED|Overall Study||46
10492604|NCT01197573|11642331|FG002|STARTED|Overall Study||12
10492605|NCT01197573|11642332|FG003|STARTED|Overall Study||12
10492606|NCT01197573|11642329|FG000|COMPLETED|Overall Study||33
10492607|NCT01197573|11642330|FG001|COMPLETED|Overall Study||46
10492608|NCT01197573|11642331|FG002|COMPLETED|Overall Study||12
10492609|NCT01197573|11642332|FG003|COMPLETED|Overall Study||12
10492610|NCT01197573|11642329|FG000|NOT COMPLETED|Overall Study||0
10492611|NCT01197573|11642330|FG001|NOT COMPLETED|Overall Study||0
10492612|NCT01197573|11642331|FG002|NOT COMPLETED|Overall Study||0
10492613|NCT01197573|11642332|FG003|NOT COMPLETED|Overall Study||0
10492614|NCT01197612|11642342|FG000|STARTED|Overall Study||18
10492615|NCT01197612|11642342|FG000|Week 3|Overall Study||16
10492616|NCT01197612|11642342|FG000|Returned for Week 24|Overall Study||6
10492617|NCT01197612|11642342|FG000|COMPLETED|Overall Study||6
10492618|NCT01197612|11642342|FG000|NOT COMPLETED|Overall Study||12
10492619|NCT01197755|11642352|FG000|STARTED|Overall Study|Patients who received treatment|105
10492620|NCT01197755|11642353|FG001|STARTED|Overall Study|Patients who received treatment|108
10492621|NCT01197755|11642354|FG002|STARTED|Overall Study|Patients who received treatment|109
10492622|NCT01197755|11642352|FG000|Randomised But Did Not Receive Treatment|Overall Study||0
10492623|NCT01197755|11642353|FG001|Randomised But Did Not Receive Treatment|Overall Study||0
10492624|NCT01197755|11642354|FG002|Randomised But Did Not Receive Treatment|Overall Study|Severe non-compliance to the protocol|1
10492625|NCT01197755|11642352|FG000|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|67
10492626|NCT01197755|11642353|FG001|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|65
10492627|NCT01197755|11642354|FG002|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|55
10492628|NCT01197755|11642352|FG000|NOT COMPLETED|Overall Study||38
10492629|NCT01197755|11642353|FG001|NOT COMPLETED|Overall Study||43
10492630|NCT01197755|11642354|FG002|NOT COMPLETED|Overall Study||54
10492631|NCT01197794|11642371|FG000|STARTED|Overall Study||164
10492632|NCT01197794|11642372|FG001|STARTED|Overall Study|Two participants did not receive study treatment|161
10492633|NCT01197794|11642373|FG002|STARTED|Overall Study|Two participants did not receive study treatment|166
10492634|NCT01197794|11642374|FG003|STARTED|Overall Study||164
10492635|NCT01197794|11642375|FG004|STARTED|Overall Study|One participant excluded due to Good Clinical Practice (GCP) violation at centre 4323|163
10492636|NCT01197794|11642376|FG005|STARTED|Overall Study||163
10492637|NCT01197794|11642377|FG006|STARTED|Overall Study|Two participants excluded due to Good Clinical Practice (GCP) violation at centre 4323|163
10492638|NCT01197794|11642371|FG000|COMPLETED|Overall Study||148
10492639|NCT01197794|11642372|FG001|COMPLETED|Overall Study||146
10492640|NCT01197794|11642373|FG002|COMPLETED|Overall Study||153
10492641|NCT01197794|11642374|FG003|COMPLETED|Overall Study||152
10492642|NCT01197794|11642375|FG004|COMPLETED|Overall Study||149
10492643|NCT01197794|11642376|FG005|COMPLETED|Overall Study||144
10492644|NCT01197794|11642377|FG006|COMPLETED|Overall Study||142
10650042|NCT02165826|11810198|FG002|NOT COMPLETED|Main Treatment Period||109
10492645|NCT01197794|11642371|FG000|NOT COMPLETED|Overall Study||16
10492646|NCT01197794|11642372|FG001|NOT COMPLETED|Overall Study||15
10492647|NCT01197794|11642373|FG002|NOT COMPLETED|Overall Study||13
10492648|NCT01197794|11642374|FG003|NOT COMPLETED|Overall Study||12
10492649|NCT01197794|11642375|FG004|NOT COMPLETED|Overall Study||14
10492650|NCT01197794|11642376|FG005|NOT COMPLETED|Overall Study||19
10492651|NCT01197794|11642377|FG006|NOT COMPLETED|Overall Study||21
10492652|NCT01197833|11642397|FG000|STARTED|Overall Study||38
10492653|NCT01197833|11642398|FG001|STARTED|Overall Study||39
10492654|NCT01197833|11642399|FG002|STARTED|Overall Study||40
10492655|NCT01197833|11642397|FG000|COMPLETED|Overall Study||38
10492656|NCT01197833|11642398|FG001|COMPLETED|Overall Study||39
10492657|NCT01197833|11642399|FG002|COMPLETED|Overall Study||40
10492658|NCT01197833|11642397|FG000|NOT COMPLETED|Overall Study||0
10492659|NCT01197833|11642398|FG001|NOT COMPLETED|Overall Study||0
10492660|NCT01197833|11642399|FG002|NOT COMPLETED|Overall Study||0
10492661|NCT01197898|11642409|FG000|STARTED|Overall Study||5
10492662|NCT01197898|11642410|FG001|STARTED|Overall Study||5
10492663|NCT01197898|11642409|FG000|COMPLETED|Overall Study||5
10492664|NCT01197898|11642410|FG001|COMPLETED|Overall Study||5
10492665|NCT01197898|11642409|FG000|NOT COMPLETED|Overall Study||0
10492666|NCT01197898|11642410|FG001|NOT COMPLETED|Overall Study||0
10492667|NCT01197911|11642419|FG000|STARTED|Overall Study||18
10492668|NCT01197911|11642420|FG001|STARTED|Overall Study||10
10492669|NCT01197911|11642421|FG002|STARTED|Overall Study||10
10492670|NCT01197911|11642419|FG000|COMPLETED|Overall Study||18
10492671|NCT01197911|11642420|FG001|COMPLETED|Overall Study||10
10492672|NCT01197911|11642421|FG002|COMPLETED|Overall Study||9
10492673|NCT01197911|11642419|FG000|NOT COMPLETED|Overall Study||0
10492674|NCT01197911|11642420|FG001|NOT COMPLETED|Overall Study||0
10492675|NCT01197911|11642421|FG002|NOT COMPLETED|Overall Study||1
10492676|NCT01198002|11642433|FG000|STARTED|Treatment Period 1 (Weeks 0-52)||345
10492677|NCT01198002|11642434|FG001|STARTED|Treatment Period 1 (Weeks 0-52)||347
10492678|NCT01198002|11642435|FG002|STARTED|Treatment Period 1 (Weeks 0-52)||349
10492679|NCT01198002|11642433|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||345
10492680|NCT01198002|11642434|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||345
10492681|NCT01198002|11642435|FG002|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||348
10492682|NCT01198002|11642433|FG000|Week 16 NR|Treatment Period 1 (Weeks 0-52)||58
10492683|NCT01198002|11642434|FG001|Week 16 NR|Treatment Period 1 (Weeks 0-52)||62
10492684|NCT01198002|11642435|FG002|Week 16 NR|Treatment Period 1 (Weeks 0-52)||90
10492685|NCT01198002|11642433|FG000|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||293
10492686|NCT01198002|11642434|FG001|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||303
10492687|NCT01198002|11642435|FG002|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||307
10492688|NCT01198002|11642433|FG000|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|70
10492689|NCT01198002|11642434|FG001|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|73
10492690|NCT01198002|11642435|FG002|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|80
10492691|NCT01198002|11642433|FG000|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||275
10492692|NCT01198002|11642434|FG001|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||274
10492693|NCT01198002|11642435|FG002|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||269
10492694|NCT01198002|11642433|FG000|STARTED|Treatment Period 2 (Weeks 52-100)||70
10492695|NCT01198002|11642434|FG001|STARTED|Treatment Period 2 (Weeks 52-100)||73
10492696|NCT01198002|11642435|FG002|STARTED|Treatment Period 2 (Weeks 52-100)||80
10492697|NCT01198002|11642433|FG000|COMPLETED|Treatment Period 2 (Weeks 52-100)||1
10492698|NCT01198002|11642434|FG001|COMPLETED|Treatment Period 2 (Weeks 52-100)||0
10492699|NCT01198002|11642435|FG002|COMPLETED|Treatment Period 2 (Weeks 52-100)||2
10492700|NCT01198002|11642433|FG000|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||69
10492701|NCT01198002|11642434|FG001|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||73
10492702|NCT01198002|11642435|FG002|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||78
10492703|NCT01198028|11642465|FG000|STARTED|Overall Study||39
10492704|NCT01198028|11642465|FG000|COMPLETED|Overall Study||29
10492705|NCT01198028|11642465|FG000|NOT COMPLETED|Overall Study||10
10492706|NCT01198132|11642471|FG000|STARTED|Overall Study||63
10492707|NCT01198132|11642472|FG001|STARTED|Overall Study||66
10492708|NCT01198132|11642471|FG000|COMPLETED|Overall Study||45
10492709|NCT01198132|11642472|FG001|COMPLETED|Overall Study||45
10492710|NCT01198132|11642471|FG000|NOT COMPLETED|Overall Study||18
10492711|NCT01198132|11642472|FG001|NOT COMPLETED|Overall Study||21
10492712|NCT01198145|11642482|FG000|STARTED|Overall Study||44
10492713|NCT01198145|11642483|FG001|STARTED|Overall Study||43
10492714|NCT01198145|11642482|FG000|COMPLETED|Overall Study||43
10492715|NCT01198145|11642483|FG001|COMPLETED|Overall Study||42
10492716|NCT01198145|11642482|FG000|NOT COMPLETED|Overall Study||1
10492717|NCT01198145|11642483|FG001|NOT COMPLETED|Overall Study||1
10492718|NCT01198158|11642492|FG000|STARTED|Overall Study||41
10492719|NCT01198158|11642493|FG001|STARTED|Overall Study||36
10492720|NCT01198158|11642492|FG000|COMPLETED|Overall Study||41
10492721|NCT01198158|11642493|FG001|COMPLETED|Overall Study||36
10492722|NCT01198158|11642492|FG000|NOT COMPLETED|Overall Study||0
10492723|NCT01198158|11642493|FG001|NOT COMPLETED|Overall Study||0
10492724|NCT01198275|11642501|FG000|STARTED|Overall Study||100
10492725|NCT01198275|11642502|FG001|STARTED|Overall Study||99
10492726|NCT01198275|11642501|FG000|COMPLETED|Overall Study||94
10492727|NCT01198275|11642502|FG001|COMPLETED|Overall Study||94
10492728|NCT01198275|11642501|FG000|NOT COMPLETED|Overall Study||6
10492729|NCT01198275|11642502|FG001|NOT COMPLETED|Overall Study||5
10492730|NCT01198327|11642508|FG000|STARTED|Overall Study||66
10492731|NCT01198327|11642508|FG000|COMPLETED|Overall Study||56
10492732|NCT01198327|11642508|FG000|NOT COMPLETED|Overall Study||10
10492733|NCT01198366|11642521|FG000|STARTED|Overall Study||52
10492734|NCT01198366|11642522|FG001|STARTED|Overall Study||51
10492735|NCT01198366|11642523|FG002|STARTED|Overall Study||51
10492736|NCT01198366|11642524|FG003|STARTED|Overall Study||52
10492737|NCT01198366|11642525|FG004|STARTED|Overall Study||140
10492738|NCT01198366|11642526|FG005|STARTED|Overall Study||141
10492739|NCT01198366|11642521|FG000|COMPLETED|Overall Study||40
10492740|NCT01198366|11642522|FG001|COMPLETED|Overall Study||44
10492741|NCT01198366|11642523|FG002|COMPLETED|Overall Study||43
10492742|NCT01198366|11642524|FG003|COMPLETED|Overall Study||47
10492743|NCT01198366|11642525|FG004|COMPLETED|Overall Study||125
10492744|NCT01198366|11642526|FG005|COMPLETED|Overall Study||128
10492745|NCT01198366|11642521|FG000|NOT COMPLETED|Overall Study||12
10492746|NCT01198366|11642522|FG001|NOT COMPLETED|Overall Study||7
10492747|NCT01198366|11642523|FG002|NOT COMPLETED|Overall Study||8
10492748|NCT01198366|11642524|FG003|NOT COMPLETED|Overall Study||5
10492749|NCT01198366|11642525|FG004|NOT COMPLETED|Overall Study||15
10492750|NCT01198366|11642526|FG005|NOT COMPLETED|Overall Study||13
10492751|NCT01198470|11642540|FG000|STARTED|Overall Study||20
10492752|NCT01198470|11642540|FG000|COMPLETED|Overall Study||18
10492753|NCT01198470|11642540|FG000|NOT COMPLETED|Overall Study||2
10492754|NCT01198509|11642550|FG000|STARTED|Overall Study||5
10492755|NCT01198509|11642551|FG001|STARTED|Overall Study||10
10492756|NCT01198509|11642552|FG002|STARTED|Overall Study||19
10492757|NCT01198509|11642553|FG003|STARTED|Overall Study||66
10492758|NCT01198509|11642554|FG004|STARTED|Overall Study||20
10492759|NCT01198509|11642555|FG005|STARTED|Overall Study||58
10492760|NCT01198509|11642550|FG000|COMPLETED|Overall Study|Patient declined further participation after enrollment and allocation to treatment group|4
10492761|NCT01198509|11642551|FG001|COMPLETED|Overall Study||10
10492762|NCT01198509|11642552|FG002|COMPLETED|Overall Study||19
10492763|NCT01198509|11642553|FG003|COMPLETED|Overall Study||66
10492764|NCT01198509|11642554|FG004|COMPLETED|Overall Study||20
10492765|NCT01198509|11642555|FG005|COMPLETED|Overall Study||58
10492766|NCT01198509|11642550|FG000|NOT COMPLETED|Overall Study||1
10492767|NCT01198509|11642551|FG001|NOT COMPLETED|Overall Study||0
10492768|NCT01198509|11642552|FG002|NOT COMPLETED|Overall Study||0
10492769|NCT01198509|11642553|FG003|NOT COMPLETED|Overall Study||0
10492770|NCT01198509|11642554|FG004|NOT COMPLETED|Overall Study||0
10492771|NCT01198509|11642555|FG005|NOT COMPLETED|Overall Study||0
10492772|NCT01198574|11642571|FG000|STARTED|Overall Study||98
10492773|NCT01198574|11642572|FG001|STARTED|Overall Study||102
10492774|NCT01198574|11642573|FG002|STARTED|Overall Study||100
10492775|NCT01198574|11642574|FG003|STARTED|Overall Study||102
10492776|NCT01198574|11642571|FG000|COMPLETED|Overall Study||94
10492777|NCT01198574|11642572|FG001|COMPLETED|Overall Study||101
10492778|NCT01198574|11642573|FG002|COMPLETED|Overall Study||99
10492779|NCT01198574|11642574|FG003|COMPLETED|Overall Study||98
10492780|NCT01198574|11642571|FG000|NOT COMPLETED|Overall Study||4
10492781|NCT01198574|11642572|FG001|NOT COMPLETED|Overall Study||1
10492782|NCT01198574|11642573|FG002|NOT COMPLETED|Overall Study||1
10492783|NCT01198574|11642574|FG003|NOT COMPLETED|Overall Study||4
10492784|NCT01198587|11642588|FG000|STARTED|Overall Study||31
10492785|NCT01198587|11642589|FG001|STARTED|Overall Study||5
10492786|NCT01198587|11642590|FG002|STARTED|Overall Study||30
10492787|NCT01198587|11642591|FG003|STARTED|Overall Study||5
10492788|NCT01198587|11642588|FG000|COMPLETED|Overall Study||23
10492789|NCT01198587|11642589|FG001|COMPLETED|Overall Study||5
10492790|NCT01198587|11642590|FG002|COMPLETED|Overall Study||21
10492791|NCT01198587|11642591|FG003|COMPLETED|Overall Study||5
10492792|NCT01198587|11642588|FG000|NOT COMPLETED|Overall Study||8
10492793|NCT01198587|11642589|FG001|NOT COMPLETED|Overall Study||0
10492794|NCT01198587|11642590|FG002|NOT COMPLETED|Overall Study||9
10492795|NCT01198587|11642591|FG003|NOT COMPLETED|Overall Study||0
10492796|NCT01198600|11642606|FG000|STARTED|Phase 1: Period One, 30 Days of Wear||35
10710224|NCT02647866|11875384|FG004|Completed Induction Therapy Follow-Up|Overall Study||2
10710225|NCT02647866|11875380|FG000|Completed Long-Term Extension Therapy|Overall Study|10 add'l treatments of KHK4083 (same dose as Induction Therapy) as maintenance therapy.|3
10713822|NCT02682563|11879354|FG001|COMPLETED|Overall Study||20
10492797|NCT01198600|11642607|FG001|STARTED|Phase 1: Period One, 30 Days of Wear||37
10492798|NCT01198600|11642608|FG002|STARTED|Phase 1: Period One, 30 Days of Wear||0
10492799|NCT01198600|11642609|FG003|STARTED|Phase 1: Period One, 30 Days of Wear||0
10492800|NCT01198600|11642606|FG000|COMPLETED|Phase 1: Period One, 30 Days of Wear||33
10492801|NCT01198600|11642607|FG001|COMPLETED|Phase 1: Period One, 30 Days of Wear||36
10492802|NCT01198600|11642608|FG002|COMPLETED|Phase 1: Period One, 30 Days of Wear||0
10492803|NCT01198600|11642609|FG003|COMPLETED|Phase 1: Period One, 30 Days of Wear||0
10492804|NCT01198600|11642606|FG000|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||2
10492805|NCT01198600|11642607|FG001|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||1
10492806|NCT01198600|11642608|FG002|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||0
10492807|NCT01198600|11642609|FG003|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||0
10492808|NCT01198600|11642606|FG000|STARTED|Phase 1: Period Two, 30 Days of Wear|One participant discontinued between Period One and Period Two due to unconvenience.|32
10492809|NCT01198600|11642607|FG001|STARTED|Phase 1: Period Two, 30 Days of Wear||36
10710226|NCT02647866|11875381|FG001|Completed Long-Term Extension Therapy|Overall Study||0
10710227|NCT02647866|11875382|FG002|Completed Long-Term Extension Therapy|Overall Study||0
10710228|NCT02647866|11875383|FG003|Completed Long-Term Extension Therapy|Overall Study||0
10710229|NCT02647866|11875384|FG004|Completed Long-Term Extension Therapy|Overall Study||0
10710230|NCT02647866|11875380|FG000|Completed LTE Follow-up|Overall Study||2
10492810|NCT01198600|11642608|FG002|STARTED|Phase 1: Period Two, 30 Days of Wear||0
10492811|NCT01198600|11642609|FG003|STARTED|Phase 1: Period Two, 30 Days of Wear||0
10492812|NCT01198600|11642606|FG000|COMPLETED|Phase 1: Period Two, 30 Days of Wear||32
10492813|NCT01198600|11642607|FG001|COMPLETED|Phase 1: Period Two, 30 Days of Wear||35
10492814|NCT01198600|11642608|FG002|COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
10492815|NCT01198600|11642609|FG003|COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
10492816|NCT01198600|11642606|FG000|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
10492817|NCT01198600|11642607|FG001|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||1
10492818|NCT01198600|11642608|FG002|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
10492819|NCT01198600|11642609|FG003|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
10492820|NCT01198600|11642606|FG000|STARTED|Phase 2: 56 Days of Wear||0
10492821|NCT01198600|11642607|FG001|STARTED|Phase 2: 56 Days of Wear||0
10492822|NCT01198600|11642608|FG002|STARTED|Phase 2: 56 Days of Wear||67
10492823|NCT01198600|11642609|FG003|STARTED|Phase 2: 56 Days of Wear||0
10492824|NCT01198600|11642606|FG000|COMPLETED|Phase 2: 56 Days of Wear||0
10492825|NCT01198600|11642607|FG001|COMPLETED|Phase 2: 56 Days of Wear||0
10492826|NCT01198600|11642608|FG002|COMPLETED|Phase 2: 56 Days of Wear||62
10492827|NCT01198600|11642609|FG003|COMPLETED|Phase 2: 56 Days of Wear||0
10492828|NCT01198600|11642606|FG000|NOT COMPLETED|Phase 2: 56 Days of Wear||0
10492829|NCT01198600|11642607|FG001|NOT COMPLETED|Phase 2: 56 Days of Wear||0
10492830|NCT01198600|11642608|FG002|NOT COMPLETED|Phase 2: 56 Days of Wear||5
10492831|NCT01198600|11642609|FG003|NOT COMPLETED|Phase 2: 56 Days of Wear||0
10492832|NCT01198600|11642606|FG000|STARTED|Phase 3: 43 Days of Wear||0
10492833|NCT01198600|11642607|FG001|STARTED|Phase 3: 43 Days of Wear||0
10492834|NCT01198600|11642608|FG002|STARTED|Phase 3: 43 Days of Wear||0
10492835|NCT01198600|11642609|FG003|STARTED|Phase 3: 43 Days of Wear||38
10492836|NCT01198600|11642606|FG000|COMPLETED|Phase 3: 43 Days of Wear||0
10492837|NCT01198600|11642607|FG001|COMPLETED|Phase 3: 43 Days of Wear||0
10492838|NCT01198600|11642608|FG002|COMPLETED|Phase 3: 43 Days of Wear||0
10492839|NCT01198600|11642609|FG003|COMPLETED|Phase 3: 43 Days of Wear||38
10492840|NCT01198600|11642606|FG000|NOT COMPLETED|Phase 3: 43 Days of Wear||0
10492841|NCT01198600|11642607|FG001|NOT COMPLETED|Phase 3: 43 Days of Wear||0
10492842|NCT01198600|11642608|FG002|NOT COMPLETED|Phase 3: 43 Days of Wear||0
10492843|NCT01198600|11642609|FG003|NOT COMPLETED|Phase 3: 43 Days of Wear||0
10492844|NCT01198691|11642619|FG000|STARTED|Completed Surgery -Received Intervention||50
10492845|NCT01198691|11642620|FG001|STARTED|Completed Surgery -Received Intervention||50
10492846|NCT01198691|11642619|FG000|COMPLETED|Completed Surgery -Received Intervention||50
10492847|NCT01198691|11642620|FG001|COMPLETED|Completed Surgery -Received Intervention||50
10492848|NCT01198691|11642619|FG000|NOT COMPLETED|Completed Surgery -Received Intervention||0
10492849|NCT01198691|11642620|FG001|NOT COMPLETED|Completed Surgery -Received Intervention||0
10492850|NCT01198691|11642619|FG000|STARTED|Completed VAS Score Postop Day 1||50
10492851|NCT01198691|11642620|FG001|STARTED|Completed VAS Score Postop Day 1||50
10492852|NCT01198691|11642619|FG000|COMPLETED|Completed VAS Score Postop Day 1||47
10492853|NCT01198691|11642620|FG001|COMPLETED|Completed VAS Score Postop Day 1||46
10492854|NCT01198691|11642619|FG000|NOT COMPLETED|Completed VAS Score Postop Day 1||3
10492855|NCT01198691|11642620|FG001|NOT COMPLETED|Completed VAS Score Postop Day 1||4
10492856|NCT01198691|11642619|FG000|STARTED|Completed VAS Score at Discharge|Missing a VAS score on postop day one did not exclude participants from having a score at discharge.|50
10492857|NCT01198691|11642620|FG001|STARTED|Completed VAS Score at Discharge|Missing a VAS score on postop day one did not exclude participants from having a score at discharge.|50
10492858|NCT01198691|11642619|FG000|COMPLETED|Completed VAS Score at Discharge||45
10492859|NCT01198691|11642620|FG001|COMPLETED|Completed VAS Score at Discharge||44
10492860|NCT01198691|11642619|FG000|NOT COMPLETED|Completed VAS Score at Discharge||5
10492861|NCT01198691|11642620|FG001|NOT COMPLETED|Completed VAS Score at Discharge||6
10492862|NCT01198691|11642619|FG000|STARTED|Survey Prior to Discharge|Survey was given to all participants even if they were missing data from previous periods.|50
10492863|NCT01198691|11642620|FG001|STARTED|Survey Prior to Discharge|Survey was given to all participants even if they were missing data from previous periods.|50
10492864|NCT01198691|11642619|FG000|COMPLETED|Survey Prior to Discharge||18
10492865|NCT01198691|11642620|FG001|COMPLETED|Survey Prior to Discharge||17
10492866|NCT01198691|11642619|FG000|NOT COMPLETED|Survey Prior to Discharge||32
10492867|NCT01198691|11642620|FG001|NOT COMPLETED|Survey Prior to Discharge||33
10492868|NCT01198691|11642619|FG000|STARTED|6 Week Post-partum Survey|Survey was sent to all participants even if they were missing data from the previous two periods.|50
10710231|NCT02647866|11875381|FG001|Completed LTE Follow-up|Overall Study||0
10710232|NCT02647866|11875382|FG002|Completed LTE Follow-up|Overall Study||0
10710233|NCT02647866|11875383|FG003|Completed LTE Follow-up|Overall Study||0
10710234|NCT02647866|11875384|FG004|Completed LTE Follow-up|Overall Study||0
10710235|NCT02647866|11875380|FG000|Completed Open-Label Extension Therapy|Overall Study||0
10710236|NCT02647866|11875381|FG001|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy.|7
10713823|NCT02682563|11879353|FG000|NOT COMPLETED|Overall Study||0
10713824|NCT02682563|11879354|FG001|NOT COMPLETED|Overall Study||0
10492869|NCT01198691|11642620|FG001|STARTED|6 Week Post-partum Survey|Survey was sent to all participants even if they were missing data from the previous two periods.|50
10492870|NCT01198691|11642619|FG000|COMPLETED|6 Week Post-partum Survey||21
10492871|NCT01198691|11642620|FG001|COMPLETED|6 Week Post-partum Survey||26
10492872|NCT01198691|11642619|FG000|NOT COMPLETED|6 Week Post-partum Survey||29
10492873|NCT01198691|11642620|FG001|NOT COMPLETED|6 Week Post-partum Survey||24
10492874|NCT01198756|11642630|FG000|STARTED|Overall Study||932
10492875|NCT01198756|11642631|FG001|STARTED|Overall Study||929
10492876|NCT01198756|11642632|FG002|STARTED|Overall Study||932
10492877|NCT01198756|11642633|FG003|STARTED|Overall Study||301
10492878|NCT01198756|11642630|FG000|COMPLETED|Overall Study||894
10492879|NCT01198756|11642631|FG001|COMPLETED|Overall Study||889
10492880|NCT01198756|11642632|FG002|COMPLETED|Overall Study||902
10492881|NCT01198756|11642633|FG003|COMPLETED|Overall Study||275
10492882|NCT01198756|11642630|FG000|NOT COMPLETED|Overall Study||38
10492883|NCT01198756|11642631|FG001|NOT COMPLETED|Overall Study||40
10492884|NCT01198756|11642632|FG002|NOT COMPLETED|Overall Study||30
10492885|NCT01198756|11642633|FG003|NOT COMPLETED|Overall Study||26
10492886|NCT01198769|11642650|FG000|STARTED|Overall Study||15
10492887|NCT01198769|11642650|FG000|COMPLETED|Overall Study||15
10492888|NCT01198769|11642650|FG000|NOT COMPLETED|Overall Study||0
10492889|NCT01198795|11642654|FG000|STARTED|Overall Study||162
10492890|NCT01198795|11642654|FG000|COMPLETED|Overall Study||80
10492891|NCT01198795|11642654|FG000|NOT COMPLETED|Overall Study||82
10492892|NCT01198873|11642660|FG000|STARTED|Overall Study||41
10492893|NCT01198873|11642661|FG001|STARTED|Overall Study||35
10492894|NCT01198873|11642660|FG000|Treated|Overall Study||41
10492895|NCT01198873|11642661|FG001|Treated|Overall Study||35
10492984|NCT01199601|11642793|FG000|COMPLETED|Overall Study||353
10492985|NCT01199601|11642794|FG001|COMPLETED|Overall Study||344
10492896|NCT01198873|11642660|FG000|Evaluable for Efficacy|Overall Study|8 participants discontinued before completing 3-month treatment and were not assessed post-baseline|33
10492897|NCT01198873|11642661|FG001|Evaluable for Efficacy|Overall Study|9 participants discontinued before completing 3-month treatment and were not assessed post-baseline|26
10492898|NCT01198873|11642660|FG000|COMPLETED|Overall Study||4
10492899|NCT01198873|11642661|FG001|COMPLETED|Overall Study||3
10492900|NCT01198873|11642660|FG000|NOT COMPLETED|Overall Study||37
10492901|NCT01198873|11642661|FG001|NOT COMPLETED|Overall Study||32
10492902|NCT01198977|11642669|FG000|STARTED|Overall Study||31
10492903|NCT01198977|11642670|FG001|STARTED|Overall Study||33
10492904|NCT01198977|11642669|FG000|COMPLETED|Overall Study||30
10492905|NCT01198977|11642670|FG001|COMPLETED|Overall Study||33
10492906|NCT01198977|11642669|FG000|NOT COMPLETED|Overall Study||1
10492907|NCT01198977|11642670|FG001|NOT COMPLETED|Overall Study||0
10492908|NCT01199016|11642678|FG000|STARTED|Overall Study||239
10492909|NCT01199016|11642678|FG000|Treated|Overall Study||236
10492910|NCT01199016|11642678|FG000|COMPLETED|Overall Study||162
10492911|NCT01199016|11642678|FG000|NOT COMPLETED|Overall Study||77
10492912|NCT01199042|11642682|FG000|STARTED|Sleep Laboratory (3 Nights)||29
10492913|NCT01199042|11642682|FG000|COMPLETED|Sleep Laboratory (3 Nights)||27
10492914|NCT01199042|11642682|FG000|NOT COMPLETED|Sleep Laboratory (3 Nights)||2
10492915|NCT01199042|11642682|FG000|STARTED|At Home (3 Months)||27
10492916|NCT01199042|11642682|FG000|COMPLETED|At Home (3 Months)||26
10492917|NCT01199042|11642682|FG000|NOT COMPLETED|At Home (3 Months)||1
10492918|NCT01199055|11642694|FG000|STARTED|Overall Study||3
10492919|NCT01199055|11642695|FG001|STARTED|Overall Study||4
10492920|NCT01199055|11642696|FG002|STARTED|Overall Study||9
10492921|NCT01199055|11642694|FG000|COMPLETED|Overall Study||1
10492922|NCT01199055|11642695|FG001|COMPLETED|Overall Study||1
10492923|NCT01199055|11642696|FG002|COMPLETED|Overall Study||5
10492924|NCT01199055|11642694|FG000|NOT COMPLETED|Overall Study||2
10492925|NCT01199055|11642695|FG001|NOT COMPLETED|Overall Study||3
10492926|NCT01199055|11642696|FG002|NOT COMPLETED|Overall Study||4
10492927|NCT01199068|11642709|FG000|STARTED|Overall Study||3
10492928|NCT01199068|11642710|FG001|STARTED|Overall Study||3
10492929|NCT01199068|11642711|FG002|STARTED|Overall Study||9
10492930|NCT01199068|11642709|FG000|Received Treatment|Overall Study||3
10492931|NCT01199068|11642710|FG001|Received Treatment|Overall Study||3
10492932|NCT01199068|11642711|FG002|Received Treatment|Overall Study||8
10492933|NCT01199068|11642709|FG000|COMPLETED|Overall Study||0
10492934|NCT01199068|11642710|FG001|COMPLETED|Overall Study||0
10492935|NCT01199068|11642711|FG002|COMPLETED|Overall Study||0
10492936|NCT01199068|11642709|FG000|NOT COMPLETED|Overall Study||3
10492937|NCT01199068|11642710|FG001|NOT COMPLETED|Overall Study||3
10492938|NCT01199068|11642711|FG002|NOT COMPLETED|Overall Study||9
10492939|NCT01199146|11642726|FG000|STARTED|Overall Study||42
10492940|NCT01199146|11642726|FG000|COMPLETED|Overall Study||39
10492941|NCT01199146|11642726|FG000|NOT COMPLETED|Overall Study||3
10492942|NCT01199198|11642732|FG000|STARTED|Overall Study||24
10492943|NCT01199198|11642733|FG001|STARTED|Overall Study||24
10492944|NCT01199198|11642732|FG000|COMPLETED|Overall Study||17
10492945|NCT01199198|11642733|FG001|COMPLETED|Overall Study||13
10492946|NCT01199198|11642732|FG000|NOT COMPLETED|Overall Study||7
10492947|NCT01199198|11642733|FG001|NOT COMPLETED|Overall Study||11
10492948|NCT01199237|11642741|FG000|STARTED|Overall Study||41
10492949|NCT01199237|11642742|FG001|STARTED|Overall Study||40
10492950|NCT01199237|11642741|FG000|COMPLETED|Overall Study||41
10492951|NCT01199237|11642742|FG001|COMPLETED|Overall Study||40
10492952|NCT01199237|11642741|FG000|NOT COMPLETED|Overall Study||0
10492953|NCT01199237|11642742|FG001|NOT COMPLETED|Overall Study||0
10492954|NCT01199263|11642752|FG000|STARTED|Overall Study||54
10492955|NCT01199263|11642753|FG001|STARTED|Overall Study||54
10492956|NCT01199263|11642752|FG000|COMPLETED|Overall Study||48
10492957|NCT01199263|11642753|FG001|COMPLETED|Overall Study||52
10492958|NCT01199263|11642752|FG000|NOT COMPLETED|Overall Study||6
10492959|NCT01199263|11642753|FG001|NOT COMPLETED|Overall Study||2
10492960|NCT01199289|11642765|FG000|STARTED|Overall Study||77
10492961|NCT01199289|11642766|FG001|STARTED|Overall Study||75
10492962|NCT01199289|11642767|FG002|STARTED|Overall Study||76
10492963|NCT01199289|11642768|FG003|STARTED|Overall Study||77
10492964|NCT01199289|11642765|FG000|Participants Who Received Study Treatment|Overall Study||76
10492965|NCT01199289|11642766|FG001|Participants Who Received Study Treatment|Overall Study||74
10492966|NCT01199289|11642767|FG002|Participants Who Received Study Treatment|Overall Study||76
10492967|NCT01199289|11642768|FG003|Participants Who Received Study Treatment|Overall Study||76
10492968|NCT01199289|11642765|FG000|COMPLETED|Overall Study||68
10492969|NCT01199289|11642766|FG001|COMPLETED|Overall Study||68
10492970|NCT01199289|11642767|FG002|COMPLETED|Overall Study||71
10492971|NCT01199289|11642768|FG003|COMPLETED|Overall Study||65
10492972|NCT01199289|11642765|FG000|NOT COMPLETED|Overall Study||9
10492973|NCT01199289|11642766|FG001|NOT COMPLETED|Overall Study||7
10492974|NCT01199289|11642767|FG002|NOT COMPLETED|Overall Study||5
10492975|NCT01199289|11642768|FG003|NOT COMPLETED|Overall Study||12
10492976|NCT01199471|11642781|FG000|STARTED|Overall Study|3 patients who did not meet ASA Physical Status Class 1 - 3 were excluded from all analyses.|4000
10492977|NCT01199471|11642781|FG000|COMPLETED|Overall Study||3994
10492978|NCT01199471|11642781|FG000|NOT COMPLETED|Overall Study||6
10492979|NCT01199575|11642786|FG000|STARTED|Overall Study||30
10492980|NCT01199575|11642786|FG000|COMPLETED|Overall Study||25
10492981|NCT01199575|11642786|FG000|NOT COMPLETED|Overall Study||5
10492982|NCT01199601|11642793|FG000|STARTED|Overall Study|Control Group|422
10492983|NCT01199601|11642794|FG001|STARTED|Overall Study|Intervention Group|422
10492986|NCT01199601|11642793|FG000|NOT COMPLETED|Overall Study||69
10492987|NCT01199601|11642794|FG001|NOT COMPLETED|Overall Study||78
10492988|NCT01199705|11642800|FG000|STARTED|IVIG Treatment||25
10492989|NCT01199705|11642800|FG000|COMPLETED|IVIG Treatment||25
10492990|NCT01199705|11642800|FG000|NOT COMPLETED|IVIG Treatment||0
10492991|NCT01199705|11642800|FG000|STARTED|SCIG Treatment (Wash-in/Wash-out)||25
10492992|NCT01199705|11642800|FG000|COMPLETED|SCIG Treatment (Wash-in/Wash-out)||24
10492993|NCT01199705|11642800|FG000|NOT COMPLETED|SCIG Treatment (Wash-in/Wash-out)||1
10492994|NCT01199705|11642800|FG000|STARTED|SCIG Treatment (Efficacy)||24
10492995|NCT01199705|11642800|FG000|COMPLETED|SCIG Treatment (Efficacy)||24
10492996|NCT01199705|11642800|FG000|NOT COMPLETED|SCIG Treatment (Efficacy)||0
10492997|NCT01199731|11642818|FG000|STARTED|Overall Study||9
10492998|NCT01199731|11642819|FG001|STARTED|Overall Study||11
10492999|NCT01199731|11642820|FG002|STARTED|Overall Study||10
10493000|NCT01199731|11642818|FG000|COMPLETED|Overall Study||0
10493001|NCT01199731|11642819|FG001|COMPLETED|Overall Study||0
10493002|NCT01199731|11642820|FG002|COMPLETED|Overall Study||0
10493003|NCT01199731|11642818|FG000|NOT COMPLETED|Overall Study||9
10493004|NCT01199731|11642819|FG001|NOT COMPLETED|Overall Study||11
10493005|NCT01199731|11642820|FG002|NOT COMPLETED|Overall Study||10
10493006|NCT01199744|11642828|FG000|STARTED|Overall Study||1575
10493007|NCT01199744|11642828|FG000|COMPLETED|Overall Study||1575
10493008|NCT01199744|11642828|FG000|NOT COMPLETED|Overall Study||0
10493009|NCT01199822|11642835|FG000|STARTED|Overall Study||3
10493010|NCT01199822|11642836|FG001|STARTED|Overall Study||7
10493011|NCT01199822|11642837|FG002|STARTED|Overall Study||6
10493012|NCT01199822|11642835|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
10493013|NCT01199822|11642836|FG001|Received at Least 1 Dose of Study Drug|Overall Study||7
10493014|NCT01199822|11642837|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
10493015|NCT01199822|11642835|FG000|COMPLETED|Overall Study||3
10493016|NCT01199822|11642836|FG001|COMPLETED|Overall Study||6
10493017|NCT01199822|11642837|FG002|COMPLETED|Overall Study||6
10493018|NCT01199822|11642835|FG000|NOT COMPLETED|Overall Study||0
10493019|NCT01199822|11642836|FG001|NOT COMPLETED|Overall Study||1
10493020|NCT01199822|11642837|FG002|NOT COMPLETED|Overall Study||0
10493021|NCT01199848|11642852|FG000|STARTED|Placebo Arm||29
10493022|NCT01199848|11642852|FG000|COMPLETED|Placebo Arm||21
10493023|NCT01199848|11642852|FG000|NOT COMPLETED|Placebo Arm||8
10493024|NCT01199848|11642852|FG000|STARTED|10g STR Arm||21
10493025|NCT01199848|11642852|FG000|COMPLETED|10g STR Arm||21
10493026|NCT01199848|11642852|FG000|NOT COMPLETED|10g STR Arm||0
10493027|NCT01199848|11642852|FG000|STARTED|20G STRB Arm||21
10493028|NCT01199848|11642852|FG000|COMPLETED|20G STRB Arm||21
10493029|NCT01199848|11642852|FG000|NOT COMPLETED|20G STRB Arm||0
10493030|NCT01199848|11642852|FG000|STARTED|40G STRB Arm||21
10493031|NCT01199848|11642852|FG000|COMPLETED|40G STRB Arm||21
10493032|NCT01199848|11642852|FG000|NOT COMPLETED|40G STRB Arm||0
10493033|NCT01199861|11642864|FG000|STARTED|Overall Study||95
10493034|NCT01199861|11642865|FG001|STARTED|Overall Study||43
10493035|NCT01199861|11642864|FG000|COMPLETED|Overall Study||93
10493036|NCT01199861|11642865|FG001|COMPLETED|Overall Study||43
10493037|NCT01199861|11642864|FG000|NOT COMPLETED|Overall Study||2
10493038|NCT01199861|11642865|FG001|NOT COMPLETED|Overall Study||0
10493039|NCT01199926|11642873|FG000|STARTED|Overall Study||17
10493040|NCT01199926|11642874|FG001|STARTED|Overall Study||17
10493041|NCT01199926|11642873|FG000|COMPLETED|Overall Study||10
10493042|NCT01199926|11642874|FG001|COMPLETED|Overall Study||13
10493043|NCT01199926|11642873|FG000|NOT COMPLETED|Overall Study||7
10493044|NCT01199926|11642874|FG001|NOT COMPLETED|Overall Study||4
10493045|NCT01199939|11642880|FG000|STARTED|Overall Study|Number of enrolled participants|54
10493046|NCT01199939|11642880|FG000|COMPLETED|Overall Study||41
10493047|NCT01199939|11642880|FG000|NOT COMPLETED|Overall Study||13
10493048|NCT01199952|11642886|FG000|STARTED|Overall Study||103
10493049|NCT01199952|11642887|FG001|STARTED|Overall Study||104
10493050|NCT01199952|11642886|FG000|COMPLETED|Overall Study||51
10493051|NCT01199952|11642887|FG001|COMPLETED|Overall Study||59
10493052|NCT01199952|11642886|FG000|NOT COMPLETED|Overall Study||52
10493053|NCT01199952|11642887|FG001|NOT COMPLETED|Overall Study||45
10493054|NCT01199965|11642896|FG000|STARTED|Overall Study||23
10493055|NCT01199965|11642897|FG001|STARTED|Overall Study||24
10493056|NCT01199965|11642896|FG000|COMPLETED|Overall Study||22
10493057|NCT01199965|11642897|FG001|COMPLETED|Overall Study||24
10493058|NCT01199965|11642896|FG000|NOT COMPLETED|Overall Study||1
10493059|NCT01199965|11642897|FG001|NOT COMPLETED|Overall Study||0
10493060|NCT01200030|11642914|FG000|STARTED|Overall Study||12
10493061|NCT01200030|11642915|FG001|STARTED|Overall Study||13
10493062|NCT01200030|11642916|FG002|STARTED|Overall Study||12
10493063|NCT01200030|11642914|FG000|COMPLETED|Overall Study||12
10493064|NCT01200030|11642915|FG001|COMPLETED|Overall Study||13
10493065|NCT01200030|11642916|FG002|COMPLETED|Overall Study||12
10493066|NCT01200030|11642914|FG000|NOT COMPLETED|Overall Study||0
10493067|NCT01200030|11642915|FG001|NOT COMPLETED|Overall Study||0
10493068|NCT01200030|11642916|FG002|NOT COMPLETED|Overall Study||0
10493069|NCT01200069|11642926|FG000|STARTED|Overall Study||8
10493070|NCT01200069|11642927|FG001|STARTED|Overall Study||6
10493071|NCT01200069|11642926|FG000|COMPLETED|Overall Study||8
10493072|NCT01200069|11642927|FG001|COMPLETED|Overall Study||5
10493073|NCT01200069|11642926|FG000|NOT COMPLETED|Overall Study||0
10493074|NCT01200069|11642927|FG001|NOT COMPLETED|Overall Study||1
10493075|NCT01200160|11642976|FG000|STARTED|Overall Study||128
10493076|NCT01200160|11642976|FG000|COMPLETED|Overall Study||66
10493077|NCT01200160|11642976|FG000|NOT COMPLETED|Overall Study||62
10493078|NCT01200238|11642982|FG000|STARTED|Overall Study||7
10493079|NCT01200238|11642983|FG001|STARTED|Overall Study||10
10493080|NCT01200238|11642982|FG000|COMPLETED|Overall Study||0
10493081|NCT01200238|11642983|FG001|COMPLETED|Overall Study||0
10493082|NCT01200238|11642982|FG000|NOT COMPLETED|Overall Study||7
10493083|NCT01200238|11642983|FG001|NOT COMPLETED|Overall Study||10
10493084|NCT01200290|11642989|FG000|STARTED|Treatment Period||18
10493085|NCT01200290|11642989|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||18
10493086|NCT01200290|11642989|FG000|COMPLETED|Treatment Period||17
10493087|NCT01200290|11642989|FG000|NOT COMPLETED|Treatment Period||1
10493088|NCT01200290|11642989|FG000|STARTED|Post-Treatment Follow-Up Period|Participant who discontinued treatment was included in the post-treatment follow-up period.|18
10493089|NCT01200290|11642989|FG000|COMPLETED|Post-Treatment Follow-Up Period||16
10493090|NCT01200290|11642989|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||2
10493091|NCT01200329|11642993|FG000|STARTED|Overall Study||81
10493092|NCT01200329|11642993|FG000|COMPLETED|Overall Study||78
10710237|NCT02647866|11875382|FG002|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy|4
10710238|NCT02647866|11875383|FG003|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy|17
10710239|NCT02647866|11875384|FG004|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy|13
10710240|NCT02647866|11875380|FG000|Completed OLE Follow-up|Overall Study||0
10710241|NCT02647866|11875381|FG001|Completed OLE Follow-up|Overall Study||6
10710242|NCT02647866|11875382|FG002|Completed OLE Follow-up|Overall Study||4
10710243|NCT02647866|11875383|FG003|Completed OLE Follow-up|Overall Study||14
10710244|NCT02647866|11875384|FG004|Completed OLE Follow-up|Overall Study||10
10710245|NCT02647866|11875380|FG000|Moved From LTE to OLE Therapy|Overall Study||0
10710246|NCT02647866|11875381|FG001|Moved From LTE to OLE Therapy|Overall Study||5
10710247|NCT02647866|11875382|FG002|Moved From LTE to OLE Therapy|Overall Study||0
10710248|NCT02647866|11875383|FG003|Moved From LTE to OLE Therapy|Overall Study||0
10710249|NCT02647866|11875384|FG004|Moved From LTE to OLE Therapy|Overall Study||2
10710250|NCT02647866|11875380|FG000|Discontinued the Treatment|Overall Study||4
10710251|NCT02647866|11875381|FG001|Discontinued the Treatment|Overall Study||5
10710252|NCT02647866|11875382|FG002|Discontinued the Treatment|Overall Study||5
10710253|NCT02647866|11875383|FG003|Discontinued the Treatment|Overall Study||5
10710254|NCT02647866|11875384|FG004|Discontinued the Treatment|Overall Study||8
10710255|NCT02647866|11875380|FG000|Discontinued the Study|Overall Study||5
10710256|NCT02647866|11875381|FG001|Discontinued the Study|Overall Study||4
10710257|NCT02647866|11875382|FG002|Discontinued the Study|Overall Study||5
10710258|NCT02647866|11875383|FG003|Discontinued the Study|Overall Study||6
10710259|NCT02647866|11875384|FG004|Discontinued the Study|Overall Study||8
10710260|NCT02647866|11875380|FG000|COMPLETED|Overall Study||4
10710261|NCT02647866|11875381|FG001|COMPLETED|Overall Study||6
10710262|NCT02647866|11875382|FG002|COMPLETED|Overall Study||4
10493093|NCT01200329|11642993|FG000|NOT COMPLETED|Overall Study||3
10493094|NCT01200342|11642997|FG000|STARTED|Overall Study||7
10493095|NCT01200342|11642997|FG000|COMPLETED|Overall Study||6
10493096|NCT01200342|11642997|FG000|NOT COMPLETED|Overall Study||1
10493097|NCT01200355|11643003|FG000|STARTED|Overall Study||58
10493098|NCT01200355|11643004|FG001|STARTED|Overall Study||55
10493099|NCT01200355|11643003|FG000|COMPLETED|Overall Study||51
10493100|NCT01200355|11643004|FG001|COMPLETED|Overall Study||53
10493101|NCT01200355|11643003|FG000|NOT COMPLETED|Overall Study||7
10710263|NCT02647866|11875383|FG003|COMPLETED|Overall Study||15
10710264|NCT02647866|11875384|FG004|COMPLETED|Overall Study||9
10710265|NCT02647866|11875380|FG000|NOT COMPLETED|Overall Study||5
10710266|NCT02647866|11875381|FG001|NOT COMPLETED|Overall Study||4
10710267|NCT02647866|11875382|FG002|NOT COMPLETED|Overall Study||5
10710268|NCT02647866|11875383|FG003|NOT COMPLETED|Overall Study||6
10493102|NCT01200355|11643004|FG001|NOT COMPLETED|Overall Study||2
10493103|NCT01200368|11643013|FG000|STARTED|Infant Series||183
10493104|NCT01200368|11643014|FG001|STARTED|Infant Series||184
10493105|NCT01200368|11643015|FG002|STARTED|Infant Series||184
10493106|NCT01200368|11643013|FG000|Vaccinated Dose 1|Infant Series||183
10493107|NCT01200368|11643014|FG001|Vaccinated Dose 1|Infant Series||183
10493108|NCT01200368|11643015|FG002|Vaccinated Dose 1|Infant Series||183
10493109|NCT01200368|11643013|FG000|Vaccinated Dose 2|Infant Series||183
10493110|NCT01200368|11643014|FG001|Vaccinated Dose 2|Infant Series||182
10493111|NCT01200368|11643015|FG002|Vaccinated Dose 2|Infant Series||183
10493112|NCT01200368|11643013|FG000|Vaccinated Dose 3|Infant Series||181
10493113|NCT01200368|11643014|FG001|Vaccinated Dose 3|Infant Series||178
10493114|NCT01200368|11643015|FG002|Vaccinated Dose 3|Infant Series||182
10493115|NCT01200368|11643013|FG000|COMPLETED|Infant Series||180
10493116|NCT01200368|11643014|FG001|COMPLETED|Infant Series||178
10493117|NCT01200368|11643015|FG002|COMPLETED|Infant Series||178
10493118|NCT01200368|11643013|FG000|NOT COMPLETED|Infant Series||3
10493119|NCT01200368|11643014|FG001|NOT COMPLETED|Infant Series||6
10493120|NCT01200368|11643015|FG002|NOT COMPLETED|Infant Series||6
10493121|NCT01200368|11643013|FG000|STARTED|After Infant Series||180
10493122|NCT01200368|11643014|FG001|STARTED|After Infant Series||178
10493123|NCT01200368|11643015|FG002|STARTED|After Infant Series||178
10493124|NCT01200368|11643013|FG000|COMPLETED|After Infant Series||162
10493125|NCT01200368|11643014|FG001|COMPLETED|After Infant Series||162
10493126|NCT01200368|11643015|FG002|COMPLETED|After Infant Series||169
10493127|NCT01200368|11643013|FG000|NOT COMPLETED|After Infant Series||18
10493128|NCT01200368|11643014|FG001|NOT COMPLETED|After Infant Series||16
10493129|NCT01200368|11643015|FG002|NOT COMPLETED|After Infant Series||9
10493130|NCT01200368|11643013|FG000|STARTED|Toddler Dose||162
10493131|NCT01200368|11643014|FG001|STARTED|Toddler Dose||162
10493132|NCT01200368|11643015|FG002|STARTED|Toddler Dose||169
10493133|NCT01200368|11643013|FG000|COMPLETED|Toddler Dose||162
10493134|NCT01200368|11643014|FG001|COMPLETED|Toddler Dose||159
10493135|NCT01200368|11643015|FG002|COMPLETED|Toddler Dose||168
10493136|NCT01200368|11643013|FG000|NOT COMPLETED|Toddler Dose||0
10493137|NCT01200368|11643014|FG001|NOT COMPLETED|Toddler Dose||3
10493138|NCT01200368|11643015|FG002|NOT COMPLETED|Toddler Dose||1
10493139|NCT01200394|11643032|FG000|STARTED|Overall Study||64
10493140|NCT01200394|11643033|FG001|STARTED|Overall Study||192
10493141|NCT01200394|11643032|FG000|COMPLETED|Overall Study||62
10493142|NCT01200394|11643033|FG001|COMPLETED|Overall Study||164
10493143|NCT01200394|11643032|FG000|NOT COMPLETED|Overall Study||2
10493144|NCT01200394|11643033|FG001|NOT COMPLETED|Overall Study||28
10493145|NCT01200407|11643040|FG000|STARTED|Overall Study||615
10493146|NCT01200407|11643040|FG000|COMPLETED|Overall Study||533
10493147|NCT01200407|11643040|FG000|NOT COMPLETED|Overall Study||82
10493148|NCT01200433|11643046|FG000|STARTED|Overall Study||21
10493149|NCT01200433|11643047|FG001|STARTED|Overall Study||23
10493150|NCT01200433|11643046|FG000|COMPLETED|Overall Study||21
10493151|NCT01200433|11643047|FG001|COMPLETED|Overall Study||23
10493152|NCT01200433|11643046|FG000|NOT COMPLETED|Overall Study||0
10493153|NCT01200433|11643047|FG001|NOT COMPLETED|Overall Study||0
10493154|NCT01200485|11643053|FG000|STARTED|Cycle 1: Rasburicase Alone Delivery|Of 55 participants screened, only 52 treated.|55
10493155|NCT01200485|11643054|FG001|STARTED|Cycle 1: Rasburicase Alone Delivery||0
10493156|NCT01200485|11643055|FG002|STARTED|Cycle 1: Rasburicase Alone Delivery||0
10493157|NCT01200485|11643053|FG000|COMPLETED|Cycle 1: Rasburicase Alone Delivery||52
10493158|NCT01200485|11643054|FG001|COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
10493159|NCT01200485|11643055|FG002|COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
10493160|NCT01200485|11643053|FG000|NOT COMPLETED|Cycle 1: Rasburicase Alone Delivery||3
10493161|NCT01200485|11643054|FG001|NOT COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
10493162|NCT01200485|11643055|FG002|NOT COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
10493163|NCT01200485|11643053|FG000|STARTED|Cycle 2: Randomization|Of 55 enrolled on study, 52 participants were treated in Cycle 1, only 46 randomized to Cycle 2|0
10493164|NCT01200485|11643054|FG001|STARTED|Cycle 2: Randomization|Six not randomized: Methemoglobinemia-1, Kidney failure-2, Chemotherapy changed-2, Not evaluable-1|21
10493165|NCT01200485|11643055|FG002|STARTED|Cycle 2: Randomization||25
10493166|NCT01200485|11643053|FG000|COMPLETED|Cycle 2: Randomization||0
10710269|NCT02647866|11875384|FG004|NOT COMPLETED|Overall Study||8
10710270|NCT02647905|11875404|FG000|STARTED|Overall Study||90
10493167|NCT01200485|11643054|FG001|COMPLETED|Cycle 2: Randomization||21
10493168|NCT01200485|11643055|FG002|COMPLETED|Cycle 2: Randomization||25
10493169|NCT01200485|11643053|FG000|NOT COMPLETED|Cycle 2: Randomization||0
10493170|NCT01200485|11643054|FG001|NOT COMPLETED|Cycle 2: Randomization||0
10493171|NCT01200485|11643055|FG002|NOT COMPLETED|Cycle 2: Randomization||0
10493172|NCT01200498|11643062|FG000|STARTED|Overall Study||22
10493173|NCT01200498|11643062|FG000|COMPLETED|Overall Study||22
10493174|NCT01200498|11643062|FG000|NOT COMPLETED|Overall Study||0
10493175|NCT01200511|11643066|FG000|STARTED|Overall Study||49
10493176|NCT01200511|11643066|FG000|COMPLETED|Overall Study||44
10493177|NCT01200511|11643066|FG000|NOT COMPLETED|Overall Study||5
10493178|NCT01200524|11643075|FG000|STARTED|Overall Study||41
10710271|NCT02647905|11875404|FG000|COMPLETED|Overall Study||87
10493179|NCT01200524|11643076|FG001|STARTED|Overall Study||48
10493180|NCT01200524|11643077|FG002|STARTED|Overall Study||44
10493181|NCT01200524|11643075|FG000|COMPLETED|Overall Study||39
10493182|NCT01200524|11643076|FG001|COMPLETED|Overall Study||47
10493183|NCT01200524|11643077|FG002|COMPLETED|Overall Study||40
10493184|NCT01200524|11643075|FG000|NOT COMPLETED|Overall Study||2
10493185|NCT01200524|11643076|FG001|NOT COMPLETED|Overall Study||1
10493186|NCT01200524|11643077|FG002|NOT COMPLETED|Overall Study||4
10493187|NCT01200589|11643087|FG000|STARTED|Overall Study||219
10493188|NCT01200589|11643088|FG001|STARTED|Overall Study||219
10493189|NCT01200589|11643087|FG000|Intent-to-treat (ITT) Analysis Set|Overall Study||219
10493190|NCT01200589|11643088|FG001|Intent-to-treat (ITT) Analysis Set|Overall Study||219
10493191|NCT01200589|11643087|FG000|Safety Set|Overall Study||217
10493192|NCT01200589|11643088|FG001|Safety Set|Overall Study||218
10493193|NCT01200589|11643087|FG000|COMPLETED|Overall Study||29
10493194|NCT01200589|11643088|FG001|COMPLETED|Overall Study||30
10493195|NCT01200589|11643087|FG000|NOT COMPLETED|Overall Study||190
10493196|NCT01200589|11643088|FG001|NOT COMPLETED|Overall Study||189
10527828|NCT01392183|11680071|FG000|Treatment Ended: Adverse Events|Second Drug Administration||1
10527829|NCT01392183|11680072|FG001|Treatment Ended: Adverse Events|Second Drug Administration||2
10527830|NCT01392183|11680071|FG000|Treatment Ended: Participant Withdrew|Second Drug Administration||2
10527831|NCT01392183|11680072|FG001|Treatment Ended: Participant Withdrew|Second Drug Administration||1
10527832|NCT01392183|11680071|FG000|Treatment Ended: Death|Second Drug Administration||0
10527833|NCT01392183|11680072|FG001|Treatment Ended: Death|Second Drug Administration||1
10527834|NCT01392183|11680071|FG000|COMPLETED|Second Drug Administration||21
10527835|NCT01392183|11680072|FG001|COMPLETED|Second Drug Administration||15
10527836|NCT01392183|11680071|FG000|NOT COMPLETED|Second Drug Administration||0
10527837|NCT01392183|11680072|FG001|NOT COMPLETED|Second Drug Administration||0
10527838|NCT01392300|11680082|FG000|STARTED|Main Period (MP)||210
10527839|NCT01392300|11680083|FG001|STARTED|Main Period (MP)||107
10527840|NCT01392300|11680084|FG002|STARTED|Main Period (MP)||0
10527841|NCT01392300|11680082|FG000|COMPLETED|Main Period (MP)||199
10527842|NCT01392300|11680083|FG001|COMPLETED|Main Period (MP)||100
10527843|NCT01392300|11680084|FG002|COMPLETED|Main Period (MP)||0
10527844|NCT01392300|11680082|FG000|NOT COMPLETED|Main Period (MP)||11
10527845|NCT01392300|11680083|FG001|NOT COMPLETED|Main Period (MP)||7
10527846|NCT01392300|11680084|FG002|NOT COMPLETED|Main Period (MP)||0
10527847|NCT01392300|11680082|FG000|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|0
10527848|NCT01392300|11680083|FG001|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|0
10527849|NCT01392300|11680084|FG002|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|299
10527850|NCT01392300|11680082|FG000|COMPLETED|Open Label Extension (OLEX) Period||0
10527851|NCT01392300|11680083|FG001|COMPLETED|Open Label Extension (OLEX) Period||0
10527852|NCT01392300|11680084|FG002|COMPLETED|Open Label Extension (OLEX) Period||248
10527853|NCT01392300|11680082|FG000|NOT COMPLETED|Open Label Extension (OLEX) Period||0
10527854|NCT01392300|11680083|FG001|NOT COMPLETED|Open Label Extension (OLEX) Period||0
10527855|NCT01392300|11680084|FG002|NOT COMPLETED|Open Label Extension (OLEX) Period||51
10527856|NCT01392326|11680094|FG000|STARTED|Overall Study||202
10527857|NCT01392326|11680095|FG001|STARTED|Overall Study||202
10527858|NCT01392326|11680096|FG002|STARTED|Overall Study||202
10527859|NCT01392326|11680094|FG000|COMPLETED|Overall Study||155
10527860|NCT01392326|11680095|FG001|COMPLETED|Overall Study||167
10527861|NCT01392326|11680096|FG002|COMPLETED|Overall Study||154
10527862|NCT01392326|11680094|FG000|NOT COMPLETED|Overall Study||47
10527863|NCT01392326|11680095|FG001|NOT COMPLETED|Overall Study||35
10527864|NCT01392326|11680096|FG002|NOT COMPLETED|Overall Study||48
10527865|NCT01392378|11680109|FG000|STARTED|Infant Series||173
10527866|NCT01392378|11680110|FG001|STARTED|Infant Series||176
10527867|NCT01392378|11680111|FG002|STARTED|Infant Series||172
10527868|NCT01392378|11680112|FG003|STARTED|Infant Series||177
10527869|NCT01392378|11680113|FG004|STARTED|Infant Series||210
10527870|NCT01392378|11680109|FG000|Vaccinated Dose 1|Infant Series||173
10527871|NCT01392378|11680110|FG001|Vaccinated Dose 1|Infant Series||176
10527872|NCT01392378|11680111|FG002|Vaccinated Dose 1|Infant Series||172
10527873|NCT01392378|11680112|FG003|Vaccinated Dose 1|Infant Series||177
10527874|NCT01392378|11680113|FG004|Vaccinated Dose 1|Infant Series||210
10527875|NCT01392378|11680109|FG000|Vaccinated Dose 2|Infant Series||171
10527876|NCT01392378|11680110|FG001|Vaccinated Dose 2|Infant Series||174
10527877|NCT01392378|11680111|FG002|Vaccinated Dose 2|Infant Series||172
10527878|NCT01392378|11680112|FG003|Vaccinated Dose 2|Infant Series||177
10527879|NCT01392378|11680113|FG004|Vaccinated Dose 2|Infant Series||210
10527880|NCT01392378|11680109|FG000|Vaccinated Dose 3|Infant Series||170
10527881|NCT01392378|11680110|FG001|Vaccinated Dose 3|Infant Series||174
10527882|NCT01392378|11680111|FG002|Vaccinated Dose 3|Infant Series||172
10527883|NCT01392378|11680112|FG003|Vaccinated Dose 3|Infant Series||176
10527884|NCT01392378|11680113|FG004|Vaccinated Dose 3|Infant Series||210
10527885|NCT01392378|11680109|FG000|COMPLETED|Infant Series||169
10527886|NCT01392378|11680110|FG001|COMPLETED|Infant Series||174
10527887|NCT01392378|11680111|FG002|COMPLETED|Infant Series||172
10527888|NCT01392378|11680112|FG003|COMPLETED|Infant Series||175
10527889|NCT01392378|11680113|FG004|COMPLETED|Infant Series||210
10527890|NCT01392378|11680109|FG000|NOT COMPLETED|Infant Series||4
10527891|NCT01392378|11680110|FG001|NOT COMPLETED|Infant Series||2
10527892|NCT01392378|11680111|FG002|NOT COMPLETED|Infant Series||0
10493197|NCT01200758|11643096|FG000|STARTED|Stage I||64
10493198|NCT01200758|11643097|FG001|STARTED|Stage I||63
10493199|NCT01200758|11643098|FG002|STARTED|Stage I|Different participants were randomized into different stages of the study.|0
10493200|NCT01200758|11643099|FG003|STARTED|Stage I|Different participants were randomized into different stages of the study.|0
10493201|NCT01200758|11643096|FG000|COMPLETED|Stage I|Participants completed treatment period.|46
10493202|NCT01200758|11643097|FG001|COMPLETED|Stage I|Participants completed treatment period.|46
10493203|NCT01200758|11643098|FG002|COMPLETED|Stage I||0
10493204|NCT01200758|11643099|FG003|COMPLETED|Stage I||0
10493205|NCT01200758|11643096|FG000|NOT COMPLETED|Stage I||18
10493206|NCT01200758|11643097|FG001|NOT COMPLETED|Stage I||17
10493207|NCT01200758|11643098|FG002|NOT COMPLETED|Stage I||0
10493208|NCT01200758|11643099|FG003|NOT COMPLETED|Stage I||0
10493209|NCT01200758|11643096|FG000|STARTED|Stage 2|Different participants were randomized into different stages of the study.|0
10493210|NCT01200758|11643097|FG001|STARTED|Stage 2|Different participants were randomized into different stages of the study.|0
10493211|NCT01200758|11643098|FG002|STARTED|Stage 2||141
10493212|NCT01200758|11643099|FG003|STARTED|Stage 2||142
10493213|NCT01200758|11643096|FG000|COMPLETED|Stage 2||0
10493214|NCT01200758|11643097|FG001|COMPLETED|Stage 2||0
10493215|NCT01200758|11643098|FG002|COMPLETED|Stage 2|Participants completed treatment period.|100
10493216|NCT01200758|11643099|FG003|COMPLETED|Stage 2|Participants completed treatment period.|92
10493217|NCT01200758|11643096|FG000|NOT COMPLETED|Stage 2||0
10493218|NCT01200758|11643097|FG001|NOT COMPLETED|Stage 2||0
10493219|NCT01200758|11643098|FG002|NOT COMPLETED|Stage 2||41
10493220|NCT01200758|11643099|FG003|NOT COMPLETED|Stage 2||50
10493221|NCT01200797|11643111|FG000|STARTED|Overall Study||19
10493222|NCT01200797|11643111|FG000|COMPLETED|Overall Study||0
10493223|NCT01200797|11643111|FG000|NOT COMPLETED|Overall Study||19
10710272|NCT02647905|11875404|FG000|NOT COMPLETED|Overall Study||3
10710273|NCT02647944|11875410|FG000|STARTED|Overall Study||19
10710274|NCT02647944|11875411|FG001|STARTED|Overall Study||21
10710275|NCT02647944|11875410|FG000|COMPLETED|Overall Study||17
10710276|NCT02647944|11875411|FG001|COMPLETED|Overall Study||18
10710277|NCT02647944|11875410|FG000|NOT COMPLETED|Overall Study||2
10710278|NCT02647944|11875411|FG001|NOT COMPLETED|Overall Study||3
10710279|NCT02648022|11875419|FG000|STARTED|Overall Study||40
10710280|NCT02648022|11875420|FG001|STARTED|Overall Study||39
10710281|NCT02648022|11875419|FG000|COMPLETED|Overall Study||40
10710282|NCT02648022|11875420|FG001|COMPLETED|Overall Study||39
10710283|NCT02648022|11875419|FG000|NOT COMPLETED|Overall Study||0
10710284|NCT02648022|11875420|FG001|NOT COMPLETED|Overall Study||0
10710285|NCT02648178|11875426|FG000|STARTED|Overall Study||19
10710286|NCT02648178|11875426|FG000|COMPLETED|Overall Study||10
10710287|NCT02648178|11875426|FG000|NOT COMPLETED|Overall Study||9
10710288|NCT02648204|11875434|FG000|STARTED|Overall Study||301
10710289|NCT02648204|11875435|FG001|STARTED|Overall Study||300
10493224|NCT01200810|11643118|FG000|STARTED|Overall Study||5
10493225|NCT01200810|11643119|FG001|STARTED|Overall Study||5
10493226|NCT01200810|11643118|FG000|COMPLETED|Overall Study||0
10493227|NCT01200810|11643119|FG001|COMPLETED|Overall Study||0
10493228|NCT01200810|11643118|FG000|NOT COMPLETED|Overall Study||5
10493229|NCT01200810|11643119|FG001|NOT COMPLETED|Overall Study||5
10493230|NCT01200875|11643125|FG000|STARTED|Overall Study||25
10493231|NCT01200875|11643125|FG000|COMPLETED|Overall Study||25
10493232|NCT01200875|11643125|FG000|NOT COMPLETED|Overall Study||0
10493233|NCT01200992|11643131|FG000|STARTED|Overall Study||39
10493234|NCT01200992|11643132|FG001|STARTED|Overall Study||45
10493235|NCT01200992|11643131|FG000|COMPLETED|Overall Study||2
10493236|NCT01200992|11643132|FG001|COMPLETED|Overall Study||4
10493237|NCT01200992|11643131|FG000|NOT COMPLETED|Overall Study||37
10493238|NCT01200992|11643132|FG001|NOT COMPLETED|Overall Study||41
10493239|NCT01201057|11643144|FG000|STARTED|Overall Study||34
10493240|NCT01201057|11643145|FG001|STARTED|Overall Study||33
10493241|NCT01201057|11643146|FG002|STARTED|Overall Study||32
10493242|NCT01201057|11643147|FG003|STARTED|Overall Study||33
10493243|NCT01201057|11643144|FG000|COMPLETED|Overall Study||32
10493244|NCT01201057|11643145|FG001|COMPLETED|Overall Study||29
10493245|NCT01201057|11643146|FG002|COMPLETED|Overall Study||27
10493246|NCT01201057|11643147|FG003|COMPLETED|Overall Study||29
10493247|NCT01201057|11643144|FG000|NOT COMPLETED|Overall Study||2
10493248|NCT01201057|11643145|FG001|NOT COMPLETED|Overall Study||4
10493249|NCT01201057|11643146|FG002|NOT COMPLETED|Overall Study||5
10493250|NCT01201057|11643147|FG003|NOT COMPLETED|Overall Study||4
10493251|NCT01201265|11643157|FG000|STARTED|Overall Study||40
10493252|NCT01201265|11643157|FG000|COMPLETED|Overall Study||2
10493253|NCT01201265|11643157|FG000|NOT COMPLETED|Overall Study||38
10493254|NCT01201317|11643164|FG000|STARTED|Overall Study||48
10710290|NCT02648204|11875436|FG002|STARTED|Overall Study||300
10710291|NCT02648204|11875437|FG003|STARTED|Overall Study||300
10710292|NCT02648204|11875434|FG000|Exposed|Overall Study||301
10710293|NCT02648204|11875435|FG001|Exposed|Overall Study||300
10493255|NCT01201317|11643165|FG001|STARTED|Overall Study||45
10493256|NCT01201317|11643166|FG002|STARTED|Overall Study||41
10493257|NCT01201317|11643164|FG000|COMPLETED|Overall Study||39
10493258|NCT01201317|11643165|FG001|COMPLETED|Overall Study||38
10493259|NCT01201317|11643166|FG002|COMPLETED|Overall Study||33
10493260|NCT01201317|11643164|FG000|NOT COMPLETED|Overall Study||9
10493261|NCT01201317|11643165|FG001|NOT COMPLETED|Overall Study||7
10493262|NCT01201317|11643166|FG002|NOT COMPLETED|Overall Study||8
10710294|NCT02648204|11875436|FG002|Exposed|Overall Study||299
10710295|NCT02648204|11875437|FG003|Exposed|Overall Study||299
10493263|NCT01201343|11643174|FG000|STARTED|Overall Study||79
10493264|NCT01201343|11643174|FG000|Treated|Overall Study||76
10493265|NCT01201343|11643174|FG000|COMPLETED|Overall Study||60
10493266|NCT01201343|11643174|FG000|NOT COMPLETED|Overall Study||19
10493267|NCT01201356|11643178|FG000|STARTED|Overall Study||4125
10493268|NCT01201356|11643178|FG000|Safety Set|Overall Study||4083
10493269|NCT01201356|11643178|FG000|Fingolimod Full Analysis Set|Overall Study||4046
10493270|NCT01201356|11643178|FG000|COMPLETED|Overall Study||3481
10493271|NCT01201356|11643178|FG000|NOT COMPLETED|Overall Study||644
10493272|NCT01201486|11643182|FG000|STARTED|Overall Study||6781
10493273|NCT01201486|11643182|FG000|COMPLETED|Overall Study||6781
10493274|NCT01201486|11643182|FG000|NOT COMPLETED|Overall Study||0
10493275|NCT01201629|11643188|FG000|STARTED|Overall Study||8
10493276|NCT01201629|11643189|FG001|STARTED|Overall Study||8
10493277|NCT01201629|11643188|FG000|COMPLETED|Overall Study||8
10493278|NCT01201629|11643189|FG001|COMPLETED|Overall Study||8
10493279|NCT01201629|11643188|FG000|NOT COMPLETED|Overall Study||0
10493280|NCT01201629|11643189|FG001|NOT COMPLETED|Overall Study||0
10493281|NCT01201759|11643197|FG000|STARTED|Visit 1 Wash-in ( Untreated)||10
10493282|NCT01201759|11643198|FG001|STARTED|Visit 1 Wash-in ( Untreated)||8
10493283|NCT01201759|11643197|FG000|COMPLETED|Visit 1 Wash-in ( Untreated)||8
10493284|NCT01201759|11643198|FG001|COMPLETED|Visit 1 Wash-in ( Untreated)||7
10493285|NCT01201759|11643197|FG000|NOT COMPLETED|Visit 1 Wash-in ( Untreated)||2
10493286|NCT01201759|11643198|FG001|NOT COMPLETED|Visit 1 Wash-in ( Untreated)||1
10493287|NCT01201759|11643197|FG000|STARTED|Visit 2||8
10493288|NCT01201759|11643198|FG001|STARTED|Visit 2||7
10493289|NCT01201759|11643197|FG000|COMPLETED|Visit 2||8
10493290|NCT01201759|11643198|FG001|COMPLETED|Visit 2||7
10493291|NCT01201759|11643197|FG000|NOT COMPLETED|Visit 2||0
10493292|NCT01201759|11643198|FG001|NOT COMPLETED|Visit 2||0
10493293|NCT01201759|11643197|FG000|STARTED|Visit 3 - Washout||8
10493294|NCT01201759|11643198|FG001|STARTED|Visit 3 - Washout||7
10493295|NCT01201759|11643197|FG000|COMPLETED|Visit 3 - Washout||7
10493296|NCT01201759|11643198|FG001|COMPLETED|Visit 3 - Washout||4
10493297|NCT01201759|11643197|FG000|NOT COMPLETED|Visit 3 - Washout||1
10493298|NCT01201759|11643198|FG001|NOT COMPLETED|Visit 3 - Washout||3
10493299|NCT01201759|11643197|FG000|STARTED|Visit 4 Crossover||7
10493300|NCT01201759|11643198|FG001|STARTED|Visit 4 Crossover||4
10493301|NCT01201759|11643197|FG000|COMPLETED|Visit 4 Crossover||7
10493302|NCT01201759|11643198|FG001|COMPLETED|Visit 4 Crossover||3
10493303|NCT01201759|11643197|FG000|NOT COMPLETED|Visit 4 Crossover||0
10493304|NCT01201759|11643198|FG001|NOT COMPLETED|Visit 4 Crossover||1
10493305|NCT01201759|11643197|FG000|STARTED|Visit 5||7
10493306|NCT01201759|11643198|FG001|STARTED|Visit 5||3
10493307|NCT01201759|11643197|FG000|COMPLETED|Visit 5||7
10493308|NCT01201759|11643198|FG001|COMPLETED|Visit 5||3
10493309|NCT01201759|11643197|FG000|NOT COMPLETED|Visit 5||0
10493310|NCT01201759|11643198|FG001|NOT COMPLETED|Visit 5||0
10493311|NCT01201772|11643209|FG000|STARTED|Overall Study||23
10493312|NCT01201772|11643210|FG001|STARTED|Overall Study||21
10493313|NCT01201772|11643211|FG002|STARTED|Overall Study||21
10493314|NCT01201772|11643209|FG000|COMPLETED|Overall Study||22
10493315|NCT01201772|11643210|FG001|COMPLETED|Overall Study||21
10493316|NCT01201772|11643211|FG002|COMPLETED|Overall Study||21
10493317|NCT01201772|11643209|FG000|NOT COMPLETED|Overall Study||1
10493318|NCT01201772|11643210|FG001|NOT COMPLETED|Overall Study||0
10493319|NCT01201772|11643211|FG002|NOT COMPLETED|Overall Study||0
10493320|NCT01201785|11643217|FG000|STARTED|Overall Study||36
10493321|NCT01201785|11643217|FG000|COMPLETED|Overall Study||20
10493322|NCT01201785|11643217|FG000|NOT COMPLETED|Overall Study||16
10493323|NCT01201798|11643223|FG000|STARTED|Overall Study||56
10493324|NCT01201798|11643224|FG001|STARTED|Overall Study||54
10493325|NCT01201798|11643223|FG000|COMPLETED|Overall Study||47
10493326|NCT01201798|11643224|FG001|COMPLETED|Overall Study||39
10493327|NCT01201798|11643223|FG000|NOT COMPLETED|Overall Study||9
10493328|NCT01201798|11643224|FG001|NOT COMPLETED|Overall Study||15
10493329|NCT01201811|11643230|FG000|STARTED|Overall Study||44
10493330|NCT01201811|11643230|FG000|COMPLETED|Overall Study||25
10493331|NCT01201811|11643230|FG000|NOT COMPLETED|Overall Study||19
10493332|NCT01201850|11643234|FG000|STARTED|Overall Study||7
10493333|NCT01201850|11643234|FG000|COMPLETED|Overall Study||3
10493334|NCT01201850|11643234|FG000|NOT COMPLETED|Overall Study||4
10493335|NCT01201863|11643241|FG000|STARTED|Overall Study||12
10493336|NCT01201863|11643242|FG001|STARTED|Overall Study||10
10493337|NCT01201863|11643243|FG002|STARTED|Overall Study||24
10493338|NCT01201863|11643241|FG000|COMPLETED|Overall Study||11
10493339|NCT01201863|11643242|FG001|COMPLETED|Overall Study||6
10493340|NCT01201863|11643243|FG002|COMPLETED|Overall Study||18
10493341|NCT01201863|11643241|FG000|NOT COMPLETED|Overall Study||1
10493342|NCT01201863|11643242|FG001|NOT COMPLETED|Overall Study||4
10493343|NCT01201863|11643243|FG002|NOT COMPLETED|Overall Study||6
10493344|NCT01201915|11643254|FG000|STARTED|Overall Study||24
10493345|NCT01201915|11643255|FG001|STARTED|Overall Study||25
10493346|NCT01201915|11643256|FG002|STARTED|Overall Study||25
10493347|NCT01201915|11643254|FG000|COMPLETED|Overall Study||16
10493348|NCT01201915|11643255|FG001|COMPLETED|Overall Study||14
10493349|NCT01201915|11643256|FG002|COMPLETED|Overall Study||19
10493350|NCT01201915|11643254|FG000|NOT COMPLETED|Overall Study||8
10493351|NCT01201915|11643255|FG001|NOT COMPLETED|Overall Study||11
10493352|NCT01201915|11643256|FG002|NOT COMPLETED|Overall Study||6
10493353|NCT01201967|11643266|FG000|STARTED|Overall Study||92
10493354|NCT01201967|11643267|FG001|STARTED|Overall Study||91
10493355|NCT01201967|11643266|FG000|COMPLETED|Overall Study||86
10493356|NCT01201967|11643267|FG001|COMPLETED|Overall Study||86
10493357|NCT01201967|11643266|FG000|NOT COMPLETED|Overall Study||6
10493358|NCT01201967|11643267|FG001|NOT COMPLETED|Overall Study||5
10493359|NCT01202071|11643274|FG000|STARTED|Overall Study||6
10493360|NCT01202071|11643275|FG001|STARTED|Overall Study||6
10493361|NCT01202071|11643276|FG002|STARTED|Overall Study||6
10493362|NCT01202071|11643277|FG003|STARTED|Overall Study||6
10493363|NCT01202071|11643274|FG000|COMPLETED|Overall Study||6
10493364|NCT01202071|11643275|FG001|COMPLETED|Overall Study||6
10493365|NCT01202071|11643276|FG002|COMPLETED|Overall Study||6
10493366|NCT01202071|11643277|FG003|COMPLETED|Overall Study||6
10493367|NCT01202071|11643274|FG000|NOT COMPLETED|Overall Study||0
10493368|NCT01202071|11643275|FG001|NOT COMPLETED|Overall Study||0
10493369|NCT01202071|11643276|FG002|NOT COMPLETED|Overall Study||0
10493370|NCT01202071|11643277|FG003|NOT COMPLETED|Overall Study||0
10493371|NCT01202162|11643289|FG000|STARTED|Overall Study||43
10493372|NCT01202162|11643290|FG001|STARTED|Overall Study||42
10493373|NCT01202162|11643289|FG000|COMPLETED|Overall Study|40 completed the intraoperative through discharge phase of the study.|40
10493374|NCT01202162|11643290|FG001|COMPLETED|Overall Study|40 completed the intraoperative through discharge phase of the study.|40
10493375|NCT01202162|11643289|FG000|NOT COMPLETED|Overall Study||3
10493376|NCT01202162|11643290|FG001|NOT COMPLETED|Overall Study||2
10493377|NCT01202175|11643298|FG000|STARTED|Overall Study||50
10493378|NCT01202175|11643298|FG000|Nebivolol|Overall Study||25
10493379|NCT01202175|11643298|FG000|Pacebo|Overall Study||25
10493380|NCT01202175|11643298|FG000|COMPLETED|Overall Study||45
10493381|NCT01202175|11643298|FG000|NOT COMPLETED|Overall Study||5
10493382|NCT01202188|11643308|FG000|STARTED|Overall Study||475
10493383|NCT01202188|11643309|FG001|STARTED|Overall Study||477
10493384|NCT01202188|11643310|FG002|STARTED|Overall Study||475
10493385|NCT01202188|11643311|FG003|STARTED|Overall Study||483
10493386|NCT01202188|11643312|FG004|STARTED|Overall Study||234
10493387|NCT01202188|11643308|FG000|Safety Set; Received Study Drug|Overall Study||474
10493388|NCT01202188|11643309|FG001|Safety Set; Received Study Drug|Overall Study||476
10493389|NCT01202188|11643310|FG002|Safety Set; Received Study Drug|Overall Study||473
10493390|NCT01202188|11643311|FG003|Safety Set; Received Study Drug|Overall Study||480
10493391|NCT01202188|11643312|FG004|Safety Set; Received Study Drug|Overall Study||232
10493392|NCT01202188|11643308|FG000|COMPLETED|Overall Study||437
10493393|NCT01202188|11643309|FG001|COMPLETED|Overall Study||421
10493394|NCT01202188|11643310|FG002|COMPLETED|Overall Study||422
10493395|NCT01202188|11643311|FG003|COMPLETED|Overall Study||441
10493396|NCT01202188|11643312|FG004|COMPLETED|Overall Study||189
10493397|NCT01202188|11643308|FG000|NOT COMPLETED|Overall Study||38
10493398|NCT01202188|11643309|FG001|NOT COMPLETED|Overall Study||56
10493399|NCT01202188|11643310|FG002|NOT COMPLETED|Overall Study||53
10493400|NCT01202188|11643311|FG003|NOT COMPLETED|Overall Study||42
10493401|NCT01202188|11643312|FG004|NOT COMPLETED|Overall Study||45
10493402|NCT01202227|11643330|FG000|STARTED|Overall Study|Treated|103
10493403|NCT01202227|11643330|FG000|COMPLETED|Overall Study||84
10493404|NCT01202227|11643330|FG000|NOT COMPLETED|Overall Study||19
10493405|NCT01202253|11643334|FG000|STARTED|Overall Study||50
10493406|NCT01202253|11643334|FG000|COMPLETED|Overall Study||50
10493407|NCT01202253|11643334|FG000|NOT COMPLETED|Overall Study||0
10493408|NCT01202279|11643340|FG000|STARTED|Overall Study||591
10493409|NCT01202279|11643341|FG001|STARTED|Overall Study||588
10493410|NCT01202279|11643340|FG000|COMPLETED|Overall Study||554
10493411|NCT01202279|11643341|FG001|COMPLETED|Overall Study||561
10493412|NCT01202279|11643340|FG000|NOT COMPLETED|Overall Study||37
10493413|NCT01202279|11643341|FG001|NOT COMPLETED|Overall Study||27
10493414|NCT01202409|11643347|FG000|STARTED|Overall Study||19
10493415|NCT01202409|11643347|FG000|COMPLETED|Overall Study||11
10493416|NCT01202409|11643347|FG000|NOT COMPLETED|Overall Study||8
10493417|NCT01202565|11643351|FG000|STARTED|Overall Study||506
10493418|NCT01202565|11643351|FG000|Full Analysis Set|Overall Study|Participants with a signed informed consent and any available data regarding adalimumab treatment.|501
10493419|NCT01202565|11643351|FG000|COMPLETED|Overall Study|Indicates participants who completed the Month 12 visit|439
10493420|NCT01202565|11643351|FG000|NOT COMPLETED|Overall Study||67
10493421|NCT01202578|11643355|FG000|STARTED|Overall Study||53
10493422|NCT01202578|11643355|FG000|COMPLETED|Overall Study||53
10493423|NCT01202578|11643355|FG000|NOT COMPLETED|Overall Study||0
10493424|NCT01202591|11643365|FG000|STARTED|Overall Study||5
10493425|NCT01202591|11643366|FG001|STARTED|Overall Study||5
10493426|NCT01202591|11643367|FG002|STARTED|Overall Study||12
10493427|NCT01202591|11643368|FG003|STARTED|Overall Study||9
10493428|NCT01202591|11643369|FG004|STARTED|Overall Study||5
10650043|NCT02165826|11810196|FG000|STARTED|Down-Titration Period||27
10493429|NCT01202591|11643370|FG005|STARTED|Overall Study||4
10493430|NCT01202591|11643365|FG000|COMPLETED|Overall Study||0
10493431|NCT01202591|11643366|FG001|COMPLETED|Overall Study||0
10493432|NCT01202591|11643367|FG002|COMPLETED|Overall Study||1
10493433|NCT01202591|11643368|FG003|COMPLETED|Overall Study||2
10493434|NCT01202591|11643369|FG004|COMPLETED|Overall Study||0
10493435|NCT01202591|11643370|FG005|COMPLETED|Overall Study||0
10493436|NCT01202591|11643365|FG000|NOT COMPLETED|Overall Study||5
10493437|NCT01202591|11643366|FG001|NOT COMPLETED|Overall Study||5
10493438|NCT01202591|11643367|FG002|NOT COMPLETED|Overall Study||11
10493439|NCT01202591|11643368|FG003|NOT COMPLETED|Overall Study||7
10493440|NCT01202591|11643369|FG004|NOT COMPLETED|Overall Study||5
10493441|NCT01202591|11643370|FG005|NOT COMPLETED|Overall Study||4
10493442|NCT01202643|11643386|FG000|STARTED|Period 1||6
10493443|NCT01202643|11643387|FG001|STARTED|Period 1||6
10493444|NCT01202643|11643386|FG000|COMPLETED|Period 1||6
10493445|NCT01202643|11643387|FG001|COMPLETED|Period 1||6
10493446|NCT01202643|11643386|FG000|NOT COMPLETED|Period 1||0
10809972|NCT03816761|11971818|FG001|COMPLETED|Second Treatment Period (7 Days)||4
10809973|NCT03816761|11971819|FG002|COMPLETED|Second Treatment Period (7 Days)||4
10809974|NCT03816761|11971820|FG003|COMPLETED|Second Treatment Period (7 Days)||3
10809975|NCT03816761|11971821|FG004|COMPLETED|Second Treatment Period (7 Days)||4
10809976|NCT03816761|11971822|FG005|COMPLETED|Second Treatment Period (7 Days)||3
10809977|NCT03816761|11971817|FG000|NOT COMPLETED|Second Treatment Period (7 Days)||0
10809978|NCT03816761|11971818|FG001|NOT COMPLETED|Second Treatment Period (7 Days)||0
10809979|NCT03816761|11971819|FG002|NOT COMPLETED|Second Treatment Period (7 Days)||0
10809980|NCT03816761|11971820|FG003|NOT COMPLETED|Second Treatment Period (7 Days)||1
10809981|NCT03816761|11971821|FG004|NOT COMPLETED|Second Treatment Period (7 Days)||0
10809982|NCT03816761|11971822|FG005|NOT COMPLETED|Second Treatment Period (7 Days)||0
10809983|NCT03801044|11971844|FG000|STARTED|Overall Study||21
10809984|NCT03801044|11971844|FG000|COMPLETED|Overall Study||21
10809985|NCT03801044|11971844|FG000|NOT COMPLETED|Overall Study||0
10809986|NCT03805672|11971854|FG000|STARTED|Overall Study||2
10809987|NCT03805672|11971855|FG001|STARTED|Overall Study||2
10809988|NCT03805672|11971854|FG000|COMPLETED|Overall Study||2
10809989|NCT03805672|11971855|FG001|COMPLETED|Overall Study||2
10809990|NCT03805672|11971854|FG000|NOT COMPLETED|Overall Study||0
10809991|NCT03805672|11971855|FG001|NOT COMPLETED|Overall Study||0
10809992|NCT03808493|11971865|FG000|STARTED|Overall Study||12
10809993|NCT03808493|11971866|FG001|STARTED|Overall Study||12
10809994|NCT03808493|11971867|FG002|STARTED|Overall Study||12
10809995|NCT03808493|11971868|FG003|STARTED|Overall Study||12
10809996|NCT03808493|11971865|FG000|COMPLETED|Overall Study||12
10809997|NCT03808493|11971866|FG001|COMPLETED|Overall Study||12
10809998|NCT03808493|11971867|FG002|COMPLETED|Overall Study||12
10493447|NCT01202643|11643387|FG001|NOT COMPLETED|Period 1||0
10493448|NCT01202643|11643386|FG000|STARTED|Crossover Cycle|One patient became pregnant following Period 1, Only one non-pregnant chose to cycle again|1
10710334|NCT02648932|11875497|FG001|STARTED|Overall Study||4
10493449|NCT01202643|11643387|FG001|STARTED|Crossover Cycle|Three patients became pregnant after Period 1, 1 patient chose not to cycle again|2
10493450|NCT01202643|11643386|FG000|COMPLETED|Crossover Cycle||1
10493451|NCT01202643|11643387|FG001|COMPLETED|Crossover Cycle||2
10493452|NCT01202643|11643386|FG000|NOT COMPLETED|Crossover Cycle||0
10493453|NCT01202643|11643387|FG001|NOT COMPLETED|Crossover Cycle||0
10493454|NCT01202656|11643395|FG000|STARTED|Cycle 1|Results reported In Barad et al 2014 are combined from both G-CSF studies|67
10493455|NCT01202656|11643396|FG001|STARTED|Cycle 1|Results reported In Barad et al 2014 are combined from both G-CSF studies|62
10493456|NCT01202656|11643395|FG000|COMPLETED|Cycle 1||67
10493457|NCT01202656|11643396|FG001|COMPLETED|Cycle 1||62
10493458|NCT01202656|11643395|FG000|NOT COMPLETED|Cycle 1||0
10493459|NCT01202656|11643396|FG001|NOT COMPLETED|Cycle 1||0
10493460|NCT01202656|11643395|FG000|STARTED|CrossoverCycle|16 ongoing pregnancies were not eligible for crossover, others chose to not have another IVF cycle|18
10493461|NCT01202656|11643396|FG001|STARTED|CrossoverCycle|14 ongoing pregnancies were not eligible for crossover, others chose to not have another IVF cycle|14
10493462|NCT01202656|11643395|FG000|COMPLETED|CrossoverCycle||18
10710296|NCT02648204|11875434|FG000|COMPLETED|Overall Study||279
10710297|NCT02648204|11875435|FG001|COMPLETED|Overall Study||279
10710298|NCT02648204|11875436|FG002|COMPLETED|Overall Study||287
10493463|NCT01202656|11643396|FG001|COMPLETED|CrossoverCycle||14
10493464|NCT01202656|11643395|FG000|NOT COMPLETED|CrossoverCycle||0
10493465|NCT01202656|11643396|FG001|NOT COMPLETED|CrossoverCycle||0
10493466|NCT01202721|11643406|FG000|STARTED|Overall Study||18
10710299|NCT02648204|11875437|FG003|COMPLETED|Overall Study||284
10710300|NCT02648204|11875434|FG000|NOT COMPLETED|Overall Study||22
10710301|NCT02648204|11875435|FG001|NOT COMPLETED|Overall Study||21
10710302|NCT02648204|11875436|FG002|NOT COMPLETED|Overall Study||13
10710303|NCT02648204|11875437|FG003|NOT COMPLETED|Overall Study||16
10710304|NCT02648217|11875449|FG000|STARTED|Overall Study||131
10710305|NCT02648217|11875450|FG001|STARTED|Overall Study||132
10710306|NCT02648217|11875449|FG000|Exposed|Overall Study||130
10710307|NCT02648217|11875450|FG001|Exposed|Overall Study||132
10710308|NCT02648217|11875449|FG000|COMPLETED|Overall Study||121
10710309|NCT02648217|11875450|FG001|COMPLETED|Overall Study||127
10710310|NCT02648217|11875449|FG000|NOT COMPLETED|Overall Study||10
10710311|NCT02648217|11875450|FG001|NOT COMPLETED|Overall Study||5
10710312|NCT02648230|11875456|FG000|STARTED|Overall Study||74
10809999|NCT03808493|11971868|FG003|COMPLETED|Overall Study||12
10810000|NCT03808493|11971865|FG000|NOT COMPLETED|Overall Study||0
10810001|NCT03808493|11971866|FG001|NOT COMPLETED|Overall Study||0
10810002|NCT03808493|11971867|FG002|NOT COMPLETED|Overall Study||0
10810003|NCT03808493|11971868|FG003|NOT COMPLETED|Overall Study||0
10810004|NCT03815292|11971880|FG000|STARTED|Overall Study||135
10493467|NCT01202721|11643407|FG001|STARTED|Overall Study||26
10493468|NCT01202721|11643408|FG002|STARTED|Overall Study||14
10493469|NCT01202721|11643409|FG003|STARTED|Overall Study||27
10710313|NCT02648230|11875456|FG000|COMPLETED|Overall Study||74
10710314|NCT02648230|11875456|FG000|NOT COMPLETED|Overall Study||0
10710315|NCT02648438|11875463|FG000|STARTED|Overall Study||12
10710316|NCT02648438|11875464|FG001|STARTED|Overall Study||12
10710317|NCT02648438|11875465|FG002|STARTED|Overall Study||6
10710318|NCT02648438|11875463|FG000|COMPLETED|Overall Study||9
10710319|NCT02648438|11875464|FG001|COMPLETED|Overall Study||9
10710320|NCT02648438|11875465|FG002|COMPLETED|Overall Study||6
10710321|NCT02648438|11875463|FG000|NOT COMPLETED|Overall Study||3
10493470|NCT01202721|11643406|FG000|COMPLETED|Overall Study||18
10493471|NCT01202721|11643407|FG001|COMPLETED|Overall Study||26
10493472|NCT01202721|11643408|FG002|COMPLETED|Overall Study||14
10493473|NCT01202721|11643409|FG003|COMPLETED|Overall Study||27
10493474|NCT01202721|11643406|FG000|NOT COMPLETED|Overall Study||0
10493475|NCT01202721|11643407|FG001|NOT COMPLETED|Overall Study||0
10493476|NCT01202721|11643408|FG002|NOT COMPLETED|Overall Study||0
10493477|NCT01202721|11643409|FG003|NOT COMPLETED|Overall Study||0
10493478|NCT01202747|11643421|FG000|STARTED|Overall Study||50
10493479|NCT01202747|11643421|FG000|COMPLETED|Overall Study|One subject did not return for the 4 Week visit due to inconvenience.|49
10493480|NCT01202747|11643421|FG000|NOT COMPLETED|Overall Study||1
10493481|NCT01202760|11643428|FG000|STARTED|Overall Study||379
10493482|NCT01202760|11643429|FG001|STARTED|Overall Study||374
10493483|NCT01202760|11643430|FG002|STARTED|Overall Study||251
10493484|NCT01202760|11643428|FG000|Received at Least One Dose of Study Drug|Overall Study||379
10493485|NCT01202760|11643429|FG001|Received at Least One Dose of Study Drug|Overall Study||371
10493486|NCT01202760|11643430|FG002|Received at Least One Dose of Study Drug|Overall Study||250
10493487|NCT01202760|11643428|FG000|COMPLETED|Overall Study||332
10493488|NCT01202760|11643429|FG001|COMPLETED|Overall Study||322
10493489|NCT01202760|11643430|FG002|COMPLETED|Overall Study||216
10710322|NCT02648438|11875464|FG001|NOT COMPLETED|Overall Study||3
10710323|NCT02648438|11875465|FG002|NOT COMPLETED|Overall Study||0
10710324|NCT02648646|11875481|FG000|STARTED|Overall Study||10
10710325|NCT02648646|11875481|FG000|COMPLETED|Overall Study||8
10710326|NCT02648646|11875481|FG000|NOT COMPLETED|Overall Study||2
10710327|NCT02648880|11875485|FG000|STARTED|Overall Study|Recruitment was significantly limited, only 3 participants were eligible, all enrolled. All three were assigned to the exercise arm, per protocol. No participants were recruited into the control arm and it was eliminated.|3
10710328|NCT02648880|11875485|FG000|COMPLETED|Overall Study||3
10710329|NCT02648880|11875485|FG000|NOT COMPLETED|Overall Study||0
10710330|NCT02648919|11875489|FG000|STARTED|Overall Study||6
10710331|NCT02648919|11875489|FG000|COMPLETED|Overall Study||6
10710332|NCT02648919|11875489|FG000|NOT COMPLETED|Overall Study||0
10710333|NCT02648932|11875496|FG000|STARTED|Overall Study||5
10710335|NCT02648932|11875496|FG000|COMPLETED|Overall Study||2
10710336|NCT02648932|11875497|FG001|COMPLETED|Overall Study||3
10710337|NCT02648932|11875496|FG000|NOT COMPLETED|Overall Study||3
10710338|NCT02648932|11875497|FG001|NOT COMPLETED|Overall Study||1
10710339|NCT02648971|11875505|FG000|STARTED|Overall Study||18
10710340|NCT02648971|11875506|FG001|STARTED|Overall Study||18
10710341|NCT02648971|11875505|FG000|COMPLETED|Overall Study||18
10710342|NCT02648971|11875506|FG001|COMPLETED|Overall Study||18
10710343|NCT02648971|11875505|FG000|NOT COMPLETED|Overall Study||0
10710344|NCT02648971|11875506|FG001|NOT COMPLETED|Overall Study||0
10710345|NCT02649192|11875518|FG000|STARTED|Overall Study||5
10710346|NCT02649192|11875519|FG001|STARTED|Overall Study||4
10493490|NCT01202760|11643428|FG000|NOT COMPLETED|Overall Study||47
10493491|NCT01202760|11643429|FG001|NOT COMPLETED|Overall Study||52
10493492|NCT01202760|11643430|FG002|NOT COMPLETED|Overall Study||35
10493493|NCT01202773|11643453|FG000|STARTED|Overall Study||153
10493494|NCT01202773|11643454|FG001|STARTED|Overall Study||148
10493495|NCT01202773|11643455|FG002|STARTED|Overall Study||155
10493496|NCT01202773|11643453|FG000|Received at Least 1 Dose of Study Drug|Overall Study||153
10493497|NCT01202773|11643454|FG001|Received at Least 1 Dose of Study Drug|Overall Study||147
10493498|NCT01202773|11643455|FG002|Received at Least 1 Dose of Study Drug|Overall Study||154
10493499|NCT01202773|11643453|FG000|Week 16 NR|Overall Study||23
10493500|NCT01202773|11643454|FG001|Week 16 NR|Overall Study||33
10493501|NCT01202773|11643455|FG002|Week 16 NR|Overall Study||37
10493502|NCT01202773|11643453|FG000|Post-Treatment Follow-Up Population|Overall Study||46
10493503|NCT01202773|11643454|FG001|Post-Treatment Follow-Up Population|Overall Study||36
10493504|NCT01202773|11643455|FG002|Post-Treatment Follow-Up Population|Overall Study||51
10493505|NCT01202773|11643453|FG000|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|96
10493506|NCT01202773|11643454|FG001|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|105
10493507|NCT01202773|11643455|FG002|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|100
10493508|NCT01202773|11643453|FG000|NOT COMPLETED|Overall Study||57
10493509|NCT01202773|11643454|FG001|NOT COMPLETED|Overall Study||43
10493510|NCT01202773|11643455|FG002|NOT COMPLETED|Overall Study||55
10493511|NCT01202877|11643476|FG000|STARTED|Overall Study||6
10493512|NCT01202877|11643477|FG001|STARTED|Overall Study||8
10493513|NCT01202877|11643478|FG002|STARTED|Overall Study||40
10493514|NCT01202877|11643476|FG000|COMPLETED|Overall Study||6
10493515|NCT01202877|11643477|FG001|COMPLETED|Overall Study||7
10493516|NCT01202877|11643478|FG002|COMPLETED|Overall Study||34
10493517|NCT01202877|11643476|FG000|NOT COMPLETED|Overall Study||0
10493518|NCT01202877|11643477|FG001|NOT COMPLETED|Overall Study||1
10493519|NCT01202877|11643478|FG002|NOT COMPLETED|Overall Study||6
10493520|NCT01202903|11643488|FG000|STARTED|Overall Study||308
10493521|NCT01202903|11643489|FG001|STARTED|Overall Study||308
10493522|NCT01202903|11643488|FG000|Full Analysis Set|Overall Study||306
10493523|NCT01202903|11643489|FG001|Full Analysis Set|Overall Study||302
10493524|NCT01202903|11643488|FG000|Safety Set*|Overall Study||310
10493525|NCT01202903|11643489|FG001|Safety Set*|Overall Study||299
10493526|NCT01202903|11643488|FG000|COMPLETED|Overall Study||297
10493527|NCT01202903|11643489|FG001|COMPLETED|Overall Study||292
10710347|NCT02649192|11875520|FG002|STARTED|Overall Study||22
10493528|NCT01202903|11643488|FG000|NOT COMPLETED|Overall Study||11
10493529|NCT01202903|11643489|FG001|NOT COMPLETED|Overall Study||16
10493530|NCT01202955|11643497|FG000|STARTED|Period 1: 10 Days||9
10493531|NCT01202955|11643498|FG001|STARTED|Period 1: 10 Days||10
10493532|NCT01202955|11643497|FG000|COMPLETED|Period 1: 10 Days||9
10493533|NCT01202955|11643498|FG001|COMPLETED|Period 1: 10 Days||8
10493534|NCT01202955|11643497|FG000|NOT COMPLETED|Period 1: 10 Days||0
10493535|NCT01202955|11643498|FG001|NOT COMPLETED|Period 1: 10 Days||2
10493536|NCT01202955|11643497|FG000|STARTED|Period 2: 7 Days (Wash-Out)||9
10493537|NCT01202955|11643498|FG001|STARTED|Period 2: 7 Days (Wash-Out)||8
10493538|NCT01202955|11643497|FG000|COMPLETED|Period 2: 7 Days (Wash-Out)||9
10493539|NCT01202955|11643498|FG001|COMPLETED|Period 2: 7 Days (Wash-Out)||8
10493540|NCT01202955|11643497|FG000|NOT COMPLETED|Period 2: 7 Days (Wash-Out)||0
10493541|NCT01202955|11643498|FG001|NOT COMPLETED|Period 2: 7 Days (Wash-Out)||0
10493542|NCT01202955|11643497|FG000|STARTED|Period 3: 10 Days||9
10493543|NCT01202955|11643498|FG001|STARTED|Period 3: 10 Days||8
10493544|NCT01202955|11643497|FG000|COMPLETED|Period 3: 10 Days||9
10493545|NCT01202955|11643498|FG001|COMPLETED|Period 3: 10 Days||8
10493546|NCT01202955|11643497|FG000|NOT COMPLETED|Period 3: 10 Days||0
10493547|NCT01202955|11643498|FG001|NOT COMPLETED|Period 3: 10 Days||0
10493548|NCT01202994|11643504|FG000|STARTED|Overall Study||27
10493549|NCT01202994|11643504|FG000|COMPLETED|Overall Study||27
10493550|NCT01202994|11643504|FG000|NOT COMPLETED|Overall Study||0
10493551|NCT01203046|11643511|FG000|STARTED|Overall Study||28
10493552|NCT01203046|11643512|FG001|STARTED|Overall Study||28
10493553|NCT01203046|11643511|FG000|COMPLETED|Overall Study||28
10493554|NCT01203046|11643512|FG001|COMPLETED|Overall Study||28
10493555|NCT01203046|11643511|FG000|NOT COMPLETED|Overall Study||0
10493556|NCT01203046|11643512|FG001|NOT COMPLETED|Overall Study||0
10493557|NCT01203072|11643525|FG000|STARTED|Overall Study||105
10493558|NCT01203072|11643526|FG001|STARTED|Overall Study||106
10493559|NCT01203072|11643527|FG002|STARTED|Overall Study||104
10493560|NCT01203072|11643528|FG003|STARTED|Overall Study||106
10493561|NCT01203072|11643529|FG004|STARTED|Overall Study||102
10493562|NCT01203072|11643525|FG000|COMPLETED|Overall Study||95
10493563|NCT01203072|11643526|FG001|COMPLETED|Overall Study||100
10493564|NCT01203072|11643527|FG002|COMPLETED|Overall Study||101
10493565|NCT01203072|11643528|FG003|COMPLETED|Overall Study||100
10493566|NCT01203072|11643529|FG004|COMPLETED|Overall Study||96
10493567|NCT01203072|11643525|FG000|NOT COMPLETED|Overall Study||10
10493568|NCT01203072|11643526|FG001|NOT COMPLETED|Overall Study||6
10493569|NCT01203072|11643527|FG002|NOT COMPLETED|Overall Study||3
10493570|NCT01203072|11643528|FG003|NOT COMPLETED|Overall Study||6
10493571|NCT01203072|11643529|FG004|NOT COMPLETED|Overall Study||6
10493572|NCT01203098|11643544|FG000|STARTED|Overall Study||89
10493573|NCT01203098|11643545|FG001|STARTED|Overall Study||86
10493574|NCT01203098|11643546|FG002|STARTED|Overall Study||89
10493575|NCT01203098|11643544|FG000|Safety Analysis Dataset|Overall Study||89
10493576|NCT01203098|11643545|FG001|Safety Analysis Dataset|Overall Study||85
10493577|NCT01203098|11643546|FG002|Safety Analysis Dataset|Overall Study||87
10493578|NCT01203098|11643544|FG000|COMPLETED|Overall Study||83
10493579|NCT01203098|11643545|FG001|COMPLETED|Overall Study||82
10493580|NCT01203098|11643546|FG002|COMPLETED|Overall Study||78
10493581|NCT01203098|11643544|FG000|NOT COMPLETED|Overall Study||6
10493582|NCT01203098|11643545|FG001|NOT COMPLETED|Overall Study||4
10493583|NCT01203098|11643546|FG002|NOT COMPLETED|Overall Study||11
10493584|NCT01203189|11643557|FG000|STARTED|First 4 Weeks Treatment||10
10493585|NCT01203189|11643558|FG001|STARTED|First 4 Weeks Treatment||10
10493586|NCT01203189|11643559|FG002|STARTED|First 4 Weeks Treatment||3
10493587|NCT01203189|11643557|FG000|COMPLETED|First 4 Weeks Treatment||8
10493588|NCT01203189|11643558|FG001|COMPLETED|First 4 Weeks Treatment||8
10493589|NCT01203189|11643559|FG002|COMPLETED|First 4 Weeks Treatment||3
10493590|NCT01203189|11643557|FG000|NOT COMPLETED|First 4 Weeks Treatment||2
10493591|NCT01203189|11643558|FG001|NOT COMPLETED|First 4 Weeks Treatment||2
10493592|NCT01203189|11643559|FG002|NOT COMPLETED|First 4 Weeks Treatment||0
10493593|NCT01203189|11643557|FG000|STARTED|Cross Over Period 4 Weeks Treatment||0
10493594|NCT01203189|11643558|FG001|STARTED|Cross Over Period 4 Weeks Treatment||0
10493595|NCT01203189|11643559|FG002|STARTED|Cross Over Period 4 Weeks Treatment||3
10493596|NCT01203189|11643557|FG000|COMPLETED|Cross Over Period 4 Weeks Treatment||0
10493597|NCT01203189|11643558|FG001|COMPLETED|Cross Over Period 4 Weeks Treatment||0
10493598|NCT01203189|11643559|FG002|COMPLETED|Cross Over Period 4 Weeks Treatment||3
10710348|NCT02649192|11875521|FG003|STARTED|Overall Study||22
10710349|NCT02649192|11875522|FG004|STARTED|Overall Study||12
10710350|NCT02649192|11875523|FG005|STARTED|Overall Study||14
10710351|NCT02649192|11875518|FG000|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||2
10710352|NCT02649192|11875519|FG001|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||2
10493599|NCT01203189|11643557|FG000|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
10493600|NCT01203189|11643558|FG001|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
10493601|NCT01203189|11643559|FG002|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
10493602|NCT01203319|11643570|FG000|STARTED|Overall Study||434
10493603|NCT01203319|11643571|FG001|STARTED|Overall Study||435
10493604|NCT01203319|11643572|FG002|STARTED|Overall Study||222
10493605|NCT01203319|11643570|FG000|COMPLETED|Overall Study||428
10493606|NCT01203319|11643571|FG001|COMPLETED|Overall Study||426
10493607|NCT01203319|11643572|FG002|COMPLETED|Overall Study||217
10493608|NCT01203319|11643570|FG000|NOT COMPLETED|Overall Study||6
10710353|NCT02649192|11875520|FG002|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||11
10493609|NCT01203319|11643571|FG001|NOT COMPLETED|Overall Study||9
10493610|NCT01203319|11643572|FG002|NOT COMPLETED|Overall Study||5
10493611|NCT01203644|11643582|FG000|STARTED|Overall Study||26
10493612|NCT01203644|11643583|FG001|STARTED|Overall Study||50
10493613|NCT01203644|11643582|FG000|COMPLETED|Overall Study||26
10493614|NCT01203644|11643583|FG001|COMPLETED|Overall Study||50
10493615|NCT01203644|11643582|FG000|NOT COMPLETED|Overall Study||0
10493616|NCT01203644|11643583|FG001|NOT COMPLETED|Overall Study||0
10493617|NCT01203774|11643592|FG000|STARTED|Overall Study||21
10493618|NCT01203774|11643593|FG001|STARTED|Overall Study||10
10493619|NCT01203774|11643592|FG000|COMPLETED|Overall Study||21
10493620|NCT01203774|11643593|FG001|COMPLETED|Overall Study||10
10493621|NCT01203774|11643592|FG000|NOT COMPLETED|Overall Study||0
10493622|NCT01203774|11643593|FG001|NOT COMPLETED|Overall Study||0
10493623|NCT01203787|11643601|FG000|STARTED|Overall Study||63
10493624|NCT01203787|11643602|FG001|STARTED|Overall Study||57
10710354|NCT02649192|11875521|FG003|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||12
10710355|NCT02649192|11875522|FG004|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||7
10710356|NCT02649192|11875523|FG005|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||8
10710357|NCT02649192|11875518|FG000|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||3
10710358|NCT02649192|11875519|FG001|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||2
10493625|NCT01203787|11643601|FG000|COMPLETED|Overall Study||32
10493626|NCT01203787|11643602|FG001|COMPLETED|Overall Study||30
10493627|NCT01203787|11643601|FG000|NOT COMPLETED|Overall Study||31
10493628|NCT01203787|11643602|FG001|NOT COMPLETED|Overall Study||27
10493629|NCT01203826|11643612|FG000|STARTED|Overall Study|Dose cohorts are per assigned dose in ENB-006-09. Results presented are for Study ENB-008-10 only.|6
10493630|NCT01203826|11643613|FG001|STARTED|Overall Study|Dose cohorts are per assigned dose in ENB-006-09. Results presented are for Study ENB-008-10 only.|6
10493631|NCT01203826|11643612|FG000|COMPLETED|Overall Study||6
10493632|NCT01203826|11643613|FG001|COMPLETED|Overall Study||6
10493633|NCT01203826|11643612|FG000|NOT COMPLETED|Overall Study||0
10493634|NCT01203826|11643613|FG001|NOT COMPLETED|Overall Study||0
10493635|NCT01203852|11643619|FG000|STARTED|Metoprolol 8 Weeks|This is the total number of subjects for both groups.|839
10493636|NCT01203852|11643619|FG000|COMPLETED|Metoprolol 8 Weeks||369
10493637|NCT01203852|11643619|FG000|NOT COMPLETED|Metoprolol 8 Weeks||470
10493638|NCT01203852|11643619|FG000|STARTED|Washout 2 Weeks|Some study subjects did not proceed to the washout phase after the first intervention.|328
10493639|NCT01203852|11643619|FG000|COMPLETED|Washout 2 Weeks||282
10493640|NCT01203852|11643619|FG000|NOT COMPLETED|Washout 2 Weeks||46
10493641|NCT01203852|11643619|FG000|STARTED|Chlorthalidone 8 Weeks|Subjects were allowed to enter the study at Chlorthalidone without completing Metoprolol.|328
10493642|NCT01203852|11643619|FG000|Continued From Metoprolol|Chlorthalidone 8 Weeks||282
10493643|NCT01203852|11643619|FG000|COMPLETED|Chlorthalidone 8 Weeks||328
10493644|NCT01203852|11643619|FG000|NOT COMPLETED|Chlorthalidone 8 Weeks||0
10493645|NCT01203878|11643629|FG000|STARTED|Overall Study||9
10493646|NCT01203878|11643630|FG001|STARTED|Overall Study||9
10493647|NCT01203878|11643631|FG002|STARTED|Overall Study||3
10493648|NCT01203878|11643629|FG000|COMPLETED|Overall Study||9
10493649|NCT01203878|11643630|FG001|COMPLETED|Overall Study||9
10493650|NCT01203878|11643631|FG002|COMPLETED|Overall Study||0
10493651|NCT01203878|11643629|FG000|NOT COMPLETED|Overall Study||0
10493652|NCT01203878|11643630|FG001|NOT COMPLETED|Overall Study||0
10493653|NCT01203878|11643631|FG002|NOT COMPLETED|Overall Study||3
10493654|NCT01203917|11643638|FG000|STARTED|Overall Study|106 patients were EGFR M+ patients and 1 patient was EGFR M+I|107
10493655|NCT01203917|11643638|FG000|COMPLETED|Overall Study|Patients on-going study at data cut-off(of which 49 were still on study treatment).|71
10493656|NCT01203917|11643638|FG000|NOT COMPLETED|Overall Study||36
10493657|NCT01203930|11643644|FG000|STARTED|Overall Study||64
10493658|NCT01203930|11643645|FG001|STARTED|Overall Study||41
10493659|NCT01203930|11643644|FG000|COMPLETED|Overall Study|43 participants completed 12 cycles and were then eligible to enroll in the extension study (101-99)|43
10493660|NCT01203930|11643645|FG001|COMPLETED|Overall Study||0
10493661|NCT01203930|11643644|FG000|NOT COMPLETED|Overall Study||21
10493662|NCT01203930|11643645|FG001|NOT COMPLETED|Overall Study||41
10493663|NCT01203956|11643653|FG000|STARTED|First Two-week Period||15
10493664|NCT01203956|11643654|FG001|STARTED|First Two-week Period||13
10493665|NCT01203956|11643653|FG000|COMPLETED|First Two-week Period|All participants continued to the second two-week period, whether or not they had evaluable results.|15
10493666|NCT01203956|11643654|FG001|COMPLETED|First Two-week Period|All participants continued to the second two-week period, whether or not they had evaluable results.|13
10493667|NCT01203956|11643653|FG000|NOT COMPLETED|First Two-week Period||0
10493668|NCT01203956|11643654|FG001|NOT COMPLETED|First Two-week Period||0
10493669|NCT01203956|11643653|FG000|STARTED|Second Two-week Period||15
10493670|NCT01203956|11643654|FG001|STARTED|Second Two-week Period||13
10493671|NCT01203956|11643653|FG000|Attended Sleep Studies for 14 Nights|Second Two-week Period||15
10493672|NCT01203956|11643654|FG001|Attended Sleep Studies for 14 Nights|Second Two-week Period||13
10493673|NCT01203956|11643653|FG000|COMPLETED|Second Two-week Period|Completed with evaluable results, as assessed over both two-week study periods.|10
10493674|NCT01203956|11643654|FG001|COMPLETED|Second Two-week Period|Completed with evaluable results, as assessed over both two-week study periods.|7
10493675|NCT01203956|11643653|FG000|NOT COMPLETED|Second Two-week Period||5
10493676|NCT01203956|11643654|FG001|NOT COMPLETED|Second Two-week Period||6
10493677|NCT01204203|11643661|FG000|STARTED|Overall Study||8
10493678|NCT01204203|11643661|FG000|COMPLETED|Overall Study||8
10493679|NCT01204203|11643661|FG000|NOT COMPLETED|Overall Study||0
10493680|NCT01204255|11643665|FG000|STARTED|Overall Study||11
10493681|NCT01204255|11643665|FG000|COMPLETED|Overall Study||10
10493682|NCT01204255|11643665|FG000|NOT COMPLETED|Overall Study||1
10493683|NCT01204294|11643676|FG000|STARTED|Overall Study||82
10493684|NCT01204294|11643677|FG001|STARTED|Overall Study||66
10493685|NCT01204294|11643678|FG002|STARTED|Overall Study||74
10493686|NCT01204294|11643679|FG003|STARTED|Overall Study||143
10493687|NCT01204294|11643680|FG004|STARTED|Overall Study||85
10493688|NCT01204294|11643681|FG005|STARTED|Overall Study||63
10493689|NCT01204294|11643682|FG006|STARTED|Overall Study||61
10493690|NCT01204294|11643676|FG000|COMPLETED|Overall Study||79
10493691|NCT01204294|11643677|FG001|COMPLETED|Overall Study||58
10493692|NCT01204294|11643678|FG002|COMPLETED|Overall Study||69
10493693|NCT01204294|11643679|FG003|COMPLETED|Overall Study||132
10493694|NCT01204294|11643680|FG004|COMPLETED|Overall Study||83
10493695|NCT01204294|11643681|FG005|COMPLETED|Overall Study||58
10493696|NCT01204294|11643682|FG006|COMPLETED|Overall Study||59
10493697|NCT01204294|11643676|FG000|NOT COMPLETED|Overall Study||3
10493698|NCT01204294|11643677|FG001|NOT COMPLETED|Overall Study||8
10493699|NCT01204294|11643678|FG002|NOT COMPLETED|Overall Study||5
10493700|NCT01204294|11643679|FG003|NOT COMPLETED|Overall Study||11
10493701|NCT01204294|11643680|FG004|NOT COMPLETED|Overall Study||2
10493702|NCT01204294|11643681|FG005|NOT COMPLETED|Overall Study||5
10493703|NCT01204294|11643682|FG006|NOT COMPLETED|Overall Study||2
10493704|NCT01204398|11643698|FG000|STARTED|Overall Study|Entered and treated.|27
10493705|NCT01204398|11643698|FG000|COMPLETED|Overall Study|Completed trial medication.|26
10493706|NCT01204398|11643698|FG000|NOT COMPLETED|Overall Study||1
10493707|NCT01204658|11643706|FG000|STARTED|Primary Phase||146
10493708|NCT01204658|11643707|FG001|STARTED|Primary Phase||142
10493709|NCT01204658|11643708|FG002|STARTED|Primary Phase||145
10493710|NCT01204658|11643709|FG003|STARTED|Primary Phase||142
10493711|NCT01204658|11643706|FG000|COMPLETED|Primary Phase||146
10493712|NCT01204658|11643707|FG001|COMPLETED|Primary Phase||142
10493713|NCT01204658|11643708|FG002|COMPLETED|Primary Phase||144
10493714|NCT01204658|11643709|FG003|COMPLETED|Primary Phase||142
10493715|NCT01204658|11643706|FG000|NOT COMPLETED|Primary Phase||0
10493716|NCT01204658|11643707|FG001|NOT COMPLETED|Primary Phase||0
10493717|NCT01204658|11643708|FG002|NOT COMPLETED|Primary Phase||1
10493718|NCT01204658|11643709|FG003|NOT COMPLETED|Primary Phase||0
10493719|NCT01204658|11643706|FG000|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|144
10493720|NCT01204658|11643707|FG001|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
10493721|NCT01204658|11643708|FG002|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
10493722|NCT01204658|11643709|FG003|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
10493723|NCT01204658|11643706|FG000|COMPLETED|Booster Phase||144
10493724|NCT01204658|11643707|FG001|COMPLETED|Booster Phase||140
10493725|NCT01204658|11643708|FG002|COMPLETED|Booster Phase||140
10493726|NCT01204658|11643709|FG003|COMPLETED|Booster Phase||140
10493727|NCT01204658|11643706|FG000|NOT COMPLETED|Booster Phase||0
10493728|NCT01204658|11643707|FG001|NOT COMPLETED|Booster Phase||0
10493729|NCT01204658|11643708|FG002|NOT COMPLETED|Booster Phase||0
10493730|NCT01204658|11643709|FG003|NOT COMPLETED|Booster Phase||0
10493731|NCT01204671|11643727|FG000|STARTED|Overall Study||1012
10493732|NCT01204671|11643728|FG001|STARTED|Overall Study||1013
10493733|NCT01204671|11643729|FG002|STARTED|Overall Study||1011
10493734|NCT01204671|11643730|FG003|STARTED|Overall Study||1010
10493735|NCT01204671|11643731|FG004|STARTED|Overall Study||610
10493736|NCT01204671|11643727|FG000|COMPLETED|Overall Study||998
10493737|NCT01204671|11643728|FG001|COMPLETED|Overall Study||998
10493738|NCT01204671|11643729|FG002|COMPLETED|Overall Study||998
10493739|NCT01204671|11643730|FG003|COMPLETED|Overall Study||997
10493740|NCT01204671|11643731|FG004|COMPLETED|Overall Study||606
10493741|NCT01204671|11643727|FG000|NOT COMPLETED|Overall Study||14
10493742|NCT01204671|11643728|FG001|NOT COMPLETED|Overall Study||15
10493743|NCT01204671|11643729|FG002|NOT COMPLETED|Overall Study||13
10493744|NCT01204671|11643730|FG003|NOT COMPLETED|Overall Study||13
10493745|NCT01204671|11643731|FG004|NOT COMPLETED|Overall Study||4
10493746|NCT01204697|11643749|FG000|STARTED|Overall Study||36
10493747|NCT01204697|11643750|FG001|STARTED|Overall Study||38
10493748|NCT01204697|11643749|FG000|Treated|Overall Study||36
10493749|NCT01204697|11643750|FG001|Treated|Overall Study||37
10493750|NCT01204697|11643749|FG000|COMPLETED|Overall Study||5
10493751|NCT01204697|11643750|FG001|COMPLETED|Overall Study||2
10493752|NCT01204697|11643749|FG000|NOT COMPLETED|Overall Study||31
10493753|NCT01204697|11643750|FG001|NOT COMPLETED|Overall Study||36
10493754|NCT01204710|11643758|FG000|STARTED|Randomization Treatment||63
10493755|NCT01204710|11643759|FG001|STARTED|Randomization Treatment||60
10493756|NCT01204710|11643758|FG000|Received ≥1 Dose of Study Drug|Randomization Treatment||62
10493757|NCT01204710|11643759|FG001|Received ≥1 Dose of Study Drug|Randomization Treatment||59
10493758|NCT01204710|11643758|FG000|COMPLETED|Randomization Treatment||49
10493759|NCT01204710|11643759|FG001|COMPLETED|Randomization Treatment||47
10493760|NCT01204710|11643758|FG000|NOT COMPLETED|Randomization Treatment||14
10493761|NCT01204710|11643759|FG001|NOT COMPLETED|Randomization Treatment||13
10493762|NCT01204710|11643758|FG000|STARTED|Optional Olaratumab Monotherapy|Olaratumab follow-on treatment was optional for participants in mitoxantrone group only who had PD.|0
10493763|NCT01204710|11643759|FG001|STARTED|Optional Olaratumab Monotherapy|Among 43 participants who experienced PD, 19 received olaratumab monotherapy.|19
10493764|NCT01204710|11643758|FG000|COMPLETED|Optional Olaratumab Monotherapy||0
10493765|NCT01204710|11643759|FG001|COMPLETED|Optional Olaratumab Monotherapy||16
10493766|NCT01204710|11643758|FG000|NOT COMPLETED|Optional Olaratumab Monotherapy||0
10493767|NCT01204710|11643759|FG001|NOT COMPLETED|Optional Olaratumab Monotherapy||3
10493768|NCT01204736|11643776|FG000|STARTED|Overall Study||4
10493769|NCT01204736|11643777|FG001|STARTED|Overall Study||5
10493770|NCT01204736|11643778|FG002|STARTED|Overall Study||3
10493771|NCT01204736|11643779|FG003|STARTED|Overall Study||2
10493772|NCT01204736|11643776|FG000|COMPLETED|Overall Study||4
10493773|NCT01204736|11643777|FG001|COMPLETED|Overall Study||5
10493774|NCT01204736|11643778|FG002|COMPLETED|Overall Study||3
10493775|NCT01204736|11643779|FG003|COMPLETED|Overall Study||2
10493776|NCT01204736|11643776|FG000|NOT COMPLETED|Overall Study||0
10493777|NCT01204736|11643777|FG001|NOT COMPLETED|Overall Study||0
10493778|NCT01204736|11643778|FG002|NOT COMPLETED|Overall Study||0
10493779|NCT01204736|11643779|FG003|NOT COMPLETED|Overall Study||0
10493780|NCT01204775|11643791|FG000|STARTED|Overall Study||4
10493781|NCT01204775|11643792|FG001|STARTED|Overall Study||4
10493782|NCT01204775|11643791|FG000|Double-blind Treatment Period|Overall Study||4
10493783|NCT01204775|11643792|FG001|Double-blind Treatment Period|Overall Study||4
10493784|NCT01204775|11643791|FG000|COMPLETED|Overall Study||3
10493785|NCT01204775|11643792|FG001|COMPLETED|Overall Study||3
10493786|NCT01204775|11643791|FG000|NOT COMPLETED|Overall Study||1
10493787|NCT01204775|11643792|FG001|NOT COMPLETED|Overall Study||1
10493788|NCT01204853|11643798|FG000|STARTED|Overall Study||2
10493789|NCT01204853|11643798|FG000|COMPLETED|Overall Study||2
10493790|NCT01204853|11643798|FG000|NOT COMPLETED|Overall Study||0
10493791|NCT01204905|11643802|FG000|STARTED|Overall Study||7
10493792|NCT01204905|11643802|FG000|COMPLETED|Overall Study||5
10493793|NCT01204905|11643802|FG000|NOT COMPLETED|Overall Study||2
10493794|NCT01204918|11643809|FG000|STARTED|Overall Study||25
10493795|NCT01204918|11643810|FG001|STARTED|Overall Study||39
10493796|NCT01204918|11643811|FG002|STARTED|Overall Study||40
10493797|NCT01204918|11643809|FG000|Stage 1 Begin|Overall Study||25
10493798|NCT01204918|11643810|FG001|Stage 1 Begin|Overall Study||39
10493799|NCT01204918|11643811|FG002|Stage 1 Begin|Overall Study||40
10493800|NCT01204918|11643809|FG000|Stage 1 End|Overall Study||22
10493801|NCT01204918|11643810|FG001|Stage 1 End|Overall Study||35
10493802|NCT01204918|11643811|FG002|Stage 1 End|Overall Study||36
10493803|NCT01204918|11643809|FG000|Stage 2 Begin|Overall Study||22
10493804|NCT01204918|11643810|FG001|Stage 2 Begin|Overall Study||35
10493805|NCT01204918|11643811|FG002|Stage 2 Begin|Overall Study||36
10493806|NCT01204918|11643809|FG000|Stage 2 End|Overall Study||21
10493807|NCT01204918|11643810|FG001|Stage 2 End|Overall Study||29
10493808|NCT01204918|11643811|FG002|Stage 2 End|Overall Study||35
10493809|NCT01204918|11643809|FG000|COMPLETED|Overall Study||21
10493810|NCT01204918|11643810|FG001|COMPLETED|Overall Study||29
10493811|NCT01204918|11643811|FG002|COMPLETED|Overall Study||35
10493812|NCT01204918|11643809|FG000|NOT COMPLETED|Overall Study||4
10493813|NCT01204918|11643810|FG001|NOT COMPLETED|Overall Study||10
10493814|NCT01204918|11643811|FG002|NOT COMPLETED|Overall Study||5
10493815|NCT01205035|11643821|FG000|STARTED|Overall Study||3
10493816|NCT01205035|11643822|FG001|STARTED|Overall Study||3
10710359|NCT02649192|11875520|FG002|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||11
10710360|NCT02649192|11875521|FG003|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||10
10710361|NCT02649192|11875522|FG004|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||5
10493817|NCT01205035|11643821|FG000|COMPLETED|Overall Study||1
10493818|NCT01205035|11643822|FG001|COMPLETED|Overall Study||3
10493819|NCT01205035|11643821|FG000|NOT COMPLETED|Overall Study||2
10493820|NCT01205035|11643822|FG001|NOT COMPLETED|Overall Study||0
10710362|NCT02649192|11875523|FG005|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||6
10710363|NCT02649192|11875518|FG000|COMPLETED|Overall Study||5
10710364|NCT02649192|11875519|FG001|COMPLETED|Overall Study||4
10710365|NCT02649192|11875520|FG002|COMPLETED|Overall Study||21
10710366|NCT02649192|11875521|FG003|COMPLETED|Overall Study||20
10710367|NCT02649192|11875522|FG004|COMPLETED|Overall Study||11
10493821|NCT01205126|11643830|FG000|STARTED|Titration Phase||130
10493822|NCT01205126|11643831|FG001|STARTED|Titration Phase||130
10493823|NCT01205126|11643830|FG000|COMPLETED|Titration Phase||107
10493824|NCT01205126|11643831|FG001|COMPLETED|Titration Phase||111
10493825|NCT01205126|11643830|FG000|NOT COMPLETED|Titration Phase||23
10493826|NCT01205126|11643831|FG001|NOT COMPLETED|Titration Phase||19
10493827|NCT01205126|11643830|FG000|STARTED|Between Titration & Maintenance Phase||107
10493828|NCT01205126|11643831|FG001|STARTED|Between Titration & Maintenance Phase||111
10493829|NCT01205126|11643830|FG000|COMPLETED|Between Titration & Maintenance Phase||107
10493830|NCT01205126|11643831|FG001|COMPLETED|Between Titration & Maintenance Phase||107
10493831|NCT01205126|11643830|FG000|NOT COMPLETED|Between Titration & Maintenance Phase||0
10493832|NCT01205126|11643831|FG001|NOT COMPLETED|Between Titration & Maintenance Phase||4
10493833|NCT01205126|11643830|FG000|STARTED|Maintenance Phase||107
10710368|NCT02649192|11875523|FG005|COMPLETED|Overall Study||14
10493834|NCT01205126|11643831|FG001|STARTED|Maintenance Phase||107
10493835|NCT01205126|11643830|FG000|COMPLETED|Maintenance Phase||70
10493836|NCT01205126|11643831|FG001|COMPLETED|Maintenance Phase||67
10493837|NCT01205126|11643830|FG000|NOT COMPLETED|Maintenance Phase||37
10493838|NCT01205126|11643831|FG001|NOT COMPLETED|Maintenance Phase||40
10493839|NCT01205152|11643837|FG000|STARTED|Overall Study||10
10493840|NCT01205152|11643837|FG000|COMPLETED|Overall Study||9
10493841|NCT01205152|11643837|FG000|NOT COMPLETED|Overall Study||1
10493842|NCT01205165|11643843|FG000|STARTED|Overall Study||104
10710369|NCT02649192|11875518|FG000|NOT COMPLETED|Overall Study||0
10493843|NCT01205165|11643843|FG000|COMPLETED|Overall Study||102
10493844|NCT01205165|11643843|FG000|NOT COMPLETED|Overall Study||2
10493845|NCT01205230|11643850|FG000|STARTED|Overall Study||21
10493846|NCT01205230|11643851|FG001|STARTED|Overall Study||13
10493847|NCT01205230|11643850|FG000|Combination Therapy|Overall Study||21
10493848|NCT01205230|11643851|FG001|Combination Therapy|Overall Study||13
10493849|NCT01205230|11643850|FG000|COMPLETED|Overall Study||16
10493850|NCT01205230|11643851|FG001|COMPLETED|Overall Study||13
10493851|NCT01205230|11643850|FG000|NOT COMPLETED|Overall Study||5
10493852|NCT01205230|11643851|FG001|NOT COMPLETED|Overall Study||0
10493853|NCT01205269|11643862|FG000|STARTED|Period 1 - First Intervention||4
10493854|NCT01205269|11643863|FG001|STARTED|Period 1 - First Intervention||4
10493855|NCT01205269|11643864|FG002|STARTED|Period 1 - First Intervention||4
10493856|NCT01205269|11643865|FG003|STARTED|Period 1 - First Intervention||6
10493857|NCT01205269|11643866|FG004|STARTED|Period 1 - First Intervention||5
10493858|NCT01205269|11643867|FG005|STARTED|Period 1 - First Intervention||5
10493859|NCT01205269|11643862|FG000|COMPLETED|Period 1 - First Intervention||4
10493860|NCT01205269|11643863|FG001|COMPLETED|Period 1 - First Intervention||4
10493861|NCT01205269|11643864|FG002|COMPLETED|Period 1 - First Intervention||4
10493862|NCT01205269|11643865|FG003|COMPLETED|Period 1 - First Intervention||6
10493863|NCT01205269|11643866|FG004|COMPLETED|Period 1 - First Intervention||5
10493864|NCT01205269|11643867|FG005|COMPLETED|Period 1 - First Intervention||5
10493865|NCT01205269|11643862|FG000|NOT COMPLETED|Period 1 - First Intervention||0
10493866|NCT01205269|11643863|FG001|NOT COMPLETED|Period 1 - First Intervention||0
10493867|NCT01205269|11643864|FG002|NOT COMPLETED|Period 1 - First Intervention||0
10493868|NCT01205269|11643865|FG003|NOT COMPLETED|Period 1 - First Intervention||0
10493869|NCT01205269|11643866|FG004|NOT COMPLETED|Period 1 - First Intervention||0
10493870|NCT01205269|11643867|FG005|NOT COMPLETED|Period 1 - First Intervention||0
10493871|NCT01205269|11643862|FG000|STARTED|Period 2 - Washout||4
10493872|NCT01205269|11643863|FG001|STARTED|Period 2 - Washout||4
10493873|NCT01205269|11643864|FG002|STARTED|Period 2 - Washout||4
10493874|NCT01205269|11643865|FG003|STARTED|Period 2 - Washout||6
10493875|NCT01205269|11643866|FG004|STARTED|Period 2 - Washout||5
10493876|NCT01205269|11643867|FG005|STARTED|Period 2 - Washout||5
10493877|NCT01205269|11643862|FG000|COMPLETED|Period 2 - Washout||4
10493878|NCT01205269|11643863|FG001|COMPLETED|Period 2 - Washout||4
10493879|NCT01205269|11643864|FG002|COMPLETED|Period 2 - Washout||4
10493880|NCT01205269|11643865|FG003|COMPLETED|Period 2 - Washout||6
10493881|NCT01205269|11643866|FG004|COMPLETED|Period 2 - Washout||5
10493882|NCT01205269|11643867|FG005|COMPLETED|Period 2 - Washout||5
10493883|NCT01205269|11643862|FG000|NOT COMPLETED|Period 2 - Washout||0
10493884|NCT01205269|11643863|FG001|NOT COMPLETED|Period 2 - Washout||0
10493885|NCT01205269|11643864|FG002|NOT COMPLETED|Period 2 - Washout||0
10493886|NCT01205269|11643865|FG003|NOT COMPLETED|Period 2 - Washout||0
10493887|NCT01205269|11643866|FG004|NOT COMPLETED|Period 2 - Washout||0
10493888|NCT01205269|11643867|FG005|NOT COMPLETED|Period 2 - Washout||0
10493889|NCT01205269|11643862|FG000|STARTED|Period 3 - Second Intervention||4
10493890|NCT01205269|11643863|FG001|STARTED|Period 3 - Second Intervention||4
10493891|NCT01205269|11643864|FG002|STARTED|Period 3 - Second Intervention||4
10493892|NCT01205269|11643865|FG003|STARTED|Period 3 - Second Intervention||6
10493893|NCT01205269|11643866|FG004|STARTED|Period 3 - Second Intervention||5
10493894|NCT01205269|11643867|FG005|STARTED|Period 3 - Second Intervention||5
10493895|NCT01205269|11643862|FG000|COMPLETED|Period 3 - Second Intervention||4
10493896|NCT01205269|11643863|FG001|COMPLETED|Period 3 - Second Intervention||4
10493897|NCT01205269|11643864|FG002|COMPLETED|Period 3 - Second Intervention||4
10493898|NCT01205269|11643865|FG003|COMPLETED|Period 3 - Second Intervention||6
10493899|NCT01205269|11643866|FG004|COMPLETED|Period 3 - Second Intervention||5
10493900|NCT01205269|11643867|FG005|COMPLETED|Period 3 - Second Intervention||5
10493901|NCT01205269|11643862|FG000|NOT COMPLETED|Period 3 - Second Intervention||0
10493902|NCT01205269|11643863|FG001|NOT COMPLETED|Period 3 - Second Intervention||0
10493903|NCT01205269|11643864|FG002|NOT COMPLETED|Period 3 - Second Intervention||0
10493904|NCT01205269|11643865|FG003|NOT COMPLETED|Period 3 - Second Intervention||0
10493905|NCT01205269|11643866|FG004|NOT COMPLETED|Period 3 - Second Intervention||0
10493906|NCT01205269|11643867|FG005|NOT COMPLETED|Period 3 - Second Intervention||0
10493907|NCT01205269|11643862|FG000|STARTED|Period 4 - Washout||4
10493908|NCT01205269|11643863|FG001|STARTED|Period 4 - Washout||4
10493909|NCT01205269|11643864|FG002|STARTED|Period 4 - Washout||4
10493910|NCT01205269|11643865|FG003|STARTED|Period 4 - Washout||6
10493911|NCT01205269|11643866|FG004|STARTED|Period 4 - Washout||5
10493912|NCT01205269|11643867|FG005|STARTED|Period 4 - Washout||5
10493913|NCT01205269|11643862|FG000|COMPLETED|Period 4 - Washout||4
10493914|NCT01205269|11643863|FG001|COMPLETED|Period 4 - Washout||4
10493915|NCT01205269|11643864|FG002|COMPLETED|Period 4 - Washout||4
10493916|NCT01205269|11643865|FG003|COMPLETED|Period 4 - Washout||5
10493917|NCT01205269|11643866|FG004|COMPLETED|Period 4 - Washout||5
10493918|NCT01205269|11643867|FG005|COMPLETED|Period 4 - Washout||5
10493919|NCT01205269|11643862|FG000|NOT COMPLETED|Period 4 - Washout||0
10493920|NCT01205269|11643863|FG001|NOT COMPLETED|Period 4 - Washout||0
10493921|NCT01205269|11643864|FG002|NOT COMPLETED|Period 4 - Washout||0
10493922|NCT01205269|11643865|FG003|NOT COMPLETED|Period 4 - Washout||1
10493923|NCT01205269|11643866|FG004|NOT COMPLETED|Period 4 - Washout||0
10493924|NCT01205269|11643867|FG005|NOT COMPLETED|Period 4 - Washout||0
10493925|NCT01205269|11643862|FG000|STARTED|Period 5 - Third Intervention||4
10493926|NCT01205269|11643863|FG001|STARTED|Period 5 - Third Intervention||4
10493927|NCT01205269|11643864|FG002|STARTED|Period 5 - Third Intervention||4
10493928|NCT01205269|11643865|FG003|STARTED|Period 5 - Third Intervention||5
10493929|NCT01205269|11643866|FG004|STARTED|Period 5 - Third Intervention||5
10493930|NCT01205269|11643867|FG005|STARTED|Period 5 - Third Intervention||5
10493931|NCT01205269|11643862|FG000|COMPLETED|Period 5 - Third Intervention||4
10493932|NCT01205269|11643863|FG001|COMPLETED|Period 5 - Third Intervention||4
10493933|NCT01205269|11643864|FG002|COMPLETED|Period 5 - Third Intervention||4
10493934|NCT01205269|11643865|FG003|COMPLETED|Period 5 - Third Intervention||5
10493935|NCT01205269|11643866|FG004|COMPLETED|Period 5 - Third Intervention||5
10493936|NCT01205269|11643867|FG005|COMPLETED|Period 5 - Third Intervention||5
10493937|NCT01205269|11643862|FG000|NOT COMPLETED|Period 5 - Third Intervention||0
10493938|NCT01205269|11643863|FG001|NOT COMPLETED|Period 5 - Third Intervention||0
10493939|NCT01205269|11643864|FG002|NOT COMPLETED|Period 5 - Third Intervention||0
10493940|NCT01205269|11643865|FG003|NOT COMPLETED|Period 5 - Third Intervention||0
10493941|NCT01205269|11643866|FG004|NOT COMPLETED|Period 5 - Third Intervention||0
10493942|NCT01205269|11643867|FG005|NOT COMPLETED|Period 5 - Third Intervention||0
10493943|NCT01205399|11643875|FG000|STARTED|Overall Study||78
10493944|NCT01205399|11643875|FG000|COMPLETED|Overall Study||78
10493945|NCT01205399|11643875|FG000|NOT COMPLETED|Overall Study||0
10493946|NCT01205438|11643882|FG000|STARTED|Overall Study||372
10493947|NCT01205438|11643883|FG001|STARTED|Overall Study||376
10493948|NCT01205438|11643884|FG002|STARTED|Overall Study||376
10493949|NCT01205438|11643882|FG000|Received At Least One Dose of Study Drug|Overall Study||371
10493950|NCT01205438|11643883|FG001|Received At Least One Dose of Study Drug|Overall Study||374
10493951|NCT01205438|11643884|FG002|Received At Least One Dose of Study Drug|Overall Study||376
10493952|NCT01205438|11643882|FG000|Participated in Follow Up|Overall Study||72
10493953|NCT01205438|11643883|FG001|Participated in Follow Up|Overall Study||78
10493954|NCT01205438|11643884|FG002|Participated in Follow Up|Overall Study||66
10493955|NCT01205438|11643882|FG000|COMPLETED|Overall Study||295
10493956|NCT01205438|11643883|FG001|COMPLETED|Overall Study||289
10493957|NCT01205438|11643884|FG002|COMPLETED|Overall Study||288
10493958|NCT01205438|11643882|FG000|NOT COMPLETED|Overall Study||77
10493959|NCT01205438|11643883|FG001|NOT COMPLETED|Overall Study||87
10493960|NCT01205438|11643884|FG002|NOT COMPLETED|Overall Study||88
10493961|NCT01205451|11643897|FG000|STARTED|Overall Study||53
10493962|NCT01205451|11643898|FG001|STARTED|Overall Study||56
10493963|NCT01205451|11643897|FG000|COMPLETED|Overall Study||47
10493964|NCT01205451|11643898|FG001|COMPLETED|Overall Study||46
10493965|NCT01205451|11643897|FG000|NOT COMPLETED|Overall Study||6
10493966|NCT01205451|11643898|FG001|NOT COMPLETED|Overall Study||10
10493967|NCT01205503|11643906|FG000|STARTED|First Intervention (1st Cycle)||16
10493968|NCT01205503|11643907|FG001|STARTED|First Intervention (1st Cycle)||16
10493969|NCT01205503|11643906|FG000|COMPLETED|First Intervention (1st Cycle)||16
10493970|NCT01205503|11643907|FG001|COMPLETED|First Intervention (1st Cycle)||16
10493971|NCT01205503|11643906|FG000|NOT COMPLETED|First Intervention (1st Cycle)||0
10493972|NCT01205503|11643907|FG001|NOT COMPLETED|First Intervention (1st Cycle)||0
10493973|NCT01205503|11643906|FG000|STARTED|Second Intervention (2nd Cycle)||16
10493974|NCT01205503|11643907|FG001|STARTED|Second Intervention (2nd Cycle)||16
10493975|NCT01205503|11643906|FG000|COMPLETED|Second Intervention (2nd Cycle)||16
10493976|NCT01205503|11643907|FG001|COMPLETED|Second Intervention (2nd Cycle)||16
10493977|NCT01205503|11643906|FG000|NOT COMPLETED|Second Intervention (2nd Cycle)||0
10493978|NCT01205503|11643907|FG001|NOT COMPLETED|Second Intervention (2nd Cycle)||0
10493979|NCT01205529|11643913|FG000|STARTED|Overall Study||161
10493980|NCT01205529|11643913|FG000|COMPLETED|Overall Study||106
10493981|NCT01205529|11643913|FG000|NOT COMPLETED|Overall Study||55
10493982|NCT01205568|11643917|FG000|STARTED|Overall Study|26 patients received only CB therapy, 39 patients received both CB and HPB therapy.|65
10493983|NCT01205568|11643918|FG001|STARTED|Overall Study|8 patients received only HPB therapy, 39 patients received both CB and HPB therapy.|47
10493984|NCT01205568|11643917|FG000|COMPLETED|Overall Study||65
10493985|NCT01205568|11643918|FG001|COMPLETED|Overall Study||47
10493986|NCT01205568|11643917|FG000|NOT COMPLETED|Overall Study||0
10493987|NCT01205568|11643918|FG001|NOT COMPLETED|Overall Study||0
10493988|NCT01205581|11643928|FG000|STARTED|Overall Study||14
10493989|NCT01205581|11643929|FG001|STARTED|Overall Study||13
10493990|NCT01205581|11643930|FG002|STARTED|Overall Study||8
10493991|NCT01205581|11643931|FG003|STARTED|Overall Study||9
10493992|NCT01205581|11643932|FG004|STARTED|Overall Study||20
10493993|NCT01205581|11643933|FG005|STARTED|Overall Study||20
10493994|NCT01205581|11643928|FG000|COMPLETED|Overall Study||13
10493995|NCT01205581|11643929|FG001|COMPLETED|Overall Study||13
10493996|NCT01205581|11643930|FG002|COMPLETED|Overall Study||8
10493997|NCT01205581|11643931|FG003|COMPLETED|Overall Study||9
10493998|NCT01205581|11643932|FG004|COMPLETED|Overall Study||20
10493999|NCT01205581|11643933|FG005|COMPLETED|Overall Study||20
10494000|NCT01205581|11643928|FG000|NOT COMPLETED|Overall Study||1
10494001|NCT01205581|11643929|FG001|NOT COMPLETED|Overall Study||0
10494002|NCT01205581|11643930|FG002|NOT COMPLETED|Overall Study||0
10494003|NCT01205581|11643931|FG003|NOT COMPLETED|Overall Study||0
10494004|NCT01205581|11643932|FG004|NOT COMPLETED|Overall Study||0
10494005|NCT01205581|11643933|FG005|NOT COMPLETED|Overall Study||0
10494006|NCT01205646|11643964|FG000|STARTED|Overall Study||11
10494007|NCT01205646|11643964|FG000|COMPLETED|Overall Study||11
10494008|NCT01205646|11643964|FG000|NOT COMPLETED|Overall Study||0
10494009|NCT01205685|11643968|FG000|STARTED|Overall Study||11
10494010|NCT01205685|11643968|FG000|COMPLETED|Overall Study||0
10494011|NCT01205685|11643968|FG000|NOT COMPLETED|Overall Study||11
10494012|NCT01205776|11643974|FG000|STARTED|Overall Study||948
10494013|NCT01205776|11643975|FG001|STARTED|Overall Study||957
10494014|NCT01205776|11643974|FG000|COMPLETED|Overall Study||884
10494015|NCT01205776|11643975|FG001|COMPLETED|Overall Study||862
10494016|NCT01205776|11643974|FG000|NOT COMPLETED|Overall Study||64
10494017|NCT01205776|11643975|FG001|NOT COMPLETED|Overall Study||95
10494018|NCT01205828|11643981|FG000|STARTED|Overall Study||16
10494019|NCT01205828|11643981|FG000|COMPLETED|Overall Study|Completed the first stage of the study, terminated as pre-planned due to lack of efficacy|16
10494020|NCT01205828|11643981|FG000|NOT COMPLETED|Overall Study||0
10494021|NCT01206062|11643988|FG000|STARTED|Overall Study||4678
10494022|NCT01206062|11643989|FG001|STARTED|Overall Study||4683
10494023|NCT01206062|11643988|FG000|COMPLETED|Overall Study||4678
10494024|NCT01206062|11643989|FG001|COMPLETED|Overall Study||4683
10494025|NCT01206062|11643988|FG000|NOT COMPLETED|Overall Study||0
10494026|NCT01206062|11643989|FG001|NOT COMPLETED|Overall Study||0
10494027|NCT01206140|11643999|FG000|STARTED|Overall Study||35
10494028|NCT01206140|11644000|FG001|STARTED|Overall Study||35
10494029|NCT01206140|11643999|FG000|COMPLETED|Overall Study||34
10494030|NCT01206140|11644000|FG001|COMPLETED|Overall Study||35
10494031|NCT01206140|11643999|FG000|NOT COMPLETED|Overall Study||1
10494032|NCT01206140|11644000|FG001|NOT COMPLETED|Overall Study||0
10494033|NCT01206166|11644008|FG000|STARTED|Overall Study||73
10494034|NCT01206166|11644009|FG001|STARTED|Overall Study||52
10494035|NCT01206166|11644008|FG000|COMPLETED|Overall Study||71
10494036|NCT01206166|11644009|FG001|COMPLETED|Overall Study||49
10710370|NCT02649192|11875519|FG001|NOT COMPLETED|Overall Study||0
10710371|NCT02649192|11875520|FG002|NOT COMPLETED|Overall Study||1
10710372|NCT02649192|11875521|FG003|NOT COMPLETED|Overall Study||2
10710373|NCT02649192|11875522|FG004|NOT COMPLETED|Overall Study||1
10494037|NCT01206166|11644008|FG000|NOT COMPLETED|Overall Study||2
10494038|NCT01206166|11644009|FG001|NOT COMPLETED|Overall Study||3
10494039|NCT01206322|11644020|FG000|STARTED|Overall Study||4
10494040|NCT01206322|11644021|FG001|STARTED|Overall Study||11
10494041|NCT01206322|11644022|FG002|STARTED|Overall Study||9
10494042|NCT01206322|11644023|FG003|STARTED|Overall Study||6
10494043|NCT01206322|11644020|FG000|COMPLETED|Overall Study||4
10494044|NCT01206322|11644021|FG001|COMPLETED|Overall Study||11
10494045|NCT01206322|11644022|FG002|COMPLETED|Overall Study||9
10494046|NCT01206322|11644023|FG003|COMPLETED|Overall Study||5
10494047|NCT01206322|11644020|FG000|NOT COMPLETED|Overall Study||0
10494048|NCT01206322|11644021|FG001|NOT COMPLETED|Overall Study||0
10494049|NCT01206322|11644022|FG002|NOT COMPLETED|Overall Study||0
10494050|NCT01206322|11644023|FG003|NOT COMPLETED|Overall Study||1
10494051|NCT01206387|11644035|FG000|STARTED|Overall Study||60
10494052|NCT01206387|11644036|FG001|STARTED|Overall Study||60
10494053|NCT01206387|11644035|FG000|COMPLETED|Overall Study||59
10494054|NCT01206387|11644036|FG001|COMPLETED|Overall Study||60
10494055|NCT01206387|11644035|FG000|NOT COMPLETED|Overall Study||1
10494056|NCT01206387|11644036|FG001|NOT COMPLETED|Overall Study||0
10710374|NCT02649192|11875523|FG005|NOT COMPLETED|Overall Study||0
10494057|NCT01206452|11644044|FG000|STARTED|Overall Study||30
10494058|NCT01206452|11644045|FG001|STARTED|Overall Study||30
10494059|NCT01206452|11644044|FG000|COMPLETED|Overall Study||30
10494060|NCT01206452|11644045|FG001|COMPLETED|Overall Study||30
10494061|NCT01206452|11644044|FG000|NOT COMPLETED|Overall Study||0
10494062|NCT01206452|11644045|FG001|NOT COMPLETED|Overall Study||0
10710375|NCT02649218|11875550|FG000|STARTED|Overall Study||226
10494063|NCT01206465|11644051|FG000|STARTED|Overall Study||3
10494064|NCT01206465|11644052|FG001|STARTED|Overall Study||6
10494065|NCT01206465|11644053|FG002|STARTED|Overall Study||6
10494066|NCT01206465|11644054|FG003|STARTED|Overall Study||6
10494067|NCT01206465|11644055|FG004|STARTED|Overall Study||6
10494068|NCT01206465|11644051|FG000|COMPLETED|Overall Study||3
10494069|NCT01206465|11644052|FG001|COMPLETED|Overall Study||6
10494070|NCT01206465|11644053|FG002|COMPLETED|Overall Study||6
10494071|NCT01206465|11644054|FG003|COMPLETED|Overall Study||6
10494072|NCT01206465|11644055|FG004|COMPLETED|Overall Study||6
10494073|NCT01206465|11644051|FG000|NOT COMPLETED|Overall Study||0
10494074|NCT01206465|11644052|FG001|NOT COMPLETED|Overall Study||0
10494075|NCT01206465|11644053|FG002|NOT COMPLETED|Overall Study||0
10494076|NCT01206465|11644054|FG003|NOT COMPLETED|Overall Study||0
10650044|NCT02165826|11810197|FG001|STARTED|Down-Titration Period||39
10650045|NCT02165826|11810198|FG002|STARTED|Down-Titration Period||38
10650046|NCT02165826|11810196|FG000|Safety Analysis Set: Received Study Drug|Down-Titration Period||27
10650047|NCT02165826|11810197|FG001|Safety Analysis Set: Received Study Drug|Down-Titration Period||39
10650048|NCT02165826|11810198|FG002|Safety Analysis Set: Received Study Drug|Down-Titration Period||38
10494077|NCT01206465|11644055|FG004|NOT COMPLETED|Overall Study||0
10494078|NCT01206478|11644073|FG000|STARTED|Overall Study||9
10494079|NCT01206478|11644074|FG001|STARTED|Overall Study||12
10494080|NCT01206478|11644073|FG000|COMPLETED|Overall Study||7
10494081|NCT01206478|11644074|FG001|COMPLETED|Overall Study||7
10494082|NCT01206478|11644073|FG000|NOT COMPLETED|Overall Study||2
10494083|NCT01206478|11644074|FG001|NOT COMPLETED|Overall Study||5
10494084|NCT01206582|11644082|FG000|STARTED|Overall Study||11
10494085|NCT01206582|11644083|FG001|STARTED|Overall Study||9
10494086|NCT01206582|11644082|FG000|COMPLETED|Overall Study||9
10494087|NCT01206582|11644083|FG001|COMPLETED|Overall Study||7
10494088|NCT01206582|11644082|FG000|NOT COMPLETED|Overall Study||2
10494089|NCT01206582|11644083|FG001|NOT COMPLETED|Overall Study||2
10494090|NCT01206595|11644091|FG000|STARTED|Overall Study||38
10494091|NCT01206595|11644092|FG001|STARTED|Overall Study||20
10494092|NCT01206595|11644091|FG000|COMPLETED|Overall Study||38
10494093|NCT01206595|11644092|FG001|COMPLETED|Overall Study||20
10494094|NCT01206595|11644091|FG000|NOT COMPLETED|Overall Study||0
10494095|NCT01206595|11644092|FG001|NOT COMPLETED|Overall Study||0
10494096|NCT01206608|11644102|FG000|STARTED|Overall Study||20
10494097|NCT01206608|11644103|FG001|STARTED|Overall Study||20
10494098|NCT01206608|11644102|FG000|COMPLETED|Overall Study||20
10494099|NCT01206608|11644103|FG001|COMPLETED|Overall Study||20
10494100|NCT01206608|11644102|FG000|NOT COMPLETED|Overall Study||0
10494101|NCT01206608|11644103|FG001|NOT COMPLETED|Overall Study||0
10494102|NCT01206660|11644111|FG000|STARTED|Overall Study||60
10494103|NCT01206660|11644112|FG001|STARTED|Overall Study||60
10494104|NCT01206660|11644111|FG000|COMPLETED|Overall Study||60
10494105|NCT01206660|11644112|FG001|COMPLETED|Overall Study||60
10494106|NCT01206660|11644111|FG000|NOT COMPLETED|Overall Study||0
10494107|NCT01206660|11644112|FG001|NOT COMPLETED|Overall Study||0
10494108|NCT01206738|11644121|FG000|STARTED|Overall Study||63
10494109|NCT01206738|11644122|FG001|STARTED|Overall Study||74
10494110|NCT01206738|11644123|FG002|STARTED|Overall Study||61
10494111|NCT01206738|11644121|FG000|COMPLETED|Overall Study||40
10494112|NCT01206738|11644122|FG001|COMPLETED|Overall Study||49
10494113|NCT01206738|11644123|FG002|COMPLETED|Overall Study||42
10494114|NCT01206738|11644121|FG000|NOT COMPLETED|Overall Study||23
10494115|NCT01206738|11644122|FG001|NOT COMPLETED|Overall Study||25
10494116|NCT01206738|11644123|FG002|NOT COMPLETED|Overall Study||19
10494117|NCT01206764|11644133|FG000|STARTED|Overall Study||142
10494118|NCT01206764|11644133|FG000|COMPLETED|Overall Study||4
10494119|NCT01206764|11644133|FG000|NOT COMPLETED|Overall Study||138
10527893|NCT01392378|11680112|FG003|NOT COMPLETED|Infant Series||2
10527894|NCT01392378|11680113|FG004|NOT COMPLETED|Infant Series||0
10527895|NCT01392378|11680109|FG000|STARTED|After Infant Series||169
10527896|NCT01392378|11680110|FG001|STARTED|After Infant Series||174
10527897|NCT01392378|11680111|FG002|STARTED|After Infant Series||172
10527898|NCT01392378|11680112|FG003|STARTED|After Infant Series||175
10527899|NCT01392378|11680113|FG004|STARTED|After Infant Series||210
10527900|NCT01392378|11680109|FG000|COMPLETED|After Infant Series||169
10527901|NCT01392378|11680110|FG001|COMPLETED|After Infant Series||173
10527902|NCT01392378|11680111|FG002|COMPLETED|After Infant Series||170
10527903|NCT01392378|11680112|FG003|COMPLETED|After Infant Series||175
10527904|NCT01392378|11680113|FG004|COMPLETED|After Infant Series||209
10527905|NCT01392378|11680109|FG000|NOT COMPLETED|After Infant Series||0
10527906|NCT01392378|11680110|FG001|NOT COMPLETED|After Infant Series||1
10527907|NCT01392378|11680111|FG002|NOT COMPLETED|After Infant Series||2
10527908|NCT01392378|11680112|FG003|NOT COMPLETED|After Infant Series||0
10527909|NCT01392378|11680113|FG004|NOT COMPLETED|After Infant Series||1
10527910|NCT01392378|11680109|FG000|STARTED|Toddler Dose||169
10527911|NCT01392378|11680110|FG001|STARTED|Toddler Dose||173
10527912|NCT01392378|11680111|FG002|STARTED|Toddler Dose||170
10527913|NCT01392378|11680112|FG003|STARTED|Toddler Dose||175
10527914|NCT01392378|11680113|FG004|STARTED|Toddler Dose||209
10527915|NCT01392378|11680109|FG000|COMPLETED|Toddler Dose||169
10527916|NCT01392378|11680110|FG001|COMPLETED|Toddler Dose||172
10527917|NCT01392378|11680111|FG002|COMPLETED|Toddler Dose||170
10527918|NCT01392378|11680112|FG003|COMPLETED|Toddler Dose||173
10527919|NCT01392378|11680113|FG004|COMPLETED|Toddler Dose||208
10527920|NCT01392378|11680109|FG000|NOT COMPLETED|Toddler Dose||0
10527921|NCT01392378|11680110|FG001|NOT COMPLETED|Toddler Dose||1
10527922|NCT01392378|11680111|FG002|NOT COMPLETED|Toddler Dose||0
10527923|NCT01392378|11680112|FG003|NOT COMPLETED|Toddler Dose||2
10527924|NCT01392378|11680113|FG004|NOT COMPLETED|Toddler Dose||1
10527925|NCT01392443|11680135|FG000|STARTED|Overall Study||120
10527926|NCT01392443|11680135|FG000|COMPLETED|Overall Study||52
10527927|NCT01392443|11680135|FG000|NOT COMPLETED|Overall Study||68
10527928|NCT01392469|11680139|FG000|STARTED|Overall Study||21
10527929|NCT01392469|11680139|FG000|COMPLETED|Overall Study||17
10527930|NCT01392469|11680139|FG000|NOT COMPLETED|Overall Study||4
10527931|NCT01392495|11680154|FG000|STARTED|Overall Study||17
10494120|NCT01206777|11644137|FG000|STARTED|Overall Study||52
10494121|NCT01206777|11644137|FG000|Discontinued Trial and Deemed Ineligible|Overall Study||2
10494122|NCT01206777|11644137|FG000|COMPLETED|Overall Study||50
10494123|NCT01206777|11644137|FG000|NOT COMPLETED|Overall Study||2
10494124|NCT01206816|11644148|FG000|STARTED|Overall Study|Started=Treated|3
10494125|NCT01206816|11644149|FG001|STARTED|Overall Study|Started=Treated|3
10494126|NCT01206816|11644150|FG002|STARTED|Overall Study|Started=Treated|20
10494127|NCT01206816|11644151|FG003|STARTED|Overall Study|Started=Treated|3
10494128|NCT01206816|11644152|FG004|STARTED|Overall Study|Started=Treated|3
10494129|NCT01206816|11644153|FG005|STARTED|Overall Study|Started=Treated|19
10494130|NCT01206816|11644154|FG006|STARTED|Overall Study|Started=Treated|6
10494131|NCT01206816|11644148|FG000|COMPLETED|Overall Study||0
10494132|NCT01206816|11644149|FG001|COMPLETED|Overall Study||0
10494133|NCT01206816|11644150|FG002|COMPLETED|Overall Study|1pt dist.due to 'Other AE' for vol& since 'other' from aftb.1pt 'PD' for vol& since,'DLT' from aftb|0
10494134|NCT01206816|11644151|FG003|COMPLETED|Overall Study|1pt discontinue (dist.)due to 'PD' for vol.& since, 'Other AE' from aftb|0
10494135|NCT01206816|11644152|FG004|COMPLETED|Overall Study||0
10494136|NCT01206816|11644153|FG005|COMPLETED|Overall Study|1pt dist. due to 'PD' for vol & since, 'Other AE' from aftb|0
10494137|NCT01206816|11644154|FG006|COMPLETED|Overall Study|1pt dist. due to 'other AE' & 1pt 'other' for vol & since,'PD' from aftb.|0
10494138|NCT01206816|11644148|FG000|NOT COMPLETED|Overall Study||3
10494139|NCT01206816|11644149|FG001|NOT COMPLETED|Overall Study||3
10494140|NCT01206816|11644150|FG002|NOT COMPLETED|Overall Study||20
10494141|NCT01206816|11644151|FG003|NOT COMPLETED|Overall Study||3
10494142|NCT01206816|11644152|FG004|NOT COMPLETED|Overall Study||3
10494143|NCT01206816|11644153|FG005|NOT COMPLETED|Overall Study||19
10494144|NCT01206816|11644154|FG006|NOT COMPLETED|Overall Study||6
10494145|NCT01207219|11644177|FG000|STARTED|Overall Study||45
10494146|NCT01207219|11644178|FG001|STARTED|Overall Study||40
10494147|NCT01207219|11644179|FG002|STARTED|Overall Study||39
10494148|NCT01207219|11644177|FG000|Included in ITT Analysis|Overall Study||40
10494149|NCT01207219|11644178|FG001|Included in ITT Analysis|Overall Study||37
10494150|NCT01207219|11644179|FG002|Included in ITT Analysis|Overall Study||38
10494151|NCT01207219|11644177|FG000|COMPLETED|Overall Study||34
10494152|NCT01207219|11644178|FG001|COMPLETED|Overall Study||29
10494153|NCT01207219|11644179|FG002|COMPLETED|Overall Study||32
10494154|NCT01207219|11644177|FG000|NOT COMPLETED|Overall Study||11
10494155|NCT01207219|11644178|FG001|NOT COMPLETED|Overall Study||11
10494156|NCT01207219|11644179|FG002|NOT COMPLETED|Overall Study||7
10494157|NCT01207388|11644187|FG000|STARTED|Overall Study||116
10494158|NCT01207388|11644187|FG000|COMPLETED|Overall Study||48
10494159|NCT01207388|11644187|FG000|NOT COMPLETED|Overall Study||68
10494160|NCT01207401|11644201|FG000|STARTED|Overall Study||26
10494161|NCT01207401|11644202|FG001|STARTED|Overall Study||24
10494162|NCT01207401|11644201|FG000|COMPLETED|Overall Study||26
10494163|NCT01207401|11644202|FG001|COMPLETED|Overall Study||24
10494164|NCT01207401|11644201|FG000|NOT COMPLETED|Overall Study||0
10494165|NCT01207401|11644202|FG001|NOT COMPLETED|Overall Study||0
10494166|NCT01207414|11644210|FG000|STARTED|Overall Study|Includes 1 patient randomized in error.|241
10494167|NCT01207414|11644211|FG001|STARTED|Overall Study||260
10494168|NCT01207414|11644210|FG000|Safety Population: Received Study Drug|Overall Study||240
10494169|NCT01207414|11644211|FG001|Safety Population: Received Study Drug|Overall Study||260
10494170|NCT01207414|11644210|FG000|COMPLETED|Overall Study||168
10494171|NCT01207414|11644211|FG001|COMPLETED|Overall Study||178
10494172|NCT01207414|11644210|FG000|NOT COMPLETED|Overall Study||73
10494173|NCT01207414|11644211|FG001|NOT COMPLETED|Overall Study||82
10494174|NCT01207427|11644220|FG000|STARTED|Run-in Placebo Period||43
10494175|NCT01207427|11644221|FG001|STARTED|Run-in Placebo Period||45
10494176|NCT01207427|11644222|FG002|STARTED|Run-in Placebo Period||43
10494177|NCT01207427|11644220|FG000|COMPLETED|Run-in Placebo Period||43
10494178|NCT01207427|11644221|FG001|COMPLETED|Run-in Placebo Period||45
10494179|NCT01207427|11644222|FG002|COMPLETED|Run-in Placebo Period||43
10494180|NCT01207427|11644220|FG000|NOT COMPLETED|Run-in Placebo Period||0
10494181|NCT01207427|11644221|FG001|NOT COMPLETED|Run-in Placebo Period||0
10494182|NCT01207427|11644222|FG002|NOT COMPLETED|Run-in Placebo Period||0
10494183|NCT01207427|11644220|FG000|STARTED|Double-blind Treatment Period||43
10494184|NCT01207427|11644221|FG001|STARTED|Double-blind Treatment Period||45
10494185|NCT01207427|11644222|FG002|STARTED|Double-blind Treatment Period||43
10494186|NCT01207427|11644220|FG000|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||43
10494187|NCT01207427|11644221|FG001|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||45
10494188|NCT01207427|11644222|FG002|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||43
10494189|NCT01207427|11644220|FG000|COMPLETED|Double-blind Treatment Period||40
10494190|NCT01207427|11644221|FG001|COMPLETED|Double-blind Treatment Period||43
10494191|NCT01207427|11644222|FG002|COMPLETED|Double-blind Treatment Period||41
10494192|NCT01207427|11644220|FG000|NOT COMPLETED|Double-blind Treatment Period||3
10494193|NCT01207427|11644221|FG001|NOT COMPLETED|Double-blind Treatment Period||2
10494194|NCT01207427|11644222|FG002|NOT COMPLETED|Double-blind Treatment Period||2
10494195|NCT01207427|11644220|FG000|STARTED|Run-out Placebo Period||40
10494196|NCT01207427|11644221|FG001|STARTED|Run-out Placebo Period||43
10494197|NCT01207427|11644222|FG002|STARTED|Run-out Placebo Period||41
10494198|NCT01207427|11644220|FG000|COMPLETED|Run-out Placebo Period||40
10494199|NCT01207427|11644221|FG001|COMPLETED|Run-out Placebo Period||43
10494200|NCT01207427|11644222|FG002|COMPLETED|Run-out Placebo Period||41
10494201|NCT01207427|11644220|FG000|NOT COMPLETED|Run-out Placebo Period||0
10494202|NCT01207427|11644221|FG001|NOT COMPLETED|Run-out Placebo Period||0
10494203|NCT01207427|11644222|FG002|NOT COMPLETED|Run-out Placebo Period||0
10494204|NCT01207440|11644237|FG000|STARTED|Overall Study||203
10494205|NCT01207440|11644238|FG001|STARTED|Overall Study||64
10494206|NCT01207440|11644239|FG002|STARTED|Overall Study||65
10494207|NCT01207440|11644240|FG003|STARTED|Overall Study||18
10494208|NCT01207440|11644241|FG004|STARTED|Overall Study||48
10494209|NCT01207440|11644242|FG005|STARTED|Overall Study||46
10494210|NCT01207440|11644243|FG006|STARTED|Overall Study||5
10494211|NCT01207440|11644237|FG000|COMPLETED|Overall Study||0
10494212|NCT01207440|11644238|FG001|COMPLETED|Overall Study||0
10494213|NCT01207440|11644239|FG002|COMPLETED|Overall Study||0
10494214|NCT01207440|11644240|FG003|COMPLETED|Overall Study||0
10494215|NCT01207440|11644241|FG004|COMPLETED|Overall Study||0
10494216|NCT01207440|11644242|FG005|COMPLETED|Overall Study||0
10494217|NCT01207440|11644243|FG006|COMPLETED|Overall Study||0
10494218|NCT01207440|11644237|FG000|NOT COMPLETED|Overall Study||203
10494219|NCT01207440|11644238|FG001|NOT COMPLETED|Overall Study||64
10494220|NCT01207440|11644239|FG002|NOT COMPLETED|Overall Study||65
10494221|NCT01207440|11644240|FG003|NOT COMPLETED|Overall Study||18
10494222|NCT01207440|11644241|FG004|NOT COMPLETED|Overall Study||48
10494223|NCT01207440|11644242|FG005|NOT COMPLETED|Overall Study||46
10494224|NCT01207440|11644243|FG006|NOT COMPLETED|Overall Study||5
10494225|NCT01207453|11644267|FG000|STARTED|First Intervention||23
10494226|NCT01207453|11644268|FG001|STARTED|First Intervention||18
10494227|NCT01207453|11644267|FG000|COMPLETED|First Intervention||21
10494228|NCT01207453|11644268|FG001|COMPLETED|First Intervention||17
10494229|NCT01207453|11644267|FG000|NOT COMPLETED|First Intervention||2
10494230|NCT01207453|11644268|FG001|NOT COMPLETED|First Intervention||1
10494231|NCT01207453|11644267|FG000|STARTED|Washout||21
10494232|NCT01207453|11644268|FG001|STARTED|Washout||17
10494233|NCT01207453|11644267|FG000|COMPLETED|Washout||19
10494234|NCT01207453|11644268|FG001|COMPLETED|Washout||17
10494235|NCT01207453|11644267|FG000|NOT COMPLETED|Washout||2
10494236|NCT01207453|11644268|FG001|NOT COMPLETED|Washout||0
10494237|NCT01207453|11644267|FG000|STARTED|2nd Intervention||19
10494238|NCT01207453|11644268|FG001|STARTED|2nd Intervention||17
10494239|NCT01207453|11644267|FG000|COMPLETED|2nd Intervention||17
10494240|NCT01207453|11644268|FG001|COMPLETED|2nd Intervention||15
10494241|NCT01207453|11644267|FG000|NOT COMPLETED|2nd Intervention||2
10494242|NCT01207453|11644268|FG001|NOT COMPLETED|2nd Intervention||2
10494243|NCT01207466|11644277|FG000|STARTED|Period 1, One Week of Wear||46
10494244|NCT01207466|11644278|FG001|STARTED|Period 1, One Week of Wear||48
10494245|NCT01207466|11644277|FG000|COMPLETED|Period 1, One Week of Wear|One participant discontinued between Period 1 and Period 2 due to inclusion/exclusion criteria.|46
10494246|NCT01207466|11644278|FG001|COMPLETED|Period 1, One Week of Wear||48
10494247|NCT01207466|11644277|FG000|NOT COMPLETED|Period 1, One Week of Wear||0
10494248|NCT01207466|11644278|FG001|NOT COMPLETED|Period 1, One Week of Wear||0
10494249|NCT01207466|11644277|FG000|STARTED|Period 2, One Week of Wear||45
10494250|NCT01207466|11644278|FG001|STARTED|Period 2, One Week of Wear||48
10494251|NCT01207466|11644277|FG000|COMPLETED|Period 2, One Week of Wear||45
10494252|NCT01207466|11644278|FG001|COMPLETED|Period 2, One Week of Wear||48
10494253|NCT01207466|11644277|FG000|NOT COMPLETED|Period 2, One Week of Wear||0
10494254|NCT01207466|11644278|FG001|NOT COMPLETED|Period 2, One Week of Wear||0
10494255|NCT01207570|11644286|FG000|STARTED|The First Stage (Before Crossover)||23
10494256|NCT01207570|11644287|FG001|STARTED|The First Stage (Before Crossover)||31
10494257|NCT01207570|11644286|FG000|COMPLETED|The First Stage (Before Crossover)||23
10494258|NCT01207570|11644287|FG001|COMPLETED|The First Stage (Before Crossover)||31
10494259|NCT01207570|11644286|FG000|NOT COMPLETED|The First Stage (Before Crossover)||0
10494260|NCT01207570|11644287|FG001|NOT COMPLETED|The First Stage (Before Crossover)||0
10494261|NCT01207570|11644286|FG000|STARTED|The Second Stage (After Crossover)||31
10494262|NCT01207570|11644287|FG001|STARTED|The Second Stage (After Crossover)||23
10494263|NCT01207570|11644286|FG000|COMPLETED|The Second Stage (After Crossover)||31
10494264|NCT01207570|11644287|FG001|COMPLETED|The Second Stage (After Crossover)||23
10494265|NCT01207570|11644286|FG000|NOT COMPLETED|The Second Stage (After Crossover)||0
10494266|NCT01207570|11644287|FG001|NOT COMPLETED|The Second Stage (After Crossover)||0
10494267|NCT01207583|11644298|FG000|STARTED|Overall Study||14
10494268|NCT01207583|11644299|FG001|STARTED|Overall Study||31
10494269|NCT01207583|11644300|FG002|STARTED|Overall Study||55
10494270|NCT01207583|11644298|FG000|Dose 1|Overall Study||14
10494271|NCT01207583|11644299|FG001|Dose 1|Overall Study||31
10494272|NCT01207583|11644300|FG002|Dose 1|Overall Study||55
10494273|NCT01207583|11644298|FG000|Dose 2|Overall Study||13
10494274|NCT01207583|11644299|FG001|Dose 2|Overall Study||29
10494275|NCT01207583|11644300|FG002|Dose 2|Overall Study||54
10494276|NCT01207583|11644298|FG000|Dose 3|Overall Study||13
10494277|NCT01207583|11644299|FG001|Dose 3|Overall Study||27
10494278|NCT01207583|11644300|FG002|Dose 3|Overall Study||0
10494279|NCT01207583|11644298|FG000|Dose 4|Overall Study||7
10494280|NCT01207583|11644299|FG001|Dose 4|Overall Study||0
10494281|NCT01207583|11644300|FG002|Dose 4|Overall Study||0
10494282|NCT01207583|11644298|FG000|COMPLETED|Overall Study||13
10494283|NCT01207583|11644299|FG001|COMPLETED|Overall Study||26
10494284|NCT01207583|11644300|FG002|COMPLETED|Overall Study||54
10494285|NCT01207583|11644298|FG000|NOT COMPLETED|Overall Study||1
10494286|NCT01207583|11644299|FG001|NOT COMPLETED|Overall Study||5
10494287|NCT01207583|11644300|FG002|NOT COMPLETED|Overall Study||1
10494288|NCT01207596|11644321|FG000|STARTED|Overall Study||30
10494289|NCT01207596|11644321|FG000|COMPLETED|Overall Study||21
10494290|NCT01207596|11644321|FG000|NOT COMPLETED|Overall Study||9
10494291|NCT01207648|11644325|FG000|STARTED|Overall Study||307
10494292|NCT01207648|11644325|FG000|COMPLETED|Overall Study||307
10494293|NCT01207648|11644325|FG000|NOT COMPLETED|Overall Study||0
10494294|NCT01207687|11644329|FG000|STARTED|Overall Study||14
10494295|NCT01207687|11644329|FG000|COMPLETED|Overall Study||12
10494296|NCT01207687|11644329|FG000|NOT COMPLETED|Overall Study||2
10494297|NCT01207752|11644341|FG000|STARTED|Overall Study||35
10494298|NCT01207752|11644342|FG001|STARTED|Overall Study||34
10494299|NCT01207752|11644341|FG000|COMPLETED|Overall Study||33
10494300|NCT01207752|11644342|FG001|COMPLETED|Overall Study||27
10494301|NCT01207752|11644341|FG000|NOT COMPLETED|Overall Study||2
10494302|NCT01207752|11644342|FG001|NOT COMPLETED|Overall Study||7
10494303|NCT01207765|11644348|FG000|STARTED|Overall Study||8
10494304|NCT01207765|11644348|FG000|COMPLETED|Overall Study||8
10494305|NCT01207765|11644348|FG000|NOT COMPLETED|Overall Study||0
10494306|NCT01207908|11644354|FG000|STARTED|Overall Study||22
10494307|NCT01207908|11644355|FG001|STARTED|Overall Study||22
10494308|NCT01207908|11644354|FG000|COMPLETED|Overall Study||17
10494309|NCT01207908|11644355|FG001|COMPLETED|Overall Study||21
10494310|NCT01207908|11644354|FG000|NOT COMPLETED|Overall Study||5
10494311|NCT01207908|11644355|FG001|NOT COMPLETED|Overall Study||1
10494312|NCT01207934|11644364|FG000|STARTED|Overall Study||6
10494313|NCT01207934|11644365|FG001|STARTED|Overall Study||6
10494314|NCT01207934|11644366|FG002|STARTED|Overall Study||6
10494315|NCT01207934|11644364|FG000|COMPLETED|Overall Study||6
10494316|NCT01207934|11644365|FG001|COMPLETED|Overall Study||6
10494317|NCT01207934|11644366|FG002|COMPLETED|Overall Study||6
10494318|NCT01207934|11644364|FG000|NOT COMPLETED|Overall Study||0
10494319|NCT01207934|11644365|FG001|NOT COMPLETED|Overall Study||0
10494320|NCT01207934|11644366|FG002|NOT COMPLETED|Overall Study||0
10494321|NCT01208038|11644374|FG000|STARTED|Overall Study||22
10494322|NCT01208038|11644374|FG000|COMPLETED|Overall Study|Patient withdrew before commencing study drug|21
10494323|NCT01208038|11644374|FG000|NOT COMPLETED|Overall Study||1
10494324|NCT01208051|11644383|FG000|STARTED|Total Enrollment||4
10494325|NCT01208051|11644384|FG001|STARTED|Total Enrollment||7
10494326|NCT01208051|11644385|FG002|STARTED|Total Enrollment||6
10494327|NCT01208051|11644386|FG003|STARTED|Total Enrollment||39
10494328|NCT01208051|11644387|FG004|STARTED|Total Enrollment||71
10494329|NCT01208051|11644383|FG000|COMPLETED|Total Enrollment||4
10494330|NCT01208051|11644384|FG001|COMPLETED|Total Enrollment||6
10494331|NCT01208051|11644385|FG002|COMPLETED|Total Enrollment||5
10494332|NCT01208051|11644386|FG003|COMPLETED|Total Enrollment||39
10494333|NCT01208051|11644387|FG004|COMPLETED|Total Enrollment||69
10494334|NCT01208051|11644383|FG000|NOT COMPLETED|Total Enrollment||0
10494335|NCT01208051|11644384|FG001|NOT COMPLETED|Total Enrollment||1
10494336|NCT01208051|11644385|FG002|NOT COMPLETED|Total Enrollment||1
10494337|NCT01208051|11644386|FG003|NOT COMPLETED|Total Enrollment||0
10494338|NCT01208051|11644387|FG004|NOT COMPLETED|Total Enrollment||2
10494339|NCT01208051|11644383|FG000|STARTED|Interim Futility Analysis||0
10494340|NCT01208051|11644384|FG001|STARTED|Interim Futility Analysis||0
10494341|NCT01208051|11644385|FG002|STARTED|Interim Futility Analysis||0
10494342|NCT01208051|11644386|FG003|STARTED|Interim Futility Analysis||39
10494343|NCT01208051|11644387|FG004|STARTED|Interim Futility Analysis||68
10494344|NCT01208051|11644383|FG000|COMPLETED|Interim Futility Analysis||0
10494345|NCT01208051|11644384|FG001|COMPLETED|Interim Futility Analysis||0
10494346|NCT01208051|11644385|FG002|COMPLETED|Interim Futility Analysis||0
10494347|NCT01208051|11644386|FG003|COMPLETED|Interim Futility Analysis||39
10494348|NCT01208051|11644387|FG004|COMPLETED|Interim Futility Analysis||68
10494349|NCT01208051|11644383|FG000|NOT COMPLETED|Interim Futility Analysis||0
10494350|NCT01208051|11644384|FG001|NOT COMPLETED|Interim Futility Analysis||0
10494351|NCT01208051|11644385|FG002|NOT COMPLETED|Interim Futility Analysis||0
10494352|NCT01208051|11644386|FG003|NOT COMPLETED|Interim Futility Analysis||0
10494353|NCT01208051|11644387|FG004|NOT COMPLETED|Interim Futility Analysis||0
10494354|NCT01208051|11644383|FG000|STARTED|After Crossover to Cediranib Only||0
10494355|NCT01208051|11644384|FG001|STARTED|After Crossover to Cediranib Only||0
10494356|NCT01208051|11644385|FG002|STARTED|After Crossover to Cediranib Only||0
10494357|NCT01208051|11644386|FG003|STARTED|After Crossover to Cediranib Only||39
10494358|NCT01208051|11644387|FG004|STARTED|After Crossover to Cediranib Only|One patient entered while futility analysis was ongoing.|69
10494359|NCT01208051|11644383|FG000|COMPLETED|After Crossover to Cediranib Only||0
10494360|NCT01208051|11644384|FG001|COMPLETED|After Crossover to Cediranib Only||0
10494361|NCT01208051|11644385|FG002|COMPLETED|After Crossover to Cediranib Only||0
10494362|NCT01208051|11644386|FG003|COMPLETED|After Crossover to Cediranib Only||39
10494363|NCT01208051|11644387|FG004|COMPLETED|After Crossover to Cediranib Only||69
10494364|NCT01208051|11644383|FG000|NOT COMPLETED|After Crossover to Cediranib Only||0
10494365|NCT01208051|11644384|FG001|NOT COMPLETED|After Crossover to Cediranib Only||0
10494366|NCT01208051|11644385|FG002|NOT COMPLETED|After Crossover to Cediranib Only||0
10494367|NCT01208051|11644386|FG003|NOT COMPLETED|After Crossover to Cediranib Only||0
10494368|NCT01208051|11644387|FG004|NOT COMPLETED|After Crossover to Cediranib Only||0
10494369|NCT01208103|11644403|FG000|STARTED|Overall Study||30
10494370|NCT01208103|11644403|FG000|COMPLETED|Overall Study||28
10494371|NCT01208103|11644403|FG000|NOT COMPLETED|Overall Study||2
10494372|NCT01208220|11644410|FG000|STARTED|Overall Study||1
10494373|NCT01208220|11644411|FG001|STARTED|Overall Study||1
10494374|NCT01208220|11644410|FG000|COMPLETED|Overall Study||1
10494375|NCT01208220|11644411|FG001|COMPLETED|Overall Study||1
10494376|NCT01208220|11644410|FG000|NOT COMPLETED|Overall Study||0
10494377|NCT01208220|11644411|FG001|NOT COMPLETED|Overall Study||0
10494378|NCT01208233|11644423|FG000|STARTED|Overall Study||11
10494379|NCT01208233|11644424|FG001|STARTED|Overall Study||9
10494380|NCT01208233|11644425|FG002|STARTED|Overall Study||11
10494381|NCT01208233|11644426|FG003|STARTED|Overall Study||10
10494382|NCT01208233|11644427|FG004|STARTED|Overall Study||70
10494383|NCT01208233|11644428|FG005|STARTED|Overall Study||67
10494384|NCT01208233|11644423|FG000|COMPLETED|Overall Study||6
10494385|NCT01208233|11644424|FG001|COMPLETED|Overall Study||6
10494386|NCT01208233|11644425|FG002|COMPLETED|Overall Study||7
10494387|NCT01208233|11644426|FG003|COMPLETED|Overall Study||9
10494388|NCT01208233|11644427|FG004|COMPLETED|Overall Study||46
10494389|NCT01208233|11644428|FG005|COMPLETED|Overall Study||46
10494390|NCT01208233|11644423|FG000|NOT COMPLETED|Overall Study||5
10494391|NCT01208233|11644424|FG001|NOT COMPLETED|Overall Study||3
10494392|NCT01208233|11644425|FG002|NOT COMPLETED|Overall Study||4
10494393|NCT01208233|11644426|FG003|NOT COMPLETED|Overall Study||1
10494394|NCT01208233|11644427|FG004|NOT COMPLETED|Overall Study||24
10494395|NCT01208233|11644428|FG005|NOT COMPLETED|Overall Study||21
10494396|NCT01208324|11644452|FG000|STARTED|Pre-randomization of Patch||14
10494397|NCT01208324|11644453|FG001|STARTED|Pre-randomization of Patch||15
10494398|NCT01208324|11644454|FG002|STARTED|Pre-randomization of Patch||10
10494399|NCT01208324|11644455|FG003|STARTED|Pre-randomization of Patch||8
10494400|NCT01208324|11644452|FG000|Test Day 1|Pre-randomization of Patch||14
10494401|NCT01208324|11644453|FG001|Test Day 1|Pre-randomization of Patch||15
10494402|NCT01208324|11644454|FG002|Test Day 1|Pre-randomization of Patch||10
10494403|NCT01208324|11644455|FG003|Test Day 1|Pre-randomization of Patch||8
10494404|NCT01208324|11644452|FG000|Test Day 2|Pre-randomization of Patch||14
10494405|NCT01208324|11644453|FG001|Test Day 2|Pre-randomization of Patch||15
10494406|NCT01208324|11644454|FG002|Test Day 2|Pre-randomization of Patch||8
10494407|NCT01208324|11644455|FG003|Test Day 2|Pre-randomization of Patch||5
10494408|NCT01208324|11644452|FG000|COMPLETED|Pre-randomization of Patch||14
10494409|NCT01208324|11644453|FG001|COMPLETED|Pre-randomization of Patch||15
10494410|NCT01208324|11644454|FG002|COMPLETED|Pre-randomization of Patch||8
10494411|NCT01208324|11644455|FG003|COMPLETED|Pre-randomization of Patch||5
10494412|NCT01208324|11644452|FG000|NOT COMPLETED|Pre-randomization of Patch||0
10494413|NCT01208324|11644453|FG001|NOT COMPLETED|Pre-randomization of Patch||0
10494414|NCT01208324|11644454|FG002|NOT COMPLETED|Pre-randomization of Patch||2
10494415|NCT01208324|11644455|FG003|NOT COMPLETED|Pre-randomization of Patch||3
10494416|NCT01208324|11644452|FG000|STARTED|Post-randomization of Patch||14
10494417|NCT01208324|11644453|FG001|STARTED|Post-randomization of Patch||15
10494418|NCT01208324|11644454|FG002|STARTED|Post-randomization of Patch||8
10494419|NCT01208324|11644455|FG003|STARTED|Post-randomization of Patch||5
10494420|NCT01208324|11644452|FG000|Test Day 3|Post-randomization of Patch||13
10494421|NCT01208324|11644453|FG001|Test Day 3|Post-randomization of Patch||15
10494422|NCT01208324|11644454|FG002|Test Day 3|Post-randomization of Patch||8
10494423|NCT01208324|11644455|FG003|Test Day 3|Post-randomization of Patch||5
10494424|NCT01208324|11644452|FG000|Test Day 4|Post-randomization of Patch||13
10494425|NCT01208324|11644453|FG001|Test Day 4|Post-randomization of Patch||15
10494426|NCT01208324|11644454|FG002|Test Day 4|Post-randomization of Patch||8
10494427|NCT01208324|11644455|FG003|Test Day 4|Post-randomization of Patch||5
10494428|NCT01208324|11644452|FG000|COMPLETED|Post-randomization of Patch||13
10494429|NCT01208324|11644453|FG001|COMPLETED|Post-randomization of Patch||15
10494430|NCT01208324|11644454|FG002|COMPLETED|Post-randomization of Patch||8
10494431|NCT01208324|11644455|FG003|COMPLETED|Post-randomization of Patch||5
10494432|NCT01208324|11644452|FG000|NOT COMPLETED|Post-randomization of Patch||1
10494433|NCT01208324|11644453|FG001|NOT COMPLETED|Post-randomization of Patch||0
10494434|NCT01208324|11644454|FG002|NOT COMPLETED|Post-randomization of Patch||0
10494435|NCT01208324|11644455|FG003|NOT COMPLETED|Post-randomization of Patch||0
10494436|NCT01208337|11644465|FG000|STARTED|Overall Study||23
10494437|NCT01208337|11644465|FG000|One-year Follow-up|Overall Study||23
10494438|NCT01208337|11644465|FG000|Five-year Follow-up|Overall Study||20
10494439|NCT01208337|11644465|FG000|COMPLETED|Overall Study||20
10494440|NCT01208337|11644465|FG000|NOT COMPLETED|Overall Study||3
10494441|NCT01208402|11644471|FG000|STARTED|Overall Study||31
10650049|NCT02165826|11810196|FG000|COMPLETED|Down-Titration Period||20
10650050|NCT02165826|11810197|FG001|COMPLETED|Down-Titration Period||28
10650051|NCT02165826|11810198|FG002|COMPLETED|Down-Titration Period||31
10650052|NCT02165826|11810196|FG000|NOT COMPLETED|Down-Titration Period||7
10650053|NCT02165826|11810197|FG001|NOT COMPLETED|Down-Titration Period||11
10650054|NCT02165826|11810198|FG002|NOT COMPLETED|Down-Titration Period||7
10650055|NCT02165839|11810225|FG000|STARTED|Overall Study||66
10494442|NCT01208402|11644472|FG001|STARTED|Overall Study||28
10494443|NCT01208402|11644471|FG000|COMPLETED|Overall Study||30
10494444|NCT01208402|11644472|FG001|COMPLETED|Overall Study||28
10494445|NCT01208402|11644471|FG000|NOT COMPLETED|Overall Study||1
10494446|NCT01208402|11644472|FG001|NOT COMPLETED|Overall Study||0
10494447|NCT01208415|11644478|FG000|STARTED|Overall Study||40
10494448|NCT01208415|11644478|FG000|6 Months|Overall Study||37
10494449|NCT01208415|11644478|FG000|COMPLETED|Overall Study||0
10494450|NCT01208415|11644478|FG000|NOT COMPLETED|Overall Study||40
10494451|NCT01208870|11644484|FG000|STARTED|Overall Study|The same group was run as Pilot 1 Spring 2012 and Pilot 2 Summer 2013|46
10494452|NCT01208870|11644485|FG001|STARTED|Overall Study|The same group was run as Pilot 1 Spring 2012 and Pilot 2 Summer 2013.|44
10494453|NCT01208870|11644484|FG000|Pilot 1|Overall Study||20
10494454|NCT01208870|11644485|FG001|Pilot 1|Overall Study||22
10494455|NCT01208870|11644484|FG000|Pilot 2|Overall Study||26
10494456|NCT01208870|11644485|FG001|Pilot 2|Overall Study||22
10494457|NCT01208870|11644484|FG000|COMPLETED|Overall Study||44
10494458|NCT01208870|11644485|FG001|COMPLETED|Overall Study||36
10494459|NCT01208870|11644484|FG000|NOT COMPLETED|Overall Study||2
10494460|NCT01208870|11644485|FG001|NOT COMPLETED|Overall Study||8
10494461|NCT01208922|11644495|FG000|STARTED|Overall Study||420
10494462|NCT01208922|11644496|FG001|STARTED|Overall Study||415
10494463|NCT01208922|11644495|FG000|COMPLETED|Overall Study||409
10494464|NCT01208922|11644496|FG001|COMPLETED|Overall Study||405
10494465|NCT01208922|11644495|FG000|NOT COMPLETED|Overall Study||11
10494466|NCT01208922|11644496|FG001|NOT COMPLETED|Overall Study||10
10494467|NCT01208961|11644502|FG000|STARTED|Low-Fat Period I||27
10494468|NCT01208961|11644503|FG001|STARTED|Low-Fat Period I||27
10494469|NCT01208961|11644502|FG000|COMPLETED|Low-Fat Period I||27
10494470|NCT01208961|11644503|FG001|COMPLETED|Low-Fat Period I||27
10494471|NCT01208961|11644502|FG000|NOT COMPLETED|Low-Fat Period I||0
10494472|NCT01208961|11644503|FG001|NOT COMPLETED|Low-Fat Period I||0
10494473|NCT01208961|11644502|FG000|STARTED|Low-Fat Period II||26
10494474|NCT01208961|11644503|FG001|STARTED|Low-Fat Period II||27
10494475|NCT01208961|11644502|FG000|COMPLETED|Low-Fat Period II||26
10494476|NCT01208961|11644503|FG001|COMPLETED|Low-Fat Period II||27
10494477|NCT01208961|11644502|FG000|NOT COMPLETED|Low-Fat Period II||0
10494478|NCT01208961|11644503|FG001|NOT COMPLETED|Low-Fat Period II||0
10494479|NCT01208961|11644502|FG000|STARTED|High-Fat Period III||26
10494480|NCT01208961|11644503|FG001|STARTED|High-Fat Period III||26
10494481|NCT01208961|11644502|FG000|COMPLETED|High-Fat Period III||25
10494482|NCT01208961|11644503|FG001|COMPLETED|High-Fat Period III||26
10494483|NCT01208961|11644502|FG000|NOT COMPLETED|High-Fat Period III||1
10494484|NCT01208961|11644503|FG001|NOT COMPLETED|High-Fat Period III||0
10494485|NCT01208961|11644502|FG000|STARTED|High-Fat Period IV||25
10494486|NCT01208961|11644503|FG001|STARTED|High-Fat Period IV||26
10494487|NCT01208961|11644502|FG000|COMPLETED|High-Fat Period IV||25
10494488|NCT01208961|11644503|FG001|COMPLETED|High-Fat Period IV||26
10494489|NCT01208961|11644502|FG000|NOT COMPLETED|High-Fat Period IV||0
10494490|NCT01208961|11644503|FG001|NOT COMPLETED|High-Fat Period IV||0
10494491|NCT01209078|11644510|FG000|STARTED|Overall Study||57
10494492|NCT01209078|11644511|FG001|STARTED|Overall Study||27
10494493|NCT01209078|11644510|FG000|COMPLETED|Overall Study||41
10494494|NCT01209078|11644511|FG001|COMPLETED|Overall Study||24
10494495|NCT01209078|11644510|FG000|NOT COMPLETED|Overall Study||16
10494496|NCT01209078|11644511|FG001|NOT COMPLETED|Overall Study||3
10494497|NCT01209143|11644521|FG000|STARTED|Overall Study||24
10494498|NCT01209143|11644522|FG001|STARTED|Overall Study||28
10494499|NCT01209143|11644521|FG000|COMPLETED|Overall Study||5
10494500|NCT01209143|11644522|FG001|COMPLETED|Overall Study||8
10494501|NCT01209143|11644521|FG000|NOT COMPLETED|Overall Study||19
10494502|NCT01209143|11644522|FG001|NOT COMPLETED|Overall Study||20
10494503|NCT01209195|11644530|FG000|STARTED|Overall Study||7
10494504|NCT01209195|11644531|FG001|STARTED|Overall Study||3
10494505|NCT01209195|11644532|FG002|STARTED|Overall Study||6
10494506|NCT01209195|11644533|FG003|STARTED|Overall Study||6
10494507|NCT01209195|11644534|FG004|STARTED|Overall Study||6
10494508|NCT01209195|11644535|FG005|STARTED|Overall Study||13
10494509|NCT01209195|11644530|FG000|COMPLETED|Overall Study||7
10494510|NCT01209195|11644531|FG001|COMPLETED|Overall Study||3
10494511|NCT01209195|11644532|FG002|COMPLETED|Overall Study||6
10494512|NCT01209195|11644533|FG003|COMPLETED|Overall Study||6
10494513|NCT01209195|11644534|FG004|COMPLETED|Overall Study||6
10494514|NCT01209195|11644535|FG005|COMPLETED|Overall Study||13
10494515|NCT01209195|11644530|FG000|NOT COMPLETED|Overall Study||0
10494516|NCT01209195|11644531|FG001|NOT COMPLETED|Overall Study||0
10494517|NCT01209195|11644532|FG002|NOT COMPLETED|Overall Study||0
10494518|NCT01209195|11644533|FG003|NOT COMPLETED|Overall Study||0
10494519|NCT01209195|11644534|FG004|NOT COMPLETED|Overall Study||0
10810005|NCT03815292|11971881|FG001|STARTED|Overall Study||140
10810006|NCT03815292|11971880|FG000|COMPLETED|Overall Study||135
10810007|NCT03815292|11971881|FG001|COMPLETED|Overall Study||140
10810008|NCT03815292|11971880|FG000|NOT COMPLETED|Overall Study||0
10810009|NCT03815292|11971881|FG001|NOT COMPLETED|Overall Study||0
10810010|NCT03812510|11971887|FG000|STARTED|Overall Study||426
10810011|NCT03812510|11971887|FG000|COMPLETED|Overall Study||274
10810012|NCT03812510|11971887|FG000|NOT COMPLETED|Overall Study||152
10810013|NCT03802994|11971897|FG000|STARTED|Overall Study||9
10810014|NCT03802994|11971898|FG001|STARTED|Overall Study||12
10810015|NCT03802994|11971899|FG002|STARTED|Overall Study||15
10494520|NCT01209195|11644535|FG005|NOT COMPLETED|Overall Study||0
10494521|NCT01209234|11644553|FG000|STARTED|Overall Study||1070
10494522|NCT01209234|11644554|FG001|STARTED|Overall Study||1070
10494523|NCT01209234|11644553|FG000|COMPLETED|Overall Study||1058
10494524|NCT01209234|11644554|FG001|COMPLETED|Overall Study||1063
10494525|NCT01209234|11644553|FG000|NOT COMPLETED|Overall Study||12
10494526|NCT01209234|11644554|FG001|NOT COMPLETED|Overall Study||7
10494527|NCT01209260|11644562|FG000|STARTED|Overall Study||36
10494528|NCT01209260|11644563|FG001|STARTED|Overall Study||36
10494529|NCT01209260|11644562|FG000|COMPLETED|Overall Study||36
10494530|NCT01209260|11644563|FG001|COMPLETED|Overall Study||36
10494531|NCT01209260|11644562|FG000|NOT COMPLETED|Overall Study||0
10494532|NCT01209260|11644563|FG001|NOT COMPLETED|Overall Study||0
10494533|NCT01209286|11644574|FG000|STARTED|Overall Study||7
10494534|NCT01209286|11644575|FG001|STARTED|Overall Study||23
10494535|NCT01209286|11644576|FG002|STARTED|Overall Study||6
10494536|NCT01209286|11644574|FG000|COMPLETED|Overall Study||2
10494537|NCT01209286|11644575|FG001|COMPLETED|Overall Study||13
10494538|NCT01209286|11644576|FG002|COMPLETED|Overall Study||3
10494539|NCT01209286|11644574|FG000|NOT COMPLETED|Overall Study||5
10494540|NCT01209286|11644575|FG001|NOT COMPLETED|Overall Study||10
10494541|NCT01209286|11644576|FG002|NOT COMPLETED|Overall Study||3
10494542|NCT01209325|11644593|FG000|STARTED|Overall Study||149
10494543|NCT01209325|11644593|FG000|Eligible|Overall Study||145
10494544|NCT01209325|11644593|FG000|Received First Vaccine Injection|Overall Study||144
10494545|NCT01209325|11644593|FG000|Received Second Vaccine Injection|Overall Study||141
10494546|NCT01209325|11644593|FG000|Received Third Vaccine Infjection|Overall Study||138
10494547|NCT01209325|11644593|FG000|Returned After Week 28|Overall Study||124
10494548|NCT01209325|11644593|FG000|COMPLETED|Overall Study||106
10494549|NCT01209325|11644593|FG000|NOT COMPLETED|Overall Study||43
10494550|NCT01209442|11644619|FG000|STARTED|Overall Study||30
10494551|NCT01209442|11644619|FG000|COMPLETED|Overall Study||30
10494552|NCT01209442|11644619|FG000|NOT COMPLETED|Overall Study||0
10494553|NCT01209598|11644625|FG000|STARTED|Overall Study||30
10494554|NCT01209598|11644626|FG001|STARTED|Overall Study||60
10494555|NCT01209598|11644625|FG000|COMPLETED|Overall Study||29
10494556|NCT01209598|11644626|FG001|COMPLETED|Overall Study||60
10494557|NCT01209598|11644625|FG000|NOT COMPLETED|Overall Study||1
10494558|NCT01209598|11644626|FG001|NOT COMPLETED|Overall Study||0
10494559|NCT01209624|11644633|FG000|STARTED|Overall Study||902
10494560|NCT01209624|11644633|FG000|Per Protocol Population|Overall Study||469
10494561|NCT01209624|11644633|FG000|COMPLETED|Overall Study||576
10494562|NCT01209624|11644633|FG000|NOT COMPLETED|Overall Study||326
10494563|NCT01209689|11644639|FG000|STARTED|Overall Study||91
10494564|NCT01209689|11644640|FG001|STARTED|Overall Study||22
10494565|NCT01209689|11644639|FG000|COMPLETED|Overall Study||0
10494566|NCT01209689|11644640|FG001|COMPLETED|Overall Study||0
10494567|NCT01209689|11644639|FG000|NOT COMPLETED|Overall Study||91
10494568|NCT01209689|11644640|FG001|NOT COMPLETED|Overall Study||22
10494569|NCT01209702|11644648|FG000|STARTED|Overall Study||51
10494570|NCT01209702|11644649|FG001|STARTED|Overall Study||51
10494571|NCT01209702|11644650|FG002|STARTED|Overall Study||51
10494572|NCT01209702|11644651|FG003|STARTED|Overall Study||153
10494573|NCT01209702|11644648|FG000|Treated|Overall Study||51
10494574|NCT01209702|11644649|FG001|Treated|Overall Study||51
10494575|NCT01209702|11644650|FG002|Treated|Overall Study||51
10494576|NCT01209702|11644651|FG003|Treated|Overall Study||152
10494577|NCT01209702|11644648|FG000|Escape or Switched to Tocilizumab|Overall Study||51
10494578|NCT01209702|11644649|FG001|Escape or Switched to Tocilizumab|Overall Study||0
10494579|NCT01209702|11644650|FG002|Escape or Switched to Tocilizumab|Overall Study||6
10494580|NCT01209702|11644651|FG003|Escape or Switched to Tocilizumab|Overall Study||0
10494581|NCT01209702|11644648|FG000|Completed 12 Weeks Treatment|Overall Study||50
10494582|NCT01209702|11644649|FG001|Completed 12 Weeks Treatment|Overall Study||48
10494583|NCT01209702|11644650|FG002|Completed 12 Weeks Treatment|Overall Study||12
10494584|NCT01209702|11644651|FG003|Completed 12 Weeks Treatment|Overall Study||59
10494585|NCT01209702|11644648|FG000|Completed 24 Weeks Treatment|Overall Study||19
10494586|NCT01209702|11644649|FG001|Completed 24 Weeks Treatment|Overall Study||28
10494587|NCT01209702|11644650|FG002|Completed 24 Weeks Treatment|Overall Study||3
10494588|NCT01209702|11644651|FG003|Completed 24 Weeks Treatment|Overall Study||10
10494589|NCT01209702|11644648|FG000|COMPLETED|Overall Study||0
10494590|NCT01209702|11644649|FG001|COMPLETED|Overall Study||0
10710376|NCT02649218|11875550|FG000|COMPLETED|Overall Study||201
10710377|NCT02649218|11875550|FG000|NOT COMPLETED|Overall Study||25
10710378|NCT02649231|11875559|FG000|STARTED|Overall Study||24
10710379|NCT02649231|11875560|FG001|STARTED|Overall Study||24
10710380|NCT02649231|11875561|FG002|STARTED|Overall Study||23
10494591|NCT01209702|11644650|FG002|COMPLETED|Overall Study||0
10494592|NCT01209702|11644651|FG003|COMPLETED|Overall Study||0
10494593|NCT01209702|11644648|FG000|NOT COMPLETED|Overall Study||51
10494594|NCT01209702|11644649|FG001|NOT COMPLETED|Overall Study||51
10494595|NCT01209702|11644650|FG002|NOT COMPLETED|Overall Study||51
10494596|NCT01209702|11644651|FG003|NOT COMPLETED|Overall Study||153
10494597|NCT01209780|11644674|FG000|STARTED|Overall Study||1042
10494598|NCT01209780|11644675|FG001|STARTED|Overall Study||485
10494599|NCT01209780|11644676|FG002|STARTED|Overall Study||48
10494600|NCT01209780|11644677|FG003|STARTED|Overall Study||817
10494601|NCT01209780|11644678|FG004|STARTED|Overall Study||412
10494602|NCT01209780|11644674|FG000|COMPLETED|Overall Study||1016
10494603|NCT01209780|11644675|FG001|COMPLETED|Overall Study||467
10494604|NCT01209780|11644676|FG002|COMPLETED|Overall Study||44
10494605|NCT01209780|11644677|FG003|COMPLETED|Overall Study||807
10494606|NCT01209780|11644678|FG004|COMPLETED|Overall Study||407
10494607|NCT01209780|11644674|FG000|NOT COMPLETED|Overall Study||26
10494608|NCT01209780|11644675|FG001|NOT COMPLETED|Overall Study||18
10494609|NCT01209780|11644676|FG002|NOT COMPLETED|Overall Study||4
10710381|NCT02649231|11875562|FG003|STARTED|Overall Study||25
10710382|NCT02649231|11875559|FG000|COMPLETED|Overall Study||20
10494610|NCT01209780|11644677|FG003|NOT COMPLETED|Overall Study||10
10494611|NCT01209780|11644678|FG004|NOT COMPLETED|Overall Study||5
10494612|NCT01209832|11644691|FG000|STARTED|Period 1||11
10494613|NCT01209832|11644691|FG000|Received At Least 1 Dose of Study Drug|Period 1||10
10494614|NCT01209832|11644691|FG000|COMPLETED|Period 1||10
10494615|NCT01209832|11644691|FG000|NOT COMPLETED|Period 1||1
10710383|NCT02649231|11875560|FG001|COMPLETED|Overall Study||21
10710384|NCT02649231|11875561|FG002|COMPLETED|Overall Study||21
10494616|NCT01209832|11644691|FG000|STARTED|Period 2||10
10494617|NCT01209832|11644691|FG000|COMPLETED|Period 2||9
10494618|NCT01209832|11644691|FG000|NOT COMPLETED|Period 2||1
10494619|NCT01209832|11644691|FG000|STARTED|Maintenance Period 1 (M1)|Five participants who completed Period 2 did not enroll into Maintenance Period.|4
10494620|NCT01209832|11644691|FG000|COMPLETED|Maintenance Period 1 (M1)||4
10494621|NCT01209832|11644691|FG000|NOT COMPLETED|Maintenance Period 1 (M1)||0
10494622|NCT01209832|11644691|FG000|STARTED|Maintenance Period 2 (M1)|One participant who completed maintenance period 1 did not enter maintenance period 2.|3
10494623|NCT01209832|11644691|FG000|COMPLETED|Maintenance Period 2 (M1)||3
10494624|NCT01209832|11644691|FG000|NOT COMPLETED|Maintenance Period 2 (M1)||0
10494628|NCT01210001|11644709|FG000|STARTED|Overall Study||166
10494629|NCT01210001|11644710|FG001|STARTED|Overall Study||165
10494630|NCT01210001|11644711|FG002|STARTED|Overall Study||168
10494631|NCT01210001|11644709|FG000|COMPLETED|Overall Study||147
10494632|NCT01210001|11644710|FG001|COMPLETED|Overall Study||154
10494633|NCT01210001|11644711|FG002|COMPLETED|Overall Study||156
10494634|NCT01210001|11644709|FG000|NOT COMPLETED|Overall Study||19
10494635|NCT01210001|11644710|FG001|NOT COMPLETED|Overall Study||11
10494636|NCT01210001|11644711|FG002|NOT COMPLETED|Overall Study||12
10494637|NCT01210079|11644721|FG000|STARTED|Overall Study||10
10494638|NCT01210079|11644722|FG001|STARTED|Overall Study||16
10494639|NCT01210079|11644721|FG000|COMPLETED|Overall Study||10
10494640|NCT01210079|11644722|FG001|COMPLETED|Overall Study||16
10494641|NCT01210079|11644721|FG000|NOT COMPLETED|Overall Study||0
10494642|NCT01210079|11644722|FG001|NOT COMPLETED|Overall Study||0
10494643|NCT01210118|11644730|FG000|STARTED|Overall Study||45
10494644|NCT01210118|11644731|FG001|STARTED|Overall Study||47
10494645|NCT01210118|11644730|FG000|COMPLETED|Overall Study||42
10494646|NCT01210118|11644731|FG001|COMPLETED|Overall Study||42
10494647|NCT01210118|11644730|FG000|NOT COMPLETED|Overall Study||3
10494648|NCT01210118|11644731|FG001|NOT COMPLETED|Overall Study||5
10494649|NCT01210144|11644742|FG000|STARTED|Overall Study||13
10494650|NCT01210144|11644743|FG001|STARTED|Overall Study||11
10494651|NCT01210144|11644742|FG000|COMPLETED|Overall Study||10
10494652|NCT01210144|11644743|FG001|COMPLETED|Overall Study||11
10494653|NCT01210144|11644742|FG000|NOT COMPLETED|Overall Study||3
10494654|NCT01210144|11644743|FG001|NOT COMPLETED|Overall Study||0
10494655|NCT01210170|11644750|FG000|STARTED|Overall Study||22
10494656|NCT01210170|11644750|FG000|COMPLETED|Overall Study||15
10494657|NCT01210170|11644750|FG000|NOT COMPLETED|Overall Study||7
10494658|NCT01210222|11644771|FG000|STARTED|Overall Study||35
10494659|NCT01210222|11644771|FG000|COMPLETED|Overall Study||32
10494660|NCT01210222|11644771|FG000|NOT COMPLETED|Overall Study||3
10494661|NCT01210352|11644790|FG000|STARTED|Overall Study||6
10494662|NCT01210352|11644791|FG001|STARTED|Overall Study||6
10494663|NCT01210352|11644792|FG002|STARTED|Overall Study||7
10494664|NCT01210352|11644793|FG003|STARTED|Overall Study||7
10494665|NCT01210352|11644794|FG004|STARTED|Overall Study||6
10494666|NCT01210352|11644795|FG005|STARTED|Overall Study||6
10494667|NCT01210352|11644796|FG006|STARTED|Overall Study||7
10494668|NCT01210352|11644797|FG007|STARTED|Overall Study||10
10494669|NCT01210352|11644798|FG008|STARTED|Overall Study||6
10494670|NCT01210352|11644790|FG000|COMPLETED|Overall Study||6
10494671|NCT01210352|11644791|FG001|COMPLETED|Overall Study||6
10494672|NCT01210352|11644792|FG002|COMPLETED|Overall Study||5
10494673|NCT01210352|11644793|FG003|COMPLETED|Overall Study||7
10494674|NCT01210352|11644794|FG004|COMPLETED|Overall Study||6
10494675|NCT01210352|11644795|FG005|COMPLETED|Overall Study||6
10494676|NCT01210352|11644796|FG006|COMPLETED|Overall Study||5
10494677|NCT01210352|11644797|FG007|COMPLETED|Overall Study||7
10494678|NCT01210352|11644798|FG008|COMPLETED|Overall Study||2
10494679|NCT01210352|11644790|FG000|NOT COMPLETED|Overall Study||0
10494680|NCT01210352|11644791|FG001|NOT COMPLETED|Overall Study||0
10494681|NCT01210352|11644792|FG002|NOT COMPLETED|Overall Study||2
10494682|NCT01210352|11644793|FG003|NOT COMPLETED|Overall Study||0
10494683|NCT01210352|11644794|FG004|NOT COMPLETED|Overall Study||0
10494684|NCT01210352|11644795|FG005|NOT COMPLETED|Overall Study||0
10494685|NCT01210352|11644796|FG006|NOT COMPLETED|Overall Study||2
10494686|NCT01210352|11644797|FG007|NOT COMPLETED|Overall Study||3
10494687|NCT01210352|11644798|FG008|NOT COMPLETED|Overall Study||4
10494688|NCT01210443|11644903|FG000|STARTED|Overall Study||2
10494689|NCT01210443|11644903|FG000|COMPLETED|Overall Study||0
10494690|NCT01210443|11644903|FG000|NOT COMPLETED|Overall Study||2
10494691|NCT01210495|11644911|FG000|STARTED|Overall Study||15
10494692|NCT01210495|11644912|FG001|STARTED|Overall Study||7
10494693|NCT01210495|11644913|FG002|STARTED|Overall Study||134
10494694|NCT01210495|11644914|FG003|STARTED|Overall Study||68
10494695|NCT01210495|11644911|FG000|COMPLETED|Overall Study||0
10494696|NCT01210495|11644912|FG001|COMPLETED|Overall Study||0
10494697|NCT01210495|11644913|FG002|COMPLETED|Overall Study||0
10494698|NCT01210495|11644914|FG003|COMPLETED|Overall Study||0
10494699|NCT01210495|11644911|FG000|NOT COMPLETED|Overall Study||15
10494700|NCT01210495|11644912|FG001|NOT COMPLETED|Overall Study||7
10494701|NCT01210495|11644913|FG002|NOT COMPLETED|Overall Study||134
10494702|NCT01210495|11644914|FG003|NOT COMPLETED|Overall Study||68
10650056|NCT02165839|11810226|FG001|STARTED|Overall Study||73
10650057|NCT02165839|11810225|FG000|COMPLETED|Overall Study||66
10650058|NCT02165839|11810226|FG001|COMPLETED|Overall Study||73
10650059|NCT02165839|11810225|FG000|NOT COMPLETED|Overall Study||0
10650060|NCT02165839|11810226|FG001|NOT COMPLETED|Overall Study||0
10650061|NCT02165904|11810233|FG000|STARTED|Overall Study||10
10494703|NCT01210560|11644926|FG000|STARTED|Intervention 1 (7 Days)||2
10494704|NCT01210560|11644927|FG001|STARTED|Intervention 1 (7 Days)||2
10494705|NCT01210560|11644928|FG002|STARTED|Intervention 1 (7 Days)||2
10494706|NCT01210560|11644929|FG003|STARTED|Intervention 1 (7 Days)||2
10494707|NCT01210560|11644930|FG004|STARTED|Intervention 1 (7 Days)||2
10494708|NCT01210560|11644931|FG005|STARTED|Intervention 1 (7 Days)||2
10494709|NCT01210560|11644932|FG006|STARTED|Intervention 1 (7 Days)||4
10494710|NCT01210560|11644933|FG007|STARTED|Intervention 1 (7 Days)||4
10494711|NCT01210560|11644934|FG008|STARTED|Intervention 1 (7 Days)||5
10494712|NCT01210560|11644926|FG000|COMPLETED|Intervention 1 (7 Days)||2
10494713|NCT01210560|11644927|FG001|COMPLETED|Intervention 1 (7 Days)||2
10494714|NCT01210560|11644928|FG002|COMPLETED|Intervention 1 (7 Days)||2
10494715|NCT01210560|11644929|FG003|COMPLETED|Intervention 1 (7 Days)||2
10494716|NCT01210560|11644930|FG004|COMPLETED|Intervention 1 (7 Days)||2
10494717|NCT01210560|11644931|FG005|COMPLETED|Intervention 1 (7 Days)||2
10494718|NCT01210560|11644932|FG006|COMPLETED|Intervention 1 (7 Days)||4
10494719|NCT01210560|11644933|FG007|COMPLETED|Intervention 1 (7 Days)||4
10494720|NCT01210560|11644934|FG008|COMPLETED|Intervention 1 (7 Days)||5
10494721|NCT01210560|11644926|FG000|NOT COMPLETED|Intervention 1 (7 Days)||0
10494722|NCT01210560|11644927|FG001|NOT COMPLETED|Intervention 1 (7 Days)||0
10494723|NCT01210560|11644928|FG002|NOT COMPLETED|Intervention 1 (7 Days)||0
10494724|NCT01210560|11644929|FG003|NOT COMPLETED|Intervention 1 (7 Days)||0
10494725|NCT01210560|11644930|FG004|NOT COMPLETED|Intervention 1 (7 Days)||0
10494726|NCT01210560|11644931|FG005|NOT COMPLETED|Intervention 1 (7 Days)||0
10494727|NCT01210560|11644932|FG006|NOT COMPLETED|Intervention 1 (7 Days)||0
10494728|NCT01210560|11644933|FG007|NOT COMPLETED|Intervention 1 (7 Days)||0
10494729|NCT01210560|11644934|FG008|NOT COMPLETED|Intervention 1 (7 Days)||0
10494730|NCT01210560|11644926|FG000|STARTED|Intervention 2 (7 Days)||2
10494731|NCT01210560|11644927|FG001|STARTED|Intervention 2 (7 Days)||2
10494732|NCT01210560|11644928|FG002|STARTED|Intervention 2 (7 Days)||2
10494733|NCT01210560|11644929|FG003|STARTED|Intervention 2 (7 Days)||2
10494734|NCT01210560|11644930|FG004|STARTED|Intervention 2 (7 Days)||2
10494735|NCT01210560|11644931|FG005|STARTED|Intervention 2 (7 Days)||2
10494736|NCT01210560|11644932|FG006|STARTED|Intervention 2 (7 Days)||4
10494737|NCT01210560|11644933|FG007|STARTED|Intervention 2 (7 Days)||4
10494738|NCT01210560|11644934|FG008|STARTED|Intervention 2 (7 Days)||5
10494739|NCT01210560|11644926|FG000|COMPLETED|Intervention 2 (7 Days)||2
10494740|NCT01210560|11644927|FG001|COMPLETED|Intervention 2 (7 Days)||2
10494741|NCT01210560|11644928|FG002|COMPLETED|Intervention 2 (7 Days)||2
10494742|NCT01210560|11644929|FG003|COMPLETED|Intervention 2 (7 Days)||2
10494743|NCT01210560|11644930|FG004|COMPLETED|Intervention 2 (7 Days)||2
10494744|NCT01210560|11644931|FG005|COMPLETED|Intervention 2 (7 Days)||2
10494745|NCT01210560|11644932|FG006|COMPLETED|Intervention 2 (7 Days)||4
10494746|NCT01210560|11644933|FG007|COMPLETED|Intervention 2 (7 Days)||4
10494747|NCT01210560|11644934|FG008|COMPLETED|Intervention 2 (7 Days)||5
10494748|NCT01210560|11644926|FG000|NOT COMPLETED|Intervention 2 (7 Days)||0
10494749|NCT01210560|11644927|FG001|NOT COMPLETED|Intervention 2 (7 Days)||0
10494750|NCT01210560|11644928|FG002|NOT COMPLETED|Intervention 2 (7 Days)||0
10494751|NCT01210560|11644929|FG003|NOT COMPLETED|Intervention 2 (7 Days)||0
10494752|NCT01210560|11644930|FG004|NOT COMPLETED|Intervention 2 (7 Days)||0
10494753|NCT01210560|11644931|FG005|NOT COMPLETED|Intervention 2 (7 Days)||0
10494754|NCT01210560|11644932|FG006|NOT COMPLETED|Intervention 2 (7 Days)||0
10494755|NCT01210560|11644933|FG007|NOT COMPLETED|Intervention 2 (7 Days)||0
10494756|NCT01210560|11644934|FG008|NOT COMPLETED|Intervention 2 (7 Days)||0
10494757|NCT01210560|11644926|FG000|STARTED|Intervention 3 (7 Days)||2
10494758|NCT01210560|11644927|FG001|STARTED|Intervention 3 (7 Days)||2
10494759|NCT01210560|11644928|FG002|STARTED|Intervention 3 (7 Days)||2
10494760|NCT01210560|11644929|FG003|STARTED|Intervention 3 (7 Days)||2
10494761|NCT01210560|11644930|FG004|STARTED|Intervention 3 (7 Days)||2
10494762|NCT01210560|11644931|FG005|STARTED|Intervention 3 (7 Days)||2
10494763|NCT01210560|11644932|FG006|STARTED|Intervention 3 (7 Days)||4
10494764|NCT01210560|11644933|FG007|STARTED|Intervention 3 (7 Days)||4
10494765|NCT01210560|11644934|FG008|STARTED|Intervention 3 (7 Days)||5
10494766|NCT01210560|11644926|FG000|COMPLETED|Intervention 3 (7 Days)||2
10494767|NCT01210560|11644927|FG001|COMPLETED|Intervention 3 (7 Days)||2
10494768|NCT01210560|11644928|FG002|COMPLETED|Intervention 3 (7 Days)||2
10494769|NCT01210560|11644929|FG003|COMPLETED|Intervention 3 (7 Days)||2
10494770|NCT01210560|11644930|FG004|COMPLETED|Intervention 3 (7 Days)||2
10650062|NCT02165904|11810233|FG000|COMPLETED|Overall Study||10
10650063|NCT02165904|11810233|FG000|NOT COMPLETED|Overall Study||0
10494771|NCT01210560|11644931|FG005|COMPLETED|Intervention 3 (7 Days)||2
10494772|NCT01210560|11644932|FG006|COMPLETED|Intervention 3 (7 Days)||4
10494773|NCT01210560|11644933|FG007|COMPLETED|Intervention 3 (7 Days)||4
10494774|NCT01210560|11644934|FG008|COMPLETED|Intervention 3 (7 Days)||5
10494775|NCT01210560|11644926|FG000|NOT COMPLETED|Intervention 3 (7 Days)||0
10494776|NCT01210560|11644927|FG001|NOT COMPLETED|Intervention 3 (7 Days)||0
10494777|NCT01210560|11644928|FG002|NOT COMPLETED|Intervention 3 (7 Days)||0
10494778|NCT01210560|11644929|FG003|NOT COMPLETED|Intervention 3 (7 Days)||0
10494779|NCT01210560|11644930|FG004|NOT COMPLETED|Intervention 3 (7 Days)||0
10494780|NCT01210560|11644931|FG005|NOT COMPLETED|Intervention 3 (7 Days)||0
10494781|NCT01210560|11644932|FG006|NOT COMPLETED|Intervention 3 (7 Days)||0
10494782|NCT01210560|11644933|FG007|NOT COMPLETED|Intervention 3 (7 Days)||0
10494783|NCT01210560|11644934|FG008|NOT COMPLETED|Intervention 3 (7 Days)||0
10494784|NCT01210651|11644949|FG000|STARTED|Overall Study|Number randomized to intervention, but not number who started intervention by attending 1st session.|20
10494785|NCT01210651|11644950|FG001|STARTED|Overall Study|Number randomized to intervention, but not number who started intervention by attending 1st session.|18
10494786|NCT01210651|11644949|FG000|Number Attending 1st Assigned Session|Overall Study||18
10494787|NCT01210651|11644950|FG001|Number Attending 1st Assigned Session|Overall Study||12
10494788|NCT01210651|11644949|FG000|COMPLETED|Overall Study||15
10494789|NCT01210651|11644950|FG001|COMPLETED|Overall Study||10
10494790|NCT01210651|11644949|FG000|NOT COMPLETED|Overall Study||5
10494791|NCT01210651|11644950|FG001|NOT COMPLETED|Overall Study||8
10494792|NCT01210664|11644960|FG000|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3
10494793|NCT01210664|11644961|FG001|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
10494794|NCT01210664|11644962|FG002|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
10494795|NCT01210664|11644963|FG003|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
10494796|NCT01210664|11644960|FG000|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3
10494797|NCT01210664|11644961|FG001|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
10494798|NCT01210664|11644962|FG002|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
10494799|NCT01210664|11644963|FG003|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
10494800|NCT01210664|11644960|FG000|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3
10494801|NCT01210664|11644961|FG001|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
10494802|NCT01210664|11644962|FG002|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
10494803|NCT01210664|11644963|FG003|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
10494804|NCT01210664|11644960|FG000|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
10494805|NCT01210664|11644961|FG001|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
10494806|NCT01210664|11644962|FG002|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
10494807|NCT01210664|11644963|FG003|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
10494808|NCT01210664|11644960|FG000|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
10494809|NCT01210664|11644961|FG001|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3
10494810|NCT01210664|11644962|FG002|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
10494811|NCT01210664|11644963|FG003|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
10494812|NCT01210664|11644960|FG000|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
10494813|NCT01210664|11644961|FG001|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3
10494814|NCT01210664|11644962|FG002|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
10494815|NCT01210664|11644963|FG003|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
10494816|NCT01210664|11644960|FG000|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
10494817|NCT01210664|11644961|FG001|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3
10494818|NCT01210664|11644962|FG002|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
10494819|NCT01210664|11644963|FG003|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
10494820|NCT01210664|11644960|FG000|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
10494821|NCT01210664|11644961|FG001|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
10494822|NCT01210664|11644962|FG002|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
10494823|NCT01210664|11644963|FG003|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
10494824|NCT01210664|11644960|FG000|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
10494825|NCT01210664|11644961|FG001|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
10494826|NCT01210664|11644962|FG002|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||5
10494827|NCT01210664|11644963|FG003|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
10494828|NCT01210664|11644960|FG000|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
10494829|NCT01210664|11644961|FG001|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
10494830|NCT01210664|11644962|FG002|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||4
10494831|NCT01210664|11644963|FG003|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
10494832|NCT01210664|11644960|FG000|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
10494833|NCT01210664|11644961|FG001|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
10494834|NCT01210664|11644962|FG002|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||3
10494835|NCT01210664|11644963|FG003|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
10494836|NCT01210664|11644960|FG000|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
10494837|NCT01210664|11644961|FG001|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
10494838|NCT01210664|11644962|FG002|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||2
10494839|NCT01210664|11644963|FG003|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
10494840|NCT01210664|11644960|FG000|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
10494841|NCT01210664|11644961|FG001|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
10494842|NCT01210664|11644962|FG002|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
10494843|NCT01210664|11644963|FG003|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||5
10494844|NCT01210664|11644960|FG000|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0
10494845|NCT01210664|11644961|FG001|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0
10494846|NCT01210664|11644962|FG002|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0
10494847|NCT01210664|11644963|FG003|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||4
10494848|NCT01210664|11644960|FG000|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
10494849|NCT01210664|11644961|FG001|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
10494850|NCT01210664|11644962|FG002|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
10494851|NCT01210664|11644963|FG003|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||4
10494852|NCT01210664|11644960|FG000|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
10494853|NCT01210664|11644961|FG001|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
10494854|NCT01210664|11644962|FG002|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
10494855|NCT01210664|11644963|FG003|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||1
10494856|NCT01210690|11644973|FG000|STARTED|Overall Study||101
10494857|NCT01210690|11644973|FG000|COMPLETED|Overall Study||75
10494858|NCT01210690|11644973|FG000|NOT COMPLETED|Overall Study||26
10494859|NCT01210716|11644978|FG000|STARTED|First TPE Procedure||20
10494860|NCT01210716|11644979|FG001|STARTED|First TPE Procedure||17
10494861|NCT01210716|11644978|FG000|COMPLETED|First TPE Procedure||18
10494862|NCT01210716|11644979|FG001|COMPLETED|First TPE Procedure||15
10494863|NCT01210716|11644978|FG000|NOT COMPLETED|First TPE Procedure||2
10494864|NCT01210716|11644979|FG001|NOT COMPLETED|First TPE Procedure||2
10494865|NCT01210716|11644978|FG000|STARTED|Second TPE Procedure||18
10494866|NCT01210716|11644979|FG001|STARTED|Second TPE Procedure||15
10494867|NCT01210716|11644978|FG000|COMPLETED|Second TPE Procedure||15
10494868|NCT01210716|11644979|FG001|COMPLETED|Second TPE Procedure||15
10494869|NCT01210716|11644978|FG000|NOT COMPLETED|Second TPE Procedure||3
10494870|NCT01210716|11644979|FG001|NOT COMPLETED|Second TPE Procedure||0
10494871|NCT01210807|11644987|FG000|STARTED|Overall Study||36
10494872|NCT01210807|11644988|FG001|STARTED|Overall Study||34
10494873|NCT01210807|11644987|FG000|COMPLETED|Overall Study||33
10494874|NCT01210807|11644988|FG001|COMPLETED|Overall Study||31
10494875|NCT01210807|11644987|FG000|NOT COMPLETED|Overall Study||3
10494876|NCT01210807|11644988|FG001|NOT COMPLETED|Overall Study||3
10494877|NCT01210820|11644996|FG000|STARTED|Overall Study||17
10494878|NCT01210820|11644997|FG001|STARTED|Overall Study||4
10494879|NCT01210820|11644996|FG000|COMPLETED|Overall Study||17
10494880|NCT01210820|11644997|FG001|COMPLETED|Overall Study||4
10494881|NCT01210820|11644996|FG000|NOT COMPLETED|Overall Study||0
10494882|NCT01210820|11644997|FG001|NOT COMPLETED|Overall Study||0
10494883|NCT01211106|11645005|FG000|STARTED|Overall Study||95
10494884|NCT01211106|11645006|FG001|STARTED|Overall Study||88
10494885|NCT01211106|11645005|FG000|COMPLETED|Overall Study||82
10494886|NCT01211106|11645006|FG001|COMPLETED|Overall Study||77
10494887|NCT01211106|11645005|FG000|NOT COMPLETED|Overall Study||13
10494888|NCT01211106|11645006|FG001|NOT COMPLETED|Overall Study||11
10494889|NCT01211145|11645018|FG000|STARTED|Overall Study||296
10494890|NCT01211145|11645019|FG001|STARTED|Overall Study||115
10494891|NCT01211145|11645020|FG002|STARTED|Overall Study||99
10494892|NCT01211145|11645021|FG003|STARTED|Overall Study||288
10494893|NCT01211145|11645018|FG000|COMPLETED|Overall Study|1 patient was not counted as completed or discontinued due to incomplete information (N=270-1=269).|270
10494894|NCT01211145|11645019|FG001|COMPLETED|Overall Study||98
10494895|NCT01211145|11645020|FG002|COMPLETED|Overall Study||86
10494896|NCT01211145|11645021|FG003|COMPLETED|Overall Study||268
10494897|NCT01211145|11645018|FG000|NOT COMPLETED|Overall Study||26
10494898|NCT01211145|11645019|FG001|NOT COMPLETED|Overall Study||17
10494899|NCT01211145|11645020|FG002|NOT COMPLETED|Overall Study||13
10494900|NCT01211145|11645021|FG003|NOT COMPLETED|Overall Study||20
10494901|NCT01211184|11645034|FG000|STARTED|Overall Study||20
10494902|NCT01211184|11645035|FG001|STARTED|Overall Study||20
10494903|NCT01211184|11645036|FG002|STARTED|Overall Study||20
10494904|NCT01211184|11645034|FG000|COMPLETED|Overall Study||20
10494905|NCT01211184|11645035|FG001|COMPLETED|Overall Study||18
10494906|NCT01211184|11645036|FG002|COMPLETED|Overall Study||19
10494907|NCT01211184|11645034|FG000|NOT COMPLETED|Overall Study||0
10494908|NCT01211184|11645035|FG001|NOT COMPLETED|Overall Study||2
10494909|NCT01211184|11645036|FG002|NOT COMPLETED|Overall Study||1
10494910|NCT01211197|11645047|FG000|STARTED|Treatment Period 1 (1 Day)||3
10494911|NCT01211197|11645048|FG001|STARTED|Treatment Period 1 (1 Day)||3
10494912|NCT01211197|11645049|FG002|STARTED|Treatment Period 1 (1 Day)||3
10494913|NCT01211197|11645050|FG003|STARTED|Treatment Period 1 (1 Day)||3
10494914|NCT01211197|11645051|FG004|STARTED|Treatment Period 1 (1 Day)||2
10494915|NCT01211197|11645052|FG005|STARTED|Treatment Period 1 (1 Day)||2
10494916|NCT01211197|11645047|FG000|COMPLETED|Treatment Period 1 (1 Day)||3
10494917|NCT01211197|11645048|FG001|COMPLETED|Treatment Period 1 (1 Day)||3
10494918|NCT01211197|11645049|FG002|COMPLETED|Treatment Period 1 (1 Day)||3
10494919|NCT01211197|11645050|FG003|COMPLETED|Treatment Period 1 (1 Day)||3
10494920|NCT01211197|11645051|FG004|COMPLETED|Treatment Period 1 (1 Day)||2
10494921|NCT01211197|11645052|FG005|COMPLETED|Treatment Period 1 (1 Day)||2
10494922|NCT01211197|11645047|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0
10494923|NCT01211197|11645048|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0
10494924|NCT01211197|11645049|FG002|NOT COMPLETED|Treatment Period 1 (1 Day)||0
10494925|NCT01211197|11645050|FG003|NOT COMPLETED|Treatment Period 1 (1 Day)||0
10494926|NCT01211197|11645051|FG004|NOT COMPLETED|Treatment Period 1 (1 Day)||0
10494927|NCT01211197|11645052|FG005|NOT COMPLETED|Treatment Period 1 (1 Day)||0
10494928|NCT01211197|11645047|FG000|STARTED|Washout Period 1 (7 Days)||3
10494929|NCT01211197|11645048|FG001|STARTED|Washout Period 1 (7 Days)||3
10494930|NCT01211197|11645049|FG002|STARTED|Washout Period 1 (7 Days)||3
10494931|NCT01211197|11645050|FG003|STARTED|Washout Period 1 (7 Days)||3
10494932|NCT01211197|11645051|FG004|STARTED|Washout Period 1 (7 Days)||2
10494933|NCT01211197|11645052|FG005|STARTED|Washout Period 1 (7 Days)||2
10494934|NCT01211197|11645047|FG000|COMPLETED|Washout Period 1 (7 Days)||3
10494935|NCT01211197|11645048|FG001|COMPLETED|Washout Period 1 (7 Days)||3
10494936|NCT01211197|11645049|FG002|COMPLETED|Washout Period 1 (7 Days)||2
10494937|NCT01211197|11645050|FG003|COMPLETED|Washout Period 1 (7 Days)||3
10494938|NCT01211197|11645051|FG004|COMPLETED|Washout Period 1 (7 Days)||2
10494939|NCT01211197|11645052|FG005|COMPLETED|Washout Period 1 (7 Days)||2
10494940|NCT01211197|11645047|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
10494941|NCT01211197|11645048|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
10494942|NCT01211197|11645049|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||1
10494943|NCT01211197|11645050|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
10494944|NCT01211197|11645051|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
10494945|NCT01211197|11645052|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
10494946|NCT01211197|11645047|FG000|STARTED|Treatment Period 2 (1 Day)||3
10494947|NCT01211197|11645048|FG001|STARTED|Treatment Period 2 (1 Day)||3
10494948|NCT01211197|11645049|FG002|STARTED|Treatment Period 2 (1 Day)||2
10494949|NCT01211197|11645050|FG003|STARTED|Treatment Period 2 (1 Day)||3
10494950|NCT01211197|11645051|FG004|STARTED|Treatment Period 2 (1 Day)||2
10494951|NCT01211197|11645052|FG005|STARTED|Treatment Period 2 (1 Day)||2
10494952|NCT01211197|11645047|FG000|COMPLETED|Treatment Period 2 (1 Day)||3
10494953|NCT01211197|11645048|FG001|COMPLETED|Treatment Period 2 (1 Day)||3
10494954|NCT01211197|11645049|FG002|COMPLETED|Treatment Period 2 (1 Day)||2
10494955|NCT01211197|11645050|FG003|COMPLETED|Treatment Period 2 (1 Day)||3
10494956|NCT01211197|11645051|FG004|COMPLETED|Treatment Period 2 (1 Day)||2
10494957|NCT01211197|11645052|FG005|COMPLETED|Treatment Period 2 (1 Day)||2
10494958|NCT01211197|11645047|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0
10494959|NCT01211197|11645048|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0
10494960|NCT01211197|11645049|FG002|NOT COMPLETED|Treatment Period 2 (1 Day)||0
10494961|NCT01211197|11645050|FG003|NOT COMPLETED|Treatment Period 2 (1 Day)||0
10494962|NCT01211197|11645051|FG004|NOT COMPLETED|Treatment Period 2 (1 Day)||0
10494963|NCT01211197|11645052|FG005|NOT COMPLETED|Treatment Period 2 (1 Day)||0
10494964|NCT01211197|11645047|FG000|STARTED|Washout Period 2 (7 Days)||3
10494965|NCT01211197|11645048|FG001|STARTED|Washout Period 2 (7 Days)||3
10494966|NCT01211197|11645049|FG002|STARTED|Washout Period 2 (7 Days)||2
10494967|NCT01211197|11645050|FG003|STARTED|Washout Period 2 (7 Days)||3
10494968|NCT01211197|11645051|FG004|STARTED|Washout Period 2 (7 Days)||2
10494969|NCT01211197|11645052|FG005|STARTED|Washout Period 2 (7 Days)||2
10494970|NCT01211197|11645047|FG000|COMPLETED|Washout Period 2 (7 Days)||2
10494971|NCT01211197|11645048|FG001|COMPLETED|Washout Period 2 (7 Days)||3
10494972|NCT01211197|11645049|FG002|COMPLETED|Washout Period 2 (7 Days)||2
10494973|NCT01211197|11645050|FG003|COMPLETED|Washout Period 2 (7 Days)||3
10494974|NCT01211197|11645051|FG004|COMPLETED|Washout Period 2 (7 Days)||2
10494975|NCT01211197|11645052|FG005|COMPLETED|Washout Period 2 (7 Days)||2
10494976|NCT01211197|11645047|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||1
10494977|NCT01211197|11645048|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
10494978|NCT01211197|11645049|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
10494979|NCT01211197|11645050|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
10494980|NCT01211197|11645051|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
10494981|NCT01211197|11645052|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
10494982|NCT01211197|11645047|FG000|STARTED|Treatment Period 3 (1 Day)||2
10494983|NCT01211197|11645048|FG001|STARTED|Treatment Period 3 (1 Day)||3
10494984|NCT01211197|11645049|FG002|STARTED|Treatment Period 3 (1 Day)||2
10494985|NCT01211197|11645050|FG003|STARTED|Treatment Period 3 (1 Day)||3
10494986|NCT01211197|11645051|FG004|STARTED|Treatment Period 3 (1 Day)||2
10494987|NCT01211197|11645052|FG005|STARTED|Treatment Period 3 (1 Day)||2
10494988|NCT01211197|11645047|FG000|COMPLETED|Treatment Period 3 (1 Day)||2
10494989|NCT01211197|11645048|FG001|COMPLETED|Treatment Period 3 (1 Day)||3
10494990|NCT01211197|11645049|FG002|COMPLETED|Treatment Period 3 (1 Day)||2
10494991|NCT01211197|11645050|FG003|COMPLETED|Treatment Period 3 (1 Day)||3
10494992|NCT01211197|11645051|FG004|COMPLETED|Treatment Period 3 (1 Day)||2
10494993|NCT01211197|11645052|FG005|COMPLETED|Treatment Period 3 (1 Day)||2
10494994|NCT01211197|11645047|FG000|NOT COMPLETED|Treatment Period 3 (1 Day)||0
10494995|NCT01211197|11645048|FG001|NOT COMPLETED|Treatment Period 3 (1 Day)||0
10494996|NCT01211197|11645049|FG002|NOT COMPLETED|Treatment Period 3 (1 Day)||0
10494997|NCT01211197|11645050|FG003|NOT COMPLETED|Treatment Period 3 (1 Day)||0
10494998|NCT01211197|11645051|FG004|NOT COMPLETED|Treatment Period 3 (1 Day)||0
10494999|NCT01211197|11645052|FG005|NOT COMPLETED|Treatment Period 3 (1 Day)||0
10495000|NCT01211262|11645062|FG000|STARTED|Overall Study||66
10495001|NCT01211262|11645063|FG001|STARTED|Overall Study||18
10495002|NCT01211262|11645062|FG000|COMPLETED|Overall Study||43
10495003|NCT01211262|11645063|FG001|COMPLETED|Overall Study||8
10495004|NCT01211262|11645062|FG000|NOT COMPLETED|Overall Study||23
10495005|NCT01211262|11645063|FG001|NOT COMPLETED|Overall Study||10
10495006|NCT01211288|11645074|FG000|STARTED|Overall Study||21
10495007|NCT01211288|11645075|FG001|STARTED|Overall Study||20
10495008|NCT01211288|11645074|FG000|COMPLETED|Overall Study||20
10495009|NCT01211288|11645075|FG001|COMPLETED|Overall Study||19
10495010|NCT01211288|11645074|FG000|NOT COMPLETED|Overall Study||1
10495011|NCT01211288|11645075|FG001|NOT COMPLETED|Overall Study||1
10495012|NCT01211340|11645085|FG000|STARTED|Overall Study||223
10495013|NCT01211340|11645086|FG001|STARTED|Overall Study||223
10495014|NCT01211340|11645085|FG000|COMPLETED|Overall Study||223
10495015|NCT01211340|11645086|FG001|COMPLETED|Overall Study||223
10495016|NCT01211340|11645085|FG000|NOT COMPLETED|Overall Study||0
10495017|NCT01211340|11645086|FG001|NOT COMPLETED|Overall Study||0
10495018|NCT01211483|11645096|FG000|STARTED|Phase 1b||7
10495019|NCT01211483|11645097|FG001|STARTED|Phase 1b||0
10495020|NCT01211483|11645098|FG002|STARTED|Phase 1b||0
10495021|NCT01211483|11645099|FG003|STARTED|Phase 1b||0
10495022|NCT01211483|11645096|FG000|COMPLETED|Phase 1b||0
10495023|NCT01211483|11645097|FG001|COMPLETED|Phase 1b||0
10495024|NCT01211483|11645098|FG002|COMPLETED|Phase 1b||0
10495025|NCT01211483|11645099|FG003|COMPLETED|Phase 1b||0
10495026|NCT01211483|11645096|FG000|NOT COMPLETED|Phase 1b||7
10495027|NCT01211483|11645097|FG001|NOT COMPLETED|Phase 1b||0
10495028|NCT01211483|11645098|FG002|NOT COMPLETED|Phase 1b||0
10495029|NCT01211483|11645099|FG003|NOT COMPLETED|Phase 1b||0
10495030|NCT01211483|11645096|FG000|STARTED|Phase 2||0
10495031|NCT01211483|11645097|FG001|STARTED|Phase 2|Participants entered only at Period 2.|72
10495032|NCT01211483|11645098|FG002|STARTED|Phase 2|Participants entered only at Period 2.|72
10495033|NCT01211483|11645099|FG003|STARTED|Phase 2|Participants entered only at Period 2.|71
10495034|NCT01211483|11645096|FG000|COMPLETED|Phase 2||0
10495035|NCT01211483|11645097|FG001|COMPLETED|Phase 2||0
10495036|NCT01211483|11645098|FG002|COMPLETED|Phase 2||0
10495037|NCT01211483|11645099|FG003|COMPLETED|Phase 2||0
10495038|NCT01211483|11645096|FG000|NOT COMPLETED|Phase 2||0
10495039|NCT01211483|11645097|FG001|NOT COMPLETED|Phase 2||72
10495040|NCT01211483|11645098|FG002|NOT COMPLETED|Phase 2||72
10495041|NCT01211483|11645099|FG003|NOT COMPLETED|Phase 2||71
10495042|NCT01211522|11645116|FG000|STARTED|Overall Study||192
10495043|NCT01211522|11645117|FG001|STARTED|Overall Study||190
10495044|NCT01211522|11645118|FG002|STARTED|Overall Study||184
10495045|NCT01211522|11645116|FG000|COMPLETED|Overall Study||189
10495046|NCT01211522|11645117|FG001|COMPLETED|Overall Study||183
10495047|NCT01211522|11645118|FG002|COMPLETED|Overall Study||179
10495048|NCT01211522|11645116|FG000|NOT COMPLETED|Overall Study||3
10495049|NCT01211522|11645117|FG001|NOT COMPLETED|Overall Study||7
10495050|NCT01211522|11645118|FG002|NOT COMPLETED|Overall Study||5
10495051|NCT01211535|11645128|FG000|STARTED|Overall Study||52
10495052|NCT01211535|11645129|FG001|STARTED|Overall Study||52
10495053|NCT01211535|11645128|FG000|COMPLETED|Overall Study||52
10495054|NCT01211535|11645129|FG001|COMPLETED|Overall Study||51
10495055|NCT01211535|11645128|FG000|NOT COMPLETED|Overall Study||0
10495056|NCT01211535|11645129|FG001|NOT COMPLETED|Overall Study||1
10495057|NCT01211600|11645137|FG000|STARTED|Overall Study||370
10495058|NCT01211600|11645138|FG001|STARTED|Overall Study||376
10495059|NCT01211600|11645137|FG000|COMPLETED|Overall Study||370
10495060|NCT01211600|11645138|FG001|COMPLETED|Overall Study||376
10495061|NCT01211600|11645137|FG000|NOT COMPLETED|Overall Study||0
10495062|NCT01211600|11645138|FG001|NOT COMPLETED|Overall Study||0
10495063|NCT01211613|11645149|FG000|STARTED|Overall Study||37
10495064|NCT01211613|11645150|FG001|STARTED|Overall Study||35
10495065|NCT01211613|11645151|FG002|STARTED|Overall Study||35
10495066|NCT01211613|11645149|FG000|COMPLETED|Overall Study||34
10495067|NCT01211613|11645150|FG001|COMPLETED|Overall Study||33
10495068|NCT01211613|11645151|FG002|COMPLETED|Overall Study||33
10495069|NCT01211613|11645149|FG000|NOT COMPLETED|Overall Study||3
10495070|NCT01211613|11645150|FG001|NOT COMPLETED|Overall Study||2
10495071|NCT01211613|11645151|FG002|NOT COMPLETED|Overall Study||2
10495072|NCT01211665|11645161|FG000|STARTED|Overall Study||2
10495073|NCT01211665|11645162|FG001|STARTED|Overall Study||1
10495074|NCT01211665|11645161|FG000|COMPLETED|Overall Study||0
10495075|NCT01211665|11645162|FG001|COMPLETED|Overall Study|completed treatment with study drug|1
10495076|NCT01211665|11645161|FG000|NOT COMPLETED|Overall Study||2
10495077|NCT01211665|11645162|FG001|NOT COMPLETED|Overall Study||0
10495078|NCT01211730|11645170|FG000|STARTED|Overall Study||82
10495079|NCT01211730|11645171|FG001|STARTED|Overall Study||82
10495080|NCT01211730|11645170|FG000|COMPLETED|Overall Study||82
10495081|NCT01211730|11645171|FG001|COMPLETED|Overall Study||82
10495082|NCT01211730|11645170|FG000|NOT COMPLETED|Overall Study||0
10495083|NCT01211730|11645171|FG001|NOT COMPLETED|Overall Study||0
10495084|NCT01211769|11645181|FG000|STARTED|Overall Study||20
10495085|NCT01211769|11645182|FG001|STARTED|Overall Study||20
10495086|NCT01211769|11645183|FG002|STARTED|Overall Study||20
10495087|NCT01211769|11645184|FG003|STARTED|Overall Study||20
10495088|NCT01211769|11645181|FG000|Participants/Group|Overall Study||20
10495089|NCT01211769|11645182|FG001|Participants/Group|Overall Study||20
10495090|NCT01211769|11645183|FG002|Participants/Group|Overall Study||20
10495091|NCT01211769|11645184|FG003|Participants/Group|Overall Study||20
10495092|NCT01211769|11645181|FG000|COMPLETED|Overall Study||11
10495093|NCT01211769|11645182|FG001|COMPLETED|Overall Study||10
10495094|NCT01211769|11645183|FG002|COMPLETED|Overall Study||12
10495095|NCT01211769|11645184|FG003|COMPLETED|Overall Study||9
10495096|NCT01211769|11645181|FG000|NOT COMPLETED|Overall Study||9
10495097|NCT01211769|11645182|FG001|NOT COMPLETED|Overall Study||10
10495098|NCT01211769|11645183|FG002|NOT COMPLETED|Overall Study||8
10495099|NCT01211769|11645184|FG003|NOT COMPLETED|Overall Study||11
10495100|NCT01211873|11645197|FG000|STARTED|Overall Study||245
10495101|NCT01211873|11645198|FG001|STARTED|Overall Study||119
10495102|NCT01211873|11645199|FG002|STARTED|Overall Study||38
10495103|NCT01211873|11645197|FG000|COMPLETED|Overall Study||240
10495104|NCT01211873|11645198|FG001|COMPLETED|Overall Study||117
10495105|NCT01211873|11645199|FG002|COMPLETED|Overall Study||36
10495106|NCT01211873|11645197|FG000|NOT COMPLETED|Overall Study||5
10495107|NCT01211873|11645198|FG001|NOT COMPLETED|Overall Study||2
10495108|NCT01211873|11645199|FG002|NOT COMPLETED|Overall Study||2
10495109|NCT01212094|11645211|FG000|STARTED|Year 1: Baseline Monitoring||43
10495110|NCT01212094|11645212|FG001|STARTED|Year 1: Baseline Monitoring||0
10495111|NCT01212094|11645213|FG002|STARTED|Year 1: Baseline Monitoring||0
10495112|NCT01212094|11645211|FG000|COMPLETED|Year 1: Baseline Monitoring||27
10495113|NCT01212094|11645212|FG001|COMPLETED|Year 1: Baseline Monitoring||0
10495114|NCT01212094|11645213|FG002|COMPLETED|Year 1: Baseline Monitoring||0
10495115|NCT01212094|11645211|FG000|NOT COMPLETED|Year 1: Baseline Monitoring||16
10495116|NCT01212094|11645212|FG001|NOT COMPLETED|Year 1: Baseline Monitoring||0
10495117|NCT01212094|11645213|FG002|NOT COMPLETED|Year 1: Baseline Monitoring||0
10495118|NCT01212094|11645211|FG000|STARTED|Years 2 & 3: Treatment Randomization||0
10495119|NCT01212094|11645212|FG001|STARTED|Years 2 & 3: Treatment Randomization||9
10495120|NCT01212094|11645213|FG002|STARTED|Years 2 & 3: Treatment Randomization||18
10495121|NCT01212094|11645211|FG000|COMPLETED|Years 2 & 3: Treatment Randomization||0
10495122|NCT01212094|11645212|FG001|COMPLETED|Years 2 & 3: Treatment Randomization||5
10495123|NCT01212094|11645213|FG002|COMPLETED|Years 2 & 3: Treatment Randomization||7
10495124|NCT01212094|11645211|FG000|NOT COMPLETED|Years 2 & 3: Treatment Randomization||0
10495125|NCT01212094|11645212|FG001|NOT COMPLETED|Years 2 & 3: Treatment Randomization||4
10495126|NCT01212094|11645213|FG002|NOT COMPLETED|Years 2 & 3: Treatment Randomization||11
10495127|NCT01212107|11645232|FG000|STARTED|Overall Study||3
10495128|NCT01212107|11645233|FG001|STARTED|Overall Study||3
10495129|NCT01212107|11645234|FG002|STARTED|Overall Study||6
10495130|NCT01212107|11645235|FG003|STARTED|Overall Study||3
10495131|NCT01212107|11645236|FG004|STARTED|Overall Study||3
10495132|NCT01212107|11645237|FG005|STARTED|Overall Study||3
10495133|NCT01212107|11645238|FG006|STARTED|Overall Study||3
10495134|NCT01212107|11645239|FG007|STARTED|Overall Study||3
10495135|NCT01212107|11645240|FG008|STARTED|Overall Study||3
10495136|NCT01212107|11645241|FG009|STARTED|Overall Study||3
10495137|NCT01212107|11645242|FG010|STARTED|Overall Study||3
10495138|NCT01212107|11645243|FG011|STARTED|Overall Study||58
10495139|NCT01212107|11645232|FG000|COMPLETED|Overall Study||2
10495140|NCT01212107|11645233|FG001|COMPLETED|Overall Study||2
10495141|NCT01212107|11645234|FG002|COMPLETED|Overall Study||3
10495142|NCT01212107|11645235|FG003|COMPLETED|Overall Study||3
10495143|NCT01212107|11645236|FG004|COMPLETED|Overall Study||2
10495144|NCT01212107|11645237|FG005|COMPLETED|Overall Study||2
10495145|NCT01212107|11645238|FG006|COMPLETED|Overall Study||3
10495146|NCT01212107|11645239|FG007|COMPLETED|Overall Study||2
10495147|NCT01212107|11645240|FG008|COMPLETED|Overall Study||1
10495148|NCT01212107|11645241|FG009|COMPLETED|Overall Study||1
10495149|NCT01212107|11645242|FG010|COMPLETED|Overall Study||2
10495150|NCT01212107|11645243|FG011|COMPLETED|Overall Study||26
10495151|NCT01212107|11645232|FG000|NOT COMPLETED|Overall Study||1
10495152|NCT01212107|11645233|FG001|NOT COMPLETED|Overall Study||1
10495153|NCT01212107|11645234|FG002|NOT COMPLETED|Overall Study||3
10495154|NCT01212107|11645235|FG003|NOT COMPLETED|Overall Study||0
10495155|NCT01212107|11645236|FG004|NOT COMPLETED|Overall Study||1
10495156|NCT01212107|11645237|FG005|NOT COMPLETED|Overall Study||1
10495157|NCT01212107|11645238|FG006|NOT COMPLETED|Overall Study||0
10495158|NCT01212107|11645239|FG007|NOT COMPLETED|Overall Study||1
10495159|NCT01212107|11645240|FG008|NOT COMPLETED|Overall Study||2
10495160|NCT01212107|11645241|FG009|NOT COMPLETED|Overall Study||2
10495161|NCT01212107|11645242|FG010|NOT COMPLETED|Overall Study||1
10495162|NCT01212107|11645243|FG011|NOT COMPLETED|Overall Study||32
10495163|NCT01212159|11645287|FG000|STARTED|Overall Study||26
10495164|NCT01212159|11645288|FG001|STARTED|Overall Study||44
10495165|NCT01212159|11645287|FG000|COMPLETED|Overall Study||14
10495166|NCT01212159|11645288|FG001|COMPLETED|Overall Study||32
10495167|NCT01212159|11645287|FG000|NOT COMPLETED|Overall Study||12
10495168|NCT01212159|11645288|FG001|NOT COMPLETED|Overall Study||12
10495169|NCT01212172|11645294|FG000|STARTED|Overall Study||10
10495170|NCT01212172|11645295|FG001|STARTED|Overall Study||10
10495171|NCT01212172|11645294|FG000|COMPLETED|Overall Study||9
10495172|NCT01212172|11645295|FG001|COMPLETED|Overall Study||9
10495173|NCT01212172|11645294|FG000|NOT COMPLETED|Overall Study||1
10495174|NCT01212172|11645295|FG001|NOT COMPLETED|Overall Study||1
10495175|NCT01212185|11645305|FG000|STARTED|Overall Study||6
10495176|NCT01212185|11645306|FG001|STARTED|Overall Study||8
10495177|NCT01212185|11645305|FG000|COMPLETED|Overall Study||4
10495178|NCT01212185|11645306|FG001|COMPLETED|Overall Study||7
10495179|NCT01212185|11645305|FG000|NOT COMPLETED|Overall Study||2
10495180|NCT01212185|11645306|FG001|NOT COMPLETED|Overall Study||1
10495181|NCT01212302|11645312|FG000|STARTED|Overall Study||504
10495182|NCT01212302|11645312|FG000|COMPLETED|Overall Study||504
10495183|NCT01212302|11645312|FG000|NOT COMPLETED|Overall Study||0
10495184|NCT01212445|11645319|FG000|STARTED|Overall Study||52
10495185|NCT01212445|11645320|FG001|STARTED|Overall Study||51
10495186|NCT01212445|11645321|FG002|STARTED|Overall Study||51
10495187|NCT01212445|11645319|FG000|COMPLETED|Overall Study||52
10495188|NCT01212445|11645320|FG001|COMPLETED|Overall Study||51
10495189|NCT01212445|11645321|FG002|COMPLETED|Overall Study||51
10495190|NCT01212445|11645319|FG000|NOT COMPLETED|Overall Study||0
10495191|NCT01212445|11645320|FG001|NOT COMPLETED|Overall Study||0
10495192|NCT01212445|11645321|FG002|NOT COMPLETED|Overall Study||0
10495193|NCT01212471|11645333|FG000|STARTED|Overall Study||141
10495194|NCT01212471|11645334|FG001|STARTED|Overall Study||140
10495195|NCT01212471|11645335|FG002|STARTED|Overall Study||139
10495196|NCT01212471|11645333|FG000|COMPLETED|Overall Study||139
10495197|NCT01212471|11645334|FG001|COMPLETED|Overall Study||137
10495198|NCT01212471|11645335|FG002|COMPLETED|Overall Study||132
10495199|NCT01212471|11645333|FG000|NOT COMPLETED|Overall Study||2
10495200|NCT01212471|11645334|FG001|NOT COMPLETED|Overall Study||3
10495201|NCT01212471|11645335|FG002|NOT COMPLETED|Overall Study||7
10495202|NCT01212484|11645343|FG000|STARTED|Carbidopa Titration Period (4 Weeks)||6
10495203|NCT01212484|11645344|FG001|STARTED|Carbidopa Titration Period (4 Weeks)||6
10495204|NCT01212484|11645343|FG000|COMPLETED|Carbidopa Titration Period (4 Weeks)||5
10495205|NCT01212484|11645344|FG001|COMPLETED|Carbidopa Titration Period (4 Weeks)||6
10495206|NCT01212484|11645343|FG000|NOT COMPLETED|Carbidopa Titration Period (4 Weeks)||1
10495207|NCT01212484|11645344|FG001|NOT COMPLETED|Carbidopa Titration Period (4 Weeks)||0
10495208|NCT01212484|11645343|FG000|STARTED|First Intervention (4 Weeks)||5
10495209|NCT01212484|11645344|FG001|STARTED|First Intervention (4 Weeks)||6
10495210|NCT01212484|11645343|FG000|COMPLETED|First Intervention (4 Weeks)||5
10495211|NCT01212484|11645344|FG001|COMPLETED|First Intervention (4 Weeks)||4
10495212|NCT01212484|11645343|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
10495213|NCT01212484|11645344|FG001|NOT COMPLETED|First Intervention (4 Weeks)||2
10495214|NCT01212484|11645343|FG000|STARTED|Second Intervention (4 Weeks)||5
10495215|NCT01212484|11645344|FG001|STARTED|Second Intervention (4 Weeks)||4
10495216|NCT01212484|11645343|FG000|COMPLETED|Second Intervention (4 Weeks)||5
10495217|NCT01212484|11645344|FG001|COMPLETED|Second Intervention (4 Weeks)||3
10495218|NCT01212484|11645343|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
10495219|NCT01212484|11645344|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1
10495220|NCT01212588|11645352|FG000|STARTED|Overall Study||10
10495221|NCT01212588|11645353|FG001|STARTED|Overall Study||12
10495222|NCT01212588|11645352|FG000|COMPLETED|Overall Study||9
10495223|NCT01212588|11645353|FG001|COMPLETED|Overall Study||10
10495224|NCT01212588|11645352|FG000|NOT COMPLETED|Overall Study||1
10495225|NCT01212588|11645353|FG001|NOT COMPLETED|Overall Study||2
10495226|NCT01212627|11645359|FG000|STARTED|Overall Study||12
10495227|NCT01212627|11645359|FG000|COMPLETED|Overall Study||12
10495228|NCT01212627|11645359|FG000|NOT COMPLETED|Overall Study||0
10495229|NCT01212744|11645363|FG000|STARTED|Overall Study||16
10495230|NCT01212744|11645363|FG000|COMPLETED|Overall Study||15
10495231|NCT01212744|11645363|FG000|NOT COMPLETED|Overall Study||1
10495232|NCT01212757|11645372|FG000|STARTED|Placebo-controlled Phase (Week 0 - 24)||162
10495233|NCT01212757|11645373|FG001|STARTED|Placebo-controlled Phase (Week 0 - 24)||163
10495234|NCT01212757|11645374|FG002|STARTED|Placebo-controlled Phase (Week 0 - 24)||163
10495235|NCT01212757|11645375|FG003|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
10495236|NCT01212757|11645376|FG004|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
10495237|NCT01212757|11645377|FG005|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
10495238|NCT01212757|11645378|FG006|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
10495239|NCT01212757|11645379|FG007|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
10495240|NCT01212757|11645380|FG008|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
10495241|NCT01212757|11645372|FG000|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||159
10495242|NCT01212757|11645373|FG001|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||163
10495243|NCT01212757|11645374|FG002|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||162
10495244|NCT01212757|11645375|FG003|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
10495245|NCT01212757|11645376|FG004|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
10495246|NCT01212757|11645377|FG005|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
10495247|NCT01212757|11645378|FG006|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
10495248|NCT01212757|11645379|FG007|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
10495249|NCT01212757|11645380|FG008|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
10495250|NCT01212757|11645372|FG000|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||148
10495251|NCT01212757|11645373|FG001|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||151
10495252|NCT01212757|11645374|FG002|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||149
10495253|NCT01212757|11645375|FG003|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
10495254|NCT01212757|11645376|FG004|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
10495255|NCT01212757|11645377|FG005|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
10495256|NCT01212757|11645378|FG006|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
10495257|NCT01212757|11645379|FG007|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
10495258|NCT01212757|11645380|FG008|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
10495259|NCT01212757|11645372|FG000|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Two participants who escaped early did not complete Week 24|88
10495260|NCT01212757|11645373|FG001|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Three participants who escaped early did not complete Week 24|59
10495261|NCT01212757|11645374|FG002|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||64
10495262|NCT01212757|11645375|FG003|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
10495263|NCT01212757|11645376|FG004|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
10495327|NCT01212757|11645377|FG005|COMPLETED|Long-Term Safety Phase (Year 2)||0
10495264|NCT01212757|11645377|FG005|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
10495265|NCT01212757|11645378|FG006|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
10650064|NCT02166047|11810249|FG000|STARTED|Overall Study||16
10650065|NCT02166047|11810250|FG001|STARTED|Overall Study||15
10650066|NCT02166047|11810251|FG002|STARTED|Overall Study||16
10650067|NCT02166047|11810252|FG003|STARTED|Overall Study||5
10650068|NCT02166047|11810253|FG004|STARTED|Overall Study||18
10650069|NCT02166047|11810254|FG005|STARTED|Overall Study||17
10495266|NCT01212757|11645379|FG007|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
10495267|NCT01212757|11645380|FG008|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
10495268|NCT01212757|11645372|FG000|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|Two participants who completed Week 24 did not enter the active treatment phase|143
10495269|NCT01212757|11645373|FG001|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||143
10495270|NCT01212757|11645374|FG002|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||142
10495271|NCT01212757|11645375|FG003|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
10495272|NCT01212757|11645376|FG004|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
10495273|NCT01212757|11645377|FG005|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
10495274|NCT01212757|11645378|FG006|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
10495275|NCT01212757|11645379|FG007|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
10495276|NCT01212757|11645380|FG008|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
10495277|NCT01212757|11645372|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||19
10495278|NCT01212757|11645373|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20
10495279|NCT01212757|11645374|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||21
10495280|NCT01212757|11645375|FG003|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
10495281|NCT01212757|11645376|FG004|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
10495282|NCT01212757|11645377|FG005|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
10495283|NCT01212757|11645378|FG006|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
10495284|NCT01212757|11645379|FG007|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
10495285|NCT01212757|11645380|FG008|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
10495286|NCT01212757|11645372|FG000|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
10495287|NCT01212757|11645373|FG001|STARTED|Active Treatment Phase (Weeks 24 - 52)|6 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|137
10495288|NCT01212757|11645374|FG002|STARTED|Active Treatment Phase (Weeks 24 - 52)|8 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|134
10495289|NCT01212757|11645375|FG003|STARTED|Active Treatment Phase (Weeks 24 - 52)||43
10495290|NCT01212757|11645376|FG004|STARTED|Active Treatment Phase (Weeks 24 - 52)||27
10495291|NCT01212757|11645377|FG005|STARTED|Active Treatment Phase (Weeks 24 - 52)|2 participants who EE and completed Week 24 did not enter the Week 24-52 active treatment phase|41
10495292|NCT01212757|11645378|FG006|STARTED|Active Treatment Phase (Weeks 24 - 52)||28
10495293|NCT01212757|11645379|FG007|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
10495294|NCT01212757|11645380|FG008|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
10495295|NCT01212757|11645372|FG000|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
10495296|NCT01212757|11645373|FG001|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||125
10495297|NCT01212757|11645374|FG002|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||114
10495298|NCT01212757|11645375|FG003|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||35
10495299|NCT01212757|11645376|FG004|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||25
10495300|NCT01212757|11645377|FG005|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||34
10495301|NCT01212757|11645378|FG006|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||28
10495302|NCT01212757|11645379|FG007|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
10495303|NCT01212757|11645380|FG008|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
10495304|NCT01212757|11645372|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
10495305|NCT01212757|11645373|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||12
10495306|NCT01212757|11645374|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||20
10495307|NCT01212757|11645375|FG003|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||8
10495308|NCT01212757|11645376|FG004|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||2
10495309|NCT01212757|11645377|FG005|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||7
10495310|NCT01212757|11645378|FG006|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
10495311|NCT01212757|11645379|FG007|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
10495312|NCT01212757|11645380|FG008|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
10495313|NCT01212757|11645372|FG000|STARTED|Long-Term Safety Phase (Year 2)||0
10495314|NCT01212757|11645373|FG001|STARTED|Long-Term Safety Phase (Year 2)|6 participants who completed Week 52 did not enter the long-term safety phase|119
10495315|NCT01212757|11645374|FG002|STARTED|Long-Term Safety Phase (Year 2)|5 participants who completed Week 52 did not enter the long-term safety phase|109
10495316|NCT01212757|11645375|FG003|STARTED|Long-Term Safety Phase (Year 2)||0
10495317|NCT01212757|11645376|FG004|STARTED|Long-Term Safety Phase (Year 2)||0
10495318|NCT01212757|11645377|FG005|STARTED|Long-Term Safety Phase (Year 2)||0
10495319|NCT01212757|11645378|FG006|STARTED|Long-Term Safety Phase (Year 2)||0
10495320|NCT01212757|11645379|FG007|STARTED|Long-Term Safety Phase (Year 2)|Combined PBO-APR 20EE+XO;2 participants who completed Week 52 did not enter long-term safety phase|58
10495321|NCT01212757|11645380|FG008|STARTED|Long-Term Safety Phase (Year 2)|Combined PBO-APR 30EE+XO;2 participants who completed Week 52 did not enter long-term safety phase|60
10495322|NCT01212757|11645372|FG000|COMPLETED|Long-Term Safety Phase (Year 2)||0
10495323|NCT01212757|11645373|FG001|COMPLETED|Long-Term Safety Phase (Year 2)||107
10495324|NCT01212757|11645374|FG002|COMPLETED|Long-Term Safety Phase (Year 2)||95
10495325|NCT01212757|11645375|FG003|COMPLETED|Long-Term Safety Phase (Year 2)||0
10495326|NCT01212757|11645376|FG004|COMPLETED|Long-Term Safety Phase (Year 2)||0
10495328|NCT01212757|11645378|FG006|COMPLETED|Long-Term Safety Phase (Year 2)||0
10495329|NCT01212757|11645379|FG007|COMPLETED|Long-Term Safety Phase (Year 2)||48
10495330|NCT01212757|11645380|FG008|COMPLETED|Long-Term Safety Phase (Year 2)||51
10495331|NCT01212757|11645372|FG000|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
10495332|NCT01212757|11645373|FG001|NOT COMPLETED|Long-Term Safety Phase (Year 2)||12
10495333|NCT01212757|11645374|FG002|NOT COMPLETED|Long-Term Safety Phase (Year 2)||14
10495334|NCT01212757|11645375|FG003|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
10495335|NCT01212757|11645376|FG004|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
10495336|NCT01212757|11645377|FG005|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
10495337|NCT01212757|11645378|FG006|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
10495338|NCT01212757|11645379|FG007|NOT COMPLETED|Long-Term Safety Phase (Year 2)||10
10495339|NCT01212757|11645380|FG008|NOT COMPLETED|Long-Term Safety Phase (Year 2)||9
10495340|NCT01212757|11645372|FG000|STARTED|Long-Term Safety Phase (Year 3)||0
10495341|NCT01212757|11645373|FG001|STARTED|Long-Term Safety Phase (Year 3)||107
10495342|NCT01212757|11645374|FG002|STARTED|Long-Term Safety Phase (Year 3)||95
10495343|NCT01212757|11645375|FG003|STARTED|Long-Term Safety Phase (Year 3)||0
10495344|NCT01212757|11645376|FG004|STARTED|Long-Term Safety Phase (Year 3)||0
10650070|NCT02166047|11810255|FG006|STARTED|Overall Study||17
10650071|NCT02166047|11810256|FG007|STARTED|Overall Study||5
10650072|NCT02166047|11810257|FG008|STARTED|Overall Study||16
10650073|NCT02166047|11810258|FG009|STARTED|Overall Study||17
10650074|NCT02166047|11810259|FG010|STARTED|Overall Study||14
10650075|NCT02166047|11810260|FG011|STARTED|Overall Study||6
10650076|NCT02166047|11810249|FG000|COMPLETED|Overall Study||16
10650077|NCT02166047|11810250|FG001|COMPLETED|Overall Study||14
10650078|NCT02166047|11810251|FG002|COMPLETED|Overall Study||14
10650079|NCT02166047|11810252|FG003|COMPLETED|Overall Study||5
10650080|NCT02166047|11810253|FG004|COMPLETED|Overall Study||17
10650081|NCT02166047|11810254|FG005|COMPLETED|Overall Study||17
10650082|NCT02166047|11810255|FG006|COMPLETED|Overall Study||15
10650083|NCT02166047|11810256|FG007|COMPLETED|Overall Study||5
10650084|NCT02166047|11810257|FG008|COMPLETED|Overall Study||16
10650085|NCT02166047|11810258|FG009|COMPLETED|Overall Study||17
10650086|NCT02166047|11810259|FG010|COMPLETED|Overall Study||12
10650087|NCT02166047|11810260|FG011|COMPLETED|Overall Study||6
10650088|NCT02166047|11810249|FG000|NOT COMPLETED|Overall Study||0
10650089|NCT02166047|11810250|FG001|NOT COMPLETED|Overall Study||1
10650090|NCT02166047|11810251|FG002|NOT COMPLETED|Overall Study||2
10650091|NCT02166047|11810252|FG003|NOT COMPLETED|Overall Study||0
10650092|NCT02166047|11810253|FG004|NOT COMPLETED|Overall Study||1
10650093|NCT02166047|11810254|FG005|NOT COMPLETED|Overall Study||0
10650094|NCT02166047|11810255|FG006|NOT COMPLETED|Overall Study||2
10650095|NCT02166047|11810256|FG007|NOT COMPLETED|Overall Study||0
10650096|NCT02166047|11810257|FG008|NOT COMPLETED|Overall Study||0
10650097|NCT02166047|11810258|FG009|NOT COMPLETED|Overall Study||0
10650098|NCT02166047|11810259|FG010|NOT COMPLETED|Overall Study||2
10650099|NCT02166047|11810260|FG011|NOT COMPLETED|Overall Study||0
10650100|NCT02166333|11810290|FG000|STARTED|Stage 1||262
10650101|NCT02166333|11810291|FG001|STARTED|Stage 1||0
10650102|NCT02166333|11810292|FG002|STARTED|Stage 1||130
10650103|NCT02166333|11810293|FG003|STARTED|Stage 1||0
10650104|NCT02166333|11810294|FG004|STARTED|Stage 1|Randomization to 2000 IU/d was stopped in February 2018 as part of planned dose-finding|68
10650105|NCT02166333|11810295|FG005|STARTED|Stage 1|Randomization to 4000 IU/d was stopped in March 2018 as part of planned dose-finding|69
10650106|NCT02166333|11810290|FG000|COMPLETED|Stage 1||242
10650107|NCT02166333|11810291|FG001|COMPLETED|Stage 1||0
10650108|NCT02166333|11810292|FG002|COMPLETED|Stage 1||122
10650109|NCT02166333|11810293|FG003|COMPLETED|Stage 1||0
10650110|NCT02166333|11810294|FG004|COMPLETED|Stage 1||59
10650111|NCT02166333|11810295|FG005|COMPLETED|Stage 1||63
10650112|NCT02166333|11810290|FG000|NOT COMPLETED|Stage 1||20
10650113|NCT02166333|11810291|FG001|NOT COMPLETED|Stage 1||0
10650114|NCT02166333|11810292|FG002|NOT COMPLETED|Stage 1||8
10650115|NCT02166333|11810293|FG003|NOT COMPLETED|Stage 1||0
10650116|NCT02166333|11810294|FG004|NOT COMPLETED|Stage 1||9
10650117|NCT02166333|11810295|FG005|NOT COMPLETED|Stage 1||6
10650118|NCT02166333|11810290|FG000|STARTED|Stage 2||242
10650119|NCT02166333|11810291|FG001|STARTED|Stage 2||77
10650120|NCT02166333|11810292|FG002|STARTED|Stage 2||122
10650121|NCT02166333|11810293|FG003|STARTED|Stage 2||82
10650122|NCT02166333|11810294|FG004|STARTED|Stage 2||59
10495345|NCT01212757|11645377|FG005|STARTED|Long-Term Safety Phase (Year 3)||0
10495346|NCT01212757|11645378|FG006|STARTED|Long-Term Safety Phase (Year 3)||0
10495347|NCT01212757|11645379|FG007|STARTED|Long-Term Safety Phase (Year 3)||48
10495348|NCT01212757|11645380|FG008|STARTED|Long-Term Safety Phase (Year 3)||51
10495349|NCT01212757|11645372|FG000|COMPLETED|Long-Term Safety Phase (Year 3)||0
10495350|NCT01212757|11645373|FG001|COMPLETED|Long-Term Safety Phase (Year 3)||89
10495351|NCT01212757|11645374|FG002|COMPLETED|Long-Term Safety Phase (Year 3)||84
10495352|NCT01212757|11645375|FG003|COMPLETED|Long-Term Safety Phase (Year 3)||0
10495353|NCT01212757|11645376|FG004|COMPLETED|Long-Term Safety Phase (Year 3)||0
10495354|NCT01212757|11645377|FG005|COMPLETED|Long-Term Safety Phase (Year 3)||0
10495355|NCT01212757|11645378|FG006|COMPLETED|Long-Term Safety Phase (Year 3)||0
10495356|NCT01212757|11645379|FG007|COMPLETED|Long-Term Safety Phase (Year 3)||42
10495357|NCT01212757|11645380|FG008|COMPLETED|Long-Term Safety Phase (Year 3)||46
10495358|NCT01212757|11645372|FG000|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
10495359|NCT01212757|11645373|FG001|NOT COMPLETED|Long-Term Safety Phase (Year 3)||18
10495360|NCT01212757|11645374|FG002|NOT COMPLETED|Long-Term Safety Phase (Year 3)||11
10495361|NCT01212757|11645375|FG003|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
10495362|NCT01212757|11645376|FG004|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
10495363|NCT01212757|11645377|FG005|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
10495364|NCT01212757|11645378|FG006|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
10495365|NCT01212757|11645379|FG007|NOT COMPLETED|Long-Term Safety Phase (Year 3)||6
10650123|NCT02166333|11810295|FG005|STARTED|Stage 2||63
10495366|NCT01212757|11645380|FG008|NOT COMPLETED|Long-Term Safety Phase (Year 3)||5
10495367|NCT01212757|11645372|FG000|STARTED|Long-Term Safety Phase (Year 4)||0
10495368|NCT01212757|11645373|FG001|STARTED|Long-Term Safety Phase (Year 4)||89
10495369|NCT01212757|11645374|FG002|STARTED|Long-Term Safety Phase (Year 4)||84
10495370|NCT01212757|11645375|FG003|STARTED|Long-Term Safety Phase (Year 4)||0
10495371|NCT01212757|11645376|FG004|STARTED|Long-Term Safety Phase (Year 4)||0
10495372|NCT01212757|11645377|FG005|STARTED|Long-Term Safety Phase (Year 4)||0
10495373|NCT01212757|11645378|FG006|STARTED|Long-Term Safety Phase (Year 4)||0
10495374|NCT01212757|11645379|FG007|STARTED|Long-Term Safety Phase (Year 4)|1 participant who completed Year 3 did not continue treatment in Year 4|41
10495375|NCT01212757|11645380|FG008|STARTED|Long-Term Safety Phase (Year 4)||46
10495376|NCT01212757|11645372|FG000|COMPLETED|Long-Term Safety Phase (Year 4)||0
10495377|NCT01212757|11645373|FG001|COMPLETED|Long-Term Safety Phase (Year 4)||80
10495378|NCT01212757|11645374|FG002|COMPLETED|Long-Term Safety Phase (Year 4)||77
10495379|NCT01212757|11645375|FG003|COMPLETED|Long-Term Safety Phase (Year 4)||0
10495380|NCT01212757|11645376|FG004|COMPLETED|Long-Term Safety Phase (Year 4)||0
10495381|NCT01212757|11645377|FG005|COMPLETED|Long-Term Safety Phase (Year 4)||0
10495382|NCT01212757|11645378|FG006|COMPLETED|Long-Term Safety Phase (Year 4)||0
10495383|NCT01212757|11645379|FG007|COMPLETED|Long-Term Safety Phase (Year 4)||37
10495384|NCT01212757|11645380|FG008|COMPLETED|Long-Term Safety Phase (Year 4)||39
10495385|NCT01212757|11645372|FG000|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
10495386|NCT01212757|11645373|FG001|NOT COMPLETED|Long-Term Safety Phase (Year 4)||9
10495387|NCT01212757|11645374|FG002|NOT COMPLETED|Long-Term Safety Phase (Year 4)||7
10495388|NCT01212757|11645375|FG003|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
10495389|NCT01212757|11645376|FG004|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
10495390|NCT01212757|11645377|FG005|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
10495391|NCT01212757|11645378|FG006|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
10495392|NCT01212757|11645379|FG007|NOT COMPLETED|Long-Term Safety Phase (Year 4)||4
10495393|NCT01212757|11645380|FG008|NOT COMPLETED|Long-Term Safety Phase (Year 4)||7
10495394|NCT01212757|11645372|FG000|STARTED|Long-Term Safety Phase (Year 5)||0
10495395|NCT01212757|11645373|FG001|STARTED|Long-Term Safety Phase (Year 5)||80
10495396|NCT01212757|11645374|FG002|STARTED|Long-Term Safety Phase (Year 5)||77
10495397|NCT01212757|11645375|FG003|STARTED|Long-Term Safety Phase (Year 5)||0
10495398|NCT01212757|11645376|FG004|STARTED|Long-Term Safety Phase (Year 5)||0
10495399|NCT01212757|11645377|FG005|STARTED|Long-Term Safety Phase (Year 5)||0
10495400|NCT01212757|11645378|FG006|STARTED|Long-Term Safety Phase (Year 5)||0
10495401|NCT01212757|11645379|FG007|STARTED|Long-Term Safety Phase (Year 5)|1 participant was only counted in year 5 but not in 4 year due to late APR dispensing|38
10495402|NCT01212757|11645380|FG008|STARTED|Long-Term Safety Phase (Year 5)||39
10495403|NCT01212757|11645372|FG000|COMPLETED|Long-Term Safety Phase (Year 5)||0
10495404|NCT01212757|11645373|FG001|COMPLETED|Long-Term Safety Phase (Year 5)||72
10495405|NCT01212757|11645374|FG002|COMPLETED|Long-Term Safety Phase (Year 5)||69
10495406|NCT01212757|11645375|FG003|COMPLETED|Long-Term Safety Phase (Year 5)||0
10495407|NCT01212757|11645376|FG004|COMPLETED|Long-Term Safety Phase (Year 5)||0
10495408|NCT01212757|11645377|FG005|COMPLETED|Long-Term Safety Phase (Year 5)||0
10495409|NCT01212757|11645378|FG006|COMPLETED|Long-Term Safety Phase (Year 5)||0
10495410|NCT01212757|11645379|FG007|COMPLETED|Long-Term Safety Phase (Year 5)||33
10495411|NCT01212757|11645380|FG008|COMPLETED|Long-Term Safety Phase (Year 5)||37
10495412|NCT01212757|11645372|FG000|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
10495413|NCT01212757|11645373|FG001|NOT COMPLETED|Long-Term Safety Phase (Year 5)||8
10495414|NCT01212757|11645374|FG002|NOT COMPLETED|Long-Term Safety Phase (Year 5)||8
10495415|NCT01212757|11645375|FG003|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
10495416|NCT01212757|11645376|FG004|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
10495417|NCT01212757|11645377|FG005|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
10495418|NCT01212757|11645378|FG006|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
10495419|NCT01212757|11645379|FG007|NOT COMPLETED|Long-Term Safety Phase (Year 5)||5
10495420|NCT01212757|11645380|FG008|NOT COMPLETED|Long-Term Safety Phase (Year 5)||2
10495421|NCT01212770|11645401|FG000|STARTED|Placebo-controlled Phase (Week 0 - 24)||169
10495422|NCT01212770|11645402|FG001|STARTED|Placebo-controlled Phase (Week 0 - 24)||169
10495423|NCT01212770|11645403|FG002|STARTED|Placebo-controlled Phase (Week 0 - 24)||167
10495424|NCT01212770|11645404|FG003|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
10495425|NCT01212770|11645405|FG004|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
10495426|NCT01212770|11645406|FG005|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
10495427|NCT01212770|11645407|FG006|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
10495428|NCT01212770|11645408|FG007|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
10710385|NCT02649231|11875562|FG003|COMPLETED|Overall Study||23
10710386|NCT02649231|11875559|FG000|NOT COMPLETED|Overall Study||4
10710387|NCT02649231|11875560|FG001|NOT COMPLETED|Overall Study||3
10650124|NCT02166333|11810290|FG000|COMPLETED|Stage 2||35
10710388|NCT02649231|11875561|FG002|NOT COMPLETED|Overall Study||2
10650125|NCT02166333|11810291|FG001|COMPLETED|Stage 2||71
10650126|NCT02166333|11810292|FG002|COMPLETED|Stage 2||47
10650127|NCT02166333|11810293|FG003|COMPLETED|Stage 2||73
10650128|NCT02166333|11810294|FG004|COMPLETED|Stage 2||2
10650129|NCT02166333|11810295|FG005|COMPLETED|Stage 2||4
10650130|NCT02166333|11810290|FG000|NOT COMPLETED|Stage 2||207
10650131|NCT02166333|11810291|FG001|NOT COMPLETED|Stage 2||6
10650132|NCT02166333|11810292|FG002|NOT COMPLETED|Stage 2||75
10650133|NCT02166333|11810293|FG003|NOT COMPLETED|Stage 2||9
10710389|NCT02649231|11875562|FG003|NOT COMPLETED|Overall Study||2
10710390|NCT02649322|11875574|FG000|STARTED|Overall Study||58
10650134|NCT02166333|11810294|FG004|NOT COMPLETED|Stage 2||57
10650135|NCT02166333|11810295|FG005|NOT COMPLETED|Stage 2||59
10650136|NCT02166346|11810307|FG000|STARTED|Screening and Randomization||12
10650137|NCT02166346|11810308|FG001|STARTED|Screening and Randomization||12
10650138|NCT02166346|11810307|FG000|COMPLETED|Screening and Randomization||8
10650139|NCT02166346|11810308|FG001|COMPLETED|Screening and Randomization||8
10650140|NCT02166346|11810307|FG000|NOT COMPLETED|Screening and Randomization||4
10650141|NCT02166346|11810308|FG001|NOT COMPLETED|Screening and Randomization||4
10650142|NCT02166346|11810307|FG000|STARTED|Intervention - Phase 1||8
10650143|NCT02166346|11810308|FG001|STARTED|Intervention - Phase 1||8
10650144|NCT02166346|11810307|FG000|COMPLETED|Intervention - Phase 1||8
10650145|NCT02166346|11810308|FG001|COMPLETED|Intervention - Phase 1||6
10650146|NCT02166346|11810307|FG000|NOT COMPLETED|Intervention - Phase 1||0
10650147|NCT02166346|11810308|FG001|NOT COMPLETED|Intervention - Phase 1||2
10650148|NCT02166346|11810307|FG000|STARTED|Intervention - Phase 2 (After Crossover)||8
10650149|NCT02166346|11810308|FG001|STARTED|Intervention - Phase 2 (After Crossover)||6
10650150|NCT02166346|11810307|FG000|COMPLETED|Intervention - Phase 2 (After Crossover)||7
10650151|NCT02166346|11810308|FG001|COMPLETED|Intervention - Phase 2 (After Crossover)||6
10650152|NCT02166346|11810307|FG000|NOT COMPLETED|Intervention - Phase 2 (After Crossover)||1
10650153|NCT02166346|11810308|FG001|NOT COMPLETED|Intervention - Phase 2 (After Crossover)||0
10650154|NCT02166476|11810316|FG000|STARTED|Overall Study||272
10650155|NCT02166476|11810317|FG001|STARTED|Overall Study||273
10650156|NCT02166476|11810316|FG000|Received at Least 1 Dose of Study Drug|Overall Study||272
10650157|NCT02166476|11810317|FG001|Received at Least 1 Dose of Study Drug|Overall Study||273
10650158|NCT02166476|11810316|FG000|COMPLETED|Overall Study||258
10650159|NCT02166476|11810317|FG001|COMPLETED|Overall Study||250
10650160|NCT02166476|11810316|FG000|NOT COMPLETED|Overall Study||14
10650161|NCT02166476|11810317|FG001|NOT COMPLETED|Overall Study||23
10650162|NCT02166606|11810326|FG000|STARTED|Overall Study||1184
10650163|NCT02166606|11810326|FG000|Actively Enrolled|Overall Study||1180
10650164|NCT02166606|11810326|FG000|Consent Eligible|Overall Study||1174
10650165|NCT02166606|11810326|FG000|COMPLETED|Overall Study||1106
10650166|NCT02166606|11810326|FG000|NOT COMPLETED|Overall Study||78
10650167|NCT02166697|11810330|FG000|STARTED|Overall Study||14151
10650168|NCT02166697|11810330|FG000|COMPLETED|Overall Study||13804
10650169|NCT02166697|11810330|FG000|NOT COMPLETED|Overall Study||347
10650170|NCT02167035|11810336|FG000|STARTED|Overall Study||21
10650171|NCT02167035|11810337|FG001|STARTED|Overall Study||22
10650172|NCT02167035|11810336|FG000|COMPLETED|Overall Study||16
10650173|NCT02167035|11810337|FG001|COMPLETED|Overall Study||16
10650174|NCT02167035|11810336|FG000|NOT COMPLETED|Overall Study||5
10650175|NCT02167035|11810337|FG001|NOT COMPLETED|Overall Study||6
10650176|NCT02167074|11810347|FG000|STARTED|Overall Study||306
10650177|NCT02167074|11810348|FG001|STARTED|Overall Study||302
10650178|NCT02167074|11810347|FG000|COMPLETED|Overall Study||306
10650179|NCT02167074|11810348|FG001|COMPLETED|Overall Study||302
10650180|NCT02167074|11810347|FG000|NOT COMPLETED|Overall Study||0
10650181|NCT02167074|11810348|FG001|NOT COMPLETED|Overall Study||0
10650182|NCT02167139|11810356|FG000|STARTED|Randomised, Double-blind||271
10650183|NCT02167139|11810357|FG001|STARTED|Randomised, Double-blind||273
10650184|NCT02167139|11810358|FG002|STARTED|Randomised, Double-blind||0
10650185|NCT02167139|11810359|FG003|STARTED|Randomised, Double-blind||0
10650186|NCT02167139|11810356|FG000|COMPLETED|Randomised, Double-blind||254
10650187|NCT02167139|11810357|FG001|COMPLETED|Randomised, Double-blind||254
10650188|NCT02167139|11810358|FG002|COMPLETED|Randomised, Double-blind||0
10650189|NCT02167139|11810359|FG003|COMPLETED|Randomised, Double-blind||0
10650190|NCT02167139|11810356|FG000|NOT COMPLETED|Randomised, Double-blind||17
10650191|NCT02167139|11810357|FG001|NOT COMPLETED|Randomised, Double-blind||19
10650192|NCT02167139|11810358|FG002|NOT COMPLETED|Randomised, Double-blind||0
10650193|NCT02167139|11810359|FG003|NOT COMPLETED|Randomised, Double-blind||0
10650194|NCT02167139|11810356|FG000|STARTED|Transition-extension||254
10650195|NCT02167139|11810357|FG001|STARTED|Transition-extension||0
10650196|NCT02167139|11810358|FG002|STARTED|Transition-extension||125
10650197|NCT02167139|11810359|FG003|STARTED|Transition-extension||129
10650198|NCT02167139|11810356|FG000|COMPLETED|Transition-extension||248
10650199|NCT02167139|11810357|FG001|COMPLETED|Transition-extension||0
10650200|NCT02167139|11810358|FG002|COMPLETED|Transition-extension||117
10650201|NCT02167139|11810359|FG003|COMPLETED|Transition-extension||124
10650202|NCT02167139|11810356|FG000|NOT COMPLETED|Transition-extension||6
10650203|NCT02167139|11810357|FG001|NOT COMPLETED|Transition-extension||0
10650204|NCT02167139|11810358|FG002|NOT COMPLETED|Transition-extension||8
10650205|NCT02167139|11810359|FG003|NOT COMPLETED|Transition-extension||5
10650206|NCT02167204|11810373|FG000|STARTED|Overall Study||9
10650207|NCT02167204|11810373|FG000|COMPLETED|Overall Study||9
10650208|NCT02167204|11810373|FG000|NOT COMPLETED|Overall Study||0
10650209|NCT02167217|11810383|FG000|STARTED|Overall Study||25
10650210|NCT02167217|11810383|FG000|COMPLETED|Overall Study||23
10650211|NCT02167217|11810383|FG000|NOT COMPLETED|Overall Study||2
10650212|NCT02167256|11810389|FG000|STARTED|Overall Study||79
10650213|NCT02167256|11810390|FG001|STARTED|Overall Study||80
10650214|NCT02167256|11810389|FG000|COMPLETED|Overall Study||58
10650215|NCT02167256|11810390|FG001|COMPLETED|Overall Study||70
10650216|NCT02167256|11810389|FG000|NOT COMPLETED|Overall Study||21
10650217|NCT02167256|11810390|FG001|NOT COMPLETED|Overall Study||10
10650218|NCT02167451|11810396|FG000|STARTED|Overall Study||31
10650219|NCT02167451|11810396|FG000|COMPLETED|Overall Study||30
10650220|NCT02167451|11810396|FG000|NOT COMPLETED|Overall Study||1
10650221|NCT02167594|11810403|FG000|STARTED|Overall Study||20
10650222|NCT02167594|11810404|FG001|STARTED|Overall Study||6
10650223|NCT02167594|11810405|FG002|STARTED|Overall Study||3
10650224|NCT02167594|11810403|FG000|COMPLETED|Overall Study||18
10650225|NCT02167594|11810404|FG001|COMPLETED|Overall Study||5
10650226|NCT02167594|11810405|FG002|COMPLETED|Overall Study||3
10650227|NCT02167594|11810403|FG000|NOT COMPLETED|Overall Study||2
10650228|NCT02167594|11810404|FG001|NOT COMPLETED|Overall Study||1
10650229|NCT02167594|11810405|FG002|NOT COMPLETED|Overall Study||0
10650230|NCT02167815|11810416|FG000|STARTED|Overall Study||9
10650231|NCT02167815|11810417|FG001|STARTED|Overall Study||21
10650232|NCT02167815|11810416|FG000|COMPLETED|Overall Study||9
10650233|NCT02167815|11810417|FG001|COMPLETED|Overall Study||21
10650234|NCT02167815|11810416|FG000|NOT COMPLETED|Overall Study||0
10650235|NCT02167815|11810417|FG001|NOT COMPLETED|Overall Study||0
10650236|NCT02167867|11810427|FG000|STARTED|Overall Study||22
10650237|NCT02167867|11810428|FG001|STARTED|Overall Study||22
10650238|NCT02167867|11810427|FG000|COMPLETED|Overall Study||22
10650239|NCT02167867|11810428|FG001|COMPLETED|Overall Study||22
10650240|NCT02167867|11810427|FG000|NOT COMPLETED|Overall Study||0
10650241|NCT02167867|11810428|FG001|NOT COMPLETED|Overall Study||0
10650242|NCT02167893|11810433|FG000|STARTED|Overall Study||11288
10650243|NCT02167893|11810433|FG000|COMPLETED|Overall Study||11125
10650244|NCT02167893|11810433|FG000|NOT COMPLETED|Overall Study||163
10650245|NCT02168062|11810440|FG000|STARTED|Overall Study||23
10650246|NCT02168062|11810441|FG001|STARTED|Overall Study||26
10650247|NCT02168062|11810442|FG002|STARTED|Overall Study||8
10650248|NCT02168062|11810440|FG000|COMPLETED|Overall Study||23
10650249|NCT02168062|11810441|FG001|COMPLETED|Overall Study||26
10650250|NCT02168062|11810442|FG002|COMPLETED|Overall Study||8
10650251|NCT02168062|11810440|FG000|NOT COMPLETED|Overall Study||0
10650252|NCT02168062|11810441|FG001|NOT COMPLETED|Overall Study||0
10650253|NCT02168062|11810442|FG002|NOT COMPLETED|Overall Study||0
10650254|NCT02168101|11810455|FG000|STARTED|Overall Study||3
10650255|NCT02168101|11810456|FG001|STARTED|Overall Study||3
10650256|NCT02168101|11810457|FG002|STARTED|Overall Study||3
10650257|NCT02168101|11810455|FG000|COMPLETED|Overall Study||1
10650258|NCT02168101|11810456|FG001|COMPLETED|Overall Study||1
10650259|NCT02168101|11810457|FG002|COMPLETED|Overall Study||2
10650260|NCT02168101|11810455|FG000|NOT COMPLETED|Overall Study||2
10650261|NCT02168101|11810456|FG001|NOT COMPLETED|Overall Study||2
10650262|NCT02168101|11810457|FG002|NOT COMPLETED|Overall Study||1
10650263|NCT02168153|11810468|FG000|STARTED|Overall Study||60
10650264|NCT02168153|11810469|FG001|STARTED|Overall Study||60
10650265|NCT02168153|11810468|FG000|COMPLETED|Overall Study||57
10650266|NCT02168153|11810469|FG001|COMPLETED|Overall Study||60
10650267|NCT02168153|11810468|FG000|NOT COMPLETED|Overall Study||3
10650268|NCT02168153|11810469|FG001|NOT COMPLETED|Overall Study||0
10650269|NCT02168309|11810477|FG000|STARTED|Overall Study||25
10650270|NCT02168309|11810478|FG001|STARTED|Overall Study||25
10650271|NCT02168309|11810477|FG000|COMPLETED|Overall Study||25
10650272|NCT02168309|11810478|FG001|COMPLETED|Overall Study||25
10650273|NCT02168309|11810477|FG000|NOT COMPLETED|Overall Study||0
10650274|NCT02168309|11810478|FG001|NOT COMPLETED|Overall Study||0
10650275|NCT02168361|11810486|FG000|STARTED|Overall Study||62
10650276|NCT02168361|11810487|FG001|STARTED|Overall Study||31
10650277|NCT02168361|11810486|FG000|COMPLETED|Overall Study||57
10650278|NCT02168361|11810487|FG001|COMPLETED|Overall Study||21
10650279|NCT02168361|11810486|FG000|NOT COMPLETED|Overall Study||5
10650280|NCT02168361|11810487|FG001|NOT COMPLETED|Overall Study||10
10650281|NCT02168387|11810495|FG000|STARTED|Overall Study||20
10650282|NCT02168387|11810496|FG001|STARTED|Overall Study||19
10650283|NCT02168387|11810495|FG000|COMPLETED|Overall Study||13
10650284|NCT02168387|11810496|FG001|COMPLETED|Overall Study||16
10650285|NCT02168387|11810495|FG000|NOT COMPLETED|Overall Study||7
10650286|NCT02168387|11810496|FG001|NOT COMPLETED|Overall Study||3
10650287|NCT02168439|11810504|FG000|STARTED|Overall Study||20
10650288|NCT02168439|11810505|FG001|STARTED|Overall Study||20
10650289|NCT02168439|11810504|FG000|COMPLETED|Overall Study||20
10650290|NCT02168439|11810505|FG001|COMPLETED|Overall Study||18
10650291|NCT02168439|11810504|FG000|NOT COMPLETED|Overall Study||0
10650292|NCT02168439|11810505|FG001|NOT COMPLETED|Overall Study||2
10650293|NCT02168478|11810511|FG000|STARTED|Overall Study||206
10650294|NCT02168478|11810511|FG000|COMPLETED|Overall Study||202
10650295|NCT02168478|11810511|FG000|NOT COMPLETED|Overall Study||4
10650296|NCT02168491|11810515|FG000|STARTED|Overall Study||9
10650297|NCT02168491|11810515|FG000|COMPLETED|Overall Study||8
10650298|NCT02168491|11810515|FG000|NOT COMPLETED|Overall Study||1
10650299|NCT02168660|11810522|FG000|STARTED|Overall Study||38
10650300|NCT02168660|11810523|FG001|STARTED|Overall Study||35
10650301|NCT02168660|11810524|FG002|STARTED|Overall Study||36
10650302|NCT02168660|11810522|FG000|COMPLETED|Overall Study||22
10650303|NCT02168660|11810523|FG001|COMPLETED|Overall Study||18
10650304|NCT02168660|11810524|FG002|COMPLETED|Overall Study||21
10650305|NCT02168660|11810522|FG000|NOT COMPLETED|Overall Study||16
10650306|NCT02168660|11810523|FG001|NOT COMPLETED|Overall Study||17
10650307|NCT02168660|11810524|FG002|NOT COMPLETED|Overall Study||15
10650308|NCT02168777|11810538|FG000|STARTED|Overall Study||2
10650309|NCT02168777|11810539|FG001|STARTED|Overall Study||7
10650310|NCT02168777|11810540|FG002|STARTED|Overall Study||11
10650311|NCT02168777|11810538|FG000|COMPLETED|Overall Study||0
10650312|NCT02168777|11810539|FG001|COMPLETED|Overall Study||0
10650313|NCT02168777|11810540|FG002|COMPLETED|Overall Study||0
10650314|NCT02168777|11810538|FG000|NOT COMPLETED|Overall Study||2
10650315|NCT02168777|11810539|FG001|NOT COMPLETED|Overall Study||7
10650316|NCT02168777|11810540|FG002|NOT COMPLETED|Overall Study||11
10650317|NCT02168803|11810554|FG000|STARTED|Overall Study||30
10650318|NCT02168803|11810555|FG001|STARTED|Overall Study||32
10650319|NCT02168803|11810556|FG002|STARTED|Overall Study||39
10650320|NCT02168803|11810554|FG000|Received at Least 1 Dose of Study Drug|Overall Study||30
10650321|NCT02168803|11810555|FG001|Received at Least 1 Dose of Study Drug|Overall Study||32
10650322|NCT02168803|11810556|FG002|Received at Least 1 Dose of Study Drug|Overall Study||39
10650323|NCT02168803|11810554|FG000|COMPLETED|Overall Study||28
10650324|NCT02168803|11810555|FG001|COMPLETED|Overall Study||29
10650325|NCT02168803|11810556|FG002|COMPLETED|Overall Study||33
10650326|NCT02168803|11810554|FG000|NOT COMPLETED|Overall Study||2
10650327|NCT02168803|11810555|FG001|NOT COMPLETED|Overall Study||3
10650328|NCT02168803|11810556|FG002|NOT COMPLETED|Overall Study||6
10650329|NCT02168816|11810573|FG000|STARTED|Overall Study||5
10650330|NCT02168816|11810574|FG001|STARTED|Overall Study||7
10650331|NCT02168816|11810573|FG000|COMPLETED|Overall Study||3
10650332|NCT02168816|11810574|FG001|COMPLETED|Overall Study||5
10650333|NCT02168816|11810573|FG000|NOT COMPLETED|Overall Study||2
10650334|NCT02168816|11810574|FG001|NOT COMPLETED|Overall Study||2
10650335|NCT02168842|11810582|FG000|STARTED|Overall Study||170
10650336|NCT02168842|11810583|FG001|STARTED|Overall Study||166
10650337|NCT02168842|11810582|FG000|COMPLETED|Overall Study||162
10650338|NCT02168842|11810583|FG001|COMPLETED|Overall Study||158
10650339|NCT02168842|11810582|FG000|NOT COMPLETED|Overall Study||8
10650340|NCT02168842|11810583|FG001|NOT COMPLETED|Overall Study||8
10650341|NCT02168855|11810593|FG000|STARTED|Overall Study||181
10710391|NCT02649322|11875575|FG001|STARTED|Overall Study||57
10710392|NCT02649322|11875574|FG000|COMPLETED|Overall Study||58
10710393|NCT02649322|11875575|FG001|COMPLETED|Overall Study||57
10710394|NCT02649322|11875574|FG000|NOT COMPLETED|Overall Study||0
10710395|NCT02649322|11875575|FG001|NOT COMPLETED|Overall Study||0
10710396|NCT02649556|11875585|FG000|STARTED|Overall Study||230
10710397|NCT02649556|11875586|FG001|STARTED|Overall Study||424
10710398|NCT02649556|11875587|FG002|STARTED|Overall Study||152
10495429|NCT01212770|11645409|FG008|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
10495430|NCT01212770|11645401|FG000|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||169
10495431|NCT01212770|11645402|FG001|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||169
10495432|NCT01212770|11645403|FG002|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||167
10495433|NCT01212770|11645404|FG003|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
10495434|NCT01212770|11645405|FG004|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
10495435|NCT01212770|11645406|FG005|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
10495436|NCT01212770|11645407|FG006|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
10495437|NCT01212770|11645408|FG007|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
10495438|NCT01212770|11645409|FG008|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
10495439|NCT01212770|11645401|FG000|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||156
10495440|NCT01212770|11645402|FG001|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||157
10495441|NCT01212770|11645403|FG002|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||156
10495442|NCT01212770|11645404|FG003|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
10495443|NCT01212770|11645405|FG004|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
10495444|NCT01212770|11645406|FG005|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
10495445|NCT01212770|11645407|FG006|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
10495446|NCT01212770|11645408|FG007|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
10495447|NCT01212770|11645409|FG008|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
10495448|NCT01212770|11645401|FG000|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|1 participant who escaped early did not complete Week (Wk) 24|97
10495449|NCT01212770|11645402|FG001|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||76
10495450|NCT01212770|11645403|FG002|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|1 participant who escaped early did not complete Week 24|53
10495451|NCT01212770|11645404|FG003|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
10495452|NCT01212770|11645405|FG004|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
10495453|NCT01212770|11645406|FG005|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
10495454|NCT01212770|11645407|FG006|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
10495455|NCT01212770|11645408|FG007|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
10495456|NCT01212770|11645409|FG008|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
10495457|NCT01212770|11645401|FG000|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||146
10495458|NCT01212770|11645402|FG001|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||147
10650342|NCT02168855|11810594|FG001|STARTED|Overall Study||188
10650343|NCT02168855|11810593|FG000|COMPLETED|Overall Study||169
10650344|NCT02168855|11810594|FG001|COMPLETED|Overall Study||177
10650345|NCT02168855|11810593|FG000|NOT COMPLETED|Overall Study||12
10650346|NCT02168855|11810594|FG001|NOT COMPLETED|Overall Study||11
10650347|NCT02168933|11810602|FG000|STARTED|Overall Study||8
10650348|NCT02168933|11810602|FG000|COMPLETED|Overall Study||7
10650349|NCT02168933|11810602|FG000|NOT COMPLETED|Overall Study||1
10650350|NCT02168946|11810612|FG000|STARTED|Overall Study|2 additional subjects were randomized to Vabomere but did not receive study drug|50
10650351|NCT02168946|11810613|FG001|STARTED|Overall Study||25
10710399|NCT02649556|11875588|FG003|STARTED|Overall Study||51
10710400|NCT02649556|11875585|FG000|COMPLETED|Overall Study||167
10710401|NCT02649556|11875586|FG001|COMPLETED|Overall Study||312
10495459|NCT01212770|11645403|FG002|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||145
10495460|NCT01212770|11645404|FG003|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
10495461|NCT01212770|11645405|FG004|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
10495462|NCT01212770|11645406|FG005|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
10495463|NCT01212770|11645407|FG006|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
10495464|NCT01212770|11645408|FG007|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
10495465|NCT01212770|11645409|FG008|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
10495466|NCT01212770|11645401|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||23
10495467|NCT01212770|11645402|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
10495468|NCT01212770|11645403|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
10495469|NCT01212770|11645404|FG003|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
10495470|NCT01212770|11645405|FG004|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
10495471|NCT01212770|11645406|FG005|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
10495472|NCT01212770|11645407|FG006|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
10495473|NCT01212770|11645408|FG007|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
10495474|NCT01212770|11645409|FG008|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
10495475|NCT01212770|11645401|FG000|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
10495476|NCT01212770|11645402|FG001|STARTED|Active Treatment Phase (Weeks 25 - 52)|8 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|139
10495477|NCT01212770|11645403|FG002|STARTED|Active Treatment Phase (Weeks 25 - 52)|7 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|138
10495478|NCT01212770|11645404|FG003|STARTED|Active Treatment Phase (Weeks 25 - 52)|3 participants who EE completed Week 24 did not enter the Week 24-52 active treatment phase|43
10495479|NCT01212770|11645405|FG004|STARTED|Active Treatment Phase (Weeks 25 - 52)||25
10495480|NCT01212770|11645406|FG005|STARTED|Active Treatment Phase (Weeks 25 - 52)|3 participants who EE completed Week 24 did not enter the Week 24-52 active treatment phase|47
10495481|NCT01212770|11645407|FG006|STARTED|Active Treatment Phase (Weeks 25 - 52)||25
10495482|NCT01212770|11645408|FG007|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
10495483|NCT01212770|11645409|FG008|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
10495484|NCT01212770|11645401|FG000|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
10495485|NCT01212770|11645402|FG001|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||120
10495486|NCT01212770|11645403|FG002|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||126
10495487|NCT01212770|11645404|FG003|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||32
10495488|NCT01212770|11645405|FG004|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||23
10495489|NCT01212770|11645406|FG005|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||44
10495490|NCT01212770|11645407|FG006|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||23
10495491|NCT01212770|11645408|FG007|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
10495492|NCT01212770|11645409|FG008|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
10495493|NCT01212770|11645401|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
10495494|NCT01212770|11645402|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||19
10495495|NCT01212770|11645403|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||12
10495496|NCT01212770|11645404|FG003|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||11
10495497|NCT01212770|11645405|FG004|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
10495498|NCT01212770|11645406|FG005|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||3
10495499|NCT01212770|11645407|FG006|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
10495500|NCT01212770|11645408|FG007|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
10495501|NCT01212770|11645409|FG008|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
10495502|NCT01212770|11645401|FG000|STARTED|Long-term Safety Phase (Year 2)||0
10495503|NCT01212770|11645402|FG001|STARTED|Long-term Safety Phase (Year 2)|9 participants who completed Week 52 did not enter the long-term safety phase (LTSP)|111
10495504|NCT01212770|11645403|FG002|STARTED|Long-term Safety Phase (Year 2)|5 participants who completed Week 52 did not enter the long-term safety phase|121
10495505|NCT01212770|11645404|FG003|STARTED|Long-term Safety Phase (Year 2)||0
10495506|NCT01212770|11645405|FG004|STARTED|Long-term Safety Phase (Year 2)||0
10495507|NCT01212770|11645406|FG005|STARTED|Long-term Safety Phase (Year 2)||0
10495508|NCT01212770|11645407|FG006|STARTED|Long-term Safety Phase (Year 2)||0
10495509|NCT01212770|11645408|FG007|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 20 mg EE and XO are combined;5 patients finished Wk 52;no entry into LTSP|51
10495510|NCT01212770|11645409|FG008|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 30 mg EE and XO are combined;3 patients finished Wk 52;no entry into LTSP|64
10495511|NCT01212770|11645401|FG000|COMPLETED|Long-term Safety Phase (Year 2)||0
10495512|NCT01212770|11645402|FG001|COMPLETED|Long-term Safety Phase (Year 2)||88
10495513|NCT01212770|11645403|FG002|COMPLETED|Long-term Safety Phase (Year 2)||106
10495514|NCT01212770|11645404|FG003|COMPLETED|Long-term Safety Phase (Year 2)||0
10495515|NCT01212770|11645405|FG004|COMPLETED|Long-term Safety Phase (Year 2)||0
10495516|NCT01212770|11645406|FG005|COMPLETED|Long-term Safety Phase (Year 2)||0
10495517|NCT01212770|11645407|FG006|COMPLETED|Long-term Safety Phase (Year 2)||0
10495518|NCT01212770|11645408|FG007|COMPLETED|Long-term Safety Phase (Year 2)||42
10495519|NCT01212770|11645409|FG008|COMPLETED|Long-term Safety Phase (Year 2)||50
10495520|NCT01212770|11645401|FG000|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
10495521|NCT01212770|11645402|FG001|NOT COMPLETED|Long-term Safety Phase (Year 2)||23
10495522|NCT01212770|11645403|FG002|NOT COMPLETED|Long-term Safety Phase (Year 2)||15
10495523|NCT01212770|11645404|FG003|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
10495524|NCT01212770|11645405|FG004|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
10495525|NCT01212770|11645406|FG005|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
10495526|NCT01212770|11645407|FG006|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
10338265|NCT00369226|11475174|FG000|NOT COMPLETED|Phase II (45 Days)||0
10338266|NCT00369226|11475175|FG001|NOT COMPLETED|Phase II (45 Days)||0
10338267|NCT00369278|11475186|FG000|STARTED|Overall Study||63
10495527|NCT01212770|11645408|FG007|NOT COMPLETED|Long-term Safety Phase (Year 2)||9
10495528|NCT01212770|11645409|FG008|NOT COMPLETED|Long-term Safety Phase (Year 2)||14
10495529|NCT01212770|11645401|FG000|STARTED|Long-term Safety Phase (Year 3)||0
10495530|NCT01212770|11645402|FG001|STARTED|Long-term Safety Phase (Year 3)|1 participant who completed Year 2 did not continue treatment in Year 3|87
10495531|NCT01212770|11645403|FG002|STARTED|Long-term Safety Phase (Year 3)|1 participant who completed Year 2 did not continue treatment in Year 3|105
10495532|NCT01212770|11645404|FG003|STARTED|Long-term Safety Phase (Year 3)||0
10495533|NCT01212770|11645405|FG004|STARTED|Long-term Safety Phase (Year 3)||0
10495534|NCT01212770|11645406|FG005|STARTED|Long-term Safety Phase (Year 3)||0
10495535|NCT01212770|11645407|FG006|STARTED|Long-term Safety Phase (Year 3)||0
10495536|NCT01212770|11645408|FG007|STARTED|Long-term Safety Phase (Year 3)|The PBO/APR 20 mg EE and XO participants from week 24-52 are combined within the LTSP.|42
10495537|NCT01212770|11645409|FG008|STARTED|Long-term Safety Phase (Year 3)|Patients from the PBO/APR 30 mg EE and XO are combined;1 patient finished Wk 52;no entry into LTSP|49
10495538|NCT01212770|11645401|FG000|COMPLETED|Long-term Safety Phase (Year 3)||0
10495539|NCT01212770|11645402|FG001|COMPLETED|Long-term Safety Phase (Year 3)|1 participant missed due to APR dispensed late|76
10495540|NCT01212770|11645403|FG002|COMPLETED|Long-term Safety Phase (Year 3)||94
10495541|NCT01212770|11645404|FG003|COMPLETED|Long-term Safety Phase (Year 3)||0
10495542|NCT01212770|11645405|FG004|COMPLETED|Long-term Safety Phase (Year 3)||0
10495543|NCT01212770|11645406|FG005|COMPLETED|Long-term Safety Phase (Year 3)||0
10495544|NCT01212770|11645407|FG006|COMPLETED|Long-term Safety Phase (Year 3)||0
10495545|NCT01212770|11645408|FG007|COMPLETED|Long-term Safety Phase (Year 3)||35
10495546|NCT01212770|11645409|FG008|COMPLETED|Long-term Safety Phase (Year 3)||44
10338268|NCT00369278|11475187|FG001|STARTED|Overall Study||65
10338269|NCT00369278|11475186|FG000|COMPLETED|Overall Study||39
10338270|NCT00369278|11475187|FG001|COMPLETED|Overall Study||44
10338271|NCT00369278|11475186|FG000|NOT COMPLETED|Overall Study||24
10338272|NCT00369278|11475187|FG001|NOT COMPLETED|Overall Study||21
10338273|NCT00369343|11475195|FG000|STARTED|Double-blind Phase||256
10338274|NCT00369343|11475196|FG001|STARTED|Double-blind Phase||125
10338275|NCT00369343|11475195|FG000|COMPLETED|Double-blind Phase||212
10338276|NCT00369343|11475196|FG001|COMPLETED|Double-blind Phase||109
10338277|NCT00369343|11475195|FG000|NOT COMPLETED|Double-blind Phase||44
10338278|NCT00369343|11475196|FG001|NOT COMPLETED|Double-blind Phase||16
10338279|NCT00369343|11475195|FG000|STARTED|Open-label Phase||212
10495547|NCT01212770|11645401|FG000|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
10495548|NCT01212770|11645402|FG001|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
10495549|NCT01212770|11645403|FG002|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
10495550|NCT01212770|11645404|FG003|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
10495551|NCT01212770|11645405|FG004|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
10495552|NCT01212770|11645406|FG005|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
10495553|NCT01212770|11645407|FG006|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
10710402|NCT02649556|11875587|FG002|COMPLETED|Overall Study||102
10710403|NCT02649556|11875588|FG003|COMPLETED|Overall Study||28
10710404|NCT02649556|11875585|FG000|NOT COMPLETED|Overall Study||63
10710405|NCT02649556|11875586|FG001|NOT COMPLETED|Overall Study||112
10710406|NCT02649556|11875587|FG002|NOT COMPLETED|Overall Study||50
10710407|NCT02649556|11875588|FG003|NOT COMPLETED|Overall Study||23
10710408|NCT02649608|11875598|FG000|STARTED|Overall Study||2
10710409|NCT02649608|11875599|FG001|STARTED|Overall Study||1
10710410|NCT02649608|11875600|FG002|STARTED|Overall Study||3
10810016|NCT03802994|11971900|FG003|STARTED|Overall Study||11
10810017|NCT03802994|11971901|FG004|STARTED|Overall Study||10
10810018|NCT03802994|11971897|FG000|COMPLETED|Overall Study||9
10810019|NCT03802994|11971898|FG001|COMPLETED|Overall Study||10
10810020|NCT03802994|11971899|FG002|COMPLETED|Overall Study||12
10810021|NCT03802994|11971900|FG003|COMPLETED|Overall Study||9
10810022|NCT03802994|11971901|FG004|COMPLETED|Overall Study||8
10810023|NCT03802994|11971897|FG000|NOT COMPLETED|Overall Study||0
10810024|NCT03802994|11971898|FG001|NOT COMPLETED|Overall Study||2
10810025|NCT03802994|11971899|FG002|NOT COMPLETED|Overall Study||3
10810026|NCT03802994|11971900|FG003|NOT COMPLETED|Overall Study||2
10810027|NCT03802994|11971901|FG004|NOT COMPLETED|Overall Study||2
10810028|NCT03810183|11971926|FG000|STARTED|Overall Study||6
10810029|NCT03810183|11971927|FG001|STARTED|Overall Study||3
10810030|NCT03810183|11971926|FG000|COMPLETED|Overall Study||4
10338280|NCT00369343|11475196|FG001|STARTED|Open-label Phase||109
10338281|NCT00369343|11475195|FG000|COMPLETED|Open-label Phase||155
10495554|NCT01212770|11645408|FG007|NOT COMPLETED|Long-term Safety Phase (Year 3)||7
10495555|NCT01212770|11645409|FG008|NOT COMPLETED|Long-term Safety Phase (Year 3)||5
10495556|NCT01212770|11645401|FG000|STARTED|Long-term Safety Phase (Year 4)||0
10495557|NCT01212770|11645402|FG001|STARTED|Long-term Safety Phase (Year 4)|1 participant was counted in Year 4 but not in year 3 due to late APR dispensing|77
10710411|NCT02649608|11875601|FG003|STARTED|Overall Study||3
10710412|NCT02649608|11875602|FG004|STARTED|Overall Study||3
10710413|NCT02649608|11875603|FG005|STARTED|Overall Study||2
10710414|NCT02649608|11875604|FG006|STARTED|Overall Study||1
10710415|NCT02649608|11875598|FG000|COMPLETED|Overall Study||2
10710416|NCT02649608|11875599|FG001|COMPLETED|Overall Study||1
10710417|NCT02649608|11875600|FG002|COMPLETED|Overall Study||3
10710418|NCT02649608|11875601|FG003|COMPLETED|Overall Study||3
10810031|NCT03810183|11971927|FG001|COMPLETED|Overall Study||2
10810032|NCT03810183|11971926|FG000|NOT COMPLETED|Overall Study||2
10810033|NCT03810183|11971927|FG001|NOT COMPLETED|Overall Study||1
10810034|NCT03809910|11971934|FG000|STARTED|Period 1 (Visit 2)||20
10810035|NCT03809910|11971935|FG001|STARTED|Period 1 (Visit 2)||19
10810036|NCT03809910|11971934|FG000|COMPLETED|Period 1 (Visit 2)||20
10810037|NCT03809910|11971935|FG001|COMPLETED|Period 1 (Visit 2)||19
10810038|NCT03809910|11971934|FG000|NOT COMPLETED|Period 1 (Visit 2)||0
10810039|NCT03809910|11971935|FG001|NOT COMPLETED|Period 1 (Visit 2)||0
10810040|NCT03809910|11971934|FG000|STARTED|Washout Period 1 (3 Days)||20
10810041|NCT03809910|11971935|FG001|STARTED|Washout Period 1 (3 Days)||19
10810042|NCT03809910|11971934|FG000|COMPLETED|Washout Period 1 (3 Days)||20
10810043|NCT03809910|11971935|FG001|COMPLETED|Washout Period 1 (3 Days)||19
10810044|NCT03809910|11971934|FG000|NOT COMPLETED|Washout Period 1 (3 Days)||0
10810045|NCT03809910|11971935|FG001|NOT COMPLETED|Washout Period 1 (3 Days)||0
10810046|NCT03809910|11971934|FG000|STARTED|Period 2 (Visit 3)||20
10810047|NCT03809910|11971935|FG001|STARTED|Period 2 (Visit 3)||19
10810048|NCT03809910|11971934|FG000|COMPLETED|Period 2 (Visit 3)||20
10810049|NCT03809910|11971935|FG001|COMPLETED|Period 2 (Visit 3)||19
10810050|NCT03809910|11971934|FG000|NOT COMPLETED|Period 2 (Visit 3)||0
10810051|NCT03809910|11971935|FG001|NOT COMPLETED|Period 2 (Visit 3)||0
10810052|NCT03809910|11971934|FG000|STARTED|Washout Period 2 (3 Days)||20
10810053|NCT03809910|11971935|FG001|STARTED|Washout Period 2 (3 Days)||19
10810054|NCT03809910|11971934|FG000|COMPLETED|Washout Period 2 (3 Days)||20
10810055|NCT03809910|11971935|FG001|COMPLETED|Washout Period 2 (3 Days)||19
10810056|NCT03809910|11971934|FG000|NOT COMPLETED|Washout Period 2 (3 Days)||0
10810057|NCT03809910|11971935|FG001|NOT COMPLETED|Washout Period 2 (3 Days)||0
10810058|NCT03809910|11971934|FG000|STARTED|Period 3 (Visit 4)||20
10810059|NCT03809910|11971935|FG001|STARTED|Period 3 (Visit 4)||19
10810060|NCT03809910|11971934|FG000|COMPLETED|Period 3 (Visit 4)||20
10810061|NCT03809910|11971935|FG001|COMPLETED|Period 3 (Visit 4)||19
10495558|NCT01212770|11645403|FG002|STARTED|Long-term Safety Phase (Year 4)||94
10495559|NCT01212770|11645404|FG003|STARTED|Long-term Safety Phase (Year 4)||0
10495560|NCT01212770|11645405|FG004|STARTED|Long-term Safety Phase (Year 4)||0
10495561|NCT01212770|11645406|FG005|STARTED|Long-term Safety Phase (Year 4)||0
10495562|NCT01212770|11645407|FG006|STARTED|Long-term Safety Phase (Year 4)||0
10495563|NCT01212770|11645408|FG007|STARTED|Long-term Safety Phase (Year 4)||35
10495564|NCT01212770|11645409|FG008|STARTED|Long-term Safety Phase (Year 4)||44
10495565|NCT01212770|11645401|FG000|COMPLETED|Long-term Safety Phase (Year 4)||0
10495566|NCT01212770|11645402|FG001|COMPLETED|Long-term Safety Phase (Year 4)||71
10495567|NCT01212770|11645403|FG002|COMPLETED|Long-term Safety Phase (Year 4)||83
10495568|NCT01212770|11645404|FG003|COMPLETED|Long-term Safety Phase (Year 4)||0
10495569|NCT01212770|11645405|FG004|COMPLETED|Long-term Safety Phase (Year 4)||0
10495570|NCT01212770|11645406|FG005|COMPLETED|Long-term Safety Phase (Year 4)||0
10495571|NCT01212770|11645407|FG006|COMPLETED|Long-term Safety Phase (Year 4)||0
10495572|NCT01212770|11645408|FG007|COMPLETED|Long-term Safety Phase (Year 4)||32
10495573|NCT01212770|11645409|FG008|COMPLETED|Long-term Safety Phase (Year 4)||42
10495574|NCT01212770|11645401|FG000|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
10495575|NCT01212770|11645402|FG001|NOT COMPLETED|Long-term Safety Phase (Year 4)||6
10495576|NCT01212770|11645403|FG002|NOT COMPLETED|Long-term Safety Phase (Year 4)||11
10495577|NCT01212770|11645404|FG003|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
10495578|NCT01212770|11645405|FG004|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
10495579|NCT01212770|11645406|FG005|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
10495580|NCT01212770|11645407|FG006|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
10495581|NCT01212770|11645408|FG007|NOT COMPLETED|Long-term Safety Phase (Year 4)||3
10495582|NCT01212770|11645409|FG008|NOT COMPLETED|Long-term Safety Phase (Year 4)||2
10495583|NCT01212770|11645401|FG000|STARTED|Long-term Safety Phase (Year 5)||0
10495584|NCT01212770|11645402|FG001|STARTED|Long-term Safety Phase (Year 5)|1 participant who completed Year 4 did not continue treatment in Year 5|70
10495585|NCT01212770|11645403|FG002|STARTED|Long-term Safety Phase (Year 5)||83
10495586|NCT01212770|11645404|FG003|STARTED|Long-term Safety Phase (Year 5)||0
10495587|NCT01212770|11645405|FG004|STARTED|Long-term Safety Phase (Year 5)||0
10495588|NCT01212770|11645406|FG005|STARTED|Long-term Safety Phase (Year 5)||0
10495589|NCT01212770|11645407|FG006|STARTED|Long-term Safety Phase (Year 5)||0
10495590|NCT01212770|11645408|FG007|STARTED|Long-term Safety Phase (Year 5)||32
10495591|NCT01212770|11645409|FG008|STARTED|Long-term Safety Phase (Year 5)||42
10495592|NCT01212770|11645401|FG000|COMPLETED|Long-term Safety Phase (Year 5)||0
10495593|NCT01212770|11645402|FG001|COMPLETED|Long-term Safety Phase (Year 5)||68
10495594|NCT01212770|11645403|FG002|COMPLETED|Long-term Safety Phase (Year 5)||72
10495595|NCT01212770|11645404|FG003|COMPLETED|Long-term Safety Phase (Year 5)||0
10495596|NCT01212770|11645405|FG004|COMPLETED|Long-term Safety Phase (Year 5)||0
10495597|NCT01212770|11645406|FG005|COMPLETED|Long-term Safety Phase (Year 5)||0
10495598|NCT01212770|11645407|FG006|COMPLETED|Long-term Safety Phase (Year 5)||0
10495599|NCT01212770|11645408|FG007|COMPLETED|Long-term Safety Phase (Year 5)||30
10495600|NCT01212770|11645409|FG008|COMPLETED|Long-term Safety Phase (Year 5)||41
10810062|NCT03809910|11971934|FG000|NOT COMPLETED|Period 3 (Visit 4)||0
10810063|NCT03809910|11971935|FG001|NOT COMPLETED|Period 3 (Visit 4)||0
10810064|NCT03806790|11971947|FG000|STARTED|Overall Study||87
10810065|NCT03806790|11971948|FG001|STARTED|Overall Study||95
10810066|NCT03806790|11971947|FG000|COMPLETED|Overall Study||87
10810067|NCT03806790|11971948|FG001|COMPLETED|Overall Study||95
10810068|NCT03806790|11971947|FG000|NOT COMPLETED|Overall Study||0
10810069|NCT03806790|11971948|FG001|NOT COMPLETED|Overall Study||0
10495601|NCT01212770|11645401|FG000|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
10495602|NCT01212770|11645402|FG001|NOT COMPLETED|Long-term Safety Phase (Year 5)||2
10495603|NCT01212770|11645403|FG002|NOT COMPLETED|Long-term Safety Phase (Year 5)||11
10495604|NCT01212770|11645404|FG003|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
10495605|NCT01212770|11645405|FG004|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
10495606|NCT01212770|11645406|FG005|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
10495607|NCT01212770|11645407|FG006|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
10495608|NCT01212770|11645408|FG007|NOT COMPLETED|Long-term Safety Phase (Year 5)||2
10495609|NCT01212770|11645409|FG008|NOT COMPLETED|Long-term Safety Phase (Year 5)||1
10495610|NCT01212874|11645433|FG000|STARTED|Overall Study||35
10495611|NCT01212874|11645434|FG001|STARTED|Overall Study||35
10495612|NCT01212874|11645433|FG000|Received Allocated Intervention|Overall Study||13
10495613|NCT01212874|11645434|FG001|Received Allocated Intervention|Overall Study||12
10495614|NCT01212874|11645433|FG000|COMPLETED|Overall Study||13
10495615|NCT01212874|11645434|FG001|COMPLETED|Overall Study||12
10495616|NCT01212874|11645433|FG000|NOT COMPLETED|Overall Study||22
10495617|NCT01212874|11645434|FG001|NOT COMPLETED|Overall Study||23
10495618|NCT01212900|11645442|FG000|STARTED|Overall Study||116
10495619|NCT01212900|11645443|FG001|STARTED|Overall Study||114
10495620|NCT01212900|11645442|FG000|COMPLETED|Overall Study||104
10495621|NCT01212900|11645443|FG001|COMPLETED|Overall Study||107
10495622|NCT01212900|11645442|FG000|NOT COMPLETED|Overall Study||12
10495623|NCT01212900|11645443|FG001|NOT COMPLETED|Overall Study||7
10495624|NCT01212952|11645452|FG000|STARTED|Overall Study||3
10495625|NCT01212952|11645453|FG001|STARTED|Overall Study||6
10495626|NCT01212952|11645454|FG002|STARTED|Overall Study||41
10495627|NCT01212952|11645452|FG000|COMPLETED|Overall Study||3
10495628|NCT01212952|11645453|FG001|COMPLETED|Overall Study||6
10495629|NCT01212952|11645454|FG002|COMPLETED|Overall Study||41
10495630|NCT01212952|11645452|FG000|NOT COMPLETED|Overall Study||0
10495631|NCT01212952|11645453|FG001|NOT COMPLETED|Overall Study||0
10495632|NCT01212952|11645454|FG002|NOT COMPLETED|Overall Study||0
10495633|NCT01212991|11645466|FG000|STARTED|Double-blind||872
10495634|NCT01212991|11645467|FG001|STARTED|Double-blind||845
10495635|NCT01212991|11645468|FG002|STARTED|Double-blind||0
10495636|NCT01212991|11645466|FG000|Safety Population|Double-blind||871
10495637|NCT01212991|11645467|FG001|Safety Population|Double-blind||844
10495638|NCT01212991|11645468|FG002|Safety Population|Double-blind||0
10495639|NCT01212991|11645466|FG000|COMPLETED|Double-blind||0
10495640|NCT01212991|11645467|FG001|COMPLETED|Double-blind||234
10495641|NCT01212991|11645468|FG002|COMPLETED|Double-blind||0
10495642|NCT01212991|11645466|FG000|NOT COMPLETED|Double-blind||872
10710419|NCT02649608|11875602|FG004|COMPLETED|Overall Study||3
10710420|NCT02649608|11875603|FG005|COMPLETED|Overall Study||2
10710421|NCT02649608|11875604|FG006|COMPLETED|Overall Study||1
10495643|NCT01212991|11645467|FG001|NOT COMPLETED|Double-blind||611
10495644|NCT01212991|11645468|FG002|NOT COMPLETED|Double-blind||0
10495645|NCT01212991|11645466|FG000|STARTED|Open-label||0
10495646|NCT01212991|11645467|FG001|STARTED|Open-label|participants were given the opportunity to receive open-label access to enzalutamide|0
10495647|NCT01212991|11645468|FG002|STARTED|Open-label|previous placebo treated participants were given the opportunity to receive enzalutamide|234
10495648|NCT01212991|11645466|FG000|COMPLETED|Open-label||0
10495649|NCT01212991|11645467|FG001|COMPLETED|Open-label||0
10495650|NCT01212991|11645468|FG002|COMPLETED|Open-label||0
10495651|NCT01212991|11645466|FG000|NOT COMPLETED|Open-label||0
10495652|NCT01212991|11645467|FG001|NOT COMPLETED|Open-label||0
10495653|NCT01212991|11645468|FG002|NOT COMPLETED|Open-label||234
10495654|NCT01213043|11645478|FG000|STARTED|Treatment Period 1||15
10495655|NCT01213043|11645479|FG001|STARTED|Treatment Period 1||15
10495656|NCT01213043|11645478|FG000|COMPLETED|Treatment Period 1||15
10495657|NCT01213043|11645479|FG001|COMPLETED|Treatment Period 1||15
10495658|NCT01213043|11645478|FG000|NOT COMPLETED|Treatment Period 1||0
10495659|NCT01213043|11645479|FG001|NOT COMPLETED|Treatment Period 1||0
10495660|NCT01213043|11645478|FG000|STARTED|Washout Period||15
10495661|NCT01213043|11645479|FG001|STARTED|Washout Period||15
10495662|NCT01213043|11645478|FG000|COMPLETED|Washout Period||15
10495663|NCT01213043|11645479|FG001|COMPLETED|Washout Period||15
10495664|NCT01213043|11645478|FG000|NOT COMPLETED|Washout Period||0
10495665|NCT01213043|11645479|FG001|NOT COMPLETED|Washout Period||0
10495666|NCT01213043|11645478|FG000|STARTED|Treatment Period 2||15
10495667|NCT01213043|11645479|FG001|STARTED|Treatment Period 2||15
10495668|NCT01213043|11645478|FG000|COMPLETED|Treatment Period 2||15
10495669|NCT01213043|11645479|FG001|COMPLETED|Treatment Period 2||15
10495670|NCT01213043|11645478|FG000|NOT COMPLETED|Treatment Period 2||0
10710422|NCT02649608|11875598|FG000|NOT COMPLETED|Overall Study||0
10710423|NCT02649608|11875599|FG001|NOT COMPLETED|Overall Study||0
10710424|NCT02649608|11875600|FG002|NOT COMPLETED|Overall Study||0
10495671|NCT01213043|11645479|FG001|NOT COMPLETED|Treatment Period 2||0
10495672|NCT01213043|11645478|FG000|STARTED|Follow-up||15
10495673|NCT01213043|11645479|FG001|STARTED|Follow-up||15
10495674|NCT01213043|11645478|FG000|COMPLETED|Follow-up||15
10495675|NCT01213043|11645479|FG001|COMPLETED|Follow-up||15
10495676|NCT01213043|11645478|FG000|NOT COMPLETED|Follow-up||0
10495677|NCT01213043|11645479|FG001|NOT COMPLETED|Follow-up||0
10495678|NCT01213082|11645488|FG000|STARTED|Overall Study||12
10495679|NCT01213082|11645489|FG001|STARTED|Overall Study||11
10495680|NCT01213082|11645490|FG002|STARTED|Overall Study||11
10495681|NCT01213082|11645488|FG000|COMPLETED|Overall Study||6
10710425|NCT02649608|11875601|FG003|NOT COMPLETED|Overall Study||0
10710426|NCT02649608|11875602|FG004|NOT COMPLETED|Overall Study||0
10710427|NCT02649608|11875603|FG005|NOT COMPLETED|Overall Study||0
10710428|NCT02649608|11875604|FG006|NOT COMPLETED|Overall Study||0
10710429|NCT02649634|11875635|FG000|STARTED|Overall Study||69
10710430|NCT02649634|11875636|FG001|STARTED|Overall Study||66
10495682|NCT01213082|11645489|FG001|COMPLETED|Overall Study||4
10495683|NCT01213082|11645490|FG002|COMPLETED|Overall Study||6
10495684|NCT01213082|11645488|FG000|NOT COMPLETED|Overall Study||6
10495685|NCT01213082|11645489|FG001|NOT COMPLETED|Overall Study||7
10495686|NCT01213082|11645490|FG002|NOT COMPLETED|Overall Study||5
10495687|NCT01213173|11645500|FG000|STARTED|Overall Study|Patients who were randomized and received treatment|125
10495688|NCT01213173|11645501|FG001|STARTED|Overall Study|Patients who were randomized and received treatment|126
10495689|NCT01213173|11645500|FG000|Patients Included in Safety Population|Overall Study||139
10495690|NCT01213173|11645501|FG001|Patients Included in Safety Population|Overall Study||112
10710431|NCT02649634|11875635|FG000|COMPLETED|Overall Study||66
10710432|NCT02649634|11875636|FG001|COMPLETED|Overall Study||60
10710433|NCT02649634|11875635|FG000|NOT COMPLETED|Overall Study||3
10495691|NCT01213173|11645500|FG000|Patients Included in ITT Population|Overall Study||116
10495692|NCT01213173|11645501|FG001|Patients Included in ITT Population|Overall Study||115
10495693|NCT01213173|11645500|FG000|Patients Included in PP Population|Overall Study||102
10495694|NCT01213173|11645501|FG001|Patients Included in PP Population|Overall Study||89
10495695|NCT01213173|11645500|FG000|COMPLETED|Overall Study|Patients who completed the study|113
10495696|NCT01213173|11645501|FG001|COMPLETED|Overall Study|Patients who completed the study|110
10495697|NCT01213173|11645500|FG000|NOT COMPLETED|Overall Study||12
10495698|NCT01213173|11645501|FG001|NOT COMPLETED|Overall Study||16
10495699|NCT01213199|11645507|FG000|STARTED|Overall Study||20
10495700|NCT01213199|11645507|FG000|COMPLETED|Overall Study||16
10495701|NCT01213199|11645507|FG000|NOT COMPLETED|Overall Study||4
10527932|NCT01392495|11680154|FG000|Received 200 mg|Overall Study||4
10527933|NCT01392495|11680154|FG000|Received 400 mg|Overall Study||13
10710434|NCT02649634|11875636|FG001|NOT COMPLETED|Overall Study||6
10710435|NCT02649842|11875642|FG000|STARTED|Overall Study||101
10710436|NCT02649842|11875642|FG000|COMPLETED|Overall Study||101
10710437|NCT02649842|11875642|FG000|NOT COMPLETED|Overall Study||0
10527934|NCT01392495|11680154|FG000|COMPLETED|Overall Study||1
10527935|NCT01392495|11680154|FG000|NOT COMPLETED|Overall Study||16
10527936|NCT01392547|11680160|FG000|STARTED|Overall Study|567 bleeds by 69 subjects, 340 were treated with vatreptacog alfa and 227 with rFVIIa|72
10527937|NCT01392547|11680160|FG000|COMPLETED|Overall Study||64
10527938|NCT01392547|11680160|FG000|NOT COMPLETED|Overall Study||8
10527939|NCT01392560|11680166|FG000|STARTED|Overall Study||52
10527940|NCT01392560|11680166|FG000|COMPLETED|Overall Study||40
10527941|NCT01392560|11680166|FG000|NOT COMPLETED|Overall Study||12
10527942|NCT01392573|11680174|FG000|STARTED|Overall Study||207
10527943|NCT01392573|11680175|FG001|STARTED|Overall Study||206
10527944|NCT01392573|11680174|FG000|Exposed|Overall Study||207
10527945|NCT01392573|11680175|FG001|Exposed|Overall Study||206
10527946|NCT01392573|11680174|FG000|COMPLETED|Overall Study||175
10527947|NCT01392573|11680175|FG001|COMPLETED|Overall Study||171
10527948|NCT01392573|11680174|FG000|NOT COMPLETED|Overall Study||32
10527949|NCT01392573|11680175|FG001|NOT COMPLETED|Overall Study||35
10527950|NCT01392625|11680183|FG000|STARTED|Overall Study||18
10527951|NCT01392625|11680184|FG001|STARTED|Overall Study||19
10527952|NCT01392625|11680183|FG000|COMPLETED|Overall Study||16
10527953|NCT01392625|11680184|FG001|COMPLETED|Overall Study||18
10527954|NCT01392625|11680183|FG000|NOT COMPLETED|Overall Study||2
10527955|NCT01392625|11680184|FG001|NOT COMPLETED|Overall Study||1
10527956|NCT01392677|11680192|FG000|STARTED|Overall Study||109
10527957|NCT01392677|11680193|FG001|STARTED|Overall Study||109
10527958|NCT01392677|11680192|FG000|COMPLETED|Overall Study||101
10527959|NCT01392677|11680193|FG001|COMPLETED|Overall Study||101
10527960|NCT01392677|11680192|FG000|NOT COMPLETED|Overall Study||8
10527961|NCT01392677|11680193|FG001|NOT COMPLETED|Overall Study||8
10527962|NCT01392703|11680199|FG000|STARTED|Day 1||26
10527963|NCT01392703|11680200|FG001|STARTED|Day 1||26
10527964|NCT01392703|11680201|FG002|STARTED|Day 1||26
10527965|NCT01392703|11680199|FG000|COMPLETED|Day 1||26
10527966|NCT01392703|11680200|FG001|COMPLETED|Day 1||26
10527967|NCT01392703|11680201|FG002|COMPLETED|Day 1||26
10527968|NCT01392703|11680199|FG000|NOT COMPLETED|Day 1||0
10527969|NCT01392703|11680200|FG001|NOT COMPLETED|Day 1||0
10527970|NCT01392703|11680201|FG002|NOT COMPLETED|Day 1||0
10527971|NCT01392703|11680199|FG000|STARTED|Day 5||26
10527972|NCT01392703|11680200|FG001|STARTED|Day 5|1 participant no longer met dosing criteria and dropped out during washout period prior to Day 5.|25
10527973|NCT01392703|11680201|FG002|STARTED|Day 5||26
10527974|NCT01392703|11680199|FG000|COMPLETED|Day 5||26
10527975|NCT01392703|11680200|FG001|COMPLETED|Day 5||25
10527976|NCT01392703|11680201|FG002|COMPLETED|Day 5||26
10527977|NCT01392703|11680199|FG000|NOT COMPLETED|Day 5||0
10527978|NCT01392703|11680200|FG001|NOT COMPLETED|Day 5||0
10527979|NCT01392703|11680201|FG002|NOT COMPLETED|Day 5||0
10527980|NCT01392703|11680199|FG000|STARTED|Day 9||26
10527981|NCT01392703|11680200|FG001|STARTED|Day 9||26
10710438|NCT02649894|11875650|FG000|STARTED|Overall Study||81
10710439|NCT02649894|11875651|FG001|STARTED|Overall Study||38
10710440|NCT02649894|11875650|FG000|Device Inserted|Overall Study||77
10527982|NCT01392703|11680201|FG002|STARTED|Day 9||25
10527983|NCT01392703|11680199|FG000|COMPLETED|Day 9||26
10527984|NCT01392703|11680200|FG001|COMPLETED|Day 9||26
10710441|NCT02649894|11875651|FG001|Device Inserted|Overall Study||37
10710442|NCT02649894|11875650|FG000|Completed Day 30|Overall Study||56
10710443|NCT02649894|11875651|FG001|Completed Day 30|Overall Study||35
10495702|NCT01213251|11645514|FG000|STARTED|Overall Study||40
10495703|NCT01213251|11645515|FG001|STARTED|Overall Study||41
10495704|NCT01213251|11645516|FG002|STARTED|Overall Study||45
10495705|NCT01213251|11645514|FG000|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|34
10495706|NCT01213251|11645515|FG001|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|37
10495707|NCT01213251|11645516|FG002|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|34
10495708|NCT01213251|11645514|FG000|NOT COMPLETED|Overall Study||6
10495709|NCT01213251|11645515|FG001|NOT COMPLETED|Overall Study||4
10495710|NCT01213251|11645516|FG002|NOT COMPLETED|Overall Study||11
10495711|NCT01213264|11645532|FG000|STARTED|Overall Study||155
10495712|NCT01213264|11645533|FG001|STARTED|Overall Study||177
10495713|NCT01213264|11645534|FG002|STARTED|Overall Study||327
10495714|NCT01213264|11645532|FG000|COMPLETED|Overall Study||153
10495715|NCT01213264|11645533|FG001|COMPLETED|Overall Study||175
10495716|NCT01213264|11645534|FG002|COMPLETED|Overall Study||321
10495717|NCT01213264|11645532|FG000|NOT COMPLETED|Overall Study||2
10495718|NCT01213264|11645533|FG001|NOT COMPLETED|Overall Study||2
10495719|NCT01213264|11645534|FG002|NOT COMPLETED|Overall Study||6
10495720|NCT01213316|11645545|FG000|STARTED|Overall Study|Participants in the initial and amendment cohorts|451
10495721|NCT01213316|11645545|FG000|Amendment Cohort: Prolonged Participants|Overall Study|Participants >=50 years of age in the initial cohort who accept an additional 48-week observation|48
10495722|NCT01213316|11645545|FG000|Amendment Cohort: Newly Enrolled|Overall Study|Participants >=50 years of age newly enrolled|179
10495723|NCT01213316|11645545|FG000|Discontinued Treatment Before 48 Weeks|Overall Study||67
10495724|NCT01213316|11645545|FG000|Initial Cohort|Overall Study|Participants >=18 years of age in the initial cohort|272
10495725|NCT01213316|11645545|FG000|COMPLETED|Overall Study||451
10495726|NCT01213316|11645545|FG000|NOT COMPLETED|Overall Study||0
10495727|NCT01213472|11645553|FG000|STARTED|Overall Study||33
10495728|NCT01213472|11645553|FG000|COMPLETED|Overall Study||6
10495729|NCT01213472|11645553|FG000|NOT COMPLETED|Overall Study||27
10495730|NCT01213524|11645559|FG000|STARTED|Baseline|Total number who signed informed consent.|75
10495731|NCT01213524|11645559|FG000|COMPLETED|Baseline|Number of participants who continued in the study past baseline|68
10495732|NCT01213524|11645559|FG000|NOT COMPLETED|Baseline||7
10495733|NCT01213524|11645559|FG000|STARTED|Session 2||68
10495734|NCT01213524|11645559|FG000|COMPLETED|Session 2|Number who continued in the study to the next session|63
10495735|NCT01213524|11645559|FG000|NOT COMPLETED|Session 2||5
10495736|NCT01213524|11645559|FG000|STARTED|Session 3||63
10495737|NCT01213524|11645559|FG000|COMPLETED|Session 3|Number who continued in study to next session|59
10495738|NCT01213524|11645559|FG000|NOT COMPLETED|Session 3||4
10495739|NCT01213524|11645559|FG000|STARTED|Session 4||59
10495740|NCT01213524|11645559|FG000|COMPLETED|Session 4|Number who continued in the study to the next session|56
10495741|NCT01213524|11645559|FG000|NOT COMPLETED|Session 4||3
10495742|NCT01213524|11645559|FG000|STARTED|Session 5||56
10495743|NCT01213524|11645559|FG000|COMPLETED|Session 5|Number who continued in the study to the next session|56
10495744|NCT01213524|11645559|FG000|NOT COMPLETED|Session 5||0
10495745|NCT01213524|11645559|FG000|STARTED|Session 6||56
10495746|NCT01213524|11645559|FG000|COMPLETED|Session 6|Number who continued in the study to the next session|56
10495747|NCT01213524|11645559|FG000|NOT COMPLETED|Session 6||0
10495748|NCT01213524|11645559|FG000|STARTED|Session 7||56
10495749|NCT01213524|11645559|FG000|COMPLETED|Session 7||56
10495750|NCT01213524|11645559|FG000|NOT COMPLETED|Session 7||0
10495751|NCT01213576|11645574|FG000|STARTED|Overall Study||18
10495752|NCT01213576|11645575|FG001|STARTED|Overall Study||17
10495753|NCT01213576|11645576|FG002|STARTED|Overall Study||18
10495754|NCT01213576|11645577|FG003|STARTED|Overall Study||17
10495755|NCT01213576|11645574|FG000|COMPLETED|Overall Study||15
10495756|NCT01213576|11645575|FG001|COMPLETED|Overall Study||13
10495757|NCT01213576|11645576|FG002|COMPLETED|Overall Study||13
10495758|NCT01213576|11645577|FG003|COMPLETED|Overall Study||13
10495759|NCT01213576|11645574|FG000|NOT COMPLETED|Overall Study||3
10495760|NCT01213576|11645575|FG001|NOT COMPLETED|Overall Study||4
10495761|NCT01213576|11645576|FG002|NOT COMPLETED|Overall Study||5
10495762|NCT01213576|11645577|FG003|NOT COMPLETED|Overall Study||4
10495763|NCT01213589|11645590|FG000|STARTED|Overall Study||50
10495764|NCT01213589|11645591|FG001|STARTED|Overall Study||24
10495765|NCT01213589|11645592|FG002|STARTED|Overall Study||26
10495766|NCT01213589|11645590|FG000|COMPLETED|Overall Study||37
10495767|NCT01213589|11645591|FG001|COMPLETED|Overall Study||19
10495768|NCT01213589|11645592|FG002|COMPLETED|Overall Study||18
10495769|NCT01213589|11645590|FG000|NOT COMPLETED|Overall Study||13
10495770|NCT01213589|11645591|FG001|NOT COMPLETED|Overall Study||5
10495771|NCT01213589|11645592|FG002|NOT COMPLETED|Overall Study||8
10495772|NCT01213706|11645600|FG000|STARTED|Sham WBPA||45
10495773|NCT01213706|11645600|FG000|COMPLETED|Sham WBPA||45
10495774|NCT01213706|11645600|FG000|NOT COMPLETED|Sham WBPA||0
10495775|NCT01213706|11645600|FG000|STARTED|Washout (1 Hour)||45
10495776|NCT01213706|11645600|FG000|COMPLETED|Washout (1 Hour)||45
10495777|NCT01213706|11645600|FG000|NOT COMPLETED|Washout (1 Hour)||0
10495778|NCT01213706|11645600|FG000|STARTED|WBPA||45
10495779|NCT01213706|11645600|FG000|COMPLETED|WBPA||45
10495780|NCT01213706|11645600|FG000|NOT COMPLETED|WBPA||0
10495781|NCT01213823|11645608|FG000|STARTED|Overall Study||69
10495782|NCT01213823|11645609|FG001|STARTED|Overall Study||467
10495783|NCT01213823|11645608|FG000|COMPLETED|Overall Study||69
10495784|NCT01213823|11645609|FG001|COMPLETED|Overall Study||467
10495785|NCT01213823|11645608|FG000|NOT COMPLETED|Overall Study||0
10495786|NCT01213823|11645609|FG001|NOT COMPLETED|Overall Study||0
10495787|NCT01213836|11645617|FG000|STARTED|Period 1, First Intervention||34
10495788|NCT01213836|11645618|FG001|STARTED|Period 1, First Intervention||32
10495789|NCT01213836|11645617|FG000|COMPLETED|Period 1, First Intervention||31
10495790|NCT01213836|11645618|FG001|COMPLETED|Period 1, First Intervention||29
10495791|NCT01213836|11645617|FG000|NOT COMPLETED|Period 1, First Intervention||3
10495792|NCT01213836|11645618|FG001|NOT COMPLETED|Period 1, First Intervention||3
10495793|NCT01213836|11645617|FG000|STARTED|Period 2, Second Intervention||31
10495794|NCT01213836|11645618|FG001|STARTED|Period 2, Second Intervention||29
10495795|NCT01213836|11645617|FG000|COMPLETED|Period 2, Second Intervention||31
10495796|NCT01213836|11645618|FG001|COMPLETED|Period 2, Second Intervention||29
10495797|NCT01213836|11645617|FG000|NOT COMPLETED|Period 2, Second Intervention||0
10495798|NCT01213836|11645618|FG001|NOT COMPLETED|Period 2, Second Intervention||0
10495799|NCT01213940|11645629|FG000|STARTED|Overall Study||14
10495800|NCT01213940|11645630|FG001|STARTED|Overall Study||6
10495801|NCT01213940|11645629|FG000|COMPLETED|Overall Study||14
10495802|NCT01213940|11645630|FG001|COMPLETED|Overall Study||6
10495803|NCT01213940|11645629|FG000|NOT COMPLETED|Overall Study||0
10495804|NCT01213940|11645630|FG001|NOT COMPLETED|Overall Study||0
10495805|NCT01213966|11645640|FG000|STARTED|Overall Study||20
10495806|NCT01213966|11645641|FG001|STARTED|Overall Study||20
10495807|NCT01213966|11645642|FG002|STARTED|Overall Study||20
10495808|NCT01213966|11645643|FG003|STARTED|Overall Study||21
10495809|NCT01213966|11645640|FG000|COMPLETED|Overall Study||19
10495810|NCT01213966|11645641|FG001|COMPLETED|Overall Study||20
10495811|NCT01213966|11645642|FG002|COMPLETED|Overall Study||17
10495812|NCT01213966|11645643|FG003|COMPLETED|Overall Study||20
10495813|NCT01213966|11645640|FG000|NOT COMPLETED|Overall Study||1
10495814|NCT01213966|11645641|FG001|NOT COMPLETED|Overall Study||0
10495815|NCT01213966|11645642|FG002|NOT COMPLETED|Overall Study||3
10495816|NCT01213966|11645643|FG003|NOT COMPLETED|Overall Study||1
10495817|NCT01214044|11645653|FG000|STARTED|Visit 1: Screening and Consent, Washout||31
10495818|NCT01214044|11645653|FG000|COMPLETED|Visit 1: Screening and Consent, Washout||19
10495819|NCT01214044|11645653|FG000|NOT COMPLETED|Visit 1: Screening and Consent, Washout||12
10495820|NCT01214044|11645653|FG000|STARTED|Visit 2: End Washout & Start Placebo||19
10495821|NCT01214044|11645653|FG000|COMPLETED|Visit 2: End Washout & Start Placebo|2 subjects dropped out during the placebo week (between study visits 2 & 3)|17
10495822|NCT01214044|11645653|FG000|NOT COMPLETED|Visit 2: End Washout & Start Placebo||2
10495823|NCT01214044|11645653|FG000|STARTED|Visits 3-5: Escitalopram 10 mg Daily||17
10495824|NCT01214044|11645653|FG000|COMPLETED|Visits 3-5: Escitalopram 10 mg Daily||14
10495825|NCT01214044|11645653|FG000|NOT COMPLETED|Visits 3-5: Escitalopram 10 mg Daily||3
10495826|NCT01214044|11645653|FG000|STARTED|Visits 6-11: Escitalopram 20 mg Daily||14
10495827|NCT01214044|11645653|FG000|COMPLETED|Visits 6-11: Escitalopram 20 mg Daily||10
10495828|NCT01214044|11645653|FG000|NOT COMPLETED|Visits 6-11: Escitalopram 20 mg Daily||4
10495829|NCT01214057|11645663|FG000|STARTED|Overall Study||12
10495830|NCT01214057|11645664|FG001|STARTED|Overall Study||11
10495831|NCT01214057|11645663|FG000|COMPLETED|Overall Study||12
10495832|NCT01214057|11645664|FG001|COMPLETED|Overall Study||11
10495833|NCT01214057|11645663|FG000|NOT COMPLETED|Overall Study||0
10495834|NCT01214057|11645664|FG001|NOT COMPLETED|Overall Study||0
10495835|NCT01214083|11645673|FG000|STARTED|Overall Study||31
10495836|NCT01214083|11645674|FG001|STARTED|Overall Study||33
10495837|NCT01214083|11645675|FG002|STARTED|Overall Study||31
10495838|NCT01214083|11645673|FG000|COMPLETED|Overall Study||19
10495839|NCT01214083|11645674|FG001|COMPLETED|Overall Study||23
10495840|NCT01214083|11645675|FG002|COMPLETED|Overall Study||21
10495841|NCT01214083|11645673|FG000|NOT COMPLETED|Overall Study||12
10495842|NCT01214083|11645674|FG001|NOT COMPLETED|Overall Study||10
10495843|NCT01214083|11645675|FG002|NOT COMPLETED|Overall Study||10
10495844|NCT01214109|11645683|FG000|STARTED|Overall Study||24
10495845|NCT01214109|11645684|FG001|STARTED|Overall Study||24
10495846|NCT01214109|11645685|FG002|STARTED|Overall Study||24
10495847|NCT01214109|11645686|FG003|STARTED|Overall Study||24
10495848|NCT01214109|11645683|FG000|COMPLETED|Overall Study||24
10495849|NCT01214109|11645684|FG001|COMPLETED|Overall Study||24
10495850|NCT01214109|11645685|FG002|COMPLETED|Overall Study||24
10495851|NCT01214109|11645686|FG003|COMPLETED|Overall Study||24
10495852|NCT01214109|11645683|FG000|NOT COMPLETED|Overall Study||0
10495853|NCT01214109|11645684|FG001|NOT COMPLETED|Overall Study||0
10495854|NCT01214109|11645685|FG002|NOT COMPLETED|Overall Study||0
10495855|NCT01214109|11645686|FG003|NOT COMPLETED|Overall Study||0
10495856|NCT01214161|11645701|FG000|STARTED|Overall Study||100
10495857|NCT01214161|11645702|FG001|STARTED|Overall Study||100
10495858|NCT01214161|11645701|FG000|COMPLETED|Overall Study||100
10495859|NCT01214161|11645702|FG001|COMPLETED|Overall Study||100
10495860|NCT01214161|11645701|FG000|NOT COMPLETED|Overall Study||0
10495861|NCT01214161|11645702|FG001|NOT COMPLETED|Overall Study||0
10495862|NCT01214174|11645713|FG000|STARTED|Overall Study||13
10495863|NCT01214174|11645714|FG001|STARTED|Overall Study||16
10495864|NCT01214174|11645715|FG002|STARTED|Overall Study||14
10495865|NCT01214174|11645713|FG000|COMPLETED|Overall Study||13
10495866|NCT01214174|11645714|FG001|COMPLETED|Overall Study||16
10495867|NCT01214174|11645715|FG002|COMPLETED|Overall Study||13
10495868|NCT01214174|11645713|FG000|NOT COMPLETED|Overall Study||0
10495869|NCT01214174|11645714|FG001|NOT COMPLETED|Overall Study||0
10495870|NCT01214174|11645715|FG002|NOT COMPLETED|Overall Study||1
10495871|NCT01214187|11645725|FG000|STARTED|Overall Study||29
10495872|NCT01214187|11645726|FG001|STARTED|Overall Study||29
10495873|NCT01214187|11645725|FG000|COMPLETED|Overall Study||22
10495874|NCT01214187|11645726|FG001|COMPLETED|Overall Study||23
10495875|NCT01214187|11645725|FG000|NOT COMPLETED|Overall Study||7
10495876|NCT01214187|11645726|FG001|NOT COMPLETED|Overall Study||6
10495877|NCT01214200|11645732|FG000|STARTED|Overall Study||20
10495878|NCT01214200|11645732|FG000|COMPLETED|Overall Study||9
10495879|NCT01214200|11645732|FG000|NOT COMPLETED|Overall Study||11
10495880|NCT01214239|11645740|FG000|STARTED|Overall Study|patients who were randomised and treated with placebo|99
10495881|NCT01214239|11645741|FG001|STARTED|Overall Study|patients who were randomised and treated with placebo. 1 patient was not treated then not included|200
10495882|NCT01214239|11645740|FG000|COMPLETED|Overall Study||87
10495883|NCT01214239|11645741|FG001|COMPLETED|Overall Study||182
10495884|NCT01214239|11645740|FG000|NOT COMPLETED|Overall Study||12
10495885|NCT01214239|11645741|FG001|NOT COMPLETED|Overall Study||18
10495886|NCT01214252|11645747|FG000|STARTED|Overall Study||425
10495887|NCT01214252|11645747|FG000|COMPLETED|Overall Study||343
10495888|NCT01214252|11645747|FG000|NOT COMPLETED|Overall Study||82
10495889|NCT01214317|11645754|FG000|STARTED|Overall Study||18
10495890|NCT01214317|11645755|FG001|STARTED|Overall Study||22
10495891|NCT01214317|11645754|FG000|COMPLETED|Overall Study||18
10495892|NCT01214317|11645755|FG001|COMPLETED|Overall Study||22
10495893|NCT01214317|11645754|FG000|NOT COMPLETED|Overall Study||0
10495894|NCT01214317|11645755|FG001|NOT COMPLETED|Overall Study||0
10495895|NCT01214330|11645763|FG000|STARTED|Overall Study||150
10495896|NCT01214330|11645763|FG000|COMPLETED|Overall Study||102
10495897|NCT01214330|11645763|FG000|NOT COMPLETED|Overall Study||48
10495898|NCT01214356|11645769|FG000|STARTED|Overall Study||27
10495899|NCT01214356|11645770|FG001|STARTED|Overall Study||27
10495900|NCT01214356|11645769|FG000|COMPLETED|Overall Study||10
10495901|NCT01214356|11645770|FG001|COMPLETED|Overall Study||13
10495902|NCT01214356|11645769|FG000|NOT COMPLETED|Overall Study||17
10495903|NCT01214356|11645770|FG001|NOT COMPLETED|Overall Study||14
10495904|NCT01214395|11645776|FG000|STARTED|Overall Study||5
10495905|NCT01214395|11645776|FG000|COMPLETED|Overall Study||0
10495906|NCT01214395|11645776|FG000|NOT COMPLETED|Overall Study||5
10495907|NCT01214421|11645785|FG000|STARTED|Overall Study||557
10495908|NCT01214421|11645786|FG001|STARTED|Overall Study||314
10495909|NCT01214421|11645787|FG002|STARTED|Overall Study||181
10495910|NCT01214421|11645788|FG003|STARTED|Overall Study||31
10495911|NCT01214421|11645785|FG000|COMPLETED|Overall Study||507
10495912|NCT01214421|11645786|FG001|COMPLETED|Overall Study||256
10495913|NCT01214421|11645787|FG002|COMPLETED|Overall Study||143
10495914|NCT01214421|11645788|FG003|COMPLETED|Overall Study||22
10495915|NCT01214421|11645785|FG000|NOT COMPLETED|Overall Study||50
10495916|NCT01214421|11645786|FG001|NOT COMPLETED|Overall Study||58
10495917|NCT01214421|11645787|FG002|NOT COMPLETED|Overall Study||38
10495918|NCT01214421|11645788|FG003|NOT COMPLETED|Overall Study||9
10495919|NCT01214434|11645800|FG000|STARTED|Overall Study||15
10495920|NCT01214434|11645801|FG001|STARTED|Overall Study||27
10495921|NCT01214434|11645800|FG000|COMPLETED|Overall Study||11
10495922|NCT01214434|11645801|FG001|COMPLETED|Overall Study||25
10495923|NCT01214434|11645800|FG000|NOT COMPLETED|Overall Study||4
10495924|NCT01214434|11645801|FG001|NOT COMPLETED|Overall Study||2
10495925|NCT01214603|11645810|FG000|STARTED|Overall Study||7
10495926|NCT01214603|11645811|FG001|STARTED|Overall Study||6
10495927|NCT01214603|11645812|FG002|STARTED|Overall Study||7
10495928|NCT01214603|11645810|FG000|Received at Least 1 Dose of LY2090314|Overall Study||7
10495929|NCT01214603|11645811|FG001|Received at Least 1 Dose of LY2090314|Overall Study||6
10495930|NCT01214603|11645812|FG002|Received at Least 1 Dose of LY2090314|Overall Study||7
10495931|NCT01214603|11645810|FG000|COMPLETED|Overall Study||2
10495932|NCT01214603|11645811|FG001|COMPLETED|Overall Study||5
10495933|NCT01214603|11645812|FG002|COMPLETED|Overall Study||3
10495934|NCT01214603|11645810|FG000|NOT COMPLETED|Overall Study||5
10495935|NCT01214603|11645811|FG001|NOT COMPLETED|Overall Study||1
10495936|NCT01214603|11645812|FG002|NOT COMPLETED|Overall Study||4
10495937|NCT01214616|11645825|FG000|STARTED|Overall Study||3
10495938|NCT01214616|11645826|FG001|STARTED|Overall Study||5
10495939|NCT01214616|11645827|FG002|STARTED|Overall Study||3
10495940|NCT01214616|11645828|FG003|STARTED|Overall Study|Cohort 3 with afatinib/vinorelbine modification. Skipping vinorelbine allowed and not considered DLT|6
10495941|NCT01214616|11645825|FG000|COMPLETED|Overall Study||0
10495942|NCT01214616|11645826|FG001|COMPLETED|Overall Study||0
10495943|NCT01214616|11645827|FG002|COMPLETED|Overall Study||0
10495944|NCT01214616|11645828|FG003|COMPLETED|Overall Study||0
10495945|NCT01214616|11645825|FG000|NOT COMPLETED|Overall Study||3
10495946|NCT01214616|11645826|FG001|NOT COMPLETED|Overall Study||5
10495947|NCT01214616|11645827|FG002|NOT COMPLETED|Overall Study||3
10495948|NCT01214616|11645828|FG003|NOT COMPLETED|Overall Study||6
10495949|NCT01214629|11645857|FG000|STARTED|Overall Study||1
10495950|NCT01214629|11645858|FG001|STARTED|Overall Study||1
10495951|NCT01214629|11645859|FG002|STARTED|Overall Study||1
10495952|NCT01214629|11645860|FG003|STARTED|Overall Study||3
10495953|NCT01214629|11645861|FG004|STARTED|Overall Study||3
10495954|NCT01214629|11645862|FG005|STARTED|Overall Study||13
10495955|NCT01214629|11645863|FG006|STARTED|Overall Study||5
10495956|NCT01214629|11645864|FG007|STARTED|Overall Study||3
10495957|NCT01214629|11645865|FG008|STARTED|Overall Study||3
10495958|NCT01214629|11645866|FG009|STARTED|Overall Study||18
10495959|NCT01214629|11645867|FG010|STARTED|Overall Study||3
10495960|NCT01214629|11645857|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1
10495961|NCT01214629|11645858|FG001|Received at Least 1 Dose of Study Drug|Overall Study||1
10495962|NCT01214629|11645859|FG002|Received at Least 1 Dose of Study Drug|Overall Study||1
10527985|NCT01392703|11680201|FG002|COMPLETED|Day 9||25
10495963|NCT01214629|11645860|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
10495964|NCT01214629|11645861|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3
10495965|NCT01214629|11645862|FG005|Received at Least 1 Dose of Study Drug|Overall Study||13
10495966|NCT01214629|11645863|FG006|Received at Least 1 Dose of Study Drug|Overall Study||5
10495967|NCT01214629|11645864|FG007|Received at Least 1 Dose of Study Drug|Overall Study||3
10495968|NCT01214629|11645865|FG008|Received at Least 1 Dose of Study Drug|Overall Study||3
10495969|NCT01214629|11645866|FG009|Received at Least 1 Dose of Study Drug|Overall Study||18
10495970|NCT01214629|11645867|FG010|Received at Least 1 Dose of Study Drug|Overall Study||3
10495971|NCT01214629|11645857|FG000|COMPLETED|Overall Study||0
10495972|NCT01214629|11645858|FG001|COMPLETED|Overall Study||0
10495973|NCT01214629|11645859|FG002|COMPLETED|Overall Study||1
10495974|NCT01214629|11645860|FG003|COMPLETED|Overall Study||1
10495975|NCT01214629|11645861|FG004|COMPLETED|Overall Study||1
10495976|NCT01214629|11645862|FG005|COMPLETED|Overall Study||9
10495977|NCT01214629|11645863|FG006|COMPLETED|Overall Study||4
10495978|NCT01214629|11645864|FG007|COMPLETED|Overall Study||2
10495979|NCT01214629|11645865|FG008|COMPLETED|Overall Study||2
10495980|NCT01214629|11645866|FG009|COMPLETED|Overall Study||11
10495981|NCT01214629|11645867|FG010|COMPLETED|Overall Study||1
10495982|NCT01214629|11645857|FG000|NOT COMPLETED|Overall Study||1
10495983|NCT01214629|11645858|FG001|NOT COMPLETED|Overall Study||1
10495984|NCT01214629|11645859|FG002|NOT COMPLETED|Overall Study||0
10495985|NCT01214629|11645860|FG003|NOT COMPLETED|Overall Study||2
10495986|NCT01214629|11645861|FG004|NOT COMPLETED|Overall Study||2
10495987|NCT01214629|11645862|FG005|NOT COMPLETED|Overall Study||4
10495988|NCT01214629|11645863|FG006|NOT COMPLETED|Overall Study||1
10495989|NCT01214629|11645864|FG007|NOT COMPLETED|Overall Study||1
10495990|NCT01214629|11645865|FG008|NOT COMPLETED|Overall Study||1
10495991|NCT01214629|11645866|FG009|NOT COMPLETED|Overall Study||7
10495992|NCT01214629|11645867|FG010|NOT COMPLETED|Overall Study||2
10495993|NCT01214642|11645917|FG000|STARTED|Overall Study||3
10495994|NCT01214642|11645918|FG001|STARTED|Overall Study||3
10495995|NCT01214642|11645919|FG002|STARTED|Overall Study||6
10495996|NCT01214642|11645920|FG003|STARTED|Overall Study||6
10495997|NCT01214642|11645921|FG004|STARTED|Overall Study||6
10495998|NCT01214642|11645922|FG005|STARTED|Overall Study||3
10495999|NCT01214642|11645923|FG006|STARTED|Overall Study||6
10496000|NCT01214642|11645924|FG007|STARTED|Overall Study||3
10496001|NCT01214642|11645925|FG008|STARTED|Overall Study|All participants who received 12 mg/m2/day on Days 1 and 5 plus PEG in Part A and Part B.|13
10496002|NCT01214642|11645926|FG009|STARTED|Overall Study||4
10496003|NCT01214642|11645927|FG010|STARTED|Overall Study||4
10496004|NCT01214642|11645928|FG011|STARTED|Overall Study||6
10496005|NCT01214642|11645917|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
10496006|NCT01214642|11645918|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
10496007|NCT01214642|11645919|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
10496008|NCT01214642|11645920|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
10496009|NCT01214642|11645921|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
10496010|NCT01214642|11645922|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3
10496011|NCT01214642|11645923|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
10496012|NCT01214642|11645924|FG007|Received at Least 1 Dose of Study Drug|Overall Study||3
10496013|NCT01214642|11645925|FG008|Received at Least 1 Dose of Study Drug|Overall Study||13
10496014|NCT01214642|11645926|FG009|Received at Least 1 Dose of Study Drug|Overall Study||4
10496015|NCT01214642|11645927|FG010|Received at Least 1 Dose of Study Drug|Overall Study||4
10496016|NCT01214642|11645928|FG011|Received at Least 1 Dose of Study Drug|Overall Study||6
10496017|NCT01214642|11645917|FG000|Complete at Least 2 Cycles of Study Drug|Overall Study||3
10496018|NCT01214642|11645918|FG001|Complete at Least 2 Cycles of Study Drug|Overall Study||1
10496019|NCT01214642|11645919|FG002|Complete at Least 2 Cycles of Study Drug|Overall Study||5
10496020|NCT01214642|11645920|FG003|Complete at Least 2 Cycles of Study Drug|Overall Study||4
10496021|NCT01214642|11645921|FG004|Complete at Least 2 Cycles of Study Drug|Overall Study||6
10496022|NCT01214642|11645922|FG005|Complete at Least 2 Cycles of Study Drug|Overall Study||1
10496023|NCT01214642|11645923|FG006|Complete at Least 2 Cycles of Study Drug|Overall Study||6
10496024|NCT01214642|11645924|FG007|Complete at Least 2 Cycles of Study Drug|Overall Study||3
10496025|NCT01214642|11645925|FG008|Complete at Least 2 Cycles of Study Drug|Overall Study||12
10496026|NCT01214642|11645926|FG009|Complete at Least 2 Cycles of Study Drug|Overall Study||2
10496027|NCT01214642|11645927|FG010|Complete at Least 2 Cycles of Study Drug|Overall Study||2
10496028|NCT01214642|11645928|FG011|Complete at Least 2 Cycles of Study Drug|Overall Study||5
10496029|NCT01214642|11645917|FG000|COMPLETED|Overall Study||0
10496030|NCT01214642|11645918|FG001|COMPLETED|Overall Study||0
10496031|NCT01214642|11645919|FG002|COMPLETED|Overall Study||0
10496032|NCT01214642|11645920|FG003|COMPLETED|Overall Study||0
10496033|NCT01214642|11645921|FG004|COMPLETED|Overall Study||0
10496034|NCT01214642|11645922|FG005|COMPLETED|Overall Study||0
10496035|NCT01214642|11645923|FG006|COMPLETED|Overall Study||0
10496036|NCT01214642|11645924|FG007|COMPLETED|Overall Study||0
10496037|NCT01214642|11645925|FG008|COMPLETED|Overall Study||0
10496038|NCT01214642|11645926|FG009|COMPLETED|Overall Study||0
10496039|NCT01214642|11645927|FG010|COMPLETED|Overall Study||0
10496040|NCT01214642|11645928|FG011|COMPLETED|Overall Study||0
10496041|NCT01214642|11645917|FG000|NOT COMPLETED|Overall Study||3
10496042|NCT01214642|11645918|FG001|NOT COMPLETED|Overall Study||3
10496043|NCT01214642|11645919|FG002|NOT COMPLETED|Overall Study||6
10496044|NCT01214642|11645920|FG003|NOT COMPLETED|Overall Study||6
10496045|NCT01214642|11645921|FG004|NOT COMPLETED|Overall Study||6
10496046|NCT01214642|11645922|FG005|NOT COMPLETED|Overall Study||3
10496047|NCT01214642|11645923|FG006|NOT COMPLETED|Overall Study||6
10496048|NCT01214642|11645924|FG007|NOT COMPLETED|Overall Study||3
10496049|NCT01214642|11645925|FG008|NOT COMPLETED|Overall Study||13
10496050|NCT01214642|11645926|FG009|NOT COMPLETED|Overall Study||4
10496051|NCT01214642|11645927|FG010|NOT COMPLETED|Overall Study||4
10496052|NCT01214642|11645928|FG011|NOT COMPLETED|Overall Study||6
10496053|NCT01214655|11645974|FG000|STARTED|Part A|Total on Schedule A, dose days 1,2,3|10
10496054|NCT01214655|11645975|FG001|STARTED|Part A||0
10496055|NCT01214655|11645976|FG002|STARTED|Part A||0
10496056|NCT01214655|11645974|FG000|Received 2 mg Study Drug|Part A||3
10496057|NCT01214655|11645975|FG001|Received 2 mg Study Drug|Part A||0
10496058|NCT01214655|11645976|FG002|Received 2 mg Study Drug|Part A||0
10496059|NCT01214655|11645974|FG000|Escalated From 2 to 4 mg/m²/Day|Part A||3
10496060|NCT01214655|11645975|FG001|Escalated From 2 to 4 mg/m²/Day|Part A||0
10496061|NCT01214655|11645976|FG002|Escalated From 2 to 4 mg/m²/Day|Part A||0
10496062|NCT01214655|11645974|FG000|Joined 4 mg Group|Part A||1
10496063|NCT01214655|11645975|FG001|Joined 4 mg Group|Part A||0
10496064|NCT01214655|11645976|FG002|Joined 4 mg Group|Part A||0
10496065|NCT01214655|11645974|FG000|Escalated From 4 mg Study Drug|Part A||0
10496066|NCT01214655|11645975|FG001|Escalated From 4 mg Study Drug|Part A||0
10496067|NCT01214655|11645976|FG002|Escalated From 4 mg Study Drug|Part A||0
10496068|NCT01214655|11645974|FG000|Joined 5 mg Study Drug|Part A||2
10496069|NCT01214655|11645975|FG001|Joined 5 mg Study Drug|Part A||0
10496070|NCT01214655|11645976|FG002|Joined 5 mg Study Drug|Part A||0
10496071|NCT01214655|11645974|FG000|Escalated From 5 mg Study Drug|Part A||1
10496072|NCT01214655|11645975|FG001|Escalated From 5 mg Study Drug|Part A||0
10496073|NCT01214655|11645976|FG002|Escalated From 5 mg Study Drug|Part A||0
10496074|NCT01214655|11645974|FG000|Joined 6 mg Group|Part A||4
10496075|NCT01214655|11645975|FG001|Joined 6 mg Group|Part A||0
10496076|NCT01214655|11645976|FG002|Joined 6 mg Group|Part A||0
10496077|NCT01214655|11645974|FG000|Received 6 mg Study Drug|Part A||5
10496078|NCT01214655|11645975|FG001|Received 6 mg Study Drug|Part A||0
10496079|NCT01214655|11645976|FG002|Received 6 mg Study Drug|Part A||0
10496080|NCT01214655|11645974|FG000|COMPLETED|Part A||2
10496081|NCT01214655|11645975|FG001|COMPLETED|Part A||0
10496082|NCT01214655|11645976|FG002|COMPLETED|Part A||0
10496083|NCT01214655|11645974|FG000|NOT COMPLETED|Part A||8
10496084|NCT01214655|11645975|FG001|NOT COMPLETED|Part A||0
10496085|NCT01214655|11645976|FG002|NOT COMPLETED|Part A||0
10496086|NCT01214655|11645974|FG000|STARTED|Part B|Part A participants did not enroll in Part B. Participants in A, B, C are considered Cohorts.|0
10496087|NCT01214655|11645975|FG001|STARTED|Part B|Total on Schedule B, dose days 1,5,9|15
10496088|NCT01214655|11645976|FG002|STARTED|Part B||0
10496089|NCT01214655|11645974|FG000|Received at Least 1 Dose of Study Drug|Part B||0
10496090|NCT01214655|11645975|FG001|Received at Least 1 Dose of Study Drug|Part B||15
10496091|NCT01214655|11645976|FG002|Received at Least 1 Dose of Study Drug|Part B||0
10496092|NCT01214655|11645974|FG000|Recieved 8 mg/m²/Day Study Drug|Part B||0
10496093|NCT01214655|11645975|FG001|Recieved 8 mg/m²/Day Study Drug|Part B||4
10496094|NCT01214655|11645976|FG002|Recieved 8 mg/m²/Day Study Drug|Part B||0
10496095|NCT01214655|11645974|FG000|Escalated From 8 to 10 mg/m²/Day|Part B||0
10496096|NCT01214655|11645975|FG001|Escalated From 8 to 10 mg/m²/Day|Part B||2
10496097|NCT01214655|11645976|FG002|Escalated From 8 to 10 mg/m²/Day|Part B||0
10496098|NCT01214655|11645974|FG000|Joined 10 mg/m²/Day Study D|Part B||0
10496099|NCT01214655|11645975|FG001|Joined 10 mg/m²/Day Study D|Part B||3
10496100|NCT01214655|11645976|FG002|Joined 10 mg/m²/Day Study D|Part B||0
10496101|NCT01214655|11645974|FG000|Escalated to 12 mg/m²/Day|Part B||0
10496102|NCT01214655|11645975|FG001|Escalated to 12 mg/m²/Day|Part B||2
10496103|NCT01214655|11645976|FG002|Escalated to 12 mg/m²/Day|Part B||0
10496104|NCT01214655|11645974|FG000|Joined 12 mg/m²/Day|Part B||0
10496105|NCT01214655|11645975|FG001|Joined 12 mg/m²/Day|Part B||5
10496106|NCT01214655|11645976|FG002|Joined 12 mg/m²/Day|Part B||0
10496107|NCT01214655|11645974|FG000|Escalated From 12 to 14 mg/m²/Day|Part B||0
10496108|NCT01214655|11645975|FG001|Escalated From 12 to 14 mg/m²/Day|Part B||1
10496109|NCT01214655|11645976|FG002|Escalated From 12 to 14 mg/m²/Day|Part B||0
10496110|NCT01214655|11645974|FG000|Joined 14 mg/m²/Day|Part B||0
10496111|NCT01214655|11645975|FG001|Joined 14 mg/m²/Day|Part B||3
10496112|NCT01214655|11645976|FG002|Joined 14 mg/m²/Day|Part B||0
10710444|NCT02649894|11875650|FG000|COMPLETED|Overall Study||37
10496113|NCT01214655|11645974|FG000|COMPLETED|Part B||0
10496114|NCT01214655|11645975|FG001|COMPLETED|Part B||2
10496115|NCT01214655|11645976|FG002|COMPLETED|Part B||0
10496116|NCT01214655|11645974|FG000|NOT COMPLETED|Part B||0
10496117|NCT01214655|11645975|FG001|NOT COMPLETED|Part B||13
10496118|NCT01214655|11645976|FG002|NOT COMPLETED|Part B||0
10496119|NCT01214655|11645974|FG000|STARTED|Part C||0
10496120|NCT01214655|11645975|FG001|STARTED|Part C||0
10496121|NCT01214655|11645976|FG002|STARTED|Part C|Total on Schedule C, dose days 1,2,3|8
10496122|NCT01214655|11645974|FG000|Received at Least 1 Dose of 5 mg/m²/Day|Part C||0
10496123|NCT01214655|11645975|FG001|Received at Least 1 Dose of 5 mg/m²/Day|Part C||0
10496124|NCT01214655|11645976|FG002|Received at Least 1 Dose of 5 mg/m²/Day|Part C||8
10496125|NCT01214655|11645974|FG000|COMPLETED|Part C||0
10496126|NCT01214655|11645975|FG001|COMPLETED|Part C||0
10496127|NCT01214655|11645976|FG002|COMPLETED|Part C||1
10496128|NCT01214655|11645974|FG000|NOT COMPLETED|Part C||0
10496129|NCT01214655|11645975|FG001|NOT COMPLETED|Part C||0
10496130|NCT01214655|11645976|FG002|NOT COMPLETED|Part C||7
10496131|NCT01214668|11646028|FG000|STARTED|Overall Study||4
10496132|NCT01214668|11646029|FG001|STARTED|Overall Study||3
10496133|NCT01214668|11646030|FG002|STARTED|Overall Study||6
10496134|NCT01214668|11646031|FG003|STARTED|Overall Study||6
10496135|NCT01214668|11646032|FG004|STARTED|Overall Study||6
10496136|NCT01214668|11646033|FG005|STARTED|Overall Study||6
10496137|NCT01214668|11646028|FG000|Received at Least One Dose of Study Drug|Overall Study||4
10496138|NCT01214668|11646029|FG001|Received at Least One Dose of Study Drug|Overall Study||3
10496139|NCT01214668|11646030|FG002|Received at Least One Dose of Study Drug|Overall Study||6
10496140|NCT01214668|11646031|FG003|Received at Least One Dose of Study Drug|Overall Study||6
10496141|NCT01214668|11646032|FG004|Received at Least One Dose of Study Drug|Overall Study||6
10496142|NCT01214668|11646033|FG005|Received at Least One Dose of Study Drug|Overall Study||6
10496143|NCT01214668|11646028|FG000|COMPLETED|Overall Study||0
10496144|NCT01214668|11646029|FG001|COMPLETED|Overall Study||0
10496145|NCT01214668|11646030|FG002|COMPLETED|Overall Study||0
10496146|NCT01214668|11646031|FG003|COMPLETED|Overall Study||0
10496147|NCT01214668|11646032|FG004|COMPLETED|Overall Study||0
10496148|NCT01214668|11646033|FG005|COMPLETED|Overall Study||0
10496149|NCT01214668|11646028|FG000|NOT COMPLETED|Overall Study||4
10496150|NCT01214668|11646029|FG001|NOT COMPLETED|Overall Study||3
10496151|NCT01214668|11646030|FG002|NOT COMPLETED|Overall Study||6
10496152|NCT01214668|11646031|FG003|NOT COMPLETED|Overall Study||6
10496153|NCT01214668|11646032|FG004|NOT COMPLETED|Overall Study||6
10496154|NCT01214668|11646033|FG005|NOT COMPLETED|Overall Study||6
10496155|NCT01214720|11646050|FG000|STARTED|Overall Study||306
10496156|NCT01214720|11646051|FG001|STARTED|Overall Study||301
10496157|NCT01214720|11646050|FG000|COMPLETED|Overall Study|Indicates patients who had died at the time of the data cut-off|221
10496158|NCT01214720|11646051|FG001|COMPLETED|Overall Study|Indicates patients who had died at the time of the data cut-off|233
10496159|NCT01214720|11646050|FG000|NOT COMPLETED|Overall Study||85
10496160|NCT01214720|11646051|FG001|NOT COMPLETED|Overall Study||68
10496161|NCT01214759|11646057|FG000|STARTED|Overall Study||103
10496162|NCT01214759|11646057|FG000|28 Days nPEP Completion|Overall Study||85
10496163|NCT01214759|11646057|FG000|COMPLETED|Overall Study||55
10496164|NCT01214759|11646057|FG000|NOT COMPLETED|Overall Study||48
10496165|NCT01214811|11646061|FG000|STARTED|Overall Study||27
10496166|NCT01214811|11646061|FG000|COMPLETED|Overall Study||24
10496167|NCT01214811|11646061|FG000|NOT COMPLETED|Overall Study||3
10496168|NCT01214824|11646065|FG000|STARTED|Overall Study||32
10496169|NCT01214824|11646065|FG000|COMPLETED|Overall Study||29
10496170|NCT01214824|11646065|FG000|NOT COMPLETED|Overall Study||3
10496171|NCT01214837|11646073|FG000|STARTED|Overall Study||249
10496172|NCT01214837|11646074|FG001|STARTED|Overall Study||256
10496173|NCT01214837|11646075|FG002|STARTED|Overall Study||246
10496174|NCT01214837|11646073|FG000|COMPLETED|Overall Study||195
10496175|NCT01214837|11646074|FG001|COMPLETED|Overall Study||192
10496176|NCT01214837|11646075|FG002|COMPLETED|Overall Study||184
10496177|NCT01214837|11646073|FG000|NOT COMPLETED|Overall Study||54
10496178|NCT01214837|11646074|FG001|NOT COMPLETED|Overall Study||64
10496179|NCT01214837|11646075|FG002|NOT COMPLETED|Overall Study||62
10496180|NCT01214850|11646087|FG000|STARTED|Overall Study||979
10496181|NCT01214850|11646088|FG001|STARTED|Overall Study||988
10496182|NCT01214850|11646089|FG002|STARTED|Overall Study||987
10496183|NCT01214850|11646087|FG000|COMPLETED|Overall Study||796
10496184|NCT01214850|11646088|FG001|COMPLETED|Overall Study||844
10496185|NCT01214850|11646089|FG002|COMPLETED|Overall Study||826
10496186|NCT01214850|11646087|FG000|NOT COMPLETED|Overall Study||183
10496187|NCT01214850|11646088|FG001|NOT COMPLETED|Overall Study||144
10496188|NCT01214850|11646089|FG002|NOT COMPLETED|Overall Study||161
10496189|NCT01214915|11646100|FG000|STARTED|Overall Study||53
10496190|NCT01214915|11646100|FG000|COMPLETED|Overall Study||42
10496191|NCT01214915|11646100|FG000|NOT COMPLETED|Overall Study||11
10496192|NCT01214980|11646106|FG000|STARTED|Overall Study||16
10496193|NCT01214980|11646107|FG001|STARTED|Overall Study||16
10496194|NCT01214980|11646106|FG000|COMPLETED|Overall Study||13
10496195|NCT01214980|11646107|FG001|COMPLETED|Overall Study||14
10496196|NCT01214980|11646106|FG000|NOT COMPLETED|Overall Study||3
10496197|NCT01214980|11646107|FG001|NOT COMPLETED|Overall Study||2
10496198|NCT01215032|11646113|FG000|STARTED|Overall Study||21
10496199|NCT01215032|11646113|FG000|COMPLETED|Overall Study||1
10496200|NCT01215032|11646113|FG000|NOT COMPLETED|Overall Study||20
10496201|NCT01215097|11646121|FG000|STARTED|Overall Study|Patients who are randomised and treated with placebo. 1 patient was not treated then not included.|100
10496202|NCT01215097|11646122|FG001|STARTED|Overall Study|Patients who are randomised and treated with linagliptin.|205
10496203|NCT01215097|11646121|FG000|COMPLETED|Overall Study||88
10496204|NCT01215097|11646122|FG001|COMPLETED|Overall Study||191
10496205|NCT01215097|11646121|FG000|NOT COMPLETED|Overall Study||12
10496206|NCT01215097|11646122|FG001|NOT COMPLETED|Overall Study||14
10496207|NCT01215110|11646133|FG000|STARTED|Overall Study||15
10496208|NCT01215110|11646134|FG001|STARTED|Overall Study||15
10496209|NCT01215110|11646135|FG002|STARTED|Overall Study||15
10496210|NCT01215110|11646136|FG003|STARTED|Overall Study||15
10496211|NCT01215110|11646137|FG004|STARTED|Overall Study||8
10496212|NCT01215110|11646133|FG000|COMPLETED|Overall Study||15
10496213|NCT01215110|11646134|FG001|COMPLETED|Overall Study||15
10496214|NCT01215110|11646135|FG002|COMPLETED|Overall Study||13
10496215|NCT01215110|11646136|FG003|COMPLETED|Overall Study||14
10496216|NCT01215110|11646137|FG004|COMPLETED|Overall Study||8
10496217|NCT01215110|11646133|FG000|NOT COMPLETED|Overall Study||0
10496218|NCT01215110|11646134|FG001|NOT COMPLETED|Overall Study||0
10496219|NCT01215110|11646135|FG002|NOT COMPLETED|Overall Study||2
10496220|NCT01215110|11646136|FG003|NOT COMPLETED|Overall Study||1
10496221|NCT01215110|11646137|FG004|NOT COMPLETED|Overall Study||0
10496222|NCT01215123|11646153|FG000|STARTED|Overall Study||28
10496223|NCT01215123|11646153|FG000|COMPLETED|Overall Study||28
10496224|NCT01215123|11646153|FG000|NOT COMPLETED|Overall Study||0
10496225|NCT01215175|11646162|FG000|STARTED|Overall Study||30
10496226|NCT01215175|11646163|FG001|STARTED|Overall Study||30
10496227|NCT01215175|11646164|FG002|STARTED|Overall Study||33
10496228|NCT01215175|11646165|FG003|STARTED|Overall Study||29
10496229|NCT01215175|11646166|FG004|STARTED|Overall Study||28
10496230|NCT01215175|11646162|FG000|Treated|Overall Study||30
10496231|NCT01215175|11646163|FG001|Treated|Overall Study||30
10496232|NCT01215175|11646164|FG002|Treated|Overall Study||33
10496233|NCT01215175|11646165|FG003|Treated|Overall Study||29
10496234|NCT01215175|11646166|FG004|Treated|Overall Study||28
10496235|NCT01215175|11646162|FG000|COMPLETED|Overall Study||30
10496236|NCT01215175|11646163|FG001|COMPLETED|Overall Study||29
10496237|NCT01215175|11646164|FG002|COMPLETED|Overall Study||33
10496238|NCT01215175|11646165|FG003|COMPLETED|Overall Study||28
10496239|NCT01215175|11646166|FG004|COMPLETED|Overall Study||28
10496240|NCT01215175|11646162|FG000|NOT COMPLETED|Overall Study||0
10496241|NCT01215175|11646163|FG001|NOT COMPLETED|Overall Study||1
10496242|NCT01215175|11646164|FG002|NOT COMPLETED|Overall Study||0
10496243|NCT01215175|11646165|FG003|NOT COMPLETED|Overall Study||1
10496244|NCT01215175|11646166|FG004|NOT COMPLETED|Overall Study||0
10496245|NCT01215188|11646181|FG000|STARTED|Overall Study||378
10496246|NCT01215188|11646182|FG001|STARTED|Overall Study||386
10496247|NCT01215188|11646183|FG002|STARTED|Overall Study||378
10496248|NCT01215188|11646181|FG000|COMPLETED|Overall Study||320
10496249|NCT01215188|11646182|FG001|COMPLETED|Overall Study||327
10496250|NCT01215188|11646183|FG002|COMPLETED|Overall Study||326
10496251|NCT01215188|11646181|FG000|NOT COMPLETED|Overall Study||58
10496252|NCT01215188|11646182|FG001|NOT COMPLETED|Overall Study||59
10496253|NCT01215188|11646183|FG002|NOT COMPLETED|Overall Study||52
10496254|NCT01215227|11646197|FG000|STARTED|Overall Study||218
10496255|NCT01215227|11646198|FG001|STARTED|Overall Study||215
10496256|NCT01215227|11646199|FG002|STARTED|Overall Study||107
10496257|NCT01215227|11646200|FG003|STARTED|Overall Study||97
10496258|NCT01215227|11646201|FG004|STARTED|Overall Study||93
10496259|NCT01215227|11646202|FG005|STARTED|Overall Study||109
10496260|NCT01215227|11646197|FG000|Treated|Overall Study||218
10496261|NCT01215227|11646198|FG001|Treated|Overall Study||215
10496262|NCT01215227|11646199|FG002|Treated|Overall Study||106
10496263|NCT01215227|11646200|FG003|Treated|Overall Study||96
10496264|NCT01215227|11646201|FG004|Treated|Overall Study||93
10496265|NCT01215227|11646202|FG005|Treated|Overall Study||108
10496266|NCT01215227|11646197|FG000|COMPLETED|Overall Study||97
10496267|NCT01215227|11646198|FG001|COMPLETED|Overall Study||96
10496268|NCT01215227|11646199|FG002|COMPLETED|Overall Study||50
10496269|NCT01215227|11646200|FG003|COMPLETED|Overall Study||48
10496270|NCT01215227|11646201|FG004|COMPLETED|Overall Study||45
10496271|NCT01215227|11646202|FG005|COMPLETED|Overall Study||51
10496272|NCT01215227|11646197|FG000|NOT COMPLETED|Overall Study||121
10496273|NCT01215227|11646198|FG001|NOT COMPLETED|Overall Study||119
10496274|NCT01215227|11646199|FG002|NOT COMPLETED|Overall Study||57
10496275|NCT01215227|11646200|FG003|NOT COMPLETED|Overall Study||49
10496276|NCT01215227|11646201|FG004|NOT COMPLETED|Overall Study||48
10496277|NCT01215227|11646202|FG005|NOT COMPLETED|Overall Study||58
10496278|NCT01215240|11646218|FG000|STARTED|Overall Study||10
10496279|NCT01215240|11646219|FG001|STARTED|Overall Study||12
10496280|NCT01215240|11646218|FG000|COMPLETED|Overall Study||10
10496281|NCT01215240|11646219|FG001|COMPLETED|Overall Study||12
10496282|NCT01215240|11646218|FG000|NOT COMPLETED|Overall Study||0
10496283|NCT01215240|11646219|FG001|NOT COMPLETED|Overall Study||0
10496284|NCT01215253|11646227|FG000|STARTED|Overall Study||510
10496285|NCT01215253|11646228|FG001|STARTED|Overall Study||502
10496286|NCT01215253|11646227|FG000|COMPLETED|Overall Study||424
10496287|NCT01215253|11646228|FG001|COMPLETED|Overall Study||439
10496288|NCT01215253|11646227|FG000|NOT COMPLETED|Overall Study||86
10496289|NCT01215253|11646228|FG001|NOT COMPLETED|Overall Study||63
10496290|NCT01215279|11646237|FG000|STARTED|Overall Study||31
10496291|NCT01215279|11646238|FG001|STARTED|Overall Study||32
10496292|NCT01215279|11646237|FG000|COMPLETED|Overall Study||31
10496293|NCT01215279|11646238|FG001|COMPLETED|Overall Study||32
10496294|NCT01215279|11646237|FG000|NOT COMPLETED|Overall Study||0
10496295|NCT01215279|11646238|FG001|NOT COMPLETED|Overall Study||0
10496296|NCT01215292|11646249|FG000|STARTED|Overall Study||8
10496297|NCT01215292|11646250|FG001|STARTED|Overall Study||8
10496298|NCT01215292|11646251|FG002|STARTED|Overall Study||8
10496299|NCT01215292|11646252|FG003|STARTED|Overall Study||8
10496300|NCT01215292|11646253|FG004|STARTED|Overall Study||8
10496301|NCT01215292|11646249|FG000|COMPLETED|Overall Study||8
10496302|NCT01215292|11646250|FG001|COMPLETED|Overall Study||8
10496303|NCT01215292|11646251|FG002|COMPLETED|Overall Study||8
10496304|NCT01215292|11646252|FG003|COMPLETED|Overall Study||8
10496305|NCT01215292|11646253|FG004|COMPLETED|Overall Study||8
10496306|NCT01215292|11646249|FG000|NOT COMPLETED|Overall Study||0
10496307|NCT01215292|11646250|FG001|NOT COMPLETED|Overall Study||0
10496308|NCT01215292|11646251|FG002|NOT COMPLETED|Overall Study||0
10496309|NCT01215292|11646252|FG003|NOT COMPLETED|Overall Study||0
10496310|NCT01215292|11646253|FG004|NOT COMPLETED|Overall Study||0
10496311|NCT01215318|11646275|FG000|STARTED|Overall Study||20
10496312|NCT01215318|11646276|FG001|STARTED|Overall Study||24
10496313|NCT01215318|11646275|FG000|COMPLETED|Overall Study||20
10496314|NCT01215318|11646276|FG001|COMPLETED|Overall Study||24
10496315|NCT01215318|11646275|FG000|NOT COMPLETED|Overall Study||0
10496316|NCT01215318|11646276|FG001|NOT COMPLETED|Overall Study||0
10496317|NCT01215344|11646286|FG000|STARTED|Overall Study||33
10496318|NCT01215344|11646287|FG001|STARTED|Overall Study||3
10496319|NCT01215344|11646286|FG000|COMPLETED|Overall Study||23
10496320|NCT01215344|11646287|FG001|COMPLETED|Overall Study||3
10496321|NCT01215344|11646286|FG000|NOT COMPLETED|Overall Study||10
10496322|NCT01215344|11646287|FG001|NOT COMPLETED|Overall Study||0
10496323|NCT01215357|11646295|FG000|STARTED|Overall Study||34
10496324|NCT01215357|11646295|FG000|COMPLETED|Overall Study||22
10496325|NCT01215357|11646295|FG000|NOT COMPLETED|Overall Study||12
10496326|NCT01215422|11646303|FG000|STARTED|Overall Study||14
10496327|NCT01215422|11646304|FG001|STARTED|Overall Study||249
10496328|NCT01215422|11646305|FG002|STARTED|Overall Study||196
10496329|NCT01215422|11646306|FG003|STARTED|Overall Study||201
10496330|NCT01215422|11646303|FG000|COMPLETED|Overall Study||6
10496331|NCT01215422|11646304|FG001|COMPLETED|Overall Study||249
10496332|NCT01215422|11646305|FG002|COMPLETED|Overall Study||193
10496333|NCT01215422|11646306|FG003|COMPLETED|Overall Study||193
10496334|NCT01215422|11646303|FG000|NOT COMPLETED|Overall Study||8
10496335|NCT01215422|11646304|FG001|NOT COMPLETED|Overall Study||0
10496336|NCT01215422|11646305|FG002|NOT COMPLETED|Overall Study||3
10496337|NCT01215422|11646306|FG003|NOT COMPLETED|Overall Study||8
10496338|NCT01215435|11646330|FG000|STARTED|Overall Study||122
10496339|NCT01215435|11646331|FG001|STARTED|Overall Study||123
10496340|NCT01215435|11646330|FG000|COMPLETED|Overall Study||103
10496341|NCT01215435|11646331|FG001|COMPLETED|Overall Study||107
10496342|NCT01215435|11646330|FG000|NOT COMPLETED|Overall Study||19
10496343|NCT01215435|11646331|FG001|NOT COMPLETED|Overall Study||16
10496344|NCT01215513|11646337|FG000|STARTED|Overall Study|157 participants were allocated to treatment in CS42 main study (Intent-to-treat analysis set)|157
10496345|NCT01215513|11646337|FG000|CS42 and CS42A Safety Analysis Set|Overall Study|156 participants received at least 1 dose of degarelix|156
10496346|NCT01215513|11646337|FG000|CS42 and CS42A Full Analysis Set|Overall Study|155 participants received at least 1 dose of degarelix and had at least 1 efficacy assessment|155
10496347|NCT01215513|11646337|FG000|CS42A Safety Analysis Set|Overall Study|127 participants were enrolled in the extension study CS42A|127
10496348|NCT01215513|11646337|FG000|COMPLETED|Overall Study||112
10496349|NCT01215513|11646337|FG000|NOT COMPLETED|Overall Study||45
10496350|NCT01215643|11646347|FG000|STARTED|Overall Study||83
10496351|NCT01215643|11646348|FG001|STARTED|Overall Study||84
10496352|NCT01215643|11646349|FG002|STARTED|Overall Study||94
10496353|NCT01215643|11646350|FG003|STARTED|Overall Study||39
10496354|NCT01215643|11646351|FG004|STARTED|Overall Study||40
10496355|NCT01215643|11646347|FG000|COMPLETED|Overall Study||74
10496356|NCT01215643|11646348|FG001|COMPLETED|Overall Study||80
10496357|NCT01215643|11646349|FG002|COMPLETED|Overall Study||82
10496358|NCT01215643|11646350|FG003|COMPLETED|Overall Study||35
10496359|NCT01215643|11646351|FG004|COMPLETED|Overall Study||29
10496360|NCT01215643|11646347|FG000|NOT COMPLETED|Overall Study||9
10496361|NCT01215643|11646348|FG001|NOT COMPLETED|Overall Study||4
10496362|NCT01215643|11646349|FG002|NOT COMPLETED|Overall Study||12
10496363|NCT01215643|11646350|FG003|NOT COMPLETED|Overall Study||4
10496364|NCT01215643|11646351|FG004|NOT COMPLETED|Overall Study||11
10496365|NCT01215695|11646370|FG000|STARTED|Overall Study||70
10496366|NCT01215695|11646371|FG001|STARTED|Overall Study||70
10496367|NCT01215695|11646370|FG000|COMPLETED|Overall Study||70
10496368|NCT01215695|11646371|FG001|COMPLETED|Overall Study||70
10496369|NCT01215695|11646370|FG000|NOT COMPLETED|Overall Study||0
10710445|NCT02649894|11875651|FG001|COMPLETED|Overall Study||27
10710446|NCT02649894|11875650|FG000|NOT COMPLETED|Overall Study||44
10710447|NCT02649894|11875651|FG001|NOT COMPLETED|Overall Study||11
10710448|NCT02650128|11875657|FG000|STARTED|Overall Study||60
10710449|NCT02650128|11875657|FG000|30 Day Primary and Safety Endpoint|Overall Study||60
10710450|NCT02650128|11875657|FG000|COMPLETED|Overall Study||58
10710451|NCT02650128|11875657|FG000|NOT COMPLETED|Overall Study||2
10496370|NCT01215695|11646371|FG001|NOT COMPLETED|Overall Study||0
10496371|NCT01215721|11646377|FG000|STARTED|Overall Study||40
10496372|NCT01215721|11646377|FG000|COMPLETED|Overall Study||38
10496373|NCT01215721|11646377|FG000|NOT COMPLETED|Overall Study||2
10496374|NCT01215734|11646383|FG000|STARTED|Overall Study||29
10496375|NCT01215734|11646384|FG001|STARTED|Overall Study||15
10496376|NCT01215734|11646383|FG000|COMPLETED|Overall Study||29
10496377|NCT01215734|11646384|FG001|COMPLETED|Overall Study||14
10496378|NCT01215734|11646383|FG000|NOT COMPLETED|Overall Study||0
10496379|NCT01215734|11646384|FG001|NOT COMPLETED|Overall Study||1
10496380|NCT01215786|11646393|FG000|STARTED|Overall Study||21
10496381|NCT01215786|11646394|FG001|STARTED|Overall Study||19
10496382|NCT01215786|11646395|FG002|STARTED|Overall Study||10
10496383|NCT01215786|11646393|FG000|COMPLETED|Overall Study||21
10496384|NCT01215786|11646394|FG001|COMPLETED|Overall Study||19
10496385|NCT01215786|11646395|FG002|COMPLETED|Overall Study||10
10496386|NCT01215786|11646393|FG000|NOT COMPLETED|Overall Study||0
10496387|NCT01215786|11646394|FG001|NOT COMPLETED|Overall Study||0
10496388|NCT01215786|11646395|FG002|NOT COMPLETED|Overall Study||0
10496389|NCT01215851|11646409|FG000|STARTED|Treatment Period||15
10710452|NCT02650193|11875665|FG000|STARTED|Overall Study||6
10710453|NCT02650193|11875666|FG001|STARTED|Overall Study||6
10710454|NCT02650193|11875667|FG002|STARTED|Overall Study||13
10710455|NCT02650193|11875665|FG000|COMPLETED|Overall Study||6
10710456|NCT02650193|11875666|FG001|COMPLETED|Overall Study||6
10496390|NCT01215851|11646410|FG001|STARTED|Treatment Period||15
10496391|NCT01215851|11646411|FG002|STARTED|Treatment Period||15
10496392|NCT01215851|11646412|FG003|STARTED|Treatment Period||15
10496393|NCT01215851|11646413|FG004|STARTED|Treatment Period||10
10496394|NCT01215851|11646414|FG005|STARTED|Treatment Period||15
10496395|NCT01215851|11646409|FG000|COMPLETED|Treatment Period||14
10496396|NCT01215851|11646410|FG001|COMPLETED|Treatment Period||14
10496397|NCT01215851|11646411|FG002|COMPLETED|Treatment Period||14
10496398|NCT01215851|11646412|FG003|COMPLETED|Treatment Period||12
10496399|NCT01215851|11646413|FG004|COMPLETED|Treatment Period||10
10496400|NCT01215851|11646414|FG005|COMPLETED|Treatment Period||14
10496401|NCT01215851|11646409|FG000|NOT COMPLETED|Treatment Period||1
10496402|NCT01215851|11646410|FG001|NOT COMPLETED|Treatment Period||1
10496403|NCT01215851|11646411|FG002|NOT COMPLETED|Treatment Period||1
10496404|NCT01215851|11646412|FG003|NOT COMPLETED|Treatment Period||3
10496405|NCT01215851|11646413|FG004|NOT COMPLETED|Treatment Period||0
10496406|NCT01215851|11646414|FG005|NOT COMPLETED|Treatment Period||1
10496407|NCT01215851|11646409|FG000|STARTED|Follow up Period||14
10496408|NCT01215851|11646410|FG001|STARTED|Follow up Period||14
10496409|NCT01215851|11646411|FG002|STARTED|Follow up Period||14
10496410|NCT01215851|11646412|FG003|STARTED|Follow up Period||12
10496411|NCT01215851|11646413|FG004|STARTED|Follow up Period||10
10496412|NCT01215851|11646414|FG005|STARTED|Follow up Period||14
10496413|NCT01215851|11646409|FG000|COMPLETED|Follow up Period||14
10496414|NCT01215851|11646410|FG001|COMPLETED|Follow up Period||14
10496415|NCT01215851|11646411|FG002|COMPLETED|Follow up Period||14
10496416|NCT01215851|11646412|FG003|COMPLETED|Follow up Period||12
10496417|NCT01215851|11646413|FG004|COMPLETED|Follow up Period||10
10496418|NCT01215851|11646414|FG005|COMPLETED|Follow up Period||13
10496419|NCT01215851|11646409|FG000|NOT COMPLETED|Follow up Period||0
10496420|NCT01215851|11646410|FG001|NOT COMPLETED|Follow up Period||0
10496421|NCT01215851|11646411|FG002|NOT COMPLETED|Follow up Period||0
10496422|NCT01215851|11646412|FG003|NOT COMPLETED|Follow up Period||0
10496423|NCT01215851|11646413|FG004|NOT COMPLETED|Follow up Period||0
10496424|NCT01215851|11646414|FG005|NOT COMPLETED|Follow up Period||1
10496425|NCT01215916|11646438|FG000|STARTED|Overall Study||1
10496426|NCT01215916|11646439|FG001|STARTED|Overall Study||5
10496427|NCT01215916|11646440|FG002|STARTED|Overall Study||3
10496428|NCT01215916|11646441|FG003|STARTED|Overall Study||6
10496429|NCT01215916|11646442|FG004|STARTED|Overall Study||6
10496430|NCT01215916|11646443|FG005|STARTED|Overall Study||4
10496431|NCT01215916|11646444|FG006|STARTED|Overall Study||9
10496432|NCT01215916|11646445|FG007|STARTED|Overall Study||3
10496433|NCT01215916|11646446|FG008|STARTED|Overall Study||2
10496434|NCT01215916|11646438|FG000|Received at Least 1 Dose of Either Drug|Overall Study||1
10496435|NCT01215916|11646439|FG001|Received at Least 1 Dose of Either Drug|Overall Study||5
10496436|NCT01215916|11646440|FG002|Received at Least 1 Dose of Either Drug|Overall Study||3
10496437|NCT01215916|11646441|FG003|Received at Least 1 Dose of Either Drug|Overall Study||6
10496438|NCT01215916|11646442|FG004|Received at Least 1 Dose of Either Drug|Overall Study||6
10496439|NCT01215916|11646443|FG005|Received at Least 1 Dose of Either Drug|Overall Study||4
10496440|NCT01215916|11646444|FG006|Received at Least 1 Dose of Either Drug|Overall Study||9
10496441|NCT01215916|11646445|FG007|Received at Least 1 Dose of Either Drug|Overall Study||3
10496442|NCT01215916|11646446|FG008|Received at Least 1 Dose of Either Drug|Overall Study||2
10496443|NCT01215916|11646438|FG000|COMPLETED|Overall Study||0
10496444|NCT01215916|11646439|FG001|COMPLETED|Overall Study||0
10496445|NCT01215916|11646440|FG002|COMPLETED|Overall Study||0
10496446|NCT01215916|11646441|FG003|COMPLETED|Overall Study||0
10496447|NCT01215916|11646442|FG004|COMPLETED|Overall Study||0
10496448|NCT01215916|11646443|FG005|COMPLETED|Overall Study||0
10496449|NCT01215916|11646444|FG006|COMPLETED|Overall Study||0
10496450|NCT01215916|11646445|FG007|COMPLETED|Overall Study||0
10496451|NCT01215916|11646446|FG008|COMPLETED|Overall Study||0
10496452|NCT01215916|11646438|FG000|NOT COMPLETED|Overall Study||1
10496453|NCT01215916|11646439|FG001|NOT COMPLETED|Overall Study||5
10496454|NCT01215916|11646440|FG002|NOT COMPLETED|Overall Study||3
10496455|NCT01215916|11646441|FG003|NOT COMPLETED|Overall Study||6
10496456|NCT01215916|11646442|FG004|NOT COMPLETED|Overall Study||6
10496457|NCT01215916|11646443|FG005|NOT COMPLETED|Overall Study||4
10496458|NCT01215916|11646444|FG006|NOT COMPLETED|Overall Study||9
10496459|NCT01215916|11646445|FG007|NOT COMPLETED|Overall Study||3
10496460|NCT01215916|11646446|FG008|NOT COMPLETED|Overall Study||2
10496461|NCT01215929|11646472|FG000|STARTED|Overall Study||18
10496462|NCT01215929|11646473|FG001|STARTED|Overall Study||17
10496463|NCT01215929|11646472|FG000|COMPLETED|Overall Study||12
10496464|NCT01215929|11646473|FG001|COMPLETED|Overall Study||12
10496465|NCT01215929|11646472|FG000|NOT COMPLETED|Overall Study||6
10496466|NCT01215929|11646473|FG001|NOT COMPLETED|Overall Study||5
10496467|NCT01215942|11646481|FG000|STARTED|Treatment Period|Participants who discontinued treatment were followed in post-treatment follow-up.|414
10496468|NCT01215942|11646482|FG001|STARTED|Treatment Period|Participants who discontinued treatment were followed in post-treatment follow-up.|672
10496469|NCT01215942|11646481|FG000|COMPLETED|Treatment Period||0
10496470|NCT01215942|11646482|FG001|COMPLETED|Treatment Period||0
10496471|NCT01215942|11646481|FG000|NOT COMPLETED|Treatment Period||414
10496472|NCT01215942|11646482|FG001|NOT COMPLETED|Treatment Period||672
10496473|NCT01215942|11646481|FG000|STARTED|Post-Treatment Follow-Up Period|Not all participants who discontinued treatment entered post-treatment follow-up period.|368
10496474|NCT01215942|11646482|FG001|STARTED|Post-Treatment Follow-Up Period|Not all participants who discontinued treatment entered post-treatment follow-up period.|591
10496475|NCT01215942|11646481|FG000|COMPLETED|Post-Treatment Follow-Up Period||283
10496476|NCT01215942|11646482|FG001|COMPLETED|Post-Treatment Follow-Up Period||445
10496477|NCT01215942|11646481|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||85
10496478|NCT01215942|11646482|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||146
10496479|NCT01215955|11646503|FG000|STARTED|Overall Study||268
10496480|NCT01215955|11646504|FG001|STARTED|Overall Study||263
10496481|NCT01215955|11646505|FG002|STARTED|Overall Study|Three (3) participants from 1 site were excluded due to quality issues and validity of data.|292
10496482|NCT01215955|11646506|FG003|STARTED|Overall Study|Two (2) participants from 1 site were excluded due to quality issues and validity of the data.|294
10496483|NCT01215955|11646503|FG000|Received at Least 1 Dose of Study Drug|Overall Study||267
10496484|NCT01215955|11646504|FG001|Received at Least 1 Dose of Study Drug|Overall Study||261
10496485|NCT01215955|11646505|FG002|Received at Least 1 Dose of Study Drug|Overall Study||288
10496486|NCT01215955|11646506|FG003|Received at Least 1 Dose of Study Drug|Overall Study||290
10496487|NCT01215955|11646503|FG000|COMPLETED|Overall Study||223
10496488|NCT01215955|11646504|FG001|COMPLETED|Overall Study||210
10496489|NCT01215955|11646505|FG002|COMPLETED|Overall Study||244
10496490|NCT01215955|11646506|FG003|COMPLETED|Overall Study||241
10496491|NCT01215955|11646503|FG000|NOT COMPLETED|Overall Study||45
10496492|NCT01215955|11646504|FG001|NOT COMPLETED|Overall Study||53
10496493|NCT01215955|11646505|FG002|NOT COMPLETED|Overall Study||48
10496494|NCT01215955|11646506|FG003|NOT COMPLETED|Overall Study||53
10496495|NCT01215968|11646521|FG000|STARTED|Overall Study||13
10496496|NCT01215968|11646522|FG001|STARTED|Overall Study||25
10496497|NCT01215968|11646521|FG000|Received at Least 1 Dose of Study Drug|Overall Study||13
10496498|NCT01215968|11646522|FG001|Received at Least 1 Dose of Study Drug|Overall Study|25 participants received placebo during Week 1.|24
10496499|NCT01215968|11646521|FG000|COMPLETED|Overall Study||11
10496500|NCT01215968|11646522|FG001|COMPLETED|Overall Study||18
10496501|NCT01215968|11646521|FG000|NOT COMPLETED|Overall Study||2
10496502|NCT01215968|11646522|FG001|NOT COMPLETED|Overall Study||7
10496503|NCT01215981|11646533|FG000|STARTED|Overall Study||35
10496504|NCT01215981|11646534|FG001|STARTED|Overall Study||33
10496505|NCT01215981|11646533|FG000|COMPLETED|Overall Study||33
10496506|NCT01215981|11646534|FG001|COMPLETED|Overall Study||32
10496507|NCT01215981|11646533|FG000|NOT COMPLETED|Overall Study||2
10496508|NCT01215981|11646534|FG001|NOT COMPLETED|Overall Study||1
10496509|NCT01216072|11646542|FG000|STARTED|Open-Label Core Period ( 6 Months)||790
10496510|NCT01216072|11646543|FG001|STARTED|Open-Label Core Period ( 6 Months)||263
10496511|NCT01216072|11646542|FG000|Full Analysis Set|Open-Label Core Period ( 6 Months)|One patient was randomized in error and was not included in FAS.|789
10496512|NCT01216072|11646543|FG001|Full Analysis Set|Open-Label Core Period ( 6 Months)||263
10496513|NCT01216072|11646542|FG000|Safety Set|Open-Label Core Period ( 6 Months)||783
10496514|NCT01216072|11646543|FG001|Safety Set|Open-Label Core Period ( 6 Months)||245
10496515|NCT01216072|11646542|FG000|COMPLETED|Open-Label Core Period ( 6 Months)||714
10496516|NCT01216072|11646543|FG001|COMPLETED|Open-Label Core Period ( 6 Months)||229
10496517|NCT01216072|11646542|FG000|NOT COMPLETED|Open-Label Core Period ( 6 Months)||76
10496518|NCT01216072|11646543|FG001|NOT COMPLETED|Open-Label Core Period ( 6 Months)||34
10496519|NCT01216072|11646542|FG000|STARTED|Open-Label Extension Period (3 Months)||0
10496520|NCT01216072|11646543|FG001|STARTED|Open-Label Extension Period (3 Months)|Only DMT patients, who completed the core study, were eligible for fingolimod.|195
10496521|NCT01216072|11646542|FG000|Safety Set|Open-Label Extension Period (3 Months)||0
10496522|NCT01216072|11646543|FG001|Safety Set|Open-Label Extension Period (3 Months)||193
10496523|NCT01216072|11646542|FG000|COMPLETED|Open-Label Extension Period (3 Months)||0
10496524|NCT01216072|11646543|FG001|COMPLETED|Open-Label Extension Period (3 Months)||181
10496525|NCT01216072|11646542|FG000|NOT COMPLETED|Open-Label Extension Period (3 Months)||0
10496526|NCT01216072|11646543|FG001|NOT COMPLETED|Open-Label Extension Period (3 Months)||14
10496527|NCT01216163|11646555|FG000|STARTED|Overall Study||45
10496528|NCT01216163|11646556|FG001|STARTED|Overall Study||88
10496529|NCT01216163|11646557|FG002|STARTED|Overall Study||85
10496530|NCT01216163|11646555|FG000|COMPLETED|Overall Study||44
10496531|NCT01216163|11646556|FG001|COMPLETED|Overall Study||87
10496532|NCT01216163|11646557|FG002|COMPLETED|Overall Study||85
10496533|NCT01216163|11646555|FG000|NOT COMPLETED|Overall Study||1
10496534|NCT01216163|11646556|FG001|NOT COMPLETED|Overall Study||1
10496535|NCT01216163|11646557|FG002|NOT COMPLETED|Overall Study||0
10496536|NCT01216176|11646568|FG000|STARTED|Overall Study||12
10496537|NCT01216176|11646569|FG001|STARTED|Overall Study||39
10496538|NCT01216176|11646570|FG002|STARTED|Overall Study||20
10496539|NCT01216176|11646568|FG000|COMPLETED|Overall Study||12
10496540|NCT01216176|11646569|FG001|COMPLETED|Overall Study||31
10496541|NCT01216176|11646570|FG002|COMPLETED|Overall Study||19
10496542|NCT01216176|11646568|FG000|NOT COMPLETED|Overall Study||0
10496543|NCT01216176|11646569|FG001|NOT COMPLETED|Overall Study||8
10496544|NCT01216176|11646570|FG002|NOT COMPLETED|Overall Study||1
10496545|NCT01216189|11646581|FG000|STARTED|Overall Study||110
10496546|NCT01216189|11646582|FG001|STARTED|Overall Study||32
10496547|NCT01216189|11646581|FG000|COMPLETED|Overall Study||85
10496548|NCT01216189|11646582|FG001|COMPLETED|Overall Study||27
10496549|NCT01216189|11646581|FG000|NOT COMPLETED|Overall Study||25
10496550|NCT01216189|11646582|FG001|NOT COMPLETED|Overall Study||5
10496551|NCT01216202|11646590|FG000|STARTED|Overall Study||101
10496552|NCT01216202|11646591|FG001|STARTED|Overall Study||77
10496553|NCT01216202|11646590|FG000|Analysed at Baseline|Overall Study||93
10496554|NCT01216202|11646591|FG001|Analysed at Baseline|Overall Study||75
10496555|NCT01216202|11646590|FG000|Analysed After RT|Overall Study||79
10496556|NCT01216202|11646591|FG001|Analysed After RT|Overall Study||0
10496557|NCT01216202|11646590|FG000|COMPLETED|Overall Study||79
10496558|NCT01216202|11646591|FG001|COMPLETED|Overall Study||75
10496559|NCT01216202|11646590|FG000|NOT COMPLETED|Overall Study||22
10710457|NCT02650193|11875667|FG002|COMPLETED|Overall Study||13
10710458|NCT02650193|11875665|FG000|NOT COMPLETED|Overall Study||0
10710459|NCT02650193|11875666|FG001|NOT COMPLETED|Overall Study||0
10710460|NCT02650193|11875667|FG002|NOT COMPLETED|Overall Study||0
10710461|NCT02650219|11875678|FG000|STARTED|Overall Study||40
10710462|NCT02650219|11875679|FG001|STARTED|Overall Study||20
10496560|NCT01216202|11646591|FG001|NOT COMPLETED|Overall Study||2
10496561|NCT01216241|11646601|FG000|STARTED|Overall Study|18 subjects randomized. All didn't receive study drug/placebo if they didn't have neutropenic fever|18
10496562|NCT01216241|11646602|FG001|STARTED|Overall Study|18 subjects randomized. All didn't receive study drug/placebo if they didn't have neutropenic fever|18
10496563|NCT01216241|11646601|FG000|COMPLETED|Overall Study|Reporter remains blinded so the 4 completed could have been either study drug or placebo.|18
10496564|NCT01216241|11646602|FG001|COMPLETED|Overall Study|Reporter remains blinded so the 4 completed could have been either study drug or placebo.|18
10496565|NCT01216241|11646601|FG000|NOT COMPLETED|Overall Study||0
10496566|NCT01216241|11646602|FG001|NOT COMPLETED|Overall Study||0
10496567|NCT01216319|11646608|FG000|STARTED|Overall Study||50
10496568|NCT01216319|11646608|FG000|COMPLETED|Overall Study||46
10496569|NCT01216319|11646608|FG000|NOT COMPLETED|Overall Study||4
10496570|NCT01216332|11646614|FG000|STARTED|Overall Study||34
10496571|NCT01216332|11646615|FG001|STARTED|Overall Study||16
10496572|NCT01216332|11646614|FG000|COMPLETED|Overall Study||30
10496573|NCT01216332|11646615|FG001|COMPLETED|Overall Study||16
10496574|NCT01216332|11646614|FG000|NOT COMPLETED|Overall Study||4
10496575|NCT01216332|11646615|FG001|NOT COMPLETED|Overall Study||0
10496576|NCT01216397|11646621|FG000|STARTED|Period 1||20
10496577|NCT01216397|11646622|FG001|STARTED|Period 1||20
10496578|NCT01216397|11646621|FG000|COMPLETED|Period 1||20
10496579|NCT01216397|11646622|FG001|COMPLETED|Period 1||20
10496580|NCT01216397|11646621|FG000|NOT COMPLETED|Period 1||0
10496581|NCT01216397|11646622|FG001|NOT COMPLETED|Period 1||0
10496582|NCT01216397|11646621|FG000|STARTED|Washout (35 Days)||20
10496583|NCT01216397|11646622|FG001|STARTED|Washout (35 Days)||20
10496584|NCT01216397|11646621|FG000|COMPLETED|Washout (35 Days)||20
10496585|NCT01216397|11646622|FG001|COMPLETED|Washout (35 Days)||20
10496586|NCT01216397|11646621|FG000|NOT COMPLETED|Washout (35 Days)||0
10496587|NCT01216397|11646622|FG001|NOT COMPLETED|Washout (35 Days)||0
10496588|NCT01216397|11646621|FG000|STARTED|Period 2||20
10496589|NCT01216397|11646622|FG001|STARTED|Period 2||20
10496590|NCT01216397|11646621|FG000|COMPLETED|Period 2||20
10496591|NCT01216397|11646622|FG001|COMPLETED|Period 2||20
10496592|NCT01216397|11646621|FG000|NOT COMPLETED|Period 2||0
10496593|NCT01216397|11646622|FG001|NOT COMPLETED|Period 2||0
10496594|NCT01216410|11646631|FG000|STARTED|Overall Study||103
10496595|NCT01216410|11646632|FG001|STARTED|Overall Study||100
10496596|NCT01216410|11646633|FG002|STARTED|Overall Study||103
10496597|NCT01216410|11646631|FG000|COMPLETED|Overall Study||101
10496598|NCT01216410|11646632|FG001|COMPLETED|Overall Study||99
10496599|NCT01216410|11646633|FG002|COMPLETED|Overall Study||100
10496600|NCT01216410|11646631|FG000|NOT COMPLETED|Overall Study||2
10496601|NCT01216410|11646632|FG001|NOT COMPLETED|Overall Study||1
10496602|NCT01216410|11646633|FG002|NOT COMPLETED|Overall Study||3
10496603|NCT01216735|11646643|FG000|STARTED|First Intervention (3 Weeks)||8
10496604|NCT01216735|11646644|FG001|STARTED|First Intervention (3 Weeks)||7
10710463|NCT02650219|11875678|FG000|COMPLETED|Overall Study||40
10496605|NCT01216735|11646643|FG000|COMPLETED|First Intervention (3 Weeks)||8
10496606|NCT01216735|11646644|FG001|COMPLETED|First Intervention (3 Weeks)||7
10496607|NCT01216735|11646643|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0
10496608|NCT01216735|11646644|FG001|NOT COMPLETED|First Intervention (3 Weeks)||0
10496609|NCT01216735|11646643|FG000|STARTED|Washout (3 Weeks)||8
10496610|NCT01216735|11646644|FG001|STARTED|Washout (3 Weeks)||7
10496611|NCT01216735|11646643|FG000|COMPLETED|Washout (3 Weeks)||8
10496612|NCT01216735|11646644|FG001|COMPLETED|Washout (3 Weeks)||7
10496613|NCT01216735|11646643|FG000|NOT COMPLETED|Washout (3 Weeks)||0
10496614|NCT01216735|11646644|FG001|NOT COMPLETED|Washout (3 Weeks)||0
10496615|NCT01216735|11646643|FG000|STARTED|Second Intervention (3 Weeks)||8
10496616|NCT01216735|11646644|FG001|STARTED|Second Intervention (3 Weeks)||7
10496617|NCT01216735|11646643|FG000|COMPLETED|Second Intervention (3 Weeks)||8
10496618|NCT01216735|11646644|FG001|COMPLETED|Second Intervention (3 Weeks)||7
10496619|NCT01216735|11646643|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
10496620|NCT01216735|11646644|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
10496621|NCT01216748|11646650|FG000|STARTED|Overall Study||10
10496622|NCT01216748|11646650|FG000|Quiet Breathing|Overall Study||10
10496623|NCT01216748|11646650|FG000|Hypocapnic Hyperventilation|Overall Study||10
10496624|NCT01216748|11646650|FG000|Hypercapnic Hyperventilation|Overall Study||10
10496625|NCT01216748|11646650|FG000|Eucapnic Hyperventilation|Overall Study||10
10496626|NCT01216748|11646650|FG000|COMPLETED|Overall Study||10
10496627|NCT01216748|11646650|FG000|NOT COMPLETED|Overall Study||0
10496628|NCT01216761|11646654|FG000|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1421
10496629|NCT01216761|11646655|FG001|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1410
10496630|NCT01216761|11646656|FG002|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1379
10710464|NCT02650219|11875679|FG001|COMPLETED|Overall Study||20
10496631|NCT01216761|11646654|FG000|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1421
10496632|NCT01216761|11646655|FG001|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1410
10496633|NCT01216761|11646656|FG002|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1379
10496634|NCT01216761|11646654|FG000|NOT COMPLETED|Overall Study||0
10496635|NCT01216761|11646655|FG001|NOT COMPLETED|Overall Study||0
10496636|NCT01216761|11646656|FG002|NOT COMPLETED|Overall Study||0
10496637|NCT01216943|11646664|FG000|STARTED|Overall Study||126
10496638|NCT01216943|11646664|FG000|COMPLETED|Overall Study||113
10496639|NCT01216943|11646664|FG000|NOT COMPLETED|Overall Study||13
10496640|NCT01217073|11646674|FG000|STARTED|Base Period||113
10496641|NCT01217073|11646675|FG001|STARTED|Base Period||115
10496642|NCT01217073|11646676|FG002|STARTED|Base Period||114
10496643|NCT01217073|11646677|FG003|STARTED|Base Period||115
10496644|NCT01217073|11646678|FG004|STARTED|Base Period||114
10496645|NCT01217073|11646679|FG005|STARTED|Base Period||114
10496646|NCT01217073|11646680|FG006|STARTED|Base Period||0
10496647|NCT01217073|11646681|FG007|STARTED|Base Period||0
10496648|NCT01217073|11646674|FG000|COMPLETED|Base Period||106
10496649|NCT01217073|11646675|FG001|COMPLETED|Base Period||110
10496650|NCT01217073|11646676|FG002|COMPLETED|Base Period||107
10496651|NCT01217073|11646677|FG003|COMPLETED|Base Period||113
10496652|NCT01217073|11646678|FG004|COMPLETED|Base Period||99
10496653|NCT01217073|11646679|FG005|COMPLETED|Base Period||105
10496654|NCT01217073|11646680|FG006|COMPLETED|Base Period||0
10710465|NCT02650219|11875678|FG000|NOT COMPLETED|Overall Study||0
10710466|NCT02650219|11875679|FG001|NOT COMPLETED|Overall Study||0
10710467|NCT02650440|11875687|FG000|STARTED|Overall Study||10
10710468|NCT02650440|11875688|FG001|STARTED|Overall Study||10
10710469|NCT02650440|11875687|FG000|COMPLETED|Overall Study||10
10710470|NCT02650440|11875688|FG001|COMPLETED|Overall Study||8
10496655|NCT01217073|11646681|FG007|COMPLETED|Base Period||0
10496656|NCT01217073|11646674|FG000|NOT COMPLETED|Base Period||7
10496657|NCT01217073|11646675|FG001|NOT COMPLETED|Base Period||5
10496658|NCT01217073|11646676|FG002|NOT COMPLETED|Base Period||7
10496659|NCT01217073|11646677|FG003|NOT COMPLETED|Base Period||2
10496660|NCT01217073|11646678|FG004|NOT COMPLETED|Base Period||15
10496661|NCT01217073|11646679|FG005|NOT COMPLETED|Base Period||9
10496662|NCT01217073|11646680|FG006|NOT COMPLETED|Base Period||0
10496663|NCT01217073|11646681|FG007|NOT COMPLETED|Base Period||0
10496664|NCT01217073|11646674|FG000|STARTED|Extension Period||0
10496665|NCT01217073|11646675|FG001|STARTED|Extension Period||0
10496666|NCT01217073|11646676|FG002|STARTED|Extension Period||0
10496667|NCT01217073|11646677|FG003|STARTED|Extension Period||0
10496668|NCT01217073|11646678|FG004|STARTED|Extension Period||0
10496669|NCT01217073|11646679|FG005|STARTED|Extension Period||0
10496670|NCT01217073|11646680|FG006|STARTED|Extension Period||405
10496671|NCT01217073|11646681|FG007|STARTED|Extension Period||80
10496672|NCT01217073|11646674|FG000|COMPLETED|Extension Period||0
10496673|NCT01217073|11646675|FG001|COMPLETED|Extension Period||0
10496674|NCT01217073|11646676|FG002|COMPLETED|Extension Period||0
10496675|NCT01217073|11646677|FG003|COMPLETED|Extension Period||0
10496676|NCT01217073|11646678|FG004|COMPLETED|Extension Period||0
10496677|NCT01217073|11646679|FG005|COMPLETED|Extension Period||0
10496678|NCT01217073|11646680|FG006|COMPLETED|Extension Period||314
10496679|NCT01217073|11646681|FG007|COMPLETED|Extension Period||60
10496680|NCT01217073|11646674|FG000|NOT COMPLETED|Extension Period||0
10496681|NCT01217073|11646675|FG001|NOT COMPLETED|Extension Period||0
10496682|NCT01217073|11646676|FG002|NOT COMPLETED|Extension Period||0
10496683|NCT01217073|11646677|FG003|NOT COMPLETED|Extension Period||0
10496684|NCT01217073|11646678|FG004|NOT COMPLETED|Extension Period||0
10496685|NCT01217073|11646679|FG005|NOT COMPLETED|Extension Period||0
10496686|NCT01217073|11646680|FG006|NOT COMPLETED|Extension Period||91
10496687|NCT01217073|11646681|FG007|NOT COMPLETED|Extension Period||20
10496688|NCT01217112|11646710|FG000|STARTED|Overall Study||11
10496689|NCT01217112|11646711|FG001|STARTED|Overall Study||12
10496690|NCT01217112|11646712|FG002|STARTED|Overall Study||13
10496691|NCT01217112|11646713|FG003|STARTED|Overall Study||12
10496692|NCT01217112|11646714|FG004|STARTED|Overall Study||14
10496693|NCT01217112|11646710|FG000|COMPLETED|Overall Study||11
10496694|NCT01217112|11646711|FG001|COMPLETED|Overall Study||10
10496695|NCT01217112|11646712|FG002|COMPLETED|Overall Study||12
10496696|NCT01217112|11646713|FG003|COMPLETED|Overall Study||10
10496697|NCT01217112|11646714|FG004|COMPLETED|Overall Study||13
10496698|NCT01217112|11646710|FG000|NOT COMPLETED|Overall Study||0
10496699|NCT01217112|11646711|FG001|NOT COMPLETED|Overall Study||2
10496700|NCT01217112|11646712|FG002|NOT COMPLETED|Overall Study||1
10496701|NCT01217112|11646713|FG003|NOT COMPLETED|Overall Study||2
10496702|NCT01217112|11646714|FG004|NOT COMPLETED|Overall Study||1
10496703|NCT01217190|11646728|FG000|STARTED|First Dosing||24
10496704|NCT01217190|11646729|FG001|STARTED|First Dosing||24
10496705|NCT01217190|11646728|FG000|COMPLETED|First Dosing||24
10496706|NCT01217190|11646729|FG001|COMPLETED|First Dosing||24
10710471|NCT02650440|11875687|FG000|NOT COMPLETED|Overall Study||0
10496707|NCT01217190|11646728|FG000|NOT COMPLETED|First Dosing||0
10496708|NCT01217190|11646729|FG001|NOT COMPLETED|First Dosing||0
10496709|NCT01217190|11646728|FG000|STARTED|Second Dosing||24
10496710|NCT01217190|11646729|FG001|STARTED|Second Dosing||24
10496711|NCT01217190|11646728|FG000|COMPLETED|Second Dosing||24
10710472|NCT02650440|11875688|FG001|NOT COMPLETED|Overall Study||2
10710473|NCT02650466|11875694|FG000|STARTED|Overall Study||24
10496712|NCT01217190|11646729|FG001|COMPLETED|Second Dosing|Two subjects withdrew for personal reasons (other than adverse event).|22
10496713|NCT01217190|11646728|FG000|NOT COMPLETED|Second Dosing||0
10496714|NCT01217190|11646729|FG001|NOT COMPLETED|Second Dosing||2
10496715|NCT01217229|11646738|FG000|STARTED|Overall Study||20
10496716|NCT01217229|11646738|FG000|COMPLETED|Overall Study||0
10496717|NCT01217229|11646738|FG000|NOT COMPLETED|Overall Study||20
10496718|NCT01217307|11646744|FG000|STARTED|Overall Study||191
10496719|NCT01217307|11646745|FG001|STARTED|Overall Study||189
10496720|NCT01217307|11646744|FG000|COMPLETED|Overall Study||191
10496721|NCT01217307|11646745|FG001|COMPLETED|Overall Study||188
10496722|NCT01217307|11646744|FG000|NOT COMPLETED|Overall Study||0
10496723|NCT01217307|11646745|FG001|NOT COMPLETED|Overall Study||1
10496724|NCT01217385|11646751|FG000|STARTED|Overall Study||60
10496725|NCT01217385|11646751|FG000|COMPLETED|Overall Study||34
10496726|NCT01217385|11646751|FG000|NOT COMPLETED|Overall Study||26
10496727|NCT01217411|11646763|FG000|STARTED|Overall Study||3
10496728|NCT01217411|11646764|FG001|STARTED|Overall Study||2
10496729|NCT01217411|11646763|FG000|5mg|Overall Study||3
10496730|NCT01217411|11646764|FG001|5mg|Overall Study||2
10496731|NCT01217411|11646763|FG000|10mg|Overall Study||0
10496732|NCT01217411|11646764|FG001|10mg|Overall Study||0
10496733|NCT01217411|11646763|FG000|20mg|Overall Study||0
10496734|NCT01217411|11646764|FG001|20mg|Overall Study||0
10496735|NCT01217411|11646763|FG000|COMPLETED|Overall Study||0
10496736|NCT01217411|11646764|FG001|COMPLETED|Overall Study||0
10496737|NCT01217411|11646763|FG000|NOT COMPLETED|Overall Study||3
10496738|NCT01217411|11646764|FG001|NOT COMPLETED|Overall Study||2
10496739|NCT01217437|11646774|FG000|STARTED|Overall Study||55
10496740|NCT01217437|11646775|FG001|STARTED|Overall Study||53
10496741|NCT01217437|11646774|FG000|COMPLETED|Overall Study||12
10496742|NCT01217437|11646775|FG001|COMPLETED|Overall Study||12
10496743|NCT01217437|11646774|FG000|NOT COMPLETED|Overall Study||43
10496744|NCT01217437|11646775|FG001|NOT COMPLETED|Overall Study||41
10496745|NCT01217463|11646783|FG000|STARTED|Overall Study||99
10496746|NCT01217463|11646784|FG001|STARTED|Overall Study||102
10496747|NCT01217463|11646783|FG000|COMPLETED|Overall Study||86
10496748|NCT01217463|11646784|FG001|COMPLETED|Overall Study||94
10496749|NCT01217463|11646783|FG000|NOT COMPLETED|Overall Study||13
10496750|NCT01217463|11646784|FG001|NOT COMPLETED|Overall Study||8
10496751|NCT01217476|11646794|FG000|STARTED|Overall Study||105
10496752|NCT01217476|11646795|FG001|STARTED|Overall Study||102
10496753|NCT01217476|11646794|FG000|COMPLETED|Overall Study||93
10496754|NCT01217476|11646795|FG001|COMPLETED|Overall Study||95
10496755|NCT01217476|11646794|FG000|NOT COMPLETED|Overall Study||12
10496756|NCT01217476|11646795|FG001|NOT COMPLETED|Overall Study||7
10496757|NCT01217515|11646804|FG000|STARTED|Overall Study||154
10496758|NCT01217515|11646805|FG001|STARTED|Overall Study||156
10710474|NCT02650466|11875694|FG000|COMPLETED|Overall Study||17
10710475|NCT02650466|11875694|FG000|NOT COMPLETED|Overall Study||7
10710476|NCT02650856|11875702|FG000|STARTED|Overall Study||19
10496759|NCT01217515|11646806|FG002|STARTED|Overall Study||155
10496760|NCT01217515|11646804|FG000|COMPLETED|Overall Study||147
10496761|NCT01217515|11646805|FG001|COMPLETED|Overall Study||148
10496762|NCT01217515|11646806|FG002|COMPLETED|Overall Study||145
10496763|NCT01217515|11646804|FG000|NOT COMPLETED|Overall Study||7
10496764|NCT01217515|11646805|FG001|NOT COMPLETED|Overall Study||8
10496765|NCT01217515|11646806|FG002|NOT COMPLETED|Overall Study||10
10496766|NCT01217606|11646816|FG000|STARTED|Initial Treatment Phase||90
10496767|NCT01217606|11646817|FG001|STARTED|Initial Treatment Phase||95
10496768|NCT01217606|11646816|FG000|COMPLETED|Initial Treatment Phase||76
10496769|NCT01217606|11646817|FG001|COMPLETED|Initial Treatment Phase||83
10496770|NCT01217606|11646816|FG000|NOT COMPLETED|Initial Treatment Phase||14
10496771|NCT01217606|11646817|FG001|NOT COMPLETED|Initial Treatment Phase||12
10496772|NCT01217606|11646816|FG000|STARTED|9-Month Masked Extension||67
10496773|NCT01217606|11646817|FG001|STARTED|9-Month Masked Extension||73
10496774|NCT01217606|11646816|FG000|Not Enrolled in Masked Extension|9-Month Masked Extension||9
10496775|NCT01217606|11646817|FG001|Not Enrolled in Masked Extension|9-Month Masked Extension||10
10496776|NCT01217606|11646816|FG000|COMPLETED|9-Month Masked Extension||54
10496777|NCT01217606|11646817|FG001|COMPLETED|9-Month Masked Extension||62
10496778|NCT01217606|11646816|FG000|NOT COMPLETED|9-Month Masked Extension||13
10496779|NCT01217606|11646817|FG001|NOT COMPLETED|9-Month Masked Extension||11
10496780|NCT01217749|11646826|FG000|STARTED|Overall Study||27
10496781|NCT01217749|11646827|FG001|STARTED|Overall Study||20
10496782|NCT01217749|11646828|FG002|STARTED|Overall Study||24
10496783|NCT01217749|11646826|FG000|COMPLETED|Overall Study||24
10496784|NCT01217749|11646827|FG001|COMPLETED|Overall Study||17
10496785|NCT01217749|11646828|FG002|COMPLETED|Overall Study||22
10496786|NCT01217749|11646826|FG000|NOT COMPLETED|Overall Study||3
10496787|NCT01217749|11646827|FG001|NOT COMPLETED|Overall Study||3
10496788|NCT01217749|11646828|FG002|NOT COMPLETED|Overall Study||2
10496789|NCT01217801|11646840|FG000|STARTED|Period 1||24
10496790|NCT01217801|11646841|FG001|STARTED|Period 1||24
10496791|NCT01217801|11646840|FG000|COMPLETED|Period 1||23
10496792|NCT01217801|11646841|FG001|COMPLETED|Period 1||22
10496793|NCT01217801|11646840|FG000|NOT COMPLETED|Period 1||1
10496794|NCT01217801|11646841|FG001|NOT COMPLETED|Period 1||2
10496795|NCT01217801|11646840|FG000|STARTED|Period 2||23
10496796|NCT01217801|11646841|FG001|STARTED|Period 2||22
10496797|NCT01217801|11646840|FG000|COMPLETED|Period 2||23
10496798|NCT01217801|11646841|FG001|COMPLETED|Period 2||22
10496799|NCT01217801|11646840|FG000|NOT COMPLETED|Period 2||0
10710477|NCT02650856|11875703|FG001|STARTED|Overall Study||21
10496800|NCT01217801|11646841|FG001|NOT COMPLETED|Period 2||0
10496801|NCT01217814|11646850|FG000|STARTED|Overall Study||4
10496802|NCT01217814|11646851|FG001|STARTED|Overall Study||5
10496803|NCT01217814|11646852|FG002|STARTED|Overall Study||7
10496804|NCT01217814|11646850|FG000|COMPLETED|Overall Study||3
10496805|NCT01217814|11646851|FG001|COMPLETED|Overall Study||4
10496806|NCT01217814|11646852|FG002|COMPLETED|Overall Study||6
10496807|NCT01217814|11646850|FG000|NOT COMPLETED|Overall Study||1
10496808|NCT01217814|11646851|FG001|NOT COMPLETED|Overall Study||1
10496809|NCT01217814|11646852|FG002|NOT COMPLETED|Overall Study||1
10527986|NCT01392703|11680199|FG000|NOT COMPLETED|Day 9||0
10527987|NCT01392703|11680200|FG001|NOT COMPLETED|Day 9||0
10527988|NCT01392703|11680201|FG002|NOT COMPLETED|Day 9||0
10527989|NCT01392742|11680211|FG000|STARTED|Overall Study||443
10527990|NCT01392742|11680211|FG000|COMPLETED|Overall Study||242
10527991|NCT01392742|11680211|FG000|NOT COMPLETED|Overall Study||201
10527992|NCT01392859|11680215|FG000|STARTED|Overall Study||15
10527993|NCT01392859|11680216|FG001|STARTED|Overall Study||13
10527994|NCT01392859|11680217|FG002|STARTED|Overall Study||183
10527995|NCT01392859|11680215|FG000|Wash Out 3-7 Days|Overall Study||15
10527996|NCT01392859|11680216|FG001|Wash Out 3-7 Days|Overall Study||13
10527997|NCT01392859|11680217|FG002|Wash Out 3-7 Days|Overall Study||0
10527998|NCT01392859|11680215|FG000|COMPLETED|Overall Study||13
10527999|NCT01392859|11680216|FG001|COMPLETED|Overall Study||13
10528000|NCT01392859|11680217|FG002|COMPLETED|Overall Study||183
10528001|NCT01392859|11680215|FG000|NOT COMPLETED|Overall Study||2
10528002|NCT01392859|11680216|FG001|NOT COMPLETED|Overall Study||0
10528003|NCT01392859|11680217|FG002|NOT COMPLETED|Overall Study||0
10528004|NCT01392963|11680225|FG000|STARTED|Week 0 (First Intervention)||11
10528005|NCT01392963|11680226|FG001|STARTED|Week 0 (First Intervention)||19
10528006|NCT01392963|11680225|FG000|COMPLETED|Week 0 (First Intervention)||11
10528007|NCT01392963|11680226|FG001|COMPLETED|Week 0 (First Intervention)||17
10528008|NCT01392963|11680225|FG000|NOT COMPLETED|Week 0 (First Intervention)||0
10528009|NCT01392963|11680226|FG001|NOT COMPLETED|Week 0 (First Intervention)||2
10528010|NCT01392963|11680225|FG000|STARTED|Week 12 (Second Intervention)||11
10528011|NCT01392963|11680226|FG001|STARTED|Week 12 (Second Intervention)||17
10528012|NCT01392963|11680225|FG000|COMPLETED|Week 12 (Second Intervention)||11
10528013|NCT01392963|11680226|FG001|COMPLETED|Week 12 (Second Intervention)||17
10528014|NCT01392963|11680225|FG000|NOT COMPLETED|Week 12 (Second Intervention)||0
10528015|NCT01392963|11680226|FG001|NOT COMPLETED|Week 12 (Second Intervention)||0
10710478|NCT02650856|11875702|FG000|Baseline|Overall Study||19
10528016|NCT01392963|11680225|FG000|STARTED|Week 24 Follow-up||11
10528017|NCT01392963|11680226|FG001|STARTED|Week 24 Follow-up||17
10528018|NCT01392963|11680225|FG000|COMPLETED|Week 24 Follow-up||9
10528019|NCT01392963|11680226|FG001|COMPLETED|Week 24 Follow-up||17
10528020|NCT01392963|11680225|FG000|NOT COMPLETED|Week 24 Follow-up||2
10528021|NCT01392963|11680226|FG001|NOT COMPLETED|Week 24 Follow-up||0
10528022|NCT01392989|11680234|FG000|STARTED|Total Lymphoid Irradiation (TLI)||44
10528023|NCT01392989|11680234|FG000|COMPLETED|Total Lymphoid Irradiation (TLI)||44
10528024|NCT01392989|11680234|FG000|NOT COMPLETED|Total Lymphoid Irradiation (TLI)||0
10528025|NCT01392989|11680234|FG000|STARTED|CIK Cell Infusion||31
10528026|NCT01392989|11680234|FG000|COMPLETED|CIK Cell Infusion||31
10528027|NCT01392989|11680234|FG000|NOT COMPLETED|CIK Cell Infusion||0
10528028|NCT01393106|11680239|FG000|STARTED|Overall Study||25
10528029|NCT01393106|11680239|FG000|COMPLETED|Overall Study|Completed: Disease Progression/Death|20
10528030|NCT01393106|11680239|FG000|NOT COMPLETED|Overall Study||5
10528031|NCT01393132|11680245|FG000|STARTED|Overall Study||6
10528032|NCT01393132|11680246|FG001|STARTED|Overall Study||3
10528033|NCT01393132|11680245|FG000|COMPLETED|Overall Study||6
10528034|NCT01393132|11680246|FG001|COMPLETED|Overall Study||3
10528035|NCT01393132|11680245|FG000|NOT COMPLETED|Overall Study||0
10528036|NCT01393132|11680246|FG001|NOT COMPLETED|Overall Study||0
10528037|NCT01393158|11680256|FG000|STARTED|Overall Study||6
10528038|NCT01393158|11680257|FG001|STARTED|Overall Study||10
10528039|NCT01393158|11680256|FG000|COMPLETED|Overall Study||5
10528040|NCT01393158|11680257|FG001|COMPLETED|Overall Study||10
10528041|NCT01393158|11680256|FG000|NOT COMPLETED|Overall Study||1
10528042|NCT01393158|11680257|FG001|NOT COMPLETED|Overall Study||0
10528043|NCT01393301|11680271|FG000|STARTED|Overall Study||26
10528044|NCT01393301|11680272|FG001|STARTED|Overall Study||27
10528045|NCT01393301|11680271|FG000|COMPLETED|Overall Study||17
10528046|NCT01393301|11680272|FG001|COMPLETED|Overall Study||24
10528047|NCT01393301|11680271|FG000|NOT COMPLETED|Overall Study||9
10528048|NCT01393301|11680272|FG001|NOT COMPLETED|Overall Study||3
10528049|NCT01393392|11680280|FG000|STARTED|Overall Study||44
10528050|NCT01393392|11680281|FG001|STARTED|Overall Study||43
10528051|NCT01393392|11680280|FG000|COMPLETED|Overall Study||33
10528052|NCT01393392|11680281|FG001|COMPLETED|Overall Study||24
10528053|NCT01393392|11680280|FG000|NOT COMPLETED|Overall Study||11
10528054|NCT01393392|11680281|FG001|NOT COMPLETED|Overall Study||19
10528055|NCT01393405|11680287|FG000|STARTED|Induction Period (week1-16)||179
10528056|NCT01393405|11680288|FG001|STARTED|Induction Period (week1-16)||0
10528057|NCT01393405|11680289|FG002|STARTED|Induction Period (week1-16)||0
10528058|NCT01393405|11680287|FG000|COMPLETED|Induction Period (week1-16)||84
10496810|NCT01217827|11646863|FG000|STARTED|Overall Study||46
10496811|NCT01217827|11646864|FG001|STARTED|Overall Study||43
10496812|NCT01217827|11646863|FG000|COMPLETED|Overall Study||46
10496813|NCT01217827|11646864|FG001|COMPLETED|Overall Study||43
10496814|NCT01217827|11646863|FG000|NOT COMPLETED|Overall Study||0
10496815|NCT01217827|11646864|FG001|NOT COMPLETED|Overall Study||0
10496816|NCT01217840|11646872|FG000|STARTED|Overall Study||20
10496817|NCT01217840|11646873|FG001|STARTED|Overall Study||20
10496818|NCT01217840|11646872|FG000|COMPLETED|Overall Study||14
10496819|NCT01217840|11646873|FG001|COMPLETED|Overall Study||17
10496820|NCT01217840|11646872|FG000|NOT COMPLETED|Overall Study||6
10496821|NCT01217840|11646873|FG001|NOT COMPLETED|Overall Study||3
10496822|NCT01217892|11646884|FG000|STARTED|Overall Study||100
10496823|NCT01217892|11646885|FG001|STARTED|Overall Study||100
10496824|NCT01217892|11646886|FG002|STARTED|Overall Study||99
10496825|NCT01217892|11646887|FG003|STARTED|Overall Study||101
10496826|NCT01217892|11646884|FG000|COMPLETED|Overall Study||93
10496827|NCT01217892|11646885|FG001|COMPLETED|Overall Study||94
10496828|NCT01217892|11646886|FG002|COMPLETED|Overall Study||90
10496829|NCT01217892|11646887|FG003|COMPLETED|Overall Study||93
10496830|NCT01217892|11646884|FG000|NOT COMPLETED|Overall Study||7
10496831|NCT01217892|11646885|FG001|NOT COMPLETED|Overall Study||6
10496832|NCT01217892|11646886|FG002|NOT COMPLETED|Overall Study||9
10496833|NCT01217892|11646887|FG003|NOT COMPLETED|Overall Study||8
10496834|NCT01217944|11646900|FG000|STARTED|Overall Study||106
10496835|NCT01217944|11646901|FG001|STARTED|Overall Study||116
10496836|NCT01217944|11646902|FG002|STARTED|Overall Study||55
10496837|NCT01217944|11646900|FG000|Completed 3 Months|Overall Study||105
10496838|NCT01217944|11646901|FG001|Completed 3 Months|Overall Study||116
10496839|NCT01217944|11646902|FG002|Completed 3 Months|Overall Study||55
10496840|NCT01217944|11646900|FG000|Completed 6 Months|Overall Study||103
10496841|NCT01217944|11646901|FG001|Completed 6 Months|Overall Study||116
10496842|NCT01217944|11646902|FG002|Completed 6 Months|Overall Study||55
10496843|NCT01217944|11646900|FG000|COMPLETED|Overall Study||100
10496844|NCT01217944|11646901|FG001|COMPLETED|Overall Study||112
10496845|NCT01217944|11646902|FG002|COMPLETED|Overall Study||55
10496846|NCT01217944|11646900|FG000|NOT COMPLETED|Overall Study||6
10496847|NCT01217944|11646901|FG001|NOT COMPLETED|Overall Study||4
10496848|NCT01217944|11646902|FG002|NOT COMPLETED|Overall Study||0
10496849|NCT01217957|11646917|FG000|STARTED|Phase 1||3
10496850|NCT01217957|11646918|FG001|STARTED|Phase 1||3
10496851|NCT01217957|11646919|FG002|STARTED|Phase 1||6
10496852|NCT01217957|11646920|FG003|STARTED|Phase 1||3
10496853|NCT01217957|11646921|FG004|STARTED|Phase 1||0
10496854|NCT01217957|11646917|FG000|COMPLETED|Phase 1||2
10496855|NCT01217957|11646918|FG001|COMPLETED|Phase 1||3
10496856|NCT01217957|11646919|FG002|COMPLETED|Phase 1||5
10496857|NCT01217957|11646920|FG003|COMPLETED|Phase 1||2
10496858|NCT01217957|11646921|FG004|COMPLETED|Phase 1||0
10496859|NCT01217957|11646917|FG000|NOT COMPLETED|Phase 1||1
10496860|NCT01217957|11646918|FG001|NOT COMPLETED|Phase 1||0
10496861|NCT01217957|11646919|FG002|NOT COMPLETED|Phase 1||1
10496862|NCT01217957|11646920|FG003|NOT COMPLETED|Phase 1||1
10496863|NCT01217957|11646921|FG004|NOT COMPLETED|Phase 1||0
10496864|NCT01217957|11646917|FG000|STARTED|Phase 2||0
10496865|NCT01217957|11646918|FG001|STARTED|Phase 2||0
10496866|NCT01217957|11646919|FG002|STARTED|Phase 2||0
10496867|NCT01217957|11646920|FG003|STARTED|Phase 2||0
10496868|NCT01217957|11646921|FG004|STARTED|Phase 2||50
10496869|NCT01217957|11646917|FG000|COMPLETED|Phase 2||0
10496870|NCT01217957|11646918|FG001|COMPLETED|Phase 2||0
10496871|NCT01217957|11646919|FG002|COMPLETED|Phase 2||0
10496872|NCT01217957|11646920|FG003|COMPLETED|Phase 2||0
10496873|NCT01217957|11646921|FG004|COMPLETED|Phase 2|Completed=Participants who are ongoing or who have died on study.|49
10496874|NCT01217957|11646917|FG000|NOT COMPLETED|Phase 2||0
10496875|NCT01217957|11646918|FG001|NOT COMPLETED|Phase 2||0
10496876|NCT01217957|11646919|FG002|NOT COMPLETED|Phase 2||0
10496877|NCT01217957|11646920|FG003|NOT COMPLETED|Phase 2||0
10496878|NCT01217957|11646921|FG004|NOT COMPLETED|Phase 2||1
10496879|NCT01218009|11646944|FG000|STARTED|Overall Study||166
10496880|NCT01218009|11646945|FG001|STARTED|Overall Study||165
10496881|NCT01218009|11646944|FG000|COMPLETED|Overall Study||0
10496882|NCT01218009|11646945|FG001|COMPLETED|Overall Study||0
10496883|NCT01218009|11646944|FG000|NOT COMPLETED|Overall Study||166
10496884|NCT01218009|11646945|FG001|NOT COMPLETED|Overall Study||165
10710479|NCT02650856|11875703|FG001|Baseline|Overall Study||21
10496885|NCT01218048|11646951|FG000|STARTED|Overall Study||40
10496886|NCT01218048|11646951|FG000|COMPLETED|Overall Study||40
10496887|NCT01218048|11646951|FG000|NOT COMPLETED|Overall Study||0
10496888|NCT01218087|11646958|FG000|STARTED|Overall Study||42
10496889|NCT01218087|11646959|FG001|STARTED|Overall Study||41
10496890|NCT01218087|11646958|FG000|COMPLETED|Overall Study||27
10496891|NCT01218087|11646959|FG001|COMPLETED|Overall Study||35
10496892|NCT01218087|11646958|FG000|NOT COMPLETED|Overall Study||15
10496893|NCT01218087|11646959|FG001|NOT COMPLETED|Overall Study||6
10496894|NCT01218100|11646969|FG000|STARTED|Overall Study||95
10496895|NCT01218100|11646970|FG001|STARTED|Overall Study||190
10496896|NCT01218100|11646971|FG002|STARTED|Overall Study||189
10496897|NCT01218100|11646972|FG003|STARTED|Overall Study||190
10496898|NCT01218100|11646969|FG000|COMPLETED|Overall Study||71
10496899|NCT01218100|11646970|FG001|COMPLETED|Overall Study||165
10496900|NCT01218100|11646971|FG002|COMPLETED|Overall Study||162
10496901|NCT01218100|11646972|FG003|COMPLETED|Overall Study||156
10496902|NCT01218100|11646969|FG000|NOT COMPLETED|Overall Study||24
10496903|NCT01218100|11646970|FG001|NOT COMPLETED|Overall Study||25
10496904|NCT01218100|11646971|FG002|NOT COMPLETED|Overall Study||27
10496905|NCT01218100|11646972|FG003|NOT COMPLETED|Overall Study||34
10496906|NCT01218113|11646985|FG000|STARTED|Overall Study||62
10496907|NCT01218113|11646986|FG001|STARTED|Overall Study||64
10496908|NCT01218113|11646987|FG002|STARTED|Overall Study||64
10496909|NCT01218113|11646985|FG000|COMPLETED|Overall Study||57
10496910|NCT01218113|11646986|FG001|COMPLETED|Overall Study||63
10496911|NCT01218113|11646987|FG002|COMPLETED|Overall Study||58
10496912|NCT01218113|11646985|FG000|NOT COMPLETED|Overall Study||5
10496913|NCT01218113|11646986|FG001|NOT COMPLETED|Overall Study||1
10496914|NCT01218113|11646987|FG002|NOT COMPLETED|Overall Study||6
10496915|NCT01218126|11647006|FG000|STARTED|Overall Study||153
10496916|NCT01218126|11647007|FG001|STARTED|Overall Study||149
10496917|NCT01218126|11647008|FG002|STARTED|Overall Study||151
10496918|NCT01218126|11647009|FG003|STARTED|Overall Study||149
10496919|NCT01218126|11647006|FG000|COMPLETED|Overall Study||129
10496920|NCT01218126|11647007|FG001|COMPLETED|Overall Study||127
10496921|NCT01218126|11647008|FG002|COMPLETED|Overall Study||127
10496922|NCT01218126|11647009|FG003|COMPLETED|Overall Study||114
10496923|NCT01218126|11647006|FG000|NOT COMPLETED|Overall Study||24
10496924|NCT01218126|11647007|FG001|NOT COMPLETED|Overall Study||22
10496925|NCT01218126|11647008|FG002|NOT COMPLETED|Overall Study||24
10496926|NCT01218126|11647009|FG003|NOT COMPLETED|Overall Study||35
10496927|NCT01218204|11647021|FG000|STARTED|Part A||6
10496928|NCT01218204|11647022|FG001|STARTED|Part A||0
10496929|NCT01218204|11647023|FG002|STARTED|Part A||0
10496930|NCT01218204|11647024|FG003|STARTED|Part A||0
10496931|NCT01218204|11647021|FG000|COMPLETED|Part A||6
10496932|NCT01218204|11647022|FG001|COMPLETED|Part A||0
10496933|NCT01218204|11647023|FG002|COMPLETED|Part A||0
10496934|NCT01218204|11647024|FG003|COMPLETED|Part A||0
10496935|NCT01218204|11647021|FG000|NOT COMPLETED|Part A||0
10496936|NCT01218204|11647022|FG001|NOT COMPLETED|Part A||0
10496937|NCT01218204|11647023|FG002|NOT COMPLETED|Part A||0
10496938|NCT01218204|11647024|FG003|NOT COMPLETED|Part A||0
10496939|NCT01218204|11647021|FG000|STARTED|Part B Washout||0
10496940|NCT01218204|11647022|FG001|STARTED|Part B Washout||281
10496941|NCT01218204|11647023|FG002|STARTED|Part B Washout||0
10496942|NCT01218204|11647024|FG003|STARTED|Part B Washout||0
10496943|NCT01218204|11647021|FG000|COMPLETED|Part B Washout||0
10496944|NCT01218204|11647022|FG001|COMPLETED|Part B Washout||136
10496945|NCT01218204|11647023|FG002|COMPLETED|Part B Washout||0
10496946|NCT01218204|11647024|FG003|COMPLETED|Part B Washout||0
10496947|NCT01218204|11647021|FG000|NOT COMPLETED|Part B Washout||0
10496948|NCT01218204|11647022|FG001|NOT COMPLETED|Part B Washout||145
10496949|NCT01218204|11647023|FG002|NOT COMPLETED|Part B Washout||0
10496950|NCT01218204|11647024|FG003|NOT COMPLETED|Part B Washout||0
10496951|NCT01218204|11647021|FG000|STARTED|Part B Run-in||0
10496952|NCT01218204|11647022|FG001|STARTED|Part B Run-in||0
10496953|NCT01218204|11647023|FG002|STARTED|Part B Run-in||89
10496954|NCT01218204|11647024|FG003|STARTED|Part B Run-in||0
10496955|NCT01218204|11647021|FG000|COMPLETED|Part B Run-in||0
10496956|NCT01218204|11647022|FG001|COMPLETED|Part B Run-in||0
10496957|NCT01218204|11647023|FG002|COMPLETED|Part B Run-in||83
10496958|NCT01218204|11647024|FG003|COMPLETED|Part B Run-in||0
10496959|NCT01218204|11647021|FG000|NOT COMPLETED|Part B Run-in||0
10496960|NCT01218204|11647022|FG001|NOT COMPLETED|Part B Run-in||0
10496961|NCT01218204|11647023|FG002|NOT COMPLETED|Part B Run-in||6
10496962|NCT01218204|11647024|FG003|NOT COMPLETED|Part B Run-in||0
10496963|NCT01218204|11647021|FG000|STARTED|Part B Pooled Treatment Arm||0
10496964|NCT01218204|11647022|FG001|STARTED|Part B Pooled Treatment Arm||0
10496965|NCT01218204|11647023|FG002|STARTED|Part B Pooled Treatment Arm||0
10496966|NCT01218204|11647024|FG003|STARTED|Part B Pooled Treatment Arm||130
10496967|NCT01218204|11647021|FG000|COMPLETED|Part B Pooled Treatment Arm||0
10496968|NCT01218204|11647022|FG001|COMPLETED|Part B Pooled Treatment Arm||0
10496969|NCT01218204|11647023|FG002|COMPLETED|Part B Pooled Treatment Arm||0
10496970|NCT01218204|11647024|FG003|COMPLETED|Part B Pooled Treatment Arm||127
10496971|NCT01218204|11647021|FG000|NOT COMPLETED|Part B Pooled Treatment Arm||0
10496972|NCT01218204|11647022|FG001|NOT COMPLETED|Part B Pooled Treatment Arm||0
10496973|NCT01218204|11647023|FG002|NOT COMPLETED|Part B Pooled Treatment Arm||0
10496974|NCT01218204|11647024|FG003|NOT COMPLETED|Part B Pooled Treatment Arm||3
10496975|NCT01218243|11647073|FG000|STARTED|Overall Study||50
10496976|NCT01218243|11647074|FG001|STARTED|Overall Study||50
10496977|NCT01218243|11647073|FG000|Treatment Completed|Overall Study||45
10496978|NCT01218243|11647074|FG001|Treatment Completed|Overall Study||42
10496979|NCT01218243|11647073|FG000|COMPLETED|Overall Study||41
10496980|NCT01218243|11647074|FG001|COMPLETED|Overall Study||36
10496981|NCT01218243|11647073|FG000|NOT COMPLETED|Overall Study||9
10496982|NCT01218243|11647074|FG001|NOT COMPLETED|Overall Study||14
10496983|NCT01218308|11647082|FG000|STARTED|Overall Study||2584
10496984|NCT01218308|11647083|FG001|STARTED|Overall Study||2584
10496985|NCT01218308|11647082|FG000|COMPLETED|Overall Study||2481
10496986|NCT01218308|11647083|FG001|COMPLETED|Overall Study||2464
10496987|NCT01218308|11647082|FG000|NOT COMPLETED|Overall Study||103
10496988|NCT01218308|11647083|FG001|NOT COMPLETED|Overall Study||120
10496989|NCT01218399|11647091|FG000|STARTED|Overall Study||5
10496990|NCT01218399|11647092|FG001|STARTED|Overall Study||5
10496991|NCT01218399|11647091|FG000|COMPLETED|Overall Study||5
10496992|NCT01218399|11647092|FG001|COMPLETED|Overall Study||5
10496993|NCT01218399|11647091|FG000|NOT COMPLETED|Overall Study||0
10496994|NCT01218399|11647092|FG001|NOT COMPLETED|Overall Study||0
10496995|NCT01218438|11647098|FG000|STARTED|Epoch 1||77
10496996|NCT01218438|11647098|FG000|COMPLETED|Epoch 1||74
10496997|NCT01218438|11647098|FG000|NOT COMPLETED|Epoch 1||3
10496998|NCT01218438|11647098|FG000|STARTED|Epoch 2||45
10496999|NCT01218438|11647098|FG000|COMPLETED|Epoch 2||45
10497000|NCT01218438|11647098|FG000|NOT COMPLETED|Epoch 2||0
10497001|NCT01218438|11647098|FG000|STARTED|Epoch 3||74
10497002|NCT01218438|11647098|FG000|COMPLETED|Epoch 3||70
10497003|NCT01218438|11647098|FG000|NOT COMPLETED|Epoch 3||4
10497004|NCT01218438|11647098|FG000|STARTED|Epoch 4||70
10497005|NCT01218438|11647098|FG000|COMPLETED|Epoch 4||67
10497006|NCT01218438|11647098|FG000|NOT COMPLETED|Epoch 4||3
10497007|NCT01218477|11647176|FG000|STARTED|Overall Study|Participants who received treatment|3
10497008|NCT01218477|11647177|FG001|STARTED|Overall Study|Participants who received treatment|8
10497009|NCT01218477|11647178|FG002|STARTED|Overall Study|Participants who received treatment|14
10497010|NCT01218477|11647179|FG003|STARTED|Overall Study|Participants who received treatment|2
10497011|NCT01218477|11647176|FG000|COMPLETED|Overall Study|Still receiving study drug|0
10497012|NCT01218477|11647177|FG001|COMPLETED|Overall Study|Still receiving study drug|0
10497013|NCT01218477|11647178|FG002|COMPLETED|Overall Study|Still receiving study drug|0
10497014|NCT01218477|11647179|FG003|COMPLETED|Overall Study|Still receiving study drug|0
10497015|NCT01218477|11647176|FG000|NOT COMPLETED|Overall Study||3
10497016|NCT01218477|11647177|FG001|NOT COMPLETED|Overall Study||8
10497017|NCT01218477|11647178|FG002|NOT COMPLETED|Overall Study||14
10497018|NCT01218477|11647179|FG003|NOT COMPLETED|Overall Study||2
10497019|NCT01218516|11647195|FG000|STARTED|Combination Therapy (up to 4.5 Months)||67
10497020|NCT01218516|11647196|FG001|STARTED|Combination Therapy (up to 4.5 Months)||63
10497021|NCT01218516|11647197|FG002|STARTED|Combination Therapy (up to 4.5 Months)||0
10497022|NCT01218516|11647198|FG003|STARTED|Combination Therapy (up to 4.5 Months)||0
10497023|NCT01218516|11647195|FG000|COMPLETED|Combination Therapy (up to 4.5 Months)||38
10497024|NCT01218516|11647196|FG001|COMPLETED|Combination Therapy (up to 4.5 Months)||28
10497025|NCT01218516|11647197|FG002|COMPLETED|Combination Therapy (up to 4.5 Months)||0
10497026|NCT01218516|11647198|FG003|COMPLETED|Combination Therapy (up to 4.5 Months)||0
10497027|NCT01218516|11647195|FG000|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||29
10497028|NCT01218516|11647196|FG001|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||35
10497029|NCT01218516|11647197|FG002|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||0
10497030|NCT01218516|11647198|FG003|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||0
10497031|NCT01218516|11647195|FG000|STARTED|Monotherapy (up to 23.5 Months)|This phase ended once all participants finished.|0
10497032|NCT01218516|11647196|FG001|STARTED|Monotherapy (up to 23.5 Months)|This phase ended once all participants finished.|0
10497033|NCT01218516|11647197|FG002|STARTED|Monotherapy (up to 23.5 Months)|Only eligible participants entered this phase of the study.|38
10497034|NCT01218516|11647198|FG003|STARTED|Monotherapy (up to 23.5 Months)|Only eligible participants entered this phase of the study.|28
10497035|NCT01218516|11647195|FG000|Safety Analysis Set|Monotherapy (up to 23.5 Months)||0
10497036|NCT01218516|11647196|FG001|Safety Analysis Set|Monotherapy (up to 23.5 Months)||0
10497037|NCT01218516|11647197|FG002|Safety Analysis Set|Monotherapy (up to 23.5 Months)||35
10497038|NCT01218516|11647198|FG003|Safety Analysis Set|Monotherapy (up to 23.5 Months)|Three participants were randomized to placebo but actually received Farletuzumab.|31
10497039|NCT01218516|11647195|FG000|COMPLETED|Monotherapy (up to 23.5 Months)||0
10497040|NCT01218516|11647196|FG001|COMPLETED|Monotherapy (up to 23.5 Months)||0
10497041|NCT01218516|11647197|FG002|COMPLETED|Monotherapy (up to 23.5 Months)||38
10497042|NCT01218516|11647198|FG003|COMPLETED|Monotherapy (up to 23.5 Months)||28
10497043|NCT01218516|11647195|FG000|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0
10497044|NCT01218516|11647196|FG001|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0
10497045|NCT01218516|11647197|FG002|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0
10497046|NCT01218516|11647198|FG003|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0
10497047|NCT01218542|11647208|FG000|STARTED|Overall Study||22
10497048|NCT01218542|11647208|FG000|COMPLETED|Overall Study||13
10497049|NCT01218542|11647208|FG000|NOT COMPLETED|Overall Study||9
10497050|NCT01218594|11647213|FG000|STARTED|Overall Study||48
10497051|NCT01218594|11647213|FG000|COMPLETED|Overall Study||36
10497052|NCT01218594|11647213|FG000|NOT COMPLETED|Overall Study||12
10497053|NCT01218646|11647221|FG000|STARTED|Overall Study||225
10497054|NCT01218646|11647222|FG001|STARTED|Overall Study||225
10497055|NCT01218646|11647223|FG002|STARTED|Overall Study||225
10497056|NCT01218646|11647224|FG003|STARTED|Overall Study||64
10497057|NCT01218646|11647221|FG000|COMPLETED|Overall Study||224
10497058|NCT01218646|11647222|FG001|COMPLETED|Overall Study||225
10497059|NCT01218646|11647223|FG002|COMPLETED|Overall Study||223
10497060|NCT01218646|11647224|FG003|COMPLETED|Overall Study||63
10497061|NCT01218646|11647221|FG000|NOT COMPLETED|Overall Study||1
10497062|NCT01218646|11647222|FG001|NOT COMPLETED|Overall Study||0
10497063|NCT01218646|11647223|FG002|NOT COMPLETED|Overall Study||2
10497064|NCT01218646|11647224|FG003|NOT COMPLETED|Overall Study||1
10497065|NCT01218659|11647236|FG000|STARTED|18-Month Randomized Period||36
10497066|NCT01218659|11647237|FG001|STARTED|18-Month Randomized Period||24
10497067|NCT01218659|11647238|FG002|STARTED|18-Month Randomized Period|Zero participants are noted here because participants started in this group during the 12-month OLE.|0
10497068|NCT01218659|11647236|FG000|Safety Population|18-Month Randomized Period||36
10497069|NCT01218659|11647237|FG001|Safety Population|18-Month Randomized Period||21
10497070|NCT01218659|11647238|FG002|Safety Population|18-Month Randomized Period|Zero participants are noted here because participants started in this group during the 12-month OLE.|0
10497071|NCT01218659|11647236|FG000|COMPLETED|18-Month Randomized Period||34
10497072|NCT01218659|11647237|FG001|COMPLETED|18-Month Randomized Period||18
10528059|NCT01393405|11680288|FG001|COMPLETED|Induction Period (week1-16)||0
10497073|NCT01218659|11647238|FG002|COMPLETED|18-Month Randomized Period|Zero participants are noted here because participants started in this group during the 12-month OLE.|0
10497074|NCT01218659|11647236|FG000|NOT COMPLETED|18-Month Randomized Period||2
10497075|NCT01218659|11647237|FG001|NOT COMPLETED|18-Month Randomized Period||6
10497076|NCT01218659|11647238|FG002|NOT COMPLETED|18-Month Randomized Period||0
10497077|NCT01218659|11647236|FG000|STARTED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
10497078|NCT01218659|11647237|FG001|STARTED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
10497079|NCT01218659|11647238|FG002|STARTED|12-Month OLE|Fifty-two participants completed the 18-mo. randomized treatment period.|52
10497080|NCT01218659|11647236|FG000|Safety Population|12-Month OLE||0
10497081|NCT01218659|11647237|FG001|Safety Population|12-Month OLE||0
10497082|NCT01218659|11647238|FG002|Safety Population|12-Month OLE||51
10497083|NCT01218659|11647236|FG000|Modified Intent-to-Treat (mITT)|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
10497084|NCT01218659|11647237|FG001|Modified Intent-to-Treat (mITT)|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
10497085|NCT01218659|11647238|FG002|Modified Intent-to-Treat (mITT)|12-Month OLE||46
10497086|NCT01218659|11647236|FG000|COMPLETED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
10497087|NCT01218659|11647237|FG001|COMPLETED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
10497088|NCT01218659|11647238|FG002|COMPLETED|12-Month OLE||42
10497089|NCT01218659|11647236|FG000|NOT COMPLETED|12-Month OLE||0
10497090|NCT01218659|11647237|FG001|NOT COMPLETED|12-Month OLE||0
10497091|NCT01218659|11647238|FG002|NOT COMPLETED|12-Month OLE||10
10497092|NCT01218672|11647247|FG000|STARTED|Overall Study||139
10497093|NCT01218672|11647248|FG001|STARTED|Overall Study||142
10497094|NCT01218672|11647247|FG000|Treated|Overall Study||136
10497095|NCT01218672|11647248|FG001|Treated|Overall Study||133
10497096|NCT01218672|11647247|FG000|COMPLETED|Overall Study||128
10497097|NCT01218672|11647248|FG001|COMPLETED|Overall Study||121
10497098|NCT01218672|11647247|FG000|NOT COMPLETED|Overall Study||11
10497099|NCT01218672|11647248|FG001|NOT COMPLETED|Overall Study||21
10497100|NCT01218802|11647258|FG000|STARTED|Overall Study||72
10497101|NCT01218802|11647259|FG001|STARTED|Overall Study||75
10497102|NCT01218802|11647258|FG000|COMPLETED|Overall Study||62
10497103|NCT01218802|11647259|FG001|COMPLETED|Overall Study||57
10497104|NCT01218802|11647258|FG000|NOT COMPLETED|Overall Study||10
10497105|NCT01218802|11647259|FG001|NOT COMPLETED|Overall Study||18
10497106|NCT01218867|11647276|FG000|STARTED|Overall Study||1
10497107|NCT01218867|11647277|FG001|STARTED|Overall Study||1
10497108|NCT01218867|11647278|FG002|STARTED|Overall Study||3
10497109|NCT01218867|11647279|FG003|STARTED|Overall Study||1
10497110|NCT01218867|11647280|FG004|STARTED|Overall Study||1
10497111|NCT01218867|11647281|FG005|STARTED|Overall Study||1
10497112|NCT01218867|11647282|FG006|STARTED|Overall Study||4
10497113|NCT01218867|11647283|FG007|STARTED|Overall Study||3
10497114|NCT01218867|11647284|FG008|STARTED|Overall Study||3
10497115|NCT01218867|11647285|FG009|STARTED|Overall Study||4
10497116|NCT01218867|11647286|FG010|STARTED|Overall Study||2
10497117|NCT01218867|11647276|FG000|COMPLETED|Overall Study||1
10497118|NCT01218867|11647277|FG001|COMPLETED|Overall Study||1
10497119|NCT01218867|11647278|FG002|COMPLETED|Overall Study||3
10497120|NCT01218867|11647279|FG003|COMPLETED|Overall Study||1
10497121|NCT01218867|11647280|FG004|COMPLETED|Overall Study||1
10497122|NCT01218867|11647281|FG005|COMPLETED|Overall Study||1
10497123|NCT01218867|11647282|FG006|COMPLETED|Overall Study||3
10497124|NCT01218867|11647283|FG007|COMPLETED|Overall Study||3
10497125|NCT01218867|11647284|FG008|COMPLETED|Overall Study||3
10497126|NCT01218867|11647285|FG009|COMPLETED|Overall Study||4
10497127|NCT01218867|11647286|FG010|COMPLETED|Overall Study||2
10497128|NCT01218867|11647276|FG000|NOT COMPLETED|Overall Study||0
10497129|NCT01218867|11647277|FG001|NOT COMPLETED|Overall Study||0
10497130|NCT01218867|11647278|FG002|NOT COMPLETED|Overall Study||0
10497131|NCT01218867|11647279|FG003|NOT COMPLETED|Overall Study||0
10497132|NCT01218867|11647280|FG004|NOT COMPLETED|Overall Study||0
10497133|NCT01218867|11647281|FG005|NOT COMPLETED|Overall Study||0
10497134|NCT01218867|11647282|FG006|NOT COMPLETED|Overall Study||1
10497135|NCT01218867|11647283|FG007|NOT COMPLETED|Overall Study||0
10497136|NCT01218867|11647284|FG008|NOT COMPLETED|Overall Study||0
10497137|NCT01218867|11647285|FG009|NOT COMPLETED|Overall Study||0
10497138|NCT01218867|11647286|FG010|NOT COMPLETED|Overall Study||0
10497139|NCT01218958|11647324|FG000|STARTED|Overall Study||210
10497140|NCT01218958|11647325|FG001|STARTED|Overall Study||205
10497141|NCT01218958|11647326|FG002|STARTED|Overall Study||209
10497142|NCT01218958|11647324|FG000|COMPLETED|Overall Study||126
10497143|NCT01218958|11647325|FG001|COMPLETED|Overall Study||124
10497144|NCT01218958|11647326|FG002|COMPLETED|Overall Study||128
10497145|NCT01218958|11647324|FG000|NOT COMPLETED|Overall Study||84
10497146|NCT01218958|11647325|FG001|NOT COMPLETED|Overall Study||81
10497147|NCT01218958|11647326|FG002|NOT COMPLETED|Overall Study||81
10497148|NCT01218971|11647336|FG000|STARTED|Overall Study||175
10497149|NCT01218971|11647337|FG001|STARTED|Overall Study||157
10497150|NCT01218971|11647336|FG000|COMPLETED|Overall Study||71
10497151|NCT01218971|11647337|FG001|COMPLETED|Overall Study||77
10497152|NCT01218971|11647336|FG000|NOT COMPLETED|Overall Study||104
10497153|NCT01218971|11647337|FG001|NOT COMPLETED|Overall Study||80
10497154|NCT01218984|11647350|FG000|STARTED|Overall Study||9
10497155|NCT01218984|11647351|FG001|STARTED|Overall Study||8
10497156|NCT01218984|11647352|FG002|STARTED|Overall Study||10
10497157|NCT01218984|11647350|FG000|COMPLETED|Overall Study||8
10497158|NCT01218984|11647351|FG001|COMPLETED|Overall Study||6
10497159|NCT01218984|11647352|FG002|COMPLETED|Overall Study||7
10497160|NCT01218984|11647350|FG000|NOT COMPLETED|Overall Study||1
10497161|NCT01218984|11647351|FG001|NOT COMPLETED|Overall Study||2
10497162|NCT01218984|11647352|FG002|NOT COMPLETED|Overall Study||3
10497163|NCT01218997|11647362|FG000|STARTED|Overall Study||371
10497164|NCT01218997|11647363|FG001|STARTED|Overall Study||65
10497165|NCT01218997|11647362|FG000|COMPLETED|Overall Study||126
10497166|NCT01218997|11647363|FG001|COMPLETED|Overall Study||24
10497167|NCT01218997|11647362|FG000|NOT COMPLETED|Overall Study||245
10497168|NCT01218997|11647363|FG001|NOT COMPLETED|Overall Study||41
10497169|NCT01219738|11647369|FG000|STARTED|Overall Study||20
10497170|NCT01219738|11647369|FG000|Budesonide 360|Overall Study||20
10497171|NCT01219738|11647369|FG000|Budesonide 720|Overall Study||20
10497172|NCT01219738|11647369|FG000|Budesonide 1440|Overall Study||20
10497173|NCT01219738|11647369|FG000|Budesonide 720- 4 Times|Overall Study||20
10497174|NCT01219738|11647369|FG000|COMPLETED|Overall Study||20
10497175|NCT01219738|11647369|FG000|NOT COMPLETED|Overall Study||0
10497176|NCT01219777|11647382|FG000|STARTED|Overall Study||9
10497177|NCT01219777|11647382|FG000|COMPLETED|Overall Study||9
10497178|NCT01219777|11647382|FG000|NOT COMPLETED|Overall Study||0
10497179|NCT01219855|11647392|FG000|STARTED|Overall Study||17
10497180|NCT01219855|11647393|FG001|STARTED|Overall Study||17
10497181|NCT01219855|11647394|FG002|STARTED|Overall Study||17
10497182|NCT01219855|11647395|FG003|STARTED|Overall Study||13
10497183|NCT01219855|11647396|FG004|STARTED|Overall Study||14
10497184|NCT01219855|11647392|FG000|COMPLETED|Overall Study||16
10497185|NCT01219855|11647393|FG001|COMPLETED|Overall Study||12
10497186|NCT01219855|11647394|FG002|COMPLETED|Overall Study||16
10497187|NCT01219855|11647395|FG003|COMPLETED|Overall Study||12
10497188|NCT01219855|11647396|FG004|COMPLETED|Overall Study||13
10497189|NCT01219855|11647392|FG000|NOT COMPLETED|Overall Study||1
10497190|NCT01219855|11647393|FG001|NOT COMPLETED|Overall Study||5
10497191|NCT01219855|11647394|FG002|NOT COMPLETED|Overall Study||1
10497192|NCT01219855|11647395|FG003|NOT COMPLETED|Overall Study||1
10497193|NCT01219855|11647396|FG004|NOT COMPLETED|Overall Study||1
10497194|NCT01219881|11647409|FG000|STARTED|Overall Study||38
10497195|NCT01219881|11647410|FG001|STARTED|Overall Study||37
10497196|NCT01219881|11647409|FG000|COMPLETED|Overall Study||34
10497197|NCT01219881|11647410|FG001|COMPLETED|Overall Study||32
10497198|NCT01219881|11647409|FG000|NOT COMPLETED|Overall Study||4
10497199|NCT01219881|11647410|FG001|NOT COMPLETED|Overall Study||5
10497200|NCT01219933|11647416|FG000|STARTED|Overall Study||68
10497201|NCT01219933|11647416|FG000|COMPLETED|Overall Study||30
10497202|NCT01219933|11647416|FG000|NOT COMPLETED|Overall Study||38
10497203|NCT01219959|11647423|FG000|STARTED|Overall Study||127
10497204|NCT01219959|11647424|FG001|STARTED|Overall Study||124
10497205|NCT01219959|11647423|FG000|COMPLETED|Overall Study||120
10497206|NCT01219959|11647424|FG001|COMPLETED|Overall Study||101
10497207|NCT01219959|11647423|FG000|NOT COMPLETED|Overall Study||7
10497208|NCT01219959|11647424|FG001|NOT COMPLETED|Overall Study||23
10497209|NCT01219985|11647430|FG000|STARTED|Overall Study||50
10497210|NCT01219985|11647430|FG000|COMPLETED|Overall Study||30
10497211|NCT01219985|11647430|FG000|NOT COMPLETED|Overall Study||20
10497212|NCT01220024|11647438|FG000|STARTED|Overall Study||25
10497213|NCT01220024|11647439|FG001|STARTED|Overall Study||25
10497214|NCT01220024|11647438|FG000|COMPLETED|Overall Study||24
10497215|NCT01220024|11647439|FG001|COMPLETED|Overall Study||24
10497216|NCT01220024|11647438|FG000|NOT COMPLETED|Overall Study||1
10497217|NCT01220024|11647439|FG001|NOT COMPLETED|Overall Study||1
10497218|NCT01220128|11647452|FG000|STARTED|Overall Study||15
10497219|NCT01220128|11647453|FG001|STARTED|Overall Study||7
10497220|NCT01220128|11647454|FG002|STARTED|Overall Study||9
10497221|NCT01220128|11647455|FG003|STARTED|Overall Study||6
10497222|NCT01220128|11647456|FG004|STARTED|Overall Study||11
10497223|NCT01220128|11647457|FG005|STARTED|Overall Study||4
10497224|NCT01220128|11647458|FG006|STARTED|Overall Study||8
10497225|NCT01220128|11647452|FG000|COMPLETED|Overall Study||11
10497226|NCT01220128|11647453|FG001|COMPLETED|Overall Study||6
10497227|NCT01220128|11647454|FG002|COMPLETED|Overall Study||6
10497228|NCT01220128|11647455|FG003|COMPLETED|Overall Study||6
10497229|NCT01220128|11647456|FG004|COMPLETED|Overall Study||11
10497230|NCT01220128|11647457|FG005|COMPLETED|Overall Study||4
10497231|NCT01220128|11647458|FG006|COMPLETED|Overall Study||3
10497232|NCT01220128|11647452|FG000|NOT COMPLETED|Overall Study||4
10497233|NCT01220128|11647453|FG001|NOT COMPLETED|Overall Study||1
10497234|NCT01220128|11647454|FG002|NOT COMPLETED|Overall Study||3
10497235|NCT01220128|11647455|FG003|NOT COMPLETED|Overall Study||0
10497236|NCT01220128|11647456|FG004|NOT COMPLETED|Overall Study||0
10497237|NCT01220128|11647457|FG005|NOT COMPLETED|Overall Study||0
10497238|NCT01220128|11647458|FG006|NOT COMPLETED|Overall Study||5
10497239|NCT01220167|11647478|FG000|STARTED|Period 1||6
10497240|NCT01220167|11647479|FG001|STARTED|Period 1||6
10497241|NCT01220167|11647480|FG002|STARTED|Period 1||6
10497242|NCT01220167|11647478|FG000|COMPLETED|Period 1||6
10497243|NCT01220167|11647479|FG001|COMPLETED|Period 1||6
10497244|NCT01220167|11647480|FG002|COMPLETED|Period 1||6
10497245|NCT01220167|11647478|FG000|NOT COMPLETED|Period 1||0
10497246|NCT01220167|11647479|FG001|NOT COMPLETED|Period 1||0
10497247|NCT01220167|11647480|FG002|NOT COMPLETED|Period 1||0
10497248|NCT01220167|11647478|FG000|STARTED|Period 2||6
10497249|NCT01220167|11647479|FG001|STARTED|Period 2||6
10497250|NCT01220167|11647480|FG002|STARTED|Period 2||6
10497251|NCT01220167|11647478|FG000|COMPLETED|Period 2||6
10497252|NCT01220167|11647479|FG001|COMPLETED|Period 2||6
10497253|NCT01220167|11647480|FG002|COMPLETED|Period 2||6
10497254|NCT01220167|11647478|FG000|NOT COMPLETED|Period 2||0
10497255|NCT01220167|11647479|FG001|NOT COMPLETED|Period 2||0
10497256|NCT01220167|11647480|FG002|NOT COMPLETED|Period 2||0
10497257|NCT01220167|11647478|FG000|STARTED|Period 3||6
10497258|NCT01220167|11647479|FG001|STARTED|Period 3||6
10497259|NCT01220167|11647480|FG002|STARTED|Period 3||6
10497260|NCT01220167|11647478|FG000|COMPLETED|Period 3||6
10497261|NCT01220167|11647479|FG001|COMPLETED|Period 3||5
10497262|NCT01220167|11647480|FG002|COMPLETED|Period 3||6
10497263|NCT01220167|11647478|FG000|NOT COMPLETED|Period 3||0
10497264|NCT01220167|11647479|FG001|NOT COMPLETED|Period 3||1
10497265|NCT01220167|11647480|FG002|NOT COMPLETED|Period 3||0
10497266|NCT01220180|11647489|FG000|STARTED|Overall Study||4175
10497267|NCT01220180|11647489|FG000|Treated|Overall Study||4174
10497268|NCT01220180|11647489|FG000|COMPLETED|Overall Study||3968
10497269|NCT01220180|11647489|FG000|NOT COMPLETED|Overall Study||207
10497270|NCT01220297|11647495|FG000|STARTED|Overall Study||3
10497271|NCT01220297|11647495|FG000|COMPLETED|Overall Study||0
10497272|NCT01220297|11647495|FG000|NOT COMPLETED|Overall Study||3
10497273|NCT01220401|11647501|FG000|STARTED|Overall Study||21
10497274|NCT01220401|11647501|FG000|COMPLETED|Overall Study||18
10497275|NCT01220401|11647501|FG000|NOT COMPLETED|Overall Study||3
10497276|NCT01220414|11647507|FG000|STARTED|Overall Study||15
10497277|NCT01220414|11647508|FG001|STARTED|Overall Study||14
10497278|NCT01220414|11647509|FG002|STARTED|Overall Study||14
10497279|NCT01220414|11647510|FG003|STARTED|Overall Study||15
10497280|NCT01220414|11647507|FG000|COMPLETED|Overall Study||14
10497281|NCT01220414|11647508|FG001|COMPLETED|Overall Study||14
10497282|NCT01220414|11647509|FG002|COMPLETED|Overall Study||14
10497283|NCT01220414|11647510|FG003|COMPLETED|Overall Study||14
10497284|NCT01220414|11647507|FG000|NOT COMPLETED|Overall Study||1
10497285|NCT01220414|11647508|FG001|NOT COMPLETED|Overall Study||0
10497286|NCT01220414|11647509|FG002|NOT COMPLETED|Overall Study||0
10497287|NCT01220414|11647510|FG003|NOT COMPLETED|Overall Study||1
10497288|NCT01220466|11647520|FG000|STARTED|Overall Study|19 eyes|11
10497289|NCT01220466|11647521|FG001|STARTED|Overall Study|108 eyes|56
10497290|NCT01220466|11647522|FG002|STARTED|Overall Study|16 eyes|10
10497291|NCT01220466|11647520|FG000|COMPLETED|Overall Study|19 eyes|11
10497292|NCT01220466|11647521|FG001|COMPLETED|Overall Study|108 eyes|56
10497293|NCT01220466|11647522|FG002|COMPLETED|Overall Study|16 eyes|10
10497294|NCT01220466|11647520|FG000|NOT COMPLETED|Overall Study||0
10497295|NCT01220466|11647521|FG001|NOT COMPLETED|Overall Study||0
10497296|NCT01220466|11647522|FG002|NOT COMPLETED|Overall Study||0
10497297|NCT01220557|11647532|FG000|STARTED|Overall Study||81
10497298|NCT01220557|11647533|FG001|STARTED|Overall Study||79
10497299|NCT01220557|11647532|FG000|COMPLETED|Overall Study|per protocol analysis including patients which participated in at least 6 out of 12 lessons.|75
10497300|NCT01220557|11647533|FG001|COMPLETED|Overall Study|per protocol analysis including patients which participated in at least 6 out of 12 lessons.|74
10497301|NCT01220557|11647532|FG000|NOT COMPLETED|Overall Study||6
10497302|NCT01220557|11647533|FG001|NOT COMPLETED|Overall Study||5
10497303|NCT01220609|11647539|FG000|STARTED|Overall Study||26
10497304|NCT01220609|11647539|FG000|COMPLETED|Overall Study|Eligible and treated patients|23
10497305|NCT01220609|11647539|FG000|NOT COMPLETED|Overall Study||3
10497306|NCT01220687|11647551|FG000|STARTED|Overall Study||16
10497307|NCT01220687|11647552|FG001|STARTED|Overall Study||15
10497308|NCT01220687|11647551|FG000|COMPLETED|Overall Study||14
10497309|NCT01220687|11647552|FG001|COMPLETED|Overall Study||14
10497310|NCT01220687|11647551|FG000|NOT COMPLETED|Overall Study||2
10497311|NCT01220687|11647552|FG001|NOT COMPLETED|Overall Study||1
10497312|NCT01220726|11647560|FG000|STARTED|Overall Study||15
10497313|NCT01220726|11647561|FG001|STARTED|Overall Study||15
10497314|NCT01220726|11647560|FG000|COMPLETED|Overall Study||15
10497315|NCT01220726|11647561|FG001|COMPLETED|Overall Study||13
10497316|NCT01220726|11647560|FG000|NOT COMPLETED|Overall Study||0
10497317|NCT01220726|11647561|FG001|NOT COMPLETED|Overall Study||2
10497318|NCT01220739|11647569|FG000|STARTED|Overall Study||7
10497319|NCT01220739|11647570|FG001|STARTED|Overall Study||5
10497320|NCT01220739|11647569|FG000|COMPLETED|Overall Study||7
10497321|NCT01220739|11647570|FG001|COMPLETED|Overall Study||5
10497322|NCT01220739|11647569|FG000|NOT COMPLETED|Overall Study||0
10497323|NCT01220739|11647570|FG001|NOT COMPLETED|Overall Study||0
10497324|NCT01220856|11647578|FG000|STARTED|Overall Study||6
10497325|NCT01220856|11647579|FG001|STARTED|Overall Study||3
10497326|NCT01220856|11647578|FG000|COMPLETED|Overall Study||2
10497327|NCT01220856|11647579|FG001|COMPLETED|Overall Study||0
10497328|NCT01220856|11647578|FG000|NOT COMPLETED|Overall Study||4
10497329|NCT01220856|11647579|FG001|NOT COMPLETED|Overall Study||3
10497330|NCT01220869|11647588|FG000|STARTED|Overall Study||110
10497331|NCT01220869|11647588|FG000|COMPLETED|Overall Study||104
10497332|NCT01220869|11647588|FG000|NOT COMPLETED|Overall Study||6
10497333|NCT01220973|11647592|FG000|STARTED|Overall Study||27
10497334|NCT01220973|11647592|FG000|COMPLETED|Overall Study||23
10497335|NCT01220973|11647592|FG000|NOT COMPLETED|Overall Study||4
10497336|NCT01220999|11647601|FG000|STARTED|Overall Study||2
10497337|NCT01220999|11647602|FG001|STARTED|Overall Study||4
10497338|NCT01220999|11647603|FG002|STARTED|Overall Study||5
10497339|NCT01220999|11647604|FG003|STARTED|Overall Study||3
10497340|NCT01220999|11647605|FG004|STARTED|Overall Study||5
10497341|NCT01220999|11647601|FG000|COMPLETED|Overall Study||2
10497342|NCT01220999|11647602|FG001|COMPLETED|Overall Study||4
10497343|NCT01220999|11647603|FG002|COMPLETED|Overall Study||4
10497344|NCT01220999|11647604|FG003|COMPLETED|Overall Study||3
10497345|NCT01220999|11647605|FG004|COMPLETED|Overall Study||5
10497346|NCT01220999|11647601|FG000|NOT COMPLETED|Overall Study||0
10497347|NCT01220999|11647602|FG001|NOT COMPLETED|Overall Study||0
10497348|NCT01220999|11647603|FG002|NOT COMPLETED|Overall Study||1
10497349|NCT01220999|11647604|FG003|NOT COMPLETED|Overall Study||0
10497350|NCT01220999|11647605|FG004|NOT COMPLETED|Overall Study||0
10497351|NCT01221090|11647621|FG000|STARTED|Overall Study||101
10497352|NCT01221090|11647622|FG001|STARTED|Overall Study||81
10497353|NCT01221090|11647623|FG002|STARTED|Overall Study||99
10497354|NCT01221090|11647624|FG003|STARTED|Overall Study||95
10497355|NCT01221090|11647621|FG000|COMPLETED|Overall Study||86
10497356|NCT01221090|11647622|FG001|COMPLETED|Overall Study||47
10497357|NCT01221090|11647623|FG002|COMPLETED|Overall Study||57
10497358|NCT01221090|11647624|FG003|COMPLETED|Overall Study||73
10497359|NCT01221090|11647621|FG000|NOT COMPLETED|Overall Study||15
10497360|NCT01221090|11647622|FG001|NOT COMPLETED|Overall Study||34
10497361|NCT01221090|11647623|FG002|NOT COMPLETED|Overall Study||42
10497362|NCT01221090|11647624|FG003|NOT COMPLETED|Overall Study||22
10497363|NCT01221181|11647634|FG000|STARTED|Overall Study||6
10497364|NCT01221181|11647634|FG000|COMPLETED|Overall Study||5
10497365|NCT01221181|11647634|FG000|NOT COMPLETED|Overall Study||1
10497366|NCT01221194|11647640|FG000|STARTED|Overall Study||195
10497367|NCT01221194|11647641|FG001|STARTED|Overall Study||186
10497368|NCT01221194|11647640|FG000|COMPLETED|Overall Study||195
10497369|NCT01221194|11647641|FG001|COMPLETED|Overall Study||186
10497370|NCT01221194|11647640|FG000|NOT COMPLETED|Overall Study||0
10497371|NCT01221194|11647641|FG001|NOT COMPLETED|Overall Study||0
10497372|NCT01221207|11647650|FG000|STARTED|Overall Study||75
10497373|NCT01221207|11647651|FG001|STARTED|Overall Study||75
10497374|NCT01221207|11647652|FG002|STARTED|Overall Study||75
10497375|NCT01221207|11647650|FG000|COMPLETED|Overall Study||43
10497376|NCT01221207|11647651|FG001|COMPLETED|Overall Study||66
10497377|NCT01221207|11647652|FG002|COMPLETED|Overall Study||54
10497378|NCT01221207|11647650|FG000|NOT COMPLETED|Overall Study||32
10497379|NCT01221207|11647651|FG001|NOT COMPLETED|Overall Study||9
10497380|NCT01221207|11647652|FG002|NOT COMPLETED|Overall Study||21
10497381|NCT01221233|11647662|FG000|STARTED|Overall Study||18
10497382|NCT01221233|11647663|FG001|STARTED|Overall Study||20
10497383|NCT01221233|11647662|FG000|COMPLETED|Overall Study||15
10497384|NCT01221233|11647663|FG001|COMPLETED|Overall Study||19
10497385|NCT01221233|11647662|FG000|NOT COMPLETED|Overall Study||3
10497386|NCT01221233|11647663|FG001|NOT COMPLETED|Overall Study||1
10497387|NCT01221272|11647669|FG000|STARTED|Period 1||41
10497388|NCT01221272|11647670|FG001|STARTED|Period 1||40
10497389|NCT01221272|11647669|FG000|COMPLETED|Period 1||39
10497390|NCT01221272|11647670|FG001|COMPLETED|Period 1||38
10497391|NCT01221272|11647669|FG000|NOT COMPLETED|Period 1||2
10497392|NCT01221272|11647670|FG001|NOT COMPLETED|Period 1||2
10497393|NCT01221272|11647669|FG000|STARTED|Period 2||39
10497394|NCT01221272|11647670|FG001|STARTED|Period 2|1 participant did not complete Period 1, but started and completed Period 2.|39
10497395|NCT01221272|11647669|FG000|COMPLETED|Period 2||39
10497396|NCT01221272|11647670|FG001|COMPLETED|Period 2||37
10497397|NCT01221272|11647669|FG000|NOT COMPLETED|Period 2||0
10497398|NCT01221272|11647670|FG001|NOT COMPLETED|Period 2||2
10497399|NCT01221285|11647679|FG000|STARTED|Overall Study||11
10497400|NCT01221285|11647679|FG000|COMPLETED|Overall Study||10
10497401|NCT01221285|11647679|FG000|NOT COMPLETED|Overall Study||1
10497402|NCT01221298|11647683|FG000|STARTED|Overall Study||11
10497403|NCT01221298|11647683|FG000|COMPLETED|Overall Study|The number of participants who completed study drug|11
10497404|NCT01221298|11647683|FG000|NOT COMPLETED|Overall Study||0
10497405|NCT01221311|11647689|FG000|STARTED|Overall Study||57
10497406|NCT01221311|11647690|FG001|STARTED|Overall Study||55
10497407|NCT01221311|11647689|FG000|COMPLETED|Overall Study||57
10497408|NCT01221311|11647690|FG001|COMPLETED|Overall Study||55
10497409|NCT01221311|11647689|FG000|NOT COMPLETED|Overall Study||0
10497410|NCT01221311|11647690|FG001|NOT COMPLETED|Overall Study||0
10497411|NCT01221350|11647698|FG000|STARTED|Overall Study||28
10497412|NCT01221350|11647699|FG001|STARTED|Overall Study||27
10497413|NCT01221350|11647698|FG000|Received Intervention|Overall Study||28
10497414|NCT01221350|11647699|FG001|Received Intervention|Overall Study||27
10497415|NCT01221350|11647698|FG000|Analysis Population|Overall Study||23
10497416|NCT01221350|11647699|FG001|Analysis Population|Overall Study||24
10497417|NCT01221350|11647698|FG000|COMPLETED|Overall Study||23
10497418|NCT01221350|11647699|FG001|COMPLETED|Overall Study||24
10497419|NCT01221350|11647698|FG000|NOT COMPLETED|Overall Study||5
10497420|NCT01221350|11647699|FG001|NOT COMPLETED|Overall Study||3
10497421|NCT01221363|11647709|FG000|STARTED|Overall Study||93
10497422|NCT01221363|11647710|FG001|STARTED|Overall Study||73
10497423|NCT01221363|11647709|FG000|COMPLETED|Overall Study||81
10497424|NCT01221363|11647710|FG001|COMPLETED|Overall Study||68
10497425|NCT01221363|11647709|FG000|NOT COMPLETED|Overall Study||12
10497426|NCT01221363|11647710|FG001|NOT COMPLETED|Overall Study||5
10497427|NCT01221441|11647718|FG000|STARTED|Overall Study||67
10497428|NCT01221441|11647719|FG001|STARTED|Overall Study||35
10497429|NCT01221441|11647718|FG000|COMPLETED|Overall Study||45
10497430|NCT01221441|11647719|FG001|COMPLETED|Overall Study||23
10497431|NCT01221441|11647718|FG000|NOT COMPLETED|Overall Study||22
10497432|NCT01221441|11647719|FG001|NOT COMPLETED|Overall Study||12
10497433|NCT01221597|11647727|FG000|STARTED|Overall Study||277
10497434|NCT01221597|11647728|FG001|STARTED|Overall Study||140
10497435|NCT01221597|11647727|FG000|COMPLETED|Overall Study||241
10497436|NCT01221597|11647728|FG001|COMPLETED|Overall Study||124
10497437|NCT01221597|11647727|FG000|NOT COMPLETED|Overall Study||36
10497438|NCT01221597|11647728|FG001|NOT COMPLETED|Overall Study||16
10497439|NCT01221623|11647737|FG000|STARTED|Overall Study||274
10497440|NCT01221623|11647738|FG001|STARTED|Overall Study||141
10497441|NCT01221623|11647737|FG000|COMPLETED|Overall Study||236
10497442|NCT01221623|11647738|FG001|COMPLETED|Overall Study||127
10497443|NCT01221623|11647737|FG000|NOT COMPLETED|Overall Study||38
10497444|NCT01221623|11647738|FG001|NOT COMPLETED|Overall Study||14
10497445|NCT01221727|11647746|FG000|STARTED|Overall Study|Number of subjects randomized into the study|21
10497446|NCT01221727|11647747|FG001|STARTED|Overall Study|Number of subjects randomized into the study|9
10497447|NCT01221727|11647746|FG000|Treated|Overall Study|Number of subjects received investigational product|19
10497448|NCT01221727|11647747|FG001|Treated|Overall Study|Number of subjects received investigational product|8
10497449|NCT01221727|11647746|FG000|COMPLETED|Overall Study||18
10497450|NCT01221727|11647747|FG001|COMPLETED|Overall Study||8
10497451|NCT01221727|11647746|FG000|NOT COMPLETED|Overall Study||3
10497452|NCT01221727|11647747|FG001|NOT COMPLETED|Overall Study||1
10497453|NCT01221753|11647759|FG000|STARTED|Overall Study||7
10497454|NCT01221753|11647759|FG000|COMPLETED|Overall Study||6
10497455|NCT01221753|11647759|FG000|NOT COMPLETED|Overall Study||1
10497456|NCT01221857|11647763|FG000|STARTED|Overall Study||12
10497457|NCT01221857|11647763|FG000|COMPLETED|Overall Study||12
10497458|NCT01221857|11647763|FG000|NOT COMPLETED|Overall Study||0
10497459|NCT01221948|11647771|FG000|STARTED|Overall Study||53
10497460|NCT01221948|11647771|FG000|COMPLETED|Overall Study||39
10497461|NCT01221948|11647771|FG000|NOT COMPLETED|Overall Study||14
10497462|NCT01222078|11647775|FG000|STARTED|Overall Study||1
10497463|NCT01222078|11647775|FG000|COMPLETED|Overall Study||0
10497464|NCT01222078|11647775|FG000|NOT COMPLETED|Overall Study||1
10497465|NCT01222091|11647780|FG000|STARTED|Overall Study||5
10497466|NCT01222091|11647781|FG001|STARTED|Overall Study||5
10497467|NCT01222091|11647780|FG000|COMPLETED|Overall Study||5
10497468|NCT01222091|11647781|FG001|COMPLETED|Overall Study||5
10497469|NCT01222091|11647780|FG000|NOT COMPLETED|Overall Study||0
10497470|NCT01222091|11647781|FG001|NOT COMPLETED|Overall Study||0
10497471|NCT01222104|11647787|FG000|STARTED|Overall Study||634
10497472|NCT01222104|11647787|FG000|Angio-Seal Deployment Attempted|Overall Study||534
10497473|NCT01222104|11647787|FG000|Successful Deployment|Overall Study||529
10497474|NCT01222104|11647787|FG000|Successful Deployment and Hemostasis|Overall Study||524
10497475|NCT01222104|11647787|FG000|Completed 30-day Visit-Angio-Seal|Overall Study||497
10497476|NCT01222104|11647787|FG000|Completed 30-day Visit-No Angio-Seal|Overall Study||90
10497477|NCT01222104|11647787|FG000|COMPLETED|Overall Study||587
10497478|NCT01222104|11647787|FG000|NOT COMPLETED|Overall Study||47
10497479|NCT01222117|11647808|FG000|STARTED|Overall Study||20
10497480|NCT01222117|11647809|FG001|STARTED|Overall Study||20
10497481|NCT01222117|11647810|FG002|STARTED|Overall Study||22
10497482|NCT01222117|11647811|FG003|STARTED|Overall Study||20
10497483|NCT01222117|11647812|FG004|STARTED|Overall Study||9
10497484|NCT01222117|11647813|FG005|STARTED|Overall Study||10
10497485|NCT01222117|11647814|FG006|STARTED|Overall Study||13
10497486|NCT01222117|11647815|FG007|STARTED|Overall Study||12
10497487|NCT01222117|11647816|FG008|STARTED|Overall Study||23
10497488|NCT01222117|11647817|FG009|STARTED|Overall Study||19
10497489|NCT01222117|11647818|FG010|STARTED|Overall Study||6
10497490|NCT01222117|11647808|FG000|COMPLETED|Overall Study||17
10497491|NCT01222117|11647809|FG001|COMPLETED|Overall Study||19
10497492|NCT01222117|11647810|FG002|COMPLETED|Overall Study||22
10497493|NCT01222117|11647811|FG003|COMPLETED|Overall Study||19
10497494|NCT01222117|11647812|FG004|COMPLETED|Overall Study||8
10497495|NCT01222117|11647813|FG005|COMPLETED|Overall Study||9
10497496|NCT01222117|11647814|FG006|COMPLETED|Overall Study||13
10497497|NCT01222117|11647815|FG007|COMPLETED|Overall Study||12
10497498|NCT01222117|11647816|FG008|COMPLETED|Overall Study||20
10497499|NCT01222117|11647817|FG009|COMPLETED|Overall Study||17
10497500|NCT01222117|11647818|FG010|COMPLETED|Overall Study||6
10497501|NCT01222117|11647808|FG000|NOT COMPLETED|Overall Study||3
10497502|NCT01222117|11647809|FG001|NOT COMPLETED|Overall Study||1
10497503|NCT01222117|11647810|FG002|NOT COMPLETED|Overall Study||0
10497504|NCT01222117|11647811|FG003|NOT COMPLETED|Overall Study||1
10497505|NCT01222117|11647812|FG004|NOT COMPLETED|Overall Study||1
10497506|NCT01222117|11647813|FG005|NOT COMPLETED|Overall Study||1
10497507|NCT01222117|11647814|FG006|NOT COMPLETED|Overall Study||0
10497508|NCT01222117|11647815|FG007|NOT COMPLETED|Overall Study||0
10710480|NCT02650856|11875702|FG000|24 Hours|Overall Study||19
10497509|NCT01222117|11647816|FG008|NOT COMPLETED|Overall Study||3
10497510|NCT01222117|11647817|FG009|NOT COMPLETED|Overall Study||2
10497511|NCT01222117|11647818|FG010|NOT COMPLETED|Overall Study||0
10497512|NCT01222195|11647842|FG000|STARTED|Overall Study||1
10497513|NCT01222195|11647842|FG000|COMPLETED|Overall Study||1
10650352|NCT02168946|11810612|FG000|COMPLETED|Overall Study||38
10650353|NCT02168946|11810613|FG001|COMPLETED|Overall Study||20
10650354|NCT02168946|11810612|FG000|NOT COMPLETED|Overall Study||12
10650355|NCT02168946|11810613|FG001|NOT COMPLETED|Overall Study||5
10650356|NCT02169115|11810622|FG000|STARTED|Overall Study||19
10650357|NCT02169115|11810623|FG001|STARTED|Overall Study||21
10650358|NCT02169115|11810624|FG002|STARTED|Overall Study||21
10650359|NCT02169115|11810622|FG000|COMPLETED|Overall Study||19
10497514|NCT01222195|11647842|FG000|NOT COMPLETED|Overall Study||0
10497515|NCT01222234|11647849|FG000|STARTED|Overall Study||15
10497516|NCT01222234|11647850|FG001|STARTED|Overall Study||17
10497517|NCT01222234|11647851|FG002|STARTED|Overall Study||24
10497518|NCT01222234|11647849|FG000|COMPLETED|Overall Study||15
10497519|NCT01222234|11647850|FG001|COMPLETED|Overall Study||15
10497520|NCT01222234|11647851|FG002|COMPLETED|Overall Study||22
10497521|NCT01222234|11647849|FG000|NOT COMPLETED|Overall Study||0
10497522|NCT01222234|11647850|FG001|NOT COMPLETED|Overall Study||2
10497523|NCT01222234|11647851|FG002|NOT COMPLETED|Overall Study||2
10497524|NCT01222260|11647860|FG000|STARTED|Overall Study||31
10497525|NCT01222260|11647860|FG000|COMPLETED|Overall Study||29
10497526|NCT01222260|11647860|FG000|NOT COMPLETED|Overall Study||2
10497527|NCT01222273|11647864|FG000|STARTED|Overall Study||7
10497528|NCT01222273|11647864|FG000|COMPLETED|Overall Study||7
10497529|NCT01222273|11647864|FG000|NOT COMPLETED|Overall Study||0
10497530|NCT01222286|11647870|FG000|STARTED|Overall Study||16
10497531|NCT01222286|11647871|FG001|STARTED|Overall Study||14
10497532|NCT01222286|11647870|FG000|COMPLETED|Overall Study||16
10497533|NCT01222286|11647871|FG001|COMPLETED|Overall Study||14
10497534|NCT01222286|11647870|FG000|NOT COMPLETED|Overall Study||0
10497535|NCT01222286|11647871|FG001|NOT COMPLETED|Overall Study||0
10497536|NCT01222299|11647881|FG000|STARTED|Overall Study||21
10497537|NCT01222299|11647882|FG001|STARTED|Overall Study||23
10497538|NCT01222299|11647883|FG002|STARTED|Overall Study||22
10497539|NCT01222299|11647884|FG003|STARTED|Overall Study||23
10497540|NCT01222299|11647881|FG000|COMPLETED|Overall Study||21
10497541|NCT01222299|11647882|FG001|COMPLETED|Overall Study||21
10497542|NCT01222299|11647883|FG002|COMPLETED|Overall Study||20
10497543|NCT01222299|11647884|FG003|COMPLETED|Overall Study||18
10497544|NCT01222299|11647881|FG000|NOT COMPLETED|Overall Study||0
10497545|NCT01222299|11647882|FG001|NOT COMPLETED|Overall Study||2
10497546|NCT01222299|11647883|FG002|NOT COMPLETED|Overall Study||2
10497547|NCT01222299|11647884|FG003|NOT COMPLETED|Overall Study||5
10497548|NCT01222390|11647894|FG000|STARTED|Overall Study||12
10497549|NCT01222390|11647894|FG000|COMPLETED|Overall Study||12
10497550|NCT01222390|11647894|FG000|NOT COMPLETED|Overall Study||0
10497551|NCT01222403|11647900|FG000|STARTED|Overall Study||386
10497552|NCT01222403|11647901|FG001|STARTED|Overall Study||381
10497553|NCT01222403|11647900|FG000|COMPLETED|Overall Study||386
10497554|NCT01222403|11647901|FG001|COMPLETED|Overall Study||379
10497555|NCT01222403|11647900|FG000|NOT COMPLETED|Overall Study||0
10497556|NCT01222403|11647901|FG001|NOT COMPLETED|Overall Study||2
10497557|NCT01222416|11647909|FG000|STARTED|Overall Study||50
10497558|NCT01222416|11647910|FG001|STARTED|Overall Study||0
10497559|NCT01222416|11647909|FG000|COMPLETED|Overall Study||30
10497560|NCT01222416|11647910|FG001|COMPLETED|Overall Study||0
10497561|NCT01222416|11647909|FG000|NOT COMPLETED|Overall Study||20
10497562|NCT01222416|11647910|FG001|NOT COMPLETED|Overall Study||0
10497563|NCT01222494|11647919|FG000|STARTED|Overall Study||7
10497564|NCT01222494|11647920|FG001|STARTED|Overall Study||19
10497565|NCT01222494|11647921|FG002|STARTED|Overall Study||21
10497566|NCT01222494|11647919|FG000|COMPLETED|Overall Study||6
10497567|NCT01222494|11647920|FG001|COMPLETED|Overall Study||15
10497568|NCT01222494|11647921|FG002|COMPLETED|Overall Study||17
10497569|NCT01222494|11647919|FG000|NOT COMPLETED|Overall Study||1
10497570|NCT01222494|11647920|FG001|NOT COMPLETED|Overall Study||4
10497571|NCT01222494|11647921|FG002|NOT COMPLETED|Overall Study||4
10497572|NCT01222507|11647929|FG000|STARTED|Overall Study||62
10497573|NCT01222507|11647929|FG000|COMPLETED|Overall Study||60
10497574|NCT01222507|11647929|FG000|NOT COMPLETED|Overall Study||2
10497575|NCT01222520|11647935|FG000|STARTED|Open-label run-in Period||0
10497576|NCT01222520|11647936|FG001|STARTED|Open-label run-in Period||197
10497577|NCT01222520|11647935|FG000|COMPLETED|Open-label run-in Period||0
10497578|NCT01222520|11647936|FG001|COMPLETED|Open-label run-in Period||174
10497579|NCT01222520|11647935|FG000|NOT COMPLETED|Open-label run-in Period||0
10497580|NCT01222520|11647936|FG001|NOT COMPLETED|Open-label run-in Period||23
10497581|NCT01222520|11647935|FG000|STARTED|Double-blind Period||87
10497582|NCT01222520|11647936|FG001|STARTED|Double-blind Period||87
10497583|NCT01222520|11647935|FG000|COMPLETED|Double-blind Period||86
10497584|NCT01222520|11647936|FG001|COMPLETED|Double-blind Period||85
10497585|NCT01222520|11647935|FG000|NOT COMPLETED|Double-blind Period||1
10497586|NCT01222520|11647936|FG001|NOT COMPLETED|Double-blind Period||2
10497587|NCT01222533|11647942|FG000|STARTED|Overall Study|Entered and treated.|154
10497588|NCT01222533|11647942|FG000|Received Placebo|Overall Study||147
10650360|NCT02169115|11810623|FG001|COMPLETED|Overall Study||21
10650361|NCT02169115|11810624|FG002|COMPLETED|Overall Study||21
10650362|NCT02169115|11810622|FG000|NOT COMPLETED|Overall Study||0
10497589|NCT01222533|11647942|FG000|Received Tio R1.25|Overall Study||147
10497590|NCT01222533|11647942|FG000|Received Tio R2.5|Overall Study||145
10497591|NCT01222533|11647942|FG000|Received Tio R5|Overall Study||150
10497592|NCT01222533|11647942|FG000|Received Tio HH18|Overall Study||146
10497593|NCT01222533|11647942|FG000|COMPLETED|Overall Study|Completed planned observation time (week 21)|140
10497594|NCT01222533|11647942|FG000|NOT COMPLETED|Overall Study||14
10497595|NCT01222572|11647954|FG000|STARTED|Overall Study||1
10497596|NCT01222572|11647955|FG001|STARTED|Overall Study||0
10497597|NCT01222572|11647956|FG002|STARTED|Overall Study||0
10497598|NCT01222572|11647954|FG000|COMPLETED|Overall Study||1
10497599|NCT01222572|11647955|FG001|COMPLETED|Overall Study||0
10497600|NCT01222572|11647956|FG002|COMPLETED|Overall Study||0
10497601|NCT01222572|11647954|FG000|NOT COMPLETED|Overall Study||0
10497602|NCT01222572|11647955|FG001|NOT COMPLETED|Overall Study||0
10497603|NCT01222572|11647956|FG002|NOT COMPLETED|Overall Study||0
10497604|NCT01222585|11647960|FG000|STARTED|Overall Study||24
10497605|NCT01222585|11647960|FG000|COMPLETED|Overall Study||24
10497606|NCT01222585|11647960|FG000|NOT COMPLETED|Overall Study||0
10497607|NCT01222689|11647964|FG000|STARTED|Overall Study||46
10497608|NCT01222689|11647964|FG000|COMPLETED|Overall Study||46
10497609|NCT01222689|11647964|FG000|NOT COMPLETED|Overall Study||0
10497610|NCT01222715|11647970|FG000|STARTED|Overall Study||44
10497611|NCT01222715|11647971|FG001|STARTED|Overall Study||43
10497612|NCT01222715|11647970|FG000|COMPLETED|Overall Study||8
10497613|NCT01222715|11647971|FG001|COMPLETED|Overall Study||16
10497614|NCT01222715|11647970|FG000|NOT COMPLETED|Overall Study||36
10497615|NCT01222715|11647971|FG001|NOT COMPLETED|Overall Study||27
10497616|NCT01222767|11647977|FG000|STARTED|Overall Study||17
10497617|NCT01222767|11647977|FG000|Received Treatment|Overall Study||16
10497618|NCT01222767|11647977|FG000|COMPLETED|Overall Study||0
10497619|NCT01222767|11647977|FG000|NOT COMPLETED|Overall Study||17
10497620|NCT01222832|11647983|FG000|STARTED|Overall Study||113
10497621|NCT01222832|11647984|FG001|STARTED|Overall Study||113
10497622|NCT01222832|11647983|FG000|COMPLETED|Overall Study||113
10497623|NCT01222832|11647984|FG001|COMPLETED|Overall Study||112
10497624|NCT01222832|11647983|FG000|NOT COMPLETED|Overall Study||0
10497625|NCT01222832|11647984|FG001|NOT COMPLETED|Overall Study||1
10497626|NCT01222884|11647992|FG000|STARTED|Overall Study||234
10497627|NCT01222884|11647993|FG001|STARTED|Overall Study||117
10497628|NCT01222884|11647992|FG000|COMPLETED|Overall Study||210
10497629|NCT01222884|11647993|FG001|COMPLETED|Overall Study||113
10497630|NCT01222884|11647992|FG000|NOT COMPLETED|Overall Study||24
10497631|NCT01222884|11647993|FG001|NOT COMPLETED|Overall Study||4
10497632|NCT01223027|11648001|FG000|STARTED|Overall Study||284
10497633|NCT01223027|11648002|FG001|STARTED|Overall Study||286
10497634|NCT01223027|11648001|FG000|COMPLETED|Overall Study|Completed = Ongoing at data cut-off of 25-Jan-2013|10
10497635|NCT01223027|11648002|FG001|COMPLETED|Overall Study|Completed = Ongoing at data cut-off of 25-Jan-2013|9
10497636|NCT01223027|11648001|FG000|NOT COMPLETED|Overall Study||274
10497637|NCT01223027|11648002|FG001|NOT COMPLETED|Overall Study||277
10497638|NCT01223183|11648010|FG000|STARTED|Imaging Day 1||10
10497639|NCT01223183|11648011|FG001|STARTED|Imaging Day 1||10
10497640|NCT01223183|11648010|FG000|COMPLETED|Imaging Day 1||10
10497641|NCT01223183|11648011|FG001|COMPLETED|Imaging Day 1||9
10497642|NCT01223183|11648010|FG000|NOT COMPLETED|Imaging Day 1||0
10497643|NCT01223183|11648011|FG001|NOT COMPLETED|Imaging Day 1||1
10497644|NCT01223183|11648010|FG000|STARTED|Washout Period (5-24 Days)||10
10497645|NCT01223183|11648011|FG001|STARTED|Washout Period (5-24 Days)||9
10497646|NCT01223183|11648010|FG000|COMPLETED|Washout Period (5-24 Days)||8
10497647|NCT01223183|11648011|FG001|COMPLETED|Washout Period (5-24 Days)||9
10497648|NCT01223183|11648010|FG000|NOT COMPLETED|Washout Period (5-24 Days)||2
10497649|NCT01223183|11648011|FG001|NOT COMPLETED|Washout Period (5-24 Days)||0
10497650|NCT01223183|11648010|FG000|STARTED|Imaging Day 2||8
10497651|NCT01223183|11648011|FG001|STARTED|Imaging Day 2||9
10497652|NCT01223183|11648010|FG000|COMPLETED|Imaging Day 2||8
10497653|NCT01223183|11648011|FG001|COMPLETED|Imaging Day 2||9
10497654|NCT01223183|11648010|FG000|NOT COMPLETED|Imaging Day 2||0
10497655|NCT01223183|11648011|FG001|NOT COMPLETED|Imaging Day 2||0
10497656|NCT01223196|11648020|FG000|STARTED|Overall Study||13
10497657|NCT01223196|11648021|FG001|STARTED|Overall Study||11
10497658|NCT01223196|11648020|FG000|COMPLETED|Overall Study||9
10497659|NCT01223196|11648021|FG001|COMPLETED|Overall Study||11
10497660|NCT01223196|11648020|FG000|NOT COMPLETED|Overall Study||4
10497661|NCT01223196|11648021|FG001|NOT COMPLETED|Overall Study||0
10497662|NCT01223235|11648029|FG000|STARTED|Overall Study||22
10497663|NCT01223235|11648029|FG000|COMPLETED|Overall Study||21
10497664|NCT01223235|11648029|FG000|NOT COMPLETED|Overall Study||1
10497665|NCT01223352|11648035|FG000|STARTED|Overall Study||31
10497666|NCT01223352|11648036|FG001|STARTED|Overall Study||33
10497667|NCT01223352|11648035|FG000|COMPLETED|Overall Study||31
10497668|NCT01223352|11648036|FG001|COMPLETED|Overall Study||33
10497669|NCT01223352|11648035|FG000|NOT COMPLETED|Overall Study||0
10497670|NCT01223352|11648036|FG001|NOT COMPLETED|Overall Study||0
10528060|NCT01393405|11680289|FG002|COMPLETED|Induction Period (week1-16)||0
10528061|NCT01393405|11680287|FG000|NOT COMPLETED|Induction Period (week1-16)||95
10528062|NCT01393405|11680288|FG001|NOT COMPLETED|Induction Period (week1-16)||0
10528063|NCT01393405|11680289|FG002|NOT COMPLETED|Induction Period (week1-16)||0
10528064|NCT01393405|11680287|FG000|STARTED|Maintenance Period Week||0
10528065|NCT01393405|11680288|FG001|STARTED|Maintenance Period Week||44
10528066|NCT01393405|11680289|FG002|STARTED|Maintenance Period Week||40
10528067|NCT01393405|11680287|FG000|COMPLETED|Maintenance Period Week||0
10497671|NCT01223365|11648048|FG000|STARTED|Open-label Titration Period||330
10497672|NCT01223365|11648048|FG000|Safety Analysis Set|Open-label Titration Period||329
10497673|NCT01223365|11648048|FG000|Achieved Stable Pain Relief|Open-label Titration Period||294
10497674|NCT01223365|11648048|FG000|COMPLETED|Open-label Titration Period||291
10497675|NCT01223365|11648048|FG000|NOT COMPLETED|Open-label Titration Period||39
10497676|NCT01223365|11648048|FG000|STARTED|Open-label Treatment Period||291
10497677|NCT01223365|11648048|FG000|COMPLETED|Open-label Treatment Period||189
10497678|NCT01223365|11648048|FG000|NOT COMPLETED|Open-label Treatment Period||102
10497679|NCT01223378|11648062|FG000|STARTED|Overall Study||82
10497680|NCT01223378|11648063|FG001|STARTED|Overall Study||85
10497681|NCT01223378|11648064|FG002|STARTED|Overall Study||83
10497682|NCT01223378|11648065|FG003|STARTED|Overall Study||81
10497683|NCT01223378|11648066|FG004|STARTED|Overall Study||82
10497684|NCT01223378|11648062|FG000|COMPLETED|Overall Study||76
10497685|NCT01223378|11648063|FG001|COMPLETED|Overall Study||81
10497686|NCT01223378|11648064|FG002|COMPLETED|Overall Study||80
10497687|NCT01223378|11648065|FG003|COMPLETED|Overall Study||80
10497688|NCT01223378|11648066|FG004|COMPLETED|Overall Study||79
10497689|NCT01223378|11648062|FG000|NOT COMPLETED|Overall Study||6
10497690|NCT01223378|11648063|FG001|NOT COMPLETED|Overall Study||4
10497691|NCT01223378|11648064|FG002|NOT COMPLETED|Overall Study||3
10497692|NCT01223378|11648065|FG003|NOT COMPLETED|Overall Study||1
10497693|NCT01223378|11648066|FG004|NOT COMPLETED|Overall Study||3
10497694|NCT01223404|11648078|FG000|STARTED|First Intervention (1 Day)||4
10497695|NCT01223404|11648079|FG001|STARTED|First Intervention (1 Day)||3
10497696|NCT01223404|11648080|FG002|STARTED|First Intervention (1 Day)||4
10497697|NCT01223404|11648081|FG003|STARTED|First Intervention (1 Day)||5
10497698|NCT01223404|11648082|FG004|STARTED|First Intervention (1 Day)||2
10497699|NCT01223404|11648083|FG005|STARTED|First Intervention (1 Day)||3
10497700|NCT01223404|11648078|FG000|COMPLETED|First Intervention (1 Day)||4
10497701|NCT01223404|11648079|FG001|COMPLETED|First Intervention (1 Day)||3
10497702|NCT01223404|11648080|FG002|COMPLETED|First Intervention (1 Day)||4
10497703|NCT01223404|11648081|FG003|COMPLETED|First Intervention (1 Day)||4
10497704|NCT01223404|11648082|FG004|COMPLETED|First Intervention (1 Day)||2
10497705|NCT01223404|11648083|FG005|COMPLETED|First Intervention (1 Day)||3
10497706|NCT01223404|11648078|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10497707|NCT01223404|11648079|FG001|NOT COMPLETED|First Intervention (1 Day)||0
10497708|NCT01223404|11648080|FG002|NOT COMPLETED|First Intervention (1 Day)||0
10497709|NCT01223404|11648081|FG003|NOT COMPLETED|First Intervention (1 Day)||1
10497710|NCT01223404|11648082|FG004|NOT COMPLETED|First Intervention (1 Day)||0
10497711|NCT01223404|11648083|FG005|NOT COMPLETED|First Intervention (1 Day)||0
10497712|NCT01223404|11648078|FG000|STARTED|Second Intervention (1 Day)||4
10497713|NCT01223404|11648079|FG001|STARTED|Second Intervention (1 Day)||3
10497714|NCT01223404|11648080|FG002|STARTED|Second Intervention (1 Day)||4
10497715|NCT01223404|11648081|FG003|STARTED|Second Intervention (1 Day)||4
10497716|NCT01223404|11648082|FG004|STARTED|Second Intervention (1 Day)||2
10497717|NCT01223404|11648083|FG005|STARTED|Second Intervention (1 Day)||3
10497718|NCT01223404|11648078|FG000|COMPLETED|Second Intervention (1 Day)||3
10497719|NCT01223404|11648079|FG001|COMPLETED|Second Intervention (1 Day)||3
10497720|NCT01223404|11648080|FG002|COMPLETED|Second Intervention (1 Day)||4
10497721|NCT01223404|11648081|FG003|COMPLETED|Second Intervention (1 Day)||4
10497722|NCT01223404|11648082|FG004|COMPLETED|Second Intervention (1 Day)||2
10497723|NCT01223404|11648083|FG005|COMPLETED|Second Intervention (1 Day)||3
10497724|NCT01223404|11648078|FG000|NOT COMPLETED|Second Intervention (1 Day)||1
10497725|NCT01223404|11648079|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10497726|NCT01223404|11648080|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
10497727|NCT01223404|11648081|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
10497728|NCT01223404|11648082|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
10497729|NCT01223404|11648083|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
10497730|NCT01223404|11648078|FG000|STARTED|Third Intervention (1 Day)||3
10497731|NCT01223404|11648079|FG001|STARTED|Third Intervention (1 Day)||3
10497732|NCT01223404|11648080|FG002|STARTED|Third Intervention (1 Day)||4
10497733|NCT01223404|11648081|FG003|STARTED|Third Intervention (1 Day)||4
10497734|NCT01223404|11648082|FG004|STARTED|Third Intervention (1 Day)||2
10497735|NCT01223404|11648083|FG005|STARTED|Third Intervention (1 Day)||3
10497736|NCT01223404|11648078|FG000|COMPLETED|Third Intervention (1 Day)||3
10497737|NCT01223404|11648079|FG001|COMPLETED|Third Intervention (1 Day)||3
10497738|NCT01223404|11648080|FG002|COMPLETED|Third Intervention (1 Day)||4
10497739|NCT01223404|11648081|FG003|COMPLETED|Third Intervention (1 Day)||3
10497740|NCT01223404|11648082|FG004|COMPLETED|Third Intervention (1 Day)||2
10497741|NCT01223404|11648083|FG005|COMPLETED|Third Intervention (1 Day)||3
10497742|NCT01223404|11648078|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
10497743|NCT01223404|11648079|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
10497744|NCT01223404|11648080|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
10497745|NCT01223404|11648081|FG003|NOT COMPLETED|Third Intervention (1 Day)||1
10497746|NCT01223404|11648082|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
10497747|NCT01223404|11648083|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
10497748|NCT01223469|11648101|FG000|STARTED|Overall Study||34
10497749|NCT01223469|11648102|FG001|STARTED|Overall Study||43
10497750|NCT01223469|11648101|FG000|COMPLETED|Overall Study||34
10497751|NCT01223469|11648102|FG001|COMPLETED|Overall Study||43
10497752|NCT01223469|11648101|FG000|NOT COMPLETED|Overall Study||0
10497753|NCT01223469|11648102|FG001|NOT COMPLETED|Overall Study||0
10497754|NCT01223703|11648110|FG000|STARTED|Overall Study||67
10497755|NCT01223703|11648111|FG001|STARTED|Overall Study||66
10497756|NCT01223703|11648110|FG000|COMPLETED|Overall Study||67
10497757|NCT01223703|11648111|FG001|COMPLETED|Overall Study||66
10497758|NCT01223703|11648110|FG000|NOT COMPLETED|Overall Study||0
10497759|NCT01223703|11648111|FG001|NOT COMPLETED|Overall Study||0
10497760|NCT01223937|11648119|FG000|STARTED|Overall Study|Intent to treat population: randomized participants regardless if they were exposed to treatment.|131
10497761|NCT01223937|11648120|FG001|STARTED|Overall Study|Intent to treat population: randomized participants regardless if they were exposed to treatment.|137
10497762|NCT01223937|11648119|FG000|Full Analysis Set (FAS)|Overall Study|FAS: participants with at least one post-treatment efficacy assessment|128
10497763|NCT01223937|11648120|FG001|Full Analysis Set (FAS)|Overall Study|FAS: participants with at least one post-treatment efficacy assessment|133
10497764|NCT01223937|11648119|FG000|Safety Analysis Set (SAS)|Overall Study|SAS: participants with at least one post-treatment safety assessment|126
10497765|NCT01223937|11648120|FG001|Safety Analysis Set (SAS)|Overall Study|SAS: participants with at least one post-treatment safety assessment|135
10497766|NCT01223937|11648119|FG000|COMPLETED|Overall Study||114
10497767|NCT01223937|11648120|FG001|COMPLETED|Overall Study||119
10497768|NCT01223937|11648119|FG000|NOT COMPLETED|Overall Study||17
10497769|NCT01223937|11648120|FG001|NOT COMPLETED|Overall Study||18
10497773|NCT01224015|11648134|FG000|STARTED|Overall Study||361
10497774|NCT01224015|11648135|FG001|STARTED|Overall Study||227
10497775|NCT01224015|11648136|FG002|STARTED|Overall Study||96
10497776|NCT01224015|11648134|FG000|COMPLETED|Overall Study||347
10497777|NCT01224015|11648135|FG001|COMPLETED|Overall Study||211
10497778|NCT01224015|11648136|FG002|COMPLETED|Overall Study||83
10497779|NCT01224015|11648134|FG000|NOT COMPLETED|Overall Study||14
10497780|NCT01224015|11648135|FG001|NOT COMPLETED|Overall Study||16
10497781|NCT01224015|11648136|FG002|NOT COMPLETED|Overall Study||13
10497782|NCT01224145|11648144|FG000|STARTED|Overall Study||10
10497783|NCT01224145|11648144|FG000|COMPLETED|Overall Study||10
10497784|NCT01224145|11648144|FG000|NOT COMPLETED|Overall Study||0
10497785|NCT01224158|11648151|FG000|STARTED|Overall Study||76
10497786|NCT01224158|11648152|FG001|STARTED|Overall Study||77
10497787|NCT01224158|11648151|FG000|COMPLETED|Overall Study||75
10497788|NCT01224158|11648152|FG001|COMPLETED|Overall Study||77
10497789|NCT01224158|11648151|FG000|NOT COMPLETED|Overall Study||1
10497790|NCT01224158|11648152|FG001|NOT COMPLETED|Overall Study||0
10497791|NCT01224171|11648160|FG000|STARTED|Overall Study||207
10497792|NCT01224171|11648161|FG001|STARTED|Overall Study||209
10497793|NCT01224171|11648160|FG000|TNFα Antagonist Failure Population|Overall Study|Previously failed (inadequate response, loss of response, or intolerance) TNFα antagonist therapy|157
10497794|NCT01224171|11648161|FG001|TNFα Antagonist Failure Population|Overall Study|Previously failed (inadequate response, loss of response, or intolerance) TNFα antagonist therapy|158
10497795|NCT01224171|11648160|FG000|COMPLETED|Overall Study|Completed study is defined as patients who completed the Week 10 assessments.|192
10497796|NCT01224171|11648161|FG001|COMPLETED|Overall Study|Completed study is defined as patients who completed the Week 10 assessments.|196
10497797|NCT01224171|11648160|FG000|NOT COMPLETED|Overall Study||15
10497798|NCT01224171|11648161|FG001|NOT COMPLETED|Overall Study||13
10497799|NCT01224210|11648167|FG000|STARTED|Overall Study||30
10497800|NCT01224210|11648167|FG000|COMPLETED|Overall Study||23
10497801|NCT01224210|11648167|FG000|NOT COMPLETED|Overall Study||7
10497802|NCT01224236|11648174|FG000|STARTED|Overall Study||76
10497803|NCT01224236|11648175|FG001|STARTED|Overall Study||74
10497804|NCT01224236|11648174|FG000|COMPLETED|Overall Study||75
10497805|NCT01224236|11648175|FG001|COMPLETED|Overall Study||73
10497806|NCT01224236|11648174|FG000|NOT COMPLETED|Overall Study||1
10497807|NCT01224236|11648175|FG001|NOT COMPLETED|Overall Study||1
10497808|NCT01224431|11648183|FG000|STARTED|Overall Study||30
10497809|NCT01224431|11648184|FG001|STARTED|Overall Study||30
10497810|NCT01224431|11648183|FG000|COMPLETED|Overall Study||30
10497811|NCT01224431|11648184|FG001|COMPLETED|Overall Study||25
10497812|NCT01224431|11648183|FG000|NOT COMPLETED|Overall Study||0
10497813|NCT01224431|11648184|FG001|NOT COMPLETED|Overall Study||5
10497814|NCT01224444|11648192|FG000|STARTED|Overall Study||269
10497815|NCT01224444|11648192|FG000|COMPLETED|Overall Study||269
10497816|NCT01224444|11648192|FG000|NOT COMPLETED|Overall Study||0
10497817|NCT01224626|11648196|FG000|STARTED|Overall Study||42
10497818|NCT01224626|11648196|FG000|COMPLETED|Overall Study||41
10497819|NCT01224626|11648196|FG000|NOT COMPLETED|Overall Study||1
10497820|NCT01224639|11648208|FG000|STARTED|Overall Study||19
10497821|NCT01224639|11648209|FG001|STARTED|Overall Study||5
10497822|NCT01224639|11648210|FG002|STARTED|Overall Study||21
10497823|NCT01224639|11648211|FG003|STARTED|Overall Study||3
10497824|NCT01224639|11648212|FG004|STARTED|Overall Study||21
10497825|NCT01224639|11648213|FG005|STARTED|Overall Study||4
10497826|NCT01224639|11648214|FG006|STARTED|Overall Study||18
10497827|NCT01224639|11648215|FG007|STARTED|Overall Study||5
10497828|NCT01224639|11648208|FG000|COMPLETED|Overall Study||19
10497829|NCT01224639|11648209|FG001|COMPLETED|Overall Study||5
10497830|NCT01224639|11648210|FG002|COMPLETED|Overall Study||21
10497831|NCT01224639|11648211|FG003|COMPLETED|Overall Study||3
10497832|NCT01224639|11648212|FG004|COMPLETED|Overall Study||19
10497833|NCT01224639|11648213|FG005|COMPLETED|Overall Study||4
10497834|NCT01224639|11648214|FG006|COMPLETED|Overall Study||17
10497835|NCT01224639|11648215|FG007|COMPLETED|Overall Study||3
10497836|NCT01224639|11648208|FG000|NOT COMPLETED|Overall Study||0
10497837|NCT01224639|11648209|FG001|NOT COMPLETED|Overall Study||0
10497838|NCT01224639|11648210|FG002|NOT COMPLETED|Overall Study||0
10497839|NCT01224639|11648211|FG003|NOT COMPLETED|Overall Study||0
10497840|NCT01224639|11648212|FG004|NOT COMPLETED|Overall Study||2
10497841|NCT01224639|11648213|FG005|NOT COMPLETED|Overall Study||0
10497842|NCT01224639|11648214|FG006|NOT COMPLETED|Overall Study||1
10497843|NCT01224639|11648215|FG007|NOT COMPLETED|Overall Study||2
10497844|NCT01224678|11648235|FG000|STARTED|Overall Study||150
10497845|NCT01224678|11648236|FG001|STARTED|Overall Study||150
10497846|NCT01224678|11648235|FG000|COMPLETED|Overall Study||150
10497847|NCT01224678|11648236|FG001|COMPLETED|Overall Study||150
10497848|NCT01224678|11648235|FG000|NOT COMPLETED|Overall Study||0
10497849|NCT01224678|11648236|FG001|NOT COMPLETED|Overall Study||0
10497850|NCT01224782|11648242|FG000|STARTED|Overall Study||994
10497851|NCT01224782|11648242|FG000|COMPLETED|Overall Study||730
10497852|NCT01224782|11648242|FG000|NOT COMPLETED|Overall Study||264
10497853|NCT01224821|11648246|FG000|STARTED|Dosimetric and Therapeutic Treatment||47
10497854|NCT01224821|11648246|FG000|COMPLETED|Dosimetric and Therapeutic Treatment|This participant completed the study per Protocol Amendment 2.|1
10497855|NCT01224821|11648246|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||46
10497856|NCT01224821|11648246|FG000|STARTED|Long-Term Follow-Up|11/47 participants withdrawing from this study enrolled in the LTFU study for continued evaluation.|11
10497857|NCT01224821|11648246|FG000|COMPLETED|Long-Term Follow-Up||0
10497858|NCT01224821|11648246|FG000|NOT COMPLETED|Long-Term Follow-Up||11
10497859|NCT01224925|11648252|FG000|STARTED|Overall Study||37
10497860|NCT01224925|11648253|FG001|STARTED|Overall Study||33
10497861|NCT01224925|11648252|FG000|COMPLETED|Overall Study||34
10497862|NCT01224925|11648253|FG001|COMPLETED|Overall Study||31
10497863|NCT01224925|11648252|FG000|NOT COMPLETED|Overall Study||3
10497864|NCT01224925|11648253|FG001|NOT COMPLETED|Overall Study||2
10497865|NCT01225029|11648263|FG000|STARTED|Overall Study||32
10497866|NCT01225029|11648264|FG001|STARTED|Overall Study||32
10497867|NCT01225029|11648263|FG000|COMPLETED|Overall Study||32
10497868|NCT01225029|11648264|FG001|COMPLETED|Overall Study||32
10497869|NCT01225029|11648263|FG000|NOT COMPLETED|Overall Study||0
10497870|NCT01225029|11648264|FG001|NOT COMPLETED|Overall Study||0
10497871|NCT01225055|11648273|FG000|STARTED|Overall Study||20
10497872|NCT01225055|11648274|FG001|STARTED|Overall Study||20
10497873|NCT01225055|11648275|FG002|STARTED|Overall Study||21
10497874|NCT01225055|11648273|FG000|COMPLETED|Overall Study||20
10497875|NCT01225055|11648274|FG001|COMPLETED|Overall Study||18
10497876|NCT01225055|11648275|FG002|COMPLETED|Overall Study||18
10497877|NCT01225055|11648273|FG000|NOT COMPLETED|Overall Study||0
10497878|NCT01225055|11648274|FG001|NOT COMPLETED|Overall Study||2
10497879|NCT01225055|11648275|FG002|NOT COMPLETED|Overall Study||3
10497880|NCT01225068|11648285|FG000|STARTED|Overall Study||20
10497881|NCT01225068|11648286|FG001|STARTED|Overall Study||20
10497882|NCT01225068|11648285|FG000|COMPLETED|Overall Study||16
10497883|NCT01225068|11648286|FG001|COMPLETED|Overall Study||19
10497884|NCT01225068|11648285|FG000|NOT COMPLETED|Overall Study||4
10497885|NCT01225068|11648286|FG001|NOT COMPLETED|Overall Study||1
10497886|NCT01225146|11648294|FG000|STARTED|Overall Study||6
10497887|NCT01225146|11648295|FG001|STARTED|Overall Study||2
10497888|NCT01225146|11648294|FG000|COMPLETED|Overall Study||6
10497889|NCT01225146|11648295|FG001|COMPLETED|Overall Study||0
10497890|NCT01225146|11648294|FG000|NOT COMPLETED|Overall Study||0
10497891|NCT01225146|11648295|FG001|NOT COMPLETED|Overall Study||2
10497892|NCT01225159|11648305|FG000|STARTED|Overall Study||100
10497893|NCT01225159|11648306|FG001|STARTED|Overall Study||100
10497894|NCT01225159|11648305|FG000|COMPLETED|Overall Study||99
10497895|NCT01225159|11648306|FG001|COMPLETED|Overall Study||100
10497896|NCT01225159|11648305|FG000|NOT COMPLETED|Overall Study||1
10497897|NCT01225159|11648306|FG001|NOT COMPLETED|Overall Study||0
10497898|NCT01225172|11648314|FG000|STARTED|Overall Study||52
10497899|NCT01225172|11648315|FG001|STARTED|Overall Study||7
10497900|NCT01225172|11648314|FG000|COMPLETED|Overall Study||46
10497901|NCT01225172|11648315|FG001|COMPLETED|Overall Study||6
10497902|NCT01225172|11648314|FG000|NOT COMPLETED|Overall Study||6
10497903|NCT01225172|11648315|FG001|NOT COMPLETED|Overall Study||1
10497904|NCT01225211|11648331|FG000|STARTED|Overall Study||21
10497905|NCT01225211|11648332|FG001|STARTED|Overall Study||20
10497906|NCT01225211|11648333|FG002|STARTED|Overall Study||21
10497907|NCT01225211|11648334|FG003|STARTED|Overall Study||27
10497908|NCT01225211|11648335|FG004|STARTED|Overall Study||23
10497909|NCT01225211|11648336|FG005|STARTED|Overall Study||21
10497910|NCT01225211|11648337|FG006|STARTED|Overall Study||42
10497911|NCT01225211|11648338|FG007|STARTED|Overall Study||11
10497912|NCT01225211|11648339|FG008|STARTED|Overall Study||63
10497913|NCT01225211|11648340|FG009|STARTED|Overall Study||62
10497914|NCT01225211|11648331|FG000|COMPLETED|Overall Study||21
10497915|NCT01225211|11648332|FG001|COMPLETED|Overall Study||20
10497916|NCT01225211|11648333|FG002|COMPLETED|Overall Study||20
10497917|NCT01225211|11648334|FG003|COMPLETED|Overall Study||27
10497918|NCT01225211|11648335|FG004|COMPLETED|Overall Study||23
10497919|NCT01225211|11648336|FG005|COMPLETED|Overall Study||21
10497920|NCT01225211|11648337|FG006|COMPLETED|Overall Study||41
10497921|NCT01225211|11648338|FG007|COMPLETED|Overall Study||11
10497922|NCT01225211|11648339|FG008|COMPLETED|Overall Study||62
10497923|NCT01225211|11648340|FG009|COMPLETED|Overall Study||57
10497924|NCT01225211|11648331|FG000|NOT COMPLETED|Overall Study||0
10497925|NCT01225211|11648332|FG001|NOT COMPLETED|Overall Study||0
10497926|NCT01225211|11648333|FG002|NOT COMPLETED|Overall Study||1
10497927|NCT01225211|11648334|FG003|NOT COMPLETED|Overall Study||0
10497928|NCT01225211|11648335|FG004|NOT COMPLETED|Overall Study||0
10497929|NCT01225211|11648336|FG005|NOT COMPLETED|Overall Study||0
10497930|NCT01225211|11648337|FG006|NOT COMPLETED|Overall Study||1
10497931|NCT01225211|11648338|FG007|NOT COMPLETED|Overall Study||0
10497932|NCT01225211|11648339|FG008|NOT COMPLETED|Overall Study||1
10497933|NCT01225211|11648340|FG009|NOT COMPLETED|Overall Study||5
10497934|NCT01225250|11648399|FG000|STARTED|Overall Study||15
10497935|NCT01225250|11648400|FG001|STARTED|Overall Study||15
10497936|NCT01225250|11648399|FG000|COMPLETED|Overall Study||10
10497937|NCT01225250|11648400|FG001|COMPLETED|Overall Study||10
10497938|NCT01225250|11648399|FG000|NOT COMPLETED|Overall Study||5
10497939|NCT01225250|11648400|FG001|NOT COMPLETED|Overall Study||5
10497940|NCT01225263|11648408|FG000|STARTED|Weeks 1 to 12||28
10497941|NCT01225263|11648409|FG001|STARTED|Weeks 1 to 12||29
10497942|NCT01225263|11648408|FG000|COMPLETED|Weeks 1 to 12||28
10497943|NCT01225263|11648409|FG001|COMPLETED|Weeks 1 to 12||29
10497944|NCT01225263|11648408|FG000|NOT COMPLETED|Weeks 1 to 12||0
10497945|NCT01225263|11648409|FG001|NOT COMPLETED|Weeks 1 to 12||0
10497946|NCT01225263|11648408|FG000|STARTED|Weeks 13 to 24||28
10497947|NCT01225263|11648409|FG001|STARTED|Weeks 13 to 24||29
10497948|NCT01225263|11648408|FG000|COMPLETED|Weeks 13 to 24||24
10497949|NCT01225263|11648409|FG001|COMPLETED|Weeks 13 to 24||28
10497950|NCT01225263|11648408|FG000|NOT COMPLETED|Weeks 13 to 24||4
10497951|NCT01225263|11648409|FG001|NOT COMPLETED|Weeks 13 to 24||1
10497952|NCT01225289|11648418|FG000|STARTED|Overall Study||18
10497953|NCT01225289|11648419|FG001|STARTED|Overall Study||18
10497954|NCT01225289|11648418|FG000|COMPLETED|Overall Study||18
10497955|NCT01225289|11648419|FG001|COMPLETED|Overall Study||17
10710481|NCT02650856|11875703|FG001|24 Hours|Overall Study||21
10497956|NCT01225289|11648418|FG000|NOT COMPLETED|Overall Study||0
10497957|NCT01225289|11648419|FG001|NOT COMPLETED|Overall Study||1
10497958|NCT01225354|11648425|FG000|STARTED|Overall Study||20
10497959|NCT01225354|11648425|FG000|COMPLETED|Overall Study||19
10497960|NCT01225354|11648425|FG000|NOT COMPLETED|Overall Study||1
10497961|NCT01225549|11648430|FG000|STARTED|Period 1 - First Treatment Period||1
10497962|NCT01225549|11648431|FG001|STARTED|Period 1 - First Treatment Period||4
10497963|NCT01225549|11648432|FG002|STARTED|Period 1 - First Treatment Period||3
10497964|NCT01225549|11648433|FG003|STARTED|Period 1 - First Treatment Period||1
10497965|NCT01225549|11648434|FG004|STARTED|Period 1 - First Treatment Period||1
10497966|NCT01225549|11648435|FG005|STARTED|Period 1 - First Treatment Period||1
10497967|NCT01225549|11648436|FG006|STARTED|Period 1 - First Treatment Period||3
10497968|NCT01225549|11648437|FG007|STARTED|Period 1 - First Treatment Period||1
10497969|NCT01225549|11648438|FG008|STARTED|Period 1 - First Treatment Period||4
10497970|NCT01225549|11648439|FG009|STARTED|Period 1 - First Treatment Period||1
10497971|NCT01225549|11648430|FG000|COMPLETED|Period 1 - First Treatment Period||1
10497972|NCT01225549|11648431|FG001|COMPLETED|Period 1 - First Treatment Period||4
10497973|NCT01225549|11648432|FG002|COMPLETED|Period 1 - First Treatment Period||3
10497974|NCT01225549|11648433|FG003|COMPLETED|Period 1 - First Treatment Period||1
10497975|NCT01225549|11648434|FG004|COMPLETED|Period 1 - First Treatment Period||1
10497976|NCT01225549|11648435|FG005|COMPLETED|Period 1 - First Treatment Period||1
10497977|NCT01225549|11648436|FG006|COMPLETED|Period 1 - First Treatment Period||3
10497978|NCT01225549|11648437|FG007|COMPLETED|Period 1 - First Treatment Period||1
10497979|NCT01225549|11648438|FG008|COMPLETED|Period 1 - First Treatment Period||4
10497980|NCT01225549|11648439|FG009|COMPLETED|Period 1 - First Treatment Period||1
10497981|NCT01225549|11648430|FG000|NOT COMPLETED|Period 1 - First Treatment Period||0
10497982|NCT01225549|11648431|FG001|NOT COMPLETED|Period 1 - First Treatment Period||0
10497983|NCT01225549|11648432|FG002|NOT COMPLETED|Period 1 - First Treatment Period||0
10497984|NCT01225549|11648433|FG003|NOT COMPLETED|Period 1 - First Treatment Period||0
10497985|NCT01225549|11648434|FG004|NOT COMPLETED|Period 1 - First Treatment Period||0
10497986|NCT01225549|11648435|FG005|NOT COMPLETED|Period 1 - First Treatment Period||0
10497987|NCT01225549|11648436|FG006|NOT COMPLETED|Period 1 - First Treatment Period||0
10497988|NCT01225549|11648437|FG007|NOT COMPLETED|Period 1 - First Treatment Period||0
10497989|NCT01225549|11648438|FG008|NOT COMPLETED|Period 1 - First Treatment Period||0
10497990|NCT01225549|11648439|FG009|NOT COMPLETED|Period 1 - First Treatment Period||0
10497991|NCT01225549|11648430|FG000|STARTED|Period 2 - Washout||1
10497992|NCT01225549|11648431|FG001|STARTED|Period 2 - Washout||4
10497993|NCT01225549|11648432|FG002|STARTED|Period 2 - Washout||3
10497994|NCT01225549|11648433|FG003|STARTED|Period 2 - Washout||1
10497995|NCT01225549|11648434|FG004|STARTED|Period 2 - Washout||1
10497996|NCT01225549|11648435|FG005|STARTED|Period 2 - Washout||1
10497997|NCT01225549|11648436|FG006|STARTED|Period 2 - Washout||3
10497998|NCT01225549|11648437|FG007|STARTED|Period 2 - Washout||1
10497999|NCT01225549|11648438|FG008|STARTED|Period 2 - Washout||4
10498000|NCT01225549|11648439|FG009|STARTED|Period 2 - Washout||1
10498001|NCT01225549|11648430|FG000|COMPLETED|Period 2 - Washout||1
10498002|NCT01225549|11648431|FG001|COMPLETED|Period 2 - Washout||4
10498003|NCT01225549|11648432|FG002|COMPLETED|Period 2 - Washout||3
10498004|NCT01225549|11648433|FG003|COMPLETED|Period 2 - Washout||1
10498005|NCT01225549|11648434|FG004|COMPLETED|Period 2 - Washout||1
10498006|NCT01225549|11648435|FG005|COMPLETED|Period 2 - Washout||1
10498007|NCT01225549|11648436|FG006|COMPLETED|Period 2 - Washout||3
10498008|NCT01225549|11648437|FG007|COMPLETED|Period 2 - Washout||1
10498009|NCT01225549|11648438|FG008|COMPLETED|Period 2 - Washout||4
10498010|NCT01225549|11648439|FG009|COMPLETED|Period 2 - Washout||1
10498011|NCT01225549|11648430|FG000|NOT COMPLETED|Period 2 - Washout||0
10498012|NCT01225549|11648431|FG001|NOT COMPLETED|Period 2 - Washout||0
10498013|NCT01225549|11648432|FG002|NOT COMPLETED|Period 2 - Washout||0
10498014|NCT01225549|11648433|FG003|NOT COMPLETED|Period 2 - Washout||0
10498015|NCT01225549|11648434|FG004|NOT COMPLETED|Period 2 - Washout||0
10498016|NCT01225549|11648435|FG005|NOT COMPLETED|Period 2 - Washout||0
10498017|NCT01225549|11648436|FG006|NOT COMPLETED|Period 2 - Washout||0
10498018|NCT01225549|11648437|FG007|NOT COMPLETED|Period 2 - Washout||0
10498019|NCT01225549|11648438|FG008|NOT COMPLETED|Period 2 - Washout||0
10498020|NCT01225549|11648439|FG009|NOT COMPLETED|Period 2 - Washout||0
10498021|NCT01225549|11648430|FG000|STARTED|Period 3 - Second Treatment Period||1
10498022|NCT01225549|11648431|FG001|STARTED|Period 3 - Second Treatment Period||4
10498023|NCT01225549|11648432|FG002|STARTED|Period 3 - Second Treatment Period||3
10498024|NCT01225549|11648433|FG003|STARTED|Period 3 - Second Treatment Period||1
10498025|NCT01225549|11648434|FG004|STARTED|Period 3 - Second Treatment Period||1
10498026|NCT01225549|11648435|FG005|STARTED|Period 3 - Second Treatment Period||1
10498027|NCT01225549|11648436|FG006|STARTED|Period 3 - Second Treatment Period||3
10498028|NCT01225549|11648437|FG007|STARTED|Period 3 - Second Treatment Period||1
10498029|NCT01225549|11648438|FG008|STARTED|Period 3 - Second Treatment Period||4
10498030|NCT01225549|11648439|FG009|STARTED|Period 3 - Second Treatment Period||1
10498031|NCT01225549|11648430|FG000|COMPLETED|Period 3 - Second Treatment Period||1
10498032|NCT01225549|11648431|FG001|COMPLETED|Period 3 - Second Treatment Period||4
10498033|NCT01225549|11648432|FG002|COMPLETED|Period 3 - Second Treatment Period||3
10498034|NCT01225549|11648433|FG003|COMPLETED|Period 3 - Second Treatment Period||1
10498035|NCT01225549|11648434|FG004|COMPLETED|Period 3 - Second Treatment Period||1
10498117|NCT01225549|11648436|FG006|STARTED|Period 6 - Washout||3
10498036|NCT01225549|11648435|FG005|COMPLETED|Period 3 - Second Treatment Period||1
10498037|NCT01225549|11648436|FG006|COMPLETED|Period 3 - Second Treatment Period||3
10498038|NCT01225549|11648437|FG007|COMPLETED|Period 3 - Second Treatment Period||1
10498039|NCT01225549|11648438|FG008|COMPLETED|Period 3 - Second Treatment Period||4
10498040|NCT01225549|11648439|FG009|COMPLETED|Period 3 - Second Treatment Period||1
10498041|NCT01225549|11648430|FG000|NOT COMPLETED|Period 3 - Second Treatment Period||0
10498042|NCT01225549|11648431|FG001|NOT COMPLETED|Period 3 - Second Treatment Period||0
10498043|NCT01225549|11648432|FG002|NOT COMPLETED|Period 3 - Second Treatment Period||0
10498044|NCT01225549|11648433|FG003|NOT COMPLETED|Period 3 - Second Treatment Period||0
10498045|NCT01225549|11648434|FG004|NOT COMPLETED|Period 3 - Second Treatment Period||0
10498046|NCT01225549|11648435|FG005|NOT COMPLETED|Period 3 - Second Treatment Period||0
10498047|NCT01225549|11648436|FG006|NOT COMPLETED|Period 3 - Second Treatment Period||0
10498048|NCT01225549|11648437|FG007|NOT COMPLETED|Period 3 - Second Treatment Period||0
10498049|NCT01225549|11648438|FG008|NOT COMPLETED|Period 3 - Second Treatment Period||0
10498050|NCT01225549|11648439|FG009|NOT COMPLETED|Period 3 - Second Treatment Period||0
10498051|NCT01225549|11648430|FG000|STARTED|Period 4 - Washout||1
10498052|NCT01225549|11648431|FG001|STARTED|Period 4 - Washout||4
10498053|NCT01225549|11648432|FG002|STARTED|Period 4 - Washout||3
10498054|NCT01225549|11648433|FG003|STARTED|Period 4 - Washout||1
10498055|NCT01225549|11648434|FG004|STARTED|Period 4 - Washout||1
10498056|NCT01225549|11648435|FG005|STARTED|Period 4 - Washout||1
10498057|NCT01225549|11648436|FG006|STARTED|Period 4 - Washout||3
10498058|NCT01225549|11648437|FG007|STARTED|Period 4 - Washout||1
10498059|NCT01225549|11648438|FG008|STARTED|Period 4 - Washout||4
10498060|NCT01225549|11648439|FG009|STARTED|Period 4 - Washout||1
10498061|NCT01225549|11648430|FG000|COMPLETED|Period 4 - Washout||1
10498062|NCT01225549|11648431|FG001|COMPLETED|Period 4 - Washout||3
10498063|NCT01225549|11648432|FG002|COMPLETED|Period 4 - Washout||3
10498064|NCT01225549|11648433|FG003|COMPLETED|Period 4 - Washout||1
10498065|NCT01225549|11648434|FG004|COMPLETED|Period 4 - Washout||1
10498066|NCT01225549|11648435|FG005|COMPLETED|Period 4 - Washout||1
10498067|NCT01225549|11648436|FG006|COMPLETED|Period 4 - Washout||3
10498068|NCT01225549|11648437|FG007|COMPLETED|Period 4 - Washout||1
10498069|NCT01225549|11648438|FG008|COMPLETED|Period 4 - Washout||4
10498070|NCT01225549|11648439|FG009|COMPLETED|Period 4 - Washout||1
10498071|NCT01225549|11648430|FG000|NOT COMPLETED|Period 4 - Washout||0
10498072|NCT01225549|11648431|FG001|NOT COMPLETED|Period 4 - Washout||1
10498073|NCT01225549|11648432|FG002|NOT COMPLETED|Period 4 - Washout||0
10498074|NCT01225549|11648433|FG003|NOT COMPLETED|Period 4 - Washout||0
10498075|NCT01225549|11648434|FG004|NOT COMPLETED|Period 4 - Washout||0
10498076|NCT01225549|11648435|FG005|NOT COMPLETED|Period 4 - Washout||0
10498077|NCT01225549|11648436|FG006|NOT COMPLETED|Period 4 - Washout||0
10498078|NCT01225549|11648437|FG007|NOT COMPLETED|Period 4 - Washout||0
10498079|NCT01225549|11648438|FG008|NOT COMPLETED|Period 4 - Washout||0
10498080|NCT01225549|11648439|FG009|NOT COMPLETED|Period 4 - Washout||0
10498081|NCT01225549|11648430|FG000|STARTED|Period 5 - Third Treatment Period||1
10498082|NCT01225549|11648431|FG001|STARTED|Period 5 - Third Treatment Period||3
10498083|NCT01225549|11648432|FG002|STARTED|Period 5 - Third Treatment Period||3
10498084|NCT01225549|11648433|FG003|STARTED|Period 5 - Third Treatment Period||1
10498085|NCT01225549|11648434|FG004|STARTED|Period 5 - Third Treatment Period||1
10498086|NCT01225549|11648435|FG005|STARTED|Period 5 - Third Treatment Period||1
10498087|NCT01225549|11648436|FG006|STARTED|Period 5 - Third Treatment Period||3
10498088|NCT01225549|11648437|FG007|STARTED|Period 5 - Third Treatment Period||1
10498089|NCT01225549|11648438|FG008|STARTED|Period 5 - Third Treatment Period||4
10498090|NCT01225549|11648439|FG009|STARTED|Period 5 - Third Treatment Period||1
10498091|NCT01225549|11648430|FG000|COMPLETED|Period 5 - Third Treatment Period||1
10498092|NCT01225549|11648431|FG001|COMPLETED|Period 5 - Third Treatment Period||3
10498093|NCT01225549|11648432|FG002|COMPLETED|Period 5 - Third Treatment Period||3
10498094|NCT01225549|11648433|FG003|COMPLETED|Period 5 - Third Treatment Period||1
10498095|NCT01225549|11648434|FG004|COMPLETED|Period 5 - Third Treatment Period||1
10498096|NCT01225549|11648435|FG005|COMPLETED|Period 5 - Third Treatment Period||1
10498097|NCT01225549|11648436|FG006|COMPLETED|Period 5 - Third Treatment Period||3
10498098|NCT01225549|11648437|FG007|COMPLETED|Period 5 - Third Treatment Period||1
10498099|NCT01225549|11648438|FG008|COMPLETED|Period 5 - Third Treatment Period||4
10498100|NCT01225549|11648439|FG009|COMPLETED|Period 5 - Third Treatment Period||1
10498101|NCT01225549|11648430|FG000|NOT COMPLETED|Period 5 - Third Treatment Period||0
10498102|NCT01225549|11648431|FG001|NOT COMPLETED|Period 5 - Third Treatment Period||0
10498103|NCT01225549|11648432|FG002|NOT COMPLETED|Period 5 - Third Treatment Period||0
10498104|NCT01225549|11648433|FG003|NOT COMPLETED|Period 5 - Third Treatment Period||0
10498105|NCT01225549|11648434|FG004|NOT COMPLETED|Period 5 - Third Treatment Period||0
10498106|NCT01225549|11648435|FG005|NOT COMPLETED|Period 5 - Third Treatment Period||0
10498107|NCT01225549|11648436|FG006|NOT COMPLETED|Period 5 - Third Treatment Period||0
10498108|NCT01225549|11648437|FG007|NOT COMPLETED|Period 5 - Third Treatment Period||0
10498109|NCT01225549|11648438|FG008|NOT COMPLETED|Period 5 - Third Treatment Period||0
10498110|NCT01225549|11648439|FG009|NOT COMPLETED|Period 5 - Third Treatment Period||0
10498111|NCT01225549|11648430|FG000|STARTED|Period 6 - Washout||1
10498112|NCT01225549|11648431|FG001|STARTED|Period 6 - Washout||3
10498113|NCT01225549|11648432|FG002|STARTED|Period 6 - Washout||3
10498114|NCT01225549|11648433|FG003|STARTED|Period 6 - Washout||1
10498115|NCT01225549|11648434|FG004|STARTED|Period 6 - Washout||1
10498116|NCT01225549|11648435|FG005|STARTED|Period 6 - Washout||1
10498118|NCT01225549|11648437|FG007|STARTED|Period 6 - Washout||1
10498119|NCT01225549|11648438|FG008|STARTED|Period 6 - Washout||4
10498120|NCT01225549|11648439|FG009|STARTED|Period 6 - Washout||1
10498121|NCT01225549|11648430|FG000|COMPLETED|Period 6 - Washout||1
10498122|NCT01225549|11648431|FG001|COMPLETED|Period 6 - Washout||3
10498123|NCT01225549|11648432|FG002|COMPLETED|Period 6 - Washout||3
10498124|NCT01225549|11648433|FG003|COMPLETED|Period 6 - Washout||0
10498125|NCT01225549|11648434|FG004|COMPLETED|Period 6 - Washout||1
10498126|NCT01225549|11648435|FG005|COMPLETED|Period 6 - Washout||1
10498127|NCT01225549|11648436|FG006|COMPLETED|Period 6 - Washout||3
10498128|NCT01225549|11648437|FG007|COMPLETED|Period 6 - Washout||1
10498129|NCT01225549|11648438|FG008|COMPLETED|Period 6 - Washout||4
10498130|NCT01225549|11648439|FG009|COMPLETED|Period 6 - Washout||1
10498131|NCT01225549|11648430|FG000|NOT COMPLETED|Period 6 - Washout||0
10498132|NCT01225549|11648431|FG001|NOT COMPLETED|Period 6 - Washout||0
10498133|NCT01225549|11648432|FG002|NOT COMPLETED|Period 6 - Washout||0
10498134|NCT01225549|11648433|FG003|NOT COMPLETED|Period 6 - Washout||1
10498135|NCT01225549|11648434|FG004|NOT COMPLETED|Period 6 - Washout||0
10498136|NCT01225549|11648435|FG005|NOT COMPLETED|Period 6 - Washout||0
10498137|NCT01225549|11648436|FG006|NOT COMPLETED|Period 6 - Washout||0
10498138|NCT01225549|11648437|FG007|NOT COMPLETED|Period 6 - Washout||0
10498139|NCT01225549|11648438|FG008|NOT COMPLETED|Period 6 - Washout||0
10498140|NCT01225549|11648439|FG009|NOT COMPLETED|Period 6 - Washout||0
10498141|NCT01225549|11648430|FG000|STARTED|Period 7 - Fourth Treatment Period||1
10498142|NCT01225549|11648431|FG001|STARTED|Period 7 - Fourth Treatment Period||3
10498143|NCT01225549|11648432|FG002|STARTED|Period 7 - Fourth Treatment Period||3
10498144|NCT01225549|11648433|FG003|STARTED|Period 7 - Fourth Treatment Period||0
10498145|NCT01225549|11648434|FG004|STARTED|Period 7 - Fourth Treatment Period||1
10498146|NCT01225549|11648435|FG005|STARTED|Period 7 - Fourth Treatment Period||1
10498147|NCT01225549|11648436|FG006|STARTED|Period 7 - Fourth Treatment Period||3
10498148|NCT01225549|11648437|FG007|STARTED|Period 7 - Fourth Treatment Period||1
10498149|NCT01225549|11648438|FG008|STARTED|Period 7 - Fourth Treatment Period||4
10498150|NCT01225549|11648439|FG009|STARTED|Period 7 - Fourth Treatment Period||1
10498151|NCT01225549|11648430|FG000|COMPLETED|Period 7 - Fourth Treatment Period||1
10498152|NCT01225549|11648431|FG001|COMPLETED|Period 7 - Fourth Treatment Period||3
10498153|NCT01225549|11648432|FG002|COMPLETED|Period 7 - Fourth Treatment Period||3
10498154|NCT01225549|11648433|FG003|COMPLETED|Period 7 - Fourth Treatment Period||0
10498155|NCT01225549|11648434|FG004|COMPLETED|Period 7 - Fourth Treatment Period||1
10498156|NCT01225549|11648435|FG005|COMPLETED|Period 7 - Fourth Treatment Period||1
10498157|NCT01225549|11648436|FG006|COMPLETED|Period 7 - Fourth Treatment Period||3
10710482|NCT02650856|11875702|FG000|48 Hours|Overall Study||19
10710483|NCT02650856|11875703|FG001|48 Hours|Overall Study||21
10710484|NCT02650856|11875702|FG000|72 Hours|Overall Study||19
10710485|NCT02650856|11875703|FG001|72 Hours|Overall Study||21
10710486|NCT02650856|11875702|FG000|COMPLETED|Overall Study||19
10498158|NCT01225549|11648437|FG007|COMPLETED|Period 7 - Fourth Treatment Period||1
10498159|NCT01225549|11648438|FG008|COMPLETED|Period 7 - Fourth Treatment Period||4
10498160|NCT01225549|11648439|FG009|COMPLETED|Period 7 - Fourth Treatment Period||1
10498161|NCT01225549|11648430|FG000|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
10498162|NCT01225549|11648431|FG001|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
10498163|NCT01225549|11648432|FG002|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
10498164|NCT01225549|11648433|FG003|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
10498165|NCT01225549|11648434|FG004|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
10498166|NCT01225549|11648435|FG005|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
10498167|NCT01225549|11648436|FG006|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
10498168|NCT01225549|11648437|FG007|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
10498169|NCT01225549|11648438|FG008|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
10498170|NCT01225549|11648439|FG009|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
10498171|NCT01225562|11648452|FG000|STARTED|Overall Study||7050
10498172|NCT01225562|11648453|FG001|STARTED|Overall Study||7045
10498173|NCT01225562|11648454|FG002|STARTED|Overall Study||7067
10498174|NCT01225562|11648452|FG000|COMPLETED|Overall Study||6995
10498175|NCT01225562|11648453|FG001|COMPLETED|Overall Study||6989
10498176|NCT01225562|11648454|FG002|COMPLETED|Overall Study||7014
10498177|NCT01225562|11648452|FG000|NOT COMPLETED|Overall Study||55
10498178|NCT01225562|11648453|FG001|NOT COMPLETED|Overall Study||56
10498179|NCT01225562|11648454|FG002|NOT COMPLETED|Overall Study||53
10498180|NCT01225731|11648467|FG000|STARTED|Part 1||42
10498181|NCT01225731|11648468|FG001|STARTED|Part 1||92
10498182|NCT01225731|11648469|FG002|STARTED|Part 1||89
10498183|NCT01225731|11648470|FG003|STARTED|Part 1||86
10498184|NCT01225731|11648471|FG004|STARTED|Part 1||46
10498185|NCT01225731|11648472|FG005|STARTED|Part 1||0
10498186|NCT01225731|11648473|FG006|STARTED|Part 1||0
10498187|NCT01225731|11648474|FG007|STARTED|Part 1||0
10498188|NCT01225731|11648475|FG008|STARTED|Part 1||0
10498189|NCT01225731|11648476|FG009|STARTED|Part 1||0
10498190|NCT01225731|11648477|FG010|STARTED|Part 1||0
10498191|NCT01225731|11648478|FG011|STARTED|Part 1||0
10498192|NCT01225731|11648479|FG012|STARTED|Part 1||0
10498193|NCT01225731|11648467|FG000|COMPLETED|Part 1||40
10498194|NCT01225731|11648468|FG001|COMPLETED|Part 1||87
10498195|NCT01225731|11648469|FG002|COMPLETED|Part 1||88
10498196|NCT01225731|11648470|FG003|COMPLETED|Part 1||84
10498197|NCT01225731|11648471|FG004|COMPLETED|Part 1||40
10498198|NCT01225731|11648472|FG005|COMPLETED|Part 1||0
10498199|NCT01225731|11648473|FG006|COMPLETED|Part 1||0
10498200|NCT01225731|11648474|FG007|COMPLETED|Part 1||0
10498201|NCT01225731|11648475|FG008|COMPLETED|Part 1||0
10498202|NCT01225731|11648476|FG009|COMPLETED|Part 1||0
10498203|NCT01225731|11648477|FG010|COMPLETED|Part 1||0
10498204|NCT01225731|11648478|FG011|COMPLETED|Part 1||0
10498205|NCT01225731|11648479|FG012|COMPLETED|Part 1||0
10498206|NCT01225731|11648467|FG000|NOT COMPLETED|Part 1||2
10498207|NCT01225731|11648468|FG001|NOT COMPLETED|Part 1||5
10498208|NCT01225731|11648469|FG002|NOT COMPLETED|Part 1||1
10498209|NCT01225731|11648470|FG003|NOT COMPLETED|Part 1||2
10498210|NCT01225731|11648471|FG004|NOT COMPLETED|Part 1||6
10498211|NCT01225731|11648472|FG005|NOT COMPLETED|Part 1||0
10498212|NCT01225731|11648473|FG006|NOT COMPLETED|Part 1||0
10498213|NCT01225731|11648474|FG007|NOT COMPLETED|Part 1||0
10498214|NCT01225731|11648475|FG008|NOT COMPLETED|Part 1||0
10498215|NCT01225731|11648476|FG009|NOT COMPLETED|Part 1||0
10498216|NCT01225731|11648477|FG010|NOT COMPLETED|Part 1||0
10498217|NCT01225731|11648478|FG011|NOT COMPLETED|Part 1||0
10498218|NCT01225731|11648479|FG012|NOT COMPLETED|Part 1||0
10498219|NCT01225731|11648467|FG000|STARTED|Part 2|Participants could progress into Part 2|0
10498220|NCT01225731|11648468|FG001|STARTED|Part 2|Participants could progress into Part 2|0
10498221|NCT01225731|11648469|FG002|STARTED|Part 2|Participants could progress into Part 2|0
10498222|NCT01225731|11648470|FG003|STARTED|Part 2|Participants could progress into Part 2|0
10498223|NCT01225731|11648471|FG004|STARTED|Part 2|Participants could progress into Part 2; no placebo was given in Part 2|0
10498224|NCT01225731|11648472|FG005|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|13
10498225|NCT01225731|11648473|FG006|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|94
10498226|NCT01225731|11648474|FG007|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|153
10498227|NCT01225731|11648475|FG008|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|79
10498228|NCT01225731|11648476|FG009|STARTED|Part 2||0
10498229|NCT01225731|11648477|FG010|STARTED|Part 2||0
10498230|NCT01225731|11648478|FG011|STARTED|Part 2||0
10498231|NCT01225731|11648479|FG012|STARTED|Part 2||0
10498232|NCT01225731|11648467|FG000|COMPLETED|Part 2||0
10498233|NCT01225731|11648468|FG001|COMPLETED|Part 2||0
10498234|NCT01225731|11648469|FG002|COMPLETED|Part 2||0
10498235|NCT01225731|11648470|FG003|COMPLETED|Part 2||0
10498236|NCT01225731|11648471|FG004|COMPLETED|Part 2||0
10498237|NCT01225731|11648472|FG005|COMPLETED|Part 2||10
10498238|NCT01225731|11648473|FG006|COMPLETED|Part 2||86
10498239|NCT01225731|11648474|FG007|COMPLETED|Part 2||128
10498240|NCT01225731|11648475|FG008|COMPLETED|Part 2||68
10498241|NCT01225731|11648476|FG009|COMPLETED|Part 2||0
10498242|NCT01225731|11648477|FG010|COMPLETED|Part 2||0
10498243|NCT01225731|11648478|FG011|COMPLETED|Part 2||0
10498244|NCT01225731|11648479|FG012|COMPLETED|Part 2||0
10498245|NCT01225731|11648467|FG000|NOT COMPLETED|Part 2||0
10498246|NCT01225731|11648468|FG001|NOT COMPLETED|Part 2||0
10710487|NCT02650856|11875703|FG001|COMPLETED|Overall Study||21
10498247|NCT01225731|11648469|FG002|NOT COMPLETED|Part 2||0
10498248|NCT01225731|11648470|FG003|NOT COMPLETED|Part 2||0
10498249|NCT01225731|11648471|FG004|NOT COMPLETED|Part 2||0
10498250|NCT01225731|11648472|FG005|NOT COMPLETED|Part 2||3
10498251|NCT01225731|11648473|FG006|NOT COMPLETED|Part 2||8
10498252|NCT01225731|11648474|FG007|NOT COMPLETED|Part 2||25
10498253|NCT01225731|11648475|FG008|NOT COMPLETED|Part 2||11
10498254|NCT01225731|11648476|FG009|NOT COMPLETED|Part 2||0
10498255|NCT01225731|11648477|FG010|NOT COMPLETED|Part 2||0
10498256|NCT01225731|11648478|FG011|NOT COMPLETED|Part 2||0
10710488|NCT02650856|11875702|FG000|NOT COMPLETED|Overall Study||0
10710489|NCT02650856|11875703|FG001|NOT COMPLETED|Overall Study||0
10710490|NCT02650895|11875715|FG000|STARTED|Overall Study||10
10710491|NCT02650895|11875716|FG001|STARTED|Overall Study||6
10710492|NCT02650895|11875717|FG002|STARTED|Overall Study||6
10710493|NCT02650895|11875718|FG003|STARTED|Overall Study||6
10710494|NCT02650895|11875719|FG004|STARTED|Overall Study||6
10498257|NCT01225731|11648479|FG012|NOT COMPLETED|Part 2||0
10498258|NCT01225731|11648467|FG000|STARTED|Part 3||0
10498259|NCT01225731|11648468|FG001|STARTED|Part 3||0
10498260|NCT01225731|11648469|FG002|STARTED|Part 3||0
10498261|NCT01225731|11648470|FG003|STARTED|Part 3||0
10498262|NCT01225731|11648471|FG004|STARTED|Part 3||0
10498263|NCT01225731|11648472|FG005|STARTED|Part 3|Participants could enter the follow-up period|0
10498264|NCT01225731|11648473|FG006|STARTED|Part 3|Participants could enter the follow-up period|0
10498265|NCT01225731|11648474|FG007|STARTED|Part 3|Participants could enter the follow-up period|0
10498266|NCT01225731|11648475|FG008|STARTED|Part 3|Participants could enter the follow-up period|0
10498267|NCT01225731|11648476|FG009|STARTED|Part 3|Not all participants entered follow-up|10
10498268|NCT01225731|11648477|FG010|STARTED|Part 3|Not all participants entered follow-up|86
10498269|NCT01225731|11648478|FG011|STARTED|Part 3|Not all participants entered follow-up|126
10498270|NCT01225731|11648479|FG012|STARTED|Part 3|Not all participants entered follow-up|67
10498271|NCT01225731|11648467|FG000|COMPLETED|Part 3||0
10498272|NCT01225731|11648468|FG001|COMPLETED|Part 3||0
10498273|NCT01225731|11648469|FG002|COMPLETED|Part 3||0
10498274|NCT01225731|11648470|FG003|COMPLETED|Part 3||0
10498275|NCT01225731|11648471|FG004|COMPLETED|Part 3||0
10498276|NCT01225731|11648472|FG005|COMPLETED|Part 3||0
10498277|NCT01225731|11648473|FG006|COMPLETED|Part 3||0
10498278|NCT01225731|11648474|FG007|COMPLETED|Part 3||0
10498279|NCT01225731|11648475|FG008|COMPLETED|Part 3||0
10498280|NCT01225731|11648476|FG009|COMPLETED|Part 3||10
10498281|NCT01225731|11648477|FG010|COMPLETED|Part 3||80
10498282|NCT01225731|11648478|FG011|COMPLETED|Part 3||116
10498283|NCT01225731|11648479|FG012|COMPLETED|Part 3||60
10498284|NCT01225731|11648467|FG000|NOT COMPLETED|Part 3||0
10498285|NCT01225731|11648468|FG001|NOT COMPLETED|Part 3||0
10498286|NCT01225731|11648469|FG002|NOT COMPLETED|Part 3||0
10498287|NCT01225731|11648470|FG003|NOT COMPLETED|Part 3||0
10498288|NCT01225731|11648471|FG004|NOT COMPLETED|Part 3||0
10498289|NCT01225731|11648472|FG005|NOT COMPLETED|Part 3||0
10498290|NCT01225731|11648473|FG006|NOT COMPLETED|Part 3||0
10498291|NCT01225731|11648474|FG007|NOT COMPLETED|Part 3||0
10498292|NCT01225731|11648475|FG008|NOT COMPLETED|Part 3||0
10498293|NCT01225731|11648476|FG009|NOT COMPLETED|Part 3||0
10498294|NCT01225731|11648477|FG010|NOT COMPLETED|Part 3||6
10498295|NCT01225731|11648478|FG011|NOT COMPLETED|Part 3||10
10498296|NCT01225731|11648479|FG012|NOT COMPLETED|Part 3||7
10498297|NCT01225822|11648513|FG000|STARTED|Overall Study||389
10498298|NCT01225822|11648514|FG001|STARTED|Overall Study||390
10498299|NCT01225822|11648515|FG002|STARTED|Overall Study||393
10498300|NCT01225822|11648516|FG003|STARTED|Overall Study||385
10498301|NCT01225822|11648517|FG004|STARTED|Overall Study||392
10498302|NCT01225822|11648513|FG000|COMPLETED|Overall Study||351
10498303|NCT01225822|11648514|FG001|COMPLETED|Overall Study||334
10498304|NCT01225822|11648515|FG002|COMPLETED|Overall Study||355
10498305|NCT01225822|11648516|FG003|COMPLETED|Overall Study||333
10498306|NCT01225822|11648517|FG004|COMPLETED|Overall Study||361
10498307|NCT01225822|11648513|FG000|NOT COMPLETED|Overall Study||38
10498308|NCT01225822|11648514|FG001|NOT COMPLETED|Overall Study||56
10498309|NCT01225822|11648515|FG002|NOT COMPLETED|Overall Study||38
10498310|NCT01225822|11648516|FG003|NOT COMPLETED|Overall Study||52
10498311|NCT01225822|11648517|FG004|NOT COMPLETED|Overall Study||31
10498312|NCT01225835|11648534|FG000|STARTED|Overall Study||62
10498313|NCT01225835|11648535|FG001|STARTED|Overall Study||62
10498314|NCT01225835|11648534|FG000|Per Protocol Population|Overall Study||48
10498315|NCT01225835|11648535|FG001|Per Protocol Population|Overall Study||58
10498316|NCT01225835|11648534|FG000|COMPLETED|Overall Study|hCG criterion met|55
10498317|NCT01225835|11648535|FG001|COMPLETED|Overall Study|hCG criterion met|59
10498318|NCT01225835|11648534|FG000|NOT COMPLETED|Overall Study||7
10498319|NCT01225835|11648535|FG001|NOT COMPLETED|Overall Study||3
10498320|NCT01225887|11648547|FG000|STARTED|Overall Study||37
10498321|NCT01225887|11648547|FG000|COMPLETED|Overall Study||32
10498322|NCT01225887|11648547|FG000|NOT COMPLETED|Overall Study||5
10498323|NCT01225926|11648553|FG000|STARTED|Overall Study||12
10498324|NCT01225926|11648554|FG001|STARTED|Overall Study||12
10498325|NCT01225926|11648553|FG000|COMPLETED|Overall Study||12
10498326|NCT01225926|11648554|FG001|COMPLETED|Overall Study||12
10498327|NCT01225926|11648553|FG000|NOT COMPLETED|Overall Study||0
10498328|NCT01225926|11648554|FG001|NOT COMPLETED|Overall Study||0
10498329|NCT01225952|11648563|FG000|STARTED|Overall Study||31
10710495|NCT02650895|11875720|FG005|STARTED|Overall Study||6
10710496|NCT02650895|11875715|FG000|COMPLETED|Overall Study||10
10710497|NCT02650895|11875716|FG001|COMPLETED|Overall Study||5
10498330|NCT01225952|11648564|FG001|STARTED|Overall Study||31
10498331|NCT01225952|11648565|FG002|STARTED|Overall Study||31
10498332|NCT01225952|11648563|FG000|COMPLETED|Overall Study||25
10498333|NCT01225952|11648564|FG001|COMPLETED|Overall Study||27
10498334|NCT01225952|11648565|FG002|COMPLETED|Overall Study||25
10498335|NCT01225952|11648563|FG000|NOT COMPLETED|Overall Study||6
10498336|NCT01225952|11648564|FG001|NOT COMPLETED|Overall Study||4
10498337|NCT01225952|11648565|FG002|NOT COMPLETED|Overall Study||6
10498338|NCT01225991|11648573|FG000|STARTED|Overall Study||18
10498339|NCT01225991|11648573|FG000|COMPLETED|Overall Study||12
10498340|NCT01225991|11648573|FG000|NOT COMPLETED|Overall Study||6
10498341|NCT01226043|11648579|FG000|STARTED|4-week Crossover Phase - Period 1||202
10498342|NCT01226043|11648580|FG001|STARTED|4-week Crossover Phase - Period 1||203
10498343|NCT01226043|11648581|FG002|STARTED|4-week Crossover Phase - Period 1||0
10498344|NCT01226043|11648582|FG003|STARTED|4-week Crossover Phase - Period 1||0
10498345|NCT01226043|11648579|FG000|TREATED|4-week Crossover Phase - Period 1||202
10498346|NCT01226043|11648580|FG001|TREATED|4-week Crossover Phase - Period 1||200
10498347|NCT01226043|11648581|FG002|TREATED|4-week Crossover Phase - Period 1||0
10498348|NCT01226043|11648582|FG003|TREATED|4-week Crossover Phase - Period 1||0
10498349|NCT01226043|11648579|FG000|COMPLETED|4-week Crossover Phase - Period 1||199
10498350|NCT01226043|11648580|FG001|COMPLETED|4-week Crossover Phase - Period 1||194
10498351|NCT01226043|11648581|FG002|COMPLETED|4-week Crossover Phase - Period 1||0
10498352|NCT01226043|11648582|FG003|COMPLETED|4-week Crossover Phase - Period 1||0
10498353|NCT01226043|11648579|FG000|NOT COMPLETED|4-week Crossover Phase - Period 1||3
10498354|NCT01226043|11648580|FG001|NOT COMPLETED|4-week Crossover Phase - Period 1||9
10498355|NCT01226043|11648581|FG002|NOT COMPLETED|4-week Crossover Phase - Period 1||0
10498356|NCT01226043|11648582|FG003|NOT COMPLETED|4-week Crossover Phase - Period 1||0
10498357|NCT01226043|11648579|FG000|STARTED|4-week Crossover Phase - Period 2||199
10498358|NCT01226043|11648580|FG001|STARTED|4-week Crossover Phase - Period 2||194
10498359|NCT01226043|11648581|FG002|STARTED|4-week Crossover Phase - Period 2||0
10498360|NCT01226043|11648582|FG003|STARTED|4-week Crossover Phase - Period 2||0
10498361|NCT01226043|11648579|FG000|TREATED|4-week Crossover Phase - Period 2||199
10498362|NCT01226043|11648580|FG001|TREATED|4-week Crossover Phase - Period 2||194
10498363|NCT01226043|11648581|FG002|TREATED|4-week Crossover Phase - Period 2||0
10498364|NCT01226043|11648582|FG003|TREATED|4-week Crossover Phase - Period 2||0
10498365|NCT01226043|11648579|FG000|COMPLETED|4-week Crossover Phase - Period 2|28 patients were not re-randomized to the second phase of the study|195
10498366|NCT01226043|11648580|FG001|COMPLETED|4-week Crossover Phase - Period 2|22 patients were not re-randomized to the second phase of the study|188
10498367|NCT01226043|11648581|FG002|COMPLETED|4-week Crossover Phase - Period 2||0
10498368|NCT01226043|11648582|FG003|COMPLETED|4-week Crossover Phase - Period 2||0
10498369|NCT01226043|11648579|FG000|NOT COMPLETED|4-week Crossover Phase - Period 2||4
10498370|NCT01226043|11648580|FG001|NOT COMPLETED|4-week Crossover Phase - Period 2||6
10498371|NCT01226043|11648581|FG002|NOT COMPLETED|4-week Crossover Phase - Period 2||0
10498372|NCT01226043|11648582|FG003|NOT COMPLETED|4-week Crossover Phase - Period 2||0
10498373|NCT01226043|11648579|FG000|STARTED|6-week Re-randomization Phase||0
10498374|NCT01226043|11648580|FG001|STARTED|6-week Re-randomization Phase||0
10498375|NCT01226043|11648581|FG002|STARTED|6-week Re-randomization Phase||166
10498376|NCT01226043|11648582|FG003|STARTED|6-week Re-randomization Phase||167
10498377|NCT01226043|11648579|FG000|TREATED|6-week Re-randomization Phase||0
10498378|NCT01226043|11648580|FG001|TREATED|6-week Re-randomization Phase||0
10498379|NCT01226043|11648581|FG002|TREATED|6-week Re-randomization Phase||165
10498380|NCT01226043|11648582|FG003|TREATED|6-week Re-randomization Phase||165
10498381|NCT01226043|11648579|FG000|COMPLETED|6-week Re-randomization Phase||0
10498382|NCT01226043|11648580|FG001|COMPLETED|6-week Re-randomization Phase||0
10498383|NCT01226043|11648581|FG002|COMPLETED|6-week Re-randomization Phase||159
10498384|NCT01226043|11648582|FG003|COMPLETED|6-week Re-randomization Phase|3 patients did not enter the observational phase of the study|156
10498385|NCT01226043|11648579|FG000|NOT COMPLETED|6-week Re-randomization Phase||0
10498386|NCT01226043|11648580|FG001|NOT COMPLETED|6-week Re-randomization Phase||0
10498387|NCT01226043|11648581|FG002|NOT COMPLETED|6-week Re-randomization Phase||7
10498388|NCT01226043|11648582|FG003|NOT COMPLETED|6-week Re-randomization Phase||11
10498389|NCT01226043|11648579|FG000|STARTED|30-week Observational Phase||0
10498390|NCT01226043|11648580|FG001|STARTED|30-week Observational Phase||0
10498391|NCT01226043|11648581|FG002|STARTED|30-week Observational Phase||159
10498392|NCT01226043|11648582|FG003|STARTED|30-week Observational Phase||153
10498393|NCT01226043|11648579|FG000|TREATED|30-week Observational Phase||0
10498394|NCT01226043|11648580|FG001|TREATED|30-week Observational Phase||0
10498395|NCT01226043|11648581|FG002|TREATED|30-week Observational Phase||159
10498396|NCT01226043|11648582|FG003|TREATED|30-week Observational Phase||153
10498397|NCT01226043|11648579|FG000|COMPLETED|30-week Observational Phase||0
10498398|NCT01226043|11648580|FG001|COMPLETED|30-week Observational Phase||0
10498399|NCT01226043|11648581|FG002|COMPLETED|30-week Observational Phase||153
10498400|NCT01226043|11648582|FG003|COMPLETED|30-week Observational Phase||140
10498401|NCT01226043|11648579|FG000|NOT COMPLETED|30-week Observational Phase||0
10498402|NCT01226043|11648580|FG001|NOT COMPLETED|30-week Observational Phase||0
10498403|NCT01226043|11648581|FG002|NOT COMPLETED|30-week Observational Phase||6
10498404|NCT01226043|11648582|FG003|NOT COMPLETED|30-week Observational Phase||13
10498405|NCT01226095|11648612|FG000|STARTED|Overall Study||519
10498406|NCT01226095|11648612|FG000|COMPLETED|Overall Study||518
10498407|NCT01226095|11648612|FG000|NOT COMPLETED|Overall Study||1
10498408|NCT01226121|11648626|FG000|STARTED|Overall Study||13
10498409|NCT01226121|11648627|FG001|STARTED|Overall Study||11
10498410|NCT01226121|11648628|FG002|STARTED|Overall Study||13
10498411|NCT01226121|11648626|FG000|30 Day Evaluation|Overall Study||12
10498412|NCT01226121|11648627|FG001|30 Day Evaluation|Overall Study||11
10498413|NCT01226121|11648628|FG002|30 Day Evaluation|Overall Study||13
10498414|NCT01226121|11648626|FG000|COMPLETED|Overall Study||11
10498415|NCT01226121|11648627|FG001|COMPLETED|Overall Study||11
10498416|NCT01226121|11648628|FG002|COMPLETED|Overall Study||12
10498417|NCT01226121|11648626|FG000|NOT COMPLETED|Overall Study||2
10498418|NCT01226121|11648627|FG001|NOT COMPLETED|Overall Study||0
10498419|NCT01226121|11648628|FG002|NOT COMPLETED|Overall Study||1
10498420|NCT01226420|11648636|FG000|STARTED|Overall Study||6
10498421|NCT01226420|11648636|FG000|COMPLETED|Overall Study||6
10498422|NCT01226420|11648636|FG000|NOT COMPLETED|Overall Study||0
10498423|NCT01226459|11648642|FG000|STARTED|Overall Study||201
10498424|NCT01226459|11648643|FG001|STARTED|Overall Study||203
10498425|NCT01226459|11648642|FG000|COMPLETED|Overall Study||180
10498426|NCT01226459|11648643|FG001|COMPLETED|Overall Study||171
10498427|NCT01226459|11648642|FG000|NOT COMPLETED|Overall Study||21
10498428|NCT01226459|11648643|FG001|NOT COMPLETED|Overall Study||32
10498429|NCT01226472|11648649|FG000|STARTED|Overall Study||1
10498430|NCT01226472|11648649|FG000|COMPLETED|Overall Study||0
10498431|NCT01226472|11648649|FG000|NOT COMPLETED|Overall Study||1
10498432|NCT01226485|11648660|FG000|STARTED|Overall Study||3
10498433|NCT01226485|11648661|FG001|STARTED|Overall Study||6
10498434|NCT01226485|11648662|FG002|STARTED|Overall Study||3
10498435|NCT01226485|11648663|FG003|STARTED|Overall Study||6
10498436|NCT01226485|11648664|FG004|STARTED|Overall Study||7
10498437|NCT01226485|11648665|FG005|STARTED|Overall Study||19
10498438|NCT01226485|11648666|FG006|STARTED|Overall Study||40
10498439|NCT01226485|11648660|FG000|Received at Least One Dose of Drug|Overall Study||3
10498440|NCT01226485|11648661|FG001|Received at Least One Dose of Drug|Overall Study||6
10498441|NCT01226485|11648662|FG002|Received at Least One Dose of Drug|Overall Study||3
10498442|NCT01226485|11648663|FG003|Received at Least One Dose of Drug|Overall Study||6
10498443|NCT01226485|11648664|FG004|Received at Least One Dose of Drug|Overall Study||7
10498444|NCT01226485|11648665|FG005|Received at Least One Dose of Drug|Overall Study||19
10498445|NCT01226485|11648666|FG006|Received at Least One Dose of Drug|Overall Study||40
10498446|NCT01226485|11648660|FG000|COMPLETED|Overall Study||3
10498447|NCT01226485|11648661|FG001|COMPLETED|Overall Study||6
10498448|NCT01226485|11648662|FG002|COMPLETED|Overall Study||3
10498449|NCT01226485|11648663|FG003|COMPLETED|Overall Study||6
10498450|NCT01226485|11648664|FG004|COMPLETED|Overall Study||7
10498451|NCT01226485|11648665|FG005|COMPLETED|Overall Study||19
10498452|NCT01226485|11648666|FG006|COMPLETED|Overall Study||40
10498453|NCT01226485|11648660|FG000|NOT COMPLETED|Overall Study||0
10498454|NCT01226485|11648661|FG001|NOT COMPLETED|Overall Study||0
10498455|NCT01226485|11648662|FG002|NOT COMPLETED|Overall Study||0
10710498|NCT02650895|11875717|FG002|COMPLETED|Overall Study||6
10710499|NCT02650895|11875718|FG003|COMPLETED|Overall Study||6
10710500|NCT02650895|11875719|FG004|COMPLETED|Overall Study||6
10710501|NCT02650895|11875720|FG005|COMPLETED|Overall Study||6
10498456|NCT01226485|11648663|FG003|NOT COMPLETED|Overall Study||0
10498457|NCT01226485|11648664|FG004|NOT COMPLETED|Overall Study||0
10498458|NCT01226485|11648665|FG005|NOT COMPLETED|Overall Study||0
10498459|NCT01226485|11648666|FG006|NOT COMPLETED|Overall Study||0
10498460|NCT01226511|11648692|FG000|STARTED|Acute Treatment Period|Thirty-one (31) participants who discontinued acute treatment did not enter the taper period.|140
10498461|NCT01226511|11648693|FG001|STARTED|Acute Treatment Period|Twenty-six (26) participants who discontinued acute treatment did not enter the taper period.|141
10498462|NCT01226511|11648692|FG000|COMPLETED|Acute Treatment Period||108
10498463|NCT01226511|11648693|FG001|COMPLETED|Acute Treatment Period||110
10498464|NCT01226511|11648692|FG000|NOT COMPLETED|Acute Treatment Period||32
10498465|NCT01226511|11648693|FG001|NOT COMPLETED|Acute Treatment Period||31
10498466|NCT01226511|11648692|FG000|STARTED|Extension Treatment Period|Nineteen (19) participants who discontinued extension treatment did not enter the taper period.|108
10498467|NCT01226511|11648693|FG001|STARTED|Extension Treatment Period|Twenty-three (23) participants who discontinued extension treatment did not enter the taper period.|110
10498468|NCT01226511|11648692|FG000|COMPLETED|Extension Treatment Period|Thirty-nine (39) participants who completed extension treatment did not enter the taper period.|81
10498469|NCT01226511|11648693|FG001|COMPLETED|Extension Treatment Period|Thirty-five (35) participants who completed extension treatment did not enter the taper period.|83
10498470|NCT01226511|11648692|FG000|NOT COMPLETED|Extension Treatment Period||27
10498471|NCT01226511|11648693|FG001|NOT COMPLETED|Extension Treatment Period||27
10498472|NCT01226511|11648692|FG000|STARTED|Taper Period||51
10498473|NCT01226511|11648693|FG001|STARTED|Taper Period||57
10710502|NCT02650895|11875715|FG000|NOT COMPLETED|Overall Study||0
10710503|NCT02650895|11875716|FG001|NOT COMPLETED|Overall Study||1
10498474|NCT01226511|11648692|FG000|COMPLETED|Taper Period||46
10498475|NCT01226511|11648693|FG001|COMPLETED|Taper Period||54
10498476|NCT01226511|11648692|FG000|NOT COMPLETED|Taper Period||5
10498477|NCT01226511|11648693|FG001|NOT COMPLETED|Taper Period||3
10498478|NCT01226706|11648707|FG000|STARTED|Overall Study||10
10498479|NCT01226706|11648708|FG001|STARTED|Overall Study||11
10498480|NCT01226706|11648707|FG000|COMPLETED|Overall Study||10
10498481|NCT01226706|11648708|FG001|COMPLETED|Overall Study||11
10498482|NCT01226706|11648707|FG000|NOT COMPLETED|Overall Study||0
10498483|NCT01226706|11648708|FG001|NOT COMPLETED|Overall Study||0
10498484|NCT01226719|11648716|FG000|STARTED|Overall Study||15
10498485|NCT01226719|11648716|FG000|COMPLETED|Overall Study|Completed = patient is surgical candidate, underwent resection, received treatment to week 24.|2
10498486|NCT01226719|11648716|FG000|NOT COMPLETED|Overall Study||13
10498487|NCT01226745|11648726|FG000|STARTED|Overall Study||80
10498488|NCT01226745|11648727|FG001|STARTED|Overall Study||87
10498489|NCT01226745|11648728|FG002|STARTED|Overall Study||89
10498490|NCT01226745|11648729|FG003|STARTED|Overall Study||29
10498491|NCT01226745|11648730|FG004|STARTED|Overall Study||26
10498492|NCT01226745|11648731|FG005|STARTED|Overall Study||29
10498493|NCT01226745|11648726|FG000|COMPLETED|Overall Study||63
10498494|NCT01226745|11648727|FG001|COMPLETED|Overall Study||71
10498495|NCT01226745|11648728|FG002|COMPLETED|Overall Study||69
10498496|NCT01226745|11648729|FG003|COMPLETED|Overall Study||24
10498497|NCT01226745|11648730|FG004|COMPLETED|Overall Study||22
10498498|NCT01226745|11648731|FG005|COMPLETED|Overall Study||24
10498499|NCT01226745|11648726|FG000|NOT COMPLETED|Overall Study||17
10498500|NCT01226745|11648727|FG001|NOT COMPLETED|Overall Study||16
10498501|NCT01226745|11648728|FG002|NOT COMPLETED|Overall Study||20
10498502|NCT01226745|11648729|FG003|NOT COMPLETED|Overall Study||5
10498503|NCT01226745|11648730|FG004|NOT COMPLETED|Overall Study||4
10498504|NCT01226745|11648731|FG005|NOT COMPLETED|Overall Study||5
10498505|NCT01226914|11648748|FG000|STARTED|Overall Study||28
10498506|NCT01226914|11648749|FG001|STARTED|Overall Study||27
10498507|NCT01226914|11648748|FG000|COMPLETED|Overall Study||28
10498508|NCT01226914|11648749|FG001|COMPLETED|Overall Study||27
10498509|NCT01226914|11648748|FG000|NOT COMPLETED|Overall Study||0
10498510|NCT01226914|11648749|FG001|NOT COMPLETED|Overall Study||0
10498511|NCT01226979|11648755|FG000|STARTED|Overall Study||16
10498512|NCT01226979|11648755|FG000|COMPLETED|Overall Study||16
10498513|NCT01226979|11648755|FG000|NOT COMPLETED|Overall Study||0
10498514|NCT01227005|11648762|FG000|STARTED|Overall Study||55
10498515|NCT01227005|11648763|FG001|STARTED|Overall Study||52
10498516|NCT01227005|11648762|FG000|COMPLETED|Overall Study||50
10498517|NCT01227005|11648763|FG001|COMPLETED|Overall Study||51
10498518|NCT01227005|11648762|FG000|NOT COMPLETED|Overall Study||5
10498519|NCT01227005|11648763|FG001|NOT COMPLETED|Overall Study||1
10498520|NCT01227018|11648769|FG000|STARTED|Overall Study||15
10498521|NCT01227018|11648769|FG000|COMPLETED|Overall Study||0
10498522|NCT01227018|11648769|FG000|NOT COMPLETED|Overall Study||15
10498523|NCT01227044|11648775|FG000|STARTED|Overall Study||25
10498524|NCT01227044|11648776|FG001|STARTED|Overall Study||26
10498525|NCT01227044|11648775|FG000|COMPLETED|Overall Study||19
10498526|NCT01227044|11648776|FG001|COMPLETED|Overall Study||17
10498527|NCT01227044|11648775|FG000|NOT COMPLETED|Overall Study||6
10498528|NCT01227044|11648776|FG001|NOT COMPLETED|Overall Study||9
10498529|NCT01227057|11648784|FG000|STARTED|Overall Study||31
10498530|NCT01227057|11648785|FG001|STARTED|Overall Study||27
10498531|NCT01227057|11648784|FG000|COMPLETED|Overall Study||25
10498532|NCT01227057|11648785|FG001|COMPLETED|Overall Study||19
10498533|NCT01227057|11648784|FG000|NOT COMPLETED|Overall Study||6
10498534|NCT01227057|11648785|FG001|NOT COMPLETED|Overall Study||8
10498535|NCT01227252|11648796|FG000|STARTED|Overall Study||12
10498536|NCT01227252|11648797|FG001|STARTED|Overall Study||10
10498537|NCT01227252|11648798|FG002|STARTED|Overall Study||10
10498538|NCT01227252|11648799|FG003|STARTED|Overall Study||10
10498539|NCT01227252|11648796|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12
10498540|NCT01227252|11648797|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
10498541|NCT01227252|11648798|FG002|Received at Least 1 Dose of Study Drug|Overall Study||10
10498542|NCT01227252|11648799|FG003|Received at Least 1 Dose of Study Drug|Overall Study||10
10498543|NCT01227252|11648796|FG000|COMPLETED|Overall Study||12
10498544|NCT01227252|11648797|FG001|COMPLETED|Overall Study||7
10498545|NCT01227252|11648798|FG002|COMPLETED|Overall Study||10
10498546|NCT01227252|11648799|FG003|COMPLETED|Overall Study||10
10498547|NCT01227252|11648796|FG000|NOT COMPLETED|Overall Study||0
10498548|NCT01227252|11648797|FG001|NOT COMPLETED|Overall Study||3
10498549|NCT01227252|11648798|FG002|NOT COMPLETED|Overall Study||0
10498550|NCT01227252|11648799|FG003|NOT COMPLETED|Overall Study||0
10498551|NCT01227265|11648815|FG000|STARTED|Overall Study||158
10498552|NCT01227265|11648816|FG001|STARTED|Overall Study||159
10498553|NCT01227265|11648817|FG002|STARTED|Overall Study||159
10498554|NCT01227265|11648815|FG000|Treated|Overall Study||157
10498555|NCT01227265|11648816|FG001|Treated|Overall Study||157
10498556|NCT01227265|11648817|FG002|Treated|Overall Study||159
10498557|NCT01227265|11648815|FG000|COMPLETED|Overall Study||139
10498558|NCT01227265|11648816|FG001|COMPLETED|Overall Study||139
10498559|NCT01227265|11648817|FG002|COMPLETED|Overall Study||145
10498560|NCT01227265|11648815|FG000|NOT COMPLETED|Overall Study||19
10498561|NCT01227265|11648816|FG001|NOT COMPLETED|Overall Study||20
10498562|NCT01227265|11648817|FG002|NOT COMPLETED|Overall Study||14
10498563|NCT01227278|11648827|FG000|STARTED|Overall Study||50
10498564|NCT01227278|11648828|FG001|STARTED|Overall Study||51
10498565|NCT01227278|11648827|FG000|COMPLETED|Overall Study||45
10498566|NCT01227278|11648828|FG001|COMPLETED|Overall Study||43
10498567|NCT01227278|11648827|FG000|NOT COMPLETED|Overall Study||5
10498568|NCT01227278|11648828|FG001|NOT COMPLETED|Overall Study||8
10498569|NCT01227382|11648834|FG000|STARTED|Overall Study||26
10498570|NCT01227382|11648834|FG000|COMPLETED|Overall Study||26
10498571|NCT01227382|11648834|FG000|NOT COMPLETED|Overall Study||0
10498572|NCT01227395|11648842|FG000|STARTED|Overall Study||391
10498573|NCT01227395|11648843|FG001|STARTED|Overall Study||85
10498574|NCT01227395|11648842|FG000|COMPLETED|Overall Study||391
10498575|NCT01227395|11648843|FG001|COMPLETED|Overall Study||84
10498576|NCT01227395|11648842|FG000|NOT COMPLETED|Overall Study||0
10498577|NCT01227395|11648843|FG001|NOT COMPLETED|Overall Study||1
10498578|NCT01227421|11648871|FG000|STARTED|Overall Study||201
10498579|NCT01227421|11648872|FG001|STARTED|Overall Study||212
10498580|NCT01227421|11648873|FG002|STARTED|Overall Study||211
10498581|NCT01227421|11648871|FG000|COMPLETED|Overall Study||190
10498582|NCT01227421|11648872|FG001|COMPLETED|Overall Study||194
10498583|NCT01227421|11648873|FG002|COMPLETED|Overall Study||201
10498584|NCT01227421|11648871|FG000|NOT COMPLETED|Overall Study||11
10498585|NCT01227421|11648872|FG001|NOT COMPLETED|Overall Study||18
10498586|NCT01227421|11648873|FG002|NOT COMPLETED|Overall Study||10
10498587|NCT01227434|11648883|FG000|STARTED|Overall Study||6
10498588|NCT01227434|11648884|FG001|STARTED|Overall Study||16
10498589|NCT01227434|11648883|FG000|COMPLETED|Overall Study||6
10498590|NCT01227434|11648884|FG001|COMPLETED|Overall Study||16
10498591|NCT01227434|11648883|FG000|NOT COMPLETED|Overall Study||0
10498592|NCT01227434|11648884|FG001|NOT COMPLETED|Overall Study||0
10498593|NCT01227512|11648893|FG000|STARTED|Overall Study||66
10498594|NCT01227512|11648894|FG001|STARTED|Overall Study||58
10498595|NCT01227512|11648893|FG000|COMPLETED|Overall Study||53
10498596|NCT01227512|11648894|FG001|COMPLETED|Overall Study||48
10498597|NCT01227512|11648893|FG000|NOT COMPLETED|Overall Study||13
10498598|NCT01227512|11648894|FG001|NOT COMPLETED|Overall Study||10
10498599|NCT01227551|11648902|FG000|STARTED|Overall Study||57
10498600|NCT01227551|11648902|FG000|COMPLETED|Overall Study||23
10498601|NCT01227551|11648902|FG000|NOT COMPLETED|Overall Study||34
10710504|NCT02650895|11875717|FG002|NOT COMPLETED|Overall Study||0
10710505|NCT02650895|11875718|FG003|NOT COMPLETED|Overall Study||0
10710506|NCT02650895|11875719|FG004|NOT COMPLETED|Overall Study||0
10498602|NCT01227564|11648909|FG000|STARTED|Overall Study||22
10498603|NCT01227564|11648910|FG001|STARTED|Overall Study||20
10498604|NCT01227564|11648911|FG002|STARTED|Overall Study||21
10498605|NCT01227564|11648909|FG000|Treated|Overall Study||22
10498606|NCT01227564|11648910|FG001|Treated|Overall Study||20
10498607|NCT01227564|11648911|FG002|Treated|Overall Study||21
10498608|NCT01227564|11648909|FG000|Completed Treatment|Overall Study|1 participant discontinued treatment due to an adverse event (AE).|21
10498609|NCT01227564|11648910|FG001|Completed Treatment|Overall Study|2 participants discontinued treatment due to no longer willing to participate in study.|18
10498610|NCT01227564|11648911|FG002|Completed Treatment|Overall Study|1 participant stopped treatment due to lack of efficacy, 3 due to no longer willing to participate.|17
10498611|NCT01227564|11648909|FG000|COMPLETED|Overall Study|Completed study|18
10498612|NCT01227564|11648910|FG001|COMPLETED|Overall Study|Completed study|18
10498613|NCT01227564|11648911|FG002|COMPLETED|Overall Study|Completed study|15
10498614|NCT01227564|11648909|FG000|NOT COMPLETED|Overall Study||4
10498615|NCT01227564|11648910|FG001|NOT COMPLETED|Overall Study||2
10498616|NCT01227564|11648911|FG002|NOT COMPLETED|Overall Study||6
10498617|NCT01227577|11648921|FG000|STARTED|Overall Study||128
10498618|NCT01227577|11648921|FG000|COMPLETED|Overall Study||93
10498619|NCT01227577|11648921|FG000|NOT COMPLETED|Overall Study||35
10498620|NCT01227629|11648935|FG000|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|58
10498621|NCT01227629|11648936|FG001|STARTED|Overall Study||20
10498622|NCT01227629|11648937|FG002|STARTED|Overall Study||27
10498623|NCT01227629|11648938|FG003|STARTED|Overall Study||99
10498624|NCT01227629|11648939|FG004|STARTED|Overall Study||34
10498625|NCT01227629|11648940|FG005|STARTED|Overall Study||33
10498626|NCT01227629|11648941|FG006|STARTED|Overall Study||98
10498627|NCT01227629|11648942|FG007|STARTED|Overall Study||33
10498628|NCT01227629|11648943|FG008|STARTED|Overall Study||30
10498629|NCT01227629|11648944|FG009|STARTED|Overall Study||70
10498630|NCT01227629|11648935|FG000|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|56
10498631|NCT01227629|11648936|FG001|COMPLETED|Overall Study||18
10498632|NCT01227629|11648937|FG002|COMPLETED|Overall Study||26
10498633|NCT01227629|11648938|FG003|COMPLETED|Overall Study||91
10498634|NCT01227629|11648939|FG004|COMPLETED|Overall Study||32
10498635|NCT01227629|11648940|FG005|COMPLETED|Overall Study||32
10498636|NCT01227629|11648941|FG006|COMPLETED|Overall Study||90
10498637|NCT01227629|11648942|FG007|COMPLETED|Overall Study||27
10498638|NCT01227629|11648943|FG008|COMPLETED|Overall Study||24
10498639|NCT01227629|11648944|FG009|COMPLETED|Overall Study||68
10498640|NCT01227629|11648935|FG000|NOT COMPLETED|Overall Study||2
10498641|NCT01227629|11648936|FG001|NOT COMPLETED|Overall Study||2
10498642|NCT01227629|11648937|FG002|NOT COMPLETED|Overall Study||1
10498643|NCT01227629|11648938|FG003|NOT COMPLETED|Overall Study||8
10498644|NCT01227629|11648939|FG004|NOT COMPLETED|Overall Study||2
10710507|NCT02650895|11875720|FG005|NOT COMPLETED|Overall Study||0
10498645|NCT01227629|11648940|FG005|NOT COMPLETED|Overall Study||1
10498646|NCT01227629|11648941|FG006|NOT COMPLETED|Overall Study||8
10498647|NCT01227629|11648942|FG007|NOT COMPLETED|Overall Study||6
10498648|NCT01227629|11648943|FG008|NOT COMPLETED|Overall Study||6
10498649|NCT01227629|11648944|FG009|NOT COMPLETED|Overall Study||2
10498650|NCT01227655|11648993|FG000|STARTED|Overall Study||129
10498651|NCT01227655|11648994|FG001|STARTED|Overall Study||154
10498652|NCT01227655|11648995|FG002|STARTED|Overall Study||144
10498653|NCT01227655|11648993|FG000|Safety Set|Overall Study||125
10498654|NCT01227655|11648994|FG001|Safety Set|Overall Study||150
10498655|NCT01227655|11648995|FG002|Safety Set|Overall Study||136
10498656|NCT01227655|11648993|FG000|Full Analysis Set|Overall Study||125
10498657|NCT01227655|11648994|FG001|Full Analysis Set|Overall Study||147
10498658|NCT01227655|11648995|FG002|Full Analysis Set|Overall Study||135
10498659|NCT01227655|11648993|FG000|COMPLETED|Overall Study||118
10498660|NCT01227655|11648994|FG001|COMPLETED|Overall Study||128
10498661|NCT01227655|11648995|FG002|COMPLETED|Overall Study||130
10498662|NCT01227655|11648993|FG000|NOT COMPLETED|Overall Study||11
10498663|NCT01227655|11648994|FG001|NOT COMPLETED|Overall Study||26
10498664|NCT01227655|11648995|FG002|NOT COMPLETED|Overall Study||14
10498665|NCT01227668|11649005|FG000|STARTED|Phase 1 (Stabilization Phase)|Randomized|157
10498666|NCT01227668|11649006|FG001|STARTED|Phase 1 (Stabilization Phase)||0
10498667|NCT01227668|11649005|FG000|Received Treatment|Phase 1 (Stabilization Phase)||155
10498668|NCT01227668|11649006|FG001|Received Treatment|Phase 1 (Stabilization Phase)||0
10498669|NCT01227668|11649005|FG000|COMPLETED|Phase 1 (Stabilization Phase)||85
10498670|NCT01227668|11649006|FG001|COMPLETED|Phase 1 (Stabilization Phase)||0
10498671|NCT01227668|11649005|FG000|NOT COMPLETED|Phase 1 (Stabilization Phase)||72
10498672|NCT01227668|11649006|FG001|NOT COMPLETED|Phase 1 (Stabilization Phase)||0
10498673|NCT01227668|11649005|FG000|STARTED|Phase 2 (Randomization Phase)|Randomized|41
10498674|NCT01227668|11649006|FG001|STARTED|Phase 2 (Randomization Phase)|Randomized|44
10498675|NCT01227668|11649005|FG000|Received Treatment|Phase 2 (Randomization Phase)||39
10498676|NCT01227668|11649006|FG001|Received Treatment|Phase 2 (Randomization Phase)||43
10498677|NCT01227668|11649005|FG000|COMPLETED|Phase 2 (Randomization Phase)||22
10498678|NCT01227668|11649006|FG001|COMPLETED|Phase 2 (Randomization Phase)||19
10498679|NCT01227668|11649005|FG000|NOT COMPLETED|Phase 2 (Randomization Phase)||19
10498680|NCT01227668|11649006|FG001|NOT COMPLETED|Phase 2 (Randomization Phase)||25
10498681|NCT01227681|11649019|FG000|STARTED|Overall Study||4
10498682|NCT01227681|11649020|FG001|STARTED|Overall Study||0
10498683|NCT01227681|11649021|FG002|STARTED|Overall Study||0
10498684|NCT01227681|11649019|FG000|COMPLETED|Overall Study||4
10498685|NCT01227681|11649020|FG001|COMPLETED|Overall Study||0
10498686|NCT01227681|11649021|FG002|COMPLETED|Overall Study||0
10498687|NCT01227681|11649019|FG000|NOT COMPLETED|Overall Study||0
10498688|NCT01227681|11649020|FG001|NOT COMPLETED|Overall Study||0
10498689|NCT01227681|11649021|FG002|NOT COMPLETED|Overall Study||0
10498690|NCT01227707|11649025|FG000|STARTED|Overall Study||43
10498691|NCT01227707|11649025|FG000|COMPLETED|Overall Study||19
10498692|NCT01227707|11649025|FG000|NOT COMPLETED|Overall Study||24
10498693|NCT01227785|11649029|FG000|STARTED|Overall Study||120
10498694|NCT01227785|11649029|FG000|COMPLETED|Overall Study||108
10498695|NCT01227785|11649029|FG000|NOT COMPLETED|Overall Study||12
10498696|NCT01227824|11649042|FG000|STARTED|Double-blind Phase: 96 Weeks Duration||411
10498697|NCT01227824|11649043|FG001|STARTED|Double-blind Phase: 96 Weeks Duration||411
10498698|NCT01227824|11649044|FG002|STARTED|Double-blind Phase: 96 Weeks Duration||0
10498699|NCT01227824|11649042|FG000|COMPLETED|Double-blind Phase: 96 Weeks Duration||304
10498700|NCT01227824|11649043|FG001|COMPLETED|Double-blind Phase: 96 Weeks Duration||332
10498701|NCT01227824|11649044|FG002|COMPLETED|Double-blind Phase: 96 Weeks Duration||0
10498702|NCT01227824|11649042|FG000|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||107
10498703|NCT01227824|11649043|FG001|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||79
10498704|NCT01227824|11649044|FG002|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||0
10498705|NCT01227824|11649042|FG000|STARTED|Open-label Phase: Median of 1267 Days||0
10498706|NCT01227824|11649043|FG001|STARTED|Open-label Phase: Median of 1267 Days||0
10498707|NCT01227824|11649044|FG002|STARTED|Open-label Phase: Median of 1267 Days|338 participants continued into the Open-label phase on completing the Double-blind Phase|338
10498708|NCT01227824|11649042|FG000|COMPLETED|Open-label Phase: Median of 1267 Days||0
10498709|NCT01227824|11649043|FG001|COMPLETED|Open-label Phase: Median of 1267 Days||0
10498710|NCT01227824|11649044|FG002|COMPLETED|Open-label Phase: Median of 1267 Days||294
10498711|NCT01227824|11649042|FG000|NOT COMPLETED|Open-label Phase: Median of 1267 Days||0
10498712|NCT01227824|11649043|FG001|NOT COMPLETED|Open-label Phase: Median of 1267 Days||0
10498713|NCT01227824|11649044|FG002|NOT COMPLETED|Open-label Phase: Median of 1267 Days||44
10498714|NCT01227889|11649053|FG000|STARTED|Randomized Phase (RP)||187
10498715|NCT01227889|11649054|FG001|STARTED|Randomized Phase (RP)||63
10498716|NCT01227889|11649053|FG000|COMPLETED|Randomized Phase (RP)||0
10498717|NCT01227889|11649054|FG001|COMPLETED|Randomized Phase (RP)||0
10498718|NCT01227889|11649053|FG000|NOT COMPLETED|Randomized Phase (RP)||187
10498719|NCT01227889|11649054|FG001|NOT COMPLETED|Randomized Phase (RP)||63
10498720|NCT01227889|11649053|FG000|STARTED|Crossover Phase||0
10498721|NCT01227889|11649054|FG001|STARTED|Crossover Phase|As of the data cut on December 18, 2012, 36 of 63 participants crossed over from DTIC to GSK2118436.|37
10498722|NCT01227889|11649053|FG000|COMPLETED|Crossover Phase||0
10498723|NCT01227889|11649054|FG001|COMPLETED|Crossover Phase||0
10498724|NCT01227889|11649053|FG000|NOT COMPLETED|Crossover Phase||0
10498725|NCT01227889|11649054|FG001|NOT COMPLETED|Crossover Phase||37
10498726|NCT01227902|11649072|FG000|STARTED|Overall Study||56
10498727|NCT01227902|11649073|FG001|STARTED|Overall Study||51
10498728|NCT01227902|11649074|FG002|STARTED|Overall Study||44
10498729|NCT01227902|11649075|FG003|STARTED|Overall Study||52
10498730|NCT01227902|11649072|FG000|COMPLETED|Overall Study||38
10498731|NCT01227902|11649073|FG001|COMPLETED|Overall Study||38
10498732|NCT01227902|11649074|FG002|COMPLETED|Overall Study||25
10498733|NCT01227902|11649075|FG003|COMPLETED|Overall Study||42
10498734|NCT01227902|11649072|FG000|NOT COMPLETED|Overall Study||18
10498735|NCT01227902|11649073|FG001|NOT COMPLETED|Overall Study||13
10498736|NCT01227902|11649074|FG002|NOT COMPLETED|Overall Study||19
10498737|NCT01227902|11649075|FG003|NOT COMPLETED|Overall Study||10
10498738|NCT01227928|11649088|FG000|STARTED|Overall Study||72
10498739|NCT01227928|11649089|FG001|STARTED|Overall Study||73
10498740|NCT01227928|11649088|FG000|COMPLETED|Overall Study||50
10498741|NCT01227928|11649089|FG001|COMPLETED|Overall Study||56
10498742|NCT01227928|11649088|FG000|NOT COMPLETED|Overall Study||22
10498743|NCT01227928|11649089|FG001|NOT COMPLETED|Overall Study||17
10498744|NCT01227954|11649095|FG000|STARTED|Overall Study||113
10498745|NCT01227954|11649095|FG000|COMPLETED|Overall Study|Eligible subjects available for analysis|100
10498746|NCT01227954|11649095|FG000|NOT COMPLETED|Overall Study||13
10498747|NCT01227967|11649101|FG000|STARTED|Overall Study||314
10498748|NCT01227967|11649102|FG001|STARTED|Overall Study||316
10498749|NCT01227967|11649101|FG000|COMPLETED|Overall Study||298
10498750|NCT01227967|11649102|FG001|COMPLETED|Overall Study||303
10498751|NCT01227967|11649101|FG000|NOT COMPLETED|Overall Study||16
10498752|NCT01227967|11649102|FG001|NOT COMPLETED|Overall Study||13
10498753|NCT01227980|11649110|FG000|STARTED|Overall Study||40
10498754|NCT01227980|11649111|FG001|STARTED|Overall Study||30
10498755|NCT01227980|11649110|FG000|Scripts Challenge Sessions|Overall Study||26
10498756|NCT01227980|11649111|FG001|Scripts Challenge Sessions|Overall Study||25
10498757|NCT01227980|11649110|FG000|Measure Drug Level Concentration|Overall Study||10
10498758|NCT01227980|11649111|FG001|Measure Drug Level Concentration|Overall Study|No placebo subjects completed this milestone which measured active drug levels|0
10498759|NCT01227980|11649110|FG000|COMPLETED|Overall Study|Two subjects did not complete the scripts sessions but completed the remainder of the protocol|38
10498760|NCT01227980|11649111|FG001|COMPLETED|Overall Study||25
10498761|NCT01227980|11649110|FG000|NOT COMPLETED|Overall Study||2
10498762|NCT01227980|11649111|FG001|NOT COMPLETED|Overall Study||5
10498763|NCT01227993|11649117|FG000|STARTED|Overall Study||3
10498764|NCT01227993|11649117|FG000|COMPLETED|Overall Study||3
10498765|NCT01227993|11649117|FG000|NOT COMPLETED|Overall Study||0
10498766|NCT01228019|11649121|FG000|STARTED|Overall Study||1166
10498767|NCT01228019|11649121|FG000|COMPLETED|Overall Study||862
10498768|NCT01228019|11649121|FG000|NOT COMPLETED|Overall Study||304
10498769|NCT01228071|11649125|FG000|STARTED|Overall Study||34
10498770|NCT01228071|11649125|FG000|COMPLETED|Overall Study||32
10498771|NCT01228071|11649125|FG000|NOT COMPLETED|Overall Study||2
10498772|NCT01228084|11649129|FG000|STARTED|Overall Study||20
10498773|NCT01228084|11649129|FG000|COMPLETED|Overall Study||16
10498774|NCT01228084|11649129|FG000|NOT COMPLETED|Overall Study||4
10498775|NCT01228149|11649135|FG000|STARTED|Overall Study||32
10498776|NCT01228149|11649136|FG001|STARTED|Overall Study||30
10498777|NCT01228149|11649135|FG000|COMPLETED|Overall Study||27
10498778|NCT01228149|11649136|FG001|COMPLETED|Overall Study||26
10498779|NCT01228149|11649135|FG000|NOT COMPLETED|Overall Study||5
10498780|NCT01228149|11649136|FG001|NOT COMPLETED|Overall Study||4
10498781|NCT01228175|11649147|FG000|STARTED|Overall Study||119
10498782|NCT01228175|11649148|FG001|STARTED|Overall Study||99
10498783|NCT01228175|11649147|FG000|COMPLETED|Overall Study||53
10498784|NCT01228175|11649148|FG001|COMPLETED|Overall Study||46
10498785|NCT01228175|11649147|FG000|NOT COMPLETED|Overall Study||66
10498786|NCT01228175|11649148|FG001|NOT COMPLETED|Overall Study||53
10498787|NCT01228318|11649156|FG000|STARTED|Overall Study||34
10498788|NCT01228318|11649157|FG001|STARTED|Overall Study||29
10498789|NCT01228318|11649156|FG000|COMPLETED|Overall Study||30
10498790|NCT01228318|11649157|FG001|COMPLETED|Overall Study||22
10498791|NCT01228318|11649156|FG000|NOT COMPLETED|Overall Study||4
10498792|NCT01228318|11649157|FG001|NOT COMPLETED|Overall Study||7
10498793|NCT01228435|11649165|FG000|STARTED|Overall Study||1
10498794|NCT01228435|11649166|FG001|STARTED|Overall Study||2
10498795|NCT01228435|11649165|FG000|COMPLETED|Overall Study||1
10498796|NCT01228435|11649166|FG001|COMPLETED|Overall Study||2
10498797|NCT01228435|11649165|FG000|NOT COMPLETED|Overall Study||0
10498798|NCT01228435|11649166|FG001|NOT COMPLETED|Overall Study||0
10498799|NCT01228591|11649172|FG000|STARTED|Baseline||18
10498800|NCT01228591|11649173|FG001|STARTED|Baseline||18
10498801|NCT01228591|11649172|FG000|COMPLETED|Baseline||17
10498802|NCT01228591|11649173|FG001|COMPLETED|Baseline||16
10498803|NCT01228591|11649172|FG000|NOT COMPLETED|Baseline||1
10498804|NCT01228591|11649173|FG001|NOT COMPLETED|Baseline||2
10498805|NCT01228591|11649172|FG000|STARTED|1-Week Follow-Up||17
10498806|NCT01228591|11649173|FG001|STARTED|1-Week Follow-Up||16
10498807|NCT01228591|11649172|FG000|COMPLETED|1-Week Follow-Up||17
10498808|NCT01228591|11649173|FG001|COMPLETED|1-Week Follow-Up||16
10498809|NCT01228591|11649172|FG000|NOT COMPLETED|1-Week Follow-Up||0
10498810|NCT01228591|11649173|FG001|NOT COMPLETED|1-Week Follow-Up||0
10498811|NCT01228591|11649172|FG000|STARTED|Final Visit||17
10498812|NCT01228591|11649173|FG001|STARTED|Final Visit||16
10498813|NCT01228591|11649172|FG000|COMPLETED|Final Visit||17
10498814|NCT01228591|11649173|FG001|COMPLETED|Final Visit||16
10498815|NCT01228591|11649172|FG000|NOT COMPLETED|Final Visit||0
10498816|NCT01228591|11649173|FG001|NOT COMPLETED|Final Visit||0
10498817|NCT01228734|11649185|FG000|STARTED|Overall Study||193
10498818|NCT01228734|11649186|FG001|STARTED|Overall Study||204
10498819|NCT01228734|11649185|FG000|Modified Intent-to-treat Population|Overall Study||193
10498820|NCT01228734|11649186|FG001|Modified Intent-to-treat Population|Overall Study||200
10498821|NCT01228734|11649185|FG000|Modified Safety Population|Overall Study|One subject was randomized to FOLFOX-4 group but received cetuximab + FOLFOX-4 treatment instead|194
10498822|NCT01228734|11649186|FG001|Modified Safety Population|Overall Study||199
10498823|NCT01228734|11649185|FG000|COMPLETED|Overall Study||193
10498824|NCT01228734|11649186|FG001|COMPLETED|Overall Study||200
10498825|NCT01228734|11649185|FG000|NOT COMPLETED|Overall Study||0
10498826|NCT01228734|11649186|FG001|NOT COMPLETED|Overall Study||4
10498827|NCT01228747|11649194|FG000|STARTED|Overall Study||125
10498828|NCT01228747|11649195|FG001|STARTED|Overall Study||126
10498829|NCT01228747|11649194|FG000|COMPLETED|Overall Study||60
10498830|NCT01228747|11649195|FG001|COMPLETED|Overall Study||81
10498831|NCT01228747|11649194|FG000|NOT COMPLETED|Overall Study||65
10498832|NCT01228747|11649195|FG001|NOT COMPLETED|Overall Study||45
10498833|NCT01228903|11649203|FG000|STARTED|Overall Study||41
10498834|NCT01228903|11649204|FG001|STARTED|Overall Study||39
10498835|NCT01228903|11649203|FG000|COMPLETED|Overall Study||36
10498836|NCT01228903|11649204|FG001|COMPLETED|Overall Study||34
10498837|NCT01228903|11649203|FG000|NOT COMPLETED|Overall Study||5
10498838|NCT01228903|11649204|FG001|NOT COMPLETED|Overall Study||5
10498839|NCT01228929|11649213|FG000|STARTED|Nominal Condition||6
10498840|NCT01228929|11649214|FG001|STARTED|Nominal Condition||6
10498841|NCT01228929|11649215|FG002|STARTED|Nominal Condition||6
10498842|NCT01228929|11649213|FG000|COMPLETED|Nominal Condition||6
10498843|NCT01228929|11649214|FG001|COMPLETED|Nominal Condition||6
10498844|NCT01228929|11649215|FG002|COMPLETED|Nominal Condition||6
10498845|NCT01228929|11649213|FG000|NOT COMPLETED|Nominal Condition||0
10498846|NCT01228929|11649214|FG001|NOT COMPLETED|Nominal Condition||0
10498847|NCT01228929|11649215|FG002|NOT COMPLETED|Nominal Condition||0
10498848|NCT01228929|11649213|FG000|STARTED|Low Humidity Condition||6
10498849|NCT01228929|11649214|FG001|STARTED|Low Humidity Condition||6
10498850|NCT01228929|11649215|FG002|STARTED|Low Humidity Condition||6
10498851|NCT01228929|11649213|FG000|COMPLETED|Low Humidity Condition||6
10498852|NCT01228929|11649214|FG001|COMPLETED|Low Humidity Condition||6
10498853|NCT01228929|11649215|FG002|COMPLETED|Low Humidity Condition||6
10498854|NCT01228929|11649213|FG000|NOT COMPLETED|Low Humidity Condition||0
10498855|NCT01228929|11649214|FG001|NOT COMPLETED|Low Humidity Condition||0
10498856|NCT01228929|11649215|FG002|NOT COMPLETED|Low Humidity Condition||0
10498857|NCT01228929|11649213|FG000|STARTED|High Temperature Condition||6
10498858|NCT01228929|11649214|FG001|STARTED|High Temperature Condition||6
10498859|NCT01228929|11649215|FG002|STARTED|High Temperature Condition||6
10498860|NCT01228929|11649213|FG000|COMPLETED|High Temperature Condition||6
10498861|NCT01228929|11649214|FG001|COMPLETED|High Temperature Condition||6
10498862|NCT01228929|11649215|FG002|COMPLETED|High Temperature Condition||6
10498863|NCT01228929|11649213|FG000|NOT COMPLETED|High Temperature Condition||0
10498864|NCT01228929|11649214|FG001|NOT COMPLETED|High Temperature Condition||0
10498865|NCT01228929|11649215|FG002|NOT COMPLETED|High Temperature Condition||0
10498866|NCT01228968|11649223|FG000|STARTED|Overall Study||9
10498867|NCT01228968|11649223|FG000|COMPLETED|Overall Study||9
10498868|NCT01228968|11649223|FG000|NOT COMPLETED|Overall Study||0
10498869|NCT01229111|11649227|FG000|STARTED|Overall Study||14
10498870|NCT01229111|11649227|FG000|COMPLETED|Overall Study||13
10498871|NCT01229111|11649227|FG000|NOT COMPLETED|Overall Study||1
10498872|NCT01229150|11649235|FG000|STARTED|Overall Study||30
10498873|NCT01229150|11649236|FG001|STARTED|Overall Study||11
10498874|NCT01229150|11649237|FG002|STARTED|Overall Study||19
10498875|NCT01229150|11649238|FG003|STARTED|Overall Study||19
10498876|NCT01229150|11649235|FG000|COMPLETED|Overall Study||28
10498877|NCT01229150|11649236|FG001|COMPLETED|Overall Study||9
10498878|NCT01229150|11649237|FG002|COMPLETED|Overall Study||19
10498879|NCT01229150|11649238|FG003|COMPLETED|Overall Study||19
10498880|NCT01229150|11649235|FG000|NOT COMPLETED|Overall Study||2
10498881|NCT01229150|11649236|FG001|NOT COMPLETED|Overall Study||2
10498882|NCT01229150|11649237|FG002|NOT COMPLETED|Overall Study||0
10498883|NCT01229150|11649238|FG003|NOT COMPLETED|Overall Study||0
10498884|NCT01229176|11649260|FG000|STARTED|Overall Study||40
10498885|NCT01229176|11649261|FG001|STARTED|Overall Study||40
10498886|NCT01229176|11649262|FG002|STARTED|Overall Study||20
10498887|NCT01229176|11649263|FG003|STARTED|Overall Study||20
10498888|NCT01229176|11649264|FG004|STARTED|Overall Study||20
10498889|NCT01229176|11649265|FG005|STARTED|Overall Study||20
10498890|NCT01229176|11649266|FG006|STARTED|Overall Study||20
10498891|NCT01229176|11649267|FG007|STARTED|Overall Study||20
10498892|NCT01229176|11649260|FG000|COMPLETED|Overall Study||40
10498893|NCT01229176|11649261|FG001|COMPLETED|Overall Study||37
10498894|NCT01229176|11649262|FG002|COMPLETED|Overall Study||20
10498895|NCT01229176|11649263|FG003|COMPLETED|Overall Study||19
10498896|NCT01229176|11649264|FG004|COMPLETED|Overall Study||18
10498897|NCT01229176|11649265|FG005|COMPLETED|Overall Study||18
10498898|NCT01229176|11649266|FG006|COMPLETED|Overall Study||20
10498899|NCT01229176|11649267|FG007|COMPLETED|Overall Study||17
10498900|NCT01229176|11649260|FG000|NOT COMPLETED|Overall Study||0
10498901|NCT01229176|11649261|FG001|NOT COMPLETED|Overall Study||3
10498902|NCT01229176|11649262|FG002|NOT COMPLETED|Overall Study||0
10498903|NCT01229176|11649263|FG003|NOT COMPLETED|Overall Study||1
10498904|NCT01229176|11649264|FG004|NOT COMPLETED|Overall Study||2
10498905|NCT01229176|11649265|FG005|NOT COMPLETED|Overall Study||2
10498906|NCT01229176|11649266|FG006|NOT COMPLETED|Overall Study||0
10498907|NCT01229176|11649267|FG007|NOT COMPLETED|Overall Study||3
10498908|NCT01229228|11649290|FG000|STARTED|Overall Study||51
10498909|NCT01229228|11649291|FG001|STARTED|Overall Study||51
10498910|NCT01229228|11649292|FG002|STARTED|Overall Study||50
10498911|NCT01229228|11649293|FG003|STARTED|Overall Study||51
10498912|NCT01229228|11649294|FG004|STARTED|Overall Study||51
10498913|NCT01229228|11649290|FG000|COMPLETED|Overall Study||50
10498914|NCT01229228|11649291|FG001|COMPLETED|Overall Study||51
10498915|NCT01229228|11649292|FG002|COMPLETED|Overall Study||49
10498916|NCT01229228|11649293|FG003|COMPLETED|Overall Study||51
10498917|NCT01229228|11649294|FG004|COMPLETED|Overall Study||50
10498918|NCT01229228|11649290|FG000|NOT COMPLETED|Overall Study||1
10498919|NCT01229228|11649291|FG001|NOT COMPLETED|Overall Study||0
10498920|NCT01229228|11649292|FG002|NOT COMPLETED|Overall Study||1
10498921|NCT01229228|11649293|FG003|NOT COMPLETED|Overall Study||0
10498922|NCT01229228|11649294|FG004|NOT COMPLETED|Overall Study||1
10528068|NCT01393405|11680288|FG001|COMPLETED|Maintenance Period Week||15
10528069|NCT01393405|11680289|FG002|COMPLETED|Maintenance Period Week||16
10528070|NCT01393405|11680287|FG000|NOT COMPLETED|Maintenance Period Week||0
10528071|NCT01393405|11680288|FG001|NOT COMPLETED|Maintenance Period Week||29
10528072|NCT01393405|11680289|FG002|NOT COMPLETED|Maintenance Period Week||24
10528073|NCT01393444|11680299|FG000|STARTED|Overall Study||6
10528074|NCT01393444|11680299|FG000|First (1st Implanted) Subject Enrolled|Overall Study|2011: Individual with cervical spinal cord injury enrolled and was eligible. Implanted in 2011.|1
10528075|NCT01393444|11680299|FG000|Second Subject Enrolled|Overall Study|2012: Second participant enrolled. Ineligible.|1
10528076|NCT01393444|11680299|FG000|Third Subject Enrolled|Overall Study|2013: Third participant enrolled. Withdrew due to family commitments.|1
10528077|NCT01393444|11680299|FG000|Fourth Subject Enrolled|Overall Study|2013: Fourth participant enrolled. Ineligible.|1
10710511|NCT02650999|11875745|FG000|STARTED|Overall Study||12
10710512|NCT02650999|11875745|FG000|COMPLETED|Overall Study||12
10710513|NCT02650999|11875745|FG000|NOT COMPLETED|Overall Study||0
10710514|NCT02651103|11875749|FG000|STARTED|Overall Study||30
10710515|NCT02651103|11875749|FG000|COMPLETED|Overall Study||30
10710516|NCT02651103|11875749|FG000|NOT COMPLETED|Overall Study||0
10710517|NCT02651116|11875755|FG000|STARTED|Overall Study||68
10710518|NCT02651116|11875756|FG001|STARTED|Overall Study||63
10710519|NCT02651116|11875755|FG000|Treated|Overall Study||68
10710520|NCT02651116|11875756|FG001|Treated|Overall Study||63
10710521|NCT02651116|11875755|FG000|COMPLETED|Overall Study||67
10710522|NCT02651116|11875756|FG001|COMPLETED|Overall Study||62
10710523|NCT02651116|11875755|FG000|NOT COMPLETED|Overall Study||1
10710524|NCT02651116|11875756|FG001|NOT COMPLETED|Overall Study||1
10710525|NCT02651155|11875764|FG000|STARTED|Overall Study||99
10710526|NCT02651155|11875765|FG001|STARTED|Overall Study||105
10710527|NCT02651155|11875764|FG000|COMPLETED|Overall Study||93
10710528|NCT02651155|11875765|FG001|COMPLETED|Overall Study||103
10710529|NCT02651155|11875764|FG000|NOT COMPLETED|Overall Study||6
10710530|NCT02651155|11875765|FG001|NOT COMPLETED|Overall Study||2
10710531|NCT02651194|11875771|FG000|STARTED|Overall Study||104
10710532|NCT02651194|11875771|FG000|COMPLETED|Overall Study||99
10710533|NCT02651194|11875771|FG000|NOT COMPLETED|Overall Study||5
10710534|NCT02651220|11875778|FG000|STARTED|Overall Study||337
10710535|NCT02651220|11875779|FG001|STARTED|Overall Study||335
10710536|NCT02651220|11875780|FG002|STARTED|Overall Study||329
10710537|NCT02651220|11875778|FG000|COMPLETED|Overall Study||314
10710538|NCT02651220|11875779|FG001|COMPLETED|Overall Study||308
10710539|NCT02651220|11875780|FG002|COMPLETED|Overall Study||300
10710540|NCT02651220|11875778|FG000|NOT COMPLETED|Overall Study||23
10710541|NCT02651220|11875779|FG001|NOT COMPLETED|Overall Study||27
10710542|NCT02651220|11875780|FG002|NOT COMPLETED|Overall Study||29
10528078|NCT01393444|11680299|FG000|Fifth (2nd Implanted) Subject Enrolled|Overall Study|2013: Individual with ALS enrolled and was eligible. Implanted in 2014.|1
10528079|NCT01393444|11680299|FG000|Sixth (3rd Implanted) Subject|Overall Study|2014: Individual with brachial plexus injury enrolled and was eligible. Implanted in 2015.|1
10528080|NCT01393444|11680299|FG000|COMPLETED|Overall Study|2015: Third implanted subject completed the study. This fulfilled the requirements of our grant.|3
10528081|NCT01393444|11680299|FG000|NOT COMPLETED|Overall Study||3
10528082|NCT01393457|11680307|FG000|STARTED|Overall Study||26
10528083|NCT01393457|11680308|FG001|STARTED|Overall Study||26
10528084|NCT01393457|11680309|FG002|STARTED|Overall Study||31
10528085|NCT01393457|11680310|FG003|STARTED|Overall Study||27
10528086|NCT01393457|11680307|FG000|COMPLETED|Overall Study||14
10528087|NCT01393457|11680308|FG001|COMPLETED|Overall Study||14
10528088|NCT01393457|11680309|FG002|COMPLETED|Overall Study||16
10528089|NCT01393457|11680310|FG003|COMPLETED|Overall Study||15
10528090|NCT01393457|11680307|FG000|NOT COMPLETED|Overall Study||12
10528091|NCT01393457|11680308|FG001|NOT COMPLETED|Overall Study||12
10528092|NCT01393457|11680309|FG002|NOT COMPLETED|Overall Study||15
10528093|NCT01393457|11680310|FG003|NOT COMPLETED|Overall Study||12
10710543|NCT02651259|11875790|FG000|STARTED|Overall Study||25
10710544|NCT02651259|11875791|FG001|STARTED|Overall Study||25
10710545|NCT02651259|11875790|FG000|COMPLETED|Overall Study||25
10710546|NCT02651259|11875791|FG001|COMPLETED|Overall Study||25
10710547|NCT02651259|11875790|FG000|NOT COMPLETED|Overall Study||0
10710548|NCT02651259|11875791|FG001|NOT COMPLETED|Overall Study||0
10710549|NCT02651272|11875805|FG000|STARTED|Overall Study||4
10710550|NCT02651272|11875805|FG000|COMPLETED|Overall Study||1
10710551|NCT02651272|11875805|FG000|NOT COMPLETED|Overall Study||3
10710552|NCT02651337|11875809|FG000|STARTED|Overall Study||5
10498923|NCT01229254|11649309|FG000|STARTED|Overall Study||42
10498924|NCT01229254|11649310|FG001|STARTED|Overall Study||74
10498925|NCT01229254|11649311|FG002|STARTED|Overall Study||73
10498926|NCT01229254|11649309|FG000|COMPLETED|Overall Study||27
10498927|NCT01229254|11649310|FG001|COMPLETED|Overall Study||58
10498928|NCT01229254|11649311|FG002|COMPLETED|Overall Study||61
10498929|NCT01229254|11649309|FG000|NOT COMPLETED|Overall Study||15
10498930|NCT01229254|11649310|FG001|NOT COMPLETED|Overall Study||16
10498931|NCT01229254|11649311|FG002|NOT COMPLETED|Overall Study||12
10498932|NCT01229267|11649325|FG000|STARTED|Overall Study||189
10498933|NCT01229267|11649326|FG001|STARTED|Overall Study||184
10498934|NCT01229267|11649327|FG002|STARTED|Overall Study||187
10498935|NCT01229267|11649328|FG003|STARTED|Overall Study||106
10498936|NCT01229267|11649329|FG004|STARTED|Overall Study||564
10498937|NCT01229267|11649325|FG000|Received Vaccination 1|Overall Study||188
10498938|NCT01229267|11649326|FG001|Received Vaccination 1|Overall Study||180
10498939|NCT01229267|11649327|FG002|Received Vaccination 1|Overall Study||186
10498940|NCT01229267|11649328|FG003|Received Vaccination 1|Overall Study||104
10498941|NCT01229267|11649329|FG004|Received Vaccination 1|Overall Study||556
10498942|NCT01229267|11649325|FG000|Received Vaccination 2|Overall Study||171
10498943|NCT01229267|11649326|FG001|Received Vaccination 2|Overall Study||163
10498944|NCT01229267|11649327|FG002|Received Vaccination 2|Overall Study||168
10498945|NCT01229267|11649328|FG003|Received Vaccination 2|Overall Study||94
10498946|NCT01229267|11649329|FG004|Received Vaccination 2|Overall Study||511
10710553|NCT02651337|11875809|FG000|COMPLETED|Overall Study||4
10710554|NCT02651337|11875809|FG000|NOT COMPLETED|Overall Study||1
10710555|NCT02651415|11875813|FG000|STARTED|Overall Study|12 patients were enrolled.|12
10498947|NCT01229267|11649325|FG000|Received Vaccination 3|Overall Study||163
10498948|NCT01229267|11649326|FG001|Received Vaccination 3|Overall Study||155
10498949|NCT01229267|11649327|FG002|Received Vaccination 3|Overall Study||160
10498950|NCT01229267|11649328|FG003|Received Vaccination 3|Overall Study||89
10498951|NCT01229267|11649329|FG004|Received Vaccination 3|Overall Study||491
10498952|NCT01229267|11649325|FG000|Received Vaccination 4|Overall Study||155
10498953|NCT01229267|11649326|FG001|Received Vaccination 4|Overall Study||149
10498954|NCT01229267|11649327|FG002|Received Vaccination 4|Overall Study||149
10498955|NCT01229267|11649328|FG003|Received Vaccination 4|Overall Study||87
10498956|NCT01229267|11649329|FG004|Received Vaccination 4|Overall Study||477
10498957|NCT01229267|11649325|FG000|COMPLETED|Overall Study||108
10498958|NCT01229267|11649326|FG001|COMPLETED|Overall Study||102
10498959|NCT01229267|11649327|FG002|COMPLETED|Overall Study||101
10498960|NCT01229267|11649328|FG003|COMPLETED|Overall Study||71
10498961|NCT01229267|11649329|FG004|COMPLETED|Overall Study||344
10498962|NCT01229267|11649325|FG000|NOT COMPLETED|Overall Study||81
10498963|NCT01229267|11649326|FG001|NOT COMPLETED|Overall Study||82
10498964|NCT01229267|11649327|FG002|NOT COMPLETED|Overall Study||86
10498965|NCT01229267|11649328|FG003|NOT COMPLETED|Overall Study||35
10498966|NCT01229267|11649329|FG004|NOT COMPLETED|Overall Study||220
10498967|NCT01229371|11649340|FG000|STARTED|Overall Study||109
10498968|NCT01229371|11649341|FG001|STARTED|Overall Study||111
10498969|NCT01229371|11649342|FG002|STARTED|Overall Study||110
10498970|NCT01229371|11649343|FG003|STARTED|Overall Study||110
10498971|NCT01229371|11649340|FG000|COMPLETED|Overall Study||109
10498972|NCT01229371|11649341|FG001|COMPLETED|Overall Study||110
10498973|NCT01229371|11649342|FG002|COMPLETED|Overall Study||110
10498974|NCT01229371|11649343|FG003|COMPLETED|Overall Study||110
10498975|NCT01229371|11649340|FG000|NOT COMPLETED|Overall Study||0
10498976|NCT01229371|11649341|FG001|NOT COMPLETED|Overall Study||1
10498977|NCT01229371|11649342|FG002|NOT COMPLETED|Overall Study||0
10498978|NCT01229371|11649343|FG003|NOT COMPLETED|Overall Study||0
10498979|NCT01229397|11649355|FG000|STARTED|Overall Study||103
10498980|NCT01229397|11649356|FG001|STARTED|Overall Study||102
10498981|NCT01229397|11649355|FG000|COMPLETED|Overall Study||92
10498982|NCT01229397|11649356|FG001|COMPLETED|Overall Study||93
10498983|NCT01229397|11649355|FG000|NOT COMPLETED|Overall Study||11
10498984|NCT01229397|11649356|FG001|NOT COMPLETED|Overall Study||9
10498985|NCT01229410|11649368|FG000|STARTED|Overall Study||12
10498986|NCT01229410|11649369|FG001|STARTED|Overall Study||12
10498987|NCT01229410|11649368|FG000|COMPLETED|Overall Study||7
10710556|NCT02651415|11875813|FG000|COMPLETED|Overall Study|10 patients were evaluable.|10
10710557|NCT02651415|11875813|FG000|NOT COMPLETED|Overall Study||2
10710558|NCT02651428|11875819|FG000|STARTED|Overall Study||403
10498988|NCT01229410|11649369|FG001|COMPLETED|Overall Study||9
10498989|NCT01229410|11649368|FG000|NOT COMPLETED|Overall Study||5
10498990|NCT01229410|11649369|FG001|NOT COMPLETED|Overall Study||3
10498991|NCT01229423|11649375|FG000|STARTED|Overall Study||62
10498992|NCT01229423|11649375|FG000|COMPLETED|Overall Study||47
10498993|NCT01229423|11649375|FG000|NOT COMPLETED|Overall Study||15
10498994|NCT01229436|11649379|FG000|STARTED|Overall Study||254
10498995|NCT01229436|11649379|FG000|COMPLETED|Overall Study||249
10498996|NCT01229436|11649379|FG000|NOT COMPLETED|Overall Study||5
10498997|NCT01229449|11649388|FG000|STARTED|Overall Study||173
10498998|NCT01229449|11649389|FG001|STARTED|Overall Study||168
10498999|NCT01229449|11649390|FG002|STARTED|Overall Study||169
10499000|NCT01229449|11649391|FG003|STARTED|Overall Study||113
10499001|NCT01229449|11649392|FG004|STARTED|Overall Study||55
10499002|NCT01229449|11649388|FG000|COMPLETED|Overall Study||172
10499003|NCT01229449|11649389|FG001|COMPLETED|Overall Study||164
10499004|NCT01229449|11649390|FG002|COMPLETED|Overall Study||167
10499005|NCT01229449|11649391|FG003|COMPLETED|Overall Study||112
10499006|NCT01229449|11649392|FG004|COMPLETED|Overall Study||54
10499007|NCT01229449|11649388|FG000|NOT COMPLETED|Overall Study||1
10499008|NCT01229449|11649389|FG001|NOT COMPLETED|Overall Study||4
10499009|NCT01229449|11649390|FG002|NOT COMPLETED|Overall Study||2
10499010|NCT01229449|11649391|FG003|NOT COMPLETED|Overall Study||1
10499011|NCT01229449|11649392|FG004|NOT COMPLETED|Overall Study||1
10499012|NCT01229462|11649406|FG000|STARTED|Overall Study||120
10499013|NCT01229462|11649407|FG001|STARTED|Overall Study||118
10499014|NCT01229462|11649406|FG000|COMPLETED|Overall Study||115
10499015|NCT01229462|11649407|FG001|COMPLETED|Overall Study||109
10499016|NCT01229462|11649406|FG000|NOT COMPLETED|Overall Study||5
10499017|NCT01229462|11649407|FG001|NOT COMPLETED|Overall Study||9
10499018|NCT01229527|11649416|FG000|STARTED|Overall Study||30
10499019|NCT01229527|11649417|FG001|STARTED|Overall Study||30
10499020|NCT01229527|11649418|FG002|STARTED|Overall Study||30
10499021|NCT01229527|11649416|FG000|COMPLETED|Overall Study||30
10499022|NCT01229527|11649417|FG001|COMPLETED|Overall Study||30
10499023|NCT01229527|11649418|FG002|COMPLETED|Overall Study||30
10499024|NCT01229527|11649416|FG000|NOT COMPLETED|Overall Study||0
10499025|NCT01229527|11649417|FG001|NOT COMPLETED|Overall Study||0
10499026|NCT01229527|11649418|FG002|NOT COMPLETED|Overall Study||0
10499027|NCT01229722|11649428|FG000|STARTED|Overall Study||36
10499028|NCT01229722|11649429|FG001|STARTED|Overall Study||34
10499029|NCT01229722|11649428|FG000|COMPLETED|Overall Study||36
10499030|NCT01229722|11649429|FG001|COMPLETED|Overall Study||30
10499031|NCT01229722|11649428|FG000|NOT COMPLETED|Overall Study||0
10499032|NCT01229722|11649429|FG001|NOT COMPLETED|Overall Study||4
10499033|NCT01229735|11649441|FG000|STARTED|Overall Study||177
10499034|NCT01229735|11649442|FG001|STARTED|Overall Study||166
10499035|NCT01229735|11649441|FG000|COMPLETED|Overall Study||111
10499036|NCT01229735|11649442|FG001|COMPLETED|Overall Study||100
10499037|NCT01229735|11649441|FG000|NOT COMPLETED|Overall Study||66
10499038|NCT01229735|11649442|FG001|NOT COMPLETED|Overall Study||66
10499039|NCT01229891|11649453|FG000|STARTED|Overall Study||30
10499040|NCT01229891|11649454|FG001|STARTED|Overall Study||30
10499041|NCT01229891|11649455|FG002|STARTED|Overall Study||30
10499042|NCT01229891|11649453|FG000|COMPLETED|Overall Study||30
10499043|NCT01229891|11649454|FG001|COMPLETED|Overall Study||30
10499044|NCT01229891|11649455|FG002|COMPLETED|Overall Study||30
10499045|NCT01229891|11649453|FG000|NOT COMPLETED|Overall Study||0
10499046|NCT01229891|11649454|FG001|NOT COMPLETED|Overall Study||0
10499047|NCT01229891|11649455|FG002|NOT COMPLETED|Overall Study||0
10499048|NCT01230021|11649463|FG000|STARTED|Overall Study||6
10499049|NCT01230021|11649463|FG000|COMPLETED|Overall Study||6
10499050|NCT01230021|11649463|FG000|NOT COMPLETED|Overall Study||0
10499051|NCT01230060|11649467|FG000|STARTED|Overall Study||122
10499052|NCT01230060|11649467|FG000|COMPLETED|Overall Study||121
10499053|NCT01230060|11649467|FG000|NOT COMPLETED|Overall Study||1
10499054|NCT01230125|11649473|FG000|STARTED|Overall Study||207
10499055|NCT01230125|11649474|FG001|STARTED|Overall Study||104
10499056|NCT01230125|11649473|FG000|COMPLETED|Overall Study||134
10499057|NCT01230125|11649474|FG001|COMPLETED|Overall Study||54
10499058|NCT01230125|11649473|FG000|NOT COMPLETED|Overall Study||73
10499059|NCT01230125|11649474|FG001|NOT COMPLETED|Overall Study||50
10499060|NCT01230177|11649480|FG000|STARTED|Overall Study||3
10499061|NCT01230177|11649480|FG000|COMPLETED|Overall Study||3
10499062|NCT01230177|11649480|FG000|NOT COMPLETED|Overall Study||0
10499063|NCT01230424|11649486|FG000|STARTED|Overall Study||70
10499064|NCT01230424|11649487|FG001|STARTED|Overall Study||70
10499065|NCT01230424|11649486|FG000|COMPLETED|Overall Study||70
10499066|NCT01230424|11649487|FG001|COMPLETED|Overall Study||70
10499067|NCT01230424|11649486|FG000|NOT COMPLETED|Overall Study||0
10499068|NCT01230424|11649487|FG001|NOT COMPLETED|Overall Study||0
10499069|NCT01230502|11649499|FG000|STARTED|Overall Study||9
10499070|NCT01230502|11649500|FG001|STARTED|Overall Study||0
10499071|NCT01230502|11649501|FG002|STARTED|Overall Study||0
10499072|NCT01230502|11649499|FG000|COMPLETED|Overall Study||9
10499073|NCT01230502|11649500|FG001|COMPLETED|Overall Study||0
10499074|NCT01230502|11649501|FG002|COMPLETED|Overall Study||0
10499075|NCT01230502|11649499|FG000|NOT COMPLETED|Overall Study||0
10499076|NCT01230502|11649500|FG001|NOT COMPLETED|Overall Study||0
10499077|NCT01230502|11649501|FG002|NOT COMPLETED|Overall Study||0
10499078|NCT01230554|11649512|FG000|STARTED|Overall Study||212
10499079|NCT01230554|11649512|FG000|COMPLETED|Overall Study||209
10499080|NCT01230554|11649512|FG000|NOT COMPLETED|Overall Study||3
10499081|NCT01230593|11649519|FG000|STARTED|Overall Study||50
10499082|NCT01230593|11649520|FG001|STARTED|Overall Study||50
10499083|NCT01230593|11649521|FG002|STARTED|Overall Study||50
10499084|NCT01230593|11649519|FG000|COMPLETED|Overall Study||35
10499085|NCT01230593|11649520|FG001|COMPLETED|Overall Study||32
10499086|NCT01230593|11649521|FG002|COMPLETED|Overall Study||38
10499087|NCT01230593|11649519|FG000|NOT COMPLETED|Overall Study||15
10499088|NCT01230593|11649520|FG001|NOT COMPLETED|Overall Study||18
10499089|NCT01230593|11649521|FG002|NOT COMPLETED|Overall Study||12
10499090|NCT01230710|11649529|FG000|STARTED|Overall Study||51
10499091|NCT01230710|11649529|FG000|COMPLETED|Overall Study||2
10499092|NCT01230710|11649529|FG000|NOT COMPLETED|Overall Study||49
10499093|NCT01230749|11649537|FG000|STARTED|Overall Study||22
10499094|NCT01230749|11649538|FG001|STARTED|Overall Study||22
10499095|NCT01230749|11649539|FG002|STARTED|Overall Study||23
10499096|NCT01230749|11649540|FG003|STARTED|Overall Study||22
10499097|NCT01230749|11649537|FG000|COMPLETED|Overall Study||22
10499098|NCT01230749|11649538|FG001|COMPLETED|Overall Study||20
10499099|NCT01230749|11649539|FG002|COMPLETED|Overall Study||21
10499100|NCT01230749|11649540|FG003|COMPLETED|Overall Study||20
10499101|NCT01230749|11649537|FG000|NOT COMPLETED|Overall Study||0
10499102|NCT01230749|11649538|FG001|NOT COMPLETED|Overall Study||2
10499103|NCT01230749|11649539|FG002|NOT COMPLETED|Overall Study||2
10499104|NCT01230749|11649540|FG003|NOT COMPLETED|Overall Study||2
10499105|NCT01230801|11649556|FG000|STARTED|Overall Study||3
10499106|NCT01230801|11649557|FG001|STARTED|Overall Study||3
10499107|NCT01230801|11649558|FG002|STARTED|Overall Study||16
10499108|NCT01230801|11649556|FG000|COMPLETED|Overall Study||3
10499109|NCT01230801|11649557|FG001|COMPLETED|Overall Study||3
10499110|NCT01230801|11649558|FG002|COMPLETED|Overall Study||15
10499111|NCT01230801|11649556|FG000|NOT COMPLETED|Overall Study||0
10499112|NCT01230801|11649557|FG001|NOT COMPLETED|Overall Study||0
10499113|NCT01230801|11649558|FG002|NOT COMPLETED|Overall Study||1
10499114|NCT01230814|11649571|FG000|STARTED|Overall Study||118
10499115|NCT01230814|11649572|FG001|STARTED|Overall Study||116
10499116|NCT01230814|11649571|FG000|COMPLETED|Overall Study||105
10499117|NCT01230814|11649572|FG001|COMPLETED|Overall Study||112
10499118|NCT01230814|11649571|FG000|NOT COMPLETED|Overall Study||13
10499119|NCT01230814|11649572|FG001|NOT COMPLETED|Overall Study||4
10499120|NCT01230827|11649582|FG000|STARTED|Overall Study||19
10499121|NCT01230827|11649583|FG001|STARTED|Overall Study||11
10499122|NCT01230827|11649584|FG002|STARTED|Overall Study||65
10499123|NCT01230827|11649585|FG003|STARTED|Overall Study||78
10499124|NCT01230827|11649582|FG000|COMPLETED|Overall Study||0
10499125|NCT01230827|11649583|FG001|COMPLETED|Overall Study||0
10499126|NCT01230827|11649584|FG002|COMPLETED|Overall Study||0
10499127|NCT01230827|11649585|FG003|COMPLETED|Overall Study||0
10499128|NCT01230827|11649582|FG000|NOT COMPLETED|Overall Study||19
10499129|NCT01230827|11649583|FG001|NOT COMPLETED|Overall Study||11
10499130|NCT01230827|11649584|FG002|NOT COMPLETED|Overall Study||65
10499131|NCT01230827|11649585|FG003|NOT COMPLETED|Overall Study||78
10499132|NCT01230892|11649595|FG000|STARTED|Overall Study||15
10499133|NCT01230892|11649596|FG001|STARTED|Overall Study||14
10499134|NCT01230892|11649595|FG000|COMPLETED|Overall Study||12
10499135|NCT01230892|11649596|FG001|COMPLETED|Overall Study||13
10499136|NCT01230892|11649595|FG000|NOT COMPLETED|Overall Study||3
10499137|NCT01230892|11649596|FG001|NOT COMPLETED|Overall Study||1
10499138|NCT01230931|11649604|FG000|STARTED|Overall Study||10
10499139|NCT01230931|11649605|FG001|STARTED|Overall Study||10
10499140|NCT01230931|11649604|FG000|COMPLETED|Overall Study||10
10499141|NCT01230931|11649605|FG001|COMPLETED|Overall Study||10
10499142|NCT01230931|11649604|FG000|NOT COMPLETED|Overall Study||0
10499143|NCT01230931|11649605|FG001|NOT COMPLETED|Overall Study||0
10499144|NCT01231230|11649612|FG000|STARTED|Overall Study||14
10499145|NCT01231230|11649612|FG000|Fluticasone|Overall Study||14
10499146|NCT01231230|11649612|FG000|Salmeterol|Overall Study||14
10499147|NCT01231230|11649612|FG000|Fluticasone/Salmeterol|Overall Study||14
10499148|NCT01231230|11649612|FG000|Placebo|Overall Study||14
10499149|NCT01231230|11649612|FG000|COMPLETED|Overall Study||14
10499150|NCT01231230|11649612|FG000|NOT COMPLETED|Overall Study||0
10499151|NCT01231321|11649622|FG000|STARTED|Overall Study||100
10710559|NCT02651428|11875820|FG001|STARTED|Overall Study||403
10710560|NCT02651428|11875819|FG000|COMPLETED|Overall Study||359
10710561|NCT02651428|11875820|FG001|COMPLETED|Overall Study||359
10499152|NCT01231321|11649622|FG000|COMPLETED|Overall Study||95
10499153|NCT01231321|11649622|FG000|NOT COMPLETED|Overall Study||5
10499154|NCT01231334|11649634|FG000|STARTED|Overall Study||145
10499155|NCT01231334|11649635|FG001|STARTED|Overall Study||141
10499156|NCT01231334|11649634|FG000|COMPLETED|Overall Study||126
10499157|NCT01231334|11649635|FG001|COMPLETED|Overall Study||120
10499158|NCT01231334|11649634|FG000|NOT COMPLETED|Overall Study||19
10499159|NCT01231334|11649635|FG001|NOT COMPLETED|Overall Study||21
10499160|NCT01231373|11649645|FG000|STARTED|Overall Study||59
10499161|NCT01231373|11649646|FG001|STARTED|Overall Study||58
10499162|NCT01231373|11649647|FG002|STARTED|Overall Study||60
10499163|NCT01231373|11649648|FG003|STARTED|Overall Study||58
10499164|NCT01231373|11649645|FG000|Patients Receiving Blinded Treatment|Overall Study||57
10499165|NCT01231373|11649646|FG001|Patients Receiving Blinded Treatment|Overall Study||57
10499166|NCT01231373|11649647|FG002|Patients Receiving Blinded Treatment|Overall Study||60
10499167|NCT01231373|11649648|FG003|Patients Receiving Blinded Treatment|Overall Study||58
10499168|NCT01231373|11649645|FG000|COMPLETED|Overall Study||56
10499169|NCT01231373|11649646|FG001|COMPLETED|Overall Study||57
10499170|NCT01231373|11649647|FG002|COMPLETED|Overall Study||60
10499171|NCT01231373|11649648|FG003|COMPLETED|Overall Study||57
10710562|NCT02651428|11875819|FG000|NOT COMPLETED|Overall Study||44
10710563|NCT02651428|11875820|FG001|NOT COMPLETED|Overall Study||44
10499172|NCT01231373|11649645|FG000|NOT COMPLETED|Overall Study||3
10499173|NCT01231373|11649646|FG001|NOT COMPLETED|Overall Study||1
10499174|NCT01231373|11649647|FG002|NOT COMPLETED|Overall Study||0
10499175|NCT01231373|11649648|FG003|NOT COMPLETED|Overall Study||1
10710564|NCT02651467|11875829|FG000|STARTED|Overall Study||74
10710565|NCT02651467|11875830|FG001|STARTED|Overall Study||74
10499176|NCT01231399|11649660|FG000|STARTED|Overall Study||6
10710566|NCT02651467|11875831|FG002|STARTED|Overall Study||73
10710567|NCT02651467|11875829|FG000|COMPLETED|Overall Study||73
10499177|NCT01231399|11649660|FG000|COMPLETED|Overall Study||6
10499178|NCT01231399|11649660|FG000|NOT COMPLETED|Overall Study||0
10499179|NCT01231412|11649668|FG000|STARTED|Overall Study||77
10499180|NCT01231412|11649669|FG001|STARTED|Overall Study||91
10499181|NCT01231412|11649670|FG002|STARTED|Overall Study||6
10499182|NCT01231412|11649668|FG000|COMPLETED|Overall Study||77
10499183|NCT01231412|11649669|FG001|COMPLETED|Overall Study||90
10499184|NCT01231412|11649670|FG002|COMPLETED|Overall Study||6
10499185|NCT01231412|11649668|FG000|NOT COMPLETED|Overall Study||0
10499186|NCT01231412|11649669|FG001|NOT COMPLETED|Overall Study||1
10499187|NCT01231412|11649670|FG002|NOT COMPLETED|Overall Study||0
10499188|NCT01231464|11649680|FG000|STARTED|Overall Study||182
10499189|NCT01231464|11649681|FG001|STARTED|Overall Study||183
10499190|NCT01231464|11649680|FG000|COMPLETED|Overall Study||177
10499191|NCT01231464|11649681|FG001|COMPLETED|Overall Study||176
10499192|NCT01231464|11649680|FG000|NOT COMPLETED|Overall Study||5
10499193|NCT01231464|11649681|FG001|NOT COMPLETED|Overall Study||7
10499194|NCT01231503|11649697|FG000|STARTED|Overall Study||60
10499195|NCT01231503|11649698|FG001|STARTED|Overall Study||59
10499196|NCT01231503|11649699|FG002|STARTED|Overall Study||60
10499197|NCT01231503|11649700|FG003|STARTED|Overall Study||60
10499198|NCT01231503|11649701|FG004|STARTED|Overall Study||60
10499199|NCT01231503|11649702|FG005|STARTED|Overall Study||60
10499200|NCT01231503|11649703|FG006|STARTED|Overall Study||60
10499201|NCT01231503|11649704|FG007|STARTED|Overall Study||60
10499202|NCT01231503|11649697|FG000|COMPLETED|Overall Study||46
10499203|NCT01231503|11649698|FG001|COMPLETED|Overall Study||46
10499204|NCT01231503|11649699|FG002|COMPLETED|Overall Study||48
10499205|NCT01231503|11649700|FG003|COMPLETED|Overall Study||52
10499206|NCT01231503|11649701|FG004|COMPLETED|Overall Study||50
10499207|NCT01231503|11649702|FG005|COMPLETED|Overall Study||44
10499208|NCT01231503|11649703|FG006|COMPLETED|Overall Study||53
10499209|NCT01231503|11649704|FG007|COMPLETED|Overall Study||52
10499210|NCT01231503|11649697|FG000|NOT COMPLETED|Overall Study||14
10499211|NCT01231503|11649698|FG001|NOT COMPLETED|Overall Study||13
10499212|NCT01231503|11649699|FG002|NOT COMPLETED|Overall Study||12
10499213|NCT01231503|11649700|FG003|NOT COMPLETED|Overall Study||8
10499214|NCT01231503|11649701|FG004|NOT COMPLETED|Overall Study||10
10499215|NCT01231503|11649702|FG005|NOT COMPLETED|Overall Study||16
10499216|NCT01231503|11649703|FG006|NOT COMPLETED|Overall Study||7
10499217|NCT01231503|11649704|FG007|NOT COMPLETED|Overall Study||8
10499218|NCT01231555|11649735|FG000|STARTED|Overall Study||8
10499219|NCT01231555|11649736|FG001|STARTED|Overall Study||7
10499220|NCT01231555|11649737|FG002|STARTED|Overall Study||8
10499221|NCT01231555|11649735|FG000|COMPLETED|Overall Study||0
10499222|NCT01231555|11649736|FG001|COMPLETED|Overall Study||0
10499223|NCT01231555|11649737|FG002|COMPLETED|Overall Study||0
10499224|NCT01231555|11649735|FG000|NOT COMPLETED|Overall Study||8
10499225|NCT01231555|11649736|FG001|NOT COMPLETED|Overall Study||7
10499226|NCT01231555|11649737|FG002|NOT COMPLETED|Overall Study||8
10499227|NCT01231581|11649747|FG000|STARTED|Overall Study||80
10499228|NCT01231581|11649748|FG001|STARTED|Overall Study||80
10499229|NCT01231581|11649747|FG000|Ongoing|Overall Study|Participant is continuing treatment with trametinib and gemcitabine under roll over study MEK114375.|1
10499230|NCT01231581|11649748|FG001|Ongoing|Overall Study||0
10499231|NCT01231581|11649747|FG000|COMPLETED|Overall Study||0
10499232|NCT01231581|11649748|FG001|COMPLETED|Overall Study||0
10499233|NCT01231581|11649747|FG000|NOT COMPLETED|Overall Study||80
10499234|NCT01231581|11649748|FG001|NOT COMPLETED|Overall Study||80
10499235|NCT01231607|11649759|FG000|STARTED|Overall Study||185
10499236|NCT01231607|11649760|FG001|STARTED|Overall Study||188
10499237|NCT01231607|11649761|FG002|STARTED|Overall Study||184
10499238|NCT01231607|11649762|FG003|STARTED|Overall Study||179
10499239|NCT01231607|11649763|FG004|STARTED|Overall Study||181
10499240|NCT01231607|11649759|FG000|COMPLETED|Overall Study||156
10499241|NCT01231607|11649760|FG001|COMPLETED|Overall Study||154
10499242|NCT01231607|11649761|FG002|COMPLETED|Overall Study||153
10499243|NCT01231607|11649762|FG003|COMPLETED|Overall Study||141
10499244|NCT01231607|11649763|FG004|COMPLETED|Overall Study||157
10499245|NCT01231607|11649759|FG000|NOT COMPLETED|Overall Study||29
10499246|NCT01231607|11649760|FG001|NOT COMPLETED|Overall Study||34
10499247|NCT01231607|11649761|FG002|NOT COMPLETED|Overall Study||31
10499248|NCT01231607|11649762|FG003|NOT COMPLETED|Overall Study||38
10499249|NCT01231607|11649763|FG004|NOT COMPLETED|Overall Study||24
10499250|NCT01231620|11649781|FG000|STARTED|Overall Study||201
10499251|NCT01231620|11649782|FG001|STARTED|Overall Study||209
10499252|NCT01231620|11649783|FG002|STARTED|Overall Study||205
10499253|NCT01231620|11649781|FG000|COMPLETED|Overall Study||175
10499254|NCT01231620|11649782|FG001|COMPLETED|Overall Study||178
10499255|NCT01231620|11649783|FG002|COMPLETED|Overall Study||166
10499256|NCT01231620|11649781|FG000|NOT COMPLETED|Overall Study||26
10499257|NCT01231620|11649782|FG001|NOT COMPLETED|Overall Study||31
10499258|NCT01231620|11649783|FG002|NOT COMPLETED|Overall Study||39
10499259|NCT01231633|11649793|FG000|STARTED|Overall Study||14
10499260|NCT01231633|11649794|FG001|STARTED|Overall Study||13
10499261|NCT01231633|11649793|FG000|COMPLETED|Overall Study||14
10499262|NCT01231633|11649794|FG001|COMPLETED|Overall Study||13
10499263|NCT01231633|11649793|FG000|NOT COMPLETED|Overall Study||0
10499264|NCT01231633|11649794|FG001|NOT COMPLETED|Overall Study||0
10499265|NCT01231646|11649804|FG000|STARTED|Overall Study||28
10499266|NCT01231646|11649805|FG001|STARTED|Overall Study||10
10499267|NCT01231646|11649804|FG000|COMPLETED|Overall Study||28
10499268|NCT01231646|11649805|FG001|COMPLETED|Overall Study||10
10499269|NCT01231646|11649804|FG000|NOT COMPLETED|Overall Study||0
10499270|NCT01231646|11649805|FG001|NOT COMPLETED|Overall Study||0
10499271|NCT01231659|11649811|FG000|STARTED|Overall Study||72
10499272|NCT01231659|11649811|FG000|Per Protocol (PP) Set|Overall Study||72
10499273|NCT01231659|11649811|FG000|Safety Set|Overall Study||72
10499274|NCT01231659|11649811|FG000|COMPLETED|Overall Study||0
10499275|NCT01231659|11649811|FG000|NOT COMPLETED|Overall Study||72
10499276|NCT01231841|11649815|FG000|STARTED|Overall Study||20
10499277|NCT01231841|11649815|FG000|COMPLETED|Overall Study||20
10499278|NCT01231841|11649815|FG000|NOT COMPLETED|Overall Study||0
10499279|NCT01231984|11649821|FG000|STARTED|Study Period 1||69
10499280|NCT01231984|11649822|FG001|STARTED|Study Period 1||70
10499281|NCT01231984|11649823|FG002|STARTED|Study Period 1||66
10499282|NCT01231984|11649824|FG003|STARTED|Study Period 1||69
10499283|NCT01231984|11649821|FG000|COMPLETED|Study Period 1||57
10499284|NCT01231984|11649822|FG001|COMPLETED|Study Period 1||63
10499285|NCT01231984|11649823|FG002|COMPLETED|Study Period 1||59
10499286|NCT01231984|11649824|FG003|COMPLETED|Study Period 1||60
10499287|NCT01231984|11649821|FG000|NOT COMPLETED|Study Period 1||12
10499288|NCT01231984|11649822|FG001|NOT COMPLETED|Study Period 1||7
10710568|NCT02651467|11875830|FG001|COMPLETED|Overall Study||74
10710569|NCT02651467|11875831|FG002|COMPLETED|Overall Study||69
10499289|NCT01231984|11649823|FG002|NOT COMPLETED|Study Period 1||7
10499290|NCT01231984|11649824|FG003|NOT COMPLETED|Study Period 1||9
10499291|NCT01231984|11649821|FG000|STARTED|Study Period 2||57
10499292|NCT01231984|11649822|FG001|STARTED|Study Period 2||63
10499293|NCT01231984|11649823|FG002|STARTED|Study Period 2||59
10499294|NCT01231984|11649824|FG003|STARTED|Study Period 2||60
10499295|NCT01231984|11649821|FG000|COMPLETED|Study Period 2||54
10499296|NCT01231984|11649822|FG001|COMPLETED|Study Period 2||61
10499297|NCT01231984|11649823|FG002|COMPLETED|Study Period 2||59
10499298|NCT01231984|11649824|FG003|COMPLETED|Study Period 2||56
10499299|NCT01231984|11649821|FG000|NOT COMPLETED|Study Period 2||3
10499300|NCT01231984|11649822|FG001|NOT COMPLETED|Study Period 2||2
10499301|NCT01231984|11649823|FG002|NOT COMPLETED|Study Period 2||0
10499302|NCT01231984|11649824|FG003|NOT COMPLETED|Study Period 2||4
10499303|NCT01232127|11649842|FG000|STARTED|Period 1: Days 1-10|Participants who received treatment.|25
10499304|NCT01232127|11649843|FG001|STARTED|Period 1: Days 1-10||0
10499305|NCT01232127|11649844|FG002|STARTED|Period 1: Days 1-10||0
10499306|NCT01232127|11649842|FG000|COMPLETED|Period 1: Days 1-10||24
10499307|NCT01232127|11649843|FG001|COMPLETED|Period 1: Days 1-10||0
10499308|NCT01232127|11649844|FG002|COMPLETED|Period 1: Days 1-10||0
10499309|NCT01232127|11649842|FG000|NOT COMPLETED|Period 1: Days 1-10||1
10499310|NCT01232127|11649843|FG001|NOT COMPLETED|Period 1: Days 1-10||0
10499311|NCT01232127|11649844|FG002|NOT COMPLETED|Period 1: Days 1-10||0
10499312|NCT01232127|11649842|FG000|STARTED|Period 2: Days 11-17||0
10499313|NCT01232127|11649843|FG001|STARTED|Period 2: Days 11-17|Participants who received treatment.|24
10499314|NCT01232127|11649844|FG002|STARTED|Period 2: Days 11-17||0
10499315|NCT01232127|11649842|FG000|COMPLETED|Period 2: Days 11-17||0
10499316|NCT01232127|11649843|FG001|COMPLETED|Period 2: Days 11-17||24
10499317|NCT01232127|11649844|FG002|COMPLETED|Period 2: Days 11-17||0
10499318|NCT01232127|11649842|FG000|NOT COMPLETED|Period 2: Days 11-17||0
10499319|NCT01232127|11649843|FG001|NOT COMPLETED|Period 2: Days 11-17||0
10499320|NCT01232127|11649844|FG002|NOT COMPLETED|Period 2: Days 11-17||0
10499321|NCT01232127|11649842|FG000|STARTED|Period 3: Days 18-24||0
10499322|NCT01232127|11649843|FG001|STARTED|Period 3: Days 18-24||0
10499323|NCT01232127|11649844|FG002|STARTED|Period 3: Days 18-24|Participants who received treatment.|24
10499324|NCT01232127|11649842|FG000|COMPLETED|Period 3: Days 18-24||0
10499325|NCT01232127|11649843|FG001|COMPLETED|Period 3: Days 18-24||0
10499326|NCT01232127|11649844|FG002|COMPLETED|Period 3: Days 18-24||24
10499327|NCT01232127|11649842|FG000|NOT COMPLETED|Period 3: Days 18-24||0
10499328|NCT01232127|11649843|FG001|NOT COMPLETED|Period 3: Days 18-24||0
10499329|NCT01232127|11649844|FG002|NOT COMPLETED|Period 3: Days 18-24||0
10499330|NCT01232205|11649858|FG000|STARTED|Overall Study||52
10499331|NCT01232205|11649859|FG001|STARTED|Overall Study||58
10499332|NCT01232205|11649858|FG000|COMPLETED|Overall Study||49
10499333|NCT01232205|11649859|FG001|COMPLETED|Overall Study||55
10499334|NCT01232205|11649858|FG000|NOT COMPLETED|Overall Study||3
10499335|NCT01232205|11649859|FG001|NOT COMPLETED|Overall Study||3
10499336|NCT01232296|11649867|FG000|STARTED|Overall Study||82
10499337|NCT01232296|11649868|FG001|STARTED|Overall Study||83
10499338|NCT01232296|11649867|FG000|Full Analysis Set|Overall Study||82
10499339|NCT01232296|11649868|FG001|Full Analysis Set|Overall Study||83
10499340|NCT01232296|11649867|FG000|Safety Set|Overall Study|The Safety Set includes all patients who received at least one dose of study medication|79
10499341|NCT01232296|11649868|FG001|Safety Set|Overall Study||83
10499342|NCT01232296|11649867|FG000|COMPLETED|Overall Study||0
10499343|NCT01232296|11649868|FG001|COMPLETED|Overall Study||0
10499344|NCT01232296|11649867|FG000|NOT COMPLETED|Overall Study||82
10499345|NCT01232296|11649868|FG001|NOT COMPLETED|Overall Study||83
10499346|NCT01232452|11649876|FG000|STARTED|Overall Study||87
10499347|NCT01232452|11649877|FG001|STARTED|Overall Study||85
10499348|NCT01232452|11649876|FG000|Received at Least One Dose of Study Drug|Overall Study||85
10499349|NCT01232452|11649877|FG001|Received at Least One Dose of Study Drug|Overall Study||81
10499350|NCT01232452|11649876|FG000|COMPLETED|Overall Study||48
10499351|NCT01232452|11649877|FG001|COMPLETED|Overall Study||46
10710570|NCT02651467|11875829|FG000|NOT COMPLETED|Overall Study||1
10499352|NCT01232452|11649876|FG000|NOT COMPLETED|Overall Study||39
10499353|NCT01232452|11649877|FG001|NOT COMPLETED|Overall Study||39
10499354|NCT01232465|11649885|FG000|STARTED|Overall Study||337
10499355|NCT01232465|11649886|FG001|STARTED|Overall Study||402
10499356|NCT01232465|11649885|FG000|COMPLETED|Overall Study||337
10499357|NCT01232465|11649886|FG001|COMPLETED|Overall Study||402
10499358|NCT01232465|11649885|FG000|NOT COMPLETED|Overall Study||0
10499359|NCT01232465|11649886|FG001|NOT COMPLETED|Overall Study||0
10499360|NCT01232491|11649894|FG000|STARTED|Overall Study||306
10499361|NCT01232491|11649895|FG001|STARTED|Overall Study||305
10499362|NCT01232491|11649894|FG000|Exposed (Safety Analysis Set)|Overall Study|One subject withdrew prior to exposure to trial drug.|305
10499363|NCT01232491|11649895|FG001|Exposed (Safety Analysis Set)|Overall Study|Four subjects withdrew prior to exposure to trial drug.|301
10499364|NCT01232491|11649894|FG000|COMPLETED|Overall Study||246
10499365|NCT01232491|11649895|FG001|COMPLETED|Overall Study||242
10499366|NCT01232491|11649894|FG000|NOT COMPLETED|Overall Study||60
10499367|NCT01232491|11649895|FG001|NOT COMPLETED|Overall Study||63
10499368|NCT01232504|11649904|FG000|STARTED|Overall Study||68
10499369|NCT01232504|11649905|FG001|STARTED|Overall Study||69
10499370|NCT01232504|11649906|FG002|STARTED|Overall Study||69
10499371|NCT01232504|11649904|FG000|COMPLETED|Overall Study||59
10499372|NCT01232504|11649905|FG001|COMPLETED|Overall Study||67
10499373|NCT01232504|11649906|FG002|COMPLETED|Overall Study||61
10499374|NCT01232504|11649904|FG000|NOT COMPLETED|Overall Study||9
10499375|NCT01232504|11649905|FG001|NOT COMPLETED|Overall Study||2
10499376|NCT01232504|11649906|FG002|NOT COMPLETED|Overall Study||8
10499377|NCT01232556|11649924|FG000|STARTED|Overall Study||166
10499378|NCT01232556|11649925|FG001|STARTED|Overall Study||172
10499379|NCT01232556|11649924|FG000|Treated|Overall Study|One subject in this arm received rituximab only and was excluded from the safety population.|165
10499380|NCT01232556|11649925|FG001|Treated|Overall Study||167
10499381|NCT01232556|11649924|FG000|COMPLETED|Overall Study||7
10499382|NCT01232556|11649925|FG001|COMPLETED|Overall Study||1
10499383|NCT01232556|11649924|FG000|NOT COMPLETED|Overall Study||159
10499384|NCT01232556|11649925|FG001|NOT COMPLETED|Overall Study||171
10499385|NCT01232569|11649933|FG000|STARTED|Double-blind Treatment Period||438
10499386|NCT01232569|11649934|FG001|STARTED|Double-blind Treatment Period||218
10499387|NCT01232569|11649935|FG002|STARTED|Double-blind Treatment Period|There were no participants in this reporting group in this period.|0
10499388|NCT01232569|11649936|FG003|STARTED|Double-blind Treatment Period|There were no participants in this reporting group in this period.|0
10499389|NCT01232569|11649933|FG000|COMPLETED|Double-blind Treatment Period||410
10499390|NCT01232569|11649934|FG001|COMPLETED|Double-blind Treatment Period||209
10499391|NCT01232569|11649935|FG002|COMPLETED|Double-blind Treatment Period||0
10499392|NCT01232569|11649936|FG003|COMPLETED|Double-blind Treatment Period||0
10499393|NCT01232569|11649933|FG000|NOT COMPLETED|Double-blind Treatment Period||28
10499394|NCT01232569|11649934|FG001|NOT COMPLETED|Double-blind Treatment Period||9
10499395|NCT01232569|11649935|FG002|NOT COMPLETED|Double-blind Treatment Period||0
10499396|NCT01232569|11649936|FG003|NOT COMPLETED|Double-blind Treatment Period||0
10499397|NCT01232569|11649933|FG000|STARTED|Open-label Extension Period|There were no participants in this reporting group in this period.|0
10499398|NCT01232569|11649934|FG001|STARTED|Open-label Extension Period|There were no participants in this reporting group in this period.|0
10499399|NCT01232569|11649935|FG002|STARTED|Open-label Extension Period|Some participants who completed the double-blind period did not enter the open-label period.|230
10499400|NCT01232569|11649936|FG003|STARTED|Open-label Extension Period|Some participants who completed the double-blind period did not enter the open-label period.|227
10499401|NCT01232569|11649933|FG000|COMPLETED|Open-label Extension Period||0
10499402|NCT01232569|11649934|FG001|COMPLETED|Open-label Extension Period||0
10499403|NCT01232569|11649935|FG002|COMPLETED|Open-label Extension Period||203
10499404|NCT01232569|11649936|FG003|COMPLETED|Open-label Extension Period||200
10499405|NCT01232569|11649933|FG000|NOT COMPLETED|Open-label Extension Period||0
10499406|NCT01232569|11649934|FG001|NOT COMPLETED|Open-label Extension Period||0
10499407|NCT01232569|11649935|FG002|NOT COMPLETED|Open-label Extension Period||27
10499408|NCT01232569|11649936|FG003|NOT COMPLETED|Open-label Extension Period||27
10499409|NCT01232738|11649945|FG000|STARTED|Overall Study||36
10499410|NCT01232738|11649945|FG000|COMPLETED|Overall Study||23
10499411|NCT01232738|11649945|FG000|NOT COMPLETED|Overall Study||13
10499412|NCT01232790|11649953|FG000|STARTED|Randomization||14
10499413|NCT01232790|11649954|FG001|STARTED|Randomization||14
10499414|NCT01232790|11649953|FG000|COMPLETED|Randomization||12
10499415|NCT01232790|11649954|FG001|COMPLETED|Randomization||12
10499416|NCT01232790|11649953|FG000|NOT COMPLETED|Randomization||2
10499417|NCT01232790|11649954|FG001|NOT COMPLETED|Randomization||2
10499418|NCT01232790|11649953|FG000|STARTED|Initial Assessment||12
10499419|NCT01232790|11649954|FG001|STARTED|Initial Assessment||12
10499420|NCT01232790|11649953|FG000|COMPLETED|Initial Assessment||12
10499421|NCT01232790|11649954|FG001|COMPLETED|Initial Assessment||11
10499422|NCT01232790|11649953|FG000|NOT COMPLETED|Initial Assessment||0
10499423|NCT01232790|11649954|FG001|NOT COMPLETED|Initial Assessment||1
10499424|NCT01232790|11649953|FG000|STARTED|First Crossover||12
10499425|NCT01232790|11649954|FG001|STARTED|First Crossover||11
10499426|NCT01232790|11649953|FG000|COMPLETED|First Crossover||11
10499427|NCT01232790|11649954|FG001|COMPLETED|First Crossover||11
10499428|NCT01232790|11649953|FG000|NOT COMPLETED|First Crossover||1
10499429|NCT01232790|11649954|FG001|NOT COMPLETED|First Crossover||0
10499430|NCT01232790|11649953|FG000|STARTED|Second Crossover||11
10499431|NCT01232790|11649954|FG001|STARTED|Second Crossover||11
10499432|NCT01232790|11649953|FG000|COMPLETED|Second Crossover||10
10499433|NCT01232790|11649954|FG001|COMPLETED|Second Crossover||9
10499434|NCT01232790|11649953|FG000|NOT COMPLETED|Second Crossover||1
10499435|NCT01232790|11649954|FG001|NOT COMPLETED|Second Crossover||2
10499436|NCT01232829|11649970|FG000|STARTED|Overall Study||18
10499437|NCT01232829|11649970|FG000|COMPLETED|Overall Study||18
10499438|NCT01232829|11649970|FG000|NOT COMPLETED|Overall Study||0
10499439|NCT01232868|11649976|FG000|STARTED|Overall Study||22
10499440|NCT01232868|11649977|FG001|STARTED|Overall Study||44
10710571|NCT02651467|11875830|FG001|NOT COMPLETED|Overall Study||0
10710572|NCT02651467|11875831|FG002|NOT COMPLETED|Overall Study||4
10710573|NCT02651545|11875842|FG000|STARTED|Overall Study||30
10710574|NCT02651545|11875843|FG001|STARTED|Overall Study||30
10710575|NCT02651545|11875842|FG000|COMPLETED|Overall Study||7
10710576|NCT02651545|11875843|FG001|COMPLETED|Overall Study||17
10710577|NCT02651545|11875842|FG000|NOT COMPLETED|Overall Study||23
10710578|NCT02651545|11875843|FG001|NOT COMPLETED|Overall Study||13
10710579|NCT02651584|11875851|FG000|STARTED|Overall Study||215
10710580|NCT02651584|11875852|FG001|STARTED|Overall Study||213
10710581|NCT02651584|11875851|FG000|COMPLETED|Overall Study||126
10710582|NCT02651584|11875852|FG001|COMPLETED|Overall Study||121
10710583|NCT02651584|11875851|FG000|NOT COMPLETED|Overall Study||89
10710584|NCT02651584|11875852|FG001|NOT COMPLETED|Overall Study||92
10713825|NCT02682602|11879362|FG000|STARTED|Pre-operative Diseased & Normal Hips||11
10713826|NCT02682602|11879363|FG001|STARTED|Pre-operative Diseased & Normal Hips||10
10713827|NCT02682602|11879362|FG000|COMPLETED|Pre-operative Diseased & Normal Hips||10
10713828|NCT02682602|11879363|FG001|COMPLETED|Pre-operative Diseased & Normal Hips||10
10713829|NCT02682602|11879362|FG000|NOT COMPLETED|Pre-operative Diseased & Normal Hips||1
10713830|NCT02682602|11879363|FG001|NOT COMPLETED|Pre-operative Diseased & Normal Hips||0
10713831|NCT02682602|11879362|FG000|STARTED|Post-operative Fluoroscopy for Implanted||10
10713832|NCT02682602|11879363|FG001|STARTED|Post-operative Fluoroscopy for Implanted||0
10713833|NCT02682602|11879362|FG000|COMPLETED|Post-operative Fluoroscopy for Implanted||7
10713834|NCT02682602|11879363|FG001|COMPLETED|Post-operative Fluoroscopy for Implanted|Nonimplanted subjects were not analyzed again for the second period, because this would be redundant|0
10713835|NCT02682602|11879362|FG000|NOT COMPLETED|Post-operative Fluoroscopy for Implanted||3
10499441|NCT01232868|11649976|FG000|COMPLETED|Overall Study||20
10499442|NCT01232868|11649977|FG001|COMPLETED|Overall Study||40
10499443|NCT01232868|11649976|FG000|NOT COMPLETED|Overall Study||2
10499444|NCT01232868|11649977|FG001|NOT COMPLETED|Overall Study||4
10499445|NCT01232894|11649985|FG000|STARTED|Overall Study||60
10499446|NCT01232894|11649986|FG001|STARTED|Overall Study||30
10499447|NCT01232894|11649985|FG000|Received Study Drug|Overall Study||59
10499448|NCT01232894|11649986|FG001|Received Study Drug|Overall Study||28
10499449|NCT01232894|11649985|FG000|COMPLETED|Overall Study||48
10499450|NCT01232894|11649986|FG001|COMPLETED|Overall Study||22
10499451|NCT01232894|11649985|FG000|NOT COMPLETED|Overall Study||12
10499452|NCT01232894|11649986|FG001|NOT COMPLETED|Overall Study||8
10499453|NCT01232920|11649994|FG000|STARTED|Overall Study||41
10499454|NCT01232920|11649995|FG001|STARTED|Overall Study||39
10499455|NCT01232920|11649994|FG000|COMPLETED|Overall Study||35
10499456|NCT01232920|11649995|FG001|COMPLETED|Overall Study||32
10499457|NCT01232920|11649994|FG000|NOT COMPLETED|Overall Study||6
10499458|NCT01232920|11649995|FG001|NOT COMPLETED|Overall Study||7
10499459|NCT01232946|11650004|FG000|STARTED|Overall Study||9
10499460|NCT01232946|11650005|FG001|STARTED|Overall Study||10
10499461|NCT01232946|11650006|FG002|STARTED|Overall Study||11
10499462|NCT01232946|11650004|FG000|COMPLETED|Overall Study||9
10499463|NCT01232946|11650005|FG001|COMPLETED|Overall Study|1 participant died unrelated to study|9
10499464|NCT01232946|11650006|FG002|COMPLETED|Overall Study|2 withdrew after baseline measurements|9
10499465|NCT01232946|11650004|FG000|NOT COMPLETED|Overall Study||0
10499466|NCT01232946|11650005|FG001|NOT COMPLETED|Overall Study||1
10499467|NCT01232946|11650006|FG002|NOT COMPLETED|Overall Study||2
10499468|NCT01233050|11650016|FG000|STARTED|Overall Study||400
10499469|NCT01233050|11650017|FG001|STARTED|Overall Study||402
10499470|NCT01233050|11650016|FG000|COMPLETED|Overall Study|8 participants were excluded after treatment administered due to inclusion/exclusion criteria|392
10499471|NCT01233050|11650017|FG001|COMPLETED|Overall Study|6 participants were excluded after treatment administered due to inclusion/exclusion criteria|396
10499472|NCT01233050|11650016|FG000|NOT COMPLETED|Overall Study||8
10499473|NCT01233050|11650017|FG001|NOT COMPLETED|Overall Study||6
10499474|NCT01233076|11650023|FG000|STARTED|Period 1, One Week||30
10499475|NCT01233076|11650024|FG001|STARTED|Period 1, One Week||30
10499476|NCT01233076|11650023|FG000|COMPLETED|Period 1, One Week||30
10499477|NCT01233076|11650024|FG001|COMPLETED|Period 1, One Week||30
10499478|NCT01233076|11650023|FG000|NOT COMPLETED|Period 1, One Week||0
10499479|NCT01233076|11650024|FG001|NOT COMPLETED|Period 1, One Week||0
10499480|NCT01233076|11650023|FG000|STARTED|Period 2, One Week||30
10499481|NCT01233076|11650024|FG001|STARTED|Period 2, One Week||30
10499482|NCT01233076|11650023|FG000|COMPLETED|Period 2, One Week||29
10499483|NCT01233076|11650024|FG001|COMPLETED|Period 2, One Week||30
10499484|NCT01233076|11650023|FG000|NOT COMPLETED|Period 2, One Week||1
10499485|NCT01233076|11650024|FG001|NOT COMPLETED|Period 2, One Week||0
10499486|NCT01233232|11650033|FG000|STARTED|Overall Study||29
10499487|NCT01233232|11650034|FG001|STARTED|Overall Study||30
10499488|NCT01233232|11650035|FG002|STARTED|Overall Study||28
10499489|NCT01233232|11650033|FG000|COMPLETED|Overall Study||28
10499490|NCT01233232|11650034|FG001|COMPLETED|Overall Study||30
10499491|NCT01233232|11650035|FG002|COMPLETED|Overall Study||28
10499492|NCT01233232|11650033|FG000|NOT COMPLETED|Overall Study||1
10499493|NCT01233232|11650034|FG001|NOT COMPLETED|Overall Study||0
10713836|NCT02682602|11879363|FG001|NOT COMPLETED|Post-operative Fluoroscopy for Implanted||0
10713837|NCT02682784|11879377|FG000|STARTED|Overall Study||40
10713838|NCT02682784|11879378|FG001|STARTED|Overall Study||37
10713839|NCT02682784|11879379|FG002|STARTED|Overall Study||29
10713840|NCT02682784|11879380|FG003|STARTED|Overall Study||32
10713841|NCT02682784|11879377|FG000|COMPLETED|Overall Study||39
10713842|NCT02682784|11879378|FG001|COMPLETED|Overall Study||35
10499494|NCT01233232|11650035|FG002|NOT COMPLETED|Overall Study||0
10499495|NCT01233258|11650048|FG000|STARTED|First Intervention (6 Months)||11
10499496|NCT01233258|11650049|FG001|STARTED|First Intervention (6 Months)||10
10499497|NCT01233258|11650050|FG002|STARTED|First Intervention (6 Months)||14
10499498|NCT01233258|11650051|FG003|STARTED|First Intervention (6 Months)||16
10499499|NCT01233258|11650052|FG004|STARTED|First Intervention (6 Months)||16
10499500|NCT01233258|11650053|FG005|STARTED|First Intervention (6 Months)||16
10499501|NCT01233258|11650048|FG000|Participants Received Treatment|First Intervention (6 Months)||11
10499502|NCT01233258|11650049|FG001|Participants Received Treatment|First Intervention (6 Months)||10
10499503|NCT01233258|11650050|FG002|Participants Received Treatment|First Intervention (6 Months)||13
10499504|NCT01233258|11650051|FG003|Participants Received Treatment|First Intervention (6 Months)||15
10499505|NCT01233258|11650052|FG004|Participants Received Treatment|First Intervention (6 Months)||16
10499506|NCT01233258|11650053|FG005|Participants Received Treatment|First Intervention (6 Months)||15
10499507|NCT01233258|11650048|FG000|COMPLETED|First Intervention (6 Months)||10
10499508|NCT01233258|11650049|FG001|COMPLETED|First Intervention (6 Months)||10
10499509|NCT01233258|11650050|FG002|COMPLETED|First Intervention (6 Months)||13
10499510|NCT01233258|11650051|FG003|COMPLETED|First Intervention (6 Months)||15
10499511|NCT01233258|11650052|FG004|COMPLETED|First Intervention (6 Months)||16
10499512|NCT01233258|11650053|FG005|COMPLETED|First Intervention (6 Months)||15
10499513|NCT01233258|11650048|FG000|NOT COMPLETED|First Intervention (6 Months)||1
10499514|NCT01233258|11650049|FG001|NOT COMPLETED|First Intervention (6 Months)||0
10499515|NCT01233258|11650050|FG002|NOT COMPLETED|First Intervention (6 Months)||1
10499516|NCT01233258|11650051|FG003|NOT COMPLETED|First Intervention (6 Months)||1
10499517|NCT01233258|11650052|FG004|NOT COMPLETED|First Intervention (6 Months)||0
10499518|NCT01233258|11650053|FG005|NOT COMPLETED|First Intervention (6 Months)||1
10499519|NCT01233258|11650048|FG000|STARTED|Washout (2-3 Days)||10
10499520|NCT01233258|11650049|FG001|STARTED|Washout (2-3 Days)||10
10499521|NCT01233258|11650050|FG002|STARTED|Washout (2-3 Days)||13
10499522|NCT01233258|11650051|FG003|STARTED|Washout (2-3 Days)||15
10499523|NCT01233258|11650052|FG004|STARTED|Washout (2-3 Days)||16
10499524|NCT01233258|11650053|FG005|STARTED|Washout (2-3 Days)||15
10499525|NCT01233258|11650048|FG000|COMPLETED|Washout (2-3 Days)||10
10499526|NCT01233258|11650049|FG001|COMPLETED|Washout (2-3 Days)||10
10499527|NCT01233258|11650050|FG002|COMPLETED|Washout (2-3 Days)||13
10499528|NCT01233258|11650051|FG003|COMPLETED|Washout (2-3 Days)||15
10499529|NCT01233258|11650052|FG004|COMPLETED|Washout (2-3 Days)||16
10499530|NCT01233258|11650053|FG005|COMPLETED|Washout (2-3 Days)||15
10499531|NCT01233258|11650048|FG000|NOT COMPLETED|Washout (2-3 Days)||0
10499532|NCT01233258|11650049|FG001|NOT COMPLETED|Washout (2-3 Days)||0
10499533|NCT01233258|11650050|FG002|NOT COMPLETED|Washout (2-3 Days)||0
10499534|NCT01233258|11650051|FG003|NOT COMPLETED|Washout (2-3 Days)||0
10499535|NCT01233258|11650052|FG004|NOT COMPLETED|Washout (2-3 Days)||0
10499536|NCT01233258|11650053|FG005|NOT COMPLETED|Washout (2-3 Days)||0
10499537|NCT01233258|11650048|FG000|STARTED|Second Intervention (6 Months)||10
10499538|NCT01233258|11650049|FG001|STARTED|Second Intervention (6 Months)||10
10499539|NCT01233258|11650050|FG002|STARTED|Second Intervention (6 Months)||13
10499540|NCT01233258|11650051|FG003|STARTED|Second Intervention (6 Months)||15
10499541|NCT01233258|11650052|FG004|STARTED|Second Intervention (6 Months)||16
10499542|NCT01233258|11650053|FG005|STARTED|Second Intervention (6 Months)||15
10499543|NCT01233258|11650048|FG000|COMPLETED|Second Intervention (6 Months)||10
10710585|NCT02651688|11875864|FG000|STARTED|Overall Study||18
10710586|NCT02651688|11875865|FG001|STARTED|Overall Study||17
10710587|NCT02651688|11875866|FG002|STARTED|Overall Study||15
10710588|NCT02651688|11875864|FG000|COMPLETED|Overall Study||16
10710589|NCT02651688|11875865|FG001|COMPLETED|Overall Study||12
10499544|NCT01233258|11650049|FG001|COMPLETED|Second Intervention (6 Months)||10
10499545|NCT01233258|11650050|FG002|COMPLETED|Second Intervention (6 Months)||13
10499546|NCT01233258|11650051|FG003|COMPLETED|Second Intervention (6 Months)||15
10499547|NCT01233258|11650052|FG004|COMPLETED|Second Intervention (6 Months)||16
10499548|NCT01233258|11650053|FG005|COMPLETED|Second Intervention (6 Months)||15
10499549|NCT01233258|11650048|FG000|NOT COMPLETED|Second Intervention (6 Months)||0
10499550|NCT01233258|11650049|FG001|NOT COMPLETED|Second Intervention (6 Months)||0
10499551|NCT01233258|11650050|FG002|NOT COMPLETED|Second Intervention (6 Months)||0
10499552|NCT01233258|11650051|FG003|NOT COMPLETED|Second Intervention (6 Months)||0
10499553|NCT01233258|11650052|FG004|NOT COMPLETED|Second Intervention (6 Months)||0
10499554|NCT01233258|11650053|FG005|NOT COMPLETED|Second Intervention (6 Months)||0
10499555|NCT01233284|11650068|FG000|STARTED|Period 1 (4 Weeks)||37
10499556|NCT01233284|11650069|FG001|STARTED|Period 1 (4 Weeks)||38
10499557|NCT01233284|11650070|FG002|STARTED|Period 1 (4 Weeks)||38
10499558|NCT01233284|11650071|FG003|STARTED|Period 1 (4 Weeks)||35
10499559|NCT01233284|11650072|FG004|STARTED|Period 1 (4 Weeks)||1
10499560|NCT01233284|11650068|FG000|COMPLETED|Period 1 (4 Weeks)||36
10499561|NCT01233284|11650069|FG001|COMPLETED|Period 1 (4 Weeks)||37
10499562|NCT01233284|11650070|FG002|COMPLETED|Period 1 (4 Weeks)||37
10499563|NCT01233284|11650071|FG003|COMPLETED|Period 1 (4 Weeks)||35
10499564|NCT01233284|11650072|FG004|COMPLETED|Period 1 (4 Weeks)||1
10499565|NCT01233284|11650068|FG000|NOT COMPLETED|Period 1 (4 Weeks)||1
10499566|NCT01233284|11650069|FG001|NOT COMPLETED|Period 1 (4 Weeks)||1
10499567|NCT01233284|11650070|FG002|NOT COMPLETED|Period 1 (4 Weeks)||1
10499568|NCT01233284|11650071|FG003|NOT COMPLETED|Period 1 (4 Weeks)||0
10710590|NCT02651688|11875866|FG002|COMPLETED|Overall Study||12
10710591|NCT02651688|11875864|FG000|NOT COMPLETED|Overall Study||2
10499569|NCT01233284|11650072|FG004|NOT COMPLETED|Period 1 (4 Weeks)||0
10499570|NCT01233284|11650068|FG000|STARTED|Period 2 (4 Weeks)||36
10499571|NCT01233284|11650069|FG001|STARTED|Period 2 (4 Weeks)||37
10499572|NCT01233284|11650070|FG002|STARTED|Period 2 (4 Weeks)||37
10499573|NCT01233284|11650071|FG003|STARTED|Period 2 (4 Weeks)||35
10499574|NCT01233284|11650072|FG004|STARTED|Period 2 (4 Weeks)||1
10499575|NCT01233284|11650068|FG000|COMPLETED|Period 2 (4 Weeks)||36
10499576|NCT01233284|11650069|FG001|COMPLETED|Period 2 (4 Weeks)||37
10499577|NCT01233284|11650070|FG002|COMPLETED|Period 2 (4 Weeks)||36
10499578|NCT01233284|11650071|FG003|COMPLETED|Period 2 (4 Weeks)||35
10499579|NCT01233284|11650072|FG004|COMPLETED|Period 2 (4 Weeks)||1
10499580|NCT01233284|11650068|FG000|NOT COMPLETED|Period 2 (4 Weeks)||0
10499581|NCT01233284|11650069|FG001|NOT COMPLETED|Period 2 (4 Weeks)||0
10499582|NCT01233284|11650070|FG002|NOT COMPLETED|Period 2 (4 Weeks)||1
10499583|NCT01233284|11650071|FG003|NOT COMPLETED|Period 2 (4 Weeks)||0
10499584|NCT01233284|11650072|FG004|NOT COMPLETED|Period 2 (4 Weeks)||0
10499585|NCT01233284|11650068|FG000|STARTED|Period 3 (4 Weeks)||36
10499586|NCT01233284|11650069|FG001|STARTED|Period 3 (4 Weeks)||37
10499587|NCT01233284|11650070|FG002|STARTED|Period 3 (4 Weeks)||36
10499588|NCT01233284|11650071|FG003|STARTED|Period 3 (4 Weeks)||35
10499589|NCT01233284|11650072|FG004|STARTED|Period 3 (4 Weeks)||1
10499590|NCT01233284|11650068|FG000|COMPLETED|Period 3 (4 Weeks)||36
10499591|NCT01233284|11650069|FG001|COMPLETED|Period 3 (4 Weeks)||37
10499592|NCT01233284|11650070|FG002|COMPLETED|Period 3 (4 Weeks)||35
10499593|NCT01233284|11650071|FG003|COMPLETED|Period 3 (4 Weeks)||34
10499594|NCT01233284|11650072|FG004|COMPLETED|Period 3 (4 Weeks)||1
10499595|NCT01233284|11650068|FG000|NOT COMPLETED|Period 3 (4 Weeks)||0
10499596|NCT01233284|11650069|FG001|NOT COMPLETED|Period 3 (4 Weeks)||0
10499597|NCT01233284|11650070|FG002|NOT COMPLETED|Period 3 (4 Weeks)||1
10499598|NCT01233284|11650071|FG003|NOT COMPLETED|Period 3 (4 Weeks)||1
10499599|NCT01233284|11650072|FG004|NOT COMPLETED|Period 3 (4 Weeks)||0
10499600|NCT01233284|11650068|FG000|STARTED|Period 4 (4 Weeks)||36
10499601|NCT01233284|11650069|FG001|STARTED|Period 4 (4 Weeks)||37
10499602|NCT01233284|11650070|FG002|STARTED|Period 4 (4 Weeks)||35
10499603|NCT01233284|11650071|FG003|STARTED|Period 4 (4 Weeks)||34
10499604|NCT01233284|11650072|FG004|STARTED|Period 4 (4 Weeks)||1
10499605|NCT01233284|11650068|FG000|COMPLETED|Period 4 (4 Weeks)||36
10499606|NCT01233284|11650069|FG001|COMPLETED|Period 4 (4 Weeks)||36
10499607|NCT01233284|11650070|FG002|COMPLETED|Period 4 (4 Weeks)||35
10499608|NCT01233284|11650071|FG003|COMPLETED|Period 4 (4 Weeks)||33
10499609|NCT01233284|11650072|FG004|COMPLETED|Period 4 (4 Weeks)||1
10499610|NCT01233284|11650068|FG000|NOT COMPLETED|Period 4 (4 Weeks)||0
10499611|NCT01233284|11650069|FG001|NOT COMPLETED|Period 4 (4 Weeks)||1
10499612|NCT01233284|11650070|FG002|NOT COMPLETED|Period 4 (4 Weeks)||0
10499613|NCT01233284|11650071|FG003|NOT COMPLETED|Period 4 (4 Weeks)||1
10499614|NCT01233284|11650072|FG004|NOT COMPLETED|Period 4 (4 Weeks)||0
10499615|NCT01233518|11650082|FG000|STARTED|Overall Study||285
10499616|NCT01233518|11650082|FG000|COMPLETED|Overall Study||252
10499617|NCT01233518|11650082|FG000|NOT COMPLETED|Overall Study||33
10499618|NCT01233609|11650089|FG000|STARTED|Overall Study||46
10499619|NCT01233609|11650090|FG001|STARTED|Overall Study||44
10499620|NCT01233609|11650089|FG000|COMPLETED|Overall Study||37
10499621|NCT01233609|11650090|FG001|COMPLETED|Overall Study||42
10499622|NCT01233609|11650089|FG000|NOT COMPLETED|Overall Study||9
10499623|NCT01233609|11650090|FG001|NOT COMPLETED|Overall Study||2
10499624|NCT01233687|11650104|FG000|STARTED|Phase I RP2D AMG 102 + Erlotinib||7
10499625|NCT01233687|11650104|FG000|COMPLETED|Phase I RP2D AMG 102 + Erlotinib||7
10499626|NCT01233687|11650104|FG000|NOT COMPLETED|Phase I RP2D AMG 102 + Erlotinib||0
10499627|NCT01233687|11650104|FG000|STARTED|Phase II AMG 102 + Erlotinib|Includes 7 participants from Phase 1 part of study.|49
10499628|NCT01233687|11650104|FG000|Response-Evaluable|Phase II AMG 102 + Erlotinib||45
10499629|NCT01233687|11650104|FG000|COMPLETED|Phase II AMG 102 + Erlotinib||45
10499630|NCT01233687|11650104|FG000|NOT COMPLETED|Phase II AMG 102 + Erlotinib||4
10499631|NCT01233726|11650111|FG000|STARTED|Overall Study||53
10499632|NCT01233726|11650112|FG001|STARTED|Overall Study||53
10499633|NCT01233726|11650113|FG002|STARTED|Overall Study||53
10499634|NCT01233726|11650111|FG000|COMPLETED|Overall Study||52
10499635|NCT01233726|11650112|FG001|COMPLETED|Overall Study||53
10499636|NCT01233726|11650113|FG002|COMPLETED|Overall Study||52
10499637|NCT01233726|11650111|FG000|NOT COMPLETED|Overall Study||1
10499638|NCT01233726|11650112|FG001|NOT COMPLETED|Overall Study||0
10499639|NCT01233726|11650113|FG002|NOT COMPLETED|Overall Study||1
10499640|NCT01233817|11650124|FG000|STARTED|Overall Study||12
10499641|NCT01233817|11650124|FG000|COMPLETED|Overall Study||9
10499642|NCT01233817|11650124|FG000|NOT COMPLETED|Overall Study||3
10499643|NCT01233869|11650132|FG000|STARTED|Initial Treatment Period (24 Months)||58
10499644|NCT01233869|11650133|FG001|STARTED|Initial Treatment Period (24 Months)||31
10499645|NCT01233869|11650134|FG002|STARTED|Initial Treatment Period (24 Months)||24
10499646|NCT01233869|11650135|FG003|STARTED|Initial Treatment Period (24 Months)||56
10499647|NCT01233869|11650132|FG000|COMPLETED|Initial Treatment Period (24 Months)||34
10499648|NCT01233869|11650133|FG001|COMPLETED|Initial Treatment Period (24 Months)||3
10499649|NCT01233869|11650134|FG002|COMPLETED|Initial Treatment Period (24 Months)||22
10499650|NCT01233869|11650135|FG003|COMPLETED|Initial Treatment Period (24 Months)||34
10499651|NCT01233869|11650132|FG000|NOT COMPLETED|Initial Treatment Period (24 Months)||24
10499652|NCT01233869|11650133|FG001|NOT COMPLETED|Initial Treatment Period (24 Months)||28
10499653|NCT01233869|11650134|FG002|NOT COMPLETED|Initial Treatment Period (24 Months)||2
10499654|NCT01233869|11650135|FG003|NOT COMPLETED|Initial Treatment Period (24 Months)||22
10499655|NCT01233869|11650132|FG000|STARTED|Washout Period 30 Days||34
10499656|NCT01233869|11650133|FG001|STARTED|Washout Period 30 Days||3
10499657|NCT01233869|11650134|FG002|STARTED|Washout Period 30 Days||22
10499658|NCT01233869|11650135|FG003|STARTED|Washout Period 30 Days||34
10499659|NCT01233869|11650132|FG000|COMPLETED|Washout Period 30 Days||34
10499660|NCT01233869|11650133|FG001|COMPLETED|Washout Period 30 Days||3
10499661|NCT01233869|11650134|FG002|COMPLETED|Washout Period 30 Days||22
10499662|NCT01233869|11650135|FG003|COMPLETED|Washout Period 30 Days||34
10499663|NCT01233869|11650132|FG000|NOT COMPLETED|Washout Period 30 Days||0
10499664|NCT01233869|11650133|FG001|NOT COMPLETED|Washout Period 30 Days||0
10499665|NCT01233869|11650134|FG002|NOT COMPLETED|Washout Period 30 Days||0
10499666|NCT01233869|11650135|FG003|NOT COMPLETED|Washout Period 30 Days||0
10499667|NCT01233869|11650132|FG000|STARTED|Extended Treatment Period (46 Months)||34
10499668|NCT01233869|11650133|FG001|STARTED|Extended Treatment Period (46 Months)||3
10499669|NCT01233869|11650134|FG002|STARTED|Extended Treatment Period (46 Months)||22
10499670|NCT01233869|11650135|FG003|STARTED|Extended Treatment Period (46 Months)||34
10499671|NCT01233869|11650132|FG000|COMPLETED|Extended Treatment Period (46 Months)||20
10499672|NCT01233869|11650133|FG001|COMPLETED|Extended Treatment Period (46 Months)||0
10499673|NCT01233869|11650134|FG002|COMPLETED|Extended Treatment Period (46 Months)||17
10499674|NCT01233869|11650135|FG003|COMPLETED|Extended Treatment Period (46 Months)||18
10499675|NCT01233869|11650132|FG000|NOT COMPLETED|Extended Treatment Period (46 Months)||14
10499676|NCT01233869|11650133|FG001|NOT COMPLETED|Extended Treatment Period (46 Months)||3
10499677|NCT01233869|11650134|FG002|NOT COMPLETED|Extended Treatment Period (46 Months)||5
10499678|NCT01233869|11650135|FG003|NOT COMPLETED|Extended Treatment Period (46 Months)||16
10499679|NCT01233921|11650147|FG000|STARTED|Overall Study||3
10499680|NCT01233921|11650148|FG001|STARTED|Overall Study||3
10499681|NCT01233921|11650147|FG000|COMPLETED|Overall Study||3
10499682|NCT01233921|11650148|FG001|COMPLETED|Overall Study||3
10499683|NCT01233921|11650147|FG000|NOT COMPLETED|Overall Study||0
10499684|NCT01233921|11650148|FG001|NOT COMPLETED|Overall Study||0
10499685|NCT01233999|11650154|FG000|STARTED|Overall Study||10
10499686|NCT01233999|11650154|FG000|COMPLETED|Overall Study||8
10499687|NCT01233999|11650154|FG000|NOT COMPLETED|Overall Study||2
10499688|NCT01234207|11650158|FG000|STARTED|First Intervention||47
10499689|NCT01234207|11650159|FG001|STARTED|First Intervention||48
10499690|NCT01234207|11650158|FG000|COMPLETED|First Intervention||47
10499691|NCT01234207|11650159|FG001|COMPLETED|First Intervention||48
10499692|NCT01234207|11650158|FG000|NOT COMPLETED|First Intervention||0
10499693|NCT01234207|11650159|FG001|NOT COMPLETED|First Intervention||0
10499694|NCT01234207|11650158|FG000|STARTED|1-Week Washout Period||47
10499695|NCT01234207|11650159|FG001|STARTED|1-Week Washout Period||48
10499696|NCT01234207|11650158|FG000|COMPLETED|1-Week Washout Period||47
10499697|NCT01234207|11650159|FG001|COMPLETED|1-Week Washout Period||48
10499698|NCT01234207|11650158|FG000|NOT COMPLETED|1-Week Washout Period||0
10499699|NCT01234207|11650159|FG001|NOT COMPLETED|1-Week Washout Period||0
10499700|NCT01234207|11650158|FG000|STARTED|Second Intervention||47
10499701|NCT01234207|11650159|FG001|STARTED|Second Intervention||48
10499702|NCT01234207|11650158|FG000|COMPLETED|Second Intervention||47
10499703|NCT01234207|11650159|FG001|COMPLETED|Second Intervention||48
10499704|NCT01234207|11650158|FG000|NOT COMPLETED|Second Intervention||0
10499705|NCT01234207|11650159|FG001|NOT COMPLETED|Second Intervention||0
10499706|NCT01234337|11650169|FG000|STARTED|Overall Study||266
10499707|NCT01234337|11650170|FG001|STARTED|Overall Study||271
10499708|NCT01234337|11650169|FG000|Participants Received Treatment|Overall Study||260
10499709|NCT01234337|11650170|FG001|Participants Received Treatment|Overall Study||267
10499710|NCT01234337|11650169|FG000|COMPLETED|Overall Study||0
10499711|NCT01234337|11650170|FG001|COMPLETED|Overall Study||0
10499712|NCT01234337|11650169|FG000|NOT COMPLETED|Overall Study||266
10499713|NCT01234337|11650170|FG001|NOT COMPLETED|Overall Study||271
10499714|NCT01234350|11650178|FG000|STARTED|Overall Study||1000
10499715|NCT01234350|11650179|FG001|STARTED|Overall Study||493
10499716|NCT01234350|11650178|FG000|COMPLETED|Overall Study||313
10710592|NCT02651688|11875865|FG001|NOT COMPLETED|Overall Study||5
10710593|NCT02651688|11875866|FG002|NOT COMPLETED|Overall Study||3
10710594|NCT02651922|11875874|FG000|STARTED|Overall Study||156
10710595|NCT02651922|11875874|FG000|COMPLETED|Overall Study||154
10499717|NCT01234350|11650179|FG001|COMPLETED|Overall Study||226
10499718|NCT01234350|11650178|FG000|NOT COMPLETED|Overall Study||687
10499719|NCT01234350|11650179|FG001|NOT COMPLETED|Overall Study||267
10499720|NCT01234402|11650190|FG000|STARTED|Overall Study||52
10499721|NCT01234402|11650191|FG001|STARTED|Overall Study||51
10499722|NCT01234402|11650192|FG002|STARTED|Overall Study||50
10499723|NCT01234402|11650190|FG000|Received at Least One Dose of Study Drug|Overall Study||52
10499724|NCT01234402|11650191|FG001|Received at Least One Dose of Study Drug|Overall Study||49
10499725|NCT01234402|11650192|FG002|Received at Least One Dose of Study Drug|Overall Study||49
10499726|NCT01234402|11650190|FG000|Capecitabine Crossover to Ramucirumab|Overall Study||0
10499727|NCT01234402|11650191|FG001|Capecitabine Crossover to Ramucirumab|Overall Study||0
10710596|NCT02651922|11875874|FG000|NOT COMPLETED|Overall Study||2
10499728|NCT01234402|11650192|FG002|Capecitabine Crossover to Ramucirumab|Overall Study||29
10499729|NCT01234402|11650190|FG000|Capecitabine Crossover to Icrucumab|Overall Study||0
10710597|NCT02651987|11875880|FG000|STARTED|Overall Study||48
10499730|NCT01234402|11650191|FG001|Capecitabine Crossover to Icrucumab|Overall Study||0
10499731|NCT01234402|11650192|FG002|Capecitabine Crossover to Icrucumab|Overall Study||1
10499732|NCT01234402|11650190|FG000|COMPLETED|Overall Study||51
10499733|NCT01234402|11650191|FG001|COMPLETED|Overall Study||45
10499734|NCT01234402|11650192|FG002|COMPLETED|Overall Study||42
10499735|NCT01234402|11650190|FG000|NOT COMPLETED|Overall Study||1
10499736|NCT01234402|11650191|FG001|NOT COMPLETED|Overall Study||6
10499737|NCT01234402|11650192|FG002|NOT COMPLETED|Overall Study||8
10499738|NCT01234467|11650202|FG000|STARTED|Overall Study||23
10499739|NCT01234467|11650202|FG000|COMPLETED|Overall Study||11
10499740|NCT01234467|11650202|FG000|NOT COMPLETED|Overall Study||12
10499741|NCT01234480|11650206|FG000|STARTED|Overall Study||5859
10499742|NCT01234480|11650206|FG000|COMPLETED|Overall Study||5416
10499743|NCT01234480|11650206|FG000|NOT COMPLETED|Overall Study||443
10499744|NCT01234649|11650215|FG000|STARTED|Overall Study||78
10499745|NCT01234649|11650216|FG001|STARTED|Overall Study||75
10499746|NCT01234649|11650215|FG000|COMPLETED|Overall Study||35
10499747|NCT01234649|11650216|FG001|COMPLETED|Overall Study||37
10499748|NCT01234649|11650215|FG000|NOT COMPLETED|Overall Study||43
10499749|NCT01234649|11650216|FG001|NOT COMPLETED|Overall Study||38
10499750|NCT01234675|11650222|FG000|STARTED|First Intervention (6 Weeks)||10
10499751|NCT01234675|11650223|FG001|STARTED|First Intervention (6 Weeks)||9
10499752|NCT01234675|11650222|FG000|COMPLETED|First Intervention (6 Weeks)||9
10499753|NCT01234675|11650223|FG001|COMPLETED|First Intervention (6 Weeks)||8
10499754|NCT01234675|11650222|FG000|NOT COMPLETED|First Intervention (6 Weeks)||1
10499755|NCT01234675|11650223|FG001|NOT COMPLETED|First Intervention (6 Weeks)||1
10499756|NCT01234675|11650222|FG000|STARTED|Second Intervention (6 Weeks)||9
10499757|NCT01234675|11650223|FG001|STARTED|Second Intervention (6 Weeks)||8
10499758|NCT01234675|11650222|FG000|COMPLETED|Second Intervention (6 Weeks)||7
10499759|NCT01234675|11650223|FG001|COMPLETED|Second Intervention (6 Weeks)||8
10499760|NCT01234675|11650222|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||2
10499761|NCT01234675|11650223|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
10499762|NCT01234714|11650229|FG000|STARTED|Overall Study||84
10499763|NCT01234714|11650229|FG000|COMPLETED|Overall Study||84
10499764|NCT01234714|11650229|FG000|NOT COMPLETED|Overall Study||0
10499765|NCT01234766|11650236|FG000|STARTED|Overall Study||39
10499766|NCT01234766|11650236|FG000|COMPLETED|Overall Study||35
10499767|NCT01234766|11650236|FG000|NOT COMPLETED|Overall Study||4
10499768|NCT01234831|11650242|FG000|STARTED|Overall Study||261
10499769|NCT01234831|11650243|FG001|STARTED|Overall Study||202
10499770|NCT01234831|11650242|FG000|COMPLETED|Overall Study||259
10499771|NCT01234831|11650243|FG001|COMPLETED|Overall Study||198
10499772|NCT01234831|11650242|FG000|NOT COMPLETED|Overall Study||2
10499773|NCT01234831|11650243|FG001|NOT COMPLETED|Overall Study||4
10499774|NCT01234870|11650250|FG000|STARTED|Overall Study||40
10499775|NCT01234870|11650250|FG000|COMPLETED|Overall Study||40
10499776|NCT01234870|11650250|FG000|NOT COMPLETED|Overall Study||0
10499777|NCT01234883|11650257|FG000|STARTED|Overall Study||51
10499778|NCT01234883|11650258|FG001|STARTED|Overall Study||49
10499779|NCT01234883|11650257|FG000|COMPLETED|Overall Study||41
10499780|NCT01234883|11650258|FG001|COMPLETED|Overall Study||36
10499781|NCT01234883|11650257|FG000|NOT COMPLETED|Overall Study||10
10499782|NCT01234883|11650258|FG001|NOT COMPLETED|Overall Study||13
10499783|NCT01234922|11650268|FG000|STARTED|Overall Study||1
10499784|NCT01234922|11650269|FG001|STARTED|Overall Study||1
10499785|NCT01234922|11650270|FG002|STARTED|Overall Study||2
10499786|NCT01234922|11650271|FG003|STARTED|Overall Study||2
10499787|NCT01234922|11650268|FG000|COMPLETED|Overall Study||1
10499788|NCT01234922|11650269|FG001|COMPLETED|Overall Study||1
10499789|NCT01234922|11650270|FG002|COMPLETED|Overall Study||2
10499790|NCT01234922|11650271|FG003|COMPLETED|Overall Study||2
10499791|NCT01234922|11650268|FG000|NOT COMPLETED|Overall Study||0
10499792|NCT01234922|11650269|FG001|NOT COMPLETED|Overall Study||0
10499793|NCT01234922|11650270|FG002|NOT COMPLETED|Overall Study||0
10499794|NCT01234922|11650271|FG003|NOT COMPLETED|Overall Study||0
10499795|NCT01235195|11650281|FG000|STARTED|First Intervention||15
10499796|NCT01235195|11650282|FG001|STARTED|First Intervention||15
10499797|NCT01235195|11650281|FG000|COMPLETED|First Intervention||15
10499798|NCT01235195|11650282|FG001|COMPLETED|First Intervention||15
10499799|NCT01235195|11650281|FG000|NOT COMPLETED|First Intervention||0
10499800|NCT01235195|11650282|FG001|NOT COMPLETED|First Intervention||0
10499801|NCT01235195|11650281|FG000|STARTED|Washout Period of At Least 8 Days||15
10499802|NCT01235195|11650282|FG001|STARTED|Washout Period of At Least 8 Days||15
10499803|NCT01235195|11650281|FG000|COMPLETED|Washout Period of At Least 8 Days||15
10499804|NCT01235195|11650282|FG001|COMPLETED|Washout Period of At Least 8 Days||15
10499805|NCT01235195|11650281|FG000|NOT COMPLETED|Washout Period of At Least 8 Days||0
10499806|NCT01235195|11650282|FG001|NOT COMPLETED|Washout Period of At Least 8 Days||0
10499807|NCT01235195|11650281|FG000|STARTED|Second Intervention||15
10499808|NCT01235195|11650282|FG001|STARTED|Second Intervention||15
10499809|NCT01235195|11650281|FG000|COMPLETED|Second Intervention||15
10499810|NCT01235195|11650282|FG001|COMPLETED|Second Intervention||15
10499811|NCT01235195|11650281|FG000|NOT COMPLETED|Second Intervention||0
10499812|NCT01235195|11650282|FG001|NOT COMPLETED|Second Intervention||0
10499813|NCT01235338|11650290|FG000|STARTED|Overall Study||42
10499814|NCT01235338|11650291|FG001|STARTED|Overall Study||38
10499815|NCT01235338|11650290|FG000|COMPLETED|Overall Study||31
10499816|NCT01235338|11650291|FG001|COMPLETED|Overall Study||33
10499817|NCT01235338|11650290|FG000|NOT COMPLETED|Overall Study||11
10499818|NCT01235338|11650291|FG001|NOT COMPLETED|Overall Study||5
10499819|NCT01235351|11650301|FG000|STARTED|Initial Treatment With 75 mg and 150 mg||247
10499820|NCT01235351|11650302|FG001|STARTED|Initial Treatment With 75 mg and 150 mg||86
10499821|NCT01235351|11650301|FG000|COMPLETED|Initial Treatment With 75 mg and 150 mg|4 allocated to initial treatment included in primary analysis|237
10499822|NCT01235351|11650302|FG001|COMPLETED|Initial Treatment With 75 mg and 150 mg||82
10499823|NCT01235351|11650301|FG000|NOT COMPLETED|Initial Treatment With 75 mg and 150 mg||10
10499824|NCT01235351|11650302|FG001|NOT COMPLETED|Initial Treatment With 75 mg and 150 mg||4
10499825|NCT01235351|11650301|FG000|STARTED|Treatment With Different Dose Sequences||233
10499826|NCT01235351|11650302|FG001|STARTED|Treatment With Different Dose Sequences||82
10499827|NCT01235351|11650301|FG000|75 mg First and Then 150 mg|Treatment With Different Dose Sequences||116
10499828|NCT01235351|11650302|FG001|75 mg First and Then 150 mg|Treatment With Different Dose Sequences||0
10499829|NCT01235351|11650301|FG000|150 mg First Then 75 mg|Treatment With Different Dose Sequences||117
10499830|NCT01235351|11650302|FG001|150 mg First Then 75 mg|Treatment With Different Dose Sequences||0
10499831|NCT01235351|11650301|FG000|225 mg First Then 300 mg|Treatment With Different Dose Sequences||0
10499832|NCT01235351|11650302|FG001|225 mg First Then 300 mg|Treatment With Different Dose Sequences||41
10710598|NCT02651987|11875881|FG001|STARTED|Overall Study||51
10710599|NCT02651987|11875880|FG000|COMPLETED|Overall Study||43
10710600|NCT02651987|11875881|FG001|COMPLETED|Overall Study||46
10710601|NCT02651987|11875880|FG000|NOT COMPLETED|Overall Study||5
10710602|NCT02651987|11875881|FG001|NOT COMPLETED|Overall Study||5
10710603|NCT02652156|11875893|FG000|STARTED|Overall Study||4
10499833|NCT01235351|11650301|FG000|300 mg First Then 225 mg|Treatment With Different Dose Sequences||0
10499834|NCT01235351|11650302|FG001|300 mg First Then 225 mg|Treatment With Different Dose Sequences||41
10499835|NCT01235351|11650301|FG000|COMPLETED|Treatment With Different Dose Sequences||233
10499836|NCT01235351|11650302|FG001|COMPLETED|Treatment With Different Dose Sequences||82
10499837|NCT01235351|11650301|FG000|NOT COMPLETED|Treatment With Different Dose Sequences||0
10499838|NCT01235351|11650302|FG001|NOT COMPLETED|Treatment With Different Dose Sequences||0
10499839|NCT01235377|11650314|FG000|STARTED|Overall Study||11
10499840|NCT01235377|11650315|FG001|STARTED|Overall Study||9
10499841|NCT01235377|11650314|FG000|COMPLETED|Overall Study||10
10499842|NCT01235377|11650315|FG001|COMPLETED|Overall Study||8
10499843|NCT01235377|11650314|FG000|NOT COMPLETED|Overall Study||1
10499844|NCT01235377|11650315|FG001|NOT COMPLETED|Overall Study||1
10499845|NCT01235403|11650321|FG000|STARTED|Overall Study||100
10499846|NCT01235403|11650321|FG000|COMPLETED|Overall Study||74
10499847|NCT01235403|11650321|FG000|NOT COMPLETED|Overall Study||26
10499848|NCT01235442|11650327|FG000|STARTED|Overall Study||297
10499849|NCT01235442|11650328|FG001|STARTED|Overall Study||295
10499850|NCT01235442|11650327|FG000|COMPLETED|Overall Study||253
10499851|NCT01235442|11650328|FG001|COMPLETED|Overall Study||251
10499852|NCT01235442|11650327|FG000|NOT COMPLETED|Overall Study||44
10499853|NCT01235442|11650328|FG001|NOT COMPLETED|Overall Study||44
10499854|NCT01235507|11650334|FG000|STARTED|Overall Study||71
10499855|NCT01235507|11650334|FG000|COMPLETED|Overall Study||69
10499856|NCT01235507|11650334|FG000|NOT COMPLETED|Overall Study||2
10499857|NCT01235546|11650340|FG000|STARTED|Overall Study||994
10499858|NCT01235546|11650341|FG001|STARTED|Overall Study||1019
10499859|NCT01235546|11650340|FG000|COMPLETED|Overall Study||992
10499860|NCT01235546|11650341|FG001|COMPLETED|Overall Study||1018
10499861|NCT01235546|11650340|FG000|NOT COMPLETED|Overall Study||2
10499862|NCT01235546|11650341|FG001|NOT COMPLETED|Overall Study||1
10499863|NCT01235598|11650358|FG000|STARTED|Overall Study||13
10499864|NCT01235598|11650359|FG001|STARTED|Overall Study|One subject was randomized to the CZP Arm but never received an injection (due to pre-treatment AE)|28
10499865|NCT01235598|11650358|FG000|COMPLETED|Overall Study||12
10499866|NCT01235598|11650359|FG001|COMPLETED|Overall Study||24
10499867|NCT01235598|11650358|FG000|NOT COMPLETED|Overall Study||1
10499868|NCT01235598|11650359|FG001|NOT COMPLETED|Overall Study||4
10499869|NCT01235689|11650368|FG000|STARTED|Overall Study|Total randomized includes participants who randomized at Week 9 and earlier.|122
10499870|NCT01235689|11650369|FG001|STARTED|Overall Study|Total randomized includes participants who randomized at Week 9 and earlier.|122
10499871|NCT01235689|11650368|FG000|Early Randomized (Baseline to Week 9)|Overall Study||63
10499872|NCT01235689|11650369|FG001|Early Randomized (Baseline to Week 9)|Overall Study||69
10499873|NCT01235689|11650368|FG000|Randomized at Week 9|Overall Study||59
10499874|NCT01235689|11650369|FG001|Randomized at Week 9|Overall Study||53
10499875|NCT01235689|11650368|FG000|COMPLETED|Overall Study||93
10499876|NCT01235689|11650369|FG001|COMPLETED|Overall Study||90
10499877|NCT01235689|11650368|FG000|NOT COMPLETED|Overall Study||29
10499878|NCT01235689|11650369|FG001|NOT COMPLETED|Overall Study||32
10499879|NCT01235715|11650377|FG000|STARTED|Overall Study||98
10499880|NCT01235715|11650378|FG001|STARTED|Overall Study||102
10499881|NCT01235715|11650377|FG000|COMPLETED|Overall Study||98
10499882|NCT01235715|11650378|FG001|COMPLETED|Overall Study||100
10499883|NCT01235715|11650377|FG000|NOT COMPLETED|Overall Study||0
10499884|NCT01235715|11650378|FG001|NOT COMPLETED|Overall Study||2
10499885|NCT01235728|11650385|FG000|STARTED|Overall Study||3
10499886|NCT01235728|11650386|FG001|STARTED|Overall Study||3
10499887|NCT01235728|11650387|FG002|STARTED|Overall Study||3
10499888|NCT01235728|11650388|FG003|STARTED|Overall Study||3
10499889|NCT01235728|11650389|FG004|STARTED|Overall Study||3
10499890|NCT01235728|11650390|FG005|STARTED|Overall Study||3
10499891|NCT01235728|11650391|FG006|STARTED|Overall Study||3
10499892|NCT01235728|11650392|FG007|STARTED|Overall Study||3
10499893|NCT01235728|11650385|FG000|COMPLETED|Overall Study||3
10499894|NCT01235728|11650386|FG001|COMPLETED|Overall Study||3
10499895|NCT01235728|11650387|FG002|COMPLETED|Overall Study||3
10710604|NCT02652156|11875894|FG001|STARTED|Overall Study||6
10499896|NCT01235728|11650388|FG003|COMPLETED|Overall Study||2
10499897|NCT01235728|11650389|FG004|COMPLETED|Overall Study||3
10499898|NCT01235728|11650390|FG005|COMPLETED|Overall Study||3
10499899|NCT01235728|11650391|FG006|COMPLETED|Overall Study||3
10499900|NCT01235728|11650392|FG007|COMPLETED|Overall Study||3
10499901|NCT01235728|11650385|FG000|NOT COMPLETED|Overall Study||0
10499902|NCT01235728|11650386|FG001|NOT COMPLETED|Overall Study||0
10499903|NCT01235728|11650387|FG002|NOT COMPLETED|Overall Study||0
10499904|NCT01235728|11650388|FG003|NOT COMPLETED|Overall Study||1
10650363|NCT02169115|11810623|FG001|NOT COMPLETED|Overall Study||0
10650364|NCT02169115|11810624|FG002|NOT COMPLETED|Overall Study||0
10650365|NCT02169219|11810633|FG000|STARTED|Overall Study||20
10650366|NCT02169219|11810633|FG000|COMPLETED|Overall Study||14
10499905|NCT01235728|11650389|FG004|NOT COMPLETED|Overall Study||0
10499906|NCT01235728|11650390|FG005|NOT COMPLETED|Overall Study||0
10499907|NCT01235728|11650391|FG006|NOT COMPLETED|Overall Study||0
10499908|NCT01235728|11650392|FG007|NOT COMPLETED|Overall Study||0
10528094|NCT01393600|11680320|FG000|STARTED|Treatment Period 1 (Day 1 to 14)||9
10528095|NCT01393600|11680321|FG001|STARTED|Treatment Period 1 (Day 1 to 14)||8
10528096|NCT01393600|11680322|FG002|STARTED|Treatment Period 1 (Day 1 to 14)||10
10528097|NCT01393600|11680323|FG003|STARTED|Treatment Period 1 (Day 1 to 14)||10
10528098|NCT01393600|11680320|FG000|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
10528099|NCT01393600|11680321|FG001|COMPLETED|Treatment Period 1 (Day 1 to 14)||7
10528100|NCT01393600|11680322|FG002|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
10528101|NCT01393600|11680323|FG003|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
10528102|NCT01393600|11680320|FG000|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||0
10528103|NCT01393600|11680321|FG001|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
10528104|NCT01393600|11680322|FG002|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
10528105|NCT01393600|11680323|FG003|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
10528106|NCT01393600|11680320|FG000|STARTED|Treatment Period 2 (Day 15 to 28)||9
10528107|NCT01393600|11680321|FG001|STARTED|Treatment Period 2 (Day 15 to 28)||7
10528108|NCT01393600|11680322|FG002|STARTED|Treatment Period 2 (Day 15 to 28)||9
10528109|NCT01393600|11680323|FG003|STARTED|Treatment Period 2 (Day 15 to 28)||9
10528110|NCT01393600|11680320|FG000|COMPLETED|Treatment Period 2 (Day 15 to 28)||9
10528111|NCT01393600|11680321|FG001|COMPLETED|Treatment Period 2 (Day 15 to 28)||7
10528112|NCT01393600|11680322|FG002|COMPLETED|Treatment Period 2 (Day 15 to 28)||7
10528113|NCT01393600|11680323|FG003|COMPLETED|Treatment Period 2 (Day 15 to 28)||8
10528114|NCT01393600|11680320|FG000|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||0
10528115|NCT01393600|11680321|FG001|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||0
10528116|NCT01393600|11680322|FG002|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||2
10528117|NCT01393600|11680323|FG003|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||1
10528118|NCT01393600|11680320|FG000|STARTED|Follow-up Period (Day 29 to 35)||9
10528119|NCT01393600|11680321|FG001|STARTED|Follow-up Period (Day 29 to 35)||7
10528120|NCT01393600|11680322|FG002|STARTED|Follow-up Period (Day 29 to 35)||7
10528121|NCT01393600|11680323|FG003|STARTED|Follow-up Period (Day 29 to 35)||8
10528122|NCT01393600|11680320|FG000|COMPLETED|Follow-up Period (Day 29 to 35)||9
10528123|NCT01393600|11680321|FG001|COMPLETED|Follow-up Period (Day 29 to 35)||7
10710605|NCT02652156|11875895|FG002|STARTED|Overall Study||4
10710606|NCT02652156|11875893|FG000|COMPLETED|Overall Study||3
10710607|NCT02652156|11875894|FG001|COMPLETED|Overall Study||6
10710608|NCT02652156|11875895|FG002|COMPLETED|Overall Study||4
10710609|NCT02652156|11875893|FG000|NOT COMPLETED|Overall Study||1
10710610|NCT02652156|11875894|FG001|NOT COMPLETED|Overall Study||0
10710611|NCT02652156|11875895|FG002|NOT COMPLETED|Overall Study||0
10710612|NCT02652208|11875905|FG000|STARTED|Overall Study||17
10528124|NCT01393600|11680322|FG002|COMPLETED|Follow-up Period (Day 29 to 35)||6
10528125|NCT01393600|11680323|FG003|COMPLETED|Follow-up Period (Day 29 to 35)||8
10528126|NCT01393600|11680320|FG000|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
10528127|NCT01393600|11680321|FG001|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
10528128|NCT01393600|11680322|FG002|NOT COMPLETED|Follow-up Period (Day 29 to 35)||1
10528129|NCT01393600|11680323|FG003|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
10528130|NCT01393613|11680339|FG000|STARTED|Overall Study||120
10528131|NCT01393613|11680340|FG001|STARTED|Overall Study||186
10528132|NCT01393613|11680341|FG002|STARTED|Overall Study||184
10528133|NCT01393613|11680342|FG003|STARTED|Overall Study||184
10528134|NCT01393613|11680339|FG000|COMPLETED|Overall Study||81
10528135|NCT01393613|11680340|FG001|COMPLETED|Overall Study||129
10528136|NCT01393613|11680341|FG002|COMPLETED|Overall Study||130
10528137|NCT01393613|11680342|FG003|COMPLETED|Overall Study||118
10528138|NCT01393613|11680339|FG000|NOT COMPLETED|Overall Study||39
10528139|NCT01393613|11680340|FG001|NOT COMPLETED|Overall Study||57
10528140|NCT01393613|11680341|FG002|NOT COMPLETED|Overall Study||54
10528141|NCT01393613|11680342|FG003|NOT COMPLETED|Overall Study||66
10528142|NCT01393626|11680358|FG000|STARTED|Overall Study||91
10528143|NCT01393626|11680359|FG001|STARTED|Overall Study||86
10650367|NCT02169219|11810633|FG000|NOT COMPLETED|Overall Study||6
10650368|NCT02169271|11810644|FG000|STARTED|Overall Study||49
10650369|NCT02169271|11810645|FG001|STARTED|Overall Study||49
10528144|NCT01393626|11680360|FG002|STARTED|Overall Study||86
10528145|NCT01393626|11680361|FG003|STARTED|Overall Study||16
10528146|NCT01393626|11680358|FG000|COMPLETED|Overall Study||73
10528147|NCT01393626|11680359|FG001|COMPLETED|Overall Study||74
10528148|NCT01393626|11680360|FG002|COMPLETED|Overall Study||74
10650370|NCT02169271|11810644|FG000|COMPLETED|Overall Study||48
10650371|NCT02169271|11810645|FG001|COMPLETED|Overall Study||47
10650372|NCT02169271|11810644|FG000|NOT COMPLETED|Overall Study||1
10650373|NCT02169271|11810645|FG001|NOT COMPLETED|Overall Study||2
10650374|NCT02169284|11810653|FG000|STARTED|Overall Study||24
10650375|NCT02169284|11810654|FG001|STARTED|Overall Study||13
10650376|NCT02169284|11810653|FG000|COMPLETED|Overall Study||24
10650377|NCT02169284|11810654|FG001|COMPLETED|Overall Study||12
10650378|NCT02169284|11810653|FG000|NOT COMPLETED|Overall Study||0
10650379|NCT02169284|11810654|FG001|NOT COMPLETED|Overall Study||1
10650380|NCT02169336|11810665|FG000|STARTED|Overall Study||31
10650381|NCT02169336|11810666|FG001|STARTED|Overall Study||32
10650382|NCT02169336|11810667|FG002|STARTED|Overall Study||32
10650383|NCT02169336|11810665|FG000|COMPLETED|Overall Study||27
10650384|NCT02169336|11810666|FG001|COMPLETED|Overall Study||28
10650385|NCT02169336|11810667|FG002|COMPLETED|Overall Study||29
10650386|NCT02169336|11810665|FG000|NOT COMPLETED|Overall Study||4
10650387|NCT02169336|11810666|FG001|NOT COMPLETED|Overall Study||4
10650388|NCT02169336|11810667|FG002|NOT COMPLETED|Overall Study||3
10650389|NCT02169414|11810679|FG000|STARTED|Overall Study||19
10499909|NCT01235741|11650403|FG000|STARTED|Non-Randomized Low Calorie Diet Lead-In|6 Week LCD period. Those who lost >=2% of body weight were randomized to treatment.|213
10499910|NCT01235741|11650404|FG001|STARTED|Non-Randomized Low Calorie Diet Lead-In||0
10499911|NCT01235741|11650405|FG002|STARTED|Non-Randomized Low Calorie Diet Lead-In||0
10499912|NCT01235741|11650403|FG000|COMPLETED|Non-Randomized Low Calorie Diet Lead-In|Study terminated by Sponsor. 72 randomized to treatment at time study halted.|72
10499913|NCT01235741|11650404|FG001|COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
10499914|NCT01235741|11650405|FG002|COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
10499915|NCT01235741|11650403|FG000|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||141
10499916|NCT01235741|11650404|FG001|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
10499917|NCT01235741|11650405|FG002|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
10499918|NCT01235741|11650403|FG000|STARTED|Randomized to Treatment||0
10499919|NCT01235741|11650404|FG001|STARTED|Randomized to Treatment||36
10499920|NCT01235741|11650405|FG002|STARTED|Randomized to Treatment||36
10650390|NCT02169414|11810680|FG001|STARTED|Overall Study||19
10650391|NCT02169414|11810681|FG002|STARTED|Overall Study||18
10650392|NCT02169414|11810682|FG003|STARTED|Overall Study||18
10650393|NCT02169414|11810679|FG000|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
10650394|NCT02169414|11810680|FG001|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||19
10650395|NCT02169414|11810681|FG002|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
10499921|NCT01235741|11650403|FG000|COMPLETED|Randomized to Treatment||0
10499922|NCT01235741|11650404|FG001|COMPLETED|Randomized to Treatment|Study terminated by Sponsor. Maximum exposure to study drug was 30 days.|0
10499923|NCT01235741|11650405|FG002|COMPLETED|Randomized to Treatment|Study terminated by Sponsor. Maximum exposure to study drug was 30 days.|0
10499924|NCT01235741|11650403|FG000|NOT COMPLETED|Randomized to Treatment||0
10499925|NCT01235741|11650404|FG001|NOT COMPLETED|Randomized to Treatment||36
10499926|NCT01235741|11650405|FG002|NOT COMPLETED|Randomized to Treatment||36
10499927|NCT01235741|11650403|FG000|STARTED|Follow-Up Post Treatment up to Month 6||0
10499928|NCT01235741|11650404|FG001|STARTED|Follow-Up Post Treatment up to Month 6|No treatment; those who had been treated with placebo (36) were followed up 6 Months post treatment.|36
10499929|NCT01235741|11650405|FG002|STARTED|Follow-Up Post Treatment up to Month 6|No treatment; those who had been treated with drug (36) were followed up 6 months post treatment.|36
10499930|NCT01235741|11650403|FG000|COMPLETED|Follow-Up Post Treatment up to Month 6||0
10499931|NCT01235741|11650404|FG001|COMPLETED|Follow-Up Post Treatment up to Month 6|9 participants did not complete the 6 month follow up period|27
10499932|NCT01235741|11650405|FG002|COMPLETED|Follow-Up Post Treatment up to Month 6|7 participants did not complete the 6 month follow up period|29
10499933|NCT01235741|11650403|FG000|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||0
10499934|NCT01235741|11650404|FG001|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||9
10499935|NCT01235741|11650405|FG002|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||7
10499936|NCT01235793|11650417|FG000|STARTED|Overall Study||11
10499937|NCT01235793|11650417|FG000|COMPLETED|Overall Study||5
10499938|NCT01235793|11650417|FG000|NOT COMPLETED|Overall Study||6
10499939|NCT01235897|11650422|FG000|STARTED|Overall Study||16
10499940|NCT01235897|11650422|FG000|COMPLETED|Overall Study||16
10499941|NCT01235897|11650422|FG000|NOT COMPLETED|Overall Study||0
10499942|NCT01235910|11650427|FG000|STARTED|Overall Study||1
10499943|NCT01235910|11650427|FG000|COMPLETED|Overall Study||1
10499944|NCT01235910|11650427|FG000|NOT COMPLETED|Overall Study||0
10499945|NCT01235949|11650449|FG000|STARTED|Primary Phase||198
10499946|NCT01235949|11650450|FG001|STARTED|Primary Phase||198
10499947|NCT01235949|11650451|FG002|STARTED|Primary Phase||199
10499948|NCT01235949|11650452|FG003|STARTED|Primary Phase||71
10499949|NCT01235949|11650453|FG004|STARTED|Primary Phase||72
10499950|NCT01235949|11650454|FG005|STARTED|Primary Phase||74
10499951|NCT01235949|11650455|FG006|STARTED|Primary Phase||0
10499952|NCT01235949|11650456|FG007|STARTED|Primary Phase||0
10499953|NCT01235949|11650457|FG008|STARTED|Primary Phase||0
10499954|NCT01235949|11650458|FG009|STARTED|Primary Phase||0
10499955|NCT01235949|11650459|FG010|STARTED|Primary Phase||0
10499956|NCT01235949|11650460|FG011|STARTED|Primary Phase||0
10499957|NCT01235949|11650461|FG012|STARTED|Primary Phase||0
10499958|NCT01235949|11650462|FG013|STARTED|Primary Phase||0
10499959|NCT01235949|11650463|FG014|STARTED|Primary Phase||0
10650396|NCT02169414|11810682|FG003|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
10650397|NCT02169414|11810679|FG000|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
10650398|NCT02169414|11810680|FG001|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
10650399|NCT02169414|11810681|FG002|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
10499960|NCT01235949|11650464|FG015|STARTED|Primary Phase||0
10499961|NCT01235949|11650465|FG016|STARTED|Primary Phase||0
10499962|NCT01235949|11650466|FG017|STARTED|Primary Phase||0
10499963|NCT01235949|11650449|FG000|COMPLETED|Primary Phase|After Primary Phase completion, 7 subjects were not willing to participate in the Booster Phase|194
10499964|NCT01235949|11650450|FG001|COMPLETED|Primary Phase|After Primary Phase completion, 6 subjects were not willing to participate in the Booster Phase|195
10499965|NCT01235949|11650451|FG002|COMPLETED|Primary Phase|After Primary Phase completion, 6 subjects were not willing to participate in the Booster Phase|196
10499966|NCT01235949|11650452|FG003|COMPLETED|Primary Phase|After Primary Phase completion, 2 subjects were not willing to participate in the Booster Phase|69
10499967|NCT01235949|11650453|FG004|COMPLETED|Primary Phase|After Primary Phase completion, 3 subjects were not willing to participate in the Booster Phase|71
10499968|NCT01235949|11650454|FG005|COMPLETED|Primary Phase|After Primary Phase completion, all subjects were willing to participate in the Booster Phase|67
10499969|NCT01235949|11650455|FG006|COMPLETED|Primary Phase||0
10499970|NCT01235949|11650456|FG007|COMPLETED|Primary Phase||0
10499971|NCT01235949|11650457|FG008|COMPLETED|Primary Phase||0
10499972|NCT01235949|11650458|FG009|COMPLETED|Primary Phase||0
10499973|NCT01235949|11650459|FG010|COMPLETED|Primary Phase||0
10499974|NCT01235949|11650460|FG011|COMPLETED|Primary Phase||0
10499975|NCT01235949|11650461|FG012|COMPLETED|Primary Phase||0
10499976|NCT01235949|11650462|FG013|COMPLETED|Primary Phase||0
10499977|NCT01235949|11650463|FG014|COMPLETED|Primary Phase||0
10499978|NCT01235949|11650464|FG015|COMPLETED|Primary Phase||0
10499979|NCT01235949|11650465|FG016|COMPLETED|Primary Phase||0
10499980|NCT01235949|11650466|FG017|COMPLETED|Primary Phase||0
10499981|NCT01235949|11650449|FG000|NOT COMPLETED|Primary Phase||4
10499982|NCT01235949|11650450|FG001|NOT COMPLETED|Primary Phase||3
10499983|NCT01235949|11650451|FG002|NOT COMPLETED|Primary Phase||3
10499984|NCT01235949|11650452|FG003|NOT COMPLETED|Primary Phase||2
10499985|NCT01235949|11650453|FG004|NOT COMPLETED|Primary Phase||1
10499986|NCT01235949|11650454|FG005|NOT COMPLETED|Primary Phase||7
10499987|NCT01235949|11650455|FG006|NOT COMPLETED|Primary Phase||0
10499988|NCT01235949|11650456|FG007|NOT COMPLETED|Primary Phase||0
10499989|NCT01235949|11650457|FG008|NOT COMPLETED|Primary Phase||0
10499990|NCT01235949|11650458|FG009|NOT COMPLETED|Primary Phase||0
10499991|NCT01235949|11650459|FG010|NOT COMPLETED|Primary Phase||0
10499992|NCT01235949|11650460|FG011|NOT COMPLETED|Primary Phase||0
10499993|NCT01235949|11650461|FG012|NOT COMPLETED|Primary Phase||0
10499994|NCT01235949|11650462|FG013|NOT COMPLETED|Primary Phase||0
10499995|NCT01235949|11650463|FG014|NOT COMPLETED|Primary Phase||0
10499996|NCT01235949|11650464|FG015|NOT COMPLETED|Primary Phase||0
10499997|NCT01235949|11650465|FG016|NOT COMPLETED|Primary Phase||0
10499998|NCT01235949|11650466|FG017|NOT COMPLETED|Primary Phase||0
10499999|NCT01235949|11650449|FG000|STARTED|Booster Phase|re-randomized to diverse treatments (IIBU-IIBU, IIBU-DIBU and IIBU-NIBU Groups) in booster phase|0
10500000|NCT01235949|11650450|FG001|STARTED|Booster Phase|re-randomized to diverse treatments (DIBU-IIBU, DIBU-DIBU and DIBU-NIBU Groups) in booster phase|0
10500001|NCT01235949|11650451|FG002|STARTED|Booster Phase|re-randomized to diverse treatments (NIBU-IIBU, NIBU-DIBU and NIBU-NIBU Groups) in booster phase|0
10500002|NCT01235949|11650452|FG003|STARTED|Booster Phase|subjects re-randomized to IPARA-NPARA Group in booster phase|0
10500003|NCT01235949|11650453|FG004|STARTED|Booster Phase|subjects re-randomized to DPARA-IPARA Group in booster phase|0
10500004|NCT01235949|11650454|FG005|STARTED|Booster Phase|subjects re-randomized to NPARA-IPARA Group in booster phase|0
10500005|NCT01235949|11650455|FG006|STARTED|Booster Phase|1/3 of subjects from primary IIBU group re-randomized to receive diverse booster phase treatments|64
10500006|NCT01235949|11650456|FG007|STARTED|Booster Phase|1/3 of subjects from primary IIBU group re-randomized to receive diverse booster phase treatments|60
10500007|NCT01235949|11650457|FG008|STARTED|Booster Phase|1/3 of subjects from primary IIBU group re-randomized to receive diverse booster phase treatments|63
10500008|NCT01235949|11650458|FG009|STARTED|Booster Phase|1/3 of subjects from primary DIBU group re-randomized to receive diverse booster phase treatments|63
10500009|NCT01235949|11650459|FG010|STARTED|Booster Phase|1/3 of subjects from primary DIBU group re-randomized to receive diverse booster phase treatments|63
10500010|NCT01235949|11650460|FG011|STARTED|Booster Phase|1/3 of subjects from primary DIBU group re-randomized to receive diverse booster phase treatments|63
10500011|NCT01235949|11650461|FG012|STARTED|Booster Phase|1/3 of subjects from primary NIBU group re-randomized to receive diverse booster phase treatments|63
10500012|NCT01235949|11650462|FG013|STARTED|Booster Phase|1/3 of subjects from primary NIBU group re-randomized to receive diverse booster phase treatments|65
10500013|NCT01235949|11650463|FG014|STARTED|Booster Phase|1/3 of subjects from primary NIBU group re-randomized to receive diverse booster phase treatments|62
10500014|NCT01235949|11650464|FG015|STARTED|Booster Phase|subjects from the primary IPARA group continuing in booster phase with different treatment|67
10500015|NCT01235949|11650465|FG016|STARTED|Booster Phase|subjects from the primary DPARA group continuing in booster phase with different treatment|68
10500016|NCT01235949|11650466|FG017|STARTED|Booster Phase|subjects from the primary NPARA group continuing in booster phase with different treatment|67
10500017|NCT01235949|11650449|FG000|COMPLETED|Booster Phase||0
10500018|NCT01235949|11650450|FG001|COMPLETED|Booster Phase||0
10500019|NCT01235949|11650451|FG002|COMPLETED|Booster Phase||0
10500020|NCT01235949|11650452|FG003|COMPLETED|Booster Phase||0
10500021|NCT01235949|11650453|FG004|COMPLETED|Booster Phase||0
10500022|NCT01235949|11650454|FG005|COMPLETED|Booster Phase||0
10500023|NCT01235949|11650455|FG006|COMPLETED|Booster Phase||64
10500024|NCT01235949|11650456|FG007|COMPLETED|Booster Phase||59
10500025|NCT01235949|11650457|FG008|COMPLETED|Booster Phase||61
10500026|NCT01235949|11650458|FG009|COMPLETED|Booster Phase||62
10500027|NCT01235949|11650459|FG010|COMPLETED|Booster Phase||61
10500028|NCT01235949|11650460|FG011|COMPLETED|Booster Phase||60
10500029|NCT01235949|11650461|FG012|COMPLETED|Booster Phase||60
10500030|NCT01235949|11650462|FG013|COMPLETED|Booster Phase||65
10500031|NCT01235949|11650463|FG014|COMPLETED|Booster Phase||60
10500032|NCT01235949|11650464|FG015|COMPLETED|Booster Phase||66
10500033|NCT01235949|11650465|FG016|COMPLETED|Booster Phase||68
10500034|NCT01235949|11650466|FG017|COMPLETED|Booster Phase||65
10500035|NCT01235949|11650449|FG000|NOT COMPLETED|Booster Phase||0
10500036|NCT01235949|11650450|FG001|NOT COMPLETED|Booster Phase||0
10500037|NCT01235949|11650451|FG002|NOT COMPLETED|Booster Phase||0
10500038|NCT01235949|11650452|FG003|NOT COMPLETED|Booster Phase||0
10500039|NCT01235949|11650453|FG004|NOT COMPLETED|Booster Phase||0
10500040|NCT01235949|11650454|FG005|NOT COMPLETED|Booster Phase||0
10500041|NCT01235949|11650455|FG006|NOT COMPLETED|Booster Phase||0
10500042|NCT01235949|11650456|FG007|NOT COMPLETED|Booster Phase||1
10500043|NCT01235949|11650457|FG008|NOT COMPLETED|Booster Phase||2
10500044|NCT01235949|11650458|FG009|NOT COMPLETED|Booster Phase||1
10500045|NCT01235949|11650459|FG010|NOT COMPLETED|Booster Phase||2
10500046|NCT01235949|11650460|FG011|NOT COMPLETED|Booster Phase||3
10500047|NCT01235949|11650461|FG012|NOT COMPLETED|Booster Phase||3
10500048|NCT01235949|11650462|FG013|NOT COMPLETED|Booster Phase||0
10500049|NCT01235949|11650463|FG014|NOT COMPLETED|Booster Phase||2
10500050|NCT01235949|11650464|FG015|NOT COMPLETED|Booster Phase||1
10500051|NCT01235949|11650465|FG016|NOT COMPLETED|Booster Phase||0
10500052|NCT01235949|11650466|FG017|NOT COMPLETED|Booster Phase||2
10500053|NCT01235975|11650506|FG000|STARTED|Overall Study||274
10500054|NCT01235975|11650507|FG001|STARTED|Overall Study||95
10500055|NCT01235975|11650506|FG000|COMPLETED|Overall Study||257
10500056|NCT01235975|11650507|FG001|COMPLETED|Overall Study||88
10500057|NCT01235975|11650506|FG000|NOT COMPLETED|Overall Study||17
10500058|NCT01235975|11650507|FG001|NOT COMPLETED|Overall Study||7
10500059|NCT01236001|11650515|FG000|STARTED|Overall Study||105
10500060|NCT01236001|11650516|FG001|STARTED|Overall Study||87
10500061|NCT01236001|11650515|FG000|COMPLETED|Overall Study||87
10500062|NCT01236001|11650516|FG001|COMPLETED|Overall Study||65
10500063|NCT01236001|11650515|FG000|NOT COMPLETED|Overall Study||18
10500064|NCT01236001|11650516|FG001|NOT COMPLETED|Overall Study||22
10500065|NCT01236053|11650545|FG000|STARTED|Overall Study||179138
10500066|NCT01236053|11650546|FG001|STARTED|Overall Study||1710950
10500067|NCT01236053|11650547|FG002|STARTED|Overall Study||1877
10500068|NCT01236053|11650548|FG003|STARTED|Overall Study||17853
10500069|NCT01236053|11650549|FG004|STARTED|Overall Study||212
10500070|NCT01236053|11650550|FG005|STARTED|Overall Study||2067
10500071|NCT01236053|11650551|FG006|STARTED|Overall Study||10855
10500072|NCT01236053|11650552|FG007|STARTED|Overall Study||102836
10500073|NCT01236053|11650553|FG008|STARTED|Overall Study||300
10500074|NCT01236053|11650554|FG009|STARTED|Overall Study||2935
10500075|NCT01236053|11650555|FG010|STARTED|Overall Study||19564
10500076|NCT01236053|11650556|FG011|STARTED|Overall Study||188924
10500077|NCT01236053|11650557|FG012|STARTED|Overall Study||148
10500078|NCT01236053|11650558|FG013|STARTED|Overall Study||1396
10500079|NCT01236053|11650559|FG014|STARTED|Overall Study||4600
10500080|NCT01236053|11650560|FG015|STARTED|Overall Study||43559
10500081|NCT01236053|11650561|FG016|STARTED|Overall Study||38
10500082|NCT01236053|11650562|FG017|STARTED|Overall Study||380
10500083|NCT01236053|11650563|FG018|STARTED|Overall Study||2155
10500084|NCT01236053|11650564|FG019|STARTED|Overall Study||20382
10500085|NCT01236053|11650565|FG020|STARTED|Overall Study||1272
10500086|NCT01236053|11650566|FG021|STARTED|Overall Study||12167
10500087|NCT01236053|11650545|FG000|COMPLETED|Overall Study||179138
10500088|NCT01236053|11650546|FG001|COMPLETED|Overall Study||1710950
10500089|NCT01236053|11650547|FG002|COMPLETED|Overall Study||1877
10500090|NCT01236053|11650548|FG003|COMPLETED|Overall Study||17853
10500091|NCT01236053|11650549|FG004|COMPLETED|Overall Study||212
10500092|NCT01236053|11650550|FG005|COMPLETED|Overall Study||2067
10500093|NCT01236053|11650551|FG006|COMPLETED|Overall Study||10855
10500094|NCT01236053|11650552|FG007|COMPLETED|Overall Study||102836
10500095|NCT01236053|11650553|FG008|COMPLETED|Overall Study||300
10500096|NCT01236053|11650554|FG009|COMPLETED|Overall Study||2935
10500097|NCT01236053|11650555|FG010|COMPLETED|Overall Study||19564
10500098|NCT01236053|11650556|FG011|COMPLETED|Overall Study||188924
10500099|NCT01236053|11650557|FG012|COMPLETED|Overall Study||148
10500100|NCT01236053|11650558|FG013|COMPLETED|Overall Study||1396
10500101|NCT01236053|11650559|FG014|COMPLETED|Overall Study||4600
10500102|NCT01236053|11650560|FG015|COMPLETED|Overall Study||43559
10500103|NCT01236053|11650561|FG016|COMPLETED|Overall Study||38
10500104|NCT01236053|11650562|FG017|COMPLETED|Overall Study||380
10500105|NCT01236053|11650563|FG018|COMPLETED|Overall Study||2155
10500106|NCT01236053|11650564|FG019|COMPLETED|Overall Study||20382
10500107|NCT01236053|11650565|FG020|COMPLETED|Overall Study||1272
10500108|NCT01236053|11650566|FG021|COMPLETED|Overall Study||12167
10500109|NCT01236053|11650545|FG000|NOT COMPLETED|Overall Study||0
10500110|NCT01236053|11650546|FG001|NOT COMPLETED|Overall Study||0
10500111|NCT01236053|11650547|FG002|NOT COMPLETED|Overall Study||0
10500112|NCT01236053|11650548|FG003|NOT COMPLETED|Overall Study||0
10500113|NCT01236053|11650549|FG004|NOT COMPLETED|Overall Study||0
10500114|NCT01236053|11650550|FG005|NOT COMPLETED|Overall Study||0
10500115|NCT01236053|11650551|FG006|NOT COMPLETED|Overall Study||0
10500116|NCT01236053|11650552|FG007|NOT COMPLETED|Overall Study||0
10500117|NCT01236053|11650553|FG008|NOT COMPLETED|Overall Study||0
10500118|NCT01236053|11650554|FG009|NOT COMPLETED|Overall Study||0
10500119|NCT01236053|11650555|FG010|NOT COMPLETED|Overall Study||0
10500120|NCT01236053|11650556|FG011|NOT COMPLETED|Overall Study||0
10500121|NCT01236053|11650557|FG012|NOT COMPLETED|Overall Study||0
10500122|NCT01236053|11650558|FG013|NOT COMPLETED|Overall Study||0
10500123|NCT01236053|11650559|FG014|NOT COMPLETED|Overall Study||0
10500124|NCT01236053|11650560|FG015|NOT COMPLETED|Overall Study||0
10500125|NCT01236053|11650561|FG016|NOT COMPLETED|Overall Study||0
10500126|NCT01236053|11650562|FG017|NOT COMPLETED|Overall Study||0
10500127|NCT01236053|11650563|FG018|NOT COMPLETED|Overall Study||0
10500128|NCT01236053|11650564|FG019|NOT COMPLETED|Overall Study||0
10500129|NCT01236053|11650565|FG020|NOT COMPLETED|Overall Study||0
10500130|NCT01236053|11650566|FG021|NOT COMPLETED|Overall Study||0
10500131|NCT01236105|11650615|FG000|STARTED|Overall Study||21
10500132|NCT01236105|11650615|FG000|COMPLETED|Overall Study||21
10500133|NCT01236105|11650615|FG000|NOT COMPLETED|Overall Study||0
10500134|NCT01236118|11650626|FG000|STARTED|Overall Study||6
10500135|NCT01236118|11650627|FG001|STARTED|Overall Study||5
10500136|NCT01236118|11650628|FG002|STARTED|Overall Study||17
10500137|NCT01236118|11650626|FG000|COMPLETED|Overall Study||4
10500138|NCT01236118|11650627|FG001|COMPLETED|Overall Study||4
10500139|NCT01236118|11650628|FG002|COMPLETED|Overall Study||14
10500140|NCT01236118|11650626|FG000|NOT COMPLETED|Overall Study||2
10500141|NCT01236118|11650627|FG001|NOT COMPLETED|Overall Study||1
10500142|NCT01236118|11650628|FG002|NOT COMPLETED|Overall Study||3
10500143|NCT01236170|11650636|FG000|STARTED|Overall Study||497
10500144|NCT01236170|11650636|FG000|COMPLETED|Overall Study||482
10500145|NCT01236170|11650636|FG000|NOT COMPLETED|Overall Study||15
10500146|NCT01236196|11650642|FG000|STARTED|Overall Study||18
10500147|NCT01236196|11650643|FG001|STARTED|Overall Study||21
10500148|NCT01236196|11650642|FG000|COMPLETED|Overall Study||17
10500149|NCT01236196|11650643|FG001|COMPLETED|Overall Study||13
10500150|NCT01236196|11650642|FG000|NOT COMPLETED|Overall Study||1
10500151|NCT01236196|11650643|FG001|NOT COMPLETED|Overall Study||8
10500152|NCT01236300|11650649|FG000|STARTED|Overall Study||66
10500153|NCT01236300|11650649|FG000|COMPLETED|Overall Study||66
10500154|NCT01236300|11650649|FG000|NOT COMPLETED|Overall Study||0
10500155|NCT01236326|11650656|FG000|STARTED|Overall Study||50
10500156|NCT01236326|11650657|FG001|STARTED|Overall Study||55
10500157|NCT01236326|11650656|FG000|COMPLETED|Overall Study||49
10500158|NCT01236326|11650657|FG001|COMPLETED|Overall Study||51
10500159|NCT01236326|11650656|FG000|NOT COMPLETED|Overall Study||1
10500160|NCT01236326|11650657|FG001|NOT COMPLETED|Overall Study||4
10500161|NCT01236339|11650665|FG000|STARTED|Overall Study||13
10500162|NCT01236339|11650666|FG001|STARTED|Overall Study||13
10500163|NCT01236339|11650665|FG000|LVP Crossover to TIPS|Overall Study||0
10500164|NCT01236339|11650666|FG001|LVP Crossover to TIPS|Overall Study|ONLY patients failing LVP and meeting crossover according to protocol definition|4
10500165|NCT01236339|11650665|FG000|COMPLETED|Overall Study||2
10500166|NCT01236339|11650666|FG001|COMPLETED|Overall Study||0
10500167|NCT01236339|11650665|FG000|NOT COMPLETED|Overall Study||11
10500168|NCT01236339|11650666|FG001|NOT COMPLETED|Overall Study||13
10500169|NCT01236352|11650684|FG000|STARTED|Overall Study||4
10500170|NCT01236352|11650685|FG001|STARTED|Overall Study||4
10500171|NCT01236352|11650686|FG002|STARTED|Overall Study||4
10500172|NCT01236352|11650687|FG003|STARTED|Overall Study||4
10500173|NCT01236352|11650688|FG004|STARTED|Overall Study||4
10500174|NCT01236352|11650689|FG005|STARTED|Overall Study||4
10500175|NCT01236352|11650690|FG006|STARTED|Overall Study||8
10500176|NCT01236352|11650691|FG007|STARTED|Overall Study||7
10500177|NCT01236352|11650692|FG008|STARTED|Overall Study||3
10500178|NCT01236352|11650693|FG009|STARTED|Overall Study||22
10500179|NCT01236352|11650694|FG010|STARTED|Overall Study||20
10500180|NCT01236352|11650684|FG000|COMPLETED|Overall Study||0
10500181|NCT01236352|11650685|FG001|COMPLETED|Overall Study||0
10500182|NCT01236352|11650686|FG002|COMPLETED|Overall Study||0
10710613|NCT02652208|11875906|FG001|STARTED|Overall Study||17
10710614|NCT02652208|11875905|FG000|COMPLETED|Overall Study||13
10710615|NCT02652208|11875906|FG001|COMPLETED|Overall Study||15
10500183|NCT01236352|11650687|FG003|COMPLETED|Overall Study||1
10500184|NCT01236352|11650688|FG004|COMPLETED|Overall Study||0
10500185|NCT01236352|11650689|FG005|COMPLETED|Overall Study||0
10500186|NCT01236352|11650690|FG006|COMPLETED|Overall Study||0
10500187|NCT01236352|11650691|FG007|COMPLETED|Overall Study||0
10500188|NCT01236352|11650692|FG008|COMPLETED|Overall Study||0
10500189|NCT01236352|11650693|FG009|COMPLETED|Overall Study||0
10500190|NCT01236352|11650694|FG010|COMPLETED|Overall Study||0
10500191|NCT01236352|11650684|FG000|NOT COMPLETED|Overall Study||4
10500192|NCT01236352|11650685|FG001|NOT COMPLETED|Overall Study||4
10710616|NCT02652208|11875905|FG000|NOT COMPLETED|Overall Study||4
10500193|NCT01236352|11650686|FG002|NOT COMPLETED|Overall Study||4
10500194|NCT01236352|11650687|FG003|NOT COMPLETED|Overall Study||3
10500195|NCT01236352|11650688|FG004|NOT COMPLETED|Overall Study||4
10500196|NCT01236352|11650689|FG005|NOT COMPLETED|Overall Study||4
10500197|NCT01236352|11650690|FG006|NOT COMPLETED|Overall Study||8
10500198|NCT01236352|11650691|FG007|NOT COMPLETED|Overall Study||7
10500199|NCT01236352|11650692|FG008|NOT COMPLETED|Overall Study||3
10500200|NCT01236352|11650693|FG009|NOT COMPLETED|Overall Study||22
10500201|NCT01236352|11650694|FG010|NOT COMPLETED|Overall Study||20
10500202|NCT01236365|11650720|FG000|STARTED|Overall Study||21
10500203|NCT01236365|11650721|FG001|STARTED|Overall Study||21
10500204|NCT01236365|11650720|FG000|COMPLETED|Overall Study||19
10500205|NCT01236365|11650721|FG001|COMPLETED|Overall Study||19
10500206|NCT01236365|11650720|FG000|NOT COMPLETED|Overall Study||2
10500207|NCT01236365|11650721|FG001|NOT COMPLETED|Overall Study||2
10710617|NCT02652208|11875906|FG001|NOT COMPLETED|Overall Study||2
10500208|NCT01236378|11650739|FG000|STARTED|Overall Study||24
10500209|NCT01236378|11650739|FG000|COMPLETED|Overall Study||24
10500210|NCT01236378|11650739|FG000|NOT COMPLETED|Overall Study||0
10500211|NCT01236391|11650743|FG000|STARTED|Overall Study|Participants who received study treatment|111
10500212|NCT01236391|11650743|FG000|COMPLETED|Overall Study|Participants who were on treatment or discontinued treatment due to disease progression or death|95
10500213|NCT01236391|11650743|FG000|NOT COMPLETED|Overall Study||16
10500214|NCT01236534|11650752|FG000|STARTED|Overall Study||11
10500215|NCT01236534|11650753|FG001|STARTED|Overall Study||10
10500216|NCT01236534|11650752|FG000|COMPLETED|Overall Study|2 subjects stopped treatment due to diarrhea, and 1 stopped treatment due to constipation.|8
10500217|NCT01236534|11650753|FG001|COMPLETED|Overall Study||10
10500218|NCT01236534|11650752|FG000|NOT COMPLETED|Overall Study||3
10500219|NCT01236534|11650753|FG001|NOT COMPLETED|Overall Study||0
10500220|NCT01236573|11650770|FG000|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
10500221|NCT01236573|11650771|FG001|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
10500222|NCT01236573|11650772|FG002|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||6
10500223|NCT01236573|11650773|FG003|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
10500224|NCT01236573|11650774|FG004|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
10500225|NCT01236573|11650775|FG005|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
10500226|NCT01236573|11650776|FG006|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
10500227|NCT01236573|11650777|FG007|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
10500228|NCT01236573|11650778|FG008|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
10500229|NCT01236573|11650779|FG009|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
10500230|NCT01236573|11650780|FG010|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
10500231|NCT01236573|11650770|FG000|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
10500232|NCT01236573|11650771|FG001|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
10500233|NCT01236573|11650772|FG002|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||6
10500234|NCT01236573|11650773|FG003|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
10500235|NCT01236573|11650774|FG004|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
10500236|NCT01236573|11650775|FG005|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
10500237|NCT01236573|11650776|FG006|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
10500238|NCT01236573|11650777|FG007|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
10500239|NCT01236573|11650778|FG008|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
10500240|NCT01236573|11650779|FG009|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
10500241|NCT01236573|11650780|FG010|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
10500242|NCT01236573|11650770|FG000|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
10500243|NCT01236573|11650771|FG001|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
10500244|NCT01236573|11650772|FG002|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
10500245|NCT01236573|11650773|FG003|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
10500246|NCT01236573|11650774|FG004|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
10500247|NCT01236573|11650775|FG005|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
10500248|NCT01236573|11650776|FG006|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
10500249|NCT01236573|11650777|FG007|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
10500250|NCT01236573|11650778|FG008|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
10500251|NCT01236573|11650779|FG009|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
10500252|NCT01236573|11650780|FG010|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
10500253|NCT01236573|11650770|FG000|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
10500254|NCT01236573|11650771|FG001|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
10500255|NCT01236573|11650772|FG002|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
10500256|NCT01236573|11650773|FG003|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
10500257|NCT01236573|11650774|FG004|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||1
10500258|NCT01236573|11650775|FG005|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
10500259|NCT01236573|11650776|FG006|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||3
10500260|NCT01236573|11650777|FG007|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||3
10500261|NCT01236573|11650778|FG008|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
10500262|NCT01236573|11650779|FG009|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
10500263|NCT01236573|11650780|FG010|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
10500264|NCT01236573|11650770|FG000|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
10500265|NCT01236573|11650771|FG001|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
10500266|NCT01236573|11650772|FG002|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
10500267|NCT01236573|11650773|FG003|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
10500268|NCT01236573|11650774|FG004|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
10500269|NCT01236573|11650775|FG005|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||4
10500270|NCT01236573|11650776|FG006|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
10500271|NCT01236573|11650777|FG007|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||3
10500272|NCT01236573|11650778|FG008|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
10710618|NCT02652221|11875912|FG000|STARTED|Overall Study||55
10710619|NCT02652221|11875912|FG000|COMPLETED|Overall Study||55
10710620|NCT02652221|11875912|FG000|NOT COMPLETED|Overall Study||0
10500273|NCT01236573|11650779|FG009|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||3
10710627|NCT02652390|11875932|FG000|STARTED|Overall Study||37
10710628|NCT02652390|11875933|FG001|STARTED|Overall Study||37
10710629|NCT02652390|11875934|FG002|STARTED|Overall Study||37
10710630|NCT02652390|11875932|FG000|COMPLETED|Overall Study||37
10710631|NCT02652390|11875933|FG001|COMPLETED|Overall Study||37
10710632|NCT02652390|11875934|FG002|COMPLETED|Overall Study||37
10500274|NCT01236573|11650780|FG010|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
10500275|NCT01236573|11650770|FG000|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
10500276|NCT01236573|11650771|FG001|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
10500277|NCT01236573|11650772|FG002|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
10500278|NCT01236573|11650773|FG003|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
10500279|NCT01236573|11650774|FG004|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
10500280|NCT01236573|11650775|FG005|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
10500281|NCT01236573|11650776|FG006|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
10500282|NCT01236573|11650777|FG007|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
10500283|NCT01236573|11650778|FG008|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
10500284|NCT01236573|11650779|FG009|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
10500285|NCT01236573|11650780|FG010|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
10500286|NCT01236573|11650770|FG000|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
10500287|NCT01236573|11650771|FG001|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
10500288|NCT01236573|11650772|FG002|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
10500289|NCT01236573|11650773|FG003|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
10500290|NCT01236573|11650774|FG004|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
10500291|NCT01236573|11650775|FG005|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
10500292|NCT01236573|11650776|FG006|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
10500293|NCT01236573|11650777|FG007|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
10500294|NCT01236573|11650778|FG008|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
10500295|NCT01236573|11650779|FG009|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
10500296|NCT01236573|11650780|FG010|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||6
10500297|NCT01236573|11650770|FG000|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
10500298|NCT01236573|11650771|FG001|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
10500299|NCT01236573|11650772|FG002|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
10500300|NCT01236573|11650773|FG003|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
10500301|NCT01236573|11650774|FG004|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
10500302|NCT01236573|11650775|FG005|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
10500303|NCT01236573|11650776|FG006|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
10500304|NCT01236573|11650777|FG007|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
10500305|NCT01236573|11650778|FG008|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
10500306|NCT01236573|11650779|FG009|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
10500307|NCT01236573|11650780|FG010|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||5
10500308|NCT01236573|11650770|FG000|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
10500309|NCT01236573|11650771|FG001|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
10500310|NCT01236573|11650772|FG002|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
10500311|NCT01236573|11650773|FG003|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
10500312|NCT01236573|11650774|FG004|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
10500313|NCT01236573|11650775|FG005|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
10500314|NCT01236573|11650776|FG006|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
10500315|NCT01236573|11650777|FG007|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
10500316|NCT01236573|11650778|FG008|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
10500317|NCT01236573|11650779|FG009|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
10500318|NCT01236573|11650780|FG010|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||1
10500319|NCT01236742|11650808|FG000|STARTED|Overall Study||18
10500320|NCT01236742|11650809|FG001|STARTED|Overall Study||19
10500321|NCT01236742|11650810|FG002|STARTED|Overall Study||16
10500322|NCT01236742|11650808|FG000|COMPLETED|Overall Study||15
10500323|NCT01236742|11650809|FG001|COMPLETED|Overall Study||16
10500324|NCT01236742|11650810|FG002|COMPLETED|Overall Study||13
10500325|NCT01236742|11650808|FG000|NOT COMPLETED|Overall Study||3
10500326|NCT01236742|11650809|FG001|NOT COMPLETED|Overall Study||3
10500327|NCT01236742|11650810|FG002|NOT COMPLETED|Overall Study||3
10500328|NCT01236755|11650818|FG000|STARTED|Spectacles Wearing Phase||91
10500329|NCT01236755|11650818|FG000|COMPLETED|Spectacles Wearing Phase||74
10500330|NCT01236755|11650818|FG000|NOT COMPLETED|Spectacles Wearing Phase||17
10500331|NCT01236755|11650818|FG000|STARTED|Orthokeratology Wearing Phase||74
10500332|NCT01236755|11650818|FG000|COMPLETED|Orthokeratology Wearing Phase||66
10500333|NCT01236755|11650818|FG000|NOT COMPLETED|Orthokeratology Wearing Phase||8
10500334|NCT01236768|11650825|FG000|STARTED|Overall Study||201
10500335|NCT01236768|11650826|FG001|STARTED|Overall Study||206
10500336|NCT01236768|11650825|FG000|COMPLETED|Overall Study||112
10500337|NCT01236768|11650826|FG001|COMPLETED|Overall Study||145
10500338|NCT01236768|11650825|FG000|NOT COMPLETED|Overall Study||89
10500339|NCT01236768|11650826|FG001|NOT COMPLETED|Overall Study||61
10500340|NCT01237041|11650838|FG000|STARTED|Overall Study||2
10500341|NCT01237041|11650839|FG001|STARTED|Overall Study||3
10500342|NCT01237041|11650840|FG002|STARTED|Overall Study||2
10500343|NCT01237041|11650841|FG003|STARTED|Overall Study||5
10500344|NCT01237041|11650842|FG004|STARTED|Overall Study||5
10710633|NCT02652390|11875932|FG000|NOT COMPLETED|Overall Study||0
10500345|NCT01237041|11650838|FG000|COMPLETED|Overall Study||2
10500346|NCT01237041|11650839|FG001|COMPLETED|Overall Study||3
10710634|NCT02652390|11875933|FG001|NOT COMPLETED|Overall Study||0
10500347|NCT01237041|11650840|FG002|COMPLETED|Overall Study||2
10500348|NCT01237041|11650841|FG003|COMPLETED|Overall Study||5
10500349|NCT01237041|11650842|FG004|COMPLETED|Overall Study||5
10500350|NCT01237041|11650838|FG000|NOT COMPLETED|Overall Study||0
10500351|NCT01237041|11650839|FG001|NOT COMPLETED|Overall Study||0
10500352|NCT01237041|11650840|FG002|NOT COMPLETED|Overall Study||0
10500353|NCT01237041|11650841|FG003|NOT COMPLETED|Overall Study||0
10500354|NCT01237041|11650842|FG004|NOT COMPLETED|Overall Study||0
10500355|NCT01237054|11650852|FG000|STARTED|Overall Study||31
10500356|NCT01237054|11650852|FG000|COMPLETED|Overall Study||30
10500357|NCT01237054|11650852|FG000|NOT COMPLETED|Overall Study||1
10500358|NCT01237080|11650861|FG000|STARTED|Overall Study||50
10500359|NCT01237080|11650862|FG001|STARTED|Overall Study||50
10500360|NCT01237080|11650861|FG000|COMPLETED|Overall Study||50
10500361|NCT01237080|11650862|FG001|COMPLETED|Overall Study||50
10500362|NCT01237080|11650861|FG000|NOT COMPLETED|Overall Study||0
10500363|NCT01237080|11650862|FG001|NOT COMPLETED|Overall Study||0
10500364|NCT01237197|11650870|FG000|STARTED|Randomization Period||13
10500365|NCT01237197|11650871|FG001|STARTED|Randomization Period||13
10500366|NCT01237197|11650870|FG000|COMPLETED|Randomization Period||12
10500367|NCT01237197|11650871|FG001|COMPLETED|Randomization Period||10
10500368|NCT01237197|11650870|FG000|NOT COMPLETED|Randomization Period||1
10500369|NCT01237197|11650871|FG001|NOT COMPLETED|Randomization Period||3
10500370|NCT01237197|11650870|FG000|STARTED|Open Label Period||12
10500371|NCT01237197|11650871|FG001|STARTED|Open Label Period||10
10500372|NCT01237197|11650870|FG000|COMPLETED|Open Label Period||12
10500373|NCT01237197|11650871|FG001|COMPLETED|Open Label Period||10
10500374|NCT01237197|11650870|FG000|NOT COMPLETED|Open Label Period||0
10500375|NCT01237197|11650871|FG001|NOT COMPLETED|Open Label Period||0
10500376|NCT01237223|11650883|FG000|STARTED|Single Blind(Run-in Period, 4 Weeks)|All the patients enrolled to single blind period received only placebo treatment.|1342
10500377|NCT01237223|11650884|FG001|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
10500378|NCT01237223|11650885|FG002|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
10500379|NCT01237223|11650886|FG003|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
10500380|NCT01237223|11650887|FG004|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
10500381|NCT01237223|11650888|FG005|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
10500382|NCT01237223|11650883|FG000|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||944
10500383|NCT01237223|11650884|FG001|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
10500384|NCT01237223|11650885|FG002|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
10500385|NCT01237223|11650886|FG003|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
10500386|NCT01237223|11650887|FG004|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
10500387|NCT01237223|11650888|FG005|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
10500388|NCT01237223|11650883|FG000|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||398
10500389|NCT01237223|11650884|FG001|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
10500390|NCT01237223|11650885|FG002|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
10500391|NCT01237223|11650886|FG003|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
10500392|NCT01237223|11650887|FG004|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
10500393|NCT01237223|11650888|FG005|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
10500394|NCT01237223|11650883|FG000|STARTED|Double Blind (Treatment Period, 8 Weeks)||153
10500395|NCT01237223|11650884|FG001|STARTED|Double Blind (Treatment Period, 8 Weeks)||157
10500396|NCT01237223|11650885|FG002|STARTED|Double Blind (Treatment Period, 8 Weeks)||158
10500397|NCT01237223|11650886|FG003|STARTED|Double Blind (Treatment Period, 8 Weeks)||158
10500398|NCT01237223|11650887|FG004|STARTED|Double Blind (Treatment Period, 8 Weeks)||159
10500399|NCT01237223|11650888|FG005|STARTED|Double Blind (Treatment Period, 8 Weeks)||159
10500400|NCT01237223|11650883|FG000|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||120
10500401|NCT01237223|11650884|FG001|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||142
10500402|NCT01237223|11650885|FG002|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||143
10500403|NCT01237223|11650886|FG003|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||153
10500404|NCT01237223|11650887|FG004|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||155
10500405|NCT01237223|11650888|FG005|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||154
10500406|NCT01237223|11650883|FG000|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||33
10500407|NCT01237223|11650884|FG001|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||15
10500408|NCT01237223|11650885|FG002|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||15
10500409|NCT01237223|11650886|FG003|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||5
10500410|NCT01237223|11650887|FG004|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||4
10500411|NCT01237223|11650888|FG005|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||5
10500412|NCT01237301|11650906|FG000|STARTED|Overall Study||65
10500413|NCT01237301|11650907|FG001|STARTED|Overall Study||59
10500414|NCT01237301|11650906|FG000|COMPLETED|Overall Study||60
10500415|NCT01237301|11650907|FG001|COMPLETED|Overall Study||55
10500416|NCT01237301|11650906|FG000|NOT COMPLETED|Overall Study||5
10500417|NCT01237301|11650907|FG001|NOT COMPLETED|Overall Study||4
10500418|NCT01237327|11650917|FG000|STARTED|Overall Study||43
10500419|NCT01237327|11650918|FG001|STARTED|Overall Study||41
10500420|NCT01237327|11650917|FG000|Stopped Treatment in Core Study (D/C)|Overall Study|Continued in Extension Study for follow-up only; not treated with study medication.|22
10500421|NCT01237327|11650918|FG001|Stopped Treatment in Core Study (D/C)|Overall Study|Continued in Extension Study for follow-up only; not treated with study medication.|24
10500422|NCT01237327|11650917|FG000|Completed Treatment in Core Study|Overall Study|Completed 26 weeks of treatment in Core Study; continued in Extension Study for follow-up only.|3
10528149|NCT01393626|11680361|FG003|COMPLETED|Overall Study||15
10500423|NCT01237327|11650918|FG001|Completed Treatment in Core Study|Overall Study|Completed 26 weeks of treatment in Core Study; continued in Extension Study for follow-up only.|2
10500424|NCT01237327|11650917|FG000|Continued Treatment in Extension Study|Overall Study||21
10500425|NCT01237327|11650918|FG001|Continued Treatment in Extension Study|Overall Study||17
10500426|NCT01237327|11650917|FG000|COMPLETED|Overall Study|On treatment at Extension Study cut-off date.|1
10500427|NCT01237327|11650918|FG001|COMPLETED|Overall Study|On treatment at Extension Study cut-off date.|1
10500428|NCT01237327|11650917|FG000|NOT COMPLETED|Overall Study||42
10500429|NCT01237327|11650918|FG001|NOT COMPLETED|Overall Study||40
10500430|NCT01237340|11650924|FG000|STARTED|Overall Study||59
10500431|NCT01237340|11650924|FG000|COMPLETED|Overall Study||19
10500432|NCT01237340|11650924|FG000|NOT COMPLETED|Overall Study||40
10500433|NCT01237353|11650931|FG000|STARTED|Overall Study||6
10500434|NCT01237353|11650931|FG000|COMPLETED|Overall Study||6
10500435|NCT01237353|11650931|FG000|NOT COMPLETED|Overall Study||0
10710635|NCT02652390|11875934|FG002|NOT COMPLETED|Overall Study||0
10710636|NCT02652416|11875948|FG000|STARTED|Overall Study||18
10710637|NCT02652416|11875949|FG001|STARTED|Overall Study||18
10710638|NCT02652416|11875950|FG002|STARTED|Overall Study||18
10710639|NCT02652416|11875951|FG003|STARTED|Overall Study||18
10710640|NCT02652416|11875948|FG000|Subjects Who Participated in MD Part|Overall Study||6
10500436|NCT01237587|11650937|FG000|STARTED|Double Blind Treatment (Acute Phase)||91
10500437|NCT01237587|11650938|FG001|STARTED|Double Blind Treatment (Acute Phase)||93
10500438|NCT01237587|11650937|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment (Acute Phase)||91
10500439|NCT01237587|11650938|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment (Acute Phase)||93
10500440|NCT01237587|11650937|FG000|COMPLETED|Double Blind Treatment (Acute Phase)||74
10500441|NCT01237587|11650938|FG001|COMPLETED|Double Blind Treatment (Acute Phase)||75
10500442|NCT01237587|11650937|FG000|NOT COMPLETED|Double Blind Treatment (Acute Phase)||17
10500443|NCT01237587|11650938|FG001|NOT COMPLETED|Double Blind Treatment (Acute Phase)||18
10500444|NCT01237587|11650937|FG000|STARTED|Open Label Treatment (Extension Phase)||74
10500445|NCT01237587|11650938|FG001|STARTED|Open Label Treatment (Extension Phase)||75
10500446|NCT01237587|11650937|FG000|Received at Least One Dose of Study Drug|Open Label Treatment (Extension Phase)||74
10500447|NCT01237587|11650938|FG001|Received at Least One Dose of Study Drug|Open Label Treatment (Extension Phase)||75
10500448|NCT01237587|11650937|FG000|COMPLETED|Open Label Treatment (Extension Phase)||56
10500449|NCT01237587|11650938|FG001|COMPLETED|Open Label Treatment (Extension Phase)||50
10500450|NCT01237587|11650937|FG000|NOT COMPLETED|Open Label Treatment (Extension Phase)||18
10500451|NCT01237587|11650938|FG001|NOT COMPLETED|Open Label Treatment (Extension Phase)||25
10500452|NCT01237587|11650937|FG000|STARTED|Taper Phase|Participants who discontinued Acute or Extension phase had an option to enter tapering phase.|36
10500453|NCT01237587|11650938|FG001|STARTED|Taper Phase|Participants who discontinued Acute or Extension phase had an option to enter tapering phase.|44
10500454|NCT01237587|11650937|FG000|COMPLETED|Taper Phase||31
10500455|NCT01237587|11650938|FG001|COMPLETED|Taper Phase||34
10500456|NCT01237587|11650937|FG000|NOT COMPLETED|Taper Phase||5
10710641|NCT02652416|11875949|FG001|Subjects Who Participated in MD Part|Overall Study||0
10710642|NCT02652416|11875950|FG002|Subjects Who Participated in MD Part|Overall Study||0
10710643|NCT02652416|11875951|FG003|Subjects Who Participated in MD Part|Overall Study||18
10710644|NCT02652416|11875948|FG000|COMPLETED|Overall Study||18
10710645|NCT02652416|11875949|FG001|COMPLETED|Overall Study||18
10710646|NCT02652416|11875950|FG002|COMPLETED|Overall Study||18
10500457|NCT01237587|11650938|FG001|NOT COMPLETED|Taper Phase||10
10500458|NCT01237678|11650954|FG000|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||33
10500459|NCT01237678|11650955|FG001|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||0
10500460|NCT01237678|11650956|FG002|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||0
10500461|NCT01237678|11650954|FG000|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||33
10500462|NCT01237678|11650955|FG001|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||0
10500463|NCT01237678|11650956|FG002|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||0
10500464|NCT01237678|11650954|FG000|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
10500465|NCT01237678|11650955|FG001|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
10500466|NCT01237678|11650956|FG002|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
10500467|NCT01237678|11650954|FG000|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||33
10500468|NCT01237678|11650955|FG001|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
10500469|NCT01237678|11650956|FG002|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
10500470|NCT01237678|11650954|FG000|STARTED|Phase II||0
10500471|NCT01237678|11650955|FG001|STARTED|Phase II|98 subjects were randomized, 94 subjects treated|98
10500472|NCT01237678|11650956|FG002|STARTED|Phase II|50 subjects were randomized, 47 subjects treated|50
10500473|NCT01237678|11650954|FG000|Received Intervention|Phase II||0
10500474|NCT01237678|11650955|FG001|Received Intervention|Phase II||94
10500475|NCT01237678|11650956|FG002|Received Intervention|Phase II||47
10500476|NCT01237678|11650954|FG000|COMPLETED|Phase II||0
10500477|NCT01237678|11650955|FG001|COMPLETED|Phase II||0
10500478|NCT01237678|11650956|FG002|COMPLETED|Phase II||0
10500479|NCT01237678|11650954|FG000|NOT COMPLETED|Phase II||0
10500480|NCT01237678|11650955|FG001|NOT COMPLETED|Phase II||98
10500481|NCT01237678|11650956|FG002|NOT COMPLETED|Phase II||50
10500482|NCT01237821|11650973|FG000|STARTED|Overall Study||32
10500483|NCT01237821|11650974|FG001|STARTED|Overall Study||34
10500484|NCT01237821|11650973|FG000|COMPLETED|Overall Study||26
10710647|NCT02652416|11875951|FG003|COMPLETED|Overall Study||18
10710648|NCT02652416|11875948|FG000|NOT COMPLETED|Overall Study||0
10500485|NCT01237821|11650974|FG001|COMPLETED|Overall Study||34
10500486|NCT01237821|11650973|FG000|NOT COMPLETED|Overall Study||6
10500487|NCT01237821|11650974|FG001|NOT COMPLETED|Overall Study||0
10500488|NCT01237899|11650991|FG000|STARTED|First Dosing Period||1
10500489|NCT01237899|11650992|FG001|STARTED|First Dosing Period||3
10500490|NCT01237899|11650993|FG002|STARTED|First Dosing Period||4
10500491|NCT01237899|11650994|FG003|STARTED|First Dosing Period||3
10500492|NCT01237899|11650995|FG004|STARTED|First Dosing Period||2
10500493|NCT01237899|11650996|FG005|STARTED|First Dosing Period||4
10500494|NCT01237899|11650997|FG006|STARTED|First Dosing Period||1
10500495|NCT01237899|11650998|FG007|STARTED|First Dosing Period||3
10500496|NCT01237899|11650999|FG008|STARTED|First Dosing Period||4
10500497|NCT01237899|11651000|FG009|STARTED|First Dosing Period||3
10500498|NCT01237899|11651001|FG010|STARTED|First Dosing Period||4
10500499|NCT01237899|11650991|FG000|COMPLETED|First Dosing Period||1
10500500|NCT01237899|11650992|FG001|COMPLETED|First Dosing Period||3
10500501|NCT01237899|11650993|FG002|COMPLETED|First Dosing Period||4
10500502|NCT01237899|11650994|FG003|COMPLETED|First Dosing Period||3
10500503|NCT01237899|11650995|FG004|COMPLETED|First Dosing Period||2
10500504|NCT01237899|11650996|FG005|COMPLETED|First Dosing Period||4
10500505|NCT01237899|11650997|FG006|COMPLETED|First Dosing Period||1
10500506|NCT01237899|11650998|FG007|COMPLETED|First Dosing Period||3
10500507|NCT01237899|11650999|FG008|COMPLETED|First Dosing Period||4
10500508|NCT01237899|11651000|FG009|COMPLETED|First Dosing Period||3
10500509|NCT01237899|11651001|FG010|COMPLETED|First Dosing Period||4
10500510|NCT01237899|11650991|FG000|NOT COMPLETED|First Dosing Period||0
10500511|NCT01237899|11650992|FG001|NOT COMPLETED|First Dosing Period||0
10500512|NCT01237899|11650993|FG002|NOT COMPLETED|First Dosing Period||0
10500513|NCT01237899|11650994|FG003|NOT COMPLETED|First Dosing Period||0
10500514|NCT01237899|11650995|FG004|NOT COMPLETED|First Dosing Period||0
10500515|NCT01237899|11650996|FG005|NOT COMPLETED|First Dosing Period||0
10500516|NCT01237899|11650997|FG006|NOT COMPLETED|First Dosing Period||0
10500517|NCT01237899|11650998|FG007|NOT COMPLETED|First Dosing Period||0
10500518|NCT01237899|11650999|FG008|NOT COMPLETED|First Dosing Period||0
10500519|NCT01237899|11651000|FG009|NOT COMPLETED|First Dosing Period||0
10500520|NCT01237899|11651001|FG010|NOT COMPLETED|First Dosing Period||0
10500521|NCT01237899|11650991|FG000|STARTED|Washout Period of at Least 7 Days||1
10500522|NCT01237899|11650992|FG001|STARTED|Washout Period of at Least 7 Days||3
10500523|NCT01237899|11650993|FG002|STARTED|Washout Period of at Least 7 Days||4
10500524|NCT01237899|11650994|FG003|STARTED|Washout Period of at Least 7 Days||3
10500525|NCT01237899|11650995|FG004|STARTED|Washout Period of at Least 7 Days||2
10500526|NCT01237899|11650996|FG005|STARTED|Washout Period of at Least 7 Days||4
10500527|NCT01237899|11650997|FG006|STARTED|Washout Period of at Least 7 Days||1
10500528|NCT01237899|11650998|FG007|STARTED|Washout Period of at Least 7 Days||3
10500529|NCT01237899|11650999|FG008|STARTED|Washout Period of at Least 7 Days||4
10500530|NCT01237899|11651000|FG009|STARTED|Washout Period of at Least 7 Days||3
10500531|NCT01237899|11651001|FG010|STARTED|Washout Period of at Least 7 Days||4
10500532|NCT01237899|11650991|FG000|COMPLETED|Washout Period of at Least 7 Days||1
10500533|NCT01237899|11650992|FG001|COMPLETED|Washout Period of at Least 7 Days||3
10500534|NCT01237899|11650993|FG002|COMPLETED|Washout Period of at Least 7 Days||3
10500535|NCT01237899|11650994|FG003|COMPLETED|Washout Period of at Least 7 Days||3
10500536|NCT01237899|11650995|FG004|COMPLETED|Washout Period of at Least 7 Days||2
10500537|NCT01237899|11650996|FG005|COMPLETED|Washout Period of at Least 7 Days||4
10500538|NCT01237899|11650997|FG006|COMPLETED|Washout Period of at Least 7 Days||1
10500539|NCT01237899|11650998|FG007|COMPLETED|Washout Period of at Least 7 Days||3
10500540|NCT01237899|11650999|FG008|COMPLETED|Washout Period of at Least 7 Days||4
10500541|NCT01237899|11651000|FG009|COMPLETED|Washout Period of at Least 7 Days||3
10500542|NCT01237899|11651001|FG010|COMPLETED|Washout Period of at Least 7 Days||4
10500543|NCT01237899|11650991|FG000|NOT COMPLETED|Washout Period of at Least 7 Days||0
10500544|NCT01237899|11650992|FG001|NOT COMPLETED|Washout Period of at Least 7 Days||0
10500545|NCT01237899|11650993|FG002|NOT COMPLETED|Washout Period of at Least 7 Days||1
10500546|NCT01237899|11650994|FG003|NOT COMPLETED|Washout Period of at Least 7 Days||0
10710649|NCT02652416|11875949|FG001|NOT COMPLETED|Overall Study||0
10710650|NCT02652416|11875950|FG002|NOT COMPLETED|Overall Study||0
10710651|NCT02652416|11875951|FG003|NOT COMPLETED|Overall Study||0
10710652|NCT02652442|11875965|FG000|STARTED|Centrifugation - Distance||6
10710653|NCT02652442|11875965|FG000|COMPLETED|Centrifugation - Distance||5
10710654|NCT02652442|11875965|FG000|NOT COMPLETED|Centrifugation - Distance||1
10710655|NCT02652442|11875965|FG000|STARTED|Centrifugation - Duration||5
10710656|NCT02652442|11875965|FG000|COMPLETED|Centrifugation - Duration||5
10710657|NCT02652442|11875965|FG000|NOT COMPLETED|Centrifugation - Duration||0
10710658|NCT02652442|11875965|FG000|STARTED|Centrifugation - Schedule||5
10500547|NCT01237899|11650995|FG004|NOT COMPLETED|Washout Period of at Least 7 Days||0
10500548|NCT01237899|11650996|FG005|NOT COMPLETED|Washout Period of at Least 7 Days||0
10500549|NCT01237899|11650997|FG006|NOT COMPLETED|Washout Period of at Least 7 Days||0
10500550|NCT01237899|11650998|FG007|NOT COMPLETED|Washout Period of at Least 7 Days||0
10500551|NCT01237899|11650999|FG008|NOT COMPLETED|Washout Period of at Least 7 Days||0
10500552|NCT01237899|11651000|FG009|NOT COMPLETED|Washout Period of at Least 7 Days||0
10500553|NCT01237899|11651001|FG010|NOT COMPLETED|Washout Period of at Least 7 Days||0
10500554|NCT01237899|11650991|FG000|STARTED|Second Dosing Period||1
10500555|NCT01237899|11650992|FG001|STARTED|Second Dosing Period||3
10500556|NCT01237899|11650993|FG002|STARTED|Second Dosing Period||3
10710659|NCT02652442|11875965|FG000|COMPLETED|Centrifugation - Schedule||5
10500557|NCT01237899|11650994|FG003|STARTED|Second Dosing Period||3
10500558|NCT01237899|11650995|FG004|STARTED|Second Dosing Period||2
10500559|NCT01237899|11650996|FG005|STARTED|Second Dosing Period||4
10500560|NCT01237899|11650997|FG006|STARTED|Second Dosing Period||1
10500561|NCT01237899|11650998|FG007|STARTED|Second Dosing Period||3
10500562|NCT01237899|11650999|FG008|STARTED|Second Dosing Period||4
10500563|NCT01237899|11651000|FG009|STARTED|Second Dosing Period||3
10500564|NCT01237899|11651001|FG010|STARTED|Second Dosing Period||4
10500565|NCT01237899|11650991|FG000|COMPLETED|Second Dosing Period||1
10500566|NCT01237899|11650992|FG001|COMPLETED|Second Dosing Period||3
10500567|NCT01237899|11650993|FG002|COMPLETED|Second Dosing Period||3
10500568|NCT01237899|11650994|FG003|COMPLETED|Second Dosing Period||3
10500569|NCT01237899|11650995|FG004|COMPLETED|Second Dosing Period||2
10500570|NCT01237899|11650996|FG005|COMPLETED|Second Dosing Period||4
10500571|NCT01237899|11650997|FG006|COMPLETED|Second Dosing Period||1
10500572|NCT01237899|11650998|FG007|COMPLETED|Second Dosing Period||3
10500573|NCT01237899|11650999|FG008|COMPLETED|Second Dosing Period||4
10500574|NCT01237899|11651000|FG009|COMPLETED|Second Dosing Period||3
10500575|NCT01237899|11651001|FG010|COMPLETED|Second Dosing Period||4
10500576|NCT01237899|11650991|FG000|NOT COMPLETED|Second Dosing Period||0
10500577|NCT01237899|11650992|FG001|NOT COMPLETED|Second Dosing Period||0
10500578|NCT01237899|11650993|FG002|NOT COMPLETED|Second Dosing Period||0
10500579|NCT01237899|11650994|FG003|NOT COMPLETED|Second Dosing Period||0
10500580|NCT01237899|11650995|FG004|NOT COMPLETED|Second Dosing Period||0
10500581|NCT01237899|11650996|FG005|NOT COMPLETED|Second Dosing Period||0
10500582|NCT01237899|11650997|FG006|NOT COMPLETED|Second Dosing Period||0
10500583|NCT01237899|11650998|FG007|NOT COMPLETED|Second Dosing Period||0
10500584|NCT01237899|11650999|FG008|NOT COMPLETED|Second Dosing Period||0
10500585|NCT01237899|11651000|FG009|NOT COMPLETED|Second Dosing Period||0
10500586|NCT01237899|11651001|FG010|NOT COMPLETED|Second Dosing Period||0
10500587|NCT01237951|11651019|FG000|STARTED|Overall Study||75
10500588|NCT01237951|11651019|FG000|COMPLETED|Overall Study||74
10500589|NCT01237951|11651019|FG000|NOT COMPLETED|Overall Study||1
10500590|NCT01238120|11651027|FG000|STARTED|Overall Study||25
10500591|NCT01238120|11651028|FG001|STARTED|Overall Study||23
10500592|NCT01238120|11651029|FG002|STARTED|Overall Study||25
10500593|NCT01238120|11651030|FG003|STARTED|Overall Study||24
10500594|NCT01238120|11651027|FG000|Received Intervention and Completed Baseline Assessments|Overall Study||21
10500595|NCT01238120|11651028|FG001|Received Intervention and Completed Baseline Assessments|Overall Study||22
10500596|NCT01238120|11651029|FG002|Received Intervention and Completed Baseline Assessments|Overall Study||22
10500597|NCT01238120|11651030|FG003|Received Intervention and Completed Baseline Assessments|Overall Study||21
10500598|NCT01238120|11651027|FG000|COMPLETED|Overall Study||17
10500599|NCT01238120|11651028|FG001|COMPLETED|Overall Study||22
10500600|NCT01238120|11651029|FG002|COMPLETED|Overall Study||21
10500601|NCT01238120|11651030|FG003|COMPLETED|Overall Study||18
10500602|NCT01238120|11651027|FG000|NOT COMPLETED|Overall Study||8
10500603|NCT01238120|11651028|FG001|NOT COMPLETED|Overall Study||1
10500604|NCT01238120|11651029|FG002|NOT COMPLETED|Overall Study||4
10500605|NCT01238120|11651030|FG003|NOT COMPLETED|Overall Study||6
10500606|NCT01238172|11651042|FG000|STARTED|Overall Study||237
10500607|NCT01238172|11651043|FG001|STARTED|Overall Study||241
10500608|NCT01238172|11651042|FG000|COMPLETED|Overall Study||226
10500609|NCT01238172|11651043|FG001|COMPLETED|Overall Study||217
10500610|NCT01238172|11651042|FG000|NOT COMPLETED|Overall Study||11
10500611|NCT01238172|11651043|FG001|NOT COMPLETED|Overall Study||24
10500612|NCT01238341|11651049|FG000|STARTED|Overall Study||7
10500613|NCT01238341|11651049|FG000|COMPLETED|Overall Study||7
10710660|NCT02652442|11875965|FG000|NOT COMPLETED|Centrifugation - Schedule||0
10710661|NCT02652481|11875977|FG000|STARTED|Phase 1||239
10710662|NCT02652481|11875977|FG000|COMPLETED|Phase 1||141
10710663|NCT02652481|11875977|FG000|NOT COMPLETED|Phase 1||98
10710664|NCT02652481|11875977|FG000|STARTED|Phase 2||261
10500614|NCT01238341|11651049|FG000|NOT COMPLETED|Overall Study||0
10500615|NCT01238471|11651055|FG000|STARTED|Overall Study||10
10500616|NCT01238471|11651056|FG001|STARTED|Overall Study||10
10500617|NCT01238471|11651055|FG000|COMPLETED|Overall Study||10
10500618|NCT01238471|11651056|FG001|COMPLETED|Overall Study||10
10500619|NCT01238471|11651055|FG000|NOT COMPLETED|Overall Study||0
10500620|NCT01238471|11651056|FG001|NOT COMPLETED|Overall Study||0
10500621|NCT01238536|11651064|FG000|STARTED|Overall Study||200
10500622|NCT01238536|11651065|FG001|STARTED|Overall Study||200
10500623|NCT01238536|11651064|FG000|COMPLETED|Overall Study||153
10500624|NCT01238536|11651065|FG001|COMPLETED|Overall Study||150
10500625|NCT01238536|11651064|FG000|NOT COMPLETED|Overall Study||47
10500626|NCT01238536|11651065|FG001|NOT COMPLETED|Overall Study||50
10500627|NCT01238549|11651073|FG000|STARTED|Overall Study||284
10500628|NCT01238549|11651073|FG000|COMPLETED|Overall Study||248
10500629|NCT01238549|11651073|FG000|NOT COMPLETED|Overall Study||36
10710665|NCT02652481|11875977|FG000|COMPLETED|Phase 2||243
10710666|NCT02652481|11875977|FG000|NOT COMPLETED|Phase 2||18
10500630|NCT01238575|11651079|FG000|STARTED|Overall Study||30
10500631|NCT01238575|11651080|FG001|STARTED|Overall Study||32
10500632|NCT01238575|11651079|FG000|COMPLETED|Overall Study||26
10500633|NCT01238575|11651080|FG001|COMPLETED|Overall Study||28
10500634|NCT01238575|11651079|FG000|NOT COMPLETED|Overall Study||4
10500635|NCT01238575|11651080|FG001|NOT COMPLETED|Overall Study||4
10500636|NCT01238588|11651086|FG000|STARTED|Overall Study||12
10710667|NCT02652624|11875983|FG000|STARTED|Randomized Phase||234
10710668|NCT02652624|11875984|FG001|STARTED|Randomized Phase||236
10500637|NCT01238588|11651086|FG000|COMPLETED|Overall Study||9
10500638|NCT01238588|11651086|FG000|NOT COMPLETED|Overall Study||3
10500639|NCT01238640|11651090|FG000|STARTED|Overall Study||84
10500640|NCT01238640|11651090|FG000|COMPLETED|Overall Study||84
10500641|NCT01238640|11651090|FG000|NOT COMPLETED|Overall Study||0
10500642|NCT01238822|11651098|FG000|STARTED|Overall Study||96
10500643|NCT01238822|11651098|FG000|Received Placebo|Overall Study||93
10500644|NCT01238822|11651098|FG000|Received Low Dosage|Overall Study||93
10500645|NCT01238822|11651098|FG000|Received Medium Dosage|Overall Study||93
10500646|NCT01238822|11651098|FG000|Received High Dosage|Overall Study||93
10500647|NCT01238822|11651098|FG000|COMPLETED|Overall Study||93
10500648|NCT01238822|11651098|FG000|NOT COMPLETED|Overall Study||3
10500649|NCT01238835|11651108|FG000|STARTED|Overall Study||218
10500650|NCT01238835|11651108|FG000|COMPLETED|Overall Study||82
10500651|NCT01238835|11651108|FG000|NOT COMPLETED|Overall Study||136
10500652|NCT01238848|11651114|FG000|STARTED|Overall Study||50
10500653|NCT01238848|11651115|FG001|STARTED|Overall Study||50
10500654|NCT01238848|11651114|FG000|COMPLETED|Overall Study||37
10500655|NCT01238848|11651115|FG001|COMPLETED|Overall Study||45
10500656|NCT01238848|11651114|FG000|NOT COMPLETED|Overall Study||13
10500657|NCT01238848|11651115|FG001|NOT COMPLETED|Overall Study||5
10500658|NCT01238861|11651127|FG000|STARTED|Overall Study||80
10500659|NCT01238861|11651128|FG001|STARTED|Overall Study||81
10500660|NCT01238861|11651129|FG002|STARTED|Overall Study||81
10500661|NCT01238861|11651130|FG003|STARTED|Overall Study||82
10500662|NCT01238861|11651131|FG004|STARTED|Overall Study||142
10500663|NCT01238861|11651132|FG005|STARTED|Overall Study||140
10500664|NCT01238861|11651127|FG000|COMPLETED|Overall Study||69
10500665|NCT01238861|11651128|FG001|COMPLETED|Overall Study||73
10500666|NCT01238861|11651129|FG002|COMPLETED|Overall Study||70
10500667|NCT01238861|11651130|FG003|COMPLETED|Overall Study||69
10500668|NCT01238861|11651131|FG004|COMPLETED|Overall Study||129
10500669|NCT01238861|11651132|FG005|COMPLETED|Overall Study||125
10500670|NCT01238861|11651127|FG000|NOT COMPLETED|Overall Study||11
10500671|NCT01238861|11651128|FG001|NOT COMPLETED|Overall Study||8
10500672|NCT01238861|11651129|FG002|NOT COMPLETED|Overall Study||11
10500673|NCT01238861|11651130|FG003|NOT COMPLETED|Overall Study||13
10500674|NCT01238861|11651131|FG004|NOT COMPLETED|Overall Study||13
10500675|NCT01238861|11651132|FG005|NOT COMPLETED|Overall Study||15
10500676|NCT01238900|11651153|FG000|STARTED|6 Months Post Stent Placement||23
10500677|NCT01238900|11651153|FG000|COMPLETED|6 Months Post Stent Placement||23
10500678|NCT01238900|11651153|FG000|NOT COMPLETED|6 Months Post Stent Placement||0
10500679|NCT01238900|11651153|FG000|STARTED|<12 Months Post Stent Removal||23
10500680|NCT01238900|11651153|FG000|COMPLETED|<12 Months Post Stent Removal||18
10500681|NCT01238900|11651153|FG000|NOT COMPLETED|<12 Months Post Stent Removal||5
10500682|NCT01238991|11651168|FG000|STARTED|Overall Study||7
10500683|NCT01238991|11651169|FG001|STARTED|Overall Study||3
10500684|NCT01238991|11651170|FG002|STARTED|Overall Study||11
10500685|NCT01238991|11651171|FG003|STARTED|Overall Study||6
10500686|NCT01238991|11651172|FG004|STARTED|Overall Study||5
10500687|NCT01238991|11651173|FG005|STARTED|Overall Study||2
10500688|NCT01238991|11651174|FG006|STARTED|Overall Study||8
10500689|NCT01238991|11651175|FG007|STARTED|Overall Study||5
10500690|NCT01238991|11651176|FG008|STARTED|Overall Study||4
10500691|NCT01238991|11651177|FG009|STARTED|Overall Study||2
10500692|NCT01238991|11651168|FG000|Received Treatment|Overall Study||7
10500693|NCT01238991|11651169|FG001|Received Treatment|Overall Study||3
10500694|NCT01238991|11651170|FG002|Received Treatment|Overall Study||11
10500695|NCT01238991|11651171|FG003|Received Treatment|Overall Study||6
10500696|NCT01238991|11651172|FG004|Received Treatment|Overall Study||5
10500697|NCT01238991|11651173|FG005|Received Treatment|Overall Study||2
10500698|NCT01238991|11651174|FG006|Received Treatment|Overall Study||8
10500699|NCT01238991|11651175|FG007|Received Treatment|Overall Study||5
10500700|NCT01238991|11651176|FG008|Received Treatment|Overall Study||4
10500701|NCT01238991|11651177|FG009|Received Treatment|Overall Study||2
10500702|NCT01238991|11651168|FG000|COMPLETED|Overall Study||5
10500703|NCT01238991|11651169|FG001|COMPLETED|Overall Study||3
10500704|NCT01238991|11651170|FG002|COMPLETED|Overall Study||5
10500705|NCT01238991|11651171|FG003|COMPLETED|Overall Study||4
10500706|NCT01238991|11651172|FG004|COMPLETED|Overall Study||3
10500707|NCT01238991|11651173|FG005|COMPLETED|Overall Study||2
10500708|NCT01238991|11651174|FG006|COMPLETED|Overall Study||0
10500709|NCT01238991|11651175|FG007|COMPLETED|Overall Study||0
10500710|NCT01238991|11651176|FG008|COMPLETED|Overall Study||0
10500711|NCT01238991|11651177|FG009|COMPLETED|Overall Study||0
10500712|NCT01238991|11651168|FG000|NOT COMPLETED|Overall Study||2
10500713|NCT01238991|11651169|FG001|NOT COMPLETED|Overall Study||0
10500714|NCT01238991|11651170|FG002|NOT COMPLETED|Overall Study||6
10500715|NCT01238991|11651171|FG003|NOT COMPLETED|Overall Study||2
10500716|NCT01238991|11651172|FG004|NOT COMPLETED|Overall Study||2
10500717|NCT01238991|11651173|FG005|NOT COMPLETED|Overall Study||0
10500718|NCT01238991|11651174|FG006|NOT COMPLETED|Overall Study||8
10500719|NCT01238991|11651175|FG007|NOT COMPLETED|Overall Study||5
10500720|NCT01238991|11651176|FG008|NOT COMPLETED|Overall Study||4
10500721|NCT01238991|11651177|FG009|NOT COMPLETED|Overall Study||2
10500722|NCT01239043|11651204|FG000|STARTED|Overall Study|For safety analysis number includes 1 participant randomized to Menactra who received Menomune.|36
10500723|NCT01239043|11651205|FG001|STARTED|Overall Study||103
10500724|NCT01239043|11651204|FG000|COMPLETED|Overall Study||34
10500725|NCT01239043|11651205|FG001|COMPLETED|Overall Study||102
10500726|NCT01239043|11651204|FG000|NOT COMPLETED|Overall Study||2
10500727|NCT01239043|11651205|FG001|NOT COMPLETED|Overall Study||1
10500728|NCT01239056|11651211|FG000|STARTED|Overall Study||20
10500729|NCT01239056|11651211|FG000|COMPLETED|Overall Study||20
10500730|NCT01239056|11651211|FG000|NOT COMPLETED|Overall Study||0
10500731|NCT01239121|11651219|FG000|STARTED|Overall Study||188
10500732|NCT01239121|11651220|FG001|STARTED|Overall Study||199
10500733|NCT01239121|11651221|FG002|STARTED|Overall Study||15
10500734|NCT01239121|11651219|FG000|COMPLETED|Overall Study||186
10500735|NCT01239121|11651220|FG001|COMPLETED|Overall Study||195
10500736|NCT01239121|11651221|FG002|COMPLETED|Overall Study||15
10500737|NCT01239121|11651219|FG000|NOT COMPLETED|Overall Study||2
10500738|NCT01239121|11651220|FG001|NOT COMPLETED|Overall Study||4
10500739|NCT01239121|11651221|FG002|NOT COMPLETED|Overall Study||0
10500740|NCT01239160|11651231|FG000|STARTED|Overall Study||114
10500741|NCT01239160|11651232|FG001|STARTED|Overall Study||114
10500742|NCT01239160|11651233|FG002|STARTED|Overall Study||10
10500743|NCT01239160|11651231|FG000|COMPLETED|Overall Study||89
10500744|NCT01239160|11651232|FG001|COMPLETED|Overall Study||95
10500745|NCT01239160|11651233|FG002|COMPLETED|Overall Study||0
10500746|NCT01239160|11651231|FG000|NOT COMPLETED|Overall Study||25
10500747|NCT01239160|11651232|FG001|NOT COMPLETED|Overall Study||19
10500748|NCT01239160|11651233|FG002|NOT COMPLETED|Overall Study||10
10500749|NCT01239212|11651239|FG000|STARTED|Overall Study||7
10500750|NCT01239212|11651239|FG000|COMPLETED|Overall Study||7
10500751|NCT01239212|11651239|FG000|NOT COMPLETED|Overall Study||0
10500752|NCT01239316|11651243|FG000|STARTED|Overall Study||12
10500753|NCT01239316|11651243|FG000|COMPLETED|Overall Study||0
10500754|NCT01239316|11651243|FG000|NOT COMPLETED|Overall Study||12
10500755|NCT01239342|11651249|FG000|STARTED|Overall Study||29
10500756|NCT01239342|11651250|FG001|STARTED|Overall Study||14
10500757|NCT01239342|11651249|FG000|COMPLETED|Overall Study||26
10500758|NCT01239342|11651250|FG001|COMPLETED|Overall Study||8
10500759|NCT01239342|11651249|FG000|NOT COMPLETED|Overall Study||3
10500760|NCT01239342|11651250|FG001|NOT COMPLETED|Overall Study||6
10500761|NCT01239355|11651256|FG000|STARTED|Overall Study||15
10500762|NCT01239355|11651256|FG000|COMPLETED|Overall Study||15
10500763|NCT01239355|11651256|FG000|NOT COMPLETED|Overall Study||0
10500764|NCT01239381|11651260|FG000|STARTED|Overall Study||92
10500765|NCT01239381|11651260|FG000|COMPLETED|Overall Study||90
10500766|NCT01239381|11651260|FG000|NOT COMPLETED|Overall Study||2
10500767|NCT01239394|11651265|FG000|STARTED|Overall Study||42
10500768|NCT01239394|11651265|FG000|COMPLETED|Overall Study||41
10500769|NCT01239394|11651265|FG000|NOT COMPLETED|Overall Study||1
10500770|NCT01239472|11651271|FG000|STARTED|Overall Study||15
10500771|NCT01239472|11651272|FG001|STARTED|Overall Study||15
10500772|NCT01239472|11651271|FG000|COMPLETED|Overall Study||10
10500773|NCT01239472|11651272|FG001|COMPLETED|Overall Study||12
10500774|NCT01239472|11651271|FG000|NOT COMPLETED|Overall Study||5
10500775|NCT01239472|11651272|FG001|NOT COMPLETED|Overall Study||3
10500776|NCT01239511|11651284|FG000|STARTED|Overall Study||47
10500777|NCT01239511|11651285|FG001|STARTED|Overall Study||45
10500778|NCT01239511|11651286|FG002|STARTED|Overall Study||47
10500779|NCT01239511|11651287|FG003|STARTED|Overall Study||47
10500780|NCT01239511|11651284|FG000|COMPLETED|Overall Study||46
10500781|NCT01239511|11651285|FG001|COMPLETED|Overall Study||40
10500782|NCT01239511|11651286|FG002|COMPLETED|Overall Study||43
10500783|NCT01239511|11651287|FG003|COMPLETED|Overall Study||38
10500784|NCT01239511|11651284|FG000|NOT COMPLETED|Overall Study||1
10500785|NCT01239511|11651285|FG001|NOT COMPLETED|Overall Study||5
10500786|NCT01239511|11651286|FG002|NOT COMPLETED|Overall Study||4
10500787|NCT01239511|11651287|FG003|NOT COMPLETED|Overall Study||9
10500788|NCT01239732|11651297|FG000|STARTED|Overall Study||1021
10500789|NCT01239732|11651297|FG000|COMPLETED|Overall Study||0
10500790|NCT01239732|11651297|FG000|NOT COMPLETED|Overall Study||1021
10500791|NCT01239745|11651301|FG000|STARTED|Overall Study||46
10500792|NCT01239745|11651301|FG000|COMPLETED|Overall Study||0
10500793|NCT01239745|11651301|FG000|NOT COMPLETED|Overall Study||46
10500794|NCT01239992|11651305|FG000|STARTED|Overall Study||12
10500795|NCT01239992|11651305|FG000|COMPLETED|Overall Study||10
10500796|NCT01239992|11651305|FG000|NOT COMPLETED|Overall Study||2
10500797|NCT01240122|11651309|FG000|STARTED|Overall Study||29
10500798|NCT01240122|11651309|FG000|COMPLETED|Overall Study||29
10500799|NCT01240122|11651309|FG000|NOT COMPLETED|Overall Study||0
10500800|NCT01240135|11651320|FG000|STARTED|Period One, 14 Days of Wear||44
10500801|NCT01240135|11651321|FG001|STARTED|Period One, 14 Days of Wear||45
10500802|NCT01240135|11651320|FG000|COMPLETED|Period One, 14 Days of Wear||44
10500803|NCT01240135|11651321|FG001|COMPLETED|Period One, 14 Days of Wear||45
10500804|NCT01240135|11651320|FG000|NOT COMPLETED|Period One, 14 Days of Wear||0
10500805|NCT01240135|11651321|FG001|NOT COMPLETED|Period One, 14 Days of Wear||0
10500806|NCT01240135|11651320|FG000|STARTED|Period Two, 14 Days of Wear||44
10500807|NCT01240135|11651321|FG001|STARTED|Period Two, 14 Days of Wear||45
10500808|NCT01240135|11651320|FG000|COMPLETED|Period Two, 14 Days of Wear||43
10500809|NCT01240135|11651321|FG001|COMPLETED|Period Two, 14 Days of Wear||43
10500810|NCT01240135|11651320|FG000|NOT COMPLETED|Period Two, 14 Days of Wear||1
10500811|NCT01240135|11651321|FG001|NOT COMPLETED|Period Two, 14 Days of Wear||2
10500812|NCT01240200|11651329|FG000|STARTED|12-week Crossover Phase - Period 1||25
10500813|NCT01240200|11651330|FG001|STARTED|12-week Crossover Phase - Period 1||24
10500814|NCT01240200|11651329|FG000|COMPLETED|12-week Crossover Phase - Period 1||23
10500815|NCT01240200|11651330|FG001|COMPLETED|12-week Crossover Phase - Period 1||23
10500816|NCT01240200|11651329|FG000|NOT COMPLETED|12-week Crossover Phase - Period 1||2
10500817|NCT01240200|11651330|FG001|NOT COMPLETED|12-week Crossover Phase - Period 1||1
10500818|NCT01240200|11651329|FG000|STARTED|12-week Crossover Phase - Period 2||23
10500819|NCT01240200|11651330|FG001|STARTED|12-week Crossover Phase - Period 2||23
10500820|NCT01240200|11651329|FG000|COMPLETED|12-week Crossover Phase - Period 2||23
10500821|NCT01240200|11651330|FG001|COMPLETED|12-week Crossover Phase - Period 2||23
10500822|NCT01240200|11651329|FG000|NOT COMPLETED|12-week Crossover Phase - Period 2||0
10500823|NCT01240200|11651330|FG001|NOT COMPLETED|12-week Crossover Phase - Period 2||0
10500824|NCT01240330|11651339|FG000|STARTED|Overall Study||33
10500825|NCT01240330|11651339|FG000|COMPLETED|Overall Study||33
10500826|NCT01240330|11651339|FG000|NOT COMPLETED|Overall Study||0
10500827|NCT01240356|11651345|FG000|STARTED|Overall Study||18
10500828|NCT01240356|11651346|FG001|STARTED|Overall Study||20
10500829|NCT01240356|11651345|FG000|COMPLETED|Overall Study||15
10500830|NCT01240356|11651346|FG001|COMPLETED|Overall Study||20
10500831|NCT01240356|11651345|FG000|NOT COMPLETED|Overall Study||3
10500832|NCT01240356|11651346|FG001|NOT COMPLETED|Overall Study||0
10500833|NCT01240382|11651357|FG000|STARTED|Overall Study||144
10500834|NCT01240382|11651358|FG001|STARTED|Overall Study||143
10500835|NCT01240382|11651357|FG000|COMPLETED|Overall Study||142
10500836|NCT01240382|11651358|FG001|COMPLETED|Overall Study||139
10500837|NCT01240382|11651357|FG000|NOT COMPLETED|Overall Study||2
10500838|NCT01240382|11651358|FG001|NOT COMPLETED|Overall Study||4
10500839|NCT01240551|11651366|FG000|STARTED|Overall Study||30
10500840|NCT01240551|11651367|FG001|STARTED|Overall Study||30
10500841|NCT01240551|11651366|FG000|COMPLETED|Overall Study||26
10500842|NCT01240551|11651367|FG001|COMPLETED|Overall Study||27
10500843|NCT01240551|11651366|FG000|NOT COMPLETED|Overall Study||4
10500844|NCT01240551|11651367|FG001|NOT COMPLETED|Overall Study||3
10500845|NCT01240590|11651378|FG000|STARTED|Phase I||0
10500846|NCT01240590|11651379|FG001|STARTED|Phase I||6
10500847|NCT01240590|11651380|FG002|STARTED|Phase I||3
10500848|NCT01240590|11651381|FG003|STARTED|Phase I||0
10500849|NCT01240590|11651382|FG004|STARTED|Phase I||0
10500850|NCT01240590|11651378|FG000|COMPLETED|Phase I||0
10500851|NCT01240590|11651379|FG001|COMPLETED|Phase I||6
10500852|NCT01240590|11651380|FG002|COMPLETED|Phase I||0
10500853|NCT01240590|11651381|FG003|COMPLETED|Phase I||0
10500854|NCT01240590|11651382|FG004|COMPLETED|Phase I||0
10500855|NCT01240590|11651378|FG000|NOT COMPLETED|Phase I||0
10500856|NCT01240590|11651379|FG001|NOT COMPLETED|Phase I||0
10500857|NCT01240590|11651380|FG002|NOT COMPLETED|Phase I||3
10500858|NCT01240590|11651381|FG003|NOT COMPLETED|Phase I||0
10500859|NCT01240590|11651382|FG004|NOT COMPLETED|Phase I||0
10500860|NCT01240590|11651378|FG000|STARTED|Phase II||0
10500861|NCT01240590|11651379|FG001|STARTED|Phase II||0
10500862|NCT01240590|11651380|FG002|STARTED|Phase II||0
10500863|NCT01240590|11651381|FG003|STARTED|Phase II||17
10500864|NCT01240590|11651382|FG004|STARTED|Phase II||1
10500865|NCT01240590|11651378|FG000|COMPLETED|Phase II||0
10500866|NCT01240590|11651379|FG001|COMPLETED|Phase II||0
10500867|NCT01240590|11651380|FG002|COMPLETED|Phase II||0
10500868|NCT01240590|11651381|FG003|COMPLETED|Phase II||15
10500869|NCT01240590|11651382|FG004|COMPLETED|Phase II||0
10500870|NCT01240590|11651378|FG000|NOT COMPLETED|Phase II||0
10500871|NCT01240590|11651379|FG001|NOT COMPLETED|Phase II||0
10500872|NCT01240590|11651380|FG002|NOT COMPLETED|Phase II||0
10500873|NCT01240590|11651381|FG003|NOT COMPLETED|Phase II||2
10500874|NCT01240590|11651382|FG004|NOT COMPLETED|Phase II||1
10500875|NCT01240746|11651411|FG000|STARTED|Overall Study||736
10500876|NCT01240746|11651412|FG001|STARTED|Overall Study||725
10500877|NCT01240746|11651413|FG002|STARTED|Overall Study||2902
10500878|NCT01240746|11651411|FG000|COMPLETED|Overall Study||677
10500879|NCT01240746|11651412|FG001|COMPLETED|Overall Study||677
10500880|NCT01240746|11651413|FG002|COMPLETED|Overall Study||2659
10500881|NCT01240746|11651411|FG000|NOT COMPLETED|Overall Study||59
10500882|NCT01240746|11651412|FG001|NOT COMPLETED|Overall Study||48
10500883|NCT01240746|11651413|FG002|NOT COMPLETED|Overall Study||243
10500884|NCT01240785|11651423|FG000|STARTED|Overall Study||111
10500885|NCT01240785|11651424|FG001|STARTED|Overall Study||110
10500886|NCT01240785|11651423|FG000|COMPLETED|Overall Study|110 women completed in the metformin arm and 107 women completed in the insulin arm.|110
10500887|NCT01240785|11651424|FG001|COMPLETED|Overall Study||107
10500888|NCT01240785|11651423|FG000|NOT COMPLETED|Overall Study||1
10500889|NCT01240785|11651424|FG001|NOT COMPLETED|Overall Study||3
10500890|NCT01240811|11651433|FG000|STARTED|Overall Study||8
10500891|NCT01240811|11651434|FG001|STARTED|Overall Study||17
10500892|NCT01240811|11651435|FG002|STARTED|Overall Study||17
10500893|NCT01240811|11651433|FG000|COMPLETED|Overall Study||8
10500894|NCT01240811|11651434|FG001|COMPLETED|Overall Study||16
10500895|NCT01240811|11651435|FG002|COMPLETED|Overall Study||16
10500896|NCT01240811|11651433|FG000|NOT COMPLETED|Overall Study||0
10500897|NCT01240811|11651434|FG001|NOT COMPLETED|Overall Study||1
10500898|NCT01240811|11651435|FG002|NOT COMPLETED|Overall Study||1
10500899|NCT01240863|11651447|FG000|STARTED|Open-label Titration Period||391
10500900|NCT01240863|11651448|FG001|STARTED|Open-label Titration Period||0
10500901|NCT01240863|11651449|FG002|STARTED|Open-label Titration Period||0
10500902|NCT01240863|11651447|FG000|Safety Analysis Set|Open-label Titration Period||389
10500903|NCT01240863|11651448|FG001|Safety Analysis Set|Open-label Titration Period||0
10500904|NCT01240863|11651449|FG002|Safety Analysis Set|Open-label Titration Period||0
10500905|NCT01240863|11651447|FG000|COMPLETED|Open-label Titration Period||294
10500906|NCT01240863|11651448|FG001|COMPLETED|Open-label Titration Period||0
10500907|NCT01240863|11651449|FG002|COMPLETED|Open-label Titration Period||0
10500908|NCT01240863|11651447|FG000|NOT COMPLETED|Open-label Titration Period||97
10500909|NCT01240863|11651448|FG001|NOT COMPLETED|Open-label Titration Period||0
10500910|NCT01240863|11651449|FG002|NOT COMPLETED|Open-label Titration Period||0
10500911|NCT01240863|11651447|FG000|STARTED|Double-blind Treatment Period (12 Weeks)||0
10500912|NCT01240863|11651448|FG001|STARTED|Double-blind Treatment Period (12 Weeks)||148
10500913|NCT01240863|11651449|FG002|STARTED|Double-blind Treatment Period (12 Weeks)||146
10500914|NCT01240863|11651447|FG000|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||0
10500915|NCT01240863|11651448|FG001|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||147
10500916|NCT01240863|11651449|FG002|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||146
10500917|NCT01240863|11651447|FG000|COMPLETED|Double-blind Treatment Period (12 Weeks)||0
10500918|NCT01240863|11651448|FG001|COMPLETED|Double-blind Treatment Period (12 Weeks)||102
10500919|NCT01240863|11651449|FG002|COMPLETED|Double-blind Treatment Period (12 Weeks)||94
10500920|NCT01240863|11651447|FG000|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||0
10500921|NCT01240863|11651448|FG001|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||46
10500922|NCT01240863|11651449|FG002|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||52
10500923|NCT01240915|11651469|FG000|STARTED|Overall Study||2
10500924|NCT01240915|11651470|FG001|STARTED|Overall Study||3
10500925|NCT01240915|11651471|FG002|STARTED|Overall Study||2
10500926|NCT01240915|11651472|FG003|STARTED|Overall Study||4
10500927|NCT01240915|11651473|FG004|STARTED|Overall Study||6
10500928|NCT01240915|11651474|FG005|STARTED|Overall Study||23
10500929|NCT01240915|11651475|FG006|STARTED|Overall Study||25
10500930|NCT01240915|11651476|FG007|STARTED|Overall Study||19
10500931|NCT01240915|11651477|FG008|STARTED|Overall Study||21
10500932|NCT01240915|11651469|FG000|COMPLETED|Overall Study||0
10500933|NCT01240915|11651470|FG001|COMPLETED|Overall Study||2
10500934|NCT01240915|11651471|FG002|COMPLETED|Overall Study||2
10500935|NCT01240915|11651472|FG003|COMPLETED|Overall Study||1
10500936|NCT01240915|11651473|FG004|COMPLETED|Overall Study||2
10500937|NCT01240915|11651474|FG005|COMPLETED|Overall Study||13
10500938|NCT01240915|11651475|FG006|COMPLETED|Overall Study||17
10500939|NCT01240915|11651476|FG007|COMPLETED|Overall Study||15
10500940|NCT01240915|11651477|FG008|COMPLETED|Overall Study||13
10500941|NCT01240915|11651469|FG000|NOT COMPLETED|Overall Study||2
10500942|NCT01240915|11651470|FG001|NOT COMPLETED|Overall Study||1
10710669|NCT02652624|11875983|FG000|COMPLETED|Randomized Phase||231
10710670|NCT02652624|11875984|FG001|COMPLETED|Randomized Phase||231
10710671|NCT02652624|11875983|FG000|NOT COMPLETED|Randomized Phase||3
10710672|NCT02652624|11875984|FG001|NOT COMPLETED|Randomized Phase||5
10710673|NCT02652624|11875983|FG000|STARTED|Extension Phase||231
10710674|NCT02652624|11875984|FG001|STARTED|Extension Phase|3 participants completed the Randomized Phase, but did not enter the Extension Phase.|228
10500943|NCT01240915|11651471|FG002|NOT COMPLETED|Overall Study||0
10500944|NCT01240915|11651472|FG003|NOT COMPLETED|Overall Study||3
10500945|NCT01240915|11651473|FG004|NOT COMPLETED|Overall Study||4
10500946|NCT01240915|11651474|FG005|NOT COMPLETED|Overall Study||10
10500947|NCT01240915|11651475|FG006|NOT COMPLETED|Overall Study||8
10500948|NCT01240915|11651476|FG007|NOT COMPLETED|Overall Study||4
10500949|NCT01240915|11651477|FG008|NOT COMPLETED|Overall Study||8
10500950|NCT01241240|11651501|FG000|STARTED|Overall Study||94
10500951|NCT01241240|11651502|FG001|STARTED|Overall Study||98
10500952|NCT01241240|11651501|FG000|COMPLETED|Overall Study||86
10500953|NCT01241240|11651502|FG001|COMPLETED|Overall Study||89
10500954|NCT01241240|11651501|FG000|NOT COMPLETED|Overall Study||8
10500955|NCT01241240|11651502|FG001|NOT COMPLETED|Overall Study||9
10710675|NCT02652624|11875983|FG000|COMPLETED|Extension Phase||227
10810070|NCT03807245|11971957|FG000|STARTED|Overall Study||24
10500956|NCT01241292|11651510|FG000|STARTED|Overall Study||3
10500957|NCT01241292|11651511|FG001|STARTED|Overall Study||3
10500958|NCT01241292|11651510|FG000|Entered Treatment Period|Overall Study||3
10500959|NCT01241292|11651511|FG001|Entered Treatment Period|Overall Study||3
10500960|NCT01241292|11651510|FG000|COMPLETED|Overall Study|completed=treatment on-going|0
10810071|NCT03807245|11971958|FG001|STARTED|Overall Study||24
10810072|NCT03807245|11971959|FG002|STARTED|Overall Study||12
10810073|NCT03807245|11971957|FG000|COMPLETED|Overall Study||23
10710676|NCT02652624|11875984|FG001|COMPLETED|Extension Phase||224
10710677|NCT02652624|11875983|FG000|NOT COMPLETED|Extension Phase||4
10810074|NCT03807245|11971958|FG001|COMPLETED|Overall Study||24
10500961|NCT01241292|11651511|FG001|COMPLETED|Overall Study|completed=treatment on-going|0
10500962|NCT01241292|11651510|FG000|NOT COMPLETED|Overall Study||3
10500963|NCT01241292|11651511|FG001|NOT COMPLETED|Overall Study||3
10500964|NCT01241318|11651523|FG000|STARTED|Overall Study|Women enrolled|19629
10500965|NCT01241318|11651524|FG001|STARTED|Overall Study|Women enrolled|20050
10500966|NCT01241318|11651523|FG000|Liveborn Infant|Overall Study|Infants|18510
10500967|NCT01241318|11651524|FG001|Liveborn Infant|Overall Study|Infants|19346
10500968|NCT01241318|11651523|FG000|COMPLETED|Overall Study|Infants|18450
10500969|NCT01241318|11651524|FG001|COMPLETED|Overall Study|Infants|19308
10500970|NCT01241318|11651523|FG000|NOT COMPLETED|Overall Study||1179
10500971|NCT01241318|11651524|FG001|NOT COMPLETED|Overall Study||742
10500972|NCT01241344|11651537|FG000|STARTED|Overall Study||14
10500973|NCT01241344|11651538|FG001|STARTED|Overall Study||16
10500974|NCT01241344|11651539|FG002|STARTED|Overall Study||18
10500975|NCT01241344|11651540|FG003|STARTED|Overall Study||4
10500976|NCT01241344|11651537|FG000|Randomized to Open-label|Overall Study||3
10500977|NCT01241344|11651538|FG001|Randomized to Open-label|Overall Study||4
10500978|NCT01241344|11651539|FG002|Randomized to Open-label|Overall Study||5
10500979|NCT01241344|11651540|FG003|Randomized to Open-label|Overall Study||0
10500980|NCT01241344|11651537|FG000|COMPLETED|Overall Study||9
10500981|NCT01241344|11651538|FG001|COMPLETED|Overall Study||7
10500982|NCT01241344|11651539|FG002|COMPLETED|Overall Study||9
10500983|NCT01241344|11651540|FG003|COMPLETED|Overall Study||2
10500984|NCT01241344|11651537|FG000|NOT COMPLETED|Overall Study||5
10500985|NCT01241344|11651538|FG001|NOT COMPLETED|Overall Study||9
10500986|NCT01241344|11651539|FG002|NOT COMPLETED|Overall Study||9
10500987|NCT01241344|11651540|FG003|NOT COMPLETED|Overall Study||2
10500988|NCT01241435|11651553|FG000|STARTED|Overall Study||12
10500989|NCT01241435|11651554|FG001|STARTED|Overall Study||8
10500990|NCT01241435|11651555|FG002|STARTED|Overall Study||8
10500991|NCT01241435|11651556|FG003|STARTED|Overall Study||8
10500992|NCT01241435|11651553|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12
10500993|NCT01241435|11651554|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
10500994|NCT01241435|11651555|FG002|Received at Least 1 Dose of Study Drug|Overall Study||8
10500995|NCT01241435|11651556|FG003|Received at Least 1 Dose of Study Drug|Overall Study||8
10500996|NCT01241435|11651553|FG000|COMPLETED|Overall Study||12
10500997|NCT01241435|11651554|FG001|COMPLETED|Overall Study||8
10500998|NCT01241435|11651555|FG002|COMPLETED|Overall Study||8
10500999|NCT01241435|11651556|FG003|COMPLETED|Overall Study||8
10501000|NCT01241435|11651553|FG000|NOT COMPLETED|Overall Study||0
10501001|NCT01241435|11651554|FG001|NOT COMPLETED|Overall Study||0
10501002|NCT01241435|11651555|FG002|NOT COMPLETED|Overall Study||0
10501003|NCT01241435|11651556|FG003|NOT COMPLETED|Overall Study||0
10501004|NCT01241448|11651570|FG000|STARTED|Overall Study||66
10501005|NCT01241448|11651571|FG001|STARTED|Overall Study||65
10501006|NCT01241448|11651572|FG002|STARTED|Overall Study||66
10501007|NCT01241448|11651573|FG003|STARTED|Overall Study||66
10501008|NCT01241448|11651570|FG000|Intent-to-Treat Population (ITT)|Overall Study||63
10501009|NCT01241448|11651571|FG001|Intent-to-Treat Population (ITT)|Overall Study||63
10501010|NCT01241448|11651572|FG002|Intent-to-Treat Population (ITT)|Overall Study||64
10501011|NCT01241448|11651573|FG003|Intent-to-Treat Population (ITT)|Overall Study||64
10501012|NCT01241448|11651570|FG000|ITT With ≥1 Post-Baseline Measure|Overall Study||61
10501013|NCT01241448|11651571|FG001|ITT With ≥1 Post-Baseline Measure|Overall Study||61
10501014|NCT01241448|11651572|FG002|ITT With ≥1 Post-Baseline Measure|Overall Study||64
10501015|NCT01241448|11651573|FG003|ITT With ≥1 Post-Baseline Measure|Overall Study||62
10501016|NCT01241448|11651570|FG000|COMPLETED|Overall Study||29
10501017|NCT01241448|11651571|FG001|COMPLETED|Overall Study||36
10501018|NCT01241448|11651572|FG002|COMPLETED|Overall Study||43
10501019|NCT01241448|11651573|FG003|COMPLETED|Overall Study||43
10501020|NCT01241448|11651570|FG000|NOT COMPLETED|Overall Study||37
10501021|NCT01241448|11651571|FG001|NOT COMPLETED|Overall Study||29
10501022|NCT01241448|11651572|FG002|NOT COMPLETED|Overall Study||23
10501023|NCT01241448|11651573|FG003|NOT COMPLETED|Overall Study||23
10501024|NCT01241461|11651586|FG000|STARTED|Overall Study||3
10501025|NCT01241461|11651587|FG001|STARTED|Overall Study||6
10501026|NCT01241461|11651586|FG000|COMPLETED|Overall Study||0
10501027|NCT01241461|11651587|FG001|COMPLETED|Overall Study||0
10501028|NCT01241461|11651586|FG000|NOT COMPLETED|Overall Study||3
10501029|NCT01241461|11651587|FG001|NOT COMPLETED|Overall Study||6
10501030|NCT01241513|11651599|FG000|STARTED|Overall Study||10
10501031|NCT01241513|11651600|FG001|STARTED|Overall Study||9
10501032|NCT01241513|11651599|FG000|COMPLETED|Overall Study|Study has been completed|10
10501033|NCT01241513|11651600|FG001|COMPLETED|Overall Study||9
10501034|NCT01241513|11651599|FG000|NOT COMPLETED|Overall Study||0
10501035|NCT01241513|11651600|FG001|NOT COMPLETED|Overall Study||0
10501036|NCT01241539|11651605|FG000|STARTED|Period 1||7
10501037|NCT01241539|11651605|FG000|COMPLETED|Period 1||7
10501038|NCT01241539|11651605|FG000|NOT COMPLETED|Period 1||0
10501039|NCT01241539|11651605|FG000|STARTED|Period 2|After a wash-out phase of at least 6 weeks.|7
10501040|NCT01241539|11651605|FG000|COMPLETED|Period 2||7
10501041|NCT01241539|11651605|FG000|NOT COMPLETED|Period 2||0
10501042|NCT01241552|11651615|FG000|STARTED|Overall Study||242
10501043|NCT01241552|11651616|FG001|STARTED|Overall Study||403
10501044|NCT01241552|11651617|FG002|STARTED|Overall Study||403
10501045|NCT01241552|11651618|FG003|STARTED|Overall Study||404
10501046|NCT01241552|11651615|FG000|Treated|Overall Study||235
10501047|NCT01241552|11651616|FG001|Treated|Overall Study||392
10501048|NCT01241552|11651617|FG002|Treated|Overall Study||388
10501049|NCT01241552|11651618|FG003|Treated|Overall Study||397
10501050|NCT01241552|11651615|FG000|COMPLETED|Overall Study||201
10501051|NCT01241552|11651616|FG001|COMPLETED|Overall Study||340
10501052|NCT01241552|11651617|FG002|COMPLETED|Overall Study||343
10501053|NCT01241552|11651618|FG003|COMPLETED|Overall Study||340
10501054|NCT01241552|11651615|FG000|NOT COMPLETED|Overall Study||41
10501055|NCT01241552|11651616|FG001|NOT COMPLETED|Overall Study||63
10501056|NCT01241552|11651617|FG002|NOT COMPLETED|Overall Study||60
10501057|NCT01241552|11651618|FG003|NOT COMPLETED|Overall Study||64
10501058|NCT01241565|11651628|FG000|STARTED|Overall Study||50
10501059|NCT01241565|11651628|FG000|COMPLETED|Overall Study||50
10501060|NCT01241565|11651628|FG000|NOT COMPLETED|Overall Study||0
10501061|NCT01241591|11651637|FG000|STARTED|Overall Study||329
10501062|NCT01241591|11651638|FG001|STARTED|Overall Study||330
10501063|NCT01241591|11651639|FG002|STARTED|Overall Study||335
10501064|NCT01241591|11651640|FG003|STARTED|Overall Study||107
10501065|NCT01241591|11651637|FG000|COMPLETED|Overall Study||306
10501066|NCT01241591|11651638|FG001|COMPLETED|Overall Study||306
10501067|NCT01241591|11651639|FG002|COMPLETED|Overall Study||313
10501068|NCT01241591|11651640|FG003|COMPLETED|Overall Study||95
10501069|NCT01241591|11651637|FG000|NOT COMPLETED|Overall Study||23
10501070|NCT01241591|11651638|FG001|NOT COMPLETED|Overall Study||24
10501071|NCT01241591|11651639|FG002|NOT COMPLETED|Overall Study||22
10501072|NCT01241591|11651640|FG003|NOT COMPLETED|Overall Study||12
10501073|NCT01241604|11651650|FG000|STARTED|Screening Period||11
10501074|NCT01241604|11651651|FG001|STARTED|Screening Period||0
10501075|NCT01241604|11651652|FG002|STARTED|Screening Period||0
10501076|NCT01241604|11651650|FG000|COMPLETED|Screening Period||8
10501077|NCT01241604|11651651|FG001|COMPLETED|Screening Period||0
10501078|NCT01241604|11651652|FG002|COMPLETED|Screening Period||0
10501079|NCT01241604|11651650|FG000|NOT COMPLETED|Screening Period||3
10501080|NCT01241604|11651651|FG001|NOT COMPLETED|Screening Period||0
10501081|NCT01241604|11651652|FG002|NOT COMPLETED|Screening Period||0
10501082|NCT01241604|11651650|FG000|STARTED|Study Period||0
10501083|NCT01241604|11651651|FG001|STARTED|Study Period||5
10501084|NCT01241604|11651652|FG002|STARTED|Study Period||3
10501085|NCT01241604|11651650|FG000|COMPLETED|Study Period||0
10501086|NCT01241604|11651651|FG001|COMPLETED|Study Period||5
10501087|NCT01241604|11651652|FG002|COMPLETED|Study Period||3
10501088|NCT01241604|11651650|FG000|NOT COMPLETED|Study Period||0
10501089|NCT01241604|11651651|FG001|NOT COMPLETED|Study Period||0
10501090|NCT01241604|11651652|FG002|NOT COMPLETED|Study Period||0
10501091|NCT01241760|11651661|FG000|STARTED|Overall Study||371
10501092|NCT01241760|11651662|FG001|STARTED|Overall Study||369
10501093|NCT01241760|11651661|FG000|COMPLETED|Overall Study||337
10501094|NCT01241760|11651662|FG001|COMPLETED|Overall Study||329
10501095|NCT01241760|11651661|FG000|NOT COMPLETED|Overall Study||34
10501096|NCT01241760|11651662|FG001|NOT COMPLETED|Overall Study||40
10501097|NCT01241903|11651671|FG000|STARTED|Overall Study||27
10501098|NCT01241903|11651672|FG001|STARTED|Overall Study||27
10501099|NCT01241903|11651671|FG000|COMPLETED|Overall Study||26
10501100|NCT01241903|11651672|FG001|COMPLETED|Overall Study||27
10501101|NCT01241903|11651671|FG000|NOT COMPLETED|Overall Study||1
10501102|NCT01241903|11651672|FG001|NOT COMPLETED|Overall Study||0
10501103|NCT01241916|11651680|FG000|STARTED|Overall Study||35
10501104|NCT01241916|11651681|FG001|STARTED|Overall Study||31
10501105|NCT01241916|11651680|FG000|COMPLETED|Overall Study||28
10501106|NCT01241916|11651681|FG001|COMPLETED|Overall Study||21
10501107|NCT01241916|11651680|FG000|NOT COMPLETED|Overall Study||7
10501108|NCT01241916|11651681|FG001|NOT COMPLETED|Overall Study||10
10501109|NCT01242085|11651690|FG000|STARTED|Overall Study||30
10501110|NCT01242085|11651691|FG001|STARTED|Overall Study||33
10501111|NCT01242085|11651692|FG002|STARTED|Overall Study||1
10501112|NCT01242085|11651690|FG000|COMPLETED|Overall Study|8 patients did not undergo intervention since 4 had medical problems and 4 withdrew|22
10501113|NCT01242085|11651691|FG001|COMPLETED|Overall Study|7 patients did not receive allocated intervention since 5 had medical problems and 2 withdrew|26
10501114|NCT01242085|11651692|FG002|COMPLETED|Overall Study||1
10501115|NCT01242085|11651690|FG000|NOT COMPLETED|Overall Study||8
10501116|NCT01242085|11651691|FG001|NOT COMPLETED|Overall Study||7
10501117|NCT01242085|11651692|FG002|NOT COMPLETED|Overall Study||0
10501118|NCT01242111|11651698|FG000|STARTED|Overall Study||20
10501119|NCT01242111|11651698|FG000|COMPLETED|Overall Study||17
10501120|NCT01242111|11651698|FG000|NOT COMPLETED|Overall Study||3
10501121|NCT01242176|11651702|FG000|STARTED|First Intervention||12
10501122|NCT01242176|11651703|FG001|STARTED|First Intervention||12
10501123|NCT01242176|11651702|FG000|COMPLETED|First Intervention||12
10501124|NCT01242176|11651703|FG001|COMPLETED|First Intervention||12
10501125|NCT01242176|11651702|FG000|NOT COMPLETED|First Intervention||0
10501126|NCT01242176|11651703|FG001|NOT COMPLETED|First Intervention||0
10501127|NCT01242176|11651702|FG000|STARTED|Washout Period of 7 Days||12
10501128|NCT01242176|11651703|FG001|STARTED|Washout Period of 7 Days||12
10501129|NCT01242176|11651702|FG000|COMPLETED|Washout Period of 7 Days||11
10501130|NCT01242176|11651703|FG001|COMPLETED|Washout Period of 7 Days||10
10501131|NCT01242176|11651702|FG000|NOT COMPLETED|Washout Period of 7 Days||1
10501132|NCT01242176|11651703|FG001|NOT COMPLETED|Washout Period of 7 Days||2
10501133|NCT01242176|11651702|FG000|STARTED|Second Intervention||11
10501134|NCT01242176|11651703|FG001|STARTED|Second Intervention||10
10501135|NCT01242176|11651702|FG000|COMPLETED|Second Intervention||11
10501136|NCT01242176|11651703|FG001|COMPLETED|Second Intervention||10
10501137|NCT01242176|11651702|FG000|NOT COMPLETED|Second Intervention||0
10501138|NCT01242176|11651703|FG001|NOT COMPLETED|Second Intervention||0
10501139|NCT01242241|11651711|FG000|STARTED|Overall Study||40
10501140|NCT01242241|11651712|FG001|STARTED|Overall Study||40
10501141|NCT01242241|11651711|FG000|COMPLETED|Overall Study||40
10501142|NCT01242241|11651712|FG001|COMPLETED|Overall Study||40
10501143|NCT01242241|11651711|FG000|NOT COMPLETED|Overall Study||0
10501144|NCT01242241|11651712|FG001|NOT COMPLETED|Overall Study||0
10501145|NCT01242371|11651720|FG000|STARTED|Overall Study||33
10501146|NCT01242371|11651721|FG001|STARTED|Overall Study||32
10501147|NCT01242371|11651720|FG000|COMPLETED|Overall Study||31
10501148|NCT01242371|11651721|FG001|COMPLETED|Overall Study||27
10501149|NCT01242371|11651720|FG000|NOT COMPLETED|Overall Study||2
10501150|NCT01242371|11651721|FG001|NOT COMPLETED|Overall Study||5
10501151|NCT01242514|11651730|FG000|STARTED|Overall Study|Patients who received treatment|1343
10501152|NCT01242514|11651731|FG001|STARTED|Overall Study|Patients who received treatment|357
10501153|NCT01242514|11651732|FG002|STARTED|Overall Study|Patients who received treatment|212
10501154|NCT01242514|11651730|FG000|Enrolled But Did Not Receive Treatment|Overall Study|Other|3
10501155|NCT01242514|11651731|FG001|Enrolled But Did Not Receive Treatment|Overall Study||0
10501156|NCT01242514|11651732|FG002|Enrolled But Did Not Receive Treatment|Overall Study|Adverse event/other|2
10501157|NCT01242514|11651730|FG000|COMPLETED|Overall Study|Due to project closure.|0
10501158|NCT01242514|11651731|FG001|COMPLETED|Overall Study|Due to project closure.|0
10501159|NCT01242514|11651732|FG002|COMPLETED|Overall Study|Due to project closure.|0
10501160|NCT01242514|11651730|FG000|NOT COMPLETED|Overall Study||1343
10501161|NCT01242514|11651731|FG001|NOT COMPLETED|Overall Study||357
10501162|NCT01242514|11651732|FG002|NOT COMPLETED|Overall Study||212
10501163|NCT01242527|11651744|FG000|STARTED|Overall Study||99
10501164|NCT01242527|11651745|FG001|STARTED|Overall Study||100
10501165|NCT01242527|11651746|FG002|STARTED|Overall Study||101
10501166|NCT01242527|11651747|FG003|STARTED|Overall Study||99
10501167|NCT01242527|11651744|FG000|COMPLETED|Overall Study||94
10501168|NCT01242527|11651745|FG001|COMPLETED|Overall Study||93
10501169|NCT01242527|11651746|FG002|COMPLETED|Overall Study||87
10501170|NCT01242527|11651747|FG003|COMPLETED|Overall Study||90
10501171|NCT01242527|11651744|FG000|NOT COMPLETED|Overall Study||5
10501172|NCT01242527|11651745|FG001|NOT COMPLETED|Overall Study||7
10501173|NCT01242527|11651746|FG002|NOT COMPLETED|Overall Study||14
10501174|NCT01242527|11651747|FG003|NOT COMPLETED|Overall Study||9
10501175|NCT01242644|11651760|FG000|STARTED|Overall Study||16
10501176|NCT01242644|11651761|FG001|STARTED|Overall Study||17
10501177|NCT01242644|11651762|FG002|STARTED|Overall Study||15
10501178|NCT01242644|11651760|FG000|COMPLETED|Overall Study||16
10501179|NCT01242644|11651761|FG001|COMPLETED|Overall Study||17
10501180|NCT01242644|11651762|FG002|COMPLETED|Overall Study||15
10501181|NCT01242644|11651760|FG000|NOT COMPLETED|Overall Study||0
10501182|NCT01242644|11651761|FG001|NOT COMPLETED|Overall Study||0
10501183|NCT01242644|11651762|FG002|NOT COMPLETED|Overall Study||0
10501184|NCT01242748|11651772|FG000|STARTED|Overall Study|Enrolled in CS35A, CS35A Full Analysis Set.|194
10501185|NCT01242748|11651773|FG001|STARTED|Overall Study||94
10501186|NCT01242748|11651772|FG000|CS35/CS35A Safety Analysis Set|Overall Study|Received at least 1 dose of trial drug during the main CS35 trial.|565
10501187|NCT01242748|11651773|FG001|CS35/CS35A Safety Analysis Set|Overall Study||283
10501188|NCT01242748|11651772|FG000|CS35/CS35A Full Analysis Set (FAS)|Overall Study|Received at least 1 dose of trial drug during CS35+had at least 1 efficacy assessment after dosing.|565
10501189|NCT01242748|11651773|FG001|CS35/CS35A Full Analysis Set (FAS)|Overall Study||282
10501190|NCT01242748|11651772|FG000|COMPLETED|Overall Study|These participants were ongoing when the trial was closed by the Sponsor.|156
10501191|NCT01242748|11651773|FG001|COMPLETED|Overall Study||80
10501192|NCT01242748|11651772|FG000|NOT COMPLETED|Overall Study||38
10501193|NCT01242748|11651773|FG001|NOT COMPLETED|Overall Study||14
10501194|NCT01242813|11651779|FG000|STARTED|Overall Study||20
10501195|NCT01242813|11651779|FG000|COMPLETED|Overall Study||18
10501196|NCT01242813|11651779|FG000|NOT COMPLETED|Overall Study||2
10501197|NCT01243112|11651783|FG000|STARTED|Overall Study||25
10501198|NCT01243112|11651783|FG000|COMPLETED|Overall Study||25
10501199|NCT01243112|11651783|FG000|NOT COMPLETED|Overall Study||0
10501200|NCT01243151|11651792|FG000|STARTED|Overall Study||12
10501201|NCT01243151|11651793|FG001|STARTED|Overall Study||14
10501202|NCT01243151|11651794|FG002|STARTED|Overall Study||14
10501203|NCT01243151|11651795|FG003|STARTED|Overall Study||14
10501204|NCT01243151|11651796|FG004|STARTED|Overall Study||14
10501205|NCT01243151|11651792|FG000|Treated|Overall Study||12
10501206|NCT01243151|11651793|FG001|Treated|Overall Study||14
10501207|NCT01243151|11651794|FG002|Treated|Overall Study||14
10501208|NCT01243151|11651795|FG003|Treated|Overall Study||13
10501209|NCT01243151|11651796|FG004|Treated|Overall Study||14
10501210|NCT01243151|11651792|FG000|COMPLETED|Overall Study||12
10501211|NCT01243151|11651793|FG001|COMPLETED|Overall Study||13
10501212|NCT01243151|11651794|FG002|COMPLETED|Overall Study||13
10501213|NCT01243151|11651795|FG003|COMPLETED|Overall Study||12
10501214|NCT01243151|11651796|FG004|COMPLETED|Overall Study||14
10501215|NCT01243151|11651792|FG000|NOT COMPLETED|Overall Study||0
10501216|NCT01243151|11651793|FG001|NOT COMPLETED|Overall Study||1
10501217|NCT01243151|11651794|FG002|NOT COMPLETED|Overall Study||1
10501218|NCT01243151|11651795|FG003|NOT COMPLETED|Overall Study||2
10501219|NCT01243151|11651796|FG004|NOT COMPLETED|Overall Study||0
10501220|NCT01243177|11651814|FG000|STARTED|Overall Study||444
10501221|NCT01243177|11651815|FG001|STARTED|Overall Study||442
10501222|NCT01243177|11651814|FG000|COMPLETED|Overall Study||266
10501223|NCT01243177|11651815|FG001|COMPLETED|Overall Study||264
10501224|NCT01243177|11651814|FG000|NOT COMPLETED|Overall Study||178
10338282|NCT00369343|11475196|FG001|COMPLETED|Open-label Phase||79
10338283|NCT00369343|11475195|FG000|NOT COMPLETED|Open-label Phase||57
10338284|NCT00369343|11475196|FG001|NOT COMPLETED|Open-label Phase||30
10339222|NCT00371566|11476130|FG001|NOT COMPLETED|Chemoradiation Phase||3
10501225|NCT01243177|11651815|FG001|NOT COMPLETED|Overall Study||178
10501226|NCT01243242|11651823|FG000|STARTED|Overall Study||60
10501227|NCT01243242|11651824|FG001|STARTED|Overall Study||60
10501228|NCT01243242|11651823|FG000|COMPLETED|Overall Study||57
10501229|NCT01243242|11651824|FG001|COMPLETED|Overall Study||56
10501230|NCT01243242|11651823|FG000|NOT COMPLETED|Overall Study||3
10501231|NCT01243242|11651824|FG001|NOT COMPLETED|Overall Study||4
10501232|NCT01243268|11651830|FG000|STARTED|Overall Study||674
10501233|NCT01243268|11651830|FG000|COMPLETED|Overall Study||610
10501234|NCT01243268|11651830|FG000|NOT COMPLETED|Overall Study||64
10501235|NCT01243294|11651834|FG000|STARTED|First Intervention (10 Days +/- 2 Days)||28
10501236|NCT01243294|11651835|FG001|STARTED|First Intervention (10 Days +/- 2 Days)||26
10501237|NCT01243294|11651834|FG000|COMPLETED|First Intervention (10 Days +/- 2 Days)||28
10501238|NCT01243294|11651835|FG001|COMPLETED|First Intervention (10 Days +/- 2 Days)||26
10501239|NCT01243294|11651834|FG000|NOT COMPLETED|First Intervention (10 Days +/- 2 Days)||0
10501240|NCT01243294|11651835|FG001|NOT COMPLETED|First Intervention (10 Days +/- 2 Days)||0
10501241|NCT01243294|11651834|FG000|STARTED|Second Intervention (10 Days +/- 2 Days)||28
10501242|NCT01243294|11651835|FG001|STARTED|Second Intervention (10 Days +/- 2 Days)||26
10501243|NCT01243294|11651834|FG000|COMPLETED|Second Intervention (10 Days +/- 2 Days)||28
10501244|NCT01243294|11651835|FG001|COMPLETED|Second Intervention (10 Days +/- 2 Days)||26
10501245|NCT01243294|11651834|FG000|NOT COMPLETED|Second Intervention (10 Days +/- 2 Days)||0
10501246|NCT01243294|11651835|FG001|NOT COMPLETED|Second Intervention (10 Days +/- 2 Days)||0
10501247|NCT01243320|11651841|FG000|STARTED|10ppm Oral Silver (3 Days)||36
10501248|NCT01243320|11651841|FG000|COMPLETED|10ppm Oral Silver (3 Days)||36
10501249|NCT01243320|11651841|FG000|NOT COMPLETED|10ppm Oral Silver (3 Days)||0
10501250|NCT01243320|11651841|FG000|STARTED|10ppm Oral Silver (7 Days)||36
10501251|NCT01243320|11651841|FG000|COMPLETED|10ppm Oral Silver (7 Days)||36
10501252|NCT01243320|11651841|FG000|NOT COMPLETED|10ppm Oral Silver (7 Days)||0
10501253|NCT01243320|11651841|FG000|STARTED|10ppm Oral Silver (14 Days)||36
10501254|NCT01243320|11651841|FG000|COMPLETED|10ppm Oral Silver (14 Days)||36
10710678|NCT02652624|11875984|FG001|NOT COMPLETED|Extension Phase||4
10710683|NCT02652780|11875998|FG000|STARTED|Overall Study||37
10501255|NCT01243320|11651841|FG000|NOT COMPLETED|10ppm Oral Silver (14 Days)||0
10501256|NCT01243320|11651841|FG000|STARTED|Washout (3 Days)||36
10501257|NCT01243320|11651841|FG000|COMPLETED|Washout (3 Days)||36
10501258|NCT01243320|11651841|FG000|NOT COMPLETED|Washout (3 Days)||0
10501259|NCT01243320|11651841|FG000|STARTED|32ppm Oral Silver (14 Days)||24
10501260|NCT01243320|11651841|FG000|COMPLETED|32ppm Oral Silver (14 Days)||24
10501261|NCT01243320|11651841|FG000|NOT COMPLETED|32ppm Oral Silver (14 Days)||0
10501262|NCT01243333|11651847|FG000|STARTED|Overall Study||26
10501263|NCT01243333|11651847|FG000|COMPLETED|Overall Study||18
10501264|NCT01243333|11651847|FG000|NOT COMPLETED|Overall Study||8
10501265|NCT01243411|11651851|FG000|STARTED|Overall Study||347
10501266|NCT01243411|11651851|FG000|COMPLETED|Overall Study||306
10501267|NCT01243411|11651851|FG000|NOT COMPLETED|Overall Study||41
10501268|NCT01243424|11651857|FG000|STARTED|Discontinuation From Study (Treated Set)||3028
10501269|NCT01243424|11651858|FG001|STARTED|Discontinuation From Study (Treated Set)||3014
10501270|NCT01243424|11651857|FG000|Patient Died (Other Cause Than CV Death)|Discontinuation From Study (Treated Set)||123
10501271|NCT01243424|11651858|FG001|Patient Died (Other Cause Than CV Death)|Discontinuation From Study (Treated Set)||146
10501272|NCT01243424|11651857|FG000|Treated|Discontinuation From Study (Treated Set)||3023
10501273|NCT01243424|11651858|FG001|Treated|Discontinuation From Study (Treated Set)||3010
10501274|NCT01243424|11651857|FG000|COMPLETED|Discontinuation From Study (Treated Set)||2899
10501275|NCT01243424|11651858|FG001|COMPLETED|Discontinuation From Study (Treated Set)||2895
10501276|NCT01243424|11651857|FG000|NOT COMPLETED|Discontinuation From Study (Treated Set)||129
10501277|NCT01243424|11651858|FG001|NOT COMPLETED|Discontinuation From Study (Treated Set)||119
10501278|NCT01243424|11651857|FG000|STARTED|Discontinuation From Treatment||3028
10501279|NCT01243424|11651858|FG001|STARTED|Discontinuation From Treatment||3014
10501280|NCT01243424|11651857|FG000|Treated|Discontinuation From Treatment||3023
10501281|NCT01243424|11651858|FG001|Treated|Discontinuation From Treatment||3010
10501282|NCT01243424|11651857|FG000|COMPLETED|Discontinuation From Treatment||1896
10501283|NCT01243424|11651858|FG001|COMPLETED|Discontinuation From Treatment||1832
10501284|NCT01243424|11651857|FG000|NOT COMPLETED|Discontinuation From Treatment||1132
10501285|NCT01243424|11651858|FG001|NOT COMPLETED|Discontinuation From Treatment||1182
10501286|NCT01243450|11651868|FG000|STARTED|Overall Study||401
10501287|NCT01243450|11651869|FG001|STARTED|Overall Study||135
10501288|NCT01243450|11651870|FG002|STARTED|Overall Study||404
10501289|NCT01243450|11651868|FG000|COMPLETED|Overall Study||318
10501290|NCT01243450|11651869|FG001|COMPLETED|Overall Study||110
10501291|NCT01243450|11651870|FG002|COMPLETED|Overall Study||337
10710684|NCT02652780|11875998|FG000|COMPLETED|Overall Study||37
10710685|NCT02652780|11875998|FG000|NOT COMPLETED|Overall Study||0
10339223|NCT00371566|11476129|FG000|STARTED|Follow Up Phase||31
10501292|NCT01243450|11651868|FG000|NOT COMPLETED|Overall Study||83
10710686|NCT02653144|11876008|FG000|STARTED|Overall Study||30
10501293|NCT01243450|11651869|FG001|NOT COMPLETED|Overall Study||25
10501294|NCT01243450|11651870|FG002|NOT COMPLETED|Overall Study||67
10501295|NCT01243567|11651880|FG000|STARTED|Overall Study||43
10501296|NCT01243567|11651881|FG001|STARTED|Overall Study||38
10501297|NCT01243567|11651880|FG000|COMPLETED|Overall Study||42
10501298|NCT01243567|11651881|FG001|COMPLETED|Overall Study||38
10501299|NCT01243567|11651880|FG000|NOT COMPLETED|Overall Study||1
10501300|NCT01243567|11651881|FG001|NOT COMPLETED|Overall Study||0
10501301|NCT01243580|11651889|FG000|STARTED|Overall Study||18
10501302|NCT01243580|11651890|FG001|STARTED|Overall Study||18
10501303|NCT01243580|11651889|FG000|COMPLETED|Overall Study||18
10501304|NCT01243580|11651890|FG001|COMPLETED|Overall Study||16
10501305|NCT01243580|11651889|FG000|NOT COMPLETED|Overall Study||0
10501306|NCT01243580|11651890|FG001|NOT COMPLETED|Overall Study||2
10501307|NCT01243593|11651900|FG000|STARTED|Overall Study||16
10501308|NCT01243593|11651901|FG001|STARTED|Overall Study||16
10501309|NCT01243593|11651900|FG000|COMPLETED|Overall Study||16
10501310|NCT01243593|11651901|FG001|COMPLETED|Overall Study||16
10501311|NCT01243593|11651900|FG000|NOT COMPLETED|Overall Study||0
10501312|NCT01243593|11651901|FG001|NOT COMPLETED|Overall Study||0
10501313|NCT01243619|11651907|FG000|STARTED|Overall Study||5
10501314|NCT01243619|11651907|FG000|COMPLETED|Overall Study|Patient enrollment is complete, data analysis is ongoing|5
10501315|NCT01243619|11651907|FG000|NOT COMPLETED|Overall Study||0
10501316|NCT01243671|11651911|FG000|STARTED|Overall Study||20
10501317|NCT01243671|11651911|FG000|Completed 24 Weeks of Treatment|Overall Study||18
10501318|NCT01243671|11651911|FG000|Completed 52 Weeks of Treatment|Overall Study||17
10501319|NCT01243671|11651911|FG000|COMPLETED|Overall Study|Completed 136 weeks of treatment.|15
10501320|NCT01243671|11651911|FG000|NOT COMPLETED|Overall Study||5
10501321|NCT01243762|11651922|FG000|STARTED|Part 1 (Dose Escalation/MTD)||4
10501322|NCT01243762|11651923|FG001|STARTED|Part 1 (Dose Escalation/MTD)||13
10501323|NCT01243762|11651924|FG002|STARTED|Part 1 (Dose Escalation/MTD)||3
10501324|NCT01243762|11651925|FG003|STARTED|Part 1 (Dose Escalation/MTD)||8
10501325|NCT01243762|11651926|FG004|STARTED|Part 1 (Dose Escalation/MTD)||10
10501326|NCT01243762|11651927|FG005|STARTED|Part 1 (Dose Escalation/MTD)||3
10501327|NCT01243762|11651928|FG006|STARTED|Part 1 (Dose Escalation/MTD)||0
10501328|NCT01243762|11651922|FG000|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|1
10501329|NCT01243762|11651923|FG001|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|5
10501330|NCT01243762|11651924|FG002|COMPLETED|Part 1 (Dose Escalation/MTD)||0
10501331|NCT01243762|11651925|FG003|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|2
10501332|NCT01243762|11651926|FG004|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|4
10501333|NCT01243762|11651927|FG005|COMPLETED|Part 1 (Dose Escalation/MTD)||0
10501334|NCT01243762|11651928|FG006|COMPLETED|Part 1 (Dose Escalation/MTD)||0
10501335|NCT01243762|11651922|FG000|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
10501336|NCT01243762|11651923|FG001|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||8
10501337|NCT01243762|11651924|FG002|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
10501338|NCT01243762|11651925|FG003|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||6
10501339|NCT01243762|11651926|FG004|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||6
10501340|NCT01243762|11651927|FG005|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
10501341|NCT01243762|11651928|FG006|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||0
10501342|NCT01243762|11651922|FG000|STARTED|Part 2 (Dose Confirmation/Efficacy)||1
10501343|NCT01243762|11651923|FG001|STARTED|Part 2 (Dose Confirmation/Efficacy)||5
10501344|NCT01243762|11651924|FG002|STARTED|Part 2 (Dose Confirmation/Efficacy)||0
10501345|NCT01243762|11651925|FG003|STARTED|Part 2 (Dose Confirmation/Efficacy)||2
10501346|NCT01243762|11651926|FG004|STARTED|Part 2 (Dose Confirmation/Efficacy)||4
10501347|NCT01243762|11651927|FG005|STARTED|Part 2 (Dose Confirmation/Efficacy)||0
10501348|NCT01243762|11651928|FG006|STARTED|Part 2 (Dose Confirmation/Efficacy)|New participants were enrolled in Part 2 of the study that did not participate in Part 1|6
10501349|NCT01243762|11651922|FG000|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
10501350|NCT01243762|11651923|FG001|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
10501351|NCT01243762|11651924|FG002|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
10501352|NCT01243762|11651925|FG003|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
10501353|NCT01243762|11651926|FG004|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
10501354|NCT01243762|11651927|FG005|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
10501355|NCT01243762|11651928|FG006|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
10501356|NCT01243762|11651922|FG000|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||1
10501357|NCT01243762|11651923|FG001|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||5
10501358|NCT01243762|11651924|FG002|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
10501359|NCT01243762|11651925|FG003|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||2
10501360|NCT01243762|11651926|FG004|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||4
10501361|NCT01243762|11651927|FG005|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
10501362|NCT01243762|11651928|FG006|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||6
10501363|NCT01243775|11651947|FG000|STARTED|Overall Study||33
10501364|NCT01243775|11651947|FG000|COMPLETED|Overall Study||31
10501365|NCT01243775|11651947|FG000|NOT COMPLETED|Overall Study||2
10501366|NCT01243944|11651953|FG000|STARTED|Overall Study||110
10501367|NCT01243944|11651954|FG001|STARTED|Overall Study|One participant withdrew consent 5 days after randomization to BAT & wasn't treated while on study.|112
10501368|NCT01243944|11651953|FG000|Treated|Overall Study||110
10501369|NCT01243944|11651954|FG001|Treated|Overall Study||111
10501370|NCT01243944|11651953|FG000|Followed for Survival|Overall Study||22
10501371|NCT01243944|11651954|FG001|Followed for Survival|Overall Study||21
10501372|NCT01243944|11651953|FG000|COMPLETED|Overall Study||65
10501373|NCT01243944|11651954|FG001|COMPLETED|Overall Study|Study evaluation completion is reported for participants that were treated & those never treatment.|61
10501374|NCT01243944|11651953|FG000|NOT COMPLETED|Overall Study||45
10501375|NCT01243944|11651954|FG001|NOT COMPLETED|Overall Study||51
10501376|NCT01243957|11651961|FG000|STARTED|Overall Study||20
10501377|NCT01243957|11651961|FG000|COMPLETED|Overall Study||20
10501378|NCT01243957|11651961|FG000|NOT COMPLETED|Overall Study||0
10501379|NCT01244035|11651967|FG000|STARTED|Part 1: Period 1||5
10501380|NCT01244035|11651968|FG001|STARTED|Part 1: Period 1||5
10501381|NCT01244035|11651969|FG002|STARTED|Part 1: Period 1||6
10501382|NCT01244035|11651970|FG003|STARTED|Part 1: Period 1||5
10501383|NCT01244035|11651971|FG004|STARTED|Part 1: Period 1||5
10501384|NCT01244035|11651972|FG005|STARTED|Part 1: Period 1||5
10501385|NCT01244035|11651967|FG000|COMPLETED|Part 1: Period 1||4
10501386|NCT01244035|11651968|FG001|COMPLETED|Part 1: Period 1||3
10501387|NCT01244035|11651969|FG002|COMPLETED|Part 1: Period 1||4
10501388|NCT01244035|11651970|FG003|COMPLETED|Part 1: Period 1||5
10501389|NCT01244035|11651971|FG004|COMPLETED|Part 1: Period 1||4
10501390|NCT01244035|11651972|FG005|COMPLETED|Part 1: Period 1||3
10501391|NCT01244035|11651967|FG000|NOT COMPLETED|Part 1: Period 1||1
10501392|NCT01244035|11651968|FG001|NOT COMPLETED|Part 1: Period 1||2
10501393|NCT01244035|11651969|FG002|NOT COMPLETED|Part 1: Period 1||2
10501394|NCT01244035|11651970|FG003|NOT COMPLETED|Part 1: Period 1||0
10501395|NCT01244035|11651971|FG004|NOT COMPLETED|Part 1: Period 1||1
10501396|NCT01244035|11651972|FG005|NOT COMPLETED|Part 1: Period 1||2
10501397|NCT01244035|11651967|FG000|STARTED|Part 1: Period 2||4
10501398|NCT01244035|11651968|FG001|STARTED|Part 1: Period 2||3
10501399|NCT01244035|11651969|FG002|STARTED|Part 1: Period 2||4
10501400|NCT01244035|11651970|FG003|STARTED|Part 1: Period 2||5
10501401|NCT01244035|11651971|FG004|STARTED|Part 1: Period 2||4
10501402|NCT01244035|11651972|FG005|STARTED|Part 1: Period 2||3
10501403|NCT01244035|11651967|FG000|COMPLETED|Part 1: Period 2||4
10501404|NCT01244035|11651968|FG001|COMPLETED|Part 1: Period 2||3
10501405|NCT01244035|11651969|FG002|COMPLETED|Part 1: Period 2||3
10501406|NCT01244035|11651970|FG003|COMPLETED|Part 1: Period 2||5
10501407|NCT01244035|11651971|FG004|COMPLETED|Part 1: Period 2||4
10501408|NCT01244035|11651972|FG005|COMPLETED|Part 1: Period 2||3
10501409|NCT01244035|11651967|FG000|NOT COMPLETED|Part 1: Period 2||0
10501410|NCT01244035|11651968|FG001|NOT COMPLETED|Part 1: Period 2||0
10501411|NCT01244035|11651969|FG002|NOT COMPLETED|Part 1: Period 2||1
10501412|NCT01244035|11651970|FG003|NOT COMPLETED|Part 1: Period 2||0
10501413|NCT01244035|11651971|FG004|NOT COMPLETED|Part 1: Period 2||0
10501414|NCT01244035|11651972|FG005|NOT COMPLETED|Part 1: Period 2||0
10501415|NCT01244035|11651967|FG000|STARTED|Part 1: Period 3||4
10501416|NCT01244035|11651968|FG001|STARTED|Part 1: Period 3||3
10501417|NCT01244035|11651969|FG002|STARTED|Part 1: Period 3||3
10501418|NCT01244035|11651970|FG003|STARTED|Part 1: Period 3||5
10501419|NCT01244035|11651971|FG004|STARTED|Part 1: Period 3||4
10501420|NCT01244035|11651972|FG005|STARTED|Part 1: Period 3||3
10501421|NCT01244035|11651967|FG000|COMPLETED|Part 1: Period 3||4
10501422|NCT01244035|11651968|FG001|COMPLETED|Part 1: Period 3||2
10501423|NCT01244035|11651969|FG002|COMPLETED|Part 1: Period 3||3
10501424|NCT01244035|11651970|FG003|COMPLETED|Part 1: Period 3||5
10501425|NCT01244035|11651971|FG004|COMPLETED|Part 1: Period 3||3
10501426|NCT01244035|11651972|FG005|COMPLETED|Part 1: Period 3||2
10501427|NCT01244035|11651967|FG000|NOT COMPLETED|Part 1: Period 3||0
10501428|NCT01244035|11651968|FG001|NOT COMPLETED|Part 1: Period 3||1
10501429|NCT01244035|11651969|FG002|NOT COMPLETED|Part 1: Period 3||0
10501430|NCT01244035|11651970|FG003|NOT COMPLETED|Part 1: Period 3||0
10501431|NCT01244035|11651971|FG004|NOT COMPLETED|Part 1: Period 3||1
10501432|NCT01244035|11651972|FG005|NOT COMPLETED|Part 1: Period 3||1
10501433|NCT01244061|11651994|FG000|STARTED|Overall Study||251
10501434|NCT01244061|11651995|FG001|STARTED|Overall Study||247
10501435|NCT01244061|11651994|FG000|COMPLETED|Overall Study||169
10501436|NCT01244061|11651995|FG001|COMPLETED|Overall Study||144
10501437|NCT01244061|11651994|FG000|NOT COMPLETED|Overall Study||82
10501438|NCT01244061|11651995|FG001|NOT COMPLETED|Overall Study||103
10501439|NCT01244126|11652004|FG000|STARTED|Overall Study||59
10501440|NCT01244126|11652005|FG001|STARTED|Overall Study||55
10501441|NCT01244126|11652006|FG002|STARTED|Overall Study||57
10501442|NCT01244126|11652004|FG000|COMPLETED|Overall Study||56
10501443|NCT01244126|11652005|FG001|COMPLETED|Overall Study||52
10501444|NCT01244126|11652006|FG002|COMPLETED|Overall Study||48
10501445|NCT01244126|11652004|FG000|NOT COMPLETED|Overall Study||3
10501446|NCT01244126|11652005|FG001|NOT COMPLETED|Overall Study||3
10501447|NCT01244126|11652006|FG002|NOT COMPLETED|Overall Study||9
10501448|NCT01244191|11652016|FG000|STARTED|Overall Study||526
10501449|NCT01244191|11652017|FG001|STARTED|Overall Study||522
10501450|NCT01244191|11652016|FG000|Did Not Receive Treatment|Overall Study||6
10501451|NCT01244191|11652017|FG001|Did Not Receive Treatment|Overall Study||5
10501452|NCT01244191|11652016|FG000|COMPLETED|Overall Study||46
10501453|NCT01244191|11652017|FG001|COMPLETED|Overall Study||24
10501454|NCT01244191|11652016|FG000|NOT COMPLETED|Overall Study||480
10501455|NCT01244191|11652017|FG001|NOT COMPLETED|Overall Study||498
10501456|NCT01244243|11652023|FG000|STARTED|Overall Study||41
10501457|NCT01244243|11652023|FG000|COMPLETED|Overall Study||41
10501458|NCT01244243|11652023|FG000|NOT COMPLETED|Overall Study||0
10501459|NCT01244412|11652027|FG000|STARTED|Overall Study||1
10501460|NCT01244412|11652027|FG000|COMPLETED|Overall Study||1
10501461|NCT01244412|11652027|FG000|NOT COMPLETED|Overall Study||0
10501462|NCT01244425|11652033|FG000|STARTED|Overall Study||35
10501463|NCT01244425|11652034|FG001|STARTED|Overall Study||35
10501464|NCT01244425|11652033|FG000|COMPLETED|Overall Study|Adverse Event: multi-organ failure (death)|32
10501465|NCT01244425|11652034|FG001|COMPLETED|Overall Study|Adverse Event: septic shock with multi-organ failure due to liver abscess (death)|32
10501466|NCT01244425|11652033|FG000|NOT COMPLETED|Overall Study||3
10501467|NCT01244425|11652034|FG001|NOT COMPLETED|Overall Study||3
10501468|NCT01244451|11652048|FG000|STARTED|Overall Study||49
10501469|NCT01244451|11652048|FG000|COMPLETED|Overall Study||36
10501470|NCT01244451|11652048|FG000|NOT COMPLETED|Overall Study||13
10501471|NCT01244477|11652055|FG000|STARTED|Overall Study||38
10501472|NCT01244477|11652056|FG001|STARTED|Overall Study||23
10501473|NCT01244477|11652055|FG000|COMPLETED|Overall Study||18
10501474|NCT01244477|11652056|FG001|COMPLETED|Overall Study||20
10501475|NCT01244477|11652055|FG000|NOT COMPLETED|Overall Study||20
10501476|NCT01244477|11652056|FG001|NOT COMPLETED|Overall Study||3
10501477|NCT01244490|11652067|FG000|STARTED|Overall Study||111
10501478|NCT01244490|11652068|FG001|STARTED|Overall Study||115
10501479|NCT01244490|11652069|FG002|STARTED|Overall Study||112
10501480|NCT01244490|11652067|FG000|COMPLETED|Overall Study||92
10501481|NCT01244490|11652068|FG001|COMPLETED|Overall Study||91
10501482|NCT01244490|11652069|FG002|COMPLETED|Overall Study||89
10501483|NCT01244490|11652067|FG000|NOT COMPLETED|Overall Study||19
10501484|NCT01244490|11652068|FG001|NOT COMPLETED|Overall Study||24
10501485|NCT01244490|11652069|FG002|NOT COMPLETED|Overall Study||23
10501486|NCT01244503|11652077|FG000|STARTED|Overall Study||61
10501487|NCT01244503|11652077|FG000|COMPLETED|Overall Study||61
10501488|NCT01244503|11652077|FG000|NOT COMPLETED|Overall Study||0
10501489|NCT01244516|11652084|FG000|STARTED|Period 1 (Baseline to 1-week Visit)||170
10501490|NCT01244516|11652085|FG001|STARTED|Period 1 (Baseline to 1-week Visit)||177
10501491|NCT01244516|11652086|FG002|STARTED|Period 1 (Baseline to 1-week Visit)||173
10501492|NCT01244516|11652084|FG000|COMPLETED|Period 1 (Baseline to 1-week Visit)||166
10501493|NCT01244516|11652085|FG001|COMPLETED|Period 1 (Baseline to 1-week Visit)||171
10501494|NCT01244516|11652086|FG002|COMPLETED|Period 1 (Baseline to 1-week Visit)||170
10501495|NCT01244516|11652084|FG000|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||4
10501496|NCT01244516|11652085|FG001|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||6
10501497|NCT01244516|11652086|FG002|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||3
10501498|NCT01244516|11652084|FG000|STARTED|Period 2 (1-week to 2-week Visit)||166
10501499|NCT01244516|11652085|FG001|STARTED|Period 2 (1-week to 2-week Visit)||171
10501500|NCT01244516|11652086|FG002|STARTED|Period 2 (1-week to 2-week Visit)||170
10501501|NCT01244516|11652084|FG000|COMPLETED|Period 2 (1-week to 2-week Visit)||163
10501502|NCT01244516|11652085|FG001|COMPLETED|Period 2 (1-week to 2-week Visit)||170
10501503|NCT01244516|11652086|FG002|COMPLETED|Period 2 (1-week to 2-week Visit)||168
10501504|NCT01244516|11652084|FG000|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||3
10501505|NCT01244516|11652085|FG001|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||1
10501506|NCT01244516|11652086|FG002|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||2
10501507|NCT01244529|11652095|FG000|STARTED|Overall Study||41
10501508|NCT01244529|11652095|FG000|COMPLETED|Overall Study||41
10501509|NCT01244529|11652095|FG000|NOT COMPLETED|Overall Study||0
10501510|NCT01244633|11652111|FG000|STARTED|Overall Study||18
10501511|NCT01244633|11652111|FG000|COMPLETED|Overall Study||15
10501512|NCT01244633|11652111|FG000|NOT COMPLETED|Overall Study||3
10501513|NCT01244711|11652115|FG000|STARTED|Overall Study||1
10501514|NCT01244711|11652115|FG000|COMPLETED|Overall Study||1
10501515|NCT01244711|11652115|FG000|NOT COMPLETED|Overall Study||0
10501516|NCT01244724|11652119|FG000|STARTED|Overall Study|Of these 15 returned for a week 2 visit and are included in the efficacy analysis.|17
10501517|NCT01244724|11652119|FG000|Week 2 Visit|Overall Study||15
10501518|NCT01244724|11652119|FG000|COMPLETED|Overall Study||9
10501519|NCT01244724|11652119|FG000|NOT COMPLETED|Overall Study||8
10501520|NCT01244893|11652123|FG000|STARTED|Baseline||22
10501521|NCT01244893|11652124|FG001|STARTED|Baseline||22
10501522|NCT01244893|11652123|FG000|COMPLETED|Baseline||22
10501523|NCT01244893|11652124|FG001|COMPLETED|Baseline||21
10501524|NCT01244893|11652123|FG000|NOT COMPLETED|Baseline||0
10501525|NCT01244893|11652124|FG001|NOT COMPLETED|Baseline||1
10501526|NCT01244893|11652123|FG000|STARTED|1-Week Follow Up||22
10501527|NCT01244893|11652124|FG001|STARTED|1-Week Follow Up||21
10501528|NCT01244893|11652123|FG000|COMPLETED|1-Week Follow Up||21
10501529|NCT01244893|11652124|FG001|COMPLETED|1-Week Follow Up||21
10501530|NCT01244893|11652123|FG000|NOT COMPLETED|1-Week Follow Up||1
10501531|NCT01244893|11652124|FG001|NOT COMPLETED|1-Week Follow Up||0
10501532|NCT01244893|11652123|FG000|STARTED|Final Visit||21
10501533|NCT01244893|11652124|FG001|STARTED|Final Visit||21
10501534|NCT01244893|11652123|FG000|COMPLETED|Final Visit||21
10501535|NCT01244893|11652124|FG001|COMPLETED|Final Visit||21
10501536|NCT01244893|11652123|FG000|NOT COMPLETED|Final Visit||0
10501537|NCT01244893|11652124|FG001|NOT COMPLETED|Final Visit||0
10501538|NCT01244906|11652135|FG000|STARTED|Overall Study||26
10501539|NCT01244906|11652135|FG000|COMPLETED|Overall Study||18
10501540|NCT01244906|11652135|FG000|NOT COMPLETED|Overall Study||8
10501541|NCT01244984|11652142|FG000|STARTED|Overall Study||60
10501542|NCT01244984|11652143|FG001|STARTED|Overall Study||93
10501543|NCT01244984|11652144|FG002|STARTED|Overall Study||90
10501544|NCT01244984|11652142|FG000|COMPLETED|Overall Study||55
10501545|NCT01244984|11652143|FG001|COMPLETED|Overall Study||79
10501546|NCT01244984|11652144|FG002|COMPLETED|Overall Study||86
10501547|NCT01244984|11652142|FG000|NOT COMPLETED|Overall Study||5
10501548|NCT01244984|11652143|FG001|NOT COMPLETED|Overall Study||14
10501549|NCT01244984|11652144|FG002|NOT COMPLETED|Overall Study||4
10501550|NCT01245049|11652155|FG000|STARTED|Overall Study||255
10501551|NCT01245049|11652156|FG001|STARTED|Overall Study||130
10501552|NCT01245049|11652155|FG000|COMPLETED|Overall Study||254
10501553|NCT01245049|11652156|FG001|COMPLETED|Overall Study||126
10501554|NCT01245049|11652155|FG000|NOT COMPLETED|Overall Study||1
10501555|NCT01245049|11652156|FG001|NOT COMPLETED|Overall Study||4
10501556|NCT01245062|11652164|FG000|STARTED|Randomization and Crossover Phase||214
10501557|NCT01245062|11652165|FG001|STARTED|Randomization and Crossover Phase||108
10501558|NCT01245062|11652166|FG002|STARTED|Randomization and Crossover Phase||0
10501559|NCT01245062|11652164|FG000|COMPLETED|Randomization and Crossover Phase||173
10501560|NCT01245062|11652165|FG001|COMPLETED|Randomization and Crossover Phase||77
10501561|NCT01245062|11652166|FG002|COMPLETED|Randomization and Crossover Phase||0
10501562|NCT01245062|11652164|FG000|NOT COMPLETED|Randomization and Crossover Phase||41
10501563|NCT01245062|11652165|FG001|NOT COMPLETED|Randomization and Crossover Phase||31
10501564|NCT01245062|11652166|FG002|NOT COMPLETED|Randomization and Crossover Phase||0
10501565|NCT01245062|11652164|FG000|STARTED|Cross-over Phase||0
10501566|NCT01245062|11652165|FG001|STARTED|Cross-over Phase||0
10501567|NCT01245062|11652166|FG002|STARTED|Cross-over Phase|As of the data cut on December 16, 2016, 70 of 108 participants crossed over from CT to trametinib.|70
10501568|NCT01245062|11652164|FG000|COMPLETED|Cross-over Phase||0
10501569|NCT01245062|11652165|FG001|COMPLETED|Cross-over Phase||0
10501570|NCT01245062|11652166|FG002|COMPLETED|Cross-over Phase||53
10501571|NCT01245062|11652164|FG000|NOT COMPLETED|Cross-over Phase||0
10501572|NCT01245062|11652165|FG001|NOT COMPLETED|Cross-over Phase||0
10501573|NCT01245062|11652166|FG002|NOT COMPLETED|Cross-over Phase||17
10501574|NCT01245101|11652176|FG000|STARTED|Period 1 (Treatment)||15
10501575|NCT01245101|11652177|FG001|STARTED|Period 1 (Treatment)||0
10501576|NCT01245101|11652176|FG000|COMPLETED|Period 1 (Treatment)||13
10501577|NCT01245101|11652177|FG001|COMPLETED|Period 1 (Treatment)||0
10501578|NCT01245101|11652176|FG000|NOT COMPLETED|Period 1 (Treatment)||2
10501579|NCT01245101|11652177|FG001|NOT COMPLETED|Period 1 (Treatment)||0
10501580|NCT01245101|11652176|FG000|STARTED|Period 2 (Washout)||13
10501581|NCT01245101|11652177|FG001|STARTED|Period 2 (Washout)||0
10501582|NCT01245101|11652176|FG000|COMPLETED|Period 2 (Washout)||12
10501583|NCT01245101|11652177|FG001|COMPLETED|Period 2 (Washout)||0
10501584|NCT01245101|11652176|FG000|NOT COMPLETED|Period 2 (Washout)||1
10501585|NCT01245101|11652177|FG001|NOT COMPLETED|Period 2 (Washout)||0
10501586|NCT01245101|11652176|FG000|STARTED|Period 3 (Treatment)||12
10501587|NCT01245101|11652177|FG001|STARTED|Period 3 (Treatment)||0
10501588|NCT01245101|11652176|FG000|COMPLETED|Period 3 (Treatment)||11
10501589|NCT01245101|11652177|FG001|COMPLETED|Period 3 (Treatment)||0
10501590|NCT01245101|11652176|FG000|NOT COMPLETED|Period 3 (Treatment)||1
10501591|NCT01245101|11652177|FG001|NOT COMPLETED|Period 3 (Treatment)||0
10501592|NCT01245140|11652185|FG000|STARTED|Overall Study||9
10501593|NCT01245140|11652186|FG001|STARTED|Overall Study||24
10501594|NCT01245140|11652185|FG000|COMPLETED|Overall Study||6
10501595|NCT01245140|11652186|FG001|COMPLETED|Overall Study||14
10501596|NCT01245140|11652185|FG000|NOT COMPLETED|Overall Study||3
10501597|NCT01245140|11652186|FG001|NOT COMPLETED|Overall Study||10
10501598|NCT01245270|11652194|FG000|STARTED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
10501599|NCT01245270|11652195|FG001|STARTED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
10501600|NCT01245270|11652194|FG000|COMPLETED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
10501601|NCT01245270|11652195|FG001|COMPLETED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
10501602|NCT01245270|11652194|FG000|NOT COMPLETED|Overall Study||0
10501603|NCT01245270|11652195|FG001|NOT COMPLETED|Overall Study||0
10501604|NCT01245283|11652206|FG000|STARTED|Overall Study||32
10501605|NCT01245283|11652207|FG001|STARTED|Overall Study||28
10501606|NCT01245283|11652208|FG002|STARTED|Overall Study||30
10501607|NCT01245283|11652206|FG000|COMPLETED|Overall Study||18
10501608|NCT01245283|11652207|FG001|COMPLETED|Overall Study||17
10501609|NCT01245283|11652208|FG002|COMPLETED|Overall Study||19
10501610|NCT01245283|11652206|FG000|NOT COMPLETED|Overall Study||14
10501611|NCT01245283|11652207|FG001|NOT COMPLETED|Overall Study||11
10501612|NCT01245283|11652208|FG002|NOT COMPLETED|Overall Study||11
10501613|NCT01245374|11652219|FG000|STARTED|Overall Study||103
10501614|NCT01245374|11652219|FG000|COMPLETED|Overall Study||99
10501615|NCT01245374|11652219|FG000|NOT COMPLETED|Overall Study||4
10501616|NCT01245387|11652224|FG000|STARTED|Overall Study||1001
10501617|NCT01245387|11652224|FG000|COMPLETED|Overall Study||188
10501618|NCT01245387|11652224|FG000|NOT COMPLETED|Overall Study||813
10501619|NCT01245413|11652228|FG000|STARTED|Sensura First,||16
10501620|NCT01245413|11652229|FG001|STARTED|Sensura First,||16
10501621|NCT01245413|11652228|FG000|COMPLETED|Sensura First,||16
10501622|NCT01245413|11652229|FG001|COMPLETED|Sensura First,||16
10501623|NCT01245413|11652228|FG000|NOT COMPLETED|Sensura First,||0
10501624|NCT01245413|11652229|FG001|NOT COMPLETED|Sensura First,||0
10501625|NCT01245413|11652228|FG000|STARTED|Athena First,||16
10501626|NCT01245413|11652229|FG001|STARTED|Athena First,||16
10501627|NCT01245413|11652228|FG000|COMPLETED|Athena First,||16
10501628|NCT01245413|11652229|FG001|COMPLETED|Athena First,||16
10501629|NCT01245413|11652228|FG000|NOT COMPLETED|Athena First,||0
10501630|NCT01245413|11652229|FG001|NOT COMPLETED|Athena First,||0
10501631|NCT01245439|11652235|FG000|STARTED|Overall Study||65
10501632|NCT01245439|11652235|FG000|COMPLETED|Overall Study||65
10338285|NCT00369382|11475211|FG000|STARTED|Overall Study||59
10338286|NCT00369382|11475212|FG001|STARTED|Overall Study||57
10338287|NCT00369382|11475211|FG000|Received Treatment|Overall Study||57
10338288|NCT00369382|11475212|FG001|Received Treatment|Overall Study||57
10338289|NCT00369382|11475211|FG000|Completed Assigned Treatment Regimen|Overall Study||48
10338290|NCT00369382|11475212|FG001|Completed Assigned Treatment Regimen|Overall Study||33
10338291|NCT00369382|11475211|FG000|COMPLETED|Overall Study||49
10338292|NCT00369382|11475212|FG001|COMPLETED|Overall Study||54
10338293|NCT00369382|11475211|FG000|NOT COMPLETED|Overall Study||10
10501633|NCT01245439|11652235|FG000|NOT COMPLETED|Overall Study||0
10501634|NCT01245595|11652243|FG000|STARTED|Overall Study||72
10501635|NCT01245595|11652244|FG001|STARTED|Overall Study||72
10501636|NCT01245595|11652243|FG000|Completed Full Course of Study Drug|Overall Study||57
10501637|NCT01245595|11652244|FG001|Completed Full Course of Study Drug|Overall Study||61
10501638|NCT01245595|11652243|FG000|COMPLETED|Overall Study||72
10501639|NCT01245595|11652244|FG001|COMPLETED|Overall Study||72
10501640|NCT01245595|11652243|FG000|NOT COMPLETED|Overall Study||0
10501641|NCT01245595|11652244|FG001|NOT COMPLETED|Overall Study||0
10501642|NCT01245647|11652252|FG000|STARTED|Overall Study||7
10501643|NCT01245647|11652253|FG001|STARTED|Overall Study||12
10501644|NCT01245647|11652252|FG000|COMPLETED|Overall Study||7
10501645|NCT01245647|11652253|FG001|COMPLETED|Overall Study||8
10501646|NCT01245647|11652252|FG000|NOT COMPLETED|Overall Study||0
10501647|NCT01245647|11652253|FG001|NOT COMPLETED|Overall Study||4
10501648|NCT01245673|11652259|FG000|STARTED|Enrollment||28
10501649|NCT01245673|11652259|FG000|COMPLETED|Enrollment|One subject failed to meet screening criteria for the trial.|27
10501650|NCT01245673|11652259|FG000|NOT COMPLETED|Enrollment||1
10501651|NCT01245673|11652259|FG000|STARTED|Pre Transplant Vaccinations||27
10501652|NCT01245673|11652259|FG000|Pre Transplant Vaccinations 1-3|Pre Transplant Vaccinations||27
10501653|NCT01245673|11652259|FG000|COMPLETED|Pre Transplant Vaccinations||27
10501654|NCT01245673|11652259|FG000|NOT COMPLETED|Pre Transplant Vaccinations||0
10501655|NCT01245673|11652259|FG000|STARTED|Activated/Costimulated Autologous T Cell||27
10501656|NCT01245673|11652259|FG000|COMPLETED|Activated/Costimulated Autologous T Cell||27
10501657|NCT01245673|11652259|FG000|NOT COMPLETED|Activated/Costimulated Autologous T Cell||0
10501658|NCT01245673|11652259|FG000|STARTED|MAGE-A3, Hiltonol®, PVC After T Cells||27
10501659|NCT01245673|11652259|FG000|COMPLETED|MAGE-A3, Hiltonol®, PVC After T Cells||26
10501660|NCT01245673|11652259|FG000|NOT COMPLETED|MAGE-A3, Hiltonol®, PVC After T Cells||1
10501661|NCT01245673|11652259|FG000|STARTED|Start Lenalidomide||26
10501662|NCT01245673|11652259|FG000|COMPLETED|Start Lenalidomide||26
10501663|NCT01245673|11652259|FG000|NOT COMPLETED|Start Lenalidomide||0
10501664|NCT01245673|11652259|FG000|STARTED|Maintenance: MAGE-A3, PVC After T Cells||26
10501665|NCT01245673|11652259|FG000|COMPLETED|Maintenance: MAGE-A3, PVC After T Cells||26
10501666|NCT01245673|11652259|FG000|NOT COMPLETED|Maintenance: MAGE-A3, PVC After T Cells||0
10501667|NCT01245699|11652265|FG000|STARTED|Overall Study||61
10501668|NCT01245699|11652266|FG001|STARTED|Overall Study||54
10501669|NCT01245699|11652265|FG000|COMPLETED|Overall Study||52
10501670|NCT01245699|11652266|FG001|COMPLETED|Overall Study||49
10501671|NCT01245699|11652265|FG000|NOT COMPLETED|Overall Study||9
10501672|NCT01245699|11652266|FG001|NOT COMPLETED|Overall Study||5
10501673|NCT01245738|11652273|FG000|STARTED|Overall Study||514
10501674|NCT01245738|11652273|FG000|COMPLETED|Overall Study||474
10501675|NCT01245738|11652273|FG000|NOT COMPLETED|Overall Study||40
10501676|NCT01245751|11652281|FG000|STARTED|Part 1: Day 1 to Week 52 (1 Year)||201
10501677|NCT01245751|11652282|FG001|STARTED|Part 1: Day 1 to Week 52 (1 Year)||199
10501678|NCT01245751|11652283|FG002|STARTED|Part 1: Day 1 to Week 52 (1 Year)||100
10501679|NCT01245751|11652284|FG003|STARTED|Part 1: Day 1 to Week 52 (1 Year)||100
10501680|NCT01245751|11652281|FG000|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||201
10501681|NCT01245751|11652282|FG001|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||199
10501682|NCT01245751|11652283|FG002|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||100
10501683|NCT01245751|11652284|FG003|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||100
10501684|NCT01245751|11652281|FG000|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||199
10501685|NCT01245751|11652282|FG001|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||194
10501686|NCT01245751|11652283|FG002|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||100
10501687|NCT01245751|11652284|FG003|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||98
10501688|NCT01245751|11652281|FG000|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||2
10501689|NCT01245751|11652282|FG001|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||5
10501690|NCT01245751|11652283|FG002|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||0
10501691|NCT01245751|11652284|FG003|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||2
10501692|NCT01245751|11652281|FG000|STARTED|Part 2: Week 156 (3 Year) Visit|Enrollment in Part 2 was voluntary|161
10501693|NCT01245751|11652282|FG001|STARTED|Part 2: Week 156 (3 Year) Visit|Enrollment in Part 2 was voluntary|139
10501694|NCT01245751|11652283|FG002|STARTED|Part 2: Week 156 (3 Year) Visit|Part 2 was planned for Groups 1 and 2 only|0
10501695|NCT01245751|11652284|FG003|STARTED|Part 2: Week 156 (3 Year) Visit|Part 2 was planned for Groups 1 and 2 only|0
10501696|NCT01245751|11652281|FG000|COMPLETED|Part 2: Week 156 (3 Year) Visit||161
10501697|NCT01245751|11652282|FG001|COMPLETED|Part 2: Week 156 (3 Year) Visit||139
10501698|NCT01245751|11652283|FG002|COMPLETED|Part 2: Week 156 (3 Year) Visit||0
10501699|NCT01245751|11652284|FG003|COMPLETED|Part 2: Week 156 (3 Year) Visit||0
10501700|NCT01245751|11652281|FG000|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
10501701|NCT01245751|11652282|FG001|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
10501702|NCT01245751|11652283|FG002|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
10501703|NCT01245751|11652284|FG003|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
10501704|NCT01245764|11652299|FG000|STARTED|Study Phase A||80
10501705|NCT01245764|11652300|FG001|STARTED|Study Phase A||30
10501706|NCT01245764|11652301|FG002|STARTED|Study Phase A||120
10501707|NCT01245764|11652302|FG003|STARTED|Study Phase A||20
10501708|NCT01245764|11652299|FG000|Completed Vaccinations in Study Phase A|Study Phase A||77
10501709|NCT01245764|11652300|FG001|Completed Vaccinations in Study Phase A|Study Phase A||28
10501710|NCT01245764|11652301|FG002|Completed Vaccinations in Study Phase A|Study Phase A||117
10501711|NCT01245764|11652302|FG003|Completed Vaccinations in Study Phase A|Study Phase A||19
10501712|NCT01245764|11652299|FG000|COMPLETED|Study Phase A||71
10501713|NCT01245764|11652300|FG001|COMPLETED|Study Phase A||25
10501714|NCT01245764|11652301|FG002|COMPLETED|Study Phase A||110
10501715|NCT01245764|11652302|FG003|COMPLETED|Study Phase A||17
10501716|NCT01245764|11652299|FG000|NOT COMPLETED|Study Phase A||9
10501717|NCT01245764|11652300|FG001|NOT COMPLETED|Study Phase A||5
10501718|NCT01245764|11652301|FG002|NOT COMPLETED|Study Phase A||10
10501719|NCT01245764|11652302|FG003|NOT COMPLETED|Study Phase A||3
10501720|NCT01245764|11652299|FG000|STARTED|Study Phase B||0
10501721|NCT01245764|11652300|FG001|STARTED|Study Phase B||0
10501722|NCT01245764|11652301|FG002|STARTED|Study Phase B||0
10501723|NCT01245764|11652302|FG003|STARTED|Study Phase B||17
10501724|NCT01245764|11652299|FG000|Completed Vaccinations in Study Phase B|Study Phase B||0
10501725|NCT01245764|11652300|FG001|Completed Vaccinations in Study Phase B|Study Phase B||0
10501726|NCT01245764|11652301|FG002|Completed Vaccinations in Study Phase B|Study Phase B||0
10501727|NCT01245764|11652302|FG003|Completed Vaccinations in Study Phase B|Study Phase B||17
10501728|NCT01245764|11652299|FG000|COMPLETED|Study Phase B||0
10501729|NCT01245764|11652300|FG001|COMPLETED|Study Phase B||0
10501730|NCT01245764|11652301|FG002|COMPLETED|Study Phase B||0
10501731|NCT01245764|11652302|FG003|COMPLETED|Study Phase B||17
10501732|NCT01245764|11652299|FG000|NOT COMPLETED|Study Phase B||0
10501733|NCT01245764|11652300|FG001|NOT COMPLETED|Study Phase B||0
10501734|NCT01245764|11652301|FG002|NOT COMPLETED|Study Phase B||0
10501735|NCT01245764|11652302|FG003|NOT COMPLETED|Study Phase B||0
10501736|NCT01245972|11652323|FG000|STARTED|Overall Study||7
10501737|NCT01245972|11652324|FG001|STARTED|Overall Study||8
10501738|NCT01245972|11652325|FG002|STARTED|Overall Study||8
10501739|NCT01245972|11652323|FG000|COMPLETED|Overall Study||7
10501740|NCT01245972|11652324|FG001|COMPLETED|Overall Study||8
10501741|NCT01245972|11652325|FG002|COMPLETED|Overall Study||8
10501742|NCT01245972|11652323|FG000|NOT COMPLETED|Overall Study||0
10501743|NCT01245972|11652324|FG001|NOT COMPLETED|Overall Study||0
10501744|NCT01245972|11652325|FG002|NOT COMPLETED|Overall Study||0
10501745|NCT01246050|11652335|FG000|STARTED|Overall Study||6
10501746|NCT01246050|11652336|FG001|STARTED|Overall Study|Control providers were other providers in the same Primary Care Clinic, not enrolled in the study|6
10501747|NCT01246050|11652335|FG000|COMPLETED|Overall Study||6
10501748|NCT01246050|11652336|FG001|COMPLETED|Overall Study|Control providers were other providers in the same Primary Care Clinic, not enrolled in the study|6
10501749|NCT01246050|11652335|FG000|NOT COMPLETED|Overall Study||0
10501750|NCT01246050|11652336|FG001|NOT COMPLETED|Overall Study||0
10501751|NCT01246063|11652348|FG000|STARTED|Overall Study||3
10501752|NCT01246063|11652349|FG001|STARTED|Overall Study||4
10501753|NCT01246063|11652350|FG002|STARTED|Overall Study||4
10501754|NCT01246063|11652351|FG003|STARTED|Overall Study||5
10501755|NCT01246063|11652352|FG004|STARTED|Overall Study||7
10501756|NCT01246063|11652353|FG005|STARTED|Overall Study||17
10501757|NCT01246063|11652348|FG000|COMPLETED|Overall Study||3
10501758|NCT01246063|11652349|FG001|COMPLETED|Overall Study||4
10501759|NCT01246063|11652350|FG002|COMPLETED|Overall Study||4
10501760|NCT01246063|11652351|FG003|COMPLETED|Overall Study||5
10501761|NCT01246063|11652352|FG004|COMPLETED|Overall Study||7
10501762|NCT01246063|11652353|FG005|COMPLETED|Overall Study||17
10501763|NCT01246063|11652348|FG000|NOT COMPLETED|Overall Study||0
10501764|NCT01246063|11652349|FG001|NOT COMPLETED|Overall Study||0
10501765|NCT01246063|11652350|FG002|NOT COMPLETED|Overall Study||0
10501766|NCT01246063|11652351|FG003|NOT COMPLETED|Overall Study||0
10501767|NCT01246063|11652352|FG004|NOT COMPLETED|Overall Study||0
10501768|NCT01246063|11652353|FG005|NOT COMPLETED|Overall Study||0
10501769|NCT01246076|11652371|FG000|STARTED|Overall Study||24
10501770|NCT01246076|11652371|FG000|COMPLETED|Overall Study||24
10501771|NCT01246076|11652371|FG000|NOT COMPLETED|Overall Study||0
10501772|NCT01246206|11652375|FG000|STARTED|Overall Study||21
10501773|NCT01246206|11652375|FG000|COMPLETED|Overall Study||20
10501774|NCT01246206|11652375|FG000|NOT COMPLETED|Overall Study||1
10501775|NCT01246258|11652379|FG000|STARTED|Overall Study||5
10501776|NCT01246258|11652379|FG000|COMPLETED|Overall Study||5
10501777|NCT01246258|11652379|FG000|NOT COMPLETED|Overall Study||0
10501778|NCT01246349|11652386|FG000|STARTED|Overall Study||20
10501779|NCT01246349|11652387|FG001|STARTED|Overall Study||20
10501780|NCT01246349|11652386|FG000|COMPLETED|Overall Study||20
10501781|NCT01246349|11652387|FG001|COMPLETED|Overall Study||20
10501782|NCT01246349|11652386|FG000|NOT COMPLETED|Overall Study||0
10501783|NCT01246349|11652387|FG001|NOT COMPLETED|Overall Study||0
10501784|NCT01246401|11652395|FG000|STARTED|Overall Study||66
10501785|NCT01246401|11652396|FG001|STARTED|Overall Study||27
10501786|NCT01246401|11652395|FG000|COMPLETED|Overall Study||66
10501787|NCT01246401|11652396|FG001|COMPLETED|Overall Study||27
10501788|NCT01246401|11652395|FG000|NOT COMPLETED|Overall Study||0
10501789|NCT01246401|11652396|FG001|NOT COMPLETED|Overall Study||0
10501790|NCT01246466|11652404|FG000|STARTED|Overall Study||24
10501791|NCT01246466|11652404|FG000|COMPLETED|Overall Study||22
10501792|NCT01246466|11652404|FG000|NOT COMPLETED|Overall Study||2
10501793|NCT01246479|11652409|FG000|STARTED|Overall Study||23
10501794|NCT01246479|11652409|FG000|COMPLETED|Overall Study|primary endpoint at Month 12|18
10501795|NCT01246479|11652409|FG000|NOT COMPLETED|Overall Study||5
10501796|NCT01246583|11652417|FG000|STARTED|Overall Study||23
10501797|NCT01246583|11652418|FG001|STARTED|Overall Study||13
10501798|NCT01246583|11652419|FG002|STARTED|Overall Study||25
10501799|NCT01246583|11652420|FG003|STARTED|Overall Study||10
10501800|NCT01246583|11652417|FG000|COMPLETED|Overall Study||22
10501801|NCT01246583|11652418|FG001|COMPLETED|Overall Study||13
10501802|NCT01246583|11652419|FG002|COMPLETED|Overall Study||24
10501803|NCT01246583|11652420|FG003|COMPLETED|Overall Study||9
10501804|NCT01246583|11652417|FG000|NOT COMPLETED|Overall Study||1
10501805|NCT01246583|11652418|FG001|NOT COMPLETED|Overall Study||0
10501806|NCT01246583|11652419|FG002|NOT COMPLETED|Overall Study||1
10501807|NCT01246583|11652420|FG003|NOT COMPLETED|Overall Study||1
10501808|NCT01246713|11652431|FG000|STARTED|First Acetaminophen Dosing (1 Day)||6
10501809|NCT01246713|11652432|FG001|STARTED|First Acetaminophen Dosing (1 Day)||9
10501810|NCT01246713|11652431|FG000|COMPLETED|First Acetaminophen Dosing (1 Day)||6
10501811|NCT01246713|11652432|FG001|COMPLETED|First Acetaminophen Dosing (1 Day)||9
10501812|NCT01246713|11652431|FG000|NOT COMPLETED|First Acetaminophen Dosing (1 Day)||0
10501813|NCT01246713|11652432|FG001|NOT COMPLETED|First Acetaminophen Dosing (1 Day)||0
10501814|NCT01246713|11652431|FG000|STARTED|Washout (at Least 14 Days)||6
10501815|NCT01246713|11652432|FG001|STARTED|Washout (at Least 14 Days)||9
10501816|NCT01246713|11652431|FG000|COMPLETED|Washout (at Least 14 Days)||6
10501817|NCT01246713|11652432|FG001|COMPLETED|Washout (at Least 14 Days)||9
10501818|NCT01246713|11652431|FG000|NOT COMPLETED|Washout (at Least 14 Days)||0
10501819|NCT01246713|11652432|FG001|NOT COMPLETED|Washout (at Least 14 Days)||0
10501820|NCT01246713|11652431|FG000|STARTED|Second Acetaminophen Dosing (1 Day)||6
10501821|NCT01246713|11652432|FG001|STARTED|Second Acetaminophen Dosing (1 Day)||9
10501822|NCT01246713|11652431|FG000|COMPLETED|Second Acetaminophen Dosing (1 Day)||6
10501823|NCT01246713|11652432|FG001|COMPLETED|Second Acetaminophen Dosing (1 Day)||9
10501824|NCT01246713|11652431|FG000|NOT COMPLETED|Second Acetaminophen Dosing (1 Day)||0
10501825|NCT01246713|11652432|FG001|NOT COMPLETED|Second Acetaminophen Dosing (1 Day)||0
10501826|NCT01246791|11652438|FG000|STARTED|Overall Study||12
10501827|NCT01246791|11652438|FG000|COMPLETED|Overall Study||12
10501828|NCT01246791|11652438|FG000|NOT COMPLETED|Overall Study||0
10501829|NCT01246895|11652444|FG000|STARTED|Overall Study||37
10501830|NCT01246895|11652445|FG001|STARTED|Overall Study||30
10501831|NCT01246895|11652444|FG000|COMPLETED|Overall Study||34
10501832|NCT01246895|11652445|FG001|COMPLETED|Overall Study||26
10501833|NCT01246895|11652444|FG000|NOT COMPLETED|Overall Study||3
10501834|NCT01246895|11652445|FG001|NOT COMPLETED|Overall Study||4
10501835|NCT01246960|11652455|FG000|STARTED|Overall Study||84
10501836|NCT01246960|11652456|FG001|STARTED|Overall Study||84
10501837|NCT01246960|11652455|FG000|Received Any Quantity of Study Drug|Overall Study||82
10501838|NCT01246960|11652456|FG001|Received Any Quantity of Study Drug|Overall Study||80
10501839|NCT01246960|11652455|FG000|COMPLETED|Overall Study||78
10501840|NCT01246960|11652456|FG001|COMPLETED|Overall Study||80
10501841|NCT01246960|11652455|FG000|NOT COMPLETED|Overall Study||6
10501842|NCT01246960|11652456|FG001|NOT COMPLETED|Overall Study||4
10501843|NCT01246973|11652464|FG000|STARTED|Overall Study||344
10501844|NCT01246973|11652465|FG001|STARTED|Overall Study||342
10501845|NCT01246973|11652464|FG000|COMPLETED|Overall Study||283
10501846|NCT01246973|11652465|FG001|COMPLETED|Overall Study||295
10501847|NCT01246973|11652464|FG000|NOT COMPLETED|Overall Study||61
10501848|NCT01246973|11652465|FG001|NOT COMPLETED|Overall Study||47
10501849|NCT01246986|11652478|FG000|STARTED|Overall Study||37
10501850|NCT01246986|11652479|FG001|STARTED|Overall Study||72
10501851|NCT01246986|11652480|FG002|STARTED|Overall Study||40
10501852|NCT01246986|11652481|FG003|STARTED|Overall Study||3
10501853|NCT01246986|11652482|FG004|STARTED|Overall Study||44
10501854|NCT01246986|11652483|FG005|STARTED|Overall Study||3
10501855|NCT01246986|11652484|FG006|STARTED|Overall Study||5
10501856|NCT01246986|11652478|FG000|Received at Least 1 Dose of Study Drug|Overall Study||37
10501857|NCT01246986|11652479|FG001|Received at Least 1 Dose of Study Drug|Overall Study||72
10501858|NCT01246986|11652480|FG002|Received at Least 1 Dose of Study Drug|Overall Study||40
10501859|NCT01246986|11652481|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
10501860|NCT01246986|11652482|FG004|Received at Least 1 Dose of Study Drug|Overall Study||44
10501861|NCT01246986|11652483|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3
10501862|NCT01246986|11652484|FG006|Received at Least 1 Dose of Study Drug|Overall Study||5
10501863|NCT01246986|11652478|FG000|COMPLETED|Overall Study||34
10501864|NCT01246986|11652479|FG001|COMPLETED|Overall Study||67
10501865|NCT01246986|11652480|FG002|COMPLETED|Overall Study||34
10501866|NCT01246986|11652481|FG003|COMPLETED|Overall Study||3
10501867|NCT01246986|11652482|FG004|COMPLETED|Overall Study||40
10501868|NCT01246986|11652483|FG005|COMPLETED|Overall Study||2
10501869|NCT01246986|11652484|FG006|COMPLETED|Overall Study||5
10501870|NCT01246986|11652478|FG000|NOT COMPLETED|Overall Study||3
10501871|NCT01246986|11652479|FG001|NOT COMPLETED|Overall Study||5
10501872|NCT01246986|11652480|FG002|NOT COMPLETED|Overall Study||6
10501873|NCT01246986|11652481|FG003|NOT COMPLETED|Overall Study||0
10501874|NCT01246986|11652482|FG004|NOT COMPLETED|Overall Study||4
10501875|NCT01246986|11652483|FG005|NOT COMPLETED|Overall Study||1
10501876|NCT01246986|11652484|FG006|NOT COMPLETED|Overall Study||0
10501877|NCT01246999|11652519|FG000|STARTED|Overall Study||11
10501878|NCT01246999|11652520|FG001|STARTED|Overall Study||4
10501879|NCT01246999|11652521|FG002|STARTED|Overall Study||2
10501880|NCT01246999|11652522|FG003|STARTED|Overall Study||17
10501881|NCT01246999|11652519|FG000|COMPLETED|Overall Study||11
10501882|NCT01246999|11652520|FG001|COMPLETED|Overall Study||3
10501883|NCT01246999|11652521|FG002|COMPLETED|Overall Study||2
10501884|NCT01246999|11652522|FG003|COMPLETED|Overall Study||15
10501885|NCT01246999|11652519|FG000|NOT COMPLETED|Overall Study||0
10501886|NCT01246999|11652520|FG001|NOT COMPLETED|Overall Study||1
10501887|NCT01246999|11652521|FG002|NOT COMPLETED|Overall Study||0
10501888|NCT01246999|11652522|FG003|NOT COMPLETED|Overall Study||2
10501889|NCT01247064|11652537|FG000|STARTED|Overall Study||31
10501890|NCT01247064|11652538|FG001|STARTED|Overall Study||31
10501891|NCT01247064|11652537|FG000|COMPLETED|Overall Study||31
10501892|NCT01247064|11652538|FG001|COMPLETED|Overall Study||31
10501893|NCT01247064|11652537|FG000|NOT COMPLETED|Overall Study||0
10501894|NCT01247064|11652538|FG001|NOT COMPLETED|Overall Study||0
10501895|NCT01247090|11652547|FG000|STARTED|Overall Study||4
10501896|NCT01247090|11652548|FG001|STARTED|Overall Study||4
10501897|NCT01247090|11652549|FG002|STARTED|Overall Study||4
10501898|NCT01247090|11652547|FG000|COMPLETED|Overall Study||3
10501899|NCT01247090|11652548|FG001|COMPLETED|Overall Study||3
10501900|NCT01247090|11652549|FG002|COMPLETED|Overall Study||4
10501901|NCT01247090|11652547|FG000|NOT COMPLETED|Overall Study||1
10501902|NCT01247090|11652548|FG001|NOT COMPLETED|Overall Study||1
10501903|NCT01247090|11652549|FG002|NOT COMPLETED|Overall Study||0
10501904|NCT01247220|11652559|FG000|STARTED|Overall Study||6
10501905|NCT01247220|11652560|FG001|STARTED|Overall Study||6
10501906|NCT01247220|11652559|FG000|COMPLETED|Overall Study||6
10501907|NCT01247220|11652560|FG001|COMPLETED|Overall Study||6
10501908|NCT01247220|11652559|FG000|NOT COMPLETED|Overall Study||0
10501909|NCT01247220|11652560|FG001|NOT COMPLETED|Overall Study||0
10501910|NCT01247272|11652568|FG000|STARTED|First Intervention||13
10501911|NCT01247272|11652569|FG001|STARTED|First Intervention||13
10501912|NCT01247272|11652568|FG000|COMPLETED|First Intervention||13
10501913|NCT01247272|11652569|FG001|COMPLETED|First Intervention||13
10501914|NCT01247272|11652568|FG000|NOT COMPLETED|First Intervention||0
10501915|NCT01247272|11652569|FG001|NOT COMPLETED|First Intervention||0
10501916|NCT01247272|11652568|FG000|STARTED|Washout of 28 Days||13
10501917|NCT01247272|11652569|FG001|STARTED|Washout of 28 Days||13
10501918|NCT01247272|11652568|FG000|COMPLETED|Washout of 28 Days||13
10501919|NCT01247272|11652569|FG001|COMPLETED|Washout of 28 Days||13
10501920|NCT01247272|11652568|FG000|NOT COMPLETED|Washout of 28 Days||0
10501921|NCT01247272|11652569|FG001|NOT COMPLETED|Washout of 28 Days||0
10501922|NCT01247272|11652568|FG000|STARTED|Second Intervention||13
10501923|NCT01247272|11652569|FG001|STARTED|Second Intervention||13
10501924|NCT01247272|11652568|FG000|COMPLETED|Second Intervention||13
10501925|NCT01247272|11652569|FG001|COMPLETED|Second Intervention||13
10501926|NCT01247272|11652568|FG000|NOT COMPLETED|Second Intervention||0
10501927|NCT01247272|11652569|FG001|NOT COMPLETED|Second Intervention||0
10501928|NCT01247285|11652577|FG000|STARTED|First Intervention||13
10501929|NCT01247285|11652578|FG001|STARTED|First Intervention||13
10501930|NCT01247285|11652577|FG000|COMPLETED|First Intervention||13
10501931|NCT01247285|11652578|FG001|COMPLETED|First Intervention||13
10501932|NCT01247285|11652577|FG000|NOT COMPLETED|First Intervention||0
10501933|NCT01247285|11652578|FG001|NOT COMPLETED|First Intervention||0
10501934|NCT01247285|11652577|FG000|STARTED|Washout of 28 Days||13
10501935|NCT01247285|11652578|FG001|STARTED|Washout of 28 Days||13
10501936|NCT01247285|11652577|FG000|COMPLETED|Washout of 28 Days||13
10501937|NCT01247285|11652578|FG001|COMPLETED|Washout of 28 Days||13
10501938|NCT01247285|11652577|FG000|NOT COMPLETED|Washout of 28 Days||0
10501939|NCT01247285|11652578|FG001|NOT COMPLETED|Washout of 28 Days||0
10501940|NCT01247285|11652577|FG000|STARTED|Second Intervention||13
10501941|NCT01247285|11652578|FG001|STARTED|Second Intervention||13
10501942|NCT01247285|11652577|FG000|COMPLETED|Second Intervention||13
10501943|NCT01247285|11652578|FG001|COMPLETED|Second Intervention||13
10501944|NCT01247285|11652577|FG000|NOT COMPLETED|Second Intervention||0
10501945|NCT01247285|11652578|FG001|NOT COMPLETED|Second Intervention||0
10501946|NCT01247298|11652584|FG000|STARTED|Overall Study||17
10501947|NCT01247298|11652584|FG000|COMPLETED|Overall Study||17
10501948|NCT01247298|11652584|FG000|NOT COMPLETED|Overall Study||0
10501949|NCT01247350|11652594|FG000|STARTED|Overall Study||6
10501950|NCT01247350|11652595|FG001|STARTED|Overall Study||6
10501951|NCT01247350|11652596|FG002|STARTED|Overall Study||6
10501952|NCT01247350|11652597|FG003|STARTED|Overall Study||7
10501953|NCT01247350|11652598|FG004|STARTED|Overall Study||9
10501954|NCT01247350|11652594|FG000|Received Multiple Doses of Study Drug|Overall Study||0
10501955|NCT01247350|11652595|FG001|Received Multiple Doses of Study Drug|Overall Study||0
10501956|NCT01247350|11652596|FG002|Received Multiple Doses of Study Drug|Overall Study||6
10501957|NCT01247350|11652597|FG003|Received Multiple Doses of Study Drug|Overall Study||6
10501958|NCT01247350|11652598|FG004|Received Multiple Doses of Study Drug|Overall Study||5
10501959|NCT01247350|11652594|FG000|COMPLETED|Overall Study||6
10501960|NCT01247350|11652595|FG001|COMPLETED|Overall Study||6
10501961|NCT01247350|11652596|FG002|COMPLETED|Overall Study||5
10501962|NCT01247350|11652597|FG003|COMPLETED|Overall Study||6
10501963|NCT01247350|11652598|FG004|COMPLETED|Overall Study||8
10501964|NCT01247350|11652594|FG000|NOT COMPLETED|Overall Study||0
10501965|NCT01247350|11652595|FG001|NOT COMPLETED|Overall Study||0
10501966|NCT01247350|11652596|FG002|NOT COMPLETED|Overall Study||1
10501967|NCT01247350|11652597|FG003|NOT COMPLETED|Overall Study||1
10501968|NCT01247350|11652598|FG004|NOT COMPLETED|Overall Study||1
10501969|NCT01247363|11652624|FG000|STARTED|Overall Study||20
10501970|NCT01247363|11652624|FG000|COMPLETED|Overall Study||20
10501971|NCT01247363|11652624|FG000|NOT COMPLETED|Overall Study||0
10501972|NCT01247428|11652639|FG000|STARTED|Overall Study||30
10501973|NCT01247428|11652639|FG000|COMPLETED|Overall Study||30
10501974|NCT01247428|11652639|FG000|NOT COMPLETED|Overall Study||0
10501975|NCT01247571|11652643|FG000|STARTED|Overall Study||22
10501976|NCT01247571|11652643|FG000|COMPLETED|Overall Study||19
10501977|NCT01247571|11652643|FG000|NOT COMPLETED|Overall Study||3
10501978|NCT01247675|11652651|FG000|STARTED|Overall Study||10
10501979|NCT01247675|11652652|FG001|STARTED|Overall Study||10
10501980|NCT01247675|11652653|FG002|STARTED|Overall Study||9
10501981|NCT01247675|11652654|FG003|STARTED|Overall Study||8
10501982|NCT01247675|11652651|FG000|COMPLETED|Overall Study||8
10501983|NCT01247675|11652652|FG001|COMPLETED|Overall Study||8
10501984|NCT01247675|11652653|FG002|COMPLETED|Overall Study||9
10501985|NCT01247675|11652654|FG003|COMPLETED|Overall Study||8
10501986|NCT01247675|11652651|FG000|NOT COMPLETED|Overall Study||2
10501987|NCT01247675|11652652|FG001|NOT COMPLETED|Overall Study||2
10501988|NCT01247675|11652653|FG002|NOT COMPLETED|Overall Study||0
10501989|NCT01247675|11652654|FG003|NOT COMPLETED|Overall Study||0
10501990|NCT01247922|11652666|FG000|STARTED|Overall Study||4
10501991|NCT01247922|11652666|FG000|Treated|Overall Study||4
10501992|NCT01247922|11652666|FG000|COMPLETED|Overall Study||0
10501993|NCT01247922|11652666|FG000|NOT COMPLETED|Overall Study||4
10501994|NCT01247974|11652672|FG000|STARTED|Overall Study||217
10501995|NCT01247974|11652673|FG001|STARTED|Overall Study||222
10501996|NCT01247974|11652672|FG000|COMPLETED|Overall Study||191
10501997|NCT01247974|11652673|FG001|COMPLETED|Overall Study||203
10501998|NCT01247974|11652672|FG000|NOT COMPLETED|Overall Study||26
10501999|NCT01247974|11652673|FG001|NOT COMPLETED|Overall Study||19
10502000|NCT01248013|11652679|FG000|STARTED|Overall Study||89
10502001|NCT01248013|11652679|FG000|Irritable Bowel Syndrome Hypnotherapy|Overall Study||75
10502002|NCT01248013|11652679|FG000|COMPLETED|Overall Study||75
10502003|NCT01248013|11652679|FG000|NOT COMPLETED|Overall Study||14
10502004|NCT01248065|11652685|FG000|STARTED|Overall Study||207
10502005|NCT01248065|11652686|FG001|STARTED|Overall Study||201
10502006|NCT01248065|11652685|FG000|COMPLETED|Overall Study|All 207 participants were included in the primary time-to-event analysis.|181
10502007|NCT01248065|11652686|FG001|COMPLETED|Overall Study|All 201 participants were included in the primary time-to-event analysis.|179
10502008|NCT01248065|11652685|FG000|NOT COMPLETED|Overall Study||26
10502009|NCT01248065|11652686|FG001|NOT COMPLETED|Overall Study||22
10502010|NCT01248104|11652694|FG000|STARTED|Overall Study||50
10502011|NCT01248104|11652695|FG001|STARTED|Overall Study||50
10502012|NCT01248104|11652694|FG000|COMPLETED|Overall Study||40
10502013|NCT01248104|11652695|FG001|COMPLETED|Overall Study||42
10502014|NCT01248104|11652694|FG000|NOT COMPLETED|Overall Study||10
10502015|NCT01248104|11652695|FG001|NOT COMPLETED|Overall Study||8
10502016|NCT01248221|11652703|FG000|STARTED|Overall Study||15
10502017|NCT01248221|11652704|FG001|STARTED|Overall Study||15
10502018|NCT01248221|11652703|FG000|COMPLETED|Overall Study||15
10502019|NCT01248221|11652704|FG001|COMPLETED|Overall Study||15
10502020|NCT01248221|11652703|FG000|NOT COMPLETED|Overall Study||0
10502021|NCT01248221|11652704|FG001|NOT COMPLETED|Overall Study||0
10502022|NCT01248364|11652716|FG000|STARTED|Overall Study||32
10502023|NCT01248364|11652717|FG001|STARTED|Overall Study||34
10502024|NCT01248364|11652718|FG002|STARTED|Overall Study||13
10502025|NCT01248364|11652719|FG003|STARTED|Overall Study||12
10502026|NCT01248364|11652716|FG000|Completed Acute Phase:Single Dose, Day 1|Overall Study||32
10502027|NCT01248364|11652717|FG001|Completed Acute Phase:Single Dose, Day 1|Overall Study||34
10502028|NCT01248364|11652718|FG002|Completed Acute Phase:Single Dose, Day 1|Overall Study||13
10502029|NCT01248364|11652719|FG003|Completed Acute Phase:Single Dose, Day 1|Overall Study||12
10502030|NCT01248364|11652716|FG000|Completed Chronic Phase:28-day Treatment|Overall Study||32
10502031|NCT01248364|11652717|FG001|Completed Chronic Phase:28-day Treatment|Overall Study||33
10502032|NCT01248364|11652718|FG002|Completed Chronic Phase:28-day Treatment|Overall Study||13
10502033|NCT01248364|11652719|FG003|Completed Chronic Phase:28-day Treatment|Overall Study||0
10502034|NCT01248364|11652716|FG000|COMPLETED|Overall Study||32
10502035|NCT01248364|11652717|FG001|COMPLETED|Overall Study||33
10502036|NCT01248364|11652718|FG002|COMPLETED|Overall Study||13
10502037|NCT01248364|11652719|FG003|COMPLETED|Overall Study||12
10502038|NCT01248364|11652716|FG000|NOT COMPLETED|Overall Study||0
10502039|NCT01248364|11652717|FG001|NOT COMPLETED|Overall Study||1
10502040|NCT01248364|11652718|FG002|NOT COMPLETED|Overall Study||0
10502041|NCT01248364|11652719|FG003|NOT COMPLETED|Overall Study||0
10502042|NCT01248416|11652732|FG000|STARTED|Overall Study||25
10502043|NCT01248416|11652733|FG001|STARTED|Overall Study||25
10502044|NCT01248416|11652734|FG002|STARTED|Overall Study||26
10502045|NCT01248416|11652732|FG000|COMPLETED|Overall Study||21
10502046|NCT01248416|11652733|FG001|COMPLETED|Overall Study||25
10502047|NCT01248416|11652734|FG002|COMPLETED|Overall Study||25
10502048|NCT01248416|11652732|FG000|NOT COMPLETED|Overall Study||4
10502049|NCT01248416|11652733|FG001|NOT COMPLETED|Overall Study||0
10502050|NCT01248416|11652734|FG002|NOT COMPLETED|Overall Study||1
10528150|NCT01393626|11680358|FG000|NOT COMPLETED|Overall Study||18
10528151|NCT01393626|11680359|FG001|NOT COMPLETED|Overall Study||12
10528152|NCT01393626|11680360|FG002|NOT COMPLETED|Overall Study||12
10528153|NCT01393626|11680361|FG003|NOT COMPLETED|Overall Study||1
10528154|NCT01393704|11680380|FG000|STARTED|Overall Study||76
10502051|NCT01248455|11652744|FG000|STARTED|Overall Study||9
10502052|NCT01248455|11652744|FG000|COMPLETED|Overall Study||8
10502053|NCT01248455|11652744|FG000|NOT COMPLETED|Overall Study||1
10502054|NCT01248468|11652751|FG000|STARTED|Overall Study||299
10502055|NCT01248468|11652752|FG001|STARTED|Overall Study||304
10502056|NCT01248468|11652753|FG002|STARTED|Overall Study||149
10502057|NCT01248468|11652751|FG000|Safety Population|Overall Study||266
10502058|NCT01248468|11652752|FG001|Safety Population|Overall Study||271
10502059|NCT01248468|11652753|FG002|Safety Population|Overall Study||133
10502060|NCT01248468|11652751|FG000|ITT Population|Overall Study||256
10502061|NCT01248468|11652752|FG001|ITT Population|Overall Study||261
10502062|NCT01248468|11652753|FG002|ITT Population|Overall Study||125
10502063|NCT01248468|11652751|FG000|COMPLETED|Overall Study||284
10502064|NCT01248468|11652752|FG001|COMPLETED|Overall Study||290
10502065|NCT01248468|11652753|FG002|COMPLETED|Overall Study||145
10502066|NCT01248468|11652751|FG000|NOT COMPLETED|Overall Study||15
10502067|NCT01248468|11652752|FG001|NOT COMPLETED|Overall Study||14
10502068|NCT01248468|11652753|FG002|NOT COMPLETED|Overall Study||4
10502069|NCT01248585|11652763|FG000|STARTED|Overall Study||148
10502070|NCT01248585|11652764|FG001|STARTED|Overall Study||150
10502071|NCT01248585|11652763|FG000|COMPLETED|Overall Study||148
10502072|NCT01248585|11652764|FG001|COMPLETED|Overall Study||150
10502073|NCT01248585|11652763|FG000|NOT COMPLETED|Overall Study||0
10502074|NCT01248585|11652764|FG001|NOT COMPLETED|Overall Study||0
10502075|NCT01248715|11652772|FG000|STARTED|Overall Study||556
10502076|NCT01248715|11652773|FG001|STARTED|Overall Study||551
10502077|NCT01248715|11652772|FG000|COMPLETED|Overall Study||55
10502078|NCT01248715|11652773|FG001|COMPLETED|Overall Study||41
10502079|NCT01248715|11652772|FG000|NOT COMPLETED|Overall Study||501
10502080|NCT01248715|11652773|FG001|NOT COMPLETED|Overall Study||510
10502081|NCT01248728|11652781|FG000|STARTED|Overall Study||19
10502082|NCT01248728|11652782|FG001|STARTED|Overall Study||19
10502083|NCT01248728|11652781|FG000|COMPLETED|Overall Study||15
10502084|NCT01248728|11652782|FG001|COMPLETED|Overall Study||17
10502085|NCT01248728|11652781|FG000|NOT COMPLETED|Overall Study||4
10502086|NCT01248728|11652782|FG001|NOT COMPLETED|Overall Study||2
10502087|NCT01248741|11652790|FG000|STARTED|Overall Study||20
10502088|NCT01248741|11652790|FG000|COMPLETED|Overall Study||20
10502089|NCT01248741|11652790|FG000|NOT COMPLETED|Overall Study||0
10502090|NCT01248780|11652796|FG000|STARTED|Overall Study||132
10502091|NCT01248780|11652797|FG001|STARTED|Overall Study||132
10502092|NCT01248780|11652796|FG000|COMPLETED|Overall Study||123
10502093|NCT01248780|11652797|FG001|COMPLETED|Overall Study||117
10502094|NCT01248780|11652796|FG000|NOT COMPLETED|Overall Study||9
10502095|NCT01248780|11652797|FG001|NOT COMPLETED|Overall Study||15
10502096|NCT01248793|11652805|FG000|STARTED|Overall Study||105
10502097|NCT01248793|11652806|FG001|STARTED|Overall Study||108
10502098|NCT01248793|11652805|FG000|COMPLETED|Overall Study||101
10502099|NCT01248793|11652806|FG001|COMPLETED|Overall Study||102
10502100|NCT01248793|11652805|FG000|NOT COMPLETED|Overall Study||4
10502101|NCT01248793|11652806|FG001|NOT COMPLETED|Overall Study||6
10502102|NCT01248884|11652815|FG000|STARTED|Overall Study||240
10502103|NCT01248884|11652816|FG001|STARTED|Overall Study||242
10502104|NCT01248884|11652817|FG002|STARTED|Overall Study||239
10502105|NCT01248884|11652815|FG000|COMPLETED|Overall Study||238
10502106|NCT01248884|11652816|FG001|COMPLETED|Overall Study||239
10502107|NCT01248884|11652817|FG002|COMPLETED|Overall Study||238
10502108|NCT01248884|11652815|FG000|NOT COMPLETED|Overall Study||2
10502109|NCT01248884|11652816|FG001|NOT COMPLETED|Overall Study||3
10502110|NCT01248884|11652817|FG002|NOT COMPLETED|Overall Study||1
10502111|NCT01248936|11652827|FG000|STARTED|Overall Study||374
10502112|NCT01248936|11652827|FG000|COMPLETED|Overall Study||0
10502113|NCT01248936|11652827|FG000|NOT COMPLETED|Overall Study||374
10502114|NCT01248949|11652837|FG000|STARTED|Overall Study||42
10502115|NCT01248949|11652838|FG001|STARTED|Overall Study||16
10502116|NCT01248949|11652839|FG002|STARTED|Overall Study||38
10502117|NCT01248949|11652840|FG003|STARTED|Overall Study||13
10502118|NCT01248949|11652841|FG004|STARTED|Overall Study||7
10502119|NCT01248949|11652837|FG000|COMPLETED|Overall Study||9
10502120|NCT01248949|11652838|FG001|COMPLETED|Overall Study||3
10502121|NCT01248949|11652839|FG002|COMPLETED|Overall Study||1
10502122|NCT01248949|11652840|FG003|COMPLETED|Overall Study||3
10502123|NCT01248949|11652841|FG004|COMPLETED|Overall Study||3
10502124|NCT01248949|11652837|FG000|NOT COMPLETED|Overall Study||33
10502125|NCT01248949|11652838|FG001|NOT COMPLETED|Overall Study||13
10502126|NCT01248949|11652839|FG002|NOT COMPLETED|Overall Study||37
10502127|NCT01248949|11652840|FG003|NOT COMPLETED|Overall Study||10
10502128|NCT01248949|11652841|FG004|NOT COMPLETED|Overall Study||4
10502129|NCT01248962|11652855|FG000|STARTED|Overall Study||74
10502130|NCT01248962|11652856|FG001|STARTED|Overall Study||72
10502131|NCT01248962|11652855|FG000|COMPLETED|Overall Study||58
10502132|NCT01248962|11652856|FG001|COMPLETED|Overall Study||56
10502133|NCT01248962|11652855|FG000|NOT COMPLETED|Overall Study||16
10502134|NCT01248962|11652856|FG001|NOT COMPLETED|Overall Study||16
10502135|NCT01249027|11652863|FG000|STARTED|1 Year Clinical Follow up||2482
10502136|NCT01249027|11652863|FG000|COMPLETED|1 Year Clinical Follow up||2391
10502137|NCT01249027|11652863|FG000|NOT COMPLETED|1 Year Clinical Follow up||91
10502138|NCT01249027|11652863|FG000|STARTED|2 Years Clinical Follow up||2391
10502139|NCT01249027|11652863|FG000|COMPLETED|2 Years Clinical Follow up||2254
10502140|NCT01249027|11652863|FG000|NOT COMPLETED|2 Years Clinical Follow up||137
10502141|NCT01249027|11652863|FG000|STARTED|3 Years Clinical Follow up||2254
10502142|NCT01249027|11652863|FG000|COMPLETED|3 Years Clinical Follow up||2223
10502143|NCT01249027|11652863|FG000|NOT COMPLETED|3 Years Clinical Follow up||31
10502144|NCT01249027|11652863|FG000|STARTED|4 Years Clinical Follow up||2223
10502145|NCT01249027|11652863|FG000|COMPLETED|4 Years Clinical Follow up||2210
10502146|NCT01249027|11652863|FG000|NOT COMPLETED|4 Years Clinical Follow up||13
10502147|NCT01249027|11652863|FG000|STARTED|5 Years Clinical Follow up||2210
10502148|NCT01249027|11652863|FG000|COMPLETED|5 Years Clinical Follow up||2142
10502149|NCT01249027|11652863|FG000|NOT COMPLETED|5 Years Clinical Follow up||68
10502150|NCT01249092|11652867|FG000|STARTED|Overall Study||20
10502151|NCT01249092|11652867|FG000|COMPLETED|Overall Study||18
10502152|NCT01249092|11652867|FG000|NOT COMPLETED|Overall Study||2
10502153|NCT01249118|11652873|FG000|STARTED|First Intervention Period||2
10502154|NCT01249118|11652874|FG001|STARTED|First Intervention Period||6
10502155|NCT01249118|11652875|FG002|STARTED|First Intervention Period||5
10502156|NCT01249118|11652873|FG000|COMPLETED|First Intervention Period||2
10502157|NCT01249118|11652874|FG001|COMPLETED|First Intervention Period||6
10502158|NCT01249118|11652875|FG002|COMPLETED|First Intervention Period||5
10502159|NCT01249118|11652873|FG000|NOT COMPLETED|First Intervention Period||0
10502160|NCT01249118|11652874|FG001|NOT COMPLETED|First Intervention Period||0
10502161|NCT01249118|11652875|FG002|NOT COMPLETED|First Intervention Period||0
10502162|NCT01249118|11652873|FG000|STARTED|First Washout Period||2
10502163|NCT01249118|11652874|FG001|STARTED|First Washout Period||6
10502164|NCT01249118|11652875|FG002|STARTED|First Washout Period||5
10502165|NCT01249118|11652873|FG000|COMPLETED|First Washout Period||2
10502166|NCT01249118|11652874|FG001|COMPLETED|First Washout Period||5
10502167|NCT01249118|11652875|FG002|COMPLETED|First Washout Period||5
10502168|NCT01249118|11652873|FG000|NOT COMPLETED|First Washout Period||0
10502169|NCT01249118|11652874|FG001|NOT COMPLETED|First Washout Period||1
10502170|NCT01249118|11652875|FG002|NOT COMPLETED|First Washout Period||0
10502171|NCT01249118|11652873|FG000|STARTED|Second Intervention Period||2
10502172|NCT01249118|11652874|FG001|STARTED|Second Intervention Period||5
10502173|NCT01249118|11652875|FG002|STARTED|Second Intervention Period||5
10502174|NCT01249118|11652873|FG000|COMPLETED|Second Intervention Period||2
10502175|NCT01249118|11652874|FG001|COMPLETED|Second Intervention Period||5
10502176|NCT01249118|11652875|FG002|COMPLETED|Second Intervention Period||5
10502177|NCT01249118|11652873|FG000|NOT COMPLETED|Second Intervention Period||0
10502178|NCT01249118|11652874|FG001|NOT COMPLETED|Second Intervention Period||0
10502179|NCT01249118|11652875|FG002|NOT COMPLETED|Second Intervention Period||0
10502180|NCT01249118|11652873|FG000|STARTED|Second Washout Period||2
10502181|NCT01249118|11652874|FG001|STARTED|Second Washout Period||5
10502182|NCT01249118|11652875|FG002|STARTED|Second Washout Period||5
10502183|NCT01249118|11652873|FG000|COMPLETED|Second Washout Period||2
10502184|NCT01249118|11652874|FG001|COMPLETED|Second Washout Period||5
10502185|NCT01249118|11652875|FG002|COMPLETED|Second Washout Period||5
10502186|NCT01249118|11652873|FG000|NOT COMPLETED|Second Washout Period||0
10502187|NCT01249118|11652874|FG001|NOT COMPLETED|Second Washout Period||0
10502188|NCT01249118|11652875|FG002|NOT COMPLETED|Second Washout Period||0
10502189|NCT01249131|11652882|FG000|STARTED|First Intervention||3
10502190|NCT01249131|11652883|FG001|STARTED|First Intervention||3
10502191|NCT01249131|11652884|FG002|STARTED|First Intervention||4
10502192|NCT01249131|11652885|FG003|STARTED|First Intervention||3
10502193|NCT01249131|11652886|FG004|STARTED|First Intervention||3
10502194|NCT01249131|11652887|FG005|STARTED|First Intervention||4
10502195|NCT01249131|11652882|FG000|COMPLETED|First Intervention||3
10502196|NCT01249131|11652883|FG001|COMPLETED|First Intervention||3
10502197|NCT01249131|11652884|FG002|COMPLETED|First Intervention||4
10502198|NCT01249131|11652885|FG003|COMPLETED|First Intervention||3
10502199|NCT01249131|11652886|FG004|COMPLETED|First Intervention||3
10502200|NCT01249131|11652887|FG005|COMPLETED|First Intervention||4
10502201|NCT01249131|11652882|FG000|NOT COMPLETED|First Intervention||0
10502202|NCT01249131|11652883|FG001|NOT COMPLETED|First Intervention||0
10502203|NCT01249131|11652884|FG002|NOT COMPLETED|First Intervention||0
10502204|NCT01249131|11652885|FG003|NOT COMPLETED|First Intervention||0
10502205|NCT01249131|11652886|FG004|NOT COMPLETED|First Intervention||0
10502206|NCT01249131|11652887|FG005|NOT COMPLETED|First Intervention||0
10502207|NCT01249131|11652882|FG000|STARTED|Washout Period of 10 Days||3
10502208|NCT01249131|11652883|FG001|STARTED|Washout Period of 10 Days||3
10502209|NCT01249131|11652884|FG002|STARTED|Washout Period of 10 Days||4
10502210|NCT01249131|11652885|FG003|STARTED|Washout Period of 10 Days||3
10502211|NCT01249131|11652886|FG004|STARTED|Washout Period of 10 Days||3
10502212|NCT01249131|11652887|FG005|STARTED|Washout Period of 10 Days||4
10502213|NCT01249131|11652882|FG000|COMPLETED|Washout Period of 10 Days||3
10502214|NCT01249131|11652883|FG001|COMPLETED|Washout Period of 10 Days||3
10502215|NCT01249131|11652884|FG002|COMPLETED|Washout Period of 10 Days||4
10502216|NCT01249131|11652885|FG003|COMPLETED|Washout Period of 10 Days||3
10710687|NCT02653144|11876009|FG001|STARTED|Overall Study||28
10710688|NCT02653144|11876010|FG002|STARTED|Overall Study||31
10502217|NCT01249131|11652886|FG004|COMPLETED|Washout Period of 10 Days||2
10502218|NCT01249131|11652887|FG005|COMPLETED|Washout Period of 10 Days||4
10502219|NCT01249131|11652882|FG000|NOT COMPLETED|Washout Period of 10 Days||0
10502220|NCT01249131|11652883|FG001|NOT COMPLETED|Washout Period of 10 Days||0
10502221|NCT01249131|11652884|FG002|NOT COMPLETED|Washout Period of 10 Days||0
10502222|NCT01249131|11652885|FG003|NOT COMPLETED|Washout Period of 10 Days||0
10502223|NCT01249131|11652886|FG004|NOT COMPLETED|Washout Period of 10 Days||1
10502224|NCT01249131|11652887|FG005|NOT COMPLETED|Washout Period of 10 Days||0
10710689|NCT02653144|11876008|FG000|COMPLETED|Overall Study||30
10502225|NCT01249131|11652882|FG000|STARTED|Second Intervention||3
10502226|NCT01249131|11652883|FG001|STARTED|Second Intervention||3
10502227|NCT01249131|11652884|FG002|STARTED|Second Intervention||4
10502228|NCT01249131|11652885|FG003|STARTED|Second Intervention||3
10502229|NCT01249131|11652886|FG004|STARTED|Second Intervention||2
10502230|NCT01249131|11652887|FG005|STARTED|Second Intervention||4
10502231|NCT01249131|11652882|FG000|COMPLETED|Second Intervention||3
10502232|NCT01249131|11652883|FG001|COMPLETED|Second Intervention||3
10502233|NCT01249131|11652884|FG002|COMPLETED|Second Intervention||4
10502234|NCT01249131|11652885|FG003|COMPLETED|Second Intervention||3
10502235|NCT01249131|11652886|FG004|COMPLETED|Second Intervention||2
10502236|NCT01249131|11652887|FG005|COMPLETED|Second Intervention||4
10502237|NCT01249131|11652882|FG000|NOT COMPLETED|Second Intervention||0
10502238|NCT01249131|11652883|FG001|NOT COMPLETED|Second Intervention||0
10502239|NCT01249131|11652884|FG002|NOT COMPLETED|Second Intervention||0
10502240|NCT01249131|11652885|FG003|NOT COMPLETED|Second Intervention||0
10502241|NCT01249131|11652886|FG004|NOT COMPLETED|Second Intervention||0
10502242|NCT01249131|11652887|FG005|NOT COMPLETED|Second Intervention||0
10502243|NCT01249131|11652882|FG000|STARTED|Washout Period of 10 Days||3
10502244|NCT01249131|11652883|FG001|STARTED|Washout Period of 10 Days||3
10502245|NCT01249131|11652884|FG002|STARTED|Washout Period of 10 Days||4
10502246|NCT01249131|11652885|FG003|STARTED|Washout Period of 10 Days||3
10502247|NCT01249131|11652886|FG004|STARTED|Washout Period of 10 Days||2
10502248|NCT01249131|11652887|FG005|STARTED|Washout Period of 10 Days||4
10502249|NCT01249131|11652882|FG000|COMPLETED|Washout Period of 10 Days||3
10502250|NCT01249131|11652883|FG001|COMPLETED|Washout Period of 10 Days||3
10502251|NCT01249131|11652884|FG002|COMPLETED|Washout Period of 10 Days||4
10502252|NCT01249131|11652885|FG003|COMPLETED|Washout Period of 10 Days||3
10502253|NCT01249131|11652886|FG004|COMPLETED|Washout Period of 10 Days||2
10502254|NCT01249131|11652887|FG005|COMPLETED|Washout Period of 10 Days||4
10502255|NCT01249131|11652882|FG000|NOT COMPLETED|Washout Period of 10 Days||0
10502256|NCT01249131|11652883|FG001|NOT COMPLETED|Washout Period of 10 Days||0
10502257|NCT01249131|11652884|FG002|NOT COMPLETED|Washout Period of 10 Days||0
10502258|NCT01249131|11652885|FG003|NOT COMPLETED|Washout Period of 10 Days||0
10502259|NCT01249131|11652886|FG004|NOT COMPLETED|Washout Period of 10 Days||0
10502260|NCT01249131|11652887|FG005|NOT COMPLETED|Washout Period of 10 Days||0
10502261|NCT01249131|11652882|FG000|STARTED|Third Intervention||3
10502262|NCT01249131|11652883|FG001|STARTED|Third Intervention||3
10502263|NCT01249131|11652884|FG002|STARTED|Third Intervention||4
10502264|NCT01249131|11652885|FG003|STARTED|Third Intervention||3
10502265|NCT01249131|11652886|FG004|STARTED|Third Intervention||2
10502266|NCT01249131|11652887|FG005|STARTED|Third Intervention||4
10502267|NCT01249131|11652882|FG000|COMPLETED|Third Intervention||3
10502268|NCT01249131|11652883|FG001|COMPLETED|Third Intervention||3
10502269|NCT01249131|11652884|FG002|COMPLETED|Third Intervention||4
10502270|NCT01249131|11652885|FG003|COMPLETED|Third Intervention||3
10502271|NCT01249131|11652886|FG004|COMPLETED|Third Intervention||2
10502272|NCT01249131|11652887|FG005|COMPLETED|Third Intervention||4
10502273|NCT01249131|11652882|FG000|NOT COMPLETED|Third Intervention||0
10502274|NCT01249131|11652883|FG001|NOT COMPLETED|Third Intervention||0
10502275|NCT01249131|11652884|FG002|NOT COMPLETED|Third Intervention||0
10502276|NCT01249131|11652885|FG003|NOT COMPLETED|Third Intervention||0
10502277|NCT01249131|11652886|FG004|NOT COMPLETED|Third Intervention||0
10502278|NCT01249131|11652887|FG005|NOT COMPLETED|Third Intervention||0
10502279|NCT01249261|11652897|FG000|STARTED|Overall Study||30
10502280|NCT01249261|11652898|FG001|STARTED|Overall Study||31
10502281|NCT01249261|11652897|FG000|COMPLETED|Overall Study||29
10502282|NCT01249261|11652898|FG001|COMPLETED|Overall Study||31
10502283|NCT01249261|11652897|FG000|NOT COMPLETED|Overall Study||1
10502284|NCT01249261|11652898|FG001|NOT COMPLETED|Overall Study||0
10502285|NCT01249274|11652906|FG000|STARTED|Overall Study|all 25 were included in intention-to-treat and safety analyses|25
10502286|NCT01249274|11652907|FG001|STARTED|Overall Study|all 25 were included in intention-to-treat and safety analyses|25
10502287|NCT01249274|11652906|FG000|Completed Treatment|Overall Study||21
10502288|NCT01249274|11652907|FG001|Completed Treatment|Overall Study||19
10502289|NCT01249274|11652906|FG000|Completed Treatment & Post Trial Visit|Overall Study||20
10502290|NCT01249274|11652907|FG001|Completed Treatment & Post Trial Visit|Overall Study||17
10502291|NCT01249274|11652906|FG000|Completed Post Trial Visit But Not tx|Overall Study||1
10502292|NCT01249274|11652907|FG001|Completed Post Trial Visit But Not tx|Overall Study||2
10502293|NCT01249274|11652906|FG000|COMPLETED|Overall Study||21
10502294|NCT01249274|11652907|FG001|COMPLETED|Overall Study||19
10502295|NCT01249274|11652906|FG000|NOT COMPLETED|Overall Study||4
10502296|NCT01249274|11652907|FG001|NOT COMPLETED|Overall Study||6
10502297|NCT01249365|11652915|FG000|STARTED|Overall Study||199
10502298|NCT01249365|11652915|FG000|COMPLETED|Overall Study||198
10502299|NCT01249365|11652915|FG000|NOT COMPLETED|Overall Study||1
10502330|NCT01249625|11652947|FG000|STARTED|Overall Study||1374
10502331|NCT01249625|11652948|FG001|STARTED|Overall Study||1488
10502332|NCT01249625|11652947|FG000|COMPLETED|Overall Study||1374
10502333|NCT01249625|11652948|FG001|COMPLETED|Overall Study||1488
10502334|NCT01249625|11652947|FG000|NOT COMPLETED|Overall Study||0
10502335|NCT01249625|11652948|FG001|NOT COMPLETED|Overall Study||0
10502336|NCT01249651|11652954|FG000|STARTED|Overall Study|Enrolled|101
10502337|NCT01249651|11652954|FG000|COMPLETED|Overall Study|Completed the 8-week treatment period|94
10502338|NCT01249651|11652954|FG000|NOT COMPLETED|Overall Study||7
10502339|NCT01249664|11652960|FG000|STARTED|Overall Study||91
10502340|NCT01249664|11652961|FG001|STARTED|Overall Study||31
10502341|NCT01249664|11652960|FG000|Participants Received Treatment|Overall Study|Safety population|91
10502342|NCT01249664|11652961|FG001|Participants Received Treatment|Overall Study|Safety population|31
10502343|NCT01249664|11652960|FG000|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) population: Basis of efficacy evaluation|90
10502344|NCT01249664|11652961|FG001|Fulfilled Requirements of FAS Population|Overall Study|FAS population: Basis of efficacy evaluation|31
10502345|NCT01249664|11652960|FG000|Completed 24 Weeks Treatment|Overall Study|Withdrawal from treatment does not equal to withdrawal from study.|83
10502346|NCT01249664|11652961|FG001|Completed 24 Weeks Treatment|Overall Study|Withdrawal from treatment does not equal to withdrawal from study.|25
10502347|NCT01249664|11652960|FG000|Completed 48 Weeks Treatment|Overall Study||78
10502348|NCT01249664|11652961|FG001|Completed 48 Weeks Treatment|Overall Study||24
10502349|NCT01249664|11652960|FG000|COMPLETED|Overall Study|Completers of study visits up to week 48|85
10502350|NCT01249664|11652961|FG001|COMPLETED|Overall Study|Completers of study visits up to week 48|31
10502351|NCT01249664|11652960|FG000|NOT COMPLETED|Overall Study||6
10502352|NCT01249664|11652961|FG001|NOT COMPLETED|Overall Study||0
10502353|NCT01249833|11652971|FG000|STARTED|Overall Study||59
10502354|NCT01249833|11652972|FG001|STARTED|Overall Study||63
10502355|NCT01249833|11652971|FG000|COMPLETED|Overall Study||59
10502356|NCT01249833|11652972|FG001|COMPLETED|Overall Study||62
10502357|NCT01249833|11652971|FG000|NOT COMPLETED|Overall Study||0
10502358|NCT01249833|11652972|FG001|NOT COMPLETED|Overall Study||1
10502359|NCT01249872|11652984|FG000|STARTED|Overall Study||16
10502360|NCT01249872|11652985|FG001|STARTED|Overall Study||16
10502361|NCT01249872|11652986|FG002|STARTED|Overall Study||16
10502362|NCT01249872|11652987|FG003|STARTED|Overall Study||16
10502363|NCT01249872|11652988|FG004|STARTED|Overall Study||16
10502364|NCT01249872|11652989|FG005|STARTED|Overall Study||16
10502365|NCT01249872|11652984|FG000|COMPLETED|Overall Study||16
10502366|NCT01249872|11652985|FG001|COMPLETED|Overall Study||16
10502367|NCT01249872|11652986|FG002|COMPLETED|Overall Study||16
10502368|NCT01249872|11652987|FG003|COMPLETED|Overall Study||16
10502369|NCT01249872|11652988|FG004|COMPLETED|Overall Study||16
10502370|NCT01249872|11652989|FG005|COMPLETED|Overall Study||16
10502371|NCT01249872|11652984|FG000|NOT COMPLETED|Overall Study||0
10502372|NCT01249872|11652985|FG001|NOT COMPLETED|Overall Study||0
10502373|NCT01249872|11652986|FG002|NOT COMPLETED|Overall Study||0
10502374|NCT01249872|11652987|FG003|NOT COMPLETED|Overall Study||0
10502375|NCT01249872|11652988|FG004|NOT COMPLETED|Overall Study||0
10502376|NCT01249872|11652989|FG005|NOT COMPLETED|Overall Study||0
10502377|NCT01250002|11653013|FG000|STARTED|Overall Study||35
10502378|NCT01250002|11653014|FG001|STARTED|Overall Study||35
10502379|NCT01250002|11653013|FG000|COMPLETED|Overall Study||31
10502380|NCT01250002|11653014|FG001|COMPLETED|Overall Study||32
10502381|NCT01250002|11653013|FG000|NOT COMPLETED|Overall Study||4
10502382|NCT01250002|11653014|FG001|NOT COMPLETED|Overall Study||3
10502383|NCT01250054|11653020|FG000|STARTED|Period 1, One Week of Wear||8
10502384|NCT01250054|11653021|FG001|STARTED|Period 1, One Week of Wear|One subject did not wear Period 1 lenses due to power availability and proceeded to Period 2 lenses.|8
10502385|NCT01250054|11653020|FG000|COMPLETED|Period 1, One Week of Wear|One subject discontinued between Period 1 and Period 2 due to power availability.|8
10502386|NCT01250054|11653021|FG001|COMPLETED|Period 1, One Week of Wear|One subject discontinued between Period 1 and Period 2 due to noncompliance.|8
10502387|NCT01250054|11653020|FG000|NOT COMPLETED|Period 1, One Week of Wear||0
10502388|NCT01250054|11653021|FG001|NOT COMPLETED|Period 1, One Week of Wear||0
10502389|NCT01250054|11653020|FG000|STARTED|Period 2, One Week of Wear||7
10502390|NCT01250054|11653021|FG001|STARTED|Period 2, One Week of Wear||8
10502391|NCT01250054|11653020|FG000|COMPLETED|Period 2, One Week of Wear||6
10502392|NCT01250054|11653021|FG001|COMPLETED|Period 2, One Week of Wear||8
10710690|NCT02653144|11876009|FG001|COMPLETED|Overall Study||28
10710691|NCT02653144|11876010|FG002|COMPLETED|Overall Study||31
10710692|NCT02653144|11876008|FG000|NOT COMPLETED|Overall Study||0
10710693|NCT02653144|11876009|FG001|NOT COMPLETED|Overall Study||0
10502393|NCT01250054|11653020|FG000|NOT COMPLETED|Period 2, One Week of Wear||1
10502394|NCT01250054|11653021|FG001|NOT COMPLETED|Period 2, One Week of Wear||0
10502395|NCT01250119|11653027|FG000|STARTED|Diagnostic Phase||688
10502396|NCT01250119|11653028|FG001|STARTED|Diagnostic Phase||0
10502397|NCT01250119|11653027|FG000|COMPLETED|Diagnostic Phase|Completed refers to participants with both positive and negative EGFR mutation test result.|575
10502398|NCT01250119|11653028|FG001|COMPLETED|Diagnostic Phase||0
10502399|NCT01250119|11653027|FG000|NOT COMPLETED|Diagnostic Phase||113
10502400|NCT01250119|11653028|FG001|NOT COMPLETED|Diagnostic Phase||0
10502401|NCT01250119|11653027|FG000|STARTED|Treatment Phase||0
10502402|NCT01250119|11653028|FG001|STARTED|Treatment Phase|Out of 52 participants with positive EGFR mutation test result, only 41 participants were treated.|41
10502403|NCT01250119|11653027|FG000|COMPLETED|Treatment Phase||0
10502404|NCT01250119|11653028|FG001|COMPLETED|Treatment Phase||0
10502405|NCT01250119|11653027|FG000|NOT COMPLETED|Treatment Phase||0
10502406|NCT01250119|11653028|FG001|NOT COMPLETED|Treatment Phase||41
10502407|NCT01250145|11653037|FG000|STARTED|Overall Study||41
10502408|NCT01250145|11653038|FG001|STARTED|Overall Study||210
10502409|NCT01250145|11653037|FG000|COMPLETED|Overall Study||39
10502410|NCT01250145|11653038|FG001|COMPLETED|Overall Study||205
10502411|NCT01250145|11653037|FG000|NOT COMPLETED|Overall Study||2
10502412|NCT01250145|11653038|FG001|NOT COMPLETED|Overall Study||5
10502413|NCT01250171|11653061|FG000|STARTED|Overall Study||26
10502414|NCT01250171|11653062|FG001|STARTED|Overall Study||22
10502415|NCT01250171|11653063|FG002|STARTED|Overall Study||24
10502416|NCT01250171|11653061|FG000|COMPLETED|Overall Study||25
10502417|NCT01250171|11653062|FG001|COMPLETED|Overall Study||22
10502418|NCT01250171|11653063|FG002|COMPLETED|Overall Study||24
10502419|NCT01250171|11653061|FG000|NOT COMPLETED|Overall Study||1
10502420|NCT01250171|11653062|FG001|NOT COMPLETED|Overall Study||0
10502421|NCT01250171|11653063|FG002|NOT COMPLETED|Overall Study||0
10502422|NCT01250184|11653074|FG000|STARTED|Overall Study||43
10502423|NCT01250184|11653075|FG001|STARTED|Overall Study||41
10502424|NCT01250184|11653076|FG002|STARTED|Overall Study||43
10502425|NCT01250184|11653074|FG000|COMPLETED|Overall Study||43
10502426|NCT01250184|11653075|FG001|COMPLETED|Overall Study||41
10502427|NCT01250184|11653076|FG002|COMPLETED|Overall Study||43
10502428|NCT01250184|11653074|FG000|NOT COMPLETED|Overall Study||0
10502429|NCT01250184|11653075|FG001|NOT COMPLETED|Overall Study||0
10502430|NCT01250184|11653076|FG002|NOT COMPLETED|Overall Study||0
10502431|NCT01250210|11653087|FG000|STARTED|Overall Study||45
10502432|NCT01250210|11653088|FG001|STARTED|Overall Study||45
10502433|NCT01250210|11653089|FG002|STARTED|Overall Study||33
10502434|NCT01250210|11653087|FG000|COMPLETED|Overall Study||41
10502435|NCT01250210|11653088|FG001|COMPLETED|Overall Study||41
10502436|NCT01250210|11653089|FG002|COMPLETED|Overall Study||25
10502437|NCT01250210|11653087|FG000|NOT COMPLETED|Overall Study||4
10502438|NCT01250210|11653088|FG001|NOT COMPLETED|Overall Study||4
10502439|NCT01250210|11653089|FG002|NOT COMPLETED|Overall Study||8
10502440|NCT01250379|11653099|FG000|STARTED|Overall Study||247
10502441|NCT01250379|11653100|FG001|STARTED|Overall Study||247
10502442|NCT01250379|11653099|FG000|COMPLETED|Overall Study|Participants under study follow-up as of Data Cutoff 30 April 2015 were considered as completers.|45
10502443|NCT01250379|11653100|FG001|COMPLETED|Overall Study|Participants under study follow-up as of Data Cutoff 30 April 2015 were considered as completers.|54
10502444|NCT01250379|11653099|FG000|NOT COMPLETED|Overall Study||202
10502445|NCT01250379|11653100|FG001|NOT COMPLETED|Overall Study||193
10502446|NCT01250418|11653108|FG000|STARTED|Overall Study||9
10502447|NCT01250418|11653109|FG001|STARTED|Overall Study||16
10502448|NCT01250418|11653108|FG000|COMPLETED|Overall Study||8
10502449|NCT01250418|11653109|FG001|COMPLETED|Overall Study||15
10502450|NCT01250418|11653108|FG000|NOT COMPLETED|Overall Study||1
10502451|NCT01250418|11653109|FG001|NOT COMPLETED|Overall Study||1
10502452|NCT01250509|11653117|FG000|STARTED|Overall Study||24
10502453|NCT01250509|11653118|FG001|STARTED|Overall Study||23
10502454|NCT01250509|11653117|FG000|COMPLETED|Overall Study||19
10502455|NCT01250509|11653118|FG001|COMPLETED|Overall Study||21
10502456|NCT01250509|11653117|FG000|NOT COMPLETED|Overall Study||5
10502457|NCT01250509|11653118|FG001|NOT COMPLETED|Overall Study||2
10502458|NCT01250717|11653126|FG000|STARTED|Overall Study||28
10502459|NCT01250717|11653126|FG000|COMPLETED|Overall Study||28
10502460|NCT01250717|11653126|FG000|NOT COMPLETED|Overall Study||0
10502461|NCT01250730|11653133|FG000|STARTED|Overall Study||6
10502462|NCT01250730|11653134|FG001|STARTED|Overall Study||6
10502463|NCT01250730|11653135|FG002|STARTED|Overall Study||6
10502464|NCT01250730|11653133|FG000|COMPLETED|Overall Study||6
10502465|NCT01250730|11653134|FG001|COMPLETED|Overall Study||6
10502466|NCT01250730|11653135|FG002|COMPLETED|Overall Study||6
10502467|NCT01250730|11653133|FG000|NOT COMPLETED|Overall Study||0
10502468|NCT01250730|11653134|FG001|NOT COMPLETED|Overall Study||0
10502469|NCT01250730|11653135|FG002|NOT COMPLETED|Overall Study||0
10502470|NCT01250756|11653145|FG000|STARTED|Infant Series||161
10502471|NCT01250756|11653146|FG001|STARTED|Infant Series||160
10502472|NCT01250756|11653145|FG000|Vaccinated Dose 1|Infant Series||159
10710694|NCT02653144|11876010|FG002|NOT COMPLETED|Overall Study||0
10502473|NCT01250756|11653146|FG001|Vaccinated Dose 1|Infant Series||158
10502474|NCT01250756|11653145|FG000|Vaccinated Dose 2|Infant Series||147
10502475|NCT01250756|11653146|FG001|Vaccinated Dose 2|Infant Series||157
10502476|NCT01250756|11653145|FG000|Vaccinated Dose 3|Infant Series||133
10502477|NCT01250756|11653146|FG001|Vaccinated Dose 3|Infant Series||155
10502478|NCT01250756|11653145|FG000|COMPLETED|Infant Series||133
10502479|NCT01250756|11653146|FG001|COMPLETED|Infant Series||153
10502480|NCT01250756|11653145|FG000|NOT COMPLETED|Infant Series||28
10502481|NCT01250756|11653146|FG001|NOT COMPLETED|Infant Series||7
10502482|NCT01250756|11653145|FG000|STARTED|After Infant Series||133
10502483|NCT01250756|11653146|FG001|STARTED|After Infant Series||153
10502484|NCT01250756|11653145|FG000|COMPLETED|After Infant Series||122
10502485|NCT01250756|11653146|FG001|COMPLETED|After Infant Series||149
10502486|NCT01250756|11653145|FG000|NOT COMPLETED|After Infant Series||11
10502487|NCT01250756|11653146|FG001|NOT COMPLETED|After Infant Series||4
10502488|NCT01250756|11653145|FG000|STARTED|Toddler Dose||122
10502489|NCT01250756|11653146|FG001|STARTED|Toddler Dose||149
10502490|NCT01250756|11653145|FG000|COMPLETED|Toddler Dose||122
10502491|NCT01250756|11653146|FG001|COMPLETED|Toddler Dose||148
10502492|NCT01250756|11653145|FG000|NOT COMPLETED|Toddler Dose||0
10502493|NCT01250756|11653146|FG001|NOT COMPLETED|Toddler Dose||1
10502494|NCT01250756|11653145|FG000|STARTED|After Toddler Dose||0
10502495|NCT01250756|11653146|FG001|STARTED|After Toddler Dose||148
10502496|NCT01250756|11653145|FG000|COMPLETED|After Toddler Dose||0
10502497|NCT01250756|11653146|FG001|COMPLETED|After Toddler Dose||147
10502498|NCT01250756|11653145|FG000|NOT COMPLETED|After Toddler Dose||0
10502499|NCT01250756|11653146|FG001|NOT COMPLETED|After Toddler Dose||1
10502500|NCT01250769|11653162|FG000|STARTED|Overall Study||11
10502501|NCT01250769|11653163|FG001|STARTED|Overall Study||73
10502502|NCT01250769|11653164|FG002|STARTED|Overall Study||75
10502503|NCT01250769|11653165|FG003|STARTED|Overall Study||11
10502504|NCT01250769|11653162|FG000|Day 14|Overall Study||11
10502505|NCT01250769|11653163|FG001|Day 14|Overall Study||72
10502506|NCT01250769|11653164|FG002|Day 14|Overall Study||74
10502507|NCT01250769|11653165|FG003|Day 14|Overall Study||11
10502508|NCT01250769|11653162|FG000|COMPLETED|Overall Study||11
10502509|NCT01250769|11653163|FG001|COMPLETED|Overall Study||72
10502510|NCT01250769|11653164|FG002|COMPLETED|Overall Study||73
10502511|NCT01250769|11653165|FG003|COMPLETED|Overall Study||11
10502512|NCT01250769|11653162|FG000|NOT COMPLETED|Overall Study||0
10502513|NCT01250769|11653163|FG001|NOT COMPLETED|Overall Study||1
10502514|NCT01250769|11653164|FG002|NOT COMPLETED|Overall Study||2
10502515|NCT01250769|11653165|FG003|NOT COMPLETED|Overall Study||0
10502516|NCT01250834|11653175|FG000|STARTED|Overall Study||27
10502517|NCT01250834|11653175|FG000|COMPLETED|Overall Study||27
10502518|NCT01250834|11653175|FG000|NOT COMPLETED|Overall Study||0
10502519|NCT01250873|11653182|FG000|STARTED|Period 1: LY2216684 (Days 1-3)||20
10502520|NCT01250873|11653182|FG000|COMPLETED|Period 1: LY2216684 (Days 1-3)||18
10502521|NCT01250873|11653182|FG000|NOT COMPLETED|Period 1: LY2216684 (Days 1-3)||2
10502522|NCT01250873|11653182|FG000|STARTED|Period 2: Sertraline (Day 4, 5-10)||18
10502523|NCT01250873|11653182|FG000|COMPLETED|Period 2: Sertraline (Day 4, 5-10)||18
10502524|NCT01250873|11653182|FG000|NOT COMPLETED|Period 2: Sertraline (Day 4, 5-10)||0
10502525|NCT01250873|11653182|FG000|STARTED|Period 3:LY2216684+Sertraline(Days11-13)||18
10502526|NCT01250873|11653182|FG000|COMPLETED|Period 3:LY2216684+Sertraline(Days11-13)||17
10502527|NCT01250873|11653182|FG000|NOT COMPLETED|Period 3:LY2216684+Sertraline(Days11-13)||1
10502528|NCT01250899|11653190|FG000|STARTED|Overall Study||40
10502529|NCT01250899|11653191|FG001|STARTED|Overall Study||82
10502530|NCT01250899|11653190|FG000|COMPLETED|Overall Study||40
10502531|NCT01250899|11653191|FG001|COMPLETED|Overall Study||82
10502532|NCT01250899|11653190|FG000|NOT COMPLETED|Overall Study||0
10502533|NCT01250899|11653191|FG001|NOT COMPLETED|Overall Study||0
10502534|NCT01250925|11653198|FG000|STARTED|Overall Study||31
10502535|NCT01250925|11653199|FG001|STARTED|Overall Study||31
10502536|NCT01250925|11653200|FG002|STARTED|Overall Study||32
10502537|NCT01250925|11653198|FG000|COMPLETED|Overall Study||26
10502538|NCT01250925|11653199|FG001|COMPLETED|Overall Study||28
10502539|NCT01250925|11653200|FG002|COMPLETED|Overall Study||30
10502540|NCT01250925|11653198|FG000|NOT COMPLETED|Overall Study||5
10502541|NCT01250925|11653199|FG001|NOT COMPLETED|Overall Study||3
10502542|NCT01250925|11653200|FG002|NOT COMPLETED|Overall Study||2
10502543|NCT01250977|11653210|FG000|STARTED|Overall Study||6
10502544|NCT01250977|11653211|FG001|STARTED|Overall Study||14
10502545|NCT01250977|11653210|FG000|COMPLETED|Overall Study||6
10502546|NCT01250977|11653211|FG001|COMPLETED|Overall Study||12
10502547|NCT01250977|11653210|FG000|NOT COMPLETED|Overall Study||0
10502548|NCT01250977|11653211|FG001|NOT COMPLETED|Overall Study||2
10502549|NCT01250990|11653219|FG000|STARTED|Overall Study||11
10502550|NCT01250990|11653220|FG001|STARTED|Overall Study||11
10502551|NCT01250990|11653219|FG000|COMPLETED|Overall Study||7
10502552|NCT01250990|11653220|FG001|COMPLETED|Overall Study||9
10502553|NCT01250990|11653219|FG000|NOT COMPLETED|Overall Study||4
10502554|NCT01250990|11653220|FG001|NOT COMPLETED|Overall Study||2
10502555|NCT01251042|11653228|FG000|STARTED|Overall Study||26
10502556|NCT01251042|11653229|FG001|STARTED|Overall Study||23
10502557|NCT01251042|11653228|FG000|COMPLETED|Overall Study||26
10502558|NCT01251042|11653229|FG001|COMPLETED|Overall Study||23
10502559|NCT01251042|11653228|FG000|NOT COMPLETED|Overall Study||0
10502560|NCT01251042|11653229|FG001|NOT COMPLETED|Overall Study||0
10502561|NCT01251146|11653237|FG000|STARTED|Overall Study||86
10502562|NCT01251146|11653238|FG001|STARTED|Overall Study||91
10502563|NCT01251146|11653237|FG000|COMPLETED|Overall Study||83
10502564|NCT01251146|11653238|FG001|COMPLETED|Overall Study||81
10502565|NCT01251146|11653237|FG000|NOT COMPLETED|Overall Study||3
10502566|NCT01251146|11653238|FG001|NOT COMPLETED|Overall Study||10
10502575|NCT01251315|11653259|FG000|STARTED|Overall Study||4
10502576|NCT01251315|11653260|FG001|STARTED|Overall Study||4
10502577|NCT01251315|11653261|FG002|STARTED|Overall Study||4
10502578|NCT01251315|11653262|FG003|STARTED|Overall Study||4
10502579|NCT01251315|11653263|FG004|STARTED|Overall Study||4
10502580|NCT01251315|11653264|FG005|STARTED|Overall Study||4
10502581|NCT01251315|11653259|FG000|COMPLETED|Overall Study||4
10502582|NCT01251315|11653260|FG001|COMPLETED|Overall Study||4
10502583|NCT01251315|11653261|FG002|COMPLETED|Overall Study||4
10502584|NCT01251315|11653262|FG003|COMPLETED|Overall Study||4
10502585|NCT01251315|11653263|FG004|COMPLETED|Overall Study||4
10502586|NCT01251315|11653264|FG005|COMPLETED|Overall Study||4
10502587|NCT01251315|11653259|FG000|NOT COMPLETED|Overall Study||0
10502588|NCT01251315|11653260|FG001|NOT COMPLETED|Overall Study||0
10502589|NCT01251315|11653261|FG002|NOT COMPLETED|Overall Study||0
10502590|NCT01251315|11653262|FG003|NOT COMPLETED|Overall Study||0
10502591|NCT01251315|11653263|FG004|NOT COMPLETED|Overall Study||0
10502592|NCT01251315|11653264|FG005|NOT COMPLETED|Overall Study||0
10502593|NCT01251354|11653282|FG000|STARTED|Overall Study||6
10502594|NCT01251354|11653282|FG000|COMPLETED|Overall Study||0
10502595|NCT01251354|11653282|FG000|NOT COMPLETED|Overall Study||6
10502610|NCT01251393|11653301|FG000|STARTED|Overall Study||56
10502611|NCT01251393|11653302|FG001|STARTED|Overall Study||55
10502612|NCT01251393|11653301|FG000|COMPLETED|Overall Study||24
10502613|NCT01251393|11653302|FG001|COMPLETED|Overall Study||11
10502614|NCT01251393|11653301|FG000|NOT COMPLETED|Overall Study||32
10502615|NCT01251393|11653302|FG001|NOT COMPLETED|Overall Study||44
10502616|NCT01251536|11653311|FG000|STARTED|Overall Study||8
10502617|NCT01251536|11653312|FG001|STARTED|Overall Study||93
10502618|NCT01251536|11653313|FG002|STARTED|Overall Study||7
10502619|NCT01251536|11653311|FG000|COMPLETED|Overall Study||8
10502620|NCT01251536|11653312|FG001|COMPLETED|Overall Study||93
10502621|NCT01251536|11653313|FG002|COMPLETED|Overall Study||7
10502622|NCT01251536|11653311|FG000|NOT COMPLETED|Overall Study||0
10502623|NCT01251536|11653312|FG001|NOT COMPLETED|Overall Study||0
10502624|NCT01251536|11653313|FG002|NOT COMPLETED|Overall Study||0
10502625|NCT01251575|11653323|FG000|STARTED|Overall Study||77
10502626|NCT01251575|11653323|FG000|COMPLETED|Overall Study||76
10502627|NCT01251575|11653323|FG000|NOT COMPLETED|Overall Study||1
10502628|NCT01251588|11653331|FG000|STARTED|Overall Study||65
10502629|NCT01251588|11653332|FG001|STARTED|Overall Study||63
10502630|NCT01251588|11653331|FG000|COMPLETED|Overall Study||65
10502631|NCT01251588|11653332|FG001|COMPLETED|Overall Study||59
10502632|NCT01251588|11653331|FG000|NOT COMPLETED|Overall Study||0
10502633|NCT01251588|11653332|FG001|NOT COMPLETED|Overall Study||4
10502634|NCT01251614|11653343|FG000|STARTED|Overall Study||37
10502635|NCT01251614|11653344|FG001|STARTED|Overall Study||39
10502636|NCT01251614|11653345|FG002|STARTED|Overall Study||38
10502637|NCT01251614|11653343|FG000|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|13
10502638|NCT01251614|11653344|FG001|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|18
10502639|NCT01251614|11653345|FG002|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|23
10502640|NCT01251614|11653343|FG000|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|8
10502641|NCT01251614|11653344|FG001|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|11
10502642|NCT01251614|11653345|FG002|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|19
10502643|NCT01251614|11653343|FG000|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
10502644|NCT01251614|11653344|FG001|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
10502645|NCT01251614|11653345|FG002|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
10502646|NCT01251614|11653343|FG000|COMPLETED|Overall Study||34
10502647|NCT01251614|11653344|FG001|COMPLETED|Overall Study||26
10502648|NCT01251614|11653345|FG002|COMPLETED|Overall Study||30
10502649|NCT01251614|11653343|FG000|NOT COMPLETED|Overall Study||3
10502650|NCT01251614|11653344|FG001|NOT COMPLETED|Overall Study||13
10502651|NCT01251614|11653345|FG002|NOT COMPLETED|Overall Study||8
10502652|NCT01251653|11653372|FG000|STARTED|Overall Study||3
10502653|NCT01251653|11653373|FG001|STARTED|Overall Study||8
10502654|NCT01251653|11653374|FG002|STARTED|Overall Study||20
10502655|NCT01251653|11653375|FG003|STARTED|Overall Study||6
10502656|NCT01251653|11653376|FG004|STARTED|Overall Study||2
10502657|NCT01251653|11653377|FG005|STARTED|Overall Study||18
10502658|NCT01251653|11653378|FG006|STARTED|Overall Study||18
10502659|NCT01251653|11653379|FG007|STARTED|Overall Study||12
10502660|NCT01251653|11653380|FG008|STARTED|Overall Study||6
10502661|NCT01251653|11653372|FG000|COMPLETED|Overall Study||0
10502662|NCT01251653|11653373|FG001|COMPLETED|Overall Study||0
10502663|NCT01251653|11653374|FG002|COMPLETED|Overall Study||0
10502664|NCT01251653|11653375|FG003|COMPLETED|Overall Study||0
10502665|NCT01251653|11653376|FG004|COMPLETED|Overall Study||0
10502666|NCT01251653|11653377|FG005|COMPLETED|Overall Study||0
10502667|NCT01251653|11653378|FG006|COMPLETED|Overall Study||0
10502668|NCT01251653|11653379|FG007|COMPLETED|Overall Study||0
10502669|NCT01251653|11653380|FG008|COMPLETED|Overall Study||0
10502670|NCT01251653|11653372|FG000|NOT COMPLETED|Overall Study||3
10502671|NCT01251653|11653373|FG001|NOT COMPLETED|Overall Study||8
10502672|NCT01251653|11653374|FG002|NOT COMPLETED|Overall Study||20
10502673|NCT01251653|11653375|FG003|NOT COMPLETED|Overall Study||6
10502674|NCT01251653|11653376|FG004|NOT COMPLETED|Overall Study||2
10502675|NCT01251653|11653377|FG005|NOT COMPLETED|Overall Study||18
10502676|NCT01251653|11653378|FG006|NOT COMPLETED|Overall Study||18
10502677|NCT01251653|11653379|FG007|NOT COMPLETED|Overall Study||12
10502678|NCT01251653|11653380|FG008|NOT COMPLETED|Overall Study||6
10502679|NCT01251744|11653418|FG000|STARTED|Overall Study||77
10502680|NCT01251744|11653419|FG001|STARTED|Overall Study||78
10502681|NCT01251744|11653418|FG000|COMPLETED|Overall Study||76
10502682|NCT01251744|11653419|FG001|COMPLETED|Overall Study||78
10502683|NCT01251744|11653418|FG000|NOT COMPLETED|Overall Study||1
10502684|NCT01251744|11653419|FG001|NOT COMPLETED|Overall Study||0
10502685|NCT01251757|11653435|FG000|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7255
10502686|NCT01251757|11653436|FG001|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7247
10502687|NCT01251757|11653437|FG002|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7250
10502688|NCT01251757|11653435|FG000|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.7 (2.3) mos, but we computed an adherence score for everyone.|7255
10502689|NCT01251757|11653436|FG001|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.6 (2.4) mos, but we computed an adherence score for everyone.|7247
10502690|NCT01251757|11653437|FG002|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.6 (2.5) mos, but we computed an adherence score for everyone.|7250
10502691|NCT01251757|11653435|FG000|NOT COMPLETED|Overall Study||0
10502692|NCT01251757|11653436|FG001|NOT COMPLETED|Overall Study||0
10502693|NCT01251757|11653437|FG002|NOT COMPLETED|Overall Study||0
10502694|NCT01251770|11653451|FG000|STARTED|Overall Study||42
10502695|NCT01251770|11653452|FG001|STARTED|Overall Study||36
10502696|NCT01251770|11653451|FG000|COMPLETED|Overall Study||29
10502697|NCT01251770|11653452|FG001|COMPLETED|Overall Study||29
10502698|NCT01251770|11653451|FG000|NOT COMPLETED|Overall Study||13
10502699|NCT01251770|11653452|FG001|NOT COMPLETED|Overall Study||7
10502700|NCT01251887|11653461|FG000|STARTED|Overall Study||18
10502701|NCT01251887|11653462|FG001|STARTED|Overall Study||29
10502702|NCT01251887|11653463|FG002|STARTED|Overall Study||18
10502703|NCT01251887|11653461|FG000|COMPLETED|Overall Study||17
10502704|NCT01251887|11653462|FG001|COMPLETED|Overall Study||26
10502705|NCT01251887|11653463|FG002|COMPLETED|Overall Study||16
10502706|NCT01251887|11653461|FG000|NOT COMPLETED|Overall Study||1
10502707|NCT01251887|11653462|FG001|NOT COMPLETED|Overall Study||3
10502708|NCT01251887|11653463|FG002|NOT COMPLETED|Overall Study||2
10502709|NCT01251965|11653474|FG000|STARTED|Overall Study||4
10502710|NCT01251965|11653475|FG001|STARTED|Overall Study||5
10502711|NCT01251965|11653476|FG002|STARTED|Overall Study||18
10502712|NCT01251965|11653474|FG000|COMPLETED|Overall Study||3
10502713|NCT01251965|11653475|FG001|COMPLETED|Overall Study||3
10502714|NCT01251965|11653476|FG002|COMPLETED|Overall Study||7
10502715|NCT01251965|11653474|FG000|NOT COMPLETED|Overall Study||1
10502716|NCT01251965|11653475|FG001|NOT COMPLETED|Overall Study||2
10502717|NCT01251965|11653476|FG002|NOT COMPLETED|Overall Study||11
10502718|NCT01251978|11653487|FG000|STARTED|Overall Study||5
10502719|NCT01251978|11653488|FG001|STARTED|Overall Study||3
10502720|NCT01251978|11653487|FG000|COMPLETED|Overall Study||5
10502721|NCT01251978|11653488|FG001|COMPLETED|Overall Study||3
10502722|NCT01251978|11653487|FG000|NOT COMPLETED|Overall Study||0
10502723|NCT01251978|11653488|FG001|NOT COMPLETED|Overall Study||0
10502724|NCT01252095|11653496|FG000|STARTED|Overall Study||3
10502725|NCT01252095|11653497|FG001|STARTED|Overall Study||1
10502726|NCT01252095|11653496|FG000|COMPLETED|Overall Study||2
10502727|NCT01252095|11653497|FG001|COMPLETED|Overall Study||1
10502728|NCT01252095|11653496|FG000|NOT COMPLETED|Overall Study||1
10502729|NCT01252095|11653497|FG001|NOT COMPLETED|Overall Study||0
10502730|NCT01252134|11653503|FG000|STARTED|Period 1, 8 Hours||3
10502731|NCT01252134|11653504|FG001|STARTED|Period 1, 8 Hours||4
10502732|NCT01252134|11653505|FG002|STARTED|Period 1, 8 Hours||3
10502733|NCT01252134|11653506|FG003|STARTED|Period 1, 8 Hours||5
10502734|NCT01252134|11653507|FG004|STARTED|Period 1, 8 Hours||3
10502735|NCT01252134|11653508|FG005|STARTED|Period 1, 8 Hours||4
10502736|NCT01252134|11653503|FG000|COMPLETED|Period 1, 8 Hours||3
10502737|NCT01252134|11653504|FG001|COMPLETED|Period 1, 8 Hours||3
10502738|NCT01252134|11653505|FG002|COMPLETED|Period 1, 8 Hours||2
10502739|NCT01252134|11653506|FG003|COMPLETED|Period 1, 8 Hours||5
10502740|NCT01252134|11653507|FG004|COMPLETED|Period 1, 8 Hours||3
10502741|NCT01252134|11653508|FG005|COMPLETED|Period 1, 8 Hours||4
10502742|NCT01252134|11653503|FG000|NOT COMPLETED|Period 1, 8 Hours||0
10502743|NCT01252134|11653504|FG001|NOT COMPLETED|Period 1, 8 Hours||1
10502744|NCT01252134|11653505|FG002|NOT COMPLETED|Period 1, 8 Hours||1
10502745|NCT01252134|11653506|FG003|NOT COMPLETED|Period 1, 8 Hours||0
10502746|NCT01252134|11653507|FG004|NOT COMPLETED|Period 1, 8 Hours||0
10502747|NCT01252134|11653508|FG005|NOT COMPLETED|Period 1, 8 Hours||0
10502748|NCT01252134|11653503|FG000|STARTED|Period 2, 8 Hours||3
10502749|NCT01252134|11653504|FG001|STARTED|Period 2, 8 Hours||3
10502750|NCT01252134|11653505|FG002|STARTED|Period 2, 8 Hours||2
10502751|NCT01252134|11653506|FG003|STARTED|Period 2, 8 Hours||5
10502752|NCT01252134|11653507|FG004|STARTED|Period 2, 8 Hours||3
10502753|NCT01252134|11653508|FG005|STARTED|Period 2, 8 Hours||4
10502754|NCT01252134|11653503|FG000|COMPLETED|Period 2, 8 Hours||3
10502755|NCT01252134|11653504|FG001|COMPLETED|Period 2, 8 Hours||3
10502756|NCT01252134|11653505|FG002|COMPLETED|Period 2, 8 Hours||2
10502757|NCT01252134|11653506|FG003|COMPLETED|Period 2, 8 Hours||5
10502758|NCT01252134|11653507|FG004|COMPLETED|Period 2, 8 Hours||3
10502759|NCT01252134|11653508|FG005|COMPLETED|Period 2, 8 Hours||4
10502760|NCT01252134|11653503|FG000|NOT COMPLETED|Period 2, 8 Hours||0
10502761|NCT01252134|11653504|FG001|NOT COMPLETED|Period 2, 8 Hours||0
10502762|NCT01252134|11653505|FG002|NOT COMPLETED|Period 2, 8 Hours||0
10502763|NCT01252134|11653506|FG003|NOT COMPLETED|Period 2, 8 Hours||0
10502764|NCT01252134|11653507|FG004|NOT COMPLETED|Period 2, 8 Hours||0
10502765|NCT01252134|11653508|FG005|NOT COMPLETED|Period 2, 8 Hours||0
10502766|NCT01252134|11653503|FG000|STARTED|Period 3, 8 Hours||3
10502767|NCT01252134|11653504|FG001|STARTED|Period 3, 8 Hours||3
10502768|NCT01252134|11653505|FG002|STARTED|Period 3, 8 Hours||2
10502769|NCT01252134|11653506|FG003|STARTED|Period 3, 8 Hours||5
10502770|NCT01252134|11653507|FG004|STARTED|Period 3, 8 Hours||3
10502771|NCT01252134|11653508|FG005|STARTED|Period 3, 8 Hours||4
10502772|NCT01252134|11653503|FG000|COMPLETED|Period 3, 8 Hours||3
10502773|NCT01252134|11653504|FG001|COMPLETED|Period 3, 8 Hours||3
10502774|NCT01252134|11653505|FG002|COMPLETED|Period 3, 8 Hours||2
10502775|NCT01252134|11653506|FG003|COMPLETED|Period 3, 8 Hours||5
10502776|NCT01252134|11653507|FG004|COMPLETED|Period 3, 8 Hours||3
10502777|NCT01252134|11653508|FG005|COMPLETED|Period 3, 8 Hours||4
10502778|NCT01252134|11653503|FG000|NOT COMPLETED|Period 3, 8 Hours||0
10502779|NCT01252134|11653504|FG001|NOT COMPLETED|Period 3, 8 Hours||0
10502780|NCT01252134|11653505|FG002|NOT COMPLETED|Period 3, 8 Hours||0
10502781|NCT01252134|11653506|FG003|NOT COMPLETED|Period 3, 8 Hours||0
10502782|NCT01252134|11653507|FG004|NOT COMPLETED|Period 3, 8 Hours||0
10502783|NCT01252134|11653508|FG005|NOT COMPLETED|Period 3, 8 Hours||0
10502784|NCT01252147|11653516|FG000|STARTED|Overall Study||68
10502785|NCT01252147|11653516|FG000|COMPLETED|Overall Study||68
10502786|NCT01252147|11653516|FG000|NOT COMPLETED|Overall Study||0
10502787|NCT01252186|11653523|FG000|STARTED|Overall Study||87
10502788|NCT01252186|11653524|FG001|STARTED|Overall Study||91
10502789|NCT01252186|11653525|FG002|STARTED|Overall Study||87
10502790|NCT01252186|11653523|FG000|Received Study Drug|Overall Study||83
10502791|NCT01252186|11653524|FG001|Received Study Drug|Overall Study||89
10502792|NCT01252186|11653525|FG002|Received Study Drug|Overall Study||80
10502793|NCT01252186|11653523|FG000|COMPLETED|Overall Study||57
10502794|NCT01252186|11653524|FG001|COMPLETED|Overall Study||59
10502795|NCT01252186|11653525|FG002|COMPLETED|Overall Study||53
10502796|NCT01252186|11653523|FG000|NOT COMPLETED|Overall Study||30
10502797|NCT01252186|11653524|FG001|NOT COMPLETED|Overall Study||32
10502798|NCT01252186|11653525|FG002|NOT COMPLETED|Overall Study||34
10502799|NCT01252238|11653536|FG000|STARTED|Overall Study||8
10502800|NCT01252238|11653537|FG001|STARTED|Overall Study||8
10502801|NCT01252238|11653538|FG002|STARTED|Overall Study||8
10502802|NCT01252238|11653536|FG000|COMPLETED|Overall Study|sponsor terminated study|4
10502803|NCT01252238|11653537|FG001|COMPLETED|Overall Study|sponsor terminated study|4
10502804|NCT01252238|11653538|FG002|COMPLETED|Overall Study|sponsor terminated study|4
10502805|NCT01252238|11653536|FG000|NOT COMPLETED|Overall Study||4
10502806|NCT01252238|11653537|FG001|NOT COMPLETED|Overall Study||4
10502807|NCT01252238|11653538|FG002|NOT COMPLETED|Overall Study||4
10502808|NCT01252251|11653549|FG000|STARTED|Overall Study||14
10502809|NCT01252251|11653549|FG000|COMPLETED|Overall Study||13
10502810|NCT01252251|11653549|FG000|NOT COMPLETED|Overall Study||1
10502811|NCT01252277|11653553|FG000|STARTED|Overall Study||36
10502812|NCT01252277|11653553|FG000|COMPLETED|Overall Study||34
10502813|NCT01252277|11653553|FG000|NOT COMPLETED|Overall Study||2
10502814|NCT01252290|11653558|FG000|STARTED|Overall Study||35
10502815|NCT01252290|11653558|FG000|COMPLETED|Overall Study||34
10502816|NCT01252290|11653558|FG000|NOT COMPLETED|Overall Study||1
10502817|NCT01252355|11653565|FG000|STARTED|Overall Study|Randomized.|177
10502818|NCT01252355|11653566|FG001|STARTED|Overall Study|Randomized.|178
10502819|NCT01252355|11653567|FG002|STARTED|Overall Study|Randomized.|179
10502820|NCT01252355|11653565|FG000|Treated|Overall Study||175
10502821|NCT01252355|11653566|FG001|Treated|Overall Study||178
10502822|NCT01252355|11653567|FG002|Treated|Overall Study|One participant received teriflunomide 7 mg.|179
10502823|NCT01252355|11653565|FG000|COMPLETED|Overall Study||0
10502824|NCT01252355|11653566|FG001|COMPLETED|Overall Study||0
10502825|NCT01252355|11653567|FG002|COMPLETED|Overall Study||0
10502826|NCT01252355|11653565|FG000|NOT COMPLETED|Overall Study||177
10502827|NCT01252355|11653566|FG001|NOT COMPLETED|Overall Study||178
10502828|NCT01252355|11653567|FG002|NOT COMPLETED|Overall Study||179
10502829|NCT01252563|11653575|FG000|STARTED|Overall Study||13775
10502830|NCT01252563|11653575|FG000|COMPLETED|Overall Study||13343
10502831|NCT01252563|11653575|FG000|NOT COMPLETED|Overall Study||432
10502832|NCT01252667|11653616|FG000|STARTED|Overall Study||3
10502833|NCT01252667|11653617|FG001|STARTED|Overall Study||3
10502834|NCT01252667|11653618|FG002|STARTED|Overall Study||3
10502835|NCT01252667|11653619|FG003|STARTED|Overall Study||0
10502836|NCT01252667|11653620|FG004|STARTED|Overall Study||0
10502837|NCT01252667|11653621|FG005|STARTED|Overall Study||35
10502838|NCT01252667|11653616|FG000|COMPLETED|Overall Study||3
10502839|NCT01252667|11653617|FG001|COMPLETED|Overall Study||3
10502840|NCT01252667|11653618|FG002|COMPLETED|Overall Study||3
10502841|NCT01252667|11653619|FG003|COMPLETED|Overall Study||0
10502842|NCT01252667|11653620|FG004|COMPLETED|Overall Study||0
10502843|NCT01252667|11653621|FG005|COMPLETED|Overall Study||34
10502844|NCT01252667|11653616|FG000|NOT COMPLETED|Overall Study||0
10502845|NCT01252667|11653617|FG001|NOT COMPLETED|Overall Study||0
10502846|NCT01252667|11653618|FG002|NOT COMPLETED|Overall Study||0
10502847|NCT01252667|11653619|FG003|NOT COMPLETED|Overall Study||0
10502848|NCT01252667|11653620|FG004|NOT COMPLETED|Overall Study||0
10502849|NCT01252667|11653621|FG005|NOT COMPLETED|Overall Study||1
10502850|NCT01252732|11653637|FG000|STARTED|Overall Study|Randomized|509
10502851|NCT01252732|11653638|FG001|STARTED|Overall Study|Randomized|510
10502852|NCT01252732|11653637|FG000|Modified Intent to Treat Population|Overall Study||503
10502853|NCT01252732|11653638|FG001|Modified Intent to Treat Population|Overall Study||502
10502854|NCT01252732|11653637|FG000|COMPLETED|Overall Study||455
10502855|NCT01252732|11653638|FG001|COMPLETED|Overall Study||446
10502856|NCT01252732|11653637|FG000|NOT COMPLETED|Overall Study||54
10710695|NCT02653170|11876021|FG000|STARTED|Overall Study||87
10710696|NCT02653170|11876022|FG001|STARTED|Overall Study||88
10710697|NCT02653170|11876023|FG002|STARTED|Overall Study||90
10710698|NCT02653170|11876021|FG000|COMPLETED|Overall Study||70
10502857|NCT01252732|11653638|FG001|NOT COMPLETED|Overall Study||64
10502858|NCT01252745|11653647|FG000|STARTED|Overall Study||8
10502859|NCT01252745|11653648|FG001|STARTED|Overall Study||7
10502860|NCT01252745|11653649|FG002|STARTED|Overall Study||7
10502861|NCT01252745|11653647|FG000|COMPLETED|Overall Study||8
10502862|NCT01252745|11653648|FG001|COMPLETED|Overall Study||7
10502863|NCT01252745|11653649|FG002|COMPLETED|Overall Study||7
10502864|NCT01252745|11653647|FG000|NOT COMPLETED|Overall Study||0
10502865|NCT01252745|11653648|FG001|NOT COMPLETED|Overall Study||0
10502866|NCT01252745|11653649|FG002|NOT COMPLETED|Overall Study||0
10502867|NCT01252810|11653662|FG000|STARTED|Overall Study||142
10502868|NCT01252810|11653663|FG001|STARTED|Overall Study||142
10502869|NCT01252810|11653662|FG000|COMPLETED|Overall Study||128
10502870|NCT01252810|11653663|FG001|COMPLETED|Overall Study||139
10502871|NCT01252810|11653662|FG000|NOT COMPLETED|Overall Study||14
10502872|NCT01252810|11653663|FG001|NOT COMPLETED|Overall Study||3
10502873|NCT01252940|11653671|FG000|STARTED|Main Study Phase||321
10502874|NCT01252940|11653672|FG001|STARTED|Main Study Phase||161
10502875|NCT01252940|11653671|FG000|Completed 24 Weeks|Main Study Phase||0
10502876|NCT01252940|11653672|FG001|Completed 24 Weeks|Main Study Phase|152 participants switched regimens at Week 24.|153
10502877|NCT01252940|11653671|FG000|COMPLETED|Main Study Phase||295
10502878|NCT01252940|11653672|FG001|COMPLETED|Main Study Phase|Discontinuations after switch: withdrawal by subject, 2; adverse event, 1; protocol violation, 1.|149
10502879|NCT01252940|11653671|FG000|NOT COMPLETED|Main Study Phase||26
10502880|NCT01252940|11653672|FG001|NOT COMPLETED|Main Study Phase||12
10502881|NCT01252940|11653671|FG000|STARTED|Extension Phase|FTC/RPV/TDF group: 110 participants completing the main study continued in extension phase.|110
10502882|NCT01252940|11653672|FG001|STARTED|Extension Phase|SBR/Delayed Switch Group: 49 participants completing the main study continued in extension phase.|49
10502883|NCT01252940|11653671|FG000|COMPLETED|Extension Phase||100
10502884|NCT01252940|11653672|FG001|COMPLETED|Extension Phase||46
10502885|NCT01252940|11653671|FG000|NOT COMPLETED|Extension Phase||10
10502886|NCT01252940|11653672|FG001|NOT COMPLETED|Extension Phase||3
10502887|NCT01252966|11653681|FG000|STARTED|Overall Study||108
10502888|NCT01252966|11653682|FG001|STARTED|Overall Study||105
10502889|NCT01252966|11653681|FG000|COMPLETED|Overall Study||85
10502890|NCT01252966|11653682|FG001|COMPLETED|Overall Study||92
10502891|NCT01252966|11653681|FG000|NOT COMPLETED|Overall Study||23
10502892|NCT01252966|11653682|FG001|NOT COMPLETED|Overall Study||13
10502893|NCT01253018|11653692|FG000|STARTED|Overall Study||22
10502894|NCT01253018|11653693|FG001|STARTED|Overall Study||23
10502895|NCT01253018|11653692|FG000|COMPLETED|Overall Study||18
10502896|NCT01253018|11653693|FG001|COMPLETED|Overall Study||21
10502897|NCT01253018|11653692|FG000|NOT COMPLETED|Overall Study||4
10502898|NCT01253018|11653693|FG001|NOT COMPLETED|Overall Study||2
10710699|NCT02653170|11876022|FG001|COMPLETED|Overall Study||72
10502899|NCT01253044|11653702|FG000|STARTED|Overall Study||80
10502900|NCT01253044|11653703|FG001|STARTED|Overall Study||80
10502901|NCT01253044|11653702|FG000|COMPLETED|Overall Study||42
10502902|NCT01253044|11653703|FG001|COMPLETED|Overall Study||51
10502903|NCT01253044|11653702|FG000|NOT COMPLETED|Overall Study||38
10502904|NCT01253044|11653703|FG001|NOT COMPLETED|Overall Study||29
10502905|NCT01253135|11653709|FG000|STARTED|Original Protocol||15
10710700|NCT02653170|11876023|FG002|COMPLETED|Overall Study||72
10710701|NCT02653170|11876021|FG000|NOT COMPLETED|Overall Study||17
10502906|NCT01253135|11653709|FG000|COMPLETED|Original Protocol||0
10502907|NCT01253135|11653709|FG000|NOT COMPLETED|Original Protocol||15
10502908|NCT01253135|11653709|FG000|STARTED|Amended Protocol||25
10502909|NCT01253135|11653709|FG000|COMPLETED|Amended Protocol||24
10502910|NCT01253135|11653709|FG000|NOT COMPLETED|Amended Protocol||1
10502911|NCT01253148|11653717|FG000|STARTED|Overall Study||25
10502912|NCT01253148|11653717|FG000|COMPLETED|Overall Study||25
10502913|NCT01253148|11653717|FG000|NOT COMPLETED|Overall Study||0
10502914|NCT01253174|11653721|FG000|STARTED|Period 1||6
10502915|NCT01253174|11653722|FG001|STARTED|Period 1||10
10502916|NCT01253174|11653723|FG002|STARTED|Period 1||9
10502917|NCT01253174|11653724|FG003|STARTED|Period 1||7
10502918|NCT01253174|11653725|FG004|STARTED|Period 1||9
10502919|NCT01253174|11653726|FG005|STARTED|Period 1||7
10502920|NCT01253174|11653721|FG000|COMPLETED|Period 1||6
10502921|NCT01253174|11653722|FG001|COMPLETED|Period 1||9
10502922|NCT01253174|11653723|FG002|COMPLETED|Period 1||8
10502923|NCT01253174|11653724|FG003|COMPLETED|Period 1||7
10502924|NCT01253174|11653725|FG004|COMPLETED|Period 1||8
10502925|NCT01253174|11653726|FG005|COMPLETED|Period 1||7
10650400|NCT02169414|11810682|FG003|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
10650401|NCT02169414|11810679|FG000|COMPLETED|Overall Study||18
10650402|NCT02169414|11810680|FG001|COMPLETED|Overall Study||18
10650403|NCT02169414|11810681|FG002|COMPLETED|Overall Study||18
10650404|NCT02169414|11810682|FG003|COMPLETED|Overall Study||18
10650405|NCT02169414|11810679|FG000|NOT COMPLETED|Overall Study||1
10650406|NCT02169414|11810680|FG001|NOT COMPLETED|Overall Study||1
10650407|NCT02169414|11810681|FG002|NOT COMPLETED|Overall Study||0
10650408|NCT02169414|11810682|FG003|NOT COMPLETED|Overall Study||0
10650409|NCT02169427|11810696|FG000|STARTED|Overall Study||6
10650410|NCT02169427|11810696|FG000|COMPLETED|Overall Study||6
10650411|NCT02169427|11810696|FG000|NOT COMPLETED|Overall Study||0
10650412|NCT02169440|11810702|FG000|STARTED|Overall Study||10
10650413|NCT02169440|11810703|FG001|STARTED|Overall Study||10
10502926|NCT01253174|11653721|FG000|NOT COMPLETED|Period 1||0
10502927|NCT01253174|11653722|FG001|NOT COMPLETED|Period 1||1
10502928|NCT01253174|11653723|FG002|NOT COMPLETED|Period 1||1
10502929|NCT01253174|11653724|FG003|NOT COMPLETED|Period 1||0
10502930|NCT01253174|11653725|FG004|NOT COMPLETED|Period 1||1
10502931|NCT01253174|11653726|FG005|NOT COMPLETED|Period 1||0
10502932|NCT01253174|11653721|FG000|STARTED|Period 2||6
10502933|NCT01253174|11653722|FG001|STARTED|Period 2||9
10502934|NCT01253174|11653723|FG002|STARTED|Period 2||8
10502935|NCT01253174|11653724|FG003|STARTED|Period 2||7
10502936|NCT01253174|11653725|FG004|STARTED|Period 2||8
10502937|NCT01253174|11653726|FG005|STARTED|Period 2||7
10502938|NCT01253174|11653721|FG000|COMPLETED|Period 2||6
10502939|NCT01253174|11653722|FG001|COMPLETED|Period 2||9
10502940|NCT01253174|11653723|FG002|COMPLETED|Period 2||7
10502941|NCT01253174|11653724|FG003|COMPLETED|Period 2||7
10502942|NCT01253174|11653725|FG004|COMPLETED|Period 2||8
10502943|NCT01253174|11653726|FG005|COMPLETED|Period 2||7
10502944|NCT01253174|11653721|FG000|NOT COMPLETED|Period 2||0
10502945|NCT01253174|11653722|FG001|NOT COMPLETED|Period 2||0
10502946|NCT01253174|11653723|FG002|NOT COMPLETED|Period 2||1
10502947|NCT01253174|11653724|FG003|NOT COMPLETED|Period 2||0
10502948|NCT01253174|11653725|FG004|NOT COMPLETED|Period 2||0
10502949|NCT01253174|11653726|FG005|NOT COMPLETED|Period 2||0
10502950|NCT01253174|11653721|FG000|STARTED|Period 3||6
10502951|NCT01253174|11653722|FG001|STARTED|Period 3||9
10502952|NCT01253174|11653723|FG002|STARTED|Period 3||7
10502953|NCT01253174|11653724|FG003|STARTED|Period 3||7
10502954|NCT01253174|11653725|FG004|STARTED|Period 3||8
10502955|NCT01253174|11653726|FG005|STARTED|Period 3||7
10502956|NCT01253174|11653721|FG000|COMPLETED|Period 3||6
10502957|NCT01253174|11653722|FG001|COMPLETED|Period 3||8
10502958|NCT01253174|11653723|FG002|COMPLETED|Period 3||6
10502959|NCT01253174|11653724|FG003|COMPLETED|Period 3||7
10502960|NCT01253174|11653725|FG004|COMPLETED|Period 3||7
10502961|NCT01253174|11653726|FG005|COMPLETED|Period 3||7
10502962|NCT01253174|11653721|FG000|NOT COMPLETED|Period 3||0
10502963|NCT01253174|11653722|FG001|NOT COMPLETED|Period 3||1
10502964|NCT01253174|11653723|FG002|NOT COMPLETED|Period 3||1
10502965|NCT01253174|11653724|FG003|NOT COMPLETED|Period 3||0
10502966|NCT01253174|11653725|FG004|NOT COMPLETED|Period 3||1
10502967|NCT01253174|11653726|FG005|NOT COMPLETED|Period 3||0
10502968|NCT01253187|11653735|FG000|STARTED|Period 1||7
10502969|NCT01253187|11653736|FG001|STARTED|Period 1||8
10502970|NCT01253187|11653737|FG002|STARTED|Period 1||7
10502971|NCT01253187|11653738|FG003|STARTED|Period 1||7
10502972|NCT01253187|11653739|FG004|STARTED|Period 1||9
10502973|NCT01253187|11653740|FG005|STARTED|Period 1||6
10502974|NCT01253187|11653735|FG000|COMPLETED|Period 1||7
10502975|NCT01253187|11653736|FG001|COMPLETED|Period 1||8
10502976|NCT01253187|11653737|FG002|COMPLETED|Period 1||7
10502977|NCT01253187|11653738|FG003|COMPLETED|Period 1||7
10502978|NCT01253187|11653739|FG004|COMPLETED|Period 1||9
10502979|NCT01253187|11653740|FG005|COMPLETED|Period 1||6
10502980|NCT01253187|11653735|FG000|NOT COMPLETED|Period 1||0
10502981|NCT01253187|11653736|FG001|NOT COMPLETED|Period 1||0
10502982|NCT01253187|11653737|FG002|NOT COMPLETED|Period 1||0
10502983|NCT01253187|11653738|FG003|NOT COMPLETED|Period 1||0
10502984|NCT01253187|11653739|FG004|NOT COMPLETED|Period 1||0
10502985|NCT01253187|11653740|FG005|NOT COMPLETED|Period 1||0
10502986|NCT01253187|11653735|FG000|STARTED|Period 2||7
10502987|NCT01253187|11653736|FG001|STARTED|Period 2||8
10502988|NCT01253187|11653737|FG002|STARTED|Period 2||7
10502989|NCT01253187|11653738|FG003|STARTED|Period 2||7
10502990|NCT01253187|11653739|FG004|STARTED|Period 2||9
10502991|NCT01253187|11653740|FG005|STARTED|Period 2||6
10502992|NCT01253187|11653735|FG000|COMPLETED|Period 2||7
10502993|NCT01253187|11653736|FG001|COMPLETED|Period 2||8
10502994|NCT01253187|11653737|FG002|COMPLETED|Period 2||7
10502995|NCT01253187|11653738|FG003|COMPLETED|Period 2||7
10502996|NCT01253187|11653739|FG004|COMPLETED|Period 2||8
10502997|NCT01253187|11653740|FG005|COMPLETED|Period 2||6
10502998|NCT01253187|11653735|FG000|NOT COMPLETED|Period 2||0
10502999|NCT01253187|11653736|FG001|NOT COMPLETED|Period 2||0
10503000|NCT01253187|11653737|FG002|NOT COMPLETED|Period 2||0
10503001|NCT01253187|11653738|FG003|NOT COMPLETED|Period 2||0
10503002|NCT01253187|11653739|FG004|NOT COMPLETED|Period 2||1
10503003|NCT01253187|11653740|FG005|NOT COMPLETED|Period 2||0
10503004|NCT01253187|11653735|FG000|STARTED|Period 3||7
10503005|NCT01253187|11653736|FG001|STARTED|Period 3||8
10503006|NCT01253187|11653737|FG002|STARTED|Period 3||7
10503007|NCT01253187|11653738|FG003|STARTED|Period 3||7
10503008|NCT01253187|11653739|FG004|STARTED|Period 3||8
10503009|NCT01253187|11653740|FG005|STARTED|Period 3||6
10503010|NCT01253187|11653735|FG000|COMPLETED|Period 3||6
10503011|NCT01253187|11653736|FG001|COMPLETED|Period 3||7
10503012|NCT01253187|11653737|FG002|COMPLETED|Period 3||7
10503013|NCT01253187|11653738|FG003|COMPLETED|Period 3||7
10503014|NCT01253187|11653739|FG004|COMPLETED|Period 3||7
10503015|NCT01253187|11653740|FG005|COMPLETED|Period 3||6
10503016|NCT01253187|11653735|FG000|NOT COMPLETED|Period 3||1
10503017|NCT01253187|11653736|FG001|NOT COMPLETED|Period 3||1
10503018|NCT01253187|11653737|FG002|NOT COMPLETED|Period 3||0
10503019|NCT01253187|11653738|FG003|NOT COMPLETED|Period 3||0
10503020|NCT01253187|11653739|FG004|NOT COMPLETED|Period 3||1
10503021|NCT01253187|11653740|FG005|NOT COMPLETED|Period 3||0
10503022|NCT01253200|11653756|FG000|STARTED|Overall Study||125
10503023|NCT01253200|11653757|FG001|STARTED|Overall Study||125
10503024|NCT01253200|11653758|FG002|STARTED|Overall Study||30
10503025|NCT01253200|11653759|FG003|STARTED|Overall Study||17
10503026|NCT01253200|11653760|FG004|STARTED|Overall Study||5
10503027|NCT01253200|11653756|FG000|Procedure|Overall Study||109
10503028|NCT01253200|11653757|FG001|Procedure|Overall Study||111
10503029|NCT01253200|11653758|FG002|Procedure|Overall Study||28
10503030|NCT01253200|11653759|FG003|Procedure|Overall Study||12
10503031|NCT01253200|11653760|FG004|Procedure|Overall Study||0
10503032|NCT01253200|11653756|FG000|10 Day Follow-up|Overall Study||106
10503033|NCT01253200|11653757|FG001|10 Day Follow-up|Overall Study||111
10503034|NCT01253200|11653758|FG002|10 Day Follow-up|Overall Study||28
10503035|NCT01253200|11653759|FG003|10 Day Follow-up|Overall Study||12
10503036|NCT01253200|11653760|FG004|10 Day Follow-up|Overall Study||0
10503037|NCT01253200|11653756|FG000|3 Month Follow-up|Overall Study||104
10503038|NCT01253200|11653757|FG001|3 Month Follow-up|Overall Study||106
10503039|NCT01253200|11653758|FG002|3 Month Follow-up|Overall Study||28
10503040|NCT01253200|11653759|FG003|3 Month Follow-up|Overall Study||12
10503041|NCT01253200|11653760|FG004|3 Month Follow-up|Overall Study||0
10503042|NCT01253200|11653756|FG000|COMPLETED|Overall Study||104
10503043|NCT01253200|11653757|FG001|COMPLETED|Overall Study||106
10503044|NCT01253200|11653758|FG002|COMPLETED|Overall Study||28
10503045|NCT01253200|11653759|FG003|COMPLETED|Overall Study||12
10503046|NCT01253200|11653760|FG004|COMPLETED|Overall Study||0
10503047|NCT01253200|11653756|FG000|NOT COMPLETED|Overall Study||21
10710702|NCT02653170|11876022|FG001|NOT COMPLETED|Overall Study||16
10710703|NCT02653170|11876023|FG002|NOT COMPLETED|Overall Study||18
10710704|NCT02653183|11876033|FG000|STARTED|Overall Study||53
10503048|NCT01253200|11653757|FG001|NOT COMPLETED|Overall Study||19
10503049|NCT01253200|11653758|FG002|NOT COMPLETED|Overall Study||2
10503050|NCT01253200|11653759|FG003|NOT COMPLETED|Overall Study||5
10503051|NCT01253200|11653760|FG004|NOT COMPLETED|Overall Study||5
10503052|NCT01253226|11653774|FG000|STARTED|Overall Study||6
10503053|NCT01253226|11653775|FG001|STARTED|Overall Study||6
10503054|NCT01253226|11653776|FG002|STARTED|Overall Study||6
10503055|NCT01253226|11653777|FG003|STARTED|Overall Study||6
10503056|NCT01253226|11653778|FG004|STARTED|Overall Study||8
10503057|NCT01253226|11653774|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
10503058|NCT01253226|11653775|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
10503059|NCT01253226|11653776|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
10503060|NCT01253226|11653777|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
10503061|NCT01253226|11653778|FG004|Received at Least 1 Dose of Study Drug|Overall Study||8
10503062|NCT01253226|11653774|FG000|COMPLETED|Overall Study||6
10503063|NCT01253226|11653775|FG001|COMPLETED|Overall Study||5
10503064|NCT01253226|11653776|FG002|COMPLETED|Overall Study||5
10503065|NCT01253226|11653777|FG003|COMPLETED|Overall Study||5
10503066|NCT01253226|11653778|FG004|COMPLETED|Overall Study||6
10503067|NCT01253226|11653774|FG000|NOT COMPLETED|Overall Study||0
10503068|NCT01253226|11653775|FG001|NOT COMPLETED|Overall Study||1
10503069|NCT01253226|11653776|FG002|NOT COMPLETED|Overall Study||1
10503070|NCT01253226|11653777|FG003|NOT COMPLETED|Overall Study||1
10503071|NCT01253226|11653778|FG004|NOT COMPLETED|Overall Study||2
10503072|NCT01253265|11653795|FG000|STARTED|Overall Study||6
10503073|NCT01253265|11653796|FG001|STARTED|Overall Study||6
10503074|NCT01253265|11653797|FG002|STARTED|Overall Study||6
10503075|NCT01253265|11653798|FG003|STARTED|Overall Study||6
10503076|NCT01253265|11653799|FG004|STARTED|Overall Study||8
10503077|NCT01253265|11653795|FG000|COMPLETED|Overall Study||5
10503078|NCT01253265|11653796|FG001|COMPLETED|Overall Study||6
10503079|NCT01253265|11653797|FG002|COMPLETED|Overall Study||6
10503080|NCT01253265|11653798|FG003|COMPLETED|Overall Study||6
10503081|NCT01253265|11653799|FG004|COMPLETED|Overall Study||7
10503082|NCT01253265|11653795|FG000|NOT COMPLETED|Overall Study||1
10503083|NCT01253265|11653796|FG001|NOT COMPLETED|Overall Study||0
10503084|NCT01253265|11653797|FG002|NOT COMPLETED|Overall Study||0
10503085|NCT01253265|11653798|FG003|NOT COMPLETED|Overall Study||0
10503086|NCT01253265|11653799|FG004|NOT COMPLETED|Overall Study||1
10503087|NCT01253291|11653816|FG000|STARTED|Overall Study||6
10503088|NCT01253291|11653817|FG001|STARTED|Overall Study||6
10503089|NCT01253291|11653818|FG002|STARTED|Overall Study||4
10503090|NCT01253291|11653819|FG003|STARTED|Overall Study||5
10503091|NCT01253291|11653820|FG004|STARTED|Overall Study||5
10503092|NCT01253291|11653816|FG000|Received Study Drug During BCDL|Overall Study||6
10503093|NCT01253291|11653817|FG001|Received Study Drug During BCDL|Overall Study||6
10503094|NCT01253291|11653818|FG002|Received Study Drug During BCDL|Overall Study||4
10503095|NCT01253291|11653819|FG003|Received Study Drug During BCDL|Overall Study||5
10503096|NCT01253291|11653820|FG004|Received Study Drug During BCDL|Overall Study||5
10503097|NCT01253291|11653816|FG000|COMPLETED|Overall Study||2
10503098|NCT01253291|11653817|FG001|COMPLETED|Overall Study||4
10503099|NCT01253291|11653818|FG002|COMPLETED|Overall Study||4
10503100|NCT01253291|11653819|FG003|COMPLETED|Overall Study||5
10503101|NCT01253291|11653820|FG004|COMPLETED|Overall Study||3
10503102|NCT01253291|11653816|FG000|NOT COMPLETED|Overall Study||4
10503103|NCT01253291|11653817|FG001|NOT COMPLETED|Overall Study||2
10503104|NCT01253291|11653818|FG002|NOT COMPLETED|Overall Study||0
10503105|NCT01253291|11653819|FG003|NOT COMPLETED|Overall Study||0
10503106|NCT01253291|11653820|FG004|NOT COMPLETED|Overall Study||2
10503107|NCT01253304|11653837|FG000|STARTED|Overall Study||11
10503108|NCT01253304|11653838|FG001|STARTED|Overall Study||6
10503109|NCT01253304|11653839|FG002|STARTED|Overall Study||6
10503110|NCT01253304|11653840|FG003|STARTED|Overall Study||3
10503111|NCT01253304|11653837|FG000|Received at Least 1 Dose of Study Drug|Overall Study||11
10503112|NCT01253304|11653838|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
10503113|NCT01253304|11653839|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
10503114|NCT01253304|11653840|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
10503115|NCT01253304|11653837|FG000|COMPLETED|Overall Study||11
10503116|NCT01253304|11653838|FG001|COMPLETED|Overall Study||6
10503117|NCT01253304|11653839|FG002|COMPLETED|Overall Study||6
10503118|NCT01253304|11653840|FG003|COMPLETED|Overall Study||2
10503119|NCT01253304|11653837|FG000|NOT COMPLETED|Overall Study||0
10503120|NCT01253304|11653838|FG001|NOT COMPLETED|Overall Study||0
10503121|NCT01253304|11653839|FG002|NOT COMPLETED|Overall Study||0
10503122|NCT01253304|11653840|FG003|NOT COMPLETED|Overall Study||1
10503123|NCT01253317|11653850|FG000|STARTED|Overall Study||12
10503124|NCT01253317|11653850|FG000|COMPLETED|Overall Study||10
10503125|NCT01253317|11653850|FG000|NOT COMPLETED|Overall Study||2
10503126|NCT01253343|11653860|FG000|STARTED|Overall Study||9
10503127|NCT01253343|11653861|FG001|STARTED|Overall Study||8
10503128|NCT01253343|11653860|FG000|COMPLETED|Overall Study||9
10503129|NCT01253343|11653861|FG001|COMPLETED|Overall Study||8
10503130|NCT01253343|11653860|FG000|NOT COMPLETED|Overall Study||0
10503131|NCT01253343|11653861|FG001|NOT COMPLETED|Overall Study||0
10503132|NCT01253369|11653883|FG000|STARTED|Overall Study||33
10503133|NCT01253369|11653883|FG000|Evaluable|Overall Study|Evaluable pts were w/ measurable disease, min 1 cycle of trt rcvd and 1 on-trt disease assessment.|30
10503134|NCT01253369|11653883|FG000|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
10503135|NCT01253369|11653883|FG000|NOT COMPLETED|Overall Study||33
10503136|NCT01253408|11653890|FG000|STARTED|Overall Study||10
10503137|NCT01253408|11653891|FG001|STARTED|Overall Study||13
10503138|NCT01253408|11653892|FG002|STARTED|Overall Study||13
10503139|NCT01253408|11653890|FG000|COMPLETED|Overall Study||10
10503140|NCT01253408|11653891|FG001|COMPLETED|Overall Study||12
10503141|NCT01253408|11653892|FG002|COMPLETED|Overall Study||13
10503142|NCT01253408|11653890|FG000|NOT COMPLETED|Overall Study||0
10503143|NCT01253408|11653891|FG001|NOT COMPLETED|Overall Study||1
10503144|NCT01253408|11653892|FG002|NOT COMPLETED|Overall Study||0
10503145|NCT01253421|11653904|FG000|STARTED|Assessment and Scheduling||159
10503146|NCT01253421|11653905|FG001|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
10503147|NCT01253421|11653906|FG002|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
10503148|NCT01253421|11653907|FG003|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
10503149|NCT01253421|11653908|FG004|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
10503150|NCT01253421|11653904|FG000|Eligible After Screening Visit|Assessment and Scheduling||85
10503151|NCT01253421|11653905|FG001|Eligible After Screening Visit|Assessment and Scheduling||0
10503152|NCT01253421|11653906|FG002|Eligible After Screening Visit|Assessment and Scheduling||0
10503153|NCT01253421|11653907|FG003|Eligible After Screening Visit|Assessment and Scheduling||0
10503154|NCT01253421|11653908|FG004|Eligible After Screening Visit|Assessment and Scheduling||0
10503155|NCT01253421|11653904|FG000|Returned for Drug+Scanning Visit|Assessment and Scheduling||60
10503156|NCT01253421|11653905|FG001|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
10503157|NCT01253421|11653906|FG002|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
10503158|NCT01253421|11653907|FG003|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
10503159|NCT01253421|11653908|FG004|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
10503160|NCT01253421|11653904|FG000|COMPLETED|Assessment and Scheduling||60
10503161|NCT01253421|11653905|FG001|COMPLETED|Assessment and Scheduling||0
10503162|NCT01253421|11653906|FG002|COMPLETED|Assessment and Scheduling||0
10503163|NCT01253421|11653907|FG003|COMPLETED|Assessment and Scheduling||0
10503164|NCT01253421|11653908|FG004|COMPLETED|Assessment and Scheduling||0
10503165|NCT01253421|11653904|FG000|NOT COMPLETED|Assessment and Scheduling||99
10503166|NCT01253421|11653905|FG001|NOT COMPLETED|Assessment and Scheduling||0
10503167|NCT01253421|11653906|FG002|NOT COMPLETED|Assessment and Scheduling||0
10503168|NCT01253421|11653907|FG003|NOT COMPLETED|Assessment and Scheduling||0
10503169|NCT01253421|11653908|FG004|NOT COMPLETED|Assessment and Scheduling||0
10503170|NCT01253421|11653904|FG000|STARTED|Drug+Scanning Visit|Arm has no participants once randomization has occurred.|0
10503171|NCT01253421|11653905|FG001|STARTED|Drug+Scanning Visit||15
10503172|NCT01253421|11653906|FG002|STARTED|Drug+Scanning Visit||14
10503173|NCT01253421|11653907|FG003|STARTED|Drug+Scanning Visit||16
10503174|NCT01253421|11653908|FG004|STARTED|Drug+Scanning Visit||15
10503175|NCT01253421|11653904|FG000|Received Drug Challenge|Drug+Scanning Visit||0
10503176|NCT01253421|11653905|FG001|Received Drug Challenge|Drug+Scanning Visit||15
10503177|NCT01253421|11653906|FG002|Received Drug Challenge|Drug+Scanning Visit||14
10503178|NCT01253421|11653907|FG003|Received Drug Challenge|Drug+Scanning Visit||16
10503179|NCT01253421|11653908|FG004|Received Drug Challenge|Drug+Scanning Visit||15
10503180|NCT01253421|11653904|FG000|COMPLETED|Drug+Scanning Visit||0
10503181|NCT01253421|11653905|FG001|COMPLETED|Drug+Scanning Visit||15
10503182|NCT01253421|11653906|FG002|COMPLETED|Drug+Scanning Visit||14
10503183|NCT01253421|11653907|FG003|COMPLETED|Drug+Scanning Visit||16
10503184|NCT01253421|11653908|FG004|COMPLETED|Drug+Scanning Visit||14
10503185|NCT01253421|11653904|FG000|NOT COMPLETED|Drug+Scanning Visit||0
10503186|NCT01253421|11653905|FG001|NOT COMPLETED|Drug+Scanning Visit||0
10503187|NCT01253421|11653906|FG002|NOT COMPLETED|Drug+Scanning Visit||0
10503188|NCT01253421|11653907|FG003|NOT COMPLETED|Drug+Scanning Visit||0
10503189|NCT01253421|11653908|FG004|NOT COMPLETED|Drug+Scanning Visit||1
10503190|NCT01253447|11653918|FG000|STARTED|Overall Study||19
10503191|NCT01253447|11653918|FG000|COMPLETED|Overall Study||17
10503192|NCT01253447|11653918|FG000|NOT COMPLETED|Overall Study||2
10503193|NCT01253460|11653923|FG000|STARTED|Overall Study||18
10503194|NCT01253460|11653923|FG000|COMPLETED|Overall Study||18
10503195|NCT01253460|11653923|FG000|NOT COMPLETED|Overall Study||0
10503196|NCT01253525|11653927|FG000|STARTED|Overall Study||6
10503197|NCT01253525|11653927|FG000|Received Any Quantity of Study Drug|Overall Study||6
10503198|NCT01253525|11653927|FG000|COMPLETED|Overall Study||6
10503199|NCT01253525|11653927|FG000|NOT COMPLETED|Overall Study||0
10528155|NCT01393704|11680381|FG001|STARTED|Overall Study||76
10528156|NCT01393704|11680380|FG000|COMPLETED|Overall Study||76
10528157|NCT01393704|11680381|FG001|COMPLETED|Overall Study||76
10528158|NCT01393704|11680380|FG000|NOT COMPLETED|Overall Study||0
10528159|NCT01393704|11680381|FG001|NOT COMPLETED|Overall Study||0
10528160|NCT01393717|11680387|FG000|STARTED|Overall Study||37
10528161|NCT01393717|11680388|FG001|STARTED|Overall Study||20
10528162|NCT01393717|11680387|FG000|COMPLETED|Overall Study||37
10528163|NCT01393717|11680388|FG001|COMPLETED|Overall Study||20
10528164|NCT01393717|11680387|FG000|NOT COMPLETED|Overall Study||0
10528165|NCT01393717|11680388|FG001|NOT COMPLETED|Overall Study||0
10528166|NCT01393730|11680398|FG000|STARTED|Overall Study||40
10528167|NCT01393730|11680398|FG000|Treated|Overall Study||38
10528168|NCT01393730|11680398|FG000|Evaluable AR Amplification|Overall Study||21
10528169|NCT01393730|11680398|FG000|Evaluable AR Mutation|Overall Study||14
10528170|NCT01393730|11680398|FG000|COMPLETED|Overall Study||34
10528171|NCT01393730|11680398|FG000|NOT COMPLETED|Overall Study||6
10528172|NCT01393743|11680404|FG000|STARTED|Core Study|Treated|82
10528173|NCT01393743|11680405|FG001|STARTED|Core Study|Treated|81
10528174|NCT01393743|11680406|FG002|STARTED|Core Study||0
10528175|NCT01393743|11680404|FG000|COMPLETED|Core Study||72
10528176|NCT01393743|11680405|FG001|COMPLETED|Core Study||68
10528177|NCT01393743|11680406|FG002|COMPLETED|Core Study||0
10528178|NCT01393743|11680404|FG000|NOT COMPLETED|Core Study||10
10528179|NCT01393743|11680405|FG001|NOT COMPLETED|Core Study||13
10528180|NCT01393743|11680406|FG002|NOT COMPLETED|Core Study||0
10528181|NCT01393743|11680404|FG000|STARTED|Extension Phase||0
10528182|NCT01393743|11680405|FG001|STARTED|Extension Phase||0
10528183|NCT01393743|11680406|FG002|STARTED|Extension Phase|Continuation into the Extension Phase was optional.|138
10528184|NCT01393743|11680404|FG000|COMPLETED|Extension Phase||0
10528185|NCT01393743|11680405|FG001|COMPLETED|Extension Phase||0
10528186|NCT01393743|11680406|FG002|COMPLETED|Extension Phase||78
10528187|NCT01393743|11680404|FG000|NOT COMPLETED|Extension Phase||0
10528188|NCT01393743|11680405|FG001|NOT COMPLETED|Extension Phase||0
10528189|NCT01393743|11680406|FG002|NOT COMPLETED|Extension Phase||60
10528190|NCT01393821|11680419|FG000|STARTED|Overall Study||14
10528191|NCT01393821|11680420|FG001|STARTED|Overall Study||13
10650414|NCT02169440|11810702|FG000|COMPLETED|Overall Study||10
10528192|NCT01393821|11680419|FG000|COMPLETED|Overall Study||9
10528193|NCT01393821|11680420|FG001|COMPLETED|Overall Study||10
10528194|NCT01393821|11680419|FG000|NOT COMPLETED|Overall Study||5
10528195|NCT01393821|11680420|FG001|NOT COMPLETED|Overall Study||3
10528196|NCT01393899|11680429|FG000|STARTED|Overall Study||59
10528197|NCT01393899|11680430|FG001|STARTED|Overall Study||60
10528198|NCT01393899|11680431|FG002|STARTED|Overall Study||61
10528199|NCT01393899|11680429|FG000|COMPLETED|Overall Study||27
10528200|NCT01393899|11680430|FG001|COMPLETED|Overall Study||32
10528201|NCT01393899|11680431|FG002|COMPLETED|Overall Study||38
10528202|NCT01393899|11680429|FG000|NOT COMPLETED|Overall Study||32
10503200|NCT01253564|11653931|FG000|STARTED|Overall Study||24
10503201|NCT01253564|11653931|FG000|COMPLETED|Overall Study||0
10503202|NCT01253564|11653931|FG000|NOT COMPLETED|Overall Study||24
10503203|NCT01253577|11653935|FG000|STARTED|Overall Study||105
10503204|NCT01253577|11653935|FG000|COMPLETED|Overall Study||102
10503205|NCT01253577|11653935|FG000|NOT COMPLETED|Overall Study||3
10503206|NCT01253642|11653941|FG000|STARTED|Overall Study||11
10503207|NCT01253642|11653941|FG000|COMPLETED|Overall Study||6
10503208|NCT01253642|11653941|FG000|NOT COMPLETED|Overall Study||5
10503209|NCT01253811|11653946|FG000|STARTED|Overall Study||6
10503210|NCT01253811|11653946|FG000|Exposed|Overall Study||6
10503211|NCT01253811|11653946|FG000|COMPLETED|Overall Study||5
10503212|NCT01253811|11653946|FG000|NOT COMPLETED|Overall Study||1
10503213|NCT01253824|11653952|FG000|STARTED|Overall Study||7
10503214|NCT01253824|11653953|FG001|STARTED|Overall Study||7
10503215|NCT01253824|11653952|FG000|COMPLETED|Overall Study||7
10503216|NCT01253824|11653953|FG001|COMPLETED|Overall Study||7
10503217|NCT01253824|11653952|FG000|NOT COMPLETED|Overall Study||0
10503218|NCT01253824|11653953|FG001|NOT COMPLETED|Overall Study||0
10503219|NCT01253902|11653962|FG000|STARTED|Overall Study||56
10503220|NCT01253902|11653963|FG001|STARTED|Overall Study||53
10503221|NCT01253902|11653964|FG002|STARTED|Overall Study||55
10503222|NCT01253902|11653962|FG000|COMPLETED|Overall Study||51
10503223|NCT01253902|11653963|FG001|COMPLETED|Overall Study||51
10503224|NCT01253902|11653964|FG002|COMPLETED|Overall Study||51
10503225|NCT01253902|11653962|FG000|NOT COMPLETED|Overall Study||5
10503226|NCT01253902|11653963|FG001|NOT COMPLETED|Overall Study||2
10503227|NCT01253902|11653964|FG002|NOT COMPLETED|Overall Study||4
10503228|NCT01253980|11653974|FG000|STARTED|Overall Study||35
10503229|NCT01253980|11653975|FG001|STARTED|Overall Study||39
10503230|NCT01253980|11653974|FG000|COMPLETED|Overall Study||35
10503231|NCT01253980|11653975|FG001|COMPLETED|Overall Study||39
10503232|NCT01253980|11653974|FG000|NOT COMPLETED|Overall Study||0
10503233|NCT01253980|11653975|FG001|NOT COMPLETED|Overall Study||0
10503234|NCT01254019|11653983|FG000|STARTED|Overall Study||61
10503235|NCT01254019|11653984|FG001|STARTED|Overall Study||125
10503236|NCT01254019|11653983|FG000|COMPLETED|Overall Study||60
10503237|NCT01254019|11653984|FG001|COMPLETED|Overall Study||121
10503238|NCT01254019|11653983|FG000|NOT COMPLETED|Overall Study||1
10503239|NCT01254019|11653984|FG001|NOT COMPLETED|Overall Study||4
10503240|NCT01254045|11653993|FG000|STARTED|First/Baseline (1 Day at Week 1 )|One completed all baseline measures including administration of placebo, but then lost to follow-up.|2
10503241|NCT01254045|11653994|FG001|STARTED|First/Baseline (1 Day at Week 1 )||2
10503242|NCT01254045|11653995|FG002|STARTED|First/Baseline (1 Day at Week 1 )||2
10503243|NCT01254045|11653996|FG003|STARTED|First/Baseline (1 Day at Week 1 )||1
10503244|NCT01254045|11653997|FG004|STARTED|First/Baseline (1 Day at Week 1 )||1
10503245|NCT01254045|11653998|FG005|STARTED|First/Baseline (1 Day at Week 1 )||1
10503246|NCT01254045|11653993|FG000|COMPLETED|First/Baseline (1 Day at Week 1 )||1
10503247|NCT01254045|11653994|FG001|COMPLETED|First/Baseline (1 Day at Week 1 )||2
10503248|NCT01254045|11653995|FG002|COMPLETED|First/Baseline (1 Day at Week 1 )||2
10503249|NCT01254045|11653996|FG003|COMPLETED|First/Baseline (1 Day at Week 1 )||1
10503250|NCT01254045|11653997|FG004|COMPLETED|First/Baseline (1 Day at Week 1 )||1
10503251|NCT01254045|11653998|FG005|COMPLETED|First/Baseline (1 Day at Week 1 )||1
10503252|NCT01254045|11653993|FG000|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||1
10503253|NCT01254045|11653994|FG001|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
10503254|NCT01254045|11653995|FG002|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
10503255|NCT01254045|11653996|FG003|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
10503256|NCT01254045|11653997|FG004|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
10503257|NCT01254045|11653998|FG005|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
10503258|NCT01254045|11653993|FG000|STARTED|Second/Time 2 (1 Day at Week 2)||1
10503259|NCT01254045|11653994|FG001|STARTED|Second/Time 2 (1 Day at Week 2)||2
10503260|NCT01254045|11653995|FG002|STARTED|Second/Time 2 (1 Day at Week 2)||2
10503261|NCT01254045|11653996|FG003|STARTED|Second/Time 2 (1 Day at Week 2)||1
10503262|NCT01254045|11653997|FG004|STARTED|Second/Time 2 (1 Day at Week 2)||1
10503263|NCT01254045|11653998|FG005|STARTED|Second/Time 2 (1 Day at Week 2)||1
10503264|NCT01254045|11653993|FG000|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
10503265|NCT01254045|11653994|FG001|COMPLETED|Second/Time 2 (1 Day at Week 2)||2
10503266|NCT01254045|11653995|FG002|COMPLETED|Second/Time 2 (1 Day at Week 2)||2
10503267|NCT01254045|11653996|FG003|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
10503268|NCT01254045|11653997|FG004|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
10503269|NCT01254045|11653998|FG005|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
10503270|NCT01254045|11653993|FG000|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
10503271|NCT01254045|11653994|FG001|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
10503272|NCT01254045|11653995|FG002|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
10503273|NCT01254045|11653996|FG003|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
10503274|NCT01254045|11653997|FG004|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
10503275|NCT01254045|11653998|FG005|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
10503276|NCT01254045|11653993|FG000|STARTED|Third/Time 3 (1 Day at Week 3)||1
10503277|NCT01254045|11653994|FG001|STARTED|Third/Time 3 (1 Day at Week 3)||2
10503278|NCT01254045|11653995|FG002|STARTED|Third/Time 3 (1 Day at Week 3)||2
10503279|NCT01254045|11653996|FG003|STARTED|Third/Time 3 (1 Day at Week 3)||1
10503280|NCT01254045|11653997|FG004|STARTED|Third/Time 3 (1 Day at Week 3)||1
10503281|NCT01254045|11653998|FG005|STARTED|Third/Time 3 (1 Day at Week 3)||1
10503282|NCT01254045|11653993|FG000|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
10503283|NCT01254045|11653994|FG001|COMPLETED|Third/Time 3 (1 Day at Week 3)||2
10503284|NCT01254045|11653995|FG002|COMPLETED|Third/Time 3 (1 Day at Week 3)||2
10503285|NCT01254045|11653996|FG003|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
10503286|NCT01254045|11653997|FG004|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
10503287|NCT01254045|11653998|FG005|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
10503288|NCT01254045|11653993|FG000|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
10503289|NCT01254045|11653994|FG001|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
10503290|NCT01254045|11653995|FG002|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
10503291|NCT01254045|11653996|FG003|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
10503292|NCT01254045|11653997|FG004|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
10503293|NCT01254045|11653998|FG005|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
10503294|NCT01254188|11654008|FG000|STARTED|Overall Study||421
10503295|NCT01254188|11654008|FG000|COMPLETED|Overall Study||328
10503296|NCT01254188|11654008|FG000|NOT COMPLETED|Overall Study||93
10503297|NCT01254214|11654014|FG000|STARTED|Overall Study||27
10503298|NCT01254214|11654015|FG001|STARTED|Overall Study||28
10503299|NCT01254214|11654014|FG000|COMPLETED|Overall Study||24
10503300|NCT01254214|11654015|FG001|COMPLETED|Overall Study||27
10503301|NCT01254214|11654014|FG000|NOT COMPLETED|Overall Study||3
10503302|NCT01254214|11654015|FG001|NOT COMPLETED|Overall Study||1
10503303|NCT01254227|11654021|FG000|STARTED|Overall Study||60
10503304|NCT01254227|11654021|FG000|Completion of 12 Months|Overall Study||39
10503305|NCT01254227|11654021|FG000|Completion of 24 Months|Overall Study||34
10503306|NCT01254227|11654021|FG000|COMPLETED|Overall Study||34
10503307|NCT01254227|11654021|FG000|NOT COMPLETED|Overall Study||26
10503308|NCT01254292|11654027|FG000|STARTED|Comparative Phase||282
10503309|NCT01254292|11654028|FG001|STARTED|Comparative Phase||285
10503310|NCT01254292|11654027|FG000|Participants Received Treatment|Comparative Phase|safety population|279
10503311|NCT01254292|11654028|FG001|Participants Received Treatment|Comparative Phase|safety population|281
10503312|NCT01254292|11654027|FG000|COMPLETED|Comparative Phase||227
10503313|NCT01254292|11654028|FG001|COMPLETED|Comparative Phase||204
10503314|NCT01254292|11654027|FG000|NOT COMPLETED|Comparative Phase||55
10503315|NCT01254292|11654028|FG001|NOT COMPLETED|Comparative Phase||81
10503316|NCT01254292|11654027|FG000|STARTED|LCS12 Extension Phase|A total of 200 participants elected to enter this optional Extension Phase.|200
10503317|NCT01254292|11654028|FG001|STARTED|LCS12 Extension Phase|Optional Extension Phase was for LCS12 group only.|0
10503318|NCT01254292|11654027|FG000|COMPLETED|LCS12 Extension Phase||163
10503319|NCT01254292|11654028|FG001|COMPLETED|LCS12 Extension Phase||0
10503320|NCT01254292|11654027|FG000|NOT COMPLETED|LCS12 Extension Phase||37
10503321|NCT01254292|11654028|FG001|NOT COMPLETED|LCS12 Extension Phase||0
10503322|NCT01254305|11654038|FG000|STARTED|Overall Study||93
10503323|NCT01254305|11654039|FG001|STARTED|Overall Study||90
10503324|NCT01254305|11654040|FG002|STARTED|Overall Study||79
10503325|NCT01254305|11654038|FG000|Safety Population|Overall Study||89
10503326|NCT01254305|11654039|FG001|Safety Population|Overall Study||85
10503327|NCT01254305|11654040|FG002|Safety Population|Overall Study||77
10503328|NCT01254305|11654038|FG000|COMPLETED|Overall Study||71
10503329|NCT01254305|11654039|FG001|COMPLETED|Overall Study||72
10503330|NCT01254305|11654040|FG002|COMPLETED|Overall Study||62
10503331|NCT01254305|11654038|FG000|NOT COMPLETED|Overall Study||22
10503332|NCT01254305|11654039|FG001|NOT COMPLETED|Overall Study||18
10503333|NCT01254305|11654040|FG002|NOT COMPLETED|Overall Study||17
10503334|NCT01254318|11654051|FG000|STARTED|Overall Study|Alive at start of study|130
10503335|NCT01254318|11654051|FG000|COMPLETED|Overall Study|Alive at end of study|78
10503336|NCT01254318|11654051|FG000|NOT COMPLETED|Overall Study||52
10503337|NCT01254331|11654055|FG000|STARTED|Initial Phase||51
10503338|NCT01254331|11654055|FG000|COMPLETED|Initial Phase||46
10503339|NCT01254331|11654055|FG000|NOT COMPLETED|Initial Phase||5
10503340|NCT01254331|11654055|FG000|STARTED|Extension Phase|1 participant withdrew consent after completing initial phase and did not enter the extension phase|45
10503341|NCT01254331|11654055|FG000|COMPLETED|Extension Phase||41
10503342|NCT01254331|11654055|FG000|NOT COMPLETED|Extension Phase||4
10503343|NCT01254344|11654061|FG000|STARTED|Overall Study||299
10503344|NCT01254344|11654062|FG001|STARTED|Overall Study||300
10503345|NCT01254344|11654061|FG000|Treated|Overall Study||290
10503346|NCT01254344|11654062|FG001|Treated|Overall Study||297
10503347|NCT01254344|11654061|FG000|COMPLETED|Overall Study||286
10503348|NCT01254344|11654062|FG001|COMPLETED|Overall Study||281
10503349|NCT01254344|11654061|FG000|NOT COMPLETED|Overall Study||13
10503350|NCT01254344|11654062|FG001|NOT COMPLETED|Overall Study||19
10503351|NCT01254396|11654068|FG000|STARTED|First Intervention Period||6
10503352|NCT01254396|11654069|FG001|STARTED|First Intervention Period||6
10503353|NCT01254396|11654068|FG000|COMPLETED|First Intervention Period||6
10503354|NCT01254396|11654069|FG001|COMPLETED|First Intervention Period||6
10503355|NCT01254396|11654068|FG000|NOT COMPLETED|First Intervention Period||0
10503356|NCT01254396|11654069|FG001|NOT COMPLETED|First Intervention Period||0
10503357|NCT01254396|11654068|FG000|STARTED|Washout Period (at Least 1 Day)||6
10503358|NCT01254396|11654069|FG001|STARTED|Washout Period (at Least 1 Day)||6
10503359|NCT01254396|11654068|FG000|COMPLETED|Washout Period (at Least 1 Day)||6
10503360|NCT01254396|11654069|FG001|COMPLETED|Washout Period (at Least 1 Day)||6
10503361|NCT01254396|11654068|FG000|NOT COMPLETED|Washout Period (at Least 1 Day)||0
10503362|NCT01254396|11654069|FG001|NOT COMPLETED|Washout Period (at Least 1 Day)||0
10503363|NCT01254396|11654068|FG000|STARTED|Second Intervention Period||6
10503364|NCT01254396|11654069|FG001|STARTED|Second Intervention Period||6
10503365|NCT01254396|11654068|FG000|COMPLETED|Second Intervention Period||6
10503366|NCT01254396|11654069|FG001|COMPLETED|Second Intervention Period||6
10503367|NCT01254396|11654068|FG000|NOT COMPLETED|Second Intervention Period||0
10503368|NCT01254396|11654069|FG001|NOT COMPLETED|Second Intervention Period||0
10503369|NCT01254552|11654075|FG000|STARTED|Screening Visit||351
10503370|NCT01254552|11654075|FG000|COMPLETED|Screening Visit||348
10503371|NCT01254552|11654075|FG000|NOT COMPLETED|Screening Visit||3
10503372|NCT01254552|11654075|FG000|STARTED|Delayed-enhanced MRI With Dotarem||348
10503373|NCT01254552|11654075|FG000|COMPLETED|Delayed-enhanced MRI With Dotarem||328
10503374|NCT01254552|11654075|FG000|NOT COMPLETED|Delayed-enhanced MRI With Dotarem||20
10503375|NCT01254552|11654075|FG000|STARTED|CCTA With Xenetix 350||328
10503376|NCT01254552|11654075|FG000|COMPLETED|CCTA With Xenetix 350||322
10503377|NCT01254552|11654075|FG000|NOT COMPLETED|CCTA With Xenetix 350||6
10503378|NCT01254565|11654089|FG000|STARTED|Overall Study||5
10503379|NCT01254565|11654090|FG001|STARTED|Overall Study||7
10503380|NCT01254565|11654091|FG002|STARTED|Overall Study||21
10503381|NCT01254565|11654092|FG003|STARTED|Overall Study||21
10503382|NCT01254565|11654093|FG004|STARTED|Overall Study||16
10503383|NCT01254565|11654094|FG005|STARTED|Overall Study||17
10503384|NCT01254565|11654089|FG000|Received Treatment|Overall Study||4
10503385|NCT01254565|11654090|FG001|Received Treatment|Overall Study||6
10503386|NCT01254565|11654091|FG002|Received Treatment|Overall Study||21
10503387|NCT01254565|11654092|FG003|Received Treatment|Overall Study||21
10503388|NCT01254565|11654093|FG004|Received Treatment|Overall Study||13
10503389|NCT01254565|11654094|FG005|Received Treatment|Overall Study||13
10503390|NCT01254565|11654089|FG000|COMPLETED|Overall Study||4
10503391|NCT01254565|11654090|FG001|COMPLETED|Overall Study||6
10503392|NCT01254565|11654091|FG002|COMPLETED|Overall Study||21
10503393|NCT01254565|11654092|FG003|COMPLETED|Overall Study||20
10503394|NCT01254565|11654093|FG004|COMPLETED|Overall Study||12
10503395|NCT01254565|11654094|FG005|COMPLETED|Overall Study||13
10503396|NCT01254565|11654089|FG000|NOT COMPLETED|Overall Study||1
10503397|NCT01254565|11654090|FG001|NOT COMPLETED|Overall Study||1
10503398|NCT01254565|11654091|FG002|NOT COMPLETED|Overall Study||0
10503399|NCT01254565|11654092|FG003|NOT COMPLETED|Overall Study||1
10503400|NCT01254565|11654093|FG004|NOT COMPLETED|Overall Study||4
10503401|NCT01254565|11654094|FG005|NOT COMPLETED|Overall Study||4
10503402|NCT01254604|11654110|FG000|STARTED|Overall Study||95
10503403|NCT01254604|11654111|FG001|STARTED|Overall Study||95
10503404|NCT01254604|11654110|FG000|Treated|Overall Study|"The 2 out of 95 started who did not take study drug discontinued due to Withdrawal by Subject"|93
10503405|NCT01254604|11654111|FG001|Treated|Overall Study|"The 1 out of 95 started who did not take study drug discontinued due to Withdrawal by Subject"|94
10503406|NCT01254604|11654110|FG000|COMPLETED|Overall Study||87
10503407|NCT01254604|11654111|FG001|COMPLETED|Overall Study||86
10503408|NCT01254604|11654110|FG000|NOT COMPLETED|Overall Study||8
10503409|NCT01254604|11654111|FG001|NOT COMPLETED|Overall Study||9
10503410|NCT01254630|11654121|FG000|STARTED|Overall Study||1348
10503411|NCT01254630|11654122|FG001|STARTED|Overall Study||1288
10503412|NCT01254630|11654123|FG002|STARTED|Overall Study||1364
10503413|NCT01254630|11654124|FG003|STARTED|Overall Study||1285
10503414|NCT01254630|11654121|FG000|Received Vaccination 1|Overall Study||1328
10503415|NCT01254630|11654122|FG001|Received Vaccination 1|Overall Study||1277
10503416|NCT01254630|11654123|FG002|Received Vaccination 1|Overall Study||1350
10503417|NCT01254630|11654124|FG003|Received Vaccination 1|Overall Study||1275
10503418|NCT01254630|11654121|FG000|Received Vaccination 2|Overall Study||1255
10503419|NCT01254630|11654122|FG001|Received Vaccination 2|Overall Study||1217
10503420|NCT01254630|11654123|FG002|Received Vaccination 2|Overall Study||1286
10503421|NCT01254630|11654124|FG003|Received Vaccination 2|Overall Study||1226
10503422|NCT01254630|11654121|FG000|Received Vaccination 3|Overall Study||1198
10503423|NCT01254630|11654122|FG001|Received Vaccination 3|Overall Study||1178
10503424|NCT01254630|11654123|FG002|Received Vaccination 3|Overall Study||1247
10503425|NCT01254630|11654124|FG003|Received Vaccination 3|Overall Study||1194
10503426|NCT01254630|11654121|FG000|Received Vaccination 4|Overall Study||1155
10503427|NCT01254630|11654122|FG001|Received Vaccination 4|Overall Study||1145
10503428|NCT01254630|11654123|FG002|Received Vaccination 4|Overall Study||1212
10503429|NCT01254630|11654124|FG003|Received Vaccination 4|Overall Study||1160
10503430|NCT01254630|11654121|FG000|COMPLETED|Overall Study||546
10503431|NCT01254630|11654122|FG001|COMPLETED|Overall Study||0
10503432|NCT01254630|11654123|FG002|COMPLETED|Overall Study||552
10503433|NCT01254630|11654124|FG003|COMPLETED|Overall Study||0
10503434|NCT01254630|11654121|FG000|NOT COMPLETED|Overall Study||802
10503435|NCT01254630|11654122|FG001|NOT COMPLETED|Overall Study||1288
10503436|NCT01254630|11654123|FG002|NOT COMPLETED|Overall Study||812
10503437|NCT01254630|11654124|FG003|NOT COMPLETED|Overall Study||1285
10503438|NCT01254643|11654132|FG000|STARTED|Overall Study||100
10503439|NCT01254643|11654132|FG000|Vaccination 1|Overall Study||100
10503440|NCT01254643|11654132|FG000|Vaccination 2|Overall Study||99
10503441|NCT01254643|11654132|FG000|Vaccination 3|Overall Study||99
10503442|NCT01254643|11654132|FG000|COMPLETED|Overall Study||99
10503443|NCT01254643|11654132|FG000|NOT COMPLETED|Overall Study||1
10503444|NCT01254656|11654139|FG000|STARTED|Overall Study||47
10503445|NCT01254656|11654140|FG001|STARTED|Overall Study||43
10503446|NCT01254656|11654141|FG002|STARTED|Overall Study||18
10503447|NCT01254656|11654139|FG000|Treated|Overall Study||47
10503448|NCT01254656|11654140|FG001|Treated|Overall Study||43
10503449|NCT01254656|11654141|FG002|Treated|Overall Study||18
10503450|NCT01254656|11654139|FG000|COMPLETED|Overall Study||0
10503451|NCT01254656|11654140|FG001|COMPLETED|Overall Study||0
10503452|NCT01254656|11654141|FG002|COMPLETED|Overall Study||0
10503453|NCT01254656|11654139|FG000|NOT COMPLETED|Overall Study||47
10503454|NCT01254656|11654140|FG001|NOT COMPLETED|Overall Study||43
10503455|NCT01254656|11654141|FG002|NOT COMPLETED|Overall Study||18
10503456|NCT01254669|11654151|FG000|STARTED|Overall Study||100
10503457|NCT01254669|11654152|FG001|STARTED|Overall Study||100
10503458|NCT01254669|11654151|FG000|COMPLETED|Overall Study||97
10503459|NCT01254669|11654152|FG001|COMPLETED|Overall Study||96
10503460|NCT01254669|11654151|FG000|NOT COMPLETED|Overall Study||3
10503461|NCT01254669|11654152|FG001|NOT COMPLETED|Overall Study||4
10503462|NCT01254721|11654162|FG000|STARTED|Overall Study|Seroquel XR: 300mg|67
10503463|NCT01254721|11654163|FG001|STARTED|Overall Study|Seroquel XR: 300mg Lithium: 900mg|64
10503464|NCT01254721|11654162|FG000|COMPLETED|Overall Study||52
10503465|NCT01254721|11654163|FG001|COMPLETED|Overall Study||42
10503466|NCT01254721|11654162|FG000|NOT COMPLETED|Overall Study||15
10503467|NCT01254721|11654163|FG001|NOT COMPLETED|Overall Study||22
10503468|NCT01254747|11654173|FG000|STARTED|Overall Study||40
10503469|NCT01254747|11654174|FG001|STARTED|Overall Study||29
10503470|NCT01254747|11654175|FG002|STARTED|Overall Study||30
10503471|NCT01254747|11654176|FG003|STARTED|Overall Study||30
10503472|NCT01254747|11654173|FG000|COMPLETED|Overall Study||40
10503473|NCT01254747|11654174|FG001|COMPLETED|Overall Study||23
10503474|NCT01254747|11654175|FG002|COMPLETED|Overall Study||26
10503475|NCT01254747|11654176|FG003|COMPLETED|Overall Study||28
10503476|NCT01254747|11654173|FG000|NOT COMPLETED|Overall Study||0
10338294|NCT00369382|11475212|FG001|NOT COMPLETED|Overall Study||3
10503477|NCT01254747|11654174|FG001|NOT COMPLETED|Overall Study||6
10503478|NCT01254747|11654175|FG002|NOT COMPLETED|Overall Study||4
10503479|NCT01254747|11654176|FG003|NOT COMPLETED|Overall Study||2
10503480|NCT01254760|11654186|FG000|STARTED|First Period, 5 Days of Wear||34
10503481|NCT01254760|11654187|FG001|STARTED|First Period, 5 Days of Wear||38
10503482|NCT01254760|11654186|FG000|COMPLETED|First Period, 5 Days of Wear||34
10503483|NCT01254760|11654187|FG001|COMPLETED|First Period, 5 Days of Wear||38
10503484|NCT01254760|11654186|FG000|NOT COMPLETED|First Period, 5 Days of Wear||0
10503485|NCT01254760|11654187|FG001|NOT COMPLETED|First Period, 5 Days of Wear||0
10503486|NCT01254760|11654186|FG000|STARTED|Second Period, 5 Days of Wear||34
10503487|NCT01254760|11654187|FG001|STARTED|Second Period, 5 Days of Wear||38
10503488|NCT01254760|11654186|FG000|COMPLETED|Second Period, 5 Days of Wear||34
10503489|NCT01254760|11654187|FG001|COMPLETED|Second Period, 5 Days of Wear||38
10503490|NCT01254760|11654186|FG000|NOT COMPLETED|Second Period, 5 Days of Wear||0
10503491|NCT01254760|11654187|FG001|NOT COMPLETED|Second Period, 5 Days of Wear||0
10503492|NCT01254851|11654196|FG000|STARTED|Overall Study||69
10503493|NCT01254851|11654197|FG001|STARTED|Overall Study||77
10503494|NCT01254851|11654196|FG000|COMPLETED|Overall Study||61
10503495|NCT01254851|11654197|FG001|COMPLETED|Overall Study||68
10503496|NCT01254851|11654196|FG000|NOT COMPLETED|Overall Study||8
10503497|NCT01254851|11654197|FG001|NOT COMPLETED|Overall Study||9
10503498|NCT01254877|11654206|FG000|STARTED|Overall Study||67
10503499|NCT01254877|11654207|FG001|STARTED|Overall Study||69
10503500|NCT01254877|11654208|FG002|STARTED|Overall Study||69
10503501|NCT01254877|11654206|FG000|COMPLETED|Overall Study||57
10503502|NCT01254877|11654207|FG001|COMPLETED|Overall Study||58
10503503|NCT01254877|11654208|FG002|COMPLETED|Overall Study||64
10503504|NCT01254877|11654206|FG000|NOT COMPLETED|Overall Study||10
10503505|NCT01254877|11654207|FG001|NOT COMPLETED|Overall Study||11
10503506|NCT01254877|11654208|FG002|NOT COMPLETED|Overall Study||5
10503507|NCT01254890|11654218|FG000|STARTED|Overall Study||3
10503508|NCT01254890|11654219|FG001|STARTED|Overall Study||57
10503509|NCT01254890|11654218|FG000|COMPLETED|Overall Study||2
10503510|NCT01254890|11654219|FG001|COMPLETED|Overall Study||47
10503511|NCT01254890|11654218|FG000|NOT COMPLETED|Overall Study||1
10503512|NCT01254890|11654219|FG001|NOT COMPLETED|Overall Study||10
10503513|NCT01255137|11654224|FG000|STARTED|Overall Study||13
10503514|NCT01255137|11654224|FG000|COMPLETED|Overall Study||13
10503515|NCT01255137|11654224|FG000|NOT COMPLETED|Overall Study||0
10503516|NCT01255163|11654230|FG000|STARTED|Overall Study||13
10503517|NCT01255163|11654231|FG001|STARTED|Overall Study||14
10710705|NCT02653183|11876034|FG001|STARTED|Overall Study||50
10710706|NCT02653183|11876033|FG000|COMPLETED|Overall Study||49
10503518|NCT01255163|11654230|FG000|COMPLETED|Overall Study||9
10503519|NCT01255163|11654231|FG001|COMPLETED|Overall Study||9
10503520|NCT01255163|11654230|FG000|NOT COMPLETED|Overall Study||4
10503521|NCT01255163|11654231|FG001|NOT COMPLETED|Overall Study||5
10503522|NCT01255306|11654241|FG000|STARTED|Overall Study||26
10503523|NCT01255306|11654242|FG001|STARTED|Overall Study||33
10503524|NCT01255306|11654241|FG000|COMPLETED|Overall Study||25
10503525|NCT01255306|11654242|FG001|COMPLETED|Overall Study||32
10503526|NCT01255306|11654241|FG000|NOT COMPLETED|Overall Study||1
10503527|NCT01255306|11654242|FG001|NOT COMPLETED|Overall Study||1
10503528|NCT01255423|11654253|FG000|STARTED|Overall Study||104
10503529|NCT01255423|11654254|FG001|STARTED|Overall Study||102
10710707|NCT02653183|11876034|FG001|COMPLETED|Overall Study||46
10503530|NCT01255423|11654253|FG000|COMPLETED|Overall Study||101
10503531|NCT01255423|11654254|FG001|COMPLETED|Overall Study||99
10503532|NCT01255423|11654253|FG000|NOT COMPLETED|Overall Study||3
10503533|NCT01255423|11654254|FG001|NOT COMPLETED|Overall Study||3
10503534|NCT01255436|11654262|FG000|STARTED|Overall Study|350 patients enrolled but 17 excluded because of missing baseline data.|333
10503535|NCT01255436|11654263|FG001|STARTED|Overall Study|350 patients enrolled but 21 excluded because of missing baseline data|329
10503536|NCT01255436|11654262|FG000|COMPLETED|Overall Study||151
10503537|NCT01255436|11654263|FG001|COMPLETED|Overall Study||135
10503538|NCT01255436|11654262|FG000|NOT COMPLETED|Overall Study||182
10503539|NCT01255436|11654263|FG001|NOT COMPLETED|Overall Study||194
10503540|NCT01255449|11654269|FG000|STARTED|Overall Study||26
10503541|NCT01255449|11654269|FG000|COMPLETED|Overall Study||26
10503542|NCT01255449|11654269|FG000|NOT COMPLETED|Overall Study||0
10503543|NCT01255592|11654276|FG000|STARTED|Overall Study||26
10503544|NCT01255592|11654277|FG001|STARTED|Overall Study||26
10503545|NCT01255592|11654276|FG000|COMPLETED|Overall Study||20
10503546|NCT01255592|11654277|FG001|COMPLETED|Overall Study||25
10503547|NCT01255592|11654276|FG000|NOT COMPLETED|Overall Study||6
10503548|NCT01255592|11654277|FG001|NOT COMPLETED|Overall Study||1
10503549|NCT01255631|11654286|FG000|STARTED|Overall Study||13
10503550|NCT01255631|11654287|FG001|STARTED|Overall Study||9
10503551|NCT01255631|11654286|FG000|COMPLETED|Overall Study|study terminated due to poor enrollment|4
10503552|NCT01255631|11654287|FG001|COMPLETED|Overall Study|study terminated due to poor enrollment|3
10503553|NCT01255631|11654286|FG000|NOT COMPLETED|Overall Study||9
10503554|NCT01255631|11654287|FG001|NOT COMPLETED|Overall Study||6
10503555|NCT01255670|11654295|FG000|STARTED|Overall Study||100
10503556|NCT01255670|11654296|FG001|STARTED|Overall Study||100
10503557|NCT01255670|11654295|FG000|COMPLETED|Overall Study||74
10503558|NCT01255670|11654296|FG001|COMPLETED|Overall Study||80
10503559|NCT01255670|11654295|FG000|NOT COMPLETED|Overall Study||26
10503560|NCT01255670|11654296|FG001|NOT COMPLETED|Overall Study||20
10503561|NCT01255722|11654305|FG000|STARTED|Overall Study||155
10503562|NCT01255722|11654306|FG001|STARTED|Overall Study||160
10503563|NCT01255722|11654307|FG002|STARTED|Overall Study||153
10503564|NCT01255722|11654305|FG000|COMPLETED|Overall Study||152
10503565|NCT01255722|11654306|FG001|COMPLETED|Overall Study||159
10503566|NCT01255722|11654307|FG002|COMPLETED|Overall Study||152
10503567|NCT01255722|11654305|FG000|NOT COMPLETED|Overall Study||3
10503568|NCT01255722|11654306|FG001|NOT COMPLETED|Overall Study||1
10503569|NCT01255722|11654307|FG002|NOT COMPLETED|Overall Study||1
10503570|NCT01255761|11654318|FG000|STARTED|Overall Study||369
10503571|NCT01255761|11654319|FG001|STARTED|Overall Study||367
10503572|NCT01255761|11654318|FG000|COMPLETED|Overall Study||187
10503573|NCT01255761|11654319|FG001|COMPLETED|Overall Study||192
10503574|NCT01255761|11654318|FG000|NOT COMPLETED|Overall Study||182
10503575|NCT01255761|11654319|FG001|NOT COMPLETED|Overall Study||175
10503576|NCT01255787|11654329|FG000|STARTED|Overall Study||152
10503577|NCT01255787|11654330|FG001|STARTED|Overall Study||144
10503578|NCT01255787|11654331|FG002|STARTED|Overall Study||150
10503579|NCT01255787|11654332|FG003|STARTED|Overall Study||154
10503580|NCT01255787|11654329|FG000|Treated|Overall Study||152
10503581|NCT01255787|11654330|FG001|Treated|Overall Study||144
10503582|NCT01255787|11654331|FG002|Treated|Overall Study||148
10503583|NCT01255787|11654332|FG003|Treated|Overall Study||150
10503584|NCT01255787|11654329|FG000|COMPLETED|Overall Study||136
10503585|NCT01255787|11654330|FG001|COMPLETED|Overall Study||127
10503586|NCT01255787|11654331|FG002|COMPLETED|Overall Study||132
10503587|NCT01255787|11654332|FG003|COMPLETED|Overall Study||132
10503588|NCT01255787|11654329|FG000|NOT COMPLETED|Overall Study||16
10503589|NCT01255787|11654330|FG001|NOT COMPLETED|Overall Study||17
10503590|NCT01255787|11654331|FG002|NOT COMPLETED|Overall Study||18
10503591|NCT01255787|11654332|FG003|NOT COMPLETED|Overall Study||22
10503592|NCT01255865|11654349|FG000|STARTED|Overall Study||1
10503593|NCT01255865|11654350|FG001|STARTED|Overall Study||10
10503594|NCT01255865|11654351|FG002|STARTED|Overall Study||10
10503595|NCT01255865|11654352|FG003|STARTED|Overall Study||30
10503596|NCT01255865|11654353|FG004|STARTED|Overall Study||20
10503597|NCT01255865|11654354|FG005|STARTED|Overall Study||20
10503598|NCT01255865|11654355|FG006|STARTED|Overall Study||20
10503599|NCT01255865|11654349|FG000|COMPLETED|Overall Study||1
10503600|NCT01255865|11654350|FG001|COMPLETED|Overall Study||10
10503601|NCT01255865|11654351|FG002|COMPLETED|Overall Study||10
10503602|NCT01255865|11654352|FG003|COMPLETED|Overall Study||30
10503603|NCT01255865|11654353|FG004|COMPLETED|Overall Study||20
10503604|NCT01255865|11654354|FG005|COMPLETED|Overall Study||20
10503605|NCT01255865|11654355|FG006|COMPLETED|Overall Study||20
10503606|NCT01255865|11654349|FG000|NOT COMPLETED|Overall Study||0
10503607|NCT01255865|11654350|FG001|NOT COMPLETED|Overall Study||0
10503608|NCT01255865|11654351|FG002|NOT COMPLETED|Overall Study||0
10503609|NCT01255865|11654352|FG003|NOT COMPLETED|Overall Study||0
10503610|NCT01255865|11654353|FG004|NOT COMPLETED|Overall Study||0
10503611|NCT01255865|11654354|FG005|NOT COMPLETED|Overall Study||0
10503612|NCT01255865|11654355|FG006|NOT COMPLETED|Overall Study||0
10503613|NCT01255904|11654373|FG000|STARTED|Overall Study||45
10503614|NCT01255904|11654374|FG001|STARTED|Overall Study||45
10503615|NCT01255904|11654373|FG000|COMPLETED|Overall Study||44
10503616|NCT01255904|11654374|FG001|COMPLETED|Overall Study||41
10503617|NCT01255904|11654373|FG000|NOT COMPLETED|Overall Study||1
10503618|NCT01255904|11654374|FG001|NOT COMPLETED|Overall Study||4
10503619|NCT01256008|11654383|FG000|STARTED|Overall Study||98
10503620|NCT01256008|11654384|FG001|STARTED|Overall Study||98
10503621|NCT01256008|11654385|FG002|STARTED|Overall Study||196
10503622|NCT01256008|11654383|FG000|COMPLETED|Overall Study||90
10503623|NCT01256008|11654384|FG001|COMPLETED|Overall Study||91
10503624|NCT01256008|11654385|FG002|COMPLETED|Overall Study||175
10503625|NCT01256008|11654383|FG000|NOT COMPLETED|Overall Study||8
10503626|NCT01256008|11654384|FG001|NOT COMPLETED|Overall Study||7
10503627|NCT01256008|11654385|FG002|NOT COMPLETED|Overall Study||21
10503628|NCT01256034|11654397|FG000|STARTED|Overall Study||25
10503629|NCT01256034|11654398|FG001|STARTED|Overall Study||25
10503630|NCT01256034|11654397|FG000|COMPLETED|Overall Study||0
10503631|NCT01256034|11654398|FG001|COMPLETED|Overall Study||0
10503632|NCT01256034|11654397|FG000|NOT COMPLETED|Overall Study||25
10503633|NCT01256034|11654398|FG001|NOT COMPLETED|Overall Study||25
10503634|NCT01256060|11654404|FG000|STARTED|Overall Study||3
10503635|NCT01256060|11654405|FG001|STARTED|Overall Study||3
10503636|NCT01256060|11654406|FG002|STARTED|Overall Study||3
10503637|NCT01256060|11654407|FG003|STARTED|Overall Study||6
10503638|NCT01256060|11654404|FG000|COMPLETED|Overall Study||3
10503639|NCT01256060|11654405|FG001|COMPLETED|Overall Study||2
10503640|NCT01256060|11654406|FG002|COMPLETED|Overall Study||3
10503641|NCT01256060|11654407|FG003|COMPLETED|Overall Study||6
10503642|NCT01256060|11654404|FG000|NOT COMPLETED|Overall Study||0
10503643|NCT01256060|11654405|FG001|NOT COMPLETED|Overall Study||1
10503644|NCT01256060|11654406|FG002|NOT COMPLETED|Overall Study||0
10503645|NCT01256060|11654407|FG003|NOT COMPLETED|Overall Study||0
10503646|NCT01256164|11654415|FG000|STARTED|Overall Study||47
10503647|NCT01256164|11654416|FG001|STARTED|Overall Study||23
10503648|NCT01256164|11654415|FG000|COMPLETED|Overall Study||47
10503649|NCT01256164|11654416|FG001|COMPLETED|Overall Study||23
10503650|NCT01256164|11654415|FG000|NOT COMPLETED|Overall Study||0
10503651|NCT01256164|11654416|FG001|NOT COMPLETED|Overall Study||0
10503652|NCT01256177|11654424|FG000|STARTED|Overall Study||148
10503653|NCT01256177|11654425|FG001|STARTED|Overall Study||148
10503654|NCT01256177|11654424|FG000|COMPLETED|Overall Study||98
10503655|NCT01256177|11654425|FG001|COMPLETED|Overall Study||111
10503656|NCT01256177|11654424|FG000|NOT COMPLETED|Overall Study||50
10503657|NCT01256177|11654425|FG001|NOT COMPLETED|Overall Study||37
10503658|NCT01256190|11654433|FG000|STARTED|Overall Study||39
10503659|NCT01256190|11654434|FG001|STARTED|Overall Study||17
10503660|NCT01256190|11654433|FG000|COMPLETED|Overall Study||37
10503661|NCT01256190|11654434|FG001|COMPLETED|Overall Study||17
10503662|NCT01256190|11654433|FG000|NOT COMPLETED|Overall Study||2
10503663|NCT01256190|11654434|FG001|NOT COMPLETED|Overall Study||0
10503664|NCT01256294|11654440|FG000|STARTED|Overall Study||36
10503665|NCT01256294|11654441|FG001|STARTED|Overall Study||35
10503666|NCT01256294|11654440|FG000|COMPLETED|Overall Study||32
10503667|NCT01256294|11654441|FG001|COMPLETED|Overall Study||33
10503668|NCT01256294|11654440|FG000|NOT COMPLETED|Overall Study||4
10503669|NCT01256294|11654441|FG001|NOT COMPLETED|Overall Study||2
10503670|NCT01256385|11654449|FG000|STARTED|Overall Study||43
10503671|NCT01256385|11654450|FG001|STARTED|Overall Study||43
10503672|NCT01256385|11654449|FG000|Crossover From Arm B to Arm A|Overall Study||0
10503673|NCT01256385|11654450|FG001|Crossover From Arm B to Arm A|Overall Study||15
10503674|NCT01256385|11654449|FG000|COMPLETED|Overall Study||40
10503675|NCT01256385|11654450|FG001|COMPLETED|Overall Study||40
10503676|NCT01256385|11654449|FG000|NOT COMPLETED|Overall Study||3
10503677|NCT01256385|11654450|FG001|NOT COMPLETED|Overall Study||3
10503678|NCT01256411|11654460|FG000|STARTED|Extension by Maximum Treatment||139
10503679|NCT01256411|11654461|FG001|STARTED|Extension by Maximum Treatment||89
10503680|NCT01256411|11654462|FG002|STARTED|Extension by Maximum Treatment||109
10503681|NCT01256411|11654463|FG003|STARTED|Extension by Maximum Treatment||4
10503682|NCT01256411|11654464|FG004|STARTED|Extension by Maximum Treatment||0
10503683|NCT01256411|11654465|FG005|STARTED|Extension by Maximum Treatment||0
10503684|NCT01256411|11654460|FG000|Down Titrated to 100 mg|Extension by Maximum Treatment||12
10503685|NCT01256411|11654461|FG001|Down Titrated to 100 mg|Extension by Maximum Treatment||0
10503686|NCT01256411|11654462|FG002|Down Titrated to 100 mg|Extension by Maximum Treatment||0
10503687|NCT01256411|11654463|FG003|Down Titrated to 100 mg|Extension by Maximum Treatment||0
10503688|NCT01256411|11654464|FG004|Down Titrated to 100 mg|Extension by Maximum Treatment||0
10503689|NCT01256411|11654465|FG005|Down Titrated to 100 mg|Extension by Maximum Treatment||0
10503690|NCT01256411|11654460|FG000|COMPLETED|Extension by Maximum Treatment||132
10503691|NCT01256411|11654461|FG001|COMPLETED|Extension by Maximum Treatment||79
10503692|NCT01256411|11654462|FG002|COMPLETED|Extension by Maximum Treatment||105
10503693|NCT01256411|11654463|FG003|COMPLETED|Extension by Maximum Treatment||4
10503694|NCT01256411|11654464|FG004|COMPLETED|Extension by Maximum Treatment||0
10503695|NCT01256411|11654465|FG005|COMPLETED|Extension by Maximum Treatment||0
10503696|NCT01256411|11654460|FG000|NOT COMPLETED|Extension by Maximum Treatment||7
10503697|NCT01256411|11654461|FG001|NOT COMPLETED|Extension by Maximum Treatment||10
10503698|NCT01256411|11654462|FG002|NOT COMPLETED|Extension by Maximum Treatment||4
10503699|NCT01256411|11654463|FG003|NOT COMPLETED|Extension by Maximum Treatment||0
10503700|NCT01256411|11654464|FG004|NOT COMPLETED|Extension by Maximum Treatment||0
10503701|NCT01256411|11654465|FG005|NOT COMPLETED|Extension by Maximum Treatment||0
10503702|NCT01256411|11654460|FG000|STARTED|Extension by Mono or Combination Therapy||0
10503703|NCT01256411|11654461|FG001|STARTED|Extension by Mono or Combination Therapy||0
10503704|NCT01256411|11654462|FG002|STARTED|Extension by Mono or Combination Therapy||0
10503705|NCT01256411|11654463|FG003|STARTED|Extension by Mono or Combination Therapy||0
10503706|NCT01256411|11654464|FG004|STARTED|Extension by Mono or Combination Therapy||228
10503707|NCT01256411|11654465|FG005|STARTED|Extension by Mono or Combination Therapy||113
10503708|NCT01256411|11654460|FG000|COMPLETED|Extension by Mono or Combination Therapy||0
10503709|NCT01256411|11654461|FG001|COMPLETED|Extension by Mono or Combination Therapy||0
10503710|NCT01256411|11654462|FG002|COMPLETED|Extension by Mono or Combination Therapy||0
10503711|NCT01256411|11654463|FG003|COMPLETED|Extension by Mono or Combination Therapy||0
10503712|NCT01256411|11654464|FG004|COMPLETED|Extension by Mono or Combination Therapy||211
10503713|NCT01256411|11654465|FG005|COMPLETED|Extension by Mono or Combination Therapy||109
10503714|NCT01256411|11654460|FG000|NOT COMPLETED|Extension by Mono or Combination Therapy||0
10503715|NCT01256411|11654461|FG001|NOT COMPLETED|Extension by Mono or Combination Therapy||0
10503716|NCT01256411|11654462|FG002|NOT COMPLETED|Extension by Mono or Combination Therapy||0
10503717|NCT01256411|11654463|FG003|NOT COMPLETED|Extension by Mono or Combination Therapy||0
10503718|NCT01256411|11654464|FG004|NOT COMPLETED|Extension by Mono or Combination Therapy||17
10503719|NCT01256411|11654465|FG005|NOT COMPLETED|Extension by Mono or Combination Therapy||4
10503720|NCT01256424|11654483|FG000|STARTED|Overall Study||65
10503721|NCT01256424|11654484|FG001|STARTED|Overall Study||67
10503722|NCT01256424|11654485|FG002|STARTED|Overall Study||62
10503723|NCT01256424|11654486|FG003|STARTED|Overall Study||68
10503724|NCT01256424|11654483|FG000|COMPLETED|Overall Study||56
10503725|NCT01256424|11654484|FG001|COMPLETED|Overall Study||59
10503726|NCT01256424|11654485|FG002|COMPLETED|Overall Study||55
10503727|NCT01256424|11654486|FG003|COMPLETED|Overall Study||61
10503728|NCT01256424|11654483|FG000|NOT COMPLETED|Overall Study||9
10503729|NCT01256424|11654484|FG001|NOT COMPLETED|Overall Study||8
10503730|NCT01256424|11654485|FG002|NOT COMPLETED|Overall Study||7
10503731|NCT01256424|11654486|FG003|NOT COMPLETED|Overall Study||7
10503732|NCT01256450|11654499|FG000|STARTED|Open-label Titration||334
10503733|NCT01256450|11654500|FG001|STARTED|Open-label Titration||0
10503734|NCT01256450|11654501|FG002|STARTED|Open-label Titration||0
10503735|NCT01256450|11654499|FG000|COMPLETED|Open-label Titration||235
10503736|NCT01256450|11654500|FG001|COMPLETED|Open-label Titration||0
10503737|NCT01256450|11654501|FG002|COMPLETED|Open-label Titration||0
10503738|NCT01256450|11654499|FG000|NOT COMPLETED|Open-label Titration||99
10503739|NCT01256450|11654500|FG001|NOT COMPLETED|Open-label Titration||0
10503740|NCT01256450|11654501|FG002|NOT COMPLETED|Open-label Titration||0
10503741|NCT01256450|11654499|FG000|STARTED|Double-blind Treatment|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
10503742|NCT01256450|11654500|FG001|STARTED|Double-blind Treatment|Subjects were randomized to DB treatment after completing OL titration in the previous period.|117
10503743|NCT01256450|11654501|FG002|STARTED|Double-blind Treatment|Subjects were randomized to DB treatment after completing OL titration in the previous period.|118
10710708|NCT02653183|11876033|FG000|NOT COMPLETED|Overall Study||4
10710709|NCT02653183|11876034|FG001|NOT COMPLETED|Overall Study||4
10710710|NCT02653300|11876040|FG000|STARTED|Overall Study||10
10710711|NCT02653300|11876040|FG000|COMPLETED|Overall Study||8
10710712|NCT02653300|11876040|FG000|NOT COMPLETED|Overall Study||2
10710713|NCT02653326|11876046|FG000|STARTED|Overall Study||32
10710714|NCT02653326|11876047|FG001|STARTED|Overall Study||34
10710715|NCT02653326|11876046|FG000|COMPLETED|Overall Study||22
10710716|NCT02653326|11876047|FG001|COMPLETED|Overall Study||27
10710717|NCT02653326|11876046|FG000|NOT COMPLETED|Overall Study||10
10503744|NCT01256450|11654499|FG000|COMPLETED|Double-blind Treatment||0
10503745|NCT01256450|11654500|FG001|COMPLETED|Double-blind Treatment||89
10503746|NCT01256450|11654501|FG002|COMPLETED|Double-blind Treatment||81
10503747|NCT01256450|11654499|FG000|NOT COMPLETED|Double-blind Treatment||0
10503748|NCT01256450|11654500|FG001|NOT COMPLETED|Double-blind Treatment||28
10503749|NCT01256450|11654501|FG002|NOT COMPLETED|Double-blind Treatment||37
10503750|NCT01256476|11654510|FG000|STARTED|Overall Study||164
10503751|NCT01256476|11654511|FG001|STARTED|Overall Study||164
10503752|NCT01256476|11654510|FG000|COMPLETED|Overall Study||158
10503753|NCT01256476|11654511|FG001|COMPLETED|Overall Study||157
10503754|NCT01256476|11654510|FG000|NOT COMPLETED|Overall Study||6
10503755|NCT01256476|11654511|FG001|NOT COMPLETED|Overall Study||7
10503756|NCT01256502|11654517|FG000|STARTED|Overall Study|Implanted with SERI during Stage I breast reconstruction surgery|139
10503757|NCT01256502|11654517|FG000|COMPLETED|Overall Study||129
10503758|NCT01256502|11654517|FG000|NOT COMPLETED|Overall Study||10
10503759|NCT01256567|11654526|FG000|STARTED|Overall Study||7
10503760|NCT01256567|11654526|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7
10503761|NCT01256567|11654526|FG000|COMPLETED|Overall Study||6
10503762|NCT01256567|11654526|FG000|NOT COMPLETED|Overall Study||1
10503763|NCT01256593|11654531|FG000|STARTED|Overall Study||3827
10503764|NCT01256593|11654531|FG000|COMPLETED|Overall Study|Number of participants whose survey form were collected and included in analyses is shown.|3613
10503765|NCT01256593|11654531|FG000|NOT COMPLETED|Overall Study||214
10503766|NCT01256658|11654537|FG000|STARTED|Period 1||6817
10503767|NCT01256658|11654538|FG001|STARTED|Period 1||7258
10503768|NCT01256658|11654537|FG000|COMPLETED|Period 1||5897
10503769|NCT01256658|11654538|FG001|COMPLETED|Period 1||6510
10503770|NCT01256658|11654537|FG000|NOT COMPLETED|Period 1||920
10503771|NCT01256658|11654538|FG001|NOT COMPLETED|Period 1||748
10503772|NCT01256658|11654537|FG000|STARTED|Period 2 - Follow up Only - No Treatment|43 participants who completed period 1 did not enroll to continue on period 2|5854
10710718|NCT02653326|11876047|FG001|NOT COMPLETED|Overall Study||7
10503773|NCT01256658|11654538|FG001|STARTED|Period 2 - Follow up Only - No Treatment|138 participants who completed period 1 did not enroll to continue on period 2|6372
10710719|NCT02653391|11876056|FG000|STARTED|Overall Study||18
10503774|NCT01256658|11654537|FG000|Lost to Follow up|Period 2 - Follow up Only - No Treatment||71
10503775|NCT01256658|11654538|FG001|Lost to Follow up|Period 2 - Follow up Only - No Treatment||77
10503776|NCT01256658|11654537|FG000|Death|Period 2 - Follow up Only - No Treatment||6
10503777|NCT01256658|11654538|FG001|Death|Period 2 - Follow up Only - No Treatment||8
10503778|NCT01256658|11654537|FG000|Study Termination|Period 2 - Follow up Only - No Treatment|43 participants who completed period 1 did not enroll to continue on period 2|5777
10503779|NCT01256658|11654538|FG001|Study Termination|Period 2 - Follow up Only - No Treatment|138 participants who completed period 1 did not enroll to continue on period 2|6287
10503780|NCT01256658|11654537|FG000|COMPLETED|Period 2 - Follow up Only - No Treatment||0
10503781|NCT01256658|11654538|FG001|COMPLETED|Period 2 - Follow up Only - No Treatment||0
10503782|NCT01256658|11654537|FG000|NOT COMPLETED|Period 2 - Follow up Only - No Treatment||5854
10503783|NCT01256658|11654538|FG001|NOT COMPLETED|Period 2 - Follow up Only - No Treatment||6372
10503784|NCT01256671|11654547|FG000|STARTED|Overall Study||530
10503785|NCT01256671|11654547|FG000|Safety Population|Overall Study||521
10503786|NCT01256671|11654547|FG000|COMPLETED|Overall Study||435
10503787|NCT01256671|11654547|FG000|NOT COMPLETED|Overall Study||95
10503788|NCT01256684|11654554|FG000|STARTED|Overall Study||81
10503789|NCT01256684|11654555|FG001|STARTED|Overall Study||87
10503790|NCT01256684|11654556|FG002|STARTED|Overall Study||87
10503791|NCT01256684|11654554|FG000|Safety Population|Overall Study||80
10503792|NCT01256684|11654555|FG001|Safety Population|Overall Study||86
10503793|NCT01256684|11654556|FG002|Safety Population|Overall Study||87
10503794|NCT01256684|11654554|FG000|ITT Population|Overall Study||77
10503795|NCT01256684|11654555|FG001|ITT Population|Overall Study||79
10503796|NCT01256684|11654556|FG002|ITT Population|Overall Study||81
10503797|NCT01256684|11654554|FG000|COMPLETED|Overall Study||72
10503798|NCT01256684|11654555|FG001|COMPLETED|Overall Study||74
10503799|NCT01256684|11654556|FG002|COMPLETED|Overall Study||76
10503800|NCT01256684|11654554|FG000|NOT COMPLETED|Overall Study||9
10503801|NCT01256684|11654555|FG001|NOT COMPLETED|Overall Study||13
10503802|NCT01256684|11654556|FG002|NOT COMPLETED|Overall Study||11
10503803|NCT01256788|11654567|FG000|STARTED|Overall Study||12
10503804|NCT01256788|11654568|FG001|STARTED|Overall Study||14
10503805|NCT01256788|11654569|FG002|STARTED|Overall Study||8
10503806|NCT01256788|11654567|FG000|COMPLETED|Overall Study||7
10503807|NCT01256788|11654568|FG001|COMPLETED|Overall Study||6
10503808|NCT01256788|11654569|FG002|COMPLETED|Overall Study||5
10503809|NCT01256788|11654567|FG000|NOT COMPLETED|Overall Study||5
10503810|NCT01256788|11654568|FG001|NOT COMPLETED|Overall Study||8
10503811|NCT01256788|11654569|FG002|NOT COMPLETED|Overall Study||3
10503812|NCT01256840|11654580|FG000|STARTED|Overall Study||30
10503813|NCT01256840|11654581|FG001|STARTED|Overall Study||16
10503814|NCT01256840|11654582|FG002|STARTED|Overall Study||25
10503815|NCT01256840|11654580|FG000|COMPLETED|Overall Study||30
10503816|NCT01256840|11654581|FG001|COMPLETED|Overall Study||16
10503817|NCT01256840|11654582|FG002|COMPLETED|Overall Study||25
10503818|NCT01256840|11654580|FG000|NOT COMPLETED|Overall Study||0
10503819|NCT01256840|11654581|FG001|NOT COMPLETED|Overall Study||0
10503820|NCT01256840|11654582|FG002|NOT COMPLETED|Overall Study||0
10503821|NCT01256879|11654590|FG000|STARTED|Overall Study|25 started in this cross-over study but only 24 completed|25
10503822|NCT01256879|11654590|FG000|CimTest-A|Overall Study|25 started this intervention but only 24 completed|25
10503823|NCT01256879|11654590|FG000|CimTest-B|Overall Study|24 started this intervention and 24 completed|24
10503824|NCT01256879|11654590|FG000|Sorbitol-free Cimetidine Solution|Overall Study|24 started this intervention and 24 completed|24
10503825|NCT01256879|11654590|FG000|Commercial Cimetidine Solution|Overall Study|24 started this intervention and 24 completed|24
10503826|NCT01256879|11654590|FG000|COMPLETED|Overall Study||24
10503827|NCT01256879|11654590|FG000|NOT COMPLETED|Overall Study||1
10503828|NCT01256918|11654600|FG000|STARTED|Overall Study||200
10503829|NCT01256918|11654600|FG000|Full Thickness Nuclear Crack Achieved|Overall Study||200
10503830|NCT01256918|11654600|FG000|COMPLETED|Overall Study||200
10503831|NCT01256918|11654600|FG000|NOT COMPLETED|Overall Study||0
10710720|NCT02653391|11876057|FG001|STARTED|Overall Study||3
10710721|NCT02653391|11876058|FG002|STARTED|Overall Study||1
10503832|NCT01256944|11654613|FG000|STARTED|Overall Study||70
10503833|NCT01256944|11654614|FG001|STARTED|Overall Study||220
10503834|NCT01256944|11654613|FG000|COMPLETED|Overall Study||70
10503835|NCT01256944|11654614|FG001|COMPLETED|Overall Study||220
10503836|NCT01256944|11654613|FG000|NOT COMPLETED|Overall Study||0
10503837|NCT01256944|11654614|FG001|NOT COMPLETED|Overall Study||0
10503838|NCT01256983|11654626|FG000|STARTED|Overall Study||15
10503839|NCT01256983|11654627|FG001|STARTED|Overall Study||15
10503840|NCT01256983|11654626|FG000|COMPLETED|Overall Study||14
10503841|NCT01256983|11654627|FG001|COMPLETED|Overall Study||12
10503842|NCT01256983|11654626|FG000|NOT COMPLETED|Overall Study||1
10503843|NCT01256983|11654627|FG001|NOT COMPLETED|Overall Study||3
10503844|NCT01257087|11654635|FG000|STARTED|Overall Study||18
10503845|NCT01257087|11654636|FG001|STARTED|Overall Study||17
10503846|NCT01257087|11654635|FG000|COMPLETED|Overall Study||18
10503847|NCT01257087|11654636|FG001|COMPLETED|Overall Study||17
10503848|NCT01257087|11654635|FG000|NOT COMPLETED|Overall Study||0
10503849|NCT01257087|11654636|FG001|NOT COMPLETED|Overall Study||0
10503850|NCT01257204|11654645|FG000|STARTED|Treatment Period (up to Week 24)||50
10503851|NCT01257204|11654646|FG001|STARTED|Treatment Period (up to Week 24)||50
10503852|NCT01257204|11654647|FG002|STARTED|Treatment Period (up to Week 24)||51
10710722|NCT02653391|11876056|FG000|COMPLETED|Overall Study||16
10710723|NCT02653391|11876057|FG001|COMPLETED|Overall Study||1
10710724|NCT02653391|11876058|FG002|COMPLETED|Overall Study||1
10503853|NCT01257204|11654645|FG000|COMPLETED|Treatment Period (up to Week 24)||45
10503854|NCT01257204|11654646|FG001|COMPLETED|Treatment Period (up to Week 24)||44
10503855|NCT01257204|11654647|FG002|COMPLETED|Treatment Period (up to Week 24)||42
10503856|NCT01257204|11654645|FG000|NOT COMPLETED|Treatment Period (up to Week 24)||5
10503857|NCT01257204|11654646|FG001|NOT COMPLETED|Treatment Period (up to Week 24)||6
10503858|NCT01257204|11654647|FG002|NOT COMPLETED|Treatment Period (up to Week 24)||9
10503859|NCT01257204|11654645|FG000|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|49
10503860|NCT01257204|11654646|FG001|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|47
10503861|NCT01257204|11654647|FG002|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|49
10503862|NCT01257204|11654645|FG000|COMPLETED|Follow-up Period (up to Week 48)||48
10503863|NCT01257204|11654646|FG001|COMPLETED|Follow-up Period (up to Week 48)||41
10503864|NCT01257204|11654647|FG002|COMPLETED|Follow-up Period (up to Week 48)||39
10503865|NCT01257204|11654645|FG000|NOT COMPLETED|Follow-up Period (up to Week 48)||1
10503866|NCT01257204|11654646|FG001|NOT COMPLETED|Follow-up Period (up to Week 48)||6
10503867|NCT01257204|11654647|FG002|NOT COMPLETED|Follow-up Period (up to Week 48)||10
10503868|NCT01257217|11654669|FG000|STARTED|Overall Study||15
10503869|NCT01257217|11654670|FG001|STARTED|Overall Study||10
10503870|NCT01257217|11654669|FG000|COMPLETED|Overall Study||13
10503871|NCT01257217|11654670|FG001|COMPLETED|Overall Study||10
10503872|NCT01257217|11654669|FG000|NOT COMPLETED|Overall Study||2
10503873|NCT01257217|11654670|FG001|NOT COMPLETED|Overall Study||0
10503874|NCT01257230|11654683|FG000|STARTED|Overall Study||138
10503875|NCT01257230|11654684|FG001|STARTED|Overall Study||125
10503876|NCT01257230|11654685|FG002|STARTED|Overall Study||135
10503877|NCT01257230|11654683|FG000|COMPLETED|Overall Study||132
10503878|NCT01257230|11654684|FG001|COMPLETED|Overall Study||115
10503879|NCT01257230|11654685|FG002|COMPLETED|Overall Study||129
10503880|NCT01257230|11654683|FG000|NOT COMPLETED|Overall Study||6
10503881|NCT01257230|11654684|FG001|NOT COMPLETED|Overall Study||10
10503882|NCT01257230|11654685|FG002|NOT COMPLETED|Overall Study||6
10503883|NCT01257347|11654698|FG000|STARTED|Overall Study|Median patients per provider = 3; range 1-10 (35 patients)|12
10503884|NCT01257347|11654699|FG001|STARTED|Overall Study|Median patients per provider = 4; range 1-13 (65 patients)|12
10503885|NCT01257347|11654700|FG002|STARTED|Overall Study||35
10503886|NCT01257347|11654701|FG003|STARTED|Overall Study||65
10503887|NCT01257347|11654698|FG000|COMPLETED|Overall Study||12
10503888|NCT01257347|11654699|FG001|COMPLETED|Overall Study||12
10503889|NCT01257347|11654700|FG002|COMPLETED|Overall Study||35
10503890|NCT01257347|11654701|FG003|COMPLETED|Overall Study||65
10503891|NCT01257347|11654698|FG000|NOT COMPLETED|Overall Study||0
10503892|NCT01257347|11654699|FG001|NOT COMPLETED|Overall Study||0
10503893|NCT01257347|11654700|FG002|NOT COMPLETED|Overall Study||0
10503894|NCT01257347|11654701|FG003|NOT COMPLETED|Overall Study||0
10503895|NCT01257425|11654716|FG000|STARTED|Overall Study||52
10503896|NCT01257425|11654717|FG001|STARTED|Overall Study||51
10503897|NCT01257425|11654716|FG000|COMPLETED|Overall Study||46
10503898|NCT01257425|11654717|FG001|COMPLETED|Overall Study||45
10503899|NCT01257425|11654716|FG000|NOT COMPLETED|Overall Study||6
10503900|NCT01257425|11654717|FG001|NOT COMPLETED|Overall Study||6
10503901|NCT01257438|11654725|FG000|STARTED|Overall Study||132
10503902|NCT01257438|11654726|FG001|STARTED|Overall Study||143
10503903|NCT01257438|11654725|FG000|COMPLETED|Overall Study||102
10503904|NCT01257438|11654726|FG001|COMPLETED|Overall Study||97
10503905|NCT01257438|11654725|FG000|NOT COMPLETED|Overall Study||30
10503906|NCT01257438|11654726|FG001|NOT COMPLETED|Overall Study||46
10503907|NCT01257503|11654734|FG000|STARTED|Overall Study||133
10503908|NCT01257503|11654735|FG001|STARTED|Overall Study||130
10503909|NCT01257503|11654734|FG000|Returned Symptom Diaries|Overall Study||80
10503910|NCT01257503|11654735|FG001|Returned Symptom Diaries|Overall Study||83
10503911|NCT01257503|11654734|FG000|Returned Dosage Logbooks|Overall Study||75
10503912|NCT01257503|11654735|FG001|Returned Dosage Logbooks|Overall Study||80
10503913|NCT01257503|11654734|FG000|COMPLETED|Overall Study|Completed defined as participants who completed telephone follow-up at end of study period|125
10710725|NCT02653391|11876056|FG000|NOT COMPLETED|Overall Study||2
10710726|NCT02653391|11876057|FG001|NOT COMPLETED|Overall Study||2
10710727|NCT02653391|11876058|FG002|NOT COMPLETED|Overall Study||0
10710728|NCT02653417|11876106|FG000|STARTED|Overall Study||38
10503914|NCT01257503|11654735|FG001|COMPLETED|Overall Study|Completed defined as participants who completed telephone follow-up at end of study period|119
10503915|NCT01257503|11654734|FG000|NOT COMPLETED|Overall Study||8
10503916|NCT01257503|11654735|FG001|NOT COMPLETED|Overall Study||11
10503917|NCT01257542|11654743|FG000|STARTED|Overall Study||55
10503918|NCT01257542|11654744|FG001|STARTED|Overall Study||52
10710729|NCT02653417|11876107|FG001|STARTED|Overall Study||34
10503919|NCT01257542|11654743|FG000|COMPLETED|Overall Study||52
10503920|NCT01257542|11654744|FG001|COMPLETED|Overall Study||45
10503921|NCT01257542|11654743|FG000|NOT COMPLETED|Overall Study||3
10503922|NCT01257542|11654744|FG001|NOT COMPLETED|Overall Study||7
10503923|NCT01257581|11654753|FG000|STARTED|Overall Study||22
10503924|NCT01257581|11654754|FG001|STARTED|Overall Study||21
10503925|NCT01257581|11654755|FG002|STARTED|Overall Study||17
10503926|NCT01257581|11654753|FG000|COMPLETED|Overall Study||17
10503927|NCT01257581|11654754|FG001|COMPLETED|Overall Study||18
10503928|NCT01257581|11654755|FG002|COMPLETED|Overall Study||11
10503929|NCT01257581|11654753|FG000|NOT COMPLETED|Overall Study||5
10503930|NCT01257581|11654754|FG001|NOT COMPLETED|Overall Study||3
10503931|NCT01257581|11654755|FG002|NOT COMPLETED|Overall Study||6
10503932|NCT01257698|11654765|FG000|STARTED|Overall Study||12
10503933|NCT01257698|11654766|FG001|STARTED|Overall Study||9
10503934|NCT01257698|11654765|FG000|COMPLETED|Overall Study||8
10503935|NCT01257698|11654766|FG001|COMPLETED|Overall Study||9
10503936|NCT01257698|11654765|FG000|NOT COMPLETED|Overall Study||4
10503937|NCT01257698|11654766|FG001|NOT COMPLETED|Overall Study||0
10503938|NCT01257737|11654774|FG000|STARTED|Overall Study||45
10503939|NCT01257737|11654775|FG001|STARTED|Overall Study||43
10503940|NCT01257737|11654774|FG000|COMPLETED|Overall Study||43
10503941|NCT01257737|11654775|FG001|COMPLETED|Overall Study||39
10503942|NCT01257737|11654774|FG000|NOT COMPLETED|Overall Study||2
10503943|NCT01257737|11654775|FG001|NOT COMPLETED|Overall Study||4
10503944|NCT01257750|11654782|FG000|STARTED|Overall Study||20
10503945|NCT01257750|11654782|FG000|COMPLETED|Overall Study||20
10503946|NCT01257750|11654782|FG000|NOT COMPLETED|Overall Study||0
10503947|NCT01257802|11654789|FG000|STARTED|Overall Study||6
10503948|NCT01257802|11654790|FG001|STARTED|Overall Study||8
10503949|NCT01257802|11654789|FG000|6 Month / 24 Week Visit|Overall Study||5
10710730|NCT02653417|11876108|FG002|STARTED|Overall Study||29
10710731|NCT02653417|11876109|FG003|STARTED|Overall Study||38
10710732|NCT02653417|11876106|FG000|COMPLETED|Overall Study||37
10503950|NCT01257802|11654790|FG001|6 Month / 24 Week Visit|Overall Study||2
10503951|NCT01257802|11654789|FG000|COMPLETED|Overall Study||5
10503952|NCT01257802|11654790|FG001|COMPLETED|Overall Study||2
10503953|NCT01257802|11654789|FG000|NOT COMPLETED|Overall Study||1
10503954|NCT01257802|11654790|FG001|NOT COMPLETED|Overall Study||6
10503955|NCT01257880|11654799|FG000|STARTED|Overall Study||12
10503956|NCT01257880|11654800|FG001|STARTED|Overall Study||19
10503957|NCT01257880|11654799|FG000|COMPLETED|Overall Study||12
10503958|NCT01257880|11654800|FG001|COMPLETED|Overall Study||19
10503959|NCT01257880|11654799|FG000|NOT COMPLETED|Overall Study||0
10503960|NCT01257880|11654800|FG001|NOT COMPLETED|Overall Study||0
10503961|NCT01258049|11654808|FG000|STARTED|Overall Study||77
10503962|NCT01258049|11654809|FG001|STARTED|Overall Study||74
10503963|NCT01258049|11654808|FG000|COMPLETED|Overall Study||75
10503964|NCT01258049|11654809|FG001|COMPLETED|Overall Study||72
10503965|NCT01258049|11654808|FG000|NOT COMPLETED|Overall Study||2
10503966|NCT01258049|11654809|FG001|NOT COMPLETED|Overall Study||2
10503967|NCT01258075|11654817|FG000|STARTED|Overall Study||141
10503968|NCT01258075|11654818|FG001|STARTED|Overall Study||95
10503969|NCT01258075|11654817|FG000|COMPLETED|Overall Study||99
10503970|NCT01258075|11654818|FG001|COMPLETED|Overall Study||72
10503971|NCT01258075|11654817|FG000|NOT COMPLETED|Overall Study||42
10503972|NCT01258075|11654818|FG001|NOT COMPLETED|Overall Study||23
10503973|NCT01258101|11654828|FG000|STARTED|Overall Study||151
10503974|NCT01258101|11654829|FG001|STARTED|Overall Study||144
10503975|NCT01258101|11654830|FG002|STARTED|Overall Study||33
10503976|NCT01258101|11654831|FG003|STARTED|Overall Study||52
10503977|NCT01258101|11654828|FG000|Safety Analysis Population|Overall Study||144
10503978|NCT01258101|11654829|FG001|Safety Analysis Population|Overall Study||141
10503979|NCT01258101|11654830|FG002|Safety Analysis Population|Overall Study||30
10503980|NCT01258101|11654831|FG003|Safety Analysis Population|Overall Study||48
10503981|NCT01258101|11654828|FG000|Standard Analysis Population|Overall Study||115
10503982|NCT01258101|11654829|FG001|Standard Analysis Population|Overall Study||110
10503983|NCT01258101|11654830|FG002|Standard Analysis Population|Overall Study||21
10503984|NCT01258101|11654831|FG003|Standard Analysis Population|Overall Study||26
10503985|NCT01258101|11654828|FG000|COMPLETED|Overall Study||118
10503986|NCT01258101|11654829|FG001|COMPLETED|Overall Study||110
10503987|NCT01258101|11654830|FG002|COMPLETED|Overall Study||22
10503988|NCT01258101|11654831|FG003|COMPLETED|Overall Study||27
10503989|NCT01258101|11654828|FG000|NOT COMPLETED|Overall Study||33
10503990|NCT01258101|11654829|FG001|NOT COMPLETED|Overall Study||34
10503991|NCT01258101|11654830|FG002|NOT COMPLETED|Overall Study||11
10503992|NCT01258101|11654831|FG003|NOT COMPLETED|Overall Study||25
10503993|NCT01258153|11654844|FG000|STARTED|Overall Study||40
10503994|NCT01258153|11654845|FG001|STARTED|Overall Study||38
10503995|NCT01258153|11654846|FG002|STARTED|Overall Study||37
10503996|NCT01258153|11654844|FG000|COMPLETED|Overall Study||39
10503997|NCT01258153|11654845|FG001|COMPLETED|Overall Study||37
10503998|NCT01258153|11654846|FG002|COMPLETED|Overall Study||36
10503999|NCT01258153|11654844|FG000|NOT COMPLETED|Overall Study||1
10504000|NCT01258153|11654845|FG001|NOT COMPLETED|Overall Study||1
10504001|NCT01258153|11654846|FG002|NOT COMPLETED|Overall Study||1
10504002|NCT01258348|11654856|FG000|STARTED|Overall Study||1
10504003|NCT01258348|11654857|FG001|STARTED|Overall Study||5
10504004|NCT01258348|11654858|FG002|STARTED|Overall Study||3
10504005|NCT01258348|11654859|FG003|STARTED|Overall Study||6
10504006|NCT01258348|11654860|FG004|STARTED|Overall Study||6
10504007|NCT01258348|11654856|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1
10504008|NCT01258348|11654857|FG001|Received at Least 1 Dose of Study Drug|Overall Study||5
10504009|NCT01258348|11654858|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
10504010|NCT01258348|11654859|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
10504011|NCT01258348|11654860|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
10504012|NCT01258348|11654856|FG000|COMPLETED|Overall Study||0
10710733|NCT02653417|11876107|FG001|COMPLETED|Overall Study||32
10504013|NCT01258348|11654857|FG001|COMPLETED|Overall Study||0
10504014|NCT01258348|11654858|FG002|COMPLETED|Overall Study||0
10504015|NCT01258348|11654859|FG003|COMPLETED|Overall Study||0
10504016|NCT01258348|11654860|FG004|COMPLETED|Overall Study||0
10504017|NCT01258348|11654856|FG000|NOT COMPLETED|Overall Study||1
10504018|NCT01258348|11654857|FG001|NOT COMPLETED|Overall Study||5
10504019|NCT01258348|11654858|FG002|NOT COMPLETED|Overall Study||3
10504020|NCT01258348|11654859|FG003|NOT COMPLETED|Overall Study||6
10504021|NCT01258348|11654860|FG004|NOT COMPLETED|Overall Study||6
10504022|NCT01258374|11654874|FG000|STARTED|Overall Study||15
10504023|NCT01258374|11654874|FG000|COMPLETED|Overall Study||15
10504024|NCT01258374|11654874|FG000|NOT COMPLETED|Overall Study||0
10504025|NCT01258387|11654887|FG000|STARTED|Overall Study||6
10504026|NCT01258387|11654888|FG001|STARTED|Overall Study||6
10504027|NCT01258387|11654889|FG002|STARTED|Overall Study||6
10504028|NCT01258387|11654890|FG003|STARTED|Overall Study||6
10504029|NCT01258387|11654891|FG004|STARTED|Overall Study||6
10504030|NCT01258387|11654892|FG005|STARTED|Overall Study||6
10504031|NCT01258387|11654893|FG006|STARTED|Overall Study||4
10504032|NCT01258387|11654887|FG000|Patients Randomized to GGF2|Overall Study||4
10504033|NCT01258387|11654888|FG001|Patients Randomized to GGF2|Overall Study||4
10504034|NCT01258387|11654889|FG002|Patients Randomized to GGF2|Overall Study||4
10504035|NCT01258387|11654890|FG003|Patients Randomized to GGF2|Overall Study||4
10504036|NCT01258387|11654891|FG004|Patients Randomized to GGF2|Overall Study||4
10504037|NCT01258387|11654892|FG005|Patients Randomized to GGF2|Overall Study||4
10504038|NCT01258387|11654893|FG006|Patients Randomized to GGF2|Overall Study||3
10504039|NCT01258387|11654887|FG000|Patients Randomized to Placebo|Overall Study||2
10504040|NCT01258387|11654888|FG001|Patients Randomized to Placebo|Overall Study||2
10504041|NCT01258387|11654889|FG002|Patients Randomized to Placebo|Overall Study||2
10504042|NCT01258387|11654890|FG003|Patients Randomized to Placebo|Overall Study||2
10504043|NCT01258387|11654891|FG004|Patients Randomized to Placebo|Overall Study||2
10504044|NCT01258387|11654892|FG005|Patients Randomized to Placebo|Overall Study||2
10504045|NCT01258387|11654893|FG006|Patients Randomized to Placebo|Overall Study||1
10504046|NCT01258387|11654887|FG000|COMPLETED|Overall Study||6
10504047|NCT01258387|11654888|FG001|COMPLETED|Overall Study||6
10504048|NCT01258387|11654889|FG002|COMPLETED|Overall Study||6
10504049|NCT01258387|11654890|FG003|COMPLETED|Overall Study||6
10504050|NCT01258387|11654891|FG004|COMPLETED|Overall Study||6
10504051|NCT01258387|11654892|FG005|COMPLETED|Overall Study||6
10504052|NCT01258387|11654893|FG006|COMPLETED|Overall Study||4
10504053|NCT01258387|11654887|FG000|NOT COMPLETED|Overall Study||0
10504054|NCT01258387|11654888|FG001|NOT COMPLETED|Overall Study||0
10504055|NCT01258387|11654889|FG002|NOT COMPLETED|Overall Study||0
10504056|NCT01258387|11654890|FG003|NOT COMPLETED|Overall Study||0
10504057|NCT01258387|11654891|FG004|NOT COMPLETED|Overall Study||0
10504058|NCT01258387|11654892|FG005|NOT COMPLETED|Overall Study||0
10504059|NCT01258387|11654893|FG006|NOT COMPLETED|Overall Study||0
10504060|NCT01258504|11654911|FG000|STARTED|Bosentan Single Dose||13
10504061|NCT01258504|11654911|FG000|COMPLETED|Bosentan Single Dose||13
10504062|NCT01258504|11654911|FG000|NOT COMPLETED|Bosentan Single Dose||0
10504063|NCT01258504|11654911|FG000|STARTED|Bosentan Steady-state||13
10504064|NCT01258504|11654911|FG000|COMPLETED|Bosentan Steady-state||13
10504065|NCT01258504|11654911|FG000|NOT COMPLETED|Bosentan Steady-state||0
10504066|NCT01258504|11654911|FG000|STARTED|Bosentan and SJW||13
10504067|NCT01258504|11654911|FG000|COMPLETED|Bosentan and SJW||13
10504068|NCT01258504|11654911|FG000|NOT COMPLETED|Bosentan and SJW||0
10504069|NCT01258582|11654922|FG000|STARTED|Overall Study||830
10504070|NCT01258582|11654923|FG001|STARTED|Overall Study||821
10504071|NCT01258582|11654922|FG000|COMPLETED|Overall Study||548
10504072|NCT01258582|11654923|FG001|COMPLETED|Overall Study||563
10504073|NCT01258582|11654922|FG000|NOT COMPLETED|Overall Study||282
10504074|NCT01258582|11654923|FG001|NOT COMPLETED|Overall Study||258
10504075|NCT01258595|11654931|FG000|STARTED|Overall Study||148
10504076|NCT01258595|11654932|FG001|STARTED|Overall Study||152
10504077|NCT01258595|11654931|FG000|COMPLETED|Overall Study||147
10504078|NCT01258595|11654932|FG001|COMPLETED|Overall Study||151
10504079|NCT01258595|11654931|FG000|NOT COMPLETED|Overall Study||1
10504080|NCT01258595|11654932|FG001|NOT COMPLETED|Overall Study||1
10504081|NCT01258608|11654940|FG000|STARTED|Overall Study||51
10504082|NCT01258608|11654941|FG001|STARTED|Overall Study||50
10504083|NCT01258608|11654940|FG000|COMPLETED|Overall Study||30
10504084|NCT01258608|11654941|FG001|COMPLETED|Overall Study||31
10504085|NCT01258608|11654940|FG000|NOT COMPLETED|Overall Study||21
10504086|NCT01258608|11654941|FG001|NOT COMPLETED|Overall Study||19
10504087|NCT01258660|11654950|FG000|STARTED|Overall Study|randomized and received at least one dose of treatment|86
10504088|NCT01258660|11654951|FG001|STARTED|Overall Study|randomized and received at least one dose of treatment|86
10504089|NCT01258660|11654950|FG000|Received Treatment|Overall Study||79
10504090|NCT01258660|11654951|FG001|Received Treatment|Overall Study||82
10504091|NCT01258660|11654950|FG000|Completed Treatment|Overall Study||79
10504092|NCT01258660|11654951|FG001|Completed Treatment|Overall Study||81
10504093|NCT01258660|11654950|FG000|COMPLETED|Overall Study|completed and valid for primary analysis data set|75
10504094|NCT01258660|11654951|FG001|COMPLETED|Overall Study|completed and valid for primary analysis data set|75
10504095|NCT01258660|11654950|FG000|NOT COMPLETED|Overall Study||11
10504096|NCT01258660|11654951|FG001|NOT COMPLETED|Overall Study||11
10504097|NCT01258738|11654960|FG000|STARTED|Double-blind Period||111
10504098|NCT01258738|11654961|FG001|STARTED|Double-blind Period||114
10504099|NCT01258738|11654960|FG000|Treated|Double-blind Period||111
10504100|NCT01258738|11654961|FG001|Treated|Double-blind Period||113
10504101|NCT01258738|11654960|FG000|COMPLETED|Double-blind Period||102
10528203|NCT01393899|11680430|FG001|NOT COMPLETED|Overall Study||28
10504102|NCT01258738|11654961|FG001|COMPLETED|Double-blind Period|Only 106 participants entered the open label period.|107
10504103|NCT01258738|11654960|FG000|NOT COMPLETED|Double-blind Period||9
10504104|NCT01258738|11654961|FG001|NOT COMPLETED|Double-blind Period||7
10504105|NCT01258738|11654960|FG000|STARTED|Open-label Period||102
10504106|NCT01258738|11654961|FG001|STARTED|Open-label Period||106
10504107|NCT01258738|11654960|FG000|COMPLETED|Open-label Period||85
10504108|NCT01258738|11654961|FG001|COMPLETED|Open-label Period||85
10504109|NCT01258738|11654960|FG000|NOT COMPLETED|Open-label Period||17
10504110|NCT01258738|11654961|FG001|NOT COMPLETED|Open-label Period||21
10504111|NCT01258790|11654969|FG000|STARTED|Overall Study||6
10504112|NCT01258790|11654970|FG001|STARTED|Overall Study||6
10504113|NCT01258790|11654969|FG000|COMPLETED|Overall Study||6
10504114|NCT01258790|11654970|FG001|COMPLETED|Overall Study||6
10504115|NCT01258790|11654969|FG000|NOT COMPLETED|Overall Study||0
10504116|NCT01258790|11654970|FG001|NOT COMPLETED|Overall Study||0
10504117|NCT01258855|11654978|FG000|STARTED|Overall Study||55
10504118|NCT01258855|11654979|FG001|STARTED|Overall Study||29
10504119|NCT01258855|11654978|FG000|COMPLETED|Overall Study||55
10504120|NCT01258855|11654979|FG001|COMPLETED|Overall Study||29
10504121|NCT01258855|11654978|FG000|NOT COMPLETED|Overall Study||0
10504122|NCT01258855|11654979|FG001|NOT COMPLETED|Overall Study||0
10504123|NCT01258985|11654987|FG000|STARTED|Overall Study||106
10504124|NCT01258985|11654988|FG001|STARTED|Overall Study||98
10504125|NCT01258985|11654987|FG000|COMPLETED|Overall Study||106
10504126|NCT01258985|11654988|FG001|COMPLETED|Overall Study||98
10504127|NCT01258985|11654987|FG000|NOT COMPLETED|Overall Study||0
10504128|NCT01258985|11654988|FG001|NOT COMPLETED|Overall Study||0
10528204|NCT01393899|11680431|FG002|NOT COMPLETED|Overall Study||23
10528205|NCT01393964|11680444|FG000|STARTED|Overall Study||8
10528206|NCT01393964|11680445|FG001|STARTED|Overall Study||9
10528207|NCT01393964|11680446|FG002|STARTED|Overall Study||9
10528208|NCT01393964|11680444|FG000|COMPLETED|Overall Study|Completed=treatment on-going|0
10528209|NCT01393964|11680445|FG001|COMPLETED|Overall Study|Completed=treatment on-going|0
10528210|NCT01393964|11680446|FG002|COMPLETED|Overall Study|Completed=treatment on-going|0
10528211|NCT01393964|11680444|FG000|NOT COMPLETED|Overall Study||8
10528212|NCT01393964|11680445|FG001|NOT COMPLETED|Overall Study||9
10528213|NCT01393964|11680446|FG002|NOT COMPLETED|Overall Study||9
10528214|NCT01393990|11680478|FG000|STARTED|Overall Study||4
10528215|NCT01393990|11680479|FG001|STARTED|Overall Study||3
10528216|NCT01393990|11680480|FG002|STARTED|Overall Study||3
10528217|NCT01393990|11680481|FG003|STARTED|Overall Study||3
10528218|NCT01393990|11680482|FG004|STARTED|Overall Study||5
10528219|NCT01393990|11680483|FG005|STARTED|Overall Study||3
10528220|NCT01393990|11680484|FG006|STARTED|Overall Study||3
10528221|NCT01393990|11680485|FG007|STARTED|Overall Study||7
10528222|NCT01393990|11680486|FG008|STARTED|Overall Study||6
10528223|NCT01393990|11680487|FG009|STARTED|Overall Study||3
10528224|NCT01393990|11680488|FG010|STARTED|Overall Study||3
10528225|NCT01393990|11680489|FG011|STARTED|Overall Study||3
10528226|NCT01393990|11680490|FG012|STARTED|Overall Study||3
10528227|NCT01393990|11680491|FG013|STARTED|Overall Study||5
10528228|NCT01393990|11680492|FG014|STARTED|Overall Study||18
10528229|NCT01393990|11680493|FG015|STARTED|Overall Study||8
10528230|NCT01393990|11680494|FG016|STARTED|Overall Study||3
10528231|NCT01393990|11680495|FG017|STARTED|Overall Study||6
10528232|NCT01393990|11680478|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
10528233|NCT01393990|11680479|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
10528234|NCT01393990|11680480|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
10528235|NCT01393990|11680481|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
10528236|NCT01393990|11680482|FG004|Received at Least 1 Dose of Study Drug|Overall Study||5
10528237|NCT01393990|11680483|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3
10528238|NCT01393990|11680484|FG006|Received at Least 1 Dose of Study Drug|Overall Study||3
10528239|NCT01393990|11680485|FG007|Received at Least 1 Dose of Study Drug|Overall Study||7
10528240|NCT01393990|11680486|FG008|Received at Least 1 Dose of Study Drug|Overall Study||6
10528241|NCT01393990|11680487|FG009|Received at Least 1 Dose of Study Drug|Overall Study||3
10528242|NCT01393990|11680488|FG010|Received at Least 1 Dose of Study Drug|Overall Study||3
10528243|NCT01393990|11680489|FG011|Received at Least 1 Dose of Study Drug|Overall Study||3
10528244|NCT01393990|11680490|FG012|Received at Least 1 Dose of Study Drug|Overall Study||3
10528245|NCT01393990|11680491|FG013|Received at Least 1 Dose of Study Drug|Overall Study||5
10528246|NCT01393990|11680492|FG014|Received at Least 1 Dose of Study Drug|Overall Study||18
10528247|NCT01393990|11680493|FG015|Received at Least 1 Dose of Study Drug|Overall Study||8
10528248|NCT01393990|11680494|FG016|Received at Least 1 Dose of Study Drug|Overall Study||3
10528249|NCT01393990|11680495|FG017|Received at Least 1 Dose of Study Drug|Overall Study||6
10528250|NCT01393990|11680478|FG000|COMPLETED|Overall Study||3
10528251|NCT01393990|11680479|FG001|COMPLETED|Overall Study||3
10528252|NCT01393990|11680480|FG002|COMPLETED|Overall Study||3
10528253|NCT01393990|11680481|FG003|COMPLETED|Overall Study||2
10528254|NCT01393990|11680482|FG004|COMPLETED|Overall Study||3
10528255|NCT01393990|11680483|FG005|COMPLETED|Overall Study||2
10528256|NCT01393990|11680484|FG006|COMPLETED|Overall Study||2
10528257|NCT01393990|11680485|FG007|COMPLETED|Overall Study||6
10528258|NCT01393990|11680486|FG008|COMPLETED|Overall Study||3
10528259|NCT01393990|11680487|FG009|COMPLETED|Overall Study||2
10528260|NCT01393990|11680488|FG010|COMPLETED|Overall Study||3
10528261|NCT01393990|11680489|FG011|COMPLETED|Overall Study||3
10528262|NCT01393990|11680490|FG012|COMPLETED|Overall Study||3
10504129|NCT01258998|11654994|FG000|STARTED|Overall Study||60
10504130|NCT01258998|11654994|FG000|COMPLETED|Overall Study||59
10504131|NCT01258998|11654994|FG000|NOT COMPLETED|Overall Study||1
10504132|NCT01259011|11655000|FG000|STARTED|Main Study Period|101 dyads (=202 individuals)|101
10504133|NCT01259011|11655001|FG001|STARTED|Main Study Period|109 dyads (=218 individuals)|109
10504134|NCT01259011|11655000|FG000|COMPLETED|Main Study Period||101
10504135|NCT01259011|11655001|FG001|COMPLETED|Main Study Period||109
10504136|NCT01259011|11655000|FG000|NOT COMPLETED|Main Study Period||0
10504137|NCT01259011|11655001|FG001|NOT COMPLETED|Main Study Period||0
10504138|NCT01259011|11655000|FG000|STARTED|After Patient Death|of 101 patient-surrogate dyads/pairs randomized, 17 surrogates of patients who died|17
10504139|NCT01259011|11655001|FG001|STARTED|After Patient Death|of 109 patient-surrogate dyads/pairs randomized, 28 surrogates of patients who died|28
10504140|NCT01259011|11655000|FG000|COMPLETED|After Patient Death||17
10504141|NCT01259011|11655001|FG001|COMPLETED|After Patient Death||28
10504142|NCT01259011|11655000|FG000|NOT COMPLETED|After Patient Death||0
10504143|NCT01259011|11655001|FG001|NOT COMPLETED|After Patient Death||0
10504144|NCT01259063|11655009|FG000|STARTED|Overall Study||33
10504145|NCT01259063|11655009|FG000|COMPLETED|Overall Study||33
10504146|NCT01259063|11655009|FG000|NOT COMPLETED|Overall Study||0
10504147|NCT01259089|11655013|FG000|STARTED|Reached First Response at 4 Weeks||3
10504148|NCT01259089|11655014|FG001|STARTED|Reached First Response at 4 Weeks||3
10504149|NCT01259089|11655015|FG002|STARTED|Reached First Response at 4 Weeks||3
10504150|NCT01259089|11655016|FG003|STARTED|Reached First Response at 4 Weeks||3
10504151|NCT01259089|11655017|FG004|STARTED|Reached First Response at 4 Weeks||6
10504152|NCT01259089|11655018|FG005|STARTED|Reached First Response at 4 Weeks||20
10504153|NCT01259089|11655013|FG000|Started Treatment on Study|Reached First Response at 4 Weeks||3
10504154|NCT01259089|11655014|FG001|Started Treatment on Study|Reached First Response at 4 Weeks||3
10504155|NCT01259089|11655015|FG002|Started Treatment on Study|Reached First Response at 4 Weeks||3
10504156|NCT01259089|11655016|FG003|Started Treatment on Study|Reached First Response at 4 Weeks||3
10504157|NCT01259089|11655017|FG004|Started Treatment on Study|Reached First Response at 4 Weeks||6
10504158|NCT01259089|11655018|FG005|Started Treatment on Study|Reached First Response at 4 Weeks||19
10504159|NCT01259089|11655013|FG000|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
10504160|NCT01259089|11655014|FG001|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
10504161|NCT01259089|11655015|FG002|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
10504162|NCT01259089|11655016|FG003|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
10504163|NCT01259089|11655017|FG004|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||6
10504164|NCT01259089|11655018|FG005|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||18
10504165|NCT01259089|11655013|FG000|COMPLETED|Reached First Response at 4 Weeks||3
10504166|NCT01259089|11655014|FG001|COMPLETED|Reached First Response at 4 Weeks||3
10504167|NCT01259089|11655015|FG002|COMPLETED|Reached First Response at 4 Weeks||3
10504168|NCT01259089|11655016|FG003|COMPLETED|Reached First Response at 4 Weeks||3
10504169|NCT01259089|11655017|FG004|COMPLETED|Reached First Response at 4 Weeks||6
10504170|NCT01259089|11655018|FG005|COMPLETED|Reached First Response at 4 Weeks||18
10504171|NCT01259089|11655013|FG000|NOT COMPLETED|Reached First Response at 4 Weeks||0
10504172|NCT01259089|11655014|FG001|NOT COMPLETED|Reached First Response at 4 Weeks||0
10504173|NCT01259089|11655015|FG002|NOT COMPLETED|Reached First Response at 4 Weeks||0
10504174|NCT01259089|11655016|FG003|NOT COMPLETED|Reached First Response at 4 Weeks||0
10504175|NCT01259089|11655017|FG004|NOT COMPLETED|Reached First Response at 4 Weeks||0
10504176|NCT01259089|11655018|FG005|NOT COMPLETED|Reached First Response at 4 Weeks||2
10504177|NCT01259089|11655013|FG000|STARTED|Confirmed Response at 8 Weeks||3
10504178|NCT01259089|11655014|FG001|STARTED|Confirmed Response at 8 Weeks||3
10504179|NCT01259089|11655015|FG002|STARTED|Confirmed Response at 8 Weeks||3
10504180|NCT01259089|11655016|FG003|STARTED|Confirmed Response at 8 Weeks||3
10504181|NCT01259089|11655017|FG004|STARTED|Confirmed Response at 8 Weeks||6
10504182|NCT01259089|11655018|FG005|STARTED|Confirmed Response at 8 Weeks||18
10504183|NCT01259089|11655013|FG000|COMPLETED|Confirmed Response at 8 Weeks||3
10504184|NCT01259089|11655014|FG001|COMPLETED|Confirmed Response at 8 Weeks||3
10504185|NCT01259089|11655015|FG002|COMPLETED|Confirmed Response at 8 Weeks||2
10504186|NCT01259089|11655016|FG003|COMPLETED|Confirmed Response at 8 Weeks||2
10504187|NCT01259089|11655017|FG004|COMPLETED|Confirmed Response at 8 Weeks||2
10504188|NCT01259089|11655018|FG005|COMPLETED|Confirmed Response at 8 Weeks||8
10504189|NCT01259089|11655013|FG000|NOT COMPLETED|Confirmed Response at 8 Weeks||0
10504190|NCT01259089|11655014|FG001|NOT COMPLETED|Confirmed Response at 8 Weeks||0
10504191|NCT01259089|11655015|FG002|NOT COMPLETED|Confirmed Response at 8 Weeks||1
10504192|NCT01259089|11655016|FG003|NOT COMPLETED|Confirmed Response at 8 Weeks||1
10504193|NCT01259089|11655017|FG004|NOT COMPLETED|Confirmed Response at 8 Weeks||4
10504194|NCT01259089|11655018|FG005|NOT COMPLETED|Confirmed Response at 8 Weeks||10
10504195|NCT01259089|11655013|FG000|STARTED|Continued Treatment After 8 Weeks||3
10504196|NCT01259089|11655014|FG001|STARTED|Continued Treatment After 8 Weeks||3
10504197|NCT01259089|11655015|FG002|STARTED|Continued Treatment After 8 Weeks||2
10504198|NCT01259089|11655016|FG003|STARTED|Continued Treatment After 8 Weeks||2
10504199|NCT01259089|11655017|FG004|STARTED|Continued Treatment After 8 Weeks||2
10504200|NCT01259089|11655018|FG005|STARTED|Continued Treatment After 8 Weeks||8
10504201|NCT01259089|11655013|FG000|COMPLETED|Continued Treatment After 8 Weeks||1
10504202|NCT01259089|11655014|FG001|COMPLETED|Continued Treatment After 8 Weeks||2
10504203|NCT01259089|11655015|FG002|COMPLETED|Continued Treatment After 8 Weeks||1
10504204|NCT01259089|11655016|FG003|COMPLETED|Continued Treatment After 8 Weeks||1
10504205|NCT01259089|11655017|FG004|COMPLETED|Continued Treatment After 8 Weeks||0
10504206|NCT01259089|11655018|FG005|COMPLETED|Continued Treatment After 8 Weeks||7
10504207|NCT01259089|11655013|FG000|NOT COMPLETED|Continued Treatment After 8 Weeks||2
10504208|NCT01259089|11655014|FG001|NOT COMPLETED|Continued Treatment After 8 Weeks||1
10504209|NCT01259089|11655015|FG002|NOT COMPLETED|Continued Treatment After 8 Weeks||1
10504210|NCT01259089|11655016|FG003|NOT COMPLETED|Continued Treatment After 8 Weeks||1
10504211|NCT01259089|11655017|FG004|NOT COMPLETED|Continued Treatment After 8 Weeks||2
10504212|NCT01259089|11655018|FG005|NOT COMPLETED|Continued Treatment After 8 Weeks||1
10504213|NCT01259089|11655013|FG000|STARTED|Survival Follow up for Two Years||3
10504214|NCT01259089|11655014|FG001|STARTED|Survival Follow up for Two Years||3
10504215|NCT01259089|11655015|FG002|STARTED|Survival Follow up for Two Years||3
10504216|NCT01259089|11655016|FG003|STARTED|Survival Follow up for Two Years||3
10504217|NCT01259089|11655017|FG004|STARTED|Survival Follow up for Two Years||6
10504218|NCT01259089|11655018|FG005|STARTED|Survival Follow up for Two Years||19
10504219|NCT01259089|11655013|FG000|COMPLETED|Survival Follow up for Two Years||0
10504220|NCT01259089|11655014|FG001|COMPLETED|Survival Follow up for Two Years||1
10504221|NCT01259089|11655015|FG002|COMPLETED|Survival Follow up for Two Years||1
10504222|NCT01259089|11655016|FG003|COMPLETED|Survival Follow up for Two Years||0
10504223|NCT01259089|11655017|FG004|COMPLETED|Survival Follow up for Two Years||0
10504224|NCT01259089|11655018|FG005|COMPLETED|Survival Follow up for Two Years||0
10504225|NCT01259089|11655013|FG000|NOT COMPLETED|Survival Follow up for Two Years||3
10504226|NCT01259089|11655014|FG001|NOT COMPLETED|Survival Follow up for Two Years||2
10504227|NCT01259089|11655015|FG002|NOT COMPLETED|Survival Follow up for Two Years||2
10504228|NCT01259089|11655016|FG003|NOT COMPLETED|Survival Follow up for Two Years||3
10504229|NCT01259089|11655017|FG004|NOT COMPLETED|Survival Follow up for Two Years||6
10504230|NCT01259089|11655018|FG005|NOT COMPLETED|Survival Follow up for Two Years||19
10710734|NCT02653417|11876108|FG002|COMPLETED|Overall Study||26
10710735|NCT02653417|11876109|FG003|COMPLETED|Overall Study||33
10504231|NCT01259102|11655037|FG000|STARTED|Overall Study||13
10504232|NCT01259102|11655038|FG001|STARTED|Overall Study||14
10504233|NCT01259102|11655039|FG002|STARTED|Overall Study||15
10504234|NCT01259102|11655040|FG003|STARTED|Overall Study||14
10504235|NCT01259102|11655041|FG004|STARTED|Overall Study||14
10504236|NCT01259102|11655037|FG000|COMPLETED|Overall Study||12
10504237|NCT01259102|11655038|FG001|COMPLETED|Overall Study||14
10504238|NCT01259102|11655039|FG002|COMPLETED|Overall Study||13
10504239|NCT01259102|11655040|FG003|COMPLETED|Overall Study||12
10504240|NCT01259102|11655041|FG004|COMPLETED|Overall Study||13
10504241|NCT01259102|11655037|FG000|NOT COMPLETED|Overall Study||1
10504242|NCT01259102|11655038|FG001|NOT COMPLETED|Overall Study||0
10504243|NCT01259102|11655039|FG002|NOT COMPLETED|Overall Study||2
10504244|NCT01259102|11655040|FG003|NOT COMPLETED|Overall Study||2
10504245|NCT01259102|11655041|FG004|NOT COMPLETED|Overall Study||1
10504246|NCT01259115|11655053|FG000|STARTED|Period 1||10
10504247|NCT01259115|11655054|FG001|STARTED|Period 1||10
10504248|NCT01259115|11655053|FG000|COMPLETED|Period 1||7
10504249|NCT01259115|11655054|FG001|COMPLETED|Period 1||9
10504250|NCT01259115|11655053|FG000|NOT COMPLETED|Period 1||3
10504251|NCT01259115|11655054|FG001|NOT COMPLETED|Period 1||1
10504252|NCT01259115|11655053|FG000|STARTED|Period: Washout Period of 4 to 18 Days||7
10504253|NCT01259115|11655054|FG001|STARTED|Period: Washout Period of 4 to 18 Days||9
10504254|NCT01259115|11655053|FG000|COMPLETED|Period: Washout Period of 4 to 18 Days||7
10504255|NCT01259115|11655054|FG001|COMPLETED|Period: Washout Period of 4 to 18 Days||9
10504256|NCT01259115|11655053|FG000|NOT COMPLETED|Period: Washout Period of 4 to 18 Days||0
10504257|NCT01259115|11655054|FG001|NOT COMPLETED|Period: Washout Period of 4 to 18 Days||0
10504258|NCT01259115|11655053|FG000|STARTED|Period 2||7
10504259|NCT01259115|11655054|FG001|STARTED|Period 2||9
10504260|NCT01259115|11655053|FG000|COMPLETED|Period 2||6
10504261|NCT01259115|11655054|FG001|COMPLETED|Period 2||9
10504262|NCT01259115|11655053|FG000|NOT COMPLETED|Period 2||1
10504263|NCT01259115|11655054|FG001|NOT COMPLETED|Period 2||0
10504264|NCT01259128|11655067|FG000|STARTED|Overall Study||15
10504265|NCT01259128|11655068|FG001|STARTED|Overall Study||17
10504266|NCT01259128|11655067|FG000|COMPLETED|Overall Study||15
10504267|NCT01259128|11655068|FG001|COMPLETED|Overall Study||15
10504268|NCT01259128|11655067|FG000|NOT COMPLETED|Overall Study||0
10504269|NCT01259128|11655068|FG001|NOT COMPLETED|Overall Study||2
10504270|NCT01259245|11655076|FG000|STARTED|Overall Study||98
10504271|NCT01259245|11655077|FG001|STARTED|Overall Study||94
10504272|NCT01259245|11655076|FG000|COMPLETED|Overall Study|27 were lost to follow-up and 1 deceased|70
10504273|NCT01259245|11655077|FG001|COMPLETED|Overall Study|24 discontinued intervention and 2 deceased|68
10504274|NCT01259245|11655076|FG000|NOT COMPLETED|Overall Study||28
10504275|NCT01259245|11655077|FG001|NOT COMPLETED|Overall Study||26
10504276|NCT01259297|11655093|FG000|STARTED|Run-in Open Label Period (4-5 Weeks)||1335
10504277|NCT01259297|11655094|FG001|STARTED|Run-in Open Label Period (4-5 Weeks)||0
10504278|NCT01259297|11655095|FG002|STARTED|Run-in Open Label Period (4-5 Weeks)||1001
10504279|NCT01259297|11655096|FG003|STARTED|Run-in Open Label Period (4-5 Weeks)||0
10504280|NCT01259297|11655097|FG004|STARTED|Run-in Open Label Period (4-5 Weeks)||0
10504281|NCT01259297|11655098|FG005|STARTED|Run-in Open Label Period (4-5 Weeks)||0
10504282|NCT01259297|11655099|FG006|STARTED|Run-in Open Label Period (4-5 Weeks)||0
10504283|NCT01259297|11655100|FG007|STARTED|Run-in Open Label Period (4-5 Weeks)||0
10710736|NCT02653417|11876106|FG000|NOT COMPLETED|Overall Study||1
10504284|NCT01259297|11655093|FG000|COMPLETED|Run-in Open Label Period (4-5 Weeks)||980
10504285|NCT01259297|11655094|FG001|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
10504286|NCT01259297|11655095|FG002|COMPLETED|Run-in Open Label Period (4-5 Weeks)||779
10504287|NCT01259297|11655096|FG003|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
10504288|NCT01259297|11655097|FG004|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
10504289|NCT01259297|11655098|FG005|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
10504290|NCT01259297|11655099|FG006|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
10504291|NCT01259297|11655100|FG007|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
10504292|NCT01259297|11655093|FG000|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||355
10504293|NCT01259297|11655094|FG001|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
10504294|NCT01259297|11655095|FG002|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||222
10504295|NCT01259297|11655096|FG003|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
10504296|NCT01259297|11655097|FG004|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
10504297|NCT01259297|11655098|FG005|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
10504298|NCT01259297|11655099|FG006|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
10504299|NCT01259297|11655100|FG007|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
10504300|NCT01259297|11655093|FG000|STARTED|Double Blind Randomized Period||244
10504301|NCT01259297|11655094|FG001|STARTED|Double Blind Randomized Period||232
10504302|NCT01259297|11655095|FG002|STARTED|Double Blind Randomized Period||189
10504303|NCT01259297|11655096|FG003|STARTED|Double Blind Randomized Period||195
10504304|NCT01259297|11655097|FG004|STARTED|Double Blind Randomized Period||251
10504305|NCT01259297|11655098|FG005|STARTED|Double Blind Randomized Period||253
10504306|NCT01259297|11655099|FG006|STARTED|Double Blind Randomized Period||196
10504307|NCT01259297|11655100|FG007|STARTED|Double Blind Randomized Period||199
10504308|NCT01259297|11655093|FG000|COMPLETED|Double Blind Randomized Period||242
10504309|NCT01259297|11655094|FG001|COMPLETED|Double Blind Randomized Period||229
10504310|NCT01259297|11655095|FG002|COMPLETED|Double Blind Randomized Period||188
10504311|NCT01259297|11655096|FG003|COMPLETED|Double Blind Randomized Period||191
10504312|NCT01259297|11655097|FG004|COMPLETED|Double Blind Randomized Period||247
10504313|NCT01259297|11655098|FG005|COMPLETED|Double Blind Randomized Period||245
10504314|NCT01259297|11655099|FG006|COMPLETED|Double Blind Randomized Period||190
10504315|NCT01259297|11655100|FG007|COMPLETED|Double Blind Randomized Period||196
10504316|NCT01259297|11655093|FG000|NOT COMPLETED|Double Blind Randomized Period||2
10504317|NCT01259297|11655094|FG001|NOT COMPLETED|Double Blind Randomized Period||3
10504318|NCT01259297|11655095|FG002|NOT COMPLETED|Double Blind Randomized Period||1
10504319|NCT01259297|11655096|FG003|NOT COMPLETED|Double Blind Randomized Period||4
10504320|NCT01259297|11655097|FG004|NOT COMPLETED|Double Blind Randomized Period||4
10504321|NCT01259297|11655098|FG005|NOT COMPLETED|Double Blind Randomized Period||8
10504322|NCT01259297|11655099|FG006|NOT COMPLETED|Double Blind Randomized Period||6
10504323|NCT01259297|11655100|FG007|NOT COMPLETED|Double Blind Randomized Period||3
10504324|NCT01259375|11655117|FG000|STARTED|Overall Study||24
10504325|NCT01259375|11655117|FG000|COMPLETED|Overall Study||23
10504326|NCT01259375|11655117|FG000|NOT COMPLETED|Overall Study||1
10504327|NCT01259388|11655125|FG000|STARTED|Overall Study||11
10504328|NCT01259388|11655126|FG001|STARTED|Overall Study||12
10504329|NCT01259388|11655125|FG000|COMPLETED|Overall Study||6
10504330|NCT01259388|11655126|FG001|COMPLETED|Overall Study||11
10504331|NCT01259388|11655125|FG000|NOT COMPLETED|Overall Study||5
10504332|NCT01259388|11655126|FG001|NOT COMPLETED|Overall Study||1
10504333|NCT01259401|11655134|FG000|STARTED|End of 4-week Intervention||21
10504334|NCT01259401|11655135|FG001|STARTED|End of 4-week Intervention||21
10504335|NCT01259401|11655134|FG000|COMPLETED|End of 4-week Intervention||21
10504336|NCT01259401|11655135|FG001|COMPLETED|End of 4-week Intervention||21
10504337|NCT01259401|11655134|FG000|NOT COMPLETED|End of 4-week Intervention||0
10504338|NCT01259401|11655135|FG001|NOT COMPLETED|End of 4-week Intervention||0
10504339|NCT01259401|11655134|FG000|STARTED|4-month Follow-up||21
10504340|NCT01259401|11655135|FG001|STARTED|4-month Follow-up||21
10504341|NCT01259401|11655134|FG000|COMPLETED|4-month Follow-up||21
10504342|NCT01259401|11655135|FG001|COMPLETED|4-month Follow-up||19
10504343|NCT01259401|11655134|FG000|NOT COMPLETED|4-month Follow-up||0
10504344|NCT01259401|11655135|FG001|NOT COMPLETED|4-month Follow-up||2
10504345|NCT01259427|11655143|FG000|STARTED|Overall Study||124
10504346|NCT01259427|11655144|FG001|STARTED|Overall Study||124
10504347|NCT01259427|11655143|FG000|COMPLETED|Overall Study||106
10504348|NCT01259427|11655144|FG001|COMPLETED|Overall Study||110
10504349|NCT01259427|11655143|FG000|NOT COMPLETED|Overall Study||18
10504350|NCT01259427|11655144|FG001|NOT COMPLETED|Overall Study||14
10504351|NCT01259440|11655153|FG000|STARTED|Overall Study||13
10504352|NCT01259440|11655154|FG001|STARTED|Overall Study||10
10504353|NCT01259440|11655153|FG000|COMPLETED|Overall Study||13
10504354|NCT01259440|11655154|FG001|COMPLETED|Overall Study||10
10504355|NCT01259440|11655153|FG000|NOT COMPLETED|Overall Study||0
10504356|NCT01259440|11655154|FG001|NOT COMPLETED|Overall Study||0
10504357|NCT01259466|11655162|FG000|STARTED|Overall Study||27
10504358|NCT01259466|11655163|FG001|STARTED|Overall Study||27
10504359|NCT01259466|11655162|FG000|COMPLETED|Overall Study||26
10504360|NCT01259466|11655163|FG001|COMPLETED|Overall Study||18
10504361|NCT01259466|11655162|FG000|NOT COMPLETED|Overall Study||1
10504362|NCT01259466|11655163|FG001|NOT COMPLETED|Overall Study||9
10504363|NCT01259492|11655173|FG000|STARTED|Period 1 (9 Weeks)||181
10504364|NCT01259492|11655174|FG001|STARTED|Period 1 (9 Weeks)||182
10504365|NCT01259492|11655175|FG002|STARTED|Period 1 (9 Weeks)||181
10504366|NCT01259492|11655176|FG003|STARTED|Period 1 (9 Weeks)||181
10504367|NCT01259492|11655173|FG000|Full Analysis Set|Period 1 (9 Weeks)||174
10504368|NCT01259492|11655174|FG001|Full Analysis Set|Period 1 (9 Weeks)||175
10504369|NCT01259492|11655175|FG002|Full Analysis Set|Period 1 (9 Weeks)||179
10504370|NCT01259492|11655176|FG003|Full Analysis Set|Period 1 (9 Weeks)||172
10504371|NCT01259492|11655173|FG000|COMPLETED|Period 1 (9 Weeks)|"Completed indicates patients entered Period 2."|152
10504372|NCT01259492|11655174|FG001|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|141
10504373|NCT01259492|11655175|FG002|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|138
10504374|NCT01259492|11655176|FG003|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|153
10504375|NCT01259492|11655173|FG000|NOT COMPLETED|Period 1 (9 Weeks)||29
10504376|NCT01259492|11655174|FG001|NOT COMPLETED|Period 1 (9 Weeks)||41
10504377|NCT01259492|11655175|FG002|NOT COMPLETED|Period 1 (9 Weeks)||43
10504378|NCT01259492|11655176|FG003|NOT COMPLETED|Period 1 (9 Weeks)||28
10504379|NCT01259492|11655173|FG000|STARTED|Period 2 (Week 10 to Week 14)|Treatment arms including Placebo indicate patients belong to respective treatment arms in Period 1|152
10504380|NCT01259492|11655174|FG001|STARTED|Period 2 (Week 10 to Week 14)||141
10504381|NCT01259492|11655175|FG002|STARTED|Period 2 (Week 10 to Week 14)||138
10504382|NCT01259492|11655176|FG003|STARTED|Period 2 (Week 10 to Week 14)||153
10504383|NCT01259492|11655173|FG000|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|127
10504384|NCT01259492|11655174|FG001|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|123
10504385|NCT01259492|11655175|FG002|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|114
10504386|NCT01259492|11655176|FG003|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|125
10504387|NCT01259492|11655173|FG000|NOT COMPLETED|Period 2 (Week 10 to Week 14)||25
10504388|NCT01259492|11655174|FG001|NOT COMPLETED|Period 2 (Week 10 to Week 14)||18
10504389|NCT01259492|11655175|FG002|NOT COMPLETED|Period 2 (Week 10 to Week 14)||24
10504390|NCT01259492|11655176|FG003|NOT COMPLETED|Period 2 (Week 10 to Week 14)||28
10504391|NCT01259492|11655173|FG000|STARTED|Period 3 (Week 15 to End of Week 40)|In period 3, all 489 patients who completed period 2 were re-randomized to 4 arms.|114
10504392|NCT01259492|11655174|FG001|STARTED|Period 3 (Week 15 to End of Week 40)||132
10504393|NCT01259492|11655175|FG002|STARTED|Period 3 (Week 15 to End of Week 40)||120
10504394|NCT01259492|11655176|FG003|STARTED|Period 3 (Week 15 to End of Week 40)||123
10504395|NCT01259492|11655173|FG000|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||110
10504396|NCT01259492|11655174|FG001|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||128
10504397|NCT01259492|11655175|FG002|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||114
10504398|NCT01259492|11655176|FG003|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||115
10504399|NCT01259492|11655173|FG000|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|60
10504400|NCT01259492|11655174|FG001|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|63
10504401|NCT01259492|11655175|FG002|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|70
10504402|NCT01259492|11655176|FG003|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|42
10504403|NCT01259492|11655173|FG000|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||54
10504404|NCT01259492|11655174|FG001|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||69
10504405|NCT01259492|11655175|FG002|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||50
10504406|NCT01259492|11655176|FG003|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||81
10710737|NCT02653417|11876107|FG001|NOT COMPLETED|Overall Study||2
10710738|NCT02653417|11876108|FG002|NOT COMPLETED|Overall Study||3
10504407|NCT01259596|11655187|FG000|STARTED|Overall Study||70
10504408|NCT01259596|11655188|FG001|STARTED|Overall Study||71
10504409|NCT01259596|11655187|FG000|COMPLETED|Overall Study||66
10504410|NCT01259596|11655188|FG001|COMPLETED|Overall Study||65
10504411|NCT01259596|11655187|FG000|NOT COMPLETED|Overall Study||4
10504412|NCT01259596|11655188|FG001|NOT COMPLETED|Overall Study||6
10504413|NCT01259713|11655198|FG000|STARTED|Overall Study||237
10504414|NCT01259713|11655199|FG001|STARTED|Overall Study||118
10504415|NCT01259713|11655198|FG000|COMPLETED|Overall Study||142
10504416|NCT01259713|11655199|FG001|COMPLETED|Overall Study||77
10504417|NCT01259713|11655198|FG000|NOT COMPLETED|Overall Study||95
10504418|NCT01259713|11655199|FG001|NOT COMPLETED|Overall Study||41
10504419|NCT01259726|11655209|FG000|STARTED|Overall Study||43
10504420|NCT01259726|11655210|FG001|STARTED|Overall Study||41
10504421|NCT01259726|11655211|FG002|STARTED|Overall Study||43
10504422|NCT01259726|11655212|FG003|STARTED|Overall Study||41
10504423|NCT01259726|11655209|FG000|Treated|Overall Study||40
10504424|NCT01259726|11655210|FG001|Treated|Overall Study||37
10504425|NCT01259726|11655211|FG002|Treated|Overall Study||41
10504426|NCT01259726|11655212|FG003|Treated|Overall Study||39
10504427|NCT01259726|11655209|FG000|COMPLETED|Overall Study||38
10504428|NCT01259726|11655210|FG001|COMPLETED|Overall Study||37
10504429|NCT01259726|11655211|FG002|COMPLETED|Overall Study||39
10504430|NCT01259726|11655212|FG003|COMPLETED|Overall Study||36
10710739|NCT02653417|11876109|FG003|NOT COMPLETED|Overall Study||5
10710740|NCT02653456|11876123|FG000|STARTED|Overall Study||64
10504431|NCT01259726|11655209|FG000|NOT COMPLETED|Overall Study||5
10504432|NCT01259726|11655210|FG001|NOT COMPLETED|Overall Study||4
10504433|NCT01259726|11655211|FG002|NOT COMPLETED|Overall Study||4
10504434|NCT01259726|11655212|FG003|NOT COMPLETED|Overall Study||5
10504435|NCT01259856|11655224|FG000|STARTED|Overall Study||82
10504436|NCT01259856|11655225|FG001|STARTED|Overall Study||86
10504437|NCT01259856|11655224|FG000|COMPLETED|Overall Study||13
10504438|NCT01259856|11655225|FG001|COMPLETED|Overall Study||12
10504439|NCT01259856|11655224|FG000|NOT COMPLETED|Overall Study||69
10710741|NCT02653456|11876123|FG000|COMPLETED|Overall Study||59
10710742|NCT02653456|11876123|FG000|NOT COMPLETED|Overall Study||5
10710743|NCT02653560|11876128|FG000|STARTED|KMgCit Phase||30
10504440|NCT01259856|11655225|FG001|NOT COMPLETED|Overall Study||74
10504441|NCT01259869|11655231|FG000|STARTED|Overall Study||34
10504442|NCT01259869|11655231|FG000|COMPLETED|Overall Study||33
10504443|NCT01259869|11655231|FG000|NOT COMPLETED|Overall Study||1
10504444|NCT01260142|11655241|FG000|STARTED|Treatment Period 1||6
10504445|NCT01260142|11655242|FG001|STARTED|Treatment Period 1||6
10504446|NCT01260142|11655243|FG002|STARTED|Treatment Period 1||6
10504447|NCT01260142|11655244|FG003|STARTED|Treatment Period 1||6
10504448|NCT01260142|11655245|FG004|STARTED|Treatment Period 1||6
10504449|NCT01260142|11655246|FG005|STARTED|Treatment Period 1||6
10504450|NCT01260142|11655241|FG000|COMPLETED|Treatment Period 1||5
10504451|NCT01260142|11655242|FG001|COMPLETED|Treatment Period 1||5
10504452|NCT01260142|11655243|FG002|COMPLETED|Treatment Period 1||6
10504453|NCT01260142|11655244|FG003|COMPLETED|Treatment Period 1||6
10504454|NCT01260142|11655245|FG004|COMPLETED|Treatment Period 1||4
10504455|NCT01260142|11655246|FG005|COMPLETED|Treatment Period 1||3
10504456|NCT01260142|11655241|FG000|NOT COMPLETED|Treatment Period 1||1
10504457|NCT01260142|11655242|FG001|NOT COMPLETED|Treatment Period 1||1
10504458|NCT01260142|11655243|FG002|NOT COMPLETED|Treatment Period 1||0
10504459|NCT01260142|11655244|FG003|NOT COMPLETED|Treatment Period 1||0
10504460|NCT01260142|11655245|FG004|NOT COMPLETED|Treatment Period 1||2
10504461|NCT01260142|11655246|FG005|NOT COMPLETED|Treatment Period 1||3
10504462|NCT01260142|11655241|FG000|STARTED|Treatment Period 2||5
10504463|NCT01260142|11655242|FG001|STARTED|Treatment Period 2||5
10504464|NCT01260142|11655243|FG002|STARTED|Treatment Period 2||6
10504465|NCT01260142|11655244|FG003|STARTED|Treatment Period 2||6
10504466|NCT01260142|11655245|FG004|STARTED|Treatment Period 2||4
10504467|NCT01260142|11655246|FG005|STARTED|Treatment Period 2||3
10504468|NCT01260142|11655241|FG000|COMPLETED|Treatment Period 2||5
10504469|NCT01260142|11655242|FG001|COMPLETED|Treatment Period 2||5
10504470|NCT01260142|11655243|FG002|COMPLETED|Treatment Period 2||6
10504471|NCT01260142|11655244|FG003|COMPLETED|Treatment Period 2||6
10504472|NCT01260142|11655245|FG004|COMPLETED|Treatment Period 2||4
10504473|NCT01260142|11655246|FG005|COMPLETED|Treatment Period 2||3
10504474|NCT01260142|11655241|FG000|NOT COMPLETED|Treatment Period 2||0
10504475|NCT01260142|11655242|FG001|NOT COMPLETED|Treatment Period 2||0
10504476|NCT01260142|11655243|FG002|NOT COMPLETED|Treatment Period 2||0
10504477|NCT01260142|11655244|FG003|NOT COMPLETED|Treatment Period 2||0
10504478|NCT01260142|11655245|FG004|NOT COMPLETED|Treatment Period 2||0
10504479|NCT01260142|11655246|FG005|NOT COMPLETED|Treatment Period 2||0
10504480|NCT01260181|11655266|FG000|STARTED|Overall Study||30
10504481|NCT01260181|11655266|FG000|COMPLETED|Overall Study||29
10504482|NCT01260181|11655266|FG000|NOT COMPLETED|Overall Study||1
10504483|NCT01260194|11655270|FG000|STARTED|Overall Study||4
10504484|NCT01260194|11655270|FG000|COMPLETED|Overall Study||3
10504485|NCT01260194|11655270|FG000|NOT COMPLETED|Overall Study||1
10504486|NCT01260272|11655276|FG000|STARTED|Overall Study||17
10504487|NCT01260272|11655277|FG001|STARTED|Overall Study||32
10504488|NCT01260272|11655276|FG000|COMPLETED|Overall Study||15
10504489|NCT01260272|11655277|FG001|COMPLETED|Overall Study||30
10504490|NCT01260272|11655276|FG000|NOT COMPLETED|Overall Study||2
10504491|NCT01260272|11655277|FG001|NOT COMPLETED|Overall Study||2
10504492|NCT01260311|11655285|FG000|STARTED|Overall Study||508
10504493|NCT01260311|11655285|FG000|COMPLETED|Overall Study||381
10504494|NCT01260311|11655285|FG000|NOT COMPLETED|Overall Study||127
10504495|NCT01260324|11655291|FG000|STARTED|Overall Study||1283
10504496|NCT01260324|11655292|FG001|STARTED|Overall Study||20000
10504497|NCT01260324|11655291|FG000|COMPLETED|Overall Study||1283
10504498|NCT01260324|11655292|FG001|COMPLETED|Overall Study||20000
10504499|NCT01260324|11655291|FG000|NOT COMPLETED|Overall Study||0
10504500|NCT01260324|11655292|FG001|NOT COMPLETED|Overall Study||0
10504501|NCT01260350|11655318|FG000|STARTED|Overall Study||10
10504502|NCT01260350|11655319|FG001|STARTED|Overall Study||9
10504503|NCT01260350|11655320|FG002|STARTED|Overall Study||10
10504504|NCT01260350|11655321|FG003|STARTED|Overall Study||11
10504505|NCT01260350|11655322|FG004|STARTED|Overall Study||10
10504506|NCT01260350|11655323|FG005|STARTED|Overall Study||10
10504507|NCT01260350|11655324|FG006|STARTED|Overall Study||10
10504508|NCT01260350|11655325|FG007|STARTED|Overall Study||25
10504509|NCT01260350|11655326|FG008|STARTED|Overall Study||25
10504510|NCT01260350|11655327|FG009|STARTED|Overall Study||25
10504511|NCT01260350|11655328|FG010|STARTED|Overall Study||10
10504512|NCT01260350|11655329|FG011|STARTED|Overall Study||9
10504513|NCT01260350|11655330|FG012|STARTED|Overall Study||25
10504514|NCT01260350|11655331|FG013|STARTED|Overall Study||10
10504515|NCT01260350|11655332|FG014|STARTED|Overall Study||25
10504516|NCT01260350|11655333|FG015|STARTED|Overall Study||10
10504517|NCT01260350|11655334|FG016|STARTED|Overall Study||9
10504518|NCT01260350|11655335|FG017|STARTED|Overall Study||10
10504519|NCT01260350|11655336|FG018|STARTED|Overall Study||0
10504520|NCT01260350|11655337|FG019|STARTED|Overall Study||14
10504521|NCT01260350|11655338|FG020|STARTED|Overall Study||25
10504522|NCT01260350|11655339|FG021|STARTED|Overall Study||0
10504523|NCT01260350|11655318|FG000|COMPLETED|Overall Study||10
10504524|NCT01260350|11655319|FG001|COMPLETED|Overall Study||9
10504525|NCT01260350|11655320|FG002|COMPLETED|Overall Study||10
10504526|NCT01260350|11655321|FG003|COMPLETED|Overall Study||11
10504527|NCT01260350|11655322|FG004|COMPLETED|Overall Study||10
10504528|NCT01260350|11655323|FG005|COMPLETED|Overall Study||10
10504529|NCT01260350|11655324|FG006|COMPLETED|Overall Study||10
10504530|NCT01260350|11655325|FG007|COMPLETED|Overall Study||25
10504531|NCT01260350|11655326|FG008|COMPLETED|Overall Study||24
10504532|NCT01260350|11655327|FG009|COMPLETED|Overall Study||25
10504533|NCT01260350|11655328|FG010|COMPLETED|Overall Study||10
10504534|NCT01260350|11655329|FG011|COMPLETED|Overall Study||9
10504535|NCT01260350|11655330|FG012|COMPLETED|Overall Study||25
10504536|NCT01260350|11655331|FG013|COMPLETED|Overall Study||10
10504537|NCT01260350|11655332|FG014|COMPLETED|Overall Study||25
10504538|NCT01260350|11655333|FG015|COMPLETED|Overall Study||10
10504539|NCT01260350|11655334|FG016|COMPLETED|Overall Study||9
10504540|NCT01260350|11655335|FG017|COMPLETED|Overall Study||9
10504541|NCT01260350|11655336|FG018|COMPLETED|Overall Study||0
10504542|NCT01260350|11655337|FG019|COMPLETED|Overall Study||14
10504543|NCT01260350|11655338|FG020|COMPLETED|Overall Study||22
10504544|NCT01260350|11655339|FG021|COMPLETED|Overall Study||0
10504545|NCT01260350|11655318|FG000|NOT COMPLETED|Overall Study||0
10504546|NCT01260350|11655319|FG001|NOT COMPLETED|Overall Study||0
10504547|NCT01260350|11655320|FG002|NOT COMPLETED|Overall Study||0
10504548|NCT01260350|11655321|FG003|NOT COMPLETED|Overall Study||0
10504549|NCT01260350|11655322|FG004|NOT COMPLETED|Overall Study||0
10504550|NCT01260350|11655323|FG005|NOT COMPLETED|Overall Study||0
10504551|NCT01260350|11655324|FG006|NOT COMPLETED|Overall Study||0
10504552|NCT01260350|11655325|FG007|NOT COMPLETED|Overall Study||0
10504553|NCT01260350|11655326|FG008|NOT COMPLETED|Overall Study||1
10504554|NCT01260350|11655327|FG009|NOT COMPLETED|Overall Study||0
10504555|NCT01260350|11655328|FG010|NOT COMPLETED|Overall Study||0
10504556|NCT01260350|11655329|FG011|NOT COMPLETED|Overall Study||0
10504557|NCT01260350|11655330|FG012|NOT COMPLETED|Overall Study||0
10504558|NCT01260350|11655331|FG013|NOT COMPLETED|Overall Study||0
10504559|NCT01260350|11655332|FG014|NOT COMPLETED|Overall Study||0
10504560|NCT01260350|11655333|FG015|NOT COMPLETED|Overall Study||0
10504561|NCT01260350|11655334|FG016|NOT COMPLETED|Overall Study||0
10504562|NCT01260350|11655335|FG017|NOT COMPLETED|Overall Study||1
10504563|NCT01260350|11655336|FG018|NOT COMPLETED|Overall Study||0
10504564|NCT01260350|11655337|FG019|NOT COMPLETED|Overall Study||0
10504565|NCT01260350|11655338|FG020|NOT COMPLETED|Overall Study||3
10504566|NCT01260350|11655339|FG021|NOT COMPLETED|Overall Study||0
10504567|NCT01260454|11655393|FG000|STARTED|Overall Study||6
10504568|NCT01260454|11655393|FG000|COMPLETED|Overall Study||6
10504569|NCT01260454|11655393|FG000|NOT COMPLETED|Overall Study||0
10504570|NCT01260467|11655397|FG000|STARTED|Overall Study||4
10504571|NCT01260467|11655397|FG000|COMPLETED|Overall Study||2
10504572|NCT01260467|11655397|FG000|NOT COMPLETED|Overall Study||2
10504573|NCT01260493|11655405|FG000|STARTED|Overall Study||92
10504574|NCT01260493|11655406|FG001|STARTED|Overall Study||89
10504575|NCT01260493|11655405|FG000|COMPLETED|Overall Study||76
10504576|NCT01260493|11655406|FG001|COMPLETED|Overall Study||85
10504577|NCT01260493|11655405|FG000|NOT COMPLETED|Overall Study||16
10504578|NCT01260493|11655406|FG001|NOT COMPLETED|Overall Study||4
10504579|NCT01260584|11655416|FG000|STARTED|Period 1||27
10504580|NCT01260584|11655417|FG001|STARTED|Period 1||28
10504581|NCT01260584|11655418|FG002|STARTED|Period 1||27
10504582|NCT01260584|11655419|FG003|STARTED|Period 1||28
10504583|NCT01260584|11655416|FG000|COMPLETED|Period 1||27
10710744|NCT02653560|11876129|FG001|STARTED|KMgCit Phase||0
10710745|NCT02653560|11876130|FG002|STARTED|KMgCit Phase||0
10710746|NCT02653560|11876131|FG003|STARTED|KMgCit Phase||0
10710747|NCT02653560|11876128|FG000|COMPLETED|KMgCit Phase||30
10710748|NCT02653560|11876129|FG001|COMPLETED|KMgCit Phase||0
10504584|NCT01260584|11655417|FG001|COMPLETED|Period 1||28
10504585|NCT01260584|11655418|FG002|COMPLETED|Period 1||25
10504586|NCT01260584|11655419|FG003|COMPLETED|Period 1||27
10504587|NCT01260584|11655416|FG000|NOT COMPLETED|Period 1||0
10504588|NCT01260584|11655417|FG001|NOT COMPLETED|Period 1||0
10504589|NCT01260584|11655418|FG002|NOT COMPLETED|Period 1||2
10504590|NCT01260584|11655419|FG003|NOT COMPLETED|Period 1||1
10504591|NCT01260584|11655416|FG000|STARTED|Period 2||27
10504592|NCT01260584|11655417|FG001|STARTED|Period 2||28
10504593|NCT01260584|11655418|FG002|STARTED|Period 2||25
10504594|NCT01260584|11655419|FG003|STARTED|Period 2||27
10504595|NCT01260584|11655416|FG000|COMPLETED|Period 2||26
10504596|NCT01260584|11655417|FG001|COMPLETED|Period 2||25
10504597|NCT01260584|11655418|FG002|COMPLETED|Period 2||20
10504598|NCT01260584|11655419|FG003|COMPLETED|Period 2||26
10504599|NCT01260584|11655416|FG000|NOT COMPLETED|Period 2||1
10504600|NCT01260584|11655417|FG001|NOT COMPLETED|Period 2||3
10504601|NCT01260584|11655418|FG002|NOT COMPLETED|Period 2||5
10504602|NCT01260584|11655419|FG003|NOT COMPLETED|Period 2||1
10504603|NCT01260649|11655431|FG000|STARTED|Overall Study||8
10504604|NCT01260649|11655432|FG001|STARTED|Overall Study||9
10504605|NCT01260649|11655431|FG000|COMPLETED|Overall Study||6
10504606|NCT01260649|11655432|FG001|COMPLETED|Overall Study||8
10504607|NCT01260649|11655431|FG000|NOT COMPLETED|Overall Study||2
10504608|NCT01260649|11655432|FG001|NOT COMPLETED|Overall Study||1
10504609|NCT01260662|11655441|FG000|STARTED|Overall Study||90
10504610|NCT01260662|11655442|FG001|STARTED|Overall Study||85
10504611|NCT01260662|11655443|FG002|STARTED|Overall Study||96
10504612|NCT01260662|11655441|FG000|COMPLETED|Overall Study||90
10504613|NCT01260662|11655442|FG001|COMPLETED|Overall Study||85
10504614|NCT01260662|11655443|FG002|COMPLETED|Overall Study||96
10504615|NCT01260662|11655441|FG000|NOT COMPLETED|Overall Study||0
10504616|NCT01260662|11655442|FG001|NOT COMPLETED|Overall Study||0
10504617|NCT01260662|11655443|FG002|NOT COMPLETED|Overall Study||0
10504618|NCT01260688|11655453|FG000|STARTED|Overall Study||11
10504619|NCT01260688|11655454|FG001|STARTED|Overall Study||11
10710749|NCT02653560|11876130|FG002|COMPLETED|KMgCit Phase||0
10504620|NCT01260688|11655453|FG000|COMPLETED|Overall Study||11
10504621|NCT01260688|11655454|FG001|COMPLETED|Overall Study||11
10504622|NCT01260688|11655453|FG000|NOT COMPLETED|Overall Study||0
10504623|NCT01260688|11655454|FG001|NOT COMPLETED|Overall Study||0
10504624|NCT01260701|11655463|FG000|STARTED|Overall Study||75
10504625|NCT01260701|11655463|FG000|Eligible|Overall Study||71
10504626|NCT01260701|11655463|FG000|Eligible and Began Protocol Therapy|Overall Study||70
10504627|NCT01260701|11655463|FG000|COMPLETED|Overall Study||0
10504628|NCT01260701|11655463|FG000|NOT COMPLETED|Overall Study||75
10504629|NCT01260883|11655470|FG000|STARTED|Overall Study||22
10504630|NCT01260883|11655471|FG001|STARTED|Overall Study||11
10504631|NCT01260883|11655472|FG002|STARTED|Overall Study||18
10504632|NCT01260883|11655470|FG000|COMPLETED|Overall Study||22
10504633|NCT01260883|11655471|FG001|COMPLETED|Overall Study||11
10504634|NCT01260883|11655472|FG002|COMPLETED|Overall Study||18
10504635|NCT01260883|11655470|FG000|NOT COMPLETED|Overall Study||0
10504636|NCT01260883|11655471|FG001|NOT COMPLETED|Overall Study||0
10504637|NCT01260883|11655472|FG002|NOT COMPLETED|Overall Study||0
10504638|NCT01260896|11655503|FG000|STARTED|First Intervention||12
10504639|NCT01260896|11655504|FG001|STARTED|First Intervention||12
10504640|NCT01260896|11655503|FG000|COMPLETED|First Intervention||10
10504641|NCT01260896|11655504|FG001|COMPLETED|First Intervention||12
10504642|NCT01260896|11655503|FG000|NOT COMPLETED|First Intervention||2
10504643|NCT01260896|11655504|FG001|NOT COMPLETED|First Intervention||0
10504644|NCT01260896|11655503|FG000|STARTED|Washout of 7 Days||10
10504645|NCT01260896|11655504|FG001|STARTED|Washout of 7 Days||12
10504646|NCT01260896|11655503|FG000|COMPLETED|Washout of 7 Days||10
10504647|NCT01260896|11655504|FG001|COMPLETED|Washout of 7 Days||12
10504648|NCT01260896|11655503|FG000|NOT COMPLETED|Washout of 7 Days||0
10504649|NCT01260896|11655504|FG001|NOT COMPLETED|Washout of 7 Days||0
10504650|NCT01260896|11655503|FG000|STARTED|Second Intervention||10
10504651|NCT01260896|11655504|FG001|STARTED|Second Intervention||12
10504652|NCT01260896|11655503|FG000|COMPLETED|Second Intervention||10
10504653|NCT01260896|11655504|FG001|COMPLETED|Second Intervention||12
10504654|NCT01260896|11655503|FG000|NOT COMPLETED|Second Intervention||0
10504655|NCT01260896|11655504|FG001|NOT COMPLETED|Second Intervention||0
10504656|NCT01260922|11655512|FG000|STARTED|First Intervention||13
10504657|NCT01260922|11655513|FG001|STARTED|First Intervention||13
10504658|NCT01260922|11655512|FG000|COMPLETED|First Intervention||13
10504659|NCT01260922|11655513|FG001|COMPLETED|First Intervention||12
10504660|NCT01260922|11655512|FG000|NOT COMPLETED|First Intervention||0
10504661|NCT01260922|11655513|FG001|NOT COMPLETED|First Intervention||1
10504662|NCT01260922|11655512|FG000|STARTED|Washout of 28 Days||13
10504663|NCT01260922|11655513|FG001|STARTED|Washout of 28 Days||12
10504664|NCT01260922|11655512|FG000|COMPLETED|Washout of 28 Days||9
10504665|NCT01260922|11655513|FG001|COMPLETED|Washout of 28 Days||10
10504666|NCT01260922|11655512|FG000|NOT COMPLETED|Washout of 28 Days||4
10504667|NCT01260922|11655513|FG001|NOT COMPLETED|Washout of 28 Days||2
10504668|NCT01260922|11655512|FG000|STARTED|Second Intervention||9
10504669|NCT01260922|11655513|FG001|STARTED|Second Intervention||10
10504670|NCT01260922|11655512|FG000|COMPLETED|Second Intervention||9
10504671|NCT01260922|11655513|FG001|COMPLETED|Second Intervention||8
10504672|NCT01260922|11655512|FG000|NOT COMPLETED|Second Intervention||0
10504673|NCT01260922|11655513|FG001|NOT COMPLETED|Second Intervention||2
10504674|NCT01260948|11655521|FG000|STARTED|First Intervention||13
10504675|NCT01260948|11655522|FG001|STARTED|First Intervention||13
10504676|NCT01260948|11655521|FG000|COMPLETED|First Intervention||13
10504677|NCT01260948|11655522|FG001|COMPLETED|First Intervention||13
10504678|NCT01260948|11655521|FG000|NOT COMPLETED|First Intervention||0
10504679|NCT01260948|11655522|FG001|NOT COMPLETED|First Intervention||0
10504680|NCT01260948|11655521|FG000|STARTED|Washout of 28 Days||13
10504681|NCT01260948|11655522|FG001|STARTED|Washout of 28 Days||13
10504682|NCT01260948|11655521|FG000|COMPLETED|Washout of 28 Days||12
10504683|NCT01260948|11655522|FG001|COMPLETED|Washout of 28 Days||10
10504684|NCT01260948|11655521|FG000|NOT COMPLETED|Washout of 28 Days||1
10504685|NCT01260948|11655522|FG001|NOT COMPLETED|Washout of 28 Days||3
10504686|NCT01260948|11655521|FG000|STARTED|Second Intervention||12
10504687|NCT01260948|11655522|FG001|STARTED|Second Intervention||10
10504688|NCT01260948|11655521|FG000|COMPLETED|Second Intervention||12
10504689|NCT01260948|11655522|FG001|COMPLETED|Second Intervention||9
10504690|NCT01260948|11655521|FG000|NOT COMPLETED|Second Intervention||0
10504691|NCT01260948|11655522|FG001|NOT COMPLETED|Second Intervention||1
10504692|NCT01261000|11655528|FG000|STARTED|Overall Study||8
10504693|NCT01261000|11655528|FG000|COMPLETED|Overall Study||7
10504694|NCT01261000|11655528|FG000|NOT COMPLETED|Overall Study||1
10504695|NCT01261052|11655532|FG000|STARTED|FMPD/APD Intervention (33 Hours)||14
10504696|NCT01261052|11655532|FG000|COMPLETED|FMPD/APD Intervention (33 Hours)||14
10504697|NCT01261052|11655532|FG000|NOT COMPLETED|FMPD/APD Intervention (33 Hours)||0
10504698|NCT01261052|11655532|FG000|STARTED|APD Only Intervention (33 Hours)||14
10504699|NCT01261052|11655532|FG000|COMPLETED|APD Only Intervention (33 Hours)||14
10504700|NCT01261052|11655532|FG000|NOT COMPLETED|APD Only Intervention (33 Hours)||0
10504710|NCT01261338|11655555|FG000|STARTED|Overall Study|One person in the olestra group started 4 months after the trial began.|14
10504711|NCT01261338|11655556|FG001|STARTED|Overall Study||14
10504712|NCT01261338|11655555|FG000|COMPLETED|Overall Study||11
10504713|NCT01261338|11655556|FG001|COMPLETED|Overall Study||12
10504714|NCT01261338|11655555|FG000|NOT COMPLETED|Overall Study||3
10504715|NCT01261338|11655556|FG001|NOT COMPLETED|Overall Study||2
10504716|NCT01261390|11655566|FG000|STARTED|Overall Study|15 of the 44 participants only had to complete a 6-month follow-up assessment.|44
10504717|NCT01261390|11655567|FG001|STARTED|Overall Study|15 of the 42 participants only had to complete a 6-month follow-up assessment.|42
10504718|NCT01261390|11655568|FG002|STARTED|Overall Study|16 of the 42 participants only had to complete a 6-month follow-up assessment.|42
10504719|NCT01261390|11655569|FG003|STARTED|Overall Study|15 of the 41 participants only had to complete a 6-month follow-up assessment.|41
10504720|NCT01261390|11655566|FG000|6-Month Visit|Overall Study|For 14 of the 30 participants in this arm, this was their final visit.|37
10504721|NCT01261390|11655567|FG001|6-Month Visit|Overall Study|For 12 of the 34 participants in this arm, this was their final visit.|34
10504722|NCT01261390|11655568|FG002|6-Month Visit|Overall Study|For 16 of the 34 participants in this arm, this was their final visit.|34
10504723|NCT01261390|11655569|FG003|6-Month Visit|Overall Study|For 14 of the 32 participants in this arm, this was their final visit.|32
10504724|NCT01261390|11655566|FG000|12-Month Visit|Overall Study||23
10504725|NCT01261390|11655567|FG001|12-Month Visit|Overall Study||21
10504726|NCT01261390|11655568|FG002|12-Month Visit|Overall Study||19
10504727|NCT01261390|11655569|FG003|12-Month Visit|Overall Study||19
10504728|NCT01261390|11655566|FG000|COMPLETED|Overall Study|14 of the 37 participants that completed the study in this arm were under the 6-Month protocol.|37
10504729|NCT01261390|11655567|FG001|COMPLETED|Overall Study|12 of the 33 participants that completed the study in this arm were under the 6-Month protocol.|33
10504730|NCT01261390|11655568|FG002|COMPLETED|Overall Study|16 of the 35 participants that completed the study in this arm were under the 6-Month protocol.|35
10504731|NCT01261390|11655569|FG003|COMPLETED|Overall Study|14 of the 33 participants that completed the study in this arm were under the 6-Month protocol.|33
10504732|NCT01261390|11655566|FG000|NOT COMPLETED|Overall Study||7
10504733|NCT01261390|11655567|FG001|NOT COMPLETED|Overall Study||9
10504734|NCT01261390|11655568|FG002|NOT COMPLETED|Overall Study||7
10504735|NCT01261390|11655569|FG003|NOT COMPLETED|Overall Study||8
10504736|NCT01261507|11655584|FG000|STARTED|Overall Study||15
10504737|NCT01261507|11655584|FG000|COMPLETED|Overall Study||15
10504738|NCT01261507|11655584|FG000|NOT COMPLETED|Overall Study||0
10504739|NCT01261559|11655593|FG000|STARTED|Overall Study||36
10504740|NCT01261559|11655594|FG001|STARTED|Overall Study||36
10504741|NCT01261559|11655593|FG000|COMPLETED|Overall Study||36
10504742|NCT01261559|11655594|FG001|COMPLETED|Overall Study||36
10504743|NCT01261559|11655593|FG000|NOT COMPLETED|Overall Study||0
10504744|NCT01261559|11655594|FG001|NOT COMPLETED|Overall Study||0
10504790|NCT01261624|11655620|FG000|STARTED|Week 0 to Week 12||10
10504791|NCT01261624|11655621|FG001|STARTED|Week 0 to Week 12||6
10504792|NCT01261624|11655620|FG000|COMPLETED|Week 0 to Week 12||9
10504793|NCT01261624|11655621|FG001|COMPLETED|Week 0 to Week 12||3
10504794|NCT01261624|11655620|FG000|NOT COMPLETED|Week 0 to Week 12||1
10504795|NCT01261624|11655621|FG001|NOT COMPLETED|Week 0 to Week 12||3
10504796|NCT01261624|11655620|FG000|STARTED|Week 13 to Week 24|Of 9 pts from LDTC: 5 non-responders switched to HDTC; 4 pts responded, but 3 switched to HDTC|1
10504797|NCT01261624|11655621|FG001|STARTED|Week 13 to Week 24|Of 6 pts of HDTC: 3 non-responders went out of study, 3 continued. 8 swithched from LDTC to HDTC|11
10504798|NCT01261624|11655620|FG000|COMPLETED|Week 13 to Week 24||1
10504799|NCT01261624|11655621|FG001|COMPLETED|Week 13 to Week 24||10
10504800|NCT01261624|11655620|FG000|NOT COMPLETED|Week 13 to Week 24||0
10504801|NCT01261624|11655621|FG001|NOT COMPLETED|Week 13 to Week 24||1
10504802|NCT01261780|11655635|FG000|STARTED|Overall Study||7
10504803|NCT01261780|11655636|FG001|STARTED|Overall Study||7
10504804|NCT01261780|11655635|FG000|COMPLETED|Overall Study||5
10504805|NCT01261780|11655636|FG001|COMPLETED|Overall Study||5
10504806|NCT01261780|11655635|FG000|NOT COMPLETED|Overall Study||2
10504807|NCT01261780|11655636|FG001|NOT COMPLETED|Overall Study||2
10504808|NCT01261793|11655645|FG000|STARTED|Overall Study||263
10504809|NCT01261793|11655646|FG001|STARTED|Overall Study||262
10504810|NCT01261793|11655647|FG002|STARTED|Overall Study||266
10504811|NCT01261793|11655645|FG000|COMPLETED|Overall Study||178
10504812|NCT01261793|11655646|FG001|COMPLETED|Overall Study||171
10504813|NCT01261793|11655647|FG002|COMPLETED|Overall Study||184
10504814|NCT01261793|11655645|FG000|NOT COMPLETED|Overall Study||85
10504815|NCT01261793|11655646|FG001|NOT COMPLETED|Overall Study||91
10504816|NCT01261793|11655647|FG002|NOT COMPLETED|Overall Study||82
10504817|NCT01261819|11655657|FG000|STARTED|Overall Study||33
10504818|NCT01261819|11655658|FG001|STARTED|Overall Study||33
10504819|NCT01261819|11655657|FG000|COMPLETED|Overall Study||33
10504820|NCT01261819|11655658|FG001|COMPLETED|Overall Study||33
10504821|NCT01261819|11655657|FG000|NOT COMPLETED|Overall Study||0
10504822|NCT01261819|11655658|FG001|NOT COMPLETED|Overall Study||0
10504823|NCT01261975|11655664|FG000|STARTED|Overall Study|36 Participants 72 eyes started|36
10504824|NCT01261975|11655664|FG000|COMPLETED|Overall Study|35 Participants 70 eyes completed|35
10504825|NCT01261975|11655664|FG000|NOT COMPLETED|Overall Study||1
10504826|NCT01262027|11655671|FG000|STARTED|Overall Study||22
10504827|NCT01262027|11655671|FG000|COMPLETED|Overall Study||17
10504828|NCT01262027|11655671|FG000|NOT COMPLETED|Overall Study||5
10504829|NCT01262092|11655677|FG000|STARTED|Buprenorphine+Gabapentin/Plac Induction||16
10504830|NCT01262092|11655678|FG001|STARTED|Buprenorphine+Gabapentin/Plac Induction||14
10504831|NCT01262092|11655677|FG000|COMPLETED|Buprenorphine+Gabapentin/Plac Induction||13
10504832|NCT01262092|11655678|FG001|COMPLETED|Buprenorphine+Gabapentin/Plac Induction||13
10504833|NCT01262092|11655677|FG000|NOT COMPLETED|Buprenorphine+Gabapentin/Plac Induction||3
10504834|NCT01262092|11655678|FG001|NOT COMPLETED|Buprenorphine+Gabapentin/Plac Induction||1
10504835|NCT01262092|11655677|FG000|STARTED|Buprenorphine Taper|One left the study prior to starting the taper due to pharmacy error (started taper in wk 2)|12
10504836|NCT01262092|11655678|FG001|STARTED|Buprenorphine Taper||13
10504837|NCT01262092|11655677|FG000|COMPLETED|Buprenorphine Taper||11
10504838|NCT01262092|11655678|FG001|COMPLETED|Buprenorphine Taper||12
10504839|NCT01262092|11655677|FG000|NOT COMPLETED|Buprenorphine Taper||1
10504840|NCT01262092|11655678|FG001|NOT COMPLETED|Buprenorphine Taper||1
10504841|NCT01262092|11655677|FG000|STARTED|Gabapentin Taper|One participant dropped out after the buprenorphine taper but prior to the gabapentin taper|10
10504842|NCT01262092|11655678|FG001|STARTED|Gabapentin Taper|One participant dropped out after the buprenorphine taper but prior to the gabapentin taper|11
10504843|NCT01262092|11655677|FG000|COMPLETED|Gabapentin Taper||9
10504844|NCT01262092|11655678|FG001|COMPLETED|Gabapentin Taper||11
10504845|NCT01262092|11655677|FG000|NOT COMPLETED|Gabapentin Taper||1
10504846|NCT01262092|11655678|FG001|NOT COMPLETED|Gabapentin Taper||0
10504847|NCT01262105|11655686|FG000|STARTED|Overall Study||13
10504848|NCT01262105|11655687|FG001|STARTED|Overall Study||10
10504849|NCT01262105|11655686|FG000|COMPLETED|Overall Study||13
10504850|NCT01262105|11655687|FG001|COMPLETED|Overall Study||10
10504851|NCT01262105|11655686|FG000|NOT COMPLETED|Overall Study||0
10504852|NCT01262105|11655687|FG001|NOT COMPLETED|Overall Study||0
10504853|NCT01262118|11655695|FG000|STARTED|Baseline Assessment Period (3 Days)||36
10504854|NCT01262118|11655696|FG001|STARTED|Baseline Assessment Period (3 Days)||33
10504855|NCT01262118|11655695|FG000|COMPLETED|Baseline Assessment Period (3 Days)||36
10504856|NCT01262118|11655696|FG001|COMPLETED|Baseline Assessment Period (3 Days)||33
10504857|NCT01262118|11655695|FG000|NOT COMPLETED|Baseline Assessment Period (3 Days)||0
10504858|NCT01262118|11655696|FG001|NOT COMPLETED|Baseline Assessment Period (3 Days)||0
10504859|NCT01262118|11655695|FG000|STARTED|Treatment Period (6 Weeks)||36
10504860|NCT01262118|11655696|FG001|STARTED|Treatment Period (6 Weeks)||0
10504861|NCT01262118|11655695|FG000|COMPLETED|Treatment Period (6 Weeks)||36
10504862|NCT01262118|11655696|FG001|COMPLETED|Treatment Period (6 Weeks)||0
10504863|NCT01262118|11655695|FG000|NOT COMPLETED|Treatment Period (6 Weeks)||0
10504864|NCT01262118|11655696|FG001|NOT COMPLETED|Treatment Period (6 Weeks)||0
10504865|NCT01262131|11655705|FG000|STARTED|Overall Study||5
10504866|NCT01262131|11655706|FG001|STARTED|Overall Study||4
10504867|NCT01262131|11655707|FG002|STARTED|Overall Study||4
10504868|NCT01262131|11655705|FG000|COMPLETED|Overall Study||5
10504869|NCT01262131|11655706|FG001|COMPLETED|Overall Study||4
10504870|NCT01262131|11655707|FG002|COMPLETED|Overall Study||4
10504871|NCT01262131|11655705|FG000|NOT COMPLETED|Overall Study||0
10504872|NCT01262131|11655706|FG001|NOT COMPLETED|Overall Study||0
10504873|NCT01262131|11655707|FG002|NOT COMPLETED|Overall Study||0
10504874|NCT01262287|11655717|FG000|STARTED|Overall Study||20
10504875|NCT01262287|11655718|FG001|STARTED|Overall Study||19
10504876|NCT01262287|11655717|FG000|COMPLETED|Overall Study||18
10504877|NCT01262287|11655718|FG001|COMPLETED|Overall Study||18
10504878|NCT01262287|11655717|FG000|NOT COMPLETED|Overall Study||2
10504879|NCT01262287|11655718|FG001|NOT COMPLETED|Overall Study||1
10504880|NCT01262352|11655730|FG000|STARTED|Period 1||11
10504881|NCT01262352|11655731|FG001|STARTED|Period 1||10
10504882|NCT01262352|11655730|FG000|Dosed|Period 1||10
10504883|NCT01262352|11655731|FG001|Dosed|Period 1||10
10504884|NCT01262352|11655730|FG000|COMPLETED|Period 1||10
10504885|NCT01262352|11655731|FG001|COMPLETED|Period 1||10
10504886|NCT01262352|11655730|FG000|NOT COMPLETED|Period 1||1
10504887|NCT01262352|11655731|FG001|NOT COMPLETED|Period 1||0
10504888|NCT01262352|11655730|FG000|STARTED|Washout||10
10504889|NCT01262352|11655731|FG001|STARTED|Washout||10
10504890|NCT01262352|11655730|FG000|COMPLETED|Washout||9
10504891|NCT01262352|11655731|FG001|COMPLETED|Washout||8
10504892|NCT01262352|11655730|FG000|NOT COMPLETED|Washout||1
10504893|NCT01262352|11655731|FG001|NOT COMPLETED|Washout||2
10504894|NCT01262352|11655730|FG000|STARTED|Period 2||9
10504895|NCT01262352|11655731|FG001|STARTED|Period 2||8
10504896|NCT01262352|11655730|FG000|Dosed|Period 2||9
10504897|NCT01262352|11655731|FG001|Dosed|Period 2||8
10504898|NCT01262352|11655730|FG000|COMPLETED|Period 2||9
10504899|NCT01262352|11655731|FG001|COMPLETED|Period 2||8
10504900|NCT01262352|11655730|FG000|NOT COMPLETED|Period 2||0
10504901|NCT01262352|11655731|FG001|NOT COMPLETED|Period 2||0
10504902|NCT01262365|11655740|FG000|STARTED|Overall Study||266
10504903|NCT01262365|11655741|FG001|STARTED|Overall Study||262
10504904|NCT01262365|11655742|FG002|STARTED|Overall Study||265
10504905|NCT01262365|11655740|FG000|COMPLETED|Overall Study||176
10504906|NCT01262365|11655741|FG001|COMPLETED|Overall Study||181
10504907|NCT01262365|11655742|FG002|COMPLETED|Overall Study||171
10504908|NCT01262365|11655740|FG000|NOT COMPLETED|Overall Study||90
10504909|NCT01262365|11655741|FG001|NOT COMPLETED|Overall Study||81
10504910|NCT01262365|11655742|FG002|NOT COMPLETED|Overall Study||94
10504984|NCT01262651|11655835|FG000|NOT COMPLETED|Overall Study||58
10504985|NCT01262651|11655836|FG001|NOT COMPLETED|Overall Study||48
10504911|NCT01262456|11655753|FG000|STARTED|3-Month Double-Blind Period|Intent-to-Treat (ITT) population: randomized participants regardless of exposure to treatment|143
10504912|NCT01262456|11655754|FG001|STARTED|3-Month Double-Blind Period|ITT population: randomized participants regardless of exposure to treatment|123
10504913|NCT01262456|11655755|FG002|STARTED|3-Month Double-Blind Period|ITT population: randomized participants regardless of exposure to treatment|129
10504914|NCT01262456|11655753|FG000|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|142
10504915|NCT01262456|11655754|FG001|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|119
10504916|NCT01262456|11655755|FG002|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|124
10504917|NCT01262456|11655753|FG000|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|143
10504918|NCT01262456|11655754|FG001|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|119
10504919|NCT01262456|11655755|FG002|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|122
10504920|NCT01262456|11655753|FG000|COMPLETED|3-Month Double-Blind Period||124
10504921|NCT01262456|11655754|FG001|COMPLETED|3-Month Double-Blind Period||100
10504922|NCT01262456|11655755|FG002|COMPLETED|3-Month Double-Blind Period||103
10504923|NCT01262456|11655753|FG000|NOT COMPLETED|3-Month Double-Blind Period||19
10504924|NCT01262456|11655754|FG001|NOT COMPLETED|3-Month Double-Blind Period||23
10504925|NCT01262456|11655755|FG002|NOT COMPLETED|3-Month Double-Blind Period||26
10504926|NCT01262456|11655753|FG000|STARTED|1-Month Open-Label Extension Period||124
10504927|NCT01262456|11655754|FG001|STARTED|1-Month Open-Label Extension Period||100
10504928|NCT01262456|11655755|FG002|STARTED|1-Month Open-Label Extension Period||103
10504929|NCT01262456|11655753|FG000|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period||124
10504930|NCT01262456|11655754|FG001|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period||101
10504931|NCT01262456|11655755|FG002|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period|1 subject was randomized to Desmopressin 75 μg but received 50 μg. Also true in Double-Blind Period|102
10504932|NCT01262456|11655753|FG000|COMPLETED|1-Month Open-Label Extension Period||120
10504933|NCT01262456|11655754|FG001|COMPLETED|1-Month Open-Label Extension Period||97
10504934|NCT01262456|11655755|FG002|COMPLETED|1-Month Open-Label Extension Period||98
10504935|NCT01262456|11655753|FG000|NOT COMPLETED|1-Month Open-Label Extension Period||4
10504936|NCT01262456|11655754|FG001|NOT COMPLETED|1-Month Open-Label Extension Period||3
10504937|NCT01262456|11655755|FG002|NOT COMPLETED|1-Month Open-Label Extension Period||5
10504938|NCT01262547|11655771|FG000|STARTED|Overall Study||3
10504939|NCT01262547|11655771|FG000|COMPLETED|Overall Study||3
10504940|NCT01262547|11655771|FG000|NOT COMPLETED|Overall Study||0
10504941|NCT01262560|11655783|FG000|STARTED|Overall Study||53
10504942|NCT01262560|11655784|FG001|STARTED|Overall Study||54
10504943|NCT01262560|11655785|FG002|STARTED|Overall Study||56
10504944|NCT01262560|11655783|FG000|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|53
10528263|NCT01393990|11680491|FG013|COMPLETED|Overall Study||3
10504945|NCT01262560|11655784|FG001|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|53
10504946|NCT01262560|11655785|FG002|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|54
10504947|NCT01262560|11655783|FG000|NOT COMPLETED|Overall Study||0
10504948|NCT01262560|11655784|FG001|NOT COMPLETED|Overall Study||1
10504949|NCT01262560|11655785|FG002|NOT COMPLETED|Overall Study||2
10504950|NCT01262573|11655795|FG000|STARTED|Overall Study||32
10504951|NCT01262573|11655796|FG001|STARTED|Overall Study||32
10504952|NCT01262573|11655795|FG000|COMPLETED|Overall Study||32
10504953|NCT01262573|11655796|FG001|COMPLETED|Overall Study||31
10504954|NCT01262573|11655795|FG000|NOT COMPLETED|Overall Study||0
10504955|NCT01262573|11655796|FG001|NOT COMPLETED|Overall Study||1
10504956|NCT01262599|11655804|FG000|STARTED|Overall Study||16
10504957|NCT01262599|11655805|FG001|STARTED|Overall Study||16
10504958|NCT01262599|11655804|FG000|COMPLETED|Overall Study||16
10504959|NCT01262599|11655805|FG001|COMPLETED|Overall Study||16
10504960|NCT01262599|11655804|FG000|NOT COMPLETED|Overall Study||0
10504961|NCT01262599|11655805|FG001|NOT COMPLETED|Overall Study||0
10504962|NCT01262638|11655817|FG000|STARTED|Overall Study||45
10504963|NCT01262638|11655818|FG001|STARTED|Overall Study||44
10504964|NCT01262638|11655819|FG002|STARTED|Overall Study||44
10504965|NCT01262638|11655820|FG003|STARTED|Overall Study||44
10504966|NCT01262638|11655817|FG000|COMPLETED|Overall Study||38
10504967|NCT01262638|11655818|FG001|COMPLETED|Overall Study||38
10504968|NCT01262638|11655819|FG002|COMPLETED|Overall Study||38
10504969|NCT01262638|11655820|FG003|COMPLETED|Overall Study||37
10504970|NCT01262638|11655817|FG000|NOT COMPLETED|Overall Study||7
10504971|NCT01262638|11655818|FG001|NOT COMPLETED|Overall Study||6
10504972|NCT01262638|11655819|FG002|NOT COMPLETED|Overall Study||6
10504973|NCT01262638|11655820|FG003|NOT COMPLETED|Overall Study||7
10504974|NCT01262651|11655835|FG000|STARTED|Overall Study||199
10504975|NCT01262651|11655836|FG001|STARTED|Overall Study||198
10504976|NCT01262651|11655835|FG000|Received at Least 1 Dose of Study Drug|Overall Study||199
10504977|NCT01262651|11655836|FG001|Received at Least 1 Dose of Study Drug|Overall Study||198
10504978|NCT01262651|11655835|FG000|Safety Population|Overall Study||199
10504979|NCT01262651|11655836|FG001|Safety Population|Overall Study||198
10504980|NCT01262651|11655835|FG000|ITT Population|Overall Study||199
10504981|NCT01262651|11655836|FG001|ITT Population|Overall Study||198
10504982|NCT01262651|11655835|FG000|COMPLETED|Overall Study||141
10504983|NCT01262651|11655836|FG001|COMPLETED|Overall Study||150
10504986|NCT01262677|11655845|FG000|STARTED|Overall Study||100
10504987|NCT01262677|11655846|FG001|STARTED|Overall Study||113
10504988|NCT01262677|11655847|FG002|STARTED|Overall Study||110
10504989|NCT01262677|11655845|FG000|COMPLETED|Overall Study||91
10504990|NCT01262677|11655846|FG001|COMPLETED|Overall Study||98
10504991|NCT01262677|11655847|FG002|COMPLETED|Overall Study||98
10504992|NCT01262677|11655845|FG000|NOT COMPLETED|Overall Study||9
10504993|NCT01262677|11655846|FG001|NOT COMPLETED|Overall Study||15
10504994|NCT01262677|11655847|FG002|NOT COMPLETED|Overall Study||12
10504995|NCT01262755|11655855|FG000|STARTED|Overall Study||450
10504996|NCT01262755|11655855|FG000|COMPLETED|Overall Study||450
10504997|NCT01262755|11655855|FG000|NOT COMPLETED|Overall Study||0
10504998|NCT01262820|11655859|FG000|STARTED|Overall Study||15
10504999|NCT01262820|11655859|FG000|COMPLETED|Overall Study||0
10505000|NCT01262820|11655859|FG000|NOT COMPLETED|Overall Study||15
10505001|NCT01262846|11655865|FG000|STARTED|Overall Study||95
10505002|NCT01262846|11655866|FG001|STARTED|Overall Study||100
10505003|NCT01262846|11655865|FG000|COMPLETED|Overall Study||93
10505004|NCT01262846|11655866|FG001|COMPLETED|Overall Study||97
10505005|NCT01262846|11655865|FG000|NOT COMPLETED|Overall Study||2
10505006|NCT01262846|11655866|FG001|NOT COMPLETED|Overall Study||3
10505007|NCT01262872|11655880|FG000|STARTED|Step 1||60
10505008|NCT01262872|11655881|FG001|STARTED|Step 1||60
10505009|NCT01262872|11655882|FG002|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
10505010|NCT01262872|11655883|FG003|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
10505011|NCT01262872|11655884|FG004|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
10505012|NCT01262872|11655885|FG005|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
10505013|NCT01262872|11655886|FG006|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
10505014|NCT01262872|11655887|FG007|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
10505015|NCT01262872|11655880|FG000|COMPLETED|Step 1||60
10505016|NCT01262872|11655881|FG001|COMPLETED|Step 1||60
10505017|NCT01262872|11655882|FG002|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
10505018|NCT01262872|11655883|FG003|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone|0
10505019|NCT01262872|11655884|FG004|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
10505020|NCT01262872|11655885|FG005|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
10505021|NCT01262872|11655886|FG006|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
10505022|NCT01262872|11655887|FG007|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
10505023|NCT01262872|11655880|FG000|NOT COMPLETED|Step 1||0
10505024|NCT01262872|11655881|FG001|NOT COMPLETED|Step 1||0
10505025|NCT01262872|11655882|FG002|NOT COMPLETED|Step 1||0
10505026|NCT01262872|11655883|FG003|NOT COMPLETED|Step 1||0
10505027|NCT01262872|11655884|FG004|NOT COMPLETED|Step 1||0
10505028|NCT01262872|11655885|FG005|NOT COMPLETED|Step 1||0
10505029|NCT01262872|11655886|FG006|NOT COMPLETED|Step 1||0
10505030|NCT01262872|11655887|FG007|NOT COMPLETED|Step 1||0
10505031|NCT01262872|11655880|FG000|STARTED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
10505032|NCT01262872|11655881|FG001|STARTED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
10505033|NCT01262872|11655882|FG002|STARTED|Step 2||200
10505034|NCT01262872|11655883|FG003|STARTED|Step 2||200
10505035|NCT01262872|11655884|FG004|STARTED|Step 2||200
10710750|NCT02653560|11876131|FG003|COMPLETED|KMgCit Phase||0
10710751|NCT02653560|11876128|FG000|NOT COMPLETED|KMgCit Phase||0
10710752|NCT02653560|11876129|FG001|NOT COMPLETED|KMgCit Phase||0
10710753|NCT02653560|11876130|FG002|NOT COMPLETED|KMgCit Phase||0
10710754|NCT02653560|11876131|FG003|NOT COMPLETED|KMgCit Phase||0
10710755|NCT02653560|11876128|FG000|STARTED|K Citrate Phase||0
10710756|NCT02653560|11876129|FG001|STARTED|K Citrate Phase||30
10710757|NCT02653560|11876130|FG002|STARTED|K Citrate Phase||0
10710758|NCT02653560|11876131|FG003|STARTED|K Citrate Phase||0
10710759|NCT02653560|11876128|FG000|COMPLETED|K Citrate Phase||0
10710760|NCT02653560|11876129|FG001|COMPLETED|K Citrate Phase||30
10710761|NCT02653560|11876130|FG002|COMPLETED|K Citrate Phase||0
10710762|NCT02653560|11876131|FG003|COMPLETED|K Citrate Phase||0
10710763|NCT02653560|11876128|FG000|NOT COMPLETED|K Citrate Phase||0
10710764|NCT02653560|11876129|FG001|NOT COMPLETED|K Citrate Phase||0
10710765|NCT02653560|11876130|FG002|NOT COMPLETED|K Citrate Phase||0
10710766|NCT02653560|11876131|FG003|NOT COMPLETED|K Citrate Phase||0
10710767|NCT02653560|11876128|FG000|STARTED|KCl Phase||0
10710768|NCT02653560|11876129|FG001|STARTED|KCl Phase||0
10710769|NCT02653560|11876130|FG002|STARTED|KCl Phase||30
10710770|NCT02653560|11876131|FG003|STARTED|KCl Phase||0
10710771|NCT02653560|11876128|FG000|COMPLETED|KCl Phase||0
10710772|NCT02653560|11876129|FG001|COMPLETED|KCl Phase||0
10710773|NCT02653560|11876130|FG002|COMPLETED|KCl Phase||30
10710774|NCT02653560|11876131|FG003|COMPLETED|KCl Phase||0
10710775|NCT02653560|11876128|FG000|NOT COMPLETED|KCl Phase||0
10710776|NCT02653560|11876129|FG001|NOT COMPLETED|KCl Phase||0
10710777|NCT02653560|11876130|FG002|NOT COMPLETED|KCl Phase||0
10710778|NCT02653560|11876131|FG003|NOT COMPLETED|KCl Phase||0
10710779|NCT02653560|11876128|FG000|STARTED|Placebo Phase||0
10710780|NCT02653560|11876129|FG001|STARTED|Placebo Phase||0
10710781|NCT02653560|11876130|FG002|STARTED|Placebo Phase||0
10710782|NCT02653560|11876131|FG003|STARTED|Placebo Phase||30
10710783|NCT02653560|11876128|FG000|COMPLETED|Placebo Phase||0
10710784|NCT02653560|11876129|FG001|COMPLETED|Placebo Phase||0
10710785|NCT02653560|11876130|FG002|COMPLETED|Placebo Phase||0
10710786|NCT02653560|11876131|FG003|COMPLETED|Placebo Phase||30
10710787|NCT02653560|11876128|FG000|NOT COMPLETED|Placebo Phase||0
10710788|NCT02653560|11876129|FG001|NOT COMPLETED|Placebo Phase||0
10710789|NCT02653560|11876130|FG002|NOT COMPLETED|Placebo Phase||0
10710790|NCT02653560|11876131|FG003|NOT COMPLETED|Placebo Phase||0
10710791|NCT02653625|11876141|FG000|STARTED|Overall Study||24
10710792|NCT02653625|11876141|FG000|COMPLETED|Overall Study||20
10710793|NCT02653625|11876141|FG000|NOT COMPLETED|Overall Study||4
10710794|NCT02653664|11876148|FG000|STARTED|Post-Treatment||110
10710795|NCT02653664|11876149|FG001|STARTED|Post-Treatment||110
10710796|NCT02653664|11876150|FG002|STARTED|Post-Treatment||108
10710797|NCT02653664|11876148|FG000|Primary and Secondary Data|Post-Treatment||93
10505036|NCT01262872|11655885|FG005|STARTED|Step 2||200
10505037|NCT01262872|11655886|FG006|STARTED|Step 2||200
10505038|NCT01262872|11655887|FG007|STARTED|Step 2||200
10528264|NCT01393990|11680492|FG014|COMPLETED|Overall Study||9
10710798|NCT02653664|11876149|FG001|Primary and Secondary Data|Post-Treatment||104
10710799|NCT02653664|11876150|FG002|Primary and Secondary Data|Post-Treatment||91
10710800|NCT02653664|11876148|FG000|Primary Outcome Data Only|Post-Treatment||3
10710801|NCT02653664|11876149|FG001|Primary Outcome Data Only|Post-Treatment||0
10710802|NCT02653664|11876150|FG002|Primary Outcome Data Only|Post-Treatment||3
10710803|NCT02653664|11876148|FG000|COMPLETED|Post-Treatment||96
10710804|NCT02653664|11876149|FG001|COMPLETED|Post-Treatment||104
10710805|NCT02653664|11876150|FG002|COMPLETED|Post-Treatment||94
10710806|NCT02653664|11876148|FG000|NOT COMPLETED|Post-Treatment||14
10710807|NCT02653664|11876149|FG001|NOT COMPLETED|Post-Treatment||6
10710808|NCT02653664|11876150|FG002|NOT COMPLETED|Post-Treatment||14
10710809|NCT02653664|11876148|FG000|STARTED|3 Month Follow-Up||110
10710810|NCT02653664|11876149|FG001|STARTED|3 Month Follow-Up||110
10710811|NCT02653664|11876150|FG002|STARTED|3 Month Follow-Up||108
10710812|NCT02653664|11876148|FG000|Primary and Secondary Data|3 Month Follow-Up||83
10710813|NCT02653664|11876149|FG001|Primary and Secondary Data|3 Month Follow-Up||95
10710814|NCT02653664|11876150|FG002|Primary and Secondary Data|3 Month Follow-Up||82
10710815|NCT02653664|11876148|FG000|Primary Outcome Data Only|3 Month Follow-Up||6
10710816|NCT02653664|11876149|FG001|Primary Outcome Data Only|3 Month Follow-Up||0
10710817|NCT02653664|11876150|FG002|Primary Outcome Data Only|3 Month Follow-Up||1
10710818|NCT02653664|11876148|FG000|COMPLETED|3 Month Follow-Up||89
10710819|NCT02653664|11876149|FG001|COMPLETED|3 Month Follow-Up||95
10710820|NCT02653664|11876150|FG002|COMPLETED|3 Month Follow-Up||83
10710821|NCT02653664|11876148|FG000|NOT COMPLETED|3 Month Follow-Up||21
10710822|NCT02653664|11876149|FG001|NOT COMPLETED|3 Month Follow-Up||15
10710823|NCT02653664|11876150|FG002|NOT COMPLETED|3 Month Follow-Up||25
10710824|NCT02653664|11876148|FG000|STARTED|6 Month Follow-Up||110
10710825|NCT02653664|11876149|FG001|STARTED|6 Month Follow-Up||110
10710826|NCT02653664|11876150|FG002|STARTED|6 Month Follow-Up||108
10710827|NCT02653664|11876148|FG000|Primary and Secondary Outcome Data|6 Month Follow-Up||85
10710828|NCT02653664|11876149|FG001|Primary and Secondary Outcome Data|6 Month Follow-Up||87
10710829|NCT02653664|11876150|FG002|Primary and Secondary Outcome Data|6 Month Follow-Up||83
10710830|NCT02653664|11876148|FG000|Primary Outcome Data Only|6 Month Follow-Up||2
10710831|NCT02653664|11876149|FG001|Primary Outcome Data Only|6 Month Follow-Up||2
10710832|NCT02653664|11876150|FG002|Primary Outcome Data Only|6 Month Follow-Up||2
10710833|NCT02653664|11876148|FG000|COMPLETED|6 Month Follow-Up||87
10710834|NCT02653664|11876149|FG001|COMPLETED|6 Month Follow-Up||89
10710835|NCT02653664|11876150|FG002|COMPLETED|6 Month Follow-Up||85
10710836|NCT02653664|11876148|FG000|NOT COMPLETED|6 Month Follow-Up||23
10710837|NCT02653664|11876149|FG001|NOT COMPLETED|6 Month Follow-Up||21
10710838|NCT02653664|11876150|FG002|NOT COMPLETED|6 Month Follow-Up||23
10710839|NCT02653768|11876163|FG000|STARTED|3-Month Follow-Up||230
10710840|NCT02653768|11876164|FG001|STARTED|3-Month Follow-Up||115
10710841|NCT02653768|11876163|FG000|COMPLETED|3-Month Follow-Up||164
10710842|NCT02653768|11876164|FG001|COMPLETED|3-Month Follow-Up||100
10710843|NCT02653768|11876163|FG000|NOT COMPLETED|3-Month Follow-Up||66
10710844|NCT02653768|11876164|FG001|NOT COMPLETED|3-Month Follow-Up||15
10710845|NCT02653768|11876163|FG000|STARTED|6-Month Follow-Up|21 participants withdrew/excluded by 3-months, others missed that assessment but remained in study|209
10710846|NCT02653768|11876164|FG001|STARTED|6-Month Follow-Up|2 participants withdrew/excluded by 3-months, others missed that assessment but remained in study|113
10710847|NCT02653768|11876163|FG000|COMPLETED|6-Month Follow-Up||164
10710848|NCT02653768|11876164|FG001|COMPLETED|6-Month Follow-Up||100
10710849|NCT02653768|11876163|FG000|NOT COMPLETED|6-Month Follow-Up||45
10710850|NCT02653768|11876164|FG001|NOT COMPLETED|6-Month Follow-Up||13
10710851|NCT02653768|11876163|FG000|STARTED|9-Month Follow-Up (Primary)|34 withdrew/excluded before 9 months; others missed prior assessments but remained in study|196
10710852|NCT02653768|11876164|FG001|STARTED|9-Month Follow-Up (Primary)|4 withdrew/excluded before 9 months; others missed prior assessments but remained in study|111
10710853|NCT02653768|11876163|FG000|COMPLETED|9-Month Follow-Up (Primary)|13 withdrew/refused before 9 months; others missed prior assessments but remained in study|163
10710854|NCT02653768|11876164|FG001|COMPLETED|9-Month Follow-Up (Primary)||95
10710855|NCT02653768|11876163|FG000|NOT COMPLETED|9-Month Follow-Up (Primary)||33
10710856|NCT02653768|11876164|FG001|NOT COMPLETED|9-Month Follow-Up (Primary)||16
10710857|NCT02653872|11876170|FG000|STARTED|Overall Study||15
10505115|NCT01262976|11655947|FG000|NOT COMPLETED|Up to Year 1||9
10710858|NCT02653872|11876170|FG000|Treatment Period 1:|Overall Study|Participants received single AZD7986 (25 mg).|15
10710859|NCT02653872|11876170|FG000|Treatment Period 2:|Overall Study|Participants received Verapamil (240 mg; extended release formulation) + AZD7986 (25 mg).|15
10710860|NCT02653872|11876170|FG000|Treatment Period 3:|Overall Study|Participants received: itraconazole 200 mg + AZD7986.|15
10710861|NCT02653872|11876170|FG000|COMPLETED|Overall Study||15
10710862|NCT02653872|11876170|FG000|NOT COMPLETED|Overall Study||0
10710863|NCT02654002|11876193|FG000|STARTED|Overall Study||12
10710864|NCT02654002|11876194|FG001|STARTED|Overall Study||12
10710865|NCT02654002|11876195|FG002|STARTED|Overall Study||12
10505039|NCT01262872|11655880|FG000|COMPLETED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
10505040|NCT01262872|11655881|FG001|COMPLETED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
10505041|NCT01262872|11655882|FG002|COMPLETED|Step 2||191
10505042|NCT01262872|11655883|FG003|COMPLETED|Step 2||190
10505043|NCT01262872|11655884|FG004|COMPLETED|Step 2||195
10505044|NCT01262872|11655885|FG005|COMPLETED|Step 2||191
10505045|NCT01262872|11655886|FG006|COMPLETED|Step 2||191
10505046|NCT01262872|11655887|FG007|COMPLETED|Step 2||194
10505047|NCT01262872|11655880|FG000|NOT COMPLETED|Step 2||0
10505048|NCT01262872|11655881|FG001|NOT COMPLETED|Step 2||0
10505049|NCT01262872|11655882|FG002|NOT COMPLETED|Step 2||9
10505050|NCT01262872|11655883|FG003|NOT COMPLETED|Step 2||10
10505051|NCT01262872|11655884|FG004|NOT COMPLETED|Step 2||5
10710866|NCT02654002|11876196|FG003|STARTED|Overall Study||12
10710867|NCT02654002|11876197|FG004|STARTED|Overall Study||12
10710868|NCT02654002|11876198|FG005|STARTED|Overall Study||12
10710869|NCT02654002|11876199|FG006|STARTED|Overall Study||12
10710870|NCT02654002|11876200|FG007|STARTED|Overall Study||12
10710871|NCT02654002|11876201|FG008|STARTED|Overall Study||24
10505052|NCT01262872|11655885|FG005|NOT COMPLETED|Step 2||9
10505053|NCT01262872|11655886|FG006|NOT COMPLETED|Step 2||9
10505054|NCT01262872|11655887|FG007|NOT COMPLETED|Step 2||6
10505055|NCT01262898|11655925|FG000|STARTED|Overall Study||21
10505056|NCT01262898|11655926|FG001|STARTED|Overall Study||18
10505057|NCT01262898|11655927|FG002|STARTED|Overall Study||18
10505058|NCT01262898|11655928|FG003|STARTED|Overall Study||22
10505059|NCT01262898|11655925|FG000|COMPLETED|Overall Study||18
10505060|NCT01262898|11655926|FG001|COMPLETED|Overall Study||16
10505061|NCT01262898|11655927|FG002|COMPLETED|Overall Study||18
10505062|NCT01262898|11655928|FG003|COMPLETED|Overall Study||22
10505063|NCT01262898|11655925|FG000|NOT COMPLETED|Overall Study||3
10505064|NCT01262898|11655926|FG001|NOT COMPLETED|Overall Study||2
10505065|NCT01262898|11655927|FG002|NOT COMPLETED|Overall Study||0
10505066|NCT01262898|11655928|FG003|NOT COMPLETED|Overall Study||0
10710872|NCT02654002|11876193|FG000|COMPLETED|Overall Study||12
10505067|NCT01262976|11655947|FG000|STARTED|Up to Month 2||40
10505068|NCT01262976|11655948|FG001|STARTED|Up to Month 2||40
10505069|NCT01262976|11655949|FG002|STARTED|Up to Month 2||40
10505070|NCT01262976|11655950|FG003|STARTED|Up to Month 2||40
10505071|NCT01262976|11655951|FG004|STARTED|Up to Month 2||40
10505072|NCT01262976|11655952|FG005|STARTED|Up to Month 2||40
10505073|NCT01262976|11655947|FG000|COMPLETED|Up to Month 2||37
10505074|NCT01262976|11655948|FG001|COMPLETED|Up to Month 2||39
10505075|NCT01262976|11655949|FG002|COMPLETED|Up to Month 2||39
10505076|NCT01262976|11655950|FG003|COMPLETED|Up to Month 2||38
10505077|NCT01262976|11655951|FG004|COMPLETED|Up to Month 2||38
10505078|NCT01262976|11655952|FG005|COMPLETED|Up to Month 2||36
10505079|NCT01262976|11655947|FG000|NOT COMPLETED|Up to Month 2||3
10505080|NCT01262976|11655948|FG001|NOT COMPLETED|Up to Month 2||1
10505081|NCT01262976|11655949|FG002|NOT COMPLETED|Up to Month 2||1
10505082|NCT01262976|11655950|FG003|NOT COMPLETED|Up to Month 2||2
10505083|NCT01262976|11655951|FG004|NOT COMPLETED|Up to Month 2||2
10505084|NCT01262976|11655952|FG005|NOT COMPLETED|Up to Month 2||4
10505085|NCT01262976|11655947|FG000|STARTED|Up to Month 7||40
10505086|NCT01262976|11655948|FG001|STARTED|Up to Month 7||40
10505087|NCT01262976|11655949|FG002|STARTED|Up to Month 7||40
10505088|NCT01262976|11655950|FG003|STARTED|Up to Month 7||40
10505089|NCT01262976|11655951|FG004|STARTED|Up to Month 7||40
10505090|NCT01262976|11655952|FG005|STARTED|Up to Month 7||40
10505091|NCT01262976|11655947|FG000|COMPLETED|Up to Month 7||35
10505092|NCT01262976|11655948|FG001|COMPLETED|Up to Month 7||40
10505093|NCT01262976|11655949|FG002|COMPLETED|Up to Month 7||34
10505094|NCT01262976|11655950|FG003|COMPLETED|Up to Month 7||34
10505095|NCT01262976|11655951|FG004|COMPLETED|Up to Month 7||38
10505096|NCT01262976|11655952|FG005|COMPLETED|Up to Month 7||36
10505097|NCT01262976|11655947|FG000|NOT COMPLETED|Up to Month 7||5
10505098|NCT01262976|11655948|FG001|NOT COMPLETED|Up to Month 7||0
10505099|NCT01262976|11655949|FG002|NOT COMPLETED|Up to Month 7||6
10505100|NCT01262976|11655950|FG003|NOT COMPLETED|Up to Month 7||6
10505101|NCT01262976|11655951|FG004|NOT COMPLETED|Up to Month 7||2
10505102|NCT01262976|11655952|FG005|NOT COMPLETED|Up to Month 7||4
10505103|NCT01262976|11655947|FG000|STARTED|Up to Year 1||40
10505104|NCT01262976|11655948|FG001|STARTED|Up to Year 1||40
10505105|NCT01262976|11655949|FG002|STARTED|Up to Year 1||40
10505106|NCT01262976|11655950|FG003|STARTED|Up to Year 1||40
10505107|NCT01262976|11655951|FG004|STARTED|Up to Year 1||40
10505108|NCT01262976|11655952|FG005|STARTED|Up to Year 1||40
10505109|NCT01262976|11655947|FG000|COMPLETED|Up to Year 1||31
10505110|NCT01262976|11655948|FG001|COMPLETED|Up to Year 1||39
10505111|NCT01262976|11655949|FG002|COMPLETED|Up to Year 1||37
10505112|NCT01262976|11655950|FG003|COMPLETED|Up to Year 1||36
10505113|NCT01262976|11655951|FG004|COMPLETED|Up to Year 1||29
10505114|NCT01262976|11655952|FG005|COMPLETED|Up to Year 1||31
10505116|NCT01262976|11655948|FG001|NOT COMPLETED|Up to Year 1||1
10505117|NCT01262976|11655949|FG002|NOT COMPLETED|Up to Year 1||3
10505118|NCT01262976|11655950|FG003|NOT COMPLETED|Up to Year 1||4
10505119|NCT01262976|11655951|FG004|NOT COMPLETED|Up to Year 1||11
10505120|NCT01262976|11655952|FG005|NOT COMPLETED|Up to Year 1||9
10505121|NCT01262976|11655947|FG000|STARTED|Up to Year 2||40
10505122|NCT01262976|11655948|FG001|STARTED|Up to Year 2||40
10505123|NCT01262976|11655949|FG002|STARTED|Up to Year 2||40
10505124|NCT01262976|11655950|FG003|STARTED|Up to Year 2||40
10505125|NCT01262976|11655951|FG004|STARTED|Up to Year 2||40
10505126|NCT01262976|11655952|FG005|STARTED|Up to Year 2||40
10505127|NCT01262976|11655947|FG000|COMPLETED|Up to Year 2||35
10505128|NCT01262976|11655948|FG001|COMPLETED|Up to Year 2||39
10505129|NCT01262976|11655949|FG002|COMPLETED|Up to Year 2||35
10505130|NCT01262976|11655950|FG003|COMPLETED|Up to Year 2||36
10505131|NCT01262976|11655951|FG004|COMPLETED|Up to Year 2||36
10505132|NCT01262976|11655952|FG005|COMPLETED|Up to Year 2||35
10505133|NCT01262976|11655947|FG000|NOT COMPLETED|Up to Year 2||5
10505134|NCT01262976|11655948|FG001|NOT COMPLETED|Up to Year 2||1
10505135|NCT01262976|11655949|FG002|NOT COMPLETED|Up to Year 2||5
10505136|NCT01262976|11655950|FG003|NOT COMPLETED|Up to Year 2||4
10505137|NCT01262976|11655951|FG004|NOT COMPLETED|Up to Year 2||4
10505138|NCT01262976|11655952|FG005|NOT COMPLETED|Up to Year 2||5
10505139|NCT01262976|11655947|FG000|STARTED|Up to Year 3||40
10505140|NCT01262976|11655948|FG001|STARTED|Up to Year 3||40
10505141|NCT01262976|11655949|FG002|STARTED|Up to Year 3||40
10505142|NCT01262976|11655950|FG003|STARTED|Up to Year 3||40
10505143|NCT01262976|11655951|FG004|STARTED|Up to Year 3||40
10505144|NCT01262976|11655952|FG005|STARTED|Up to Year 3||40
10505145|NCT01262976|11655947|FG000|COMPLETED|Up to Year 3||34
10505146|NCT01262976|11655948|FG001|COMPLETED|Up to Year 3||38
10505147|NCT01262976|11655949|FG002|COMPLETED|Up to Year 3||33
10505148|NCT01262976|11655950|FG003|COMPLETED|Up to Year 3||35
10505149|NCT01262976|11655951|FG004|COMPLETED|Up to Year 3||38
10505150|NCT01262976|11655952|FG005|COMPLETED|Up to Year 3||36
10505151|NCT01262976|11655947|FG000|NOT COMPLETED|Up to Year 3||6
10505152|NCT01262976|11655948|FG001|NOT COMPLETED|Up to Year 3||2
10505153|NCT01262976|11655949|FG002|NOT COMPLETED|Up to Year 3||7
10505154|NCT01262976|11655950|FG003|NOT COMPLETED|Up to Year 3||5
10505155|NCT01262976|11655951|FG004|NOT COMPLETED|Up to Year 3||2
10505156|NCT01262976|11655952|FG005|NOT COMPLETED|Up to Year 3||4
10505157|NCT01262989|11655967|FG000|STARTED|Period 1||20
10505158|NCT01262989|11655968|FG001|STARTED|Period 1||20
10505159|NCT01262989|11655967|FG000|COMPLETED|Period 1||19
10505160|NCT01262989|11655968|FG001|COMPLETED|Period 1||17
10505161|NCT01262989|11655967|FG000|NOT COMPLETED|Period 1||1
10505162|NCT01262989|11655968|FG001|NOT COMPLETED|Period 1||3
10505163|NCT01262989|11655967|FG000|STARTED|7-Day Washout Period||19
10505164|NCT01262989|11655968|FG001|STARTED|7-Day Washout Period||17
10505165|NCT01262989|11655967|FG000|COMPLETED|7-Day Washout Period||19
10505166|NCT01262989|11655968|FG001|COMPLETED|7-Day Washout Period||17
10505167|NCT01262989|11655967|FG000|NOT COMPLETED|7-Day Washout Period||0
10505168|NCT01262989|11655968|FG001|NOT COMPLETED|7-Day Washout Period||0
10505169|NCT01262989|11655967|FG000|STARTED|Period 2||19
10505170|NCT01262989|11655968|FG001|STARTED|Period 2||17
10505171|NCT01262989|11655967|FG000|COMPLETED|Period 2||19
10505172|NCT01262989|11655968|FG001|COMPLETED|Period 2||16
10505173|NCT01262989|11655967|FG000|NOT COMPLETED|Period 2||0
10505174|NCT01262989|11655968|FG001|NOT COMPLETED|Period 2||1
10505175|NCT01263015|11655976|FG000|STARTED|Double-blind Phase: 96 Weeks Duration||414
10710873|NCT02654002|11876194|FG001|COMPLETED|Overall Study||12
10710874|NCT02654002|11876195|FG002|COMPLETED|Overall Study||12
10710875|NCT02654002|11876196|FG003|COMPLETED|Overall Study||12
10505176|NCT01263015|11655977|FG001|STARTED|Double-blind Phase: 96 Weeks Duration||419
10505177|NCT01263015|11655976|FG000|COMPLETED|Double-blind Phase: 96 Weeks Duration||342
10505178|NCT01263015|11655977|FG001|COMPLETED|Double-blind Phase: 96 Weeks Duration||310
10505179|NCT01263015|11655976|FG000|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||72
10505180|NCT01263015|11655977|FG001|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||109
10505181|NCT01263015|11655976|FG000|STARTED|Open-label Phase: 48 Weeks Duration||341
10505182|NCT01263015|11655977|FG001|STARTED|Open-label Phase: 48 Weeks Duration||309
10505183|NCT01263015|11655976|FG000|COMPLETED|Open-label Phase: 48 Weeks Duration||317
10505184|NCT01263015|11655977|FG001|COMPLETED|Open-label Phase: 48 Weeks Duration||278
10505185|NCT01263015|11655976|FG000|NOT COMPLETED|Open-label Phase: 48 Weeks Duration||24
10505186|NCT01263015|11655977|FG001|NOT COMPLETED|Open-label Phase: 48 Weeks Duration||31
10505187|NCT01263054|11655985|FG000|STARTED|Overall Study||29
10505188|NCT01263054|11655986|FG001|STARTED|Overall Study||34
10505189|NCT01263054|11655985|FG000|COMPLETED|Overall Study||24
10505190|NCT01263054|11655986|FG001|COMPLETED|Overall Study||28
10505191|NCT01263054|11655985|FG000|NOT COMPLETED|Overall Study||5
10505192|NCT01263054|11655986|FG001|NOT COMPLETED|Overall Study||6
10505193|NCT01263093|11655994|FG000|STARTED|Period 1||24
10710876|NCT02654002|11876197|FG004|COMPLETED|Overall Study||12
10505194|NCT01263093|11655995|FG001|STARTED|Period 1||23
10505195|NCT01263093|11655994|FG000|COMPLETED|Period 1||24
10505196|NCT01263093|11655995|FG001|COMPLETED|Period 1||23
10505197|NCT01263093|11655994|FG000|NOT COMPLETED|Period 1||0
10505198|NCT01263093|11655995|FG001|NOT COMPLETED|Period 1||0
10505199|NCT01263093|11655994|FG000|STARTED|Washout||24
10505200|NCT01263093|11655995|FG001|STARTED|Washout||23
10505201|NCT01263093|11655994|FG000|COMPLETED|Washout||23
10505202|NCT01263093|11655995|FG001|COMPLETED|Washout||23
10505203|NCT01263093|11655994|FG000|NOT COMPLETED|Washout||1
10505204|NCT01263093|11655995|FG001|NOT COMPLETED|Washout||0
10505205|NCT01263093|11655994|FG000|STARTED|Period 2||23
10505206|NCT01263093|11655995|FG001|STARTED|Period 2||23
10505207|NCT01263093|11655994|FG000|COMPLETED|Period 2||22
10505208|NCT01263093|11655995|FG001|COMPLETED|Period 2||23
10505209|NCT01263093|11655994|FG000|NOT COMPLETED|Period 2||1
10505210|NCT01263093|11655995|FG001|NOT COMPLETED|Period 2||0
10505211|NCT01263106|11656002|FG000|STARTED|Period 1 (7 Days)||11
10505212|NCT01263106|11656003|FG001|STARTED|Period 1 (7 Days)||10
10505213|NCT01263106|11656002|FG000|COMPLETED|Period 1 (7 Days)|Period 1: 1 participant took theophylline alone but was not given LY + theophylline.|11
10505214|NCT01263106|11656003|FG001|COMPLETED|Period 1 (7 Days)|Period 1: 1 participant took LY + theophylline but was not given theophylline alone.|10
10505215|NCT01263106|11656002|FG000|NOT COMPLETED|Period 1 (7 Days)||0
10505216|NCT01263106|11656003|FG001|NOT COMPLETED|Period 1 (7 Days)||0
10505217|NCT01263106|11656002|FG000|STARTED|Washout (at Least 7 Days)||11
10505218|NCT01263106|11656003|FG001|STARTED|Washout (at Least 7 Days)||10
10505219|NCT01263106|11656002|FG000|COMPLETED|Washout (at Least 7 Days)||10
10505220|NCT01263106|11656003|FG001|COMPLETED|Washout (at Least 7 Days)||9
10505221|NCT01263106|11656002|FG000|NOT COMPLETED|Washout (at Least 7 Days)||1
10505222|NCT01263106|11656003|FG001|NOT COMPLETED|Washout (at Least 7 Days)||1
10505223|NCT01263106|11656002|FG000|STARTED|Period 2 (7 Days)||10
10505224|NCT01263106|11656003|FG001|STARTED|Period 2 (7 Days)||9
10505225|NCT01263106|11656002|FG000|COMPLETED|Period 2 (7 Days)||10
10505226|NCT01263106|11656003|FG001|COMPLETED|Period 2 (7 Days)||9
10505227|NCT01263106|11656002|FG000|NOT COMPLETED|Period 2 (7 Days)||0
10505228|NCT01263106|11656003|FG001|NOT COMPLETED|Period 2 (7 Days)||0
10505229|NCT01263119|11656012|FG000|STARTED|Period 1||18
10505230|NCT01263119|11656012|FG000|COMPLETED|Period 1||16
10505231|NCT01263119|11656012|FG000|NOT COMPLETED|Period 1||2
10505232|NCT01263119|11656012|FG000|STARTED|Period 2||16
10505233|NCT01263119|11656012|FG000|COMPLETED|Period 2||14
10710877|NCT02654002|11876198|FG005|COMPLETED|Overall Study||11
10505234|NCT01263119|11656012|FG000|NOT COMPLETED|Period 2||2
10505235|NCT01263132|11656022|FG000|STARTED|Overall Study||38
10505236|NCT01263132|11656023|FG001|STARTED|Overall Study||37
10505237|NCT01263132|11656022|FG000|COMPLETED|Overall Study||38
10505238|NCT01263132|11656023|FG001|COMPLETED|Overall Study||37
10710878|NCT02654002|11876199|FG006|COMPLETED|Overall Study||11
10505239|NCT01263132|11656022|FG000|NOT COMPLETED|Overall Study||0
10505240|NCT01263132|11656023|FG001|NOT COMPLETED|Overall Study||0
10505241|NCT01263197|11656031|FG000|STARTED|First Intervention (Period 1)||8
10710879|NCT02654002|11876200|FG007|COMPLETED|Overall Study||11
10505242|NCT01263197|11656032|FG001|STARTED|First Intervention (Period 1)||8
10505243|NCT01263197|11656033|FG002|STARTED|First Intervention (Period 1)||8
10505244|NCT01263197|11656034|FG003|STARTED|First Intervention (Period 1)||8
10505245|NCT01263197|11656035|FG004|STARTED|First Intervention (Period 1)||8
10505246|NCT01263197|11656036|FG005|STARTED|First Intervention (Period 1)||8
10505247|NCT01263197|11656031|FG000|COMPLETED|First Intervention (Period 1)||8
10505248|NCT01263197|11656032|FG001|COMPLETED|First Intervention (Period 1)||8
10505249|NCT01263197|11656033|FG002|COMPLETED|First Intervention (Period 1)||8
10505250|NCT01263197|11656034|FG003|COMPLETED|First Intervention (Period 1)||8
10505251|NCT01263197|11656035|FG004|COMPLETED|First Intervention (Period 1)||8
10505252|NCT01263197|11656036|FG005|COMPLETED|First Intervention (Period 1)||7
10505253|NCT01263197|11656031|FG000|NOT COMPLETED|First Intervention (Period 1)||0
10505254|NCT01263197|11656032|FG001|NOT COMPLETED|First Intervention (Period 1)||0
10505255|NCT01263197|11656033|FG002|NOT COMPLETED|First Intervention (Period 1)||0
10505256|NCT01263197|11656034|FG003|NOT COMPLETED|First Intervention (Period 1)||0
10505257|NCT01263197|11656035|FG004|NOT COMPLETED|First Intervention (Period 1)||0
10505258|NCT01263197|11656036|FG005|NOT COMPLETED|First Intervention (Period 1)||1
10505259|NCT01263197|11656031|FG000|STARTED|Washout Period 1||8
10505260|NCT01263197|11656032|FG001|STARTED|Washout Period 1||8
10505261|NCT01263197|11656033|FG002|STARTED|Washout Period 1||8
10505262|NCT01263197|11656034|FG003|STARTED|Washout Period 1||8
10505263|NCT01263197|11656035|FG004|STARTED|Washout Period 1||8
10505264|NCT01263197|11656036|FG005|STARTED|Washout Period 1||7
10505265|NCT01263197|11656031|FG000|COMPLETED|Washout Period 1||8
10505266|NCT01263197|11656032|FG001|COMPLETED|Washout Period 1||8
10505267|NCT01263197|11656033|FG002|COMPLETED|Washout Period 1||8
10505268|NCT01263197|11656034|FG003|COMPLETED|Washout Period 1||8
10505269|NCT01263197|11656035|FG004|COMPLETED|Washout Period 1||7
10505270|NCT01263197|11656036|FG005|COMPLETED|Washout Period 1||7
10505271|NCT01263197|11656031|FG000|NOT COMPLETED|Washout Period 1||0
10505272|NCT01263197|11656032|FG001|NOT COMPLETED|Washout Period 1||0
10505273|NCT01263197|11656033|FG002|NOT COMPLETED|Washout Period 1||0
10505274|NCT01263197|11656034|FG003|NOT COMPLETED|Washout Period 1||0
10505275|NCT01263197|11656035|FG004|NOT COMPLETED|Washout Period 1||1
10505276|NCT01263197|11656036|FG005|NOT COMPLETED|Washout Period 1||0
10505277|NCT01263197|11656031|FG000|STARTED|Second Intervention (Period 2)||8
10505278|NCT01263197|11656032|FG001|STARTED|Second Intervention (Period 2)||8
10505279|NCT01263197|11656033|FG002|STARTED|Second Intervention (Period 2)||8
10505280|NCT01263197|11656034|FG003|STARTED|Second Intervention (Period 2)||8
10505281|NCT01263197|11656035|FG004|STARTED|Second Intervention (Period 2)||7
10505282|NCT01263197|11656036|FG005|STARTED|Second Intervention (Period 2)||7
10505283|NCT01263197|11656031|FG000|COMPLETED|Second Intervention (Period 2)||8
10505284|NCT01263197|11656032|FG001|COMPLETED|Second Intervention (Period 2)||8
10505285|NCT01263197|11656033|FG002|COMPLETED|Second Intervention (Period 2)||8
10505286|NCT01263197|11656034|FG003|COMPLETED|Second Intervention (Period 2)||8
10505287|NCT01263197|11656035|FG004|COMPLETED|Second Intervention (Period 2)||7
10505288|NCT01263197|11656036|FG005|COMPLETED|Second Intervention (Period 2)||7
10505289|NCT01263197|11656031|FG000|NOT COMPLETED|Second Intervention (Period 2)||0
10505290|NCT01263197|11656032|FG001|NOT COMPLETED|Second Intervention (Period 2)||0
10505291|NCT01263197|11656033|FG002|NOT COMPLETED|Second Intervention (Period 2)||0
10505292|NCT01263197|11656034|FG003|NOT COMPLETED|Second Intervention (Period 2)||0
10505293|NCT01263197|11656035|FG004|NOT COMPLETED|Second Intervention (Period 2)||0
10505294|NCT01263197|11656036|FG005|NOT COMPLETED|Second Intervention (Period 2)||0
10505295|NCT01263197|11656031|FG000|STARTED|Washout Period 2||8
10505296|NCT01263197|11656032|FG001|STARTED|Washout Period 2||8
10505297|NCT01263197|11656033|FG002|STARTED|Washout Period 2||8
10505298|NCT01263197|11656034|FG003|STARTED|Washout Period 2||8
10505299|NCT01263197|11656035|FG004|STARTED|Washout Period 2||7
10505300|NCT01263197|11656036|FG005|STARTED|Washout Period 2||7
10505301|NCT01263197|11656031|FG000|COMPLETED|Washout Period 2||8
10505302|NCT01263197|11656032|FG001|COMPLETED|Washout Period 2||8
10505303|NCT01263197|11656033|FG002|COMPLETED|Washout Period 2||8
10505304|NCT01263197|11656034|FG003|COMPLETED|Washout Period 2||7
10505305|NCT01263197|11656035|FG004|COMPLETED|Washout Period 2||7
10505306|NCT01263197|11656036|FG005|COMPLETED|Washout Period 2||6
10505307|NCT01263197|11656031|FG000|NOT COMPLETED|Washout Period 2||0
10505308|NCT01263197|11656032|FG001|NOT COMPLETED|Washout Period 2||0
10505309|NCT01263197|11656033|FG002|NOT COMPLETED|Washout Period 2||0
10505310|NCT01263197|11656034|FG003|NOT COMPLETED|Washout Period 2||1
10505311|NCT01263197|11656035|FG004|NOT COMPLETED|Washout Period 2||0
10505312|NCT01263197|11656036|FG005|NOT COMPLETED|Washout Period 2||1
10505313|NCT01263197|11656031|FG000|STARTED|Third Intervention (Period 3)||8
10505314|NCT01263197|11656032|FG001|STARTED|Third Intervention (Period 3)||8
10505315|NCT01263197|11656033|FG002|STARTED|Third Intervention (Period 3)||8
10505316|NCT01263197|11656034|FG003|STARTED|Third Intervention (Period 3)||7
10505317|NCT01263197|11656035|FG004|STARTED|Third Intervention (Period 3)||7
10505318|NCT01263197|11656036|FG005|STARTED|Third Intervention (Period 3)||6
10505319|NCT01263197|11656031|FG000|COMPLETED|Third Intervention (Period 3)||8
10505320|NCT01263197|11656032|FG001|COMPLETED|Third Intervention (Period 3)||7
10505321|NCT01263197|11656033|FG002|COMPLETED|Third Intervention (Period 3)||8
10505322|NCT01263197|11656034|FG003|COMPLETED|Third Intervention (Period 3)||7
10505323|NCT01263197|11656035|FG004|COMPLETED|Third Intervention (Period 3)||7
10505324|NCT01263197|11656036|FG005|COMPLETED|Third Intervention (Period 3)||6
10505325|NCT01263197|11656031|FG000|NOT COMPLETED|Third Intervention (Period 3)||0
10505326|NCT01263197|11656032|FG001|NOT COMPLETED|Third Intervention (Period 3)||1
10505327|NCT01263197|11656033|FG002|NOT COMPLETED|Third Intervention (Period 3)||0
10505328|NCT01263197|11656034|FG003|NOT COMPLETED|Third Intervention (Period 3)||0
10505329|NCT01263197|11656035|FG004|NOT COMPLETED|Third Intervention (Period 3)||0
10505330|NCT01263197|11656036|FG005|NOT COMPLETED|Third Intervention (Period 3)||0
10505331|NCT01263223|11656050|FG000|STARTED|Period 1||12
10505332|NCT01263223|11656051|FG001|STARTED|Period 1||12
10710880|NCT02654002|11876201|FG008|COMPLETED|Overall Study||24
10710881|NCT02654002|11876193|FG000|NOT COMPLETED|Overall Study||0
10710882|NCT02654002|11876194|FG001|NOT COMPLETED|Overall Study||0
10710883|NCT02654002|11876195|FG002|NOT COMPLETED|Overall Study||0
10710884|NCT02654002|11876196|FG003|NOT COMPLETED|Overall Study||0
10710885|NCT02654002|11876197|FG004|NOT COMPLETED|Overall Study||0
10710886|NCT02654002|11876198|FG005|NOT COMPLETED|Overall Study||1
10710887|NCT02654002|11876199|FG006|NOT COMPLETED|Overall Study||1
10710888|NCT02654002|11876200|FG007|NOT COMPLETED|Overall Study||1
10710889|NCT02654002|11876201|FG008|NOT COMPLETED|Overall Study||0
10710890|NCT02654054|11876239|FG000|STARTED|Treatment Period||102
10710891|NCT02654054|11876240|FG001|STARTED|Treatment Period||104
10710892|NCT02654054|11876241|FG002|STARTED|Treatment Period||207
10710893|NCT02654054|11876239|FG000|Randomized and Treated|Treatment Period||102
10710894|NCT02654054|11876240|FG001|Randomized and Treated|Treatment Period||104
10505333|NCT01263223|11656050|FG000|COMPLETED|Period 1||12
10505334|NCT01263223|11656051|FG001|COMPLETED|Period 1||12
10505335|NCT01263223|11656050|FG000|NOT COMPLETED|Period 1||0
10505336|NCT01263223|11656051|FG001|NOT COMPLETED|Period 1||0
10505337|NCT01263223|11656050|FG000|STARTED|3-Day Washout||12
10505338|NCT01263223|11656051|FG001|STARTED|3-Day Washout||12
10505339|NCT01263223|11656050|FG000|COMPLETED|3-Day Washout||12
10505340|NCT01263223|11656051|FG001|COMPLETED|3-Day Washout||12
10505341|NCT01263223|11656050|FG000|NOT COMPLETED|3-Day Washout||0
10505342|NCT01263223|11656051|FG001|NOT COMPLETED|3-Day Washout||0
10505343|NCT01263223|11656050|FG000|STARTED|Period 2||12
10505344|NCT01263223|11656051|FG001|STARTED|Period 2||12
10505345|NCT01263223|11656050|FG000|COMPLETED|Period 2||12
10505346|NCT01263223|11656051|FG001|COMPLETED|Period 2||11
10505347|NCT01263223|11656050|FG000|NOT COMPLETED|Period 2||0
10505348|NCT01263223|11656051|FG001|NOT COMPLETED|Period 2||1
10505349|NCT01263223|11656050|FG000|STARTED|Period 3||12
10505350|NCT01263223|11656051|FG001|STARTED|Period 3||11
10505351|NCT01263223|11656050|FG000|COMPLETED|Period 3||12
10505352|NCT01263223|11656051|FG001|COMPLETED|Period 3||11
10505353|NCT01263223|11656050|FG000|NOT COMPLETED|Period 3||0
10505354|NCT01263223|11656051|FG001|NOT COMPLETED|Period 3||0
10505355|NCT01263223|11656050|FG000|STARTED|7-day Follow-up||12
10505356|NCT01263223|11656051|FG001|STARTED|7-day Follow-up||11
10505357|NCT01263223|11656050|FG000|COMPLETED|7-day Follow-up|One participant who did not complete received Placebo in Period 3.|11
10505358|NCT01263223|11656051|FG001|COMPLETED|7-day Follow-up|One participant who did not complete received 36-mg LY2216684 in Period 3.|10
10505359|NCT01263223|11656050|FG000|NOT COMPLETED|7-day Follow-up||1
10505360|NCT01263223|11656051|FG001|NOT COMPLETED|7-day Follow-up||1
10505361|NCT01263301|11656062|FG000|STARTED|Overall Study||5
10505362|NCT01263301|11656063|FG001|STARTED|Overall Study||11
10505363|NCT01263301|11656062|FG000|COMPLETED|Overall Study||5
10505364|NCT01263301|11656063|FG001|COMPLETED|Overall Study||11
10505365|NCT01263301|11656062|FG000|NOT COMPLETED|Overall Study||0
10505366|NCT01263301|11656063|FG001|NOT COMPLETED|Overall Study||0
10505367|NCT01263314|11656077|FG000|STARTED|Period 1||2
10505368|NCT01263314|11656078|FG001|STARTED|Period 1||2
10505369|NCT01263314|11656079|FG002|STARTED|Period 1||2
10505370|NCT01263314|11656080|FG003|STARTED|Period 1||2
10505371|NCT01263314|11656081|FG004|STARTED|Period 1||2
10505372|NCT01263314|11656082|FG005|STARTED|Period 1||2
10505373|NCT01263314|11656083|FG006|STARTED|Period 1||2
10505374|NCT01263314|11656084|FG007|STARTED|Period 1||2
10505375|NCT01263314|11656077|FG000|COMPLETED|Period 1||2
10505376|NCT01263314|11656078|FG001|COMPLETED|Period 1||2
10505377|NCT01263314|11656079|FG002|COMPLETED|Period 1||2
10505378|NCT01263314|11656080|FG003|COMPLETED|Period 1||2
10505379|NCT01263314|11656081|FG004|COMPLETED|Period 1||2
10505380|NCT01263314|11656082|FG005|COMPLETED|Period 1||2
10505381|NCT01263314|11656083|FG006|COMPLETED|Period 1||2
10505382|NCT01263314|11656084|FG007|COMPLETED|Period 1||2
10505383|NCT01263314|11656077|FG000|NOT COMPLETED|Period 1||0
10505384|NCT01263314|11656078|FG001|NOT COMPLETED|Period 1||0
10710895|NCT02654054|11876241|FG002|Randomized and Treated|Treatment Period||206
10710896|NCT02654054|11876239|FG000|COMPLETED|Treatment Period||83
10710897|NCT02654054|11876240|FG001|COMPLETED|Treatment Period||81
10710898|NCT02654054|11876241|FG002|COMPLETED|Treatment Period||164
10710899|NCT02654054|11876239|FG000|NOT COMPLETED|Treatment Period||19
10505385|NCT01263314|11656079|FG002|NOT COMPLETED|Period 1||0
10505386|NCT01263314|11656080|FG003|NOT COMPLETED|Period 1||0
10505387|NCT01263314|11656081|FG004|NOT COMPLETED|Period 1||0
10505388|NCT01263314|11656082|FG005|NOT COMPLETED|Period 1||0
10505389|NCT01263314|11656083|FG006|NOT COMPLETED|Period 1||0
10505390|NCT01263314|11656084|FG007|NOT COMPLETED|Period 1||0
10505391|NCT01263314|11656077|FG000|STARTED|Period 2||2
10505392|NCT01263314|11656078|FG001|STARTED|Period 2||2
10505393|NCT01263314|11656079|FG002|STARTED|Period 2||2
10505394|NCT01263314|11656080|FG003|STARTED|Period 2||2
10505395|NCT01263314|11656081|FG004|STARTED|Period 2||2
10505396|NCT01263314|11656082|FG005|STARTED|Period 2||2
10505397|NCT01263314|11656083|FG006|STARTED|Period 2||2
10505398|NCT01263314|11656084|FG007|STARTED|Period 2||2
10505399|NCT01263314|11656077|FG000|COMPLETED|Period 2||2
10505400|NCT01263314|11656078|FG001|COMPLETED|Period 2||2
10505401|NCT01263314|11656079|FG002|COMPLETED|Period 2||2
10505402|NCT01263314|11656080|FG003|COMPLETED|Period 2||2
10505403|NCT01263314|11656081|FG004|COMPLETED|Period 2||2
10505404|NCT01263314|11656082|FG005|COMPLETED|Period 2||2
10505405|NCT01263314|11656083|FG006|COMPLETED|Period 2||2
10505406|NCT01263314|11656084|FG007|COMPLETED|Period 2||2
10505407|NCT01263314|11656077|FG000|NOT COMPLETED|Period 2||0
10505408|NCT01263314|11656078|FG001|NOT COMPLETED|Period 2||0
10505409|NCT01263314|11656079|FG002|NOT COMPLETED|Period 2||0
10505410|NCT01263314|11656080|FG003|NOT COMPLETED|Period 2||0
10505411|NCT01263314|11656081|FG004|NOT COMPLETED|Period 2||0
10505412|NCT01263314|11656082|FG005|NOT COMPLETED|Period 2||0
10505413|NCT01263314|11656083|FG006|NOT COMPLETED|Period 2||0
10505414|NCT01263314|11656084|FG007|NOT COMPLETED|Period 2||0
10505415|NCT01263314|11656077|FG000|STARTED|Period 3||2
10505416|NCT01263314|11656078|FG001|STARTED|Period 3||2
10505417|NCT01263314|11656079|FG002|STARTED|Period 3||2
10505418|NCT01263314|11656080|FG003|STARTED|Period 3||2
10505419|NCT01263314|11656081|FG004|STARTED|Period 3||2
10505420|NCT01263314|11656082|FG005|STARTED|Period 3||2
10505421|NCT01263314|11656083|FG006|STARTED|Period 3||2
10505422|NCT01263314|11656084|FG007|STARTED|Period 3||2
10505423|NCT01263314|11656077|FG000|COMPLETED|Period 3||2
10505424|NCT01263314|11656078|FG001|COMPLETED|Period 3||2
10505425|NCT01263314|11656079|FG002|COMPLETED|Period 3||2
10505426|NCT01263314|11656080|FG003|COMPLETED|Period 3||2
10505427|NCT01263314|11656081|FG004|COMPLETED|Period 3||2
10505428|NCT01263314|11656082|FG005|COMPLETED|Period 3||2
10505429|NCT01263314|11656083|FG006|COMPLETED|Period 3||2
10505430|NCT01263314|11656084|FG007|COMPLETED|Period 3||2
10505431|NCT01263314|11656077|FG000|NOT COMPLETED|Period 3||0
10505432|NCT01263314|11656078|FG001|NOT COMPLETED|Period 3||0
10505433|NCT01263314|11656079|FG002|NOT COMPLETED|Period 3||0
10505434|NCT01263314|11656080|FG003|NOT COMPLETED|Period 3||0
10505435|NCT01263314|11656081|FG004|NOT COMPLETED|Period 3||0
10505436|NCT01263314|11656082|FG005|NOT COMPLETED|Period 3||0
10505437|NCT01263314|11656083|FG006|NOT COMPLETED|Period 3||0
10505438|NCT01263314|11656084|FG007|NOT COMPLETED|Period 3||0
10505439|NCT01263444|11656108|FG000|STARTED|Overall Study||47
10505440|NCT01263444|11656108|FG000|COMPLETED|Overall Study||37
10505441|NCT01263444|11656108|FG000|NOT COMPLETED|Overall Study||10
10505442|NCT01263470|11656118|FG000|STARTED|Overall Study||75
10505443|NCT01263470|11656119|FG001|STARTED|Overall Study||79
10505444|NCT01263470|11656120|FG002|STARTED|Overall Study||84
10505445|NCT01263470|11656121|FG003|STARTED|Overall Study||80
10505446|NCT01263470|11656122|FG004|STARTED|Overall Study||79
10505447|NCT01263470|11656123|FG005|STARTED|Overall Study||83
10505448|NCT01263470|11656118|FG000|COMPLETED|Overall Study||73
10505449|NCT01263470|11656119|FG001|COMPLETED|Overall Study||74
10505450|NCT01263470|11656120|FG002|COMPLETED|Overall Study||80
10505451|NCT01263470|11656121|FG003|COMPLETED|Overall Study||77
10505452|NCT01263470|11656122|FG004|COMPLETED|Overall Study||76
10505453|NCT01263470|11656123|FG005|COMPLETED|Overall Study||78
10505454|NCT01263470|11656118|FG000|NOT COMPLETED|Overall Study||2
10505455|NCT01263470|11656119|FG001|NOT COMPLETED|Overall Study||5
10505456|NCT01263470|11656120|FG002|NOT COMPLETED|Overall Study||4
10710900|NCT02654054|11876240|FG001|NOT COMPLETED|Treatment Period||23
10710901|NCT02654054|11876241|FG002|NOT COMPLETED|Treatment Period||43
10710902|NCT02654054|11876239|FG000|STARTED|Post-Treatment Follow-Up Period||25
10710903|NCT02654054|11876240|FG001|STARTED|Post-Treatment Follow-Up Period||32
10710904|NCT02654054|11876241|FG002|STARTED|Post-Treatment Follow-Up Period||59
10710905|NCT02654054|11876239|FG000|COMPLETED|Post-Treatment Follow-Up Period||17
10710906|NCT02654054|11876240|FG001|COMPLETED|Post-Treatment Follow-Up Period||24
10710907|NCT02654054|11876241|FG002|COMPLETED|Post-Treatment Follow-Up Period||29
10710908|NCT02654054|11876239|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||8
10710909|NCT02654054|11876240|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||8
10505457|NCT01263470|11656121|FG003|NOT COMPLETED|Overall Study||3
10505458|NCT01263470|11656122|FG004|NOT COMPLETED|Overall Study||3
10505459|NCT01263470|11656123|FG005|NOT COMPLETED|Overall Study||5
10505460|NCT01263483|11656140|FG000|STARTED|Overall Study||75
10505461|NCT01263483|11656141|FG001|STARTED|Overall Study||76
10505462|NCT01263483|11656142|FG002|STARTED|Overall Study||79
10505463|NCT01263483|11656140|FG000|COMPLETED|Overall Study||68
10505464|NCT01263483|11656141|FG001|COMPLETED|Overall Study||74
10505465|NCT01263483|11656142|FG002|COMPLETED|Overall Study||74
10710910|NCT02654054|11876241|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||30
10505466|NCT01263483|11656140|FG000|NOT COMPLETED|Overall Study||7
10505467|NCT01263483|11656141|FG001|NOT COMPLETED|Overall Study||2
10505468|NCT01263483|11656142|FG002|NOT COMPLETED|Overall Study||5
10505469|NCT01263496|11656155|FG000|STARTED|Enrolled - Long-Term Extension Study||72
10505470|NCT01263496|11656156|FG001|STARTED|Enrolled - Long-Term Extension Study||75
10505471|NCT01263496|11656157|FG002|STARTED|Enrolled - Long-Term Extension Study||72
10505472|NCT01263496|11656158|FG003|STARTED|Enrolled - Long-Term Extension Study||75
10505473|NCT01263496|11656159|FG004|STARTED|Enrolled - Long-Term Extension Study||74
10505474|NCT01263496|11656160|FG005|STARTED|Enrolled - Long-Term Extension Study||17
10505475|NCT01263496|11656161|FG006|STARTED|Enrolled - Long-Term Extension Study||17
10505476|NCT01263496|11656162|FG007|STARTED|Enrolled - Long-Term Extension Study||18
10505477|NCT01263496|11656163|FG008|STARTED|Enrolled - Long-Term Extension Study||18
10505478|NCT01263496|11656155|FG000|COMPLETED|Enrolled - Long-Term Extension Study||71
10505479|NCT01263496|11656156|FG001|COMPLETED|Enrolled - Long-Term Extension Study||75
10505480|NCT01263496|11656157|FG002|COMPLETED|Enrolled - Long-Term Extension Study||72
10505481|NCT01263496|11656158|FG003|COMPLETED|Enrolled - Long-Term Extension Study||74
10505482|NCT01263496|11656159|FG004|COMPLETED|Enrolled - Long-Term Extension Study||72
10505483|NCT01263496|11656160|FG005|COMPLETED|Enrolled - Long-Term Extension Study||17
10505484|NCT01263496|11656161|FG006|COMPLETED|Enrolled - Long-Term Extension Study||17
10505485|NCT01263496|11656162|FG007|COMPLETED|Enrolled - Long-Term Extension Study||18
10505486|NCT01263496|11656163|FG008|COMPLETED|Enrolled - Long-Term Extension Study||18
10505487|NCT01263496|11656155|FG000|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
10505488|NCT01263496|11656156|FG001|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
10505489|NCT01263496|11656157|FG002|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
10505490|NCT01263496|11656158|FG003|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
10505491|NCT01263496|11656159|FG004|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
10505492|NCT01263496|11656160|FG005|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
10505493|NCT01263496|11656161|FG006|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
10505494|NCT01263496|11656162|FG007|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
10505495|NCT01263496|11656163|FG008|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
10505496|NCT01263496|11656155|FG000|STARTED|Entered - Long-Term Extension Study||71
10505497|NCT01263496|11656156|FG001|STARTED|Entered - Long-Term Extension Study|3 participants did not enter from previous period (1 voluntary withdraw; 2 did not meet criteria).|72
10505498|NCT01263496|11656157|FG002|STARTED|Entered - Long-Term Extension Study||72
10505499|NCT01263496|11656158|FG003|STARTED|Entered - Long-Term Extension Study||74
10505500|NCT01263496|11656159|FG004|STARTED|Entered - Long-Term Extension Study|1 participant did not enter from previous period (voluntary withdraw).|71
10505501|NCT01263496|11656160|FG005|STARTED|Entered - Long-Term Extension Study||17
10505502|NCT01263496|11656161|FG006|STARTED|Entered - Long-Term Extension Study||17
10505503|NCT01263496|11656162|FG007|STARTED|Entered - Long-Term Extension Study|1 participant did not enter from previous period (voluntary withdraw).|17
10505504|NCT01263496|11656163|FG008|STARTED|Entered - Long-Term Extension Study||18
10505505|NCT01263496|11656155|FG000|COMPLETED|Entered - Long-Term Extension Study||62
10505506|NCT01263496|11656156|FG001|COMPLETED|Entered - Long-Term Extension Study||59
10505507|NCT01263496|11656157|FG002|COMPLETED|Entered - Long-Term Extension Study||62
10505508|NCT01263496|11656158|FG003|COMPLETED|Entered - Long-Term Extension Study||68
10505509|NCT01263496|11656159|FG004|COMPLETED|Entered - Long-Term Extension Study||61
10505510|NCT01263496|11656160|FG005|COMPLETED|Entered - Long-Term Extension Study||16
10505511|NCT01263496|11656161|FG006|COMPLETED|Entered - Long-Term Extension Study||16
10505512|NCT01263496|11656162|FG007|COMPLETED|Entered - Long-Term Extension Study||16
10505513|NCT01263496|11656163|FG008|COMPLETED|Entered - Long-Term Extension Study||15
10505514|NCT01263496|11656155|FG000|NOT COMPLETED|Entered - Long-Term Extension Study||9
10505515|NCT01263496|11656156|FG001|NOT COMPLETED|Entered - Long-Term Extension Study||13
10505516|NCT01263496|11656157|FG002|NOT COMPLETED|Entered - Long-Term Extension Study||10
10505517|NCT01263496|11656158|FG003|NOT COMPLETED|Entered - Long-Term Extension Study||6
10505518|NCT01263496|11656159|FG004|NOT COMPLETED|Entered - Long-Term Extension Study||10
10505519|NCT01263496|11656160|FG005|NOT COMPLETED|Entered - Long-Term Extension Study||1
10505520|NCT01263496|11656161|FG006|NOT COMPLETED|Entered - Long-Term Extension Study||1
10505521|NCT01263496|11656162|FG007|NOT COMPLETED|Entered - Long-Term Extension Study||1
10505522|NCT01263496|11656163|FG008|NOT COMPLETED|Entered - Long-Term Extension Study||3
10505523|NCT01263509|11656177|FG000|STARTED|Enrolled - Long-Term Extension Study||61
10505524|NCT01263509|11656178|FG001|STARTED|Enrolled - Long-Term Extension Study||60
10505525|NCT01263509|11656179|FG002|STARTED|Enrolled - Long-Term Extension Study||32
10505526|NCT01263509|11656180|FG003|STARTED|Enrolled - Long-Term Extension Study||26
10505527|NCT01263509|11656177|FG000|COMPLETED|Enrolled - Long-Term Extension Study||61
10505528|NCT01263509|11656178|FG001|COMPLETED|Enrolled - Long-Term Extension Study||60
10505529|NCT01263509|11656179|FG002|COMPLETED|Enrolled - Long-Term Extension Study||32
10505530|NCT01263509|11656180|FG003|COMPLETED|Enrolled - Long-Term Extension Study||26
10505531|NCT01263509|11656177|FG000|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
10505532|NCT01263509|11656178|FG001|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
10505533|NCT01263509|11656179|FG002|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
10505534|NCT01263509|11656180|FG003|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
10505535|NCT01263509|11656177|FG000|STARTED|Entered - Long-Term Extension Study||61
10505536|NCT01263509|11656178|FG001|STARTED|Entered - Long-Term Extension Study||60
10505537|NCT01263509|11656179|FG002|STARTED|Entered - Long-Term Extension Study||32
10505538|NCT01263509|11656180|FG003|STARTED|Entered - Long-Term Extension Study||26
10505539|NCT01263509|11656177|FG000|COMPLETED|Entered - Long-Term Extension Study||53
10505540|NCT01263509|11656178|FG001|COMPLETED|Entered - Long-Term Extension Study||48
10505541|NCT01263509|11656179|FG002|COMPLETED|Entered - Long-Term Extension Study||27
10505542|NCT01263509|11656180|FG003|COMPLETED|Entered - Long-Term Extension Study||24
10505543|NCT01263509|11656177|FG000|NOT COMPLETED|Entered - Long-Term Extension Study||8
10505544|NCT01263509|11656178|FG001|NOT COMPLETED|Entered - Long-Term Extension Study||12
10505545|NCT01263509|11656179|FG002|NOT COMPLETED|Entered - Long-Term Extension Study||5
10505546|NCT01263509|11656180|FG003|NOT COMPLETED|Entered - Long-Term Extension Study||2
10505547|NCT01263561|11656188|FG000|STARTED|Overall Study||31
10505548|NCT01263561|11656189|FG001|STARTED|Overall Study||33
10505549|NCT01263561|11656188|FG000|COMPLETED|Overall Study||30
10505550|NCT01263561|11656189|FG001|COMPLETED|Overall Study||31
10505551|NCT01263561|11656188|FG000|NOT COMPLETED|Overall Study||1
10505552|NCT01263561|11656189|FG001|NOT COMPLETED|Overall Study||2
10505553|NCT01263639|11656197|FG000|STARTED|Overall Study||107
10505554|NCT01263639|11656198|FG001|STARTED|Overall Study||121
10505555|NCT01263639|11656197|FG000|COMPLETED|Overall Study||34
10505556|NCT01263639|11656198|FG001|COMPLETED|Overall Study||42
10505557|NCT01263639|11656197|FG000|NOT COMPLETED|Overall Study||73
10505558|NCT01263639|11656198|FG001|NOT COMPLETED|Overall Study||79
10505559|NCT01263665|11656204|FG000|STARTED|Overall Study||71
10505560|NCT01263665|11656204|FG000|COMPLETED|Overall Study||62
10505561|NCT01263665|11656204|FG000|NOT COMPLETED|Overall Study||9
10505562|NCT01263691|11656214|FG000|STARTED|Overall Study||18
10505563|NCT01263691|11656215|FG001|STARTED|Overall Study||18
10505564|NCT01263691|11656216|FG002|STARTED|Overall Study||17
10505565|NCT01263691|11656217|FG003|STARTED|Overall Study||19
10505566|NCT01263691|11656218|FG004|STARTED|Overall Study||18
10505567|NCT01263691|11656219|FG005|STARTED|Overall Study||15
10505568|NCT01263691|11656214|FG000|COMPLETED|Overall Study||15
10505569|NCT01263691|11656215|FG001|COMPLETED|Overall Study||18
10505570|NCT01263691|11656216|FG002|COMPLETED|Overall Study||16
10505571|NCT01263691|11656217|FG003|COMPLETED|Overall Study||18
10505572|NCT01263691|11656218|FG004|COMPLETED|Overall Study||18
10505573|NCT01263691|11656219|FG005|COMPLETED|Overall Study||15
10505574|NCT01263691|11656214|FG000|NOT COMPLETED|Overall Study||3
10505575|NCT01263691|11656215|FG001|NOT COMPLETED|Overall Study||0
10505576|NCT01263691|11656216|FG002|NOT COMPLETED|Overall Study||1
10505577|NCT01263691|11656217|FG003|NOT COMPLETED|Overall Study||1
10505578|NCT01263691|11656218|FG004|NOT COMPLETED|Overall Study||0
10505579|NCT01263691|11656219|FG005|NOT COMPLETED|Overall Study||0
10505580|NCT01263704|11656254|FG000|STARTED|Overall Study||42
10505581|NCT01263704|11656254|FG000|COMPLETED|Overall Study||13
10505582|NCT01263704|11656254|FG000|NOT COMPLETED|Overall Study||29
10505583|NCT01263717|11656260|FG000|STARTED|Overall Study||28
10505584|NCT01263717|11656261|FG001|STARTED|Overall Study||26
10505585|NCT01263717|11656260|FG000|Baseline Visit|Overall Study||28
10505586|NCT01263717|11656261|FG001|Baseline Visit|Overall Study||22
10505587|NCT01263717|11656260|FG000|COMPLETED|Overall Study||23
10505588|NCT01263717|11656261|FG001|COMPLETED|Overall Study||20
10505589|NCT01263717|11656260|FG000|NOT COMPLETED|Overall Study||5
10505590|NCT01263717|11656261|FG001|NOT COMPLETED|Overall Study||6
10505591|NCT01263782|11656271|FG000|STARTED|Overall Study||6
10505592|NCT01263782|11656272|FG001|STARTED|Overall Study||6
10505593|NCT01263782|11656273|FG002|STARTED|Overall Study||6
10505594|NCT01263782|11656274|FG003|STARTED|Overall Study||6
10505595|NCT01263782|11656271|FG000|COMPLETED|Overall Study||6
10505596|NCT01263782|11656272|FG001|COMPLETED|Overall Study||6
10505597|NCT01263782|11656273|FG002|COMPLETED|Overall Study||3
10505598|NCT01263782|11656274|FG003|COMPLETED|Overall Study||5
10505599|NCT01263782|11656271|FG000|NOT COMPLETED|Overall Study||0
10505600|NCT01263782|11656272|FG001|NOT COMPLETED|Overall Study||0
10505601|NCT01263782|11656273|FG002|NOT COMPLETED|Overall Study||3
10505602|NCT01263782|11656274|FG003|NOT COMPLETED|Overall Study||1
10505603|NCT01263873|11656286|FG000|STARTED|Overall Study||30
10505604|NCT01263873|11656287|FG001|STARTED|Overall Study||30
10505605|NCT01263873|11656286|FG000|COMPLETED|Overall Study||29
10505606|NCT01263873|11656287|FG001|COMPLETED|Overall Study||29
10505607|NCT01263873|11656286|FG000|NOT COMPLETED|Overall Study||1
10505608|NCT01263873|11656287|FG001|NOT COMPLETED|Overall Study||1
10505609|NCT01263925|11656295|FG000|STARTED|Overall Study||276
10505610|NCT01263925|11656296|FG001|STARTED|Overall Study||285
10505611|NCT01263925|11656295|FG000|Full Analysis Set|Overall Study||269
10505612|NCT01263925|11656296|FG001|Full Analysis Set|Overall Study||272
10505613|NCT01263925|11656295|FG000|COMPLETED|Overall Study||225
10505614|NCT01263925|11656296|FG001|COMPLETED|Overall Study||233
10505615|NCT01263925|11656295|FG000|NOT COMPLETED|Overall Study||51
10505616|NCT01263925|11656296|FG001|NOT COMPLETED|Overall Study||52
10528265|NCT01393990|11680493|FG015|COMPLETED|Overall Study||5
10528266|NCT01393990|11680494|FG016|COMPLETED|Overall Study||3
10528267|NCT01393990|11680495|FG017|COMPLETED|Overall Study||6
10528268|NCT01393990|11680478|FG000|NOT COMPLETED|Overall Study||1
10528269|NCT01393990|11680479|FG001|NOT COMPLETED|Overall Study||0
10528270|NCT01393990|11680480|FG002|NOT COMPLETED|Overall Study||0
10528271|NCT01393990|11680481|FG003|NOT COMPLETED|Overall Study||1
10528272|NCT01393990|11680482|FG004|NOT COMPLETED|Overall Study||2
10528273|NCT01393990|11680483|FG005|NOT COMPLETED|Overall Study||1
10528274|NCT01393990|11680484|FG006|NOT COMPLETED|Overall Study||1
10528275|NCT01393990|11680485|FG007|NOT COMPLETED|Overall Study||1
10528276|NCT01393990|11680486|FG008|NOT COMPLETED|Overall Study||3
10528277|NCT01393990|11680487|FG009|NOT COMPLETED|Overall Study||1
10528278|NCT01393990|11680488|FG010|NOT COMPLETED|Overall Study||0
10528279|NCT01393990|11680489|FG011|NOT COMPLETED|Overall Study||0
10528280|NCT01393990|11680490|FG012|NOT COMPLETED|Overall Study||0
10528281|NCT01393990|11680491|FG013|NOT COMPLETED|Overall Study||2
10528282|NCT01393990|11680492|FG014|NOT COMPLETED|Overall Study||9
10528283|NCT01393990|11680493|FG015|NOT COMPLETED|Overall Study||3
10528284|NCT01393990|11680494|FG016|NOT COMPLETED|Overall Study||0
10528285|NCT01393990|11680495|FG017|NOT COMPLETED|Overall Study||0
10528286|NCT01394003|11680552|FG000|STARTED|Overall Study||3
10528287|NCT01394003|11680553|FG001|STARTED|Overall Study||8
10528288|NCT01394003|11680554|FG002|STARTED|Overall Study||3
10528289|NCT01394003|11680555|FG003|STARTED|Overall Study||6
10505617|NCT01263938|11656302|FG000|STARTED|Overall Study||5
10505618|NCT01263938|11656302|FG000|COMPLETED|Overall Study||5
10505619|NCT01263938|11656302|FG000|NOT COMPLETED|Overall Study||0
10505620|NCT01264016|11656307|FG000|STARTED|Overall Study||96
10505621|NCT01264016|11656307|FG000|COMPLETED|Overall Study||94
10505622|NCT01264016|11656307|FG000|NOT COMPLETED|Overall Study||2
10505623|NCT01264081|11656312|FG000|STARTED|Participants Screened||34
10505624|NCT01264081|11656312|FG000|COMPLETED|Participants Screened||4
10505625|NCT01264081|11656312|FG000|NOT COMPLETED|Participants Screened||30
10505626|NCT01264081|11656312|FG000|STARTED|Started Treatment||4
10505627|NCT01264081|11656312|FG000|COMPLETED|Started Treatment||2
10505628|NCT01264081|11656312|FG000|NOT COMPLETED|Started Treatment||2
10505629|NCT01264081|11656312|FG000|STARTED|Analysis||2
10505630|NCT01264081|11656312|FG000|COMPLETED|Analysis||2
10505631|NCT01264081|11656312|FG000|NOT COMPLETED|Analysis||0
10505632|NCT01264380|11656316|FG000|STARTED|Period A||8
10505633|NCT01264380|11656317|FG001|STARTED|Period A||8
10505634|NCT01264380|11656318|FG002|STARTED|Period A||0
10505635|NCT01264380|11656316|FG000|COMPLETED|Period A||8
10505636|NCT01264380|11656317|FG001|COMPLETED|Period A||8
10505637|NCT01264380|11656318|FG002|COMPLETED|Period A||0
10505638|NCT01264380|11656316|FG000|NOT COMPLETED|Period A||0
10505639|NCT01264380|11656317|FG001|NOT COMPLETED|Period A||0
10505640|NCT01264380|11656318|FG002|NOT COMPLETED|Period A||0
10505641|NCT01264380|11656316|FG000|STARTED|Period B||8
10505642|NCT01264380|11656317|FG001|STARTED|Period B||8
10505643|NCT01264380|11656318|FG002|STARTED|Period B||0
10505644|NCT01264380|11656316|FG000|COMPLETED|Period B||8
10505645|NCT01264380|11656317|FG001|COMPLETED|Period B||8
10505646|NCT01264380|11656318|FG002|COMPLETED|Period B||0
10505647|NCT01264380|11656316|FG000|NOT COMPLETED|Period B||0
10505648|NCT01264380|11656317|FG001|NOT COMPLETED|Period B||0
10505649|NCT01264380|11656318|FG002|NOT COMPLETED|Period B||0
10505650|NCT01264380|11656316|FG000|STARTED|Period C||0
10505651|NCT01264380|11656317|FG001|STARTED|Period C||0
10505652|NCT01264380|11656318|FG002|STARTED|Period C||16
10505653|NCT01264380|11656316|FG000|COMPLETED|Period C||0
10505654|NCT01264380|11656317|FG001|COMPLETED|Period C||0
10505655|NCT01264380|11656318|FG002|COMPLETED|Period C||2
10505656|NCT01264380|11656316|FG000|NOT COMPLETED|Period C||0
10505657|NCT01264380|11656317|FG001|NOT COMPLETED|Period C||0
10505658|NCT01264380|11656318|FG002|NOT COMPLETED|Period C||14
10505659|NCT01264419|11656326|FG000|STARTED|Overall Study||75
10505660|NCT01264419|11656326|FG000|COMPLETED|Overall Study||72
10505661|NCT01264419|11656326|FG000|NOT COMPLETED|Overall Study||3
10505662|NCT01264601|11656332|FG000|STARTED|Overall Study||17
10505663|NCT01264601|11656333|FG001|STARTED|Overall Study||14
10505664|NCT01264601|11656332|FG000|COMPLETED|Overall Study||17
10505665|NCT01264601|11656333|FG001|COMPLETED|Overall Study||14
10505666|NCT01264601|11656332|FG000|NOT COMPLETED|Overall Study||0
10505667|NCT01264601|11656333|FG001|NOT COMPLETED|Overall Study||0
10505668|NCT01264614|11656341|FG000|STARTED|Overall Study||13
10505669|NCT01264614|11656342|FG001|STARTED|Overall Study||9
10505670|NCT01264614|11656341|FG000|COMPLETED|Overall Study||12
10505671|NCT01264614|11656342|FG001|COMPLETED|Overall Study||7
10505672|NCT01264614|11656341|FG000|NOT COMPLETED|Overall Study||1
10505673|NCT01264614|11656342|FG001|NOT COMPLETED|Overall Study||2
10505674|NCT01264705|11656351|FG000|STARTED|Overall Study||3
10505675|NCT01264705|11656352|FG001|STARTED|Overall Study||3
10505676|NCT01264705|11656353|FG002|STARTED|Overall Study||41
10505677|NCT01264705|11656351|FG000|COMPLETED|Overall Study||3
10505678|NCT01264705|11656352|FG001|COMPLETED|Overall Study||3
10505679|NCT01264705|11656353|FG002|COMPLETED|Overall Study||41
10505680|NCT01264705|11656351|FG000|NOT COMPLETED|Overall Study||0
10505681|NCT01264705|11656352|FG001|NOT COMPLETED|Overall Study||0
10505682|NCT01264705|11656353|FG002|NOT COMPLETED|Overall Study||0
10505683|NCT01264718|11656366|FG000|STARTED|Overall Study||172
10505684|NCT01264718|11656367|FG001|STARTED|Overall Study||157
10505685|NCT01264718|11656366|FG000|COMPLETED|Overall Study||123
10505686|NCT01264718|11656367|FG001|COMPLETED|Overall Study||114
10505687|NCT01264718|11656366|FG000|NOT COMPLETED|Overall Study||49
10505688|NCT01264718|11656367|FG001|NOT COMPLETED|Overall Study||43
10505689|NCT01264770|11656379|FG000|STARTED|Overall Study|Patients who received treatment|54
10505690|NCT01264770|11656380|FG001|STARTED|Overall Study|Patients who received treatment|48
10505691|NCT01264770|11656381|FG002|STARTED|Overall Study|Patients who received treatment|57
10505692|NCT01264770|11656382|FG003|STARTED|Overall Study|Patients who received treatment|54
10505693|NCT01264770|11656383|FG004|STARTED|Overall Study|Patients who received treatment|27
10505694|NCT01264770|11656384|FG005|STARTED|Overall Study|Patients who received treatment|25
10505695|NCT01264770|11656379|FG000|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
10505696|NCT01264770|11656380|FG001|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|5
10505697|NCT01264770|11656381|FG002|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
10505698|NCT01264770|11656382|FG003|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|3
10505699|NCT01264770|11656383|FG004|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
10505700|NCT01264770|11656384|FG005|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|0
10505701|NCT01264770|11656379|FG000|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|36
10528290|NCT01394003|11680556|FG004|STARTED|Overall Study||3
10505702|NCT01264770|11656380|FG001|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|38
10505703|NCT01264770|11656381|FG002|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|41
10505704|NCT01264770|11656382|FG003|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|48
10505705|NCT01264770|11656383|FG004|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|19
10505706|NCT01264770|11656384|FG005|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|19
10505707|NCT01264770|11656379|FG000|NOT COMPLETED|Overall Study||18
10505708|NCT01264770|11656380|FG001|NOT COMPLETED|Overall Study||10
10505709|NCT01264770|11656381|FG002|NOT COMPLETED|Overall Study||16
10505710|NCT01264770|11656382|FG003|NOT COMPLETED|Overall Study||6
10505711|NCT01264770|11656383|FG004|NOT COMPLETED|Overall Study||8
10505712|NCT01264770|11656384|FG005|NOT COMPLETED|Overall Study||6
10505713|NCT01264887|11656404|FG000|STARTED|Overall Study||31
10505714|NCT01264887|11656404|FG000|COMPLETED|Overall Study||0
10505715|NCT01264887|11656404|FG000|NOT COMPLETED|Overall Study||31
10505716|NCT01264939|11656412|FG000|STARTED|Overall Study||84
10505717|NCT01264939|11656413|FG001|STARTED|Overall Study||252
10505718|NCT01264939|11656412|FG000|COMPLETED|Overall Study||66
10505719|NCT01264939|11656413|FG001|COMPLETED|Overall Study||224
10505720|NCT01264939|11656412|FG000|NOT COMPLETED|Overall Study||18
10505721|NCT01264939|11656413|FG001|NOT COMPLETED|Overall Study||28
10505722|NCT01264952|11656422|FG000|STARTED|Overall Study||6
10505723|NCT01264952|11656423|FG001|STARTED|Overall Study||2
10505724|NCT01264952|11656424|FG002|STARTED|Overall Study||8
10505725|NCT01264952|11656422|FG000|COMPLETED|Overall Study||6
10505726|NCT01264952|11656423|FG001|COMPLETED|Overall Study||2
10505727|NCT01264952|11656424|FG002|COMPLETED|Overall Study||8
10505728|NCT01264952|11656422|FG000|NOT COMPLETED|Overall Study||0
10505729|NCT01264952|11656423|FG001|NOT COMPLETED|Overall Study||0
10505730|NCT01264952|11656424|FG002|NOT COMPLETED|Overall Study||0
10710911|NCT02654145|11876250|FG000|STARTED|Overall Study||145
10710912|NCT02654145|11876250|FG000|COMPLETED|Overall Study||138
10710913|NCT02654145|11876250|FG000|NOT COMPLETED|Overall Study||7
10710914|NCT02654483|11876256|FG000|STARTED|Double-blind||7
10710915|NCT02654483|11876257|FG001|STARTED|Double-blind||7
10710916|NCT02654483|11876256|FG000|COMPLETED|Double-blind||7
10710917|NCT02654483|11876257|FG001|COMPLETED|Double-blind||7
10710918|NCT02654483|11876256|FG000|NOT COMPLETED|Double-blind||0
10505731|NCT01265056|11656434|FG000|STARTED|Initial Study Period||26
10505732|NCT01265056|11656435|FG001|STARTED|Initial Study Period||27
10505733|NCT01265056|11656434|FG000|COMPLETED|Initial Study Period||24
10505734|NCT01265056|11656435|FG001|COMPLETED|Initial Study Period||25
10505735|NCT01265056|11656434|FG000|NOT COMPLETED|Initial Study Period||2
10505736|NCT01265056|11656435|FG001|NOT COMPLETED|Initial Study Period||2
10505737|NCT01265056|11656434|FG000|STARTED|Follow up||26
10505738|NCT01265056|11656435|FG001|STARTED|Follow up||27
10505739|NCT01265056|11656434|FG000|COMPLETED|Follow up||19
10505740|NCT01265056|11656435|FG001|COMPLETED|Follow up||24
10505741|NCT01265056|11656434|FG000|NOT COMPLETED|Follow up||7
10505742|NCT01265056|11656435|FG001|NOT COMPLETED|Follow up||3
10505743|NCT01265394|11656441|FG000|STARTED|Overall Study||218
10710919|NCT02654483|11876257|FG001|NOT COMPLETED|Double-blind||0
10710920|NCT02654483|11876256|FG000|STARTED|Open-label|2 participants did not proceed to open-label arm|5
10710921|NCT02654483|11876257|FG001|STARTED|Open-label|4 participants did not continue to open-label arm|3
10710922|NCT02654483|11876256|FG000|COMPLETED|Open-label||5
10710923|NCT02654483|11876257|FG001|COMPLETED|Open-label||3
10710924|NCT02654483|11876256|FG000|NOT COMPLETED|Open-label||0
10710925|NCT02654483|11876257|FG001|NOT COMPLETED|Open-label||0
10710926|NCT02654652|11876271|FG000|STARTED|Overall Study||19
10505744|NCT01265394|11656441|FG000|COMPLETED|Overall Study||181
10505745|NCT01265394|11656441|FG000|NOT COMPLETED|Overall Study||37
10505746|NCT01265420|11656446|FG000|STARTED|Overall Study||7
10505747|NCT01265420|11656446|FG000|COMPLETED|Overall Study|One patient was seen at Day 10 but did not return for Day 30 evaluation|6
10505748|NCT01265420|11656446|FG000|NOT COMPLETED|Overall Study||1
10505749|NCT01265446|11656452|FG000|STARTED|Overall Study||125
10505750|NCT01265446|11656453|FG001|STARTED|Overall Study||125
10505751|NCT01265446|11656452|FG000|COMPLETED|Overall Study||124
10505752|NCT01265446|11656453|FG001|COMPLETED|Overall Study||125
10505753|NCT01265446|11656452|FG000|NOT COMPLETED|Overall Study||1
10505754|NCT01265446|11656453|FG001|NOT COMPLETED|Overall Study||0
10710927|NCT02654652|11876272|FG001|STARTED|Overall Study||21
10505764|NCT01265498|11656486|FG000|STARTED|Overall Study||141
10505765|NCT01265498|11656487|FG001|STARTED|Overall Study||142
10710928|NCT02654652|11876271|FG000|COMPLETED|Overall Study||18
10710929|NCT02654652|11876272|FG001|COMPLETED|Overall Study||18
10505766|NCT01265498|11656486|FG000|Both Baseline and Week 72 Biopsy|Overall Study||102
10505767|NCT01265498|11656487|FG001|Both Baseline and Week 72 Biopsy|Overall Study||98
10505768|NCT01265498|11656486|FG000|COMPLETED|Overall Study||110
10505769|NCT01265498|11656487|FG001|COMPLETED|Overall Study||109
10505770|NCT01265498|11656486|FG000|NOT COMPLETED|Overall Study||31
10505771|NCT01265498|11656487|FG001|NOT COMPLETED|Overall Study||33
10505772|NCT01265511|11656495|FG000|STARTED|Overall Study||2
10505773|NCT01265511|11656496|FG001|STARTED|Overall Study||8
10505774|NCT01265511|11656495|FG000|COMPLETED|Overall Study||0
10505775|NCT01265511|11656496|FG001|COMPLETED|Overall Study||5
10505776|NCT01265511|11656495|FG000|NOT COMPLETED|Overall Study||2
10505777|NCT01265511|11656496|FG001|NOT COMPLETED|Overall Study||3
10505778|NCT01265524|11656504|FG000|STARTED|Overall Study||59
10505779|NCT01265524|11656505|FG001|STARTED|Overall Study||52
10505780|NCT01265524|11656504|FG000|COMPLETED|Overall Study||41
10505781|NCT01265524|11656505|FG001|COMPLETED|Overall Study||46
10505782|NCT01265524|11656504|FG000|NOT COMPLETED|Overall Study||18
10505783|NCT01265524|11656505|FG001|NOT COMPLETED|Overall Study||6
10505784|NCT01265537|11656513|FG000|STARTED|Overall Study||15
10505785|NCT01265537|11656514|FG001|STARTED|Overall Study||15
10505786|NCT01265537|11656513|FG000|COMPLETED|Overall Study||13
10505787|NCT01265537|11656514|FG001|COMPLETED|Overall Study||13
10505788|NCT01265537|11656513|FG000|NOT COMPLETED|Overall Study||2
10505789|NCT01265537|11656514|FG001|NOT COMPLETED|Overall Study||2
10505790|NCT01265550|11656524|FG000|STARTED|Pre Randomization||0
10505791|NCT01265550|11656525|FG001|STARTED|Pre Randomization||0
10505792|NCT01265550|11656526|FG002|STARTED|Pre Randomization||0
10505793|NCT01265550|11656527|FG003|STARTED|Pre Randomization||366
10505794|NCT01265550|11656524|FG000|COMPLETED|Pre Randomization||0
10505795|NCT01265550|11656525|FG001|COMPLETED|Pre Randomization||0
10505796|NCT01265550|11656526|FG002|COMPLETED|Pre Randomization||0
10505797|NCT01265550|11656527|FG003|COMPLETED|Pre Randomization||78
10505798|NCT01265550|11656524|FG000|NOT COMPLETED|Pre Randomization||0
10505799|NCT01265550|11656525|FG001|NOT COMPLETED|Pre Randomization||0
10505800|NCT01265550|11656526|FG002|NOT COMPLETED|Pre Randomization||0
10505801|NCT01265550|11656527|FG003|NOT COMPLETED|Pre Randomization||288
10505802|NCT01265550|11656524|FG000|STARTED|Post Randomization||25
10505803|NCT01265550|11656525|FG001|STARTED|Post Randomization||27
10505804|NCT01265550|11656526|FG002|STARTED|Post Randomization||26
10505805|NCT01265550|11656527|FG003|STARTED|Post Randomization||0
10505806|NCT01265550|11656524|FG000|COMPLETED|Post Randomization||10
10505807|NCT01265550|11656525|FG001|COMPLETED|Post Randomization||19
10505808|NCT01265550|11656526|FG002|COMPLETED|Post Randomization||6
10505809|NCT01265550|11656527|FG003|COMPLETED|Post Randomization||0
10505810|NCT01265550|11656524|FG000|NOT COMPLETED|Post Randomization||15
10505811|NCT01265550|11656525|FG001|NOT COMPLETED|Post Randomization||8
10505812|NCT01265550|11656526|FG002|NOT COMPLETED|Post Randomization||20
10505813|NCT01265550|11656527|FG003|NOT COMPLETED|Post Randomization||0
10505814|NCT01265563|11656546|FG000|STARTED|Overall Study||16
10505815|NCT01265563|11656547|FG001|STARTED|Overall Study||13
10505816|NCT01265563|11656548|FG002|STARTED|Overall Study||17
10505817|NCT01265563|11656549|FG003|STARTED|Overall Study||16
10505818|NCT01265563|11656550|FG004|STARTED|Overall Study||16
10505819|NCT01265563|11656546|FG000|COMPLETED|Overall Study||16
10505820|NCT01265563|11656547|FG001|COMPLETED|Overall Study||12
10505821|NCT01265563|11656548|FG002|COMPLETED|Overall Study||16
10505822|NCT01265563|11656549|FG003|COMPLETED|Overall Study||16
10505823|NCT01265563|11656550|FG004|COMPLETED|Overall Study||14
10505824|NCT01265563|11656546|FG000|NOT COMPLETED|Overall Study||0
10505825|NCT01265563|11656547|FG001|NOT COMPLETED|Overall Study||1
10505826|NCT01265563|11656548|FG002|NOT COMPLETED|Overall Study||1
10505827|NCT01265563|11656549|FG003|NOT COMPLETED|Overall Study||0
10505828|NCT01265563|11656550|FG004|NOT COMPLETED|Overall Study||2
10505829|NCT01265615|11656571|FG000|STARTED|Overall Study||30
10505830|NCT01265615|11656572|FG001|STARTED|Overall Study||30
10505831|NCT01265615|11656573|FG002|STARTED|Overall Study||30
10505832|NCT01265615|11656574|FG003|STARTED|Overall Study||30
10505833|NCT01265615|11656571|FG000|COMPLETED|Overall Study||28
10505834|NCT01265615|11656572|FG001|COMPLETED|Overall Study||28
10505835|NCT01265615|11656573|FG002|COMPLETED|Overall Study||26
10505836|NCT01265615|11656574|FG003|COMPLETED|Overall Study||27
10505837|NCT01265615|11656571|FG000|NOT COMPLETED|Overall Study||2
10505838|NCT01265615|11656572|FG001|NOT COMPLETED|Overall Study||2
10505839|NCT01265615|11656573|FG002|NOT COMPLETED|Overall Study||4
10505840|NCT01265615|11656574|FG003|NOT COMPLETED|Overall Study||3
10505841|NCT01265667|11656586|FG000|STARTED|Overall Study||145
10505842|NCT01265667|11656587|FG001|STARTED|Overall Study||148
10505843|NCT01265667|11656586|FG000|COMPLETED|Overall Study||125
10505844|NCT01265667|11656587|FG001|COMPLETED|Overall Study||135
10505845|NCT01265667|11656586|FG000|NOT COMPLETED|Overall Study||20
10505846|NCT01265667|11656587|FG001|NOT COMPLETED|Overall Study||13
10505847|NCT01265719|11656595|FG000|STARTED|Overall Study||102
10505848|NCT01265719|11656596|FG001|STARTED|Overall Study||73
10505849|NCT01265719|11656595|FG000|COMPLETED|Overall Study||88
10505850|NCT01265719|11656596|FG001|COMPLETED|Overall Study||60
10505851|NCT01265719|11656595|FG000|NOT COMPLETED|Overall Study||14
10505852|NCT01265719|11656596|FG001|NOT COMPLETED|Overall Study||13
10505853|NCT01265797|11656604|FG000|STARTED|Run-in Month||34
10505854|NCT01265797|11656605|FG001|STARTED|Run-in Month||34
10505855|NCT01265797|11656604|FG000|COMPLETED|Run-in Month||34
10505856|NCT01265797|11656605|FG001|COMPLETED|Run-in Month||29
10505857|NCT01265797|11656604|FG000|NOT COMPLETED|Run-in Month||0
10505858|NCT01265797|11656605|FG001|NOT COMPLETED|Run-in Month||5
10505859|NCT01265797|11656604|FG000|STARTED|Blinded Month||34
10505860|NCT01265797|11656605|FG001|STARTED|Blinded Month||29
10505861|NCT01265797|11656604|FG000|COMPLETED|Blinded Month||24
10505862|NCT01265797|11656605|FG001|COMPLETED|Blinded Month||27
10505863|NCT01265797|11656604|FG000|NOT COMPLETED|Blinded Month||10
10505864|NCT01265797|11656605|FG001|NOT COMPLETED|Blinded Month||2
10505865|NCT01265797|11656604|FG000|STARTED|Open Label Month||24
10505866|NCT01265797|11656605|FG001|STARTED|Open Label Month||27
10505867|NCT01265797|11656604|FG000|COMPLETED|Open Label Month||24
10505868|NCT01265797|11656605|FG001|COMPLETED|Open Label Month||26
10505869|NCT01265797|11656604|FG000|NOT COMPLETED|Open Label Month||0
10505870|NCT01265797|11656605|FG001|NOT COMPLETED|Open Label Month||1
10505871|NCT01265823|11656613|FG000|STARTED|Overall Study||150
10505872|NCT01265823|11656613|FG000|COMPLETED|Overall Study||143
10505873|NCT01265823|11656613|FG000|NOT COMPLETED|Overall Study||7
10505874|NCT01265875|11656621|FG000|STARTED|Overall Study||12
10505875|NCT01265875|11656621|FG000|COMPLETED|Overall Study||11
10505876|NCT01265875|11656621|FG000|NOT COMPLETED|Overall Study||1
10505877|NCT01265953|11656628|FG000|STARTED|Overall Study||50
10505878|NCT01265953|11656629|FG001|STARTED|Overall Study||48
10505879|NCT01265953|11656628|FG000|COMPLETED|Overall Study||45
10505880|NCT01265953|11656629|FG001|COMPLETED|Overall Study||45
10505881|NCT01265953|11656628|FG000|NOT COMPLETED|Overall Study||5
10505882|NCT01265953|11656629|FG001|NOT COMPLETED|Overall Study||3
10505883|NCT01265966|11656638|FG000|STARTED|Overall Study||47
10505884|NCT01265966|11656639|FG001|STARTED|Overall Study||41
10505885|NCT01265966|11656640|FG002|STARTED|Overall Study||29
10505886|NCT01265966|11656638|FG000|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|3
10505887|NCT01265966|11656639|FG001|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|2
10505888|NCT01265966|11656640|FG002|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|2
10505889|NCT01265966|11656638|FG000|COMPLETED|Overall Study||44
10505890|NCT01265966|11656639|FG001|COMPLETED|Overall Study||39
10505891|NCT01265966|11656640|FG002|COMPLETED|Overall Study||27
10505892|NCT01265966|11656638|FG000|NOT COMPLETED|Overall Study||3
10505893|NCT01265966|11656639|FG001|NOT COMPLETED|Overall Study||2
10505894|NCT01265966|11656640|FG002|NOT COMPLETED|Overall Study||2
10505895|NCT01265992|11656648|FG000|STARTED|Overall Study||50
10505896|NCT01265992|11656648|FG000|Received Treatment|Overall Study||49
10505897|NCT01265992|11656648|FG000|COMPLETED|Overall Study||41
10505898|NCT01265992|11656648|FG000|NOT COMPLETED|Overall Study||9
10505899|NCT01266018|11656652|FG000|STARTED|Overall Study||9
10505900|NCT01266018|11656653|FG001|STARTED|Overall Study||13
10505901|NCT01266018|11656652|FG000|COMPLETED|Overall Study|Defined as evaluable for the primary endpoint|8
10505902|NCT01266018|11656653|FG001|COMPLETED|Overall Study||12
10505903|NCT01266018|11656652|FG000|NOT COMPLETED|Overall Study||1
10505904|NCT01266018|11656653|FG001|NOT COMPLETED|Overall Study||1
10505905|NCT01266070|11656659|FG000|STARTED|Overall Study||6
10505906|NCT01266070|11656659|FG000|COMPLETED|Overall Study||2
10505907|NCT01266070|11656659|FG000|NOT COMPLETED|Overall Study||4
10505908|NCT01266122|11656665|FG000|STARTED|Overall Study||48
10505909|NCT01266122|11656666|FG001|STARTED|Overall Study||48
10505910|NCT01266122|11656665|FG000|COMPLETED|Overall Study||42
10505911|NCT01266122|11656666|FG001|COMPLETED|Overall Study||42
10505912|NCT01266122|11656665|FG000|NOT COMPLETED|Overall Study||6
10505913|NCT01266122|11656666|FG001|NOT COMPLETED|Overall Study||6
10505914|NCT01266148|11656674|FG000|STARTED|Overall Study||56
10505915|NCT01266148|11656675|FG001|STARTED|Overall Study||59
10505916|NCT01266148|11656674|FG000|COMPLETED|Overall Study||49
10505917|NCT01266148|11656675|FG001|COMPLETED|Overall Study||56
10505918|NCT01266148|11656674|FG000|NOT COMPLETED|Overall Study||7
10505919|NCT01266148|11656675|FG001|NOT COMPLETED|Overall Study||3
10505920|NCT01266161|11656683|FG000|STARTED|Overall Study||52
10505921|NCT01266161|11656684|FG001|STARTED|Overall Study||54
10505922|NCT01266161|11656683|FG000|COMPLETED|Overall Study||48
10505923|NCT01266161|11656684|FG001|COMPLETED|Overall Study||53
10505924|NCT01266161|11656683|FG000|NOT COMPLETED|Overall Study||4
10505925|NCT01266161|11656684|FG001|NOT COMPLETED|Overall Study||1
10505926|NCT01266265|11656692|FG000|STARTED|Overall Study||666
10505927|NCT01266265|11656693|FG001|STARTED|Overall Study||667
10505928|NCT01266265|11656692|FG000|COMPLETED|Overall Study||461
10505929|NCT01266265|11656693|FG001|COMPLETED|Overall Study||477
10505930|NCT01266265|11656692|FG000|NOT COMPLETED|Overall Study||205
10505931|NCT01266265|11656693|FG001|NOT COMPLETED|Overall Study||190
10505932|NCT01266291|11656699|FG000|STARTED|Overall Study||1
10505933|NCT01266291|11656699|FG000|COMPLETED|Overall Study||0
10505934|NCT01266291|11656699|FG000|NOT COMPLETED|Overall Study||1
10505935|NCT01266317|11656703|FG000|STARTED|Overall Study|One additional patient was a protocol violation post consent when autoantibodies returned positive|9
10505936|NCT01266317|11656703|FG000|COMPLETED|Overall Study||7
10505937|NCT01266317|11656703|FG000|NOT COMPLETED|Overall Study||2
10505938|NCT01266447|11656707|FG000|STARTED|Overall Study||27
10505939|NCT01266447|11656707|FG000|COMPLETED|Overall Study|Eligible and treated patients|27
10505940|NCT01266447|11656707|FG000|NOT COMPLETED|Overall Study||0
10505941|NCT01266460|11656711|FG000|STARTED|Overall Study||50
10505942|NCT01266460|11656711|FG000|COMPLETED|Overall Study||16
10505943|NCT01266460|11656711|FG000|NOT COMPLETED|Overall Study||34
10505944|NCT01266590|11656715|FG000|STARTED|Overall Study||30
10505945|NCT01266590|11656715|FG000|COMPLETED|Overall Study||24
10505946|NCT01266590|11656715|FG000|NOT COMPLETED|Overall Study||6
10505947|NCT01266603|11656722|FG000|STARTED|Overall Study||44
10505948|NCT01266603|11656722|FG000|MAGE-A3 Positive Tumor|Overall Study||18
10505949|NCT01266603|11656722|FG000|Patients Evaluable for Safety|Overall Study||17
10505950|NCT01266603|11656722|FG000|Patients Evaluable for Response|Overall Study||16
10505951|NCT01266603|11656722|FG000|Continued to Maintenance- MAGE-A3|Overall Study||4
10505952|NCT01266603|11656722|FG000|Maintenance Completion|Overall Study||2
10505953|NCT01266603|11656722|FG000|COMPLETED|Overall Study||2
10505954|NCT01266603|11656722|FG000|NOT COMPLETED|Overall Study||42
10505955|NCT01266642|11656728|FG000|STARTED|Overall Study||149
10505956|NCT01266642|11656729|FG001|STARTED|Overall Study||138
10505957|NCT01266642|11656728|FG000|COMPLETED|Overall Study||149
10505958|NCT01266642|11656729|FG001|COMPLETED|Overall Study||137
10505959|NCT01266642|11656728|FG000|NOT COMPLETED|Overall Study||0
10505960|NCT01266642|11656729|FG001|NOT COMPLETED|Overall Study||1
10505961|NCT01266850|11656740|FG000|STARTED|Overall Study||242
10505962|NCT01266850|11656741|FG001|STARTED|Overall Study||248
10505963|NCT01266850|11656742|FG002|STARTED|Overall Study||238
10505964|NCT01266850|11656743|FG003|STARTED|Overall Study||329
10505965|NCT01266850|11656744|FG004|STARTED|Overall Study||327
10505966|NCT01266850|11656740|FG000|Received Second Vaccine|Overall Study||231
10505967|NCT01266850|11656741|FG001|Received Second Vaccine|Overall Study||233
10505968|NCT01266850|11656742|FG002|Received Second Vaccine|Overall Study||227
10505969|NCT01266850|11656743|FG003|Received Second Vaccine|Overall Study||311
10505970|NCT01266850|11656744|FG004|Received Second Vaccine|Overall Study||307
10505971|NCT01266850|11656740|FG000|Received Third Vaccine|Overall Study||221
10505972|NCT01266850|11656741|FG001|Received Third Vaccine|Overall Study||221
10505973|NCT01266850|11656742|FG002|Received Third Vaccine|Overall Study||217
10505974|NCT01266850|11656743|FG003|Received Third Vaccine|Overall Study||0
10505975|NCT01266850|11656744|FG004|Received Third Vaccine|Overall Study||299
10505976|NCT01266850|11656740|FG000|COMPLETED|Overall Study||212
10505977|NCT01266850|11656741|FG001|COMPLETED|Overall Study||212
10505978|NCT01266850|11656742|FG002|COMPLETED|Overall Study||214
10505979|NCT01266850|11656743|FG003|COMPLETED|Overall Study||301
10505980|NCT01266850|11656744|FG004|COMPLETED|Overall Study||297
10505981|NCT01266850|11656740|FG000|NOT COMPLETED|Overall Study||30
10505982|NCT01266850|11656741|FG001|NOT COMPLETED|Overall Study||36
10505983|NCT01266850|11656742|FG002|NOT COMPLETED|Overall Study||24
10505984|NCT01266850|11656743|FG003|NOT COMPLETED|Overall Study||28
10505985|NCT01266850|11656744|FG004|NOT COMPLETED|Overall Study||30
10505986|NCT01266876|11656761|FG000|STARTED|Overall Study||15
10505987|NCT01266876|11656762|FG001|STARTED|Overall Study||15
10505988|NCT01266876|11656763|FG002|STARTED|Overall Study||16
10505989|NCT01266876|11656764|FG003|STARTED|Overall Study||15
10505990|NCT01266876|11656765|FG004|STARTED|Overall Study||16
10505991|NCT01266876|11656761|FG000|COMPLETED|Overall Study||15
10505992|NCT01266876|11656762|FG001|COMPLETED|Overall Study||15
10505993|NCT01266876|11656763|FG002|COMPLETED|Overall Study||16
10505994|NCT01266876|11656764|FG003|COMPLETED|Overall Study||14
10505995|NCT01266876|11656765|FG004|COMPLETED|Overall Study||16
10505996|NCT01266876|11656761|FG000|NOT COMPLETED|Overall Study||0
10505997|NCT01266876|11656762|FG001|NOT COMPLETED|Overall Study||0
10505998|NCT01266876|11656763|FG002|NOT COMPLETED|Overall Study||0
10505999|NCT01266876|11656764|FG003|NOT COMPLETED|Overall Study||1
10506000|NCT01266876|11656765|FG004|NOT COMPLETED|Overall Study||0
10506001|NCT01266902|11656779|FG000|STARTED|Period 1 (Main Study)||119
10506002|NCT01266902|11656780|FG001|STARTED|Period 1 (Main Study)||363
10506003|NCT01266902|11656781|FG002|STARTED|Period 1 (Main Study)||0
10506004|NCT01266902|11656779|FG000|COMPLETED|Period 1 (Main Study)||89
10506005|NCT01266902|11656780|FG001|COMPLETED|Period 1 (Main Study)||282
10506006|NCT01266902|11656781|FG002|COMPLETED|Period 1 (Main Study)||0
10506007|NCT01266902|11656779|FG000|NOT COMPLETED|Period 1 (Main Study)||30
10506008|NCT01266902|11656780|FG001|NOT COMPLETED|Period 1 (Main Study)||81
10506009|NCT01266902|11656781|FG002|NOT COMPLETED|Period 1 (Main Study)||0
10506010|NCT01266902|11656779|FG000|STARTED|Period 2 (After Protocol Amendment 3)||0
10506011|NCT01266902|11656780|FG001|STARTED|Period 2 (After Protocol Amendment 3)||0
10506012|NCT01266902|11656781|FG002|STARTED|Period 2 (After Protocol Amendment 3)||45
10506013|NCT01266902|11656779|FG000|COMPLETED|Period 2 (After Protocol Amendment 3)||0
10506014|NCT01266902|11656780|FG001|COMPLETED|Period 2 (After Protocol Amendment 3)||0
10506015|NCT01266902|11656781|FG002|COMPLETED|Period 2 (After Protocol Amendment 3)||37
10506016|NCT01266902|11656779|FG000|NOT COMPLETED|Period 2 (After Protocol Amendment 3)||0
10506017|NCT01266902|11656780|FG001|NOT COMPLETED|Period 2 (After Protocol Amendment 3)||0
10506018|NCT01266902|11656781|FG002|NOT COMPLETED|Period 2 (After Protocol Amendment 3)||8
10506019|NCT01266967|11656791|FG000|STARTED|Overall Study||89
10506020|NCT01266967|11656792|FG001|STARTED|Overall Study||83
10506021|NCT01266967|11656791|FG000|COMPLETED|Overall Study||0
10506022|NCT01266967|11656792|FG001|COMPLETED|Overall Study||0
10506023|NCT01266967|11656791|FG000|NOT COMPLETED|Overall Study||89
10506024|NCT01266967|11656792|FG001|NOT COMPLETED|Overall Study||83
10506025|NCT01266993|11656803|FG000|STARTED|Persistence Phase (Month 32-44)||199
10506026|NCT01266993|11656804|FG001|STARTED|Persistence Phase (Month 32-44)||72
10506027|NCT01266993|11656803|FG000|COMPLETED|Persistence Phase (Month 32-44)||199
10506028|NCT01266993|11656804|FG001|COMPLETED|Persistence Phase (Month 32-44)||72
10506029|NCT01266993|11656803|FG000|NOT COMPLETED|Persistence Phase (Month 32-44)||0
10506030|NCT01266993|11656804|FG001|NOT COMPLETED|Persistence Phase (Month 32-44)||0
10506031|NCT01266993|11656803|FG000|STARTED|Persistence Phase (Month 44-56)||193
10506032|NCT01266993|11656804|FG001|STARTED|Persistence Phase (Month 44-56)||68
10506033|NCT01266993|11656803|FG000|COMPLETED|Persistence Phase (Month 44-56)||193
10506034|NCT01266993|11656804|FG001|COMPLETED|Persistence Phase (Month 44-56)||68
10506035|NCT01266993|11656803|FG000|NOT COMPLETED|Persistence Phase (Month 44-56)||0
10506036|NCT01266993|11656804|FG001|NOT COMPLETED|Persistence Phase (Month 44-56)||0
10506037|NCT01266993|11656803|FG000|STARTED|Persistence Phase (Month 56-68)||193
10506038|NCT01266993|11656804|FG001|STARTED|Persistence Phase (Month 56-68)||67
10506039|NCT01266993|11656803|FG000|COMPLETED|Persistence Phase (Month 56-68)||193
10506040|NCT01266993|11656804|FG001|COMPLETED|Persistence Phase (Month 56-68)||67
10506041|NCT01266993|11656803|FG000|NOT COMPLETED|Persistence Phase (Month 56-68)||0
10506042|NCT01266993|11656804|FG001|NOT COMPLETED|Persistence Phase (Month 56-68)||0
10506043|NCT01266993|11656803|FG000|STARTED|Booster Phase (Month 68-69)||179
10506044|NCT01266993|11656804|FG001|STARTED|Booster Phase (Month 68-69)||62
10506045|NCT01266993|11656803|FG000|COMPLETED|Booster Phase (Month 68-69)||174
10506046|NCT01266993|11656804|FG001|COMPLETED|Booster Phase (Month 68-69)||60
10506047|NCT01266993|11656803|FG000|NOT COMPLETED|Booster Phase (Month 68-69)||5
10506048|NCT01266993|11656804|FG001|NOT COMPLETED|Booster Phase (Month 68-69)||2
10506049|NCT01267019|11656813|FG000|STARTED|Overall Study||47
10506050|NCT01267019|11656814|FG001|STARTED|Overall Study||53
10506051|NCT01267019|11656815|FG002|STARTED|Overall Study||53
10506052|NCT01267019|11656813|FG000|COMPLETED|Overall Study||41
10506053|NCT01267019|11656814|FG001|COMPLETED|Overall Study||47
10506054|NCT01267019|11656815|FG002|COMPLETED|Overall Study||47
10506055|NCT01267019|11656813|FG000|NOT COMPLETED|Overall Study||6
10506056|NCT01267019|11656814|FG001|NOT COMPLETED|Overall Study||6
10506057|NCT01267019|11656815|FG002|NOT COMPLETED|Overall Study||6
10506058|NCT01267045|11656825|FG000|STARTED|2-month Outcomes||26
10506059|NCT01267045|11656826|FG001|STARTED|2-month Outcomes||29
10506060|NCT01267045|11656825|FG000|COMPLETED|2-month Outcomes||22
10506061|NCT01267045|11656826|FG001|COMPLETED|2-month Outcomes||26
10506062|NCT01267045|11656825|FG000|NOT COMPLETED|2-month Outcomes||4
10506063|NCT01267045|11656826|FG001|NOT COMPLETED|2-month Outcomes||3
10506064|NCT01267045|11656825|FG000|STARTED|6-month Outcome||22
10506065|NCT01267045|11656826|FG001|STARTED|6-month Outcome||26
10506066|NCT01267045|11656825|FG000|COMPLETED|6-month Outcome||22
10506067|NCT01267045|11656826|FG001|COMPLETED|6-month Outcome||23
10506068|NCT01267045|11656825|FG000|NOT COMPLETED|6-month Outcome||0
10506069|NCT01267045|11656826|FG001|NOT COMPLETED|6-month Outcome||3
10506070|NCT01267136|11656835|FG000|STARTED|Overall Study||42
10506071|NCT01267136|11656836|FG001|STARTED|Overall Study||42
10506072|NCT01267136|11656835|FG000|COMPLETED|Overall Study||38
10506073|NCT01267136|11656836|FG001|COMPLETED|Overall Study||36
10506074|NCT01267136|11656835|FG000|NOT COMPLETED|Overall Study||4
10506075|NCT01267136|11656836|FG001|NOT COMPLETED|Overall Study||6
10506076|NCT01267175|11656844|FG000|STARTED|Overall Study||31
10506077|NCT01267175|11656844|FG000|COMPLETED|Overall Study||29
10506078|NCT01267175|11656844|FG000|NOT COMPLETED|Overall Study||2
10506079|NCT01267201|11656848|FG000|STARTED|First Intervention Period||4
10506080|NCT01267201|11656849|FG001|STARTED|First Intervention Period||4
10506081|NCT01267201|11656850|FG002|STARTED|First Intervention Period||4
10506082|NCT01267201|11656851|FG003|STARTED|First Intervention Period||4
10506083|NCT01267201|11656852|FG004|STARTED|First Intervention Period||4
10506084|NCT01267201|11656853|FG005|STARTED|First Intervention Period||4
10506085|NCT01267201|11656848|FG000|COMPLETED|First Intervention Period||3
10506086|NCT01267201|11656849|FG001|COMPLETED|First Intervention Period||4
10506087|NCT01267201|11656850|FG002|COMPLETED|First Intervention Period||4
10506088|NCT01267201|11656851|FG003|COMPLETED|First Intervention Period||4
10506089|NCT01267201|11656852|FG004|COMPLETED|First Intervention Period||4
10506090|NCT01267201|11656853|FG005|COMPLETED|First Intervention Period||4
10506091|NCT01267201|11656848|FG000|NOT COMPLETED|First Intervention Period||1
10506092|NCT01267201|11656849|FG001|NOT COMPLETED|First Intervention Period||0
10506093|NCT01267201|11656850|FG002|NOT COMPLETED|First Intervention Period||0
10506094|NCT01267201|11656851|FG003|NOT COMPLETED|First Intervention Period||0
10506095|NCT01267201|11656852|FG004|NOT COMPLETED|First Intervention Period||0
10506096|NCT01267201|11656853|FG005|NOT COMPLETED|First Intervention Period||0
10506097|NCT01267201|11656848|FG000|STARTED|Washout Period (At Least 2 Days)||3
10506098|NCT01267201|11656849|FG001|STARTED|Washout Period (At Least 2 Days)||4
10506099|NCT01267201|11656850|FG002|STARTED|Washout Period (At Least 2 Days)||4
10506100|NCT01267201|11656851|FG003|STARTED|Washout Period (At Least 2 Days)||4
10506101|NCT01267201|11656852|FG004|STARTED|Washout Period (At Least 2 Days)||4
10506102|NCT01267201|11656853|FG005|STARTED|Washout Period (At Least 2 Days)||4
10506103|NCT01267201|11656848|FG000|COMPLETED|Washout Period (At Least 2 Days)||3
10506104|NCT01267201|11656849|FG001|COMPLETED|Washout Period (At Least 2 Days)||4
10506105|NCT01267201|11656850|FG002|COMPLETED|Washout Period (At Least 2 Days)||4
10506106|NCT01267201|11656851|FG003|COMPLETED|Washout Period (At Least 2 Days)||4
10506107|NCT01267201|11656852|FG004|COMPLETED|Washout Period (At Least 2 Days)||4
10506108|NCT01267201|11656853|FG005|COMPLETED|Washout Period (At Least 2 Days)||4
10506109|NCT01267201|11656848|FG000|NOT COMPLETED|Washout Period (At Least 2 Days)||0
10506110|NCT01267201|11656849|FG001|NOT COMPLETED|Washout Period (At Least 2 Days)||0
10506111|NCT01267201|11656850|FG002|NOT COMPLETED|Washout Period (At Least 2 Days)||0
10506112|NCT01267201|11656851|FG003|NOT COMPLETED|Washout Period (At Least 2 Days)||0
10506113|NCT01267201|11656852|FG004|NOT COMPLETED|Washout Period (At Least 2 Days)||0
10506114|NCT01267201|11656853|FG005|NOT COMPLETED|Washout Period (At Least 2 Days)||0
10506115|NCT01267201|11656848|FG000|STARTED|Second Intervention Period||3
10506116|NCT01267201|11656849|FG001|STARTED|Second Intervention Period||4
10506117|NCT01267201|11656850|FG002|STARTED|Second Intervention Period||4
10506118|NCT01267201|11656851|FG003|STARTED|Second Intervention Period||4
10506119|NCT01267201|11656852|FG004|STARTED|Second Intervention Period||4
10506120|NCT01267201|11656853|FG005|STARTED|Second Intervention Period||4
10506121|NCT01267201|11656848|FG000|COMPLETED|Second Intervention Period||3
10506122|NCT01267201|11656849|FG001|COMPLETED|Second Intervention Period||3
10506123|NCT01267201|11656850|FG002|COMPLETED|Second Intervention Period||4
10506124|NCT01267201|11656851|FG003|COMPLETED|Second Intervention Period||4
10506125|NCT01267201|11656852|FG004|COMPLETED|Second Intervention Period||4
10506126|NCT01267201|11656853|FG005|COMPLETED|Second Intervention Period||4
10506127|NCT01267201|11656848|FG000|NOT COMPLETED|Second Intervention Period||0
10506128|NCT01267201|11656849|FG001|NOT COMPLETED|Second Intervention Period||1
10506129|NCT01267201|11656850|FG002|NOT COMPLETED|Second Intervention Period||0
10506130|NCT01267201|11656851|FG003|NOT COMPLETED|Second Intervention Period||0
10506131|NCT01267201|11656852|FG004|NOT COMPLETED|Second Intervention Period||0
10506132|NCT01267201|11656853|FG005|NOT COMPLETED|Second Intervention Period||0
10506133|NCT01267201|11656848|FG000|STARTED|Washout Period (At Least 2 Days)||3
10506134|NCT01267201|11656849|FG001|STARTED|Washout Period (At Least 2 Days)||3
10506135|NCT01267201|11656850|FG002|STARTED|Washout Period (At Least 2 Days)||4
10506136|NCT01267201|11656851|FG003|STARTED|Washout Period (At Least 2 Days)||4
10506137|NCT01267201|11656852|FG004|STARTED|Washout Period (At Least 2 Days)||4
10506138|NCT01267201|11656853|FG005|STARTED|Washout Period (At Least 2 Days)||4
10506139|NCT01267201|11656848|FG000|COMPLETED|Washout Period (At Least 2 Days)||3
10506140|NCT01267201|11656849|FG001|COMPLETED|Washout Period (At Least 2 Days)||3
10506141|NCT01267201|11656850|FG002|COMPLETED|Washout Period (At Least 2 Days)||4
10506142|NCT01267201|11656851|FG003|COMPLETED|Washout Period (At Least 2 Days)||4
10506143|NCT01267201|11656852|FG004|COMPLETED|Washout Period (At Least 2 Days)||4
10506144|NCT01267201|11656853|FG005|COMPLETED|Washout Period (At Least 2 Days)||4
10506145|NCT01267201|11656848|FG000|NOT COMPLETED|Washout Period (At Least 2 Days)||0
10506146|NCT01267201|11656849|FG001|NOT COMPLETED|Washout Period (At Least 2 Days)||0
10506147|NCT01267201|11656850|FG002|NOT COMPLETED|Washout Period (At Least 2 Days)||0
10506148|NCT01267201|11656851|FG003|NOT COMPLETED|Washout Period (At Least 2 Days)||0
10506149|NCT01267201|11656852|FG004|NOT COMPLETED|Washout Period (At Least 2 Days)||0
10506150|NCT01267201|11656853|FG005|NOT COMPLETED|Washout Period (At Least 2 Days)||0
10506151|NCT01267201|11656848|FG000|STARTED|Third Intervention Period||3
10506152|NCT01267201|11656849|FG001|STARTED|Third Intervention Period||3
10506153|NCT01267201|11656850|FG002|STARTED|Third Intervention Period||4
10506154|NCT01267201|11656851|FG003|STARTED|Third Intervention Period||4
10506155|NCT01267201|11656852|FG004|STARTED|Third Intervention Period||4
10506156|NCT01267201|11656853|FG005|STARTED|Third Intervention Period||4
10506157|NCT01267201|11656848|FG000|COMPLETED|Third Intervention Period||3
10506158|NCT01267201|11656849|FG001|COMPLETED|Third Intervention Period||3
10506159|NCT01267201|11656850|FG002|COMPLETED|Third Intervention Period||4
10506160|NCT01267201|11656851|FG003|COMPLETED|Third Intervention Period||4
10506161|NCT01267201|11656852|FG004|COMPLETED|Third Intervention Period||4
10506162|NCT01267201|11656853|FG005|COMPLETED|Third Intervention Period||4
10506163|NCT01267201|11656848|FG000|NOT COMPLETED|Third Intervention Period||0
10506164|NCT01267201|11656849|FG001|NOT COMPLETED|Third Intervention Period||0
10506165|NCT01267201|11656850|FG002|NOT COMPLETED|Third Intervention Period||0
10506166|NCT01267201|11656851|FG003|NOT COMPLETED|Third Intervention Period||0
10506167|NCT01267201|11656852|FG004|NOT COMPLETED|Third Intervention Period||0
10506168|NCT01267201|11656853|FG005|NOT COMPLETED|Third Intervention Period||0
10506169|NCT01267227|11656865|FG000|STARTED|Overall Study||20
10506170|NCT01267227|11656866|FG001|STARTED|Overall Study||20
10506171|NCT01267227|11656867|FG002|STARTED|Overall Study||20
10506172|NCT01267227|11656868|FG003|STARTED|Overall Study||20
10506173|NCT01267227|11656865|FG000|COMPLETED|Overall Study||19
10506174|NCT01267227|11656866|FG001|COMPLETED|Overall Study||19
10506175|NCT01267227|11656867|FG002|COMPLETED|Overall Study||18
10506176|NCT01267227|11656868|FG003|COMPLETED|Overall Study||17
10506177|NCT01267227|11656865|FG000|NOT COMPLETED|Overall Study||1
10506178|NCT01267227|11656866|FG001|NOT COMPLETED|Overall Study||1
10506179|NCT01267227|11656867|FG002|NOT COMPLETED|Overall Study||2
10506180|NCT01267227|11656868|FG003|NOT COMPLETED|Overall Study||3
10506181|NCT01267240|11656882|FG000|STARTED|Overall Study||25
10506182|NCT01267240|11656882|FG000|COMPLETED|Overall Study||25
10506183|NCT01267240|11656882|FG000|NOT COMPLETED|Overall Study||0
10506184|NCT01267253|11656886|FG000|STARTED|Overall Study||31
10506185|NCT01267253|11656886|FG000|COMPLETED|Overall Study|Eligible and treated patients|28
10506186|NCT01267253|11656886|FG000|NOT COMPLETED|Overall Study||3
10506187|NCT01267266|11656890|FG000|STARTED|Enrollment Phase||33
10506188|NCT01267266|11656891|FG001|STARTED|Enrollment Phase||0
10506189|NCT01267266|11656890|FG000|COMPLETED|Enrollment Phase|Two patients signed consent but did not proceed to treatment.|31
10506190|NCT01267266|11656891|FG001|COMPLETED|Enrollment Phase||0
10506191|NCT01267266|11656890|FG000|NOT COMPLETED|Enrollment Phase||2
10506192|NCT01267266|11656891|FG001|NOT COMPLETED|Enrollment Phase||0
10506193|NCT01267266|11656890|FG000|STARTED|Lead-in Phase||31
10506194|NCT01267266|11656891|FG001|STARTED|Lead-in Phase||0
10506195|NCT01267266|11656890|FG000|COMPLETED|Lead-in Phase|12 patients had radiographic progression, 8 clinical progression, 2 toxicity, 1 withdrawal.|8
10506196|NCT01267266|11656891|FG001|COMPLETED|Lead-in Phase||0
10506197|NCT01267266|11656890|FG000|NOT COMPLETED|Lead-in Phase||23
10506198|NCT01267266|11656891|FG001|NOT COMPLETED|Lead-in Phase||0
10506199|NCT01267266|11656890|FG000|STARTED|Randomized Phase|3 of 8 patients randomized to saracatinib.|3
10506200|NCT01267266|11656891|FG001|STARTED|Randomized Phase|5 of 8 patients randomized to placebo.|5
10506201|NCT01267266|11656890|FG000|COMPLETED|Randomized Phase||3
10506202|NCT01267266|11656891|FG001|COMPLETED|Randomized Phase||5
10506203|NCT01267266|11656890|FG000|NOT COMPLETED|Randomized Phase||0
10506204|NCT01267266|11656891|FG001|NOT COMPLETED|Randomized Phase||0
10506205|NCT01267279|11656902|FG000|STARTED|Overall Study||24
10506206|NCT01267279|11656903|FG001|STARTED|Overall Study||27
10506207|NCT01267279|11656902|FG000|COMPLETED|Overall Study||22
10506208|NCT01267279|11656903|FG001|COMPLETED|Overall Study||21
10506209|NCT01267279|11656902|FG000|NOT COMPLETED|Overall Study||2
10506210|NCT01267279|11656903|FG001|NOT COMPLETED|Overall Study||6
10506211|NCT01267292|11656911|FG000|STARTED|Overall Study||24
10506212|NCT01267292|11656912|FG001|STARTED|Overall Study||26
10506213|NCT01267292|11656911|FG000|COMPLETED|Overall Study||20
10506214|NCT01267292|11656912|FG001|COMPLETED|Overall Study||20
10506215|NCT01267292|11656911|FG000|NOT COMPLETED|Overall Study||4
10506216|NCT01267292|11656912|FG001|NOT COMPLETED|Overall Study||6
10506217|NCT01267422|11656918|FG000|STARTED|Intravitreal rAAV2-ND4 Injection||5
10506218|NCT01267422|11656919|FG001|STARTED|Intravitreal rAAV2-ND4 Injection||4
10506219|NCT01267422|11656918|FG000|COMPLETED|Intravitreal rAAV2-ND4 Injection||5
10506220|NCT01267422|11656919|FG001|COMPLETED|Intravitreal rAAV2-ND4 Injection||4
10506221|NCT01267422|11656918|FG000|NOT COMPLETED|Intravitreal rAAV2-ND4 Injection||0
10506222|NCT01267422|11656919|FG001|NOT COMPLETED|Intravitreal rAAV2-ND4 Injection||0
10506223|NCT01267422|11656918|FG000|STARTED|Safety and Efficacy Study||5
10506224|NCT01267422|11656919|FG001|STARTED|Safety and Efficacy Study||4
10506225|NCT01267422|11656918|FG000|COMPLETED|Safety and Efficacy Study||5
10506226|NCT01267422|11656919|FG001|COMPLETED|Safety and Efficacy Study||4
10506227|NCT01267422|11656918|FG000|NOT COMPLETED|Safety and Efficacy Study||0
10506228|NCT01267422|11656919|FG001|NOT COMPLETED|Safety and Efficacy Study||0
10506229|NCT01267656|11656937|FG000|STARTED|Overall Study||83
10506230|NCT01267656|11656938|FG001|STARTED|Overall Study||83
10506231|NCT01267656|11656937|FG000|COMPLETED|Overall Study||82
10506232|NCT01267656|11656938|FG001|COMPLETED|Overall Study||82
10506233|NCT01267656|11656937|FG000|NOT COMPLETED|Overall Study||1
10506234|NCT01267656|11656938|FG001|NOT COMPLETED|Overall Study||1
10506235|NCT01267864|11656947|FG000|STARTED|Overall Study||110
10506236|NCT01267864|11656948|FG001|STARTED|Overall Study||110
10506237|NCT01267864|11656949|FG002|STARTED|Overall Study||110
10506238|NCT01267864|11656947|FG000|COMPLETED|Overall Study||110
10506239|NCT01267864|11656948|FG001|COMPLETED|Overall Study||110
10506240|NCT01267864|11656949|FG002|COMPLETED|Overall Study||110
10506241|NCT01267864|11656947|FG000|NOT COMPLETED|Overall Study||0
10506242|NCT01267864|11656948|FG001|NOT COMPLETED|Overall Study||0
10506243|NCT01267864|11656949|FG002|NOT COMPLETED|Overall Study||0
10506244|NCT01267929|11656959|FG000|STARTED|Overall Study||15
10506245|NCT01267929|11656960|FG001|STARTED|Overall Study||15
10506246|NCT01267929|11656959|FG000|COMPLETED|Overall Study||15
10506247|NCT01267929|11656960|FG001|COMPLETED|Overall Study||15
10506248|NCT01267929|11656959|FG000|NOT COMPLETED|Overall Study||0
10506249|NCT01267929|11656960|FG001|NOT COMPLETED|Overall Study||0
10506250|NCT01267994|11656966|FG000|STARTED|Overall Study|Declined to participate. n=1 Did not receive intervention due to infeciton, n=1|12
10506251|NCT01267994|11656966|FG000|COMPLETED|Overall Study|Excluded from analysis, could not reach first milestone (day 28) for efficacy assessment, n=2|10
10506252|NCT01267994|11656966|FG000|NOT COMPLETED|Overall Study||2
10506253|NCT01268046|11656975|FG000|STARTED|Overall Study||13
10506254|NCT01268046|11656976|FG001|STARTED|Overall Study||9
10506255|NCT01268046|11656977|FG002|STARTED|Overall Study||8
10506256|NCT01268046|11656978|FG003|STARTED|Overall Study||8
10506257|NCT01268046|11656975|FG000|COMPLETED|Overall Study||12
10506258|NCT01268046|11656976|FG001|COMPLETED|Overall Study||9
10506259|NCT01268046|11656977|FG002|COMPLETED|Overall Study||7
10506260|NCT01268046|11656978|FG003|COMPLETED|Overall Study||7
10506261|NCT01268046|11656975|FG000|NOT COMPLETED|Overall Study||1
10506262|NCT01268046|11656976|FG001|NOT COMPLETED|Overall Study||0
10506263|NCT01268046|11656977|FG002|NOT COMPLETED|Overall Study||1
10506264|NCT01268046|11656978|FG003|NOT COMPLETED|Overall Study||1
10506265|NCT01268059|11656992|FG000|STARTED|Overall Study||40
10506266|NCT01268059|11656993|FG001|STARTED|Overall Study|Arm applicable for both dose-determination (Phase 1b) and randomization phase (Phase 2) of study.|45
10506267|NCT01268059|11656994|FG002|STARTED|Overall Study||6
10506268|NCT01268059|11656995|FG003|STARTED|Overall Study||8
10506269|NCT01268059|11656992|FG000|COMPLETED|Overall Study|End of study defined as 14 months from the last participant enrolled, or sponsor stopped the study.|12
10506270|NCT01268059|11656993|FG001|COMPLETED|Overall Study|End of study defined as 14 months from the last participant enrolled, or sponsor stopped the study.|10
10506271|NCT01268059|11656994|FG002|COMPLETED|Overall Study|End of study defined as 14 months from the last participant enrolled, or sponsor stopped the study.|3
10506272|NCT01268059|11656995|FG003|COMPLETED|Overall Study|End of study defined as 14 months from the last participant enrolled, or sponsor stopped the study.|3
10506273|NCT01268059|11656992|FG000|NOT COMPLETED|Overall Study||28
10506274|NCT01268059|11656993|FG001|NOT COMPLETED|Overall Study||35
10506275|NCT01268059|11656994|FG002|NOT COMPLETED|Overall Study||3
10506276|NCT01268059|11656995|FG003|NOT COMPLETED|Overall Study||5
10506277|NCT01268098|11657010|FG000|STARTED|Overall Study||19
10506278|NCT01268098|11657011|FG001|STARTED|Overall Study||23
10506279|NCT01268098|11657010|FG000|COMPLETED|Overall Study||18
10506280|NCT01268098|11657011|FG001|COMPLETED|Overall Study||23
10506281|NCT01268098|11657010|FG000|NOT COMPLETED|Overall Study||1
10506282|NCT01268098|11657011|FG001|NOT COMPLETED|Overall Study||0
10506283|NCT01268111|11657019|FG000|STARTED|Overall Study||6
10506284|NCT01268111|11657020|FG001|STARTED|Overall Study||6
10506285|NCT01268111|11657019|FG000|COMPLETED|Overall Study||6
10506286|NCT01268111|11657020|FG001|COMPLETED|Overall Study||6
10506287|NCT01268111|11657019|FG000|NOT COMPLETED|Overall Study||0
10506288|NCT01268111|11657020|FG001|NOT COMPLETED|Overall Study||0
10506289|NCT01268150|11657026|FG000|STARTED|Treatment Phase||56
10506290|NCT01268150|11657026|FG000|COMPLETED|Treatment Phase||28
10506291|NCT01268150|11657026|FG000|NOT COMPLETED|Treatment Phase||28
10506292|NCT01268150|11657026|FG000|STARTED|Extension Phase|28 participants discontinued study drug in Treatment Phase so did not enter the Extension Phase|28
10506293|NCT01268150|11657026|FG000|Treatment Ongoing at Data Cutoff Date|Extension Phase||1
10506294|NCT01268150|11657026|FG000|COMPLETED|Extension Phase||1
10506295|NCT01268150|11657026|FG000|NOT COMPLETED|Extension Phase||27
10506296|NCT01268189|11657030|FG000|STARTED|Overall Study||20
10506297|NCT01268189|11657030|FG000|COMPLETED|Overall Study||17
10506298|NCT01268189|11657030|FG000|NOT COMPLETED|Overall Study||3
10506299|NCT01268267|11657036|FG000|STARTED|Overall Study||94
10506300|NCT01268267|11657036|FG000|COMPLETED|Overall Study||93
10506301|NCT01268267|11657036|FG000|NOT COMPLETED|Overall Study||1
10506302|NCT01268293|11657041|FG000|STARTED|Overall Study||9
10506303|NCT01268293|11657041|FG000|Completed Cycle 1|Overall Study||9
10506304|NCT01268293|11657041|FG000|COMPLETED|Overall Study||0
10506305|NCT01268293|11657041|FG000|NOT COMPLETED|Overall Study||9
10506306|NCT01268306|11657045|FG000|STARTED|Overall Study||8
10506307|NCT01268306|11657045|FG000|COMPLETED|Overall Study||7
10506308|NCT01268306|11657045|FG000|NOT COMPLETED|Overall Study||1
10506309|NCT01268488|11657049|FG000|STARTED|Overall Study||98
10506310|NCT01268488|11657049|FG000|COMPLETED|Overall Study||93
10506311|NCT01268488|11657049|FG000|NOT COMPLETED|Overall Study||5
10506312|NCT01268501|11657054|FG000|STARTED|Overall Study||96
10506313|NCT01268501|11657054|FG000|COMPLETED|Overall Study||87
10506314|NCT01268501|11657054|FG000|NOT COMPLETED|Overall Study||9
10506315|NCT01268514|11657058|FG000|STARTED|Overall Study||115
10506316|NCT01268514|11657058|FG000|Participants Who Received the Device|Overall Study||114
10506317|NCT01268514|11657058|FG000|COMPLETED|Overall Study||74
10506318|NCT01268514|11657058|FG000|NOT COMPLETED|Overall Study||41
10506319|NCT01268527|11657066|FG000|STARTED|Overall Study||15
10506320|NCT01268527|11657067|FG001|STARTED|Overall Study||15
10506321|NCT01268527|11657066|FG000|COMPLETED|Overall Study||15
10506322|NCT01268527|11657067|FG001|COMPLETED|Overall Study||15
10506323|NCT01268527|11657066|FG000|NOT COMPLETED|Overall Study||0
10506324|NCT01268527|11657067|FG001|NOT COMPLETED|Overall Study||0
10506325|NCT01268553|11657086|FG000|STARTED|Overall Study||6
10506326|NCT01268553|11657086|FG000|COMPLETED|Overall Study||6
10506327|NCT01268553|11657086|FG000|NOT COMPLETED|Overall Study||0
10506328|NCT01268566|11657090|FG000|STARTED|Overall Study||56
10506329|NCT01268566|11657090|FG000|COMPLETED|Overall Study||13
10506330|NCT01268566|11657090|FG000|NOT COMPLETED|Overall Study||43
10506331|NCT01268644|11657094|FG000|STARTED|Baseline Period (Week 0)||8
10506332|NCT01268644|11657094|FG000|COMPLETED|Baseline Period (Week 0)||8
10506333|NCT01268644|11657094|FG000|NOT COMPLETED|Baseline Period (Week 0)||0
10506334|NCT01268644|11657094|FG000|STARTED|Phase A (Weeks 0-12) Leptin Therapy||8
10506335|NCT01268644|11657094|FG000|COMPLETED|Phase A (Weeks 0-12) Leptin Therapy||8
10506336|NCT01268644|11657094|FG000|NOT COMPLETED|Phase A (Weeks 0-12) Leptin Therapy||0
10506478|NCT01270321|11657260|FG000|STARTED|Overall Study||19
10506337|NCT01268644|11657094|FG000|STARTED|Phase B (Weeks 12-20) Leptin Therapy|One subject withdrew after 12 weeks .|7
10506338|NCT01268644|11657094|FG000|COMPLETED|Phase B (Weeks 12-20) Leptin Therapy||7
10506339|NCT01268644|11657094|FG000|NOT COMPLETED|Phase B (Weeks 12-20) Leptin Therapy||0
10506340|NCT01268644|11657094|FG000|STARTED|Phase C (Weeks 20-24) Off Leptin Therapy||7
10506341|NCT01268644|11657094|FG000|COMPLETED|Phase C (Weeks 20-24) Off Leptin Therapy||7
10506342|NCT01268644|11657094|FG000|NOT COMPLETED|Phase C (Weeks 20-24) Off Leptin Therapy||0
10506343|NCT01268683|11657101|FG000|STARTED|Overall Study||10
10506344|NCT01268683|11657101|FG000|COMPLETED|Overall Study||8
10506345|NCT01268683|11657101|FG000|NOT COMPLETED|Overall Study||2
10506346|NCT01268891|11657107|FG000|STARTED|Overall Study||66
10506347|NCT01268891|11657108|FG001|STARTED|Overall Study||66
10506348|NCT01268891|11657107|FG000|COMPLETED|Overall Study||58
10506349|NCT01268891|11657108|FG001|COMPLETED|Overall Study||58
10506350|NCT01268891|11657107|FG000|NOT COMPLETED|Overall Study||8
10506351|NCT01268891|11657108|FG001|NOT COMPLETED|Overall Study||8
10506352|NCT01268943|11657118|FG000|STARTED|Overall Study||6
10506353|NCT01268943|11657119|FG001|STARTED|Overall Study||3
10506354|NCT01268943|11657120|FG002|STARTED|Overall Study||3
10506355|NCT01268943|11657121|FG003|STARTED|Overall Study||6
10506356|NCT01268943|11657118|FG000|COMPLETED|Overall Study||6
10506357|NCT01268943|11657119|FG001|COMPLETED|Overall Study||3
10506358|NCT01268943|11657120|FG002|COMPLETED|Overall Study||3
10506359|NCT01268943|11657121|FG003|COMPLETED|Overall Study||6
10506360|NCT01268943|11657118|FG000|NOT COMPLETED|Overall Study||0
10506361|NCT01268943|11657119|FG001|NOT COMPLETED|Overall Study||0
10506362|NCT01268943|11657120|FG002|NOT COMPLETED|Overall Study||0
10506363|NCT01268943|11657121|FG003|NOT COMPLETED|Overall Study||0
10506364|NCT01269047|11657134|FG000|STARTED|Overall Study||13
10506365|NCT01269047|11657135|FG001|STARTED|Overall Study||13
10506366|NCT01269047|11657136|FG002|STARTED|Overall Study||11
10506367|NCT01269047|11657134|FG000|COMPLETED|Overall Study||12
10506368|NCT01269047|11657135|FG001|COMPLETED|Overall Study||11
10506369|NCT01269047|11657136|FG002|COMPLETED|Overall Study||10
10506370|NCT01269047|11657134|FG000|NOT COMPLETED|Overall Study||1
10506371|NCT01269047|11657135|FG001|NOT COMPLETED|Overall Study||2
10506372|NCT01269047|11657136|FG002|NOT COMPLETED|Overall Study||1
10506373|NCT01269125|11657149|FG000|STARTED|Overall Study||60
10506374|NCT01269125|11657150|FG001|STARTED|Overall Study||60
10506375|NCT01269125|11657151|FG002|STARTED|Overall Study||60
10506376|NCT01269125|11657149|FG000|COMPLETED|Overall Study|lost to follow up:4; OHSS: 2; premature luteinization: 1|53
10506377|NCT01269125|11657150|FG001|COMPLETED|Overall Study|OHSS:4; premature luteinization: 1|55
10506378|NCT01269125|11657151|FG002|COMPLETED|Overall Study||60
10506379|NCT01269125|11657149|FG000|NOT COMPLETED|Overall Study||7
10506380|NCT01269125|11657150|FG001|NOT COMPLETED|Overall Study||5
10506381|NCT01269125|11657151|FG002|NOT COMPLETED|Overall Study||0
10506382|NCT01269346|11657159|FG000|STARTED|Treatment Phase||52
10506383|NCT01269346|11657159|FG000|Completed 6 Cycles|Treatment Phase||45
10506384|NCT01269346|11657159|FG000|COMPLETED|Treatment Phase||43
10506385|NCT01269346|11657159|FG000|NOT COMPLETED|Treatment Phase||9
10506386|NCT01269346|11657159|FG000|STARTED|Extension Phase|Out of 52 participants randomized, only 43 continued into the Extension Phase of the study.|43
10506387|NCT01269346|11657159|FG000|COMPLETED|Extension Phase||0
10506388|NCT01269346|11657159|FG000|NOT COMPLETED|Extension Phase||43
10506389|NCT01269372|11657164|FG000|STARTED|Overall Study||30
10506390|NCT01269372|11657164|FG000|COMPLETED|Overall Study||30
10506391|NCT01269372|11657164|FG000|NOT COMPLETED|Overall Study||0
10506392|NCT01269385|11657173|FG000|STARTED|Overall Study||4
10506393|NCT01269385|11657174|FG001|STARTED|Overall Study||4
10506394|NCT01269385|11657175|FG002|STARTED|Overall Study||6
10506395|NCT01269385|11657176|FG003|STARTED|Overall Study||8
10506396|NCT01269385|11657173|FG000|COMPLETED|Overall Study||3
10506397|NCT01269385|11657174|FG001|COMPLETED|Overall Study||3
10506398|NCT01269385|11657175|FG002|COMPLETED|Overall Study||6
10506399|NCT01269385|11657176|FG003|COMPLETED|Overall Study||8
10506400|NCT01269385|11657173|FG000|NOT COMPLETED|Overall Study||1
10506401|NCT01269385|11657174|FG001|NOT COMPLETED|Overall Study||1
10710930|NCT02654652|11876271|FG000|NOT COMPLETED|Overall Study||1
10710931|NCT02654652|11876272|FG001|NOT COMPLETED|Overall Study||3
10710932|NCT02654691|11876278|FG000|STARTED|Overall Study||63
10710933|NCT02654691|11876278|FG000|COMPLETED|Overall Study||63
10710934|NCT02654691|11876278|FG000|NOT COMPLETED|Overall Study||0
10506402|NCT01269385|11657175|FG002|NOT COMPLETED|Overall Study||0
10506403|NCT01269385|11657176|FG003|NOT COMPLETED|Overall Study||0
10506404|NCT01269710|11657186|FG000|STARTED|Overall Study||4
10506405|NCT01269710|11657186|FG000|Week 12|Overall Study||3
10506406|NCT01269710|11657186|FG000|Week 36|Overall Study||2
10506407|NCT01269710|11657186|FG000|COMPLETED|Overall Study|This refers to Week 52.|1
10506408|NCT01269710|11657186|FG000|NOT COMPLETED|Overall Study||3
10506409|NCT01269736|11657192|FG000|STARTED|Nurses' Knowledge Assessments|873 unique nurses were assessed at 9 hospitals at the initiation of the study.|1585
10506410|NCT01269736|11657193|FG001|STARTED|Nurses' Knowledge Assessments|866 unique nurses were assessed at 8 hospitals at the initiation of the study.|1428
10506411|NCT01269736|11657192|FG000|Baseline Assessment|Nurses' Knowledge Assessments|873 unique nurses, assessed at 9 hospitals.|873
10506412|NCT01269736|11657193|FG001|Baseline Assessment|Nurses' Knowledge Assessments|866 unique nurses, assessed at 8 hospitals.|866
10506413|NCT01269736|11657192|FG000|15 Months Assessment|Nurses' Knowledge Assessments|1108 unique nurses, assessed at 9 hospitals.|1108
10506414|NCT01269736|11657193|FG001|15 Months Assessment|Nurses' Knowledge Assessments|866 unique nurses, assessed at 8 hospitals.|782
10506415|NCT01269736|11657192|FG000|30 Months Assessment|Nurses' Knowledge Assessments|741 unique nurses, assessed at 8 hospitals.|741
10506416|NCT01269736|11657193|FG001|30 Months Assessment|Nurses' Knowledge Assessments|926 unique nurses, assessed at 8 hospitals.|926
10506417|NCT01269736|11657192|FG000|COMPLETED|Nurses' Knowledge Assessments|1585 unique nurses assessed overall (at any time point) by end of study.|1585
10506418|NCT01269736|11657193|FG001|COMPLETED|Nurses' Knowledge Assessments|1428 unique nurses assessed overall (at any time point) by end of study.|1428
10506419|NCT01269736|11657192|FG000|NOT COMPLETED|Nurses' Knowledge Assessments||0
10506420|NCT01269736|11657193|FG001|NOT COMPLETED|Nurses' Knowledge Assessments||0
10506421|NCT01269736|11657192|FG000|STARTED|Patient Quality of Care Assessments|915 unique patients were assessed at 9 hospitals at the initiation of the study.|2299
10506422|NCT01269736|11657193|FG001|STARTED|Patient Quality of Care Assessments|889 unique patients were assessed at 8 hospitals at the initiation of the study.|2288
10506423|NCT01269736|11657192|FG000|Baseline Assessment|Patient Quality of Care Assessments|915 unique patients, assessed at 9 hospitals.|915
10506424|NCT01269736|11657193|FG001|Baseline Assessment|Patient Quality of Care Assessments|889 unique patients, assessed at 8 hospitals.|889
10506425|NCT01269736|11657192|FG000|15 Months Assessment|Patient Quality of Care Assessments|687 unique patients, assessed at 8 hospitals.|687
10506426|NCT01269736|11657193|FG001|15 Months Assessment|Patient Quality of Care Assessments|773 unique patients, assessed at 8 hospitals.|773
10506427|NCT01269736|11657192|FG000|30 Months Assessment|Patient Quality of Care Assessments|697 unique patients, assessed at 8 hospitals.|697
10506428|NCT01269736|11657193|FG001|30 Months Assessment|Patient Quality of Care Assessments|626 unique patients, assessed at 7 hospitals.|626
10506429|NCT01269736|11657192|FG000|COMPLETED|Patient Quality of Care Assessments|2299 unique patients assessed overall (at any time point) by end of study.|2299
10506430|NCT01269736|11657193|FG001|COMPLETED|Patient Quality of Care Assessments|2288 unique patients assessed overall (at any time point) by end of study.|2288
10710935|NCT02654717|11876284|FG000|STARTED|Overall Study||56
10710936|NCT02654717|11876285|FG001|STARTED|Overall Study||55
10710937|NCT02654717|11876284|FG000|COMPLETED|Overall Study||50
10506431|NCT01269736|11657192|FG000|NOT COMPLETED|Patient Quality of Care Assessments||0
10506432|NCT01269736|11657193|FG001|NOT COMPLETED|Patient Quality of Care Assessments||0
10506433|NCT01269736|11657192|FG000|STARTED|Patient Outcomes (Hospital Admissions)|17352 unique patients were assessed at 7 hospitals at the initiation of the study.|52085
10506434|NCT01269736|11657193|FG001|STARTED|Patient Outcomes (Hospital Admissions)|16459 unique patients were assessed at 6 hospitals at the initiation of the study.|43799
10506435|NCT01269736|11657192|FG000|Baseline Assessment|Patient Outcomes (Hospital Admissions)|17352 unique patients, assessed at 7 hospitals.|17352
10506436|NCT01269736|11657193|FG001|Baseline Assessment|Patient Outcomes (Hospital Admissions)|16549 unique patients, assessed at 6 hospitals.|16549
10506437|NCT01269736|11657192|FG000|15 Months Assessment|Patient Outcomes (Hospital Admissions)|18031 unique patients, assessed at 7 hospitals.|18031
10506438|NCT01269736|11657193|FG001|15 Months Assessment|Patient Outcomes (Hospital Admissions)|14075 unique patients, assessed at 6 hospitals.|14075
10506439|NCT01269736|11657192|FG000|30 Months Assessment|Patient Outcomes (Hospital Admissions)|16702 unique patients, assessed at 7 hospitals.|16702
10506440|NCT01269736|11657193|FG001|30 Months Assessment|Patient Outcomes (Hospital Admissions)|13265 unique patients, assessed at 6 hospitals.|13265
10506441|NCT01269736|11657192|FG000|COMPLETED|Patient Outcomes (Hospital Admissions)|52085 unique patients assessed overall (at any time point) by end of study.|52085
10506442|NCT01269736|11657193|FG001|COMPLETED|Patient Outcomes (Hospital Admissions)|43799 unique patients assessed overall (at any time point) by end of study.|43799
10506443|NCT01269736|11657192|FG000|NOT COMPLETED|Patient Outcomes (Hospital Admissions)||0
10506444|NCT01269736|11657193|FG001|NOT COMPLETED|Patient Outcomes (Hospital Admissions)||0
10506445|NCT01269801|11657203|FG000|STARTED|Overall Study||74
10506446|NCT01269801|11657204|FG001|STARTED|Overall Study||80
10506447|NCT01269801|11657203|FG000|COMPLETED|Overall Study||74
10506448|NCT01269801|11657204|FG001|COMPLETED|Overall Study||77
10506449|NCT01269801|11657203|FG000|NOT COMPLETED|Overall Study||0
10506450|NCT01269801|11657204|FG001|NOT COMPLETED|Overall Study||3
10506451|NCT01269918|11657212|FG000|STARTED|Overall Study||71
10506452|NCT01269918|11657213|FG001|STARTED|Overall Study||71
10506453|NCT01269918|11657212|FG000|COMPLETED|Overall Study||71
10506454|NCT01269918|11657213|FG001|COMPLETED|Overall Study||68
10506455|NCT01269918|11657212|FG000|NOT COMPLETED|Overall Study||0
10506456|NCT01269918|11657213|FG001|NOT COMPLETED|Overall Study||3
10506457|NCT01270126|11657221|FG000|STARTED|Overall Study||12
10506458|NCT01270126|11657222|FG001|STARTED|Overall Study||10
10506459|NCT01270126|11657221|FG000|COMPLETED|Overall Study||12
10506460|NCT01270126|11657222|FG001|COMPLETED|Overall Study||10
10506461|NCT01270126|11657221|FG000|NOT COMPLETED|Overall Study||0
10506462|NCT01270126|11657222|FG001|NOT COMPLETED|Overall Study||0
10506463|NCT01270139|11657231|FG000|STARTED|Overall Study|Intention-to-treat population|60
10506464|NCT01270139|11657232|FG001|STARTED|Overall Study|Intention-to-treat population|60
10506465|NCT01270139|11657233|FG002|STARTED|Overall Study|Intention-to-treat population|60
10506466|NCT01270139|11657231|FG000|COMPLETED|Overall Study|Pre-treatment evaluable population|42
10506467|NCT01270139|11657232|FG001|COMPLETED|Overall Study|Pre-treatment evaluable population|34
10506468|NCT01270139|11657233|FG002|COMPLETED|Overall Study|Pre-treatment evaluable population|40
10506469|NCT01270139|11657231|FG000|NOT COMPLETED|Overall Study||18
10506470|NCT01270139|11657232|FG001|NOT COMPLETED|Overall Study||26
10506471|NCT01270139|11657233|FG002|NOT COMPLETED|Overall Study||20
10506472|NCT01270256|11657250|FG000|STARTED|Overall Study||21
10506473|NCT01270256|11657251|FG001|STARTED|Overall Study||20
10506474|NCT01270256|11657250|FG000|COMPLETED|Overall Study||20
10506475|NCT01270256|11657251|FG001|COMPLETED|Overall Study||20
10506476|NCT01270256|11657250|FG000|NOT COMPLETED|Overall Study||1
10506477|NCT01270256|11657251|FG001|NOT COMPLETED|Overall Study||0
10506479|NCT01270321|11657261|FG001|STARTED|Overall Study||11
10506480|NCT01270321|11657262|FG002|STARTED|Overall Study||12
10506481|NCT01270321|11657260|FG000|COMPLETED|Overall Study||9
10506482|NCT01270321|11657261|FG001|COMPLETED|Overall Study||1
10506483|NCT01270321|11657262|FG002|COMPLETED|Overall Study||3
10506484|NCT01270321|11657260|FG000|NOT COMPLETED|Overall Study||10
10506485|NCT01270321|11657261|FG001|NOT COMPLETED|Overall Study||10
10506486|NCT01270321|11657262|FG002|NOT COMPLETED|Overall Study||9
10506487|NCT01270464|11657273|FG000|STARTED|Overall Study||105
10506488|NCT01270464|11657274|FG001|STARTED|Overall Study||104
10506489|NCT01270464|11657275|FG002|STARTED|Overall Study||106
10506490|NCT01270464|11657273|FG000|Safety Analysis Set|Overall Study||105
10506491|NCT01270464|11657274|FG001|Safety Analysis Set|Overall Study||103
10506492|NCT01270464|11657275|FG002|Safety Analysis Set|Overall Study||103
10506493|NCT01270464|11657273|FG000|Full Analysis Set|Overall Study||105
10506494|NCT01270464|11657274|FG001|Full Analysis Set|Overall Study||103
10506495|NCT01270464|11657275|FG002|Full Analysis Set|Overall Study||103
10506496|NCT01270464|11657273|FG000|Pharmacokinetic Analysis Set|Overall Study||105
10506497|NCT01270464|11657274|FG001|Pharmacokinetic Analysis Set|Overall Study||103
10506498|NCT01270464|11657275|FG002|Pharmacokinetic Analysis Set|Overall Study||103
10506499|NCT01270464|11657273|FG000|COMPLETED|Overall Study||85
10506500|NCT01270464|11657274|FG001|COMPLETED|Overall Study||92
10506501|NCT01270464|11657275|FG002|COMPLETED|Overall Study||88
10506502|NCT01270464|11657273|FG000|NOT COMPLETED|Overall Study||20
10506503|NCT01270464|11657274|FG001|NOT COMPLETED|Overall Study||12
10506504|NCT01270464|11657275|FG002|NOT COMPLETED|Overall Study||18
10528291|NCT01394003|11680557|FG005|STARTED|Overall Study||3
10528292|NCT01394003|11680558|FG006|STARTED|Overall Study||6
10528293|NCT01394003|11680559|FG007|STARTED|Overall Study||2
10548416|NCT01519414|11702217|FG000|NOT COMPLETED|Pre Cross-over||0
10506505|NCT01270503|11657283|FG000|STARTED|Overall Study||538
10506506|NCT01270503|11657283|FG000|COMPLETED|Overall Study||537
10506507|NCT01270503|11657283|FG000|NOT COMPLETED|Overall Study||1
10506508|NCT01270516|11657292|FG000|STARTED|Overall Study||20
10506509|NCT01270516|11657293|FG001|STARTED|Overall Study||17
10506510|NCT01270516|11657294|FG002|STARTED|Overall Study||18
10506511|NCT01270516|11657295|FG003|STARTED|Overall Study||18
10506512|NCT01270516|11657292|FG000|COMPLETED|Overall Study||17
10506513|NCT01270516|11657293|FG001|COMPLETED|Overall Study||13
10506514|NCT01270516|11657294|FG002|COMPLETED|Overall Study||13
10506515|NCT01270516|11657295|FG003|COMPLETED|Overall Study||13
10506516|NCT01270516|11657292|FG000|NOT COMPLETED|Overall Study||3
10506517|NCT01270516|11657293|FG001|NOT COMPLETED|Overall Study||4
10506518|NCT01270516|11657294|FG002|NOT COMPLETED|Overall Study||5
10506519|NCT01270516|11657295|FG003|NOT COMPLETED|Overall Study||5
10506520|NCT01270529|11657308|FG000|STARTED|Overall Study||12
10506521|NCT01270529|11657309|FG001|STARTED|Overall Study||7
10506522|NCT01270529|11657310|FG002|STARTED|Overall Study||25
10506523|NCT01270529|11657308|FG000|COMPLETED|Overall Study||12
10506524|NCT01270529|11657309|FG001|COMPLETED|Overall Study||7
10506525|NCT01270529|11657310|FG002|COMPLETED|Overall Study||25
10506526|NCT01270529|11657308|FG000|NOT COMPLETED|Overall Study||0
10506527|NCT01270529|11657309|FG001|NOT COMPLETED|Overall Study||0
10506528|NCT01270529|11657310|FG002|NOT COMPLETED|Overall Study||0
10506529|NCT01270542|11657320|FG000|STARTED|Overall Study||10
10506530|NCT01270542|11657321|FG001|STARTED|Overall Study||9
10506531|NCT01270542|11657320|FG000|COMPLETED|Overall Study||9
10506532|NCT01270542|11657321|FG001|COMPLETED|Overall Study||8
10506533|NCT01270542|11657320|FG000|NOT COMPLETED|Overall Study||1
10506534|NCT01270542|11657321|FG001|NOT COMPLETED|Overall Study||1
10506535|NCT01270555|11657327|FG000|STARTED|Overall Study||32
10506536|NCT01270555|11657327|FG000|COMPLETED|Overall Study||19
10506537|NCT01270555|11657327|FG000|NOT COMPLETED|Overall Study||13
10506538|NCT01270620|11657333|FG000|STARTED|Overall Study||50
10506539|NCT01270620|11657334|FG001|STARTED|Overall Study||50
10506540|NCT01270620|11657333|FG000|COMPLETED|Overall Study||49
10506541|NCT01270620|11657334|FG001|COMPLETED|Overall Study||47
10506542|NCT01270620|11657333|FG000|NOT COMPLETED|Overall Study||1
10506543|NCT01270620|11657334|FG001|NOT COMPLETED|Overall Study||3
10506544|NCT01270659|11657350|FG000|STARTED|Overall Study||6
10506545|NCT01270659|11657351|FG001|STARTED|Overall Study||25
10506546|NCT01270659|11657352|FG002|STARTED|Overall Study||4
10506547|NCT01270659|11657353|FG003|STARTED|Overall Study||25
10506548|NCT01270659|11657350|FG000|COMPLETED|Overall Study||6
10506549|NCT01270659|11657351|FG001|COMPLETED|Overall Study||25
10506550|NCT01270659|11657352|FG002|COMPLETED|Overall Study||4
10506551|NCT01270659|11657353|FG003|COMPLETED|Overall Study||25
10506552|NCT01270659|11657350|FG000|NOT COMPLETED|Overall Study||0
10506553|NCT01270659|11657351|FG001|NOT COMPLETED|Overall Study||0
10506554|NCT01270659|11657352|FG002|NOT COMPLETED|Overall Study||0
10506555|NCT01270659|11657353|FG003|NOT COMPLETED|Overall Study||0
10506556|NCT01270711|11657371|FG000|STARTED|Part 1: Compliance||7537
10506557|NCT01270711|11657372|FG001|STARTED|Part 1: Compliance||6580
10506558|NCT01270711|11657373|FG002|STARTED|Part 1: Compliance||326
10506559|NCT01270711|11657374|FG003|STARTED|Part 1: Compliance||5486
10506560|NCT01270711|11657375|FG004|STARTED|Part 1: Compliance||2024
10506561|NCT01270711|11657376|FG005|STARTED|Part 1: Compliance||0
10506562|NCT01270711|11657377|FG006|STARTED|Part 1: Compliance||0
10506563|NCT01270711|11657378|FG007|STARTED|Part 1: Compliance||0
10506564|NCT01270711|11657371|FG000|COMPLETED|Part 1: Compliance||7537
10506565|NCT01270711|11657372|FG001|COMPLETED|Part 1: Compliance||6580
10506566|NCT01270711|11657373|FG002|COMPLETED|Part 1: Compliance||326
10506567|NCT01270711|11657374|FG003|COMPLETED|Part 1: Compliance||5486
10506568|NCT01270711|11657375|FG004|COMPLETED|Part 1: Compliance||2024
10506569|NCT01270711|11657376|FG005|COMPLETED|Part 1: Compliance||0
10506570|NCT01270711|11657377|FG006|COMPLETED|Part 1: Compliance||0
10506571|NCT01270711|11657378|FG007|COMPLETED|Part 1: Compliance||0
10506572|NCT01270711|11657371|FG000|NOT COMPLETED|Part 1: Compliance||0
10506573|NCT01270711|11657372|FG001|NOT COMPLETED|Part 1: Compliance||0
10506574|NCT01270711|11657373|FG002|NOT COMPLETED|Part 1: Compliance||0
10506575|NCT01270711|11657374|FG003|NOT COMPLETED|Part 1: Compliance||0
10506576|NCT01270711|11657375|FG004|NOT COMPLETED|Part 1: Compliance||0
10506577|NCT01270711|11657376|FG005|NOT COMPLETED|Part 1: Compliance||0
10506578|NCT01270711|11657377|FG006|NOT COMPLETED|Part 1: Compliance||0
10506579|NCT01270711|11657378|FG007|NOT COMPLETED|Part 1: Compliance||0
10506580|NCT01270711|11657371|FG000|STARTED|Part 2: Effectiveness||0
10506581|NCT01270711|11657372|FG001|STARTED|Part 2: Effectiveness||0
10506582|NCT01270711|11657373|FG002|STARTED|Part 2: Effectiveness||0
10506583|NCT01270711|11657374|FG003|STARTED|Part 2: Effectiveness||0
10506584|NCT01270711|11657375|FG004|STARTED|Part 2: Effectiveness||0
10506585|NCT01270711|11657376|FG005|STARTED|Part 2: Effectiveness||11
10506586|NCT01270711|11657377|FG006|STARTED|Part 2: Effectiveness||2
10506587|NCT01270711|11657378|FG007|STARTED|Part 2: Effectiveness||48
10506588|NCT01270711|11657371|FG000|COMPLETED|Part 2: Effectiveness||0
10506589|NCT01270711|11657372|FG001|COMPLETED|Part 2: Effectiveness||0
10506590|NCT01270711|11657373|FG002|COMPLETED|Part 2: Effectiveness||0
10506591|NCT01270711|11657374|FG003|COMPLETED|Part 2: Effectiveness||0
10506592|NCT01270711|11657375|FG004|COMPLETED|Part 2: Effectiveness||0
10506593|NCT01270711|11657376|FG005|COMPLETED|Part 2: Effectiveness||11
10506594|NCT01270711|11657377|FG006|COMPLETED|Part 2: Effectiveness||2
10506595|NCT01270711|11657378|FG007|COMPLETED|Part 2: Effectiveness||48
10506596|NCT01270711|11657371|FG000|NOT COMPLETED|Part 2: Effectiveness||0
10506597|NCT01270711|11657372|FG001|NOT COMPLETED|Part 2: Effectiveness||0
10506598|NCT01270711|11657373|FG002|NOT COMPLETED|Part 2: Effectiveness||0
10506599|NCT01270711|11657374|FG003|NOT COMPLETED|Part 2: Effectiveness||0
10506600|NCT01270711|11657375|FG004|NOT COMPLETED|Part 2: Effectiveness||0
10506601|NCT01270711|11657376|FG005|NOT COMPLETED|Part 2: Effectiveness||0
10506602|NCT01270711|11657377|FG006|NOT COMPLETED|Part 2: Effectiveness||0
10506603|NCT01270711|11657378|FG007|NOT COMPLETED|Part 2: Effectiveness||0
10506604|NCT01270802|11657399|FG000|STARTED|Overall Study||15
10506605|NCT01270802|11657400|FG001|STARTED|Overall Study||15
10506606|NCT01270802|11657399|FG000|COMPLETED|Overall Study||13
10506607|NCT01270802|11657400|FG001|COMPLETED|Overall Study||14
10506608|NCT01270802|11657399|FG000|NOT COMPLETED|Overall Study||2
10506609|NCT01270802|11657400|FG001|NOT COMPLETED|Overall Study||1
10506610|NCT01270828|11657409|FG000|STARTED|Pregabalin CR SB||0
10506611|NCT01270828|11657410|FG001|STARTED|Pregabalin CR SB||0
10506612|NCT01270828|11657411|FG002|STARTED|Pregabalin CR SB||806
10506613|NCT01270828|11657409|FG000|COMPLETED|Pregabalin CR SB||0
10506614|NCT01270828|11657410|FG001|COMPLETED|Pregabalin CR SB||0
10506615|NCT01270828|11657411|FG002|COMPLETED|Pregabalin CR SB||660
10506616|NCT01270828|11657409|FG000|NOT COMPLETED|Pregabalin CR SB||0
10506617|NCT01270828|11657410|FG001|NOT COMPLETED|Pregabalin CR SB||0
10506618|NCT01270828|11657411|FG002|NOT COMPLETED|Pregabalin CR SB||146
10506619|NCT01270828|11657409|FG000|STARTED|Double Blind Phase||208
10506620|NCT01270828|11657410|FG001|STARTED|Double Blind Phase||205
10506621|NCT01270828|11657411|FG002|STARTED|Double Blind Phase||0
10506622|NCT01270828|11657409|FG000|COMPLETED|Double Blind Phase||182
10506623|NCT01270828|11657410|FG001|COMPLETED|Double Blind Phase||160
10506624|NCT01270828|11657411|FG002|COMPLETED|Double Blind Phase||0
10506625|NCT01270828|11657409|FG000|NOT COMPLETED|Double Blind Phase||26
10506626|NCT01270828|11657410|FG001|NOT COMPLETED|Double Blind Phase||45
10506627|NCT01270828|11657411|FG002|NOT COMPLETED|Double Blind Phase||0
10506628|NCT01270841|11657423|FG000|STARTED|Overall Study||29
10506629|NCT01270841|11657424|FG001|STARTED|Overall Study||33
10506630|NCT01270841|11657425|FG002|STARTED|Overall Study||29
10506631|NCT01270841|11657426|FG003|STARTED|Overall Study||33
10506632|NCT01270841|11657423|FG000|COMPLETED|Overall Study||16
10506633|NCT01270841|11657424|FG001|COMPLETED|Overall Study||19
10506634|NCT01270841|11657425|FG002|COMPLETED|Overall Study||18
10506635|NCT01270841|11657426|FG003|COMPLETED|Overall Study||20
10506636|NCT01270841|11657423|FG000|NOT COMPLETED|Overall Study||13
10506637|NCT01270841|11657424|FG001|NOT COMPLETED|Overall Study||14
10506638|NCT01270841|11657425|FG002|NOT COMPLETED|Overall Study||11
10506639|NCT01270841|11657426|FG003|NOT COMPLETED|Overall Study||13
10506640|NCT01270867|11657438|FG000|STARTED|Overall Study||90
10506641|NCT01270867|11657439|FG001|STARTED|Overall Study||88
10506642|NCT01270867|11657438|FG000|COMPLETED|Overall Study||89
10506643|NCT01270867|11657439|FG001|COMPLETED|Overall Study||88
10506644|NCT01270867|11657438|FG000|NOT COMPLETED|Overall Study||1
10506645|NCT01270867|11657439|FG001|NOT COMPLETED|Overall Study||0
10506646|NCT01270880|11657445|FG000|STARTED|Overall Study||18
10506647|NCT01270880|11657445|FG000|COMPLETED|Overall Study||17
10506648|NCT01270880|11657445|FG000|NOT COMPLETED|Overall Study||1
10506649|NCT01270958|11657449|FG000|STARTED|Overall Study||60
10506650|NCT01270958|11657449|FG000|COMPLETED|Overall Study||56
10506651|NCT01270958|11657449|FG000|NOT COMPLETED|Overall Study||4
10506652|NCT01270971|11657455|FG000|STARTED|Overall Study||400
10506653|NCT01270971|11657456|FG001|STARTED|Overall Study||194
10506654|NCT01270971|11657455|FG000|COMPLETED|Overall Study||348
10506655|NCT01270971|11657456|FG001|COMPLETED|Overall Study||171
10506656|NCT01270971|11657455|FG000|NOT COMPLETED|Overall Study||52
10506657|NCT01270971|11657456|FG001|NOT COMPLETED|Overall Study||23
10506658|NCT01271010|11657462|FG000|STARTED|Overall Study||89
10506659|NCT01271010|11657462|FG000|COMPLETED|Overall Study||28
10506660|NCT01271010|11657462|FG000|NOT COMPLETED|Overall Study||61
10506661|NCT01271036|11657468|FG000|STARTED|Overall Study||62
10506662|NCT01271036|11657469|FG001|STARTED|Overall Study||62
10506663|NCT01271036|11657468|FG000|COMPLETED|Overall Study||62
10506664|NCT01271036|11657469|FG001|COMPLETED|Overall Study||62
10506665|NCT01271036|11657468|FG000|NOT COMPLETED|Overall Study||0
10506666|NCT01271036|11657469|FG001|NOT COMPLETED|Overall Study||0
10506667|NCT01271244|11657477|FG000|STARTED|Overall Study||18
10506668|NCT01271244|11657478|FG001|STARTED|Overall Study||8
10506669|NCT01271244|11657477|FG000|COMPLETED|Overall Study||11
10506670|NCT01271244|11657478|FG001|COMPLETED|Overall Study||5
10506671|NCT01271244|11657477|FG000|NOT COMPLETED|Overall Study||7
10506672|NCT01271244|11657478|FG001|NOT COMPLETED|Overall Study||3
10506673|NCT01271413|11657486|FG000|STARTED|Overall Study||37
10506674|NCT01271413|11657487|FG001|STARTED|Overall Study||36
10506675|NCT01271413|11657486|FG000|COMPLETED|Overall Study||28
10506676|NCT01271413|11657487|FG001|COMPLETED|Overall Study||28
10506677|NCT01271413|11657486|FG000|NOT COMPLETED|Overall Study||9
10506678|NCT01271413|11657487|FG001|NOT COMPLETED|Overall Study||8
10506679|NCT01271452|11657495|FG000|STARTED|Overall Study||112
10506680|NCT01271452|11657496|FG001|STARTED|Overall Study||112
10506681|NCT01271452|11657495|FG000|COMPLETED|Overall Study||105
10506682|NCT01271452|11657496|FG001|COMPLETED|Overall Study||104
10506683|NCT01271452|11657495|FG000|NOT COMPLETED|Overall Study||7
10506684|NCT01271452|11657496|FG001|NOT COMPLETED|Overall Study||8
10506685|NCT01271504|11657506|FG000|STARTED|Overall Study||7
10506686|NCT01271504|11657507|FG001|STARTED|Overall Study||8
10506687|NCT01271504|11657508|FG002|STARTED|Overall Study||44
10506688|NCT01271504|11657509|FG003|STARTED|Overall Study||43
10506689|NCT01271504|11657506|FG000|Treated|Overall Study||7
10506690|NCT01271504|11657507|FG001|Treated|Overall Study||7
10506691|NCT01271504|11657508|FG002|Treated|Overall Study||42
10506692|NCT01271504|11657509|FG003|Treated|Overall Study||42
10506693|NCT01271504|11657506|FG000|COMPLETED|Overall Study||0
10506694|NCT01271504|11657507|FG001|COMPLETED|Overall Study||0
10506695|NCT01271504|11657508|FG002|COMPLETED|Overall Study||0
10506696|NCT01271504|11657509|FG003|COMPLETED|Overall Study||0
10506697|NCT01271504|11657506|FG000|NOT COMPLETED|Overall Study||7
10506698|NCT01271504|11657507|FG001|NOT COMPLETED|Overall Study||8
10506699|NCT01271504|11657508|FG002|NOT COMPLETED|Overall Study||44
10506700|NCT01271504|11657509|FG003|NOT COMPLETED|Overall Study||43
10506701|NCT01271543|11657531|FG000|STARTED|Overall Study||30
10506702|NCT01271543|11657532|FG001|STARTED|Overall Study||30
10506703|NCT01271543|11657531|FG000|COMPLETED|Overall Study||29
10506704|NCT01271543|11657532|FG001|COMPLETED|Overall Study||29
10506705|NCT01271543|11657531|FG000|NOT COMPLETED|Overall Study||1
10506706|NCT01271543|11657532|FG001|NOT COMPLETED|Overall Study||1
10506707|NCT01271686|11657539|FG000|STARTED|Overall Study||16
10506708|NCT01271686|11657539|FG000|COMPLETED|Overall Study||16
10506709|NCT01271686|11657539|FG000|NOT COMPLETED|Overall Study||0
10506710|NCT01271712|11657545|FG000|STARTED|Double Blind Treatment||133
10506711|NCT01271712|11657546|FG001|STARTED|Double Blind Treatment||66
10506712|NCT01271712|11657545|FG000|Participants Received Treatment|Double Blind Treatment||132
10506713|NCT01271712|11657546|FG001|Participants Received Treatment|Double Blind Treatment||66
10506714|NCT01271712|11657545|FG000|COMPLETED|Double Blind Treatment|91 participants started open-label treatment with regorafenib|91
10506715|NCT01271712|11657546|FG001|COMPLETED|Double Blind Treatment|58 participants started open-label treatment with regorafenib|58
10506716|NCT01271712|11657545|FG000|NOT COMPLETED|Double Blind Treatment||42
10506717|NCT01271712|11657546|FG001|NOT COMPLETED|Double Blind Treatment||8
10506718|NCT01271712|11657545|FG000|STARTED|Open Label Treatment||91
10506719|NCT01271712|11657546|FG001|STARTED|Open Label Treatment||58
10506720|NCT01271712|11657545|FG000|COMPLETED|Open Label Treatment||0
10506721|NCT01271712|11657546|FG001|COMPLETED|Open Label Treatment||0
10506722|NCT01271712|11657545|FG000|NOT COMPLETED|Open Label Treatment||91
10506723|NCT01271712|11657546|FG001|NOT COMPLETED|Open Label Treatment||58
10506724|NCT01271712|11657545|FG000|STARTED|Safety Follow-up|All participants who discontinued study drug entered 30-day Safety Follow-up|118
10506725|NCT01271712|11657546|FG001|STARTED|Safety Follow-up|All participants who discontinued study drug entered 30-day Safety Follow-up|52
10506726|NCT01271712|11657545|FG000|COMPLETED|Safety Follow-up||97
10506727|NCT01271712|11657546|FG001|COMPLETED|Safety Follow-up||37
10506728|NCT01271712|11657545|FG000|NOT COMPLETED|Safety Follow-up||21
10506729|NCT01271712|11657546|FG001|NOT COMPLETED|Safety Follow-up||15
10506730|NCT01271712|11657545|FG000|STARTED|Survival Follow-up|All participants entered Survival Follow-up immediately after safety follow-up|100
10506731|NCT01271712|11657546|FG001|STARTED|Survival Follow-up|All participants entered Survival Follow-up immediately after safety follow-up|39
10506732|NCT01271712|11657545|FG000|COMPLETED|Survival Follow-up|85 participants died and completed survival follow-up.|85
10506733|NCT01271712|11657546|FG001|COMPLETED|Survival Follow-up|33 participants died and completed survival follow-up.|33
10506734|NCT01271712|11657545|FG000|NOT COMPLETED|Survival Follow-up||15
10506735|NCT01271712|11657546|FG001|NOT COMPLETED|Survival Follow-up||6
10506736|NCT01271725|11657555|FG000|STARTED|Part A|Started are the treated patients|74
10506737|NCT01271725|11657556|FG001|STARTED|Part A||0
10506738|NCT01271725|11657555|FG000|COMPLETED|Part A||39
10506739|NCT01271725|11657556|FG001|COMPLETED|Part A||0
10506740|NCT01271725|11657555|FG000|NOT COMPLETED|Part A||35
10506741|NCT01271725|11657556|FG001|NOT COMPLETED|Part A||0
10506742|NCT01271725|11657555|FG000|STARTED|Part B||0
10506743|NCT01271725|11657556|FG001|STARTED|Part B||39
10506744|NCT01271725|11657555|FG000|COMPLETED|Part B||0
10506745|NCT01271725|11657556|FG001|COMPLETED|Part B|Patient deemed to have completed the trial once they showed progressive disease according to RECIST|27
10506746|NCT01271725|11657555|FG000|NOT COMPLETED|Part B||0
10506747|NCT01271725|11657556|FG001|NOT COMPLETED|Part B||12
10506748|NCT01271803|11657568|FG000|STARTED|Overall Study||66
10506749|NCT01271803|11657569|FG001|STARTED|Overall Study||63
10506750|NCT01271803|11657570|FG002|STARTED|Overall Study||2
10506751|NCT01271803|11657568|FG000|COMPLETED|Overall Study||11
10506752|NCT01271803|11657569|FG001|COMPLETED|Overall Study||24
10506753|NCT01271803|11657570|FG002|COMPLETED|Overall Study||0
10506754|NCT01271803|11657568|FG000|NOT COMPLETED|Overall Study||55
10506755|NCT01271803|11657569|FG001|NOT COMPLETED|Overall Study||39
10506756|NCT01271803|11657570|FG002|NOT COMPLETED|Overall Study||2
10506757|NCT01271855|11657617|FG000|STARTED|Overall Study||48
10506758|NCT01271855|11657618|FG001|STARTED|Overall Study||52
10506759|NCT01271855|11657617|FG000|COMPLETED|Overall Study||48
10506760|NCT01271855|11657618|FG001|COMPLETED|Overall Study||52
10506761|NCT01271855|11657617|FG000|NOT COMPLETED|Overall Study||0
10506762|NCT01271855|11657618|FG001|NOT COMPLETED|Overall Study||0
10506763|NCT01271868|11657624|FG000|STARTED|Pharmacokinetic Study||9
10506764|NCT01271868|11657624|FG000|COMPLETED|Pharmacokinetic Study||9
10506765|NCT01271868|11657624|FG000|NOT COMPLETED|Pharmacokinetic Study||0
10506766|NCT01271868|11657624|FG000|STARTED|Treatment Study||9
10506767|NCT01271868|11657624|FG000|COMPLETED|Treatment Study||9
10506768|NCT01271868|11657624|FG000|NOT COMPLETED|Treatment Study||0
10506769|NCT01271907|11657633|FG000|STARTED|Overall Study||3
10506770|NCT01271907|11657634|FG001|STARTED|Overall Study||0
10506771|NCT01271907|11657635|FG002|STARTED|Overall Study||0
10506772|NCT01271907|11657633|FG000|COMPLETED|Overall Study||3
10506773|NCT01271907|11657634|FG001|COMPLETED|Overall Study||0
10506774|NCT01271907|11657635|FG002|COMPLETED|Overall Study||0
10506775|NCT01271907|11657633|FG000|NOT COMPLETED|Overall Study||0
10506776|NCT01271907|11657634|FG001|NOT COMPLETED|Overall Study||0
10506777|NCT01271907|11657635|FG002|NOT COMPLETED|Overall Study||0
10506778|NCT01271933|11657643|FG000|STARTED|Single-Blind Phase||441
10506779|NCT01271933|11657644|FG001|STARTED|Single-Blind Phase||0
10506780|NCT01271933|11657645|FG002|STARTED|Single-Blind Phase||0
10506781|NCT01271933|11657643|FG000|COMPLETED|Single-Blind Phase||320
10506782|NCT01271933|11657644|FG001|COMPLETED|Single-Blind Phase||0
10506783|NCT01271933|11657645|FG002|COMPLETED|Single-Blind Phase||0
10506784|NCT01271933|11657643|FG000|NOT COMPLETED|Single-Blind Phase||121
10506785|NCT01271933|11657644|FG001|NOT COMPLETED|Single-Blind Phase||0
10506786|NCT01271933|11657645|FG002|NOT COMPLETED|Single-Blind Phase||0
10506787|NCT01271933|11657643|FG000|STARTED|Double-Blind Phase||0
10506788|NCT01271933|11657644|FG001|STARTED|Double-Blind Phase||63
10506789|NCT01271933|11657645|FG002|STARTED|Double-Blind Phase||59
10506790|NCT01271933|11657643|FG000|Treated|Double-Blind Phase||0
10506791|NCT01271933|11657644|FG001|Treated|Double-Blind Phase||63
10506792|NCT01271933|11657645|FG002|Treated|Double-Blind Phase||58
10506793|NCT01271933|11657643|FG000|COMPLETED|Double-Blind Phase||0
10506794|NCT01271933|11657644|FG001|COMPLETED|Double-Blind Phase||46
10506795|NCT01271933|11657645|FG002|COMPLETED|Double-Blind Phase||47
10506796|NCT01271933|11657643|FG000|NOT COMPLETED|Double-Blind Phase||0
10506797|NCT01271933|11657644|FG001|NOT COMPLETED|Double-Blind Phase||17
10506798|NCT01271933|11657645|FG002|NOT COMPLETED|Double-Blind Phase||12
10506799|NCT01271946|11657657|FG000|STARTED|Overall Study||346
10506800|NCT01271946|11657658|FG001|STARTED|Overall Study||5
10506801|NCT01271946|11657657|FG000|COMPLETED|Overall Study||346
10506802|NCT01271946|11657658|FG001|COMPLETED|Overall Study||5
10506803|NCT01271946|11657657|FG000|NOT COMPLETED|Overall Study||0
10506804|NCT01271946|11657658|FG001|NOT COMPLETED|Overall Study||0
10506805|NCT01272011|11657681|FG000|STARTED|Overall Study||3
10506806|NCT01272011|11657682|FG001|STARTED|Overall Study||10
10506807|NCT01272011|11657683|FG002|STARTED|Overall Study||3
10506808|NCT01272011|11657681|FG000|COMPLETED|Overall Study||3
10506809|NCT01272011|11657682|FG001|COMPLETED|Overall Study||8
10506810|NCT01272011|11657683|FG002|COMPLETED|Overall Study||3
10506811|NCT01272011|11657681|FG000|NOT COMPLETED|Overall Study||0
10506812|NCT01272011|11657682|FG001|NOT COMPLETED|Overall Study||2
10506813|NCT01272011|11657683|FG002|NOT COMPLETED|Overall Study||0
10506814|NCT01272076|11657691|FG000|STARTED|Overall Study||52
10506815|NCT01272076|11657691|FG000|COMPLETED|Overall Study||52
10506816|NCT01272076|11657691|FG000|NOT COMPLETED|Overall Study||0
10506817|NCT01272180|11657699|FG000|STARTED|Overall Study||120
10506818|NCT01272180|11657700|FG001|STARTED|Overall Study||121
10506819|NCT01272180|11657701|FG002|STARTED|Overall Study||122
10506820|NCT01272180|11657702|FG003|STARTED|Overall Study||121
10506821|NCT01272180|11657699|FG000|COMPLETED|Overall Study||103
10710938|NCT02654717|11876285|FG001|COMPLETED|Overall Study||50
10710939|NCT02654717|11876284|FG000|NOT COMPLETED|Overall Study||6
10710940|NCT02654717|11876285|FG001|NOT COMPLETED|Overall Study||5
10506822|NCT01272180|11657700|FG001|COMPLETED|Overall Study||100
10506823|NCT01272180|11657701|FG002|COMPLETED|Overall Study||109
10506824|NCT01272180|11657702|FG003|COMPLETED|Overall Study||107
10506825|NCT01272180|11657699|FG000|NOT COMPLETED|Overall Study||17
10506826|NCT01272180|11657700|FG001|NOT COMPLETED|Overall Study||21
10506827|NCT01272180|11657701|FG002|NOT COMPLETED|Overall Study||13
10506828|NCT01272180|11657702|FG003|NOT COMPLETED|Overall Study||14
10506829|NCT01272193|11657718|FG000|STARTED|Overall Study||147
10506830|NCT01272193|11657719|FG001|STARTED|Overall Study||149
10506831|NCT01272193|11657718|FG000|COMPLETED|Overall Study||137
10506832|NCT01272193|11657719|FG001|COMPLETED|Overall Study||137
10506833|NCT01272193|11657718|FG000|NOT COMPLETED|Overall Study||10
10710941|NCT02654769|11876294|FG000|STARTED|Overall Study||149
10506834|NCT01272193|11657719|FG001|NOT COMPLETED|Overall Study||12
10506835|NCT01272219|11657729|FG000|STARTED|Main Period: Week 0 to Week 56||959
10506836|NCT01272219|11657730|FG001|STARTED|Main Period: Week 0 to Week 56|This arm is not considered for main period as these subjects belong to re-randomised period|0
10506837|NCT01272219|11657731|FG002|STARTED|Main Period: Week 0 to Week 56|This arm is not considered for main period as these subjects belong to re-randomised period|0
10506838|NCT01272219|11657732|FG003|STARTED|Main Period: Week 0 to Week 56||487
10506839|NCT01272219|11657733|FG004|STARTED|Main Period: Week 0 to Week 56||1528
10710942|NCT02654769|11876295|FG001|STARTED|Overall Study||149
10710943|NCT02654769|11876296|FG002|STARTED|Overall Study||143
10710944|NCT02654769|11876294|FG000|COMPLETED|Overall Study||145
10710945|NCT02654769|11876295|FG001|COMPLETED|Overall Study||148
10506840|NCT01272219|11657734|FG005|STARTED|Main Period: Week 0 to Week 56||757
10506841|NCT01272219|11657729|FG000|Exposed|Main Period: Week 0 to Week 56||957
10506842|NCT01272219|11657730|FG001|Exposed|Main Period: Week 0 to Week 56||0
10506843|NCT01272219|11657731|FG002|Exposed|Main Period: Week 0 to Week 56||0
10506844|NCT01272219|11657732|FG003|Exposed|Main Period: Week 0 to Week 56||487
10506845|NCT01272219|11657733|FG004|Exposed|Main Period: Week 0 to Week 56||1524
10506846|NCT01272219|11657734|FG005|Exposed|Main Period: Week 0 to Week 56||755
10506847|NCT01272219|11657729|FG000|COMPLETED|Main Period: Week 0 to Week 56||679
10506848|NCT01272219|11657730|FG001|COMPLETED|Main Period: Week 0 to Week 56||0
10710946|NCT02654769|11876296|FG002|COMPLETED|Overall Study||142
10710947|NCT02654769|11876294|FG000|NOT COMPLETED|Overall Study||4
10710948|NCT02654769|11876295|FG001|NOT COMPLETED|Overall Study||1
10506849|NCT01272219|11657731|FG002|COMPLETED|Main Period: Week 0 to Week 56||0
10506850|NCT01272219|11657732|FG003|COMPLETED|Main Period: Week 0 to Week 56||296
10506851|NCT01272219|11657733|FG004|COMPLETED|Main Period: Week 0 to Week 56||1110
10506852|NCT01272219|11657734|FG005|COMPLETED|Main Period: Week 0 to Week 56||505
10506853|NCT01272219|11657729|FG000|NOT COMPLETED|Main Period: Week 0 to Week 56||280
10506854|NCT01272219|11657730|FG001|NOT COMPLETED|Main Period: Week 0 to Week 56||0
10506855|NCT01272219|11657731|FG002|NOT COMPLETED|Main Period: Week 0 to Week 56||0
10506856|NCT01272219|11657732|FG003|NOT COMPLETED|Main Period: Week 0 to Week 56||191
10506857|NCT01272219|11657733|FG004|NOT COMPLETED|Main Period: Week 0 to Week 56||418
10506858|NCT01272219|11657734|FG005|NOT COMPLETED|Main Period: Week 0 to Week 56||252
10506859|NCT01272219|11657729|FG000|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
10506860|NCT01272219|11657730|FG001|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|351
10506861|NCT01272219|11657731|FG002|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|350
10506862|NCT01272219|11657732|FG003|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|304
10506863|NCT01272219|11657733|FG004|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
10506864|NCT01272219|11657734|FG005|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
10506865|NCT01272219|11657729|FG000|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
10506866|NCT01272219|11657730|FG001|COMPLETED|Re-randomised Period: Week 56 to Week 68||342
10506867|NCT01272219|11657731|FG002|COMPLETED|Re-randomised Period: Week 56 to Week 68||343
10506868|NCT01272219|11657732|FG003|COMPLETED|Re-randomised Period: Week 56 to Week 68||289
10506869|NCT01272219|11657733|FG004|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
10506870|NCT01272219|11657734|FG005|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
10506871|NCT01272219|11657729|FG000|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
10506872|NCT01272219|11657730|FG001|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||9
10506873|NCT01272219|11657731|FG002|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||7
10506874|NCT01272219|11657732|FG003|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||15
10506875|NCT01272219|11657733|FG004|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
10506876|NCT01272219|11657734|FG005|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
10506877|NCT01272219|11657729|FG000|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to main period|0
10506878|NCT01272219|11657730|FG001|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to re-randomised period|0
10506879|NCT01272219|11657731|FG002|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to re-randomised period|0
10506880|NCT01272219|11657732|FG003|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to main and re-randomised period|0
10506881|NCT01272219|11657733|FG004|STARTED|Main + Extension Period: Week 0-172|Incorrect stratification: In this period, overall 6 subjects with no pre-diabetes included by error.|1505
10506882|NCT01272219|11657734|FG005|STARTED|Main + Extension Period: Week 0-172|Incorrect stratification: In this period, overall 6 subjects with no pre-diabetes included by error.|749
10506883|NCT01272219|11657729|FG000|Exposed|Main + Extension Period: Week 0-172||0
10506884|NCT01272219|11657730|FG001|Exposed|Main + Extension Period: Week 0-172||0
10506885|NCT01272219|11657731|FG002|Exposed|Main + Extension Period: Week 0-172||0
10506886|NCT01272219|11657732|FG003|Exposed|Main + Extension Period: Week 0-172||0
10506887|NCT01272219|11657733|FG004|Exposed|Main + Extension Period: Week 0-172||1501
10506888|NCT01272219|11657734|FG005|Exposed|Main + Extension Period: Week 0-172||747
10506889|NCT01272219|11657729|FG000|COMPLETED|Main + Extension Period: Week 0-172||0
10506890|NCT01272219|11657730|FG001|COMPLETED|Main + Extension Period: Week 0-172||0
10506891|NCT01272219|11657731|FG002|COMPLETED|Main + Extension Period: Week 0-172||0
10506892|NCT01272219|11657732|FG003|COMPLETED|Main + Extension Period: Week 0-172||0
10506893|NCT01272219|11657733|FG004|COMPLETED|Main + Extension Period: Week 0-172||783
10506894|NCT01272219|11657734|FG005|COMPLETED|Main + Extension Period: Week 0-172||327
10506895|NCT01272219|11657729|FG000|NOT COMPLETED|Main + Extension Period: Week 0-172||0
10506896|NCT01272219|11657730|FG001|NOT COMPLETED|Main + Extension Period: Week 0-172||0
10506897|NCT01272219|11657731|FG002|NOT COMPLETED|Main + Extension Period: Week 0-172||0
10506898|NCT01272219|11657732|FG003|NOT COMPLETED|Main + Extension Period: Week 0-172||0
10506899|NCT01272219|11657733|FG004|NOT COMPLETED|Main + Extension Period: Week 0-172||722
10506900|NCT01272219|11657734|FG005|NOT COMPLETED|Main + Extension Period: Week 0-172||422
10506901|NCT01272232|11657750|FG000|STARTED|Weeks 0-56||423
10506902|NCT01272232|11657751|FG001|STARTED|Weeks 0-56||211
10506903|NCT01272232|11657752|FG002|STARTED|Weeks 0-56||212
10506904|NCT01272232|11657750|FG000|Exposed|Weeks 0-56|1 subject dropped out after randomisation and before exposure to trial drug.|422
10506905|NCT01272232|11657751|FG001|Exposed|Weeks 0-56|1 subject dropped out after randomisation and before exposure to trial drug.|210
10506906|NCT01272232|11657752|FG002|Exposed|Weeks 0-56||212
10506907|NCT01272232|11657750|FG000|COMPLETED|Weeks 0-56||324
10506908|NCT01272232|11657751|FG001|COMPLETED|Weeks 0-56||164
10506909|NCT01272232|11657752|FG002|COMPLETED|Weeks 0-56||140
10506910|NCT01272232|11657750|FG000|NOT COMPLETED|Weeks 0-56||99
10506911|NCT01272232|11657751|FG001|NOT COMPLETED|Weeks 0-56||47
10506912|NCT01272232|11657752|FG002|NOT COMPLETED|Weeks 0-56||72
10506913|NCT01272232|11657750|FG000|STARTED|Off Drug Follow-up Period (Weeks 56-68)||324
10506914|NCT01272232|11657751|FG001|STARTED|Off Drug Follow-up Period (Weeks 56-68)||164
10506915|NCT01272232|11657752|FG002|STARTED|Off Drug Follow-up Period (Weeks 56-68)||140
10506916|NCT01272232|11657750|FG000|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||310
10506917|NCT01272232|11657751|FG001|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||154
10506918|NCT01272232|11657752|FG002|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||135
10506919|NCT01272232|11657750|FG000|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||14
10506920|NCT01272232|11657751|FG001|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||10
10506921|NCT01272232|11657752|FG002|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||5
10506922|NCT01272245|11657760|FG000|STARTED|Overall Study||36
10506923|NCT01272245|11657760|FG000|COMPLETED|Overall Study||36
10506924|NCT01272245|11657760|FG000|NOT COMPLETED|Overall Study||0
10506925|NCT01272284|11657764|FG000|STARTED|3-month Follow-up Visit||113
10506926|NCT01272284|11657764|FG000|COMPLETED|3-month Follow-up Visit||112
10506927|NCT01272284|11657764|FG000|NOT COMPLETED|3-month Follow-up Visit||1
10506928|NCT01272284|11657764|FG000|STARTED|6-month Follow-up Visit||112
10506929|NCT01272284|11657764|FG000|COMPLETED|6-month Follow-up Visit||109
10506930|NCT01272284|11657764|FG000|NOT COMPLETED|6-month Follow-up Visit||3
10506931|NCT01272284|11657764|FG000|STARTED|12-month Follow-up Visit||109
10506932|NCT01272284|11657764|FG000|COMPLETED|12-month Follow-up Visit||105
10506933|NCT01272284|11657764|FG000|NOT COMPLETED|12-month Follow-up Visit||4
10506934|NCT01272388|11657771|FG000|STARTED|Overall Study||1
10506935|NCT01272388|11657772|FG001|STARTED|Overall Study||0
10506936|NCT01272388|11657771|FG000|COMPLETED|Overall Study||1
10506937|NCT01272388|11657772|FG001|COMPLETED|Overall Study||0
10506938|NCT01272388|11657771|FG000|NOT COMPLETED|Overall Study||0
10506939|NCT01272388|11657772|FG001|NOT COMPLETED|Overall Study||0
10506940|NCT01272583|11657780|FG000|STARTED|Overall Study||8
10506941|NCT01272583|11657781|FG001|STARTED|Overall Study||8
10506942|NCT01272583|11657780|FG000|COMPLETED|Overall Study||8
10506943|NCT01272583|11657781|FG001|COMPLETED|Overall Study||8
10506944|NCT01272583|11657780|FG000|NOT COMPLETED|Overall Study||0
10506945|NCT01272583|11657781|FG001|NOT COMPLETED|Overall Study||0
10506946|NCT01272635|11657791|FG000|STARTED|Overall Study||153
10506947|NCT01272635|11657792|FG001|STARTED|Overall Study||154
10506948|NCT01272635|11657793|FG002|STARTED|Overall Study||148
10506949|NCT01272635|11657794|FG003|STARTED|Overall Study||152
10506950|NCT01272635|11657791|FG000|COMPLETED|Overall Study||122
10506951|NCT01272635|11657792|FG001|COMPLETED|Overall Study||134
10506952|NCT01272635|11657793|FG002|COMPLETED|Overall Study||117
10506953|NCT01272635|11657794|FG003|COMPLETED|Overall Study||129
10506954|NCT01272635|11657791|FG000|NOT COMPLETED|Overall Study||31
10506955|NCT01272635|11657792|FG001|NOT COMPLETED|Overall Study||20
10506956|NCT01272635|11657793|FG002|NOT COMPLETED|Overall Study||31
10506957|NCT01272635|11657794|FG003|NOT COMPLETED|Overall Study||23
10506958|NCT01272661|11657805|FG000|STARTED|Overall Study||413
10506959|NCT01272661|11657806|FG001|STARTED|Overall Study||497
10506960|NCT01272661|11657807|FG002|STARTED|Overall Study||386
10506961|NCT01272661|11657805|FG000|COMPLETED|Overall Study||287
10506962|NCT01272661|11657806|FG001|COMPLETED|Overall Study||288
10506963|NCT01272661|11657807|FG002|COMPLETED|Overall Study||314
10506964|NCT01272661|11657805|FG000|NOT COMPLETED|Overall Study||126
10506965|NCT01272661|11657806|FG001|NOT COMPLETED|Overall Study||209
10506966|NCT01272661|11657807|FG002|NOT COMPLETED|Overall Study||72
10506967|NCT01272804|11657821|FG000|STARTED|Overall Study||9
10506968|NCT01272804|11657822|FG001|STARTED|Overall Study||9
10506969|NCT01272804|11657823|FG002|STARTED|Overall Study||9
10506970|NCT01272804|11657824|FG003|STARTED|Overall Study||9
10506971|NCT01272804|11657825|FG004|STARTED|Overall Study||9
10506972|NCT01272804|11657826|FG005|STARTED|Overall Study||16
10506973|NCT01272804|11657821|FG000|COMPLETED|Overall Study||8
10506974|NCT01272804|11657822|FG001|COMPLETED|Overall Study||9
10506975|NCT01272804|11657823|FG002|COMPLETED|Overall Study||9
10506976|NCT01272804|11657824|FG003|COMPLETED|Overall Study||9
10506977|NCT01272804|11657825|FG004|COMPLETED|Overall Study||7
10506978|NCT01272804|11657826|FG005|COMPLETED|Overall Study||15
10506979|NCT01272804|11657821|FG000|NOT COMPLETED|Overall Study||1
10506980|NCT01272804|11657822|FG001|NOT COMPLETED|Overall Study||0
10506981|NCT01272804|11657823|FG002|NOT COMPLETED|Overall Study||0
10506982|NCT01272804|11657824|FG003|NOT COMPLETED|Overall Study||0
10506983|NCT01272804|11657825|FG004|NOT COMPLETED|Overall Study||2
10506984|NCT01272804|11657826|FG005|NOT COMPLETED|Overall Study||1
10506985|NCT01272830|11657842|FG000|STARTED|Overall Study||25
10506986|NCT01272830|11657843|FG001|STARTED|Overall Study||26
10506987|NCT01272830|11657842|FG000|COMPLETED|Overall Study||17
10506988|NCT01272830|11657843|FG001|COMPLETED|Overall Study||21
10506989|NCT01272830|11657842|FG000|NOT COMPLETED|Overall Study||8
10506990|NCT01272830|11657843|FG001|NOT COMPLETED|Overall Study||5
10506991|NCT01272869|11657851|FG000|STARTED|Period 1 (14 Days)||10
10506992|NCT01272869|11657852|FG001|STARTED|Period 1 (14 Days)||10
10506993|NCT01272869|11657851|FG000|COMPLETED|Period 1 (14 Days)||10
10506994|NCT01272869|11657852|FG001|COMPLETED|Period 1 (14 Days)||10
10506995|NCT01272869|11657851|FG000|NOT COMPLETED|Period 1 (14 Days)||0
10506996|NCT01272869|11657852|FG001|NOT COMPLETED|Period 1 (14 Days)||0
10506997|NCT01272869|11657851|FG000|STARTED|Period 2 (14 Days)||10
10506998|NCT01272869|11657852|FG001|STARTED|Period 2 (14 Days)||10
10506999|NCT01272869|11657851|FG000|COMPLETED|Period 2 (14 Days)||9
10507000|NCT01272869|11657852|FG001|COMPLETED|Period 2 (14 Days)||10
10507001|NCT01272869|11657851|FG000|NOT COMPLETED|Period 2 (14 Days)||1
10710949|NCT02654769|11876296|FG002|NOT COMPLETED|Overall Study||1
10710950|NCT02654808|11876308|FG000|STARTED|Overall Study||33
10710951|NCT02654808|11876309|FG001|STARTED|Overall Study||33
10710952|NCT02654808|11876310|FG002|STARTED|Overall Study||33
10710953|NCT02654808|11876311|FG003|STARTED|Overall Study||33
10710954|NCT02654808|11876308|FG000|COMPLETED|Overall Study||33
10710955|NCT02654808|11876309|FG001|COMPLETED|Overall Study||33
10507002|NCT01272869|11657852|FG001|NOT COMPLETED|Period 2 (14 Days)||0
10507003|NCT01272882|11657858|FG000|STARTED|Overall Study||13
10507004|NCT01272882|11657858|FG000|COMPLETED|Overall Study||13
10507005|NCT01272882|11657858|FG000|NOT COMPLETED|Overall Study||0
10507006|NCT01272908|11657862|FG000|STARTED|Initial Treatment Period||120
10507007|NCT01272908|11657862|FG000|COMPLETED|Initial Treatment Period||112
10507008|NCT01272908|11657862|FG000|NOT COMPLETED|Initial Treatment Period||8
10507009|NCT01272908|11657862|FG000|STARTED|Re-Treatment Period|Only participants with active disease as characterized by DAS-28 score ≥2.6 were included.|77
10507010|NCT01272908|11657862|FG000|COMPLETED|Re-Treatment Period||71
10507011|NCT01272908|11657862|FG000|NOT COMPLETED|Re-Treatment Period||6
10507012|NCT01272921|11657870|FG000|STARTED|Overall Study||71
10507013|NCT01272921|11657871|FG001|STARTED|Overall Study||71
10507014|NCT01272921|11657870|FG000|COMPLETED|Overall Study||69
10507015|NCT01272921|11657871|FG001|COMPLETED|Overall Study||70
10507016|NCT01272921|11657870|FG000|NOT COMPLETED|Overall Study||2
10507017|NCT01272921|11657871|FG001|NOT COMPLETED|Overall Study||1
10507018|NCT01272934|11657881|FG000|STARTED|Overall Study||102
10507019|NCT01272934|11657882|FG001|STARTED|Overall Study||103
10507020|NCT01272934|11657881|FG000|COMPLETED|Overall Study||102
10507021|NCT01272934|11657882|FG001|COMPLETED|Overall Study||101
10507022|NCT01272934|11657881|FG000|NOT COMPLETED|Overall Study||0
10507023|NCT01272934|11657882|FG001|NOT COMPLETED|Overall Study||2
10507024|NCT01272947|11657891|FG000|STARTED|Overall Study||104
10507025|NCT01272947|11657892|FG001|STARTED|Overall Study||100
10507026|NCT01272947|11657891|FG000|COMPLETED|Overall Study||102
10507027|NCT01272947|11657892|FG001|COMPLETED|Overall Study||98
10507028|NCT01272947|11657891|FG000|NOT COMPLETED|Overall Study||2
10507029|NCT01272947|11657892|FG001|NOT COMPLETED|Overall Study||2
10507030|NCT01272960|11657900|FG000|STARTED|Overall Study||14
10507031|NCT01272960|11657901|FG001|STARTED|Overall Study||15
10507032|NCT01272960|11657900|FG000|COMPLETED|Overall Study||14
10507033|NCT01272960|11657901|FG001|COMPLETED|Overall Study||15
10507034|NCT01272960|11657900|FG000|NOT COMPLETED|Overall Study||0
10507035|NCT01272960|11657901|FG001|NOT COMPLETED|Overall Study||0
10507036|NCT01272999|11657912|FG000|STARTED|Overall Study||357
10507037|NCT01272999|11657913|FG001|STARTED|Overall Study||34
10507038|NCT01272999|11657912|FG000|COMPLETED|Overall Study||357
10507039|NCT01272999|11657913|FG001|COMPLETED|Overall Study||34
10507040|NCT01272999|11657912|FG000|NOT COMPLETED|Overall Study||0
10507041|NCT01272999|11657913|FG001|NOT COMPLETED|Overall Study||0
10507042|NCT01273038|11657921|FG000|STARTED|First Intervention (14 Days)||10
10507043|NCT01273038|11657922|FG001|STARTED|First Intervention (14 Days)||10
10507044|NCT01273038|11657921|FG000|COMPLETED|First Intervention (14 Days)||10
10507045|NCT01273038|11657922|FG001|COMPLETED|First Intervention (14 Days)||10
10507046|NCT01273038|11657921|FG000|NOT COMPLETED|First Intervention (14 Days)||0
10507047|NCT01273038|11657922|FG001|NOT COMPLETED|First Intervention (14 Days)||0
10507048|NCT01273038|11657921|FG000|STARTED|Second Intervention (14 Days)||10
10507049|NCT01273038|11657922|FG001|STARTED|Second Intervention (14 Days)||10
10507050|NCT01273038|11657921|FG000|COMPLETED|Second Intervention (14 Days)||10
10507051|NCT01273038|11657922|FG001|COMPLETED|Second Intervention (14 Days)||8
10507052|NCT01273038|11657921|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
10507053|NCT01273038|11657922|FG001|NOT COMPLETED|Second Intervention (14 Days)||2
10507054|NCT01273155|11657932|FG000|STARTED|Overall Study||14
10507055|NCT01273155|11657933|FG001|STARTED|Overall Study||12
10507056|NCT01273155|11657934|FG002|STARTED|Overall Study||18
10507057|NCT01273155|11657935|FG003|STARTED|Overall Study||5
10507058|NCT01273155|11657936|FG004|STARTED|Overall Study||5
10710956|NCT02654808|11876310|FG002|COMPLETED|Overall Study||33
10710957|NCT02654808|11876311|FG003|COMPLETED|Overall Study||33
10710958|NCT02654808|11876308|FG000|NOT COMPLETED|Overall Study||0
10710959|NCT02654808|11876309|FG001|NOT COMPLETED|Overall Study||0
10710960|NCT02654808|11876310|FG002|NOT COMPLETED|Overall Study||0
10710961|NCT02654808|11876311|FG003|NOT COMPLETED|Overall Study||0
10710962|NCT02654860|11876329|FG000|STARTED|First Part||3
10710963|NCT02654860|11876330|FG001|STARTED|First Part||3
10507059|NCT01273155|11657937|FG005|STARTED|Overall Study||10
10507060|NCT01273155|11657938|FG006|STARTED|Overall Study||8
10507061|NCT01273155|11657932|FG000|COMPLETED|Overall Study||12
10507062|NCT01273155|11657933|FG001|COMPLETED|Overall Study||8
10507063|NCT01273155|11657934|FG002|COMPLETED|Overall Study||6
10507064|NCT01273155|11657935|FG003|COMPLETED|Overall Study||4
10507065|NCT01273155|11657936|FG004|COMPLETED|Overall Study||3
10507066|NCT01273155|11657937|FG005|COMPLETED|Overall Study||5
10507067|NCT01273155|11657938|FG006|COMPLETED|Overall Study||2
10507068|NCT01273155|11657932|FG000|NOT COMPLETED|Overall Study||2
10507069|NCT01273155|11657933|FG001|NOT COMPLETED|Overall Study||4
10507070|NCT01273155|11657934|FG002|NOT COMPLETED|Overall Study||12
10507071|NCT01273155|11657935|FG003|NOT COMPLETED|Overall Study||1
10507072|NCT01273155|11657936|FG004|NOT COMPLETED|Overall Study||2
10507073|NCT01273155|11657937|FG005|NOT COMPLETED|Overall Study||5
10710964|NCT02654860|11876331|FG002|STARTED|First Part||3
10710965|NCT02654860|11876332|FG003|STARTED|First Part||0
10710966|NCT02654860|11876329|FG000|COMPLETED|First Part||3
10710967|NCT02654860|11876330|FG001|COMPLETED|First Part||3
10710968|NCT02654860|11876331|FG002|COMPLETED|First Part||3
10710969|NCT02654860|11876332|FG003|COMPLETED|First Part||0
10710970|NCT02654860|11876329|FG000|NOT COMPLETED|First Part||0
10710971|NCT02654860|11876330|FG001|NOT COMPLETED|First Part||0
10710972|NCT02654860|11876331|FG002|NOT COMPLETED|First Part||0
10710973|NCT02654860|11876332|FG003|NOT COMPLETED|First Part||0
10507074|NCT01273155|11657938|FG006|NOT COMPLETED|Overall Study||6
10507075|NCT01273181|11657965|FG000|STARTED|Phase I, Dose 1||3
10507076|NCT01273181|11657966|FG001|STARTED|Phase I, Dose 1||0
10507077|NCT01273181|11657967|FG002|STARTED|Phase I, Dose 1||0
10507078|NCT01273181|11657968|FG003|STARTED|Phase I, Dose 1||0
10507079|NCT01273181|11657965|FG000|COMPLETED|Phase I, Dose 1||2
10507080|NCT01273181|11657966|FG001|COMPLETED|Phase I, Dose 1||0
10507081|NCT01273181|11657967|FG002|COMPLETED|Phase I, Dose 1||0
10507082|NCT01273181|11657968|FG003|COMPLETED|Phase I, Dose 1||0
10507083|NCT01273181|11657965|FG000|NOT COMPLETED|Phase I, Dose 1||1
10507084|NCT01273181|11657966|FG001|NOT COMPLETED|Phase I, Dose 1||0
10507085|NCT01273181|11657967|FG002|NOT COMPLETED|Phase I, Dose 1||0
10507086|NCT01273181|11657968|FG003|NOT COMPLETED|Phase I, Dose 1||0
10507087|NCT01273181|11657965|FG000|STARTED|Phase I, Dose 2||0
10507088|NCT01273181|11657966|FG001|STARTED|Phase I, Dose 2||3
10507089|NCT01273181|11657967|FG002|STARTED|Phase I, Dose 2||0
10507090|NCT01273181|11657968|FG003|STARTED|Phase I, Dose 2||0
10507091|NCT01273181|11657965|FG000|COMPLETED|Phase I, Dose 2||0
10507092|NCT01273181|11657966|FG001|COMPLETED|Phase I, Dose 2||2
10507093|NCT01273181|11657967|FG002|COMPLETED|Phase I, Dose 2||0
10507094|NCT01273181|11657968|FG003|COMPLETED|Phase I, Dose 2||0
10507095|NCT01273181|11657965|FG000|NOT COMPLETED|Phase I, Dose 2||0
10507096|NCT01273181|11657966|FG001|NOT COMPLETED|Phase I, Dose 2||1
10507097|NCT01273181|11657967|FG002|NOT COMPLETED|Phase I, Dose 2||0
10507098|NCT01273181|11657968|FG003|NOT COMPLETED|Phase I, Dose 2||0
10507099|NCT01273181|11657965|FG000|STARTED|Phase 2, Dose 1||0
10507100|NCT01273181|11657966|FG001|STARTED|Phase 2, Dose 1||0
10507101|NCT01273181|11657967|FG002|STARTED|Phase 2, Dose 1||2
10507102|NCT01273181|11657968|FG003|STARTED|Phase 2, Dose 1||0
10507103|NCT01273181|11657965|FG000|COMPLETED|Phase 2, Dose 1||0
10507104|NCT01273181|11657966|FG001|COMPLETED|Phase 2, Dose 1||0
10507105|NCT01273181|11657967|FG002|COMPLETED|Phase 2, Dose 1||1
10507106|NCT01273181|11657968|FG003|COMPLETED|Phase 2, Dose 1||0
10507107|NCT01273181|11657965|FG000|NOT COMPLETED|Phase 2, Dose 1||0
10507108|NCT01273181|11657966|FG001|NOT COMPLETED|Phase 2, Dose 1||0
10507109|NCT01273181|11657967|FG002|NOT COMPLETED|Phase 2, Dose 1||1
10507110|NCT01273181|11657968|FG003|NOT COMPLETED|Phase 2, Dose 1||0
10507111|NCT01273181|11657965|FG000|STARTED|Phase 2, Dose 2||0
10507112|NCT01273181|11657966|FG001|STARTED|Phase 2, Dose 2||0
10507113|NCT01273181|11657967|FG002|STARTED|Phase 2, Dose 2||0
10507114|NCT01273181|11657968|FG003|STARTED|Phase 2, Dose 2||1
10507115|NCT01273181|11657965|FG000|COMPLETED|Phase 2, Dose 2||0
10507116|NCT01273181|11657966|FG001|COMPLETED|Phase 2, Dose 2||0
10507117|NCT01273181|11657967|FG002|COMPLETED|Phase 2, Dose 2||0
10507118|NCT01273181|11657968|FG003|COMPLETED|Phase 2, Dose 2||0
10507119|NCT01273181|11657965|FG000|NOT COMPLETED|Phase 2, Dose 2||0
10507120|NCT01273181|11657966|FG001|NOT COMPLETED|Phase 2, Dose 2||0
10507121|NCT01273181|11657967|FG002|NOT COMPLETED|Phase 2, Dose 2||0
10507122|NCT01273181|11657968|FG003|NOT COMPLETED|Phase 2, Dose 2||1
10507123|NCT01273207|11657982|FG000|STARTED|Overall Study||7
10507124|NCT01273207|11657982|FG000|COMPLETED|Overall Study||2
10507125|NCT01273207|11657982|FG000|NOT COMPLETED|Overall Study||5
10507126|NCT01273519|11657989|FG000|STARTED|Overall Study||78
10507127|NCT01273519|11657990|FG001|STARTED|Overall Study||30
10507128|NCT01273519|11657991|FG002|STARTED|Overall Study||47
10507129|NCT01273519|11657989|FG000|COMPLETED|Overall Study||59
10507130|NCT01273519|11657990|FG001|COMPLETED|Overall Study||25
10507131|NCT01273519|11657991|FG002|COMPLETED|Overall Study||39
10507132|NCT01273519|11657989|FG000|NOT COMPLETED|Overall Study||19
10507133|NCT01273519|11657990|FG001|NOT COMPLETED|Overall Study||5
10507134|NCT01273519|11657991|FG002|NOT COMPLETED|Overall Study||8
10507135|NCT01273597|11658002|FG000|STARTED|Overall Study||60
10507136|NCT01273597|11658002|FG000|COMPLETED|Overall Study||52
10507137|NCT01273597|11658002|FG000|NOT COMPLETED|Overall Study||8
10507138|NCT01273623|11658006|FG000|STARTED|Overall Study|met angiographic criteria|55
10507139|NCT01273623|11658006|FG000|COMPLETED|Overall Study|met IVUS criteria|26
10507140|NCT01273623|11658006|FG000|NOT COMPLETED|Overall Study||29
10507141|NCT01273766|11658015|FG000|STARTED|Overall Study||4
10507142|NCT01273766|11658016|FG001|STARTED|Overall Study||7
10507143|NCT01273766|11658017|FG002|STARTED|Overall Study||5
10507144|NCT01273766|11658015|FG000|COMPLETED|Overall Study||4
10507145|NCT01273766|11658016|FG001|COMPLETED|Overall Study||7
10507146|NCT01273766|11658017|FG002|COMPLETED|Overall Study||5
10507147|NCT01273766|11658015|FG000|NOT COMPLETED|Overall Study||0
10710974|NCT02654860|11876329|FG000|STARTED|Second Part||15
10710975|NCT02654860|11876330|FG001|STARTED|Second Part||15
10507148|NCT01273766|11658016|FG001|NOT COMPLETED|Overall Study||0
10507149|NCT01273766|11658017|FG002|NOT COMPLETED|Overall Study||0
10507150|NCT01273805|11658026|FG000|STARTED|Overall Study||10
10710976|NCT02654860|11876331|FG002|STARTED|Second Part||15
10710977|NCT02654860|11876332|FG003|STARTED|Second Part||15
10507151|NCT01273805|11658027|FG001|STARTED|Overall Study||10
10507152|NCT01273805|11658026|FG000|COMPLETED|Overall Study||0
10507153|NCT01273805|11658027|FG001|COMPLETED|Overall Study||0
10507154|NCT01273805|11658026|FG000|NOT COMPLETED|Overall Study||10
10507155|NCT01273805|11658027|FG001|NOT COMPLETED|Overall Study||10
10507156|NCT01273818|11658036|FG000|STARTED|Overall Study||100
10507157|NCT01273818|11658037|FG001|STARTED|Overall Study||100
10507158|NCT01273818|11658038|FG002|STARTED|Overall Study||100
10507159|NCT01273818|11658036|FG000|COMPLETED|Overall Study||87
10507160|NCT01273818|11658037|FG001|COMPLETED|Overall Study||98
10507161|NCT01273818|11658038|FG002|COMPLETED|Overall Study||91
10507162|NCT01273818|11658036|FG000|NOT COMPLETED|Overall Study||13
10507163|NCT01273818|11658037|FG001|NOT COMPLETED|Overall Study||2
10507164|NCT01273818|11658038|FG002|NOT COMPLETED|Overall Study||9
10507165|NCT01273857|11658048|FG000|STARTED|Overall Study||7
10507166|NCT01273857|11658049|FG001|STARTED|Overall Study||7
10507167|NCT01273857|11658048|FG000|COMPLETED|Overall Study||7
10507168|NCT01273857|11658049|FG001|COMPLETED|Overall Study||7
10507169|NCT01273857|11658048|FG000|NOT COMPLETED|Overall Study||0
10507170|NCT01273857|11658049|FG001|NOT COMPLETED|Overall Study||0
10507171|NCT01273883|11658055|FG000|STARTED|First Intervention|Received at least 1 dose of study drug.|19
10507172|NCT01273883|11658056|FG001|STARTED|First Intervention|Received at least 1 dose of study drug.|19
10507173|NCT01273883|11658055|FG000|COMPLETED|First Intervention||17
10507174|NCT01273883|11658056|FG001|COMPLETED|First Intervention||18
10507175|NCT01273883|11658055|FG000|NOT COMPLETED|First Intervention||2
10507176|NCT01273883|11658056|FG001|NOT COMPLETED|First Intervention||1
10507177|NCT01273883|11658055|FG000|STARTED|Washout Period of 2 Weeks||17
10507178|NCT01273883|11658056|FG001|STARTED|Washout Period of 2 Weeks||18
10507179|NCT01273883|11658055|FG000|COMPLETED|Washout Period of 2 Weeks||17
10507180|NCT01273883|11658056|FG001|COMPLETED|Washout Period of 2 Weeks||18
10507181|NCT01273883|11658055|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
10507182|NCT01273883|11658056|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
10507183|NCT01273883|11658055|FG000|STARTED|Second Intervention||17
10507184|NCT01273883|11658056|FG001|STARTED|Second Intervention||18
10507185|NCT01273883|11658055|FG000|COMPLETED|Second Intervention||15
10507186|NCT01273883|11658056|FG001|COMPLETED|Second Intervention||17
10507187|NCT01273883|11658055|FG000|NOT COMPLETED|Second Intervention||2
10507188|NCT01273883|11658056|FG001|NOT COMPLETED|Second Intervention||1
10507189|NCT01273896|11658062|FG000|STARTED|Overall Study||22
10507190|NCT01273896|11658062|FG000|COMPLETED|Overall Study||22
10507191|NCT01273896|11658062|FG000|NOT COMPLETED|Overall Study||0
10507192|NCT01274182|11658069|FG000|STARTED|Overall Study||133
10507193|NCT01274182|11658070|FG001|STARTED|Overall Study||87
10507194|NCT01274182|11658071|FG002|STARTED|Overall Study||92
10507195|NCT01274182|11658069|FG000|24 Weeks|Overall Study||123
10507196|NCT01274182|11658070|FG001|24 Weeks|Overall Study||83
10507197|NCT01274182|11658071|FG002|24 Weeks|Overall Study||84
10507198|NCT01274182|11658069|FG000|COMPLETED|Overall Study||112
10507199|NCT01274182|11658070|FG001|COMPLETED|Overall Study||69
10507200|NCT01274182|11658071|FG002|COMPLETED|Overall Study||80
10507201|NCT01274182|11658069|FG000|NOT COMPLETED|Overall Study||21
10507202|NCT01274182|11658070|FG001|NOT COMPLETED|Overall Study||18
10507203|NCT01274182|11658071|FG002|NOT COMPLETED|Overall Study||12
10507204|NCT01274338|11658089|FG000|STARTED|Overall Study||511
10507205|NCT01274338|11658090|FG001|STARTED|Overall Study||636
10507206|NCT01274338|11658091|FG002|STARTED|Overall Study||523
10507207|NCT01274338|11658092|FG003|STARTED|Overall Study||1
10507208|NCT01274338|11658093|FG004|STARTED|Overall Study||1
10507209|NCT01274338|11658094|FG005|STARTED|Overall Study||1
10507210|NCT01274338|11658089|FG000|Received Treatment|Overall Study||503
10507211|NCT01274338|11658090|FG001|Received Treatment|Overall Study||520
10507212|NCT01274338|11658091|FG002|Received Treatment|Overall Study||516
10507213|NCT01274338|11658092|FG003|Received Treatment|Overall Study||1
10507214|NCT01274338|11658093|FG004|Received Treatment|Overall Study||1
10507215|NCT01274338|11658094|FG005|Received Treatment|Overall Study||1
10507216|NCT01274338|11658089|FG000|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||110
10507217|NCT01274338|11658090|FG001|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||114
10507218|NCT01274338|11658091|FG002|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||97
10507219|NCT01274338|11658092|FG003|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||0
10507220|NCT01274338|11658093|FG004|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||0
10507221|NCT01274338|11658094|FG005|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||0
10507222|NCT01274338|11658089|FG000|Data Available for FACIT-D Analysis|Overall Study||109
10507223|NCT01274338|11658090|FG001|Data Available for FACIT-D Analysis|Overall Study||114
10507224|NCT01274338|11658091|FG002|Data Available for FACIT-D Analysis|Overall Study||97
10507225|NCT01274338|11658092|FG003|Data Available for FACIT-D Analysis|Overall Study||0
10507226|NCT01274338|11658093|FG004|Data Available for FACIT-D Analysis|Overall Study||0
10507227|NCT01274338|11658094|FG005|Data Available for FACIT-D Analysis|Overall Study||0
10507228|NCT01274338|11658089|FG000|COMPLETED|Overall Study||108
10507229|NCT01274338|11658090|FG001|COMPLETED|Overall Study||182
10507230|NCT01274338|11658091|FG002|COMPLETED|Overall Study||198
10507231|NCT01274338|11658092|FG003|COMPLETED|Overall Study||0
10507232|NCT01274338|11658093|FG004|COMPLETED|Overall Study||0
10507233|NCT01274338|11658094|FG005|COMPLETED|Overall Study||1
10507234|NCT01274338|11658089|FG000|NOT COMPLETED|Overall Study||403
10507235|NCT01274338|11658090|FG001|NOT COMPLETED|Overall Study||454
10507236|NCT01274338|11658091|FG002|NOT COMPLETED|Overall Study||325
10507237|NCT01274338|11658092|FG003|NOT COMPLETED|Overall Study||1
10507238|NCT01274338|11658093|FG004|NOT COMPLETED|Overall Study||1
10507239|NCT01274338|11658094|FG005|NOT COMPLETED|Overall Study||0
10507240|NCT01274351|11658107|FG000|STARTED|Overall Study||112
10507241|NCT01274351|11658107|FG000|COMPLETED|Overall Study||92
10507242|NCT01274351|11658107|FG000|NOT COMPLETED|Overall Study||20
10507243|NCT01274520|11658113|FG000|STARTED|Overall Study||25
10507244|NCT01274520|11658114|FG001|STARTED|Overall Study||24
10507245|NCT01274520|11658113|FG000|COMPLETED|Overall Study||25
10507246|NCT01274520|11658114|FG001|COMPLETED|Overall Study||24
10507247|NCT01274520|11658113|FG000|NOT COMPLETED|Overall Study||0
10507248|NCT01274520|11658114|FG001|NOT COMPLETED|Overall Study||0
10507249|NCT01274585|11658125|FG000|STARTED|Overall Study||2
10507250|NCT01274585|11658126|FG001|STARTED|Overall Study||3
10507251|NCT01274585|11658125|FG000|COMPLETED|Overall Study||2
10507252|NCT01274585|11658126|FG001|COMPLETED|Overall Study||3
10507253|NCT01274585|11658125|FG000|NOT COMPLETED|Overall Study||0
10507254|NCT01274585|11658126|FG001|NOT COMPLETED|Overall Study||0
10507255|NCT01274637|11658134|FG000|STARTED|Overall Study||30
10507256|NCT01274637|11658135|FG001|STARTED|Overall Study||32
10507257|NCT01274637|11658134|FG000|COMPLETED|Overall Study||30
10507258|NCT01274637|11658135|FG001|COMPLETED|Overall Study||30
10507259|NCT01274637|11658134|FG000|NOT COMPLETED|Overall Study||0
10507260|NCT01274637|11658135|FG001|NOT COMPLETED|Overall Study||2
10507261|NCT01274715|11658141|FG000|STARTED|Overall Study||12
10507262|NCT01274715|11658141|FG000|Screened Out at Baseline|Overall Study||3
10507263|NCT01274715|11658141|FG000|COMPLETED|Overall Study||8
10507264|NCT01274715|11658141|FG000|NOT COMPLETED|Overall Study||4
10507265|NCT01274897|11658147|FG000|STARTED|Overall Study||297
10507266|NCT01274897|11658148|FG001|STARTED|Overall Study||153
10507267|NCT01274897|11658147|FG000|COMPLETED|Overall Study||297
10507268|NCT01274897|11658148|FG001|COMPLETED|Overall Study||153
10507269|NCT01274897|11658147|FG000|NOT COMPLETED|Overall Study||0
10507270|NCT01274897|11658148|FG001|NOT COMPLETED|Overall Study||0
10507271|NCT01275053|11658154|FG000|STARTED|Overall Study||12
10507272|NCT01275053|11658154|FG000|COMPLETED|Overall Study||12
10507273|NCT01275053|11658154|FG000|NOT COMPLETED|Overall Study||0
10507274|NCT01275066|11658161|FG000|STARTED|Overall Study||60
10507275|NCT01275066|11658162|FG001|STARTED|Overall Study||59
10507276|NCT01275066|11658163|FG002|STARTED|Overall Study||58
10507277|NCT01275066|11658161|FG000|Treated|Overall Study||59
10507278|NCT01275066|11658162|FG001|Treated|Overall Study||59
10507279|NCT01275066|11658163|FG002|Treated|Overall Study||58
10507280|NCT01275066|11658161|FG000|COMPLETED|Overall Study||59
10507281|NCT01275066|11658162|FG001|COMPLETED|Overall Study||59
10507282|NCT01275066|11658163|FG002|COMPLETED|Overall Study||57
10710978|NCT02654860|11876329|FG000|COMPLETED|Second Part||15
10507283|NCT01275066|11658161|FG000|NOT COMPLETED|Overall Study||1
10507284|NCT01275066|11658162|FG001|NOT COMPLETED|Overall Study||0
10507285|NCT01275066|11658163|FG002|NOT COMPLETED|Overall Study||1
10507286|NCT01275092|11658171|FG000|STARTED|Overall Study||164
10507287|NCT01275092|11658171|FG000|COMPLETED|Overall Study||164
10507288|NCT01275092|11658171|FG000|NOT COMPLETED|Overall Study||0
10507289|NCT01275131|11658179|FG000|STARTED|Period 1||11
10507290|NCT01275131|11658180|FG001|STARTED|Period 1||9
10507291|NCT01275131|11658181|FG002|STARTED|Period 1||13
10507292|NCT01275131|11658182|FG003|STARTED|Period 1||12
10507293|NCT01275131|11658179|FG000|Received at Least One Dose of Study Drug|Period 1||11
10507294|NCT01275131|11658180|FG001|Received at Least One Dose of Study Drug|Period 1||9
10507295|NCT01275131|11658181|FG002|Received at Least One Dose of Study Drug|Period 1||13
10507296|NCT01275131|11658182|FG003|Received at Least One Dose of Study Drug|Period 1||12
10507297|NCT01275131|11658179|FG000|COMPLETED|Period 1||9
10507298|NCT01275131|11658180|FG001|COMPLETED|Period 1||9
10507299|NCT01275131|11658181|FG002|COMPLETED|Period 1||10
10507300|NCT01275131|11658182|FG003|COMPLETED|Period 1||10
10507301|NCT01275131|11658179|FG000|NOT COMPLETED|Period 1||2
10507302|NCT01275131|11658180|FG001|NOT COMPLETED|Period 1||0
10507303|NCT01275131|11658181|FG002|NOT COMPLETED|Period 1||3
10507304|NCT01275131|11658182|FG003|NOT COMPLETED|Period 1||2
10507305|NCT01275131|11658179|FG000|STARTED|5- to 14-Day Washout Period||9
10507306|NCT01275131|11658180|FG001|STARTED|5- to 14-Day Washout Period||9
10507307|NCT01275131|11658181|FG002|STARTED|5- to 14-Day Washout Period||10
10507308|NCT01275131|11658182|FG003|STARTED|5- to 14-Day Washout Period||10
10507309|NCT01275131|11658179|FG000|COMPLETED|5- to 14-Day Washout Period||9
10507310|NCT01275131|11658180|FG001|COMPLETED|5- to 14-Day Washout Period||9
10507311|NCT01275131|11658181|FG002|COMPLETED|5- to 14-Day Washout Period||10
10507312|NCT01275131|11658182|FG003|COMPLETED|5- to 14-Day Washout Period||10
10507313|NCT01275131|11658179|FG000|NOT COMPLETED|5- to 14-Day Washout Period||0
10507314|NCT01275131|11658180|FG001|NOT COMPLETED|5- to 14-Day Washout Period||0
10507315|NCT01275131|11658181|FG002|NOT COMPLETED|5- to 14-Day Washout Period||0
10507316|NCT01275131|11658182|FG003|NOT COMPLETED|5- to 14-Day Washout Period||0
10507317|NCT01275131|11658179|FG000|STARTED|Period 2 (Crossover)||9
10507318|NCT01275131|11658180|FG001|STARTED|Period 2 (Crossover)||9
10507319|NCT01275131|11658181|FG002|STARTED|Period 2 (Crossover)||10
10507320|NCT01275131|11658182|FG003|STARTED|Period 2 (Crossover)||10
10507321|NCT01275131|11658179|FG000|COMPLETED|Period 2 (Crossover)||8
10507322|NCT01275131|11658180|FG001|COMPLETED|Period 2 (Crossover)||8
10507323|NCT01275131|11658181|FG002|COMPLETED|Period 2 (Crossover)||9
10507324|NCT01275131|11658182|FG003|COMPLETED|Period 2 (Crossover)||8
10507325|NCT01275131|11658179|FG000|NOT COMPLETED|Period 2 (Crossover)||1
10507326|NCT01275131|11658180|FG001|NOT COMPLETED|Period 2 (Crossover)||1
10710979|NCT02654860|11876330|FG001|COMPLETED|Second Part||15
10507327|NCT01275131|11658181|FG002|NOT COMPLETED|Period 2 (Crossover)||1
10507328|NCT01275131|11658182|FG003|NOT COMPLETED|Period 2 (Crossover)||2
10507329|NCT01275144|11658200|FG000|STARTED|First Intervention (6 Days)||14
10507330|NCT01275144|11658201|FG001|STARTED|First Intervention (6 Days)||14
10507331|NCT01275144|11658200|FG000|Received at Least 1 Dose of Study Drug|First Intervention (6 Days)||14
10507332|NCT01275144|11658201|FG001|Received at Least 1 Dose of Study Drug|First Intervention (6 Days)||14
10507333|NCT01275144|11658200|FG000|COMPLETED|First Intervention (6 Days)||14
10507334|NCT01275144|11658201|FG001|COMPLETED|First Intervention (6 Days)||14
10507335|NCT01275144|11658200|FG000|NOT COMPLETED|First Intervention (6 Days)||0
10507336|NCT01275144|11658201|FG001|NOT COMPLETED|First Intervention (6 Days)||0
10507337|NCT01275144|11658200|FG000|STARTED|Washout (7 Days)||14
10507338|NCT01275144|11658201|FG001|STARTED|Washout (7 Days)||14
10507339|NCT01275144|11658200|FG000|COMPLETED|Washout (7 Days)||14
10507340|NCT01275144|11658201|FG001|COMPLETED|Washout (7 Days)||14
10507341|NCT01275144|11658200|FG000|NOT COMPLETED|Washout (7 Days)||0
10507342|NCT01275144|11658201|FG001|NOT COMPLETED|Washout (7 Days)||0
10507343|NCT01275144|11658200|FG000|STARTED|Second Intervention (6 Days)||14
10507344|NCT01275144|11658201|FG001|STARTED|Second Intervention (6 Days)||14
10710980|NCT02654860|11876331|FG002|COMPLETED|Second Part||15
10710981|NCT02654860|11876332|FG003|COMPLETED|Second Part||15
10710982|NCT02654860|11876329|FG000|NOT COMPLETED|Second Part||0
10710983|NCT02654860|11876330|FG001|NOT COMPLETED|Second Part||0
10710984|NCT02654860|11876331|FG002|NOT COMPLETED|Second Part||0
10710985|NCT02654860|11876332|FG003|NOT COMPLETED|Second Part||0
10710986|NCT02654977|11876342|FG000|STARTED|Overall Study||11
10710987|NCT02654977|11876342|FG000|COMPLETED|Overall Study||4
10507345|NCT01275144|11658200|FG000|COMPLETED|Second Intervention (6 Days)||13
10507346|NCT01275144|11658201|FG001|COMPLETED|Second Intervention (6 Days)||14
10507347|NCT01275144|11658200|FG000|NOT COMPLETED|Second Intervention (6 Days)||1
10507348|NCT01275144|11658201|FG001|NOT COMPLETED|Second Intervention (6 Days)||0
10507349|NCT01275170|11658217|FG000|STARTED|Part 1: Period 1||7
10507350|NCT01275170|11658218|FG001|STARTED|Part 1: Period 1||6
10507351|NCT01275170|11658219|FG002|STARTED|Part 1: Period 1||6
10507352|NCT01275170|11658220|FG003|STARTED|Part 1: Period 1||6
10507353|NCT01275170|11658221|FG004|STARTED|Part 1: Period 1||6
10507354|NCT01275170|11658222|FG005|STARTED|Part 1: Period 1||6
10507355|NCT01275170|11658223|FG006|STARTED|Part 1: Period 1||6
10507356|NCT01275170|11658224|FG007|STARTED|Part 1: Period 1||6
10507357|NCT01275170|11658217|FG000|Treated|Part 1: Period 1||6
10507358|NCT01275170|11658218|FG001|Treated|Part 1: Period 1||6
10507359|NCT01275170|11658219|FG002|Treated|Part 1: Period 1||6
10507360|NCT01275170|11658220|FG003|Treated|Part 1: Period 1||6
10507361|NCT01275170|11658221|FG004|Treated|Part 1: Period 1||6
10507362|NCT01275170|11658222|FG005|Treated|Part 1: Period 1||6
10507363|NCT01275170|11658223|FG006|Treated|Part 1: Period 1||6
10507364|NCT01275170|11658224|FG007|Treated|Part 1: Period 1||6
10507365|NCT01275170|11658217|FG000|COMPLETED|Part 1: Period 1||6
10507366|NCT01275170|11658218|FG001|COMPLETED|Part 1: Period 1||6
10507367|NCT01275170|11658219|FG002|COMPLETED|Part 1: Period 1||6
10507368|NCT01275170|11658220|FG003|COMPLETED|Part 1: Period 1||6
10507369|NCT01275170|11658221|FG004|COMPLETED|Part 1: Period 1||6
10507370|NCT01275170|11658222|FG005|COMPLETED|Part 1: Period 1||6
10507371|NCT01275170|11658223|FG006|COMPLETED|Part 1: Period 1||6
10507372|NCT01275170|11658224|FG007|COMPLETED|Part 1: Period 1||6
10507373|NCT01275170|11658217|FG000|NOT COMPLETED|Part 1: Period 1||1
10507374|NCT01275170|11658218|FG001|NOT COMPLETED|Part 1: Period 1||0
10507375|NCT01275170|11658219|FG002|NOT COMPLETED|Part 1: Period 1||0
10507376|NCT01275170|11658220|FG003|NOT COMPLETED|Part 1: Period 1||0
10507377|NCT01275170|11658221|FG004|NOT COMPLETED|Part 1: Period 1||0
10507378|NCT01275170|11658222|FG005|NOT COMPLETED|Part 1: Period 1||0
10507379|NCT01275170|11658223|FG006|NOT COMPLETED|Part 1: Period 1||0
10507380|NCT01275170|11658224|FG007|NOT COMPLETED|Part 1: Period 1||0
10507381|NCT01275170|11658217|FG000|STARTED|Part 1: Period 2|Panel A participated in Part 1, Period 1 only.|0
10507382|NCT01275170|11658218|FG001|STARTED|Part 1: Period 2|Panel B participated in Part 1, Period 1 only.|0
10507383|NCT01275170|11658219|FG002|STARTED|Part 1: Period 2|Panel C participated in Part 1, Period 1 only.|0
10507384|NCT01275170|11658220|FG003|STARTED|Part 1: Period 2|Panel D participated in Part 1, Period 1 only.|0
10507385|NCT01275170|11658221|FG004|STARTED|Part 1: Period 2|Panel E participated in Part 1, Period 1 and Part 2, Period 1.|0
10507386|NCT01275170|11658222|FG005|STARTED|Part 1: Period 2|Panel E participated in Part 1, Period 1 and Part 2, Period 1.|0
10507387|NCT01275170|11658223|FG006|STARTED|Part 1: Period 2||6
10507388|NCT01275170|11658224|FG007|STARTED|Part 1: Period 2||6
10507389|NCT01275170|11658217|FG000|COMPLETED|Part 1: Period 2||0
10507390|NCT01275170|11658218|FG001|COMPLETED|Part 1: Period 2||0
10507391|NCT01275170|11658219|FG002|COMPLETED|Part 1: Period 2||0
10507392|NCT01275170|11658220|FG003|COMPLETED|Part 1: Period 2||0
10507393|NCT01275170|11658221|FG004|COMPLETED|Part 1: Period 2||0
10507394|NCT01275170|11658222|FG005|COMPLETED|Part 1: Period 2||0
10507395|NCT01275170|11658223|FG006|COMPLETED|Part 1: Period 2||6
10507396|NCT01275170|11658224|FG007|COMPLETED|Part 1: Period 2||6
10507397|NCT01275170|11658217|FG000|NOT COMPLETED|Part 1: Period 2||0
10507398|NCT01275170|11658218|FG001|NOT COMPLETED|Part 1: Period 2||0
10507399|NCT01275170|11658219|FG002|NOT COMPLETED|Part 1: Period 2||0
10507400|NCT01275170|11658220|FG003|NOT COMPLETED|Part 1: Period 2||0
10710988|NCT02654977|11876342|FG000|NOT COMPLETED|Overall Study||7
10710989|NCT02655224|11876348|FG000|STARTED|Overall Study||33
10710990|NCT02655224|11876349|FG001|STARTED|Overall Study||32
10710991|NCT02655224|11876348|FG000|COMPLETED|Overall Study||32
10710992|NCT02655224|11876349|FG001|COMPLETED|Overall Study||31
10710993|NCT02655224|11876348|FG000|NOT COMPLETED|Overall Study||1
10710994|NCT02655224|11876349|FG001|NOT COMPLETED|Overall Study||1
10710995|NCT02655237|11876357|FG000|STARTED|Overall Study||139
10507401|NCT01275170|11658221|FG004|NOT COMPLETED|Part 1: Period 2||0
10507402|NCT01275170|11658222|FG005|NOT COMPLETED|Part 1: Period 2||0
10507403|NCT01275170|11658223|FG006|NOT COMPLETED|Part 1: Period 2||0
10507404|NCT01275170|11658224|FG007|NOT COMPLETED|Part 1: Period 2||0
10507405|NCT01275170|11658217|FG000|STARTED|Part 2: Period 1||0
10507406|NCT01275170|11658218|FG001|STARTED|Part 2: Period 1||0
10507407|NCT01275170|11658219|FG002|STARTED|Part 2: Period 1||0
10507408|NCT01275170|11658220|FG003|STARTED|Part 2: Period 1||0
10507409|NCT01275170|11658221|FG004|STARTED|Part 2: Period 1||6
10507410|NCT01275170|11658222|FG005|STARTED|Part 2: Period 1||6
10507411|NCT01275170|11658223|FG006|STARTED|Part 2: Period 1||6
10507412|NCT01275170|11658224|FG007|STARTED|Part 2: Period 1||6
10507413|NCT01275170|11658217|FG000|COMPLETED|Part 2: Period 1||0
10507414|NCT01275170|11658218|FG001|COMPLETED|Part 2: Period 1||0
10507415|NCT01275170|11658219|FG002|COMPLETED|Part 2: Period 1||0
10507416|NCT01275170|11658220|FG003|COMPLETED|Part 2: Period 1||0
10507417|NCT01275170|11658221|FG004|COMPLETED|Part 2: Period 1||6
10507418|NCT01275170|11658222|FG005|COMPLETED|Part 2: Period 1||6
10507419|NCT01275170|11658223|FG006|COMPLETED|Part 2: Period 1||6
10507420|NCT01275170|11658224|FG007|COMPLETED|Part 2: Period 1||6
10507421|NCT01275170|11658217|FG000|NOT COMPLETED|Part 2: Period 1||0
10507422|NCT01275170|11658218|FG001|NOT COMPLETED|Part 2: Period 1||0
10507423|NCT01275170|11658219|FG002|NOT COMPLETED|Part 2: Period 1||0
10507424|NCT01275170|11658220|FG003|NOT COMPLETED|Part 2: Period 1||0
10507425|NCT01275170|11658221|FG004|NOT COMPLETED|Part 2: Period 1||0
10507426|NCT01275170|11658222|FG005|NOT COMPLETED|Part 2: Period 1||0
10507427|NCT01275170|11658223|FG006|NOT COMPLETED|Part 2: Period 1||0
10507428|NCT01275170|11658224|FG007|NOT COMPLETED|Part 2: Period 1||0
10507429|NCT01275170|11658217|FG000|STARTED|Part 2: Period 2||0
10507430|NCT01275170|11658218|FG001|STARTED|Part 2: Period 2||0
10507431|NCT01275170|11658219|FG002|STARTED|Part 2: Period 2||0
10507432|NCT01275170|11658220|FG003|STARTED|Part 2: Period 2||0
10507433|NCT01275170|11658221|FG004|STARTED|Part 2: Period 2|Panel E participated in Part 1, Period 1 and Part 2, Period 1.|0
10507434|NCT01275170|11658222|FG005|STARTED|Part 2: Period 2|Panel F participated in Part 1, Period 1 and Part 2, Period 1.|0
10507435|NCT01275170|11658223|FG006|STARTED|Part 2: Period 2||6
10507436|NCT01275170|11658224|FG007|STARTED|Part 2: Period 2||6
10507437|NCT01275170|11658217|FG000|COMPLETED|Part 2: Period 2||0
10507438|NCT01275170|11658218|FG001|COMPLETED|Part 2: Period 2||0
10507439|NCT01275170|11658219|FG002|COMPLETED|Part 2: Period 2||0
10507440|NCT01275170|11658220|FG003|COMPLETED|Part 2: Period 2||0
10507441|NCT01275170|11658221|FG004|COMPLETED|Part 2: Period 2||0
10507442|NCT01275170|11658222|FG005|COMPLETED|Part 2: Period 2||0
10507443|NCT01275170|11658223|FG006|COMPLETED|Part 2: Period 2||6
10507444|NCT01275170|11658224|FG007|COMPLETED|Part 2: Period 2||6
10507445|NCT01275170|11658217|FG000|NOT COMPLETED|Part 2: Period 2||0
10507446|NCT01275170|11658218|FG001|NOT COMPLETED|Part 2: Period 2||0
10507447|NCT01275170|11658219|FG002|NOT COMPLETED|Part 2: Period 2||0
10507448|NCT01275170|11658220|FG003|NOT COMPLETED|Part 2: Period 2||0
10507449|NCT01275170|11658221|FG004|NOT COMPLETED|Part 2: Period 2||0
10507450|NCT01275170|11658222|FG005|NOT COMPLETED|Part 2: Period 2||0
10507451|NCT01275170|11658223|FG006|NOT COMPLETED|Part 2: Period 2||0
10507452|NCT01275170|11658224|FG007|NOT COMPLETED|Part 2: Period 2||0
10507453|NCT01275196|11658259|FG000|STARTED|Overall Study||133
10507454|NCT01275196|11658260|FG001|STARTED|Overall Study||134
10507455|NCT01275196|11658259|FG000|Intended to Continue Into Extension|Overall Study||112
10507456|NCT01275196|11658260|FG001|Intended to Continue Into Extension|Overall Study||113
10507457|NCT01275196|11658259|FG000|COMPLETED|Overall Study||113
10507458|NCT01275196|11658260|FG001|COMPLETED|Overall Study||113
10507459|NCT01275196|11658259|FG000|NOT COMPLETED|Overall Study||20
10507460|NCT01275196|11658260|FG001|NOT COMPLETED|Overall Study||21
10507461|NCT01275222|11658274|FG000|STARTED|Phase l by Treatment||13
10507462|NCT01275222|11658275|FG001|STARTED|Phase l by Treatment||13
10507463|NCT01275222|11658276|FG002|STARTED|Phase l by Treatment||5
10507464|NCT01275222|11658277|FG003|STARTED|Phase l by Treatment||11
10507465|NCT01275222|11658278|FG004|STARTED|Phase l by Treatment||0
10507466|NCT01275222|11658279|FG005|STARTED|Phase l by Treatment||0
10507467|NCT01275222|11658274|FG000|COMPLETED|Phase l by Treatment||0
10507468|NCT01275222|11658275|FG001|COMPLETED|Phase l by Treatment||0
10507469|NCT01275222|11658276|FG002|COMPLETED|Phase l by Treatment||0
10507470|NCT01275222|11658277|FG003|COMPLETED|Phase l by Treatment||0
10507471|NCT01275222|11658278|FG004|COMPLETED|Phase l by Treatment||0
10507472|NCT01275222|11658279|FG005|COMPLETED|Phase l by Treatment||0
10507473|NCT01275222|11658274|FG000|NOT COMPLETED|Phase l by Treatment||13
10507474|NCT01275222|11658275|FG001|NOT COMPLETED|Phase l by Treatment||13
10507475|NCT01275222|11658276|FG002|NOT COMPLETED|Phase l by Treatment||5
10507476|NCT01275222|11658277|FG003|NOT COMPLETED|Phase l by Treatment||11
10507477|NCT01275222|11658278|FG004|NOT COMPLETED|Phase l by Treatment||0
10507478|NCT01275222|11658279|FG005|NOT COMPLETED|Phase l by Treatment||0
10710996|NCT02655237|11876358|FG001|STARTED|Overall Study||142
10710997|NCT02655237|11876357|FG000|COMPLETED|Overall Study||122
10710998|NCT02655237|11876358|FG001|COMPLETED|Overall Study||131
10507479|NCT01275222|11658274|FG000|STARTED|Phase ll by Stratum||0
10710999|NCT02655237|11876357|FG000|NOT COMPLETED|Overall Study||17
10507480|NCT01275222|11658275|FG001|STARTED|Phase ll by Stratum||0
10507481|NCT01275222|11658276|FG002|STARTED|Phase ll by Stratum||0
10507482|NCT01275222|11658277|FG003|STARTED|Phase ll by Stratum||0
10507483|NCT01275222|11658278|FG004|STARTED|Phase ll by Stratum||28
10507484|NCT01275222|11658279|FG005|STARTED|Phase ll by Stratum||47
10507485|NCT01275222|11658274|FG000|COMPLETED|Phase ll by Stratum||0
10507486|NCT01275222|11658275|FG001|COMPLETED|Phase ll by Stratum||0
10507487|NCT01275222|11658276|FG002|COMPLETED|Phase ll by Stratum||0
10507488|NCT01275222|11658277|FG003|COMPLETED|Phase ll by Stratum||0
10507489|NCT01275222|11658278|FG004|COMPLETED|Phase ll by Stratum||0
10507490|NCT01275222|11658279|FG005|COMPLETED|Phase ll by Stratum||1
10507491|NCT01275222|11658274|FG000|NOT COMPLETED|Phase ll by Stratum||0
10507492|NCT01275222|11658275|FG001|NOT COMPLETED|Phase ll by Stratum||0
10507493|NCT01275222|11658276|FG002|NOT COMPLETED|Phase ll by Stratum||0
10507494|NCT01275222|11658277|FG003|NOT COMPLETED|Phase ll by Stratum||0
10507495|NCT01275222|11658278|FG004|NOT COMPLETED|Phase ll by Stratum||28
10711000|NCT02655237|11876358|FG001|NOT COMPLETED|Overall Study||11
10711001|NCT02655354|11876366|FG000|STARTED|Overall Study||265
10711002|NCT02655354|11876367|FG001|STARTED|Overall Study||370
10711003|NCT02655354|11876366|FG000|COMPLETED|Overall Study||188
10711004|NCT02655354|11876367|FG001|COMPLETED|Overall Study||289
10507496|NCT01275222|11658279|FG005|NOT COMPLETED|Phase ll by Stratum||46
10507497|NCT01275300|11658297|FG000|STARTED|1st Intervention (5 Days)||5
10507498|NCT01275300|11658298|FG001|STARTED|1st Intervention (5 Days)||4
10507499|NCT01275300|11658297|FG000|COMPLETED|1st Intervention (5 Days)||5
10507500|NCT01275300|11658298|FG001|COMPLETED|1st Intervention (5 Days)||4
10507501|NCT01275300|11658297|FG000|NOT COMPLETED|1st Intervention (5 Days)||0
10507502|NCT01275300|11658298|FG001|NOT COMPLETED|1st Intervention (5 Days)||0
10507503|NCT01275300|11658297|FG000|STARTED|Washout (14 Days)||5
10507504|NCT01275300|11658298|FG001|STARTED|Washout (14 Days)||4
10507505|NCT01275300|11658297|FG000|COMPLETED|Washout (14 Days)||5
10507506|NCT01275300|11658298|FG001|COMPLETED|Washout (14 Days)||4
10507507|NCT01275300|11658297|FG000|NOT COMPLETED|Washout (14 Days)||0
10507508|NCT01275300|11658298|FG001|NOT COMPLETED|Washout (14 Days)||0
10507509|NCT01275300|11658297|FG000|STARTED|2nd Intervention(5 Days)||5
10507510|NCT01275300|11658298|FG001|STARTED|2nd Intervention(5 Days)||4
10507511|NCT01275300|11658297|FG000|COMPLETED|2nd Intervention(5 Days)||5
10507512|NCT01275300|11658298|FG001|COMPLETED|2nd Intervention(5 Days)||4
10507513|NCT01275300|11658297|FG000|NOT COMPLETED|2nd Intervention(5 Days)||0
10507514|NCT01275300|11658298|FG001|NOT COMPLETED|2nd Intervention(5 Days)||0
10507515|NCT01275300|11658297|FG000|STARTED|Washout (14 Days)||5
10507516|NCT01275300|11658298|FG001|STARTED|Washout (14 Days)||4
10507517|NCT01275300|11658297|FG000|COMPLETED|Washout (14 Days)||5
10507518|NCT01275300|11658298|FG001|COMPLETED|Washout (14 Days)||4
10507519|NCT01275300|11658297|FG000|NOT COMPLETED|Washout (14 Days)||0
10507520|NCT01275300|11658298|FG001|NOT COMPLETED|Washout (14 Days)||0
10507521|NCT01275300|11658297|FG000|STARTED|Phase 2: Open-label 6days)||5
10507522|NCT01275300|11658298|FG001|STARTED|Phase 2: Open-label 6days)||4
10507523|NCT01275300|11658297|FG000|COMPLETED|Phase 2: Open-label 6days)||5
10507524|NCT01275300|11658298|FG001|COMPLETED|Phase 2: Open-label 6days)||4
10507525|NCT01275300|11658297|FG000|NOT COMPLETED|Phase 2: Open-label 6days)||0
10507526|NCT01275300|11658298|FG001|NOT COMPLETED|Phase 2: Open-label 6days)||0
10507527|NCT01275339|11658308|FG000|STARTED|Overall Study||2
10507528|NCT01275339|11658309|FG001|STARTED|Overall Study||0
10711005|NCT02655354|11876366|FG000|NOT COMPLETED|Overall Study||77
10711006|NCT02655354|11876367|FG001|NOT COMPLETED|Overall Study||81
10711007|NCT02655419|11876375|FG000|STARTED|Overall Study||17
10711008|NCT02655419|11876376|FG001|STARTED|Overall Study||23
10711009|NCT02655419|11876375|FG000|Treated|Overall Study||16
10711010|NCT02655419|11876376|FG001|Treated|Overall Study||18
10711011|NCT02655419|11876375|FG000|COMPLETED|Overall Study||12
10711012|NCT02655419|11876376|FG001|COMPLETED|Overall Study||16
10711013|NCT02655419|11876375|FG000|NOT COMPLETED|Overall Study||5
10711014|NCT02655419|11876376|FG001|NOT COMPLETED|Overall Study||7
10711015|NCT02655510|11876389|FG000|STARTED|Overall Study||6
10711016|NCT02655510|11876390|FG001|STARTED|Overall Study||6
10711017|NCT02655510|11876391|FG002|STARTED|Overall Study||6
10711018|NCT02655510|11876389|FG000|COMPLETED|Overall Study||6
10711019|NCT02655510|11876390|FG001|COMPLETED|Overall Study||6
10711020|NCT02655510|11876391|FG002|COMPLETED|Overall Study||6
10711021|NCT02655510|11876389|FG000|NOT COMPLETED|Overall Study||0
10711022|NCT02655510|11876390|FG001|NOT COMPLETED|Overall Study||0
10711023|NCT02655510|11876391|FG002|NOT COMPLETED|Overall Study||0
10711024|NCT02655653|11876401|FG000|STARTED|Overall Study||56
10711025|NCT02655653|11876402|FG001|STARTED|Overall Study||58
10711026|NCT02655653|11876401|FG000|COMPLETED|Overall Study||56
10711027|NCT02655653|11876402|FG001|COMPLETED|Overall Study||58
10711028|NCT02655653|11876401|FG000|NOT COMPLETED|Overall Study||0
10711029|NCT02655653|11876402|FG001|NOT COMPLETED|Overall Study||0
10507529|NCT01275339|11658310|FG002|STARTED|Overall Study||4
10507530|NCT01275339|11658311|FG003|STARTED|Overall Study||4
10507531|NCT01275339|11658308|FG000|COMPLETED|Overall Study||1
10507532|NCT01275339|11658309|FG001|COMPLETED|Overall Study||0
10507533|NCT01275339|11658310|FG002|COMPLETED|Overall Study||3
10711030|NCT02655666|11876414|FG000|STARTED|Overall Study||16
10711031|NCT02655666|11876414|FG000|COMPLETED|Overall Study||4
10711032|NCT02655666|11876414|FG000|NOT COMPLETED|Overall Study||12
10711033|NCT02655679|11876423|FG000|STARTED|Overall Study||21
10711034|NCT02655679|11876424|FG001|STARTED|Overall Study||19
10711035|NCT02655679|11876425|FG002|STARTED|Overall Study||20
10507534|NCT01275339|11658311|FG003|COMPLETED|Overall Study||4
10507535|NCT01275339|11658308|FG000|NOT COMPLETED|Overall Study||1
10507536|NCT01275339|11658309|FG001|NOT COMPLETED|Overall Study||0
10507537|NCT01275339|11658310|FG002|NOT COMPLETED|Overall Study||1
10507538|NCT01275339|11658311|FG003|NOT COMPLETED|Overall Study||0
10507539|NCT01275365|11658325|FG000|STARTED|Overall Study||24
10507540|NCT01275365|11658326|FG001|STARTED|Overall Study||24
10507541|NCT01275365|11658327|FG002|STARTED|Overall Study||22
10507542|NCT01275365|11658328|FG003|STARTED|Overall Study||22
10507543|NCT01275365|11658325|FG000|COMPLETED|Overall Study||21
10507544|NCT01275365|11658326|FG001|COMPLETED|Overall Study||21
10507545|NCT01275365|11658327|FG002|COMPLETED|Overall Study||17
10507546|NCT01275365|11658328|FG003|COMPLETED|Overall Study||19
10507547|NCT01275365|11658325|FG000|NOT COMPLETED|Overall Study||3
10507548|NCT01275365|11658326|FG001|NOT COMPLETED|Overall Study||3
10507549|NCT01275365|11658327|FG002|NOT COMPLETED|Overall Study||5
10507550|NCT01275365|11658328|FG003|NOT COMPLETED|Overall Study||3
10507551|NCT01275430|11658338|FG000|STARTED|Overall Study||27
10507552|NCT01275430|11658338|FG000|COMPLETED|Overall Study||18
10507553|NCT01275430|11658338|FG000|NOT COMPLETED|Overall Study||9
10507554|NCT01275586|11658343|FG000|STARTED|Overall Study||6
10507555|NCT01275586|11658343|FG000|COMPLETED|Overall Study||3
10507556|NCT01275586|11658343|FG000|NOT COMPLETED|Overall Study||3
10507557|NCT01275625|11658347|FG000|STARTED|Overall Study||77
10507558|NCT01275625|11658347|FG000|Treated|Overall Study||77
10507559|NCT01275625|11658347|FG000|COMPLETED|Overall Study||64
10507560|NCT01275625|11658347|FG000|NOT COMPLETED|Overall Study||13
10507561|NCT01275664|11658351|FG000|STARTED|Overall Study||4
10507562|NCT01275664|11658351|FG000|COMPLETED|Overall Study||4
10507563|NCT01275664|11658351|FG000|NOT COMPLETED|Overall Study||0
10507564|NCT01275755|11658357|FG000|STARTED|Run-in Placebo Period||41
10507565|NCT01275755|11658358|FG001|STARTED|Run-in Placebo Period||40
10507566|NCT01275755|11658357|FG000|COMPLETED|Run-in Placebo Period||41
10507567|NCT01275755|11658358|FG001|COMPLETED|Run-in Placebo Period||40
10507568|NCT01275755|11658357|FG000|NOT COMPLETED|Run-in Placebo Period||0
10507569|NCT01275755|11658358|FG001|NOT COMPLETED|Run-in Placebo Period||0
10507570|NCT01275755|11658357|FG000|STARTED|Double-blind Treatment Period||41
10507571|NCT01275755|11658358|FG001|STARTED|Double-blind Treatment Period||40
10507572|NCT01275755|11658357|FG000|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||41
10507573|NCT01275755|11658358|FG001|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||40
10507574|NCT01275755|11658357|FG000|COMPLETED|Double-blind Treatment Period||39
10507575|NCT01275755|11658358|FG001|COMPLETED|Double-blind Treatment Period||37
10507576|NCT01275755|11658357|FG000|NOT COMPLETED|Double-blind Treatment Period||2
10507577|NCT01275755|11658358|FG001|NOT COMPLETED|Double-blind Treatment Period||3
10507578|NCT01275755|11658357|FG000|STARTED|Run-out Placebo Period||39
10507579|NCT01275755|11658358|FG001|STARTED|Run-out Placebo Period||37
10507580|NCT01275755|11658357|FG000|COMPLETED|Run-out Placebo Period||38
10507581|NCT01275755|11658358|FG001|COMPLETED|Run-out Placebo Period||37
10507582|NCT01275755|11658357|FG000|NOT COMPLETED|Run-out Placebo Period||1
10507583|NCT01275755|11658358|FG001|NOT COMPLETED|Run-out Placebo Period||0
10507584|NCT01275833|11658366|FG000|STARTED|Overall Study||1
10507585|NCT01275833|11658367|FG001|STARTED|Overall Study||1
10507586|NCT01275833|11658366|FG000|COMPLETED|Overall Study||0
10507587|NCT01275833|11658367|FG001|COMPLETED|Overall Study||0
10507588|NCT01275833|11658366|FG000|NOT COMPLETED|Overall Study||1
10507589|NCT01275833|11658367|FG001|NOT COMPLETED|Overall Study||1
10507590|NCT01276041|11658373|FG000|STARTED|Overall Study||70
10507591|NCT01276041|11658373|FG000|COMPLETED|Overall Study||67
10507592|NCT01276041|11658373|FG000|NOT COMPLETED|Overall Study||3
10507593|NCT01276106|11658381|FG000|STARTED|Overall Study||65
10507594|NCT01276106|11658382|FG001|STARTED|Overall Study||64
10507595|NCT01276106|11658383|FG002|STARTED|Overall Study||65
10507596|NCT01276106|11658384|FG003|STARTED|Overall Study||65
10507597|NCT01276106|11658381|FG000|COMPLETED|Overall Study||53
10507598|NCT01276106|11658382|FG001|COMPLETED|Overall Study||55
10507599|NCT01276106|11658383|FG002|COMPLETED|Overall Study||49
10507600|NCT01276106|11658384|FG003|COMPLETED|Overall Study||52
10507601|NCT01276106|11658381|FG000|NOT COMPLETED|Overall Study||12
10507602|NCT01276106|11658382|FG001|NOT COMPLETED|Overall Study||9
10507603|NCT01276106|11658383|FG002|NOT COMPLETED|Overall Study||16
10507604|NCT01276106|11658384|FG003|NOT COMPLETED|Overall Study||13
10507605|NCT01276171|11658397|FG000|STARTED|Overall Study||249
10507606|NCT01276171|11658398|FG001|STARTED|Overall Study||244
10507607|NCT01276171|11658399|FG002|STARTED|Overall Study||256
10507608|NCT01276171|11658397|FG000|COMPLETED|Overall Study||249
10507609|NCT01276171|11658398|FG001|COMPLETED|Overall Study||244
10507610|NCT01276171|11658399|FG002|COMPLETED|Overall Study||256
10507611|NCT01276171|11658397|FG000|NOT COMPLETED|Overall Study||0
10507612|NCT01276171|11658398|FG001|NOT COMPLETED|Overall Study||0
10507613|NCT01276171|11658399|FG002|NOT COMPLETED|Overall Study||0
10507614|NCT01276184|11658409|FG000|STARTED|Overall Study||13
10507615|NCT01276184|11658410|FG001|STARTED|Overall Study||9
10507616|NCT01276184|11658409|FG000|COMPLETED|Overall Study||13
10507617|NCT01276184|11658410|FG001|COMPLETED|Overall Study||9
10507618|NCT01276184|11658409|FG000|NOT COMPLETED|Overall Study||0
10507619|NCT01276184|11658410|FG001|NOT COMPLETED|Overall Study||0
10507620|NCT01276197|11658418|FG000|STARTED|Overall Study||308
10507621|NCT01276197|11658419|FG001|STARTED|Overall Study||310
10507622|NCT01276197|11658418|FG000|COMPLETED|Overall Study||200
10507623|NCT01276197|11658419|FG001|COMPLETED|Overall Study||200
10507624|NCT01276197|11658418|FG000|NOT COMPLETED|Overall Study||108
10507625|NCT01276197|11658419|FG001|NOT COMPLETED|Overall Study||110
10507626|NCT01276223|11658428|FG000|STARTED|Overall Study||78
10507627|NCT01276223|11658429|FG001|STARTED|Overall Study||107
10507628|NCT01276223|11658430|FG002|STARTED|Overall Study||104
10507629|NCT01276223|11658428|FG000|COMPLETED|Overall Study||67
10507630|NCT01276223|11658429|FG001|COMPLETED|Overall Study||103
10507631|NCT01276223|11658430|FG002|COMPLETED|Overall Study||101
10507632|NCT01276223|11658428|FG000|NOT COMPLETED|Overall Study||11
10507633|NCT01276223|11658429|FG001|NOT COMPLETED|Overall Study||4
10507634|NCT01276223|11658430|FG002|NOT COMPLETED|Overall Study||3
10507635|NCT01276236|11658437|FG000|STARTED|Overall Study||13
10507636|NCT01276236|11658437|FG000|Week 36 Visit|Overall Study||13
10507637|NCT01276236|11658437|FG000|Week 56 Visit|Overall Study||9
10507638|NCT01276236|11658437|FG000|Week 76 Visit|Overall Study||8
10507639|NCT01276236|11658437|FG000|COMPLETED|Overall Study||7
10507640|NCT01276236|11658437|FG000|NOT COMPLETED|Overall Study||6
10507641|NCT01276288|11658441|FG000|STARTED|Overall Study||7
10507642|NCT01276288|11658442|FG001|STARTED|Overall Study||6
10507643|NCT01276288|11658443|FG002|STARTED|Overall Study||5
10507644|NCT01276288|11658444|FG003|STARTED|Overall Study||5
10507645|NCT01276288|11658441|FG000|Received EMPA|Overall Study||6
10507646|NCT01276288|11658442|FG001|Received EMPA|Overall Study||5
10711036|NCT02655679|11876426|FG003|STARTED|Overall Study||24
10711037|NCT02655679|11876427|FG004|STARTED|Overall Study||20
10711038|NCT02655679|11876423|FG000|Received Study Drug (Safety Population)|Overall Study||20
10711039|NCT02655679|11876424|FG001|Received Study Drug (Safety Population)|Overall Study||19
10810075|NCT03807245|11971959|FG002|COMPLETED|Overall Study||12
10810076|NCT03807245|11971957|FG000|NOT COMPLETED|Overall Study||1
10810077|NCT03807245|11971958|FG001|NOT COMPLETED|Overall Study||0
10810078|NCT03807245|11971959|FG002|NOT COMPLETED|Overall Study||0
10810079|NCT03805971|11971967|FG000|STARTED|Overall Study||65
10507647|NCT01276288|11658443|FG002|Received EMPA|Overall Study||5
10507648|NCT01276288|11658444|FG003|Received EMPA|Overall Study||5
10507649|NCT01276288|11658441|FG000|Received EMPA+HCT|Overall Study||5
10507650|NCT01276288|11658442|FG001|Received EMPA+HCT|Overall Study||5
10507651|NCT01276288|11658443|FG002|Received EMPA+HCT|Overall Study||0
10507652|NCT01276288|11658444|FG003|Received EMPA+HCT|Overall Study||0
10507653|NCT01276288|11658441|FG000|Received EMPA+TOR|Overall Study||0
10507654|NCT01276288|11658442|FG001|Received EMPA+TOR|Overall Study||0
10507655|NCT01276288|11658443|FG002|Received EMPA+TOR|Overall Study||5
10507656|NCT01276288|11658444|FG003|Received EMPA+TOR|Overall Study||5
10507657|NCT01276288|11658441|FG000|COMPLETED|Overall Study||5
10507658|NCT01276288|11658442|FG001|COMPLETED|Overall Study||5
10507659|NCT01276288|11658443|FG002|COMPLETED|Overall Study||5
10507660|NCT01276288|11658444|FG003|COMPLETED|Overall Study||5
10507661|NCT01276288|11658441|FG000|NOT COMPLETED|Overall Study||2
10507662|NCT01276288|11658442|FG001|NOT COMPLETED|Overall Study||1
10507663|NCT01276288|11658443|FG002|NOT COMPLETED|Overall Study||0
10507664|NCT01276288|11658444|FG003|NOT COMPLETED|Overall Study||0
10507665|NCT01276301|11658466|FG000|STARTED|First Intervention||8
10507666|NCT01276301|11658467|FG001|STARTED|First Intervention||8
10507667|NCT01276301|11658466|FG000|COMPLETED|First Intervention||8
10507668|NCT01276301|11658467|FG001|COMPLETED|First Intervention||8
10507669|NCT01276301|11658466|FG000|NOT COMPLETED|First Intervention||0
10507670|NCT01276301|11658467|FG001|NOT COMPLETED|First Intervention||0
10507671|NCT01276301|11658466|FG000|STARTED|Washout Period of 7 Days||8
10507672|NCT01276301|11658467|FG001|STARTED|Washout Period of 7 Days||8
10507673|NCT01276301|11658466|FG000|COMPLETED|Washout Period of 7 Days||8
10507674|NCT01276301|11658467|FG001|COMPLETED|Washout Period of 7 Days||8
10507675|NCT01276301|11658466|FG000|NOT COMPLETED|Washout Period of 7 Days||0
10507676|NCT01276301|11658467|FG001|NOT COMPLETED|Washout Period of 7 Days||0
10507677|NCT01276301|11658466|FG000|STARTED|Second Intervention||8
10507678|NCT01276301|11658467|FG001|STARTED|Second Intervention||8
10507679|NCT01276301|11658466|FG000|COMPLETED|Second Intervention||8
10507680|NCT01276301|11658467|FG001|COMPLETED|Second Intervention||8
10507681|NCT01276301|11658466|FG000|NOT COMPLETED|Second Intervention||0
10507682|NCT01276301|11658467|FG001|NOT COMPLETED|Second Intervention||0
10528294|NCT01394003|11680552|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
10528295|NCT01394003|11680553|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
10528296|NCT01394003|11680554|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
10528297|NCT01394003|11680555|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
10528298|NCT01394003|11680556|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3
10528299|NCT01394003|11680557|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3
10528300|NCT01394003|11680558|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
10528301|NCT01394003|11680559|FG007|Received at Least 1 Dose of Study Drug|Overall Study||2
10528302|NCT01394003|11680552|FG000|COMPLETED|Overall Study||3
10528303|NCT01394003|11680553|FG001|COMPLETED|Overall Study||8
10528304|NCT01394003|11680554|FG002|COMPLETED|Overall Study||3
10528305|NCT01394003|11680555|FG003|COMPLETED|Overall Study||6
10528306|NCT01394003|11680556|FG004|COMPLETED|Overall Study||3
10711040|NCT02655679|11876425|FG002|Received Study Drug (Safety Population)|Overall Study||20
10711041|NCT02655679|11876426|FG003|Received Study Drug (Safety Population)|Overall Study||24
10711042|NCT02655679|11876427|FG004|Received Study Drug (Safety Population)|Overall Study||20
10711043|NCT02655679|11876423|FG000|COMPLETED|Overall Study||18
10711044|NCT02655679|11876424|FG001|COMPLETED|Overall Study||16
10711045|NCT02655679|11876425|FG002|COMPLETED|Overall Study||19
10507683|NCT01276314|11658478|FG000|STARTED|Overall Study||48
10507684|NCT01276314|11658479|FG001|STARTED|Overall Study||43
10507685|NCT01276314|11658480|FG002|STARTED|Overall Study||22
10507686|NCT01276314|11658481|FG003|STARTED|Overall Study||22
10507687|NCT01276314|11658478|FG000|COMPLETED|Overall Study||38
10507688|NCT01276314|11658479|FG001|COMPLETED|Overall Study||33
10507689|NCT01276314|11658480|FG002|COMPLETED|Overall Study||18
10507690|NCT01276314|11658481|FG003|COMPLETED|Overall Study||17
10507691|NCT01276314|11658478|FG000|NOT COMPLETED|Overall Study||10
10507692|NCT01276314|11658479|FG001|NOT COMPLETED|Overall Study||10
10507693|NCT01276314|11658480|FG002|NOT COMPLETED|Overall Study||4
10507694|NCT01276314|11658481|FG003|NOT COMPLETED|Overall Study||5
10507695|NCT01276327|11658493|FG000|STARTED|Overall Study||32
10507696|NCT01276327|11658494|FG001|STARTED|Overall Study||32
10507697|NCT01276327|11658493|FG000|COMPLETED|Overall Study||30
10507698|NCT01276327|11658494|FG001|COMPLETED|Overall Study||29
10507699|NCT01276327|11658493|FG000|NOT COMPLETED|Overall Study||2
10507700|NCT01276327|11658494|FG001|NOT COMPLETED|Overall Study||3
10507701|NCT01276353|11658502|FG000|STARTED|Double-blind||22
10507702|NCT01276353|11658503|FG001|STARTED|Double-blind||23
10507703|NCT01276353|11658502|FG000|COMPLETED|Double-blind||19
10507704|NCT01276353|11658503|FG001|COMPLETED|Double-blind||23
10507705|NCT01276353|11658502|FG000|NOT COMPLETED|Double-blind||3
10507706|NCT01276353|11658503|FG001|NOT COMPLETED|Double-blind||0
10507707|NCT01276353|11658502|FG000|STARTED|Extension||19
10507708|NCT01276353|11658503|FG001|STARTED|Extension||23
10507709|NCT01276353|11658502|FG000|COMPLETED|Extension||12
10507710|NCT01276353|11658503|FG001|COMPLETED|Extension||14
10507711|NCT01276353|11658502|FG000|NOT COMPLETED|Extension||7
10507712|NCT01276353|11658503|FG001|NOT COMPLETED|Extension||9
10507713|NCT01276379|11658515|FG000|STARTED|Overall Study||221
10507714|NCT01276379|11658515|FG000|COMPLETED|Overall Study||181
10507715|NCT01276379|11658515|FG000|NOT COMPLETED|Overall Study||40
10507716|NCT01276457|11658523|FG000|STARTED|Core Study||142
10507717|NCT01276457|11658524|FG001|STARTED|Core Study||143
10507718|NCT01276457|11658523|FG000|COMPLETED|Core Study||129
10507719|NCT01276457|11658524|FG001|COMPLETED|Core Study||123
10507720|NCT01276457|11658523|FG000|NOT COMPLETED|Core Study||13
10507721|NCT01276457|11658524|FG001|NOT COMPLETED|Core Study||20
10507722|NCT01276457|11658523|FG000|STARTED|Extension Study||111
10507723|NCT01276457|11658524|FG001|STARTED|Extension Study||112
10507724|NCT01276457|11658523|FG000|COMPLETED|Extension Study||105
10507725|NCT01276457|11658524|FG001|COMPLETED|Extension Study||110
10507726|NCT01276457|11658523|FG000|NOT COMPLETED|Extension Study||6
10507727|NCT01276457|11658524|FG001|NOT COMPLETED|Extension Study||2
10507728|NCT01276509|11658534|FG000|STARTED|Overall Study||66
10507729|NCT01276509|11658535|FG001|STARTED|Overall Study||65
10507730|NCT01276509|11658536|FG002|STARTED|Overall Study||68
10507731|NCT01276509|11658537|FG003|STARTED|Overall Study||63
10507732|NCT01276509|11658534|FG000|COMPLETED|Overall Study||53
10507733|NCT01276509|11658535|FG001|COMPLETED|Overall Study||53
10507734|NCT01276509|11658536|FG002|COMPLETED|Overall Study||63
10507735|NCT01276509|11658537|FG003|COMPLETED|Overall Study||58
10507736|NCT01276509|11658534|FG000|NOT COMPLETED|Overall Study||13
10507737|NCT01276509|11658535|FG001|NOT COMPLETED|Overall Study||12
10507738|NCT01276509|11658536|FG002|NOT COMPLETED|Overall Study||5
10507739|NCT01276509|11658537|FG003|NOT COMPLETED|Overall Study||5
10507740|NCT01276535|11658547|FG000|STARTED|Overall Study||12
10507741|NCT01276535|11658547|FG000|COMPLETED|Overall Study||12
10507742|NCT01276535|11658547|FG000|NOT COMPLETED|Overall Study||0
10507743|NCT01276639|11658554|FG000|STARTED|Week 0 to 16||363
10507744|NCT01276639|11658555|FG001|STARTED|Week 0 to 16||361
10507745|NCT01276639|11658556|FG002|STARTED|Week 0 to 16||177
10507746|NCT01276639|11658557|FG003|STARTED|Week 0 to 16||0
10507747|NCT01276639|11658558|FG004|STARTED|Week 0 to 16||0
10507748|NCT01276639|11658554|FG000|Treated|Week 0 to 16||363
10507749|NCT01276639|11658555|FG001|Treated|Week 0 to 16||360
10507750|NCT01276639|11658556|FG002|Treated|Week 0 to 16||177
10711046|NCT02655679|11876426|FG003|COMPLETED|Overall Study||20
10711047|NCT02655679|11876427|FG004|COMPLETED|Overall Study||19
10711048|NCT02655679|11876423|FG000|NOT COMPLETED|Overall Study||3
10711049|NCT02655679|11876424|FG001|NOT COMPLETED|Overall Study||3
10711050|NCT02655679|11876425|FG002|NOT COMPLETED|Overall Study||1
10711051|NCT02655679|11876426|FG003|NOT COMPLETED|Overall Study||4
10711052|NCT02655679|11876427|FG004|NOT COMPLETED|Overall Study||1
10711053|NCT02655887|11876440|FG000|STARTED|Overall Study|Intent to Treat (ITT) population.|170
10711054|NCT02655887|11876440|FG000|COMPLETED|Overall Study|Completed 12-month follow-up.|156
10507751|NCT01276639|11658557|FG003|Treated|Week 0 to 16||0
10507752|NCT01276639|11658558|FG004|Treated|Week 0 to 16||0
10507753|NCT01276639|11658554|FG000|COMPLETED|Week 0 to 16||313
10507754|NCT01276639|11658555|FG001|COMPLETED|Week 0 to 16||320
10507755|NCT01276639|11658556|FG002|COMPLETED|Week 0 to 16||132
10507756|NCT01276639|11658557|FG003|COMPLETED|Week 0 to 16||0
10507757|NCT01276639|11658558|FG004|COMPLETED|Week 0 to 16||0
10507758|NCT01276639|11658554|FG000|NOT COMPLETED|Week 0 to 16||50
10507759|NCT01276639|11658555|FG001|NOT COMPLETED|Week 0 to 16||41
10507760|NCT01276639|11658556|FG002|NOT COMPLETED|Week 0 to 16||45
10507761|NCT01276639|11658557|FG003|NOT COMPLETED|Week 0 to 16||0
10507762|NCT01276639|11658558|FG004|NOT COMPLETED|Week 0 to 16||0
10507763|NCT01276639|11658554|FG000|STARTED|Week 16 to 52||313
10507764|NCT01276639|11658555|FG001|STARTED|Week 16 to 52||320
10507765|NCT01276639|11658556|FG002|STARTED|Week 16 to 52||0
10711055|NCT02655887|11876440|FG000|NOT COMPLETED|Overall Study||14
10507766|NCT01276639|11658557|FG003|STARTED|Week 16 to 52||66
10507767|NCT01276639|11658558|FG004|STARTED|Week 16 to 52||66
10507768|NCT01276639|11658554|FG000|COMPLETED|Week 16 to 52||186
10507769|NCT01276639|11658555|FG001|COMPLETED|Week 16 to 52||219
10507770|NCT01276639|11658556|FG002|COMPLETED|Week 16 to 52||0
10507771|NCT01276639|11658557|FG003|COMPLETED|Week 16 to 52||50
10507772|NCT01276639|11658558|FG004|COMPLETED|Week 16 to 52||45
10507773|NCT01276639|11658554|FG000|NOT COMPLETED|Week 16 to 52||127
10507774|NCT01276639|11658555|FG001|NOT COMPLETED|Week 16 to 52||101
10507775|NCT01276639|11658556|FG002|NOT COMPLETED|Week 16 to 52||0
10507776|NCT01276639|11658557|FG003|NOT COMPLETED|Week 16 to 52||16
10507777|NCT01276639|11658558|FG004|NOT COMPLETED|Week 16 to 52||21
10507778|NCT01276652|11658576|FG000|STARTED|Period 1: Randomization||9
10711056|NCT02656069|11876446|FG000|STARTED|First Intervention||44
10711057|NCT02656069|11876447|FG001|STARTED|First Intervention||36
10711058|NCT02656069|11876446|FG000|COMPLETED|First Intervention||44
10711059|NCT02656069|11876447|FG001|COMPLETED|First Intervention||36
10507779|NCT01276652|11658577|FG001|STARTED|Period 1: Randomization||8
10507780|NCT01276652|11658578|FG002|STARTED|Period 1: Randomization|No subjects were enrolled in this arm during Period 1.|0
10507781|NCT01276652|11658576|FG000|COMPLETED|Period 1: Randomization||9
10507782|NCT01276652|11658577|FG001|COMPLETED|Period 1: Randomization||8
10507783|NCT01276652|11658578|FG002|COMPLETED|Period 1: Randomization||0
10507784|NCT01276652|11658576|FG000|NOT COMPLETED|Period 1: Randomization||0
10507785|NCT01276652|11658577|FG001|NOT COMPLETED|Period 1: Randomization||0
10507786|NCT01276652|11658578|FG002|NOT COMPLETED|Period 1: Randomization||0
10507787|NCT01276652|11658576|FG000|STARTED|Period 2: Observational||9
10507788|NCT01276652|11658577|FG001|STARTED|Period 2: Observational||8
10507789|NCT01276652|11658578|FG002|STARTED|Period 2: Observational|Subjects were only enrolled in the Observational arm during Period 2.|5
10507790|NCT01276652|11658576|FG000|COMPLETED|Period 2: Observational||9
10507791|NCT01276652|11658577|FG001|COMPLETED|Period 2: Observational||8
10507792|NCT01276652|11658578|FG002|COMPLETED|Period 2: Observational||5
10507793|NCT01276652|11658576|FG000|NOT COMPLETED|Period 2: Observational||0
10507794|NCT01276652|11658577|FG001|NOT COMPLETED|Period 2: Observational||0
10507795|NCT01276652|11658578|FG002|NOT COMPLETED|Period 2: Observational||0
10507796|NCT01276756|11658593|FG000|STARTED|Overall Study||50
10507797|NCT01276756|11658594|FG001|STARTED|Overall Study||50
10507798|NCT01276756|11658593|FG000|COMPLETED|Overall Study||45
10507799|NCT01276756|11658594|FG001|COMPLETED|Overall Study||48
10507800|NCT01276756|11658593|FG000|NOT COMPLETED|Overall Study||5
10507801|NCT01276756|11658594|FG001|NOT COMPLETED|Overall Study||2
10507802|NCT01276821|11658602|FG000|STARTED|Overall Study||50
10507803|NCT01276821|11658603|FG001|STARTED|Overall Study||50
10507804|NCT01276821|11658602|FG000|COMPLETED|Overall Study||50
10507805|NCT01276821|11658603|FG001|COMPLETED|Overall Study||49
10507806|NCT01276821|11658602|FG000|NOT COMPLETED|Overall Study||0
10507807|NCT01276821|11658603|FG001|NOT COMPLETED|Overall Study||1
10507808|NCT01276847|11658612|FG000|STARTED|Overall Study||10
10507809|NCT01276847|11658613|FG001|STARTED|Overall Study||10
10507810|NCT01276847|11658614|FG002|STARTED|Overall Study||20
10507811|NCT01276847|11658612|FG000|COMPLETED|Overall Study||9
10507812|NCT01276847|11658613|FG001|COMPLETED|Overall Study||10
10507813|NCT01276847|11658614|FG002|COMPLETED|Overall Study||20
10507814|NCT01276847|11658612|FG000|NOT COMPLETED|Overall Study||1
10507815|NCT01276847|11658613|FG001|NOT COMPLETED|Overall Study||0
10507816|NCT01276847|11658614|FG002|NOT COMPLETED|Overall Study||0
10507817|NCT01276860|11658623|FG000|STARTED|Overall Study||5
10507818|NCT01276860|11658624|FG001|STARTED|Overall Study||2
10507819|NCT01276860|11658623|FG000|COMPLETED|Overall Study||5
10507820|NCT01276860|11658624|FG001|COMPLETED|Overall Study||2
10507821|NCT01276860|11658623|FG000|NOT COMPLETED|Overall Study||0
10507822|NCT01276860|11658624|FG001|NOT COMPLETED|Overall Study||0
10507823|NCT01277042|11658632|FG000|STARTED|Overall Study||606
10507824|NCT01277042|11658633|FG001|STARTED|Overall Study||606
10507825|NCT01277042|11658632|FG000|COMPLETED|Overall Study||598
10507826|NCT01277042|11658633|FG001|COMPLETED|Overall Study||601
10507827|NCT01277042|11658632|FG000|NOT COMPLETED|Overall Study||8
10507828|NCT01277042|11658633|FG001|NOT COMPLETED|Overall Study||5
10507829|NCT01277081|11658642|FG000|STARTED|Overall Study||100
10507830|NCT01277081|11658643|FG001|STARTED|Overall Study||100
10507831|NCT01277081|11658642|FG000|COMPLETED|Overall Study||100
10507832|NCT01277081|11658643|FG001|COMPLETED|Overall Study||100
10507833|NCT01277081|11658642|FG000|NOT COMPLETED|Overall Study||0
10507834|NCT01277081|11658643|FG001|NOT COMPLETED|Overall Study||0
10507835|NCT01277159|11658654|FG000|STARTED|Overall Study||21
10507836|NCT01277159|11658655|FG001|STARTED|Overall Study||22
10507837|NCT01277159|11658656|FG002|STARTED|Overall Study||22
10507838|NCT01277159|11658657|FG003|STARTED|Overall Study||22
10507839|NCT01277159|11658658|FG004|STARTED|Overall Study||21
10507840|NCT01277159|11658654|FG000|COMPLETED|Overall Study||17
10507841|NCT01277159|11658655|FG001|COMPLETED|Overall Study||21
10507842|NCT01277159|11658656|FG002|COMPLETED|Overall Study||19
10507843|NCT01277159|11658657|FG003|COMPLETED|Overall Study||19
10507844|NCT01277159|11658658|FG004|COMPLETED|Overall Study||16
10507845|NCT01277159|11658654|FG000|NOT COMPLETED|Overall Study||4
10507846|NCT01277159|11658655|FG001|NOT COMPLETED|Overall Study||1
10507847|NCT01277159|11658656|FG002|NOT COMPLETED|Overall Study||3
10507848|NCT01277159|11658657|FG003|NOT COMPLETED|Overall Study||3
10507849|NCT01277159|11658658|FG004|NOT COMPLETED|Overall Study||5
10507850|NCT01277302|11658673|FG000|STARTED|7-Month Fixed Treatment Period||85
10711060|NCT02656069|11876446|FG000|NOT COMPLETED|First Intervention||0
10810080|NCT03805971|11971967|FG000|COMPLETED|Overall Study||62
10810081|NCT03805971|11971967|FG000|NOT COMPLETED|Overall Study||3
10810082|NCT03802916|11971974|FG000|STARTED|Overall Study||15
10810083|NCT03802916|11971975|FG001|STARTED|Overall Study||15
10810084|NCT03802916|11971974|FG000|COMPLETED|Overall Study||15
10507851|NCT01277302|11658674|FG001|STARTED|7-Month Fixed Treatment Period||86
10507852|NCT01277302|11658675|FG002|STARTED|7-Month Fixed Treatment Period||31
10507853|NCT01277302|11658673|FG000|COMPLETED|7-Month Fixed Treatment Period||85
10507854|NCT01277302|11658674|FG001|COMPLETED|7-Month Fixed Treatment Period||86
10507855|NCT01277302|11658675|FG002|COMPLETED|7-Month Fixed Treatment Period||19
10507856|NCT01277302|11658673|FG000|NOT COMPLETED|7-Month Fixed Treatment Period||0
10507857|NCT01277302|11658674|FG001|NOT COMPLETED|7-Month Fixed Treatment Period||0
10507858|NCT01277302|11658675|FG002|NOT COMPLETED|7-Month Fixed Treatment Period||12
10507859|NCT01277302|11658673|FG000|STARTED|8-Month Alternate Dose Regimen Period||85
10507860|NCT01277302|11658674|FG001|STARTED|8-Month Alternate Dose Regimen Period||86
10507861|NCT01277302|11658675|FG002|STARTED|8-Month Alternate Dose Regimen Period||19
10507862|NCT01277302|11658673|FG000|COMPLETED|8-Month Alternate Dose Regimen Period||80
10507863|NCT01277302|11658674|FG001|COMPLETED|8-Month Alternate Dose Regimen Period||82
10507864|NCT01277302|11658675|FG002|COMPLETED|8-Month Alternate Dose Regimen Period||13
10810085|NCT03802916|11971975|FG001|COMPLETED|Overall Study||13
10507865|NCT01277302|11658673|FG000|NOT COMPLETED|8-Month Alternate Dose Regimen Period||5
10507866|NCT01277302|11658674|FG001|NOT COMPLETED|8-Month Alternate Dose Regimen Period||4
10507867|NCT01277302|11658675|FG002|NOT COMPLETED|8-Month Alternate Dose Regimen Period||6
10507868|NCT01277341|11658687|FG000|STARTED|Overall Study||150
10507869|NCT01277341|11658688|FG001|STARTED|Overall Study||150
10507870|NCT01277341|11658689|FG002|STARTED|Overall Study||149
10507871|NCT01277341|11658690|FG003|STARTED|Overall Study||152
10507872|NCT01277341|11658687|FG000|COMPLETED|Overall Study||146
10507873|NCT01277341|11658688|FG001|COMPLETED|Overall Study||145
10507874|NCT01277341|11658689|FG002|COMPLETED|Overall Study||145
10507875|NCT01277341|11658690|FG003|COMPLETED|Overall Study||146
10507876|NCT01277341|11658687|FG000|NOT COMPLETED|Overall Study||4
10507877|NCT01277341|11658688|FG001|NOT COMPLETED|Overall Study||5
10507878|NCT01277341|11658689|FG002|NOT COMPLETED|Overall Study||4
10507879|NCT01277341|11658690|FG003|NOT COMPLETED|Overall Study||6
10507880|NCT01277354|11658702|FG000|STARTED|Overall Study||1
10507881|NCT01277354|11658703|FG001|STARTED|Overall Study||1
10507882|NCT01277354|11658702|FG000|COMPLETED|Overall Study||1
10507883|NCT01277354|11658703|FG001|COMPLETED|Overall Study||1
10507884|NCT01277354|11658702|FG000|NOT COMPLETED|Overall Study||0
10507885|NCT01277354|11658703|FG001|NOT COMPLETED|Overall Study||0
10507886|NCT01277510|11658711|FG000|STARTED|Double-blind Phase||21
10507887|NCT01277510|11658712|FG001|STARTED|Double-blind Phase||22
10711061|NCT02656069|11876447|FG001|NOT COMPLETED|First Intervention||0
10711062|NCT02656069|11876446|FG000|STARTED|Second Intervention||44
10711063|NCT02656069|11876447|FG001|STARTED|Second Intervention||36
10711064|NCT02656069|11876446|FG000|COMPLETED|Second Intervention||43
10711065|NCT02656069|11876447|FG001|COMPLETED|Second Intervention||35
10711066|NCT02656069|11876446|FG000|NOT COMPLETED|Second Intervention||1
10711067|NCT02656069|11876447|FG001|NOT COMPLETED|Second Intervention||1
10711068|NCT02656160|11876453|FG000|STARTED|First Study Night||7
10711069|NCT02656160|11876454|FG001|STARTED|First Study Night||6
10711070|NCT02656160|11876453|FG000|COMPLETED|First Study Night||7
10711071|NCT02656160|11876454|FG001|COMPLETED|First Study Night||6
10711072|NCT02656160|11876453|FG000|NOT COMPLETED|First Study Night||0
10711073|NCT02656160|11876454|FG001|NOT COMPLETED|First Study Night||0
10711074|NCT02656160|11876453|FG000|STARTED|Second Study Night|3 subjects did not return for the second study night|4
10711075|NCT02656160|11876454|FG001|STARTED|Second Study Night||6
10711076|NCT02656160|11876453|FG000|COMPLETED|Second Study Night||4
10711077|NCT02656160|11876454|FG001|COMPLETED|Second Study Night||6
10711078|NCT02656160|11876453|FG000|NOT COMPLETED|Second Study Night||0
10711079|NCT02656160|11876454|FG001|NOT COMPLETED|Second Study Night||0
10711080|NCT02656173|11876462|FG000|STARTED|Overall Study||285
10711081|NCT02656173|11876463|FG001|STARTED|Overall Study||283
10711082|NCT02656173|11876462|FG000|Received Treatment|Overall Study||284
10711083|NCT02656173|11876463|FG001|Received Treatment|Overall Study||282
10711084|NCT02656173|11876462|FG000|COMPLETED|Overall Study||272
10711085|NCT02656173|11876463|FG001|COMPLETED|Overall Study||272
10711086|NCT02656173|11876462|FG000|NOT COMPLETED|Overall Study||13
10711087|NCT02656173|11876463|FG001|NOT COMPLETED|Overall Study||11
10711088|NCT02656329|11876473|FG000|STARTED|Overall Study||164
10711089|NCT02656329|11876474|FG001|STARTED|Overall Study||157
10711090|NCT02656329|11876473|FG000|COMPLETED|Overall Study||0
10810086|NCT03802916|11971974|FG000|NOT COMPLETED|Overall Study||0
10810087|NCT03802916|11971975|FG001|NOT COMPLETED|Overall Study||2
10810088|NCT03809039|11971992|FG000|STARTED|Part 1|11 subjects (2 subjects in each of Part 1 MT-6345 1 mg, 5 mg, 20 mg, 60 mg, 240 mg, and 1 subject in Part 1 MT-6345 120 mg) received a matching placebo per their respective dose. The subjects are unique subjects, and were not counted more than once across any arms except for Part 2 Placebo.|11
10810089|NCT03809039|11971993|FG001|STARTED|Part 1|The subjects are unique subjects, and were not counted more than once across any arms.|6
10811213|NCT03769896|11972940|FG000|STARTED|Open-label Phase||47
10711091|NCT02656329|11876474|FG001|COMPLETED|Overall Study||0
10711092|NCT02656329|11876473|FG000|NOT COMPLETED|Overall Study||164
10711093|NCT02656329|11876474|FG001|NOT COMPLETED|Overall Study||157
10711094|NCT02656420|11876485|FG000|STARTED|Overall Study||55
10711095|NCT02656420|11876486|FG001|STARTED|Overall Study||25
10711096|NCT02656420|11876487|FG002|STARTED|Overall Study||35
10711097|NCT02656420|11876488|FG003|STARTED|Overall Study||55
10711098|NCT02656420|11876485|FG000|COMPLETED|Overall Study||55
10711099|NCT02656420|11876486|FG001|COMPLETED|Overall Study||24
10711100|NCT02656420|11876487|FG002|COMPLETED|Overall Study||35
10711101|NCT02656420|11876488|FG003|COMPLETED|Overall Study||55
10711102|NCT02656420|11876485|FG000|NOT COMPLETED|Overall Study||0
10711103|NCT02656420|11876486|FG001|NOT COMPLETED|Overall Study||1
10507888|NCT01277510|11658711|FG000|Received Investigational Product|Double-blind Phase||21
10507889|NCT01277510|11658712|FG001|Received Investigational Product|Double-blind Phase||22
10507890|NCT01277510|11658711|FG000|COMPLETED|Double-blind Phase|Completed investigational product|8
10507891|NCT01277510|11658712|FG001|COMPLETED|Double-blind Phase|Completed investigational product|4
10507892|NCT01277510|11658711|FG000|NOT COMPLETED|Double-blind Phase||13
10507893|NCT01277510|11658712|FG001|NOT COMPLETED|Double-blind Phase||18
10507894|NCT01277510|11658711|FG000|STARTED|Open-label Phase||8
10507895|NCT01277510|11658712|FG001|STARTED|Open-label Phase||4
10507896|NCT01277510|11658711|FG000|Received Investigational Product|Open-label Phase||6
10711104|NCT02656420|11876487|FG002|NOT COMPLETED|Overall Study||0
10711105|NCT02656420|11876488|FG003|NOT COMPLETED|Overall Study||0
10711106|NCT02656485|11876504|FG000|STARTED|Overall Study||9
10711107|NCT02656485|11876505|FG001|STARTED|Overall Study||9
10711108|NCT02656485|11876506|FG002|STARTED|Overall Study||9
10711109|NCT02656485|11876507|FG003|STARTED|Overall Study||9
10711110|NCT02656485|11876504|FG000|COMPLETED|Overall Study||7
10711111|NCT02656485|11876505|FG001|COMPLETED|Overall Study||6
10711112|NCT02656485|11876506|FG002|COMPLETED|Overall Study||7
10711113|NCT02656485|11876507|FG003|COMPLETED|Overall Study||7
10711114|NCT02656485|11876504|FG000|NOT COMPLETED|Overall Study||2
10711115|NCT02656485|11876505|FG001|NOT COMPLETED|Overall Study||3
10711116|NCT02656485|11876506|FG002|NOT COMPLETED|Overall Study||2
10711117|NCT02656485|11876507|FG003|NOT COMPLETED|Overall Study||2
10711118|NCT02656680|11876521|FG000|STARTED|Overall Study||40
10711119|NCT02656680|11876522|FG001|STARTED|Overall Study||40
10810090|NCT03809039|11971994|FG002|STARTED|Part 1|The subjects are unique subjects, and were not counted more than once across any arms.|6
10810091|NCT03809039|11971995|FG003|STARTED|Part 1|The subjects are unique subjects, and were not counted more than once across any arms except for Part 2 MT-6345 20mg.|6
10810092|NCT03809039|11971996|FG004|STARTED|Part 1|The subjects are unique subjects, and were not counted more than once across any arms.|6
10810093|NCT03809039|11971997|FG005|STARTED|Part 1|The subjects are unique subjects, and were not counted more than once across any arms.|4
10810094|NCT03809039|11971998|FG006|STARTED|Part 1|The subjects are unique subjects, and were not counted more than once across any arms.|5
10810095|NCT03809039|11971999|FG007|STARTED|Part 1||0
10507897|NCT01277510|11658712|FG001|Received Investigational Product|Open-label Phase||4
10507898|NCT01277510|11658711|FG000|COMPLETED|Open-label Phase|Completed investigational product|1
10507899|NCT01277510|11658712|FG001|COMPLETED|Open-label Phase|Completed investigational product|1
10507900|NCT01277510|11658711|FG000|NOT COMPLETED|Open-label Phase||7
10507901|NCT01277510|11658712|FG001|NOT COMPLETED|Open-label Phase||3
10507902|NCT01277523|11658723|FG000|STARTED|Overall Study||135
10507903|NCT01277523|11658724|FG001|STARTED|Overall Study||127
10507904|NCT01277523|11658725|FG002|STARTED|Overall Study||130
10507905|NCT01277523|11658723|FG000|COMPLETED|Overall Study||132
10507906|NCT01277523|11658724|FG001|COMPLETED|Overall Study||126
10507907|NCT01277523|11658725|FG002|COMPLETED|Overall Study||130
10507908|NCT01277523|11658723|FG000|NOT COMPLETED|Overall Study||3
10507909|NCT01277523|11658724|FG001|NOT COMPLETED|Overall Study||1
10507910|NCT01277523|11658725|FG002|NOT COMPLETED|Overall Study||0
10507911|NCT01277549|11658735|FG000|STARTED|Overall Study||41
10507912|NCT01277549|11658736|FG001|STARTED|Overall Study||29
10507913|NCT01277549|11658735|FG000|COMPLETED|Overall Study||15
10507914|NCT01277549|11658736|FG001|COMPLETED|Overall Study||15
10507915|NCT01277549|11658735|FG000|NOT COMPLETED|Overall Study||26
10507916|NCT01277549|11658736|FG001|NOT COMPLETED|Overall Study||14
10507917|NCT01277601|11658749|FG000|STARTED|Overall Study||188
10507918|NCT01277601|11658750|FG001|STARTED|Overall Study||187
10507919|NCT01277601|11658751|FG002|STARTED|Overall Study||190
10507920|NCT01277601|11658752|FG003|STARTED|Overall Study||186
10507921|NCT01277601|11658749|FG000|COMPLETED|Overall Study||151
10507922|NCT01277601|11658750|FG001|COMPLETED|Overall Study||139
10507923|NCT01277601|11658751|FG002|COMPLETED|Overall Study||163
10507924|NCT01277601|11658752|FG003|COMPLETED|Overall Study||150
10507925|NCT01277601|11658749|FG000|NOT COMPLETED|Overall Study||37
10507926|NCT01277601|11658750|FG001|NOT COMPLETED|Overall Study||48
10507927|NCT01277601|11658751|FG002|NOT COMPLETED|Overall Study||27
10507928|NCT01277601|11658752|FG003|NOT COMPLETED|Overall Study||36
10507929|NCT01277666|11658782|FG000|STARTED|Overall Study||203
10507930|NCT01277666|11658783|FG001|STARTED|Overall Study||203
10507931|NCT01277666|11658784|FG002|STARTED|Overall Study||202
10507932|NCT01277666|11658782|FG000|COMPLETED|Overall Study||158
10507933|NCT01277666|11658783|FG001|COMPLETED|Overall Study||144
10507934|NCT01277666|11658784|FG002|COMPLETED|Overall Study||153
10507935|NCT01277666|11658782|FG000|NOT COMPLETED|Overall Study||45
10507936|NCT01277666|11658783|FG001|NOT COMPLETED|Overall Study||59
10507937|NCT01277666|11658784|FG002|NOT COMPLETED|Overall Study||49
10507938|NCT01277718|11658792|FG000|STARTED|Period 1 - First Intervention||10
10507939|NCT01277718|11658793|FG001|STARTED|Period 1 - First Intervention||10
10507940|NCT01277718|11658792|FG000|COMPLETED|Period 1 - First Intervention||10
10507941|NCT01277718|11658793|FG001|COMPLETED|Period 1 - First Intervention||10
10507942|NCT01277718|11658792|FG000|NOT COMPLETED|Period 1 - First Intervention||0
10507943|NCT01277718|11658793|FG001|NOT COMPLETED|Period 1 - First Intervention||0
10507944|NCT01277718|11658792|FG000|STARTED|Washout Period of 13 Days||10
10810096|NCT03809039|11972000|FG008|STARTED|Part 1||0
10810097|NCT03809039|11971992|FG000|COMPLETED|Part 1||10
10810098|NCT03809039|11971993|FG001|COMPLETED|Part 1||6
10507945|NCT01277718|11658793|FG001|STARTED|Washout Period of 13 Days||10
10507946|NCT01277718|11658792|FG000|COMPLETED|Washout Period of 13 Days||10
10507947|NCT01277718|11658793|FG001|COMPLETED|Washout Period of 13 Days||10
10507948|NCT01277718|11658792|FG000|NOT COMPLETED|Washout Period of 13 Days||0
10507949|NCT01277718|11658793|FG001|NOT COMPLETED|Washout Period of 13 Days||0
10507950|NCT01277718|11658792|FG000|STARTED|Period 2 - Second Intervention||10
10507951|NCT01277718|11658793|FG001|STARTED|Period 2 - Second Intervention||10
10507952|NCT01277718|11658792|FG000|COMPLETED|Period 2 - Second Intervention||10
10507953|NCT01277718|11658793|FG001|COMPLETED|Period 2 - Second Intervention||7
10507954|NCT01277718|11658792|FG000|NOT COMPLETED|Period 2 - Second Intervention||0
10507955|NCT01277718|11658793|FG001|NOT COMPLETED|Period 2 - Second Intervention||3
10507956|NCT01277718|11658792|FG000|STARTED|Washout Period of 13 Days||10
10711120|NCT02656680|11876521|FG000|COMPLETED|Overall Study||40
10711121|NCT02656680|11876522|FG001|COMPLETED|Overall Study||39
10711122|NCT02656680|11876521|FG000|NOT COMPLETED|Overall Study||0
10711123|NCT02656680|11876522|FG001|NOT COMPLETED|Overall Study||1
10507957|NCT01277718|11658793|FG001|STARTED|Washout Period of 13 Days||7
10507958|NCT01277718|11658792|FG000|COMPLETED|Washout Period of 13 Days||10
10507959|NCT01277718|11658793|FG001|COMPLETED|Washout Period of 13 Days||7
10507960|NCT01277718|11658792|FG000|NOT COMPLETED|Washout Period of 13 Days||0
10507961|NCT01277718|11658793|FG001|NOT COMPLETED|Washout Period of 13 Days||0
10507962|NCT01277718|11658792|FG000|STARTED|Period 3 - Third Intervention||10
10507963|NCT01277718|11658793|FG001|STARTED|Period 3 - Third Intervention||7
10507964|NCT01277718|11658792|FG000|COMPLETED|Period 3 - Third Intervention||10
10507965|NCT01277718|11658793|FG001|COMPLETED|Period 3 - Third Intervention||7
10507966|NCT01277718|11658792|FG000|NOT COMPLETED|Period 3 - Third Intervention||0
10507967|NCT01277718|11658793|FG001|NOT COMPLETED|Period 3 - Third Intervention||0
10507968|NCT01277744|11658801|FG000|STARTED|Overall Study||22
10507969|NCT01277744|11658801|FG000|COMPLETED|Overall Study||20
10507970|NCT01277744|11658801|FG000|NOT COMPLETED|Overall Study||2
10507971|NCT01277757|11658805|FG000|STARTED|Overall Study||30
10507972|NCT01277757|11658805|FG000|COMPLETED|Overall Study||28
10507973|NCT01277757|11658805|FG000|NOT COMPLETED|Overall Study||2
10507974|NCT01277783|11658809|FG000|STARTED|Overall Study||138
10507975|NCT01277783|11658809|FG000|COMPLETED|Overall Study||138
10507976|NCT01277783|11658809|FG000|NOT COMPLETED|Overall Study||0
10507977|NCT01277861|11658816|FG000|STARTED|Overall Study||51
10507978|NCT01277861|11658817|FG001|STARTED|Overall Study||49
10507979|NCT01277861|11658816|FG000|COMPLETED|Overall Study||49
10507980|NCT01277861|11658817|FG001|COMPLETED|Overall Study||47
10711124|NCT02656693|11876533|FG000|STARTED|Overall Study||326
10711125|NCT02656693|11876534|FG001|STARTED|Overall Study||216
10711126|NCT02656693|11876535|FG002|STARTED|Overall Study||298
10711127|NCT02656693|11876533|FG000|COMPLETED|Overall Study||325
10711128|NCT02656693|11876534|FG001|COMPLETED|Overall Study||214
10711129|NCT02656693|11876535|FG002|COMPLETED|Overall Study||295
10507981|NCT01277861|11658816|FG000|NOT COMPLETED|Overall Study||2
10507982|NCT01277861|11658817|FG001|NOT COMPLETED|Overall Study||2
10507983|NCT01277887|11658827|FG000|STARTED|Pre-Quit Treatment Phase||9
10507984|NCT01277887|11658828|FG001|STARTED|Pre-Quit Treatment Phase||10
10507985|NCT01277887|11658827|FG000|Entered Study|Pre-Quit Treatment Phase||7
10507986|NCT01277887|11658828|FG001|Entered Study|Pre-Quit Treatment Phase||10
10507987|NCT01277887|11658827|FG000|COMPLETED|Pre-Quit Treatment Phase||6
10507988|NCT01277887|11658828|FG001|COMPLETED|Pre-Quit Treatment Phase||10
10507989|NCT01277887|11658827|FG000|NOT COMPLETED|Pre-Quit Treatment Phase||3
10507990|NCT01277887|11658828|FG001|NOT COMPLETED|Pre-Quit Treatment Phase||0
10507991|NCT01277887|11658827|FG000|STARTED|Post-Quit Treatment Phase||6
10711130|NCT02656693|11876533|FG000|NOT COMPLETED|Overall Study||1
10711131|NCT02656693|11876534|FG001|NOT COMPLETED|Overall Study||2
10711132|NCT02656693|11876535|FG002|NOT COMPLETED|Overall Study||3
10711133|NCT02656745|11876543|FG000|STARTED|Overall Study||416
10711134|NCT02656745|11876543|FG000|COMPLETED|Overall Study||416
10711135|NCT02656745|11876543|FG000|NOT COMPLETED|Overall Study||0
10711136|NCT02656836|11876550|FG000|STARTED|Overall Study||9
10711137|NCT02656836|11876550|FG000|COMPLETED|Overall Study||6
10711138|NCT02656836|11876550|FG000|NOT COMPLETED|Overall Study||3
10711139|NCT02656875|11876554|FG000|STARTED|Overall Study||768
10507992|NCT01277887|11658828|FG001|STARTED|Post-Quit Treatment Phase||10
10507993|NCT01277887|11658827|FG000|COMPLETED|Post-Quit Treatment Phase||3
10507994|NCT01277887|11658828|FG001|COMPLETED|Post-Quit Treatment Phase||5
10507995|NCT01277887|11658827|FG000|NOT COMPLETED|Post-Quit Treatment Phase||3
10507996|NCT01277887|11658828|FG001|NOT COMPLETED|Post-Quit Treatment Phase||5
10507997|NCT01278030|11658836|FG000|STARTED|Overall Study||43
10507998|NCT01278030|11658837|FG001|STARTED|Overall Study||35
10507999|NCT01278030|11658836|FG000|COMPLETED|Overall Study||35
10508000|NCT01278030|11658837|FG001|COMPLETED|Overall Study||31
10508001|NCT01278030|11658836|FG000|NOT COMPLETED|Overall Study||8
10508002|NCT01278030|11658837|FG001|NOT COMPLETED|Overall Study||4
10508003|NCT01278160|11658845|FG000|STARTED|Overall Study||89
10508004|NCT01278160|11658846|FG001|STARTED|Overall Study||90
10508005|NCT01278160|11658845|FG000|COMPLETED|Overall Study||84
10508006|NCT01278160|11658846|FG001|COMPLETED|Overall Study||84
10508007|NCT01278160|11658845|FG000|NOT COMPLETED|Overall Study||5
10508008|NCT01278160|11658846|FG001|NOT COMPLETED|Overall Study||6
10508009|NCT01278173|11658852|FG000|STARTED|Overall Study||65
10508010|NCT01278173|11658852|FG000|COMPLETED|Overall Study||38
10508011|NCT01278173|11658852|FG000|NOT COMPLETED|Overall Study||27
10508012|NCT01278303|11658856|FG000|STARTED|Overall Study||82
10508013|NCT01278303|11658856|FG000|COMPLETED|Overall Study||82
10711140|NCT02656875|11876554|FG000|COMPLETED|Overall Study||698
10711141|NCT02656875|11876554|FG000|NOT COMPLETED|Overall Study||70
10711142|NCT02657031|11876560|FG000|STARTED|Overall Study||29
10711143|NCT02657031|11876561|FG001|STARTED|Overall Study||25
10508014|NCT01278303|11658856|FG000|NOT COMPLETED|Overall Study||0
10508015|NCT01278342|11658863|FG000|STARTED|Overall Study||7
10508016|NCT01278342|11658864|FG001|STARTED|Overall Study||31
10508017|NCT01278342|11658865|FG002|STARTED|Overall Study||32
10508018|NCT01278342|11658863|FG000|COMPLETED|Overall Study||3
10508019|NCT01278342|11658864|FG001|COMPLETED|Overall Study||30
10508020|NCT01278342|11658865|FG002|COMPLETED|Overall Study||32
10508021|NCT01278342|11658863|FG000|NOT COMPLETED|Overall Study||4
10508022|NCT01278342|11658864|FG001|NOT COMPLETED|Overall Study||1
10508023|NCT01278342|11658865|FG002|NOT COMPLETED|Overall Study||0
10711144|NCT02657031|11876560|FG000|COMPLETED|Overall Study||28
10711145|NCT02657031|11876561|FG001|COMPLETED|Overall Study||23
10711146|NCT02657031|11876560|FG000|NOT COMPLETED|Overall Study||1
10508024|NCT01278394|11658873|FG000|STARTED|Overall Study||29
10508025|NCT01278394|11658873|FG000|COMPLETED|Overall Study||28
10508026|NCT01278394|11658873|FG000|NOT COMPLETED|Overall Study||1
10508027|NCT01278407|11658880|FG000|STARTED|Confirmatory Phase||46
10508028|NCT01278407|11658881|FG001|STARTED|Confirmatory Phase||47
10508029|NCT01278407|11658882|FG002|STARTED|Confirmatory Phase||49
10508030|NCT01278407|11658883|FG003|STARTED|Confirmatory Phase||0
10508031|NCT01278407|11658884|FG004|STARTED|Confirmatory Phase||0
10508032|NCT01278407|11658880|FG000|COMPLETED|Confirmatory Phase||37
10508033|NCT01278407|11658881|FG001|COMPLETED|Confirmatory Phase||31
10508034|NCT01278407|11658882|FG002|COMPLETED|Confirmatory Phase||43
10508035|NCT01278407|11658883|FG003|COMPLETED|Confirmatory Phase||0
10508036|NCT01278407|11658884|FG004|COMPLETED|Confirmatory Phase||0
10650415|NCT02169440|11810703|FG001|COMPLETED|Overall Study||10
10650416|NCT02169440|11810702|FG000|NOT COMPLETED|Overall Study||0
10650417|NCT02169440|11810703|FG001|NOT COMPLETED|Overall Study||0
10650418|NCT02169453|11810714|FG000|STARTED|Overall Study||3
10650419|NCT02169453|11810715|FG001|STARTED|Overall Study||3
10650420|NCT02169453|11810716|FG002|STARTED|Overall Study||3
10650421|NCT02169453|11810717|FG003|STARTED|Overall Study||3
10650422|NCT02169453|11810714|FG000|25 mg BIA 9-1067|Overall Study||3
10650423|NCT02169453|11810715|FG001|25 mg BIA 9-1067|Overall Study||3
10650424|NCT02169453|11810716|FG002|25 mg BIA 9-1067|Overall Study||3
10650425|NCT02169453|11810717|FG003|25 mg BIA 9-1067|Overall Study||3
10508037|NCT01278407|11658880|FG000|NOT COMPLETED|Confirmatory Phase||9
10508038|NCT01278407|11658881|FG001|NOT COMPLETED|Confirmatory Phase||16
10508039|NCT01278407|11658882|FG002|NOT COMPLETED|Confirmatory Phase||6
10508040|NCT01278407|11658883|FG003|NOT COMPLETED|Confirmatory Phase||0
10508041|NCT01278407|11658884|FG004|NOT COMPLETED|Confirmatory Phase||0
10508042|NCT01278407|11658880|FG000|STARTED|Extension Phase||0
10508043|NCT01278407|11658881|FG001|STARTED|Extension Phase||0
10508044|NCT01278407|11658882|FG002|STARTED|Extension Phase||0
10508045|NCT01278407|11658883|FG003|STARTED|Extension Phase||46
10508046|NCT01278407|11658884|FG004|STARTED|Extension Phase||96
10508047|NCT01278407|11658880|FG000|COMPLETED|Extension Phase||0
10508048|NCT01278407|11658881|FG001|COMPLETED|Extension Phase||0
10508049|NCT01278407|11658882|FG002|COMPLETED|Extension Phase||0
10508050|NCT01278407|11658883|FG003|COMPLETED|Extension Phase||34
10508051|NCT01278407|11658884|FG004|COMPLETED|Extension Phase||66
10508052|NCT01278407|11658880|FG000|NOT COMPLETED|Extension Phase||0
10508053|NCT01278407|11658881|FG001|NOT COMPLETED|Extension Phase||0
10508054|NCT01278407|11658882|FG002|NOT COMPLETED|Extension Phase||0
10508055|NCT01278407|11658883|FG003|NOT COMPLETED|Extension Phase||12
10508056|NCT01278407|11658884|FG004|NOT COMPLETED|Extension Phase||30
10508057|NCT01278485|11658894|FG000|STARTED|Overall Study||719
10508058|NCT01278485|11658894|FG000|COMPLETED|Overall Study||719
10508059|NCT01278485|11658894|FG000|NOT COMPLETED|Overall Study||0
10508060|NCT01278615|11658898|FG000|STARTED|Overall Study||16
10508061|NCT01278615|11658898|FG000|COMPLETED|Overall Study||14
10508062|NCT01278615|11658898|FG000|NOT COMPLETED|Overall Study||2
10508063|NCT01278745|11658904|FG000|STARTED|Overall Study||89
10508064|NCT01278745|11658905|FG001|STARTED|Overall Study||74
10508065|NCT01278745|11658906|FG002|STARTED|Overall Study||121
10508066|NCT01278745|11658907|FG003|STARTED|Overall Study||78
10508067|NCT01278745|11658904|FG000|COMPLETED|Overall Study||84
10508068|NCT01278745|11658905|FG001|COMPLETED|Overall Study||68
10508069|NCT01278745|11658906|FG002|COMPLETED|Overall Study||0
10508070|NCT01278745|11658907|FG003|COMPLETED|Overall Study||0
10508071|NCT01278745|11658904|FG000|NOT COMPLETED|Overall Study||5
10508072|NCT01278745|11658905|FG001|NOT COMPLETED|Overall Study||6
10508073|NCT01278745|11658906|FG002|NOT COMPLETED|Overall Study||121
10508074|NCT01278745|11658907|FG003|NOT COMPLETED|Overall Study||78
10508075|NCT01278797|11658915|FG000|STARTED|Period 1||14
10508076|NCT01278797|11658916|FG001|STARTED|Period 1||14
10508077|NCT01278797|11658915|FG000|COMPLETED|Period 1||13
10508078|NCT01278797|11658916|FG001|COMPLETED|Period 1||13
10508079|NCT01278797|11658915|FG000|NOT COMPLETED|Period 1||1
10508080|NCT01278797|11658916|FG001|NOT COMPLETED|Period 1||1
10508081|NCT01278797|11658915|FG000|STARTED|Washout Period of 21 Days||13
10508082|NCT01278797|11658916|FG001|STARTED|Washout Period of 21 Days||13
10508083|NCT01278797|11658915|FG000|COMPLETED|Washout Period of 21 Days||13
10508084|NCT01278797|11658916|FG001|COMPLETED|Washout Period of 21 Days||13
10508085|NCT01278797|11658915|FG000|NOT COMPLETED|Washout Period of 21 Days||0
10508086|NCT01278797|11658916|FG001|NOT COMPLETED|Washout Period of 21 Days||0
10508087|NCT01278797|11658915|FG000|STARTED|Period 2||13
10508088|NCT01278797|11658916|FG001|STARTED|Period 2||13
10508089|NCT01278797|11658915|FG000|COMPLETED|Period 2||13
10508090|NCT01278797|11658916|FG001|COMPLETED|Period 2||13
10508091|NCT01278797|11658915|FG000|NOT COMPLETED|Period 2||0
10508092|NCT01278797|11658916|FG001|NOT COMPLETED|Period 2||0
10508093|NCT01278862|11658924|FG000|STARTED|Overall Study||45
10650426|NCT02169453|11810714|FG000|50 mg BIA 9-1067|Overall Study||3
10650427|NCT02169453|11810715|FG001|50 mg BIA 9-1067|Overall Study||3
10650428|NCT02169453|11810716|FG002|50 mg BIA 9-1067|Overall Study||2
10650429|NCT02169453|11810717|FG003|50 mg BIA 9-1067|Overall Study||3
10508094|NCT01278862|11658925|FG001|STARTED|Overall Study||43
10508095|NCT01278862|11658924|FG000|COMPLETED|Overall Study||44
10508096|NCT01278862|11658925|FG001|COMPLETED|Overall Study||42
10508097|NCT01278862|11658924|FG000|NOT COMPLETED|Overall Study||1
10508098|NCT01278862|11658925|FG001|NOT COMPLETED|Overall Study||1
10508099|NCT01278927|11658935|FG000|STARTED|Overall Study||180
10508100|NCT01278927|11658936|FG001|STARTED|Overall Study||178
10508101|NCT01278927|11658937|FG002|STARTED|Overall Study||178
10508102|NCT01278927|11658938|FG003|STARTED|Overall Study||175
10508103|NCT01278927|11658935|FG000|COMPLETED|Overall Study||180
10508104|NCT01278927|11658936|FG001|COMPLETED|Overall Study||178
10508105|NCT01278927|11658937|FG002|COMPLETED|Overall Study||178
10508106|NCT01278927|11658938|FG003|COMPLETED|Overall Study||175
10508107|NCT01278927|11658935|FG000|NOT COMPLETED|Overall Study||0
10508108|NCT01278927|11658936|FG001|NOT COMPLETED|Overall Study||0
10508109|NCT01278927|11658937|FG002|NOT COMPLETED|Overall Study||0
10508110|NCT01278927|11658938|FG003|NOT COMPLETED|Overall Study||0
10508111|NCT01278953|11658951|FG000|STARTED|Overall Study||155
10508112|NCT01278953|11658952|FG001|STARTED|Overall Study||145
10508113|NCT01278953|11658951|FG000|COMPLETED|Overall Study||146
10508114|NCT01278953|11658952|FG001|COMPLETED|Overall Study||134
10508115|NCT01278953|11658951|FG000|NOT COMPLETED|Overall Study||9
10508116|NCT01278953|11658952|FG001|NOT COMPLETED|Overall Study||11
10508117|NCT01279044|11658961|FG000|STARTED|PHASE 1 - Formative||59
10508118|NCT01279044|11658962|FG001|STARTED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
10508119|NCT01279044|11658963|FG002|STARTED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
10508120|NCT01279044|11658961|FG000|COMPLETED|PHASE 1 - Formative||59
10508121|NCT01279044|11658962|FG001|COMPLETED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
10508122|NCT01279044|11658963|FG002|COMPLETED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
10508123|NCT01279044|11658961|FG000|NOT COMPLETED|PHASE 1 - Formative||0
10508124|NCT01279044|11658962|FG001|NOT COMPLETED|PHASE 1 - Formative||0
10508125|NCT01279044|11658963|FG002|NOT COMPLETED|PHASE 1 - Formative||0
10508126|NCT01279044|11658961|FG000|STARTED|PHASE 2 - Randmonized Controlled Trial|Participants who participated in the RCT did not participate in the formative phase.|0
10508127|NCT01279044|11658962|FG001|STARTED|PHASE 2 - Randmonized Controlled Trial||162
10508128|NCT01279044|11658963|FG002|STARTED|PHASE 2 - Randmonized Controlled Trial||164
10508129|NCT01279044|11658961|FG000|COMPLETED|PHASE 2 - Randmonized Controlled Trial|Participants who participated in the RCT did not participate in the formative phase.|0
10508130|NCT01279044|11658962|FG001|COMPLETED|PHASE 2 - Randmonized Controlled Trial||151
10508131|NCT01279044|11658963|FG002|COMPLETED|PHASE 2 - Randmonized Controlled Trial||161
10508132|NCT01279044|11658961|FG000|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||0
10508133|NCT01279044|11658962|FG001|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||11
10508134|NCT01279044|11658963|FG002|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||3
10508135|NCT01279057|11658972|FG000|STARTED|Overall Study||288
10508136|NCT01279057|11658973|FG001|STARTED|Overall Study||292
10508137|NCT01279057|11658974|FG002|STARTED|Overall Study||147
10508138|NCT01279057|11658972|FG000|Per-Protocol (PPP) Population|Overall Study||257
10508139|NCT01279057|11658973|FG001|Per-Protocol (PPP) Population|Overall Study||245
10508140|NCT01279057|11658974|FG002|Per-Protocol (PPP) Population|Overall Study||126
10508141|NCT01279057|11658972|FG000|Intent-to-Treat (ITT) Population|Overall Study||284
10508142|NCT01279057|11658973|FG001|Intent-to-Treat (ITT) Population|Overall Study||285
10508143|NCT01279057|11658974|FG002|Intent-to-Treat (ITT) Population|Overall Study||144
10508144|NCT01279057|11658972|FG000|COMPLETED|Overall Study||282
10508145|NCT01279057|11658973|FG001|COMPLETED|Overall Study||287
10508146|NCT01279057|11658974|FG002|COMPLETED|Overall Study||144
10508147|NCT01279057|11658972|FG000|NOT COMPLETED|Overall Study||6
10508148|NCT01279057|11658973|FG001|NOT COMPLETED|Overall Study||5
10508149|NCT01279057|11658974|FG002|NOT COMPLETED|Overall Study||3
10508150|NCT01279070|11658984|FG000|STARTED|Overall Study|34 outpatients were randomly assigned to 32 sessions of REPYFLEC.|34
10508151|NCT01279070|11658985|FG001|STARTED|Overall Study|28 outpatients were randomly assigned to 32 sessions of leisure group.|28
10508152|NCT01279070|11658984|FG000|COMPLETED|Overall Study|5 outpatients left the treatment up to 2 months after starting REPYFLEC.|29
10508153|NCT01279070|11658985|FG001|COMPLETED|Overall Study|4 outpatients left the leisure group up to 2 months after starting Leisure group.|24
10508154|NCT01279070|11658984|FG000|NOT COMPLETED|Overall Study||5
10508155|NCT01279070|11658985|FG001|NOT COMPLETED|Overall Study||4
10508156|NCT01279109|11658997|FG000|STARTED|Overall Study||68
10508157|NCT01279109|11658998|FG001|STARTED|Overall Study||67
10508158|NCT01279109|11658997|FG000|COMPLETED|Overall Study||55
10508159|NCT01279109|11658998|FG001|COMPLETED|Overall Study||55
10508160|NCT01279109|11658997|FG000|NOT COMPLETED|Overall Study||13
10508161|NCT01279109|11658998|FG001|NOT COMPLETED|Overall Study||12
10508162|NCT01279187|11659006|FG000|STARTED|Overall Study||14
10508163|NCT01279187|11659007|FG001|STARTED|Overall Study||13
10508164|NCT01279187|11659006|FG000|COMPLETED|Overall Study||14
10508165|NCT01279187|11659007|FG001|COMPLETED|Overall Study||13
10508166|NCT01279187|11659006|FG000|NOT COMPLETED|Overall Study||0
10508167|NCT01279187|11659007|FG001|NOT COMPLETED|Overall Study||0
10508168|NCT01279200|11659015|FG000|STARTED|Overall Study||10
10508169|NCT01279200|11659016|FG001|STARTED|Overall Study||11
10508170|NCT01279200|11659015|FG000|COMPLETED|Overall Study||8
10508171|NCT01279200|11659016|FG001|COMPLETED|Overall Study||4
10508172|NCT01279200|11659015|FG000|NOT COMPLETED|Overall Study||2
10508173|NCT01279200|11659016|FG001|NOT COMPLETED|Overall Study||7
10508174|NCT01279265|11659024|FG000|STARTED|Overall Study||13
10508175|NCT01279265|11659025|FG001|STARTED|Overall Study||17
10508176|NCT01279265|11659024|FG000|COMPLETED|Overall Study||9
10508177|NCT01279265|11659025|FG001|COMPLETED|Overall Study||11
10508178|NCT01279265|11659024|FG000|NOT COMPLETED|Overall Study||4
10508179|NCT01279265|11659025|FG001|NOT COMPLETED|Overall Study||6
10508180|NCT01279317|11659033|FG000|STARTED|Period 1||6
10508181|NCT01279317|11659034|FG001|STARTED|Period 1||6
10508182|NCT01279317|11659033|FG000|COMPLETED|Period 1||6
10508183|NCT01279317|11659034|FG001|COMPLETED|Period 1||6
10508184|NCT01279317|11659033|FG000|NOT COMPLETED|Period 1||0
10711147|NCT02657031|11876561|FG001|NOT COMPLETED|Overall Study||2
10711148|NCT02657226|11876567|FG000|STARTED|Overall Study||15724
10508185|NCT01279317|11659034|FG001|NOT COMPLETED|Period 1||0
10508186|NCT01279317|11659033|FG000|STARTED|Washout||6
10508187|NCT01279317|11659034|FG001|STARTED|Washout||6
10508188|NCT01279317|11659033|FG000|COMPLETED|Washout||6
10508189|NCT01279317|11659034|FG001|COMPLETED|Washout||6
10508190|NCT01279317|11659033|FG000|NOT COMPLETED|Washout||0
10508191|NCT01279317|11659034|FG001|NOT COMPLETED|Washout||0
10508192|NCT01279317|11659033|FG000|STARTED|Period 2||6
10508193|NCT01279317|11659034|FG001|STARTED|Period 2||6
10508194|NCT01279317|11659033|FG000|COMPLETED|Period 2||6
10508195|NCT01279317|11659034|FG001|COMPLETED|Period 2||6
10508196|NCT01279317|11659033|FG000|NOT COMPLETED|Period 2||0
10508197|NCT01279317|11659034|FG001|NOT COMPLETED|Period 2||0
10508198|NCT01279343|11659041|FG000|STARTED|Overall Study||59
10508199|NCT01279343|11659042|FG001|STARTED|Overall Study||64
10508200|NCT01279343|11659041|FG000|COMPLETED|Overall Study||57
10508201|NCT01279343|11659042|FG001|COMPLETED|Overall Study||58
10508202|NCT01279343|11659041|FG000|NOT COMPLETED|Overall Study||2
10508203|NCT01279343|11659042|FG001|NOT COMPLETED|Overall Study||6
10508204|NCT01279447|11659050|FG000|STARTED|Overall Study||34
10508205|NCT01279447|11659051|FG001|STARTED|Overall Study||34
10508206|NCT01279447|11659050|FG000|COMPLETED|Overall Study||31
10508207|NCT01279447|11659051|FG001|COMPLETED|Overall Study||33
10508208|NCT01279447|11659050|FG000|NOT COMPLETED|Overall Study||3
10508209|NCT01279447|11659051|FG001|NOT COMPLETED|Overall Study||1
10508210|NCT01279486|11659057|FG000|STARTED|Overall Study||120
10508211|NCT01279486|11659057|FG000|COMPLETED|Overall Study|1 result questionnaire was not returned so 119 volunteers results were used for consumer accuracy.|119
10508212|NCT01279486|11659057|FG000|NOT COMPLETED|Overall Study||1
10508213|NCT01279564|11659063|FG000|STARTED|Overall Study||40
10508214|NCT01279564|11659064|FG001|STARTED|Overall Study||32
10508215|NCT01279564|11659063|FG000|COMPLETED|Overall Study||40
10508216|NCT01279564|11659064|FG001|COMPLETED|Overall Study||32
10508217|NCT01279564|11659063|FG000|NOT COMPLETED|Overall Study||0
10508218|NCT01279564|11659064|FG001|NOT COMPLETED|Overall Study||0
10508219|NCT01279681|11659072|FG000|STARTED|Overall Study||15
10508220|NCT01279681|11659073|FG001|STARTED|Overall Study||17
10508221|NCT01279681|11659072|FG000|COMPLETED|Overall Study||0
10508222|NCT01279681|11659073|FG001|COMPLETED|Overall Study||0
10508223|NCT01279681|11659072|FG000|NOT COMPLETED|Overall Study||15
10508224|NCT01279681|11659073|FG001|NOT COMPLETED|Overall Study||17
10508225|NCT01279850|11659079|FG000|STARTED|Overall Study||891
10508226|NCT01279850|11659079|FG000|COMPLETED|Overall Study|Number of participants whose survey form were collected and included in analyses is shown.|800
10508227|NCT01279850|11659079|FG000|NOT COMPLETED|Overall Study||91
10508228|NCT01279954|11659085|FG000|STARTED|Overall Study||5
10508229|NCT01279954|11659086|FG001|STARTED|Overall Study||5
10508230|NCT01279954|11659085|FG000|COMPLETED|Overall Study||2
10508231|NCT01279954|11659086|FG001|COMPLETED|Overall Study||1
10508232|NCT01279954|11659085|FG000|NOT COMPLETED|Overall Study||3
10508233|NCT01279954|11659086|FG001|NOT COMPLETED|Overall Study||4
10508234|NCT01280058|11659097|FG000|STARTED|Overall Study||36
10508235|NCT01280058|11659098|FG001|STARTED|Overall Study||37
10508236|NCT01280058|11659097|FG000|COMPLETED|Overall Study||36
10508237|NCT01280058|11659098|FG001|COMPLETED|Overall Study||37
10508238|NCT01280058|11659097|FG000|NOT COMPLETED|Overall Study||0
10508239|NCT01280058|11659098|FG001|NOT COMPLETED|Overall Study||0
10508240|NCT01280110|11659108|FG000|STARTED|Overall Study||22
10508241|NCT01280110|11659109|FG001|STARTED|Overall Study||22
10508242|NCT01280110|11659108|FG000|COMPLETED|Overall Study||22
10508243|NCT01280110|11659109|FG001|COMPLETED|Overall Study||22
10508244|NCT01280110|11659108|FG000|NOT COMPLETED|Overall Study||0
10508245|NCT01280110|11659109|FG001|NOT COMPLETED|Overall Study||0
10508246|NCT01280123|11659120|FG000|STARTED|Overall Study||72
10508247|NCT01280123|11659121|FG001|STARTED|Overall Study||67
10508248|NCT01280123|11659122|FG002|STARTED|Overall Study||71
10508249|NCT01280123|11659120|FG000|COMPLETED|Overall Study||71
10711149|NCT02657226|11876567|FG000|COMPLETED|Overall Study||15724
10508250|NCT01280123|11659121|FG001|COMPLETED|Overall Study||63
10508251|NCT01280123|11659122|FG002|COMPLETED|Overall Study||70
10508252|NCT01280123|11659120|FG000|NOT COMPLETED|Overall Study||1
10508253|NCT01280123|11659121|FG001|NOT COMPLETED|Overall Study||4
10508254|NCT01280123|11659122|FG002|NOT COMPLETED|Overall Study||1
10711150|NCT02657226|11876567|FG000|NOT COMPLETED|Overall Study||0
10711151|NCT02657252|11876576|FG000|STARTED|Overall Study||57
10508255|NCT01280201|11659130|FG000|STARTED|Overall Study||44
10508256|NCT01280201|11659130|FG000|COMPLETED|Overall Study||44
10508257|NCT01280201|11659130|FG000|NOT COMPLETED|Overall Study||0
10508258|NCT01280266|11659136|FG000|STARTED|First Intervention (Week 1-4)||15
10508259|NCT01280266|11659137|FG001|STARTED|First Intervention (Week 1-4)||14
10508260|NCT01280266|11659136|FG000|COMPLETED|First Intervention (Week 1-4)||14
10508261|NCT01280266|11659137|FG001|COMPLETED|First Intervention (Week 1-4)||12
10508262|NCT01280266|11659136|FG000|NOT COMPLETED|First Intervention (Week 1-4)||1
10508263|NCT01280266|11659137|FG001|NOT COMPLETED|First Intervention (Week 1-4)||2
10508264|NCT01280266|11659136|FG000|STARTED|Washout Period (Week 4-5)||14
10508265|NCT01280266|11659137|FG001|STARTED|Washout Period (Week 4-5)||12
10508266|NCT01280266|11659136|FG000|COMPLETED|Washout Period (Week 4-5)||14
10508267|NCT01280266|11659137|FG001|COMPLETED|Washout Period (Week 4-5)||12
10508268|NCT01280266|11659136|FG000|NOT COMPLETED|Washout Period (Week 4-5)||0
10508269|NCT01280266|11659137|FG001|NOT COMPLETED|Washout Period (Week 4-5)||0
10508270|NCT01280266|11659136|FG000|STARTED|Second Intervention (Week 5-9)||14
10508271|NCT01280266|11659137|FG001|STARTED|Second Intervention (Week 5-9)||12
10508272|NCT01280266|11659136|FG000|COMPLETED|Second Intervention (Week 5-9)||14
10508273|NCT01280266|11659137|FG001|COMPLETED|Second Intervention (Week 5-9)||12
10508274|NCT01280266|11659136|FG000|NOT COMPLETED|Second Intervention (Week 5-9)||0
10508275|NCT01280266|11659137|FG001|NOT COMPLETED|Second Intervention (Week 5-9)||0
10508276|NCT01280357|11659147|FG000|STARTED|Overall Study||60
10508277|NCT01280357|11659147|FG000|COMPLETED|Overall Study||34
10508278|NCT01280357|11659147|FG000|NOT COMPLETED|Overall Study||26
10508279|NCT01280409|11659156|FG000|STARTED|Overall Study||59
10508280|NCT01280409|11659157|FG001|STARTED|Overall Study||55
10508281|NCT01280409|11659156|FG000|COMPLETED|Overall Study||43
10508282|NCT01280409|11659157|FG001|COMPLETED|Overall Study||36
10508283|NCT01280409|11659156|FG000|NOT COMPLETED|Overall Study||16
10508284|NCT01280409|11659157|FG001|NOT COMPLETED|Overall Study||19
10508285|NCT01280552|11659165|FG000|STARTED|Overall Study||81
10508286|NCT01280552|11659166|FG001|STARTED|Overall Study||43
10508287|NCT01280552|11659165|FG000|COMPLETED|Overall Study|Survival is still being assessed|75
10508288|NCT01280552|11659166|FG001|COMPLETED|Overall Study||42
10508289|NCT01280552|11659165|FG000|NOT COMPLETED|Overall Study||6
10508290|NCT01280552|11659166|FG001|NOT COMPLETED|Overall Study||1
10508291|NCT01280591|11659179|FG000|STARTED|Overall Study||203
10508292|NCT01280591|11659180|FG001|STARTED|Overall Study||204
10508293|NCT01280591|11659181|FG002|STARTED|Overall Study||203
10508294|NCT01280591|11659182|FG003|STARTED|Overall Study||102
10508295|NCT01280591|11659179|FG000|COMPLETED|Overall Study||203
10711152|NCT02657252|11876577|FG001|STARTED|Overall Study||58
10711153|NCT02657252|11876576|FG000|COMPLETED|Overall Study||47
10711154|NCT02657252|11876577|FG001|COMPLETED|Overall Study||51
10711155|NCT02657252|11876576|FG000|NOT COMPLETED|Overall Study||10
10711156|NCT02657252|11876577|FG001|NOT COMPLETED|Overall Study||7
10711157|NCT02657369|11876583|FG000|STARTED|Overall Study||34
10711158|NCT02657369|11876583|FG000|COMPLETED|Overall Study||0
10711159|NCT02657369|11876583|FG000|NOT COMPLETED|Overall Study||34
10711160|NCT02657408|11876589|FG000|STARTED|Overall Study||28
10711161|NCT02657408|11876590|FG001|STARTED|Overall Study||29
10711162|NCT02657408|11876589|FG000|COMPLETED|Overall Study||25
10711163|NCT02657408|11876590|FG001|COMPLETED|Overall Study||22
10711164|NCT02657408|11876589|FG000|NOT COMPLETED|Overall Study||3
10711165|NCT02657408|11876590|FG001|NOT COMPLETED|Overall Study||7
10711166|NCT02657538|11876596|FG000|STARTED|Overall Study||35
10508296|NCT01280591|11659180|FG001|COMPLETED|Overall Study||204
10508297|NCT01280591|11659181|FG002|COMPLETED|Overall Study||203
10508298|NCT01280591|11659182|FG003|COMPLETED|Overall Study||99
10508299|NCT01280591|11659179|FG000|NOT COMPLETED|Overall Study||0
10508300|NCT01280591|11659180|FG001|NOT COMPLETED|Overall Study||0
10508301|NCT01280591|11659181|FG002|NOT COMPLETED|Overall Study||0
10508302|NCT01280591|11659182|FG003|NOT COMPLETED|Overall Study||3
10508303|NCT01280604|11659194|FG000|STARTED|Overall Study||33
10508304|NCT01280604|11659195|FG001|STARTED|Overall Study||33
10508305|NCT01280604|11659194|FG000|Subjects Meeting All Inclusion Criteria|Overall Study||25
10508306|NCT01280604|11659195|FG001|Subjects Meeting All Inclusion Criteria|Overall Study||29
10508307|NCT01280604|11659194|FG000|COMPLETED|Overall Study||24
10508308|NCT01280604|11659195|FG001|COMPLETED|Overall Study||28
10508309|NCT01280604|11659194|FG000|NOT COMPLETED|Overall Study||9
10508310|NCT01280604|11659195|FG001|NOT COMPLETED|Overall Study||5
10508311|NCT01280617|11659203|FG000|STARTED|Overall Study||23
10508312|NCT01280617|11659204|FG001|STARTED|Overall Study||21
10508313|NCT01280617|11659203|FG000|COMPLETED|Overall Study||23
10508314|NCT01280617|11659204|FG001|COMPLETED|Overall Study||20
10508315|NCT01280617|11659203|FG000|NOT COMPLETED|Overall Study||0
10508316|NCT01280617|11659204|FG001|NOT COMPLETED|Overall Study||1
10508317|NCT01280656|11659213|FG000|STARTED|Overall Study||62
10508318|NCT01280656|11659214|FG001|STARTED|Overall Study||312
10508319|NCT01280656|11659215|FG002|STARTED|Overall Study||286
10508320|NCT01280656|11659213|FG000|COMPLETED|Overall Study||59
10508321|NCT01280656|11659214|FG001|COMPLETED|Overall Study||265
10508322|NCT01280656|11659215|FG002|COMPLETED|Overall Study||223
10508323|NCT01280656|11659213|FG000|NOT COMPLETED|Overall Study||3
10508324|NCT01280656|11659214|FG001|NOT COMPLETED|Overall Study||47
10508325|NCT01280656|11659215|FG002|NOT COMPLETED|Overall Study||63
10508326|NCT01280695|11659228|FG000|STARTED|Overall Study||26
10508327|NCT01280695|11659229|FG001|STARTED|Overall Study||25
10508328|NCT01280695|11659230|FG002|STARTED|Overall Study||26
10508329|NCT01280695|11659231|FG003|STARTED|Overall Study||26
10508330|NCT01280695|11659232|FG004|STARTED|Overall Study||26
10508331|NCT01280695|11659228|FG000|COMPLETED|Overall Study||26
10711167|NCT02657538|11876596|FG000|Received Near Infrared Transillumination|Overall Study||35
10711168|NCT02657538|11876596|FG000|Received Visual Caries Detection + Bite|Overall Study||35
10711169|NCT02657538|11876596|FG000|COMPLETED|Overall Study||31
10508332|NCT01280695|11659229|FG001|COMPLETED|Overall Study||24
10508333|NCT01280695|11659230|FG002|COMPLETED|Overall Study||21
10508334|NCT01280695|11659231|FG003|COMPLETED|Overall Study||22
10508335|NCT01280695|11659232|FG004|COMPLETED|Overall Study||24
10508336|NCT01280695|11659228|FG000|NOT COMPLETED|Overall Study||0
10508337|NCT01280695|11659229|FG001|NOT COMPLETED|Overall Study||1
10508338|NCT01280695|11659230|FG002|NOT COMPLETED|Overall Study||5
10508339|NCT01280695|11659231|FG003|NOT COMPLETED|Overall Study||4
10508340|NCT01280695|11659232|FG004|NOT COMPLETED|Overall Study||2
10508341|NCT01280721|11659244|FG000|STARTED|Overall Study||135
10508342|NCT01280721|11659244|FG000|COMPLETED|Overall Study||113
10508343|NCT01280721|11659244|FG000|NOT COMPLETED|Overall Study||22
10508344|NCT01280812|11659262|FG000|STARTED|Overall Study||70
10508345|NCT01280812|11659263|FG001|STARTED|Overall Study||71
10508346|NCT01280812|11659264|FG002|STARTED|Overall Study||69
10508347|NCT01280812|11659262|FG000|COMPLETED|Overall Study||67
10508348|NCT01280812|11659263|FG001|COMPLETED|Overall Study||69
10508349|NCT01280812|11659264|FG002|COMPLETED|Overall Study||68
10508350|NCT01280812|11659262|FG000|NOT COMPLETED|Overall Study||3
10508351|NCT01280812|11659263|FG001|NOT COMPLETED|Overall Study||2
10508352|NCT01280812|11659264|FG002|NOT COMPLETED|Overall Study||1
10508353|NCT01280903|11659275|FG000|STARTED|Overall Study||91
10508354|NCT01280903|11659276|FG001|STARTED|Overall Study||91
10508355|NCT01280903|11659275|FG000|COMPLETED|Overall Study|91 participants analyzed per intention-to-treat|68
10508356|NCT01280903|11659276|FG001|COMPLETED|Overall Study|91 participants analyzed per intention-to-treat|75
10508357|NCT01280903|11659275|FG000|NOT COMPLETED|Overall Study||23
10508358|NCT01280903|11659276|FG001|NOT COMPLETED|Overall Study||16
10508359|NCT01280942|11659284|FG000|STARTED|Overall Study||10120
10508360|NCT01280942|11659285|FG001|STARTED|Overall Study||9911
10508361|NCT01280942|11659284|FG000|COMPLETED|Overall Study||10120
10508362|NCT01280942|11659285|FG001|COMPLETED|Overall Study||9911
10508363|NCT01280942|11659284|FG000|NOT COMPLETED|Overall Study||0
10508364|NCT01280942|11659285|FG001|NOT COMPLETED|Overall Study||0
10508365|NCT01280955|11659291|FG000|STARTED|Overall Study||30
10508366|NCT01280955|11659291|FG000|COMPLETED|Overall Study||27
10508367|NCT01280955|11659291|FG000|NOT COMPLETED|Overall Study||3
10508368|NCT01280968|11659299|FG000|STARTED|Overall Study||45
10508369|NCT01280968|11659300|FG001|STARTED|Overall Study||7
10508370|NCT01280968|11659299|FG000|COMPLETED|Overall Study||27
10508371|NCT01280968|11659300|FG001|COMPLETED|Overall Study||4
10508372|NCT01280968|11659299|FG000|NOT COMPLETED|Overall Study||18
10508373|NCT01280968|11659300|FG001|NOT COMPLETED|Overall Study||3
10508374|NCT01280981|11659307|FG000|STARTED|Overall Study||288
10508375|NCT01280981|11659307|FG000|Intent to Treat (ITT) Population|Overall Study|Participants who took drug during at least one menstrual cycle|260
10508376|NCT01280981|11659307|FG000|COMPLETED|Overall Study||196
10508377|NCT01280981|11659307|FG000|NOT COMPLETED|Overall Study||92
10508378|NCT01281007|11659313|FG000|STARTED|Overall Study||75
10508379|NCT01281007|11659314|FG001|STARTED|Overall Study||75
10508380|NCT01281007|11659313|FG000|COMPLETED|Overall Study||71
10508381|NCT01281007|11659314|FG001|COMPLETED|Overall Study||67
10508382|NCT01281007|11659313|FG000|NOT COMPLETED|Overall Study||4
10508383|NCT01281007|11659314|FG001|NOT COMPLETED|Overall Study||8
10508384|NCT01281137|11659322|FG000|STARTED|Baseline Population||25
10508385|NCT01281137|11659323|FG001|STARTED|Baseline Population||79
10508386|NCT01281137|11659322|FG000|COMPLETED|Baseline Population||25
10508387|NCT01281137|11659323|FG001|COMPLETED|Baseline Population||78
10508388|NCT01281137|11659322|FG000|NOT COMPLETED|Baseline Population||0
10508389|NCT01281137|11659323|FG001|NOT COMPLETED|Baseline Population||1
10508390|NCT01281137|11659322|FG000|STARTED|Analysis Population (Baseline)||25
10508391|NCT01281137|11659323|FG001|STARTED|Analysis Population (Baseline)||78
10508392|NCT01281137|11659322|FG000|COMPLETED|Analysis Population (Baseline)||21
10508393|NCT01281137|11659323|FG001|COMPLETED|Analysis Population (Baseline)||69
10508394|NCT01281137|11659322|FG000|NOT COMPLETED|Analysis Population (Baseline)||4
10508395|NCT01281137|11659323|FG001|NOT COMPLETED|Analysis Population (Baseline)||9
10508396|NCT01281137|11659322|FG000|STARTED|Analysis Population (9 Months)||21
10508397|NCT01281137|11659323|FG001|STARTED|Analysis Population (9 Months)||69
10508398|NCT01281137|11659322|FG000|COMPLETED|Analysis Population (9 Months)||21
10508399|NCT01281137|11659323|FG001|COMPLETED|Analysis Population (9 Months)||64
10508400|NCT01281137|11659322|FG000|NOT COMPLETED|Analysis Population (9 Months)||0
10508401|NCT01281137|11659323|FG001|NOT COMPLETED|Analysis Population (9 Months)||5
10508402|NCT01281137|11659322|FG000|STARTED|Analysis Population (10.5 Months)||21
10508403|NCT01281137|11659323|FG001|STARTED|Analysis Population (10.5 Months)||64
10508404|NCT01281137|11659322|FG000|COMPLETED|Analysis Population (10.5 Months)||20
10508405|NCT01281137|11659323|FG001|COMPLETED|Analysis Population (10.5 Months)||64
10508406|NCT01281137|11659322|FG000|NOT COMPLETED|Analysis Population (10.5 Months)||1
10508407|NCT01281137|11659323|FG001|NOT COMPLETED|Analysis Population (10.5 Months)||0
10508408|NCT01281137|11659322|FG000|STARTED|Analysis Population (12 Months)||20
10508409|NCT01281137|11659323|FG001|STARTED|Analysis Population (12 Months)||64
10508410|NCT01281137|11659322|FG000|COMPLETED|Analysis Population (12 Months)||19
10508411|NCT01281137|11659323|FG001|COMPLETED|Analysis Population (12 Months)||62
10508412|NCT01281137|11659322|FG000|NOT COMPLETED|Analysis Population (12 Months)||1
10508413|NCT01281137|11659323|FG001|NOT COMPLETED|Analysis Population (12 Months)||2
10508414|NCT01281189|11659349|FG000|STARTED|Overall Study||468
10508415|NCT01281189|11659350|FG001|STARTED|Overall Study||474
10508416|NCT01281189|11659349|FG000|COMPLETED|Overall Study||321
10508417|NCT01281189|11659350|FG001|COMPLETED|Overall Study||331
10508418|NCT01281189|11659349|FG000|NOT COMPLETED|Overall Study||147
10508419|NCT01281189|11659350|FG001|NOT COMPLETED|Overall Study||143
10508420|NCT01281202|11659358|FG000|STARTED|Overall Study||103
10508421|NCT01281202|11659359|FG001|STARTED|Overall Study||104
10508422|NCT01281202|11659358|FG000|COMPLETED|Overall Study||75
10508423|NCT01281202|11659359|FG001|COMPLETED|Overall Study||68
10508424|NCT01281202|11659358|FG000|NOT COMPLETED|Overall Study||28
10508425|NCT01281202|11659359|FG001|NOT COMPLETED|Overall Study||36
10508426|NCT01281306|11659374|FG000|STARTED|Overall Study||144
10508427|NCT01281306|11659375|FG001|STARTED|Overall Study||145
10508428|NCT01281306|11659376|FG002|STARTED|Overall Study||141
10508429|NCT01281306|11659377|FG003|STARTED|Overall Study||134
10508430|NCT01281306|11659378|FG004|STARTED|Overall Study||143
10508431|NCT01281306|11659379|FG005|STARTED|Overall Study||142
10508432|NCT01281306|11659380|FG006|STARTED|Overall Study||58
10508433|NCT01281306|11659374|FG000|Full Analysis Set|Overall Study||143
10508434|NCT01281306|11659375|FG001|Full Analysis Set|Overall Study||145
10508435|NCT01281306|11659376|FG002|Full Analysis Set|Overall Study||141
10508436|NCT01281306|11659377|FG003|Full Analysis Set|Overall Study||133
10508437|NCT01281306|11659378|FG004|Full Analysis Set|Overall Study||143
10508438|NCT01281306|11659379|FG005|Full Analysis Set|Overall Study||142
10508439|NCT01281306|11659380|FG006|Full Analysis Set|Overall Study||58
10508440|NCT01281306|11659374|FG000|Safety Set|Overall Study||143
10508441|NCT01281306|11659375|FG001|Safety Set|Overall Study||145
10508442|NCT01281306|11659376|FG002|Safety Set|Overall Study||141
10508443|NCT01281306|11659377|FG003|Safety Set|Overall Study||133
10508444|NCT01281306|11659378|FG004|Safety Set|Overall Study||143
10508445|NCT01281306|11659379|FG005|Safety Set|Overall Study||142
10508446|NCT01281306|11659380|FG006|Safety Set|Overall Study||58
10508447|NCT01281306|11659374|FG000|Ambulatory Blood Pressure Monitoring Set|Overall Study||95
10508448|NCT01281306|11659375|FG001|Ambulatory Blood Pressure Monitoring Set|Overall Study||99
10508449|NCT01281306|11659376|FG002|Ambulatory Blood Pressure Monitoring Set|Overall Study||92
10508450|NCT01281306|11659377|FG003|Ambulatory Blood Pressure Monitoring Set|Overall Study||95
10508451|NCT01281306|11659378|FG004|Ambulatory Blood Pressure Monitoring Set|Overall Study||93
10508452|NCT01281306|11659379|FG005|Ambulatory Blood Pressure Monitoring Set|Overall Study||91
10508453|NCT01281306|11659380|FG006|Ambulatory Blood Pressure Monitoring Set|Overall Study||35
10508454|NCT01281306|11659374|FG000|COMPLETED|Overall Study||136
10508455|NCT01281306|11659375|FG001|COMPLETED|Overall Study||141
10508456|NCT01281306|11659376|FG002|COMPLETED|Overall Study||133
10508457|NCT01281306|11659377|FG003|COMPLETED|Overall Study||123
10508458|NCT01281306|11659378|FG004|COMPLETED|Overall Study||134
10508459|NCT01281306|11659379|FG005|COMPLETED|Overall Study||135
10508460|NCT01281306|11659380|FG006|COMPLETED|Overall Study||51
10508461|NCT01281306|11659374|FG000|NOT COMPLETED|Overall Study||8
10508462|NCT01281306|11659375|FG001|NOT COMPLETED|Overall Study||4
10508463|NCT01281306|11659376|FG002|NOT COMPLETED|Overall Study||8
10508464|NCT01281306|11659377|FG003|NOT COMPLETED|Overall Study||11
10508465|NCT01281306|11659378|FG004|NOT COMPLETED|Overall Study||9
10508466|NCT01281306|11659379|FG005|NOT COMPLETED|Overall Study||7
10508467|NCT01281306|11659380|FG006|NOT COMPLETED|Overall Study||7
10508468|NCT01281475|11659398|FG000|STARTED|Overall Study||33
10508469|NCT01281475|11659399|FG001|STARTED|Overall Study||34
10508470|NCT01281475|11659398|FG000|COMPLETED|Overall Study||29
10508471|NCT01281475|11659399|FG001|COMPLETED|Overall Study||26
10508472|NCT01281475|11659398|FG000|NOT COMPLETED|Overall Study||4
10508473|NCT01281475|11659399|FG001|NOT COMPLETED|Overall Study||8
10508474|NCT01281501|11659409|FG000|STARTED|Overall Study||44
10508475|NCT01281501|11659410|FG001|STARTED|Overall Study||43
10508476|NCT01281501|11659409|FG000|COMPLETED|Overall Study||44
10508477|NCT01281501|11659410|FG001|COMPLETED|Overall Study||43
10508478|NCT01281501|11659409|FG000|NOT COMPLETED|Overall Study||0
10508479|NCT01281501|11659410|FG001|NOT COMPLETED|Overall Study||0
10508480|NCT01281839|11659418|FG000|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|260
10508481|NCT01281839|11659419|FG001|STARTED|Overall Study||133
10508482|NCT01281839|11659418|FG000|COMPLETED|Overall Study||250
10508483|NCT01281839|11659419|FG001|COMPLETED|Overall Study||119
10508484|NCT01281839|11659418|FG000|NOT COMPLETED|Overall Study||10
10508485|NCT01281839|11659419|FG001|NOT COMPLETED|Overall Study||14
10508486|NCT01281865|11659427|FG000|STARTED|Overall Study||12
10508487|NCT01281865|11659428|FG001|STARTED|Overall Study||2
10508488|NCT01281865|11659427|FG000|COMPLETED|Overall Study||9
10508489|NCT01281865|11659428|FG001|COMPLETED|Overall Study||1
10508490|NCT01281865|11659427|FG000|NOT COMPLETED|Overall Study||3
10508491|NCT01281865|11659428|FG001|NOT COMPLETED|Overall Study||1
10508492|NCT01281917|11659434|FG000|STARTED|Overall Study||40
10508493|NCT01281917|11659434|FG000|COMPLETED|Overall Study||39
10508494|NCT01281917|11659434|FG000|NOT COMPLETED|Overall Study||1
10508495|NCT01281956|11659438|FG000|STARTED|1st Intervention (3 Months)||5
10508496|NCT01281956|11659439|FG001|STARTED|1st Intervention (3 Months)||5
10508497|NCT01281956|11659438|FG000|COMPLETED|1st Intervention (3 Months)||5
10508498|NCT01281956|11659439|FG001|COMPLETED|1st Intervention (3 Months)||5
10508499|NCT01281956|11659438|FG000|NOT COMPLETED|1st Intervention (3 Months)||0
10508500|NCT01281956|11659439|FG001|NOT COMPLETED|1st Intervention (3 Months)||0
10508501|NCT01281956|11659438|FG000|STARTED|2nd Intervention (3 Months)||5
10508502|NCT01281956|11659439|FG001|STARTED|2nd Intervention (3 Months)||5
10508503|NCT01281956|11659438|FG000|COMPLETED|2nd Intervention (3 Months)||4
10508504|NCT01281956|11659439|FG001|COMPLETED|2nd Intervention (3 Months)||5
10508505|NCT01281956|11659438|FG000|NOT COMPLETED|2nd Intervention (3 Months)||1
10508506|NCT01281956|11659439|FG001|NOT COMPLETED|2nd Intervention (3 Months)||0
10508507|NCT01281969|11659450|FG000|STARTED|Overall Study||18
10508508|NCT01281969|11659451|FG001|STARTED|Overall Study||18
10508509|NCT01281969|11659452|FG002|STARTED|Overall Study||12
10508510|NCT01281969|11659450|FG000|COMPLETED|Overall Study||17
10508511|NCT01281969|11659451|FG001|COMPLETED|Overall Study||18
10508512|NCT01281969|11659452|FG002|COMPLETED|Overall Study||0
10508513|NCT01281969|11659450|FG000|NOT COMPLETED|Overall Study||1
10508514|NCT01281969|11659451|FG001|NOT COMPLETED|Overall Study||0
10508515|NCT01281969|11659452|FG002|NOT COMPLETED|Overall Study||12
10508516|NCT01282086|11659460|FG000|STARTED|Overall Study||1365
10508517|NCT01282086|11659460|FG000|COMPLETED|Overall Study||1365
10508518|NCT01282086|11659460|FG000|NOT COMPLETED|Overall Study||0
10508519|NCT01282138|11659467|FG000|STARTED|EEC||6
10508520|NCT01282138|11659468|FG001|STARTED|EEC||7
10508521|NCT01282138|11659467|FG000|COMPLETED|EEC||6
10508522|NCT01282138|11659468|FG001|COMPLETED|EEC||7
10508523|NCT01282138|11659467|FG000|NOT COMPLETED|EEC||0
10508524|NCT01282138|11659468|FG001|NOT COMPLETED|EEC||0
10508525|NCT01282138|11659467|FG000|STARTED|CAPT||6
10508526|NCT01282138|11659468|FG001|STARTED|CAPT||7
10508527|NCT01282138|11659467|FG000|COMPLETED|CAPT||6
10508528|NCT01282138|11659468|FG001|COMPLETED|CAPT||7
10508529|NCT01282138|11659467|FG000|NOT COMPLETED|CAPT||0
10508530|NCT01282138|11659468|FG001|NOT COMPLETED|CAPT||0
10508531|NCT01282164|11659476|FG000|STARTED|Overall Study||29
10508532|NCT01282164|11659477|FG001|STARTED|Overall Study||14
10508533|NCT01282164|11659476|FG000|COMPLETED|Overall Study||28
10508534|NCT01282164|11659477|FG001|COMPLETED|Overall Study||14
10508535|NCT01282164|11659476|FG000|NOT COMPLETED|Overall Study||1
10508536|NCT01282164|11659477|FG001|NOT COMPLETED|Overall Study||0
10508537|NCT01282203|11659491|FG000|STARTED|Overall Study||1122
10508538|NCT01282203|11659491|FG000|COMPLETED|Overall Study||1121
10508539|NCT01282203|11659491|FG000|NOT COMPLETED|Overall Study||1
10508540|NCT01282229|11659498|FG000|STARTED|Overall Study|59 Participants contributed 236 quadrants (59*4)|59
10508541|NCT01282229|11659498|FG000|COMPLETED|Overall Study|57 Participants contributed 228 quadrants (57*4)|57
10508542|NCT01282229|11659498|FG000|NOT COMPLETED|Overall Study||2
10508543|NCT01282242|11659518|FG000|STARTED|Overall Study||80
10508544|NCT01282242|11659519|FG001|STARTED|Overall Study||8
10508545|NCT01282242|11659518|FG000|COMPLETED|Overall Study||80
10508546|NCT01282242|11659519|FG001|COMPLETED|Overall Study||8
10508547|NCT01282242|11659518|FG000|NOT COMPLETED|Overall Study||0
10508548|NCT01282242|11659519|FG001|NOT COMPLETED|Overall Study||0
10508549|NCT01282294|11659525|FG000|STARTED|Overall Study||100
10508550|NCT01282294|11659525|FG000|Intra-operative|Overall Study||99
10508551|NCT01282294|11659525|FG000|Post-operative|Overall Study||99
10508552|NCT01282294|11659525|FG000|6 Weeks|Overall Study||95
10508553|NCT01282294|11659525|FG000|3 Months|Overall Study||95
10508554|NCT01282294|11659525|FG000|6 Months|Overall Study||94
10508555|NCT01282294|11659525|FG000|12 Months|Overall Study||86
10508556|NCT01282294|11659525|FG000|COMPLETED|Overall Study||81
10508557|NCT01282294|11659525|FG000|NOT COMPLETED|Overall Study||19
10508558|NCT01282372|11659529|FG000|STARTED|Overall Study||500
10508559|NCT01282372|11659529|FG000|COMPLETED|Overall Study||421
10508560|NCT01282372|11659529|FG000|NOT COMPLETED|Overall Study||79
10508561|NCT01282424|11659540|FG000|STARTED|Treatment Period (TP) (81 Months)||125
10508562|NCT01282424|11659540|FG000|Completed: Disease Progression|Treatment Period (TP) (81 Months)||70
10508563|NCT01282424|11659540|FG000|Completed: Death|Treatment Period (TP) (81 Months)||9
10508564|NCT01282424|11659540|FG000|COMPLETED|Treatment Period (TP) (81 Months)||79
10508565|NCT01282424|11659540|FG000|NOT COMPLETED|Treatment Period (TP) (81 Months)||46
10711181|NCT02657889|11876622|FG001|STARTED|Overall Study||7
10711182|NCT02657889|11876623|FG002|STARTED|Overall Study||53
10508566|NCT01282424|11659540|FG000|STARTED|Long-term Follow-up Period (5 Years)|Participants did not have to complete the TP in order to enter the Long-term Follow-up Period.|84
10508567|NCT01282424|11659540|FG000|COMPLETED|Long-term Follow-up Period (5 Years)||20
10508568|NCT01282424|11659540|FG000|NOT COMPLETED|Long-term Follow-up Period (5 Years)||64
10528307|NCT01394003|11680557|FG005|COMPLETED|Overall Study||3
10528308|NCT01394003|11680558|FG006|COMPLETED|Overall Study||6
10528309|NCT01394003|11680559|FG007|COMPLETED|Overall Study||2
10528310|NCT01394003|11680552|FG000|NOT COMPLETED|Overall Study||0
10528311|NCT01394003|11680553|FG001|NOT COMPLETED|Overall Study||0
10528312|NCT01394003|11680554|FG002|NOT COMPLETED|Overall Study||0
10508569|NCT01282463|11659547|FG000|STARTED|Overall Study||49
10508570|NCT01282463|11659548|FG001|STARTED|Overall Study||49
10508571|NCT01282463|11659549|FG002|STARTED|Overall Study||50
10508572|NCT01282463|11659547|FG000|Received at Least 1 Dose of Study Drug|Overall Study||45
10508573|NCT01282463|11659548|FG001|Received at Least 1 Dose of Study Drug|Overall Study||46
10508574|NCT01282463|11659549|FG002|Received at Least 1 Dose of Study Drug|Overall Study||49
10508575|NCT01282463|11659547|FG000|COMPLETED|Overall Study||41
10508576|NCT01282463|11659548|FG001|COMPLETED|Overall Study||45
10508577|NCT01282463|11659549|FG002|COMPLETED|Overall Study||46
10508578|NCT01282463|11659547|FG000|NOT COMPLETED|Overall Study||8
10508579|NCT01282463|11659548|FG001|NOT COMPLETED|Overall Study||4
10508580|NCT01282463|11659549|FG002|NOT COMPLETED|Overall Study||4
10508581|NCT01282476|11659565|FG000|STARTED|Overall Study||18
10508582|NCT01282476|11659565|FG000|COMPLETED|Overall Study||7
10508583|NCT01282476|11659565|FG000|NOT COMPLETED|Overall Study||11
10508584|NCT01282710|11659569|FG000|STARTED|Overall Study||20
10508585|NCT01282710|11659569|FG000|COMPLETED|Overall Study||20
10508586|NCT01282710|11659569|FG000|NOT COMPLETED|Overall Study||0
10508587|NCT01282723|11659573|FG000|STARTED|Overall Study||20
10508588|NCT01282723|11659573|FG000|COMPLETED|Overall Study||20
10508589|NCT01282723|11659573|FG000|NOT COMPLETED|Overall Study||0
10508590|NCT01282801|11659579|FG000|STARTED|First Intervention||9
10508591|NCT01282801|11659580|FG001|STARTED|First Intervention||9
10508592|NCT01282801|11659579|FG000|COMPLETED|First Intervention||9
10508593|NCT01282801|11659580|FG001|COMPLETED|First Intervention||9
10508594|NCT01282801|11659579|FG000|NOT COMPLETED|First Intervention||0
10508595|NCT01282801|11659580|FG001|NOT COMPLETED|First Intervention||0
10508596|NCT01282801|11659579|FG000|STARTED|Washout of 7 Days||9
10508597|NCT01282801|11659580|FG001|STARTED|Washout of 7 Days||9
10508598|NCT01282801|11659579|FG000|COMPLETED|Washout of 7 Days||9
10508599|NCT01282801|11659580|FG001|COMPLETED|Washout of 7 Days||9
10508600|NCT01282801|11659579|FG000|NOT COMPLETED|Washout of 7 Days||0
10508601|NCT01282801|11659580|FG001|NOT COMPLETED|Washout of 7 Days||0
10508602|NCT01282801|11659579|FG000|STARTED|Second Intervention||9
10508603|NCT01282801|11659580|FG001|STARTED|Second Intervention||9
10508604|NCT01282801|11659579|FG000|COMPLETED|Second Intervention||9
10508605|NCT01282801|11659580|FG001|COMPLETED|Second Intervention||8
10508606|NCT01282801|11659579|FG000|NOT COMPLETED|Second Intervention||0
10508607|NCT01282801|11659580|FG001|NOT COMPLETED|Second Intervention||1
10508608|NCT01282814|11659588|FG000|STARTED|First Intervention||12
10508609|NCT01282814|11659589|FG001|STARTED|First Intervention||12
10508610|NCT01282814|11659588|FG000|COMPLETED|First Intervention||12
10508611|NCT01282814|11659589|FG001|COMPLETED|First Intervention||9
10508612|NCT01282814|11659588|FG000|NOT COMPLETED|First Intervention||0
10508613|NCT01282814|11659589|FG001|NOT COMPLETED|First Intervention||3
10508614|NCT01282814|11659588|FG000|STARTED|Washout of 7 Days||12
10508615|NCT01282814|11659589|FG001|STARTED|Washout of 7 Days||9
10508616|NCT01282814|11659588|FG000|COMPLETED|Washout of 7 Days||10
10508617|NCT01282814|11659589|FG001|COMPLETED|Washout of 7 Days||9
10508618|NCT01282814|11659588|FG000|NOT COMPLETED|Washout of 7 Days||2
10508619|NCT01282814|11659589|FG001|NOT COMPLETED|Washout of 7 Days||0
10508620|NCT01282814|11659588|FG000|STARTED|Second Intervention||10
10508621|NCT01282814|11659589|FG001|STARTED|Second Intervention||9
10508622|NCT01282814|11659588|FG000|COMPLETED|Second Intervention||10
10508623|NCT01282814|11659589|FG001|COMPLETED|Second Intervention||9
10508624|NCT01282814|11659588|FG000|NOT COMPLETED|Second Intervention||0
10508625|NCT01282814|11659589|FG001|NOT COMPLETED|Second Intervention||0
10508626|NCT01282866|11659595|FG000|STARTED|Overall Study||35
10508627|NCT01282866|11659595|FG000|COMPLETED|Overall Study||34
10508628|NCT01282866|11659595|FG000|NOT COMPLETED|Overall Study||1
10508629|NCT01283009|11659601|FG000|STARTED|Overall Study||287
10508630|NCT01283009|11659602|FG001|STARTED|Overall Study||297
10711170|NCT02657538|11876596|FG000|NOT COMPLETED|Overall Study||4
10711171|NCT02657564|11876603|FG000|STARTED|Overall Study||1237
10711172|NCT02657564|11876603|FG000|COMPLETED|Overall Study||1163
10711173|NCT02657564|11876603|FG000|NOT COMPLETED|Overall Study||74
10711174|NCT02657629|11876610|FG000|STARTED|Overall Study||14
10711175|NCT02657629|11876611|FG001|STARTED|Overall Study||14
10711176|NCT02657629|11876610|FG000|COMPLETED|Overall Study||12
10711177|NCT02657629|11876611|FG001|COMPLETED|Overall Study||14
10711178|NCT02657629|11876610|FG000|NOT COMPLETED|Overall Study||2
10508631|NCT01283009|11659601|FG000|COMPLETED|Overall Study||169
10508632|NCT01283009|11659602|FG001|COMPLETED|Overall Study||180
10508633|NCT01283009|11659601|FG000|NOT COMPLETED|Overall Study||118
10508634|NCT01283009|11659602|FG001|NOT COMPLETED|Overall Study||117
10508635|NCT01283022|11659608|FG000|STARTED|Overall Study||24
10508636|NCT01283022|11659608|FG000|COMPLETED|Overall Study||24
10508637|NCT01283022|11659608|FG000|NOT COMPLETED|Overall Study||0
10711179|NCT02657629|11876611|FG001|NOT COMPLETED|Overall Study||0
10711180|NCT02657889|11876621|FG000|STARTED|Overall Study||7
10508638|NCT01283035|11659613|FG000|STARTED|Overall Study||6
10508639|NCT01283035|11659613|FG000|COMPLETED|Overall Study||5
10508640|NCT01283035|11659613|FG000|NOT COMPLETED|Overall Study||1
10508641|NCT01283139|11659621|FG000|STARTED|Overall Study||108
10508642|NCT01283139|11659622|FG001|STARTED|Overall Study||108
10508643|NCT01283139|11659623|FG002|STARTED|Overall Study||109
10508644|NCT01283139|11659624|FG003|STARTED|Overall Study||107
10508645|NCT01283139|11659621|FG000|COMPLETED|Overall Study||91
10508646|NCT01283139|11659622|FG001|COMPLETED|Overall Study||90
10508647|NCT01283139|11659623|FG002|COMPLETED|Overall Study||91
10508648|NCT01283139|11659624|FG003|COMPLETED|Overall Study||92
10508649|NCT01283139|11659621|FG000|NOT COMPLETED|Overall Study||17
10508650|NCT01283139|11659622|FG001|NOT COMPLETED|Overall Study||18
10508651|NCT01283139|11659623|FG002|NOT COMPLETED|Overall Study||18
10508652|NCT01283139|11659624|FG003|NOT COMPLETED|Overall Study||15
10508653|NCT01283152|11659636|FG000|STARTED|Overall Study||25
10508654|NCT01283152|11659637|FG001|STARTED|Overall Study||25
10508655|NCT01283152|11659636|FG000|ITT Population|Overall Study||25
10508656|NCT01283152|11659637|FG001|ITT Population|Overall Study||25
10508657|NCT01283152|11659636|FG000|Study Treatment Received|Overall Study||25
10508658|NCT01283152|11659637|FG001|Study Treatment Received|Overall Study||25
10508659|NCT01283152|11659636|FG000|24-hr HESA Attempted|Overall Study||25
10508660|NCT01283152|11659637|FG001|24-hr HESA Attempted|Overall Study||25
10508661|NCT01283152|11659636|FG000|COMPLETED|Overall Study||23
10508662|NCT01283152|11659637|FG001|COMPLETED|Overall Study||25
10508663|NCT01283152|11659636|FG000|NOT COMPLETED|Overall Study||2
10508664|NCT01283152|11659637|FG001|NOT COMPLETED|Overall Study||0
10508665|NCT01283282|11659643|FG000|STARTED|First Intervention (6 Weeks)||25
10508666|NCT01283282|11659644|FG001|STARTED|First Intervention (6 Weeks)||23
10508667|NCT01283282|11659643|FG000|COMPLETED|First Intervention (6 Weeks)||22
10508668|NCT01283282|11659644|FG001|COMPLETED|First Intervention (6 Weeks)||19
10508669|NCT01283282|11659643|FG000|NOT COMPLETED|First Intervention (6 Weeks)||3
10508670|NCT01283282|11659644|FG001|NOT COMPLETED|First Intervention (6 Weeks)||4
10508671|NCT01283282|11659643|FG000|STARTED|Second Intervention (6 Weeks)||22
10508672|NCT01283282|11659644|FG001|STARTED|Second Intervention (6 Weeks)||19
10508673|NCT01283282|11659643|FG000|COMPLETED|Second Intervention (6 Weeks)||22
10508674|NCT01283282|11659644|FG001|COMPLETED|Second Intervention (6 Weeks)||19
10508675|NCT01283282|11659643|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
10508676|NCT01283282|11659644|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
10508677|NCT01283321|11659653|FG000|STARTED|Overall Study||10
10508678|NCT01283321|11659654|FG001|STARTED|Overall Study||10
10508679|NCT01283321|11659653|FG000|COMPLETED|Overall Study||10
10508680|NCT01283321|11659654|FG001|COMPLETED|Overall Study||10
10508681|NCT01283321|11659653|FG000|NOT COMPLETED|Overall Study||0
10508682|NCT01283321|11659654|FG001|NOT COMPLETED|Overall Study||0
10508683|NCT01283334|11659662|FG000|STARTED|Overall Study||20
10508684|NCT01283334|11659662|FG000|COMPLETED|Overall Study||13
10508685|NCT01283334|11659662|FG000|NOT COMPLETED|Overall Study||7
10508686|NCT01283386|11659670|FG000|STARTED|Overall Study||10
10508687|NCT01283386|11659671|FG001|STARTED|Overall Study||16
10508688|NCT01283386|11659670|FG000|COMPLETED|Overall Study||2
10508689|NCT01283386|11659671|FG001|COMPLETED|Overall Study||4
10508690|NCT01283386|11659670|FG000|NOT COMPLETED|Overall Study||8
10508691|NCT01283386|11659671|FG001|NOT COMPLETED|Overall Study||12
10508692|NCT01283464|11659679|FG000|STARTED|Overall Study||12
10508693|NCT01283464|11659680|FG001|STARTED|Overall Study||12
10508694|NCT01283464|11659679|FG000|COMPLETED|Overall Study||10
10508695|NCT01283464|11659680|FG001|COMPLETED|Overall Study||11
10508696|NCT01283464|11659679|FG000|NOT COMPLETED|Overall Study||2
10508697|NCT01283464|11659680|FG001|NOT COMPLETED|Overall Study||1
10508698|NCT01283516|11659695|FG000|STARTED|Overall Study|Started = Full Analysis Set and Safety Set|2
10508699|NCT01283516|11659696|FG001|STARTED|Overall Study||2
10508700|NCT01283516|11659697|FG002|STARTED|Overall Study||3
10508701|NCT01283516|11659698|FG003|STARTED|Overall Study||3
10508702|NCT01283516|11659699|FG004|STARTED|Overall Study||14
10508703|NCT01283516|11659700|FG005|STARTED|Overall Study||10
10508704|NCT01283516|11659701|FG006|STARTED|Overall Study||10
10508705|NCT01283516|11659702|FG007|STARTED|Overall Study||5
10508706|NCT01283516|11659703|FG008|STARTED|Overall Study||255
10508707|NCT01283516|11659695|FG000|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||2
10508708|NCT01283516|11659696|FG001|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||1
10508709|NCT01283516|11659697|FG002|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||2
10508710|NCT01283516|11659698|FG003|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||3
10508711|NCT01283516|11659699|FG004|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||12
10508712|NCT01283516|11659700|FG005|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||10
10508713|NCT01283516|11659701|FG006|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||9
10508714|NCT01283516|11659702|FG007|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||5
10508715|NCT01283516|11659703|FG008|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||246
10508716|NCT01283516|11659695|FG000|Dose-Determining Set (DDS)|Overall Study||2
10508717|NCT01283516|11659696|FG001|Dose-Determining Set (DDS)|Overall Study||1
10508718|NCT01283516|11659697|FG002|Dose-Determining Set (DDS)|Overall Study||3
10508719|NCT01283516|11659698|FG003|Dose-Determining Set (DDS)|Overall Study||3
10508720|NCT01283516|11659699|FG004|Dose-Determining Set (DDS)|Overall Study||14
10508721|NCT01283516|11659700|FG005|Dose-Determining Set (DDS)|Overall Study||8
10508722|NCT01283516|11659701|FG006|Dose-Determining Set (DDS)|Overall Study||10
10508723|NCT01283516|11659702|FG007|Dose-Determining Set (DDS)|Overall Study||5
10508724|NCT01283516|11659703|FG008|Dose-Determining Set (DDS)|Overall Study||8
10508725|NCT01283516|11659695|FG000|Non-NSCLC|Overall Study||0
10508726|NCT01283516|11659696|FG001|Non-NSCLC|Overall Study||1
10508727|NCT01283516|11659697|FG002|Non-NSCLC|Overall Study||1
10508728|NCT01283516|11659698|FG003|Non-NSCLC|Overall Study||0
10508729|NCT01283516|11659699|FG004|Non-NSCLC|Overall Study||2
10508730|NCT01283516|11659700|FG005|Non-NSCLC|Overall Study||0
10508731|NCT01283516|11659701|FG006|Non-NSCLC|Overall Study||1
10508732|NCT01283516|11659702|FG007|Non-NSCLC|Overall Study||0
10528313|NCT01394003|11680555|FG003|NOT COMPLETED|Overall Study||0
10508733|NCT01283516|11659703|FG008|Non-NSCLC|Overall Study|Small number of patients at 750 mg - non-NSCLC, assessment limited, not included in efficacy tables|9
10508734|NCT01283516|11659695|FG000|COMPLETED|Overall Study|Completed - see explanation in Recruitment Details.|0
10508735|NCT01283516|11659696|FG001|COMPLETED|Overall Study||0
10508736|NCT01283516|11659697|FG002|COMPLETED|Overall Study||0
10508737|NCT01283516|11659698|FG003|COMPLETED|Overall Study||0
10508738|NCT01283516|11659699|FG004|COMPLETED|Overall Study||0
10508739|NCT01283516|11659700|FG005|COMPLETED|Overall Study||0
10508740|NCT01283516|11659701|FG006|COMPLETED|Overall Study||0
10508741|NCT01283516|11659702|FG007|COMPLETED|Overall Study||0
10711183|NCT02657889|11876624|FG003|STARTED|Overall Study||55
10711184|NCT02657889|11876621|FG000|COMPLETED|Overall Study||0
10711185|NCT02657889|11876622|FG001|COMPLETED|Overall Study||0
10711186|NCT02657889|11876623|FG002|COMPLETED|Overall Study||0
10711187|NCT02657889|11876624|FG003|COMPLETED|Overall Study||0
10711188|NCT02657889|11876621|FG000|NOT COMPLETED|Overall Study||7
10508742|NCT01283516|11659703|FG008|COMPLETED|Overall Study||0
10508743|NCT01283516|11659695|FG000|NOT COMPLETED|Overall Study||2
10508744|NCT01283516|11659696|FG001|NOT COMPLETED|Overall Study||2
10508745|NCT01283516|11659697|FG002|NOT COMPLETED|Overall Study||3
10508746|NCT01283516|11659698|FG003|NOT COMPLETED|Overall Study||3
10508747|NCT01283516|11659699|FG004|NOT COMPLETED|Overall Study||14
10508748|NCT01283516|11659700|FG005|NOT COMPLETED|Overall Study||10
10508749|NCT01283516|11659701|FG006|NOT COMPLETED|Overall Study||10
10508750|NCT01283516|11659702|FG007|NOT COMPLETED|Overall Study||5
10508751|NCT01283516|11659703|FG008|NOT COMPLETED|Overall Study||255
10508752|NCT01283542|11659731|FG000|STARTED|Main Phase||20
10508753|NCT01283542|11659731|FG000|Full Analysis Set (FAS)|Main Phase||20
10508754|NCT01283542|11659731|FG000|Safety Analysis Set|Main Phase||20
10508755|NCT01283542|11659731|FG000|COMPLETED|Main Phase||13
10508756|NCT01283542|11659731|FG000|NOT COMPLETED|Main Phase||7
10508757|NCT01283542|11659731|FG000|STARTED|Extension Phase||13
10508758|NCT01283542|11659731|FG000|Full Analysis Set (FAS)|Extension Phase||13
10508759|NCT01283542|11659731|FG000|Safety Analysis Set|Extension Phase||13
10508760|NCT01283542|11659731|FG000|COMPLETED|Extension Phase||10
10508761|NCT01283542|11659731|FG000|NOT COMPLETED|Extension Phase||3
10508762|NCT01283555|11659753|FG000|STARTED|First Intervention||13
10508763|NCT01283555|11659754|FG001|STARTED|First Intervention||12
10508764|NCT01283555|11659753|FG000|COMPLETED|First Intervention||13
10508765|NCT01283555|11659754|FG001|COMPLETED|First Intervention||12
10508766|NCT01283555|11659753|FG000|NOT COMPLETED|First Intervention||0
10508767|NCT01283555|11659754|FG001|NOT COMPLETED|First Intervention||0
10508768|NCT01283555|11659753|FG000|STARTED|Washout Period of at Least 21 Days||13
10508769|NCT01283555|11659754|FG001|STARTED|Washout Period of at Least 21 Days||12
10508770|NCT01283555|11659753|FG000|COMPLETED|Washout Period of at Least 21 Days||13
10508771|NCT01283555|11659754|FG001|COMPLETED|Washout Period of at Least 21 Days||12
10508772|NCT01283555|11659753|FG000|NOT COMPLETED|Washout Period of at Least 21 Days||0
10508773|NCT01283555|11659754|FG001|NOT COMPLETED|Washout Period of at Least 21 Days||0
10508774|NCT01283555|11659753|FG000|STARTED|Second Intervention||13
10508775|NCT01283555|11659754|FG001|STARTED|Second Intervention||12
10508776|NCT01283555|11659753|FG000|COMPLETED|Second Intervention||13
10508777|NCT01283555|11659754|FG001|COMPLETED|Second Intervention||12
10508778|NCT01283555|11659753|FG000|NOT COMPLETED|Second Intervention||0
10508779|NCT01283555|11659754|FG001|NOT COMPLETED|Second Intervention||0
10508780|NCT01283581|11659767|FG000|STARTED|Overall Study||81
10508781|NCT01283581|11659768|FG001|STARTED|Overall Study||77
10508782|NCT01283581|11659769|FG002|STARTED|Overall Study||98
10508783|NCT01283581|11659767|FG000|COMPLETED|Overall Study||69
10508784|NCT01283581|11659768|FG001|COMPLETED|Overall Study||63
10508785|NCT01283581|11659769|FG002|COMPLETED|Overall Study||78
10508786|NCT01283581|11659767|FG000|NOT COMPLETED|Overall Study||12
10508787|NCT01283581|11659768|FG001|NOT COMPLETED|Overall Study||14
10508788|NCT01283581|11659769|FG002|NOT COMPLETED|Overall Study||20
10508789|NCT01283971|11659782|FG000|STARTED|Overall Study||48
10711189|NCT02657889|11876622|FG001|NOT COMPLETED|Overall Study||7
10711190|NCT02657889|11876623|FG002|NOT COMPLETED|Overall Study||53
10711191|NCT02657889|11876624|FG003|NOT COMPLETED|Overall Study||55
10508790|NCT01283971|11659783|FG001|STARTED|Overall Study||48
10508791|NCT01283971|11659782|FG000|Intent to Treat Population|Overall Study||46
10508792|NCT01283971|11659783|FG001|Intent to Treat Population|Overall Study||48
10508793|NCT01283971|11659782|FG000|COMPLETED|Overall Study||33
10508794|NCT01283971|11659783|FG001|COMPLETED|Overall Study||36
10508795|NCT01283971|11659782|FG000|NOT COMPLETED|Overall Study||15
10508796|NCT01283971|11659783|FG001|NOT COMPLETED|Overall Study||12
10508797|NCT01284062|11659793|FG000|STARTED|Overall Study||21
10508798|NCT01284062|11659794|FG001|STARTED|Overall Study||21
10508799|NCT01284062|11659795|FG002|STARTED|Overall Study||21
10508800|NCT01284062|11659796|FG003|STARTED|Overall Study||21
10508801|NCT01284062|11659793|FG000|COMPLETED|Overall Study||10
10508802|NCT01284062|11659794|FG001|COMPLETED|Overall Study||13
10508803|NCT01284062|11659795|FG002|COMPLETED|Overall Study||15
10508804|NCT01284062|11659796|FG003|COMPLETED|Overall Study||7
10508805|NCT01284062|11659793|FG000|NOT COMPLETED|Overall Study||11
10508806|NCT01284062|11659794|FG001|NOT COMPLETED|Overall Study||8
10508807|NCT01284062|11659795|FG002|NOT COMPLETED|Overall Study||6
10508808|NCT01284062|11659796|FG003|NOT COMPLETED|Overall Study||14
10711192|NCT02657915|11876638|FG000|STARTED|Overall Study||24
10711193|NCT02657915|11876639|FG001|STARTED|Overall Study||28
10711194|NCT02657915|11876638|FG000|Intent-to Treat (ITT) Population|Overall Study||24
10508809|NCT01284114|11659809|FG000|STARTED|Overall Study||23
10508810|NCT01284114|11659809|FG000|COMPLETED|Overall Study||19
10508811|NCT01284114|11659809|FG000|NOT COMPLETED|Overall Study||4
10508812|NCT01284127|11659814|FG000|STARTED|Overall Study||38
10508813|NCT01284127|11659814|FG000|COMPLETED|Overall Study||31
10508814|NCT01284127|11659814|FG000|NOT COMPLETED|Overall Study||7
10508815|NCT01284140|11659820|FG000|STARTED|Randomization and Intervention||11
10508816|NCT01284140|11659821|FG001|STARTED|Randomization and Intervention||11
10508817|NCT01284140|11659820|FG000|COMPLETED|Randomization and Intervention||11
10508818|NCT01284140|11659821|FG001|COMPLETED|Randomization and Intervention||11
10508819|NCT01284140|11659820|FG000|NOT COMPLETED|Randomization and Intervention||0
10508820|NCT01284140|11659821|FG001|NOT COMPLETED|Randomization and Intervention||0
10508821|NCT01284140|11659820|FG000|STARTED|Subjects With Paired 24hr Collections||11
10508822|NCT01284140|11659821|FG001|STARTED|Subjects With Paired 24hr Collections||11
10508823|NCT01284140|11659820|FG000|COMPLETED|Subjects With Paired 24hr Collections||6
10508824|NCT01284140|11659821|FG001|COMPLETED|Subjects With Paired 24hr Collections||5
10508825|NCT01284140|11659820|FG000|NOT COMPLETED|Subjects With Paired 24hr Collections||5
10508826|NCT01284140|11659821|FG001|NOT COMPLETED|Subjects With Paired 24hr Collections||6
10508827|NCT01284244|11659829|FG000|STARTED|Overall Study||18
10508828|NCT01284244|11659830|FG001|STARTED|Overall Study||18
10508829|NCT01284244|11659829|FG000|COMPLETED|Overall Study||18
10508830|NCT01284244|11659830|FG001|COMPLETED|Overall Study||18
10508831|NCT01284244|11659829|FG000|NOT COMPLETED|Overall Study||0
10508832|NCT01284244|11659830|FG001|NOT COMPLETED|Overall Study||0
10508833|NCT01284296|11659836|FG000|STARTED|Overall Study||20
10508834|NCT01284296|11659836|FG000|COMPLETED|Overall Study||20
10508835|NCT01284296|11659836|FG000|NOT COMPLETED|Overall Study||0
10508836|NCT01284335|11659854|FG000|STARTED|Overall Study||25
10508837|NCT01284335|11659855|FG001|STARTED|Overall Study||33
10508838|NCT01284335|11659856|FG002|STARTED|Overall Study||5
10508839|NCT01284335|11659857|FG003|STARTED|Overall Study||5
10508840|NCT01284335|11659858|FG004|STARTED|Overall Study||24
10508841|NCT01284335|11659859|FG005|STARTED|Overall Study||26
10508842|NCT01284335|11659860|FG006|STARTED|Overall Study||19
10508843|NCT01284335|11659861|FG007|STARTED|Overall Study||6
10508844|NCT01284335|11659862|FG008|STARTED|Overall Study||4
10508845|NCT01284335|11659863|FG009|STARTED|Overall Study||14
10508846|NCT01284335|11659864|FG010|STARTED|Overall Study||45
10508847|NCT01284335|11659865|FG011|STARTED|Overall Study||16
10508848|NCT01284335|11659866|FG012|STARTED|Overall Study||12
10508849|NCT01284335|11659854|FG000|Received at Least One Dose of Study Drug|Overall Study||25
10508850|NCT01284335|11659855|FG001|Received at Least One Dose of Study Drug|Overall Study||33
10508851|NCT01284335|11659856|FG002|Received at Least One Dose of Study Drug|Overall Study||5
10508852|NCT01284335|11659857|FG003|Received at Least One Dose of Study Drug|Overall Study||5
10508853|NCT01284335|11659858|FG004|Received at Least One Dose of Study Drug|Overall Study||24
10508854|NCT01284335|11659859|FG005|Received at Least One Dose of Study Drug|Overall Study||26
10508855|NCT01284335|11659860|FG006|Received at Least One Dose of Study Drug|Overall Study||19
10508856|NCT01284335|11659861|FG007|Received at Least One Dose of Study Drug|Overall Study||6
10508857|NCT01284335|11659862|FG008|Received at Least One Dose of Study Drug|Overall Study||4
10508858|NCT01284335|11659863|FG009|Received at Least One Dose of Study Drug|Overall Study||14
10508859|NCT01284335|11659864|FG010|Received at Least One Dose of Study Drug|Overall Study||45
10508860|NCT01284335|11659865|FG011|Received at Least One Dose of Study Drug|Overall Study||16
10508861|NCT01284335|11659866|FG012|Received at Least One Dose of Study Drug|Overall Study||12
10508862|NCT01284335|11659854|FG000|COMPLETED|Overall Study||25
10508863|NCT01284335|11659855|FG001|COMPLETED|Overall Study||33
10508864|NCT01284335|11659856|FG002|COMPLETED|Overall Study||5
10508865|NCT01284335|11659857|FG003|COMPLETED|Overall Study||5
10508866|NCT01284335|11659858|FG004|COMPLETED|Overall Study||24
10508867|NCT01284335|11659859|FG005|COMPLETED|Overall Study||26
10508868|NCT01284335|11659860|FG006|COMPLETED|Overall Study||19
10508869|NCT01284335|11659861|FG007|COMPLETED|Overall Study||6
10508870|NCT01284335|11659862|FG008|COMPLETED|Overall Study||4
10508871|NCT01284335|11659863|FG009|COMPLETED|Overall Study||14
10508872|NCT01284335|11659864|FG010|COMPLETED|Overall Study||45
10508873|NCT01284335|11659865|FG011|COMPLETED|Overall Study||16
10508874|NCT01284335|11659866|FG012|COMPLETED|Overall Study||12
10508875|NCT01284335|11659854|FG000|NOT COMPLETED|Overall Study||0
10508876|NCT01284335|11659855|FG001|NOT COMPLETED|Overall Study||0
10508877|NCT01284335|11659856|FG002|NOT COMPLETED|Overall Study||0
10508878|NCT01284335|11659857|FG003|NOT COMPLETED|Overall Study||0
10508879|NCT01284335|11659858|FG004|NOT COMPLETED|Overall Study||0
10508880|NCT01284335|11659859|FG005|NOT COMPLETED|Overall Study||0
10508881|NCT01284335|11659860|FG006|NOT COMPLETED|Overall Study||0
10508882|NCT01284335|11659861|FG007|NOT COMPLETED|Overall Study||0
10508883|NCT01284335|11659862|FG008|NOT COMPLETED|Overall Study||0
10508884|NCT01284335|11659863|FG009|NOT COMPLETED|Overall Study||0
10508885|NCT01284335|11659864|FG010|NOT COMPLETED|Overall Study||0
10508886|NCT01284335|11659865|FG011|NOT COMPLETED|Overall Study||0
10508887|NCT01284335|11659866|FG012|NOT COMPLETED|Overall Study||0
10508888|NCT01284361|11659906|FG000|STARTED|Overall Study||91
10508889|NCT01284361|11659906|FG000|COMPLETED|Overall Study||82
10508890|NCT01284361|11659906|FG000|NOT COMPLETED|Overall Study||9
10508891|NCT01284426|11659913|FG000|STARTED|Overall Study||94
10508892|NCT01284426|11659913|FG000|COMPLETED|Overall Study||92
10508893|NCT01284426|11659913|FG000|NOT COMPLETED|Overall Study||2
10508894|NCT01284517|11659919|FG000|STARTED|Overall Study||180
10508895|NCT01284517|11659920|FG001|STARTED|Overall Study||176
10508896|NCT01284517|11659919|FG000|COMPLETED|Overall Study||148
10508897|NCT01284517|11659920|FG001|COMPLETED|Overall Study||140
10508898|NCT01284517|11659919|FG000|NOT COMPLETED|Overall Study||32
10508899|NCT01284517|11659920|FG001|NOT COMPLETED|Overall Study||36
10508900|NCT01284621|11659926|FG000|STARTED|First Intervention (8 Days)||3
10508901|NCT01284621|11659927|FG001|STARTED|First Intervention (8 Days)||4
10508902|NCT01284621|11659928|FG002|STARTED|First Intervention (8 Days)||4
10508903|NCT01284621|11659929|FG003|STARTED|First Intervention (8 Days)||4
10508904|NCT01284621|11659930|FG004|STARTED|First Intervention (8 Days)||4
10508905|NCT01284621|11659931|FG005|STARTED|First Intervention (8 Days)||4
10508906|NCT01284621|11659926|FG000|COMPLETED|First Intervention (8 Days)||3
10508907|NCT01284621|11659927|FG001|COMPLETED|First Intervention (8 Days)||4
10508908|NCT01284621|11659928|FG002|COMPLETED|First Intervention (8 Days)||4
10508909|NCT01284621|11659929|FG003|COMPLETED|First Intervention (8 Days)||4
10508910|NCT01284621|11659930|FG004|COMPLETED|First Intervention (8 Days)||4
10508911|NCT01284621|11659931|FG005|COMPLETED|First Intervention (8 Days)||4
10508912|NCT01284621|11659926|FG000|NOT COMPLETED|First Intervention (8 Days)||0
10508913|NCT01284621|11659927|FG001|NOT COMPLETED|First Intervention (8 Days)||0
10508914|NCT01284621|11659928|FG002|NOT COMPLETED|First Intervention (8 Days)||0
10508915|NCT01284621|11659929|FG003|NOT COMPLETED|First Intervention (8 Days)||0
10508916|NCT01284621|11659930|FG004|NOT COMPLETED|First Intervention (8 Days)||0
10508917|NCT01284621|11659931|FG005|NOT COMPLETED|First Intervention (8 Days)||0
10508918|NCT01284621|11659926|FG000|STARTED|Washout Period 1 (7 Days)||3
10508919|NCT01284621|11659927|FG001|STARTED|Washout Period 1 (7 Days)||4
10508920|NCT01284621|11659928|FG002|STARTED|Washout Period 1 (7 Days)||4
10508921|NCT01284621|11659929|FG003|STARTED|Washout Period 1 (7 Days)||4
10508922|NCT01284621|11659930|FG004|STARTED|Washout Period 1 (7 Days)||4
10508923|NCT01284621|11659931|FG005|STARTED|Washout Period 1 (7 Days)||4
10508924|NCT01284621|11659926|FG000|COMPLETED|Washout Period 1 (7 Days)||3
10508925|NCT01284621|11659927|FG001|COMPLETED|Washout Period 1 (7 Days)||4
10508926|NCT01284621|11659928|FG002|COMPLETED|Washout Period 1 (7 Days)||4
10508927|NCT01284621|11659929|FG003|COMPLETED|Washout Period 1 (7 Days)||4
10508928|NCT01284621|11659930|FG004|COMPLETED|Washout Period 1 (7 Days)||3
10508929|NCT01284621|11659931|FG005|COMPLETED|Washout Period 1 (7 Days)||4
10508930|NCT01284621|11659926|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
10508931|NCT01284621|11659927|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
10508932|NCT01284621|11659928|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
10508933|NCT01284621|11659929|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
10508934|NCT01284621|11659930|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||1
10508935|NCT01284621|11659931|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
10508936|NCT01284621|11659926|FG000|STARTED|Second Intervention (8 Days)||3
10508937|NCT01284621|11659927|FG001|STARTED|Second Intervention (8 Days)||4
10508938|NCT01284621|11659928|FG002|STARTED|Second Intervention (8 Days)||4
10508939|NCT01284621|11659929|FG003|STARTED|Second Intervention (8 Days)||4
10508940|NCT01284621|11659930|FG004|STARTED|Second Intervention (8 Days)||3
10508941|NCT01284621|11659931|FG005|STARTED|Second Intervention (8 Days)||4
10508942|NCT01284621|11659926|FG000|COMPLETED|Second Intervention (8 Days)||3
10508943|NCT01284621|11659927|FG001|COMPLETED|Second Intervention (8 Days)||4
10508944|NCT01284621|11659928|FG002|COMPLETED|Second Intervention (8 Days)||4
10508945|NCT01284621|11659929|FG003|COMPLETED|Second Intervention (8 Days)||4
10508946|NCT01284621|11659930|FG004|COMPLETED|Second Intervention (8 Days)||3
10508947|NCT01284621|11659931|FG005|COMPLETED|Second Intervention (8 Days)||4
10508948|NCT01284621|11659926|FG000|NOT COMPLETED|Second Intervention (8 Days)||0
10508949|NCT01284621|11659927|FG001|NOT COMPLETED|Second Intervention (8 Days)||0
10508950|NCT01284621|11659928|FG002|NOT COMPLETED|Second Intervention (8 Days)||0
10508951|NCT01284621|11659929|FG003|NOT COMPLETED|Second Intervention (8 Days)||0
10508952|NCT01284621|11659930|FG004|NOT COMPLETED|Second Intervention (8 Days)||0
10508953|NCT01284621|11659931|FG005|NOT COMPLETED|Second Intervention (8 Days)||0
10508954|NCT01284621|11659926|FG000|STARTED|Washout Period 2 (7 Days)||3
10508955|NCT01284621|11659927|FG001|STARTED|Washout Period 2 (7 Days)||4
10508956|NCT01284621|11659928|FG002|STARTED|Washout Period 2 (7 Days)||4
10508957|NCT01284621|11659929|FG003|STARTED|Washout Period 2 (7 Days)||4
10508958|NCT01284621|11659930|FG004|STARTED|Washout Period 2 (7 Days)||3
10508959|NCT01284621|11659931|FG005|STARTED|Washout Period 2 (7 Days)||4
10508960|NCT01284621|11659926|FG000|COMPLETED|Washout Period 2 (7 Days)||3
10508961|NCT01284621|11659927|FG001|COMPLETED|Washout Period 2 (7 Days)||4
10508962|NCT01284621|11659928|FG002|COMPLETED|Washout Period 2 (7 Days)||4
10508963|NCT01284621|11659929|FG003|COMPLETED|Washout Period 2 (7 Days)||4
10508964|NCT01284621|11659930|FG004|COMPLETED|Washout Period 2 (7 Days)||3
10508965|NCT01284621|11659931|FG005|COMPLETED|Washout Period 2 (7 Days)||4
10508966|NCT01284621|11659926|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
10508967|NCT01284621|11659927|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
10508968|NCT01284621|11659928|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
10508969|NCT01284621|11659929|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
10508970|NCT01284621|11659930|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
10508971|NCT01284621|11659931|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
10508972|NCT01284621|11659926|FG000|STARTED|Third Intervention (8 Days)||3
10508973|NCT01284621|11659927|FG001|STARTED|Third Intervention (8 Days)||4
10508974|NCT01284621|11659928|FG002|STARTED|Third Intervention (8 Days)||4
10508975|NCT01284621|11659929|FG003|STARTED|Third Intervention (8 Days)||4
10508976|NCT01284621|11659930|FG004|STARTED|Third Intervention (8 Days)||3
10508977|NCT01284621|11659931|FG005|STARTED|Third Intervention (8 Days)||4
10508978|NCT01284621|11659926|FG000|COMPLETED|Third Intervention (8 Days)||3
10508979|NCT01284621|11659927|FG001|COMPLETED|Third Intervention (8 Days)||4
10508980|NCT01284621|11659928|FG002|COMPLETED|Third Intervention (8 Days)||4
10508981|NCT01284621|11659929|FG003|COMPLETED|Third Intervention (8 Days)||4
10508982|NCT01284621|11659930|FG004|COMPLETED|Third Intervention (8 Days)||3
10508983|NCT01284621|11659931|FG005|COMPLETED|Third Intervention (8 Days)||4
10508984|NCT01284621|11659926|FG000|NOT COMPLETED|Third Intervention (8 Days)||0
10508985|NCT01284621|11659927|FG001|NOT COMPLETED|Third Intervention (8 Days)||0
10508986|NCT01284621|11659928|FG002|NOT COMPLETED|Third Intervention (8 Days)||0
10508987|NCT01284621|11659929|FG003|NOT COMPLETED|Third Intervention (8 Days)||0
10508988|NCT01284621|11659930|FG004|NOT COMPLETED|Third Intervention (8 Days)||0
10508989|NCT01284621|11659931|FG005|NOT COMPLETED|Third Intervention (8 Days)||0
10508990|NCT01284634|11659945|FG000|STARTED|Overall Study||7
10508991|NCT01284634|11659946|FG001|STARTED|Overall Study||6
10508992|NCT01284634|11659947|FG002|STARTED|Overall Study||7
10508993|NCT01284634|11659948|FG003|STARTED|Overall Study||5
10508994|NCT01284634|11659945|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7
10508995|NCT01284634|11659946|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
10508996|NCT01284634|11659947|FG002|Received at Least 1 Dose of Study Drug|Overall Study||7
10508997|NCT01284634|11659948|FG003|Received at Least 1 Dose of Study Drug|Overall Study||5
10508998|NCT01284634|11659945|FG000|Intent to Treat (ITT) Analysis Set|Overall Study||7
10508999|NCT01284634|11659946|FG001|Intent to Treat (ITT) Analysis Set|Overall Study||6
10509000|NCT01284634|11659947|FG002|Intent to Treat (ITT) Analysis Set|Overall Study||7
10509001|NCT01284634|11659948|FG003|Intent to Treat (ITT) Analysis Set|Overall Study||5
10509002|NCT01284634|11659945|FG000|COMPLETED|Overall Study||6
10509003|NCT01284634|11659946|FG001|COMPLETED|Overall Study||6
10509004|NCT01284634|11659947|FG002|COMPLETED|Overall Study||5
10509005|NCT01284634|11659948|FG003|COMPLETED|Overall Study||4
10509006|NCT01284634|11659945|FG000|NOT COMPLETED|Overall Study||1
10509007|NCT01284634|11659946|FG001|NOT COMPLETED|Overall Study||0
10509008|NCT01284634|11659947|FG002|NOT COMPLETED|Overall Study||2
10509009|NCT01284634|11659948|FG003|NOT COMPLETED|Overall Study||1
10509010|NCT01284959|11659961|FG000|STARTED|Overall Study||11
10509011|NCT01284959|11659962|FG001|STARTED|Overall Study||12
10509012|NCT01284959|11659963|FG002|STARTED|Overall Study||11
10509013|NCT01284959|11659961|FG000|COMPLETED|Overall Study||10
10509014|NCT01284959|11659962|FG001|COMPLETED|Overall Study||12
10509015|NCT01284959|11659963|FG002|COMPLETED|Overall Study||10
10509016|NCT01284959|11659961|FG000|NOT COMPLETED|Overall Study||1
10509017|NCT01284959|11659962|FG001|NOT COMPLETED|Overall Study||0
10509018|NCT01284959|11659963|FG002|NOT COMPLETED|Overall Study||1
10509019|NCT01285024|11659973|FG000|STARTED|Overall Study||49
10509020|NCT01285024|11659974|FG001|STARTED|Overall Study||60
10509021|NCT01285024|11659973|FG000|COMPLETED|Overall Study||49
10509022|NCT01285024|11659974|FG001|COMPLETED|Overall Study||60
10509023|NCT01285024|11659973|FG000|NOT COMPLETED|Overall Study||0
10509024|NCT01285024|11659974|FG001|NOT COMPLETED|Overall Study||0
10509025|NCT01285050|11659980|FG000|STARTED|Overall Study||20
10509026|NCT01285050|11659980|FG000|COMPLETED|Overall Study||19
10509027|NCT01285050|11659980|FG000|NOT COMPLETED|Overall Study||1
10509028|NCT01285076|11659985|FG000|STARTED|Overall Study||834
10509029|NCT01285076|11659985|FG000|COMPLETED|Overall Study||834
10509030|NCT01285076|11659985|FG000|NOT COMPLETED|Overall Study||0
10509031|NCT01285310|11659992|FG000|STARTED|Placebo Controlled Phase: Weeks 0-24||79
10509032|NCT01285310|11659993|FG001|STARTED|Placebo Controlled Phase: Weeks 0-24||82
10509033|NCT01285310|11659994|FG002|STARTED|Placebo Controlled Phase: Weeks 0-24||76
10509034|NCT01285310|11659995|FG003|STARTED|Placebo Controlled Phase: Weeks 0-24||0
10509035|NCT01285310|11659996|FG004|STARTED|Placebo Controlled Phase: Weeks 0-24||0
10509036|NCT01285310|11659992|FG000|COMPLETED|Placebo Controlled Phase: Weeks 0-24|1 participant chose not to enter the active treatment phase|70
10509037|NCT01285310|11659993|FG001|COMPLETED|Placebo Controlled Phase: Weeks 0-24|Four participants chose not to enter the active treatment phase|67
10509038|NCT01285310|11659994|FG002|COMPLETED|Placebo Controlled Phase: Weeks 0-24|1 participant chose not to enter active treatment phase|61
10509039|NCT01285310|11659995|FG003|COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
10509040|NCT01285310|11659996|FG004|COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
10509041|NCT01285310|11659992|FG000|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||9
10509042|NCT01285310|11659993|FG001|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||15
10509043|NCT01285310|11659994|FG002|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||15
10509044|NCT01285310|11659995|FG003|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
10509045|NCT01285310|11659996|FG004|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
10509046|NCT01285310|11659992|FG000|STARTED|Active Treatment Phase: Weeks 25-52||0
10509047|NCT01285310|11659993|FG001|STARTED|Active Treatment Phase: Weeks 25-52||63
10509048|NCT01285310|11659994|FG002|STARTED|Active Treatment Phase: Weeks 25-52||60
10509049|NCT01285310|11659995|FG003|STARTED|Active Treatment Phase: Weeks 25-52||27
10509050|NCT01285310|11659996|FG004|STARTED|Active Treatment Phase: Weeks 25-52||42
10509051|NCT01285310|11659992|FG000|COMPLETED|Active Treatment Phase: Weeks 25-52||0
10509052|NCT01285310|11659993|FG001|COMPLETED|Active Treatment Phase: Weeks 25-52||31
10509053|NCT01285310|11659994|FG002|COMPLETED|Active Treatment Phase: Weeks 25-52||34
10509054|NCT01285310|11659995|FG003|COMPLETED|Active Treatment Phase: Weeks 25-52||17
10509055|NCT01285310|11659996|FG004|COMPLETED|Active Treatment Phase: Weeks 25-52||23
10509056|NCT01285310|11659992|FG000|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||0
10509057|NCT01285310|11659993|FG001|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||32
10509058|NCT01285310|11659994|FG002|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||26
10509059|NCT01285310|11659995|FG003|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||10
10509060|NCT01285310|11659996|FG004|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||19
10509061|NCT01285323|11660036|FG000|STARTED|Overall Study||232
10509062|NCT01285323|11660037|FG001|STARTED|Overall Study||232
10509063|NCT01285323|11660036|FG000|Full Analysis Set|Overall Study|Randomized participants who received at least 1 dose of study drug|232
10509064|NCT01285323|11660037|FG001|Full Analysis Set|Overall Study||232
10509065|NCT01285323|11660036|FG000|Safety Analysis Set|Overall Study|Participants who received at least 1 dose of study drug|232
10509066|NCT01285323|11660037|FG001|Safety Analysis Set|Overall Study||232
10509067|NCT01285323|11660036|FG000|COMPLETED|Overall Study||199
10509068|NCT01285323|11660037|FG001|COMPLETED|Overall Study||202
10509069|NCT01285323|11660036|FG000|NOT COMPLETED|Overall Study||33
10509070|NCT01285323|11660037|FG001|NOT COMPLETED|Overall Study||30
10509071|NCT01285349|11660046|FG000|STARTED|Overall Study||190
10509072|NCT01285349|11660047|FG001|STARTED|Overall Study||190
10509073|NCT01285349|11660048|FG002|STARTED|Overall Study||184
10509074|NCT01285349|11660046|FG000|COMPLETED|Overall Study||163
10509075|NCT01285349|11660047|FG001|COMPLETED|Overall Study||170
10509076|NCT01285349|11660048|FG002|COMPLETED|Overall Study||157
10509077|NCT01285349|11660046|FG000|NOT COMPLETED|Overall Study||27
10509078|NCT01285349|11660047|FG001|NOT COMPLETED|Overall Study||20
10509079|NCT01285349|11660048|FG002|NOT COMPLETED|Overall Study||27
10509080|NCT01285401|11660059|FG000|STARTED|Overall Study||115
10509081|NCT01285401|11660060|FG001|STARTED|Overall Study||117
10509082|NCT01285401|11660059|FG000|Treated|Overall Study||113
10509083|NCT01285401|11660060|FG001|Treated|Overall Study||116
10509084|NCT01285401|11660059|FG000|COMPLETED|Overall Study||98
10509085|NCT01285401|11660060|FG001|COMPLETED|Overall Study||88
10509086|NCT01285401|11660059|FG000|NOT COMPLETED|Overall Study||17
10509087|NCT01285401|11660060|FG001|NOT COMPLETED|Overall Study||29
10509088|NCT01285427|11660066|FG000|STARTED|Overall Study||300
10509089|NCT01285427|11660066|FG000|COMPLETED|Overall Study|One sample be discarded per FDA, sample drawn with heparin tube, not specified in protocol.|299
10509090|NCT01285427|11660066|FG000|NOT COMPLETED|Overall Study||1
10509091|NCT01285492|11660080|FG000|STARTED|Overall Study|All patients randomized to this group|121
10509092|NCT01285492|11660081|FG001|STARTED|Overall Study|All patients randomized to this group|39
10509093|NCT01285492|11660080|FG000|Safety Set (for Demographics)|Overall Study|All patients who took study drug; 2 patients did not|119
10509094|NCT01285492|11660081|FG001|Safety Set (for Demographics)|Overall Study|All patients who took study drug|39
10509095|NCT01285492|11660080|FG000|COMPLETED|Overall Study||104
10509096|NCT01285492|11660081|FG001|COMPLETED|Overall Study||38
10509097|NCT01285492|11660080|FG000|NOT COMPLETED|Overall Study||17
10509098|NCT01285492|11660081|FG001|NOT COMPLETED|Overall Study||1
10509099|NCT01285518|11660095|FG000|STARTED|Overall Study||10
10509100|NCT01285518|11660096|FG001|STARTED|Overall Study||10
10509101|NCT01285518|11660097|FG002|STARTED|Overall Study||10
10509102|NCT01285518|11660098|FG003|STARTED|Overall Study||10
10509103|NCT01285518|11660099|FG004|STARTED|Overall Study||10
10509104|NCT01285518|11660100|FG005|STARTED|Overall Study||10
10509105|NCT01285518|11660101|FG006|STARTED|Overall Study||10
10509106|NCT01285518|11660102|FG007|STARTED|Overall Study||14
10509107|NCT01285518|11660095|FG000|COMPLETED|Overall Study||10
10509108|NCT01285518|11660096|FG001|COMPLETED|Overall Study||10
10509109|NCT01285518|11660097|FG002|COMPLETED|Overall Study||10
10509110|NCT01285518|11660098|FG003|COMPLETED|Overall Study||10
10509111|NCT01285518|11660099|FG004|COMPLETED|Overall Study||10
10509112|NCT01285518|11660100|FG005|COMPLETED|Overall Study||9
10509113|NCT01285518|11660101|FG006|COMPLETED|Overall Study||10
10509114|NCT01285518|11660102|FG007|COMPLETED|Overall Study||14
10509115|NCT01285518|11660095|FG000|NOT COMPLETED|Overall Study||0
10509116|NCT01285518|11660096|FG001|NOT COMPLETED|Overall Study||0
10509117|NCT01285518|11660097|FG002|NOT COMPLETED|Overall Study||0
10509118|NCT01285518|11660098|FG003|NOT COMPLETED|Overall Study||0
10509119|NCT01285518|11660099|FG004|NOT COMPLETED|Overall Study||0
10509120|NCT01285518|11660100|FG005|NOT COMPLETED|Overall Study||1
10509121|NCT01285518|11660101|FG006|NOT COMPLETED|Overall Study||0
10509122|NCT01285518|11660102|FG007|NOT COMPLETED|Overall Study||0
10509123|NCT01285609|11660123|FG000|STARTED|Randomized|Represents participants randomized to this arm prior to 1st dose of chemotherapy treatment|479
10509124|NCT01285609|11660124|FG001|STARTED|Randomized|Represents participants randomized to this arm prior to 1st dose of chemotherapy treatment|477
10509125|NCT01285609|11660123|FG000|Treated With Chemotherapy (1st Dose)|Randomized||475
10509126|NCT01285609|11660124|FG001|Treated With Chemotherapy (1st Dose)|Randomized||473
10509127|NCT01285609|11660123|FG000|COMPLETED|Randomized||388
10509128|NCT01285609|11660124|FG001|COMPLETED|Randomized||361
10509129|NCT01285609|11660123|FG000|NOT COMPLETED|Randomized||91
10509130|NCT01285609|11660124|FG001|NOT COMPLETED|Randomized||116
10509131|NCT01285609|11660123|FG000|STARTED|Treated With Blinded Therapy||388
10509132|NCT01285609|11660124|FG001|STARTED|Treated With Blinded Therapy||361
10509133|NCT01285609|11660123|FG000|COMPLETED|Treated With Blinded Therapy||1
10509134|NCT01285609|11660124|FG001|COMPLETED|Treated With Blinded Therapy||2
10509135|NCT01285609|11660123|FG000|NOT COMPLETED|Treated With Blinded Therapy||387
10509136|NCT01285609|11660124|FG001|NOT COMPLETED|Treated With Blinded Therapy||359
10509137|NCT01285635|11660135|FG000|STARTED|First Intervention (2 Weeks)||13
10509138|NCT01285635|11660136|FG001|STARTED|First Intervention (2 Weeks)||11
10509139|NCT01285635|11660137|FG002|STARTED|First Intervention (2 Weeks)||11
10509140|NCT01285635|11660135|FG000|COMPLETED|First Intervention (2 Weeks)||13
10509141|NCT01285635|11660136|FG001|COMPLETED|First Intervention (2 Weeks)||11
10509142|NCT01285635|11660137|FG002|COMPLETED|First Intervention (2 Weeks)||11
10509143|NCT01285635|11660135|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
10509144|NCT01285635|11660136|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
10509145|NCT01285635|11660137|FG002|NOT COMPLETED|First Intervention (2 Weeks)||0
10509146|NCT01285635|11660135|FG000|STARTED|Second Intervention (10, 3 Week Cycles)||13
10509147|NCT01285635|11660136|FG001|STARTED|Second Intervention (10, 3 Week Cycles)||11
10509148|NCT01285635|11660137|FG002|STARTED|Second Intervention (10, 3 Week Cycles)||11
10509149|NCT01285635|11660135|FG000|COMPLETED|Second Intervention (10, 3 Week Cycles)||13
10509150|NCT01285635|11660136|FG001|COMPLETED|Second Intervention (10, 3 Week Cycles)||11
10509151|NCT01285635|11660137|FG002|COMPLETED|Second Intervention (10, 3 Week Cycles)||11
10509152|NCT01285635|11660135|FG000|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
10509153|NCT01285635|11660136|FG001|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
10509154|NCT01285635|11660137|FG002|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
10509155|NCT01285713|11660150|FG000|STARTED|Overall Study||42
10509156|NCT01285713|11660151|FG001|STARTED|Overall Study||41
10509157|NCT01285713|11660150|FG000|COMPLETED|Overall Study||42
10509158|NCT01285713|11660151|FG001|COMPLETED|Overall Study||41
10509159|NCT01285713|11660150|FG000|NOT COMPLETED|Overall Study||0
10509160|NCT01285713|11660151|FG001|NOT COMPLETED|Overall Study||0
10509161|NCT01285791|11660160|FG000|STARTED|Overall Study||11
10509162|NCT01285791|11660161|FG001|STARTED|Overall Study||15
10509163|NCT01285791|11660162|FG002|STARTED|Overall Study||13
10509164|NCT01285791|11660160|FG000|COMPLETED|Overall Study||11
10509165|NCT01285791|11660161|FG001|COMPLETED|Overall Study||15
10509166|NCT01285791|11660162|FG002|COMPLETED|Overall Study||13
10509167|NCT01285791|11660160|FG000|NOT COMPLETED|Overall Study||0
10509168|NCT01285791|11660161|FG001|NOT COMPLETED|Overall Study||0
10509169|NCT01285791|11660162|FG002|NOT COMPLETED|Overall Study||0
10509170|NCT01285843|11660172|FG000|STARTED|Overall Study||20
10509171|NCT01285843|11660173|FG001|STARTED|Overall Study||20
10509172|NCT01285843|11660172|FG000|COMPLETED|Overall Study||18
10509173|NCT01285843|11660173|FG001|COMPLETED|Overall Study||18
10509174|NCT01285843|11660172|FG000|NOT COMPLETED|Overall Study||2
10509175|NCT01285843|11660173|FG001|NOT COMPLETED|Overall Study||2
10509176|NCT01285908|11660179|FG000|STARTED|Baseline Measurement||6
10509177|NCT01285908|11660180|FG001|STARTED|Baseline Measurement||0
10509178|NCT01285908|11660181|FG002|STARTED|Baseline Measurement||0
10509179|NCT01285908|11660179|FG000|COMPLETED|Baseline Measurement||3
10509180|NCT01285908|11660180|FG001|COMPLETED|Baseline Measurement||0
10509181|NCT01285908|11660181|FG002|COMPLETED|Baseline Measurement||0
10509182|NCT01285908|11660179|FG000|NOT COMPLETED|Baseline Measurement||3
10509183|NCT01285908|11660180|FG001|NOT COMPLETED|Baseline Measurement||0
10509184|NCT01285908|11660181|FG002|NOT COMPLETED|Baseline Measurement||0
10509185|NCT01285908|11660179|FG000|STARTED|Treatment Crossover||0
10509186|NCT01285908|11660180|FG001|STARTED|Treatment Crossover|One subject in treatment crossover did not complete baseline testing as unable to complete tasks|2
10509187|NCT01285908|11660181|FG002|STARTED|Treatment Crossover||2
10509188|NCT01285908|11660179|FG000|COMPLETED|Treatment Crossover||0
10509189|NCT01285908|11660180|FG001|COMPLETED|Treatment Crossover||2
10509190|NCT01285908|11660181|FG002|COMPLETED|Treatment Crossover||2
10509191|NCT01285908|11660179|FG000|NOT COMPLETED|Treatment Crossover||0
10509192|NCT01285908|11660180|FG001|NOT COMPLETED|Treatment Crossover||0
10509193|NCT01285908|11660181|FG002|NOT COMPLETED|Treatment Crossover||0
10509194|NCT01285960|11660211|FG000|STARTED|Overall Study|2 subjects receiving fewer than 10 sonications were added to the 106 for safety population of 108|108
10509195|NCT01285960|11660211|FG000|COMPLETED|Overall Study|An additional 2 subjects receiving fewer than 10 sonications were included in the safety population|102
10509196|NCT01285960|11660211|FG000|NOT COMPLETED|Overall Study||6
10509197|NCT01286012|11660217|FG000|STARTED|Overall Study|2 patients randomized to SFP did not receive study drug.|54
10509198|NCT01286012|11660218|FG001|STARTED|Overall Study|3 patients randomized to placebo did not receive study drug.|54
10509199|NCT01286012|11660217|FG000|COMPLETED|Overall Study||41
10509200|NCT01286012|11660218|FG001|COMPLETED|Overall Study||40
10509201|NCT01286012|11660217|FG000|NOT COMPLETED|Overall Study||13
10509202|NCT01286012|11660218|FG001|NOT COMPLETED|Overall Study||14
10509203|NCT01286077|11660227|FG000|STARTED|Overall Study|One patient did not start treatment and was excluded from the Intent to Treat (ITT) population.|51
10509204|NCT01286077|11660228|FG001|STARTED|Overall Study|One patient did not have any post-baseline assessment and was excluded from the ITT population.|53
10509205|NCT01286077|11660227|FG000|COMPLETED|Overall Study||41
10509206|NCT01286077|11660228|FG001|COMPLETED|Overall Study||46
10509207|NCT01286077|11660227|FG000|NOT COMPLETED|Overall Study||10
10509208|NCT01286077|11660228|FG001|NOT COMPLETED|Overall Study||7
10509209|NCT01286129|11660236|FG000|STARTED|Overall Study||27
10509210|NCT01286129|11660237|FG001|STARTED|Overall Study||18
10509211|NCT01286129|11660236|FG000|COMPLETED|Overall Study||19
10509212|NCT01286129|11660237|FG001|COMPLETED|Overall Study||13
10509213|NCT01286129|11660236|FG000|NOT COMPLETED|Overall Study||8
10509214|NCT01286129|11660237|FG001|NOT COMPLETED|Overall Study||5
10509215|NCT01286168|11660245|FG000|STARTED|Overall Study||104
10509216|NCT01286168|11660245|FG000|COMPLETED|Overall Study||101
10509217|NCT01286168|11660245|FG000|NOT COMPLETED|Overall Study||3
10509218|NCT01286259|11660250|FG000|STARTED|Overall Study||16
10509219|NCT01286259|11660250|FG000|COMPLETED|Overall Study||16
10509220|NCT01286259|11660250|FG000|NOT COMPLETED|Overall Study||0
10509221|NCT01286311|11660256|FG000|STARTED|Overall Study|218 patients (of the 14 physician randomized to the intervention) started the study.|232
10509222|NCT01286311|11660257|FG001|STARTED|Overall Study|217 patients (of the 15 physician randomized to the intervention) started the study.|232
10711195|NCT02657915|11876639|FG001|Intent-to Treat (ITT) Population|Overall Study||28
10711196|NCT02657915|11876638|FG000|Per-protocol Population|Overall Study||23
10711197|NCT02657915|11876639|FG001|Per-protocol Population|Overall Study||24
10509223|NCT01286311|11660256|FG000|COMPLETED|Overall Study|204 patients (of the 14 physician randomized to the intervention) completed the study.|218
10509224|NCT01286311|11660257|FG001|COMPLETED|Overall Study|217 patients (of the 15 physician randomized to the intervention) completed the study.|232
10509225|NCT01286311|11660256|FG000|NOT COMPLETED|Overall Study||14
10509226|NCT01286311|11660257|FG001|NOT COMPLETED|Overall Study||0
10509227|NCT01286324|11660265|FG000|STARTED|Overall Study||17
10509228|NCT01286324|11660266|FG001|STARTED|Overall Study||17
10509229|NCT01286324|11660265|FG000|COMPLETED|Overall Study||17
10509230|NCT01286324|11660266|FG001|COMPLETED|Overall Study||17
10509231|NCT01286324|11660265|FG000|NOT COMPLETED|Overall Study||0
10509232|NCT01286324|11660266|FG001|NOT COMPLETED|Overall Study||0
10509233|NCT01286402|11660274|FG000|STARTED|Overall Study||5
10509234|NCT01286402|11660275|FG001|STARTED|Overall Study||6
10509235|NCT01286402|11660274|FG000|COMPLETED|Overall Study||5
10509236|NCT01286402|11660275|FG001|COMPLETED|Overall Study||6
10509237|NCT01286402|11660274|FG000|NOT COMPLETED|Overall Study||0
10509238|NCT01286402|11660275|FG001|NOT COMPLETED|Overall Study||0
10509239|NCT01286441|11660285|FG000|STARTED|Overall Study||45
10509240|NCT01286441|11660286|FG001|STARTED|Overall Study||44
10509241|NCT01286441|11660287|FG002|STARTED|Overall Study||46
10509242|NCT01286441|11660288|FG003|STARTED|Overall Study||48
10509243|NCT01286441|11660285|FG000|COMPLETED|Overall Study||38
10509244|NCT01286441|11660286|FG001|COMPLETED|Overall Study||37
10509245|NCT01286441|11660287|FG002|COMPLETED|Overall Study||39
10509246|NCT01286441|11660288|FG003|COMPLETED|Overall Study||37
10509247|NCT01286441|11660285|FG000|NOT COMPLETED|Overall Study||7
10509248|NCT01286441|11660286|FG001|NOT COMPLETED|Overall Study||7
10509249|NCT01286441|11660287|FG002|NOT COMPLETED|Overall Study||7
10509250|NCT01286441|11660288|FG003|NOT COMPLETED|Overall Study||11
10509251|NCT01286454|11660298|FG000|STARTED|Part I- First Intervention Period||2
10509252|NCT01286454|11660299|FG001|STARTED|Part I- First Intervention Period||2
10509253|NCT01286454|11660300|FG002|STARTED|Part I- First Intervention Period||2
10509254|NCT01286454|11660301|FG003|STARTED|Part I- First Intervention Period||2
10509255|NCT01286454|11660302|FG004|STARTED|Part I- First Intervention Period||2
10509256|NCT01286454|11660303|FG005|STARTED|Part I- First Intervention Period||2
10509257|NCT01286454|11660304|FG006|STARTED|Part I- First Intervention Period||2
10509258|NCT01286454|11660305|FG007|STARTED|Part I- First Intervention Period||2
10509259|NCT01286454|11660306|FG008|STARTED|Part I- First Intervention Period||2
10509260|NCT01286454|11660307|FG009|STARTED|Part I- First Intervention Period||2
10509261|NCT01286454|11660308|FG010|STARTED|Part I- First Intervention Period||0
10509262|NCT01286454|11660298|FG000|COMPLETED|Part I- First Intervention Period||2
10509263|NCT01286454|11660299|FG001|COMPLETED|Part I- First Intervention Period||2
10509264|NCT01286454|11660300|FG002|COMPLETED|Part I- First Intervention Period||2
10509265|NCT01286454|11660301|FG003|COMPLETED|Part I- First Intervention Period||2
10509266|NCT01286454|11660302|FG004|COMPLETED|Part I- First Intervention Period||2
10509267|NCT01286454|11660303|FG005|COMPLETED|Part I- First Intervention Period||2
10509268|NCT01286454|11660304|FG006|COMPLETED|Part I- First Intervention Period||2
10509269|NCT01286454|11660305|FG007|COMPLETED|Part I- First Intervention Period||2
10509270|NCT01286454|11660306|FG008|COMPLETED|Part I- First Intervention Period||2
10509271|NCT01286454|11660307|FG009|COMPLETED|Part I- First Intervention Period||2
10509272|NCT01286454|11660308|FG010|COMPLETED|Part I- First Intervention Period||0
10509273|NCT01286454|11660298|FG000|NOT COMPLETED|Part I- First Intervention Period||0
10509274|NCT01286454|11660299|FG001|NOT COMPLETED|Part I- First Intervention Period||0
10509275|NCT01286454|11660300|FG002|NOT COMPLETED|Part I- First Intervention Period||0
10509276|NCT01286454|11660301|FG003|NOT COMPLETED|Part I- First Intervention Period||0
10509277|NCT01286454|11660302|FG004|NOT COMPLETED|Part I- First Intervention Period||0
10509278|NCT01286454|11660303|FG005|NOT COMPLETED|Part I- First Intervention Period||0
10509279|NCT01286454|11660304|FG006|NOT COMPLETED|Part I- First Intervention Period||0
10509280|NCT01286454|11660305|FG007|NOT COMPLETED|Part I- First Intervention Period||0
10509281|NCT01286454|11660306|FG008|NOT COMPLETED|Part I- First Intervention Period||0
10509282|NCT01286454|11660307|FG009|NOT COMPLETED|Part I- First Intervention Period||0
10509283|NCT01286454|11660308|FG010|NOT COMPLETED|Part I- First Intervention Period||0
10509284|NCT01286454|11660298|FG000|STARTED|Washout Period (At Least 3 Days)||2
10509285|NCT01286454|11660299|FG001|STARTED|Washout Period (At Least 3 Days)||2
10509286|NCT01286454|11660300|FG002|STARTED|Washout Period (At Least 3 Days)||2
10509287|NCT01286454|11660301|FG003|STARTED|Washout Period (At Least 3 Days)||2
10509288|NCT01286454|11660302|FG004|STARTED|Washout Period (At Least 3 Days)||2
10509289|NCT01286454|11660303|FG005|STARTED|Washout Period (At Least 3 Days)||2
10509290|NCT01286454|11660304|FG006|STARTED|Washout Period (At Least 3 Days)||2
10509291|NCT01286454|11660305|FG007|STARTED|Washout Period (At Least 3 Days)||2
10509292|NCT01286454|11660306|FG008|STARTED|Washout Period (At Least 3 Days)||2
10509293|NCT01286454|11660307|FG009|STARTED|Washout Period (At Least 3 Days)||2
10509294|NCT01286454|11660308|FG010|STARTED|Washout Period (At Least 3 Days)||0
10509295|NCT01286454|11660298|FG000|COMPLETED|Washout Period (At Least 3 Days)||2
10509296|NCT01286454|11660299|FG001|COMPLETED|Washout Period (At Least 3 Days)||2
10509297|NCT01286454|11660300|FG002|COMPLETED|Washout Period (At Least 3 Days)||2
10509298|NCT01286454|11660301|FG003|COMPLETED|Washout Period (At Least 3 Days)||2
10509299|NCT01286454|11660302|FG004|COMPLETED|Washout Period (At Least 3 Days)||2
10509300|NCT01286454|11660303|FG005|COMPLETED|Washout Period (At Least 3 Days)||2
10509301|NCT01286454|11660304|FG006|COMPLETED|Washout Period (At Least 3 Days)||2
10509302|NCT01286454|11660305|FG007|COMPLETED|Washout Period (At Least 3 Days)||2
10509303|NCT01286454|11660306|FG008|COMPLETED|Washout Period (At Least 3 Days)||2
10509304|NCT01286454|11660307|FG009|COMPLETED|Washout Period (At Least 3 Days)||2
10509305|NCT01286454|11660308|FG010|COMPLETED|Washout Period (At Least 3 Days)||0
10509306|NCT01286454|11660298|FG000|NOT COMPLETED|Washout Period (At Least 3 Days)||0
10509307|NCT01286454|11660299|FG001|NOT COMPLETED|Washout Period (At Least 3 Days)||0
10509308|NCT01286454|11660300|FG002|NOT COMPLETED|Washout Period (At Least 3 Days)||0
10509309|NCT01286454|11660301|FG003|NOT COMPLETED|Washout Period (At Least 3 Days)||0
10509310|NCT01286454|11660302|FG004|NOT COMPLETED|Washout Period (At Least 3 Days)||0
10509311|NCT01286454|11660303|FG005|NOT COMPLETED|Washout Period (At Least 3 Days)||0
10509312|NCT01286454|11660304|FG006|NOT COMPLETED|Washout Period (At Least 3 Days)||0
10509313|NCT01286454|11660305|FG007|NOT COMPLETED|Washout Period (At Least 3 Days)||0
10509314|NCT01286454|11660306|FG008|NOT COMPLETED|Washout Period (At Least 3 Days)||0
10509315|NCT01286454|11660307|FG009|NOT COMPLETED|Washout Period (At Least 3 Days)||0
10509316|NCT01286454|11660308|FG010|NOT COMPLETED|Washout Period (At Least 3 Days)||0
10509317|NCT01286454|11660298|FG000|STARTED|Second Intervention Period||2
10509318|NCT01286454|11660299|FG001|STARTED|Second Intervention Period||2
10509319|NCT01286454|11660300|FG002|STARTED|Second Intervention Period||2
10509320|NCT01286454|11660301|FG003|STARTED|Second Intervention Period||2
10509321|NCT01286454|11660302|FG004|STARTED|Second Intervention Period||2
10509322|NCT01286454|11660303|FG005|STARTED|Second Intervention Period||2
10509323|NCT01286454|11660304|FG006|STARTED|Second Intervention Period||2
10509324|NCT01286454|11660305|FG007|STARTED|Second Intervention Period||2
10509325|NCT01286454|11660306|FG008|STARTED|Second Intervention Period||2
10509326|NCT01286454|11660307|FG009|STARTED|Second Intervention Period||2
10509327|NCT01286454|11660308|FG010|STARTED|Second Intervention Period||0
10509328|NCT01286454|11660298|FG000|COMPLETED|Second Intervention Period||2
10509329|NCT01286454|11660299|FG001|COMPLETED|Second Intervention Period||2
10509330|NCT01286454|11660300|FG002|COMPLETED|Second Intervention Period||2
10509331|NCT01286454|11660301|FG003|COMPLETED|Second Intervention Period||2
10509332|NCT01286454|11660302|FG004|COMPLETED|Second Intervention Period||2
10509333|NCT01286454|11660303|FG005|COMPLETED|Second Intervention Period||2
10509334|NCT01286454|11660304|FG006|COMPLETED|Second Intervention Period||2
10509335|NCT01286454|11660305|FG007|COMPLETED|Second Intervention Period||2
10509336|NCT01286454|11660306|FG008|COMPLETED|Second Intervention Period||2
10509337|NCT01286454|11660307|FG009|COMPLETED|Second Intervention Period||2
10509338|NCT01286454|11660308|FG010|COMPLETED|Second Intervention Period||0
10509339|NCT01286454|11660298|FG000|NOT COMPLETED|Second Intervention Period||0
10509340|NCT01286454|11660299|FG001|NOT COMPLETED|Second Intervention Period||0
10509341|NCT01286454|11660300|FG002|NOT COMPLETED|Second Intervention Period||0
10509342|NCT01286454|11660301|FG003|NOT COMPLETED|Second Intervention Period||0
10509343|NCT01286454|11660302|FG004|NOT COMPLETED|Second Intervention Period||0
10509344|NCT01286454|11660303|FG005|NOT COMPLETED|Second Intervention Period||0
10509345|NCT01286454|11660304|FG006|NOT COMPLETED|Second Intervention Period||0
10509346|NCT01286454|11660305|FG007|NOT COMPLETED|Second Intervention Period||0
10509347|NCT01286454|11660306|FG008|NOT COMPLETED|Second Intervention Period||0
10509348|NCT01286454|11660307|FG009|NOT COMPLETED|Second Intervention Period||0
10509349|NCT01286454|11660308|FG010|NOT COMPLETED|Second Intervention Period||0
10509350|NCT01286454|11660298|FG000|STARTED|Washout Period (At Least 3 Days)||2
10509351|NCT01286454|11660299|FG001|STARTED|Washout Period (At Least 3 Days)||2
10509352|NCT01286454|11660300|FG002|STARTED|Washout Period (At Least 3 Days)||2
10509353|NCT01286454|11660301|FG003|STARTED|Washout Period (At Least 3 Days)||2
10509354|NCT01286454|11660302|FG004|STARTED|Washout Period (At Least 3 Days)||2
10509355|NCT01286454|11660303|FG005|STARTED|Washout Period (At Least 3 Days)||2
10509356|NCT01286454|11660304|FG006|STARTED|Washout Period (At Least 3 Days)||2
10509357|NCT01286454|11660305|FG007|STARTED|Washout Period (At Least 3 Days)||2
10509358|NCT01286454|11660306|FG008|STARTED|Washout Period (At Least 3 Days)||2
10509359|NCT01286454|11660307|FG009|STARTED|Washout Period (At Least 3 Days)||2
10509360|NCT01286454|11660308|FG010|STARTED|Washout Period (At Least 3 Days)||0
10509361|NCT01286454|11660298|FG000|COMPLETED|Washout Period (At Least 3 Days)||2
10509362|NCT01286454|11660299|FG001|COMPLETED|Washout Period (At Least 3 Days)||2
10509363|NCT01286454|11660300|FG002|COMPLETED|Washout Period (At Least 3 Days)||2
10509364|NCT01286454|11660301|FG003|COMPLETED|Washout Period (At Least 3 Days)||2
10509365|NCT01286454|11660302|FG004|COMPLETED|Washout Period (At Least 3 Days)||2
10509366|NCT01286454|11660303|FG005|COMPLETED|Washout Period (At Least 3 Days)||2
10509367|NCT01286454|11660304|FG006|COMPLETED|Washout Period (At Least 3 Days)||2
10509368|NCT01286454|11660305|FG007|COMPLETED|Washout Period (At Least 3 Days)||2
10509369|NCT01286454|11660306|FG008|COMPLETED|Washout Period (At Least 3 Days)||2
10509370|NCT01286454|11660307|FG009|COMPLETED|Washout Period (At Least 3 Days)||2
10509371|NCT01286454|11660308|FG010|COMPLETED|Washout Period (At Least 3 Days)||0
10509372|NCT01286454|11660298|FG000|NOT COMPLETED|Washout Period (At Least 3 Days)||0
10509373|NCT01286454|11660299|FG001|NOT COMPLETED|Washout Period (At Least 3 Days)||0
10509374|NCT01286454|11660300|FG002|NOT COMPLETED|Washout Period (At Least 3 Days)||0
10509375|NCT01286454|11660301|FG003|NOT COMPLETED|Washout Period (At Least 3 Days)||0
10509376|NCT01286454|11660302|FG004|NOT COMPLETED|Washout Period (At Least 3 Days)||0
10509377|NCT01286454|11660303|FG005|NOT COMPLETED|Washout Period (At Least 3 Days)||0
10509378|NCT01286454|11660304|FG006|NOT COMPLETED|Washout Period (At Least 3 Days)||0
10509379|NCT01286454|11660305|FG007|NOT COMPLETED|Washout Period (At Least 3 Days)||0
10509380|NCT01286454|11660306|FG008|NOT COMPLETED|Washout Period (At Least 3 Days)||0
10509381|NCT01286454|11660307|FG009|NOT COMPLETED|Washout Period (At Least 3 Days)||0
10509382|NCT01286454|11660308|FG010|NOT COMPLETED|Washout Period (At Least 3 Days)||0
10509383|NCT01286454|11660298|FG000|STARTED|Third Intervention Period||2
10509384|NCT01286454|11660299|FG001|STARTED|Third Intervention Period||2
10509385|NCT01286454|11660300|FG002|STARTED|Third Intervention Period||2
10509386|NCT01286454|11660301|FG003|STARTED|Third Intervention Period||2
10509387|NCT01286454|11660302|FG004|STARTED|Third Intervention Period||2
10509388|NCT01286454|11660303|FG005|STARTED|Third Intervention Period||2
10509389|NCT01286454|11660304|FG006|STARTED|Third Intervention Period||2
10509390|NCT01286454|11660305|FG007|STARTED|Third Intervention Period||2
10509391|NCT01286454|11660306|FG008|STARTED|Third Intervention Period||2
10509392|NCT01286454|11660307|FG009|STARTED|Third Intervention Period||2
10509393|NCT01286454|11660308|FG010|STARTED|Third Intervention Period||0
10509394|NCT01286454|11660298|FG000|COMPLETED|Third Intervention Period||2
10509395|NCT01286454|11660299|FG001|COMPLETED|Third Intervention Period||2
10509396|NCT01286454|11660300|FG002|COMPLETED|Third Intervention Period||2
10509397|NCT01286454|11660301|FG003|COMPLETED|Third Intervention Period||2
10509398|NCT01286454|11660302|FG004|COMPLETED|Third Intervention Period||2
10509399|NCT01286454|11660303|FG005|COMPLETED|Third Intervention Period||2
10509400|NCT01286454|11660304|FG006|COMPLETED|Third Intervention Period||2
10509401|NCT01286454|11660305|FG007|COMPLETED|Third Intervention Period||2
10509402|NCT01286454|11660306|FG008|COMPLETED|Third Intervention Period||2
10509403|NCT01286454|11660307|FG009|COMPLETED|Third Intervention Period||2
10509404|NCT01286454|11660308|FG010|COMPLETED|Third Intervention Period||0
10509405|NCT01286454|11660298|FG000|NOT COMPLETED|Third Intervention Period||0
10509406|NCT01286454|11660299|FG001|NOT COMPLETED|Third Intervention Period||0
10509407|NCT01286454|11660300|FG002|NOT COMPLETED|Third Intervention Period||0
10509408|NCT01286454|11660301|FG003|NOT COMPLETED|Third Intervention Period||0
10509409|NCT01286454|11660302|FG004|NOT COMPLETED|Third Intervention Period||0
10509410|NCT01286454|11660303|FG005|NOT COMPLETED|Third Intervention Period||0
10509411|NCT01286454|11660304|FG006|NOT COMPLETED|Third Intervention Period||0
10509412|NCT01286454|11660305|FG007|NOT COMPLETED|Third Intervention Period||0
10509413|NCT01286454|11660306|FG008|NOT COMPLETED|Third Intervention Period||0
10509414|NCT01286454|11660307|FG009|NOT COMPLETED|Third Intervention Period||0
10509415|NCT01286454|11660308|FG010|NOT COMPLETED|Third Intervention Period||0
10509416|NCT01286454|11660298|FG000|STARTED|Washout Period (At Least 3 Days)||2
10509417|NCT01286454|11660299|FG001|STARTED|Washout Period (At Least 3 Days)||2
10509418|NCT01286454|11660300|FG002|STARTED|Washout Period (At Least 3 Days)||2
10509419|NCT01286454|11660301|FG003|STARTED|Washout Period (At Least 3 Days)||2
10509420|NCT01286454|11660302|FG004|STARTED|Washout Period (At Least 3 Days)||2
10509421|NCT01286454|11660303|FG005|STARTED|Washout Period (At Least 3 Days)||2
10509422|NCT01286454|11660304|FG006|STARTED|Washout Period (At Least 3 Days)||2
10509423|NCT01286454|11660305|FG007|STARTED|Washout Period (At Least 3 Days)||2
10509424|NCT01286454|11660306|FG008|STARTED|Washout Period (At Least 3 Days)||2
10509425|NCT01286454|11660307|FG009|STARTED|Washout Period (At Least 3 Days)||2
10509426|NCT01286454|11660308|FG010|STARTED|Washout Period (At Least 3 Days)||0
10509427|NCT01286454|11660298|FG000|COMPLETED|Washout Period (At Least 3 Days)||2
10509428|NCT01286454|11660299|FG001|COMPLETED|Washout Period (At Least 3 Days)||2
10509429|NCT01286454|11660300|FG002|COMPLETED|Washout Period (At Least 3 Days)||2
10509430|NCT01286454|11660301|FG003|COMPLETED|Washout Period (At Least 3 Days)||2
10509431|NCT01286454|11660302|FG004|COMPLETED|Washout Period (At Least 3 Days)||2
10509432|NCT01286454|11660303|FG005|COMPLETED|Washout Period (At Least 3 Days)||2
10509433|NCT01286454|11660304|FG006|COMPLETED|Washout Period (At Least 3 Days)||2
10509434|NCT01286454|11660305|FG007|COMPLETED|Washout Period (At Least 3 Days)||2
10509435|NCT01286454|11660306|FG008|COMPLETED|Washout Period (At Least 3 Days)||2
10509436|NCT01286454|11660307|FG009|COMPLETED|Washout Period (At Least 3 Days)||2
10509437|NCT01286454|11660308|FG010|COMPLETED|Washout Period (At Least 3 Days)||0
10509438|NCT01286454|11660298|FG000|NOT COMPLETED|Washout Period (At Least 3 Days)||0
10509439|NCT01286454|11660299|FG001|NOT COMPLETED|Washout Period (At Least 3 Days)||0
10509440|NCT01286454|11660300|FG002|NOT COMPLETED|Washout Period (At Least 3 Days)||0
10509441|NCT01286454|11660301|FG003|NOT COMPLETED|Washout Period (At Least 3 Days)||0
10509442|NCT01286454|11660302|FG004|NOT COMPLETED|Washout Period (At Least 3 Days)||0
10509443|NCT01286454|11660303|FG005|NOT COMPLETED|Washout Period (At Least 3 Days)||0
10509444|NCT01286454|11660304|FG006|NOT COMPLETED|Washout Period (At Least 3 Days)||0
10509445|NCT01286454|11660305|FG007|NOT COMPLETED|Washout Period (At Least 3 Days)||0
10509446|NCT01286454|11660306|FG008|NOT COMPLETED|Washout Period (At Least 3 Days)||0
10509447|NCT01286454|11660307|FG009|NOT COMPLETED|Washout Period (At Least 3 Days)||0
10509448|NCT01286454|11660308|FG010|NOT COMPLETED|Washout Period (At Least 3 Days)||0
10509449|NCT01286454|11660298|FG000|STARTED|Fourth Intervention Period||2
10509450|NCT01286454|11660299|FG001|STARTED|Fourth Intervention Period||2
10509451|NCT01286454|11660300|FG002|STARTED|Fourth Intervention Period||2
10509452|NCT01286454|11660301|FG003|STARTED|Fourth Intervention Period||2
10509453|NCT01286454|11660302|FG004|STARTED|Fourth Intervention Period||2
10509454|NCT01286454|11660303|FG005|STARTED|Fourth Intervention Period||2
10509455|NCT01286454|11660304|FG006|STARTED|Fourth Intervention Period||2
10509456|NCT01286454|11660305|FG007|STARTED|Fourth Intervention Period||2
10509457|NCT01286454|11660306|FG008|STARTED|Fourth Intervention Period||2
10509458|NCT01286454|11660307|FG009|STARTED|Fourth Intervention Period||2
10509459|NCT01286454|11660308|FG010|STARTED|Fourth Intervention Period||0
10509460|NCT01286454|11660298|FG000|COMPLETED|Fourth Intervention Period||2
10509461|NCT01286454|11660299|FG001|COMPLETED|Fourth Intervention Period||2
10509462|NCT01286454|11660300|FG002|COMPLETED|Fourth Intervention Period||2
10509463|NCT01286454|11660301|FG003|COMPLETED|Fourth Intervention Period||2
10509464|NCT01286454|11660302|FG004|COMPLETED|Fourth Intervention Period||2
10509465|NCT01286454|11660303|FG005|COMPLETED|Fourth Intervention Period||2
10509466|NCT01286454|11660304|FG006|COMPLETED|Fourth Intervention Period||2
10509467|NCT01286454|11660305|FG007|COMPLETED|Fourth Intervention Period||2
10509468|NCT01286454|11660306|FG008|COMPLETED|Fourth Intervention Period||2
10711198|NCT02657915|11876638|FG000|COMPLETED|Overall Study||24
10711199|NCT02657915|11876639|FG001|COMPLETED|Overall Study||28
10711200|NCT02657915|11876638|FG000|NOT COMPLETED|Overall Study||0
10711201|NCT02657915|11876639|FG001|NOT COMPLETED|Overall Study||0
10509469|NCT01286454|11660307|FG009|COMPLETED|Fourth Intervention Period||2
10509470|NCT01286454|11660308|FG010|COMPLETED|Fourth Intervention Period||0
10509471|NCT01286454|11660298|FG000|NOT COMPLETED|Fourth Intervention Period||0
10509472|NCT01286454|11660299|FG001|NOT COMPLETED|Fourth Intervention Period||0
10509473|NCT01286454|11660300|FG002|NOT COMPLETED|Fourth Intervention Period||0
10509474|NCT01286454|11660301|FG003|NOT COMPLETED|Fourth Intervention Period||0
10509475|NCT01286454|11660302|FG004|NOT COMPLETED|Fourth Intervention Period||0
10509476|NCT01286454|11660303|FG005|NOT COMPLETED|Fourth Intervention Period||0
10509477|NCT01286454|11660304|FG006|NOT COMPLETED|Fourth Intervention Period||0
10509478|NCT01286454|11660305|FG007|NOT COMPLETED|Fourth Intervention Period||0
10509479|NCT01286454|11660306|FG008|NOT COMPLETED|Fourth Intervention Period||0
10509480|NCT01286454|11660307|FG009|NOT COMPLETED|Fourth Intervention Period||0
10509481|NCT01286454|11660308|FG010|NOT COMPLETED|Fourth Intervention Period||0
10509482|NCT01286454|11660298|FG000|STARTED|Washout Period (At Least 3 Days)||2
10509483|NCT01286454|11660299|FG001|STARTED|Washout Period (At Least 3 Days)||2
10509484|NCT01286454|11660300|FG002|STARTED|Washout Period (At Least 3 Days)||2
10509485|NCT01286454|11660301|FG003|STARTED|Washout Period (At Least 3 Days)||2
10509486|NCT01286454|11660302|FG004|STARTED|Washout Period (At Least 3 Days)||2
10509487|NCT01286454|11660303|FG005|STARTED|Washout Period (At Least 3 Days)||2
10509488|NCT01286454|11660304|FG006|STARTED|Washout Period (At Least 3 Days)||2
10509489|NCT01286454|11660305|FG007|STARTED|Washout Period (At Least 3 Days)||2
10509490|NCT01286454|11660306|FG008|STARTED|Washout Period (At Least 3 Days)||2
10509491|NCT01286454|11660307|FG009|STARTED|Washout Period (At Least 3 Days)||2
10509492|NCT01286454|11660308|FG010|STARTED|Washout Period (At Least 3 Days)||0
10509493|NCT01286454|11660298|FG000|COMPLETED|Washout Period (At Least 3 Days)||2
10509494|NCT01286454|11660299|FG001|COMPLETED|Washout Period (At Least 3 Days)||2
10509495|NCT01286454|11660300|FG002|COMPLETED|Washout Period (At Least 3 Days)||2
10509496|NCT01286454|11660301|FG003|COMPLETED|Washout Period (At Least 3 Days)||2
10509497|NCT01286454|11660302|FG004|COMPLETED|Washout Period (At Least 3 Days)||2
10509498|NCT01286454|11660303|FG005|COMPLETED|Washout Period (At Least 3 Days)||2
10509499|NCT01286454|11660304|FG006|COMPLETED|Washout Period (At Least 3 Days)||2
10509500|NCT01286454|11660305|FG007|COMPLETED|Washout Period (At Least 3 Days)||2
10509501|NCT01286454|11660306|FG008|COMPLETED|Washout Period (At Least 3 Days)||2
10509502|NCT01286454|11660307|FG009|COMPLETED|Washout Period (At Least 3 Days)||2
10509503|NCT01286454|11660308|FG010|COMPLETED|Washout Period (At Least 3 Days)||0
10509504|NCT01286454|11660298|FG000|NOT COMPLETED|Washout Period (At Least 3 Days)||0
10509505|NCT01286454|11660299|FG001|NOT COMPLETED|Washout Period (At Least 3 Days)||0
10509506|NCT01286454|11660300|FG002|NOT COMPLETED|Washout Period (At Least 3 Days)||0
10509507|NCT01286454|11660301|FG003|NOT COMPLETED|Washout Period (At Least 3 Days)||0
10509508|NCT01286454|11660302|FG004|NOT COMPLETED|Washout Period (At Least 3 Days)||0
10509509|NCT01286454|11660303|FG005|NOT COMPLETED|Washout Period (At Least 3 Days)||0
10711202|NCT02657928|11876647|FG000|STARTED|Overall Study||20
10509510|NCT01286454|11660304|FG006|NOT COMPLETED|Washout Period (At Least 3 Days)||0
10509511|NCT01286454|11660305|FG007|NOT COMPLETED|Washout Period (At Least 3 Days)||0
10509512|NCT01286454|11660306|FG008|NOT COMPLETED|Washout Period (At Least 3 Days)||0
10509513|NCT01286454|11660307|FG009|NOT COMPLETED|Washout Period (At Least 3 Days)||0
10509514|NCT01286454|11660308|FG010|NOT COMPLETED|Washout Period (At Least 3 Days)||0
10509515|NCT01286454|11660298|FG000|STARTED|Fifth Intervention Period||2
10509516|NCT01286454|11660299|FG001|STARTED|Fifth Intervention Period||2
10509517|NCT01286454|11660300|FG002|STARTED|Fifth Intervention Period||2
10509518|NCT01286454|11660301|FG003|STARTED|Fifth Intervention Period||2
10509519|NCT01286454|11660302|FG004|STARTED|Fifth Intervention Period||2
10509520|NCT01286454|11660303|FG005|STARTED|Fifth Intervention Period||2
10509521|NCT01286454|11660304|FG006|STARTED|Fifth Intervention Period||2
10509522|NCT01286454|11660305|FG007|STARTED|Fifth Intervention Period||2
10509523|NCT01286454|11660306|FG008|STARTED|Fifth Intervention Period||2
10509524|NCT01286454|11660307|FG009|STARTED|Fifth Intervention Period||2
10509525|NCT01286454|11660308|FG010|STARTED|Fifth Intervention Period||0
10509526|NCT01286454|11660298|FG000|COMPLETED|Fifth Intervention Period||2
10509527|NCT01286454|11660299|FG001|COMPLETED|Fifth Intervention Period||2
10509528|NCT01286454|11660300|FG002|COMPLETED|Fifth Intervention Period||2
10509529|NCT01286454|11660301|FG003|COMPLETED|Fifth Intervention Period||2
10509530|NCT01286454|11660302|FG004|COMPLETED|Fifth Intervention Period||2
10509531|NCT01286454|11660303|FG005|COMPLETED|Fifth Intervention Period||2
10509532|NCT01286454|11660304|FG006|COMPLETED|Fifth Intervention Period||2
10509533|NCT01286454|11660305|FG007|COMPLETED|Fifth Intervention Period||2
10509534|NCT01286454|11660306|FG008|COMPLETED|Fifth Intervention Period||2
10509535|NCT01286454|11660307|FG009|COMPLETED|Fifth Intervention Period||2
10509536|NCT01286454|11660308|FG010|COMPLETED|Fifth Intervention Period||0
10509537|NCT01286454|11660298|FG000|NOT COMPLETED|Fifth Intervention Period||0
10509538|NCT01286454|11660299|FG001|NOT COMPLETED|Fifth Intervention Period||0
10509539|NCT01286454|11660300|FG002|NOT COMPLETED|Fifth Intervention Period||0
10509540|NCT01286454|11660301|FG003|NOT COMPLETED|Fifth Intervention Period||0
10509541|NCT01286454|11660302|FG004|NOT COMPLETED|Fifth Intervention Period||0
10509542|NCT01286454|11660303|FG005|NOT COMPLETED|Fifth Intervention Period||0
10509543|NCT01286454|11660304|FG006|NOT COMPLETED|Fifth Intervention Period||0
10509544|NCT01286454|11660305|FG007|NOT COMPLETED|Fifth Intervention Period||0
10509545|NCT01286454|11660306|FG008|NOT COMPLETED|Fifth Intervention Period||0
10509546|NCT01286454|11660307|FG009|NOT COMPLETED|Fifth Intervention Period||0
10509547|NCT01286454|11660308|FG010|NOT COMPLETED|Fifth Intervention Period||0
10509548|NCT01286454|11660298|FG000|STARTED|Washout Period (Approximately 2 Weeks)||2
10509549|NCT01286454|11660299|FG001|STARTED|Washout Period (Approximately 2 Weeks)||2
10509550|NCT01286454|11660300|FG002|STARTED|Washout Period (Approximately 2 Weeks)||2
10509551|NCT01286454|11660301|FG003|STARTED|Washout Period (Approximately 2 Weeks)||2
10509552|NCT01286454|11660302|FG004|STARTED|Washout Period (Approximately 2 Weeks)||2
10509553|NCT01286454|11660303|FG005|STARTED|Washout Period (Approximately 2 Weeks)||2
10509554|NCT01286454|11660304|FG006|STARTED|Washout Period (Approximately 2 Weeks)||2
10509555|NCT01286454|11660305|FG007|STARTED|Washout Period (Approximately 2 Weeks)||2
10509556|NCT01286454|11660306|FG008|STARTED|Washout Period (Approximately 2 Weeks)||2
10509557|NCT01286454|11660307|FG009|STARTED|Washout Period (Approximately 2 Weeks)||2
10509558|NCT01286454|11660308|FG010|STARTED|Washout Period (Approximately 2 Weeks)||0
10509559|NCT01286454|11660298|FG000|COMPLETED|Washout Period (Approximately 2 Weeks)||2
10509560|NCT01286454|11660299|FG001|COMPLETED|Washout Period (Approximately 2 Weeks)||2
10509561|NCT01286454|11660300|FG002|COMPLETED|Washout Period (Approximately 2 Weeks)||2
10509562|NCT01286454|11660301|FG003|COMPLETED|Washout Period (Approximately 2 Weeks)||2
10509563|NCT01286454|11660302|FG004|COMPLETED|Washout Period (Approximately 2 Weeks)||2
10509564|NCT01286454|11660303|FG005|COMPLETED|Washout Period (Approximately 2 Weeks)||2
10509565|NCT01286454|11660304|FG006|COMPLETED|Washout Period (Approximately 2 Weeks)||2
10509566|NCT01286454|11660305|FG007|COMPLETED|Washout Period (Approximately 2 Weeks)||2
10509567|NCT01286454|11660306|FG008|COMPLETED|Washout Period (Approximately 2 Weeks)||2
10509568|NCT01286454|11660307|FG009|COMPLETED|Washout Period (Approximately 2 Weeks)||2
10509569|NCT01286454|11660308|FG010|COMPLETED|Washout Period (Approximately 2 Weeks)||0
10509570|NCT01286454|11660298|FG000|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
10509571|NCT01286454|11660299|FG001|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
10509572|NCT01286454|11660300|FG002|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
10509573|NCT01286454|11660301|FG003|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
10509574|NCT01286454|11660302|FG004|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
10509575|NCT01286454|11660303|FG005|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
10509576|NCT01286454|11660304|FG006|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
10509577|NCT01286454|11660305|FG007|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
10509578|NCT01286454|11660306|FG008|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
10509579|NCT01286454|11660307|FG009|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
10509580|NCT01286454|11660308|FG010|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
10509581|NCT01286454|11660298|FG000|STARTED|Part II- Sixth Intervention Period||0
10509582|NCT01286454|11660299|FG001|STARTED|Part II- Sixth Intervention Period||0
10509583|NCT01286454|11660300|FG002|STARTED|Part II- Sixth Intervention Period||0
10509584|NCT01286454|11660301|FG003|STARTED|Part II- Sixth Intervention Period||0
10509585|NCT01286454|11660302|FG004|STARTED|Part II- Sixth Intervention Period||0
10509586|NCT01286454|11660303|FG005|STARTED|Part II- Sixth Intervention Period||0
10711203|NCT02657928|11876648|FG001|STARTED|Overall Study||20
10711204|NCT02657928|11876647|FG000|COMPLETED|Overall Study||20
10711205|NCT02657928|11876648|FG001|COMPLETED|Overall Study||20
10509587|NCT01286454|11660304|FG006|STARTED|Part II- Sixth Intervention Period||0
10509588|NCT01286454|11660305|FG007|STARTED|Part II- Sixth Intervention Period||0
10509589|NCT01286454|11660306|FG008|STARTED|Part II- Sixth Intervention Period||0
10509590|NCT01286454|11660307|FG009|STARTED|Part II- Sixth Intervention Period||0
10509591|NCT01286454|11660308|FG010|STARTED|Part II- Sixth Intervention Period||20
10509592|NCT01286454|11660298|FG000|COMPLETED|Part II- Sixth Intervention Period||0
10509593|NCT01286454|11660299|FG001|COMPLETED|Part II- Sixth Intervention Period||0
10509594|NCT01286454|11660300|FG002|COMPLETED|Part II- Sixth Intervention Period||0
10509595|NCT01286454|11660301|FG003|COMPLETED|Part II- Sixth Intervention Period||0
10509596|NCT01286454|11660302|FG004|COMPLETED|Part II- Sixth Intervention Period||0
10509597|NCT01286454|11660303|FG005|COMPLETED|Part II- Sixth Intervention Period||0
10509598|NCT01286454|11660304|FG006|COMPLETED|Part II- Sixth Intervention Period||0
10509599|NCT01286454|11660305|FG007|COMPLETED|Part II- Sixth Intervention Period||0
10509600|NCT01286454|11660306|FG008|COMPLETED|Part II- Sixth Intervention Period||0
10509601|NCT01286454|11660307|FG009|COMPLETED|Part II- Sixth Intervention Period||0
10711206|NCT02657928|11876647|FG000|NOT COMPLETED|Overall Study||0
10711207|NCT02657928|11876648|FG001|NOT COMPLETED|Overall Study||0
10711208|NCT02658019|11876655|FG000|STARTED|Overall Study||29
10711209|NCT02658019|11876655|FG000|COMPLETED|Overall Study||28
10509602|NCT01286454|11660308|FG010|COMPLETED|Part II- Sixth Intervention Period||20
10509603|NCT01286454|11660298|FG000|NOT COMPLETED|Part II- Sixth Intervention Period||0
10509604|NCT01286454|11660299|FG001|NOT COMPLETED|Part II- Sixth Intervention Period||0
10509605|NCT01286454|11660300|FG002|NOT COMPLETED|Part II- Sixth Intervention Period||0
10509606|NCT01286454|11660301|FG003|NOT COMPLETED|Part II- Sixth Intervention Period||0
10509607|NCT01286454|11660302|FG004|NOT COMPLETED|Part II- Sixth Intervention Period||0
10509608|NCT01286454|11660303|FG005|NOT COMPLETED|Part II- Sixth Intervention Period||0
10509609|NCT01286454|11660304|FG006|NOT COMPLETED|Part II- Sixth Intervention Period||0
10509610|NCT01286454|11660305|FG007|NOT COMPLETED|Part II- Sixth Intervention Period||0
10509611|NCT01286454|11660306|FG008|NOT COMPLETED|Part II- Sixth Intervention Period||0
10509612|NCT01286454|11660307|FG009|NOT COMPLETED|Part II- Sixth Intervention Period||0
10509613|NCT01286454|11660308|FG010|NOT COMPLETED|Part II- Sixth Intervention Period||0
10509614|NCT01286480|11660324|FG000|STARTED|Overall Study||32
10509615|NCT01286480|11660325|FG001|STARTED|Overall Study||34
10509616|NCT01286480|11660324|FG000|COMPLETED|Overall Study||27
10509617|NCT01286480|11660325|FG001|COMPLETED|Overall Study||31
10509618|NCT01286480|11660324|FG000|NOT COMPLETED|Overall Study||5
10509619|NCT01286480|11660325|FG001|NOT COMPLETED|Overall Study||3
10509620|NCT01286493|11660331|FG000|STARTED|Overall Study||33
10509621|NCT01286493|11660331|FG000|COMPLETED|Overall Study||30
10509622|NCT01286493|11660331|FG000|NOT COMPLETED|Overall Study||3
10509623|NCT01286558|11660337|FG000|STARTED|Overall Study||112
10509624|NCT01286558|11660338|FG001|STARTED|Overall Study||113
10509625|NCT01286558|11660337|FG000|COMPLETED|Overall Study||111
10509626|NCT01286558|11660338|FG001|COMPLETED|Overall Study||111
10509627|NCT01286558|11660337|FG000|NOT COMPLETED|Overall Study||1
10509628|NCT01286558|11660338|FG001|NOT COMPLETED|Overall Study||2
10509629|NCT01286740|11660344|FG000|STARTED|Overall Study||50
10509630|NCT01286740|11660344|FG000|Enrolled and Treated|Overall Study||49
10509631|NCT01286740|11660344|FG000|Week 12 (Primary Endpoint)|Overall Study||49
10509632|NCT01286740|11660344|FG000|COMPLETED|Overall Study||48
10509633|NCT01286740|11660344|FG000|NOT COMPLETED|Overall Study||2
10509634|NCT01286753|11660350|FG000|STARTED|Overall Study||26
10509635|NCT01286753|11660351|FG001|STARTED|Overall Study||25
10509636|NCT01286753|11660350|FG000|COMPLETED|Overall Study||0
10509637|NCT01286753|11660351|FG001|COMPLETED|Overall Study||0
10509638|NCT01286753|11660350|FG000|NOT COMPLETED|Overall Study||26
10509639|NCT01286753|11660351|FG001|NOT COMPLETED|Overall Study||25
10509640|NCT01286779|11660358|FG000|STARTED|Overall Study||115
10509641|NCT01286779|11660358|FG000|COMPLETED|Overall Study||96
10509642|NCT01286779|11660358|FG000|NOT COMPLETED|Overall Study||19
10509643|NCT01286805|11660374|FG000|STARTED|Overall Study||41
10509644|NCT01286805|11660375|FG001|STARTED|Overall Study||42
10509645|NCT01286805|11660374|FG000|COMPLETED|Overall Study||41
10509646|NCT01286805|11660375|FG001|COMPLETED|Overall Study||41
10509647|NCT01286805|11660374|FG000|NOT COMPLETED|Overall Study||0
10509648|NCT01286805|11660375|FG001|NOT COMPLETED|Overall Study||1
10509649|NCT01286818|11660381|FG000|STARTED|Overall Study||6
10509650|NCT01286818|11660381|FG000|Completed DLT Assessment Period|Overall Study||5
10509651|NCT01286818|11660381|FG000|COMPLETED|Overall Study||6
10509652|NCT01286818|11660381|FG000|NOT COMPLETED|Overall Study||0
10509653|NCT01286870|11660385|FG000|STARTED|Overall Study||11
10509654|NCT01286870|11660385|FG000|COMPLETED|Overall Study||11
10509655|NCT01286870|11660385|FG000|NOT COMPLETED|Overall Study||0
10711210|NCT02658019|11876655|FG000|NOT COMPLETED|Overall Study||1
10711211|NCT02658084|11876661|FG000|STARTED|Overall Study||2
10509656|NCT01286987|11660404|FG000|STARTED|Part 1: Dose Escalation||3
10509657|NCT01286987|11660405|FG001|STARTED|Part 1: Dose Escalation||3
10509658|NCT01286987|11660406|FG002|STARTED|Part 1: Dose Escalation||3
10509659|NCT01286987|11660407|FG003|STARTED|Part 1: Dose Escalation||3
10509660|NCT01286987|11660408|FG004|STARTED|Part 1: Dose Escalation||3
10509661|NCT01286987|11660409|FG005|STARTED|Part 1: Dose Escalation||6
10509662|NCT01286987|11660410|FG006|STARTED|Part 1: Dose Escalation||6
10509663|NCT01286987|11660411|FG007|STARTED|Part 1: Dose Escalation||6
10509664|NCT01286987|11660412|FG008|STARTED|Part 1: Dose Escalation||6
10509665|NCT01286987|11660413|FG009|STARTED|Part 1: Dose Escalation||0
10509666|NCT01286987|11660414|FG010|STARTED|Part 1: Dose Escalation||0
10509667|NCT01286987|11660415|FG011|STARTED|Part 1: Dose Escalation||0
10509668|NCT01286987|11660416|FG012|STARTED|Part 1: Dose Escalation||0
10509669|NCT01286987|11660417|FG013|STARTED|Part 1: Dose Escalation||0
10509670|NCT01286987|11660418|FG014|STARTED|Part 1: Dose Escalation||0
10509671|NCT01286987|11660404|FG000|Colorectal Cancer|Part 1: Dose Escalation||1
10509672|NCT01286987|11660405|FG001|Colorectal Cancer|Part 1: Dose Escalation||0
10509673|NCT01286987|11660406|FG002|Colorectal Cancer|Part 1: Dose Escalation||1
10509674|NCT01286987|11660407|FG003|Colorectal Cancer|Part 1: Dose Escalation||0
10509675|NCT01286987|11660408|FG004|Colorectal Cancer|Part 1: Dose Escalation||0
10509676|NCT01286987|11660409|FG005|Colorectal Cancer|Part 1: Dose Escalation||0
10509677|NCT01286987|11660410|FG006|Colorectal Cancer|Part 1: Dose Escalation||0
10509678|NCT01286987|11660411|FG007|Colorectal Cancer|Part 1: Dose Escalation||0
10509679|NCT01286987|11660412|FG008|Colorectal Cancer|Part 1: Dose Escalation||0
10509680|NCT01286987|11660413|FG009|Colorectal Cancer|Part 1: Dose Escalation||0
10509681|NCT01286987|11660414|FG010|Colorectal Cancer|Part 1: Dose Escalation||0
10509682|NCT01286987|11660415|FG011|Colorectal Cancer|Part 1: Dose Escalation||0
10509683|NCT01286987|11660416|FG012|Colorectal Cancer|Part 1: Dose Escalation||0
10509684|NCT01286987|11660417|FG013|Colorectal Cancer|Part 1: Dose Escalation||0
10509685|NCT01286987|11660418|FG014|Colorectal Cancer|Part 1: Dose Escalation||0
10509686|NCT01286987|11660404|FG000|Prostate Cancer|Part 1: Dose Escalation||0
10509687|NCT01286987|11660405|FG001|Prostate Cancer|Part 1: Dose Escalation||0
10509688|NCT01286987|11660406|FG002|Prostate Cancer|Part 1: Dose Escalation||0
10509689|NCT01286987|11660407|FG003|Prostate Cancer|Part 1: Dose Escalation||0
10509690|NCT01286987|11660408|FG004|Prostate Cancer|Part 1: Dose Escalation||0
10509691|NCT01286987|11660409|FG005|Prostate Cancer|Part 1: Dose Escalation||1
10509692|NCT01286987|11660410|FG006|Prostate Cancer|Part 1: Dose Escalation||0
10509693|NCT01286987|11660411|FG007|Prostate Cancer|Part 1: Dose Escalation||0
10509694|NCT01286987|11660412|FG008|Prostate Cancer|Part 1: Dose Escalation||0
10509695|NCT01286987|11660413|FG009|Prostate Cancer|Part 1: Dose Escalation||0
10509696|NCT01286987|11660414|FG010|Prostate Cancer|Part 1: Dose Escalation||0
10509697|NCT01286987|11660415|FG011|Prostate Cancer|Part 1: Dose Escalation||0
10509698|NCT01286987|11660416|FG012|Prostate Cancer|Part 1: Dose Escalation||0
10509699|NCT01286987|11660417|FG013|Prostate Cancer|Part 1: Dose Escalation||0
10509700|NCT01286987|11660418|FG014|Prostate Cancer|Part 1: Dose Escalation||0
10509701|NCT01286987|11660404|FG000|Ewing Cancer|Part 1: Dose Escalation||0
10509702|NCT01286987|11660405|FG001|Ewing Cancer|Part 1: Dose Escalation||0
10509703|NCT01286987|11660406|FG002|Ewing Cancer|Part 1: Dose Escalation||0
10509704|NCT01286987|11660407|FG003|Ewing Cancer|Part 1: Dose Escalation||0
10509705|NCT01286987|11660408|FG004|Ewing Cancer|Part 1: Dose Escalation||0
10509706|NCT01286987|11660409|FG005|Ewing Cancer|Part 1: Dose Escalation||0
10509707|NCT01286987|11660410|FG006|Ewing Cancer|Part 1: Dose Escalation||0
10509708|NCT01286987|11660411|FG007|Ewing Cancer|Part 1: Dose Escalation||1
10509709|NCT01286987|11660412|FG008|Ewing Cancer|Part 1: Dose Escalation||1
10509710|NCT01286987|11660413|FG009|Ewing Cancer|Part 1: Dose Escalation||0
10509711|NCT01286987|11660414|FG010|Ewing Cancer|Part 1: Dose Escalation||0
10509712|NCT01286987|11660415|FG011|Ewing Cancer|Part 1: Dose Escalation||0
10509713|NCT01286987|11660416|FG012|Ewing Cancer|Part 1: Dose Escalation||0
10509714|NCT01286987|11660417|FG013|Ewing Cancer|Part 1: Dose Escalation||0
10509715|NCT01286987|11660418|FG014|Ewing Cancer|Part 1: Dose Escalation||0
10509716|NCT01286987|11660404|FG000|Pancreatic Cancer|Part 1: Dose Escalation||1
10509717|NCT01286987|11660405|FG001|Pancreatic Cancer|Part 1: Dose Escalation||2
10509718|NCT01286987|11660406|FG002|Pancreatic Cancer|Part 1: Dose Escalation||0
10509719|NCT01286987|11660407|FG003|Pancreatic Cancer|Part 1: Dose Escalation||0
10509720|NCT01286987|11660408|FG004|Pancreatic Cancer|Part 1: Dose Escalation||0
10509721|NCT01286987|11660409|FG005|Pancreatic Cancer|Part 1: Dose Escalation||0
10509722|NCT01286987|11660410|FG006|Pancreatic Cancer|Part 1: Dose Escalation||0
10509723|NCT01286987|11660411|FG007|Pancreatic Cancer|Part 1: Dose Escalation||0
10509724|NCT01286987|11660412|FG008|Pancreatic Cancer|Part 1: Dose Escalation||0
10509725|NCT01286987|11660413|FG009|Pancreatic Cancer|Part 1: Dose Escalation||0
10509726|NCT01286987|11660414|FG010|Pancreatic Cancer|Part 1: Dose Escalation||0
10509727|NCT01286987|11660415|FG011|Pancreatic Cancer|Part 1: Dose Escalation||0
10509728|NCT01286987|11660416|FG012|Pancreatic Cancer|Part 1: Dose Escalation||0
10509729|NCT01286987|11660417|FG013|Pancreatic Cancer|Part 1: Dose Escalation||0
10509730|NCT01286987|11660418|FG014|Pancreatic Cancer|Part 1: Dose Escalation||0
10509731|NCT01286987|11660404|FG000|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||1
10509732|NCT01286987|11660405|FG001|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||1
10509733|NCT01286987|11660406|FG002|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||2
10509734|NCT01286987|11660407|FG003|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||3
10509735|NCT01286987|11660408|FG004|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||3
10509736|NCT01286987|11660409|FG005|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||4
10711212|NCT02658084|11876662|FG001|STARTED|Overall Study||0
10711213|NCT02658084|11876661|FG000|COMPLETED|Overall Study||0
10711214|NCT02658084|11876662|FG001|COMPLETED|Overall Study||0
10509737|NCT01286987|11660410|FG006|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||4
10509738|NCT01286987|11660411|FG007|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||3
10509739|NCT01286987|11660412|FG008|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||2
10509740|NCT01286987|11660413|FG009|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
10509741|NCT01286987|11660414|FG010|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
10509742|NCT01286987|11660415|FG011|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
10711215|NCT02658084|11876661|FG000|NOT COMPLETED|Overall Study||2
10711216|NCT02658084|11876662|FG001|NOT COMPLETED|Overall Study||0
10711217|NCT02658149|11876669|FG000|STARTED|Overall Study||50
10711218|NCT02658149|11876670|FG001|STARTED|Overall Study||50
10711219|NCT02658149|11876669|FG000|COMPLETED|Overall Study||49
10711220|NCT02658149|11876670|FG001|COMPLETED|Overall Study||50
10509743|NCT01286987|11660416|FG012|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
10509744|NCT01286987|11660417|FG013|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
10509745|NCT01286987|11660418|FG014|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
10509746|NCT01286987|11660404|FG000|Breast Cancer|Part 1: Dose Escalation||0
10509747|NCT01286987|11660405|FG001|Breast Cancer|Part 1: Dose Escalation||0
10509748|NCT01286987|11660406|FG002|Breast Cancer|Part 1: Dose Escalation||0
10509749|NCT01286987|11660407|FG003|Breast Cancer|Part 1: Dose Escalation||0
10509750|NCT01286987|11660408|FG004|Breast Cancer|Part 1: Dose Escalation||0
10509751|NCT01286987|11660409|FG005|Breast Cancer|Part 1: Dose Escalation||1
10509752|NCT01286987|11660410|FG006|Breast Cancer|Part 1: Dose Escalation||2
10509753|NCT01286987|11660411|FG007|Breast Cancer|Part 1: Dose Escalation||2
10509754|NCT01286987|11660412|FG008|Breast Cancer|Part 1: Dose Escalation||3
10509755|NCT01286987|11660413|FG009|Breast Cancer|Part 1: Dose Escalation||0
10509756|NCT01286987|11660414|FG010|Breast Cancer|Part 1: Dose Escalation||0
10509757|NCT01286987|11660415|FG011|Breast Cancer|Part 1: Dose Escalation||0
10509758|NCT01286987|11660416|FG012|Breast Cancer|Part 1: Dose Escalation||0
10509759|NCT01286987|11660417|FG013|Breast Cancer|Part 1: Dose Escalation||0
10509760|NCT01286987|11660418|FG014|Breast Cancer|Part 1: Dose Escalation||0
10509761|NCT01286987|11660404|FG000|COMPLETED|Part 1: Dose Escalation||0
10509762|NCT01286987|11660405|FG001|COMPLETED|Part 1: Dose Escalation||0
10509763|NCT01286987|11660406|FG002|COMPLETED|Part 1: Dose Escalation||0
10509764|NCT01286987|11660407|FG003|COMPLETED|Part 1: Dose Escalation||0
10509765|NCT01286987|11660408|FG004|COMPLETED|Part 1: Dose Escalation||0
10509766|NCT01286987|11660409|FG005|COMPLETED|Part 1: Dose Escalation||0
10509767|NCT01286987|11660410|FG006|COMPLETED|Part 1: Dose Escalation||1
10509768|NCT01286987|11660411|FG007|COMPLETED|Part 1: Dose Escalation||1
10509769|NCT01286987|11660412|FG008|COMPLETED|Part 1: Dose Escalation||0
10509770|NCT01286987|11660413|FG009|COMPLETED|Part 1: Dose Escalation||0
10509771|NCT01286987|11660414|FG010|COMPLETED|Part 1: Dose Escalation||0
10509772|NCT01286987|11660415|FG011|COMPLETED|Part 1: Dose Escalation||0
10509773|NCT01286987|11660416|FG012|COMPLETED|Part 1: Dose Escalation||0
10509774|NCT01286987|11660417|FG013|COMPLETED|Part 1: Dose Escalation||0
10509775|NCT01286987|11660418|FG014|COMPLETED|Part 1: Dose Escalation||0
10509776|NCT01286987|11660404|FG000|NOT COMPLETED|Part 1: Dose Escalation||3
10509777|NCT01286987|11660405|FG001|NOT COMPLETED|Part 1: Dose Escalation||3
10509778|NCT01286987|11660406|FG002|NOT COMPLETED|Part 1: Dose Escalation||3
10509779|NCT01286987|11660407|FG003|NOT COMPLETED|Part 1: Dose Escalation||3
10509780|NCT01286987|11660408|FG004|NOT COMPLETED|Part 1: Dose Escalation||3
10509781|NCT01286987|11660409|FG005|NOT COMPLETED|Part 1: Dose Escalation||6
10509782|NCT01286987|11660410|FG006|NOT COMPLETED|Part 1: Dose Escalation||5
10509783|NCT01286987|11660411|FG007|NOT COMPLETED|Part 1: Dose Escalation||5
10509784|NCT01286987|11660412|FG008|NOT COMPLETED|Part 1: Dose Escalation||6
10509785|NCT01286987|11660413|FG009|NOT COMPLETED|Part 1: Dose Escalation||0
10509786|NCT01286987|11660414|FG010|NOT COMPLETED|Part 1: Dose Escalation||0
10509787|NCT01286987|11660415|FG011|NOT COMPLETED|Part 1: Dose Escalation||0
10509788|NCT01286987|11660416|FG012|NOT COMPLETED|Part 1: Dose Escalation||0
10509789|NCT01286987|11660417|FG013|NOT COMPLETED|Part 1: Dose Escalation||0
10509790|NCT01286987|11660418|FG014|NOT COMPLETED|Part 1: Dose Escalation||0
10509791|NCT01286987|11660404|FG000|STARTED|Part 2: Dose Expansion||0
10509792|NCT01286987|11660405|FG001|STARTED|Part 2: Dose Expansion||0
10509793|NCT01286987|11660406|FG002|STARTED|Part 2: Dose Expansion||0
10509794|NCT01286987|11660407|FG003|STARTED|Part 2: Dose Expansion||0
10509795|NCT01286987|11660408|FG004|STARTED|Part 2: Dose Expansion||0
10509796|NCT01286987|11660409|FG005|STARTED|Part 2: Dose Expansion||0
10509797|NCT01286987|11660410|FG006|STARTED|Part 2: Dose Expansion||0
10509798|NCT01286987|11660411|FG007|STARTED|Part 2: Dose Expansion||0
10509799|NCT01286987|11660412|FG008|STARTED|Part 2: Dose Expansion||0
10509800|NCT01286987|11660413|FG009|STARTED|Part 2: Dose Expansion||12
10509801|NCT01286987|11660414|FG010|STARTED|Part 2: Dose Expansion||12
10509802|NCT01286987|11660415|FG011|STARTED|Part 2: Dose Expansion||11
10509803|NCT01286987|11660416|FG012|STARTED|Part 2: Dose Expansion||12
10509804|NCT01286987|11660417|FG013|STARTED|Part 2: Dose Expansion||24
10509805|NCT01286987|11660418|FG014|STARTED|Part 2: Dose Expansion||3
10509806|NCT01286987|11660404|FG000|Treated|Part 2: Dose Expansion||0
10509807|NCT01286987|11660405|FG001|Treated|Part 2: Dose Expansion||0
10509808|NCT01286987|11660406|FG002|Treated|Part 2: Dose Expansion||0
10711221|NCT02658149|11876669|FG000|NOT COMPLETED|Overall Study||1
10711222|NCT02658149|11876670|FG001|NOT COMPLETED|Overall Study||0
10509809|NCT01286987|11660407|FG003|Treated|Part 2: Dose Expansion||0
10509810|NCT01286987|11660408|FG004|Treated|Part 2: Dose Expansion||0
10509811|NCT01286987|11660409|FG005|Treated|Part 2: Dose Expansion||0
10509812|NCT01286987|11660410|FG006|Treated|Part 2: Dose Expansion||0
10509813|NCT01286987|11660411|FG007|Treated|Part 2: Dose Expansion||0
10509814|NCT01286987|11660412|FG008|Treated|Part 2: Dose Expansion||0
10509815|NCT01286987|11660413|FG009|Treated|Part 2: Dose Expansion||12
10509816|NCT01286987|11660414|FG010|Treated|Part 2: Dose Expansion||11
10509817|NCT01286987|11660415|FG011|Treated|Part 2: Dose Expansion||10
10509818|NCT01286987|11660416|FG012|Treated|Part 2: Dose Expansion||12
10509819|NCT01286987|11660417|FG013|Treated|Part 2: Dose Expansion||23
10509820|NCT01286987|11660418|FG014|Treated|Part 2: Dose Expansion||3
10509821|NCT01286987|11660404|FG000|COMPLETED|Part 2: Dose Expansion||0
10509822|NCT01286987|11660405|FG001|COMPLETED|Part 2: Dose Expansion||0
10509823|NCT01286987|11660406|FG002|COMPLETED|Part 2: Dose Expansion||0
10509824|NCT01286987|11660407|FG003|COMPLETED|Part 2: Dose Expansion||0
10509825|NCT01286987|11660408|FG004|COMPLETED|Part 2: Dose Expansion||0
10509826|NCT01286987|11660409|FG005|COMPLETED|Part 2: Dose Expansion||0
10509827|NCT01286987|11660410|FG006|COMPLETED|Part 2: Dose Expansion||0
10509828|NCT01286987|11660411|FG007|COMPLETED|Part 2: Dose Expansion||0
10509829|NCT01286987|11660412|FG008|COMPLETED|Part 2: Dose Expansion||0
10509830|NCT01286987|11660413|FG009|COMPLETED|Part 2: Dose Expansion||1
10509831|NCT01286987|11660414|FG010|COMPLETED|Part 2: Dose Expansion||2
10509832|NCT01286987|11660415|FG011|COMPLETED|Part 2: Dose Expansion||1
10509833|NCT01286987|11660416|FG012|COMPLETED|Part 2: Dose Expansion||0
10509834|NCT01286987|11660417|FG013|COMPLETED|Part 2: Dose Expansion||0
10509835|NCT01286987|11660418|FG014|COMPLETED|Part 2: Dose Expansion||1
10509836|NCT01286987|11660404|FG000|NOT COMPLETED|Part 2: Dose Expansion||0
10509837|NCT01286987|11660405|FG001|NOT COMPLETED|Part 2: Dose Expansion||0
10509838|NCT01286987|11660406|FG002|NOT COMPLETED|Part 2: Dose Expansion||0
10509839|NCT01286987|11660407|FG003|NOT COMPLETED|Part 2: Dose Expansion||0
10509840|NCT01286987|11660408|FG004|NOT COMPLETED|Part 2: Dose Expansion||0
10509841|NCT01286987|11660409|FG005|NOT COMPLETED|Part 2: Dose Expansion||0
10509842|NCT01286987|11660410|FG006|NOT COMPLETED|Part 2: Dose Expansion||0
10509843|NCT01286987|11660411|FG007|NOT COMPLETED|Part 2: Dose Expansion||0
10509844|NCT01286987|11660412|FG008|NOT COMPLETED|Part 2: Dose Expansion||0
10509845|NCT01286987|11660413|FG009|NOT COMPLETED|Part 2: Dose Expansion||11
10509846|NCT01286987|11660414|FG010|NOT COMPLETED|Part 2: Dose Expansion||10
10509847|NCT01286987|11660415|FG011|NOT COMPLETED|Part 2: Dose Expansion||10
10509848|NCT01286987|11660416|FG012|NOT COMPLETED|Part 2: Dose Expansion||12
10509849|NCT01286987|11660417|FG013|NOT COMPLETED|Part 2: Dose Expansion||24
10509850|NCT01286987|11660418|FG014|NOT COMPLETED|Part 2: Dose Expansion||2
10509851|NCT01287013|11660462|FG000|STARTED|Overall Study||32
10509852|NCT01287013|11660463|FG001|STARTED|Overall Study||34
10509853|NCT01287013|11660464|FG002|STARTED|Overall Study||21
10509854|NCT01287013|11660462|FG000|COMPLETED|Overall Study||29
10509855|NCT01287013|11660463|FG001|COMPLETED|Overall Study||29
10509856|NCT01287013|11660464|FG002|COMPLETED|Overall Study||0
10509857|NCT01287013|11660462|FG000|NOT COMPLETED|Overall Study||3
10509858|NCT01287013|11660463|FG001|NOT COMPLETED|Overall Study||5
10509859|NCT01287013|11660464|FG002|NOT COMPLETED|Overall Study||21
10509860|NCT01287039|11660474|FG000|STARTED|Overall Study||244
10509861|NCT01287039|11660475|FG001|STARTED|Overall Study||245
10509862|NCT01287039|11660474|FG000|COMPLETED|Overall Study||215
10509863|NCT01287039|11660475|FG001|COMPLETED|Overall Study||218
10509864|NCT01287039|11660474|FG000|NOT COMPLETED|Overall Study||29
10509865|NCT01287039|11660475|FG001|NOT COMPLETED|Overall Study||27
10509866|NCT01287065|11660481|FG000|STARTED|Treatment Period 1||4
10509867|NCT01287065|11660482|FG001|STARTED|Treatment Period 1||4
10509868|NCT01287065|11660483|FG002|STARTED|Treatment Period 1||4
10509869|NCT01287065|11660484|FG003|STARTED|Treatment Period 1||4
10509870|NCT01287065|11660485|FG004|STARTED|Treatment Period 1||5
10509871|NCT01287065|11660486|FG005|STARTED|Treatment Period 1||5
10509872|NCT01287065|11660481|FG000|COMPLETED|Treatment Period 1||4
10509873|NCT01287065|11660482|FG001|COMPLETED|Treatment Period 1||4
10509874|NCT01287065|11660483|FG002|COMPLETED|Treatment Period 1||4
10509875|NCT01287065|11660484|FG003|COMPLETED|Treatment Period 1||4
10509876|NCT01287065|11660485|FG004|COMPLETED|Treatment Period 1||4
10509877|NCT01287065|11660486|FG005|COMPLETED|Treatment Period 1||4
10509878|NCT01287065|11660481|FG000|NOT COMPLETED|Treatment Period 1||0
10509879|NCT01287065|11660482|FG001|NOT COMPLETED|Treatment Period 1||0
10509880|NCT01287065|11660483|FG002|NOT COMPLETED|Treatment Period 1||0
10509881|NCT01287065|11660484|FG003|NOT COMPLETED|Treatment Period 1||0
10509882|NCT01287065|11660485|FG004|NOT COMPLETED|Treatment Period 1||1
10509883|NCT01287065|11660486|FG005|NOT COMPLETED|Treatment Period 1||1
10509884|NCT01287065|11660481|FG000|STARTED|Washout Period 1||4
10509885|NCT01287065|11660482|FG001|STARTED|Washout Period 1||4
10509886|NCT01287065|11660483|FG002|STARTED|Washout Period 1||4
10509887|NCT01287065|11660484|FG003|STARTED|Washout Period 1||4
10509888|NCT01287065|11660485|FG004|STARTED|Washout Period 1||4
10509889|NCT01287065|11660486|FG005|STARTED|Washout Period 1||4
10509890|NCT01287065|11660481|FG000|COMPLETED|Washout Period 1||4
10509891|NCT01287065|11660482|FG001|COMPLETED|Washout Period 1||4
10509892|NCT01287065|11660483|FG002|COMPLETED|Washout Period 1||4
10509893|NCT01287065|11660484|FG003|COMPLETED|Washout Period 1||4
10509894|NCT01287065|11660485|FG004|COMPLETED|Washout Period 1||4
10509895|NCT01287065|11660486|FG005|COMPLETED|Washout Period 1||4
10509896|NCT01287065|11660481|FG000|NOT COMPLETED|Washout Period 1||0
10509897|NCT01287065|11660482|FG001|NOT COMPLETED|Washout Period 1||0
10509898|NCT01287065|11660483|FG002|NOT COMPLETED|Washout Period 1||0
10509899|NCT01287065|11660484|FG003|NOT COMPLETED|Washout Period 1||0
10509900|NCT01287065|11660485|FG004|NOT COMPLETED|Washout Period 1||0
10509901|NCT01287065|11660486|FG005|NOT COMPLETED|Washout Period 1||0
10509902|NCT01287065|11660481|FG000|STARTED|Treatment Period 2||4
10509903|NCT01287065|11660482|FG001|STARTED|Treatment Period 2||4
10509904|NCT01287065|11660483|FG002|STARTED|Treatment Period 2||4
10509905|NCT01287065|11660484|FG003|STARTED|Treatment Period 2||4
10509906|NCT01287065|11660485|FG004|STARTED|Treatment Period 2||4
10509907|NCT01287065|11660486|FG005|STARTED|Treatment Period 2||4
10509908|NCT01287065|11660481|FG000|COMPLETED|Treatment Period 2||4
10509909|NCT01287065|11660482|FG001|COMPLETED|Treatment Period 2||4
10509910|NCT01287065|11660483|FG002|COMPLETED|Treatment Period 2||4
10509911|NCT01287065|11660484|FG003|COMPLETED|Treatment Period 2||4
10509912|NCT01287065|11660485|FG004|COMPLETED|Treatment Period 2||4
10509913|NCT01287065|11660486|FG005|COMPLETED|Treatment Period 2||4
10509914|NCT01287065|11660481|FG000|NOT COMPLETED|Treatment Period 2||0
10509915|NCT01287065|11660482|FG001|NOT COMPLETED|Treatment Period 2||0
10509916|NCT01287065|11660483|FG002|NOT COMPLETED|Treatment Period 2||0
10509917|NCT01287065|11660484|FG003|NOT COMPLETED|Treatment Period 2||0
10509918|NCT01287065|11660485|FG004|NOT COMPLETED|Treatment Period 2||0
10509919|NCT01287065|11660486|FG005|NOT COMPLETED|Treatment Period 2||0
10509920|NCT01287065|11660481|FG000|STARTED|Washout Period 2||4
10509921|NCT01287065|11660482|FG001|STARTED|Washout Period 2||4
10509922|NCT01287065|11660483|FG002|STARTED|Washout Period 2||4
10509923|NCT01287065|11660484|FG003|STARTED|Washout Period 2||4
10509924|NCT01287065|11660485|FG004|STARTED|Washout Period 2||4
10509925|NCT01287065|11660486|FG005|STARTED|Washout Period 2||4
10509926|NCT01287065|11660481|FG000|COMPLETED|Washout Period 2||4
10509927|NCT01287065|11660482|FG001|COMPLETED|Washout Period 2||4
10509928|NCT01287065|11660483|FG002|COMPLETED|Washout Period 2||4
10509929|NCT01287065|11660484|FG003|COMPLETED|Washout Period 2||4
10509930|NCT01287065|11660485|FG004|COMPLETED|Washout Period 2||4
10509931|NCT01287065|11660486|FG005|COMPLETED|Washout Period 2||4
10509932|NCT01287065|11660481|FG000|NOT COMPLETED|Washout Period 2||0
10509933|NCT01287065|11660482|FG001|NOT COMPLETED|Washout Period 2||0
10509934|NCT01287065|11660483|FG002|NOT COMPLETED|Washout Period 2||0
10509935|NCT01287065|11660484|FG003|NOT COMPLETED|Washout Period 2||0
10509936|NCT01287065|11660485|FG004|NOT COMPLETED|Washout Period 2||0
10509937|NCT01287065|11660486|FG005|NOT COMPLETED|Washout Period 2||0
10509938|NCT01287065|11660481|FG000|STARTED|Treatment Period 3||4
10509939|NCT01287065|11660482|FG001|STARTED|Treatment Period 3||4
10509940|NCT01287065|11660483|FG002|STARTED|Treatment Period 3||4
10509941|NCT01287065|11660484|FG003|STARTED|Treatment Period 3||4
10509942|NCT01287065|11660485|FG004|STARTED|Treatment Period 3||4
10509943|NCT01287065|11660486|FG005|STARTED|Treatment Period 3||4
10509944|NCT01287065|11660481|FG000|COMPLETED|Treatment Period 3||4
10509945|NCT01287065|11660482|FG001|COMPLETED|Treatment Period 3||4
10509946|NCT01287065|11660483|FG002|COMPLETED|Treatment Period 3||4
10509947|NCT01287065|11660484|FG003|COMPLETED|Treatment Period 3||4
10509948|NCT01287065|11660485|FG004|COMPLETED|Treatment Period 3||4
10509949|NCT01287065|11660486|FG005|COMPLETED|Treatment Period 3||4
10509950|NCT01287065|11660481|FG000|NOT COMPLETED|Treatment Period 3||0
10509951|NCT01287065|11660482|FG001|NOT COMPLETED|Treatment Period 3||0
10509952|NCT01287065|11660483|FG002|NOT COMPLETED|Treatment Period 3||0
10509953|NCT01287065|11660484|FG003|NOT COMPLETED|Treatment Period 3||0
10509954|NCT01287065|11660485|FG004|NOT COMPLETED|Treatment Period 3||0
10509955|NCT01287065|11660486|FG005|NOT COMPLETED|Treatment Period 3||0
10509956|NCT01287078|11660496|FG000|STARTED|Overall Study||20
10509957|NCT01287078|11660497|FG001|STARTED|Overall Study||3
10509958|NCT01287078|11660496|FG000|COMPLETED|Overall Study||10
10509959|NCT01287078|11660497|FG001|COMPLETED|Overall Study||1
10509960|NCT01287078|11660496|FG000|NOT COMPLETED|Overall Study||10
10509961|NCT01287078|11660497|FG001|NOT COMPLETED|Overall Study||2
10509962|NCT01287104|11660507|FG000|STARTED|Overall Study||4
10509963|NCT01287104|11660508|FG001|STARTED|Overall Study||7
10509964|NCT01287104|11660509|FG002|STARTED|Overall Study||12
10509965|NCT01287104|11660510|FG003|STARTED|Overall Study||11
10509966|NCT01287104|11660507|FG000|COMPLETED|Overall Study||3
10509967|NCT01287104|11660508|FG001|COMPLETED|Overall Study||2
10509968|NCT01287104|11660509|FG002|COMPLETED|Overall Study||5
10509969|NCT01287104|11660510|FG003|COMPLETED|Overall Study||8
10509970|NCT01287104|11660507|FG000|NOT COMPLETED|Overall Study||1
10509971|NCT01287104|11660508|FG001|NOT COMPLETED|Overall Study||5
10509972|NCT01287104|11660509|FG002|NOT COMPLETED|Overall Study||7
10509973|NCT01287104|11660510|FG003|NOT COMPLETED|Overall Study||3
10509974|NCT01287117|11660531|FG000|STARTED|Overall Study||80
10509975|NCT01287117|11660532|FG001|STARTED|Overall Study||78
10509976|NCT01287117|11660533|FG002|STARTED|Overall Study||80
10509977|NCT01287117|11660534|FG003|STARTED|Overall Study||81
10509978|NCT01287117|11660531|FG000|Received Treatment|Overall Study||80
10509979|NCT01287117|11660532|FG001|Received Treatment|Overall Study||77
10509980|NCT01287117|11660533|FG002|Received Treatment|Overall Study||80
10509981|NCT01287117|11660534|FG003|Received Treatment|Overall Study||81
10509982|NCT01287117|11660531|FG000|COMPLETED|Overall Study||65
10509983|NCT01287117|11660532|FG001|COMPLETED|Overall Study||64
10509984|NCT01287117|11660533|FG002|COMPLETED|Overall Study||64
10509985|NCT01287117|11660534|FG003|COMPLETED|Overall Study||69
10509986|NCT01287117|11660531|FG000|NOT COMPLETED|Overall Study||15
10509987|NCT01287117|11660532|FG001|NOT COMPLETED|Overall Study||14
10509988|NCT01287117|11660533|FG002|NOT COMPLETED|Overall Study||16
10509989|NCT01287117|11660534|FG003|NOT COMPLETED|Overall Study||12
10509990|NCT01287195|11660544|FG000|STARTED|Overall Study||6
10509991|NCT01287195|11660544|FG000|COMPLETED|Overall Study||4
10509992|NCT01287195|11660544|FG000|NOT COMPLETED|Overall Study||2
10509993|NCT01287208|11660550|FG000|STARTED|Phase 1: Randomized Phase||52
10509994|NCT01287208|11660551|FG001|STARTED|Phase 1: Randomized Phase||52
10509995|NCT01287208|11660550|FG000|COMPLETED|Phase 1: Randomized Phase||50
10509996|NCT01287208|11660551|FG001|COMPLETED|Phase 1: Randomized Phase||49
10509997|NCT01287208|11660550|FG000|NOT COMPLETED|Phase 1: Randomized Phase||2
10509998|NCT01287208|11660551|FG001|NOT COMPLETED|Phase 1: Randomized Phase||3
10509999|NCT01287208|11660550|FG000|STARTED|Phase 2: Team Competition||50
10510000|NCT01287208|11660551|FG001|STARTED|Phase 2: Team Competition||49
10510001|NCT01287208|11660550|FG000|COMPLETED|Phase 2: Team Competition||50
10510002|NCT01287208|11660551|FG001|COMPLETED|Phase 2: Team Competition||49
10510003|NCT01287208|11660550|FG000|NOT COMPLETED|Phase 2: Team Competition||0
10510004|NCT01287208|11660551|FG001|NOT COMPLETED|Phase 2: Team Competition||0
10510005|NCT01287221|11660561|FG000|STARTED|Overall Study||50
10510006|NCT01287221|11660562|FG001|STARTED|Overall Study||50
10510007|NCT01287221|11660561|FG000|Completed 3 Months Follow-up|Overall Study||49
10510008|NCT01287221|11660562|FG001|Completed 3 Months Follow-up|Overall Study||50
10510009|NCT01287221|11660561|FG000|Completed 6 Months Follow-up|Overall Study||47
10510010|NCT01287221|11660562|FG001|Completed 6 Months Follow-up|Overall Study||43
10510011|NCT01287221|11660561|FG000|Completed 9 Months Follow-up|Overall Study||42
10510012|NCT01287221|11660562|FG001|Completed 9 Months Follow-up|Overall Study||40
10510013|NCT01287221|11660561|FG000|Completed 12 Months Follow-up|Overall Study||40
10510014|NCT01287221|11660562|FG001|Completed 12 Months Follow-up|Overall Study||39
10510015|NCT01287221|11660561|FG000|COMPLETED|Overall Study||46
10510016|NCT01287221|11660562|FG001|COMPLETED|Overall Study||45
10510017|NCT01287221|11660561|FG000|NOT COMPLETED|Overall Study||4
10510018|NCT01287221|11660562|FG001|NOT COMPLETED|Overall Study||5
10510019|NCT01287364|11660570|FG000|STARTED|Overall Study||94
10510020|NCT01287364|11660571|FG001|STARTED|Overall Study||91
10510021|NCT01287364|11660570|FG000|COMPLETED|Overall Study||85
10510022|NCT01287364|11660571|FG001|COMPLETED|Overall Study||81
10510023|NCT01287364|11660570|FG000|NOT COMPLETED|Overall Study||9
10510024|NCT01287364|11660571|FG001|NOT COMPLETED|Overall Study||10
10510025|NCT01287377|11660593|FG000|STARTED|Overall Study||80
10510026|NCT01287377|11660594|FG001|STARTED|Overall Study||81
10510027|NCT01287377|11660595|FG002|STARTED|Overall Study||82
10510028|NCT01287377|11660593|FG000|COMPLETED|Overall Study|Study Complete|80
10510029|NCT01287377|11660594|FG001|COMPLETED|Overall Study|Study Complete|81
10510030|NCT01287377|11660595|FG002|COMPLETED|Overall Study|Study Complete|82
10510031|NCT01287377|11660593|FG000|NOT COMPLETED|Overall Study||0
10510032|NCT01287377|11660594|FG001|NOT COMPLETED|Overall Study||0
10510033|NCT01287377|11660595|FG002|NOT COMPLETED|Overall Study||0
10510034|NCT01287403|11660603|FG000|STARTED|Diet Restriction (7 Days)||14
10510035|NCT01287403|11660603|FG000|COMPLETED|Diet Restriction (7 Days)||14
10510036|NCT01287403|11660603|FG000|NOT COMPLETED|Diet Restriction (7 Days)||0
10510037|NCT01287403|11660603|FG000|STARTED|1st Intervention (1 Day)||14
10510038|NCT01287403|11660603|FG000|COMPLETED|1st Intervention (1 Day)|"The adverse event was linked to the intake of refined wheat flour"|13
10510039|NCT01287403|11660603|FG000|NOT COMPLETED|1st Intervention (1 Day)||1
10510040|NCT01287403|11660603|FG000|STARTED|Washout 7 Days||13
10510041|NCT01287403|11660603|FG000|COMPLETED|Washout 7 Days||13
10510042|NCT01287403|11660603|FG000|NOT COMPLETED|Washout 7 Days||0
10510043|NCT01287403|11660603|FG000|STARTED|2nd Intervention (1 Day)||13
10510044|NCT01287403|11660603|FG000|COMPLETED|2nd Intervention (1 Day)||13
10510045|NCT01287403|11660603|FG000|NOT COMPLETED|2nd Intervention (1 Day)||0
10510046|NCT01287403|11660603|FG000|STARTED|Washout (7 Days)||13
10510047|NCT01287403|11660603|FG000|COMPLETED|Washout (7 Days)||13
10510048|NCT01287403|11660603|FG000|NOT COMPLETED|Washout (7 Days)||0
10510049|NCT01287403|11660603|FG000|STARTED|3rd Intervention (1 Day)||13
10510050|NCT01287403|11660603|FG000|COMPLETED|3rd Intervention (1 Day)||13
10510051|NCT01287403|11660603|FG000|NOT COMPLETED|3rd Intervention (1 Day)||0
10510052|NCT01287403|11660603|FG000|STARTED|Washout (7 Days)||13
10510053|NCT01287403|11660603|FG000|COMPLETED|Washout (7 Days)||13
10510054|NCT01287403|11660603|FG000|NOT COMPLETED|Washout (7 Days)||0
10510055|NCT01287403|11660603|FG000|STARTED|4th Intervention (1 Day)||13
10510056|NCT01287403|11660603|FG000|COMPLETED|4th Intervention (1 Day)||13
10510057|NCT01287403|11660603|FG000|NOT COMPLETED|4th Intervention (1 Day)||0
10510058|NCT01287403|11660603|FG000|STARTED|Washout (7 Days)||13
10510059|NCT01287403|11660603|FG000|COMPLETED|Washout (7 Days)||13
10510060|NCT01287403|11660603|FG000|NOT COMPLETED|Washout (7 Days)||0
10510061|NCT01287403|11660603|FG000|STARTED|5th Intervention (1 Day)||13
10510062|NCT01287403|11660603|FG000|COMPLETED|5th Intervention (1 Day)||13
10510063|NCT01287403|11660603|FG000|NOT COMPLETED|5th Intervention (1 Day)||0
10510064|NCT01287403|11660603|FG000|STARTED|Washout (7 Days)||13
10510065|NCT01287403|11660603|FG000|COMPLETED|Washout (7 Days)||13
10510066|NCT01287403|11660603|FG000|NOT COMPLETED|Washout (7 Days)||0
10510067|NCT01287403|11660603|FG000|STARTED|6th and Last Intervention (1 Day)||13
10510068|NCT01287403|11660603|FG000|COMPLETED|6th and Last Intervention (1 Day)||13
10510069|NCT01287403|11660603|FG000|NOT COMPLETED|6th and Last Intervention (1 Day)||0
10510070|NCT01287416|11660619|FG000|STARTED|Pre-post Training|number of people that were invited to participate based on eligibility and consent received|48
10510071|NCT01287416|11660620|FG001|STARTED|Pre-post Training|number of people that were invited to participate based on eligibility and consent received|48
10510072|NCT01287416|11660619|FG000|Training Workshop|Pre-post Training|number of people that showed up for the training session|31
10510073|NCT01287416|11660620|FG001|Training Workshop|Pre-post Training|number of people that showed up for the training session|24
10510074|NCT01287416|11660619|FG000|Post Training Questionnaire|Pre-post Training||26
10510075|NCT01287416|11660620|FG001|Post Training Questionnaire|Pre-post Training||23
10510076|NCT01287416|11660619|FG000|COMPLETED|Pre-post Training||26
10510077|NCT01287416|11660620|FG001|COMPLETED|Pre-post Training||23
10510078|NCT01287416|11660619|FG000|NOT COMPLETED|Pre-post Training||22
10510079|NCT01287416|11660620|FG001|NOT COMPLETED|Pre-post Training||25
10510080|NCT01287416|11660619|FG000|STARTED|6 Month Follow-up|all participants that had completed the baseline measure were invited to do the follow-up|31
10510081|NCT01287416|11660620|FG001|STARTED|6 Month Follow-up|all participants that had completed the baseline measure were invited to do the follow-up|24
10510082|NCT01287416|11660619|FG000|COMPLETED|6 Month Follow-up||28
10510083|NCT01287416|11660620|FG001|COMPLETED|6 Month Follow-up||22
10510084|NCT01287416|11660619|FG000|NOT COMPLETED|6 Month Follow-up||3
10510085|NCT01287416|11660620|FG001|NOT COMPLETED|6 Month Follow-up||2
10510086|NCT01287520|11660635|FG000|STARTED|Overall Study||3
10510087|NCT01287520|11660636|FG001|STARTED|Overall Study|One participant who received study drug but did not complete Cycle 1 was replaced.|7
10510088|NCT01287520|11660637|FG002|STARTED|Overall Study||5
10510089|NCT01287520|11660638|FG003|STARTED|Overall Study|One participant who received study drug but did not complete Cycle 1 was replaced.|7
10510090|NCT01287520|11660639|FG004|STARTED|Overall Study||3
10510091|NCT01287520|11660640|FG005|STARTED|Overall Study||4
10510092|NCT01287520|11660641|FG006|STARTED|Overall Study||2
10510093|NCT01287520|11660642|FG007|STARTED|Overall Study||5
10510094|NCT01287520|11660643|FG008|STARTED|Overall Study||5
10510095|NCT01287520|11660635|FG000|COMPLETED|Overall Study||0
10510096|NCT01287520|11660636|FG001|COMPLETED|Overall Study||0
10510097|NCT01287520|11660637|FG002|COMPLETED|Overall Study||0
10510098|NCT01287520|11660638|FG003|COMPLETED|Overall Study||0
10510099|NCT01287520|11660639|FG004|COMPLETED|Overall Study||0
10510100|NCT01287520|11660640|FG005|COMPLETED|Overall Study||0
10510101|NCT01287520|11660641|FG006|COMPLETED|Overall Study||0
10510102|NCT01287520|11660642|FG007|COMPLETED|Overall Study||0
10510103|NCT01287520|11660643|FG008|COMPLETED|Overall Study||0
10510104|NCT01287520|11660635|FG000|NOT COMPLETED|Overall Study||3
10510105|NCT01287520|11660636|FG001|NOT COMPLETED|Overall Study||7
10510106|NCT01287520|11660637|FG002|NOT COMPLETED|Overall Study||5
10510107|NCT01287520|11660638|FG003|NOT COMPLETED|Overall Study||7
10510108|NCT01287520|11660639|FG004|NOT COMPLETED|Overall Study||3
10510109|NCT01287520|11660640|FG005|NOT COMPLETED|Overall Study||4
10510110|NCT01287520|11660641|FG006|NOT COMPLETED|Overall Study||2
10510111|NCT01287520|11660642|FG007|NOT COMPLETED|Overall Study||5
10510112|NCT01287520|11660643|FG008|NOT COMPLETED|Overall Study||5
10528314|NCT01394003|11680556|FG004|NOT COMPLETED|Overall Study||0
10528315|NCT01394003|11680557|FG005|NOT COMPLETED|Overall Study||0
10528316|NCT01394003|11680558|FG006|NOT COMPLETED|Overall Study||0
10528317|NCT01394003|11680559|FG007|NOT COMPLETED|Overall Study||0
10528318|NCT01394081|11680585|FG000|STARTED|Overall Study||101
10528319|NCT01394081|11680586|FG001|STARTED|Overall Study||102
10528320|NCT01394081|11680585|FG000|COMPLETED|Overall Study||101
10528321|NCT01394081|11680586|FG001|COMPLETED|Overall Study||102
10528322|NCT01394081|11680585|FG000|NOT COMPLETED|Overall Study||0
10528323|NCT01394081|11680586|FG001|NOT COMPLETED|Overall Study||0
10528324|NCT01394159|11680596|FG000|STARTED|Overall Study||28
10528325|NCT01394159|11680597|FG001|STARTED|Overall Study||28
10528326|NCT01394159|11680596|FG000|COMPLETED|Overall Study||28
10528327|NCT01394159|11680597|FG001|COMPLETED|Overall Study||28
10528328|NCT01394159|11680596|FG000|NOT COMPLETED|Overall Study||0
10528329|NCT01394159|11680597|FG001|NOT COMPLETED|Overall Study||0
10528330|NCT01394185|11680603|FG000|STARTED|Overall Study||8
10528331|NCT01394185|11680604|FG001|STARTED|Overall Study||2
10528332|NCT01394185|11680605|FG002|STARTED|Overall Study||2
10528333|NCT01394185|11680606|FG003|STARTED|Overall Study||4
10528334|NCT01394185|11680607|FG004|STARTED|Overall Study||6
10528335|NCT01394185|11680608|FG005|STARTED|Overall Study||3
10528336|NCT01394185|11680603|FG000|COMPLETED|Overall Study||2
10528337|NCT01394185|11680604|FG001|COMPLETED|Overall Study||2
10528338|NCT01394185|11680605|FG002|COMPLETED|Overall Study||2
10528339|NCT01394185|11680606|FG003|COMPLETED|Overall Study||3
10528340|NCT01394185|11680607|FG004|COMPLETED|Overall Study||2
10528341|NCT01394185|11680608|FG005|COMPLETED|Overall Study||2
10528342|NCT01394185|11680603|FG000|NOT COMPLETED|Overall Study||6
10528343|NCT01394185|11680604|FG001|NOT COMPLETED|Overall Study||0
10528344|NCT01394185|11680605|FG002|NOT COMPLETED|Overall Study||0
10528345|NCT01394185|11680606|FG003|NOT COMPLETED|Overall Study||1
10528346|NCT01394185|11680607|FG004|NOT COMPLETED|Overall Study||4
10528347|NCT01394185|11680608|FG005|NOT COMPLETED|Overall Study||1
10528348|NCT01394250|11680618|FG000|STARTED|Randomization and IV Placement Attempt||134
10528349|NCT01394250|11680619|FG001|STARTED|Randomization and IV Placement Attempt||134
10528350|NCT01394250|11680618|FG000|COMPLETED|Randomization and IV Placement Attempt||120
10528351|NCT01394250|11680619|FG001|COMPLETED|Randomization and IV Placement Attempt||121
10528352|NCT01394250|11680618|FG000|NOT COMPLETED|Randomization and IV Placement Attempt||14
10528353|NCT01394250|11680619|FG001|NOT COMPLETED|Randomization and IV Placement Attempt||13
10528354|NCT01394250|11680618|FG000|STARTED|Successful IV Placement & Follow-Up||120
10510113|NCT01287754|11660694|FG000|STARTED|Overall Study||3
10510114|NCT01287754|11660695|FG001|STARTED|Overall Study||21
10510115|NCT01287754|11660694|FG000|COMPLETED|Overall Study||0
10510116|NCT01287754|11660695|FG001|COMPLETED|Overall Study||0
10510117|NCT01287754|11660694|FG000|NOT COMPLETED|Overall Study||3
10510118|NCT01287754|11660695|FG001|NOT COMPLETED|Overall Study||21
10510119|NCT01287832|11660703|FG000|STARTED|Overall Study||6
10510120|NCT01287832|11660704|FG001|STARTED|Overall Study||5
10510121|NCT01287832|11660703|FG000|COMPLETED|Overall Study||5
10510122|NCT01287832|11660704|FG001|COMPLETED|Overall Study||4
10510123|NCT01287832|11660703|FG000|NOT COMPLETED|Overall Study||1
10510124|NCT01287832|11660704|FG001|NOT COMPLETED|Overall Study||1
10510125|NCT01287897|11660714|FG000|STARTED|Overall Study||70
10510126|NCT01287897|11660715|FG001|STARTED|Overall Study||69
10510127|NCT01287897|11660716|FG002|STARTED|Overall Study||71
10510128|NCT01287897|11660717|FG003|STARTED|Overall Study|Enrollment was halted before reaching the planned sample size due to safety findings in NCT01405196.|40
10510129|NCT01287897|11660714|FG000|Treated|Overall Study||69
10510130|NCT01287897|11660715|FG001|Treated|Overall Study||67
10510131|NCT01287897|11660716|FG002|Treated|Overall Study||71
10510132|NCT01287897|11660717|FG003|Treated|Overall Study||40
10510133|NCT01287897|11660714|FG000|Completed Treatment Period|Overall Study||58
10510134|NCT01287897|11660715|FG001|Completed Treatment Period|Overall Study||52
10510135|NCT01287897|11660716|FG002|Completed Treatment Period|Overall Study||58
10510136|NCT01287897|11660717|FG003|Completed Treatment Period|Overall Study||29
10510137|NCT01287897|11660714|FG000|Completed Follow-up Period|Overall Study||3
10510138|NCT01287897|11660715|FG001|Completed Follow-up Period|Overall Study||8
10510139|NCT01287897|11660716|FG002|Completed Follow-up Period|Overall Study||3
10510140|NCT01287897|11660717|FG003|Completed Follow-up Period|Overall Study||4
10510141|NCT01287897|11660714|FG000|Enrolled in NCT01345318|Overall Study||56
10510142|NCT01287897|11660715|FG001|Enrolled in NCT01345318|Overall Study||50
10510143|NCT01287897|11660716|FG002|Enrolled in NCT01345318|Overall Study||56
10510144|NCT01287897|11660717|FG003|Enrolled in NCT01345318|Overall Study||29
10510145|NCT01287897|11660714|FG000|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|59
10510146|NCT01287897|11660715|FG001|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|58
10510147|NCT01287897|11660716|FG002|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|59
10510148|NCT01287897|11660717|FG003|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|33
10510149|NCT01287897|11660714|FG000|NOT COMPLETED|Overall Study||11
10510150|NCT01287897|11660715|FG001|NOT COMPLETED|Overall Study||11
10510151|NCT01287897|11660716|FG002|NOT COMPLETED|Overall Study||12
10510152|NCT01287897|11660717|FG003|NOT COMPLETED|Overall Study||7
10510153|NCT01288027|11660731|FG000|STARTED|Overall Study||16
10510154|NCT01288027|11660731|FG000|Full Analysis Set (FAS)|Overall Study|All participants who received at least 1 complete infusion of alglucosidase alfa.|16
10711223|NCT02658175|11876679|FG000|STARTED|Treatment Period: Weeks 1 to 52||51
10711224|NCT02658175|11876680|FG001|STARTED|Treatment Period: Weeks 1 to 52||14
10711225|NCT02658175|11876681|FG002|STARTED|Treatment Period: Weeks 1 to 52||3
10711226|NCT02658175|11876679|FG000|COMPLETED|Treatment Period: Weeks 1 to 52||36
10711227|NCT02658175|11876680|FG001|COMPLETED|Treatment Period: Weeks 1 to 52||7
10510155|NCT01288027|11660731|FG000|COMPLETED|Overall Study||16
10510156|NCT01288027|11660731|FG000|NOT COMPLETED|Overall Study||0
10510157|NCT01288053|11660735|FG000|STARTED|Overall Study||9
10510158|NCT01288053|11660735|FG000|COMPLETED|Overall Study||8
10510159|NCT01288053|11660735|FG000|NOT COMPLETED|Overall Study||1
10510160|NCT01288079|11660743|FG000|STARTED|Overall Study||37
10510161|NCT01288079|11660744|FG001|STARTED|Overall Study||36
10510162|NCT01288079|11660745|FG002|STARTED|Overall Study||37
10510163|NCT01288079|11660746|FG003|STARTED|Overall Study||35
10510164|NCT01288079|11660743|FG000|COMPLETED|Overall Study||17
10510165|NCT01288079|11660744|FG001|COMPLETED|Overall Study||9
10510166|NCT01288079|11660745|FG002|COMPLETED|Overall Study||18
10510167|NCT01288079|11660746|FG003|COMPLETED|Overall Study||18
10510168|NCT01288079|11660743|FG000|NOT COMPLETED|Overall Study||20
10510169|NCT01288079|11660744|FG001|NOT COMPLETED|Overall Study||27
10510170|NCT01288079|11660745|FG002|NOT COMPLETED|Overall Study||19
10510171|NCT01288079|11660746|FG003|NOT COMPLETED|Overall Study||17
10510172|NCT01288209|11660758|FG000|STARTED|Overall Study||53
10510173|NCT01288209|11660759|FG001|STARTED|Overall Study||53
10510174|NCT01288209|11660758|FG000|COMPLETED|Overall Study||51
10510175|NCT01288209|11660759|FG001|COMPLETED|Overall Study||50
10510176|NCT01288209|11660758|FG000|NOT COMPLETED|Overall Study||2
10510177|NCT01288209|11660759|FG001|NOT COMPLETED|Overall Study||3
10510178|NCT01288287|11660765|FG000|STARTED|Overall Study||149
10510179|NCT01288287|11660765|FG000|Safety Set|Overall Study||147
10510180|NCT01288287|11660765|FG000|Full Analysis Set|Overall Study||111
10510181|NCT01288287|11660765|FG000|COMPLETED|Overall Study||103
10510182|NCT01288287|11660765|FG000|NOT COMPLETED|Overall Study||46
10510183|NCT01288430|11660780|FG000|STARTED|Part 1||2
10510184|NCT01288430|11660781|FG001|STARTED|Part 1||3
10510185|NCT01288430|11660782|FG002|STARTED|Part 1||5
10510186|NCT01288430|11660783|FG003|STARTED|Part 1||7
10510187|NCT01288430|11660784|FG004|STARTED|Part 1||3
10510188|NCT01288430|11660785|FG005|STARTED|Part 1||6
10510189|NCT01288430|11660786|FG006|STARTED|Part 1||7
10510190|NCT01288430|11660787|FG007|STARTED|Part 1||0
10510191|NCT01288430|11660788|FG008|STARTED|Part 1||0
10711228|NCT02658175|11876681|FG002|COMPLETED|Treatment Period: Weeks 1 to 52||3
10510192|NCT01288430|11660789|FG009|STARTED|Part 1||0
10510193|NCT01288430|11660780|FG000|COMPLETED|Part 1||0
10510194|NCT01288430|11660781|FG001|COMPLETED|Part 1||0
10510195|NCT01288430|11660782|FG002|COMPLETED|Part 1||0
10510196|NCT01288430|11660783|FG003|COMPLETED|Part 1||0
10510197|NCT01288430|11660784|FG004|COMPLETED|Part 1||0
10510198|NCT01288430|11660785|FG005|COMPLETED|Part 1||0
10510199|NCT01288430|11660786|FG006|COMPLETED|Part 1||0
10510200|NCT01288430|11660787|FG007|COMPLETED|Part 1||0
10510201|NCT01288430|11660788|FG008|COMPLETED|Part 1||0
10510202|NCT01288430|11660789|FG009|COMPLETED|Part 1||0
10510203|NCT01288430|11660780|FG000|NOT COMPLETED|Part 1||2
10510204|NCT01288430|11660781|FG001|NOT COMPLETED|Part 1||3
10510205|NCT01288430|11660782|FG002|NOT COMPLETED|Part 1||5
10510206|NCT01288430|11660783|FG003|NOT COMPLETED|Part 1||7
10510207|NCT01288430|11660784|FG004|NOT COMPLETED|Part 1||3
10510208|NCT01288430|11660785|FG005|NOT COMPLETED|Part 1||6
10510209|NCT01288430|11660786|FG006|NOT COMPLETED|Part 1||7
10510210|NCT01288430|11660787|FG007|NOT COMPLETED|Part 1||0
10510211|NCT01288430|11660788|FG008|NOT COMPLETED|Part 1||0
10510212|NCT01288430|11660789|FG009|NOT COMPLETED|Part 1||0
10510213|NCT01288430|11660780|FG000|STARTED|Part 2||0
10510214|NCT01288430|11660781|FG001|STARTED|Part 2||0
10510215|NCT01288430|11660782|FG002|STARTED|Part 2||0
10510216|NCT01288430|11660783|FG003|STARTED|Part 2||0
10510217|NCT01288430|11660784|FG004|STARTED|Part 2||0
10510218|NCT01288430|11660785|FG005|STARTED|Part 2||0
10510219|NCT01288430|11660786|FG006|STARTED|Part 2||0
10510220|NCT01288430|11660787|FG007|STARTED|Part 2||12
10510221|NCT01288430|11660788|FG008|STARTED|Part 2||12
10510222|NCT01288430|11660789|FG009|STARTED|Part 2||3
10510223|NCT01288430|11660780|FG000|COMPLETED|Part 2||0
10510224|NCT01288430|11660781|FG001|COMPLETED|Part 2||0
10510225|NCT01288430|11660782|FG002|COMPLETED|Part 2||0
10510226|NCT01288430|11660783|FG003|COMPLETED|Part 2||0
10510227|NCT01288430|11660784|FG004|COMPLETED|Part 2||0
10510228|NCT01288430|11660785|FG005|COMPLETED|Part 2||0
10510229|NCT01288430|11660786|FG006|COMPLETED|Part 2||0
10510230|NCT01288430|11660787|FG007|COMPLETED|Part 2||0
10510231|NCT01288430|11660788|FG008|COMPLETED|Part 2||0
10510232|NCT01288430|11660789|FG009|COMPLETED|Part 2||0
10510233|NCT01288430|11660780|FG000|NOT COMPLETED|Part 2||0
10510234|NCT01288430|11660781|FG001|NOT COMPLETED|Part 2||0
10510235|NCT01288430|11660782|FG002|NOT COMPLETED|Part 2||0
10510236|NCT01288430|11660783|FG003|NOT COMPLETED|Part 2||0
10510237|NCT01288430|11660784|FG004|NOT COMPLETED|Part 2||0
10510238|NCT01288430|11660785|FG005|NOT COMPLETED|Part 2||0
10510239|NCT01288430|11660786|FG006|NOT COMPLETED|Part 2||0
10510240|NCT01288430|11660787|FG007|NOT COMPLETED|Part 2||12
10510241|NCT01288430|11660788|FG008|NOT COMPLETED|Part 2||12
10510242|NCT01288430|11660789|FG009|NOT COMPLETED|Part 2||3
10510243|NCT01288443|11660822|FG000|STARTED|Overall Study|Randomized|31
10510244|NCT01288443|11660823|FG001|STARTED|Overall Study|Randomized|30
10510245|NCT01288443|11660824|FG002|STARTED|Overall Study|Randomized|31
10510246|NCT01288443|11660825|FG003|STARTED|Overall Study|Randomized|31
10510247|NCT01288443|11660826|FG004|STARTED|Overall Study|Randomized|30
10510248|NCT01288443|11660827|FG005|STARTED|Overall Study|Randomized|30
10510249|NCT01288443|11660822|FG000|Treated|Overall Study||31
10510250|NCT01288443|11660823|FG001|Treated|Overall Study||30
10510251|NCT01288443|11660824|FG002|Treated|Overall Study||31
10510252|NCT01288443|11660825|FG003|Treated|Overall Study||31
10510253|NCT01288443|11660826|FG004|Treated|Overall Study||29
10510254|NCT01288443|11660827|FG005|Treated|Overall Study||30
10510255|NCT01288443|11660822|FG000|COMPLETED|Overall Study||31
10510256|NCT01288443|11660823|FG001|COMPLETED|Overall Study||29
10510257|NCT01288443|11660824|FG002|COMPLETED|Overall Study||30
10510258|NCT01288443|11660825|FG003|COMPLETED|Overall Study||27
10510259|NCT01288443|11660826|FG004|COMPLETED|Overall Study||23
10510260|NCT01288443|11660827|FG005|COMPLETED|Overall Study||25
10510261|NCT01288443|11660822|FG000|NOT COMPLETED|Overall Study||0
10510262|NCT01288443|11660823|FG001|NOT COMPLETED|Overall Study||1
10510263|NCT01288443|11660824|FG002|NOT COMPLETED|Overall Study||1
10510264|NCT01288443|11660825|FG003|NOT COMPLETED|Overall Study||4
10510265|NCT01288443|11660826|FG004|NOT COMPLETED|Overall Study||7
10510266|NCT01288443|11660827|FG005|NOT COMPLETED|Overall Study||5
10510267|NCT01288469|11660844|FG000|STARTED|Overall Study|Randomized|31
10510268|NCT01288469|11660845|FG001|STARTED|Overall Study|Randomized|31
10510269|NCT01288469|11660846|FG002|STARTED|Overall Study|Randomized|30
10510270|NCT01288469|11660844|FG000|Treated|Overall Study||31
10510271|NCT01288469|11660845|FG001|Treated|Overall Study||31
10510272|NCT01288469|11660846|FG002|Treated|Overall Study||30
10510273|NCT01288469|11660844|FG000|COMPLETED|Overall Study||24
10510274|NCT01288469|11660845|FG001|COMPLETED|Overall Study||28
10510275|NCT01288469|11660846|FG002|COMPLETED|Overall Study||28
10510276|NCT01288469|11660844|FG000|NOT COMPLETED|Overall Study||7
10510277|NCT01288469|11660845|FG001|NOT COMPLETED|Overall Study||3
10510278|NCT01288469|11660846|FG002|NOT COMPLETED|Overall Study||2
10510279|NCT01288521|11660856|FG000|STARTED|Overall Study||3
10510280|NCT01288521|11660857|FG001|STARTED|Overall Study||5
10510281|NCT01288521|11660856|FG000|COMPLETED|Overall Study||3
10510282|NCT01288521|11660857|FG001|COMPLETED|Overall Study||5
10510283|NCT01288521|11660856|FG000|NOT COMPLETED|Overall Study||0
10510284|NCT01288521|11660857|FG001|NOT COMPLETED|Overall Study||0
10510285|NCT01288534|11660863|FG000|STARTED|Overall Study||68
10510286|NCT01288534|11660863|FG000|COMPLETED|Overall Study||68
10510287|NCT01288534|11660863|FG000|NOT COMPLETED|Overall Study||0
10510288|NCT01288612|11660870|FG000|STARTED|Overall Study||150
10510289|NCT01288612|11660871|FG001|STARTED|Overall Study||151
10510290|NCT01288612|11660872|FG002|STARTED|Overall Study||158
10510291|NCT01288612|11660870|FG000|Contacted|Overall Study||139
10510292|NCT01288612|11660871|FG001|Contacted|Overall Study||135
10510293|NCT01288612|11660872|FG002|Contacted|Overall Study||138
10510294|NCT01288612|11660870|FG000|Agreed to Take Part|Overall Study||61
10510295|NCT01288612|11660871|FG001|Agreed to Take Part|Overall Study||72
10510296|NCT01288612|11660872|FG002|Agreed to Take Part|Overall Study||76
10510297|NCT01288612|11660870|FG000|COMPLETED|Overall Study||61
10510298|NCT01288612|11660871|FG001|COMPLETED|Overall Study||69
10510299|NCT01288612|11660872|FG002|COMPLETED|Overall Study||76
10510300|NCT01288612|11660870|FG000|NOT COMPLETED|Overall Study||89
10510301|NCT01288612|11660871|FG001|NOT COMPLETED|Overall Study||82
10510302|NCT01288612|11660872|FG002|NOT COMPLETED|Overall Study||82
10528355|NCT01394250|11680619|FG001|STARTED|Successful IV Placement & Follow-Up||121
10528356|NCT01394250|11680618|FG000|COMPLETED|Successful IV Placement & Follow-Up||114
10528357|NCT01394250|11680619|FG001|COMPLETED|Successful IV Placement & Follow-Up||110
10528358|NCT01394250|11680618|FG000|NOT COMPLETED|Successful IV Placement & Follow-Up||6
10528359|NCT01394250|11680619|FG001|NOT COMPLETED|Successful IV Placement & Follow-Up||11
10528360|NCT01394276|11680625|FG000|STARTED|Overall Study||322
10528361|NCT01394276|11680625|FG000|COMPLETED|Overall Study||260
10528362|NCT01394276|11680625|FG000|NOT COMPLETED|Overall Study||62
10528363|NCT01394510|11680634|FG000|STARTED|Overall Study||13
10510303|NCT01288729|11660882|FG000|STARTED|Overall Study||10
10510304|NCT01288729|11660883|FG001|STARTED|Overall Study||10
10510305|NCT01288729|11660882|FG000|COMPLETED|Overall Study||9
10510306|NCT01288729|11660883|FG001|COMPLETED|Overall Study||10
10510307|NCT01288729|11660882|FG000|NOT COMPLETED|Overall Study||1
10510308|NCT01288729|11660883|FG001|NOT COMPLETED|Overall Study||0
10510309|NCT01288781|11660891|FG000|STARTED|Overall Study||11
10510310|NCT01288781|11660892|FG001|STARTED|Overall Study||12
10510311|NCT01288781|11660891|FG000|COMPLETED|Overall Study||11
10510312|NCT01288781|11660892|FG001|COMPLETED|Overall Study||12
10510313|NCT01288781|11660891|FG000|NOT COMPLETED|Overall Study||0
10510314|NCT01288781|11660892|FG001|NOT COMPLETED|Overall Study||0
10711229|NCT02658175|11876679|FG000|NOT COMPLETED|Treatment Period: Weeks 1 to 52||15
10711230|NCT02658175|11876680|FG001|NOT COMPLETED|Treatment Period: Weeks 1 to 52||7
10711231|NCT02658175|11876681|FG002|NOT COMPLETED|Treatment Period: Weeks 1 to 52||0
10510315|NCT01288807|11660898|FG000|STARTED|Overall Study||8
10510316|NCT01288807|11660898|FG000|COMPLETED|Overall Study||8
10510317|NCT01288807|11660898|FG000|NOT COMPLETED|Overall Study||0
10510318|NCT01288833|11660904|FG000|STARTED|Overall Study||277
10510319|NCT01288833|11660905|FG001|STARTED|Overall Study||281
10510320|NCT01288833|11660904|FG000|COMPLETED|Overall Study||277
10510321|NCT01288833|11660905|FG001|COMPLETED|Overall Study||281
10510322|NCT01288833|11660904|FG000|NOT COMPLETED|Overall Study||0
10510323|NCT01288833|11660905|FG001|NOT COMPLETED|Overall Study||0
10510324|NCT01288859|11660911|FG000|STARTED|Free Then Encapsulated Curcumin (1 Day)||5
10510325|NCT01288859|11660912|FG001|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
10510326|NCT01288859|11660913|FG002|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
10510327|NCT01288859|11660914|FG003|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
10510328|NCT01288859|11660915|FG004|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
10510329|NCT01288859|11660916|FG005|STARTED|Free Then Encapsulated Curcumin (1 Day)||5
10510330|NCT01288859|11660911|FG000|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||5
10510331|NCT01288859|11660912|FG001|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
10510332|NCT01288859|11660913|FG002|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
10510333|NCT01288859|11660914|FG003|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
10510334|NCT01288859|11660915|FG004|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
10510335|NCT01288859|11660916|FG005|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||5
10510336|NCT01288859|11660911|FG000|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
10510337|NCT01288859|11660912|FG001|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
10510338|NCT01288859|11660913|FG002|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
10510339|NCT01288859|11660914|FG003|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
10510340|NCT01288859|11660915|FG004|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
10510341|NCT01288859|11660916|FG005|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
10510342|NCT01288859|11660911|FG000|STARTED|Washout Period of 1 Week||5
10510343|NCT01288859|11660912|FG001|STARTED|Washout Period of 1 Week||0
10510344|NCT01288859|11660913|FG002|STARTED|Washout Period of 1 Week||0
10510345|NCT01288859|11660914|FG003|STARTED|Washout Period of 1 Week||0
10510346|NCT01288859|11660915|FG004|STARTED|Washout Period of 1 Week||0
10510347|NCT01288859|11660916|FG005|STARTED|Washout Period of 1 Week||5
10510348|NCT01288859|11660911|FG000|COMPLETED|Washout Period of 1 Week||5
10510349|NCT01288859|11660912|FG001|COMPLETED|Washout Period of 1 Week||0
10510350|NCT01288859|11660913|FG002|COMPLETED|Washout Period of 1 Week||0
10510351|NCT01288859|11660914|FG003|COMPLETED|Washout Period of 1 Week||0
10510352|NCT01288859|11660915|FG004|COMPLETED|Washout Period of 1 Week||0
10510353|NCT01288859|11660916|FG005|COMPLETED|Washout Period of 1 Week||5
10510354|NCT01288859|11660911|FG000|NOT COMPLETED|Washout Period of 1 Week||0
10510355|NCT01288859|11660912|FG001|NOT COMPLETED|Washout Period of 1 Week||0
10510356|NCT01288859|11660913|FG002|NOT COMPLETED|Washout Period of 1 Week||0
10510357|NCT01288859|11660914|FG003|NOT COMPLETED|Washout Period of 1 Week||0
10510358|NCT01288859|11660915|FG004|NOT COMPLETED|Washout Period of 1 Week||0
10510359|NCT01288859|11660916|FG005|NOT COMPLETED|Washout Period of 1 Week||0
10510360|NCT01288859|11660911|FG000|STARTED|Encapsulated Then Free Curcumin (1 Day)||5
10510361|NCT01288859|11660912|FG001|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
10510362|NCT01288859|11660913|FG002|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
10510363|NCT01288859|11660914|FG003|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
10510364|NCT01288859|11660915|FG004|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
10510365|NCT01288859|11660916|FG005|STARTED|Encapsulated Then Free Curcumin (1 Day)||5
10711232|NCT02658175|11876679|FG000|STARTED|1st Extended Treatment: Weeks 53 to 104||36
10510366|NCT01288859|11660911|FG000|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||5
10510367|NCT01288859|11660912|FG001|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
10510368|NCT01288859|11660913|FG002|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
10510369|NCT01288859|11660914|FG003|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
10510370|NCT01288859|11660915|FG004|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
10510371|NCT01288859|11660916|FG005|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||5
10510372|NCT01288859|11660911|FG000|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
10510373|NCT01288859|11660912|FG001|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
10510374|NCT01288859|11660913|FG002|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
10510375|NCT01288859|11660914|FG003|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
10510376|NCT01288859|11660915|FG004|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
10510377|NCT01288859|11660916|FG005|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
10510378|NCT01288859|11660911|FG000|STARTED|Washout Period of 1 Week||5
10510379|NCT01288859|11660912|FG001|STARTED|Washout Period of 1 Week||0
10510380|NCT01288859|11660913|FG002|STARTED|Washout Period of 1 Week||0
10510381|NCT01288859|11660914|FG003|STARTED|Washout Period of 1 Week||0
10510382|NCT01288859|11660915|FG004|STARTED|Washout Period of 1 Week||0
10510383|NCT01288859|11660916|FG005|STARTED|Washout Period of 1 Week||5
10510384|NCT01288859|11660911|FG000|COMPLETED|Washout Period of 1 Week||5
10510385|NCT01288859|11660912|FG001|COMPLETED|Washout Period of 1 Week||0
10510386|NCT01288859|11660913|FG002|COMPLETED|Washout Period of 1 Week||0
10510387|NCT01288859|11660914|FG003|COMPLETED|Washout Period of 1 Week||0
10510388|NCT01288859|11660915|FG004|COMPLETED|Washout Period of 1 Week||0
10510389|NCT01288859|11660916|FG005|COMPLETED|Washout Period of 1 Week||5
10510390|NCT01288859|11660911|FG000|NOT COMPLETED|Washout Period of 1 Week||0
10510391|NCT01288859|11660912|FG001|NOT COMPLETED|Washout Period of 1 Week||0
10510392|NCT01288859|11660913|FG002|NOT COMPLETED|Washout Period of 1 Week||0
10510393|NCT01288859|11660914|FG003|NOT COMPLETED|Washout Period of 1 Week||0
10510394|NCT01288859|11660915|FG004|NOT COMPLETED|Washout Period of 1 Week||0
10510395|NCT01288859|11660916|FG005|NOT COMPLETED|Washout Period of 1 Week||0
10510396|NCT01288859|11660911|FG000|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
10510397|NCT01288859|11660912|FG001|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
10510398|NCT01288859|11660913|FG002|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
10510399|NCT01288859|11660914|FG003|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
10510400|NCT01288859|11660915|FG004|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
10510401|NCT01288859|11660916|FG005|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
10510402|NCT01288859|11660911|FG000|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
10711233|NCT02658175|11876680|FG001|STARTED|1st Extended Treatment: Weeks 53 to 104||7
10711234|NCT02658175|11876681|FG002|STARTED|1st Extended Treatment: Weeks 53 to 104||3
10711235|NCT02658175|11876679|FG000|COMPLETED|1st Extended Treatment: Weeks 53 to 104||15
10510403|NCT01288859|11660912|FG001|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
10510404|NCT01288859|11660913|FG002|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
10510405|NCT01288859|11660914|FG003|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
10510406|NCT01288859|11660915|FG004|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
10510407|NCT01288859|11660916|FG005|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
10510408|NCT01288859|11660911|FG000|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
10510409|NCT01288859|11660912|FG001|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
10510410|NCT01288859|11660913|FG002|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
10510411|NCT01288859|11660914|FG003|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
10510412|NCT01288859|11660915|FG004|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
10510413|NCT01288859|11660916|FG005|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
10510414|NCT01288859|11660911|FG000|STARTED|Washout Period of 1 Week||0
10510415|NCT01288859|11660912|FG001|STARTED|Washout Period of 1 Week||5
10510416|NCT01288859|11660913|FG002|STARTED|Washout Period of 1 Week||5
10510417|NCT01288859|11660914|FG003|STARTED|Washout Period of 1 Week||0
10510418|NCT01288859|11660915|FG004|STARTED|Washout Period of 1 Week||0
10510419|NCT01288859|11660916|FG005|STARTED|Washout Period of 1 Week||0
10510420|NCT01288859|11660911|FG000|COMPLETED|Washout Period of 1 Week||0
10510421|NCT01288859|11660912|FG001|COMPLETED|Washout Period of 1 Week||5
10510422|NCT01288859|11660913|FG002|COMPLETED|Washout Period of 1 Week||5
10510423|NCT01288859|11660914|FG003|COMPLETED|Washout Period of 1 Week||0
10510424|NCT01288859|11660915|FG004|COMPLETED|Washout Period of 1 Week||0
10510425|NCT01288859|11660916|FG005|COMPLETED|Washout Period of 1 Week||0
10510426|NCT01288859|11660911|FG000|NOT COMPLETED|Washout Period of 1 Week||0
10510427|NCT01288859|11660912|FG001|NOT COMPLETED|Washout Period of 1 Week||0
10510428|NCT01288859|11660913|FG002|NOT COMPLETED|Washout Period of 1 Week||0
10510429|NCT01288859|11660914|FG003|NOT COMPLETED|Washout Period of 1 Week||0
10510430|NCT01288859|11660915|FG004|NOT COMPLETED|Washout Period of 1 Week||0
10510431|NCT01288859|11660916|FG005|NOT COMPLETED|Washout Period of 1 Week||0
10510432|NCT01288859|11660911|FG000|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
10510433|NCT01288859|11660912|FG001|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
10510434|NCT01288859|11660913|FG002|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
10510435|NCT01288859|11660914|FG003|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
10510436|NCT01288859|11660915|FG004|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
10510437|NCT01288859|11660916|FG005|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
10510438|NCT01288859|11660911|FG000|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
10510439|NCT01288859|11660912|FG001|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
10510440|NCT01288859|11660913|FG002|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
10510441|NCT01288859|11660914|FG003|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
10510442|NCT01288859|11660915|FG004|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
10510443|NCT01288859|11660916|FG005|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
10510444|NCT01288859|11660911|FG000|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
10510445|NCT01288859|11660912|FG001|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
10510446|NCT01288859|11660913|FG002|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
10510447|NCT01288859|11660914|FG003|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
10510448|NCT01288859|11660915|FG004|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
10510449|NCT01288859|11660916|FG005|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
10510450|NCT01288859|11660911|FG000|STARTED|Washout Period of 1 Week||0
10510451|NCT01288859|11660912|FG001|STARTED|Washout Period of 1 Week||0
10510452|NCT01288859|11660913|FG002|STARTED|Washout Period of 1 Week||0
10510453|NCT01288859|11660914|FG003|STARTED|Washout Period of 1 Week||5
10510454|NCT01288859|11660915|FG004|STARTED|Washout Period of 1 Week||5
10510455|NCT01288859|11660916|FG005|STARTED|Washout Period of 1 Week||0
10510456|NCT01288859|11660911|FG000|COMPLETED|Washout Period of 1 Week||0
10510457|NCT01288859|11660912|FG001|COMPLETED|Washout Period of 1 Week||0
10510458|NCT01288859|11660913|FG002|COMPLETED|Washout Period of 1 Week||0
10510459|NCT01288859|11660914|FG003|COMPLETED|Washout Period of 1 Week||5
10510460|NCT01288859|11660915|FG004|COMPLETED|Washout Period of 1 Week||5
10510461|NCT01288859|11660916|FG005|COMPLETED|Washout Period of 1 Week||0
10510462|NCT01288859|11660911|FG000|NOT COMPLETED|Washout Period of 1 Week||0
10510463|NCT01288859|11660912|FG001|NOT COMPLETED|Washout Period of 1 Week||0
10510464|NCT01288859|11660913|FG002|NOT COMPLETED|Washout Period of 1 Week||0
10510465|NCT01288859|11660914|FG003|NOT COMPLETED|Washout Period of 1 Week||0
10510466|NCT01288859|11660915|FG004|NOT COMPLETED|Washout Period of 1 Week||0
10510467|NCT01288859|11660916|FG005|NOT COMPLETED|Washout Period of 1 Week||0
10510468|NCT01288859|11660911|FG000|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
10510469|NCT01288859|11660912|FG001|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
10510470|NCT01288859|11660913|FG002|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
10510471|NCT01288859|11660914|FG003|STARTED|Enc Polyph. Then Control Cream (1 Day)||5
10510472|NCT01288859|11660915|FG004|STARTED|Enc Polyph. Then Control Cream (1 Day)||5
10510473|NCT01288859|11660916|FG005|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
10510474|NCT01288859|11660911|FG000|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
10510475|NCT01288859|11660912|FG001|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
10510476|NCT01288859|11660913|FG002|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
10510477|NCT01288859|11660914|FG003|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||5
10510478|NCT01288859|11660915|FG004|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||5
10510479|NCT01288859|11660916|FG005|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
10510480|NCT01288859|11660911|FG000|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
10510481|NCT01288859|11660912|FG001|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
10510482|NCT01288859|11660913|FG002|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
10510483|NCT01288859|11660914|FG003|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
10510484|NCT01288859|11660915|FG004|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
10510485|NCT01288859|11660916|FG005|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
10510486|NCT01288859|11660911|FG000|STARTED|Washout Period of 1 Week||0
10510487|NCT01288859|11660912|FG001|STARTED|Washout Period of 1 Week||0
10510488|NCT01288859|11660913|FG002|STARTED|Washout Period of 1 Week||0
10510489|NCT01288859|11660914|FG003|STARTED|Washout Period of 1 Week||5
10510490|NCT01288859|11660915|FG004|STARTED|Washout Period of 1 Week||5
10510491|NCT01288859|11660916|FG005|STARTED|Washout Period of 1 Week||0
10510492|NCT01288859|11660911|FG000|COMPLETED|Washout Period of 1 Week||0
10510493|NCT01288859|11660912|FG001|COMPLETED|Washout Period of 1 Week||0
10711236|NCT02658175|11876680|FG001|COMPLETED|1st Extended Treatment: Weeks 53 to 104||5
10711237|NCT02658175|11876681|FG002|COMPLETED|1st Extended Treatment: Weeks 53 to 104||1
10711238|NCT02658175|11876679|FG000|NOT COMPLETED|1st Extended Treatment: Weeks 53 to 104||21
10711239|NCT02658175|11876680|FG001|NOT COMPLETED|1st Extended Treatment: Weeks 53 to 104||2
10711240|NCT02658175|11876681|FG002|NOT COMPLETED|1st Extended Treatment: Weeks 53 to 104||2
10711241|NCT02658175|11876679|FG000|STARTED|2nd Extended Treatment: Weeks 105 to156||1
10711242|NCT02658175|11876680|FG001|STARTED|2nd Extended Treatment: Weeks 105 to156||0
10711243|NCT02658175|11876681|FG002|STARTED|2nd Extended Treatment: Weeks 105 to156||1
10711244|NCT02658175|11876679|FG000|COMPLETED|2nd Extended Treatment: Weeks 105 to156||0
10711245|NCT02658175|11876680|FG001|COMPLETED|2nd Extended Treatment: Weeks 105 to156||0
10711246|NCT02658175|11876681|FG002|COMPLETED|2nd Extended Treatment: Weeks 105 to156||0
10711247|NCT02658175|11876679|FG000|NOT COMPLETED|2nd Extended Treatment: Weeks 105 to156||1
10711248|NCT02658175|11876680|FG001|NOT COMPLETED|2nd Extended Treatment: Weeks 105 to156||0
10711249|NCT02658175|11876681|FG002|NOT COMPLETED|2nd Extended Treatment: Weeks 105 to156||1
10711250|NCT02658240|11876691|FG000|STARTED|Overall Study||30
10510494|NCT01288859|11660913|FG002|COMPLETED|Washout Period of 1 Week||0
10510495|NCT01288859|11660914|FG003|COMPLETED|Washout Period of 1 Week||5
10510496|NCT01288859|11660915|FG004|COMPLETED|Washout Period of 1 Week||5
10510497|NCT01288859|11660916|FG005|COMPLETED|Washout Period of 1 Week||0
10510498|NCT01288859|11660911|FG000|NOT COMPLETED|Washout Period of 1 Week||0
10510499|NCT01288859|11660912|FG001|NOT COMPLETED|Washout Period of 1 Week||0
10510500|NCT01288859|11660913|FG002|NOT COMPLETED|Washout Period of 1 Week||0
10510501|NCT01288859|11660914|FG003|NOT COMPLETED|Washout Period of 1 Week||0
10510502|NCT01288859|11660915|FG004|NOT COMPLETED|Washout Period of 1 Week||0
10510503|NCT01288859|11660916|FG005|NOT COMPLETED|Washout Period of 1 Week||0
10510504|NCT01288859|11660911|FG000|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
10510505|NCT01288859|11660912|FG001|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
10510506|NCT01288859|11660913|FG002|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
10711251|NCT02658240|11876692|FG001|STARTED|Overall Study||30
10510507|NCT01288859|11660914|FG003|STARTED|Control Cream Then Enc Polyph. (1 Day)||5
10510508|NCT01288859|11660915|FG004|STARTED|Control Cream Then Enc Polyph. (1 Day)||5
10510509|NCT01288859|11660916|FG005|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
10510510|NCT01288859|11660911|FG000|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
10510511|NCT01288859|11660912|FG001|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
10510512|NCT01288859|11660913|FG002|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
10510513|NCT01288859|11660914|FG003|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||5
10510514|NCT01288859|11660915|FG004|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||5
10510515|NCT01288859|11660916|FG005|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
10510516|NCT01288859|11660911|FG000|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
10510517|NCT01288859|11660912|FG001|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
10510518|NCT01288859|11660913|FG002|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
10510519|NCT01288859|11660914|FG003|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
10510520|NCT01288859|11660915|FG004|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
10510521|NCT01288859|11660916|FG005|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
10510538|NCT01288937|11660950|FG000|STARTED|Overall Study||4
10510539|NCT01288937|11660951|FG001|STARTED|Overall Study||2
10510540|NCT01288937|11660950|FG000|COMPLETED|Overall Study||3
10510541|NCT01288937|11660951|FG001|COMPLETED|Overall Study||2
10510542|NCT01288937|11660950|FG000|NOT COMPLETED|Overall Study||1
10510543|NCT01288937|11660951|FG001|NOT COMPLETED|Overall Study||0
10510544|NCT01288976|11660960|FG000|STARTED|Overall Study||567
10510545|NCT01288976|11660961|FG001|STARTED|Overall Study||49
10510546|NCT01288976|11660962|FG002|STARTED|Overall Study||105
10510547|NCT01288976|11660960|FG000|COMPLETED|Overall Study||389
10510548|NCT01288976|11660961|FG001|COMPLETED|Overall Study||22
10510549|NCT01288976|11660962|FG002|COMPLETED|Overall Study||85
10510550|NCT01288976|11660960|FG000|NOT COMPLETED|Overall Study||178
10510551|NCT01288976|11660961|FG001|NOT COMPLETED|Overall Study||27
10510552|NCT01288976|11660962|FG002|NOT COMPLETED|Overall Study||20
10510553|NCT01288989|11660973|FG000|STARTED|Overall Study||6
10510554|NCT01288989|11660974|FG001|STARTED|Overall Study||3
10510555|NCT01288989|11660975|FG002|STARTED|Overall Study||3
10510556|NCT01288989|11660976|FG003|STARTED|Overall Study||11
10510557|NCT01288989|11660977|FG004|STARTED|Overall Study||21
10510558|NCT01288989|11660973|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
10510559|NCT01288989|11660974|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
10510560|NCT01288989|11660975|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
10510561|NCT01288989|11660976|FG003|Received at Least 1 Dose of Study Drug|Overall Study||11
10510562|NCT01288989|11660977|FG004|Received at Least 1 Dose of Study Drug|Overall Study||21
10510563|NCT01288989|11660973|FG000|COMPLETED|Overall Study||5
10510564|NCT01288989|11660974|FG001|COMPLETED|Overall Study||3
10510565|NCT01288989|11660975|FG002|COMPLETED|Overall Study||3
10510566|NCT01288989|11660976|FG003|COMPLETED|Overall Study||10
10510567|NCT01288989|11660977|FG004|COMPLETED|Overall Study||15
10510568|NCT01288989|11660973|FG000|NOT COMPLETED|Overall Study||1
10510569|NCT01288989|11660974|FG001|NOT COMPLETED|Overall Study||0
10510570|NCT01288989|11660975|FG002|NOT COMPLETED|Overall Study||0
10510571|NCT01288989|11660976|FG003|NOT COMPLETED|Overall Study||1
10510572|NCT01288989|11660977|FG004|NOT COMPLETED|Overall Study||6
10510573|NCT01289015|11660997|FG000|STARTED|Overall Study||571
10510574|NCT01289015|11660998|FG001|STARTED|Overall Study||284
10510575|NCT01289015|11660997|FG000|COMPLETED|Overall Study||472
10510576|NCT01289015|11660998|FG001|COMPLETED|Overall Study||230
10510577|NCT01289015|11660997|FG000|NOT COMPLETED|Overall Study||99
10510578|NCT01289015|11660998|FG001|NOT COMPLETED|Overall Study||54
10510579|NCT01289028|11661004|FG000|STARTED|Overall Study||125
10510580|NCT01289028|11661004|FG000|COMPLETED|Overall Study||42
10510581|NCT01289028|11661004|FG000|NOT COMPLETED|Overall Study||83
10510582|NCT01289041|11661010|FG000|STARTED|Overall Study||70
10510583|NCT01289041|11661010|FG000|COMPLETED|Overall Study||0
10510584|NCT01289041|11661010|FG000|NOT COMPLETED|Overall Study||70
10510585|NCT01289067|11661016|FG000|STARTED|Overall Study||13
10510586|NCT01289067|11661016|FG000|COMPLETED|Overall Study||13
10510587|NCT01289067|11661016|FG000|NOT COMPLETED|Overall Study||0
10510588|NCT01289080|11661022|FG000|STARTED|Overall Study||9
10510589|NCT01289080|11661023|FG001|STARTED|Overall Study||10
10510590|NCT01289080|11661022|FG000|COMPLETED|Overall Study||9
10510591|NCT01289080|11661023|FG001|COMPLETED|Overall Study||10
10510592|NCT01289080|11661022|FG000|NOT COMPLETED|Overall Study||0
10510593|NCT01289080|11661023|FG001|NOT COMPLETED|Overall Study||0
10510594|NCT01289119|11661036|FG000|STARTED|Overall Study||93
10510595|NCT01289119|11661037|FG001|STARTED|Overall Study||92
10510596|NCT01289119|11661038|FG002|STARTED|Overall Study||98
10510597|NCT01289119|11661039|FG003|STARTED|Overall Study||99
10510598|NCT01289119|11661040|FG004|STARTED|Overall Study||63
10510599|NCT01289119|11661041|FG005|STARTED|Overall Study||61
10510600|NCT01289119|11661036|FG000|Treated|Overall Study|Patients who took at least one dose of double-blind study drug.|92
10510601|NCT01289119|11661037|FG001|Treated|Overall Study||92
10510602|NCT01289119|11661038|FG002|Treated|Overall Study||98
10510603|NCT01289119|11661039|FG003|Treated|Overall Study||99
10510604|NCT01289119|11661040|FG004|Treated|Overall Study||63
10510605|NCT01289119|11661041|FG005|Treated|Overall Study||61
10510606|NCT01289119|11661036|FG000|COMPLETED|Overall Study||84
10510607|NCT01289119|11661037|FG001|COMPLETED|Overall Study||83
10510608|NCT01289119|11661038|FG002|COMPLETED|Overall Study||89
10510609|NCT01289119|11661039|FG003|COMPLETED|Overall Study||93
10510610|NCT01289119|11661040|FG004|COMPLETED|Overall Study||58
10510611|NCT01289119|11661041|FG005|COMPLETED|Overall Study||57
10510612|NCT01289119|11661036|FG000|NOT COMPLETED|Overall Study||9
10510613|NCT01289119|11661037|FG001|NOT COMPLETED|Overall Study||9
10510614|NCT01289119|11661038|FG002|NOT COMPLETED|Overall Study||9
10510615|NCT01289119|11661039|FG003|NOT COMPLETED|Overall Study||6
10510616|NCT01289119|11661040|FG004|NOT COMPLETED|Overall Study||5
10510617|NCT01289119|11661041|FG005|NOT COMPLETED|Overall Study||4
10510618|NCT01289210|11661055|FG000|STARTED|Overall Study||2
10510619|NCT01289210|11661055|FG000|COMPLETED|Overall Study||1
10510620|NCT01289210|11661055|FG000|NOT COMPLETED|Overall Study||1
10510621|NCT01289275|11661063|FG000|STARTED|Overall Study||317
10510622|NCT01289275|11661064|FG001|STARTED|Overall Study||320
10510623|NCT01289275|11661065|FG002|STARTED|Overall Study||317
10510624|NCT01289275|11661066|FG003|STARTED|Overall Study||316
10510625|NCT01289275|11661063|FG000|COMPLETED|Overall Study||317
10510626|NCT01289275|11661064|FG001|COMPLETED|Overall Study||320
10510627|NCT01289275|11661065|FG002|COMPLETED|Overall Study||317
10510628|NCT01289275|11661066|FG003|COMPLETED|Overall Study||316
10510629|NCT01289275|11661063|FG000|NOT COMPLETED|Overall Study||0
10510630|NCT01289275|11661064|FG001|NOT COMPLETED|Overall Study||0
10510631|NCT01289275|11661065|FG002|NOT COMPLETED|Overall Study||0
10510632|NCT01289275|11661066|FG003|NOT COMPLETED|Overall Study||0
10510633|NCT01289353|11661080|FG000|STARTED|Overall Study||92
10510634|NCT01289353|11661080|FG000|COMPLETED|Overall Study||90
10510635|NCT01289353|11661080|FG000|NOT COMPLETED|Overall Study||2
10510636|NCT01289392|11661087|FG000|STARTED|Overall Study||9
10510637|NCT01289392|11661088|FG001|STARTED|Overall Study||9
10510638|NCT01289392|11661089|FG002|STARTED|Overall Study||7
10510639|NCT01289392|11661087|FG000|COMPLETED|Overall Study||9
10510640|NCT01289392|11661088|FG001|COMPLETED|Overall Study||9
10510641|NCT01289392|11661089|FG002|COMPLETED|Overall Study||7
10510642|NCT01289392|11661087|FG000|NOT COMPLETED|Overall Study||0
10510643|NCT01289392|11661088|FG001|NOT COMPLETED|Overall Study||0
10510644|NCT01289392|11661089|FG002|NOT COMPLETED|Overall Study||0
10510645|NCT01289418|11661100|FG000|STARTED|Day 8 Survey||6525
10510646|NCT01289418|11661100|FG000|COMPLETED|Day 8 Survey||4307
10510647|NCT01289418|11661100|FG000|NOT COMPLETED|Day 8 Survey||2218
10510648|NCT01289418|11661100|FG000|STARTED|Day 29 Survey||6525
10510649|NCT01289418|11661100|FG000|COMPLETED|Day 29 Survey||4057
10510650|NCT01289418|11661100|FG000|NOT COMPLETED|Day 29 Survey||2468
10510651|NCT01289431|11661113|FG000|STARTED|Overall Study||34
10510652|NCT01289431|11661114|FG001|STARTED|Overall Study||34
10510653|NCT01289431|11661115|FG002|STARTED|Overall Study||34
10510654|NCT01289431|11661116|FG003|STARTED|Overall Study||33
10510655|NCT01289431|11661117|FG004|STARTED|Overall Study||34
10510656|NCT01289431|11661118|FG005|STARTED|Overall Study||33
10510657|NCT01289431|11661119|FG006|STARTED|Overall Study||34
10510658|NCT01289431|11661113|FG000|COMPLETED|Overall Study||29
10510659|NCT01289431|11661114|FG001|COMPLETED|Overall Study||32
10510660|NCT01289431|11661115|FG002|COMPLETED|Overall Study||30
10510661|NCT01289431|11661116|FG003|COMPLETED|Overall Study||28
10510662|NCT01289431|11661117|FG004|COMPLETED|Overall Study||32
10510663|NCT01289431|11661118|FG005|COMPLETED|Overall Study||31
10510664|NCT01289431|11661119|FG006|COMPLETED|Overall Study||33
10510665|NCT01289431|11661113|FG000|NOT COMPLETED|Overall Study||5
10510666|NCT01289431|11661114|FG001|NOT COMPLETED|Overall Study||2
10510667|NCT01289431|11661115|FG002|NOT COMPLETED|Overall Study||4
10510668|NCT01289431|11661116|FG003|NOT COMPLETED|Overall Study||5
10510669|NCT01289431|11661117|FG004|NOT COMPLETED|Overall Study||2
10510670|NCT01289431|11661118|FG005|NOT COMPLETED|Overall Study||2
10510671|NCT01289431|11661119|FG006|NOT COMPLETED|Overall Study||1
10510672|NCT01289457|11661138|FG000|STARTED|Overall Study||12
10510673|NCT01289457|11661139|FG001|STARTED|Overall Study||157
10510674|NCT01289457|11661140|FG002|STARTED|Overall Study||113
10510675|NCT01289457|11661138|FG000|COMPLETED|Overall Study||12
10510676|NCT01289457|11661139|FG001|COMPLETED|Overall Study||157
10510677|NCT01289457|11661140|FG002|COMPLETED|Overall Study||113
10510678|NCT01289457|11661138|FG000|NOT COMPLETED|Overall Study||0
10510679|NCT01289457|11661139|FG001|NOT COMPLETED|Overall Study||0
10510680|NCT01289457|11661140|FG002|NOT COMPLETED|Overall Study||0
10510681|NCT01289522|11661148|FG000|STARTED|Overall Study||54
10510682|NCT01289522|11661148|FG000|COMPLETED|Overall Study||43
10510683|NCT01289522|11661148|FG000|NOT COMPLETED|Overall Study||11
10510684|NCT01289548|11661155|FG000|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
10510685|NCT01289548|11661156|FG001|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
10510686|NCT01289548|11661157|FG002|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
10510687|NCT01289548|11661155|FG000|Donors|Overall Study||20
10510688|NCT01289548|11661156|FG001|Donors|Overall Study||20
10510689|NCT01289548|11661157|FG002|Donors|Overall Study||20
10510690|NCT01289548|11661155|FG000|Recipients|Overall Study||20
10510691|NCT01289548|11661156|FG001|Recipients|Overall Study||20
10510692|NCT01289548|11661157|FG002|Recipients|Overall Study||20
10510693|NCT01289548|11661155|FG000|COMPLETED|Overall Study||40
10510694|NCT01289548|11661156|FG001|COMPLETED|Overall Study||40
10510695|NCT01289548|11661157|FG002|COMPLETED|Overall Study||40
10510696|NCT01289548|11661155|FG000|NOT COMPLETED|Overall Study||0
10510697|NCT01289548|11661156|FG001|NOT COMPLETED|Overall Study||0
10510698|NCT01289548|11661157|FG002|NOT COMPLETED|Overall Study||0
10510699|NCT01289574|11661168|FG000|STARTED|Overall Study||58
10510700|NCT01289574|11661169|FG001|STARTED|Overall Study||60
10510701|NCT01289574|11661170|FG002|STARTED|Overall Study||63
10510702|NCT01289574|11661168|FG000|COMPLETED|Overall Study||51
10510703|NCT01289574|11661169|FG001|COMPLETED|Overall Study||57
10510704|NCT01289574|11661170|FG002|COMPLETED|Overall Study||60
10510705|NCT01289574|11661168|FG000|NOT COMPLETED|Overall Study||7
10510706|NCT01289574|11661169|FG001|NOT COMPLETED|Overall Study||3
10510707|NCT01289574|11661170|FG002|NOT COMPLETED|Overall Study||3
10510708|NCT01289639|11661182|FG000|STARTED|Overall Study||5
10510709|NCT01289639|11661183|FG001|STARTED|Overall Study||6
10510710|NCT01289639|11661184|FG002|STARTED|Overall Study||0
10510711|NCT01289639|11661182|FG000|COMPLETED|Overall Study||4
10510712|NCT01289639|11661183|FG001|COMPLETED|Overall Study||6
10510713|NCT01289639|11661184|FG002|COMPLETED|Overall Study||0
10510714|NCT01289639|11661182|FG000|NOT COMPLETED|Overall Study||1
10510715|NCT01289639|11661183|FG001|NOT COMPLETED|Overall Study||0
10510716|NCT01289639|11661184|FG002|NOT COMPLETED|Overall Study||0
10510717|NCT01289665|11661194|FG000|STARTED|Overall Study||60
10510718|NCT01289665|11661195|FG001|STARTED|Overall Study||60
10510719|NCT01289665|11661194|FG000|COMPLETED|Overall Study||59
10510720|NCT01289665|11661195|FG001|COMPLETED|Overall Study||60
10510721|NCT01289665|11661194|FG000|NOT COMPLETED|Overall Study||1
10510722|NCT01289665|11661195|FG001|NOT COMPLETED|Overall Study||0
10510723|NCT01289678|11661201|FG000|STARTED|Overall Study||18
10510724|NCT01289678|11661201|FG000|COMPLETED|Overall Study||12
10510725|NCT01289678|11661201|FG000|NOT COMPLETED|Overall Study||6
10510726|NCT01289782|11661207|FG000|STARTED|Overall Study||264
10510727|NCT01289782|11661208|FG001|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|130
10510728|NCT01289782|11661207|FG000|COMPLETED|Overall Study||239
10510729|NCT01289782|11661208|FG001|COMPLETED|Overall Study||118
10510730|NCT01289782|11661207|FG000|NOT COMPLETED|Overall Study||25
10510731|NCT01289782|11661208|FG001|NOT COMPLETED|Overall Study||12
10510732|NCT01289821|11661214|FG000|STARTED|Treatment Period||54
10510733|NCT01289821|11661214|FG000|Participants Received Regorafenib|Treatment Period||54
10510734|NCT01289821|11661214|FG000|COMPLETED|Treatment Period||0
10510735|NCT01289821|11661214|FG000|NOT COMPLETED|Treatment Period||54
10510736|NCT01289821|11661214|FG000|STARTED|Safety Follow-up Period||54
10510737|NCT01289821|11661214|FG000|COMPLETED|Safety Follow-up Period||49
10510738|NCT01289821|11661214|FG000|NOT COMPLETED|Safety Follow-up Period||5
10510739|NCT01289821|11661214|FG000|STARTED|Survival Follow-up Period||52
10510740|NCT01289821|11661214|FG000|COMPLETED|Survival Follow-up Period|34 participants died and completed survival follow-up period.|34
10510741|NCT01289821|11661214|FG000|NOT COMPLETED|Survival Follow-up Period||18
10510742|NCT01289847|11661218|FG000|STARTED|Overall Study||25
10510743|NCT01289847|11661218|FG000|COMPLETED|Overall Study||24
10510744|NCT01289847|11661218|FG000|NOT COMPLETED|Overall Study||1
10510745|NCT01289912|11661224|FG000|STARTED|Overall Study||32
10510746|NCT01289912|11661225|FG001|STARTED|Overall Study||15
10510747|NCT01289912|11661224|FG000|COMPLETED|Overall Study||29
10510748|NCT01289912|11661225|FG001|COMPLETED|Overall Study||13
10510749|NCT01289912|11661224|FG000|NOT COMPLETED|Overall Study||3
10510750|NCT01289912|11661225|FG001|NOT COMPLETED|Overall Study||2
10510751|NCT01289990|11661254|FG000|STARTED|Overall Study||224
10510752|NCT01289990|11661255|FG001|STARTED|Overall Study||224
10510753|NCT01289990|11661256|FG002|STARTED|Overall Study||228
10510754|NCT01289990|11661257|FG003|STARTED|Overall Study||223
10510755|NCT01289990|11661258|FG004|STARTED|Overall Study||165
10510756|NCT01289990|11661259|FG005|STARTED|Overall Study||168
10510757|NCT01289990|11661260|FG006|STARTED|Overall Study||166
10510758|NCT01289990|11661261|FG007|STARTED|Overall Study||217
10510759|NCT01289990|11661262|FG008|STARTED|Overall Study||214
10510760|NCT01289990|11661263|FG009|STARTED|Overall Study||207
10510761|NCT01289990|11661264|FG010|STARTED|Overall Study||226
10510762|NCT01289990|11661265|FG011|STARTED|Overall Study||218
10510763|NCT01289990|11661266|FG012|STARTED|Overall Study||225
10510764|NCT01289990|11661254|FG000|COMPLETED|Overall Study||147
10510765|NCT01289990|11661255|FG001|COMPLETED|Overall Study||143
10510766|NCT01289990|11661256|FG002|COMPLETED|Overall Study||119
10510767|NCT01289990|11661257|FG003|COMPLETED|Overall Study||136
10510768|NCT01289990|11661258|FG004|COMPLETED|Overall Study||93
10510769|NCT01289990|11661259|FG005|COMPLETED|Overall Study||94
10510770|NCT01289990|11661260|FG006|COMPLETED|Overall Study||78
10510771|NCT01289990|11661261|FG007|COMPLETED|Overall Study||162
10510772|NCT01289990|11661262|FG008|COMPLETED|Overall Study||139
10510773|NCT01289990|11661263|FG009|COMPLETED|Overall Study||121
10510774|NCT01289990|11661264|FG010|COMPLETED|Overall Study||150
10510775|NCT01289990|11661265|FG011|COMPLETED|Overall Study||150
10510776|NCT01289990|11661266|FG012|COMPLETED|Overall Study||127
10510777|NCT01289990|11661254|FG000|NOT COMPLETED|Overall Study||77
10510778|NCT01289990|11661255|FG001|NOT COMPLETED|Overall Study||81
10510779|NCT01289990|11661256|FG002|NOT COMPLETED|Overall Study||109
10510780|NCT01289990|11661257|FG003|NOT COMPLETED|Overall Study||87
10510781|NCT01289990|11661258|FG004|NOT COMPLETED|Overall Study||72
10510782|NCT01289990|11661259|FG005|NOT COMPLETED|Overall Study||74
10510783|NCT01289990|11661260|FG006|NOT COMPLETED|Overall Study||88
10510784|NCT01289990|11661261|FG007|NOT COMPLETED|Overall Study||55
10510785|NCT01289990|11661262|FG008|NOT COMPLETED|Overall Study||75
10510786|NCT01289990|11661263|FG009|NOT COMPLETED|Overall Study||86
10510787|NCT01289990|11661264|FG010|NOT COMPLETED|Overall Study||76
10510788|NCT01289990|11661265|FG011|NOT COMPLETED|Overall Study||68
10510789|NCT01289990|11661266|FG012|NOT COMPLETED|Overall Study||98
10510790|NCT01290029|11661294|FG000|STARTED|Overall Study||14
10510791|NCT01290029|11661294|FG000|Received Study Treatment|Overall Study||12
10510792|NCT01290029|11661294|FG000|COMPLETED|Overall Study||12
10510793|NCT01290029|11661294|FG000|NOT COMPLETED|Overall Study||2
10510794|NCT01290068|11661300|FG000|STARTED|Overall Study||108
10510795|NCT01290068|11661301|FG001|STARTED|Overall Study||100
10510796|NCT01290068|11661300|FG000|Implanted|Overall Study||108
10510797|NCT01290068|11661301|FG001|Implanted|Overall Study||98
10510798|NCT01290068|11661300|FG000|COMPLETED|Overall Study||101
10510799|NCT01290068|11661301|FG001|COMPLETED|Overall Study||94
10510800|NCT01290068|11661300|FG000|NOT COMPLETED|Overall Study||7
10510801|NCT01290068|11661301|FG001|NOT COMPLETED|Overall Study||6
10510802|NCT01290094|11661307|FG000|STARTED|Overall Study||41
10510803|NCT01290094|11661307|FG000|COMPLETED|Overall Study||35
10510804|NCT01290094|11661307|FG000|NOT COMPLETED|Overall Study||6
10510805|NCT01290224|11661311|FG000|STARTED|Overall Study||10
10510806|NCT01290224|11661311|FG000|COMPLETED|Overall Study||5
10510807|NCT01290224|11661311|FG000|NOT COMPLETED|Overall Study||5
10510808|NCT01290237|11661319|FG000|STARTED|Overall Study||30
10510809|NCT01290237|11661320|FG001|STARTED|Overall Study||29
10510810|NCT01290237|11661319|FG000|COMPLETED|Overall Study||19
10510811|NCT01290237|11661320|FG001|COMPLETED|Overall Study||27
10510812|NCT01290237|11661319|FG000|NOT COMPLETED|Overall Study||11
10510813|NCT01290237|11661320|FG001|NOT COMPLETED|Overall Study||2
10510814|NCT01290263|11661330|FG000|STARTED|Overall Study||11
10510815|NCT01290263|11661331|FG001|STARTED|Overall Study||3
10510816|NCT01290263|11661332|FG002|STARTED|Overall Study||7
10510817|NCT01290263|11661333|FG003|STARTED|Overall Study||27
10510818|NCT01290263|11661334|FG004|STARTED|Overall Study||37
10510819|NCT01290263|11661330|FG000|COMPLETED|Overall Study||0
10510820|NCT01290263|11661331|FG001|COMPLETED|Overall Study||0
10510821|NCT01290263|11661332|FG002|COMPLETED|Overall Study||0
10510822|NCT01290263|11661333|FG003|COMPLETED|Overall Study||0
10510823|NCT01290263|11661334|FG004|COMPLETED|Overall Study||0
10510824|NCT01290263|11661330|FG000|NOT COMPLETED|Overall Study||11
10510825|NCT01290263|11661331|FG001|NOT COMPLETED|Overall Study||3
10510826|NCT01290263|11661332|FG002|NOT COMPLETED|Overall Study||7
10510827|NCT01290263|11661333|FG003|NOT COMPLETED|Overall Study||27
10510828|NCT01290263|11661334|FG004|NOT COMPLETED|Overall Study||37
10510829|NCT01290315|11661346|FG000|STARTED|Overall Study||14
10510830|NCT01290315|11661347|FG001|STARTED|Overall Study||12
10510831|NCT01290315|11661348|FG002|STARTED|Overall Study||10
10510832|NCT01290315|11661349|FG003|STARTED|Overall Study||13
10510833|NCT01290315|11661346|FG000|COMPLETED|Overall Study||11
10510834|NCT01290315|11661347|FG001|COMPLETED|Overall Study||9
10510835|NCT01290315|11661348|FG002|COMPLETED|Overall Study||10
10510836|NCT01290315|11661349|FG003|COMPLETED|Overall Study||8
10510837|NCT01290315|11661346|FG000|NOT COMPLETED|Overall Study||3
10510838|NCT01290315|11661347|FG001|NOT COMPLETED|Overall Study||3
10510839|NCT01290315|11661348|FG002|NOT COMPLETED|Overall Study||0
10510840|NCT01290315|11661349|FG003|NOT COMPLETED|Overall Study||5
10510841|NCT01290341|11661360|FG000|STARTED|Overall Study||573
10510842|NCT01290341|11661361|FG001|STARTED|Overall Study||287
10510843|NCT01290341|11661360|FG000|COMPLETED|Overall Study||481
10510844|NCT01290341|11661361|FG001|COMPLETED|Overall Study||258
10510845|NCT01290341|11661360|FG000|NOT COMPLETED|Overall Study||92
10510846|NCT01290341|11661361|FG001|NOT COMPLETED|Overall Study||29
10510847|NCT01290445|11661370|FG000|STARTED|Overall Study||335
10510848|NCT01290445|11661371|FG001|STARTED|Overall Study||78412
10510849|NCT01290445|11661372|FG002|STARTED|Overall Study||806438
10510850|NCT01290445|11661370|FG000|COMPLETED|Overall Study||335
10510851|NCT01290445|11661371|FG001|COMPLETED|Overall Study||78412
10510852|NCT01290445|11661372|FG002|COMPLETED|Overall Study||806438
10510853|NCT01290445|11661370|FG000|NOT COMPLETED|Overall Study||0
10510854|NCT01290445|11661371|FG001|NOT COMPLETED|Overall Study||0
10510855|NCT01290445|11661372|FG002|NOT COMPLETED|Overall Study||0
10510856|NCT01290484|11661380|FG000|STARTED|Overall Study||7
10510857|NCT01290484|11661380|FG000|COMPLETED|Overall Study||7
10510858|NCT01290484|11661380|FG000|NOT COMPLETED|Overall Study||0
10510859|NCT01290523|11661384|FG000|STARTED|Overall Study||14
10510860|NCT01290523|11661384|FG000|COMPLETED|Overall Study||11
10510861|NCT01290523|11661384|FG000|NOT COMPLETED|Overall Study||3
10510862|NCT01290536|11661388|FG000|STARTED|Overall Study||42
10510863|NCT01290536|11661388|FG000|COMPLETED|Overall Study||42
10510864|NCT01290536|11661388|FG000|NOT COMPLETED|Overall Study||0
10510865|NCT01290601|11661397|FG000|STARTED|Overall Study||46
10510866|NCT01290601|11661398|FG001|STARTED|Overall Study||24
10510867|NCT01290601|11661399|FG002|STARTED|Overall Study||0
10510868|NCT01290601|11661400|FG003|STARTED|Overall Study||0
10510869|NCT01290601|11661397|FG000|COMPLETED|Overall Study||35
10510870|NCT01290601|11661398|FG001|COMPLETED|Overall Study||19
10510871|NCT01290601|11661399|FG002|COMPLETED|Overall Study||0
10510872|NCT01290601|11661400|FG003|COMPLETED|Overall Study||0
10510873|NCT01290601|11661397|FG000|NOT COMPLETED|Overall Study||11
10510874|NCT01290601|11661398|FG001|NOT COMPLETED|Overall Study||5
10510875|NCT01290601|11661399|FG002|NOT COMPLETED|Overall Study||0
10510876|NCT01290601|11661400|FG003|NOT COMPLETED|Overall Study||0
10510877|NCT01290614|11661408|FG000|STARTED|Overall Study||1070
10510878|NCT01290614|11661409|FG001|STARTED|Overall Study||1129
10510879|NCT01290614|11661408|FG000|COMPLETED|Overall Study||518
10510880|NCT01290614|11661409|FG001|COMPLETED|Overall Study||1129
10510881|NCT01290614|11661408|FG000|NOT COMPLETED|Overall Study||552
10510882|NCT01290614|11661409|FG001|NOT COMPLETED|Overall Study||0
10510883|NCT01290627|11661418|FG000|STARTED|Overall Study||10
10510884|NCT01290627|11661419|FG001|STARTED|Overall Study||10
10510885|NCT01290627|11661420|FG002|STARTED|Overall Study||10
10510886|NCT01290627|11661418|FG000|COMPLETED|Overall Study||10
10510887|NCT01290627|11661419|FG001|COMPLETED|Overall Study||10
10510888|NCT01290627|11661420|FG002|COMPLETED|Overall Study||10
10510889|NCT01290627|11661418|FG000|NOT COMPLETED|Overall Study||0
10510890|NCT01290627|11661419|FG001|NOT COMPLETED|Overall Study||0
10510891|NCT01290627|11661420|FG002|NOT COMPLETED|Overall Study||0
10510892|NCT01290640|11661430|FG000|STARTED|Overall Study||12
10510893|NCT01290640|11661431|FG001|STARTED|Overall Study||10
10510894|NCT01290640|11661430|FG000|COMPLETED|Overall Study||12
10510895|NCT01290640|11661431|FG001|COMPLETED|Overall Study||10
10510896|NCT01290640|11661430|FG000|NOT COMPLETED|Overall Study||0
10510897|NCT01290640|11661431|FG001|NOT COMPLETED|Overall Study||0
10510898|NCT01290666|11661437|FG000|STARTED|Overall Study||93
10510899|NCT01290666|11661437|FG000|COMPLETED|Overall Study||55
10510900|NCT01290666|11661437|FG000|NOT COMPLETED|Overall Study||38
10510901|NCT01290679|11661443|FG000|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|257
10510902|NCT01290679|11661444|FG001|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|134
10510903|NCT01290679|11661443|FG000|COMPLETED|Overall Study||241
10510904|NCT01290679|11661444|FG001|COMPLETED|Overall Study||113
10510905|NCT01290679|11661443|FG000|NOT COMPLETED|Overall Study||16
10510906|NCT01290679|11661444|FG001|NOT COMPLETED|Overall Study||21
10510907|NCT01290731|11661450|FG000|STARTED|Overall Study||49
10510908|NCT01290731|11661450|FG000|COMPLETED|Overall Study||48
10510909|NCT01290731|11661450|FG000|NOT COMPLETED|Overall Study||1
10510910|NCT01290757|11661456|FG000|STARTED|Overall Study||90
10510911|NCT01290757|11661457|FG001|STARTED|Overall Study||90
10510912|NCT01290757|11661456|FG000|COMPLETED|Overall Study||88
10510913|NCT01290757|11661457|FG001|COMPLETED|Overall Study||88
10510914|NCT01290757|11661456|FG000|NOT COMPLETED|Overall Study||2
10510915|NCT01290757|11661457|FG001|NOT COMPLETED|Overall Study||2
10510916|NCT01290796|11661463|FG000|STARTED|Overall Study||153
10510917|NCT01290796|11661463|FG000|COMPLETED|Overall Study||123
10510918|NCT01290796|11661463|FG000|NOT COMPLETED|Overall Study||30
10510919|NCT01290874|11661469|FG000|STARTED|Overall Study||532
10510920|NCT01290874|11661470|FG001|STARTED|Overall Study||538
10510921|NCT01290874|11661469|FG000|COMPLETED|Overall Study||122
10510922|NCT01290874|11661470|FG001|COMPLETED|Overall Study||134
10510923|NCT01290874|11661469|FG000|NOT COMPLETED|Overall Study||410
10510924|NCT01290874|11661470|FG001|NOT COMPLETED|Overall Study||404
10510925|NCT01290887|11661479|FG000|STARTED|Overall Study||481
10510926|NCT01290887|11661480|FG001|STARTED|Overall Study||571
10510927|NCT01290887|11661479|FG000|Safety Analysis Set|Overall Study|One patient was enrolled but not treated.|480
10510928|NCT01290887|11661480|FG001|Safety Analysis Set|Overall Study||571
10510929|NCT01290887|11661479|FG000|COMPLETED|Overall Study|Completed study includes completion of the 104 week treatment phase and the 90-day follow-up.|15
10510930|NCT01290887|11661480|FG001|COMPLETED|Overall Study|Completed study includes completion of the 104 week treatment phase and the 90-day follow-up.|35
10510931|NCT01290887|11661479|FG000|NOT COMPLETED|Overall Study||466
10510932|NCT01290887|11661480|FG001|NOT COMPLETED|Overall Study||536
10510933|NCT01290913|11661486|FG000|STARTED|Overall Study||13
10510934|NCT01290913|11661486|FG000|COMPLETED|Overall Study||12
10510935|NCT01290913|11661486|FG000|NOT COMPLETED|Overall Study||1
10510936|NCT01290952|11661492|FG000|STARTED|Overall Study||204
10510937|NCT01290952|11661493|FG001|STARTED|Overall Study||207
10510938|NCT01290952|11661492|FG000|COMPLETED|Overall Study||192
10510939|NCT01290952|11661493|FG001|COMPLETED|Overall Study||193
10510940|NCT01290952|11661492|FG000|NOT COMPLETED|Overall Study||12
10510941|NCT01290952|11661493|FG001|NOT COMPLETED|Overall Study||14
10510942|NCT01290978|11661501|FG000|STARTED|Overall Study||22
10510943|NCT01290978|11661501|FG000|COMPLETED|Overall Study||22
10510944|NCT01290978|11661501|FG000|NOT COMPLETED|Overall Study||0
10510945|NCT01291017|11661506|FG000|STARTED|Overall Study||19
10510946|NCT01291017|11661506|FG000|COMPLETED|Overall Study||14
10510947|NCT01291017|11661506|FG000|NOT COMPLETED|Overall Study||5
10510948|NCT01291056|11661512|FG000|STARTED|Intervention One (Menstraution Day 3-7)||10
10510949|NCT01291056|11661513|FG001|STARTED|Intervention One (Menstraution Day 3-7)||10
10510950|NCT01291056|11661512|FG000|COMPLETED|Intervention One (Menstraution Day 3-7)||10
10510951|NCT01291056|11661513|FG001|COMPLETED|Intervention One (Menstraution Day 3-7)||10
10510952|NCT01291056|11661512|FG000|NOT COMPLETED|Intervention One (Menstraution Day 3-7)||0
10510953|NCT01291056|11661513|FG001|NOT COMPLETED|Intervention One (Menstraution Day 3-7)||0
10510954|NCT01291056|11661512|FG000|STARTED|Washout||10
10510955|NCT01291056|11661513|FG001|STARTED|Washout||10
10510956|NCT01291056|11661512|FG000|COMPLETED|Washout||10
10510957|NCT01291056|11661513|FG001|COMPLETED|Washout||10
10510958|NCT01291056|11661512|FG000|NOT COMPLETED|Washout||0
10510959|NCT01291056|11661513|FG001|NOT COMPLETED|Washout||0
10510960|NCT01291056|11661512|FG000|STARTED|Intervention Two (Menstration Days 3-7)||10
10510961|NCT01291056|11661513|FG001|STARTED|Intervention Two (Menstration Days 3-7)||10
10510962|NCT01291056|11661512|FG000|COMPLETED|Intervention Two (Menstration Days 3-7)||10
10510963|NCT01291056|11661513|FG001|COMPLETED|Intervention Two (Menstration Days 3-7)||10
10510964|NCT01291056|11661512|FG000|NOT COMPLETED|Intervention Two (Menstration Days 3-7)||0
10510965|NCT01291056|11661513|FG001|NOT COMPLETED|Intervention Two (Menstration Days 3-7)||0
10510966|NCT01291108|11661523|FG000|STARTED|Month 1 (Monotherapy)||65
10510967|NCT01291108|11661524|FG001|STARTED|Month 1 (Monotherapy)||0
10510968|NCT01291108|11661525|FG002|STARTED|Month 1 (Monotherapy)||0
10510969|NCT01291108|11661526|FG003|STARTED|Month 1 (Monotherapy)||60
10510970|NCT01291108|11661527|FG004|STARTED|Month 1 (Monotherapy)||0
10510971|NCT01291108|11661528|FG005|STARTED|Month 1 (Monotherapy)||0
10510972|NCT01291108|11661523|FG000|COMPLETED|Month 1 (Monotherapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|64
10510973|NCT01291108|11661524|FG001|COMPLETED|Month 1 (Monotherapy)||0
10510974|NCT01291108|11661525|FG002|COMPLETED|Month 1 (Monotherapy)||0
10510975|NCT01291108|11661526|FG003|COMPLETED|Month 1 (Monotherapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|60
10510976|NCT01291108|11661527|FG004|COMPLETED|Month 1 (Monotherapy)||0
10510977|NCT01291108|11661528|FG005|COMPLETED|Month 1 (Monotherapy)||0
10510978|NCT01291108|11661523|FG000|NOT COMPLETED|Month 1 (Monotherapy)||1
10510979|NCT01291108|11661524|FG001|NOT COMPLETED|Month 1 (Monotherapy)||0
10510980|NCT01291108|11661525|FG002|NOT COMPLETED|Month 1 (Monotherapy)||0
10510981|NCT01291108|11661526|FG003|NOT COMPLETED|Month 1 (Monotherapy)||0
10510982|NCT01291108|11661527|FG004|NOT COMPLETED|Month 1 (Monotherapy)||0
10510983|NCT01291108|11661528|FG005|NOT COMPLETED|Month 1 (Monotherapy)||0
10510984|NCT01291108|11661523|FG000|STARTED|Month 2 (Adjunctive Therapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|0
10510985|NCT01291108|11661524|FG001|STARTED|Month 2 (Adjunctive Therapy)||40
10510986|NCT01291108|11661525|FG002|STARTED|Month 2 (Adjunctive Therapy)||24
10510987|NCT01291108|11661526|FG003|STARTED|Month 2 (Adjunctive Therapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|0
10510988|NCT01291108|11661527|FG004|STARTED|Month 2 (Adjunctive Therapy)||34
10510989|NCT01291108|11661528|FG005|STARTED|Month 2 (Adjunctive Therapy)||26
10510990|NCT01291108|11661523|FG000|COMPLETED|Month 2 (Adjunctive Therapy)||0
10510991|NCT01291108|11661524|FG001|COMPLETED|Month 2 (Adjunctive Therapy)||38
10510992|NCT01291108|11661525|FG002|COMPLETED|Month 2 (Adjunctive Therapy)||24
10510993|NCT01291108|11661526|FG003|COMPLETED|Month 2 (Adjunctive Therapy)||0
10510994|NCT01291108|11661527|FG004|COMPLETED|Month 2 (Adjunctive Therapy)||34
10510995|NCT01291108|11661528|FG005|COMPLETED|Month 2 (Adjunctive Therapy)||25
10510996|NCT01291108|11661523|FG000|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
10510997|NCT01291108|11661524|FG001|NOT COMPLETED|Month 2 (Adjunctive Therapy)||2
10510998|NCT01291108|11661525|FG002|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
10510999|NCT01291108|11661526|FG003|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
10511000|NCT01291108|11661527|FG004|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
10511001|NCT01291108|11661528|FG005|NOT COMPLETED|Month 2 (Adjunctive Therapy)||1
10511002|NCT01291160|11661541|FG000|STARTED|Overall Study||66
10511003|NCT01291160|11661542|FG001|STARTED|Overall Study||64
10511004|NCT01291160|11661541|FG000|COMPLETED|Overall Study||48
10511005|NCT01291160|11661542|FG001|COMPLETED|Overall Study||48
10511006|NCT01291160|11661541|FG000|NOT COMPLETED|Overall Study||18
10511007|NCT01291160|11661542|FG001|NOT COMPLETED|Overall Study||16
10511008|NCT01291173|11661552|FG000|STARTED|Overall Study||64
10511009|NCT01291173|11661553|FG001|STARTED|Overall Study||66
10511010|NCT01291173|11661554|FG002|STARTED|Overall Study||65
10511011|NCT01291173|11661555|FG003|STARTED|Overall Study||65
10511012|NCT01291173|11661552|FG000|COMPLETED|Overall Study||47
10511013|NCT01291173|11661553|FG001|COMPLETED|Overall Study||51
10511014|NCT01291173|11661554|FG002|COMPLETED|Overall Study||52
10511015|NCT01291173|11661555|FG003|COMPLETED|Overall Study||52
10511016|NCT01291173|11661552|FG000|NOT COMPLETED|Overall Study||17
10511017|NCT01291173|11661553|FG001|NOT COMPLETED|Overall Study||15
10511018|NCT01291173|11661554|FG002|NOT COMPLETED|Overall Study||13
10511019|NCT01291173|11661555|FG003|NOT COMPLETED|Overall Study||13
10511020|NCT01291225|11661567|FG000|STARTED|Overall Study||151
10511021|NCT01291225|11661568|FG001|STARTED|Overall Study||160
10511022|NCT01291225|11661567|FG000|COMPLETED|Overall Study||66
10511023|NCT01291225|11661568|FG001|COMPLETED|Overall Study||121
10511024|NCT01291225|11661567|FG000|NOT COMPLETED|Overall Study||85
10511025|NCT01291225|11661568|FG001|NOT COMPLETED|Overall Study||39
10511026|NCT01291264|11661578|FG000|STARTED|Overall Study||260
10511027|NCT01291264|11661578|FG000|COMPLETED|Overall Study||260
10511028|NCT01291264|11661578|FG000|NOT COMPLETED|Overall Study||0
10511029|NCT01291277|11661584|FG000|STARTED|Overall Study||45
10511030|NCT01291277|11661585|FG001|STARTED|Overall Study||45
10511031|NCT01291277|11661584|FG000|COMPLETED|Overall Study||40
10511032|NCT01291277|11661585|FG001|COMPLETED|Overall Study||42
10511033|NCT01291277|11661584|FG000|NOT COMPLETED|Overall Study||5
10511034|NCT01291277|11661585|FG001|NOT COMPLETED|Overall Study||3
10511035|NCT01291498|11661591|FG000|STARTED|Overall Study||1
10511036|NCT01291498|11661591|FG000|COMPLETED|Overall Study||0
10511037|NCT01291498|11661591|FG000|NOT COMPLETED|Overall Study||1
10511038|NCT01291784|11661597|FG000|STARTED|Overall Study||1
10511039|NCT01291784|11661598|FG001|STARTED|Overall Study||1
10511040|NCT01291784|11661599|FG002|STARTED|Overall Study||1
10511041|NCT01291784|11661597|FG000|COMPLETED|Overall Study||1
10511042|NCT01291784|11661598|FG001|COMPLETED|Overall Study||0
10511043|NCT01291784|11661599|FG002|COMPLETED|Overall Study||1
10511044|NCT01291784|11661597|FG000|NOT COMPLETED|Overall Study||0
10511045|NCT01291784|11661598|FG001|NOT COMPLETED|Overall Study||1
10511046|NCT01291784|11661599|FG002|NOT COMPLETED|Overall Study||0
10511047|NCT01291836|11661607|FG000|STARTED|Overall Study||930
10511048|NCT01291836|11661608|FG001|STARTED|Overall Study||71
10511049|NCT01291836|11661607|FG000|COMPLETED|Overall Study||930
10511050|NCT01291836|11661608|FG001|COMPLETED|Overall Study||71
10511051|NCT01291836|11661607|FG000|NOT COMPLETED|Overall Study||0
10511052|NCT01291836|11661608|FG001|NOT COMPLETED|Overall Study||0
10511053|NCT01292005|11661616|FG000|STARTED|Overall Study||14
10511054|NCT01292005|11661617|FG001|STARTED|Overall Study||14
10511055|NCT01292005|11661616|FG000|COMPLETED|Overall Study||14
10511056|NCT01292005|11661617|FG001|COMPLETED|Overall Study||14
10511057|NCT01292005|11661616|FG000|NOT COMPLETED|Overall Study||0
10511058|NCT01292005|11661617|FG001|NOT COMPLETED|Overall Study||0
10511059|NCT01292057|11661625|FG000|STARTED|Overall Study||49
10511060|NCT01292057|11661626|FG001|STARTED|Overall Study||50
10511061|NCT01292057|11661625|FG000|COMPLETED|Overall Study||47
10511062|NCT01292057|11661626|FG001|COMPLETED|Overall Study||48
10511063|NCT01292057|11661625|FG000|NOT COMPLETED|Overall Study||2
10511064|NCT01292057|11661626|FG001|NOT COMPLETED|Overall Study||2
10511065|NCT01292135|11661634|FG000|STARTED|Overall Study||3
10511066|NCT01292135|11661635|FG001|STARTED|Overall Study||30
10511067|NCT01292135|11661634|FG000|COMPLETED|Overall Study||3
10511068|NCT01292135|11661635|FG001|COMPLETED|Overall Study||21
10511069|NCT01292135|11661634|FG000|NOT COMPLETED|Overall Study||0
10511070|NCT01292135|11661635|FG001|NOT COMPLETED|Overall Study||9
10511071|NCT01292187|11661645|FG000|STARTED|Overall Study||86
10511072|NCT01292187|11661646|FG001|STARTED|Overall Study||43
10511073|NCT01292187|11661645|FG000|COMPLETED|Overall Study||69
10511074|NCT01292187|11661646|FG001|COMPLETED|Overall Study||30
10511075|NCT01292187|11661645|FG000|NOT COMPLETED|Overall Study||17
10511076|NCT01292187|11661646|FG001|NOT COMPLETED|Overall Study||13
10511077|NCT01292226|11661653|FG000|STARTED|Overall Study||45
10511078|NCT01292226|11661653|FG000|COMPLETED|Overall Study||32
10511079|NCT01292226|11661653|FG000|NOT COMPLETED|Overall Study||13
10511080|NCT01292239|11661659|FG000|STARTED|Overall Study||123
10511081|NCT01292239|11661660|FG001|STARTED|Overall Study||60
10511082|NCT01292239|11661659|FG000|COMPLETED|Overall Study||119
10511083|NCT01292239|11661660|FG001|COMPLETED|Overall Study||53
10511084|NCT01292239|11661659|FG000|NOT COMPLETED|Overall Study||4
10511085|NCT01292239|11661660|FG001|NOT COMPLETED|Overall Study||7
10511086|NCT01292252|11661668|FG000|STARTED|Overall Study||21
10511087|NCT01292252|11661669|FG001|STARTED|Overall Study||15
10511088|NCT01292252|11661668|FG000|COMPLETED|Overall Study||21
10511089|NCT01292252|11661669|FG001|COMPLETED|Overall Study||14
10511090|NCT01292252|11661668|FG000|NOT COMPLETED|Overall Study||0
10511091|NCT01292252|11661669|FG001|NOT COMPLETED|Overall Study||1
10511092|NCT01292304|11661675|FG000|STARTED|Overall Study||10
10511093|NCT01292304|11661675|FG000|COMPLETED|Overall Study||10
10511094|NCT01292304|11661675|FG000|NOT COMPLETED|Overall Study||0
10711252|NCT02658240|11876691|FG000|COMPLETED|Overall Study||30
10711253|NCT02658240|11876692|FG001|COMPLETED|Overall Study||30
10711254|NCT02658240|11876691|FG000|NOT COMPLETED|Overall Study||0
10711255|NCT02658240|11876692|FG001|NOT COMPLETED|Overall Study||0
10511095|NCT01292447|11661681|FG000|STARTED|Overall Study||75
10511096|NCT01292447|11661682|FG001|STARTED|Overall Study||75
10511097|NCT01292447|11661681|FG000|COMPLETED|Overall Study||73
10511098|NCT01292447|11661682|FG001|COMPLETED|Overall Study||72
10511099|NCT01292447|11661681|FG000|NOT COMPLETED|Overall Study||2
10511100|NCT01292447|11661682|FG001|NOT COMPLETED|Overall Study||3
10511101|NCT01292473|11661692|FG000|STARTED|Overall Study||79
10511102|NCT01292473|11661693|FG001|STARTED|Overall Study||82
10511103|NCT01292473|11661694|FG002|STARTED|Overall Study||83
10511104|NCT01292473|11661695|FG003|STARTED|Overall Study||79
10511105|NCT01292473|11661692|FG000|COMPLETED|Overall Study||74
10511106|NCT01292473|11661693|FG001|COMPLETED|Overall Study||75
10511107|NCT01292473|11661694|FG002|COMPLETED|Overall Study||74
10511108|NCT01292473|11661695|FG003|COMPLETED|Overall Study||67
10511109|NCT01292473|11661692|FG000|NOT COMPLETED|Overall Study||5
10511110|NCT01292473|11661693|FG001|NOT COMPLETED|Overall Study||7
10511111|NCT01292473|11661694|FG002|NOT COMPLETED|Overall Study||9
10511112|NCT01292473|11661695|FG003|NOT COMPLETED|Overall Study||12
10511113|NCT01292486|11661709|FG000|STARTED|Overall Study||32
10511114|NCT01292486|11661709|FG000|COMPLETED|Overall Study||26
10511115|NCT01292486|11661709|FG000|NOT COMPLETED|Overall Study||6
10511116|NCT01292538|11661716|FG000|STARTED|Overall Study||35
10511117|NCT01292538|11661717|FG001|STARTED|Overall Study||32
10511118|NCT01292538|11661716|FG000|COMPLETED|Overall Study||35
10511119|NCT01292538|11661717|FG001|COMPLETED|Overall Study||32
10511120|NCT01292538|11661716|FG000|NOT COMPLETED|Overall Study||0
10511121|NCT01292538|11661717|FG001|NOT COMPLETED|Overall Study||0
10511122|NCT01292603|11661728|FG000|STARTED|Part 1: Pilot Dose Selection Period||16
10511123|NCT01292603|11661729|FG001|STARTED|Part 1: Pilot Dose Selection Period||17
10511124|NCT01292603|11661730|FG002|STARTED|Part 1: Pilot Dose Selection Period|1 participant received a dose of 1000mg of rituximab by oversight.|23
10511125|NCT01292603|11661731|FG003|STARTED|Part 1: Pilot Dose Selection Period|These participants were withdrawn prior to SC treatment.|8
10511126|NCT01292603|11661732|FG004|STARTED|Part 1: Pilot Dose Selection Period||0
10511127|NCT01292603|11661733|FG005|STARTED|Part 1: Pilot Dose Selection Period||0
10511128|NCT01292603|11661728|FG000|COMPLETED|Part 1: Pilot Dose Selection Period||16
10511129|NCT01292603|11661729|FG001|COMPLETED|Part 1: Pilot Dose Selection Period||17
10511130|NCT01292603|11661730|FG002|COMPLETED|Part 1: Pilot Dose Selection Period||23
10511131|NCT01292603|11661731|FG003|COMPLETED|Part 1: Pilot Dose Selection Period||0
10511132|NCT01292603|11661732|FG004|COMPLETED|Part 1: Pilot Dose Selection Period||0
10511133|NCT01292603|11661733|FG005|COMPLETED|Part 1: Pilot Dose Selection Period||0
10511134|NCT01292603|11661728|FG000|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
10511135|NCT01292603|11661729|FG001|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
10511136|NCT01292603|11661730|FG002|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
10511137|NCT01292603|11661731|FG003|NOT COMPLETED|Part 1: Pilot Dose Selection Period||8
10511138|NCT01292603|11661732|FG004|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
10511139|NCT01292603|11661733|FG005|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
10511140|NCT01292603|11661728|FG000|STARTED|Part 1: Regular Follow-Up Period||16
10511141|NCT01292603|11661729|FG001|STARTED|Part 1: Regular Follow-Up Period||17
10511142|NCT01292603|11661730|FG002|STARTED|Part 1: Regular Follow-Up Period||23
10511143|NCT01292603|11661731|FG003|STARTED|Part 1: Regular Follow-Up Period||8
10511144|NCT01292603|11661732|FG004|STARTED|Part 1: Regular Follow-Up Period||0
10511145|NCT01292603|11661733|FG005|STARTED|Part 1: Regular Follow-Up Period||0
10711256|NCT02658448|11876698|FG000|STARTED|Overall Study||19
10511146|NCT01292603|11661728|FG000|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|10
10511147|NCT01292603|11661729|FG001|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|10
10511148|NCT01292603|11661730|FG002|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|17
10511149|NCT01292603|11661731|FG003|COMPLETED|Part 1: Regular Follow-Up Period||7
10511150|NCT01292603|11661732|FG004|COMPLETED|Part 1: Regular Follow-Up Period||0
10511151|NCT01292603|11661733|FG005|COMPLETED|Part 1: Regular Follow-Up Period||0
10511152|NCT01292603|11661728|FG000|NOT COMPLETED|Part 1: Regular Follow-Up Period||6
10511153|NCT01292603|11661729|FG001|NOT COMPLETED|Part 1: Regular Follow-Up Period||7
10511154|NCT01292603|11661730|FG002|NOT COMPLETED|Part 1: Regular Follow-Up Period||6
10511155|NCT01292603|11661731|FG003|NOT COMPLETED|Part 1: Regular Follow-Up Period||1
10511156|NCT01292603|11661732|FG004|NOT COMPLETED|Part 1: Regular Follow-Up Period||0
10511157|NCT01292603|11661733|FG005|NOT COMPLETED|Part 1: Regular Follow-Up Period||0
10511158|NCT01292603|11661728|FG000|STARTED|Part 2: Dose Confirmation Period||0
10511159|NCT01292603|11661729|FG001|STARTED|Part 2: Dose Confirmation Period||0
10511160|NCT01292603|11661730|FG002|STARTED|Part 2: Dose Confirmation Period||0
10511161|NCT01292603|11661731|FG003|STARTED|Part 2: Dose Confirmation Period||0
10511162|NCT01292603|11661732|FG004|STARTED|Part 2: Dose Confirmation Period||88
10511163|NCT01292603|11661733|FG005|STARTED|Part 2: Dose Confirmation Period||88
10511164|NCT01292603|11661728|FG000|COMPLETED|Part 2: Dose Confirmation Period||0
10511165|NCT01292603|11661729|FG001|COMPLETED|Part 2: Dose Confirmation Period||0
10511166|NCT01292603|11661730|FG002|COMPLETED|Part 2: Dose Confirmation Period||0
10511167|NCT01292603|11661731|FG003|COMPLETED|Part 2: Dose Confirmation Period||0
10511168|NCT01292603|11661732|FG004|COMPLETED|Part 2: Dose Confirmation Period||72
10511169|NCT01292603|11661733|FG005|COMPLETED|Part 2: Dose Confirmation Period||73
10511170|NCT01292603|11661728|FG000|NOT COMPLETED|Part 2: Dose Confirmation Period||0
10511171|NCT01292603|11661729|FG001|NOT COMPLETED|Part 2: Dose Confirmation Period||0
10511172|NCT01292603|11661730|FG002|NOT COMPLETED|Part 2: Dose Confirmation Period||0
10511173|NCT01292603|11661731|FG003|NOT COMPLETED|Part 2: Dose Confirmation Period||0
10511174|NCT01292603|11661732|FG004|NOT COMPLETED|Part 2: Dose Confirmation Period||16
10511175|NCT01292603|11661733|FG005|NOT COMPLETED|Part 2: Dose Confirmation Period||15
10511176|NCT01292603|11661728|FG000|STARTED|Part 2: Regular Follow-Up||0
10511177|NCT01292603|11661729|FG001|STARTED|Part 2: Regular Follow-Up||0
10511178|NCT01292603|11661730|FG002|STARTED|Part 2: Regular Follow-Up||0
10511179|NCT01292603|11661731|FG003|STARTED|Part 2: Regular Follow-Up||0
10511180|NCT01292603|11661732|FG004|STARTED|Part 2: Regular Follow-Up|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|87
10511181|NCT01292603|11661733|FG005|STARTED|Part 2: Regular Follow-Up|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|87
10511182|NCT01292603|11661728|FG000|COMPLETED|Part 2: Regular Follow-Up||0
10511183|NCT01292603|11661729|FG001|COMPLETED|Part 2: Regular Follow-Up||0
10511184|NCT01292603|11661730|FG002|COMPLETED|Part 2: Regular Follow-Up||0
10511185|NCT01292603|11661731|FG003|COMPLETED|Part 2: Regular Follow-Up||0
10511186|NCT01292603|11661732|FG004|COMPLETED|Part 2: Regular Follow-Up||68
10511187|NCT01292603|11661733|FG005|COMPLETED|Part 2: Regular Follow-Up||75
10511188|NCT01292603|11661728|FG000|NOT COMPLETED|Part 2: Regular Follow-Up||0
10511189|NCT01292603|11661729|FG001|NOT COMPLETED|Part 2: Regular Follow-Up||0
10511190|NCT01292603|11661730|FG002|NOT COMPLETED|Part 2: Regular Follow-Up||0
10511191|NCT01292603|11661731|FG003|NOT COMPLETED|Part 2: Regular Follow-Up||0
10511192|NCT01292603|11661732|FG004|NOT COMPLETED|Part 2: Regular Follow-Up||19
10511193|NCT01292603|11661733|FG005|NOT COMPLETED|Part 2: Regular Follow-Up||12
10511194|NCT01292603|11661728|FG000|STARTED|Overall Survival Status||16
10511195|NCT01292603|11661729|FG001|STARTED|Overall Survival Status||17
10511196|NCT01292603|11661730|FG002|STARTED|Overall Survival Status||23
10511197|NCT01292603|11661731|FG003|STARTED|Overall Survival Status||8
10511198|NCT01292603|11661732|FG004|STARTED|Overall Survival Status||88
10511199|NCT01292603|11661733|FG005|STARTED|Overall Survival Status||88
10511200|NCT01292603|11661728|FG000|COMPLETED|Overall Survival Status||13
10511201|NCT01292603|11661729|FG001|COMPLETED|Overall Survival Status||16
10711257|NCT02658448|11876698|FG000|COMPLETED|Overall Study|One patient was lost to follow-up after enrollment and prior to visit 1|18
10711258|NCT02658448|11876698|FG000|NOT COMPLETED|Overall Study||1
10711259|NCT02658461|11876705|FG000|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
10711260|NCT02658461|11876706|FG001|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
10711261|NCT02658461|11876707|FG002|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
10711262|NCT02658461|11876705|FG000|COMPLETED|Overall Study||12
10711263|NCT02658461|11876706|FG001|COMPLETED|Overall Study||12
10711264|NCT02658461|11876707|FG002|COMPLETED|Overall Study||12
10711265|NCT02658461|11876705|FG000|NOT COMPLETED|Overall Study||0
10711266|NCT02658461|11876706|FG001|NOT COMPLETED|Overall Study||0
10711267|NCT02658461|11876707|FG002|NOT COMPLETED|Overall Study||0
10711268|NCT02658487|11876717|FG000|STARTED|Overall Study||42
10711269|NCT02658487|11876717|FG000|COMPLETED|Overall Study||26
10711270|NCT02658487|11876717|FG000|NOT COMPLETED|Overall Study||16
10711271|NCT02658630|11876722|FG000|STARTED|Overall Study||46
10511202|NCT01292603|11661730|FG002|COMPLETED|Overall Survival Status||20
10511203|NCT01292603|11661731|FG003|COMPLETED|Overall Survival Status||7
10511204|NCT01292603|11661732|FG004|COMPLETED|Overall Survival Status||72
10511205|NCT01292603|11661733|FG005|COMPLETED|Overall Survival Status||78
10511206|NCT01292603|11661728|FG000|NOT COMPLETED|Overall Survival Status||3
10511207|NCT01292603|11661729|FG001|NOT COMPLETED|Overall Survival Status||1
10511208|NCT01292603|11661730|FG002|NOT COMPLETED|Overall Survival Status||3
10511209|NCT01292603|11661731|FG003|NOT COMPLETED|Overall Survival Status||1
10511210|NCT01292603|11661732|FG004|NOT COMPLETED|Overall Survival Status||16
10511211|NCT01292603|11661733|FG005|NOT COMPLETED|Overall Survival Status||10
10511212|NCT01292629|11661754|FG000|STARTED|Overall Study||125
10511213|NCT01292629|11661754|FG000|COMPLETED|Overall Study||125
10511214|NCT01292629|11661754|FG000|NOT COMPLETED|Overall Study||0
10511215|NCT01292642|11661759|FG000|STARTED|Overall Study||12
10511216|NCT01292642|11661759|FG000|COMPLETED|Overall Study||7
10511217|NCT01292642|11661759|FG000|NOT COMPLETED|Overall Study||5
10511218|NCT01292746|11661767|FG000|STARTED|Overall Study||14
10511219|NCT01292746|11661767|FG000|COMPLETED|Overall Study||14
10511220|NCT01292746|11661767|FG000|NOT COMPLETED|Overall Study||0
10511221|NCT01292798|11661771|FG000|STARTED|Overall Study||43
10511222|NCT01292798|11661771|FG000|Persistent DME After 3 Months|Overall Study|Subjects with persistent DME after 3 monthly injections of 0.5 mg of ranibizumab|29
10511223|NCT01292798|11661771|FG000|COMPLETED|Overall Study||43
10511224|NCT01292798|11661771|FG000|NOT COMPLETED|Overall Study||0
10511225|NCT01292837|11661775|FG000|STARTED|Overall Study||13
10511226|NCT01292837|11661775|FG000|COMPLETED|Overall Study||11
10511227|NCT01292837|11661775|FG000|NOT COMPLETED|Overall Study||2
10511228|NCT01292876|11661779|FG000|STARTED|Overall Study||17
10511229|NCT01292876|11661779|FG000|COMPLETED|Overall Study||13
10511230|NCT01292876|11661779|FG000|NOT COMPLETED|Overall Study||4
10511231|NCT01292928|11661785|FG000|STARTED|Overall Study||299
10511232|NCT01292928|11661785|FG000|Completed 12-Month Clinical Follow-up|Overall Study||266
10511233|NCT01292928|11661785|FG000|COMPLETED|Overall Study||275
10511234|NCT01292928|11661785|FG000|NOT COMPLETED|Overall Study||24
10511235|NCT01293006|11661795|FG000|STARTED|Period 1||11
10511236|NCT01293006|11661796|FG001|STARTED|Period 1||2
10511237|NCT01293006|11661797|FG002|STARTED|Period 1||9
10511238|NCT01293006|11661798|FG003|STARTED|Period 1||3
10511239|NCT01293006|11661795|FG000|COMPLETED|Period 1||11
10511240|NCT01293006|11661796|FG001|COMPLETED|Period 1||2
10511241|NCT01293006|11661797|FG002|COMPLETED|Period 1||9
10511242|NCT01293006|11661798|FG003|COMPLETED|Period 1||3
10511243|NCT01293006|11661795|FG000|NOT COMPLETED|Period 1||0
10511244|NCT01293006|11661796|FG001|NOT COMPLETED|Period 1||0
10511245|NCT01293006|11661797|FG002|NOT COMPLETED|Period 1||0
10511246|NCT01293006|11661798|FG003|NOT COMPLETED|Period 1||0
10511247|NCT01293006|11661795|FG000|STARTED|Washout||11
10511248|NCT01293006|11661796|FG001|STARTED|Washout||2
10511249|NCT01293006|11661797|FG002|STARTED|Washout||9
10511250|NCT01293006|11661798|FG003|STARTED|Washout||3
10511251|NCT01293006|11661795|FG000|COMPLETED|Washout||11
10511252|NCT01293006|11661796|FG001|COMPLETED|Washout||2
10511253|NCT01293006|11661797|FG002|COMPLETED|Washout||9
10511254|NCT01293006|11661798|FG003|COMPLETED|Washout||3
10511255|NCT01293006|11661795|FG000|NOT COMPLETED|Washout||0
10511256|NCT01293006|11661796|FG001|NOT COMPLETED|Washout||0
10511257|NCT01293006|11661797|FG002|NOT COMPLETED|Washout||0
10511258|NCT01293006|11661798|FG003|NOT COMPLETED|Washout||0
10511259|NCT01293006|11661795|FG000|STARTED|Period 2||11
10511260|NCT01293006|11661796|FG001|STARTED|Period 2||2
10511261|NCT01293006|11661797|FG002|STARTED|Period 2||9
10511262|NCT01293006|11661798|FG003|STARTED|Period 2||3
10511263|NCT01293006|11661795|FG000|COMPLETED|Period 2||10
10511264|NCT01293006|11661796|FG001|COMPLETED|Period 2||2
10511265|NCT01293006|11661797|FG002|COMPLETED|Period 2||9
10511266|NCT01293006|11661798|FG003|COMPLETED|Period 2||3
10511267|NCT01293006|11661795|FG000|NOT COMPLETED|Period 2||1
10511268|NCT01293006|11661796|FG001|NOT COMPLETED|Period 2||0
10511269|NCT01293006|11661797|FG002|NOT COMPLETED|Period 2||0
10511270|NCT01293006|11661798|FG003|NOT COMPLETED|Period 2||0
10511271|NCT01293032|11661817|FG000|STARTED|Recurrence Score(RS)Assigned/Randomized||12
10511272|NCT01293032|11661818|FG001|STARTED|Recurrence Score(RS)Assigned/Randomized||17
10511273|NCT01293032|11661819|FG002|STARTED|Recurrence Score(RS)Assigned/Randomized||16
10511274|NCT01293032|11661820|FG003|STARTED|Recurrence Score(RS)Assigned/Randomized||14
10511275|NCT01293032|11661817|FG000|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||12
10511276|NCT01293032|11661818|FG001|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||17
10511277|NCT01293032|11661819|FG002|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||16
10511278|NCT01293032|11661820|FG003|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||14
10511279|NCT01293032|11661817|FG000|COMPLETED|Recurrence Score(RS)Assigned/Randomized||12
10511280|NCT01293032|11661818|FG001|COMPLETED|Recurrence Score(RS)Assigned/Randomized||17
10511281|NCT01293032|11661819|FG002|COMPLETED|Recurrence Score(RS)Assigned/Randomized|2/5 subjects who refused Arm 2(chemo) were treated with Arm 1(hormonal) and evaluable for response.|11
10511282|NCT01293032|11661820|FG003|COMPLETED|Recurrence Score(RS)Assigned/Randomized||14
10511283|NCT01293032|11661817|FG000|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
10511284|NCT01293032|11661818|FG001|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
10511285|NCT01293032|11661819|FG002|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||5
10511286|NCT01293032|11661820|FG003|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
10511287|NCT01293032|11661817|FG000|STARTED|Treatment||12
10511288|NCT01293032|11661818|FG001|STARTED|Treatment|2/5 subjects who refused Arm 2(chemo) were treated with Arm 1(hormonal) and evaluable for response.|19
10511289|NCT01293032|11661819|FG002|STARTED|Treatment||11
10511290|NCT01293032|11661820|FG003|STARTED|Treatment||14
10511291|NCT01293032|11661817|FG000|COMPLETED|Treatment||10
10511292|NCT01293032|11661818|FG001|COMPLETED|Treatment||14
10511293|NCT01293032|11661819|FG002|COMPLETED|Treatment||10
10511294|NCT01293032|11661820|FG003|COMPLETED|Treatment||13
10511295|NCT01293032|11661817|FG000|NOT COMPLETED|Treatment||2
10511296|NCT01293032|11661818|FG001|NOT COMPLETED|Treatment||5
10511297|NCT01293032|11661819|FG002|NOT COMPLETED|Treatment||1
10511298|NCT01293032|11661820|FG003|NOT COMPLETED|Treatment||1
10511299|NCT01293084|11661827|FG000|STARTED|Overall Study||17
10511300|NCT01293084|11661827|FG000|COMPLETED|Overall Study||12
10511301|NCT01293084|11661827|FG000|NOT COMPLETED|Overall Study||5
10511302|NCT01293240|11661833|FG000|STARTED|Overall Study||117
10511303|NCT01293240|11661833|FG000|COMPLETED|Overall Study||115
10511304|NCT01293240|11661833|FG000|NOT COMPLETED|Overall Study||2
10511305|NCT01293396|11661837|FG000|STARTED|First Intervention||6
10511306|NCT01293396|11661838|FG001|STARTED|First Intervention||7
10511307|NCT01293396|11661839|FG002|STARTED|First Intervention||7
10511308|NCT01293396|11661837|FG000|COMPLETED|First Intervention||6
10511309|NCT01293396|11661838|FG001|COMPLETED|First Intervention||7
10511310|NCT01293396|11661839|FG002|COMPLETED|First Intervention||7
10511311|NCT01293396|11661837|FG000|NOT COMPLETED|First Intervention||0
10511312|NCT01293396|11661838|FG001|NOT COMPLETED|First Intervention||0
10511313|NCT01293396|11661839|FG002|NOT COMPLETED|First Intervention||0
10511314|NCT01293396|11661837|FG000|STARTED|Wash Out Period 1 (3 Days)||6
10511315|NCT01293396|11661838|FG001|STARTED|Wash Out Period 1 (3 Days)||7
10511316|NCT01293396|11661839|FG002|STARTED|Wash Out Period 1 (3 Days)||7
10511317|NCT01293396|11661837|FG000|COMPLETED|Wash Out Period 1 (3 Days)||6
10511318|NCT01293396|11661838|FG001|COMPLETED|Wash Out Period 1 (3 Days)||7
10511319|NCT01293396|11661839|FG002|COMPLETED|Wash Out Period 1 (3 Days)||7
10511320|NCT01293396|11661837|FG000|NOT COMPLETED|Wash Out Period 1 (3 Days)||0
10511321|NCT01293396|11661838|FG001|NOT COMPLETED|Wash Out Period 1 (3 Days)||0
10511322|NCT01293396|11661839|FG002|NOT COMPLETED|Wash Out Period 1 (3 Days)||0
10511323|NCT01293396|11661837|FG000|STARTED|Second Intervention||5
10511324|NCT01293396|11661838|FG001|STARTED|Second Intervention||5
10511325|NCT01293396|11661839|FG002|STARTED|Second Intervention||10
10511326|NCT01293396|11661837|FG000|COMPLETED|Second Intervention||5
10511327|NCT01293396|11661838|FG001|COMPLETED|Second Intervention||5
10511328|NCT01293396|11661839|FG002|COMPLETED|Second Intervention||10
10511329|NCT01293396|11661837|FG000|NOT COMPLETED|Second Intervention||0
10511330|NCT01293396|11661838|FG001|NOT COMPLETED|Second Intervention||0
10511331|NCT01293396|11661839|FG002|NOT COMPLETED|Second Intervention||0
10511332|NCT01293396|11661837|FG000|STARTED|Wash Out Period 2 (3 Days)||5
10511333|NCT01293396|11661838|FG001|STARTED|Wash Out Period 2 (3 Days)||5
10511334|NCT01293396|11661839|FG002|STARTED|Wash Out Period 2 (3 Days)||10
10511335|NCT01293396|11661837|FG000|COMPLETED|Wash Out Period 2 (3 Days)||5
10511336|NCT01293396|11661838|FG001|COMPLETED|Wash Out Period 2 (3 Days)||5
10511337|NCT01293396|11661839|FG002|COMPLETED|Wash Out Period 2 (3 Days)||10
10511338|NCT01293396|11661837|FG000|NOT COMPLETED|Wash Out Period 2 (3 Days)||0
10511339|NCT01293396|11661838|FG001|NOT COMPLETED|Wash Out Period 2 (3 Days)||0
10511340|NCT01293396|11661839|FG002|NOT COMPLETED|Wash Out Period 2 (3 Days)||0
10511341|NCT01293396|11661837|FG000|STARTED|Third Intervention||9
10511342|NCT01293396|11661838|FG001|STARTED|Third Intervention||8
10511343|NCT01293396|11661839|FG002|STARTED|Third Intervention||3
10511344|NCT01293396|11661837|FG000|COMPLETED|Third Intervention||9
10511345|NCT01293396|11661838|FG001|COMPLETED|Third Intervention||8
10511346|NCT01293396|11661839|FG002|COMPLETED|Third Intervention||3
10511347|NCT01293396|11661837|FG000|NOT COMPLETED|Third Intervention||0
10511348|NCT01293396|11661838|FG001|NOT COMPLETED|Third Intervention||0
10511349|NCT01293396|11661839|FG002|NOT COMPLETED|Third Intervention||0
10511350|NCT01293539|11661847|FG000|STARTED|Overall Study||10
10511351|NCT01293539|11661847|FG000|COMPLETED|Overall Study||9
10511352|NCT01293539|11661847|FG000|NOT COMPLETED|Overall Study||1
10511353|NCT01293695|11661853|FG000|STARTED|Overall Study||93
10511354|NCT01293695|11661854|FG001|STARTED|Overall Study||94
10511355|NCT01293695|11661853|FG000|COMPLETED|Overall Study||78
10511356|NCT01293695|11661854|FG001|COMPLETED|Overall Study||87
10511357|NCT01293695|11661853|FG000|NOT COMPLETED|Overall Study||15
10511358|NCT01293695|11661854|FG001|NOT COMPLETED|Overall Study||7
10511359|NCT01293825|11661863|FG000|STARTED|Overall Study||30
10511360|NCT01293825|11661863|FG000|COMPLETED|Overall Study||20
10511361|NCT01293825|11661863|FG000|NOT COMPLETED|Overall Study||10
10511362|NCT01293968|11661869|FG000|STARTED|Overall Study||20
10511363|NCT01293968|11661870|FG001|STARTED|Overall Study||17
10511364|NCT01293968|11661869|FG000|COMPLETED|Overall Study||17
10511365|NCT01293968|11661870|FG001|COMPLETED|Overall Study||14
10511366|NCT01293968|11661869|FG000|NOT COMPLETED|Overall Study||3
10511367|NCT01293968|11661870|FG001|NOT COMPLETED|Overall Study||3
10511368|NCT01294098|11661879|FG000|STARTED|Overall Study||0
10511369|NCT01294098|11661880|FG001|STARTED|Overall Study||1
10511370|NCT01294098|11661881|FG002|STARTED|Overall Study||1
10511371|NCT01294098|11661879|FG000|COMPLETED|Overall Study||0
10511372|NCT01294098|11661880|FG001|COMPLETED|Overall Study||0
10511373|NCT01294098|11661881|FG002|COMPLETED|Overall Study||0
10511374|NCT01294098|11661879|FG000|NOT COMPLETED|Overall Study||0
10511375|NCT01294098|11661880|FG001|NOT COMPLETED|Overall Study||1
10511376|NCT01294098|11661881|FG002|NOT COMPLETED|Overall Study||1
10528364|NCT01394510|11680634|FG000|COMPLETED|Overall Study||13
10528365|NCT01394510|11680634|FG000|NOT COMPLETED|Overall Study||0
10528366|NCT01394523|11680641|FG000|STARTED|Overall Study||13
10528367|NCT01394523|11680642|FG001|STARTED|Overall Study||13
10528368|NCT01394523|11680643|FG002|STARTED|Overall Study||13
10528369|NCT01394523|11680641|FG000|COMPLETED|Overall Study||12
10528370|NCT01394523|11680642|FG001|COMPLETED|Overall Study||13
10528371|NCT01394523|11680643|FG002|COMPLETED|Overall Study||13
10528372|NCT01394523|11680641|FG000|NOT COMPLETED|Overall Study||1
10528373|NCT01394523|11680642|FG001|NOT COMPLETED|Overall Study||0
10528374|NCT01394523|11680643|FG002|NOT COMPLETED|Overall Study||0
10528375|NCT01394614|11680653|FG000|STARTED|Overall Study||8
10528376|NCT01394614|11680654|FG001|STARTED|Overall Study||16
10528377|NCT01394614|11680653|FG000|COMPLETED|Overall Study||8
10528378|NCT01394614|11680654|FG001|COMPLETED|Overall Study||16
10528379|NCT01394614|11680653|FG000|NOT COMPLETED|Overall Study||0
10528380|NCT01394614|11680654|FG001|NOT COMPLETED|Overall Study||0
10528381|NCT01394627|11680660|FG000|STARTED|First Intervention (1 Day)||8
10528382|NCT01394627|11680661|FG001|STARTED|First Intervention (1 Day)||13
10528383|NCT01394627|11680660|FG000|COMPLETED|First Intervention (1 Day)||8
10528384|NCT01394627|11680661|FG001|COMPLETED|First Intervention (1 Day)||12
10528385|NCT01394627|11680660|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10528386|NCT01394627|11680661|FG001|NOT COMPLETED|First Intervention (1 Day)||1
10528387|NCT01394627|11680660|FG000|STARTED|Washout (1-3 Months)||8
10528388|NCT01394627|11680661|FG001|STARTED|Washout (1-3 Months)||12
10528389|NCT01394627|11680660|FG000|COMPLETED|Washout (1-3 Months)||7
10528390|NCT01394627|11680661|FG001|COMPLETED|Washout (1-3 Months)||12
10528391|NCT01394627|11680660|FG000|NOT COMPLETED|Washout (1-3 Months)||1
10528392|NCT01394627|11680661|FG001|NOT COMPLETED|Washout (1-3 Months)||0
10528393|NCT01394627|11680660|FG000|STARTED|Second Intervention (1 Day)||7
10528394|NCT01394627|11680661|FG001|STARTED|Second Intervention (1 Day)||12
10528395|NCT01394627|11680660|FG000|COMPLETED|Second Intervention (1 Day)||7
10528396|NCT01394627|11680661|FG001|COMPLETED|Second Intervention (1 Day)||12
10528397|NCT01394627|11680660|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10528398|NCT01394627|11680661|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10528399|NCT01394692|11680669|FG000|STARTED|Overall Study||29
10528400|NCT01394692|11680670|FG001|STARTED|Overall Study||29
10528401|NCT01394692|11680669|FG000|COMPLETED|Overall Study||29
10528402|NCT01394692|11680670|FG001|COMPLETED|Overall Study||29
10528403|NCT01394692|11680669|FG000|NOT COMPLETED|Overall Study||0
10528404|NCT01394692|11680670|FG001|NOT COMPLETED|Overall Study||0
10528405|NCT01394705|11680678|FG000|STARTED|Overall Study||21
10528406|NCT01394705|11680679|FG001|STARTED|Overall Study||21
10528407|NCT01394705|11680678|FG000|COMPLETED|Overall Study||19
10528408|NCT01394705|11680679|FG001|COMPLETED|Overall Study||19
10528409|NCT01394705|11680678|FG000|NOT COMPLETED|Overall Study||2
10528410|NCT01394705|11680679|FG001|NOT COMPLETED|Overall Study||2
10528411|NCT01394718|11680688|FG000|STARTED|Overall Study||30
10528412|NCT01394718|11680689|FG001|STARTED|Overall Study||30
10528413|NCT01394718|11680688|FG000|COMPLETED|Overall Study||28
10528414|NCT01394718|11680689|FG001|COMPLETED|Overall Study||29
10528415|NCT01394718|11680688|FG000|NOT COMPLETED|Overall Study||2
10528416|NCT01394718|11680689|FG001|NOT COMPLETED|Overall Study||1
10528417|NCT01394939|11680699|FG000|STARTED|Overall Study||4
10528418|NCT01394939|11680700|FG001|STARTED|Overall Study||25
10528419|NCT01394939|11680701|FG002|STARTED|Overall Study||4
10528420|NCT01394939|11680702|FG003|STARTED|Overall Study||17
10528421|NCT01394939|11680699|FG000|COMPLETED|Overall Study||3
10528422|NCT01394939|11680700|FG001|COMPLETED|Overall Study||15
10528423|NCT01394939|11680701|FG002|COMPLETED|Overall Study||4
10528424|NCT01394939|11680702|FG003|COMPLETED|Overall Study||10
10528425|NCT01394939|11680699|FG000|NOT COMPLETED|Overall Study||1
10528426|NCT01394939|11680700|FG001|NOT COMPLETED|Overall Study||10
10511377|NCT01294150|11661891|FG000|STARTED|Overall Study||140
10511378|NCT01294150|11661892|FG001|STARTED|Overall Study||66
10511379|NCT01294150|11661891|FG000|COMPLETED|Overall Study||138
10511380|NCT01294150|11661892|FG001|COMPLETED|Overall Study||64
10511381|NCT01294150|11661891|FG000|NOT COMPLETED|Overall Study||2
10511382|NCT01294150|11661892|FG001|NOT COMPLETED|Overall Study||2
10511383|NCT01294163|11661903|FG000|STARTED|Overall Study||178
10511384|NCT01294163|11661904|FG001|STARTED|Overall Study||165
10511385|NCT01294163|11661905|FG002|STARTED|Overall Study||166
10511386|NCT01294163|11661903|FG000|COMPLETED|Overall Study||177
10511387|NCT01294163|11661904|FG001|COMPLETED|Overall Study||165
10511388|NCT01294163|11661905|FG002|COMPLETED|Overall Study||163
10511389|NCT01294163|11661903|FG000|NOT COMPLETED|Overall Study||1
10511390|NCT01294163|11661904|FG001|NOT COMPLETED|Overall Study||0
10511391|NCT01294163|11661905|FG002|NOT COMPLETED|Overall Study||3
10511392|NCT01294228|11661912|FG000|STARTED|Overall Study||1001
10511393|NCT01294228|11661912|FG000|COMPLETED|Overall Study||1001
10511394|NCT01294228|11661912|FG000|NOT COMPLETED|Overall Study||0
10511395|NCT01294241|11661916|FG000|STARTED|Overall Study||10
10511396|NCT01294241|11661916|FG000|COMPLETED|Overall Study||10
10511397|NCT01294241|11661916|FG000|NOT COMPLETED|Overall Study||0
10511398|NCT01294267|11661922|FG000|STARTED|Overall Study||20
10511399|NCT01294267|11661922|FG000|COMPLETED|Overall Study||20
10511400|NCT01294267|11661922|FG000|NOT COMPLETED|Overall Study||0
10511401|NCT01294306|11661928|FG000|STARTED|Overall Study||45
10511402|NCT01294306|11661929|FG001|STARTED|Overall Study||35
10511403|NCT01294306|11661928|FG000|COMPLETED|Overall Study||45
10511404|NCT01294306|11661929|FG001|COMPLETED|Overall Study||35
10511405|NCT01294306|11661928|FG000|NOT COMPLETED|Overall Study||0
10511406|NCT01294306|11661929|FG001|NOT COMPLETED|Overall Study||0
10511407|NCT01294319|11661943|FG000|STARTED|Overall Study||4
10511408|NCT01294319|11661944|FG001|STARTED|Overall Study||6
10511409|NCT01294319|11661945|FG002|STARTED|Overall Study||5
10511410|NCT01294319|11661946|FG003|STARTED|Overall Study||5
10511411|NCT01294319|11661947|FG004|STARTED|Overall Study||5
10511412|NCT01294319|11661948|FG005|STARTED|Overall Study||4
10511413|NCT01294319|11661949|FG006|STARTED|Overall Study||5
10511414|NCT01294319|11661950|FG007|STARTED|Overall Study||5
10511415|NCT01294319|11661943|FG000|COMPLETED|Overall Study||4
10511416|NCT01294319|11661944|FG001|COMPLETED|Overall Study||6
10511417|NCT01294319|11661945|FG002|COMPLETED|Overall Study||5
10511418|NCT01294319|11661946|FG003|COMPLETED|Overall Study||5
10511419|NCT01294319|11661947|FG004|COMPLETED|Overall Study||5
10511420|NCT01294319|11661948|FG005|COMPLETED|Overall Study||4
10511421|NCT01294319|11661949|FG006|COMPLETED|Overall Study||5
10511422|NCT01294319|11661950|FG007|COMPLETED|Overall Study||5
10511423|NCT01294319|11661943|FG000|NOT COMPLETED|Overall Study||0
10511424|NCT01294319|11661944|FG001|NOT COMPLETED|Overall Study||0
10511425|NCT01294319|11661945|FG002|NOT COMPLETED|Overall Study||0
10511426|NCT01294319|11661946|FG003|NOT COMPLETED|Overall Study||0
10511427|NCT01294319|11661947|FG004|NOT COMPLETED|Overall Study||0
10511428|NCT01294319|11661948|FG005|NOT COMPLETED|Overall Study||0
10511429|NCT01294319|11661949|FG006|NOT COMPLETED|Overall Study||0
10511430|NCT01294319|11661950|FG007|NOT COMPLETED|Overall Study||0
10511431|NCT01294358|11661957|FG000|STARTED|Cohort 1: 5/11/11-11/9/11||4
10511432|NCT01294358|11661958|FG001|STARTED|Cohort 1: 5/11/11-11/9/11||0
10711272|NCT02658630|11876722|FG000|COMPLETED|Overall Study||42
10711273|NCT02658630|11876722|FG000|NOT COMPLETED|Overall Study||4
10711274|NCT02658734|11876726|FG000|STARTED|Overall Study||70
10711275|NCT02658734|11876726|FG000|COMPLETED|Overall Study||13
10511433|NCT01294358|11661959|FG002|STARTED|Cohort 1: 5/11/11-11/9/11||0
10511434|NCT01294358|11661960|FG003|STARTED|Cohort 1: 5/11/11-11/9/11||0
10511435|NCT01294358|11661961|FG004|STARTED|Cohort 1: 5/11/11-11/9/11||0
10511436|NCT01294358|11661957|FG000|COMPLETED|Cohort 1: 5/11/11-11/9/11||4
10511437|NCT01294358|11661958|FG001|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
10511438|NCT01294358|11661959|FG002|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
10511439|NCT01294358|11661960|FG003|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
10511440|NCT01294358|11661961|FG004|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
10511441|NCT01294358|11661957|FG000|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
10511442|NCT01294358|11661958|FG001|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
10511443|NCT01294358|11661959|FG002|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
10511444|NCT01294358|11661960|FG003|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
10511445|NCT01294358|11661961|FG004|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
10511446|NCT01294358|11661957|FG000|STARTED|Cohort 2: 6/9/11-9/17/12||0
10511447|NCT01294358|11661958|FG001|STARTED|Cohort 2: 6/9/11-9/17/12|4 participants from 18mg move to 36mg and 2 additional participants were enrolled at this dose.|6
10511448|NCT01294358|11661959|FG002|STARTED|Cohort 2: 6/9/11-9/17/12||0
10511449|NCT01294358|11661960|FG003|STARTED|Cohort 2: 6/9/11-9/17/12||0
10511450|NCT01294358|11661961|FG004|STARTED|Cohort 2: 6/9/11-9/17/12||0
10511451|NCT01294358|11661957|FG000|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
10511452|NCT01294358|11661958|FG001|COMPLETED|Cohort 2: 6/9/11-9/17/12||4
10511453|NCT01294358|11661959|FG002|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
10511454|NCT01294358|11661960|FG003|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
10511455|NCT01294358|11661961|FG004|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
10511456|NCT01294358|11661957|FG000|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
10511457|NCT01294358|11661958|FG001|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||2
10711276|NCT02658734|11876726|FG000|NOT COMPLETED|Overall Study||57
10711277|NCT02658851|11876730|FG000|STARTED|Overall Study||100
10511458|NCT01294358|11661959|FG002|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
10711278|NCT02658851|11876730|FG000|COMPLETED|Overall Study||100
10511459|NCT01294358|11661960|FG003|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
10511460|NCT01294358|11661961|FG004|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
10511461|NCT01294358|11661957|FG000|STARTED|Cohort 3: 12/1/11-10/6/12||0
10511462|NCT01294358|11661958|FG001|STARTED|Cohort 3: 12/1/11-10/6/12||0
10511463|NCT01294358|11661959|FG002|STARTED|Cohort 3: 12/1/11-10/6/12|4 participants from 36mg move to 72mg.|4
10511464|NCT01294358|11661960|FG003|STARTED|Cohort 3: 12/1/11-10/6/12||0
10511465|NCT01294358|11661961|FG004|STARTED|Cohort 3: 12/1/11-10/6/12||0
10511466|NCT01294358|11661957|FG000|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
10511467|NCT01294358|11661958|FG001|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
10511468|NCT01294358|11661959|FG002|COMPLETED|Cohort 3: 12/1/11-10/6/12||2
10511469|NCT01294358|11661960|FG003|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
10511470|NCT01294358|11661961|FG004|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
10511471|NCT01294358|11661957|FG000|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
10511472|NCT01294358|11661958|FG001|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
10511473|NCT01294358|11661959|FG002|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||2
10511474|NCT01294358|11661960|FG003|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
10511475|NCT01294358|11661961|FG004|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
10511476|NCT01294358|11661957|FG000|STARTED|Cohort 4: 12/30/11-2/17/17||0
10511477|NCT01294358|11661958|FG001|STARTED|Cohort 4: 12/30/11-2/17/17||0
10511478|NCT01294358|11661959|FG002|STARTED|Cohort 4: 12/30/11-2/17/17||0
10511479|NCT01294358|11661960|FG003|STARTED|Cohort 4: 12/30/11-2/17/17|2 participants from 72mg move to 96mg.|2
10511480|NCT01294358|11661961|FG004|STARTED|Cohort 4: 12/30/11-2/17/17||0
10511481|NCT01294358|11661957|FG000|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
10511482|NCT01294358|11661958|FG001|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
10511483|NCT01294358|11661959|FG002|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
10511484|NCT01294358|11661960|FG003|COMPLETED|Cohort 4: 12/30/11-2/17/17||1
10511485|NCT01294358|11661961|FG004|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
10511486|NCT01294358|11661957|FG000|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
10511487|NCT01294358|11661958|FG001|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
10511488|NCT01294358|11661959|FG002|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
10511489|NCT01294358|11661960|FG003|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||1
10511490|NCT01294358|11661961|FG004|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
10511491|NCT01294358|11661957|FG000|STARTED|Cohort 5: 3/8/12-3/9/12||0
10511492|NCT01294358|11661958|FG001|STARTED|Cohort 5: 3/8/12-3/9/12||0
10511493|NCT01294358|11661959|FG002|STARTED|Cohort 5: 3/8/12-3/9/12||0
10511494|NCT01294358|11661960|FG003|STARTED|Cohort 5: 3/8/12-3/9/12||0
10511495|NCT01294358|11661961|FG004|STARTED|Cohort 5: 3/8/12-3/9/12|1 participant from 96mg move to 115mg.|1
10511496|NCT01294358|11661957|FG000|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
10511497|NCT01294358|11661958|FG001|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
10511498|NCT01294358|11661959|FG002|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
10511499|NCT01294358|11661960|FG003|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
10511500|NCT01294358|11661961|FG004|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
10511501|NCT01294358|11661957|FG000|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
10511502|NCT01294358|11661958|FG001|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
10511503|NCT01294358|11661959|FG002|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
10511504|NCT01294358|11661960|FG003|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
10511505|NCT01294358|11661961|FG004|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||1
10511506|NCT01294371|11661978|FG000|STARTED|Overall Study||391
10511507|NCT01294371|11661978|FG000|Treated|Overall Study||390
10511508|NCT01294371|11661978|FG000|COMPLETED|Overall Study||357
10511509|NCT01294371|11661978|FG000|NOT COMPLETED|Overall Study||34
10511510|NCT01294384|11661988|FG000|STARTED|Overall Study||101
10511511|NCT01294384|11661989|FG001|STARTED|Overall Study||100
10511512|NCT01294384|11661990|FG002|STARTED|Overall Study||104
10511513|NCT01294384|11661988|FG000|COMPLETED|Overall Study||97
10511514|NCT01294384|11661989|FG001|COMPLETED|Overall Study||94
10511515|NCT01294384|11661990|FG002|COMPLETED|Overall Study||95
10511516|NCT01294384|11661988|FG000|NOT COMPLETED|Overall Study||4
10511517|NCT01294384|11661989|FG001|NOT COMPLETED|Overall Study||6
10511518|NCT01294384|11661990|FG002|NOT COMPLETED|Overall Study||9
10511519|NCT01294397|11661998|FG000|STARTED|Overall Study||19
10511520|NCT01294397|11661998|FG000|COMPLETED|Overall Study||17
10511521|NCT01294397|11661998|FG000|NOT COMPLETED|Overall Study||2
10511522|NCT01294423|11662007|FG000|STARTED|Overall Study||86
10511523|NCT01294423|11662008|FG001|STARTED|Overall Study||88
10511524|NCT01294423|11662009|FG002|STARTED|Overall Study||87
10511525|NCT01294423|11662007|FG000|COMPLETED|Overall Study||81
10511526|NCT01294423|11662008|FG001|COMPLETED|Overall Study||79
10511527|NCT01294423|11662009|FG002|COMPLETED|Overall Study||79
10511528|NCT01294423|11662007|FG000|NOT COMPLETED|Overall Study||5
10511529|NCT01294423|11662008|FG001|NOT COMPLETED|Overall Study||9
10511530|NCT01294423|11662009|FG002|NOT COMPLETED|Overall Study||8
10511531|NCT01294436|11662019|FG000|STARTED|Overall Study||249
10511532|NCT01294436|11662020|FG001|STARTED|Overall Study||479
10511533|NCT01294436|11662019|FG000|COMPLETED|Overall Study||221
10650430|NCT02169453|11810714|FG000|100 mg BIA 9-1067|Overall Study||3
10511534|NCT01294436|11662020|FG001|COMPLETED|Overall Study||409
10511535|NCT01294436|11662019|FG000|NOT COMPLETED|Overall Study||28
10511536|NCT01294436|11662020|FG001|NOT COMPLETED|Overall Study||70
10511537|NCT01294449|11662028|FG000|STARTED|Overall Study||156
10511538|NCT01294449|11662029|FG001|STARTED|Overall Study||252
10511539|NCT01294449|11662028|FG000|Consent to Registry|Overall Study||149
10511540|NCT01294449|11662029|FG001|Consent to Registry|Overall Study||245
10511541|NCT01294449|11662028|FG000|COMPLETED|Overall Study||144
10511542|NCT01294449|11662029|FG001|COMPLETED|Overall Study||237
10511543|NCT01294449|11662028|FG000|NOT COMPLETED|Overall Study||12
10511544|NCT01294449|11662029|FG001|NOT COMPLETED|Overall Study||15
10511545|NCT01294462|11662037|FG000|STARTED|Overall Study||401
10511546|NCT01294462|11662038|FG001|STARTED|Overall Study||400
10511547|NCT01294462|11662037|FG000|Received Randomized Treatment|Overall Study||387
10511548|NCT01294462|11662038|FG001|Received Randomized Treatment|Overall Study||380
10511549|NCT01294462|11662037|FG000|COMPLETED|Overall Study||335
10511550|NCT01294462|11662038|FG001|COMPLETED|Overall Study||337
10511551|NCT01294462|11662037|FG000|NOT COMPLETED|Overall Study||66
10511552|NCT01294462|11662038|FG001|NOT COMPLETED|Overall Study||63
10511553|NCT01294514|11662044|FG000|STARTED|Overall Study||27
10511554|NCT01294514|11662044|FG000|COMPLETED|Overall Study||26
10511555|NCT01294514|11662044|FG000|NOT COMPLETED|Overall Study||1
10511556|NCT01294553|11662052|FG000|STARTED|Overall Study||982
10511557|NCT01294553|11662052|FG000|COMPLETED|Overall Study||713
10511558|NCT01294553|11662052|FG000|NOT COMPLETED|Overall Study||269
10511559|NCT01294579|11662057|FG000|STARTED|Overall Study||49
10511560|NCT01294579|11662057|FG000|COMPLETED|Overall Study||14
10511561|NCT01294579|11662057|FG000|NOT COMPLETED|Overall Study||35
10511562|NCT01294592|11662063|FG000|STARTED|Overall Study||369
10511563|NCT01294592|11662064|FG001|STARTED|Overall Study||373
10511564|NCT01294592|11662063|FG000|COMPLETED|Overall Study||292
10511565|NCT01294592|11662064|FG001|COMPLETED|Overall Study||300
10711279|NCT02658851|11876730|FG000|NOT COMPLETED|Overall Study||0
10711280|NCT02658994|11876737|FG000|STARTED|Enrollment||287
10511566|NCT01294592|11662063|FG000|NOT COMPLETED|Overall Study||77
10511567|NCT01294592|11662064|FG001|NOT COMPLETED|Overall Study||73
10511568|NCT01294644|11662076|FG000|STARTED|Overall Study||121
10511569|NCT01294644|11662077|FG001|STARTED|Overall Study||122
10511570|NCT01294644|11662078|FG002|STARTED|Overall Study||117
10511571|NCT01294644|11662076|FG000|Received Treatment|Overall Study||118
10511572|NCT01294644|11662077|FG001|Received Treatment|Overall Study||122
10511573|NCT01294644|11662078|FG002|Received Treatment|Overall Study||114
10511574|NCT01294644|11662076|FG000|COMPLETED|Overall Study||111
10511575|NCT01294644|11662077|FG001|COMPLETED|Overall Study||112
10711281|NCT02658994|11876738|FG001|STARTED|Enrollment||283
10711282|NCT02658994|11876739|FG002|STARTED|Enrollment||584
10511576|NCT01294644|11662078|FG002|COMPLETED|Overall Study||103
10511577|NCT01294644|11662076|FG000|NOT COMPLETED|Overall Study||10
10511578|NCT01294644|11662077|FG001|NOT COMPLETED|Overall Study||10
10511579|NCT01294644|11662078|FG002|NOT COMPLETED|Overall Study||14
10711283|NCT02658994|11876737|FG000|COMPLETED|Enrollment||287
10711284|NCT02658994|11876738|FG001|COMPLETED|Enrollment||283
10711285|NCT02658994|11876739|FG002|COMPLETED|Enrollment||584
10711286|NCT02658994|11876737|FG000|NOT COMPLETED|Enrollment||0
10711287|NCT02658994|11876738|FG001|NOT COMPLETED|Enrollment||0
10511580|NCT01294683|11662088|FG000|STARTED|Precrossover (Periods I/II)||489
10511581|NCT01294683|11662089|FG001|STARTED|Precrossover (Periods I/II)||488
10511582|NCT01294683|11662088|FG000|Treated|Precrossover (Periods I/II)||486
10511583|NCT01294683|11662089|FG001|Treated|Precrossover (Periods I/II)||486
10511584|NCT01294683|11662088|FG000|COMPLETED|Precrossover (Periods I/II)||232
10511585|NCT01294683|11662089|FG001|COMPLETED|Precrossover (Periods I/II)||222
10511586|NCT01294683|11662088|FG000|NOT COMPLETED|Precrossover (Periods I/II)||257
10511587|NCT01294683|11662089|FG001|NOT COMPLETED|Precrossover (Periods I/II)||266
10511588|NCT01294683|11662088|FG000|STARTED|Post Crossover (Period III)||232
10511589|NCT01294683|11662089|FG001|STARTED|Post Crossover (Period III)||222
10511590|NCT01294683|11662088|FG000|COMPLETED|Post Crossover (Period III)||199
10511591|NCT01294683|11662089|FG001|COMPLETED|Post Crossover (Period III)||190
10511592|NCT01294683|11662088|FG000|NOT COMPLETED|Post Crossover (Period III)||33
10511593|NCT01294683|11662089|FG001|NOT COMPLETED|Post Crossover (Period III)||32
10511594|NCT01294709|11662101|FG000|STARTED|Period 1||31
10511595|NCT01294709|11662102|FG001|STARTED|Period 1||33
10511596|NCT01294709|11662101|FG000|COMPLETED|Period 1||30
10511597|NCT01294709|11662102|FG001|COMPLETED|Period 1||32
10511598|NCT01294709|11662101|FG000|NOT COMPLETED|Period 1||1
10511599|NCT01294709|11662102|FG001|NOT COMPLETED|Period 1||1
10511600|NCT01294709|11662101|FG000|STARTED|Washout Period||30
10511601|NCT01294709|11662102|FG001|STARTED|Washout Period||32
10511602|NCT01294709|11662101|FG000|COMPLETED|Washout Period||29
10511603|NCT01294709|11662102|FG001|COMPLETED|Washout Period||31
10511604|NCT01294709|11662101|FG000|NOT COMPLETED|Washout Period||1
10511605|NCT01294709|11662102|FG001|NOT COMPLETED|Washout Period||1
10711288|NCT02658994|11876739|FG002|NOT COMPLETED|Enrollment||0
10511606|NCT01294709|11662101|FG000|STARTED|Period 2||29
10511607|NCT01294709|11662102|FG001|STARTED|Period 2||31
10711289|NCT02658994|11876737|FG000|STARTED|3 Month Follow up||287
10711290|NCT02658994|11876738|FG001|STARTED|3 Month Follow up||283
10511608|NCT01294709|11662101|FG000|COMPLETED|Period 2||28
10511609|NCT01294709|11662102|FG001|COMPLETED|Period 2||31
10511610|NCT01294709|11662101|FG000|NOT COMPLETED|Period 2||1
10511611|NCT01294709|11662102|FG001|NOT COMPLETED|Period 2||0
10511612|NCT01294748|11662115|FG000|STARTED|Overall Study||123
10511613|NCT01294748|11662116|FG001|STARTED|Overall Study||61
10511614|NCT01294748|11662115|FG000|COMPLETED|Overall Study|At 270 days|118
10511615|NCT01294748|11662116|FG001|COMPLETED|Overall Study|At 270 days|59
10711291|NCT02658994|11876739|FG002|STARTED|3 Month Follow up||584
10711292|NCT02658994|11876737|FG000|COMPLETED|3 Month Follow up||221
10511616|NCT01294748|11662115|FG000|NOT COMPLETED|Overall Study||5
10511617|NCT01294748|11662116|FG001|NOT COMPLETED|Overall Study||2
10511618|NCT01294787|11662122|FG000|STARTED|Period 1||12
10511619|NCT01294787|11662123|FG001|STARTED|Period 1||16
10511620|NCT01294787|11662124|FG002|STARTED|Period 1||14
10511621|NCT01294787|11662125|FG003|STARTED|Period 1||12
10511622|NCT01294787|11662126|FG004|STARTED|Period 1||16
10511623|NCT01294787|11662127|FG005|STARTED|Period 1|One randomized participant did not receive study drug|15
10511624|NCT01294787|11662122|FG000|COMPLETED|Period 1||12
10511625|NCT01294787|11662123|FG001|COMPLETED|Period 1||16
10511626|NCT01294787|11662124|FG002|COMPLETED|Period 1||13
10511627|NCT01294787|11662125|FG003|COMPLETED|Period 1||11
10511628|NCT01294787|11662126|FG004|COMPLETED|Period 1||14
10711293|NCT02658994|11876738|FG001|COMPLETED|3 Month Follow up||223
10711294|NCT02658994|11876739|FG002|COMPLETED|3 Month Follow up||451
10711295|NCT02658994|11876737|FG000|NOT COMPLETED|3 Month Follow up||66
10511629|NCT01294787|11662127|FG005|COMPLETED|Period 1||13
10511630|NCT01294787|11662122|FG000|NOT COMPLETED|Period 1||0
10511631|NCT01294787|11662123|FG001|NOT COMPLETED|Period 1||0
10511632|NCT01294787|11662124|FG002|NOT COMPLETED|Period 1||1
10511633|NCT01294787|11662125|FG003|NOT COMPLETED|Period 1||1
10511634|NCT01294787|11662126|FG004|NOT COMPLETED|Period 1||2
10511635|NCT01294787|11662127|FG005|NOT COMPLETED|Period 1||2
10511636|NCT01294787|11662122|FG000|STARTED|Period 2||12
10511637|NCT01294787|11662123|FG001|STARTED|Period 2||16
10511638|NCT01294787|11662124|FG002|STARTED|Period 2||13
10511639|NCT01294787|11662125|FG003|STARTED|Period 2||11
10511640|NCT01294787|11662126|FG004|STARTED|Period 2||14
10511641|NCT01294787|11662127|FG005|STARTED|Period 2||13
10511642|NCT01294787|11662122|FG000|COMPLETED|Period 2||12
10511643|NCT01294787|11662123|FG001|COMPLETED|Period 2||13
10711296|NCT02658994|11876738|FG001|NOT COMPLETED|3 Month Follow up||60
10711297|NCT02658994|11876739|FG002|NOT COMPLETED|3 Month Follow up||133
10511644|NCT01294787|11662124|FG002|COMPLETED|Period 2||13
10511645|NCT01294787|11662125|FG003|COMPLETED|Period 2||9
10511646|NCT01294787|11662126|FG004|COMPLETED|Period 2||14
10511647|NCT01294787|11662127|FG005|COMPLETED|Period 2||13
10511648|NCT01294787|11662122|FG000|NOT COMPLETED|Period 2||0
10511649|NCT01294787|11662123|FG001|NOT COMPLETED|Period 2||3
10511650|NCT01294787|11662124|FG002|NOT COMPLETED|Period 2||0
10511651|NCT01294787|11662125|FG003|NOT COMPLETED|Period 2||2
10511652|NCT01294787|11662126|FG004|NOT COMPLETED|Period 2||0
10511653|NCT01294787|11662127|FG005|NOT COMPLETED|Period 2||0
10511654|NCT01294787|11662122|FG000|STARTED|Period 3||12
10511655|NCT01294787|11662123|FG001|STARTED|Period 3||13
10511656|NCT01294787|11662124|FG002|STARTED|Period 3||13
10511657|NCT01294787|11662125|FG003|STARTED|Period 3||9
10511658|NCT01294787|11662126|FG004|STARTED|Period 3||14
10511659|NCT01294787|11662127|FG005|STARTED|Period 3||13
10511660|NCT01294787|11662122|FG000|COMPLETED|Period 3||12
10511661|NCT01294787|11662123|FG001|COMPLETED|Period 3||13
10511662|NCT01294787|11662124|FG002|COMPLETED|Period 3||13
10511663|NCT01294787|11662125|FG003|COMPLETED|Period 3||9
10511664|NCT01294787|11662126|FG004|COMPLETED|Period 3||13
10511665|NCT01294787|11662127|FG005|COMPLETED|Period 3||13
10511666|NCT01294787|11662122|FG000|NOT COMPLETED|Period 3||0
10511667|NCT01294787|11662123|FG001|NOT COMPLETED|Period 3||0
10511668|NCT01294787|11662124|FG002|NOT COMPLETED|Period 3||0
10511669|NCT01294787|11662125|FG003|NOT COMPLETED|Period 3||0
10511670|NCT01294787|11662126|FG004|NOT COMPLETED|Period 3||1
10511671|NCT01294787|11662127|FG005|NOT COMPLETED|Period 3||0
10511672|NCT01294800|11662142|FG000|STARTED|Overall Study||111
10511673|NCT01294800|11662143|FG001|STARTED|Overall Study||113
10511674|NCT01294800|11662144|FG002|STARTED|Overall Study||113
10511675|NCT01294800|11662145|FG003|STARTED|Overall Study||113
10511676|NCT01294800|11662142|FG000|COMPLETED|Overall Study||100
10511677|NCT01294800|11662143|FG001|COMPLETED|Overall Study||103
10511678|NCT01294800|11662144|FG002|COMPLETED|Overall Study||96
10711298|NCT02658994|11876737|FG000|STARTED|6 Month Follow up|Participants who did not complete 3 month follow up were still eligible for 6 month follow up|287
10713843|NCT02682784|11879379|FG002|COMPLETED|Overall Study||27
10511679|NCT01294800|11662145|FG003|COMPLETED|Overall Study||97
10511680|NCT01294800|11662142|FG000|NOT COMPLETED|Overall Study||11
10511681|NCT01294800|11662143|FG001|NOT COMPLETED|Overall Study||10
10511682|NCT01294800|11662144|FG002|NOT COMPLETED|Overall Study||17
10511683|NCT01294800|11662145|FG003|NOT COMPLETED|Overall Study||16
10511684|NCT01294917|11662155|FG000|STARTED|Overall Study||42
10511685|NCT01294917|11662155|FG000|Received Investigational MPS|Overall Study||36
10511686|NCT01294917|11662155|FG000|Received Clear Care|Overall Study||36
10511687|NCT01294917|11662155|FG000|Received OptiFree RepleniSH MPS|Overall Study||36
10511688|NCT01294917|11662155|FG000|COMPLETED|Overall Study||36
10511689|NCT01294917|11662155|FG000|NOT COMPLETED|Overall Study||6
10511690|NCT01295034|11662163|FG000|STARTED|Overall Study||32
10511691|NCT01295034|11662164|FG001|STARTED|Overall Study||30
10511692|NCT01295034|11662163|FG000|COMPLETED|Overall Study||27
10511693|NCT01295034|11662164|FG001|COMPLETED|Overall Study||25
10511694|NCT01295034|11662163|FG000|NOT COMPLETED|Overall Study||5
10511695|NCT01295034|11662164|FG001|NOT COMPLETED|Overall Study||5
10511696|NCT01295112|11662173|FG000|STARTED|Overall Study||35
10511697|NCT01295112|11662174|FG001|STARTED|Overall Study||33
10511698|NCT01295112|11662173|FG000|COMPLETED|Overall Study||35
10511699|NCT01295112|11662174|FG001|COMPLETED|Overall Study||33
10511700|NCT01295112|11662173|FG000|NOT COMPLETED|Overall Study||0
10511701|NCT01295112|11662174|FG001|NOT COMPLETED|Overall Study||0
10511702|NCT01295216|11662182|FG000|STARTED|Overall Study||316
10511703|NCT01295216|11662183|FG001|STARTED|Overall Study||321
10511704|NCT01295216|11662182|FG000|COMPLETED|Overall Study||266
10511705|NCT01295216|11662183|FG001|COMPLETED|Overall Study||287
10511706|NCT01295216|11662182|FG000|NOT COMPLETED|Overall Study||50
10511707|NCT01295216|11662183|FG001|NOT COMPLETED|Overall Study||34
10511708|NCT01295281|11662191|FG000|STARTED|First Intervention (7 Days)||53
10511709|NCT01295281|11662192|FG001|STARTED|First Intervention (7 Days)||52
10511710|NCT01295281|11662191|FG000|COMPLETED|First Intervention (7 Days)||53
10511711|NCT01295281|11662192|FG001|COMPLETED|First Intervention (7 Days)||51
10511712|NCT01295281|11662191|FG000|NOT COMPLETED|First Intervention (7 Days)||0
10511713|NCT01295281|11662192|FG001|NOT COMPLETED|First Intervention (7 Days)||1
10511714|NCT01295281|11662191|FG000|STARTED|Second Intervention (7days)||53
10511715|NCT01295281|11662192|FG001|STARTED|Second Intervention (7days)||51
10511716|NCT01295281|11662191|FG000|COMPLETED|Second Intervention (7days)||53
10511717|NCT01295281|11662192|FG001|COMPLETED|Second Intervention (7days)||51
10511718|NCT01295281|11662191|FG000|NOT COMPLETED|Second Intervention (7days)||0
10511719|NCT01295281|11662192|FG001|NOT COMPLETED|Second Intervention (7days)||0
10511720|NCT01295320|11662198|FG000|STARTED|Overall Study||129
10511721|NCT01295320|11662198|FG000|COMPLETED|Overall Study||119
10511722|NCT01295320|11662198|FG000|NOT COMPLETED|Overall Study||10
10511723|NCT01295515|11662202|FG000|STARTED|Overall Study||7
10511724|NCT01295515|11662202|FG000|COMPLETED|Overall Study||7
10511725|NCT01295515|11662202|FG000|NOT COMPLETED|Overall Study||0
10511726|NCT01295580|11662208|FG000|STARTED|Overall Study||174
10511727|NCT01295580|11662209|FG001|STARTED|Overall Study||175
10511728|NCT01295580|11662208|FG000|COMPLETED|Overall Study||164
10511729|NCT01295580|11662209|FG001|COMPLETED|Overall Study||167
10511730|NCT01295580|11662208|FG000|NOT COMPLETED|Overall Study||10
10511731|NCT01295580|11662209|FG001|NOT COMPLETED|Overall Study||8
10511732|NCT01295671|11662218|FG000|STARTED|Overall Study||67
10511733|NCT01295671|11662219|FG001|STARTED|Overall Study||67
10511734|NCT01295671|11662220|FG002|STARTED|Overall Study||69
10511735|NCT01295671|11662218|FG000|COMPLETED|Overall Study||60
10511736|NCT01295671|11662219|FG001|COMPLETED|Overall Study||60
10511737|NCT01295671|11662220|FG002|COMPLETED|Overall Study||66
10511738|NCT01295671|11662218|FG000|NOT COMPLETED|Overall Study||7
10511739|NCT01295671|11662219|FG001|NOT COMPLETED|Overall Study||7
10511740|NCT01295671|11662220|FG002|NOT COMPLETED|Overall Study||3
10511741|NCT01295710|11662230|FG000|STARTED|Overall Study|Randomized and treated|126
10511742|NCT01295710|11662231|FG001|STARTED|Overall Study|Randomized and treated|128
10511743|NCT01295710|11662230|FG000|COMPLETED|Overall Study||48
10511744|NCT01295710|11662231|FG001|COMPLETED|Overall Study||78
10511745|NCT01295710|11662230|FG000|NOT COMPLETED|Overall Study||78
10511746|NCT01295710|11662231|FG001|NOT COMPLETED|Overall Study||50
10511747|NCT01295814|11662239|FG000|STARTED|Overall Study||22
10511748|NCT01295814|11662240|FG001|STARTED|Overall Study||21
10511749|NCT01295814|11662239|FG000|COMPLETED|Overall Study||20
10511750|NCT01295814|11662240|FG001|COMPLETED|Overall Study||19
10511751|NCT01295814|11662239|FG000|NOT COMPLETED|Overall Study||2
10511752|NCT01295814|11662240|FG001|NOT COMPLETED|Overall Study||2
10511753|NCT01295827|11662258|FG000|STARTED|Overall Study||4
10511754|NCT01295827|11662259|FG001|STARTED|Overall Study||3
10511755|NCT01295827|11662260|FG002|STARTED|Overall Study||12
10511756|NCT01295827|11662261|FG003|STARTED|Overall Study||4
10511757|NCT01295827|11662262|FG004|STARTED|Overall Study||3
10511758|NCT01295827|11662263|FG005|STARTED|Overall Study||6
10511759|NCT01295827|11662264|FG006|STARTED|Overall Study||164
10511760|NCT01295827|11662265|FG007|STARTED|Overall Study||321
10511761|NCT01295827|11662266|FG008|STARTED|Overall Study||183
10511762|NCT01295827|11662267|FG009|STARTED|Overall Study||61
10511763|NCT01295827|11662268|FG010|STARTED|Overall Study||296
10511764|NCT01295827|11662269|FG011|STARTED|Overall Study||203
10511765|NCT01295827|11662270|FG012|STARTED|Overall Study||0
10511766|NCT01295827|11662271|FG013|STARTED|Overall Study||0
10511767|NCT01295827|11662272|FG014|STARTED|Overall Study||0
10511768|NCT01295827|11662258|FG000|Treated (All Treated Population)|Overall Study||4
10511769|NCT01295827|11662259|FG001|Treated (All Treated Population)|Overall Study||3
10511770|NCT01295827|11662260|FG002|Treated (All Treated Population)|Overall Study||10
10511771|NCT01295827|11662261|FG003|Treated (All Treated Population)|Overall Study||4
10511772|NCT01295827|11662262|FG004|Treated (All Treated Population)|Overall Study||3
10511773|NCT01295827|11662263|FG005|Treated (All Treated Population)|Overall Study||6
10511774|NCT01295827|11662264|FG006|Treated (All Treated Population)|Overall Study||162
10511775|NCT01295827|11662265|FG007|Treated (All Treated Population)|Overall Study||313
10511776|NCT01295827|11662266|FG008|Treated (All Treated Population)|Overall Study||180
10511777|NCT01295827|11662267|FG009|Treated (All Treated Population)|Overall Study||61
10511778|NCT01295827|11662268|FG010|Treated (All Treated Population)|Overall Study||287
10511779|NCT01295827|11662269|FG011|Treated (All Treated Population)|Overall Study||202
10511780|NCT01295827|11662270|FG012|Treated (All Treated Population)|Overall Study||0
10511781|NCT01295827|11662271|FG013|Treated (All Treated Population)|Overall Study||0
10511782|NCT01295827|11662272|FG014|Treated (All Treated Population)|Overall Study||0
10511783|NCT01295827|11662258|FG000|COMPLETED|Overall Study||0
10511784|NCT01295827|11662259|FG001|COMPLETED|Overall Study||0
10511785|NCT01295827|11662260|FG002|COMPLETED|Overall Study||0
10511786|NCT01295827|11662261|FG003|COMPLETED|Overall Study||0
10511787|NCT01295827|11662262|FG004|COMPLETED|Overall Study||1
10511788|NCT01295827|11662263|FG005|COMPLETED|Overall Study||0
10511789|NCT01295827|11662264|FG006|COMPLETED|Overall Study||18
10511790|NCT01295827|11662265|FG007|COMPLETED|Overall Study||24
10511791|NCT01295827|11662266|FG008|COMPLETED|Overall Study||14
10511792|NCT01295827|11662267|FG009|COMPLETED|Overall Study||6
10511793|NCT01295827|11662268|FG010|COMPLETED|Overall Study||20
10511794|NCT01295827|11662269|FG011|COMPLETED|Overall Study||17
10511795|NCT01295827|11662270|FG012|COMPLETED|Overall Study||0
10511796|NCT01295827|11662271|FG013|COMPLETED|Overall Study||0
10511797|NCT01295827|11662272|FG014|COMPLETED|Overall Study||0
10511798|NCT01295827|11662258|FG000|NOT COMPLETED|Overall Study||4
10511799|NCT01295827|11662259|FG001|NOT COMPLETED|Overall Study||3
10511800|NCT01295827|11662260|FG002|NOT COMPLETED|Overall Study||12
10511801|NCT01295827|11662261|FG003|NOT COMPLETED|Overall Study||4
10511802|NCT01295827|11662262|FG004|NOT COMPLETED|Overall Study||2
10511803|NCT01295827|11662263|FG005|NOT COMPLETED|Overall Study||6
10511804|NCT01295827|11662264|FG006|NOT COMPLETED|Overall Study||146
10511805|NCT01295827|11662265|FG007|NOT COMPLETED|Overall Study||297
10511806|NCT01295827|11662266|FG008|NOT COMPLETED|Overall Study||169
10511807|NCT01295827|11662267|FG009|NOT COMPLETED|Overall Study||55
10511808|NCT01295827|11662268|FG010|NOT COMPLETED|Overall Study||276
10511809|NCT01295827|11662269|FG011|NOT COMPLETED|Overall Study||186
10511810|NCT01295827|11662270|FG012|NOT COMPLETED|Overall Study||0
10511811|NCT01295827|11662271|FG013|NOT COMPLETED|Overall Study||0
10511812|NCT01295827|11662272|FG014|NOT COMPLETED|Overall Study||0
10511813|NCT01295840|11662325|FG000|STARTED|Overall Study||51
10511814|NCT01295840|11662325|FG000|COMPLETED|Overall Study||50
10511815|NCT01295840|11662325|FG000|NOT COMPLETED|Overall Study||1
10511816|NCT01295879|11662331|FG000|STARTED|Overall Study||29
10511817|NCT01295879|11662331|FG000|COMPLETED|Overall Study||29
10511818|NCT01295879|11662331|FG000|NOT COMPLETED|Overall Study||0
10511819|NCT01295905|11662337|FG000|STARTED|Overall Study||60
10511820|NCT01295905|11662338|FG001|STARTED|Overall Study||30
10511821|NCT01295905|11662337|FG000|COMPLETED|Overall Study||58
10511822|NCT01295905|11662338|FG001|COMPLETED|Overall Study||30
10511823|NCT01295905|11662337|FG000|NOT COMPLETED|Overall Study||2
10511824|NCT01295905|11662338|FG001|NOT COMPLETED|Overall Study||0
10511825|NCT01296035|11662344|FG000|STARTED|Overall Study||8
10511826|NCT01296035|11662344|FG000|COMPLETED|Overall Study||7
10511827|NCT01296035|11662344|FG000|NOT COMPLETED|Overall Study||1
10511828|NCT01296152|11662348|FG000|STARTED|Overall Study||25
10511829|NCT01296152|11662348|FG000|COMPLETED|Overall Study||24
10511830|NCT01296152|11662348|FG000|NOT COMPLETED|Overall Study||1
10511831|NCT01296191|11662354|FG000|STARTED|Overall Study||60
10511832|NCT01296191|11662355|FG001|STARTED|Overall Study||60
10711299|NCT02658994|11876738|FG001|STARTED|6 Month Follow up|Participants who did not complete 3 month follow up were still eligible for 6 month follow up|283
10711300|NCT02658994|11876739|FG002|STARTED|6 Month Follow up|Participants who did not complete 3 month follow up were still eligible for 6 month follow up|584
10711301|NCT02658994|11876737|FG000|COMPLETED|6 Month Follow up||228
10711302|NCT02658994|11876738|FG001|COMPLETED|6 Month Follow up||230
10511833|NCT01296191|11662354|FG000|COMPLETED|Overall Study||57
10511834|NCT01296191|11662355|FG001|COMPLETED|Overall Study||59
10511835|NCT01296191|11662354|FG000|NOT COMPLETED|Overall Study||3
10511836|NCT01296191|11662355|FG001|NOT COMPLETED|Overall Study||1
10711303|NCT02658994|11876739|FG002|COMPLETED|6 Month Follow up||471
10511837|NCT01296347|11662363|FG000|STARTED|Allocation||38
10511838|NCT01296347|11662364|FG001|STARTED|Allocation||39
10511839|NCT01296347|11662363|FG000|COMPLETED|Allocation||35
10511840|NCT01296347|11662364|FG001|COMPLETED|Allocation||35
10511841|NCT01296347|11662363|FG000|NOT COMPLETED|Allocation||3
10511842|NCT01296347|11662364|FG001|NOT COMPLETED|Allocation||4
10511843|NCT01296347|11662363|FG000|STARTED|6 Week Follow up||35
10511844|NCT01296347|11662364|FG001|STARTED|6 Week Follow up||35
10511845|NCT01296347|11662363|FG000|COMPLETED|6 Week Follow up||35
10511846|NCT01296347|11662364|FG001|COMPLETED|6 Week Follow up||34
10511847|NCT01296347|11662363|FG000|NOT COMPLETED|6 Week Follow up||0
10511848|NCT01296347|11662364|FG001|NOT COMPLETED|6 Week Follow up||1
10511849|NCT01296347|11662363|FG000|STARTED|3 Month Follow up||35
10511850|NCT01296347|11662364|FG001|STARTED|3 Month Follow up||34
10511851|NCT01296347|11662363|FG000|COMPLETED|3 Month Follow up||34
10511852|NCT01296347|11662364|FG001|COMPLETED|3 Month Follow up||33
10511853|NCT01296347|11662363|FG000|NOT COMPLETED|3 Month Follow up||1
10511854|NCT01296347|11662364|FG001|NOT COMPLETED|3 Month Follow up||1
10511855|NCT01296347|11662363|FG000|STARTED|6 Month Follow up||34
10511856|NCT01296347|11662364|FG001|STARTED|6 Month Follow up||33
10511857|NCT01296347|11662363|FG000|COMPLETED|6 Month Follow up||32
10511858|NCT01296347|11662364|FG001|COMPLETED|6 Month Follow up||31
10511859|NCT01296347|11662363|FG000|NOT COMPLETED|6 Month Follow up||2
10511860|NCT01296347|11662364|FG001|NOT COMPLETED|6 Month Follow up||2
10511861|NCT01296347|11662363|FG000|STARTED|12 Month Follow up||32
10511862|NCT01296347|11662364|FG001|STARTED|12 Month Follow up||31
10511863|NCT01296347|11662363|FG000|COMPLETED|12 Month Follow up||28
10511864|NCT01296347|11662364|FG001|COMPLETED|12 Month Follow up||28
10511865|NCT01296347|11662363|FG000|NOT COMPLETED|12 Month Follow up||4
10511866|NCT01296347|11662364|FG001|NOT COMPLETED|12 Month Follow up||3
10511867|NCT01296360|11662375|FG000|STARTED|Overall Study||150
10511868|NCT01296360|11662376|FG001|STARTED|Overall Study||150
10511869|NCT01296360|11662375|FG000|Visit 2 (Month 12)|Overall Study|booster was administered|148
10511870|NCT01296360|11662376|FG001|Visit 2 (Month 12)|Overall Study||149
10511871|NCT01296360|11662375|FG000|Visit 2a (Month 13)|Overall Study|visit in Booster Group only: ~13 months after immunization in IC51-323 (i.e., 1 month post booster)|148
10511872|NCT01296360|11662376|FG001|Visit 2a (Month 13)|Overall Study||0
10511873|NCT01296360|11662375|FG000|COMPLETED|Overall Study||144
10511874|NCT01296360|11662376|FG001|COMPLETED|Overall Study||142
10511875|NCT01296360|11662375|FG000|NOT COMPLETED|Overall Study||6
10511876|NCT01296360|11662376|FG001|NOT COMPLETED|Overall Study||8
10511877|NCT01296412|11662384|FG000|STARTED|Overall Study||326
10511878|NCT01296412|11662385|FG001|STARTED|Overall Study||327
10511879|NCT01296412|11662384|FG000|COMPLETED|Overall Study||275
10511880|NCT01296412|11662385|FG001|COMPLETED|Overall Study||257
10511881|NCT01296412|11662384|FG000|NOT COMPLETED|Overall Study||51
10511882|NCT01296412|11662385|FG001|NOT COMPLETED|Overall Study||70
10511883|NCT01296542|11662393|FG000|STARTED|Overall Study||30
10511884|NCT01296542|11662394|FG001|STARTED|Overall Study||30
10511885|NCT01296542|11662393|FG000|COMPLETED|Overall Study||30
10511886|NCT01296542|11662394|FG001|COMPLETED|Overall Study||28
10711304|NCT02658994|11876737|FG000|NOT COMPLETED|6 Month Follow up||59
10511887|NCT01296542|11662393|FG000|NOT COMPLETED|Overall Study||0
10511888|NCT01296542|11662394|FG001|NOT COMPLETED|Overall Study||2
10511889|NCT01296568|11662400|FG000|STARTED|[^14C]LY2603618 Single Dose and Washout||3
10511890|NCT01296568|11662400|FG000|COMPLETED|[^14C]LY2603618 Single Dose and Washout||3
10511891|NCT01296568|11662400|FG000|NOT COMPLETED|[^14C]LY2603618 Single Dose and Washout||0
10511892|NCT01296568|11662400|FG000|STARTED|Continued Access Phase||3
10511893|NCT01296568|11662400|FG000|COMPLETED|Continued Access Phase|After study discontinuation participants assessed for disease progression (21-day safety follow-up).|0
10511894|NCT01296568|11662400|FG000|NOT COMPLETED|Continued Access Phase||3
10511895|NCT01296646|11662408|FG000|STARTED|Overall Study||40
10511896|NCT01296646|11662409|FG001|STARTED|Overall Study||40
10511897|NCT01296646|11662408|FG000|COMPLETED|Overall Study||29
10511898|NCT01296646|11662409|FG001|COMPLETED|Overall Study||29
10650431|NCT02169453|11810715|FG001|100 mg BIA 9-1067|Overall Study||3
10511899|NCT01296646|11662408|FG000|NOT COMPLETED|Overall Study||11
10511900|NCT01296646|11662409|FG001|NOT COMPLETED|Overall Study||11
10650432|NCT02169453|11810716|FG002|100 mg BIA 9-1067|Overall Study||3
10511901|NCT01296672|11662417|FG000|STARTED|Overall Study||306
10511902|NCT01296672|11662418|FG001|STARTED|Overall Study||77
10511903|NCT01296672|11662417|FG000|COMPLETED|Overall Study||233
10511904|NCT01296672|11662418|FG001|COMPLETED|Overall Study||59
10511905|NCT01296672|11662417|FG000|NOT COMPLETED|Overall Study||73
10511906|NCT01296672|11662418|FG001|NOT COMPLETED|Overall Study||18
10511907|NCT01296698|11662428|FG000|STARTED|Overall Study||244
10511908|NCT01296698|11662429|FG001|STARTED|Overall Study||13
10511909|NCT01296698|11662428|FG000|COMPLETED|Overall Study||0
10511910|NCT01296698|11662429|FG001|COMPLETED|Overall Study||0
10511911|NCT01296698|11662428|FG000|NOT COMPLETED|Overall Study||244
10511912|NCT01296698|11662429|FG001|NOT COMPLETED|Overall Study||13
10511913|NCT01296763|11662438|FG000|STARTED|Overall Study||7
10511914|NCT01296763|11662439|FG001|STARTED|Overall Study||5
10511915|NCT01296763|11662440|FG002|STARTED|Overall Study||6
10511916|NCT01296763|11662438|FG000|COMPLETED|Overall Study||7
10511917|NCT01296763|11662439|FG001|COMPLETED|Overall Study||5
10511918|NCT01296763|11662440|FG002|COMPLETED|Overall Study||6
10511919|NCT01296763|11662438|FG000|NOT COMPLETED|Overall Study||0
10511920|NCT01296763|11662439|FG001|NOT COMPLETED|Overall Study||0
10511921|NCT01296763|11662440|FG002|NOT COMPLETED|Overall Study||0
10511922|NCT01296815|11662450|FG000|STARTED|Overall Study||7
10511923|NCT01296815|11662451|FG001|STARTED|Overall Study||7
10511924|NCT01296815|11662450|FG000|COMPLETED|Overall Study||7
10511925|NCT01296815|11662451|FG001|COMPLETED|Overall Study||7
10511926|NCT01296815|11662450|FG000|NOT COMPLETED|Overall Study||0
10511927|NCT01296815|11662451|FG001|NOT COMPLETED|Overall Study||0
10511928|NCT01296841|11662459|FG000|STARTED|Overall Study||19
10511929|NCT01296841|11662460|FG001|STARTED|Overall Study||15
10511930|NCT01296841|11662459|FG000|COMPLETED|Overall Study||19
10511931|NCT01296841|11662460|FG001|COMPLETED|Overall Study||15
10511932|NCT01296841|11662459|FG000|NOT COMPLETED|Overall Study||0
10511933|NCT01296841|11662460|FG001|NOT COMPLETED|Overall Study||0
10511934|NCT01296932|11662477|FG000|STARTED|Overall Study||3
10511935|NCT01296932|11662478|FG001|STARTED|Overall Study||3
10511936|NCT01296932|11662479|FG002|STARTED|Overall Study||6
10511937|NCT01296932|11662480|FG003|STARTED|Overall Study||6
10511938|NCT01296932|11662481|FG004|STARTED|Overall Study||3
10511939|NCT01296932|11662482|FG005|STARTED|Overall Study||3
10511940|NCT01296932|11662483|FG006|STARTED|Overall Study||6
10511941|NCT01296932|11662484|FG007|STARTED|Overall Study||3
10511942|NCT01296932|11662485|FG008|STARTED|Overall Study||4
10511943|NCT01296932|11662477|FG000|COMPLETED|Overall Study||0
10511944|NCT01296932|11662478|FG001|COMPLETED|Overall Study||0
10511945|NCT01296932|11662479|FG002|COMPLETED|Overall Study||0
10511946|NCT01296932|11662480|FG003|COMPLETED|Overall Study||0
10511947|NCT01296932|11662481|FG004|COMPLETED|Overall Study||0
10511948|NCT01296932|11662482|FG005|COMPLETED|Overall Study||0
10511949|NCT01296932|11662483|FG006|COMPLETED|Overall Study||0
10511950|NCT01296932|11662484|FG007|COMPLETED|Overall Study||1
10511951|NCT01296932|11662485|FG008|COMPLETED|Overall Study||0
10511952|NCT01296932|11662477|FG000|NOT COMPLETED|Overall Study||3
10511953|NCT01296932|11662478|FG001|NOT COMPLETED|Overall Study||3
10511954|NCT01296932|11662479|FG002|NOT COMPLETED|Overall Study||6
10711305|NCT02658994|11876738|FG001|NOT COMPLETED|6 Month Follow up||53
10711306|NCT02658994|11876739|FG002|NOT COMPLETED|6 Month Follow up||113
10711307|NCT02658994|11876737|FG000|STARTED|12 Month Follow up|Participants who did not complete 6 month follow up were still eligible for 12 month follow up|287
10511955|NCT01296932|11662480|FG003|NOT COMPLETED|Overall Study||6
10511956|NCT01296932|11662481|FG004|NOT COMPLETED|Overall Study||3
10511957|NCT01296932|11662482|FG005|NOT COMPLETED|Overall Study||3
10511958|NCT01296932|11662483|FG006|NOT COMPLETED|Overall Study||6
10511959|NCT01296932|11662484|FG007|NOT COMPLETED|Overall Study||2
10511960|NCT01296932|11662485|FG008|NOT COMPLETED|Overall Study||4
10511961|NCT01297062|11662512|FG000|STARTED|Overall Study||15
10511962|NCT01297062|11662513|FG001|STARTED|Overall Study||14
10511963|NCT01297062|11662514|FG002|STARTED|Overall Study||14
10511964|NCT01297062|11662515|FG003|STARTED|Overall Study||14
10511965|NCT01297062|11662516|FG004|STARTED|Overall Study||15
10511966|NCT01297062|11662517|FG005|STARTED|Overall Study||14
10511967|NCT01297062|11662518|FG006|STARTED|Overall Study||8
10511968|NCT01297062|11662512|FG000|Intent to Treat (ITT)|Overall Study||15
10511969|NCT01297062|11662513|FG001|Intent to Treat (ITT)|Overall Study||14
10511970|NCT01297062|11662514|FG002|Intent to Treat (ITT)|Overall Study||14
10511971|NCT01297062|11662515|FG003|Intent to Treat (ITT)|Overall Study||14
10511972|NCT01297062|11662516|FG004|Intent to Treat (ITT)|Overall Study||15
10511973|NCT01297062|11662517|FG005|Intent to Treat (ITT)|Overall Study||14
10511974|NCT01297062|11662518|FG006|Intent to Treat (ITT)|Overall Study||0
10511975|NCT01297062|11662512|FG000|Evaluable Population|Overall Study||11
10511976|NCT01297062|11662513|FG001|Evaluable Population|Overall Study||12
10511977|NCT01297062|11662514|FG002|Evaluable Population|Overall Study||12
10511978|NCT01297062|11662515|FG003|Evaluable Population|Overall Study||13
10711308|NCT02658994|11876738|FG001|STARTED|12 Month Follow up|Participants who did not complete 6 month follow up were still eligible for 12 month follow up|283
10711309|NCT02658994|11876739|FG002|STARTED|12 Month Follow up|Participants who did not complete 6 month follow up were still eligible for 12 month follow up|584
10711310|NCT02658994|11876737|FG000|COMPLETED|12 Month Follow up||228
10711311|NCT02658994|11876738|FG001|COMPLETED|12 Month Follow up||223
10711312|NCT02658994|11876739|FG002|COMPLETED|12 Month Follow up||489
10711313|NCT02658994|11876737|FG000|NOT COMPLETED|12 Month Follow up||59
10711314|NCT02658994|11876738|FG001|NOT COMPLETED|12 Month Follow up||60
10511979|NCT01297062|11662516|FG004|Evaluable Population|Overall Study||13
10711315|NCT02658994|11876739|FG002|NOT COMPLETED|12 Month Follow up||95
10512018|NCT01297309|11662558|FG000|Treated|Overall Study||49
10711316|NCT02658994|11876737|FG000|STARTED|24 Month Follow up|Participants who did not complete 12 month follow up were still eligible for 24 month follow up|287
10511980|NCT01297062|11662517|FG005|Evaluable Population|Overall Study||13
10511981|NCT01297062|11662518|FG006|Evaluable Population|Overall Study||0
10511982|NCT01297062|11662512|FG000|COMPLETED|Overall Study||11
10511983|NCT01297062|11662513|FG001|COMPLETED|Overall Study||13
10511984|NCT01297062|11662514|FG002|COMPLETED|Overall Study||12
10511985|NCT01297062|11662515|FG003|COMPLETED|Overall Study||13
10511986|NCT01297062|11662516|FG004|COMPLETED|Overall Study||13
10511987|NCT01297062|11662517|FG005|COMPLETED|Overall Study||13
10511988|NCT01297062|11662518|FG006|COMPLETED|Overall Study||0
10511989|NCT01297062|11662512|FG000|NOT COMPLETED|Overall Study||4
10511990|NCT01297062|11662513|FG001|NOT COMPLETED|Overall Study||1
10511991|NCT01297062|11662514|FG002|NOT COMPLETED|Overall Study||2
10511992|NCT01297062|11662515|FG003|NOT COMPLETED|Overall Study||1
10511993|NCT01297062|11662516|FG004|NOT COMPLETED|Overall Study||2
10511994|NCT01297062|11662517|FG005|NOT COMPLETED|Overall Study||1
10711317|NCT02658994|11876738|FG001|STARTED|24 Month Follow up|Participants who did not complete 12 month follow up were still eligible for 24 month follow up|283
10711318|NCT02658994|11876739|FG002|STARTED|24 Month Follow up|Participants who did not complete 12 month follow up were still eligible for 24 month follow up|584
10810099|NCT03809039|11971994|FG002|COMPLETED|Part 1||6
10810100|NCT03809039|11971995|FG003|COMPLETED|Part 1||5
10810101|NCT03809039|11971996|FG004|COMPLETED|Part 1||6
10810102|NCT03809039|11971997|FG005|COMPLETED|Part 1||4
10810103|NCT03809039|11971998|FG006|COMPLETED|Part 1||5
10810104|NCT03809039|11971999|FG007|COMPLETED|Part 1||0
10810105|NCT03809039|11972000|FG008|COMPLETED|Part 1||0
10810106|NCT03809039|11971992|FG000|NOT COMPLETED|Part 1||1
10810107|NCT03809039|11971993|FG001|NOT COMPLETED|Part 1||0
10810108|NCT03809039|11971994|FG002|NOT COMPLETED|Part 1||0
10810109|NCT03809039|11971995|FG003|NOT COMPLETED|Part 1||1
10810110|NCT03809039|11971996|FG004|NOT COMPLETED|Part 1||0
10810111|NCT03809039|11971997|FG005|NOT COMPLETED|Part 1||0
10810112|NCT03809039|11971998|FG006|NOT COMPLETED|Part 1||0
10711319|NCT02658994|11876737|FG000|COMPLETED|24 Month Follow up||220
10711320|NCT02658994|11876738|FG001|COMPLETED|24 Month Follow up||210
10711321|NCT02658994|11876739|FG002|COMPLETED|24 Month Follow up||473
10711322|NCT02658994|11876737|FG000|NOT COMPLETED|24 Month Follow up||67
10711323|NCT02658994|11876738|FG001|NOT COMPLETED|24 Month Follow up||73
10711324|NCT02658994|11876739|FG002|NOT COMPLETED|24 Month Follow up||111
10711325|NCT02658994|11876737|FG000|STARTED|36 Month Follow up|Participants who did not complete 24 month follow up were still eligible for 36 month follow up|287
10711326|NCT02658994|11876738|FG001|STARTED|36 Month Follow up|Participants who did not complete 24 month follow up were still eligible for 36 month follow up|283
10711327|NCT02658994|11876739|FG002|STARTED|36 Month Follow up|Participants who did not complete 24 month follow up were still eligible for 36 month follow up|584
10810113|NCT03809039|11971999|FG007|NOT COMPLETED|Part 1||0
10810114|NCT03809039|11972000|FG008|NOT COMPLETED|Part 1||0
10810115|NCT03809039|11971992|FG000|STARTED|Part 2|2 subjects who received a matching placebo per Part 1 MT-6345 20mg were selected to return for Part 2. Out of 2 subjects, only 1 subject received the placebo, and another subject withdrew the consent after Part 1. Therefore, this 1 subject is not a unique subject and was not counted again in the total number of exposed subjects.|1
10810116|NCT03809039|11971993|FG001|STARTED|Part 2||0
10810117|NCT03809039|11971994|FG002|STARTED|Part 2||0
10810118|NCT03809039|11971995|FG003|STARTED|Part 2|6 subjects in Part 1 MT-6345 20mg were selected to return for Part 2. Out of 6 subjects, only 5 subjects received MT-6345, and 1 subject withdrew the consent after Part 1. Therefore, these 5 subjects are not a unique subject and were not counted again in the total number of exposed subjects.|5
10810119|NCT03809039|11971996|FG004|STARTED|Part 2||0
10810120|NCT03809039|11971997|FG005|STARTED|Part 2||0
10810121|NCT03809039|11971998|FG006|STARTED|Part 2||0
10810122|NCT03809039|11971999|FG007|STARTED|Part 2||0
10810123|NCT03809039|11972000|FG008|STARTED|Part 2||0
10810124|NCT03809039|11971992|FG000|COMPLETED|Part 2||1
10711328|NCT02658994|11876737|FG000|COMPLETED|36 Month Follow up||216
10711329|NCT02658994|11876738|FG001|COMPLETED|36 Month Follow up||206
10711330|NCT02658994|11876739|FG002|COMPLETED|36 Month Follow up||467
10711331|NCT02658994|11876737|FG000|NOT COMPLETED|36 Month Follow up||71
10810125|NCT03809039|11971993|FG001|COMPLETED|Part 2||0
10511995|NCT01297062|11662518|FG006|NOT COMPLETED|Overall Study||8
10511996|NCT01297244|11662528|FG000|STARTED|Overall Study||90
10511997|NCT01297244|11662529|FG001|STARTED|Overall Study||15
10511998|NCT01297244|11662528|FG000|COMPLETED|Overall Study||55
10511999|NCT01297244|11662529|FG001|COMPLETED|Overall Study||9
10512000|NCT01297244|11662528|FG000|NOT COMPLETED|Overall Study||35
10512001|NCT01297244|11662529|FG001|NOT COMPLETED|Overall Study||6
10512002|NCT01297257|11662536|FG000|STARTED|Overall Study||7740
10512003|NCT01297257|11662536|FG000|COMPLETED|Overall Study||7740
10512004|NCT01297257|11662536|FG000|NOT COMPLETED|Overall Study||0
10512005|NCT01297270|11662544|FG000|STARTED|Overall Study||262
10512006|NCT01297270|11662545|FG001|STARTED|Overall Study||264
10512007|NCT01297270|11662546|FG002|STARTED|Overall Study||132
10512008|NCT01297270|11662544|FG000|COMPLETED|Overall Study||217
10512009|NCT01297270|11662545|FG001|COMPLETED|Overall Study||192
10512010|NCT01297270|11662546|FG002|COMPLETED|Overall Study||103
10512011|NCT01297270|11662544|FG000|NOT COMPLETED|Overall Study||45
10512012|NCT01297270|11662545|FG001|NOT COMPLETED|Overall Study||72
10512013|NCT01297270|11662546|FG002|NOT COMPLETED|Overall Study||29
10512014|NCT01297283|11662554|FG000|STARTED|Overall Study||195
10512015|NCT01297283|11662554|FG000|COMPLETED|Overall Study||176
10512016|NCT01297283|11662554|FG000|NOT COMPLETED|Overall Study||19
10512017|NCT01297309|11662558|FG000|STARTED|Overall Study||51
10512019|NCT01297309|11662558|FG000|Started Extension Period|Overall Study||46
10512020|NCT01297309|11662558|FG000|COMPLETED|Overall Study||37
10512021|NCT01297309|11662558|FG000|NOT COMPLETED|Overall Study||14
10512022|NCT01297322|11662564|FG000|STARTED|Overall Study||142
10512023|NCT01297322|11662565|FG001|STARTED|Overall Study||278
10512024|NCT01297322|11662564|FG000|COMPLETED|Overall Study||141
10512025|NCT01297322|11662565|FG001|COMPLETED|Overall Study||274
10512026|NCT01297322|11662564|FG000|NOT COMPLETED|Overall Study||1
10512027|NCT01297322|11662565|FG001|NOT COMPLETED|Overall Study||4
10512028|NCT01297335|11662572|FG000|STARTED|Overall Study||10
10512029|NCT01297335|11662572|FG000|COMPLETED|Overall Study||10
10512030|NCT01297335|11662572|FG000|NOT COMPLETED|Overall Study||0
10512031|NCT01297348|11662580|FG000|STARTED|Overall Study||12281
10512032|NCT01297348|11662581|FG001|STARTED|Overall Study||586401
10512033|NCT01297348|11662580|FG000|COMPLETED|Overall Study||12281
10512034|NCT01297348|11662581|FG001|COMPLETED|Overall Study||586401
10512035|NCT01297348|11662580|FG000|NOT COMPLETED|Overall Study||0
10512036|NCT01297348|11662581|FG001|NOT COMPLETED|Overall Study||0
10512037|NCT01297465|11662590|FG000|STARTED|Overall Study||99
10512038|NCT01297465|11662591|FG001|STARTED|Overall Study||103
10512039|NCT01297465|11662590|FG000|COMPLETED|Overall Study||91
10512040|NCT01297465|11662591|FG001|COMPLETED|Overall Study||93
10512041|NCT01297465|11662590|FG000|NOT COMPLETED|Overall Study||8
10512042|NCT01297465|11662591|FG001|NOT COMPLETED|Overall Study||10
10512043|NCT01297491|11662599|FG000|STARTED|Overall Study||30
10512044|NCT01297491|11662600|FG001|STARTED|Overall Study||33
10512045|NCT01297491|11662599|FG000|COMPLETED|Overall Study||0
10512046|NCT01297491|11662600|FG001|COMPLETED|Overall Study||0
10512047|NCT01297491|11662599|FG000|NOT COMPLETED|Overall Study||30
10512048|NCT01297491|11662600|FG001|NOT COMPLETED|Overall Study||33
10512049|NCT01297504|11662606|FG000|STARTED|Overall Study||464
10512050|NCT01297504|11662606|FG000|Participants Studied|Overall Study|Six participants were eliminated due to invalid consent, previous palivizumab or no study visits|458
10512051|NCT01297504|11662606|FG000|COMPLETED|Overall Study||397
10512052|NCT01297504|11662606|FG000|NOT COMPLETED|Overall Study||67
10512053|NCT01297517|11662617|FG000|STARTED|Overall Study||214
10512054|NCT01297517|11662618|FG001|STARTED|Overall Study||226
10512055|NCT01297517|11662619|FG002|STARTED|Overall Study||220
10512056|NCT01297517|11662617|FG000|COMPLETED|Overall Study||187
10512057|NCT01297517|11662618|FG001|COMPLETED|Overall Study||214
10512058|NCT01297517|11662619|FG002|COMPLETED|Overall Study||193
10512059|NCT01297517|11662617|FG000|NOT COMPLETED|Overall Study||27
10512060|NCT01297517|11662618|FG001|NOT COMPLETED|Overall Study||12
10512061|NCT01297517|11662619|FG002|NOT COMPLETED|Overall Study||27
10512062|NCT01297595|11662627|FG000|STARTED|First Intervention Period||11
10512063|NCT01297595|11662628|FG001|STARTED|First Intervention Period||11
10512064|NCT01297595|11662627|FG000|COMPLETED|First Intervention Period||11
10512065|NCT01297595|11662628|FG001|COMPLETED|First Intervention Period||11
10512066|NCT01297595|11662627|FG000|NOT COMPLETED|First Intervention Period||0
10512067|NCT01297595|11662628|FG001|NOT COMPLETED|First Intervention Period||0
10512068|NCT01297595|11662627|FG000|STARTED|Washout Period (At Least 14 Days)||11
10512069|NCT01297595|11662628|FG001|STARTED|Washout Period (At Least 14 Days)||11
10512070|NCT01297595|11662627|FG000|COMPLETED|Washout Period (At Least 14 Days)||11
10512071|NCT01297595|11662628|FG001|COMPLETED|Washout Period (At Least 14 Days)||11
10512072|NCT01297595|11662627|FG000|NOT COMPLETED|Washout Period (At Least 14 Days)||0
10512073|NCT01297595|11662628|FG001|NOT COMPLETED|Washout Period (At Least 14 Days)||0
10512074|NCT01297595|11662627|FG000|STARTED|Second Intervention Period||11
10512075|NCT01297595|11662628|FG001|STARTED|Second Intervention Period||11
10512076|NCT01297595|11662627|FG000|COMPLETED|Second Intervention Period||11
10512077|NCT01297595|11662628|FG001|COMPLETED|Second Intervention Period||11
10512078|NCT01297595|11662627|FG000|NOT COMPLETED|Second Intervention Period||0
10512079|NCT01297595|11662628|FG001|NOT COMPLETED|Second Intervention Period||0
10512080|NCT01297920|11662637|FG000|STARTED|Overall Study||221
10512081|NCT01297920|11662638|FG001|STARTED|Overall Study||234
10512082|NCT01297920|11662639|FG002|STARTED|Overall Study||235
10512083|NCT01297920|11662637|FG000|COMPLETED|Overall Study||163
10512084|NCT01297920|11662638|FG001|COMPLETED|Overall Study||207
10512085|NCT01297920|11662639|FG002|COMPLETED|Overall Study||178
10512086|NCT01297920|11662637|FG000|NOT COMPLETED|Overall Study||58
10512087|NCT01297920|11662638|FG001|NOT COMPLETED|Overall Study||27
10512088|NCT01297920|11662639|FG002|NOT COMPLETED|Overall Study||57
10512089|NCT01297959|11662649|FG000|STARTED|Overall Study||261
10512090|NCT01297959|11662650|FG001|STARTED|Overall Study||242
10512091|NCT01297959|11662649|FG000|COMPLETED|Overall Study||241
10512092|NCT01297959|11662650|FG001|COMPLETED|Overall Study||226
10512093|NCT01297959|11662649|FG000|NOT COMPLETED|Overall Study||20
10512094|NCT01297959|11662650|FG001|NOT COMPLETED|Overall Study||16
10512095|NCT01297985|11662658|FG000|STARTED|Overall Study||212
10512096|NCT01297985|11662659|FG001|STARTED|Overall Study||216
10512097|NCT01297985|11662658|FG000|COMPLETED|Overall Study||157
10512098|NCT01297985|11662659|FG001|COMPLETED|Overall Study||163
10512099|NCT01297985|11662658|FG000|NOT COMPLETED|Overall Study||55
10512100|NCT01297985|11662659|FG001|NOT COMPLETED|Overall Study||53
10512101|NCT01298063|11662670|FG000|STARTED|Overall Study||8
10512102|NCT01298063|11662671|FG001|STARTED|Overall Study||3
10512103|NCT01298063|11662672|FG002|STARTED|Overall Study||8
10512104|NCT01298063|11662673|FG003|STARTED|Overall Study||8
10512105|NCT01298063|11662674|FG004|STARTED|Overall Study||8
10512106|NCT01298063|11662670|FG000|COMPLETED|Overall Study||8
10512107|NCT01298063|11662671|FG001|COMPLETED|Overall Study||3
10512108|NCT01298063|11662672|FG002|COMPLETED|Overall Study||8
10512109|NCT01298063|11662673|FG003|COMPLETED|Overall Study||8
10512110|NCT01298063|11662674|FG004|COMPLETED|Overall Study||8
10512111|NCT01298063|11662670|FG000|NOT COMPLETED|Overall Study||0
10512112|NCT01298063|11662671|FG001|NOT COMPLETED|Overall Study||0
10512113|NCT01298063|11662672|FG002|NOT COMPLETED|Overall Study||0
10512114|NCT01298063|11662673|FG003|NOT COMPLETED|Overall Study||0
10512115|NCT01298063|11662674|FG004|NOT COMPLETED|Overall Study||0
10512116|NCT01298128|11662689|FG000|STARTED|Overall Study||35
10810126|NCT03809039|11971994|FG002|COMPLETED|Part 2||0
10810127|NCT03809039|11971995|FG003|COMPLETED|Part 2||5
10810128|NCT03809039|11971996|FG004|COMPLETED|Part 2||0
10810129|NCT03809039|11971997|FG005|COMPLETED|Part 2||0
10810130|NCT03809039|11971998|FG006|COMPLETED|Part 2||0
10810131|NCT03809039|11971999|FG007|COMPLETED|Part 2||0
10810132|NCT03809039|11972000|FG008|COMPLETED|Part 2||0
10810133|NCT03809039|11971992|FG000|NOT COMPLETED|Part 2||0
10810134|NCT03809039|11971993|FG001|NOT COMPLETED|Part 2||0
10810135|NCT03809039|11971994|FG002|NOT COMPLETED|Part 2||0
10810136|NCT03809039|11971995|FG003|NOT COMPLETED|Part 2||0
10810137|NCT03809039|11971996|FG004|NOT COMPLETED|Part 2||0
10810138|NCT03809039|11971997|FG005|NOT COMPLETED|Part 2||0
10810139|NCT03809039|11971998|FG006|NOT COMPLETED|Part 2||0
10810140|NCT03809039|11971999|FG007|NOT COMPLETED|Part 2||0
10810141|NCT03809039|11972000|FG008|NOT COMPLETED|Part 2||0
10810142|NCT03809039|11971992|FG000|STARTED|Part 3||0
10810143|NCT03809039|11971993|FG001|STARTED|Part 3||0
10810144|NCT03809039|11971994|FG002|STARTED|Part 3||0
10810145|NCT03809039|11971995|FG003|STARTED|Part 3||0
10810146|NCT03809039|11971996|FG004|STARTED|Part 3||0
10810147|NCT03809039|11971997|FG005|STARTED|Part 3||0
10810148|NCT03809039|11971998|FG006|STARTED|Part 3||0
10810149|NCT03809039|11971999|FG007|STARTED|Part 3|The subjects are unique subjects, and were not counted more than once across any arms.|2
10810150|NCT03809039|11972000|FG008|STARTED|Part 3|The subjects are unique subjects, and were not counted more than once across any arms.|6
10810151|NCT03809039|11971992|FG000|COMPLETED|Part 3||0
10810152|NCT03809039|11971993|FG001|COMPLETED|Part 3||0
10810153|NCT03809039|11971994|FG002|COMPLETED|Part 3||0
10512117|NCT01298128|11662690|FG001|STARTED|Overall Study||35
10512118|NCT01298128|11662689|FG000|COMPLETED|Overall Study||26
10512119|NCT01298128|11662690|FG001|COMPLETED|Overall Study||27
10512120|NCT01298128|11662689|FG000|NOT COMPLETED|Overall Study||9
10512121|NCT01298128|11662690|FG001|NOT COMPLETED|Overall Study||8
10512122|NCT01298141|11662696|FG000|STARTED|Overall Study||171
10512123|NCT01298141|11662696|FG000|Treated|Overall Study||167
10512124|NCT01298141|11662696|FG000|COMPLETED|Overall Study||140
10512125|NCT01298141|11662696|FG000|NOT COMPLETED|Overall Study||31
10512126|NCT01298167|11662702|FG000|STARTED|Overall Study||6
10512127|NCT01298167|11662703|FG001|STARTED|Overall Study||8
10512128|NCT01298167|11662702|FG000|COMPLETED|Overall Study||5
10512129|NCT01298167|11662703|FG001|COMPLETED|Overall Study||8
10512130|NCT01298167|11662702|FG000|NOT COMPLETED|Overall Study||1
10512131|NCT01298167|11662703|FG001|NOT COMPLETED|Overall Study||0
10512132|NCT01298193|11662709|FG000|STARTED|Observational Phase (First Cycle)||212
10512133|NCT01298193|11662709|FG000|COMPLETED|Observational Phase (First Cycle)|From these 185 completed patients, only 24 experiment emesis on Cycle 1 (NCR) (efficacy phase).|185
10512134|NCT01298193|11662709|FG000|NOT COMPLETED|Observational Phase (First Cycle)||27
10512135|NCT01298193|11662709|FG000|STARTED|Efficacy Phase (Second Cycle)||24
10512136|NCT01298193|11662709|FG000|COMPLETED|Efficacy Phase (Second Cycle)||23
10512137|NCT01298193|11662709|FG000|NOT COMPLETED|Efficacy Phase (Second Cycle)||1
10512138|NCT01298219|11662718|FG000|STARTED|Overall Study||219
10512139|NCT01298219|11662719|FG001|STARTED|Overall Study||220
10810154|NCT03809039|11971995|FG003|COMPLETED|Part 3||0
10810155|NCT03809039|11971996|FG004|COMPLETED|Part 3||0
10810156|NCT03809039|11971997|FG005|COMPLETED|Part 3||0
10810157|NCT03809039|11971998|FG006|COMPLETED|Part 3||0
10810158|NCT03809039|11971999|FG007|COMPLETED|Part 3||0
10810159|NCT03809039|11972000|FG008|COMPLETED|Part 3||0
10810160|NCT03809039|11971992|FG000|NOT COMPLETED|Part 3||0
10810161|NCT03809039|11971993|FG001|NOT COMPLETED|Part 3||0
10810162|NCT03809039|11971994|FG002|NOT COMPLETED|Part 3||0
10810163|NCT03809039|11971995|FG003|NOT COMPLETED|Part 3||0
10512140|NCT01298219|11662718|FG000|Intention to Treat (ITT)|Overall Study||219
10512141|NCT01298219|11662719|FG001|Intention to Treat (ITT)|Overall Study||220
10512142|NCT01298219|11662718|FG000|Safety Analysis Set|Overall Study||219
10512143|NCT01298219|11662719|FG001|Safety Analysis Set|Overall Study||220
10512144|NCT01298219|11662718|FG000|COMPLETED|Overall Study||169
10512145|NCT01298219|11662719|FG001|COMPLETED|Overall Study||184
10512146|NCT01298219|11662718|FG000|NOT COMPLETED|Overall Study||50
10512147|NCT01298219|11662719|FG001|NOT COMPLETED|Overall Study||36
10512148|NCT01298323|11662727|FG000|STARTED|Overall Study||102
10512149|NCT01298323|11662728|FG001|STARTED|Overall Study||103
10512150|NCT01298323|11662727|FG000|Ongoing|Overall Study||55
10512151|NCT01298323|11662728|FG001|Ongoing|Overall Study||55
10512152|NCT01298323|11662727|FG000|COMPLETED|Overall Study||16
10512153|NCT01298323|11662728|FG001|COMPLETED|Overall Study||15
10512154|NCT01298323|11662727|FG000|NOT COMPLETED|Overall Study||86
10512155|NCT01298323|11662728|FG001|NOT COMPLETED|Overall Study||88
10512156|NCT01298362|11662736|FG000|STARTED|Overall Study||124
10512157|NCT01298362|11662737|FG001|STARTED|Overall Study||166
10512158|NCT01298362|11662736|FG000|COMPLETED|Overall Study||86
10512159|NCT01298362|11662737|FG001|COMPLETED|Overall Study||123
10512160|NCT01298362|11662736|FG000|NOT COMPLETED|Overall Study||38
10512161|NCT01298362|11662737|FG001|NOT COMPLETED|Overall Study||43
10512162|NCT01298492|11662745|FG000|STARTED|Overall Study||268
10512163|NCT01298492|11662745|FG000|COMPLETED|Overall Study||149
10512164|NCT01298492|11662745|FG000|NOT COMPLETED|Overall Study||119
10512165|NCT01298518|11662752|FG000|STARTED|Overall Study||16
10512166|NCT01298518|11662753|FG001|STARTED|Overall Study||16
10512167|NCT01298518|11662754|FG002|STARTED|Overall Study||16
10512168|NCT01298518|11662752|FG000|COMPLETED|Overall Study||16
10512169|NCT01298518|11662753|FG001|COMPLETED|Overall Study||16
10512170|NCT01298518|11662754|FG002|COMPLETED|Overall Study||15
10512171|NCT01298518|11662752|FG000|NOT COMPLETED|Overall Study||0
10512172|NCT01298518|11662753|FG001|NOT COMPLETED|Overall Study||0
10512173|NCT01298518|11662754|FG002|NOT COMPLETED|Overall Study||1
10512174|NCT01298531|11662764|FG000|STARTED|Overall Study||42
10512175|NCT01298531|11662765|FG001|STARTED|Overall Study||48
10512176|NCT01298531|11662764|FG000|COMPLETED|Overall Study||33
10512177|NCT01298531|11662765|FG001|COMPLETED|Overall Study||41
10512178|NCT01298531|11662764|FG000|NOT COMPLETED|Overall Study||9
10512179|NCT01298531|11662765|FG001|NOT COMPLETED|Overall Study||7
10512180|NCT01298544|11662772|FG000|STARTED|Overall Study||335
10512181|NCT01298544|11662772|FG000|COMPLETED|Overall Study||335
10512182|NCT01298544|11662772|FG000|NOT COMPLETED|Overall Study||0
10512183|NCT01298570|11662780|FG000|STARTED|Overall Study||120
10512184|NCT01298570|11662781|FG001|STARTED|Overall Study||61
10512185|NCT01298570|11662780|FG000|COMPLETED|Overall Study||0
10512186|NCT01298570|11662781|FG001|COMPLETED|Overall Study||0
10512187|NCT01298570|11662780|FG000|NOT COMPLETED|Overall Study||120
10512188|NCT01298570|11662781|FG001|NOT COMPLETED|Overall Study||61
10512189|NCT01298596|11662789|FG000|STARTED|Overall Study||200
10512190|NCT01298596|11662790|FG001|STARTED|Overall Study||200
10512191|NCT01298596|11662789|FG000|COMPLETED|Overall Study||172
10512192|NCT01298596|11662790|FG001|COMPLETED|Overall Study||167
10512193|NCT01298596|11662789|FG000|NOT COMPLETED|Overall Study||28
10512194|NCT01298596|11662790|FG001|NOT COMPLETED|Overall Study||33
10512195|NCT01298648|11662796|FG000|STARTED|Overall Study||1716
10512196|NCT01298648|11662796|FG000|COMPLETED|Overall Study||1693
10512197|NCT01298648|11662796|FG000|NOT COMPLETED|Overall Study||23
10512198|NCT01298661|11662803|FG000|STARTED|Overall Study||33
10512199|NCT01298661|11662804|FG001|STARTED|Overall Study||24
10512200|NCT01298661|11662805|FG002|STARTED|Overall Study||34
10512201|NCT01298661|11662803|FG000|COMPLETED|Overall Study||31
10512202|NCT01298661|11662804|FG001|COMPLETED|Overall Study||24
10512203|NCT01298661|11662805|FG002|COMPLETED|Overall Study||32
10512204|NCT01298661|11662803|FG000|NOT COMPLETED|Overall Study||2
10512205|NCT01298661|11662804|FG001|NOT COMPLETED|Overall Study||0
10512206|NCT01298661|11662805|FG002|NOT COMPLETED|Overall Study||2
10512207|NCT01298700|11662816|FG000|STARTED|Overall Study||403
10512208|NCT01298700|11662817|FG001|STARTED|Overall Study||403
10512209|NCT01298700|11662816|FG000|Safety Population: Received Study Drug|Overall Study||400
10512210|NCT01298700|11662817|FG001|Safety Population: Received Study Drug|Overall Study||398
10512211|NCT01298700|11662816|FG000|COMPLETED|Overall Study||302
10512212|NCT01298700|11662817|FG001|COMPLETED|Overall Study||303
10512213|NCT01298700|11662816|FG000|NOT COMPLETED|Overall Study||101
10512214|NCT01298700|11662817|FG001|NOT COMPLETED|Overall Study||100
10512215|NCT01298752|11662825|FG000|STARTED|Overall Study||120
10512216|NCT01298752|11662826|FG001|STARTED|Overall Study||57
10512217|NCT01298752|11662825|FG000|COMPLETED|Overall Study||77
10512218|NCT01298752|11662826|FG001|COMPLETED|Overall Study||31
10512219|NCT01298752|11662825|FG000|NOT COMPLETED|Overall Study||43
10512220|NCT01298752|11662826|FG001|NOT COMPLETED|Overall Study||26
10512221|NCT01298765|11662832|FG000|STARTED|Titration Period||302
10512222|NCT01298765|11662832|FG000|COMPLETED|Titration Period||226
10512223|NCT01298765|11662832|FG000|NOT COMPLETED|Titration Period||76
10512224|NCT01298765|11662832|FG000|STARTED|Long-Term Treatment Period||226
10512225|NCT01298765|11662832|FG000|COMPLETED|Long-Term Treatment Period||127
10512226|NCT01298765|11662832|FG000|NOT COMPLETED|Long-Term Treatment Period||99
10512227|NCT01298778|11662838|FG000|STARTED|Overall Study||33
10512228|NCT01298778|11662839|FG001|STARTED|Overall Study||36
10512229|NCT01298778|11662838|FG000|COMPLETED|Overall Study||30
10512230|NCT01298778|11662839|FG001|COMPLETED|Overall Study||30
10512231|NCT01298778|11662838|FG000|NOT COMPLETED|Overall Study||3
10512232|NCT01298778|11662839|FG001|NOT COMPLETED|Overall Study||6
10512233|NCT01298999|11662849|FG000|STARTED|Overall Study||13
10512234|NCT01298999|11662850|FG001|STARTED|Overall Study||11
10512235|NCT01298999|11662849|FG000|COMPLETED|Overall Study||10
10512236|NCT01298999|11662850|FG001|COMPLETED|Overall Study||10
10512237|NCT01298999|11662849|FG000|NOT COMPLETED|Overall Study||3
10512238|NCT01298999|11662850|FG001|NOT COMPLETED|Overall Study||1
10512239|NCT01299025|11662858|FG000|STARTED|Overall Study||42
10512240|NCT01299025|11662859|FG001|STARTED|Overall Study||42
10512241|NCT01299025|11662858|FG000|COMPLETED|Overall Study||39
10512242|NCT01299025|11662859|FG001|COMPLETED|Overall Study||41
10512243|NCT01299025|11662858|FG000|NOT COMPLETED|Overall Study||3
10512244|NCT01299025|11662859|FG001|NOT COMPLETED|Overall Study||1
10512245|NCT01299038|11662867|FG000|STARTED|Overall Study|Consented|10
10512246|NCT01299038|11662868|FG001|STARTED|Overall Study|Consented|10
10512247|NCT01299038|11662867|FG000|COMPLETED|Overall Study|Evaluable|9
10512248|NCT01299038|11662868|FG001|COMPLETED|Overall Study|Evaluable|10
10512249|NCT01299038|11662867|FG000|NOT COMPLETED|Overall Study||1
10512250|NCT01299038|11662868|FG001|NOT COMPLETED|Overall Study||0
10512251|NCT01299077|11662874|FG000|STARTED|Overall Study||478
10512252|NCT01299077|11662874|FG000|COMPLETED|Overall Study||478
10512253|NCT01299077|11662874|FG000|NOT COMPLETED|Overall Study||0
10512254|NCT01299090|11662878|FG000|STARTED|Overall Study||49
10512255|NCT01299090|11662878|FG000|COMPLETED|Overall Study||49
10512256|NCT01299090|11662878|FG000|NOT COMPLETED|Overall Study||0
10512257|NCT01299103|11662885|FG000|STARTED|Overall Study||15
10512258|NCT01299103|11662886|FG001|STARTED|Overall Study||15
10512259|NCT01299103|11662887|FG002|STARTED|Overall Study||10
10512260|NCT01299103|11662885|FG000|COMPLETED|Overall Study||15
10512261|NCT01299103|11662886|FG001|COMPLETED|Overall Study||13
10512262|NCT01299103|11662887|FG002|COMPLETED|Overall Study||8
10512263|NCT01299103|11662885|FG000|NOT COMPLETED|Overall Study||0
10512264|NCT01299103|11662886|FG001|NOT COMPLETED|Overall Study||2
10512265|NCT01299103|11662887|FG002|NOT COMPLETED|Overall Study||2
10512266|NCT01299116|11662898|FG000|STARTED|Overall Study||522
10512267|NCT01299116|11662899|FG001|STARTED|Overall Study||177
10512268|NCT01299116|11662900|FG002|STARTED|Overall Study||195
10512269|NCT01299116|11662898|FG000|COMPLETED|Overall Study||457
10512270|NCT01299116|11662899|FG001|COMPLETED|Overall Study||168
10512271|NCT01299116|11662900|FG002|COMPLETED|Overall Study||184
10711332|NCT02658994|11876738|FG001|NOT COMPLETED|36 Month Follow up||77
10711333|NCT02658994|11876739|FG002|NOT COMPLETED|36 Month Follow up||117
10711334|NCT02659098|11876748|FG000|STARTED|Overall Study||21
10711335|NCT02659098|11876748|FG000|COMPLETED|Overall Study||14
10711336|NCT02659098|11876748|FG000|NOT COMPLETED|Overall Study||7
10711337|NCT02659150|11876752|FG000|STARTED|Subject Enrollment||16
10711338|NCT02659150|11876752|FG000|COMPLETED|Subject Enrollment||11
10711339|NCT02659150|11876752|FG000|NOT COMPLETED|Subject Enrollment||5
10711340|NCT02659150|11876752|FG000|STARTED|Baseline Imaging||11
10512272|NCT01299116|11662898|FG000|NOT COMPLETED|Overall Study||65
10512273|NCT01299116|11662899|FG001|NOT COMPLETED|Overall Study||9
10512274|NCT01299116|11662900|FG002|NOT COMPLETED|Overall Study||11
10512275|NCT01299272|11662911|FG000|STARTED|Acute Open-label (OL) Period||1249
10512276|NCT01299272|11662912|FG001|STARTED|Acute Open-label (OL) Period||0
10512277|NCT01299272|11662913|FG002|STARTED|Acute Open-label (OL) Period||0
10512278|NCT01299272|11662914|FG003|STARTED|Acute Open-label (OL) Period||0
10512279|NCT01299272|11662911|FG000|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period|Participants who discontinued the Acute OL Period had the option to enter the DC Period.|271
10512280|NCT01299272|11662912|FG001|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
10512281|NCT01299272|11662913|FG002|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
10512282|NCT01299272|11662914|FG003|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
10512283|NCT01299272|11662911|FG000|COMPLETED|Acute Open-label (OL) Period|Participants who completed the Acute OL Period entered the Stabilization OL Period.|835
10512284|NCT01299272|11662912|FG001|COMPLETED|Acute Open-label (OL) Period||0
10512285|NCT01299272|11662913|FG002|COMPLETED|Acute Open-label (OL) Period||0
10512286|NCT01299272|11662914|FG003|COMPLETED|Acute Open-label (OL) Period||0
10512287|NCT01299272|11662911|FG000|NOT COMPLETED|Acute Open-label (OL) Period||414
10512288|NCT01299272|11662912|FG001|NOT COMPLETED|Acute Open-label (OL) Period||0
10512289|NCT01299272|11662913|FG002|NOT COMPLETED|Acute Open-label (OL) Period||0
10512290|NCT01299272|11662914|FG003|NOT COMPLETED|Acute Open-label (OL) Period||0
10512291|NCT01299272|11662911|FG000|STARTED|Stabilization Open-label (OL) Period||0
10512292|NCT01299272|11662912|FG001|STARTED|Stabilization Open-label (OL) Period||835
10512293|NCT01299272|11662913|FG002|STARTED|Stabilization Open-label (OL) Period||0
10512294|NCT01299272|11662914|FG003|STARTED|Stabilization Open-label (OL) Period||0
10512295|NCT01299272|11662911|FG000|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
10512296|NCT01299272|11662912|FG001|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period|Participants who discontinued the Stabilization OL Period had the option to enter the DC Period.|164
10512297|NCT01299272|11662913|FG002|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
10512298|NCT01299272|11662914|FG003|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
10512299|NCT01299272|11662911|FG000|COMPLETED|Stabilization Open-label (OL) Period||0
10512300|NCT01299272|11662912|FG001|COMPLETED|Stabilization Open-label (OL) Period|Participants who completed the Stabilization OL Period were randomized to the DB Period.|586
10512301|NCT01299272|11662913|FG002|COMPLETED|Stabilization Open-label (OL) Period||0
10711341|NCT02659150|11876752|FG000|COMPLETED|Baseline Imaging||9
10512302|NCT01299272|11662914|FG003|COMPLETED|Stabilization Open-label (OL) Period||0
10512303|NCT01299272|11662911|FG000|NOT COMPLETED|Stabilization Open-label (OL) Period||0
10512304|NCT01299272|11662912|FG001|NOT COMPLETED|Stabilization Open-label (OL) Period||249
10512305|NCT01299272|11662913|FG002|NOT COMPLETED|Stabilization Open-label (OL) Period||0
10512306|NCT01299272|11662914|FG003|NOT COMPLETED|Stabilization Open-label (OL) Period||0
10512307|NCT01299272|11662911|FG000|STARTED|Double-blind (DB) Randomized Period||0
10512308|NCT01299272|11662912|FG001|STARTED|Double-blind (DB) Randomized Period||0
10512309|NCT01299272|11662913|FG002|STARTED|Double-blind (DB) Randomized Period||294
10512310|NCT01299272|11662914|FG003|STARTED|Double-blind (DB) Randomized Period||292
10512311|NCT01299272|11662911|FG000|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
10512312|NCT01299272|11662912|FG001|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
10512313|NCT01299272|11662913|FG002|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period were randomized to the taper DC Period.|129
10512314|NCT01299272|11662914|FG003|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
10512315|NCT01299272|11662911|FG000|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period||0
10512316|NCT01299272|11662912|FG001|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period||0
10512317|NCT01299272|11662913|FG002|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period were randomized to the abrupt DC Period.|132
10512318|NCT01299272|11662914|FG003|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period entered the DC Period.|268
10512319|NCT01299272|11662911|FG000|COMPLETED|Double-blind (DB) Randomized Period||0
10512320|NCT01299272|11662912|FG001|COMPLETED|Double-blind (DB) Randomized Period||0
10512321|NCT01299272|11662913|FG002|COMPLETED|Double-blind (DB) Randomized Period||224
10512322|NCT01299272|11662914|FG003|COMPLETED|Double-blind (DB) Randomized Period||234
10512323|NCT01299272|11662911|FG000|NOT COMPLETED|Double-blind (DB) Randomized Period||0
10512324|NCT01299272|11662912|FG001|NOT COMPLETED|Double-blind (DB) Randomized Period||0
10512325|NCT01299272|11662913|FG002|NOT COMPLETED|Double-blind (DB) Randomized Period||70
10512326|NCT01299272|11662914|FG003|NOT COMPLETED|Double-blind (DB) Randomized Period||58
10528427|NCT01394939|11680701|FG002|NOT COMPLETED|Overall Study||0
10528428|NCT01394939|11680702|FG003|NOT COMPLETED|Overall Study||7
10528429|NCT01394952|11680714|FG000|STARTED|Overall Study||4952
10528430|NCT01394952|11680715|FG001|STARTED|Overall Study||4949
10528431|NCT01394952|11680714|FG000|Received at Least One Dose of Study Drug|Overall Study||4949
10528432|NCT01394952|11680715|FG001|Received at Least One Dose of Study Drug|Overall Study||4943
10528433|NCT01394952|11680714|FG000|COMPLETED|Overall Study||4935
10528434|NCT01394952|11680715|FG001|COMPLETED|Overall Study||4932
10528435|NCT01394952|11680714|FG000|NOT COMPLETED|Overall Study||17
10528436|NCT01394952|11680715|FG001|NOT COMPLETED|Overall Study||17
10528437|NCT01394978|11680724|FG000|STARTED|Overall Study||168
10528438|NCT01394978|11680725|FG001|STARTED|Overall Study||276
10528439|NCT01394978|11680724|FG000|COMPLETED|Overall Study||147
10528440|NCT01394978|11680725|FG001|COMPLETED|Overall Study||245
10528441|NCT01394978|11680724|FG000|NOT COMPLETED|Overall Study||21
10528442|NCT01394978|11680725|FG001|NOT COMPLETED|Overall Study||31
10528443|NCT01394991|11680734|FG000|STARTED|Overall Study||242
10528444|NCT01394991|11680735|FG001|STARTED|Overall Study||262
10528445|NCT01394991|11680734|FG000|COMPLETED|Overall Study||183
10528446|NCT01394991|11680735|FG001|COMPLETED|Overall Study||190
10528447|NCT01394991|11680734|FG000|NOT COMPLETED|Overall Study||59
10528448|NCT01394991|11680735|FG001|NOT COMPLETED|Overall Study||72
10528449|NCT01395017|11680743|FG000|STARTED|Overall Study||100
10528450|NCT01395017|11680744|FG001|STARTED|Overall Study||102
10528451|NCT01395017|11680743|FG000|Treated|Overall Study||98
10528452|NCT01395017|11680744|FG001|Treated|Overall Study||101
10528453|NCT01395017|11680743|FG000|COMPLETED|Overall Study||0
10528454|NCT01395017|11680744|FG001|COMPLETED|Overall Study||0
10528455|NCT01395017|11680743|FG000|NOT COMPLETED|Overall Study||100
10528456|NCT01395017|11680744|FG001|NOT COMPLETED|Overall Study||102
10528457|NCT01395030|11680751|FG000|STARTED|Overall Study||64
10528458|NCT01395030|11680751|FG000|Complete FCH PET/CT|Overall Study||57
10528459|NCT01395030|11680751|FG000|Adequate Tissue for Analysis|Overall Study||50
10528460|NCT01395030|11680751|FG000|COMPLETED|Overall Study||57
10528461|NCT01395030|11680751|FG000|NOT COMPLETED|Overall Study||7
10528462|NCT01395043|11680757|FG000|STARTED|Overall Study||15
10528463|NCT01395043|11680757|FG000|COMPLETED|Overall Study||15
10528464|NCT01395043|11680757|FG000|NOT COMPLETED|Overall Study||0
10528465|NCT01395277|11680764|FG000|STARTED|Overall Study||15
10528466|NCT01395277|11680765|FG001|STARTED|Overall Study||15
10528467|NCT01395277|11680764|FG000|COMPLETED|Overall Study||15
10528468|NCT01395277|11680765|FG001|COMPLETED|Overall Study||15
10528469|NCT01395277|11680764|FG000|NOT COMPLETED|Overall Study||0
10528470|NCT01395277|11680765|FG001|NOT COMPLETED|Overall Study||0
10528471|NCT01395316|11680773|FG000|STARTED|Overall Study||8
10528472|NCT01395316|11680773|FG000|COMPLETED|Overall Study||5
10528473|NCT01395316|11680773|FG000|NOT COMPLETED|Overall Study||3
10528474|NCT01395329|11680780|FG000|STARTED|Overall Study||14
10528475|NCT01395329|11680781|FG001|STARTED|Overall Study||14
10528476|NCT01395329|11680782|FG002|STARTED|Overall Study||14
10528477|NCT01395329|11680780|FG000|COMPLETED|Overall Study||14
10528478|NCT01395329|11680781|FG001|COMPLETED|Overall Study||14
10528479|NCT01395329|11680782|FG002|COMPLETED|Overall Study||14
10528480|NCT01395329|11680780|FG000|NOT COMPLETED|Overall Study||0
10528481|NCT01395329|11680781|FG001|NOT COMPLETED|Overall Study||0
10512327|NCT01299285|11662928|FG000|STARTED|Overall Study||6
10512328|NCT01299285|11662928|FG000|COMPLETED|Overall Study||6
10512329|NCT01299285|11662928|FG000|NOT COMPLETED|Overall Study||0
10512330|NCT01299376|11662936|FG000|STARTED|Double-blind Treatment (Weeks 1 to 8)||141
10512331|NCT01299376|11662937|FG001|STARTED|Double-blind Treatment (Weeks 1 to 8)||145
10512332|NCT01299376|11662936|FG000|COMPLETED|Double-blind Treatment (Weeks 1 to 8)||134
10512333|NCT01299376|11662937|FG001|COMPLETED|Double-blind Treatment (Weeks 1 to 8)||133
10512334|NCT01299376|11662936|FG000|NOT COMPLETED|Double-blind Treatment (Weeks 1 to 8)||7
10512335|NCT01299376|11662937|FG001|NOT COMPLETED|Double-blind Treatment (Weeks 1 to 8)||12
10512336|NCT01299376|11662936|FG000|STARTED|Extension (Weeks 9 to 52)||134
10512337|NCT01299376|11662937|FG001|STARTED|Extension (Weeks 9 to 52)||133
10512338|NCT01299376|11662936|FG000|COMPLETED|Extension (Weeks 9 to 52)||124
10512339|NCT01299376|11662937|FG001|COMPLETED|Extension (Weeks 9 to 52)||118
10512340|NCT01299376|11662936|FG000|NOT COMPLETED|Extension (Weeks 9 to 52)||10
10512341|NCT01299376|11662937|FG001|NOT COMPLETED|Extension (Weeks 9 to 52)||15
10512342|NCT01299389|11662949|FG000|STARTED|Double-blind||164
10512343|NCT01299389|11662950|FG001|STARTED|Double-blind||159
10512344|NCT01299389|11662951|FG002|STARTED|Double-blind||0
10512345|NCT01299389|11662952|FG003|STARTED|Double-blind||0
10512346|NCT01299389|11662949|FG000|COMPLETED|Double-blind||55
10512347|NCT01299389|11662950|FG001|COMPLETED|Double-blind||95
10711342|NCT02659150|11876752|FG000|NOT COMPLETED|Baseline Imaging||2
10711343|NCT02659150|11876752|FG000|STARTED|Study Drug Dosing||9
10512348|NCT01299389|11662951|FG002|COMPLETED|Double-blind||0
10512349|NCT01299389|11662952|FG003|COMPLETED|Double-blind||0
10512350|NCT01299389|11662949|FG000|NOT COMPLETED|Double-blind||109
10512351|NCT01299389|11662950|FG001|NOT COMPLETED|Double-blind||64
10512352|NCT01299389|11662951|FG002|NOT COMPLETED|Double-blind||0
10512353|NCT01299389|11662952|FG003|NOT COMPLETED|Double-blind||0
10512354|NCT01299389|11662949|FG000|STARTED|Post-observational||0
10512355|NCT01299389|11662950|FG001|STARTED|Post-observational||0
10512356|NCT01299389|11662951|FG002|STARTED|Post-observational||156
10512357|NCT01299389|11662952|FG003|STARTED|Post-observational||155
10512358|NCT01299389|11662949|FG000|COMPLETED|Post-observational||0
10512359|NCT01299389|11662950|FG001|COMPLETED|Post-observational||0
10512360|NCT01299389|11662951|FG002|COMPLETED|Post-observational||144
10512361|NCT01299389|11662952|FG003|COMPLETED|Post-observational||149
10512362|NCT01299389|11662949|FG000|NOT COMPLETED|Post-observational||0
10512363|NCT01299389|11662950|FG001|NOT COMPLETED|Post-observational||0
10512364|NCT01299389|11662951|FG002|NOT COMPLETED|Post-observational||12
10512365|NCT01299389|11662952|FG003|NOT COMPLETED|Post-observational||6
10512366|NCT01299454|11662965|FG000|STARTED|Overall Study||8
10512367|NCT01299454|11662966|FG001|STARTED|Overall Study||8
10512368|NCT01299454|11662967|FG002|STARTED|Overall Study||6
10512369|NCT01299454|11662968|FG003|STARTED|Overall Study||23
10512370|NCT01299454|11662965|FG000|COMPLETED|Overall Study||8
10512371|NCT01299454|11662966|FG001|COMPLETED|Overall Study||8
10512372|NCT01299454|11662967|FG002|COMPLETED|Overall Study||6
10512373|NCT01299454|11662968|FG003|COMPLETED|Overall Study||23
10512374|NCT01299454|11662965|FG000|NOT COMPLETED|Overall Study||0
10512375|NCT01299454|11662966|FG001|NOT COMPLETED|Overall Study||0
10512376|NCT01299454|11662967|FG002|NOT COMPLETED|Overall Study||0
10512377|NCT01299454|11662968|FG003|NOT COMPLETED|Overall Study||0
10512378|NCT01299480|11663009|FG000|STARTED|Overall Study||427
10512379|NCT01299480|11663010|FG001|STARTED|Overall Study||430
10512380|NCT01299480|11663011|FG002|STARTED|Overall Study||427
10512381|NCT01299480|11663012|FG003|STARTED|Overall Study||286
10512382|NCT01299480|11663013|FG004|STARTED|Overall Study||143
10512383|NCT01299480|11663009|FG000|COMPLETED|Overall Study||385
10512384|NCT01299480|11663010|FG001|COMPLETED|Overall Study||395
10512385|NCT01299480|11663011|FG002|COMPLETED|Overall Study||386
10512386|NCT01299480|11663012|FG003|COMPLETED|Overall Study||261
10512387|NCT01299480|11663013|FG004|COMPLETED|Overall Study||123
10512388|NCT01299480|11663009|FG000|NOT COMPLETED|Overall Study||42
10711344|NCT02659150|11876752|FG000|COMPLETED|Study Drug Dosing||8
10512389|NCT01299480|11663010|FG001|NOT COMPLETED|Overall Study||35
10512390|NCT01299480|11663011|FG002|NOT COMPLETED|Overall Study||41
10512391|NCT01299480|11663012|FG003|NOT COMPLETED|Overall Study||25
10512392|NCT01299480|11663013|FG004|NOT COMPLETED|Overall Study||20
10512393|NCT01299571|11663026|FG000|STARTED|Overall Study||3977
10512394|NCT01299571|11663026|FG000|COMPLETED|Overall Study||3870
10512395|NCT01299571|11663026|FG000|NOT COMPLETED|Overall Study||107
10512396|NCT01299584|11663031|FG000|STARTED|Overall Study||775
10512397|NCT01299584|11663031|FG000|COMPLETED|Overall Study||766
10512398|NCT01299584|11663031|FG000|NOT COMPLETED|Overall Study||9
10512399|NCT01299610|11663038|FG000|STARTED|Overall Study||10
10512400|NCT01299610|11663039|FG001|STARTED|Overall Study||5
10512401|NCT01299610|11663040|FG002|STARTED|Overall Study||10
10512402|NCT01299610|11663038|FG000|COMPLETED|Overall Study||10
10512403|NCT01299610|11663039|FG001|COMPLETED|Overall Study||5
10512404|NCT01299610|11663040|FG002|COMPLETED|Overall Study||10
10512405|NCT01299610|11663038|FG000|NOT COMPLETED|Overall Study||0
10512406|NCT01299610|11663039|FG001|NOT COMPLETED|Overall Study||0
10512407|NCT01299610|11663040|FG002|NOT COMPLETED|Overall Study||0
10512408|NCT01299727|11663055|FG000|STARTED|Overall Study||4
10512409|NCT01299727|11663056|FG001|STARTED|Overall Study||4
10512410|NCT01299727|11663057|FG002|STARTED|Overall Study||4
10512411|NCT01299727|11663055|FG000|COMPLETED|Overall Study||0
10512412|NCT01299727|11663056|FG001|COMPLETED|Overall Study||0
10512413|NCT01299727|11663057|FG002|COMPLETED|Overall Study||0
10512414|NCT01299727|11663055|FG000|NOT COMPLETED|Overall Study||4
10512415|NCT01299727|11663056|FG001|NOT COMPLETED|Overall Study||4
10512416|NCT01299727|11663057|FG002|NOT COMPLETED|Overall Study||4
10512417|NCT01299766|11663067|FG000|STARTED|Overall Study||111
10512418|NCT01299766|11663068|FG001|STARTED|Overall Study||110
10512419|NCT01299766|11663067|FG000|COMPLETED|Overall Study||77
10512420|NCT01299766|11663068|FG001|COMPLETED|Overall Study||87
10512421|NCT01299766|11663067|FG000|NOT COMPLETED|Overall Study||34
10512422|NCT01299766|11663068|FG001|NOT COMPLETED|Overall Study||23
10512423|NCT01299805|11663076|FG000|STARTED|Overall Study||12
10512424|NCT01299805|11663077|FG001|STARTED|Overall Study||5
10512425|NCT01299805|11663076|FG000|COMPLETED|Overall Study||10
10512426|NCT01299805|11663077|FG001|COMPLETED|Overall Study||5
10512427|NCT01299805|11663076|FG000|NOT COMPLETED|Overall Study||2
10512428|NCT01299805|11663077|FG001|NOT COMPLETED|Overall Study||0
10711345|NCT02659150|11876752|FG000|NOT COMPLETED|Study Drug Dosing||1
10711346|NCT02659150|11876752|FG000|STARTED|Follow-up Imaging||8
10512429|NCT01299896|11663085|FG000|STARTED|Overall Study||319
10512430|NCT01299896|11663086|FG001|STARTED|Overall Study||314
10512431|NCT01299896|11663085|FG000|COMPLETED|Overall Study||318
10512432|NCT01299896|11663086|FG001|COMPLETED|Overall Study||296
10512433|NCT01299896|11663085|FG000|NOT COMPLETED|Overall Study||1
10512434|NCT01299896|11663086|FG001|NOT COMPLETED|Overall Study||18
10512435|NCT01299909|11663095|FG000|STARTED|Overall Study||68
10512436|NCT01299909|11663096|FG001|STARTED|Overall Study||67
10512437|NCT01299909|11663097|FG002|STARTED|Overall Study||40
10512438|NCT01299909|11663095|FG000|COMPLETED|Overall Study||46
10512439|NCT01299909|11663096|FG001|COMPLETED|Overall Study||49
10512440|NCT01299909|11663097|FG002|COMPLETED|Overall Study||23
10512441|NCT01299909|11663095|FG000|NOT COMPLETED|Overall Study||22
10512442|NCT01299909|11663096|FG001|NOT COMPLETED|Overall Study||18
10512443|NCT01299909|11663097|FG002|NOT COMPLETED|Overall Study||17
10512444|NCT01299961|11663104|FG000|STARTED|Overall Study||25
10512445|NCT01299961|11663104|FG000|COMPLETED|Overall Study||19
10512446|NCT01299961|11663104|FG000|NOT COMPLETED|Overall Study||6
10512447|NCT01300052|11663110|FG000|STARTED|Overall Study||46
10512448|NCT01300052|11663111|FG001|STARTED|Overall Study||22
10512449|NCT01300052|11663110|FG000|COMPLETED|Overall Study||40
10512450|NCT01300052|11663111|FG001|COMPLETED|Overall Study||19
10512451|NCT01300052|11663110|FG000|NOT COMPLETED|Overall Study||6
10512452|NCT01300052|11663111|FG001|NOT COMPLETED|Overall Study||3
10512453|NCT01300065|11663119|FG000|STARTED|Overall Study||221
10512454|NCT01300065|11663120|FG001|STARTED|Overall Study||220
10512455|NCT01300065|11663119|FG000|COMPLETED|Overall Study||215
10512456|NCT01300065|11663120|FG001|COMPLETED|Overall Study||217
10512457|NCT01300065|11663119|FG000|NOT COMPLETED|Overall Study||6
10512458|NCT01300065|11663120|FG001|NOT COMPLETED|Overall Study||3
10512459|NCT01300234|11663128|FG000|STARTED|Overall Study||257
10512460|NCT01300234|11663129|FG001|STARTED|Overall Study||255
10512461|NCT01300234|11663128|FG000|COMPLETED|Overall Study||229
10512462|NCT01300234|11663129|FG001|COMPLETED|Overall Study||228
10512463|NCT01300234|11663128|FG000|NOT COMPLETED|Overall Study||28
10512464|NCT01300234|11663129|FG001|NOT COMPLETED|Overall Study||27
10512465|NCT01300247|11663148|FG000|STARTED|Overall Study||21
10512466|NCT01300247|11663149|FG001|STARTED|Overall Study||20
10512467|NCT01300247|11663148|FG000|COMPLETED|Overall Study||17
10512468|NCT01300247|11663149|FG001|COMPLETED|Overall Study||18
10512469|NCT01300247|11663148|FG000|NOT COMPLETED|Overall Study||4
10512470|NCT01300247|11663149|FG001|NOT COMPLETED|Overall Study||2
10512471|NCT01300260|11663157|FG000|STARTED|Period 1 of Study: First Intervention||15
10512472|NCT01300260|11663158|FG001|STARTED|Period 1 of Study: First Intervention||17
10512473|NCT01300260|11663157|FG000|Received at Least 1 Dose of Study Drug|Period 1 of Study: First Intervention||15
10512474|NCT01300260|11663158|FG001|Received at Least 1 Dose of Study Drug|Period 1 of Study: First Intervention||17
10512475|NCT01300260|11663157|FG000|COMPLETED|Period 1 of Study: First Intervention||14
10512476|NCT01300260|11663158|FG001|COMPLETED|Period 1 of Study: First Intervention||16
10512477|NCT01300260|11663157|FG000|NOT COMPLETED|Period 1 of Study: First Intervention||1
10512478|NCT01300260|11663158|FG001|NOT COMPLETED|Period 1 of Study: First Intervention||1
10512479|NCT01300260|11663157|FG000|STARTED|Washout Period of at Least 28 Days||14
10512480|NCT01300260|11663158|FG001|STARTED|Washout Period of at Least 28 Days||16
10512481|NCT01300260|11663157|FG000|COMPLETED|Washout Period of at Least 28 Days||14
10512482|NCT01300260|11663158|FG001|COMPLETED|Washout Period of at Least 28 Days||16
10512483|NCT01300260|11663157|FG000|NOT COMPLETED|Washout Period of at Least 28 Days||0
10512484|NCT01300260|11663158|FG001|NOT COMPLETED|Washout Period of at Least 28 Days||0
10512485|NCT01300260|11663157|FG000|STARTED|Period 2 of Study: Second Intervention||14
10512486|NCT01300260|11663158|FG001|STARTED|Period 2 of Study: Second Intervention||16
10512487|NCT01300260|11663157|FG000|COMPLETED|Period 2 of Study: Second Intervention||14
10512488|NCT01300260|11663158|FG001|COMPLETED|Period 2 of Study: Second Intervention||15
10512489|NCT01300260|11663157|FG000|NOT COMPLETED|Period 2 of Study: Second Intervention||0
10512490|NCT01300260|11663158|FG001|NOT COMPLETED|Period 2 of Study: Second Intervention||1
10512491|NCT01300286|11663175|FG000|STARTED|Overall Study||23
10512492|NCT01300286|11663175|FG000|COMPLETED|Overall Study||22
10512493|NCT01300286|11663175|FG000|NOT COMPLETED|Overall Study||1
10711347|NCT02659150|11876752|FG000|COMPLETED|Follow-up Imaging||8
10512494|NCT01300338|11663182|FG000|STARTED|Overall Study||25
10512495|NCT01300338|11663183|FG001|STARTED|Overall Study||25
10512496|NCT01300338|11663182|FG000|COMPLETED|Overall Study||20
10512497|NCT01300338|11663183|FG001|COMPLETED|Overall Study||25
10512498|NCT01300338|11663182|FG000|NOT COMPLETED|Overall Study||5
10512499|NCT01300338|11663183|FG001|NOT COMPLETED|Overall Study||0
10512500|NCT01300351|11663191|FG000|STARTED|Overall Study||111
10512501|NCT01300351|11663192|FG001|STARTED|Overall Study||110
10512502|NCT01300351|11663191|FG000|Received Study Treatment|Overall Study||109
10512503|NCT01300351|11663192|FG001|Received Study Treatment|Overall Study||110
10512504|NCT01300351|11663191|FG000|COMPLETED|Overall Study||75
10512505|NCT01300351|11663192|FG001|COMPLETED|Overall Study||72
10512506|NCT01300351|11663191|FG000|NOT COMPLETED|Overall Study||36
10711348|NCT02659150|11876752|FG000|NOT COMPLETED|Follow-up Imaging||0
10711349|NCT02659501|11876759|FG000|STARTED|Overall Study||12
10711350|NCT02659501|11876760|FG001|STARTED|Overall Study||12
10512507|NCT01300351|11663192|FG001|NOT COMPLETED|Overall Study||38
10512508|NCT01300455|11663200|FG000|STARTED|Period 1||13
10512509|NCT01300455|11663201|FG001|STARTED|Period 1||13
10512510|NCT01300455|11663200|FG000|COMPLETED|Period 1||13
10512511|NCT01300455|11663201|FG001|COMPLETED|Period 1||13
10512512|NCT01300455|11663200|FG000|NOT COMPLETED|Period 1||0
10512513|NCT01300455|11663201|FG001|NOT COMPLETED|Period 1||0
10512514|NCT01300455|11663200|FG000|STARTED|Washout||13
10512515|NCT01300455|11663201|FG001|STARTED|Washout||13
10512516|NCT01300455|11663200|FG000|COMPLETED|Washout||12
10512517|NCT01300455|11663201|FG001|COMPLETED|Washout||13
10512518|NCT01300455|11663200|FG000|NOT COMPLETED|Washout||1
10512519|NCT01300455|11663201|FG001|NOT COMPLETED|Washout||0
10512520|NCT01300455|11663200|FG000|STARTED|Period 2||12
10512521|NCT01300455|11663201|FG001|STARTED|Period 2||13
10512522|NCT01300455|11663200|FG000|COMPLETED|Period 2||12
10512523|NCT01300455|11663201|FG001|COMPLETED|Period 2||13
10512524|NCT01300455|11663200|FG000|NOT COMPLETED|Period 2||0
10512525|NCT01300455|11663201|FG001|NOT COMPLETED|Period 2||0
10512526|NCT01300546|11663209|FG000|STARTED|Overall Study||19
10512527|NCT01300546|11663210|FG001|STARTED|Overall Study||20
10512528|NCT01300546|11663209|FG000|COMPLETED|Overall Study||18
10512529|NCT01300546|11663210|FG001|COMPLETED|Overall Study||14
10512530|NCT01300546|11663209|FG000|NOT COMPLETED|Overall Study||1
10512531|NCT01300546|11663210|FG001|NOT COMPLETED|Overall Study||6
10512532|NCT01300559|11663218|FG000|STARTED|Overall Study||30
10512533|NCT01300559|11663219|FG001|STARTED|Overall Study||30
10512534|NCT01300559|11663218|FG000|COMPLETED|Overall Study||30
10512535|NCT01300559|11663219|FG001|COMPLETED|Overall Study||30
10512536|NCT01300559|11663218|FG000|NOT COMPLETED|Overall Study||0
10512537|NCT01300559|11663219|FG001|NOT COMPLETED|Overall Study||0
10512538|NCT01300572|11663225|FG000|STARTED|Overall Study||16
10512539|NCT01300572|11663225|FG000|COMPLETED|Overall Study||15
10512540|NCT01300572|11663225|FG000|NOT COMPLETED|Overall Study||1
10512541|NCT01300624|11663230|FG000|STARTED|Overall Study||11
10512542|NCT01300624|11663230|FG000|COMPLETED|Overall Study||11
10512543|NCT01300624|11663230|FG000|NOT COMPLETED|Overall Study||0
10512544|NCT01300650|11663235|FG000|STARTED|Overall Study||8
10512545|NCT01300650|11663235|FG000|COMPLETED|Overall Study||7
10512546|NCT01300650|11663235|FG000|NOT COMPLETED|Overall Study||1
10512547|NCT01300728|11663242|FG000|STARTED|Overall Study||26
10512548|NCT01300728|11663243|FG001|STARTED|Overall Study||26
10512549|NCT01300728|11663242|FG000|COMPLETED|Overall Study||24
10512550|NCT01300728|11663243|FG001|COMPLETED|Overall Study||25
10512551|NCT01300728|11663242|FG000|NOT COMPLETED|Overall Study||2
10512552|NCT01300728|11663243|FG001|NOT COMPLETED|Overall Study||1
10512553|NCT01300741|11663249|FG000|STARTED|Overall Study||75
10512554|NCT01300741|11663249|FG000|COMPLETED|Overall Study||72
10512555|NCT01300741|11663249|FG000|NOT COMPLETED|Overall Study||3
10512556|NCT01300767|11663255|FG000|STARTED|Overall Study||74
10512557|NCT01300767|11663255|FG000|COMPLETED|Overall Study||70
10512558|NCT01300767|11663255|FG000|NOT COMPLETED|Overall Study||4
10512559|NCT01300819|11663263|FG000|STARTED|Overall Study||125
10512560|NCT01300819|11663264|FG001|STARTED|Overall Study||224
10512561|NCT01300819|11663263|FG000|COMPLETED|Overall Study||103
10512562|NCT01300819|11663264|FG001|COMPLETED|Overall Study||180
10512563|NCT01300819|11663263|FG000|NOT COMPLETED|Overall Study||22
10711351|NCT02659501|11876759|FG000|COMPLETED|Overall Study||12
10512564|NCT01300819|11663264|FG001|NOT COMPLETED|Overall Study||44
10512565|NCT01300923|11663270|FG000|STARTED|Overall Study||12
10512566|NCT01300923|11663271|FG001|STARTED|Overall Study||2
10512567|NCT01300923|11663270|FG000|COMPLETED|Overall Study||12
10512568|NCT01300923|11663271|FG001|COMPLETED|Overall Study||0
10512569|NCT01300923|11663270|FG000|NOT COMPLETED|Overall Study||0
10512570|NCT01300923|11663271|FG001|NOT COMPLETED|Overall Study||2
10711352|NCT02659501|11876760|FG001|COMPLETED|Overall Study||12
10512571|NCT01300949|11663279|FG000|STARTED|Overall Study||154
10512572|NCT01300949|11663280|FG001|STARTED|Overall Study||125
10512573|NCT01300949|11663281|FG002|STARTED|Overall Study||35
10512574|NCT01300949|11663279|FG000|COMPLETED|Overall Study||154
10512575|NCT01300949|11663280|FG001|COMPLETED|Overall Study||125
10512576|NCT01300949|11663281|FG002|COMPLETED|Overall Study||35
10512577|NCT01300949|11663279|FG000|NOT COMPLETED|Overall Study||0
10512578|NCT01300949|11663280|FG001|NOT COMPLETED|Overall Study||0
10512579|NCT01300949|11663281|FG002|NOT COMPLETED|Overall Study||0
10512580|NCT01301001|11663289|FG000|STARTED|First Intervention||44
10512581|NCT01301001|11663290|FG001|STARTED|First Intervention||45
10512582|NCT01301001|11663289|FG000|COMPLETED|First Intervention||34
10512583|NCT01301001|11663290|FG001|COMPLETED|First Intervention||36
10512584|NCT01301001|11663289|FG000|NOT COMPLETED|First Intervention||10
10512585|NCT01301001|11663290|FG001|NOT COMPLETED|First Intervention||9
10711353|NCT02659501|11876759|FG000|NOT COMPLETED|Overall Study||0
10512586|NCT01301001|11663289|FG000|STARTED|Washout (2 Weeks)||34
10512587|NCT01301001|11663290|FG001|STARTED|Washout (2 Weeks)||36
10512588|NCT01301001|11663289|FG000|COMPLETED|Washout (2 Weeks)||34
10512589|NCT01301001|11663290|FG001|COMPLETED|Washout (2 Weeks)||36
10512590|NCT01301001|11663289|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10512591|NCT01301001|11663290|FG001|NOT COMPLETED|Washout (2 Weeks)||0
10512592|NCT01301001|11663289|FG000|STARTED|Second Intervention||34
10512593|NCT01301001|11663290|FG001|STARTED|Second Intervention||36
10512594|NCT01301001|11663289|FG000|COMPLETED|Second Intervention||30
10512595|NCT01301001|11663290|FG001|COMPLETED|Second Intervention||36
10512596|NCT01301001|11663289|FG000|NOT COMPLETED|Second Intervention||4
10512597|NCT01301001|11663290|FG001|NOT COMPLETED|Second Intervention||0
10512598|NCT01301027|11663299|FG000|STARTED|Overall Study||48
10512599|NCT01301027|11663300|FG001|STARTED|Overall Study||47
10512600|NCT01301027|11663299|FG000|COMPLETED|Overall Study||40
10512601|NCT01301027|11663300|FG001|COMPLETED|Overall Study||37
10512602|NCT01301027|11663299|FG000|NOT COMPLETED|Overall Study||8
10512603|NCT01301027|11663300|FG001|NOT COMPLETED|Overall Study||10
10512604|NCT01301066|11663308|FG000|STARTED|Overall Study||126
10512605|NCT01301066|11663309|FG001|STARTED|Overall Study||126
10512606|NCT01301066|11663308|FG000|COMPLETED|Overall Study||99
10512607|NCT01301066|11663309|FG001|COMPLETED|Overall Study||91
10512608|NCT01301066|11663308|FG000|NOT COMPLETED|Overall Study||27
10512609|NCT01301066|11663309|FG001|NOT COMPLETED|Overall Study||35
10512610|NCT01301079|11663317|FG000|STARTED|Overall Study||30
10512611|NCT01301079|11663318|FG001|STARTED|Overall Study||30
10512612|NCT01301079|11663317|FG000|COMPLETED|Overall Study||28
10512613|NCT01301079|11663318|FG001|COMPLETED|Overall Study||28
10512614|NCT01301079|11663317|FG000|NOT COMPLETED|Overall Study||2
10512615|NCT01301079|11663318|FG001|NOT COMPLETED|Overall Study||2
10711354|NCT02659501|11876760|FG001|NOT COMPLETED|Overall Study||0
10711355|NCT02659540|11876768|FG000|STARTED|Overall Study||10
10711356|NCT02659540|11876769|FG001|STARTED|Overall Study||10
10711357|NCT02659540|11876768|FG000|COMPLETED|Overall Study||4
10711358|NCT02659540|11876769|FG001|COMPLETED|Overall Study||2
10711359|NCT02659540|11876768|FG000|NOT COMPLETED|Overall Study||6
10711360|NCT02659540|11876769|FG001|NOT COMPLETED|Overall Study||8
10711361|NCT02659631|11876785|FG000|STARTED|Overall Study||1
10711362|NCT02659631|11876786|FG001|STARTED|Overall Study||2
10711363|NCT02659631|11876787|FG002|STARTED|Overall Study||3
10711364|NCT02659631|11876788|FG003|STARTED|Overall Study||2
10711365|NCT02659631|11876789|FG004|STARTED|Overall Study||5
10711366|NCT02659631|11876790|FG005|STARTED|Overall Study||5
10711367|NCT02659631|11876791|FG006|STARTED|Overall Study||4
10711368|NCT02659631|11876792|FG007|STARTED|Overall Study||3
10711369|NCT02659631|11876793|FG008|STARTED|Overall Study||2
10711370|NCT02659631|11876794|FG009|STARTED|Overall Study||1
10711371|NCT02659631|11876785|FG000|COMPLETED|Overall Study||0
10711372|NCT02659631|11876786|FG001|COMPLETED|Overall Study||0
10711373|NCT02659631|11876787|FG002|COMPLETED|Overall Study||0
10711374|NCT02659631|11876788|FG003|COMPLETED|Overall Study||0
10711375|NCT02659631|11876789|FG004|COMPLETED|Overall Study||0
10711376|NCT02659631|11876790|FG005|COMPLETED|Overall Study||2
10711377|NCT02659631|11876791|FG006|COMPLETED|Overall Study||3
10711378|NCT02659631|11876792|FG007|COMPLETED|Overall Study||0
10711379|NCT02659631|11876793|FG008|COMPLETED|Overall Study||0
10711380|NCT02659631|11876794|FG009|COMPLETED|Overall Study||1
10711381|NCT02659631|11876785|FG000|NOT COMPLETED|Overall Study||1
10711382|NCT02659631|11876786|FG001|NOT COMPLETED|Overall Study||2
10711383|NCT02659631|11876787|FG002|NOT COMPLETED|Overall Study||3
10711384|NCT02659631|11876788|FG003|NOT COMPLETED|Overall Study||2
10711385|NCT02659631|11876789|FG004|NOT COMPLETED|Overall Study||5
10711386|NCT02659631|11876790|FG005|NOT COMPLETED|Overall Study||3
10711387|NCT02659631|11876791|FG006|NOT COMPLETED|Overall Study||1
10711388|NCT02659631|11876792|FG007|NOT COMPLETED|Overall Study||3
10711389|NCT02659631|11876793|FG008|NOT COMPLETED|Overall Study||2
10711390|NCT02659631|11876794|FG009|NOT COMPLETED|Overall Study||0
10711391|NCT02659709|11876818|FG000|STARTED|Overall Study||50
10711392|NCT02659709|11876818|FG000|COMPLETED|Overall Study||50
10711393|NCT02659709|11876818|FG000|NOT COMPLETED|Overall Study||0
10711394|NCT02659787|11876822|FG000|STARTED|First Intervention (1 Day)||19
10711395|NCT02659787|11876823|FG001|STARTED|First Intervention (1 Day)||19
10711396|NCT02659787|11876822|FG000|COMPLETED|First Intervention (1 Day)||19
10711397|NCT02659787|11876823|FG001|COMPLETED|First Intervention (1 Day)||19
10512616|NCT01301092|11663331|FG000|STARTED|Overall Study||6
10512617|NCT01301092|11663332|FG001|STARTED|Overall Study||16
10512618|NCT01301092|11663333|FG002|STARTED|Overall Study||8
10512619|NCT01301092|11663331|FG000|COMPLETED|Overall Study||6
10711398|NCT02659787|11876822|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10711399|NCT02659787|11876823|FG001|NOT COMPLETED|First Intervention (1 Day)||0
10711400|NCT02659787|11876822|FG000|STARTED|Washout (3 Days)||19
10711401|NCT02659787|11876823|FG001|STARTED|Washout (3 Days)||19
10711402|NCT02659787|11876822|FG000|COMPLETED|Washout (3 Days)||19
10512620|NCT01301092|11663332|FG001|COMPLETED|Overall Study||16
10512621|NCT01301092|11663333|FG002|COMPLETED|Overall Study||7
10512622|NCT01301092|11663331|FG000|NOT COMPLETED|Overall Study||0
10512623|NCT01301092|11663332|FG001|NOT COMPLETED|Overall Study||0
10512624|NCT01301092|11663333|FG002|NOT COMPLETED|Overall Study||1
10512625|NCT01301183|11663348|FG000|STARTED|Overall Study||38
10512626|NCT01301183|11663349|FG001|STARTED|Overall Study||37
10512627|NCT01301183|11663348|FG000|COMPLETED|Overall Study||12
10512628|NCT01301183|11663349|FG001|COMPLETED|Overall Study||21
10711403|NCT02659787|11876823|FG001|COMPLETED|Washout (3 Days)||19
10711404|NCT02659787|11876822|FG000|NOT COMPLETED|Washout (3 Days)||0
10711405|NCT02659787|11876823|FG001|NOT COMPLETED|Washout (3 Days)||0
10711406|NCT02659787|11876822|FG000|STARTED|Second Intervention (1 Day)||19
10711407|NCT02659787|11876823|FG001|STARTED|Second Intervention (1 Day)||19
10711408|NCT02659787|11876822|FG000|COMPLETED|Second Intervention (1 Day)||19
10711409|NCT02659787|11876823|FG001|COMPLETED|Second Intervention (1 Day)||19
10711410|NCT02659787|11876822|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10711411|NCT02659787|11876823|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10711412|NCT02659943|11876836|FG000|STARTED|Overall Study||3
10810164|NCT03809039|11971996|FG004|NOT COMPLETED|Part 3||0
10810165|NCT03809039|11971997|FG005|NOT COMPLETED|Part 3||0
10810166|NCT03809039|11971998|FG006|NOT COMPLETED|Part 3||0
10810167|NCT03809039|11971999|FG007|NOT COMPLETED|Part 3||2
10711413|NCT02659943|11876837|FG001|STARTED|Overall Study||2
10711414|NCT02659943|11876838|FG002|STARTED|Overall Study||1
10711415|NCT02659943|11876839|FG003|STARTED|Overall Study||4
10711416|NCT02659943|11876840|FG004|STARTED|Overall Study||2
10711417|NCT02659943|11876841|FG005|STARTED|Overall Study||9
10711418|NCT02659943|11876842|FG006|STARTED|Overall Study||6
10711419|NCT02659943|11876836|FG000|COMPLETED|Overall Study||2
10711420|NCT02659943|11876837|FG001|COMPLETED|Overall Study||0
10810168|NCT03809039|11972000|FG008|NOT COMPLETED|Part 3||6
10810169|NCT03807700|11972035|FG000|STARTED|Overall Study||60
10810170|NCT03807700|11972036|FG001|STARTED|Overall Study||59
10810171|NCT03807700|11972035|FG000|COMPLETED|Overall Study||58
10810172|NCT03807700|11972036|FG001|COMPLETED|Overall Study||58
10810173|NCT03807700|11972035|FG000|NOT COMPLETED|Overall Study||2
10711421|NCT02659943|11876838|FG002|COMPLETED|Overall Study||0
10711422|NCT02659943|11876839|FG003|COMPLETED|Overall Study||1
10711423|NCT02659943|11876840|FG004|COMPLETED|Overall Study||0
10711424|NCT02659943|11876841|FG005|COMPLETED|Overall Study||4
10711425|NCT02659943|11876842|FG006|COMPLETED|Overall Study||0
10711426|NCT02659943|11876836|FG000|NOT COMPLETED|Overall Study||1
10711427|NCT02659943|11876837|FG001|NOT COMPLETED|Overall Study||2
10711428|NCT02659943|11876838|FG002|NOT COMPLETED|Overall Study||1
10711429|NCT02659943|11876839|FG003|NOT COMPLETED|Overall Study||3
10711430|NCT02659943|11876840|FG004|NOT COMPLETED|Overall Study||2
10711431|NCT02659943|11876841|FG005|NOT COMPLETED|Overall Study||5
10711432|NCT02659943|11876842|FG006|NOT COMPLETED|Overall Study||6
10711433|NCT02660112|11876863|FG000|STARTED|Overall Study||10
10711434|NCT02660112|11876863|FG000|COMPLETED|Overall Study||10
10711435|NCT02660112|11876863|FG000|NOT COMPLETED|Overall Study||0
10810174|NCT03807700|11972036|FG001|NOT COMPLETED|Overall Study||1
10810175|NCT03804918|11972043|FG000|STARTED|Overall Study||17
10810176|NCT03804918|11972043|FG000|COMPLETED|Overall Study||16
10810177|NCT03804918|11972043|FG000|NOT COMPLETED|Overall Study||1
10810178|NCT03805386|11972049|FG000|STARTED|Overall Study||32
10810179|NCT03805386|11972050|FG001|STARTED|Overall Study||33
10810180|NCT03805386|11972049|FG000|COMPLETED|Overall Study||32
10810181|NCT03805386|11972050|FG001|COMPLETED|Overall Study||33
10810182|NCT03805386|11972049|FG000|NOT COMPLETED|Overall Study||0
10810183|NCT03805386|11972050|FG001|NOT COMPLETED|Overall Study||0
10810184|NCT03803475|11972059|FG000|STARTED|Overall Study||485
10810185|NCT03803475|11972059|FG000|COMPLETED|Overall Study||484
10810186|NCT03803475|11972059|FG000|NOT COMPLETED|Overall Study||1
10810187|NCT03802227|11972065|FG000|STARTED|Overall Study||4
10810188|NCT03802227|11972066|FG001|STARTED|Overall Study||4
10810189|NCT03802227|11972065|FG000|COMPLETED|Overall Study||4
10810190|NCT03802227|11972066|FG001|COMPLETED|Overall Study||4
10810191|NCT03802227|11972065|FG000|NOT COMPLETED|Overall Study||0
10512629|NCT01301183|11663348|FG000|NOT COMPLETED|Overall Study||26
10512630|NCT01301183|11663349|FG001|NOT COMPLETED|Overall Study||16
10512631|NCT01301274|11663357|FG000|STARTED|Overall Study||34
10512632|NCT01301274|11663358|FG001|STARTED|Overall Study||32
10810192|NCT03802227|11972066|FG001|NOT COMPLETED|Overall Study||0
10811214|NCT03769896|11972941|FG001|STARTED|Open-label Phase||0
10811215|NCT03769896|11972940|FG000|COMPLETED|Open-label Phase||38
10811216|NCT03769896|11972941|FG001|COMPLETED|Open-label Phase||0
10512633|NCT01301274|11663357|FG000|COMPLETED|Overall Study||32
10811217|NCT03769896|11972940|FG000|NOT COMPLETED|Open-label Phase||9
10811218|NCT03769896|11972941|FG001|NOT COMPLETED|Open-label Phase||0
10811219|NCT03769896|11972940|FG000|STARTED|Double-blind Treatment Phase||19
10512634|NCT01301274|11663358|FG001|COMPLETED|Overall Study||31
10512635|NCT01301274|11663357|FG000|NOT COMPLETED|Overall Study||2
10512636|NCT01301274|11663358|FG001|NOT COMPLETED|Overall Study||1
10512637|NCT01301391|11663369|FG000|STARTED|Overall Study|On treatment until disease progression, patient withdrawal of consent, or unacceptable toxicity.|30
10512638|NCT01301391|11663369|FG000|COMPLETED|Overall Study||4
10512639|NCT01301391|11663369|FG000|NOT COMPLETED|Overall Study||26
10512640|NCT01301456|11663385|FG000|STARTED|Stage 1||15
10512641|NCT01301456|11663386|FG001|STARTED|Stage 1||5
10512642|NCT01301456|11663387|FG002|STARTED|Stage 1||6
10512643|NCT01301456|11663388|FG003|STARTED|Stage 1||6
10512644|NCT01301456|11663389|FG004|STARTED|Stage 1||7
10512645|NCT01301456|11663390|FG005|STARTED|Stage 1||5
10512646|NCT01301456|11663391|FG006|STARTED|Stage 1||8
10512647|NCT01301456|11663392|FG007|STARTED|Stage 1||0
10512648|NCT01301456|11663393|FG008|STARTED|Stage 1||0
10512649|NCT01301456|11663394|FG009|STARTED|Stage 1||0
10512650|NCT01301456|11663395|FG010|STARTED|Stage 1||0
10512651|NCT01301456|11663396|FG011|STARTED|Stage 1||0
10512652|NCT01301456|11663385|FG000|Received Treatment|Stage 1||15
10512653|NCT01301456|11663386|FG001|Received Treatment|Stage 1||5
10512654|NCT01301456|11663387|FG002|Received Treatment|Stage 1||6
10512655|NCT01301456|11663388|FG003|Received Treatment|Stage 1||6
10512656|NCT01301456|11663389|FG004|Received Treatment|Stage 1||7
10512657|NCT01301456|11663390|FG005|Received Treatment|Stage 1||5
10512658|NCT01301456|11663391|FG006|Received Treatment|Stage 1||7
10512659|NCT01301456|11663392|FG007|Received Treatment|Stage 1||0
10512660|NCT01301456|11663393|FG008|Received Treatment|Stage 1||0
10512661|NCT01301456|11663394|FG009|Received Treatment|Stage 1||0
10512662|NCT01301456|11663395|FG010|Received Treatment|Stage 1||0
10512663|NCT01301456|11663396|FG011|Received Treatment|Stage 1||0
10512664|NCT01301456|11663385|FG000|COMPLETED|Stage 1||15
10512665|NCT01301456|11663386|FG001|COMPLETED|Stage 1||5
10512666|NCT01301456|11663387|FG002|COMPLETED|Stage 1||5
10512667|NCT01301456|11663388|FG003|COMPLETED|Stage 1||6
10512668|NCT01301456|11663389|FG004|COMPLETED|Stage 1||6
10512669|NCT01301456|11663390|FG005|COMPLETED|Stage 1||5
10512670|NCT01301456|11663391|FG006|COMPLETED|Stage 1||7
10512671|NCT01301456|11663392|FG007|COMPLETED|Stage 1||0
10512672|NCT01301456|11663393|FG008|COMPLETED|Stage 1||0
10512673|NCT01301456|11663394|FG009|COMPLETED|Stage 1||0
10512674|NCT01301456|11663395|FG010|COMPLETED|Stage 1||0
10512675|NCT01301456|11663396|FG011|COMPLETED|Stage 1||0
10512676|NCT01301456|11663385|FG000|NOT COMPLETED|Stage 1||0
10512677|NCT01301456|11663386|FG001|NOT COMPLETED|Stage 1||0
10512678|NCT01301456|11663387|FG002|NOT COMPLETED|Stage 1||1
10512679|NCT01301456|11663388|FG003|NOT COMPLETED|Stage 1||0
10512680|NCT01301456|11663389|FG004|NOT COMPLETED|Stage 1||1
10512681|NCT01301456|11663390|FG005|NOT COMPLETED|Stage 1||0
10512682|NCT01301456|11663391|FG006|NOT COMPLETED|Stage 1||1
10512683|NCT01301456|11663392|FG007|NOT COMPLETED|Stage 1||0
10512684|NCT01301456|11663393|FG008|NOT COMPLETED|Stage 1||0
10512685|NCT01301456|11663394|FG009|NOT COMPLETED|Stage 1||0
10512686|NCT01301456|11663395|FG010|NOT COMPLETED|Stage 1||0
10512687|NCT01301456|11663396|FG011|NOT COMPLETED|Stage 1||0
10512688|NCT01301456|11663385|FG000|STARTED|Stage 2||0
10512689|NCT01301456|11663386|FG001|STARTED|Stage 2||0
10512690|NCT01301456|11663387|FG002|STARTED|Stage 2||0
10512691|NCT01301456|11663388|FG003|STARTED|Stage 2||0
10512692|NCT01301456|11663389|FG004|STARTED|Stage 2||0
10512693|NCT01301456|11663390|FG005|STARTED|Stage 2||0
10512694|NCT01301456|11663391|FG006|STARTED|Stage 2||0
10512695|NCT01301456|11663392|FG007|STARTED|Stage 2||7
10512696|NCT01301456|11663393|FG008|STARTED|Stage 2||5
10512697|NCT01301456|11663394|FG009|STARTED|Stage 2||7
10512698|NCT01301456|11663395|FG010|STARTED|Stage 2||7
10512699|NCT01301456|11663396|FG011|STARTED|Stage 2||6
10512700|NCT01301456|11663385|FG000|Received Treatment|Stage 2||0
10512701|NCT01301456|11663386|FG001|Received Treatment|Stage 2||0
10512702|NCT01301456|11663387|FG002|Received Treatment|Stage 2||0
10512703|NCT01301456|11663388|FG003|Received Treatment|Stage 2||0
10512704|NCT01301456|11663389|FG004|Received Treatment|Stage 2||0
10512705|NCT01301456|11663390|FG005|Received Treatment|Stage 2||0
10512706|NCT01301456|11663391|FG006|Received Treatment|Stage 2||0
10512707|NCT01301456|11663392|FG007|Received Treatment|Stage 2||7
10512708|NCT01301456|11663393|FG008|Received Treatment|Stage 2||5
10512709|NCT01301456|11663394|FG009|Received Treatment|Stage 2||7
10512710|NCT01301456|11663395|FG010|Received Treatment|Stage 2||7
10512711|NCT01301456|11663396|FG011|Received Treatment|Stage 2||6
10512712|NCT01301456|11663385|FG000|COMPLETED|Stage 2||0
10512713|NCT01301456|11663386|FG001|COMPLETED|Stage 2||0
10512714|NCT01301456|11663387|FG002|COMPLETED|Stage 2||0
10512715|NCT01301456|11663388|FG003|COMPLETED|Stage 2||0
10512716|NCT01301456|11663389|FG004|COMPLETED|Stage 2||0
10512717|NCT01301456|11663390|FG005|COMPLETED|Stage 2||0
10512718|NCT01301456|11663391|FG006|COMPLETED|Stage 2||0
10512719|NCT01301456|11663392|FG007|COMPLETED|Stage 2||7
10512720|NCT01301456|11663393|FG008|COMPLETED|Stage 2||5
10512721|NCT01301456|11663394|FG009|COMPLETED|Stage 2||7
10512722|NCT01301456|11663395|FG010|COMPLETED|Stage 2||6
10512723|NCT01301456|11663396|FG011|COMPLETED|Stage 2||6
10512724|NCT01301456|11663385|FG000|NOT COMPLETED|Stage 2||0
10512725|NCT01301456|11663386|FG001|NOT COMPLETED|Stage 2||0
10512726|NCT01301456|11663387|FG002|NOT COMPLETED|Stage 2||0
10512727|NCT01301456|11663388|FG003|NOT COMPLETED|Stage 2||0
10512728|NCT01301456|11663389|FG004|NOT COMPLETED|Stage 2||0
10512729|NCT01301456|11663390|FG005|NOT COMPLETED|Stage 2||0
10512730|NCT01301456|11663391|FG006|NOT COMPLETED|Stage 2||0
10512731|NCT01301456|11663392|FG007|NOT COMPLETED|Stage 2||0
10512732|NCT01301456|11663393|FG008|NOT COMPLETED|Stage 2||0
10512733|NCT01301456|11663394|FG009|NOT COMPLETED|Stage 2||0
10512734|NCT01301456|11663395|FG010|NOT COMPLETED|Stage 2||1
10512735|NCT01301456|11663396|FG011|NOT COMPLETED|Stage 2||0
10512736|NCT01301508|11663442|FG000|STARTED|Overall Study||21
10512737|NCT01301508|11663443|FG001|STARTED|Overall Study||25
10512738|NCT01301508|11663442|FG000|COMPLETED|Overall Study||20
10512739|NCT01301508|11663443|FG001|COMPLETED|Overall Study||22
10512740|NCT01301508|11663442|FG000|NOT COMPLETED|Overall Study||1
10512741|NCT01301508|11663443|FG001|NOT COMPLETED|Overall Study||3
10512742|NCT01301625|11663449|FG000|STARTED|Overall Study||78
10512743|NCT01301625|11663449|FG000|COMPLETED|Overall Study||43
10512744|NCT01301625|11663449|FG000|NOT COMPLETED|Overall Study||35
10512745|NCT01301729|11663453|FG000|STARTED|Overall Study||32
10512746|NCT01301729|11663453|FG000|COMPLETED|Overall Study||28
10512747|NCT01301729|11663453|FG000|NOT COMPLETED|Overall Study||4
10512748|NCT01301742|11663458|FG000|STARTED|First Intervention||9
10512749|NCT01301742|11663459|FG001|STARTED|First Intervention||9
10512750|NCT01301742|11663458|FG000|COMPLETED|First Intervention||9
10512751|NCT01301742|11663459|FG001|COMPLETED|First Intervention||9
10512752|NCT01301742|11663458|FG000|NOT COMPLETED|First Intervention||0
10512753|NCT01301742|11663459|FG001|NOT COMPLETED|First Intervention||0
10512754|NCT01301742|11663458|FG000|STARTED|Washout Period of at Least 7 Days||9
10512755|NCT01301742|11663459|FG001|STARTED|Washout Period of at Least 7 Days||9
10512756|NCT01301742|11663458|FG000|COMPLETED|Washout Period of at Least 7 Days||9
10512757|NCT01301742|11663459|FG001|COMPLETED|Washout Period of at Least 7 Days||9
10512758|NCT01301742|11663458|FG000|NOT COMPLETED|Washout Period of at Least 7 Days||0
10512759|NCT01301742|11663459|FG001|NOT COMPLETED|Washout Period of at Least 7 Days||0
10512760|NCT01301742|11663458|FG000|STARTED|Second Intervention||9
10512761|NCT01301742|11663459|FG001|STARTED|Second Intervention||9
10512762|NCT01301742|11663458|FG000|COMPLETED|Second Intervention||9
10512763|NCT01301742|11663459|FG001|COMPLETED|Second Intervention||9
10512764|NCT01301742|11663458|FG000|NOT COMPLETED|Second Intervention||0
10512765|NCT01301742|11663459|FG001|NOT COMPLETED|Second Intervention||0
10512766|NCT01301833|11663470|FG000|STARTED|Overall Study||212
10512767|NCT01301833|11663471|FG001|STARTED|Overall Study||80
10512768|NCT01301833|11663472|FG002|STARTED|Overall Study||95
10512769|NCT01301833|11663473|FG003|STARTED|Overall Study||75
10512770|NCT01301833|11663470|FG000|COMPLETED|Overall Study||197
10512771|NCT01301833|11663471|FG001|COMPLETED|Overall Study||72
10512772|NCT01301833|11663472|FG002|COMPLETED|Overall Study||88
10512773|NCT01301833|11663473|FG003|COMPLETED|Overall Study||68
10512774|NCT01301833|11663470|FG000|NOT COMPLETED|Overall Study||15
10512775|NCT01301833|11663471|FG001|NOT COMPLETED|Overall Study||8
10512776|NCT01301833|11663472|FG002|NOT COMPLETED|Overall Study||7
10512777|NCT01301833|11663473|FG003|NOT COMPLETED|Overall Study||7
10512778|NCT01301950|11663485|FG000|STARTED|Overall Study||15
10512779|NCT01301950|11663486|FG001|STARTED|Overall Study||15
10512780|NCT01301950|11663485|FG000|COMPLETED|Overall Study||15
10512781|NCT01301950|11663486|FG001|COMPLETED|Overall Study||14
10512782|NCT01301950|11663485|FG000|NOT COMPLETED|Overall Study||0
10512783|NCT01301950|11663486|FG001|NOT COMPLETED|Overall Study||1
10512784|NCT01302041|11663492|FG000|STARTED|Overall Study||67
10512785|NCT01302041|11663492|FG000|Treatment Received|Overall Study||67
10512786|NCT01302041|11663492|FG000|COMPLETED|Overall Study|Participants who discontinued treatment and completed the 30-day follow-up visit|27
10512787|NCT01302041|11663492|FG000|NOT COMPLETED|Overall Study||40
10512788|NCT01302054|11663497|FG000|STARTED|Tolterodine Open-Label Run-In Phase||990
10512789|NCT01302054|11663498|FG001|STARTED|Tolterodine Open-Label Run-In Phase||0
10512790|NCT01302054|11663499|FG002|STARTED|Tolterodine Open-Label Run-In Phase||0
10512791|NCT01302054|11663497|FG000|COMPLETED|Tolterodine Open-Label Run-In Phase||611
10512792|NCT01302054|11663498|FG001|COMPLETED|Tolterodine Open-Label Run-In Phase||0
10512793|NCT01302054|11663499|FG002|COMPLETED|Tolterodine Open-Label Run-In Phase||0
10512794|NCT01302054|11663497|FG000|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||379
10512795|NCT01302054|11663498|FG001|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||0
10512796|NCT01302054|11663499|FG002|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||0
10512797|NCT01302054|11663497|FG000|STARTED|Between Open-Label and Double Blind||611
10512798|NCT01302054|11663498|FG001|STARTED|Between Open-Label and Double Blind||0
10512799|NCT01302054|11663499|FG002|STARTED|Between Open-Label and Double Blind||0
10512800|NCT01302054|11663497|FG000|COMPLETED|Between Open-Label and Double Blind||609
10512801|NCT01302054|11663498|FG001|COMPLETED|Between Open-Label and Double Blind||0
10512802|NCT01302054|11663499|FG002|COMPLETED|Between Open-Label and Double Blind||0
10512803|NCT01302054|11663497|FG000|NOT COMPLETED|Between Open-Label and Double Blind||2
10512804|NCT01302054|11663498|FG001|NOT COMPLETED|Between Open-Label and Double Blind||0
10512805|NCT01302054|11663499|FG002|NOT COMPLETED|Between Open-Label and Double Blind||0
10512806|NCT01302054|11663497|FG000|STARTED|Double-Blind Treatment Phase||0
10512807|NCT01302054|11663498|FG001|STARTED|Double-Blind Treatment Phase||308
10512808|NCT01302054|11663499|FG002|STARTED|Double-Blind Treatment Phase||301
10512809|NCT01302054|11663497|FG000|COMPLETED|Double-Blind Treatment Phase||0
10512810|NCT01302054|11663498|FG001|COMPLETED|Double-Blind Treatment Phase||281
10512811|NCT01302054|11663499|FG002|COMPLETED|Double-Blind Treatment Phase||255
10512812|NCT01302054|11663497|FG000|NOT COMPLETED|Double-Blind Treatment Phase||0
10512813|NCT01302054|11663498|FG001|NOT COMPLETED|Double-Blind Treatment Phase||27
10512814|NCT01302054|11663499|FG002|NOT COMPLETED|Double-Blind Treatment Phase||46
10512815|NCT01302067|11663511|FG000|STARTED|Overall Study||790
10512816|NCT01302067|11663512|FG001|STARTED|Overall Study||386
10512817|NCT01302067|11663513|FG002|STARTED|Overall Study||779
10512818|NCT01302067|11663511|FG000|COMPLETED|Overall Study||712
10512819|NCT01302067|11663512|FG001|COMPLETED|Overall Study||352
10512820|NCT01302067|11663513|FG002|COMPLETED|Overall Study||681
10512821|NCT01302067|11663511|FG000|NOT COMPLETED|Overall Study||78
10512822|NCT01302067|11663512|FG001|NOT COMPLETED|Overall Study||34
10512823|NCT01302067|11663513|FG002|NOT COMPLETED|Overall Study||98
10512824|NCT01302080|11663524|FG000|STARTED|Overall Study|Out of 696 participants, 1 participant started treatment with another antidepressant alone or along with psychotherapy.|696
10512825|NCT01302080|11663525|FG001|STARTED|Overall Study|Out of 245 participants, 2 participants started treatment with another antidepressant alone or along with psychotherapy.|245
10512826|NCT01302080|11663524|FG000|COMPLETED|Overall Study||330
10512827|NCT01302080|11663525|FG001|COMPLETED|Overall Study||102
10512828|NCT01302080|11663524|FG000|NOT COMPLETED|Overall Study||366
10512829|NCT01302080|11663525|FG001|NOT COMPLETED|Overall Study||143
10512830|NCT01302119|11663557|FG000|STARTED|Overall Study||399
10512831|NCT01302119|11663558|FG001|STARTED|Overall Study||205
10512832|NCT01302119|11663557|FG000|COMPLETED|Overall Study||349
10512833|NCT01302119|11663558|FG001|COMPLETED|Overall Study||177
10512834|NCT01302119|11663557|FG000|NOT COMPLETED|Overall Study||50
10512835|NCT01302119|11663558|FG001|NOT COMPLETED|Overall Study||28
10512836|NCT01302366|11663564|FG000|STARTED|Overall Study||20
10512837|NCT01302366|11663564|FG000|COMPLETED|Overall Study||15
10512838|NCT01302366|11663564|FG000|NOT COMPLETED|Overall Study||5
10512839|NCT01302379|11663572|FG000|STARTED|Overall Study||83
10512840|NCT01302379|11663573|FG001|STARTED|Overall Study||83
10512841|NCT01302379|11663574|FG002|STARTED|Overall Study||84
10512842|NCT01302379|11663575|FG003|STARTED|Overall Study||83
10512843|NCT01302379|11663572|FG000|COMPLETED|Overall Study||76
10512844|NCT01302379|11663573|FG001|COMPLETED|Overall Study||78
10512845|NCT01302379|11663574|FG002|COMPLETED|Overall Study||80
10512846|NCT01302379|11663575|FG003|COMPLETED|Overall Study||79
10512847|NCT01302379|11663572|FG000|NOT COMPLETED|Overall Study||7
10512848|NCT01302379|11663573|FG001|NOT COMPLETED|Overall Study||5
10512849|NCT01302379|11663574|FG002|NOT COMPLETED|Overall Study||4
10512850|NCT01302379|11663575|FG003|NOT COMPLETED|Overall Study||4
10512851|NCT01302392|11663585|FG000|STARTED|Overall Study||158
10512852|NCT01302392|11663586|FG001|STARTED|Overall Study||157
10512853|NCT01302392|11663585|FG000|Treated|Overall Study||153
10512854|NCT01302392|11663586|FG001|Treated|Overall Study||157
10512855|NCT01302392|11663585|FG000|COMPLETED|Overall Study||151
10512856|NCT01302392|11663586|FG001|COMPLETED|Overall Study||156
10512857|NCT01302392|11663585|FG000|NOT COMPLETED|Overall Study||7
10512858|NCT01302392|11663586|FG001|NOT COMPLETED|Overall Study||1
10512859|NCT01302418|11663592|FG000|STARTED|Overall Study||272
10512860|NCT01302418|11663592|FG000|COMPLETED|Overall Study||254
10512861|NCT01302418|11663592|FG000|NOT COMPLETED|Overall Study||18
10512862|NCT01302483|11663598|FG000|STARTED|Overall Study||30
10512863|NCT01302483|11663599|FG001|STARTED|Overall Study||15
10512864|NCT01302483|11663598|FG000|COMPLETED|Overall Study||30
10512865|NCT01302483|11663599|FG001|COMPLETED|Overall Study||15
10512866|NCT01302483|11663598|FG000|NOT COMPLETED|Overall Study||0
10512867|NCT01302483|11663599|FG001|NOT COMPLETED|Overall Study||0
10512868|NCT01302548|11663613|FG000|STARTED|Overall Study||14
10512869|NCT01302548|11663614|FG001|STARTED|Overall Study||19
10512870|NCT01302548|11663613|FG000|COMPLETED|Overall Study||12
10512871|NCT01302548|11663614|FG001|COMPLETED|Overall Study||18
10512872|NCT01302548|11663613|FG000|NOT COMPLETED|Overall Study||2
10512873|NCT01302548|11663614|FG001|NOT COMPLETED|Overall Study||1
10512874|NCT01302691|11663622|FG000|STARTED|Overall Study||164
10512875|NCT01302691|11663623|FG001|STARTED|Overall Study||163
10512876|NCT01302691|11663622|FG000|COMPLETED|Overall Study||154
10512877|NCT01302691|11663623|FG001|COMPLETED|Overall Study||157
10512878|NCT01302691|11663622|FG000|NOT COMPLETED|Overall Study||10
10512879|NCT01302691|11663623|FG001|NOT COMPLETED|Overall Study||6
10711451|NCT02660229|11876885|FG000|STARTED|Overall Study|Randomization|34
10711452|NCT02660229|11876886|FG001|STARTED|Overall Study|Randomization|32
10711453|NCT02660229|11876885|FG000|Safety Analysis Set|Overall Study||34
10711454|NCT02660229|11876886|FG001|Safety Analysis Set|Overall Study||32
10810193|NCT03802864|11972076|FG000|STARTED|Overall Study||25
10512880|NCT01302743|11663632|FG000|STARTED|Overall Study||7
10512881|NCT01302743|11663633|FG001|STARTED|Overall Study||8
10512882|NCT01302743|11663634|FG002|STARTED|Overall Study||10
10512883|NCT01302743|11663632|FG000|COMPLETED|Overall Study||6
10512884|NCT01302743|11663633|FG001|COMPLETED|Overall Study||7
10512885|NCT01302743|11663634|FG002|COMPLETED|Overall Study||8
10512886|NCT01302743|11663632|FG000|NOT COMPLETED|Overall Study||1
10512887|NCT01302743|11663633|FG001|NOT COMPLETED|Overall Study||1
10512888|NCT01302743|11663634|FG002|NOT COMPLETED|Overall Study||2
10512889|NCT01302808|11663646|FG000|STARTED|Overall Study||3
10512890|NCT01302808|11663647|FG001|STARTED|Overall Study||7
10512891|NCT01302808|11663648|FG002|STARTED|Overall Study||4
10512892|NCT01302808|11663649|FG003|STARTED|Overall Study||3
10512893|NCT01302808|11663646|FG000|COMPLETED|Overall Study||3
10711455|NCT02660229|11876885|FG000|FAS Set|Overall Study|Oxycodone group: 1 patient was missed any efficacy assessment.|33
10512894|NCT01302808|11663647|FG001|COMPLETED|Overall Study||7
10512895|NCT01302808|11663648|FG002|COMPLETED|Overall Study||4
10512896|NCT01302808|11663649|FG003|COMPLETED|Overall Study||3
10512897|NCT01302808|11663646|FG000|NOT COMPLETED|Overall Study||0
10512898|NCT01302808|11663647|FG001|NOT COMPLETED|Overall Study||0
10512899|NCT01302808|11663648|FG002|NOT COMPLETED|Overall Study||0
10512900|NCT01302808|11663649|FG003|NOT COMPLETED|Overall Study||0
10512901|NCT01302860|11663661|FG000|STARTED|Overall Study||17
10512902|NCT01302860|11663661|FG000|COMPLETED|Overall Study||17
10512903|NCT01302860|11663661|FG000|NOT COMPLETED|Overall Study||0
10512904|NCT01302899|11663667|FG000|STARTED|Period 1 (Day 1 to End of Week 6)||4
10512905|NCT01302899|11663668|FG001|STARTED|Period 1 (Day 1 to End of Week 6)||4
10512906|NCT01302899|11663667|FG000|COMPLETED|Period 1 (Day 1 to End of Week 6)||4
10512907|NCT01302899|11663668|FG001|COMPLETED|Period 1 (Day 1 to End of Week 6)||4
10512908|NCT01302899|11663667|FG000|NOT COMPLETED|Period 1 (Day 1 to End of Week 6)||0
10512909|NCT01302899|11663668|FG001|NOT COMPLETED|Period 1 (Day 1 to End of Week 6)||0
10512910|NCT01302899|11663667|FG000|STARTED|Period 2 (Weeks 7 to 12)||4
10810194|NCT03802864|11972077|FG001|STARTED|Overall Study||25
10810195|NCT03802864|11972076|FG000|COMPLETED|Overall Study||25
10512911|NCT01302899|11663668|FG001|STARTED|Period 2 (Weeks 7 to 12)||4
10711456|NCT02660229|11876886|FG001|FAS Set|Overall Study||32
10512912|NCT01302899|11663667|FG000|COMPLETED|Period 2 (Weeks 7 to 12)||3
10512913|NCT01302899|11663668|FG001|COMPLETED|Period 2 (Weeks 7 to 12)||3
10512914|NCT01302899|11663667|FG000|NOT COMPLETED|Period 2 (Weeks 7 to 12)||1
10512915|NCT01302899|11663668|FG001|NOT COMPLETED|Period 2 (Weeks 7 to 12)||1
10512916|NCT01302899|11663667|FG000|STARTED|Period 3 (Weeks 13 to 18)||3
10512917|NCT01302899|11663668|FG001|STARTED|Period 3 (Weeks 13 to 18)||3
10512918|NCT01302899|11663667|FG000|COMPLETED|Period 3 (Weeks 13 to 18)||3
10512919|NCT01302899|11663668|FG001|COMPLETED|Period 3 (Weeks 13 to 18)||3
10512920|NCT01302899|11663667|FG000|NOT COMPLETED|Period 3 (Weeks 13 to 18)||0
10512921|NCT01302899|11663668|FG001|NOT COMPLETED|Period 3 (Weeks 13 to 18)||0
10512922|NCT01302899|11663667|FG000|STARTED|Period 4 (Weeks 19 to 26)||3
10512923|NCT01302899|11663668|FG001|STARTED|Period 4 (Weeks 19 to 26)||3
10512924|NCT01302899|11663667|FG000|COMPLETED|Period 4 (Weeks 19 to 26)||3
10512925|NCT01302899|11663668|FG001|COMPLETED|Period 4 (Weeks 19 to 26)||3
10512926|NCT01302899|11663667|FG000|NOT COMPLETED|Period 4 (Weeks 19 to 26)||0
10512927|NCT01302899|11663668|FG001|NOT COMPLETED|Period 4 (Weeks 19 to 26)||0
10512928|NCT01302938|11663680|FG000|STARTED|Overall Study||12
10512929|NCT01302938|11663681|FG001|STARTED|Overall Study||6
10512930|NCT01302938|11663680|FG000|COMPLETED|Overall Study||10
10512931|NCT01302938|11663681|FG001|COMPLETED|Overall Study||6
10512932|NCT01302938|11663680|FG000|NOT COMPLETED|Overall Study||2
10512933|NCT01302938|11663681|FG001|NOT COMPLETED|Overall Study||0
10512934|NCT01302964|11663690|FG000|STARTED|Overall Study||20
10512935|NCT01302964|11663691|FG001|STARTED|Overall Study||10
10512936|NCT01302964|11663690|FG000|COMPLETED|Overall Study||19
10512937|NCT01302964|11663691|FG001|COMPLETED|Overall Study||10
10512938|NCT01302964|11663690|FG000|NOT COMPLETED|Overall Study||1
10512939|NCT01302964|11663691|FG001|NOT COMPLETED|Overall Study||0
10512940|NCT01303068|11663699|FG000|STARTED|Overall Study||6
10512941|NCT01303068|11663700|FG001|STARTED|Overall Study||6
10512942|NCT01303068|11663699|FG000|COMPLETED|Overall Study||6
10512943|NCT01303068|11663700|FG001|COMPLETED|Overall Study||6
10512944|NCT01303068|11663699|FG000|NOT COMPLETED|Overall Study||0
10512945|NCT01303068|11663700|FG001|NOT COMPLETED|Overall Study||0
10512946|NCT01303159|11663706|FG000|STARTED|Overall Study||29
10512947|NCT01303159|11663706|FG000|COMPLETED|Overall Study||6
10512948|NCT01303159|11663706|FG000|NOT COMPLETED|Overall Study||23
10512949|NCT01303172|11663712|FG000|STARTED|Overall Study||75
10512950|NCT01303172|11663713|FG001|STARTED|Overall Study||35
10512951|NCT01303172|11663712|FG000|COMPLETED|Overall Study||12
10512952|NCT01303172|11663713|FG001|COMPLETED|Overall Study||1
10512953|NCT01303172|11663712|FG000|NOT COMPLETED|Overall Study||63
10512954|NCT01303172|11663713|FG001|NOT COMPLETED|Overall Study||34
10512955|NCT01303224|11663724|FG000|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|141
10512956|NCT01303224|11663725|FG001|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|142
10512957|NCT01303224|11663726|FG002|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|139
10512958|NCT01303224|11663727|FG003|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|143
10512959|NCT01303224|11663724|FG000|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|140
10512960|NCT01303224|11663725|FG001|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|138
10512961|NCT01303224|11663726|FG002|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|139
10512962|NCT01303224|11663727|FG003|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|142
10512963|NCT01303224|11663724|FG000|COMPLETED|Overall Study||130
10512964|NCT01303224|11663725|FG001|COMPLETED|Overall Study||131
10512965|NCT01303224|11663726|FG002|COMPLETED|Overall Study||133
10512966|NCT01303224|11663727|FG003|COMPLETED|Overall Study||133
10512967|NCT01303224|11663724|FG000|NOT COMPLETED|Overall Study||11
10512968|NCT01303224|11663725|FG001|NOT COMPLETED|Overall Study||11
10512969|NCT01303224|11663726|FG002|NOT COMPLETED|Overall Study||6
10512970|NCT01303224|11663727|FG003|NOT COMPLETED|Overall Study||10
10512971|NCT01303380|11663737|FG000|STARTED|Overall Study||9
10512972|NCT01303380|11663737|FG000|COMPLETED|Overall Study||8
10810196|NCT03802864|11972077|FG001|COMPLETED|Overall Study||25
10512973|NCT01303380|11663737|FG000|NOT COMPLETED|Overall Study||1
10512974|NCT01303406|11663743|FG000|STARTED|Overall Study||13
10512975|NCT01303406|11663744|FG001|STARTED|Overall Study||16
10512976|NCT01303406|11663743|FG000|COMPLETED|Overall Study||13
10512977|NCT01303406|11663744|FG001|COMPLETED|Overall Study||15
10512978|NCT01303406|11663743|FG000|NOT COMPLETED|Overall Study||0
10512979|NCT01303406|11663744|FG001|NOT COMPLETED|Overall Study||1
10512980|NCT01303419|11663750|FG000|STARTED|Overall Study|Subjects who met all Inclusion and none of the Exclusion criteria|224
10512981|NCT01303419|11663750|FG000|COMPLETED|Overall Study||128
10512982|NCT01303419|11663750|FG000|NOT COMPLETED|Overall Study||96
10512983|NCT01303445|11663754|FG000|STARTED|First Intervention (7 Days)||30
10512984|NCT01303445|11663755|FG001|STARTED|First Intervention (7 Days)||30
10512985|NCT01303445|11663754|FG000|COMPLETED|First Intervention (7 Days)||29
10512986|NCT01303445|11663755|FG001|COMPLETED|First Intervention (7 Days)||30
10512987|NCT01303445|11663754|FG000|NOT COMPLETED|First Intervention (7 Days)||1
10512988|NCT01303445|11663755|FG001|NOT COMPLETED|First Intervention (7 Days)||0
10512989|NCT01303445|11663754|FG000|STARTED|Second Intervention (7 Days)||29
10512990|NCT01303445|11663755|FG001|STARTED|Second Intervention (7 Days)||30
10512991|NCT01303445|11663754|FG000|COMPLETED|Second Intervention (7 Days)||28
10512992|NCT01303445|11663755|FG001|COMPLETED|Second Intervention (7 Days)||28
10512993|NCT01303445|11663754|FG000|NOT COMPLETED|Second Intervention (7 Days)||1
10512994|NCT01303445|11663755|FG001|NOT COMPLETED|Second Intervention (7 Days)||2
10512995|NCT01303445|11663754|FG000|STARTED|Washout (14 Days)||28
10512996|NCT01303445|11663755|FG001|STARTED|Washout (14 Days)||28
10512997|NCT01303445|11663754|FG000|COMPLETED|Washout (14 Days)||27
10512998|NCT01303445|11663755|FG001|COMPLETED|Washout (14 Days)||26
10512999|NCT01303445|11663754|FG000|NOT COMPLETED|Washout (14 Days)||1
10513000|NCT01303445|11663755|FG001|NOT COMPLETED|Washout (14 Days)||2
10513001|NCT01303445|11663754|FG000|STARTED|Third Intervention (7 Days)||27
10513002|NCT01303445|11663755|FG001|STARTED|Third Intervention (7 Days)||26
10513003|NCT01303445|11663754|FG000|COMPLETED|Third Intervention (7 Days)||27
10513004|NCT01303445|11663755|FG001|COMPLETED|Third Intervention (7 Days)||26
10513005|NCT01303445|11663754|FG000|NOT COMPLETED|Third Intervention (7 Days)||0
10513006|NCT01303445|11663755|FG001|NOT COMPLETED|Third Intervention (7 Days)||0
10513007|NCT01303445|11663754|FG000|STARTED|Fourth Intervention (7 Days)||27
10513008|NCT01303445|11663755|FG001|STARTED|Fourth Intervention (7 Days)||26
10513009|NCT01303445|11663754|FG000|COMPLETED|Fourth Intervention (7 Days)||26
10513010|NCT01303445|11663755|FG001|COMPLETED|Fourth Intervention (7 Days)||26
10513011|NCT01303445|11663754|FG000|NOT COMPLETED|Fourth Intervention (7 Days)||1
10513012|NCT01303445|11663755|FG001|NOT COMPLETED|Fourth Intervention (7 Days)||0
10513013|NCT01303445|11663754|FG000|STARTED|Follow-up Period (14 Days)||26
10513014|NCT01303445|11663755|FG001|STARTED|Follow-up Period (14 Days)||26
10513015|NCT01303445|11663754|FG000|COMPLETED|Follow-up Period (14 Days)||26
10513016|NCT01303445|11663755|FG001|COMPLETED|Follow-up Period (14 Days)||25
10513017|NCT01303445|11663754|FG000|NOT COMPLETED|Follow-up Period (14 Days)||0
10513018|NCT01303445|11663755|FG001|NOT COMPLETED|Follow-up Period (14 Days)||1
10513019|NCT01303510|11663767|FG000|STARTED|Overall Study||55
10513020|NCT01303510|11663768|FG001|STARTED|Overall Study||56
10513021|NCT01303510|11663767|FG000|COMPLETED|Overall Study||54
10513022|NCT01303510|11663768|FG001|COMPLETED|Overall Study||56
10513023|NCT01303510|11663767|FG000|NOT COMPLETED|Overall Study||1
10513024|NCT01303510|11663768|FG001|NOT COMPLETED|Overall Study||0
10513025|NCT01303627|11663776|FG000|STARTED|Overall Study||21
10513026|NCT01303627|11663777|FG001|STARTED|Overall Study||21
10513027|NCT01303627|11663776|FG000|COMPLETED|Overall Study||21
10513028|NCT01303627|11663777|FG001|COMPLETED|Overall Study|One patient excluded from the study because of the failure while performing uretero-renoscopy|20
10513029|NCT01303627|11663776|FG000|NOT COMPLETED|Overall Study||0
10513030|NCT01303627|11663777|FG001|NOT COMPLETED|Overall Study||1
10513031|NCT01303744|11663787|FG000|STARTED|Overall Study||24
10513032|NCT01303744|11663788|FG001|STARTED|Overall Study||24
10513033|NCT01303744|11663789|FG002|STARTED|Overall Study||24
10513034|NCT01303744|11663790|FG003|STARTED|Overall Study||24
10513035|NCT01303744|11663787|FG000|COMPLETED|Overall Study||24
10513036|NCT01303744|11663788|FG001|COMPLETED|Overall Study||24
10513037|NCT01303744|11663789|FG002|COMPLETED|Overall Study||24
10513038|NCT01303744|11663790|FG003|COMPLETED|Overall Study||24
10513039|NCT01303744|11663787|FG000|NOT COMPLETED|Overall Study||0
10513040|NCT01303744|11663788|FG001|NOT COMPLETED|Overall Study||0
10513041|NCT01303744|11663789|FG002|NOT COMPLETED|Overall Study||0
10513042|NCT01303744|11663790|FG003|NOT COMPLETED|Overall Study||0
10513043|NCT01303835|11663802|FG000|STARTED|Overall Study||54
10513044|NCT01303835|11663803|FG001|STARTED|Overall Study||56
10513045|NCT01303835|11663802|FG000|COMPLETED|Overall Study||35
10513046|NCT01303835|11663803|FG001|COMPLETED|Overall Study||31
10513047|NCT01303835|11663802|FG000|NOT COMPLETED|Overall Study||19
10513048|NCT01303835|11663803|FG001|NOT COMPLETED|Overall Study||25
10513049|NCT01303861|11663814|FG000|STARTED|Overall Study||109
10513050|NCT01303861|11663815|FG001|STARTED|Overall Study||50
10513051|NCT01303861|11663816|FG002|STARTED|Overall Study||55
10513052|NCT01303861|11663817|FG003|STARTED|Overall Study||113
10513053|NCT01303861|11663814|FG000|Finished Treatment Phase|Overall Study||71
10513054|NCT01303861|11663815|FG001|Finished Treatment Phase|Overall Study||34
10513055|NCT01303861|11663816|FG002|Finished Treatment Phase|Overall Study||39
10513056|NCT01303861|11663817|FG003|Finished Treatment Phase|Overall Study||72
10513057|NCT01303861|11663814|FG000|COMPLETED|Overall Study||51
10513058|NCT01303861|11663815|FG001|COMPLETED|Overall Study||25
10513059|NCT01303861|11663816|FG002|COMPLETED|Overall Study||19
10513060|NCT01303861|11663817|FG003|COMPLETED|Overall Study||54
10513061|NCT01303861|11663814|FG000|NOT COMPLETED|Overall Study||58
10513062|NCT01303861|11663815|FG001|NOT COMPLETED|Overall Study||25
10513063|NCT01303861|11663816|FG002|NOT COMPLETED|Overall Study||36
10513064|NCT01303861|11663817|FG003|NOT COMPLETED|Overall Study||59
10513065|NCT01303939|11663830|FG000|STARTED|Overall Study||22
10513066|NCT01303939|11663831|FG001|STARTED|Overall Study||15
10513067|NCT01303939|11663830|FG000|COMPLETED|Overall Study|Matched controls not found for comparisons. Only best matched glaucoma patients were included.|15
10513068|NCT01303939|11663831|FG001|COMPLETED|Overall Study||15
10513069|NCT01303939|11663830|FG000|NOT COMPLETED|Overall Study||7
10513070|NCT01303939|11663831|FG001|NOT COMPLETED|Overall Study||0
10513071|NCT01303965|11663841|FG000|STARTED|Overall Study||3
10513072|NCT01303965|11663842|FG001|STARTED|Overall Study||11
10513073|NCT01303965|11663841|FG000|COMPLETED|Overall Study||0
10513074|NCT01303965|11663842|FG001|COMPLETED|Overall Study||1
10513075|NCT01303965|11663841|FG000|NOT COMPLETED|Overall Study||3
10513076|NCT01303965|11663842|FG001|NOT COMPLETED|Overall Study||10
10513077|NCT01304082|11663848|FG000|STARTED|Overall Study||3
10513078|NCT01304082|11663849|FG001|STARTED|Overall Study||2
10513079|NCT01304082|11663850|FG002|STARTED|Overall Study||11
10513080|NCT01304082|11663851|FG003|STARTED|Overall Study||8
10513081|NCT01304082|11663852|FG004|STARTED|Overall Study||5
10513082|NCT01304082|11663848|FG000|First Intervention|Overall Study||3
10513083|NCT01304082|11663849|FG001|First Intervention|Overall Study||2
10513084|NCT01304082|11663850|FG002|First Intervention|Overall Study||11
10513085|NCT01304082|11663851|FG003|First Intervention|Overall Study||8
10513086|NCT01304082|11663852|FG004|First Intervention|Overall Study||5
10513087|NCT01304082|11663848|FG000|Second Intervention|Overall Study||3
10513088|NCT01304082|11663849|FG001|Second Intervention|Overall Study||2
10513089|NCT01304082|11663850|FG002|Second Intervention|Overall Study||11
10513090|NCT01304082|11663851|FG003|Second Intervention|Overall Study||8
10513091|NCT01304082|11663852|FG004|Second Intervention|Overall Study||5
10513092|NCT01304082|11663848|FG000|Third Intervention|Overall Study||3
10513093|NCT01304082|11663849|FG001|Third Intervention|Overall Study||2
10513094|NCT01304082|11663850|FG002|Third Intervention|Overall Study||11
10513095|NCT01304082|11663851|FG003|Third Intervention|Overall Study||8
10513096|NCT01304082|11663852|FG004|Third Intervention|Overall Study||5
10513097|NCT01304082|11663848|FG000|COMPLETED|Overall Study||3
10513098|NCT01304082|11663849|FG001|COMPLETED|Overall Study||2
10513099|NCT01304082|11663850|FG002|COMPLETED|Overall Study||11
10513100|NCT01304082|11663851|FG003|COMPLETED|Overall Study||8
10513101|NCT01304082|11663852|FG004|COMPLETED|Overall Study||5
10513102|NCT01304082|11663848|FG000|NOT COMPLETED|Overall Study||0
10513103|NCT01304082|11663849|FG001|NOT COMPLETED|Overall Study||0
10513104|NCT01304082|11663850|FG002|NOT COMPLETED|Overall Study||0
10513105|NCT01304082|11663851|FG003|NOT COMPLETED|Overall Study||0
10513106|NCT01304082|11663852|FG004|NOT COMPLETED|Overall Study||0
10513107|NCT01304147|11663860|FG000|STARTED|First Intervention (7days)||10
10513108|NCT01304147|11663861|FG001|STARTED|First Intervention (7days)||10
10513109|NCT01304147|11663860|FG000|COMPLETED|First Intervention (7days)||10
10513110|NCT01304147|11663861|FG001|COMPLETED|First Intervention (7days)||10
10513111|NCT01304147|11663860|FG000|NOT COMPLETED|First Intervention (7days)||0
10513112|NCT01304147|11663861|FG001|NOT COMPLETED|First Intervention (7days)||0
10513113|NCT01304147|11663860|FG000|STARTED|Washout (1 Day)||10
10513114|NCT01304147|11663861|FG001|STARTED|Washout (1 Day)||10
10513115|NCT01304147|11663860|FG000|COMPLETED|Washout (1 Day)||10
10513116|NCT01304147|11663861|FG001|COMPLETED|Washout (1 Day)||10
10513117|NCT01304147|11663860|FG000|NOT COMPLETED|Washout (1 Day)||0
10513118|NCT01304147|11663861|FG001|NOT COMPLETED|Washout (1 Day)||0
10513119|NCT01304147|11663860|FG000|STARTED|Second Intervention (7days)||10
10513120|NCT01304147|11663861|FG001|STARTED|Second Intervention (7days)||10
10513121|NCT01304147|11663860|FG000|COMPLETED|Second Intervention (7days)||9
10513122|NCT01304147|11663861|FG001|COMPLETED|Second Intervention (7days)||9
10513123|NCT01304147|11663860|FG000|NOT COMPLETED|Second Intervention (7days)||1
10513124|NCT01304147|11663861|FG001|NOT COMPLETED|Second Intervention (7days)||1
10513125|NCT01304238|11663877|FG000|STARTED|Overall Study||32
10513126|NCT01304238|11663878|FG001|STARTED|Overall Study||4
10513127|NCT01304238|11663879|FG002|STARTED|Overall Study||46
10513128|NCT01304238|11663880|FG003|STARTED|Overall Study||78
10513129|NCT01304238|11663881|FG004|STARTED|Overall Study||11
10513130|NCT01304238|11663882|FG005|STARTED|Overall Study||11
10513131|NCT01304238|11663883|FG006|STARTED|Overall Study||5
10513132|NCT01304238|11663884|FG007|STARTED|Overall Study||4
10513133|NCT01304238|11663885|FG008|STARTED|Overall Study||1
10513134|NCT01304238|11663886|FG009|STARTED|Overall Study||3
10513135|NCT01304238|11663877|FG000|COMPLETED|Overall Study||32
10513136|NCT01304238|11663878|FG001|COMPLETED|Overall Study||4
10513137|NCT01304238|11663879|FG002|COMPLETED|Overall Study||46
10513138|NCT01304238|11663880|FG003|COMPLETED|Overall Study||78
10513139|NCT01304238|11663881|FG004|COMPLETED|Overall Study||11
10513140|NCT01304238|11663882|FG005|COMPLETED|Overall Study||11
10513141|NCT01304238|11663883|FG006|COMPLETED|Overall Study||5
10513142|NCT01304238|11663884|FG007|COMPLETED|Overall Study||4
10513143|NCT01304238|11663885|FG008|COMPLETED|Overall Study||1
10513144|NCT01304238|11663886|FG009|COMPLETED|Overall Study||3
10513145|NCT01304238|11663877|FG000|NOT COMPLETED|Overall Study||0
10513146|NCT01304238|11663878|FG001|NOT COMPLETED|Overall Study||0
10513147|NCT01304238|11663879|FG002|NOT COMPLETED|Overall Study||0
10513148|NCT01304238|11663880|FG003|NOT COMPLETED|Overall Study||0
10513149|NCT01304238|11663881|FG004|NOT COMPLETED|Overall Study||0
10513150|NCT01304238|11663882|FG005|NOT COMPLETED|Overall Study||0
10513151|NCT01304238|11663883|FG006|NOT COMPLETED|Overall Study||0
10513152|NCT01304238|11663884|FG007|NOT COMPLETED|Overall Study||0
10513153|NCT01304238|11663885|FG008|NOT COMPLETED|Overall Study||0
10513154|NCT01304238|11663886|FG009|NOT COMPLETED|Overall Study||0
10513155|NCT01304277|11663908|FG000|STARTED|Screening (Replagal RB, Week 0- Week 2)||17
10513156|NCT01304277|11663908|FG000|COMPLETED|Screening (Replagal RB, Week 0- Week 2)||17
10513157|NCT01304277|11663908|FG000|NOT COMPLETED|Screening (Replagal RB, Week 0- Week 2)||0
10513158|NCT01304277|11663908|FG000|STARTED|Treatment (Replagal AF, Week 2- EOS)||17
10513159|NCT01304277|11663908|FG000|COMPLETED|Treatment (Replagal AF, Week 2- EOS)||17
10711457|NCT02660229|11876885|FG000|Per Protocol Set|Overall Study|Adverse events N=1, Prohibited medication N=4|28
10711458|NCT02660229|11876886|FG001|Per Protocol Set|Overall Study|Withdrawal of ICF N=1, IC/EC deviation N=1, Prohibited medication N=1|29
10711459|NCT02660229|11876885|FG000|COMPLETED|Overall Study||32
10513160|NCT01304277|11663908|FG000|NOT COMPLETED|Treatment (Replagal AF, Week 2- EOS)||0
10513161|NCT01304329|11663915|FG000|STARTED|First Intervention (3 Days)||3
10513162|NCT01304329|11663916|FG001|STARTED|First Intervention (3 Days)||3
10513163|NCT01304329|11663917|FG002|STARTED|First Intervention (3 Days)||3
10513164|NCT01304329|11663918|FG003|STARTED|First Intervention (3 Days)||3
10513165|NCT01304329|11663919|FG004|STARTED|First Intervention (3 Days)||3
10513166|NCT01304329|11663920|FG005|STARTED|First Intervention (3 Days)||3
10513167|NCT01304329|11663915|FG000|COMPLETED|First Intervention (3 Days)||3
10513168|NCT01304329|11663916|FG001|COMPLETED|First Intervention (3 Days)||3
10513169|NCT01304329|11663917|FG002|COMPLETED|First Intervention (3 Days)||3
10513170|NCT01304329|11663918|FG003|COMPLETED|First Intervention (3 Days)||3
10513171|NCT01304329|11663919|FG004|COMPLETED|First Intervention (3 Days)||3
10513172|NCT01304329|11663920|FG005|COMPLETED|First Intervention (3 Days)||3
10513173|NCT01304329|11663915|FG000|NOT COMPLETED|First Intervention (3 Days)||0
10513174|NCT01304329|11663916|FG001|NOT COMPLETED|First Intervention (3 Days)||0
10513175|NCT01304329|11663917|FG002|NOT COMPLETED|First Intervention (3 Days)||0
10513176|NCT01304329|11663918|FG003|NOT COMPLETED|First Intervention (3 Days)||0
10513177|NCT01304329|11663919|FG004|NOT COMPLETED|First Intervention (3 Days)||0
10513178|NCT01304329|11663920|FG005|NOT COMPLETED|First Intervention (3 Days)||0
10513179|NCT01304329|11663915|FG000|STARTED|Second Intervention (3 Days)||3
10513180|NCT01304329|11663916|FG001|STARTED|Second Intervention (3 Days)||3
10513181|NCT01304329|11663917|FG002|STARTED|Second Intervention (3 Days)||3
10513182|NCT01304329|11663918|FG003|STARTED|Second Intervention (3 Days)||3
10513183|NCT01304329|11663919|FG004|STARTED|Second Intervention (3 Days)||3
10513184|NCT01304329|11663920|FG005|STARTED|Second Intervention (3 Days)||3
10513185|NCT01304329|11663915|FG000|COMPLETED|Second Intervention (3 Days)||3
10513186|NCT01304329|11663916|FG001|COMPLETED|Second Intervention (3 Days)||3
10513187|NCT01304329|11663917|FG002|COMPLETED|Second Intervention (3 Days)||3
10513188|NCT01304329|11663918|FG003|COMPLETED|Second Intervention (3 Days)||3
10513189|NCT01304329|11663919|FG004|COMPLETED|Second Intervention (3 Days)||3
10513190|NCT01304329|11663920|FG005|COMPLETED|Second Intervention (3 Days)||3
10513191|NCT01304329|11663915|FG000|NOT COMPLETED|Second Intervention (3 Days)||0
10513192|NCT01304329|11663916|FG001|NOT COMPLETED|Second Intervention (3 Days)||0
10513193|NCT01304329|11663917|FG002|NOT COMPLETED|Second Intervention (3 Days)||0
10513194|NCT01304329|11663918|FG003|NOT COMPLETED|Second Intervention (3 Days)||0
10513195|NCT01304329|11663919|FG004|NOT COMPLETED|Second Intervention (3 Days)||0
10513196|NCT01304329|11663920|FG005|NOT COMPLETED|Second Intervention (3 Days)||0
10513197|NCT01304329|11663915|FG000|STARTED|Third Intervention (3 Days)||3
10513198|NCT01304329|11663916|FG001|STARTED|Third Intervention (3 Days)||3
10513199|NCT01304329|11663917|FG002|STARTED|Third Intervention (3 Days)||3
10513200|NCT01304329|11663918|FG003|STARTED|Third Intervention (3 Days)||3
10513201|NCT01304329|11663919|FG004|STARTED|Third Intervention (3 Days)||3
10513202|NCT01304329|11663920|FG005|STARTED|Third Intervention (3 Days)||3
10513203|NCT01304329|11663915|FG000|COMPLETED|Third Intervention (3 Days)||3
10513204|NCT01304329|11663916|FG001|COMPLETED|Third Intervention (3 Days)||2
10513205|NCT01304329|11663917|FG002|COMPLETED|Third Intervention (3 Days)||3
10711460|NCT02660229|11876886|FG001|COMPLETED|Overall Study||31
10711461|NCT02660229|11876885|FG000|NOT COMPLETED|Overall Study||2
10711462|NCT02660229|11876886|FG001|NOT COMPLETED|Overall Study||1
10711463|NCT02660242|11876892|FG000|STARTED|Control||16
10711464|NCT02660242|11876892|FG000|COMPLETED|Control||16
10711465|NCT02660242|11876892|FG000|NOT COMPLETED|Control||0
10711466|NCT02660242|11876892|FG000|STARTED|Basal Insulin Reduction||16
10711467|NCT02660242|11876892|FG000|COMPLETED|Basal Insulin Reduction||16
10513206|NCT01304329|11663918|FG003|COMPLETED|Third Intervention (3 Days)||3
10513207|NCT01304329|11663919|FG004|COMPLETED|Third Intervention (3 Days)||3
10513208|NCT01304329|11663920|FG005|COMPLETED|Third Intervention (3 Days)||3
10513209|NCT01304329|11663915|FG000|NOT COMPLETED|Third Intervention (3 Days)||0
10513210|NCT01304329|11663916|FG001|NOT COMPLETED|Third Intervention (3 Days)||1
10513211|NCT01304329|11663917|FG002|NOT COMPLETED|Third Intervention (3 Days)||0
10513212|NCT01304329|11663918|FG003|NOT COMPLETED|Third Intervention (3 Days)||0
10513213|NCT01304329|11663919|FG004|NOT COMPLETED|Third Intervention (3 Days)||0
10513214|NCT01304329|11663920|FG005|NOT COMPLETED|Third Intervention (3 Days)||0
10513215|NCT01304407|11663928|FG000|STARTED|Overall Study||29
10513216|NCT01304407|11663928|FG000|COMPLETED|Overall Study||29
10513217|NCT01304407|11663928|FG000|NOT COMPLETED|Overall Study||0
10711468|NCT02660242|11876892|FG000|NOT COMPLETED|Basal Insulin Reduction||0
10513218|NCT01304498|11663934|FG000|STARTED|Overall Study||300
10713844|NCT02682784|11879380|FG003|COMPLETED|Overall Study||29
10513219|NCT01304498|11663935|FG001|STARTED|Overall Study||300
10513220|NCT01304498|11663934|FG000|Received ≥1 Dose|Overall Study||300
10513221|NCT01304498|11663935|FG001|Received ≥1 Dose|Overall Study||300
10513222|NCT01304498|11663934|FG000|COMPLETED|Overall Study||294
10513223|NCT01304498|11663935|FG001|COMPLETED|Overall Study||295
10513224|NCT01304498|11663934|FG000|NOT COMPLETED|Overall Study||6
10513225|NCT01304498|11663935|FG001|NOT COMPLETED|Overall Study||5
10513226|NCT01304589|11663941|FG000|STARTED|Overall Study||31
10513227|NCT01304589|11663941|FG000|COMPLETED|Overall Study||18
10513228|NCT01304589|11663941|FG000|NOT COMPLETED|Overall Study||13
10513229|NCT01304641|11663948|FG000|STARTED|Overall Study||11470
10513230|NCT01304641|11663949|FG001|STARTED|Overall Study||20132
10513231|NCT01304641|11663948|FG000|COMPLETED|Overall Study||11470
10513232|NCT01304641|11663949|FG001|COMPLETED|Overall Study||20132
10513233|NCT01304641|11663948|FG000|NOT COMPLETED|Overall Study||0
10513234|NCT01304641|11663949|FG001|NOT COMPLETED|Overall Study||0
10513235|NCT01304693|11663960|FG000|STARTED|Overall Study||10
10513236|NCT01304693|11663961|FG001|STARTED|Overall Study||35
10513237|NCT01304693|11663962|FG002|STARTED|Overall Study||48
10513238|NCT01304693|11663963|FG003|STARTED|Overall Study||40
10513239|NCT01304693|11663964|FG004|STARTED|Overall Study||61
10513240|NCT01304693|11663960|FG000|COMPLETED|Overall Study||10
10513241|NCT01304693|11663961|FG001|COMPLETED|Overall Study||35
10513242|NCT01304693|11663962|FG002|COMPLETED|Overall Study||47
10513243|NCT01304693|11663963|FG003|COMPLETED|Overall Study||39
10513244|NCT01304693|11663964|FG004|COMPLETED|Overall Study||60
10513245|NCT01304693|11663960|FG000|NOT COMPLETED|Overall Study||0
10513246|NCT01304693|11663961|FG001|NOT COMPLETED|Overall Study||0
10513247|NCT01304693|11663962|FG002|NOT COMPLETED|Overall Study||1
10513248|NCT01304693|11663963|FG003|NOT COMPLETED|Overall Study||1
10513249|NCT01304693|11663964|FG004|NOT COMPLETED|Overall Study||1
10513250|NCT01304706|11663976|FG000|STARTED|Overall Study||121
10513251|NCT01304706|11663976|FG000|COMPLETED|Overall Study||104
10513252|NCT01304706|11663976|FG000|NOT COMPLETED|Overall Study||17
10513253|NCT01304940|11663982|FG000|STARTED|Overall Study||25
10513254|NCT01304940|11663983|FG001|STARTED|Overall Study||25
10513255|NCT01304940|11663982|FG000|Completed Study|Overall Study|recruitment ended when 25 participants completed study procedures|25
10513256|NCT01304940|11663983|FG001|Completed Study|Overall Study|recruitment ended when 25 participants completed study procedures|25
10711469|NCT02660242|11876892|FG000|STARTED|Glucose Tabs|16 participants were randomized but only 15 completed all 4 periods.|16
10711470|NCT02660242|11876892|FG000|COMPLETED|Glucose Tabs||15
10711471|NCT02660242|11876892|FG000|NOT COMPLETED|Glucose Tabs||1
10711472|NCT02660242|11876892|FG000|STARTED|Glucagon Injection|16 participants were randomized but only 15 completed all 4 periods.|16
10711473|NCT02660242|11876892|FG000|COMPLETED|Glucagon Injection||15
10711474|NCT02660242|11876892|FG000|NOT COMPLETED|Glucagon Injection||1
10513257|NCT01304940|11663982|FG000|COMPLETED|Overall Study|these participants met severity requirement and were included in study analyses|22
10513258|NCT01304940|11663983|FG001|COMPLETED|Overall Study||25
10513259|NCT01304940|11663982|FG000|NOT COMPLETED|Overall Study||3
10513260|NCT01304940|11663983|FG001|NOT COMPLETED|Overall Study||0
10513261|NCT01304966|11663989|FG000|STARTED|Overall Study||15
10513262|NCT01304966|11663989|FG000|COMPLETED|Overall Study||15
10513263|NCT01304966|11663989|FG000|NOT COMPLETED|Overall Study||0
10513264|NCT01305044|11663997|FG000|STARTED|Overall Study||32
10513265|NCT01305044|11663998|FG001|STARTED|Overall Study||31
10513266|NCT01305044|11663997|FG000|COMPLETED|Overall Study||29
10513267|NCT01305044|11663998|FG001|COMPLETED|Overall Study||25
10513268|NCT01305044|11663997|FG000|NOT COMPLETED|Overall Study||3
10513269|NCT01305044|11663998|FG001|NOT COMPLETED|Overall Study||6
10513270|NCT01305200|11664007|FG000|STARTED|Overall Study||111
10513271|NCT01305200|11664008|FG001|STARTED|Overall Study||112
10513272|NCT01305200|11664009|FG002|STARTED|Overall Study||3
10513273|NCT01305200|11664007|FG000|COMPLETED|Overall Study||82
10513274|NCT01305200|11664008|FG001|COMPLETED|Overall Study||81
10513275|NCT01305200|11664009|FG002|COMPLETED|Overall Study||0
10513276|NCT01305200|11664007|FG000|NOT COMPLETED|Overall Study||29
10513277|NCT01305200|11664008|FG001|NOT COMPLETED|Overall Study||31
10513278|NCT01305200|11664009|FG002|NOT COMPLETED|Overall Study||3
10513279|NCT01305213|11664017|FG000|STARTED|Overall Study||53
10513280|NCT01305213|11664018|FG001|STARTED|Overall Study||54
10513281|NCT01305213|11664017|FG000|COMPLETED|Overall Study||53
10513282|NCT01305213|11664018|FG001|COMPLETED|Overall Study||54
10513283|NCT01305213|11664017|FG000|NOT COMPLETED|Overall Study||0
10513284|NCT01305213|11664018|FG001|NOT COMPLETED|Overall Study||0
10513285|NCT01305239|11664027|FG000|STARTED|Overall Study||398
10513286|NCT01305239|11664027|FG000|Safety Set|Overall Study||397
10513287|NCT01305239|11664027|FG000|Intent to Treat Population|Overall Study||287
10513288|NCT01305239|11664027|FG000|COMPLETED|Overall Study||375
10513289|NCT01305239|11664027|FG000|NOT COMPLETED|Overall Study||23
10513290|NCT01305252|11664033|FG000|STARTED|Overall Study||10
10513291|NCT01305252|11664034|FG001|STARTED|Overall Study||11
10513292|NCT01305252|11664033|FG000|COMPLETED|Overall Study||9
10513293|NCT01305252|11664034|FG001|COMPLETED|Overall Study||11
10513294|NCT01305252|11664033|FG000|NOT COMPLETED|Overall Study||1
10513295|NCT01305252|11664034|FG001|NOT COMPLETED|Overall Study||0
10528482|NCT01395329|11680782|FG002|NOT COMPLETED|Overall Study||0
10528483|NCT01395368|11680793|FG000|STARTED|Overall Study||108
10528484|NCT01395368|11680793|FG000|COMPLETED|Overall Study||92
10528485|NCT01395368|11680793|FG000|NOT COMPLETED|Overall Study||16
10528486|NCT01395394|11680800|FG000|STARTED|Baseline Study Visit||4
10528487|NCT01395394|11680801|FG001|STARTED|Baseline Study Visit||3
10528488|NCT01395394|11680802|FG002|STARTED|Baseline Study Visit||5
10528489|NCT01395394|11680800|FG000|COMPLETED|Baseline Study Visit||3
10528490|NCT01395394|11680801|FG001|COMPLETED|Baseline Study Visit||3
10528491|NCT01395394|11680802|FG002|COMPLETED|Baseline Study Visit||5
10528492|NCT01395394|11680800|FG000|NOT COMPLETED|Baseline Study Visit||1
10528493|NCT01395394|11680801|FG001|NOT COMPLETED|Baseline Study Visit||0
10528494|NCT01395394|11680802|FG002|NOT COMPLETED|Baseline Study Visit||0
10528495|NCT01395394|11680800|FG000|STARTED|Study Visit 2 (Non-responders Only)||3
10528496|NCT01395394|11680801|FG001|STARTED|Study Visit 2 (Non-responders Only)||0
10528497|NCT01395394|11680802|FG002|STARTED|Study Visit 2 (Non-responders Only)||0
10528498|NCT01395394|11680800|FG000|COMPLETED|Study Visit 2 (Non-responders Only)||3
10528499|NCT01395394|11680801|FG001|COMPLETED|Study Visit 2 (Non-responders Only)||0
10528500|NCT01395394|11680802|FG002|COMPLETED|Study Visit 2 (Non-responders Only)||0
10528501|NCT01395394|11680800|FG000|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
10528502|NCT01395394|11680801|FG001|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
10528503|NCT01395394|11680802|FG002|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
10528504|NCT01395524|11680813|FG000|STARTED|Overall Study||97
10528505|NCT01395524|11680814|FG001|STARTED|Overall Study||99
10528506|NCT01395524|11680815|FG002|STARTED|Overall Study||106
10528507|NCT01395524|11680813|FG000|COMPLETED|Overall Study||79
10528508|NCT01395524|11680814|FG001|COMPLETED|Overall Study||83
10528509|NCT01395524|11680815|FG002|COMPLETED|Overall Study||89
10528510|NCT01395524|11680813|FG000|NOT COMPLETED|Overall Study||18
10528511|NCT01395524|11680814|FG001|NOT COMPLETED|Overall Study||16
10528512|NCT01395524|11680815|FG002|NOT COMPLETED|Overall Study||17
10528513|NCT01395537|11680823|FG000|STARTED|Phase I||13
10528514|NCT01395537|11680823|FG000|COMPLETED|Phase I||13
10528515|NCT01395537|11680823|FG000|NOT COMPLETED|Phase I||0
10528516|NCT01395537|11680823|FG000|STARTED|Phase II||1
10528517|NCT01395537|11680823|FG000|COMPLETED|Phase II||1
10528518|NCT01395537|11680823|FG000|NOT COMPLETED|Phase II||0
10528519|NCT01395758|11680829|FG000|STARTED|Open-label Treatment Period||51
10528520|NCT01395758|11680830|FG001|STARTED|Open-label Treatment Period||45
10528521|NCT01395758|11680831|FG002|STARTED|Open-label Treatment Period||0
10528522|NCT01395758|11680829|FG000|COMPLETED|Open-label Treatment Period||47
10528523|NCT01395758|11680830|FG001|COMPLETED|Open-label Treatment Period||45
10528524|NCT01395758|11680831|FG002|COMPLETED|Open-label Treatment Period||0
10528525|NCT01395758|11680829|FG000|NOT COMPLETED|Open-label Treatment Period||4
10528526|NCT01395758|11680830|FG001|NOT COMPLETED|Open-label Treatment Period||0
10528527|NCT01395758|11680831|FG002|NOT COMPLETED|Open-label Treatment Period||0
10528528|NCT01395758|11680829|FG000|STARTED|Crossover Period||0
10528529|NCT01395758|11680830|FG001|STARTED|Crossover Period||0
10528530|NCT01395758|11680831|FG002|STARTED|Crossover Period||26
10528531|NCT01395758|11680829|FG000|COMPLETED|Crossover Period||0
10528532|NCT01395758|11680830|FG001|COMPLETED|Crossover Period||0
10528533|NCT01395758|11680831|FG002|COMPLETED|Crossover Period||26
10528534|NCT01395758|11680829|FG000|NOT COMPLETED|Crossover Period||0
10528535|NCT01395758|11680830|FG001|NOT COMPLETED|Crossover Period||0
10528536|NCT01395758|11680831|FG002|NOT COMPLETED|Crossover Period||0
10528537|NCT01395784|11680838|FG000|STARTED|Overall Study||32
10528538|NCT01395784|11680838|FG000|COMPLETED|Overall Study||17
10528539|NCT01395784|11680838|FG000|NOT COMPLETED|Overall Study||15
10528540|NCT01395797|11680848|FG000|STARTED|Overall Study||19
10528541|NCT01395797|11680849|FG001|STARTED|Overall Study||4
10528542|NCT01395797|11680850|FG002|STARTED|Overall Study||18
10528543|NCT01395797|11680851|FG003|STARTED|Overall Study||15
10528544|NCT01395797|11680852|FG004|STARTED|Overall Study||9
10528545|NCT01395797|11680853|FG005|STARTED|Overall Study||17
10528546|NCT01395797|11680848|FG000|COMPLETED|Overall Study||16
10528547|NCT01395797|11680849|FG001|COMPLETED|Overall Study||3
10528548|NCT01395797|11680850|FG002|COMPLETED|Overall Study||14
10528549|NCT01395797|11680851|FG003|COMPLETED|Overall Study||13
10528550|NCT01395797|11680852|FG004|COMPLETED|Overall Study||7
10528551|NCT01395797|11680853|FG005|COMPLETED|Overall Study||14
10528552|NCT01395797|11680848|FG000|NOT COMPLETED|Overall Study||3
10528553|NCT01395797|11680849|FG001|NOT COMPLETED|Overall Study||1
10528554|NCT01395797|11680850|FG002|NOT COMPLETED|Overall Study||4
10528555|NCT01395797|11680851|FG003|NOT COMPLETED|Overall Study||2
10528556|NCT01395797|11680852|FG004|NOT COMPLETED|Overall Study||2
10528557|NCT01395797|11680853|FG005|NOT COMPLETED|Overall Study||3
10528558|NCT01395810|11680877|FG000|STARTED|Overall Study||18
10528559|NCT01395810|11680878|FG001|STARTED|Overall Study||48
10528560|NCT01395810|11680879|FG002|STARTED|Overall Study||0
10528561|NCT01395810|11680880|FG003|STARTED|Overall Study||5
10528562|NCT01395810|11680877|FG000|After Switching the Arms|Overall Study|18 subjects started in this arm and additional 3 subjects from 40 IU/kg switched to this arm|21
10528563|NCT01395810|11680878|FG001|After Switching the Arms|Overall Study|48 subjects started in this arm, 3 subjects in 10 IU/kg+1 subject in on-demand switched to this arm|52
10528564|NCT01395810|11680879|FG002|After Switching the Arms|Overall Study|No subjects started in this arm initially, 2 patients in 40 IU/kg arm switched to this arm.|2
10513296|NCT01305265|11664046|FG000|STARTED|Overall Study||71
10513297|NCT01305265|11664047|FG001|STARTED|Overall Study||70
10513298|NCT01305265|11664046|FG000|COMPLETED|Overall Study||69
10513299|NCT01305265|11664047|FG001|COMPLETED|Overall Study||64
10513300|NCT01305265|11664046|FG000|NOT COMPLETED|Overall Study||2
10513301|NCT01305265|11664047|FG001|NOT COMPLETED|Overall Study||6
10513302|NCT01305356|11664055|FG000|STARTED|Overall Study||132
10513303|NCT01305356|11664056|FG001|STARTED|Overall Study||167
10513304|NCT01305356|11664055|FG000|COMPLETED|Overall Study||132
10513305|NCT01305356|11664056|FG001|COMPLETED|Overall Study||167
10513306|NCT01305356|11664055|FG000|NOT COMPLETED|Overall Study||0
10513307|NCT01305356|11664056|FG001|NOT COMPLETED|Overall Study||0
10513308|NCT01305408|11664064|FG000|STARTED|Overall Study||199
10513309|NCT01305408|11664065|FG001|STARTED|Overall Study||200
10513310|NCT01305408|11664064|FG000|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|198
10513311|NCT01305408|11664065|FG001|Safety Population|Overall Study|Treated participants.|200
10513312|NCT01305408|11664064|FG000|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|196
10513313|NCT01305408|11664065|FG001|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|197
10513314|NCT01305408|11664064|FG000|COMPLETED|Overall Study||167
10513315|NCT01305408|11664065|FG001|COMPLETED|Overall Study||169
10513316|NCT01305408|11664064|FG000|NOT COMPLETED|Overall Study||32
10513317|NCT01305408|11664065|FG001|NOT COMPLETED|Overall Study||31
10513318|NCT01305473|11664071|FG000|STARTED|Overall Study||90
10513319|NCT01305473|11664071|FG000|COMPLETED|Overall Study||90
10513320|NCT01305473|11664071|FG000|NOT COMPLETED|Overall Study||0
10513321|NCT01305564|11664075|FG000|STARTED|Overall Study||200
10513322|NCT01305564|11664075|FG000|COMPLETED|Overall Study||163
10513323|NCT01305564|11664075|FG000|NOT COMPLETED|Overall Study||37
10513324|NCT01305577|11664093|FG000|STARTED|Overall Study||120
10513325|NCT01305577|11664094|FG001|STARTED|Overall Study||121
10513326|NCT01305577|11664095|FG002|STARTED|Overall Study||122
10513327|NCT01305577|11664093|FG000|Received Treatment|Overall Study||119
10513328|NCT01305577|11664094|FG001|Received Treatment|Overall Study||121
10513329|NCT01305577|11664095|FG002|Received Treatment|Overall Study||122
10513330|NCT01305577|11664093|FG000|COMPLETED|Overall Study||107
10513331|NCT01305577|11664094|FG001|COMPLETED|Overall Study||110
10513332|NCT01305577|11664095|FG002|COMPLETED|Overall Study||112
10513333|NCT01305577|11664093|FG000|NOT COMPLETED|Overall Study||13
10513334|NCT01305577|11664094|FG001|NOT COMPLETED|Overall Study||11
10513335|NCT01305577|11664095|FG002|NOT COMPLETED|Overall Study||10
10513336|NCT01305655|11664103|FG000|STARTED|Overall Study|July 2008|47
10513337|NCT01305655|11664103|FG000|COMPLETED|Overall Study|December 31, 2014|47
10513338|NCT01305655|11664103|FG000|NOT COMPLETED|Overall Study||0
10513339|NCT01305772|11664109|FG000|STARTED|Overall Study||5
10513340|NCT01305772|11664110|FG001|STARTED|Overall Study||1
10513341|NCT01305772|11664109|FG000|Genomic Screening + Biopsy #1|Overall Study||5
10513342|NCT01305772|11664110|FG001|Genomic Screening + Biopsy #1|Overall Study||1
10513343|NCT01305772|11664109|FG000|Research PET/CT #1|Overall Study||5
10513344|NCT01305772|11664110|FG001|Research PET/CT #1|Overall Study||1
10513345|NCT01305772|11664109|FG000|Panitumumab Dose #1|Overall Study||5
10513346|NCT01305772|11664110|FG001|Panitumumab Dose #1|Overall Study||1
10513347|NCT01305772|11664109|FG000|Research PET/CT #2|Overall Study||5
10513348|NCT01305772|11664110|FG001|Research PET/CT #2|Overall Study||1
10513349|NCT01305772|11664109|FG000|Surgery/Biopsy #2|Overall Study|2nd research tissue sample not collected for 4 patients due to safety risk to subject.|1
10513350|NCT01305772|11664110|FG001|Surgery/Biopsy #2|Overall Study||1
10513351|NCT01305772|11664109|FG000|RT + Panitumumab Dose #2 / #3|Overall Study|RT and doses #2 and #3 of panitumumab administered to patients regardless of 2nd biopsy status.|5
10513352|NCT01305772|11664110|FG001|RT + Panitumumab Dose #2 / #3|Overall Study||1
10513353|NCT01305772|11664109|FG000|COMPLETED|Overall Study||5
10513354|NCT01305772|11664110|FG001|COMPLETED|Overall Study||1
10513355|NCT01305772|11664109|FG000|NOT COMPLETED|Overall Study||0
10513356|NCT01305772|11664110|FG001|NOT COMPLETED|Overall Study||0
10513357|NCT01305811|11664117|FG000|STARTED|Overall Study||52
10513358|NCT01305811|11664118|FG001|STARTED|Overall Study||52
10513359|NCT01305811|11664117|FG000|COMPLETED|Overall Study||44
10513360|NCT01305811|11664118|FG001|COMPLETED|Overall Study||41
10513361|NCT01305811|11664117|FG000|NOT COMPLETED|Overall Study||8
10513362|NCT01305811|11664118|FG001|NOT COMPLETED|Overall Study||11
10513363|NCT01305941|11664126|FG000|STARTED|Overall Study||32
10513364|NCT01305941|11664126|FG000|COMPLETED|Overall Study||22
10513365|NCT01305941|11664126|FG000|NOT COMPLETED|Overall Study||10
10513366|NCT01306032|11664136|FG000|STARTED|First Intervention||22
10513367|NCT01306032|11664137|FG001|STARTED|First Intervention|Not all participants on the Cyclophosphamide Alone Arm met eligibility criteria to crossover.|20
10513368|NCT01306032|11664138|FG002|STARTED|First Intervention||37
10513369|NCT01306032|11664139|FG003|STARTED|First Intervention|Not all participants on the Cyclophosphamide Alone Arm met eligibility criteria to crossover.|38
10513370|NCT01306032|11664140|FG004|STARTED|First Intervention||2
10513371|NCT01306032|11664141|FG005|STARTED|First Intervention||2
10513372|NCT01306032|11664136|FG000|COMPLETED|First Intervention||21
10513373|NCT01306032|11664137|FG001|COMPLETED|First Intervention||18
10513374|NCT01306032|11664138|FG002|COMPLETED|First Intervention||35
10513375|NCT01306032|11664139|FG003|COMPLETED|First Intervention||37
10513376|NCT01306032|11664140|FG004|COMPLETED|First Intervention||0
10513377|NCT01306032|11664141|FG005|COMPLETED|First Intervention||0
10513378|NCT01306032|11664136|FG000|NOT COMPLETED|First Intervention||1
10513379|NCT01306032|11664137|FG001|NOT COMPLETED|First Intervention||2
10513380|NCT01306032|11664138|FG002|NOT COMPLETED|First Intervention||2
10513381|NCT01306032|11664139|FG003|NOT COMPLETED|First Intervention||1
10513382|NCT01306032|11664140|FG004|NOT COMPLETED|First Intervention||2
10513383|NCT01306032|11664141|FG005|NOT COMPLETED|First Intervention||2
10513384|NCT01306032|11664136|FG000|STARTED|Disease Progression/Crossover||0
10513385|NCT01306032|11664137|FG001|STARTED|Disease Progression/Crossover||16
10513386|NCT01306032|11664138|FG002|STARTED|Disease Progression/Crossover||0
10513387|NCT01306032|11664139|FG003|STARTED|Disease Progression/Crossover||29
10513388|NCT01306032|11664140|FG004|STARTED|Disease Progression/Crossover||0
10513389|NCT01306032|11664141|FG005|STARTED|Disease Progression/Crossover||0
10513390|NCT01306032|11664136|FG000|COMPLETED|Disease Progression/Crossover||0
10513391|NCT01306032|11664137|FG001|COMPLETED|Disease Progression/Crossover||14
10513392|NCT01306032|11664138|FG002|COMPLETED|Disease Progression/Crossover||0
10513393|NCT01306032|11664139|FG003|COMPLETED|Disease Progression/Crossover||26
10513394|NCT01306032|11664140|FG004|COMPLETED|Disease Progression/Crossover||0
10513395|NCT01306032|11664141|FG005|COMPLETED|Disease Progression/Crossover||0
10513396|NCT01306032|11664136|FG000|NOT COMPLETED|Disease Progression/Crossover||0
10513397|NCT01306032|11664137|FG001|NOT COMPLETED|Disease Progression/Crossover||2
10513398|NCT01306032|11664138|FG002|NOT COMPLETED|Disease Progression/Crossover||0
10513399|NCT01306032|11664139|FG003|NOT COMPLETED|Disease Progression/Crossover||3
10513400|NCT01306032|11664140|FG004|NOT COMPLETED|Disease Progression/Crossover||0
10513401|NCT01306032|11664141|FG005|NOT COMPLETED|Disease Progression/Crossover||0
10513402|NCT01306058|11664167|FG000|STARTED|Overall Study||27
10513403|NCT01306058|11664167|FG000|COMPLETED|Overall Study||25
10513404|NCT01306058|11664167|FG000|NOT COMPLETED|Overall Study||2
10513405|NCT01306162|11664175|FG000|STARTED|Period 1||9
10513406|NCT01306162|11664176|FG001|STARTED|Period 1||9
10513407|NCT01306162|11664177|FG002|STARTED|Period 1||9
10513408|NCT01306162|11664178|FG003|STARTED|Period 1||9
10513409|NCT01306162|11664175|FG000|COMPLETED|Period 1||9
10513410|NCT01306162|11664176|FG001|COMPLETED|Period 1||9
10513411|NCT01306162|11664177|FG002|COMPLETED|Period 1||9
10513412|NCT01306162|11664178|FG003|COMPLETED|Period 1||8
10513413|NCT01306162|11664175|FG000|NOT COMPLETED|Period 1||0
10513414|NCT01306162|11664176|FG001|NOT COMPLETED|Period 1||0
10513415|NCT01306162|11664177|FG002|NOT COMPLETED|Period 1||0
10513416|NCT01306162|11664178|FG003|NOT COMPLETED|Period 1||1
10513417|NCT01306162|11664175|FG000|STARTED|Washout 1|Treatment A was followed by a washout period of at least 96 hours.|9
10513418|NCT01306162|11664176|FG001|STARTED|Washout 1|Treatment A was followed by a washout period of at least 96 hours.|9
10513419|NCT01306162|11664177|FG002|STARTED|Washout 1|No washout period. Treatment D followed directly after treatment B.|9
10513420|NCT01306162|11664178|FG003|STARTED|Washout 1|No washout period.Treatment E followed directly after treatment C.|8
10513421|NCT01306162|11664175|FG000|COMPLETED|Washout 1||9
10513422|NCT01306162|11664176|FG001|COMPLETED|Washout 1||8
10513423|NCT01306162|11664177|FG002|COMPLETED|Washout 1||9
10513424|NCT01306162|11664178|FG003|COMPLETED|Washout 1||8
10513425|NCT01306162|11664175|FG000|NOT COMPLETED|Washout 1||0
10513426|NCT01306162|11664176|FG001|NOT COMPLETED|Washout 1||1
10513427|NCT01306162|11664177|FG002|NOT COMPLETED|Washout 1||0
10513428|NCT01306162|11664178|FG003|NOT COMPLETED|Washout 1||0
10513429|NCT01306162|11664175|FG000|STARTED|Period 2|No washout phase after Period 2.|9
10513430|NCT01306162|11664176|FG001|STARTED|Period 2|No washout phase after Period 2.|8
10513431|NCT01306162|11664177|FG002|STARTED|Period 2|No washout phase after Period 2.|9
10513432|NCT01306162|11664178|FG003|STARTED|Period 2|No washout phase after Period 2.|8
10513433|NCT01306162|11664175|FG000|COMPLETED|Period 2||9
10513434|NCT01306162|11664176|FG001|COMPLETED|Period 2||8
10513435|NCT01306162|11664177|FG002|COMPLETED|Period 2||9
10513436|NCT01306162|11664178|FG003|COMPLETED|Period 2||8
10513437|NCT01306162|11664175|FG000|NOT COMPLETED|Period 2||0
10513438|NCT01306162|11664176|FG001|NOT COMPLETED|Period 2||0
10513439|NCT01306162|11664177|FG002|NOT COMPLETED|Period 2||0
10513440|NCT01306162|11664178|FG003|NOT COMPLETED|Period 2||0
10513441|NCT01306162|11664175|FG000|STARTED|Period 3||9
10513442|NCT01306162|11664176|FG001|STARTED|Period 3||8
10513443|NCT01306162|11664177|FG002|STARTED|Period 3||9
10513444|NCT01306162|11664178|FG003|STARTED|Period 3||8
10513445|NCT01306162|11664175|FG000|COMPLETED|Period 3||9
10513446|NCT01306162|11664176|FG001|COMPLETED|Period 3||8
10513447|NCT01306162|11664177|FG002|COMPLETED|Period 3||9
10513448|NCT01306162|11664178|FG003|COMPLETED|Period 3||8
10513449|NCT01306162|11664175|FG000|NOT COMPLETED|Period 3||0
10513450|NCT01306162|11664176|FG001|NOT COMPLETED|Period 3||0
10513451|NCT01306162|11664177|FG002|NOT COMPLETED|Period 3||0
10513452|NCT01306162|11664178|FG003|NOT COMPLETED|Period 3||0
10513453|NCT01306162|11664175|FG000|STARTED|Washout 2|No washout period. Treatment E followed directly after treatment D.|9
10513454|NCT01306162|11664176|FG001|STARTED|Washout 2|No washout period. Treatment D followed directly after treatment E.|8
10513455|NCT01306162|11664177|FG002|STARTED|Washout 2|The last dose of Dronedarone was followed by a washout period of at least 10 days.|9
10513456|NCT01306162|11664178|FG003|STARTED|Washout 2|The last dose of Dronedarone was followed by a washout period of at least 10 days.|8
10513457|NCT01306162|11664175|FG000|COMPLETED|Washout 2||9
10513458|NCT01306162|11664176|FG001|COMPLETED|Washout 2||8
10513459|NCT01306162|11664177|FG002|COMPLETED|Washout 2||9
10513460|NCT01306162|11664178|FG003|COMPLETED|Washout 2||8
10513461|NCT01306162|11664175|FG000|NOT COMPLETED|Washout 2||0
10513462|NCT01306162|11664176|FG001|NOT COMPLETED|Washout 2||0
10513463|NCT01306162|11664177|FG002|NOT COMPLETED|Washout 2||0
10513464|NCT01306162|11664178|FG003|NOT COMPLETED|Washout 2||0
10513465|NCT01306162|11664175|FG000|STARTED|Period 4||9
10513466|NCT01306162|11664176|FG001|STARTED|Period 4||8
10513467|NCT01306162|11664177|FG002|STARTED|Period 4||9
10513468|NCT01306162|11664178|FG003|STARTED|Period 4||8
10513469|NCT01306162|11664175|FG000|COMPLETED|Period 4||9
10513470|NCT01306162|11664176|FG001|COMPLETED|Period 4||8
10513471|NCT01306162|11664177|FG002|COMPLETED|Period 4||9
10513472|NCT01306162|11664178|FG003|COMPLETED|Period 4||8
10513473|NCT01306162|11664175|FG000|NOT COMPLETED|Period 4||0
10513474|NCT01306162|11664176|FG001|NOT COMPLETED|Period 4||0
10513475|NCT01306162|11664177|FG002|NOT COMPLETED|Period 4||0
10513476|NCT01306162|11664178|FG003|NOT COMPLETED|Period 4||0
10513477|NCT01306175|11664191|FG000|STARTED|First Intervention||20
10513478|NCT01306175|11664191|FG000|COMPLETED|First Intervention||20
10513479|NCT01306175|11664191|FG000|NOT COMPLETED|First Intervention||0
10513480|NCT01306175|11664191|FG000|STARTED|Washout Period of at Least 14 Days||20
10513481|NCT01306175|11664191|FG000|COMPLETED|Washout Period of at Least 14 Days||20
10513482|NCT01306175|11664191|FG000|NOT COMPLETED|Washout Period of at Least 14 Days||0
10513483|NCT01306175|11664191|FG000|STARTED|Second Intervention||20
10513484|NCT01306175|11664191|FG000|COMPLETED|Second Intervention||20
10513485|NCT01306175|11664191|FG000|NOT COMPLETED|Second Intervention||0
10513486|NCT01306201|11664197|FG000|STARTED|Overall Study||63
10513487|NCT01306201|11664197|FG000|COMPLETED|Overall Study|Total of 10 subjects were excluded from analysis|53
10513488|NCT01306201|11664197|FG000|NOT COMPLETED|Overall Study||10
10513489|NCT01306214|11664208|FG000|STARTED|Overall Study||189
10513490|NCT01306214|11664209|FG001|STARTED|Overall Study||187
10513491|NCT01306214|11664210|FG002|STARTED|Overall Study||190
10513492|NCT01306214|11664208|FG000|COMPLETED|Overall Study||161
10513493|NCT01306214|11664209|FG001|COMPLETED|Overall Study||159
10513494|NCT01306214|11664210|FG002|COMPLETED|Overall Study||168
10513495|NCT01306214|11664208|FG000|NOT COMPLETED|Overall Study||28
10513496|NCT01306214|11664209|FG001|NOT COMPLETED|Overall Study||28
10513497|NCT01306214|11664210|FG002|NOT COMPLETED|Overall Study||22
10513498|NCT01306253|11664220|FG000|STARTED|Overall Study||57
10513499|NCT01306253|11664221|FG001|STARTED|Overall Study||57
10513500|NCT01306253|11664220|FG000|COMPLETED|Overall Study||56
10513501|NCT01306253|11664221|FG001|COMPLETED|Overall Study||56
10513502|NCT01306253|11664220|FG000|NOT COMPLETED|Overall Study||1
10513503|NCT01306253|11664221|FG001|NOT COMPLETED|Overall Study||1
10513504|NCT01306292|11664229|FG000|STARTED|First Injection||10
10513505|NCT01306292|11664230|FG001|STARTED|First Injection||8
10513506|NCT01306292|11664231|FG002|STARTED|First Injection||8
10513507|NCT01306292|11664232|FG003|STARTED|First Injection||10
10513508|NCT01306292|11664229|FG000|COMPLETED|First Injection||10
10513509|NCT01306292|11664230|FG001|COMPLETED|First Injection||8
10513510|NCT01306292|11664231|FG002|COMPLETED|First Injection||8
10513511|NCT01306292|11664232|FG003|COMPLETED|First Injection||10
10513512|NCT01306292|11664229|FG000|NOT COMPLETED|First Injection||0
10513513|NCT01306292|11664230|FG001|NOT COMPLETED|First Injection||0
10513514|NCT01306292|11664231|FG002|NOT COMPLETED|First Injection||0
10513515|NCT01306292|11664232|FG003|NOT COMPLETED|First Injection||0
10513516|NCT01306292|11664229|FG000|STARTED|Washout (at Least 10 Minutes)||10
10513517|NCT01306292|11664230|FG001|STARTED|Washout (at Least 10 Minutes)||8
10513518|NCT01306292|11664231|FG002|STARTED|Washout (at Least 10 Minutes)||8
10513519|NCT01306292|11664232|FG003|STARTED|Washout (at Least 10 Minutes)||10
10513520|NCT01306292|11664229|FG000|COMPLETED|Washout (at Least 10 Minutes)||10
10513521|NCT01306292|11664230|FG001|COMPLETED|Washout (at Least 10 Minutes)||8
10513522|NCT01306292|11664231|FG002|COMPLETED|Washout (at Least 10 Minutes)||8
10513523|NCT01306292|11664232|FG003|COMPLETED|Washout (at Least 10 Minutes)||10
10513524|NCT01306292|11664229|FG000|NOT COMPLETED|Washout (at Least 10 Minutes)||0
10513525|NCT01306292|11664230|FG001|NOT COMPLETED|Washout (at Least 10 Minutes)||0
10513526|NCT01306292|11664231|FG002|NOT COMPLETED|Washout (at Least 10 Minutes)||0
10513527|NCT01306292|11664232|FG003|NOT COMPLETED|Washout (at Least 10 Minutes)||0
10513528|NCT01306292|11664229|FG000|STARTED|Second Injection||10
10513529|NCT01306292|11664230|FG001|STARTED|Second Injection||8
10513530|NCT01306292|11664231|FG002|STARTED|Second Injection||8
10513531|NCT01306292|11664232|FG003|STARTED|Second Injection||10
10513532|NCT01306292|11664229|FG000|COMPLETED|Second Injection||10
10513533|NCT01306292|11664230|FG001|COMPLETED|Second Injection||8
10513534|NCT01306292|11664231|FG002|COMPLETED|Second Injection|1 subject completed both injections but not 24-hour follow-up; all other values were recorded.|7
10513535|NCT01306292|11664232|FG003|COMPLETED|Second Injection||10
10513536|NCT01306292|11664229|FG000|NOT COMPLETED|Second Injection||0
10513537|NCT01306292|11664230|FG001|NOT COMPLETED|Second Injection||0
10513538|NCT01306292|11664231|FG002|NOT COMPLETED|Second Injection||1
10513539|NCT01306292|11664232|FG003|NOT COMPLETED|Second Injection||0
10513540|NCT01306305|11664242|FG000|STARTED|Overall Study||55
10513541|NCT01306305|11664243|FG001|STARTED|Overall Study||55
10513542|NCT01306305|11664242|FG000|COMPLETED|Overall Study||53
10513543|NCT01306305|11664243|FG001|COMPLETED|Overall Study||55
10513544|NCT01306305|11664242|FG000|NOT COMPLETED|Overall Study||2
10513545|NCT01306305|11664243|FG001|NOT COMPLETED|Overall Study||0
10810197|NCT03802864|11972076|FG000|NOT COMPLETED|Overall Study||0
10810198|NCT03802864|11972077|FG001|NOT COMPLETED|Overall Study||0
10810199|NCT03801265|11972085|FG000|STARTED|Overall Study||23
10810200|NCT03801265|11972086|FG001|STARTED|Overall Study||23
10810201|NCT03801265|11972085|FG000|COMPLETED|Overall Study||23
10810202|NCT03801265|11972086|FG001|COMPLETED|Overall Study||23
10513552|NCT01306617|11664261|FG000|STARTED|Overall Study||19
10513553|NCT01306617|11664262|FG001|STARTED|Overall Study||14
10513554|NCT01306617|11664263|FG002|STARTED|Overall Study||17
10513555|NCT01306617|11664261|FG000|COMPLETED|Overall Study|The number of participants who completed study drug|18
10513556|NCT01306617|11664262|FG001|COMPLETED|Overall Study|The number of participants who completed study drug|13
10513557|NCT01306617|11664263|FG002|COMPLETED|Overall Study|The number of participants who completed study drug|12
10513558|NCT01306617|11664261|FG000|NOT COMPLETED|Overall Study||1
10513559|NCT01306617|11664262|FG001|NOT COMPLETED|Overall Study||1
10513560|NCT01306617|11664263|FG002|NOT COMPLETED|Overall Study||5
10513561|NCT01306643|11664271|FG000|STARTED|Overall Study||18
10513562|NCT01306643|11664271|FG000|COMPLETED|Overall Study|Completed Study was defined as participants who completed through Cycle 12 (Week 48) per protocol.|5
10513563|NCT01306643|11664271|FG000|NOT COMPLETED|Overall Study||13
10513564|NCT01306656|11664277|FG000|STARTED|Overall Study||7
10513565|NCT01306656|11664278|FG001|STARTED|Overall Study||2
10513566|NCT01306656|11664277|FG000|COMPLETED|Overall Study||6
10513567|NCT01306656|11664278|FG001|COMPLETED|Overall Study||2
10513568|NCT01306656|11664277|FG000|NOT COMPLETED|Overall Study||1
10513569|NCT01306656|11664278|FG001|NOT COMPLETED|Overall Study||0
10513570|NCT01306877|11664288|FG000|STARTED|Overall Study||78
10513571|NCT01306877|11664289|FG001|STARTED|Overall Study||71
10513572|NCT01306877|11664288|FG000|COMPLETED|Overall Study||75
10513573|NCT01306877|11664289|FG001|COMPLETED|Overall Study||67
10513574|NCT01306877|11664288|FG000|NOT COMPLETED|Overall Study||3
10513575|NCT01306877|11664289|FG001|NOT COMPLETED|Overall Study||4
10513576|NCT01306890|11664295|FG000|STARTED|Overall Study||1976
10513577|NCT01306890|11664295|FG000|COMPLETED|Overall Study|Subjects were alive at the end of the study and had completed at least 3 years of follow up.|457
10513578|NCT01306890|11664295|FG000|NOT COMPLETED|Overall Study||1519
10513579|NCT01306942|11664302|FG000|STARTED|Phase I||6
10513580|NCT01306942|11664303|FG001|STARTED|Phase I||4
10513581|NCT01306942|11664304|FG002|STARTED|Phase I||0
10513582|NCT01306942|11664305|FG003|STARTED|Phase I||0
10513583|NCT01306942|11664302|FG000|COMPLETED|Phase I||1
10513584|NCT01306942|11664303|FG001|COMPLETED|Phase I||1
10513585|NCT01306942|11664304|FG002|COMPLETED|Phase I||0
10513586|NCT01306942|11664305|FG003|COMPLETED|Phase I||0
10513587|NCT01306942|11664302|FG000|NOT COMPLETED|Phase I||5
10513588|NCT01306942|11664303|FG001|NOT COMPLETED|Phase I||3
10513589|NCT01306942|11664304|FG002|NOT COMPLETED|Phase I||0
10513590|NCT01306942|11664305|FG003|NOT COMPLETED|Phase I||0
10513591|NCT01306942|11664302|FG000|STARTED|Phase II|Two patients from phase I with measurable disease and RP2D were included in the phase II analyses.|2
10513592|NCT01306942|11664303|FG001|STARTED|Phase II|Dasatinib 140mg was not the RP2D, so these patients were not included in the phase II analyses.|0
10513593|NCT01306942|11664304|FG002|STARTED|Phase II||0
10513594|NCT01306942|11664305|FG003|STARTED|Phase II||27
10513595|NCT01306942|11664302|FG000|COMPLETED|Phase II||0
10513596|NCT01306942|11664303|FG001|COMPLETED|Phase II||0
10513597|NCT01306942|11664304|FG002|COMPLETED|Phase II||0
10513598|NCT01306942|11664305|FG003|COMPLETED|Phase II||11
10513599|NCT01306942|11664302|FG000|NOT COMPLETED|Phase II||2
10513600|NCT01306942|11664303|FG001|NOT COMPLETED|Phase II||0
10513601|NCT01306942|11664304|FG002|NOT COMPLETED|Phase II||0
10513602|NCT01306942|11664305|FG003|NOT COMPLETED|Phase II||16
10513603|NCT01306968|11664321|FG000|STARTED|Overall Study||7
10513604|NCT01306968|11664322|FG001|STARTED|Overall Study||23
10513605|NCT01306968|11664323|FG002|STARTED|Overall Study||24
10513606|NCT01306968|11664324|FG003|STARTED|Overall Study|2 participants withdrew before chamber sessions were initiated|25
10513607|NCT01306968|11664321|FG000|COMPLETED|Overall Study||6
10513608|NCT01306968|11664322|FG001|COMPLETED|Overall Study||20
10513609|NCT01306968|11664323|FG002|COMPLETED|Overall Study||23
10513610|NCT01306968|11664324|FG003|COMPLETED|Overall Study||21
10513611|NCT01306968|11664321|FG000|NOT COMPLETED|Overall Study||1
10513612|NCT01306968|11664322|FG001|NOT COMPLETED|Overall Study||3
10513613|NCT01306968|11664323|FG002|NOT COMPLETED|Overall Study||1
10513614|NCT01306968|11664324|FG003|NOT COMPLETED|Overall Study||4
10513615|NCT01307007|11664338|FG000|STARTED|Overall Study||25
10513616|NCT01307007|11664339|FG001|STARTED|Overall Study||30
10513617|NCT01307007|11664338|FG000|COMPLETED|Overall Study||25
10513618|NCT01307007|11664339|FG001|COMPLETED|Overall Study||30
10513619|NCT01307007|11664338|FG000|NOT COMPLETED|Overall Study||0
10513620|NCT01307007|11664339|FG001|NOT COMPLETED|Overall Study||0
10513621|NCT01307020|11664355|FG000|STARTED|Overall Study||61
10513622|NCT01307020|11664356|FG001|STARTED|Overall Study||63
10513623|NCT01307020|11664357|FG002|STARTED|Overall Study||63
10513624|NCT01307020|11664358|FG003|STARTED|Overall Study||61
10513625|NCT01307020|11664359|FG004|STARTED|Overall Study||60
10513626|NCT01307020|11664360|FG005|STARTED|Overall Study||61
10513627|NCT01307020|11664361|FG006|STARTED|Overall Study||59
10513628|NCT01307020|11664362|FG007|STARTED|Overall Study||60
10513629|NCT01307020|11664363|FG008|STARTED|Overall Study||61
10513630|NCT01307020|11664364|FG009|STARTED|Overall Study||62
10513631|NCT01307020|11664355|FG000|Safety Population|Overall Study||61
10513632|NCT01307020|11664356|FG001|Safety Population|Overall Study||63
10513633|NCT01307020|11664357|FG002|Safety Population|Overall Study||63
10513634|NCT01307020|11664358|FG003|Safety Population|Overall Study||61
10513635|NCT01307020|11664359|FG004|Safety Population|Overall Study||60
10513636|NCT01307020|11664360|FG005|Safety Population|Overall Study||61
10513637|NCT01307020|11664361|FG006|Safety Population|Overall Study||59
10513638|NCT01307020|11664362|FG007|Safety Population|Overall Study||60
10513639|NCT01307020|11664363|FG008|Safety Population|Overall Study||61
10513640|NCT01307020|11664364|FG009|Safety Population|Overall Study||62
10513641|NCT01307020|11664355|FG000|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
10513642|NCT01307020|11664356|FG001|ITT (>= 1 Assessment Post Randomization)|Overall Study||62
10513643|NCT01307020|11664357|FG002|ITT (>= 1 Assessment Post Randomization)|Overall Study||63
10513644|NCT01307020|11664358|FG003|ITT (>= 1 Assessment Post Randomization)|Overall Study||61
10513645|NCT01307020|11664359|FG004|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
10513646|NCT01307020|11664360|FG005|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
10513647|NCT01307020|11664361|FG006|ITT (>= 1 Assessment Post Randomization)|Overall Study||59
10513648|NCT01307020|11664362|FG007|ITT (>= 1 Assessment Post Randomization)|Overall Study||59
10513649|NCT01307020|11664363|FG008|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
10513650|NCT01307020|11664364|FG009|ITT (>= 1 Assessment Post Randomization)|Overall Study||62
10513651|NCT01307020|11664355|FG000|COMPLETED|Overall Study||61
10513652|NCT01307020|11664356|FG001|COMPLETED|Overall Study||62
10513653|NCT01307020|11664357|FG002|COMPLETED|Overall Study||62
10513654|NCT01307020|11664358|FG003|COMPLETED|Overall Study||60
10513655|NCT01307020|11664359|FG004|COMPLETED|Overall Study||60
10513656|NCT01307020|11664360|FG005|COMPLETED|Overall Study||61
10513657|NCT01307020|11664361|FG006|COMPLETED|Overall Study||58
10513658|NCT01307020|11664362|FG007|COMPLETED|Overall Study||60
10513659|NCT01307020|11664363|FG008|COMPLETED|Overall Study||61
10513660|NCT01307020|11664364|FG009|COMPLETED|Overall Study||62
10513661|NCT01307020|11664355|FG000|NOT COMPLETED|Overall Study||0
10513662|NCT01307020|11664356|FG001|NOT COMPLETED|Overall Study||1
10513663|NCT01307020|11664357|FG002|NOT COMPLETED|Overall Study||1
10513664|NCT01307020|11664358|FG003|NOT COMPLETED|Overall Study||1
10513665|NCT01307020|11664359|FG004|NOT COMPLETED|Overall Study||0
10513666|NCT01307020|11664360|FG005|NOT COMPLETED|Overall Study||0
10513667|NCT01307020|11664361|FG006|NOT COMPLETED|Overall Study||1
10513668|NCT01307020|11664362|FG007|NOT COMPLETED|Overall Study||0
10513669|NCT01307020|11664363|FG008|NOT COMPLETED|Overall Study||0
10513670|NCT01307020|11664364|FG009|NOT COMPLETED|Overall Study||0
10513671|NCT01307098|11664389|FG000|STARTED|Overall Study||3
10513672|NCT01307098|11664390|FG001|STARTED|Overall Study||3
10513673|NCT01307098|11664391|FG002|STARTED|Overall Study||3
10513765|NCT01307319|11664517|FG001|STARTED|Overall Study|Randomized|242
10513674|NCT01307098|11664389|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
10513675|NCT01307098|11664390|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
10513676|NCT01307098|11664391|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
10513677|NCT01307098|11664389|FG000|COMPLETED|Overall Study||3
10513678|NCT01307098|11664390|FG001|COMPLETED|Overall Study||3
10513679|NCT01307098|11664391|FG002|COMPLETED|Overall Study||3
10513680|NCT01307098|11664389|FG000|NOT COMPLETED|Overall Study||0
10513681|NCT01307098|11664390|FG001|NOT COMPLETED|Overall Study||0
10513682|NCT01307098|11664391|FG002|NOT COMPLETED|Overall Study||0
10513683|NCT01307111|11664402|FG000|STARTED|IUD Insertion||42
10513684|NCT01307111|11664403|FG001|STARTED|IUD Insertion||40
10513685|NCT01307111|11664402|FG000|COMPLETED|IUD Insertion||40
10513686|NCT01307111|11664403|FG001|COMPLETED|IUD Insertion||40
10513687|NCT01307111|11664402|FG000|NOT COMPLETED|IUD Insertion||2
10513688|NCT01307111|11664403|FG001|NOT COMPLETED|IUD Insertion||0
10513689|NCT01307111|11664402|FG000|STARTED|1-2 Week IUD Check up||40
10513690|NCT01307111|11664403|FG001|STARTED|1-2 Week IUD Check up||40
10513691|NCT01307111|11664402|FG000|COMPLETED|1-2 Week IUD Check up||38
10513692|NCT01307111|11664403|FG001|COMPLETED|1-2 Week IUD Check up||38
10513693|NCT01307111|11664402|FG000|NOT COMPLETED|1-2 Week IUD Check up||2
10513694|NCT01307111|11664403|FG001|NOT COMPLETED|1-2 Week IUD Check up||2
10513695|NCT01307267|11664432|FG000|STARTED|Overall Study||4
10513696|NCT01307267|11664433|FG001|STARTED|Overall Study||3
10513697|NCT01307267|11664434|FG002|STARTED|Overall Study||6
10513698|NCT01307267|11664435|FG003|STARTED|Overall Study||4
10513699|NCT01307267|11664436|FG004|STARTED|Overall Study||3
10513700|NCT01307267|11664437|FG005|STARTED|Overall Study||42
10513701|NCT01307267|11664438|FG006|STARTED|Overall Study||3
10513702|NCT01307267|11664439|FG007|STARTED|Overall Study||4
10513703|NCT01307267|11664440|FG008|STARTED|Overall Study||31
10513704|NCT01307267|11664441|FG009|STARTED|Overall Study||5
10513705|NCT01307267|11664442|FG010|STARTED|Overall Study||6
10513706|NCT01307267|11664443|FG011|STARTED|Overall Study||11
10513707|NCT01307267|11664444|FG012|STARTED|Overall Study||3
10513708|NCT01307267|11664445|FG013|STARTED|Overall Study||3
10513709|NCT01307267|11664446|FG014|STARTED|Overall Study||4
10513710|NCT01307267|11664447|FG015|STARTED|Overall Study||3
10513711|NCT01307267|11664448|FG016|STARTED|Overall Study||3
10513712|NCT01307267|11664449|FG017|STARTED|Overall Study||3
10513713|NCT01307267|11664450|FG018|STARTED|Overall Study||4
10513714|NCT01307267|11664451|FG019|STARTED|Overall Study||32
10513715|NCT01307267|11664452|FG020|STARTED|Overall Study||3
10513716|NCT01307267|11664453|FG021|STARTED|Overall Study||5
10513717|NCT01307267|11664454|FG022|STARTED|Overall Study||4
10513718|NCT01307267|11664432|FG000|COMPLETED|Overall Study||0
10513719|NCT01307267|11664433|FG001|COMPLETED|Overall Study||0
10513720|NCT01307267|11664434|FG002|COMPLETED|Overall Study||1
10513721|NCT01307267|11664435|FG003|COMPLETED|Overall Study||1
10513722|NCT01307267|11664436|FG004|COMPLETED|Overall Study||2
10513723|NCT01307267|11664437|FG005|COMPLETED|Overall Study||1
10513724|NCT01307267|11664438|FG006|COMPLETED|Overall Study||1
10513725|NCT01307267|11664439|FG007|COMPLETED|Overall Study||0
10513726|NCT01307267|11664440|FG008|COMPLETED|Overall Study||1
10513727|NCT01307267|11664441|FG009|COMPLETED|Overall Study||0
10513728|NCT01307267|11664442|FG010|COMPLETED|Overall Study||0
10513729|NCT01307267|11664443|FG011|COMPLETED|Overall Study||0
10513730|NCT01307267|11664444|FG012|COMPLETED|Overall Study||2
10513731|NCT01307267|11664445|FG013|COMPLETED|Overall Study||3
10513732|NCT01307267|11664446|FG014|COMPLETED|Overall Study||2
10513733|NCT01307267|11664447|FG015|COMPLETED|Overall Study||2
10513734|NCT01307267|11664448|FG016|COMPLETED|Overall Study||2
10513735|NCT01307267|11664449|FG017|COMPLETED|Overall Study||2
10513736|NCT01307267|11664450|FG018|COMPLETED|Overall Study||2
10513737|NCT01307267|11664451|FG019|COMPLETED|Overall Study||0
10513738|NCT01307267|11664452|FG020|COMPLETED|Overall Study||0
10513739|NCT01307267|11664453|FG021|COMPLETED|Overall Study||0
10513740|NCT01307267|11664454|FG022|COMPLETED|Overall Study||0
10513741|NCT01307267|11664432|FG000|NOT COMPLETED|Overall Study||4
10513742|NCT01307267|11664433|FG001|NOT COMPLETED|Overall Study||3
10513743|NCT01307267|11664434|FG002|NOT COMPLETED|Overall Study||5
10513744|NCT01307267|11664435|FG003|NOT COMPLETED|Overall Study||3
10513745|NCT01307267|11664436|FG004|NOT COMPLETED|Overall Study||1
10513746|NCT01307267|11664437|FG005|NOT COMPLETED|Overall Study||41
10513747|NCT01307267|11664438|FG006|NOT COMPLETED|Overall Study||2
10513748|NCT01307267|11664439|FG007|NOT COMPLETED|Overall Study||4
10513749|NCT01307267|11664440|FG008|NOT COMPLETED|Overall Study||30
10513750|NCT01307267|11664441|FG009|NOT COMPLETED|Overall Study||5
10513751|NCT01307267|11664442|FG010|NOT COMPLETED|Overall Study||6
10513752|NCT01307267|11664443|FG011|NOT COMPLETED|Overall Study||11
10513753|NCT01307267|11664444|FG012|NOT COMPLETED|Overall Study||1
10513754|NCT01307267|11664445|FG013|NOT COMPLETED|Overall Study||0
10513755|NCT01307267|11664446|FG014|NOT COMPLETED|Overall Study||2
10513756|NCT01307267|11664447|FG015|NOT COMPLETED|Overall Study||1
10513757|NCT01307267|11664448|FG016|NOT COMPLETED|Overall Study||1
10513758|NCT01307267|11664449|FG017|NOT COMPLETED|Overall Study||1
10513759|NCT01307267|11664450|FG018|NOT COMPLETED|Overall Study||2
10513760|NCT01307267|11664451|FG019|NOT COMPLETED|Overall Study||32
10513761|NCT01307267|11664452|FG020|NOT COMPLETED|Overall Study||3
10513762|NCT01307267|11664453|FG021|NOT COMPLETED|Overall Study||5
10513763|NCT01307267|11664454|FG022|NOT COMPLETED|Overall Study||4
10513764|NCT01307319|11664516|FG000|STARTED|Overall Study|Randomized|239
10513766|NCT01307319|11664518|FG002|STARTED|Overall Study|Randomized|234
10513767|NCT01307319|11664516|FG000|Safety Population|Overall Study||239
10513768|NCT01307319|11664517|FG001|Safety Population|Overall Study|One participant was randomized in error and did not receive study medication.|241
10513769|NCT01307319|11664518|FG002|Safety Population|Overall Study||234
10513770|NCT01307319|11664516|FG000|ITT Population|Overall Study|One participant provided no post-baseline assessment.|238
10513771|NCT01307319|11664517|FG001|ITT Population|Overall Study||241
10513772|NCT01307319|11664518|FG002|ITT Population|Overall Study||234
10513773|NCT01307319|11664516|FG000|COMPLETED|Overall Study||235
10513774|NCT01307319|11664517|FG001|COMPLETED|Overall Study||234
10513775|NCT01307319|11664518|FG002|COMPLETED|Overall Study||227
10513776|NCT01307319|11664516|FG000|NOT COMPLETED|Overall Study||4
10513777|NCT01307319|11664517|FG001|NOT COMPLETED|Overall Study||8
10513778|NCT01307319|11664518|FG002|NOT COMPLETED|Overall Study||7
10513779|NCT01307397|11664526|FG000|STARTED|Overall Study||3219
10513780|NCT01307397|11664526|FG000|COMPLETED|Overall Study|A participant completed study in case of progressive disease, adverse events or consent withdrawn|3219
10513781|NCT01307397|11664526|FG000|NOT COMPLETED|Overall Study||0
10513782|NCT01307449|11664534|FG000|STARTED|Overall Study||33
10513783|NCT01307449|11664535|FG001|STARTED|Overall Study||33
10513784|NCT01307449|11664536|FG002|STARTED|Overall Study||11
10513785|NCT01307449|11664537|FG003|STARTED|Overall Study||11
10513786|NCT01307449|11664534|FG000|COMPLETED|Overall Study||32
10513787|NCT01307449|11664535|FG001|COMPLETED|Overall Study||33
10513788|NCT01307449|11664536|FG002|COMPLETED|Overall Study||11
10513789|NCT01307449|11664537|FG003|COMPLETED|Overall Study||11
10513790|NCT01307449|11664534|FG000|NOT COMPLETED|Overall Study||1
10513791|NCT01307449|11664535|FG001|NOT COMPLETED|Overall Study||0
10513792|NCT01307449|11664536|FG002|NOT COMPLETED|Overall Study||0
10513793|NCT01307449|11664537|FG003|NOT COMPLETED|Overall Study||0
10513794|NCT01307462|11664547|FG000|STARTED|Overall Study||36
10513795|NCT01307462|11664547|FG000|COMPLETED|Overall Study||35
10513796|NCT01307462|11664547|FG000|NOT COMPLETED|Overall Study||1
10513797|NCT01307501|11664551|FG000|STARTED|Overall Study||40
10513798|NCT01307501|11664551|FG000|Intent-to-Treat (ITT) Population|Overall Study||40
10513799|NCT01307501|11664551|FG000|COMPLETED|Overall Study||17
10513800|NCT01307501|11664551|FG000|NOT COMPLETED|Overall Study||23
10513801|NCT01307579|11664557|FG000|STARTED|Overall Study||257
10513802|NCT01307579|11664558|FG001|STARTED|Overall Study||260
10513803|NCT01307579|11664557|FG000|COMPLETED|Overall Study||117
10513804|NCT01307579|11664558|FG001|COMPLETED|Overall Study||115
10513805|NCT01307579|11664557|FG000|NOT COMPLETED|Overall Study||140
10513806|NCT01307579|11664558|FG001|NOT COMPLETED|Overall Study||145
10513807|NCT01307618|11664566|FG000|STARTED|Overall Study||5
10513808|NCT01307618|11664567|FG001|STARTED|Overall Study||5
10513809|NCT01307618|11664566|FG000|COMPLETED|Overall Study||5
10513810|NCT01307618|11664567|FG001|COMPLETED|Overall Study||5
10513811|NCT01307618|11664566|FG000|NOT COMPLETED|Overall Study||0
10513812|NCT01307618|11664567|FG001|NOT COMPLETED|Overall Study||0
10513813|NCT01307748|11664576|FG000|STARTED|Overall Study||31
10513814|NCT01307748|11664577|FG001|STARTED|Overall Study||31
10513815|NCT01307748|11664578|FG002|STARTED|Overall Study||30
10513816|NCT01307748|11664576|FG000|COMPLETED|Overall Study||31
10513817|NCT01307748|11664577|FG001|COMPLETED|Overall Study||31
10513818|NCT01307748|11664578|FG002|COMPLETED|Overall Study||30
10513819|NCT01307748|11664576|FG000|NOT COMPLETED|Overall Study||0
10513820|NCT01307748|11664577|FG001|NOT COMPLETED|Overall Study||0
10513821|NCT01307748|11664578|FG002|NOT COMPLETED|Overall Study||0
10513822|NCT01307891|11664594|FG000|STARTED|Overall Study||42
10513823|NCT01307891|11664595|FG001|STARTED|Overall Study||22
10513824|NCT01307891|11664594|FG000|COMPLETED|Overall Study||39
10513825|NCT01307891|11664595|FG001|COMPLETED|Overall Study||21
10513826|NCT01307891|11664594|FG000|NOT COMPLETED|Overall Study||3
10513827|NCT01307891|11664595|FG001|NOT COMPLETED|Overall Study||1
10513828|NCT01307930|11664601|FG000|STARTED|Overall Study||20
10513829|NCT01307930|11664601|FG000|COMPLETED|Overall Study||18
10513830|NCT01307930|11664601|FG000|NOT COMPLETED|Overall Study||2
10513831|NCT01307956|11664605|FG000|STARTED|Overall Study||11
10513832|NCT01307956|11664605|FG000|COMPLETED|Overall Study||11
10513833|NCT01307956|11664605|FG000|NOT COMPLETED|Overall Study||0
10513834|NCT01308008|11664611|FG000|STARTED|4 Weeks||71
10513835|NCT01308008|11664612|FG001|STARTED|4 Weeks||73
10513836|NCT01308008|11664611|FG000|COMPLETED|4 Weeks||62
10513837|NCT01308008|11664612|FG001|COMPLETED|4 Weeks||71
10513838|NCT01308008|11664611|FG000|NOT COMPLETED|4 Weeks||9
10513839|NCT01308008|11664612|FG001|NOT COMPLETED|4 Weeks||2
10513840|NCT01308008|11664611|FG000|STARTED|6 Months||62
10513841|NCT01308008|11664612|FG001|STARTED|6 Months||71
10513842|NCT01308008|11664611|FG000|COMPLETED|6 Months||54
10513843|NCT01308008|11664612|FG001|COMPLETED|6 Months||62
10513844|NCT01308008|11664611|FG000|NOT COMPLETED|6 Months||8
10513845|NCT01308008|11664612|FG001|NOT COMPLETED|6 Months||9
10513846|NCT01308008|11664611|FG000|STARTED|12 Months||54
10513847|NCT01308008|11664612|FG001|STARTED|12 Months||62
10513848|NCT01308008|11664611|FG000|COMPLETED|12 Months||46
10513849|NCT01308008|11664612|FG001|COMPLETED|12 Months||58
10513850|NCT01308008|11664611|FG000|NOT COMPLETED|12 Months||8
10513851|NCT01308008|11664612|FG001|NOT COMPLETED|12 Months||4
10513852|NCT01308060|11664620|FG000|STARTED|Part A||252
10513853|NCT01308060|11664621|FG001|STARTED|Part A||83
10513854|NCT01308060|11664620|FG000|COMPLETED|Part A||238
10513855|NCT01308060|11664621|FG001|COMPLETED|Part A||77
10513856|NCT01308060|11664620|FG000|NOT COMPLETED|Part A||14
10513857|NCT01308060|11664621|FG001|NOT COMPLETED|Part A||6
10513858|NCT01308060|11664620|FG000|STARTED|Part B||238
10513859|NCT01308060|11664621|FG001|STARTED|Part B||77
10513860|NCT01308060|11664620|FG000|COMPLETED|Part B||219
10513861|NCT01308060|11664621|FG001|COMPLETED|Part B||69
10513862|NCT01308060|11664620|FG000|NOT COMPLETED|Part B||19
10513863|NCT01308060|11664621|FG001|NOT COMPLETED|Part B||8
10513864|NCT01308294|11664631|FG000|STARTED|Cycle 1||10
10513865|NCT01308294|11664632|FG001|STARTED|Cycle 1||6
10513866|NCT01308294|11664633|FG002|STARTED|Cycle 1||0
10513867|NCT01308294|11664631|FG000|COMPLETED|Cycle 1||10
10513868|NCT01308294|11664632|FG001|COMPLETED|Cycle 1||6
10513869|NCT01308294|11664633|FG002|COMPLETED|Cycle 1||0
10513870|NCT01308294|11664631|FG000|NOT COMPLETED|Cycle 1||0
10513871|NCT01308294|11664632|FG001|NOT COMPLETED|Cycle 1||0
10513872|NCT01308294|11664633|FG002|NOT COMPLETED|Cycle 1||0
10513873|NCT01308294|11664631|FG000|STARTED|Cycle 2||10
10513874|NCT01308294|11664632|FG001|STARTED|Cycle 2||6
10513875|NCT01308294|11664633|FG002|STARTED|Cycle 2||0
10513876|NCT01308294|11664631|FG000|COMPLETED|Cycle 2||10
10513877|NCT01308294|11664632|FG001|COMPLETED|Cycle 2||5
10513878|NCT01308294|11664633|FG002|COMPLETED|Cycle 2||0
10513879|NCT01308294|11664631|FG000|NOT COMPLETED|Cycle 2||0
10513880|NCT01308294|11664632|FG001|NOT COMPLETED|Cycle 2||1
10513881|NCT01308294|11664633|FG002|NOT COMPLETED|Cycle 2||0
10513882|NCT01308294|11664631|FG000|STARTED|Cycle 3||10
10513883|NCT01308294|11664632|FG001|STARTED|Cycle 3||5
10513884|NCT01308294|11664633|FG002|STARTED|Cycle 3||0
10513885|NCT01308294|11664631|FG000|COMPLETED|Cycle 3||10
10513886|NCT01308294|11664632|FG001|COMPLETED|Cycle 3||4
10513887|NCT01308294|11664633|FG002|COMPLETED|Cycle 3||0
10513888|NCT01308294|11664631|FG000|NOT COMPLETED|Cycle 3||0
10513889|NCT01308294|11664632|FG001|NOT COMPLETED|Cycle 3||1
10513890|NCT01308294|11664633|FG002|NOT COMPLETED|Cycle 3||0
10513891|NCT01308424|11664646|FG000|STARTED|Baseline Eligibility||242
10513892|NCT01308424|11664647|FG001|STARTED|Baseline Eligibility||0
10513893|NCT01308424|11664648|FG002|STARTED|Baseline Eligibility||0
10513894|NCT01308424|11664646|FG000|COMPLETED|Baseline Eligibility|Completed baseline run in and were eligible for randomization|171
10513895|NCT01308424|11664647|FG001|COMPLETED|Baseline Eligibility||0
10513896|NCT01308424|11664648|FG002|COMPLETED|Baseline Eligibility||0
10513897|NCT01308424|11664646|FG000|NOT COMPLETED|Baseline Eligibility||71
10513898|NCT01308424|11664647|FG001|NOT COMPLETED|Baseline Eligibility||0
10513899|NCT01308424|11664648|FG002|NOT COMPLETED|Baseline Eligibility||0
10513900|NCT01308424|11664646|FG000|STARTED|Randomization||0
10513901|NCT01308424|11664647|FG001|STARTED|Randomization||87
10513902|NCT01308424|11664648|FG002|STARTED|Randomization||84
10513903|NCT01308424|11664646|FG000|COMPLETED|Randomization||0
10513904|NCT01308424|11664647|FG001|COMPLETED|Randomization||84
10513905|NCT01308424|11664648|FG002|COMPLETED|Randomization||82
10513906|NCT01308424|11664646|FG000|NOT COMPLETED|Randomization||0
10513907|NCT01308424|11664647|FG001|NOT COMPLETED|Randomization||3
10513908|NCT01308424|11664648|FG002|NOT COMPLETED|Randomization||2
10513909|NCT01308450|11664655|FG000|STARTED|Overall Study|302 subjects were screen. 300 subjects were enrolled in this one site, one visit study.|302
10513910|NCT01308450|11664655|FG000|COMPLETED|Overall Study|Last subject was enrolled 06/28/2011|300
10513911|NCT01308450|11664655|FG000|NOT COMPLETED|Overall Study||2
10513912|NCT01308463|11664659|FG000|STARTED|Overall Study||29
10513913|NCT01308463|11664659|FG000|6 Months|Overall Study||23
10513914|NCT01308463|11664659|FG000|1 Year|Overall Study||21
10513915|NCT01308463|11664659|FG000|2 Years|Overall Study||18
10513916|NCT01308463|11664659|FG000|3 Years|Overall Study||17
10513917|NCT01308463|11664659|FG000|4 Years|Overall Study||20
10513918|NCT01308463|11664659|FG000|5 Years|Overall Study||20
10513919|NCT01308463|11664659|FG000|6 Years|Overall Study||11
10513920|NCT01308463|11664659|FG000|7 Years|Overall Study||12
10513921|NCT01308463|11664659|FG000|8 Years|Overall Study||14
10513922|NCT01308463|11664659|FG000|9 Years|Overall Study||11
10513923|NCT01308463|11664659|FG000|10 Years|Overall Study||8
10513924|NCT01308463|11664659|FG000|11 Years|Overall Study||8
10513925|NCT01308463|11664659|FG000|12 Years|Overall Study||2
10513926|NCT01308463|11664659|FG000|COMPLETED|Overall Study||0
10513927|NCT01308463|11664659|FG000|NOT COMPLETED|Overall Study||29
10513928|NCT01308476|11664665|FG000|STARTED|Overall Study|Entered and treated.|48
10513929|NCT01308476|11664666|FG001|STARTED|Overall Study|Entered and treated.|47
10513930|NCT01308476|11664665|FG000|COMPLETED|Overall Study||45
10513931|NCT01308476|11664666|FG001|COMPLETED|Overall Study||45
10513932|NCT01308476|11664665|FG000|NOT COMPLETED|Overall Study||3
10513933|NCT01308476|11664666|FG001|NOT COMPLETED|Overall Study||2
10513934|NCT01308567|11664675|FG000|STARTED|Overall Study|Randomized|391
10513935|NCT01308567|11664676|FG001|STARTED|Overall Study|Randomized|389
10513936|NCT01308567|11664677|FG002|STARTED|Overall Study|Randomized|388
10513937|NCT01308567|11664675|FG000|Treated|Overall Study|For 1 participant, actual treatment received was Cabazitaxel 25 mg/m^2.|388
10513938|NCT01308567|11664676|FG001|Treated|Overall Study|For 15 participants, actual treatment received was Cabazitaxel 25 mg/m^2.|382
10513939|NCT01308567|11664677|FG002|Treated|Overall Study|For 2 participants, actual treatment received was Cabazitaxel 20 mg/m^2.|377
10513940|NCT01308567|11664675|FG000|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|389
10513941|NCT01308567|11664676|FG001|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|385
10514015|NCT01309100|11664784|FG000|COMPLETED|Overall Study||142
10514016|NCT01309100|11664784|FG000|NOT COMPLETED|Overall Study||2
10513942|NCT01308567|11664677|FG002|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|384
10513943|NCT01308567|11664675|FG000|NOT COMPLETED|Overall Study||2
10513944|NCT01308567|11664676|FG001|NOT COMPLETED|Overall Study||4
10513945|NCT01308567|11664677|FG002|NOT COMPLETED|Overall Study||4
10513946|NCT01308580|11664687|FG000|STARTED|Overall Study||598
10513947|NCT01308580|11664688|FG001|STARTED|Overall Study||602
10513948|NCT01308580|11664687|FG000|Treated|Overall Study|Random assignment, was not actual treatment in some cases|587
10513949|NCT01308580|11664688|FG001|Treated|Overall Study|Random assignment, was not actual treatment in some cases|588
10513950|NCT01308580|11664687|FG000|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival|586
10513951|NCT01308580|11664688|FG001|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival|595
10513952|NCT01308580|11664687|FG000|NOT COMPLETED|Overall Study||12
10513953|NCT01308580|11664688|FG001|NOT COMPLETED|Overall Study||7
10513960|NCT01308736|11664708|FG000|STARTED|Overall Study||31
10513961|NCT01308736|11664709|FG001|STARTED|Overall Study||32
10513962|NCT01308736|11664708|FG000|COMPLETED|Overall Study||25
10513963|NCT01308736|11664709|FG001|COMPLETED|Overall Study||27
10513964|NCT01308736|11664708|FG000|NOT COMPLETED|Overall Study||6
10513965|NCT01308736|11664709|FG001|NOT COMPLETED|Overall Study||5
10513966|NCT01308749|11664717|FG000|STARTED|Period 1: Double Blind Treatment||12
10513967|NCT01308749|11664718|FG001|STARTED|Period 1: Double Blind Treatment||13
10513968|NCT01308749|11664717|FG000|COMPLETED|Period 1: Double Blind Treatment||11
10513969|NCT01308749|11664718|FG001|COMPLETED|Period 1: Double Blind Treatment||13
10513970|NCT01308749|11664717|FG000|NOT COMPLETED|Period 1: Double Blind Treatment||1
10513971|NCT01308749|11664718|FG001|NOT COMPLETED|Period 1: Double Blind Treatment||0
10513972|NCT01308749|11664717|FG000|STARTED|Period 2: Open Label Treatment||11
10513973|NCT01308749|11664718|FG001|STARTED|Period 2: Open Label Treatment||13
10513974|NCT01308749|11664717|FG000|COMPLETED|Period 2: Open Label Treatment||11
10513975|NCT01308749|11664718|FG001|COMPLETED|Period 2: Open Label Treatment||11
10513976|NCT01308749|11664717|FG000|NOT COMPLETED|Period 2: Open Label Treatment||0
10513977|NCT01308749|11664718|FG001|NOT COMPLETED|Period 2: Open Label Treatment||2
10513978|NCT01308762|11664741|FG000|STARTED|Overall Study||6
10513979|NCT01308762|11664742|FG001|STARTED|Overall Study||7
10513980|NCT01308762|11664743|FG002|STARTED|Overall Study||6
10513981|NCT01308762|11664741|FG000|COMPLETED|Overall Study||6
10513982|NCT01308762|11664742|FG001|COMPLETED|Overall Study|One patient was withdrawn as they were retrospecively found to have been ineligible at study entry|6
10513983|NCT01308762|11664743|FG002|COMPLETED|Overall Study||6
10513984|NCT01308762|11664741|FG000|NOT COMPLETED|Overall Study||0
10513985|NCT01308762|11664742|FG001|NOT COMPLETED|Overall Study||1
10513986|NCT01308762|11664743|FG002|NOT COMPLETED|Overall Study||0
10513987|NCT01308788|11664756|FG000|STARTED|6-month Treatment||14
10513988|NCT01308788|11664757|FG001|STARTED|6-month Treatment||21
10513989|NCT01308788|11664756|FG000|COMPLETED|6-month Treatment||14
10513990|NCT01308788|11664757|FG001|COMPLETED|6-month Treatment||21
10513991|NCT01308788|11664756|FG000|NOT COMPLETED|6-month Treatment||0
10513992|NCT01308788|11664757|FG001|NOT COMPLETED|6-month Treatment||0
10513993|NCT01308788|11664756|FG000|STARTED|2-year Treatment||14
10513994|NCT01308788|11664757|FG001|STARTED|2-year Treatment||21
10513995|NCT01308788|11664756|FG000|COMPLETED|2-year Treatment||10
10513996|NCT01308788|11664757|FG001|COMPLETED|2-year Treatment||10
10513997|NCT01308788|11664756|FG000|NOT COMPLETED|2-year Treatment||4
10513998|NCT01308788|11664757|FG001|NOT COMPLETED|2-year Treatment||11
10513999|NCT01308814|11664765|FG000|STARTED|Overall Study||86
10514000|NCT01308814|11664766|FG001|STARTED|Overall Study||86
10514001|NCT01308814|11664765|FG000|COMPLETED|Overall Study||69
10514002|NCT01308814|11664766|FG001|COMPLETED|Overall Study||63
10514003|NCT01308814|11664765|FG000|NOT COMPLETED|Overall Study||17
10514004|NCT01308814|11664766|FG001|NOT COMPLETED|Overall Study||23
10514005|NCT01308840|11664772|FG000|STARTED|Overall Study||31
10514006|NCT01308840|11664772|FG000|COMPLETED|Overall Study||31
10711487|NCT02660489|11876920|FG000|STARTED|Overall Study||22
10711488|NCT02660489|11876921|FG001|STARTED|Overall Study||22
10711489|NCT02660489|11876920|FG000|COMPLETED|Overall Study|Completed with confirmed rhinovirus infection|16
10711490|NCT02660489|11876921|FG001|COMPLETED|Overall Study|Completed with confirmed rhinovirus infection|14
10711491|NCT02660489|11876920|FG000|NOT COMPLETED|Overall Study||6
10711492|NCT02660489|11876921|FG001|NOT COMPLETED|Overall Study||8
10514007|NCT01308840|11664772|FG000|NOT COMPLETED|Overall Study||0
10514011|NCT01308918|11664780|FG000|STARTED|Overall Study||50
10514012|NCT01308918|11664780|FG000|COMPLETED|Overall Study||50
10810203|NCT03801265|11972085|FG000|NOT COMPLETED|Overall Study||0
10810204|NCT03801265|11972086|FG001|NOT COMPLETED|Overall Study||0
10810205|NCT03802344|11972095|FG000|STARTED|Overall Study||213
10810206|NCT03802344|11972096|FG001|STARTED|Overall Study||209
10514013|NCT01308918|11664780|FG000|NOT COMPLETED|Overall Study||0
10514014|NCT01309100|11664784|FG000|STARTED|Overall Study||144
10514017|NCT01309165|11664793|FG000|STARTED|Overall Study||19
10514018|NCT01309165|11664794|FG001|STARTED|Overall Study||16
10514019|NCT01309165|11664793|FG000|Received Allocated Intervention|Overall Study||16
10514020|NCT01309165|11664794|FG001|Received Allocated Intervention|Overall Study||14
10514021|NCT01309165|11664793|FG000|Included in Primary Analysis|Overall Study||14
10514022|NCT01309165|11664794|FG001|Included in Primary Analysis|Overall Study||12
10514023|NCT01309165|11664793|FG000|COMPLETED|Overall Study||13
10514024|NCT01309165|11664794|FG001|COMPLETED|Overall Study||9
10514025|NCT01309165|11664793|FG000|NOT COMPLETED|Overall Study||6
10514026|NCT01309165|11664794|FG001|NOT COMPLETED|Overall Study||7
10514027|NCT01309204|11664803|FG000|STARTED|Overall Study||452
10514028|NCT01309204|11664804|FG001|STARTED|Overall Study||436
10514029|NCT01309204|11664803|FG000|COMPLETED|Overall Study||385
10514030|NCT01309204|11664804|FG001|COMPLETED|Overall Study||361
10514031|NCT01309204|11664803|FG000|NOT COMPLETED|Overall Study||67
10514032|NCT01309204|11664804|FG001|NOT COMPLETED|Overall Study||75
10514033|NCT01309243|11664812|FG000|STARTED|Randomized Phase Through Week 96||400
10514034|NCT01309243|11664813|FG001|STARTED|Randomized Phase Through Week 96||399
10514035|NCT01309243|11664812|FG000|Randomized and Treated|Randomized Phase Through Week 96||394
10514036|NCT01309243|11664813|FG001|Randomized and Treated|Randomized Phase Through Week 96||392
10514037|NCT01309243|11664812|FG000|COMPLETED|Randomized Phase Through Week 96||316
10514038|NCT01309243|11664813|FG001|COMPLETED|Randomized Phase Through Week 96||290
10514039|NCT01309243|11664812|FG000|NOT COMPLETED|Randomized Phase Through Week 96||84
10514040|NCT01309243|11664813|FG001|NOT COMPLETED|Randomized Phase Through Week 96||109
10514041|NCT01309243|11664812|FG000|STARTED|Extension Phase|40 participants from the Randomized Phase continued the study in the Extension Phase.|40
10514042|NCT01309243|11664813|FG001|STARTED|Extension Phase|117 participants from the Randomized Phase continued the study in the Extension Phase.|117
10514043|NCT01309243|11664812|FG000|COMPLETED|Extension Phase||34
10514044|NCT01309243|11664813|FG001|COMPLETED|Extension Phase||117
10514045|NCT01309243|11664812|FG000|NOT COMPLETED|Extension Phase||6
10514046|NCT01309243|11664813|FG001|NOT COMPLETED|Extension Phase||0
10514047|NCT01309269|11664819|FG000|STARTED|Overall Study||1085
10711493|NCT02660580|11876929|FG000|STARTED|Core Treatment Period (Week 1 to 16)||222
10514048|NCT01309269|11664819|FG000|Treated|Overall Study||978
10514049|NCT01309269|11664819|FG000|COMPLETED|Overall Study||245
10514050|NCT01309269|11664819|FG000|NOT COMPLETED|Overall Study||840
10514051|NCT01309282|11664823|FG000|STARTED|Overall Study||9
10810207|NCT03802344|11972097|FG002|STARTED|Overall Study||68
10514052|NCT01309282|11664823|FG000|COMPLETED|Overall Study||8
10711494|NCT02660580|11876930|FG001|STARTED|Core Treatment Period (Week 1 to 16)||221
10711495|NCT02660580|11876931|FG002|STARTED|Core Treatment Period (Week 1 to 16)||0
10514053|NCT01309282|11664823|FG000|NOT COMPLETED|Overall Study||1
10514054|NCT01309308|11664829|FG000|STARTED|Overall Study||75
10514055|NCT01309308|11664830|FG001|STARTED|Overall Study||75
10514056|NCT01309308|11664829|FG000|COMPLETED|Overall Study||69
10514057|NCT01309308|11664830|FG001|COMPLETED|Overall Study||71
10514058|NCT01309308|11664829|FG000|NOT COMPLETED|Overall Study||6
10514059|NCT01309308|11664830|FG001|NOT COMPLETED|Overall Study||4
10514060|NCT01309360|11664839|FG000|STARTED|Overall Study||40
10514061|NCT01309360|11664840|FG001|STARTED|Overall Study||40
10514062|NCT01309360|11664841|FG002|STARTED|Overall Study||40
10514063|NCT01309360|11664839|FG000|COMPLETED|Overall Study||40
10514064|NCT01309360|11664840|FG001|COMPLETED|Overall Study||40
10514065|NCT01309360|11664841|FG002|COMPLETED|Overall Study||40
10514066|NCT01309360|11664839|FG000|NOT COMPLETED|Overall Study||0
10514067|NCT01309360|11664840|FG001|NOT COMPLETED|Overall Study||0
10514068|NCT01309360|11664841|FG002|NOT COMPLETED|Overall Study||0
10514069|NCT01309386|11664851|FG000|STARTED|Overall Study||50
10514070|NCT01309386|11664852|FG001|STARTED|Overall Study||50
10514071|NCT01309386|11664851|FG000|COMPLETED|Overall Study||28
10514072|NCT01309386|11664852|FG001|COMPLETED|Overall Study||29
10514073|NCT01309386|11664851|FG000|NOT COMPLETED|Overall Study||22
10514074|NCT01309386|11664852|FG001|NOT COMPLETED|Overall Study||21
10514075|NCT01309451|11664860|FG000|STARTED|Overall Study|unit of measure is number of eyes|19
10514076|NCT01309451|11664861|FG001|STARTED|Overall Study|unit of measure is number of eyes|21
10514077|NCT01309451|11664860|FG000|COMPLETED|Overall Study|unit of measure is number of eyes|17
10514078|NCT01309451|11664861|FG001|COMPLETED|Overall Study|unit of measure is number of eyes|18
10514079|NCT01309451|11664860|FG000|NOT COMPLETED|Overall Study||2
10514080|NCT01309451|11664861|FG001|NOT COMPLETED|Overall Study||3
10514081|NCT01309646|11664871|FG000|STARTED|Overall Study||224
10514082|NCT01309646|11664872|FG001|STARTED|Overall Study||227
10514083|NCT01309646|11664871|FG000|COMPLETED|Overall Study||224
10514084|NCT01309646|11664872|FG001|COMPLETED|Overall Study||227
10514085|NCT01309646|11664871|FG000|NOT COMPLETED|Overall Study||0
10514086|NCT01309646|11664872|FG001|NOT COMPLETED|Overall Study||0
10514087|NCT01309659|11664880|FG000|STARTED|Overall Study||9
10514088|NCT01309659|11664881|FG001|STARTED|Overall Study||10
10514089|NCT01309659|11664880|FG000|COMPLETED|Overall Study||9
10514090|NCT01309659|11664881|FG001|COMPLETED|Overall Study||9
10514091|NCT01309659|11664880|FG000|NOT COMPLETED|Overall Study||0
10514092|NCT01309659|11664881|FG001|NOT COMPLETED|Overall Study||1
10514093|NCT01309737|11664890|FG000|STARTED|Week 0 to 16||383
10514094|NCT01309737|11664891|FG001|STARTED|Week 0 to 16||381
10514095|NCT01309737|11664892|FG002|STARTED|Week 0 to 16||196
10514096|NCT01309737|11664893|FG003|STARTED|Week 0 to 16||0
10514097|NCT01309737|11664894|FG004|STARTED|Week 0 to 16||0
10514098|NCT01309737|11664890|FG000|Treated|Week 0 to 16||382
10514099|NCT01309737|11664891|FG001|Treated|Week 0 to 16||381
10514100|NCT01309737|11664892|FG002|Treated|Week 0 to 16||196
10514101|NCT01309737|11664893|FG003|Treated|Week 0 to 16||0
10514102|NCT01309737|11664894|FG004|Treated|Week 0 to 16||0
10514103|NCT01309737|11664890|FG000|COMPLETED|Week 0 to 16||331
10514104|NCT01309737|11664891|FG001|COMPLETED|Week 0 to 16||341
10514105|NCT01309737|11664892|FG002|COMPLETED|Week 0 to 16||152
10514106|NCT01309737|11664893|FG003|COMPLETED|Week 0 to 16||0
10514107|NCT01309737|11664894|FG004|COMPLETED|Week 0 to 16||0
10514108|NCT01309737|11664890|FG000|NOT COMPLETED|Week 0 to 16||52
10514109|NCT01309737|11664891|FG001|NOT COMPLETED|Week 0 to 16||40
10514110|NCT01309737|11664892|FG002|NOT COMPLETED|Week 0 to 16||44
10514111|NCT01309737|11664893|FG003|NOT COMPLETED|Week 0 to 16||0
10514112|NCT01309737|11664894|FG004|NOT COMPLETED|Week 0 to 16||0
10514113|NCT01309737|11664890|FG000|STARTED|Week 16 to 52||331
10514114|NCT01309737|11664891|FG001|STARTED|Week 16 to 52||341
10514115|NCT01309737|11664892|FG002|STARTED|Week 16 to 52||0
10514116|NCT01309737|11664893|FG003|STARTED|Week 16 to 52||75
10514117|NCT01309737|11664894|FG004|STARTED|Week 16 to 52||77
10514118|NCT01309737|11664890|FG000|COMPLETED|Week 16 to 52||198
10514119|NCT01309737|11664891|FG001|COMPLETED|Week 16 to 52||238
10514120|NCT01309737|11664892|FG002|COMPLETED|Week 16 to 52||0
10514121|NCT01309737|11664893|FG003|COMPLETED|Week 16 to 52||41
10514122|NCT01309737|11664894|FG004|COMPLETED|Week 16 to 52||44
10514123|NCT01309737|11664890|FG000|NOT COMPLETED|Week 16 to 52||133
10514124|NCT01309737|11664891|FG001|NOT COMPLETED|Week 16 to 52||103
10514125|NCT01309737|11664892|FG002|NOT COMPLETED|Week 16 to 52||0
10514126|NCT01309737|11664893|FG003|NOT COMPLETED|Week 16 to 52||34
10514127|NCT01309737|11664894|FG004|NOT COMPLETED|Week 16 to 52||33
10514128|NCT01309802|11664919|FG000|STARTED|Overall Study||25
10514129|NCT01309802|11664920|FG001|STARTED|Overall Study||23
10514130|NCT01309802|11664919|FG000|COMPLETED|Overall Study||13
10514131|NCT01309802|11664920|FG001|COMPLETED|Overall Study||14
10514132|NCT01309802|11664919|FG000|NOT COMPLETED|Overall Study||12
10514133|NCT01309802|11664920|FG001|NOT COMPLETED|Overall Study||9
10514134|NCT01309828|11664928|FG000|STARTED|Overall Study||77
10514135|NCT01309828|11664929|FG001|STARTED|Overall Study||76
10514136|NCT01309828|11664928|FG000|COMPLETED|Overall Study||61
10514137|NCT01309828|11664929|FG001|COMPLETED|Overall Study||60
10514138|NCT01309828|11664928|FG000|NOT COMPLETED|Overall Study||16
10514139|NCT01309828|11664929|FG001|NOT COMPLETED|Overall Study||16
10514140|NCT01309841|11664938|FG000|STARTED|Overall Study||217
10514141|NCT01309841|11664939|FG001|STARTED|Overall Study||218
10514142|NCT01309841|11664940|FG002|STARTED|Overall Study||217
10514143|NCT01309841|11664938|FG000|COMPLETED|Overall Study||178
10514144|NCT01309841|11664939|FG001|COMPLETED|Overall Study||177
10514145|NCT01309841|11664940|FG002|COMPLETED|Overall Study||180
10514146|NCT01309841|11664938|FG000|NOT COMPLETED|Overall Study||39
10514147|NCT01309841|11664939|FG001|NOT COMPLETED|Overall Study||41
10514148|NCT01309841|11664940|FG002|NOT COMPLETED|Overall Study||37
10514149|NCT01309867|11664948|FG000|STARTED|Overall Study||151
10514150|NCT01309867|11664949|FG001|STARTED|Overall Study||151
10514151|NCT01309867|11664948|FG000|COMPLETED|Overall Study||148
10514152|NCT01309867|11664949|FG001|COMPLETED|Overall Study||139
10514153|NCT01309867|11664948|FG000|NOT COMPLETED|Overall Study||3
10514154|NCT01309867|11664949|FG001|NOT COMPLETED|Overall Study||12
10514155|NCT01309880|11664955|FG000|STARTED|Overall Study||33
10514156|NCT01309880|11664956|FG001|STARTED|Overall Study||33
10514157|NCT01309880|11664955|FG000|COMPLETED|Overall Study||33
10514158|NCT01309880|11664956|FG001|COMPLETED|Overall Study||33
10514159|NCT01309880|11664955|FG000|NOT COMPLETED|Overall Study||0
10514160|NCT01309880|11664956|FG001|NOT COMPLETED|Overall Study||0
10514161|NCT01309893|11664962|FG000|STARTED|Week 1 - First Intervention||33
10514162|NCT01309893|11664963|FG001|STARTED|Week 1 - First Intervention||33
10514163|NCT01309893|11664962|FG000|COMPLETED|Week 1 - First Intervention||33
10514164|NCT01309893|11664963|FG001|COMPLETED|Week 1 - First Intervention||33
10514165|NCT01309893|11664962|FG000|NOT COMPLETED|Week 1 - First Intervention||0
10514166|NCT01309893|11664963|FG001|NOT COMPLETED|Week 1 - First Intervention||0
10514167|NCT01309893|11664962|FG000|STARTED|Week 2 - Crossover Intervention||33
10514168|NCT01309893|11664963|FG001|STARTED|Week 2 - Crossover Intervention||33
10514169|NCT01309893|11664962|FG000|COMPLETED|Week 2 - Crossover Intervention||32
10514170|NCT01309893|11664963|FG001|COMPLETED|Week 2 - Crossover Intervention||32
10514171|NCT01309893|11664962|FG000|NOT COMPLETED|Week 2 - Crossover Intervention||1
10514172|NCT01309893|11664963|FG001|NOT COMPLETED|Week 2 - Crossover Intervention||1
10514173|NCT01309906|11664969|FG000|STARTED|Overall Study||33
10514174|NCT01309906|11664970|FG001|STARTED|Overall Study||33
10514175|NCT01309906|11664969|FG000|COMPLETED|Overall Study||32
10514176|NCT01309906|11664970|FG001|COMPLETED|Overall Study||32
10514177|NCT01309906|11664969|FG000|NOT COMPLETED|Overall Study||1
10514178|NCT01309906|11664970|FG001|NOT COMPLETED|Overall Study||1
10514179|NCT01309919|11664978|FG000|STARTED|Overall Study||75
10514180|NCT01309919|11664979|FG001|STARTED|Overall Study||75
10514181|NCT01309919|11664978|FG000|COMPLETED|Overall Study||58
10514182|NCT01309919|11664979|FG001|COMPLETED|Overall Study||27
10514183|NCT01309919|11664978|FG000|NOT COMPLETED|Overall Study||17
10514184|NCT01309919|11664979|FG001|NOT COMPLETED|Overall Study||48
10514185|NCT01309997|11664987|FG000|STARTED|Overall Study||35
10514186|NCT01309997|11664988|FG001|STARTED|Overall Study||37
10514187|NCT01309997|11664987|FG000|Remained on First Arm Only|Overall Study||16
10514188|NCT01309997|11664988|FG001|Remained on First Arm Only|Overall Study||14
10514189|NCT01309997|11664987|FG000|Crossed Over to Second Arm|Overall Study||19
10514190|NCT01309997|11664988|FG001|Crossed Over to Second Arm|Overall Study||23
10514191|NCT01309997|11664987|FG000|COMPLETED|Overall Study||30
10514192|NCT01309997|11664988|FG001|COMPLETED|Overall Study||31
10514193|NCT01309997|11664987|FG000|NOT COMPLETED|Overall Study||5
10514194|NCT01309997|11664988|FG001|NOT COMPLETED|Overall Study||6
10514195|NCT01310036|11665005|FG000|STARTED|Overall Study||208
10514196|NCT01310036|11665005|FG000|COMPLETED|Overall Study||6
10514197|NCT01310036|11665005|FG000|NOT COMPLETED|Overall Study||202
10514198|NCT01310075|11665011|FG000|STARTED|Overall Study||45
10514199|NCT01310075|11665012|FG001|STARTED|Overall Study||45
10514200|NCT01310075|11665011|FG000|COMPLETED|Overall Study||31
10514201|NCT01310075|11665012|FG001|COMPLETED|Overall Study||35
10514202|NCT01310075|11665011|FG000|NOT COMPLETED|Overall Study||14
10514203|NCT01310075|11665012|FG001|NOT COMPLETED|Overall Study||10
10514204|NCT01310127|11665020|FG000|STARTED|Overall Study||12
10514205|NCT01310127|11665021|FG001|STARTED|Overall Study||11
10514206|NCT01310127|11665020|FG000|COMPLETED|Overall Study||10
10514207|NCT01310127|11665021|FG001|COMPLETED|Overall Study||10
10514208|NCT01310127|11665020|FG000|NOT COMPLETED|Overall Study||2
10514209|NCT01310127|11665021|FG001|NOT COMPLETED|Overall Study||1
10514210|NCT01310179|11665027|FG000|STARTED|Overall Study||12
10514211|NCT01310179|11665027|FG000|COMPLETED|Overall Study||12
10514212|NCT01310179|11665027|FG000|NOT COMPLETED|Overall Study||0
10514213|NCT01310231|11665033|FG000|STARTED|Overall Study||22
10514214|NCT01310231|11665034|FG001|STARTED|Overall Study||18
10514215|NCT01310231|11665033|FG000|Received Intervention|Overall Study||22
10514216|NCT01310231|11665034|FG001|Received Intervention|Overall Study||17
10514217|NCT01310231|11665033|FG000|Discontinued Intervention|Overall Study||0
10514218|NCT01310231|11665034|FG001|Discontinued Intervention|Overall Study||1
10514219|NCT01310231|11665033|FG000|Analyzed for Survival|Overall Study||22
10514220|NCT01310231|11665034|FG001|Analyzed for Survival|Overall Study||18
10514221|NCT01310231|11665033|FG000|Analyzed for Response, Toxicity, QOL|Overall Study||22
10514222|NCT01310231|11665034|FG001|Analyzed for Response, Toxicity, QOL|Overall Study||17
10514223|NCT01310231|11665033|FG000|COMPLETED|Overall Study||22
10514224|NCT01310231|11665034|FG001|COMPLETED|Overall Study||17
10514225|NCT01310231|11665033|FG000|NOT COMPLETED|Overall Study||0
10514226|NCT01310231|11665034|FG001|NOT COMPLETED|Overall Study||1
10514227|NCT01310400|11665043|FG000|STARTED|Overall Study||452
10514228|NCT01310400|11665044|FG001|STARTED|Overall Study||452
10514229|NCT01310400|11665045|FG002|STARTED|Overall Study||452
10514230|NCT01310400|11665043|FG000|COMPLETED|Overall Study||424
10514231|NCT01310400|11665044|FG001|COMPLETED|Overall Study||420
10514232|NCT01310400|11665045|FG002|COMPLETED|Overall Study||422
10514233|NCT01310400|11665043|FG000|NOT COMPLETED|Overall Study||28
10514234|NCT01310400|11665044|FG001|NOT COMPLETED|Overall Study||32
10514235|NCT01310400|11665045|FG002|NOT COMPLETED|Overall Study||30
10514236|NCT01310413|11665062|FG000|STARTED|Day 0 to Day 385||199
10514237|NCT01310413|11665063|FG001|STARTED|Day 0 to Day 385||198
10514238|NCT01310413|11665064|FG002|STARTED|Day 0 to Day 385||210
10514239|NCT01310413|11665065|FG003|STARTED|Day 0 to Day 385||75
10514240|NCT01310413|11665066|FG004|STARTED|Day 0 to Day 385||76
10514241|NCT01310413|11665067|FG005|STARTED|Day 0 to Day 385||80
10514242|NCT01310413|11665068|FG006|STARTED|Day 0 to Day 385|This group is only followed during the Unblinded Phase of the study, from Days U0 to U385.|0
10514243|NCT01310413|11665062|FG000|COMPLETED|Day 0 to Day 385||172
10514244|NCT01310413|11665063|FG001|COMPLETED|Day 0 to Day 385||190
10514245|NCT01310413|11665064|FG002|COMPLETED|Day 0 to Day 385||203
10514246|NCT01310413|11665065|FG003|COMPLETED|Day 0 to Day 385||67
10514247|NCT01310413|11665066|FG004|COMPLETED|Day 0 to Day 385||73
10514248|NCT01310413|11665067|FG005|COMPLETED|Day 0 to Day 385||77
10514249|NCT01310413|11665068|FG006|COMPLETED|Day 0 to Day 385|This group is only followed during the Unblinded Phase of the study, from Days U0 to U385.|0
10514250|NCT01310413|11665062|FG000|NOT COMPLETED|Day 0 to Day 385||27
10514251|NCT01310413|11665063|FG001|NOT COMPLETED|Day 0 to Day 385||8
10514252|NCT01310413|11665064|FG002|NOT COMPLETED|Day 0 to Day 385||7
10514253|NCT01310413|11665065|FG003|NOT COMPLETED|Day 0 to Day 385||8
10514254|NCT01310413|11665066|FG004|NOT COMPLETED|Day 0 to Day 385||3
10514255|NCT01310413|11665067|FG005|NOT COMPLETED|Day 0 to Day 385||3
10514256|NCT01310413|11665068|FG006|NOT COMPLETED|Day 0 to Day 385||0
10514257|NCT01310413|11665062|FG000|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
10514258|NCT01310413|11665063|FG001|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
10514259|NCT01310413|11665064|FG002|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
10514260|NCT01310413|11665065|FG003|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
10514261|NCT01310413|11665066|FG004|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
10514262|NCT01310413|11665067|FG005|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
10514263|NCT01310413|11665068|FG006|STARTED|From Day U0 to Day U385|Upto Day U42|155
10514264|NCT01310413|11665062|FG000|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
10514265|NCT01310413|11665063|FG001|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
10514266|NCT01310413|11665064|FG002|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
10514267|NCT01310413|11665065|FG003|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
10514268|NCT01310413|11665066|FG004|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
10514269|NCT01310413|11665067|FG005|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
10514270|NCT01310413|11665068|FG006|COMPLETED|From Day U0 to Day U385|Upto Day U42|152
10514271|NCT01310413|11665062|FG000|NOT COMPLETED|From Day U0 to Day U385||0
10514272|NCT01310413|11665063|FG001|NOT COMPLETED|From Day U0 to Day U385||0
10514273|NCT01310413|11665064|FG002|NOT COMPLETED|From Day U0 to Day U385||0
10514274|NCT01310413|11665065|FG003|NOT COMPLETED|From Day U0 to Day U385||0
10514275|NCT01310413|11665066|FG004|NOT COMPLETED|From Day U0 to Day U385||0
10514276|NCT01310413|11665067|FG005|NOT COMPLETED|From Day U0 to Day U385||0
10514277|NCT01310413|11665068|FG006|NOT COMPLETED|From Day U0 to Day U385||3
10514278|NCT01310582|11665099|FG000|STARTED|Overall Study||31
10514279|NCT01310582|11665100|FG001|STARTED|Overall Study||26
10514280|NCT01310582|11665099|FG000|COMPLETED|Overall Study||31
10810208|NCT03802344|11972095|FG000|COMPLETED|Overall Study||205
10810209|NCT03802344|11972096|FG001|COMPLETED|Overall Study||203
10514281|NCT01310582|11665100|FG001|COMPLETED|Overall Study||26
10514282|NCT01310582|11665099|FG000|NOT COMPLETED|Overall Study||0
10514283|NCT01310582|11665100|FG001|NOT COMPLETED|Overall Study||0
10514284|NCT01310699|11665108|FG000|STARTED|Overall Study||132
10514285|NCT01310699|11665109|FG001|STARTED|Overall Study||149
10514286|NCT01310699|11665108|FG000|COMPLETED|Overall Study||128
10514287|NCT01310699|11665109|FG001|COMPLETED|Overall Study||143
10514288|NCT01310699|11665108|FG000|NOT COMPLETED|Overall Study||4
10514289|NCT01310699|11665109|FG001|NOT COMPLETED|Overall Study||6
10514290|NCT01310777|11665120|FG000|STARTED|Overall Study||193
10514291|NCT01310777|11665121|FG001|STARTED|Overall Study||192
10514292|NCT01310777|11665122|FG002|STARTED|Overall Study||175
10514293|NCT01310777|11665120|FG000|COMPLETED|Overall Study||160
10514294|NCT01310777|11665121|FG001|COMPLETED|Overall Study||178
10514295|NCT01310777|11665122|FG002|COMPLETED|Overall Study||145
10810210|NCT03802344|11972097|FG002|COMPLETED|Overall Study||55
10810211|NCT03802344|11972095|FG000|NOT COMPLETED|Overall Study||8
10514296|NCT01310777|11665120|FG000|NOT COMPLETED|Overall Study||33
10514297|NCT01310777|11665121|FG001|NOT COMPLETED|Overall Study||14
10514298|NCT01310777|11665122|FG002|NOT COMPLETED|Overall Study||30
10514299|NCT01310855|11665132|FG000|STARTED|Overall Study||19
10514300|NCT01310855|11665133|FG001|STARTED|Overall Study||19
10514301|NCT01310855|11665132|FG000|COMPLETED|Overall Study||19
10514302|NCT01310855|11665133|FG001|COMPLETED|Overall Study||19
10514303|NCT01310855|11665132|FG000|NOT COMPLETED|Overall Study||0
10514304|NCT01310855|11665133|FG001|NOT COMPLETED|Overall Study||0
10514305|NCT01310868|11665139|FG000|STARTED|Overall Study||72
10514306|NCT01310868|11665139|FG000|COMPLETED|Overall Study||59
10514307|NCT01310868|11665139|FG000|NOT COMPLETED|Overall Study||13
10514308|NCT01311024|11665145|FG000|STARTED|Overall Study||1530
10514309|NCT01311024|11665146|FG001|STARTED|Overall Study||811
10514310|NCT01311024|11665145|FG000|COMPLETED|Overall Study||1495
10514311|NCT01311024|11665146|FG001|COMPLETED|Overall Study||789
10514312|NCT01311024|11665145|FG000|NOT COMPLETED|Overall Study||35
10514313|NCT01311024|11665146|FG001|NOT COMPLETED|Overall Study||22
10514314|NCT01311102|11665154|FG000|STARTED|Overall Study||20
10514315|NCT01311102|11665155|FG001|STARTED|Overall Study||20
10514316|NCT01311102|11665154|FG000|COMPLETED|Overall Study||20
10514317|NCT01311102|11665155|FG001|COMPLETED|Overall Study||20
10514318|NCT01311102|11665154|FG000|NOT COMPLETED|Overall Study||0
10514319|NCT01311102|11665155|FG001|NOT COMPLETED|Overall Study||0
10514320|NCT01311362|11665163|FG000|STARTED|Ambrisentan Single Dose|All 20 study participants completed each study period. Total number of study participants: 20|20
10514321|NCT01311362|11665163|FG000|COMPLETED|Ambrisentan Single Dose||20
10810212|NCT03802344|11972096|FG001|NOT COMPLETED|Overall Study||6
10711496|NCT02660580|11876932|FG003|STARTED|Core Treatment Period (Week 1 to 16)||0
10514322|NCT01311362|11665163|FG000|NOT COMPLETED|Ambrisentan Single Dose||0
10514323|NCT01311362|11665163|FG000|STARTED|Ambrisentan Steady-state||20
10514324|NCT01311362|11665163|FG000|COMPLETED|Ambrisentan Steady-state||20
10514325|NCT01311362|11665163|FG000|NOT COMPLETED|Ambrisentan Steady-state||0
10514326|NCT01311362|11665163|FG000|STARTED|Ambrisentan and SJW||20
10514327|NCT01311362|11665163|FG000|COMPLETED|Ambrisentan and SJW||20
10514328|NCT01311362|11665163|FG000|NOT COMPLETED|Ambrisentan and SJW||0
10514329|NCT01311505|11665172|FG000|STARTED|First Intervention Period||10
10514330|NCT01311505|11665173|FG001|STARTED|First Intervention Period||11
10514331|NCT01311505|11665172|FG000|COMPLETED|First Intervention Period||10
10514332|NCT01311505|11665173|FG001|COMPLETED|First Intervention Period||10
10514333|NCT01311505|11665172|FG000|NOT COMPLETED|First Intervention Period||0
10514334|NCT01311505|11665173|FG001|NOT COMPLETED|First Intervention Period||1
10514335|NCT01311505|11665172|FG000|STARTED|Washout Period (at Least 7 Days)||10
10514336|NCT01311505|11665173|FG001|STARTED|Washout Period (at Least 7 Days)||10
10514337|NCT01311505|11665172|FG000|COMPLETED|Washout Period (at Least 7 Days)||10
10514338|NCT01311505|11665173|FG001|COMPLETED|Washout Period (at Least 7 Days)||10
10514339|NCT01311505|11665172|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
10514340|NCT01311505|11665173|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
10514341|NCT01311505|11665172|FG000|STARTED|Second Intervention Period||10
10514342|NCT01311505|11665173|FG001|STARTED|Second Intervention Period||10
10514343|NCT01311505|11665172|FG000|COMPLETED|Second Intervention Period||10
10514344|NCT01311505|11665173|FG001|COMPLETED|Second Intervention Period||10
10514345|NCT01311505|11665172|FG000|NOT COMPLETED|Second Intervention Period||0
10514346|NCT01311505|11665173|FG001|NOT COMPLETED|Second Intervention Period||0
10514347|NCT01311557|11665184|FG000|STARTED|Overall Study||651
10514348|NCT01311557|11665185|FG001|STARTED|Overall Study||651
10514349|NCT01311557|11665184|FG000|COMPLETED|Overall Study||646
10514350|NCT01311557|11665185|FG001|COMPLETED|Overall Study||645
10514351|NCT01311557|11665184|FG000|NOT COMPLETED|Overall Study||5
10514352|NCT01311557|11665185|FG001|NOT COMPLETED|Overall Study||6
10528565|NCT01395810|11680880|FG003|After Switching the Arms|Overall Study||5
10528566|NCT01395810|11680877|FG000|COMPLETED|Overall Study||16
10528567|NCT01395810|11680878|FG001|COMPLETED|Overall Study||44
10528568|NCT01395810|11680879|FG002|COMPLETED|Overall Study||0
10528569|NCT01395810|11680880|FG003|COMPLETED|Overall Study||5
10528570|NCT01395810|11680877|FG000|NOT COMPLETED|Overall Study||2
10711497|NCT02660580|11876933|FG004|STARTED|Core Treatment Period (Week 1 to 16)||0
10711498|NCT02660580|11876929|FG000|Treated|Core Treatment Period (Week 1 to 16)||221
10711499|NCT02660580|11876930|FG001|Treated|Core Treatment Period (Week 1 to 16)||220
10528571|NCT01395810|11680878|FG001|NOT COMPLETED|Overall Study||4
10528572|NCT01395810|11680879|FG002|NOT COMPLETED|Overall Study||0
10528573|NCT01395810|11680880|FG003|NOT COMPLETED|Overall Study||0
10528574|NCT01395823|11680893|FG000|STARTED|Overall Study||137
10528575|NCT01395823|11680894|FG001|STARTED|Overall Study||139
10528576|NCT01395823|11680893|FG000|COMPLETED|Overall Study||122
10528577|NCT01395823|11680894|FG001|COMPLETED|Overall Study||130
10528578|NCT01395823|11680893|FG000|NOT COMPLETED|Overall Study||15
10528579|NCT01395823|11680894|FG001|NOT COMPLETED|Overall Study||9
10529064|NCT01398475|11681470|FG002|Received Second Intervention|Overall Study||4
10529065|NCT01398475|11681471|FG003|Received Second Intervention|Overall Study||4
10711500|NCT02660580|11876931|FG002|Treated|Core Treatment Period (Week 1 to 16)||0
10711501|NCT02660580|11876932|FG003|Treated|Core Treatment Period (Week 1 to 16)||0
10529066|NCT01398475|11681468|FG000|Received Third Intervention|Overall Study||4
10529067|NCT01398475|11681469|FG001|Received Third Intervention|Overall Study||3
10529068|NCT01398475|11681470|FG002|Received Third Intervention|Overall Study||4
10529069|NCT01398475|11681471|FG003|Received Third Intervention|Overall Study||4
10514353|NCT01311648|11665194|FG000|STARTED|Main Study||51
10514354|NCT01311648|11665195|FG001|STARTED|Main Study||43
10514355|NCT01311648|11665194|FG000|Started 0-<6 Years|Main Study||25
10514356|NCT01311648|11665195|FG001|Started 0-<6 Years|Main Study||43
10514357|NCT01311648|11665194|FG000|Started 6-12 Years|Main Study||26
10514358|NCT01311648|11665195|FG001|Started 6-12 Years|Main Study||0
10514359|NCT01311648|11665194|FG000|COMPLETED|Main Study||51
10514360|NCT01311648|11665195|FG001|COMPLETED|Main Study||22
10514361|NCT01311648|11665194|FG000|NOT COMPLETED|Main Study||0
10514362|NCT01311648|11665195|FG001|NOT COMPLETED|Main Study||21
10514363|NCT01311648|11665194|FG000|STARTED|Extension Study||46
10514364|NCT01311648|11665195|FG001|STARTED|Extension Study||36
10514365|NCT01311648|11665194|FG000|COMPLETED|Extension Study||45
10514366|NCT01311648|11665195|FG001|COMPLETED|Extension Study||25
10514367|NCT01311648|11665194|FG000|NOT COMPLETED|Extension Study||1
10514368|NCT01311648|11665195|FG001|NOT COMPLETED|Extension Study||11
10514369|NCT01311661|11665208|FG000|STARTED|Overall Study|Entered and treated|206
10514370|NCT01311661|11665208|FG000|Received Placebo|Overall Study||201
10514371|NCT01311661|11665208|FG000|Received Olo 2.5 mcg Bid|Overall Study||101
10514372|NCT01311661|11665208|FG000|Received Olo 5 mcg qd|Overall Study||101
10514373|NCT01311661|11665208|FG000|Received Olo 5 mcg Bid|Overall Study||101
10514374|NCT01311661|11665208|FG000|Received Olo 10 mcg qd|Overall Study||102
10514375|NCT01311661|11665208|FG000|COMPLETED|Overall Study||199
10514376|NCT01311661|11665208|FG000|NOT COMPLETED|Overall Study||7
10514377|NCT01311674|11665222|FG000|STARTED|Overall Study||72
10514378|NCT01311674|11665223|FG001|STARTED|Overall Study||69
10514379|NCT01311674|11665222|FG000|COMPLETED|Overall Study||28
10514380|NCT01311674|11665223|FG001|COMPLETED|Overall Study||29
10514381|NCT01311674|11665222|FG000|NOT COMPLETED|Overall Study||44
10514382|NCT01311674|11665223|FG001|NOT COMPLETED|Overall Study||40
10514383|NCT01311687|11665232|FG000|STARTED|Treatment Phase||302
10514384|NCT01311687|11665233|FG001|STARTED|Treatment Phase||153
10514385|NCT01311687|11665232|FG000|Received Study Drug|Treatment Phase||300
10514386|NCT01311687|11665233|FG001|Received Study Drug|Treatment Phase||150
10514387|NCT01311687|11665232|FG000|Crossed-over to Pomalidomide|Treatment Phase|Not applicable to participants initially randomized to receive pomalidomide|0
10514388|NCT01311687|11665233|FG001|Crossed-over to Pomalidomide|Treatment Phase|After Amendment 4 participants still on HD-Dex treatment were permitted to crossover to pomalidomide|11
10514389|NCT01311687|11665232|FG000|COMPLETED|Treatment Phase||302
10514390|NCT01311687|11665233|FG001|COMPLETED|Treatment Phase||153
10514391|NCT01311687|11665232|FG000|NOT COMPLETED|Treatment Phase||0
10514392|NCT01311687|11665233|FG001|NOT COMPLETED|Treatment Phase||0
10514393|NCT01311687|11665232|FG000|STARTED|PFS Follow-up Phase||11
10514394|NCT01311687|11665233|FG001|STARTED|PFS Follow-up Phase||8
10514395|NCT01311687|11665232|FG000|Crossed-over to Pomalidomide|PFS Follow-up Phase||11
10514396|NCT01311687|11665233|FG001|Crossed-over to Pomalidomide|PFS Follow-up Phase||0
10514397|NCT01311687|11665232|FG000|COMPLETED|PFS Follow-up Phase||11
10514398|NCT01311687|11665233|FG001|COMPLETED|PFS Follow-up Phase||8
10514399|NCT01311687|11665232|FG000|NOT COMPLETED|PFS Follow-up Phase||0
10514400|NCT01311687|11665233|FG001|NOT COMPLETED|PFS Follow-up Phase||0
10514401|NCT01311895|11665244|FG000|STARTED|Overall Study||175
10514402|NCT01311895|11665245|FG001|STARTED|Overall Study||175
10514403|NCT01311895|11665244|FG000|COMPLETED|Overall Study||175
10514404|NCT01311895|11665245|FG001|COMPLETED|Overall Study||175
10514405|NCT01311895|11665244|FG000|NOT COMPLETED|Overall Study||0
10514406|NCT01311895|11665245|FG001|NOT COMPLETED|Overall Study||0
10514407|NCT01312038|11665253|FG000|STARTED|Overall Study||13
10514408|NCT01312038|11665254|FG001|STARTED|Overall Study||12
10514409|NCT01312038|11665253|FG000|COMPLETED|Overall Study||13
10514410|NCT01312038|11665254|FG001|COMPLETED|Overall Study||12
10514411|NCT01312038|11665253|FG000|NOT COMPLETED|Overall Study||0
10514412|NCT01312038|11665254|FG001|NOT COMPLETED|Overall Study||0
10514413|NCT01312129|11665262|FG000|STARTED|First Intervention (24 Hours)||6
10514414|NCT01312129|11665263|FG001|STARTED|First Intervention (24 Hours)||7
10514415|NCT01312129|11665262|FG000|Control Cue|First Intervention (24 Hours)||6
10514416|NCT01312129|11665263|FG001|Control Cue|First Intervention (24 Hours)||7
10514417|NCT01312129|11665262|FG000|Alcohol Cue|First Intervention (24 Hours)||6
10514418|NCT01312129|11665263|FG001|Alcohol Cue|First Intervention (24 Hours)||7
10514419|NCT01312129|11665262|FG000|COMPLETED|First Intervention (24 Hours)||6
10514420|NCT01312129|11665263|FG001|COMPLETED|First Intervention (24 Hours)||7
10514421|NCT01312129|11665262|FG000|NOT COMPLETED|First Intervention (24 Hours)||0
10338295|NCT00369486|11475224|FG000|STARTED|4-Week Visit|Number of eyes|38
10338296|NCT00369486|11475225|FG001|STARTED|4-Week Visit|Number of eyes|21
10338297|NCT00369486|11475226|FG002|STARTED|4-Week Visit|Number of eyes|23
10338298|NCT00369486|11475227|FG003|STARTED|4-Week Visit|Number of eyes|22
10338299|NCT00369486|11475228|FG004|STARTED|4-Week Visit|Number of eyes|25
10338300|NCT00369486|11475224|FG000|COMPLETED|4-Week Visit|Number of eyes|36
10514422|NCT01312129|11665263|FG001|NOT COMPLETED|First Intervention (24 Hours)||0
10514423|NCT01312129|11665262|FG000|STARTED|Washout (1 Week)||6
10514424|NCT01312129|11665263|FG001|STARTED|Washout (1 Week)||7
10514425|NCT01312129|11665262|FG000|COMPLETED|Washout (1 Week)||6
10514426|NCT01312129|11665263|FG001|COMPLETED|Washout (1 Week)||7
10514427|NCT01312129|11665262|FG000|NOT COMPLETED|Washout (1 Week)||0
10514428|NCT01312129|11665263|FG001|NOT COMPLETED|Washout (1 Week)||0
10514429|NCT01312129|11665262|FG000|STARTED|Second Intervention (24 Hours)||6
10514430|NCT01312129|11665263|FG001|STARTED|Second Intervention (24 Hours)||7
10514431|NCT01312129|11665262|FG000|Control Cue|Second Intervention (24 Hours)||6
10514432|NCT01312129|11665263|FG001|Control Cue|Second Intervention (24 Hours)||6
10514433|NCT01312129|11665262|FG000|Alcohol Cue|Second Intervention (24 Hours)||6
10514434|NCT01312129|11665263|FG001|Alcohol Cue|Second Intervention (24 Hours)||6
10514435|NCT01312129|11665262|FG000|COMPLETED|Second Intervention (24 Hours)||6
10514436|NCT01312129|11665263|FG001|COMPLETED|Second Intervention (24 Hours)||6
10514437|NCT01312129|11665262|FG000|NOT COMPLETED|Second Intervention (24 Hours)||0
10514438|NCT01312129|11665263|FG001|NOT COMPLETED|Second Intervention (24 Hours)||1
10514439|NCT01312181|11665272|FG000|STARTED|Overall Study||80
10514440|NCT01312181|11665273|FG001|STARTED|Overall Study||77
10514441|NCT01312181|11665274|FG002|STARTED|Overall Study||83
10514442|NCT01312181|11665272|FG000|COMPLETED|Overall Study||78
10514443|NCT01312181|11665273|FG001|COMPLETED|Overall Study||71
10514444|NCT01312181|11665274|FG002|COMPLETED|Overall Study||75
10514445|NCT01312181|11665272|FG000|NOT COMPLETED|Overall Study||2
10514446|NCT01312181|11665273|FG001|NOT COMPLETED|Overall Study||6
10514447|NCT01312181|11665274|FG002|NOT COMPLETED|Overall Study||8
10514448|NCT01312233|11665285|FG000|STARTED|Overall Study||44
10514449|NCT01312233|11665286|FG001|STARTED|Overall Study||44
10514450|NCT01312233|11665287|FG002|STARTED|Overall Study||43
10514451|NCT01312233|11665285|FG000|COMPLETED|Overall Study||42
10514452|NCT01312233|11665286|FG001|COMPLETED|Overall Study||44
10514453|NCT01312233|11665287|FG002|COMPLETED|Overall Study||36
10514454|NCT01312233|11665285|FG000|NOT COMPLETED|Overall Study||2
10514455|NCT01312233|11665286|FG001|NOT COMPLETED|Overall Study||0
10514456|NCT01312233|11665287|FG002|NOT COMPLETED|Overall Study||7
10514457|NCT01312272|11665297|FG000|STARTED|Overall Study||12
10514458|NCT01312272|11665298|FG001|STARTED|Overall Study||12
10514459|NCT01312272|11665297|FG000|COMPLETED|Overall Study||12
10514460|NCT01312272|11665298|FG001|COMPLETED|Overall Study||11
10514461|NCT01312272|11665297|FG000|NOT COMPLETED|Overall Study||0
10514462|NCT01312272|11665298|FG001|NOT COMPLETED|Overall Study||1
10514463|NCT01312389|11665307|FG000|STARTED|Phase 1||3
10514464|NCT01312389|11665308|FG001|STARTED|Phase 1||0
10514465|NCT01312389|11665309|FG002|STARTED|Phase 1||0
10514466|NCT01312389|11665307|FG000|COMPLETED|Phase 1||3
10514467|NCT01312389|11665308|FG001|COMPLETED|Phase 1||0
10514468|NCT01312389|11665309|FG002|COMPLETED|Phase 1||0
10514469|NCT01312389|11665307|FG000|NOT COMPLETED|Phase 1||0
10514470|NCT01312389|11665308|FG001|NOT COMPLETED|Phase 1||0
10514471|NCT01312389|11665309|FG002|NOT COMPLETED|Phase 1||0
10514472|NCT01312389|11665307|FG000|STARTED|Phase 2||0
10514473|NCT01312389|11665308|FG001|STARTED|Phase 2||0
10514474|NCT01312389|11665309|FG002|STARTED|Phase 2||0
10514475|NCT01312389|11665307|FG000|COMPLETED|Phase 2||0
10514476|NCT01312389|11665308|FG001|COMPLETED|Phase 2||0
10514477|NCT01312389|11665309|FG002|COMPLETED|Phase 2||0
10514478|NCT01312389|11665307|FG000|NOT COMPLETED|Phase 2||0
10514479|NCT01312389|11665308|FG001|NOT COMPLETED|Phase 2||0
10514480|NCT01312389|11665309|FG002|NOT COMPLETED|Phase 2||0
10514481|NCT01312467|11665317|FG000|STARTED|Overall Study||45
10514482|NCT01312467|11665317|FG000|COMPLETED|Overall Study||32
10514483|NCT01312467|11665317|FG000|NOT COMPLETED|Overall Study||13
10514484|NCT01312519|11665324|FG000|STARTED|Overall Study||26
10514485|NCT01312519|11665325|FG001|STARTED|Overall Study||24
10514486|NCT01312519|11665324|FG000|COMPLETED|Overall Study||26
10514487|NCT01312519|11665325|FG001|COMPLETED|Overall Study||24
10514488|NCT01312519|11665324|FG000|NOT COMPLETED|Overall Study||0
10514489|NCT01312519|11665325|FG001|NOT COMPLETED|Overall Study||0
10514490|NCT01312675|11665333|FG000|STARTED|Overall Study||9
10514491|NCT01312675|11665334|FG001|STARTED|Overall Study||7
10514492|NCT01312675|11665333|FG000|COMPLETED|Overall Study||9
10514493|NCT01312675|11665334|FG001|COMPLETED|Overall Study||7
10514494|NCT01312675|11665333|FG000|NOT COMPLETED|Overall Study||0
10514495|NCT01312675|11665334|FG001|NOT COMPLETED|Overall Study||0
10514496|NCT01312766|11665342|FG000|STARTED|Overall Study||135
10514497|NCT01312766|11665343|FG001|STARTED|Overall Study||135
10514498|NCT01312766|11665342|FG000|COMPLETED|Overall Study||129
10514499|NCT01312766|11665343|FG001|COMPLETED|Overall Study||130
10514500|NCT01312766|11665342|FG000|NOT COMPLETED|Overall Study||6
10514501|NCT01312766|11665343|FG001|NOT COMPLETED|Overall Study||5
10514502|NCT01312779|11665349|FG000|STARTED|Overall Study||39
10514503|NCT01312779|11665349|FG000|Implanted With Device|Overall Study||12
10514504|NCT01312779|11665349|FG000|COMPLETED|Overall Study||7
10514505|NCT01312779|11665349|FG000|NOT COMPLETED|Overall Study||32
10514506|NCT01312805|11665364|FG000|STARTED|Overall Study||1016
10514507|NCT01312805|11665365|FG001|STARTED|Overall Study||1082
10514508|NCT01312805|11665364|FG000|COMPLETED|Overall Study||1016
10514509|NCT01312805|11665365|FG001|COMPLETED|Overall Study||1082
10514510|NCT01312805|11665364|FG000|NOT COMPLETED|Overall Study||0
10514511|NCT01312805|11665365|FG001|NOT COMPLETED|Overall Study||0
10514512|NCT01312818|11665371|FG000|STARTED|Overall Study||2
10514513|NCT01312818|11665371|FG000|COMPLETED|Overall Study||2
10514514|NCT01312818|11665371|FG000|NOT COMPLETED|Overall Study||0
10514515|NCT01312844|11665379|FG000|STARTED|Overall Study||4
10514516|NCT01312844|11665380|FG001|STARTED|Overall Study||3
10514517|NCT01312844|11665379|FG000|COMPLETED|Overall Study||4
10514518|NCT01312844|11665380|FG001|COMPLETED|Overall Study||3
10514519|NCT01312844|11665379|FG000|NOT COMPLETED|Overall Study||0
10514520|NCT01312844|11665380|FG001|NOT COMPLETED|Overall Study||0
10514521|NCT01312909|11665389|FG000|STARTED|Overall Study||109
10514522|NCT01312909|11665390|FG001|STARTED|Overall Study||103
10514523|NCT01312909|11665391|FG002|STARTED|Overall Study||100
10514524|NCT01312909|11665389|FG000|Treated|Overall Study||108
10514525|NCT01312909|11665390|FG001|Treated|Overall Study||100
10514526|NCT01312909|11665391|FG002|Treated|Overall Study||99
10514527|NCT01312909|11665389|FG000|COMPLETED|Overall Study||67
10514528|NCT01312909|11665390|FG001|COMPLETED|Overall Study||67
10514529|NCT01312909|11665391|FG002|COMPLETED|Overall Study||53
10514530|NCT01312909|11665389|FG000|NOT COMPLETED|Overall Study||42
10514531|NCT01312909|11665390|FG001|NOT COMPLETED|Overall Study||36
10514532|NCT01312909|11665391|FG002|NOT COMPLETED|Overall Study||47
10514533|NCT01312948|11665399|FG000|STARTED|Overall Study||6
10514534|NCT01312948|11665399|FG000|COMPLETED|Overall Study||6
10514535|NCT01312948|11665399|FG000|NOT COMPLETED|Overall Study||0
10514536|NCT01312961|11665408|FG000|STARTED|Overall Study||52
10514537|NCT01312961|11665409|FG001|STARTED|Overall Study||52
10514538|NCT01312961|11665408|FG000|Treated|Overall Study||52
10514539|NCT01312961|11665409|FG001|Treated|Overall Study||52
10514540|NCT01312961|11665408|FG000|COMPLETED|Overall Study||35
10514541|NCT01312961|11665409|FG001|COMPLETED|Overall Study||45
10514542|NCT01312961|11665408|FG000|NOT COMPLETED|Overall Study||17
10514543|NCT01312961|11665409|FG001|NOT COMPLETED|Overall Study||7
10514544|NCT01313039|11665416|FG000|STARTED|Overall Study||4
10514545|NCT01313039|11665416|FG000|COMPLETED|Overall Study||2
10514546|NCT01313039|11665416|FG000|NOT COMPLETED|Overall Study||2
10514547|NCT01313078|11665420|FG000|STARTED|Overall Study||4
10514548|NCT01313078|11665420|FG000|COMPLETED|Overall Study||1
10514549|NCT01313078|11665420|FG000|NOT COMPLETED|Overall Study||3
10514550|NCT01313117|11665424|FG000|STARTED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||2
10514551|NCT01313117|11665424|FG000|COMPLETED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||2
10514552|NCT01313117|11665424|FG000|NOT COMPLETED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||0
10514553|NCT01313117|11665424|FG000|STARTED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||2
10514554|NCT01313117|11665424|FG000|COMPLETED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||1
10514555|NCT01313117|11665424|FG000|NOT COMPLETED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||1
10514556|NCT01313117|11665424|FG000|STARTED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||2
10514557|NCT01313117|11665424|FG000|COMPLETED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||2
10514558|NCT01313117|11665424|FG000|NOT COMPLETED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||0
10514559|NCT01313117|11665424|FG000|STARTED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||2
10514560|NCT01313117|11665424|FG000|COMPLETED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||2
10514561|NCT01313117|11665424|FG000|NOT COMPLETED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||0
10514562|NCT01313117|11665424|FG000|STARTED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||1
10514563|NCT01313117|11665424|FG000|COMPLETED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||0
10514564|NCT01313117|11665424|FG000|NOT COMPLETED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||1
10514565|NCT01313182|11665431|FG000|STARTED|Overall Study||842
10514566|NCT01313182|11665432|FG001|STARTED|Overall Study||855
10514567|NCT01313182|11665431|FG000|COMPLETED|Overall Study||776
10514568|NCT01313182|11665432|FG001|COMPLETED|Overall Study||763
10514569|NCT01313182|11665431|FG000|NOT COMPLETED|Overall Study||66
10514570|NCT01313182|11665432|FG001|NOT COMPLETED|Overall Study||92
10514571|NCT01313208|11665440|FG000|STARTED|Double-blind Phase (Weeks 1 - 12)||104
10514572|NCT01313208|11665441|FG001|STARTED|Double-blind Phase (Weeks 1 - 12)||106
10514573|NCT01313208|11665440|FG000|COMPLETED|Double-blind Phase (Weeks 1 - 12)||98
10514574|NCT01313208|11665441|FG001|COMPLETED|Double-blind Phase (Weeks 1 - 12)||101
10514575|NCT01313208|11665440|FG000|NOT COMPLETED|Double-blind Phase (Weeks 1 - 12)||6
10514576|NCT01313208|11665441|FG001|NOT COMPLETED|Double-blind Phase (Weeks 1 - 12)||5
10514577|NCT01313208|11665440|FG000|STARTED|Open-label Phase (Weeks 13 - 24)||98
10514578|NCT01313208|11665441|FG001|STARTED|Open-label Phase (Weeks 13 - 24)||101
10514579|NCT01313208|11665440|FG000|COMPLETED|Open-label Phase (Weeks 13 - 24)||92
10514580|NCT01313208|11665441|FG001|COMPLETED|Open-label Phase (Weeks 13 - 24)||98
10514581|NCT01313208|11665440|FG000|NOT COMPLETED|Open-label Phase (Weeks 13 - 24)||6
10514582|NCT01313208|11665441|FG001|NOT COMPLETED|Open-label Phase (Weeks 13 - 24)||3
10514583|NCT01313221|11665452|FG000|STARTED|Overall Study||144
10514584|NCT01313221|11665453|FG001|STARTED|Overall Study||143
10514585|NCT01313221|11665454|FG002|STARTED|Overall Study||23
10514586|NCT01313221|11665452|FG000|Randomized|Overall Study||144
10514587|NCT01313221|11665453|FG001|Randomized|Overall Study||143
10514588|NCT01313221|11665454|FG002|Randomized|Overall Study||0
10514589|NCT01313221|11665452|FG000|COMPLETED|Overall Study||132
10514590|NCT01313221|11665453|FG001|COMPLETED|Overall Study||135
10514591|NCT01313221|11665454|FG002|COMPLETED|Overall Study||0
10514592|NCT01313221|11665452|FG000|NOT COMPLETED|Overall Study||12
10514593|NCT01313221|11665453|FG001|NOT COMPLETED|Overall Study||8
10514594|NCT01313221|11665454|FG002|NOT COMPLETED|Overall Study||23
10514595|NCT01313286|11665462|FG000|STARTED|Period 1||8
10514596|NCT01313286|11665463|FG001|STARTED|Period 1||8
10514597|NCT01313286|11665462|FG000|COMPLETED|Period 1||6
10514598|NCT01313286|11665463|FG001|COMPLETED|Period 1||8
10514599|NCT01313286|11665462|FG000|NOT COMPLETED|Period 1||2
10514600|NCT01313286|11665463|FG001|NOT COMPLETED|Period 1||0
10514601|NCT01313286|11665462|FG000|STARTED|Period 2||6
10514602|NCT01313286|11665463|FG001|STARTED|Period 2||8
10514603|NCT01313286|11665462|FG000|COMPLETED|Period 2||6
10514604|NCT01313286|11665463|FG001|COMPLETED|Period 2||8
10514605|NCT01313286|11665462|FG000|NOT COMPLETED|Period 2||0
10514606|NCT01313286|11665463|FG001|NOT COMPLETED|Period 2||0
10514624|NCT01313494|11665488|FG000|STARTED|Overall Study||313
10514625|NCT01313494|11665489|FG001|STARTED|Overall Study||313
10514626|NCT01313494|11665488|FG000|Safety Set|Overall Study|2 patients in the placebo arm were misallocated and may have received roflumilast in error.|315
10514627|NCT01313494|11665489|FG001|Safety Set|Overall Study|2 patients in the placebo arm were misallocated and may have received roflumilast in error.|311
10514628|NCT01313494|11665488|FG000|COMPLETED|Overall Study||246
10514629|NCT01313494|11665489|FG001|COMPLETED|Overall Study||263
10514630|NCT01313494|11665488|FG000|NOT COMPLETED|Overall Study||67
10514631|NCT01313494|11665489|FG001|NOT COMPLETED|Overall Study||50
10514632|NCT01313507|11665495|FG000|STARTED|Overall Study||21
10514633|NCT01313507|11665495|FG000|COMPLETED|Overall Study||21
10514634|NCT01313507|11665495|FG000|NOT COMPLETED|Overall Study||0
10514635|NCT01313520|11665501|FG000|STARTED|Overall Study||30
10514636|NCT01313520|11665502|FG001|STARTED|Overall Study||31
10514637|NCT01313520|11665501|FG000|COMPLETED|Overall Study||30
10514638|NCT01313520|11665502|FG001|COMPLETED|Overall Study||31
10514639|NCT01313520|11665501|FG000|NOT COMPLETED|Overall Study||0
10514640|NCT01313520|11665502|FG001|NOT COMPLETED|Overall Study||0
10514641|NCT01313559|11665512|FG000|STARTED|Overall Study||4
10514642|NCT01313559|11665513|FG001|STARTED|Overall Study||2
10514643|NCT01313559|11665512|FG000|COMPLETED|Overall Study||0
10514644|NCT01313559|11665513|FG001|COMPLETED|Overall Study||0
10514645|NCT01313559|11665512|FG000|NOT COMPLETED|Overall Study||4
10514646|NCT01313559|11665513|FG001|NOT COMPLETED|Overall Study||2
10514647|NCT01313624|11665521|FG000|STARTED|Double-Blind Phase||134
10514648|NCT01313624|11665522|FG001|STARTED|Double-Blind Phase||132
10514649|NCT01313624|11665521|FG000|COMPLETED|Double-Blind Phase||96
10514650|NCT01313624|11665522|FG001|COMPLETED|Double-Blind Phase||122
10514651|NCT01313624|11665521|FG000|NOT COMPLETED|Double-Blind Phase||38
10514652|NCT01313624|11665522|FG001|NOT COMPLETED|Double-Blind Phase||10
10514653|NCT01313624|11665521|FG000|STARTED|Open-Label Phase||96
10514654|NCT01313624|11665522|FG001|STARTED|Open-Label Phase||122
10514655|NCT01313624|11665521|FG000|COMPLETED|Open-Label Phase||92
10514656|NCT01313624|11665522|FG001|COMPLETED|Open-Label Phase||109
10514657|NCT01313624|11665521|FG000|NOT COMPLETED|Open-Label Phase||4
10514658|NCT01313624|11665522|FG001|NOT COMPLETED|Open-Label Phase||13
10514659|NCT01313637|11665534|FG000|STARTED|Overall Study||275
10514660|NCT01313637|11665535|FG001|STARTED|Overall Study||407
10514661|NCT01313637|11665536|FG002|STARTED|Overall Study||404
10514662|NCT01313637|11665537|FG003|STARTED|Overall Study||403
10514663|NCT01313637|11665534|FG000|COMPLETED|Overall Study||183
10514664|NCT01313637|11665535|FG001|COMPLETED|Overall Study||312
10514665|NCT01313637|11665536|FG002|COMPLETED|Overall Study||298
10514666|NCT01313637|11665537|FG003|COMPLETED|Overall Study||325
10514667|NCT01313637|11665534|FG000|NOT COMPLETED|Overall Study||92
10514668|NCT01313637|11665535|FG001|NOT COMPLETED|Overall Study||95
10514669|NCT01313637|11665536|FG002|NOT COMPLETED|Overall Study||106
10514670|NCT01313637|11665537|FG003|NOT COMPLETED|Overall Study||78
10514671|NCT01313650|11665551|FG000|STARTED|Overall Study||280
10514672|NCT01313650|11665552|FG001|STARTED|Overall Study||418
10514673|NCT01313650|11665553|FG002|STARTED|Overall Study||421
10514674|NCT01313650|11665554|FG003|STARTED|Overall Study||413
10514675|NCT01313650|11665551|FG000|COMPLETED|Overall Study||204
10514676|NCT01313650|11665552|FG001|COMPLETED|Overall Study||324
10514677|NCT01313650|11665553|FG002|COMPLETED|Overall Study||318
10514678|NCT01313650|11665554|FG003|COMPLETED|Overall Study||332
10514679|NCT01313650|11665551|FG000|NOT COMPLETED|Overall Study||76
10514680|NCT01313650|11665552|FG001|NOT COMPLETED|Overall Study||94
10514681|NCT01313650|11665553|FG002|NOT COMPLETED|Overall Study||103
10514682|NCT01313650|11665554|FG003|NOT COMPLETED|Overall Study||81
10514683|NCT01313663|11665566|FG000|STARTED|Overall Study||9
10514684|NCT01313663|11665567|FG001|STARTED|Overall Study||11
10514685|NCT01313663|11665566|FG000|COMPLETED|Overall Study||5
10514686|NCT01313663|11665567|FG001|COMPLETED|Overall Study||3
10514687|NCT01313663|11665566|FG000|NOT COMPLETED|Overall Study||4
10514688|NCT01313663|11665567|FG001|NOT COMPLETED|Overall Study||8
10514689|NCT01313676|11665577|FG000|STARTED|Overall Study||4131
10514690|NCT01313676|11665578|FG001|STARTED|Overall Study||4157
10514691|NCT01313676|11665579|FG002|STARTED|Overall Study||4140
10514692|NCT01313676|11665580|FG003|STARTED|Overall Study||4140
10514693|NCT01313676|11665577|FG000|COMPLETED|Overall Study||2881
10514694|NCT01313676|11665578|FG001|COMPLETED|Overall Study||3044
10514695|NCT01313676|11665579|FG002|COMPLETED|Overall Study||3052
10514696|NCT01313676|11665580|FG003|COMPLETED|Overall Study||3146
10514697|NCT01313676|11665577|FG000|NOT COMPLETED|Overall Study||1250
10514698|NCT01313676|11665578|FG001|NOT COMPLETED|Overall Study||1113
10514699|NCT01313676|11665579|FG002|NOT COMPLETED|Overall Study||1088
10514700|NCT01313676|11665580|FG003|NOT COMPLETED|Overall Study||994
10514701|NCT01313728|11665591|FG000|STARTED|Informed Consent to Baseline||26
10528580|NCT01395888|11680902|FG000|STARTED|2-week Run-in Period||279
10528581|NCT01395888|11680903|FG001|STARTED|2-week Run-in Period||0
10514702|NCT01313728|11665591|FG000|COMPLETED|Informed Consent to Baseline|One subject withdrew after signing informed consent, but prior to Baseline measurements being taken.|25
10514703|NCT01313728|11665591|FG000|NOT COMPLETED|Informed Consent to Baseline||1
10514704|NCT01313728|11665591|FG000|STARTED|Baseline to Completion||25
10514705|NCT01313728|11665591|FG000|COMPLETED|Baseline to Completion||25
10514706|NCT01313728|11665591|FG000|NOT COMPLETED|Baseline to Completion||0
10514707|NCT01313767|11665598|FG000|STARTED|Overall Study||98
10514708|NCT01313767|11665599|FG001|STARTED|Overall Study||98
10514709|NCT01313767|11665598|FG000|COMPLETED|Overall Study||91
10514710|NCT01313767|11665599|FG001|COMPLETED|Overall Study||96
10514711|NCT01313767|11665598|FG000|NOT COMPLETED|Overall Study||7
10514712|NCT01313767|11665599|FG001|NOT COMPLETED|Overall Study||2
10514713|NCT01313780|11665607|FG000|STARTED|Overall Study|FAS|58
10514714|NCT01313780|11665608|FG001|STARTED|Overall Study|FAS|59
10514715|NCT01313780|11665607|FG000|COMPLETED|Overall Study|PPS|33
10514716|NCT01313780|11665608|FG001|COMPLETED|Overall Study|PPS|31
10514717|NCT01313780|11665607|FG000|NOT COMPLETED|Overall Study||25
10514718|NCT01313780|11665608|FG001|NOT COMPLETED|Overall Study||28
10514719|NCT01313858|11665617|FG000|STARTED|Overall Study||524
10514720|NCT01313858|11665618|FG001|STARTED|Overall Study||546
10514721|NCT01313858|11665619|FG002|STARTED|Overall Study||543
10514722|NCT01313858|11665617|FG000|COMPLETED|Overall Study||238
10514723|NCT01313858|11665618|FG001|COMPLETED|Overall Study||276
10514724|NCT01313858|11665619|FG002|COMPLETED|Overall Study||305
10514725|NCT01313858|11665617|FG000|NOT COMPLETED|Overall Study||286
10514726|NCT01313858|11665618|FG001|NOT COMPLETED|Overall Study||270
10514727|NCT01313858|11665619|FG002|NOT COMPLETED|Overall Study||238
10514728|NCT01313884|11665625|FG000|STARTED|Overall Study||3
10514729|NCT01313884|11665625|FG000|COMPLETED|Overall Study||2
10514730|NCT01313884|11665625|FG000|NOT COMPLETED|Overall Study||1
10514731|NCT01313897|11665629|FG000|STARTED|Overall Study||10
10514732|NCT01313897|11665629|FG000|COMPLETED|Overall Study||8
10514733|NCT01313897|11665629|FG000|NOT COMPLETED|Overall Study||2
10514734|NCT01313910|11665633|FG000|STARTED|Overall Study||8
10514735|NCT01313910|11665633|FG000|COMPLETED|Overall Study||8
10514736|NCT01313910|11665633|FG000|NOT COMPLETED|Overall Study||0
10514737|NCT01313936|11665639|FG000|STARTED|Overall Study||6
10514738|NCT01313936|11665640|FG001|STARTED|Overall Study||26
10514739|NCT01313936|11665639|FG000|COMPLETED|Overall Study||6
10514740|NCT01313936|11665640|FG001|COMPLETED|Overall Study||26
10514741|NCT01313936|11665639|FG000|NOT COMPLETED|Overall Study||0
10514742|NCT01313936|11665640|FG001|NOT COMPLETED|Overall Study||0
10514743|NCT01314001|11665655|FG000|STARTED|Overall Study||215
10514744|NCT01314001|11665656|FG001|STARTED|Overall Study||193
10514745|NCT01314001|11665657|FG002|STARTED|Overall Study||227
10514746|NCT01314001|11665658|FG003|STARTED|Overall Study||191
10514747|NCT01314001|11665659|FG004|STARTED|Overall Study||220
10514748|NCT01314001|11665660|FG005|STARTED|Overall Study||200
10514749|NCT01314001|11665655|FG000|End-of-Treatment Visit|Overall Study||156
10514750|NCT01314001|11665656|FG001|End-of-Treatment Visit|Overall Study||141
10514751|NCT01314001|11665657|FG002|End-of-Treatment Visit|Overall Study||179
10514752|NCT01314001|11665658|FG003|End-of-Treatment Visit|Overall Study||146
10514753|NCT01314001|11665659|FG004|End-of-Treatment Visit|Overall Study||174
10514754|NCT01314001|11665660|FG005|End-of-Treatment Visit|Overall Study||160
10514755|NCT01314001|11665655|FG000|6-Month Follow Up Survey|Overall Study||146
10514756|NCT01314001|11665656|FG001|6-Month Follow Up Survey|Overall Study||137
10514757|NCT01314001|11665657|FG002|6-Month Follow Up Survey|Overall Study||165
10514758|NCT01314001|11665658|FG003|6-Month Follow Up Survey|Overall Study||135
10514759|NCT01314001|11665659|FG004|6-Month Follow Up Survey|Overall Study||157
10514760|NCT01314001|11665660|FG005|6-Month Follow Up Survey|Overall Study||139
10514761|NCT01314001|11665655|FG000|COMPLETED|Overall Study||140
10514762|NCT01314001|11665656|FG001|COMPLETED|Overall Study||124
10514763|NCT01314001|11665657|FG002|COMPLETED|Overall Study||158
10514764|NCT01314001|11665658|FG003|COMPLETED|Overall Study||122
10514765|NCT01314001|11665659|FG004|COMPLETED|Overall Study||148
10514766|NCT01314001|11665660|FG005|COMPLETED|Overall Study||129
10514767|NCT01314001|11665655|FG000|NOT COMPLETED|Overall Study||75
10514768|NCT01314001|11665656|FG001|NOT COMPLETED|Overall Study||69
10514769|NCT01314001|11665657|FG002|NOT COMPLETED|Overall Study||69
10514770|NCT01314001|11665658|FG003|NOT COMPLETED|Overall Study||69
10514771|NCT01314001|11665659|FG004|NOT COMPLETED|Overall Study||72
10514772|NCT01314001|11665660|FG005|NOT COMPLETED|Overall Study||71
10514773|NCT01314014|11665674|FG000|STARTED|Overall Study||22
10514774|NCT01314014|11665674|FG000|COMPLETED|Overall Study|Treatment continued for as long as the subject derived benefit.|22
10514775|NCT01314014|11665674|FG000|NOT COMPLETED|Overall Study||0
10514776|NCT01314105|11665680|FG000|STARTED|Overall Study||7
10514777|NCT01314105|11665681|FG001|STARTED|Overall Study||12
10514778|NCT01314105|11665680|FG000|COMPLETED|Overall Study||0
10514779|NCT01314105|11665681|FG001|COMPLETED|Overall Study||0
10514780|NCT01314105|11665680|FG000|NOT COMPLETED|Overall Study||7
10514781|NCT01314105|11665681|FG001|NOT COMPLETED|Overall Study||12
10514782|NCT01314261|11665693|FG000|STARTED|Overall Study||9
10514783|NCT01314261|11665694|FG001|STARTED|Overall Study||9
10514784|NCT01314261|11665695|FG002|STARTED|Overall Study||10
10514785|NCT01314261|11665696|FG003|STARTED|Overall Study||9
10514786|NCT01314261|11665693|FG000|Discontinued ABT-267 or Placebo|Overall Study||1
10514787|NCT01314261|11665694|FG001|Discontinued ABT-267 or Placebo|Overall Study||0
10514788|NCT01314261|11665695|FG002|Discontinued ABT-267 or Placebo|Overall Study||1
10514789|NCT01314261|11665696|FG003|Discontinued ABT-267 or Placebo|Overall Study||0
10514790|NCT01314261|11665693|FG000|Discontinued pegIFN/RBV|Overall Study||1
10514791|NCT01314261|11665694|FG001|Discontinued pegIFN/RBV|Overall Study||4
10514792|NCT01314261|11665695|FG002|Discontinued pegIFN/RBV|Overall Study||5
10514793|NCT01314261|11665696|FG003|Discontinued pegIFN/RBV|Overall Study||1
10514794|NCT01314261|11665693|FG000|COMPLETED|Overall Study||7
10514795|NCT01314261|11665694|FG001|COMPLETED|Overall Study||5
10514796|NCT01314261|11665695|FG002|COMPLETED|Overall Study||7
10514797|NCT01314261|11665696|FG003|COMPLETED|Overall Study||6
10514798|NCT01314261|11665693|FG000|NOT COMPLETED|Overall Study||2
10514799|NCT01314261|11665694|FG001|NOT COMPLETED|Overall Study||4
10514800|NCT01314261|11665695|FG002|NOT COMPLETED|Overall Study||3
10514801|NCT01314261|11665696|FG003|NOT COMPLETED|Overall Study||3
10514812|NCT01314417|11665717|FG000|STARTED|Overall Study||2
10514813|NCT01314417|11665717|FG000|COMPLETED|Overall Study||2
10514814|NCT01314417|11665717|FG000|NOT COMPLETED|Overall Study||0
10514815|NCT01314443|11665725|FG000|STARTED|Overall Study||18
10514816|NCT01314443|11665726|FG001|STARTED|Overall Study||19
10514817|NCT01314443|11665727|FG002|STARTED|Overall Study||15
10514818|NCT01314443|11665728|FG003|STARTED|Overall Study||15
10514819|NCT01314443|11665725|FG000|COMPLETED|Overall Study||14
10514820|NCT01314443|11665726|FG001|COMPLETED|Overall Study||16
10514821|NCT01314443|11665727|FG002|COMPLETED|Overall Study||13
10514822|NCT01314443|11665728|FG003|COMPLETED|Overall Study||13
10514823|NCT01314443|11665725|FG000|NOT COMPLETED|Overall Study||4
10514824|NCT01314443|11665726|FG001|NOT COMPLETED|Overall Study||3
10514825|NCT01314443|11665727|FG002|NOT COMPLETED|Overall Study||2
10514826|NCT01314443|11665728|FG003|NOT COMPLETED|Overall Study||2
10514827|NCT01314703|11665738|FG000|STARTED|Overall Study||35
10514828|NCT01314703|11665738|FG000|Signed Informed Consent|Overall Study||35
10514829|NCT01314703|11665738|FG000|Completed Screen Visit|Overall Study||33
10514830|NCT01314703|11665738|FG000|Completed Treatment Visit|Overall Study||27
10514831|NCT01314703|11665738|FG000|Completed Study|Overall Study||27
10514832|NCT01314703|11665738|FG000|Excluded Prior to Screening Baseline|Overall Study||2
10514833|NCT01314703|11665738|FG000|Non Qualified Bacterial Screening Counts|Overall Study||3
10514834|NCT01314703|11665738|FG000|Discontinued When Enrollment Completed|Overall Study||3
10514835|NCT01314703|11665738|FG000|COMPLETED|Overall Study||27
10514836|NCT01314703|11665738|FG000|NOT COMPLETED|Overall Study||8
10514837|NCT01314716|11665745|FG000|STARTED|Double-Blind Phase||136
10514838|NCT01314716|11665746|FG001|STARTED|Double-Blind Phase||138
10514839|NCT01314716|11665745|FG000|Randomized and Treated|Double-Blind Phase||135
10514840|NCT01314716|11665746|FG001|Randomized and Treated|Double-Blind Phase||137
10514841|NCT01314716|11665745|FG000|COMPLETED|Double-Blind Phase||119
10514842|NCT01314716|11665746|FG001|COMPLETED|Double-Blind Phase||123
10514843|NCT01314716|11665745|FG000|NOT COMPLETED|Double-Blind Phase||17
10514844|NCT01314716|11665746|FG001|NOT COMPLETED|Double-Blind Phase||15
10514845|NCT01314716|11665745|FG000|STARTED|Open-Label Phase|7 participants in this group did not continue from the randomized to the open-label phase.|112
10514846|NCT01314716|11665746|FG001|STARTED|Open-Label Phase|13 participants in this group did not continue from the randomized to the open-label phase.|110
10514847|NCT01314716|11665745|FG000|COMPLETED|Open-Label Phase||102
10514848|NCT01314716|11665746|FG001|COMPLETED|Open-Label Phase||98
10514849|NCT01314716|11665745|FG000|NOT COMPLETED|Open-Label Phase||10
10514850|NCT01314716|11665746|FG001|NOT COMPLETED|Open-Label Phase||12
10514851|NCT01314742|11665756|FG000|STARTED|Overall Study||20
10514852|NCT01314742|11665757|FG001|STARTED|Overall Study||21
10514853|NCT01314742|11665756|FG000|COMPLETED|Overall Study||20
10514854|NCT01314742|11665757|FG001|COMPLETED|Overall Study||21
10514855|NCT01314742|11665756|FG000|NOT COMPLETED|Overall Study||0
10514856|NCT01314742|11665757|FG001|NOT COMPLETED|Overall Study||0
10514857|NCT01314872|11665776|FG000|STARTED|Treatment Period 1||141
10514858|NCT01314872|11665777|FG001|STARTED|Treatment Period 1||144
10514859|NCT01314872|11665778|FG002|STARTED|Treatment Period 1||134
10514860|NCT01314872|11665779|FG003|STARTED|Treatment Period 1||150
10514861|NCT01314872|11665780|FG004|STARTED|Treatment Period 1||149
10514862|NCT01314872|11665781|FG005|STARTED|Treatment Period 1||135
10514863|NCT01314872|11665782|FG006|STARTED|Treatment Period 1||134
10514864|NCT01314872|11665783|FG007|STARTED|Treatment Period 1||64
10514865|NCT01314872|11665784|FG008|STARTED|Treatment Period 1||112
10514866|NCT01314872|11665785|FG009|STARTED|Treatment Period 1||122
10514867|NCT01314872|11665786|FG010|STARTED|Treatment Period 1||110
10514868|NCT01314872|11665787|FG011|STARTED|Treatment Period 1||0
10514869|NCT01314872|11665788|FG012|STARTED|Treatment Period 1||0
10514870|NCT01314872|11665789|FG013|STARTED|Treatment Period 1||0
10514871|NCT01314872|11665790|FG014|STARTED|Treatment Period 1||0
10514872|NCT01314872|11665776|FG000|COMPLETED|Treatment Period 1||131
10514873|NCT01314872|11665777|FG001|COMPLETED|Treatment Period 1||138
10514874|NCT01314872|11665778|FG002|COMPLETED|Treatment Period 1||128
10514875|NCT01314872|11665779|FG003|COMPLETED|Treatment Period 1||143
10514876|NCT01314872|11665780|FG004|COMPLETED|Treatment Period 1||142
10514877|NCT01314872|11665781|FG005|COMPLETED|Treatment Period 1||128
10514878|NCT01314872|11665782|FG006|COMPLETED|Treatment Period 1||126
10514879|NCT01314872|11665783|FG007|COMPLETED|Treatment Period 1||57
10514880|NCT01314872|11665784|FG008|COMPLETED|Treatment Period 1||106
10514881|NCT01314872|11665785|FG009|COMPLETED|Treatment Period 1||118
10514882|NCT01314872|11665786|FG010|COMPLETED|Treatment Period 1||107
10514883|NCT01314872|11665787|FG011|COMPLETED|Treatment Period 1||0
10514884|NCT01314872|11665788|FG012|COMPLETED|Treatment Period 1||0
10514885|NCT01314872|11665789|FG013|COMPLETED|Treatment Period 1||0
10514886|NCT01314872|11665790|FG014|COMPLETED|Treatment Period 1||0
10514887|NCT01314872|11665776|FG000|NOT COMPLETED|Treatment Period 1||10
10514888|NCT01314872|11665777|FG001|NOT COMPLETED|Treatment Period 1||6
10514889|NCT01314872|11665778|FG002|NOT COMPLETED|Treatment Period 1||6
10514890|NCT01314872|11665779|FG003|NOT COMPLETED|Treatment Period 1||7
10514891|NCT01314872|11665780|FG004|NOT COMPLETED|Treatment Period 1||7
10514892|NCT01314872|11665781|FG005|NOT COMPLETED|Treatment Period 1||7
10514893|NCT01314872|11665782|FG006|NOT COMPLETED|Treatment Period 1||8
10514894|NCT01314872|11665783|FG007|NOT COMPLETED|Treatment Period 1||7
10514895|NCT01314872|11665784|FG008|NOT COMPLETED|Treatment Period 1||6
10514896|NCT01314872|11665785|FG009|NOT COMPLETED|Treatment Period 1||4
10514897|NCT01314872|11665786|FG010|NOT COMPLETED|Treatment Period 1||3
10514898|NCT01314872|11665787|FG011|NOT COMPLETED|Treatment Period 1||0
10514899|NCT01314872|11665788|FG012|NOT COMPLETED|Treatment Period 1||0
10514900|NCT01314872|11665789|FG013|NOT COMPLETED|Treatment Period 1||0
10514901|NCT01314872|11665790|FG014|NOT COMPLETED|Treatment Period 1||0
10514902|NCT01314872|11665776|FG000|STARTED|Period 2||0
10514903|NCT01314872|11665777|FG001|STARTED|Period 2||0
10514904|NCT01314872|11665778|FG002|STARTED|Period 2||0
10514905|NCT01314872|11665779|FG003|STARTED|Period 2||0
10514906|NCT01314872|11665780|FG004|STARTED|Period 2||0
10514907|NCT01314872|11665781|FG005|STARTED|Period 2||0
10514908|NCT01314872|11665782|FG006|STARTED|Period 2||0
10514909|NCT01314872|11665783|FG007|STARTED|Period 2||0
10514910|NCT01314872|11665784|FG008|STARTED|Period 2||0
10514911|NCT01314872|11665785|FG009|STARTED|Period 2||0
10514912|NCT01314872|11665786|FG010|STARTED|Period 2||0
10514913|NCT01314872|11665787|FG011|STARTED|Period 2||223
10514914|NCT01314872|11665788|FG012|STARTED|Period 2||248
10514915|NCT01314872|11665789|FG013|STARTED|Period 2||240
10514916|NCT01314872|11665790|FG014|STARTED|Period 2||134
10514917|NCT01314872|11665776|FG000|COMPLETED|Period 2||0
10514918|NCT01314872|11665777|FG001|COMPLETED|Period 2||0
10514919|NCT01314872|11665778|FG002|COMPLETED|Period 2||0
10514920|NCT01314872|11665779|FG003|COMPLETED|Period 2||0
10514921|NCT01314872|11665780|FG004|COMPLETED|Period 2||0
10514922|NCT01314872|11665781|FG005|COMPLETED|Period 2||0
10514923|NCT01314872|11665782|FG006|COMPLETED|Period 2||0
10514924|NCT01314872|11665783|FG007|COMPLETED|Period 2||0
10514925|NCT01314872|11665784|FG008|COMPLETED|Period 2||0
10514926|NCT01314872|11665785|FG009|COMPLETED|Period 2||0
10514927|NCT01314872|11665786|FG010|COMPLETED|Period 2||0
10514928|NCT01314872|11665787|FG011|COMPLETED|Period 2||175
10514929|NCT01314872|11665788|FG012|COMPLETED|Period 2||188
10514930|NCT01314872|11665789|FG013|COMPLETED|Period 2||187
10514931|NCT01314872|11665790|FG014|COMPLETED|Period 2||110
10514932|NCT01314872|11665776|FG000|NOT COMPLETED|Period 2||0
10514933|NCT01314872|11665777|FG001|NOT COMPLETED|Period 2||0
10514934|NCT01314872|11665778|FG002|NOT COMPLETED|Period 2||0
10514935|NCT01314872|11665779|FG003|NOT COMPLETED|Period 2||0
10514936|NCT01314872|11665780|FG004|NOT COMPLETED|Period 2||0
10514937|NCT01314872|11665781|FG005|NOT COMPLETED|Period 2||0
10514938|NCT01314872|11665782|FG006|NOT COMPLETED|Period 2||0
10514939|NCT01314872|11665783|FG007|NOT COMPLETED|Period 2||0
10514940|NCT01314872|11665784|FG008|NOT COMPLETED|Period 2||0
10514941|NCT01314872|11665785|FG009|NOT COMPLETED|Period 2||0
10514942|NCT01314872|11665786|FG010|NOT COMPLETED|Period 2||0
10514943|NCT01314872|11665787|FG011|NOT COMPLETED|Period 2||48
10514944|NCT01314872|11665788|FG012|NOT COMPLETED|Period 2||60
10514945|NCT01314872|11665789|FG013|NOT COMPLETED|Period 2||53
10514946|NCT01314872|11665790|FG014|NOT COMPLETED|Period 2||24
10514947|NCT01314911|11665824|FG000|STARTED|Overall Study||278
10514948|NCT01314911|11665825|FG001|STARTED|Overall Study||280
10514949|NCT01314911|11665824|FG000|COMPLETED|Overall Study||273
10514950|NCT01314911|11665825|FG001|COMPLETED|Overall Study||274
10514951|NCT01314911|11665824|FG000|NOT COMPLETED|Overall Study||5
10514952|NCT01314911|11665825|FG001|NOT COMPLETED|Overall Study||6
10514953|NCT01314963|11665831|FG000|STARTED|Overall Study||50
10514954|NCT01314963|11665831|FG000|COMPLETED|Overall Study||50
10514955|NCT01314963|11665831|FG000|NOT COMPLETED|Overall Study||0
10514956|NCT01315002|11665837|FG000|STARTED|Overall Study||61
10514957|NCT01315002|11665838|FG001|STARTED|Overall Study||60
10514958|NCT01315002|11665837|FG000|COMPLETED|Overall Study||56
10514959|NCT01315002|11665838|FG001|COMPLETED|Overall Study||55
10514960|NCT01315002|11665837|FG000|NOT COMPLETED|Overall Study||5
10514961|NCT01315002|11665838|FG001|NOT COMPLETED|Overall Study||5
10514962|NCT01315028|11665846|FG000|STARTED|Overall Study||10
10514963|NCT01315028|11665847|FG001|STARTED|Overall Study||10
10514964|NCT01315028|11665846|FG000|COMPLETED|Overall Study||9
10514965|NCT01315028|11665847|FG001|COMPLETED|Overall Study||9
10514966|NCT01315028|11665846|FG000|NOT COMPLETED|Overall Study||1
10514967|NCT01315028|11665847|FG001|NOT COMPLETED|Overall Study||1
10514968|NCT01315132|11665853|FG000|STARTED|Overall Study||47
10514969|NCT01315132|11665853|FG000|COMPLETED|Overall Study||46
10514970|NCT01315132|11665853|FG000|NOT COMPLETED|Overall Study||1
10514971|NCT01315145|11665859|FG000|STARTED|Overall Study||122
10514972|NCT01315145|11665860|FG001|STARTED|Overall Study||16
10514973|NCT01315145|11665859|FG000|COMPLETED|Overall Study||105
10514974|NCT01315145|11665860|FG001|COMPLETED|Overall Study||11
10514975|NCT01315145|11665859|FG000|NOT COMPLETED|Overall Study||17
10514976|NCT01315145|11665860|FG001|NOT COMPLETED|Overall Study||5
10514977|NCT01315158|11665868|FG000|STARTED|Overall Study||17
10514978|NCT01315158|11665869|FG001|STARTED|Overall Study||19
10514979|NCT01315158|11665868|FG000|COMPLETED|Overall Study||17
10514980|NCT01315158|11665869|FG001|COMPLETED|Overall Study||19
10514981|NCT01315158|11665868|FG000|NOT COMPLETED|Overall Study||0
10514982|NCT01315158|11665869|FG001|NOT COMPLETED|Overall Study||0
10514983|NCT01315236|11665877|FG000|STARTED|Double-blind Phase||44
10514984|NCT01315236|11665878|FG001|STARTED|Double-blind Phase||45
10514985|NCT01315236|11665877|FG000|COMPLETED|Double-blind Phase||40
10514986|NCT01315236|11665878|FG001|COMPLETED|Double-blind Phase||45
10514987|NCT01315236|11665877|FG000|NOT COMPLETED|Double-blind Phase||4
10514988|NCT01315236|11665878|FG001|NOT COMPLETED|Double-blind Phase||0
10514989|NCT01315236|11665877|FG000|STARTED|Open-label Phase|Some subjects did not consent to the open label after the double blind phase.|35
10514990|NCT01315236|11665878|FG001|STARTED|Open-label Phase|Some subjects did not consent to the open label after the double blind phase.|43
10514991|NCT01315236|11665877|FG000|COMPLETED|Open-label Phase||34
10514992|NCT01315236|11665878|FG001|COMPLETED|Open-label Phase||41
10514993|NCT01315236|11665877|FG000|NOT COMPLETED|Open-label Phase||1
10514994|NCT01315236|11665878|FG001|NOT COMPLETED|Open-label Phase||2
10514995|NCT01315236|11665877|FG000|STARTED|12-Month Follow-up Period|Some subjects did not consent to the 12 month safety.|27
10514996|NCT01315236|11665878|FG001|STARTED|12-Month Follow-up Period|Some subjects did not consent to the 12 month safety.|32
10514997|NCT01315236|11665877|FG000|COMPLETED|12-Month Follow-up Period||26
10514998|NCT01315236|11665878|FG001|COMPLETED|12-Month Follow-up Period||31
10514999|NCT01315236|11665877|FG000|NOT COMPLETED|12-Month Follow-up Period||1
10515000|NCT01315236|11665878|FG001|NOT COMPLETED|12-Month Follow-up Period||1
10515001|NCT01315249|11665888|FG000|STARTED|Overall Study||259
10515002|NCT01315249|11665889|FG001|STARTED|Overall Study||264
10515003|NCT01315249|11665888|FG000|COMPLETED|Overall Study||215
10515004|NCT01315249|11665889|FG001|COMPLETED|Overall Study||217
10515005|NCT01315249|11665888|FG000|NOT COMPLETED|Overall Study||44
10515006|NCT01315249|11665889|FG001|NOT COMPLETED|Overall Study||47
10515007|NCT01315574|11665897|FG000|STARTED|Overall Study||7
10515008|NCT01315574|11665898|FG001|STARTED|Overall Study||7
10515009|NCT01315574|11665897|FG000|COMPLETED|Overall Study||7
10515010|NCT01315574|11665898|FG001|COMPLETED|Overall Study||7
10515011|NCT01315574|11665897|FG000|NOT COMPLETED|Overall Study||0
10515012|NCT01315574|11665898|FG001|NOT COMPLETED|Overall Study||0
10515013|NCT01315665|11665906|FG000|STARTED|Overall Study||10
10515014|NCT01315665|11665907|FG001|STARTED|Overall Study||5
10515015|NCT01315665|11665906|FG000|COMPLETED|Overall Study||10
10515016|NCT01315665|11665907|FG001|COMPLETED|Overall Study||5
10515017|NCT01315665|11665906|FG000|NOT COMPLETED|Overall Study||0
10515018|NCT01315665|11665907|FG001|NOT COMPLETED|Overall Study||0
10515019|NCT01315678|11665917|FG000|STARTED|Overall Study||148
10515020|NCT01315678|11665918|FG001|STARTED|Overall Study||146
10515021|NCT01315678|11665917|FG000|COMPLETED|Overall Study||134
10515022|NCT01315678|11665918|FG001|COMPLETED|Overall Study||140
10515023|NCT01315678|11665917|FG000|NOT COMPLETED|Overall Study||14
10515024|NCT01315678|11665918|FG001|NOT COMPLETED|Overall Study||6
10515025|NCT01315847|11665928|FG000|STARTED|Part I, Period 1|Subjects who participated in Part I did not participate in Part III.|5
10515026|NCT01315847|11665929|FG001|STARTED|Part I, Period 1||0
10515027|NCT01315847|11665928|FG000|Received Telcagepant|Part I, Period 1||5
10515028|NCT01315847|11665929|FG001|Received Telcagepant|Part I, Period 1||0
10515029|NCT01315847|11665928|FG000|Received [11C]MK-4232|Part I, Period 1|One of these participants received [11C]MK-4232 only at baseline.|5
10515030|NCT01315847|11665929|FG001|Received [11C]MK-4232|Part I, Period 1||0
10515031|NCT01315847|11665928|FG000|COMPLETED|Part I, Period 1||2
10515032|NCT01315847|11665929|FG001|COMPLETED|Part I, Period 1||0
10515033|NCT01315847|11665928|FG000|NOT COMPLETED|Part I, Period 1||3
10515034|NCT01315847|11665929|FG001|NOT COMPLETED|Part I, Period 1||0
10515035|NCT01315847|11665928|FG000|STARTED|Part I, Period 2|One of these subjects did not participate in Part I, Period 1.|3
10515036|NCT01315847|11665929|FG001|STARTED|Part I, Period 2||0
10515037|NCT01315847|11665928|FG000|Received Telcagepant|Part I, Period 2||3
10515038|NCT01315847|11665929|FG001|Received Telcagepant|Part I, Period 2||0
10515039|NCT01315847|11665928|FG000|Received [11C]MK-4232|Part I, Period 2||3
10515040|NCT01315847|11665929|FG001|Received [11C]MK-4232|Part I, Period 2||0
10515041|NCT01315847|11665928|FG000|COMPLETED|Part I, Period 2||3
10711502|NCT02660580|11876933|FG004|Treated|Core Treatment Period (Week 1 to 16)||0
10711503|NCT02660580|11876929|FG000|COMPLETED|Core Treatment Period (Week 1 to 16)||213
10515042|NCT01315847|11665929|FG001|COMPLETED|Part I, Period 2||0
10515043|NCT01315847|11665928|FG000|NOT COMPLETED|Part I, Period 2||0
10515044|NCT01315847|11665929|FG001|NOT COMPLETED|Part I, Period 2||0
10515045|NCT01315847|11665928|FG000|STARTED|Part III, Period 1||0
10515046|NCT01315847|11665929|FG001|STARTED|Part III, Period 1|Subjects who participated in Part III did not participate in Part I.|4
10515047|NCT01315847|11665928|FG000|Received Telcagepant|Part III, Period 1||0
10515048|NCT01315847|11665929|FG001|Received Telcagepant|Part III, Period 1||4
10515049|NCT01315847|11665928|FG000|Received [11C]MK-4232|Part III, Period 1||0
10515050|NCT01315847|11665929|FG001|Received [11C]MK-4232|Part III, Period 1|One of these participants received [11C]MK-4232 only at baseline.|4
10515051|NCT01315847|11665928|FG000|COMPLETED|Part III, Period 1||0
10515052|NCT01315847|11665929|FG001|COMPLETED|Part III, Period 1||3
10515053|NCT01315847|11665928|FG000|NOT COMPLETED|Part III, Period 1||0
10515054|NCT01315847|11665929|FG001|NOT COMPLETED|Part III, Period 1||1
10515055|NCT01315847|11665928|FG000|STARTED|Part III, Period 2||0
10515056|NCT01315847|11665929|FG001|STARTED|Part III, Period 2||3
10515057|NCT01315847|11665928|FG000|Received Telcagepant|Part III, Period 2||0
10515058|NCT01315847|11665929|FG001|Received Telcagepant|Part III, Period 2||3
10515059|NCT01315847|11665928|FG000|Received [11C]MK-4232|Part III, Period 2||0
10515060|NCT01315847|11665929|FG001|Received [11C]MK-4232|Part III, Period 2||3
10515061|NCT01315847|11665928|FG000|COMPLETED|Part III, Period 2||0
10515062|NCT01315847|11665929|FG001|COMPLETED|Part III, Period 2||3
10515063|NCT01315847|11665928|FG000|NOT COMPLETED|Part III, Period 2||0
10515064|NCT01315847|11665929|FG001|NOT COMPLETED|Part III, Period 2||0
10515065|NCT01316042|11665937|FG000|STARTED|Overall Study||2
10515066|NCT01316042|11665938|FG001|STARTED|Overall Study||2
10515067|NCT01316042|11665937|FG000|COMPLETED|Overall Study||2
10515068|NCT01316042|11665938|FG001|COMPLETED|Overall Study||1
10515069|NCT01316042|11665937|FG000|NOT COMPLETED|Overall Study||0
10515070|NCT01316042|11665938|FG001|NOT COMPLETED|Overall Study||1
10515071|NCT01316055|11665947|FG000|STARTED|Overall Study||13
10515072|NCT01316055|11665948|FG001|STARTED|Overall Study||17
10515073|NCT01316055|11665949|FG002|STARTED|Overall Study||12
10515074|NCT01316055|11665947|FG000|COMPLETED|Overall Study||12
10515075|NCT01316055|11665948|FG001|COMPLETED|Overall Study||17
10515076|NCT01316055|11665949|FG002|COMPLETED|Overall Study||12
10515077|NCT01316055|11665947|FG000|NOT COMPLETED|Overall Study||1
10515078|NCT01316055|11665948|FG001|NOT COMPLETED|Overall Study||0
10515079|NCT01316055|11665949|FG002|NOT COMPLETED|Overall Study||0
10515080|NCT01316211|11665962|FG000|STARTED|Overall Study||116
10515081|NCT01316211|11665963|FG001|STARTED|Overall Study||123
10515082|NCT01316211|11665962|FG000|COMPLETED|Overall Study||105
10515083|NCT01316211|11665963|FG001|COMPLETED|Overall Study||111
10515084|NCT01316211|11665962|FG000|NOT COMPLETED|Overall Study||11
10515085|NCT01316211|11665963|FG001|NOT COMPLETED|Overall Study||12
10515086|NCT01316224|11665969|FG000|STARTED|Overall Study||52
10515087|NCT01316224|11665969|FG000|Completed Visit 1 to Dermatologist|Overall Study||52
10515088|NCT01316224|11665969|FG000|Completed Visit 1 to Rheumatologist|Overall Study||49
10515089|NCT01316224|11665969|FG000|Completed Visit 2 to Dermatologist|Overall Study||51
10515090|NCT01316224|11665969|FG000|Completed Visit 3 to Dermatologist|Overall Study||48
10515091|NCT01316224|11665969|FG000|Completed Visit 3 to Rheumatologist|Overall Study||39
10515092|NCT01316224|11665969|FG000|Completed Visit 4 to Dermatologist|Overall Study||42
10515093|NCT01316224|11665969|FG000|Completed Visit 4 to Rheumatologist|Overall Study||28
10515094|NCT01316224|11665969|FG000|COMPLETED|Overall Study||42
10515095|NCT01316224|11665969|FG000|NOT COMPLETED|Overall Study||10
10515096|NCT01316263|11665975|FG000|STARTED|Overall Study||7
10515097|NCT01316263|11665976|FG001|STARTED|Overall Study||14
10515098|NCT01316263|11665975|FG000|Received Any Study Drug|Overall Study||7
10515099|NCT01316263|11665976|FG001|Received Any Study Drug|Overall Study||14
10515100|NCT01316263|11665975|FG000|COMPLETED|Overall Study||7
10515101|NCT01316263|11665976|FG001|COMPLETED|Overall Study||14
10515102|NCT01316263|11665975|FG000|NOT COMPLETED|Overall Study||0
10515103|NCT01316263|11665976|FG001|NOT COMPLETED|Overall Study||0
10515104|NCT01316276|11665984|FG000|STARTED|Overall Study||206
10515105|NCT01316276|11665984|FG000|COMPLETED|Overall Study||139
10515106|NCT01316276|11665984|FG000|NOT COMPLETED|Overall Study||67
10515107|NCT01316302|11665991|FG000|STARTED|Overall Study||30
10515108|NCT01316302|11665992|FG001|STARTED|Overall Study||33
10515109|NCT01316302|11665991|FG000|COMPLETED|Overall Study||20
10515110|NCT01316302|11665992|FG001|COMPLETED|Overall Study||22
10515111|NCT01316302|11665991|FG000|NOT COMPLETED|Overall Study||10
10515112|NCT01316302|11665992|FG001|NOT COMPLETED|Overall Study||11
10515113|NCT01316315|11666002|FG000|STARTED|Sequence 1||7
10515114|NCT01316315|11666003|FG001|STARTED|Sequence 1||7
10515115|NCT01316315|11666002|FG000|COMPLETED|Sequence 1||7
10515116|NCT01316315|11666003|FG001|COMPLETED|Sequence 1||7
10515117|NCT01316315|11666002|FG000|NOT COMPLETED|Sequence 1||0
10515118|NCT01316315|11666003|FG001|NOT COMPLETED|Sequence 1||0
10515119|NCT01316315|11666002|FG000|STARTED|Sequence 2||7
10515120|NCT01316315|11666003|FG001|STARTED|Sequence 2||7
10515121|NCT01316315|11666002|FG000|COMPLETED|Sequence 2||7
10515122|NCT01316315|11666003|FG001|COMPLETED|Sequence 2||7
10515123|NCT01316315|11666002|FG000|NOT COMPLETED|Sequence 2||0
10515124|NCT01316315|11666003|FG001|NOT COMPLETED|Sequence 2||0
10515125|NCT01316341|11666014|FG000|STARTED|Overall Study||6
10515126|NCT01316341|11666015|FG001|STARTED|Overall Study||9
10515127|NCT01316341|11666016|FG002|STARTED|Overall Study||9
10515128|NCT01316341|11666014|FG000|COMPLETED|Overall Study||6
10515129|NCT01316341|11666015|FG001|COMPLETED|Overall Study||9
10515130|NCT01316341|11666016|FG002|COMPLETED|Overall Study||9
10515131|NCT01316341|11666014|FG000|NOT COMPLETED|Overall Study||0
10515132|NCT01316341|11666015|FG001|NOT COMPLETED|Overall Study||0
10515133|NCT01316341|11666016|FG002|NOT COMPLETED|Overall Study||0
10515134|NCT01316380|11666036|FG000|STARTED|Overall Study||156
10515135|NCT01316380|11666037|FG001|STARTED|Overall Study||154
10515136|NCT01316380|11666038|FG002|STARTED|Overall Study||155
10515137|NCT01316380|11666036|FG000|COMPLETED|Overall Study||154
10515138|NCT01316380|11666037|FG001|COMPLETED|Overall Study||149
10515139|NCT01316380|11666038|FG002|COMPLETED|Overall Study||152
10515140|NCT01316380|11666036|FG000|NOT COMPLETED|Overall Study||2
10515141|NCT01316380|11666037|FG001|NOT COMPLETED|Overall Study||5
10515142|NCT01316380|11666038|FG002|NOT COMPLETED|Overall Study||3
10515143|NCT01316419|11666046|FG000|STARTED|Overall Study||2089
10515144|NCT01316419|11666046|FG000|COMPLETED|Overall Study||1824
10515145|NCT01316419|11666046|FG000|NOT COMPLETED|Overall Study||265
10515146|NCT01316510|11666052|FG000|STARTED|Overall Study||12
10515147|NCT01316510|11666053|FG001|STARTED|Overall Study||12
10515148|NCT01316510|11666052|FG000|COMPLETED|Overall Study||12
10515149|NCT01316510|11666053|FG001|COMPLETED|Overall Study||12
10515150|NCT01316510|11666052|FG000|NOT COMPLETED|Overall Study||0
10515151|NCT01316510|11666053|FG001|NOT COMPLETED|Overall Study||0
10515152|NCT01316575|11666061|FG000|STARTED|Overall Study||20
10515153|NCT01316575|11666062|FG001|STARTED|Overall Study||20
10515154|NCT01316575|11666061|FG000|COMPLETED|Overall Study||18
10515155|NCT01316575|11666062|FG001|COMPLETED|Overall Study||19
10515156|NCT01316575|11666061|FG000|NOT COMPLETED|Overall Study||2
10515157|NCT01316575|11666062|FG001|NOT COMPLETED|Overall Study||1
10515158|NCT01316614|11666068|FG000|STARTED|Overall Study||137
10515159|NCT01316614|11666068|FG000|COMPLETED|Overall Study||100
10515160|NCT01316614|11666068|FG000|NOT COMPLETED|Overall Study||37
10515161|NCT01316692|11666073|FG000|STARTED|Overall Study||12
10515162|NCT01316692|11666073|FG000|COMPLETED|Overall Study||0
10515163|NCT01316692|11666073|FG000|NOT COMPLETED|Overall Study||12
10515164|NCT01316770|11666077|FG000|STARTED|Overall Study|Each study participant received the dexamethasone parotid irrigation on one side of mouth.|9
10515165|NCT01316770|11666078|FG001|STARTED|Overall Study|Each study participant received the placebo parotid irrigation on the other side of mouth.|9
10515166|NCT01316770|11666077|FG000|COMPLETED|Overall Study||9
10515167|NCT01316770|11666078|FG001|COMPLETED|Overall Study||9
10515168|NCT01316770|11666077|FG000|NOT COMPLETED|Overall Study||0
10515169|NCT01316770|11666078|FG001|NOT COMPLETED|Overall Study||0
10515170|NCT01316887|11666091|FG000|STARTED|Overall Study||109
10515171|NCT01316887|11666092|FG001|STARTED|Overall Study||227
10515172|NCT01316887|11666093|FG002|STARTED|Overall Study||226
10515173|NCT01316887|11666091|FG000|COMPLETED|Overall Study||66
10515174|NCT01316887|11666092|FG001|COMPLETED|Overall Study||133
10515175|NCT01316887|11666093|FG002|COMPLETED|Overall Study||143
10515176|NCT01316887|11666091|FG000|NOT COMPLETED|Overall Study||43
10515177|NCT01316887|11666092|FG001|NOT COMPLETED|Overall Study||94
10515178|NCT01316887|11666093|FG002|NOT COMPLETED|Overall Study||83
10515179|NCT01316900|11666106|FG000|STARTED|Overall Study||209
10515180|NCT01316900|11666107|FG001|STARTED|Overall Study||212
10515181|NCT01316900|11666108|FG002|STARTED|Overall Study||214
10515182|NCT01316900|11666109|FG003|STARTED|Overall Study||208
10515183|NCT01316900|11666106|FG000|COMPLETED|Overall Study||165
10515184|NCT01316900|11666107|FG001|COMPLETED|Overall Study||181
10515185|NCT01316900|11666108|FG002|COMPLETED|Overall Study||173
10515186|NCT01316900|11666109|FG003|COMPLETED|Overall Study||177
10515187|NCT01316900|11666106|FG000|NOT COMPLETED|Overall Study||44
10515188|NCT01316900|11666107|FG001|NOT COMPLETED|Overall Study||31
10515189|NCT01316900|11666108|FG002|NOT COMPLETED|Overall Study||41
10515190|NCT01316900|11666109|FG003|NOT COMPLETED|Overall Study||31
10515191|NCT01316913|11666123|FG000|STARTED|Overall Study||222
10515192|NCT01316913|11666124|FG001|STARTED|Overall Study||217
10515193|NCT01316913|11666125|FG002|STARTED|Overall Study||215
10515194|NCT01316913|11666126|FG003|STARTED|Overall Study||215
10515195|NCT01316913|11666123|FG000|COMPLETED|Overall Study||165
10515196|NCT01316913|11666124|FG001|COMPLETED|Overall Study||163
10515197|NCT01316913|11666125|FG002|COMPLETED|Overall Study||166
10515198|NCT01316913|11666126|FG003|COMPLETED|Overall Study||176
10515199|NCT01316913|11666123|FG000|NOT COMPLETED|Overall Study||57
10515200|NCT01316913|11666124|FG001|NOT COMPLETED|Overall Study||54
10515201|NCT01316913|11666125|FG002|NOT COMPLETED|Overall Study||49
10515202|NCT01316913|11666126|FG003|NOT COMPLETED|Overall Study||39
10515203|NCT01316926|11666137|FG000|STARTED|Period 1||30
10515204|NCT01316926|11666138|FG001|STARTED|Period 1||30
10515205|NCT01316926|11666137|FG000|COMPLETED|Period 1||30
10515206|NCT01316926|11666138|FG001|COMPLETED|Period 1||30
10515207|NCT01316926|11666137|FG000|NOT COMPLETED|Period 1||0
10515208|NCT01316926|11666138|FG001|NOT COMPLETED|Period 1||0
10515209|NCT01316926|11666137|FG000|STARTED|Period 2|One participant completed Period 1, but did not appear in Period 2|29
10515210|NCT01316926|11666138|FG001|STARTED|Period 2||30
10515211|NCT01316926|11666137|FG000|COMPLETED|Period 2||29
10515212|NCT01316926|11666138|FG001|COMPLETED|Period 2||30
10515213|NCT01316926|11666137|FG000|NOT COMPLETED|Period 2||0
10515214|NCT01316926|11666138|FG001|NOT COMPLETED|Period 2||0
10515215|NCT01316939|11666148|FG000|STARTED|Overall Study||76
10515216|NCT01316939|11666149|FG001|STARTED|Overall Study||77
10515217|NCT01316939|11666150|FG002|STARTED|Overall Study||76
10515218|NCT01316939|11666148|FG000|COMPLETED|Overall Study||13
10515219|NCT01316939|11666149|FG001|COMPLETED|Overall Study||9
10515220|NCT01316939|11666150|FG002|COMPLETED|Overall Study||7
10515221|NCT01316939|11666148|FG000|NOT COMPLETED|Overall Study||63
10515222|NCT01316939|11666149|FG001|NOT COMPLETED|Overall Study||68
10515223|NCT01316939|11666150|FG002|NOT COMPLETED|Overall Study||69
10515224|NCT01317004|11666160|FG000|STARTED|Overall Study||51
10515225|NCT01317004|11666161|FG001|STARTED|Overall Study||14
10515226|NCT01317004|11666160|FG000|Safety Set|Overall Study||50
10515227|NCT01317004|11666161|FG001|Safety Set|Overall Study||11
10515228|NCT01317004|11666160|FG000|COMPLETED|Overall Study||47
10515229|NCT01317004|11666161|FG001|COMPLETED|Overall Study||5
10515230|NCT01317004|11666160|FG000|NOT COMPLETED|Overall Study||4
10515231|NCT01317004|11666161|FG001|NOT COMPLETED|Overall Study||9
10515232|NCT01317030|11666169|FG000|STARTED|Overall Study||12
10515233|NCT01317030|11666170|FG001|STARTED|Overall Study||13
10515234|NCT01317030|11666169|FG000|COMPLETED|Overall Study||12
10515235|NCT01317030|11666170|FG001|COMPLETED|Overall Study||13
10515236|NCT01317030|11666169|FG000|NOT COMPLETED|Overall Study||0
10515237|NCT01317030|11666170|FG001|NOT COMPLETED|Overall Study||0
10515238|NCT01317095|11666178|FG000|STARTED|Overall Study||39
10515239|NCT01317095|11666179|FG001|STARTED|Overall Study||41
10515240|NCT01317095|11666178|FG000|COMPLETED|Overall Study||39
10515241|NCT01317095|11666179|FG001|COMPLETED|Overall Study||41
10515242|NCT01317095|11666178|FG000|NOT COMPLETED|Overall Study||0
10515243|NCT01317095|11666179|FG001|NOT COMPLETED|Overall Study||0
10515244|NCT01317199|11666189|FG000|STARTED|Dose-escalation Phase 1||14
10515245|NCT01317199|11666190|FG001|STARTED|Dose-escalation Phase 1||0
10515246|NCT01317199|11666191|FG002|STARTED|Dose-escalation Phase 1||0
10515247|NCT01317199|11666192|FG003|STARTED|Dose-escalation Phase 1||0
10515248|NCT01317199|11666189|FG000|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||2
10515249|NCT01317199|11666190|FG001|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0
10515250|NCT01317199|11666191|FG002|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0
10515251|NCT01317199|11666192|FG003|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0
10515252|NCT01317199|11666189|FG000|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2
10515253|NCT01317199|11666190|FG001|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
10515254|NCT01317199|11666191|FG002|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
10515255|NCT01317199|11666192|FG003|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
10515256|NCT01317199|11666189|FG000|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2
10515257|NCT01317199|11666190|FG001|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
10515258|NCT01317199|11666191|FG002|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
10515259|NCT01317199|11666192|FG003|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
10515260|NCT01317199|11666189|FG000|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2
10515261|NCT01317199|11666190|FG001|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
10515262|NCT01317199|11666191|FG002|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
10515263|NCT01317199|11666192|FG003|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
10515264|NCT01317199|11666189|FG000|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||6
10515265|NCT01317199|11666190|FG001|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
10515266|NCT01317199|11666191|FG002|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
10515267|NCT01317199|11666192|FG003|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
10515268|NCT01317199|11666189|FG000|COMPLETED|Dose-escalation Phase 1||7
10515269|NCT01317199|11666190|FG001|COMPLETED|Dose-escalation Phase 1||0
10515270|NCT01317199|11666191|FG002|COMPLETED|Dose-escalation Phase 1||0
10515271|NCT01317199|11666192|FG003|COMPLETED|Dose-escalation Phase 1||0
10515272|NCT01317199|11666189|FG000|NOT COMPLETED|Dose-escalation Phase 1||7
10515273|NCT01317199|11666190|FG001|NOT COMPLETED|Dose-escalation Phase 1||0
10515274|NCT01317199|11666191|FG002|NOT COMPLETED|Dose-escalation Phase 1||0
10515275|NCT01317199|11666192|FG003|NOT COMPLETED|Dose-escalation Phase 1||0
10515276|NCT01317199|11666189|FG000|STARTED|Randomized Phase 2||0
10515277|NCT01317199|11666190|FG001|STARTED|Randomized Phase 2||24
10515278|NCT01317199|11666191|FG002|STARTED|Randomized Phase 2||56
10515279|NCT01317199|11666192|FG003|STARTED|Randomized Phase 2||49
10515280|NCT01317199|11666189|FG000|COMPLETED|Randomized Phase 2||0
10515281|NCT01317199|11666190|FG001|COMPLETED|Randomized Phase 2||13
10515282|NCT01317199|11666191|FG002|COMPLETED|Randomized Phase 2||35
10515283|NCT01317199|11666192|FG003|COMPLETED|Randomized Phase 2||32
10515284|NCT01317199|11666189|FG000|NOT COMPLETED|Randomized Phase 2||0
10515285|NCT01317199|11666190|FG001|NOT COMPLETED|Randomized Phase 2||11
10515286|NCT01317199|11666191|FG002|NOT COMPLETED|Randomized Phase 2||21
10515287|NCT01317199|11666192|FG003|NOT COMPLETED|Randomized Phase 2||17
10515288|NCT01317277|11666211|FG000|STARTED|Overall Study||50
10515289|NCT01317277|11666212|FG001|STARTED|Overall Study||25
10515290|NCT01317277|11666211|FG000|COMPLETED|Overall Study||43
10515291|NCT01317277|11666212|FG001|COMPLETED|Overall Study||23
10515292|NCT01317277|11666211|FG000|NOT COMPLETED|Overall Study||7
10515293|NCT01317277|11666212|FG001|NOT COMPLETED|Overall Study||2
10515294|NCT01317472|11666220|FG000|STARTED|Overall Study||9
10515295|NCT01317472|11666221|FG001|STARTED|Overall Study||2
10515296|NCT01317472|11666220|FG000|COMPLETED|Overall Study||7
10515297|NCT01317472|11666221|FG001|COMPLETED|Overall Study||2
10515298|NCT01317472|11666220|FG000|NOT COMPLETED|Overall Study||2
10515299|NCT01317472|11666221|FG001|NOT COMPLETED|Overall Study||0
10515300|NCT01317550|11666231|FG000|STARTED|Overall Study||5
10515301|NCT01317550|11666232|FG001|STARTED|Overall Study||3
10515302|NCT01317550|11666233|FG002|STARTED|Overall Study||3
10515303|NCT01317550|11666234|FG003|STARTED|Overall Study||3
10515304|NCT01317550|11666231|FG000|COMPLETED|Overall Study||3
10515305|NCT01317550|11666232|FG001|COMPLETED|Overall Study||3
10515306|NCT01317550|11666233|FG002|COMPLETED|Overall Study||3
10515307|NCT01317550|11666234|FG003|COMPLETED|Overall Study||3
10515308|NCT01317550|11666231|FG000|NOT COMPLETED|Overall Study||2
10515309|NCT01317550|11666232|FG001|NOT COMPLETED|Overall Study||0
10515310|NCT01317550|11666233|FG002|NOT COMPLETED|Overall Study||0
10515311|NCT01317550|11666234|FG003|NOT COMPLETED|Overall Study||0
10528582|NCT01395888|11680904|FG002|STARTED|2-week Run-in Period||0
10528583|NCT01395888|11680902|FG000|COMPLETED|2-week Run-in Period||257
10528584|NCT01395888|11680903|FG001|COMPLETED|2-week Run-in Period||0
10528585|NCT01395888|11680904|FG002|COMPLETED|2-week Run-in Period||0
10528586|NCT01395888|11680902|FG000|NOT COMPLETED|2-week Run-in Period||22
10515312|NCT01317615|11666244|FG000|STARTED|Overall Study||49
10515313|NCT01317615|11666244|FG000|COMPLETED|Overall Study||0
10515314|NCT01317615|11666244|FG000|NOT COMPLETED|Overall Study||49
10515315|NCT01317641|11666257|FG000|STARTED|Overall Study||4
10515316|NCT01317641|11666258|FG001|STARTED|Overall Study||7
10515317|NCT01317641|11666259|FG002|STARTED|Overall Study||3
10515318|NCT01317641|11666260|FG003|STARTED|Overall Study||4
10515319|NCT01317641|11666261|FG004|STARTED|Overall Study||3
10515320|NCT01317641|11666262|FG005|STARTED|Overall Study||3
10515321|NCT01317641|11666263|FG006|STARTED|Overall Study||38
10515322|NCT01317641|11666264|FG007|STARTED|Overall Study||38
10515323|NCT01317641|11666265|FG008|STARTED|Overall Study||36
10515324|NCT01317641|11666257|FG000|COMPLETED|Overall Study||3
10515325|NCT01317641|11666258|FG001|COMPLETED|Overall Study||6
10515326|NCT01317641|11666259|FG002|COMPLETED|Overall Study||3
10515327|NCT01317641|11666260|FG003|COMPLETED|Overall Study||3
10515328|NCT01317641|11666261|FG004|COMPLETED|Overall Study||3
10515329|NCT01317641|11666262|FG005|COMPLETED|Overall Study||3
10515330|NCT01317641|11666263|FG006|COMPLETED|Overall Study||35
10515331|NCT01317641|11666264|FG007|COMPLETED|Overall Study||33
10515332|NCT01317641|11666265|FG008|COMPLETED|Overall Study||31
10515333|NCT01317641|11666257|FG000|NOT COMPLETED|Overall Study||1
10515334|NCT01317641|11666258|FG001|NOT COMPLETED|Overall Study||1
10515335|NCT01317641|11666259|FG002|NOT COMPLETED|Overall Study||0
10515336|NCT01317641|11666260|FG003|NOT COMPLETED|Overall Study||1
10515337|NCT01317641|11666261|FG004|NOT COMPLETED|Overall Study||0
10515338|NCT01317641|11666262|FG005|NOT COMPLETED|Overall Study||0
10515339|NCT01317641|11666263|FG006|NOT COMPLETED|Overall Study||3
10515340|NCT01317641|11666264|FG007|NOT COMPLETED|Overall Study||5
10515341|NCT01317641|11666265|FG008|NOT COMPLETED|Overall Study||5
10515342|NCT01317667|11666304|FG000|STARTED|Overall Study||10
10515343|NCT01317667|11666305|FG001|STARTED|Overall Study||10
10515344|NCT01317667|11666306|FG002|STARTED|Overall Study||10
10515345|NCT01317667|11666304|FG000|COMPLETED|Overall Study||10
10515346|NCT01317667|11666305|FG001|COMPLETED|Overall Study||10
10515347|NCT01317667|11666306|FG002|COMPLETED|Overall Study|The original trial design was modified to limit the number of vaccinations in Group 3 to 1 dose.|10
10515348|NCT01317667|11666304|FG000|NOT COMPLETED|Overall Study||0
10515349|NCT01317667|11666305|FG001|NOT COMPLETED|Overall Study||0
10515350|NCT01317667|11666306|FG002|NOT COMPLETED|Overall Study||0
10515351|NCT01317797|11666317|FG000|STARTED|Overall Study||8
10515352|NCT01317797|11666318|FG001|STARTED|Overall Study||7
10515353|NCT01317797|11666319|FG002|STARTED|Overall Study||9
10515354|NCT01317797|11666317|FG000|COMPLETED|Overall Study||8
10515355|NCT01317797|11666318|FG001|COMPLETED|Overall Study||6
10515356|NCT01317797|11666319|FG002|COMPLETED|Overall Study||8
10515357|NCT01317797|11666317|FG000|NOT COMPLETED|Overall Study||0
10515358|NCT01317797|11666318|FG001|NOT COMPLETED|Overall Study||1
10515359|NCT01317797|11666319|FG002|NOT COMPLETED|Overall Study||1
10515360|NCT01317901|11666329|FG000|STARTED|Overall Study||6
10515361|NCT01317901|11666330|FG001|STARTED|Overall Study||6
10515362|NCT01317901|11666329|FG000|COMPLETED|Overall Study||6
10515363|NCT01317901|11666330|FG001|COMPLETED|Overall Study||6
10515364|NCT01317901|11666329|FG000|NOT COMPLETED|Overall Study||0
10515365|NCT01317901|11666330|FG001|NOT COMPLETED|Overall Study||0
10515366|NCT01317940|11666342|FG000|STARTED|Overall Study||19
10515367|NCT01317940|11666343|FG001|STARTED|Overall Study||10
10515368|NCT01317940|11666344|FG002|STARTED|Overall Study||20
10515369|NCT01317940|11666345|FG003|STARTED|Overall Study||6
10515370|NCT01317940|11666346|FG004|STARTED|Overall Study||13
10515371|NCT01317940|11666347|FG005|STARTED|Overall Study||4
10515372|NCT01317940|11666342|FG000|COMPLETED|Overall Study||18
10515373|NCT01317940|11666343|FG001|COMPLETED|Overall Study||10
10515374|NCT01317940|11666344|FG002|COMPLETED|Overall Study||15
10515375|NCT01317940|11666345|FG003|COMPLETED|Overall Study||5
10515376|NCT01317940|11666346|FG004|COMPLETED|Overall Study||12
10515377|NCT01317940|11666347|FG005|COMPLETED|Overall Study||4
10515378|NCT01317940|11666342|FG000|NOT COMPLETED|Overall Study||1
10515379|NCT01317940|11666343|FG001|NOT COMPLETED|Overall Study||0
10515380|NCT01317940|11666344|FG002|NOT COMPLETED|Overall Study||5
10515381|NCT01317940|11666345|FG003|NOT COMPLETED|Overall Study||1
10515382|NCT01317940|11666346|FG004|NOT COMPLETED|Overall Study||1
10515383|NCT01317940|11666347|FG005|NOT COMPLETED|Overall Study||0
10515384|NCT01318018|11666364|FG000|STARTED|Overall Study||10
10515385|NCT01318018|11666365|FG001|STARTED|Overall Study||10
10515386|NCT01318018|11666364|FG000|COMPLETED|Overall Study||10
10515387|NCT01318018|11666365|FG001|COMPLETED|Overall Study||10
10515388|NCT01318018|11666364|FG000|NOT COMPLETED|Overall Study||0
10515389|NCT01318018|11666365|FG001|NOT COMPLETED|Overall Study||0
10515390|NCT01318070|11666374|FG000|STARTED|Overall Study||111
10515391|NCT01318070|11666375|FG001|STARTED|Overall Study||113
10515392|NCT01318070|11666376|FG002|STARTED|Overall Study||115
10515393|NCT01318070|11666374|FG000|COMPLETED|Overall Study||109
10515394|NCT01318070|11666375|FG001|COMPLETED|Overall Study||111
10515395|NCT01318070|11666376|FG002|COMPLETED|Overall Study||108
10515396|NCT01318070|11666374|FG000|NOT COMPLETED|Overall Study||2
10515397|NCT01318070|11666375|FG001|NOT COMPLETED|Overall Study||2
10515398|NCT01318070|11666376|FG002|NOT COMPLETED|Overall Study||7
10515399|NCT01318083|11666387|FG000|STARTED|Overall Study||105
10515400|NCT01318083|11666388|FG001|STARTED|Overall Study||104
10515401|NCT01318083|11666389|FG002|STARTED|Overall Study||103
10515402|NCT01318083|11666387|FG000|COMPLETED|Overall Study||99
10515403|NCT01318083|11666388|FG001|COMPLETED|Overall Study||102
10515404|NCT01318083|11666389|FG002|COMPLETED|Overall Study||98
10515405|NCT01318083|11666387|FG000|NOT COMPLETED|Overall Study||6
10515406|NCT01318083|11666388|FG001|NOT COMPLETED|Overall Study||2
10515407|NCT01318083|11666389|FG002|NOT COMPLETED|Overall Study||5
10515408|NCT01318109|11666400|FG000|STARTED|Overall Study||92
10515409|NCT01318109|11666401|FG001|STARTED|Overall Study||96
10515410|NCT01318109|11666402|FG002|STARTED|Overall Study||100
10515411|NCT01318109|11666400|FG000|COMPLETED|Overall Study||91
10515412|NCT01318109|11666401|FG001|COMPLETED|Overall Study||93
10515413|NCT01318109|11666402|FG002|COMPLETED|Overall Study||100
10515414|NCT01318109|11666400|FG000|NOT COMPLETED|Overall Study||1
10515415|NCT01318109|11666401|FG001|NOT COMPLETED|Overall Study||3
10515416|NCT01318109|11666402|FG002|NOT COMPLETED|Overall Study||0
10515417|NCT01318122|11666412|FG000|STARTED|Enrolled - Long-Term Extension Study|5 randomized participants from alogliptin 12.5 & 25 mg group CCT-004 study did not enter this study|106
10515418|NCT01318122|11666413|FG001|STARTED|Enrolled - Long-Term Extension Study|5 randomized participants from alogliptin 12.5 & 25 mg group CCT-004 study did not enter this study|110
10515419|NCT01318122|11666414|FG002|STARTED|Enrolled - Long-Term Extension Study||57
10515420|NCT01318122|11666415|FG003|STARTED|Enrolled - Long-Term Extension Study||53
10515421|NCT01318122|11666412|FG000|COMPLETED|Enrolled - Long-Term Extension Study||105
10515422|NCT01318122|11666413|FG001|COMPLETED|Enrolled - Long-Term Extension Study||110
10515423|NCT01318122|11666414|FG002|COMPLETED|Enrolled - Long-Term Extension Study||55
10515424|NCT01318122|11666415|FG003|COMPLETED|Enrolled - Long-Term Extension Study||52
10515425|NCT01318122|11666412|FG000|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
10515426|NCT01318122|11666413|FG001|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
10515427|NCT01318122|11666414|FG002|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
10515428|NCT01318122|11666415|FG003|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
10515429|NCT01318122|11666412|FG000|STARTED|Entered - Long-Term Extension Study||105
10515430|NCT01318122|11666413|FG001|STARTED|Entered - Long-Term Extension Study||110
10515431|NCT01318122|11666414|FG002|STARTED|Entered - Long-Term Extension Study||55
10515432|NCT01318122|11666415|FG003|STARTED|Entered - Long-Term Extension Study||52
10515433|NCT01318122|11666412|FG000|COMPLETED|Entered - Long-Term Extension Study||96
10515434|NCT01318122|11666413|FG001|COMPLETED|Entered - Long-Term Extension Study||99
10515435|NCT01318122|11666414|FG002|COMPLETED|Entered - Long-Term Extension Study||49
10515436|NCT01318122|11666415|FG003|COMPLETED|Entered - Long-Term Extension Study||48
10515437|NCT01318122|11666412|FG000|NOT COMPLETED|Entered - Long-Term Extension Study||9
10515438|NCT01318122|11666413|FG001|NOT COMPLETED|Entered - Long-Term Extension Study||11
10515439|NCT01318122|11666414|FG002|NOT COMPLETED|Entered - Long-Term Extension Study||6
10515440|NCT01318122|11666415|FG003|NOT COMPLETED|Entered - Long-Term Extension Study||4
10515441|NCT01318135|11666425|FG000|STARTED|Enrolled - Long-Term Extension Study||99
10515442|NCT01318135|11666426|FG001|STARTED|Enrolled - Long-Term Extension Study||102
10515443|NCT01318135|11666427|FG002|STARTED|Enrolled - Long-Term Extension Study||46
10515444|NCT01318135|11666428|FG003|STARTED|Enrolled - Long-Term Extension Study||49
10515445|NCT01318135|11666429|FG004|STARTED|Enrolled - Long-Term Extension Study||91
10515446|NCT01318135|11666430|FG005|STARTED|Enrolled - Long-Term Extension Study||90
10515447|NCT01318135|11666431|FG006|STARTED|Enrolled - Long-Term Extension Study||50
10515448|NCT01318135|11666432|FG007|STARTED|Enrolled - Long-Term Extension Study||49
10515449|NCT01318135|11666425|FG000|COMPLETED|Enrolled - Long-Term Extension Study||97
10515450|NCT01318135|11666426|FG001|COMPLETED|Enrolled - Long-Term Extension Study||102
10515451|NCT01318135|11666427|FG002|COMPLETED|Enrolled - Long-Term Extension Study||46
10515452|NCT01318135|11666428|FG003|COMPLETED|Enrolled - Long-Term Extension Study||49
10515453|NCT01318135|11666429|FG004|COMPLETED|Enrolled - Long-Term Extension Study||91
10515454|NCT01318135|11666430|FG005|COMPLETED|Enrolled - Long-Term Extension Study||90
10515455|NCT01318135|11666431|FG006|COMPLETED|Enrolled - Long-Term Extension Study||50
10515456|NCT01318135|11666432|FG007|COMPLETED|Enrolled - Long-Term Extension Study||49
10515457|NCT01318135|11666425|FG000|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
10515458|NCT01318135|11666426|FG001|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
10515459|NCT01318135|11666427|FG002|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
10515460|NCT01318135|11666428|FG003|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
10515461|NCT01318135|11666429|FG004|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
10515462|NCT01318135|11666430|FG005|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
10515463|NCT01318135|11666431|FG006|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
10515464|NCT01318135|11666432|FG007|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
10515465|NCT01318135|11666425|FG000|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|97
10515466|NCT01318135|11666426|FG001|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|102
10515467|NCT01318135|11666427|FG002|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|46
10515468|NCT01318135|11666428|FG003|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|49
10515469|NCT01318135|11666429|FG004|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|90
10515470|NCT01318135|11666430|FG005|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|87
10515471|NCT01318135|11666431|FG006|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|50
10528587|NCT01395888|11680903|FG001|NOT COMPLETED|2-week Run-in Period||0
10515472|NCT01318135|11666432|FG007|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|49
10515473|NCT01318135|11666425|FG000|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|80
10515474|NCT01318135|11666426|FG001|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|89
10515475|NCT01318135|11666427|FG002|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|38
10528588|NCT01395888|11680904|FG002|NOT COMPLETED|2-week Run-in Period||0
10528589|NCT01395888|11680902|FG000|STARTED|Treatment Period (TP)||0
10711504|NCT02660580|11876930|FG001|COMPLETED|Core Treatment Period (Week 1 to 16)||202
10711505|NCT02660580|11876931|FG002|COMPLETED|Core Treatment Period (Week 1 to 16)||0
10711506|NCT02660580|11876932|FG003|COMPLETED|Core Treatment Period (Week 1 to 16)||0
10711507|NCT02660580|11876933|FG004|COMPLETED|Core Treatment Period (Week 1 to 16)||0
10711508|NCT02660580|11876929|FG000|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||9
10711509|NCT02660580|11876930|FG001|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||19
10711510|NCT02660580|11876931|FG002|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||0
10711511|NCT02660580|11876932|FG003|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||0
10711512|NCT02660580|11876933|FG004|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||0
10711513|NCT02660580|11876929|FG000|STARTED|Extended Treatment Period(Week 16 to 52)||0
10711514|NCT02660580|11876930|FG001|STARTED|Extended Treatment Period(Week 16 to 52)||0
10711515|NCT02660580|11876931|FG002|STARTED|Extended Treatment Period(Week 16 to 52)||213
10711516|NCT02660580|11876932|FG003|STARTED|Extended Treatment Period(Week 16 to 52)||101
10711517|NCT02660580|11876933|FG004|STARTED|Extended Treatment Period(Week 16 to 52)||101
10711518|NCT02660580|11876929|FG000|COMPLETED|Extended Treatment Period(Week 16 to 52)||0
10711519|NCT02660580|11876930|FG001|COMPLETED|Extended Treatment Period(Week 16 to 52)||0
10711520|NCT02660580|11876931|FG002|COMPLETED|Extended Treatment Period(Week 16 to 52)||195
10711521|NCT02660580|11876932|FG003|COMPLETED|Extended Treatment Period(Week 16 to 52)||90
10711522|NCT02660580|11876933|FG004|COMPLETED|Extended Treatment Period(Week 16 to 52)||90
10711523|NCT02660580|11876929|FG000|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||0
10711524|NCT02660580|11876930|FG001|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||0
10711525|NCT02660580|11876931|FG002|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||18
10711526|NCT02660580|11876932|FG003|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||11
10711527|NCT02660580|11876933|FG004|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||11
10711528|NCT02660788|11876954|FG000|STARTED|Overall Study||2749
10711529|NCT02660788|11876955|FG001|STARTED|Overall Study||2749
10711530|NCT02660788|11876954|FG000|COMPLETED|Overall Study||2749
10711531|NCT02660788|11876955|FG001|COMPLETED|Overall Study||2749
10711532|NCT02660788|11876954|FG000|NOT COMPLETED|Overall Study||0
10711533|NCT02660788|11876955|FG001|NOT COMPLETED|Overall Study||0
10711534|NCT02660801|11876961|FG000|STARTED|Overall Study||11
10711535|NCT02660801|11876962|FG001|STARTED|Overall Study||15
10711536|NCT02660801|11876961|FG000|COMPLETED|Overall Study||11
10711537|NCT02660801|11876962|FG001|COMPLETED|Overall Study||15
10711538|NCT02660801|11876961|FG000|NOT COMPLETED|Overall Study||0
10711539|NCT02660801|11876962|FG001|NOT COMPLETED|Overall Study||0
10711540|NCT02660853|11876968|FG000|STARTED|Overall Study||25
10711541|NCT02660853|11876968|FG000|COMPLETED|Overall Study||25
10711542|NCT02660853|11876968|FG000|NOT COMPLETED|Overall Study||0
10711543|NCT02660918|11876974|FG000|STARTED|Overall Study||42
10711544|NCT02660918|11876975|FG001|STARTED|Overall Study||42
10711545|NCT02660918|11876974|FG000|COMPLETED|Overall Study|Age ineligible|41
10711546|NCT02660918|11876975|FG001|COMPLETED|Overall Study|Age ineligible|41
10711547|NCT02660918|11876974|FG000|NOT COMPLETED|Overall Study||1
10711548|NCT02660918|11876975|FG001|NOT COMPLETED|Overall Study||1
10713845|NCT02682784|11879377|FG000|NOT COMPLETED|Overall Study||1
10713846|NCT02682784|11879378|FG001|NOT COMPLETED|Overall Study||2
10713847|NCT02682784|11879379|FG002|NOT COMPLETED|Overall Study||2
10713848|NCT02682784|11879380|FG003|NOT COMPLETED|Overall Study||3
10713849|NCT02682823|11879395|FG000|STARTED|Overall Study||17
10713850|NCT02682823|11879396|FG001|STARTED|Overall Study||19
10713851|NCT02682823|11879397|FG002|STARTED|Overall Study||19
10713852|NCT02682823|11879398|FG003|STARTED|Overall Study||17
10713853|NCT02682823|11879399|FG004|STARTED|Overall Study||19
10713854|NCT02682823|11879395|FG000|Safety Population|Overall Study|All CGs who administered at least one dose of study drug.|17
10713855|NCT02682823|11879396|FG001|Safety Population|Overall Study|All HCPs who administered at least one dose of study drug.|19
10713856|NCT02682823|11879397|FG002|Safety Population|Overall Study|All participants who received at least one dose of study drug.|18
10713857|NCT02682823|11879398|FG003|Safety Population|Overall Study|All participants who received at least one dose of study drug.|17
10713858|NCT02682823|11879399|FG004|Safety Population|Overall Study|All participants who received at least one dose of study drug.|19
10713859|NCT02682823|11879395|FG000|COMPLETED|Overall Study||17
10713860|NCT02682823|11879396|FG001|COMPLETED|Overall Study||18
10713861|NCT02682823|11879397|FG002|COMPLETED|Overall Study||18
10713862|NCT02682823|11879398|FG003|COMPLETED|Overall Study||16
10713863|NCT02682823|11879399|FG004|COMPLETED|Overall Study||18
10713864|NCT02682823|11879395|FG000|NOT COMPLETED|Overall Study||0
10713865|NCT02682823|11879396|FG001|NOT COMPLETED|Overall Study||1
10713866|NCT02682823|11879397|FG002|NOT COMPLETED|Overall Study||1
10713867|NCT02682823|11879398|FG003|NOT COMPLETED|Overall Study||1
10713868|NCT02682823|11879399|FG004|NOT COMPLETED|Overall Study||1
10713869|NCT02683083|11879411|FG000|STARTED|Overall Study||9
10711549|NCT02660944|11876984|FG000|STARTED|Overall Study||42
10711550|NCT02660944|11876985|FG001|STARTED|Overall Study||22
10711551|NCT02660944|11876984|FG000|COMPLETED|Overall Study||25
10711552|NCT02660944|11876985|FG001|COMPLETED|Overall Study||12
10711553|NCT02660944|11876984|FG000|NOT COMPLETED|Overall Study||17
10711554|NCT02660944|11876985|FG001|NOT COMPLETED|Overall Study||10
10810213|NCT03802344|11972097|FG002|NOT COMPLETED|Overall Study||13
10810214|NCT03801928|11972112|FG000|STARTED|Overall Study||18
10810215|NCT03801928|11972113|FG001|STARTED|Overall Study||21
10810216|NCT03801928|11972114|FG002|STARTED|Overall Study||9
10515476|NCT01318135|11666428|FG003|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|42
10515477|NCT01318135|11666429|FG004|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|81
10515478|NCT01318135|11666430|FG005|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|83
10515479|NCT01318135|11666431|FG006|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|49
10515480|NCT01318135|11666432|FG007|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|46
10515481|NCT01318135|11666425|FG000|NOT COMPLETED|Entered - Long-Term Extension Study||17
10515482|NCT01318135|11666426|FG001|NOT COMPLETED|Entered - Long-Term Extension Study||13
10515483|NCT01318135|11666427|FG002|NOT COMPLETED|Entered - Long-Term Extension Study||8
10515484|NCT01318135|11666428|FG003|NOT COMPLETED|Entered - Long-Term Extension Study||7
10515485|NCT01318135|11666429|FG004|NOT COMPLETED|Entered - Long-Term Extension Study||9
10515486|NCT01318135|11666430|FG005|NOT COMPLETED|Entered - Long-Term Extension Study||4
10515487|NCT01318135|11666431|FG006|NOT COMPLETED|Entered - Long-Term Extension Study||1
10515488|NCT01318135|11666432|FG007|NOT COMPLETED|Entered - Long-Term Extension Study||3
10515489|NCT01318278|11666445|FG000|STARTED|Overall Study||10
10515490|NCT01318278|11666446|FG001|STARTED|Overall Study||10
10515491|NCT01318278|11666447|FG002|STARTED|Overall Study||50
10515492|NCT01318278|11666445|FG000|COMPLETED|Overall Study||10
10515493|NCT01318278|11666446|FG001|COMPLETED|Overall Study||10
10515494|NCT01318278|11666447|FG002|COMPLETED|Overall Study||50
10515495|NCT01318278|11666445|FG000|NOT COMPLETED|Overall Study||0
10515496|NCT01318278|11666446|FG001|NOT COMPLETED|Overall Study||0
10515497|NCT01318278|11666447|FG002|NOT COMPLETED|Overall Study||0
10515498|NCT01318356|11666459|FG000|STARTED|Overall Study||51
10515499|NCT01318356|11666460|FG001|STARTED|Overall Study||52
10515500|NCT01318356|11666461|FG002|STARTED|Overall Study||52
10515501|NCT01318356|11666459|FG000|COMPLETED|Overall Study||43
10515502|NCT01318356|11666460|FG001|COMPLETED|Overall Study||49
10515503|NCT01318356|11666461|FG002|COMPLETED|Overall Study||50
10515504|NCT01318356|11666459|FG000|NOT COMPLETED|Overall Study||8
10515505|NCT01318356|11666460|FG001|NOT COMPLETED|Overall Study||3
10515506|NCT01318356|11666461|FG002|NOT COMPLETED|Overall Study||2
10515507|NCT01318382|11666469|FG000|STARTED|Overall Study||302
10515508|NCT01318382|11666469|FG000|COMPLETED|Overall Study||289
10515509|NCT01318382|11666469|FG000|NOT COMPLETED|Overall Study||13
10515510|NCT01318408|11666474|FG000|STARTED|Overall Study||24
10515511|NCT01318408|11666474|FG000|COMPLETED|Overall Study||16
10515512|NCT01318408|11666474|FG000|NOT COMPLETED|Overall Study||8
10515513|NCT01318499|11666481|FG000|STARTED|Overall Study||540
10515514|NCT01318499|11666482|FG001|STARTED|Overall Study||534
10515515|NCT01318499|11666483|FG002|STARTED|Overall Study||268
10515516|NCT01318499|11666481|FG000|COMPLETED|Overall Study||475
10515517|NCT01318499|11666482|FG001|COMPLETED|Overall Study||458
10515518|NCT01318499|11666483|FG002|COMPLETED|Overall Study||121
10515519|NCT01318499|11666481|FG000|NOT COMPLETED|Overall Study||65
10515520|NCT01318499|11666482|FG001|NOT COMPLETED|Overall Study||76
10515521|NCT01318499|11666483|FG002|NOT COMPLETED|Overall Study||147
10515522|NCT01318512|11666493|FG000|STARTED|Titration Period (4 Months)||340
10515523|NCT01318512|11666493|FG000|COMPLETED|Titration Period (4 Months)||340
10515524|NCT01318512|11666493|FG000|NOT COMPLETED|Titration Period (4 Months)||0
10515525|NCT01318512|11666493|FG000|STARTED|Maintenance Period (6 Months)||340
10515526|NCT01318512|11666493|FG000|COMPLETED|Maintenance Period (6 Months)||329
10515527|NCT01318512|11666493|FG000|NOT COMPLETED|Maintenance Period (6 Months)||11
10515528|NCT01318538|11666501|FG000|STARTED|Overall Study||52
10515529|NCT01318538|11666502|FG001|STARTED|Overall Study||106
10711555|NCT02660983|11876993|FG000|STARTED|Double-blind (DB) Phase (24 Weeks)||154
10810217|NCT03801928|11972115|FG003|STARTED|Overall Study||21
10810218|NCT03801928|11972116|FG004|STARTED|Overall Study||36
10810219|NCT03801928|11972117|FG005|STARTED|Overall Study||10
10810220|NCT03801928|11972112|FG000|COMPLETED|Overall Study||12
10810221|NCT03801928|11972113|FG001|COMPLETED|Overall Study||18
10810222|NCT03801928|11972114|FG002|COMPLETED|Overall Study||4
10810223|NCT03801928|11972115|FG003|COMPLETED|Overall Study||13
10810224|NCT03801928|11972116|FG004|COMPLETED|Overall Study||32
10810225|NCT03801928|11972117|FG005|COMPLETED|Overall Study||5
10810226|NCT03801928|11972112|FG000|NOT COMPLETED|Overall Study||6
10810227|NCT03801928|11972113|FG001|NOT COMPLETED|Overall Study||3
10711556|NCT02660983|11876994|FG001|STARTED|Double-blind (DB) Phase (24 Weeks)||148
10711557|NCT02660983|11876993|FG000|Treated/Safety Set|Double-blind (DB) Phase (24 Weeks)||153
10711558|NCT02660983|11876994|FG001|Treated/Safety Set|Double-blind (DB) Phase (24 Weeks)||147
10711559|NCT02660983|11876993|FG000|COMPLETED|Double-blind (DB) Phase (24 Weeks)||130
10810228|NCT03801928|11972114|FG002|NOT COMPLETED|Overall Study||5
10810229|NCT03801928|11972115|FG003|NOT COMPLETED|Overall Study||8
10515530|NCT01318538|11666503|FG002|STARTED|Overall Study||8
10515531|NCT01318538|11666501|FG000|COMPLETED|Overall Study||52
10711560|NCT02660983|11876994|FG001|COMPLETED|Double-blind (DB) Phase (24 Weeks)||122
10711561|NCT02660983|11876993|FG000|NOT COMPLETED|Double-blind (DB) Phase (24 Weeks)||24
10711562|NCT02660983|11876994|FG001|NOT COMPLETED|Double-blind (DB) Phase (24 Weeks)||26
10711563|NCT02660983|11876993|FG000|STARTED|Open Label Extension Phase (24 Weeks)|Eligible participants who consented to continue from DB phase to OLE phase.|86
10711564|NCT02660983|11876994|FG001|STARTED|Open Label Extension Phase (24 Weeks)|Eligible participants who consented to continue from DB phase to OLE phase.|75
10711565|NCT02660983|11876993|FG000|Safety Set|Open Label Extension Phase (24 Weeks)||86
10515532|NCT01318538|11666502|FG001|COMPLETED|Overall Study||106
10515533|NCT01318538|11666503|FG002|COMPLETED|Overall Study||8
10515534|NCT01318538|11666501|FG000|NOT COMPLETED|Overall Study||0
10515535|NCT01318538|11666502|FG001|NOT COMPLETED|Overall Study||0
10515536|NCT01318538|11666503|FG002|NOT COMPLETED|Overall Study||0
10515537|NCT01318577|11666513|FG000|STARTED|Overall Study||224
10515538|NCT01318577|11666514|FG001|STARTED|Overall Study||220
10515539|NCT01318577|11666513|FG000|COMPLETED|Overall Study||211
10515540|NCT01318577|11666514|FG001|COMPLETED|Overall Study||212
10515541|NCT01318577|11666513|FG000|NOT COMPLETED|Overall Study||13
10515542|NCT01318577|11666514|FG001|NOT COMPLETED|Overall Study||8
10515543|NCT01318694|11666524|FG000|STARTED|Overall Study||275
10515544|NCT01318694|11666525|FG001|STARTED|Overall Study||270
10515545|NCT01318694|11666526|FG002|STARTED|Overall Study||268
10515546|NCT01318694|11666527|FG003|STARTED|Overall Study||268
10515547|NCT01318694|11666524|FG000|Full Analysis Set|Overall Study||274
10515548|NCT01318694|11666525|FG001|Full Analysis Set|Overall Study||270
10515549|NCT01318694|11666526|FG002|Full Analysis Set|Overall Study||265
10515550|NCT01318694|11666527|FG003|Full Analysis Set|Overall Study||268
10515551|NCT01318694|11666524|FG000|Safety Set|Overall Study||273
10515552|NCT01318694|11666525|FG001|Safety Set|Overall Study||268
10515553|NCT01318694|11666526|FG002|Safety Set|Overall Study||265
10515554|NCT01318694|11666527|FG003|Safety Set|Overall Study||265
10515555|NCT01318694|11666524|FG000|COMPLETED|Overall Study||223
10515556|NCT01318694|11666525|FG001|COMPLETED|Overall Study||212
10515557|NCT01318694|11666526|FG002|COMPLETED|Overall Study||225
10515558|NCT01318694|11666527|FG003|COMPLETED|Overall Study||200
10515559|NCT01318694|11666524|FG000|NOT COMPLETED|Overall Study||52
10515560|NCT01318694|11666525|FG001|NOT COMPLETED|Overall Study||58
10515561|NCT01318694|11666526|FG002|NOT COMPLETED|Overall Study||43
10515562|NCT01318694|11666527|FG003|NOT COMPLETED|Overall Study||68
10515563|NCT01318733|11666537|FG000|STARTED|Overall Study||449
10515564|NCT01318733|11666537|FG000|COMPLETED|Overall Study||279
10515565|NCT01318733|11666537|FG000|NOT COMPLETED|Overall Study||170
10515566|NCT01318811|11666543|FG000|STARTED|Overall Study||4
10515567|NCT01318811|11666544|FG001|STARTED|Overall Study||8
10515568|NCT01318811|11666543|FG000|COMPLETED|Overall Study||3
10515569|NCT01318811|11666544|FG001|COMPLETED|Overall Study||4
10515570|NCT01318811|11666543|FG000|NOT COMPLETED|Overall Study||1
10515571|NCT01318811|11666544|FG001|NOT COMPLETED|Overall Study||4
10515572|NCT01318876|11666550|FG000|STARTED|Day 8 Survey||7645
10515573|NCT01318876|11666550|FG000|COMPLETED|Day 8 Survey||5825
10515574|NCT01318876|11666550|FG000|NOT COMPLETED|Day 8 Survey||1820
10515575|NCT01318876|11666550|FG000|STARTED|Day 29 Survey|All participants with a valid e-mail, have received the second survey|7549
10515576|NCT01318876|11666550|FG000|COMPLETED|Day 29 Survey||5724
10515577|NCT01318876|11666550|FG000|NOT COMPLETED|Day 29 Survey||1825
10515578|NCT01318902|11666558|FG000|STARTED|Overall Study||6
10515579|NCT01318902|11666559|FG001|STARTED|Overall Study||5
10515580|NCT01318902|11666560|FG002|STARTED|Overall Study||5
10515581|NCT01318902|11666561|FG003|STARTED|Overall Study||11
10515582|NCT01318902|11666558|FG000|COMPLETED|Overall Study||5
10515583|NCT01318902|11666559|FG001|COMPLETED|Overall Study||2
10515584|NCT01318902|11666560|FG002|COMPLETED|Overall Study||3
10515585|NCT01318902|11666561|FG003|COMPLETED|Overall Study||5
10515586|NCT01318902|11666558|FG000|NOT COMPLETED|Overall Study||1
10515587|NCT01318902|11666559|FG001|NOT COMPLETED|Overall Study||3
10515588|NCT01318902|11666560|FG002|NOT COMPLETED|Overall Study||2
10515589|NCT01318902|11666561|FG003|NOT COMPLETED|Overall Study||6
10515590|NCT01318915|11666573|FG000|STARTED|Overall Study||10
10515591|NCT01318915|11666573|FG000|COMPLETED|Overall Study||9
10515592|NCT01318915|11666573|FG000|NOT COMPLETED|Overall Study||1
10515593|NCT01318967|11666579|FG000|STARTED|Overall Study||10
10515594|NCT01318967|11666579|FG000|COMPLETED|Overall Study||10
10515595|NCT01318967|11666579|FG000|NOT COMPLETED|Overall Study||0
10515596|NCT01319045|11666584|FG000|STARTED|Overall Study||5
10515597|NCT01319045|11666584|FG000|COMPLETED|Overall Study|Study was discontinued due to low enrollment|3
10515598|NCT01319045|11666584|FG000|NOT COMPLETED|Overall Study||2
10515599|NCT01319110|11666590|FG000|STARTED|Overall Study||5
10515600|NCT01319110|11666591|FG001|STARTED|Overall Study||5
10515601|NCT01319110|11666590|FG000|COMPLETED|Overall Study||5
10515602|NCT01319110|11666591|FG001|COMPLETED|Overall Study||5
10515603|NCT01319110|11666590|FG000|NOT COMPLETED|Overall Study||0
10515604|NCT01319110|11666591|FG001|NOT COMPLETED|Overall Study||0
10515605|NCT01319318|11666597|FG000|STARTED|Overall Study||25
10515606|NCT01319318|11666597|FG000|COMPLETED|Overall Study||25
10515607|NCT01319318|11666597|FG000|NOT COMPLETED|Overall Study||0
10515608|NCT01319383|11666601|FG000|STARTED|Overall Study||12
10515609|NCT01319383|11666602|FG001|STARTED|Overall Study||13
10515610|NCT01319383|11666601|FG000|Step 1|Overall Study||8
10515611|NCT01319383|11666602|FG001|Step 1|Overall Study|The 2 participants without an ex vivo response were terminated from the study.|11
10515612|NCT01319383|11666601|FG000|Step 2|Overall Study|These participants demonstrated an ex vivo response in Step 1|8
10515613|NCT01319383|11666602|FG001|Step 2|Overall Study|The 7 participants without an in vivo response to single dose of VOR 400 mg PO were terminated.|4
10515614|NCT01319383|11666601|FG000|Step 2|Overall Study|The 4 without ex vivo response (Step 1) took a single dose to see if in vivo response would occur|4
10515615|NCT01319383|11666602|FG001|Step 2|Overall Study||0
10515616|NCT01319383|11666601|FG000|Step 3|Overall Study|None who qualified for the 2 series of 11 doses of VOR (taken M-T-W & off for 4 days for 4 wks).|0
10515617|NCT01319383|11666602|FG001|Step 3|Overall Study|3 Arm 1 participants enrolled here; 6/7 had in vivo response to 2 VOR doses given 72 hours apart.|6
10515618|NCT01319383|11666601|FG000|Step 4|Overall Study|Arm 1 did not have a Step 4|0
10515619|NCT01319383|11666602|FG001|Step 4|Overall Study|Only 3/6 completed the study.|3
10515620|NCT01319383|11666601|FG000|COMPLETED|Overall Study||0
10515621|NCT01319383|11666602|FG001|COMPLETED|Overall Study||3
10515622|NCT01319383|11666601|FG000|NOT COMPLETED|Overall Study||12
10515623|NCT01319383|11666602|FG001|NOT COMPLETED|Overall Study||10
10515624|NCT01319396|11666619|FG000|STARTED|Overall Study||24
10515625|NCT01319396|11666619|FG000|COMPLETED|Overall Study||24
10515626|NCT01319396|11666619|FG000|NOT COMPLETED|Overall Study||0
10515627|NCT01319422|11666625|FG000|STARTED|Overall Study||20
10515628|NCT01319422|11666626|FG001|STARTED|Overall Study||20
10515629|NCT01319422|11666625|FG000|COMPLETED|Overall Study||19
10515630|NCT01319422|11666626|FG001|COMPLETED|Overall Study||20
10515631|NCT01319422|11666625|FG000|NOT COMPLETED|Overall Study||1
10515632|NCT01319422|11666626|FG001|NOT COMPLETED|Overall Study||0
10515633|NCT01319500|11666634|FG000|STARTED|Overall Study||1187
10515634|NCT01319500|11666635|FG001|STARTED|Overall Study||2589
10711566|NCT02660983|11876994|FG001|Safety Set|Open Label Extension Phase (24 Weeks)||75
10711567|NCT02660983|11876993|FG000|COMPLETED|Open Label Extension Phase (24 Weeks)||83
10711568|NCT02660983|11876994|FG001|COMPLETED|Open Label Extension Phase (24 Weeks)||66
10711569|NCT02660983|11876993|FG000|NOT COMPLETED|Open Label Extension Phase (24 Weeks)||3
10711570|NCT02660983|11876994|FG001|NOT COMPLETED|Open Label Extension Phase (24 Weeks)||9
10810230|NCT03801928|11972116|FG004|NOT COMPLETED|Overall Study||4
10810231|NCT03801928|11972117|FG005|NOT COMPLETED|Overall Study||5
10810232|NCT03800173|11972139|FG000|STARTED|Overall Study||8
10711571|NCT02661061|11877003|FG000|STARTED|Overall Study||5
10711572|NCT02661061|11877004|FG001|STARTED|Overall Study||4
10711573|NCT02661061|11877003|FG000|COMPLETED|Overall Study||3
10711574|NCT02661061|11877004|FG001|COMPLETED|Overall Study||2
10711575|NCT02661061|11877003|FG000|NOT COMPLETED|Overall Study||2
10711576|NCT02661061|11877004|FG001|NOT COMPLETED|Overall Study||2
10711577|NCT02661126|11877012|FG000|STARTED|Overall Study||8
10711578|NCT02661126|11877013|FG001|STARTED|Overall Study||8
10711579|NCT02661126|11877012|FG000|COMPLETED|Overall Study||8
10711580|NCT02661126|11877013|FG001|COMPLETED|Overall Study||8
10810233|NCT03800173|11972140|FG001|STARTED|Overall Study||6
10810234|NCT03800173|11972141|FG002|STARTED|Overall Study||6
10810235|NCT03800173|11972142|FG003|STARTED|Overall Study||6
10810236|NCT03800173|11972143|FG004|STARTED|Overall Study||6
10810237|NCT03800173|11972139|FG000|Safety Population|Overall Study||8
10810238|NCT03800173|11972140|FG001|Safety Population|Overall Study||6
10810239|NCT03800173|11972141|FG002|Safety Population|Overall Study||6
10810240|NCT03800173|11972142|FG003|Safety Population|Overall Study||6
10810241|NCT03800173|11972143|FG004|Safety Population|Overall Study||6
10810242|NCT03800173|11972139|FG000|PK Population|Overall Study||0
10515635|NCT01319500|11666634|FG000|COMPLETED|Overall Study||1187
10515636|NCT01319500|11666635|FG001|COMPLETED|Overall Study||2589
10515637|NCT01319500|11666634|FG000|NOT COMPLETED|Overall Study||0
10515638|NCT01319500|11666635|FG001|NOT COMPLETED|Overall Study||0
10515639|NCT01319539|11666646|FG000|STARTED|Overall Study||12
10515640|NCT01319539|11666646|FG000|COMPLETED|Overall Study||12
10515641|NCT01319539|11666646|FG000|NOT COMPLETED|Overall Study||0
10515642|NCT01319552|11666652|FG000|STARTED|Overall Study||14
10515643|NCT01319552|11666652|FG000|COMPLETED|Overall Study||14
10515644|NCT01319552|11666652|FG000|NOT COMPLETED|Overall Study||0
10515645|NCT01319617|11666657|FG000|STARTED|Overall Study||41
10515646|NCT01319617|11666657|FG000|COMPLETED|Overall Study||40
10515647|NCT01319617|11666657|FG000|NOT COMPLETED|Overall Study||1
10515648|NCT01319721|11666663|FG000|STARTED|Overall Study|The unit of measure is eyes.|48
10515649|NCT01319721|11666664|FG001|STARTED|Overall Study|The unit of measure is eyes.|48
10515650|NCT01319721|11666663|FG000|COMPLETED|Overall Study|The unit of measure is eyes.|47
10515651|NCT01319721|11666664|FG001|COMPLETED|Overall Study|The unit of measure is eyes.|42
10515652|NCT01319721|11666663|FG000|NOT COMPLETED|Overall Study||1
10515653|NCT01319721|11666664|FG001|NOT COMPLETED|Overall Study||6
10711581|NCT02661126|11877012|FG000|NOT COMPLETED|Overall Study||0
10711582|NCT02661126|11877013|FG001|NOT COMPLETED|Overall Study||0
10711583|NCT02661178|11877034|FG000|STARTED|Part 1||1
10810243|NCT03800173|11972140|FG001|PK Population|Overall Study||6
10810244|NCT03800173|11972141|FG002|PK Population|Overall Study||6
10515654|NCT01319773|11666675|FG000|STARTED|Overall Study||10
10515655|NCT01319773|11666676|FG001|STARTED|Overall Study||10
10515656|NCT01319773|11666677|FG002|STARTED|Overall Study||8
10515657|NCT01319773|11666678|FG003|STARTED|Overall Study||8
10515658|NCT01319773|11666679|FG004|STARTED|Overall Study||8
10515659|NCT01319773|11666675|FG000|COMPLETED|Overall Study||10
10515660|NCT01319773|11666676|FG001|COMPLETED|Overall Study||10
10515661|NCT01319773|11666677|FG002|COMPLETED|Overall Study||8
10515662|NCT01319773|11666678|FG003|COMPLETED|Overall Study||8
10515663|NCT01319773|11666679|FG004|COMPLETED|Overall Study||8
10515664|NCT01319773|11666675|FG000|NOT COMPLETED|Overall Study||0
10515665|NCT01319773|11666676|FG001|NOT COMPLETED|Overall Study||0
10515666|NCT01319773|11666677|FG002|NOT COMPLETED|Overall Study||0
10515667|NCT01319773|11666678|FG003|NOT COMPLETED|Overall Study||0
10515668|NCT01319773|11666679|FG004|NOT COMPLETED|Overall Study||0
10515669|NCT01319799|11666689|FG000|STARTED|Overall Study||10
10515670|NCT01319799|11666689|FG000|COMPLETED|Overall Study||10
10515671|NCT01319799|11666689|FG000|NOT COMPLETED|Overall Study||0
10515672|NCT01319812|11666695|FG000|STARTED|Overall Study||161
10515673|NCT01319812|11666696|FG001|STARTED|Overall Study||302
10515674|NCT01319812|11666695|FG000|COMPLETED|Overall Study||145
10515675|NCT01319812|11666696|FG001|COMPLETED|Overall Study||280
10515676|NCT01319812|11666695|FG000|NOT COMPLETED|Overall Study||16
10515677|NCT01319812|11666696|FG001|NOT COMPLETED|Overall Study||22
10515678|NCT01319851|11666709|FG000|STARTED|Overall Study||3
10515679|NCT01319851|11666709|FG000|COMPLETED|Overall Study||3
10515680|NCT01319851|11666709|FG000|NOT COMPLETED|Overall Study||0
10515681|NCT01319877|11666715|FG000|STARTED|Overall Study||453
10515682|NCT01319877|11666716|FG001|STARTED|Overall Study||153
10515683|NCT01319877|11666715|FG000|COMPLETED|Overall Study||345
10515684|NCT01319877|11666716|FG001|COMPLETED|Overall Study||108
10515685|NCT01319877|11666715|FG000|NOT COMPLETED|Overall Study||108
10515686|NCT01319877|11666716|FG001|NOT COMPLETED|Overall Study||45
10515687|NCT01319929|11666723|FG000|STARTED|First Treatment Period (4 Weeks)||20
10515688|NCT01319929|11666724|FG001|STARTED|First Treatment Period (4 Weeks)||19
10515689|NCT01319929|11666723|FG000|COMPLETED|First Treatment Period (4 Weeks)||17
10515690|NCT01319929|11666724|FG001|COMPLETED|First Treatment Period (4 Weeks)||17
10515691|NCT01319929|11666723|FG000|NOT COMPLETED|First Treatment Period (4 Weeks)||3
10515692|NCT01319929|11666724|FG001|NOT COMPLETED|First Treatment Period (4 Weeks)||2
10515693|NCT01319929|11666723|FG000|STARTED|Washout Period (3 Weeks)||17
10515694|NCT01319929|11666724|FG001|STARTED|Washout Period (3 Weeks)||17
10515695|NCT01319929|11666723|FG000|COMPLETED|Washout Period (3 Weeks)||17
10515696|NCT01319929|11666724|FG001|COMPLETED|Washout Period (3 Weeks)||17
10515697|NCT01319929|11666723|FG000|NOT COMPLETED|Washout Period (3 Weeks)||0
10515698|NCT01319929|11666724|FG001|NOT COMPLETED|Washout Period (3 Weeks)||0
10515699|NCT01319929|11666723|FG000|STARTED|Second Treatment Period (4 Weeks)||17
10515700|NCT01319929|11666724|FG001|STARTED|Second Treatment Period (4 Weeks)||17
10515701|NCT01319929|11666723|FG000|COMPLETED|Second Treatment Period (4 Weeks)||16
10515702|NCT01319929|11666724|FG001|COMPLETED|Second Treatment Period (4 Weeks)||16
10515703|NCT01319929|11666723|FG000|NOT COMPLETED|Second Treatment Period (4 Weeks)||1
10515704|NCT01319929|11666724|FG001|NOT COMPLETED|Second Treatment Period (4 Weeks)||1
10515705|NCT01319994|11666733|FG000|STARTED|Overall Study||26
10515706|NCT01319994|11666734|FG001|STARTED|Overall Study||27
10515707|NCT01319994|11666733|FG000|Abto Keep Appoinment Shedule|Overall Study||23
10515708|NCT01319994|11666734|FG001|Abto Keep Appoinment Shedule|Overall Study||24
10515709|NCT01319994|11666733|FG000|Tolerated at Least 1.7g/Day Dose|Overall Study||19
10515710|NCT01319994|11666734|FG001|Tolerated at Least 1.7g/Day Dose|Overall Study||24
10515711|NCT01319994|11666733|FG000|Glucocorticoid Dose as Inc Cri|Overall Study||19
10515712|NCT01319994|11666734|FG001|Glucocorticoid Dose as Inc Cri|Overall Study||22
10515713|NCT01319994|11666733|FG000|Did Not Develop Overt Diabetes|Overall Study||19
10515714|NCT01319994|11666734|FG001|Did Not Develop Overt Diabetes|Overall Study||21
10515715|NCT01319994|11666733|FG000|COMPLETED|Overall Study||19
10515716|NCT01319994|11666734|FG001|COMPLETED|Overall Study||21
10515717|NCT01319994|11666733|FG000|NOT COMPLETED|Overall Study||7
10515718|NCT01319994|11666734|FG001|NOT COMPLETED|Overall Study||6
10515719|NCT01320033|11666743|FG000|STARTED|Overall Study||216
10515720|NCT01320033|11666744|FG001|STARTED|Overall Study||224
10515721|NCT01320033|11666745|FG002|STARTED|Overall Study||222
10515722|NCT01320033|11666743|FG000|COMPLETED|Overall Study||158
10515723|NCT01320033|11666744|FG001|COMPLETED|Overall Study||160
10515724|NCT01320033|11666745|FG002|COMPLETED|Overall Study||169
10515725|NCT01320033|11666743|FG000|NOT COMPLETED|Overall Study||58
10515726|NCT01320033|11666744|FG001|NOT COMPLETED|Overall Study||64
10515727|NCT01320033|11666745|FG002|NOT COMPLETED|Overall Study||53
10515728|NCT01320085|11666756|FG000|STARTED|Overall Study||41
10515729|NCT01320085|11666757|FG001|STARTED|Overall Study||117
10515730|NCT01320085|11666758|FG002|STARTED|Overall Study||25
10515731|NCT01320085|11666756|FG000|COMPLETED|Overall Study||0
10515732|NCT01320085|11666757|FG001|COMPLETED|Overall Study||0
10515733|NCT01320085|11666758|FG002|COMPLETED|Overall Study||0
10515734|NCT01320085|11666756|FG000|NOT COMPLETED|Overall Study||41
10515735|NCT01320085|11666757|FG001|NOT COMPLETED|Overall Study||117
10515736|NCT01320085|11666758|FG002|NOT COMPLETED|Overall Study||25
10515737|NCT01320137|11666768|FG000|STARTED|Overall Study||40
10515738|NCT01320137|11666769|FG001|STARTED|Overall Study||40
10515739|NCT01320137|11666768|FG000|COMPLETED|Overall Study||40
10515740|NCT01320137|11666769|FG001|COMPLETED|Overall Study||40
10515741|NCT01320137|11666768|FG000|NOT COMPLETED|Overall Study||0
10515742|NCT01320137|11666769|FG001|NOT COMPLETED|Overall Study||0
10515743|NCT01320150|11666777|FG000|STARTED|Overall Study||311
10515744|NCT01320150|11666777|FG000|PPP|Overall Study||34
10515745|NCT01320150|11666777|FG000|Non-PPP|Overall Study||211
10515746|NCT01320150|11666777|FG000|COMPLETED|Overall Study||245
10515747|NCT01320150|11666777|FG000|NOT COMPLETED|Overall Study||66
10515748|NCT01320202|11666783|FG000|STARTED|Overall Study||152
10515749|NCT01320202|11666784|FG001|STARTED|Overall Study||153
10515750|NCT01320202|11666783|FG000|Comp 48 Wks in St 2|Overall Study||27
10515751|NCT01320202|11666784|FG001|Comp 48 Wks in St 2|Overall Study||27
10515752|NCT01320202|11666783|FG000|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||69
10515753|NCT01320202|11666784|FG001|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||82
10515754|NCT01320202|11666783|FG000|Enrolled in St 3|Overall Study||98
10515755|NCT01320202|11666784|FG001|Enrolled in St 3|Overall Study||109
10515756|NCT01320202|11666783|FG000|Completed St 3|Overall Study||79
10515757|NCT01320202|11666784|FG001|Completed St 3|Overall Study||82
10515758|NCT01320202|11666783|FG000|COMPLETED|Overall Study||96
10515759|NCT01320202|11666784|FG001|COMPLETED|Overall Study||109
10515760|NCT01320202|11666783|FG000|NOT COMPLETED|Overall Study||56
10515761|NCT01320202|11666784|FG001|NOT COMPLETED|Overall Study||44
10515762|NCT01320293|11666793|FG000|STARTED|Overall Study||18
10515763|NCT01320293|11666793|FG000|COMPLETED|Overall Study||16
10515764|NCT01320293|11666793|FG000|NOT COMPLETED|Overall Study||2
10515765|NCT01320553|11666801|FG000|STARTED|Overall Study||31
10515766|NCT01320553|11666802|FG001|STARTED|Overall Study||30
10515767|NCT01320553|11666803|FG002|STARTED|Overall Study||31
10515768|NCT01320553|11666804|FG003|STARTED|Overall Study||30
10515769|NCT01320553|11666801|FG000|COMPLETED|Overall Study||30
10515770|NCT01320553|11666802|FG001|COMPLETED|Overall Study||26
10515771|NCT01320553|11666803|FG002|COMPLETED|Overall Study||29
10515772|NCT01320553|11666804|FG003|COMPLETED|Overall Study||29
10515773|NCT01320553|11666801|FG000|NOT COMPLETED|Overall Study||1
10515774|NCT01320553|11666802|FG001|NOT COMPLETED|Overall Study||4
10515775|NCT01320553|11666803|FG002|NOT COMPLETED|Overall Study||2
10515776|NCT01320553|11666804|FG003|NOT COMPLETED|Overall Study||1
10515777|NCT01320722|11666819|FG000|STARTED|Overall Study||46
10515778|NCT01320722|11666820|FG001|STARTED|Overall Study||47
10515779|NCT01320722|11666821|FG002|STARTED|Overall Study||47
10515780|NCT01320722|11666822|FG003|STARTED|Overall Study||49
10711584|NCT02661178|11877035|FG001|STARTED|Part 1||5
10711585|NCT02661178|11877036|FG002|STARTED|Part 1||6
10711586|NCT02661178|11877037|FG003|STARTED|Part 1||6
10515781|NCT01320722|11666823|FG004|STARTED|Overall Study||53
10515782|NCT01320722|11666819|FG000|Received Intervention|Overall Study||43
10515783|NCT01320722|11666820|FG001|Received Intervention|Overall Study||45
10515784|NCT01320722|11666821|FG002|Received Intervention|Overall Study||46
10515785|NCT01320722|11666822|FG003|Received Intervention|Overall Study||48
10515786|NCT01320722|11666823|FG004|Received Intervention|Overall Study||51
10515787|NCT01320722|11666819|FG000|COMPLETED|Overall Study||43
10515788|NCT01320722|11666820|FG001|COMPLETED|Overall Study||41
10515789|NCT01320722|11666821|FG002|COMPLETED|Overall Study||40
10515790|NCT01320722|11666822|FG003|COMPLETED|Overall Study||35
10515791|NCT01320722|11666823|FG004|COMPLETED|Overall Study||45
10515792|NCT01320722|11666819|FG000|NOT COMPLETED|Overall Study||3
10515793|NCT01320722|11666820|FG001|NOT COMPLETED|Overall Study||6
10515794|NCT01320722|11666821|FG002|NOT COMPLETED|Overall Study||7
10515795|NCT01320722|11666822|FG003|NOT COMPLETED|Overall Study||14
10515796|NCT01320722|11666823|FG004|NOT COMPLETED|Overall Study||8
10515797|NCT01320735|11666838|FG000|STARTED|Overall Study||300
10515798|NCT01320735|11666838|FG000|COMPLETED|Overall Study||194
10515799|NCT01320735|11666838|FG000|NOT COMPLETED|Overall Study||106
10515800|NCT01320826|11666842|FG000|STARTED|Overall Study||577
10515801|NCT01320826|11666842|FG000|COMPLETED|Overall Study||577
10515802|NCT01320826|11666842|FG000|NOT COMPLETED|Overall Study||0
10515803|NCT01320943|11666859|FG000|STARTED|Overall Study|13 participants did not restart TDF; 8 participants restarted TDF during the study.|21
10515804|NCT01320943|11666860|FG001|STARTED|Overall Study||22
10515805|NCT01320943|11666859|FG000|COMPLETED|Overall Study||20
10515806|NCT01320943|11666860|FG001|COMPLETED|Overall Study||20
10515807|NCT01320943|11666859|FG000|NOT COMPLETED|Overall Study||1
10515808|NCT01320943|11666860|FG001|NOT COMPLETED|Overall Study||2
10515812|NCT01321151|11666879|FG000|STARTED|Overall Study|The boxer was treated once-a-day for 30 days.|6
10515813|NCT01321151|11666880|FG001|STARTED|Overall Study|The boxer was treated with once-a-day for 30 days.|6
10515814|NCT01321151|11666879|FG000|COMPLETED|Overall Study||6
10515815|NCT01321151|11666880|FG001|COMPLETED|Overall Study||6
10515816|NCT01321151|11666879|FG000|NOT COMPLETED|Overall Study||0
10515817|NCT01321151|11666880|FG001|NOT COMPLETED|Overall Study||0
10515818|NCT01321177|11666888|FG000|STARTED|Overall Study||223
10711587|NCT02661178|11877038|FG004|STARTED|Part 1||5
10711588|NCT02661178|11877039|FG005|STARTED|Part 1||6
10515819|NCT01321177|11666889|FG001|STARTED|Overall Study||181
10515820|NCT01321177|11666888|FG000|COMPLETED|Overall Study||147
10515821|NCT01321177|11666889|FG001|COMPLETED|Overall Study||84
10711589|NCT02661178|11877040|FG006|STARTED|Part 1||6
10515822|NCT01321177|11666888|FG000|NOT COMPLETED|Overall Study||76
10515823|NCT01321177|11666889|FG001|NOT COMPLETED|Overall Study||97
10515824|NCT01321437|11666895|FG000|STARTED|Overall Study||11
10515825|NCT01321437|11666895|FG000|COMPLETED|Overall Study||11
10515826|NCT01321437|11666895|FG000|NOT COMPLETED|Overall Study||0
10515827|NCT01321541|11666901|FG000|STARTED|Overall Study||155
10515828|NCT01321541|11666902|FG001|STARTED|Overall Study||157
10515829|NCT01321541|11666901|FG000|COMPLETED|Overall Study||72
10515830|NCT01321541|11666902|FG001|COMPLETED|Overall Study||61
10515831|NCT01321541|11666901|FG000|NOT COMPLETED|Overall Study||83
10515832|NCT01321541|11666902|FG001|NOT COMPLETED|Overall Study||96
10515833|NCT01321554|11666910|FG000|STARTED|Randomization Phase||261
10515834|NCT01321554|11666911|FG001|STARTED|Randomization Phase||131
10515835|NCT01321554|11666912|FG002|STARTED|Randomization Phase||0
10515836|NCT01321554|11666913|FG003|STARTED|Randomization Phase||0
10515837|NCT01321554|11666910|FG000|COMPLETED|Randomization Phase||261
10515838|NCT01321554|11666911|FG001|COMPLETED|Randomization Phase||131
10515839|NCT01321554|11666912|FG002|COMPLETED|Randomization Phase||0
10515840|NCT01321554|11666913|FG003|COMPLETED|Randomization Phase||0
10515841|NCT01321554|11666910|FG000|NOT COMPLETED|Randomization Phase||0
10515842|NCT01321554|11666911|FG001|NOT COMPLETED|Randomization Phase||0
10515843|NCT01321554|11666912|FG002|NOT COMPLETED|Randomization Phase||0
10515844|NCT01321554|11666913|FG003|NOT COMPLETED|Randomization Phase||0
10515845|NCT01321554|11666910|FG000|STARTED|OOL Lenvatinib Treatment Period||0
10515846|NCT01321554|11666911|FG001|STARTED|OOL Lenvatinib Treatment Period||0
10515847|NCT01321554|11666912|FG002|STARTED|OOL Lenvatinib Treatment Period|Participants from randomization phase were re-randomized to OOL, treatment period.|85
10515848|NCT01321554|11666913|FG003|STARTED|OOL Lenvatinib Treatment Period|Participants from randomization phase were re-randomized to OOL, treatment period.|30
10515849|NCT01321554|11666910|FG000|COMPLETED|OOL Lenvatinib Treatment Period||0
10515850|NCT01321554|11666911|FG001|COMPLETED|OOL Lenvatinib Treatment Period||0
10515851|NCT01321554|11666912|FG002|COMPLETED|OOL Lenvatinib Treatment Period||85
10515852|NCT01321554|11666913|FG003|COMPLETED|OOL Lenvatinib Treatment Period||30
10515853|NCT01321554|11666910|FG000|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
10515854|NCT01321554|11666911|FG001|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
10515855|NCT01321554|11666912|FG002|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
10515856|NCT01321554|11666913|FG003|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
10515857|NCT01321606|11666923|FG000|STARTED|Overall Study||18
10515858|NCT01321606|11666924|FG001|STARTED|Overall Study||32
10515859|NCT01321606|11666925|FG002|STARTED|Overall Study||34
10515860|NCT01321606|11666926|FG003|STARTED|Overall Study||29
10515861|NCT01321606|11666923|FG000|COMPLETED|Overall Study||18
10515862|NCT01321606|11666924|FG001|COMPLETED|Overall Study||32
10515863|NCT01321606|11666925|FG002|COMPLETED|Overall Study||34
10515864|NCT01321606|11666926|FG003|COMPLETED|Overall Study||28
10515865|NCT01321606|11666923|FG000|NOT COMPLETED|Overall Study||0
10515866|NCT01321606|11666924|FG001|NOT COMPLETED|Overall Study||0
10515867|NCT01321606|11666925|FG002|NOT COMPLETED|Overall Study||0
10515868|NCT01321606|11666926|FG003|NOT COMPLETED|Overall Study||1
10515869|NCT01321710|11666939|FG000|STARTED|Overall Study||50
10515870|NCT01321710|11666940|FG001|STARTED|Overall Study||58
10515871|NCT01321710|11666941|FG002|STARTED|Overall Study||44
10515872|NCT01321710|11666939|FG000|COMPLETED|Overall Study||46
10515873|NCT01321710|11666940|FG001|COMPLETED|Overall Study||53
10515874|NCT01321710|11666941|FG002|COMPLETED|Overall Study||44
10515875|NCT01321710|11666939|FG000|NOT COMPLETED|Overall Study||4
10515876|NCT01321710|11666940|FG001|NOT COMPLETED|Overall Study||5
10515877|NCT01321710|11666941|FG002|NOT COMPLETED|Overall Study||0
10515878|NCT01321723|11666954|FG000|STARTED|Overall Study||32
10515879|NCT01321723|11666955|FG001|STARTED|Overall Study||33
10515880|NCT01321723|11666956|FG002|STARTED|Overall Study||32
10515881|NCT01321723|11666954|FG000|COMPLETED|Overall Study||27
10515882|NCT01321723|11666955|FG001|COMPLETED|Overall Study||28
10515883|NCT01321723|11666956|FG002|COMPLETED|Overall Study||28
10515884|NCT01321723|11666954|FG000|NOT COMPLETED|Overall Study||5
10515885|NCT01321723|11666955|FG001|NOT COMPLETED|Overall Study||5
10515886|NCT01321723|11666956|FG002|NOT COMPLETED|Overall Study||4
10515887|NCT01321749|11666966|FG000|STARTED|Overall Study||51
10515888|NCT01321749|11666967|FG001|STARTED|Overall Study||52
10515889|NCT01321749|11666966|FG000|COMPLETED|Overall Study||38
10515890|NCT01321749|11666967|FG001|COMPLETED|Overall Study||30
10515891|NCT01321749|11666966|FG000|NOT COMPLETED|Overall Study||13
10515892|NCT01321749|11666967|FG001|NOT COMPLETED|Overall Study||22
10515893|NCT01321879|11666973|FG000|STARTED|Overall Study||39
10515894|NCT01321879|11666973|FG000|COMPLETED|Overall Study||25
10515895|NCT01321879|11666973|FG000|NOT COMPLETED|Overall Study||14
10515896|NCT01322009|11666979|FG000|STARTED|Overall Study||7
10515897|NCT01322009|11666980|FG001|STARTED|Overall Study||7
10515898|NCT01322009|11666979|FG000|COMPLETED|Overall Study||7
10515899|NCT01322009|11666980|FG001|COMPLETED|Overall Study||4
10515900|NCT01322009|11666979|FG000|NOT COMPLETED|Overall Study||0
10515901|NCT01322009|11666980|FG001|NOT COMPLETED|Overall Study||3
10515902|NCT01322022|11666988|FG000|STARTED|Overall Study||20
10515903|NCT01322022|11666989|FG001|STARTED|Overall Study||20
10515904|NCT01322022|11666988|FG000|Week 4|Overall Study||15
10515905|NCT01322022|11666989|FG001|Week 4|Overall Study||18
10515906|NCT01322022|11666988|FG000|COMPLETED|Overall Study||15
10515907|NCT01322022|11666989|FG001|COMPLETED|Overall Study||18
10515908|NCT01322022|11666988|FG000|NOT COMPLETED|Overall Study||5
10515909|NCT01322022|11666989|FG001|NOT COMPLETED|Overall Study||2
10515910|NCT01322048|11666997|FG000|STARTED|Overall Study||21
10515911|NCT01322048|11666998|FG001|STARTED|Overall Study||26
10515912|NCT01322048|11666997|FG000|COMPLETED|Overall Study||21
10515913|NCT01322048|11666998|FG001|COMPLETED|Overall Study||26
10515914|NCT01322048|11666997|FG000|NOT COMPLETED|Overall Study||0
10515915|NCT01322048|11666998|FG001|NOT COMPLETED|Overall Study||0
10515916|NCT01322347|11667006|FG000|STARTED|Overall Study||147
10515917|NCT01322347|11667007|FG001|STARTED|Overall Study||147
10515918|NCT01322347|11667006|FG000|Completed 48 Wks in St 2|Overall Study||28
10515919|NCT01322347|11667007|FG001|Completed 48 Wks in St 2|Overall Study||22
10515920|NCT01322347|11667006|FG000|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||68
10515921|NCT01322347|11667007|FG001|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||90
10515922|NCT01322347|11667006|FG000|Enrolled in St 3|Overall Study||101
10515923|NCT01322347|11667007|FG001|Enrolled in St 3|Overall Study||113
10515924|NCT01322347|11667006|FG000|Completed St 3|Overall Study||82
10515925|NCT01322347|11667007|FG001|Completed St 3|Overall Study||86
10515926|NCT01322347|11667006|FG000|COMPLETED|Overall Study||96
10515927|NCT01322347|11667007|FG001|COMPLETED|Overall Study||112
10515928|NCT01322347|11667006|FG000|NOT COMPLETED|Overall Study||51
10515929|NCT01322347|11667007|FG001|NOT COMPLETED|Overall Study||35
10515930|NCT01322360|11667014|FG000|STARTED|Overall Study||50
10515931|NCT01322360|11667014|FG000|COMPLETED|Overall Study||50
10515932|NCT01322360|11667014|FG000|NOT COMPLETED|Overall Study||0
10515933|NCT01322386|11667021|FG000|STARTED|Overall Study||10
10515934|NCT01322386|11667022|FG001|STARTED|Overall Study||11
10515935|NCT01322386|11667021|FG000|COMPLETED|Overall Study||10
10515936|NCT01322386|11667022|FG001|COMPLETED|Overall Study||9
10515937|NCT01322386|11667021|FG000|NOT COMPLETED|Overall Study||0
10515938|NCT01322386|11667022|FG001|NOT COMPLETED|Overall Study||2
10515939|NCT01322490|11667033|FG000|STARTED|Treatment Period||432
10515940|NCT01322490|11667034|FG001|STARTED|Treatment Period||432
10515941|NCT01322490|11667035|FG002|STARTED|Treatment Period||433
10515942|NCT01322490|11667033|FG000|Treated|Treatment Period||429
10515943|NCT01322490|11667034|FG001|Treated|Treatment Period||429
10515944|NCT01322490|11667035|FG002|Treated|Treatment Period||428
10515945|NCT01322490|11667033|FG000|COMPLETED|Treatment Period||300
10515946|NCT01322490|11667034|FG001|COMPLETED|Treatment Period||279
10515947|NCT01322490|11667035|FG002|COMPLETED|Treatment Period||280
10515948|NCT01322490|11667033|FG000|NOT COMPLETED|Treatment Period||132
10515949|NCT01322490|11667034|FG001|NOT COMPLETED|Treatment Period||153
10515950|NCT01322490|11667035|FG002|NOT COMPLETED|Treatment Period||153
10515951|NCT01322490|11667033|FG000|STARTED|Long Term Follow-up Period|You did not have to complete treatment to enter follow up.|409
10515952|NCT01322490|11667034|FG001|STARTED|Long Term Follow-up Period|You did not have to complete treatment to enter follow up.|408
10515953|NCT01322490|11667035|FG002|STARTED|Long Term Follow-up Period|You did not have to complete treatment to enter follow up.|413
10515954|NCT01322490|11667033|FG000|COMPLETED|Long Term Follow-up Period||0
10515955|NCT01322490|11667034|FG001|COMPLETED|Long Term Follow-up Period||0
10515956|NCT01322490|11667035|FG002|COMPLETED|Long Term Follow-up Period||0
10515957|NCT01322490|11667033|FG000|NOT COMPLETED|Long Term Follow-up Period||409
10515958|NCT01322490|11667034|FG001|NOT COMPLETED|Long Term Follow-up Period||408
10515959|NCT01322490|11667035|FG002|NOT COMPLETED|Long Term Follow-up Period||413
10515960|NCT01322594|11667049|FG000|STARTED|Overall Study|RANDOMIZED SUBJECTS THROUGH STUDY DAY 240-300|6
10515961|NCT01322594|11667050|FG001|STARTED|Overall Study||3
10515962|NCT01322594|11667051|FG002|STARTED|Overall Study||3
10515963|NCT01322594|11667052|FG003|STARTED|Overall Study||6
10515964|NCT01322594|11667053|FG004|STARTED|Overall Study||7
10515965|NCT01322594|11667054|FG005|STARTED|Overall Study||6
10515966|NCT01322594|11667049|FG000|COMPLETED|Overall Study||6
10515967|NCT01322594|11667050|FG001|COMPLETED|Overall Study||3
10515968|NCT01322594|11667051|FG002|COMPLETED|Overall Study||3
10515969|NCT01322594|11667052|FG003|COMPLETED|Overall Study||6
10515970|NCT01322594|11667053|FG004|COMPLETED|Overall Study||7
10711590|NCT02661178|11877041|FG007|STARTED|Part 1||6
10711591|NCT02661178|11877042|FG008|STARTED|Part 1||6
10711592|NCT02661178|11877043|FG009|STARTED|Part 1||12
10711593|NCT02661178|11877044|FG010|STARTED|Part 1||4
10711594|NCT02661178|11877045|FG011|STARTED|Part 1||0
10711595|NCT02661178|11877046|FG012|STARTED|Part 1||0
10515971|NCT01322594|11667054|FG005|COMPLETED|Overall Study||6
10515972|NCT01322594|11667049|FG000|NOT COMPLETED|Overall Study||0
10515973|NCT01322594|11667050|FG001|NOT COMPLETED|Overall Study||0
10515974|NCT01322594|11667051|FG002|NOT COMPLETED|Overall Study||0
10515975|NCT01322594|11667052|FG003|NOT COMPLETED|Overall Study||0
10515976|NCT01322594|11667053|FG004|NOT COMPLETED|Overall Study||0
10711596|NCT02661178|11877047|FG013|STARTED|Part 1||0
10515977|NCT01322594|11667054|FG005|NOT COMPLETED|Overall Study||0
10515978|NCT01322607|11667070|FG000|STARTED|Overall Study||11
10515979|NCT01322607|11667071|FG001|STARTED|Overall Study||9
10515980|NCT01322607|11667070|FG000|COMPLETED|Overall Study||10
10515981|NCT01322607|11667071|FG001|COMPLETED|Overall Study||9
10515982|NCT01322607|11667070|FG000|NOT COMPLETED|Overall Study||1
10515983|NCT01322607|11667071|FG001|NOT COMPLETED|Overall Study||0
10515984|NCT01322633|11667079|FG000|STARTED|Overall Study||34178
10515985|NCT01322633|11667080|FG001|STARTED|Overall Study||27686
10515986|NCT01322633|11667079|FG000|COMPLETED|Overall Study||34178
10515987|NCT01322633|11667080|FG001|COMPLETED|Overall Study||27686
10515988|NCT01322633|11667079|FG000|NOT COMPLETED|Overall Study||0
10711597|NCT02661178|11877048|FG014|STARTED|Part 1||0
10711598|NCT02661178|11877034|FG000|COMPLETED|Part 1||0
10711599|NCT02661178|11877035|FG001|COMPLETED|Part 1||5
10711600|NCT02661178|11877036|FG002|COMPLETED|Part 1||6
10515989|NCT01322633|11667080|FG001|NOT COMPLETED|Overall Study||0
10515990|NCT01322815|11667088|FG000|STARTED|Overall Study||7
10515991|NCT01322815|11667089|FG001|STARTED|Overall Study||4
10515992|NCT01322815|11667088|FG000|COMPLETED|Overall Study||7
10515993|NCT01322815|11667089|FG001|COMPLETED|Overall Study||4
10515994|NCT01322815|11667088|FG000|NOT COMPLETED|Overall Study||0
10515995|NCT01322815|11667089|FG001|NOT COMPLETED|Overall Study||0
10515996|NCT01322841|11667097|FG000|STARTED|Overall Study||1116
10515997|NCT01322841|11667098|FG001|STARTED|Overall Study||1123
10515998|NCT01322841|11667097|FG000|COMPLETED|Overall Study||1116
10515999|NCT01322841|11667098|FG001|COMPLETED|Overall Study||1123
10516000|NCT01322841|11667097|FG000|NOT COMPLETED|Overall Study||0
10516001|NCT01322841|11667098|FG001|NOT COMPLETED|Overall Study||0
10516002|NCT01322945|11667106|FG000|STARTED|Overall Study||52
10516003|NCT01322945|11667107|FG001|STARTED|Overall Study||42
10516004|NCT01322945|11667106|FG000|COMPLETED|Overall Study||52
10516005|NCT01322945|11667107|FG001|COMPLETED|Overall Study||42
10516006|NCT01322945|11667106|FG000|NOT COMPLETED|Overall Study||0
10516007|NCT01322945|11667107|FG001|NOT COMPLETED|Overall Study||0
10516008|NCT01323010|11667117|FG000|STARTED|Overall Study||60
10516009|NCT01323010|11667118|FG001|STARTED|Overall Study||59
10516010|NCT01323010|11667117|FG000|COMPLETED|Overall Study||60
10516011|NCT01323010|11667118|FG001|COMPLETED|Overall Study||59
10516012|NCT01323010|11667117|FG000|NOT COMPLETED|Overall Study||0
10516013|NCT01323010|11667118|FG001|NOT COMPLETED|Overall Study||0
10516014|NCT01323140|11667136|FG000|STARTED|Overall Study||40
10516015|NCT01323140|11667136|FG000|COMPLETED|Overall Study||38
10516016|NCT01323140|11667136|FG000|NOT COMPLETED|Overall Study||2
10516017|NCT01323153|11667142|FG000|STARTED|Overall Study||150
10516018|NCT01323153|11667143|FG001|STARTED|Overall Study||150
10516019|NCT01323153|11667142|FG000|COMPLETED|Overall Study||133
10516020|NCT01323153|11667143|FG001|COMPLETED|Overall Study||142
10516021|NCT01323153|11667142|FG000|NOT COMPLETED|Overall Study||17
10516022|NCT01323153|11667143|FG001|NOT COMPLETED|Overall Study||8
10516023|NCT01323192|11667151|FG000|STARTED|Overall Study||143
10516024|NCT01323192|11667152|FG001|STARTED|Overall Study||141
10516025|NCT01323192|11667151|FG000|COMPLETED|Overall Study||134
10516026|NCT01323192|11667152|FG001|COMPLETED|Overall Study||135
10516027|NCT01323192|11667151|FG000|NOT COMPLETED|Overall Study||9
10516028|NCT01323192|11667152|FG001|NOT COMPLETED|Overall Study||6
10516029|NCT01323270|11667160|FG000|STARTED|Overall Study||373
10516030|NCT01323270|11667161|FG001|STARTED|Overall Study||376
10516031|NCT01323270|11667160|FG000|COMPLETED|Overall Study||330
10516032|NCT01323270|11667161|FG001|COMPLETED|Overall Study||347
10516033|NCT01323270|11667160|FG000|NOT COMPLETED|Overall Study||43
10516034|NCT01323270|11667161|FG001|NOT COMPLETED|Overall Study||29
10516035|NCT01323387|11667168|FG000|STARTED|Overall Study||178
10516036|NCT01323387|11667168|FG000|COMPLETED|Overall Study||94
10516037|NCT01323387|11667168|FG000|NOT COMPLETED|Overall Study||84
10516038|NCT01323478|11667174|FG000|STARTED|Overall Study||71
10516039|NCT01323478|11667174|FG000|COMPLETED|Overall Study||47
10516040|NCT01323478|11667174|FG000|NOT COMPLETED|Overall Study||24
10516041|NCT01323517|11667178|FG000|STARTED|Overall Study||26
10516042|NCT01323517|11667178|FG000|COMPLETED|Overall Study||26
10516043|NCT01323517|11667178|FG000|NOT COMPLETED|Overall Study||0
10516044|NCT01323530|11667189|FG000|STARTED|Phase 1b (Dose Escalation Phase)||8
10516045|NCT01323530|11667190|FG001|STARTED|Phase 1b (Dose Escalation Phase)||6
10516046|NCT01323530|11667191|FG002|STARTED|Phase 1b (Dose Escalation Phase)||5
10516047|NCT01323530|11667192|FG003|STARTED|Phase 1b (Dose Escalation Phase)||3
10516048|NCT01323530|11667193|FG004|STARTED|Phase 1b (Dose Escalation Phase)||6
10516049|NCT01323530|11667194|FG005|STARTED|Phase 1b (Dose Escalation Phase)||6
10516050|NCT01323530|11667195|FG006|STARTED|Phase 1b (Dose Escalation Phase)||0
10516051|NCT01323530|11667189|FG000|COMPLETED|Phase 1b (Dose Escalation Phase)||5
10516052|NCT01323530|11667190|FG001|COMPLETED|Phase 1b (Dose Escalation Phase)||4
10516053|NCT01323530|11667191|FG002|COMPLETED|Phase 1b (Dose Escalation Phase)||4
10516054|NCT01323530|11667192|FG003|COMPLETED|Phase 1b (Dose Escalation Phase)||3
10516055|NCT01323530|11667193|FG004|COMPLETED|Phase 1b (Dose Escalation Phase)||3
10516056|NCT01323530|11667194|FG005|COMPLETED|Phase 1b (Dose Escalation Phase)||3
10516057|NCT01323530|11667195|FG006|COMPLETED|Phase 1b (Dose Escalation Phase)||0
10516058|NCT01323530|11667189|FG000|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||3
10516059|NCT01323530|11667190|FG001|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||2
10516060|NCT01323530|11667191|FG002|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||1
10516061|NCT01323530|11667192|FG003|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||0
10516062|NCT01323530|11667193|FG004|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||3
10516063|NCT01323530|11667194|FG005|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||3
10516064|NCT01323530|11667195|FG006|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||0
10516065|NCT01323530|11667189|FG000|STARTED|Phase 2 (Dose-confirmation Phase)||0
10516066|NCT01323530|11667190|FG001|STARTED|Phase 2 (Dose-confirmation Phase)||0
10516067|NCT01323530|11667191|FG002|STARTED|Phase 2 (Dose-confirmation Phase)||0
10516068|NCT01323530|11667192|FG003|STARTED|Phase 2 (Dose-confirmation Phase)||0
10516069|NCT01323530|11667193|FG004|STARTED|Phase 2 (Dose-confirmation Phase)||0
10516070|NCT01323530|11667194|FG005|STARTED|Phase 2 (Dose-confirmation Phase)||0
10516071|NCT01323530|11667195|FG006|STARTED|Phase 2 (Dose-confirmation Phase)||42
10516072|NCT01323530|11667189|FG000|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
10516073|NCT01323530|11667190|FG001|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
10516074|NCT01323530|11667191|FG002|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
10516075|NCT01323530|11667192|FG003|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
10516076|NCT01323530|11667193|FG004|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
10516077|NCT01323530|11667194|FG005|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
10516078|NCT01323530|11667195|FG006|COMPLETED|Phase 2 (Dose-confirmation Phase)||25
10516079|NCT01323530|11667189|FG000|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
10516080|NCT01323530|11667190|FG001|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
10516081|NCT01323530|11667191|FG002|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
10516082|NCT01323530|11667192|FG003|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
10516083|NCT01323530|11667193|FG004|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
10516084|NCT01323530|11667194|FG005|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
10516085|NCT01323530|11667195|FG006|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||17
10516086|NCT01323582|11667214|FG000|STARTED|Weeks 1-4 (First Period)||12
10516087|NCT01323582|11667215|FG001|STARTED|Weeks 1-4 (First Period)||14
10516088|NCT01323582|11667214|FG000|COMPLETED|Weeks 1-4 (First Period)||10
10516089|NCT01323582|11667215|FG001|COMPLETED|Weeks 1-4 (First Period)||12
10516090|NCT01323582|11667214|FG000|NOT COMPLETED|Weeks 1-4 (First Period)||2
10516091|NCT01323582|11667215|FG001|NOT COMPLETED|Weeks 1-4 (First Period)||2
10516092|NCT01323582|11667214|FG000|STARTED|Weeks 5-7 (Washout)||10
10516093|NCT01323582|11667215|FG001|STARTED|Weeks 5-7 (Washout)||12
10516094|NCT01323582|11667214|FG000|COMPLETED|Weeks 5-7 (Washout)||10
10516095|NCT01323582|11667215|FG001|COMPLETED|Weeks 5-7 (Washout)||11
10516096|NCT01323582|11667214|FG000|NOT COMPLETED|Weeks 5-7 (Washout)||0
10516097|NCT01323582|11667215|FG001|NOT COMPLETED|Weeks 5-7 (Washout)||1
10516098|NCT01323582|11667214|FG000|STARTED|Weeks 8-11 (Period 2)||10
10516099|NCT01323582|11667215|FG001|STARTED|Weeks 8-11 (Period 2)||11
10516100|NCT01323582|11667214|FG000|COMPLETED|Weeks 8-11 (Period 2)||10
10516101|NCT01323582|11667215|FG001|COMPLETED|Weeks 8-11 (Period 2)||10
10516102|NCT01323582|11667214|FG000|NOT COMPLETED|Weeks 8-11 (Period 2)||0
10516103|NCT01323582|11667215|FG001|NOT COMPLETED|Weeks 8-11 (Period 2)||1
10516104|NCT01323595|11667225|FG000|STARTED|Overall Study||39
10516105|NCT01323595|11667226|FG001|STARTED|Overall Study||39
10516106|NCT01323595|11667225|FG000|COMPLETED|Overall Study|Remaining subjects did not return questionnaire|16
10516107|NCT01323595|11667226|FG001|COMPLETED|Overall Study|Remaining subjects did not return questionaire|18
10516108|NCT01323595|11667225|FG000|NOT COMPLETED|Overall Study||23
10516109|NCT01323595|11667226|FG001|NOT COMPLETED|Overall Study||21
10516110|NCT01323621|11667236|FG000|STARTED|2-week, Single-blind Run In Period||739
10711601|NCT02661178|11877037|FG003|COMPLETED|Part 1||6
10711602|NCT02661178|11877038|FG004|COMPLETED|Part 1||5
10711603|NCT02661178|11877039|FG005|COMPLETED|Part 1||6
10711604|NCT02661178|11877040|FG006|COMPLETED|Part 1||6
10516111|NCT01323621|11667237|FG001|STARTED|2-week, Single-blind Run In Period||0
10516112|NCT01323621|11667238|FG002|STARTED|2-week, Single-blind Run In Period||0
10516113|NCT01323621|11667236|FG000|COMPLETED|2-week, Single-blind Run In Period||511
10516114|NCT01323621|11667237|FG001|COMPLETED|2-week, Single-blind Run In Period||0
10516115|NCT01323621|11667238|FG002|COMPLETED|2-week, Single-blind Run In Period||0
10516116|NCT01323621|11667236|FG000|NOT COMPLETED|2-week, Single-blind Run In Period||228
10516117|NCT01323621|11667237|FG001|NOT COMPLETED|2-week, Single-blind Run In Period||0
10516118|NCT01323621|11667238|FG002|NOT COMPLETED|2-week, Single-blind Run In Period||0
10516119|NCT01323621|11667236|FG000|STARTED|12-week, Double-blind Treatment Period||0
10516120|NCT01323621|11667237|FG001|STARTED|12-week, Double-blind Treatment Period||252
10516121|NCT01323621|11667238|FG002|STARTED|12-week, Double-blind Treatment Period||259
10516122|NCT01323621|11667236|FG000|COMPLETED|12-week, Double-blind Treatment Period||0
10516123|NCT01323621|11667237|FG001|COMPLETED|12-week, Double-blind Treatment Period||237
10516124|NCT01323621|11667238|FG002|COMPLETED|12-week, Double-blind Treatment Period||239
10516125|NCT01323621|11667236|FG000|NOT COMPLETED|12-week, Double-blind Treatment Period||0
10516126|NCT01323621|11667237|FG001|NOT COMPLETED|12-week, Double-blind Treatment Period||15
10516127|NCT01323621|11667238|FG002|NOT COMPLETED|12-week, Double-blind Treatment Period||20
10516128|NCT01323634|11667246|FG000|STARTED|2-week Run-in Period||733
10516129|NCT01323634|11667247|FG001|STARTED|2-week Run-in Period||0
10516130|NCT01323634|11667248|FG002|STARTED|2-week Run-in Period||0
10516131|NCT01323634|11667246|FG000|COMPLETED|2-week Run-in Period||521
10516132|NCT01323634|11667247|FG001|COMPLETED|2-week Run-in Period||0
10516133|NCT01323634|11667248|FG002|COMPLETED|2-week Run-in Period||0
10516134|NCT01323634|11667246|FG000|NOT COMPLETED|2-week Run-in Period||212
10516135|NCT01323634|11667247|FG001|NOT COMPLETED|2-week Run-in Period||0
10516136|NCT01323634|11667248|FG002|NOT COMPLETED|2-week Run-in Period||0
10516137|NCT01323634|11667246|FG000|STARTED|Double-Blind (DB) Treatment Period||0
10516138|NCT01323634|11667247|FG001|STARTED|Double-Blind (DB) Treatment Period||260
10516139|NCT01323634|11667248|FG002|STARTED|Double-Blind (DB) Treatment Period||261
10516140|NCT01323634|11667246|FG000|COMPLETED|Double-Blind (DB) Treatment Period||0
10516141|NCT01323634|11667247|FG001|COMPLETED|Double-Blind (DB) Treatment Period||235
10711605|NCT02661178|11877041|FG007|COMPLETED|Part 1||6
10516142|NCT01323634|11667248|FG002|COMPLETED|Double-Blind (DB) Treatment Period||239
10516143|NCT01323634|11667246|FG000|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
10516144|NCT01323634|11667247|FG001|NOT COMPLETED|Double-Blind (DB) Treatment Period||25
10516145|NCT01323634|11667248|FG002|NOT COMPLETED|Double-Blind (DB) Treatment Period||22
10516146|NCT01323647|11667256|FG000|STARTED|Overall Study||470
10516147|NCT01323647|11667257|FG001|STARTED|Overall Study||487
10516148|NCT01323647|11667256|FG000|COMPLETED|Overall Study||461
10516149|NCT01323647|11667257|FG001|COMPLETED|Overall Study||487
10516150|NCT01323647|11667256|FG000|NOT COMPLETED|Overall Study||9
10711606|NCT02661178|11877042|FG008|COMPLETED|Part 1||6
10516151|NCT01323647|11667257|FG001|NOT COMPLETED|Overall Study||0
10516152|NCT01323660|11667263|FG000|STARTED|Treatment Period 1 (12 Weeks)||84
10516153|NCT01323660|11667264|FG001|STARTED|Treatment Period 1 (12 Weeks)||22
10516154|NCT01323660|11667265|FG002|STARTED|Treatment Period 1 (12 Weeks)||24
10516155|NCT01323660|11667266|FG003|STARTED|Treatment Period 1 (12 Weeks)||36
10516156|NCT01323660|11667267|FG004|STARTED|Treatment Period 1 (12 Weeks)||71
10516157|NCT01323660|11667268|FG005|STARTED|Treatment Period 1 (12 Weeks)||70
10516158|NCT01323660|11667263|FG000|COMPLETED|Treatment Period 1 (12 Weeks)||65
10516159|NCT01323660|11667264|FG001|COMPLETED|Treatment Period 1 (12 Weeks)||21
10516160|NCT01323660|11667265|FG002|COMPLETED|Treatment Period 1 (12 Weeks)||19
10516161|NCT01323660|11667266|FG003|COMPLETED|Treatment Period 1 (12 Weeks)||31
10516162|NCT01323660|11667267|FG004|COMPLETED|Treatment Period 1 (12 Weeks)||61
10516163|NCT01323660|11667268|FG005|COMPLETED|Treatment Period 1 (12 Weeks)||61
10516164|NCT01323660|11667263|FG000|NOT COMPLETED|Treatment Period 1 (12 Weeks)||19
10516165|NCT01323660|11667264|FG001|NOT COMPLETED|Treatment Period 1 (12 Weeks)||1
10516166|NCT01323660|11667265|FG002|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
10516167|NCT01323660|11667266|FG003|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
10516168|NCT01323660|11667267|FG004|NOT COMPLETED|Treatment Period 1 (12 Weeks)||10
10516169|NCT01323660|11667268|FG005|NOT COMPLETED|Treatment Period 1 (12 Weeks)||9
10516170|NCT01323660|11667263|FG000|STARTED|Washout Period (14 Days)||65
10516171|NCT01323660|11667264|FG001|STARTED|Washout Period (14 Days)||21
10516172|NCT01323660|11667265|FG002|STARTED|Washout Period (14 Days)||19
10516173|NCT01323660|11667266|FG003|STARTED|Washout Period (14 Days)||31
10516174|NCT01323660|11667267|FG004|STARTED|Washout Period (14 Days)||61
10516175|NCT01323660|11667268|FG005|STARTED|Washout Period (14 Days)||61
10516176|NCT01323660|11667263|FG000|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|65
10516177|NCT01323660|11667264|FG001|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
10516178|NCT01323660|11667265|FG002|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
10516179|NCT01323660|11667266|FG003|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|28
10516180|NCT01323660|11667267|FG004|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|58
10516181|NCT01323660|11667268|FG005|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|59
10516182|NCT01323660|11667263|FG000|NOT COMPLETED|Washout Period (14 Days)||0
10516183|NCT01323660|11667264|FG001|NOT COMPLETED|Washout Period (14 Days)||0
10516184|NCT01323660|11667265|FG002|NOT COMPLETED|Washout Period (14 Days)||1
10516185|NCT01323660|11667266|FG003|NOT COMPLETED|Washout Period (14 Days)||3
10516186|NCT01323660|11667267|FG004|NOT COMPLETED|Washout Period (14 Days)||3
10516187|NCT01323660|11667268|FG005|NOT COMPLETED|Washout Period (14 Days)||2
10516188|NCT01323660|11667263|FG000|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|67
10516189|NCT01323660|11667264|FG001|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|18
10516190|NCT01323660|11667265|FG002|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|17
10516191|NCT01323660|11667266|FG003|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|28
10516192|NCT01323660|11667267|FG004|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|59
10516193|NCT01323660|11667268|FG005|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|58
10516194|NCT01323660|11667263|FG000|COMPLETED|Treatment Period 2 (12 Weeks)||55
10516195|NCT01323660|11667264|FG001|COMPLETED|Treatment Period 2 (12 Weeks)||17
10516196|NCT01323660|11667265|FG002|COMPLETED|Treatment Period 2 (12 Weeks)||14
10516197|NCT01323660|11667266|FG003|COMPLETED|Treatment Period 2 (12 Weeks)||25
10516198|NCT01323660|11667267|FG004|COMPLETED|Treatment Period 2 (12 Weeks)||55
10516199|NCT01323660|11667268|FG005|COMPLETED|Treatment Period 2 (12 Weeks)||51
10516200|NCT01323660|11667263|FG000|NOT COMPLETED|Treatment Period 2 (12 Weeks)||12
10516201|NCT01323660|11667264|FG001|NOT COMPLETED|Treatment Period 2 (12 Weeks)||1
10516202|NCT01323660|11667265|FG002|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
10516203|NCT01323660|11667266|FG003|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
10516204|NCT01323660|11667267|FG004|NOT COMPLETED|Treatment Period 2 (12 Weeks)||4
10516205|NCT01323660|11667268|FG005|NOT COMPLETED|Treatment Period 2 (12 Weeks)||7
10516206|NCT01323673|11667284|FG000|STARTED|Overall Study||62
10516207|NCT01323673|11667285|FG001|STARTED|Overall Study||63
10516208|NCT01323673|11667284|FG000|COMPLETED|Overall Study||59
10516209|NCT01323673|11667285|FG001|COMPLETED|Overall Study||58
10516210|NCT01323673|11667284|FG000|NOT COMPLETED|Overall Study||3
10516211|NCT01323673|11667285|FG001|NOT COMPLETED|Overall Study||5
10516212|NCT01323777|11667291|FG000|STARTED|Overall Study||65
10516213|NCT01323777|11667291|FG000|COMPLETED|Overall Study||65
10516214|NCT01323777|11667291|FG000|NOT COMPLETED|Overall Study||0
10516215|NCT01323790|11667305|FG000|STARTED|Overall Study||233
10516216|NCT01323790|11667306|FG001|STARTED|Overall Study||234
10516217|NCT01323790|11667307|FG002|STARTED|Overall Study||233
10516218|NCT01323790|11667305|FG000|COMPLETED|Overall Study||178
10516219|NCT01323790|11667306|FG001|COMPLETED|Overall Study||174
10516220|NCT01323790|11667307|FG002|COMPLETED|Overall Study||188
10516221|NCT01323790|11667305|FG000|NOT COMPLETED|Overall Study||55
10516222|NCT01323790|11667306|FG001|NOT COMPLETED|Overall Study||60
10516223|NCT01323790|11667307|FG002|NOT COMPLETED|Overall Study||45
10516224|NCT01323855|11667320|FG000|STARTED|Overall Study||9
10516225|NCT01323855|11667321|FG001|STARTED|Overall Study||9
10516226|NCT01323855|11667322|FG002|STARTED|Overall Study||8
10516227|NCT01323855|11667323|FG003|STARTED|Overall Study||9
10516228|NCT01323855|11667324|FG004|STARTED|Overall Study||11
10516229|NCT01323855|11667320|FG000|COMPLETED|Overall Study||9
10516230|NCT01323855|11667321|FG001|COMPLETED|Overall Study||9
10516231|NCT01323855|11667322|FG002|COMPLETED|Overall Study||8
10516232|NCT01323855|11667323|FG003|COMPLETED|Overall Study||9
10516233|NCT01323855|11667324|FG004|COMPLETED|Overall Study||11
10516234|NCT01323855|11667320|FG000|NOT COMPLETED|Overall Study||0
10516235|NCT01323855|11667321|FG001|NOT COMPLETED|Overall Study||0
10516236|NCT01323855|11667322|FG002|NOT COMPLETED|Overall Study||0
10516237|NCT01323855|11667323|FG003|NOT COMPLETED|Overall Study||0
10516238|NCT01323855|11667324|FG004|NOT COMPLETED|Overall Study||0
10516239|NCT01323920|11667336|FG000|STARTED|Overall Study||35
10516240|NCT01323920|11667336|FG000|COMPLETED|Overall Study||29
10516241|NCT01323920|11667336|FG000|NOT COMPLETED|Overall Study||6
10528590|NCT01395888|11680903|FG001|STARTED|Treatment Period (TP)||127
10528591|NCT01395888|11680904|FG002|STARTED|Treatment Period (TP)||130
10528592|NCT01395888|11680902|FG000|Completed the Treatment Period|Treatment Period (TP)||0
10528593|NCT01395888|11680903|FG001|Completed the Treatment Period|Treatment Period (TP)|Participants were considered to have completed the TP if they attended Visit 5 (Week 12).|112
10528594|NCT01395888|11680904|FG002|Completed the Treatment Period|Treatment Period (TP)|Participants were considered to have completed the TP if they attended Visit 5 (Week 12).|113
10528595|NCT01395888|11680902|FG000|COMPLETED|Treatment Period (TP)||0
10528596|NCT01395888|11680903|FG001|COMPLETED|Treatment Period (TP)|Par. completed the study if they completed the TP and a safety follow-up phone contact 1 week later.|112
10528597|NCT01395888|11680904|FG002|COMPLETED|Treatment Period (TP)|Par. completed the study if they completed the TP and a safety follow-up phone contact 1 week later.|113
10528598|NCT01395888|11680902|FG000|NOT COMPLETED|Treatment Period (TP)||0
10528599|NCT01395888|11680903|FG001|NOT COMPLETED|Treatment Period (TP)||15
10528600|NCT01395888|11680904|FG002|NOT COMPLETED|Treatment Period (TP)||17
10528601|NCT01395901|11680912|FG000|STARTED|Overall Study|Randomized Population|336
10528602|NCT01395901|11680913|FG001|STARTED|Overall Study|Randomized Population|334
10528603|NCT01395901|11680912|FG000|COMPLETED|Overall Study|Treated patients completing the study|326
10528604|NCT01395901|11680913|FG001|COMPLETED|Overall Study|Treated patients completing the study|329
10528605|NCT01395901|11680912|FG000|NOT COMPLETED|Overall Study||10
10528606|NCT01395901|11680913|FG001|NOT COMPLETED|Overall Study||5
10528607|NCT01395914|11680921|FG000|STARTED|Overall Study||345
10528608|NCT01395914|11680922|FG001|STARTED|Overall Study||168
10528609|NCT01395914|11680921|FG000|ITT Population|Overall Study||345
10528610|NCT01395914|11680922|FG001|ITT Population|Overall Study||168
10528611|NCT01395914|11680921|FG000|Safety Population|Overall Study||343
10528612|NCT01395914|11680922|FG001|Safety Population|Overall Study||167
10528613|NCT01395914|11680921|FG000|COMPLETED|Overall Study||273
10528614|NCT01395914|11680922|FG001|COMPLETED|Overall Study||131
10528615|NCT01395914|11680921|FG000|NOT COMPLETED|Overall Study||72
10528616|NCT01395914|11680922|FG001|NOT COMPLETED|Overall Study||37
10528617|NCT01395966|11680931|FG000|STARTED|Overall Study||109
10528618|NCT01395966|11680932|FG001|STARTED|Overall Study||110
10711607|NCT02661178|11877043|FG009|COMPLETED|Part 1||12
10711608|NCT02661178|11877044|FG010|COMPLETED|Part 1||4
10711609|NCT02661178|11877045|FG011|COMPLETED|Part 1||0
10528619|NCT01395966|11680933|FG002|STARTED|Overall Study||112
10528620|NCT01395966|11680931|FG000|COMPLETED|Overall Study||99
10528621|NCT01395966|11680932|FG001|COMPLETED|Overall Study||91
10528622|NCT01395966|11680933|FG002|COMPLETED|Overall Study||104
10528623|NCT01395966|11680931|FG000|NOT COMPLETED|Overall Study||10
10528624|NCT01395966|11680932|FG001|NOT COMPLETED|Overall Study||19
10528625|NCT01395966|11680933|FG002|NOT COMPLETED|Overall Study||8
10528626|NCT01396005|11680943|FG000|STARTED|Overall Study||10
10528627|NCT01396005|11680944|FG001|STARTED|Overall Study||11
10528628|NCT01396005|11680943|FG000|COMPLETED|Overall Study||10
10528629|NCT01396005|11680944|FG001|COMPLETED|Overall Study||9
10528630|NCT01396005|11680943|FG000|NOT COMPLETED|Overall Study||0
10528631|NCT01396005|11680944|FG001|NOT COMPLETED|Overall Study||2
10528632|NCT01396044|11680954|FG000|STARTED|Overall Study||125
10528633|NCT01396044|11680955|FG001|STARTED|Overall Study||171
10528634|NCT01396044|11680954|FG000|COMPLETED|Overall Study||125
10528635|NCT01396044|11680955|FG001|COMPLETED|Overall Study||171
10528636|NCT01396044|11680954|FG000|NOT COMPLETED|Overall Study||0
10528637|NCT01396044|11680955|FG001|NOT COMPLETED|Overall Study||0
10528638|NCT01396057|11680963|FG000|STARTED|Overall Study||126
10528639|NCT01396057|11680964|FG001|STARTED|Overall Study||118
10528640|NCT01396057|11680963|FG000|COMPLETED|Overall Study||115
10528641|NCT01396057|11680964|FG001|COMPLETED|Overall Study||100
10711610|NCT02661178|11877046|FG012|COMPLETED|Part 1||0
10528642|NCT01396057|11680963|FG000|NOT COMPLETED|Overall Study||11
10528643|NCT01396057|11680964|FG001|NOT COMPLETED|Overall Study||18
10528644|NCT01396070|11680970|FG000|STARTED|Overall Study||36
10528645|NCT01396070|11680970|FG000|COMPLETED|Overall Study||17
10528646|NCT01396070|11680970|FG000|NOT COMPLETED|Overall Study||19
10528647|NCT01396083|11680977|FG000|STARTED|Overall Study||124
10528648|NCT01396083|11680978|FG001|STARTED|Overall Study||119
10528649|NCT01396083|11680977|FG000|COMPLETED|Overall Study||113
10528650|NCT01396083|11680978|FG001|COMPLETED|Overall Study||72
10528651|NCT01396083|11680977|FG000|NOT COMPLETED|Overall Study||11
10711611|NCT02661178|11877047|FG013|COMPLETED|Part 1||0
10516242|NCT01323946|11667343|FG000|STARTED|Overall Study||46
10516243|NCT01323946|11667344|FG001|STARTED|Overall Study||34
10516244|NCT01323946|11667345|FG002|STARTED|Overall Study||33
10516245|NCT01323946|11667343|FG000|COMPLETED|Overall Study||43
10516246|NCT01323946|11667344|FG001|COMPLETED|Overall Study||31
10516247|NCT01323946|11667345|FG002|COMPLETED|Overall Study||33
10516248|NCT01323946|11667343|FG000|NOT COMPLETED|Overall Study||3
10516249|NCT01323946|11667344|FG001|NOT COMPLETED|Overall Study||3
10516250|NCT01323946|11667345|FG002|NOT COMPLETED|Overall Study||0
10516251|NCT01323959|11667358|FG000|STARTED|Overall Study||67
10516252|NCT01323959|11667359|FG001|STARTED|Overall Study||72
10516253|NCT01323959|11667360|FG002|STARTED|Overall Study||72
10516254|NCT01323959|11667358|FG000|COMPLETED|Overall Study||67
10516255|NCT01323959|11667359|FG001|COMPLETED|Overall Study||72
10516256|NCT01323959|11667360|FG002|COMPLETED|Overall Study||72
10711612|NCT02661178|11877048|FG014|COMPLETED|Part 1||0
10711613|NCT02661178|11877034|FG000|NOT COMPLETED|Part 1||1
10711614|NCT02661178|11877035|FG001|NOT COMPLETED|Part 1||0
10711615|NCT02661178|11877036|FG002|NOT COMPLETED|Part 1||0
10711616|NCT02661178|11877037|FG003|NOT COMPLETED|Part 1||0
10711617|NCT02661178|11877038|FG004|NOT COMPLETED|Part 1||0
10711618|NCT02661178|11877039|FG005|NOT COMPLETED|Part 1||0
10711619|NCT02661178|11877040|FG006|NOT COMPLETED|Part 1||0
10516257|NCT01323959|11667358|FG000|NOT COMPLETED|Overall Study||0
10516258|NCT01323959|11667359|FG001|NOT COMPLETED|Overall Study||0
10516259|NCT01323959|11667360|FG002|NOT COMPLETED|Overall Study||0
10516260|NCT01323972|11667372|FG000|STARTED|Overall Study||81
10516261|NCT01323972|11667373|FG001|STARTED|Overall Study||79
10516262|NCT01323972|11667374|FG002|STARTED|Overall Study||80
10711620|NCT02661178|11877041|FG007|NOT COMPLETED|Part 1||0
10711621|NCT02661178|11877042|FG008|NOT COMPLETED|Part 1||0
10711622|NCT02661178|11877043|FG009|NOT COMPLETED|Part 1||0
10711623|NCT02661178|11877044|FG010|NOT COMPLETED|Part 1||0
10711624|NCT02661178|11877045|FG011|NOT COMPLETED|Part 1||0
10711625|NCT02661178|11877046|FG012|NOT COMPLETED|Part 1||0
10516263|NCT01323972|11667375|FG003|STARTED|Overall Study||80
10516264|NCT01323972|11667372|FG000|COMPLETED|Overall Study||79
10516265|NCT01323972|11667373|FG001|COMPLETED|Overall Study||76
10516266|NCT01323972|11667374|FG002|COMPLETED|Overall Study||78
10516267|NCT01323972|11667375|FG003|COMPLETED|Overall Study||79
10516268|NCT01323972|11667372|FG000|NOT COMPLETED|Overall Study||2
10516269|NCT01323972|11667373|FG001|NOT COMPLETED|Overall Study||3
10516270|NCT01323972|11667374|FG002|NOT COMPLETED|Overall Study||2
10516271|NCT01323972|11667375|FG003|NOT COMPLETED|Overall Study||1
10516272|NCT01323998|11667392|FG000|STARTED|Overall Study||200631
10516273|NCT01323998|11667393|FG001|STARTED|Overall Study||18681
10516274|NCT01323998|11667394|FG002|STARTED|Overall Study||10294
10516275|NCT01323998|11667395|FG003|STARTED|Overall Study||12052
10516276|NCT01323998|11667396|FG004|STARTED|Overall Study||6735
10516277|NCT01323998|11667392|FG000|COMPLETED|Overall Study||200631
10516278|NCT01323998|11667393|FG001|COMPLETED|Overall Study||18681
10516279|NCT01323998|11667394|FG002|COMPLETED|Overall Study||10294
10516280|NCT01323998|11667395|FG003|COMPLETED|Overall Study||12052
10516281|NCT01323998|11667396|FG004|COMPLETED|Overall Study||6735
10516282|NCT01323998|11667392|FG000|NOT COMPLETED|Overall Study||0
10516283|NCT01323998|11667393|FG001|NOT COMPLETED|Overall Study||0
10516284|NCT01323998|11667394|FG002|NOT COMPLETED|Overall Study||0
10516285|NCT01323998|11667395|FG003|NOT COMPLETED|Overall Study||0
10516286|NCT01323998|11667396|FG004|NOT COMPLETED|Overall Study||0
10516287|NCT01324024|11667408|FG000|STARTED|First Intervention (4 Weeks)||18
10516288|NCT01324024|11667409|FG001|STARTED|First Intervention (4 Weeks)||17
10516289|NCT01324024|11667408|FG000|COMPLETED|First Intervention (4 Weeks)||18
10516290|NCT01324024|11667409|FG001|COMPLETED|First Intervention (4 Weeks)||17
10516291|NCT01324024|11667408|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
10516292|NCT01324024|11667409|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
10516293|NCT01324024|11667408|FG000|STARTED|Washout (2 Weeks)||18
10516294|NCT01324024|11667409|FG001|STARTED|Washout (2 Weeks)||17
10516295|NCT01324024|11667408|FG000|COMPLETED|Washout (2 Weeks)||18
10516296|NCT01324024|11667409|FG001|COMPLETED|Washout (2 Weeks)||17
10516297|NCT01324024|11667408|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10516298|NCT01324024|11667409|FG001|NOT COMPLETED|Washout (2 Weeks)||0
10516299|NCT01324024|11667408|FG000|STARTED|Second Intervention (4 Weeks)||18
10516300|NCT01324024|11667409|FG001|STARTED|Second Intervention (4 Weeks)||17
10711626|NCT02661178|11877047|FG013|NOT COMPLETED|Part 1||0
10711627|NCT02661178|11877048|FG014|NOT COMPLETED|Part 1||0
10711628|NCT02661178|11877034|FG000|STARTED|Part 2||0
10711629|NCT02661178|11877035|FG001|STARTED|Part 2||0
10711630|NCT02661178|11877036|FG002|STARTED|Part 2||0
10711631|NCT02661178|11877037|FG003|STARTED|Part 2||0
10711632|NCT02661178|11877038|FG004|STARTED|Part 2||0
10711633|NCT02661178|11877039|FG005|STARTED|Part 2||0
10516301|NCT01324024|11667408|FG000|COMPLETED|Second Intervention (4 Weeks)||16
10516302|NCT01324024|11667409|FG001|COMPLETED|Second Intervention (4 Weeks)||16
10516303|NCT01324024|11667408|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||2
10516304|NCT01324024|11667409|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1
10516305|NCT01324102|11667421|FG000|STARTED|Overall Study|Yoga groups 3 and 5 (not including pre-randomization group)|11
10516306|NCT01324102|11667422|FG001|STARTED|Overall Study|Yoga group 4 and 6|12
10516307|NCT01324102|11667421|FG000|COMPLETED|Overall Study||10
10516308|NCT01324102|11667422|FG001|COMPLETED|Overall Study||6
10516309|NCT01324102|11667421|FG000|NOT COMPLETED|Overall Study||1
10711634|NCT02661178|11877040|FG006|STARTED|Part 2||0
10711635|NCT02661178|11877041|FG007|STARTED|Part 2||0
10516310|NCT01324102|11667422|FG001|NOT COMPLETED|Overall Study||6
10516311|NCT01324128|11667431|FG000|STARTED|Stage 1||710
10516312|NCT01324128|11667432|FG001|STARTED|Stage 1||349
10516313|NCT01324128|11667433|FG002|STARTED|Stage 1||0
10516314|NCT01324128|11667434|FG003|STARTED|Stage 1||0
10516315|NCT01324128|11667431|FG000|COMPLETED|Stage 1||515
10516316|NCT01324128|11667432|FG001|COMPLETED|Stage 1||293
10516317|NCT01324128|11667433|FG002|COMPLETED|Stage 1||0
10516318|NCT01324128|11667434|FG003|COMPLETED|Stage 1||0
10516319|NCT01324128|11667431|FG000|NOT COMPLETED|Stage 1||195
10516320|NCT01324128|11667432|FG001|NOT COMPLETED|Stage 1||56
10516321|NCT01324128|11667433|FG002|NOT COMPLETED|Stage 1||0
10516322|NCT01324128|11667434|FG003|NOT COMPLETED|Stage 1||0
10516323|NCT01324128|11667431|FG000|STARTED|Stage 2||0
10516324|NCT01324128|11667432|FG001|STARTED|Stage 2||0
10516325|NCT01324128|11667433|FG002|STARTED|Stage 2||50
10516326|NCT01324128|11667434|FG003|STARTED|Stage 2||49
10516327|NCT01324128|11667431|FG000|COMPLETED|Stage 2||0
10516328|NCT01324128|11667432|FG001|COMPLETED|Stage 2||0
10516329|NCT01324128|11667433|FG002|COMPLETED|Stage 2||42
10516330|NCT01324128|11667434|FG003|COMPLETED|Stage 2||46
10516331|NCT01324128|11667431|FG000|NOT COMPLETED|Stage 2||0
10516332|NCT01324128|11667432|FG001|NOT COMPLETED|Stage 2||0
10516333|NCT01324128|11667433|FG002|NOT COMPLETED|Stage 2||8
10516334|NCT01324128|11667434|FG003|NOT COMPLETED|Stage 2||3
10516335|NCT01324141|11667444|FG000|STARTED|Overall Study||6
10516336|NCT01324141|11667444|FG000|COMPLETED|Overall Study||4
10516337|NCT01324141|11667444|FG000|NOT COMPLETED|Overall Study||2
10516338|NCT01324232|11667462|FG000|STARTED|Overall Study||49
10516339|NCT01324232|11667463|FG001|STARTED|Overall Study||53
10516340|NCT01324232|11667464|FG002|STARTED|Overall Study||54
10516341|NCT01324232|11667465|FG003|STARTED|Overall Study||53
10516342|NCT01324232|11667462|FG000|COMPLETED|Overall Study||44
10516343|NCT01324232|11667463|FG001|COMPLETED|Overall Study||42
10516344|NCT01324232|11667464|FG002|COMPLETED|Overall Study||41
10516345|NCT01324232|11667465|FG003|COMPLETED|Overall Study||42
10516346|NCT01324232|11667462|FG000|NOT COMPLETED|Overall Study||5
10516347|NCT01324232|11667463|FG001|NOT COMPLETED|Overall Study||11
10516348|NCT01324232|11667464|FG002|NOT COMPLETED|Overall Study||13
10516349|NCT01324232|11667465|FG003|NOT COMPLETED|Overall Study||11
10516350|NCT01324271|11667480|FG000|STARTED|Overall Study||57
10516351|NCT01324271|11667481|FG001|STARTED|Overall Study||28
10516352|NCT01324271|11667480|FG000|COMPLETED|Overall Study||53
10516353|NCT01324271|11667481|FG001|COMPLETED|Overall Study||28
10516354|NCT01324271|11667480|FG000|NOT COMPLETED|Overall Study||4
10516355|NCT01324271|11667481|FG001|NOT COMPLETED|Overall Study||0
10516356|NCT01324310|11667487|FG000|STARTED|Overall Study||15
10516357|NCT01324310|11667487|FG000|COMPLETED|Overall Study||13
10516358|NCT01324310|11667487|FG000|NOT COMPLETED|Overall Study||2
10516359|NCT01324323|11667493|FG000|STARTED|Overall Study||14
10516360|NCT01324323|11667493|FG000|COMPLETED|Overall Study||13
10516361|NCT01324323|11667493|FG000|NOT COMPLETED|Overall Study||1
10516362|NCT01324349|11667507|FG000|STARTED|Overall Study||32
10516363|NCT01324349|11667508|FG001|STARTED|Overall Study||18
10516364|NCT01324349|11667507|FG000|COMPLETED|Overall Study||31
10516365|NCT01324349|11667508|FG001|COMPLETED|Overall Study||16
10516366|NCT01324349|11667507|FG000|NOT COMPLETED|Overall Study||1
10516367|NCT01324349|11667508|FG001|NOT COMPLETED|Overall Study||2
10516368|NCT01324388|11667517|FG000|STARTED|Part 1 of Study||23
10516369|NCT01324388|11667518|FG001|STARTED|Part 1 of Study||8
10516370|NCT01324388|11667519|FG002|STARTED|Part 1 of Study||0
10516371|NCT01324388|11667520|FG003|STARTED|Part 1 of Study||0
10516372|NCT01324388|11667517|FG000|Received at Least 1 Dose|Part 1 of Study||23
10516373|NCT01324388|11667518|FG001|Received at Least 1 Dose|Part 1 of Study||8
10516374|NCT01324388|11667519|FG002|Received at Least 1 Dose|Part 1 of Study||0
10516375|NCT01324388|11667520|FG003|Received at Least 1 Dose|Part 1 of Study||0
10516376|NCT01324388|11667517|FG000|COMPLETED|Part 1 of Study||19
10516377|NCT01324388|11667518|FG001|COMPLETED|Part 1 of Study||6
10516378|NCT01324388|11667519|FG002|COMPLETED|Part 1 of Study||0
10516379|NCT01324388|11667520|FG003|COMPLETED|Part 1 of Study||0
10516380|NCT01324388|11667517|FG000|NOT COMPLETED|Part 1 of Study||4
10516381|NCT01324388|11667518|FG001|NOT COMPLETED|Part 1 of Study||2
10516382|NCT01324388|11667519|FG002|NOT COMPLETED|Part 1 of Study||0
10516383|NCT01324388|11667520|FG003|NOT COMPLETED|Part 1 of Study||0
10516384|NCT01324388|11667517|FG000|STARTED|Part 2 of Study: First Intervention||0
10516385|NCT01324388|11667518|FG001|STARTED|Part 2 of Study: First Intervention||0
10516386|NCT01324388|11667519|FG002|STARTED|Part 2 of Study: First Intervention||10
10516387|NCT01324388|11667520|FG003|STARTED|Part 2 of Study: First Intervention||10
10516388|NCT01324388|11667517|FG000|COMPLETED|Part 2 of Study: First Intervention||0
10516389|NCT01324388|11667518|FG001|COMPLETED|Part 2 of Study: First Intervention||0
10516390|NCT01324388|11667519|FG002|COMPLETED|Part 2 of Study: First Intervention||10
10516391|NCT01324388|11667520|FG003|COMPLETED|Part 2 of Study: First Intervention||9
10516392|NCT01324388|11667517|FG000|NOT COMPLETED|Part 2 of Study: First Intervention||0
10516393|NCT01324388|11667518|FG001|NOT COMPLETED|Part 2 of Study: First Intervention||0
10516394|NCT01324388|11667519|FG002|NOT COMPLETED|Part 2 of Study: First Intervention||0
10516395|NCT01324388|11667520|FG003|NOT COMPLETED|Part 2 of Study: First Intervention||1
10516396|NCT01324388|11667517|FG000|STARTED|Part 2: Washout of at Least 21 Days||0
10516397|NCT01324388|11667518|FG001|STARTED|Part 2: Washout of at Least 21 Days||0
10516398|NCT01324388|11667519|FG002|STARTED|Part 2: Washout of at Least 21 Days||10
10516399|NCT01324388|11667520|FG003|STARTED|Part 2: Washout of at Least 21 Days||9
10516400|NCT01324388|11667517|FG000|COMPLETED|Part 2: Washout of at Least 21 Days||0
10516401|NCT01324388|11667518|FG001|COMPLETED|Part 2: Washout of at Least 21 Days||0
10516402|NCT01324388|11667519|FG002|COMPLETED|Part 2: Washout of at Least 21 Days||10
10516403|NCT01324388|11667520|FG003|COMPLETED|Part 2: Washout of at Least 21 Days||9
10516404|NCT01324388|11667517|FG000|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
10516405|NCT01324388|11667518|FG001|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
10516406|NCT01324388|11667519|FG002|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
10516407|NCT01324388|11667520|FG003|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
10516408|NCT01324388|11667517|FG000|STARTED|Part 2 of Study: Second Intervention||0
10516409|NCT01324388|11667518|FG001|STARTED|Part 2 of Study: Second Intervention||0
10516410|NCT01324388|11667519|FG002|STARTED|Part 2 of Study: Second Intervention||10
10516411|NCT01324388|11667520|FG003|STARTED|Part 2 of Study: Second Intervention||9
10516412|NCT01324388|11667517|FG000|COMPLETED|Part 2 of Study: Second Intervention||0
10516413|NCT01324388|11667518|FG001|COMPLETED|Part 2 of Study: Second Intervention||0
10516414|NCT01324388|11667519|FG002|COMPLETED|Part 2 of Study: Second Intervention||9
10516415|NCT01324388|11667520|FG003|COMPLETED|Part 2 of Study: Second Intervention||9
10516416|NCT01324388|11667517|FG000|NOT COMPLETED|Part 2 of Study: Second Intervention||0
10516417|NCT01324388|11667518|FG001|NOT COMPLETED|Part 2 of Study: Second Intervention||0
10516418|NCT01324388|11667519|FG002|NOT COMPLETED|Part 2 of Study: Second Intervention||1
10516419|NCT01324388|11667520|FG003|NOT COMPLETED|Part 2 of Study: Second Intervention||0
10516420|NCT01324401|11667534|FG000|STARTED|Overall Study||4
10516421|NCT01324401|11667535|FG001|STARTED|Overall Study|3 excluded from ITT analysis: 1 screen fail, 2 voluntary withdrawal pre-treatment|26
10516422|NCT01324401|11667534|FG000|COMPLETED|Overall Study|one (1) could not tolerate minimum starting dose|3
10516423|NCT01324401|11667535|FG001|COMPLETED|Overall Study|three (3) unable to complete due to adverse events|20
10516424|NCT01324401|11667534|FG000|NOT COMPLETED|Overall Study||1
10516425|NCT01324401|11667535|FG001|NOT COMPLETED|Overall Study||6
10516426|NCT01324440|11667543|FG000|STARTED|Overall Study||32
10516427|NCT01324440|11667544|FG001|STARTED|Overall Study||32
10516428|NCT01324440|11667543|FG000|COMPLETED|Overall Study||32
10516429|NCT01324440|11667544|FG001|COMPLETED|Overall Study||31
10516430|NCT01324440|11667543|FG000|NOT COMPLETED|Overall Study||0
10516431|NCT01324440|11667544|FG001|NOT COMPLETED|Overall Study||1
10516432|NCT01324453|11667552|FG000|STARTED|Overall Study||54
10516433|NCT01324453|11667553|FG001|STARTED|Overall Study||49
10516434|NCT01324453|11667552|FG000|COMPLETED|Overall Study||54
10516435|NCT01324453|11667553|FG001|COMPLETED|Overall Study||49
10516436|NCT01324453|11667552|FG000|NOT COMPLETED|Overall Study||0
10516437|NCT01324453|11667553|FG001|NOT COMPLETED|Overall Study||0
10516438|NCT01324518|11667562|FG000|STARTED|Overall Study||33
10516439|NCT01324518|11667563|FG001|STARTED|Overall Study||33
10516440|NCT01324518|11667564|FG002|STARTED|Overall Study||34
10516441|NCT01324518|11667562|FG000|COMPLETED|Overall Study||28
10516442|NCT01324518|11667563|FG001|COMPLETED|Overall Study||30
10516443|NCT01324518|11667564|FG002|COMPLETED|Overall Study||33
10516444|NCT01324518|11667562|FG000|NOT COMPLETED|Overall Study||5
10516445|NCT01324518|11667563|FG001|NOT COMPLETED|Overall Study||3
10516446|NCT01324518|11667564|FG002|NOT COMPLETED|Overall Study||1
10516447|NCT01324570|11667574|FG000|STARTED|Overall Study||6
10516448|NCT01324570|11667575|FG001|STARTED|Overall Study||35
10516449|NCT01324570|11667574|FG000|COMPLETED|Overall Study||2
10516450|NCT01324570|11667575|FG001|COMPLETED|Overall Study||21
10516451|NCT01324570|11667574|FG000|NOT COMPLETED|Overall Study||4
10516452|NCT01324570|11667575|FG001|NOT COMPLETED|Overall Study||14
10516453|NCT01324622|11667585|FG000|STARTED|Overall Study||13
10516454|NCT01324622|11667586|FG001|STARTED|Overall Study||11
10516455|NCT01324622|11667585|FG000|COMPLETED|Overall Study||4
10516456|NCT01324622|11667586|FG001|COMPLETED|Overall Study||4
10516457|NCT01324622|11667585|FG000|NOT COMPLETED|Overall Study||9
10516458|NCT01324622|11667586|FG001|NOT COMPLETED|Overall Study||7
10516459|NCT01324687|11667595|FG000|STARTED|Overall Study||1058
10516460|NCT01324687|11667596|FG001|STARTED|Overall Study||494
10516461|NCT01324687|11667595|FG000|COMPLETED|Overall Study||1058
10516462|NCT01324687|11667596|FG001|COMPLETED|Overall Study||479
10516463|NCT01324687|11667595|FG000|NOT COMPLETED|Overall Study||0
10516464|NCT01324687|11667596|FG001|NOT COMPLETED|Overall Study||15
10516465|NCT01324700|11667606|FG000|STARTED|Overall Study||22
10516466|NCT01324700|11667607|FG001|STARTED|Overall Study||20
10516467|NCT01324700|11667608|FG002|STARTED|Overall Study||49
10516468|NCT01324700|11667609|FG003|STARTED|Overall Study||48
10516469|NCT01324700|11667606|FG000|COMPLETED|Overall Study||13
10516470|NCT01324700|11667607|FG001|COMPLETED|Overall Study||16
10516471|NCT01324700|11667608|FG002|COMPLETED|Overall Study||33
10516472|NCT01324700|11667609|FG003|COMPLETED|Overall Study||37
10516473|NCT01324700|11667606|FG000|NOT COMPLETED|Overall Study||9
10516474|NCT01324700|11667607|FG001|NOT COMPLETED|Overall Study||4
10516475|NCT01324700|11667608|FG002|NOT COMPLETED|Overall Study||16
10516476|NCT01324700|11667609|FG003|NOT COMPLETED|Overall Study||11
10516477|NCT01324830|11667638|FG000|STARTED|Overall Study||3
10516478|NCT01324830|11667639|FG001|STARTED|Overall Study||3
10516479|NCT01324830|11667640|FG002|STARTED|Overall Study||3
10516480|NCT01324830|11667641|FG003|STARTED|Overall Study||3
10516481|NCT01324830|11667642|FG004|STARTED|Overall Study||7
10516482|NCT01324830|11667643|FG005|STARTED|Overall Study||7
10516483|NCT01324830|11667644|FG006|STARTED|Overall Study||3
10516484|NCT01324830|11667645|FG007|STARTED|Overall Study||3
10516485|NCT01324830|11667646|FG008|STARTED|Overall Study||5
10516486|NCT01324830|11667647|FG009|STARTED|Overall Study||6
10516487|NCT01324830|11667648|FG010|STARTED|Overall Study||4
10516488|NCT01324830|11667649|FG011|STARTED|Overall Study||1
10516489|NCT01324830|11667650|FG012|STARTED|Overall Study||1
10516490|NCT01324830|11667651|FG013|STARTED|Overall Study||1
10516491|NCT01324830|11667652|FG014|STARTED|Overall Study||1
10516492|NCT01324830|11667653|FG015|STARTED|Overall Study||3
10516493|NCT01324830|11667654|FG016|STARTED|Overall Study||3
10516494|NCT01324830|11667655|FG017|STARTED|Overall Study||6
10516495|NCT01324830|11667656|FG018|STARTED|Overall Study||6
10516496|NCT01324830|11667638|FG000|COMPLETED|Overall Study||0
10516497|NCT01324830|11667639|FG001|COMPLETED|Overall Study||0
10516498|NCT01324830|11667640|FG002|COMPLETED|Overall Study||0
10516499|NCT01324830|11667641|FG003|COMPLETED|Overall Study||0
10516500|NCT01324830|11667642|FG004|COMPLETED|Overall Study||0
10516501|NCT01324830|11667643|FG005|COMPLETED|Overall Study||0
10516502|NCT01324830|11667644|FG006|COMPLETED|Overall Study||0
10516503|NCT01324830|11667645|FG007|COMPLETED|Overall Study||0
10516504|NCT01324830|11667646|FG008|COMPLETED|Overall Study||0
10516505|NCT01324830|11667647|FG009|COMPLETED|Overall Study||0
10516506|NCT01324830|11667648|FG010|COMPLETED|Overall Study||0
10516507|NCT01324830|11667649|FG011|COMPLETED|Overall Study||0
10516508|NCT01324830|11667650|FG012|COMPLETED|Overall Study||0
10516509|NCT01324830|11667651|FG013|COMPLETED|Overall Study||0
10516510|NCT01324830|11667652|FG014|COMPLETED|Overall Study||0
10516511|NCT01324830|11667653|FG015|COMPLETED|Overall Study||0
10516512|NCT01324830|11667654|FG016|COMPLETED|Overall Study||0
10516513|NCT01324830|11667655|FG017|COMPLETED|Overall Study||0
10516514|NCT01324830|11667656|FG018|COMPLETED|Overall Study||0
10516515|NCT01324830|11667638|FG000|NOT COMPLETED|Overall Study||3
10516516|NCT01324830|11667639|FG001|NOT COMPLETED|Overall Study||3
10516517|NCT01324830|11667640|FG002|NOT COMPLETED|Overall Study||3
10516518|NCT01324830|11667641|FG003|NOT COMPLETED|Overall Study||3
10516519|NCT01324830|11667642|FG004|NOT COMPLETED|Overall Study||7
10516520|NCT01324830|11667643|FG005|NOT COMPLETED|Overall Study||7
10516521|NCT01324830|11667644|FG006|NOT COMPLETED|Overall Study||3
10516522|NCT01324830|11667645|FG007|NOT COMPLETED|Overall Study||3
10516523|NCT01324830|11667646|FG008|NOT COMPLETED|Overall Study||5
10516524|NCT01324830|11667647|FG009|NOT COMPLETED|Overall Study||6
10516525|NCT01324830|11667648|FG010|NOT COMPLETED|Overall Study||4
10516526|NCT01324830|11667649|FG011|NOT COMPLETED|Overall Study||1
10516527|NCT01324830|11667650|FG012|NOT COMPLETED|Overall Study||1
10516528|NCT01324830|11667651|FG013|NOT COMPLETED|Overall Study||1
10516529|NCT01324830|11667652|FG014|NOT COMPLETED|Overall Study||1
10516530|NCT01324830|11667653|FG015|NOT COMPLETED|Overall Study||3
10516531|NCT01324830|11667654|FG016|NOT COMPLETED|Overall Study||3
10516532|NCT01324830|11667655|FG017|NOT COMPLETED|Overall Study||6
10516533|NCT01324830|11667656|FG018|NOT COMPLETED|Overall Study||6
10516534|NCT01324882|11667704|FG000|STARTED|Overall Study|27 patients were randomized to this arm.|27
10516535|NCT01324882|11667705|FG001|STARTED|Overall Study|30 patients were randomized to this arm|30
10516536|NCT01324882|11667704|FG000|COMPLETED|Overall Study|27 patients had the colonoscopy|27
10516537|NCT01324882|11667705|FG001|COMPLETED|Overall Study|30 patients had the colonoscopy|30
10516538|NCT01324882|11667704|FG000|NOT COMPLETED|Overall Study||0
10516539|NCT01324882|11667705|FG001|NOT COMPLETED|Overall Study||0
10516540|NCT01324947|11667713|FG000|STARTED|Overall Study||74
10516541|NCT01324947|11667713|FG000|Safety Population|Overall Study|Safety Population includes those who were enrolled and received at least one dose of study drug|73
10516542|NCT01324947|11667713|FG000|Efficacy Evaluable Population (EEP)|Overall Study|Participants who received ≥ 1 dose of study drug and had at least 1 postbaseline efficacy assessment|64
10516543|NCT01324947|11667713|FG000|COMPLETED|Overall Study||0
10516544|NCT01324947|11667713|FG000|NOT COMPLETED|Overall Study||74
10516545|NCT01324999|11667719|FG000|STARTED|Overall Study||12
10516546|NCT01324999|11667719|FG000|COMPLETED|Overall Study||7
10516547|NCT01324999|11667719|FG000|NOT COMPLETED|Overall Study||5
10516548|NCT01325181|11667725|FG000|STARTED|Overall Study||18
10516549|NCT01325181|11667726|FG001|STARTED|Overall Study||16
10516550|NCT01325181|11667725|FG000|COMPLETED|Overall Study||18
10516551|NCT01325181|11667726|FG001|COMPLETED|Overall Study||14
10516552|NCT01325181|11667725|FG000|NOT COMPLETED|Overall Study||0
10516553|NCT01325181|11667726|FG001|NOT COMPLETED|Overall Study||2
10516554|NCT01325207|11667738|FG000|STARTED|Completed 4 Weeks/1 Cycle of Treatment||3
10516555|NCT01325207|11667739|FG001|STARTED|Completed 4 Weeks/1 Cycle of Treatment||3
10516556|NCT01325207|11667740|FG002|STARTED|Completed 4 Weeks/1 Cycle of Treatment||1
10516557|NCT01325207|11667741|FG003|STARTED|Completed 4 Weeks/1 Cycle of Treatment||1
10516558|NCT01325207|11667742|FG004|STARTED|Completed 4 Weeks/1 Cycle of Treatment||7
10516559|NCT01325207|11667743|FG005|STARTED|Completed 4 Weeks/1 Cycle of Treatment||19
10516560|NCT01325207|11667738|FG000|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||3
10516561|NCT01325207|11667739|FG001|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||3
10516562|NCT01325207|11667740|FG002|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||1
10516563|NCT01325207|11667741|FG003|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||1
10516564|NCT01325207|11667742|FG004|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||5
10516565|NCT01325207|11667743|FG005|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||19
10516566|NCT01325207|11667738|FG000|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
10516567|NCT01325207|11667739|FG001|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
10516568|NCT01325207|11667740|FG002|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
10516569|NCT01325207|11667741|FG003|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
10516570|NCT01325207|11667742|FG004|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||2
10516571|NCT01325207|11667743|FG005|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
10516572|NCT01325207|11667738|FG000|STARTED|Completed 8 Weeks/2 Cycles of Treatment||3
10516573|NCT01325207|11667739|FG001|STARTED|Completed 8 Weeks/2 Cycles of Treatment||3
10516574|NCT01325207|11667740|FG002|STARTED|Completed 8 Weeks/2 Cycles of Treatment||1
10516575|NCT01325207|11667741|FG003|STARTED|Completed 8 Weeks/2 Cycles of Treatment||1
10516576|NCT01325207|11667742|FG004|STARTED|Completed 8 Weeks/2 Cycles of Treatment||5
10516577|NCT01325207|11667743|FG005|STARTED|Completed 8 Weeks/2 Cycles of Treatment||19
10516578|NCT01325207|11667738|FG000|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||2
10516579|NCT01325207|11667739|FG001|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||2
10516580|NCT01325207|11667740|FG002|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
10516581|NCT01325207|11667741|FG003|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
10516582|NCT01325207|11667742|FG004|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||3
10516583|NCT01325207|11667743|FG005|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||14
10516584|NCT01325207|11667738|FG000|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
10516585|NCT01325207|11667739|FG001|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
10516586|NCT01325207|11667740|FG002|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||0
10516587|NCT01325207|11667741|FG003|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||0
10516588|NCT01325207|11667742|FG004|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||2
10516589|NCT01325207|11667743|FG005|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||5
10516590|NCT01325207|11667738|FG000|STARTED|Started 9th Week/Cycle 3 of Treatment||2
10516591|NCT01325207|11667739|FG001|STARTED|Started 9th Week/Cycle 3 of Treatment||2
10516592|NCT01325207|11667740|FG002|STARTED|Started 9th Week/Cycle 3 of Treatment||1
10516593|NCT01325207|11667741|FG003|STARTED|Started 9th Week/Cycle 3 of Treatment||1
10516594|NCT01325207|11667742|FG004|STARTED|Started 9th Week/Cycle 3 of Treatment||3
10516595|NCT01325207|11667743|FG005|STARTED|Started 9th Week/Cycle 3 of Treatment||14
10516596|NCT01325207|11667738|FG000|COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
10516597|NCT01325207|11667739|FG001|COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
10516598|NCT01325207|11667740|FG002|COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
10516599|NCT01325207|11667741|FG003|COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
10516600|NCT01325207|11667742|FG004|COMPLETED|Started 9th Week/Cycle 3 of Treatment||3
10516601|NCT01325207|11667743|FG005|COMPLETED|Started 9th Week/Cycle 3 of Treatment||9
10516602|NCT01325207|11667738|FG000|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
10516603|NCT01325207|11667739|FG001|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||2
10516604|NCT01325207|11667740|FG002|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
10516605|NCT01325207|11667741|FG003|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
10516606|NCT01325207|11667742|FG004|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
10516607|NCT01325207|11667743|FG005|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||5
10516608|NCT01325207|11667738|FG000|STARTED|Follow-up Every 3 Months Until Death||3
10516609|NCT01325207|11667739|FG001|STARTED|Follow-up Every 3 Months Until Death||3
10516610|NCT01325207|11667740|FG002|STARTED|Follow-up Every 3 Months Until Death||1
10516611|NCT01325207|11667741|FG003|STARTED|Follow-up Every 3 Months Until Death||1
10516612|NCT01325207|11667742|FG004|STARTED|Follow-up Every 3 Months Until Death||7
10516613|NCT01325207|11667743|FG005|STARTED|Follow-up Every 3 Months Until Death||19
10516614|NCT01325207|11667738|FG000|COMPLETED|Follow-up Every 3 Months Until Death||3
10516615|NCT01325207|11667739|FG001|COMPLETED|Follow-up Every 3 Months Until Death||3
10516616|NCT01325207|11667740|FG002|COMPLETED|Follow-up Every 3 Months Until Death||1
10516617|NCT01325207|11667741|FG003|COMPLETED|Follow-up Every 3 Months Until Death||1
10516618|NCT01325207|11667742|FG004|COMPLETED|Follow-up Every 3 Months Until Death||6
10516619|NCT01325207|11667743|FG005|COMPLETED|Follow-up Every 3 Months Until Death||18
10516620|NCT01325207|11667738|FG000|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
10516621|NCT01325207|11667739|FG001|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
10516622|NCT01325207|11667740|FG002|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
10516623|NCT01325207|11667741|FG003|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
10516624|NCT01325207|11667742|FG004|NOT COMPLETED|Follow-up Every 3 Months Until Death||1
10516625|NCT01325207|11667743|FG005|NOT COMPLETED|Follow-up Every 3 Months Until Death||1
10516626|NCT01325311|11667760|FG000|STARTED|Overall Study||8
10516627|NCT01325311|11667761|FG001|STARTED|Overall Study||7
10516628|NCT01325311|11667760|FG000|COMPLETED|Overall Study||8
10516629|NCT01325311|11667761|FG001|COMPLETED|Overall Study||7
10516630|NCT01325311|11667760|FG000|NOT COMPLETED|Overall Study||0
10516631|NCT01325311|11667761|FG001|NOT COMPLETED|Overall Study||0
10516632|NCT01325337|11667772|FG000|STARTED|Overall Study||61
10516633|NCT01325337|11667773|FG001|STARTED|Overall Study||61
10516634|NCT01325337|11667774|FG002|STARTED|Overall Study||62
10516635|NCT01325337|11667775|FG003|STARTED|Overall Study||62
10516636|NCT01325337|11667776|FG004|STARTED|Overall Study||61
10516637|NCT01325337|11667772|FG000|COMPLETED|Overall Study||56
10516638|NCT01325337|11667773|FG001|COMPLETED|Overall Study||52
10516639|NCT01325337|11667774|FG002|COMPLETED|Overall Study||53
10516640|NCT01325337|11667775|FG003|COMPLETED|Overall Study||52
10516641|NCT01325337|11667776|FG004|COMPLETED|Overall Study||53
10516642|NCT01325337|11667772|FG000|NOT COMPLETED|Overall Study||5
10516643|NCT01325337|11667773|FG001|NOT COMPLETED|Overall Study||9
10516644|NCT01325337|11667774|FG002|NOT COMPLETED|Overall Study||9
10516645|NCT01325337|11667775|FG003|NOT COMPLETED|Overall Study||10
10516646|NCT01325337|11667776|FG004|NOT COMPLETED|Overall Study||8
10516647|NCT01325350|11667793|FG000|STARTED|Overall Study||61
10516648|NCT01325350|11667794|FG001|STARTED|Overall Study||61
10516649|NCT01325350|11667795|FG002|STARTED|Overall Study||61
10516650|NCT01325350|11667796|FG003|STARTED|Overall Study||61
10516651|NCT01325350|11667797|FG004|STARTED|Overall Study||62
10516652|NCT01325350|11667793|FG000|COMPLETED|Overall Study||55
10516653|NCT01325350|11667794|FG001|COMPLETED|Overall Study||56
10516654|NCT01325350|11667795|FG002|COMPLETED|Overall Study||44
10516655|NCT01325350|11667796|FG003|COMPLETED|Overall Study||52
10516656|NCT01325350|11667797|FG004|COMPLETED|Overall Study||50
10516657|NCT01325350|11667793|FG000|NOT COMPLETED|Overall Study||6
10516658|NCT01325350|11667794|FG001|NOT COMPLETED|Overall Study||5
10516659|NCT01325350|11667795|FG002|NOT COMPLETED|Overall Study||17
10516660|NCT01325350|11667796|FG003|NOT COMPLETED|Overall Study||9
10516661|NCT01325350|11667797|FG004|NOT COMPLETED|Overall Study||12
10516662|NCT01325428|11667809|FG000|STARTED|Part A||26
10516663|NCT01325428|11667809|FG000|COMPLETED|Part A||10
10516664|NCT01325428|11667809|FG000|NOT COMPLETED|Part A||16
10516665|NCT01325428|11667809|FG000|STARTED|Part B||10
10516666|NCT01325428|11667809|FG000|COMPLETED|Part B||7
10516667|NCT01325428|11667809|FG000|NOT COMPLETED|Part B||3
10516668|NCT01325493|11667820|FG000|STARTED|Overall Study||30
10516669|NCT01325493|11667821|FG001|STARTED|Overall Study||24
10516670|NCT01325493|11667820|FG000|COMPLETED|Overall Study||29
10516671|NCT01325493|11667821|FG001|COMPLETED|Overall Study||21
10516672|NCT01325493|11667820|FG000|NOT COMPLETED|Overall Study||1
10516673|NCT01325493|11667821|FG001|NOT COMPLETED|Overall Study||3
10516674|NCT01325532|11667829|FG000|STARTED|Overall Study||17
10516675|NCT01325532|11667830|FG001|STARTED|Overall Study||13
10516676|NCT01325532|11667829|FG000|COMPLETED|Overall Study||15
10516677|NCT01325532|11667830|FG001|COMPLETED|Overall Study||13
10516678|NCT01325532|11667829|FG000|NOT COMPLETED|Overall Study||2
10516679|NCT01325532|11667830|FG001|NOT COMPLETED|Overall Study||0
10516680|NCT01325584|11667836|FG000|STARTED|Overall Study||12
10516681|NCT01325584|11667836|FG000|COMPLETED|Overall Study||11
10516682|NCT01325584|11667836|FG000|NOT COMPLETED|Overall Study||1
10516683|NCT01325623|11667840|FG000|STARTED|Overall Study||31
10516684|NCT01325623|11667840|FG000|COMPLETED|Overall Study||28
10516685|NCT01325623|11667840|FG000|NOT COMPLETED|Overall Study||3
10516686|NCT01325701|11667879|FG000|STARTED|Overall Study||70
10516687|NCT01325701|11667880|FG001|STARTED|Overall Study||8
10516688|NCT01325701|11667879|FG000|COMPLETED|Overall Study||49
10516689|NCT01325701|11667880|FG001|COMPLETED|Overall Study||5
10516690|NCT01325701|11667879|FG000|NOT COMPLETED|Overall Study||21
10516691|NCT01325701|11667880|FG001|NOT COMPLETED|Overall Study||3
10516692|NCT01325714|11667889|FG000|STARTED|Overall Study||101
10516693|NCT01325714|11667890|FG001|STARTED|Overall Study||102
10516694|NCT01325714|11667889|FG000|3 Month Assessment|Overall Study||82
10516695|NCT01325714|11667890|FG001|3 Month Assessment|Overall Study||86
10516696|NCT01325714|11667889|FG000|6 Month Asessment|Overall Study||75
10516697|NCT01325714|11667890|FG001|6 Month Asessment|Overall Study||82
10516698|NCT01325714|11667889|FG000|12 Month Assessment|Overall Study||67
10516699|NCT01325714|11667890|FG001|12 Month Assessment|Overall Study||71
10516700|NCT01325714|11667889|FG000|COMPLETED|Overall Study||67
10516701|NCT01325714|11667890|FG001|COMPLETED|Overall Study||71
10516702|NCT01325714|11667889|FG000|NOT COMPLETED|Overall Study||34
10516703|NCT01325714|11667890|FG001|NOT COMPLETED|Overall Study||31
10516704|NCT01325792|11667898|FG000|STARTED|Overall Study||104
10516705|NCT01325792|11667898|FG000|COMPLETED|Overall Study||87
10516706|NCT01325792|11667898|FG000|NOT COMPLETED|Overall Study||17
10516707|NCT01325870|11667905|FG000|STARTED|Overall Study||18
10516708|NCT01325870|11667906|FG001|STARTED|Overall Study||16
10516709|NCT01325870|11667907|FG002|STARTED|Overall Study||14
10516710|NCT01325870|11667905|FG000|COMPLETED|Overall Study||7
10516711|NCT01325870|11667906|FG001|COMPLETED|Overall Study||3
10516712|NCT01325870|11667907|FG002|COMPLETED|Overall Study||6
10516713|NCT01325870|11667905|FG000|NOT COMPLETED|Overall Study||11
10516714|NCT01325870|11667906|FG001|NOT COMPLETED|Overall Study||13
10516715|NCT01325870|11667907|FG002|NOT COMPLETED|Overall Study||8
10516716|NCT01326026|11667917|FG000|STARTED|Overall Study||111
10516717|NCT01326026|11667918|FG001|STARTED|Overall Study||111
10516718|NCT01326026|11667917|FG000|Exposed|Overall Study|One subject withdrew before exposure to trial drug|110
10516719|NCT01326026|11667918|FG001|Exposed|Overall Study||111
10516720|NCT01326026|11667917|FG000|COMPLETED|Overall Study||99
10516721|NCT01326026|11667918|FG001|COMPLETED|Overall Study||98
10516722|NCT01326026|11667917|FG000|NOT COMPLETED|Overall Study||12
10516723|NCT01326026|11667918|FG001|NOT COMPLETED|Overall Study||13
10516724|NCT01326481|11667924|FG000|STARTED|7.5 mg/kg TRC105, 1000 mg/m2 Cape||4
10516725|NCT01326481|11667924|FG000|COMPLETED|7.5 mg/kg TRC105, 1000 mg/m2 Cape||3
10516726|NCT01326481|11667924|FG000|NOT COMPLETED|7.5 mg/kg TRC105, 1000 mg/m2 Cape||1
10516727|NCT01326481|11667924|FG000|STARTED|10 mg/kg TRC105, 1000 mg/m2 Cape||15
10516728|NCT01326481|11667924|FG000|COMPLETED|10 mg/kg TRC105, 1000 mg/m2 Cape||15
10516729|NCT01326481|11667924|FG000|NOT COMPLETED|10 mg/kg TRC105, 1000 mg/m2 Cape||0
10516730|NCT01326533|11667932|FG000|STARTED|Overall Study||17
10516731|NCT01326533|11667933|FG001|STARTED|Overall Study||15
10516732|NCT01326533|11667932|FG000|COMPLETED|Overall Study||13
10516733|NCT01326533|11667933|FG001|COMPLETED|Overall Study||15
10516734|NCT01326533|11667932|FG000|NOT COMPLETED|Overall Study||4
10516735|NCT01326533|11667933|FG001|NOT COMPLETED|Overall Study||0
10516736|NCT01326546|11667941|FG000|STARTED|Overall Study||189
10516737|NCT01326546|11667942|FG001|STARTED|Overall Study||189
10516738|NCT01326546|11667941|FG000|COMPLETED|Overall Study||172
10516739|NCT01326546|11667942|FG001|COMPLETED|Overall Study||176
10516740|NCT01326546|11667941|FG000|NOT COMPLETED|Overall Study||17
10516741|NCT01326546|11667942|FG001|NOT COMPLETED|Overall Study||13
10516742|NCT01326702|11667955|FG000|STARTED|Overall Study||3
10516743|NCT01326702|11667956|FG001|STARTED|Overall Study||3
10516744|NCT01326702|11667957|FG002|STARTED|Overall Study||6
10516745|NCT01326702|11667958|FG003|STARTED|Overall Study||4
10516746|NCT01326702|11667959|FG004|STARTED|Overall Study||5
10516747|NCT01326702|11667960|FG005|STARTED|Overall Study||15
10516748|NCT01326702|11667961|FG006|STARTED|Overall Study||7
10516749|NCT01326702|11667955|FG000|COMPLETED|Overall Study||1
10516750|NCT01326702|11667956|FG001|COMPLETED|Overall Study||1
10516751|NCT01326702|11667957|FG002|COMPLETED|Overall Study||1
10516752|NCT01326702|11667958|FG003|COMPLETED|Overall Study||1
10516753|NCT01326702|11667959|FG004|COMPLETED|Overall Study||1
10516754|NCT01326702|11667960|FG005|COMPLETED|Overall Study||7
10516755|NCT01326702|11667961|FG006|COMPLETED|Overall Study||0
10516756|NCT01326702|11667955|FG000|NOT COMPLETED|Overall Study||2
10516757|NCT01326702|11667956|FG001|NOT COMPLETED|Overall Study||2
10516758|NCT01326702|11667957|FG002|NOT COMPLETED|Overall Study||5
10516759|NCT01326702|11667958|FG003|NOT COMPLETED|Overall Study||3
10516760|NCT01326702|11667959|FG004|NOT COMPLETED|Overall Study||4
10516761|NCT01326702|11667960|FG005|NOT COMPLETED|Overall Study||8
10516762|NCT01326702|11667961|FG006|NOT COMPLETED|Overall Study||7
10516763|NCT01326728|11667982|FG000|STARTED|Overall Study||47
10516764|NCT01326728|11667983|FG001|STARTED|Overall Study||9
10516765|NCT01326728|11667982|FG000|COMPLETED|Overall Study||0
10516766|NCT01326728|11667983|FG001|COMPLETED|Overall Study||0
10516767|NCT01326728|11667982|FG000|NOT COMPLETED|Overall Study||47
10516768|NCT01326728|11667983|FG001|NOT COMPLETED|Overall Study||9
10516769|NCT01326780|11667992|FG000|STARTED|Overall Study||106
10516770|NCT01326780|11667993|FG001|STARTED|Overall Study||109
10516771|NCT01326780|11667994|FG002|STARTED|Overall Study||109
10516772|NCT01326780|11667995|FG003|STARTED|Overall Study||107
10516773|NCT01326780|11667992|FG000|COMPLETED|Overall Study||93
10516774|NCT01326780|11667993|FG001|COMPLETED|Overall Study||100
10516775|NCT01326780|11667994|FG002|COMPLETED|Overall Study||103
10516776|NCT01326780|11667995|FG003|COMPLETED|Overall Study||94
10516777|NCT01326780|11667992|FG000|NOT COMPLETED|Overall Study||13
10516778|NCT01326780|11667993|FG001|NOT COMPLETED|Overall Study||9
10516779|NCT01326780|11667994|FG002|NOT COMPLETED|Overall Study||6
10516780|NCT01326780|11667995|FG003|NOT COMPLETED|Overall Study||13
10516781|NCT01326910|11668007|FG000|STARTED|Overall Study||45
10516782|NCT01326910|11668008|FG001|STARTED|Overall Study||45
10516783|NCT01326910|11668007|FG000|COMPLETED|Overall Study||41
10516784|NCT01326910|11668008|FG001|COMPLETED|Overall Study||42
10516785|NCT01326910|11668007|FG000|NOT COMPLETED|Overall Study||4
10516786|NCT01326910|11668008|FG001|NOT COMPLETED|Overall Study||3
10516787|NCT01326962|11668014|FG000|STARTED|Overall Study||28
10516788|NCT01326962|11668014|FG000|COMPLETED|Overall Study||21
10516789|NCT01326962|11668014|FG000|NOT COMPLETED|Overall Study||7
10516790|NCT01327053|11668020|FG000|STARTED|Overall Study||79
10516791|NCT01327053|11668021|FG001|STARTED|Overall Study||151
10516792|NCT01327053|11668020|FG000|Untreated|Overall Study||0
10516793|NCT01327053|11668021|FG001|Untreated|Overall Study|one patient randomized to LDE225 (sonidegib) 800 mg did not receive study treatment|1
10516794|NCT01327053|11668020|FG000|Patients Cont. to Next Phase of Trial|Overall Study||52
10516795|NCT01327053|11668021|FG001|Patients Cont. to Next Phase of Trial|Overall Study||89
10516796|NCT01327053|11668020|FG000|Survival Follow-up|Overall Study||33
10516797|NCT01327053|11668021|FG001|Survival Follow-up|Overall Study||49
10516798|NCT01327053|11668020|FG000|Post-treatment Follow-up|Overall Study||19
10516799|NCT01327053|11668021|FG001|Post-treatment Follow-up|Overall Study||40
10516800|NCT01327053|11668020|FG000|COMPLETED|Overall Study||0
10516801|NCT01327053|11668021|FG001|COMPLETED|Overall Study||0
10516802|NCT01327053|11668020|FG000|NOT COMPLETED|Overall Study||79
10516803|NCT01327053|11668021|FG001|NOT COMPLETED|Overall Study||151
10516804|NCT01327157|11668033|FG000|STARTED|01-90||7
10516805|NCT01327157|11668034|FG001|STARTED|01-90||7
10516806|NCT01327157|11668033|FG000|COMPLETED|01-90||7
10516807|NCT01327157|11668034|FG001|COMPLETED|01-90||7
10516808|NCT01327157|11668033|FG000|NOT COMPLETED|01-90||0
10516809|NCT01327157|11668034|FG001|NOT COMPLETED|01-90||0
10516810|NCT01327157|11668033|FG000|STARTED|91-180||7
10516811|NCT01327157|11668034|FG001|STARTED|91-180||0
10516812|NCT01327157|11668033|FG000|COMPLETED|91-180||7
10516813|NCT01327157|11668034|FG001|COMPLETED|91-180||0
10516814|NCT01327157|11668033|FG000|NOT COMPLETED|91-180||0
10516815|NCT01327157|11668034|FG001|NOT COMPLETED|91-180||0
10516816|NCT01327274|11668045|FG000|STARTED|Overall Study||15
10516817|NCT01327274|11668045|FG000|COMPLETED|Overall Study||15
10516818|NCT01327274|11668045|FG000|NOT COMPLETED|Overall Study||0
10516819|NCT01327300|11668050|FG000|STARTED|First Intervention (12 Weeks)||5
10516820|NCT01327300|11668051|FG001|STARTED|First Intervention (12 Weeks)||2
10516821|NCT01327300|11668050|FG000|COMPLETED|First Intervention (12 Weeks)||5
10516822|NCT01327300|11668051|FG001|COMPLETED|First Intervention (12 Weeks)||2
10516823|NCT01327300|11668050|FG000|NOT COMPLETED|First Intervention (12 Weeks)||0
10516824|NCT01327300|11668051|FG001|NOT COMPLETED|First Intervention (12 Weeks)||0
10516825|NCT01327300|11668050|FG000|STARTED|Washout (3 Weeks)||5
10516826|NCT01327300|11668051|FG001|STARTED|Washout (3 Weeks)||2
10516827|NCT01327300|11668050|FG000|COMPLETED|Washout (3 Weeks)||4
10516828|NCT01327300|11668051|FG001|COMPLETED|Washout (3 Weeks)||2
10516829|NCT01327300|11668050|FG000|NOT COMPLETED|Washout (3 Weeks)||1
10516830|NCT01327300|11668051|FG001|NOT COMPLETED|Washout (3 Weeks)||0
10516831|NCT01327300|11668050|FG000|STARTED|Second Intervention (12 Weeks)||4
10516832|NCT01327300|11668051|FG001|STARTED|Second Intervention (12 Weeks)||2
10516833|NCT01327300|11668050|FG000|COMPLETED|Second Intervention (12 Weeks)||4
10516834|NCT01327300|11668051|FG001|COMPLETED|Second Intervention (12 Weeks)||2
10516835|NCT01327300|11668050|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0
10516836|NCT01327300|11668051|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||0
10516837|NCT01327313|11668071|FG000|STARTED|Overall Study||8
10516838|NCT01327313|11668072|FG001|STARTED|Overall Study||6
10516839|NCT01327313|11668073|FG002|STARTED|Overall Study||6
10516840|NCT01327313|11668074|FG003|STARTED|Overall Study||7
10516841|NCT01327313|11668071|FG000|COMPLETED|Overall Study||8
10516842|NCT01327313|11668072|FG001|COMPLETED|Overall Study||6
10516843|NCT01327313|11668073|FG002|COMPLETED|Overall Study||6
10516844|NCT01327313|11668074|FG003|COMPLETED|Overall Study||7
10516845|NCT01327313|11668071|FG000|NOT COMPLETED|Overall Study||0
10516846|NCT01327313|11668072|FG001|NOT COMPLETED|Overall Study||0
10516847|NCT01327313|11668073|FG002|NOT COMPLETED|Overall Study||0
10516848|NCT01327313|11668074|FG003|NOT COMPLETED|Overall Study||0
10516849|NCT01327339|11668084|FG000|STARTED|Overall Study||755
10516850|NCT01327339|11668084|FG000|COMPLETED|Overall Study||747
10516851|NCT01327339|11668084|FG000|NOT COMPLETED|Overall Study||8
10516852|NCT01327482|11668088|FG000|STARTED|Overall Study||10
10516853|NCT01327482|11668088|FG000|COMPLETED|Overall Study|The 10th participant completed 2/3 visits|9
10516854|NCT01327482|11668088|FG000|NOT COMPLETED|Overall Study||1
10516855|NCT01327495|11668098|FG000|STARTED|Overall Study||10
10516856|NCT01327495|11668099|FG001|STARTED|Overall Study||11
10516857|NCT01327495|11668100|FG002|STARTED|Overall Study||10
10516858|NCT01327495|11668101|FG003|STARTED|Overall Study||9
10516859|NCT01327495|11668102|FG004|STARTED|Overall Study||11
10516860|NCT01327495|11668103|FG005|STARTED|Overall Study||11
10516861|NCT01327495|11668098|FG000|COMPLETED|Overall Study|1 dropped due to decreased libido & energy, 1 dropped due to too much pain with acyline injections|8
10516862|NCT01327495|11668099|FG001|COMPLETED|Overall Study|1 subject declined prostate biopsy & no-showed to final visit, 1 subject dropped d/t elevated LFTs.|9
10516863|NCT01327495|11668100|FG002|COMPLETED|Overall Study|1 withdrawn due to injection AE. 1 drop-out (declined prostate biopsy and final visit).|8
10516864|NCT01327495|11668101|FG003|COMPLETED|Overall Study||9
10516865|NCT01327495|11668102|FG004|COMPLETED|Overall Study|1 dropped out pre drug finish, 2 non-compliant subjects dropped|8
10516866|NCT01327495|11668103|FG005|COMPLETED|Overall Study|1 subject withdrawn d/t elevated LFTs, 1 dropped out d/t ski accident|9
10516867|NCT01327495|11668098|FG000|NOT COMPLETED|Overall Study||2
10516868|NCT01327495|11668099|FG001|NOT COMPLETED|Overall Study||2
10516869|NCT01327495|11668100|FG002|NOT COMPLETED|Overall Study||2
10516870|NCT01327495|11668101|FG003|NOT COMPLETED|Overall Study||0
10516871|NCT01327495|11668102|FG004|NOT COMPLETED|Overall Study||3
10516872|NCT01327495|11668103|FG005|NOT COMPLETED|Overall Study||2
10516873|NCT01327508|11668125|FG000|STARTED|Overall Study||30
10516874|NCT01327508|11668126|FG001|STARTED|Overall Study||30
10516875|NCT01327508|11668125|FG000|COMPLETED|Overall Study||30
10516876|NCT01327508|11668126|FG001|COMPLETED|Overall Study||30
10516877|NCT01327508|11668125|FG000|NOT COMPLETED|Overall Study||0
10516878|NCT01327508|11668126|FG001|NOT COMPLETED|Overall Study||0
10516879|NCT01327547|11668134|FG000|STARTED|Overall Study||70
10516880|NCT01327547|11668135|FG001|STARTED|Overall Study||67
10516881|NCT01327547|11668134|FG000|Randomized and Not Treated|Overall Study||0
10516882|NCT01327547|11668135|FG001|Randomized and Not Treated|Overall Study|Randomized but was withdrawn prior to receiving treatment due to poor venous access.|1
10516883|NCT01327547|11668134|FG000|COMPLETED|Overall Study||50
10516884|NCT01327547|11668135|FG001|COMPLETED|Overall Study||45
10516885|NCT01327547|11668134|FG000|NOT COMPLETED|Overall Study||20
10516886|NCT01327547|11668135|FG001|NOT COMPLETED|Overall Study||22
10516887|NCT01327573|11668152|FG000|STARTED|Overall Study||11
10516888|NCT01327573|11668153|FG001|STARTED|Overall Study||5
10516889|NCT01327573|11668152|FG000|Received Treatment/Control as Allocated|Overall Study||10
10516890|NCT01327573|11668153|FG001|Received Treatment/Control as Allocated|Overall Study||5
10516891|NCT01327573|11668152|FG000|COMPLETED|Overall Study||8
10516892|NCT01327573|11668153|FG001|COMPLETED|Overall Study||4
10516893|NCT01327573|11668152|FG000|NOT COMPLETED|Overall Study||3
10516894|NCT01327573|11668153|FG001|NOT COMPLETED|Overall Study||1
10516895|NCT01327599|11668160|FG000|STARTED|Overall Study||60
10516896|NCT01327599|11668160|FG000|COMPLETED|Overall Study||57
10516897|NCT01327599|11668160|FG000|NOT COMPLETED|Overall Study||3
10516898|NCT01327612|11668171|FG000|STARTED|Overall Study||2
10516899|NCT01327612|11668172|FG001|STARTED|Overall Study||1
10516900|NCT01327612|11668173|FG002|STARTED|Overall Study||1
10516901|NCT01327612|11668174|FG003|STARTED|Overall Study||1
10516902|NCT01327612|11668175|FG004|STARTED|Overall Study||2
10516903|NCT01327612|11668176|FG005|STARTED|Overall Study||3
10516904|NCT01327612|11668177|FG006|STARTED|Overall Study||2
10516905|NCT01327612|11668171|FG000|COMPLETED|Overall Study||1
10516906|NCT01327612|11668172|FG001|COMPLETED|Overall Study||0
10516907|NCT01327612|11668173|FG002|COMPLETED|Overall Study||0
10516908|NCT01327612|11668174|FG003|COMPLETED|Overall Study||0
10516909|NCT01327612|11668175|FG004|COMPLETED|Overall Study||0
10516910|NCT01327612|11668176|FG005|COMPLETED|Overall Study||0
10516911|NCT01327612|11668177|FG006|COMPLETED|Overall Study||0
10516912|NCT01327612|11668171|FG000|NOT COMPLETED|Overall Study||1
10516913|NCT01327612|11668172|FG001|NOT COMPLETED|Overall Study||1
10516914|NCT01327612|11668173|FG002|NOT COMPLETED|Overall Study||1
10516915|NCT01327612|11668174|FG003|NOT COMPLETED|Overall Study||1
10516916|NCT01327612|11668175|FG004|NOT COMPLETED|Overall Study||2
10516917|NCT01327612|11668176|FG005|NOT COMPLETED|Overall Study||3
10516918|NCT01327612|11668177|FG006|NOT COMPLETED|Overall Study||2
10517018|NCT01327677|11668252|FG000|STARTED|Overall Study||68
10517019|NCT01327677|11668253|FG001|STARTED|Overall Study||69
10517020|NCT01327677|11668252|FG000|COMPLETED|Overall Study||48
10517021|NCT01327677|11668253|FG001|COMPLETED|Overall Study||56
10517022|NCT01327677|11668252|FG000|NOT COMPLETED|Overall Study||20
10517023|NCT01327677|11668253|FG001|NOT COMPLETED|Overall Study||13
10517024|NCT01327703|11668261|FG000|STARTED|First Treatment Period||42
10517025|NCT01327703|11668262|FG001|STARTED|First Treatment Period||45
10517026|NCT01327703|11668261|FG000|COMPLETED|First Treatment Period||42
10517027|NCT01327703|11668262|FG001|COMPLETED|First Treatment Period||45
10517028|NCT01327703|11668261|FG000|NOT COMPLETED|First Treatment Period||0
10517029|NCT01327703|11668262|FG001|NOT COMPLETED|First Treatment Period||0
10517030|NCT01327703|11668261|FG000|STARTED|Second Treatment Period|Two participants discontinued between first and second treatment periods due to adverse event.|40
10517031|NCT01327703|11668262|FG001|STARTED|Second Treatment Period|One participant discontinued between first and second treatment periods due to adverse event.|44
10517032|NCT01327703|11668261|FG000|COMPLETED|Second Treatment Period||39
10517033|NCT01327703|11668262|FG001|COMPLETED|Second Treatment Period||42
10517034|NCT01327703|11668261|FG000|NOT COMPLETED|Second Treatment Period||1
10517035|NCT01327703|11668262|FG001|NOT COMPLETED|Second Treatment Period||2
10517052|NCT01327885|11668315|FG000|STARTED|Overall Study||228
10517053|NCT01327885|11668316|FG001|STARTED|Overall Study||224
10517054|NCT01327885|11668315|FG000|COMPLETED|Overall Study||0
10517055|NCT01327885|11668316|FG001|COMPLETED|Overall Study||0
10517056|NCT01327885|11668315|FG000|NOT COMPLETED|Overall Study||228
10517057|NCT01327885|11668316|FG001|NOT COMPLETED|Overall Study||224
10517058|NCT01327963|11668323|FG000|STARTED|Overall Study||110
10517059|NCT01327963|11668323|FG000|COMPLETED|Overall Study|110 participants signed informed consent to be included in the study.|110
10517060|NCT01327963|11668323|FG000|NOT COMPLETED|Overall Study||0
10517061|NCT01327976|11668331|FG000|STARTED|Overall Study||162
10517062|NCT01327976|11668332|FG001|STARTED|Overall Study||77
10517063|NCT01327976|11668331|FG000|COMPLETED|Overall Study||154
10517064|NCT01327976|11668332|FG001|COMPLETED|Overall Study||70
10517065|NCT01327976|11668331|FG000|NOT COMPLETED|Overall Study||8
10517066|NCT01327976|11668332|FG001|NOT COMPLETED|Overall Study||7
10517067|NCT01327989|11668340|FG000|STARTED|Overall Study||202
10517068|NCT01327989|11668340|FG000|COMPLETED|Overall Study||188
10517069|NCT01327989|11668340|FG000|NOT COMPLETED|Overall Study||14
10517070|NCT01328002|11668344|FG000|STARTED|Open-Label Period||116
10517071|NCT01328002|11668345|FG001|STARTED|Open-Label Period||0
10517072|NCT01328002|11668344|FG000|COMPLETED|Open-Label Period||20
10517073|NCT01328002|11668345|FG001|COMPLETED|Open-Label Period||0
10517074|NCT01328002|11668344|FG000|NOT COMPLETED|Open-Label Period||96
10517075|NCT01328002|11668345|FG001|NOT COMPLETED|Open-Label Period||0
10517076|NCT01328002|11668344|FG000|STARTED|Double-Blind Period||14
10517077|NCT01328002|11668345|FG001|STARTED|Double-Blind Period||6
10517078|NCT01328002|11668344|FG000|COMPLETED|Double-Blind Period||12
10517079|NCT01328002|11668345|FG001|COMPLETED|Double-Blind Period||6
10517080|NCT01328002|11668344|FG000|NOT COMPLETED|Double-Blind Period||2
10517081|NCT01328002|11668345|FG001|NOT COMPLETED|Double-Blind Period||0
10517082|NCT01328041|11668352|FG000|STARTED|Overall Study||183
10517083|NCT01328041|11668352|FG000|COMPLETED|Overall Study||126
10517084|NCT01328041|11668352|FG000|NOT COMPLETED|Overall Study||57
10517085|NCT01328054|11668356|FG000|STARTED|Placebo on Day 1 and Day 2 (2 Days)||57
10517086|NCT01328054|11668357|FG001|STARTED|Placebo on Day 1 and Day 2 (2 Days)||0
10517087|NCT01328054|11668356|FG000|COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||57
10517088|NCT01328054|11668357|FG001|COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
10517089|NCT01328054|11668356|FG000|NOT COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
10517090|NCT01328054|11668357|FG001|NOT COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
10517091|NCT01328054|11668356|FG000|STARTED|Lapatinib on Day 3 and Day 4 (2 Days)||0
10517172|NCT01328444|11668432|FG000|STARTED|Washout Period (14 Days)||83
10517092|NCT01328054|11668357|FG001|STARTED|Lapatinib on Day 3 and Day 4 (2 Days)|One par. was double dosed with lapatinib due to a dosing error - reason for difference in # Started.|58
10517093|NCT01328054|11668356|FG000|COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||0
10517094|NCT01328054|11668357|FG001|COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||53
10517095|NCT01328054|11668356|FG000|NOT COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||0
10517096|NCT01328054|11668357|FG001|NOT COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||5
10517097|NCT01328080|11668369|FG000|STARTED|Overall Study|11 subjects consented; 1 withdrew consent before first UVB treatment|11
10517098|NCT01328080|11668369|FG000|COMPLETED|Overall Study||6
10517099|NCT01328080|11668369|FG000|NOT COMPLETED|Overall Study||5
10517100|NCT01328158|11668373|FG000|STARTED|Overall Study||220
10517101|NCT01328158|11668373|FG000|COMPLETED|Overall Study||220
10517102|NCT01328158|11668373|FG000|NOT COMPLETED|Overall Study||0
10517103|NCT01328184|11668380|FG000|STARTED|Overall Study||18
10517104|NCT01328184|11668380|FG000|COMPLETED|Overall Study||18
10517105|NCT01328184|11668380|FG000|NOT COMPLETED|Overall Study||0
10517106|NCT01328249|11668388|FG000|STARTED|Overall Study||55
10517107|NCT01328249|11668389|FG001|STARTED|Overall Study||26
10517108|NCT01328249|11668388|FG000|COMPLETED|Overall Study||48
10517109|NCT01328249|11668389|FG001|COMPLETED|Overall Study||23
10517110|NCT01328249|11668388|FG000|NOT COMPLETED|Overall Study||7
10517111|NCT01328249|11668389|FG001|NOT COMPLETED|Overall Study||3
10517112|NCT01328366|11668397|FG000|STARTED|Overall Study||153
10517113|NCT01328366|11668397|FG000|COMPLETED|Overall Study||143
10517114|NCT01328366|11668397|FG000|NOT COMPLETED|Overall Study||10
10517115|NCT01328379|11668404|FG000|STARTED|Overall Study||143
10517116|NCT01328379|11668405|FG001|STARTED|Overall Study||144
10517117|NCT01328379|11668406|FG002|STARTED|Overall Study||143
10517118|NCT01328379|11668404|FG000|COMPLETED|Overall Study||142
10517119|NCT01328379|11668405|FG001|COMPLETED|Overall Study||144
10517120|NCT01328379|11668406|FG002|COMPLETED|Overall Study||143
10517121|NCT01328379|11668404|FG000|NOT COMPLETED|Overall Study||1
10517122|NCT01328379|11668405|FG001|NOT COMPLETED|Overall Study||0
10517123|NCT01328379|11668406|FG002|NOT COMPLETED|Overall Study||0
10517124|NCT01328405|11668416|FG000|STARTED|Overall Study||52
10517125|NCT01328405|11668417|FG001|STARTED|Overall Study||48
10517126|NCT01328405|11668416|FG000|COMPLETED|Overall Study||52
10517127|NCT01328405|11668417|FG001|COMPLETED|Overall Study||48
10517128|NCT01328405|11668416|FG000|NOT COMPLETED|Overall Study||0
10517129|NCT01328405|11668417|FG001|NOT COMPLETED|Overall Study||0
10517130|NCT01328431|11668425|FG000|STARTED|Baseline||390
10517131|NCT01328431|11668426|FG001|STARTED|Baseline||390
10517132|NCT01328431|11668425|FG000|COMPLETED|Baseline||390
10517133|NCT01328431|11668426|FG001|COMPLETED|Baseline|Two subjects enrolled in study twice. Protocol violation.|388
10517134|NCT01328431|11668425|FG000|NOT COMPLETED|Baseline||0
10517135|NCT01328431|11668426|FG001|NOT COMPLETED|Baseline||2
10517136|NCT01328431|11668425|FG000|STARTED|1 Month (1M)||390
10517137|NCT01328431|11668426|FG001|STARTED|1 Month (1M)||388
10517138|NCT01328431|11668425|FG000|COMPLETED|1 Month (1M)||335
10517139|NCT01328431|11668426|FG001|COMPLETED|1 Month (1M)||330
10517140|NCT01328431|11668425|FG000|NOT COMPLETED|1 Month (1M)||55
10517141|NCT01328431|11668426|FG001|NOT COMPLETED|1 Month (1M)||58
10517142|NCT01328431|11668425|FG000|STARTED|3 Month (3M)|Attempted to contact all subjects for 3M follow-up, regardless of whether they completed 1M.|390
10517143|NCT01328431|11668426|FG001|STARTED|3 Month (3M)|Attempted to contact all subjects for 3M follow-up, regardless of whether they completed 1M.|388
10517144|NCT01328431|11668425|FG000|COMPLETED|3 Month (3M)||313
10517145|NCT01328431|11668426|FG001|COMPLETED|3 Month (3M)||316
10517146|NCT01328431|11668425|FG000|NOT COMPLETED|3 Month (3M)||77
10517147|NCT01328431|11668426|FG001|NOT COMPLETED|3 Month (3M)||72
10517148|NCT01328431|11668425|FG000|STARTED|12 Month (12M)|Attempted to contact all subjects at 12M follow-up. Deceased subjects excluded.|388
10517149|NCT01328431|11668426|FG001|STARTED|12 Month (12M)|Attempted to contact all subjects at 12M follow-up. Deceased subjects excluded.|386
10517150|NCT01328431|11668425|FG000|COMPLETED|12 Month (12M)||304
10517151|NCT01328431|11668426|FG001|COMPLETED|12 Month (12M)||289
10517152|NCT01328431|11668425|FG000|NOT COMPLETED|12 Month (12M)||84
10517153|NCT01328431|11668426|FG001|NOT COMPLETED|12 Month (12M)||97
10517154|NCT01328444|11668432|FG000|STARTED|Treatment Period 1 (12 Weeks)||94
10517155|NCT01328444|11668433|FG001|STARTED|Treatment Period 1 (12 Weeks)||26
10517156|NCT01328444|11668434|FG002|STARTED|Treatment Period 1 (12 Weeks)||28
10517157|NCT01328444|11668435|FG003|STARTED|Treatment Period 1 (12 Weeks)||41
10517158|NCT01328444|11668436|FG004|STARTED|Treatment Period 1 (12 Weeks)||81
10517159|NCT01328444|11668437|FG005|STARTED|Treatment Period 1 (12 Weeks)||78
10517160|NCT01328444|11668432|FG000|COMPLETED|Treatment Period 1 (12 Weeks)||83
10517161|NCT01328444|11668433|FG001|COMPLETED|Treatment Period 1 (12 Weeks)||21
10517162|NCT01328444|11668434|FG002|COMPLETED|Treatment Period 1 (12 Weeks)||25
10517163|NCT01328444|11668435|FG003|COMPLETED|Treatment Period 1 (12 Weeks)||33
10711636|NCT02661178|11877042|FG008|STARTED|Part 2||0
10517164|NCT01328444|11668436|FG004|COMPLETED|Treatment Period 1 (12 Weeks)||67
10517165|NCT01328444|11668437|FG005|COMPLETED|Treatment Period 1 (12 Weeks)||72
10517166|NCT01328444|11668432|FG000|NOT COMPLETED|Treatment Period 1 (12 Weeks)||11
10517167|NCT01328444|11668433|FG001|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
10517168|NCT01328444|11668434|FG002|NOT COMPLETED|Treatment Period 1 (12 Weeks)||3
10517169|NCT01328444|11668435|FG003|NOT COMPLETED|Treatment Period 1 (12 Weeks)||8
10517170|NCT01328444|11668436|FG004|NOT COMPLETED|Treatment Period 1 (12 Weeks)||14
10711637|NCT02661178|11877043|FG009|STARTED|Part 2||0
10711638|NCT02661178|11877044|FG010|STARTED|Part 2||0
10517171|NCT01328444|11668437|FG005|NOT COMPLETED|Treatment Period 1 (12 Weeks)||6
10517173|NCT01328444|11668433|FG001|STARTED|Washout Period (14 Days)||21
10517174|NCT01328444|11668434|FG002|STARTED|Washout Period (14 Days)||25
10517175|NCT01328444|11668435|FG003|STARTED|Washout Period (14 Days)||33
10517176|NCT01328444|11668436|FG004|STARTED|Washout Period (14 Days)||67
10517177|NCT01328444|11668437|FG005|STARTED|Washout Period (14 Days)||72
10517178|NCT01328444|11668432|FG000|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|82
10517179|NCT01328444|11668433|FG001|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
10517180|NCT01328444|11668434|FG002|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|25
10517181|NCT01328444|11668435|FG003|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|32
10517182|NCT01328444|11668436|FG004|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|66
10517183|NCT01328444|11668437|FG005|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|68
10517184|NCT01328444|11668432|FG000|NOT COMPLETED|Washout Period (14 Days)||1
10517185|NCT01328444|11668433|FG001|NOT COMPLETED|Washout Period (14 Days)||1
10517186|NCT01328444|11668434|FG002|NOT COMPLETED|Washout Period (14 Days)||0
10517187|NCT01328444|11668435|FG003|NOT COMPLETED|Washout Period (14 Days)||1
10517188|NCT01328444|11668436|FG004|NOT COMPLETED|Washout Period (14 Days)||1
10517189|NCT01328444|11668437|FG005|NOT COMPLETED|Washout Period (14 Days)||4
10517190|NCT01328444|11668432|FG000|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|76
10517191|NCT01328444|11668433|FG001|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|23
10517192|NCT01328444|11668434|FG002|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|22
10517193|NCT01328444|11668435|FG003|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|35
10517194|NCT01328444|11668436|FG004|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|71
10517195|NCT01328444|11668437|FG005|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|66
10517196|NCT01328444|11668432|FG000|COMPLETED|Treatment Period 2 (12 Weeks)||65
10517197|NCT01328444|11668433|FG001|COMPLETED|Treatment Period 2 (12 Weeks)||22
10517198|NCT01328444|11668434|FG002|COMPLETED|Treatment Period 2 (12 Weeks)||19
10517199|NCT01328444|11668435|FG003|COMPLETED|Treatment Period 2 (12 Weeks)||30
10517200|NCT01328444|11668436|FG004|COMPLETED|Treatment Period 2 (12 Weeks)||63
10517201|NCT01328444|11668437|FG005|COMPLETED|Treatment Period 2 (12 Weeks)||59
10517202|NCT01328444|11668432|FG000|NOT COMPLETED|Treatment Period 2 (12 Weeks)||11
10517203|NCT01328444|11668433|FG001|NOT COMPLETED|Treatment Period 2 (12 Weeks)||1
10517204|NCT01328444|11668434|FG002|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
10517205|NCT01328444|11668435|FG003|NOT COMPLETED|Treatment Period 2 (12 Weeks)||5
10650433|NCT02169453|11810717|FG003|100 mg BIA 9-1067|Overall Study||3
10650434|NCT02169453|11810714|FG000|Placebo|Overall Study||3
10650435|NCT02169453|11810715|FG001|Placebo|Overall Study||3
10650436|NCT02169453|11810716|FG002|Placebo|Overall Study||3
10650437|NCT02169453|11810717|FG003|Placebo|Overall Study||3
10650438|NCT02169453|11810714|FG000|COMPLETED|Overall Study||3
10650439|NCT02169453|11810715|FG001|COMPLETED|Overall Study||3
10650440|NCT02169453|11810716|FG002|COMPLETED|Overall Study||2
10650441|NCT02169453|11810717|FG003|COMPLETED|Overall Study||3
10650442|NCT02169453|11810714|FG000|NOT COMPLETED|Overall Study||0
10650443|NCT02169453|11810715|FG001|NOT COMPLETED|Overall Study||0
10810245|NCT03800173|11972142|FG003|PK Population|Overall Study||6
10810246|NCT03800173|11972143|FG004|PK Population|Overall Study||6
10810247|NCT03800173|11972139|FG000|COMPLETED|Overall Study||8
10810248|NCT03800173|11972140|FG001|COMPLETED|Overall Study||6
10810249|NCT03800173|11972141|FG002|COMPLETED|Overall Study||6
10810250|NCT03800173|11972142|FG003|COMPLETED|Overall Study||6
10810251|NCT03800173|11972143|FG004|COMPLETED|Overall Study||5
10810252|NCT03800173|11972139|FG000|NOT COMPLETED|Overall Study||0
10810253|NCT03800173|11972140|FG001|NOT COMPLETED|Overall Study||0
10810254|NCT03800173|11972141|FG002|NOT COMPLETED|Overall Study||0
10810255|NCT03800173|11972142|FG003|NOT COMPLETED|Overall Study||0
10810256|NCT03800173|11972143|FG004|NOT COMPLETED|Overall Study||1
10810257|NCT03799783|11972159|FG000|STARTED|Overall Study||19
10810258|NCT03799783|11972159|FG000|COMPLETED|Overall Study||19
10810259|NCT03799783|11972159|FG000|NOT COMPLETED|Overall Study||0
10810260|NCT03800030|11972163|FG000|STARTED|Baseline||4
10810261|NCT03800030|11972164|FG001|STARTED|Baseline||4
10810262|NCT03800030|11972165|FG002|STARTED|Baseline||4
10650444|NCT02169453|11810716|FG002|NOT COMPLETED|Overall Study||1
10650445|NCT02169453|11810717|FG003|NOT COMPLETED|Overall Study||0
10650446|NCT02169466|11810731|FG000|STARTED|Overall Study||6
10650447|NCT02169466|11810732|FG001|STARTED|Overall Study||6
10650448|NCT02169466|11810733|FG002|STARTED|Overall Study||5
10650449|NCT02169466|11810734|FG003|STARTED|Overall Study||5
10650450|NCT02169466|11810731|FG000|25 mg BIA 9-1067|Overall Study||6
10650451|NCT02169466|11810732|FG001|25 mg BIA 9-1067|Overall Study||5
10650452|NCT02169466|11810733|FG002|25 mg BIA 9-1067|Overall Study||5
10650453|NCT02169466|11810734|FG003|25 mg BIA 9-1067|Overall Study||5
10810263|NCT03800030|11972166|FG003|STARTED|Baseline||6
10650454|NCT02169466|11810731|FG000|50 mg BIA 9-1067|Overall Study||6
10650455|NCT02169466|11810732|FG001|50 mg BIA 9-1067|Overall Study||6
10650456|NCT02169466|11810733|FG002|50 mg BIA 9-1067|Overall Study||5
10650457|NCT02169466|11810734|FG003|50 mg BIA 9-1067|Overall Study||5
10650458|NCT02169466|11810731|FG000|100 mg BIA 9-1067|Overall Study||6
10650459|NCT02169466|11810732|FG001|100 mg BIA 9-1067|Overall Study||6
10650460|NCT02169466|11810733|FG002|100 mg BIA 9-1067|Overall Study||5
10650461|NCT02169466|11810734|FG003|100 mg BIA 9-1067|Overall Study||5
10650462|NCT02169466|11810731|FG000|Placebo|Overall Study||5
10711639|NCT02661178|11877045|FG011|STARTED|Part 2||6
10711640|NCT02661178|11877046|FG012|STARTED|Part 2||6
10711641|NCT02661178|11877047|FG013|STARTED|Part 2||2
10650463|NCT02169466|11810732|FG001|Placebo|Overall Study||6
10650464|NCT02169466|11810733|FG002|Placebo|Overall Study||5
10650465|NCT02169466|11810734|FG003|Placebo|Overall Study||5
10650466|NCT02169466|11810731|FG000|COMPLETED|Overall Study||5
10711642|NCT02661178|11877048|FG014|STARTED|Part 2||2
10517206|NCT01328444|11668436|FG004|NOT COMPLETED|Treatment Period 2 (12 Weeks)||8
10517207|NCT01328444|11668437|FG005|NOT COMPLETED|Treatment Period 2 (12 Weeks)||7
10517208|NCT01328496|11668453|FG000|STARTED|Overall Study||10
10517209|NCT01328496|11668454|FG001|STARTED|Overall Study||4
10711643|NCT02661178|11877034|FG000|COMPLETED|Part 2||0
10711644|NCT02661178|11877035|FG001|COMPLETED|Part 2||0
10711645|NCT02661178|11877036|FG002|COMPLETED|Part 2||0
10711646|NCT02661178|11877037|FG003|COMPLETED|Part 2||0
10711647|NCT02661178|11877038|FG004|COMPLETED|Part 2||0
10517210|NCT01328496|11668453|FG000|COMPLETED|Overall Study||9
10517211|NCT01328496|11668454|FG001|COMPLETED|Overall Study||4
10517212|NCT01328496|11668453|FG000|NOT COMPLETED|Overall Study||1
10517213|NCT01328496|11668454|FG001|NOT COMPLETED|Overall Study||0
10517214|NCT01328535|11668463|FG000|STARTED|Overall Study||25
10517215|NCT01328535|11668463|FG000|COMPLETED|Overall Study||24
10517216|NCT01328535|11668463|FG000|NOT COMPLETED|Overall Study||1
10517217|NCT01328548|11668471|FG000|STARTED|Overall Study||191
10517218|NCT01328548|11668472|FG001|STARTED|Overall Study||50
10517219|NCT01328548|11668471|FG000|COMPLETED|Overall Study||187
10517220|NCT01328548|11668472|FG001|COMPLETED|Overall Study||50
10517221|NCT01328548|11668471|FG000|NOT COMPLETED|Overall Study||4
10517222|NCT01328548|11668472|FG001|NOT COMPLETED|Overall Study||0
10517223|NCT01328574|11668478|FG000|STARTED|Overall Study||13
10517224|NCT01328574|11668478|FG000|COMPLETED|Overall Study||12
10517225|NCT01328574|11668478|FG000|NOT COMPLETED|Overall Study||1
10517226|NCT01328717|11668487|FG000|STARTED|Overall Study||78
10517227|NCT01328717|11668487|FG000|COMPLETED|Overall Study||77
10517228|NCT01328717|11668487|FG000|NOT COMPLETED|Overall Study||1
10517229|NCT01328743|11668493|FG000|STARTED|Overall Study||91
10517230|NCT01328743|11668494|FG001|STARTED|Overall Study||89
10517231|NCT01328743|11668493|FG000|COMPLETED|Overall Study||82
10517232|NCT01328743|11668494|FG001|COMPLETED|Overall Study||79
10517233|NCT01328743|11668493|FG000|NOT COMPLETED|Overall Study||9
10517234|NCT01328743|11668494|FG001|NOT COMPLETED|Overall Study||10
10517235|NCT01328756|11668500|FG000|STARTED|Overall Study||314
10517236|NCT01328756|11668500|FG000|COMPLETED|Overall Study||191
10517237|NCT01328756|11668500|FG000|NOT COMPLETED|Overall Study||123
10517238|NCT01328769|11668506|FG000|STARTED|Overall Study||25
10517239|NCT01328769|11668507|FG001|STARTED|Overall Study||24
10517240|NCT01328769|11668506|FG000|COMPLETED|Overall Study||25
10517241|NCT01328769|11668507|FG001|COMPLETED|Overall Study||23
10517242|NCT01328769|11668506|FG000|NOT COMPLETED|Overall Study||0
10517243|NCT01328769|11668507|FG001|NOT COMPLETED|Overall Study||1
10517244|NCT01328782|11668516|FG000|STARTED|Overall Study||43
10517245|NCT01328782|11668517|FG001|STARTED|Overall Study||42
10517246|NCT01328782|11668518|FG002|STARTED|Overall Study||39
10517247|NCT01328782|11668516|FG000|COMPLETED|Overall Study||43
10517248|NCT01328782|11668517|FG001|COMPLETED|Overall Study||42
10517249|NCT01328782|11668518|FG002|COMPLETED|Overall Study||39
10517250|NCT01328782|11668516|FG000|NOT COMPLETED|Overall Study||0
10517251|NCT01328782|11668517|FG001|NOT COMPLETED|Overall Study||0
10517252|NCT01328782|11668518|FG002|NOT COMPLETED|Overall Study||0
10517253|NCT01328873|11668526|FG000|STARTED|Overall Study||49
10517254|NCT01328873|11668526|FG000|COMPLETED|Overall Study||49
10517255|NCT01328873|11668526|FG000|NOT COMPLETED|Overall Study||0
10517256|NCT01328951|11668534|FG000|STARTED|Overall Study||321
10517257|NCT01328951|11668535|FG001|STARTED|Overall Study||322
10517258|NCT01328951|11668534|FG000|COMPLETED|Overall Study||0
10517259|NCT01328951|11668535|FG001|COMPLETED|Overall Study||0
10517260|NCT01328951|11668534|FG000|NOT COMPLETED|Overall Study||321
10517261|NCT01328951|11668535|FG001|NOT COMPLETED|Overall Study||322
10517262|NCT01328964|11668548|FG000|STARTED|Overall Study||2212
10517263|NCT01328964|11668549|FG001|STARTED|Overall Study||3270
10517264|NCT01328964|11668550|FG002|STARTED|Overall Study||4424
10517265|NCT01328964|11668548|FG000|COMPLETED|Overall Study||2212
10517266|NCT01328964|11668549|FG001|COMPLETED|Overall Study||3270
10517267|NCT01328964|11668550|FG002|COMPLETED|Overall Study||4424
10517268|NCT01328964|11668548|FG000|NOT COMPLETED|Overall Study||0
10517269|NCT01328964|11668549|FG001|NOT COMPLETED|Overall Study||0
10517270|NCT01328964|11668550|FG002|NOT COMPLETED|Overall Study||0
10517271|NCT01329029|11668560|FG000|STARTED|Overall Study||973
10650467|NCT02169466|11810732|FG001|COMPLETED|Overall Study||5
10650468|NCT02169466|11810733|FG002|COMPLETED|Overall Study||5
10650469|NCT02169466|11810734|FG003|COMPLETED|Overall Study||5
10650470|NCT02169466|11810731|FG000|NOT COMPLETED|Overall Study||1
10650471|NCT02169466|11810732|FG001|NOT COMPLETED|Overall Study||1
10711648|NCT02661178|11877039|FG005|COMPLETED|Part 2||0
10517272|NCT01329029|11668561|FG001|STARTED|Overall Study||972
10517273|NCT01329029|11668560|FG000|Full Analysis Set (FAS)|Overall Study||969
10517274|NCT01329029|11668561|FG001|Full Analysis Set (FAS)|Overall Study||966
10517275|NCT01329029|11668560|FG000|Safety Population|Overall Study||968
10517276|NCT01329029|11668561|FG001|Safety Population|Overall Study||967
10517277|NCT01329029|11668560|FG000|COMPLETED|Overall Study||704
10517278|NCT01329029|11668561|FG001|COMPLETED|Overall Study||780
10517279|NCT01329029|11668560|FG000|NOT COMPLETED|Overall Study||269
10517280|NCT01329029|11668561|FG001|NOT COMPLETED|Overall Study||192
10517281|NCT01329185|11668569|FG000|STARTED|Overall Study||10
10517282|NCT01329185|11668570|FG001|STARTED|Overall Study||7
10517283|NCT01329185|11668569|FG000|CMV Disease|Overall Study||1
10517284|NCT01329185|11668570|FG001|CMV Disease|Overall Study||0
10517285|NCT01329185|11668569|FG000|PTLD|Overall Study||1
10517286|NCT01329185|11668570|FG001|PTLD|Overall Study||0
10517287|NCT01329185|11668569|FG000|COMPLETED|Overall Study||10
10517288|NCT01329185|11668570|FG001|COMPLETED|Overall Study||7
10517289|NCT01329185|11668569|FG000|NOT COMPLETED|Overall Study||0
10517290|NCT01329185|11668570|FG001|NOT COMPLETED|Overall Study||0
10517291|NCT01329198|11668578|FG000|STARTED|Overall Study||3
10517292|NCT01329198|11668579|FG001|STARTED|Overall Study||2
10711649|NCT02661178|11877040|FG006|COMPLETED|Part 2||0
10711650|NCT02661178|11877041|FG007|COMPLETED|Part 2||0
10711651|NCT02661178|11877042|FG008|COMPLETED|Part 2||0
10517293|NCT01329198|11668578|FG000|COMPLETED|Overall Study||3
10517294|NCT01329198|11668579|FG001|COMPLETED|Overall Study||2
10517295|NCT01329198|11668578|FG000|NOT COMPLETED|Overall Study||0
10517296|NCT01329198|11668579|FG001|NOT COMPLETED|Overall Study||0
10517297|NCT01329263|11668592|FG000|STARTED|Overall Study||15
10517298|NCT01329263|11668593|FG001|STARTED|Overall Study||45
10517299|NCT01329263|11668592|FG000|Completed Period 1 Own Menthol|Overall Study||15
10517300|NCT01329263|11668593|FG001|Completed Period 1 Own Menthol|Overall Study||45
10517301|NCT01329263|11668592|FG000|Completed Period 2 Own or CCrush Menthol|Overall Study||10
10517302|NCT01329263|11668593|FG001|Completed Period 2 Own or CCrush Menthol|Overall Study||30
10517303|NCT01329263|11668592|FG000|CompletedPer 3 Own or CCrush Non-menthol|Overall Study||10
10517304|NCT01329263|11668593|FG001|CompletedPer 3 Own or CCrush Non-menthol|Overall Study||22
10517305|NCT01329263|11668592|FG000|COMPLETED|Overall Study||10
10517306|NCT01329263|11668593|FG001|COMPLETED|Overall Study||22
10517307|NCT01329263|11668592|FG000|NOT COMPLETED|Overall Study||5
10517308|NCT01329263|11668593|FG001|NOT COMPLETED|Overall Study||23
10517309|NCT01329328|11668604|FG000|STARTED|Overall Study||15
10517310|NCT01329328|11668605|FG001|STARTED|Overall Study||17
10517311|NCT01329328|11668606|FG002|STARTED|Overall Study||18
10517312|NCT01329328|11668604|FG000|COMPLETED|Overall Study||13
10517313|NCT01329328|11668605|FG001|COMPLETED|Overall Study||13
10517314|NCT01329328|11668606|FG002|COMPLETED|Overall Study||15
10517315|NCT01329328|11668604|FG000|NOT COMPLETED|Overall Study||2
10517316|NCT01329328|11668605|FG001|NOT COMPLETED|Overall Study||4
10517317|NCT01329328|11668606|FG002|NOT COMPLETED|Overall Study||3
10517318|NCT01329380|11668614|FG000|STARTED|Overall Study||403
10517319|NCT01329380|11668614|FG000|Safety Population|Overall Study||396
10517320|NCT01329380|11668614|FG000|COMPLETED|Overall Study||374
10517321|NCT01329380|11668614|FG000|NOT COMPLETED|Overall Study||29
10517322|NCT01329419|11668618|FG000|STARTED|Overall Study||4393
10517323|NCT01329419|11668618|FG000|COMPLETED|Overall Study||4158
10517324|NCT01329419|11668618|FG000|NOT COMPLETED|Overall Study||235
10517325|NCT01329562|11668625|FG000|STARTED|Overall Study||20
10517326|NCT01329562|11668626|FG001|STARTED|Overall Study||21
10517327|NCT01329562|11668625|FG000|COMPLETED|Overall Study||11
10517328|NCT01329562|11668626|FG001|COMPLETED|Overall Study||14
10517329|NCT01329562|11668625|FG000|NOT COMPLETED|Overall Study||9
10517330|NCT01329562|11668626|FG001|NOT COMPLETED|Overall Study||7
10517331|NCT01329679|11668634|FG000|STARTED|Overall Study||13
10517332|NCT01329679|11668635|FG001|STARTED|Overall Study||13
10517333|NCT01329679|11668634|FG000|COMPLETED|Overall Study||13
10517334|NCT01329679|11668635|FG001|COMPLETED|Overall Study||13
10517335|NCT01329679|11668634|FG000|NOT COMPLETED|Overall Study||0
10517336|NCT01329679|11668635|FG001|NOT COMPLETED|Overall Study||0
10517337|NCT01329848|11668643|FG000|STARTED|Overall Study||83
10517338|NCT01329848|11668643|FG000|COMPLETED|Overall Study||54
10517339|NCT01329848|11668643|FG000|NOT COMPLETED|Overall Study||29
10517340|NCT01329900|11668647|FG000|STARTED|Overall Study||50
10517341|NCT01329900|11668647|FG000|COMPLETED|Overall Study||49
10517342|NCT01329900|11668647|FG000|NOT COMPLETED|Overall Study||1
10517343|NCT01329939|11668655|FG000|STARTED|Overall Study||7
10517344|NCT01329939|11668656|FG001|STARTED|Overall Study||5
10517345|NCT01329939|11668657|FG002|STARTED|Overall Study||5
10517346|NCT01329939|11668658|FG003|STARTED|Overall Study||9
10517347|NCT01329939|11668655|FG000|COMPLETED|Overall Study||4
10517348|NCT01329939|11668656|FG001|COMPLETED|Overall Study||4
10517349|NCT01329939|11668657|FG002|COMPLETED|Overall Study||4
10517350|NCT01329939|11668658|FG003|COMPLETED|Overall Study||4
10517351|NCT01329939|11668655|FG000|NOT COMPLETED|Overall Study||3
10517352|NCT01329939|11668656|FG001|NOT COMPLETED|Overall Study||1
10517353|NCT01329939|11668657|FG002|NOT COMPLETED|Overall Study||1
10711652|NCT02661178|11877043|FG009|COMPLETED|Part 2||0
10517354|NCT01329939|11668658|FG003|NOT COMPLETED|Overall Study||5
10517355|NCT01329978|11668671|FG000|STARTED|Sofosbuvir+PEG+RBV Treatment Period||52
10517356|NCT01329978|11668672|FG001|STARTED|Sofosbuvir+PEG+RBV Treatment Period||125
10517357|NCT01329978|11668673|FG002|STARTED|Sofosbuvir+PEG+RBV Treatment Period||155
10528652|NCT01396083|11680978|FG001|NOT COMPLETED|Overall Study||47
10711653|NCT02661178|11877044|FG010|COMPLETED|Part 2||0
10711654|NCT02661178|11877045|FG011|COMPLETED|Part 2||6
10711655|NCT02661178|11877046|FG012|COMPLETED|Part 2||6
10711656|NCT02661178|11877047|FG013|COMPLETED|Part 2||2
10711657|NCT02661178|11877048|FG014|COMPLETED|Part 2||2
10711658|NCT02661178|11877034|FG000|NOT COMPLETED|Part 2||0
10711659|NCT02661178|11877035|FG001|NOT COMPLETED|Part 2||0
10711660|NCT02661178|11877036|FG002|NOT COMPLETED|Part 2||0
10517358|NCT01329978|11668674|FG003|STARTED|Sofosbuvir+PEG+RBV Treatment Period||0
10517359|NCT01329978|11668675|FG004|STARTED|Sofosbuvir+PEG+RBV Treatment Period||0
10517360|NCT01329978|11668671|FG000|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|Participants in this group were not re-randomized for further treatment|48
10517361|NCT01329978|11668672|FG001|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|Participants in this group were not re-randomized for further treatment|112
10517362|NCT01329978|11668673|FG002|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|150 participants were re-randomized after 12 weeks of treatment.|150
10517363|NCT01329978|11668674|FG003|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
10517364|NCT01329978|11668675|FG004|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
10517365|NCT01329978|11668671|FG000|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||4
10517366|NCT01329978|11668672|FG001|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||13
10517367|NCT01329978|11668673|FG002|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||5
10517368|NCT01329978|11668674|FG003|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
10517369|NCT01329978|11668675|FG004|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
10517370|NCT01329978|11668671|FG000|STARTED|Rerandomization Treatment Period||0
10517371|NCT01329978|11668672|FG001|STARTED|Rerandomization Treatment Period||0
10517372|NCT01329978|11668673|FG002|STARTED|Rerandomization Treatment Period||0
10517373|NCT01329978|11668674|FG003|STARTED|Rerandomization Treatment Period|This group includes participants rerandomized from the SOF+PEG+RBV 12 week/Rerandomization Group.|75
10517374|NCT01329978|11668675|FG004|STARTED|Rerandomization Treatment Period|This group includes participants rerandomized from the SOF+PEG+RBV 12 week/Rerandomization Group.|75
10517375|NCT01329978|11668671|FG000|COMPLETED|Rerandomization Treatment Period||0
10517376|NCT01329978|11668672|FG001|COMPLETED|Rerandomization Treatment Period||0
10517377|NCT01329978|11668673|FG002|COMPLETED|Rerandomization Treatment Period||0
10517378|NCT01329978|11668674|FG003|COMPLETED|Rerandomization Treatment Period||70
10517379|NCT01329978|11668675|FG004|COMPLETED|Rerandomization Treatment Period||71
10517380|NCT01329978|11668671|FG000|NOT COMPLETED|Rerandomization Treatment Period||0
10517381|NCT01329978|11668672|FG001|NOT COMPLETED|Rerandomization Treatment Period||0
10517382|NCT01329978|11668673|FG002|NOT COMPLETED|Rerandomization Treatment Period||0
10517383|NCT01329978|11668674|FG003|NOT COMPLETED|Rerandomization Treatment Period||5
10517384|NCT01329978|11668675|FG004|NOT COMPLETED|Rerandomization Treatment Period||4
10517385|NCT01330017|11668692|FG000|STARTED|Overall Study||109
10517386|NCT01330017|11668693|FG001|STARTED|Overall Study||108
10517387|NCT01330017|11668694|FG002|STARTED|Overall Study||107
10517388|NCT01330017|11668695|FG003|STARTED|Overall Study||112
10517389|NCT01330017|11668696|FG004|STARTED|Overall Study||103
10517390|NCT01330017|11668692|FG000|COMPLETED|Overall Study||104
10517391|NCT01330017|11668693|FG001|COMPLETED|Overall Study||104
10517392|NCT01330017|11668694|FG002|COMPLETED|Overall Study||99
10517393|NCT01330017|11668695|FG003|COMPLETED|Overall Study||100
10517394|NCT01330017|11668696|FG004|COMPLETED|Overall Study||100
10517395|NCT01330017|11668692|FG000|NOT COMPLETED|Overall Study||5
10517396|NCT01330017|11668693|FG001|NOT COMPLETED|Overall Study||4
10517397|NCT01330017|11668694|FG002|NOT COMPLETED|Overall Study||8
10517398|NCT01330017|11668695|FG003|NOT COMPLETED|Overall Study||12
10517399|NCT01330017|11668696|FG004|NOT COMPLETED|Overall Study||3
10517400|NCT01330030|11668710|FG000|STARTED|Overall Study||121
10517401|NCT01330030|11668711|FG001|STARTED|Overall Study||122
10517402|NCT01330030|11668710|FG000|COMPLETED|Overall Study|number assessed at week 52 follow-up|105
10517403|NCT01330030|11668711|FG001|COMPLETED|Overall Study|number assessed at week 52 follow-up|105
10517404|NCT01330030|11668710|FG000|NOT COMPLETED|Overall Study||16
10517405|NCT01330030|11668711|FG001|NOT COMPLETED|Overall Study||17
10517406|NCT01330043|11668719|FG000|STARTED|Overall Study||111
10517407|NCT01330043|11668720|FG001|STARTED|Overall Study||112
10517408|NCT01330043|11668719|FG000|COMPLETED|Overall Study||111
10517409|NCT01330043|11668720|FG001|COMPLETED|Overall Study||108
10517410|NCT01330043|11668719|FG000|NOT COMPLETED|Overall Study||0
10517411|NCT01330043|11668720|FG001|NOT COMPLETED|Overall Study||4
10517412|NCT01330108|11668726|FG000|STARTED|Overall Study||32
10517413|NCT01330108|11668726|FG000|COMPLETED|Overall Study||28
10517414|NCT01330108|11668726|FG000|NOT COMPLETED|Overall Study||4
10517415|NCT01330134|11668732|FG000|STARTED|Overall Study||244
10517416|NCT01330134|11668733|FG001|STARTED|Overall Study||237
10517417|NCT01330134|11668732|FG000|COMPLETED|Overall Study||244
10517418|NCT01330134|11668733|FG001|COMPLETED|Overall Study||237
10517419|NCT01330134|11668732|FG000|NOT COMPLETED|Overall Study||0
10517420|NCT01330134|11668733|FG001|NOT COMPLETED|Overall Study||0
10711661|NCT02661178|11877037|FG003|NOT COMPLETED|Part 2||0
10711662|NCT02661178|11877038|FG004|NOT COMPLETED|Part 2||0
10711663|NCT02661178|11877039|FG005|NOT COMPLETED|Part 2||0
10711664|NCT02661178|11877040|FG006|NOT COMPLETED|Part 2||0
10711665|NCT02661178|11877041|FG007|NOT COMPLETED|Part 2||0
10517421|NCT01330290|11668739|FG000|STARTED|Overall Study||148
10711666|NCT02661178|11877042|FG008|NOT COMPLETED|Part 2||0
10711667|NCT02661178|11877043|FG009|NOT COMPLETED|Part 2||0
10711668|NCT02661178|11877044|FG010|NOT COMPLETED|Part 2||0
10711669|NCT02661178|11877045|FG011|NOT COMPLETED|Part 2||0
10711670|NCT02661178|11877046|FG012|NOT COMPLETED|Part 2||0
10517422|NCT01330290|11668739|FG000|COMPLETED|Overall Study|As this is a cross-sectional study, the terms completed/not completed are not applicable.|148
10517423|NCT01330290|11668739|FG000|NOT COMPLETED|Overall Study||0
10517424|NCT01330303|11668743|FG000|STARTED|Period 1||20
10517425|NCT01330303|11668744|FG001|STARTED|Period 1||20
10517426|NCT01330303|11668743|FG000|COMPLETED|Period 1||19
10517427|NCT01330303|11668744|FG001|COMPLETED|Period 1||18
10517428|NCT01330303|11668743|FG000|NOT COMPLETED|Period 1||1
10517429|NCT01330303|11668744|FG001|NOT COMPLETED|Period 1||2
10517430|NCT01330303|11668743|FG000|STARTED|7-Day Washout Period||19
10517431|NCT01330303|11668744|FG001|STARTED|7-Day Washout Period||18
10517432|NCT01330303|11668743|FG000|COMPLETED|7-Day Washout Period||19
10517433|NCT01330303|11668744|FG001|COMPLETED|7-Day Washout Period||18
10517434|NCT01330303|11668743|FG000|NOT COMPLETED|7-Day Washout Period||0
10517435|NCT01330303|11668744|FG001|NOT COMPLETED|7-Day Washout Period||0
10517436|NCT01330303|11668743|FG000|STARTED|Period 2||19
10517437|NCT01330303|11668744|FG001|STARTED|Period 2||18
10517438|NCT01330303|11668743|FG000|COMPLETED|Period 2||19
10517439|NCT01330303|11668744|FG001|COMPLETED|Period 2||18
10517440|NCT01330303|11668743|FG000|NOT COMPLETED|Period 2||0
10517441|NCT01330303|11668744|FG001|NOT COMPLETED|Period 2||0
10517442|NCT01330316|11668753|FG000|STARTED|Overall Study||43
10517443|NCT01330316|11668754|FG001|STARTED|Overall Study||75
10517444|NCT01330316|11668753|FG000|COMPLETED|Overall Study||41
10517445|NCT01330316|11668754|FG001|COMPLETED|Overall Study||60
10517446|NCT01330316|11668753|FG000|NOT COMPLETED|Overall Study||2
10517447|NCT01330316|11668754|FG001|NOT COMPLETED|Overall Study||15
10517448|NCT01330355|11668762|FG000|STARTED|Overall Study||16
10517449|NCT01330355|11668763|FG001|STARTED|Overall Study||17
10517450|NCT01330355|11668762|FG000|COMPLETED|Overall Study||16
10517451|NCT01330355|11668763|FG001|COMPLETED|Overall Study||17
10517452|NCT01330355|11668762|FG000|NOT COMPLETED|Overall Study||0
10517453|NCT01330355|11668763|FG001|NOT COMPLETED|Overall Study||0
10517454|NCT01330381|11668771|FG000|STARTED|Double-blind Treatment Period (8 Weeks)||107
10517455|NCT01330381|11668772|FG001|STARTED|Double-blind Treatment Period (8 Weeks)||108
10517456|NCT01330381|11668773|FG002|STARTED|Double-blind Treatment Period (8 Weeks)||0
10517457|NCT01330381|11668771|FG000|Received Treatment|Double-blind Treatment Period (8 Weeks)||106
10517458|NCT01330381|11668772|FG001|Received Treatment|Double-blind Treatment Period (8 Weeks)||107
10517459|NCT01330381|11668773|FG002|Received Treatment|Double-blind Treatment Period (8 Weeks)||0
10517460|NCT01330381|11668771|FG000|COMPLETED|Double-blind Treatment Period (8 Weeks)||96
10517461|NCT01330381|11668772|FG001|COMPLETED|Double-blind Treatment Period (8 Weeks)||101
10517462|NCT01330381|11668773|FG002|COMPLETED|Double-blind Treatment Period (8 Weeks)||0
10517463|NCT01330381|11668771|FG000|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||11
10517464|NCT01330381|11668772|FG001|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||7
10517465|NCT01330381|11668773|FG002|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||0
10517466|NCT01330381|11668771|FG000|STARTED|Open-label Treatment Period (16 Weeks)||98
10517467|NCT01330381|11668772|FG001|STARTED|Open-label Treatment Period (16 Weeks)||0
10517468|NCT01330381|11668773|FG002|STARTED|Open-label Treatment Period (16 Weeks)||99
10517469|NCT01330381|11668771|FG000|COMPLETED|Open-label Treatment Period (16 Weeks)||88
10517470|NCT01330381|11668772|FG001|COMPLETED|Open-label Treatment Period (16 Weeks)||0
10517471|NCT01330381|11668773|FG002|COMPLETED|Open-label Treatment Period (16 Weeks)||81
10517472|NCT01330381|11668771|FG000|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||10
10517473|NCT01330381|11668772|FG001|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||0
10517474|NCT01330381|11668773|FG002|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||18
10517475|NCT01330394|11668784|FG000|STARTED|Overall Study||17
10517476|NCT01330394|11668785|FG001|STARTED|Overall Study||16
10517477|NCT01330394|11668784|FG000|COMPLETED|Overall Study||17
10517478|NCT01330394|11668785|FG001|COMPLETED|Overall Study||16
10517479|NCT01330394|11668784|FG000|NOT COMPLETED|Overall Study||0
10517480|NCT01330394|11668785|FG001|NOT COMPLETED|Overall Study||0
10517481|NCT01330420|11668791|FG000|STARTED|Overall Study||28
10517482|NCT01330420|11668791|FG000|COMPLETED|Overall Study||24
10517483|NCT01330420|11668791|FG000|NOT COMPLETED|Overall Study||4
10517484|NCT01330433|11668797|FG000|STARTED|Overall Study||16
10517485|NCT01330433|11668798|FG001|STARTED|Overall Study||19
10517486|NCT01330433|11668797|FG000|COMPLETED|Overall Study||14
10517487|NCT01330433|11668798|FG001|COMPLETED|Overall Study||16
10517488|NCT01330433|11668797|FG000|NOT COMPLETED|Overall Study||2
10517489|NCT01330433|11668798|FG001|NOT COMPLETED|Overall Study||3
10517490|NCT01330459|11668806|FG000|STARTED|Overall Study||61
10517491|NCT01330459|11668807|FG001|STARTED|Overall Study||60
10517492|NCT01330459|11668806|FG000|COMPLETED|Overall Study||61
10517493|NCT01330459|11668807|FG001|COMPLETED|Overall Study||58
10517494|NCT01330459|11668806|FG000|NOT COMPLETED|Overall Study||0
10517495|NCT01330459|11668807|FG001|NOT COMPLETED|Overall Study||2
10517496|NCT01330628|11668817|FG000|STARTED|Overall Study||170
10517497|NCT01330628|11668818|FG001|STARTED|Overall Study||82
10517498|NCT01330628|11668817|FG000|30 Day Follow-up|Overall Study||165
10517499|NCT01330628|11668818|FG001|30 Day Follow-up|Overall Study||73
10517500|NCT01330628|11668817|FG000|6 Month Follow-up|Overall Study||135
10517501|NCT01330628|11668818|FG001|6 Month Follow-up|Overall Study||60
10517502|NCT01330628|11668817|FG000|COMPLETED|Overall Study||100
10517503|NCT01330628|11668818|FG001|COMPLETED|Overall Study||42
10517504|NCT01330628|11668817|FG000|NOT COMPLETED|Overall Study||70
10517505|NCT01330628|11668818|FG001|NOT COMPLETED|Overall Study||40
10517506|NCT01330914|11668824|FG000|STARTED|Overall Study||55
10517507|NCT01330914|11668824|FG000|COMPLETED|Overall Study||48
10517508|NCT01330914|11668824|FG000|NOT COMPLETED|Overall Study||7
10517509|NCT01330953|11668833|FG000|STARTED|Overall Study||8
10517510|NCT01330953|11668834|FG001|STARTED|Overall Study||6
10517511|NCT01330953|11668835|FG002|STARTED|Overall Study||6
10517512|NCT01330953|11668836|FG003|STARTED|Overall Study||6
10517513|NCT01330953|11668837|FG004|STARTED|Overall Study||6
10517514|NCT01330953|11668833|FG000|COMPLETED|Overall Study||8
10517515|NCT01330953|11668834|FG001|COMPLETED|Overall Study||6
10517516|NCT01330953|11668835|FG002|COMPLETED|Overall Study||6
10517517|NCT01330953|11668836|FG003|COMPLETED|Overall Study||6
10517518|NCT01330953|11668837|FG004|COMPLETED|Overall Study||6
10517519|NCT01330953|11668833|FG000|NOT COMPLETED|Overall Study||0
10517520|NCT01330953|11668834|FG001|NOT COMPLETED|Overall Study||0
10517521|NCT01330953|11668835|FG002|NOT COMPLETED|Overall Study||0
10517522|NCT01330953|11668836|FG003|NOT COMPLETED|Overall Study||0
10517523|NCT01330953|11668837|FG004|NOT COMPLETED|Overall Study||0
10517524|NCT01330966|11668854|FG000|STARTED|Overall Study||47
10517525|NCT01330966|11668854|FG000|COMPLETED|Overall Study|Tumor responses evaluable in 42 of 47 pts; 5 pts discontinued prior to first tumor assessment.|42
10517526|NCT01330966|11668854|FG000|NOT COMPLETED|Overall Study||5
10517527|NCT01331005|11668860|FG000|STARTED|Overall Study||64
10517528|NCT01331005|11668861|FG001|STARTED|Overall Study||61
10517529|NCT01331005|11668860|FG000|COMPLETED|Overall Study||60
10517530|NCT01331005|11668861|FG001|COMPLETED|Overall Study||57
10517531|NCT01331005|11668860|FG000|NOT COMPLETED|Overall Study||4
10517532|NCT01331005|11668861|FG001|NOT COMPLETED|Overall Study||4
10517533|NCT01331083|11668869|FG000|STARTED|Overall Study||43
10517534|NCT01331083|11668870|FG001|STARTED|Overall Study||25
10517535|NCT01331083|11668869|FG000|COMPLETED|Overall Study||43
10517536|NCT01331083|11668870|FG001|COMPLETED|Overall Study||25
10517537|NCT01331083|11668869|FG000|NOT COMPLETED|Overall Study||0
10517538|NCT01331083|11668870|FG001|NOT COMPLETED|Overall Study||0
10517539|NCT01331109|11668876|FG000|STARTED|Overall Study||57
10517540|NCT01331109|11668876|FG000|COMPLETED|Overall Study||0
10517541|NCT01331109|11668876|FG000|NOT COMPLETED|Overall Study||57
10517542|NCT01331161|11668882|FG000|STARTED|Overall Study||44
10517543|NCT01331161|11668883|FG001|STARTED|Overall Study||33
10517544|NCT01331161|11668882|FG000|COMPLETED|Overall Study||43
10517545|NCT01331161|11668883|FG001|COMPLETED|Overall Study||31
10517546|NCT01331161|11668882|FG000|NOT COMPLETED|Overall Study||1
10517547|NCT01331161|11668883|FG001|NOT COMPLETED|Overall Study||2
10517548|NCT01331213|11668893|FG000|STARTED|Overall Study||8
10517549|NCT01331213|11668894|FG001|STARTED|Overall Study||10
10517550|NCT01331213|11668893|FG000|COMPLETED|Overall Study||8
10517551|NCT01331213|11668894|FG001|COMPLETED|Overall Study||10
10517552|NCT01331213|11668893|FG000|NOT COMPLETED|Overall Study||0
10517553|NCT01331213|11668894|FG001|NOT COMPLETED|Overall Study||0
10517554|NCT01331239|11668902|FG000|STARTED|Part I: Core Study||12
10517555|NCT01331239|11668903|FG001|STARTED|Part I: Core Study||0
10517556|NCT01331239|11668904|FG002|STARTED|Part I: Core Study||0
10517557|NCT01331239|11668902|FG000|COMPLETED|Part I: Core Study||12
10517558|NCT01331239|11668903|FG001|COMPLETED|Part I: Core Study||0
10517559|NCT01331239|11668904|FG002|COMPLETED|Part I: Core Study||0
10517560|NCT01331239|11668902|FG000|NOT COMPLETED|Part I: Core Study||0
10517561|NCT01331239|11668903|FG001|NOT COMPLETED|Part I: Core Study||0
10517562|NCT01331239|11668904|FG002|NOT COMPLETED|Part I: Core Study||0
10517563|NCT01331239|11668902|FG000|STARTED|Part II: Core Study||0
10517564|NCT01331239|11668903|FG001|STARTED|Part II: Core Study||15
10517565|NCT01331239|11668904|FG002|STARTED|Part II: Core Study||4
10517566|NCT01331239|11668902|FG000|COMPLETED|Part II: Core Study||0
10517567|NCT01331239|11668903|FG001|COMPLETED|Part II: Core Study||7
10517568|NCT01331239|11668904|FG002|COMPLETED|Part II: Core Study||3
10517569|NCT01331239|11668902|FG000|NOT COMPLETED|Part II: Core Study||0
10517570|NCT01331239|11668903|FG001|NOT COMPLETED|Part II: Core Study||8
10517571|NCT01331239|11668904|FG002|NOT COMPLETED|Part II: Core Study||1
10517572|NCT01331291|11668922|FG000|STARTED|Overall Study||2
10517573|NCT01331291|11668923|FG001|STARTED|Overall Study||9
10517574|NCT01331291|11668922|FG000|COMPLETED|Overall Study||0
10517575|NCT01331291|11668923|FG001|COMPLETED|Overall Study||0
10517576|NCT01331291|11668922|FG000|NOT COMPLETED|Overall Study||2
10517577|NCT01331291|11668923|FG001|NOT COMPLETED|Overall Study||9
10517578|NCT01331304|11668930|FG000|STARTED|Overall Study||240
10517579|NCT01331304|11668931|FG001|STARTED|Overall Study||242
10517580|NCT01331304|11668930|FG000|COMPLETED|Overall Study||182
10517581|NCT01331304|11668931|FG001|COMPLETED|Overall Study||182
10517582|NCT01331304|11668930|FG000|NOT COMPLETED|Overall Study||58
10517583|NCT01331304|11668931|FG001|NOT COMPLETED|Overall Study||60
10517587|NCT01331681|11668945|FG000|STARTED|Overall Study|randomized|136
10517588|NCT01331681|11668946|FG001|STARTED|Overall Study|randomized|135
10517589|NCT01331681|11668947|FG002|STARTED|Overall Study|randomized|135
10517590|NCT01331681|11668945|FG000|Participants Received Treatment|Overall Study|safety population|136
10517591|NCT01331681|11668946|FG001|Participants Received Treatment|Overall Study|safety population|135
10517592|NCT01331681|11668947|FG002|Participants Received Treatment|Overall Study|safety population|133
10517593|NCT01331681|11668945|FG000|Completed Week 52|Overall Study||125
10517594|NCT01331681|11668946|FG001|Completed Week 52|Overall Study||121
10517595|NCT01331681|11668947|FG002|Completed Week 52|Overall Study||115
10517596|NCT01331681|11668945|FG000|Completed Week 100|Overall Study||115
10517597|NCT01331681|11668946|FG001|Completed Week 100|Overall Study||110
10517598|NCT01331681|11668947|FG002|Completed Week 100|Overall Study||105
10517599|NCT01331681|11668945|FG000|Completed Week 148|Overall Study||101
10517600|NCT01331681|11668946|FG001|Completed Week 148|Overall Study||101
10517601|NCT01331681|11668947|FG002|Completed Week 148|Overall Study||100
10517602|NCT01331681|11668945|FG000|COMPLETED|Overall Study|Completed Week 148|101
10517603|NCT01331681|11668946|FG001|COMPLETED|Overall Study|Completed Week 148|101
10517604|NCT01331681|11668947|FG002|COMPLETED|Overall Study|Completed Week 148|100
10517605|NCT01331681|11668945|FG000|NOT COMPLETED|Overall Study||35
10517606|NCT01331681|11668946|FG001|NOT COMPLETED|Overall Study||34
10517607|NCT01331681|11668947|FG002|NOT COMPLETED|Overall Study||35
10517608|NCT01331694|11668961|FG000|STARTED|Overall Study||16684
10517609|NCT01331694|11668962|FG001|STARTED|Overall Study||14449
10517610|NCT01331694|11668963|FG002|STARTED|Overall Study||12659
10517611|NCT01331694|11668964|FG003|STARTED|Overall Study||12595
10517612|NCT01331694|11668965|FG004|STARTED|Overall Study||10617
10517613|NCT01331694|11668966|FG005|STARTED|Overall Study||9126
10517614|NCT01331694|11668961|FG000|COMPLETED|Overall Study||16684
10517615|NCT01331694|11668962|FG001|COMPLETED|Overall Study||14449
10517616|NCT01331694|11668963|FG002|COMPLETED|Overall Study||12659
10517617|NCT01331694|11668964|FG003|COMPLETED|Overall Study||12595
10517618|NCT01331694|11668965|FG004|COMPLETED|Overall Study||10617
10517619|NCT01331694|11668966|FG005|COMPLETED|Overall Study||9126
10517620|NCT01331694|11668961|FG000|NOT COMPLETED|Overall Study||0
10517621|NCT01331694|11668962|FG001|NOT COMPLETED|Overall Study||0
10517622|NCT01331694|11668963|FG002|NOT COMPLETED|Overall Study||0
10517623|NCT01331694|11668964|FG003|NOT COMPLETED|Overall Study||0
10517624|NCT01331694|11668965|FG004|NOT COMPLETED|Overall Study||0
10517625|NCT01331694|11668966|FG005|NOT COMPLETED|Overall Study||0
10517626|NCT01331824|11668980|FG000|STARTED|Overall Study||22
10517627|NCT01331824|11668980|FG000|COMPLETED|Overall Study||9
10517628|NCT01331824|11668980|FG000|NOT COMPLETED|Overall Study||13
10517629|NCT01331837|11668986|FG000|STARTED|Overall Study||1538
10517630|NCT01331837|11668987|FG001|STARTED|Overall Study||1542
10517631|NCT01331837|11668986|FG000|COMPLETED|Overall Study||1482
10517632|NCT01331837|11668987|FG001|COMPLETED|Overall Study||1475
10517633|NCT01331837|11668986|FG000|NOT COMPLETED|Overall Study||56
10517634|NCT01331837|11668987|FG001|NOT COMPLETED|Overall Study||67
10517635|NCT01332019|11668995|FG000|STARTED|Overall Study||530
10517636|NCT01332019|11668996|FG001|STARTED|Overall Study||547
10517637|NCT01332019|11668995|FG000|COMPLETED|Overall Study||417
10517638|NCT01332019|11668996|FG001|COMPLETED|Overall Study||425
10517639|NCT01332019|11668995|FG000|NOT COMPLETED|Overall Study||113
10517640|NCT01332019|11668996|FG001|NOT COMPLETED|Overall Study||122
10517641|NCT01332071|11669002|FG000|STARTED|Period 1||13
10517642|NCT01332071|11669003|FG001|STARTED|Period 1||13
10517643|NCT01332071|11669002|FG000|COMPLETED|Period 1||13
10517644|NCT01332071|11669003|FG001|COMPLETED|Period 1||13
10517645|NCT01332071|11669002|FG000|NOT COMPLETED|Period 1||0
10517646|NCT01332071|11669003|FG001|NOT COMPLETED|Period 1||0
10517647|NCT01332071|11669002|FG000|STARTED|7-Day Washout Period||13
10517648|NCT01332071|11669003|FG001|STARTED|7-Day Washout Period||13
10517649|NCT01332071|11669002|FG000|COMPLETED|7-Day Washout Period||13
10517650|NCT01332071|11669003|FG001|COMPLETED|7-Day Washout Period||13
10517651|NCT01332071|11669002|FG000|NOT COMPLETED|7-Day Washout Period||0
10517652|NCT01332071|11669003|FG001|NOT COMPLETED|7-Day Washout Period||0
10517653|NCT01332071|11669002|FG000|STARTED|Period 2||13
10517654|NCT01332071|11669003|FG001|STARTED|Period 2||13
10517655|NCT01332071|11669002|FG000|COMPLETED|Period 2||13
10517656|NCT01332071|11669003|FG001|COMPLETED|Period 2||13
10517657|NCT01332071|11669002|FG000|NOT COMPLETED|Period 2||0
10517658|NCT01332071|11669003|FG001|NOT COMPLETED|Period 2||0
10517659|NCT01332123|11669011|FG000|STARTED|Overall Study||10
10517660|NCT01332123|11669011|FG000|COMPLETED|Overall Study||10
10517661|NCT01332123|11669011|FG000|NOT COMPLETED|Overall Study||0
10517662|NCT01332149|11669018|FG000|STARTED|Overall Study|Assigned to study treatment.|314
10517663|NCT01332149|11669019|FG001|STARTED|Overall Study|Assigned to study treatment.|309
10517664|NCT01332149|11669018|FG000|Treated|Overall Study||313
10517665|NCT01332149|11669019|FG001|Treated|Overall Study||307
10517666|NCT01332149|11669018|FG000|COMPLETED|Overall Study||284
10517667|NCT01332149|11669019|FG001|COMPLETED|Overall Study||271
10517668|NCT01332149|11669018|FG000|NOT COMPLETED|Overall Study||30
10517669|NCT01332149|11669019|FG001|NOT COMPLETED|Overall Study||38
10517670|NCT01332188|11669029|FG000|STARTED|Overall Study||25
10517671|NCT01332188|11669030|FG001|STARTED|Overall Study||26
10517672|NCT01332188|11669031|FG002|STARTED|Overall Study||25
10517673|NCT01332188|11669032|FG003|STARTED|Overall Study||25
10517674|NCT01332188|11669029|FG000|COMPLETED|Overall Study||23
10517675|NCT01332188|11669030|FG001|COMPLETED|Overall Study||25
10517676|NCT01332188|11669031|FG002|COMPLETED|Overall Study||21
10338301|NCT00369486|11475225|FG001|COMPLETED|4-Week Visit|Number of eyes;|19
10338302|NCT00369486|11475226|FG002|COMPLETED|4-Week Visit|Number of eyes|22
10338303|NCT00369486|11475227|FG003|COMPLETED|4-Week Visit|Number of eyes|20
10517677|NCT01332188|11669032|FG003|COMPLETED|Overall Study||25
10517678|NCT01332188|11669029|FG000|NOT COMPLETED|Overall Study||2
10517679|NCT01332188|11669030|FG001|NOT COMPLETED|Overall Study||1
10517680|NCT01332188|11669031|FG002|NOT COMPLETED|Overall Study||4
10517681|NCT01332188|11669032|FG003|NOT COMPLETED|Overall Study||0
10517682|NCT01332227|11669044|FG000|STARTED|Overall Study|Participants who received treatment|72
10517683|NCT01332227|11669045|FG001|STARTED|Overall Study|Participants who received treatment|37
10517684|NCT01332227|11669044|FG000|COMPLETED|Overall Study||56
10517685|NCT01332227|11669045|FG001|COMPLETED|Overall Study||32
10517686|NCT01332227|11669044|FG000|NOT COMPLETED|Overall Study||16
10517687|NCT01332227|11669045|FG001|NOT COMPLETED|Overall Study||5
10517688|NCT01332253|11669053|FG000|STARTED|Overall Study||82
10517689|NCT01332253|11669054|FG001|STARTED|Overall Study||79
10517690|NCT01332253|11669053|FG000|COMPLETED|Overall Study||82
10517691|NCT01332253|11669054|FG001|COMPLETED|Overall Study||79
10517692|NCT01332253|11669053|FG000|NOT COMPLETED|Overall Study||0
10517693|NCT01332253|11669054|FG001|NOT COMPLETED|Overall Study||0
10517694|NCT01332292|11669060|FG000|STARTED|Treatment Period 1 (14 Days)||14
10517695|NCT01332292|11669061|FG001|STARTED|Treatment Period 1 (14 Days)||13
10517696|NCT01332292|11669060|FG000|COMPLETED|Treatment Period 1 (14 Days)||12
10517697|NCT01332292|11669061|FG001|COMPLETED|Treatment Period 1 (14 Days)||12
10517698|NCT01332292|11669060|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||2
10517699|NCT01332292|11669061|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||1
10517700|NCT01332292|11669060|FG000|STARTED|Washout Period (>=7 Days)||12
10517701|NCT01332292|11669061|FG001|STARTED|Washout Period (>=7 Days)||12
10517702|NCT01332292|11669060|FG000|COMPLETED|Washout Period (>=7 Days)||12
10517703|NCT01332292|11669061|FG001|COMPLETED|Washout Period (>=7 Days)||12
10517704|NCT01332292|11669060|FG000|NOT COMPLETED|Washout Period (>=7 Days)||0
10517705|NCT01332292|11669061|FG001|NOT COMPLETED|Washout Period (>=7 Days)||0
10517706|NCT01332292|11669060|FG000|STARTED|Treatment Period 2 (14 Days)||12
10517707|NCT01332292|11669061|FG001|STARTED|Treatment Period 2 (14 Days)||12
10517708|NCT01332292|11669060|FG000|COMPLETED|Treatment Period 2 (14 Days)||11
10517709|NCT01332292|11669061|FG001|COMPLETED|Treatment Period 2 (14 Days)||11
10517710|NCT01332292|11669060|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||1
10517711|NCT01332292|11669061|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||1
10517712|NCT01332305|11669074|FG000|STARTED|Overall Study||41
10517713|NCT01332305|11669075|FG001|STARTED|Overall Study||48
10517714|NCT01332305|11669076|FG002|STARTED|Overall Study||45
10517715|NCT01332305|11669077|FG003|STARTED|Overall Study||38
10517716|NCT01332305|11669078|FG004|STARTED|Overall Study||45
10517717|NCT01332305|11669074|FG000|COMPLETED|Overall Study||31
10517718|NCT01332305|11669075|FG001|COMPLETED|Overall Study||34
10517719|NCT01332305|11669076|FG002|COMPLETED|Overall Study||31
10517720|NCT01332305|11669077|FG003|COMPLETED|Overall Study||30
10517721|NCT01332305|11669078|FG004|COMPLETED|Overall Study||33
10517722|NCT01332305|11669074|FG000|NOT COMPLETED|Overall Study||10
10517723|NCT01332305|11669075|FG001|NOT COMPLETED|Overall Study||14
10517724|NCT01332305|11669076|FG002|NOT COMPLETED|Overall Study||14
10517725|NCT01332305|11669077|FG003|NOT COMPLETED|Overall Study||8
10517726|NCT01332305|11669078|FG004|NOT COMPLETED|Overall Study||12
10517727|NCT01332318|11669094|FG000|STARTED|Overall Study||34
10517728|NCT01332318|11669095|FG001|STARTED|Overall Study||32
10517729|NCT01332318|11669096|FG002|STARTED|Overall Study||34
10517730|NCT01332318|11669097|FG003|STARTED|Overall Study||30
10517731|NCT01332318|11669094|FG000|COMPLETED|Overall Study||32
10517732|NCT01332318|11669095|FG001|COMPLETED|Overall Study||28
10517733|NCT01332318|11669096|FG002|COMPLETED|Overall Study||33
10517734|NCT01332318|11669097|FG003|COMPLETED|Overall Study||28
10517735|NCT01332318|11669094|FG000|NOT COMPLETED|Overall Study||2
10517736|NCT01332318|11669095|FG001|NOT COMPLETED|Overall Study||4
10517737|NCT01332318|11669096|FG002|NOT COMPLETED|Overall Study||1
10517738|NCT01332318|11669097|FG003|NOT COMPLETED|Overall Study||2
10517739|NCT01332331|11669110|FG000|STARTED|Overall Study||21
10517740|NCT01332331|11669111|FG001|STARTED|Overall Study||20
10711671|NCT02661178|11877047|FG013|NOT COMPLETED|Part 2||0
10711672|NCT02661178|11877048|FG014|NOT COMPLETED|Part 2||0
10711673|NCT02661217|11877100|FG000|STARTED|Overall Study||500
10711674|NCT02661217|11877101|FG001|STARTED|Overall Study||502
10711675|NCT02661217|11877100|FG000|Started 10 Weeks Treatment Epoch|Overall Study||497
10711676|NCT02661217|11877101|FG001|Started 10 Weeks Treatment Epoch|Overall Study||501
10711677|NCT02661217|11877100|FG000|Completed 10 Weeks Treatment Epoch|Overall Study||460
10711678|NCT02661217|11877101|FG001|Completed 10 Weeks Treatment Epoch|Overall Study||455
10711679|NCT02661217|11877100|FG000|COMPLETED|Overall Study||425
10711680|NCT02661217|11877101|FG001|COMPLETED|Overall Study||419
10711681|NCT02661217|11877100|FG000|NOT COMPLETED|Overall Study||75
10711682|NCT02661217|11877101|FG001|NOT COMPLETED|Overall Study||83
10711683|NCT02661256|11877108|FG000|STARTED|Overall Study|Each participant went through arms in same order: on nCPAP then off nCPAP. 1 participant at a time.|7
10711684|NCT02661256|11877108|FG000|COMPLETED|Overall Study||7
10711685|NCT02661256|11877108|FG000|NOT COMPLETED|Overall Study||0
10711686|NCT02661490|11877119|FG000|STARTED|Overall Study||76
10711687|NCT02661490|11877120|FG001|STARTED|Overall Study||74
10711688|NCT02661490|11877121|FG002|STARTED|Overall Study||72
10711689|NCT02661490|11877122|FG003|STARTED|Overall Study||72
10517741|NCT01332331|11669110|FG000|COMPLETED|Overall Study||19
10517742|NCT01332331|11669111|FG001|COMPLETED|Overall Study||18
10517743|NCT01332331|11669110|FG000|NOT COMPLETED|Overall Study||2
10517744|NCT01332331|11669111|FG001|NOT COMPLETED|Overall Study||2
10517745|NCT01332357|11669118|FG000|STARTED|Overall Study||6139
10517746|NCT01332357|11669118|FG000|COMPLETED|Overall Study||6139
10517747|NCT01332357|11669118|FG000|NOT COMPLETED|Overall Study||0
10517748|NCT01332435|11669126|FG000|STARTED|Overall Study||1572
10711690|NCT02661490|11877123|FG004|STARTED|Overall Study||26
10517749|NCT01332435|11669127|FG001|STARTED|Overall Study||1064
10517750|NCT01332435|11669128|FG002|STARTED|Overall Study||2604
10517751|NCT01332435|11669129|FG003|STARTED|Overall Study||1656
10517752|NCT01332435|11669126|FG000|COMPLETED|Overall Study||1572
10517753|NCT01332435|11669127|FG001|COMPLETED|Overall Study||1064
10517754|NCT01332435|11669128|FG002|COMPLETED|Overall Study||2604
10517755|NCT01332435|11669129|FG003|COMPLETED|Overall Study||1656
10517756|NCT01332435|11669126|FG000|NOT COMPLETED|Overall Study||0
10517757|NCT01332435|11669127|FG001|NOT COMPLETED|Overall Study||0
10517758|NCT01332435|11669128|FG002|NOT COMPLETED|Overall Study||0
10517759|NCT01332435|11669129|FG003|NOT COMPLETED|Overall Study||0
10711691|NCT02661490|11877119|FG000|COMPLETED|Overall Study||73
10711692|NCT02661490|11877120|FG001|COMPLETED|Overall Study||72
10711693|NCT02661490|11877121|FG002|COMPLETED|Overall Study||70
10517760|NCT01332461|11669142|FG000|STARTED|Overall Study||1291
10517761|NCT01332461|11669143|FG001|STARTED|Overall Study||4386
10517762|NCT01332461|11669142|FG000|COMPLETED|Overall Study||1291
10517763|NCT01332461|11669143|FG001|COMPLETED|Overall Study||4386
10517764|NCT01332461|11669142|FG000|NOT COMPLETED|Overall Study||0
10517765|NCT01332461|11669143|FG001|NOT COMPLETED|Overall Study||0
10517766|NCT01332487|11669151|FG000|STARTED|Overall Study||5554
10517767|NCT01332487|11669152|FG001|STARTED|Overall Study||3063
10517768|NCT01332487|11669151|FG000|COMPLETED|Overall Study||5554
10517769|NCT01332487|11669152|FG001|COMPLETED|Overall Study||3063
10517770|NCT01332487|11669151|FG000|NOT COMPLETED|Overall Study||0
10517771|NCT01332487|11669152|FG001|NOT COMPLETED|Overall Study||0
10517772|NCT01332500|11669162|FG000|STARTED|Overall Study||13257
10517773|NCT01332500|11669163|FG001|STARTED|Overall Study||39771
10517774|NCT01332500|11669164|FG002|STARTED|Overall Study||2903
10517775|NCT01332500|11669165|FG003|STARTED|Overall Study||5806
10517776|NCT01332500|11669162|FG000|COMPLETED|Overall Study||13257
10517777|NCT01332500|11669163|FG001|COMPLETED|Overall Study||39771
10517778|NCT01332500|11669164|FG002|COMPLETED|Overall Study||2903
10517779|NCT01332500|11669165|FG003|COMPLETED|Overall Study||5806
10517780|NCT01332500|11669162|FG000|NOT COMPLETED|Overall Study||0
10517781|NCT01332500|11669163|FG001|NOT COMPLETED|Overall Study||0
10517782|NCT01332500|11669164|FG002|NOT COMPLETED|Overall Study||0
10517783|NCT01332500|11669165|FG003|NOT COMPLETED|Overall Study||0
10517784|NCT01332578|11669175|FG000|STARTED|Period I||12
10517785|NCT01332578|11669176|FG001|STARTED|Period I||13
10517786|NCT01332578|11669175|FG000|COMPLETED|Period I||12
10517787|NCT01332578|11669176|FG001|COMPLETED|Period I||13
10517788|NCT01332578|11669175|FG000|NOT COMPLETED|Period I||0
10517789|NCT01332578|11669176|FG001|NOT COMPLETED|Period I||0
10517790|NCT01332578|11669175|FG000|STARTED|Washout Period||12
10517791|NCT01332578|11669176|FG001|STARTED|Washout Period||13
10517792|NCT01332578|11669175|FG000|COMPLETED|Washout Period||12
10517793|NCT01332578|11669176|FG001|COMPLETED|Washout Period||13
10517794|NCT01332578|11669175|FG000|NOT COMPLETED|Washout Period||0
10517795|NCT01332578|11669176|FG001|NOT COMPLETED|Washout Period||0
10711694|NCT02661490|11877122|FG003|COMPLETED|Overall Study||71
10711695|NCT02661490|11877123|FG004|COMPLETED|Overall Study||23
10711696|NCT02661490|11877119|FG000|NOT COMPLETED|Overall Study||3
10711697|NCT02661490|11877120|FG001|NOT COMPLETED|Overall Study||2
10711698|NCT02661490|11877121|FG002|NOT COMPLETED|Overall Study||2
10517796|NCT01332578|11669175|FG000|STARTED|Period II||12
10517797|NCT01332578|11669176|FG001|STARTED|Period II||13
10517798|NCT01332578|11669175|FG000|COMPLETED|Period II||12
10517799|NCT01332578|11669176|FG001|COMPLETED|Period II||13
10517800|NCT01332578|11669175|FG000|NOT COMPLETED|Period II||0
10517801|NCT01332578|11669176|FG001|NOT COMPLETED|Period II||0
10517802|NCT01332630|11669183|FG000|STARTED|Overall Study||24
10517803|NCT01332630|11669183|FG000|COMPLETED|Overall Study||21
10517804|NCT01332630|11669183|FG000|NOT COMPLETED|Overall Study||3
10517805|NCT01332721|11669187|FG000|STARTED|Overall Study||38
10517806|NCT01332721|11669187|FG000|COMPLETED|Overall Study||38
10517807|NCT01332721|11669187|FG000|NOT COMPLETED|Overall Study||0
10517808|NCT01332851|11669193|FG000|STARTED|Overall Study||124
10517809|NCT01332851|11669194|FG001|STARTED|Overall Study||123
10517810|NCT01332851|11669193|FG000|Completed Intervention|Overall Study|9 no intervention, 8 <full dose, 107 full dose; 3 new caregivers enrolled-initial parent dropped out|107
10517811|NCT01332851|11669194|FG001|Completed Intervention|Overall Study|4 no intervention, 9 <full dose, 110 full dose; 4 new caregivers enrolled-initial parent dropped out|110
10517812|NCT01332851|11669193|FG000|Completed Follow up 1|Overall Study||116
10517813|NCT01332851|11669194|FG001|Completed Follow up 1|Overall Study|Includes 1 new caregiver enrolled due to initial parent no longer parenting|112
10517814|NCT01332851|11669193|FG000|Completed Follow up 2|Overall Study|Includes 1 new caregiver enrolled due to initial parent no longer parenting|111
10517815|NCT01332851|11669194|FG001|Completed Follow up 2|Overall Study|Includes 4 new caregivers enrolled due to initial parent no longer parenting|111
10517816|NCT01332851|11669193|FG000|Completed Follow up 3|Overall Study|Includes 3 new caregivers enrolled due to initial parent no longer parenting|113
10517817|NCT01332851|11669194|FG001|Completed Follow up 3|Overall Study|Includes 3 new caregivers enrolled due to initial parent no longer parenting|110
10517818|NCT01332851|11669193|FG000|COMPLETED|Overall Study||113
10517819|NCT01332851|11669194|FG001|COMPLETED|Overall Study||110
10517820|NCT01332851|11669193|FG000|NOT COMPLETED|Overall Study||11
10517821|NCT01332851|11669194|FG001|NOT COMPLETED|Overall Study||13
10517822|NCT01332981|11669204|FG000|STARTED|Overall Study||220
10517823|NCT01332981|11669204|FG000|COMPLETED|Overall Study||220
10517824|NCT01332981|11669204|FG000|NOT COMPLETED|Overall Study||0
10517825|NCT01332994|11669211|FG000|STARTED|Overall Study||519
10517826|NCT01332994|11669211|FG000|Completed Week 16|Overall Study||463
10517827|NCT01332994|11669211|FG000|Completed Week 32 (TCZ/TCZ)|Overall Study||200
10517828|NCT01332994|11669211|FG000|Completed Week 32 (TCZ/RTX)|Overall Study||26
10517829|NCT01332994|11669211|FG000|Completed Week 66 (TCZ/RTX)|Overall Study||25
10711699|NCT02661490|11877122|FG003|NOT COMPLETED|Overall Study||1
10711700|NCT02661490|11877123|FG004|NOT COMPLETED|Overall Study||3
10517830|NCT01332994|11669211|FG000|COMPLETED|Overall Study||448
10517831|NCT01332994|11669211|FG000|NOT COMPLETED|Overall Study||71
10517832|NCT01333033|11669217|FG000|STARTED|Overall Study||72
10517833|NCT01333033|11669218|FG001|STARTED|Overall Study||39
10517834|NCT01333033|11669219|FG002|STARTED|Overall Study||64
10517835|NCT01333033|11669220|FG003|STARTED|Overall Study||50
10517836|NCT01333033|11669221|FG004|STARTED|Overall Study||14
10517837|NCT01333033|11669222|FG005|STARTED|Overall Study||18
10517838|NCT01333033|11669217|FG000|COMPLETED|Overall Study||72
10517839|NCT01333033|11669218|FG001|COMPLETED|Overall Study||39
10517840|NCT01333033|11669219|FG002|COMPLETED|Overall Study||64
10517841|NCT01333033|11669220|FG003|COMPLETED|Overall Study||50
10517842|NCT01333033|11669221|FG004|COMPLETED|Overall Study||0
10517843|NCT01333033|11669222|FG005|COMPLETED|Overall Study||0
10517844|NCT01333033|11669217|FG000|NOT COMPLETED|Overall Study||0
10517845|NCT01333033|11669218|FG001|NOT COMPLETED|Overall Study||0
10517846|NCT01333033|11669219|FG002|NOT COMPLETED|Overall Study||0
10517847|NCT01333033|11669220|FG003|NOT COMPLETED|Overall Study||0
10517848|NCT01333033|11669221|FG004|NOT COMPLETED|Overall Study||14
10517849|NCT01333033|11669222|FG005|NOT COMPLETED|Overall Study||18
10517850|NCT01333059|11669242|FG000|STARTED|Overall Study||14
10517851|NCT01333059|11669243|FG001|STARTED|Overall Study||11
10517852|NCT01333059|11669242|FG000|COMPLETED|Overall Study||8
10517853|NCT01333059|11669243|FG001|COMPLETED|Overall Study||8
10517854|NCT01333059|11669242|FG000|NOT COMPLETED|Overall Study||6
10517855|NCT01333059|11669243|FG001|NOT COMPLETED|Overall Study||3
10517856|NCT01333072|11669253|FG000|STARTED|Overall Study||30
10517857|NCT01333072|11669254|FG001|STARTED|Overall Study||31
10517858|NCT01333072|11669253|FG000|COMPLETED|Overall Study||24
10517859|NCT01333072|11669254|FG001|COMPLETED|Overall Study||27
10517860|NCT01333072|11669253|FG000|NOT COMPLETED|Overall Study||6
10517861|NCT01333072|11669254|FG001|NOT COMPLETED|Overall Study||4
10517862|NCT01333098|11669260|FG000|STARTED|Overall Study||15
10517863|NCT01333098|11669260|FG000|COMPLETED|Overall Study||12
10517864|NCT01333098|11669260|FG000|NOT COMPLETED|Overall Study||3
10517865|NCT01333111|11669269|FG000|STARTED|Overall Study||30
10517866|NCT01333111|11669270|FG001|STARTED|Overall Study||29
10517867|NCT01333111|11669271|FG002|STARTED|Overall Study||15
10517868|NCT01333111|11669269|FG000|COMPLETED|Overall Study||28
10517869|NCT01333111|11669270|FG001|COMPLETED|Overall Study||26
10517870|NCT01333111|11669271|FG002|COMPLETED|Overall Study||13
10517871|NCT01333111|11669269|FG000|NOT COMPLETED|Overall Study||2
10517872|NCT01333111|11669270|FG001|NOT COMPLETED|Overall Study||3
10517873|NCT01333111|11669271|FG002|NOT COMPLETED|Overall Study||2
10517874|NCT01333189|11669281|FG000|STARTED|Overall Study||13
10517875|NCT01333189|11669282|FG001|STARTED|Overall Study||13
10517876|NCT01333189|11669281|FG000|COMPLETED|Overall Study||11
10517877|NCT01333189|11669282|FG001|COMPLETED|Overall Study||11
10517878|NCT01333189|11669281|FG000|NOT COMPLETED|Overall Study||2
10517879|NCT01333189|11669282|FG001|NOT COMPLETED|Overall Study||2
10528653|NCT01396148|11680984|FG000|STARTED|Overall Study||6
10528654|NCT01396148|11680984|FG000|COMPLETED|Overall Study||5
10528655|NCT01396148|11680984|FG000|NOT COMPLETED|Overall Study||1
10528656|NCT01396161|11680997|FG000|STARTED|Overall Study||12
10528657|NCT01396161|11680998|FG001|STARTED|Overall Study||5
10528658|NCT01396161|11680999|FG002|STARTED|Overall Study||9
10528659|NCT01396161|11681000|FG003|STARTED|Overall Study||9
10528660|NCT01396161|11681001|FG004|STARTED|Overall Study||9
10528661|NCT01396161|11681002|FG005|STARTED|Overall Study||9
10528662|NCT01396161|11681003|FG006|STARTED|Overall Study||11
10528663|NCT01396161|11680997|FG000|COMPLETED|Overall Study||12
10528664|NCT01396161|11680998|FG001|COMPLETED|Overall Study||5
10528665|NCT01396161|11680999|FG002|COMPLETED|Overall Study||9
10528666|NCT01396161|11681000|FG003|COMPLETED|Overall Study||9
10528667|NCT01396161|11681001|FG004|COMPLETED|Overall Study||8
10528668|NCT01396161|11681002|FG005|COMPLETED|Overall Study||9
10528669|NCT01396161|11681003|FG006|COMPLETED|Overall Study||10
10528670|NCT01396161|11680997|FG000|NOT COMPLETED|Overall Study||0
10528671|NCT01396161|11680998|FG001|NOT COMPLETED|Overall Study||0
10528672|NCT01396161|11680999|FG002|NOT COMPLETED|Overall Study||0
10528673|NCT01396161|11681000|FG003|NOT COMPLETED|Overall Study||0
10528674|NCT01396161|11681001|FG004|NOT COMPLETED|Overall Study||1
10528675|NCT01396161|11681002|FG005|NOT COMPLETED|Overall Study||0
10528676|NCT01396161|11681003|FG006|NOT COMPLETED|Overall Study||1
10528677|NCT01396187|11681029|FG000|STARTED|Overall Study||8
10528678|NCT01396187|11681030|FG001|STARTED|Overall Study||12
10528679|NCT01396187|11681031|FG002|STARTED|Overall Study||10
10528680|NCT01396187|11681032|FG003|STARTED|Overall Study||10
10528681|NCT01396187|11681033|FG004|STARTED|Overall Study||10
10528682|NCT01396187|11681029|FG000|COMPLETED|Overall Study||7
10528683|NCT01396187|11681030|FG001|COMPLETED|Overall Study||9
10528684|NCT01396187|11681031|FG002|COMPLETED|Overall Study||9
10528685|NCT01396187|11681032|FG003|COMPLETED|Overall Study||10
10528686|NCT01396187|11681033|FG004|COMPLETED|Overall Study||9
10528687|NCT01396187|11681029|FG000|NOT COMPLETED|Overall Study||1
10528688|NCT01396187|11681030|FG001|NOT COMPLETED|Overall Study||3
10528689|NCT01396187|11681031|FG002|NOT COMPLETED|Overall Study||1
10528690|NCT01396187|11681032|FG003|NOT COMPLETED|Overall Study||0
10528691|NCT01396187|11681033|FG004|NOT COMPLETED|Overall Study||1
10528692|NCT01396226|11681051|FG000|STARTED|Overall Study||12
10528693|NCT01396226|11681052|FG001|STARTED|Overall Study||6
10528694|NCT01396226|11681051|FG000|Patients Who Received Treatment|Overall Study||12
10528695|NCT01396226|11681052|FG001|Patients Who Received Treatment|Overall Study||6
10711701|NCT02661594|11877139|FG000|STARTED|Overall Study||10
10711702|NCT02661594|11877140|FG001|STARTED|Overall Study||11
10711703|NCT02661594|11877141|FG002|STARTED|Overall Study||10
10517895|NCT01333475|11669320|FG000|STARTED|Overall Study||12
10517896|NCT01333475|11669321|FG001|STARTED|Overall Study||9
10517897|NCT01333475|11669320|FG000|COMPLETED|Overall Study||10
10517898|NCT01333475|11669321|FG001|COMPLETED|Overall Study||6
10517899|NCT01333475|11669320|FG000|NOT COMPLETED|Overall Study||2
10517900|NCT01333475|11669321|FG001|NOT COMPLETED|Overall Study||3
10517901|NCT01333488|11669331|FG000|STARTED|Overall Study||2
10517902|NCT01333488|11669332|FG001|STARTED|Overall Study||1
10517903|NCT01333488|11669333|FG002|STARTED|Overall Study||3
10517904|NCT01333488|11669331|FG000|COMPLETED|Overall Study||2
10517905|NCT01333488|11669332|FG001|COMPLETED|Overall Study||1
10517906|NCT01333488|11669333|FG002|COMPLETED|Overall Study||3
10517907|NCT01333488|11669331|FG000|NOT COMPLETED|Overall Study||0
10517908|NCT01333488|11669332|FG001|NOT COMPLETED|Overall Study||0
10517909|NCT01333488|11669333|FG002|NOT COMPLETED|Overall Study||0
10517910|NCT01333501|11669344|FG000|STARTED|Overall Study||106
10517911|NCT01333501|11669345|FG001|STARTED|Overall Study||51
10517912|NCT01333501|11669344|FG000|Full Analysis Set (FAS)|Overall Study||80
10517913|NCT01333501|11669345|FG001|Full Analysis Set (FAS)|Overall Study||28
10517914|NCT01333501|11669344|FG000|Safety Population|Overall Study||104
10517915|NCT01333501|11669345|FG001|Safety Population|Overall Study||47
10517916|NCT01333501|11669344|FG000|COMPLETED|Overall Study||97
10517917|NCT01333501|11669345|FG001|COMPLETED|Overall Study||30
10517918|NCT01333501|11669344|FG000|NOT COMPLETED|Overall Study||9
10517919|NCT01333501|11669345|FG001|NOT COMPLETED|Overall Study||21
10517920|NCT01333527|11669353|FG000|STARTED|Overall Study||105
10517921|NCT01333527|11669354|FG001|STARTED|Overall Study||106
10517922|NCT01333527|11669353|FG000|COMPLETED|Overall Study||87
10517923|NCT01333527|11669354|FG001|COMPLETED|Overall Study||89
10517924|NCT01333527|11669353|FG000|NOT COMPLETED|Overall Study||18
10517925|NCT01333527|11669354|FG001|NOT COMPLETED|Overall Study||17
10517926|NCT01333592|11669362|FG000|STARTED|Overall Study||67
10517927|NCT01333592|11669363|FG001|STARTED|Overall Study||69
10517928|NCT01333592|11669362|FG000|COMPLETED|Overall Study||58
10517929|NCT01333592|11669363|FG001|COMPLETED|Overall Study||52
10517930|NCT01333592|11669362|FG000|NOT COMPLETED|Overall Study||9
10517931|NCT01333592|11669363|FG001|NOT COMPLETED|Overall Study||17
10517932|NCT01333722|11669371|FG000|STARTED|Overall Study||51
10517933|NCT01333722|11669372|FG001|STARTED|Overall Study||49
10517934|NCT01333722|11669371|FG000|COMPLETED|Overall Study||51
10517935|NCT01333722|11669372|FG001|COMPLETED|Overall Study||46
10517936|NCT01333722|11669371|FG000|NOT COMPLETED|Overall Study||0
10517937|NCT01333722|11669372|FG001|NOT COMPLETED|Overall Study||3
10517938|NCT01333813|11669380|FG000|STARTED|Overall Study||297
10517939|NCT01333813|11669380|FG000|COMPLETED|Overall Study||297
10517940|NCT01333813|11669380|FG000|NOT COMPLETED|Overall Study||0
10517941|NCT01333865|11669384|FG000|STARTED|Overall Study|25 participants signed consent, but only 19 completed screening and were analyzed at baseline.|19
10517942|NCT01333865|11669384|FG000|COMPLETED|Overall Study|2 participants were withdrawn. One was still analyzed, but one was withdrawn too early for analysis|17
10517943|NCT01333865|11669384|FG000|NOT COMPLETED|Overall Study||2
10517944|NCT01333956|11669392|FG000|STARTED|Overall Study||30
10517945|NCT01333956|11669393|FG001|STARTED|Overall Study||30
10517946|NCT01333956|11669394|FG002|STARTED|Overall Study||30
10517947|NCT01333956|11669395|FG003|STARTED|Overall Study||30
10517948|NCT01333956|11669392|FG000|COMPLETED|Overall Study||28
10517949|NCT01333956|11669393|FG001|COMPLETED|Overall Study||26
10517950|NCT01333956|11669394|FG002|COMPLETED|Overall Study||29
10517951|NCT01333956|11669395|FG003|COMPLETED|Overall Study||28
10517952|NCT01333956|11669392|FG000|NOT COMPLETED|Overall Study||2
10517953|NCT01333956|11669393|FG001|NOT COMPLETED|Overall Study||4
10517954|NCT01333956|11669394|FG002|NOT COMPLETED|Overall Study||1
10517955|NCT01333956|11669395|FG003|NOT COMPLETED|Overall Study||2
10711704|NCT02661594|11877142|FG003|STARTED|Overall Study||9
10711705|NCT02661594|11877139|FG000|COMPLETED|Overall Study||9
10517956|NCT01334086|11669406|FG000|STARTED|Overall Study||41
10517957|NCT01334086|11669406|FG000|COMPLETED|Overall Study||41
10517958|NCT01334086|11669406|FG000|NOT COMPLETED|Overall Study||0
10517959|NCT01334125|11669412|FG000|STARTED|Overall Study||15
10517960|NCT01334125|11669413|FG001|STARTED|Overall Study||13
10517961|NCT01334125|11669412|FG000|COMPLETED|Overall Study|3 subjects move to another city|12
10517962|NCT01334125|11669413|FG001|COMPLETED|Overall Study|3 subjects left for college and moved out of the area|10
10517963|NCT01334125|11669412|FG000|NOT COMPLETED|Overall Study||3
10711706|NCT02661594|11877140|FG001|COMPLETED|Overall Study||11
10517964|NCT01334125|11669413|FG001|NOT COMPLETED|Overall Study||3
10517965|NCT01334216|11669422|FG000|STARTED|Overall Study||168
10517966|NCT01334216|11669423|FG001|STARTED|Overall Study||194
10517967|NCT01334216|11669422|FG000|COMPLETED|Overall Study||168
10517968|NCT01334216|11669423|FG001|COMPLETED|Overall Study||194
10517969|NCT01334216|11669422|FG000|NOT COMPLETED|Overall Study||0
10517970|NCT01334216|11669423|FG001|NOT COMPLETED|Overall Study||0
10517971|NCT01334229|11669431|FG000|STARTED|Overall Study||11
10517972|NCT01334229|11669432|FG001|STARTED|Overall Study||11
10517973|NCT01334229|11669431|FG000|COMPLETED|Overall Study||11
10517974|NCT01334229|11669432|FG001|COMPLETED|Overall Study||11
10517975|NCT01334229|11669431|FG000|NOT COMPLETED|Overall Study||0
10517976|NCT01334229|11669432|FG001|NOT COMPLETED|Overall Study||0
10517977|NCT01334515|11669440|FG000|STARTED|Overall Study||16
10517978|NCT01334515|11669441|FG001|STARTED|Overall Study||36
10517979|NCT01334515|11669440|FG000|COMPLETED|Overall Study||4
10517980|NCT01334515|11669441|FG001|COMPLETED|Overall Study||7
10517981|NCT01334515|11669440|FG000|NOT COMPLETED|Overall Study||12
10517982|NCT01334515|11669441|FG001|NOT COMPLETED|Overall Study||29
10517983|NCT01334554|11669449|FG000|STARTED|Overall Study||23
10517984|NCT01334554|11669450|FG001|STARTED|Overall Study||23
10517985|NCT01334554|11669449|FG000|COMPLETED|Overall Study||19
10517986|NCT01334554|11669450|FG001|COMPLETED|Overall Study||21
10517987|NCT01334554|11669449|FG000|NOT COMPLETED|Overall Study||4
10517988|NCT01334554|11669450|FG001|NOT COMPLETED|Overall Study||2
10517989|NCT01334710|11669458|FG000|STARTED|Overall Study||3
10517990|NCT01334710|11669458|FG000|COMPLETED|Overall Study|Due to safety signals in a parallel trial ON OSI906 in hepatocellular cancer the trial was stopped.|0
10517991|NCT01334710|11669458|FG000|NOT COMPLETED|Overall Study||3
10517992|NCT01334723|11669465|FG000|STARTED|Overall Study||17293
10517993|NCT01334723|11669466|FG001|STARTED|Overall Study||17739
10517994|NCT01334723|11669465|FG000|COMPLETED|Overall Study||17293
10517995|NCT01334723|11669466|FG001|COMPLETED|Overall Study||17739
10517996|NCT01334723|11669465|FG000|NOT COMPLETED|Overall Study||0
10517997|NCT01334723|11669466|FG001|NOT COMPLETED|Overall Study||0
10517998|NCT01334827|11669486|FG000|STARTED|Overall Study||48
10517999|NCT01334827|11669486|FG000|COMPLETED|Overall Study||48
10518000|NCT01334827|11669486|FG000|NOT COMPLETED|Overall Study||0
10518001|NCT01334866|11669492|FG000|STARTED|Overall Study|91 subjects were enrolled in the study; with 89 subjects receiving the study treatment.|91
10518002|NCT01334866|11669492|FG000|COMPLETED|Overall Study||72
10518003|NCT01334866|11669492|FG000|NOT COMPLETED|Overall Study||19
10518004|NCT01334918|11669500|FG000|STARTED|Overall Study||63
10518005|NCT01334918|11669501|FG001|STARTED|Overall Study||61
10518006|NCT01334918|11669500|FG000|Randomized + 1 Stress Scan|Overall Study|Equates to Safety Analysis Set (SAF)|57
10518007|NCT01334918|11669501|FG001|Randomized + 1 Stress Scan|Overall Study|Equates to Safety Analysis Set (SAF)|61
10518008|NCT01334918|11669500|FG000|COMPLETED|Overall Study||55
10518009|NCT01334918|11669501|FG001|COMPLETED|Overall Study||60
10518010|NCT01334918|11669500|FG000|NOT COMPLETED|Overall Study||8
10518011|NCT01334918|11669501|FG001|NOT COMPLETED|Overall Study||1
10518012|NCT01334944|11669518|FG000|STARTED|Overall Study||11
10518013|NCT01334944|11669519|FG001|STARTED|Overall Study||139
10518014|NCT01334944|11669518|FG000|Received Singel Dose|Overall Study||1
10518015|NCT01334944|11669519|FG001|Received Singel Dose|Overall Study||96
10518016|NCT01334944|11669518|FG000|Received Multiple Doses|Overall Study||10
10518017|NCT01334944|11669519|FG001|Received Multiple Doses|Overall Study||43
10518018|NCT01334944|11669518|FG000|COMPLETED|Overall Study||11
10518019|NCT01334944|11669519|FG001|COMPLETED|Overall Study||139
10711707|NCT02661594|11877141|FG002|COMPLETED|Overall Study||9
10711708|NCT02661594|11877142|FG003|COMPLETED|Overall Study||9
10711709|NCT02661594|11877139|FG000|NOT COMPLETED|Overall Study||1
10518020|NCT01334944|11669518|FG000|NOT COMPLETED|Overall Study||0
10518021|NCT01334944|11669519|FG001|NOT COMPLETED|Overall Study||0
10518022|NCT01334957|11669528|FG000|STARTED|Overall Study||300
10518023|NCT01334957|11669528|FG000|Received Single Dose|Overall Study||252
10518024|NCT01334957|11669528|FG000|Received Multiple Doses|Overall Study||48
10711710|NCT02661594|11877140|FG001|NOT COMPLETED|Overall Study||0
10518025|NCT01334957|11669528|FG000|COMPLETED|Overall Study||300
10518026|NCT01334957|11669528|FG000|NOT COMPLETED|Overall Study||0
10518027|NCT01335009|11669534|FG000|STARTED|Overall Study||40
10518028|NCT01335009|11669535|FG001|STARTED|Overall Study||36
10518029|NCT01335009|11669534|FG000|COMPLETED|Overall Study||9
10518030|NCT01335009|11669535|FG001|COMPLETED|Overall Study||3
10518031|NCT01335009|11669534|FG000|NOT COMPLETED|Overall Study||31
10518032|NCT01335009|11669535|FG001|NOT COMPLETED|Overall Study||33
10518033|NCT01335061|11669541|FG000|STARTED|Overall Study||25
10518034|NCT01335061|11669541|FG000|COMPLETED|Overall Study||25
10518035|NCT01335061|11669541|FG000|NOT COMPLETED|Overall Study||0
10518036|NCT01335191|11669554|FG000|STARTED|Overall Study||16
10518037|NCT01335191|11669555|FG001|STARTED|Overall Study||11
10518038|NCT01335191|11669554|FG000|COMPLETED|Overall Study||16
10518039|NCT01335191|11669555|FG001|COMPLETED|Overall Study||11
10518040|NCT01335191|11669554|FG000|NOT COMPLETED|Overall Study||0
10518041|NCT01335191|11669555|FG001|NOT COMPLETED|Overall Study||0
10518042|NCT01335204|11669561|FG000|STARTED|Overall Study||4
10518043|NCT01335204|11669561|FG000|COMPLETED|Overall Study||4
10518044|NCT01335204|11669561|FG000|NOT COMPLETED|Overall Study||0
10518045|NCT01335230|11669569|FG000|STARTED|Overall Study|subjects|10
10518046|NCT01335230|11669570|FG001|STARTED|Overall Study|subjects|10
10518047|NCT01335230|11669571|FG002|STARTED|Overall Study|subjects|10
10518048|NCT01335230|11669572|FG003|STARTED|Overall Study|subjects|10
10711711|NCT02661594|11877141|FG002|NOT COMPLETED|Overall Study||1
10711712|NCT02661594|11877142|FG003|NOT COMPLETED|Overall Study||0
10711713|NCT02661737|11877152|FG000|STARTED|Overall Study||503
10711714|NCT02661737|11877152|FG000|COMPLETED|Overall Study||469
10711715|NCT02661737|11877152|FG000|NOT COMPLETED|Overall Study||34
10711716|NCT02661815|11877160|FG000|STARTED|Overall Study||6
10711717|NCT02661815|11877161|FG001|STARTED|Overall Study||0
10518049|NCT01335230|11669569|FG000|COMPLETED|Overall Study|subjects|10
10518050|NCT01335230|11669570|FG001|COMPLETED|Overall Study|subjects|10
10518051|NCT01335230|11669571|FG002|COMPLETED|Overall Study|subjects|10
10518052|NCT01335230|11669572|FG003|COMPLETED|Overall Study|subjects|10
10518053|NCT01335230|11669569|FG000|NOT COMPLETED|Overall Study||0
10518054|NCT01335230|11669570|FG001|NOT COMPLETED|Overall Study||0
10518055|NCT01335230|11669571|FG002|NOT COMPLETED|Overall Study||0
10518056|NCT01335230|11669572|FG003|NOT COMPLETED|Overall Study||0
10518057|NCT01335308|11669585|FG000|STARTED|Overall Study||198
10518058|NCT01335308|11669586|FG001|STARTED|Overall Study||212
10518059|NCT01335308|11669587|FG002|STARTED|Overall Study||235
10518060|NCT01335308|11669585|FG000|COMPLETED|Overall Study||158
10518061|NCT01335308|11669586|FG001|COMPLETED|Overall Study||145
10518062|NCT01335308|11669587|FG002|COMPLETED|Overall Study||154
10518063|NCT01335308|11669585|FG000|NOT COMPLETED|Overall Study||40
10518064|NCT01335308|11669586|FG001|NOT COMPLETED|Overall Study||67
10518065|NCT01335308|11669587|FG002|NOT COMPLETED|Overall Study||81
10518066|NCT01335464|11669597|FG000|STARTED|Overall Study||206
10518067|NCT01335464|11669598|FG001|STARTED|Overall Study||309
10518068|NCT01335464|11669597|FG000|COMPLETED|Overall Study||174
10518069|NCT01335464|11669598|FG001|COMPLETED|Overall Study||260
10518070|NCT01335464|11669597|FG000|NOT COMPLETED|Overall Study||32
10518071|NCT01335464|11669598|FG001|NOT COMPLETED|Overall Study||49
10518072|NCT01335477|11669606|FG000|STARTED|Overall Study||220
10518073|NCT01335477|11669607|FG001|STARTED|Overall Study||331
10518074|NCT01335477|11669606|FG000|COMPLETED|Overall Study||179
10518075|NCT01335477|11669607|FG001|COMPLETED|Overall Study||272
10518076|NCT01335477|11669606|FG000|NOT COMPLETED|Overall Study||41
10518077|NCT01335477|11669607|FG001|NOT COMPLETED|Overall Study||59
10518078|NCT01335542|11669615|FG000|STARTED|Overall Study||45
10518079|NCT01335542|11669616|FG001|STARTED|Overall Study||45
10518080|NCT01335542|11669615|FG000|COMPLETED|Overall Study||45
10518081|NCT01335542|11669616|FG001|COMPLETED|Overall Study||45
10518082|NCT01335542|11669615|FG000|NOT COMPLETED|Overall Study||0
10518083|NCT01335542|11669616|FG001|NOT COMPLETED|Overall Study||0
10518084|NCT01335620|11669622|FG000|STARTED|Overall Study||19
10518085|NCT01335620|11669622|FG000|COMPLETED|Overall Study||19
10518086|NCT01335620|11669622|FG000|NOT COMPLETED|Overall Study||0
10518087|NCT01335698|11669631|FG000|STARTED|Treatment Stage 1||23
10518088|NCT01335698|11669632|FG001|STARTED|Treatment Stage 1||12
10518089|NCT01335698|11669633|FG002|STARTED|Treatment Stage 1||21
10518090|NCT01335698|11669634|FG003|STARTED|Treatment Stage 1||35
10518091|NCT01335698|11669635|FG004|STARTED|Treatment Stage 1||8
10518092|NCT01335698|11669631|FG000|COMPLETED|Treatment Stage 1||15
10518093|NCT01335698|11669632|FG001|COMPLETED|Treatment Stage 1||4
10518094|NCT01335698|11669633|FG002|COMPLETED|Treatment Stage 1||16
10518095|NCT01335698|11669634|FG003|COMPLETED|Treatment Stage 1||26
10518096|NCT01335698|11669635|FG004|COMPLETED|Treatment Stage 1||6
10518097|NCT01335698|11669631|FG000|NOT COMPLETED|Treatment Stage 1||8
10518098|NCT01335698|11669632|FG001|NOT COMPLETED|Treatment Stage 1||8
10518099|NCT01335698|11669633|FG002|NOT COMPLETED|Treatment Stage 1||5
10518100|NCT01335698|11669634|FG003|NOT COMPLETED|Treatment Stage 1||9
10518101|NCT01335698|11669635|FG004|NOT COMPLETED|Treatment Stage 1||2
10518102|NCT01335698|11669631|FG000|STARTED|Treatment Stage 2||15
10518103|NCT01335698|11669632|FG001|STARTED|Treatment Stage 2||4
10518104|NCT01335698|11669633|FG002|STARTED|Treatment Stage 2||16
10518105|NCT01335698|11669634|FG003|STARTED|Treatment Stage 2||26
10518106|NCT01335698|11669635|FG004|STARTED|Treatment Stage 2||6
10518107|NCT01335698|11669631|FG000|COMPLETED|Treatment Stage 2||4
10518108|NCT01335698|11669632|FG001|COMPLETED|Treatment Stage 2||1
10518109|NCT01335698|11669633|FG002|COMPLETED|Treatment Stage 2||11
10518110|NCT01335698|11669634|FG003|COMPLETED|Treatment Stage 2||18
10518111|NCT01335698|11669635|FG004|COMPLETED|Treatment Stage 2||5
10518112|NCT01335698|11669631|FG000|NOT COMPLETED|Treatment Stage 2||11
10518113|NCT01335698|11669632|FG001|NOT COMPLETED|Treatment Stage 2||3
10518114|NCT01335698|11669633|FG002|NOT COMPLETED|Treatment Stage 2||5
10518115|NCT01335698|11669634|FG003|NOT COMPLETED|Treatment Stage 2||8
10518116|NCT01335698|11669635|FG004|NOT COMPLETED|Treatment Stage 2||1
10518117|NCT01335724|11669651|FG000|STARTED|Overall Study||36
10518118|NCT01335724|11669652|FG001|STARTED|Overall Study||36
10518119|NCT01335724|11669651|FG000|COMPLETED|Overall Study||36
10518120|NCT01335724|11669652|FG001|COMPLETED|Overall Study||36
10518121|NCT01335724|11669651|FG000|NOT COMPLETED|Overall Study||0
10518122|NCT01335724|11669652|FG001|NOT COMPLETED|Overall Study||0
10711718|NCT02661815|11877162|FG002|STARTED|Overall Study||0
10711719|NCT02661815|11877163|FG003|STARTED|Overall Study||0
10711720|NCT02661815|11877160|FG000|COMPLETED|Overall Study||5
10711721|NCT02661815|11877161|FG001|COMPLETED|Overall Study||0
10518123|NCT01335750|11669658|FG000|STARTED|Overall Study||32
10518124|NCT01335750|11669658|FG000|COMPLETED|Overall Study||32
10518125|NCT01335750|11669658|FG000|NOT COMPLETED|Overall Study||0
10518126|NCT01335789|11669672|FG000|STARTED|Overall Study||8
10518127|NCT01335789|11669673|FG001|STARTED|Overall Study||8
10518128|NCT01335789|11669672|FG000|COMPLETED|Overall Study||8
10518129|NCT01335789|11669673|FG001|COMPLETED|Overall Study||8
10518130|NCT01335789|11669672|FG000|NOT COMPLETED|Overall Study||0
10518131|NCT01335789|11669673|FG001|NOT COMPLETED|Overall Study||0
10518132|NCT01335867|11669681|FG000|STARTED|Overall Study||16
10518133|NCT01335867|11669682|FG001|STARTED|Overall Study||16
10518134|NCT01335867|11669681|FG000|COMPLETED|Overall Study||9
10518135|NCT01335867|11669682|FG001|COMPLETED|Overall Study||12
10518136|NCT01335867|11669681|FG000|NOT COMPLETED|Overall Study||7
10518137|NCT01335867|11669682|FG001|NOT COMPLETED|Overall Study||4
10518138|NCT01335932|11669697|FG000|STARTED|Overall Study||84
10518139|NCT01335932|11669698|FG001|STARTED|Overall Study||76
10711722|NCT02661815|11877162|FG002|COMPLETED|Overall Study||0
10518140|NCT01335932|11669697|FG000|COMPLETED|Overall Study||84
10518141|NCT01335932|11669698|FG001|COMPLETED|Overall Study||72
10518142|NCT01335932|11669697|FG000|NOT COMPLETED|Overall Study||0
10518143|NCT01335932|11669698|FG001|NOT COMPLETED|Overall Study||4
10518144|NCT01335971|11669707|FG000|STARTED|Overall Study||31
10518145|NCT01335971|11669708|FG001|STARTED|Overall Study||29
10518146|NCT01335971|11669709|FG002|STARTED|Overall Study||29
10518147|NCT01335971|11669707|FG000|COMPLETED|Overall Study||29
10518148|NCT01335971|11669708|FG001|COMPLETED|Overall Study||28
10518149|NCT01335971|11669709|FG002|COMPLETED|Overall Study||28
10518150|NCT01335971|11669707|FG000|NOT COMPLETED|Overall Study||2
10518151|NCT01335971|11669708|FG001|NOT COMPLETED|Overall Study||1
10518152|NCT01335971|11669709|FG002|NOT COMPLETED|Overall Study||1
10518153|NCT01336023|11669720|FG000|STARTED|Week 0 to Week 26||414
10518154|NCT01336023|11669721|FG001|STARTED|Week 0 to Week 26||834
10518155|NCT01336023|11669722|FG002|STARTED|Week 0 to Week 26||415
10518156|NCT01336023|11669720|FG000|Exposed|Week 0 to Week 26|1 subject withdrew before exposure to trial drug and was not included in the analysis|413
10518157|NCT01336023|11669721|FG001|Exposed|Week 0 to Week 26|8 subjects withdrew before exposure to trial drug and were not included in the analysis|826
10518158|NCT01336023|11669722|FG002|Exposed|Week 0 to Week 26|2 subjects withdrew before exposure to trial drug and were not included in the analysis|413
10518159|NCT01336023|11669720|FG000|COMPLETED|Week 0 to Week 26||366
10518160|NCT01336023|11669721|FG001|COMPLETED|Week 0 to Week 26||736
10518161|NCT01336023|11669722|FG002|COMPLETED|Week 0 to Week 26||342
10518162|NCT01336023|11669720|FG000|NOT COMPLETED|Week 0 to Week 26||48
10518163|NCT01336023|11669721|FG001|NOT COMPLETED|Week 0 to Week 26||98
10518164|NCT01336023|11669722|FG002|NOT COMPLETED|Week 0 to Week 26||73
10518165|NCT01336023|11669720|FG000|STARTED|Week 27 to 52|From the main trial, 33 subjects were not enrolled in the extension (week 27-52).|333
10518166|NCT01336023|11669721|FG001|STARTED|Week 27 to 52|From the main trial, 71 subjects were not enrolled in the extension (week 27-52).|665
10518167|NCT01336023|11669722|FG002|STARTED|Week 27 to 52|From the main trial, 29 subjects were not enrolled in the extension (week 27-52).|313
10518168|NCT01336023|11669720|FG000|COMPLETED|Week 27 to 52||305
10518169|NCT01336023|11669721|FG001|COMPLETED|Week 27 to 52||621
10518170|NCT01336023|11669722|FG002|COMPLETED|Week 27 to 52||285
10518171|NCT01336023|11669720|FG000|NOT COMPLETED|Week 27 to 52||28
10518172|NCT01336023|11669721|FG001|NOT COMPLETED|Week 27 to 52||44
10518173|NCT01336023|11669722|FG002|NOT COMPLETED|Week 27 to 52||28
10518174|NCT01336140|11669732|FG000|STARTED|Overall Study||150
10518175|NCT01336140|11669733|FG001|STARTED|Overall Study||150
10518176|NCT01336140|11669732|FG000|COMPLETED|Overall Study||150
10518177|NCT01336140|11669733|FG001|COMPLETED|Overall Study||150
10518178|NCT01336140|11669732|FG000|NOT COMPLETED|Overall Study||0
10518179|NCT01336140|11669733|FG001|NOT COMPLETED|Overall Study||0
10518180|NCT01336205|11669741|FG000|STARTED|Overall Study||563
10518181|NCT01336205|11669742|FG001|STARTED|Overall Study||281
10518182|NCT01336205|11669741|FG000|COMPLETED|Overall Study||330
10518183|NCT01336205|11669742|FG001|COMPLETED|Overall Study||192
10518184|NCT01336205|11669741|FG000|NOT COMPLETED|Overall Study||233
10518185|NCT01336205|11669742|FG001|NOT COMPLETED|Overall Study||89
10518186|NCT01336296|11669750|FG000|STARTED|Overall Study||40
10518187|NCT01336296|11669751|FG001|STARTED|Overall Study||21
10518188|NCT01336296|11669750|FG000|COMPLETED|Overall Study||35
10518189|NCT01336296|11669751|FG001|COMPLETED|Overall Study||17
10518190|NCT01336296|11669750|FG000|NOT COMPLETED|Overall Study||5
10518191|NCT01336296|11669751|FG001|NOT COMPLETED|Overall Study||4
10518192|NCT01336413|11669759|FG000|STARTED|Overall Study||27
10518193|NCT01336413|11669760|FG001|STARTED|Overall Study||26
10518194|NCT01336413|11669759|FG000|COMPLETED|Overall Study||26
10518195|NCT01336413|11669760|FG001|COMPLETED|Overall Study||18
10518196|NCT01336413|11669759|FG000|NOT COMPLETED|Overall Study||1
10518197|NCT01336413|11669760|FG001|NOT COMPLETED|Overall Study||8
10518198|NCT01336569|11669768|FG000|STARTED|Overall Study||49
10518199|NCT01336569|11669768|FG000|COMPLETED|Overall Study||45
10518200|NCT01336569|11669768|FG000|NOT COMPLETED|Overall Study||4
10518201|NCT01336608|11669775|FG000|STARTED|2-week, Single-blind Run-In Period||559
10518202|NCT01336608|11669776|FG001|STARTED|2-week, Single-blind Run-In Period||0
10518203|NCT01336608|11669777|FG002|STARTED|2-week, Single-blind Run-In Period||0
10518204|NCT01336608|11669778|FG003|STARTED|2-week, Single-blind Run-In Period||0
10518205|NCT01336608|11669775|FG000|COMPLETED|2-week, Single-blind Run-In Period||444
10518206|NCT01336608|11669776|FG001|COMPLETED|2-week, Single-blind Run-In Period||0
10518207|NCT01336608|11669777|FG002|COMPLETED|2-week, Single-blind Run-In Period||0
10711723|NCT02661815|11877163|FG003|COMPLETED|Overall Study||0
10711724|NCT02661815|11877160|FG000|NOT COMPLETED|Overall Study||1
10518208|NCT01336608|11669778|FG003|COMPLETED|2-week, Single-blind Run-In Period||0
10518209|NCT01336608|11669775|FG000|NOT COMPLETED|2-week, Single-blind Run-In Period||115
10518210|NCT01336608|11669776|FG001|NOT COMPLETED|2-week, Single-blind Run-In Period||0
10711725|NCT02661815|11877161|FG001|NOT COMPLETED|Overall Study||0
10518211|NCT01336608|11669777|FG002|NOT COMPLETED|2-week, Single-blind Run-In Period||0
10518212|NCT01336608|11669778|FG003|NOT COMPLETED|2-week, Single-blind Run-In Period||0
10518213|NCT01336608|11669775|FG000|STARTED|24-week, Double-blind Treatment Period||0
10518214|NCT01336608|11669776|FG001|STARTED|24-week, Double-blind Treatment Period||141
10518215|NCT01336608|11669777|FG002|STARTED|24-week, Double-blind Treatment Period||154
10518216|NCT01336608|11669778|FG003|STARTED|24-week, Double-blind Treatment Period||135
10518217|NCT01336608|11669775|FG000|Completed the Treatment Period|24-week, Double-blind Treatment Period||0
10518218|NCT01336608|11669776|FG001|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|96
10518219|NCT01336608|11669777|FG002|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|124
10518220|NCT01336608|11669778|FG003|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|110
10518221|NCT01336608|11669775|FG000|COMPLETED|24-week, Double-blind Treatment Period||0
10518222|NCT01336608|11669776|FG001|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|97
10518223|NCT01336608|11669777|FG002|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|124
10518224|NCT01336608|11669778|FG003|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|111
10518225|NCT01336608|11669775|FG000|NOT COMPLETED|24-week, Double-blind Treatment Period||0
10518226|NCT01336608|11669776|FG001|NOT COMPLETED|24-week, Double-blind Treatment Period||44
10518227|NCT01336608|11669777|FG002|NOT COMPLETED|24-week, Double-blind Treatment Period||30
10518228|NCT01336608|11669778|FG003|NOT COMPLETED|24-week, Double-blind Treatment Period||24
10518229|NCT01336647|11669789|FG000|STARTED|Overall Study||46
10518230|NCT01336647|11669790|FG001|STARTED|Overall Study||49
10518231|NCT01336647|11669791|FG002|STARTED|Overall Study||47
10518232|NCT01336647|11669789|FG000|COMPLETED|Overall Study||42
10518233|NCT01336647|11669790|FG001|COMPLETED|Overall Study||48
10518234|NCT01336647|11669791|FG002|COMPLETED|Overall Study||44
10518235|NCT01336647|11669789|FG000|NOT COMPLETED|Overall Study||4
10518236|NCT01336647|11669790|FG001|NOT COMPLETED|Overall Study||1
10518237|NCT01336647|11669791|FG002|NOT COMPLETED|Overall Study||3
10518238|NCT01336712|11669801|FG000|STARTED|Overall Study||30
10518239|NCT01336712|11669801|FG000|COMPLETED|Overall Study||27
10518240|NCT01336712|11669801|FG000|NOT COMPLETED|Overall Study||3
10518241|NCT01336738|11669810|FG000|STARTED|Overall Study||52
10518242|NCT01336738|11669811|FG001|STARTED|Overall Study||54
10518243|NCT01336738|11669812|FG002|STARTED|Overall Study||53
10518244|NCT01336738|11669813|FG003|STARTED|Overall Study||54
10518245|NCT01336738|11669814|FG004|STARTED|Overall Study||53
10518246|NCT01336738|11669810|FG000|COMPLETED|Overall Study||45
10518247|NCT01336738|11669811|FG001|COMPLETED|Overall Study||45
10518248|NCT01336738|11669812|FG002|COMPLETED|Overall Study||45
10711726|NCT02661815|11877162|FG002|NOT COMPLETED|Overall Study||0
10518249|NCT01336738|11669813|FG003|COMPLETED|Overall Study||47
10518250|NCT01336738|11669814|FG004|COMPLETED|Overall Study||43
10518251|NCT01336738|11669810|FG000|NOT COMPLETED|Overall Study||7
10518252|NCT01336738|11669811|FG001|NOT COMPLETED|Overall Study||9
10518253|NCT01336738|11669812|FG002|NOT COMPLETED|Overall Study||8
10518254|NCT01336738|11669813|FG003|NOT COMPLETED|Overall Study||7
10518255|NCT01336738|11669814|FG004|NOT COMPLETED|Overall Study||10
10518256|NCT01336764|11669828|FG000|STARTED|Overall Study||12
10518257|NCT01336764|11669829|FG001|STARTED|Overall Study||10
10518258|NCT01336764|11669828|FG000|COMPLETED|Overall Study||7
10518259|NCT01336764|11669829|FG001|COMPLETED|Overall Study||5
10518260|NCT01336764|11669828|FG000|NOT COMPLETED|Overall Study||5
10518261|NCT01336764|11669829|FG001|NOT COMPLETED|Overall Study||5
10518262|NCT01336803|11669835|FG000|STARTED|Overall Study||21
10518263|NCT01336803|11669835|FG000|Bone Sarcoma|Overall Study||10
10518264|NCT01336803|11669835|FG000|Osteomyelitis|Overall Study||4
10518265|NCT01336803|11669835|FG000|Lymphoma|Overall Study||7
10518266|NCT01336803|11669835|FG000|COMPLETED|Overall Study||21
10518267|NCT01336803|11669835|FG000|NOT COMPLETED|Overall Study||0
10518268|NCT01336894|11669849|FG000|STARTED|Protocol Interventions||4
10518269|NCT01336894|11669850|FG001|STARTED|Protocol Interventions||7
10518270|NCT01336894|11669849|FG000|COMPLETED|Protocol Interventions||4
10518271|NCT01336894|11669850|FG001|COMPLETED|Protocol Interventions||7
10518272|NCT01336894|11669849|FG000|NOT COMPLETED|Protocol Interventions||0
10518273|NCT01336894|11669850|FG001|NOT COMPLETED|Protocol Interventions||0
10518274|NCT01336894|11669849|FG000|STARTED|Follow-up||4
10518275|NCT01336894|11669850|FG001|STARTED|Follow-up||7
10518276|NCT01336894|11669849|FG000|COMPLETED|Follow-up||2
10518277|NCT01336894|11669850|FG001|COMPLETED|Follow-up||0
10518278|NCT01336894|11669849|FG000|NOT COMPLETED|Follow-up||2
10518279|NCT01336894|11669850|FG001|NOT COMPLETED|Follow-up||7
10518280|NCT01336933|11669856|FG000|STARTED|Overall Study||34
10518281|NCT01336933|11669856|FG000|COMPLETED|Overall Study||33
10518282|NCT01336933|11669856|FG000|NOT COMPLETED|Overall Study||1
10711727|NCT02661815|11877163|FG003|NOT COMPLETED|Overall Study||0
10711728|NCT02661828|11877179|FG000|STARTED|Overall Study||1
10518283|NCT01336959|11669864|FG000|STARTED|Overall Study||8
10518284|NCT01336959|11669865|FG001|STARTED|Overall Study||42
10518285|NCT01336959|11669866|FG002|STARTED|Overall Study||41
10518286|NCT01336959|11669864|FG000|COMPLETED|Overall Study||8
10518287|NCT01336959|11669865|FG001|COMPLETED|Overall Study||37
10518288|NCT01336959|11669866|FG002|COMPLETED|Overall Study||40
10518289|NCT01336959|11669864|FG000|NOT COMPLETED|Overall Study||0
10711729|NCT02661828|11877180|FG001|STARTED|Overall Study||0
10711730|NCT02661828|11877179|FG000|COMPLETED|Overall Study||1
10518290|NCT01336959|11669865|FG001|NOT COMPLETED|Overall Study||5
10518291|NCT01336959|11669866|FG002|NOT COMPLETED|Overall Study||1
10518292|NCT01336972|11669880|FG000|STARTED|Overall Study||10
10518293|NCT01336972|11669881|FG001|STARTED|Overall Study||10
10518294|NCT01336972|11669882|FG002|STARTED|Overall Study||9
10518295|NCT01336972|11669880|FG000|COMPLETED|Overall Study||9
10518296|NCT01336972|11669881|FG001|COMPLETED|Overall Study||9
10518297|NCT01336972|11669882|FG002|COMPLETED|Overall Study||9
10518298|NCT01336972|11669880|FG000|NOT COMPLETED|Overall Study||1
10518299|NCT01336972|11669881|FG001|NOT COMPLETED|Overall Study||1
10518300|NCT01336972|11669882|FG002|NOT COMPLETED|Overall Study||0
10518301|NCT01337050|11669894|FG000|STARTED|Overall Study||4
10518302|NCT01337050|11669895|FG001|STARTED|Overall Study||13
10518303|NCT01337050|11669896|FG002|STARTED|Overall Study||19
10518304|NCT01337050|11669894|FG000|COMPLETED|Overall Study||0
10518305|NCT01337050|11669895|FG001|COMPLETED|Overall Study||0
10518306|NCT01337050|11669896|FG002|COMPLETED|Overall Study||0
10518307|NCT01337050|11669894|FG000|NOT COMPLETED|Overall Study||4
10518308|NCT01337050|11669895|FG001|NOT COMPLETED|Overall Study||13
10518309|NCT01337050|11669896|FG002|NOT COMPLETED|Overall Study||19
10518310|NCT01337076|11669905|FG000|STARTED|Overall Study|subjects implanted|21
10518311|NCT01337076|11669905|FG000|COMPLETED|Overall Study|subjects met the primary endpoint of 6 months postimplant activation|19
10518312|NCT01337076|11669905|FG000|NOT COMPLETED|Overall Study||2
10518313|NCT01337089|11669909|FG000|STARTED|Overall Study||660
10518314|NCT01337089|11669909|FG000|Received at Least 1 Dose of Study Drug|Overall Study||660
10518315|NCT01337089|11669909|FG000|Safety Population|Overall Study||660
10518316|NCT01337089|11669909|FG000|Efficacy Dataset|Overall Study|One participant withdrew after administering nabiximols, but no efficacy data were collected.|659
10518317|NCT01337089|11669909|FG000|COMPLETED|Overall Study||256
10518318|NCT01337089|11669909|FG000|NOT COMPLETED|Overall Study||404
10518319|NCT01337115|11669915|FG000|STARTED|Overall Study||25
10518320|NCT01337115|11669916|FG001|STARTED|Overall Study||25
10518321|NCT01337115|11669915|FG000|COMPLETED|Overall Study|2 patients could not be assessed after 12h because of catheter dislocation|23
10518322|NCT01337115|11669916|FG001|COMPLETED|Overall Study||25
10518323|NCT01337115|11669915|FG000|NOT COMPLETED|Overall Study||2
10518324|NCT01337115|11669916|FG001|NOT COMPLETED|Overall Study||0
10518325|NCT01337167|11669926|FG000|STARTED|Infant Series||986
10518326|NCT01337167|11669927|FG001|STARTED|Infant Series||487
10518327|NCT01337167|11669926|FG000|COMPLETED|Infant Series||924
10518328|NCT01337167|11669927|FG001|COMPLETED|Infant Series||460
10518329|NCT01337167|11669926|FG000|NOT COMPLETED|Infant Series||62
10518330|NCT01337167|11669927|FG001|NOT COMPLETED|Infant Series||27
10518331|NCT01337167|11669926|FG000|STARTED|Interim Period||924
10518332|NCT01337167|11669927|FG001|STARTED|Interim Period||460
10518333|NCT01337167|11669926|FG000|COMPLETED|Interim Period||843
10518334|NCT01337167|11669927|FG001|COMPLETED|Interim Period||420
10518335|NCT01337167|11669926|FG000|NOT COMPLETED|Interim Period||81
10518336|NCT01337167|11669927|FG001|NOT COMPLETED|Interim Period||40
10518337|NCT01337167|11669926|FG000|STARTED|Toddler Vaccinations||843
10518338|NCT01337167|11669927|FG001|STARTED|Toddler Vaccinations||420
10518339|NCT01337167|11669926|FG000|COMPLETED|Toddler Vaccinations||829
10518340|NCT01337167|11669927|FG001|COMPLETED|Toddler Vaccinations||407
10518341|NCT01337167|11669926|FG000|NOT COMPLETED|Toddler Vaccinations||14
10518342|NCT01337167|11669927|FG001|NOT COMPLETED|Toddler Vaccinations||13
10518343|NCT01337297|11669935|FG000|STARTED|Overall Study||11
10518344|NCT01337297|11669936|FG001|STARTED|Overall Study||9
10518345|NCT01337297|11669935|FG000|COMPLETED|Overall Study||6
10518346|NCT01337297|11669936|FG001|COMPLETED|Overall Study||3
10518347|NCT01337297|11669935|FG000|NOT COMPLETED|Overall Study||5
10518348|NCT01337297|11669936|FG001|NOT COMPLETED|Overall Study||6
10518349|NCT01337336|11669944|FG000|STARTED|Overall Study||1078
10518350|NCT01337336|11669945|FG001|STARTED|Overall Study||2923
10518351|NCT01337336|11669944|FG000|COMPLETED|Overall Study||1078
10518352|NCT01337336|11669945|FG001|COMPLETED|Overall Study||2923
10518353|NCT01337336|11669944|FG000|NOT COMPLETED|Overall Study||0
10518354|NCT01337336|11669945|FG001|NOT COMPLETED|Overall Study||0
10518355|NCT01337596|11669960|FG000|STARTED|Overall Study||7
10518356|NCT01337596|11669961|FG001|STARTED|Overall Study||7
10518357|NCT01337596|11669962|FG002|STARTED|Overall Study||7
10518358|NCT01337596|11669963|FG003|STARTED|Overall Study||7
10518359|NCT01337596|11669964|FG004|STARTED|Overall Study||7
10518360|NCT01337596|11669965|FG005|STARTED|Overall Study||7
10518361|NCT01337596|11669966|FG006|STARTED|Overall Study||12
10518362|NCT01337596|11669967|FG007|STARTED|Overall Study||2
10518363|NCT01337596|11669968|FG008|STARTED|Overall Study||7
10518364|NCT01337596|11669960|FG000|Safety Population|Overall Study||7
10518365|NCT01337596|11669961|FG001|Safety Population|Overall Study||7
10518366|NCT01337596|11669962|FG002|Safety Population|Overall Study||7
10518367|NCT01337596|11669963|FG003|Safety Population|Overall Study||7
10518368|NCT01337596|11669964|FG004|Safety Population|Overall Study||7
10518369|NCT01337596|11669965|FG005|Safety Population|Overall Study||7
10518370|NCT01337596|11669966|FG006|Safety Population|Overall Study||12
10518371|NCT01337596|11669967|FG007|Safety Population|Overall Study||2
10518372|NCT01337596|11669968|FG008|Safety Population|Overall Study||7
10518373|NCT01337596|11669960|FG000|COMPLETED|Overall Study||7
10518374|NCT01337596|11669961|FG001|COMPLETED|Overall Study||7
10518375|NCT01337596|11669962|FG002|COMPLETED|Overall Study||7
10518376|NCT01337596|11669963|FG003|COMPLETED|Overall Study||7
10518377|NCT01337596|11669964|FG004|COMPLETED|Overall Study||5
10518378|NCT01337596|11669965|FG005|COMPLETED|Overall Study||7
10518379|NCT01337596|11669966|FG006|COMPLETED|Overall Study||12
10518380|NCT01337596|11669967|FG007|COMPLETED|Overall Study||2
10518381|NCT01337596|11669968|FG008|COMPLETED|Overall Study||7
10518382|NCT01337596|11669960|FG000|NOT COMPLETED|Overall Study||0
10518383|NCT01337596|11669961|FG001|NOT COMPLETED|Overall Study||0
10518384|NCT01337596|11669962|FG002|NOT COMPLETED|Overall Study||0
10518385|NCT01337596|11669963|FG003|NOT COMPLETED|Overall Study||0
10518386|NCT01337596|11669964|FG004|NOT COMPLETED|Overall Study||2
10518387|NCT01337596|11669965|FG005|NOT COMPLETED|Overall Study||0
10518388|NCT01337596|11669966|FG006|NOT COMPLETED|Overall Study||0
10518389|NCT01337596|11669967|FG007|NOT COMPLETED|Overall Study||0
10518390|NCT01337596|11669968|FG008|NOT COMPLETED|Overall Study||0
10518391|NCT01337635|11669993|FG000|STARTED|Overall Study||3
10518392|NCT01337635|11669994|FG001|STARTED|Overall Study||4
10518393|NCT01337635|11669993|FG000|COMPLETED|Overall Study||3
10518394|NCT01337635|11669994|FG001|COMPLETED|Overall Study||3
10518395|NCT01337635|11669993|FG000|NOT COMPLETED|Overall Study||0
10518396|NCT01337635|11669994|FG001|NOT COMPLETED|Overall Study||1
10518397|NCT01337674|11670002|FG000|STARTED|Treatment Period 1||6
10518398|NCT01337674|11670003|FG001|STARTED|Treatment Period 1|The discontinued participant was replaced|7
10518399|NCT01337674|11670004|FG002|STARTED|Treatment Period 1||6
10518400|NCT01337674|11670005|FG003|STARTED|Treatment Period 1|The discontinued participant was replaced|7
10518401|NCT01337674|11670002|FG000|COMPLETED|Treatment Period 1||6
10518402|NCT01337674|11670003|FG001|COMPLETED|Treatment Period 1||6
10518403|NCT01337674|11670004|FG002|COMPLETED|Treatment Period 1||6
10518404|NCT01337674|11670005|FG003|COMPLETED|Treatment Period 1||6
10518405|NCT01337674|11670002|FG000|NOT COMPLETED|Treatment Period 1||0
10518406|NCT01337674|11670003|FG001|NOT COMPLETED|Treatment Period 1||1
10518407|NCT01337674|11670004|FG002|NOT COMPLETED|Treatment Period 1||0
10518408|NCT01337674|11670005|FG003|NOT COMPLETED|Treatment Period 1||1
10518409|NCT01337674|11670002|FG000|STARTED|Two-week Washout Period||6
10518410|NCT01337674|11670003|FG001|STARTED|Two-week Washout Period||6
10518411|NCT01337674|11670004|FG002|STARTED|Two-week Washout Period||6
10518412|NCT01337674|11670005|FG003|STARTED|Two-week Washout Period||6
10518413|NCT01337674|11670002|FG000|COMPLETED|Two-week Washout Period||6
10518414|NCT01337674|11670003|FG001|COMPLETED|Two-week Washout Period||6
10518415|NCT01337674|11670004|FG002|COMPLETED|Two-week Washout Period||6
10518416|NCT01337674|11670005|FG003|COMPLETED|Two-week Washout Period||6
10518417|NCT01337674|11670002|FG000|NOT COMPLETED|Two-week Washout Period||0
10518418|NCT01337674|11670003|FG001|NOT COMPLETED|Two-week Washout Period||0
10518419|NCT01337674|11670004|FG002|NOT COMPLETED|Two-week Washout Period||0
10518420|NCT01337674|11670005|FG003|NOT COMPLETED|Two-week Washout Period||0
10518421|NCT01337674|11670002|FG000|STARTED|Treatment Period 2||6
10518422|NCT01337674|11670003|FG001|STARTED|Treatment Period 2||6
10518423|NCT01337674|11670004|FG002|STARTED|Treatment Period 2||6
10518424|NCT01337674|11670005|FG003|STARTED|Treatment Period 2||6
10518425|NCT01337674|11670002|FG000|COMPLETED|Treatment Period 2||6
10518426|NCT01337674|11670003|FG001|COMPLETED|Treatment Period 2||6
10518427|NCT01337674|11670004|FG002|COMPLETED|Treatment Period 2||5
10518428|NCT01337674|11670005|FG003|COMPLETED|Treatment Period 2||6
10518429|NCT01337674|11670002|FG000|NOT COMPLETED|Treatment Period 2||0
10518430|NCT01337674|11670003|FG001|NOT COMPLETED|Treatment Period 2||0
10518431|NCT01337674|11670004|FG002|NOT COMPLETED|Treatment Period 2||1
10518432|NCT01337674|11670005|FG003|NOT COMPLETED|Treatment Period 2||0
10518433|NCT01337687|11670020|FG000|STARTED|Overall Study||10
10518434|NCT01337687|11670021|FG001|STARTED|Overall Study||9
10518435|NCT01337687|11670020|FG000|COMPLETED|Overall Study||10
10518436|NCT01337687|11670021|FG001|COMPLETED|Overall Study||9
10518437|NCT01337687|11670020|FG000|NOT COMPLETED|Overall Study||0
10518438|NCT01337687|11670021|FG001|NOT COMPLETED|Overall Study||0
10518439|NCT01337700|11670029|FG000|STARTED|Overall Study||5
10711731|NCT02661828|11877180|FG001|COMPLETED|Overall Study||0
10711732|NCT02661828|11877179|FG000|NOT COMPLETED|Overall Study||0
10518440|NCT01337700|11670030|FG001|STARTED|Overall Study||5
10518441|NCT01337700|11670029|FG000|COMPLETED|Overall Study||5
10518442|NCT01337700|11670030|FG001|COMPLETED|Overall Study||5
10338304|NCT00369486|11475228|FG004|COMPLETED|4-Week Visit|Number of eyes|24
10338305|NCT00369486|11475224|FG000|NOT COMPLETED|4-Week Visit||2
10518443|NCT01337700|11670029|FG000|NOT COMPLETED|Overall Study||0
10518444|NCT01337700|11670030|FG001|NOT COMPLETED|Overall Study||0
10518445|NCT01337739|11670038|FG000|STARTED|Overall Study||6
10711733|NCT02661828|11877180|FG001|NOT COMPLETED|Overall Study||0
10518446|NCT01337739|11670039|FG001|STARTED|Overall Study||4
10518447|NCT01337739|11670038|FG000|COMPLETED|Overall Study||6
10518448|NCT01337739|11670039|FG001|COMPLETED|Overall Study||4
10518449|NCT01337739|11670038|FG000|NOT COMPLETED|Overall Study||0
10518450|NCT01337739|11670039|FG001|NOT COMPLETED|Overall Study||0
10518451|NCT01337960|11670048|FG000|STARTED|Overall Study||14
10518452|NCT01337960|11670049|FG001|STARTED|Overall Study||14
10518453|NCT01337960|11670050|FG002|STARTED|Overall Study||6
10518454|NCT01337960|11670048|FG000|COMPLETED|Overall Study||12
10518455|NCT01337960|11670049|FG001|COMPLETED|Overall Study||14
10518456|NCT01337960|11670050|FG002|COMPLETED|Overall Study||6
10518457|NCT01337960|11670048|FG000|NOT COMPLETED|Overall Study||2
10518458|NCT01337960|11670049|FG001|NOT COMPLETED|Overall Study||0
10518459|NCT01337960|11670050|FG002|NOT COMPLETED|Overall Study||0
10518460|NCT01337973|11670061|FG000|STARTED|Overall Study||60
10518461|NCT01337973|11670062|FG001|STARTED|Overall Study||60
10518462|NCT01337973|11670063|FG002|STARTED|Overall Study||60
10518463|NCT01337973|11670061|FG000|COMPLETED|Overall Study||44
10518464|NCT01337973|11670062|FG001|COMPLETED|Overall Study||45
10518465|NCT01337973|11670063|FG002|COMPLETED|Overall Study||49
10518466|NCT01337973|11670061|FG000|NOT COMPLETED|Overall Study||16
10518467|NCT01337973|11670062|FG001|NOT COMPLETED|Overall Study||15
10518468|NCT01337973|11670063|FG002|NOT COMPLETED|Overall Study||11
10518469|NCT01337986|11670073|FG000|STARTED|Overall Study||23
10518470|NCT01337986|11670074|FG001|STARTED|Overall Study||23
10518471|NCT01337986|11670073|FG000|COMPLETED|Overall Study||20
10518472|NCT01337986|11670074|FG001|COMPLETED|Overall Study||18
10518473|NCT01337986|11670073|FG000|NOT COMPLETED|Overall Study||3
10518474|NCT01337986|11670074|FG001|NOT COMPLETED|Overall Study||5
10518475|NCT01338012|11670096|FG000|STARTED|Overall Study||8
10518476|NCT01338012|11670096|FG000|COMPLETED|Overall Study||0
10518477|NCT01338012|11670096|FG000|NOT COMPLETED|Overall Study||8
10518478|NCT01338025|11670102|FG000|STARTED|Overall Study||16
10518479|NCT01338025|11670103|FG001|STARTED|Overall Study||17
10518480|NCT01338025|11670102|FG000|COMPLETED|Overall Study||5
10518481|NCT01338025|11670103|FG001|COMPLETED|Overall Study||6
10518482|NCT01338025|11670102|FG000|NOT COMPLETED|Overall Study||11
10518483|NCT01338025|11670103|FG001|NOT COMPLETED|Overall Study||11
10518484|NCT01338298|11670111|FG000|STARTED|Overall Study||24
10518485|NCT01338298|11670112|FG001|STARTED|Overall Study||18
10518486|NCT01338298|11670111|FG000|COMPLETED|Overall Study||20
10518487|NCT01338298|11670112|FG001|COMPLETED|Overall Study||15
10518488|NCT01338298|11670111|FG000|NOT COMPLETED|Overall Study||4
10518489|NCT01338298|11670112|FG001|NOT COMPLETED|Overall Study||3
10518490|NCT01338415|11670120|FG000|STARTED|Core + Extension||33
10518491|NCT01338415|11670121|FG001|STARTED|Core + Extension||31
10518492|NCT01338415|11670122|FG002|STARTED|Core + Extension||0
10518493|NCT01338415|11670120|FG000|Enrolled in FUTURE 3 Extension|Core + Extension||31
10518494|NCT01338415|11670121|FG001|Enrolled in FUTURE 3 Extension|Core + Extension||27
10518495|NCT01338415|11670122|FG002|Enrolled in FUTURE 3 Extension|Core + Extension||0
10518496|NCT01338415|11670120|FG000|COMPLETED|Core + Extension||23
10518497|NCT01338415|11670121|FG001|COMPLETED|Core + Extension||22
10518498|NCT01338415|11670122|FG002|COMPLETED|Core + Extension||0
10518499|NCT01338415|11670120|FG000|NOT COMPLETED|Core + Extension||10
10518500|NCT01338415|11670121|FG001|NOT COMPLETED|Core + Extension||9
10518501|NCT01338415|11670122|FG002|NOT COMPLETED|Core + Extension||0
10518502|NCT01338415|11670120|FG000|STARTED|Exceptional Use Treatment Period||0
10518503|NCT01338415|11670121|FG001|STARTED|Exceptional Use Treatment Period||0
10518504|NCT01338415|11670122|FG002|STARTED|Exceptional Use Treatment Period||10
10518505|NCT01338415|11670120|FG000|COMPLETED|Exceptional Use Treatment Period||0
10518506|NCT01338415|11670121|FG001|COMPLETED|Exceptional Use Treatment Period||0
10518507|NCT01338415|11670122|FG002|COMPLETED|Exceptional Use Treatment Period||4
10518508|NCT01338415|11670120|FG000|NOT COMPLETED|Exceptional Use Treatment Period||0
10518509|NCT01338415|11670121|FG001|NOT COMPLETED|Exceptional Use Treatment Period||0
10518510|NCT01338415|11670122|FG002|NOT COMPLETED|Exceptional Use Treatment Period||6
10518511|NCT01338493|11670130|FG000|STARTED|Enrolled||139
10518512|NCT01338493|11670130|FG000|COMPLETED|Enrolled||134
10518513|NCT01338493|11670130|FG000|NOT COMPLETED|Enrolled||5
10518514|NCT01338493|11670130|FG000|STARTED|Implant||134
10518515|NCT01338493|11670130|FG000|COMPLETED|Implant||134
10518516|NCT01338493|11670130|FG000|NOT COMPLETED|Implant||0
10518517|NCT01338493|11670130|FG000|STARTED|Discharge||134
10518518|NCT01338493|11670130|FG000|COMPLETED|Discharge||132
10518519|NCT01338493|11670130|FG000|NOT COMPLETED|Discharge||2
10518520|NCT01338493|11670130|FG000|STARTED|6 Months Follow up||132
10518521|NCT01338493|11670130|FG000|COMPLETED|6 Months Follow up||113
10518522|NCT01338493|11670130|FG000|NOT COMPLETED|6 Months Follow up||19
10518523|NCT01338493|11670130|FG000|STARTED|12 Months Follow up||113
10518524|NCT01338493|11670130|FG000|COMPLETED|12 Months Follow up||104
10518525|NCT01338493|11670130|FG000|NOT COMPLETED|12 Months Follow up||9
10518526|NCT01338493|11670130|FG000|STARTED|24 Months Follow up||104
10518527|NCT01338493|11670130|FG000|COMPLETED|24 Months Follow up||104
10518528|NCT01338493|11670130|FG000|NOT COMPLETED|24 Months Follow up||0
10518529|NCT01338506|11670136|FG000|STARTED|Overall Study||54
10518530|NCT01338506|11670137|FG001|STARTED|Overall Study||27
10518531|NCT01338506|11670136|FG000|COMPLETED|Overall Study||29
10518532|NCT01338506|11670137|FG001|COMPLETED|Overall Study||13
10518533|NCT01338506|11670136|FG000|NOT COMPLETED|Overall Study||25
10518534|NCT01338506|11670137|FG001|NOT COMPLETED|Overall Study||14
10518535|NCT01338610|11670150|FG000|STARTED|Overall Study||39
10518536|NCT01338610|11670151|FG001|STARTED|Overall Study||56
10518537|NCT01338610|11670152|FG002|STARTED|Overall Study||29
10518538|NCT01338610|11670150|FG000|COMPLETED|Overall Study||34
10518539|NCT01338610|11670151|FG001|COMPLETED|Overall Study||55
10518540|NCT01338610|11670152|FG002|COMPLETED|Overall Study||28
10518541|NCT01338610|11670150|FG000|NOT COMPLETED|Overall Study||5
10518542|NCT01338610|11670151|FG001|NOT COMPLETED|Overall Study||1
10518543|NCT01338610|11670152|FG002|NOT COMPLETED|Overall Study||1
10518544|NCT01338649|11670161|FG000|STARTED|Overall Study||13
10518545|NCT01338649|11670162|FG001|STARTED|Overall Study||14
10518546|NCT01338649|11670161|FG000|COMPLETED|Overall Study||13
10518547|NCT01338649|11670162|FG001|COMPLETED|Overall Study||14
10518548|NCT01338649|11670161|FG000|NOT COMPLETED|Overall Study||0
10518549|NCT01338649|11670162|FG001|NOT COMPLETED|Overall Study||0
10518550|NCT01338792|11670168|FG000|STARTED|Overall Study||47
10518551|NCT01338792|11670168|FG000|COMPLETED|Overall Study||43
10518552|NCT01338792|11670168|FG000|NOT COMPLETED|Overall Study||4
10518553|NCT01338818|11670172|FG000|STARTED|Overall Study||298
10518554|NCT01338818|11670172|FG000|COMPLETED|Overall Study||262
10518555|NCT01338818|11670172|FG000|NOT COMPLETED|Overall Study||36
10518556|NCT01338857|11670176|FG000|STARTED|Overall Study||12
10518557|NCT01338857|11670176|FG000|COMPLETED|Overall Study||1
10518558|NCT01338857|11670176|FG000|NOT COMPLETED|Overall Study||11
10518559|NCT01338870|11670186|FG000|STARTED|Overall Study||50
10518560|NCT01338870|11670187|FG001|STARTED|Overall Study||49
10518561|NCT01338870|11670188|FG002|STARTED|Overall Study||50
10518562|NCT01338870|11670189|FG003|STARTED|Overall Study||50
10518563|NCT01338870|11670190|FG004|STARTED|Overall Study||52
10518564|NCT01338870|11670191|FG005|STARTED|Overall Study||50
10518565|NCT01338870|11670186|FG000|COMPLETED|Overall Study||41
10518566|NCT01338870|11670187|FG001|COMPLETED|Overall Study||37
10518567|NCT01338870|11670188|FG002|COMPLETED|Overall Study||39
10518568|NCT01338870|11670189|FG003|COMPLETED|Overall Study||41
10518569|NCT01338870|11670190|FG004|COMPLETED|Overall Study||46
10518570|NCT01338870|11670191|FG005|COMPLETED|Overall Study||44
10518571|NCT01338870|11670186|FG000|NOT COMPLETED|Overall Study||9
10518572|NCT01338870|11670187|FG001|NOT COMPLETED|Overall Study||12
10518573|NCT01338870|11670188|FG002|NOT COMPLETED|Overall Study||11
10518574|NCT01338870|11670189|FG003|NOT COMPLETED|Overall Study||9
10518575|NCT01338870|11670190|FG004|NOT COMPLETED|Overall Study||6
10518576|NCT01338870|11670191|FG005|NOT COMPLETED|Overall Study||6
10518577|NCT01338987|11670210|FG000|STARTED|Overall Study||12
10518578|NCT01338987|11670211|FG001|STARTED|Overall Study||9
10518579|NCT01338987|11670212|FG002|STARTED|Overall Study||22
10518580|NCT01338987|11670213|FG003|STARTED|Overall Study||31
10518581|NCT01338987|11670214|FG004|STARTED|Overall Study||2
10518582|NCT01338987|11670210|FG000|COMPLETED|Overall Study||10
10518583|NCT01338987|11670211|FG001|COMPLETED|Overall Study||8
10518584|NCT01338987|11670212|FG002|COMPLETED|Overall Study||20
10518585|NCT01338987|11670213|FG003|COMPLETED|Overall Study||31
10518586|NCT01338987|11670214|FG004|COMPLETED|Overall Study||2
10518587|NCT01338987|11670210|FG000|NOT COMPLETED|Overall Study||2
10518588|NCT01338987|11670211|FG001|NOT COMPLETED|Overall Study||1
10518589|NCT01338987|11670212|FG002|NOT COMPLETED|Overall Study||2
10518590|NCT01338987|11670213|FG003|NOT COMPLETED|Overall Study||0
10518591|NCT01338987|11670214|FG004|NOT COMPLETED|Overall Study||0
10518592|NCT01339000|11670230|FG000|STARTED|Overall Study|The patient received day 1, 29, 36, 43, 50, and 57 vaccines but did not receive interleukin-7 (IL-7)|1
10518593|NCT01339000|11670231|FG001|STARTED|Overall Study||0
10518594|NCT01339000|11670230|FG000|COMPLETED|Overall Study||0
10518595|NCT01339000|11670231|FG001|COMPLETED|Overall Study||0
10518596|NCT01339000|11670230|FG000|NOT COMPLETED|Overall Study||1
10518597|NCT01339000|11670231|FG001|NOT COMPLETED|Overall Study||0
10518598|NCT01339013|11670240|FG000|STARTED|Overall Study||6
10518599|NCT01339013|11670240|FG000|COMPLETED|Overall Study||6
10518600|NCT01339013|11670240|FG000|NOT COMPLETED|Overall Study||0
10518601|NCT01339052|11670246|FG000|STARTED|Overall Study||15
10518602|NCT01339052|11670247|FG001|STARTED|Overall Study||50
10518603|NCT01339052|11670246|FG000|Measurable Disease|Overall Study||11
10518604|NCT01339052|11670247|FG001|Measurable Disease|Overall Study|Radiographic response evaluated on participants with measurable disease only.|40
10518605|NCT01339052|11670246|FG000|Evaluable Tumor Sample at Surgery|Overall Study||14
10518606|NCT01339052|11670247|FG001|Evaluable Tumor Sample at Surgery|Overall Study|Milestone is not relevant for non-surgical cohort.|0
10711734|NCT02662023|11877187|FG000|STARTED|Overall Study||12
10711735|NCT02662023|11877188|FG001|STARTED|Overall Study||12
10711736|NCT02662023|11877187|FG000|COMPLETED|Overall Study||12
10711737|NCT02662023|11877188|FG001|COMPLETED|Overall Study||12
10810264|NCT03800030|11972167|FG004|STARTED|Baseline||4
10810265|NCT03800030|11972168|FG005|STARTED|Baseline||4
10810266|NCT03800030|11972163|FG000|COMPLETED|Baseline||4
10518607|NCT01339052|11670246|FG000|Evaluable Plasma Sample at Surgery|Overall Study||13
10518608|NCT01339052|11670247|FG001|Evaluable Plasma Sample at Surgery|Overall Study|Milestone is not relevant for non-surgical cohort.|0
10518609|NCT01339052|11670246|FG000|COMPLETED|Overall Study||0
10518610|NCT01339052|11670247|FG001|COMPLETED|Overall Study||0
10711738|NCT02662023|11877187|FG000|NOT COMPLETED|Overall Study||0
10518611|NCT01339052|11670246|FG000|NOT COMPLETED|Overall Study||15
10518612|NCT01339052|11670247|FG001|NOT COMPLETED|Overall Study||50
10518613|NCT01339091|11670258|FG000|STARTED|Overall Study||288
10518614|NCT01339091|11670259|FG001|STARTED|Overall Study||285
10518615|NCT01339091|11670258|FG000|Safety Population|Overall Study||284
10518616|NCT01339091|11670259|FG001|Safety Population|Overall Study||284
10518617|NCT01339091|11670258|FG000|COMPLETED|Overall Study||261
10518618|NCT01339091|11670259|FG001|COMPLETED|Overall Study||257
10518619|NCT01339091|11670258|FG000|NOT COMPLETED|Overall Study||27
10518620|NCT01339091|11670259|FG001|NOT COMPLETED|Overall Study||28
10518621|NCT01339247|11670265|FG000|STARTED|Period 1||30
10518622|NCT01339247|11670266|FG001|STARTED|Period 1||30
10711739|NCT02662023|11877188|FG001|NOT COMPLETED|Overall Study||0
10711740|NCT02662036|11877196|FG000|STARTED|Overall Study||35
10711741|NCT02662036|11877197|FG001|STARTED|Overall Study||35
10810267|NCT03800030|11972164|FG001|COMPLETED|Baseline||4
10518623|NCT01339247|11670265|FG000|COMPLETED|Period 1||30
10518624|NCT01339247|11670266|FG001|COMPLETED|Period 1||30
10518625|NCT01339247|11670265|FG000|NOT COMPLETED|Period 1||0
10518626|NCT01339247|11670266|FG001|NOT COMPLETED|Period 1||0
10518627|NCT01339247|11670265|FG000|STARTED|Period 2||30
10518628|NCT01339247|11670266|FG001|STARTED|Period 2||30
10518629|NCT01339247|11670265|FG000|COMPLETED|Period 2||30
10518630|NCT01339247|11670266|FG001|COMPLETED|Period 2||30
10518631|NCT01339247|11670265|FG000|NOT COMPLETED|Period 2||0
10518632|NCT01339247|11670266|FG001|NOT COMPLETED|Period 2||0
10518633|NCT01339260|11670274|FG000|STARTED|Cycle 1|Intent-To-Treat: randomized patients|726
10518634|NCT01339260|11670275|FG001|STARTED|Cycle 1|Intent-To-Treat: randomized patients|729
10518635|NCT01339260|11670274|FG000|Safety Population|Cycle 1|Patients receiving netupitant/palonosetron combination|725
10518636|NCT01339260|11670275|FG001|Safety Population|Cycle 1|Patients receiving palonosetron|725
10518637|NCT01339260|11670274|FG000|Full Analysis Set|Cycle 1|Patients receiving chemotherapy and randomized to netupitant/palonosetron combination|724
10518638|NCT01339260|11670275|FG001|Full Analysis Set|Cycle 1|Patients receiving chemotherapy and randomized to palonosetron|725
10518639|NCT01339260|11670274|FG000|COMPLETED|Cycle 1||719
10518640|NCT01339260|11670275|FG001|COMPLETED|Cycle 1||719
10518641|NCT01339260|11670274|FG000|NOT COMPLETED|Cycle 1||7
10518642|NCT01339260|11670275|FG001|NOT COMPLETED|Cycle 1||10
10518643|NCT01339260|11670274|FG000|STARTED|Multi-cycle Extension|Patients scheduled to netupitant/palonosetron combination|635
10518644|NCT01339260|11670275|FG001|STARTED|Multi-cycle Extension|Patients scheduled to palonosetron|651
10518645|NCT01339260|11670274|FG000|Safety Population|Multi-cycle Extension|Patients receiving netupitant/palonosetron combination|635
10518646|NCT01339260|11670275|FG001|Safety Population|Multi-cycle Extension|Patients receiving palonosetron|651
10518647|NCT01339260|11670274|FG000|COMPLETED|Multi-cycle Extension|Patients completing at least number of cycles they were scheduled to|449
10518648|NCT01339260|11670275|FG001|COMPLETED|Multi-cycle Extension|Patients completing at least number of cycles they were scheduled to|458
10518649|NCT01339260|11670274|FG000|NOT COMPLETED|Multi-cycle Extension||186
10518650|NCT01339260|11670275|FG001|NOT COMPLETED|Multi-cycle Extension||193
10518651|NCT01339273|11670285|FG000|STARTED|Overall Study||36
10518652|NCT01339273|11670286|FG001|STARTED|Overall Study||36
10518653|NCT01339273|11670285|FG000|COMPLETED|Overall Study||28
10518654|NCT01339273|11670286|FG001|COMPLETED|Overall Study||28
10518655|NCT01339273|11670285|FG000|NOT COMPLETED|Overall Study||8
10518656|NCT01339273|11670286|FG001|NOT COMPLETED|Overall Study||8
10518657|NCT01339299|11670294|FG000|STARTED|Overall Study||50
10518658|NCT01339299|11670295|FG001|STARTED|Overall Study||50
10518659|NCT01339299|11670294|FG000|COMPLETED|Overall Study||50
10518660|NCT01339299|11670295|FG001|COMPLETED|Overall Study||50
10518661|NCT01339299|11670294|FG000|NOT COMPLETED|Overall Study||0
10518662|NCT01339299|11670295|FG001|NOT COMPLETED|Overall Study||0
10518663|NCT01339390|11670303|FG000|STARTED|Overall Study||1571
10518664|NCT01339390|11670304|FG001|STARTED|Overall Study||1598
10518665|NCT01339390|11670303|FG000|COMPLETED|Overall Study||1414
10518666|NCT01339390|11670304|FG001|COMPLETED|Overall Study||1442
10518667|NCT01339390|11670303|FG000|NOT COMPLETED|Overall Study||157
10518668|NCT01339390|11670304|FG001|NOT COMPLETED|Overall Study||156
10518669|NCT01339403|11670312|FG000|STARTED|Overall Study||24768
10518670|NCT01339403|11670313|FG001|STARTED|Overall Study||257600
10518671|NCT01339403|11670312|FG000|COMPLETED|Overall Study||24768
10518672|NCT01339403|11670313|FG001|COMPLETED|Overall Study||257600
10518673|NCT01339403|11670312|FG000|NOT COMPLETED|Overall Study||0
10518674|NCT01339403|11670313|FG001|NOT COMPLETED|Overall Study||0
10518675|NCT01339416|11670319|FG000|STARTED|Overall Study||8202
10518676|NCT01339416|11670319|FG000|COMPLETED|Overall Study||8202
10518677|NCT01339416|11670319|FG000|NOT COMPLETED|Overall Study||0
10518678|NCT01339429|11670323|FG000|STARTED|Overall Study||41
10518679|NCT01339429|11670323|FG000|COMPLETED|Overall Study||37
10518680|NCT01339429|11670323|FG000|NOT COMPLETED|Overall Study||4
10518681|NCT01339559|11670327|FG000|STARTED|Overall Study||766
10518682|NCT01339559|11670327|FG000|COMPLETED|Overall Study||368
10518683|NCT01339559|11670327|FG000|NOT COMPLETED|Overall Study||398
10518684|NCT01339832|11670332|FG000|STARTED|Overall Study||51
10518685|NCT01339832|11670332|FG000|COMPLETED|Overall Study||37
10518686|NCT01339832|11670332|FG000|NOT COMPLETED|Overall Study||14
10518687|NCT01339858|11670338|FG000|STARTED|Overall Study||30
10518688|NCT01339858|11670339|FG001|STARTED|Overall Study||30
10518689|NCT01339858|11670338|FG000|COMPLETED|Overall Study||14
10518690|NCT01339858|11670339|FG001|COMPLETED|Overall Study||18
10518691|NCT01339858|11670338|FG000|NOT COMPLETED|Overall Study||16
10518692|NCT01339858|11670339|FG001|NOT COMPLETED|Overall Study||12
10528696|NCT01396226|11681051|FG000|Patients Who Completed Treatment|Overall Study||12
10528697|NCT01396226|11681052|FG001|Patients Who Completed Treatment|Overall Study||6
10528698|NCT01396226|11681051|FG000|COMPLETED|Overall Study||12
10528699|NCT01396226|11681052|FG001|COMPLETED|Overall Study||6
10528700|NCT01396226|11681051|FG000|NOT COMPLETED|Overall Study||0
10528701|NCT01396226|11681052|FG001|NOT COMPLETED|Overall Study||0
10528702|NCT01396239|11681061|FG000|STARTED|Overall Study||4
10528703|NCT01396239|11681062|FG001|STARTED|Overall Study||2
10528704|NCT01396239|11681063|FG002|STARTED|Overall Study||4
10528705|NCT01396239|11681064|FG003|STARTED|Overall Study||2
10528706|NCT01396239|11681061|FG000|COMPLETED|Overall Study||4
10528707|NCT01396239|11681062|FG001|COMPLETED|Overall Study||2
10528708|NCT01396239|11681063|FG002|COMPLETED|Overall Study||4
10528709|NCT01396239|11681064|FG003|COMPLETED|Overall Study||2
10528710|NCT01396239|11681061|FG000|NOT COMPLETED|Overall Study||0
10528711|NCT01396239|11681062|FG001|NOT COMPLETED|Overall Study||0
10518693|NCT01339897|11670351|FG000|STARTED|Overall Study||7
10518694|NCT01339897|11670352|FG001|STARTED|Overall Study||6
10518695|NCT01339897|11670353|FG002|STARTED|Overall Study||6
10518696|NCT01339897|11670354|FG003|STARTED|Overall Study||6
10518697|NCT01339897|11670351|FG000|COMPLETED|Overall Study||6
10518698|NCT01339897|11670352|FG001|COMPLETED|Overall Study||6
10518699|NCT01339897|11670353|FG002|COMPLETED|Overall Study||6
10518700|NCT01339897|11670354|FG003|COMPLETED|Overall Study||5
10518701|NCT01339897|11670351|FG000|NOT COMPLETED|Overall Study||1
10518702|NCT01339897|11670352|FG001|NOT COMPLETED|Overall Study||0
10518703|NCT01339897|11670353|FG002|NOT COMPLETED|Overall Study||0
10518704|NCT01339897|11670354|FG003|NOT COMPLETED|Overall Study||1
10518705|NCT01339910|11670368|FG000|STARTED|Overall Study||135
10518706|NCT01339910|11670369|FG001|STARTED|Overall Study||137
10518707|NCT01339910|11670368|FG000|COMPLETED|Overall Study||132
10518708|NCT01339910|11670369|FG001|COMPLETED|Overall Study||133
10518709|NCT01339910|11670368|FG000|NOT COMPLETED|Overall Study||3
10518710|NCT01339910|11670369|FG001|NOT COMPLETED|Overall Study||4
10518711|NCT01339923|11670382|FG000|STARTED|Overall Study||253
10518712|NCT01339923|11670383|FG001|STARTED|Overall Study||250
10518713|NCT01339923|11670384|FG002|STARTED|Overall Study||251
10518714|NCT01339923|11670385|FG003|STARTED|Overall Study||104
10518715|NCT01339923|11670386|FG004|STARTED|Overall Study||300
10518716|NCT01339923|11670387|FG005|STARTED|Overall Study||126
10518717|NCT01339923|11670388|FG006|STARTED|Overall Study||125
10518718|NCT01339923|11670382|FG000|COMPLETED|Overall Study||239
10518719|NCT01339923|11670383|FG001|COMPLETED|Overall Study||234
10518720|NCT01339923|11670384|FG002|COMPLETED|Overall Study||243
10518721|NCT01339923|11670385|FG003|COMPLETED|Overall Study||100
10518722|NCT01339923|11670386|FG004|COMPLETED|Overall Study||295
10518723|NCT01339923|11670387|FG005|COMPLETED|Overall Study||117
10518724|NCT01339923|11670388|FG006|COMPLETED|Overall Study||111
10518725|NCT01339923|11670382|FG000|NOT COMPLETED|Overall Study||14
10518726|NCT01339923|11670383|FG001|NOT COMPLETED|Overall Study||16
10518727|NCT01339923|11670384|FG002|NOT COMPLETED|Overall Study||8
10518728|NCT01339923|11670385|FG003|NOT COMPLETED|Overall Study||4
10518729|NCT01339923|11670386|FG004|NOT COMPLETED|Overall Study||5
10518730|NCT01339923|11670387|FG005|NOT COMPLETED|Overall Study||9
10518731|NCT01339923|11670388|FG006|NOT COMPLETED|Overall Study||14
10518732|NCT01339936|11670417|FG000|STARTED|Overall Study|plus 2 screen failures|38
10518733|NCT01339936|11670417|FG000|COMPLETED|Overall Study|plus 1 excluded from analysis set|36
10518734|NCT01339936|11670417|FG000|NOT COMPLETED|Overall Study||2
10518735|NCT01340014|11670423|FG000|STARTED|Period 1, First 7 Days||55
10518736|NCT01340014|11670424|FG001|STARTED|Period 1, First 7 Days||57
10518737|NCT01340014|11670423|FG000|COMPLETED|Period 1, First 7 Days||53
10518738|NCT01340014|11670424|FG001|COMPLETED|Period 1, First 7 Days||57
10518739|NCT01340014|11670423|FG000|NOT COMPLETED|Period 1, First 7 Days||2
10518740|NCT01340014|11670424|FG001|NOT COMPLETED|Period 1, First 7 Days||0
10518741|NCT01340014|11670423|FG000|STARTED|Period 2, Second 7 Days||53
10518742|NCT01340014|11670424|FG001|STARTED|Period 2, Second 7 Days||57
10518743|NCT01340014|11670423|FG000|COMPLETED|Period 2, Second 7 Days||53
10518744|NCT01340014|11670424|FG001|COMPLETED|Period 2, Second 7 Days||56
10518745|NCT01340014|11670423|FG000|NOT COMPLETED|Period 2, Second 7 Days||0
10518746|NCT01340014|11670424|FG001|NOT COMPLETED|Period 2, Second 7 Days||1
10518747|NCT01340027|11670442|FG000|STARTED|Overall Study||81
10518748|NCT01340027|11670443|FG001|STARTED|Overall Study||78
10518749|NCT01340027|11670444|FG002|STARTED|Overall Study||79
10518750|NCT01340027|11670445|FG003|STARTED|Overall Study||79
10518751|NCT01340027|11670446|FG004|STARTED|Overall Study||156
10518752|NCT01340027|11670447|FG005|STARTED|Overall Study||78
10518753|NCT01340027|11670448|FG006|STARTED|Overall Study||149
10518754|NCT01340027|11670449|FG007|STARTED|Overall Study||149
10518755|NCT01340027|11670450|FG008|STARTED|Overall Study||144
10518756|NCT01340027|11670451|FG009|STARTED|Overall Study||152
10518757|NCT01340027|11670452|FG010|STARTED|Overall Study||81
10518758|NCT01340027|11670453|FG011|STARTED|Overall Study||81
10518759|NCT01340027|11670442|FG000|Received Treatment|Overall Study||81
10518760|NCT01340027|11670443|FG001|Received Treatment|Overall Study||78
10518761|NCT01340027|11670444|FG002|Received Treatment|Overall Study||78
10518762|NCT01340027|11670445|FG003|Received Treatment|Overall Study||79
10518763|NCT01340027|11670446|FG004|Received Treatment|Overall Study||156
10518764|NCT01340027|11670447|FG005|Received Treatment|Overall Study||78
10518765|NCT01340027|11670448|FG006|Received Treatment|Overall Study||149
10518766|NCT01340027|11670449|FG007|Received Treatment|Overall Study||149
10518767|NCT01340027|11670450|FG008|Received Treatment|Overall Study||144
10518768|NCT01340027|11670451|FG009|Received Treatment|Overall Study||152
10518769|NCT01340027|11670452|FG010|Received Treatment|Overall Study||81
10518770|NCT01340027|11670453|FG011|Received Treatment|Overall Study||81
10518771|NCT01340027|11670442|FG000|COMPLETED|Overall Study||76
10518772|NCT01340027|11670443|FG001|COMPLETED|Overall Study||71
10518773|NCT01340027|11670444|FG002|COMPLETED|Overall Study||75
10518774|NCT01340027|11670445|FG003|COMPLETED|Overall Study||75
10518775|NCT01340027|11670446|FG004|COMPLETED|Overall Study||146
10518776|NCT01340027|11670447|FG005|COMPLETED|Overall Study||74
10518777|NCT01340027|11670448|FG006|COMPLETED|Overall Study||142
10518778|NCT01340027|11670449|FG007|COMPLETED|Overall Study||142
10518779|NCT01340027|11670450|FG008|COMPLETED|Overall Study||136
10518780|NCT01340027|11670451|FG009|COMPLETED|Overall Study||146
10518781|NCT01340027|11670452|FG010|COMPLETED|Overall Study||79
10518782|NCT01340027|11670453|FG011|COMPLETED|Overall Study||77
10518783|NCT01340027|11670442|FG000|NOT COMPLETED|Overall Study||5
10518784|NCT01340027|11670443|FG001|NOT COMPLETED|Overall Study||7
10518785|NCT01340027|11670444|FG002|NOT COMPLETED|Overall Study||4
10518786|NCT01340027|11670445|FG003|NOT COMPLETED|Overall Study||4
10518787|NCT01340027|11670446|FG004|NOT COMPLETED|Overall Study||10
10518788|NCT01340027|11670447|FG005|NOT COMPLETED|Overall Study||4
10518789|NCT01340027|11670448|FG006|NOT COMPLETED|Overall Study||7
10518790|NCT01340027|11670449|FG007|NOT COMPLETED|Overall Study||7
10518791|NCT01340027|11670450|FG008|NOT COMPLETED|Overall Study||8
10518792|NCT01340027|11670451|FG009|NOT COMPLETED|Overall Study||6
10518793|NCT01340027|11670452|FG010|NOT COMPLETED|Overall Study||2
10518794|NCT01340027|11670453|FG011|NOT COMPLETED|Overall Study||4
10518795|NCT01340053|11670483|FG000|STARTED|Overall Study||47
10518796|NCT01340053|11670484|FG001|STARTED|Overall Study||46
10518797|NCT01340053|11670485|FG002|STARTED|Overall Study||47
10518798|NCT01340053|11670486|FG003|STARTED|Overall Study||46
10518799|NCT01340053|11670483|FG000|COMPLETED|Overall Study||43
10518800|NCT01340053|11670484|FG001|COMPLETED|Overall Study||44
10518801|NCT01340053|11670485|FG002|COMPLETED|Overall Study||43
10518802|NCT01340053|11670486|FG003|COMPLETED|Overall Study||43
10518803|NCT01340053|11670483|FG000|NOT COMPLETED|Overall Study||4
10518804|NCT01340053|11670484|FG001|NOT COMPLETED|Overall Study||2
10518805|NCT01340053|11670485|FG002|NOT COMPLETED|Overall Study||4
10518806|NCT01340053|11670486|FG003|NOT COMPLETED|Overall Study||3
10518807|NCT01340066|11670498|FG000|STARTED|Placebo Run in Period||94
10518808|NCT01340066|11670499|FG001|STARTED|Placebo Run in Period||0
10518809|NCT01340066|11670500|FG002|STARTED|Placebo Run in Period||0
10518810|NCT01340066|11670498|FG000|COMPLETED|Placebo Run in Period|Completed run in period and were eligible for randomization|67
10518811|NCT01340066|11670499|FG001|COMPLETED|Placebo Run in Period||0
10518812|NCT01340066|11670500|FG002|COMPLETED|Placebo Run in Period||0
10518813|NCT01340066|11670498|FG000|NOT COMPLETED|Placebo Run in Period||27
10518814|NCT01340066|11670499|FG001|NOT COMPLETED|Placebo Run in Period||0
10518815|NCT01340066|11670500|FG002|NOT COMPLETED|Placebo Run in Period||0
10518816|NCT01340066|11670498|FG000|STARTED|5 Week Double Blind Randomization Period||0
10518817|NCT01340066|11670499|FG001|STARTED|5 Week Double Blind Randomization Period||33
10518818|NCT01340066|11670500|FG002|STARTED|5 Week Double Blind Randomization Period||34
10518819|NCT01340066|11670498|FG000|COMPLETED|5 Week Double Blind Randomization Period||0
10518820|NCT01340066|11670499|FG001|COMPLETED|5 Week Double Blind Randomization Period||28
10518821|NCT01340066|11670500|FG002|COMPLETED|5 Week Double Blind Randomization Period||31
10518822|NCT01340066|11670498|FG000|NOT COMPLETED|5 Week Double Blind Randomization Period||0
10518823|NCT01340066|11670499|FG001|NOT COMPLETED|5 Week Double Blind Randomization Period||5
10518824|NCT01340066|11670500|FG002|NOT COMPLETED|5 Week Double Blind Randomization Period||3
10518825|NCT01340144|11670509|FG000|STARTED|Overall Study||625
10518826|NCT01340144|11670510|FG001|STARTED|Overall Study||625
10518827|NCT01340144|11670509|FG000|COMPLETED|Overall Study||553
10518828|NCT01340144|11670510|FG001|COMPLETED|Overall Study||567
10518829|NCT01340144|11670509|FG000|NOT COMPLETED|Overall Study||72
10518830|NCT01340144|11670510|FG001|NOT COMPLETED|Overall Study||58
10518831|NCT01340196|11670516|FG000|STARTED|Treat. Period 1 (Tenofovir)||16
10518832|NCT01340196|11670516|FG000|COMPLETED|Treat. Period 1 (Tenofovir)||16
10518833|NCT01340196|11670516|FG000|NOT COMPLETED|Treat. Period 1 (Tenofovir)||0
10518834|NCT01340196|11670516|FG000|STARTED|Treat. Period 2 (Tenofovir/Faldaprevir)||16
10518835|NCT01340196|11670516|FG000|COMPLETED|Treat. Period 2 (Tenofovir/Faldaprevir)||16
10518836|NCT01340196|11670516|FG000|NOT COMPLETED|Treat. Period 2 (Tenofovir/Faldaprevir)||0
10518837|NCT01340196|11670516|FG000|STARTED|Treat. Period 3 (Faldaprevir)||16
10518838|NCT01340196|11670516|FG000|COMPLETED|Treat. Period 3 (Faldaprevir)||14
10518839|NCT01340196|11670516|FG000|NOT COMPLETED|Treat. Period 3 (Faldaprevir)||2
10518840|NCT01340209|11670528|FG000|STARTED|Overall Study||57
10518841|NCT01340209|11670529|FG001|STARTED|Overall Study||114
10518842|NCT01340209|11670530|FG002|STARTED|Overall Study||114
10518843|NCT01340209|11670528|FG000|COMPLETED|Overall Study||52
10518844|NCT01340209|11670529|FG001|COMPLETED|Overall Study||106
10518845|NCT01340209|11670530|FG002|COMPLETED|Overall Study||106
10518846|NCT01340209|11670528|FG000|NOT COMPLETED|Overall Study||5
10518847|NCT01340209|11670529|FG001|NOT COMPLETED|Overall Study||8
10518848|NCT01340209|11670530|FG002|NOT COMPLETED|Overall Study||8
10518849|NCT01340300|11670542|FG000|STARTED|Overall Study||35
10518850|NCT01340300|11670543|FG001|STARTED|Overall Study||35
10518851|NCT01340300|11670544|FG002|STARTED|Overall Study||35
10518852|NCT01340300|11670545|FG003|STARTED|Overall Study||34
10518853|NCT01340300|11670542|FG000|Baseline Blood Sample|Overall Study||33
10518854|NCT01340300|11670543|FG001|Baseline Blood Sample|Overall Study||34
10711742|NCT02662036|11877196|FG000|COMPLETED|Overall Study||22
10711743|NCT02662036|11877197|FG001|COMPLETED|Overall Study||22
10711744|NCT02662036|11877196|FG000|NOT COMPLETED|Overall Study||13
10711745|NCT02662036|11877197|FG001|NOT COMPLETED|Overall Study||13
10518855|NCT01340300|11670544|FG002|Baseline Blood Sample|Overall Study||32
10711746|NCT02662244|11877203|FG000|STARTED|Overall Study||33
10711747|NCT02662244|11877203|FG000|COMPLETED|Overall Study||31
10711748|NCT02662244|11877203|FG000|NOT COMPLETED|Overall Study||2
10711749|NCT02662387|11877211|FG000|STARTED|Overall Study||27
10711750|NCT02662387|11877212|FG001|STARTED|Overall Study||28
10711751|NCT02662387|11877211|FG000|COMPLETED|Overall Study||27
10711752|NCT02662387|11877212|FG001|COMPLETED|Overall Study||28
10711753|NCT02662387|11877211|FG000|NOT COMPLETED|Overall Study||0
10518856|NCT01340300|11670545|FG003|Baseline Blood Sample|Overall Study||29
10518857|NCT01340300|11670542|FG000|Follow-up Blood Sample|Overall Study||25
10518858|NCT01340300|11670543|FG001|Follow-up Blood Sample|Overall Study||26
10518859|NCT01340300|11670544|FG002|Follow-up Blood Sample|Overall Study||19
10518860|NCT01340300|11670545|FG003|Follow-up Blood Sample|Overall Study||18
10518861|NCT01340300|11670542|FG000|COMPLETED|Overall Study||26
10518862|NCT01340300|11670543|FG001|COMPLETED|Overall Study||26
10518863|NCT01340300|11670544|FG002|COMPLETED|Overall Study||20
10518864|NCT01340300|11670545|FG003|COMPLETED|Overall Study||20
10518865|NCT01340300|11670542|FG000|NOT COMPLETED|Overall Study||9
10518866|NCT01340300|11670543|FG001|NOT COMPLETED|Overall Study||9
10518867|NCT01340300|11670544|FG002|NOT COMPLETED|Overall Study||15
10518868|NCT01340300|11670545|FG003|NOT COMPLETED|Overall Study||14
10518869|NCT01340482|11670558|FG000|STARTED|Overall Study||27
10518870|NCT01340482|11670559|FG001|STARTED|Overall Study||1
10518871|NCT01340482|11670560|FG002|STARTED|Overall Study||1
10518872|NCT01340482|11670558|FG000|COMPLETED|Overall Study||25
10518873|NCT01340482|11670559|FG001|COMPLETED|Overall Study||1
10518874|NCT01340482|11670560|FG002|COMPLETED|Overall Study||1
10518875|NCT01340482|11670558|FG000|NOT COMPLETED|Overall Study||2
10518876|NCT01340482|11670559|FG001|NOT COMPLETED|Overall Study||0
10518877|NCT01340482|11670560|FG002|NOT COMPLETED|Overall Study||0
10518878|NCT01340495|11670570|FG000|STARTED|Overall Study||70
10518879|NCT01340495|11670570|FG000|COMPLETED|Overall Study||69
10518880|NCT01340495|11670570|FG000|NOT COMPLETED|Overall Study||1
10518881|NCT01340586|11670576|FG000|STARTED|Overall Study||8
10518882|NCT01340586|11670577|FG001|STARTED|Overall Study||8
10518883|NCT01340586|11670576|FG000|COMPLETED|Overall Study||8
10518884|NCT01340586|11670577|FG001|COMPLETED|Overall Study||8
10518885|NCT01340586|11670576|FG000|NOT COMPLETED|Overall Study||0
10518886|NCT01340586|11670577|FG001|NOT COMPLETED|Overall Study||0
10518887|NCT01340625|11670590|FG000|STARTED|First Intervention||18
10518888|NCT01340625|11670591|FG001|STARTED|First Intervention||18
10518889|NCT01340625|11670590|FG000|COMPLETED|First Intervention||17
10518890|NCT01340625|11670591|FG001|COMPLETED|First Intervention||18
10518891|NCT01340625|11670590|FG000|NOT COMPLETED|First Intervention||1
10518892|NCT01340625|11670591|FG001|NOT COMPLETED|First Intervention||0
10518893|NCT01340625|11670590|FG000|STARTED|Washout Period of 28 Days||17
10518894|NCT01340625|11670591|FG001|STARTED|Washout Period of 28 Days||18
10518895|NCT01340625|11670590|FG000|COMPLETED|Washout Period of 28 Days||16
10518896|NCT01340625|11670591|FG001|COMPLETED|Washout Period of 28 Days||18
10518897|NCT01340625|11670590|FG000|NOT COMPLETED|Washout Period of 28 Days||1
10518898|NCT01340625|11670591|FG001|NOT COMPLETED|Washout Period of 28 Days||0
10518899|NCT01340625|11670590|FG000|STARTED|Second Intervention||16
10518900|NCT01340625|11670591|FG001|STARTED|Second Intervention||18
10518901|NCT01340625|11670590|FG000|COMPLETED|Second Intervention||16
10518902|NCT01340625|11670591|FG001|COMPLETED|Second Intervention||18
10518903|NCT01340625|11670590|FG000|NOT COMPLETED|Second Intervention||0
10518904|NCT01340625|11670591|FG001|NOT COMPLETED|Second Intervention||0
10518905|NCT01340651|11670597|FG000|STARTED|Overall Study||41
10518906|NCT01340651|11670597|FG000|COMPLETED|Overall Study||24
10518907|NCT01340651|11670597|FG000|NOT COMPLETED|Overall Study||17
10518908|NCT01340664|11670606|FG000|STARTED|Overall Study||93
10518909|NCT01340664|11670607|FG001|STARTED|Overall Study||93
10518910|NCT01340664|11670608|FG002|STARTED|Overall Study||93
10518911|NCT01340664|11670606|FG000|COMPLETED|Overall Study||86
10518912|NCT01340664|11670607|FG001|COMPLETED|Overall Study||85
10518913|NCT01340664|11670608|FG002|COMPLETED|Overall Study||80
10518914|NCT01340664|11670606|FG000|NOT COMPLETED|Overall Study||7
10518915|NCT01340664|11670607|FG001|NOT COMPLETED|Overall Study||8
10518916|NCT01340664|11670608|FG002|NOT COMPLETED|Overall Study||13
10518917|NCT01340768|11670618|FG000|STARTED|Overall Study||436
10518918|NCT01340768|11670619|FG001|STARTED|Overall Study||434
10518919|NCT01340768|11670618|FG000|COMPLETED|Overall Study||419
10518920|NCT01340768|11670619|FG001|COMPLETED|Overall Study||429
10518921|NCT01340768|11670618|FG000|NOT COMPLETED|Overall Study||17
10518922|NCT01340768|11670619|FG001|NOT COMPLETED|Overall Study||5
10518923|NCT01340794|11670627|FG000|STARTED|Overall Study||2
10518924|NCT01340794|11670628|FG001|STARTED|Overall Study||5
10518925|NCT01340794|11670627|FG000|COMPLETED|Overall Study||2
10518926|NCT01340794|11670628|FG001|COMPLETED|Overall Study||4
10518927|NCT01340794|11670627|FG000|NOT COMPLETED|Overall Study||0
10518928|NCT01340794|11670628|FG001|NOT COMPLETED|Overall Study||1
10518929|NCT01340872|11670638|FG000|STARTED|Double-blind Phase||64
10518930|NCT01340872|11670639|FG001|STARTED|Double-blind Phase||64
10518931|NCT01340872|11670640|FG002|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
10518932|NCT01340872|11670641|FG003|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
10518933|NCT01340872|11670638|FG000|COMPLETED|Double-blind Phase||55
10518934|NCT01340872|11670639|FG001|COMPLETED|Double-blind Phase||53
10518935|NCT01340872|11670640|FG002|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
10518936|NCT01340872|11670641|FG003|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
10518937|NCT01340872|11670638|FG000|NOT COMPLETED|Double-blind Phase||9
10518938|NCT01340872|11670639|FG001|NOT COMPLETED|Double-blind Phase||11
10518939|NCT01340872|11670640|FG002|NOT COMPLETED|Double-blind Phase||0
10518940|NCT01340872|11670641|FG003|NOT COMPLETED|Double-blind Phase||0
10518941|NCT01340872|11670638|FG000|STARTED|Open-label Phase|Not Applicable to open-label phase|0
10518942|NCT01340872|11670639|FG001|STARTED|Open-label Phase|Not Applicable to open-label phase|0
10518943|NCT01340872|11670640|FG002|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|50
10518944|NCT01340872|11670641|FG003|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|47
10518945|NCT01340872|11670638|FG000|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
10518946|NCT01340872|11670639|FG001|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
10518947|NCT01340872|11670640|FG002|COMPLETED|Open-label Phase||37
10518948|NCT01340872|11670641|FG003|COMPLETED|Open-label Phase||36
10518949|NCT01340872|11670638|FG000|NOT COMPLETED|Open-label Phase||0
10518950|NCT01340872|11670639|FG001|NOT COMPLETED|Open-label Phase||0
10518951|NCT01340872|11670640|FG002|NOT COMPLETED|Open-label Phase||13
10518952|NCT01340872|11670641|FG003|NOT COMPLETED|Open-label Phase||11
10518953|NCT01340898|11670656|FG000|STARTED|Primary Phase||376
10518954|NCT01340898|11670657|FG001|STARTED|Primary Phase||187
10518955|NCT01340898|11670658|FG002|STARTED|Primary Phase||187
10518956|NCT01340898|11670656|FG000|COMPLETED|Primary Phase||360
10518957|NCT01340898|11670657|FG001|COMPLETED|Primary Phase||178
10518958|NCT01340898|11670658|FG002|COMPLETED|Primary Phase||181
10518959|NCT01340898|11670656|FG000|NOT COMPLETED|Primary Phase||16
10518960|NCT01340898|11670657|FG001|NOT COMPLETED|Primary Phase||9
10518961|NCT01340898|11670658|FG002|NOT COMPLETED|Primary Phase||6
10518962|NCT01340898|11670656|FG000|STARTED|Booster Phase||342
10518963|NCT01340898|11670657|FG001|STARTED|Booster Phase||166
10518964|NCT01340898|11670658|FG002|STARTED|Booster Phase||170
10518965|NCT01340898|11670656|FG000|COMPLETED|Booster Phase||332
10518966|NCT01340898|11670657|FG001|COMPLETED|Booster Phase||164
10518967|NCT01340898|11670658|FG002|COMPLETED|Booster Phase||163
10518968|NCT01340898|11670656|FG000|NOT COMPLETED|Booster Phase||10
10518969|NCT01340898|11670657|FG001|NOT COMPLETED|Booster Phase||2
10518970|NCT01340898|11670658|FG002|NOT COMPLETED|Booster Phase||7
10518971|NCT01340937|11670672|FG000|STARTED|Period 1: Infant Series||800
10518972|NCT01340937|11670673|FG001|STARTED|Period 1: Infant Series||797
10518973|NCT01340937|11670674|FG002|STARTED|Period 1: Infant Series||809
10518974|NCT01340937|11670675|FG003|STARTED|Period 1: Infant Series||402
10518975|NCT01340937|11670672|FG000|COMPLETED|Period 1: Infant Series||742
10518976|NCT01340937|11670673|FG001|COMPLETED|Period 1: Infant Series||737
10518977|NCT01340937|11670674|FG002|COMPLETED|Period 1: Infant Series||753
10518978|NCT01340937|11670675|FG003|COMPLETED|Period 1: Infant Series||370
10518979|NCT01340937|11670672|FG000|NOT COMPLETED|Period 1: Infant Series||58
10518980|NCT01340937|11670673|FG001|NOT COMPLETED|Period 1: Infant Series||60
10518981|NCT01340937|11670674|FG002|NOT COMPLETED|Period 1: Infant Series||56
10518982|NCT01340937|11670675|FG003|NOT COMPLETED|Period 1: Infant Series||32
10518983|NCT01340937|11670672|FG000|STARTED|Period 2: Interim Period||742
10518984|NCT01340937|11670673|FG001|STARTED|Period 2: Interim Period||737
10518985|NCT01340937|11670674|FG002|STARTED|Period 2: Interim Period||753
10518986|NCT01340937|11670675|FG003|STARTED|Period 2: Interim Period||370
10518987|NCT01340937|11670672|FG000|COMPLETED|Period 2: Interim Period||675
10518988|NCT01340937|11670673|FG001|COMPLETED|Period 2: Interim Period||658
10518989|NCT01340937|11670674|FG002|COMPLETED|Period 2: Interim Period||669
10518990|NCT01340937|11670675|FG003|COMPLETED|Period 2: Interim Period||329
10518991|NCT01340937|11670672|FG000|NOT COMPLETED|Period 2: Interim Period||67
10518992|NCT01340937|11670673|FG001|NOT COMPLETED|Period 2: Interim Period||79
10518993|NCT01340937|11670674|FG002|NOT COMPLETED|Period 2: Interim Period||84
10518994|NCT01340937|11670675|FG003|NOT COMPLETED|Period 2: Interim Period||41
10518995|NCT01340937|11670672|FG000|STARTED|Period 3: Toddler Vaccinations||675
10518996|NCT01340937|11670673|FG001|STARTED|Period 3: Toddler Vaccinations||658
10518997|NCT01340937|11670674|FG002|STARTED|Period 3: Toddler Vaccinations||669
10518998|NCT01340937|11670675|FG003|STARTED|Period 3: Toddler Vaccinations||329
10518999|NCT01340937|11670672|FG000|COMPLETED|Period 3: Toddler Vaccinations||666
10519000|NCT01340937|11670673|FG001|COMPLETED|Period 3: Toddler Vaccinations||641
10519001|NCT01340937|11670674|FG002|COMPLETED|Period 3: Toddler Vaccinations||660
10519002|NCT01340937|11670675|FG003|COMPLETED|Period 3: Toddler Vaccinations||319
10519003|NCT01340937|11670672|FG000|NOT COMPLETED|Period 3: Toddler Vaccinations||9
10519004|NCT01340937|11670673|FG001|NOT COMPLETED|Period 3: Toddler Vaccinations||17
10519005|NCT01340937|11670674|FG002|NOT COMPLETED|Period 3: Toddler Vaccinations||9
10519006|NCT01340937|11670675|FG003|NOT COMPLETED|Period 3: Toddler Vaccinations||10
10519007|NCT01340976|11670697|FG000|STARTED|Overall Study||4
10519008|NCT01340976|11670698|FG001|STARTED|Overall Study||3
10519009|NCT01340976|11670699|FG002|STARTED|Overall Study||7
10519010|NCT01340976|11670700|FG003|STARTED|Overall Study||5
10519011|NCT01340976|11670701|FG004|STARTED|Overall Study||7
10519012|NCT01340976|11670702|FG005|STARTED|Overall Study||7
10519013|NCT01340976|11670697|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
10519014|NCT01340976|11670698|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
10519015|NCT01340976|11670699|FG002|Received at Least 1 Dose of Study Drug|Overall Study||7
10519016|NCT01340976|11670700|FG003|Received at Least 1 Dose of Study Drug|Overall Study||5
10519017|NCT01340976|11670701|FG004|Received at Least 1 Dose of Study Drug|Overall Study||7
10519018|NCT01340976|11670702|FG005|Received at Least 1 Dose of Study Drug|Overall Study||7
10519019|NCT01340976|11670697|FG000|COMPLETED|Overall Study||0
10519020|NCT01340976|11670698|FG001|COMPLETED|Overall Study||1
10519021|NCT01340976|11670699|FG002|COMPLETED|Overall Study||4
10519022|NCT01340976|11670700|FG003|COMPLETED|Overall Study||2
10519023|NCT01340976|11670701|FG004|COMPLETED|Overall Study||5
10519024|NCT01340976|11670702|FG005|COMPLETED|Overall Study||6
10519025|NCT01340976|11670697|FG000|NOT COMPLETED|Overall Study||4
10519026|NCT01340976|11670698|FG001|NOT COMPLETED|Overall Study||2
10519027|NCT01340976|11670699|FG002|NOT COMPLETED|Overall Study||3
10519028|NCT01340976|11670700|FG003|NOT COMPLETED|Overall Study||3
10519029|NCT01340976|11670701|FG004|NOT COMPLETED|Overall Study||2
10519030|NCT01340976|11670702|FG005|NOT COMPLETED|Overall Study||1
10519031|NCT01341067|11670722|FG000|STARTED|Overall Study||30
10519032|NCT01341067|11670722|FG000|COMPLETED|Overall Study||26
10519033|NCT01341067|11670722|FG000|NOT COMPLETED|Overall Study||4
10519034|NCT01341301|11670726|FG000|STARTED|Overall Study||25
10519035|NCT01341301|11670726|FG000|COMPLETED|Overall Study||25
10519036|NCT01341301|11670726|FG000|NOT COMPLETED|Overall Study||0
10519043|NCT01341457|11670743|FG000|STARTED|Overall Study||7
10519044|NCT01341457|11670744|FG001|STARTED|Overall Study||10
10519045|NCT01341457|11670743|FG000|Received at Least One Dose of Study Drug|Overall Study||7
10519046|NCT01341457|11670744|FG001|Received at Least One Dose of Study Drug|Overall Study||10
10519047|NCT01341457|11670743|FG000|COMPLETED|Overall Study||5
10519048|NCT01341457|11670744|FG001|COMPLETED|Overall Study||10
10519049|NCT01341457|11670743|FG000|NOT COMPLETED|Overall Study||2
10519050|NCT01341457|11670744|FG001|NOT COMPLETED|Overall Study||0
10519051|NCT01341470|11670757|FG000|STARTED|Overall Study||6
10519052|NCT01341470|11670758|FG001|STARTED|Overall Study||9
10519053|NCT01341470|11670759|FG002|STARTED|Overall Study||10
10519054|NCT01341470|11670760|FG003|STARTED|Overall Study||10
10519055|NCT01341470|11670761|FG004|STARTED|Overall Study||2
10519056|NCT01341470|11670762|FG005|STARTED|Overall Study||10
10519057|NCT01341470|11670757|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
10519058|NCT01341470|11670758|FG001|Received at Least 1 Dose of Study Drug|Overall Study||9
10519059|NCT01341470|11670759|FG002|Received at Least 1 Dose of Study Drug|Overall Study||10
10519060|NCT01341470|11670760|FG003|Received at Least 1 Dose of Study Drug|Overall Study||10
10519061|NCT01341470|11670761|FG004|Received at Least 1 Dose of Study Drug|Overall Study||2
10519062|NCT01341470|11670762|FG005|Received at Least 1 Dose of Study Drug|Overall Study||10
10519063|NCT01341470|11670757|FG000|COMPLETED|Overall Study||6
10519064|NCT01341470|11670758|FG001|COMPLETED|Overall Study||9
10519065|NCT01341470|11670759|FG002|COMPLETED|Overall Study||9
10519066|NCT01341470|11670760|FG003|COMPLETED|Overall Study||9
10519067|NCT01341470|11670761|FG004|COMPLETED|Overall Study||2
10519068|NCT01341470|11670762|FG005|COMPLETED|Overall Study||9
10519069|NCT01341470|11670757|FG000|NOT COMPLETED|Overall Study||0
10519070|NCT01341470|11670758|FG001|NOT COMPLETED|Overall Study||0
10519071|NCT01341470|11670759|FG002|NOT COMPLETED|Overall Study||1
10519072|NCT01341470|11670760|FG003|NOT COMPLETED|Overall Study||1
10519073|NCT01341470|11670761|FG004|NOT COMPLETED|Overall Study||0
10519074|NCT01341470|11670762|FG005|NOT COMPLETED|Overall Study||1
10519075|NCT01341639|11670780|FG000|STARTED|Infant Series||628
10519076|NCT01341639|11670781|FG001|STARTED|Infant Series||622
10519077|NCT01341639|11670780|FG000|Site 0048 Excluded|Infant Series||611
10519078|NCT01341639|11670781|FG001|Site 0048 Excluded|Infant Series||606
10519079|NCT01341639|11670780|FG000|Treated|Infant Series||610
10519080|NCT01341639|11670781|FG001|Treated|Infant Series||605
10519081|NCT01341639|11670780|FG000|COMPLETED|Infant Series||599
10519082|NCT01341639|11670781|FG001|COMPLETED|Infant Series||590
10519083|NCT01341639|11670780|FG000|NOT COMPLETED|Infant Series||29
10519084|NCT01341639|11670781|FG001|NOT COMPLETED|Infant Series||32
10519085|NCT01341639|11670780|FG000|STARTED|Interim Period||599
10519086|NCT01341639|11670781|FG001|STARTED|Interim Period||590
10519087|NCT01341639|11670780|FG000|COMPLETED|Interim Period||591
10519088|NCT01341639|11670781|FG001|COMPLETED|Interim Period||581
10519089|NCT01341639|11670780|FG000|NOT COMPLETED|Interim Period||8
10519090|NCT01341639|11670781|FG001|NOT COMPLETED|Interim Period||9
10519091|NCT01341639|11670780|FG000|STARTED|Toddler Dose|One participant randomized to the PR5I group mistakenly received INFANRIX™ hexa instead|590
10519092|NCT01341639|11670781|FG001|STARTED|Toddler Dose|One participant randomized to the PR5I group mistakenly received INFANRIX™ hexa instead|582
10519093|NCT01341639|11670780|FG000|COMPLETED|Toddler Dose||539
10519094|NCT01341639|11670781|FG001|COMPLETED|Toddler Dose||548
10519095|NCT01341639|11670780|FG000|NOT COMPLETED|Toddler Dose||51
10519096|NCT01341639|11670781|FG001|NOT COMPLETED|Toddler Dose||34
10519097|NCT01341639|11670780|FG000|STARTED|Post-Treatment||539
10519098|NCT01341639|11670781|FG001|STARTED|Post-Treatment||548
10519099|NCT01341639|11670780|FG000|COMPLETED|Post-Treatment||539
10519100|NCT01341639|11670781|FG001|COMPLETED|Post-Treatment||545
10519101|NCT01341639|11670780|FG000|NOT COMPLETED|Post-Treatment||0
10519102|NCT01341639|11670781|FG001|NOT COMPLETED|Post-Treatment||3
10519103|NCT01341652|11670789|FG000|STARTED|Overall Study||49
10519104|NCT01341652|11670790|FG001|STARTED|Overall Study||50
10519105|NCT01341652|11670789|FG000|COMPLETED|Overall Study||49
10519106|NCT01341652|11670790|FG001|COMPLETED|Overall Study||48
10519107|NCT01341652|11670789|FG000|NOT COMPLETED|Overall Study||0
10519108|NCT01341652|11670790|FG001|NOT COMPLETED|Overall Study||2
10519109|NCT01341730|11670798|FG000|STARTED|Overall Study||20
10519110|NCT01341730|11670799|FG001|STARTED|Overall Study||21
10519111|NCT01341730|11670798|FG000|COMPLETED|Overall Study||16
10519112|NCT01341730|11670799|FG001|COMPLETED|Overall Study||17
10519113|NCT01341730|11670798|FG000|NOT COMPLETED|Overall Study||4
10519114|NCT01341730|11670799|FG001|NOT COMPLETED|Overall Study||4
10519115|NCT01341782|11670809|FG000|STARTED|Overall Study||127
10519116|NCT01341782|11670810|FG001|STARTED|Overall Study||128
10519117|NCT01341782|11670809|FG000|COMPLETED|Overall Study||112
10519118|NCT01341782|11670810|FG001|COMPLETED|Overall Study||114
10519119|NCT01341782|11670809|FG000|NOT COMPLETED|Overall Study||15
10519120|NCT01341782|11670810|FG001|NOT COMPLETED|Overall Study||14
10519121|NCT01341912|11670816|FG000|STARTED|Overall Study||3
10519122|NCT01341912|11670816|FG000|COMPLETED|Overall Study||3
10519123|NCT01341912|11670816|FG000|NOT COMPLETED|Overall Study||0
10519124|NCT01341977|11670822|FG000|STARTED|Overall Study||288
10519125|NCT01341977|11670823|FG001|STARTED|Overall Study||285
10519126|NCT01341977|11670822|FG000|COMPLETED|Overall Study||274
10519127|NCT01341977|11670823|FG001|COMPLETED|Overall Study||270
10519128|NCT01341977|11670822|FG000|NOT COMPLETED|Overall Study||14
10519129|NCT01341977|11670823|FG001|NOT COMPLETED|Overall Study||15
10519130|NCT01341990|11670831|FG000|STARTED|Overall Study||35
10519131|NCT01341990|11670832|FG001|STARTED|Overall Study||33
10519132|NCT01341990|11670831|FG000|COMPLETED|Overall Study||32
10519133|NCT01341990|11670832|FG001|COMPLETED|Overall Study||32
10519134|NCT01341990|11670831|FG000|NOT COMPLETED|Overall Study||3
10519135|NCT01341990|11670832|FG001|NOT COMPLETED|Overall Study||1
10519136|NCT01342029|11670838|FG000|STARTED|Period 1||70
10519137|NCT01342029|11670839|FG001|STARTED|Period 1||72
10519138|NCT01342029|11670838|FG000|Dropout|Period 1||3
10519139|NCT01342029|11670839|FG001|Dropout|Period 1||1
10519140|NCT01342029|11670838|FG000|COMPLETED|Period 1||67
10519141|NCT01342029|11670839|FG001|COMPLETED|Period 1||71
10519142|NCT01342029|11670838|FG000|NOT COMPLETED|Period 1||3
10519143|NCT01342029|11670839|FG001|NOT COMPLETED|Period 1||1
10519144|NCT01342029|11670838|FG000|STARTED|Washout||67
10519145|NCT01342029|11670839|FG001|STARTED|Washout||71
10519146|NCT01342029|11670838|FG000|COMPLETED|Washout||67
10519147|NCT01342029|11670839|FG001|COMPLETED|Washout||67
10519148|NCT01342029|11670838|FG000|NOT COMPLETED|Washout||0
10519149|NCT01342029|11670839|FG001|NOT COMPLETED|Washout||4
10519150|NCT01342029|11670838|FG000|STARTED|Period 2||67
10519151|NCT01342029|11670839|FG001|STARTED|Period 2||67
10519152|NCT01342029|11670838|FG000|Dropout|Period 2||2
10519153|NCT01342029|11670839|FG001|Dropout|Period 2||0
10519154|NCT01342029|11670838|FG000|COMPLETED|Period 2||65
10519155|NCT01342029|11670839|FG001|COMPLETED|Period 2||67
10519156|NCT01342029|11670838|FG000|NOT COMPLETED|Period 2||2
10519157|NCT01342029|11670839|FG001|NOT COMPLETED|Period 2||0
10519158|NCT01342081|11670850|FG000|STARTED|Overall Study||161
10519159|NCT01342081|11670851|FG001|STARTED|Overall Study||164
10519160|NCT01342081|11670852|FG002|STARTED|Overall Study||164
10519161|NCT01342081|11670850|FG000|COMPLETED|Overall Study||159
10519162|NCT01342081|11670851|FG001|COMPLETED|Overall Study||162
10519163|NCT01342081|11670852|FG002|COMPLETED|Overall Study||163
10519164|NCT01342081|11670850|FG000|NOT COMPLETED|Overall Study||2
10519165|NCT01342081|11670851|FG001|NOT COMPLETED|Overall Study||2
10519166|NCT01342081|11670852|FG002|NOT COMPLETED|Overall Study||1
10519167|NCT01342094|11670862|FG000|STARTED|Overall Study||82
10519168|NCT01342094|11670863|FG001|STARTED|Overall Study||84
10519169|NCT01342094|11670862|FG000|COMPLETED|Overall Study||77
10519170|NCT01342094|11670863|FG001|COMPLETED|Overall Study||81
10519171|NCT01342094|11670862|FG000|NOT COMPLETED|Overall Study||5
10519172|NCT01342094|11670863|FG001|NOT COMPLETED|Overall Study||3
10519173|NCT01342107|11670871|FG000|STARTED|Overall Study||34
10519174|NCT01342107|11670872|FG001|STARTED|Overall Study||32
10519175|NCT01342107|11670871|FG000|COMPLETED|Overall Study||34
10519176|NCT01342107|11670872|FG001|COMPLETED|Overall Study||32
10519177|NCT01342107|11670871|FG000|NOT COMPLETED|Overall Study||0
10519178|NCT01342107|11670872|FG001|NOT COMPLETED|Overall Study||0
10519179|NCT01342172|11670878|FG000|STARTED|Overall Study||9
10519180|NCT01342172|11670878|FG000|COMPLETED|Overall Study||9
10519181|NCT01342172|11670878|FG000|NOT COMPLETED|Overall Study||0
10519182|NCT01342211|11670888|FG000|STARTED|Overall Study||19
10519183|NCT01342211|11670889|FG001|STARTED|Overall Study||19
10519184|NCT01342211|11670890|FG002|STARTED|Overall Study||18
10519185|NCT01342211|11670891|FG003|STARTED|Overall Study||19
10519186|NCT01342211|11670892|FG004|STARTED|Overall Study||18
10519187|NCT01342211|11670888|FG000|Treated|Overall Study||19
10519188|NCT01342211|11670889|FG001|Treated|Overall Study||17
10519189|NCT01342211|11670890|FG002|Treated|Overall Study||18
10519190|NCT01342211|11670891|FG003|Treated|Overall Study||19
10519191|NCT01342211|11670892|FG004|Treated|Overall Study||17
10519192|NCT01342211|11670888|FG000|COMPLETED|Overall Study||19
10519193|NCT01342211|11670889|FG001|COMPLETED|Overall Study||17
10519194|NCT01342211|11670890|FG002|COMPLETED|Overall Study||18
10519195|NCT01342211|11670891|FG003|COMPLETED|Overall Study||17
10519196|NCT01342211|11670892|FG004|COMPLETED|Overall Study||16
10519197|NCT01342211|11670888|FG000|NOT COMPLETED|Overall Study||0
10519198|NCT01342211|11670889|FG001|NOT COMPLETED|Overall Study||2
10519199|NCT01342211|11670890|FG002|NOT COMPLETED|Overall Study||0
10519200|NCT01342211|11670891|FG003|NOT COMPLETED|Overall Study||2
10519201|NCT01342211|11670892|FG004|NOT COMPLETED|Overall Study||2
10519202|NCT01342341|11670910|FG000|STARTED|Overall Study||24
10519203|NCT01342341|11670911|FG001|STARTED|Overall Study||24
10519204|NCT01342341|11670910|FG000|COMPLETED|Overall Study||20
10519205|NCT01342341|11670911|FG001|COMPLETED|Overall Study||20
10519206|NCT01342341|11670910|FG000|NOT COMPLETED|Overall Study||4
10519207|NCT01342341|11670911|FG001|NOT COMPLETED|Overall Study||4
10519208|NCT01342367|11670919|FG000|STARTED|Overall Study||32
10519209|NCT01342367|11670920|FG001|STARTED|Overall Study||42
10519210|NCT01342367|11670919|FG000|COMPLETED|Overall Study||30
10519211|NCT01342367|11670920|FG001|COMPLETED|Overall Study||40
10519212|NCT01342367|11670919|FG000|NOT COMPLETED|Overall Study||2
10519213|NCT01342367|11670920|FG001|NOT COMPLETED|Overall Study||2
10519214|NCT01342445|11670928|FG000|STARTED|Overall Study||26
10519215|NCT01342445|11670929|FG001|STARTED|Overall Study||24
10519216|NCT01342445|11670928|FG000|COMPLETED|Overall Study||26
10519217|NCT01342445|11670929|FG001|COMPLETED|Overall Study||22
10519218|NCT01342445|11670928|FG000|NOT COMPLETED|Overall Study||0
10519219|NCT01342445|11670929|FG001|NOT COMPLETED|Overall Study||2
10519220|NCT01342458|11670941|FG000|STARTED|Overall Study||28
10519221|NCT01342458|11670942|FG001|STARTED|Overall Study||28
10519222|NCT01342458|11670941|FG000|COMPLETED|Overall Study||26
10519223|NCT01342458|11670942|FG001|COMPLETED|Overall Study||24
10519224|NCT01342458|11670941|FG000|NOT COMPLETED|Overall Study||2
10519225|NCT01342458|11670942|FG001|NOT COMPLETED|Overall Study||4
10519226|NCT01342471|11670964|FG000|STARTED|Overall Study||29
10519227|NCT01342471|11670965|FG001|STARTED|Overall Study||29
10519228|NCT01342471|11670964|FG000|COMPLETED|Overall Study||24
10519229|NCT01342471|11670965|FG001|COMPLETED|Overall Study||23
10519230|NCT01342471|11670964|FG000|NOT COMPLETED|Overall Study||5
10519231|NCT01342471|11670965|FG001|NOT COMPLETED|Overall Study||6
10519232|NCT01342484|11670974|FG000|STARTED|Overall Study||15
10519233|NCT01342484|11670975|FG001|STARTED|Overall Study||10
10519234|NCT01342484|11670976|FG002|STARTED|Overall Study||14
10519235|NCT01342484|11670974|FG000|COMPLETED|Overall Study||13
10519236|NCT01342484|11670975|FG001|COMPLETED|Overall Study||10
10519237|NCT01342484|11670976|FG002|COMPLETED|Overall Study||13
10519238|NCT01342484|11670974|FG000|NOT COMPLETED|Overall Study||2
10519239|NCT01342484|11670975|FG001|NOT COMPLETED|Overall Study||0
10519240|NCT01342484|11670976|FG002|NOT COMPLETED|Overall Study||1
10519241|NCT01342510|11670988|FG000|STARTED|Overall Study||50
10519242|NCT01342510|11670989|FG001|STARTED|Overall Study||50
10519243|NCT01342510|11670990|FG002|STARTED|Overall Study||50
10519244|NCT01342510|11670991|FG003|STARTED|Overall Study||50
10519245|NCT01342510|11670988|FG000|COMPLETED|Overall Study||38
10519246|NCT01342510|11670989|FG001|COMPLETED|Overall Study||44
10519247|NCT01342510|11670990|FG002|COMPLETED|Overall Study||37
10519248|NCT01342510|11670991|FG003|COMPLETED|Overall Study||39
10519249|NCT01342510|11670988|FG000|NOT COMPLETED|Overall Study||12
10519250|NCT01342510|11670989|FG001|NOT COMPLETED|Overall Study||6
10519251|NCT01342510|11670990|FG002|NOT COMPLETED|Overall Study||13
10519252|NCT01342510|11670991|FG003|NOT COMPLETED|Overall Study||11
10519253|NCT01342523|11671037|FG000|STARTED|Overall Study||35
10519254|NCT01342523|11671038|FG001|STARTED|Overall Study||32
10519255|NCT01342523|11671039|FG002|STARTED|Overall Study||36
10519256|NCT01342523|11671040|FG003|STARTED|Overall Study||33
10519257|NCT01342523|11671041|FG004|STARTED|Overall Study||36
10519258|NCT01342523|11671042|FG005|STARTED|Overall Study||36
10519259|NCT01342523|11671043|FG006|STARTED|Overall Study||22
10519260|NCT01342523|11671044|FG007|STARTED|Overall Study||27
10519261|NCT01342523|11671045|FG008|STARTED|Overall Study||28
10519262|NCT01342523|11671046|FG009|STARTED|Overall Study||28
10519263|NCT01342523|11671047|FG010|STARTED|Overall Study||38
10519264|NCT01342523|11671048|FG011|STARTED|Overall Study||38
10519265|NCT01342523|11671049|FG012|STARTED|Overall Study||39
10519266|NCT01342523|11671050|FG013|STARTED|Overall Study||38
10519267|NCT01342523|11671051|FG014|STARTED|Overall Study||38
10519268|NCT01342523|11671052|FG015|STARTED|Overall Study||32
10519269|NCT01342523|11671053|FG016|STARTED|Overall Study||29
10519270|NCT01342523|11671054|FG017|STARTED|Overall Study||27
10519271|NCT01342523|11671055|FG018|STARTED|Overall Study||21
10519272|NCT01342523|11671056|FG019|STARTED|Overall Study||27
10519273|NCT01342523|11671057|FG020|STARTED|Overall Study||29
10519274|NCT01342523|11671058|FG021|STARTED|Overall Study||30
10519275|NCT01342523|11671059|FG022|STARTED|Overall Study||36
10519276|NCT01342523|11671060|FG023|STARTED|Overall Study||36
10519277|NCT01342523|11671061|FG024|STARTED|Overall Study||37
10519278|NCT01342523|11671062|FG025|STARTED|Overall Study||38
10519279|NCT01342523|11671063|FG026|STARTED|Overall Study||34
10519280|NCT01342523|11671064|FG027|STARTED|Overall Study||31
10519281|NCT01342523|11671065|FG028|STARTED|Overall Study||35
10519282|NCT01342523|11671066|FG029|STARTED|Overall Study||29
10519283|NCT01342523|11671067|FG030|STARTED|Overall Study||31
10519284|NCT01342523|11671068|FG031|STARTED|Overall Study||28
10519285|NCT01342523|11671037|FG000|COMPLETED|Overall Study||34
10519286|NCT01342523|11671038|FG001|COMPLETED|Overall Study||32
10519287|NCT01342523|11671039|FG002|COMPLETED|Overall Study||36
10519288|NCT01342523|11671040|FG003|COMPLETED|Overall Study||32
10519289|NCT01342523|11671041|FG004|COMPLETED|Overall Study||36
10519290|NCT01342523|11671042|FG005|COMPLETED|Overall Study||36
10519291|NCT01342523|11671043|FG006|COMPLETED|Overall Study||22
10519292|NCT01342523|11671044|FG007|COMPLETED|Overall Study||27
10519293|NCT01342523|11671045|FG008|COMPLETED|Overall Study||28
10519294|NCT01342523|11671046|FG009|COMPLETED|Overall Study||28
10519295|NCT01342523|11671047|FG010|COMPLETED|Overall Study||38
10519296|NCT01342523|11671048|FG011|COMPLETED|Overall Study||36
10519297|NCT01342523|11671049|FG012|COMPLETED|Overall Study||39
10519298|NCT01342523|11671050|FG013|COMPLETED|Overall Study||36
10519299|NCT01342523|11671051|FG014|COMPLETED|Overall Study||37
10519300|NCT01342523|11671052|FG015|COMPLETED|Overall Study||32
10519301|NCT01342523|11671053|FG016|COMPLETED|Overall Study||28
10519302|NCT01342523|11671054|FG017|COMPLETED|Overall Study||27
10519303|NCT01342523|11671055|FG018|COMPLETED|Overall Study||21
10519304|NCT01342523|11671056|FG019|COMPLETED|Overall Study||27
10519305|NCT01342523|11671057|FG020|COMPLETED|Overall Study||29
10519306|NCT01342523|11671058|FG021|COMPLETED|Overall Study||30
10519307|NCT01342523|11671059|FG022|COMPLETED|Overall Study||36
10519308|NCT01342523|11671060|FG023|COMPLETED|Overall Study||35
10519309|NCT01342523|11671061|FG024|COMPLETED|Overall Study||36
10519310|NCT01342523|11671062|FG025|COMPLETED|Overall Study||36
10519311|NCT01342523|11671063|FG026|COMPLETED|Overall Study||33
10519312|NCT01342523|11671064|FG027|COMPLETED|Overall Study||30
10519313|NCT01342523|11671065|FG028|COMPLETED|Overall Study||34
10519314|NCT01342523|11671066|FG029|COMPLETED|Overall Study||28
10519315|NCT01342523|11671067|FG030|COMPLETED|Overall Study||30
10519316|NCT01342523|11671068|FG031|COMPLETED|Overall Study||27
10519317|NCT01342523|11671037|FG000|NOT COMPLETED|Overall Study||1
10519318|NCT01342523|11671038|FG001|NOT COMPLETED|Overall Study||0
10519319|NCT01342523|11671039|FG002|NOT COMPLETED|Overall Study||0
10519320|NCT01342523|11671040|FG003|NOT COMPLETED|Overall Study||1
10519321|NCT01342523|11671041|FG004|NOT COMPLETED|Overall Study||0
10519322|NCT01342523|11671042|FG005|NOT COMPLETED|Overall Study||0
10519323|NCT01342523|11671043|FG006|NOT COMPLETED|Overall Study||0
10519324|NCT01342523|11671044|FG007|NOT COMPLETED|Overall Study||0
10519325|NCT01342523|11671045|FG008|NOT COMPLETED|Overall Study||0
10519326|NCT01342523|11671046|FG009|NOT COMPLETED|Overall Study||0
10519327|NCT01342523|11671047|FG010|NOT COMPLETED|Overall Study||0
10519328|NCT01342523|11671048|FG011|NOT COMPLETED|Overall Study||2
10519329|NCT01342523|11671049|FG012|NOT COMPLETED|Overall Study||0
10519330|NCT01342523|11671050|FG013|NOT COMPLETED|Overall Study||2
10519331|NCT01342523|11671051|FG014|NOT COMPLETED|Overall Study||1
10519332|NCT01342523|11671052|FG015|NOT COMPLETED|Overall Study||0
10519333|NCT01342523|11671053|FG016|NOT COMPLETED|Overall Study||1
10519334|NCT01342523|11671054|FG017|NOT COMPLETED|Overall Study||0
10519335|NCT01342523|11671055|FG018|NOT COMPLETED|Overall Study||0
10519336|NCT01342523|11671056|FG019|NOT COMPLETED|Overall Study||0
10519337|NCT01342523|11671057|FG020|NOT COMPLETED|Overall Study||0
10519338|NCT01342523|11671058|FG021|NOT COMPLETED|Overall Study||0
10519339|NCT01342523|11671059|FG022|NOT COMPLETED|Overall Study||0
10519340|NCT01342523|11671060|FG023|NOT COMPLETED|Overall Study||1
10519341|NCT01342523|11671061|FG024|NOT COMPLETED|Overall Study||1
10519342|NCT01342523|11671062|FG025|NOT COMPLETED|Overall Study||2
10519343|NCT01342523|11671063|FG026|NOT COMPLETED|Overall Study||1
10519344|NCT01342523|11671064|FG027|NOT COMPLETED|Overall Study||1
10519345|NCT01342523|11671065|FG028|NOT COMPLETED|Overall Study||1
10519346|NCT01342523|11671066|FG029|NOT COMPLETED|Overall Study||1
10519347|NCT01342523|11671067|FG030|NOT COMPLETED|Overall Study||1
10519348|NCT01342523|11671068|FG031|NOT COMPLETED|Overall Study||1
10519349|NCT01342549|11671083|FG000|STARTED|Overall Study||31
10519350|NCT01342549|11671084|FG001|STARTED|Overall Study||31
10519351|NCT01342549|11671083|FG000|COMPLETED|Overall Study||31
10519352|NCT01342549|11671084|FG001|COMPLETED|Overall Study||31
10519353|NCT01342549|11671083|FG000|NOT COMPLETED|Overall Study||0
10519354|NCT01342549|11671084|FG001|NOT COMPLETED|Overall Study||0
10519355|NCT01342640|11671090|FG000|STARTED|Overall Study||70
10519356|NCT01342640|11671090|FG000|COMPLETED|Overall Study||29
10519357|NCT01342640|11671090|FG000|NOT COMPLETED|Overall Study||41
10519358|NCT01342666|11671096|FG000|STARTED|Overall Study||26
10519359|NCT01342666|11671097|FG001|STARTED|Overall Study||24
10519360|NCT01342666|11671096|FG000|COMPLETED|Overall Study||26
10519361|NCT01342666|11671097|FG001|COMPLETED|Overall Study||24
10519362|NCT01342666|11671096|FG000|NOT COMPLETED|Overall Study||0
10519363|NCT01342666|11671097|FG001|NOT COMPLETED|Overall Study||0
10519364|NCT01342757|11671103|FG000|STARTED|Overall Study||12
10519365|NCT01342757|11671103|FG000|COMPLETED|Overall Study||12
10519366|NCT01342757|11671103|FG000|NOT COMPLETED|Overall Study||0
10519367|NCT01342770|11671107|FG000|STARTED|Overall Study||6
10519368|NCT01342770|11671107|FG000|COMPLETED|Overall Study||6
10519369|NCT01342770|11671107|FG000|NOT COMPLETED|Overall Study||0
10519370|NCT01342796|11671113|FG000|STARTED|Overall Study||43
10519371|NCT01342796|11671114|FG001|STARTED|Overall Study||41
10519372|NCT01342796|11671113|FG000|COMPLETED|Overall Study||40
10519373|NCT01342796|11671114|FG001|COMPLETED|Overall Study||38
10519374|NCT01342796|11671113|FG000|NOT COMPLETED|Overall Study||3
10519375|NCT01342796|11671114|FG001|NOT COMPLETED|Overall Study||3
10519376|NCT01342887|11671120|FG000|STARTED|Overall Study||6
10519377|NCT01342887|11671120|FG000|COMPLETED|Overall Study||4
10519378|NCT01342887|11671120|FG000|NOT COMPLETED|Overall Study||2
10519379|NCT01342913|11671126|FG000|STARTED|2-week Run-in Period||702
10519380|NCT01342913|11671127|FG001|STARTED|2-week Run-in Period||0
10519381|NCT01342913|11671128|FG002|STARTED|2-week Run-in Period||0
10519382|NCT01342913|11671126|FG000|COMPLETED|2-week Run-in Period||528
10519383|NCT01342913|11671127|FG001|COMPLETED|2-week Run-in Period||0
10519384|NCT01342913|11671128|FG002|COMPLETED|2-week Run-in Period||0
10519385|NCT01342913|11671126|FG000|NOT COMPLETED|2-week Run-in Period||174
10519386|NCT01342913|11671127|FG001|NOT COMPLETED|2-week Run-in Period||0
10519387|NCT01342913|11671128|FG002|NOT COMPLETED|2-week Run-in Period||0
10519388|NCT01342913|11671126|FG000|STARTED|Double-Blind Treatment Period||0
10519389|NCT01342913|11671127|FG001|STARTED|Double-Blind Treatment Period||262
10519390|NCT01342913|11671128|FG002|STARTED|Double-Blind Treatment Period||266
10519391|NCT01342913|11671126|FG000|COMPLETED|Double-Blind Treatment Period||0
10519392|NCT01342913|11671127|FG001|COMPLETED|Double-Blind Treatment Period||246
10519393|NCT01342913|11671128|FG002|COMPLETED|Double-Blind Treatment Period||243
10519394|NCT01342913|11671126|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
10519395|NCT01342913|11671127|FG001|NOT COMPLETED|Double-Blind Treatment Period||16
10519396|NCT01342913|11671128|FG002|NOT COMPLETED|Double-Blind Treatment Period||23
10519397|NCT01342926|11671138|FG000|STARTED|Overall Study||46
10519398|NCT01342926|11671139|FG001|STARTED|Overall Study||46
10519399|NCT01342926|11671140|FG002|STARTED|Overall Study||48
10519400|NCT01342926|11671141|FG003|STARTED|Overall Study||51
10519401|NCT01342926|11671138|FG000|COMPLETED|Overall Study||37
10519402|NCT01342926|11671139|FG001|COMPLETED|Overall Study||31
10519403|NCT01342926|11671140|FG002|COMPLETED|Overall Study||34
10519404|NCT01342926|11671141|FG003|COMPLETED|Overall Study||39
10519405|NCT01342926|11671138|FG000|NOT COMPLETED|Overall Study||9
10519406|NCT01342926|11671139|FG001|NOT COMPLETED|Overall Study||15
10519407|NCT01342926|11671140|FG002|NOT COMPLETED|Overall Study||14
10519408|NCT01342926|11671141|FG003|NOT COMPLETED|Overall Study||12
10519409|NCT01342965|11671153|FG000|STARTED|Overall Study||110
10519410|NCT01342965|11671154|FG001|STARTED|Overall Study||107
10519411|NCT01342965|11671153|FG000|Received Treatment|Overall Study||110
10519412|NCT01342965|11671154|FG001|Received Treatment|Overall Study||104
10519413|NCT01342965|11671153|FG000|COMPLETED|Overall Study||1
10519414|NCT01342965|11671154|FG001|COMPLETED|Overall Study||0
10519415|NCT01342965|11671153|FG000|NOT COMPLETED|Overall Study||109
10519416|NCT01342965|11671154|FG001|NOT COMPLETED|Overall Study||107
10519417|NCT01343004|11671163|FG000|STARTED|Overall Study||821
10519418|NCT01343004|11671164|FG001|STARTED|Overall Study||824
10519419|NCT01343004|11671165|FG002|STARTED|Overall Study||818
10519420|NCT01343004|11671163|FG000|COMPLETED|Overall Study||637
10519421|NCT01343004|11671164|FG001|COMPLETED|Overall Study||606
10519422|NCT01343004|11671165|FG002|COMPLETED|Overall Study||658
10519423|NCT01343004|11671163|FG000|NOT COMPLETED|Overall Study||184
10519424|NCT01343004|11671164|FG001|NOT COMPLETED|Overall Study||218
10519425|NCT01343004|11671165|FG002|NOT COMPLETED|Overall Study||160
10519426|NCT01343043|11671177|FG000|STARTED|Overall Study||15
10519427|NCT01343043|11671178|FG001|STARTED|Overall Study||14
10519428|NCT01343043|11671179|FG002|STARTED|Overall Study||5
10519429|NCT01343043|11671180|FG003|STARTED|Overall Study||16
10519430|NCT01343043|11671177|FG000|Received T-cell Infusion|Overall Study||12
10519431|NCT01343043|11671178|FG001|Received T-cell Infusion|Overall Study||13
10519432|NCT01343043|11671179|FG002|Received T-cell Infusion|Overall Study||5
10519433|NCT01343043|11671180|FG003|Received T-cell Infusion|Overall Study||15
10519434|NCT01343043|11671177|FG000|COMPLETED|Overall Study||12
10519435|NCT01343043|11671178|FG001|COMPLETED|Overall Study||13
10519436|NCT01343043|11671179|FG002|COMPLETED|Overall Study||5
10519437|NCT01343043|11671180|FG003|COMPLETED|Overall Study||15
10519438|NCT01343043|11671177|FG000|NOT COMPLETED|Overall Study||3
10519439|NCT01343043|11671178|FG001|NOT COMPLETED|Overall Study||1
10519440|NCT01343043|11671179|FG002|NOT COMPLETED|Overall Study||0
10519441|NCT01343043|11671180|FG003|NOT COMPLETED|Overall Study||1
10519442|NCT01343056|11671197|FG000|STARTED|Overall Study||35
10519443|NCT01343056|11671198|FG001|STARTED|Overall Study||36
10519444|NCT01343056|11671199|FG002|STARTED|Overall Study||32
10519445|NCT01343056|11671200|FG003|STARTED|Overall Study||38
10519446|NCT01343056|11671197|FG000|COMPLETED|Overall Study||28
10519447|NCT01343056|11671198|FG001|COMPLETED|Overall Study||31
10519448|NCT01343056|11671199|FG002|COMPLETED|Overall Study||29
10519449|NCT01343056|11671200|FG003|COMPLETED|Overall Study||29
10519450|NCT01343056|11671197|FG000|NOT COMPLETED|Overall Study||7
10519451|NCT01343056|11671198|FG001|NOT COMPLETED|Overall Study||5
10519452|NCT01343056|11671199|FG002|NOT COMPLETED|Overall Study||3
10519453|NCT01343056|11671200|FG003|NOT COMPLETED|Overall Study||9
10519454|NCT01343082|11671214|FG000|STARTED|The run-in Period||51
10519455|NCT01343082|11671215|FG001|STARTED|The run-in Period||49
10519456|NCT01343082|11671216|FG002|STARTED|The run-in Period||48
10519457|NCT01343082|11671214|FG000|COMPLETED|The run-in Period||48
10519458|NCT01343082|11671215|FG001|COMPLETED|The run-in Period||45
10519459|NCT01343082|11671216|FG002|COMPLETED|The run-in Period||43
10519460|NCT01343082|11671214|FG000|NOT COMPLETED|The run-in Period||3
10519461|NCT01343082|11671215|FG001|NOT COMPLETED|The run-in Period||4
10519462|NCT01343082|11671216|FG002|NOT COMPLETED|The run-in Period||5
10519463|NCT01343082|11671214|FG000|STARTED|Treatment Period , Switched to DE-111||48
10519464|NCT01343082|11671215|FG001|STARTED|Treatment Period , Switched to DE-111||45
10519465|NCT01343082|11671216|FG002|STARTED|Treatment Period , Switched to DE-111||43
10519466|NCT01343082|11671214|FG000|COMPLETED|Treatment Period , Switched to DE-111||43
10519467|NCT01343082|11671215|FG001|COMPLETED|Treatment Period , Switched to DE-111||36
10519468|NCT01343082|11671216|FG002|COMPLETED|Treatment Period , Switched to DE-111||31
10519469|NCT01343082|11671214|FG000|NOT COMPLETED|Treatment Period , Switched to DE-111||5
10519470|NCT01343082|11671215|FG001|NOT COMPLETED|Treatment Period , Switched to DE-111||9
10519471|NCT01343082|11671216|FG002|NOT COMPLETED|Treatment Period , Switched to DE-111||12
10519472|NCT01343095|11671223|FG000|STARTED|Overall Study||2
10519473|NCT01343095|11671224|FG001|STARTED|Overall Study||3
10519474|NCT01343095|11671225|FG002|STARTED|Overall Study||3
10519475|NCT01343095|11671223|FG000|COMPLETED|Overall Study||2
10519476|NCT01343095|11671224|FG001|COMPLETED|Overall Study||3
10519477|NCT01343095|11671225|FG002|COMPLETED|Overall Study||3
10519478|NCT01343095|11671223|FG000|NOT COMPLETED|Overall Study||0
10519479|NCT01343095|11671224|FG001|NOT COMPLETED|Overall Study||0
10519480|NCT01343095|11671225|FG002|NOT COMPLETED|Overall Study||0
10519481|NCT01343160|11671235|FG000|STARTED|Overall Study||36
10519482|NCT01343160|11671235|FG000|COMPLETED|Overall Study||31
10519483|NCT01343160|11671235|FG000|NOT COMPLETED|Overall Study||5
10519484|NCT01343251|11671242|FG000|STARTED|Overall Study||16
10519485|NCT01343251|11671243|FG001|STARTED|Overall Study||17
10519486|NCT01343251|11671242|FG000|COMPLETED|Overall Study||16
10519487|NCT01343251|11671243|FG001|COMPLETED|Overall Study||17
10519488|NCT01343251|11671242|FG000|NOT COMPLETED|Overall Study||0
10519489|NCT01343251|11671243|FG001|NOT COMPLETED|Overall Study||0
10519490|NCT01343277|11671254|FG000|STARTED|Overall Study||384
10519491|NCT01343277|11671255|FG001|STARTED|Overall Study||193
10519492|NCT01343277|11671254|FG000|Treated|Overall Study||378
10519493|NCT01343277|11671255|FG001|Treated|Overall Study||172
10519494|NCT01343277|11671254|FG000|COMPLETED|Overall Study||0
10519495|NCT01343277|11671255|FG001|COMPLETED|Overall Study||0
10519496|NCT01343277|11671254|FG000|NOT COMPLETED|Overall Study||384
10519497|NCT01343277|11671255|FG001|NOT COMPLETED|Overall Study||193
10519498|NCT01343368|11671263|FG000|STARTED|Overall Study||9
10519499|NCT01343368|11671264|FG001|STARTED|Overall Study||10
10519500|NCT01343368|11671263|FG000|COMPLETED|Overall Study||7
10519501|NCT01343368|11671264|FG001|COMPLETED|Overall Study||10
10519502|NCT01343368|11671263|FG000|NOT COMPLETED|Overall Study||2
10519503|NCT01343368|11671264|FG001|NOT COMPLETED|Overall Study||0
10519504|NCT01343407|11671270|FG000|STARTED|First Treatment Period (Part 2)||2
10519505|NCT01343407|11671271|FG001|STARTED|First Treatment Period (Part 2)||2
10519506|NCT01343407|11671272|FG002|STARTED|First Treatment Period (Part 2)||3
10519507|NCT01343407|11671273|FG003|STARTED|First Treatment Period (Part 2)||3
10519508|NCT01343407|11671274|FG004|STARTED|First Treatment Period (Part 2)||3
10519509|NCT01343407|11671275|FG005|STARTED|First Treatment Period (Part 2)||3
10519510|NCT01343407|11671270|FG000|COMPLETED|First Treatment Period (Part 2)||2
10519511|NCT01343407|11671271|FG001|COMPLETED|First Treatment Period (Part 2)||2
10519512|NCT01343407|11671272|FG002|COMPLETED|First Treatment Period (Part 2)||3
10519513|NCT01343407|11671273|FG003|COMPLETED|First Treatment Period (Part 2)||3
10519514|NCT01343407|11671274|FG004|COMPLETED|First Treatment Period (Part 2)||3
10519515|NCT01343407|11671275|FG005|COMPLETED|First Treatment Period (Part 2)||3
10519516|NCT01343407|11671270|FG000|NOT COMPLETED|First Treatment Period (Part 2)||0
10519517|NCT01343407|11671271|FG001|NOT COMPLETED|First Treatment Period (Part 2)||0
10519518|NCT01343407|11671272|FG002|NOT COMPLETED|First Treatment Period (Part 2)||0
10519519|NCT01343407|11671273|FG003|NOT COMPLETED|First Treatment Period (Part 2)||0
10519520|NCT01343407|11671274|FG004|NOT COMPLETED|First Treatment Period (Part 2)||0
10519521|NCT01343407|11671275|FG005|NOT COMPLETED|First Treatment Period (Part 2)||0
10519522|NCT01343407|11671270|FG000|STARTED|First Washout (Part 2)||2
10519523|NCT01343407|11671271|FG001|STARTED|First Washout (Part 2)||2
10519524|NCT01343407|11671272|FG002|STARTED|First Washout (Part 2)||3
10519525|NCT01343407|11671273|FG003|STARTED|First Washout (Part 2)||3
10519526|NCT01343407|11671274|FG004|STARTED|First Washout (Part 2)||3
10519527|NCT01343407|11671275|FG005|STARTED|First Washout (Part 2)||3
10519528|NCT01343407|11671270|FG000|COMPLETED|First Washout (Part 2)||2
10519529|NCT01343407|11671271|FG001|COMPLETED|First Washout (Part 2)||2
10519530|NCT01343407|11671272|FG002|COMPLETED|First Washout (Part 2)||3
10519531|NCT01343407|11671273|FG003|COMPLETED|First Washout (Part 2)||3
10519532|NCT01343407|11671274|FG004|COMPLETED|First Washout (Part 2)||3
10519533|NCT01343407|11671275|FG005|COMPLETED|First Washout (Part 2)||3
10519534|NCT01343407|11671270|FG000|NOT COMPLETED|First Washout (Part 2)||0
10519535|NCT01343407|11671271|FG001|NOT COMPLETED|First Washout (Part 2)||0
10519536|NCT01343407|11671272|FG002|NOT COMPLETED|First Washout (Part 2)||0
10519537|NCT01343407|11671273|FG003|NOT COMPLETED|First Washout (Part 2)||0
10519538|NCT01343407|11671274|FG004|NOT COMPLETED|First Washout (Part 2)||0
10519539|NCT01343407|11671275|FG005|NOT COMPLETED|First Washout (Part 2)||0
10519540|NCT01343407|11671270|FG000|STARTED|Second Treatment Period (Part 2)||2
10519541|NCT01343407|11671271|FG001|STARTED|Second Treatment Period (Part 2)||2
10519542|NCT01343407|11671272|FG002|STARTED|Second Treatment Period (Part 2)||3
10519543|NCT01343407|11671273|FG003|STARTED|Second Treatment Period (Part 2)||3
10519544|NCT01343407|11671274|FG004|STARTED|Second Treatment Period (Part 2)||3
10519545|NCT01343407|11671275|FG005|STARTED|Second Treatment Period (Part 2)||3
10519546|NCT01343407|11671270|FG000|COMPLETED|Second Treatment Period (Part 2)||2
10519547|NCT01343407|11671271|FG001|COMPLETED|Second Treatment Period (Part 2)||2
10519548|NCT01343407|11671272|FG002|COMPLETED|Second Treatment Period (Part 2)||2
10519549|NCT01343407|11671273|FG003|COMPLETED|Second Treatment Period (Part 2)||3
10519550|NCT01343407|11671274|FG004|COMPLETED|Second Treatment Period (Part 2)||3
10519551|NCT01343407|11671275|FG005|COMPLETED|Second Treatment Period (Part 2)||3
10519552|NCT01343407|11671270|FG000|NOT COMPLETED|Second Treatment Period (Part 2)||0
10519553|NCT01343407|11671271|FG001|NOT COMPLETED|Second Treatment Period (Part 2)||0
10519554|NCT01343407|11671272|FG002|NOT COMPLETED|Second Treatment Period (Part 2)||1
10519555|NCT01343407|11671273|FG003|NOT COMPLETED|Second Treatment Period (Part 2)||0
10519556|NCT01343407|11671274|FG004|NOT COMPLETED|Second Treatment Period (Part 2)||0
10519557|NCT01343407|11671275|FG005|NOT COMPLETED|Second Treatment Period (Part 2)||0
10519558|NCT01343407|11671270|FG000|STARTED|Second Washout (Part 2)||2
10519559|NCT01343407|11671271|FG001|STARTED|Second Washout (Part 2)||2
10519560|NCT01343407|11671272|FG002|STARTED|Second Washout (Part 2)||2
10519561|NCT01343407|11671273|FG003|STARTED|Second Washout (Part 2)||3
10519562|NCT01343407|11671274|FG004|STARTED|Second Washout (Part 2)||3
10519563|NCT01343407|11671275|FG005|STARTED|Second Washout (Part 2)||3
10519564|NCT01343407|11671270|FG000|COMPLETED|Second Washout (Part 2)||2
10519565|NCT01343407|11671271|FG001|COMPLETED|Second Washout (Part 2)||2
10519566|NCT01343407|11671272|FG002|COMPLETED|Second Washout (Part 2)||1
10519567|NCT01343407|11671273|FG003|COMPLETED|Second Washout (Part 2)||3
10519568|NCT01343407|11671274|FG004|COMPLETED|Second Washout (Part 2)||3
10519569|NCT01343407|11671275|FG005|COMPLETED|Second Washout (Part 2)||3
10519570|NCT01343407|11671270|FG000|NOT COMPLETED|Second Washout (Part 2)||0
10519571|NCT01343407|11671271|FG001|NOT COMPLETED|Second Washout (Part 2)||0
10519572|NCT01343407|11671272|FG002|NOT COMPLETED|Second Washout (Part 2)||1
10519573|NCT01343407|11671273|FG003|NOT COMPLETED|Second Washout (Part 2)||0
10519574|NCT01343407|11671274|FG004|NOT COMPLETED|Second Washout (Part 2)||0
10519575|NCT01343407|11671275|FG005|NOT COMPLETED|Second Washout (Part 2)||0
10519576|NCT01343407|11671270|FG000|STARTED|Third Treatment Period (Part 2)||2
10519577|NCT01343407|11671271|FG001|STARTED|Third Treatment Period (Part 2)||2
10519578|NCT01343407|11671272|FG002|STARTED|Third Treatment Period (Part 2)||1
10519579|NCT01343407|11671273|FG003|STARTED|Third Treatment Period (Part 2)||3
10519580|NCT01343407|11671274|FG004|STARTED|Third Treatment Period (Part 2)||3
10519581|NCT01343407|11671275|FG005|STARTED|Third Treatment Period (Part 2)||3
10519582|NCT01343407|11671270|FG000|COMPLETED|Third Treatment Period (Part 2)||2
10519583|NCT01343407|11671271|FG001|COMPLETED|Third Treatment Period (Part 2)||2
10519584|NCT01343407|11671272|FG002|COMPLETED|Third Treatment Period (Part 2)||1
10519585|NCT01343407|11671273|FG003|COMPLETED|Third Treatment Period (Part 2)||3
10519586|NCT01343407|11671274|FG004|COMPLETED|Third Treatment Period (Part 2)||3
10519587|NCT01343407|11671275|FG005|COMPLETED|Third Treatment Period (Part 2)||3
10519588|NCT01343407|11671270|FG000|NOT COMPLETED|Third Treatment Period (Part 2)||0
10519589|NCT01343407|11671271|FG001|NOT COMPLETED|Third Treatment Period (Part 2)||0
10519590|NCT01343407|11671272|FG002|NOT COMPLETED|Third Treatment Period (Part 2)||0
10519591|NCT01343407|11671273|FG003|NOT COMPLETED|Third Treatment Period (Part 2)||0
10519592|NCT01343407|11671274|FG004|NOT COMPLETED|Third Treatment Period (Part 2)||0
10519593|NCT01343407|11671275|FG005|NOT COMPLETED|Third Treatment Period (Part 2)||0
10519594|NCT01343485|11671285|FG000|STARTED|Overall Study||185
10519595|NCT01343485|11671286|FG001|STARTED|Overall Study||180
10519596|NCT01343485|11671285|FG000|COMPLETED|Overall Study||36
10519597|NCT01343485|11671286|FG001|COMPLETED|Overall Study||46
10519598|NCT01343485|11671285|FG000|NOT COMPLETED|Overall Study||149
10519599|NCT01343485|11671286|FG001|NOT COMPLETED|Overall Study||134
10519600|NCT01343667|11671294|FG000|STARTED|Overall Study||425
10519601|NCT01343667|11671295|FG001|STARTED|Overall Study||972
10519602|NCT01343667|11671294|FG000|COMPLETED|Overall Study||413
10519603|NCT01343667|11671295|FG001|COMPLETED|Overall Study||916
10519604|NCT01343667|11671294|FG000|NOT COMPLETED|Overall Study||12
10519605|NCT01343667|11671295|FG001|NOT COMPLETED|Overall Study||56
10519606|NCT01343693|11671301|FG000|STARTED|Overall Study||119
10519607|NCT01343693|11671301|FG000|COMPLETED|Overall Study||110
10519608|NCT01343693|11671301|FG000|NOT COMPLETED|Overall Study||9
10519609|NCT01343823|11671309|FG000|STARTED|Overall Study||20
10519610|NCT01343823|11671310|FG001|STARTED|Overall Study||20
10519611|NCT01343823|11671311|FG002|STARTED|Overall Study||19
10519612|NCT01343823|11671312|FG003|STARTED|Overall Study||20
10519613|NCT01343823|11671309|FG000|COMPLETED|Overall Study||18
10519614|NCT01343823|11671310|FG001|COMPLETED|Overall Study||20
10519615|NCT01343823|11671311|FG002|COMPLETED|Overall Study||19
10519616|NCT01343823|11671312|FG003|COMPLETED|Overall Study||19
10519617|NCT01343823|11671309|FG000|NOT COMPLETED|Overall Study||2
10519618|NCT01343823|11671310|FG001|NOT COMPLETED|Overall Study||0
10519619|NCT01343823|11671311|FG002|NOT COMPLETED|Overall Study||0
10519620|NCT01343823|11671312|FG003|NOT COMPLETED|Overall Study||1
10519621|NCT01343888|11671325|FG000|STARTED|Overall Study|261 subject randomized; 259 subjects treated with at least one dose; 2 subjects were not treated|259
10519622|NCT01343888|11671326|FG001|STARTED|Overall Study|262 subject randomized; 261 subjects treated with at least one dose; 1 subject was not treated|261
10519623|NCT01343888|11671327|FG002|STARTED|Overall Study|133 subject randomized; 132 subjects treated with at least one dose; 1 subject was not treated|132
10519624|NCT01343888|11671325|FG000|COMPLETED|Overall Study||234
10519625|NCT01343888|11671326|FG001|COMPLETED|Overall Study||222
10519626|NCT01343888|11671327|FG002|COMPLETED|Overall Study||110
10519627|NCT01343888|11671325|FG000|NOT COMPLETED|Overall Study||25
10519628|NCT01343888|11671326|FG001|NOT COMPLETED|Overall Study||39
10519629|NCT01343888|11671327|FG002|NOT COMPLETED|Overall Study||22
10711754|NCT02662387|11877212|FG001|NOT COMPLETED|Overall Study||0
10711755|NCT02662556|11877220|FG000|STARTED|Overall Study||140
10711756|NCT02662556|11877220|FG000|COMPLETED|Overall Study||132
10711757|NCT02662556|11877220|FG000|NOT COMPLETED|Overall Study||8
10711758|NCT02662569|11877229|FG000|STARTED|Overall Study||166
10711759|NCT02662569|11877230|FG001|STARTED|Overall Study||161
10711760|NCT02662569|11877231|FG002|STARTED|Overall Study||327
10711761|NCT02662569|11877232|FG003|STARTED|Overall Study||332
10711762|NCT02662569|11877229|FG000|Received Study Drug|Overall Study||164
10519630|NCT01343901|11671335|FG000|STARTED|Overall Study||210
10519631|NCT01343901|11671335|FG000|Efficacy Population|Overall Study||205
10519632|NCT01343901|11671335|FG000|COMPLETED|Overall Study||97
10519633|NCT01343901|11671335|FG000|NOT COMPLETED|Overall Study||113
10519634|NCT01344057|11671339|FG000|STARTED|Overall Study||63
10711763|NCT02662569|11877230|FG001|Received Study Drug|Overall Study||160
10711764|NCT02662569|11877231|FG002|Received Study Drug|Overall Study||325
10519635|NCT01344057|11671339|FG000|COMPLETED|Overall Study||62
10519636|NCT01344057|11671339|FG000|NOT COMPLETED|Overall Study||1
10519637|NCT01344161|11671345|FG000|STARTED|Overall Study||43
10519638|NCT01344161|11671346|FG001|STARTED|Overall Study||42
10519639|NCT01344161|11671345|FG000|COMPLETED|Overall Study||38
10519640|NCT01344161|11671346|FG001|COMPLETED|Overall Study||39
10711765|NCT02662569|11877232|FG003|Received Study Drug|Overall Study||332
10711766|NCT02662569|11877229|FG000|COMPLETED|Overall Study||159
10711767|NCT02662569|11877230|FG001|COMPLETED|Overall Study||160
10519641|NCT01344161|11671345|FG000|NOT COMPLETED|Overall Study||5
10519642|NCT01344161|11671346|FG001|NOT COMPLETED|Overall Study||3
10519643|NCT01344226|11671352|FG000|STARTED|Overall Study||49
10519644|NCT01344226|11671352|FG000|COMPLETED|Overall Study||41
10519645|NCT01344226|11671352|FG000|NOT COMPLETED|Overall Study||8
10519646|NCT01344356|11671358|FG000|STARTED|Overall Study||1
10519647|NCT01344356|11671359|FG001|STARTED|Overall Study||18
10519648|NCT01344356|11671358|FG000|COMPLETED|Overall Study||1
10519649|NCT01344356|11671359|FG001|COMPLETED|Overall Study||9
10519650|NCT01344356|11671358|FG000|NOT COMPLETED|Overall Study||0
10519651|NCT01344356|11671359|FG001|NOT COMPLETED|Overall Study||9
10519652|NCT01344369|11671369|FG000|STARTED|First Intervention||18
10519653|NCT01344369|11671370|FG001|STARTED|First Intervention||18
10519654|NCT01344369|11671369|FG000|COMPLETED|First Intervention||18
10519655|NCT01344369|11671370|FG001|COMPLETED|First Intervention||18
10519656|NCT01344369|11671369|FG000|NOT COMPLETED|First Intervention||0
10519657|NCT01344369|11671370|FG001|NOT COMPLETED|First Intervention||0
10519658|NCT01344369|11671369|FG000|STARTED|Washout of 28 Days||18
10519659|NCT01344369|11671370|FG001|STARTED|Washout of 28 Days||18
10519660|NCT01344369|11671369|FG000|COMPLETED|Washout of 28 Days||17
10519661|NCT01344369|11671370|FG001|COMPLETED|Washout of 28 Days||17
10519662|NCT01344369|11671369|FG000|NOT COMPLETED|Washout of 28 Days||1
10519663|NCT01344369|11671370|FG001|NOT COMPLETED|Washout of 28 Days||1
10519664|NCT01344369|11671369|FG000|STARTED|Second Intervention||17
10519665|NCT01344369|11671370|FG001|STARTED|Second Intervention||17
10519666|NCT01344369|11671369|FG000|COMPLETED|Second Intervention||17
10519667|NCT01344369|11671370|FG001|COMPLETED|Second Intervention||16
10519668|NCT01344369|11671369|FG000|NOT COMPLETED|Second Intervention||0
10519669|NCT01344369|11671370|FG001|NOT COMPLETED|Second Intervention||1
10519670|NCT01344447|11671376|FG000|STARTED|Overall Study|Participant received study drug; Safety analysis set|479
10519671|NCT01344447|11671376|FG000|Fulfilled Requirement of FAS Population|Overall Study|Full Analysis Set (FAS)|457
10519672|NCT01344447|11671376|FG000|COMPLETED|Overall Study||471
10519673|NCT01344447|11671376|FG000|NOT COMPLETED|Overall Study||8
10519674|NCT01344460|11671384|FG000|STARTED|Overall Study|Participants received study drug; Safety analysis set|315
10519675|NCT01344460|11671384|FG000|Fulfilled Requirements of FAS Population|Overall Study|Full analysis set (FAS)|292
10519676|NCT01344460|11671384|FG000|COMPLETED|Overall Study||312
10519677|NCT01344460|11671384|FG000|NOT COMPLETED|Overall Study||3
10519678|NCT01344538|11671394|FG000|STARTED|Overall Study||16
10519679|NCT01344538|11671395|FG001|STARTED|Overall Study||17
10519680|NCT01344538|11671394|FG000|COMPLETED|Overall Study||14
10519681|NCT01344538|11671395|FG001|COMPLETED|Overall Study||16
10519682|NCT01344538|11671394|FG000|NOT COMPLETED|Overall Study||2
10519683|NCT01344538|11671395|FG001|NOT COMPLETED|Overall Study||1
10519684|NCT01344616|11671403|FG000|STARTED|Overall Study||244
10519685|NCT01344616|11671404|FG001|STARTED|Overall Study||238
10519686|NCT01344616|11671403|FG000|COMPLETED|Overall Study||209
10519687|NCT01344616|11671404|FG001|COMPLETED|Overall Study||194
10519688|NCT01344616|11671403|FG000|NOT COMPLETED|Overall Study||35
10519689|NCT01344616|11671404|FG001|NOT COMPLETED|Overall Study||44
10519690|NCT01344629|11671412|FG000|STARTED|Crossover Period 1||32
10519691|NCT01344629|11671413|FG001|STARTED|Crossover Period 1||32
10519692|NCT01344629|11671412|FG000|COMPLETED|Crossover Period 1||32
10519693|NCT01344629|11671413|FG001|COMPLETED|Crossover Period 1||32
10519694|NCT01344629|11671412|FG000|NOT COMPLETED|Crossover Period 1||0
10519695|NCT01344629|11671413|FG001|NOT COMPLETED|Crossover Period 1||0
10519696|NCT01344629|11671412|FG000|STARTED|Crossover Period 2||32
10519697|NCT01344629|11671413|FG001|STARTED|Crossover Period 2||32
10519698|NCT01344629|11671412|FG000|COMPLETED|Crossover Period 2||32
10519699|NCT01344629|11671413|FG001|COMPLETED|Crossover Period 2||31
10519700|NCT01344629|11671412|FG000|NOT COMPLETED|Crossover Period 2||0
10519701|NCT01344629|11671413|FG001|NOT COMPLETED|Crossover Period 2||1
10519702|NCT01344629|11671412|FG000|STARTED|Crossover Period 3||32
10519703|NCT01344629|11671413|FG001|STARTED|Crossover Period 3||31
10519704|NCT01344629|11671412|FG000|COMPLETED|Crossover Period 3||32
10519705|NCT01344629|11671413|FG001|COMPLETED|Crossover Period 3||31
10519706|NCT01344629|11671412|FG000|NOT COMPLETED|Crossover Period 3||0
10519707|NCT01344629|11671413|FG001|NOT COMPLETED|Crossover Period 3||0
10519708|NCT01344629|11671412|FG000|STARTED|Crossover Period 4||32
10519709|NCT01344629|11671413|FG001|STARTED|Crossover Period 4||31
10519710|NCT01344629|11671412|FG000|COMPLETED|Crossover Period 4||32
10519711|NCT01344629|11671413|FG001|COMPLETED|Crossover Period 4||31
10519712|NCT01344629|11671412|FG000|NOT COMPLETED|Crossover Period 4||0
10519713|NCT01344629|11671413|FG001|NOT COMPLETED|Crossover Period 4||0
10519714|NCT01344759|11671421|FG000|STARTED|Overall Study||30
10519715|NCT01344759|11671422|FG001|STARTED|Overall Study||30
10519716|NCT01344759|11671421|FG000|COMPLETED|Overall Study||30
10519717|NCT01344759|11671422|FG001|COMPLETED|Overall Study|Two of the original DEX group subjects were removed, due to receiving dexmedetomidine and propofol.|28
10519718|NCT01344759|11671421|FG000|NOT COMPLETED|Overall Study||0
10519719|NCT01344759|11671422|FG001|NOT COMPLETED|Overall Study||2
10519720|NCT01344824|11671434|FG000|STARTED|Overall Study||38
10519721|NCT01344824|11671434|FG000|COMPLETED|Overall Study||1
10519722|NCT01344824|11671434|FG000|NOT COMPLETED|Overall Study||37
10519723|NCT01344876|11671439|FG000|STARTED|Overall Study||4
10519724|NCT01344876|11671440|FG001|STARTED|Overall Study||3
10519725|NCT01344876|11671441|FG002|STARTED|Overall Study||4
10519726|NCT01344876|11671442|FG003|STARTED|Overall Study||6
10519727|NCT01344876|11671443|FG004|STARTED|Overall Study||3
10519728|NCT01344876|11671439|FG000|COMPLETED|Overall Study||3
10519729|NCT01344876|11671440|FG001|COMPLETED|Overall Study||3
10519730|NCT01344876|11671441|FG002|COMPLETED|Overall Study||3
10519731|NCT01344876|11671442|FG003|COMPLETED|Overall Study||3
10519732|NCT01344876|11671443|FG004|COMPLETED|Overall Study||2
10519733|NCT01344876|11671439|FG000|NOT COMPLETED|Overall Study||1
10519734|NCT01344876|11671440|FG001|NOT COMPLETED|Overall Study||0
10519735|NCT01344876|11671441|FG002|NOT COMPLETED|Overall Study||1
10519736|NCT01344876|11671442|FG003|NOT COMPLETED|Overall Study||3
10519737|NCT01344876|11671443|FG004|NOT COMPLETED|Overall Study||1
10519738|NCT01345019|11671458|FG000|STARTED|Blinded Treatment Phase||859
10519739|NCT01345019|11671459|FG001|STARTED|Blinded Treatment Phase||859
10519740|NCT01345019|11671458|FG000|Received Treatment|Blinded Treatment Phase||852
10519741|NCT01345019|11671459|FG001|Received Treatment|Blinded Treatment Phase||850
10519742|NCT01345019|11671458|FG000|COMPLETED|Blinded Treatment Phase||541
10519743|NCT01345019|11671459|FG001|COMPLETED|Blinded Treatment Phase||555
10519744|NCT01345019|11671458|FG000|NOT COMPLETED|Blinded Treatment Phase||318
10519745|NCT01345019|11671459|FG001|NOT COMPLETED|Blinded Treatment Phase||304
10519746|NCT01345019|11671458|FG000|STARTED|Open Label Treatment Phase||418
10519747|NCT01345019|11671459|FG001|STARTED|Open Label Treatment Phase||426
10519748|NCT01345019|11671458|FG000|COMPLETED|Open Label Treatment Phase||227
10519749|NCT01345019|11671459|FG001|COMPLETED|Open Label Treatment Phase||233
10519750|NCT01345019|11671458|FG000|NOT COMPLETED|Open Label Treatment Phase||191
10519751|NCT01345019|11671459|FG001|NOT COMPLETED|Open Label Treatment Phase||193
10519752|NCT01345058|11671469|FG000|STARTED|Overall Study||20
10519753|NCT01345058|11671470|FG001|STARTED|Overall Study||36
10519754|NCT01345058|11671469|FG000|Received Lacosamide|Overall Study||19
10519755|NCT01345058|11671470|FG001|Received Lacosamide|Overall Study||0
10519756|NCT01345058|11671469|FG000|COMPLETED|Overall Study||15
10519757|NCT01345058|11671470|FG001|COMPLETED|Overall Study||36
10519758|NCT01345058|11671469|FG000|NOT COMPLETED|Overall Study||5
10519759|NCT01345058|11671470|FG001|NOT COMPLETED|Overall Study||0
10519760|NCT01345123|11671479|FG000|STARTED|Overall Study||3323
10519761|NCT01345123|11671480|FG001|STARTED|Overall Study||3311
10519762|NCT01345123|11671481|FG002|STARTED|Overall Study||3291
10519763|NCT01345123|11671479|FG000|COMPLETED|Overall Study|3323 - 79 study participants who were no longer health plan eligible members (zero eligible months)|3244
10519764|NCT01345123|11671480|FG001|COMPLETED|Overall Study|3311 - 85 study participants who were no longer health plan eligible members (zero eligible months)|3226
10519765|NCT01345123|11671481|FG002|COMPLETED|Overall Study|3291 - 88 study participants who were no longer health plan eligible members (zero eligible months)|3203
10519766|NCT01345123|11671479|FG000|NOT COMPLETED|Overall Study||79
10519767|NCT01345123|11671480|FG001|NOT COMPLETED|Overall Study||85
10519768|NCT01345123|11671481|FG002|NOT COMPLETED|Overall Study||88
10519769|NCT01345162|11671492|FG000|STARTED|Overall Study||100
10519770|NCT01345162|11671493|FG001|STARTED|Overall Study||100
10519771|NCT01345162|11671492|FG000|COMPLETED|Overall Study||98
10519772|NCT01345162|11671493|FG001|COMPLETED|Overall Study||96
10519773|NCT01345162|11671492|FG000|NOT COMPLETED|Overall Study||2
10519774|NCT01345162|11671493|FG001|NOT COMPLETED|Overall Study||4
10519775|NCT01345188|11671499|FG000|STARTED|Randomization Ranolazine/Placebo 6 Weeks||28
10519776|NCT01345188|11671499|FG000|COMPLETED|Randomization Ranolazine/Placebo 6 Weeks||26
10519777|NCT01345188|11671499|FG000|NOT COMPLETED|Randomization Ranolazine/Placebo 6 Weeks||2
10519778|NCT01345188|11671499|FG000|STARTED|Crossover Ranolazine/Placebo 6 Weeks||26
10519779|NCT01345188|11671499|FG000|COMPLETED|Crossover Ranolazine/Placebo 6 Weeks||25
10519780|NCT01345188|11671499|FG000|NOT COMPLETED|Crossover Ranolazine/Placebo 6 Weeks||1
10519781|NCT01345253|11671508|FG000|STARTED|Double-blind (DB) Phase (52 Weeks)||226
10519782|NCT01345253|11671509|FG001|STARTED|Double-blind (DB) Phase (52 Weeks)||451
10519783|NCT01345253|11671508|FG000|COMPLETED|Double-blind (DB) Phase (52 Weeks)||170
10519784|NCT01345253|11671509|FG001|COMPLETED|Double-blind (DB) Phase (52 Weeks)||372
10519785|NCT01345253|11671508|FG000|NOT COMPLETED|Double-blind (DB) Phase (52 Weeks)||56
10519786|NCT01345253|11671509|FG001|NOT COMPLETED|Double-blind (DB) Phase (52 Weeks)||79
10519787|NCT01345253|11671508|FG000|STARTED|Open-label Phase (Up to Year 5 Week 44)|Only eligible China par. enrolled in OL phase from MITT + additional 9 China par. from Safety Pop|134
10519788|NCT01345253|11671509|FG001|STARTED|Open-label Phase (Up to Year 5 Week 44)|Only eligible China par. enrolled in OL phase from MITT + additional 16 China par. from Safety Pop|290
10519789|NCT01345253|11671508|FG000|COMPLETED|Open-label Phase (Up to Year 5 Week 44)||69
10519790|NCT01345253|11671509|FG001|COMPLETED|Open-label Phase (Up to Year 5 Week 44)||146
10519791|NCT01345253|11671508|FG000|NOT COMPLETED|Open-label Phase (Up to Year 5 Week 44)||65
10519792|NCT01345253|11671509|FG001|NOT COMPLETED|Open-label Phase (Up to Year 5 Week 44)||144
10519793|NCT01345292|11671520|FG000|STARTED|Overall Study||75
10519794|NCT01345292|11671521|FG001|STARTED|Overall Study||76
10519795|NCT01345292|11671522|FG002|STARTED|Overall Study||75
10519796|NCT01345292|11671520|FG000|COMPLETED|Overall Study||73
10519797|NCT01345292|11671521|FG001|COMPLETED|Overall Study||76
10519798|NCT01345292|11671522|FG002|COMPLETED|Overall Study||74
10519799|NCT01345292|11671520|FG000|NOT COMPLETED|Overall Study||2
10519800|NCT01345292|11671521|FG001|NOT COMPLETED|Overall Study||0
10519801|NCT01345292|11671522|FG002|NOT COMPLETED|Overall Study||1
10519802|NCT01345318|11671530|FG000|STARTED|Overall Study||191
10519803|NCT01345318|11671530|FG000|COMPLETED|Overall Study||111
10519804|NCT01345318|11671530|FG000|NOT COMPLETED|Overall Study||80
10519805|NCT01345513|11671535|FG000|STARTED|Overall Study||50
10519806|NCT01345513|11671535|FG000|COMPLETED|Overall Study||50
10519807|NCT01345513|11671535|FG000|NOT COMPLETED|Overall Study||0
10519808|NCT01345591|11671539|FG000|STARTED|Overall Study||20
10519809|NCT01345591|11671539|FG000|COMPLETED|Overall Study||19
10519810|NCT01345591|11671539|FG000|NOT COMPLETED|Overall Study||1
10519811|NCT01345630|11671550|FG000|STARTED|Overall Study||396
10519812|NCT01345630|11671551|FG001|STARTED|Overall Study||401
10519813|NCT01345630|11671550|FG000|COMPLETED|Overall Study||35
10519814|NCT01345630|11671551|FG001|COMPLETED|Overall Study||42
10519815|NCT01345630|11671550|FG000|NOT COMPLETED|Overall Study||361
10519816|NCT01345630|11671551|FG001|NOT COMPLETED|Overall Study||359
10528712|NCT01396239|11681063|FG002|NOT COMPLETED|Overall Study||0
10528713|NCT01396239|11681064|FG003|NOT COMPLETED|Overall Study||0
10528714|NCT01396265|11681081|FG000|STARTED|Afatinib||22
10528715|NCT01396265|11681081|FG000|COMPLETED|Afatinib||22
10528716|NCT01396265|11681081|FG000|NOT COMPLETED|Afatinib||0
10528717|NCT01396265|11681081|FG000|STARTED|Washout||22
10528718|NCT01396265|11681081|FG000|COMPLETED|Washout||22
10528719|NCT01396265|11681081|FG000|NOT COMPLETED|Washout||0
10528720|NCT01396265|11681081|FG000|STARTED|Rifa+Afatinib||22
10528721|NCT01396265|11681081|FG000|COMPLETED|Rifa+Afatinib||21
10528722|NCT01396265|11681081|FG000|NOT COMPLETED|Rifa+Afatinib||1
10528723|NCT01396317|11681089|FG000|STARTED|Overall Study||10
10528724|NCT01396317|11681090|FG001|STARTED|Overall Study||10
10528725|NCT01396317|11681089|FG000|COMPLETED|Overall Study||9
10528726|NCT01396317|11681090|FG001|COMPLETED|Overall Study||10
10528727|NCT01396317|11681089|FG000|NOT COMPLETED|Overall Study||1
10528728|NCT01396317|11681090|FG001|NOT COMPLETED|Overall Study||0
10528729|NCT01396382|11681098|FG000|STARTED|Overall Study||97
10528730|NCT01396382|11681098|FG000|COMPLETED|Overall Study||97
10528731|NCT01396382|11681098|FG000|NOT COMPLETED|Overall Study||0
10528732|NCT01396395|11681105|FG000|STARTED|Overall Study||200
10528733|NCT01396395|11681106|FG001|STARTED|Overall Study||202
10528734|NCT01396395|11681105|FG000|Safety Analysis Set|Overall Study|1 subject randomized to standard was included in standard+nicorandil as nicorandil was received.|197
10528735|NCT01396395|11681106|FG001|Safety Analysis Set|Overall Study|4 subjects randomized to standard+nicorandil were included in standard as no nicorandil was received|205
10528736|NCT01396395|11681105|FG000|COMPLETED|Overall Study||160
10528737|NCT01396395|11681106|FG001|COMPLETED|Overall Study||175
10528738|NCT01396395|11681105|FG000|NOT COMPLETED|Overall Study||40
10528739|NCT01396395|11681106|FG001|NOT COMPLETED|Overall Study||27
10528740|NCT01396421|11681118|FG000|STARTED|Overall Study||180
10528741|NCT01396421|11681119|FG001|STARTED|Overall Study||182
10528742|NCT01396421|11681120|FG002|STARTED|Overall Study||90
10528743|NCT01396421|11681121|FG003|STARTED|Overall Study||184
10528744|NCT01396421|11681118|FG000|COMPLETED|Overall Study||121
10528745|NCT01396421|11681119|FG001|COMPLETED|Overall Study||124
10528746|NCT01396421|11681120|FG002|COMPLETED|Overall Study||56
10528747|NCT01396421|11681121|FG003|COMPLETED|Overall Study||109
10528748|NCT01396421|11681118|FG000|NOT COMPLETED|Overall Study||59
10528749|NCT01396421|11681119|FG001|NOT COMPLETED|Overall Study||58
10528750|NCT01396421|11681120|FG002|NOT COMPLETED|Overall Study||34
10528751|NCT01396421|11681121|FG003|NOT COMPLETED|Overall Study||75
10528752|NCT01396434|11681148|FG000|STARTED|Overall Study||2817
10528753|NCT01396434|11681149|FG001|STARTED|Overall Study||175
10528754|NCT01396434|11681150|FG002|STARTED|Overall Study||14
10528755|NCT01396434|11681148|FG000|COMPLETED|Overall Study||2806
10528756|NCT01396434|11681149|FG001|COMPLETED|Overall Study||175
10528757|NCT01396434|11681150|FG002|COMPLETED|Overall Study||14
10528758|NCT01396434|11681148|FG000|NOT COMPLETED|Overall Study||11
10528759|NCT01396434|11681149|FG001|NOT COMPLETED|Overall Study||0
10528760|NCT01396434|11681150|FG002|NOT COMPLETED|Overall Study||0
10528761|NCT01396447|11681162|FG000|STARTED|Overall Study||148
10528762|NCT01396447|11681163|FG001|STARTED|Overall Study||143
10528763|NCT01396447|11681164|FG002|STARTED|Overall Study||147
10528764|NCT01396447|11681165|FG003|STARTED|Overall Study||146
10528765|NCT01396447|11681162|FG000|Received Treatment|Overall Study||145
10528766|NCT01396447|11681163|FG001|Received Treatment|Overall Study||141
10528767|NCT01396447|11681164|FG002|Received Treatment|Overall Study||146
10528768|NCT01396447|11681165|FG003|Received Treatment|Overall Study||146
10528769|NCT01396447|11681162|FG000|COMPLETED|Overall Study||105
10528770|NCT01396447|11681163|FG001|COMPLETED|Overall Study||103
10528771|NCT01396447|11681164|FG002|COMPLETED|Overall Study||117
10528772|NCT01396447|11681165|FG003|COMPLETED|Overall Study||94
10528773|NCT01396447|11681162|FG000|NOT COMPLETED|Overall Study||43
10528774|NCT01396447|11681163|FG001|NOT COMPLETED|Overall Study||40
10528775|NCT01396447|11681164|FG002|NOT COMPLETED|Overall Study||30
10528776|NCT01396447|11681165|FG003|NOT COMPLETED|Overall Study||52
10528777|NCT01396486|11681178|FG000|STARTED|Overall Study||20
10528778|NCT01396486|11681179|FG001|STARTED|Overall Study||19
10528779|NCT01396486|11681180|FG002|STARTED|Overall Study||22
10528780|NCT01396486|11681178|FG000|Exposed|Overall Study||19
10528781|NCT01396486|11681179|FG001|Exposed|Overall Study||16
10528782|NCT01396486|11681180|FG002|Exposed|Overall Study||17
10528783|NCT01396486|11681178|FG000|COMPLETED|Overall Study||10
10528784|NCT01396486|11681179|FG001|COMPLETED|Overall Study||7
10528785|NCT01396486|11681180|FG002|COMPLETED|Overall Study||10
10528786|NCT01396486|11681178|FG000|NOT COMPLETED|Overall Study||10
10528787|NCT01396486|11681179|FG001|NOT COMPLETED|Overall Study||12
10528788|NCT01396486|11681180|FG002|NOT COMPLETED|Overall Study||12
10528789|NCT01396512|11681190|FG000|STARTED|Overall Study||137
10528790|NCT01396512|11681191|FG001|STARTED|Overall Study||137
10528791|NCT01396512|11681190|FG000|COMPLETED|Overall Study||137
10528792|NCT01396512|11681191|FG001|COMPLETED|Overall Study||136
10528793|NCT01396512|11681190|FG000|NOT COMPLETED|Overall Study||0
10528794|NCT01396512|11681191|FG001|NOT COMPLETED|Overall Study||1
10528795|NCT01396525|11681197|FG000|STARTED|Overall Study||153
10528796|NCT01396525|11681197|FG000|COMPLETED|Overall Study||127
10519817|NCT01345669|11671563|FG000|STARTED|Overall Study||411
10519818|NCT01345669|11671564|FG001|STARTED|Overall Study||206
10519819|NCT01345669|11671563|FG000|COMPLETED|Overall Study||124
10519820|NCT01345669|11671564|FG001|COMPLETED|Overall Study||87
10519821|NCT01345669|11671563|FG000|NOT COMPLETED|Overall Study||287
10519822|NCT01345669|11671564|FG001|NOT COMPLETED|Overall Study||119
10519823|NCT01345682|11671572|FG000|STARTED|Overall Study|Randomised|322
10519824|NCT01345682|11671573|FG001|STARTED|Overall Study|Randomised|161
10519825|NCT01345682|11671572|FG000|COMPLETED|Overall Study||0
10519826|NCT01345682|11671573|FG001|COMPLETED|Overall Study||0
10519827|NCT01345682|11671572|FG000|NOT COMPLETED|Overall Study||322
10519828|NCT01345682|11671573|FG001|NOT COMPLETED|Overall Study||161
10519829|NCT01345721|11671582|FG000|STARTED|Overall Study||74
10519830|NCT01345721|11671583|FG001|STARTED|Overall Study||66
10519831|NCT01345721|11671584|FG002|STARTED|Overall Study||65
10519832|NCT01345721|11671582|FG000|COMPLETED|Overall Study||74
10519833|NCT01345721|11671583|FG001|COMPLETED|Overall Study||66
10519834|NCT01345721|11671584|FG002|COMPLETED|Overall Study||65
10519835|NCT01345721|11671582|FG000|NOT COMPLETED|Overall Study||0
10519836|NCT01345721|11671583|FG001|NOT COMPLETED|Overall Study||0
10519837|NCT01345721|11671584|FG002|NOT COMPLETED|Overall Study||0
10519838|NCT01345929|11671598|FG000|STARTED|Overall Study||533
10519839|NCT01345929|11671599|FG001|STARTED|Overall Study||535
10519840|NCT01345929|11671598|FG000|COMPLETED|Overall Study||512
10519841|NCT01345929|11671599|FG001|COMPLETED|Overall Study||516
10519842|NCT01345929|11671598|FG000|NOT COMPLETED|Overall Study||21
10519843|NCT01345929|11671599|FG001|NOT COMPLETED|Overall Study||19
10519844|NCT01346059|11671607|FG000|STARTED|Overall Study||1
10519845|NCT01346059|11671608|FG001|STARTED|Overall Study||1
10519846|NCT01346059|11671607|FG000|COMPLETED|Overall Study||0
10519847|NCT01346059|11671608|FG001|COMPLETED|Overall Study||1
10519848|NCT01346059|11671607|FG000|NOT COMPLETED|Overall Study||1
10519849|NCT01346059|11671608|FG001|NOT COMPLETED|Overall Study||0
10519850|NCT01346072|11671616|FG000|STARTED|Overall Study||11
10519851|NCT01346072|11671617|FG001|STARTED|Overall Study||10
10519852|NCT01346072|11671616|FG000|COMPLETED|Overall Study||11
10519853|NCT01346072|11671617|FG001|COMPLETED|Overall Study||10
10519854|NCT01346072|11671616|FG000|NOT COMPLETED|Overall Study||0
10519855|NCT01346072|11671617|FG001|NOT COMPLETED|Overall Study||0
10519856|NCT01346085|11671623|FG000|STARTED|Overall Study||10
10519857|NCT01346085|11671623|FG000|COMPLETED|Overall Study||10
10519858|NCT01346085|11671623|FG000|NOT COMPLETED|Overall Study||0
10519859|NCT01346176|11671630|FG000|STARTED|Recruited||49
10519860|NCT01346176|11671631|FG001|STARTED|Recruited||40
10519861|NCT01346176|11671632|FG002|STARTED|Recruited||43
10519862|NCT01346176|11671630|FG000|COMPLETED|Recruited||48
10519863|NCT01346176|11671631|FG001|COMPLETED|Recruited||40
10519864|NCT01346176|11671632|FG002|COMPLETED|Recruited||43
10519865|NCT01346176|11671630|FG000|NOT COMPLETED|Recruited||1
10519866|NCT01346176|11671631|FG001|NOT COMPLETED|Recruited||0
10519867|NCT01346176|11671632|FG002|NOT COMPLETED|Recruited||0
10519868|NCT01346176|11671630|FG000|STARTED|Completed Advance Directive||48
10519869|NCT01346176|11671631|FG001|STARTED|Completed Advance Directive||40
10519870|NCT01346176|11671632|FG002|STARTED|Completed Advance Directive||43
10519871|NCT01346176|11671630|FG000|COMPLETED|Completed Advance Directive||35
10519872|NCT01346176|11671631|FG001|COMPLETED|Completed Advance Directive||26
10519873|NCT01346176|11671632|FG002|COMPLETED|Completed Advance Directive||33
10519874|NCT01346176|11671630|FG000|NOT COMPLETED|Completed Advance Directive||13
10519875|NCT01346176|11671631|FG001|NOT COMPLETED|Completed Advance Directive||14
10519876|NCT01346176|11671632|FG002|NOT COMPLETED|Completed Advance Directive||10
10519877|NCT01346176|11671630|FG000|STARTED|Completed Satisfaction Survey||35
10519878|NCT01346176|11671631|FG001|STARTED|Completed Satisfaction Survey||26
10519879|NCT01346176|11671632|FG002|STARTED|Completed Satisfaction Survey||33
10519880|NCT01346176|11671630|FG000|COMPLETED|Completed Satisfaction Survey||29
10519881|NCT01346176|11671631|FG001|COMPLETED|Completed Satisfaction Survey||22
10519882|NCT01346176|11671632|FG002|COMPLETED|Completed Satisfaction Survey||27
10519883|NCT01346176|11671630|FG000|NOT COMPLETED|Completed Satisfaction Survey||6
10519884|NCT01346176|11671631|FG001|NOT COMPLETED|Completed Satisfaction Survey||4
10519885|NCT01346176|11671632|FG002|NOT COMPLETED|Completed Satisfaction Survey||6
10519886|NCT01346189|11671644|FG000|STARTED|Overall Study||433
10519887|NCT01346189|11671645|FG001|STARTED|Overall Study||358
10519888|NCT01346189|11671646|FG002|STARTED|Overall Study||346
10519889|NCT01346189|11671647|FG003|STARTED|Overall Study||366
10519890|NCT01346189|11671644|FG000|COMPLETED|Overall Study|433 patients (64 primary care physicians) included in analysis|417
10519891|NCT01346189|11671645|FG001|COMPLETED|Overall Study|358 Patients (58 primary care physicians) included in analysis|341
10519892|NCT01346189|11671646|FG002|COMPLETED|Overall Study|346 patients (58 primary care physicians) included in analysis|332
10519893|NCT01346189|11671647|FG003|COMPLETED|Overall Study|366 patients (58 primary care physicians) included in analysis|355
10519894|NCT01346189|11671644|FG000|NOT COMPLETED|Overall Study||16
10519895|NCT01346189|11671645|FG001|NOT COMPLETED|Overall Study||17
10519896|NCT01346189|11671646|FG002|NOT COMPLETED|Overall Study||14
10519897|NCT01346189|11671647|FG003|NOT COMPLETED|Overall Study||11
10519898|NCT01346267|11671659|FG000|STARTED|Overall Study||93
10519899|NCT01346267|11671660|FG001|STARTED|Overall Study||94
10519900|NCT01346267|11671659|FG000|COMPLETED|Overall Study||70
10519901|NCT01346267|11671660|FG001|COMPLETED|Overall Study||67
10519902|NCT01346267|11671659|FG000|NOT COMPLETED|Overall Study||23
10519903|NCT01346267|11671660|FG001|NOT COMPLETED|Overall Study||27
10519904|NCT01346293|11671668|FG000|STARTED|Overall Study||2743
10519905|NCT01346293|11671669|FG001|STARTED|Overall Study||629
10519906|NCT01346293|11671668|FG000|COMPLETED|Overall Study||2676
10519907|NCT01346293|11671669|FG001|COMPLETED|Overall Study||608
10519908|NCT01346293|11671668|FG000|NOT COMPLETED|Overall Study||67
10519909|NCT01346293|11671669|FG001|NOT COMPLETED|Overall Study||21
10519910|NCT01346371|11671679|FG000|STARTED|Overall Study||20
10519911|NCT01346371|11671680|FG001|STARTED|Overall Study||20
10519912|NCT01346371|11671679|FG000|COMPLETED|Overall Study||18
10519913|NCT01346371|11671680|FG001|COMPLETED|Overall Study||20
10519914|NCT01346371|11671679|FG000|NOT COMPLETED|Overall Study||2
10519915|NCT01346371|11671680|FG001|NOT COMPLETED|Overall Study||0
10519916|NCT01346397|11671688|FG000|STARTED|Overall Study||85
10519917|NCT01346397|11671689|FG001|STARTED|Overall Study||85
10519918|NCT01346397|11671688|FG000|COMPLETED|Overall Study||85
10519919|NCT01346397|11671689|FG001|COMPLETED|Overall Study||85
10519920|NCT01346397|11671688|FG000|NOT COMPLETED|Overall Study||0
10519921|NCT01346397|11671689|FG001|NOT COMPLETED|Overall Study||0
10519922|NCT01346410|11671695|FG000|STARTED|Overall Study||1
10519923|NCT01346410|11671695|FG000|COMPLETED|Overall Study||0
10519924|NCT01346410|11671695|FG000|NOT COMPLETED|Overall Study||1
10519925|NCT01346475|11671701|FG000|STARTED|First Intervention||22
10519926|NCT01346475|11671702|FG001|STARTED|First Intervention||28
10519927|NCT01346475|11671701|FG000|COMPLETED|First Intervention||18
10519928|NCT01346475|11671702|FG001|COMPLETED|First Intervention||25
10519929|NCT01346475|11671701|FG000|NOT COMPLETED|First Intervention||4
10519930|NCT01346475|11671702|FG001|NOT COMPLETED|First Intervention||3
10519931|NCT01346475|11671701|FG000|STARTED|Second Intervention||18
10519932|NCT01346475|11671702|FG001|STARTED|Second Intervention||25
10519933|NCT01346475|11671701|FG000|COMPLETED|Second Intervention||18
10519934|NCT01346475|11671702|FG001|COMPLETED|Second Intervention||25
10519935|NCT01346475|11671701|FG000|NOT COMPLETED|Second Intervention||0
10519936|NCT01346475|11671702|FG001|NOT COMPLETED|Second Intervention||0
10519937|NCT01346488|11671708|FG000|STARTED|Overall Study||1968
10519938|NCT01346488|11671708|FG000|COMPLETED|Overall Study||1262
10519939|NCT01346488|11671708|FG000|NOT COMPLETED|Overall Study||706
10519940|NCT01346501|11671714|FG000|STARTED|Overall Study||79
10519941|NCT01346501|11671715|FG001|STARTED|Overall Study||93
10519942|NCT01346501|11671714|FG000|COMPLETED|Overall Study||68
10519943|NCT01346501|11671715|FG001|COMPLETED|Overall Study||80
10519944|NCT01346501|11671714|FG000|NOT COMPLETED|Overall Study||11
10519945|NCT01346501|11671715|FG001|NOT COMPLETED|Overall Study||13
10519946|NCT01346514|11671725|FG000|STARTED|Overall Study||91
10519947|NCT01346514|11671726|FG001|STARTED|Overall Study||90
10519948|NCT01346514|11671725|FG000|3 Month Assessment|Overall Study||83
10519949|NCT01346514|11671726|FG001|3 Month Assessment|Overall Study||68
10519950|NCT01346514|11671725|FG000|6 Month Assessment|Overall Study||74
10519951|NCT01346514|11671726|FG001|6 Month Assessment|Overall Study||61
10519952|NCT01346514|11671725|FG000|9 Month Assessment|Overall Study||67
10519953|NCT01346514|11671726|FG001|9 Month Assessment|Overall Study||59
10519954|NCT01346514|11671725|FG000|12 Month Assessment|Overall Study||62
10519955|NCT01346514|11671726|FG001|12 Month Assessment|Overall Study||53
10519956|NCT01346514|11671725|FG000|COMPLETED|Overall Study|Number of patients completing BL-12 months|62
10519957|NCT01346514|11671726|FG001|COMPLETED|Overall Study|Number of patients completing BL-12 months.|53
10519958|NCT01346514|11671725|FG000|NOT COMPLETED|Overall Study||29
10519959|NCT01346514|11671726|FG001|NOT COMPLETED|Overall Study||37
10519960|NCT01346540|11671736|FG000|STARTED|Overall Study||4
10519961|NCT01346540|11671737|FG001|STARTED|Overall Study||12
10519962|NCT01346540|11671736|FG000|COMPLETED|Overall Study||1
10519963|NCT01346540|11671737|FG001|COMPLETED|Overall Study||0
10519964|NCT01346540|11671736|FG000|NOT COMPLETED|Overall Study||3
10519965|NCT01346540|11671737|FG001|NOT COMPLETED|Overall Study||12
10519966|NCT01346592|11671747|FG000|STARTED|Overall Study||3136
10519967|NCT01346592|11671748|FG001|STARTED|Overall Study||1478
10519968|NCT01346592|11671749|FG002|STARTED|Overall Study||1486
10519969|NCT01346592|11671747|FG000|COMPLETED|Overall Study||2983
10519970|NCT01346592|11671748|FG001|COMPLETED|Overall Study||1389
10519971|NCT01346592|11671749|FG002|COMPLETED|Overall Study||1408
10519972|NCT01346592|11671747|FG000|NOT COMPLETED|Overall Study||153
10519973|NCT01346592|11671748|FG001|NOT COMPLETED|Overall Study||89
10519974|NCT01346592|11671749|FG002|NOT COMPLETED|Overall Study||78
10519975|NCT01346683|11671774|FG000|STARTED|Overall Study||45
10519976|NCT01346683|11671774|FG000|COMPLETED|Overall Study||45
10519977|NCT01346683|11671774|FG000|NOT COMPLETED|Overall Study||0
10519978|NCT01346696|11671778|FG000|STARTED|Overall Study||45
10519979|NCT01346696|11671778|FG000|COMPLETED|Overall Study||44
10519980|NCT01346696|11671778|FG000|NOT COMPLETED|Overall Study||1
10519981|NCT01346774|11671784|FG000|STARTED|Overall Study||80
10519982|NCT01346774|11671785|FG001|STARTED|Overall Study||80
10519983|NCT01346774|11671784|FG000|COMPLETED|Overall Study||67
10519984|NCT01346774|11671785|FG001|COMPLETED|Overall Study||63
10519985|NCT01346774|11671784|FG000|NOT COMPLETED|Overall Study||13
10519986|NCT01346774|11671785|FG001|NOT COMPLETED|Overall Study||17
10519987|NCT01346839|11671793|FG000|STARTED|Overall Study||683
10519988|NCT01346839|11671794|FG001|STARTED|Overall Study||573
10519989|NCT01346839|11671793|FG000|COMPLETED|Overall Study||369
10519990|NCT01346839|11671794|FG001|COMPLETED|Overall Study|All triggers were applied retrospectively on 7/19/2012.|364
10519991|NCT01346839|11671793|FG000|NOT COMPLETED|Overall Study||314
10519992|NCT01346839|11671794|FG001|NOT COMPLETED|Overall Study||209
10519993|NCT01346852|11671802|FG000|STARTED|Overall Study||41753
10519994|NCT01346852|11671803|FG001|STARTED|Overall Study||59684
10519995|NCT01346852|11671802|FG000|COMPLETED|Overall Study||41753
10519996|NCT01346852|11671803|FG001|COMPLETED|Overall Study||59684
10519997|NCT01346852|11671802|FG000|NOT COMPLETED|Overall Study||0
10519998|NCT01346852|11671803|FG001|NOT COMPLETED|Overall Study||0
10519999|NCT01346969|11671813|FG000|STARTED|Overall Study||28
10520000|NCT01346969|11671814|FG001|STARTED|Overall Study||14
10520001|NCT01346969|11671815|FG002|STARTED|Overall Study||13
10520002|NCT01346969|11671816|FG003|STARTED|Overall Study||13
10520003|NCT01346969|11671813|FG000|Safety Population|Overall Study||27
10520004|NCT01346969|11671814|FG001|Safety Population|Overall Study||14
10520005|NCT01346969|11671815|FG002|Safety Population|Overall Study||13
10520006|NCT01346969|11671816|FG003|Safety Population|Overall Study||13
10520007|NCT01346969|11671813|FG000|COMPLETED|Overall Study||26
10520008|NCT01346969|11671814|FG001|COMPLETED|Overall Study||14
10520009|NCT01346969|11671815|FG002|COMPLETED|Overall Study||10
10520010|NCT01346969|11671816|FG003|COMPLETED|Overall Study||12
10520011|NCT01346969|11671813|FG000|NOT COMPLETED|Overall Study||2
10520012|NCT01346969|11671814|FG001|NOT COMPLETED|Overall Study||0
10520013|NCT01346969|11671815|FG002|NOT COMPLETED|Overall Study||3
10520014|NCT01346969|11671816|FG003|NOT COMPLETED|Overall Study||1
10520015|NCT01347008|11671828|FG000|STARTED|Overall Study||21
10520016|NCT01347008|11671829|FG001|STARTED|Overall Study||20
10520017|NCT01347008|11671828|FG000|COMPLETED|Overall Study||21
10520018|NCT01347008|11671829|FG001|COMPLETED|Overall Study||20
10520019|NCT01347008|11671828|FG000|NOT COMPLETED|Overall Study||0
10520020|NCT01347008|11671829|FG001|NOT COMPLETED|Overall Study||0
10520021|NCT01347034|11671837|FG000|STARTED|Overall Study||6
10520022|NCT01347034|11671838|FG001|STARTED|Overall Study||14
10520023|NCT01347034|11671837|FG000|COMPLETED|Overall Study||6
10520024|NCT01347034|11671838|FG001|COMPLETED|Overall Study||14
10520025|NCT01347034|11671837|FG000|NOT COMPLETED|Overall Study||0
10520026|NCT01347034|11671838|FG001|NOT COMPLETED|Overall Study||0
10520027|NCT01347060|11671846|FG000|STARTED|Overall Study||9868
10520028|NCT01347060|11671847|FG001|STARTED|Overall Study||7580
10520029|NCT01347060|11671846|FG000|COMPLETED|Overall Study||9868
10520030|NCT01347060|11671847|FG001|COMPLETED|Overall Study||7580
10520031|NCT01347060|11671846|FG000|NOT COMPLETED|Overall Study||0
10520032|NCT01347060|11671847|FG001|NOT COMPLETED|Overall Study||0
10520033|NCT01347073|11671853|FG000|STARTED|Overall Study||23
10520034|NCT01347073|11671853|FG000|COMPLETED|Overall Study||21
10520035|NCT01347073|11671853|FG000|NOT COMPLETED|Overall Study||2
10520036|NCT01347086|11671873|FG000|STARTED|Overall Study||2
10520037|NCT01347086|11671874|FG001|STARTED|Overall Study||6
10520038|NCT01347086|11671875|FG002|STARTED|Overall Study|"2 participants were treated together with each dose level of Deleobuvir.~1 subject was not treated."|7
10520039|NCT01347086|11671876|FG003|STARTED|Overall Study||6
10520040|NCT01347086|11671877|FG004|STARTED|Overall Study||6
10520041|NCT01347086|11671878|FG005|STARTED|Overall Study||6
10520042|NCT01347086|11671879|FG006|STARTED|Overall Study|"2 participants treated together with each dose level of Deleobuvir.~1 subject was not treated."|7
10520043|NCT01347086|11671880|FG007|STARTED|Overall Study|One subject was not treated.|7
10520044|NCT01347086|11671881|FG008|STARTED|Overall Study||6
10520045|NCT01347086|11671882|FG009|STARTED|Overall Study|One subject was not treated.|7
10520046|NCT01347086|11671873|FG000|COMPLETED|Overall Study||2
10520047|NCT01347086|11671874|FG001|COMPLETED|Overall Study||6
10520048|NCT01347086|11671875|FG002|COMPLETED|Overall Study||6
10520049|NCT01347086|11671876|FG003|COMPLETED|Overall Study||6
10520050|NCT01347086|11671877|FG004|COMPLETED|Overall Study||6
10520051|NCT01347086|11671878|FG005|COMPLETED|Overall Study||6
10520052|NCT01347086|11671879|FG006|COMPLETED|Overall Study||6
10520053|NCT01347086|11671880|FG007|COMPLETED|Overall Study||6
10520054|NCT01347086|11671881|FG008|COMPLETED|Overall Study||6
10520055|NCT01347086|11671882|FG009|COMPLETED|Overall Study||6
10520056|NCT01347086|11671873|FG000|NOT COMPLETED|Overall Study||0
10520057|NCT01347086|11671874|FG001|NOT COMPLETED|Overall Study||0
10520058|NCT01347086|11671875|FG002|NOT COMPLETED|Overall Study||1
10520059|NCT01347086|11671876|FG003|NOT COMPLETED|Overall Study||0
10520060|NCT01347086|11671877|FG004|NOT COMPLETED|Overall Study||0
10520061|NCT01347086|11671878|FG005|NOT COMPLETED|Overall Study||0
10520062|NCT01347086|11671879|FG006|NOT COMPLETED|Overall Study||1
10520063|NCT01347086|11671880|FG007|NOT COMPLETED|Overall Study||1
10520064|NCT01347086|11671881|FG008|NOT COMPLETED|Overall Study||0
10520065|NCT01347086|11671882|FG009|NOT COMPLETED|Overall Study||1
10520066|NCT01347112|11671916|FG000|STARTED|Overall Study||16
10520067|NCT01347112|11671917|FG001|STARTED|Overall Study||17
10520068|NCT01347112|11671916|FG000|COMPLETED|Overall Study||12
10520069|NCT01347112|11671917|FG001|COMPLETED|Overall Study||5
10520070|NCT01347112|11671916|FG000|NOT COMPLETED|Overall Study||4
10520071|NCT01347112|11671917|FG001|NOT COMPLETED|Overall Study||12
10520072|NCT01347255|11671924|FG000|STARTED|Overall Study||24
10520073|NCT01347255|11671924|FG000|COMPLETED|Overall Study||24
10520074|NCT01347255|11671924|FG000|NOT COMPLETED|Overall Study||0
10520075|NCT01347307|11671933|FG000|STARTED|Overall Study||3
10520076|NCT01347307|11671934|FG001|STARTED|Overall Study||33
10520077|NCT01347307|11671933|FG000|COMPLETED|Overall Study||3
10520078|NCT01347307|11671934|FG001|COMPLETED|Overall Study||28
10520079|NCT01347307|11671933|FG000|NOT COMPLETED|Overall Study||0
10520080|NCT01347307|11671934|FG001|NOT COMPLETED|Overall Study||5
10520081|NCT01347333|11671942|FG000|STARTED|Overall Study||23
10520082|NCT01347333|11671943|FG001|STARTED|Overall Study|No participants were enrolled in the Primary Liver Tumor arm.|0
10520083|NCT01347333|11671942|FG000|COMPLETED|Overall Study||23
10520084|NCT01347333|11671943|FG001|COMPLETED|Overall Study||0
10520085|NCT01347333|11671942|FG000|NOT COMPLETED|Overall Study||0
10520086|NCT01347333|11671943|FG001|NOT COMPLETED|Overall Study||0
10520087|NCT01347541|11671951|FG000|STARTED|Overall Study||3
10520088|NCT01347541|11671952|FG001|STARTED|Overall Study||1
10520089|NCT01347541|11671951|FG000|COMPLETED|Overall Study||3
10520090|NCT01347541|11671952|FG001|COMPLETED|Overall Study||1
10520091|NCT01347541|11671951|FG000|NOT COMPLETED|Overall Study||0
10520092|NCT01347541|11671952|FG001|NOT COMPLETED|Overall Study||0
10520093|NCT01347554|11671960|FG000|STARTED|Overall Study||237
10520094|NCT01347554|11671961|FG001|STARTED|Overall Study||242
10520095|NCT01347554|11671960|FG000|COMPLETED|Overall Study|Final TIMI flow grade 0 or 1 patients or failed PCI cases (N=7) were excluded.|230
10520096|NCT01347554|11671961|FG001|COMPLETED|Overall Study|Final TIMI flow grade 0 or 1 patients or failed PCI cases (N=11) were excluded.|231
10520097|NCT01347554|11671960|FG000|NOT COMPLETED|Overall Study||7
10520098|NCT01347554|11671961|FG001|NOT COMPLETED|Overall Study||11
10520099|NCT01347580|11671969|FG000|STARTED|Overall Study|based on randomized treatment|909
10520100|NCT01347580|11671970|FG001|STARTED|Overall Study|based on randomized treatment|953
10520101|NCT01347580|11671969|FG000|Modified Intent to Treat Population|Overall Study|based on randomized treatment|906
10520102|NCT01347580|11671970|FG001|Modified Intent to Treat Population|Overall Study|based on randomized treatment|952
10520103|NCT01347580|11671969|FG000|Safety Population|Overall Study|based on actual treatment|908
10520104|NCT01347580|11671970|FG001|Safety Population|Overall Study|based on actual treatment|950
10520105|NCT01347580|11671969|FG000|COMPLETED|Overall Study|based on randomized treatment|844
10520106|NCT01347580|11671970|FG001|COMPLETED|Overall Study|based on randomized treatment|897
10520107|NCT01347580|11671969|FG000|NOT COMPLETED|Overall Study||65
10520108|NCT01347580|11671970|FG001|NOT COMPLETED|Overall Study||56
10520109|NCT01347710|11671976|FG000|STARTED|Overall Study||795
10520110|NCT01347710|11671976|FG000|COMPLETED|Overall Study||764
10520111|NCT01347710|11671976|FG000|NOT COMPLETED|Overall Study||31
10520112|NCT01347762|11671988|FG000|STARTED|Overall Study||10
10520113|NCT01347762|11671989|FG001|STARTED|Overall Study||8
10520114|NCT01347762|11671990|FG002|STARTED|Overall Study||16
10520115|NCT01347762|11671991|FG003|STARTED|Overall Study||18
10520116|NCT01347762|11671988|FG000|COMPLETED|Overall Study||6
10520117|NCT01347762|11671989|FG001|COMPLETED|Overall Study||6
10520118|NCT01347762|11671990|FG002|COMPLETED|Overall Study||7
10520119|NCT01347762|11671991|FG003|COMPLETED|Overall Study||10
10520120|NCT01347762|11671988|FG000|NOT COMPLETED|Overall Study||4
10520121|NCT01347762|11671989|FG001|NOT COMPLETED|Overall Study||2
10520122|NCT01347762|11671990|FG002|NOT COMPLETED|Overall Study||9
10520123|NCT01347762|11671991|FG003|NOT COMPLETED|Overall Study||8
10520124|NCT01347788|11672001|FG000|STARTED|Overall Study||11
10520125|NCT01347788|11672002|FG001|STARTED|Overall Study||10
10520126|NCT01347788|11672003|FG002|STARTED|Overall Study||13
10520127|NCT01347788|11672001|FG000|COMPLETED|Overall Study||11
10520128|NCT01347788|11672002|FG001|COMPLETED|Overall Study||10
10520129|NCT01347788|11672003|FG002|COMPLETED|Overall Study||13
10520130|NCT01347788|11672001|FG000|NOT COMPLETED|Overall Study||0
10520131|NCT01347788|11672002|FG001|NOT COMPLETED|Overall Study||0
10520132|NCT01347788|11672003|FG002|NOT COMPLETED|Overall Study||0
10520133|NCT01347866|11672028|FG000|STARTED|Overall Study||5
10520134|NCT01347866|11672029|FG001|STARTED|Overall Study||1
10520135|NCT01347866|11672030|FG002|STARTED|Overall Study||1
10520136|NCT01347866|11672031|FG003|STARTED|Overall Study||7
10520137|NCT01347866|11672032|FG004|STARTED|Overall Study||7
10520138|NCT01347866|11672033|FG005|STARTED|Overall Study||3
10520139|NCT01347866|11672034|FG006|STARTED|Overall Study||6
10520140|NCT01347866|11672035|FG007|STARTED|Overall Study||4
10520141|NCT01347866|11672036|FG008|STARTED|Overall Study||31
10520142|NCT01347866|11672037|FG009|STARTED|Overall Study||7
10520143|NCT01347866|11672038|FG010|STARTED|Overall Study||3
10520144|NCT01347866|11672039|FG011|STARTED|Overall Study||4
10520145|NCT01347866|11672040|FG012|STARTED|Overall Study||7
10520146|NCT01347866|11672041|FG013|STARTED|Overall Study||7
10711768|NCT02662569|11877231|FG002|COMPLETED|Overall Study||321
10711769|NCT02662569|11877232|FG003|COMPLETED|Overall Study||328
10711770|NCT02662569|11877229|FG000|NOT COMPLETED|Overall Study||7
10520147|NCT01347866|11672042|FG014|STARTED|Overall Study||3
10520148|NCT01347866|11672043|FG015|STARTED|Overall Study||4
10520149|NCT01347866|11672044|FG016|STARTED|Overall Study||2
10520150|NCT01347866|11672028|FG000|COMPLETED|Overall Study||0
10520151|NCT01347866|11672029|FG001|COMPLETED|Overall Study||0
10520152|NCT01347866|11672030|FG002|COMPLETED|Overall Study||0
10520153|NCT01347866|11672031|FG003|COMPLETED|Overall Study||0
10520154|NCT01347866|11672032|FG004|COMPLETED|Overall Study||0
10520155|NCT01347866|11672033|FG005|COMPLETED|Overall Study||0
10520156|NCT01347866|11672034|FG006|COMPLETED|Overall Study||0
10520157|NCT01347866|11672035|FG007|COMPLETED|Overall Study||0
10711771|NCT02662569|11877230|FG001|NOT COMPLETED|Overall Study||1
10711772|NCT02662569|11877231|FG002|NOT COMPLETED|Overall Study||6
10520158|NCT01347866|11672036|FG008|COMPLETED|Overall Study||0
10520159|NCT01347866|11672037|FG009|COMPLETED|Overall Study||0
10520160|NCT01347866|11672038|FG010|COMPLETED|Overall Study||0
10520161|NCT01347866|11672039|FG011|COMPLETED|Overall Study||0
10520162|NCT01347866|11672040|FG012|COMPLETED|Overall Study||0
10520163|NCT01347866|11672041|FG013|COMPLETED|Overall Study||0
10520164|NCT01347866|11672042|FG014|COMPLETED|Overall Study||0
10520165|NCT01347866|11672043|FG015|COMPLETED|Overall Study||0
10520166|NCT01347866|11672044|FG016|COMPLETED|Overall Study||0
10520167|NCT01347866|11672028|FG000|NOT COMPLETED|Overall Study||5
10520168|NCT01347866|11672029|FG001|NOT COMPLETED|Overall Study||1
10520169|NCT01347866|11672030|FG002|NOT COMPLETED|Overall Study||1
10520170|NCT01347866|11672031|FG003|NOT COMPLETED|Overall Study||7
10520171|NCT01347866|11672032|FG004|NOT COMPLETED|Overall Study||7
10520172|NCT01347866|11672033|FG005|NOT COMPLETED|Overall Study||3
10520173|NCT01347866|11672034|FG006|NOT COMPLETED|Overall Study||6
10520174|NCT01347866|11672035|FG007|NOT COMPLETED|Overall Study||4
10520175|NCT01347866|11672036|FG008|NOT COMPLETED|Overall Study||31
10520176|NCT01347866|11672037|FG009|NOT COMPLETED|Overall Study||7
10520177|NCT01347866|11672038|FG010|NOT COMPLETED|Overall Study||3
10520178|NCT01347866|11672039|FG011|NOT COMPLETED|Overall Study||4
10520179|NCT01347866|11672040|FG012|NOT COMPLETED|Overall Study||7
10520180|NCT01347866|11672041|FG013|NOT COMPLETED|Overall Study||7
10520181|NCT01347866|11672042|FG014|NOT COMPLETED|Overall Study||3
10520182|NCT01347866|11672043|FG015|NOT COMPLETED|Overall Study||4
10520183|NCT01347866|11672044|FG016|NOT COMPLETED|Overall Study||2
10520184|NCT01347879|11672117|FG000|STARTED|Overall Study||53
10520185|NCT01347879|11672118|FG001|STARTED|Overall Study||100
10520186|NCT01347879|11672117|FG000|COMPLETED|Overall Study||46
10520187|NCT01347879|11672118|FG001|COMPLETED|Overall Study||83
10520188|NCT01347879|11672117|FG000|NOT COMPLETED|Overall Study||7
10520189|NCT01347879|11672118|FG001|NOT COMPLETED|Overall Study||17
10520190|NCT01347931|11672124|FG000|STARTED|Standard Oxygen Therapy||30
10520191|NCT01347931|11672124|FG000|COMPLETED|Standard Oxygen Therapy||29
10520192|NCT01347931|11672124|FG000|NOT COMPLETED|Standard Oxygen Therapy||1
10520193|NCT01347931|11672124|FG000|STARTED|NIOV System||29
10520194|NCT01347931|11672124|FG000|COMPLETED|NIOV System||29
10520195|NCT01347931|11672124|FG000|NOT COMPLETED|NIOV System||0
10520196|NCT01348087|11672130|FG000|STARTED|Overall Study||148
10520197|NCT01348087|11672130|FG000|COMPLETED|Overall Study||0
10520198|NCT01348087|11672130|FG000|NOT COMPLETED|Overall Study||148
10520199|NCT01348100|11672151|FG000|STARTED|Overall Study||2
10520200|NCT01348100|11672152|FG001|STARTED|Overall Study||2
10520201|NCT01348100|11672153|FG002|STARTED|Overall Study||15
10520202|NCT01348100|11672154|FG003|STARTED|Overall Study||15
10520203|NCT01348100|11672155|FG004|STARTED|Overall Study||15
10520204|NCT01348100|11672156|FG005|STARTED|Overall Study||16
10520205|NCT01348100|11672157|FG006|STARTED|Overall Study||16
10520206|NCT01348100|11672151|FG000|COMPLETED|Overall Study||2
10520207|NCT01348100|11672152|FG001|COMPLETED|Overall Study||2
10520208|NCT01348100|11672153|FG002|COMPLETED|Overall Study||13
10520209|NCT01348100|11672154|FG003|COMPLETED|Overall Study||14
10520210|NCT01348100|11672155|FG004|COMPLETED|Overall Study||14
10520211|NCT01348100|11672156|FG005|COMPLETED|Overall Study||14
10520212|NCT01348100|11672157|FG006|COMPLETED|Overall Study||13
10520213|NCT01348100|11672151|FG000|NOT COMPLETED|Overall Study||0
10520214|NCT01348100|11672152|FG001|NOT COMPLETED|Overall Study||0
10520215|NCT01348100|11672153|FG002|NOT COMPLETED|Overall Study||2
10520216|NCT01348100|11672154|FG003|NOT COMPLETED|Overall Study||1
10520217|NCT01348100|11672155|FG004|NOT COMPLETED|Overall Study||1
10520218|NCT01348100|11672156|FG005|NOT COMPLETED|Overall Study||2
10520219|NCT01348100|11672157|FG006|NOT COMPLETED|Overall Study||3
10520220|NCT01348139|11672178|FG000|STARTED|Period 1||5
10520221|NCT01348139|11672179|FG001|STARTED|Period 1||4
10520222|NCT01348139|11672180|FG002|STARTED|Period 1||4
10520223|NCT01348139|11672181|FG003|STARTED|Period 1||4
10520224|NCT01348139|11672182|FG004|STARTED|Period 1||5
10520225|NCT01348139|11672183|FG005|STARTED|Period 1||4
10520226|NCT01348139|11672178|FG000|COMPLETED|Period 1||4
10520227|NCT01348139|11672179|FG001|COMPLETED|Period 1||4
10520228|NCT01348139|11672180|FG002|COMPLETED|Period 1||4
10520229|NCT01348139|11672181|FG003|COMPLETED|Period 1||4
10520230|NCT01348139|11672182|FG004|COMPLETED|Period 1||5
10520231|NCT01348139|11672183|FG005|COMPLETED|Period 1||4
10520232|NCT01348139|11672178|FG000|NOT COMPLETED|Period 1||1
10520233|NCT01348139|11672179|FG001|NOT COMPLETED|Period 1||0
10520234|NCT01348139|11672180|FG002|NOT COMPLETED|Period 1||0
10520235|NCT01348139|11672181|FG003|NOT COMPLETED|Period 1||0
10520236|NCT01348139|11672182|FG004|NOT COMPLETED|Period 1||0
10520237|NCT01348139|11672183|FG005|NOT COMPLETED|Period 1||0
10520238|NCT01348139|11672178|FG000|STARTED|Period 2||4
10520239|NCT01348139|11672179|FG001|STARTED|Period 2||4
10520240|NCT01348139|11672180|FG002|STARTED|Period 2||4
10520241|NCT01348139|11672181|FG003|STARTED|Period 2||4
10520242|NCT01348139|11672182|FG004|STARTED|Period 2||5
10520243|NCT01348139|11672183|FG005|STARTED|Period 2||4
10520244|NCT01348139|11672178|FG000|COMPLETED|Period 2||4
10520245|NCT01348139|11672179|FG001|COMPLETED|Period 2||4
10520246|NCT01348139|11672180|FG002|COMPLETED|Period 2||4
10520247|NCT01348139|11672181|FG003|COMPLETED|Period 2||4
10520248|NCT01348139|11672182|FG004|COMPLETED|Period 2||5
10520249|NCT01348139|11672183|FG005|COMPLETED|Period 2||4
10520250|NCT01348139|11672178|FG000|NOT COMPLETED|Period 2||0
10520251|NCT01348139|11672179|FG001|NOT COMPLETED|Period 2||0
10520252|NCT01348139|11672180|FG002|NOT COMPLETED|Period 2||0
10520253|NCT01348139|11672181|FG003|NOT COMPLETED|Period 2||0
10520254|NCT01348139|11672182|FG004|NOT COMPLETED|Period 2||0
10520255|NCT01348139|11672183|FG005|NOT COMPLETED|Period 2||0
10520256|NCT01348139|11672178|FG000|STARTED|Period 3||4
10520257|NCT01348139|11672179|FG001|STARTED|Period 3||4
10520258|NCT01348139|11672180|FG002|STARTED|Period 3||4
10520259|NCT01348139|11672181|FG003|STARTED|Period 3||4
10520260|NCT01348139|11672182|FG004|STARTED|Period 3||5
10520261|NCT01348139|11672183|FG005|STARTED|Period 3||4
10520262|NCT01348139|11672178|FG000|COMPLETED|Period 3||4
10520263|NCT01348139|11672179|FG001|COMPLETED|Period 3||4
10520264|NCT01348139|11672180|FG002|COMPLETED|Period 3||4
10520265|NCT01348139|11672181|FG003|COMPLETED|Period 3||4
10520266|NCT01348139|11672182|FG004|COMPLETED|Period 3||5
10520267|NCT01348139|11672183|FG005|COMPLETED|Period 3||4
10520268|NCT01348139|11672178|FG000|NOT COMPLETED|Period 3||0
10520269|NCT01348139|11672179|FG001|NOT COMPLETED|Period 3||0
10520270|NCT01348139|11672180|FG002|NOT COMPLETED|Period 3||0
10520271|NCT01348139|11672181|FG003|NOT COMPLETED|Period 3||0
10520272|NCT01348139|11672182|FG004|NOT COMPLETED|Period 3||0
10520273|NCT01348139|11672183|FG005|NOT COMPLETED|Period 3||0
10520274|NCT01348139|11672178|FG000|STARTED|Period 4||4
10520275|NCT01348139|11672179|FG001|STARTED|Period 4||4
10520276|NCT01348139|11672180|FG002|STARTED|Period 4||4
10520277|NCT01348139|11672181|FG003|STARTED|Period 4||4
10520278|NCT01348139|11672182|FG004|STARTED|Period 4||5
10520279|NCT01348139|11672183|FG005|STARTED|Period 4||4
10520280|NCT01348139|11672178|FG000|COMPLETED|Period 4||4
10520281|NCT01348139|11672179|FG001|COMPLETED|Period 4||4
10520282|NCT01348139|11672180|FG002|COMPLETED|Period 4||4
10520283|NCT01348139|11672181|FG003|COMPLETED|Period 4||4
10520284|NCT01348139|11672182|FG004|COMPLETED|Period 4||5
10520285|NCT01348139|11672183|FG005|COMPLETED|Period 4||4
10520286|NCT01348139|11672178|FG000|NOT COMPLETED|Period 4||0
10520287|NCT01348139|11672179|FG001|NOT COMPLETED|Period 4||0
10520288|NCT01348139|11672180|FG002|NOT COMPLETED|Period 4||0
10520289|NCT01348139|11672181|FG003|NOT COMPLETED|Period 4||0
10520290|NCT01348139|11672182|FG004|NOT COMPLETED|Period 4||0
10520291|NCT01348139|11672183|FG005|NOT COMPLETED|Period 4||0
10520292|NCT01348139|11672178|FG000|STARTED|Period 5||4
10520293|NCT01348139|11672179|FG001|STARTED|Period 5||4
10520294|NCT01348139|11672180|FG002|STARTED|Period 5||4
10520295|NCT01348139|11672181|FG003|STARTED|Period 5||4
10520296|NCT01348139|11672182|FG004|STARTED|Period 5||5
10520297|NCT01348139|11672183|FG005|STARTED|Period 5||4
10520298|NCT01348139|11672178|FG000|COMPLETED|Period 5||4
10520299|NCT01348139|11672179|FG001|COMPLETED|Period 5||4
10520300|NCT01348139|11672180|FG002|COMPLETED|Period 5||4
10520301|NCT01348139|11672181|FG003|COMPLETED|Period 5||4
10520302|NCT01348139|11672182|FG004|COMPLETED|Period 5||5
10520303|NCT01348139|11672183|FG005|COMPLETED|Period 5||4
10520304|NCT01348139|11672178|FG000|NOT COMPLETED|Period 5||0
10520305|NCT01348139|11672179|FG001|NOT COMPLETED|Period 5||0
10520306|NCT01348139|11672180|FG002|NOT COMPLETED|Period 5||0
10520307|NCT01348139|11672181|FG003|NOT COMPLETED|Period 5||0
10520308|NCT01348139|11672182|FG004|NOT COMPLETED|Period 5||0
10520309|NCT01348139|11672183|FG005|NOT COMPLETED|Period 5||0
10520310|NCT01348139|11672178|FG000|STARTED|Period 6||4
10810268|NCT03800030|11972165|FG002|COMPLETED|Baseline||4
10810269|NCT03800030|11972166|FG003|COMPLETED|Baseline||6
10810270|NCT03800030|11972167|FG004|COMPLETED|Baseline||4
10810271|NCT03800030|11972168|FG005|COMPLETED|Baseline||4
10810272|NCT03800030|11972163|FG000|NOT COMPLETED|Baseline||0
10810273|NCT03800030|11972164|FG001|NOT COMPLETED|Baseline||0
10810274|NCT03800030|11972165|FG002|NOT COMPLETED|Baseline||0
10520311|NCT01348139|11672179|FG001|STARTED|Period 6||4
10520312|NCT01348139|11672180|FG002|STARTED|Period 6||4
10520313|NCT01348139|11672181|FG003|STARTED|Period 6||4
10520314|NCT01348139|11672182|FG004|STARTED|Period 6||5
10520315|NCT01348139|11672183|FG005|STARTED|Period 6||4
10520316|NCT01348139|11672178|FG000|COMPLETED|Period 6||4
10520317|NCT01348139|11672179|FG001|COMPLETED|Period 6||4
10520318|NCT01348139|11672180|FG002|COMPLETED|Period 6||4
10520319|NCT01348139|11672181|FG003|COMPLETED|Period 6||4
10520320|NCT01348139|11672182|FG004|COMPLETED|Period 6||5
10520321|NCT01348139|11672183|FG005|COMPLETED|Period 6||4
10520322|NCT01348139|11672178|FG000|NOT COMPLETED|Period 6||0
10520323|NCT01348139|11672179|FG001|NOT COMPLETED|Period 6||0
10520324|NCT01348139|11672180|FG002|NOT COMPLETED|Period 6||0
10520325|NCT01348139|11672181|FG003|NOT COMPLETED|Period 6||0
10520326|NCT01348139|11672182|FG004|NOT COMPLETED|Period 6||0
10520327|NCT01348139|11672183|FG005|NOT COMPLETED|Period 6||0
10520328|NCT01348165|11672204|FG000|STARTED|Overall Study||10
10810275|NCT03800030|11972166|FG003|NOT COMPLETED|Baseline||0
10520329|NCT01348165|11672205|FG001|STARTED|Overall Study||5
10520330|NCT01348165|11672206|FG002|STARTED|Overall Study||6
10810276|NCT03800030|11972167|FG004|NOT COMPLETED|Baseline||0
10520331|NCT01348165|11672207|FG003|STARTED|Overall Study||6
10520332|NCT01348165|11672208|FG004|STARTED|Overall Study||6
10520333|NCT01348165|11672209|FG005|STARTED|Overall Study||1
10520334|NCT01348165|11672210|FG006|STARTED|Overall Study||6
10520335|NCT01348165|11672204|FG000|COMPLETED|Overall Study||10
10520336|NCT01348165|11672205|FG001|COMPLETED|Overall Study||5
10520337|NCT01348165|11672206|FG002|COMPLETED|Overall Study||6
10520338|NCT01348165|11672207|FG003|COMPLETED|Overall Study||6
10520339|NCT01348165|11672208|FG004|COMPLETED|Overall Study||6
10520340|NCT01348165|11672209|FG005|COMPLETED|Overall Study||1
10520341|NCT01348165|11672210|FG006|COMPLETED|Overall Study||5
10520342|NCT01348165|11672204|FG000|NOT COMPLETED|Overall Study||0
10520343|NCT01348165|11672205|FG001|NOT COMPLETED|Overall Study||0
10520344|NCT01348165|11672206|FG002|NOT COMPLETED|Overall Study||0
10520345|NCT01348165|11672207|FG003|NOT COMPLETED|Overall Study||0
10520346|NCT01348165|11672208|FG004|NOT COMPLETED|Overall Study||0
10520347|NCT01348165|11672209|FG005|NOT COMPLETED|Overall Study||0
10520348|NCT01348165|11672210|FG006|NOT COMPLETED|Overall Study||1
10520349|NCT01348347|11672233|FG000|STARTED|Overall Study||3
10520350|NCT01348347|11672234|FG001|STARTED|Overall Study||6
10520351|NCT01348347|11672235|FG002|STARTED|Overall Study||6
10520352|NCT01348347|11672233|FG000|COMPLETED|Overall Study||0
10520353|NCT01348347|11672234|FG001|COMPLETED|Overall Study||0
10520354|NCT01348347|11672235|FG002|COMPLETED|Overall Study||0
10520355|NCT01348347|11672233|FG000|NOT COMPLETED|Overall Study||3
10520356|NCT01348347|11672234|FG001|NOT COMPLETED|Overall Study||6
10520357|NCT01348347|11672235|FG002|NOT COMPLETED|Overall Study||6
10520358|NCT01348425|11672246|FG000|STARTED|Overall Study||31
10520359|NCT01348425|11672247|FG001|STARTED|Overall Study||14
10520360|NCT01348425|11672246|FG000|COMPLETED|Overall Study||30
10520361|NCT01348425|11672247|FG001|COMPLETED|Overall Study||13
10520362|NCT01348425|11672246|FG000|NOT COMPLETED|Overall Study||1
10520363|NCT01348425|11672247|FG001|NOT COMPLETED|Overall Study||1
10520364|NCT01348490|11672252|FG000|STARTED|Overall Study||66
10520365|NCT01348490|11672252|FG000|COMPLETED|Overall Study||42
10520366|NCT01348490|11672252|FG000|NOT COMPLETED|Overall Study||24
10520367|NCT01348542|11672275|FG000|STARTED|Overall Study||13
10520368|NCT01348542|11672276|FG001|STARTED|Overall Study||11
10520369|NCT01348542|11672275|FG000|COMPLETED|Overall Study||10
10520370|NCT01348542|11672276|FG001|COMPLETED|Overall Study||11
10520371|NCT01348542|11672275|FG000|NOT COMPLETED|Overall Study||3
10520372|NCT01348542|11672276|FG001|NOT COMPLETED|Overall Study||0
10520373|NCT01348607|11672285|FG000|STARTED|Overall Study||1
10520374|NCT01348607|11672286|FG001|STARTED|Overall Study||0
10520375|NCT01348607|11672287|FG002|STARTED|Overall Study||0
10520376|NCT01348607|11672285|FG000|COMPLETED|Overall Study||1
10520377|NCT01348607|11672286|FG001|COMPLETED|Overall Study||0
10520378|NCT01348607|11672287|FG002|COMPLETED|Overall Study||0
10520379|NCT01348607|11672285|FG000|NOT COMPLETED|Overall Study||0
10520380|NCT01348607|11672286|FG001|NOT COMPLETED|Overall Study||0
10520381|NCT01348607|11672287|FG002|NOT COMPLETED|Overall Study||0
10520382|NCT01348698|11672295|FG000|STARTED|Overall Study||74
10520383|NCT01348698|11672295|FG000|COMPLETED|Overall Study||2
10520384|NCT01348698|11672295|FG000|NOT COMPLETED|Overall Study||72
10520385|NCT01348763|11672299|FG000|STARTED|With Tenofovir/Emtricitabine (10 Days)||13
10520386|NCT01348763|11672299|FG000|COMPLETED|With Tenofovir/Emtricitabine (10 Days)||11
10520387|NCT01348763|11672299|FG000|NOT COMPLETED|With Tenofovir/Emtricitabine (10 Days)||2
10520388|NCT01348763|11672299|FG000|STARTED|Without Tenofovir/Emtricitabine (11 Day)||11
10520389|NCT01348763|11672299|FG000|COMPLETED|Without Tenofovir/Emtricitabine (11 Day)||11
10520390|NCT01348763|11672299|FG000|NOT COMPLETED|Without Tenofovir/Emtricitabine (11 Day)||0
10520391|NCT01348776|11672303|FG000|STARTED|Overall Study|3 subjects were lost to follow-up: 2 after the 1-month follow-up, 1 after performing 4 treatments|87
10520392|NCT01348776|11672303|FG000|COMPLETED|Overall Study||84
10520393|NCT01348776|11672303|FG000|NOT COMPLETED|Overall Study||3
10520394|NCT01348789|11672316|FG000|STARTED|Overall Study||37
10520395|NCT01348789|11672316|FG000|COMPLETED|Overall Study|4 subjects did not complete all 3 treatments but were evaluated for primary and secondary endpoints.|33
10520396|NCT01348789|11672316|FG000|NOT COMPLETED|Overall Study||4
10520397|NCT01348828|11672327|FG000|STARTED|Overall Study||49
10520398|NCT01348828|11672327|FG000|COMPLETED|Overall Study||16
10520399|NCT01348828|11672327|FG000|NOT COMPLETED|Overall Study||33
10520400|NCT01348854|11672333|FG000|STARTED|Overall Study|53 eyes of 34 participants|34
10520401|NCT01348854|11672334|FG001|STARTED|Overall Study|10 eyes of 6 participants|6
10520402|NCT01348854|11672333|FG000|COMPLETED|Overall Study|47 eyes of 31 participants|31
10711773|NCT02662569|11877232|FG003|NOT COMPLETED|Overall Study||4
10711774|NCT02662582|11877244|FG000|STARTED|Treatment Period 1 (14 Days)||23
10711775|NCT02662582|11877245|FG001|STARTED|Treatment Period 1 (14 Days)||23
10711776|NCT02662582|11877244|FG000|COMPLETED|Treatment Period 1 (14 Days)||18
10711777|NCT02662582|11877245|FG001|COMPLETED|Treatment Period 1 (14 Days)||19
10711778|NCT02662582|11877244|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||5
10711779|NCT02662582|11877245|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||4
10711780|NCT02662582|11877244|FG000|STARTED|Washout Period (14 Days)||18
10711781|NCT02662582|11877245|FG001|STARTED|Washout Period (14 Days)||19
10711782|NCT02662582|11877244|FG000|COMPLETED|Washout Period (14 Days)||18
10520403|NCT01348854|11672334|FG001|COMPLETED|Overall Study|9 eyes of 5 participants|5
10520404|NCT01348854|11672333|FG000|NOT COMPLETED|Overall Study||3
10520405|NCT01348854|11672334|FG001|NOT COMPLETED|Overall Study||1
10520406|NCT01349036|11672342|FG000|STARTED|Overall Study||14
10520407|NCT01349036|11672343|FG001|STARTED|Overall Study||24
10520408|NCT01349036|11672342|FG000|COMPLETED|Overall Study||0
10520409|NCT01349036|11672343|FG001|COMPLETED|Overall Study||0
10520410|NCT01349036|11672342|FG000|NOT COMPLETED|Overall Study||14
10520411|NCT01349036|11672343|FG001|NOT COMPLETED|Overall Study||24
10520412|NCT01349049|11672362|FG000|STARTED|Overall Study||3
10520413|NCT01349049|11672363|FG001|STARTED|Overall Study||7
10520414|NCT01349049|11672364|FG002|STARTED|Overall Study||3
10520415|NCT01349049|11672365|FG003|STARTED|Overall Study||3
10520416|NCT01349049|11672366|FG004|STARTED|Overall Study||3
10520417|NCT01349049|11672367|FG005|STARTED|Overall Study||6
10520418|NCT01349049|11672368|FG006|STARTED|Overall Study||5
10711783|NCT02662582|11877245|FG001|COMPLETED|Washout Period (14 Days)||19
10520419|NCT01349049|11672369|FG007|STARTED|Overall Study||4
10520420|NCT01349049|11672370|FG008|STARTED|Overall Study||56
10520421|NCT01349049|11672362|FG000|COMPLETED|Overall Study||0
10520422|NCT01349049|11672363|FG001|COMPLETED|Overall Study||0
10520423|NCT01349049|11672364|FG002|COMPLETED|Overall Study||0
10520424|NCT01349049|11672365|FG003|COMPLETED|Overall Study||0
10520425|NCT01349049|11672366|FG004|COMPLETED|Overall Study||0
10520426|NCT01349049|11672367|FG005|COMPLETED|Overall Study||0
10520427|NCT01349049|11672368|FG006|COMPLETED|Overall Study||0
10520428|NCT01349049|11672369|FG007|COMPLETED|Overall Study||0
10520429|NCT01349049|11672370|FG008|COMPLETED|Overall Study||1
10520430|NCT01349049|11672362|FG000|NOT COMPLETED|Overall Study||3
10520431|NCT01349049|11672363|FG001|NOT COMPLETED|Overall Study||7
10520432|NCT01349049|11672364|FG002|NOT COMPLETED|Overall Study||3
10520433|NCT01349049|11672365|FG003|NOT COMPLETED|Overall Study||3
10520434|NCT01349049|11672366|FG004|NOT COMPLETED|Overall Study||3
10520435|NCT01349049|11672367|FG005|NOT COMPLETED|Overall Study||6
10520436|NCT01349049|11672368|FG006|NOT COMPLETED|Overall Study||5
10520437|NCT01349049|11672369|FG007|NOT COMPLETED|Overall Study||4
10520438|NCT01349049|11672370|FG008|NOT COMPLETED|Overall Study||55
10520439|NCT01349114|11672404|FG000|STARTED|Overall Study||10
10520440|NCT01349114|11672405|FG001|STARTED|Overall Study||11
10520441|NCT01349114|11672404|FG000|COMPLETED|Overall Study||10
10520442|NCT01349114|11672405|FG001|COMPLETED|Overall Study||11
10520443|NCT01349114|11672404|FG000|NOT COMPLETED|Overall Study||0
10520444|NCT01349114|11672405|FG001|NOT COMPLETED|Overall Study||0
10520445|NCT01349140|11672413|FG000|STARTED|Overall Study|"We enrolled 14 subjects, and therefore Protocol Enrollment is 14. However, each leg of each subject was treated separately with a different dose of liposomal bupivacaine (Exparel); and, therefore the number of units for each subject was 2 and the total number of units analyzed was 28."|14
10520522|NCT01349829|11672529|FG001|STARTED|Overall Study||125
10520523|NCT01349829|11672528|FG000|COMPLETED|Overall Study||117
10520446|NCT01349140|11672413|FG000|COMPLETED|Overall Study|"We enrolled 14 subjects, and therefore Protocol Enrollment is 14. However, each leg of each subject was treated separately with a different dose of liposomal bupivacaine (Exparel); and, therefore the number of units for each subject was 2 and the total number of units analyzed was 28."|14
10520447|NCT01349140|11672413|FG000|NOT COMPLETED|Overall Study||0
10520448|NCT01349192|11672419|FG000|STARTED|Overall Study||24
10520449|NCT01349192|11672420|FG001|STARTED|Overall Study||23
10520450|NCT01349192|11672419|FG000|Evaluable for Primary Endpoint|Overall Study||22
10520451|NCT01349192|11672420|FG001|Evaluable for Primary Endpoint|Overall Study||19
10520452|NCT01349192|11672419|FG000|Withdrawals|Overall Study||3
10520453|NCT01349192|11672420|FG001|Withdrawals|Overall Study||6
10520454|NCT01349192|11672419|FG000|COMPLETED|Overall Study||21
10711784|NCT02662582|11877244|FG000|NOT COMPLETED|Washout Period (14 Days)||0
10711785|NCT02662582|11877245|FG001|NOT COMPLETED|Washout Period (14 Days)||0
10711786|NCT02662582|11877244|FG000|STARTED|Treatment Period 2 (14 Days)||18
10711787|NCT02662582|11877245|FG001|STARTED|Treatment Period 2 (14 Days)||19
10711788|NCT02662582|11877244|FG000|COMPLETED|Treatment Period 2 (14 Days)||18
10711789|NCT02662582|11877245|FG001|COMPLETED|Treatment Period 2 (14 Days)||19
10520455|NCT01349192|11672420|FG001|COMPLETED|Overall Study||17
10520456|NCT01349192|11672419|FG000|NOT COMPLETED|Overall Study||3
10520457|NCT01349192|11672420|FG001|NOT COMPLETED|Overall Study||6
10520458|NCT01349231|11672428|FG000|STARTED|Overall Study||10
10520459|NCT01349231|11672428|FG000|COMPLETED|Overall Study||10
10520460|NCT01349231|11672428|FG000|NOT COMPLETED|Overall Study||0
10520461|NCT01349465|11672434|FG000|STARTED|Overall Study||200
10520462|NCT01349465|11672435|FG001|STARTED|Overall Study||49
10520463|NCT01349465|11672434|FG000|COMPLETED|Overall Study||182
10520464|NCT01349465|11672435|FG001|COMPLETED|Overall Study||27
10520465|NCT01349465|11672434|FG000|NOT COMPLETED|Overall Study||18
10520466|NCT01349465|11672435|FG001|NOT COMPLETED|Overall Study||22
10520467|NCT01349491|11672445|FG000|STARTED|Overall Study||5
10520468|NCT01349491|11672446|FG001|STARTED|Overall Study||5
10520469|NCT01349491|11672445|FG000|COMPLETED|Overall Study||5
10520470|NCT01349491|11672446|FG001|COMPLETED|Overall Study||5
10520471|NCT01349491|11672445|FG000|NOT COMPLETED|Overall Study||0
10520472|NCT01349491|11672446|FG001|NOT COMPLETED|Overall Study||0
10520473|NCT01349569|11672452|FG000|STARTED|Overall Study||16
10520474|NCT01349569|11672452|FG000|COMPLETED|Overall Study||12
10711790|NCT02662582|11877244|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||0
10711791|NCT02662582|11877245|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||0
10711792|NCT02662608|11877252|FG000|STARTED|Overall Study||1
10711793|NCT02662608|11877252|FG000|COMPLETED|Overall Study||1
10520475|NCT01349569|11672452|FG000|NOT COMPLETED|Overall Study||4
10520476|NCT01349660|11672462|FG000|STARTED|Overall Study||6
10520477|NCT01349660|11672463|FG001|STARTED|Overall Study||6
10520478|NCT01349660|11672464|FG002|STARTED|Overall Study||76
10520479|NCT01349660|11672462|FG000|COMPLETED|Overall Study||0
10520480|NCT01349660|11672463|FG001|COMPLETED|Overall Study||0
10520481|NCT01349660|11672464|FG002|COMPLETED|Overall Study||0
10520482|NCT01349660|11672462|FG000|NOT COMPLETED|Overall Study||6
10520483|NCT01349660|11672463|FG001|NOT COMPLETED|Overall Study||6
10520484|NCT01349660|11672464|FG002|NOT COMPLETED|Overall Study||76
10520485|NCT01349673|11672479|FG000|STARTED|Overall Study||114
10520486|NCT01349673|11672479|FG000|Participants Entered Cycle 1|Overall Study||114
10520487|NCT01349673|11672479|FG000|Participants Entered Cycle 2|Overall Study||65
10520488|NCT01349673|11672479|FG000|Participants Entered Cycle 3|Overall Study||41
10520489|NCT01349673|11672479|FG000|Participants Entered Cycle 4|Overall Study||22
10520490|NCT01349673|11672479|FG000|Participants Entered Cycle 5|Overall Study||12
10520491|NCT01349673|11672479|FG000|Participants Entered Cycle 6|Overall Study||5
10520492|NCT01349673|11672479|FG000|Participants Entered Cycle 7|Overall Study||3
10520493|NCT01349673|11672479|FG000|Participants Entered Cycle 8|Overall Study||1
10520494|NCT01349673|11672479|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||114
10520495|NCT01349673|11672479|FG000|COMPLETED|Overall Study||0
10520496|NCT01349673|11672479|FG000|NOT COMPLETED|Overall Study||114
10520497|NCT01349790|11672483|FG000|STARTED|Overall Study||40
10520498|NCT01349790|11672483|FG000|COMPLETED|Overall Study||31
10520499|NCT01349790|11672483|FG000|NOT COMPLETED|Overall Study||9
10520500|NCT01349803|11672491|FG000|STARTED|Overall Study||60
10520501|NCT01349803|11672492|FG001|STARTED|Overall Study||58
10520502|NCT01349803|11672493|FG002|STARTED|Overall Study||60
10520503|NCT01349803|11672494|FG003|STARTED|Overall Study||59
10520504|NCT01349803|11672491|FG000|COMPLETED|Overall Study||59
10520505|NCT01349803|11672492|FG001|COMPLETED|Overall Study||57
10520506|NCT01349803|11672493|FG002|COMPLETED|Overall Study||57
10520507|NCT01349803|11672494|FG003|COMPLETED|Overall Study||57
10520508|NCT01349803|11672491|FG000|NOT COMPLETED|Overall Study||1
10520509|NCT01349803|11672492|FG001|NOT COMPLETED|Overall Study||1
10520510|NCT01349803|11672493|FG002|NOT COMPLETED|Overall Study||3
10520511|NCT01349803|11672494|FG003|NOT COMPLETED|Overall Study||2
10520512|NCT01349816|11672512|FG000|STARTED|Overall Study||185
10520513|NCT01349816|11672512|FG000|GP MDI 36 µg|Overall Study||61
10520514|NCT01349816|11672512|FG000|GFF MDI 36/7.2 µg|Overall Study||58
10520515|NCT01349816|11672512|FG000|GFF MDI 36/9.6 µg|Overall Study||56
10520516|NCT01349816|11672512|FG000|GFF MDI 18/9.6 µg|Overall Study||57
10520517|NCT01349816|11672512|FG000|GFF MDI 9/9.6 µg|Overall Study||57
10520518|NCT01349816|11672512|FG000|FF MDI 9.6 µg|Overall Study||61
10520519|NCT01349816|11672512|FG000|COMPLETED|Overall Study||155
10520520|NCT01349816|11672512|FG000|NOT COMPLETED|Overall Study||30
10520521|NCT01349829|11672528|FG000|STARTED|Overall Study||126
10520524|NCT01349829|11672529|FG001|COMPLETED|Overall Study||102
10520525|NCT01349829|11672528|FG000|NOT COMPLETED|Overall Study||9
10520526|NCT01349829|11672529|FG001|NOT COMPLETED|Overall Study||23
10520527|NCT01349920|11672537|FG000|STARTED|Overall Study||15
10520528|NCT01349920|11672537|FG000|COMPLETED|Overall Study||15
10520529|NCT01349920|11672537|FG000|NOT COMPLETED|Overall Study||0
10520530|NCT01349933|11672543|FG000|STARTED|Overall Study||21
10520531|NCT01349933|11672543|FG000|COMPLETED|Overall Study||21
10520532|NCT01349933|11672543|FG000|NOT COMPLETED|Overall Study||0
10520533|NCT01349972|11672549|FG000|STARTED|Overall Study||114
10520534|NCT01349972|11672550|FG001|STARTED|Overall Study||58
10520535|NCT01349972|11672549|FG000|COMPLETED|Overall Study||109
10520536|NCT01349972|11672550|FG001|COMPLETED|Overall Study||56
10520537|NCT01349972|11672549|FG000|NOT COMPLETED|Overall Study||5
10520538|NCT01349972|11672550|FG001|NOT COMPLETED|Overall Study||2
10520539|NCT01350102|11672560|FG000|STARTED|Overall Study||0
10520540|NCT01350102|11672561|FG001|STARTED|Overall Study||1
10520541|NCT01350102|11672562|FG002|STARTED|Overall Study||1
10520542|NCT01350102|11672563|FG003|STARTED|Overall Study||0
10520543|NCT01350102|11672560|FG000|COMPLETED|Overall Study||0
10520544|NCT01350102|11672561|FG001|COMPLETED|Overall Study||1
10520545|NCT01350102|11672562|FG002|COMPLETED|Overall Study||0
10520546|NCT01350102|11672563|FG003|COMPLETED|Overall Study||0
10711794|NCT02662608|11877252|FG000|NOT COMPLETED|Overall Study||0
10711795|NCT02662764|11877256|FG000|STARTED|Overall Study||320
10711796|NCT02662764|11877256|FG000|COMPLETED|Overall Study|First 24-hours of study treatment|290
10711797|NCT02662764|11877256|FG000|NOT COMPLETED|Overall Study||30
10520547|NCT01350102|11672560|FG000|NOT COMPLETED|Overall Study||0
10520548|NCT01350102|11672561|FG001|NOT COMPLETED|Overall Study||0
10520549|NCT01350102|11672562|FG002|NOT COMPLETED|Overall Study||1
10520550|NCT01350102|11672563|FG003|NOT COMPLETED|Overall Study||0
10520551|NCT01350115|11672575|FG000|STARTED|Core Study (All Patients)||8
10520552|NCT01350115|11672576|FG001|STARTED|Core Study (All Patients)||2
10520553|NCT01350115|11672575|FG000|Safety Anlysis Set|Core Study (All Patients)||8
10520554|NCT01350115|11672576|FG001|Safety Anlysis Set|Core Study (All Patients)||2
10520555|NCT01350115|11672575|FG000|Pharmacodynamic Set|Core Study (All Patients)||7
10520556|NCT01350115|11672576|FG001|Pharmacodynamic Set|Core Study (All Patients)||2
10520557|NCT01350115|11672575|FG000|COMPLETED|Core Study (All Patients)||8
10520558|NCT01350115|11672576|FG001|COMPLETED|Core Study (All Patients)||2
10520559|NCT01350115|11672575|FG000|NOT COMPLETED|Core Study (All Patients)||0
10520560|NCT01350115|11672576|FG001|NOT COMPLETED|Core Study (All Patients)||0
10520561|NCT01350115|11672575|FG000|STARTED|Long Term Follow-Up (All Patients)||8
10520562|NCT01350115|11672576|FG001|STARTED|Long Term Follow-Up (All Patients)||2
10520563|NCT01350115|11672575|FG000|COMPLETED|Long Term Follow-Up (All Patients)||7
10520564|NCT01350115|11672576|FG001|COMPLETED|Long Term Follow-Up (All Patients)||0
10520565|NCT01350115|11672575|FG000|NOT COMPLETED|Long Term Follow-Up (All Patients)||1
10520566|NCT01350115|11672576|FG001|NOT COMPLETED|Long Term Follow-Up (All Patients)||2
10520567|NCT01350128|11672584|FG000|STARTED|Overall Study||103
10520568|NCT01350128|11672584|FG000|GP MDI 36 µg BID|Overall Study|Glycopyrronium Metered Dose Inhaler|49
10520569|NCT01350128|11672584|FG000|GP MDI 18 µg BID|Overall Study||49
10520570|NCT01350128|11672584|FG000|GP MDI 9 µg BID|Overall Study||49
10711798|NCT02663128|11877267|FG000|STARTED|Period 1||3
10711799|NCT02663128|11877268|FG001|STARTED|Period 1||3
10711800|NCT02663128|11877269|FG002|STARTED|Period 1||3
10520571|NCT01350128|11672584|FG000|GP MDI 4.6 µg BID|Overall Study||45
10520572|NCT01350128|11672584|FG000|Placebo MDI BID|Overall Study||48
10520573|NCT01350128|11672584|FG000|Atrovent HFA 34 µg BID|Overall Study||48
10520574|NCT01350128|11672584|FG000|COMPLETED|Overall Study||89
10520575|NCT01350128|11672584|FG000|NOT COMPLETED|Overall Study||14
10520576|NCT01350141|11672601|FG000|STARTED|Overall Study||15
10520577|NCT01350141|11672602|FG001|STARTED|Overall Study||15
10520578|NCT01350141|11672603|FG002|STARTED|Overall Study||16
10520579|NCT01350141|11672601|FG000|Treated|Overall Study||14
10520580|NCT01350141|11672602|FG001|Treated|Overall Study||15
10520581|NCT01350141|11672603|FG002|Treated|Overall Study||16
10520582|NCT01350141|11672601|FG000|COMPLETED|Overall Study||12
10520583|NCT01350141|11672602|FG001|COMPLETED|Overall Study||15
10520584|NCT01350141|11672603|FG002|COMPLETED|Overall Study||15
10520585|NCT01350141|11672601|FG000|NOT COMPLETED|Overall Study||3
10520586|NCT01350141|11672602|FG001|NOT COMPLETED|Overall Study||0
10520587|NCT01350141|11672603|FG002|NOT COMPLETED|Overall Study||1
10520588|NCT01350245|11672613|FG000|STARTED|Overall Study||28
10520589|NCT01350245|11672613|FG000|COMPLETED|Overall Study||28
10520590|NCT01350245|11672613|FG000|NOT COMPLETED|Overall Study||0
10520591|NCT01350271|11672620|FG000|STARTED|Overall Study||70
10520592|NCT01350271|11672621|FG001|STARTED|Overall Study||70
10520593|NCT01350271|11672622|FG002|STARTED|Overall Study||74
10520594|NCT01350271|11672620|FG000|COMPLETED|Overall Study||49
10520595|NCT01350271|11672621|FG001|COMPLETED|Overall Study||53
10520596|NCT01350271|11672622|FG002|COMPLETED|Overall Study||48
10520597|NCT01350271|11672620|FG000|NOT COMPLETED|Overall Study||21
10520598|NCT01350271|11672621|FG001|NOT COMPLETED|Overall Study||17
10520599|NCT01350271|11672622|FG002|NOT COMPLETED|Overall Study||26
10520600|NCT01350336|11672633|FG000|STARTED|Overall Study||284
10520601|NCT01350336|11672633|FG000|COMPLETED|Overall Study||227
10520602|NCT01350336|11672633|FG000|NOT COMPLETED|Overall Study||57
10520603|NCT01350388|11672684|FG000|STARTED|Overall Study||40
10520604|NCT01350388|11672685|FG001|STARTED|Overall Study||40
10520605|NCT01350388|11672684|FG000|COMPLETED|Overall Study||37
10520606|NCT01350388|11672685|FG001|COMPLETED|Overall Study||39
10520607|NCT01350388|11672684|FG000|NOT COMPLETED|Overall Study||3
10520608|NCT01350388|11672685|FG001|NOT COMPLETED|Overall Study||1
10520609|NCT01350401|11672691|FG000|STARTED|Overall Study||4
10520610|NCT01350401|11672691|FG000|COMPLETED|Overall Study||4
10520611|NCT01350401|11672691|FG000|NOT COMPLETED|Overall Study||0
10520612|NCT01350414|11672699|FG000|STARTED|Overall Study||181
10520613|NCT01350414|11672699|FG000|Year 2|Overall Study||165
10520614|NCT01350414|11672699|FG000|Year 3|Overall Study||162
10520615|NCT01350414|11672699|FG000|Year 4|Overall Study||159
10520616|NCT01350414|11672699|FG000|Year 5|Overall Study||162
10520617|NCT01350414|11672699|FG000|COMPLETED|Overall Study||162
10520618|NCT01350414|11672699|FG000|NOT COMPLETED|Overall Study||19
10520619|NCT01350453|11672711|FG000|STARTED|Overall Study||11
10520620|NCT01350453|11672712|FG001|STARTED|Overall Study||8
10520621|NCT01350453|11672711|FG000|COMPLETED|Overall Study||9
10520622|NCT01350453|11672712|FG001|COMPLETED|Overall Study||7
10520623|NCT01350453|11672711|FG000|NOT COMPLETED|Overall Study||2
10520624|NCT01350453|11672712|FG001|NOT COMPLETED|Overall Study||1
10520625|NCT01350479|11672722|FG000|STARTED|Overall Study||94
10520626|NCT01350479|11672723|FG001|STARTED|Overall Study||106
10520627|NCT01350479|11672722|FG000|COMPLETED|Overall Study||94
10520628|NCT01350479|11672723|FG001|COMPLETED|Overall Study||106
10520629|NCT01350479|11672722|FG000|NOT COMPLETED|Overall Study||0
10520630|NCT01350479|11672723|FG001|NOT COMPLETED|Overall Study||0
10520631|NCT01350492|11672731|FG000|STARTED|Intervention||28
10520632|NCT01350492|11672732|FG001|STARTED|Intervention||26
10520633|NCT01350492|11672731|FG000|6-week MRI Scan|Intervention||24
10520634|NCT01350492|11672732|FG001|6-week MRI Scan|Intervention||22
10520635|NCT01350492|11672731|FG000|11-week MRI Scan|Intervention||23
10520636|NCT01350492|11672732|FG001|11-week MRI Scan|Intervention||21
10520637|NCT01350492|11672731|FG000|COMPLETED|Intervention||23
10520638|NCT01350492|11672732|FG001|COMPLETED|Intervention||20
10520639|NCT01350492|11672731|FG000|NOT COMPLETED|Intervention||5
10520640|NCT01350492|11672732|FG001|NOT COMPLETED|Intervention||6
10711801|NCT02663128|11877270|FG003|STARTED|Period 1||3
10711802|NCT02663128|11877271|FG004|STARTED|Period 1||3
10520641|NCT01350492|11672731|FG000|STARTED|Post Intervention Follow-Up||23
10520642|NCT01350492|11672732|FG001|STARTED|Post Intervention Follow-Up||20
10520643|NCT01350492|11672731|FG000|6-month MRI Scan|Post Intervention Follow-Up||20
10520644|NCT01350492|11672732|FG001|6-month MRI Scan|Post Intervention Follow-Up||20
10520645|NCT01350492|11672731|FG000|COMPLETED|Post Intervention Follow-Up||17
10520646|NCT01350492|11672732|FG001|COMPLETED|Post Intervention Follow-Up||18
10520647|NCT01350492|11672731|FG000|NOT COMPLETED|Post Intervention Follow-Up||6
10520648|NCT01350492|11672732|FG001|NOT COMPLETED|Post Intervention Follow-Up||2
10520649|NCT01350505|11672738|FG000|STARTED|Overall Study||21
10520650|NCT01350505|11672738|FG000|COMPLETED|Overall Study||17
10520651|NCT01350505|11672738|FG000|NOT COMPLETED|Overall Study||4
10520652|NCT01350544|11672744|FG000|STARTED|Overall Study||108
10711803|NCT02663128|11877272|FG005|STARTED|Period 1||3
10520653|NCT01350544|11672745|FG001|STARTED|Overall Study||108
10520654|NCT01350544|11672744|FG000|COMPLETED|Overall Study||85
10520655|NCT01350544|11672745|FG001|COMPLETED|Overall Study||86
10520656|NCT01350544|11672744|FG000|NOT COMPLETED|Overall Study||23
10520657|NCT01350544|11672745|FG001|NOT COMPLETED|Overall Study||22
10520658|NCT01350804|11672755|FG000|STARTED|Core Study||138
10520659|NCT01350804|11672756|FG001|STARTED|Core Study||137
10520660|NCT01350804|11672757|FG002|STARTED|Core Study||138
10520661|NCT01350804|11672758|FG003|STARTED|Core Study||138
10520662|NCT01350804|11672755|FG000|Safety Set|Core Study|1 participant actually received placebo; participant was reassigned to placebo for safety analysis.|137
10520663|NCT01350804|11672756|FG001|Safety Set|Core Study|1 participant did not receive treatment; therefore participant was not counted in safety analysis.|136
10520664|NCT01350804|11672757|FG002|Safety Set|Core Study|1 participant actually received placebo; participant was reassigned to placebo for safety analysis.|139
10520665|NCT01350804|11672758|FG003|Safety Set|Core Study|1 participant did not receive treatment; therefore participant was not counted in safety analysis.|137
10520666|NCT01350804|11672755|FG000|Tratment Switch to AIN457 at Week 16|Core Study||0
10520667|NCT01350804|11672756|FG001|Tratment Switch to AIN457 at Week 16|Core Study||0
10520668|NCT01350804|11672757|FG002|Tratment Switch to AIN457 at Week 16|Core Study|15 participantsdiscontinued prior to the treatment switch|78
10520669|NCT01350804|11672758|FG003|Tratment Switch to AIN457 at Week 16|Core Study||0
10520670|NCT01350804|11672755|FG000|Treatment Switch to AIN457 at Week 24|Core Study||0
10520671|NCT01350804|11672756|FG001|Treatment Switch to AIN457 at Week 24|Core Study||0
10520672|NCT01350804|11672757|FG002|Treatment Switch to AIN457 at Week 24|Core Study||45
10520673|NCT01350804|11672758|FG003|Treatment Switch to AIN457 at Week 24|Core Study||37
10520674|NCT01350804|11672755|FG000|Full Analysis Set|Core Study||138
10520675|NCT01350804|11672756|FG001|Full Analysis Set|Core Study||137
10520676|NCT01350804|11672757|FG002|Full Analysis Set|Core Study||138
10520677|NCT01350804|11672758|FG003|Full Analysis Set|Core Study||138
10520678|NCT01350804|11672755|FG000|COMPLETED|Core Study||97
10520679|NCT01350804|11672756|FG001|COMPLETED|Core Study||90
10520680|NCT01350804|11672757|FG002|COMPLETED|Core Study||91
10520681|NCT01350804|11672758|FG003|COMPLETED|Core Study||112
10520682|NCT01350804|11672755|FG000|NOT COMPLETED|Core Study||41
10520683|NCT01350804|11672756|FG001|NOT COMPLETED|Core Study||47
10520684|NCT01350804|11672757|FG002|NOT COMPLETED|Core Study||47
10520685|NCT01350804|11672758|FG003|NOT COMPLETED|Core Study||26
10520686|NCT01350804|11672755|FG000|STARTED|Extension Study, Weeks 52 - 260||80
10520687|NCT01350804|11672756|FG001|STARTED|Extension Study, Weeks 52 - 260||79
10520688|NCT01350804|11672757|FG002|STARTED|Extension Study, Weeks 52 - 260|During the extension, these participants received AIN457.|72
10520689|NCT01350804|11672758|FG003|STARTED|Extension Study, Weeks 52 - 260|During the extension, these participants received AIN457.|23
10520690|NCT01350804|11672755|FG000|COMPLETED|Extension Study, Weeks 52 - 260||0
10520691|NCT01350804|11672756|FG001|COMPLETED|Extension Study, Weeks 52 - 260||0
10520692|NCT01350804|11672757|FG002|COMPLETED|Extension Study, Weeks 52 - 260||0
10520693|NCT01350804|11672758|FG003|COMPLETED|Extension Study, Weeks 52 - 260||0
10520694|NCT01350804|11672755|FG000|NOT COMPLETED|Extension Study, Weeks 52 - 260||80
10520695|NCT01350804|11672756|FG001|NOT COMPLETED|Extension Study, Weeks 52 - 260||79
10520696|NCT01350804|11672757|FG002|NOT COMPLETED|Extension Study, Weeks 52 - 260||72
10520697|NCT01350804|11672758|FG003|NOT COMPLETED|Extension Study, Weeks 52 - 260||23
10520698|NCT01350947|11672778|FG000|STARTED|Overall Study||11
10520699|NCT01350947|11672778|FG000|COMPLETED|Overall Study||11
10520700|NCT01350947|11672778|FG000|NOT COMPLETED|Overall Study||0
10520701|NCT01350973|11672785|FG000|STARTED|Overall Study||206
10520702|NCT01350973|11672786|FG001|STARTED|Overall Study||210
10520703|NCT01350973|11672787|FG002|STARTED|Overall Study||195
10520704|NCT01350973|11672785|FG000|Received Treatment|Overall Study||205
10520705|NCT01350973|11672786|FG001|Received Treatment|Overall Study||210
10520706|NCT01350973|11672787|FG002|Received Treatment|Overall Study||195
10520707|NCT01350973|11672785|FG000|COMPLETED|Overall Study||200
10520708|NCT01350973|11672786|FG001|COMPLETED|Overall Study||202
10520709|NCT01350973|11672787|FG002|COMPLETED|Overall Study||187
10520710|NCT01350973|11672785|FG000|NOT COMPLETED|Overall Study||6
10520711|NCT01350973|11672786|FG001|NOT COMPLETED|Overall Study||8
10520712|NCT01350973|11672787|FG002|NOT COMPLETED|Overall Study||8
10520713|NCT01350999|11672798|FG000|STARTED|Overall Study||165
10520714|NCT01350999|11672799|FG001|STARTED|Overall Study||171
10520715|NCT01350999|11672800|FG002|STARTED|Overall Study||167
10520716|NCT01350999|11672798|FG000|Treated|Overall Study||165
10520717|NCT01350999|11672799|FG001|Treated|Overall Study||171
10520718|NCT01350999|11672800|FG002|Treated|Overall Study||167
10520719|NCT01350999|11672798|FG000|COMPLETED|Overall Study||157
10520720|NCT01350999|11672799|FG001|COMPLETED|Overall Study||157
10520721|NCT01350999|11672800|FG002|COMPLETED|Overall Study||146
10520722|NCT01350999|11672798|FG000|NOT COMPLETED|Overall Study||8
10520723|NCT01350999|11672799|FG001|NOT COMPLETED|Overall Study||14
10520724|NCT01350999|11672800|FG002|NOT COMPLETED|Overall Study||21
10520725|NCT01351025|11672810|FG000|STARTED|Week 0 - 20||46
10520726|NCT01351025|11672811|FG001|STARTED|Week 0 - 20||48
10520727|NCT01351025|11672810|FG000|COMPLETED|Week 0 - 20||43
10520728|NCT01351025|11672811|FG001|COMPLETED|Week 0 - 20||47
10520729|NCT01351025|11672810|FG000|NOT COMPLETED|Week 0 - 20||3
10520730|NCT01351025|11672811|FG001|NOT COMPLETED|Week 0 - 20||1
10520731|NCT01351025|11672810|FG000|STARTED|Week 20 - 24||43
10520732|NCT01351025|11672811|FG001|STARTED|Week 20 - 24||47
10520733|NCT01351025|11672810|FG000|COMPLETED|Week 20 - 24||43
10520734|NCT01351025|11672811|FG001|COMPLETED|Week 20 - 24||47
10520735|NCT01351025|11672810|FG000|NOT COMPLETED|Week 20 - 24||0
10520736|NCT01351025|11672811|FG001|NOT COMPLETED|Week 20 - 24||0
10520737|NCT01351025|11672810|FG000|STARTED|Week 24 - 44||43
10520738|NCT01351025|11672811|FG001|STARTED|Week 24 - 44||47
10520739|NCT01351025|11672810|FG000|COMPLETED|Week 24 - 44||42
10520740|NCT01351025|11672811|FG001|COMPLETED|Week 24 - 44||43
10520741|NCT01351025|11672810|FG000|NOT COMPLETED|Week 24 - 44||1
10520742|NCT01351025|11672811|FG001|NOT COMPLETED|Week 24 - 44||4
10520743|NCT01351025|11672810|FG000|STARTED|Week 44 - 48||42
10520744|NCT01351025|11672811|FG001|STARTED|Week 44 - 48||43
10520745|NCT01351025|11672810|FG000|COMPLETED|Week 44 - 48||42
10520746|NCT01351025|11672811|FG001|COMPLETED|Week 44 - 48||43
10520747|NCT01351025|11672810|FG000|NOT COMPLETED|Week 44 - 48||0
10520748|NCT01351025|11672811|FG001|NOT COMPLETED|Week 44 - 48||0
10520749|NCT01351064|11672825|FG000|STARTED|Overall Study||42
10520750|NCT01351064|11672826|FG001|STARTED|Overall Study||42
10520751|NCT01351064|11672825|FG000|COMPLETED|Overall Study||42
10520752|NCT01351064|11672826|FG001|COMPLETED|Overall Study||42
10520753|NCT01351064|11672825|FG000|NOT COMPLETED|Overall Study||0
10520754|NCT01351064|11672826|FG001|NOT COMPLETED|Overall Study||0
10520755|NCT01351077|11672834|FG000|STARTED|Overall Study||180
10520756|NCT01351077|11672835|FG001|STARTED|Overall Study||180
10520757|NCT01351077|11672834|FG000|COMPLETED|Overall Study||180
10520758|NCT01351077|11672835|FG001|COMPLETED|Overall Study||180
10520759|NCT01351077|11672834|FG000|NOT COMPLETED|Overall Study||0
10520760|NCT01351077|11672835|FG001|NOT COMPLETED|Overall Study||0
10520761|NCT01351090|11672844|FG000|STARTED|Overall Study||43
10520762|NCT01351090|11672845|FG001|STARTED|Overall Study||42
10520763|NCT01351090|11672846|FG002|STARTED|Overall Study||42
10520764|NCT01351090|11672844|FG000|COMPLETED|Overall Study||32
10520765|NCT01351090|11672845|FG001|COMPLETED|Overall Study||31
10520766|NCT01351090|11672846|FG002|COMPLETED|Overall Study||36
10520767|NCT01351090|11672844|FG000|NOT COMPLETED|Overall Study||11
10520768|NCT01351090|11672845|FG001|NOT COMPLETED|Overall Study||11
10520769|NCT01351090|11672846|FG002|NOT COMPLETED|Overall Study||6
10528797|NCT01396525|11681197|FG000|NOT COMPLETED|Overall Study||26
10528798|NCT01396551|11681205|FG000|STARTED|Overall Study||69
10528799|NCT01396551|11681205|FG000|COMPLETED|Overall Study||69
10528800|NCT01396551|11681205|FG000|NOT COMPLETED|Overall Study||0
10528801|NCT01396837|11681209|FG000|STARTED|Overall Study||20
10528802|NCT01396837|11681209|FG000|COMPLETED|Overall Study||16
10528803|NCT01396837|11681209|FG000|NOT COMPLETED|Overall Study||4
10711804|NCT02663128|11877267|FG000|Received at Least One Dose of Study Drug|Period 1||3
10711805|NCT02663128|11877268|FG001|Received at Least One Dose of Study Drug|Period 1||3
10711806|NCT02663128|11877269|FG002|Received at Least One Dose of Study Drug|Period 1||3
10711807|NCT02663128|11877270|FG003|Received at Least One Dose of Study Drug|Period 1||3
10528804|NCT01397071|11681213|FG000|STARTED|Consumption of Beef Patty Alone||11
10528805|NCT01397071|11681213|FG000|COMPLETED|Consumption of Beef Patty Alone||11
10528806|NCT01397071|11681213|FG000|NOT COMPLETED|Consumption of Beef Patty Alone||0
10528807|NCT01397071|11681213|FG000|STARTED|Consumption of Beef Patty With Avocado||11
10528808|NCT01397071|11681213|FG000|COMPLETED|Consumption of Beef Patty With Avocado||11
10528809|NCT01397071|11681213|FG000|NOT COMPLETED|Consumption of Beef Patty With Avocado||0
10528810|NCT01397084|11681221|FG000|STARTED|Overall Study||108
10528811|NCT01397084|11681221|FG000|COMPLETED|Overall Study||100
10528812|NCT01397084|11681221|FG000|NOT COMPLETED|Overall Study||8
10528813|NCT01397253|11681227|FG000|STARTED|Overall Study||443
10528814|NCT01397253|11681228|FG001|STARTED|Overall Study||392
10528815|NCT01397253|11681227|FG000|COMPLETED|Overall Study|Primary analysis, remaining patients included in a sensitivity analysis|317
10528816|NCT01397253|11681228|FG001|COMPLETED|Overall Study|Primary analysis, remaining patients included in a sensitivity analysis|243
10528817|NCT01397253|11681227|FG000|NOT COMPLETED|Overall Study||126
10528818|NCT01397253|11681228|FG001|NOT COMPLETED|Overall Study||149
10528819|NCT01397409|11681244|FG000|STARTED|Stage 1||9
10528820|NCT01397409|11681245|FG001|STARTED|Stage 1||6
10528821|NCT01397409|11681246|FG002|STARTED|Stage 1||6
10528822|NCT01397409|11681247|FG003|STARTED|Stage 1||3
10528823|NCT01397409|11681248|FG004|STARTED|Stage 1||0
10528824|NCT01397409|11681249|FG005|STARTED|Stage 1||0
10528825|NCT01397409|11681250|FG006|STARTED|Stage 1||0
10528826|NCT01397409|11681251|FG007|STARTED|Stage 1||0
10528827|NCT01397409|11681252|FG008|STARTED|Stage 1||0
10528828|NCT01397409|11681253|FG009|STARTED|Stage 1||0
10528829|NCT01397409|11681244|FG000|COMPLETED|Stage 1||9
10528830|NCT01397409|11681245|FG001|COMPLETED|Stage 1||6
10528831|NCT01397409|11681246|FG002|COMPLETED|Stage 1||6
10528832|NCT01397409|11681247|FG003|COMPLETED|Stage 1||3
10528833|NCT01397409|11681248|FG004|COMPLETED|Stage 1||0
10528834|NCT01397409|11681249|FG005|COMPLETED|Stage 1||0
10528835|NCT01397409|11681250|FG006|COMPLETED|Stage 1||0
10528836|NCT01397409|11681251|FG007|COMPLETED|Stage 1||0
10528837|NCT01397409|11681252|FG008|COMPLETED|Stage 1||0
10528838|NCT01397409|11681253|FG009|COMPLETED|Stage 1||0
10528839|NCT01397409|11681244|FG000|NOT COMPLETED|Stage 1||0
10528840|NCT01397409|11681245|FG001|NOT COMPLETED|Stage 1||0
10528841|NCT01397409|11681246|FG002|NOT COMPLETED|Stage 1||0
10528842|NCT01397409|11681247|FG003|NOT COMPLETED|Stage 1||0
10713870|NCT02683083|11879411|FG000|COMPLETED|Overall Study||9
10528843|NCT01397409|11681248|FG004|NOT COMPLETED|Stage 1||0
10528844|NCT01397409|11681249|FG005|NOT COMPLETED|Stage 1||0
10528845|NCT01397409|11681250|FG006|NOT COMPLETED|Stage 1||0
10528846|NCT01397409|11681251|FG007|NOT COMPLETED|Stage 1||0
10528847|NCT01397409|11681252|FG008|NOT COMPLETED|Stage 1||0
10528848|NCT01397409|11681253|FG009|NOT COMPLETED|Stage 1||0
10528849|NCT01397409|11681244|FG000|STARTED|Stage 2||0
10528850|NCT01397409|11681245|FG001|STARTED|Stage 2||0
10528851|NCT01397409|11681246|FG002|STARTED|Stage 2||0
10520770|NCT01351337|11672854|FG000|STARTED|Overall Study||58
10520771|NCT01351337|11672854|FG000|COMPLETED|Overall Study||58
10520772|NCT01351337|11672854|FG000|NOT COMPLETED|Overall Study||0
10520773|NCT01351350|11672864|FG000|STARTED|Overall Study||8
10520774|NCT01351350|11672865|FG001|STARTED|Overall Study||29
10520775|NCT01351350|11672866|FG002|STARTED|Overall Study||11
10520776|NCT01351350|11672867|FG003|STARTED|Overall Study||13
10520777|NCT01351350|11672868|FG004|STARTED|Overall Study||7
10520778|NCT01351350|11672864|FG000|Treated|Overall Study||8
10520779|NCT01351350|11672865|FG001|Treated|Overall Study||29
10520780|NCT01351350|11672866|FG002|Treated|Overall Study||10
10520781|NCT01351350|11672867|FG003|Treated|Overall Study||13
10520782|NCT01351350|11672868|FG004|Treated|Overall Study||7
10520783|NCT01351350|11672864|FG000|Dose-escalation Evaluable|Overall Study||7
10520784|NCT01351350|11672865|FG001|Dose-escalation Evaluable|Overall Study||23
10520785|NCT01351350|11672866|FG002|Dose-escalation Evaluable|Overall Study||10
10520786|NCT01351350|11672867|FG003|Dose-escalation Evaluable|Overall Study||0
10520787|NCT01351350|11672868|FG004|Dose-escalation Evaluable|Overall Study||0
10520788|NCT01351350|11672864|FG000|COMPLETED|Overall Study||0
10520789|NCT01351350|11672865|FG001|COMPLETED|Overall Study||0
10520790|NCT01351350|11672866|FG002|COMPLETED|Overall Study||0
10520791|NCT01351350|11672867|FG003|COMPLETED|Overall Study||0
10520792|NCT01351350|11672868|FG004|COMPLETED|Overall Study||0
10520793|NCT01351350|11672864|FG000|NOT COMPLETED|Overall Study||8
10520794|NCT01351350|11672865|FG001|NOT COMPLETED|Overall Study||29
10520795|NCT01351350|11672866|FG002|NOT COMPLETED|Overall Study||11
10520796|NCT01351350|11672867|FG003|NOT COMPLETED|Overall Study||13
10520797|NCT01351350|11672868|FG004|NOT COMPLETED|Overall Study||7
10520798|NCT01351376|11672895|FG000|STARTED|Overall Study||10
10520799|NCT01351376|11672896|FG001|STARTED|Overall Study||11
10520800|NCT01351376|11672895|FG000|COMPLETED|Overall Study||10
10520801|NCT01351376|11672896|FG001|COMPLETED|Overall Study||11
10520802|NCT01351376|11672895|FG000|NOT COMPLETED|Overall Study||0
10520803|NCT01351376|11672896|FG001|NOT COMPLETED|Overall Study||0
10520804|NCT01351415|11672904|FG000|STARTED|Overall Study||245
10520805|NCT01351415|11672905|FG001|STARTED|Overall Study||240
10520806|NCT01351415|11672904|FG000|Treated Participants|Overall Study||243
10520807|NCT01351415|11672905|FG001|Treated Participants|Overall Study||232
10520808|NCT01351415|11672904|FG000|COMPLETED|Overall Study||0
10520809|NCT01351415|11672905|FG001|COMPLETED|Overall Study||0
10520810|NCT01351415|11672904|FG000|NOT COMPLETED|Overall Study||245
10520811|NCT01351415|11672905|FG001|NOT COMPLETED|Overall Study||240
10520812|NCT01351480|11672911|FG000|STARTED|Overall Study||34
10520813|NCT01351480|11672911|FG000|COMPLETED|Overall Study||26
10520814|NCT01351480|11672911|FG000|NOT COMPLETED|Overall Study||8
10520815|NCT01351506|11672917|FG000|STARTED|Overall Study||602
10520816|NCT01351506|11672917|FG000|COMPLETED|Overall Study||465
10520817|NCT01351506|11672917|FG000|NOT COMPLETED|Overall Study||137
10520818|NCT01351623|11672923|FG000|STARTED|Overall Study||44
10520819|NCT01351623|11672923|FG000|COMPLETED|Overall Study||35
10520820|NCT01351623|11672923|FG000|NOT COMPLETED|Overall Study||9
10520821|NCT01351740|11672929|FG000|STARTED|Overall Study||25
10520822|NCT01351740|11672930|FG001|STARTED|Overall Study||25
10520823|NCT01351740|11672929|FG000|COMPLETED|Overall Study||23
10520824|NCT01351740|11672930|FG001|COMPLETED|Overall Study||19
10520825|NCT01351740|11672929|FG000|NOT COMPLETED|Overall Study||2
10520826|NCT01351740|11672930|FG001|NOT COMPLETED|Overall Study||6
10520827|NCT01351753|11672943|FG000|STARTED|Overall Study||22
10520828|NCT01351753|11672944|FG001|STARTED|Overall Study||20
10520829|NCT01351753|11672945|FG002|STARTED|Overall Study||21
10520830|NCT01351753|11672946|FG003|STARTED|Overall Study||21
10520831|NCT01351753|11672947|FG004|STARTED|Overall Study||21
10520832|NCT01351753|11672948|FG005|STARTED|Overall Study||23
10520833|NCT01351753|11672943|FG000|COMPLETED|Overall Study||15
10520834|NCT01351753|11672944|FG001|COMPLETED|Overall Study||13
10520835|NCT01351753|11672945|FG002|COMPLETED|Overall Study||14
10520836|NCT01351753|11672946|FG003|COMPLETED|Overall Study||21
10520837|NCT01351753|11672947|FG004|COMPLETED|Overall Study||14
10520838|NCT01351753|11672948|FG005|COMPLETED|Overall Study||22
10520839|NCT01351753|11672943|FG000|NOT COMPLETED|Overall Study||7
10520840|NCT01351753|11672944|FG001|NOT COMPLETED|Overall Study||7
10711808|NCT02663128|11877271|FG004|Received at Least One Dose of Study Drug|Period 1||3
10711809|NCT02663128|11877272|FG005|Received at Least One Dose of Study Drug|Period 1||3
10711810|NCT02663128|11877267|FG000|COMPLETED|Period 1||3
10711811|NCT02663128|11877268|FG001|COMPLETED|Period 1||3
10711812|NCT02663128|11877269|FG002|COMPLETED|Period 1||3
10520841|NCT01351753|11672945|FG002|NOT COMPLETED|Overall Study||7
10520842|NCT01351753|11672946|FG003|NOT COMPLETED|Overall Study||0
10520843|NCT01351753|11672947|FG004|NOT COMPLETED|Overall Study||7
10520844|NCT01351753|11672948|FG005|NOT COMPLETED|Overall Study||1
10711813|NCT02663128|11877270|FG003|COMPLETED|Period 1||3
10528852|NCT01397409|11681247|FG003|STARTED|Stage 2||0
10520865|NCT01352117|11672987|FG000|STARTED|Overall Study||96
10520866|NCT01352117|11672988|FG001|STARTED|Overall Study||96
10520867|NCT01352117|11672987|FG000|Entered Step 2 to Initiate Delayed ET|Overall Study||32
10520868|NCT01352117|11672988|FG001|Entered Step 2 to Initiate Delayed ET|Overall Study|Only Arm A participants could enter Step 2 to receive delayed ET.|0
10520869|NCT01352117|11672987|FG000|Study Week 48 Data Potential|Overall Study||80
10520870|NCT01352117|11672988|FG001|Study Week 48 Data Potential|Overall Study||83
10520871|NCT01352117|11672987|FG000|Study Week 96 Data Potential|Overall Study||58
10520872|NCT01352117|11672988|FG001|Study Week 96 Data Potential|Overall Study||61
10520873|NCT01352117|11672987|FG000|COMPLETED|Overall Study||75
10520874|NCT01352117|11672988|FG001|COMPLETED|Overall Study||72
10520875|NCT01352117|11672987|FG000|NOT COMPLETED|Overall Study||21
10520876|NCT01352117|11672988|FG001|NOT COMPLETED|Overall Study||24
10520877|NCT01352182|11672999|FG000|STARTED|Overall Study||8
10520878|NCT01352182|11673000|FG001|STARTED|Overall Study||4
10520879|NCT01352182|11672999|FG000|COMPLETED|Overall Study||8
10520880|NCT01352182|11673000|FG001|COMPLETED|Overall Study||4
10520881|NCT01352182|11672999|FG000|NOT COMPLETED|Overall Study||0
10520882|NCT01352182|11673000|FG001|NOT COMPLETED|Overall Study||0
10520883|NCT01352221|11673010|FG000|STARTED|Double-blind Phase||64
10520884|NCT01352221|11673011|FG001|STARTED|Double-blind Phase||64
10520885|NCT01352221|11673012|FG002|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
10520886|NCT01352221|11673013|FG003|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
10520887|NCT01352221|11673010|FG000|COMPLETED|Double-blind Phase||55
10520888|NCT01352221|11673011|FG001|COMPLETED|Double-blind Phase||53
10520889|NCT01352221|11673012|FG002|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
10520890|NCT01352221|11673013|FG003|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
10520891|NCT01352221|11673010|FG000|NOT COMPLETED|Double-blind Phase||9
10520892|NCT01352221|11673011|FG001|NOT COMPLETED|Double-blind Phase||11
10520893|NCT01352221|11673012|FG002|NOT COMPLETED|Double-blind Phase||0
10520894|NCT01352221|11673013|FG003|NOT COMPLETED|Double-blind Phase||0
10520895|NCT01352221|11673010|FG000|STARTED|Open-label Phase|Not Applicable to open-label phase|0
10520896|NCT01352221|11673011|FG001|STARTED|Open-label Phase|Not Applicable to open-label phase|0
10520897|NCT01352221|11673012|FG002|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|50
10520898|NCT01352221|11673013|FG003|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|47
10520899|NCT01352221|11673010|FG000|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
10520900|NCT01352221|11673011|FG001|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
10520901|NCT01352221|11673012|FG002|COMPLETED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|37
10520902|NCT01352221|11673013|FG003|COMPLETED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|36
10520903|NCT01352221|11673010|FG000|NOT COMPLETED|Open-label Phase||0
10520904|NCT01352221|11673011|FG001|NOT COMPLETED|Open-label Phase||0
10520905|NCT01352221|11673012|FG002|NOT COMPLETED|Open-label Phase||13
10520906|NCT01352221|11673013|FG003|NOT COMPLETED|Open-label Phase||11
10520907|NCT01352286|11673025|FG000|STARTED|Overall Study||25
10520908|NCT01352286|11673025|FG000|Received T-cells|Overall Study||25
10520909|NCT01352286|11673025|FG000|COMPLETED|Overall Study||25
10520910|NCT01352286|11673025|FG000|NOT COMPLETED|Overall Study||0
10520911|NCT01352442|11673030|FG000|STARTED|Overall Study||151
10520912|NCT01352442|11673030|FG000|COMPLETED|Overall Study||139
10520913|NCT01352442|11673030|FG000|NOT COMPLETED|Overall Study||12
10520914|NCT01352468|11673036|FG000|STARTED|Overall Study||22
10520915|NCT01352468|11673037|FG001|STARTED|Overall Study||22
10520916|NCT01352468|11673036|FG000|COMPLETED|Overall Study||17
10520917|NCT01352468|11673037|FG001|COMPLETED|Overall Study||18
10520918|NCT01352468|11673036|FG000|NOT COMPLETED|Overall Study||5
10520919|NCT01352468|11673037|FG001|NOT COMPLETED|Overall Study||4
10520920|NCT01352507|11673045|FG000|STARTED|Treatment Period 1||190
10520921|NCT01352507|11673046|FG001|STARTED|Treatment Period 1||193
10520922|NCT01352507|11673045|FG000|Received Treatment|Treatment Period 1||182
10520923|NCT01352507|11673046|FG001|Received Treatment|Treatment Period 1||188
10520924|NCT01352507|11673045|FG000|COMPLETED|Treatment Period 1||176
10520925|NCT01352507|11673046|FG001|COMPLETED|Treatment Period 1||184
10520926|NCT01352507|11673045|FG000|NOT COMPLETED|Treatment Period 1||14
10520927|NCT01352507|11673046|FG001|NOT COMPLETED|Treatment Period 1||9
10520928|NCT01352507|11673045|FG000|STARTED|Washout Period||176
10520929|NCT01352507|11673046|FG001|STARTED|Washout Period||184
10520930|NCT01352507|11673045|FG000|COMPLETED|Washout Period||176
10520931|NCT01352507|11673046|FG001|COMPLETED|Washout Period||183
10520932|NCT01352507|11673045|FG000|NOT COMPLETED|Washout Period||0
10520933|NCT01352507|11673046|FG001|NOT COMPLETED|Washout Period||1
10520934|NCT01352507|11673045|FG000|STARTED|Treatment Period 2||176
10520935|NCT01352507|11673046|FG001|STARTED|Treatment Period 2||183
10520936|NCT01352507|11673045|FG000|Received Treatment|Treatment Period 2||173
10520937|NCT01352507|11673046|FG001|Received Treatment|Treatment Period 2||181
10520938|NCT01352507|11673045|FG000|COMPLETED|Treatment Period 2|Six participants who completed Treatment Period 2 chose not to enter the Extension Phase.|170
10520939|NCT01352507|11673046|FG001|COMPLETED|Treatment Period 2|Seven participants who completed Treatment Period 2 chose not to enter the Extension Phase.|180
10520940|NCT01352507|11673045|FG000|NOT COMPLETED|Treatment Period 2||6
10520941|NCT01352507|11673046|FG001|NOT COMPLETED|Treatment Period 2||3
10520942|NCT01352507|11673045|FG000|STARTED|Extension Phase||164
10520943|NCT01352507|11673046|FG001|STARTED|Extension Phase||173
10520944|NCT01352507|11673045|FG000|COMPLETED|Extension Phase||164
10520945|NCT01352507|11673046|FG001|COMPLETED|Extension Phase||173
10520946|NCT01352507|11673045|FG000|NOT COMPLETED|Extension Phase||0
10520947|NCT01352507|11673046|FG001|NOT COMPLETED|Extension Phase||0
10520948|NCT01352546|11673058|FG000|STARTED|Overall Study||31
10520949|NCT01352546|11673058|FG000|COMPLETED|Overall Study||31
10520950|NCT01352546|11673058|FG000|NOT COMPLETED|Overall Study||0
10520951|NCT01352585|11673064|FG000|STARTED|Overall Study||23
10520952|NCT01352585|11673065|FG001|STARTED|Overall Study||24
10520953|NCT01352585|11673064|FG000|COMPLETED|Overall Study||15
10520954|NCT01352585|11673065|FG001|COMPLETED|Overall Study||21
10520955|NCT01352585|11673064|FG000|NOT COMPLETED|Overall Study||8
10520956|NCT01352585|11673065|FG001|NOT COMPLETED|Overall Study||3
10520957|NCT01352598|11673072|FG000|STARTED|Overall Study||84
10520958|NCT01352598|11673072|FG000|COMPLETED|Overall Study||72
10520959|NCT01352598|11673072|FG000|NOT COMPLETED|Overall Study||12
10520960|NCT01352637|11673080|FG000|STARTED|Exposure Therapy||97
10520961|NCT01352637|11673081|FG001|STARTED|Exposure Therapy||95
10520962|NCT01352637|11673082|FG002|STARTED|Exposure Therapy||0
10520963|NCT01352637|11673083|FG003|STARTED|Exposure Therapy||0
10520964|NCT01352637|11673080|FG000|COMPLETED|Exposure Therapy||70
10520965|NCT01352637|11673081|FG001|COMPLETED|Exposure Therapy||62
10520966|NCT01352637|11673082|FG002|COMPLETED|Exposure Therapy||0
10520967|NCT01352637|11673083|FG003|COMPLETED|Exposure Therapy||0
10520968|NCT01352637|11673080|FG000|NOT COMPLETED|Exposure Therapy||27
10520969|NCT01352637|11673081|FG001|NOT COMPLETED|Exposure Therapy||33
10520970|NCT01352637|11673082|FG002|NOT COMPLETED|Exposure Therapy||0
10520971|NCT01352637|11673083|FG003|NOT COMPLETED|Exposure Therapy||0
10711814|NCT02663128|11877271|FG004|COMPLETED|Period 1||3
10711815|NCT02663128|11877272|FG005|COMPLETED|Period 1||3
10711816|NCT02663128|11877267|FG000|NOT COMPLETED|Period 1||0
10711817|NCT02663128|11877268|FG001|NOT COMPLETED|Period 1||0
10711818|NCT02663128|11877269|FG002|NOT COMPLETED|Period 1||0
10711819|NCT02663128|11877270|FG003|NOT COMPLETED|Period 1||0
10520972|NCT01352637|11673080|FG000|STARTED|Drug||0
10520973|NCT01352637|11673081|FG001|STARTED|Drug||0
10520974|NCT01352637|11673082|FG002|STARTED|Drug||95
10520975|NCT01352637|11673083|FG003|STARTED|Drug||97
10520976|NCT01352637|11673080|FG000|COMPLETED|Drug||0
10520977|NCT01352637|11673081|FG001|COMPLETED|Drug||0
10520978|NCT01352637|11673082|FG002|COMPLETED|Drug||70
10520979|NCT01352637|11673083|FG003|COMPLETED|Drug||62
10520980|NCT01352637|11673080|FG000|NOT COMPLETED|Drug||0
10711820|NCT02663128|11877271|FG004|NOT COMPLETED|Period 1||0
10711821|NCT02663128|11877272|FG005|NOT COMPLETED|Period 1||0
10711822|NCT02663128|11877267|FG000|STARTED|Period 2||3
10711823|NCT02663128|11877268|FG001|STARTED|Period 2||3
10711824|NCT02663128|11877269|FG002|STARTED|Period 2||3
10711825|NCT02663128|11877270|FG003|STARTED|Period 2||3
10520981|NCT01352637|11673081|FG001|NOT COMPLETED|Drug||0
10520982|NCT01352637|11673082|FG002|NOT COMPLETED|Drug||25
10520983|NCT01352637|11673083|FG003|NOT COMPLETED|Drug||35
10520984|NCT01352715|11673095|FG000|STARTED|Overall Study||260
10520985|NCT01352715|11673096|FG001|STARTED|Overall Study||255
10520986|NCT01352715|11673095|FG000|COMPLETED|Overall Study||215
10520987|NCT01352715|11673096|FG001|COMPLETED|Overall Study||209
10711826|NCT02663128|11877271|FG004|STARTED|Period 2||3
10711827|NCT02663128|11877272|FG005|STARTED|Period 2||3
10520988|NCT01352715|11673095|FG000|NOT COMPLETED|Overall Study||45
10520989|NCT01352715|11673096|FG001|NOT COMPLETED|Overall Study||46
10711828|NCT02663128|11877267|FG000|COMPLETED|Period 2||3
10520990|NCT01352741|11673102|FG000|STARTED|Open-label Tapentadol Titration Period|All participants started with 2 x 50 mg tapentadol PR and titrated upwards in steps of 100 mg/day.|445
10520991|NCT01352741|11673103|FG001|STARTED|Open-label Tapentadol Titration Period||0
10520992|NCT01352741|11673102|FG000|Switched to Open-label Continuation Arm|Open-label Tapentadol Titration Period||59
10520993|NCT01352741|11673103|FG001|Switched to Open-label Continuation Arm|Open-label Tapentadol Titration Period||0
10520994|NCT01352741|11673102|FG000|Full Analysis Set|Open-label Tapentadol Titration Period||436
10711829|NCT02663128|11877268|FG001|COMPLETED|Period 2||3
10520995|NCT01352741|11673103|FG001|Full Analysis Set|Open-label Tapentadol Titration Period||0
10520996|NCT01352741|11673102|FG000|COMPLETED|Open-label Tapentadol Titration Period|59 of 73 participants not completing the titration period entered the open-label continuation arm.|372
10520997|NCT01352741|11673103|FG001|COMPLETED|Open-label Tapentadol Titration Period||0
10520998|NCT01352741|11673102|FG000|NOT COMPLETED|Open-label Tapentadol Titration Period||73
10520999|NCT01352741|11673103|FG001|NOT COMPLETED|Open-label Tapentadol Titration Period||0
10521000|NCT01352741|11673102|FG000|STARTED|Double-blind Comparative Period|Of the 313 participants that qualified for randomization 154 were randomized to tapentadol.|154
10521001|NCT01352741|11673103|FG001|STARTED|Double-blind Comparative Period|159 of the 313 participants that qualified were randomized to tapentadol and pregabalin treatment.|159
10521002|NCT01352741|11673102|FG000|Switched to Open-label Pick-up Arm|Double-blind Comparative Period||19
10521003|NCT01352741|11673103|FG001|Switched to Open-label Pick-up Arm|Double-blind Comparative Period||18
10521004|NCT01352741|11673102|FG000|No Pain Assessments Available|Double-blind Comparative Period||2
10521005|NCT01352741|11673103|FG001|No Pain Assessments Available|Double-blind Comparative Period||2
10521006|NCT01352741|11673102|FG000|Full Analysis Set|Double-blind Comparative Period||152
10521007|NCT01352741|11673103|FG001|Full Analysis Set|Double-blind Comparative Period||157
10521008|NCT01352741|11673102|FG000|Major Protocol Deviations|Double-blind Comparative Period||13
10521009|NCT01352741|11673103|FG001|Major Protocol Deviations|Double-blind Comparative Period||8
10521010|NCT01352741|11673102|FG000|Per Protocol Set|Double-blind Comparative Period||139
10521011|NCT01352741|11673103|FG001|Per Protocol Set|Double-blind Comparative Period||149
10521012|NCT01352741|11673102|FG000|painDetect Per Protocol Set|Double-blind Comparative Period||109
10521013|NCT01352741|11673103|FG001|painDetect Per Protocol Set|Double-blind Comparative Period||127
10521014|NCT01352741|11673102|FG000|SF-12 Per Protocol Set|Double-blind Comparative Period||131
10521015|NCT01352741|11673103|FG001|SF-12 Per Protocol Set|Double-blind Comparative Period||143
10521016|NCT01352741|11673102|FG000|EQ-5D Per Protocol Set|Double-blind Comparative Period||131
10521017|NCT01352741|11673103|FG001|EQ-5D Per Protocol Set|Double-blind Comparative Period||143
10521018|NCT01352741|11673102|FG000|HADS Per Protocol Set (PPS)|Double-blind Comparative Period||123
10521019|NCT01352741|11673103|FG001|HADS Per Protocol Set (PPS)|Double-blind Comparative Period||137
10521020|NCT01352741|11673102|FG000|Sleep Evaluation (Latency) PPS|Double-blind Comparative Period||123
10521021|NCT01352741|11673103|FG001|Sleep Evaluation (Latency) PPS|Double-blind Comparative Period||137
10521022|NCT01352741|11673102|FG000|Sleep Evaluations (Awakenings) PPS|Double-blind Comparative Period||123
10521023|NCT01352741|11673103|FG001|Sleep Evaluations (Awakenings) PPS|Double-blind Comparative Period||137
10521024|NCT01352741|11673102|FG000|Sleep Evaluations (Hours Slept) PPS|Double-blind Comparative Period||123
10521025|NCT01352741|11673103|FG001|Sleep Evaluations (Hours Slept) PPS|Double-blind Comparative Period||137
10521026|NCT01352741|11673102|FG000|COMPLETED|Double-blind Comparative Period||126
10521027|NCT01352741|11673103|FG001|COMPLETED|Double-blind Comparative Period||133
10521028|NCT01352741|11673102|FG000|NOT COMPLETED|Double-blind Comparative Period||28
10521029|NCT01352741|11673103|FG001|NOT COMPLETED|Double-blind Comparative Period||26
10521030|NCT01352741|11673102|FG000|STARTED|Open-Label Tapentadol Continuation Arm|59 of the 73 participants that did not qualify for the comparative period entered this arm.|59
10521031|NCT01352741|11673103|FG001|STARTED|Open-Label Tapentadol Continuation Arm|In this period no tapentadol PR and pregabalin treatment was planned by the protocol.|0
10521032|NCT01352741|11673102|FG000|Major Protocol Deviation|Open-Label Tapentadol Continuation Arm||2
10521033|NCT01352741|11673103|FG001|Major Protocol Deviation|Open-Label Tapentadol Continuation Arm||0
10521034|NCT01352741|11673102|FG000|Full Analysis Set|Open-Label Tapentadol Continuation Arm||57
10521035|NCT01352741|11673103|FG001|Full Analysis Set|Open-Label Tapentadol Continuation Arm||0
10521036|NCT01352741|11673102|FG000|COMPLETED|Open-Label Tapentadol Continuation Arm||51
10521037|NCT01352741|11673103|FG001|COMPLETED|Open-Label Tapentadol Continuation Arm||0
10521038|NCT01352741|11673102|FG000|NOT COMPLETED|Open-Label Tapentadol Continuation Arm||8
10521039|NCT01352741|11673103|FG001|NOT COMPLETED|Open-Label Tapentadol Continuation Arm||0
10521040|NCT01352741|11673102|FG000|STARTED|Open-Label Tapentadol Pick-Up Arm|19 from tapentadol in the comparative phase and 18 from tapentadol & pregabalin entered this arm.|37
10521041|NCT01352741|11673103|FG001|STARTED|Open-Label Tapentadol Pick-Up Arm|Participants did not continue treatment. They were switched to tapentadol PR or discontinued.|0
10521042|NCT01352741|11673102|FG000|COMPLETED|Open-Label Tapentadol Pick-Up Arm||37
10521043|NCT01352741|11673103|FG001|COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
10521044|NCT01352741|11673102|FG000|NOT COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
10521045|NCT01352741|11673103|FG001|NOT COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
10521046|NCT01352793|11673125|FG000|STARTED|Overall Study||3804
10521047|NCT01352793|11673126|FG001|STARTED|Overall Study||1908
10521048|NCT01352793|11673125|FG000|Vaccination 1|Overall Study||3796
10521049|NCT01352793|11673126|FG001|Vaccination 1|Overall Study||1908
10521050|NCT01352793|11673125|FG000|Vaccination 2|Overall Study||3530
10521051|NCT01352793|11673126|FG001|Vaccination 2|Overall Study||1806
10521052|NCT01352793|11673125|FG000|Vaccination 3|Overall Study||3314
10521053|NCT01352793|11673126|FG001|Vaccination 3|Overall Study||1710
10521054|NCT01352793|11673125|FG000|COMPLETED|Overall Study||3219
10521055|NCT01352793|11673126|FG001|COMPLETED|Overall Study||1663
10521056|NCT01352793|11673125|FG000|NOT COMPLETED|Overall Study||585
10521057|NCT01352793|11673126|FG001|NOT COMPLETED|Overall Study||245
10521058|NCT01352845|11673134|FG000|STARTED|Overall Study||2471
10521059|NCT01352845|11673135|FG001|STARTED|Overall Study||822
10521060|NCT01352845|11673134|FG000|COMPLETED|Overall Study||1800
10521061|NCT01352845|11673135|FG001|COMPLETED|Overall Study||619
10521062|NCT01352845|11673134|FG000|NOT COMPLETED|Overall Study||671
10521063|NCT01352845|11673135|FG001|NOT COMPLETED|Overall Study||203
10521064|NCT01353079|11673143|FG000|STARTED|Overall Study||218
10521065|NCT01353079|11673144|FG001|STARTED|Overall Study||211
10521066|NCT01353079|11673143|FG000|COMPLETED|Overall Study||191
10521067|NCT01353079|11673144|FG001|COMPLETED|Overall Study||190
10521068|NCT01353079|11673143|FG000|NOT COMPLETED|Overall Study||27
10521069|NCT01353079|11673144|FG001|NOT COMPLETED|Overall Study||21
10338306|NCT00369486|11475225|FG001|NOT COMPLETED|4-Week Visit||2
10338307|NCT00369486|11475226|FG002|NOT COMPLETED|4-Week Visit||1
10338308|NCT00369486|11475227|FG003|NOT COMPLETED|4-Week Visit||2
10338309|NCT00369486|11475228|FG004|NOT COMPLETED|4-Week Visit||1
10338310|NCT00369486|11475224|FG000|STARTED|8-Week Visit|Number of eyes|38
10521070|NCT01353144|11673154|FG000|STARTED|Overall Study||89
10521071|NCT01353144|11673155|FG001|STARTED|Overall Study||89
10521072|NCT01353144|11673154|FG000|COMPLETED|Overall Study||80
10521073|NCT01353144|11673155|FG001|COMPLETED|Overall Study||81
10521074|NCT01353144|11673154|FG000|NOT COMPLETED|Overall Study||9
10521075|NCT01353144|11673155|FG001|NOT COMPLETED|Overall Study||8
10521076|NCT01353196|11673165|FG000|STARTED|Overall Study||100
10521077|NCT01353196|11673166|FG001|STARTED|Overall Study||70
10521078|NCT01353196|11673165|FG000|COMPLETED|Overall Study||71
10521079|NCT01353196|11673166|FG001|COMPLETED|Overall Study||59
10521080|NCT01353196|11673165|FG000|NOT COMPLETED|Overall Study||29
10521081|NCT01353196|11673166|FG001|NOT COMPLETED|Overall Study||11
10521082|NCT01353222|11673174|FG000|STARTED|Overall Study||70
10521083|NCT01353222|11673175|FG001|STARTED|Overall Study||72
10521084|NCT01353222|11673174|FG000|DN24-02 Arm ≥1 Leukapheresis|Overall Study||67
10521085|NCT01353222|11673175|FG001|DN24-02 Arm ≥1 Leukapheresis|Overall Study||0
10521086|NCT01353222|11673174|FG000|Standard Care Arm ≥1 Post-baseline Visit|Overall Study||0
10521087|NCT01353222|11673175|FG001|Standard Care Arm ≥1 Post-baseline Visit|Overall Study||72
10521088|NCT01353222|11673174|FG000|COMPLETED|Overall Study||0
10521089|NCT01353222|11673175|FG001|COMPLETED|Overall Study||0
10521090|NCT01353222|11673174|FG000|NOT COMPLETED|Overall Study||70
10521091|NCT01353222|11673175|FG001|NOT COMPLETED|Overall Study||72
10521092|NCT01353274|11673181|FG000|STARTED|Overall Study||1157
10521093|NCT01353274|11673181|FG000|COMPLETED|Overall Study||1129
10521094|NCT01353274|11673181|FG000|NOT COMPLETED|Overall Study||28
10521095|NCT01353495|11673187|FG000|STARTED|Overall Study||19
10521096|NCT01353495|11673188|FG001|STARTED|Overall Study||20
10521097|NCT01353495|11673187|FG000|COMPLETED|Overall Study||19
10521098|NCT01353495|11673188|FG001|COMPLETED|Overall Study||20
10521099|NCT01353495|11673187|FG000|NOT COMPLETED|Overall Study||0
10521100|NCT01353495|11673188|FG001|NOT COMPLETED|Overall Study||0
10521101|NCT01353508|11673198|FG000|STARTED|Period 1 - First Intervention (7 Days)||8
10521102|NCT01353508|11673199|FG001|STARTED|Period 1 - First Intervention (7 Days)||8
10521103|NCT01353508|11673200|FG002|STARTED|Period 1 - First Intervention (7 Days)||8
10521104|NCT01353508|11673201|FG003|STARTED|Period 1 - First Intervention (7 Days)||8
10521105|NCT01353508|11673198|FG000|COMPLETED|Period 1 - First Intervention (7 Days)||8
10521106|NCT01353508|11673199|FG001|COMPLETED|Period 1 - First Intervention (7 Days)||8
10521107|NCT01353508|11673200|FG002|COMPLETED|Period 1 - First Intervention (7 Days)||8
10521108|NCT01353508|11673201|FG003|COMPLETED|Period 1 - First Intervention (7 Days)||7
10521109|NCT01353508|11673198|FG000|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
10521110|NCT01353508|11673199|FG001|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
10521111|NCT01353508|11673200|FG002|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
10521112|NCT01353508|11673201|FG003|NOT COMPLETED|Period 1 - First Intervention (7 Days)||1
10521113|NCT01353508|11673198|FG000|STARTED|Period 2 - Second Intervention (7 Days)||8
10521114|NCT01353508|11673199|FG001|STARTED|Period 2 - Second Intervention (7 Days)||8
10521115|NCT01353508|11673200|FG002|STARTED|Period 2 - Second Intervention (7 Days)||8
10521116|NCT01353508|11673201|FG003|STARTED|Period 2 - Second Intervention (7 Days)||7
10521117|NCT01353508|11673198|FG000|COMPLETED|Period 2 - Second Intervention (7 Days)||7
10521118|NCT01353508|11673199|FG001|COMPLETED|Period 2 - Second Intervention (7 Days)||8
10521119|NCT01353508|11673200|FG002|COMPLETED|Period 2 - Second Intervention (7 Days)||8
10521120|NCT01353508|11673201|FG003|COMPLETED|Period 2 - Second Intervention (7 Days)||7
10521121|NCT01353508|11673198|FG000|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||1
10521122|NCT01353508|11673199|FG001|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
10521123|NCT01353508|11673200|FG002|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
10521124|NCT01353508|11673201|FG003|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
10521125|NCT01353586|11673213|FG000|STARTED|Overall Study||167
10521126|NCT01353586|11673214|FG001|STARTED|Overall Study||19
10521127|NCT01353586|11673213|FG000|Participated in Workflow Phase|Overall Study||20
10521128|NCT01353586|11673214|FG001|Participated in Workflow Phase|Overall Study||0
10521129|NCT01353586|11673213|FG000|Participated in Roll-in Phase|Overall Study||22
10521130|NCT01353586|11673214|FG001|Participated in Roll-in Phase|Overall Study||0
10521131|NCT01353586|11673213|FG000|Participated in SNA Substudy|Overall Study||19
10521132|NCT01353586|11673214|FG001|Participated in SNA Substudy|Overall Study||19
10521133|NCT01353586|11673213|FG000|COMPLETED|Overall Study||160
10521134|NCT01353586|11673214|FG001|COMPLETED|Overall Study||17
10521135|NCT01353586|11673213|FG000|NOT COMPLETED|Overall Study||7
10521136|NCT01353586|11673214|FG001|NOT COMPLETED|Overall Study||2
10521137|NCT01353664|11673223|FG000|STARTED|Overall Study|Participants who received at least 1 dose of study drug.|19
10521138|NCT01353664|11673223|FG000|COMPLETED|Overall Study|Completed = Number of participants who continued on Romidepsin treatment|0
10521139|NCT01353664|11673223|FG000|NOT COMPLETED|Overall Study||19
10521140|NCT01353703|11673229|FG000|STARTED|Overall Study||112
10521141|NCT01353703|11673230|FG001|STARTED|Overall Study||112
10521142|NCT01353703|11673229|FG000|COMPLETED|Overall Study||111
10521143|NCT01353703|11673230|FG001|COMPLETED|Overall Study||112
10521144|NCT01353703|11673229|FG000|NOT COMPLETED|Overall Study||1
10521145|NCT01353703|11673230|FG001|NOT COMPLETED|Overall Study||0
10521146|NCT01353859|11673238|FG000|STARTED|Overall Study||39
10521147|NCT01353859|11673238|FG000|COMPLETED|Overall Study||35
10521148|NCT01353859|11673238|FG000|NOT COMPLETED|Overall Study||4
10521149|NCT01353898|11673248|FG000|STARTED|Overall Study||2
10521150|NCT01353898|11673249|FG001|STARTED|Overall Study||2
10521151|NCT01353898|11673250|FG002|STARTED|Overall Study||2
10521152|NCT01353898|11673251|FG003|STARTED|Overall Study||2
10521153|NCT01353898|11673252|FG004|STARTED|Overall Study||2
10521154|NCT01353898|11673253|FG005|STARTED|Overall Study||2
10521155|NCT01353898|11673248|FG000|COMPLETED|Overall Study||2
10521156|NCT01353898|11673249|FG001|COMPLETED|Overall Study||2
10521157|NCT01353898|11673250|FG002|COMPLETED|Overall Study||2
10521158|NCT01353898|11673251|FG003|COMPLETED|Overall Study||2
10521159|NCT01353898|11673252|FG004|COMPLETED|Overall Study||2
10521160|NCT01353898|11673253|FG005|COMPLETED|Overall Study||1
10521161|NCT01353898|11673248|FG000|NOT COMPLETED|Overall Study||0
10521162|NCT01353898|11673249|FG001|NOT COMPLETED|Overall Study||0
10521163|NCT01353898|11673250|FG002|NOT COMPLETED|Overall Study||0
10521164|NCT01353898|11673251|FG003|NOT COMPLETED|Overall Study||0
10521165|NCT01353898|11673252|FG004|NOT COMPLETED|Overall Study||0
10521166|NCT01353898|11673253|FG005|NOT COMPLETED|Overall Study||1
10521167|NCT01353911|11673275|FG000|STARTED|Overall Study||36
10521168|NCT01353911|11673276|FG001|STARTED|Overall Study||66
10521169|NCT01353911|11673277|FG002|STARTED|Overall Study||68
10521170|NCT01353911|11673278|FG003|STARTED|Overall Study||24
10521171|NCT01353911|11673279|FG004|STARTED|Overall Study||29
10521172|NCT01353911|11673280|FG005|STARTED|Overall Study||43
10521173|NCT01353911|11673281|FG006|STARTED|Overall Study||36
10521174|NCT01353911|11673282|FG007|STARTED|Overall Study||66
10521175|NCT01353911|11673275|FG000|COMPLETED|Overall Study||28
10521176|NCT01353911|11673276|FG001|COMPLETED|Overall Study||57
10521177|NCT01353911|11673277|FG002|COMPLETED|Overall Study||59
10521178|NCT01353911|11673278|FG003|COMPLETED|Overall Study||22
10521179|NCT01353911|11673279|FG004|COMPLETED|Overall Study||23
10521180|NCT01353911|11673280|FG005|COMPLETED|Overall Study||36
10521181|NCT01353911|11673281|FG006|COMPLETED|Overall Study||30
10521182|NCT01353911|11673282|FG007|COMPLETED|Overall Study||51
10521183|NCT01353911|11673275|FG000|NOT COMPLETED|Overall Study||8
10521184|NCT01353911|11673276|FG001|NOT COMPLETED|Overall Study||9
10521185|NCT01353911|11673277|FG002|NOT COMPLETED|Overall Study||9
10521186|NCT01353911|11673278|FG003|NOT COMPLETED|Overall Study||2
10521187|NCT01353911|11673279|FG004|NOT COMPLETED|Overall Study||6
10521188|NCT01353911|11673280|FG005|NOT COMPLETED|Overall Study||7
10521189|NCT01353911|11673281|FG006|NOT COMPLETED|Overall Study||6
10521190|NCT01353911|11673282|FG007|NOT COMPLETED|Overall Study||15
10521191|NCT01353963|11673300|FG000|STARTED|Overall Study||13
10521192|NCT01353963|11673300|FG000|COMPLETED|Overall Study||11
10521193|NCT01353963|11673300|FG000|NOT COMPLETED|Overall Study||2
10521194|NCT01353976|11673306|FG000|STARTED|Overall Study||130
10521195|NCT01353976|11673307|FG001|STARTED|Overall Study||134
10521196|NCT01353976|11673306|FG000|COMPLETED|Overall Study||82
10521197|NCT01353976|11673307|FG001|COMPLETED|Overall Study||83
10521198|NCT01353976|11673306|FG000|NOT COMPLETED|Overall Study||48
10521199|NCT01353976|11673307|FG001|NOT COMPLETED|Overall Study||51
10521200|NCT01354015|11673315|FG000|STARTED|Overall Study||50
10521201|NCT01354015|11673316|FG001|STARTED|Overall Study||48
10521202|NCT01354015|11673315|FG000|COMPLETED|Overall Study||44
10521203|NCT01354015|11673316|FG001|COMPLETED|Overall Study||43
10521204|NCT01354015|11673315|FG000|NOT COMPLETED|Overall Study||6
10521205|NCT01354015|11673316|FG001|NOT COMPLETED|Overall Study||5
10521206|NCT01354028|11673322|FG000|STARTED|Overall Study||15
10521207|NCT01354028|11673323|FG001|STARTED|Overall Study||15
10521208|NCT01354028|11673322|FG000|COMPLETED|Overall Study||13
10521209|NCT01354028|11673323|FG001|COMPLETED|Overall Study||10
10521210|NCT01354028|11673322|FG000|NOT COMPLETED|Overall Study||2
10521211|NCT01354028|11673323|FG001|NOT COMPLETED|Overall Study||5
10521212|NCT01354106|11673335|FG000|STARTED|Overall Study||26
10521213|NCT01354106|11673335|FG000|COMPLETED|Overall Study||24
10521214|NCT01354106|11673335|FG000|NOT COMPLETED|Overall Study||2
10521215|NCT01354132|11673343|FG000|STARTED|Randomization|1 never took study medication dropped by physician decision (White matter lesion on MRI)|32
10521216|NCT01354132|11673344|FG001|STARTED|Randomization|1 never took study medication due to subject withdrawal|31
10521217|NCT01354132|11673343|FG000|COMPLETED|Randomization||31
10521218|NCT01354132|11673344|FG001|COMPLETED|Randomization||30
10521219|NCT01354132|11673343|FG000|NOT COMPLETED|Randomization||1
10521220|NCT01354132|11673344|FG001|NOT COMPLETED|Randomization||1
10521221|NCT01354132|11673343|FG000|STARTED|Double Blind (Visits 1-7)|9 did not compete 7 study visits|31
10521222|NCT01354132|11673344|FG001|STARTED|Double Blind (Visits 1-7)|11 did not compete 7 study visits|30
10521223|NCT01354132|11673343|FG000|Completed More Than 1 Visit|Double Blind (Visits 1-7)||4
10521224|NCT01354132|11673344|FG001|Completed More Than 1 Visit|Double Blind (Visits 1-7)||5
10521225|NCT01354132|11673343|FG000|Stopped After First Visit|Double Blind (Visits 1-7)||3
10521226|NCT01354132|11673344|FG001|Stopped After First Visit|Double Blind (Visits 1-7)||2
10521227|NCT01354132|11673343|FG000|Didn't Complete at Least 1 Visit|Double Blind (Visits 1-7)||2
10521228|NCT01354132|11673344|FG001|Didn't Complete at Least 1 Visit|Double Blind (Visits 1-7)||4
10521229|NCT01354132|11673343|FG000|COMPLETED|Double Blind (Visits 1-7)||22
10521230|NCT01354132|11673344|FG001|COMPLETED|Double Blind (Visits 1-7)||19
10521231|NCT01354132|11673343|FG000|NOT COMPLETED|Double Blind (Visits 1-7)||9
10521232|NCT01354132|11673344|FG001|NOT COMPLETED|Double Blind (Visits 1-7)||11
10521233|NCT01354132|11673343|FG000|STARTED|1 Month Post Study Medication||22
10521234|NCT01354132|11673344|FG001|STARTED|1 Month Post Study Medication||19
10521235|NCT01354132|11673343|FG000|1 Follow-up Visit (Visit 8)|1 Month Post Study Medication||21
10521236|NCT01354132|11673344|FG001|1 Follow-up Visit (Visit 8)|1 Month Post Study Medication||16
10521237|NCT01354132|11673343|FG000|COMPLETED|1 Month Post Study Medication||21
10521238|NCT01354132|11673344|FG001|COMPLETED|1 Month Post Study Medication||16
10521239|NCT01354132|11673343|FG000|NOT COMPLETED|1 Month Post Study Medication||1
10521240|NCT01354132|11673344|FG001|NOT COMPLETED|1 Month Post Study Medication||3
10521241|NCT01354145|11673355|FG000|STARTED|Overall Study||97
10521242|NCT01354145|11673356|FG001|STARTED|Overall Study||97
10521243|NCT01354145|11673355|FG000|COMPLETED|Overall Study||58
10521244|NCT01354145|11673356|FG001|COMPLETED|Overall Study||63
10521245|NCT01354145|11673355|FG000|NOT COMPLETED|Overall Study||39
10521246|NCT01354145|11673356|FG001|NOT COMPLETED|Overall Study||34
10521247|NCT01354197|11673364|FG000|STARTED|Overall Study||4652
10521248|NCT01354197|11673364|FG000|COMPLETED|Overall Study||4652
10521249|NCT01354197|11673364|FG000|NOT COMPLETED|Overall Study||0
10521250|NCT01354223|11673371|FG000|STARTED|Overall Study||60
10521251|NCT01354223|11673372|FG001|STARTED|Overall Study||30
10521252|NCT01354223|11673371|FG000|COMPLETED|Overall Study||57
10521253|NCT01354223|11673372|FG001|COMPLETED|Overall Study||29
10521254|NCT01354223|11673371|FG000|NOT COMPLETED|Overall Study||3
10521255|NCT01354223|11673372|FG001|NOT COMPLETED|Overall Study||1
10521256|NCT01354314|11673382|FG000|STARTED|Overall Study||12
10521257|NCT01354314|11673383|FG001|STARTED|Overall Study||11
10521258|NCT01354314|11673384|FG002|STARTED|Overall Study||11
10521259|NCT01354314|11673385|FG003|STARTED|Overall Study||11
10521260|NCT01354314|11673382|FG000|Completed (ITT)|Overall Study||11
10521261|NCT01354314|11673383|FG001|Completed (ITT)|Overall Study||11
10521262|NCT01354314|11673384|FG002|Completed (ITT)|Overall Study||9
10521263|NCT01354314|11673385|FG003|Completed (ITT)|Overall Study||10
10521264|NCT01354314|11673382|FG000|COMPLETED|Overall Study||6
10521265|NCT01354314|11673383|FG001|COMPLETED|Overall Study||8
10521266|NCT01354314|11673384|FG002|COMPLETED|Overall Study||3
10521267|NCT01354314|11673385|FG003|COMPLETED|Overall Study||5
10521268|NCT01354314|11673382|FG000|NOT COMPLETED|Overall Study||6
10521269|NCT01354314|11673383|FG001|NOT COMPLETED|Overall Study||3
10521270|NCT01354314|11673384|FG002|NOT COMPLETED|Overall Study||8
10521271|NCT01354314|11673385|FG003|NOT COMPLETED|Overall Study||6
10521296|NCT01354444|11673431|FG000|STARTED|Overall Study||14
10521297|NCT01354444|11673432|FG001|STARTED|Overall Study||15
10521298|NCT01354444|11673431|FG000|COMPLETED|Overall Study||6
10521299|NCT01354444|11673432|FG001|COMPLETED|Overall Study||11
10521300|NCT01354444|11673431|FG000|NOT COMPLETED|Overall Study||8
10521301|NCT01354444|11673432|FG001|NOT COMPLETED|Overall Study||4
10521302|NCT01354496|11673442|FG000|STARTED|Period 1||6
10521303|NCT01354496|11673443|FG001|STARTED|Period 1||6
10521304|NCT01354496|11673444|FG002|STARTED|Period 1||6
10521305|NCT01354496|11673445|FG003|STARTED|Period 1||6
10521306|NCT01354496|11673446|FG004|STARTED|Period 1||5
10521307|NCT01354496|11673447|FG005|STARTED|Period 1||6
10521308|NCT01354496|11673442|FG000|Received at Least 1 Dose of Study Drug|Period 1||6
10521309|NCT01354496|11673443|FG001|Received at Least 1 Dose of Study Drug|Period 1||6
10521310|NCT01354496|11673444|FG002|Received at Least 1 Dose of Study Drug|Period 1||6
10521311|NCT01354496|11673445|FG003|Received at Least 1 Dose of Study Drug|Period 1||6
10521312|NCT01354496|11673446|FG004|Received at Least 1 Dose of Study Drug|Period 1||5
10521313|NCT01354496|11673447|FG005|Received at Least 1 Dose of Study Drug|Period 1||6
10521314|NCT01354496|11673442|FG000|COMPLETED|Period 1||6
10521315|NCT01354496|11673443|FG001|COMPLETED|Period 1||6
10521316|NCT01354496|11673444|FG002|COMPLETED|Period 1||4
10521317|NCT01354496|11673445|FG003|COMPLETED|Period 1||6
10521318|NCT01354496|11673446|FG004|COMPLETED|Period 1||5
10521319|NCT01354496|11673447|FG005|COMPLETED|Period 1||6
10521320|NCT01354496|11673442|FG000|NOT COMPLETED|Period 1||0
10521321|NCT01354496|11673443|FG001|NOT COMPLETED|Period 1||0
10521322|NCT01354496|11673444|FG002|NOT COMPLETED|Period 1||2
10521323|NCT01354496|11673445|FG003|NOT COMPLETED|Period 1||0
10521324|NCT01354496|11673446|FG004|NOT COMPLETED|Period 1||0
10521325|NCT01354496|11673447|FG005|NOT COMPLETED|Period 1||0
10521326|NCT01354496|11673442|FG000|STARTED|Washout (at Least 14 Days)||6
10521327|NCT01354496|11673443|FG001|STARTED|Washout (at Least 14 Days)||6
10521328|NCT01354496|11673444|FG002|STARTED|Washout (at Least 14 Days)||4
10521329|NCT01354496|11673445|FG003|STARTED|Washout (at Least 14 Days)||6
10521330|NCT01354496|11673446|FG004|STARTED|Washout (at Least 14 Days)||5
10521331|NCT01354496|11673447|FG005|STARTED|Washout (at Least 14 Days)||6
10521332|NCT01354496|11673442|FG000|COMPLETED|Washout (at Least 14 Days)||6
10521333|NCT01354496|11673443|FG001|COMPLETED|Washout (at Least 14 Days)||6
10521334|NCT01354496|11673444|FG002|COMPLETED|Washout (at Least 14 Days)||4
10521335|NCT01354496|11673445|FG003|COMPLETED|Washout (at Least 14 Days)||6
10521336|NCT01354496|11673446|FG004|COMPLETED|Washout (at Least 14 Days)||5
10521337|NCT01354496|11673447|FG005|COMPLETED|Washout (at Least 14 Days)||6
10521338|NCT01354496|11673442|FG000|NOT COMPLETED|Washout (at Least 14 Days)||0
10521339|NCT01354496|11673443|FG001|NOT COMPLETED|Washout (at Least 14 Days)||0
10521340|NCT01354496|11673444|FG002|NOT COMPLETED|Washout (at Least 14 Days)||0
10521341|NCT01354496|11673445|FG003|NOT COMPLETED|Washout (at Least 14 Days)||0
10521342|NCT01354496|11673446|FG004|NOT COMPLETED|Washout (at Least 14 Days)||0
10521343|NCT01354496|11673447|FG005|NOT COMPLETED|Washout (at Least 14 Days)||0
10521344|NCT01354496|11673442|FG000|STARTED|Period 2||6
10521345|NCT01354496|11673443|FG001|STARTED|Period 2||6
10521346|NCT01354496|11673444|FG002|STARTED|Period 2||4
10521347|NCT01354496|11673445|FG003|STARTED|Period 2||6
10521348|NCT01354496|11673446|FG004|STARTED|Period 2||5
10521349|NCT01354496|11673447|FG005|STARTED|Period 2||6
10521350|NCT01354496|11673442|FG000|COMPLETED|Period 2||6
10521351|NCT01354496|11673443|FG001|COMPLETED|Period 2||6
10521352|NCT01354496|11673444|FG002|COMPLETED|Period 2||4
10521353|NCT01354496|11673445|FG003|COMPLETED|Period 2||5
10521354|NCT01354496|11673446|FG004|COMPLETED|Period 2||5
10521355|NCT01354496|11673447|FG005|COMPLETED|Period 2||6
10521356|NCT01354496|11673442|FG000|NOT COMPLETED|Period 2||0
10521357|NCT01354496|11673443|FG001|NOT COMPLETED|Period 2||0
10521358|NCT01354496|11673444|FG002|NOT COMPLETED|Period 2||0
10521359|NCT01354496|11673445|FG003|NOT COMPLETED|Period 2||1
10521360|NCT01354496|11673446|FG004|NOT COMPLETED|Period 2||0
10521361|NCT01354496|11673447|FG005|NOT COMPLETED|Period 2||0
10521362|NCT01354496|11673442|FG000|STARTED|Washout (at Least 14 Days)||6
10521363|NCT01354496|11673443|FG001|STARTED|Washout (at Least 14 Days)||6
10521364|NCT01354496|11673444|FG002|STARTED|Washout (at Least 14 Days)||4
10521365|NCT01354496|11673445|FG003|STARTED|Washout (at Least 14 Days)||5
10521366|NCT01354496|11673446|FG004|STARTED|Washout (at Least 14 Days)||5
10521367|NCT01354496|11673447|FG005|STARTED|Washout (at Least 14 Days)||6
10521368|NCT01354496|11673442|FG000|COMPLETED|Washout (at Least 14 Days)||6
10521369|NCT01354496|11673443|FG001|COMPLETED|Washout (at Least 14 Days)||5
10521370|NCT01354496|11673444|FG002|COMPLETED|Washout (at Least 14 Days)||4
10521371|NCT01354496|11673445|FG003|COMPLETED|Washout (at Least 14 Days)||4
10521372|NCT01354496|11673446|FG004|COMPLETED|Washout (at Least 14 Days)||5
10521373|NCT01354496|11673447|FG005|COMPLETED|Washout (at Least 14 Days)||6
10521374|NCT01354496|11673442|FG000|NOT COMPLETED|Washout (at Least 14 Days)||0
10521375|NCT01354496|11673443|FG001|NOT COMPLETED|Washout (at Least 14 Days)||1
10521376|NCT01354496|11673444|FG002|NOT COMPLETED|Washout (at Least 14 Days)||0
10521377|NCT01354496|11673445|FG003|NOT COMPLETED|Washout (at Least 14 Days)||1
10521378|NCT01354496|11673446|FG004|NOT COMPLETED|Washout (at Least 14 Days)||0
10521379|NCT01354496|11673447|FG005|NOT COMPLETED|Washout (at Least 14 Days)||0
10521380|NCT01354496|11673442|FG000|STARTED|Period 3||6
10521381|NCT01354496|11673443|FG001|STARTED|Period 3||5
10521382|NCT01354496|11673444|FG002|STARTED|Period 3||4
10521383|NCT01354496|11673445|FG003|STARTED|Period 3||4
10521384|NCT01354496|11673446|FG004|STARTED|Period 3||5
10521385|NCT01354496|11673447|FG005|STARTED|Period 3||6
10521386|NCT01354496|11673442|FG000|COMPLETED|Period 3||6
10521387|NCT01354496|11673443|FG001|COMPLETED|Period 3||5
10521388|NCT01354496|11673444|FG002|COMPLETED|Period 3||4
10521389|NCT01354496|11673445|FG003|COMPLETED|Period 3||4
10521390|NCT01354496|11673446|FG004|COMPLETED|Period 3||5
10521391|NCT01354496|11673447|FG005|COMPLETED|Period 3||6
10521392|NCT01354496|11673442|FG000|NOT COMPLETED|Period 3||0
10711830|NCT02663128|11877269|FG002|COMPLETED|Period 2||3
10711831|NCT02663128|11877270|FG003|COMPLETED|Period 2||3
10711832|NCT02663128|11877271|FG004|COMPLETED|Period 2||2
10521393|NCT01354496|11673443|FG001|NOT COMPLETED|Period 3||0
10521394|NCT01354496|11673444|FG002|NOT COMPLETED|Period 3||0
10521395|NCT01354496|11673445|FG003|NOT COMPLETED|Period 3||0
10521396|NCT01354496|11673446|FG004|NOT COMPLETED|Period 3||0
10521397|NCT01354496|11673447|FG005|NOT COMPLETED|Period 3||0
10521398|NCT01354652|11673471|FG000|STARTED|Overall Study||3
10521399|NCT01354652|11673472|FG001|STARTED|Overall Study||2
10521400|NCT01354652|11673473|FG002|STARTED|Overall Study||0
10521401|NCT01354652|11673471|FG000|COMPLETED|Overall Study||0
10521402|NCT01354652|11673472|FG001|COMPLETED|Overall Study||0
10521403|NCT01354652|11673473|FG002|COMPLETED|Overall Study||0
10521404|NCT01354652|11673471|FG000|NOT COMPLETED|Overall Study||3
10521405|NCT01354652|11673472|FG001|NOT COMPLETED|Overall Study||2
10521406|NCT01354652|11673473|FG002|NOT COMPLETED|Overall Study||0
10521407|NCT01354691|11673484|FG000|STARTED|Overall Study||101
10521408|NCT01354691|11673485|FG001|STARTED|Overall Study||99
10521409|NCT01354691|11673484|FG000|ITT|Overall Study||99
10521410|NCT01354691|11673485|FG001|ITT|Overall Study||96
10521411|NCT01354691|11673484|FG000|PP|Overall Study||79
10521412|NCT01354691|11673485|FG001|PP|Overall Study||75
10521413|NCT01354691|11673484|FG000|COMPLETED|Overall Study||80
10521414|NCT01354691|11673485|FG001|COMPLETED|Overall Study||77
10521415|NCT01354691|11673484|FG000|NOT COMPLETED|Overall Study||21
10521416|NCT01354691|11673485|FG001|NOT COMPLETED|Overall Study||22
10521417|NCT01354899|11673491|FG000|STARTED|Overall Study||24
10521418|NCT01354899|11673491|FG000|COMPLETED|Overall Study||21
10521419|NCT01354899|11673491|FG000|NOT COMPLETED|Overall Study||3
10521420|NCT01354938|11673495|FG000|STARTED|Overall Study||220
10521421|NCT01354938|11673495|FG000|COMPLETED|Overall Study||219
10711833|NCT02663128|11877272|FG005|COMPLETED|Period 2||3
10521422|NCT01354938|11673495|FG000|NOT COMPLETED|Overall Study||1
10521423|NCT01354964|11673501|FG000|STARTED|Overall Study||11
10521424|NCT01354964|11673502|FG001|STARTED|Overall Study||8
10521425|NCT01354964|11673501|FG000|COMPLETED|Overall Study||7
10521426|NCT01354964|11673502|FG001|COMPLETED|Overall Study||7
10521427|NCT01354964|11673501|FG000|NOT COMPLETED|Overall Study||4
10521428|NCT01354964|11673502|FG001|NOT COMPLETED|Overall Study||1
10521429|NCT01354990|11673510|FG000|STARTED|Overall Study||2974
10521430|NCT01354990|11673510|FG000|COMPLETED|Overall Study||2974
10521431|NCT01354990|11673510|FG000|NOT COMPLETED|Overall Study||0
10521432|NCT01355068|11673514|FG000|STARTED|First Intervention Period||13
10521433|NCT01355068|11673515|FG001|STARTED|First Intervention Period||13
10521434|NCT01355068|11673514|FG000|COMPLETED|First Intervention Period||13
10521435|NCT01355068|11673515|FG001|COMPLETED|First Intervention Period||11
10521436|NCT01355068|11673514|FG000|NOT COMPLETED|First Intervention Period||0
10521437|NCT01355068|11673515|FG001|NOT COMPLETED|First Intervention Period||2
10521438|NCT01355068|11673514|FG000|STARTED|Washout Period (at Least 7 Days)||13
10521439|NCT01355068|11673515|FG001|STARTED|Washout Period (at Least 7 Days)||11
10521440|NCT01355068|11673514|FG000|COMPLETED|Washout Period (at Least 7 Days)||13
10521441|NCT01355068|11673515|FG001|COMPLETED|Washout Period (at Least 7 Days)||11
10521442|NCT01355068|11673514|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
10521443|NCT01355068|11673515|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
10521444|NCT01355068|11673514|FG000|STARTED|Second Intervention Period||13
10521445|NCT01355068|11673515|FG001|STARTED|Second Intervention Period||11
10521446|NCT01355068|11673514|FG000|COMPLETED|Second Intervention Period||13
10521447|NCT01355068|11673515|FG001|COMPLETED|Second Intervention Period||11
10521448|NCT01355068|11673514|FG000|NOT COMPLETED|Second Intervention Period||0
10521449|NCT01355068|11673515|FG001|NOT COMPLETED|Second Intervention Period||0
10521450|NCT01355081|11673524|FG000|STARTED|Overall Study||119
10521451|NCT01355081|11673525|FG001|STARTED|Overall Study||123
10521452|NCT01355081|11673526|FG002|STARTED|Overall Study||124
10521453|NCT01355081|11673524|FG000|COMPLETED|Overall Study||112
10521454|NCT01355081|11673525|FG001|COMPLETED|Overall Study||113
10521455|NCT01355081|11673526|FG002|COMPLETED|Overall Study||113
10521456|NCT01355081|11673524|FG000|NOT COMPLETED|Overall Study||7
10521457|NCT01355081|11673525|FG001|NOT COMPLETED|Overall Study||10
10521458|NCT01355081|11673526|FG002|NOT COMPLETED|Overall Study||11
10521459|NCT01355159|11673536|FG000|STARTED|Overall Study||1228
10521460|NCT01355159|11673537|FG001|STARTED|Overall Study||1236
10521461|NCT01355159|11673536|FG000|COMPLETED|Overall Study||1144
10521462|NCT01355159|11673537|FG001|COMPLETED|Overall Study||1157
10521463|NCT01355159|11673536|FG000|NOT COMPLETED|Overall Study||84
10521464|NCT01355159|11673537|FG001|NOT COMPLETED|Overall Study||79
10521465|NCT01355224|11673547|FG000|STARTED|Overall Study||198
10521466|NCT01355224|11673548|FG001|STARTED|Overall Study||203
10521467|NCT01355224|11673549|FG002|STARTED|Overall Study||196
10521468|NCT01355224|11673550|FG003|STARTED|Overall Study||201
10521469|NCT01355224|11673547|FG000|Competed Baseline|Overall Study||191
10521470|NCT01355224|11673548|FG001|Competed Baseline|Overall Study||200
10711834|NCT02663128|11877267|FG000|NOT COMPLETED|Period 2||0
10711835|NCT02663128|11877268|FG001|NOT COMPLETED|Period 2||0
10711836|NCT02663128|11877269|FG002|NOT COMPLETED|Period 2||0
10521471|NCT01355224|11673549|FG002|Competed Baseline|Overall Study||193
10521472|NCT01355224|11673550|FG003|Competed Baseline|Overall Study||193
10521473|NCT01355224|11673547|FG000|COMPLETED|Overall Study||167
10521474|NCT01355224|11673548|FG001|COMPLETED|Overall Study||180
10521475|NCT01355224|11673549|FG002|COMPLETED|Overall Study||177
10521476|NCT01355224|11673550|FG003|COMPLETED|Overall Study||172
10711837|NCT02663128|11877270|FG003|NOT COMPLETED|Period 2||0
10521477|NCT01355224|11673547|FG000|NOT COMPLETED|Overall Study||31
10521478|NCT01355224|11673548|FG001|NOT COMPLETED|Overall Study||23
10521479|NCT01355224|11673549|FG002|NOT COMPLETED|Overall Study||19
10521480|NCT01355224|11673550|FG003|NOT COMPLETED|Overall Study||29
10521481|NCT01355289|11673572|FG000|STARTED|Core Study||17
10521482|NCT01355289|11673573|FG001|STARTED|Core Study||16
10521483|NCT01355289|11673574|FG002|STARTED|Core Study||18
10521484|NCT01355289|11673575|FG003|STARTED|Core Study||14
10521485|NCT01355289|11673576|FG004|STARTED|Core Study||0
10521486|NCT01355289|11673572|FG000|COMPLETED|Core Study||16
10521487|NCT01355289|11673573|FG001|COMPLETED|Core Study||16
10521488|NCT01355289|11673574|FG002|COMPLETED|Core Study||18
10521489|NCT01355289|11673575|FG003|COMPLETED|Core Study||12
10521490|NCT01355289|11673576|FG004|COMPLETED|Core Study||0
10521491|NCT01355289|11673572|FG000|NOT COMPLETED|Core Study||1
10521492|NCT01355289|11673573|FG001|NOT COMPLETED|Core Study||0
10521493|NCT01355289|11673574|FG002|NOT COMPLETED|Core Study||0
10521494|NCT01355289|11673575|FG003|NOT COMPLETED|Core Study||2
10521495|NCT01355289|11673576|FG004|NOT COMPLETED|Core Study||0
10521496|NCT01355289|11673572|FG000|STARTED|Open Label Extension||0
10521497|NCT01355289|11673573|FG001|STARTED|Open Label Extension||0
10521498|NCT01355289|11673574|FG002|STARTED|Open Label Extension||0
10521499|NCT01355289|11673575|FG003|STARTED|Open Label Extension||0
10521500|NCT01355289|11673576|FG004|STARTED|Open Label Extension||62
10521501|NCT01355289|11673572|FG000|COMPLETED|Open Label Extension||0
10521502|NCT01355289|11673573|FG001|COMPLETED|Open Label Extension||0
10521503|NCT01355289|11673574|FG002|COMPLETED|Open Label Extension||0
10521504|NCT01355289|11673575|FG003|COMPLETED|Open Label Extension||0
10521505|NCT01355289|11673576|FG004|COMPLETED|Open Label Extension||28
10521506|NCT01355289|11673572|FG000|NOT COMPLETED|Open Label Extension||0
10521507|NCT01355289|11673573|FG001|NOT COMPLETED|Open Label Extension||0
10521508|NCT01355289|11673574|FG002|NOT COMPLETED|Open Label Extension||0
10521509|NCT01355289|11673575|FG003|NOT COMPLETED|Open Label Extension||0
10521510|NCT01355289|11673576|FG004|NOT COMPLETED|Open Label Extension||34
10521511|NCT01355302|11673589|FG000|STARTED|Phase 1b|Replaced 1 subject; who discontinued study drug in first cycle|7
10521512|NCT01355302|11673590|FG001|STARTED|Phase 1b||0
10521513|NCT01355302|11673591|FG002|STARTED|Phase 1b||0
10521514|NCT01355302|11673589|FG000|COMPLETED|Phase 1b|The subject who completed 6 cycles was withdrawn by sponsor request.|1
10521515|NCT01355302|11673590|FG001|COMPLETED|Phase 1b||0
10521516|NCT01355302|11673591|FG002|COMPLETED|Phase 1b||0
10521517|NCT01355302|11673589|FG000|NOT COMPLETED|Phase 1b||6
10521518|NCT01355302|11673590|FG001|NOT COMPLETED|Phase 1b||0
10521519|NCT01355302|11673591|FG002|NOT COMPLETED|Phase 1b||0
10521520|NCT01355302|11673589|FG000|STARTED|Phase 2|Treatment arm not designated for phase 2.|0
10521521|NCT01355302|11673590|FG001|STARTED|Phase 2|The study was terminated prior to enrollment|0
10521522|NCT01355302|11673591|FG002|STARTED|Phase 2|The study was terminated prior to enrollment|0
10521523|NCT01355302|11673589|FG000|COMPLETED|Phase 2||0
10521524|NCT01355302|11673590|FG001|COMPLETED|Phase 2||0
10521525|NCT01355302|11673591|FG002|COMPLETED|Phase 2||0
10521526|NCT01355302|11673589|FG000|NOT COMPLETED|Phase 2||0
10521527|NCT01355302|11673590|FG001|NOT COMPLETED|Phase 2||0
10521528|NCT01355302|11673591|FG002|NOT COMPLETED|Phase 2||0
10521529|NCT01355419|11673599|FG000|STARTED|Overall Study||150
10521530|NCT01355419|11673599|FG000|COMPLETED|Overall Study||142
10521531|NCT01355419|11673599|FG000|NOT COMPLETED|Overall Study||8
10521532|NCT01355458|11673605|FG000|STARTED|Overall Study||129
10521533|NCT01355458|11673606|FG001|STARTED|Overall Study||131
10521534|NCT01355458|11673605|FG000|COMPLETED|Overall Study||127
10521535|NCT01355458|11673606|FG001|COMPLETED|Overall Study||127
10521536|NCT01355458|11673605|FG000|NOT COMPLETED|Overall Study||2
10521537|NCT01355458|11673606|FG001|NOT COMPLETED|Overall Study||4
10521538|NCT01355471|11673614|FG000|STARTED|Overall Study||148
10521539|NCT01355471|11673615|FG001|STARTED|Overall Study||145
10521540|NCT01355471|11673614|FG000|COMPLETED|Overall Study||141
10521541|NCT01355471|11673615|FG001|COMPLETED|Overall Study||142
10521542|NCT01355471|11673614|FG000|NOT COMPLETED|Overall Study||7
10521543|NCT01355471|11673615|FG001|NOT COMPLETED|Overall Study||3
10521544|NCT01355484|11673623|FG000|STARTED|Overall Study||160
10521545|NCT01355484|11673624|FG001|STARTED|Overall Study||161
10521546|NCT01355484|11673623|FG000|COMPLETED|Overall Study||109
10521547|NCT01355484|11673624|FG001|COMPLETED|Overall Study||107
10521548|NCT01355484|11673623|FG000|NOT COMPLETED|Overall Study||51
10521549|NCT01355484|11673624|FG001|NOT COMPLETED|Overall Study||54
10521550|NCT01355497|11673632|FG000|STARTED|Overall Study||165
10521551|NCT01355497|11673633|FG001|STARTED|Overall Study||165
10521552|NCT01355497|11673632|FG000|COMPLETED|Overall Study||99
10521553|NCT01355497|11673633|FG001|COMPLETED|Overall Study||102
10521554|NCT01355497|11673632|FG000|NOT COMPLETED|Overall Study||66
10521555|NCT01355497|11673633|FG001|NOT COMPLETED|Overall Study||63
10521556|NCT01355523|11673641|FG000|STARTED|Overall Study||28
10521557|NCT01355523|11673642|FG001|STARTED|Overall Study||26
10521558|NCT01355523|11673641|FG000|COMPLETED|Overall Study||27
10521559|NCT01355523|11673642|FG001|COMPLETED|Overall Study||16
10521560|NCT01355523|11673641|FG000|NOT COMPLETED|Overall Study||1
10521561|NCT01355523|11673642|FG001|NOT COMPLETED|Overall Study||10
10521562|NCT01355575|11673648|FG000|STARTED|Overall Study||15
10521563|NCT01355575|11673648|FG000|COMPLETED|Overall Study||13
10521564|NCT01355575|11673648|FG000|NOT COMPLETED|Overall Study||2
10521565|NCT01355588|11673660|FG000|STARTED|First Intervention (Day 1)||4
10521566|NCT01355588|11673661|FG001|STARTED|First Intervention (Day 1)||4
10521567|NCT01355588|11673662|FG002|STARTED|First Intervention (Day 1)||4
10521568|NCT01355588|11673663|FG003|STARTED|First Intervention (Day 1)||4
10521569|NCT01355588|11673660|FG000|COMPLETED|First Intervention (Day 1)||4
10521570|NCT01355588|11673661|FG001|COMPLETED|First Intervention (Day 1)||4
10521571|NCT01355588|11673662|FG002|COMPLETED|First Intervention (Day 1)||4
10521572|NCT01355588|11673663|FG003|COMPLETED|First Intervention (Day 1)||4
10521573|NCT01355588|11673660|FG000|NOT COMPLETED|First Intervention (Day 1)||0
10521574|NCT01355588|11673661|FG001|NOT COMPLETED|First Intervention (Day 1)||0
10521575|NCT01355588|11673662|FG002|NOT COMPLETED|First Intervention (Day 1)||0
10521576|NCT01355588|11673663|FG003|NOT COMPLETED|First Intervention (Day 1)||0
10521577|NCT01355588|11673660|FG000|STARTED|Washout (3-7 Days)||4
10521578|NCT01355588|11673661|FG001|STARTED|Washout (3-7 Days)||4
10521579|NCT01355588|11673662|FG002|STARTED|Washout (3-7 Days)||4
10521580|NCT01355588|11673663|FG003|STARTED|Washout (3-7 Days)||4
10521581|NCT01355588|11673660|FG000|COMPLETED|Washout (3-7 Days)||4
10521582|NCT01355588|11673661|FG001|COMPLETED|Washout (3-7 Days)||4
10521583|NCT01355588|11673662|FG002|COMPLETED|Washout (3-7 Days)||4
10521584|NCT01355588|11673663|FG003|COMPLETED|Washout (3-7 Days)||4
10521585|NCT01355588|11673660|FG000|NOT COMPLETED|Washout (3-7 Days)||0
10521586|NCT01355588|11673661|FG001|NOT COMPLETED|Washout (3-7 Days)||0
10521587|NCT01355588|11673662|FG002|NOT COMPLETED|Washout (3-7 Days)||0
10521588|NCT01355588|11673663|FG003|NOT COMPLETED|Washout (3-7 Days)||0
10521589|NCT01355588|11673660|FG000|STARTED|Second Intervention (After Washout)||4
10521590|NCT01355588|11673661|FG001|STARTED|Second Intervention (After Washout)||4
10521591|NCT01355588|11673662|FG002|STARTED|Second Intervention (After Washout)||4
10521592|NCT01355588|11673663|FG003|STARTED|Second Intervention (After Washout)||4
10521593|NCT01355588|11673660|FG000|COMPLETED|Second Intervention (After Washout)||4
10521594|NCT01355588|11673661|FG001|COMPLETED|Second Intervention (After Washout)||4
10521595|NCT01355588|11673662|FG002|COMPLETED|Second Intervention (After Washout)||4
10521596|NCT01355588|11673663|FG003|COMPLETED|Second Intervention (After Washout)||4
10521597|NCT01355588|11673660|FG000|NOT COMPLETED|Second Intervention (After Washout)||0
10521598|NCT01355588|11673661|FG001|NOT COMPLETED|Second Intervention (After Washout)||0
10521599|NCT01355588|11673662|FG002|NOT COMPLETED|Second Intervention (After Washout)||0
10521600|NCT01355588|11673663|FG003|NOT COMPLETED|Second Intervention (After Washout)||0
10521601|NCT01355588|11673660|FG000|STARTED|Washout (3-7 Days)||4
10521602|NCT01355588|11673661|FG001|STARTED|Washout (3-7 Days)||4
10521603|NCT01355588|11673662|FG002|STARTED|Washout (3-7 Days)||4
10521604|NCT01355588|11673663|FG003|STARTED|Washout (3-7 Days)||4
10521605|NCT01355588|11673660|FG000|COMPLETED|Washout (3-7 Days)||4
10521606|NCT01355588|11673661|FG001|COMPLETED|Washout (3-7 Days)||4
10521607|NCT01355588|11673662|FG002|COMPLETED|Washout (3-7 Days)||4
10521608|NCT01355588|11673663|FG003|COMPLETED|Washout (3-7 Days)||4
10521609|NCT01355588|11673660|FG000|NOT COMPLETED|Washout (3-7 Days)||0
10521610|NCT01355588|11673661|FG001|NOT COMPLETED|Washout (3-7 Days)||0
10521611|NCT01355588|11673662|FG002|NOT COMPLETED|Washout (3-7 Days)||0
10521612|NCT01355588|11673663|FG003|NOT COMPLETED|Washout (3-7 Days)||0
10521613|NCT01355588|11673660|FG000|STARTED|Third Intervention (After Washout)||4
10521614|NCT01355588|11673661|FG001|STARTED|Third Intervention (After Washout)||4
10521615|NCT01355588|11673662|FG002|STARTED|Third Intervention (After Washout)||4
10521616|NCT01355588|11673663|FG003|STARTED|Third Intervention (After Washout)||4
10521617|NCT01355588|11673660|FG000|COMPLETED|Third Intervention (After Washout)||4
10521618|NCT01355588|11673661|FG001|COMPLETED|Third Intervention (After Washout)||4
10521619|NCT01355588|11673662|FG002|COMPLETED|Third Intervention (After Washout)||4
10521620|NCT01355588|11673663|FG003|COMPLETED|Third Intervention (After Washout)||4
10521621|NCT01355588|11673660|FG000|NOT COMPLETED|Third Intervention (After Washout)||0
10521622|NCT01355588|11673661|FG001|NOT COMPLETED|Third Intervention (After Washout)||0
10521623|NCT01355588|11673662|FG002|NOT COMPLETED|Third Intervention (After Washout)||0
10521624|NCT01355588|11673663|FG003|NOT COMPLETED|Third Intervention (After Washout)||0
10521625|NCT01355588|11673660|FG000|STARTED|Washout (3-7 Days)||4
10521626|NCT01355588|11673661|FG001|STARTED|Washout (3-7 Days)||4
10521627|NCT01355588|11673662|FG002|STARTED|Washout (3-7 Days)||4
10521628|NCT01355588|11673663|FG003|STARTED|Washout (3-7 Days)||4
10521629|NCT01355588|11673660|FG000|COMPLETED|Washout (3-7 Days)||4
10521630|NCT01355588|11673661|FG001|COMPLETED|Washout (3-7 Days)||4
10521631|NCT01355588|11673662|FG002|COMPLETED|Washout (3-7 Days)||4
10521632|NCT01355588|11673663|FG003|COMPLETED|Washout (3-7 Days)||4
10521633|NCT01355588|11673660|FG000|NOT COMPLETED|Washout (3-7 Days)||0
10521634|NCT01355588|11673661|FG001|NOT COMPLETED|Washout (3-7 Days)||0
10521635|NCT01355588|11673662|FG002|NOT COMPLETED|Washout (3-7 Days)||0
10521636|NCT01355588|11673663|FG003|NOT COMPLETED|Washout (3-7 Days)||0
10521637|NCT01355588|11673660|FG000|STARTED|Fourth Intervention (After Washout)||4
10521638|NCT01355588|11673661|FG001|STARTED|Fourth Intervention (After Washout)||4
10521639|NCT01355588|11673662|FG002|STARTED|Fourth Intervention (After Washout)||4
10521640|NCT01355588|11673663|FG003|STARTED|Fourth Intervention (After Washout)||4
10521641|NCT01355588|11673660|FG000|COMPLETED|Fourth Intervention (After Washout)||4
10521642|NCT01355588|11673661|FG001|COMPLETED|Fourth Intervention (After Washout)||4
10521643|NCT01355588|11673662|FG002|COMPLETED|Fourth Intervention (After Washout)||4
10521644|NCT01355588|11673663|FG003|COMPLETED|Fourth Intervention (After Washout)||4
10521645|NCT01355588|11673660|FG000|NOT COMPLETED|Fourth Intervention (After Washout)||0
10521646|NCT01355588|11673661|FG001|NOT COMPLETED|Fourth Intervention (After Washout)||0
10521647|NCT01355588|11673662|FG002|NOT COMPLETED|Fourth Intervention (After Washout)||0
10521648|NCT01355588|11673663|FG003|NOT COMPLETED|Fourth Intervention (After Washout)||0
10521649|NCT01355627|11673675|FG000|STARTED|Overall Study||362
10521650|NCT01355627|11673676|FG001|STARTED|Overall Study||364
10521651|NCT01355627|11673675|FG000|Safety Analysis Set|Overall Study||362
10521652|NCT01355627|11673676|FG001|Safety Analysis Set|Overall Study||364
10521653|NCT01355627|11673675|FG000|Full Analysis Set|Overall Study|One participant's data for final follow-up is missing, completion status could not be confirmed.|361
10521654|NCT01355627|11673676|FG001|Full Analysis Set|Overall Study|One participant randomized to Current Practice actually received TachoSil®.|365
10521655|NCT01355627|11673675|FG000|COMPLETED|Overall Study||329
10521656|NCT01355627|11673676|FG001|COMPLETED|Overall Study||326
10521657|NCT01355627|11673675|FG000|NOT COMPLETED|Overall Study||33
10521658|NCT01355627|11673676|FG001|NOT COMPLETED|Overall Study||38
10521659|NCT01355705|11673682|FG000|STARTED|Overall Study||14
10521660|NCT01355705|11673682|FG000|COMPLETED|Overall Study||14
10521661|NCT01355705|11673682|FG000|NOT COMPLETED|Overall Study||0
10521662|NCT01355796|11673687|FG000|STARTED|Overall Study||15
10521663|NCT01355796|11673688|FG001|STARTED|Overall Study||15
10711838|NCT02663128|11877271|FG004|NOT COMPLETED|Period 2||1
10711839|NCT02663128|11877272|FG005|NOT COMPLETED|Period 2||0
10711840|NCT02663128|11877267|FG000|STARTED|Period 3||3
10711841|NCT02663128|11877268|FG001|STARTED|Period 3||3
10711842|NCT02663128|11877269|FG002|STARTED|Period 3||3
10711843|NCT02663128|11877270|FG003|STARTED|Period 3||3
10711844|NCT02663128|11877271|FG004|STARTED|Period 3||2
10711845|NCT02663128|11877272|FG005|STARTED|Period 3||3
10711846|NCT02663128|11877267|FG000|COMPLETED|Period 3||3
10711847|NCT02663128|11877268|FG001|COMPLETED|Period 3||3
10711848|NCT02663128|11877269|FG002|COMPLETED|Period 3||3
10711849|NCT02663128|11877270|FG003|COMPLETED|Period 3||3
10711850|NCT02663128|11877271|FG004|COMPLETED|Period 3||2
10711851|NCT02663128|11877272|FG005|COMPLETED|Period 3||3
10711852|NCT02663128|11877267|FG000|NOT COMPLETED|Period 3||0
10711853|NCT02663128|11877268|FG001|NOT COMPLETED|Period 3||0
10711854|NCT02663128|11877269|FG002|NOT COMPLETED|Period 3||0
10711855|NCT02663128|11877270|FG003|NOT COMPLETED|Period 3||0
10711856|NCT02663128|11877271|FG004|NOT COMPLETED|Period 3||0
10711857|NCT02663128|11877272|FG005|NOT COMPLETED|Period 3||0
10711858|NCT02663232|11877281|FG000|STARTED|Overall Study||264
10711859|NCT02663232|11877281|FG000|COMPLETED|Overall Study||264
10711860|NCT02663232|11877281|FG000|NOT COMPLETED|Overall Study||0
10711861|NCT02663453|11877287|FG000|STARTED|Overall Study||22
10711862|NCT02663453|11877288|FG001|STARTED|Overall Study||22
10711863|NCT02663453|11877287|FG000|COMPLETED|Overall Study||17
10521664|NCT01355796|11673687|FG000|First Intervention for 14 Days|Overall Study||15
10521665|NCT01355796|11673688|FG001|First Intervention for 14 Days|Overall Study||15
10521666|NCT01355796|11673687|FG000|Washout Period for 7 Days|Overall Study||15
10521667|NCT01355796|11673688|FG001|Washout Period for 7 Days|Overall Study||15
10521668|NCT01355796|11673687|FG000|Second Intervention for 14 Days|Overall Study||15
10521669|NCT01355796|11673688|FG001|Second Intervention for 14 Days|Overall Study||15
10521670|NCT01355796|11673687|FG000|COMPLETED|Overall Study||15
10521671|NCT01355796|11673688|FG001|COMPLETED|Overall Study||15
10521672|NCT01355796|11673687|FG000|NOT COMPLETED|Overall Study||0
10521673|NCT01355796|11673688|FG001|NOT COMPLETED|Overall Study||0
10521674|NCT01355978|11673694|FG000|STARTED|Overall Study||22
10521675|NCT01355978|11673694|FG000|COMPLETED|Overall Study||18
10521676|NCT01355978|11673694|FG000|NOT COMPLETED|Overall Study||4
10521677|NCT01356147|11673700|FG000|STARTED|Overall Study||5
10521678|NCT01356147|11673701|FG001|STARTED|Overall Study||6
10521679|NCT01356147|11673700|FG000|COMPLETED|Overall Study||5
10521680|NCT01356147|11673701|FG001|COMPLETED|Overall Study||6
10521681|NCT01356147|11673700|FG000|NOT COMPLETED|Overall Study||0
10521682|NCT01356147|11673701|FG001|NOT COMPLETED|Overall Study||0
10521683|NCT01356277|11673709|FG000|STARTED|Run-in||81
10521684|NCT01356277|11673710|FG001|STARTED|Run-in||88
10521685|NCT01356277|11673709|FG000|COMPLETED|Run-in||76
10521686|NCT01356277|11673710|FG001|COMPLETED|Run-in||88
10521687|NCT01356277|11673709|FG000|NOT COMPLETED|Run-in||5
10521688|NCT01356277|11673710|FG001|NOT COMPLETED|Run-in||0
10521689|NCT01356277|11673709|FG000|STARTED|Intervention Interval||76
10521690|NCT01356277|11673710|FG001|STARTED|Intervention Interval||88
10521691|NCT01356277|11673709|FG000|COMPLETED|Intervention Interval||66
10521692|NCT01356277|11673710|FG001|COMPLETED|Intervention Interval||81
10521693|NCT01356277|11673709|FG000|NOT COMPLETED|Intervention Interval||10
10521694|NCT01356277|11673710|FG001|NOT COMPLETED|Intervention Interval||7
10521695|NCT01356407|11673720|FG000|STARTED|Overall Study||150
10521696|NCT01356407|11673721|FG001|STARTED|Overall Study||150
10521697|NCT01356407|11673720|FG000|COMPLETED|Overall Study||144
10521698|NCT01356407|11673721|FG001|COMPLETED|Overall Study||146
10521699|NCT01356407|11673720|FG000|NOT COMPLETED|Overall Study||6
10521700|NCT01356407|11673721|FG001|NOT COMPLETED|Overall Study||4
10521701|NCT01356498|11673733|FG000|STARTED|Overall Study||35
10521702|NCT01356498|11673734|FG001|STARTED|Overall Study|2 other patients received no investigational drug in C0407 but elected to be followed in Observation|25
10521703|NCT01356498|11673735|FG002|STARTED|Overall Study||23
10521704|NCT01356498|11673736|FG003|STARTED|Overall Study||22
10711864|NCT02663453|11877288|FG001|COMPLETED|Overall Study||18
10711865|NCT02663453|11877287|FG000|NOT COMPLETED|Overall Study||5
10711866|NCT02663453|11877288|FG001|NOT COMPLETED|Overall Study||4
10711867|NCT02663674|11877296|FG000|STARTED|Overall Study||33
10711868|NCT02663674|11877297|FG001|STARTED|Overall Study||39
10711869|NCT02663674|11877296|FG000|COMPLETED|Overall Study||26
10711870|NCT02663674|11877297|FG001|COMPLETED|Overall Study||29
10521705|NCT01356498|11673737|FG004|STARTED|Overall Study||28
10521706|NCT01356498|11673738|FG005|STARTED|Overall Study||16
10521707|NCT01356498|11673733|FG000|COMPLETED|Overall Study||24
10521708|NCT01356498|11673734|FG001|COMPLETED|Overall Study||17
10521709|NCT01356498|11673735|FG002|COMPLETED|Overall Study||11
10521710|NCT01356498|11673736|FG003|COMPLETED|Overall Study||8
10521711|NCT01356498|11673737|FG004|COMPLETED|Overall Study||8
10521712|NCT01356498|11673738|FG005|COMPLETED|Overall Study||2
10521713|NCT01356498|11673733|FG000|NOT COMPLETED|Overall Study||11
10521714|NCT01356498|11673734|FG001|NOT COMPLETED|Overall Study||8
10521715|NCT01356498|11673735|FG002|NOT COMPLETED|Overall Study||12
10521716|NCT01356498|11673736|FG003|NOT COMPLETED|Overall Study||14
10521717|NCT01356498|11673737|FG004|NOT COMPLETED|Overall Study||20
10521718|NCT01356498|11673738|FG005|NOT COMPLETED|Overall Study||14
10521719|NCT01356589|11673758|FG000|STARTED|Overall Study||1288
10521720|NCT01356589|11673758|FG000|Treated|Overall Study||1285
10521721|NCT01356589|11673758|FG000|COMPLETED|Overall Study||1283
10521722|NCT01356589|11673758|FG000|NOT COMPLETED|Overall Study||5
10521723|NCT01356602|11673765|FG000|STARTED|Overall Study||133
10521724|NCT01356602|11673766|FG001|STARTED|Overall Study||132
10521725|NCT01356602|11673767|FG002|STARTED|Overall Study||132
10521726|NCT01356602|11673765|FG000|Safety Set|Overall Study|In this arm, 1 patient had only 3 placebo injections and 3 patients also took other active drug.|133
10521727|NCT01356602|11673766|FG001|Safety Set|Overall Study|In this arm, 3 patients also took other active drug.|133
10521728|NCT01356602|11673767|FG002|Safety Set|Overall Study|In this arm, 3 patients also took other active drug.|133
10521729|NCT01356602|11673765|FG000|Full Analysis Set|Overall Study||131
10521730|NCT01356602|11673766|FG001|Full Analysis Set|Overall Study||129
10521731|NCT01356602|11673767|FG002|Full Analysis Set|Overall Study||129
10521732|NCT01356602|11673765|FG000|COMPLETED|Overall Study||124
10521733|NCT01356602|11673766|FG001|COMPLETED|Overall Study||117
10521734|NCT01356602|11673767|FG002|COMPLETED|Overall Study||108
10521735|NCT01356602|11673765|FG000|NOT COMPLETED|Overall Study||9
10521736|NCT01356602|11673766|FG001|NOT COMPLETED|Overall Study||15
10521737|NCT01356602|11673767|FG002|NOT COMPLETED|Overall Study||24
10521738|NCT01356628|11673775|FG000|STARTED|Overall Study||23
10521739|NCT01356628|11673775|FG000|COMPLETED|Overall Study||23
10521740|NCT01356628|11673775|FG000|NOT COMPLETED|Overall Study||0
10521741|NCT01356940|11673781|FG000|STARTED|First Intervention (28 Days)||22
10521742|NCT01356940|11673782|FG001|STARTED|First Intervention (28 Days)||21
10521743|NCT01356940|11673781|FG000|COMPLETED|First Intervention (28 Days)||21
10521744|NCT01356940|11673782|FG001|COMPLETED|First Intervention (28 Days)||21
10521745|NCT01356940|11673781|FG000|NOT COMPLETED|First Intervention (28 Days)||1
10521746|NCT01356940|11673782|FG001|NOT COMPLETED|First Intervention (28 Days)||0
10521747|NCT01356940|11673781|FG000|STARTED|Washout (14 Days)||21
10521748|NCT01356940|11673782|FG001|STARTED|Washout (14 Days)||21
10521749|NCT01356940|11673781|FG000|COMPLETED|Washout (14 Days)||21
10521750|NCT01356940|11673782|FG001|COMPLETED|Washout (14 Days)||21
10521751|NCT01356940|11673781|FG000|NOT COMPLETED|Washout (14 Days)||0
10521752|NCT01356940|11673782|FG001|NOT COMPLETED|Washout (14 Days)||0
10521753|NCT01356940|11673781|FG000|STARTED|Second Intervention (28 Days)||21
10521754|NCT01356940|11673782|FG001|STARTED|Second Intervention (28 Days)||21
10521755|NCT01356940|11673781|FG000|COMPLETED|Second Intervention (28 Days)||20
10521756|NCT01356940|11673782|FG001|COMPLETED|Second Intervention (28 Days)||21
10521757|NCT01356940|11673781|FG000|NOT COMPLETED|Second Intervention (28 Days)||1
10521758|NCT01356940|11673782|FG001|NOT COMPLETED|Second Intervention (28 Days)||0
10521759|NCT01356966|11673792|FG000|STARTED|Overall Study||18
10521760|NCT01356966|11673793|FG001|STARTED|Overall Study||14
10521761|NCT01356966|11673792|FG000|COMPLETED|Overall Study||16
10521762|NCT01356966|11673793|FG001|COMPLETED|Overall Study||12
10521763|NCT01356966|11673792|FG000|NOT COMPLETED|Overall Study||2
10521764|NCT01356966|11673793|FG001|NOT COMPLETED|Overall Study||2
10521765|NCT01357135|11673802|FG000|STARTED|Overall Study||1874
10521766|NCT01357135|11673803|FG001|STARTED|Overall Study||733
10521767|NCT01357135|11673804|FG002|STARTED|Overall Study||846
10521768|NCT01357135|11673802|FG000|COMPLETED|Overall Study||1276
10521769|NCT01357135|11673803|FG001|COMPLETED|Overall Study||510
10521770|NCT01357135|11673804|FG002|COMPLETED|Overall Study||583
10521771|NCT01357135|11673802|FG000|NOT COMPLETED|Overall Study||598
10521772|NCT01357135|11673803|FG001|NOT COMPLETED|Overall Study||223
10521773|NCT01357135|11673804|FG002|NOT COMPLETED|Overall Study||263
10521774|NCT01357148|11673811|FG000|STARTED|Overall Study||143
10521775|NCT01357148|11673811|FG000|COMPLETED|Overall Study||143
10521776|NCT01357148|11673811|FG000|NOT COMPLETED|Overall Study||0
10521777|NCT01357161|11673819|FG000|STARTED|Part 1 (Open Label Run-in)||15
10521778|NCT01357161|11673820|FG001|STARTED|Part 1 (Open Label Run-in)||0
10521779|NCT01357161|11673821|FG002|STARTED|Part 1 (Open Label Run-in)||0
10521780|NCT01357161|11673819|FG000|COMPLETED|Part 1 (Open Label Run-in)||0
10521781|NCT01357161|11673820|FG001|COMPLETED|Part 1 (Open Label Run-in)||0
10521782|NCT01357161|11673821|FG002|COMPLETED|Part 1 (Open Label Run-in)||0
10521783|NCT01357161|11673819|FG000|NOT COMPLETED|Part 1 (Open Label Run-in)||15
10521784|NCT01357161|11673820|FG001|NOT COMPLETED|Part 1 (Open Label Run-in)||0
10521785|NCT01357161|11673821|FG002|NOT COMPLETED|Part 1 (Open Label Run-in)||0
10521786|NCT01357161|11673819|FG000|STARTED|Part 2 (Double-Blind Comparison)||0
10521787|NCT01357161|11673820|FG001|STARTED|Part 2 (Double-Blind Comparison)|New participants enrolled in Part 2.|59
10521788|NCT01357161|11673821|FG002|STARTED|Part 2 (Double-Blind Comparison)|New participants enrolled in Part 2.|62
10521789|NCT01357161|11673819|FG000|Treated|Part 2 (Double-Blind Comparison)||0
10521790|NCT01357161|11673820|FG001|Treated|Part 2 (Double-Blind Comparison)||59
10521791|NCT01357161|11673821|FG002|Treated|Part 2 (Double-Blind Comparison)||60
10521792|NCT01357161|11673819|FG000|COMPLETED|Part 2 (Double-Blind Comparison)||0
10521793|NCT01357161|11673820|FG001|COMPLETED|Part 2 (Double-Blind Comparison)||0
10521794|NCT01357161|11673821|FG002|COMPLETED|Part 2 (Double-Blind Comparison)||0
10521795|NCT01357161|11673819|FG000|NOT COMPLETED|Part 2 (Double-Blind Comparison)||0
10521796|NCT01357161|11673820|FG001|NOT COMPLETED|Part 2 (Double-Blind Comparison)||59
10521797|NCT01357161|11673821|FG002|NOT COMPLETED|Part 2 (Double-Blind Comparison)||62
10521798|NCT01357239|11673833|FG000|STARTED|Stratum: All Patients||31
10521799|NCT01357239|11673834|FG001|STARTED|Stratum: All Patients||27
10521800|NCT01357239|11673835|FG002|STARTED|Stratum: All Patients||39
10521801|NCT01357239|11673836|FG003|STARTED|Stratum: All Patients||42
10521802|NCT01357239|11673833|FG000|COMPLETED|Stratum: All Patients||31
10521803|NCT01357239|11673834|FG001|COMPLETED|Stratum: All Patients||27
10521804|NCT01357239|11673835|FG002|COMPLETED|Stratum: All Patients||37
10521805|NCT01357239|11673836|FG003|COMPLETED|Stratum: All Patients||40
10521806|NCT01357239|11673833|FG000|NOT COMPLETED|Stratum: All Patients||0
10521807|NCT01357239|11673834|FG001|NOT COMPLETED|Stratum: All Patients||0
10521808|NCT01357239|11673835|FG002|NOT COMPLETED|Stratum: All Patients||2
10521809|NCT01357239|11673836|FG003|NOT COMPLETED|Stratum: All Patients||2
10521810|NCT01357239|11673833|FG000|STARTED|Stratum I: Fully-Methylated||8
10521811|NCT01357239|11673834|FG001|STARTED|Stratum I: Fully-Methylated||6
10521812|NCT01357239|11673835|FG002|STARTED|Stratum I: Fully-Methylated||17
10521813|NCT01357239|11673836|FG003|STARTED|Stratum I: Fully-Methylated||22
10521814|NCT01357239|11673833|FG000|COMPLETED|Stratum I: Fully-Methylated||8
10521815|NCT01357239|11673834|FG001|COMPLETED|Stratum I: Fully-Methylated||6
10521816|NCT01357239|11673835|FG002|COMPLETED|Stratum I: Fully-Methylated||16
10521817|NCT01357239|11673836|FG003|COMPLETED|Stratum I: Fully-Methylated||22
10521818|NCT01357239|11673833|FG000|NOT COMPLETED|Stratum I: Fully-Methylated||0
10521819|NCT01357239|11673834|FG001|NOT COMPLETED|Stratum I: Fully-Methylated||0
10521820|NCT01357239|11673835|FG002|NOT COMPLETED|Stratum I: Fully-Methylated||1
10521821|NCT01357239|11673836|FG003|NOT COMPLETED|Stratum I: Fully-Methylated||0
10521822|NCT01357239|11673833|FG000|STARTED|Stratum II: Partially-Methylated||23
10521823|NCT01357239|11673834|FG001|STARTED|Stratum II: Partially-Methylated||21
10521824|NCT01357239|11673835|FG002|STARTED|Stratum II: Partially-Methylated||22
10521825|NCT01357239|11673836|FG003|STARTED|Stratum II: Partially-Methylated||20
10521826|NCT01357239|11673833|FG000|COMPLETED|Stratum II: Partially-Methylated||23
10521827|NCT01357239|11673834|FG001|COMPLETED|Stratum II: Partially-Methylated||21
10521828|NCT01357239|11673835|FG002|COMPLETED|Stratum II: Partially-Methylated||21
10521829|NCT01357239|11673836|FG003|COMPLETED|Stratum II: Partially-Methylated||18
10521830|NCT01357239|11673833|FG000|NOT COMPLETED|Stratum II: Partially-Methylated||0
10521831|NCT01357239|11673834|FG001|NOT COMPLETED|Stratum II: Partially-Methylated||0
10521832|NCT01357239|11673835|FG002|NOT COMPLETED|Stratum II: Partially-Methylated||1
10521833|NCT01357239|11673836|FG003|NOT COMPLETED|Stratum II: Partially-Methylated||2
10521834|NCT01357356|11673853|FG000|STARTED|Overall Study||188
10521835|NCT01357356|11673854|FG001|STARTED|Overall Study||188
10521836|NCT01357356|11673855|FG002|STARTED|Overall Study||186
10521837|NCT01357356|11673856|FG003|STARTED|Overall Study||188
10521838|NCT01357356|11673853|FG000|COMPLETED|Overall Study||166
10521839|NCT01357356|11673854|FG001|COMPLETED|Overall Study||163
10521840|NCT01357356|11673855|FG002|COMPLETED|Overall Study||158
10521841|NCT01357356|11673856|FG003|COMPLETED|Overall Study||171
10521842|NCT01357356|11673853|FG000|NOT COMPLETED|Overall Study||22
10521843|NCT01357356|11673854|FG001|NOT COMPLETED|Overall Study||25
10521844|NCT01357356|11673855|FG002|NOT COMPLETED|Overall Study||28
10521845|NCT01357356|11673856|FG003|NOT COMPLETED|Overall Study||17
10521846|NCT01357512|11673870|FG000|STARTED|Overall Study||65
10521847|NCT01357512|11673871|FG001|STARTED|Overall Study||65
10521848|NCT01357512|11673870|FG000|COMPLETED|Overall Study||53
10521849|NCT01357512|11673871|FG001|COMPLETED|Overall Study||60
10521850|NCT01357512|11673870|FG000|NOT COMPLETED|Overall Study||12
10521851|NCT01357512|11673871|FG001|NOT COMPLETED|Overall Study||5
10521852|NCT01357525|11673877|FG000|STARTED|Overall Study||50
10711871|NCT02663674|11877296|FG000|NOT COMPLETED|Overall Study||7
10711872|NCT02663674|11877297|FG001|NOT COMPLETED|Overall Study||10
10711873|NCT02663687|11877308|FG000|STARTED|Overall Study||12
10711874|NCT02663687|11877309|FG001|STARTED|Overall Study||9
10711875|NCT02663687|11877310|FG002|STARTED|Overall Study||9
10711876|NCT02663687|11877311|FG003|STARTED|Overall Study||9
10711877|NCT02663687|11877312|FG004|STARTED|Overall Study||9
10711878|NCT02663687|11877308|FG000|Treatment Period 1 (IV)|Overall Study||12
10711879|NCT02663687|11877309|FG001|Treatment Period 1 (IV)|Overall Study||9
10711880|NCT02663687|11877310|FG002|Treatment Period 1 (IV)|Overall Study||9
10711881|NCT02663687|11877311|FG003|Treatment Period 1 (IV)|Overall Study||9
10521853|NCT01357525|11673877|FG000|COMPLETED|Overall Study||49
10521854|NCT01357525|11673877|FG000|NOT COMPLETED|Overall Study||1
10521855|NCT01357551|11673883|FG000|STARTED|Overall Study||110
10521856|NCT01357551|11673884|FG001|STARTED|Overall Study||112
10521857|NCT01357551|11673883|FG000|COMPLETED|Overall Study||88
10711882|NCT02663687|11877312|FG004|Treatment Period 1 (IV)|Overall Study||9
10521858|NCT01357551|11673884|FG001|COMPLETED|Overall Study||101
10521859|NCT01357551|11673883|FG000|NOT COMPLETED|Overall Study||22
10521860|NCT01357551|11673884|FG001|NOT COMPLETED|Overall Study||11
10521861|NCT01357564|11673895|FG000|STARTED|Short-term (4-month) Follow up||154
10711883|NCT02663687|11877308|FG000|Treatment Period 2 (SC)|Overall Study||10
10521862|NCT01357564|11673896|FG001|STARTED|Short-term (4-month) Follow up||168
10521863|NCT01357564|11673895|FG000|COMPLETED|Short-term (4-month) Follow up||106
10521864|NCT01357564|11673896|FG001|COMPLETED|Short-term (4-month) Follow up||118
10521865|NCT01357564|11673895|FG000|NOT COMPLETED|Short-term (4-month) Follow up||48
10521866|NCT01357564|11673896|FG001|NOT COMPLETED|Short-term (4-month) Follow up||50
10521867|NCT01357564|11673895|FG000|STARTED|Long-term (8-month) Follow-up||106
10521868|NCT01357564|11673896|FG001|STARTED|Long-term (8-month) Follow-up||118
10521869|NCT01357564|11673895|FG000|COMPLETED|Long-term (8-month) Follow-up||104
10521870|NCT01357564|11673896|FG001|COMPLETED|Long-term (8-month) Follow-up||102
10521871|NCT01357564|11673895|FG000|NOT COMPLETED|Long-term (8-month) Follow-up||2
10521872|NCT01357564|11673896|FG001|NOT COMPLETED|Long-term (8-month) Follow-up||16
10521873|NCT01357577|11673906|FG000|STARTED|Overall Study||64
10711884|NCT02663687|11877309|FG001|Treatment Period 2 (SC)|Overall Study||9
10711885|NCT02663687|11877310|FG002|Treatment Period 2 (SC)|Overall Study||8
10711886|NCT02663687|11877311|FG003|Treatment Period 2 (SC)|Overall Study||9
10711887|NCT02663687|11877312|FG004|Treatment Period 2 (SC)|Overall Study||9
10711888|NCT02663687|11877308|FG000|COMPLETED|Overall Study||10
10711889|NCT02663687|11877309|FG001|COMPLETED|Overall Study||9
10711890|NCT02663687|11877310|FG002|COMPLETED|Overall Study||8
10711891|NCT02663687|11877311|FG003|COMPLETED|Overall Study||9
10711892|NCT02663687|11877312|FG004|COMPLETED|Overall Study||9
10711893|NCT02663687|11877308|FG000|NOT COMPLETED|Overall Study||2
10711894|NCT02663687|11877309|FG001|NOT COMPLETED|Overall Study||0
10711895|NCT02663687|11877310|FG002|NOT COMPLETED|Overall Study||1
10711896|NCT02663687|11877311|FG003|NOT COMPLETED|Overall Study||0
10711897|NCT02663687|11877312|FG004|NOT COMPLETED|Overall Study||0
10711898|NCT02663817|11877337|FG000|STARTED|Overall Study||52
10711899|NCT02663817|11877337|FG000|COMPLETED|Overall Study||50
10711900|NCT02663817|11877337|FG000|NOT COMPLETED|Overall Study||2
10711901|NCT02663882|11877345|FG000|STARTED|Overall Study||39
10521874|NCT01357577|11673907|FG001|STARTED|Overall Study||65
10521875|NCT01357577|11673906|FG000|Post-Treatment Assessment Completed|Overall Study||24
10521876|NCT01357577|11673907|FG001|Post-Treatment Assessment Completed|Overall Study||39
10521877|NCT01357577|11673906|FG000|COMPLETED|Overall Study||27
10521878|NCT01357577|11673907|FG001|COMPLETED|Overall Study||39
10521879|NCT01357577|11673906|FG000|NOT COMPLETED|Overall Study||37
10521880|NCT01357577|11673907|FG001|NOT COMPLETED|Overall Study||26
10521881|NCT01357616|11673916|FG000|STARTED|Overall Study||166
10521882|NCT01357616|11673917|FG001|STARTED|Overall Study||162
10521883|NCT01357616|11673916|FG000|COMPLETED|Overall Study||156
10521884|NCT01357616|11673917|FG001|COMPLETED|Overall Study||153
10521885|NCT01357616|11673916|FG000|NOT COMPLETED|Overall Study||10
10521886|NCT01357616|11673917|FG001|NOT COMPLETED|Overall Study||9
10521887|NCT01357655|11673925|FG000|STARTED|Overall Study||66
10521888|NCT01357655|11673926|FG001|STARTED|Overall Study||0
10521889|NCT01357655|11673925|FG000|COMPLETED|Overall Study||0
10521890|NCT01357655|11673926|FG001|COMPLETED|Overall Study||0
10521891|NCT01357655|11673925|FG000|NOT COMPLETED|Overall Study||66
10521892|NCT01357655|11673926|FG001|NOT COMPLETED|Overall Study||0
10521893|NCT01357720|11673933|FG000|STARTED|Overall Study||200
10521894|NCT01357720|11673934|FG001|STARTED|Overall Study||200
10521895|NCT01357720|11673933|FG000|COMPLETED|Overall Study||198
10521896|NCT01357720|11673934|FG001|COMPLETED|Overall Study||195
10521897|NCT01357720|11673933|FG000|NOT COMPLETED|Overall Study||2
10521898|NCT01357720|11673934|FG001|NOT COMPLETED|Overall Study||5
10521899|NCT01357850|11673944|FG000|STARTED|Overall Study||30
10521900|NCT01357850|11673945|FG001|STARTED|Overall Study||12
10521901|NCT01357850|11673946|FG002|STARTED|Overall Study||13
10521902|NCT01357850|11673947|FG003|STARTED|Overall Study||27
10521903|NCT01357850|11673944|FG000|COMPLETED|Overall Study||29
10521904|NCT01357850|11673945|FG001|COMPLETED|Overall Study||12
10521905|NCT01357850|11673946|FG002|COMPLETED|Overall Study||13
10521906|NCT01357850|11673947|FG003|COMPLETED|Overall Study||27
10521907|NCT01357850|11673944|FG000|NOT COMPLETED|Overall Study||1
10521908|NCT01357850|11673945|FG001|NOT COMPLETED|Overall Study||0
10521909|NCT01357850|11673946|FG002|NOT COMPLETED|Overall Study||0
10521910|NCT01357850|11673947|FG003|NOT COMPLETED|Overall Study||0
10521911|NCT01357889|11673960|FG000|STARTED|Single-dose Phase (BE Phase: 28 Days)||86
10521912|NCT01357889|11673961|FG001|STARTED|Single-dose Phase (BE Phase: 28 Days)||81
10521913|NCT01357889|11673960|FG000|COMPLETED|Single-dose Phase (BE Phase: 28 Days)||82
10521914|NCT01357889|11673961|FG001|COMPLETED|Single-dose Phase (BE Phase: 28 Days)||79
10521915|NCT01357889|11673960|FG000|NOT COMPLETED|Single-dose Phase (BE Phase: 28 Days)||4
10521916|NCT01357889|11673961|FG001|NOT COMPLETED|Single-dose Phase (BE Phase: 28 Days)||2
10521917|NCT01357889|11673960|FG000|STARTED|Multiple-dose Phase (MDP) (Overall)|After completion of the BE Phase, additional participants were randomized to the Overall Phase.|141
10521918|NCT01357889|11673961|FG001|STARTED|Multiple-dose Phase (MDP) (Overall)|After completion of the BE Phase, additional participants were randomized to the Overall Phase.|142
10521919|NCT01357889|11673960|FG000|COMPLETED|Multiple-dose Phase (MDP) (Overall)||125
10521920|NCT01357889|11673961|FG001|COMPLETED|Multiple-dose Phase (MDP) (Overall)||126
10521921|NCT01357889|11673960|FG000|NOT COMPLETED|Multiple-dose Phase (MDP) (Overall)||16
10521922|NCT01357889|11673961|FG001|NOT COMPLETED|Multiple-dose Phase (MDP) (Overall)||16
10521923|NCT01357889|11673960|FG000|STARTED|Follow-up Phase (FUP) (8 Weeks)|All participants who started the MDP entered the FUP, regardless of MDP completion status.|141
10711902|NCT02663882|11877346|FG001|STARTED|Overall Study||36
10711903|NCT02663882|11877345|FG000|COMPLETED|Overall Study||35
10711904|NCT02663882|11877346|FG001|COMPLETED|Overall Study||34
10521924|NCT01357889|11673961|FG001|STARTED|Follow-up Phase (FUP) (8 Weeks)|All participants who started the MDP entered the FUP, regardless of MDP completion status.|142
10521925|NCT01357889|11673960|FG000|COMPLETED|Follow-up Phase (FUP) (8 Weeks)||138
10521926|NCT01357889|11673961|FG001|COMPLETED|Follow-up Phase (FUP) (8 Weeks)||138
10521927|NCT01357889|11673960|FG000|NOT COMPLETED|Follow-up Phase (FUP) (8 Weeks)||3
10521928|NCT01357889|11673961|FG001|NOT COMPLETED|Follow-up Phase (FUP) (8 Weeks)||4
10521929|NCT01357915|11673971|FG000|STARTED|Overall Study||30
10521930|NCT01357915|11673972|FG001|STARTED|Overall Study||17
10521931|NCT01357915|11673971|FG000|COMPLETED|Overall Study||27
10521932|NCT01357915|11673972|FG001|COMPLETED|Overall Study||17
10521933|NCT01357915|11673971|FG000|NOT COMPLETED|Overall Study||3
10521934|NCT01357915|11673972|FG001|NOT COMPLETED|Overall Study||0
10528853|NCT01397409|11681248|FG004|STARTED|Stage 2||67
10528854|NCT01397409|11681249|FG005|STARTED|Stage 2||58
10528855|NCT01397409|11681250|FG006|STARTED|Stage 2||58
10528856|NCT01397409|11681251|FG007|STARTED|Stage 2||0
10528857|NCT01397409|11681252|FG008|STARTED|Stage 2||0
10528858|NCT01397409|11681253|FG009|STARTED|Stage 2||0
10528859|NCT01397409|11681244|FG000|COMPLETED|Stage 2||0
10528860|NCT01397409|11681245|FG001|COMPLETED|Stage 2||0
10528861|NCT01397409|11681246|FG002|COMPLETED|Stage 2||0
10528862|NCT01397409|11681247|FG003|COMPLETED|Stage 2||0
10528863|NCT01397409|11681248|FG004|COMPLETED|Stage 2||59
10528864|NCT01397409|11681249|FG005|COMPLETED|Stage 2||54
10528865|NCT01397409|11681250|FG006|COMPLETED|Stage 2||58
10528866|NCT01397409|11681251|FG007|COMPLETED|Stage 2||0
10528867|NCT01397409|11681252|FG008|COMPLETED|Stage 2||0
10528868|NCT01397409|11681253|FG009|COMPLETED|Stage 2||0
10528869|NCT01397409|11681244|FG000|NOT COMPLETED|Stage 2||0
10528870|NCT01397409|11681245|FG001|NOT COMPLETED|Stage 2||0
10528871|NCT01397409|11681246|FG002|NOT COMPLETED|Stage 2||0
10528872|NCT01397409|11681247|FG003|NOT COMPLETED|Stage 2||0
10528873|NCT01397409|11681248|FG004|NOT COMPLETED|Stage 2||8
10528874|NCT01397409|11681249|FG005|NOT COMPLETED|Stage 2||4
10528875|NCT01397409|11681250|FG006|NOT COMPLETED|Stage 2||0
10528876|NCT01397409|11681251|FG007|NOT COMPLETED|Stage 2||0
10528877|NCT01397409|11681252|FG008|NOT COMPLETED|Stage 2||0
10528878|NCT01397409|11681253|FG009|NOT COMPLETED|Stage 2||0
10528879|NCT01397409|11681244|FG000|STARTED|Stage 3||0
10528880|NCT01397409|11681245|FG001|STARTED|Stage 3||0
10528881|NCT01397409|11681246|FG002|STARTED|Stage 3||0
10528882|NCT01397409|11681247|FG003|STARTED|Stage 3||0
10528883|NCT01397409|11681248|FG004|STARTED|Stage 3||0
10528884|NCT01397409|11681249|FG005|STARTED|Stage 3||0
10528885|NCT01397409|11681250|FG006|STARTED|Stage 3||0
10711905|NCT02663882|11877345|FG000|NOT COMPLETED|Overall Study||4
10711906|NCT02663882|11877346|FG001|NOT COMPLETED|Overall Study||2
10711907|NCT02663895|11877352|FG000|STARTED|Overall Study||12
10711908|NCT02663895|11877352|FG000|COMPLETED|Overall Study||5
10711909|NCT02663895|11877352|FG000|NOT COMPLETED|Overall Study||7
10711910|NCT02664220|11877359|FG000|STARTED|Overall Study||50
10711911|NCT02664220|11877360|FG001|STARTED|Overall Study||50
10711912|NCT02664220|11877359|FG000|COMPLETED|Overall Study||50
10711913|NCT02664220|11877360|FG001|COMPLETED|Overall Study||50
10528886|NCT01397409|11681251|FG007|STARTED|Stage 3||23
10528887|NCT01397409|11681252|FG008|STARTED|Stage 3||25
10528888|NCT01397409|11681253|FG009|STARTED|Stage 3||16
10528889|NCT01397409|11681244|FG000|COMPLETED|Stage 3||0
10528890|NCT01397409|11681245|FG001|COMPLETED|Stage 3||0
10528891|NCT01397409|11681246|FG002|COMPLETED|Stage 3||0
10528892|NCT01397409|11681247|FG003|COMPLETED|Stage 3||0
10528893|NCT01397409|11681248|FG004|COMPLETED|Stage 3||0
10528894|NCT01397409|11681249|FG005|COMPLETED|Stage 3||0
10528895|NCT01397409|11681250|FG006|COMPLETED|Stage 3||0
10528896|NCT01397409|11681251|FG007|COMPLETED|Stage 3||21
10528897|NCT01397409|11681252|FG008|COMPLETED|Stage 3||25
10528898|NCT01397409|11681253|FG009|COMPLETED|Stage 3||16
10528899|NCT01397409|11681244|FG000|NOT COMPLETED|Stage 3||0
10528900|NCT01397409|11681245|FG001|NOT COMPLETED|Stage 3||0
10528901|NCT01397409|11681246|FG002|NOT COMPLETED|Stage 3||0
10528902|NCT01397409|11681247|FG003|NOT COMPLETED|Stage 3||0
10528903|NCT01397409|11681248|FG004|NOT COMPLETED|Stage 3||0
10711914|NCT02664220|11877359|FG000|NOT COMPLETED|Overall Study||0
10528904|NCT01397409|11681249|FG005|NOT COMPLETED|Stage 3||0
10528905|NCT01397409|11681250|FG006|NOT COMPLETED|Stage 3||0
10528906|NCT01397409|11681251|FG007|NOT COMPLETED|Stage 3||2
10528907|NCT01397409|11681252|FG008|NOT COMPLETED|Stage 3||0
10528908|NCT01397409|11681253|FG009|NOT COMPLETED|Stage 3||0
10528909|NCT01397422|11681280|FG000|STARTED|Overall Study||22
10528910|NCT01397422|11681281|FG001|STARTED|Overall Study||20
10528911|NCT01397422|11681282|FG002|STARTED|Overall Study|Of the 3 participants who discontinued, 1 withdrew due to both an AE and an eGFR < 50 mL/min/1.73m^2|21
10528912|NCT01397422|11681283|FG003|STARTED|Overall Study||20
10528913|NCT01397422|11681280|FG000|COMPLETED|Overall Study||20
10711915|NCT02664220|11877360|FG001|NOT COMPLETED|Overall Study||0
10711916|NCT02664272|11877366|FG000|STARTED|Overall Study||40
10711917|NCT02664272|11877366|FG000|COMPLETED|Overall Study||38
10711918|NCT02664272|11877366|FG000|NOT COMPLETED|Overall Study||2
10528914|NCT01397422|11681281|FG001|COMPLETED|Overall Study||17
10528915|NCT01397422|11681282|FG002|COMPLETED|Overall Study|AE = adverse event; eGFR = estimated glomerular filtration rate|18
10528916|NCT01397422|11681283|FG003|COMPLETED|Overall Study||12
10528917|NCT01397422|11681280|FG000|NOT COMPLETED|Overall Study||2
10528918|NCT01397422|11681281|FG001|NOT COMPLETED|Overall Study||3
10528919|NCT01397422|11681282|FG002|NOT COMPLETED|Overall Study||3
10528920|NCT01397422|11681283|FG003|NOT COMPLETED|Overall Study||8
10528921|NCT01397448|11681298|FG000|STARTED|Overall Study||156
10548394|NCT01519284|11702192|FG000|COMPLETED|Overall Study||16
10711919|NCT02664311|11877372|FG000|STARTED|Overall Study||6
10711920|NCT02664311|11877373|FG001|STARTED|Overall Study||3
10521947|NCT01358175|11673998|FG000|STARTED|Overall Study||124
10521948|NCT01358175|11673999|FG001|STARTED|Overall Study||125
10521949|NCT01358175|11674000|FG002|STARTED|Overall Study||122
10521950|NCT01358175|11673998|FG000|COMPLETED|Overall Study||103
10521951|NCT01358175|11673999|FG001|COMPLETED|Overall Study||97
10521952|NCT01358175|11674000|FG002|COMPLETED|Overall Study||90
10521953|NCT01358175|11673998|FG000|NOT COMPLETED|Overall Study||21
10521954|NCT01358175|11673999|FG001|NOT COMPLETED|Overall Study||28
10521955|NCT01358175|11674000|FG002|NOT COMPLETED|Overall Study||32
10521956|NCT01358266|11674015|FG000|STARTED|Double-Masked Period||208
10521957|NCT01358266|11674016|FG001|STARTED|Double-Masked Period||208
10521958|NCT01358266|11674017|FG002|STARTED|Double-Masked Period||176
10521959|NCT01358266|11674015|FG000|COMPLETED|Double-Masked Period||175
10521960|NCT01358266|11674016|FG001|COMPLETED|Double-Masked Period||162
10521961|NCT01358266|11674017|FG002|COMPLETED|Double-Masked Period||137
10521962|NCT01358266|11674015|FG000|NOT COMPLETED|Double-Masked Period||33
10521963|NCT01358266|11674016|FG001|NOT COMPLETED|Double-Masked Period||46
10521964|NCT01358266|11674017|FG002|NOT COMPLETED|Double-Masked Period||39
10521965|NCT01358266|11674015|FG000|STARTED|Open-Label Period||119
10521966|NCT01358266|11674016|FG001|STARTED|Open-Label Period||102
10521967|NCT01358266|11674017|FG002|STARTED|Open-Label Period||114
10521968|NCT01358266|11674015|FG000|COMPLETED|Open-Label Period||63
10521969|NCT01358266|11674016|FG001|COMPLETED|Open-Label Period||58
10521970|NCT01358266|11674017|FG002|COMPLETED|Open-Label Period||44
10521971|NCT01358266|11674015|FG000|NOT COMPLETED|Open-Label Period||56
10521972|NCT01358266|11674016|FG001|NOT COMPLETED|Open-Label Period||44
10521973|NCT01358266|11674017|FG002|NOT COMPLETED|Open-Label Period||70
10521974|NCT01358331|11674032|FG000|STARTED|Overall Study||2
10521975|NCT01358331|11674033|FG001|STARTED|Overall Study||3
10521976|NCT01358331|11674034|FG002|STARTED|Overall Study||4
10521977|NCT01358331|11674035|FG003|STARTED|Overall Study||3
10521978|NCT01358331|11674036|FG004|STARTED|Overall Study||7
10521979|NCT01358331|11674037|FG005|STARTED|Overall Study||6
10521980|NCT01358331|11674032|FG000|COMPLETED|Overall Study||0
10521981|NCT01358331|11674033|FG001|COMPLETED|Overall Study||0
10521982|NCT01358331|11674034|FG002|COMPLETED|Overall Study||0
10521983|NCT01358331|11674035|FG003|COMPLETED|Overall Study||0
10521984|NCT01358331|11674036|FG004|COMPLETED|Overall Study||0
10521985|NCT01358331|11674037|FG005|COMPLETED|Overall Study||0
10521986|NCT01358331|11674032|FG000|NOT COMPLETED|Overall Study||2
10521987|NCT01358331|11674033|FG001|NOT COMPLETED|Overall Study||3
10521988|NCT01358331|11674034|FG002|NOT COMPLETED|Overall Study||4
10521989|NCT01358331|11674035|FG003|NOT COMPLETED|Overall Study||3
10521990|NCT01358331|11674036|FG004|NOT COMPLETED|Overall Study||7
10521991|NCT01358331|11674037|FG005|NOT COMPLETED|Overall Study||6
10521992|NCT01358357|11674053|FG000|STARTED|Open Label Phase||0
10521993|NCT01358357|11674054|FG001|STARTED|Open Label Phase||0
10521994|NCT01358357|11674055|FG002|STARTED|Open Label Phase||965
10521995|NCT01358357|11674053|FG000|COMPLETED|Open Label Phase||0
10521996|NCT01358357|11674054|FG001|COMPLETED|Open Label Phase||0
10521997|NCT01358357|11674055|FG002|COMPLETED|Open Label Phase||503
10521998|NCT01358357|11674053|FG000|NOT COMPLETED|Open Label Phase||0
10521999|NCT01358357|11674054|FG001|NOT COMPLETED|Open Label Phase||0
10522000|NCT01358357|11674055|FG002|NOT COMPLETED|Open Label Phase||462
10522001|NCT01358357|11674053|FG000|STARTED|Double-Blind Phase||246
10522002|NCT01358357|11674054|FG001|STARTED|Double-Blind Phase||250
10522003|NCT01358357|11674055|FG002|STARTED|Double-Blind Phase||0
10522004|NCT01358357|11674053|FG000|COMPLETED|Double-Blind Phase||166
10522005|NCT01358357|11674054|FG001|COMPLETED|Double-Blind Phase||150
10522006|NCT01358357|11674055|FG002|COMPLETED|Double-Blind Phase||0
10522007|NCT01358357|11674053|FG000|NOT COMPLETED|Double-Blind Phase||80
10711921|NCT02664311|11877372|FG000|COMPLETED|Overall Study||6
10522008|NCT01358357|11674054|FG001|NOT COMPLETED|Double-Blind Phase||100
10522009|NCT01358357|11674055|FG002|NOT COMPLETED|Double-Blind Phase||0
10522010|NCT01358526|11674064|FG000|STARTED|Open-label Titration Period||1095
10522011|NCT01358526|11674065|FG001|STARTED|Open-label Titration Period||0
10522012|NCT01358526|11674066|FG002|STARTED|Open-label Titration Period||0
10522013|NCT01358526|11674064|FG000|COMPLETED|Open-label Titration Period|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|601
10522014|NCT01358526|11674065|FG001|COMPLETED|Open-label Titration Period||0
10522015|NCT01358526|11674066|FG002|COMPLETED|Open-label Titration Period||0
10522016|NCT01358526|11674064|FG000|NOT COMPLETED|Open-label Titration Period||494
10522017|NCT01358526|11674065|FG001|NOT COMPLETED|Open-label Titration Period||0
10522018|NCT01358526|11674066|FG002|NOT COMPLETED|Open-label Titration Period||0
10522019|NCT01358526|11674064|FG000|STARTED|Double-blind Phase||0
10548395|NCT01519284|11702193|FG001|COMPLETED|Overall Study||16
10522020|NCT01358526|11674065|FG001|STARTED|Double-blind Phase|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|298
10522021|NCT01358526|11674066|FG002|STARTED|Double-blind Phase|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|302
10522022|NCT01358526|11674064|FG000|COMPLETED|Double-blind Phase||0
10522023|NCT01358526|11674065|FG001|COMPLETED|Double-blind Phase||218
10522024|NCT01358526|11674066|FG002|COMPLETED|Double-blind Phase||181
10522025|NCT01358526|11674064|FG000|NOT COMPLETED|Double-blind Phase||0
10522026|NCT01358526|11674065|FG001|NOT COMPLETED|Double-blind Phase||80
10522027|NCT01358526|11674066|FG002|NOT COMPLETED|Double-blind Phase||121
10522028|NCT01358578|11674077|FG000|STARTED|Induction Period||327
10522029|NCT01358578|11674078|FG001|STARTED|Induction Period||327
10522030|NCT01358578|11674079|FG002|STARTED|Induction Period||326
10522031|NCT01358578|11674080|FG003|STARTED|Induction Period||326
10522032|NCT01358578|11674081|FG004|STARTED|Induction Period|These groups are populated after the induction period|0
10522033|NCT01358578|11674082|FG005|STARTED|Induction Period|These groups are populated after the induction period|0
10522034|NCT01358578|11674077|FG000|COMPLETED|Induction Period||315
10522035|NCT01358578|11674078|FG001|COMPLETED|Induction Period||312
10522036|NCT01358578|11674079|FG002|COMPLETED|Induction Period||301
10522037|NCT01358578|11674080|FG003|COMPLETED|Induction Period||305
10522038|NCT01358578|11674081|FG004|COMPLETED|Induction Period|These groups are populated after the induction period|0
10522039|NCT01358578|11674082|FG005|COMPLETED|Induction Period|These groups are populated after the induction period|0
10522040|NCT01358578|11674077|FG000|NOT COMPLETED|Induction Period||12
10522041|NCT01358578|11674078|FG001|NOT COMPLETED|Induction Period||15
10522042|NCT01358578|11674079|FG002|NOT COMPLETED|Induction Period||25
10522043|NCT01358578|11674080|FG003|NOT COMPLETED|Induction Period||21
10522044|NCT01358578|11674081|FG004|NOT COMPLETED|Induction Period||0
10522045|NCT01358578|11674082|FG005|NOT COMPLETED|Induction Period||0
10522046|NCT01358578|11674077|FG000|STARTED|Maintenance Period||315
10522047|NCT01358578|11674078|FG001|STARTED|Maintenance Period||312
10522048|NCT01358578|11674079|FG002|STARTED|Maintenance Period||17
10522049|NCT01358578|11674080|FG003|STARTED|Maintenance Period||305
10522050|NCT01358578|11674081|FG004|STARTED|Maintenance Period||142
10522051|NCT01358578|11674082|FG005|STARTED|Maintenance Period||142
10522052|NCT01358578|11674077|FG000|COMPLETED|Maintenance Period||276
10522053|NCT01358578|11674078|FG001|COMPLETED|Maintenance Period||290
10522054|NCT01358578|11674079|FG002|COMPLETED|Maintenance Period||15
10522055|NCT01358578|11674080|FG003|COMPLETED|Maintenance Period||263
10522056|NCT01358578|11674081|FG004|COMPLETED|Maintenance Period||125
10522057|NCT01358578|11674082|FG005|COMPLETED|Maintenance Period||131
10522058|NCT01358578|11674077|FG000|NOT COMPLETED|Maintenance Period||39
10522059|NCT01358578|11674078|FG001|NOT COMPLETED|Maintenance Period||22
10522060|NCT01358578|11674079|FG002|NOT COMPLETED|Maintenance Period||2
10522061|NCT01358578|11674080|FG003|NOT COMPLETED|Maintenance Period||42
10522062|NCT01358578|11674081|FG004|NOT COMPLETED|Maintenance Period||17
10522063|NCT01358578|11674082|FG005|NOT COMPLETED|Maintenance Period||11
10522064|NCT01358578|11674077|FG000|STARTED|Follow-up Period|Patients prior to follow up who did not enter the extension study but received the 150 mg dose|148
10522065|NCT01358578|11674078|FG001|STARTED|Follow-up Period|Patients prior to follow up who did not enter the extension study but received the 300 mg dose|125
10522066|NCT01358578|11674079|FG002|STARTED|Follow-up Period|contains patients who participated in follow up period from induction and maintenance|26
10522067|NCT01358578|11674080|FG003|STARTED|Follow-up Period|contains patients who participated in follow up period from induction and maintenance|279
10522068|NCT01358578|11674081|FG004|STARTED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
10522069|NCT01358578|11674082|FG005|STARTED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
10522070|NCT01358578|11674077|FG000|COMPLETED|Follow-up Period||138
10522071|NCT01358578|11674078|FG001|COMPLETED|Follow-up Period||119
10522072|NCT01358578|11674079|FG002|COMPLETED|Follow-up Period|contains patients who completed follow up period from induction and maintenance|21
10522073|NCT01358578|11674080|FG003|COMPLETED|Follow-up Period|contains patients who completed follow up period from induction and maintenance|260
10522074|NCT01358578|11674081|FG004|COMPLETED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
10522149|NCT01358864|11674189|FG006|STARTED|Overall Study||146
10522075|NCT01358578|11674082|FG005|COMPLETED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
10522076|NCT01358578|11674077|FG000|NOT COMPLETED|Follow-up Period||10
10522077|NCT01358578|11674078|FG001|NOT COMPLETED|Follow-up Period||6
10522078|NCT01358578|11674079|FG002|NOT COMPLETED|Follow-up Period||5
10522079|NCT01358578|11674080|FG003|NOT COMPLETED|Follow-up Period||19
10522080|NCT01358578|11674081|FG004|NOT COMPLETED|Follow-up Period||0
10522081|NCT01358578|11674082|FG005|NOT COMPLETED|Follow-up Period||0
10522082|NCT01358708|11674112|FG000|STARTED|Double-Blind Treatment Phase||13
10522083|NCT01358708|11674113|FG001|STARTED|Double-Blind Treatment Phase||13
10522084|NCT01358708|11674112|FG000|Randomized|Double-Blind Treatment Phase||13
10522085|NCT01358708|11674113|FG001|Randomized|Double-Blind Treatment Phase||13
10522086|NCT01358708|11674112|FG000|Received Study Medication|Double-Blind Treatment Phase|For 1 subject, unused med not returned to the site and intake of study medication not confirmed.|12
10522087|NCT01358708|11674113|FG001|Received Study Medication|Double-Blind Treatment Phase||13
10711922|NCT02664311|11877373|FG001|COMPLETED|Overall Study||3
10711923|NCT02664311|11877372|FG000|NOT COMPLETED|Overall Study||0
10711924|NCT02664311|11877373|FG001|NOT COMPLETED|Overall Study||0
10711925|NCT02664363|11877379|FG000|STARTED|Overall Study||3
10711926|NCT02664363|11877379|FG000|COMPLETED|Overall Study||3
10522088|NCT01358708|11674112|FG000|COMPLETED|Double-Blind Treatment Phase||10
10522089|NCT01358708|11674113|FG001|COMPLETED|Double-Blind Treatment Phase||13
10522090|NCT01358708|11674112|FG000|NOT COMPLETED|Double-Blind Treatment Phase||3
10522091|NCT01358708|11674113|FG001|NOT COMPLETED|Double-Blind Treatment Phase||0
10522092|NCT01358708|11674112|FG000|STARTED|Open-Label Treatment Phase|Number of subjects on LACTEOL® during double-blind treatment and entering the Open-Label Phase|5
10522093|NCT01358708|11674113|FG001|STARTED|Open-Label Treatment Phase|Number of subjects on PLACEBO during double-blind treatment and entering the Open-Label Phase|12
10522094|NCT01358708|11674112|FG000|COMPLETED|Open-Label Treatment Phase||5
10522095|NCT01358708|11674113|FG001|COMPLETED|Open-Label Treatment Phase||12
10522096|NCT01358708|11674112|FG000|NOT COMPLETED|Open-Label Treatment Phase||0
10522097|NCT01358708|11674113|FG001|NOT COMPLETED|Open-Label Treatment Phase||0
10522098|NCT01358721|11674127|FG000|STARTED|Overall Study||22
10522099|NCT01358721|11674128|FG001|STARTED|Overall Study||22
10711927|NCT02664363|11877379|FG000|NOT COMPLETED|Overall Study||0
10711928|NCT02664415|11877385|FG000|STARTED|Overall Study||14
10711929|NCT02664415|11877386|FG001|STARTED|Overall Study||5
10522100|NCT01358721|11674129|FG002|STARTED|Overall Study||23
10522101|NCT01358721|11674130|FG003|STARTED|Overall Study||24
10522102|NCT01358721|11674127|FG000|COMPLETED|Overall Study||1
10522103|NCT01358721|11674128|FG001|COMPLETED|Overall Study||0
10522104|NCT01358721|11674129|FG002|COMPLETED|Overall Study||1
10522105|NCT01358721|11674130|FG003|COMPLETED|Overall Study||0
10522106|NCT01358721|11674127|FG000|NOT COMPLETED|Overall Study||21
10522107|NCT01358721|11674128|FG001|NOT COMPLETED|Overall Study||22
10522108|NCT01358721|11674129|FG002|NOT COMPLETED|Overall Study||22
10522109|NCT01358721|11674130|FG003|NOT COMPLETED|Overall Study||24
10522110|NCT01358734|11674143|FG000|STARTED|Overall Study||15
10522111|NCT01358734|11674144|FG001|STARTED|Overall Study||39
10522112|NCT01358734|11674145|FG002|STARTED|Overall Study||34
10522113|NCT01358734|11674143|FG000|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|14
10522114|NCT01358734|11674144|FG001|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|38
10522115|NCT01358734|11674145|FG002|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|32
10522116|NCT01358734|11674143|FG000|COMPLETED|Overall Study||0
10522117|NCT01358734|11674144|FG001|COMPLETED|Overall Study||0
10522118|NCT01358734|11674145|FG002|COMPLETED|Overall Study||0
10522119|NCT01358734|11674143|FG000|NOT COMPLETED|Overall Study||15
10522120|NCT01358734|11674144|FG001|NOT COMPLETED|Overall Study||39
10522121|NCT01358734|11674145|FG002|NOT COMPLETED|Overall Study||34
10522122|NCT01358760|11674156|FG000|STARTED|Overall Study||152
10522123|NCT01358760|11674157|FG001|STARTED|Overall Study||148
10522124|NCT01358760|11674158|FG002|STARTED|Overall Study||150
10522125|NCT01358760|11674156|FG000|Safety Population|Overall Study||150
10522126|NCT01358760|11674157|FG001|Safety Population|Overall Study||143
10522127|NCT01358760|11674158|FG002|Safety Population|Overall Study||148
10522128|NCT01358760|11674156|FG000|ITT Population|Overall Study||139
10522129|NCT01358760|11674157|FG001|ITT Population|Overall Study||134
10522130|NCT01358760|11674158|FG002|ITT Population|Overall Study||134
10522131|NCT01358760|11674156|FG000|COMPLETED|Overall Study||130
10522132|NCT01358760|11674157|FG001|COMPLETED|Overall Study||128
10522133|NCT01358760|11674158|FG002|COMPLETED|Overall Study||125
10522134|NCT01358760|11674156|FG000|NOT COMPLETED|Overall Study||22
10522135|NCT01358760|11674157|FG001|NOT COMPLETED|Overall Study||20
10522136|NCT01358760|11674158|FG002|NOT COMPLETED|Overall Study||25
10522137|NCT01358825|11674168|FG000|STARTED|Overall Study||12
10522138|NCT01358825|11674169|FG001|STARTED|Overall Study||46
10522139|NCT01358825|11674168|FG000|COMPLETED|Overall Study||12
10522140|NCT01358825|11674169|FG001|COMPLETED|Overall Study||45
10522141|NCT01358825|11674168|FG000|NOT COMPLETED|Overall Study||0
10522142|NCT01358825|11674169|FG001|NOT COMPLETED|Overall Study||1
10522143|NCT01358864|11674183|FG000|STARTED|Overall Study||49
10522144|NCT01358864|11674184|FG001|STARTED|Overall Study||99
10522145|NCT01358864|11674185|FG002|STARTED|Overall Study||103
10522146|NCT01358864|11674186|FG003|STARTED|Overall Study||29
10522147|NCT01358864|11674187|FG004|STARTED|Overall Study||57
10522148|NCT01358864|11674188|FG005|STARTED|Overall Study||55
10522150|NCT01358864|11674190|FG007|STARTED|Overall Study||140
10522151|NCT01358864|11674183|FG000|COMPLETED|Overall Study||18
10522152|NCT01358864|11674184|FG001|COMPLETED|Overall Study||86
10522153|NCT01358864|11674185|FG002|COMPLETED|Overall Study||87
10522154|NCT01358864|11674186|FG003|COMPLETED|Overall Study||10
10522155|NCT01358864|11674187|FG004|COMPLETED|Overall Study||46
10522156|NCT01358864|11674188|FG005|COMPLETED|Overall Study||42
10522157|NCT01358864|11674189|FG006|COMPLETED|Overall Study||81
10522158|NCT01358864|11674190|FG007|COMPLETED|Overall Study||85
10522159|NCT01358864|11674183|FG000|NOT COMPLETED|Overall Study||31
10522160|NCT01358864|11674184|FG001|NOT COMPLETED|Overall Study||13
10522161|NCT01358864|11674185|FG002|NOT COMPLETED|Overall Study||16
10522162|NCT01358864|11674186|FG003|NOT COMPLETED|Overall Study||19
10522163|NCT01358864|11674187|FG004|NOT COMPLETED|Overall Study||11
10522164|NCT01358864|11674188|FG005|NOT COMPLETED|Overall Study||13
10522165|NCT01358864|11674189|FG006|NOT COMPLETED|Overall Study||65
10711930|NCT02664415|11877385|FG000|COMPLETED|Overall Study||13
10711931|NCT02664415|11877386|FG001|COMPLETED|Overall Study||5
10522166|NCT01358864|11674190|FG007|NOT COMPLETED|Overall Study||55
10522167|NCT01358968|11674210|FG000|STARTED|Period 1||20
10522168|NCT01358968|11674211|FG001|STARTED|Period 1||0
10522169|NCT01358968|11674212|FG002|STARTED|Period 1||0
10522170|NCT01358968|11674213|FG003|STARTED|Period 1||0
10522171|NCT01358968|11674210|FG000|Received at Least 1 Dose of Study Drug|Period 1||20
10522172|NCT01358968|11674211|FG001|Received at Least 1 Dose of Study Drug|Period 1||0
10522173|NCT01358968|11674212|FG002|Received at Least 1 Dose of Study Drug|Period 1||0
10522174|NCT01358968|11674213|FG003|Received at Least 1 Dose of Study Drug|Period 1||0
10522175|NCT01358968|11674210|FG000|COMPLETED|Period 1||20
10522176|NCT01358968|11674211|FG001|COMPLETED|Period 1||0
10522177|NCT01358968|11674212|FG002|COMPLETED|Period 1||0
10522178|NCT01358968|11674213|FG003|COMPLETED|Period 1||0
10522179|NCT01358968|11674210|FG000|NOT COMPLETED|Period 1||0
10522180|NCT01358968|11674211|FG001|NOT COMPLETED|Period 1||0
10522181|NCT01358968|11674212|FG002|NOT COMPLETED|Period 1||0
10522182|NCT01358968|11674213|FG003|NOT COMPLETED|Period 1||0
10522183|NCT01358968|11674210|FG000|STARTED|Period 2||0
10522184|NCT01358968|11674211|FG001|STARTED|Period 2||20
10522185|NCT01358968|11674212|FG002|STARTED|Period 2||0
10522186|NCT01358968|11674213|FG003|STARTED|Period 2||0
10522187|NCT01358968|11674210|FG000|Received at Least 1 Dose of Study Drug|Period 2||0
10810277|NCT03800030|11972168|FG005|NOT COMPLETED|Baseline||0
10810278|NCT03800030|11972163|FG000|STARTED|Pre-Randomization Period (1 Week)||4
10810279|NCT03800030|11972164|FG001|STARTED|Pre-Randomization Period (1 Week)||4
10522188|NCT01358968|11674211|FG001|Received at Least 1 Dose of Study Drug|Period 2||19
10522189|NCT01358968|11674212|FG002|Received at Least 1 Dose of Study Drug|Period 2||0
10522190|NCT01358968|11674213|FG003|Received at Least 1 Dose of Study Drug|Period 2||0
10522191|NCT01358968|11674210|FG000|COMPLETED|Period 2||0
10522192|NCT01358968|11674211|FG001|COMPLETED|Period 2||19
10522193|NCT01358968|11674212|FG002|COMPLETED|Period 2||0
10522194|NCT01358968|11674213|FG003|COMPLETED|Period 2||0
10522195|NCT01358968|11674210|FG000|NOT COMPLETED|Period 2||0
10522196|NCT01358968|11674211|FG001|NOT COMPLETED|Period 2||1
10522197|NCT01358968|11674212|FG002|NOT COMPLETED|Period 2||0
10522198|NCT01358968|11674213|FG003|NOT COMPLETED|Period 2||0
10522199|NCT01358968|11674210|FG000|STARTED|Continued Access Phase||0
10522200|NCT01358968|11674211|FG001|STARTED|Continued Access Phase||0
10522201|NCT01358968|11674212|FG002|STARTED|Continued Access Phase||12
10522202|NCT01358968|11674213|FG003|STARTED|Continued Access Phase||7
10522203|NCT01358968|11674210|FG000|Received at Least 1 Dose of Study Drug|Continued Access Phase||0
10522204|NCT01358968|11674211|FG001|Received at Least 1 Dose of Study Drug|Continued Access Phase||0
10522205|NCT01358968|11674212|FG002|Received at Least 1 Dose of Study Drug|Continued Access Phase||12
10522206|NCT01358968|11674213|FG003|Received at Least 1 Dose of Study Drug|Continued Access Phase||7
10522207|NCT01358968|11674210|FG000|COMPLETED|Continued Access Phase||0
10522208|NCT01358968|11674211|FG001|COMPLETED|Continued Access Phase||0
10522209|NCT01358968|11674212|FG002|COMPLETED|Continued Access Phase||0
10522210|NCT01358968|11674213|FG003|COMPLETED|Continued Access Phase||0
10522211|NCT01358968|11674210|FG000|NOT COMPLETED|Continued Access Phase||0
10810280|NCT03800030|11972165|FG002|STARTED|Pre-Randomization Period (1 Week)||4
10810281|NCT03800030|11972166|FG003|STARTED|Pre-Randomization Period (1 Week)||6
10810282|NCT03800030|11972167|FG004|STARTED|Pre-Randomization Period (1 Week)||4
10810283|NCT03800030|11972168|FG005|STARTED|Pre-Randomization Period (1 Week)||4
10810284|NCT03800030|11972163|FG000|COMPLETED|Pre-Randomization Period (1 Week)||4
10810285|NCT03800030|11972164|FG001|COMPLETED|Pre-Randomization Period (1 Week)||4
10810286|NCT03800030|11972165|FG002|COMPLETED|Pre-Randomization Period (1 Week)||4
10810287|NCT03800030|11972166|FG003|COMPLETED|Pre-Randomization Period (1 Week)||6
10810288|NCT03800030|11972167|FG004|COMPLETED|Pre-Randomization Period (1 Week)||4
10810289|NCT03800030|11972168|FG005|COMPLETED|Pre-Randomization Period (1 Week)||4
10810290|NCT03800030|11972163|FG000|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
10810291|NCT03800030|11972164|FG001|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
10810292|NCT03800030|11972165|FG002|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
10810293|NCT03800030|11972166|FG003|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
10810294|NCT03800030|11972167|FG004|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
10810295|NCT03800030|11972168|FG005|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
10810296|NCT03800030|11972163|FG000|STARTED|First Intervention||4
10810297|NCT03800030|11972164|FG001|STARTED|First Intervention||4
10810298|NCT03800030|11972165|FG002|STARTED|First Intervention||4
10810299|NCT03800030|11972166|FG003|STARTED|First Intervention||6
10810300|NCT03800030|11972167|FG004|STARTED|First Intervention||4
10522212|NCT01358968|11674211|FG001|NOT COMPLETED|Continued Access Phase||0
10522213|NCT01358968|11674212|FG002|NOT COMPLETED|Continued Access Phase||12
10522214|NCT01358968|11674213|FG003|NOT COMPLETED|Continued Access Phase||7
10522215|NCT01358981|11674230|FG000|STARTED|Period 1||2
10522216|NCT01358981|11674231|FG001|STARTED|Period 1||2
10522217|NCT01358981|11674232|FG002|STARTED|Period 1||2
10522218|NCT01358981|11674233|FG003|STARTED|Period 1||2
10522219|NCT01358981|11674234|FG004|STARTED|Period 1||3
10522220|NCT01358981|11674235|FG005|STARTED|Period 1||3
10522221|NCT01358981|11674236|FG006|STARTED|Period 1||3
10522222|NCT01358981|11674230|FG000|Received at Least 1dose of Study Drug|Period 1||2
10522223|NCT01358981|11674231|FG001|Received at Least 1dose of Study Drug|Period 1||2
10522224|NCT01358981|11674232|FG002|Received at Least 1dose of Study Drug|Period 1||2
10522225|NCT01358981|11674233|FG003|Received at Least 1dose of Study Drug|Period 1||2
10522226|NCT01358981|11674234|FG004|Received at Least 1dose of Study Drug|Period 1||3
10522227|NCT01358981|11674235|FG005|Received at Least 1dose of Study Drug|Period 1||3
10522228|NCT01358981|11674236|FG006|Received at Least 1dose of Study Drug|Period 1||3
10522229|NCT01358981|11674230|FG000|COMPLETED|Period 1||2
10522230|NCT01358981|11674231|FG001|COMPLETED|Period 1||2
10522231|NCT01358981|11674232|FG002|COMPLETED|Period 1||2
10522232|NCT01358981|11674233|FG003|COMPLETED|Period 1||1
10522233|NCT01358981|11674234|FG004|COMPLETED|Period 1||3
10522234|NCT01358981|11674235|FG005|COMPLETED|Period 1||3
10522235|NCT01358981|11674236|FG006|COMPLETED|Period 1||3
10522236|NCT01358981|11674230|FG000|NOT COMPLETED|Period 1||0
10522237|NCT01358981|11674231|FG001|NOT COMPLETED|Period 1||0
10522238|NCT01358981|11674232|FG002|NOT COMPLETED|Period 1||0
10522239|NCT01358981|11674233|FG003|NOT COMPLETED|Period 1||1
10522240|NCT01358981|11674234|FG004|NOT COMPLETED|Period 1||0
10522241|NCT01358981|11674235|FG005|NOT COMPLETED|Period 1||0
10522242|NCT01358981|11674236|FG006|NOT COMPLETED|Period 1||0
10522243|NCT01358981|11674230|FG000|STARTED|Period 2||2
10522244|NCT01358981|11674231|FG001|STARTED|Period 2||2
10522245|NCT01358981|11674232|FG002|STARTED|Period 2||2
10522246|NCT01358981|11674233|FG003|STARTED|Period 2|One participant who withdrew in period 1 was replaced by another participant in period 2.|2
10522247|NCT01358981|11674234|FG004|STARTED|Period 2||3
10522248|NCT01358981|11674235|FG005|STARTED|Period 2||3
10522249|NCT01358981|11674236|FG006|STARTED|Period 2||3
10522250|NCT01358981|11674230|FG000|COMPLETED|Period 2||2
10522251|NCT01358981|11674231|FG001|COMPLETED|Period 2||2
10522252|NCT01358981|11674232|FG002|COMPLETED|Period 2||2
10522253|NCT01358981|11674233|FG003|COMPLETED|Period 2||2
10522254|NCT01358981|11674234|FG004|COMPLETED|Period 2||3
10522255|NCT01358981|11674235|FG005|COMPLETED|Period 2||3
10522256|NCT01358981|11674236|FG006|COMPLETED|Period 2||3
10522257|NCT01358981|11674230|FG000|NOT COMPLETED|Period 2||0
10522258|NCT01358981|11674231|FG001|NOT COMPLETED|Period 2||0
10522259|NCT01358981|11674232|FG002|NOT COMPLETED|Period 2||0
10522260|NCT01358981|11674233|FG003|NOT COMPLETED|Period 2||0
10522261|NCT01358981|11674234|FG004|NOT COMPLETED|Period 2||0
10522262|NCT01358981|11674235|FG005|NOT COMPLETED|Period 2||0
10522263|NCT01358981|11674236|FG006|NOT COMPLETED|Period 2||0
10522264|NCT01358981|11674230|FG000|STARTED|Period 3||2
10522265|NCT01358981|11674231|FG001|STARTED|Period 3||2
10522266|NCT01358981|11674232|FG002|STARTED|Period 3||2
10522267|NCT01358981|11674233|FG003|STARTED|Period 3||2
10522268|NCT01358981|11674234|FG004|STARTED|Period 3||3
10522269|NCT01358981|11674235|FG005|STARTED|Period 3||3
10522270|NCT01358981|11674236|FG006|STARTED|Period 3||3
10522271|NCT01358981|11674230|FG000|COMPLETED|Period 3||2
10522272|NCT01358981|11674231|FG001|COMPLETED|Period 3||2
10522273|NCT01358981|11674232|FG002|COMPLETED|Period 3||2
10522274|NCT01358981|11674233|FG003|COMPLETED|Period 3||2
10522275|NCT01358981|11674234|FG004|COMPLETED|Period 3||3
10522276|NCT01358981|11674235|FG005|COMPLETED|Period 3||3
10522277|NCT01358981|11674236|FG006|COMPLETED|Period 3||3
10522278|NCT01358981|11674230|FG000|NOT COMPLETED|Period 3||0
10522279|NCT01358981|11674231|FG001|NOT COMPLETED|Period 3||0
10522280|NCT01358981|11674232|FG002|NOT COMPLETED|Period 3||0
10522281|NCT01358981|11674233|FG003|NOT COMPLETED|Period 3||0
10522282|NCT01358981|11674234|FG004|NOT COMPLETED|Period 3||0
10522283|NCT01358981|11674235|FG005|NOT COMPLETED|Period 3||0
10522284|NCT01358981|11674236|FG006|NOT COMPLETED|Period 3||0
10522285|NCT01358981|11674230|FG000|STARTED|Period 4||2
10522286|NCT01358981|11674231|FG001|STARTED|Period 4||2
10522287|NCT01358981|11674232|FG002|STARTED|Period 4||2
10522288|NCT01358981|11674233|FG003|STARTED|Period 4||2
10522289|NCT01358981|11674234|FG004|STARTED|Period 4|Part B was planned for only 3 dosing periods.|0
10522290|NCT01358981|11674235|FG005|STARTED|Period 4|Part B was planned for only 3 dosing periods.|0
10522291|NCT01358981|11674236|FG006|STARTED|Period 4|Part B was planned for only 3 dosing periods.|0
10522292|NCT01358981|11674230|FG000|COMPLETED|Period 4||2
10522293|NCT01358981|11674231|FG001|COMPLETED|Period 4||2
10522294|NCT01358981|11674232|FG002|COMPLETED|Period 4||2
10522295|NCT01358981|11674233|FG003|COMPLETED|Period 4||2
10522296|NCT01358981|11674234|FG004|COMPLETED|Period 4||0
10522297|NCT01358981|11674235|FG005|COMPLETED|Period 4||0
10522298|NCT01358981|11674236|FG006|COMPLETED|Period 4||0
10522299|NCT01358981|11674230|FG000|NOT COMPLETED|Period 4||0
10522300|NCT01358981|11674231|FG001|NOT COMPLETED|Period 4||0
10522301|NCT01358981|11674232|FG002|NOT COMPLETED|Period 4||0
10522302|NCT01358981|11674233|FG003|NOT COMPLETED|Period 4||0
10522303|NCT01358981|11674234|FG004|NOT COMPLETED|Period 4||0
10522304|NCT01358981|11674235|FG005|NOT COMPLETED|Period 4||0
10522305|NCT01358981|11674236|FG006|NOT COMPLETED|Period 4||0
10522306|NCT01359007|11674261|FG000|STARTED|Overall Study||5
10522307|NCT01359007|11674261|FG000|COMPLETED|Overall Study||3
10522308|NCT01359007|11674261|FG000|NOT COMPLETED|Overall Study||2
10522309|NCT01359046|11674268|FG000|STARTED|Overall Study||144
10522310|NCT01359046|11674269|FG001|STARTED|Overall Study||144
10522311|NCT01359046|11674268|FG000|COMPLETED|Overall Study||137
10522312|NCT01359046|11674269|FG001|COMPLETED|Overall Study||127
10522313|NCT01359046|11674268|FG000|NOT COMPLETED|Overall Study||7
10522314|NCT01359046|11674269|FG001|NOT COMPLETED|Overall Study||17
10522315|NCT01359111|11674275|FG000|STARTED|Overall Study||20
10522316|NCT01359111|11674275|FG000|COMPLETED|Overall Study||20
10522317|NCT01359111|11674275|FG000|NOT COMPLETED|Overall Study||0
10522318|NCT01359150|11674283|FG000|STARTED|Overall Study||112
10522319|NCT01359150|11674284|FG001|STARTED|Overall Study||111
10522320|NCT01359150|11674283|FG000|COMPLETED|Overall Study||105
10522321|NCT01359150|11674284|FG001|COMPLETED|Overall Study||106
10522322|NCT01359150|11674283|FG000|NOT COMPLETED|Overall Study||7
10522323|NCT01359150|11674284|FG001|NOT COMPLETED|Overall Study||5
10522324|NCT01359371|11674290|FG000|STARTED|Overall Study||131
10522325|NCT01359371|11674290|FG000|COMPLETED|Overall Study||131
10522326|NCT01359371|11674290|FG000|NOT COMPLETED|Overall Study||0
10522327|NCT01359410|11674301|FG000|STARTED|Overall Study||54
10522328|NCT01359410|11674302|FG001|STARTED|Overall Study||46
10522329|NCT01359410|11674301|FG000|COMPLETED|Overall Study||54
10522330|NCT01359410|11674302|FG001|COMPLETED|Overall Study||46
10522331|NCT01359410|11674301|FG000|NOT COMPLETED|Overall Study||0
10522332|NCT01359410|11674302|FG001|NOT COMPLETED|Overall Study||0
10522333|NCT01359449|11674310|FG000|STARTED|Overall Study||61
10522334|NCT01359449|11674311|FG001|STARTED|Overall Study||62
10522335|NCT01359449|11674310|FG000|COMPLETED|Overall Study||57
10522336|NCT01359449|11674311|FG001|COMPLETED|Overall Study||58
10522337|NCT01359449|11674310|FG000|NOT COMPLETED|Overall Study||4
10711932|NCT02664415|11877385|FG000|NOT COMPLETED|Overall Study||1
10711933|NCT02664415|11877386|FG001|NOT COMPLETED|Overall Study||0
10711934|NCT02664532|11877394|FG000|STARTED|Overall Study||75
10522338|NCT01359449|11674311|FG001|NOT COMPLETED|Overall Study||4
10522371|NCT01359644|11674345|FG000|STARTED|Treatment Period||15
10522372|NCT01359644|11674346|FG001|STARTED|Treatment Period||16
10522373|NCT01359644|11674347|FG002|STARTED|Treatment Period||14
10522374|NCT01359644|11674348|FG003|STARTED|Treatment Period||14
10522375|NCT01359644|11674349|FG004|STARTED|Treatment Period||15
10522376|NCT01359644|11674350|FG005|STARTED|Treatment Period||14
10522377|NCT01359644|11674351|FG006|STARTED|Treatment Period||41
10522378|NCT01359644|11674352|FG007|STARTED|Treatment Period||41
10522379|NCT01359644|11674353|FG008|STARTED|Treatment Period||21
10522380|NCT01359644|11674354|FG009|STARTED|Treatment Period||20
10522381|NCT01359644|11674345|FG000|COMPLETED|Treatment Period||15
10522382|NCT01359644|11674346|FG001|COMPLETED|Treatment Period||15
10522383|NCT01359644|11674347|FG002|COMPLETED|Treatment Period||13
10522384|NCT01359644|11674348|FG003|COMPLETED|Treatment Period||14
10522385|NCT01359644|11674349|FG004|COMPLETED|Treatment Period||15
10711935|NCT02664532|11877395|FG001|STARTED|Overall Study||75
10711936|NCT02664532|11877394|FG000|COMPLETED|Overall Study||75
10711937|NCT02664532|11877395|FG001|COMPLETED|Overall Study||75
10711938|NCT02664532|11877394|FG000|NOT COMPLETED|Overall Study||0
10711939|NCT02664532|11877395|FG001|NOT COMPLETED|Overall Study||0
10711940|NCT02664610|11877403|FG000|STARTED|Overall Study||46
10711941|NCT02664610|11877404|FG001|STARTED|Overall Study||48
10522386|NCT01359644|11674350|FG005|COMPLETED|Treatment Period||12
10711942|NCT02664610|11877403|FG000|COMPLETED|Overall Study||32
10522387|NCT01359644|11674351|FG006|COMPLETED|Treatment Period||41
10522388|NCT01359644|11674352|FG007|COMPLETED|Treatment Period||41
10522389|NCT01359644|11674353|FG008|COMPLETED|Treatment Period||21
10522390|NCT01359644|11674354|FG009|COMPLETED|Treatment Period||20
10522391|NCT01359644|11674345|FG000|NOT COMPLETED|Treatment Period||0
10522392|NCT01359644|11674346|FG001|NOT COMPLETED|Treatment Period||1
10522393|NCT01359644|11674347|FG002|NOT COMPLETED|Treatment Period||1
10522394|NCT01359644|11674348|FG003|NOT COMPLETED|Treatment Period||0
10522395|NCT01359644|11674349|FG004|NOT COMPLETED|Treatment Period||0
10522396|NCT01359644|11674350|FG005|NOT COMPLETED|Treatment Period||2
10711943|NCT02664610|11877404|FG001|COMPLETED|Overall Study||41
10711944|NCT02664610|11877403|FG000|NOT COMPLETED|Overall Study||14
10711945|NCT02664610|11877404|FG001|NOT COMPLETED|Overall Study||7
10711946|NCT02664909|11877412|FG000|STARTED|Overall Study||17
10711947|NCT02664909|11877413|FG001|STARTED|Overall Study||19
10522397|NCT01359644|11674351|FG006|NOT COMPLETED|Treatment Period||0
10522398|NCT01359644|11674352|FG007|NOT COMPLETED|Treatment Period||0
10522399|NCT01359644|11674353|FG008|NOT COMPLETED|Treatment Period||0
10522400|NCT01359644|11674354|FG009|NOT COMPLETED|Treatment Period||0
10522401|NCT01359644|11674345|FG000|STARTED|Follow-up Period||15
10522402|NCT01359644|11674346|FG001|STARTED|Follow-up Period||16
10522403|NCT01359644|11674347|FG002|STARTED|Follow-up Period||14
10522404|NCT01359644|11674348|FG003|STARTED|Follow-up Period||14
10522405|NCT01359644|11674349|FG004|STARTED|Follow-up Period||15
10522406|NCT01359644|11674350|FG005|STARTED|Follow-up Period||13
10522407|NCT01359644|11674351|FG006|STARTED|Follow-up Period||41
10522408|NCT01359644|11674352|FG007|STARTED|Follow-up Period||41
10522409|NCT01359644|11674353|FG008|STARTED|Follow-up Period||21
10522410|NCT01359644|11674354|FG009|STARTED|Follow-up Period||20
10522411|NCT01359644|11674345|FG000|COMPLETED|Follow-up Period||15
10522412|NCT01359644|11674346|FG001|COMPLETED|Follow-up Period||16
10522413|NCT01359644|11674347|FG002|COMPLETED|Follow-up Period||14
10522414|NCT01359644|11674348|FG003|COMPLETED|Follow-up Period||14
10522415|NCT01359644|11674349|FG004|COMPLETED|Follow-up Period||15
10522416|NCT01359644|11674350|FG005|COMPLETED|Follow-up Period||12
10522417|NCT01359644|11674351|FG006|COMPLETED|Follow-up Period||40
10522418|NCT01359644|11674352|FG007|COMPLETED|Follow-up Period||39
10522419|NCT01359644|11674353|FG008|COMPLETED|Follow-up Period||21
10522420|NCT01359644|11674354|FG009|COMPLETED|Follow-up Period||20
10522421|NCT01359644|11674345|FG000|NOT COMPLETED|Follow-up Period||0
10522422|NCT01359644|11674346|FG001|NOT COMPLETED|Follow-up Period||0
10522423|NCT01359644|11674347|FG002|NOT COMPLETED|Follow-up Period||0
10522424|NCT01359644|11674348|FG003|NOT COMPLETED|Follow-up Period||0
10522425|NCT01359644|11674349|FG004|NOT COMPLETED|Follow-up Period||0
10522426|NCT01359644|11674350|FG005|NOT COMPLETED|Follow-up Period||1
10522427|NCT01359644|11674351|FG006|NOT COMPLETED|Follow-up Period||1
10522428|NCT01359644|11674352|FG007|NOT COMPLETED|Follow-up Period||2
10522429|NCT01359644|11674353|FG008|NOT COMPLETED|Follow-up Period||0
10522430|NCT01359644|11674354|FG009|NOT COMPLETED|Follow-up Period||0
10522431|NCT01359735|11674389|FG000|STARTED|Overall Study||4
10522432|NCT01359735|11674390|FG001|STARTED|Overall Study||4
10522433|NCT01359735|11674389|FG000|COMPLETED|Overall Study||4
10522434|NCT01359735|11674390|FG001|COMPLETED|Overall Study||4
10522435|NCT01359735|11674389|FG000|NOT COMPLETED|Overall Study||0
10522436|NCT01359735|11674390|FG001|NOT COMPLETED|Overall Study||0
10522437|NCT01359748|11674400|FG000|STARTED|Overall Study||48
10711948|NCT02664909|11877412|FG000|COMPLETED|Overall Study||15
10711949|NCT02664909|11877413|FG001|COMPLETED|Overall Study||16
10711950|NCT02664909|11877412|FG000|NOT COMPLETED|Overall Study||2
10711951|NCT02664909|11877413|FG001|NOT COMPLETED|Overall Study||3
10711952|NCT02664922|11877423|FG000|STARTED|Overall Study||11
10522438|NCT01359748|11674401|FG001|STARTED|Overall Study||20
10522439|NCT01359748|11674402|FG002|STARTED|Overall Study||10
10522440|NCT01359748|11674403|FG003|STARTED|Overall Study||11
10522441|NCT01359748|11674400|FG000|COMPLETED|Overall Study||48
10522442|NCT01359748|11674401|FG001|COMPLETED|Overall Study||20
10522443|NCT01359748|11674402|FG002|COMPLETED|Overall Study||10
10522444|NCT01359748|11674403|FG003|COMPLETED|Overall Study||11
10522445|NCT01359748|11674400|FG000|NOT COMPLETED|Overall Study||0
10522446|NCT01359748|11674401|FG001|NOT COMPLETED|Overall Study||0
10522447|NCT01359748|11674402|FG002|NOT COMPLETED|Overall Study||0
10522448|NCT01359748|11674403|FG003|NOT COMPLETED|Overall Study||0
10522449|NCT01359904|11674413|FG000|STARTED|Overall Study||15
10522450|NCT01359904|11674414|FG001|STARTED|Overall Study||19
10522451|NCT01359904|11674413|FG000|COMPLETED|Overall Study||14
10522452|NCT01359904|11674414|FG001|COMPLETED|Overall Study||19
10522453|NCT01359904|11674413|FG000|NOT COMPLETED|Overall Study||1
10522454|NCT01359904|11674414|FG001|NOT COMPLETED|Overall Study||0
10522455|NCT01359943|11674423|FG000|STARTED|Double-blind (Weeks 0 - 16)||88
10522456|NCT01359943|11674424|FG001|STARTED|Double-blind (Weeks 0 - 16)||89
10522457|NCT01359943|11674425|FG002|STARTED|Double-blind (Weeks 0 - 16)||44
10522458|NCT01359943|11674423|FG000|COMPLETED|Double-blind (Weeks 0 - 16)||86
10522459|NCT01359943|11674424|FG001|COMPLETED|Double-blind (Weeks 0 - 16)||85
10522460|NCT01359943|11674425|FG002|COMPLETED|Double-blind (Weeks 0 - 16)||44
10711953|NCT02664922|11877424|FG001|STARTED|Overall Study||12
10711954|NCT02664922|11877425|FG002|STARTED|Overall Study||7
10711955|NCT02664922|11877426|FG003|STARTED|Overall Study||5
10522461|NCT01359943|11674423|FG000|NOT COMPLETED|Double-blind (Weeks 0 - 16)||2
10522462|NCT01359943|11674424|FG001|NOT COMPLETED|Double-blind (Weeks 0 - 16)||4
10522463|NCT01359943|11674425|FG002|NOT COMPLETED|Double-blind (Weeks 0 - 16)||0
10522464|NCT01359943|11674423|FG000|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)||86
10522465|NCT01359943|11674424|FG001|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)|One participant, who was continuing as of week 12, did not receive study drug at week 16.|84
10711956|NCT02664922|11877423|FG000|COMPLETED|Overall Study||10
10522466|NCT01359943|11674425|FG002|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)||44
10522467|NCT01359943|11674423|FG000|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||78
10522468|NCT01359943|11674424|FG001|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||71
10522469|NCT01359943|11674425|FG002|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||36
10522470|NCT01359943|11674423|FG000|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||8
10522471|NCT01359943|11674424|FG001|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||13
10522472|NCT01359943|11674425|FG002|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||8
10522473|NCT01359943|11674423|FG000|STARTED|Follow-up (Weeks 52 - 60)||86
10711957|NCT02664922|11877424|FG001|COMPLETED|Overall Study||12
10810301|NCT03800030|11972168|FG005|STARTED|First Intervention||4
10810302|NCT03800030|11972163|FG000|COMPLETED|First Intervention||4
10810303|NCT03800030|11972164|FG001|COMPLETED|First Intervention||4
10810304|NCT03800030|11972165|FG002|COMPLETED|First Intervention||4
10810305|NCT03800030|11972166|FG003|COMPLETED|First Intervention||6
10810306|NCT03800030|11972167|FG004|COMPLETED|First Intervention||4
10810307|NCT03800030|11972168|FG005|COMPLETED|First Intervention||4
10810308|NCT03800030|11972163|FG000|NOT COMPLETED|First Intervention||0
10810309|NCT03800030|11972164|FG001|NOT COMPLETED|First Intervention||0
10810310|NCT03800030|11972165|FG002|NOT COMPLETED|First Intervention||0
10711958|NCT02664922|11877425|FG002|COMPLETED|Overall Study||7
10711959|NCT02664922|11877426|FG003|COMPLETED|Overall Study||5
10711960|NCT02664922|11877423|FG000|NOT COMPLETED|Overall Study||1
10711961|NCT02664922|11877424|FG001|NOT COMPLETED|Overall Study||0
10711962|NCT02664922|11877425|FG002|NOT COMPLETED|Overall Study||0
10711963|NCT02664922|11877426|FG003|NOT COMPLETED|Overall Study||0
10711964|NCT02664961|11877436|FG000|STARTED|Overall Study||3
10711965|NCT02664961|11877436|FG000|COMPLETED|Overall Study||3
10711966|NCT02664961|11877436|FG000|NOT COMPLETED|Overall Study||0
10711967|NCT02664987|11877440|FG000|STARTED|Overall Study||462
10711968|NCT02664987|11877440|FG000|COMPLETED|Overall Study||462
10711969|NCT02664987|11877440|FG000|NOT COMPLETED|Overall Study||0
10711970|NCT02665052|11877448|FG000|STARTED|Overall Study||11
10711971|NCT02665052|11877449|FG001|STARTED|Overall Study||9
10711972|NCT02665052|11877450|FG002|STARTED|Overall Study||9
10810311|NCT03800030|11972166|FG003|NOT COMPLETED|First Intervention||0
10810312|NCT03800030|11972167|FG004|NOT COMPLETED|First Intervention||0
10810313|NCT03800030|11972168|FG005|NOT COMPLETED|First Intervention||0
10810314|NCT03800030|11972163|FG000|STARTED|First Washout (1 Week)||4
10810315|NCT03800030|11972164|FG001|STARTED|First Washout (1 Week)||4
10810316|NCT03800030|11972165|FG002|STARTED|First Washout (1 Week)||4
10810317|NCT03800030|11972166|FG003|STARTED|First Washout (1 Week)||6
10810318|NCT03800030|11972167|FG004|STARTED|First Washout (1 Week)||4
10810319|NCT03800030|11972168|FG005|STARTED|First Washout (1 Week)||4
10810320|NCT03800030|11972163|FG000|COMPLETED|First Washout (1 Week)||4
10810321|NCT03800030|11972164|FG001|COMPLETED|First Washout (1 Week)||4
10810322|NCT03800030|11972165|FG002|COMPLETED|First Washout (1 Week)||4
10810323|NCT03800030|11972166|FG003|COMPLETED|First Washout (1 Week)||6
10810324|NCT03800030|11972167|FG004|COMPLETED|First Washout (1 Week)||4
10810325|NCT03800030|11972168|FG005|COMPLETED|First Washout (1 Week)||4
10810326|NCT03800030|11972163|FG000|NOT COMPLETED|First Washout (1 Week)||0
10810327|NCT03800030|11972164|FG001|NOT COMPLETED|First Washout (1 Week)||0
10810328|NCT03800030|11972165|FG002|NOT COMPLETED|First Washout (1 Week)||0
10810329|NCT03800030|11972166|FG003|NOT COMPLETED|First Washout (1 Week)||0
10810330|NCT03800030|11972167|FG004|NOT COMPLETED|First Washout (1 Week)||0
10810331|NCT03800030|11972168|FG005|NOT COMPLETED|First Washout (1 Week)||0
10810332|NCT03800030|11972163|FG000|STARTED|Second Intervention||4
10810333|NCT03800030|11972164|FG001|STARTED|Second Intervention||4
10810334|NCT03800030|11972165|FG002|STARTED|Second Intervention||4
10810335|NCT03800030|11972166|FG003|STARTED|Second Intervention||6
10810336|NCT03800030|11972167|FG004|STARTED|Second Intervention||4
10810337|NCT03800030|11972168|FG005|STARTED|Second Intervention||4
10810338|NCT03800030|11972163|FG000|COMPLETED|Second Intervention||4
10810339|NCT03800030|11972164|FG001|COMPLETED|Second Intervention||4
10810340|NCT03800030|11972165|FG002|COMPLETED|Second Intervention||4
10810341|NCT03800030|11972166|FG003|COMPLETED|Second Intervention||5
10810342|NCT03800030|11972167|FG004|COMPLETED|Second Intervention||4
10810343|NCT03800030|11972168|FG005|COMPLETED|Second Intervention||4
10810344|NCT03800030|11972163|FG000|NOT COMPLETED|Second Intervention||0
10810345|NCT03800030|11972164|FG001|NOT COMPLETED|Second Intervention||0
10810346|NCT03800030|11972165|FG002|NOT COMPLETED|Second Intervention||0
10810347|NCT03800030|11972166|FG003|NOT COMPLETED|Second Intervention||1
10810348|NCT03800030|11972167|FG004|NOT COMPLETED|Second Intervention||0
10810349|NCT03800030|11972168|FG005|NOT COMPLETED|Second Intervention||0
10810350|NCT03800030|11972163|FG000|STARTED|Second Washout (1 Week)||4
10810351|NCT03800030|11972164|FG001|STARTED|Second Washout (1 Week)||4
10810352|NCT03800030|11972165|FG002|STARTED|Second Washout (1 Week)||4
10810353|NCT03800030|11972166|FG003|STARTED|Second Washout (1 Week)||5
10810354|NCT03800030|11972167|FG004|STARTED|Second Washout (1 Week)||4
10810355|NCT03800030|11972168|FG005|STARTED|Second Washout (1 Week)||4
10810356|NCT03800030|11972163|FG000|COMPLETED|Second Washout (1 Week)||4
10711973|NCT02665052|11877451|FG003|STARTED|Overall Study||19
10711974|NCT02665052|11877448|FG000|COMPLETED|Overall Study||8
10711975|NCT02665052|11877449|FG001|COMPLETED|Overall Study||7
10711976|NCT02665052|11877450|FG002|COMPLETED|Overall Study||9
10711977|NCT02665052|11877451|FG003|COMPLETED|Overall Study||14
10711978|NCT02665052|11877448|FG000|NOT COMPLETED|Overall Study||3
10810357|NCT03800030|11972164|FG001|COMPLETED|Second Washout (1 Week)||4
10810358|NCT03800030|11972165|FG002|COMPLETED|Second Washout (1 Week)||4
10810359|NCT03800030|11972166|FG003|COMPLETED|Second Washout (1 Week)||4
10810360|NCT03800030|11972167|FG004|COMPLETED|Second Washout (1 Week)||4
10810361|NCT03800030|11972168|FG005|COMPLETED|Second Washout (1 Week)||4
10810362|NCT03800030|11972163|FG000|NOT COMPLETED|Second Washout (1 Week)||0
10810363|NCT03800030|11972164|FG001|NOT COMPLETED|Second Washout (1 Week)||0
10810364|NCT03800030|11972165|FG002|NOT COMPLETED|Second Washout (1 Week)||0
10810365|NCT03800030|11972166|FG003|NOT COMPLETED|Second Washout (1 Week)||1
10810366|NCT03800030|11972167|FG004|NOT COMPLETED|Second Washout (1 Week)||0
10810367|NCT03800030|11972168|FG005|NOT COMPLETED|Second Washout (1 Week)||0
10810368|NCT03800030|11972163|FG000|STARTED|Third Intervention||4
10810369|NCT03800030|11972164|FG001|STARTED|Third Intervention||4
10810370|NCT03800030|11972165|FG002|STARTED|Third Intervention||4
10810371|NCT03800030|11972166|FG003|STARTED|Third Intervention||4
10810372|NCT03800030|11972167|FG004|STARTED|Third Intervention||4
10810373|NCT03800030|11972168|FG005|STARTED|Third Intervention||4
10810374|NCT03800030|11972163|FG000|COMPLETED|Third Intervention||4
10810375|NCT03800030|11972164|FG001|COMPLETED|Third Intervention||4
10810376|NCT03800030|11972165|FG002|COMPLETED|Third Intervention||4
10810377|NCT03800030|11972166|FG003|COMPLETED|Third Intervention||4
10810378|NCT03800030|11972167|FG004|COMPLETED|Third Intervention||4
10810379|NCT03800030|11972168|FG005|COMPLETED|Third Intervention||4
10810380|NCT03800030|11972163|FG000|NOT COMPLETED|Third Intervention||0
10810381|NCT03800030|11972164|FG001|NOT COMPLETED|Third Intervention||0
10810382|NCT03800030|11972165|FG002|NOT COMPLETED|Third Intervention||0
10810383|NCT03800030|11972166|FG003|NOT COMPLETED|Third Intervention||0
10810384|NCT03800030|11972167|FG004|NOT COMPLETED|Third Intervention||0
10810385|NCT03800030|11972168|FG005|NOT COMPLETED|Third Intervention||0
10810386|NCT03799211|11972178|FG000|STARTED|Overall Study||36
10810387|NCT03799211|11972179|FG001|STARTED|Overall Study||40
10810388|NCT03799211|11972178|FG000|COMPLETED|Overall Study||32
10810389|NCT03799211|11972179|FG001|COMPLETED|Overall Study||27
10810390|NCT03799211|11972178|FG000|NOT COMPLETED|Overall Study||4
10810391|NCT03799211|11972179|FG001|NOT COMPLETED|Overall Study||13
10810392|NCT03798717|11972193|FG000|STARTED|Overall Study||4
10810393|NCT03798717|11972194|FG001|STARTED|Overall Study||3
10810394|NCT03798717|11972195|FG002|STARTED|Overall Study||3
10810395|NCT03798717|11972196|FG003|STARTED|Overall Study||4
10810396|NCT03798717|11972197|FG004|STARTED|Overall Study||3
10810397|NCT03798717|11972198|FG005|STARTED|Overall Study||3
10810398|NCT03798717|11972193|FG000|COMPLETED|Overall Study||2
10810399|NCT03798717|11972194|FG001|COMPLETED|Overall Study||2
10810400|NCT03798717|11972195|FG002|COMPLETED|Overall Study||2
10810401|NCT03798717|11972196|FG003|COMPLETED|Overall Study||2
10810402|NCT03798717|11972197|FG004|COMPLETED|Overall Study||2
10810403|NCT03798717|11972198|FG005|COMPLETED|Overall Study||2
10810404|NCT03798717|11972193|FG000|NOT COMPLETED|Overall Study||2
10810405|NCT03798717|11972194|FG001|NOT COMPLETED|Overall Study||1
10810406|NCT03798717|11972195|FG002|NOT COMPLETED|Overall Study||1
10810407|NCT03798717|11972196|FG003|NOT COMPLETED|Overall Study||2
10810408|NCT03798717|11972197|FG004|NOT COMPLETED|Overall Study||1
10810409|NCT03798717|11972198|FG005|NOT COMPLETED|Overall Study||1
10810410|NCT03798483|11972207|FG000|STARTED|Overall Study||15
10810411|NCT03798483|11972207|FG000|Returned All Follow-up Outcome Data|Overall Study||11
10810412|NCT03798483|11972207|FG000|COMPLETED|Overall Study||13
10810413|NCT03798483|11972207|FG000|NOT COMPLETED|Overall Study||2
10810414|NCT03798366|11972217|FG000|STARTED|Overall Study||21
10810415|NCT03798366|11972218|FG001|STARTED|Overall Study||12
10810416|NCT03798366|11972217|FG000|COMPLETED|Overall Study||21
10810417|NCT03798366|11972218|FG001|COMPLETED|Overall Study||11
10810418|NCT03798366|11972217|FG000|NOT COMPLETED|Overall Study||0
10810419|NCT03798366|11972218|FG001|NOT COMPLETED|Overall Study||1
10810420|NCT03799952|11972226|FG000|STARTED|Overall Study||31
10810421|NCT03799952|11972227|FG001|STARTED|Overall Study||31
10810422|NCT03799952|11972226|FG000|COMPLETED|Overall Study||30
10810423|NCT03799952|11972227|FG001|COMPLETED|Overall Study||29
10810424|NCT03799952|11972226|FG000|NOT COMPLETED|Overall Study||1
10810425|NCT03799952|11972227|FG001|NOT COMPLETED|Overall Study||2
10810426|NCT03797872|11972235|FG000|STARTED|Overall Study||1
10810427|NCT03797872|11972236|FG001|STARTED|Overall Study||0
10810428|NCT03797872|11972235|FG000|COMPLETED|Overall Study||0
10810429|NCT03797872|11972236|FG001|COMPLETED|Overall Study||0
10810430|NCT03797872|11972235|FG000|NOT COMPLETED|Overall Study||1
10810431|NCT03797872|11972236|FG001|NOT COMPLETED|Overall Study||0
10522474|NCT01359943|11674424|FG001|STARTED|Follow-up (Weeks 52 - 60)||84
10522475|NCT01359943|11674425|FG002|STARTED|Follow-up (Weeks 52 - 60)||44
10810432|NCT03799614|11972244|FG000|STARTED|Overall Study||15
10810433|NCT03799614|11972245|FG001|STARTED|Overall Study||15
10810434|NCT03799614|11972244|FG000|COMPLETED|Overall Study||15
10810435|NCT03799614|11972245|FG001|COMPLETED|Overall Study||15
10810436|NCT03799614|11972244|FG000|NOT COMPLETED|Overall Study||0
10810437|NCT03799614|11972245|FG001|NOT COMPLETED|Overall Study||0
10810438|NCT03799484|11972254|FG000|STARTED|Overall Study||14
10810439|NCT03799484|11972254|FG000|COMPLETED|Overall Study||14
10810440|NCT03799484|11972254|FG000|NOT COMPLETED|Overall Study||0
10810441|NCT03796728|11972261|FG000|STARTED|Overall Study||60
10810442|NCT03796728|11972261|FG000|COMPLETED|Overall Study||36
10810443|NCT03796728|11972261|FG000|NOT COMPLETED|Overall Study||24
10810444|NCT03797144|11972267|FG000|STARTED|Enrollment||16
10810445|NCT03797144|11972268|FG001|STARTED|Enrollment||11
10522476|NCT01359943|11674423|FG000|COMPLETED|Follow-up (Weeks 52 - 60)||78
10522477|NCT01359943|11674424|FG001|COMPLETED|Follow-up (Weeks 52 - 60)||69
10522478|NCT01359943|11674425|FG002|COMPLETED|Follow-up (Weeks 52 - 60)||36
10522479|NCT01359943|11674423|FG000|NOT COMPLETED|Follow-up (Weeks 52 - 60)||8
10522480|NCT01359943|11674424|FG001|NOT COMPLETED|Follow-up (Weeks 52 - 60)||15
10522481|NCT01359943|11674425|FG002|NOT COMPLETED|Follow-up (Weeks 52 - 60)||8
10522482|NCT01359956|11674439|FG000|STARTED|Overall Study||67
10711979|NCT02665052|11877449|FG001|NOT COMPLETED|Overall Study||2
10711980|NCT02665052|11877450|FG002|NOT COMPLETED|Overall Study||0
10711981|NCT02665052|11877451|FG003|NOT COMPLETED|Overall Study||5
10522483|NCT01359956|11674440|FG001|STARTED|Overall Study||69
10522484|NCT01359956|11674441|FG002|STARTED|Overall Study||71
10522485|NCT01359956|11674442|FG003|STARTED|Overall Study||62
10522486|NCT01359956|11674439|FG000|COMPLETED|Overall Study||6
10522487|NCT01359956|11674440|FG001|COMPLETED|Overall Study||5
10522488|NCT01359956|11674441|FG002|COMPLETED|Overall Study||4
10522489|NCT01359956|11674442|FG003|COMPLETED|Overall Study||4
10522490|NCT01359956|11674439|FG000|NOT COMPLETED|Overall Study||61
10522491|NCT01359956|11674440|FG001|NOT COMPLETED|Overall Study||64
10522492|NCT01359956|11674441|FG002|NOT COMPLETED|Overall Study||67
10522493|NCT01359956|11674442|FG003|NOT COMPLETED|Overall Study||58
10522494|NCT01360021|11674455|FG000|STARTED|Overall Study|Patients randomized|71
10522495|NCT01360021|11674456|FG001|STARTED|Overall Study|Patients randomized|71
10522496|NCT01360021|11674457|FG002|STARTED|Overall Study|Patients randomized|72
10522497|NCT01360021|11674455|FG000|COMPLETED|Overall Study|Patients who completed study|63
10522498|NCT01360021|11674456|FG001|COMPLETED|Overall Study|Patients who completed study|67
10522499|NCT01360021|11674457|FG002|COMPLETED|Overall Study|Patients who completed study|65
10522500|NCT01360021|11674455|FG000|NOT COMPLETED|Overall Study||8
10522501|NCT01360021|11674456|FG001|NOT COMPLETED|Overall Study||4
10522502|NCT01360021|11674457|FG002|NOT COMPLETED|Overall Study||7
10522503|NCT01360229|11674467|FG000|STARTED|Overall Study||47
10522504|NCT01360229|11674468|FG001|STARTED|Overall Study||47
10522505|NCT01360229|11674467|FG000|COMPLETED|Overall Study||44
10522506|NCT01360229|11674468|FG001|COMPLETED|Overall Study||45
10522507|NCT01360229|11674467|FG000|NOT COMPLETED|Overall Study||3
10522508|NCT01360229|11674468|FG001|NOT COMPLETED|Overall Study||2
10522509|NCT01360398|11674474|FG000|STARTED|Overall Study||127
10522510|NCT01360398|11674474|FG000|COMPLETED|Overall Study||105
10522511|NCT01360398|11674474|FG000|NOT COMPLETED|Overall Study||22
10522512|NCT01360450|11674480|FG000|STARTED|Overall Study||6
10522513|NCT01360450|11674481|FG001|STARTED|Overall Study||6
10522514|NCT01360450|11674480|FG000|Completed Treatment|Overall Study||6
10522515|NCT01360450|11674481|FG001|Completed Treatment|Overall Study||6
10522516|NCT01360450|11674480|FG000|COMPLETED|Overall Study||6
10522517|NCT01360450|11674481|FG001|COMPLETED|Overall Study||6
10522518|NCT01360450|11674480|FG000|NOT COMPLETED|Overall Study||0
10522519|NCT01360450|11674481|FG001|NOT COMPLETED|Overall Study||0
10522520|NCT01360554|11674490|FG000|STARTED|Overall Study|Three participants were randomized but not treated.|439
10522521|NCT01360554|11674491|FG001|STARTED|Overall Study|Three participants were randomized but not treated.|439
10522522|NCT01360554|11674490|FG000|Treated|Overall Study||436
10522523|NCT01360554|11674491|FG001|Treated|Overall Study||436
10522524|NCT01360554|11674490|FG000|COMPLETED|Overall Study||0
10522525|NCT01360554|11674491|FG001|COMPLETED|Overall Study||0
10522526|NCT01360554|11674490|FG000|NOT COMPLETED|Overall Study||439
10522527|NCT01360554|11674491|FG001|NOT COMPLETED|Overall Study||439
10522528|NCT01360632|11674500|FG000|STARTED|Phase A (8 Weeks)|A total of 1539 participants were enrolled, 7 discontinued before taking any sponsor-provided ADT|1532
10522529|NCT01360632|11674501|FG001|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
10522530|NCT01360632|11674502|FG002|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
10522531|NCT01360632|11674503|FG003|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
10522532|NCT01360632|11674504|FG004|STARTED|Phase A (8 Weeks)||0
10522533|NCT01360632|11674500|FG000|COMPLETED|Phase A (8 Weeks)||1277
10522534|NCT01360632|11674501|FG001|COMPLETED|Phase A (8 Weeks)||0
10522535|NCT01360632|11674502|FG002|COMPLETED|Phase A (8 Weeks)||0
10522536|NCT01360632|11674503|FG003|COMPLETED|Phase A (8 Weeks)||0
10522537|NCT01360632|11674504|FG004|COMPLETED|Phase A (8 Weeks)||0
10522538|NCT01360632|11674500|FG000|NOT COMPLETED|Phase A (8 Weeks)||255
10810446|NCT03797144|11972267|FG000|COMPLETED|Enrollment||12
10810447|NCT03797144|11972268|FG001|COMPLETED|Enrollment||10
10522539|NCT01360632|11674501|FG001|NOT COMPLETED|Phase A (8 Weeks)||0
10522540|NCT01360632|11674502|FG002|NOT COMPLETED|Phase A (8 Weeks)||0
10522541|NCT01360632|11674503|FG003|NOT COMPLETED|Phase A (8 Weeks)||0
10522542|NCT01360632|11674504|FG004|NOT COMPLETED|Phase A (8 Weeks)||0
10522543|NCT01360632|11674500|FG000|STARTED|Phase B (6 Weeks)||0
10522544|NCT01360632|11674501|FG001|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|226
10522545|NCT01360632|11674502|FG002|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|230
10522546|NCT01360632|11674503|FG003|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|221
10522547|NCT01360632|11674504|FG004|STARTED|Phase B (6 Weeks)||0
10522548|NCT01360632|11674500|FG000|COMPLETED|Phase B (6 Weeks)||0
10522549|NCT01360632|11674501|FG001|COMPLETED|Phase B (6 Weeks)||216
10522550|NCT01360632|11674502|FG002|COMPLETED|Phase B (6 Weeks)||210
10522551|NCT01360632|11674503|FG003|COMPLETED|Phase B (6 Weeks)||208
10522552|NCT01360632|11674504|FG004|COMPLETED|Phase B (6 Weeks)||0
10711982|NCT02665260|11877466|FG000|STARTED|Overall Study||24
10711983|NCT02665260|11877467|FG001|STARTED|Overall Study||23
10522553|NCT01360632|11674500|FG000|NOT COMPLETED|Phase B (6 Weeks)||0
10522554|NCT01360632|11674501|FG001|NOT COMPLETED|Phase B (6 Weeks)||10
10522555|NCT01360632|11674502|FG002|NOT COMPLETED|Phase B (6 Weeks)||20
10522556|NCT01360632|11674503|FG003|NOT COMPLETED|Phase B (6 Weeks)||13
10522557|NCT01360632|11674504|FG004|NOT COMPLETED|Phase B (6 Weeks)||0
10522558|NCT01360632|11674500|FG000|STARTED|Phase A+||0
10522559|NCT01360632|11674501|FG001|STARTED|Phase A+||0
10522560|NCT01360632|11674502|FG002|STARTED|Phase A+||0
10522561|NCT01360632|11674503|FG003|STARTED|Phase A+||0
10522562|NCT01360632|11674504|FG004|STARTED|Phase A+||600
10522563|NCT01360632|11674500|FG000|COMPLETED|Phase A+||0
10522564|NCT01360632|11674501|FG001|COMPLETED|Phase A+||0
10522565|NCT01360632|11674502|FG002|COMPLETED|Phase A+||0
10522566|NCT01360632|11674503|FG003|COMPLETED|Phase A+||0
10522567|NCT01360632|11674504|FG004|COMPLETED|Phase A+||575
10522568|NCT01360632|11674500|FG000|NOT COMPLETED|Phase A+||0
10522569|NCT01360632|11674501|FG001|NOT COMPLETED|Phase A+||0
10522570|NCT01360632|11674502|FG002|NOT COMPLETED|Phase A+||0
10522571|NCT01360632|11674503|FG003|NOT COMPLETED|Phase A+||0
10522572|NCT01360632|11674504|FG004|NOT COMPLETED|Phase A+||25
10522573|NCT01360645|11674514|FG000|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)|826 participants were enrolled but 2 participants discontinued trial before taking study medication.|824
10522574|NCT01360645|11674515|FG001|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
10522575|NCT01360645|11674516|FG002|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
10522576|NCT01360645|11674517|FG003|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
10522577|NCT01360645|11674514|FG000|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||710
10522578|NCT01360645|11674515|FG001|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
10522579|NCT01360645|11674516|FG002|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
10522580|NCT01360645|11674517|FG003|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
10711984|NCT02665260|11877468|FG002|STARTED|Overall Study||25
10711985|NCT02665260|11877469|FG003|STARTED|Overall Study||22
10711986|NCT02665260|11877466|FG000|COMPLETED|Overall Study||22
10711987|NCT02665260|11877467|FG001|COMPLETED|Overall Study||22
10522581|NCT01360645|11674514|FG000|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||114
10522582|NCT01360645|11674515|FG001|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
10522583|NCT01360645|11674516|FG002|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
10522584|NCT01360645|11674517|FG003|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
10522585|NCT01360645|11674514|FG000|STARTED|Phase B (6 Weeks)||0
10522586|NCT01360645|11674515|FG001|STARTED|Phase B (6 Weeks)||188
10522587|NCT01360645|11674516|FG002|STARTED|Phase B (6 Weeks)||191
10522588|NCT01360645|11674517|FG003|STARTED|Phase B (6 Weeks)||0
10522589|NCT01360645|11674514|FG000|COMPLETED|Phase B (6 Weeks)||0
10522590|NCT01360645|11674515|FG001|COMPLETED|Phase B (6 Weeks)||174
10522591|NCT01360645|11674516|FG002|COMPLETED|Phase B (6 Weeks)||178
10522592|NCT01360645|11674517|FG003|COMPLETED|Phase B (6 Weeks)||0
10522593|NCT01360645|11674514|FG000|NOT COMPLETED|Phase B (6 Weeks)||0
10522594|NCT01360645|11674515|FG001|NOT COMPLETED|Phase B (6 Weeks)||14
10522595|NCT01360645|11674516|FG002|NOT COMPLETED|Phase B (6 Weeks)||13
10522596|NCT01360645|11674517|FG003|NOT COMPLETED|Phase B (6 Weeks)||0
10522597|NCT01360645|11674514|FG000|STARTED|Phase A+||0
10522598|NCT01360645|11674515|FG001|STARTED|Phase A+||0
10522599|NCT01360645|11674516|FG002|STARTED|Phase A+||0
10522600|NCT01360645|11674517|FG003|STARTED|Phase A+||331
10522601|NCT01360645|11674514|FG000|COMPLETED|Phase A+||0
10522602|NCT01360645|11674515|FG001|COMPLETED|Phase A+||0
10522603|NCT01360645|11674516|FG002|COMPLETED|Phase A+||0
10522604|NCT01360645|11674517|FG003|COMPLETED|Phase A+||307
10711988|NCT02665260|11877468|FG002|COMPLETED|Overall Study||21
10522605|NCT01360645|11674514|FG000|NOT COMPLETED|Phase A+||0
10522606|NCT01360645|11674515|FG001|NOT COMPLETED|Phase A+||0
10522607|NCT01360645|11674516|FG002|NOT COMPLETED|Phase A+||0
10522608|NCT01360645|11674517|FG003|NOT COMPLETED|Phase A+||24
10522609|NCT01360762|11674523|FG000|STARTED|Main Study Period (12-month Treatment)||74
10522610|NCT01360762|11674523|FG000|COMPLETED|Main Study Period (12-month Treatment)||45
10522611|NCT01360762|11674523|FG000|NOT COMPLETED|Main Study Period (12-month Treatment)||29
10522612|NCT01360762|11674523|FG000|STARTED|Whole Study Period||74
10522613|NCT01360762|11674523|FG000|COMPLETED|Whole Study Period||38
10522614|NCT01360762|11674523|FG000|NOT COMPLETED|Whole Study Period||36
10522615|NCT01360840|11674530|FG000|STARTED|Overall Study||60
10522616|NCT01360840|11674531|FG001|STARTED|Overall Study||60
10522617|NCT01360840|11674532|FG002|STARTED|Overall Study||60
10522618|NCT01360840|11674530|FG000|COMPLETED|Overall Study||50
10522619|NCT01360840|11674531|FG001|COMPLETED|Overall Study||50
10522620|NCT01360840|11674532|FG002|COMPLETED|Overall Study||51
10522621|NCT01360840|11674530|FG000|NOT COMPLETED|Overall Study||10
10522622|NCT01360840|11674531|FG001|NOT COMPLETED|Overall Study||10
10522623|NCT01360840|11674532|FG002|NOT COMPLETED|Overall Study||9
10522624|NCT01360866|11674546|FG000|STARTED|Overall Study||516
10522625|NCT01360866|11674547|FG001|STARTED|Overall Study||707
10522626|NCT01360866|11674548|FG002|STARTED|Overall Study||1645
10522627|NCT01360866|11674549|FG003|STARTED|Overall Study||76
10522628|NCT01360866|11674546|FG000|COMPLETED|Overall Study||295
10522629|NCT01360866|11674547|FG001|COMPLETED|Overall Study||420
10522630|NCT01360866|11674548|FG002|COMPLETED|Overall Study||1126
10522631|NCT01360866|11674549|FG003|COMPLETED|Overall Study||54
10522632|NCT01360866|11674546|FG000|NOT COMPLETED|Overall Study||221
10522633|NCT01360866|11674547|FG001|NOT COMPLETED|Overall Study||287
10522634|NCT01360866|11674548|FG002|NOT COMPLETED|Overall Study||519
10522635|NCT01360866|11674549|FG003|NOT COMPLETED|Overall Study||22
10522636|NCT01360996|11674562|FG000|STARTED|Overall Study||20
10522637|NCT01360996|11674563|FG001|STARTED|Overall Study||21
10522638|NCT01360996|11674564|FG002|STARTED|Overall Study||23
10522639|NCT01360996|11674562|FG000|COMPLETED|Overall Study||14
10522640|NCT01360996|11674563|FG001|COMPLETED|Overall Study||18
10522641|NCT01360996|11674564|FG002|COMPLETED|Overall Study||21
10522642|NCT01360996|11674562|FG000|NOT COMPLETED|Overall Study||6
10522643|NCT01360996|11674563|FG001|NOT COMPLETED|Overall Study||3
10522644|NCT01360996|11674564|FG002|NOT COMPLETED|Overall Study||2
10522645|NCT01361009|11674571|FG000|STARTED|Overall Study||2017
10522646|NCT01361009|11674571|FG000|COMPLETED|Overall Study||1901
10522647|NCT01361009|11674571|FG000|NOT COMPLETED|Overall Study||116
10522648|NCT01361048|11674578|FG000|STARTED|Overall Study||20
10522649|NCT01361048|11674579|FG001|STARTED|Overall Study||10
10522650|NCT01361048|11674580|FG002|STARTED|Overall Study||10
10522651|NCT01361048|11674578|FG000|COMPLETED|Overall Study||20
10522652|NCT01361048|11674579|FG001|COMPLETED|Overall Study||10
10522653|NCT01361048|11674580|FG002|COMPLETED|Overall Study||9
10522654|NCT01361048|11674578|FG000|NOT COMPLETED|Overall Study||0
10522655|NCT01361048|11674579|FG001|NOT COMPLETED|Overall Study||0
10522656|NCT01361048|11674580|FG002|NOT COMPLETED|Overall Study||1
10522657|NCT01361113|11674591|FG000|STARTED|Overall Study||21
10522658|NCT01361113|11674591|FG000|COMPLETED|Overall Study||21
10522659|NCT01361113|11674591|FG000|NOT COMPLETED|Overall Study||0
10522660|NCT01361126|11674599|FG000|STARTED|Overall Study||13
10522661|NCT01361126|11674600|FG001|STARTED|Overall Study||4
10522662|NCT01361126|11674599|FG000|COMPLETED|Overall Study||13
10522663|NCT01361126|11674600|FG001|COMPLETED|Overall Study||2
10522664|NCT01361126|11674599|FG000|NOT COMPLETED|Overall Study||0
10522665|NCT01361126|11674600|FG001|NOT COMPLETED|Overall Study||2
10522666|NCT01361178|11674609|FG000|STARTED|Overall Study||122
10711989|NCT02665260|11877469|FG003|COMPLETED|Overall Study||21
10711990|NCT02665260|11877466|FG000|NOT COMPLETED|Overall Study||2
10522667|NCT01361178|11674610|FG001|STARTED|Overall Study||11
10522668|NCT01361178|11674609|FG000|COMPLETED|Overall Study||109
10522669|NCT01361178|11674610|FG001|COMPLETED|Overall Study||11
10522670|NCT01361178|11674609|FG000|NOT COMPLETED|Overall Study||13
10522671|NCT01361178|11674610|FG001|NOT COMPLETED|Overall Study||0
10522672|NCT01361217|11674616|FG000|STARTED|Overall Study||10
10522673|NCT01361217|11674616|FG000|COMPLETED|Overall Study||10
10522674|NCT01361217|11674616|FG000|NOT COMPLETED|Overall Study||0
10522675|NCT01361308|11674624|FG000|STARTED|Overall Study||306
10522676|NCT01361308|11674625|FG001|STARTED|Overall Study||308
10522677|NCT01361308|11674624|FG000|COMPLETED|Overall Study||271
10522678|NCT01361308|11674625|FG001|COMPLETED|Overall Study||278
10522679|NCT01361308|11674624|FG000|NOT COMPLETED|Overall Study||35
10522680|NCT01361308|11674625|FG001|NOT COMPLETED|Overall Study||30
10522681|NCT01361464|11674631|FG000|STARTED|Overall Study||21
10522682|NCT01361464|11674631|FG000|COMPLETED|Overall Study||18
10522683|NCT01361464|11674631|FG000|NOT COMPLETED|Overall Study||3
10522684|NCT01361568|11674641|FG000|STARTED|Overall Study||71
10522685|NCT01361568|11674642|FG001|STARTED|Overall Study||71
10522686|NCT01361568|11674643|FG002|STARTED|Overall Study||20
10711991|NCT02665260|11877467|FG001|NOT COMPLETED|Overall Study||1
10711992|NCT02665260|11877468|FG002|NOT COMPLETED|Overall Study||4
10522687|NCT01361568|11674644|FG003|STARTED|Overall Study||21
10522688|NCT01361568|11674645|FG004|STARTED|Overall Study||7
10522689|NCT01361568|11674646|FG005|STARTED|Overall Study||13
10522690|NCT01361568|11674641|FG000|COMPLETED|Overall Study||69
10711993|NCT02665260|11877469|FG003|NOT COMPLETED|Overall Study||1
10522691|NCT01361568|11674642|FG001|COMPLETED|Overall Study||70
10522692|NCT01361568|11674643|FG002|COMPLETED|Overall Study||20
10522693|NCT01361568|11674644|FG003|COMPLETED|Overall Study||21
10522694|NCT01361568|11674645|FG004|COMPLETED|Overall Study||6
10522695|NCT01361568|11674646|FG005|COMPLETED|Overall Study||11
10522696|NCT01361568|11674641|FG000|NOT COMPLETED|Overall Study||2
10522697|NCT01361568|11674642|FG001|NOT COMPLETED|Overall Study||1
10522698|NCT01361568|11674643|FG002|NOT COMPLETED|Overall Study||0
10522699|NCT01361568|11674644|FG003|NOT COMPLETED|Overall Study||0
10522700|NCT01361568|11674645|FG004|NOT COMPLETED|Overall Study||1
10522701|NCT01361568|11674646|FG005|NOT COMPLETED|Overall Study||2
10522702|NCT01361594|11674663|FG000|STARTED|Overall Study||152
10522703|NCT01361594|11674664|FG001|STARTED|Overall Study||153
10522704|NCT01361594|11674663|FG000|COMPLETED|Overall Study||151
10522705|NCT01361594|11674664|FG001|COMPLETED|Overall Study||151
10522706|NCT01361594|11674663|FG000|NOT COMPLETED|Overall Study||1
10522707|NCT01361594|11674664|FG001|NOT COMPLETED|Overall Study||2
10522708|NCT01361607|11674672|FG000|STARTED|Overall Study|Two participants randomized to nabiximols did not receive any study drug|200
10522709|NCT01361607|11674673|FG001|STARTED|Overall Study||199
10522710|NCT01361607|11674672|FG000|Received at Least 1 Dose of Study Drug|Overall Study||198
10522711|NCT01361607|11674673|FG001|Received at Least 1 Dose of Study Drug|Overall Study||199
10522712|NCT01361607|11674672|FG000|Safety Population|Overall Study|One participant randomized to nabiximols received placebo Day 22 but analyzed as nabiximols-treated|199
10522713|NCT01361607|11674673|FG001|Safety Population|Overall Study|One participant randomized to placebo received nabiximols Day 1 but analyzed as nabiximols-treated|198
10522714|NCT01361607|11674672|FG000|ITT Population|Overall Study||198
10522799|NCT01362049|11674728|FG001|COMPLETED|Follow-Up at 52 Weeks (12 Months)||13
10522715|NCT01361607|11674673|FG001|ITT Population|Overall Study|One participant randomized to placebo received nabiximols Day 1 but analyzed as placebo-treated|199
10522716|NCT01361607|11674672|FG000|COMPLETED|Overall Study||136
10522717|NCT01361607|11674673|FG001|COMPLETED|Overall Study||158
10522718|NCT01361607|11674672|FG000|NOT COMPLETED|Overall Study||64
10522719|NCT01361607|11674673|FG001|NOT COMPLETED|Overall Study||41
10522720|NCT01361620|11674680|FG000|STARTED|Overall Study||132
10522721|NCT01361620|11674680|FG000|COMPLETED|Overall Study||132
10522722|NCT01361620|11674680|FG000|NOT COMPLETED|Overall Study||0
10522723|NCT01361633|11674686|FG000|STARTED|Overall Study||25
10522724|NCT01361633|11674687|FG001|STARTED|Overall Study||26
10522725|NCT01361633|11674686|FG000|COMPLETED|Overall Study||19
10522726|NCT01361633|11674687|FG001|COMPLETED|Overall Study||23
10522727|NCT01361633|11674686|FG000|NOT COMPLETED|Overall Study||6
10522728|NCT01361633|11674687|FG001|NOT COMPLETED|Overall Study||3
10522729|NCT01361711|11674695|FG000|STARTED|Trial Entry (Registration)||53
10522730|NCT01361711|11674695|FG000|Received Dose of Study Drug|Trial Entry (Registration)||52
10522731|NCT01361711|11674695|FG000|COMPLETED|Trial Entry (Registration)||52
10522732|NCT01361711|11674695|FG000|NOT COMPLETED|Trial Entry (Registration)||1
10522733|NCT01361711|11674695|FG000|STARTED|Week 9 Bone Marrow Response Assessment||52
10522734|NCT01361711|11674695|FG000|COMPLETED|Week 9 Bone Marrow Response Assessment||51
10522735|NCT01361711|11674695|FG000|NOT COMPLETED|Week 9 Bone Marrow Response Assessment||1
10522736|NCT01361711|11674695|FG000|STARTED|Continued Treatment After 9 Weeks||51
10522737|NCT01361711|11674695|FG000|COMPLETED|Continued Treatment After 9 Weeks||44
10522738|NCT01361711|11674695|FG000|NOT COMPLETED|Continued Treatment After 9 Weeks||7
10522739|NCT01361711|11674695|FG000|STARTED|Continued Treatment After 12 Weeks||44
10522740|NCT01361711|11674695|FG000|COMPLETED|Continued Treatment After 12 Weeks||41
10522741|NCT01361711|11674695|FG000|NOT COMPLETED|Continued Treatment After 12 Weeks||3
10522742|NCT01361711|11674695|FG000|STARTED|Completed Week 18 of Treatment||41
10522743|NCT01361711|11674695|FG000|COMPLETED|Completed Week 18 of Treatment||30
10522744|NCT01361711|11674695|FG000|NOT COMPLETED|Completed Week 18 of Treatment||11
10522745|NCT01361711|11674695|FG000|STARTED|10 Year Follow-up|All patients who receive at least one dose of study drug go into follow-up.|52
10522746|NCT01361711|11674695|FG000|COMPLETED|10 Year Follow-up||2
10522747|NCT01361711|11674695|FG000|NOT COMPLETED|10 Year Follow-up||50
10522748|NCT01361854|11674699|FG000|STARTED|Day 1||51
10522749|NCT01361854|11674700|FG001|STARTED|Day 1||51
10522750|NCT01361854|11674699|FG000|COMPLETED|Day 1||47
10522751|NCT01361854|11674700|FG001|COMPLETED|Day 1||48
10522752|NCT01361854|11674699|FG000|NOT COMPLETED|Day 1||4
10522753|NCT01361854|11674700|FG001|NOT COMPLETED|Day 1||3
10522754|NCT01361854|11674699|FG000|STARTED|Wash-out, Maximum 2 Weeks||47
10522755|NCT01361854|11674700|FG001|STARTED|Wash-out, Maximum 2 Weeks||48
10522756|NCT01361854|11674699|FG000|COMPLETED|Wash-out, Maximum 2 Weeks||47
10522757|NCT01361854|11674700|FG001|COMPLETED|Wash-out, Maximum 2 Weeks||48
10522758|NCT01361854|11674699|FG000|NOT COMPLETED|Wash-out, Maximum 2 Weeks||0
10522759|NCT01361854|11674700|FG001|NOT COMPLETED|Wash-out, Maximum 2 Weeks||0
10522760|NCT01361854|11674699|FG000|STARTED|Second Intervention||47
10522761|NCT01361854|11674700|FG001|STARTED|Second Intervention||48
10522762|NCT01361854|11674699|FG000|COMPLETED|Second Intervention||47
10522763|NCT01361854|11674700|FG001|COMPLETED|Second Intervention||48
10522764|NCT01361854|11674699|FG000|NOT COMPLETED|Second Intervention||0
10522765|NCT01361854|11674700|FG001|NOT COMPLETED|Second Intervention||0
10522766|NCT01361867|11674706|FG000|STARTED|Overall Study||15
10522767|NCT01361867|11674706|FG000|COMPLETED|Overall Study||15
10522768|NCT01361867|11674706|FG000|NOT COMPLETED|Overall Study||0
10522769|NCT01361919|11674713|FG000|STARTED|Overall Study||100
10522770|NCT01361919|11674714|FG001|STARTED|Overall Study||100
10522771|NCT01361919|11674715|FG002|STARTED|Overall Study||98
10522772|NCT01361919|11674713|FG000|COMPLETED|Overall Study||90
10522773|NCT01361919|11674714|FG001|COMPLETED|Overall Study||88
10522774|NCT01361919|11674715|FG002|COMPLETED|Overall Study||88
10522775|NCT01361919|11674713|FG000|NOT COMPLETED|Overall Study||10
10522776|NCT01361919|11674714|FG001|NOT COMPLETED|Overall Study||12
10522777|NCT01361919|11674715|FG002|NOT COMPLETED|Overall Study||10
10522778|NCT01362049|11674727|FG000|STARTED|Follow-Up at 7 Weeks||26
10522779|NCT01362049|11674728|FG001|STARTED|Follow-Up at 7 Weeks||19
10522780|NCT01362049|11674729|FG002|STARTED|Follow-Up at 7 Weeks||32
10522781|NCT01362049|11674730|FG003|STARTED|Follow-Up at 7 Weeks||25
10522782|NCT01362049|11674727|FG000|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||26
10522783|NCT01362049|11674728|FG001|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||18
10522784|NCT01362049|11674729|FG002|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||32
10522785|NCT01362049|11674730|FG003|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||25
10522786|NCT01362049|11674727|FG000|COMPLETED|Follow-Up at 7 Weeks||23
10522787|NCT01362049|11674728|FG001|COMPLETED|Follow-Up at 7 Weeks||16
10522788|NCT01362049|11674729|FG002|COMPLETED|Follow-Up at 7 Weeks||30
10522789|NCT01362049|11674730|FG003|COMPLETED|Follow-Up at 7 Weeks||24
10522790|NCT01362049|11674727|FG000|NOT COMPLETED|Follow-Up at 7 Weeks||3
10522791|NCT01362049|11674728|FG001|NOT COMPLETED|Follow-Up at 7 Weeks||3
10522792|NCT01362049|11674729|FG002|NOT COMPLETED|Follow-Up at 7 Weeks||2
10522793|NCT01362049|11674730|FG003|NOT COMPLETED|Follow-Up at 7 Weeks||1
10522794|NCT01362049|11674727|FG000|STARTED|Follow-Up at 52 Weeks (12 Months)||23
10522795|NCT01362049|11674728|FG001|STARTED|Follow-Up at 52 Weeks (12 Months)||16
10522796|NCT01362049|11674729|FG002|STARTED|Follow-Up at 52 Weeks (12 Months)||30
10522797|NCT01362049|11674730|FG003|STARTED|Follow-Up at 52 Weeks (12 Months)||24
10522798|NCT01362049|11674727|FG000|COMPLETED|Follow-Up at 52 Weeks (12 Months)||18
10522800|NCT01362049|11674729|FG002|COMPLETED|Follow-Up at 52 Weeks (12 Months)||28
10522801|NCT01362049|11674730|FG003|COMPLETED|Follow-Up at 52 Weeks (12 Months)||21
10522802|NCT01362049|11674727|FG000|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||5
10522803|NCT01362049|11674728|FG001|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||3
10338311|NCT00369486|11475225|FG001|STARTED|8-Week Visit|Number of eyes|21
10338312|NCT00369486|11475226|FG002|STARTED|8-Week Visit|Number of eyes|22
10338313|NCT00369486|11475227|FG003|STARTED|8-Week Visit|Number of eyes|22
10338314|NCT00369486|11475228|FG004|STARTED|8-Week Visit|Number of eyes|25
10338315|NCT00369486|11475224|FG000|COMPLETED|8-Week Visit|Number of eyes|38
10522804|NCT01362049|11674729|FG002|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||2
10522805|NCT01362049|11674730|FG003|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||3
10522806|NCT01362062|11674746|FG000|STARTED|Overall Study||48
10522807|NCT01362062|11674747|FG001|STARTED|Overall Study||62
10522808|NCT01362062|11674746|FG000|COMPLETED|Overall Study||22
10522809|NCT01362062|11674747|FG001|COMPLETED|Overall Study||62
10522810|NCT01362062|11674746|FG000|NOT COMPLETED|Overall Study||26
10522811|NCT01362062|11674747|FG001|NOT COMPLETED|Overall Study||0
10522812|NCT01362127|11674754|FG000|STARTED|Overall Study||90
10522813|NCT01362127|11674755|FG001|STARTED|Overall Study||91
10522814|NCT01362127|11674754|FG000|COMPLETED|Overall Study||90
10522815|NCT01362127|11674755|FG001|COMPLETED|Overall Study||91
10522816|NCT01362127|11674754|FG000|NOT COMPLETED|Overall Study||0
10522817|NCT01362127|11674755|FG001|NOT COMPLETED|Overall Study||0
10522818|NCT01362140|11674763|FG000|STARTED|Overall Study||49
10522819|NCT01362140|11674764|FG001|STARTED|Overall Study||98
10522820|NCT01362140|11674763|FG000|Received Treatment|Overall Study||49
10522821|NCT01362140|11674764|FG001|Received Treatment|Overall Study||97
10522822|NCT01362140|11674763|FG000|COMPLETED|Overall Study|Completed treatment in the double-blind treatment period|39
10522823|NCT01362140|11674764|FG001|COMPLETED|Overall Study|Completed treatment in the double-blind treatment period|87
10522824|NCT01362140|11674763|FG000|NOT COMPLETED|Overall Study||10
10522825|NCT01362140|11674764|FG001|NOT COMPLETED|Overall Study||11
10522826|NCT01362192|11674770|FG000|STARTED|Overall Study||20
10522827|NCT01362192|11674770|FG000|COMPLETED|Overall Study||16
10522828|NCT01362192|11674770|FG000|NOT COMPLETED|Overall Study||4
10522829|NCT01362205|11674776|FG000|STARTED|Overall Study||22
10522830|NCT01362205|11674777|FG001|STARTED|Overall Study||27
10522831|NCT01362205|11674776|FG000|COMPLETED|Overall Study||22
10522832|NCT01362205|11674777|FG001|COMPLETED|Overall Study||27
10522833|NCT01362205|11674776|FG000|NOT COMPLETED|Overall Study||0
10522834|NCT01362205|11674777|FG001|NOT COMPLETED|Overall Study||0
10522835|NCT01362244|11674785|FG000|STARTED|Overall Study||54
10522836|NCT01362244|11674786|FG001|STARTED|Overall Study||51
10522837|NCT01362244|11674785|FG000|COMPLETED|Overall Study||22
10522838|NCT01362244|11674786|FG001|COMPLETED|Overall Study||19
10522839|NCT01362244|11674785|FG000|NOT COMPLETED|Overall Study||32
10522840|NCT01362244|11674786|FG001|NOT COMPLETED|Overall Study||32
10522841|NCT01362270|11674794|FG000|STARTED|Overall Study||7
10522842|NCT01362270|11674795|FG001|STARTED|Overall Study||8
10522843|NCT01362270|11674794|FG000|COMPLETED|Overall Study||5
10522844|NCT01362270|11674795|FG001|COMPLETED|Overall Study||6
10522845|NCT01362270|11674794|FG000|NOT COMPLETED|Overall Study||2
10522846|NCT01362270|11674795|FG001|NOT COMPLETED|Overall Study||2
10522847|NCT01362296|11674803|FG000|STARTED|Randomized Phase (RP)||87
10522848|NCT01362296|11674804|FG001|STARTED|Randomized Phase (RP)||43
10522849|NCT01362296|11674805|FG002|STARTED|Randomized Phase (RP)||0
10522850|NCT01362296|11674806|FG003|STARTED|Randomized Phase (RP)||0
10522851|NCT01362296|11674803|FG000|COMPLETED|Randomized Phase (RP)||0
10522852|NCT01362296|11674804|FG001|COMPLETED|Randomized Phase (RP)||0
10522853|NCT01362296|11674805|FG002|COMPLETED|Randomized Phase (RP)||0
10522854|NCT01362296|11674806|FG003|COMPLETED|Randomized Phase (RP)||0
10522855|NCT01362296|11674803|FG000|NOT COMPLETED|Randomized Phase (RP)||87
10522856|NCT01362296|11674804|FG001|NOT COMPLETED|Randomized Phase (RP)||43
10522857|NCT01362296|11674805|FG002|NOT COMPLETED|Randomized Phase (RP)||0
10522858|NCT01362296|11674806|FG003|NOT COMPLETED|Randomized Phase (RP)||0
10522859|NCT01362296|11674803|FG000|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|0
10522860|NCT01362296|11674804|FG001|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|0
10522861|NCT01362296|11674805|FG002|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|23
10522862|NCT01362296|11674806|FG003|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|2
10522863|NCT01362296|11674803|FG000|COMPLETED|Crossover Phase||0
10522864|NCT01362296|11674804|FG001|COMPLETED|Crossover Phase||0
10522865|NCT01362296|11674805|FG002|COMPLETED|Crossover Phase||0
10522866|NCT01362296|11674806|FG003|COMPLETED|Crossover Phase||0
10522867|NCT01362296|11674803|FG000|NOT COMPLETED|Crossover Phase||0
10522868|NCT01362296|11674804|FG001|NOT COMPLETED|Crossover Phase||0
10522869|NCT01362296|11674805|FG002|NOT COMPLETED|Crossover Phase||23
10522870|NCT01362296|11674806|FG003|NOT COMPLETED|Crossover Phase||2
10522871|NCT01362322|11674818|FG000|STARTED|Overall Study||335
10522872|NCT01362322|11674819|FG001|STARTED|Overall Study||336
10522873|NCT01362322|11674818|FG000|COMPLETED|Overall Study||330
10522874|NCT01362322|11674819|FG001|COMPLETED|Overall Study||329
10522875|NCT01362322|11674818|FG000|NOT COMPLETED|Overall Study||5
10522876|NCT01362322|11674819|FG001|NOT COMPLETED|Overall Study||7
10522877|NCT01362348|11674825|FG000|STARTED|Overall Study||19
10522878|NCT01362348|11674825|FG000|COMPLETED|Overall Study||5
10522879|NCT01362348|11674825|FG000|NOT COMPLETED|Overall Study||14
10522880|NCT01362439|11674829|FG000|STARTED|Overall Study||133
10522881|NCT01362439|11674829|FG000|COMPLETED|Overall Study||118
10522882|NCT01362439|11674829|FG000|NOT COMPLETED|Overall Study||15
10522883|NCT01362491|11674837|FG000|STARTED|Overall Study||91
10522884|NCT01362491|11674838|FG001|STARTED|Overall Study||89
10522885|NCT01362491|11674839|FG002|STARTED|Overall Study||46
10522886|NCT01362491|11674837|FG000|COMPLETED|Overall Study||90
10522887|NCT01362491|11674838|FG001|COMPLETED|Overall Study||89
10522888|NCT01362491|11674839|FG002|COMPLETED|Overall Study||46
10522889|NCT01362491|11674837|FG000|NOT COMPLETED|Overall Study||1
10522890|NCT01362491|11674838|FG001|NOT COMPLETED|Overall Study||0
10522891|NCT01362491|11674839|FG002|NOT COMPLETED|Overall Study||0
10522892|NCT01362517|11674848|FG000|STARTED|Overall Study||131
10522893|NCT01362517|11674848|FG000|COMPLETED|Overall Study||129
10522894|NCT01362517|11674848|FG000|NOT COMPLETED|Overall Study||2
10522895|NCT01362530|11674857|FG000|STARTED|Base Study (Cycle 1)||155
10522896|NCT01362530|11674858|FG001|STARTED|Base Study (Cycle 1)||152
10522897|NCT01362530|11674857|FG000|Received Study Treatment|Base Study (Cycle 1)||152
10522898|NCT01362530|11674858|FG001|Received Study Treatment|Base Study (Cycle 1)||150
10522899|NCT01362530|11674857|FG000|COMPLETED|Base Study (Cycle 1)||150
10522900|NCT01362530|11674858|FG001|COMPLETED|Base Study (Cycle 1)||149
10522901|NCT01362530|11674857|FG000|NOT COMPLETED|Base Study (Cycle 1)||5
10522902|NCT01362530|11674858|FG001|NOT COMPLETED|Base Study (Cycle 1)||3
10522903|NCT01362530|11674857|FG000|STARTED|Optional Extension (Cycles 2-6)||171
10522904|NCT01362530|11674858|FG001|STARTED|Optional Extension (Cycles 2-6)||0
10522905|NCT01362530|11674857|FG000|COMPLETED|Optional Extension (Cycles 2-6)||46
10522906|NCT01362530|11674858|FG001|COMPLETED|Optional Extension (Cycles 2-6)||0
10522907|NCT01362530|11674857|FG000|NOT COMPLETED|Optional Extension (Cycles 2-6)||125
10522908|NCT01362530|11674858|FG001|NOT COMPLETED|Optional Extension (Cycles 2-6)||0
10522909|NCT01362608|11674867|FG000|STARTED|Overall Study||67
10522910|NCT01362608|11674868|FG001|STARTED|Overall Study||69
10522911|NCT01362608|11674867|FG000|COMPLETED|Overall Study||63
10522912|NCT01362608|11674868|FG001|COMPLETED|Overall Study||61
10522913|NCT01362608|11674867|FG000|NOT COMPLETED|Overall Study||4
10522914|NCT01362608|11674868|FG001|NOT COMPLETED|Overall Study||8
10522915|NCT01362686|11674877|FG000|STARTED|Overall Study||67
10522916|NCT01362686|11674878|FG001|STARTED|Overall Study||66
10522917|NCT01362686|11674879|FG002|STARTED|Overall Study||63
10522918|NCT01362686|11674877|FG000|COMPLETED|Overall Study||59
10522919|NCT01362686|11674878|FG001|COMPLETED|Overall Study||54
10522920|NCT01362686|11674879|FG002|COMPLETED|Overall Study||53
10522921|NCT01362686|11674877|FG000|NOT COMPLETED|Overall Study||8
10522922|NCT01362686|11674878|FG001|NOT COMPLETED|Overall Study||12
10522923|NCT01362686|11674879|FG002|NOT COMPLETED|Overall Study||10
10522924|NCT01362790|11674893|FG000|STARTED|Pilot Phase & Phase 2||11
10522925|NCT01362790|11674894|FG001|STARTED|Pilot Phase & Phase 2||8
10522926|NCT01362790|11674895|FG002|STARTED|Pilot Phase & Phase 2||7
10522927|NCT01362790|11674896|FG003|STARTED|Pilot Phase & Phase 2||15
10522928|NCT01362790|11674897|FG004|STARTED|Pilot Phase & Phase 2||0
10522929|NCT01362790|11674898|FG005|STARTED|Pilot Phase & Phase 2||4
10522930|NCT01362790|11674899|FG006|STARTED|Pilot Phase & Phase 2||0
10522931|NCT01362790|11674893|FG000|COMPLETED|Pilot Phase & Phase 2||1
10522932|NCT01362790|11674894|FG001|COMPLETED|Pilot Phase & Phase 2||0
10522933|NCT01362790|11674895|FG002|COMPLETED|Pilot Phase & Phase 2||2
10522934|NCT01362790|11674896|FG003|COMPLETED|Pilot Phase & Phase 2||1
10522935|NCT01362790|11674897|FG004|COMPLETED|Pilot Phase & Phase 2||0
10522936|NCT01362790|11674898|FG005|COMPLETED|Pilot Phase & Phase 2||0
10522937|NCT01362790|11674899|FG006|COMPLETED|Pilot Phase & Phase 2||0
10522938|NCT01362790|11674893|FG000|NOT COMPLETED|Pilot Phase & Phase 2||10
10522939|NCT01362790|11674894|FG001|NOT COMPLETED|Pilot Phase & Phase 2||8
10522940|NCT01362790|11674895|FG002|NOT COMPLETED|Pilot Phase & Phase 2||5
10522941|NCT01362790|11674896|FG003|NOT COMPLETED|Pilot Phase & Phase 2||14
10522942|NCT01362790|11674897|FG004|NOT COMPLETED|Pilot Phase & Phase 2||0
10522943|NCT01362790|11674898|FG005|NOT COMPLETED|Pilot Phase & Phase 2||4
10522944|NCT01362790|11674899|FG006|NOT COMPLETED|Pilot Phase & Phase 2||0
10522945|NCT01362790|11674893|FG000|STARTED|Dose De-escalation of Regimen A||0
10522946|NCT01362790|11674894|FG001|STARTED|Dose De-escalation of Regimen A||0
10522947|NCT01362790|11674895|FG002|STARTED|Dose De-escalation of Regimen A||0
10522948|NCT01362790|11674896|FG003|STARTED|Dose De-escalation of Regimen A||0
10522949|NCT01362790|11674897|FG004|STARTED|Dose De-escalation of Regimen A||8
10522950|NCT01362790|11674898|FG005|STARTED|Dose De-escalation of Regimen A||0
10522951|NCT01362790|11674899|FG006|STARTED|Dose De-escalation of Regimen A||0
10522952|NCT01362790|11674893|FG000|COMPLETED|Dose De-escalation of Regimen A||0
10522953|NCT01362790|11674894|FG001|COMPLETED|Dose De-escalation of Regimen A||0
10522954|NCT01362790|11674895|FG002|COMPLETED|Dose De-escalation of Regimen A||0
10522955|NCT01362790|11674896|FG003|COMPLETED|Dose De-escalation of Regimen A||0
10522956|NCT01362790|11674897|FG004|COMPLETED|Dose De-escalation of Regimen A||2
10522957|NCT01362790|11674898|FG005|COMPLETED|Dose De-escalation of Regimen A||0
10522958|NCT01362790|11674899|FG006|COMPLETED|Dose De-escalation of Regimen A||0
10522959|NCT01362790|11674893|FG000|NOT COMPLETED|Dose De-escalation of Regimen A||0
10522960|NCT01362790|11674894|FG001|NOT COMPLETED|Dose De-escalation of Regimen A||0
10522961|NCT01362790|11674895|FG002|NOT COMPLETED|Dose De-escalation of Regimen A||0
10522962|NCT01362790|11674896|FG003|NOT COMPLETED|Dose De-escalation of Regimen A||0
10522963|NCT01362790|11674897|FG004|NOT COMPLETED|Dose De-escalation of Regimen A||6
10522964|NCT01362790|11674898|FG005|NOT COMPLETED|Dose De-escalation of Regimen A||0
10522965|NCT01362790|11674899|FG006|NOT COMPLETED|Dose De-escalation of Regimen A||0
10522966|NCT01362894|11674919|FG000|STARTED|Period One, 1 Week|One participant was not dispensed lenses until Period 2.|119
10522967|NCT01362894|11674920|FG001|STARTED|Period One, 1 Week|One participant was not dispensed lenses until Period 2.|117
10522968|NCT01362894|11674919|FG000|COMPLETED|Period One, 1 Week||119
10522969|NCT01362894|11674920|FG001|COMPLETED|Period One, 1 Week||117
10522970|NCT01362894|11674919|FG000|NOT COMPLETED|Period One, 1 Week||0
10522971|NCT01362894|11674920|FG001|NOT COMPLETED|Period One, 1 Week||0
10522972|NCT01362894|11674919|FG000|STARTED|Period Two, 1 Week|Two participants discontinued between Periods 1 and 2 due to discomfort (1) and poor fit (1).|118
10522973|NCT01362894|11674920|FG001|STARTED|Period Two, 1 Week|Three participants discontinued between Periods 1 and 2 due to unacceptable vision.|115
10522974|NCT01362894|11674919|FG000|COMPLETED|Period Two, 1 Week||118
10522975|NCT01362894|11674920|FG001|COMPLETED|Period Two, 1 Week||115
10522976|NCT01362894|11674919|FG000|NOT COMPLETED|Period Two, 1 Week||0
10522977|NCT01362894|11674920|FG001|NOT COMPLETED|Period Two, 1 Week||0
10522978|NCT01362907|11674926|FG000|STARTED|Period 1, One Week||20
10522979|NCT01362907|11674927|FG001|STARTED|Period 1, One Week||20
10522980|NCT01362907|11674926|FG000|COMPLETED|Period 1, One Week||20
10522981|NCT01362907|11674927|FG001|COMPLETED|Period 1, One Week||20
10522982|NCT01362907|11674926|FG000|NOT COMPLETED|Period 1, One Week||0
10522983|NCT01362907|11674927|FG001|NOT COMPLETED|Period 1, One Week||0
10522984|NCT01362907|11674926|FG000|STARTED|Period 2, One Week||20
10522985|NCT01362907|11674927|FG001|STARTED|Period 2, One Week||20
10522986|NCT01362907|11674926|FG000|COMPLETED|Period 2, One Week||20
10522987|NCT01362907|11674927|FG001|COMPLETED|Period 2, One Week||20
10522988|NCT01362907|11674926|FG000|NOT COMPLETED|Period 2, One Week||0
10522989|NCT01362907|11674927|FG001|NOT COMPLETED|Period 2, One Week||0
10522990|NCT01362946|11674933|FG000|STARTED|First Behavior Modification Block||24
10522991|NCT01362946|11674934|FG001|STARTED|First Behavior Modification Block||24
10522992|NCT01362946|11674933|FG000|COMPLETED|First Behavior Modification Block||24
10522993|NCT01362946|11674934|FG001|COMPLETED|First Behavior Modification Block||24
10522994|NCT01362946|11674933|FG000|NOT COMPLETED|First Behavior Modification Block||0
10522995|NCT01362946|11674934|FG001|NOT COMPLETED|First Behavior Modification Block||0
10522996|NCT01362946|11674933|FG000|STARTED|Second Behavior Modification Block|1 participant withdrew after last but before this treatment period - illness unrelated to study.|23
10522997|NCT01362946|11674934|FG001|STARTED|Second Behavior Modification Block||24
10522998|NCT01362946|11674933|FG000|COMPLETED|Second Behavior Modification Block||23
10522999|NCT01362946|11674934|FG001|COMPLETED|Second Behavior Modification Block||24
10523000|NCT01362946|11674933|FG000|NOT COMPLETED|Second Behavior Modification Block||0
10523001|NCT01362946|11674934|FG001|NOT COMPLETED|Second Behavior Modification Block||0
10523002|NCT01362959|11674942|FG000|STARTED|Overall Study||21
10523003|NCT01362959|11674943|FG001|STARTED|Overall Study||26
10523004|NCT01362959|11674942|FG000|COMPLETED|Overall Study||21
10523005|NCT01362959|11674943|FG001|COMPLETED|Overall Study||26
10523006|NCT01362959|11674942|FG000|NOT COMPLETED|Overall Study||0
10523007|NCT01362959|11674943|FG001|NOT COMPLETED|Overall Study||0
10523008|NCT01363011|11674951|FG000|STARTED|Main Study||33
10523009|NCT01363011|11674952|FG001|STARTED|Main Study||73
10523010|NCT01363011|11674951|FG000|COMPLETED|Main Study||29
10523011|NCT01363011|11674952|FG001|COMPLETED|Main Study||64
10523012|NCT01363011|11674951|FG000|NOT COMPLETED|Main Study||4
10523013|NCT01363011|11674952|FG001|NOT COMPLETED|Main Study||9
10523014|NCT01363011|11674951|FG000|STARTED|Extension Phase|11 participants who completed the main study did not enroll into the extension phase.|18
10523015|NCT01363011|11674952|FG001|STARTED|Extension Phase|15 participants who completed the main study did not enroll into the extension phase.|49
10523016|NCT01363011|11674951|FG000|COMPLETED|Extension Phase||13
10523017|NCT01363011|11674952|FG001|COMPLETED|Extension Phase||41
10523018|NCT01363011|11674951|FG000|NOT COMPLETED|Extension Phase||5
10523019|NCT01363011|11674952|FG001|NOT COMPLETED|Extension Phase||8
10523020|NCT01363050|11674958|FG000|STARTED|Overall Study||15
10523021|NCT01363050|11674958|FG000|COMPLETED|Overall Study||15
10523022|NCT01363050|11674958|FG000|NOT COMPLETED|Overall Study||0
10523023|NCT01363076|11674966|FG000|STARTED|Overall Study||7
10523024|NCT01363076|11674967|FG001|STARTED|Overall Study||13
10523025|NCT01363076|11674966|FG000|COMPLETED|Overall Study||7
10523026|NCT01363076|11674967|FG001|COMPLETED|Overall Study||12
10523027|NCT01363076|11674966|FG000|NOT COMPLETED|Overall Study||0
10523028|NCT01363076|11674967|FG001|NOT COMPLETED|Overall Study||1
10523029|NCT01363128|11674973|FG000|STARTED|Overall Study||69
10523030|NCT01363128|11674973|FG000|COMPLETED|Overall Study||69
10523031|NCT01363128|11674973|FG000|NOT COMPLETED|Overall Study||0
10523032|NCT01363258|11674979|FG000|STARTED|Overall Study||54
10523033|NCT01363258|11674980|FG001|STARTED|Overall Study||46
10523034|NCT01363258|11674979|FG000|COMPLETED|Overall Study||54
10523035|NCT01363258|11674980|FG001|COMPLETED|Overall Study||46
10523036|NCT01363258|11674979|FG000|NOT COMPLETED|Overall Study||0
10523037|NCT01363258|11674980|FG001|NOT COMPLETED|Overall Study||0
10523038|NCT01363297|11674991|FG000|STARTED|Overall Study||3
10523039|NCT01363297|11674992|FG001|STARTED|Overall Study||12
10523040|NCT01363297|11674993|FG002|STARTED|Overall Study||9
10523041|NCT01363297|11674994|FG003|STARTED|Overall Study||13
10523042|NCT01363297|11674995|FG004|STARTED|Overall Study||35
10523043|NCT01363297|11674991|FG000|COMPLETED|Overall Study||0
10523044|NCT01363297|11674992|FG001|COMPLETED|Overall Study||6
10523045|NCT01363297|11674993|FG002|COMPLETED|Overall Study||3
10523046|NCT01363297|11674994|FG003|COMPLETED|Overall Study||3
10523047|NCT01363297|11674995|FG004|COMPLETED|Overall Study||4
10523048|NCT01363297|11674991|FG000|NOT COMPLETED|Overall Study||3
10523049|NCT01363297|11674992|FG001|NOT COMPLETED|Overall Study||6
10523050|NCT01363297|11674993|FG002|NOT COMPLETED|Overall Study||6
10523051|NCT01363297|11674994|FG003|NOT COMPLETED|Overall Study||10
10523052|NCT01363297|11674995|FG004|NOT COMPLETED|Overall Study||31
10523053|NCT01363349|11675014|FG000|STARTED|Overall Study||133
10523054|NCT01363349|11675015|FG001|STARTED|Overall Study||136
10523055|NCT01363349|11675014|FG000|Randomized|Overall Study||133
10523056|NCT01363349|11675015|FG001|Randomized|Overall Study||136
10523057|NCT01363349|11675014|FG000|COMPLETED|Overall Study||66
10523058|NCT01363349|11675015|FG001|COMPLETED|Overall Study||66
10523059|NCT01363349|11675014|FG000|NOT COMPLETED|Overall Study||67
10523060|NCT01363349|11675015|FG001|NOT COMPLETED|Overall Study||70
10523061|NCT01363388|11675024|FG000|STARTED|Overall Study||23
10523062|NCT01363388|11675025|FG001|STARTED|Overall Study||22
10523063|NCT01363388|11675026|FG002|STARTED|Overall Study||22
10523064|NCT01363388|11675024|FG000|COMPLETED|Overall Study||18
10523065|NCT01363388|11675025|FG001|COMPLETED|Overall Study||19
10523066|NCT01363388|11675026|FG002|COMPLETED|Overall Study||18
10523067|NCT01363388|11675024|FG000|NOT COMPLETED|Overall Study||5
10523068|NCT01363388|11675025|FG001|NOT COMPLETED|Overall Study||3
10523069|NCT01363388|11675026|FG002|NOT COMPLETED|Overall Study||4
10523070|NCT01363440|11675037|FG000|STARTED|Overall Study|randomized|156
10523071|NCT01363440|11675038|FG001|STARTED|Overall Study|randomized|156
10523072|NCT01363440|11675039|FG002|STARTED|Overall Study|randomized|154
10523073|NCT01363440|11675037|FG000|Participants Received Treatment|Overall Study|safety analysis set (SAF)|154
10523074|NCT01363440|11675038|FG001|Participants Received Treatment|Overall Study|safety analysis set (SAF)|155
10523075|NCT01363440|11675039|FG002|Participants Received Treatment|Overall Study|safety analysis set (SAF)|152
10523076|NCT01363440|11675037|FG000|Completed Week 52|Overall Study||145
10523077|NCT01363440|11675038|FG001|Completed Week 52|Overall Study||146
10523078|NCT01363440|11675039|FG002|Completed Week 52|Overall Study||144
10523079|NCT01363440|11675037|FG000|Completed Week 100|Overall Study||133
10523080|NCT01363440|11675038|FG001|Completed Week 100|Overall Study||125
10523081|NCT01363440|11675039|FG002|Completed Week 100|Overall Study||127
10523082|NCT01363440|11675037|FG000|COMPLETED|Overall Study|Completed Week 100|133
10523083|NCT01363440|11675038|FG001|COMPLETED|Overall Study|Completed Week 100|125
10523084|NCT01363440|11675039|FG002|COMPLETED|Overall Study|Completed Week 100|127
10523085|NCT01363440|11675037|FG000|NOT COMPLETED|Overall Study||23
10523086|NCT01363440|11675038|FG001|NOT COMPLETED|Overall Study||31
10523087|NCT01363440|11675039|FG002|NOT COMPLETED|Overall Study||27
10523088|NCT01363479|11675052|FG000|STARTED|Overall Study|number of randomised patients|371
10523089|NCT01363479|11675053|FG001|STARTED|Overall Study|number of randomised patients|372
10523090|NCT01363479|11675052|FG000|COMPLETED|Overall Study||359
10523091|NCT01363479|11675053|FG001|COMPLETED|Overall Study||351
10523092|NCT01363479|11675052|FG000|NOT COMPLETED|Overall Study||12
10523093|NCT01363479|11675053|FG001|NOT COMPLETED|Overall Study||21
10523094|NCT01363492|11675059|FG000|STARTED|Overall Study||14
10523095|NCT01363492|11675059|FG000|COMPLETED|Overall Study||14
10523096|NCT01363492|11675059|FG000|NOT COMPLETED|Overall Study||0
10523097|NCT01363661|11675067|FG000|STARTED|Overall Study||32
10523098|NCT01363661|11675068|FG001|STARTED|Overall Study||32
10523099|NCT01363661|11675067|FG000|COMPLETED|Overall Study||18
10523100|NCT01363661|11675068|FG001|COMPLETED|Overall Study||28
10523101|NCT01363661|11675067|FG000|NOT COMPLETED|Overall Study||14
10523102|NCT01363661|11675068|FG001|NOT COMPLETED|Overall Study||4
10523103|NCT01363700|11675077|FG000|STARTED|Epinastine vs Placebo Period1||43
10523104|NCT01363700|11675078|FG001|STARTED|Epinastine vs Placebo Period1||22
10523105|NCT01363700|11675079|FG002|STARTED|Epinastine vs Placebo Period1||22
10523106|NCT01363700|11675080|FG003|STARTED|Epinastine vs Placebo Period1|No Allocation|0
10523107|NCT01363700|11675081|FG004|STARTED|Epinastine vs Placebo Period1|No Allocation|0
10523108|NCT01363700|11675077|FG000|COMPLETED|Epinastine vs Placebo Period1||43
10523109|NCT01363700|11675078|FG001|COMPLETED|Epinastine vs Placebo Period1||21
10523110|NCT01363700|11675079|FG002|COMPLETED|Epinastine vs Placebo Period1||22
10523111|NCT01363700|11675080|FG003|COMPLETED|Epinastine vs Placebo Period1||0
10523112|NCT01363700|11675081|FG004|COMPLETED|Epinastine vs Placebo Period1||0
10523113|NCT01363700|11675077|FG000|NOT COMPLETED|Epinastine vs Placebo Period1||0
10523114|NCT01363700|11675078|FG001|NOT COMPLETED|Epinastine vs Placebo Period1||1
10523115|NCT01363700|11675079|FG002|NOT COMPLETED|Epinastine vs Placebo Period1||0
10523116|NCT01363700|11675080|FG003|NOT COMPLETED|Epinastine vs Placebo Period1||0
10523117|NCT01363700|11675081|FG004|NOT COMPLETED|Epinastine vs Placebo Period1||0
10523118|NCT01363700|11675077|FG000|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
10523119|NCT01363700|11675078|FG001|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
10523120|NCT01363700|11675079|FG002|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
10523121|NCT01363700|11675080|FG003|STARTED|Epinastine vs Olopatadine Period2||43
10523122|NCT01363700|11675081|FG004|STARTED|Epinastine vs Olopatadine Period2||43
10523123|NCT01363700|11675077|FG000|COMPLETED|Epinastine vs Olopatadine Period2||0
10523124|NCT01363700|11675078|FG001|COMPLETED|Epinastine vs Olopatadine Period2||0
10711994|NCT02665273|11877485|FG000|STARTED|Overall Study||13
10711995|NCT02665273|11877486|FG001|STARTED|Overall Study||15
10711996|NCT02665273|11877485|FG000|COMPLETED|Overall Study||13
10711997|NCT02665273|11877486|FG001|COMPLETED|Overall Study||15
10711998|NCT02665273|11877485|FG000|NOT COMPLETED|Overall Study||0
10523125|NCT01363700|11675079|FG002|COMPLETED|Epinastine vs Olopatadine Period2||0
10523126|NCT01363700|11675080|FG003|COMPLETED|Epinastine vs Olopatadine Period2||43
10523127|NCT01363700|11675081|FG004|COMPLETED|Epinastine vs Olopatadine Period2||43
10523128|NCT01363700|11675077|FG000|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
10523129|NCT01363700|11675078|FG001|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
10523130|NCT01363700|11675079|FG002|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
10523131|NCT01363700|11675080|FG003|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
10523132|NCT01363700|11675081|FG004|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
10523133|NCT01363713|11675092|FG000|STARTED|Overall Study|Assessed for eligibility|130
10711999|NCT02665273|11877486|FG001|NOT COMPLETED|Overall Study||0
10712000|NCT02665286|11877495|FG000|STARTED|Overall Study||79
10523134|NCT01363713|11675092|FG000|ALLOCATED|Overall Study||130
10523135|NCT01363713|11675092|FG000|COMPLETED|Overall Study|Analysed (n=130)|124
10523136|NCT01363713|11675092|FG000|NOT COMPLETED|Overall Study||6
10523137|NCT01363765|11675098|FG000|STARTED|Overall Study|This is number of participants enrolled, each with one sample submitted to Xpert in intervention arm|18322
10523138|NCT01363765|11675099|FG001|STARTED|Overall Study|This is number of participants enrolled, each with one sample considered in baseline arm.|16436
10523139|NCT01363765|11675098|FG000|COMPLETED|Overall Study|Excluded were duplicates, non-residents, missing age, unavailability of system (smears done instead)|12522
10523140|NCT01363765|11675099|FG001|COMPLETED|Overall Study|Samples contributing to observation arm. Excluded were duplicates, non-residents, missing age.|11705
10523141|NCT01363765|11675098|FG000|NOT COMPLETED|Overall Study||5800
10523142|NCT01363765|11675099|FG001|NOT COMPLETED|Overall Study||4731
10523143|NCT01363843|11675107|FG000|STARTED|Overall Study||39
10523144|NCT01363843|11675107|FG000|COMPLETED|Overall Study|39 enrolled, 36 completed 8 cycles of mFOLFOX6, 35 completed chemo-radiation, 38 underwent surgery.|38
10523145|NCT01363843|11675107|FG000|NOT COMPLETED|Overall Study||1
10523146|NCT01363908|11675114|FG000|STARTED|Screening/Enrollment||14
10523147|NCT01363908|11675115|FG001|STARTED|Screening/Enrollment||16
10523148|NCT01363908|11675114|FG000|COMPLETED|Screening/Enrollment|One participant did not receive investigational product.|13
10523149|NCT01363908|11675115|FG001|COMPLETED|Screening/Enrollment||16
10523150|NCT01363908|11675114|FG000|NOT COMPLETED|Screening/Enrollment||1
10523151|NCT01363908|11675115|FG001|NOT COMPLETED|Screening/Enrollment||0
10523152|NCT01363908|11675114|FG000|STARTED|Pharmacokinetic (PK) Phase|Per study design, at least 8 participants in each age cohort participated in the PK phase.|8
10523153|NCT01363908|11675115|FG001|STARTED|Pharmacokinetic (PK) Phase|Per study design, at least 8 participants in each age cohort participated in the PK phase.|8
10523154|NCT01363908|11675114|FG000|COMPLETED|Pharmacokinetic (PK) Phase||8
10523155|NCT01363908|11675115|FG001|COMPLETED|Pharmacokinetic (PK) Phase||8
10523156|NCT01363908|11675114|FG000|NOT COMPLETED|Pharmacokinetic (PK) Phase||0
10523157|NCT01363908|11675115|FG001|NOT COMPLETED|Pharmacokinetic (PK) Phase||0
10523158|NCT01363908|11675114|FG000|STARTED|Chronic Dosing (CD) Phase|The CD phase enrolled willing participants who completed the PK phase plus additional participants.|13
10523159|NCT01363908|11675115|FG001|STARTED|Chronic Dosing (CD) Phase|The CD phase enrolled willing participants who completed the PK phase plus additional participants.|16
10523160|NCT01363908|11675114|FG000|COMPLETED|Chronic Dosing (CD) Phase||3
10523161|NCT01363908|11675115|FG001|COMPLETED|Chronic Dosing (CD) Phase||10
10523162|NCT01363908|11675114|FG000|NOT COMPLETED|Chronic Dosing (CD) Phase||10
10523163|NCT01363908|11675115|FG001|NOT COMPLETED|Chronic Dosing (CD) Phase||6
10523164|NCT01363986|11675121|FG000|STARTED|Overall Study||3
10523165|NCT01363986|11675121|FG000|COMPLETED|Overall Study||2
10523166|NCT01363986|11675121|FG000|NOT COMPLETED|Overall Study||1
10523167|NCT01363999|11675125|FG000|STARTED|A: RO5317116/F01 Bilayer Tablet||24
10523168|NCT01363999|11675125|FG000|COMPLETED|A: RO5317116/F01 Bilayer Tablet||24
10523169|NCT01363999|11675125|FG000|NOT COMPLETED|A: RO5317116/F01 Bilayer Tablet||0
10523170|NCT01363999|11675125|FG000|STARTED|B: RO5317116/F03 Bilayer Tablet||24
10523171|NCT01363999|11675125|FG000|COMPLETED|B: RO5317116/F03 Bilayer Tablet||24
10523172|NCT01363999|11675125|FG000|NOT COMPLETED|B: RO5317116/F03 Bilayer Tablet||0
10523173|NCT01363999|11675125|FG000|STARTED|C: RO5317116/ F04 Active-coated Tablet||24
10523174|NCT01363999|11675125|FG000|COMPLETED|C: RO5317116/ F04 Active-coated Tablet||24
10523175|NCT01363999|11675125|FG000|NOT COMPLETED|C: RO5317116/ F04 Active-coated Tablet||0
10523176|NCT01363999|11675125|FG000|STARTED|D: RO4607381/ F49 Tablet||24
10523177|NCT01363999|11675125|FG000|COMPLETED|D: RO4607381/ F49 Tablet||24
10523178|NCT01363999|11675125|FG000|NOT COMPLETED|D: RO4607381/ F49 Tablet||0
10523179|NCT01364090|11675135|FG000|STARTED|Overall Study||61
10523180|NCT01364090|11675136|FG001|STARTED|Overall Study||26
10523181|NCT01364090|11675137|FG002|STARTED|Overall Study||6
10523182|NCT01364090|11675135|FG000|COMPLETED|Overall Study||58
10523183|NCT01364090|11675136|FG001|COMPLETED|Overall Study||12
10523184|NCT01364090|11675137|FG002|COMPLETED|Overall Study||0
10523185|NCT01364090|11675135|FG000|NOT COMPLETED|Overall Study||3
10523186|NCT01364090|11675136|FG001|NOT COMPLETED|Overall Study||14
10523187|NCT01364090|11675137|FG002|NOT COMPLETED|Overall Study||6
10523188|NCT01364207|11675145|FG000|STARTED|First Visit (~1.5-2 Hours)||54
10523189|NCT01364207|11675146|FG001|STARTED|First Visit (~1.5-2 Hours)||58
10523190|NCT01364207|11675145|FG000|COMPLETED|First Visit (~1.5-2 Hours)||54
10523191|NCT01364207|11675146|FG001|COMPLETED|First Visit (~1.5-2 Hours)||58
10523192|NCT01364207|11675145|FG000|NOT COMPLETED|First Visit (~1.5-2 Hours)||0
10523193|NCT01364207|11675146|FG001|NOT COMPLETED|First Visit (~1.5-2 Hours)||0
10523194|NCT01364207|11675145|FG000|STARTED|Time Between Visits (2 Days to 4 Weeks)||54
10523195|NCT01364207|11675146|FG001|STARTED|Time Between Visits (2 Days to 4 Weeks)||58
10523196|NCT01364207|11675145|FG000|COMPLETED|Time Between Visits (2 Days to 4 Weeks)||52
10523197|NCT01364207|11675146|FG001|COMPLETED|Time Between Visits (2 Days to 4 Weeks)||54
10523198|NCT01364207|11675145|FG000|NOT COMPLETED|Time Between Visits (2 Days to 4 Weeks)||2
10523199|NCT01364207|11675146|FG001|NOT COMPLETED|Time Between Visits (2 Days to 4 Weeks)||4
10523200|NCT01364207|11675145|FG000|STARTED|Second Visit (~1.5-2 Hours)||52
10523201|NCT01364207|11675146|FG001|STARTED|Second Visit (~1.5-2 Hours)||54
10523202|NCT01364207|11675145|FG000|COMPLETED|Second Visit (~1.5-2 Hours)||52
10523203|NCT01364207|11675146|FG001|COMPLETED|Second Visit (~1.5-2 Hours)||54
10523204|NCT01364207|11675145|FG000|NOT COMPLETED|Second Visit (~1.5-2 Hours)||0
10523205|NCT01364207|11675146|FG001|NOT COMPLETED|Second Visit (~1.5-2 Hours)||0
10528922|NCT01397448|11681299|FG001|STARTED|Overall Study|158 participants were randomized but 1 participant was not treated with drug.|157
10528923|NCT01397448|11681300|FG002|STARTED|Overall Study||158
10528924|NCT01397448|11681298|FG000|COMPLETED|Overall Study||138
10528925|NCT01397448|11681299|FG001|COMPLETED|Overall Study||142
10523206|NCT01364233|11675152|FG000|STARTED|Overall Study||10
10523207|NCT01364233|11675152|FG000|COMPLETED|Overall Study||9
10523208|NCT01364233|11675152|FG000|NOT COMPLETED|Overall Study||1
10523209|NCT01364259|11675158|FG000|STARTED|Overall Study||9
10523210|NCT01364259|11675159|FG001|STARTED|Overall Study||8
10523211|NCT01364259|11675158|FG000|COMPLETED|Overall Study||9
10712001|NCT02665286|11877496|FG001|STARTED|Overall Study||80
10712002|NCT02665286|11877497|FG002|STARTED|Overall Study||81
10712003|NCT02665286|11877495|FG000|COMPLETED|Overall Study||76
10712004|NCT02665286|11877496|FG001|COMPLETED|Overall Study||78
10712005|NCT02665286|11877497|FG002|COMPLETED|Overall Study||80
10712006|NCT02665286|11877495|FG000|NOT COMPLETED|Overall Study||3
10712007|NCT02665286|11877496|FG001|NOT COMPLETED|Overall Study||2
10712008|NCT02665286|11877497|FG002|NOT COMPLETED|Overall Study||1
10712009|NCT02665364|11877507|FG000|STARTED|Overall Study||91
10523212|NCT01364259|11675159|FG001|COMPLETED|Overall Study||8
10523213|NCT01364259|11675158|FG000|NOT COMPLETED|Overall Study||0
10523214|NCT01364259|11675159|FG001|NOT COMPLETED|Overall Study||0
10523215|NCT01364298|11675167|FG000|STARTED|Overall Study||176
10523216|NCT01364298|11675168|FG001|STARTED|Overall Study||177
10523217|NCT01364298|11675167|FG000|Treated|Overall Study||174
10523218|NCT01364298|11675168|FG001|Treated|Overall Study||174
10523219|NCT01364298|11675167|FG000|COMPLETED|Overall Study||162
10523220|NCT01364298|11675168|FG001|COMPLETED|Overall Study||154
10523221|NCT01364298|11675167|FG000|NOT COMPLETED|Overall Study||14
10523222|NCT01364298|11675168|FG001|NOT COMPLETED|Overall Study||23
10523223|NCT01364389|11675177|FG000|STARTED|Overall Study||5
10523224|NCT01364389|11675178|FG001|STARTED|Overall Study||6
10523225|NCT01364389|11675179|FG002|STARTED|Overall Study||5
10523226|NCT01364389|11675177|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||5
10523227|NCT01364389|11675178|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||6
10523228|NCT01364389|11675179|FG002|Pharmacodynamic (PD) Analysis Set|Overall Study|One patient excluded: did not receive study drug; received placebo caps. and infusion only in error.|4
10523229|NCT01364389|11675177|FG000|COMPLETED|Overall Study||3
10523230|NCT01364389|11675178|FG001|COMPLETED|Overall Study||5
10523231|NCT01364389|11675179|FG002|COMPLETED|Overall Study||4
10523232|NCT01364389|11675177|FG000|NOT COMPLETED|Overall Study||2
10523233|NCT01364389|11675178|FG001|NOT COMPLETED|Overall Study||1
10523234|NCT01364389|11675179|FG002|NOT COMPLETED|Overall Study||1
10523235|NCT01364428|11675189|FG000|STARTED|Overall Study||186
10523236|NCT01364428|11675190|FG001|STARTED|Overall Study||187
10523237|NCT01364428|11675189|FG000|Exposed|Overall Study|Two subjects were randomised in error and withdrew prior to exposure to drug|184
10523238|NCT01364428|11675190|FG001|Exposed|Overall Study||187
10523239|NCT01364428|11675189|FG000|COMPLETED|Overall Study||166
10523240|NCT01364428|11675190|FG001|COMPLETED|Overall Study||172
10523241|NCT01364428|11675189|FG000|NOT COMPLETED|Overall Study||20
10523242|NCT01364428|11675190|FG001|NOT COMPLETED|Overall Study||15
10523243|NCT01364467|11675198|FG000|STARTED|Overall Study||10
10523244|NCT01364467|11675199|FG001|STARTED|Overall Study||20
10523245|NCT01364467|11675198|FG000|COMPLETED|Overall Study||9
10523246|NCT01364467|11675199|FG001|COMPLETED|Overall Study||18
10523247|NCT01364467|11675198|FG000|NOT COMPLETED|Overall Study||1
10523248|NCT01364467|11675199|FG001|NOT COMPLETED|Overall Study||2
10523249|NCT01364558|11675205|FG000|STARTED|Dose One||8
10523250|NCT01364558|11675206|FG001|STARTED|Dose One||8
10523251|NCT01364558|11675207|FG002|STARTED|Dose One||8
10523252|NCT01364558|11675205|FG000|COMPLETED|Dose One||8
10523253|NCT01364558|11675206|FG001|COMPLETED|Dose One||8
10523254|NCT01364558|11675207|FG002|COMPLETED|Dose One||8
10523255|NCT01364558|11675205|FG000|NOT COMPLETED|Dose One||0
10523256|NCT01364558|11675206|FG001|NOT COMPLETED|Dose One||0
10523257|NCT01364558|11675207|FG002|NOT COMPLETED|Dose One||0
10523258|NCT01364558|11675205|FG000|STARTED|Dose Two||8
10523259|NCT01364558|11675206|FG001|STARTED|Dose Two||8
10523260|NCT01364558|11675207|FG002|STARTED|Dose Two||8
10523261|NCT01364558|11675205|FG000|COMPLETED|Dose Two||8
10523262|NCT01364558|11675206|FG001|COMPLETED|Dose Two||8
10523263|NCT01364558|11675207|FG002|COMPLETED|Dose Two||8
10523264|NCT01364558|11675205|FG000|NOT COMPLETED|Dose Two||0
10523265|NCT01364558|11675206|FG001|NOT COMPLETED|Dose Two||0
10523266|NCT01364558|11675207|FG002|NOT COMPLETED|Dose Two||0
10523267|NCT01364558|11675205|FG000|STARTED|Dose Three||8
10712010|NCT02665364|11877508|FG001|STARTED|Overall Study||93
10712011|NCT02665364|11877507|FG000|COMPLETED|Overall Study||85
10712012|NCT02665364|11877508|FG001|COMPLETED|Overall Study||84
10712013|NCT02665364|11877507|FG000|NOT COMPLETED|Overall Study||6
10712014|NCT02665364|11877508|FG001|NOT COMPLETED|Overall Study||9
10523268|NCT01364558|11675206|FG001|STARTED|Dose Three||8
10523269|NCT01364558|11675207|FG002|STARTED|Dose Three||8
10523270|NCT01364558|11675205|FG000|COMPLETED|Dose Three||8
10523271|NCT01364558|11675206|FG001|COMPLETED|Dose Three||8
10523272|NCT01364558|11675207|FG002|COMPLETED|Dose Three||8
10523273|NCT01364558|11675205|FG000|NOT COMPLETED|Dose Three||0
10523274|NCT01364558|11675206|FG001|NOT COMPLETED|Dose Three||0
10523275|NCT01364558|11675207|FG002|NOT COMPLETED|Dose Three||0
10523276|NCT01364584|11675217|FG000|STARTED|Overall Study||11
10523277|NCT01364584|11675218|FG001|STARTED|Overall Study||12
10523278|NCT01364584|11675217|FG000|COMPLETED|Overall Study||11
10523279|NCT01364584|11675218|FG001|COMPLETED|Overall Study||12
10523280|NCT01364584|11675217|FG000|NOT COMPLETED|Overall Study||0
10523281|NCT01364584|11675218|FG001|NOT COMPLETED|Overall Study||0
10523282|NCT01364623|11675229|FG000|STARTED|Single Dose||8
10523283|NCT01364623|11675230|FG001|STARTED|Single Dose||8
10523284|NCT01364623|11675231|FG002|STARTED|Single Dose||8
10523285|NCT01364623|11675232|FG003|STARTED|Single Dose||0
10523286|NCT01364623|11675229|FG000|COMPLETED|Single Dose||8
10523287|NCT01364623|11675230|FG001|COMPLETED|Single Dose||8
10523288|NCT01364623|11675231|FG002|COMPLETED|Single Dose||8
10523289|NCT01364623|11675232|FG003|COMPLETED|Single Dose||0
10712015|NCT02665455|11877514|FG000|STARTED|Overall Study||83
10712016|NCT02665455|11877514|FG000|COMPLETED|Overall Study||74
10712017|NCT02665455|11877514|FG000|NOT COMPLETED|Overall Study||9
10712018|NCT02665468|11877520|FG000|STARTED|Overall Study||595
10712019|NCT02665468|11877521|FG001|STARTED|Overall Study||601
10712020|NCT02665468|11877520|FG000|COMPLETED|Overall Study||595
10712021|NCT02665468|11877521|FG001|COMPLETED|Overall Study||601
10712022|NCT02665468|11877520|FG000|NOT COMPLETED|Overall Study||0
10523290|NCT01364623|11675229|FG000|NOT COMPLETED|Single Dose||0
10523291|NCT01364623|11675230|FG001|NOT COMPLETED|Single Dose||0
10523292|NCT01364623|11675231|FG002|NOT COMPLETED|Single Dose||0
10523293|NCT01364623|11675232|FG003|NOT COMPLETED|Single Dose||0
10523294|NCT01364623|11675229|FG000|STARTED|Multiple Dose||0
10523295|NCT01364623|11675230|FG001|STARTED|Multiple Dose||0
10523296|NCT01364623|11675231|FG002|STARTED|Multiple Dose||0
10523297|NCT01364623|11675232|FG003|STARTED|Multiple Dose||8
10523298|NCT01364623|11675229|FG000|COMPLETED|Multiple Dose||0
10523299|NCT01364623|11675230|FG001|COMPLETED|Multiple Dose||0
10523300|NCT01364623|11675231|FG002|COMPLETED|Multiple Dose||0
10523301|NCT01364623|11675232|FG003|COMPLETED|Multiple Dose||8
10523302|NCT01364623|11675229|FG000|NOT COMPLETED|Multiple Dose||0
10523303|NCT01364623|11675230|FG001|NOT COMPLETED|Multiple Dose||0
10523304|NCT01364623|11675231|FG002|NOT COMPLETED|Multiple Dose||0
10523305|NCT01364623|11675232|FG003|NOT COMPLETED|Multiple Dose||0
10523306|NCT01364649|11675249|FG000|STARTED|Overall Study||225
10523307|NCT01364649|11675250|FG001|STARTED|Overall Study||222
10523308|NCT01364649|11675249|FG000|COMPLETED|Overall Study||169
10523309|NCT01364649|11675250|FG001|COMPLETED|Overall Study||179
10523310|NCT01364649|11675249|FG000|NOT COMPLETED|Overall Study||56
10523311|NCT01364649|11675250|FG001|NOT COMPLETED|Overall Study||43
10523312|NCT01364727|11675256|FG000|STARTED|Overall Study||35
10523313|NCT01364727|11675256|FG000|COMPLETED|Overall Study||33
10523314|NCT01364727|11675256|FG000|NOT COMPLETED|Overall Study||2
10523315|NCT01364740|11675262|FG000|STARTED|Overall Study||10
10523316|NCT01364740|11675262|FG000|COMPLETED|Overall Study||10
10523317|NCT01364740|11675262|FG000|NOT COMPLETED|Overall Study||0
10523318|NCT01364870|11675270|FG000|STARTED|Overall Study||122
10523319|NCT01364870|11675271|FG001|STARTED|Overall Study||123
10523320|NCT01364870|11675272|FG002|STARTED|Overall Study||72
10523321|NCT01364870|11675270|FG000|COMPLETED|Overall Study||100
10523322|NCT01364870|11675271|FG001|COMPLETED|Overall Study||93
10523323|NCT01364870|11675272|FG002|COMPLETED|Overall Study||58
10523324|NCT01364870|11675270|FG000|NOT COMPLETED|Overall Study||22
10523325|NCT01364870|11675271|FG001|NOT COMPLETED|Overall Study||30
10523326|NCT01364870|11675272|FG002|NOT COMPLETED|Overall Study||14
10523327|NCT01364896|11675280|FG000|STARTED|Overall Study||46
10523328|NCT01364896|11675280|FG000|COMPLETED|Overall Study||46
10523329|NCT01364896|11675280|FG000|NOT COMPLETED|Overall Study||0
10523330|NCT01364922|11675287|FG000|STARTED|Open-label (OL) Period||168
10523331|NCT01364922|11675288|FG001|STARTED|Open-label (OL) Period||0
10523332|NCT01364922|11675289|FG002|STARTED|Open-label (OL) Period||0
10523333|NCT01364922|11675287|FG000|COMPLETED|Open-label (OL) Period||146
10523334|NCT01364922|11675288|FG001|COMPLETED|Open-label (OL) Period||0
10523335|NCT01364922|11675289|FG002|COMPLETED|Open-label (OL) Period||0
10523336|NCT01364922|11675287|FG000|NOT COMPLETED|Open-label (OL) Period||22
10712023|NCT02665468|11877521|FG001|NOT COMPLETED|Overall Study||0
10523337|NCT01364922|11675288|FG001|NOT COMPLETED|Open-label (OL) Period||0
10523338|NCT01364922|11675289|FG002|NOT COMPLETED|Open-label (OL) Period||0
10523339|NCT01364922|11675287|FG000|STARTED|Double-Blind (DB) Period||0
10523340|NCT01364922|11675288|FG001|STARTED|Double-Blind (DB) Period||99
10523341|NCT01364922|11675289|FG002|STARTED|Double-Blind (DB) Period||47
10523342|NCT01364922|11675287|FG000|COMPLETED|Double-Blind (DB) Period||0
10523343|NCT01364922|11675288|FG001|COMPLETED|Double-Blind (DB) Period||94
10523344|NCT01364922|11675289|FG002|COMPLETED|Double-Blind (DB) Period||42
10523345|NCT01364922|11675287|FG000|NOT COMPLETED|Double-Blind (DB) Period||0
10523346|NCT01364922|11675288|FG001|NOT COMPLETED|Double-Blind (DB) Period||5
10523347|NCT01364922|11675289|FG002|NOT COMPLETED|Double-Blind (DB) Period||5
10523348|NCT01365039|11675298|FG000|STARTED|Overall Study||86
10523349|NCT01365039|11675299|FG001|STARTED|Overall Study||87
10523350|NCT01365039|11675298|FG000|COMPLETED|Overall Study||85
10523351|NCT01365039|11675299|FG001|COMPLETED|Overall Study||87
10523352|NCT01365039|11675298|FG000|NOT COMPLETED|Overall Study||1
10523353|NCT01365039|11675299|FG001|NOT COMPLETED|Overall Study||0
10523354|NCT01365052|11675308|FG000|STARTED|Overall Study||217
10523355|NCT01365052|11675309|FG001|STARTED|Overall Study||109
10523356|NCT01365052|11675308|FG000|COMPLETED|Overall Study||213
10523357|NCT01365052|11675309|FG001|COMPLETED|Overall Study||105
10523358|NCT01365052|11675308|FG000|NOT COMPLETED|Overall Study||4
10523359|NCT01365052|11675309|FG001|NOT COMPLETED|Overall Study||4
10523360|NCT01365091|11675319|FG000|STARTED|Period 1||28
10523361|NCT01365091|11675320|FG001|STARTED|Period 1||28
10523362|NCT01365091|11675321|FG002|STARTED|Period 1||28
10523363|NCT01365091|11675322|FG003|STARTED|Period 1||28
10523364|NCT01365091|11675319|FG000|COMPLETED|Period 1||26
10523365|NCT01365091|11675320|FG001|COMPLETED|Period 1||26
10523366|NCT01365091|11675321|FG002|COMPLETED|Period 1||25
10523367|NCT01365091|11675322|FG003|COMPLETED|Period 1||25
10523368|NCT01365091|11675319|FG000|NOT COMPLETED|Period 1||2
10523369|NCT01365091|11675320|FG001|NOT COMPLETED|Period 1||2
10523370|NCT01365091|11675321|FG002|NOT COMPLETED|Period 1||3
10523371|NCT01365091|11675322|FG003|NOT COMPLETED|Period 1||3
10523372|NCT01365091|11675319|FG000|STARTED|Period 2||26
10523373|NCT01365091|11675320|FG001|STARTED|Period 2||26
10523374|NCT01365091|11675321|FG002|STARTED|Period 2||25
10523375|NCT01365091|11675322|FG003|STARTED|Period 2||25
10523376|NCT01365091|11675319|FG000|COMPLETED|Period 2||25
10523377|NCT01365091|11675320|FG001|COMPLETED|Period 2||26
10523378|NCT01365091|11675321|FG002|COMPLETED|Period 2||24
10523379|NCT01365091|11675322|FG003|COMPLETED|Period 2||25
10523380|NCT01365091|11675319|FG000|NOT COMPLETED|Period 2||1
10523381|NCT01365091|11675320|FG001|NOT COMPLETED|Period 2||0
10523382|NCT01365091|11675321|FG002|NOT COMPLETED|Period 2||1
10523383|NCT01365091|11675322|FG003|NOT COMPLETED|Period 2||0
10523384|NCT01365130|11675346|FG000|STARTED|Overall Study|15 patients were enrolled to the study but only 13 went on to begin treatment|15
10523385|NCT01365130|11675346|FG000|COMPLETED|Overall Study||13
10523386|NCT01365130|11675346|FG000|NOT COMPLETED|Overall Study||2
10523387|NCT01365273|11675352|FG000|STARTED|Overall Study||22
10523388|NCT01365273|11675353|FG001|STARTED|Overall Study||21
10523389|NCT01365273|11675352|FG000|Compl. Pts, Not Evaluable for Pain.|Overall Study||2
10523390|NCT01365273|11675353|FG001|Compl. Pts, Not Evaluable for Pain.|Overall Study||4
10523391|NCT01365273|11675352|FG000|COMPLETED|Overall Study||20
10523392|NCT01365273|11675353|FG001|COMPLETED|Overall Study||20
10523393|NCT01365273|11675352|FG000|NOT COMPLETED|Overall Study||2
10523394|NCT01365273|11675353|FG001|NOT COMPLETED|Overall Study||1
10523395|NCT01365455|11675362|FG000|STARTED|Induction Period||245
10523396|NCT01365455|11675363|FG001|STARTED|Induction Period||245
10523397|NCT01365455|11675364|FG002|STARTED|Induction Period||248
10523398|NCT01365455|11675365|FG003|STARTED|Induction Period||0
10523399|NCT01365455|11675366|FG004|STARTED|Induction Period||0
10523400|NCT01365455|11675362|FG000|COMPLETED|Induction Period||230
10523401|NCT01365455|11675363|FG001|COMPLETED|Induction Period||238
10523402|NCT01365455|11675364|FG002|COMPLETED|Induction Period||232
10523403|NCT01365455|11675365|FG003|COMPLETED|Induction Period||0
10523404|NCT01365455|11675366|FG004|COMPLETED|Induction Period||0
10523405|NCT01365455|11675362|FG000|NOT COMPLETED|Induction Period||15
10523406|NCT01365455|11675363|FG001|NOT COMPLETED|Induction Period||7
10523407|NCT01365455|11675364|FG002|NOT COMPLETED|Induction Period||16
10523408|NCT01365455|11675365|FG003|NOT COMPLETED|Induction Period||0
10523409|NCT01365455|11675366|FG004|NOT COMPLETED|Induction Period||0
10523410|NCT01365455|11675362|FG000|STARTED|Maintenance Period||230
10523411|NCT01365455|11675363|FG001|STARTED|Maintenance Period||238
10523412|NCT01365455|11675364|FG002|STARTED|Maintenance Period||18
10523413|NCT01365455|11675365|FG003|STARTED|Maintenance Period||109
10523414|NCT01365455|11675366|FG004|STARTED|Maintenance Period||105
10523415|NCT01365455|11675362|FG000|COMPLETED|Maintenance Period||201
10523416|NCT01365455|11675363|FG001|COMPLETED|Maintenance Period||215
10523417|NCT01365455|11675364|FG002|COMPLETED|Maintenance Period||15
10523418|NCT01365455|11675365|FG003|COMPLETED|Maintenance Period||100
10523419|NCT01365455|11675366|FG004|COMPLETED|Maintenance Period||92
10523420|NCT01365455|11675362|FG000|NOT COMPLETED|Maintenance Period||29
10523421|NCT01365455|11675363|FG001|NOT COMPLETED|Maintenance Period||23
10523422|NCT01365455|11675364|FG002|NOT COMPLETED|Maintenance Period||3
10523423|NCT01365455|11675365|FG003|NOT COMPLETED|Maintenance Period||9
10523424|NCT01365455|11675366|FG004|NOT COMPLETED|Maintenance Period||13
10523425|NCT01365455|11675362|FG000|STARTED|Follow-up Period||58
10523426|NCT01365455|11675363|FG001|STARTED|Follow-up Period||47
10523427|NCT01365455|11675364|FG002|STARTED|Follow-up Period||18
10523428|NCT01365455|11675365|FG003|STARTED|Follow-up Period||0
10523429|NCT01365455|11675366|FG004|STARTED|Follow-up Period||0
10523430|NCT01365455|11675362|FG000|COMPLETED|Follow-up Period||58
10523431|NCT01365455|11675363|FG001|COMPLETED|Follow-up Period||47
10523432|NCT01365455|11675364|FG002|COMPLETED|Follow-up Period||18
10523433|NCT01365455|11675365|FG003|COMPLETED|Follow-up Period||0
10523434|NCT01365455|11675366|FG004|COMPLETED|Follow-up Period||0
10523435|NCT01365455|11675362|FG000|NOT COMPLETED|Follow-up Period||0
10523436|NCT01365455|11675363|FG001|NOT COMPLETED|Follow-up Period||0
10523437|NCT01365455|11675364|FG002|NOT COMPLETED|Follow-up Period||0
10523438|NCT01365455|11675365|FG003|NOT COMPLETED|Follow-up Period||0
10523439|NCT01365455|11675366|FG004|NOT COMPLETED|Follow-up Period||0
10523440|NCT01365468|11675386|FG000|STARTED|Overall Study||4
10523441|NCT01365468|11675387|FG001|STARTED|Overall Study||5
10523442|NCT01365468|11675386|FG000|COMPLETED|Overall Study||0
10523443|NCT01365468|11675387|FG001|COMPLETED|Overall Study||5
10523444|NCT01365468|11675386|FG000|NOT COMPLETED|Overall Study||4
10523445|NCT01365468|11675387|FG001|NOT COMPLETED|Overall Study||0
10523446|NCT01365481|11675398|FG000|STARTED|Overall Study||23
10523447|NCT01365481|11675399|FG001|STARTED|Overall Study||52
10523448|NCT01365481|11675400|FG002|STARTED|Overall Study||18
10523449|NCT01365481|11675401|FG003|STARTED|Overall Study||57
10523450|NCT01365481|11675398|FG000|COMPLETED|Overall Study||16
10523451|NCT01365481|11675399|FG001|COMPLETED|Overall Study||37
10523452|NCT01365481|11675400|FG002|COMPLETED|Overall Study||14
10523453|NCT01365481|11675401|FG003|COMPLETED|Overall Study||50
10523454|NCT01365481|11675398|FG000|NOT COMPLETED|Overall Study||7
10523455|NCT01365481|11675399|FG001|NOT COMPLETED|Overall Study||15
10523456|NCT01365481|11675400|FG002|NOT COMPLETED|Overall Study||4
10523457|NCT01365481|11675401|FG003|NOT COMPLETED|Overall Study||7
10523458|NCT01365494|11675413|FG000|STARTED|Overall Study||126
10523459|NCT01365494|11675414|FG001|STARTED|Overall Study||124
10523460|NCT01365494|11675413|FG000|COMPLETED|Overall Study||124
10523461|NCT01365494|11675414|FG001|COMPLETED|Overall Study||121
10523462|NCT01365494|11675413|FG000|NOT COMPLETED|Overall Study||2
10523463|NCT01365494|11675414|FG001|NOT COMPLETED|Overall Study||3
10523464|NCT01365507|11675423|FG000|STARTED|Overall Study||136
10523465|NCT01365507|11675424|FG001|STARTED|Overall Study||140
10523466|NCT01365507|11675423|FG000|Exposed|Overall Study|Two subjects withdrew before exposure to trial drug|134
10523467|NCT01365507|11675424|FG001|Exposed|Overall Study||140
10523468|NCT01365507|11675423|FG000|COMPLETED|Overall Study||127
10523469|NCT01365507|11675424|FG001|COMPLETED|Overall Study||131
10523470|NCT01365507|11675423|FG000|NOT COMPLETED|Overall Study||9
10523471|NCT01365507|11675424|FG001|NOT COMPLETED|Overall Study||9
10523472|NCT01365546|11675430|FG000|STARTED|Overall Study|in this study 41 patients were screened but only 30 patients completed the study.|41
10523473|NCT01365546|11675430|FG000|COMPLETED|Overall Study||30
10523474|NCT01365546|11675430|FG000|NOT COMPLETED|Overall Study||11
10523475|NCT01365585|11675438|FG000|STARTED|Overall Study||227
10523476|NCT01365585|11675438|FG000|COMPLETED|Overall Study||227
10523477|NCT01365585|11675438|FG000|NOT COMPLETED|Overall Study||0
10523478|NCT01365611|11675442|FG000|STARTED|Overall Study||36
10523479|NCT01365611|11675442|FG000|COMPLETED|Overall Study||36
10523480|NCT01365611|11675442|FG000|NOT COMPLETED|Overall Study||0
10523481|NCT01365624|11675450|FG000|STARTED|Overall Study||15
10523482|NCT01365624|11675451|FG001|STARTED|Overall Study||15
10523483|NCT01365624|11675450|FG000|COMPLETED|Overall Study||15
10523484|NCT01365624|11675451|FG001|COMPLETED|Overall Study||15
10523485|NCT01365624|11675450|FG000|NOT COMPLETED|Overall Study||0
10523486|NCT01365624|11675451|FG001|NOT COMPLETED|Overall Study||0
10523487|NCT01365650|11675457|FG000|STARTED|Treatment A||24
10523488|NCT01365650|11675457|FG000|COMPLETED|Treatment A||24
10523489|NCT01365650|11675457|FG000|NOT COMPLETED|Treatment A||0
10523490|NCT01365650|11675457|FG000|STARTED|Treatment B||24
10523491|NCT01365650|11675457|FG000|COMPLETED|Treatment B||24
10523492|NCT01365650|11675457|FG000|NOT COMPLETED|Treatment B||0
10523493|NCT01365650|11675457|FG000|STARTED|Treatment C||24
10523494|NCT01365650|11675457|FG000|COMPLETED|Treatment C||24
10523495|NCT01365650|11675457|FG000|NOT COMPLETED|Treatment C||0
10523496|NCT01365793|11675469|FG000|STARTED|Overall Study||344
10523497|NCT01365793|11675470|FG001|STARTED|Overall Study||351
10523498|NCT01365793|11675471|FG002|STARTED|Overall Study||345
10523499|NCT01365793|11675472|FG003|STARTED|Overall Study||349
10523500|NCT01365793|11675469|FG000|COMPLETED|Overall Study||342
10523501|NCT01365793|11675470|FG001|COMPLETED|Overall Study||344
10523502|NCT01365793|11675471|FG002|COMPLETED|Overall Study||338
10523503|NCT01365793|11675472|FG003|COMPLETED|Overall Study||347
10523504|NCT01365793|11675469|FG000|NOT COMPLETED|Overall Study||2
10523505|NCT01365793|11675470|FG001|NOT COMPLETED|Overall Study||7
10523506|NCT01365793|11675471|FG002|NOT COMPLETED|Overall Study||7
10523507|NCT01365793|11675472|FG003|NOT COMPLETED|Overall Study||2
10523508|NCT01365819|11675484|FG000|STARTED|Overall Study||25
10523509|NCT01365819|11675485|FG001|STARTED|Overall Study||27
10523510|NCT01365819|11675484|FG000|COMPLETED|Overall Study||12
10523511|NCT01365819|11675485|FG001|COMPLETED|Overall Study||14
10523512|NCT01365819|11675484|FG000|NOT COMPLETED|Overall Study||13
10523513|NCT01365819|11675485|FG001|NOT COMPLETED|Overall Study||13
10523514|NCT01365845|11675491|FG000|STARTED|Induction Phase||18
10523515|NCT01365845|11675492|FG001|STARTED|Induction Phase||0
10523516|NCT01365845|11675493|FG002|STARTED|Induction Phase||0
10523517|NCT01365845|11675491|FG000|COMPLETED|Induction Phase||18
10523518|NCT01365845|11675492|FG001|COMPLETED|Induction Phase||0
10523519|NCT01365845|11675493|FG002|COMPLETED|Induction Phase||0
10523520|NCT01365845|11675491|FG000|NOT COMPLETED|Induction Phase||0
10523521|NCT01365845|11675492|FG001|NOT COMPLETED|Induction Phase||0
10523522|NCT01365845|11675493|FG002|NOT COMPLETED|Induction Phase||0
10523523|NCT01365845|11675491|FG000|STARTED|Treatment Phase||0
10523524|NCT01365845|11675492|FG001|STARTED|Treatment Phase||0
10523525|NCT01365845|11675493|FG002|STARTED|Treatment Phase||18
10523526|NCT01365845|11675491|FG000|COMPLETED|Treatment Phase||0
10523527|NCT01365845|11675492|FG001|COMPLETED|Treatment Phase||0
10523528|NCT01365845|11675493|FG002|COMPLETED|Treatment Phase||18
10523529|NCT01365845|11675491|FG000|NOT COMPLETED|Treatment Phase||0
10523530|NCT01365845|11675492|FG001|NOT COMPLETED|Treatment Phase||0
10523531|NCT01365845|11675493|FG002|NOT COMPLETED|Treatment Phase||0
10523532|NCT01365910|11675498|FG000|STARTED|Overall Study||30
10523533|NCT01365910|11675498|FG000|COMPLETED|Overall Study||0
10523534|NCT01365910|11675498|FG000|NOT COMPLETED|Overall Study||30
10523535|NCT01366196|11675504|FG000|STARTED|Overall Study||43
10523536|NCT01366196|11675505|FG001|STARTED|Overall Study||43
10523537|NCT01366196|11675504|FG000|COMPLETED|Overall Study||43
10523538|NCT01366196|11675505|FG001|COMPLETED|Overall Study||43
10523539|NCT01366196|11675504|FG000|NOT COMPLETED|Overall Study||0
10523540|NCT01366196|11675505|FG001|NOT COMPLETED|Overall Study||0
10523541|NCT01366209|11675513|FG000|STARTED|Overall Study||278
10523542|NCT01366209|11675514|FG001|STARTED|Overall Study||277
10523543|NCT01366209|11675513|FG000|COMPLETED|Overall Study|Participants completing study assessment at Week 52 were completers, even if treatment was withdrawn|243
10523544|NCT01366209|11675514|FG001|COMPLETED|Overall Study||241
10523545|NCT01366209|11675513|FG000|NOT COMPLETED|Overall Study||35
10523546|NCT01366209|11675514|FG001|NOT COMPLETED|Overall Study||36
10523547|NCT01366417|11675520|FG000|STARTED|Overall Study||43
10523548|NCT01366417|11675520|FG000|Signed Informed Consent|Overall Study|Microbial samples were taken from 43 subjects for screening baseline.|43
10523549|NCT01366417|11675520|FG000|Completed Screen Visit|Overall Study|33 subjects had qualifying screening bacterial counts and were eligible for the Treatment Visit|33
10523550|NCT01366417|11675520|FG000|Completed Treatment Visit|Overall Study|28 subjects were treated with ChloraPrep and 70% Isopropyl Alcohol (single topical treatment)|28
10523551|NCT01366417|11675520|FG000|Completed the Study|Overall Study|treatment baseline microbial counts not available until after treatment; subjects not evaluable|28
10523552|NCT01366417|11675520|FG000|Discontinued Prior to Treatment|Overall Study|5 eligible subjects were not treated because enrollment target of 25 was met and enrollment closed.|5
10523553|NCT01366417|11675520|FG000|Excluded From Analysis|Overall Study|3 subjects did not have qualifying Treatment Day microbial counts and were excluded from analysis|3
10523554|NCT01366417|11675520|FG000|COMPLETED|Overall Study|25 subjects included in the analysis|25
10523555|NCT01366417|11675520|FG000|NOT COMPLETED|Overall Study||18
10523556|NCT01366443|11675525|FG000|STARTED|Overall Study||288
10523557|NCT01366443|11675525|FG000|COMPLETED|Overall Study||285
10523558|NCT01366443|11675525|FG000|NOT COMPLETED|Overall Study||3
10523559|NCT01366495|11675534|FG000|STARTED|Testing Study||0
10523560|NCT01366495|11675535|FG001|STARTED|Testing Study||0
10523561|NCT01366495|11675536|FG002|STARTED|Testing Study||349
10523562|NCT01366495|11675537|FG003|STARTED|Testing Study||348
10523563|NCT01366495|11675534|FG000|COMPLETED|Testing Study||0
10523564|NCT01366495|11675535|FG001|COMPLETED|Testing Study||0
10523565|NCT01366495|11675536|FG002|COMPLETED|Testing Study||349
10523566|NCT01366495|11675537|FG003|COMPLETED|Testing Study||348
10523567|NCT01366495|11675534|FG000|NOT COMPLETED|Testing Study||0
10523568|NCT01366495|11675535|FG001|NOT COMPLETED|Testing Study||0
10523569|NCT01366495|11675536|FG002|NOT COMPLETED|Testing Study||0
10523570|NCT01366495|11675537|FG003|NOT COMPLETED|Testing Study||0
10523571|NCT01366495|11675534|FG000|STARTED|HIV Study||50
10523572|NCT01366495|11675535|FG001|STARTED|HIV Study||50
10523573|NCT01366495|11675536|FG002|STARTED|HIV Study||0
10523574|NCT01366495|11675537|FG003|STARTED|HIV Study||0
10523575|NCT01366495|11675534|FG000|COMPLETED|HIV Study||49
10523576|NCT01366495|11675535|FG001|COMPLETED|HIV Study||50
10523577|NCT01366495|11675536|FG002|COMPLETED|HIV Study||0
10523578|NCT01366495|11675537|FG003|COMPLETED|HIV Study||0
10523579|NCT01366495|11675534|FG000|NOT COMPLETED|HIV Study||1
10523580|NCT01366495|11675535|FG001|NOT COMPLETED|HIV Study||0
10523581|NCT01366495|11675536|FG002|NOT COMPLETED|HIV Study||0
10523582|NCT01366495|11675537|FG003|NOT COMPLETED|HIV Study||0
10523583|NCT01366521|11675551|FG000|STARTED|Overall Study||21
10523584|NCT01366521|11675552|FG001|STARTED|Overall Study||15
10523585|NCT01366521|11675553|FG002|STARTED|Overall Study||23
10523586|NCT01366521|11675554|FG003|STARTED|Overall Study||11
10523587|NCT01366521|11675551|FG000|COMPLETED|Overall Study||20
10523588|NCT01366521|11675552|FG001|COMPLETED|Overall Study||14
10523589|NCT01366521|11675553|FG002|COMPLETED|Overall Study||21
10523590|NCT01366521|11675554|FG003|COMPLETED|Overall Study||11
10523591|NCT01366521|11675551|FG000|NOT COMPLETED|Overall Study||1
10523592|NCT01366521|11675552|FG001|NOT COMPLETED|Overall Study||1
10523593|NCT01366521|11675553|FG002|NOT COMPLETED|Overall Study||2
10523594|NCT01366521|11675554|FG003|NOT COMPLETED|Overall Study||0
10523595|NCT01366534|11675569|FG000|STARTED|Overall Study||28
10523596|NCT01366534|11675570|FG001|STARTED|Overall Study||27
10523597|NCT01366534|11675571|FG002|STARTED|Overall Study||12
10523598|NCT01366534|11675569|FG000|COMPLETED|Overall Study||26
10523599|NCT01366534|11675570|FG001|COMPLETED|Overall Study||25
10523600|NCT01366534|11675571|FG002|COMPLETED|Overall Study||12
10523601|NCT01366534|11675569|FG000|NOT COMPLETED|Overall Study||2
10523602|NCT01366534|11675570|FG001|NOT COMPLETED|Overall Study||2
10523603|NCT01366534|11675571|FG002|NOT COMPLETED|Overall Study||0
10523604|NCT01366638|11675582|FG000|STARTED|Overall Study||24
10523605|NCT01366638|11675583|FG001|STARTED|Overall Study||29
10523606|NCT01366638|11675584|FG002|STARTED|Overall Study||26
10523607|NCT01366638|11675582|FG000|COMPLETED|Overall Study||23
10523608|NCT01366638|11675583|FG001|COMPLETED|Overall Study||29
10523609|NCT01366638|11675584|FG002|COMPLETED|Overall Study||20
10523610|NCT01366638|11675582|FG000|NOT COMPLETED|Overall Study||1
10523611|NCT01366638|11675583|FG001|NOT COMPLETED|Overall Study||0
10523612|NCT01366638|11675584|FG002|NOT COMPLETED|Overall Study||6
10523613|NCT01366846|11675596|FG000|STARTED|Overall Study||235
10523614|NCT01366846|11675597|FG001|STARTED|Overall Study||228
10523615|NCT01366846|11675598|FG002|STARTED|Overall Study||47
10523616|NCT01366846|11675599|FG003|STARTED|Overall Study||46
10523617|NCT01366846|11675596|FG000|COMPLETED|Overall Study||232
10523618|NCT01366846|11675597|FG001|COMPLETED|Overall Study||224
10523619|NCT01366846|11675598|FG002|COMPLETED|Overall Study||46
10523620|NCT01366846|11675599|FG003|COMPLETED|Overall Study||45
10523621|NCT01366846|11675596|FG000|NOT COMPLETED|Overall Study||3
10523622|NCT01366846|11675597|FG001|NOT COMPLETED|Overall Study||4
10338316|NCT00369486|11475225|FG001|COMPLETED|8-Week Visit|Number of eyes|20
10338317|NCT00369486|11475226|FG002|COMPLETED|8-Week Visit|Number of eyes|22
10338318|NCT00369486|11475227|FG003|COMPLETED|8-Week Visit|Number of eyes|21
10523623|NCT01366846|11675598|FG002|NOT COMPLETED|Overall Study||1
10523624|NCT01366846|11675599|FG003|NOT COMPLETED|Overall Study||1
10523625|NCT01366872|11675612|FG000|STARTED|Overall Study||50
10523626|NCT01366872|11675612|FG000|COMPLETED|Overall Study||50
10523627|NCT01366872|11675612|FG000|NOT COMPLETED|Overall Study||0
10523628|NCT01366885|11675616|FG000|STARTED|Overall Study|We started recruiting in February 2008 and recruited 20 mothers.|20
10523629|NCT01366885|11675616|FG000|COMPLETED|Overall Study|We completed our study when the last child born had reached 36 months of age.|19
10523630|NCT01366885|11675616|FG000|NOT COMPLETED|Overall Study||1
10523631|NCT01366976|11675622|FG000|STARTED|Overall Study||30
10523632|NCT01366976|11675623|FG001|STARTED|Overall Study||30
10523633|NCT01366976|11675622|FG000|COMPLETED|Overall Study||30
10523634|NCT01366976|11675623|FG001|COMPLETED|Overall Study||30
10523635|NCT01366976|11675622|FG000|NOT COMPLETED|Overall Study||0
10523636|NCT01366976|11675623|FG001|NOT COMPLETED|Overall Study||0
10523637|NCT01367080|11675631|FG000|STARTED|1st Administration||6
10523638|NCT01367080|11675632|FG001|STARTED|1st Administration||6
10523639|NCT01367080|11675631|FG000|COMPLETED|1st Administration||6
10523640|NCT01367080|11675632|FG001|COMPLETED|1st Administration||6
10523641|NCT01367080|11675631|FG000|NOT COMPLETED|1st Administration||0
10523642|NCT01367080|11675632|FG001|NOT COMPLETED|1st Administration||0
10523643|NCT01367080|11675631|FG000|STARTED|2nd Administration||6
10523644|NCT01367080|11675632|FG001|STARTED|2nd Administration||6
10523645|NCT01367080|11675631|FG000|COMPLETED|2nd Administration||6
10523646|NCT01367080|11675632|FG001|COMPLETED|2nd Administration||6
10523647|NCT01367080|11675631|FG000|NOT COMPLETED|2nd Administration||0
10523648|NCT01367080|11675632|FG001|NOT COMPLETED|2nd Administration||0
10523649|NCT01367119|11675642|FG000|STARTED|Overall Study||21
10523650|NCT01367119|11675643|FG001|STARTED|Overall Study||17
10523651|NCT01367119|11675642|FG000|COMPLETED|Overall Study||19
10523652|NCT01367119|11675643|FG001|COMPLETED|Overall Study||16
10523653|NCT01367119|11675642|FG000|NOT COMPLETED|Overall Study||2
10523654|NCT01367119|11675643|FG001|NOT COMPLETED|Overall Study||1
10523655|NCT01367158|11675660|FG000|STARTED|Overall Study||25
10523656|NCT01367158|11675661|FG001|STARTED|Overall Study||49
10523657|NCT01367158|11675662|FG002|STARTED|Overall Study||24
10712024|NCT02665689|11877529|FG000|STARTED|Overall Study||2
10523658|NCT01367158|11675663|FG003|STARTED|Overall Study||49
10523659|NCT01367158|11675664|FG004|STARTED|Overall Study||25
10523660|NCT01367158|11675665|FG005|STARTED|Overall Study||48
10523661|NCT01367158|11675666|FG006|STARTED|Overall Study||25
10523662|NCT01367158|11675667|FG007|STARTED|Overall Study||49
10523663|NCT01367158|11675668|FG008|STARTED|Overall Study||23
10523664|NCT01367158|11675669|FG009|STARTED|Overall Study||50
10523665|NCT01367158|11675670|FG010|STARTED|Overall Study||73
10523666|NCT01367158|11675660|FG000|COMPLETED|Overall Study||25
10523667|NCT01367158|11675661|FG001|COMPLETED|Overall Study||46
10523668|NCT01367158|11675662|FG002|COMPLETED|Overall Study||23
10523669|NCT01367158|11675663|FG003|COMPLETED|Overall Study||48
10523670|NCT01367158|11675664|FG004|COMPLETED|Overall Study||23
10523671|NCT01367158|11675665|FG005|COMPLETED|Overall Study||46
10523672|NCT01367158|11675666|FG006|COMPLETED|Overall Study||25
10523673|NCT01367158|11675667|FG007|COMPLETED|Overall Study||47
10523674|NCT01367158|11675668|FG008|COMPLETED|Overall Study||23
10523675|NCT01367158|11675669|FG009|COMPLETED|Overall Study||50
10523676|NCT01367158|11675670|FG010|COMPLETED|Overall Study||72
10523677|NCT01367158|11675660|FG000|NOT COMPLETED|Overall Study||0
10523678|NCT01367158|11675661|FG001|NOT COMPLETED|Overall Study||3
10523679|NCT01367158|11675662|FG002|NOT COMPLETED|Overall Study||1
10523680|NCT01367158|11675663|FG003|NOT COMPLETED|Overall Study||1
10523681|NCT01367158|11675664|FG004|NOT COMPLETED|Overall Study||2
10523682|NCT01367158|11675665|FG005|NOT COMPLETED|Overall Study||2
10523683|NCT01367158|11675666|FG006|NOT COMPLETED|Overall Study||0
10523684|NCT01367158|11675667|FG007|NOT COMPLETED|Overall Study||2
10523685|NCT01367158|11675668|FG008|NOT COMPLETED|Overall Study||0
10523686|NCT01367158|11675669|FG009|NOT COMPLETED|Overall Study||0
10523687|NCT01367158|11675670|FG010|NOT COMPLETED|Overall Study||1
10523688|NCT01367236|11675707|FG000|STARTED|Overall Study||30
10523689|NCT01367236|11675708|FG001|STARTED|Overall Study||30
10523690|NCT01367236|11675707|FG000|COMPLETED|Overall Study||27
10523691|NCT01367236|11675708|FG001|COMPLETED|Overall Study||29
10523692|NCT01367236|11675707|FG000|NOT COMPLETED|Overall Study||3
10523693|NCT01367236|11675708|FG001|NOT COMPLETED|Overall Study||1
10523694|NCT01367249|11675716|FG000|STARTED|Overall Study||222
10523695|NCT01367249|11675717|FG001|STARTED|Overall Study||218
10523696|NCT01367249|11675716|FG000|COMPLETED|Overall Study||213
10523697|NCT01367249|11675717|FG001|COMPLETED|Overall Study||202
10523698|NCT01367249|11675716|FG000|NOT COMPLETED|Overall Study||9
10523699|NCT01367249|11675717|FG001|NOT COMPLETED|Overall Study||16
10523700|NCT01367262|11675723|FG000|STARTED|Overall Study||6
10523701|NCT01367262|11675723|FG000|COMPLETED|Overall Study||6
10523702|NCT01367262|11675723|FG000|NOT COMPLETED|Overall Study||0
10523703|NCT01367275|11675727|FG000|STARTED|Overall Study||8
10523704|NCT01367275|11675727|FG000|COMPLETED|Overall Study||5
10523705|NCT01367275|11675727|FG000|NOT COMPLETED|Overall Study||3
10523706|NCT01367444|11675738|FG000|STARTED|Overall Study||4
10523707|NCT01367444|11675739|FG001|STARTED|Overall Study||4
10523708|NCT01367444|11675740|FG002|STARTED|Overall Study||4
10523709|NCT01367444|11675741|FG003|STARTED|Overall Study||4
10523710|NCT01367444|11675742|FG004|STARTED|Overall Study||6
10523711|NCT01367444|11675743|FG005|STARTED|Overall Study||4
10523712|NCT01367444|11675744|FG006|STARTED|Overall Study||1
10523713|NCT01367444|11675738|FG000|COMPLETED|Overall Study||4
10523714|NCT01367444|11675739|FG001|COMPLETED|Overall Study||4
10523715|NCT01367444|11675740|FG002|COMPLETED|Overall Study||4
10523716|NCT01367444|11675741|FG003|COMPLETED|Overall Study||4
10523717|NCT01367444|11675742|FG004|COMPLETED|Overall Study||6
10523718|NCT01367444|11675743|FG005|COMPLETED|Overall Study||4
10523719|NCT01367444|11675744|FG006|COMPLETED|Overall Study||1
10523720|NCT01367444|11675738|FG000|NOT COMPLETED|Overall Study||0
10523721|NCT01367444|11675739|FG001|NOT COMPLETED|Overall Study||0
10523722|NCT01367444|11675740|FG002|NOT COMPLETED|Overall Study||0
10523723|NCT01367444|11675741|FG003|NOT COMPLETED|Overall Study||0
10523724|NCT01367444|11675742|FG004|NOT COMPLETED|Overall Study||0
10523725|NCT01367444|11675743|FG005|NOT COMPLETED|Overall Study||0
10523726|NCT01367444|11675744|FG006|NOT COMPLETED|Overall Study||0
10523727|NCT01367457|11675763|FG000|STARTED|Overall Study||193
10523728|NCT01367457|11675764|FG001|STARTED|Overall Study||23
10523729|NCT01367457|11675765|FG002|STARTED|Overall Study||26
10523730|NCT01367457|11675763|FG000|COMPLETED|Overall Study||5
10523731|NCT01367457|11675764|FG001|COMPLETED|Overall Study||23
10523732|NCT01367457|11675765|FG002|COMPLETED|Overall Study||26
10523733|NCT01367457|11675763|FG000|NOT COMPLETED|Overall Study||188
10523734|NCT01367457|11675764|FG001|NOT COMPLETED|Overall Study||0
10523735|NCT01367457|11675765|FG002|NOT COMPLETED|Overall Study||0
10523736|NCT01367665|11675775|FG000|STARTED|Overall Study||1119
10523737|NCT01367665|11675776|FG001|STARTED|Overall Study||96
10523738|NCT01367665|11675775|FG000|COMPLETED|Overall Study||677
10523739|NCT01367665|11675776|FG001|COMPLETED|Overall Study||41
10523740|NCT01367665|11675775|FG000|NOT COMPLETED|Overall Study||442
10523741|NCT01367665|11675776|FG001|NOT COMPLETED|Overall Study||55
10523742|NCT01367704|11675785|FG000|STARTED|Overall Study||998
10523743|NCT01367704|11675786|FG001|STARTED|Overall Study||1008
10523744|NCT01367704|11675785|FG000|COMPLETED|Overall Study||951
10523745|NCT01367704|11675786|FG001|COMPLETED|Overall Study||847
10523746|NCT01367704|11675785|FG000|NOT COMPLETED|Overall Study||47
10523747|NCT01367704|11675786|FG001|NOT COMPLETED|Overall Study||161
10523748|NCT01367834|11675794|FG000|STARTED|Overall Study||11
10523749|NCT01367834|11675795|FG001|STARTED|Overall Study||6
10523750|NCT01367834|11675794|FG000|COMPLETED|Overall Study||9
10523751|NCT01367834|11675795|FG001|COMPLETED|Overall Study||3
10523752|NCT01367834|11675794|FG000|NOT COMPLETED|Overall Study||2
10523753|NCT01367834|11675795|FG001|NOT COMPLETED|Overall Study||3
10523754|NCT01367847|11675803|FG000|STARTED|Overall Study||10
10523755|NCT01367847|11675804|FG001|STARTED|Overall Study||9
10523756|NCT01367847|11675803|FG000|COMPLETED|Overall Study||8
10523757|NCT01367847|11675804|FG001|COMPLETED|Overall Study||7
10523758|NCT01367847|11675803|FG000|NOT COMPLETED|Overall Study||2
10523759|NCT01367847|11675804|FG001|NOT COMPLETED|Overall Study||2
10523760|NCT01367860|11675813|FG000|STARTED|Overall Study||20
10523761|NCT01367860|11675814|FG001|STARTED|Overall Study||20
10523762|NCT01367860|11675813|FG000|COMPLETED|Overall Study||20
10523763|NCT01367860|11675814|FG001|COMPLETED|Overall Study||20
10523764|NCT01367860|11675813|FG000|NOT COMPLETED|Overall Study||0
10523765|NCT01367860|11675814|FG001|NOT COMPLETED|Overall Study||0
10523766|NCT01367886|11675820|FG000|STARTED|Overall Study||21
10523767|NCT01367886|11675820|FG000|COMPLETED|Overall Study||14
10523768|NCT01367886|11675820|FG000|NOT COMPLETED|Overall Study||7
10523769|NCT01368042|11675825|FG000|STARTED|Overall Study||265
10523770|NCT01368042|11675825|FG000|COMPLETED|Overall Study||235
10523771|NCT01368042|11675825|FG000|NOT COMPLETED|Overall Study||30
10523772|NCT01368081|11675842|FG000|STARTED|Overall Study||136
10523773|NCT01368081|11675843|FG001|STARTED|Overall Study||137
10523774|NCT01368081|11675844|FG002|STARTED|Overall Study||63
10523775|NCT01368081|11675845|FG003|STARTED|Overall Study||68
10523776|NCT01368081|11675846|FG004|STARTED|Overall Study||65
10523777|NCT01368081|11675847|FG005|STARTED|Overall Study||137
10523778|NCT01368081|11675848|FG006|STARTED|Overall Study||136
10523779|NCT01368081|11675849|FG007|STARTED|Overall Study||69
10523780|NCT01368081|11675850|FG008|STARTED|Overall Study||70
10523781|NCT01368081|11675851|FG009|STARTED|Overall Study||68
10523782|NCT01368081|11675852|FG010|STARTED|Overall Study||71
10523783|NCT01368081|11675853|FG011|STARTED|Overall Study||70
10523784|NCT01368081|11675854|FG012|STARTED|Overall Study||70
10523785|NCT01368081|11675842|FG000|COMPLETED|Overall Study||126
10523786|NCT01368081|11675843|FG001|COMPLETED|Overall Study||128
10523787|NCT01368081|11675844|FG002|COMPLETED|Overall Study||59
10523788|NCT01368081|11675845|FG003|COMPLETED|Overall Study||63
10523789|NCT01368081|11675846|FG004|COMPLETED|Overall Study||63
10523790|NCT01368081|11675847|FG005|COMPLETED|Overall Study||127
10523791|NCT01368081|11675848|FG006|COMPLETED|Overall Study||124
10523792|NCT01368081|11675849|FG007|COMPLETED|Overall Study||62
10523793|NCT01368081|11675850|FG008|COMPLETED|Overall Study||62
10523794|NCT01368081|11675851|FG009|COMPLETED|Overall Study||58
10523795|NCT01368081|11675852|FG010|COMPLETED|Overall Study||62
10523796|NCT01368081|11675853|FG011|COMPLETED|Overall Study||67
10523797|NCT01368081|11675854|FG012|COMPLETED|Overall Study||63
10523798|NCT01368081|11675842|FG000|NOT COMPLETED|Overall Study||10
10523799|NCT01368081|11675843|FG001|NOT COMPLETED|Overall Study||9
10523800|NCT01368081|11675844|FG002|NOT COMPLETED|Overall Study||4
10523801|NCT01368081|11675845|FG003|NOT COMPLETED|Overall Study||5
10523802|NCT01368081|11675846|FG004|NOT COMPLETED|Overall Study||2
10523803|NCT01368081|11675847|FG005|NOT COMPLETED|Overall Study||10
10523804|NCT01368081|11675848|FG006|NOT COMPLETED|Overall Study||12
10523805|NCT01368081|11675849|FG007|NOT COMPLETED|Overall Study||7
10523806|NCT01368081|11675850|FG008|NOT COMPLETED|Overall Study||8
10523807|NCT01368081|11675851|FG009|NOT COMPLETED|Overall Study||10
10523808|NCT01368081|11675852|FG010|NOT COMPLETED|Overall Study||9
10523809|NCT01368081|11675853|FG011|NOT COMPLETED|Overall Study||3
10523810|NCT01368081|11675854|FG012|NOT COMPLETED|Overall Study||7
10523811|NCT01368211|11675884|FG000|STARTED|First Platelets Transfusion||8
10523812|NCT01368211|11675885|FG001|STARTED|First Platelets Transfusion||7
10523813|NCT01368211|11675884|FG000|COMPLETED|First Platelets Transfusion||8
10523814|NCT01368211|11675885|FG001|COMPLETED|First Platelets Transfusion||7
10523815|NCT01368211|11675884|FG000|NOT COMPLETED|First Platelets Transfusion||0
10523816|NCT01368211|11675885|FG001|NOT COMPLETED|First Platelets Transfusion||0
10523817|NCT01368211|11675884|FG000|STARTED|Second Platelets Transfusion||8
10523818|NCT01368211|11675885|FG001|STARTED|Second Platelets Transfusion||7
10523819|NCT01368211|11675884|FG000|COMPLETED|Second Platelets Transfusion||7
10523820|NCT01368211|11675885|FG001|COMPLETED|Second Platelets Transfusion||5
10523821|NCT01368211|11675884|FG000|NOT COMPLETED|Second Platelets Transfusion||1
10523822|NCT01368211|11675885|FG001|NOT COMPLETED|Second Platelets Transfusion||2
10523823|NCT01368263|11675894|FG000|STARTED|Overall Study||6
10810448|NCT03797144|11972267|FG000|NOT COMPLETED|Enrollment||4
10810449|NCT03797144|11972268|FG001|NOT COMPLETED|Enrollment||1
10810450|NCT03797144|11972267|FG000|STARTED|Surgery||12
10810451|NCT03797144|11972268|FG001|STARTED|Surgery||10
10810452|NCT03797144|11972267|FG000|COMPLETED|Surgery||11
10810453|NCT03797144|11972268|FG001|COMPLETED|Surgery||10
10810454|NCT03797144|11972267|FG000|NOT COMPLETED|Surgery||1
10523824|NCT01368263|11675895|FG001|STARTED|Overall Study||1
10523825|NCT01368263|11675896|FG002|STARTED|Overall Study||1
10810455|NCT03797144|11972268|FG001|NOT COMPLETED|Surgery||0
10810456|NCT03797144|11972267|FG000|STARTED|3 Month||11
10810457|NCT03797144|11972268|FG001|STARTED|3 Month||10
10810458|NCT03797144|11972267|FG000|COMPLETED|3 Month||9
10810459|NCT03797144|11972268|FG001|COMPLETED|3 Month||10
10810460|NCT03797144|11972267|FG000|NOT COMPLETED|3 Month||2
10810461|NCT03797144|11972268|FG001|NOT COMPLETED|3 Month||0
10810462|NCT03797144|11972267|FG000|STARTED|12 Month||9
10523826|NCT01368263|11675894|FG000|COMPLETED|Overall Study||6
10523827|NCT01368263|11675895|FG001|COMPLETED|Overall Study||1
10523828|NCT01368263|11675896|FG002|COMPLETED|Overall Study||1
10523829|NCT01368263|11675894|FG000|NOT COMPLETED|Overall Study||0
10523830|NCT01368263|11675895|FG001|NOT COMPLETED|Overall Study||0
10523831|NCT01368263|11675896|FG002|NOT COMPLETED|Overall Study||0
10810463|NCT03797144|11972268|FG001|STARTED|12 Month||10
10810464|NCT03797144|11972267|FG000|COMPLETED|12 Month||1
10523832|NCT01368276|11675906|FG000|STARTED|Overall Study||3
10523833|NCT01368276|11675907|FG001|STARTED|Overall Study||28
10523834|NCT01368276|11675906|FG000|COMPLETED|Overall Study||2
10523835|NCT01368276|11675907|FG001|COMPLETED|Overall Study||18
10523836|NCT01368276|11675906|FG000|NOT COMPLETED|Overall Study||1
10523837|NCT01368276|11675907|FG001|NOT COMPLETED|Overall Study||10
10523838|NCT01368406|11675915|FG000|STARTED|Overall Study||81
10523839|NCT01368406|11675916|FG001|STARTED|Overall Study||79
10523840|NCT01368406|11675915|FG000|COMPLETED|Overall Study||60
10523841|NCT01368406|11675916|FG001|COMPLETED|Overall Study||66
10523842|NCT01368406|11675915|FG000|NOT COMPLETED|Overall Study||21
10523843|NCT01368406|11675916|FG001|NOT COMPLETED|Overall Study||13
10523844|NCT01368432|11675924|FG000|STARTED|Overall Study||6
10523845|NCT01368432|11675925|FG001|STARTED|Overall Study||8
10523846|NCT01368432|11675924|FG000|COMPLETED|Overall Study||6
10523847|NCT01368432|11675925|FG001|COMPLETED|Overall Study||7
10523848|NCT01368432|11675924|FG000|NOT COMPLETED|Overall Study||0
10523849|NCT01368432|11675925|FG001|NOT COMPLETED|Overall Study||1
10523850|NCT01368536|11675948|FG000|STARTED|Overall Study||138
10523851|NCT01368536|11675949|FG001|STARTED|Overall Study||137
10523852|NCT01368536|11675950|FG002|STARTED|Overall Study||142
10523853|NCT01368536|11675948|FG000|Full Analysis Set|Overall Study||138
10523854|NCT01368536|11675949|FG001|Full Analysis Set|Overall Study||137
10523855|NCT01368536|11675950|FG002|Full Analysis Set|Overall Study|One patient was excluded from efficacy analysis as there was no post baseline data|141
10523856|NCT01368536|11675948|FG000|COMPLETED|Overall Study||87
10523857|NCT01368536|11675949|FG001|COMPLETED|Overall Study||78
10523858|NCT01368536|11675950|FG002|COMPLETED|Overall Study||83
10523859|NCT01368536|11675948|FG000|NOT COMPLETED|Overall Study||51
10523860|NCT01368536|11675949|FG001|NOT COMPLETED|Overall Study||59
10523861|NCT01368536|11675950|FG002|NOT COMPLETED|Overall Study||59
10523862|NCT01368562|11675959|FG000|STARTED|Overall Study||26
10523863|NCT01368562|11675959|FG000|Received at Least 1 Dose of Study Drug|Overall Study||25
10523864|NCT01368562|11675959|FG000|COMPLETED|Overall Study||7
10523865|NCT01368562|11675959|FG000|NOT COMPLETED|Overall Study||19
10523866|NCT01368614|11675963|FG000|STARTED|Screening Period||90
10523867|NCT01368614|11675964|FG001|STARTED|Screening Period||0
10523868|NCT01368614|11675965|FG002|STARTED|Screening Period||0
10523869|NCT01368614|11675966|FG003|STARTED|Screening Period||0
10523870|NCT01368614|11675963|FG000|COMPLETED|Screening Period||32
10523871|NCT01368614|11675964|FG001|COMPLETED|Screening Period||0
10523872|NCT01368614|11675965|FG002|COMPLETED|Screening Period||0
10523873|NCT01368614|11675966|FG003|COMPLETED|Screening Period||0
10523874|NCT01368614|11675963|FG000|NOT COMPLETED|Screening Period||58
10523875|NCT01368614|11675964|FG001|NOT COMPLETED|Screening Period||0
10523876|NCT01368614|11675965|FG002|NOT COMPLETED|Screening Period||0
10523877|NCT01368614|11675966|FG003|NOT COMPLETED|Screening Period||0
10523878|NCT01368614|11675963|FG000|STARTED|Study Period||0
10523879|NCT01368614|11675964|FG001|STARTED|Study Period||11
10523880|NCT01368614|11675965|FG002|STARTED|Study Period||10
10523881|NCT01368614|11675966|FG003|STARTED|Study Period||11
10523882|NCT01368614|11675963|FG000|COMPLETED|Study Period||0
10523883|NCT01368614|11675964|FG001|COMPLETED|Study Period||10
10523884|NCT01368614|11675965|FG002|COMPLETED|Study Period||8
10523885|NCT01368614|11675966|FG003|COMPLETED|Study Period||8
10523886|NCT01368614|11675963|FG000|NOT COMPLETED|Study Period||0
10523887|NCT01368614|11675964|FG001|NOT COMPLETED|Study Period||1
10523888|NCT01368614|11675965|FG002|NOT COMPLETED|Study Period||2
10523889|NCT01368614|11675966|FG003|NOT COMPLETED|Study Period||3
10523890|NCT01368653|11675976|FG000|STARTED|Overall Study||47
10523891|NCT01368653|11675977|FG001|STARTED|Overall Study||46
10523892|NCT01368653|11675976|FG000|Completed 4-week Follow-up|Overall Study||44
10523893|NCT01368653|11675977|FG001|Completed 4-week Follow-up|Overall Study||37
10523894|NCT01368653|11675976|FG000|Smoked in Past 7 Days at 4-weeks|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|29
10523895|NCT01368653|11675977|FG001|Smoked in Past 7 Days at 4-weeks|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|20
10523896|NCT01368653|11675976|FG000|Randomized to Phase 2|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|21
10523897|NCT01368653|11675977|FG001|Randomized to Phase 2|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|19
10523898|NCT01368653|11675976|FG000|Randomized to VLNC in Phase 2|Overall Study|VLNC=6-week supply of Very Low Nicotine Cigarettes plus Advice to Quit (vs. Advice Only)|11
10523899|NCT01368653|11675977|FG001|Randomized to VLNC in Phase 2|Overall Study|VLNC=6-week supply of Very Low Nicotine Cigarettes plus Advice to Quit (vs. Advice Only)|9
10523900|NCT01368653|11675976|FG000|Randomized to Advice Only in Phase 2|Overall Study||10
10523901|NCT01368653|11675977|FG001|Randomized to Advice Only in Phase 2|Overall Study||10
10523902|NCT01368653|11675976|FG000|COMPLETED|Overall Study||41
10523903|NCT01368653|11675977|FG001|COMPLETED|Overall Study||37
10523904|NCT01368653|11675976|FG000|NOT COMPLETED|Overall Study||6
10523905|NCT01368653|11675977|FG001|NOT COMPLETED|Overall Study||9
10523906|NCT01368809|11675992|FG000|STARTED|Overall Study||50
10523907|NCT01368809|11675993|FG001|STARTED|Overall Study||50
10523908|NCT01368809|11675992|FG000|COMPLETED|Overall Study||50
10523909|NCT01368809|11675993|FG001|COMPLETED|Overall Study||50
10523910|NCT01368809|11675992|FG000|NOT COMPLETED|Overall Study||0
10523911|NCT01368809|11675993|FG001|NOT COMPLETED|Overall Study||0
10523912|NCT01368835|11676001|FG000|STARTED|Overall Study|103 Subjects Enrolled|103
10523913|NCT01368835|11676001|FG000|COMPLETED|Overall Study||70
10523914|NCT01368835|11676001|FG000|NOT COMPLETED|Overall Study||33
10523915|NCT01368874|11676009|FG000|STARTED|Overall Study||34
10523916|NCT01368874|11676010|FG001|STARTED|Overall Study||5
10523917|NCT01368874|11676011|FG002|STARTED|Overall Study||25
10523918|NCT01368874|11676009|FG000|COMPLETED|Overall Study||31
10523919|NCT01368874|11676010|FG001|COMPLETED|Overall Study||5
10523920|NCT01368874|11676011|FG002|COMPLETED|Overall Study||24
10523921|NCT01368874|11676009|FG000|NOT COMPLETED|Overall Study||3
10523922|NCT01368874|11676010|FG001|NOT COMPLETED|Overall Study||0
10523923|NCT01368874|11676011|FG002|NOT COMPLETED|Overall Study||1
10523924|NCT01368900|11676053|FG000|STARTED|Overall Study||68
10523925|NCT01368900|11676053|FG000|COMPLETED|Overall Study||61
10523926|NCT01368900|11676053|FG000|NOT COMPLETED|Overall Study||7
10523927|NCT01368965|11676059|FG000|STARTED|Overall Study|Two subjects withdrew consent prior to study treatment. Data analyses are based on 52 subjects.|52
10523928|NCT01368965|11676059|FG000|Subject Withdrawal Prior to Treatment|Overall Study||2
10523929|NCT01368965|11676059|FG000|COMPLETED|Overall Study||40
10523930|NCT01368965|11676059|FG000|NOT COMPLETED|Overall Study||12
10523931|NCT01369030|11676065|FG000|STARTED|Overall Study||594
10523932|NCT01369030|11676065|FG000|COMPLETED|Overall Study||554
10523933|NCT01369030|11676065|FG000|NOT COMPLETED|Overall Study||40
10523934|NCT01369069|11676071|FG000|STARTED|Overall Study||581
10523935|NCT01369069|11676072|FG001|STARTED|Overall Study||570
10523936|NCT01369069|11676071|FG000|COMPLETED|Overall Study||564
10523937|NCT01369069|11676072|FG001|COMPLETED|Overall Study||554
10523938|NCT01369069|11676071|FG000|NOT COMPLETED|Overall Study||17
10523939|NCT01369069|11676072|FG001|NOT COMPLETED|Overall Study||16
10523940|NCT01369108|11676078|FG000|STARTED|Overall Study|120 teeth|60
10523941|NCT01369108|11676078|FG000|COMPLETED|Overall Study||49
10523942|NCT01369108|11676078|FG000|NOT COMPLETED|Overall Study||11
10523943|NCT01369225|11676089|FG000|STARTED|Overall Study||6
10523944|NCT01369225|11676090|FG001|STARTED|Overall Study||3
10523945|NCT01369225|11676091|FG002|STARTED|Overall Study||12
10523946|NCT01369225|11676092|FG003|STARTED|Overall Study||10
10523947|NCT01369225|11676093|FG004|STARTED|Overall Study||12
10523948|NCT01369225|11676094|FG005|STARTED|Overall Study||9
10523949|NCT01369225|11676089|FG000|COMPLETED|Overall Study||4
10523950|NCT01369225|11676090|FG001|COMPLETED|Overall Study||3
10523951|NCT01369225|11676091|FG002|COMPLETED|Overall Study||9
10523952|NCT01369225|11676092|FG003|COMPLETED|Overall Study||8
10523953|NCT01369225|11676093|FG004|COMPLETED|Overall Study||10
10523954|NCT01369225|11676094|FG005|COMPLETED|Overall Study||9
10523955|NCT01369225|11676089|FG000|NOT COMPLETED|Overall Study||2
10523956|NCT01369225|11676090|FG001|NOT COMPLETED|Overall Study||0
10712025|NCT02665689|11877530|FG001|STARTED|Overall Study||2
10712026|NCT02665689|11877529|FG000|COMPLETED|Overall Study||0
10712027|NCT02665689|11877530|FG001|COMPLETED|Overall Study||0
10712028|NCT02665689|11877529|FG000|NOT COMPLETED|Overall Study||2
10712029|NCT02665689|11877530|FG001|NOT COMPLETED|Overall Study||2
10712030|NCT02665728|11877536|FG000|STARTED|Overall Study||33
10712031|NCT02665728|11877536|FG000|COMPLETED|Overall Study||33
10712032|NCT02665728|11877536|FG000|NOT COMPLETED|Overall Study||0
10712033|NCT02665741|11877543|FG000|STARTED|Overall Study||42
10712034|NCT02665741|11877544|FG001|STARTED|Overall Study||42
10712035|NCT02665741|11877545|FG002|STARTED|Overall Study||42
10712036|NCT02665741|11877543|FG000|COMPLETED|Overall Study||42
10712037|NCT02665741|11877544|FG001|COMPLETED|Overall Study||42
10712038|NCT02665741|11877545|FG002|COMPLETED|Overall Study||42
10712039|NCT02665741|11877543|FG000|NOT COMPLETED|Overall Study||0
10712040|NCT02665741|11877544|FG001|NOT COMPLETED|Overall Study||0
10712041|NCT02665741|11877545|FG002|NOT COMPLETED|Overall Study||0
10523957|NCT01369225|11676091|FG002|NOT COMPLETED|Overall Study||3
10523958|NCT01369225|11676092|FG003|NOT COMPLETED|Overall Study||2
10523959|NCT01369225|11676093|FG004|NOT COMPLETED|Overall Study||2
10712042|NCT02665975|11877555|FG000|STARTED|Overall Study||46
10712043|NCT02665975|11877556|FG001|STARTED|Overall Study||46
10523960|NCT01369225|11676094|FG005|NOT COMPLETED|Overall Study||0
10523961|NCT01369329|11676111|FG000|STARTED|Overall Study||256
10523962|NCT01369329|11676112|FG001|STARTED|Overall Study||254
10523963|NCT01369329|11676113|FG002|STARTED|Overall Study||259
10523964|NCT01369329|11676111|FG000|COMPLETED|Overall Study||244
10712044|NCT02665975|11877555|FG000|COMPLETED|Overall Study||37
10712045|NCT02665975|11877556|FG001|COMPLETED|Overall Study||37
10712046|NCT02665975|11877555|FG000|NOT COMPLETED|Overall Study||9
10712047|NCT02665975|11877556|FG001|NOT COMPLETED|Overall Study||9
10712048|NCT02666222|11877562|FG000|STARTED|Overall Study||51
10712049|NCT02666222|11877562|FG000|COMPLETED|Overall Study||49
10712050|NCT02666222|11877562|FG000|NOT COMPLETED|Overall Study||2
10712051|NCT02666352|11877569|FG000|STARTED|Overall Study||8
10712052|NCT02666352|11877570|FG001|STARTED|Overall Study||8
10712053|NCT02666352|11877571|FG002|STARTED|Overall Study||8
10712054|NCT02666352|11877569|FG000|COMPLETED|Overall Study||8
10712055|NCT02666352|11877570|FG001|COMPLETED|Overall Study||8
10712056|NCT02666352|11877571|FG002|COMPLETED|Overall Study||8
10712057|NCT02666352|11877569|FG000|NOT COMPLETED|Overall Study||0
10712058|NCT02666352|11877570|FG001|NOT COMPLETED|Overall Study||0
10712059|NCT02666352|11877571|FG002|NOT COMPLETED|Overall Study||0
10712060|NCT02666508|11877581|FG000|STARTED|Overall Study||31
10523965|NCT01369329|11676112|FG001|COMPLETED|Overall Study||243
10523966|NCT01369329|11676113|FG002|COMPLETED|Overall Study||245
10523967|NCT01369329|11676111|FG000|NOT COMPLETED|Overall Study||12
10523968|NCT01369329|11676112|FG001|NOT COMPLETED|Overall Study||11
10523969|NCT01369329|11676113|FG002|NOT COMPLETED|Overall Study||14
10523970|NCT01369342|11676124|FG000|STARTED|Overall Study||214
10523971|NCT01369342|11676125|FG001|STARTED|Overall Study||213
10523972|NCT01369342|11676126|FG002|STARTED|Overall Study||213
10523973|NCT01369342|11676124|FG000|COMPLETED|Overall Study||201
10523974|NCT01369342|11676125|FG001|COMPLETED|Overall Study||204
10523975|NCT01369342|11676126|FG002|COMPLETED|Overall Study||210
10523976|NCT01369342|11676124|FG000|NOT COMPLETED|Overall Study||13
10523977|NCT01369342|11676125|FG001|NOT COMPLETED|Overall Study||9
10523978|NCT01369342|11676126|FG002|NOT COMPLETED|Overall Study||3
10523979|NCT01369355|11676140|FG000|STARTED|Week 0 - Week 44 (Maintenance)||133
10523980|NCT01369355|11676141|FG001|STARTED|Week 0 - Week 44 (Maintenance)||132
10523981|NCT01369355|11676142|FG002|STARTED|Week 0 - Week 44 (Maintenance)||132
10523982|NCT01369355|11676143|FG003|STARTED|Week 0 - Week 44 (Maintenance)||123
10523983|NCT01369355|11676144|FG004|STARTED|Week 0 - Week 44 (Maintenance)||285
10523984|NCT01369355|11676145|FG005|STARTED|Week 0 - Week 44 (Maintenance)||476
10523985|NCT01369355|11676146|FG006|STARTED|Week 0 - Week 44 (Maintenance)||0
10523986|NCT01369355|11676147|FG007|STARTED|Week 0 - Week 44 (Maintenance)||0
10523987|NCT01369355|11676148|FG008|STARTED|Week 0 - Week 44 (Maintenance)||0
10523988|NCT01369355|11676140|FG000|COMPLETED|Week 0 - Week 44 (Maintenance)||102
10712061|NCT02666508|11877582|FG001|STARTED|Overall Study||30
10523989|NCT01369355|11676141|FG001|COMPLETED|Week 0 - Week 44 (Maintenance)||103
10523990|NCT01369355|11676142|FG002|COMPLETED|Week 0 - Week 44 (Maintenance)||101
10523991|NCT01369355|11676143|FG003|COMPLETED|Week 0 - Week 44 (Maintenance)||93
10523992|NCT01369355|11676144|FG004|COMPLETED|Week 0 - Week 44 (Maintenance)||131
10712062|NCT02666508|11877581|FG000|COMPLETED|Overall Study||31
10712063|NCT02666508|11877582|FG001|COMPLETED|Overall Study||30
10523993|NCT01369355|11676145|FG005|COMPLETED|Week 0 - Week 44 (Maintenance)||204
10523994|NCT01369355|11676146|FG006|COMPLETED|Week 0 - Week 44 (Maintenance)||0
10523995|NCT01369355|11676147|FG007|COMPLETED|Week 0 - Week 44 (Maintenance)||0
10523996|NCT01369355|11676148|FG008|COMPLETED|Week 0 - Week 44 (Maintenance)||0
10523997|NCT01369355|11676140|FG000|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||31
10523998|NCT01369355|11676141|FG001|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||29
10523999|NCT01369355|11676142|FG002|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||31
10524000|NCT01369355|11676143|FG003|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||30
10524001|NCT01369355|11676144|FG004|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||154
10524002|NCT01369355|11676145|FG005|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||272
10524003|NCT01369355|11676146|FG006|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||0
10524004|NCT01369355|11676147|FG007|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||0
10524005|NCT01369355|11676148|FG008|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||0
10524006|NCT01369355|11676140|FG000|STARTED|Long-term Extension (Week 44-272)||0
10524007|NCT01369355|11676141|FG001|STARTED|Long-term Extension (Week 44-272)||0
10524008|NCT01369355|11676142|FG002|STARTED|Long-term Extension (Week 44-272)||0
10524009|NCT01369355|11676143|FG003|STARTED|Long-term Extension (Week 44-272)||0
10524010|NCT01369355|11676144|FG004|STARTED|Long-term Extension (Week 44-272)||0
10524011|NCT01369355|11676145|FG005|STARTED|Long-term Extension (Week 44-272)||0
10524012|NCT01369355|11676146|FG006|STARTED|Long-term Extension (Week 44-272)||151
10524013|NCT01369355|11676147|FG007|STARTED|Long-term Extension (Week 44-272)||213
10524014|NCT01369355|11676148|FG008|STARTED|Long-term Extension (Week 44-272)||354
10524015|NCT01369355|11676140|FG000|COMPLETED|Long-term Extension (Week 44-272)||0
10524016|NCT01369355|11676141|FG001|COMPLETED|Long-term Extension (Week 44-272)||0
10524017|NCT01369355|11676142|FG002|COMPLETED|Long-term Extension (Week 44-272)||0
10524018|NCT01369355|11676143|FG003|COMPLETED|Long-term Extension (Week 44-272)||0
10524019|NCT01369355|11676144|FG004|COMPLETED|Long-term Extension (Week 44-272)||0
10524020|NCT01369355|11676145|FG005|COMPLETED|Long-term Extension (Week 44-272)||0
10524021|NCT01369355|11676146|FG006|COMPLETED|Long-term Extension (Week 44-272)||0
10524022|NCT01369355|11676147|FG007|COMPLETED|Long-term Extension (Week 44-272)||107
10524023|NCT01369355|11676148|FG008|COMPLETED|Long-term Extension (Week 44-272)||183
10524024|NCT01369355|11676140|FG000|NOT COMPLETED|Long-term Extension (Week 44-272)||0
10524025|NCT01369355|11676141|FG001|NOT COMPLETED|Long-term Extension (Week 44-272)||0
10524026|NCT01369355|11676142|FG002|NOT COMPLETED|Long-term Extension (Week 44-272)||0
10524027|NCT01369355|11676143|FG003|NOT COMPLETED|Long-term Extension (Week 44-272)||0
10524028|NCT01369355|11676144|FG004|NOT COMPLETED|Long-term Extension (Week 44-272)||0
10524029|NCT01369355|11676145|FG005|NOT COMPLETED|Long-term Extension (Week 44-272)||0
10524030|NCT01369355|11676146|FG006|NOT COMPLETED|Long-term Extension (Week 44-272)||151
10524031|NCT01369355|11676147|FG007|NOT COMPLETED|Long-term Extension (Week 44-272)||106
10524032|NCT01369355|11676148|FG008|NOT COMPLETED|Long-term Extension (Week 44-272)||171
10524033|NCT01369433|11676167|FG000|STARTED|Overall Study||209
10524034|NCT01369433|11676168|FG001|STARTED|Overall Study||16
10524035|NCT01369433|11676167|FG000|COMPLETED|Overall Study||0
10524036|NCT01369433|11676168|FG001|COMPLETED|Overall Study||0
10524037|NCT01369433|11676167|FG000|NOT COMPLETED|Overall Study||209
10524038|NCT01369433|11676168|FG001|NOT COMPLETED|Overall Study||16
10524039|NCT01369485|11676176|FG000|STARTED|Randomized Phase (Day 0 to Week 12)||80
10524040|NCT01369485|11676177|FG001|STARTED|Randomized Phase (Day 0 to Week 12)||83
10524041|NCT01369485|11676176|FG000|COMPLETED|Randomized Phase (Day 0 to Week 12)||57
10524042|NCT01369485|11676177|FG001|COMPLETED|Randomized Phase (Day 0 to Week 12)||66
10524043|NCT01369485|11676176|FG000|NOT COMPLETED|Randomized Phase (Day 0 to Week 12)||23
10524044|NCT01369485|11676177|FG001|NOT COMPLETED|Randomized Phase (Day 0 to Week 12)||17
10524045|NCT01369485|11676176|FG000|STARTED|Open Label Phase (Week 12 to Month 12)||57
10524046|NCT01369485|11676177|FG001|STARTED|Open Label Phase (Week 12 to Month 12)||66
10524047|NCT01369485|11676176|FG000|COMPLETED|Open Label Phase (Week 12 to Month 12)||24
10524048|NCT01369485|11676177|FG001|COMPLETED|Open Label Phase (Week 12 to Month 12)||26
10524049|NCT01369485|11676176|FG000|NOT COMPLETED|Open Label Phase (Week 12 to Month 12)||33
10524050|NCT01369485|11676177|FG001|NOT COMPLETED|Open Label Phase (Week 12 to Month 12)||40
10524051|NCT01369498|11676195|FG000|STARTED|Overall Study||12
10524052|NCT01369498|11676196|FG001|STARTED|Overall Study||12
10524053|NCT01369498|11676197|FG002|STARTED|Overall Study||15
10524054|NCT01369498|11676198|FG003|STARTED|Overall Study||15
10524055|NCT01369498|11676195|FG000|COMPLETED|Overall Study||0
10524056|NCT01369498|11676196|FG001|COMPLETED|Overall Study||0
10524057|NCT01369498|11676197|FG002|COMPLETED|Overall Study||0
10524058|NCT01369498|11676198|FG003|COMPLETED|Overall Study||0
10524059|NCT01369498|11676195|FG000|NOT COMPLETED|Overall Study||12
10524060|NCT01369498|11676196|FG001|NOT COMPLETED|Overall Study||12
10524061|NCT01369498|11676197|FG002|NOT COMPLETED|Overall Study||15
10524062|NCT01369498|11676198|FG003|NOT COMPLETED|Overall Study||15
10524063|NCT01369511|11676213|FG000|STARTED|Overall Study||98
10524064|NCT01369511|11676214|FG001|STARTED|Overall Study||104
10524065|NCT01369511|11676215|FG002|STARTED|Overall Study||98
10524066|NCT01369511|11676216|FG003|STARTED|Overall Study||100
10524067|NCT01369511|11676213|FG000|Received at Least 1 Dose of Study Drug|Overall Study||98
10524068|NCT01369511|11676214|FG001|Received at Least 1 Dose of Study Drug|Overall Study|One participant was a screen failure and inadvertently randomized but did not receive study drug.|103
10524069|NCT01369511|11676215|FG002|Received at Least 1 Dose of Study Drug|Overall Study||98
10524070|NCT01369511|11676216|FG003|Received at Least 1 Dose of Study Drug|Overall Study||100
10524071|NCT01369511|11676213|FG000|COMPLETED|Overall Study||85
10524072|NCT01369511|11676214|FG001|COMPLETED|Overall Study||91
10524073|NCT01369511|11676215|FG002|COMPLETED|Overall Study||87
10524074|NCT01369511|11676216|FG003|COMPLETED|Overall Study||89
10524075|NCT01369511|11676213|FG000|NOT COMPLETED|Overall Study||13
10524076|NCT01369511|11676214|FG001|NOT COMPLETED|Overall Study||13
10524077|NCT01369511|11676215|FG002|NOT COMPLETED|Overall Study||11
10524078|NCT01369511|11676216|FG003|NOT COMPLETED|Overall Study||11
10524079|NCT01369615|11676228|FG000|STARTED|Overall Study||9
10524080|NCT01369615|11676229|FG001|STARTED|Overall Study||14
10524081|NCT01369615|11676228|FG000|COMPLETED|Overall Study||9
10524082|NCT01369615|11676229|FG001|COMPLETED|Overall Study||12
10524083|NCT01369615|11676228|FG000|NOT COMPLETED|Overall Study||0
10524084|NCT01369615|11676229|FG001|NOT COMPLETED|Overall Study||2
10524085|NCT01369680|11676239|FG000|STARTED|Overall Study||3
10524086|NCT01369680|11676240|FG001|STARTED|Overall Study||3
10524087|NCT01369680|11676241|FG002|STARTED|Overall Study||3
10524088|NCT01369680|11676242|FG003|STARTED|Overall Study||3
10524089|NCT01369680|11676239|FG000|COMPLETED|Overall Study||3
10524090|NCT01369680|11676240|FG001|COMPLETED|Overall Study||3
10524091|NCT01369680|11676241|FG002|COMPLETED|Overall Study||2
10524092|NCT01369680|11676242|FG003|COMPLETED|Overall Study||1
10524093|NCT01369680|11676239|FG000|NOT COMPLETED|Overall Study||0
10524094|NCT01369680|11676240|FG001|NOT COMPLETED|Overall Study||0
10524095|NCT01369680|11676241|FG002|NOT COMPLETED|Overall Study||1
10524096|NCT01369680|11676242|FG003|NOT COMPLETED|Overall Study||2
10524097|NCT01369706|11676263|FG000|STARTED|Overall Study||388
10524098|NCT01369706|11676263|FG000|COMPLETED|Overall Study||388
10524099|NCT01369706|11676263|FG000|NOT COMPLETED|Overall Study||0
10524100|NCT01369732|11676269|FG000|STARTED|Overall Study||33
10524101|NCT01369732|11676270|FG001|STARTED|Overall Study||33
10524102|NCT01369732|11676269|FG000|COMPLETED|Overall Study||29
10524103|NCT01369732|11676270|FG001|COMPLETED|Overall Study||31
10524104|NCT01369732|11676269|FG000|NOT COMPLETED|Overall Study||4
10524105|NCT01369732|11676270|FG001|NOT COMPLETED|Overall Study||2
10524106|NCT01369745|11676281|FG000|STARTED|Overall Study||32
10524107|NCT01369745|11676282|FG001|STARTED|Overall Study||41
10524108|NCT01369745|11676283|FG002|STARTED|Overall Study||18
10524109|NCT01369745|11676284|FG003|STARTED|Overall Study||84
10524110|NCT01369745|11676285|FG004|STARTED|Overall Study||83
10524111|NCT01369745|11676281|FG000|COMPLETED|Overall Study||25
10524112|NCT01369745|11676282|FG001|COMPLETED|Overall Study||28
10524113|NCT01369745|11676283|FG002|COMPLETED|Overall Study||16
10524114|NCT01369745|11676284|FG003|COMPLETED|Overall Study||64
10524115|NCT01369745|11676285|FG004|COMPLETED|Overall Study||65
10524116|NCT01369745|11676281|FG000|NOT COMPLETED|Overall Study||7
10524117|NCT01369745|11676282|FG001|NOT COMPLETED|Overall Study||13
10524118|NCT01369745|11676283|FG002|NOT COMPLETED|Overall Study||2
10524119|NCT01369745|11676284|FG003|NOT COMPLETED|Overall Study||20
10524120|NCT01369745|11676285|FG004|NOT COMPLETED|Overall Study||18
10524121|NCT01369758|11676297|FG000|STARTED|Overall Study||290
10524122|NCT01369758|11676297|FG000|COMPLETED|Overall Study||290
10524123|NCT01369758|11676297|FG000|NOT COMPLETED|Overall Study||0
10524124|NCT01369784|11676301|FG000|STARTED|Overall Study||158
10524125|NCT01369784|11676301|FG000|COMPLETED|Overall Study||146
10524126|NCT01369784|11676301|FG000|NOT COMPLETED|Overall Study||12
10524127|NCT01369849|11676308|FG000|STARTED|Overall Study||6
10524128|NCT01369849|11676309|FG001|STARTED|Overall Study||4
10524129|NCT01369849|11676310|FG002|STARTED|Overall Study||5
10524130|NCT01369849|11676308|FG000|COMPLETED|Overall Study||6
10524131|NCT01369849|11676309|FG001|COMPLETED|Overall Study||3
10524132|NCT01369849|11676310|FG002|COMPLETED|Overall Study||4
10524133|NCT01369849|11676308|FG000|NOT COMPLETED|Overall Study||0
10524134|NCT01369849|11676309|FG001|NOT COMPLETED|Overall Study||1
10524135|NCT01369849|11676310|FG002|NOT COMPLETED|Overall Study||1
10524136|NCT01369875|11676322|FG000|STARTED|Overall Study||1
10524137|NCT01369875|11676323|FG001|STARTED|Overall Study||1
10524138|NCT01369875|11676322|FG000|COMPLETED|Overall Study||1
10524139|NCT01369875|11676323|FG001|COMPLETED|Overall Study||1
10524140|NCT01369875|11676322|FG000|NOT COMPLETED|Overall Study||0
10524141|NCT01369875|11676323|FG001|NOT COMPLETED|Overall Study||0
10524142|NCT01369888|11676333|FG000|STARTED|Overall Study||1
10524143|NCT01369888|11676334|FG001|STARTED|Overall Study||2
10524144|NCT01369888|11676335|FG002|STARTED|Overall Study||0
10524145|NCT01369888|11676336|FG003|STARTED|Overall Study||0
10524146|NCT01369888|11676333|FG000|COMPLETED|Overall Study||1
10524147|NCT01369888|11676334|FG001|COMPLETED|Overall Study||2
10524148|NCT01369888|11676335|FG002|COMPLETED|Overall Study||0
10524149|NCT01369888|11676336|FG003|COMPLETED|Overall Study||0
10524150|NCT01369888|11676333|FG000|NOT COMPLETED|Overall Study||0
10524151|NCT01369888|11676334|FG001|NOT COMPLETED|Overall Study||0
10524152|NCT01369888|11676335|FG002|NOT COMPLETED|Overall Study||0
10524153|NCT01369888|11676336|FG003|NOT COMPLETED|Overall Study||0
10524154|NCT01370005|11676345|FG000|STARTED|Overall Study||272
10524155|NCT01370005|11676346|FG001|STARTED|Overall Study||276
10524156|NCT01370005|11676347|FG002|STARTED|Overall Study||277
10524157|NCT01370005|11676345|FG000|COMPLETED|Overall Study||256
10524158|NCT01370005|11676346|FG001|COMPLETED|Overall Study||265
10524159|NCT01370005|11676347|FG002|COMPLETED|Overall Study||266
10524160|NCT01370005|11676345|FG000|NOT COMPLETED|Overall Study||16
10524161|NCT01370005|11676346|FG001|NOT COMPLETED|Overall Study||11
10524162|NCT01370005|11676347|FG002|NOT COMPLETED|Overall Study||11
10524163|NCT01370018|11676355|FG000|STARTED|Overall Study||4
10524164|NCT01370018|11676355|FG000|COMPLETED|Overall Study||3
10524165|NCT01370018|11676355|FG000|NOT COMPLETED|Overall Study||1
10524166|NCT01370083|11676361|FG000|STARTED|Overall Study||7
10524167|NCT01370083|11676362|FG001|STARTED|Overall Study||7
10524168|NCT01370083|11676361|FG000|COMPLETED|Overall Study||5
10524169|NCT01370083|11676362|FG001|COMPLETED|Overall Study||6
10524170|NCT01370083|11676361|FG000|NOT COMPLETED|Overall Study||2
10524171|NCT01370083|11676362|FG001|NOT COMPLETED|Overall Study||1
10524172|NCT01370174|11676372|FG000|STARTED|Overall Study||25
10524173|NCT01370174|11676373|FG001|STARTED|Overall Study||26
10524174|NCT01370174|11676374|FG002|STARTED|Overall Study||25
10524175|NCT01370174|11676375|FG003|STARTED|Overall Study||26
10524176|NCT01370174|11676372|FG000|COMPLETED|Overall Study||18
10524177|NCT01370174|11676373|FG001|COMPLETED|Overall Study||15
10524178|NCT01370174|11676374|FG002|COMPLETED|Overall Study||13
10524179|NCT01370174|11676375|FG003|COMPLETED|Overall Study||17
10524180|NCT01370174|11676372|FG000|NOT COMPLETED|Overall Study||7
10524181|NCT01370174|11676373|FG001|NOT COMPLETED|Overall Study||11
10524182|NCT01370174|11676374|FG002|NOT COMPLETED|Overall Study||12
10524183|NCT01370174|11676375|FG003|NOT COMPLETED|Overall Study||9
10524184|NCT01370213|11676388|FG000|STARTED|Overall Study||7
10524185|NCT01370213|11676389|FG001|STARTED|Overall Study||17
10524186|NCT01370213|11676390|FG002|STARTED|Overall Study||1
10524187|NCT01370213|11676388|FG000|COMPLETED|Overall Study||6
10524188|NCT01370213|11676389|FG001|COMPLETED|Overall Study||15
10524189|NCT01370213|11676390|FG002|COMPLETED|Overall Study||1
10524190|NCT01370213|11676388|FG000|NOT COMPLETED|Overall Study||1
10524191|NCT01370213|11676389|FG001|NOT COMPLETED|Overall Study||2
10524192|NCT01370213|11676390|FG002|NOT COMPLETED|Overall Study||0
10524193|NCT01370265|11676397|FG000|STARTED|Resting Myocardial Blood Flow (MBF)||6
10524194|NCT01370265|11676398|FG001|STARTED|Resting Myocardial Blood Flow (MBF)||6
10524195|NCT01370265|11676397|FG000|COMPLETED|Resting Myocardial Blood Flow (MBF)||6
10524196|NCT01370265|11676398|FG001|COMPLETED|Resting Myocardial Blood Flow (MBF)||6
10524197|NCT01370265|11676397|FG000|NOT COMPLETED|Resting Myocardial Blood Flow (MBF)||0
10524198|NCT01370265|11676398|FG001|NOT COMPLETED|Resting Myocardial Blood Flow (MBF)||0
10524199|NCT01370265|11676397|FG000|STARTED|Washout Period (50-minute Period Decay)||6
10524200|NCT01370265|11676398|FG001|STARTED|Washout Period (50-minute Period Decay)||6
10524201|NCT01370265|11676397|FG000|COMPLETED|Washout Period (50-minute Period Decay)||6
10524202|NCT01370265|11676398|FG001|COMPLETED|Washout Period (50-minute Period Decay)||6
10524203|NCT01370265|11676397|FG000|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
10524204|NCT01370265|11676398|FG001|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
10524205|NCT01370265|11676397|FG000|STARTED|First Intervention||6
10524206|NCT01370265|11676398|FG001|STARTED|First Intervention||6
10524207|NCT01370265|11676397|FG000|COMPLETED|First Intervention||5
10524208|NCT01370265|11676398|FG001|COMPLETED|First Intervention||5
10524209|NCT01370265|11676397|FG000|NOT COMPLETED|First Intervention||1
10524210|NCT01370265|11676398|FG001|NOT COMPLETED|First Intervention||1
10524211|NCT01370265|11676397|FG000|STARTED|Washout Period (50-minute Period Decay)||5
10524212|NCT01370265|11676398|FG001|STARTED|Washout Period (50-minute Period Decay)||5
10524213|NCT01370265|11676397|FG000|COMPLETED|Washout Period (50-minute Period Decay)||5
10524214|NCT01370265|11676398|FG001|COMPLETED|Washout Period (50-minute Period Decay)||5
10524215|NCT01370265|11676397|FG000|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
10524216|NCT01370265|11676398|FG001|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
10524217|NCT01370265|11676397|FG000|STARTED|Second Intervention||5
10524218|NCT01370265|11676398|FG001|STARTED|Second Intervention||5
10524219|NCT01370265|11676397|FG000|COMPLETED|Second Intervention||5
10524220|NCT01370265|11676398|FG001|COMPLETED|Second Intervention||5
10524221|NCT01370265|11676397|FG000|NOT COMPLETED|Second Intervention||0
10524222|NCT01370265|11676398|FG001|NOT COMPLETED|Second Intervention||0
10524223|NCT01370317|11676407|FG000|STARTED|Overall Study||18
10524224|NCT01370317|11676408|FG001|STARTED|Overall Study||9
10524225|NCT01370317|11676407|FG000|COMPLETED|Overall Study||17
10524226|NCT01370317|11676408|FG001|COMPLETED|Overall Study||8
10524227|NCT01370317|11676407|FG000|NOT COMPLETED|Overall Study||1
10524228|NCT01370317|11676408|FG001|NOT COMPLETED|Overall Study||1
10524229|NCT01370356|11676416|FG000|STARTED|Overall Study||751
10524230|NCT01370356|11676417|FG001|STARTED|Overall Study||742
10524231|NCT01370356|11676416|FG000|COMPLETED|Overall Study||559
10524232|NCT01370356|11676417|FG001|COMPLETED|Overall Study||515
10524233|NCT01370356|11676416|FG000|NOT COMPLETED|Overall Study||192
10712064|NCT02666508|11877581|FG000|NOT COMPLETED|Overall Study||0
10712065|NCT02666508|11877582|FG001|NOT COMPLETED|Overall Study||0
10712066|NCT02666560|11877592|FG000|STARTED|Condition 1 (1 Day)||8
10712067|NCT02666560|11877593|FG001|STARTED|Condition 1 (1 Day)||11
10712068|NCT02666560|11877592|FG000|COMPLETED|Condition 1 (1 Day)||8
10712069|NCT02666560|11877593|FG001|COMPLETED|Condition 1 (1 Day)||11
10712070|NCT02666560|11877592|FG000|NOT COMPLETED|Condition 1 (1 Day)||0
10712071|NCT02666560|11877593|FG001|NOT COMPLETED|Condition 1 (1 Day)||0
10524234|NCT01370356|11676417|FG001|NOT COMPLETED|Overall Study||227
10524235|NCT01370369|11676423|FG000|STARTED|Overall Study||20
10524236|NCT01370369|11676423|FG000|COMPLETED|Overall Study||20
10524237|NCT01370369|11676423|FG000|NOT COMPLETED|Overall Study||0
10524238|NCT01370408|11676436|FG000|STARTED|Overall Study||85
10524239|NCT01370408|11676436|FG000|COMPLETED|Overall Study||76
10524240|NCT01370408|11676436|FG000|NOT COMPLETED|Overall Study||9
10524241|NCT01370460|11676442|FG000|STARTED|Overall Study||50
10524242|NCT01370460|11676443|FG001|STARTED|Overall Study||51
10524243|NCT01370460|11676442|FG000|COMPLETED|Overall Study||50
10524244|NCT01370460|11676443|FG001|COMPLETED|Overall Study||51
10524245|NCT01370460|11676442|FG000|NOT COMPLETED|Overall Study||0
10524246|NCT01370460|11676443|FG001|NOT COMPLETED|Overall Study||0
10524247|NCT01370499|11676452|FG000|STARTED|Overall Study||195
10524248|NCT01370499|11676453|FG001|STARTED|Overall Study||93
10524249|NCT01370499|11676452|FG000|Entered Abrupt Discontinuation Phase|Overall Study||188
10524250|NCT01370499|11676453|FG001|Entered Abrupt Discontinuation Phase|Overall Study|One participant who entered the abrupt discontinuation phase did not receive study drug.|85
10524251|NCT01370499|11676452|FG000|Received at Least 1 Dose of Study Drug|Overall Study||195
10524252|NCT01370499|11676453|FG001|Received at Least 1 Dose of Study Drug|Overall Study||92
10524253|NCT01370499|11676452|FG000|COMPLETED|Overall Study||84
10524254|NCT01370499|11676453|FG001|COMPLETED|Overall Study||49
10524255|NCT01370499|11676452|FG000|NOT COMPLETED|Overall Study||111
10524256|NCT01370499|11676453|FG001|NOT COMPLETED|Overall Study||44
10524257|NCT01370525|11676463|FG000|STARTED|Overall Study||171
10524258|NCT01370525|11676464|FG001|STARTED|Overall Study||169
10524259|NCT01370525|11676463|FG000|Patients Who Received Treatment|Overall Study||168
10524260|NCT01370525|11676464|FG001|Patients Who Received Treatment|Overall Study||163
10524261|NCT01370525|11676463|FG000|Patients Who Completed Treatment|Overall Study||163
10712072|NCT02666560|11877592|FG000|STARTED|Condition 2 (1 Day)||8
10712073|NCT02666560|11877593|FG001|STARTED|Condition 2 (1 Day)||11
10712074|NCT02666560|11877592|FG000|COMPLETED|Condition 2 (1 Day)||8
10712075|NCT02666560|11877593|FG001|COMPLETED|Condition 2 (1 Day)||11
10712076|NCT02666560|11877592|FG000|NOT COMPLETED|Condition 2 (1 Day)||0
10712077|NCT02666560|11877593|FG001|NOT COMPLETED|Condition 2 (1 Day)||0
10712078|NCT02666664|11877602|FG000|STARTED|Overall Study||742
10712079|NCT02666664|11877603|FG001|STARTED|Overall Study||1488
10712080|NCT02666664|11877602|FG000|COMPLETED|Overall Study||706
10712081|NCT02666664|11877603|FG001|COMPLETED|Overall Study||1404
10712082|NCT02666664|11877602|FG000|NOT COMPLETED|Overall Study||36
10712083|NCT02666664|11877603|FG001|NOT COMPLETED|Overall Study||84
10524262|NCT01370525|11676464|FG001|Patients Who Completed Treatment|Overall Study||158
10524263|NCT01370525|11676463|FG000|COMPLETED|Overall Study||163
10524264|NCT01370525|11676464|FG001|COMPLETED|Overall Study||158
10712090|NCT02666846|11877623|FG000|STARTED|Overall Study||20
10712091|NCT02666846|11877624|FG001|STARTED|Overall Study||20
10524265|NCT01370525|11676463|FG000|NOT COMPLETED|Overall Study||8
10524266|NCT01370525|11676464|FG001|NOT COMPLETED|Overall Study||11
10524267|NCT01370538|11676472|FG000|STARTED|Overall Study||170
10524268|NCT01370538|11676473|FG001|STARTED|Overall Study||171
10524269|NCT01370538|11676472|FG000|Patients Who Received Treatment|Overall Study||165
10524270|NCT01370538|11676473|FG001|Patients Who Received Treatment|Overall Study||161
10524271|NCT01370538|11676472|FG000|Patients Who Completed Treatment|Overall Study||151
10524272|NCT01370538|11676473|FG001|Patients Who Completed Treatment|Overall Study||152
10524273|NCT01370538|11676472|FG000|COMPLETED|Overall Study||151
10524274|NCT01370538|11676473|FG001|COMPLETED|Overall Study||152
10524275|NCT01370538|11676472|FG000|NOT COMPLETED|Overall Study||19
10524276|NCT01370538|11676473|FG001|NOT COMPLETED|Overall Study||19
10524277|NCT01370564|11676479|FG000|STARTED|Overall Study||21
10524278|NCT01370564|11676479|FG000|COMPLETED|Overall Study||21
10524279|NCT01370564|11676479|FG000|NOT COMPLETED|Overall Study||0
10524280|NCT01370616|11676485|FG000|STARTED|Overall Study|Participants randomized|282
10524281|NCT01370616|11676486|FG001|STARTED|Overall Study|Participants randomized|283
10524282|NCT01370616|11676485|FG000|Treated|Overall Study||275
10524283|NCT01370616|11676486|FG001|Treated|Overall Study||275
10524284|NCT01370616|11676485|FG000|COMPLETED|Overall Study||220
10524285|NCT01370616|11676486|FG001|COMPLETED|Overall Study||216
10524286|NCT01370616|11676485|FG000|NOT COMPLETED|Overall Study||62
10524287|NCT01370616|11676486|FG001|NOT COMPLETED|Overall Study||67
10524288|NCT01370629|11676492|FG000|STARTED|Overall Study||2015
10524289|NCT01370629|11676492|FG000|COMPLETED|Overall Study||2009
10524290|NCT01370629|11676492|FG000|NOT COMPLETED|Overall Study||6
10524291|NCT01370642|11676499|FG000|STARTED|Overall Study||98
10524292|NCT01370642|11676500|FG001|STARTED|Overall Study||98
10524293|NCT01370642|11676501|FG002|STARTED|Overall Study||98
10524294|NCT01370642|11676499|FG000|FAS Population|Overall Study||98
10524295|NCT01370642|11676500|FG001|FAS Population|Overall Study||97
10524296|NCT01370642|11676501|FG002|FAS Population|Overall Study||98
10524297|NCT01370642|11676499|FG000|COMPLETED|Overall Study||90
10524298|NCT01370642|11676500|FG001|COMPLETED|Overall Study||92
10524299|NCT01370642|11676501|FG002|COMPLETED|Overall Study||69
10524300|NCT01370642|11676499|FG000|NOT COMPLETED|Overall Study||8
10524301|NCT01370642|11676500|FG001|NOT COMPLETED|Overall Study||6
10524302|NCT01370642|11676501|FG002|NOT COMPLETED|Overall Study||29
10524303|NCT01370655|11676521|FG000|STARTED|Period 1||7
10524304|NCT01370655|11676522|FG001|STARTED|Period 1||7
10524305|NCT01370655|11676523|FG002|STARTED|Period 1||3
10524306|NCT01370655|11676524|FG003|STARTED|Period 1||3
10524307|NCT01370655|11676525|FG004|STARTED|Period 1||3
10524308|NCT01370655|11676526|FG005|STARTED|Period 1||4
10524309|NCT01370655|11676527|FG006|STARTED|Period 1||4
10524310|NCT01370655|11676528|FG007|STARTED|Period 1||4
10524311|NCT01370655|11676529|FG008|STARTED|Period 1||3
10524312|NCT01370655|11676530|FG009|STARTED|Period 1||2
10524313|NCT01370655|11676531|FG010|STARTED|Period 1||3
10524314|NCT01370655|11676532|FG011|STARTED|Period 1||3
10524315|NCT01370655|11676521|FG000|COMPLETED|Period 1||5
10524316|NCT01370655|11676522|FG001|COMPLETED|Period 1||7
10524317|NCT01370655|11676523|FG002|COMPLETED|Period 1||3
10524318|NCT01370655|11676524|FG003|COMPLETED|Period 1||3
10524319|NCT01370655|11676525|FG004|COMPLETED|Period 1||3
10524320|NCT01370655|11676526|FG005|COMPLETED|Period 1||4
10524321|NCT01370655|11676527|FG006|COMPLETED|Period 1||3
10524322|NCT01370655|11676528|FG007|COMPLETED|Period 1||4
10524323|NCT01370655|11676529|FG008|COMPLETED|Period 1||3
10524324|NCT01370655|11676530|FG009|COMPLETED|Period 1||2
10524325|NCT01370655|11676531|FG010|COMPLETED|Period 1||3
10524326|NCT01370655|11676532|FG011|COMPLETED|Period 1||3
10524327|NCT01370655|11676521|FG000|NOT COMPLETED|Period 1||2
10524328|NCT01370655|11676522|FG001|NOT COMPLETED|Period 1||0
10524329|NCT01370655|11676523|FG002|NOT COMPLETED|Period 1||0
10524330|NCT01370655|11676524|FG003|NOT COMPLETED|Period 1||0
10524331|NCT01370655|11676525|FG004|NOT COMPLETED|Period 1||0
10524332|NCT01370655|11676526|FG005|NOT COMPLETED|Period 1||0
10524333|NCT01370655|11676527|FG006|NOT COMPLETED|Period 1||1
10524334|NCT01370655|11676528|FG007|NOT COMPLETED|Period 1||0
10524335|NCT01370655|11676529|FG008|NOT COMPLETED|Period 1||0
10524336|NCT01370655|11676530|FG009|NOT COMPLETED|Period 1||0
10524337|NCT01370655|11676531|FG010|NOT COMPLETED|Period 1||0
10524338|NCT01370655|11676532|FG011|NOT COMPLETED|Period 1||0
10524339|NCT01370655|11676521|FG000|STARTED|Period 2||5
10524340|NCT01370655|11676522|FG001|STARTED|Period 2||7
10524341|NCT01370655|11676523|FG002|STARTED|Period 2||3
10524342|NCT01370655|11676524|FG003|STARTED|Period 2||3
10524343|NCT01370655|11676525|FG004|STARTED|Period 2||3
10524344|NCT01370655|11676526|FG005|STARTED|Period 2||4
10524345|NCT01370655|11676527|FG006|STARTED|Period 2||3
10524346|NCT01370655|11676528|FG007|STARTED|Period 2||4
10524347|NCT01370655|11676529|FG008|STARTED|Period 2||3
10524348|NCT01370655|11676530|FG009|STARTED|Period 2||2
10524349|NCT01370655|11676531|FG010|STARTED|Period 2||3
10524350|NCT01370655|11676532|FG011|STARTED|Period 2||3
10524351|NCT01370655|11676521|FG000|COMPLETED|Period 2||5
10524352|NCT01370655|11676522|FG001|COMPLETED|Period 2||7
10524353|NCT01370655|11676523|FG002|COMPLETED|Period 2||1
10524354|NCT01370655|11676524|FG003|COMPLETED|Period 2||3
10524355|NCT01370655|11676525|FG004|COMPLETED|Period 2||2
10524356|NCT01370655|11676526|FG005|COMPLETED|Period 2||4
10524357|NCT01370655|11676527|FG006|COMPLETED|Period 2||2
10524358|NCT01370655|11676528|FG007|COMPLETED|Period 2||3
10524359|NCT01370655|11676529|FG008|COMPLETED|Period 2||1
10524360|NCT01370655|11676530|FG009|COMPLETED|Period 2||2
10524361|NCT01370655|11676531|FG010|COMPLETED|Period 2||2
10524362|NCT01370655|11676532|FG011|COMPLETED|Period 2||3
10524363|NCT01370655|11676521|FG000|NOT COMPLETED|Period 2||0
10524364|NCT01370655|11676522|FG001|NOT COMPLETED|Period 2||0
10524365|NCT01370655|11676523|FG002|NOT COMPLETED|Period 2||2
10524366|NCT01370655|11676524|FG003|NOT COMPLETED|Period 2||0
10524367|NCT01370655|11676525|FG004|NOT COMPLETED|Period 2||1
10524368|NCT01370655|11676526|FG005|NOT COMPLETED|Period 2||0
10524369|NCT01370655|11676527|FG006|NOT COMPLETED|Period 2||1
10524370|NCT01370655|11676528|FG007|NOT COMPLETED|Period 2||1
10524371|NCT01370655|11676529|FG008|NOT COMPLETED|Period 2||2
10524372|NCT01370655|11676530|FG009|NOT COMPLETED|Period 2||0
10524373|NCT01370655|11676531|FG010|NOT COMPLETED|Period 2||1
10524374|NCT01370655|11676532|FG011|NOT COMPLETED|Period 2||0
10524375|NCT01370694|11676542|FG000|STARTED|Overall Study||7
10524376|NCT01370694|11676542|FG000|COMPLETED|Overall Study||1
10524377|NCT01370694|11676542|FG000|NOT COMPLETED|Overall Study||6
10524378|NCT01370733|11676548|FG000|STARTED|Overall Study||103
10524379|NCT01370733|11676549|FG001|STARTED|Overall Study||99
10524380|NCT01370733|11676548|FG000|COMPLETED|Overall Study||86
10524381|NCT01370733|11676549|FG001|COMPLETED|Overall Study||77
10524382|NCT01370733|11676548|FG000|NOT COMPLETED|Overall Study||17
10524383|NCT01370733|11676549|FG001|NOT COMPLETED|Overall Study||22
10524384|NCT01370837|11676558|FG000|STARTED|Overall Study||12
10524385|NCT01370837|11676559|FG001|STARTED|Overall Study||12
10524386|NCT01370837|11676560|FG002|STARTED|Overall Study||17
10524387|NCT01370837|11676558|FG000|COMPLETED|Overall Study||12
10524388|NCT01370837|11676559|FG001|COMPLETED|Overall Study||12
10524389|NCT01370837|11676560|FG002|COMPLETED|Overall Study||17
10524390|NCT01370837|11676558|FG000|NOT COMPLETED|Overall Study||0
10524391|NCT01370837|11676559|FG001|NOT COMPLETED|Overall Study||0
10524392|NCT01370837|11676560|FG002|NOT COMPLETED|Overall Study||0
10524393|NCT01370863|11676570|FG000|STARTED|Overall Study||34
10524394|NCT01370863|11676571|FG001|STARTED|Overall Study||33
10524395|NCT01370863|11676570|FG000|COMPLETED|Overall Study||32
10524396|NCT01370863|11676571|FG001|COMPLETED|Overall Study||30
10524397|NCT01370863|11676570|FG000|NOT COMPLETED|Overall Study||2
10524398|NCT01370863|11676571|FG001|NOT COMPLETED|Overall Study||3
10524399|NCT01371006|11676579|FG000|STARTED|Overall Study||14
10524400|NCT01371006|11676580|FG001|STARTED|Overall Study||15
10524401|NCT01371006|11676579|FG000|COMPLETED|Overall Study||13
10524402|NCT01371006|11676580|FG001|COMPLETED|Overall Study||15
10524403|NCT01371006|11676579|FG000|NOT COMPLETED|Overall Study||1
10524404|NCT01371006|11676580|FG001|NOT COMPLETED|Overall Study||0
10524405|NCT01371032|11676608|FG000|STARTED|Overall Study||14
10524406|NCT01371032|11676609|FG001|STARTED|Overall Study||14
10524407|NCT01371032|11676608|FG000|COMPLETED|Overall Study||14
10524408|NCT01371032|11676609|FG001|COMPLETED|Overall Study||14
10524409|NCT01371032|11676608|FG000|NOT COMPLETED|Overall Study||0
10524410|NCT01371032|11676609|FG001|NOT COMPLETED|Overall Study||0
10524411|NCT01371110|11676619|FG000|STARTED|Overall Study||1
10524412|NCT01371110|11676620|FG001|STARTED|Overall Study||2
10524413|NCT01371110|11676619|FG000|COMPLETED|Overall Study||1
10524414|NCT01371110|11676620|FG001|COMPLETED|Overall Study||2
10524415|NCT01371110|11676619|FG000|NOT COMPLETED|Overall Study||0
10524416|NCT01371110|11676620|FG001|NOT COMPLETED|Overall Study||0
10524417|NCT01371539|11676626|FG000|STARTED|Period One: One Week||53
10524418|NCT01371539|11676627|FG001|STARTED|Period One: One Week||51
10524419|NCT01371539|11676626|FG000|COMPLETED|Period One: One Week||53
10524420|NCT01371539|11676627|FG001|COMPLETED|Period One: One Week||50
10524421|NCT01371539|11676626|FG000|NOT COMPLETED|Period One: One Week||0
10524422|NCT01371539|11676627|FG001|NOT COMPLETED|Period One: One Week||1
10524423|NCT01371539|11676626|FG000|STARTED|Period Two: One Week||53
10524424|NCT01371539|11676627|FG001|STARTED|Period Two: One Week||50
10524425|NCT01371539|11676626|FG000|COMPLETED|Period Two: One Week||53
10524426|NCT01371539|11676627|FG001|COMPLETED|Period Two: One Week||47
10524427|NCT01371539|11676626|FG000|NOT COMPLETED|Period Two: One Week||0
10524428|NCT01371539|11676627|FG001|NOT COMPLETED|Period Two: One Week||3
10524429|NCT01371552|11676633|FG000|STARTED|Part 1, First 3 Days||19
10524430|NCT01371552|11676634|FG001|STARTED|Part 1, First 3 Days||17
10524431|NCT01371552|11676635|FG002|STARTED|Part 1, First 3 Days||20
10524432|NCT01371552|11676636|FG003|STARTED|Part 1, First 3 Days||20
10524433|NCT01371552|11676637|FG004|STARTED|Part 1, First 3 Days||15
10524434|NCT01371552|11676638|FG005|STARTED|Part 1, First 3 Days||18
10524435|NCT01371552|11676633|FG000|COMPLETED|Part 1, First 3 Days||19
10524436|NCT01371552|11676634|FG001|COMPLETED|Part 1, First 3 Days||17
10524437|NCT01371552|11676635|FG002|COMPLETED|Part 1, First 3 Days||19
10524438|NCT01371552|11676636|FG003|COMPLETED|Part 1, First 3 Days||20
10524439|NCT01371552|11676637|FG004|COMPLETED|Part 1, First 3 Days||15
10524440|NCT01371552|11676638|FG005|COMPLETED|Part 1, First 3 Days||18
10524441|NCT01371552|11676633|FG000|NOT COMPLETED|Part 1, First 3 Days||0
10524442|NCT01371552|11676634|FG001|NOT COMPLETED|Part 1, First 3 Days||0
10524443|NCT01371552|11676635|FG002|NOT COMPLETED|Part 1, First 3 Days||1
10524444|NCT01371552|11676636|FG003|NOT COMPLETED|Part 1, First 3 Days||0
10524445|NCT01371552|11676637|FG004|NOT COMPLETED|Part 1, First 3 Days||0
10524446|NCT01371552|11676638|FG005|NOT COMPLETED|Part 1, First 3 Days||0
10524447|NCT01371552|11676633|FG000|STARTED|Part 1, Second 3 Days||19
10524448|NCT01371552|11676634|FG001|STARTED|Part 1, Second 3 Days||17
10524449|NCT01371552|11676635|FG002|STARTED|Part 1, Second 3 Days|1 subject discontinued after First 3 days due to positive slit lamp findings unrelated to lens wear|18
10524450|NCT01371552|11676636|FG003|STARTED|Part 1, Second 3 Days||20
10524451|NCT01371552|11676637|FG004|STARTED|Part 1, Second 3 Days||15
10524452|NCT01371552|11676638|FG005|STARTED|Part 1, Second 3 Days||18
10528926|NCT01397448|11681300|FG002|COMPLETED|Overall Study||140
10524453|NCT01371552|11676633|FG000|COMPLETED|Part 1, Second 3 Days|One subject did not complete period due to discomfort but continued to next, as allowed by protocol|18
10524454|NCT01371552|11676634|FG001|COMPLETED|Part 1, Second 3 Days||17
10524455|NCT01371552|11676635|FG002|COMPLETED|Part 1, Second 3 Days||18
10524456|NCT01371552|11676636|FG003|COMPLETED|Part 1, Second 3 Days||20
10524457|NCT01371552|11676637|FG004|COMPLETED|Part 1, Second 3 Days||15
10524458|NCT01371552|11676638|FG005|COMPLETED|Part 1, Second 3 Days||18
10524459|NCT01371552|11676633|FG000|NOT COMPLETED|Part 1, Second 3 Days||1
10524460|NCT01371552|11676634|FG001|NOT COMPLETED|Part 1, Second 3 Days||0
10524461|NCT01371552|11676635|FG002|NOT COMPLETED|Part 1, Second 3 Days||0
10524462|NCT01371552|11676636|FG003|NOT COMPLETED|Part 1, Second 3 Days||0
10524463|NCT01371552|11676637|FG004|NOT COMPLETED|Part 1, Second 3 Days||0
10524464|NCT01371552|11676638|FG005|NOT COMPLETED|Part 1, Second 3 Days||0
10524465|NCT01371552|11676633|FG000|STARTED|Part 1, Third 3 Days||19
10524466|NCT01371552|11676634|FG001|STARTED|Part 1, Third 3 Days||17
10524467|NCT01371552|11676635|FG002|STARTED|Part 1, Third 3 Days||18
10524468|NCT01371552|11676636|FG003|STARTED|Part 1, Third 3 Days||20
10524469|NCT01371552|11676637|FG004|STARTED|Part 1, Third 3 Days||15
10524470|NCT01371552|11676638|FG005|STARTED|Part 1, Third 3 Days||18
10524471|NCT01371552|11676633|FG000|COMPLETED|Part 1, Third 3 Days||19
10524472|NCT01371552|11676634|FG001|COMPLETED|Part 1, Third 3 Days||17
10524473|NCT01371552|11676635|FG002|COMPLETED|Part 1, Third 3 Days||18
10524474|NCT01371552|11676636|FG003|COMPLETED|Part 1, Third 3 Days||20
10524475|NCT01371552|11676637|FG004|COMPLETED|Part 1, Third 3 Days|One subject did not complete period due to randomization error, but continued into Part 2.|14
10524476|NCT01371552|11676638|FG005|COMPLETED|Part 1, Third 3 Days|One subject did not complete period due to discomfort, but continued into Part 2.|17
10524477|NCT01371552|11676633|FG000|NOT COMPLETED|Part 1, Third 3 Days||0
10524478|NCT01371552|11676634|FG001|NOT COMPLETED|Part 1, Third 3 Days||0
10524479|NCT01371552|11676635|FG002|NOT COMPLETED|Part 1, Third 3 Days||0
10524480|NCT01371552|11676636|FG003|NOT COMPLETED|Part 1, Third 3 Days||0
10524481|NCT01371552|11676637|FG004|NOT COMPLETED|Part 1, Third 3 Days||1
10524482|NCT01371552|11676638|FG005|NOT COMPLETED|Part 1, Third 3 Days||1
10524483|NCT01371552|11676633|FG000|STARTED|Part 2, One Week|One participant discontinued between Part 1 and Part 2 due to inconvenience|18
10524484|NCT01371552|11676634|FG001|STARTED|Part 2, One Week||17
10524485|NCT01371552|11676635|FG002|STARTED|Part 2, One Week||18
10524486|NCT01371552|11676636|FG003|STARTED|Part 2, One Week||20
10524487|NCT01371552|11676637|FG004|STARTED|Part 2, One Week||15
10524488|NCT01371552|11676638|FG005|STARTED|Part 2, One Week||18
10524489|NCT01371552|11676633|FG000|COMPLETED|Part 2, One Week||18
10524490|NCT01371552|11676634|FG001|COMPLETED|Part 2, One Week||17
10524491|NCT01371552|11676635|FG002|COMPLETED|Part 2, One Week||18
10524492|NCT01371552|11676636|FG003|COMPLETED|Part 2, One Week||20
10524493|NCT01371552|11676637|FG004|COMPLETED|Part 2, One Week||15
10524494|NCT01371552|11676638|FG005|COMPLETED|Part 2, One Week||18
10524495|NCT01371552|11676633|FG000|NOT COMPLETED|Part 2, One Week||0
10524496|NCT01371552|11676634|FG001|NOT COMPLETED|Part 2, One Week||0
10524497|NCT01371552|11676635|FG002|NOT COMPLETED|Part 2, One Week||0
10524498|NCT01371552|11676636|FG003|NOT COMPLETED|Part 2, One Week||0
10524499|NCT01371552|11676637|FG004|NOT COMPLETED|Part 2, One Week||0
10524500|NCT01371552|11676638|FG005|NOT COMPLETED|Part 2, One Week||0
10524501|NCT01371565|11676647|FG000|STARTED|Overall Study||4
10524502|NCT01371565|11676647|FG000|COMPLETED|Overall Study||1
10524503|NCT01371565|11676647|FG000|NOT COMPLETED|Overall Study||3
10524504|NCT01371643|11676653|FG000|STARTED|Overall Study||15
10524505|NCT01371643|11676654|FG001|STARTED|Overall Study||26
10524506|NCT01371643|11676653|FG000|COMPLETED|Overall Study||12
10524507|NCT01371643|11676654|FG001|COMPLETED|Overall Study||26
10524508|NCT01371643|11676653|FG000|NOT COMPLETED|Overall Study||3
10524509|NCT01371643|11676654|FG001|NOT COMPLETED|Overall Study||0
10524510|NCT01371656|11676662|FG000|STARTED|Overall Study||314
10524511|NCT01371656|11676663|FG001|STARTED|Overall Study||310
10524512|NCT01371656|11676662|FG000|COMPLETED|Overall Study||250
10524513|NCT01371656|11676663|FG001|COMPLETED|Overall Study||296
10524514|NCT01371656|11676662|FG000|NOT COMPLETED|Overall Study||64
10524515|NCT01371656|11676663|FG001|NOT COMPLETED|Overall Study||14
10524516|NCT01371708|11676672|FG000|STARTED|Overall Study||92
10524517|NCT01371708|11676673|FG001|STARTED|Overall Study||93
10524518|NCT01371708|11676674|FG002|STARTED|Overall Study||98
10524519|NCT01371708|11676672|FG000|Received Treatment|Overall Study||91
10524520|NCT01371708|11676673|FG001|Received Treatment|Overall Study||93
10524521|NCT01371708|11676674|FG002|Received Treatment|Overall Study||97
10524522|NCT01371708|11676672|FG000|COMPLETED|Overall Study||66
10524523|NCT01371708|11676673|FG001|COMPLETED|Overall Study||63
10524524|NCT01371708|11676674|FG002|COMPLETED|Overall Study||59
10524525|NCT01371708|11676672|FG000|NOT COMPLETED|Overall Study||26
10712092|NCT02666846|11877625|FG002|STARTED|Overall Study||20
10712093|NCT02666846|11877623|FG000|COMPLETED|Overall Study||20
10338319|NCT00369486|11475228|FG004|COMPLETED|8-Week Visit|Number of eyes|24
10524526|NCT01371708|11676673|FG001|NOT COMPLETED|Overall Study||30
10524527|NCT01371708|11676674|FG002|NOT COMPLETED|Overall Study||39
10524528|NCT01371721|11676687|FG000|STARTED|Overall Study||88
10524529|NCT01371721|11676688|FG001|STARTED|Overall Study||89
10524530|NCT01371721|11676689|FG002|STARTED|Overall Study||92
10524531|NCT01371721|11676687|FG000|Treated|Overall Study||87
10524532|NCT01371721|11676688|FG001|Treated|Overall Study||89
10524533|NCT01371721|11676689|FG002|Treated|Overall Study||92
10524534|NCT01371721|11676687|FG000|COMPLETED|Overall Study||59
10524535|NCT01371721|11676688|FG001|COMPLETED|Overall Study||65
10524536|NCT01371721|11676689|FG002|COMPLETED|Overall Study||62
10524537|NCT01371721|11676687|FG000|NOT COMPLETED|Overall Study||29
10524538|NCT01371721|11676688|FG001|NOT COMPLETED|Overall Study||24
10524539|NCT01371721|11676689|FG002|NOT COMPLETED|Overall Study||30
10524540|NCT01371734|11676702|FG000|STARTED|Overall Study||120
10524541|NCT01371734|11676703|FG001|STARTED|Overall Study||122
10524542|NCT01371734|11676704|FG002|STARTED|Overall Study||121
10524543|NCT01371734|11676702|FG000|COMPLETED|Overall Study||97
10524544|NCT01371734|11676703|FG001|COMPLETED|Overall Study||103
10524545|NCT01371734|11676704|FG002|COMPLETED|Overall Study||104
10524546|NCT01371734|11676702|FG000|NOT COMPLETED|Overall Study||23
10524547|NCT01371734|11676703|FG001|NOT COMPLETED|Overall Study||19
10524548|NCT01371734|11676704|FG002|NOT COMPLETED|Overall Study||17
10524549|NCT01371747|11676718|FG000|STARTED|Overall Study||74
10524550|NCT01371747|11676719|FG001|STARTED|Overall Study||74
10524551|NCT01371747|11676720|FG002|STARTED|Overall Study||74
10524552|NCT01371747|11676721|FG003|STARTED|Overall Study||26
10524553|NCT01371747|11676722|FG004|STARTED|Overall Study||28
10524554|NCT01371747|11676723|FG005|STARTED|Overall Study||30
10524555|NCT01371747|11676718|FG000|COMPLETED|Overall Study||56
10524556|NCT01371747|11676719|FG001|COMPLETED|Overall Study||51
10524557|NCT01371747|11676720|FG002|COMPLETED|Overall Study||50
10524558|NCT01371747|11676721|FG003|COMPLETED|Overall Study||17
10524559|NCT01371747|11676722|FG004|COMPLETED|Overall Study||21
10524560|NCT01371747|11676723|FG005|COMPLETED|Overall Study||16
10524561|NCT01371747|11676718|FG000|NOT COMPLETED|Overall Study||18
10524562|NCT01371747|11676719|FG001|NOT COMPLETED|Overall Study||23
10524563|NCT01371747|11676720|FG002|NOT COMPLETED|Overall Study||24
10524564|NCT01371747|11676721|FG003|NOT COMPLETED|Overall Study||9
10524565|NCT01371747|11676722|FG004|NOT COMPLETED|Overall Study||7
10524566|NCT01371747|11676723|FG005|NOT COMPLETED|Overall Study||14
10524567|NCT01371786|11676740|FG000|STARTED|Overall Study||7
10524568|NCT01371786|11676741|FG001|STARTED|Overall Study||7
10524569|NCT01371786|11676740|FG000|COMPLETED|Overall Study||7
10524570|NCT01371786|11676741|FG001|COMPLETED|Overall Study||7
10524571|NCT01371786|11676740|FG000|NOT COMPLETED|Overall Study||0
10524572|NCT01371786|11676741|FG001|NOT COMPLETED|Overall Study||0
10524573|NCT01371825|11676747|FG000|STARTED|Overall Study||9
10524574|NCT01371825|11676747|FG000|Received at Least 1 Dose of Study Drug|Overall Study||9
10524575|NCT01371825|11676747|FG000|COMPLETED|Overall Study||5
10524576|NCT01371825|11676747|FG000|NOT COMPLETED|Overall Study||4
10524577|NCT01371838|11676753|FG000|STARTED|Overall Study||381
10524578|NCT01371838|11676754|FG001|STARTED|Overall Study||383
10524579|NCT01371838|11676753|FG000|COMPLETED|Overall Study||332
10524580|NCT01371838|11676754|FG001|COMPLETED|Overall Study||317
10524581|NCT01371838|11676753|FG000|NOT COMPLETED|Overall Study||49
10524582|NCT01371838|11676754|FG001|NOT COMPLETED|Overall Study||66
10524583|NCT01371851|11676762|FG000|STARTED|Overall Study|Eligible participants who showed up on day 1 of week 1 and received at least one dose of study med.|11
10524584|NCT01371851|11676763|FG001|STARTED|Overall Study|Eligible participants who showed up on day 1 of week 1 and received at least one dose of study med.|11
10524585|NCT01371851|11676762|FG000|COMPLETED|Overall Study||3
10524586|NCT01371851|11676763|FG001|COMPLETED|Overall Study||2
10524587|NCT01371851|11676762|FG000|NOT COMPLETED|Overall Study||8
10524588|NCT01371851|11676763|FG001|NOT COMPLETED|Overall Study||9
10524589|NCT01371877|11676771|FG000|STARTED|Overall Study||21
10524590|NCT01371877|11676772|FG001|STARTED|Overall Study||21
10524591|NCT01371877|11676771|FG000|COMPLETED|Overall Study||21
10524592|NCT01371877|11676772|FG001|COMPLETED|Overall Study||17
10524593|NCT01371877|11676771|FG000|NOT COMPLETED|Overall Study||0
10524594|NCT01371877|11676772|FG001|NOT COMPLETED|Overall Study||4
10524595|NCT01371994|11676780|FG000|STARTED|Overall Study||320
10524596|NCT01371994|11676781|FG001|STARTED|Overall Study||320
10524597|NCT01371994|11676780|FG000|Received Treatment|Overall Study||310
10712094|NCT02666846|11877624|FG001|COMPLETED|Overall Study||20
10712095|NCT02666846|11877625|FG002|COMPLETED|Overall Study||20
10712096|NCT02666846|11877623|FG000|NOT COMPLETED|Overall Study||0
10712097|NCT02666846|11877624|FG001|NOT COMPLETED|Overall Study||0
10712098|NCT02666846|11877625|FG002|NOT COMPLETED|Overall Study||0
10524598|NCT01371994|11676781|FG001|Received Treatment|Overall Study||313
10524599|NCT01371994|11676780|FG000|COMPLETED|Overall Study||263
10524600|NCT01371994|11676781|FG001|COMPLETED|Overall Study||278
10524601|NCT01371994|11676780|FG000|NOT COMPLETED|Overall Study||57
10712099|NCT02666950|11877655|FG000|STARTED|Overall Study||3
10524602|NCT01371994|11676781|FG001|NOT COMPLETED|Overall Study||42
10524603|NCT01372085|11676797|FG000|STARTED|First Intervention (Period 1)||8
10524604|NCT01372085|11676798|FG001|STARTED|First Intervention (Period 1)||2
10524605|NCT01372085|11676799|FG002|STARTED|First Intervention (Period 1)||2
10524606|NCT01372085|11676800|FG003|STARTED|First Intervention (Period 1)||1
10524607|NCT01372085|11676801|FG004|STARTED|First Intervention (Period 1)|Replacement participant repeated Periods 1, 2 to fulfill treatment arm comparison requirements.|3
10524608|NCT01372085|11676802|FG005|STARTED|First Intervention (Period 1)||5
10524609|NCT01372085|11676803|FG006|STARTED|First Intervention (Period 1)||3
10524610|NCT01372085|11676804|FG007|STARTED|First Intervention (Period 1)||1
10524611|NCT01372085|11676805|FG008|STARTED|First Intervention (Period 1)||1
10524612|NCT01372085|11676806|FG009|STARTED|First Intervention (Period 1)||0
10524613|NCT01372085|11676797|FG000|COMPLETED|First Intervention (Period 1)||8
10524614|NCT01372085|11676798|FG001|COMPLETED|First Intervention (Period 1)||2
10524615|NCT01372085|11676799|FG002|COMPLETED|First Intervention (Period 1)||2
10524616|NCT01372085|11676800|FG003|COMPLETED|First Intervention (Period 1)||1
10524617|NCT01372085|11676801|FG004|COMPLETED|First Intervention (Period 1)||3
10524618|NCT01372085|11676802|FG005|COMPLETED|First Intervention (Period 1)||5
10524619|NCT01372085|11676803|FG006|COMPLETED|First Intervention (Period 1)||3
10524620|NCT01372085|11676804|FG007|COMPLETED|First Intervention (Period 1)||1
10524621|NCT01372085|11676805|FG008|COMPLETED|First Intervention (Period 1)||1
10524622|NCT01372085|11676806|FG009|COMPLETED|First Intervention (Period 1)||0
10524623|NCT01372085|11676797|FG000|NOT COMPLETED|First Intervention (Period 1)||0
10524624|NCT01372085|11676798|FG001|NOT COMPLETED|First Intervention (Period 1)||0
10524625|NCT01372085|11676799|FG002|NOT COMPLETED|First Intervention (Period 1)||0
10524626|NCT01372085|11676800|FG003|NOT COMPLETED|First Intervention (Period 1)||0
10524627|NCT01372085|11676801|FG004|NOT COMPLETED|First Intervention (Period 1)||0
10524628|NCT01372085|11676802|FG005|NOT COMPLETED|First Intervention (Period 1)||0
10524629|NCT01372085|11676803|FG006|NOT COMPLETED|First Intervention (Period 1)||0
10524630|NCT01372085|11676804|FG007|NOT COMPLETED|First Intervention (Period 1)||0
10524631|NCT01372085|11676805|FG008|NOT COMPLETED|First Intervention (Period 1)||0
10524632|NCT01372085|11676806|FG009|NOT COMPLETED|First Intervention (Period 1)||0
10524633|NCT01372085|11676797|FG000|STARTED|Washout Period 1|Pts completed one period and did not enter washout for Part A.|0
10524634|NCT01372085|11676798|FG001|STARTED|Washout Period 1|Pts completed one period and did not enter washout for Part A.|0
10524635|NCT01372085|11676799|FG002|STARTED|Washout Period 1||2
10524636|NCT01372085|11676800|FG003|STARTED|Washout Period 1||1
10524637|NCT01372085|11676801|FG004|STARTED|Washout Period 1||3
10524638|NCT01372085|11676802|FG005|STARTED|Washout Period 1||5
10524639|NCT01372085|11676803|FG006|STARTED|Washout Period 1||3
10524640|NCT01372085|11676804|FG007|STARTED|Washout Period 1||1
10524641|NCT01372085|11676805|FG008|STARTED|Washout Period 1||1
10524642|NCT01372085|11676806|FG009|STARTED|Washout Period 1||0
10524643|NCT01372085|11676797|FG000|COMPLETED|Washout Period 1||0
10524644|NCT01372085|11676798|FG001|COMPLETED|Washout Period 1||0
10524645|NCT01372085|11676799|FG002|COMPLETED|Washout Period 1||2
10524646|NCT01372085|11676800|FG003|COMPLETED|Washout Period 1||1
10524647|NCT01372085|11676801|FG004|COMPLETED|Washout Period 1||3
10524648|NCT01372085|11676802|FG005|COMPLETED|Washout Period 1||5
10524649|NCT01372085|11676803|FG006|COMPLETED|Washout Period 1||3
10524650|NCT01372085|11676804|FG007|COMPLETED|Washout Period 1||1
10524651|NCT01372085|11676805|FG008|COMPLETED|Washout Period 1||1
10524652|NCT01372085|11676806|FG009|COMPLETED|Washout Period 1||0
10524653|NCT01372085|11676797|FG000|NOT COMPLETED|Washout Period 1||0
10524654|NCT01372085|11676798|FG001|NOT COMPLETED|Washout Period 1||0
10524655|NCT01372085|11676799|FG002|NOT COMPLETED|Washout Period 1||0
10524656|NCT01372085|11676800|FG003|NOT COMPLETED|Washout Period 1||0
10524657|NCT01372085|11676801|FG004|NOT COMPLETED|Washout Period 1||0
10524658|NCT01372085|11676802|FG005|NOT COMPLETED|Washout Period 1||0
10524659|NCT01372085|11676803|FG006|NOT COMPLETED|Washout Period 1||0
10524660|NCT01372085|11676804|FG007|NOT COMPLETED|Washout Period 1||0
10524661|NCT01372085|11676805|FG008|NOT COMPLETED|Washout Period 1||0
10524662|NCT01372085|11676806|FG009|NOT COMPLETED|Washout Period 1||0
10524663|NCT01372085|11676797|FG000|STARTED|Second Intervention (Period 2)||0
10524664|NCT01372085|11676798|FG001|STARTED|Second Intervention (Period 2)||0
10524665|NCT01372085|11676799|FG002|STARTED|Second Intervention (Period 2)||2
10524666|NCT01372085|11676800|FG003|STARTED|Second Intervention (Period 2)||1
10524667|NCT01372085|11676801|FG004|STARTED|Second Intervention (Period 2)||3
10524668|NCT01372085|11676802|FG005|STARTED|Second Intervention (Period 2)||5
10524669|NCT01372085|11676803|FG006|STARTED|Second Intervention (Period 2)||3
10524670|NCT01372085|11676804|FG007|STARTED|Second Intervention (Period 2)||1
10524671|NCT01372085|11676805|FG008|STARTED|Second Intervention (Period 2)||1
10524672|NCT01372085|11676806|FG009|STARTED|Second Intervention (Period 2)||0
10524673|NCT01372085|11676797|FG000|COMPLETED|Second Intervention (Period 2)||0
10524674|NCT01372085|11676798|FG001|COMPLETED|Second Intervention (Period 2)||0
10524675|NCT01372085|11676799|FG002|COMPLETED|Second Intervention (Period 2)||2
10524676|NCT01372085|11676800|FG003|COMPLETED|Second Intervention (Period 2)||1
10524677|NCT01372085|11676801|FG004|COMPLETED|Second Intervention (Period 2)||3
10524678|NCT01372085|11676802|FG005|COMPLETED|Second Intervention (Period 2)||5
10524679|NCT01372085|11676803|FG006|COMPLETED|Second Intervention (Period 2)||3
10524680|NCT01372085|11676804|FG007|COMPLETED|Second Intervention (Period 2)||1
10524681|NCT01372085|11676805|FG008|COMPLETED|Second Intervention (Period 2)||1
10524682|NCT01372085|11676806|FG009|COMPLETED|Second Intervention (Period 2)||0
10524683|NCT01372085|11676797|FG000|NOT COMPLETED|Second Intervention (Period 2)||0
10524684|NCT01372085|11676798|FG001|NOT COMPLETED|Second Intervention (Period 2)||0
10524685|NCT01372085|11676799|FG002|NOT COMPLETED|Second Intervention (Period 2)||0
10524686|NCT01372085|11676800|FG003|NOT COMPLETED|Second Intervention (Period 2)||0
10524687|NCT01372085|11676801|FG004|NOT COMPLETED|Second Intervention (Period 2)||0
10524688|NCT01372085|11676802|FG005|NOT COMPLETED|Second Intervention (Period 2)||0
10524689|NCT01372085|11676803|FG006|NOT COMPLETED|Second Intervention (Period 2)||0
10524690|NCT01372085|11676804|FG007|NOT COMPLETED|Second Intervention (Period 2)||0
10524691|NCT01372085|11676805|FG008|NOT COMPLETED|Second Intervention (Period 2)||0
10524692|NCT01372085|11676806|FG009|NOT COMPLETED|Second Intervention (Period 2)||0
10524693|NCT01372085|11676797|FG000|STARTED|Washout Period 2||0
10524694|NCT01372085|11676798|FG001|STARTED|Washout Period 2||0
10524695|NCT01372085|11676799|FG002|STARTED|Washout Period 2||2
10524696|NCT01372085|11676800|FG003|STARTED|Washout Period 2||1
10524697|NCT01372085|11676801|FG004|STARTED|Washout Period 2||3
10524698|NCT01372085|11676802|FG005|STARTED|Washout Period 2||5
10524699|NCT01372085|11676803|FG006|STARTED|Washout Period 2||3
10524700|NCT01372085|11676804|FG007|STARTED|Washout Period 2||1
10524701|NCT01372085|11676805|FG008|STARTED|Washout Period 2||1
10524702|NCT01372085|11676806|FG009|STARTED|Washout Period 2||0
10524703|NCT01372085|11676797|FG000|COMPLETED|Washout Period 2||0
10524704|NCT01372085|11676798|FG001|COMPLETED|Washout Period 2||0
10524705|NCT01372085|11676799|FG002|COMPLETED|Washout Period 2||2
10524706|NCT01372085|11676800|FG003|COMPLETED|Washout Period 2||1
10524707|NCT01372085|11676801|FG004|COMPLETED|Washout Period 2|One participant discontinued Washout Period 2 and was replaced in Period 1.|2
10524708|NCT01372085|11676802|FG005|COMPLETED|Washout Period 2||5
10524709|NCT01372085|11676803|FG006|COMPLETED|Washout Period 2||3
10524710|NCT01372085|11676804|FG007|COMPLETED|Washout Period 2||1
10524711|NCT01372085|11676805|FG008|COMPLETED|Washout Period 2||1
10524712|NCT01372085|11676806|FG009|COMPLETED|Washout Period 2||0
10524713|NCT01372085|11676797|FG000|NOT COMPLETED|Washout Period 2||0
10524714|NCT01372085|11676798|FG001|NOT COMPLETED|Washout Period 2||0
10524715|NCT01372085|11676799|FG002|NOT COMPLETED|Washout Period 2||0
10524716|NCT01372085|11676800|FG003|NOT COMPLETED|Washout Period 2||0
10524717|NCT01372085|11676801|FG004|NOT COMPLETED|Washout Period 2||1
10524718|NCT01372085|11676802|FG005|NOT COMPLETED|Washout Period 2||0
10524719|NCT01372085|11676803|FG006|NOT COMPLETED|Washout Period 2||0
10524720|NCT01372085|11676804|FG007|NOT COMPLETED|Washout Period 2||0
10524721|NCT01372085|11676805|FG008|NOT COMPLETED|Washout Period 2||0
10524722|NCT01372085|11676806|FG009|NOT COMPLETED|Washout Period 2||0
10524723|NCT01372085|11676797|FG000|STARTED|Third Intervention (Period 3)||0
10524724|NCT01372085|11676798|FG001|STARTED|Third Intervention (Period 3)||0
10524725|NCT01372085|11676799|FG002|STARTED|Third Intervention (Period 3)||2
10524726|NCT01372085|11676800|FG003|STARTED|Third Intervention (Period 3)||1
10524727|NCT01372085|11676801|FG004|STARTED|Third Intervention (Period 3)||2
10524728|NCT01372085|11676802|FG005|STARTED|Third Intervention (Period 3)|Replacement pts repeated Period (P) 3 to fulfill requirement for P3 versus P4a comparison.|7
10524729|NCT01372085|11676803|FG006|STARTED|Third Intervention (Period 3)||3
10524730|NCT01372085|11676804|FG007|STARTED|Third Intervention (Period 3)||1
10524731|NCT01372085|11676805|FG008|STARTED|Third Intervention (Period 3)||1
10524732|NCT01372085|11676806|FG009|STARTED|Third Intervention (Period 3)||0
10524733|NCT01372085|11676797|FG000|COMPLETED|Third Intervention (Period 3)||0
10524734|NCT01372085|11676798|FG001|COMPLETED|Third Intervention (Period 3)||0
10524735|NCT01372085|11676799|FG002|COMPLETED|Third Intervention (Period 3)||2
10524736|NCT01372085|11676800|FG003|COMPLETED|Third Intervention (Period 3)||1
10524737|NCT01372085|11676801|FG004|COMPLETED|Third Intervention (Period 3)||2
10524738|NCT01372085|11676802|FG005|COMPLETED|Third Intervention (Period 3)||7
10524739|NCT01372085|11676803|FG006|COMPLETED|Third Intervention (Period 3)||3
10524740|NCT01372085|11676804|FG007|COMPLETED|Third Intervention (Period 3)||1
10524741|NCT01372085|11676805|FG008|COMPLETED|Third Intervention (Period 3)||1
10524742|NCT01372085|11676806|FG009|COMPLETED|Third Intervention (Period 3)||0
10524743|NCT01372085|11676797|FG000|NOT COMPLETED|Third Intervention (Period 3)||0
10524744|NCT01372085|11676798|FG001|NOT COMPLETED|Third Intervention (Period 3)||0
10524745|NCT01372085|11676799|FG002|NOT COMPLETED|Third Intervention (Period 3)||0
10524746|NCT01372085|11676800|FG003|NOT COMPLETED|Third Intervention (Period 3)||0
10524747|NCT01372085|11676801|FG004|NOT COMPLETED|Third Intervention (Period 3)||0
10524748|NCT01372085|11676802|FG005|NOT COMPLETED|Third Intervention (Period 3)||0
10524749|NCT01372085|11676803|FG006|NOT COMPLETED|Third Intervention (Period 3)||0
10524750|NCT01372085|11676804|FG007|NOT COMPLETED|Third Intervention (Period 3)||0
10524751|NCT01372085|11676805|FG008|NOT COMPLETED|Third Intervention (Period 3)||0
10524752|NCT01372085|11676806|FG009|NOT COMPLETED|Third Intervention (Period 3)||0
10524753|NCT01372085|11676797|FG000|STARTED|Washout Period 3||0
10524754|NCT01372085|11676798|FG001|STARTED|Washout Period 3||0
10524755|NCT01372085|11676799|FG002|STARTED|Washout Period 3||2
10524756|NCT01372085|11676800|FG003|STARTED|Washout Period 3||1
10524757|NCT01372085|11676801|FG004|STARTED|Washout Period 3||2
10524758|NCT01372085|11676802|FG005|STARTED|Washout Period 3||7
10524759|NCT01372085|11676803|FG006|STARTED|Washout Period 3||3
10524760|NCT01372085|11676804|FG007|STARTED|Washout Period 3||1
10524761|NCT01372085|11676805|FG008|STARTED|Washout Period 3||1
10524762|NCT01372085|11676806|FG009|STARTED|Washout Period 3||0
10524763|NCT01372085|11676797|FG000|COMPLETED|Washout Period 3||0
10524764|NCT01372085|11676798|FG001|COMPLETED|Washout Period 3||0
10524765|NCT01372085|11676799|FG002|COMPLETED|Washout Period 3||2
10524766|NCT01372085|11676800|FG003|COMPLETED|Washout Period 3||1
10524767|NCT01372085|11676801|FG004|COMPLETED|Washout Period 3||2
10524768|NCT01372085|11676802|FG005|COMPLETED|Washout Period 3|Two participants (pts) discontinued Washout P3 and were replaced in P3.|5
10524769|NCT01372085|11676803|FG006|COMPLETED|Washout Period 3||3
10524770|NCT01372085|11676804|FG007|COMPLETED|Washout Period 3||1
10524771|NCT01372085|11676805|FG008|COMPLETED|Washout Period 3||1
10524772|NCT01372085|11676806|FG009|COMPLETED|Washout Period 3||0
10524773|NCT01372085|11676797|FG000|NOT COMPLETED|Washout Period 3||0
10524774|NCT01372085|11676798|FG001|NOT COMPLETED|Washout Period 3||0
10524775|NCT01372085|11676799|FG002|NOT COMPLETED|Washout Period 3||0
10712100|NCT02666950|11877655|FG000|COMPLETED|Overall Study||3
10712101|NCT02666950|11877655|FG000|NOT COMPLETED|Overall Study||0
10712102|NCT02667236|11877661|FG000|STARTED|Overall Study||223
10524776|NCT01372085|11676800|FG003|NOT COMPLETED|Washout Period 3||0
10524777|NCT01372085|11676801|FG004|NOT COMPLETED|Washout Period 3||0
10524778|NCT01372085|11676802|FG005|NOT COMPLETED|Washout Period 3||2
10524779|NCT01372085|11676803|FG006|NOT COMPLETED|Washout Period 3||0
10524780|NCT01372085|11676804|FG007|NOT COMPLETED|Washout Period 3||0
10524781|NCT01372085|11676805|FG008|NOT COMPLETED|Washout Period 3||0
10524782|NCT01372085|11676806|FG009|NOT COMPLETED|Washout Period 3||0
10524783|NCT01372085|11676797|FG000|STARTED|Forth Intervention (Period 4a/4b)||0
10524784|NCT01372085|11676798|FG001|STARTED|Forth Intervention (Period 4a/4b)||0
10524785|NCT01372085|11676799|FG002|STARTED|Forth Intervention (Period 4a/4b)||2
10524786|NCT01372085|11676800|FG003|STARTED|Forth Intervention (Period 4a/4b)||1
10524787|NCT01372085|11676801|FG004|STARTED|Forth Intervention (Period 4a/4b)||2
10524788|NCT01372085|11676802|FG005|STARTED|Forth Intervention (Period 4a/4b)||5
10524789|NCT01372085|11676803|FG006|STARTED|Forth Intervention (Period 4a/4b)||3
10524790|NCT01372085|11676804|FG007|STARTED|Forth Intervention (Period 4a/4b)||1
10524791|NCT01372085|11676805|FG008|STARTED|Forth Intervention (Period 4a/4b)||1
10528927|NCT01397448|11681298|FG000|NOT COMPLETED|Overall Study||18
10712103|NCT02667236|11877662|FG001|STARTED|Overall Study||227
10524792|NCT01372085|11676806|FG009|STARTED|Forth Intervention (Period 4a/4b)|One pt was enrolled directly into P4b to fulfill requirement for safety and tolerability assessment.|1
10524793|NCT01372085|11676797|FG000|COMPLETED|Forth Intervention (Period 4a/4b)||0
10524794|NCT01372085|11676798|FG001|COMPLETED|Forth Intervention (Period 4a/4b)||0
10524795|NCT01372085|11676799|FG002|COMPLETED|Forth Intervention (Period 4a/4b)||2
10524796|NCT01372085|11676800|FG003|COMPLETED|Forth Intervention (Period 4a/4b)||1
10524797|NCT01372085|11676801|FG004|COMPLETED|Forth Intervention (Period 4a/4b)||2
10524798|NCT01372085|11676802|FG005|COMPLETED|Forth Intervention (Period 4a/4b)||5
10524799|NCT01372085|11676803|FG006|COMPLETED|Forth Intervention (Period 4a/4b)||3
10524800|NCT01372085|11676804|FG007|COMPLETED|Forth Intervention (Period 4a/4b)||1
10524801|NCT01372085|11676805|FG008|COMPLETED|Forth Intervention (Period 4a/4b)||1
10524802|NCT01372085|11676806|FG009|COMPLETED|Forth Intervention (Period 4a/4b)||1
10524803|NCT01372085|11676797|FG000|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
10524804|NCT01372085|11676798|FG001|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
10524805|NCT01372085|11676799|FG002|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
10524806|NCT01372085|11676800|FG003|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
10524807|NCT01372085|11676801|FG004|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
10524808|NCT01372085|11676802|FG005|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
10524809|NCT01372085|11676803|FG006|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
10524810|NCT01372085|11676804|FG007|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
10524811|NCT01372085|11676805|FG008|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
10524812|NCT01372085|11676806|FG009|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
10524813|NCT01372150|11676833|FG000|STARTED|Overall Study||112
10524814|NCT01372150|11676834|FG001|STARTED|Overall Study||113
10524815|NCT01372150|11676835|FG002|STARTED|Overall Study||115
10524816|NCT01372150|11676833|FG000|Treated|Overall Study||112
10524817|NCT01372150|11676834|FG001|Treated|Overall Study||112
10524818|NCT01372150|11676835|FG002|Treated|Overall Study||115
10524819|NCT01372150|11676833|FG000|COMPLETED|Overall Study||99
10524820|NCT01372150|11676834|FG001|COMPLETED|Overall Study||99
10524821|NCT01372150|11676835|FG002|COMPLETED|Overall Study||99
10524822|NCT01372150|11676833|FG000|NOT COMPLETED|Overall Study||13
10524823|NCT01372150|11676834|FG001|NOT COMPLETED|Overall Study||14
10524824|NCT01372150|11676835|FG002|NOT COMPLETED|Overall Study||16
10524825|NCT01372202|11676846|FG000|STARTED|Overall Study||13
10524826|NCT01372202|11676847|FG001|STARTED|Overall Study||9
10524827|NCT01372202|11676848|FG002|STARTED|Overall Study||9
10524828|NCT01372202|11676846|FG000|COMPLETED|Overall Study||13
10524829|NCT01372202|11676847|FG001|COMPLETED|Overall Study||9
10524830|NCT01372202|11676848|FG002|COMPLETED|Overall Study||9
10524831|NCT01372202|11676846|FG000|NOT COMPLETED|Overall Study||0
10524832|NCT01372202|11676847|FG001|NOT COMPLETED|Overall Study||0
10524833|NCT01372202|11676848|FG002|NOT COMPLETED|Overall Study||0
10524834|NCT01372384|11676861|FG000|STARTED|Overall Study||6
10524835|NCT01372384|11676861|FG000|COMPLETED|Overall Study||3
10524836|NCT01372384|11676861|FG000|NOT COMPLETED|Overall Study||3
10524837|NCT01372410|11676865|FG000|STARTED|Treatment Period 1 (7 Days)||20
10524838|NCT01372410|11676866|FG001|STARTED|Treatment Period 1 (7 Days)||21
10524839|NCT01372410|11676867|FG002|STARTED|Treatment Period 1 (7 Days)||19
10524840|NCT01372410|11676868|FG003|STARTED|Treatment Period 1 (7 Days)||20
10524841|NCT01372410|11676869|FG004|STARTED|Treatment Period 1 (7 Days)||21
10524842|NCT01372410|11676870|FG005|STARTED|Treatment Period 1 (7 Days)||21
10524843|NCT01372410|11676871|FG006|STARTED|Treatment Period 1 (7 Days)||22
10524844|NCT01372410|11676872|FG007|STARTED|Treatment Period 1 (7 Days)||19
10524845|NCT01372410|11676865|FG000|COMPLETED|Treatment Period 1 (7 Days)||19
10524846|NCT01372410|11676866|FG001|COMPLETED|Treatment Period 1 (7 Days)||19
10524847|NCT01372410|11676867|FG002|COMPLETED|Treatment Period 1 (7 Days)||19
10524848|NCT01372410|11676868|FG003|COMPLETED|Treatment Period 1 (7 Days)||20
10524849|NCT01372410|11676869|FG004|COMPLETED|Treatment Period 1 (7 Days)||19
10524850|NCT01372410|11676870|FG005|COMPLETED|Treatment Period 1 (7 Days)||21
10524851|NCT01372410|11676871|FG006|COMPLETED|Treatment Period 1 (7 Days)||20
10524852|NCT01372410|11676872|FG007|COMPLETED|Treatment Period 1 (7 Days)||19
10524853|NCT01372410|11676865|FG000|NOT COMPLETED|Treatment Period 1 (7 Days)||1
10524854|NCT01372410|11676866|FG001|NOT COMPLETED|Treatment Period 1 (7 Days)||2
10524855|NCT01372410|11676867|FG002|NOT COMPLETED|Treatment Period 1 (7 Days)||0
10524856|NCT01372410|11676868|FG003|NOT COMPLETED|Treatment Period 1 (7 Days)||0
10524857|NCT01372410|11676869|FG004|NOT COMPLETED|Treatment Period 1 (7 Days)||2
10524858|NCT01372410|11676870|FG005|NOT COMPLETED|Treatment Period 1 (7 Days)||0
10524859|NCT01372410|11676871|FG006|NOT COMPLETED|Treatment Period 1 (7 Days)||2
10524860|NCT01372410|11676872|FG007|NOT COMPLETED|Treatment Period 1 (7 Days)||0
10524861|NCT01372410|11676865|FG000|STARTED|Washout Period 1 (10-14 Days)||19
10524862|NCT01372410|11676866|FG001|STARTED|Washout Period 1 (10-14 Days)||19
10524863|NCT01372410|11676867|FG002|STARTED|Washout Period 1 (10-14 Days)||19
10524864|NCT01372410|11676868|FG003|STARTED|Washout Period 1 (10-14 Days)||20
10524865|NCT01372410|11676869|FG004|STARTED|Washout Period 1 (10-14 Days)||19
10524866|NCT01372410|11676870|FG005|STARTED|Washout Period 1 (10-14 Days)||21
10524867|NCT01372410|11676871|FG006|STARTED|Washout Period 1 (10-14 Days)||20
10524868|NCT01372410|11676872|FG007|STARTED|Washout Period 1 (10-14 Days)||19
10524869|NCT01372410|11676865|FG000|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
10524870|NCT01372410|11676866|FG001|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
10524871|NCT01372410|11676867|FG002|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
10524872|NCT01372410|11676868|FG003|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
10524873|NCT01372410|11676869|FG004|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
10524874|NCT01372410|11676870|FG005|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
10524875|NCT01372410|11676871|FG006|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
10524876|NCT01372410|11676872|FG007|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
10524877|NCT01372410|11676865|FG000|NOT COMPLETED|Washout Period 1 (10-14 Days)||1
10524878|NCT01372410|11676866|FG001|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
10524879|NCT01372410|11676867|FG002|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
10524880|NCT01372410|11676868|FG003|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
10524881|NCT01372410|11676869|FG004|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
10524882|NCT01372410|11676870|FG005|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
10524883|NCT01372410|11676871|FG006|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
10524884|NCT01372410|11676872|FG007|NOT COMPLETED|Washout Period 1 (10-14 Days)||1
10524885|NCT01372410|11676865|FG000|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
10524886|NCT01372410|11676866|FG001|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
10524887|NCT01372410|11676867|FG002|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|22
10524888|NCT01372410|11676868|FG003|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|17
10524889|NCT01372410|11676869|FG004|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
10524890|NCT01372410|11676870|FG005|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|16
10524891|NCT01372410|11676871|FG006|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
10524892|NCT01372410|11676872|FG007|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
10524893|NCT01372410|11676865|FG000|COMPLETED|Treatment Period 2 (7 Days)||19
10524894|NCT01372410|11676866|FG001|COMPLETED|Treatment Period 2 (7 Days)||21
10524895|NCT01372410|11676867|FG002|COMPLETED|Treatment Period 2 (7 Days)||22
10524896|NCT01372410|11676868|FG003|COMPLETED|Treatment Period 2 (7 Days)||17
10524897|NCT01372410|11676869|FG004|COMPLETED|Treatment Period 2 (7 Days)||19
10524898|NCT01372410|11676870|FG005|COMPLETED|Treatment Period 2 (7 Days)||16
10524899|NCT01372410|11676871|FG006|COMPLETED|Treatment Period 2 (7 Days)||21
10524900|NCT01372410|11676872|FG007|COMPLETED|Treatment Period 2 (7 Days)||19
10524901|NCT01372410|11676865|FG000|NOT COMPLETED|Treatment Period 2 (7 Days)||0
10524902|NCT01372410|11676866|FG001|NOT COMPLETED|Treatment Period 2 (7 Days)||0
10524903|NCT01372410|11676867|FG002|NOT COMPLETED|Treatment Period 2 (7 Days)||0
10524904|NCT01372410|11676868|FG003|NOT COMPLETED|Treatment Period 2 (7 Days)||0
10524905|NCT01372410|11676869|FG004|NOT COMPLETED|Treatment Period 2 (7 Days)||0
10524906|NCT01372410|11676870|FG005|NOT COMPLETED|Treatment Period 2 (7 Days)||0
10524907|NCT01372410|11676871|FG006|NOT COMPLETED|Treatment Period 2 (7 Days)||0
10524908|NCT01372410|11676872|FG007|NOT COMPLETED|Treatment Period 2 (7 Days)||0
10524909|NCT01372410|11676865|FG000|STARTED|Washout Period 2 (10-14 Days)||19
10524910|NCT01372410|11676866|FG001|STARTED|Washout Period 2 (10-14 Days)||21
10524911|NCT01372410|11676867|FG002|STARTED|Washout Period 2 (10-14 Days)||22
10524912|NCT01372410|11676868|FG003|STARTED|Washout Period 2 (10-14 Days)||17
10524913|NCT01372410|11676869|FG004|STARTED|Washout Period 2 (10-14 Days)||19
10524914|NCT01372410|11676870|FG005|STARTED|Washout Period 2 (10-14 Days)||16
10524915|NCT01372410|11676871|FG006|STARTED|Washout Period 2 (10-14 Days)||21
10524916|NCT01372410|11676872|FG007|STARTED|Washout Period 2 (10-14 Days)||19
10524917|NCT01372410|11676865|FG000|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
10524918|NCT01372410|11676866|FG001|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
10524919|NCT01372410|11676867|FG002|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|22
10524920|NCT01372410|11676868|FG003|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
10524921|NCT01372410|11676869|FG004|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
10524922|NCT01372410|11676870|FG005|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|16
10524923|NCT01372410|11676871|FG006|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
10524924|NCT01372410|11676872|FG007|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
10524925|NCT01372410|11676865|FG000|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
10524926|NCT01372410|11676866|FG001|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
10524927|NCT01372410|11676867|FG002|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
10524928|NCT01372410|11676868|FG003|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
10524929|NCT01372410|11676869|FG004|NOT COMPLETED|Washout Period 2 (10-14 Days)||2
10524930|NCT01372410|11676870|FG005|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
10524931|NCT01372410|11676871|FG006|NOT COMPLETED|Washout Period 2 (10-14 Days)||1
10524932|NCT01372410|11676872|FG007|NOT COMPLETED|Washout Period 2 (10-14 Days)||2
10524933|NCT01372410|11676865|FG000|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
10524934|NCT01372410|11676866|FG001|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|18
10524935|NCT01372410|11676867|FG002|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|16
10524936|NCT01372410|11676868|FG003|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|22
10524937|NCT01372410|11676869|FG004|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|20
10524938|NCT01372410|11676870|FG005|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
10524939|NCT01372410|11676871|FG006|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|15
10524940|NCT01372410|11676872|FG007|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|18
10524941|NCT01372410|11676865|FG000|COMPLETED|Treatment Period 3 (7 Days)||21
10524942|NCT01372410|11676866|FG001|COMPLETED|Treatment Period 3 (7 Days)||18
10524943|NCT01372410|11676867|FG002|COMPLETED|Treatment Period 3 (7 Days)||15
10524944|NCT01372410|11676868|FG003|COMPLETED|Treatment Period 3 (7 Days)||22
10524945|NCT01372410|11676869|FG004|COMPLETED|Treatment Period 3 (7 Days)||20
10524946|NCT01372410|11676870|FG005|COMPLETED|Treatment Period 3 (7 Days)||18
10524947|NCT01372410|11676871|FG006|COMPLETED|Treatment Period 3 (7 Days)||15
10524948|NCT01372410|11676872|FG007|COMPLETED|Treatment Period 3 (7 Days)||18
10524949|NCT01372410|11676865|FG000|NOT COMPLETED|Treatment Period 3 (7 Days)||0
10524950|NCT01372410|11676866|FG001|NOT COMPLETED|Treatment Period 3 (7 Days)||0
10524951|NCT01372410|11676867|FG002|NOT COMPLETED|Treatment Period 3 (7 Days)||1
10524952|NCT01372410|11676868|FG003|NOT COMPLETED|Treatment Period 3 (7 Days)||0
10524953|NCT01372410|11676869|FG004|NOT COMPLETED|Treatment Period 3 (7 Days)||0
10524954|NCT01372410|11676870|FG005|NOT COMPLETED|Treatment Period 3 (7 Days)||1
10524955|NCT01372410|11676871|FG006|NOT COMPLETED|Treatment Period 3 (7 Days)||0
10524956|NCT01372410|11676872|FG007|NOT COMPLETED|Treatment Period 3 (7 Days)||0
10524957|NCT01372462|11676891|FG000|STARTED|NIOV - Room Air||15
10524958|NCT01372462|11676891|FG000|COMPLETED|NIOV - Room Air||15
10524959|NCT01372462|11676891|FG000|NOT COMPLETED|NIOV - Room Air||0
10524960|NCT01372462|11676891|FG000|STARTED|NIOV - Oxygen||15
10524961|NCT01372462|11676891|FG000|COMPLETED|NIOV - Oxygen||15
10524962|NCT01372462|11676891|FG000|NOT COMPLETED|NIOV - Oxygen||0
10524963|NCT01372462|11676891|FG000|STARTED|Oxygen Nasal Cannula||15
10524964|NCT01372462|11676891|FG000|COMPLETED|Oxygen Nasal Cannula||15
10524965|NCT01372462|11676891|FG000|NOT COMPLETED|Oxygen Nasal Cannula||0
10524966|NCT01372462|11676891|FG000|STARTED|No Treatment Control||15
10524967|NCT01372462|11676891|FG000|COMPLETED|No Treatment Control||15
10524968|NCT01372462|11676891|FG000|NOT COMPLETED|No Treatment Control||0
10524969|NCT01372501|11676901|FG000|STARTED|Overall Study||19
10524970|NCT01372501|11676901|FG000|COMPLETED|Overall Study||14
10524971|NCT01372501|11676901|FG000|NOT COMPLETED|Overall Study||5
10524972|NCT01372605|11676908|FG000|STARTED|Overall Study||149
10524973|NCT01372605|11676909|FG001|STARTED|Overall Study||155
10524974|NCT01372605|11676908|FG000|COMPLETED|Overall Study||137
10524975|NCT01372605|11676909|FG001|COMPLETED|Overall Study||145
10524976|NCT01372605|11676908|FG000|NOT COMPLETED|Overall Study||12
10524977|NCT01372605|11676909|FG001|NOT COMPLETED|Overall Study||10
10524978|NCT01372748|11676917|FG000|STARTED|Overall Study||11045
10524979|NCT01372748|11676918|FG001|STARTED|Overall Study||12642
10524980|NCT01372748|11676917|FG000|COMPLETED|Overall Study|defined as having vital status|11022
10524981|NCT01372748|11676918|FG001|COMPLETED|Overall Study|defined as having vital status|12603
10524982|NCT01372748|11676917|FG000|NOT COMPLETED|Overall Study||23
10524983|NCT01372748|11676918|FG001|NOT COMPLETED|Overall Study||39
10712104|NCT02667236|11877661|FG000|COMPLETED|Overall Study||220
10712105|NCT02667236|11877662|FG001|COMPLETED|Overall Study||226
10524990|NCT01372813|11676935|FG000|STARTED|Overall Study||3
10524991|NCT01372813|11676935|FG000|COMPLETED|Overall Study||3
10524992|NCT01372813|11676935|FG000|NOT COMPLETED|Overall Study||0
10524993|NCT01372878|11676939|FG000|STARTED|Overall Study||884
10524994|NCT01372878|11676939|FG000|COMPLETED|Overall Study||700
10524995|NCT01372878|11676939|FG000|NOT COMPLETED|Overall Study||184
10524996|NCT01372995|11676946|FG000|STARTED|Overall Study||10
10524997|NCT01372995|11676947|FG001|STARTED|Overall Study||10
10524998|NCT01372995|11676948|FG002|STARTED|Overall Study|One participant was transferred to comfort care prior to completing the intervention.|11
10524999|NCT01372995|11676946|FG000|COMPLETED|Overall Study||10
10525000|NCT01372995|11676947|FG001|COMPLETED|Overall Study||9
10525001|NCT01372995|11676948|FG002|COMPLETED|Overall Study|The transferred participant was included in the intent to treat analyses.|10
10525002|NCT01372995|11676946|FG000|NOT COMPLETED|Overall Study||0
10525003|NCT01372995|11676947|FG001|NOT COMPLETED|Overall Study||1
10525004|NCT01372995|11676948|FG002|NOT COMPLETED|Overall Study||1
10525005|NCT01373164|11676961|FG000|STARTED|Overall Study||5
10525006|NCT01373164|11676962|FG001|STARTED|Overall Study||4
10525007|NCT01373164|11676963|FG002|STARTED|Overall Study||5
10525008|NCT01373164|11676964|FG003|STARTED|Overall Study||104
10525009|NCT01373164|11676965|FG004|STARTED|Overall Study||52
10525010|NCT01373164|11676961|FG000|Received at Least One Dose|Overall Study||5
10525011|NCT01373164|11676962|FG001|Received at Least One Dose|Overall Study||4
10525012|NCT01373164|11676963|FG002|Received at Least One Dose|Overall Study||5
10525013|NCT01373164|11676964|FG003|Received at Least One Dose|Overall Study||103
10525014|NCT01373164|11676965|FG004|Received at Least One Dose|Overall Study||52
10712106|NCT02667236|11877661|FG000|NOT COMPLETED|Overall Study||3
10712107|NCT02667236|11877662|FG001|NOT COMPLETED|Overall Study||1
10712108|NCT02667275|11877670|FG000|STARTED|Overall Study||244
10525015|NCT01373164|11676961|FG000|COMPLETED|Overall Study||5
10525016|NCT01373164|11676962|FG001|COMPLETED|Overall Study||3
10525017|NCT01373164|11676963|FG002|COMPLETED|Overall Study||4
10525018|NCT01373164|11676964|FG003|COMPLETED|Overall Study||92
10525019|NCT01373164|11676965|FG004|COMPLETED|Overall Study||50
10525020|NCT01373164|11676961|FG000|NOT COMPLETED|Overall Study||0
10525021|NCT01373164|11676962|FG001|NOT COMPLETED|Overall Study||1
10525022|NCT01373164|11676963|FG002|NOT COMPLETED|Overall Study||1
10525023|NCT01373164|11676964|FG003|NOT COMPLETED|Overall Study||12
10525024|NCT01373164|11676965|FG004|NOT COMPLETED|Overall Study||2
10525025|NCT01373229|11676980|FG000|STARTED|Overall Study||15
10525026|NCT01373229|11676980|FG000|COMPLETED|Overall Study||9
10712109|NCT02667275|11877671|FG001|STARTED|Overall Study||243
10712110|NCT02667275|11877670|FG000|COMPLETED|Overall Study||233
10712111|NCT02667275|11877671|FG001|COMPLETED|Overall Study||228
10712112|NCT02667275|11877670|FG000|NOT COMPLETED|Overall Study||11
10712113|NCT02667275|11877671|FG001|NOT COMPLETED|Overall Study||15
10338320|NCT00369486|11475224|FG000|NOT COMPLETED|8-Week Visit||0
10525027|NCT01373229|11676980|FG000|NOT COMPLETED|Overall Study||6
10525028|NCT01373242|11676984|FG000|STARTED|Overall Study||54
10525029|NCT01373242|11676984|FG000|COMPLETED|Overall Study||38
10712114|NCT02667288|11877677|FG000|STARTED|Overall Study||147
10525030|NCT01373242|11676984|FG000|NOT COMPLETED|Overall Study||16
10525031|NCT01373294|11676992|FG000|STARTED|Overall Study||15
10525032|NCT01373294|11676993|FG001|STARTED|Overall Study||2
10525033|NCT01373294|11676992|FG000|COMPLETED|Overall Study||14
10525034|NCT01373294|11676993|FG001|COMPLETED|Overall Study||2
10525035|NCT01373294|11676992|FG000|NOT COMPLETED|Overall Study||1
10525036|NCT01373294|11676993|FG001|NOT COMPLETED|Overall Study||0
10525037|NCT01373346|11676999|FG000|STARTED|Overall Study||15
10525038|NCT01373346|11676999|FG000|COMPLETED|Overall Study||14
10525039|NCT01373346|11676999|FG000|NOT COMPLETED|Overall Study||1
10525040|NCT01373450|11677008|FG000|STARTED|Crossover Period 1||2
10525041|NCT01373450|11677009|FG001|STARTED|Crossover Period 1||2
10525042|NCT01373450|11677010|FG002|STARTED|Crossover Period 1||2
10525043|NCT01373450|11677011|FG003|STARTED|Crossover Period 1||2
10525044|NCT01373450|11677012|FG004|STARTED|Crossover Period 1||2
10525045|NCT01373450|11677013|FG005|STARTED|Crossover Period 1||2
10525046|NCT01373450|11677008|FG000|COMPLETED|Crossover Period 1||2
10525047|NCT01373450|11677009|FG001|COMPLETED|Crossover Period 1||2
10525048|NCT01373450|11677010|FG002|COMPLETED|Crossover Period 1||2
10525049|NCT01373450|11677011|FG003|COMPLETED|Crossover Period 1||2
10525050|NCT01373450|11677012|FG004|COMPLETED|Crossover Period 1||2
10525051|NCT01373450|11677013|FG005|COMPLETED|Crossover Period 1||2
10525052|NCT01373450|11677008|FG000|NOT COMPLETED|Crossover Period 1||0
10525053|NCT01373450|11677009|FG001|NOT COMPLETED|Crossover Period 1||0
10525054|NCT01373450|11677010|FG002|NOT COMPLETED|Crossover Period 1||0
10525055|NCT01373450|11677011|FG003|NOT COMPLETED|Crossover Period 1||0
10525056|NCT01373450|11677012|FG004|NOT COMPLETED|Crossover Period 1||0
10525057|NCT01373450|11677013|FG005|NOT COMPLETED|Crossover Period 1||0
10525058|NCT01373450|11677008|FG000|STARTED|7 Day Wash-out||2
10525059|NCT01373450|11677009|FG001|STARTED|7 Day Wash-out||2
10525060|NCT01373450|11677010|FG002|STARTED|7 Day Wash-out||2
10525061|NCT01373450|11677011|FG003|STARTED|7 Day Wash-out||2
10525062|NCT01373450|11677012|FG004|STARTED|7 Day Wash-out||2
10525063|NCT01373450|11677013|FG005|STARTED|7 Day Wash-out||2
10525064|NCT01373450|11677008|FG000|COMPLETED|7 Day Wash-out||2
10525065|NCT01373450|11677009|FG001|COMPLETED|7 Day Wash-out||2
10525066|NCT01373450|11677010|FG002|COMPLETED|7 Day Wash-out||2
10525067|NCT01373450|11677011|FG003|COMPLETED|7 Day Wash-out||2
10525068|NCT01373450|11677012|FG004|COMPLETED|7 Day Wash-out||2
10525069|NCT01373450|11677013|FG005|COMPLETED|7 Day Wash-out||2
10525070|NCT01373450|11677008|FG000|NOT COMPLETED|7 Day Wash-out||0
10525071|NCT01373450|11677009|FG001|NOT COMPLETED|7 Day Wash-out||0
10525072|NCT01373450|11677010|FG002|NOT COMPLETED|7 Day Wash-out||0
10525073|NCT01373450|11677011|FG003|NOT COMPLETED|7 Day Wash-out||0
10525074|NCT01373450|11677012|FG004|NOT COMPLETED|7 Day Wash-out||0
10525075|NCT01373450|11677013|FG005|NOT COMPLETED|7 Day Wash-out||0
10525076|NCT01373450|11677008|FG000|STARTED|Crossover Period 2||2
10525077|NCT01373450|11677009|FG001|STARTED|Crossover Period 2||2
10525078|NCT01373450|11677010|FG002|STARTED|Crossover Period 2||2
10525079|NCT01373450|11677011|FG003|STARTED|Crossover Period 2||2
10525080|NCT01373450|11677012|FG004|STARTED|Crossover Period 2||2
10525081|NCT01373450|11677013|FG005|STARTED|Crossover Period 2||2
10525082|NCT01373450|11677008|FG000|COMPLETED|Crossover Period 2||2
10525083|NCT01373450|11677009|FG001|COMPLETED|Crossover Period 2||2
10525084|NCT01373450|11677010|FG002|COMPLETED|Crossover Period 2||2
10525085|NCT01373450|11677011|FG003|COMPLETED|Crossover Period 2||2
10525086|NCT01373450|11677012|FG004|COMPLETED|Crossover Period 2||2
10525087|NCT01373450|11677013|FG005|COMPLETED|Crossover Period 2||2
10525088|NCT01373450|11677008|FG000|NOT COMPLETED|Crossover Period 2||0
10525089|NCT01373450|11677009|FG001|NOT COMPLETED|Crossover Period 2||0
10525090|NCT01373450|11677010|FG002|NOT COMPLETED|Crossover Period 2||0
10525091|NCT01373450|11677011|FG003|NOT COMPLETED|Crossover Period 2||0
10525092|NCT01373450|11677012|FG004|NOT COMPLETED|Crossover Period 2||0
10525093|NCT01373450|11677013|FG005|NOT COMPLETED|Crossover Period 2||0
10525094|NCT01373450|11677008|FG000|STARTED|7 Day Wash-out||2
10525095|NCT01373450|11677009|FG001|STARTED|7 Day Wash-out||2
10525096|NCT01373450|11677010|FG002|STARTED|7 Day Wash-out||2
10525097|NCT01373450|11677011|FG003|STARTED|7 Day Wash-out||2
10525098|NCT01373450|11677012|FG004|STARTED|7 Day Wash-out||2
10525099|NCT01373450|11677013|FG005|STARTED|7 Day Wash-out||2
10525100|NCT01373450|11677008|FG000|COMPLETED|7 Day Wash-out||2
10525101|NCT01373450|11677009|FG001|COMPLETED|7 Day Wash-out||2
10525102|NCT01373450|11677010|FG002|COMPLETED|7 Day Wash-out||2
10525103|NCT01373450|11677011|FG003|COMPLETED|7 Day Wash-out||2
10525104|NCT01373450|11677012|FG004|COMPLETED|7 Day Wash-out||2
10525105|NCT01373450|11677013|FG005|COMPLETED|7 Day Wash-out||2
10525106|NCT01373450|11677008|FG000|NOT COMPLETED|7 Day Wash-out||0
10525107|NCT01373450|11677009|FG001|NOT COMPLETED|7 Day Wash-out||0
10525108|NCT01373450|11677010|FG002|NOT COMPLETED|7 Day Wash-out||0
10525109|NCT01373450|11677011|FG003|NOT COMPLETED|7 Day Wash-out||0
10525110|NCT01373450|11677012|FG004|NOT COMPLETED|7 Day Wash-out||0
10525111|NCT01373450|11677013|FG005|NOT COMPLETED|7 Day Wash-out||0
10525112|NCT01373450|11677008|FG000|STARTED|Crossover Period 3||2
10525113|NCT01373450|11677009|FG001|STARTED|Crossover Period 3||2
10525114|NCT01373450|11677010|FG002|STARTED|Crossover Period 3||2
10525115|NCT01373450|11677011|FG003|STARTED|Crossover Period 3||2
10525116|NCT01373450|11677012|FG004|STARTED|Crossover Period 3||2
10525117|NCT01373450|11677013|FG005|STARTED|Crossover Period 3||2
10525118|NCT01373450|11677008|FG000|COMPLETED|Crossover Period 3||2
10525119|NCT01373450|11677009|FG001|COMPLETED|Crossover Period 3||2
10525120|NCT01373450|11677010|FG002|COMPLETED|Crossover Period 3||2
10525121|NCT01373450|11677011|FG003|COMPLETED|Crossover Period 3||2
10525122|NCT01373450|11677012|FG004|COMPLETED|Crossover Period 3||2
10525123|NCT01373450|11677013|FG005|COMPLETED|Crossover Period 3||2
10525124|NCT01373450|11677008|FG000|NOT COMPLETED|Crossover Period 3||0
10525125|NCT01373450|11677009|FG001|NOT COMPLETED|Crossover Period 3||0
10525126|NCT01373450|11677010|FG002|NOT COMPLETED|Crossover Period 3||0
10525127|NCT01373450|11677011|FG003|NOT COMPLETED|Crossover Period 3||0
10525128|NCT01373450|11677012|FG004|NOT COMPLETED|Crossover Period 3||0
10525129|NCT01373450|11677013|FG005|NOT COMPLETED|Crossover Period 3||0
10525130|NCT01373450|11677008|FG000|STARTED|7 Day Wash-out||2
10525131|NCT01373450|11677009|FG001|STARTED|7 Day Wash-out||2
10525132|NCT01373450|11677010|FG002|STARTED|7 Day Wash-out||2
10525133|NCT01373450|11677011|FG003|STARTED|7 Day Wash-out||2
10810465|NCT03797144|11972268|FG001|COMPLETED|12 Month||1
10810466|NCT03797144|11972267|FG000|NOT COMPLETED|12 Month||8
10810467|NCT03797144|11972268|FG001|NOT COMPLETED|12 Month||9
10810468|NCT03797144|11972267|FG000|STARTED|24 Month||1
10525134|NCT01373450|11677012|FG004|STARTED|7 Day Wash-out||2
10525135|NCT01373450|11677013|FG005|STARTED|7 Day Wash-out||2
10525136|NCT01373450|11677008|FG000|COMPLETED|7 Day Wash-out||2
10810469|NCT03797144|11972268|FG001|STARTED|24 Month||1
10810470|NCT03797144|11972267|FG000|COMPLETED|24 Month||0
10810471|NCT03797144|11972268|FG001|COMPLETED|24 Month||0
10810472|NCT03797144|11972267|FG000|NOT COMPLETED|24 Month||1
10810473|NCT03797144|11972268|FG001|NOT COMPLETED|24 Month||1
10810474|NCT03782571|11972275|FG000|STARTED|Period 1||6
10810475|NCT03782571|11972276|FG001|STARTED|Period 1||6
10810476|NCT03782571|11972277|FG002|STARTED|Period 1||6
10525137|NCT01373450|11677009|FG001|COMPLETED|7 Day Wash-out||2
10810477|NCT03782571|11972278|FG003|STARTED|Period 1||7
10810478|NCT03782571|11972275|FG000|COMPLETED|Period 1||5
10810479|NCT03782571|11972276|FG001|COMPLETED|Period 1||6
10525138|NCT01373450|11677010|FG002|COMPLETED|7 Day Wash-out||2
10525139|NCT01373450|11677011|FG003|COMPLETED|7 Day Wash-out||2
10525140|NCT01373450|11677012|FG004|COMPLETED|7 Day Wash-out||2
10525141|NCT01373450|11677013|FG005|COMPLETED|7 Day Wash-out||2
10525142|NCT01373450|11677008|FG000|NOT COMPLETED|7 Day Wash-out||0
10525143|NCT01373450|11677009|FG001|NOT COMPLETED|7 Day Wash-out||0
10525144|NCT01373450|11677010|FG002|NOT COMPLETED|7 Day Wash-out||0
10525145|NCT01373450|11677011|FG003|NOT COMPLETED|7 Day Wash-out||0
10810480|NCT03782571|11972277|FG002|COMPLETED|Period 1||6
10810481|NCT03782571|11972278|FG003|COMPLETED|Period 1||7
10810482|NCT03782571|11972275|FG000|NOT COMPLETED|Period 1||1
10810483|NCT03782571|11972276|FG001|NOT COMPLETED|Period 1||0
10810484|NCT03782571|11972277|FG002|NOT COMPLETED|Period 1||0
10810485|NCT03782571|11972278|FG003|NOT COMPLETED|Period 1||0
10810486|NCT03782571|11972275|FG000|STARTED|Period 2||5
10810487|NCT03782571|11972276|FG001|STARTED|Period 2||6
10810488|NCT03782571|11972277|FG002|STARTED|Period 2||6
10712115|NCT02667288|11877677|FG000|COMPLETED|Overall Study||134
10525146|NCT01373450|11677012|FG004|NOT COMPLETED|7 Day Wash-out||0
10525147|NCT01373450|11677013|FG005|NOT COMPLETED|7 Day Wash-out||0
10525148|NCT01373450|11677008|FG000|STARTED|Crossover Period 4||2
10525149|NCT01373450|11677009|FG001|STARTED|Crossover Period 4||2
10712116|NCT02667288|11877677|FG000|NOT COMPLETED|Overall Study||13
10712117|NCT02667301|11877681|FG000|STARTED|Overall Study||16
10712118|NCT02667301|11877681|FG000|COMPLETED|Overall Study||14
10712119|NCT02667301|11877681|FG000|NOT COMPLETED|Overall Study||2
10712120|NCT02667392|11877687|FG000|STARTED|Overall Study||11
10712121|NCT02667392|11877687|FG000|COMPLETED|Overall Study||11
10712122|NCT02667392|11877687|FG000|NOT COMPLETED|Overall Study||0
10712123|NCT02667457|11877693|FG000|STARTED|Overall Study||27
10810489|NCT03782571|11972278|FG003|STARTED|Period 2||7
10525150|NCT01373450|11677010|FG002|STARTED|Crossover Period 4||2
10525151|NCT01373450|11677011|FG003|STARTED|Crossover Period 4||2
10712124|NCT02667457|11877694|FG001|STARTED|Overall Study||12
10712125|NCT02667457|11877693|FG000|Dosed Participants|Overall Study||26
10810490|NCT03782571|11972275|FG000|COMPLETED|Period 2||5
10810491|NCT03782571|11972276|FG001|COMPLETED|Period 2||6
10713954|NCT02683772|11879504|FG000|NOT COMPLETED|Overall Study||0
10713955|NCT02683772|11879505|FG001|NOT COMPLETED|Overall Study||0
10713956|NCT02683785|11879517|FG000|STARTED|Overall Study||22
10713957|NCT02683785|11879518|FG001|STARTED|Overall Study||22
10713958|NCT02683785|11879517|FG000|COMPLETED|Overall Study||21
10713959|NCT02683785|11879518|FG001|COMPLETED|Overall Study||18
10315655|NCT00181714|11449603|FG000|COMPLETED|Began Treatment With OROS-MPH||30
10713960|NCT02683785|11879517|FG000|NOT COMPLETED|Overall Study||1
10713961|NCT02683785|11879518|FG001|NOT COMPLETED|Overall Study||4
10713962|NCT02683876|11879528|FG000|STARTED|Overall Study||17
10713963|NCT02683876|11879529|FG001|STARTED|Overall Study||22
10713964|NCT02683876|11879528|FG000|COMPLETED|Overall Study||15
10713965|NCT02683876|11879529|FG001|COMPLETED|Overall Study||22
10713966|NCT02683876|11879528|FG000|NOT COMPLETED|Overall Study||2
10713967|NCT02683876|11879529|FG001|NOT COMPLETED|Overall Study||0
10713968|NCT02683928|11879539|FG000|STARTED|Overall Study||48
10713969|NCT02683928|11879540|FG001|STARTED|Overall Study||16
10713970|NCT02683928|11879539|FG000|COMPLETED|Overall Study||26
10713971|NCT02683928|11879540|FG001|COMPLETED|Overall Study||8
10713972|NCT02683928|11879539|FG000|NOT COMPLETED|Overall Study||22
10713973|NCT02683928|11879540|FG001|NOT COMPLETED|Overall Study||8
10713974|NCT02683941|11879548|FG000|STARTED|Double-blind Phase||51
10713975|NCT02683941|11879549|FG001|STARTED|Double-blind Phase||26
10713976|NCT02683941|11879548|FG000|COMPLETED|Double-blind Phase||41
10713977|NCT02683941|11879549|FG001|COMPLETED|Double-blind Phase||21
10713978|NCT02683941|11879548|FG000|NOT COMPLETED|Double-blind Phase||10
10713979|NCT02683941|11879549|FG001|NOT COMPLETED|Double-blind Phase||5
10713980|NCT02683941|11879548|FG000|STARTED|Open-label Treatment Phase||21
10713981|NCT02683941|11879549|FG001|STARTED|Open-label Treatment Phase||19
10713982|NCT02683941|11879548|FG000|COMPLETED|Open-label Treatment Phase||1
10713983|NCT02683941|11879549|FG001|COMPLETED|Open-label Treatment Phase||6
10713984|NCT02683941|11879548|FG000|NOT COMPLETED|Open-label Treatment Phase||20
10713985|NCT02683941|11879549|FG001|NOT COMPLETED|Open-label Treatment Phase||13
10713986|NCT02683941|11879548|FG000|STARTED|Open-label Follow-up Phase||18
10713987|NCT02683941|11879549|FG001|STARTED|Open-label Follow-up Phase||8
10713988|NCT02683941|11879548|FG000|COMPLETED|Open-label Follow-up Phase||0
10713989|NCT02683941|11879549|FG001|COMPLETED|Open-label Follow-up Phase||0
10713990|NCT02683941|11879548|FG000|NOT COMPLETED|Open-label Follow-up Phase||18
10713991|NCT02683941|11879549|FG001|NOT COMPLETED|Open-label Follow-up Phase||8
10713992|NCT02683954|11879561|FG000|STARTED|Overall Study||30
10713993|NCT02683954|11879562|FG001|STARTED|Overall Study||30
10713994|NCT02683954|11879561|FG000|COMPLETED|Overall Study||30
10713995|NCT02683954|11879562|FG001|COMPLETED|Overall Study||30
10713996|NCT02683954|11879561|FG000|NOT COMPLETED|Overall Study||0
10713997|NCT02683954|11879562|FG001|NOT COMPLETED|Overall Study||0
10713998|NCT02684097|11879570|FG000|STARTED|Overall Study||15
10713999|NCT02684097|11879571|FG001|STARTED|Overall Study||7
10714000|NCT02684097|11879570|FG000|COMPLETED|Overall Study||2
10714001|NCT02684097|11879571|FG001|COMPLETED|Overall Study||1
10714002|NCT02684097|11879570|FG000|NOT COMPLETED|Overall Study||13
10714003|NCT02684097|11879571|FG001|NOT COMPLETED|Overall Study||6
10714004|NCT02684136|11879577|FG000|STARTED|First Intervention (9 Nights)||5
10714005|NCT02684136|11879578|FG001|STARTED|First Intervention (9 Nights)||5
10714006|NCT02684136|11879577|FG000|COMPLETED|First Intervention (9 Nights)||5
10714007|NCT02684136|11879578|FG001|COMPLETED|First Intervention (9 Nights)||5
10714008|NCT02684136|11879577|FG000|NOT COMPLETED|First Intervention (9 Nights)||0
10714009|NCT02684136|11879578|FG001|NOT COMPLETED|First Intervention (9 Nights)||0
10714010|NCT02684136|11879577|FG000|STARTED|Washout (7 Days)||5
10714011|NCT02684136|11879578|FG001|STARTED|Washout (7 Days)||5
10714012|NCT02684136|11879577|FG000|COMPLETED|Washout (7 Days)||5
10714013|NCT02684136|11879578|FG001|COMPLETED|Washout (7 Days)||5
10714014|NCT02684136|11879577|FG000|NOT COMPLETED|Washout (7 Days)||0
10714015|NCT02684136|11879578|FG001|NOT COMPLETED|Washout (7 Days)||0
10714016|NCT02684136|11879577|FG000|STARTED|Second Intervention (9 Nights)||5
10714017|NCT02684136|11879578|FG001|STARTED|Second Intervention (9 Nights)||5
10714018|NCT02684136|11879577|FG000|COMPLETED|Second Intervention (9 Nights)||5
10714019|NCT02684136|11879578|FG001|COMPLETED|Second Intervention (9 Nights)||5
10714020|NCT02684136|11879577|FG000|NOT COMPLETED|Second Intervention (9 Nights)||0
10714021|NCT02684136|11879578|FG001|NOT COMPLETED|Second Intervention (9 Nights)||0
10714022|NCT02684188|11879586|FG000|STARTED|Overall Study||77
10714023|NCT02684188|11879587|FG001|STARTED|Overall Study||50
10714024|NCT02684188|11879586|FG000|COMPLETED|Overall Study||75
10714025|NCT02684188|11879587|FG001|COMPLETED|Overall Study||47
10714026|NCT02684188|11879586|FG000|NOT COMPLETED|Overall Study||2
10714027|NCT02684188|11879587|FG001|NOT COMPLETED|Overall Study||3
10714028|NCT02684279|11879596|FG000|STARTED|Overall Study||528
10714029|NCT02684279|11879596|FG000|COMPLETED|Overall Study||249
10714030|NCT02684279|11879596|FG000|NOT COMPLETED|Overall Study||279
10714031|NCT02684344|11879602|FG000|STARTED|Overall Study||1
10714032|NCT02684344|11879603|FG001|STARTED|Overall Study||4
10714033|NCT02684344|11879602|FG000|COMPLETED|Overall Study||1
10714034|NCT02684344|11879603|FG001|COMPLETED|Overall Study||3
10714035|NCT02684344|11879602|FG000|NOT COMPLETED|Overall Study||0
10714036|NCT02684344|11879603|FG001|NOT COMPLETED|Overall Study||1
10714037|NCT02684357|11879612|FG000|STARTED|Part A||98
10315656|NCT00181714|11449603|FG000|NOT COMPLETED|Began Treatment With OROS-MPH||124
10714038|NCT02684357|11879613|FG001|STARTED|Part A||99
10301627|NCT00063622|11434500|FG000|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|70
10301628|NCT00063622|11434501|FG001|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|80
10301629|NCT00063622|11434502|FG002|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|72
10301630|NCT00063622|11434500|FG000|NOT COMPLETED|Overall Study||10
10301631|NCT00063622|11434501|FG001|NOT COMPLETED|Overall Study||4
10301632|NCT00063622|11434502|FG002|NOT COMPLETED|Overall Study||11
10301633|NCT00063635|11434513|FG000|STARTED|Overall Study||57
10301634|NCT00063635|11434514|FG001|STARTED|Overall Study||58
10301635|NCT00063635|11434515|FG002|STARTED|Overall Study||58
10301636|NCT00063635|11434513|FG000|COMPLETED|Overall Study||51
10301637|NCT00063635|11434514|FG001|COMPLETED|Overall Study||50
10301638|NCT00063635|11434515|FG002|COMPLETED|Overall Study||49
10301639|NCT00063635|11434513|FG000|NOT COMPLETED|Overall Study||6
10301640|NCT00063635|11434514|FG001|NOT COMPLETED|Overall Study||8
10301641|NCT00063635|11434515|FG002|NOT COMPLETED|Overall Study||9
10301642|NCT00063882|11434525|FG000|STARTED|Overall Study||292
10301643|NCT00063882|11434526|FG001|STARTED|Overall Study||296
10301644|NCT00063882|11434525|FG000|Has Acute Adverse Event Data|Overall Study||282
10301645|NCT00063882|11434526|FG001|Has Acute Adverse Event Data|Overall Study||288
10301646|NCT00063882|11434525|FG000|Has Late Adverse Event Data|Overall Study||282
10301647|NCT00063882|11434526|FG001|Has Late Adverse Event Data|Overall Study||287
10301648|NCT00063882|11434525|FG000|Has Baseline/4-month EPIC Data|Overall Study||222
10301649|NCT00063882|11434526|FG001|Has Baseline/4-month EPIC Data|Overall Study||241
10301650|NCT00063882|11434525|FG000|Has Baseline/24-month EPIC Data|Overall Study||201
10301651|NCT00063882|11434526|FG001|Has Baseline/24-month EPIC Data|Overall Study||219
10301652|NCT00063882|11434525|FG000|Eligible Patients|Overall Study||287
10301653|NCT00063882|11434526|FG001|Eligible Patients|Overall Study||292
10301654|NCT00063882|11434525|FG000|COMPLETED|Overall Study||287
10301655|NCT00063882|11434526|FG001|COMPLETED|Overall Study||292
10301656|NCT00063882|11434525|FG000|NOT COMPLETED|Overall Study||5
10301657|NCT00063882|11434526|FG001|NOT COMPLETED|Overall Study||4
10301658|NCT00063934|11434532|FG000|STARTED|Overall Study||31
10301659|NCT00063934|11434532|FG000|COMPLETED|Overall Study||30
10301660|NCT00063934|11434532|FG000|NOT COMPLETED|Overall Study||1
10301661|NCT00063986|11434536|FG000|STARTED|Overall Study||110
10301662|NCT00063986|11434536|FG000|Treated|Overall Study||105
10301663|NCT00063986|11434536|FG000|Eligible and Treated|Overall Study||104
10301664|NCT00063986|11434536|FG000|COMPLETED|Overall Study||104
10301665|NCT00063986|11434536|FG000|NOT COMPLETED|Overall Study||6
10301666|NCT00063999|11434542|FG000|STARTED|Overall Study||692
10301667|NCT00063999|11434543|FG001|STARTED|Overall Study||689
10301668|NCT00063999|11434542|FG000|COMPLETED|Overall Study||647
10301669|NCT00063999|11434543|FG001|COMPLETED|Overall Study||665
10301670|NCT00063999|11434542|FG000|NOT COMPLETED|Overall Study||45
10301671|NCT00063999|11434543|FG001|NOT COMPLETED|Overall Study||24
10301672|NCT00064025|11434556|FG000|STARTED|Overall Study||75
10301673|NCT00064025|11434556|FG000|COMPLETED|Overall Study||68
10301674|NCT00064025|11434556|FG000|NOT COMPLETED|Overall Study||7
10301675|NCT00064038|11434564|FG000|STARTED|Initial Randomization||100
10301676|NCT00064038|11434565|FG001|STARTED|Initial Randomization||98
10301677|NCT00064038|11434566|FG002|STARTED|Initial Randomization||0
10301678|NCT00064038|11434564|FG000|Eligible and Analyzable|Initial Randomization||97
10301679|NCT00064038|11434565|FG001|Eligible and Analyzable|Initial Randomization||95
10301680|NCT00064038|11434566|FG002|Eligible and Analyzable|Initial Randomization||0
10301681|NCT00064038|11434564|FG000|Safety Population|Initial Randomization||96
10301682|NCT00064038|11434565|FG001|Safety Population|Initial Randomization||94
10301683|NCT00064038|11434566|FG002|Safety Population|Initial Randomization||0
10301684|NCT00064038|11434564|FG000|COMPLETED|Initial Randomization|The study was closed early per recommedation of the Data Safety Monitoring Committee.|0
10301685|NCT00064038|11434565|FG001|COMPLETED|Initial Randomization|The study was closed early per recommedation of the Data Safety Monitoring Committee.|0
10339298|NCT00371839|11476202|FG000|NOT COMPLETED|Overall Study||17
10301686|NCT00064038|11434566|FG002|COMPLETED|Initial Randomization||0
10654627|NCT02203591|11815406|FG001|NOT COMPLETED|Overall Study||142
10654628|NCT02203591|11815407|FG002|NOT COMPLETED|Overall Study||151
10654629|NCT02203591|11815408|FG003|NOT COMPLETED|Overall Study||45
10654630|NCT02203591|11815409|FG004|NOT COMPLETED|Overall Study||34
10654631|NCT02203591|11815410|FG005|NOT COMPLETED|Overall Study||35
10654632|NCT02203591|11815411|FG006|NOT COMPLETED|Overall Study||29
10654633|NCT02203591|11815412|FG007|NOT COMPLETED|Overall Study||13
10654634|NCT02203630|11815436|FG000|STARTED|Overall Study||8
10654635|NCT02203630|11815437|FG001|STARTED|Overall Study||9
10654636|NCT02203630|11815436|FG000|COMPLETED|Overall Study||8
10654637|NCT02203630|11815437|FG001|COMPLETED|Overall Study||9
10654638|NCT02203630|11815436|FG000|NOT COMPLETED|Overall Study||0
10654639|NCT02203630|11815437|FG001|NOT COMPLETED|Overall Study||0
10654640|NCT02203721|11815445|FG000|STARTED|Overall Study||148
10654641|NCT02203721|11815446|FG001|STARTED|Overall Study||151
10714039|NCT02684357|11879614|FG002|STARTED|Part A||294
10714040|NCT02684357|11879615|FG003|STARTED|Part A||0
10714041|NCT02684357|11879616|FG004|STARTED|Part A||0
10714042|NCT02684357|11879617|FG005|STARTED|Part A||0
10714043|NCT02684357|11879612|FG000|COMPLETED|Part A||94
10714044|NCT02684357|11879613|FG001|COMPLETED|Part A||96
10714045|NCT02684357|11879614|FG002|COMPLETED|Part A||292
10714046|NCT02684357|11879615|FG003|COMPLETED|Part A||0
10714047|NCT02684357|11879616|FG004|COMPLETED|Part A||0
10714048|NCT02684357|11879617|FG005|COMPLETED|Part A||0
10714049|NCT02684357|11879612|FG000|NOT COMPLETED|Part A||4
10714050|NCT02684357|11879613|FG001|NOT COMPLETED|Part A||3
10811223|NCT03769896|11972940|FG000|NOT COMPLETED|Double-blind Treatment Phase||0
10811224|NCT03769896|11972941|FG001|NOT COMPLETED|Double-blind Treatment Phase||0
10811225|NCT03769207|11972948|FG000|STARTED|Overall Study||17
10811226|NCT03769207|11972948|FG000|Attended First Study Visit|Overall Study||11
10811227|NCT03769207|11972948|FG000|ECG Patch Shipped|Overall Study||11
10811228|NCT03769207|11972948|FG000|ECG Patch Returned and Readable|Overall Study||9
10811229|NCT03769207|11972948|FG000|Attended Second Study Visit|Overall Study||6
10811230|NCT03769207|11972948|FG000|COMPLETED|Overall Study||6
10811231|NCT03769207|11972948|FG000|NOT COMPLETED|Overall Study||11
10811232|NCT03768856|11972952|FG000|STARTED|Overall Study||5
10811233|NCT03768856|11972952|FG000|COMPLETED|Overall Study||5
10811234|NCT03768856|11972952|FG000|NOT COMPLETED|Overall Study||0
10811235|NCT03768726|11972958|FG000|STARTED|Treatment Phase||10
10811236|NCT03768726|11972959|FG001|STARTED|Treatment Phase||13
10811237|NCT03768726|11972958|FG000|COMPLETED|Treatment Phase||2
10811238|NCT03768726|11972959|FG001|COMPLETED|Treatment Phase||10
10811239|NCT03768726|11972958|FG000|NOT COMPLETED|Treatment Phase||8
10811240|NCT03768726|11972959|FG001|NOT COMPLETED|Treatment Phase||3
10811241|NCT03768726|11972958|FG000|STARTED|Follow-Up|Participants were followed up after completion or discontinuation of treatment.|8
10811242|NCT03768726|11972959|FG001|STARTED|Follow-Up|Participants were followed up after completion or discontinuation of treatment.|12
10811243|NCT03768726|11972958|FG000|Received Treatment|Follow-Up||8
10811244|NCT03768726|11972959|FG001|Received Treatment|Follow-Up||12
10811245|NCT03768726|11972958|FG000|COMPLETED|Follow-Up||2
10811246|NCT03768726|11972959|FG001|COMPLETED|Follow-Up||9
10811247|NCT03768726|11972958|FG000|NOT COMPLETED|Follow-Up||6
10811248|NCT03768726|11972959|FG001|NOT COMPLETED|Follow-Up||3
10811249|NCT03768206|11972967|FG000|STARTED|Overall Study||24
10811250|NCT03768206|11972968|FG001|STARTED|Overall Study||21
10811251|NCT03768206|11972967|FG000|COMPLETED|Overall Study||22
10811252|NCT03768206|11972968|FG001|COMPLETED|Overall Study||19
10811253|NCT03768206|11972967|FG000|NOT COMPLETED|Overall Study||2
10811254|NCT03768206|11972968|FG001|NOT COMPLETED|Overall Study||2
10811255|NCT03767894|11972975|FG000|STARTED|Overall Study||12
10811256|NCT03767894|11972975|FG000|COMPLETED|Overall Study||11
10811257|NCT03767894|11972975|FG000|NOT COMPLETED|Overall Study||1
10811258|NCT03767738|11972981|FG000|STARTED|Overall Study||35
10811259|NCT03767738|11972982|FG001|STARTED|Overall Study||30
10811260|NCT03767738|11972981|FG000|COMPLETED|Overall Study||35
10811261|NCT03767738|11972982|FG001|COMPLETED|Overall Study||30
10811262|NCT03767738|11972981|FG000|NOT COMPLETED|Overall Study||0
10811263|NCT03767738|11972982|FG001|NOT COMPLETED|Overall Study||0
10811264|NCT03767153|11972990|FG000|STARTED|Overall Study||14
10811265|NCT03767153|11972991|FG001|STARTED|Overall Study||11
10811266|NCT03767153|11972990|FG000|COMPLETED|Overall Study||14
10811267|NCT03767153|11972991|FG001|COMPLETED|Overall Study||11
10811268|NCT03767153|11972990|FG000|NOT COMPLETED|Overall Study||0
10811269|NCT03767153|11972991|FG001|NOT COMPLETED|Overall Study||0
10811270|NCT03767062|11972999|FG000|STARTED|Overall Study||45
10811271|NCT03767062|11973000|FG001|STARTED|Overall Study||45
10811272|NCT03767062|11972999|FG000|COMPLETED|Overall Study||37
10811273|NCT03767062|11973000|FG001|COMPLETED|Overall Study||41
10811274|NCT03767062|11972999|FG000|NOT COMPLETED|Overall Study||8
10811275|NCT03767062|11973000|FG001|NOT COMPLETED|Overall Study||4
10811276|NCT03766646|11973008|FG000|STARTED|Overall Study||19
10811277|NCT03766646|11973009|FG001|STARTED|Overall Study||15
10811278|NCT03766646|11973008|FG000|COMPLETED|Overall Study||18
10811279|NCT03766646|11973009|FG001|COMPLETED|Overall Study||12
10811280|NCT03766646|11973008|FG000|NOT COMPLETED|Overall Study||1
10811281|NCT03766646|11973009|FG001|NOT COMPLETED|Overall Study||3
10811282|NCT03766373|11973017|FG000|STARTED|Overall Study||12
10811283|NCT03766373|11973018|FG001|STARTED|Overall Study||12
10811284|NCT03766373|11973017|FG000|COMPLETED|Overall Study||12
10811285|NCT03766373|11973018|FG001|COMPLETED|Overall Study||12
10811286|NCT03766373|11973017|FG000|NOT COMPLETED|Overall Study||0
10811287|NCT03766373|11973018|FG001|NOT COMPLETED|Overall Study||0
10811288|NCT03766165|11973026|FG000|STARTED|Overall Study||19
10811289|NCT03766165|11973027|FG001|STARTED|Overall Study||19
10811290|NCT03766165|11973026|FG000|COMPLETED|Overall Study||19
10811291|NCT03766165|11973027|FG001|COMPLETED|Overall Study||19
10811292|NCT03766165|11973026|FG000|NOT COMPLETED|Overall Study||0
10811293|NCT03766165|11973027|FG001|NOT COMPLETED|Overall Study||0
10811294|NCT03765996|11973036|FG000|STARTED|Overall Study||18
10811295|NCT03765996|11973037|FG001|STARTED|Overall Study||18
10811296|NCT03765996|11973036|FG000|COMPLETED|Overall Study||14
10811297|NCT03765996|11973037|FG001|COMPLETED|Overall Study||18
10811298|NCT03765996|11973036|FG000|NOT COMPLETED|Overall Study||4
10811299|NCT03765996|11973037|FG001|NOT COMPLETED|Overall Study||0
10811300|NCT03765762|11973045|FG000|STARTED|Overall Study||18
10811301|NCT03765762|11973046|FG001|STARTED|Overall Study||8
10811302|NCT03765762|11973045|FG000|COMPLETED|Overall Study||18
10811303|NCT03765762|11973046|FG001|COMPLETED|Overall Study||8
10811304|NCT03765762|11973045|FG000|NOT COMPLETED|Overall Study||0
10811305|NCT03765762|11973046|FG001|NOT COMPLETED|Overall Study||0
10811306|NCT03765502|11973055|FG000|STARTED|Simulation 1||20
10811307|NCT03765502|11973056|FG001|STARTED|Simulation 1||13
10811308|NCT03765502|11973057|FG002|STARTED|Simulation 1||33
10811309|NCT03765502|11973058|FG003|STARTED|Simulation 1||16
10811310|NCT03765502|11973059|FG004|STARTED|Simulation 1||17
10811311|NCT03765502|11973055|FG000|COMPLETED|Simulation 1||20
10811312|NCT03765502|11973056|FG001|COMPLETED|Simulation 1||13
10811313|NCT03765502|11973057|FG002|COMPLETED|Simulation 1||33
10811314|NCT03765502|11973058|FG003|COMPLETED|Simulation 1||16
10811315|NCT03765502|11973059|FG004|COMPLETED|Simulation 1||17
10811316|NCT03765502|11973055|FG000|NOT COMPLETED|Simulation 1||0
10811317|NCT03765502|11973056|FG001|NOT COMPLETED|Simulation 1||0
10811318|NCT03765502|11973057|FG002|NOT COMPLETED|Simulation 1||0
10811319|NCT03765502|11973058|FG003|NOT COMPLETED|Simulation 1||0
10811320|NCT03765502|11973059|FG004|NOT COMPLETED|Simulation 1||0
10811321|NCT03765502|11973055|FG000|STARTED|Simulation 2||20
10811322|NCT03765502|11973056|FG001|STARTED|Simulation 2|Participant completed Period 1 GEK simulation but did not return for the Period 2 NG simulation.|12
10714051|NCT02684357|11879614|FG002|NOT COMPLETED|Part A||2
10811323|NCT03765502|11973057|FG002|STARTED|Simulation 2|PWD completed Period 1 GEK simulation but did not return for the Period 2 NG simulation.|32
10811324|NCT03765502|11973058|FG003|STARTED|Simulation 2||16
10811325|NCT03765502|11973059|FG004|STARTED|Simulation 2||17
10811326|NCT03765502|11973055|FG000|COMPLETED|Simulation 2||20
10811327|NCT03765502|11973056|FG001|COMPLETED|Simulation 2||12
10811328|NCT03765502|11973057|FG002|COMPLETED|Simulation 2||32
10811329|NCT03765502|11973058|FG003|COMPLETED|Simulation 2||16
10811330|NCT03765502|11973059|FG004|COMPLETED|Simulation 2||17
10811331|NCT03765502|11973055|FG000|NOT COMPLETED|Simulation 2||0
10811332|NCT03765502|11973056|FG001|NOT COMPLETED|Simulation 2||0
10811333|NCT03765502|11973057|FG002|NOT COMPLETED|Simulation 2||0
10811334|NCT03765502|11973058|FG003|NOT COMPLETED|Simulation 2||0
10811335|NCT03765502|11973059|FG004|NOT COMPLETED|Simulation 2||0
10811336|NCT03765164|11973081|FG000|STARTED|Pre-intervention||78
10811337|NCT03765164|11973082|FG001|STARTED|Pre-intervention||78
10811338|NCT03765164|11973081|FG000|COMPLETED|Pre-intervention||73
10714052|NCT02684357|11879615|FG003|NOT COMPLETED|Part A||0
10811339|NCT03765164|11973082|FG001|COMPLETED|Pre-intervention||72
10811340|NCT03765164|11973081|FG000|NOT COMPLETED|Pre-intervention||5
10811341|NCT03765164|11973082|FG001|NOT COMPLETED|Pre-intervention||6
10811342|NCT03765164|11973081|FG000|STARTED|Post-intervention||73
10811343|NCT03765164|11973082|FG001|STARTED|Post-intervention||72
10811344|NCT03765164|11973081|FG000|COMPLETED|Post-intervention||0
10811345|NCT03765164|11973082|FG001|COMPLETED|Post-intervention||0
10811346|NCT03765164|11973081|FG000|NOT COMPLETED|Post-intervention||73
10811347|NCT03765164|11973082|FG001|NOT COMPLETED|Post-intervention||72
10811348|NCT03765138|11973088|FG000|STARTED|Overall Study||1
10811349|NCT03765138|11973088|FG000|COMPLETED|Overall Study||0
10811350|NCT03765138|11973088|FG000|NOT COMPLETED|Overall Study||1
10811351|NCT03764449|11973095|FG000|STARTED|Overall Study||8
10811352|NCT03764449|11973096|FG001|STARTED|Overall Study||8
10811353|NCT03764449|11973095|FG000|COMPLETED|Overall Study||8
10301687|NCT00064038|11434564|FG000|NOT COMPLETED|Initial Randomization||100
10301688|NCT00064038|11434565|FG001|NOT COMPLETED|Initial Randomization||98
10315657|NCT00181766|11449607|FG000|STARTED|Overall Study|Number of subjects enrolled and treated with Atomoxetine.|45
10315658|NCT00181766|11449607|FG000|COMPLETED|Overall Study|Completed the trial.|33
10315659|NCT00181766|11449607|FG000|NOT COMPLETED|Overall Study||12
10315660|NCT00181844|11449611|FG000|STARTED|Signed Consent||51
10315661|NCT00181844|11449611|FG000|COMPLETED|Signed Consent||39
10315662|NCT00181844|11449611|FG000|NOT COMPLETED|Signed Consent||12
10315663|NCT00181844|11449611|FG000|STARTED|Exposed to Study Medication||39
10315664|NCT00181844|11449611|FG000|COMPLETED|Exposed to Study Medication||22
10315665|NCT00181844|11449611|FG000|NOT COMPLETED|Exposed to Study Medication||17
10339299|NCT00371839|11476203|FG001|NOT COMPLETED|Overall Study||7
10339300|NCT00371839|11476204|FG002|NOT COMPLETED|Overall Study||2
10339301|NCT00371865|11476212|FG000|STARTED|Overall Study||57
10339302|NCT00371865|11476213|FG001|STARTED|Overall Study||57
10339303|NCT00371865|11476212|FG000|COMPLETED|Overall Study|7 withdrew before starting the intervention. 8 withdrew after starting the intervention.|42
10339304|NCT00371865|11476213|FG001|COMPLETED|Overall Study|8 withdrew before starting the intervention. 6 withdrew after starting the intervention.|43
10339305|NCT00371865|11476212|FG000|NOT COMPLETED|Overall Study||15
10339306|NCT00371865|11476213|FG001|NOT COMPLETED|Overall Study||14
10339307|NCT00372060|11476221|FG000|STARTED|Period I - Double-blind (Weeks 0-12)|The planned number of enrolled patients was 130. The actual number of enrolled patients was 134.|66
10339308|NCT00372060|11476222|FG001|STARTED|Period I - Double-blind (Weeks 0-12)||68
10339309|NCT00372060|11476221|FG000|COMPLETED|Period I - Double-blind (Weeks 0-12)||63
10339310|NCT00372060|11476222|FG001|COMPLETED|Period I - Double-blind (Weeks 0-12)||67
10339311|NCT00372060|11476221|FG000|NOT COMPLETED|Period I - Double-blind (Weeks 0-12)||3
10339312|NCT00372060|11476222|FG001|NOT COMPLETED|Period I - Double-blind (Weeks 0-12)||1
10339313|NCT00372060|11476221|FG000|STARTED|Period II - Open-label (Weeks 12-52)||63
10339314|NCT00372060|11476222|FG001|STARTED|Period II - Open-label (Weeks 12-52)||67
10339315|NCT00372060|11476221|FG000|COMPLETED|Period II - Open-label (Weeks 12-52)||49
10339316|NCT00372060|11476222|FG001|COMPLETED|Period II - Open-label (Weeks 12-52)||59
10339317|NCT00372060|11476221|FG000|NOT COMPLETED|Period II - Open-label (Weeks 12-52)||14
10339318|NCT00372060|11476222|FG001|NOT COMPLETED|Period II - Open-label (Weeks 12-52)||8
10339319|NCT00372112|11476235|FG000|STARTED|Overall Study||17
10339320|NCT00372112|11476236|FG001|STARTED|Overall Study||16
10339321|NCT00372112|11476237|FG002|STARTED|Overall Study||17
10339322|NCT00372112|11476238|FG003|STARTED|Overall Study||18
10339323|NCT00372112|11476235|FG000|COMPLETED|Overall Study||16
10339324|NCT00372112|11476236|FG001|COMPLETED|Overall Study||15
10811354|NCT03764449|11973096|FG001|COMPLETED|Overall Study||8
10811355|NCT03764449|11973095|FG000|NOT COMPLETED|Overall Study||0
10301689|NCT00064038|11434566|FG002|NOT COMPLETED|Initial Randomization||0
10301690|NCT00064038|11434564|FG000|STARTED|Crossover to Lenalidomide+Dexamethasone||0
10301691|NCT00064038|11434565|FG001|STARTED|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
10301692|NCT00064038|11434566|FG002|STARTED|Crossover to Lenalidomide+Dexamethasone||42
10301693|NCT00064038|11434564|FG000|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone||0
10301694|NCT00064038|11434565|FG001|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
10301695|NCT00064038|11434566|FG002|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone||40
10301696|NCT00064038|11434564|FG000|Safety Population|Crossover to Lenalidomide+Dexamethasone||0
10301697|NCT00064038|11434565|FG001|Safety Population|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
10301698|NCT00064038|11434566|FG002|Safety Population|Crossover to Lenalidomide+Dexamethasone||40
10301699|NCT00064038|11434564|FG000|COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
10301700|NCT00064038|11434565|FG001|COMPLETED|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
10301701|NCT00064038|11434566|FG002|COMPLETED|Crossover to Lenalidomide+Dexamethasone||40
10301702|NCT00064038|11434564|FG000|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
10301703|NCT00064038|11434565|FG001|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
10301704|NCT00064038|11434566|FG002|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||2
10301705|NCT00064077|11434579|FG000|STARTED|Overall Study||118
10301706|NCT00064077|11434580|FG001|STARTED|Overall Study||117
10301707|NCT00064077|11434581|FG002|STARTED|Overall Study||119
10301708|NCT00064077|11434582|FG003|STARTED|Overall Study||118
10301709|NCT00064077|11434579|FG000|COMPLETED|Overall Study|Evaluable (treatment)|103
10301710|NCT00064077|11434580|FG001|COMPLETED|Overall Study|Evaluable (treatment)|108
10301711|NCT00064077|11434581|FG002|COMPLETED|Overall Study|Evaluable (treatment)|112
10301712|NCT00064077|11434582|FG003|COMPLETED|Overall Study|Evaluable (treatment)|111
10301713|NCT00064077|11434579|FG000|NOT COMPLETED|Overall Study||15
10301714|NCT00064077|11434580|FG001|NOT COMPLETED|Overall Study||9
10301715|NCT00064077|11434581|FG002|NOT COMPLETED|Overall Study||7
10301716|NCT00064077|11434582|FG003|NOT COMPLETED|Overall Study||7
10301717|NCT00064259|11434592|FG000|STARTED|Overall Study||4
10301718|NCT00064259|11434593|FG001|STARTED|Overall Study||4
10301719|NCT00064259|11434594|FG002|STARTED|Overall Study||6
10301720|NCT00064259|11434595|FG003|STARTED|Overall Study||1
10301721|NCT00064259|11434592|FG000|COMPLETED|Overall Study||3
10301722|NCT00064259|11434593|FG001|COMPLETED|Overall Study||4
10301723|NCT00064259|11434594|FG002|COMPLETED|Overall Study||6
10301724|NCT00064259|11434595|FG003|COMPLETED|Overall Study||0
10301725|NCT00064259|11434592|FG000|NOT COMPLETED|Overall Study||1
10301726|NCT00064259|11434593|FG001|NOT COMPLETED|Overall Study||0
10301727|NCT00064259|11434594|FG002|NOT COMPLETED|Overall Study||0
10301728|NCT00064259|11434595|FG003|NOT COMPLETED|Overall Study||1
10301729|NCT00064298|11434602|FG000|STARTED|Overall Study||72
10301730|NCT00064298|11434603|FG001|STARTED|Overall Study||62
10301731|NCT00064298|11434602|FG000|COMPLETED|Overall Study||66
10301732|NCT00064298|11434603|FG001|COMPLETED|Overall Study||57
10301733|NCT00064298|11434602|FG000|NOT COMPLETED|Overall Study||6
10301734|NCT00064298|11434603|FG001|NOT COMPLETED|Overall Study||5
10301735|NCT00064337|11434609|FG000|STARTED|PBSCC or Induction/PBSCC|104 patients were registered, 93 of whom were eligible and analyzable.|93
10301736|NCT00064337|11434609|FG000|COMPLETED|PBSCC or Induction/PBSCC||73
10301737|NCT00064337|11434609|FG000|NOT COMPLETED|PBSCC or Induction/PBSCC||20
10301738|NCT00064337|11434609|FG000|STARTED|Transplant|6 patients who completed PBSCC or Induction/PBSCC did not begin Transplant|67
10301739|NCT00064337|11434609|FG000|COMPLETED|Transplant||46
10301740|NCT00064337|11434609|FG000|NOT COMPLETED|Transplant||21
10301741|NCT00064337|11434609|FG000|STARTED|Maintenance|Only patients with High Risk MM or AL + MM were allowed to enroll to Maintenance treatment.|13
10301742|NCT00064337|11434609|FG000|COMPLETED|Maintenance||3
10339325|NCT00372112|11476237|FG002|COMPLETED|Overall Study||13
10339326|NCT00372112|11476238|FG003|COMPLETED|Overall Study||14
10339327|NCT00372112|11476235|FG000|NOT COMPLETED|Overall Study||1
10339328|NCT00372112|11476236|FG001|NOT COMPLETED|Overall Study||1
10339329|NCT00372112|11476237|FG002|NOT COMPLETED|Overall Study||4
10339330|NCT00372112|11476238|FG003|NOT COMPLETED|Overall Study||4
10339331|NCT00372190|11476253|FG000|STARTED|Overall Study|95 were allocated to mesh group, however 2 never underwent any surgery|93
10339332|NCT00372190|11476254|FG001|STARTED|Overall Study|99 were allocated to conventional arm, however 2 never underwent any surgery|97
10339333|NCT00372190|11476253|FG000|COMPLETED|Overall Study||90
10339334|NCT00372190|11476254|FG001|COMPLETED|Overall Study||96
10339335|NCT00372190|11476253|FG000|NOT COMPLETED|Overall Study||3
10339336|NCT00372190|11476254|FG001|NOT COMPLETED|Overall Study||1
10654642|NCT02203721|11815445|FG000|COMPLETED|Overall Study||147
10339337|NCT00372255|11476264|FG000|STARTED|Overall Study||110
10339338|NCT00372255|11476265|FG001|STARTED|Overall Study||114
10339339|NCT00372255|11476264|FG000|COMPLETED|Overall Study||108
10339340|NCT00372255|11476265|FG001|COMPLETED|Overall Study||113
10654643|NCT02203721|11815446|FG001|COMPLETED|Overall Study||148
10654644|NCT02203721|11815445|FG000|NOT COMPLETED|Overall Study||1
10654645|NCT02203721|11815446|FG001|NOT COMPLETED|Overall Study||3
10654646|NCT02203747|11815454|FG000|STARTED|Overall Study||45
10654647|NCT02203747|11815455|FG001|STARTED|Overall Study||34
10654648|NCT02203747|11815454|FG000|COMPLETED|Overall Study||45
10654649|NCT02203747|11815455|FG001|COMPLETED|Overall Study||34
10339341|NCT00372255|11476264|FG000|NOT COMPLETED|Overall Study||2
10654650|NCT02203747|11815454|FG000|NOT COMPLETED|Overall Study||0
10301743|NCT00064337|11434609|FG000|NOT COMPLETED|Maintenance||10
10301744|NCT00064350|11434619|FG000|STARTED|Induction Treatment||59
10339342|NCT00372255|11476265|FG001|NOT COMPLETED|Overall Study||1
10339343|NCT00372385|11476276|FG000|STARTED|Overall Study||82
10339344|NCT00372385|11476277|FG001|STARTED|Overall Study||81
10654651|NCT02203747|11815455|FG001|NOT COMPLETED|Overall Study||0
10301745|NCT00064350|11434620|FG001|STARTED|Induction Treatment||46
10301746|NCT00064350|11434621|FG002|STARTED|Induction Treatment||237
10301747|NCT00064350|11434619|FG000|Treated|Induction Treatment||59
10301748|NCT00064350|11434620|FG001|Treated|Induction Treatment||46
10301749|NCT00064350|11434621|FG002|Treated|Induction Treatment||228
10301750|NCT00064350|11434619|FG000|Eligible and Treated|Induction Treatment||59
10301751|NCT00064350|11434620|FG001|Eligible and Treated|Induction Treatment||46
10301752|NCT00064350|11434621|FG002|Eligible and Treated|Induction Treatment||194
10301753|NCT00064350|11434619|FG000|COMPLETED|Induction Treatment||51
10301754|NCT00064350|11434620|FG001|COMPLETED|Induction Treatment||37
10301755|NCT00064350|11434621|FG002|COMPLETED|Induction Treatment||1
10301756|NCT00064350|11434619|FG000|NOT COMPLETED|Induction Treatment||8
10301757|NCT00064350|11434620|FG001|NOT COMPLETED|Induction Treatment||9
10301758|NCT00064350|11434621|FG002|NOT COMPLETED|Induction Treatment||236
10301759|NCT00064350|11434619|FG000|STARTED|Randomization||59
10301760|NCT00064350|11434620|FG001|STARTED|Randomization||46
10301761|NCT00064350|11434621|FG002|STARTED|Randomization||0
10301762|NCT00064350|11434619|FG000|Treated|Randomization||55
10301763|NCT00064350|11434620|FG001|Treated|Randomization||40
10301764|NCT00064350|11434621|FG002|Treated|Randomization||0
10301765|NCT00064350|11434619|FG000|Eligible and Treated|Randomization||50
10301766|NCT00064350|11434620|FG001|Eligible and Treated|Randomization||31
10301767|NCT00064350|11434621|FG002|Eligible and Treated|Randomization||0
10301768|NCT00064350|11434619|FG000|COMPLETED|Randomization||33
10301769|NCT00064350|11434620|FG001|COMPLETED|Randomization||28
10301770|NCT00064350|11434621|FG002|COMPLETED|Randomization||0
10301771|NCT00064350|11434619|FG000|NOT COMPLETED|Randomization||26
10301772|NCT00064350|11434620|FG001|NOT COMPLETED|Randomization||18
10714053|NCT02684357|11879616|FG004|NOT COMPLETED|Part A||0
10714054|NCT02684357|11879617|FG005|NOT COMPLETED|Part A||0
10714055|NCT02684357|11879612|FG000|STARTED|Part B||0
10339345|NCT00372385|11476278|FG002|STARTED|Overall Study||82
10339346|NCT00372385|11476279|FG003|STARTED|Overall Study||78
10339347|NCT00372385|11476276|FG000|COMPLETED|Overall Study||49
10714056|NCT02684357|11879613|FG001|STARTED|Part B||0
10714057|NCT02684357|11879614|FG002|STARTED|Part B||0
10714058|NCT02684357|11879615|FG003|STARTED|Part B|Participants who received placebo in Part A received risankizumab in Part B|94
10714059|NCT02684357|11879616|FG004|STARTED|Part B|2 participants who received ustekinumab in Part A did not receive a dose of study drug in Part B.|94
10529070|NCT01398475|11681468|FG000|Received Fourth Intervention|Overall Study||4
10529071|NCT01398475|11681469|FG001|Received Fourth Intervention|Overall Study||3
10547842|NCT01515319|11701604|FG008|NOT COMPLETED|Overall Study||5
10339348|NCT00372385|11476277|FG001|COMPLETED|Overall Study||61
10339349|NCT00372385|11476278|FG002|COMPLETED|Overall Study||72
10339350|NCT00372385|11476279|FG003|COMPLETED|Overall Study||70
10339351|NCT00372385|11476276|FG000|NOT COMPLETED|Overall Study||33
10339352|NCT00372385|11476277|FG001|NOT COMPLETED|Overall Study||20
10339353|NCT00372385|11476278|FG002|NOT COMPLETED|Overall Study||10
10339354|NCT00372385|11476279|FG003|NOT COMPLETED|Overall Study||8
10339355|NCT00372411|11476293|FG000|STARTED|Overall Study||49
10339356|NCT00372411|11476294|FG001|STARTED|Overall Study||50
10339357|NCT00372411|11476295|FG002|STARTED|Overall Study||28
10339358|NCT00372411|11476293|FG000|COMPLETED|Overall Study||44
10339359|NCT00372411|11476294|FG001|COMPLETED|Overall Study||42
10339360|NCT00372411|11476295|FG002|COMPLETED|Overall Study||25
10339361|NCT00372411|11476293|FG000|NOT COMPLETED|Overall Study||5
10339362|NCT00372411|11476294|FG001|NOT COMPLETED|Overall Study||8
10339363|NCT00372411|11476295|FG002|NOT COMPLETED|Overall Study||3
10339364|NCT00372424|11476303|FG000|STARTED|Overall Study||26
10339365|NCT00372424|11476303|FG000|Treated|Overall Study||25
10339366|NCT00372424|11476303|FG000|COMPLETED|Overall Study||0
10339367|NCT00372424|11476303|FG000|NOT COMPLETED|Overall Study||26
10339368|NCT00372489|11476307|FG000|STARTED|Overall Study||81
10339369|NCT00372489|11476307|FG000|COMPLETED|Overall Study||2
10339370|NCT00372489|11476307|FG000|NOT COMPLETED|Overall Study||79
10339371|NCT00372528|11476311|FG000|STARTED|Overall Study||21
10339372|NCT00372528|11476311|FG000|COMPLETED|Overall Study||0
10339373|NCT00372528|11476311|FG000|NOT COMPLETED|Overall Study||21
10339374|NCT00372567|11476318|FG000|STARTED|Phase 1 Sub-study||0
10339375|NCT00372567|11476319|FG001|STARTED|Phase 1 Sub-study||0
10339376|NCT00372567|11476320|FG002|STARTED|Phase 1 Sub-study||12
10339377|NCT00372567|11476318|FG000|COMPLETED|Phase 1 Sub-study||0
10339378|NCT00372567|11476319|FG001|COMPLETED|Phase 1 Sub-study||0
10339379|NCT00372567|11476320|FG002|COMPLETED|Phase 1 Sub-study||12
10339380|NCT00372567|11476318|FG000|NOT COMPLETED|Phase 1 Sub-study||0
10339381|NCT00372567|11476319|FG001|NOT COMPLETED|Phase 1 Sub-study||0
10339382|NCT00372567|11476320|FG002|NOT COMPLETED|Phase 1 Sub-study||0
10339383|NCT00372567|11476318|FG000|STARTED|Phase 3 Study||31
10339384|NCT00372567|11476319|FG001|STARTED|Phase 3 Study||26
10339385|NCT00372567|11476320|FG002|STARTED|Phase 3 Study||12
10339386|NCT00372567|11476318|FG000|Received Treatment|Phase 3 Study||31
10339387|NCT00372567|11476319|FG001|Received Treatment|Phase 3 Study||25
10339388|NCT00372567|11476320|FG002|Received Treatment|Phase 3 Study||12
10339389|NCT00372567|11476318|FG000|COMPLETED|Phase 3 Study||0
10339390|NCT00372567|11476319|FG001|COMPLETED|Phase 3 Study||0
10339391|NCT00372567|11476320|FG002|COMPLETED|Phase 3 Study||0
10339392|NCT00372567|11476318|FG000|NOT COMPLETED|Phase 3 Study||31
10339393|NCT00372567|11476319|FG001|NOT COMPLETED|Phase 3 Study||26
10339394|NCT00372567|11476320|FG002|NOT COMPLETED|Phase 3 Study||12
10339395|NCT00372593|11476331|FG000|STARTED|Overall Study||531
10339396|NCT00372593|11476332|FG001|STARTED|Overall Study||532
10339397|NCT00372593|11476333|FG002|STARTED|Overall Study||7
10339398|NCT00372593|11476331|FG000|COMPLETED|Overall Study||327
10339399|NCT00372593|11476332|FG001|COMPLETED|Overall Study||334
10339400|NCT00372593|11476333|FG002|COMPLETED|Overall Study||3
10339401|NCT00372593|11476331|FG000|NOT COMPLETED|Overall Study||204
10339402|NCT00372593|11476332|FG001|NOT COMPLETED|Overall Study||198
10339403|NCT00372593|11476333|FG002|NOT COMPLETED|Overall Study||4
10339404|NCT00372619|11476349|FG000|STARTED|Overall Study||8
10339405|NCT00372619|11476350|FG001|STARTED|Overall Study||2
10339406|NCT00372619|11476351|FG002|STARTED|Overall Study||3
10339407|NCT00372619|11476352|FG003|STARTED|Overall Study||10
10339408|NCT00372619|11476353|FG004|STARTED|Overall Study||7
10339409|NCT00372619|11476354|FG005|STARTED|Overall Study||42
10339410|NCT00372619|11476355|FG006|STARTED|Overall Study||2
10339411|NCT00372619|11476349|FG000|COMPLETED|Overall Study||8
10339412|NCT00372619|11476350|FG001|COMPLETED|Overall Study||2
10339413|NCT00372619|11476351|FG002|COMPLETED|Overall Study||3
10339414|NCT00372619|11476352|FG003|COMPLETED|Overall Study||10
10339415|NCT00372619|11476353|FG004|COMPLETED|Overall Study||7
10339416|NCT00372619|11476354|FG005|COMPLETED|Overall Study||39
10339417|NCT00372619|11476355|FG006|COMPLETED|Overall Study||2
10339418|NCT00372619|11476349|FG000|NOT COMPLETED|Overall Study||0
10339419|NCT00372619|11476350|FG001|NOT COMPLETED|Overall Study||0
10339420|NCT00372619|11476351|FG002|NOT COMPLETED|Overall Study||0
10339421|NCT00372619|11476352|FG003|NOT COMPLETED|Overall Study||0
10339422|NCT00372619|11476353|FG004|NOT COMPLETED|Overall Study||0
10301773|NCT00064350|11434621|FG002|NOT COMPLETED|Randomization||0
10301774|NCT00064350|11434619|FG000|STARTED|Cross-Over||10
10301775|NCT00064350|11434620|FG001|STARTED|Cross-Over||27
10301776|NCT00064350|11434621|FG002|STARTED|Cross-Over||0
10301777|NCT00064350|11434619|FG000|Treated|Cross-Over||9
10301778|NCT00064350|11434620|FG001|Treated|Cross-Over||26
10301779|NCT00064350|11434621|FG002|Treated|Cross-Over||0
10301780|NCT00064350|11434619|FG000|Eligible and Treated|Cross-Over||7
10301781|NCT00064350|11434620|FG001|Eligible and Treated|Cross-Over||21
10301782|NCT00064350|11434621|FG002|Eligible and Treated|Cross-Over||0
10301783|NCT00064350|11434619|FG000|COMPLETED|Cross-Over||4
10301784|NCT00064350|11434620|FG001|COMPLETED|Cross-Over||13
10301785|NCT00064350|11434621|FG002|COMPLETED|Cross-Over||0
10529072|NCT01398475|11681470|FG002|Received Fourth Intervention|Overall Study||4
10529073|NCT01398475|11681471|FG003|Received Fourth Intervention|Overall Study||4
10301786|NCT00064350|11434619|FG000|NOT COMPLETED|Cross-Over||6
10301787|NCT00064350|11434620|FG001|NOT COMPLETED|Cross-Over||14
10301788|NCT00064350|11434621|FG002|NOT COMPLETED|Cross-Over||0
10301789|NCT00064662|11434632|FG000|STARTED|Overall Study||329
10301790|NCT00064662|11434633|FG001|STARTED|Overall Study||326
10301791|NCT00064662|11434632|FG000|COMPLETED|Overall Study||255
10301792|NCT00064662|11434633|FG001|COMPLETED|Overall Study||265
10301793|NCT00064662|11434632|FG000|NOT COMPLETED|Overall Study||74
10301794|NCT00064662|11434633|FG001|NOT COMPLETED|Overall Study||61
10301795|NCT00064701|11434642|FG000|STARTED|One Year Post-transplant||219
10301796|NCT00064701|11434643|FG001|STARTED|One Year Post-transplant||226
10301797|NCT00064701|11434644|FG002|STARTED|One Year Post-transplant||223
10301798|NCT00064701|11434642|FG000|Received Study Drug|One Year Post-transplant||212
10301799|NCT00064701|11434643|FG001|Received Study Drug|One Year Post-transplant||214
10301800|NCT00064701|11434644|FG002|Received Study Drug|One Year Post-transplant||212
10301801|NCT00064701|11434642|FG000|COMPLETED|One Year Post-transplant||179
10301802|NCT00064701|11434643|FG001|COMPLETED|One Year Post-transplant||183
10301803|NCT00064701|11434644|FG002|COMPLETED|One Year Post-transplant||151
10301804|NCT00064701|11434642|FG000|NOT COMPLETED|One Year Post-transplant||40
10301805|NCT00064701|11434643|FG001|NOT COMPLETED|One Year Post-transplant||43
10301806|NCT00064701|11434644|FG002|NOT COMPLETED|One Year Post-transplant||72
10301807|NCT00064701|11434642|FG000|STARTED|Clinical Continuation Phase||179
10301808|NCT00064701|11434643|FG001|STARTED|Clinical Continuation Phase|One participant did not enter the Clinical Continuation phase|182
10301809|NCT00064701|11434644|FG002|STARTED|Clinical Continuation Phase||151
10301810|NCT00064701|11434642|FG000|COMPLETED|Clinical Continuation Phase||9
10301811|NCT00064701|11434643|FG001|COMPLETED|Clinical Continuation Phase||4
10301812|NCT00064701|11434644|FG002|COMPLETED|Clinical Continuation Phase||11
10301813|NCT00064701|11434642|FG000|NOT COMPLETED|Clinical Continuation Phase||170
10301814|NCT00064701|11434643|FG001|NOT COMPLETED|Clinical Continuation Phase||178
10301815|NCT00064701|11434644|FG002|NOT COMPLETED|Clinical Continuation Phase||140
10301816|NCT00064753|11434654|FG000|STARTED|Overall Study||2056
10301817|NCT00064753|11434655|FG001|STARTED|Overall Study||2054
10301818|NCT00064753|11434654|FG000|COMPLETED|Overall Study||1382
10301819|NCT00064753|11434655|FG001|COMPLETED|Overall Study||1406
10301820|NCT00064753|11434654|FG000|NOT COMPLETED|Overall Study||674
10301821|NCT00064753|11434655|FG001|NOT COMPLETED|Overall Study||648
10301822|NCT00064792|11434663|FG000|STARTED|Overall Study||13
10301823|NCT00064792|11434664|FG001|STARTED|Overall Study||10
10301824|NCT00064792|11434663|FG000|COMPLETED|Overall Study||8
10301825|NCT00064792|11434664|FG001|COMPLETED|Overall Study||10
10301826|NCT00064792|11434663|FG000|NOT COMPLETED|Overall Study||5
10301827|NCT00064792|11434664|FG001|NOT COMPLETED|Overall Study||0
10301828|NCT00064844|11434672|FG000|STARTED|Overall Study||45
10301829|NCT00064844|11434673|FG001|STARTED|Overall Study||51
10301830|NCT00064844|11434672|FG000|2 Week Follow-up|Overall Study||45
10301831|NCT00064844|11434673|FG001|2 Week Follow-up|Overall Study||51
10301832|NCT00064844|11434672|FG000|3 Month Follow-up|Overall Study||40
10301833|NCT00064844|11434673|FG001|3 Month Follow-up|Overall Study||47
10301834|NCT00064844|11434672|FG000|6 Month Follow-up|Overall Study||39
10301835|NCT00064844|11434673|FG001|6 Month Follow-up|Overall Study||40
10301836|NCT00064844|11434672|FG000|12 Month Follow-up|Overall Study||37
10301837|NCT00064844|11434673|FG001|12 Month Follow-up|Overall Study||32
10301838|NCT00064844|11434672|FG000|COMPLETED|Overall Study||37
10301839|NCT00064844|11434673|FG001|COMPLETED|Overall Study||32
10301840|NCT00064844|11434672|FG000|NOT COMPLETED|Overall Study||8
10301841|NCT00064844|11434673|FG001|NOT COMPLETED|Overall Study||19
10301842|NCT00064987|11434681|FG000|STARTED|Overall Study||10
10301843|NCT00064987|11434682|FG001|STARTED|Overall Study||6
10301844|NCT00064987|11434681|FG000|COMPLETED|Overall Study||7
10301845|NCT00064987|11434682|FG001|COMPLETED|Overall Study||6
10301846|NCT00064987|11434681|FG000|NOT COMPLETED|Overall Study||3
10301847|NCT00064987|11434682|FG001|NOT COMPLETED|Overall Study||0
10301848|NCT00065065|11434690|FG000|STARTED|Overall Study||52
10301849|NCT00065065|11434691|FG001|STARTED|Overall Study||53
10301850|NCT00065065|11434690|FG000|COMPLETED|Overall Study||42
10529074|NCT01398475|11681468|FG000|COMPLETED|Overall Study||4
10714060|NCT02684357|11879617|FG005|STARTED|Part B|1 participant who received risankizumab in Part A did not receive a dose of study drug in Part B|291
10714061|NCT02684357|11879612|FG000|COMPLETED|Part B||0
10714062|NCT02684357|11879613|FG001|COMPLETED|Part B||0
10714063|NCT02684357|11879614|FG002|COMPLETED|Part B||0
10714064|NCT02684357|11879615|FG003|COMPLETED|Part B||91
10529075|NCT01398475|11681469|FG001|COMPLETED|Overall Study||3
10529076|NCT01398475|11681470|FG002|COMPLETED|Overall Study||4
10714065|NCT02684357|11879616|FG004|COMPLETED|Part B||90
10714066|NCT02684357|11879617|FG005|COMPLETED|Part B||278
10714067|NCT02684357|11879612|FG000|NOT COMPLETED|Part B||0
10654652|NCT02203786|11815465|FG000|STARTED|Overall Study||15
10654653|NCT02203786|11815466|FG001|STARTED|Overall Study||15
10654654|NCT02203786|11815467|FG002|STARTED|Overall Study||17
10339423|NCT00372619|11476354|FG005|NOT COMPLETED|Overall Study||3
10339424|NCT00372619|11476355|FG006|NOT COMPLETED|Overall Study||0
10339425|NCT00372697|11476373|FG000|STARTED|Overall Study||16
10339426|NCT00372697|11476374|FG001|STARTED|Overall Study||12
10339427|NCT00372697|11476373|FG000|COMPLETED|Overall Study||15
10339428|NCT00372697|11476374|FG001|COMPLETED|Overall Study||11
10339429|NCT00372697|11476373|FG000|NOT COMPLETED|Overall Study||1
10339430|NCT00372697|11476374|FG001|NOT COMPLETED|Overall Study||1
10339431|NCT00372775|11476380|FG000|STARTED|Overall Study||66
10339432|NCT00372775|11476380|FG000|Received Treatment|Overall Study||64
10339433|NCT00372775|11476380|FG000|COMPLETED|Overall Study||3
10339434|NCT00372775|11476380|FG000|NOT COMPLETED|Overall Study||63
10339435|NCT00372905|11476384|FG000|STARTED|Cohort 1: Dose Level 1.0mg/m2||3
10339436|NCT00372905|11476385|FG001|STARTED|Cohort 1: Dose Level 1.0mg/m2||0
10339437|NCT00372905|11476386|FG002|STARTED|Cohort 1: Dose Level 1.0mg/m2||0
10339438|NCT00372905|11476387|FG003|STARTED|Cohort 1: Dose Level 1.0mg/m2||0
10339439|NCT00372905|11476384|FG000|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||3
10339440|NCT00372905|11476385|FG001|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0
10339441|NCT00372905|11476386|FG002|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0
10339442|NCT00372905|11476387|FG003|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0
10339443|NCT00372905|11476384|FG000|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||3
10339444|NCT00372905|11476385|FG001|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0
10339445|NCT00372905|11476386|FG002|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0
10339446|NCT00372905|11476387|FG003|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0
10339447|NCT00372905|11476384|FG000|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||1
10339448|NCT00372905|11476385|FG001|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0
10339449|NCT00372905|11476386|FG002|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0
10529077|NCT01398475|11681471|FG003|COMPLETED|Overall Study||4
10529078|NCT01398475|11681468|FG000|NOT COMPLETED|Overall Study||0
10529079|NCT01398475|11681469|FG001|NOT COMPLETED|Overall Study||0
10529080|NCT01398475|11681470|FG002|NOT COMPLETED|Overall Study||0
10529081|NCT01398475|11681471|FG003|NOT COMPLETED|Overall Study||0
10529082|NCT01398514|11681483|FG000|STARTED|Overall Study||26
10529083|NCT01398514|11681484|FG001|STARTED|Overall Study||26
10529084|NCT01398514|11681483|FG000|COMPLETED|Overall Study||18
10529085|NCT01398514|11681484|FG001|COMPLETED|Overall Study||20
10529086|NCT01398514|11681483|FG000|NOT COMPLETED|Overall Study||8
10529087|NCT01398514|11681484|FG001|NOT COMPLETED|Overall Study||6
10529088|NCT01398566|11681492|FG000|STARTED|Overall Study|20 enrolled|20
10529089|NCT01398566|11681492|FG000|COMPLETED|Overall Study||20
10529090|NCT01398566|11681492|FG000|NOT COMPLETED|Overall Study||0
10529091|NCT01398787|11681496|FG000|STARTED|Overall Study||198
10529092|NCT01398787|11681496|FG000|COMPLETED|Overall Study||197
10529093|NCT01398787|11681496|FG000|NOT COMPLETED|Overall Study||1
10529094|NCT01398943|11681504|FG000|STARTED|First Intervention (1 Day)||15
10529095|NCT01398943|11681505|FG001|STARTED|First Intervention (1 Day)||15
10529096|NCT01398943|11681506|FG002|STARTED|First Intervention (1 Day)||15
10529097|NCT01398943|11681507|FG003|STARTED|First Intervention (1 Day)||15
10529098|NCT01398943|11681504|FG000|COMPLETED|First Intervention (1 Day)||15
10529099|NCT01398943|11681505|FG001|COMPLETED|First Intervention (1 Day)||15
10529100|NCT01398943|11681506|FG002|COMPLETED|First Intervention (1 Day)||15
10529101|NCT01398943|11681507|FG003|COMPLETED|First Intervention (1 Day)||15
10529102|NCT01398943|11681504|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10529103|NCT01398943|11681505|FG001|NOT COMPLETED|First Intervention (1 Day)||0
10529104|NCT01398943|11681506|FG002|NOT COMPLETED|First Intervention (1 Day)||0
10654655|NCT02203786|11815468|FG003|STARTED|Overall Study||15
10654656|NCT02203786|11815465|FG000|COMPLETED|Overall Study||15
10654657|NCT02203786|11815466|FG001|COMPLETED|Overall Study||15
10654658|NCT02203786|11815467|FG002|COMPLETED|Overall Study||15
10654659|NCT02203786|11815468|FG003|COMPLETED|Overall Study||15
10654660|NCT02203786|11815465|FG000|NOT COMPLETED|Overall Study||0
10529105|NCT01398943|11681507|FG003|NOT COMPLETED|First Intervention (1 Day)||0
10529106|NCT01398943|11681504|FG000|STARTED|Washout (2-7 Days)||15
10529107|NCT01398943|11681505|FG001|STARTED|Washout (2-7 Days)||15
10529108|NCT01398943|11681506|FG002|STARTED|Washout (2-7 Days)||15
10529109|NCT01398943|11681507|FG003|STARTED|Washout (2-7 Days)||15
10654661|NCT02203786|11815466|FG001|NOT COMPLETED|Overall Study||0
10529110|NCT01398943|11681504|FG000|COMPLETED|Washout (2-7 Days)||15
10529111|NCT01398943|11681505|FG001|COMPLETED|Washout (2-7 Days)||15
10529112|NCT01398943|11681506|FG002|COMPLETED|Washout (2-7 Days)||15
10529113|NCT01398943|11681507|FG003|COMPLETED|Washout (2-7 Days)||15
10529114|NCT01398943|11681504|FG000|NOT COMPLETED|Washout (2-7 Days)||0
10529115|NCT01398943|11681505|FG001|NOT COMPLETED|Washout (2-7 Days)||0
10529116|NCT01398943|11681506|FG002|NOT COMPLETED|Washout (2-7 Days)||0
10529117|NCT01398943|11681507|FG003|NOT COMPLETED|Washout (2-7 Days)||0
10529118|NCT01398943|11681504|FG000|STARTED|Second Intervention (1 Day)||15
10714068|NCT02684357|11879613|FG001|NOT COMPLETED|Part B||0
10714069|NCT02684357|11879614|FG002|NOT COMPLETED|Part B||0
10714070|NCT02684357|11879615|FG003|NOT COMPLETED|Part B||3
10714071|NCT02684357|11879616|FG004|NOT COMPLETED|Part B||4
10714072|NCT02684357|11879617|FG005|NOT COMPLETED|Part B||13
10714073|NCT02684370|11879633|FG000|STARTED|Part A||102
10714074|NCT02684370|11879634|FG001|STARTED|Part A||100
10529119|NCT01398943|11681505|FG001|STARTED|Second Intervention (1 Day)||15
10529120|NCT01398943|11681506|FG002|STARTED|Second Intervention (1 Day)||15
10529121|NCT01398943|11681507|FG003|STARTED|Second Intervention (1 Day)||15
10529122|NCT01398943|11681504|FG000|COMPLETED|Second Intervention (1 Day)||15
10529123|NCT01398943|11681505|FG001|COMPLETED|Second Intervention (1 Day)||15
10529124|NCT01398943|11681506|FG002|COMPLETED|Second Intervention (1 Day)||15
10529125|NCT01398943|11681507|FG003|COMPLETED|Second Intervention (1 Day)||15
10529126|NCT01398943|11681504|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10529127|NCT01398943|11681505|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10529128|NCT01398943|11681506|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
10529129|NCT01398943|11681507|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
10529130|NCT01398956|11681515|FG000|STARTED|Overall Study||44
10529131|NCT01398956|11681515|FG000|COMPLETED|Overall Study||34
10529132|NCT01398956|11681515|FG000|NOT COMPLETED|Overall Study||10
10529133|NCT01398982|11681522|FG000|STARTED|Overall Study||44
10529134|NCT01398982|11681523|FG001|STARTED|Overall Study||49
10529135|NCT01398982|11681522|FG000|COMPLETED|Overall Study||38
10529136|NCT01398982|11681523|FG001|COMPLETED|Overall Study||47
10529137|NCT01398982|11681522|FG000|NOT COMPLETED|Overall Study||6
10529138|NCT01398982|11681523|FG001|NOT COMPLETED|Overall Study||2
10529139|NCT01399008|11681532|FG000|STARTED|Overall Study||35
10529140|NCT01399008|11681533|FG001|STARTED|Overall Study||32
10529141|NCT01399008|11681534|FG002|STARTED|Overall Study||33
10529142|NCT01399008|11681532|FG000|COMPLETED|Overall Study||32
10529143|NCT01399008|11681533|FG001|COMPLETED|Overall Study||27
10529144|NCT01399008|11681534|FG002|COMPLETED|Overall Study||31
10529145|NCT01399008|11681532|FG000|NOT COMPLETED|Overall Study||3
10529146|NCT01399008|11681533|FG001|NOT COMPLETED|Overall Study||5
10529147|NCT01399008|11681534|FG002|NOT COMPLETED|Overall Study||2
10529148|NCT01399047|11681544|FG000|STARTED|Overall Study||10
10529149|NCT01399047|11681545|FG001|STARTED|Overall Study||9
10529150|NCT01399047|11681544|FG000|COMPLETED|Overall Study||10
10529151|NCT01399047|11681545|FG001|COMPLETED|Overall Study||8
10529152|NCT01399047|11681544|FG000|NOT COMPLETED|Overall Study||0
10529153|NCT01399047|11681545|FG001|NOT COMPLETED|Overall Study||1
10529154|NCT01399099|11681553|FG000|STARTED|Overall Study||67
10529155|NCT01399099|11681553|FG000|6 Months|Overall Study||47
10529156|NCT01399099|11681553|FG000|COMPLETED|Overall Study||36
10529157|NCT01399099|11681553|FG000|NOT COMPLETED|Overall Study||31
10714075|NCT02684370|11879635|FG002|STARTED|Part A||304
10714076|NCT02684370|11879636|FG003|STARTED|Part A||0
10529158|NCT01399125|11681560|FG000|STARTED|Overall Study||248
10529159|NCT01399125|11681561|FG001|STARTED|Overall Study||253
10529160|NCT01399125|11681560|FG000|Per Protocol (PP) Population|Overall Study||192
10529161|NCT01399125|11681561|FG001|Per Protocol (PP) Population|Overall Study||188
10529162|NCT01399125|11681560|FG000|COMPLETED|Overall Study||197
10529163|NCT01399125|11681561|FG001|COMPLETED|Overall Study||193
10529164|NCT01399125|11681560|FG000|NOT COMPLETED|Overall Study||51
10529165|NCT01399125|11681561|FG001|NOT COMPLETED|Overall Study||60
10529166|NCT01399190|11681567|FG000|STARTED|Overall Study||68
10529167|NCT01399190|11681567|FG000|Included in Final Analysis|Overall Study||63
10529168|NCT01399190|11681567|FG000|Evaluable for Primary Endpoint Analysis|Overall Study||60
10529169|NCT01399190|11681567|FG000|COMPLETED|Overall Study||48
10529170|NCT01399190|11681567|FG000|NOT COMPLETED|Overall Study||20
10714077|NCT02684370|11879637|FG004|STARTED|Part A||0
10811356|NCT03764449|11973096|FG001|NOT COMPLETED|Overall Study||0
10811357|NCT03763929|11973111|FG000|STARTED|Overall Study||2
10811358|NCT03763929|11973112|FG001|STARTED|Overall Study||4
10811359|NCT03763929|11973111|FG000|COMPLETED|Overall Study||2
10811360|NCT03763929|11973112|FG001|COMPLETED|Overall Study||4
10811361|NCT03763929|11973111|FG000|NOT COMPLETED|Overall Study||0
10811362|NCT03763929|11973112|FG001|NOT COMPLETED|Overall Study||0
10811363|NCT03763747|11973118|FG000|STARTED|Overall Study||200
10811364|NCT03763747|11973118|FG000|COMPLETED|Overall Study||200
10811365|NCT03763747|11973118|FG000|NOT COMPLETED|Overall Study||0
10811366|NCT03763058|11973122|FG000|STARTED|Overall Study||20
10811367|NCT03763058|11973122|FG000|COMPLETED|Overall Study||18
10301851|NCT00065065|11434691|FG001|COMPLETED|Overall Study||33
10301852|NCT00065065|11434690|FG000|NOT COMPLETED|Overall Study||10
10301853|NCT00065065|11434691|FG001|NOT COMPLETED|Overall Study||20
10301854|NCT00065156|11434699|FG000|STARTED|Overall Study||148
10301855|NCT00065156|11434699|FG000|Modified Intent to Treat Population|Overall Study||94
10301856|NCT00065156|11434699|FG000|COMPLETED|Overall Study|24 patients rolled over to free drug due to sponsor closure of study.|24
10301857|NCT00065156|11434699|FG000|NOT COMPLETED|Overall Study||124
10301858|NCT00065182|11434705|FG000|STARTED|Overall Study||202
10301859|NCT00065182|11434706|FG001|STARTED|Overall Study||197
10301860|NCT00065182|11434705|FG000|COMPLETED|Overall Study||154
10301861|NCT00065182|11434706|FG001|COMPLETED|Overall Study||160
10301862|NCT00065182|11434705|FG000|NOT COMPLETED|Overall Study||48
10301863|NCT00065182|11434706|FG001|NOT COMPLETED|Overall Study||37
10301864|NCT00065260|11434714|FG000|STARTED|Overall Study||27
10301865|NCT00065260|11434715|FG001|STARTED|Overall Study||27
10301866|NCT00065260|11434714|FG000|COMPLETED|Overall Study||27
10301867|NCT00065260|11434715|FG001|COMPLETED|Overall Study||26
10301868|NCT00065260|11434714|FG000|NOT COMPLETED|Overall Study||0
10301869|NCT00065260|11434715|FG001|NOT COMPLETED|Overall Study||1
10301870|NCT00065429|11434728|FG000|STARTED|Phase I - May 2001 - Oct 2002||4
10301871|NCT00065429|11434729|FG001|STARTED|Phase I - May 2001 - Oct 2002||3
10301872|NCT00065429|11434730|FG002|STARTED|Phase I - May 2001 - Oct 2002||4
10301873|NCT00065429|11434731|FG003|STARTED|Phase I - May 2001 - Oct 2002||4
10301874|NCT00065429|11434732|FG004|STARTED|Phase I - May 2001 - Oct 2002||9
10301875|NCT00065429|11434733|FG005|STARTED|Phase I - May 2001 - Oct 2002||4
10301876|NCT00065429|11434734|FG006|STARTED|Phase I - May 2001 - Oct 2002||4
10301877|NCT00065429|11434728|FG000|COMPLETED|Phase I - May 2001 - Oct 2002||3
10301878|NCT00065429|11434729|FG001|COMPLETED|Phase I - May 2001 - Oct 2002||3
10301879|NCT00065429|11434730|FG002|COMPLETED|Phase I - May 2001 - Oct 2002||3
10301880|NCT00065429|11434731|FG003|COMPLETED|Phase I - May 2001 - Oct 2002||3
10301881|NCT00065429|11434732|FG004|COMPLETED|Phase I - May 2001 - Oct 2002||8
10301882|NCT00065429|11434733|FG005|COMPLETED|Phase I - May 2001 - Oct 2002||2
10301883|NCT00065429|11434734|FG006|COMPLETED|Phase I - May 2001 - Oct 2002||2
10301884|NCT00065429|11434728|FG000|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
10301885|NCT00065429|11434729|FG001|NOT COMPLETED|Phase I - May 2001 - Oct 2002||0
10301886|NCT00065429|11434730|FG002|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
10301887|NCT00065429|11434731|FG003|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
10301888|NCT00065429|11434732|FG004|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
10301889|NCT00065429|11434733|FG005|NOT COMPLETED|Phase I - May 2001 - Oct 2002||2
10301890|NCT00065429|11434734|FG006|NOT COMPLETED|Phase I - May 2001 - Oct 2002||2
10301891|NCT00065429|11434728|FG000|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
10301892|NCT00065429|11434729|FG001|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
10301893|NCT00065429|11434730|FG002|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
10301894|NCT00065429|11434731|FG003|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
10301895|NCT00065429|11434732|FG004|STARTED|Phase II - Apr 2003 - Aug 2008|All 32 patients enrolled in Phase 2 were at 60 mg/m2.|32
10714078|NCT02684370|11879638|FG005|STARTED|Part A||0
10714079|NCT02684370|11879633|FG000|COMPLETED|Part A||98
10714080|NCT02684370|11879634|FG001|COMPLETED|Part A||99
10714081|NCT02684370|11879635|FG002|COMPLETED|Part A||299
10714082|NCT02684370|11879636|FG003|COMPLETED|Part A||0
10301896|NCT00065429|11434733|FG005|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
10301897|NCT00065429|11434734|FG006|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
10301898|NCT00065429|11434728|FG000|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
10301899|NCT00065429|11434729|FG001|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
10301900|NCT00065429|11434730|FG002|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
10301901|NCT00065429|11434731|FG003|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
10301902|NCT00065429|11434732|FG004|COMPLETED|Phase II - Apr 2003 - Aug 2008||26
10301903|NCT00065429|11434733|FG005|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
10714083|NCT02684370|11879637|FG004|COMPLETED|Part A||0
10714084|NCT02684370|11879638|FG005|COMPLETED|Part A||0
10714085|NCT02684370|11879633|FG000|NOT COMPLETED|Part A||4
10714086|NCT02684370|11879634|FG001|NOT COMPLETED|Part A||1
10714087|NCT02684370|11879635|FG002|NOT COMPLETED|Part A||5
10714088|NCT02684370|11879636|FG003|NOT COMPLETED|Part A||0
10714089|NCT02684370|11879637|FG004|NOT COMPLETED|Part A||0
10714090|NCT02684370|11879638|FG005|NOT COMPLETED|Part A||0
10714091|NCT02684370|11879633|FG000|STARTED|Part B||0
10714092|NCT02684370|11879634|FG001|STARTED|Part B||0
10714093|NCT02684370|11879635|FG002|STARTED|Part B||0
10714094|NCT02684370|11879636|FG003|STARTED|Part B|1 participant who received placebo in Part A did not receive a dose of study drug in Part B|97
10714095|NCT02684370|11879637|FG004|STARTED|Part B|Participants who received ustekinumab in Part A received ustekinumab in Part B|99
10529171|NCT01399229|11681571|FG000|STARTED|Overall Study||20
10529172|NCT01399229|11681572|FG001|STARTED|Overall Study||5
10529173|NCT01399229|11681573|FG002|STARTED|Overall Study||5
10529174|NCT01399229|11681571|FG000|COMPLETED|Overall Study||20
10654662|NCT02203786|11815467|FG002|NOT COMPLETED|Overall Study||2
10654663|NCT02203786|11815468|FG003|NOT COMPLETED|Overall Study||0
10654664|NCT02203838|11815484|FG000|STARTED|Overall Study||408
10654665|NCT02203838|11815485|FG001|STARTED|Overall Study||28
10654666|NCT02203838|11815486|FG002|STARTED|Overall Study||31
10654667|NCT02203838|11815487|FG003|STARTED|Overall Study||33
10654668|NCT02203838|11815484|FG000|COMPLETED|Overall Study||198
10654669|NCT02203838|11815485|FG001|COMPLETED|Overall Study||6
10654670|NCT02203838|11815486|FG002|COMPLETED|Overall Study||15
10654671|NCT02203838|11815487|FG003|COMPLETED|Overall Study||15
10654672|NCT02203838|11815484|FG000|NOT COMPLETED|Overall Study||210
10654673|NCT02203838|11815485|FG001|NOT COMPLETED|Overall Study||22
10654674|NCT02203838|11815486|FG002|NOT COMPLETED|Overall Study||16
10654675|NCT02203838|11815487|FG003|NOT COMPLETED|Overall Study||18
10654676|NCT02203851|11815497|FG000|STARTED|Overall Study||110
10654677|NCT02203851|11815497|FG000|COMPLETED|Overall Study||99
10529175|NCT01399229|11681572|FG001|COMPLETED|Overall Study||5
10529176|NCT01399229|11681573|FG002|COMPLETED|Overall Study||5
10529177|NCT01399229|11681571|FG000|NOT COMPLETED|Overall Study||0
10529178|NCT01399229|11681572|FG001|NOT COMPLETED|Overall Study||0
10529179|NCT01399229|11681573|FG002|NOT COMPLETED|Overall Study||0
10529180|NCT01399268|11681579|FG000|STARTED|Overall Study||15
10529181|NCT01399268|11681580|FG001|STARTED|Overall Study||15
10529182|NCT01399268|11681579|FG000|COMPLETED|Overall Study||15
10529183|NCT01399268|11681580|FG001|COMPLETED|Overall Study||15
10529184|NCT01399268|11681579|FG000|NOT COMPLETED|Overall Study||0
10654678|NCT02203851|11815497|FG000|NOT COMPLETED|Overall Study||11
10654679|NCT02203916|11815511|FG000|STARTED|Overall Study||65
10654680|NCT02203916|11815512|FG001|STARTED|Overall Study||132
10654681|NCT02203916|11815513|FG002|STARTED|Overall Study|1 participant was randomized twice and counted only once.|131
10529185|NCT01399268|11681580|FG001|NOT COMPLETED|Overall Study||0
10529186|NCT01399593|11681588|FG000|STARTED|Overall Study||51
10301904|NCT00065429|11434734|FG006|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
10301905|NCT00065429|11434728|FG000|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
10301906|NCT00065429|11434729|FG001|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
10301907|NCT00065429|11434730|FG002|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
10301908|NCT00065429|11434731|FG003|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
10301909|NCT00065429|11434732|FG004|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||6
10301910|NCT00065429|11434733|FG005|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
10301911|NCT00065429|11434734|FG006|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
10315080|NCT00174187|11448871|FG000|STARTED|Between Period 1 and Period 2||0
10315081|NCT00174187|11448872|FG001|STARTED|Between Period 1 and Period 2||0
10315082|NCT00174187|11448873|FG002|STARTED|Between Period 1 and Period 2||26
10315083|NCT00174187|11448871|FG000|Consented|Between Period 1 and Period 2||0
10315084|NCT00174187|11448872|FG001|Consented|Between Period 1 and Period 2||0
10315085|NCT00174187|11448873|FG002|Consented|Between Period 1 and Period 2||24
10315086|NCT00174187|11448871|FG000|COMPLETED|Between Period 1 and Period 2||0
10315087|NCT00174187|11448872|FG001|COMPLETED|Between Period 1 and Period 2||0
10315088|NCT00174187|11448873|FG002|COMPLETED|Between Period 1 and Period 2||21
10315089|NCT00174187|11448871|FG000|NOT COMPLETED|Between Period 1 and Period 2||0
10315090|NCT00174187|11448872|FG001|NOT COMPLETED|Between Period 1 and Period 2||0
10315091|NCT00174187|11448873|FG002|NOT COMPLETED|Between Period 1 and Period 2||5
10315092|NCT00174187|11448871|FG000|STARTED|Period 2 (After 3 Years)||0
10315093|NCT00174187|11448872|FG001|STARTED|Period 2 (After 3 Years)||0
10315094|NCT00174187|11448873|FG002|STARTED|Period 2 (After 3 Years)||21
10315095|NCT00174187|11448871|FG000|COMPLETED|Period 2 (After 3 Years)||0
10315096|NCT00174187|11448872|FG001|COMPLETED|Period 2 (After 3 Years)||0
10315097|NCT00174187|11448873|FG002|COMPLETED|Period 2 (After 3 Years)||13
10315098|NCT00174187|11448871|FG000|NOT COMPLETED|Period 2 (After 3 Years)||0
10315099|NCT00174187|11448872|FG001|NOT COMPLETED|Period 2 (After 3 Years)||0
10315100|NCT00174187|11448873|FG002|NOT COMPLETED|Period 2 (After 3 Years)||8
10315101|NCT00174252|11448881|FG000|STARTED|Overall Study||57
10714096|NCT02684370|11879638|FG005|STARTED|Part B|2 participants who received risankizumab in Part A did not receive a dose of study drug in Part B|297
10339450|NCT00372905|11476387|FG003|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0
10339451|NCT00372905|11476384|FG000|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||1
10339452|NCT00372905|11476385|FG001|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
10339453|NCT00372905|11476386|FG002|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
10339454|NCT00372905|11476387|FG003|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
10529187|NCT01399593|11681589|FG001|STARTED|Overall Study||51
10529188|NCT01399593|11681588|FG000|COMPLETED|Overall Study||48
10529189|NCT01399593|11681589|FG001|COMPLETED|Overall Study||49
10529190|NCT01399593|11681588|FG000|NOT COMPLETED|Overall Study||3
10529191|NCT01399593|11681589|FG001|NOT COMPLETED|Overall Study||2
10529192|NCT01399619|11681597|FG000|STARTED|Overall Study||123
10529193|NCT01399619|11681598|FG001|STARTED|Overall Study||84
10529194|NCT01399619|11681599|FG002|STARTED|Overall Study||86
10529195|NCT01399619|11681600|FG003|STARTED|Overall Study||17
10529196|NCT01399619|11681597|FG000|COMPLETED|Overall Study||98
10529197|NCT01399619|11681598|FG001|COMPLETED|Overall Study||84
10529198|NCT01399619|11681599|FG002|COMPLETED|Overall Study||74
10529199|NCT01399619|11681600|FG003|COMPLETED|Overall Study||0
10529200|NCT01399619|11681597|FG000|NOT COMPLETED|Overall Study||25
10529201|NCT01399619|11681598|FG001|NOT COMPLETED|Overall Study||0
10529202|NCT01399619|11681599|FG002|NOT COMPLETED|Overall Study||12
10529203|NCT01399619|11681600|FG003|NOT COMPLETED|Overall Study||17
10529204|NCT01399697|11681618|FG000|STARTED|Overall Study||96
10529205|NCT01399697|11681619|FG001|STARTED|Overall Study||83
10529206|NCT01399697|11681620|FG002|STARTED|Overall Study||82
10529207|NCT01399697|11681618|FG000|COMPLETED|Overall Study||55
10529208|NCT01399697|11681619|FG001|COMPLETED|Overall Study||80
10529209|NCT01399697|11681620|FG002|COMPLETED|Overall Study||78
10529210|NCT01399697|11681618|FG000|NOT COMPLETED|Overall Study||41
10529211|NCT01399697|11681619|FG001|NOT COMPLETED|Overall Study||3
10529212|NCT01399697|11681620|FG002|NOT COMPLETED|Overall Study||4
10529213|NCT01399723|11681633|FG000|STARTED|Overall Study||263
10529214|NCT01399723|11681634|FG001|STARTED|Overall Study||264
10529215|NCT01399723|11681633|FG000|COMPLETED|Overall Study||263
10529216|NCT01399723|11681634|FG001|COMPLETED|Overall Study||263
10529217|NCT01399723|11681633|FG000|NOT COMPLETED|Overall Study||0
10529218|NCT01399723|11681634|FG001|NOT COMPLETED|Overall Study||1
10529219|NCT01399736|11681643|FG000|STARTED|Overall Study||295
10529220|NCT01399736|11681644|FG001|STARTED|Overall Study||590
10529221|NCT01399736|11681643|FG000|COMPLETED|Overall Study||291
10529222|NCT01399736|11681644|FG001|COMPLETED|Overall Study||586
10529223|NCT01399736|11681643|FG000|NOT COMPLETED|Overall Study||4
10529224|NCT01399736|11681644|FG001|NOT COMPLETED|Overall Study||4
10529225|NCT01399788|11681658|FG000|STARTED|First Intervention Period||18
10529226|NCT01399788|11681659|FG001|STARTED|First Intervention Period||18
10529227|NCT01399788|11681658|FG000|COMPLETED|First Intervention Period||17
10529228|NCT01399788|11681659|FG001|COMPLETED|First Intervention Period||18
10529229|NCT01399788|11681658|FG000|NOT COMPLETED|First Intervention Period||1
10529230|NCT01399788|11681659|FG001|NOT COMPLETED|First Intervention Period||0
10529231|NCT01399788|11681658|FG000|STARTED|Washout Period (at Least 1 Week)||17
10529232|NCT01399788|11681659|FG001|STARTED|Washout Period (at Least 1 Week)||18
10654682|NCT02203916|11815511|FG000|Full Analysis Set (FAS)|Overall Study||65
10654683|NCT02203916|11815512|FG001|Full Analysis Set (FAS)|Overall Study||132
10301912|NCT00065442|11434747|FG000|STARTED|Overall Study||171
10301913|NCT00065442|11434748|FG001|STARTED|Overall Study||341
10301914|NCT00065442|11434747|FG000|COMPLETED|Overall Study||46
10301915|NCT00065442|11434748|FG001|COMPLETED|Overall Study||121
10301916|NCT00065442|11434747|FG000|NOT COMPLETED|Overall Study||125
10301917|NCT00065442|11434748|FG001|NOT COMPLETED|Overall Study||220
10301918|NCT00065468|11434757|FG000|STARTED|Overall Study||207
10301919|NCT00065468|11434758|FG001|STARTED|Overall Study||209
10301920|NCT00065468|11434759|FG002|STARTED|Overall Study||210
10301921|NCT00065468|11434757|FG000|Received Treatment|Overall Study||200
10301922|NCT00065468|11434758|FG001|Received Treatment|Overall Study||208
10301923|NCT00065468|11434759|FG002|Received Treatment|Overall Study||208
10301924|NCT00065468|11434757|FG000|COMPLETED|Overall Study||0
10301925|NCT00065468|11434758|FG001|COMPLETED|Overall Study||0
10301926|NCT00065468|11434759|FG002|COMPLETED|Overall Study||0
10301927|NCT00065468|11434757|FG000|NOT COMPLETED|Overall Study||207
10301928|NCT00065468|11434758|FG001|NOT COMPLETED|Overall Study||209
10301929|NCT00065468|11434759|FG002|NOT COMPLETED|Overall Study||210
10301930|NCT00065507|11434769|FG000|STARTED|Overall Study|101 participants were randomized; 1 never treated.|100
10301931|NCT00065507|11434770|FG001|STARTED|Overall Study|94 participants were randomized; 3 never treated.|91
10714105|NCT02684370|11879635|FG002|NOT COMPLETED|Part B||0
10529269|NCT01400139|11681706|FG000|NOT COMPLETED|HYD Core Study||512
10301932|NCT00065507|11434769|FG000|Treated (As-Randomized Population)|Overall Study|As-randomized population was used in efficacy analyses, unless otherwise noted.|100
10301933|NCT00065507|11434770|FG001|Treated (As-Randomized Population)|Overall Study|As-randomized population was used in efficacy analyses, unless otherwise noted.|91
10301934|NCT00065507|11434769|FG000|Treated (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|102
10301935|NCT00065507|11434770|FG001|Treated (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|89
10301936|NCT00065507|11434769|FG000|Treated, Wk 48 (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|102
10301937|NCT00065507|11434770|FG001|Treated, Wk 48 (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|89
10301938|NCT00065507|11434769|FG000|Treated, 24-Week Follow-Up Population|Overall Study||25
10301939|NCT00065507|11434770|FG001|Treated, 24-Week Follow-Up Population|Overall Study||28
10301940|NCT00065507|11434769|FG000|COMPLETED|Overall Study|Completed first 48 weeks of treatment|71
10301941|NCT00065507|11434770|FG001|COMPLETED|Overall Study|Completed first 48 weeks of treatment|62
10301942|NCT00065507|11434769|FG000|NOT COMPLETED|Overall Study||29
10301943|NCT00065507|11434770|FG001|NOT COMPLETED|Overall Study||29
10301944|NCT00065611|11434782|FG000|STARTED|Overall Study||4
10301945|NCT00065611|11434783|FG001|STARTED|Overall Study||4
10301946|NCT00065611|11434782|FG000|COMPLETED|Overall Study||4
10301947|NCT00065611|11434783|FG001|COMPLETED|Overall Study||3
10301948|NCT00065611|11434782|FG000|NOT COMPLETED|Overall Study||0
10301949|NCT00065611|11434783|FG001|NOT COMPLETED|Overall Study||1
10301950|NCT00065806|11434791|FG000|STARTED|Overall Study||113
10301951|NCT00065806|11434792|FG001|STARTED|Overall Study||108
10301952|NCT00065806|11434791|FG000|COMPLETED|Overall Study||93
10301953|NCT00065806|11434792|FG001|COMPLETED|Overall Study||89
10301954|NCT00065806|11434791|FG000|NOT COMPLETED|Overall Study||20
10301955|NCT00065806|11434792|FG001|NOT COMPLETED|Overall Study||19
10301956|NCT00066066|11434801|FG000|STARTED|Overall Study||27
10301957|NCT00066066|11434802|FG001|STARTED|Overall Study||22
10301958|NCT00066066|11434803|FG002|STARTED|Overall Study||30
10301959|NCT00066066|11434804|FG003|STARTED|Overall Study||20
10529233|NCT01399788|11681658|FG000|COMPLETED|Washout Period (at Least 1 Week)||17
10529234|NCT01399788|11681659|FG001|COMPLETED|Washout Period (at Least 1 Week)||18
10529235|NCT01399788|11681658|FG000|NOT COMPLETED|Washout Period (at Least 1 Week)||0
10529236|NCT01399788|11681659|FG001|NOT COMPLETED|Washout Period (at Least 1 Week)||0
10529237|NCT01399788|11681658|FG000|STARTED|Second Intervention Period||17
10529238|NCT01399788|11681659|FG001|STARTED|Second Intervention Period||18
10301960|NCT00066066|11434805|FG004|STARTED|Overall Study||27
10301961|NCT00066066|11434806|FG005|STARTED|Overall Study||20
10301962|NCT00066066|11434801|FG000|Baseline|Overall Study||27
10301963|NCT00066066|11434802|FG001|Baseline|Overall Study||22
10301964|NCT00066066|11434803|FG002|Baseline|Overall Study||30
10301965|NCT00066066|11434804|FG003|Baseline|Overall Study||20
10301966|NCT00066066|11434805|FG004|Baseline|Overall Study||27
10529239|NCT01399788|11681658|FG000|COMPLETED|Second Intervention Period||17
10654684|NCT02203916|11815513|FG002|Full Analysis Set (FAS)|Overall Study|1 participant was randomized twice, counted once in randomized set, and excluded from the FAS.|130
10529240|NCT01399788|11681659|FG001|COMPLETED|Second Intervention Period||18
10529241|NCT01399788|11681658|FG000|NOT COMPLETED|Second Intervention Period||0
10529242|NCT01399788|11681659|FG001|NOT COMPLETED|Second Intervention Period||0
10529243|NCT01399827|11681667|FG000|STARTED|Overall Study||1
10529244|NCT01399827|11681668|FG001|STARTED|Overall Study||1
10529245|NCT01399827|11681667|FG000|COMPLETED|Overall Study||1
10529246|NCT01399827|11681668|FG001|COMPLETED|Overall Study||1
10529247|NCT01399827|11681667|FG000|NOT COMPLETED|Overall Study||0
10529248|NCT01399827|11681668|FG001|NOT COMPLETED|Overall Study||0
10529249|NCT01399866|11681676|FG000|STARTED|Overall Study||32
10529250|NCT01399866|11681677|FG001|STARTED|Overall Study||30
10529251|NCT01399866|11681676|FG000|COMPLETED|Overall Study||28
10529252|NCT01399866|11681677|FG001|COMPLETED|Overall Study||28
10529253|NCT01399866|11681676|FG000|NOT COMPLETED|Overall Study||4
10529254|NCT01399866|11681677|FG001|NOT COMPLETED|Overall Study||2
10529255|NCT01399905|11681685|FG000|STARTED|Overall Study||7
10529256|NCT01399905|11681686|FG001|STARTED|Overall Study||7
10529257|NCT01399905|11681685|FG000|COMPLETED|Overall Study|Subject withdrew from the study before receiving treatment.|6
10529258|NCT01399905|11681686|FG001|COMPLETED|Overall Study|Subject was treated at least one dose of carbidopa before withdrawing from the study.|6
10529259|NCT01399905|11681685|FG000|NOT COMPLETED|Overall Study||1
10529260|NCT01399905|11681686|FG001|NOT COMPLETED|Overall Study||1
10529261|NCT01400113|11681699|FG000|STARTED|Overall Study||60
10714097|NCT02684370|11879633|FG000|COMPLETED|Part B||0
10714098|NCT02684370|11879634|FG001|COMPLETED|Part B||0
10714099|NCT02684370|11879635|FG002|COMPLETED|Part B||0
10714100|NCT02684370|11879636|FG003|COMPLETED|Part B||95
10714101|NCT02684370|11879637|FG004|COMPLETED|Part B||94
10529262|NCT01400113|11681700|FG001|STARTED|Overall Study||60
10529263|NCT01400113|11681699|FG000|COMPLETED|Overall Study||59
10529264|NCT01400113|11681700|FG001|COMPLETED|Overall Study||59
10529265|NCT01400113|11681699|FG000|NOT COMPLETED|Overall Study||1
10529266|NCT01400113|11681700|FG001|NOT COMPLETED|Overall Study||1
10529267|NCT01400139|11681706|FG000|STARTED|HYD Core Study||922
10529268|NCT01400139|11681706|FG000|COMPLETED|HYD Core Study||410
10714102|NCT02684370|11879638|FG005|COMPLETED|Part B||289
10714103|NCT02684370|11879633|FG000|NOT COMPLETED|Part B||0
10714104|NCT02684370|11879634|FG001|NOT COMPLETED|Part B||0
10529270|NCT01400139|11681706|FG000|STARTED|HYD Extension Period|Subjects completing the Core Study were offered an option to enter the 24-week open-label Extension|106
10529271|NCT01400139|11681706|FG000|COMPLETED|HYD Extension Period||83
10714106|NCT02684370|11879636|FG003|NOT COMPLETED|Part B||2
10301967|NCT00066066|11434806|FG005|Baseline|Overall Study||20
10301968|NCT00066066|11434801|FG000|3 Month|Overall Study||21
10301969|NCT00066066|11434802|FG001|3 Month|Overall Study||17
10301970|NCT00066066|11434803|FG002|3 Month|Overall Study||23
10301971|NCT00066066|11434804|FG003|3 Month|Overall Study||16
10301972|NCT00066066|11434805|FG004|3 Month|Overall Study||22
10301973|NCT00066066|11434806|FG005|3 Month|Overall Study||15
10301974|NCT00066066|11434801|FG000|6 Month|Overall Study||19
10301975|NCT00066066|11434802|FG001|6 Month|Overall Study||13
10301976|NCT00066066|11434803|FG002|6 Month|Overall Study||23
10301977|NCT00066066|11434804|FG003|6 Month|Overall Study||13
10301978|NCT00066066|11434805|FG004|6 Month|Overall Study||21
10301979|NCT00066066|11434806|FG005|6 Month|Overall Study||14
10301980|NCT00066066|11434801|FG000|12 Month|Overall Study||18
10301981|NCT00066066|11434802|FG001|12 Month|Overall Study||11
10301982|NCT00066066|11434803|FG002|12 Month|Overall Study||21
10301983|NCT00066066|11434804|FG003|12 Month|Overall Study||11
10301984|NCT00066066|11434805|FG004|12 Month|Overall Study||19
10301985|NCT00066066|11434806|FG005|12 Month|Overall Study||9
10301986|NCT00066066|11434801|FG000|COMPLETED|Overall Study|27 enrolled, 21 analyzed,18 subjects had complete data,3 subjects had data carried forward.|21
10301987|NCT00066066|11434802|FG001|COMPLETED|Overall Study|22 enrolled, 18 analyzed,11 subjects had complete data,7 subjects had data carried forward.|18
10301988|NCT00066066|11434803|FG002|COMPLETED|Overall Study|30 enrolled, 23 analyzed,21 subjects had complete data,2 subjects had data carried forward.|23
10301989|NCT00066066|11434804|FG003|COMPLETED|Overall Study|20 enrolled, 16 analyzed,11 subjects had complete data,5 subjects had data carried forward.|16
10301990|NCT00066066|11434805|FG004|COMPLETED|Overall Study|27 enrolled, 24 analyzed,19 subjects had complete data,5 subjects had data carried forward.|24
10301991|NCT00066066|11434806|FG005|COMPLETED|Overall Study|20 enrolled, 15 analyzed,9 subjects had complete data,6 subjects had data carried forward.|15
10301992|NCT00066066|11434801|FG000|NOT COMPLETED|Overall Study||6
10301993|NCT00066066|11434802|FG001|NOT COMPLETED|Overall Study||4
10301994|NCT00066066|11434803|FG002|NOT COMPLETED|Overall Study||7
10529272|NCT01400139|11681706|FG000|NOT COMPLETED|HYD Extension Period||23
10714107|NCT02684370|11879637|FG004|NOT COMPLETED|Part B||5
10714108|NCT02684370|11879638|FG005|NOT COMPLETED|Part B||8
10714109|NCT02684396|11879658|FG000|STARTED|Overall Study||6
10714110|NCT02684396|11879659|FG001|STARTED|Overall Study||6
10714111|NCT02684396|11879660|FG002|STARTED|Overall Study||6
10714112|NCT02684396|11879661|FG003|STARTED|Overall Study||6
10529273|NCT01400243|11681714|FG000|STARTED|Overall Study||64
10529274|NCT01400243|11681715|FG001|STARTED|Overall Study||63
10529275|NCT01400243|11681714|FG000|COMPLETED|Overall Study||56
10714113|NCT02684396|11879662|FG004|STARTED|Overall Study||5
10714114|NCT02684396|11879663|FG005|STARTED|Overall Study||10
10714115|NCT02684396|11879658|FG000|COMPLETED|Overall Study||6
10714116|NCT02684396|11879659|FG001|COMPLETED|Overall Study||6
10714117|NCT02684396|11879660|FG002|COMPLETED|Overall Study||6
10714118|NCT02684396|11879661|FG003|COMPLETED|Overall Study||6
10714119|NCT02684396|11879662|FG004|COMPLETED|Overall Study||5
10714120|NCT02684396|11879663|FG005|COMPLETED|Overall Study||10
10654685|NCT02203916|11815511|FG000|Safety Analysis Set (SAS)|Overall Study||65
10654686|NCT02203916|11815512|FG001|Safety Analysis Set (SAS)|Overall Study||132
10654687|NCT02203916|11815513|FG002|Safety Analysis Set (SAS)|Overall Study|1 participant was randomized twice, counted once in randomized set, and excluded from the SAS.|130
10654688|NCT02203916|11815511|FG000|COMPLETED|Overall Study||57
10811368|NCT03763058|11973122|FG000|NOT COMPLETED|Overall Study||2
10811369|NCT03762993|11973128|FG000|STARTED|Overall Study||21
10811370|NCT03762993|11973129|FG001|STARTED|Overall Study||10
10811371|NCT03762993|11973128|FG000|COMPLETED|Overall Study||21
10811372|NCT03762993|11973129|FG001|COMPLETED|Overall Study||10
10811373|NCT03762993|11973128|FG000|NOT COMPLETED|Overall Study||0
10811374|NCT03762993|11973129|FG001|NOT COMPLETED|Overall Study||0
10811375|NCT03762681|11973143|FG000|STARTED|Part 1||8
10811376|NCT03762681|11973144|FG001|STARTED|Part 1||8
10811377|NCT03762681|11973145|FG002|STARTED|Part 1||8
10811378|NCT03762681|11973146|FG003|STARTED|Part 1||8
10811379|NCT03762681|11973147|FG004|STARTED|Part 1||8
10811380|NCT03762681|11973148|FG005|STARTED|Part 1||0
10811381|NCT03762681|11973149|FG006|STARTED|Part 1||0
10811382|NCT03762681|11973150|FG007|STARTED|Part 1||0
10811383|NCT03762681|11973143|FG000|COMPLETED|Part 1||8
10811384|NCT03762681|11973144|FG001|COMPLETED|Part 1||8
10811385|NCT03762681|11973145|FG002|COMPLETED|Part 1||8
10811386|NCT03762681|11973146|FG003|COMPLETED|Part 1||7
10811387|NCT03762681|11973147|FG004|COMPLETED|Part 1||8
10811388|NCT03762681|11973148|FG005|COMPLETED|Part 1||0
10811389|NCT03762681|11973149|FG006|COMPLETED|Part 1||0
10811390|NCT03762681|11973150|FG007|COMPLETED|Part 1||0
10811391|NCT03762681|11973143|FG000|NOT COMPLETED|Part 1||0
10811392|NCT03762681|11973144|FG001|NOT COMPLETED|Part 1||0
10811393|NCT03762681|11973145|FG002|NOT COMPLETED|Part 1||0
10811394|NCT03762681|11973146|FG003|NOT COMPLETED|Part 1||1
10811395|NCT03762681|11973147|FG004|NOT COMPLETED|Part 1||0
10811396|NCT03762681|11973148|FG005|NOT COMPLETED|Part 1||0
10811397|NCT03762681|11973149|FG006|NOT COMPLETED|Part 1||0
10811398|NCT03762681|11973150|FG007|NOT COMPLETED|Part 1||0
10811399|NCT03762681|11973143|FG000|STARTED|Part 2a||0
10811400|NCT03762681|11973144|FG001|STARTED|Part 2a||0
10811401|NCT03762681|11973145|FG002|STARTED|Part 2a||0
10811402|NCT03762681|11973146|FG003|STARTED|Part 2a||0
10811403|NCT03762681|11973147|FG004|STARTED|Part 2a||0
10811404|NCT03762681|11973148|FG005|STARTED|Part 2a||2
10811405|NCT03762681|11973149|FG006|STARTED|Part 2a||8
10811406|NCT03762681|11973150|FG007|STARTED|Part 2a||5
10811407|NCT03762681|11973143|FG000|COMPLETED|Part 2a||0
10811408|NCT03762681|11973144|FG001|COMPLETED|Part 2a||0
10811409|NCT03762681|11973145|FG002|COMPLETED|Part 2a||0
10811410|NCT03762681|11973146|FG003|COMPLETED|Part 2a||0
10811411|NCT03762681|11973147|FG004|COMPLETED|Part 2a||0
10811412|NCT03762681|11973148|FG005|COMPLETED|Part 2a||2
10811413|NCT03762681|11973149|FG006|COMPLETED|Part 2a||8
10811414|NCT03762681|11973150|FG007|COMPLETED|Part 2a||4
10811415|NCT03762681|11973143|FG000|NOT COMPLETED|Part 2a||0
10811416|NCT03762681|11973144|FG001|NOT COMPLETED|Part 2a||0
10811417|NCT03762681|11973145|FG002|NOT COMPLETED|Part 2a||0
10811418|NCT03762681|11973146|FG003|NOT COMPLETED|Part 2a||0
10811419|NCT03762681|11973147|FG004|NOT COMPLETED|Part 2a||0
10811420|NCT03762681|11973148|FG005|NOT COMPLETED|Part 2a||0
10811421|NCT03762681|11973149|FG006|NOT COMPLETED|Part 2a||0
10811422|NCT03762681|11973150|FG007|NOT COMPLETED|Part 2a||1
10811423|NCT03762668|11973179|FG000|STARTED|Period 1, First Week of Wear||30
10811424|NCT03762668|11973180|FG001|STARTED|Period 1, First Week of Wear||30
10811425|NCT03762668|11973179|FG000|COMPLETED|Period 1, First Week of Wear||30
10811426|NCT03762668|11973180|FG001|COMPLETED|Period 1, First Week of Wear||29
10811427|NCT03762668|11973179|FG000|NOT COMPLETED|Period 1, First Week of Wear||0
10811428|NCT03762668|11973180|FG001|NOT COMPLETED|Period 1, First Week of Wear||1
10811429|NCT03762668|11973179|FG000|STARTED|Period 2, Second Week of Wear||30
10811430|NCT03762668|11973180|FG001|STARTED|Period 2, Second Week of Wear||29
10811431|NCT03762668|11973179|FG000|COMPLETED|Period 2, Second Week of Wear||30
10811432|NCT03762668|11973180|FG001|COMPLETED|Period 2, Second Week of Wear||29
10811433|NCT03762668|11973179|FG000|NOT COMPLETED|Period 2, Second Week of Wear||0
10811434|NCT03762668|11973180|FG001|NOT COMPLETED|Period 2, Second Week of Wear||0
10811435|NCT03762616|11973186|FG000|STARTED|Overall Study||120
10811436|NCT03762616|11973186|FG000|COMPLETED|Overall Study||118
10811437|NCT03762616|11973186|FG000|NOT COMPLETED|Overall Study||2
10811438|NCT03762213|11973194|FG000|STARTED|Overall Study||16
10811439|NCT03762213|11973195|FG001|STARTED|Overall Study||14
10811440|NCT03762213|11973194|FG000|COMPLETED|Overall Study||16
10811441|NCT03762213|11973195|FG001|COMPLETED|Overall Study||14
10811442|NCT03762213|11973194|FG000|NOT COMPLETED|Overall Study||0
10811443|NCT03762213|11973195|FG001|NOT COMPLETED|Overall Study||0
10811444|NCT03762200|11973201|FG000|STARTED|Overall Study||103
10811445|NCT03762200|11973201|FG000|COMPLETED|Overall Study||101
10811446|NCT03762200|11973201|FG000|NOT COMPLETED|Overall Study||2
10811447|NCT03761368|11973207|FG000|STARTED|Overall Study||50
10811448|NCT03761368|11973208|FG001|STARTED|Overall Study||51
10811449|NCT03761368|11973207|FG000|COMPLETED|Overall Study||50
10811450|NCT03761368|11973208|FG001|COMPLETED|Overall Study||51
10811451|NCT03761368|11973207|FG000|NOT COMPLETED|Overall Study||0
10811452|NCT03761368|11973208|FG001|NOT COMPLETED|Overall Study||0
10811453|NCT03761147|11973216|FG000|STARTED|Overall Study||32
10811454|NCT03761147|11973217|FG001|STARTED|Overall Study||32
10811455|NCT03761147|11973216|FG000|COMPLETED|Overall Study||25
10811456|NCT03761147|11973217|FG001|COMPLETED|Overall Study||28
10811457|NCT03761147|11973216|FG000|NOT COMPLETED|Overall Study||7
10811458|NCT03761147|11973217|FG001|NOT COMPLETED|Overall Study||4
10811459|NCT03760913|11973242|FG000|STARTED|Overall Study||17
10811460|NCT03760913|11973243|FG001|STARTED|Overall Study||3
10811461|NCT03760913|11973244|FG002|STARTED|Overall Study||6
10811462|NCT03760913|11973245|FG003|STARTED|Overall Study||3
10811463|NCT03760913|11973246|FG004|STARTED|Overall Study||6
10811464|NCT03760913|11973247|FG005|STARTED|Overall Study||3
10811465|NCT03760913|11973248|FG006|STARTED|Overall Study||6
10714121|NCT02684396|11879658|FG000|NOT COMPLETED|Overall Study||0
10714122|NCT02684396|11879659|FG001|NOT COMPLETED|Overall Study||0
10714123|NCT02684396|11879660|FG002|NOT COMPLETED|Overall Study||0
10714124|NCT02684396|11879661|FG003|NOT COMPLETED|Overall Study||0
10811466|NCT03760913|11973249|FG007|STARTED|Overall Study||3
10811467|NCT03760913|11973250|FG008|STARTED|Overall Study||3
10811468|NCT03760913|11973251|FG009|STARTED|Overall Study||6
10811469|NCT03760913|11973252|FG010|STARTED|Overall Study||6
10811470|NCT03760913|11973253|FG011|STARTED|Overall Study||6
10811471|NCT03760913|11973254|FG012|STARTED|Overall Study||12
10811472|NCT03760913|11973255|FG013|STARTED|Overall Study||6
10811473|NCT03760913|11973256|FG014|STARTED|Overall Study||6
10811474|NCT03760913|11973257|FG015|STARTED|Overall Study||6
10811475|NCT03760913|11973258|FG016|STARTED|Overall Study||6
10811476|NCT03760913|11973259|FG017|STARTED|Overall Study||6
10811477|NCT03760913|11973260|FG018|STARTED|Overall Study||6
10811478|NCT03760913|11973242|FG000|COMPLETED|Overall Study||17
10811479|NCT03760913|11973243|FG001|COMPLETED|Overall Study||3
10811480|NCT03760913|11973244|FG002|COMPLETED|Overall Study||6
10811481|NCT03760913|11973245|FG003|COMPLETED|Overall Study||3
10811482|NCT03760913|11973246|FG004|COMPLETED|Overall Study||6
10811483|NCT03760913|11973247|FG005|COMPLETED|Overall Study||3
10811484|NCT03760913|11973248|FG006|COMPLETED|Overall Study||6
10811485|NCT03760913|11973249|FG007|COMPLETED|Overall Study||3
10811486|NCT03760913|11973250|FG008|COMPLETED|Overall Study||3
10811487|NCT03760913|11973251|FG009|COMPLETED|Overall Study||6
10811488|NCT03760913|11973252|FG010|COMPLETED|Overall Study||6
10811489|NCT03760913|11973253|FG011|COMPLETED|Overall Study||6
10811490|NCT03760913|11973254|FG012|COMPLETED|Overall Study||12
10811491|NCT03760913|11973255|FG013|COMPLETED|Overall Study||6
10714125|NCT02684396|11879662|FG004|NOT COMPLETED|Overall Study||0
10811492|NCT03760913|11973256|FG014|COMPLETED|Overall Study||6
10811493|NCT03760913|11973257|FG015|COMPLETED|Overall Study||6
10811494|NCT03760913|11973258|FG016|COMPLETED|Overall Study||6
10811495|NCT03760913|11973259|FG017|COMPLETED|Overall Study||6
10811496|NCT03760913|11973260|FG018|COMPLETED|Overall Study||6
10811497|NCT03760913|11973242|FG000|NOT COMPLETED|Overall Study||0
10811498|NCT03760913|11973243|FG001|NOT COMPLETED|Overall Study||0
10811499|NCT03760913|11973244|FG002|NOT COMPLETED|Overall Study||0
10811500|NCT03760913|11973245|FG003|NOT COMPLETED|Overall Study||0
10811501|NCT03760913|11973246|FG004|NOT COMPLETED|Overall Study||0
10811502|NCT03760913|11973247|FG005|NOT COMPLETED|Overall Study||0
10811503|NCT03760913|11973248|FG006|NOT COMPLETED|Overall Study||0
10811504|NCT03760913|11973249|FG007|NOT COMPLETED|Overall Study||0
10811505|NCT03760913|11973250|FG008|NOT COMPLETED|Overall Study||0
10811506|NCT03760913|11973251|FG009|NOT COMPLETED|Overall Study||0
10811507|NCT03760913|11973252|FG010|NOT COMPLETED|Overall Study||0
10811508|NCT03760913|11973253|FG011|NOT COMPLETED|Overall Study||0
10811509|NCT03760913|11973254|FG012|NOT COMPLETED|Overall Study||0
10811510|NCT03760913|11973255|FG013|NOT COMPLETED|Overall Study||0
10811511|NCT03760913|11973256|FG014|NOT COMPLETED|Overall Study||0
10811512|NCT03760913|11973257|FG015|NOT COMPLETED|Overall Study||0
10811513|NCT03760913|11973258|FG016|NOT COMPLETED|Overall Study||0
10811514|NCT03760913|11973259|FG017|NOT COMPLETED|Overall Study||0
10811515|NCT03760913|11973260|FG018|NOT COMPLETED|Overall Study||0
10811516|NCT03760796|11973313|FG000|STARTED|Overall Study||200
10811517|NCT03760796|11973314|FG001|STARTED|Overall Study||864
10811518|NCT03760796|11973313|FG000|COMPLETED|Overall Study||200
10811519|NCT03760796|11973314|FG001|COMPLETED|Overall Study||864
10811520|NCT03760796|11973313|FG000|NOT COMPLETED|Overall Study||0
10811521|NCT03760796|11973314|FG001|NOT COMPLETED|Overall Study||0
10811522|NCT03760640|11973322|FG000|STARTED|Period 1||20
10811523|NCT03760640|11973323|FG001|STARTED|Period 1||22
10811524|NCT03760640|11973322|FG000|Received at Least 1 Dose of Study Drug|Period 1||20
10811525|NCT03760640|11973323|FG001|Received at Least 1 Dose of Study Drug|Period 1||22
10811526|NCT03760640|11973322|FG000|COMPLETED|Period 1||20
10811527|NCT03760640|11973323|FG001|COMPLETED|Period 1||22
10811528|NCT03760640|11973322|FG000|NOT COMPLETED|Period 1||0
10811529|NCT03760640|11973323|FG001|NOT COMPLETED|Period 1||0
10811530|NCT03760640|11973322|FG000|STARTED|Period 2||20
10811531|NCT03760640|11973323|FG001|STARTED|Period 2||22
10811532|NCT03760640|11973322|FG000|COMPLETED|Period 2||20
10811533|NCT03760640|11973323|FG001|COMPLETED|Period 2||22
10811534|NCT03760640|11973322|FG000|NOT COMPLETED|Period 2||0
10811535|NCT03760640|11973323|FG001|NOT COMPLETED|Period 2||0
10714126|NCT02684396|11879663|FG005|NOT COMPLETED|Overall Study||0
10714127|NCT02684435|11879677|FG000|STARTED|Overall Study||63
10714128|NCT02684435|11879677|FG000|COMPLETED|Overall Study||63
10714129|NCT02684435|11879677|FG000|NOT COMPLETED|Overall Study||0
10714130|NCT02684591|11879683|FG000|STARTED|Overall Study||25
10714131|NCT02684591|11879684|FG001|STARTED|Overall Study||25
10714132|NCT02684591|11879683|FG000|COMPLETED|Overall Study||24
10714133|NCT02684591|11879684|FG001|COMPLETED|Overall Study||22
10714134|NCT02684591|11879683|FG000|NOT COMPLETED|Overall Study||1
10714135|NCT02684591|11879684|FG001|NOT COMPLETED|Overall Study||3
10714136|NCT02684604|11879692|FG000|STARTED|Overall Study||44
10714137|NCT02684604|11879693|FG001|STARTED|Overall Study||44
10811536|NCT03760510|11973331|FG000|STARTED|Overall Study||250
10811537|NCT03760510|11973332|FG001|STARTED|Overall Study||250
10811538|NCT03760510|11973331|FG000|COMPLETED|Overall Study||145
10811539|NCT03760510|11973332|FG001|COMPLETED|Overall Study||153
10529276|NCT01400243|11681715|FG001|COMPLETED|Overall Study||52
10529277|NCT01400243|11681714|FG000|NOT COMPLETED|Overall Study||8
10529278|NCT01400243|11681715|FG001|NOT COMPLETED|Overall Study||11
10714138|NCT02684604|11879692|FG000|COMPLETED|Overall Study||44
10714139|NCT02684604|11879693|FG001|COMPLETED|Overall Study||44
10811540|NCT03760510|11973331|FG000|NOT COMPLETED|Overall Study||105
10811541|NCT03760510|11973332|FG001|NOT COMPLETED|Overall Study||97
10811542|NCT03760250|11973338|FG000|STARTED|Overall Study||6
10714140|NCT02684604|11879692|FG000|NOT COMPLETED|Overall Study||0
10714141|NCT02684604|11879693|FG001|NOT COMPLETED|Overall Study||0
10714142|NCT02684617|11879702|FG000|STARTED|Overall Study||18
10714143|NCT02684617|11879703|FG001|STARTED|Overall Study||17
10714144|NCT02684617|11879704|FG002|STARTED|Overall Study||40
10714145|NCT02684617|11879702|FG000|Treated|Overall Study||17
10811543|NCT03760250|11973338|FG000|COMPLETED|Overall Study||4
10811544|NCT03760250|11973338|FG000|NOT COMPLETED|Overall Study||2
10811545|NCT03759600|11973342|FG000|STARTED|Overall Study||20
10811546|NCT03759600|11973342|FG000|COMPLETED|Overall Study||0
10811547|NCT03759600|11973342|FG000|NOT COMPLETED|Overall Study||20
10811548|NCT03759340|11973346|FG000|STARTED|Overall Study||56
10811549|NCT03759340|11973346|FG000|COMPLETED|Overall Study||0
10811550|NCT03759340|11973346|FG000|NOT COMPLETED|Overall Study||56
10811551|NCT03758716|11973350|FG000|STARTED|Overall Study||12
10811552|NCT03758716|11973350|FG000|COMPLETED|Overall Study||12
10811553|NCT03758716|11973350|FG000|NOT COMPLETED|Overall Study||0
10811554|NCT03758365|11973354|FG000|STARTED|Overall Study||36
10714146|NCT02684617|11879703|FG001|Treated|Overall Study||17
10811555|NCT03758365|11973354|FG000|MC2-01 Cream|Overall Study||36
10811556|NCT03758365|11973354|FG000|Clobetasol Propionate 0.05% Lotion|Overall Study||36
10811557|NCT03758365|11973354|FG000|Betamethasone Dipropionate 0.05% Cream|Overall Study||36
10811558|NCT03758365|11973354|FG000|Triamcinolone Acetonide 0,1% Cream|Overall Study||36
10339455|NCT00372905|11476384|FG000|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||2
10339456|NCT00372905|11476385|FG001|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
10339457|NCT00372905|11476386|FG002|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
10339458|NCT00372905|11476387|FG003|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
10339459|NCT00372905|11476384|FG000|STARTED|Cohort 2: Dose Level 1.3mg/m2||0
10339460|NCT00372905|11476385|FG001|STARTED|Cohort 2: Dose Level 1.3mg/m2||3
10339461|NCT00372905|11476386|FG002|STARTED|Cohort 2: Dose Level 1.3mg/m2||0
10339462|NCT00372905|11476387|FG003|STARTED|Cohort 2: Dose Level 1.3mg/m2||0
10529279|NCT01400412|11681725|FG000|STARTED|Overall Study||130
10714147|NCT02684617|11879704|FG002|Treated|Overall Study||38
10714148|NCT02684617|11879702|FG000|COMPLETED|Overall Study||0
10714149|NCT02684617|11879703|FG001|COMPLETED|Overall Study||0
10714150|NCT02684617|11879704|FG002|COMPLETED|Overall Study||0
10714151|NCT02684617|11879702|FG000|NOT COMPLETED|Overall Study||18
10811559|NCT03758365|11973354|FG000|Hydrocortisone Butyrate 0.1% Cream|Overall Study||36
10811560|NCT03758365|11973354|FG000|Desonide 0.05% Cream|Overall Study||36
10811561|NCT03758365|11973354|FG000|Vehicle Cream|Overall Study||36
10811562|NCT03758365|11973354|FG000|COMPLETED|Overall Study||36
10811563|NCT03758365|11973354|FG000|NOT COMPLETED|Overall Study||0
10811564|NCT03758157|11973365|FG000|STARTED|Overall Study||110
10811565|NCT03758157|11973365|FG000|COMPLETED|Overall Study||110
10811566|NCT03758157|11973365|FG000|NOT COMPLETED|Overall Study||0
10811567|NCT03757988|11973369|FG000|STARTED|Overall Study||17
10811568|NCT03757988|11973369|FG000|COMPLETED|Overall Study||16
10811569|NCT03757988|11973369|FG000|NOT COMPLETED|Overall Study||1
10811570|NCT03757312|11973376|FG000|STARTED|Overall Study||5
10811571|NCT03757312|11973377|FG001|STARTED|Overall Study||9
10811572|NCT03757312|11973376|FG000|COMPLETED|Overall Study||5
10811573|NCT03757312|11973377|FG001|COMPLETED|Overall Study||9
10811574|NCT03757312|11973376|FG000|NOT COMPLETED|Overall Study||0
10811575|NCT03757312|11973377|FG001|NOT COMPLETED|Overall Study||0
10811576|NCT03757234|11973390|FG000|STARTED|Overall Study||75
10301995|NCT00066066|11434804|FG003|NOT COMPLETED|Overall Study||4
10301996|NCT00066066|11434805|FG004|NOT COMPLETED|Overall Study||3
10301997|NCT00066066|11434806|FG005|NOT COMPLETED|Overall Study||5
10301998|NCT00066170|11434824|FG000|STARTED|Overall Study||56
10301999|NCT00066170|11434825|FG001|STARTED|Overall Study||55
10302000|NCT00066170|11434826|FG002|STARTED|Overall Study||63
10302001|NCT00066170|11434827|FG003|STARTED|Overall Study||57
10529280|NCT01400412|11681726|FG001|STARTED|Overall Study||132
10529281|NCT01400412|11681725|FG000|COMPLETED|Overall Study||120
10529282|NCT01400412|11681726|FG001|COMPLETED|Overall Study||115
10529283|NCT01400412|11681725|FG000|NOT COMPLETED|Overall Study||10
10529284|NCT01400412|11681726|FG001|NOT COMPLETED|Overall Study||17
10529285|NCT01400425|11681734|FG000|STARTED|Overall Study||239
10529286|NCT01400425|11681734|FG000|COMPLETED|Overall Study||229
10529287|NCT01400425|11681734|FG000|NOT COMPLETED|Overall Study||10
10529288|NCT01400451|11681743|FG000|STARTED|28 Day Lead In With Vemurafenib Alone||6
10654689|NCT02203916|11815512|FG001|COMPLETED|Overall Study||122
10654690|NCT02203916|11815513|FG002|COMPLETED|Overall Study||120
10654691|NCT02203916|11815511|FG000|NOT COMPLETED|Overall Study||8
10529289|NCT01400451|11681744|FG001|STARTED|28 Day Lead In With Vemurafenib Alone||4
10529290|NCT01400451|11681745|FG002|STARTED|28 Day Lead In With Vemurafenib Alone||2
10529291|NCT01400451|11681743|FG000|COMPLETED|28 Day Lead In With Vemurafenib Alone||6
10529292|NCT01400451|11681744|FG001|COMPLETED|28 Day Lead In With Vemurafenib Alone||4
10529293|NCT01400451|11681745|FG002|COMPLETED|28 Day Lead In With Vemurafenib Alone||2
10529294|NCT01400451|11681743|FG000|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
10529295|NCT01400451|11681744|FG001|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
10529296|NCT01400451|11681745|FG002|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
10529297|NCT01400451|11681743|FG000|STARTED|Combination Treatment (or Intended)||6
10529298|NCT01400451|11681744|FG001|STARTED|Combination Treatment (or Intended)||4
10529299|NCT01400451|11681745|FG002|STARTED|Combination Treatment (or Intended)|Did not start Ipilimumab but remained on vemurafenib alone.|2
10529300|NCT01400451|11681743|FG000|COMPLETED|Combination Treatment (or Intended)||0
10529301|NCT01400451|11681744|FG001|COMPLETED|Combination Treatment (or Intended)||0
10529302|NCT01400451|11681745|FG002|COMPLETED|Combination Treatment (or Intended)||0
10529303|NCT01400451|11681743|FG000|NOT COMPLETED|Combination Treatment (or Intended)||6
10529304|NCT01400451|11681744|FG001|NOT COMPLETED|Combination Treatment (or Intended)||4
10529305|NCT01400451|11681745|FG002|NOT COMPLETED|Combination Treatment (or Intended)||2
10529306|NCT01400477|11681760|FG000|STARTED|Overall Study||40
10529307|NCT01400477|11681761|FG001|STARTED|Overall Study||40
10529308|NCT01400477|11681760|FG000|COMPLETED|Overall Study||38
10529309|NCT01400477|11681761|FG001|COMPLETED|Overall Study||40
10529310|NCT01400477|11681760|FG000|NOT COMPLETED|Overall Study||2
10529311|NCT01400477|11681761|FG001|NOT COMPLETED|Overall Study||0
10529312|NCT01400503|11681767|FG000|STARTED|Overall Study||60
10529313|NCT01400503|11681767|FG000|COMPLETED|Overall Study||0
10654692|NCT02203916|11815512|FG001|NOT COMPLETED|Overall Study||10
10654693|NCT02203916|11815513|FG002|NOT COMPLETED|Overall Study||11
10654694|NCT02204007|11815523|FG000|STARTED|Overall Study||18
10654695|NCT02204007|11815524|FG001|STARTED|Overall Study||18
10654696|NCT02204007|11815523|FG000|COMPLETED|Overall Study||17
10654697|NCT02204007|11815524|FG001|COMPLETED|Overall Study||17
10654698|NCT02204007|11815523|FG000|NOT COMPLETED|Overall Study||1
10654699|NCT02204007|11815524|FG001|NOT COMPLETED|Overall Study||1
10654700|NCT02204124|11815532|FG000|STARTED|Overall Study||13
10654701|NCT02204124|11815533|FG001|STARTED|Overall Study||19
10654702|NCT02204124|11815532|FG000|COMPLETED|Overall Study||13
10654703|NCT02204124|11815533|FG001|COMPLETED|Overall Study||19
10654704|NCT02204124|11815532|FG000|NOT COMPLETED|Overall Study||0
10654705|NCT02204124|11815533|FG001|NOT COMPLETED|Overall Study||0
10654706|NCT02204150|11815539|FG000|STARTED|Overall Study||56
10654707|NCT02204150|11815539|FG000|COMPLETED|Overall Study||56
10529314|NCT01400503|11681767|FG000|NOT COMPLETED|Overall Study||60
10529315|NCT01400516|11681773|FG000|STARTED|Primary Trial||12
10529316|NCT01400516|11681774|FG001|STARTED|Primary Trial||14
10529317|NCT01400516|11681773|FG000|COMPLETED|Primary Trial||12
10529318|NCT01400516|11681774|FG001|COMPLETED|Primary Trial||12
10529319|NCT01400516|11681773|FG000|NOT COMPLETED|Primary Trial||0
10529320|NCT01400516|11681774|FG001|NOT COMPLETED|Primary Trial||2
10529321|NCT01400516|11681773|FG000|STARTED|Extension Trial|Only 6 participants in the Control arm entered the Extension Trial.|6
10529322|NCT01400516|11681774|FG001|STARTED|Extension Trial|Only 7 participants in the Teriparatide arm entered the Extension Trial.|7
10529323|NCT01400516|11681773|FG000|COMPLETED|Extension Trial||6
10529324|NCT01400516|11681774|FG001|COMPLETED|Extension Trial||7
10529325|NCT01400516|11681773|FG000|NOT COMPLETED|Extension Trial||0
10529326|NCT01400516|11681774|FG001|NOT COMPLETED|Extension Trial||0
10529327|NCT01400698|11681784|FG000|STARTED|Overall Study||23
10529328|NCT01400698|11681785|FG001|STARTED|Overall Study||23
10529329|NCT01400698|11681786|FG002|STARTED|Overall Study||2
10529330|NCT01400698|11681787|FG003|STARTED|Overall Study||14
10529331|NCT01400698|11681788|FG004|STARTED|Overall Study||14
10529332|NCT01400698|11681789|FG005|STARTED|Overall Study||15
10811577|NCT03757234|11973391|FG001|STARTED|Overall Study||18
10811578|NCT03757234|11973392|FG002|STARTED|Overall Study||17
10811579|NCT03757234|11973393|FG003|STARTED|Overall Study||17
10811580|NCT03757234|11973394|FG004|STARTED|Overall Study||74
10811581|NCT03757234|11973390|FG000|Completed PTE Visit|Overall Study||72
10811582|NCT03757234|11973391|FG001|Completed PTE Visit|Overall Study||16
10811583|NCT03757234|11973392|FG002|Completed PTE Visit|Overall Study||17
10811584|NCT03757234|11973393|FG003|Completed PTE Visit|Overall Study||16
10811585|NCT03757234|11973394|FG004|Completed PTE Visit|Overall Study||71
10811586|NCT03757234|11973390|FG000|COMPLETED|Overall Study||72
10811587|NCT03757234|11973391|FG001|COMPLETED|Overall Study||16
10811588|NCT03757234|11973392|FG002|COMPLETED|Overall Study||17
10302002|NCT00066170|11434824|FG000|Intent to Treat|Overall Study||55
10302003|NCT00066170|11434825|FG001|Intent to Treat|Overall Study||50
10302004|NCT00066170|11434826|FG002|Intent to Treat|Overall Study||63
10302005|NCT00066170|11434827|FG003|Intent to Treat|Overall Study||54
10302006|NCT00066170|11434824|FG000|COMPLETED|Overall Study||49
10302007|NCT00066170|11434825|FG001|COMPLETED|Overall Study||45
10302008|NCT00066170|11434826|FG002|COMPLETED|Overall Study||59
10302009|NCT00066170|11434827|FG003|COMPLETED|Overall Study||48
10302010|NCT00066170|11434824|FG000|NOT COMPLETED|Overall Study||7
10302011|NCT00066170|11434825|FG001|NOT COMPLETED|Overall Study||10
10302012|NCT00066170|11434826|FG002|NOT COMPLETED|Overall Study||4
10302013|NCT00066170|11434827|FG003|NOT COMPLETED|Overall Study||9
10302014|NCT00066222|11434837|FG000|STARTED|Overall Study||72
10339463|NCT00372905|11476384|FG000|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0
10339464|NCT00372905|11476385|FG001|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||3
10339465|NCT00372905|11476386|FG002|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0
10339466|NCT00372905|11476387|FG003|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0
10339467|NCT00372905|11476384|FG000|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0
10339468|NCT00372905|11476385|FG001|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||3
10339469|NCT00372905|11476386|FG002|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0
10339470|NCT00372905|11476387|FG003|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0
10339471|NCT00372905|11476384|FG000|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0
10339472|NCT00372905|11476385|FG001|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||3
10339473|NCT00372905|11476386|FG002|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0
10339474|NCT00372905|11476387|FG003|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0
10339475|NCT00372905|11476384|FG000|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
10529333|NCT01400698|11681784|FG000|COMPLETED|Overall Study||8
10529334|NCT01400698|11681785|FG001|COMPLETED|Overall Study||12
10529335|NCT01400698|11681786|FG002|COMPLETED|Overall Study||0
10811589|NCT03757234|11973393|FG003|COMPLETED|Overall Study||16
10811590|NCT03757234|11973394|FG004|COMPLETED|Overall Study||70
10302015|NCT00066222|11434837|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|71
10302016|NCT00066222|11434837|FG000|NOT COMPLETED|Overall Study||1
10302017|NCT00066365|11434843|FG000|STARTED|Overall Study||31
10302018|NCT00066365|11434844|FG001|STARTED|Overall Study||18
10302019|NCT00066365|11434843|FG000|COMPLETED|Overall Study||8
10302020|NCT00066365|11434844|FG001|COMPLETED|Overall Study||4
10302021|NCT00066365|11434843|FG000|NOT COMPLETED|Overall Study||23
10302022|NCT00066365|11434844|FG001|NOT COMPLETED|Overall Study||14
10302023|NCT00066469|11434852|FG000|STARTED|Overall Study||55
10302024|NCT00066469|11434852|FG000|COMPLETED|Overall Study||39
10714152|NCT02684617|11879703|FG001|NOT COMPLETED|Overall Study||17
10714153|NCT02684617|11879704|FG002|NOT COMPLETED|Overall Study||40
10714154|NCT02684630|11879714|FG000|STARTED|Overall Study||65
10714155|NCT02684630|11879715|FG001|STARTED|Overall Study||63
10714156|NCT02684630|11879714|FG000|COMPLETED|Overall Study||60
10714157|NCT02684630|11879715|FG001|COMPLETED|Overall Study||60
10714158|NCT02684630|11879714|FG000|NOT COMPLETED|Overall Study||5
10714159|NCT02684630|11879715|FG001|NOT COMPLETED|Overall Study||3
10714160|NCT02684942|11879723|FG000|STARTED|Overall Study||7
10714161|NCT02684942|11879724|FG001|STARTED|Overall Study||7
10714162|NCT02684942|11879725|FG002|STARTED|Overall Study||7
10714163|NCT02684942|11879726|FG003|STARTED|Overall Study||7
10714164|NCT02684942|11879727|FG004|STARTED|Overall Study||6
10714165|NCT02684942|11879728|FG005|STARTED|Overall Study||6
10302025|NCT00066469|11434852|FG000|NOT COMPLETED|Overall Study||16
10302026|NCT00066573|11434858|FG000|STARTED|Overall Study||3789
10302027|NCT00066573|11434859|FG001|STARTED|Overall Study||3787
10302028|NCT00066573|11434858|FG000|COMPLETED|Overall Study||3761
10302029|NCT00066573|11434859|FG001|COMPLETED|Overall Study||3759
10302030|NCT00066573|11434858|FG000|NOT COMPLETED|Overall Study||28
10302031|NCT00066573|11434859|FG001|NOT COMPLETED|Overall Study||28
10302032|NCT00066677|11434867|FG000|STARTED|Overall Study||16
10302033|NCT00066677|11434868|FG001|STARTED|Overall Study||16
10302034|NCT00066677|11434867|FG000|COMPLETED|Overall Study||16
10302035|NCT00066677|11434868|FG001|COMPLETED|Overall Study||16
10302036|NCT00066677|11434867|FG000|NOT COMPLETED|Overall Study||0
10302037|NCT00066677|11434868|FG001|NOT COMPLETED|Overall Study||0
10302038|NCT00066690|11434877|FG000|STARTED|Overall Study||1021
10302039|NCT00066690|11434878|FG001|STARTED|Overall Study||1024
10302040|NCT00066690|11434879|FG002|STARTED|Overall Study||1021
10302041|NCT00066690|11434877|FG000|COMPLETED|Overall Study||423
10302042|NCT00066690|11434878|FG001|COMPLETED|Overall Study||502
10302043|NCT00066690|11434879|FG002|COMPLETED|Overall Study||457
10302044|NCT00066690|11434877|FG000|NOT COMPLETED|Overall Study||598
10302045|NCT00066690|11434878|FG001|NOT COMPLETED|Overall Study||522
10302046|NCT00066690|11434879|FG002|NOT COMPLETED|Overall Study||564
10302047|NCT00066703|11434892|FG000|STARTED|Overall Study||1334
10302048|NCT00066703|11434893|FG001|STARTED|Overall Study||1338
10302049|NCT00066703|11434892|FG000|COMPLETED|Overall Study||722
10302050|NCT00066703|11434893|FG001|COMPLETED|Overall Study||756
10302051|NCT00066703|11434892|FG000|NOT COMPLETED|Overall Study||612
10302052|NCT00066703|11434893|FG001|NOT COMPLETED|Overall Study||582
10302053|NCT00066729|11434899|FG000|STARTED|Overall Study||9
10302054|NCT00066729|11434899|FG000|COMPLETED|Overall Study||7
10302055|NCT00066729|11434899|FG000|NOT COMPLETED|Overall Study||2
10302056|NCT00066742|11434903|FG000|STARTED|Induction Chemoradiotherapy||72
10302057|NCT00066742|11434903|FG000|Eligible|Induction Chemoradiotherapy||69
10302058|NCT00066742|11434903|FG000|Began Protocol Treatment|Induction Chemoradiotherapy||68
10529336|NCT01400698|11681787|FG003|COMPLETED|Overall Study||6
10529337|NCT01400698|11681788|FG004|COMPLETED|Overall Study||7
10529338|NCT01400698|11681789|FG005|COMPLETED|Overall Study||9
10529339|NCT01400698|11681784|FG000|NOT COMPLETED|Overall Study||15
10529340|NCT01400698|11681785|FG001|NOT COMPLETED|Overall Study||11
10529341|NCT01400698|11681786|FG002|NOT COMPLETED|Overall Study||2
10529342|NCT01400698|11681787|FG003|NOT COMPLETED|Overall Study||8
10529343|NCT01400698|11681788|FG004|NOT COMPLETED|Overall Study||7
10529344|NCT01400698|11681789|FG005|NOT COMPLETED|Overall Study||6
10529345|NCT01400815|11681801|FG000|STARTED|Overall Study||118
10529346|NCT01400815|11681802|FG001|STARTED|Overall Study||116
10529347|NCT01400815|11681801|FG000|COMPLETED|Overall Study||80
10529348|NCT01400815|11681802|FG001|COMPLETED|Overall Study||95
10529349|NCT01400815|11681801|FG000|NOT COMPLETED|Overall Study||38
10529350|NCT01400815|11681802|FG001|NOT COMPLETED|Overall Study||21
10529351|NCT01400841|11681808|FG000|STARTED|Initial Study Phase (6 Months)|2 of the 18 consented subjects did not receive the device|16
10529352|NCT01400841|11681808|FG000|COMPLETED|Initial Study Phase (6 Months)||15
10529353|NCT01400841|11681808|FG000|NOT COMPLETED|Initial Study Phase (6 Months)||1
10529354|NCT01400841|11681808|FG000|STARTED|Extended Study Phase (2 Years)|"1 subject refused further participation~1 subject death prior to agreeing to extended follow-up"|13
10529355|NCT01400841|11681808|FG000|COMPLETED|Extended Study Phase (2 Years)||11
10529356|NCT01400841|11681808|FG000|NOT COMPLETED|Extended Study Phase (2 Years)||2
10529357|NCT01400880|11681812|FG000|STARTED|Overall Study|patients were added throughout the study. There was not a set number of patients that we began with|103
10529358|NCT01400880|11681812|FG000|COMPLETED|Overall Study|patients were added throughout the study. There was not a set number of patients that we began with|101
10529359|NCT01400880|11681812|FG000|NOT COMPLETED|Overall Study||2
10529360|NCT01400893|11681818|FG000|STARTED|Overall Study||69
10529361|NCT01400893|11681819|FG001|STARTED|Overall Study||65
10529362|NCT01400893|11681818|FG000|COMPLETED|Overall Study||42
10529363|NCT01400893|11681819|FG001|COMPLETED|Overall Study||38
10529364|NCT01400893|11681818|FG000|NOT COMPLETED|Overall Study||27
10529365|NCT01400893|11681819|FG001|NOT COMPLETED|Overall Study||27
10529366|NCT01400906|11681827|FG000|STARTED|Treatment Period 1||6
10529367|NCT01400906|11681828|FG001|STARTED|Treatment Period 1||6
10529368|NCT01400906|11681829|FG002|STARTED|Treatment Period 1||6
10529369|NCT01400906|11681830|FG003|STARTED|Treatment Period 1||6
10529370|NCT01400906|11681831|FG004|STARTED|Treatment Period 1||6
10529371|NCT01400906|11681832|FG005|STARTED|Treatment Period 1||5
10529372|NCT01400906|11681827|FG000|COMPLETED|Treatment Period 1||6
10529373|NCT01400906|11681828|FG001|COMPLETED|Treatment Period 1||6
10529374|NCT01400906|11681829|FG002|COMPLETED|Treatment Period 1||6
10529375|NCT01400906|11681830|FG003|COMPLETED|Treatment Period 1||6
10529376|NCT01400906|11681831|FG004|COMPLETED|Treatment Period 1||6
10529377|NCT01400906|11681832|FG005|COMPLETED|Treatment Period 1||5
10529378|NCT01400906|11681827|FG000|NOT COMPLETED|Treatment Period 1||0
10529379|NCT01400906|11681828|FG001|NOT COMPLETED|Treatment Period 1||0
10529380|NCT01400906|11681829|FG002|NOT COMPLETED|Treatment Period 1||0
10529381|NCT01400906|11681830|FG003|NOT COMPLETED|Treatment Period 1||0
10529382|NCT01400906|11681831|FG004|NOT COMPLETED|Treatment Period 1||0
10529383|NCT01400906|11681832|FG005|NOT COMPLETED|Treatment Period 1||0
10529384|NCT01400906|11681827|FG000|STARTED|Washout Period 1||6
10529385|NCT01400906|11681828|FG001|STARTED|Washout Period 1||6
10529386|NCT01400906|11681829|FG002|STARTED|Washout Period 1||6
10529387|NCT01400906|11681830|FG003|STARTED|Washout Period 1||6
10529388|NCT01400906|11681831|FG004|STARTED|Washout Period 1||6
10529389|NCT01400906|11681832|FG005|STARTED|Washout Period 1||5
10529390|NCT01400906|11681827|FG000|COMPLETED|Washout Period 1||6
10529391|NCT01400906|11681828|FG001|COMPLETED|Washout Period 1||6
10529392|NCT01400906|11681829|FG002|COMPLETED|Washout Period 1||6
10529393|NCT01400906|11681830|FG003|COMPLETED|Washout Period 1||6
10529394|NCT01400906|11681831|FG004|COMPLETED|Washout Period 1||6
10529395|NCT01400906|11681832|FG005|COMPLETED|Washout Period 1||5
10529396|NCT01400906|11681827|FG000|NOT COMPLETED|Washout Period 1||0
10529397|NCT01400906|11681828|FG001|NOT COMPLETED|Washout Period 1||0
10529398|NCT01400906|11681829|FG002|NOT COMPLETED|Washout Period 1||0
10529399|NCT01400906|11681830|FG003|NOT COMPLETED|Washout Period 1||0
10529400|NCT01400906|11681831|FG004|NOT COMPLETED|Washout Period 1||0
10529401|NCT01400906|11681832|FG005|NOT COMPLETED|Washout Period 1||0
10529402|NCT01400906|11681827|FG000|STARTED|Treatment Period 2||6
10529403|NCT01400906|11681828|FG001|STARTED|Treatment Period 2||6
10529404|NCT01400906|11681829|FG002|STARTED|Treatment Period 2||6
10529405|NCT01400906|11681830|FG003|STARTED|Treatment Period 2||6
10529406|NCT01400906|11681831|FG004|STARTED|Treatment Period 2||6
10529407|NCT01400906|11681832|FG005|STARTED|Treatment Period 2||5
10529408|NCT01400906|11681827|FG000|COMPLETED|Treatment Period 2||6
10339476|NCT00372905|11476385|FG001|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||3
10339477|NCT00372905|11476386|FG002|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
10339478|NCT00372905|11476387|FG003|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
10339479|NCT00372905|11476384|FG000|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
10339480|NCT00372905|11476385|FG001|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
10339481|NCT00372905|11476386|FG002|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
10339482|NCT00372905|11476387|FG003|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
10339483|NCT00372905|11476384|FG000|STARTED|Cohort 3: Dose Level 1.6mg/m2||0
10339484|NCT00372905|11476385|FG001|STARTED|Cohort 3: Dose Level 1.6mg/m2||0
10339485|NCT00372905|11476386|FG002|STARTED|Cohort 3: Dose Level 1.6mg/m2||4
10339486|NCT00372905|11476387|FG003|STARTED|Cohort 3: Dose Level 1.6mg/m2||0
10339487|NCT00372905|11476384|FG000|Registered|Cohort 3: Dose Level 1.6mg/m2||0
10339488|NCT00372905|11476385|FG001|Registered|Cohort 3: Dose Level 1.6mg/m2||0
10339489|NCT00372905|11476386|FG002|Registered|Cohort 3: Dose Level 1.6mg/m2||4
10339490|NCT00372905|11476387|FG003|Registered|Cohort 3: Dose Level 1.6mg/m2||0
10529409|NCT01400906|11681828|FG001|COMPLETED|Treatment Period 2||6
10529410|NCT01400906|11681829|FG002|COMPLETED|Treatment Period 2||6
10529411|NCT01400906|11681830|FG003|COMPLETED|Treatment Period 2||6
10529412|NCT01400906|11681831|FG004|COMPLETED|Treatment Period 2||6
10529413|NCT01400906|11681832|FG005|COMPLETED|Treatment Period 2||5
10529414|NCT01400906|11681827|FG000|NOT COMPLETED|Treatment Period 2||0
10529415|NCT01400906|11681828|FG001|NOT COMPLETED|Treatment Period 2||0
10529416|NCT01400906|11681829|FG002|NOT COMPLETED|Treatment Period 2||0
10529417|NCT01400906|11681830|FG003|NOT COMPLETED|Treatment Period 2||0
10529418|NCT01400906|11681831|FG004|NOT COMPLETED|Treatment Period 2||0
10529419|NCT01400906|11681832|FG005|NOT COMPLETED|Treatment Period 2||0
10529420|NCT01400906|11681827|FG000|STARTED|Washout Period 2||6
10529421|NCT01400906|11681828|FG001|STARTED|Washout Period 2||6
10529422|NCT01400906|11681829|FG002|STARTED|Washout Period 2||6
10529423|NCT01400906|11681830|FG003|STARTED|Washout Period 2||6
10529424|NCT01400906|11681831|FG004|STARTED|Washout Period 2||6
10529425|NCT01400906|11681832|FG005|STARTED|Washout Period 2||5
10529426|NCT01400906|11681827|FG000|COMPLETED|Washout Period 2||6
10529427|NCT01400906|11681828|FG001|COMPLETED|Washout Period 2||6
10529428|NCT01400906|11681829|FG002|COMPLETED|Washout Period 2||6
10529429|NCT01400906|11681830|FG003|COMPLETED|Washout Period 2||6
10529430|NCT01400906|11681831|FG004|COMPLETED|Washout Period 2||6
10529431|NCT01400906|11681832|FG005|COMPLETED|Washout Period 2||5
10529432|NCT01400906|11681827|FG000|NOT COMPLETED|Washout Period 2||0
10529433|NCT01400906|11681828|FG001|NOT COMPLETED|Washout Period 2||0
10529434|NCT01400906|11681829|FG002|NOT COMPLETED|Washout Period 2||0
10529435|NCT01400906|11681830|FG003|NOT COMPLETED|Washout Period 2||0
10529436|NCT01400906|11681831|FG004|NOT COMPLETED|Washout Period 2||0
10529437|NCT01400906|11681832|FG005|NOT COMPLETED|Washout Period 2||0
10529438|NCT01400906|11681827|FG000|STARTED|Treatment Period 3||6
10529439|NCT01400906|11681828|FG001|STARTED|Treatment Period 3||6
10529440|NCT01400906|11681829|FG002|STARTED|Treatment Period 3||6
10529441|NCT01400906|11681830|FG003|STARTED|Treatment Period 3||6
10529442|NCT01400906|11681831|FG004|STARTED|Treatment Period 3||6
10529443|NCT01400906|11681832|FG005|STARTED|Treatment Period 3||5
10529444|NCT01400906|11681827|FG000|COMPLETED|Treatment Period 3||6
10529445|NCT01400906|11681828|FG001|COMPLETED|Treatment Period 3||6
10529446|NCT01400906|11681829|FG002|COMPLETED|Treatment Period 3||6
10529447|NCT01400906|11681830|FG003|COMPLETED|Treatment Period 3||6
10529448|NCT01400906|11681831|FG004|COMPLETED|Treatment Period 3||6
10529449|NCT01400906|11681832|FG005|COMPLETED|Treatment Period 3||5
10529450|NCT01400906|11681827|FG000|NOT COMPLETED|Treatment Period 3||0
10529451|NCT01400906|11681828|FG001|NOT COMPLETED|Treatment Period 3||0
10529452|NCT01400906|11681829|FG002|NOT COMPLETED|Treatment Period 3||0
10529453|NCT01400906|11681830|FG003|NOT COMPLETED|Treatment Period 3||0
10529454|NCT01400906|11681831|FG004|NOT COMPLETED|Treatment Period 3||0
10529455|NCT01400906|11681832|FG005|NOT COMPLETED|Treatment Period 3||0
10529456|NCT01400919|11681840|FG000|STARTED|Overall Study||75
10529457|NCT01400919|11681840|FG000|COMPLETED|Overall Study||67
10529458|NCT01400919|11681840|FG000|NOT COMPLETED|Overall Study||8
10529459|NCT01400932|11681846|FG000|STARTED|Overall Study||178
10529460|NCT01400932|11681847|FG001|STARTED|Overall Study||182
10529461|NCT01400932|11681846|FG000|COMPLETED|Overall Study||164
10529462|NCT01400932|11681847|FG001|COMPLETED|Overall Study||167
10529463|NCT01400932|11681846|FG000|NOT COMPLETED|Overall Study||14
10529464|NCT01400932|11681847|FG001|NOT COMPLETED|Overall Study||15
10529465|NCT01400958|11681855|FG000|STARTED|Overall Study||3
10529466|NCT01400958|11681856|FG001|STARTED|Overall Study||3
10529467|NCT01400958|11681855|FG000|COMPLETED|Overall Study||2
10529468|NCT01400958|11681856|FG001|COMPLETED|Overall Study||1
10529469|NCT01400958|11681855|FG000|NOT COMPLETED|Overall Study||1
10529470|NCT01400958|11681856|FG001|NOT COMPLETED|Overall Study||2
10529471|NCT01400971|11681862|FG000|STARTED|Overall Study||4299
10529472|NCT01400971|11681862|FG000|Complete Treatment Data|Overall Study||2528
10529473|NCT01400971|11681862|FG000|COMPLETED|Overall Study||3382
10529474|NCT01400971|11681862|FG000|NOT COMPLETED|Overall Study||917
10529475|NCT01401010|11681868|FG000|STARTED|Overall Study||6
10529476|NCT01401010|11681869|FG001|STARTED|Overall Study||6
10811591|NCT03757234|11973390|FG000|NOT COMPLETED|Overall Study||3
10811592|NCT03757234|11973391|FG001|NOT COMPLETED|Overall Study||2
10811593|NCT03757234|11973392|FG002|NOT COMPLETED|Overall Study||0
10811594|NCT03757234|11973393|FG003|NOT COMPLETED|Overall Study||1
10811595|NCT03757234|11973394|FG004|NOT COMPLETED|Overall Study||4
10811596|NCT03757039|11973410|FG000|STARTED|Overall Study||32
10302059|NCT00066742|11434903|FG000|COMPLETED|Induction Chemoradiotherapy||43
10714166|NCT02684942|11879723|FG000|COMPLETED|Overall Study||7
10714167|NCT02684942|11879724|FG001|COMPLETED|Overall Study||7
10529477|NCT01401010|11681868|FG000|COMPLETED|Overall Study||5
10529478|NCT01401010|11681869|FG001|COMPLETED|Overall Study||6
10529479|NCT01401010|11681868|FG000|NOT COMPLETED|Overall Study||1
10302060|NCT00066742|11434903|FG000|NOT COMPLETED|Induction Chemoradiotherapy||29
10302061|NCT00066742|11434903|FG000|STARTED|Consolidation Chemotherapy||42
10302062|NCT00066742|11434903|FG000|Eligible|Consolidation Chemotherapy||40
10302063|NCT00066742|11434903|FG000|COMPLETED|Consolidation Chemotherapy||39
10302064|NCT00066742|11434903|FG000|NOT COMPLETED|Consolidation Chemotherapy||3
10302065|NCT00066781|11434911|FG000|STARTED|Overall Study||14
10302066|NCT00066781|11434912|FG001|STARTED|Overall Study||17
10302067|NCT00066781|11434911|FG000|COMPLETED|Overall Study||14
10302068|NCT00066781|11434912|FG001|COMPLETED|Overall Study||17
10302069|NCT00066781|11434911|FG000|NOT COMPLETED|Overall Study||0
10302070|NCT00066781|11434912|FG001|NOT COMPLETED|Overall Study||0
10302071|NCT00066937|11434922|FG000|STARTED|Treatment Phase||41
10302072|NCT00066937|11434923|FG001|STARTED|Treatment Phase||38
10302073|NCT00066937|11434924|FG002|STARTED|Treatment Phase||37
10302074|NCT00066937|11434925|FG003|STARTED|Treatment Phase||24
10302075|NCT00066937|11434922|FG000|COMPLETED|Treatment Phase||38
10302076|NCT00066937|11434923|FG001|COMPLETED|Treatment Phase||33
10302077|NCT00066937|11434924|FG002|COMPLETED|Treatment Phase||26
10302078|NCT00066937|11434925|FG003|COMPLETED|Treatment Phase||19
10302079|NCT00066937|11434922|FG000|NOT COMPLETED|Treatment Phase||3
10302080|NCT00066937|11434923|FG001|NOT COMPLETED|Treatment Phase||5
10302081|NCT00066937|11434924|FG002|NOT COMPLETED|Treatment Phase||11
10302082|NCT00066937|11434925|FG003|NOT COMPLETED|Treatment Phase||5
10302083|NCT00066937|11434922|FG000|STARTED|3 Month Follow-up||38
10302084|NCT00066937|11434923|FG001|STARTED|3 Month Follow-up||33
10339491|NCT00372905|11476384|FG000|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0
10339492|NCT00372905|11476385|FG001|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0
10529480|NCT01401010|11681869|FG001|NOT COMPLETED|Overall Study||0
10302085|NCT00066937|11434924|FG002|STARTED|3 Month Follow-up||26
10302086|NCT00066937|11434925|FG003|STARTED|3 Month Follow-up||19
10302087|NCT00066937|11434922|FG000|COMPLETED|3 Month Follow-up||33
10714168|NCT02684942|11879725|FG002|COMPLETED|Overall Study||7
10714169|NCT02684942|11879726|FG003|COMPLETED|Overall Study||7
10339493|NCT00372905|11476386|FG002|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||3
10339494|NCT00372905|11476387|FG003|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0
10339495|NCT00372905|11476384|FG000|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0
10339496|NCT00372905|11476385|FG001|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0
10339497|NCT00372905|11476386|FG002|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||1
10339498|NCT00372905|11476387|FG003|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0
10339499|NCT00372905|11476384|FG000|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
10339500|NCT00372905|11476385|FG001|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
10339501|NCT00372905|11476386|FG002|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||1
10339502|NCT00372905|11476387|FG003|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
10339503|NCT00372905|11476384|FG000|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
10339504|NCT00372905|11476385|FG001|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
10339505|NCT00372905|11476386|FG002|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||3
10339506|NCT00372905|11476387|FG003|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
10339507|NCT00372905|11476384|FG000|STARTED|Expansion Phase at Dose 1.3mg/m2||0
10339508|NCT00372905|11476385|FG001|STARTED|Expansion Phase at Dose 1.3mg/m2||0
10339509|NCT00372905|11476386|FG002|STARTED|Expansion Phase at Dose 1.3mg/m2||0
10339510|NCT00372905|11476387|FG003|STARTED|Expansion Phase at Dose 1.3mg/m2||8
10339511|NCT00372905|11476384|FG000|Registration|Expansion Phase at Dose 1.3mg/m2||0
10339512|NCT00372905|11476385|FG001|Registration|Expansion Phase at Dose 1.3mg/m2||0
10339513|NCT00372905|11476386|FG002|Registration|Expansion Phase at Dose 1.3mg/m2||0
10339514|NCT00372905|11476387|FG003|Registration|Expansion Phase at Dose 1.3mg/m2||8
10339515|NCT00372905|11476384|FG000|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0
10339516|NCT00372905|11476385|FG001|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0
10339517|NCT00372905|11476386|FG002|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0
10339518|NCT00372905|11476387|FG003|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||8
10339519|NCT00372905|11476384|FG000|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0
10339520|NCT00372905|11476385|FG001|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0
10339521|NCT00372905|11476386|FG002|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0
10339522|NCT00372905|11476387|FG003|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||6
10339523|NCT00372905|11476384|FG000|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
10339524|NCT00372905|11476385|FG001|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
10339525|NCT00372905|11476386|FG002|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
10339526|NCT00372905|11476387|FG003|COMPLETED|Expansion Phase at Dose 1.3mg/m2||6
10339527|NCT00372905|11476384|FG000|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
10339528|NCT00372905|11476385|FG001|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
10339529|NCT00372905|11476386|FG002|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
10339530|NCT00372905|11476387|FG003|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||2
10339531|NCT00372905|11476384|FG000|STARTED|Follow up Until Relapse or Progression|All patients that are treated on study move into the follow up phase at the completion of therapy.|3
10339532|NCT00372905|11476385|FG001|STARTED|Follow up Until Relapse or Progression||3
10714170|NCT02684942|11879727|FG004|COMPLETED|Overall Study||6
10714171|NCT02684942|11879728|FG005|COMPLETED|Overall Study||6
10714172|NCT02684942|11879723|FG000|NOT COMPLETED|Overall Study||0
10302088|NCT00066937|11434923|FG001|COMPLETED|3 Month Follow-up||32
10302089|NCT00066937|11434924|FG002|COMPLETED|3 Month Follow-up||25
10302090|NCT00066937|11434925|FG003|COMPLETED|3 Month Follow-up||15
10302091|NCT00066937|11434922|FG000|NOT COMPLETED|3 Month Follow-up||5
10302092|NCT00066937|11434923|FG001|NOT COMPLETED|3 Month Follow-up||1
10302093|NCT00066937|11434924|FG002|NOT COMPLETED|3 Month Follow-up||1
10302094|NCT00066937|11434925|FG003|NOT COMPLETED|3 Month Follow-up||4
10302095|NCT00066937|11434922|FG000|STARTED|6 Month Follow-up||33
10302096|NCT00066937|11434923|FG001|STARTED|6 Month Follow-up||32
10302097|NCT00066937|11434924|FG002|STARTED|6 Month Follow-up||25
10302098|NCT00066937|11434925|FG003|STARTED|6 Month Follow-up||15
10302099|NCT00066937|11434922|FG000|COMPLETED|6 Month Follow-up||26
10302100|NCT00066937|11434923|FG001|COMPLETED|6 Month Follow-up||29
10302101|NCT00066937|11434924|FG002|COMPLETED|6 Month Follow-up||22
10714173|NCT02684942|11879724|FG001|NOT COMPLETED|Overall Study||0
10714174|NCT02684942|11879725|FG002|NOT COMPLETED|Overall Study||0
10714175|NCT02684942|11879726|FG003|NOT COMPLETED|Overall Study||0
10714176|NCT02684942|11879727|FG004|NOT COMPLETED|Overall Study||0
10714177|NCT02684942|11879728|FG005|NOT COMPLETED|Overall Study||0
10714178|NCT02684981|11879742|FG000|STARTED|Overall Study||4100
10714179|NCT02684981|11879743|FG001|STARTED|Overall Study||3179
10714180|NCT02684981|11879744|FG002|STARTED|Overall Study||2186
10714181|NCT02684981|11879742|FG000|COMPLETED|Overall Study||3860
10714182|NCT02684981|11879743|FG001|COMPLETED|Overall Study||2969
10339533|NCT00372905|11476386|FG002|STARTED|Follow up Until Relapse or Progression||3
10339534|NCT00372905|11476387|FG003|STARTED|Follow up Until Relapse or Progression||8
10339535|NCT00372905|11476384|FG000|COMPLETED|Follow up Until Relapse or Progression||3
10339536|NCT00372905|11476385|FG001|COMPLETED|Follow up Until Relapse or Progression||2
10339537|NCT00372905|11476386|FG002|COMPLETED|Follow up Until Relapse or Progression||3
10339538|NCT00372905|11476387|FG003|COMPLETED|Follow up Until Relapse or Progression||5
10339539|NCT00372905|11476384|FG000|NOT COMPLETED|Follow up Until Relapse or Progression||0
10339540|NCT00372905|11476385|FG001|NOT COMPLETED|Follow up Until Relapse or Progression||1
10339541|NCT00372905|11476386|FG002|NOT COMPLETED|Follow up Until Relapse or Progression||0
10339542|NCT00372905|11476387|FG003|NOT COMPLETED|Follow up Until Relapse or Progression||3
10339543|NCT00372957|11476400|FG000|STARTED|Overall Study||10
10339544|NCT00372957|11476401|FG001|STARTED|Overall Study||10
10339545|NCT00372957|11476402|FG002|STARTED|Overall Study||10
10339546|NCT00372957|11476400|FG000|COMPLETED|Overall Study||10
10339547|NCT00372957|11476401|FG001|COMPLETED|Overall Study||10
10339548|NCT00372957|11476402|FG002|COMPLETED|Overall Study||10
10339549|NCT00372957|11476400|FG000|NOT COMPLETED|Overall Study||0
10339550|NCT00372957|11476401|FG001|NOT COMPLETED|Overall Study||0
10339551|NCT00372957|11476402|FG002|NOT COMPLETED|Overall Study||0
10339552|NCT00372970|11476414|FG000|STARTED|Overall Study||16
10339553|NCT00372970|11476415|FG001|STARTED|Overall Study||16
10339554|NCT00372970|11476414|FG000|COMPLETED|Overall Study||16
10339555|NCT00372970|11476415|FG001|COMPLETED|Overall Study||16
10339556|NCT00372970|11476414|FG000|NOT COMPLETED|Overall Study||0
10339557|NCT00372970|11476415|FG001|NOT COMPLETED|Overall Study||0
10339558|NCT00372996|11476423|FG000|STARTED|Overall Study||79
10339559|NCT00372996|11476424|FG001|STARTED|Overall Study||36
10339560|NCT00372996|11476425|FG002|STARTED|Overall Study||61
10339561|NCT00372996|11476426|FG003|STARTED|Overall Study||43
10339562|NCT00372996|11476423|FG000|COMPLETED|Overall Study||42
10339563|NCT00372996|11476424|FG001|COMPLETED|Overall Study||22
10339564|NCT00372996|11476425|FG002|COMPLETED|Overall Study||33
10339565|NCT00372996|11476426|FG003|COMPLETED|Overall Study||23
10339566|NCT00372996|11476423|FG000|NOT COMPLETED|Overall Study||37
10339567|NCT00372996|11476424|FG001|NOT COMPLETED|Overall Study||14
10339568|NCT00372996|11476425|FG002|NOT COMPLETED|Overall Study||28
10714183|NCT02684981|11879744|FG002|COMPLETED|Overall Study||2059
10714184|NCT02684981|11879742|FG000|NOT COMPLETED|Overall Study||240
10714185|NCT02684981|11879743|FG001|NOT COMPLETED|Overall Study||210
10714186|NCT02684981|11879744|FG002|NOT COMPLETED|Overall Study||127
10714187|NCT02685007|11879758|FG000|STARTED|Overall Study||131
10714188|NCT02685007|11879758|FG000|COMPLETED|Overall Study||131
10714189|NCT02685007|11879758|FG000|NOT COMPLETED|Overall Study||0
10714190|NCT02685033|11879764|FG000|STARTED|Overall Study||70
10714191|NCT02685033|11879765|FG001|STARTED|Overall Study||10
10714192|NCT02685033|11879764|FG000|COMPLETED|Overall Study||67
10714193|NCT02685033|11879765|FG001|COMPLETED|Overall Study||8
10714194|NCT02685033|11879764|FG000|NOT COMPLETED|Overall Study||3
10714195|NCT02685033|11879765|FG001|NOT COMPLETED|Overall Study||2
10714196|NCT02685072|11879773|FG000|STARTED|Treatment Period||33
10714197|NCT02685072|11879774|FG001|STARTED|Treatment Period||31
10714198|NCT02685072|11879773|FG000|Completed Week 2 Visit|Treatment Period||23
10714199|NCT02685072|11879774|FG001|Completed Week 2 Visit|Treatment Period||26
10714200|NCT02685072|11879773|FG000|Completed Week 3 Visit|Treatment Period||20
10714201|NCT02685072|11879774|FG001|Completed Week 3 Visit|Treatment Period||23
10339569|NCT00372996|11476426|FG003|NOT COMPLETED|Overall Study||20
10339570|NCT00373113|11476438|FG000|STARTED|Overall Study||238
10654708|NCT02204150|11815539|FG000|NOT COMPLETED|Overall Study||0
10654709|NCT02204176|11815546|FG000|STARTED|Overall Study||74
10654710|NCT02204176|11815547|FG001|STARTED|Overall Study||73
10654711|NCT02204176|11815548|FG002|STARTED|Overall Study||74
10654712|NCT02204176|11815546|FG000|COMPLETED|Overall Study||64
10654713|NCT02204176|11815547|FG001|COMPLETED|Overall Study||61
10654714|NCT02204176|11815548|FG002|COMPLETED|Overall Study||58
10654715|NCT02204176|11815546|FG000|NOT COMPLETED|Overall Study||10
10654716|NCT02204176|11815547|FG001|NOT COMPLETED|Overall Study||12
10654717|NCT02204176|11815548|FG002|NOT COMPLETED|Overall Study||16
10654718|NCT02204293|11815558|FG000|STARTED|Core Study Part I||19
10654719|NCT02204293|11815559|FG001|STARTED|Core Study Part I||17
10654720|NCT02204293|11815560|FG002|STARTED|Core Study Part I||0
10654721|NCT02204293|11815561|FG003|STARTED|Core Study Part I||0
10654722|NCT02204293|11815562|FG004|STARTED|Core Study Part I||0
10714202|NCT02685072|11879773|FG000|Completed Week 4 Visit|Treatment Period||19
10714203|NCT02685072|11879774|FG001|Completed Week 4 Visit|Treatment Period||23
10714204|NCT02685072|11879773|FG000|Completed Week 5 Visit|Treatment Period||19
10714205|NCT02685072|11879774|FG001|Completed Week 5 Visit|Treatment Period||22
10339571|NCT00373113|11476439|FG001|STARTED|Overall Study||244
10339572|NCT00373113|11476438|FG000|Received Treatment|Overall Study||238
10529481|NCT01401023|11681880|FG000|STARTED|Overall Study||10
10529482|NCT01401023|11681880|FG000|COMPLETED|Overall Study||10
10529483|NCT01401023|11681880|FG000|NOT COMPLETED|Overall Study||0
10529484|NCT01401062|11681888|FG000|STARTED|Overall Study||11
10529485|NCT01401062|11681889|FG001|STARTED|Overall Study||12
10339573|NCT00373113|11476439|FG001|Received Treatment|Overall Study||240
10529486|NCT01401062|11681888|FG000|COMPLETED|Overall Study||0
10529487|NCT01401062|11681889|FG001|COMPLETED|Overall Study|At time of data entry, these 4 patients are still undergoing follow-up|4
10529488|NCT01401062|11681888|FG000|NOT COMPLETED|Overall Study||11
10529489|NCT01401062|11681889|FG001|NOT COMPLETED|Overall Study||8
10529490|NCT01401101|11681897|FG000|STARTED|Overall Study||206
10529491|NCT01401101|11681898|FG001|STARTED|Overall Study||198
10529492|NCT01401101|11681897|FG000|COMPLETED|Overall Study||184
10529493|NCT01401101|11681898|FG001|COMPLETED|Overall Study||171
10529494|NCT01401101|11681897|FG000|NOT COMPLETED|Overall Study||22
10529495|NCT01401101|11681898|FG001|NOT COMPLETED|Overall Study||27
10529496|NCT01401153|11681906|FG000|STARTED|First Test Day||66
10529497|NCT01401153|11681907|FG001|STARTED|First Test Day||55
10529498|NCT01401153|11681906|FG000|COMPLETED|First Test Day||65
10529499|NCT01401153|11681907|FG001|COMPLETED|First Test Day||45
10529500|NCT01401153|11681906|FG000|NOT COMPLETED|First Test Day||1
10529501|NCT01401153|11681907|FG001|NOT COMPLETED|First Test Day||10
10529502|NCT01401153|11681906|FG000|STARTED|Second Test Day||45
10529503|NCT01401153|11681907|FG001|STARTED|Second Test Day||65
10529504|NCT01401153|11681906|FG000|COMPLETED|Second Test Day||45
10529505|NCT01401153|11681907|FG001|COMPLETED|Second Test Day||60
10529506|NCT01401153|11681906|FG000|NOT COMPLETED|Second Test Day||0
10529507|NCT01401153|11681907|FG001|NOT COMPLETED|Second Test Day||5
10529508|NCT01401166|11681916|FG000|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 124 participants were randomized, but 2 did not receive any treatment.|122
10529509|NCT01401166|11681917|FG001|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 124 participants were randomized, but 2 did not receive any treatment.|122
10529510|NCT01401166|11681918|FG002|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 121 participants were randomized who all received study treatment.|121
10529511|NCT01401166|11681919|FG003|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 119 participants were randomized, but 1 did not receive any treatment.|118
10529512|NCT01401166|11681916|FG000|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||119
10529513|NCT01401166|11681917|FG001|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||120
10654723|NCT02204293|11815563|FG005|STARTED|Core Study Part I||0
10654724|NCT02204293|11815558|FG000|Intention-to-treat Population|Core Study Part I|One participant left the study before treatment was started.|18
10654725|NCT02204293|11815559|FG001|Intention-to-treat Population|Core Study Part I||17
10654726|NCT02204293|11815560|FG002|Intention-to-treat Population|Core Study Part I||0
10654727|NCT02204293|11815561|FG003|Intention-to-treat Population|Core Study Part I||0
10654728|NCT02204293|11815562|FG004|Intention-to-treat Population|Core Study Part I||0
10654729|NCT02204293|11815563|FG005|Intention-to-treat Population|Core Study Part I||0
10654730|NCT02204293|11815558|FG000|Safety Population|Core Study Part I|2 participants from placebo arm received canakinumab at Week 4, included in Safety population.|20
10654731|NCT02204293|11815559|FG001|Safety Population|Core Study Part I||15
10654732|NCT02204293|11815560|FG002|Safety Population|Core Study Part I||0
10654733|NCT02204293|11815561|FG003|Safety Population|Core Study Part I||0
10654734|NCT02204293|11815562|FG004|Safety Population|Core Study Part I||0
10654735|NCT02204293|11815563|FG005|Safety Population|Core Study Part I||0
10654736|NCT02204293|11815558|FG000|COMPLETED|Core Study Part I||17
10654737|NCT02204293|11815559|FG001|COMPLETED|Core Study Part I||14
10654738|NCT02204293|11815560|FG002|COMPLETED|Core Study Part I||0
10654739|NCT02204293|11815561|FG003|COMPLETED|Core Study Part I||0
10654740|NCT02204293|11815562|FG004|COMPLETED|Core Study Part I||0
10654741|NCT02204293|11815563|FG005|COMPLETED|Core Study Part I||0
10654742|NCT02204293|11815558|FG000|NOT COMPLETED|Core Study Part I||2
10654743|NCT02204293|11815559|FG001|NOT COMPLETED|Core Study Part I||3
10654744|NCT02204293|11815560|FG002|NOT COMPLETED|Core Study Part I||0
10529514|NCT01401166|11681918|FG002|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||119
10529515|NCT01401166|11681919|FG003|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||116
10547843|NCT01515319|11701605|FG009|NOT COMPLETED|Overall Study||0
10339574|NCT00373113|11476438|FG000|COMPLETED|Overall Study||0
10339575|NCT00373113|11476439|FG001|COMPLETED|Overall Study||0
10339576|NCT00373113|11476438|FG000|NOT COMPLETED|Overall Study||238
10302102|NCT00066937|11434925|FG003|COMPLETED|6 Month Follow-up||14
10302103|NCT00066937|11434922|FG000|NOT COMPLETED|6 Month Follow-up||7
10302104|NCT00066937|11434923|FG001|NOT COMPLETED|6 Month Follow-up||3
10302105|NCT00066937|11434924|FG002|NOT COMPLETED|6 Month Follow-up||3
10302106|NCT00066937|11434925|FG003|NOT COMPLETED|6 Month Follow-up||1
10302107|NCT00067002|11434937|FG000|STARTED|Overall Study||52
10302108|NCT00067002|11434938|FG001|STARTED|Overall Study||53
10302109|NCT00067002|11434937|FG000|COMPLETED|Overall Study||45
10302110|NCT00067002|11434938|FG001|COMPLETED|Overall Study||44
10302111|NCT00067002|11434937|FG000|NOT COMPLETED|Overall Study||7
10302112|NCT00067002|11434938|FG001|NOT COMPLETED|Overall Study||9
10302113|NCT00067028|11434947|FG000|STARTED|Overall Study||17
10302114|NCT00067028|11434948|FG001|STARTED|Overall Study||36
10302115|NCT00067028|11434949|FG002|STARTED|Overall Study||63
10302116|NCT00067028|11434947|FG000|COMPLETED|Overall Study||17
10302117|NCT00067028|11434948|FG001|COMPLETED|Overall Study||36
10302118|NCT00067028|11434949|FG002|COMPLETED|Overall Study||63
10302119|NCT00067028|11434947|FG000|NOT COMPLETED|Overall Study||0
10302120|NCT00067028|11434948|FG001|NOT COMPLETED|Overall Study||0
10302121|NCT00067028|11434949|FG002|NOT COMPLETED|Overall Study||0
10302122|NCT00067236|11434961|FG000|STARTED|Overall Study||128
10302123|NCT00067236|11434962|FG001|STARTED|Overall Study||125
10302124|NCT00067236|11434961|FG000|COMPLETED|Overall Study||108
10302125|NCT00067236|11434962|FG001|COMPLETED|Overall Study||99
10302126|NCT00067236|11434961|FG000|NOT COMPLETED|Overall Study||20
10302127|NCT00067236|11434962|FG001|NOT COMPLETED|Overall Study||26
10302128|NCT00067470|11434970|FG000|STARTED|Overall Study||19
10302129|NCT00067470|11434971|FG001|STARTED|Overall Study||20
10302130|NCT00067470|11434970|FG000|COMPLETED|Overall Study||19
10339577|NCT00373113|11476439|FG001|NOT COMPLETED|Overall Study||244
10654745|NCT02204293|11815561|FG003|NOT COMPLETED|Core Study Part I||0
10654746|NCT02204293|11815562|FG004|NOT COMPLETED|Core Study Part I||0
10654747|NCT02204293|11815563|FG005|NOT COMPLETED|Core Study Part I||0
10654748|NCT02204293|11815558|FG000|STARTED|Core Study Part 2|Participants who achieved response at Week 12, entered Part II.|0
10654749|NCT02204293|11815559|FG001|STARTED|Core Study Part 2||0
10654750|NCT02204293|11815560|FG002|STARTED|Core Study Part 2|Participants who achieved response at Week 12, entered Part II.|12
10654751|NCT02204293|11815561|FG003|STARTED|Core Study Part 2||4
10654752|NCT02204293|11815562|FG004|STARTED|Core Study Part 2||7
10654753|NCT02204293|11815563|FG005|STARTED|Core Study Part 2||0
10654754|NCT02204293|11815558|FG000|Safety Population|Core Study Part 2||0
10654755|NCT02204293|11815559|FG001|Safety Population|Core Study Part 2||0
10654756|NCT02204293|11815560|FG002|Safety Population|Core Study Part 2|Included 2 participants from placebo arm who received canakinumab at Week 4.|14
10654757|NCT02204293|11815561|FG003|Safety Population|Core Study Part 2||2
10654758|NCT02204293|11815562|FG004|Safety Population|Core Study Part 2||7
10654759|NCT02204293|11815563|FG005|Safety Population|Core Study Part 2||0
10654760|NCT02204293|11815558|FG000|COMPLETED|Core Study Part 2||0
10654761|NCT02204293|11815559|FG001|COMPLETED|Core Study Part 2||0
10654762|NCT02204293|11815560|FG002|COMPLETED|Core Study Part 2||12
10654763|NCT02204293|11815561|FG003|COMPLETED|Core Study Part 2||4
10654764|NCT02204293|11815562|FG004|COMPLETED|Core Study Part 2||7
10654765|NCT02204293|11815563|FG005|COMPLETED|Core Study Part 2||0
10654766|NCT02204293|11815558|FG000|NOT COMPLETED|Core Study Part 2||0
10654767|NCT02204293|11815559|FG001|NOT COMPLETED|Core Study Part 2||0
10654768|NCT02204293|11815560|FG002|NOT COMPLETED|Core Study Part 2||0
10654769|NCT02204293|11815561|FG003|NOT COMPLETED|Core Study Part 2||0
10654770|NCT02204293|11815562|FG004|NOT COMPLETED|Core Study Part 2||0
10654771|NCT02204293|11815563|FG005|NOT COMPLETED|Core Study Part 2||0
10654772|NCT02204293|11815558|FG000|STARTED|LTE Phase||0
10654773|NCT02204293|11815559|FG001|STARTED|LTE Phase||0
10654774|NCT02204293|11815560|FG002|STARTED|LTE Phase||0
10654775|NCT02204293|11815561|FG003|STARTED|LTE Phase||0
10654776|NCT02204293|11815562|FG004|STARTED|LTE Phase||0
10654777|NCT02204293|11815563|FG005|STARTED|LTE Phase||7
10654778|NCT02204293|11815558|FG000|COMPLETED|LTE Phase||0
10654779|NCT02204293|11815559|FG001|COMPLETED|LTE Phase||0
10654780|NCT02204293|11815560|FG002|COMPLETED|LTE Phase||0
10654781|NCT02204293|11815561|FG003|COMPLETED|LTE Phase||0
10654782|NCT02204293|11815562|FG004|COMPLETED|LTE Phase||0
10654783|NCT02204293|11815563|FG005|COMPLETED|LTE Phase||0
10654784|NCT02204293|11815558|FG000|NOT COMPLETED|LTE Phase||0
10654785|NCT02204293|11815559|FG001|NOT COMPLETED|LTE Phase||0
10654786|NCT02204293|11815560|FG002|NOT COMPLETED|LTE Phase||0
10654787|NCT02204293|11815561|FG003|NOT COMPLETED|LTE Phase||0
10654788|NCT02204293|11815562|FG004|NOT COMPLETED|LTE Phase||0
10302131|NCT00067470|11434971|FG001|COMPLETED|Overall Study||19
10302132|NCT00067470|11434970|FG000|NOT COMPLETED|Overall Study||0
10302133|NCT00067470|11434971|FG001|NOT COMPLETED|Overall Study||1
10302134|NCT00067808|11434980|FG000|STARTED|Overall Study||17
10302135|NCT00067808|11434981|FG001|STARTED|Overall Study||93
10302136|NCT00067808|11434982|FG002|STARTED|Overall Study||14
10302137|NCT00067808|11434980|FG000|COMPLETED|Overall Study||17
10302138|NCT00067808|11434981|FG001|COMPLETED|Overall Study||93
10302139|NCT00067808|11434982|FG002|COMPLETED|Overall Study||14
10302140|NCT00067808|11434980|FG000|NOT COMPLETED|Overall Study||0
10302141|NCT00067808|11434981|FG001|NOT COMPLETED|Overall Study||0
10302142|NCT00067808|11434982|FG002|NOT COMPLETED|Overall Study||0
10302143|NCT00067990|11434992|FG000|STARTED|Overall Study||77
10654789|NCT02204293|11815563|FG005|NOT COMPLETED|LTE Phase||7
10302144|NCT00067990|11434993|FG001|STARTED|Overall Study||76
10302145|NCT00067990|11434992|FG000|COMPLETED|Overall Study||67
10654790|NCT02204319|11815577|FG000|STARTED|Overall Study||10
10302146|NCT00067990|11434993|FG001|COMPLETED|Overall Study||54
10302147|NCT00067990|11434992|FG000|NOT COMPLETED|Overall Study||10
10654791|NCT02204319|11815577|FG000|COMPLETED|Overall Study|3 did not complete study.|7
10714206|NCT02685072|11879773|FG000|Completed Week 6 Visit|Treatment Period||18
10714207|NCT02685072|11879774|FG001|Completed Week 6 Visit|Treatment Period||19
10714208|NCT02685072|11879773|FG000|Completed Week 7 Visit|Treatment Period||17
10714209|NCT02685072|11879774|FG001|Completed Week 7 Visit|Treatment Period||18
10302148|NCT00067990|11434993|FG001|NOT COMPLETED|Overall Study||22
10302149|NCT00068107|11434999|FG000|STARTED|Overall Study||12
10302150|NCT00068107|11434999|FG000|COMPLETED|Overall Study||3
10302151|NCT00068107|11434999|FG000|NOT COMPLETED|Overall Study||9
10302152|NCT00068237|11435006|FG000|STARTED|Overall Study||49
10302153|NCT00068237|11435006|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
10302154|NCT00068237|11435006|FG000|NOT COMPLETED|Overall Study||5
10302155|NCT00068250|11435013|FG000|STARTED|Phase I: Dose Level 1||6
10654792|NCT02204319|11815577|FG000|NOT COMPLETED|Overall Study||3
10654793|NCT02204371|11815582|FG000|STARTED|Overall Study||7
10654794|NCT02204371|11815582|FG000|COMPLETED|Overall Study||6
10654795|NCT02204371|11815582|FG000|NOT COMPLETED|Overall Study||1
10529516|NCT01401166|11681916|FG000|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||3
10529517|NCT01401166|11681917|FG001|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
10529518|NCT01401166|11681918|FG002|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
10529519|NCT01401166|11681919|FG003|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
10529520|NCT01401166|11681916|FG000|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||119
10811597|NCT03757039|11973411|FG001|STARTED|Overall Study||9
10811598|NCT03757039|11973410|FG000|AOHG MF|Overall Study||11
10811599|NCT03757039|11973411|FG001|AOHG MF|Overall Study||0
10811600|NCT03757039|11973410|FG000|DT1 MF|Overall Study||11
10811601|NCT03757039|11973411|FG001|DT1 MF|Overall Study||0
10811602|NCT03757039|11973410|FG000|DACP MF|Overall Study||10
10811603|NCT03757039|11973411|FG001|DACP MF|Overall Study||0
10811604|NCT03757039|11973410|FG000|COMPLETED|Overall Study||32
10811605|NCT03757039|11973411|FG001|COMPLETED|Overall Study||9
10811606|NCT03757039|11973410|FG000|NOT COMPLETED|Overall Study||0
10811607|NCT03757039|11973411|FG001|NOT COMPLETED|Overall Study||0
10811608|NCT03756883|11973422|FG000|STARTED|Overall Study||485
10811609|NCT03756883|11973423|FG001|STARTED|Overall Study||413
10811610|NCT03756883|11973424|FG002|STARTED|Overall Study||101
10811611|NCT03756883|11973422|FG000|COMPLETED|Overall Study||472
10811612|NCT03756883|11973423|FG001|COMPLETED|Overall Study||402
10811613|NCT03756883|11973424|FG002|COMPLETED|Overall Study||94
10811614|NCT03756883|11973422|FG000|NOT COMPLETED|Overall Study||13
10811615|NCT03756883|11973423|FG001|NOT COMPLETED|Overall Study||11
10811616|NCT03756883|11973424|FG002|NOT COMPLETED|Overall Study||7
10811617|NCT03756506|11973434|FG000|STARTED|Overall Study||7
10811618|NCT03756506|11973435|FG001|STARTED|Overall Study||6
10811619|NCT03756506|11973434|FG000|COMPLETED|Overall Study||6
10811620|NCT03756506|11973435|FG001|COMPLETED|Overall Study||6
10811621|NCT03756506|11973434|FG000|NOT COMPLETED|Overall Study||1
10811622|NCT03756506|11973435|FG001|NOT COMPLETED|Overall Study||0
10811623|NCT03756285|11973443|FG000|STARTED|Overall Study||27
10811624|NCT03756285|11973444|FG001|STARTED|Overall Study||14
10811625|NCT03756285|11973443|FG000|COMPLETED|Overall Study||24
10811626|NCT03756285|11973444|FG001|COMPLETED|Overall Study||9
10811627|NCT03756285|11973443|FG000|NOT COMPLETED|Overall Study||3
10811628|NCT03756285|11973444|FG001|NOT COMPLETED|Overall Study||5
10811629|NCT03756129|11973457|FG000|STARTED|Overall Study||11
10811630|NCT03756129|11973458|FG001|STARTED|Overall Study||10
10811631|NCT03756129|11973459|FG002|STARTED|Overall Study||10
10811632|NCT03756129|11973460|FG003|STARTED|Overall Study|1 participant in this group was randomized but not treated, and is not included in this data set.|9
10529521|NCT01401166|11681917|FG001|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||120
10302156|NCT00068250|11435014|FG001|STARTED|Phase I: Dose Level 1||0
10302157|NCT00068250|11435015|FG002|STARTED|Phase I: Dose Level 1||0
10302158|NCT00068250|11435016|FG003|STARTED|Phase I: Dose Level 1||0
10302159|NCT00068250|11435013|FG000|COMPLETED|Phase I: Dose Level 1|Subjects with data available for the primary analysis are considered to have completed the study.|6
10302160|NCT00068250|11435014|FG001|COMPLETED|Phase I: Dose Level 1||0
10302161|NCT00068250|11435015|FG002|COMPLETED|Phase I: Dose Level 1||0
10302162|NCT00068250|11435016|FG003|COMPLETED|Phase I: Dose Level 1||0
10302163|NCT00068250|11435013|FG000|NOT COMPLETED|Phase I: Dose Level 1||0
10302164|NCT00068250|11435014|FG001|NOT COMPLETED|Phase I: Dose Level 1||0
10302165|NCT00068250|11435015|FG002|NOT COMPLETED|Phase I: Dose Level 1||0
10302166|NCT00068250|11435016|FG003|NOT COMPLETED|Phase I: Dose Level 1||0
10302167|NCT00068250|11435013|FG000|STARTED|Phase I: Dose Level 2||0
10302168|NCT00068250|11435014|FG001|STARTED|Phase I: Dose Level 2||7
10302169|NCT00068250|11435015|FG002|STARTED|Phase I: Dose Level 2||0
10302170|NCT00068250|11435016|FG003|STARTED|Phase I: Dose Level 2||0
10302171|NCT00068250|11435013|FG000|COMPLETED|Phase I: Dose Level 2||0
10302172|NCT00068250|11435014|FG001|COMPLETED|Phase I: Dose Level 2|Subjects with data available for the primary analysis are considered to have completed the study.|6
10302173|NCT00068250|11435015|FG002|COMPLETED|Phase I: Dose Level 2||0
10302174|NCT00068250|11435016|FG003|COMPLETED|Phase I: Dose Level 2||0
10302175|NCT00068250|11435013|FG000|NOT COMPLETED|Phase I: Dose Level 2||0
10302176|NCT00068250|11435014|FG001|NOT COMPLETED|Phase I: Dose Level 2||1
10714210|NCT02685072|11879773|FG000|Completed Week 8 Visit|Treatment Period||20
10714211|NCT02685072|11879774|FG001|Completed Week 8 Visit|Treatment Period|Week 8 data were collected at the 1-month follow-up for 1 participant|22
10714212|NCT02685072|11879773|FG000|COMPLETED|Treatment Period||20
10339578|NCT00373256|11476447|FG000|STARTED|Overall Study||241
10339579|NCT00373256|11476448|FG001|STARTED|Overall Study||247
10339580|NCT00373256|11476447|FG000|Treated|Overall Study||235
10339581|NCT00373256|11476448|FG001|Treated|Overall Study||236
10339582|NCT00373256|11476447|FG000|COMPLETED|Overall Study||0
10339583|NCT00373256|11476448|FG001|COMPLETED|Overall Study||0
10339584|NCT00373256|11476447|FG000|NOT COMPLETED|Overall Study||241
10714213|NCT02685072|11879774|FG001|COMPLETED|Treatment Period||22
10339585|NCT00373256|11476448|FG001|NOT COMPLETED|Overall Study||247
10339586|NCT00373269|11476456|FG000|STARTED|Overall Study||11
10714214|NCT02685072|11879773|FG000|NOT COMPLETED|Treatment Period||13
10714215|NCT02685072|11879774|FG001|NOT COMPLETED|Treatment Period||9
10714216|NCT02685072|11879773|FG000|STARTED|1-Month Follow-Up||20
10714217|NCT02685072|11879774|FG001|STARTED|1-Month Follow-Up||22
10714218|NCT02685072|11879773|FG000|COMPLETED|1-Month Follow-Up||19
10714219|NCT02685072|11879774|FG001|COMPLETED|1-Month Follow-Up||22
10339587|NCT00373269|11476457|FG001|STARTED|Overall Study||10
10714220|NCT02685072|11879773|FG000|NOT COMPLETED|1-Month Follow-Up||1
10714221|NCT02685072|11879774|FG001|NOT COMPLETED|1-Month Follow-Up||0
10339588|NCT00373269|11476456|FG000|COMPLETED|Overall Study||11
10714222|NCT02685072|11879773|FG000|STARTED|3-Month Follow-Up||19
10714223|NCT02685072|11879774|FG001|STARTED|3-Month Follow-Up||22
10714224|NCT02685072|11879773|FG000|COMPLETED|3-Month Follow-Up||19
10714225|NCT02685072|11879774|FG001|COMPLETED|3-Month Follow-Up||22
10714226|NCT02685072|11879773|FG000|NOT COMPLETED|3-Month Follow-Up||0
10714227|NCT02685072|11879774|FG001|NOT COMPLETED|3-Month Follow-Up||0
10714228|NCT02685267|11879783|FG000|STARTED|Overall Study||5
10714229|NCT02685267|11879784|FG001|STARTED|Overall Study||4
10714230|NCT02685267|11879783|FG000|COMPLETED|Overall Study||5
10714231|NCT02685267|11879784|FG001|COMPLETED|Overall Study||4
10714232|NCT02685267|11879783|FG000|NOT COMPLETED|Overall Study||0
10339589|NCT00373269|11476457|FG001|COMPLETED|Overall Study||10
10339590|NCT00373269|11476456|FG000|NOT COMPLETED|Overall Study||0
10339591|NCT00373269|11476457|FG001|NOT COMPLETED|Overall Study||0
10339592|NCT00373295|11476463|FG000|STARTED|Intervention 1 (8 Days)||2
10339593|NCT00373295|11476464|FG001|STARTED|Intervention 1 (8 Days)||3
10339594|NCT00373295|11476465|FG002|STARTED|Intervention 1 (8 Days)||1
10339595|NCT00373295|11476466|FG003|STARTED|Intervention 1 (8 Days)||2
10339596|NCT00373295|11476467|FG004|STARTED|Intervention 1 (8 Days)||3
10339597|NCT00373295|11476468|FG005|STARTED|Intervention 1 (8 Days)||2
10339598|NCT00373295|11476463|FG000|COMPLETED|Intervention 1 (8 Days)||2
10339599|NCT00373295|11476464|FG001|COMPLETED|Intervention 1 (8 Days)||1
10339600|NCT00373295|11476465|FG002|COMPLETED|Intervention 1 (8 Days)||1
10339601|NCT00373295|11476466|FG003|COMPLETED|Intervention 1 (8 Days)||2
10339602|NCT00373295|11476467|FG004|COMPLETED|Intervention 1 (8 Days)||2
10339603|NCT00373295|11476468|FG005|COMPLETED|Intervention 1 (8 Days)||2
10339604|NCT00373295|11476463|FG000|NOT COMPLETED|Intervention 1 (8 Days)||0
10339605|NCT00373295|11476464|FG001|NOT COMPLETED|Intervention 1 (8 Days)||2
10339606|NCT00373295|11476465|FG002|NOT COMPLETED|Intervention 1 (8 Days)||0
10339607|NCT00373295|11476466|FG003|NOT COMPLETED|Intervention 1 (8 Days)||0
10339608|NCT00373295|11476467|FG004|NOT COMPLETED|Intervention 1 (8 Days)||1
10339609|NCT00373295|11476468|FG005|NOT COMPLETED|Intervention 1 (8 Days)||0
10339610|NCT00373295|11476463|FG000|STARTED|Intervention 2 (8 Days)||2
10339611|NCT00373295|11476464|FG001|STARTED|Intervention 2 (8 Days)||1
10339612|NCT00373295|11476465|FG002|STARTED|Intervention 2 (8 Days)||1
10529522|NCT01401166|11681918|FG002|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||119
10529523|NCT01401166|11681919|FG003|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||116
10529524|NCT01401166|11681916|FG000|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||113
10529525|NCT01401166|11681917|FG001|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||116
10529526|NCT01401166|11681918|FG002|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||107
10529527|NCT01401166|11681919|FG003|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||105
10529528|NCT01401166|11681916|FG000|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||6
10529529|NCT01401166|11681917|FG001|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||4
10529530|NCT01401166|11681918|FG002|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||12
10529531|NCT01401166|11681919|FG003|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||11
10714233|NCT02685267|11879784|FG001|NOT COMPLETED|Overall Study||0
10339613|NCT00373295|11476466|FG003|STARTED|Intervention 2 (8 Days)||2
10529532|NCT01401166|11681916|FG000|STARTED|Continuation Treatment (Cycles 9 to 18)||113
10529533|NCT01401166|11681917|FG001|STARTED|Continuation Treatment (Cycles 9 to 18)||116
10714234|NCT02685293|11879790|FG000|STARTED|Treatment Period 1||1
10714235|NCT02685293|11879791|FG001|STARTED|Treatment Period 1||3
10714236|NCT02685293|11879790|FG000|COMPLETED|Treatment Period 1||1
10714237|NCT02685293|11879791|FG001|COMPLETED|Treatment Period 1||3
10714238|NCT02685293|11879790|FG000|NOT COMPLETED|Treatment Period 1||0
10714239|NCT02685293|11879791|FG001|NOT COMPLETED|Treatment Period 1||0
10714240|NCT02685293|11879790|FG000|STARTED|Washout Period||1
10529534|NCT01401166|11681918|FG002|STARTED|Continuation Treatment (Cycles 9 to 18)||107
10529535|NCT01401166|11681919|FG003|STARTED|Continuation Treatment (Cycles 9 to 18)||105
10529536|NCT01401166|11681916|FG000|COMPLETED|Continuation Treatment (Cycles 9 to 18)||109
10529537|NCT01401166|11681917|FG001|COMPLETED|Continuation Treatment (Cycles 9 to 18)||109
10529538|NCT01401166|11681918|FG002|COMPLETED|Continuation Treatment (Cycles 9 to 18)||105
10529539|NCT01401166|11681919|FG003|COMPLETED|Continuation Treatment (Cycles 9 to 18)||102
10529540|NCT01401166|11681916|FG000|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||4
10529541|NCT01401166|11681917|FG001|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||7
10529542|NCT01401166|11681918|FG002|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||2
10529543|NCT01401166|11681919|FG003|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||3
10529544|NCT01401166|11681916|FG000|STARTED|Safety Follow-Up Period|All 124 randomized participants entered follow-up regardless of whether they received treatment.|124
10714241|NCT02685293|11879791|FG001|STARTED|Washout Period||3
10339614|NCT00373295|11476467|FG004|STARTED|Intervention 2 (8 Days)||2
10339615|NCT00373295|11476468|FG005|STARTED|Intervention 2 (8 Days)||2
10339616|NCT00373295|11476463|FG000|COMPLETED|Intervention 2 (8 Days)||2
10339617|NCT00373295|11476464|FG001|COMPLETED|Intervention 2 (8 Days)||1
10339618|NCT00373295|11476465|FG002|COMPLETED|Intervention 2 (8 Days)||1
10339619|NCT00373295|11476466|FG003|COMPLETED|Intervention 2 (8 Days)||2
10339620|NCT00373295|11476467|FG004|COMPLETED|Intervention 2 (8 Days)||2
10339621|NCT00373295|11476468|FG005|COMPLETED|Intervention 2 (8 Days)||2
10339622|NCT00373295|11476463|FG000|NOT COMPLETED|Intervention 2 (8 Days)||0
10714242|NCT02685293|11879790|FG000|COMPLETED|Washout Period||1
10714243|NCT02685293|11879791|FG001|COMPLETED|Washout Period||3
10811633|NCT03756129|11973461|FG004|STARTED|Overall Study|1 participant in this group was randomized but not treated, and is not included in this data set.|10
10811634|NCT03756129|11973462|FG005|STARTED|Overall Study||20
10811635|NCT03756129|11973457|FG000|COMPLETED|Overall Study||8
10811636|NCT03756129|11973458|FG001|COMPLETED|Overall Study||8
10811637|NCT03756129|11973459|FG002|COMPLETED|Overall Study||7
10811638|NCT03756129|11973460|FG003|COMPLETED|Overall Study||6
10714244|NCT02685293|11879790|FG000|NOT COMPLETED|Washout Period||0
10714245|NCT02685293|11879791|FG001|NOT COMPLETED|Washout Period||0
10714246|NCT02685293|11879790|FG000|STARTED|Treatment Period 2||1
10714247|NCT02685293|11879791|FG001|STARTED|Treatment Period 2||3
10714248|NCT02685293|11879790|FG000|COMPLETED|Treatment Period 2||1
10714249|NCT02685293|11879791|FG001|COMPLETED|Treatment Period 2||3
10714250|NCT02685293|11879790|FG000|NOT COMPLETED|Treatment Period 2||0
10714251|NCT02685293|11879791|FG001|NOT COMPLETED|Treatment Period 2||0
10714252|NCT02685436|11879797|FG000|STARTED|Overall Study|the overall studied group|52
10714253|NCT02685436|11879797|FG000|COMPLETED|Overall Study|GERD positive patients by either combined MII-pH or esophageal biopsy|38
10714254|NCT02685436|11879797|FG000|NOT COMPLETED|Overall Study||14
10714255|NCT02685488|11879803|FG000|STARTED|Overall Study||12
10714256|NCT02685488|11879804|FG001|STARTED|Overall Study||14
10714257|NCT02685488|11879803|FG000|COMPLETED|Overall Study||12
10714258|NCT02685488|11879804|FG001|COMPLETED|Overall Study||13
10714259|NCT02685488|11879803|FG000|NOT COMPLETED|Overall Study||0
10714260|NCT02685488|11879804|FG001|NOT COMPLETED|Overall Study||1
10714261|NCT02685566|11879810|FG000|STARTED|First Reading Session||50
10714262|NCT02685566|11879811|FG001|STARTED|First Reading Session||50
10714263|NCT02685566|11879810|FG000|COMPLETED|First Reading Session||50
10714264|NCT02685566|11879811|FG001|COMPLETED|First Reading Session||50
10714265|NCT02685566|11879810|FG000|NOT COMPLETED|First Reading Session||0
10714266|NCT02685566|11879811|FG001|NOT COMPLETED|First Reading Session||0
10714267|NCT02685566|11879810|FG000|STARTED|4 Week Memory Washout Period||50
10714268|NCT02685566|11879811|FG001|STARTED|4 Week Memory Washout Period||50
10714269|NCT02685566|11879810|FG000|COMPLETED|4 Week Memory Washout Period||50
10714270|NCT02685566|11879811|FG001|COMPLETED|4 Week Memory Washout Period||50
10811639|NCT03756129|11973461|FG004|COMPLETED|Overall Study||9
10811640|NCT03756129|11973462|FG005|COMPLETED|Overall Study||15
10714271|NCT02685566|11879810|FG000|NOT COMPLETED|4 Week Memory Washout Period||0
10714272|NCT02685566|11879811|FG001|NOT COMPLETED|4 Week Memory Washout Period||0
10714273|NCT02685566|11879810|FG000|STARTED|Second Reading Session||50
10714274|NCT02685566|11879811|FG001|STARTED|Second Reading Session||50
10811641|NCT03756129|11973457|FG000|NOT COMPLETED|Overall Study||3
10339623|NCT00373295|11476464|FG001|NOT COMPLETED|Intervention 2 (8 Days)||0
10339624|NCT00373295|11476465|FG002|NOT COMPLETED|Intervention 2 (8 Days)||0
10339625|NCT00373295|11476466|FG003|NOT COMPLETED|Intervention 2 (8 Days)||0
10339626|NCT00373295|11476467|FG004|NOT COMPLETED|Intervention 2 (8 Days)||0
10339627|NCT00373295|11476468|FG005|NOT COMPLETED|Intervention 2 (8 Days)||0
10339628|NCT00373295|11476463|FG000|STARTED|Intervention 3 (8 Days)||2
10339629|NCT00373295|11476464|FG001|STARTED|Intervention 3 (8 Days)||1
10339630|NCT00373295|11476465|FG002|STARTED|Intervention 3 (8 Days)||1
10339631|NCT00373295|11476466|FG003|STARTED|Intervention 3 (8 Days)||2
10339632|NCT00373295|11476467|FG004|STARTED|Intervention 3 (8 Days)||2
10339633|NCT00373295|11476468|FG005|STARTED|Intervention 3 (8 Days)||2
10339634|NCT00373295|11476463|FG000|COMPLETED|Intervention 3 (8 Days)||2
10339635|NCT00373295|11476464|FG001|COMPLETED|Intervention 3 (8 Days)||1
10339636|NCT00373295|11476465|FG002|COMPLETED|Intervention 3 (8 Days)||1
10339637|NCT00373295|11476466|FG003|COMPLETED|Intervention 3 (8 Days)||2
10339638|NCT00373295|11476467|FG004|COMPLETED|Intervention 3 (8 Days)||2
10339639|NCT00373295|11476468|FG005|COMPLETED|Intervention 3 (8 Days)||2
10339640|NCT00373295|11476463|FG000|NOT COMPLETED|Intervention 3 (8 Days)||0
10339641|NCT00373295|11476464|FG001|NOT COMPLETED|Intervention 3 (8 Days)||0
10339642|NCT00373295|11476465|FG002|NOT COMPLETED|Intervention 3 (8 Days)||0
10339643|NCT00373295|11476466|FG003|NOT COMPLETED|Intervention 3 (8 Days)||0
10339644|NCT00373295|11476467|FG004|NOT COMPLETED|Intervention 3 (8 Days)||0
10339645|NCT00373295|11476468|FG005|NOT COMPLETED|Intervention 3 (8 Days)||0
10339646|NCT00373334|11476479|FG000|STARTED|Overall Study||43
10339647|NCT00373334|11476480|FG001|STARTED|Overall Study||50
10339648|NCT00373334|11476481|FG002|STARTED|Overall Study||45
10339649|NCT00373334|11476479|FG000|COMPLETED|Overall Study||33
10339650|NCT00373334|11476480|FG001|COMPLETED|Overall Study||32
10339651|NCT00373334|11476481|FG002|COMPLETED|Overall Study||32
10339652|NCT00373334|11476479|FG000|NOT COMPLETED|Overall Study||10
10339653|NCT00373334|11476480|FG001|NOT COMPLETED|Overall Study||18
10339654|NCT00373334|11476481|FG002|NOT COMPLETED|Overall Study||13
10339655|NCT00373360|11476489|FG000|STARTED|Overall Study||10
10339656|NCT00373360|11476489|FG000|COMPLETED|Overall Study||10
10339657|NCT00373360|11476489|FG000|NOT COMPLETED|Overall Study||0
10426340|NCT00847145|11571972|FG004|COMPLETED|Overall Study||131
10426341|NCT00847145|11571973|FG005|COMPLETED|Overall Study||152
10426342|NCT00847145|11571974|FG006|COMPLETED|Overall Study||143
10426343|NCT00847145|11571975|FG007|COMPLETED|Overall Study||136
10426344|NCT00847145|11571968|FG000|NOT COMPLETED|Overall Study||6
10426345|NCT00847145|11571969|FG001|NOT COMPLETED|Overall Study||6
10426346|NCT00847145|11571970|FG002|NOT COMPLETED|Overall Study||11
10426347|NCT00847145|11571971|FG003|NOT COMPLETED|Overall Study||1
10426348|NCT00847145|11571972|FG004|NOT COMPLETED|Overall Study||6
10426349|NCT00847145|11571973|FG005|NOT COMPLETED|Overall Study||4
10426350|NCT00847145|11571974|FG006|NOT COMPLETED|Overall Study||9
10426351|NCT00847145|11571975|FG007|NOT COMPLETED|Overall Study||4
10426352|NCT00847171|11572002|FG000|STARTED|Overall Study||20
10426353|NCT00847171|11572002|FG000|COMPLETED|Overall Study||20
10426354|NCT00847171|11572002|FG000|NOT COMPLETED|Overall Study||0
10426355|NCT00847197|11572009|FG000|STARTED|Overall Study||116
10426356|NCT00847197|11572010|FG001|STARTED|Overall Study||75
10426357|NCT00847197|11572009|FG000|COMPLETED|Overall Study||92
10426358|NCT00847197|11572010|FG001|COMPLETED|Overall Study||70
10426359|NCT00847197|11572009|FG000|NOT COMPLETED|Overall Study||24
10426360|NCT00847197|11572010|FG001|NOT COMPLETED|Overall Study||5
10426361|NCT00847210|11572018|FG000|STARTED|Overall Study||18
10426362|NCT00847210|11572019|FG001|STARTED|Overall Study||18
10426363|NCT00847210|11572018|FG000|COMPLETED|Overall Study||18
10426364|NCT00847210|11572019|FG001|COMPLETED|Overall Study||18
10426365|NCT00847210|11572018|FG000|NOT COMPLETED|Overall Study||0
10426366|NCT00847210|11572019|FG001|NOT COMPLETED|Overall Study||0
10426367|NCT00847288|11572027|FG000|STARTED|Overall Study||841
10426368|NCT00847288|11572028|FG001|STARTED|Overall Study||827
10426369|NCT00847288|11572027|FG000|COMPLETED|Overall Study||811
10529545|NCT01401166|11681917|FG001|STARTED|Safety Follow-Up Period|All 124 randomized participants entered follow-up regardless of whether they received treatment.|124
10529546|NCT01401166|11681918|FG002|STARTED|Safety Follow-Up Period|All 121 randomized participants entered follow-up regardless of whether they received treatment.|121
10529547|NCT01401166|11681919|FG003|STARTED|Safety Follow-Up Period|All 119 randomized participants entered follow-up regardless of whether they received treatment.|119
10529548|NCT01401166|11681916|FG000|COMPLETED|Safety Follow-Up Period||99
10714275|NCT02685566|11879810|FG000|COMPLETED|Second Reading Session||50
10714276|NCT02685566|11879811|FG001|COMPLETED|Second Reading Session||50
10714277|NCT02685566|11879810|FG000|NOT COMPLETED|Second Reading Session||0
10302177|NCT00068250|11435015|FG002|NOT COMPLETED|Phase I: Dose Level 2||0
10529549|NCT01401166|11681917|FG001|COMPLETED|Safety Follow-Up Period||106
10529550|NCT01401166|11681918|FG002|COMPLETED|Safety Follow-Up Period||104
10529551|NCT01401166|11681919|FG003|COMPLETED|Safety Follow-Up Period||100
10714278|NCT02685566|11879811|FG001|NOT COMPLETED|Second Reading Session||0
10714279|NCT02685956|11879821|FG000|STARTED|Overall Study||317
10339658|NCT00373386|11476493|FG000|STARTED|Overall Study||9
10339659|NCT00373386|11476493|FG000|COMPLETED|Overall Study||9
10339660|NCT00373386|11476493|FG000|NOT COMPLETED|Overall Study||0
10714280|NCT02685956|11879822|FG001|STARTED|Overall Study||1978
10714281|NCT02685956|11879821|FG000|COMPLETED|Overall Study||317
10714282|NCT02685956|11879822|FG001|COMPLETED|Overall Study||1978
10714283|NCT02685956|11879821|FG000|NOT COMPLETED|Overall Study||0
10714284|NCT02685956|11879822|FG001|NOT COMPLETED|Overall Study||0
10714285|NCT02685995|11879832|FG000|STARTED|Overall Study||50
10714286|NCT02685995|11879833|FG001|STARTED|Overall Study||50
10714287|NCT02685995|11879832|FG000|COMPLETED|Overall Study||49
10714288|NCT02685995|11879833|FG001|COMPLETED|Overall Study||49
10714289|NCT02685995|11879832|FG000|NOT COMPLETED|Overall Study||1
10714290|NCT02685995|11879833|FG001|NOT COMPLETED|Overall Study||1
10714291|NCT02686034|11879841|FG000|STARTED|Run-In Period 1||142
10714292|NCT02686034|11879842|FG001|STARTED|Run-In Period 1||143
10714293|NCT02686034|11879841|FG000|COMPLETED|Run-In Period 1||122
10714294|NCT02686034|11879842|FG001|COMPLETED|Run-In Period 1||126
10714295|NCT02686034|11879841|FG000|NOT COMPLETED|Run-In Period 1||20
10714296|NCT02686034|11879842|FG001|NOT COMPLETED|Run-In Period 1||17
10714297|NCT02686034|11879841|FG000|STARTED|Randomized Controlled Period 2||122
10714298|NCT02686034|11879842|FG001|STARTED|Randomized Controlled Period 2||126
10811642|NCT03756129|11973458|FG001|NOT COMPLETED|Overall Study||2
10811643|NCT03756129|11973459|FG002|NOT COMPLETED|Overall Study||3
10811644|NCT03756129|11973460|FG003|NOT COMPLETED|Overall Study||3
10811645|NCT03756129|11973461|FG004|NOT COMPLETED|Overall Study||1
10811646|NCT03756129|11973462|FG005|NOT COMPLETED|Overall Study||5
10811647|NCT03756038|11973486|FG000|STARTED|Overall Study||1
10811648|NCT03756038|11973487|FG001|STARTED|Overall Study||0
10811649|NCT03756038|11973486|FG000|COMPLETED|Overall Study||1
10811650|NCT03756038|11973487|FG001|COMPLETED|Overall Study||0
10811651|NCT03756038|11973486|FG000|NOT COMPLETED|Overall Study||0
10811652|NCT03756038|11973487|FG001|NOT COMPLETED|Overall Study||0
10811653|NCT03756012|11973493|FG000|STARTED|Overall Study||15
10811654|NCT03756012|11973493|FG000|COMPLETED|Overall Study||15
10811655|NCT03756012|11973493|FG000|NOT COMPLETED|Overall Study||0
10811656|NCT03755882|11973498|FG000|STARTED|Period 1||23
10811657|NCT03755882|11973499|FG001|STARTED|Period 1||22
10811658|NCT03755882|11973498|FG000|COMPLETED|Period 1||19
10811659|NCT03755882|11973499|FG001|COMPLETED|Period 1||22
10811660|NCT03755882|11973498|FG000|NOT COMPLETED|Period 1||4
10811661|NCT03755882|11973499|FG001|NOT COMPLETED|Period 1||0
10811662|NCT03755882|11973498|FG000|STARTED|Period 2||19
10811663|NCT03755882|11973499|FG001|STARTED|Period 2||22
10811664|NCT03755882|11973498|FG000|COMPLETED|Period 2||19
10811665|NCT03755882|11973499|FG001|COMPLETED|Period 2||22
10811666|NCT03755882|11973498|FG000|NOT COMPLETED|Period 2||0
10811667|NCT03755882|11973499|FG001|NOT COMPLETED|Period 2||0
10811668|NCT03755661|11973507|FG000|STARTED|Overall Study||12
10811669|NCT03755661|11973508|FG001|STARTED|Overall Study||12
10811670|NCT03755661|11973507|FG000|COMPLETED|Overall Study||11
10811671|NCT03755661|11973508|FG001|COMPLETED|Overall Study||12
10811672|NCT03755661|11973507|FG000|NOT COMPLETED|Overall Study||1
10811673|NCT03755661|11973508|FG001|NOT COMPLETED|Overall Study||0
10811674|NCT03754582|11973514|FG000|STARTED|Pretreatment Phase||21
10811675|NCT03754582|11973515|FG001|STARTED|Pretreatment Phase||0
10811676|NCT03754582|11973516|FG002|STARTED|Pretreatment Phase||0
10811677|NCT03754582|11973514|FG000|COMPLETED|Pretreatment Phase||21
10811678|NCT03754582|11973515|FG001|COMPLETED|Pretreatment Phase||0
10811679|NCT03754582|11973516|FG002|COMPLETED|Pretreatment Phase||0
10811680|NCT03754582|11973514|FG000|NOT COMPLETED|Pretreatment Phase||0
10811681|NCT03754582|11973515|FG001|NOT COMPLETED|Pretreatment Phase||0
10811682|NCT03754582|11973516|FG002|NOT COMPLETED|Pretreatment Phase||0
10811683|NCT03754582|11973514|FG000|STARTED|Treatment Phase||0
10811684|NCT03754582|11973515|FG001|STARTED|Treatment Phase||21
10811685|NCT03754582|11973516|FG002|STARTED|Treatment Phase||0
10811686|NCT03754582|11973514|FG000|COMPLETED|Treatment Phase||0
10811687|NCT03754582|11973515|FG001|COMPLETED|Treatment Phase||20
10811688|NCT03754582|11973516|FG002|COMPLETED|Treatment Phase||0
10811689|NCT03754582|11973514|FG000|NOT COMPLETED|Treatment Phase||0
10714299|NCT02686034|11879841|FG000|COMPLETED|Randomized Controlled Period 2||117
10714300|NCT02686034|11879842|FG001|COMPLETED|Randomized Controlled Period 2||122
10714301|NCT02686034|11879841|FG000|NOT COMPLETED|Randomized Controlled Period 2||5
10714302|NCT02686034|11879842|FG001|NOT COMPLETED|Randomized Controlled Period 2||4
10811690|NCT03754582|11973515|FG001|NOT COMPLETED|Treatment Phase||1
10811691|NCT03754582|11973516|FG002|NOT COMPLETED|Treatment Phase||0
10811692|NCT03754582|11973514|FG000|STARTED|Follow-up Phase||0
10811693|NCT03754582|11973515|FG001|STARTED|Follow-up Phase||0
10811694|NCT03754582|11973516|FG002|STARTED|Follow-up Phase|1 participant who discontinued in Treatment Phase was assessed at Follow-up Visit.|21
10714303|NCT02686034|11879841|FG000|STARTED|Open Label Period 3||117
10811695|NCT03754582|11973514|FG000|COMPLETED|Follow-up Phase||0
10302178|NCT00068250|11435016|FG003|NOT COMPLETED|Phase I: Dose Level 2||0
10714304|NCT02686034|11879842|FG001|STARTED|Open Label Period 3||122
10714305|NCT02686034|11879841|FG000|COMPLETED|Open Label Period 3||117
10714306|NCT02686034|11879842|FG001|COMPLETED|Open Label Period 3||121
10714307|NCT02686034|11879841|FG000|NOT COMPLETED|Open Label Period 3||0
10714308|NCT02686034|11879842|FG001|NOT COMPLETED|Open Label Period 3||1
10714309|NCT02686138|11879850|FG000|STARTED|Overall Study||293
10714310|NCT02686138|11879851|FG001|STARTED|Overall Study||300
10714311|NCT02686138|11879850|FG000|COMPLETED|Overall Study||219
10811696|NCT03754582|11973515|FG001|COMPLETED|Follow-up Phase||0
10811697|NCT03754582|11973516|FG002|COMPLETED|Follow-up Phase||20
10811698|NCT03754582|11973514|FG000|NOT COMPLETED|Follow-up Phase||0
10811699|NCT03754582|11973515|FG001|NOT COMPLETED|Follow-up Phase||0
10811700|NCT03754582|11973516|FG002|NOT COMPLETED|Follow-up Phase||1
10811701|NCT03754556|11973532|FG000|STARTED|Overall Study||326658
10811702|NCT03754556|11973532|FG000|COMPLETED|Overall Study||326658
10811703|NCT03754556|11973532|FG000|NOT COMPLETED|Overall Study||0
10811704|NCT03753113|11973538|FG000|STARTED|Overall Study||12
10811705|NCT03753113|11973539|FG001|STARTED|Overall Study||12
10529552|NCT01401166|11681916|FG000|NOT COMPLETED|Safety Follow-Up Period||25
10529553|NCT01401166|11681917|FG001|NOT COMPLETED|Safety Follow-Up Period||18
10529554|NCT01401166|11681918|FG002|NOT COMPLETED|Safety Follow-Up Period||17
10529555|NCT01401166|11681919|FG003|NOT COMPLETED|Safety Follow-Up Period||19
10529556|NCT01401257|11681940|FG000|STARTED|Overall Study||21
10529557|NCT01401257|11681941|FG001|STARTED|Overall Study||21
10339661|NCT00373399|11476499|FG000|STARTED|Overall Study||5
10339662|NCT00373399|11476500|FG001|STARTED|Overall Study||7
10339663|NCT00373399|11476501|FG002|STARTED|Overall Study||4
10339664|NCT00373399|11476502|FG003|STARTED|Overall Study||6
10339665|NCT00373399|11476503|FG004|STARTED|Overall Study||7
10339666|NCT00373399|11476504|FG005|STARTED|Overall Study||7
10339667|NCT00373399|11476499|FG000|COMPLETED|Overall Study||5
10339668|NCT00373399|11476500|FG001|COMPLETED|Overall Study||7
10339669|NCT00373399|11476501|FG002|COMPLETED|Overall Study||4
10339670|NCT00373399|11476502|FG003|COMPLETED|Overall Study||6
10339671|NCT00373399|11476503|FG004|COMPLETED|Overall Study||7
10339672|NCT00373399|11476504|FG005|COMPLETED|Overall Study||7
10339673|NCT00373399|11476499|FG000|NOT COMPLETED|Overall Study||0
10339674|NCT00373399|11476500|FG001|NOT COMPLETED|Overall Study||0
10339675|NCT00373399|11476501|FG002|NOT COMPLETED|Overall Study||0
10339676|NCT00373399|11476502|FG003|NOT COMPLETED|Overall Study||0
10339677|NCT00373399|11476503|FG004|NOT COMPLETED|Overall Study||0
10339678|NCT00373399|11476504|FG005|NOT COMPLETED|Overall Study||0
10339679|NCT00373425|11476517|FG000|STARTED|Overall Study||623
10339680|NCT00373425|11476518|FG001|STARTED|Overall Study||350
10339681|NCT00373425|11476519|FG002|STARTED|Overall Study||134
10339682|NCT00373425|11476520|FG003|STARTED|Overall Study||11
10339683|NCT00373425|11476521|FG004|STARTED|Overall Study||132
10339684|NCT00373425|11476517|FG000|Received Treatment|Overall Study||612
10339685|NCT00373425|11476518|FG001|Received Treatment|Overall Study||342
10339686|NCT00373425|11476519|FG002|Received Treatment|Overall Study||134
10339687|NCT00373425|11476520|FG003|Received Treatment|Overall Study||7
10714312|NCT02686138|11879851|FG001|COMPLETED|Overall Study||235
10714313|NCT02686138|11879850|FG000|NOT COMPLETED|Overall Study||74
10714314|NCT02686138|11879851|FG001|NOT COMPLETED|Overall Study||65
10714315|NCT02686164|11879857|FG000|STARTED|Overall Study||30
10714316|NCT02686164|11879857|FG000|COMPLETED|Overall Study||27
10714317|NCT02686164|11879857|FG000|NOT COMPLETED|Overall Study||3
10714318|NCT02686437|11879866|FG000|STARTED|Overall Study||16
10714319|NCT02686437|11879867|FG001|STARTED|Overall Study||20
10714320|NCT02686437|11879866|FG000|COMPLETED|Overall Study||13
10811706|NCT03753113|11973538|FG000|COMPLETED|Overall Study||12
10811707|NCT03753113|11973539|FG001|COMPLETED|Overall Study||12
10811708|NCT03753113|11973538|FG000|NOT COMPLETED|Overall Study||0
10811709|NCT03753113|11973539|FG001|NOT COMPLETED|Overall Study||0
10811710|NCT03752567|11973545|FG000|STARTED|Overall Study||40
10811711|NCT03752567|11973545|FG000|COMPLETED|Overall Study||40
10811712|NCT03752567|11973545|FG000|NOT COMPLETED|Overall Study||0
10811713|NCT03752528|11973549|FG000|STARTED|Part A||53
10811714|NCT03752528|11973549|FG000|COMPLETED|Part A||51
10811715|NCT03752528|11973549|FG000|NOT COMPLETED|Part A||2
10811716|NCT03752528|11973549|FG000|STARTED|Part B||24
10811717|NCT03752528|11973549|FG000|COMPLETED|Part B||20
10714321|NCT02686437|11879867|FG001|COMPLETED|Overall Study||12
10714322|NCT02686437|11879866|FG000|NOT COMPLETED|Overall Study||3
10811718|NCT03752528|11973549|FG000|NOT COMPLETED|Part B||4
10811719|NCT03752151|11973556|FG000|STARTED|Overall Study||77
10811720|NCT03752151|11973556|FG000|COMPLETED|Overall Study||75
10811721|NCT03752151|11973556|FG000|NOT COMPLETED|Overall Study||2
10811722|NCT03751657|11973563|FG000|STARTED|Overall Study||125
10339688|NCT00373425|11476521|FG004|Received Treatment|Overall Study||132
10339689|NCT00373425|11476517|FG000|COMPLETED|Overall Study|Completed 2 years of study treatment|253
10339690|NCT00373425|11476518|FG001|COMPLETED|Overall Study|Completed 2 years of study treatment|197
10339691|NCT00373425|11476519|FG002|COMPLETED|Overall Study|Completed 2 years of study treatment|0
10339692|NCT00373425|11476520|FG003|COMPLETED|Overall Study|Completed 2 years of study treatment|0
10339693|NCT00373425|11476521|FG004|COMPLETED|Overall Study|Completed 2 years of study treatment|60
10339694|NCT00373425|11476517|FG000|NOT COMPLETED|Overall Study||370
10339695|NCT00373425|11476518|FG001|NOT COMPLETED|Overall Study||153
10339696|NCT00373425|11476519|FG002|NOT COMPLETED|Overall Study||134
10339697|NCT00373425|11476520|FG003|NOT COMPLETED|Overall Study||11
10339698|NCT00373425|11476521|FG004|NOT COMPLETED|Overall Study||72
10339699|NCT00373490|11476532|FG000|STARTED|Overall Study||10
10339700|NCT00373490|11476533|FG001|STARTED|Overall Study||6
10339701|NCT00373490|11476532|FG000|COMPLETED|Overall Study||1
10339702|NCT00373490|11476533|FG001|COMPLETED|Overall Study||0
10339703|NCT00373490|11476532|FG000|NOT COMPLETED|Overall Study||9
10339704|NCT00373490|11476533|FG001|NOT COMPLETED|Overall Study||6
10339705|NCT00373529|11476539|FG000|STARTED|Overall Study||116
10339706|NCT00373529|11476539|FG000|Full Analysis Set|Overall Study|3 Failed Independent Confirmation of AML; 1 consent violation|112
10339707|NCT00373529|11476539|FG000|COMPLETED|Overall Study|Completed: initiated full 6 cycles of treatment. Not Completed: initiated <6 cycles of treatment|8
10339708|NCT00373529|11476539|FG000|NOT COMPLETED|Overall Study||108
10339709|NCT00373685|11476545|FG000|STARTED|Overall Study||4035
10339710|NCT00373685|11476546|FG001|STARTED|Overall Study||4032
10339711|NCT00373685|11476545|FG000|Treated|Overall Study||3984
10339712|NCT00373685|11476546|FG001|Treated|Overall Study||3955
10339713|NCT00373685|11476545|FG000|COMPLETED|Overall Study||2596
10339714|NCT00373685|11476546|FG001|COMPLETED|Overall Study||2611
10339715|NCT00373685|11476545|FG000|NOT COMPLETED|Overall Study||1439
10339716|NCT00373685|11476546|FG001|NOT COMPLETED|Overall Study||1421
10339717|NCT00373698|11476554|FG000|STARTED|Overall Study||96
10339718|NCT00373698|11476555|FG001|STARTED|Overall Study||99
10339719|NCT00373698|11476554|FG000|COMPLETED|Overall Study||85
10339720|NCT00373698|11476555|FG001|COMPLETED|Overall Study||99
10339721|NCT00373698|11476554|FG000|NOT COMPLETED|Overall Study||11
10339722|NCT00373698|11476555|FG001|NOT COMPLETED|Overall Study||0
10339723|NCT00373880|11476563|FG000|STARTED|Overall Study||26
10339724|NCT00373880|11476563|FG000|COMPLETED|Overall Study||8
10339725|NCT00373880|11476563|FG000|NOT COMPLETED|Overall Study||18
10339726|NCT00373958|11476577|FG000|STARTED|Infant Series|One participant was prerandomized but not consented.|334
10339727|NCT00373958|11476578|FG001|STARTED|Infant Series||332
10339728|NCT00373958|11476577|FG000|Vaccinated Dose 1|Infant Series||332
10529558|NCT01401257|11681942|FG002|STARTED|Overall Study||19
10529559|NCT01401257|11681943|FG003|STARTED|Overall Study||19
10529560|NCT01401257|11681940|FG000|COMPLETED|Overall Study||21
10529561|NCT01401257|11681941|FG001|COMPLETED|Overall Study||19
10529562|NCT01401257|11681942|FG002|COMPLETED|Overall Study||16
10529563|NCT01401257|11681943|FG003|COMPLETED|Overall Study||17
10529564|NCT01401257|11681940|FG000|NOT COMPLETED|Overall Study||0
10529565|NCT01401257|11681941|FG001|NOT COMPLETED|Overall Study||2
10529566|NCT01401257|11681942|FG002|NOT COMPLETED|Overall Study||3
10529567|NCT01401257|11681943|FG003|NOT COMPLETED|Overall Study||2
10529568|NCT01401283|11681955|FG000|STARTED|Overall Study||89
10529569|NCT01401283|11681956|FG001|STARTED|Overall Study||91
10529570|NCT01401283|11681955|FG000|COMPLETED|Overall Study||79
10529571|NCT01401283|11681956|FG001|COMPLETED|Overall Study||81
10529572|NCT01401283|11681955|FG000|NOT COMPLETED|Overall Study||10
10529573|NCT01401283|11681956|FG001|NOT COMPLETED|Overall Study||10
10529574|NCT01401322|11681962|FG000|STARTED|Overall Study||5
10529575|NCT01401322|11681962|FG000|COMPLETED|Overall Study||3
10529576|NCT01401322|11681962|FG000|NOT COMPLETED|Overall Study||2
10529577|NCT01401361|11681966|FG000|STARTED|Overall Study||150
10529578|NCT01401361|11681966|FG000|COMPLETED|Overall Study|16 subjects were withdrawn prior to the use of the investigational device|122
10529579|NCT01401361|11681966|FG000|NOT COMPLETED|Overall Study||28
10529580|NCT01401452|11681970|FG000|STARTED|Overall Study||246
10529581|NCT01401452|11681970|FG000|Visit 1 (Baseline)|Overall Study||246
10529582|NCT01401452|11681970|FG000|Visit 2 (1 Month)|Overall Study||225
10529583|NCT01401452|11681970|FG000|Visit 3 (3 Months)|Overall Study||217
10529584|NCT01401452|11681970|FG000|Visit 4 (6 Months)|Overall Study||172
10529585|NCT01401452|11681970|FG000|Visit 5 (9 Months)|Overall Study||175
10529586|NCT01401452|11681970|FG000|COMPLETED|Overall Study||174
10529587|NCT01401452|11681970|FG000|NOT COMPLETED|Overall Study||72
10529588|NCT01401465|11681976|FG000|STARTED|Treatment Period 1||165
10529589|NCT01401465|11681977|FG001|STARTED|Treatment Period 1||162
10529590|NCT01401465|11681976|FG000|COMPLETED|Treatment Period 1||150
10529591|NCT01401465|11681977|FG001|COMPLETED|Treatment Period 1||146
10529592|NCT01401465|11681976|FG000|NOT COMPLETED|Treatment Period 1||15
10529593|NCT01401465|11681977|FG001|NOT COMPLETED|Treatment Period 1||16
10529594|NCT01401465|11681976|FG000|STARTED|Washout||150
10529595|NCT01401465|11681977|FG001|STARTED|Washout||146
10529596|NCT01401465|11681976|FG000|COMPLETED|Washout||150
10529597|NCT01401465|11681977|FG001|COMPLETED|Washout||146
10529598|NCT01401465|11681976|FG000|NOT COMPLETED|Washout||0
10529599|NCT01401465|11681977|FG001|NOT COMPLETED|Washout||0
10529600|NCT01401465|11681976|FG000|STARTED|Treatment Period 2||150
10529601|NCT01401465|11681977|FG001|STARTED|Treatment Period 2||146
10529602|NCT01401465|11681976|FG000|COMPLETED|Treatment Period 2||150
10529603|NCT01401465|11681977|FG001|COMPLETED|Treatment Period 2||144
10529604|NCT01401465|11681976|FG000|NOT COMPLETED|Treatment Period 2||0
10529605|NCT01401465|11681977|FG001|NOT COMPLETED|Treatment Period 2||2
10547844|NCT01515345|11701629|FG000|STARTED|Overall Study||665
10547845|NCT01515345|11701630|FG001|STARTED|Overall Study||343
10547846|NCT01515345|11701629|FG000|COMPLETED|Overall Study||664
10547847|NCT01515345|11701630|FG001|COMPLETED|Overall Study||343
10547848|NCT01515345|11701629|FG000|NOT COMPLETED|Overall Study||1
10547849|NCT01515345|11701630|FG001|NOT COMPLETED|Overall Study||0
10547850|NCT01515410|11701636|FG000|STARTED|Overall Study||19
10547851|NCT01515410|11701637|FG001|STARTED|Overall Study||15
10547852|NCT01515410|11701636|FG000|COMPLETED|Overall Study||19
10547853|NCT01515410|11701637|FG001|COMPLETED|Overall Study||15
10547854|NCT01515410|11701636|FG000|NOT COMPLETED|Overall Study||0
10811723|NCT03751657|11973564|FG001|STARTED|Overall Study||122
10811724|NCT03751657|11973563|FG000|COMPLETED|Overall Study||122
10811725|NCT03751657|11973564|FG001|COMPLETED|Overall Study||119
10811726|NCT03751657|11973563|FG000|NOT COMPLETED|Overall Study||3
10811727|NCT03751657|11973564|FG001|NOT COMPLETED|Overall Study||3
10811728|NCT03751280|11973572|FG000|STARTED|Overall Study||56
10811729|NCT03751280|11973573|FG001|STARTED|Overall Study||56
10811730|NCT03751280|11973572|FG000|Full Analysis Set (FAS)|Overall Study||54
10811731|NCT03751280|11973573|FG001|Full Analysis Set (FAS)|Overall Study||55
10811732|NCT03751280|11973572|FG000|Safety Set (SAF)|Overall Study||55
10811733|NCT03751280|11973573|FG001|Safety Set (SAF)|Overall Study||55
10811734|NCT03751280|11973572|FG000|COMPLETED|Overall Study||48
10811735|NCT03751280|11973573|FG001|COMPLETED|Overall Study||44
10811736|NCT03751280|11973572|FG000|NOT COMPLETED|Overall Study||8
10811737|NCT03751280|11973573|FG001|NOT COMPLETED|Overall Study||12
10811738|NCT03751020|11973583|FG000|STARTED|Overall Study||36
10811739|NCT03751020|11973584|FG001|STARTED|Overall Study||36
10811740|NCT03751020|11973585|FG002|STARTED|Overall Study||36
10811741|NCT03751020|11973583|FG000|Post Intervention|Overall Study||33
10811742|NCT03751020|11973584|FG001|Post Intervention|Overall Study||33
10811743|NCT03751020|11973585|FG002|Post Intervention|Overall Study||30
10811744|NCT03751020|11973583|FG000|3 Month Follow Up|Overall Study||27
10811745|NCT03751020|11973584|FG001|3 Month Follow Up|Overall Study||32
10811746|NCT03751020|11973585|FG002|3 Month Follow Up|Overall Study||26
10811747|NCT03751020|11973583|FG000|COMPLETED|Overall Study||27
10811748|NCT03751020|11973584|FG001|COMPLETED|Overall Study||32
10811749|NCT03751020|11973585|FG002|COMPLETED|Overall Study||26
10811750|NCT03751020|11973583|FG000|NOT COMPLETED|Overall Study||9
10811751|NCT03751020|11973584|FG001|NOT COMPLETED|Overall Study||4
10811752|NCT03751020|11973585|FG002|NOT COMPLETED|Overall Study||10
10811753|NCT03750955|11973595|FG000|STARTED|Hygiene Phase of 2 Weeks|No intervention during the hygiene phase.|16
10811754|NCT03750955|11973596|FG001|STARTED|Hygiene Phase of 2 Weeks|No intervention during the hygiene phase.|16
10811755|NCT03750955|11973595|FG000|COMPLETED|Hygiene Phase of 2 Weeks||13
10811756|NCT03750955|11973596|FG001|COMPLETED|Hygiene Phase of 2 Weeks||13
10811757|NCT03750955|11973595|FG000|NOT COMPLETED|Hygiene Phase of 2 Weeks||3
10811758|NCT03750955|11973596|FG001|NOT COMPLETED|Hygiene Phase of 2 Weeks||3
10811759|NCT03750955|11973595|FG000|STARTED|Gingivitis Induction Phase of 2 Weeks||13
10811760|NCT03750955|11973596|FG001|STARTED|Gingivitis Induction Phase of 2 Weeks||13
10811761|NCT03750955|11973595|FG000|COMPLETED|Gingivitis Induction Phase of 2 Weeks|6 participants randomized to L maxillary sextant SIBO; 7 randomized to R maxillary sextant SIBO.|13
10811762|NCT03750955|11973596|FG001|COMPLETED|Gingivitis Induction Phase of 2 Weeks|6 randomized to R max. sextant oral hygiene maintenance (OHM); 7 randomized to L max. sextant OHM.|13
10811763|NCT03750955|11973595|FG000|NOT COMPLETED|Gingivitis Induction Phase of 2 Weeks||0
10811764|NCT03750955|11973596|FG001|NOT COMPLETED|Gingivitis Induction Phase of 2 Weeks||0
10811765|NCT03750955|11973595|FG000|STARTED|Resolution Phase of 2 Weeks|No stent in use; oral hygiene resumed.|13
10811766|NCT03750955|11973596|FG001|STARTED|Resolution Phase of 2 Weeks|Oral hygiene maintenance continued.|13
10811767|NCT03750955|11973595|FG000|COMPLETED|Resolution Phase of 2 Weeks||13
10811768|NCT03750955|11973596|FG001|COMPLETED|Resolution Phase of 2 Weeks||13
10811769|NCT03750955|11973595|FG000|NOT COMPLETED|Resolution Phase of 2 Weeks||0
10811770|NCT03750955|11973596|FG001|NOT COMPLETED|Resolution Phase of 2 Weeks||0
10811771|NCT03750695|11973604|FG000|STARTED|Overall Study||8
10811772|NCT03750695|11973605|FG001|STARTED|Overall Study||8
10339729|NCT00373958|11476578|FG001|Vaccinated Dose 1|Infant Series||331
10339730|NCT00373958|11476577|FG000|Vaccinated Dose 2|Infant Series||309
10339731|NCT00373958|11476578|FG001|Vaccinated Dose 2|Infant Series||305
10339732|NCT00373958|11476577|FG000|Vaccinated Dose 3|Infant Series||298
10339733|NCT00373958|11476578|FG001|Vaccinated Dose 3|Infant Series||300
10339734|NCT00373958|11476577|FG000|COMPLETED|Infant Series||294
10339735|NCT00373958|11476578|FG001|COMPLETED|Infant Series||290
10339736|NCT00373958|11476577|FG000|NOT COMPLETED|Infant Series||40
10339737|NCT00373958|11476578|FG001|NOT COMPLETED|Infant Series||42
10339738|NCT00373958|11476577|FG000|STARTED|Toddler Dose||294
10339739|NCT00373958|11476578|FG001|STARTED|Toddler Dose||290
10339740|NCT00373958|11476577|FG000|Withdrawn After Infant Series|Toddler Dose||22
10339741|NCT00373958|11476578|FG001|Withdrawn After Infant Series|Toddler Dose||25
10339742|NCT00373958|11476577|FG000|Vaccinated Toddler Dose|Toddler Dose||272
10339743|NCT00373958|11476578|FG001|Vaccinated Toddler Dose|Toddler Dose||265
10339744|NCT00373958|11476577|FG000|COMPLETED|Toddler Dose||264
10339745|NCT00373958|11476578|FG001|COMPLETED|Toddler Dose||252
10339746|NCT00373958|11476577|FG000|NOT COMPLETED|Toddler Dose||30
10339747|NCT00373958|11476578|FG001|NOT COMPLETED|Toddler Dose||38
10339748|NCT00374088|11476609|FG000|STARTED|Overall Study||10
10339749|NCT00374088|11476610|FG001|STARTED|Overall Study||11
10339750|NCT00374088|11476609|FG000|COMPLETED|Overall Study||9
10339751|NCT00374088|11476610|FG001|COMPLETED|Overall Study||10
10339752|NCT00374088|11476609|FG000|NOT COMPLETED|Overall Study||1
10339753|NCT00374088|11476610|FG001|NOT COMPLETED|Overall Study||1
10339754|NCT00374127|11476616|FG000|STARTED|Overall Study||35
10339755|NCT00374127|11476616|FG000|COMPLETED|Overall Study||24
10339756|NCT00374127|11476616|FG000|NOT COMPLETED|Overall Study||11
10339757|NCT00374140|11476626|FG000|STARTED|Overall Study||40
10339758|NCT00374140|11476626|FG000|COMPLETED|Overall Study||38
10339759|NCT00374140|11476626|FG000|NOT COMPLETED|Overall Study||2
10339760|NCT00374231|11476630|FG000|STARTED|Overall Study||40
10339761|NCT00374231|11476630|FG000|COMPLETED|Overall Study||40
10339762|NCT00374231|11476630|FG000|NOT COMPLETED|Overall Study||0
10339763|NCT00374244|11476637|FG000|STARTED|Overall Study||14
10339764|NCT00374244|11476638|FG001|STARTED|Overall Study||14
10339765|NCT00374244|11476637|FG000|COMPLETED|Overall Study||14
10339766|NCT00374244|11476638|FG001|COMPLETED|Overall Study||14
10339767|NCT00374244|11476637|FG000|NOT COMPLETED|Overall Study||0
10339768|NCT00374244|11476638|FG001|NOT COMPLETED|Overall Study||0
10339769|NCT00374322|11476646|FG000|STARTED|Overall Study||1579
10339770|NCT00374322|11476647|FG001|STARTED|Overall Study||1582
10339771|NCT00374322|11476646|FG000|Received >=1 Dose of Study Treatment|Overall Study||1571
10339772|NCT00374322|11476647|FG001|Received >=1 Dose of Study Treatment|Overall Study||1576
10339773|NCT00374322|11476646|FG000|COMPLETED|Overall Study||322
10339774|NCT00374322|11476647|FG001|COMPLETED|Overall Study||278
10339775|NCT00374322|11476646|FG000|NOT COMPLETED|Overall Study||1257
10339776|NCT00374322|11476647|FG001|NOT COMPLETED|Overall Study||1304
10339777|NCT00374335|11476654|FG000|STARTED|Overall Study||261
10339778|NCT00374335|11476654|FG000|COMPLETED|Overall Study||261
10339779|NCT00374335|11476654|FG000|NOT COMPLETED|Overall Study||0
10302179|NCT00068250|11435013|FG000|STARTED|Phase II: Dose Level 2||0
10302180|NCT00068250|11435014|FG001|STARTED|Phase II: Dose Level 2||0
10302181|NCT00068250|11435015|FG002|STARTED|Phase II: Dose Level 2||0
10302182|NCT00068250|11435016|FG003|STARTED|Phase II: Dose Level 2||47
10302183|NCT00068250|11435013|FG000|COMPLETED|Phase II: Dose Level 2||0
10302184|NCT00068250|11435014|FG001|COMPLETED|Phase II: Dose Level 2||0
10302185|NCT00068250|11435015|FG002|COMPLETED|Phase II: Dose Level 2||0
10302186|NCT00068250|11435016|FG003|COMPLETED|Phase II: Dose Level 2|Subjects with data available for the primary analysis are considered to have completed the study.|47
10302187|NCT00068250|11435013|FG000|NOT COMPLETED|Phase II: Dose Level 2||0
10302188|NCT00068250|11435014|FG001|NOT COMPLETED|Phase II: Dose Level 2||0
10302189|NCT00068250|11435015|FG002|NOT COMPLETED|Phase II: Dose Level 2||0
10302190|NCT00068250|11435016|FG003|NOT COMPLETED|Phase II: Dose Level 2||0
10302191|NCT00068341|11435027|FG000|STARTED|Overall Study||15
10302192|NCT00068341|11435028|FG001|STARTED|Overall Study||15
10302193|NCT00068341|11435029|FG002|STARTED|Overall Study||44
10302194|NCT00068341|11435027|FG000|COMPLETED|Overall Study||15
10302195|NCT00068341|11435028|FG001|COMPLETED|Overall Study||15
10302196|NCT00068341|11435029|FG002|COMPLETED|Overall Study||44
10302197|NCT00068341|11435027|FG000|NOT COMPLETED|Overall Study||0
10302198|NCT00068341|11435028|FG001|NOT COMPLETED|Overall Study||0
10302199|NCT00068341|11435029|FG002|NOT COMPLETED|Overall Study||0
10302200|NCT00068367|11435050|FG000|STARTED|Overall Study||20
10302201|NCT00068367|11435050|FG000|COMPLETED|Overall Study||20
10302202|NCT00068367|11435050|FG000|NOT COMPLETED|Overall Study||0
10302203|NCT00068380|11435054|FG000|STARTED|Overall Study||17
10302204|NCT00068380|11435054|FG000|COMPLETED|Overall Study||12
10302205|NCT00068380|11435054|FG000|NOT COMPLETED|Overall Study||5
10302206|NCT00068393|11435058|FG000|STARTED|Overall Study||39
10302207|NCT00068393|11435058|FG000|Eligible and Treated|Overall Study||38
10302208|NCT00068393|11435058|FG000|COMPLETED|Overall Study||29
10302209|NCT00068393|11435058|FG000|NOT COMPLETED|Overall Study||10
10302210|NCT00068406|11435062|FG000|STARTED|Overall Study||61
10302211|NCT00068406|11435062|FG000|COMPLETED|Overall Study||58
10302212|NCT00068406|11435062|FG000|NOT COMPLETED|Overall Study||3
10302213|NCT00068419|11435066|FG000|STARTED|Overall Study||70
10302214|NCT00068419|11435066|FG000|COMPLETED|Overall Study|Participant flow data reported here are for the period of protocol therapy.|10
10302215|NCT00068419|11435066|FG000|NOT COMPLETED|Overall Study||60
10302216|NCT00068445|11435072|FG000|STARTED|Randomization||65
10302217|NCT00068445|11435073|FG001|STARTED|Randomization||66
10302218|NCT00068445|11435072|FG000|COMPLETED|Randomization||63
10302219|NCT00068445|11435073|FG001|COMPLETED|Randomization||62
10302220|NCT00068445|11435072|FG000|NOT COMPLETED|Randomization||2
10302221|NCT00068445|11435073|FG001|NOT COMPLETED|Randomization||4
10302222|NCT00068445|11435072|FG000|STARTED|Treatment||63
10302223|NCT00068445|11435073|FG001|STARTED|Treatment||62
10302224|NCT00068445|11435072|FG000|COMPLETED|Treatment||34
10302225|NCT00068445|11435073|FG001|COMPLETED|Treatment||46
10302226|NCT00068445|11435072|FG000|NOT COMPLETED|Treatment||29
10302227|NCT00068445|11435073|FG001|NOT COMPLETED|Treatment||16
10302228|NCT00068575|11435079|FG000|STARTED|Overall Study||28
10302229|NCT00068575|11435079|FG000|COMPLETED|Overall Study||28
10302230|NCT00068575|11435079|FG000|NOT COMPLETED|Overall Study||0
10302231|NCT00068588|11435086|FG000|STARTED|Overall Study||0
10302232|NCT00068588|11435087|FG001|STARTED|Overall Study||3
10302233|NCT00068588|11435088|FG002|STARTED|Overall Study||21
10302234|NCT00068588|11435086|FG000|COMPLETED|Overall Study||0
10302235|NCT00068588|11435087|FG001|COMPLETED|Overall Study||3
10302236|NCT00068588|11435088|FG002|COMPLETED|Overall Study||17
10302237|NCT00068588|11435086|FG000|NOT COMPLETED|Overall Study||0
10302238|NCT00068588|11435087|FG001|NOT COMPLETED|Overall Study||0
10302239|NCT00068588|11435088|FG002|NOT COMPLETED|Overall Study||4
10339780|NCT00374452|11476660|FG000|STARTED|Overall Study||34
10339781|NCT00374452|11476661|FG001|STARTED|Overall Study||48
10339782|NCT00374452|11476660|FG000|Intervention Started|Overall Study||30
10339783|NCT00374452|11476661|FG001|Intervention Started|Overall Study||46
10339784|NCT00374452|11476660|FG000|COMPLETED|Overall Study||29
10302240|NCT00068601|11435097|FG000|STARTED|Overall Study||131
10302241|NCT00068601|11435098|FG001|STARTED|Overall Study||126
10302242|NCT00068601|11435097|FG000|COMPLETED|Overall Study||69
10302243|NCT00068601|11435098|FG001|COMPLETED|Overall Study||66
10302244|NCT00068601|11435097|FG000|NOT COMPLETED|Overall Study||62
10302245|NCT00068601|11435098|FG001|NOT COMPLETED|Overall Study||60
10302246|NCT00068692|11435107|FG000|STARTED|Step 1: Registration||128
10302247|NCT00068692|11435108|FG001|STARTED|Step 1: Registration|Group II patients were registered and randomized at the same time, and were reported in Step 2.|97
10302248|NCT00068692|11435109|FG002|STARTED|Step 1: Registration||0
10302249|NCT00068692|11435110|FG003|STARTED|Step 1: Registration||0
10302250|NCT00068692|11435111|FG004|STARTED|Step 1: Registration||0
10302251|NCT00068692|11435112|FG005|STARTED|Step 1: Registration|Group II patients was registered and randomized at the same time, and reported in step 2|0
10302252|NCT00068692|11435113|FG006|STARTED|Step 1: Registration|Group II patients was registered and randomized at the same time, and reported in step 2|0
10302253|NCT00068692|11435114|FG007|STARTED|Step 1: Registration|Group II patients was registered and randomized at the same time, and reported in step 2|0
10302254|NCT00068692|11435107|FG000|Started Concurrent Chemo/Radiation|Step 1: Registration||125
10302255|NCT00068692|11435108|FG001|Started Concurrent Chemo/Radiation|Step 1: Registration|Group II patients receive protocol therapy in Step 2 after randomization|0
10302256|NCT00068692|11435109|FG002|Started Concurrent Chemo/Radiation|Step 1: Registration||0
10302257|NCT00068692|11435110|FG003|Started Concurrent Chemo/Radiation|Step 1: Registration||0
10302258|NCT00068692|11435111|FG004|Started Concurrent Chemo/Radiation|Step 1: Registration||0
10302259|NCT00068692|11435112|FG005|Started Concurrent Chemo/Radiation|Step 1: Registration||0
10302260|NCT00068692|11435113|FG006|Started Concurrent Chemo/Radiation|Step 1: Registration||0
10302261|NCT00068692|11435114|FG007|Started Concurrent Chemo/Radiation|Step 1: Registration||0
10302262|NCT00068692|11435107|FG000|Reported AE Data|Step 1: Registration||123
10302263|NCT00068692|11435108|FG001|Reported AE Data|Step 1: Registration||0
10302264|NCT00068692|11435109|FG002|Reported AE Data|Step 1: Registration||0
10302265|NCT00068692|11435110|FG003|Reported AE Data|Step 1: Registration||0
10302266|NCT00068692|11435111|FG004|Reported AE Data|Step 1: Registration||0
10302267|NCT00068692|11435112|FG005|Reported AE Data|Step 1: Registration||0
10302268|NCT00068692|11435113|FG006|Reported AE Data|Step 1: Registration||0
10302269|NCT00068692|11435114|FG007|Reported AE Data|Step 1: Registration||0
10302270|NCT00068692|11435107|FG000|COMPLETED|Step 1: Registration||88
10302271|NCT00068692|11435108|FG001|COMPLETED|Step 1: Registration|Case 32191 entered the study as Group II patient but was never randomized.|96
10302272|NCT00068692|11435109|FG002|COMPLETED|Step 1: Registration||0
10302273|NCT00068692|11435110|FG003|COMPLETED|Step 1: Registration||0
10302274|NCT00068692|11435111|FG004|COMPLETED|Step 1: Registration||0
10302275|NCT00068692|11435112|FG005|COMPLETED|Step 1: Registration||0
10302276|NCT00068692|11435113|FG006|COMPLETED|Step 1: Registration||0
10302277|NCT00068692|11435114|FG007|COMPLETED|Step 1: Registration||0
10302278|NCT00068692|11435107|FG000|NOT COMPLETED|Step 1: Registration||40
10302279|NCT00068692|11435108|FG001|NOT COMPLETED|Step 1: Registration||1
10302280|NCT00068692|11435109|FG002|NOT COMPLETED|Step 1: Registration||0
10302281|NCT00068692|11435110|FG003|NOT COMPLETED|Step 1: Registration||0
10302282|NCT00068692|11435111|FG004|NOT COMPLETED|Step 1: Registration||0
10302283|NCT00068692|11435112|FG005|NOT COMPLETED|Step 1: Registration||0
10302284|NCT00068692|11435113|FG006|NOT COMPLETED|Step 1: Registration||0
10302285|NCT00068692|11435114|FG007|NOT COMPLETED|Step 1: Registration||0
10302286|NCT00068692|11435107|FG000|STARTED|Step 2: Randomization|Patients on arm S completing step 1 treatment were randomized to step 2 (Arms I-III).|0
10302287|NCT00068692|11435108|FG001|STARTED|Step 2: Randomization|Group II patients were registered and randomized at the same time, reported as arms I,II,III here.|0
10302288|NCT00068692|11435109|FG002|STARTED|Step 2: Randomization|Of the 128 patients registered to step 1in group 1, 83 were randomized to step 2(arms I-III).|28
10302289|NCT00068692|11435110|FG003|STARTED|Step 2: Randomization|Of the 128 patients registered to step 1in group 1, 83 were randomized to step 2(arms I-III).|25
10302290|NCT00068692|11435111|FG004|STARTED|Step 2: Randomization|Of the 128 patients registered to step 1in group 1, 83 were randomized to step 2(arms I-III).|30
10302291|NCT00068692|11435112|FG005|STARTED|Step 2: Randomization|Group 2 patients were registered and randomized at the same time.|31
10302292|NCT00068692|11435113|FG006|STARTED|Step 2: Randomization|Group 2 patients were registered and randomized at the same time.|33
10302293|NCT00068692|11435114|FG007|STARTED|Step 2: Randomization|Group 2 patients were registered and randomized at the same time.|32
10302294|NCT00068692|11435107|FG000|Treated|Step 2: Randomization||0
10302295|NCT00068692|11435108|FG001|Treated|Step 2: Randomization||0
10302296|NCT00068692|11435109|FG002|Treated|Step 2: Randomization||27
10714323|NCT02686437|11879867|FG001|NOT COMPLETED|Overall Study||8
10714324|NCT02687035|11879873|FG000|STARTED|Overall Study||1822
10714325|NCT02687035|11879873|FG000|COMPLETED|Overall Study||1638
10714326|NCT02687035|11879873|FG000|NOT COMPLETED|Overall Study||184
10302297|NCT00068692|11435110|FG003|Treated|Step 2: Randomization||25
10302298|NCT00068692|11435111|FG004|Treated|Step 2: Randomization||29
10302299|NCT00068692|11435112|FG005|Treated|Step 2: Randomization||31
10302300|NCT00068692|11435113|FG006|Treated|Step 2: Randomization||33
10302301|NCT00068692|11435114|FG007|Treated|Step 2: Randomization||32
10302302|NCT00068692|11435107|FG000|Had Sphincter Preservation|Step 2: Randomization||0
10302303|NCT00068692|11435108|FG001|Had Sphincter Preservation|Step 2: Randomization||0
10302304|NCT00068692|11435109|FG002|Had Sphincter Preservation|Step 2: Randomization||28
10529606|NCT01401478|11681986|FG000|STARTED|Overall Study||86
10529607|NCT01401478|11681986|FG000|COMPLETED|Overall Study||55
10529608|NCT01401478|11681986|FG000|NOT COMPLETED|Overall Study||31
10529609|NCT01401517|11681993|FG000|STARTED|Overall Study||18
10529610|NCT01401517|11681994|FG001|STARTED|Overall Study||19
10529611|NCT01401517|11681995|FG002|STARTED|Overall Study||18
10529612|NCT01401517|11681993|FG000|COMPLETED|Overall Study||15
10529613|NCT01401517|11681994|FG001|COMPLETED|Overall Study||17
10714327|NCT02687126|11879877|FG000|STARTED|Data Collection||106
10714328|NCT02687126|11879877|FG000|COMPLETED|Data Collection||106
10529614|NCT01401517|11681995|FG002|COMPLETED|Overall Study||15
10529615|NCT01401517|11681993|FG000|NOT COMPLETED|Overall Study||3
10529616|NCT01401517|11681994|FG001|NOT COMPLETED|Overall Study||2
10529617|NCT01401517|11681995|FG002|NOT COMPLETED|Overall Study||3
10529618|NCT01401530|11682006|FG000|STARTED|Overall Study||3
10529619|NCT01401530|11682007|FG001|STARTED|Overall Study||7
10529620|NCT01401530|11682008|FG002|STARTED|Overall Study||3
10529621|NCT01401530|11682006|FG000|COMPLETED|Overall Study||0
10529622|NCT01401530|11682007|FG001|COMPLETED|Overall Study||1
10529623|NCT01401530|11682008|FG002|COMPLETED|Overall Study||0
10529624|NCT01401530|11682006|FG000|NOT COMPLETED|Overall Study||3
10529625|NCT01401530|11682007|FG001|NOT COMPLETED|Overall Study||6
10529626|NCT01401530|11682008|FG002|NOT COMPLETED|Overall Study||3
10529627|NCT01401543|11682018|FG000|STARTED|First Intervention||6
10529628|NCT01401543|11682019|FG001|STARTED|First Intervention||6
10529629|NCT01401543|11682020|FG002|STARTED|First Intervention||6
10529630|NCT01401543|11682021|FG003|STARTED|First Intervention||6
10529631|NCT01401543|11682018|FG000|COMPLETED|First Intervention||6
10529632|NCT01401543|11682019|FG001|COMPLETED|First Intervention||6
10529633|NCT01401543|11682020|FG002|COMPLETED|First Intervention||6
10529634|NCT01401543|11682021|FG003|COMPLETED|First Intervention||6
10529635|NCT01401543|11682018|FG000|NOT COMPLETED|First Intervention||0
10529636|NCT01401543|11682019|FG001|NOT COMPLETED|First Intervention||0
10529637|NCT01401543|11682020|FG002|NOT COMPLETED|First Intervention||0
10529638|NCT01401543|11682021|FG003|NOT COMPLETED|First Intervention||0
10529639|NCT01401543|11682018|FG000|STARTED|First Washout Period of 1 Week||6
10529640|NCT01401543|11682019|FG001|STARTED|First Washout Period of 1 Week||6
10529641|NCT01401543|11682020|FG002|STARTED|First Washout Period of 1 Week||6
10529642|NCT01401543|11682021|FG003|STARTED|First Washout Period of 1 Week||6
10529643|NCT01401543|11682018|FG000|COMPLETED|First Washout Period of 1 Week||6
10529644|NCT01401543|11682019|FG001|COMPLETED|First Washout Period of 1 Week||6
10529645|NCT01401543|11682020|FG002|COMPLETED|First Washout Period of 1 Week||6
10529646|NCT01401543|11682021|FG003|COMPLETED|First Washout Period of 1 Week||6
10529647|NCT01401543|11682018|FG000|NOT COMPLETED|First Washout Period of 1 Week||0
10529648|NCT01401543|11682019|FG001|NOT COMPLETED|First Washout Period of 1 Week||0
10529649|NCT01401543|11682020|FG002|NOT COMPLETED|First Washout Period of 1 Week||0
10529650|NCT01401543|11682021|FG003|NOT COMPLETED|First Washout Period of 1 Week||0
10529651|NCT01401543|11682018|FG000|STARTED|Second Intervention||6
10529652|NCT01401543|11682019|FG001|STARTED|Second Intervention||6
10529653|NCT01401543|11682020|FG002|STARTED|Second Intervention||6
10529654|NCT01401543|11682021|FG003|STARTED|Second Intervention||6
10529655|NCT01401543|11682018|FG000|COMPLETED|Second Intervention||6
10529656|NCT01401543|11682019|FG001|COMPLETED|Second Intervention||6
10529657|NCT01401543|11682020|FG002|COMPLETED|Second Intervention||6
10529658|NCT01401543|11682021|FG003|COMPLETED|Second Intervention||6
10529659|NCT01401543|11682018|FG000|NOT COMPLETED|Second Intervention||0
10529660|NCT01401543|11682019|FG001|NOT COMPLETED|Second Intervention||0
10529661|NCT01401543|11682020|FG002|NOT COMPLETED|Second Intervention||0
10529662|NCT01401543|11682021|FG003|NOT COMPLETED|Second Intervention||0
10529663|NCT01401543|11682018|FG000|STARTED|Second Washout Period of 1 Week||6
10714329|NCT02687126|11879877|FG000|NOT COMPLETED|Data Collection||0
10714330|NCT02687126|11879877|FG000|STARTED|Data Analysis||106
10714331|NCT02687126|11879877|FG000|COMPLETED|Data Analysis||106
10714332|NCT02687126|11879877|FG000|NOT COMPLETED|Data Analysis||0
10529664|NCT01401543|11682019|FG001|STARTED|Second Washout Period of 1 Week||6
10529665|NCT01401543|11682020|FG002|STARTED|Second Washout Period of 1 Week||6
10529666|NCT01401543|11682021|FG003|STARTED|Second Washout Period of 1 Week||6
10529667|NCT01401543|11682018|FG000|COMPLETED|Second Washout Period of 1 Week||6
10529668|NCT01401543|11682019|FG001|COMPLETED|Second Washout Period of 1 Week||6
10529669|NCT01401543|11682020|FG002|COMPLETED|Second Washout Period of 1 Week||6
10529670|NCT01401543|11682021|FG003|COMPLETED|Second Washout Period of 1 Week||6
10529671|NCT01401543|11682018|FG000|NOT COMPLETED|Second Washout Period of 1 Week||0
10654796|NCT02204410|11815586|FG000|STARTED|Overall Study||21
10654797|NCT02204410|11815586|FG000|COMPLETED|Overall Study||10
10654798|NCT02204410|11815586|FG000|NOT COMPLETED|Overall Study||11
10654799|NCT02204449|11815592|FG000|STARTED|Overall Study||46
10654800|NCT02204449|11815593|FG001|STARTED|Overall Study||48
10654801|NCT02204449|11815592|FG000|COMPLETED|Overall Study||39
10654802|NCT02204449|11815593|FG001|COMPLETED|Overall Study||37
10654803|NCT02204449|11815592|FG000|NOT COMPLETED|Overall Study||7
10654804|NCT02204449|11815593|FG001|NOT COMPLETED|Overall Study||11
10654805|NCT02204566|11815599|FG000|STARTED|Overall Study||5
10654806|NCT02204566|11815599|FG000|COMPLETED|Overall Study||1
10654807|NCT02204566|11815599|FG000|NOT COMPLETED|Overall Study||4
10654808|NCT02204579|11815603|FG000|STARTED|Overall Study||7
10654809|NCT02204579|11815603|FG000|Participants Started in Pre-Amendment|Overall Study|Two participants completed treatment in pre-amendment and were re-enrolled in post-amendment.|2
10654810|NCT02204579|11815603|FG000|Participants Started in Post-Amendment|Overall Study|Two participants from pre-amendment were re-enrolled with different identification numbers.|5
10654811|NCT02204579|11815603|FG000|Treated|Overall Study||5
10654812|NCT02204579|11815603|FG000|COMPLETED|Overall Study||5
10654813|NCT02204579|11815603|FG000|NOT COMPLETED|Overall Study||2
10654814|NCT02204657|11815614|FG000|STARTED|Overall Study||32
10654815|NCT02204657|11815615|FG001|STARTED|Overall Study||25
10654816|NCT02204657|11815614|FG000|COMPLETED|Overall Study||25
10654817|NCT02204657|11815615|FG001|COMPLETED|Overall Study||25
10714333|NCT02687139|11879884|FG000|STARTED|Overall Study||34
10339785|NCT00374452|11476661|FG001|COMPLETED|Overall Study||43
10339786|NCT00374452|11476660|FG000|NOT COMPLETED|Overall Study||5
10339787|NCT00374452|11476661|FG001|NOT COMPLETED|Overall Study||5
10339788|NCT00374556|11476669|FG000|STARTED|Overall Study||14
10339789|NCT00374556|11476670|FG001|STARTED|Overall Study||16
10339790|NCT00374556|11476669|FG000|COMPLETED|Overall Study||13
10339791|NCT00374556|11476670|FG001|COMPLETED|Overall Study||15
10339792|NCT00374556|11476669|FG000|NOT COMPLETED|Overall Study||1
10339793|NCT00374556|11476670|FG001|NOT COMPLETED|Overall Study||1
10339794|NCT00374803|11476678|FG000|STARTED|Overall Study||22
10339795|NCT00374803|11476679|FG001|STARTED|Overall Study||23
10339796|NCT00374803|11476678|FG000|COMPLETED|Overall Study||22
10339797|NCT00374803|11476679|FG001|COMPLETED|Overall Study||23
10339798|NCT00374803|11476678|FG000|NOT COMPLETED|Overall Study||0
10714334|NCT02687139|11879884|FG000|COMPLETED|Overall Study||34
10714335|NCT02687139|11879884|FG000|NOT COMPLETED|Overall Study||0
10714336|NCT02687191|11879894|FG000|STARTED|Overall Study||3
10339799|NCT00374803|11476679|FG001|NOT COMPLETED|Overall Study||0
10339800|NCT00374842|11476690|FG000|STARTED|Overall Study||100
10339801|NCT00374842|11476691|FG001|STARTED|Overall Study||100
10339802|NCT00374842|11476692|FG002|STARTED|Overall Study||100
10339803|NCT00374842|11476690|FG000|COMPLETED|Overall Study||100
10339804|NCT00374842|11476691|FG001|COMPLETED|Overall Study||100
10811773|NCT03750695|11973604|FG000|COMPLETED|Overall Study||8
10811774|NCT03750695|11973605|FG001|COMPLETED|Overall Study||7
10339805|NCT00374842|11476692|FG002|COMPLETED|Overall Study||100
10339806|NCT00374842|11476690|FG000|NOT COMPLETED|Overall Study||0
10339807|NCT00374842|11476691|FG001|NOT COMPLETED|Overall Study||0
10339808|NCT00374842|11476692|FG002|NOT COMPLETED|Overall Study||0
10339809|NCT00374868|11476702|FG000|STARTED|Overall Study||38
10339810|NCT00374868|11476702|FG000|COMPLETED|Overall Study||2
10339811|NCT00374868|11476702|FG000|NOT COMPLETED|Overall Study||36
10339812|NCT00374907|11476708|FG000|STARTED|12-Week Short-term Period||20
10339813|NCT00374907|11476709|FG001|STARTED|12-Week Short-term Period||16
10339814|NCT00374907|11476708|FG000|COMPLETED|12-Week Short-term Period||17
10339815|NCT00374907|11476709|FG001|COMPLETED|12-Week Short-term Period||15
10339816|NCT00374907|11476708|FG000|NOT COMPLETED|12-Week Short-term Period||3
10339817|NCT00374907|11476709|FG001|NOT COMPLETED|12-Week Short-term Period||1
10339818|NCT00374907|11476708|FG000|STARTED|116-Week Short-term + Long-term Period||20
10339819|NCT00374907|11476709|FG001|STARTED|116-Week Short-term + Long-term Period||16
10811775|NCT03750695|11973604|FG000|NOT COMPLETED|Overall Study||0
10811776|NCT03750695|11973605|FG001|NOT COMPLETED|Overall Study||1
10811777|NCT03748992|11973616|FG000|STARTED|Overall Study||10
10811778|NCT03748992|11973616|FG000|COMPLETED|Overall Study||10
10811779|NCT03748992|11973616|FG000|NOT COMPLETED|Overall Study||0
10811780|NCT03748979|11973631|FG000|STARTED|Overall Study||6
10811781|NCT03748979|11973632|FG001|STARTED|Overall Study||6
10811782|NCT03748979|11973633|FG002|STARTED|Overall Study||6
10811783|NCT03748979|11973634|FG003|STARTED|Overall Study||6
10339820|NCT00374907|11476708|FG000|Completed 12-week Short Term Period|116-Week Short-term + Long-term Period||17
10339821|NCT00374907|11476709|FG001|Completed 12-week Short Term Period|116-Week Short-term + Long-term Period||15
10339822|NCT00374907|11476708|FG000|COMPLETED|116-Week Short-term + Long-term Period||7
10811784|NCT03748979|11973635|FG004|STARTED|Overall Study||4
10811785|NCT03748979|11973636|FG005|STARTED|Overall Study||4
10811786|NCT03748979|11973637|FG006|STARTED|Overall Study||5
10811787|NCT03748979|11973638|FG007|STARTED|Overall Study||5
10811788|NCT03748979|11973639|FG008|STARTED|Overall Study||4
10811789|NCT03748979|11973640|FG009|STARTED|Overall Study||5
10811790|NCT03748979|11973641|FG010|STARTED|Overall Study||6
10811791|NCT03748979|11973631|FG000|COMPLETED|Overall Study||6
10811792|NCT03748979|11973632|FG001|COMPLETED|Overall Study||6
10302305|NCT00068692|11435110|FG003|Had Sphincter Preservation|Step 2: Randomization||25
10302306|NCT00068692|11435111|FG004|Had Sphincter Preservation|Step 2: Randomization||28
10302307|NCT00068692|11435112|FG005|Had Sphincter Preservation|Step 2: Randomization||31
10302308|NCT00068692|11435113|FG006|Had Sphincter Preservation|Step 2: Randomization||33
10302309|NCT00068692|11435114|FG007|Had Sphincter Preservation|Step 2: Randomization||30
10302310|NCT00068692|11435107|FG000|Reported AE Data|Step 2: Randomization||0
10302311|NCT00068692|11435108|FG001|Reported AE Data|Step 2: Randomization||0
10302312|NCT00068692|11435109|FG002|Reported AE Data|Step 2: Randomization||27
10302313|NCT00068692|11435110|FG003|Reported AE Data|Step 2: Randomization||22
10302314|NCT00068692|11435111|FG004|Reported AE Data|Step 2: Randomization||28
10302315|NCT00068692|11435112|FG005|Reported AE Data|Step 2: Randomization||31
10302316|NCT00068692|11435113|FG006|Reported AE Data|Step 2: Randomization||33
10302317|NCT00068692|11435114|FG007|Reported AE Data|Step 2: Randomization||32
10302318|NCT00068692|11435107|FG000|COMPLETED|Step 2: Randomization||0
10302319|NCT00068692|11435108|FG001|COMPLETED|Step 2: Randomization||0
10302320|NCT00068692|11435109|FG002|COMPLETED|Step 2: Randomization||18
10302321|NCT00068692|11435110|FG003|COMPLETED|Step 2: Randomization||13
10302322|NCT00068692|11435111|FG004|COMPLETED|Step 2: Randomization||21
10302323|NCT00068692|11435112|FG005|COMPLETED|Step 2: Randomization||25
10302324|NCT00068692|11435113|FG006|COMPLETED|Step 2: Randomization||29
10302325|NCT00068692|11435114|FG007|COMPLETED|Step 2: Randomization||24
10302326|NCT00068692|11435107|FG000|NOT COMPLETED|Step 2: Randomization||0
10529672|NCT01401543|11682019|FG001|NOT COMPLETED|Second Washout Period of 1 Week||0
10529673|NCT01401543|11682020|FG002|NOT COMPLETED|Second Washout Period of 1 Week||0
10529674|NCT01401543|11682021|FG003|NOT COMPLETED|Second Washout Period of 1 Week||0
10529675|NCT01401543|11682018|FG000|STARTED|Third Intervention||6
10714337|NCT02687191|11879895|FG001|STARTED|Overall Study||3
10811793|NCT03748979|11973633|FG002|COMPLETED|Overall Study||6
10811794|NCT03748979|11973634|FG003|COMPLETED|Overall Study||6
10811795|NCT03748979|11973635|FG004|COMPLETED|Overall Study||4
10302327|NCT00068692|11435108|FG001|NOT COMPLETED|Step 2: Randomization||0
10302328|NCT00068692|11435109|FG002|NOT COMPLETED|Step 2: Randomization||10
10302329|NCT00068692|11435110|FG003|NOT COMPLETED|Step 2: Randomization||12
10302330|NCT00068692|11435111|FG004|NOT COMPLETED|Step 2: Randomization||9
10302331|NCT00068692|11435112|FG005|NOT COMPLETED|Step 2: Randomization||6
10302332|NCT00068692|11435113|FG006|NOT COMPLETED|Step 2: Randomization||4
10302333|NCT00068692|11435114|FG007|NOT COMPLETED|Step 2: Randomization||8
10302334|NCT00068718|11435127|FG000|STARTED|Overall Study||35
10302335|NCT00068718|11435127|FG000|COMPLETED|Overall Study||35
10811796|NCT03748979|11973636|FG005|COMPLETED|Overall Study||4
10811797|NCT03748979|11973637|FG006|COMPLETED|Overall Study||5
10811798|NCT03748979|11973638|FG007|COMPLETED|Overall Study||5
10811799|NCT03748979|11973639|FG008|COMPLETED|Overall Study||4
10654818|NCT02204657|11815614|FG000|NOT COMPLETED|Overall Study||7
10654819|NCT02204657|11815615|FG001|NOT COMPLETED|Overall Study||0
10654820|NCT02204748|11815621|FG000|STARTED|Overall Study||5
10654821|NCT02204748|11815621|FG000|COMPLETED|Overall Study||5
10654822|NCT02204748|11815621|FG000|NOT COMPLETED|Overall Study||0
10654823|NCT02204761|11815625|FG000|STARTED|Overall Study||6
10654824|NCT02204761|11815625|FG000|COMPLETED|Overall Study||6
10654825|NCT02204761|11815625|FG000|NOT COMPLETED|Overall Study||0
10654826|NCT02204917|11815629|FG000|STARTED|Overall Study||31
10654827|NCT02204917|11815629|FG000|COMPLETED|Overall Study||30
10654828|NCT02204917|11815629|FG000|NOT COMPLETED|Overall Study||1
10654829|NCT02204982|11815638|FG000|STARTED|Overall Study||6
10654830|NCT02204982|11815639|FG001|STARTED|Overall Study||7
10714338|NCT02687191|11879896|FG002|STARTED|Overall Study||3
10811800|NCT03748979|11973640|FG009|COMPLETED|Overall Study||5
10811801|NCT03748979|11973641|FG010|COMPLETED|Overall Study||6
10811802|NCT03748979|11973631|FG000|NOT COMPLETED|Overall Study||0
10654831|NCT02204982|11815638|FG000|COMPLETED|Overall Study||2
10714339|NCT02687191|11879897|FG003|STARTED|Overall Study||6
10714340|NCT02687191|11879898|FG004|STARTED|Overall Study||3
10714341|NCT02687191|11879899|FG005|STARTED|Overall Study||3
10714342|NCT02687191|11879894|FG000|COMPLETED|Overall Study||3
10714343|NCT02687191|11879895|FG001|COMPLETED|Overall Study||2
10714344|NCT02687191|11879896|FG002|COMPLETED|Overall Study||2
10714345|NCT02687191|11879897|FG003|COMPLETED|Overall Study||5
10714346|NCT02687191|11879898|FG004|COMPLETED|Overall Study||2
10714347|NCT02687191|11879899|FG005|COMPLETED|Overall Study||2
10714348|NCT02687191|11879894|FG000|NOT COMPLETED|Overall Study||0
10714349|NCT02687191|11879895|FG001|NOT COMPLETED|Overall Study||1
10714350|NCT02687191|11879896|FG002|NOT COMPLETED|Overall Study||1
10714351|NCT02687191|11879897|FG003|NOT COMPLETED|Overall Study||1
10714352|NCT02687191|11879898|FG004|NOT COMPLETED|Overall Study||1
10714353|NCT02687191|11879899|FG005|NOT COMPLETED|Overall Study||1
10714354|NCT02687217|11879915|FG000|STARTED|Overall Study||30
10714355|NCT02687217|11879916|FG001|STARTED|Overall Study||30
10714356|NCT02687217|11879915|FG000|COMPLETED|Overall Study||30
10714357|NCT02687217|11879916|FG001|COMPLETED|Overall Study||30
10714358|NCT02687217|11879915|FG000|NOT COMPLETED|Overall Study||0
10714359|NCT02687217|11879916|FG001|NOT COMPLETED|Overall Study||0
10714360|NCT02687412|11879924|FG000|STARTED|Overall Study||50
10714361|NCT02687412|11879925|FG001|STARTED|Overall Study||57
10714362|NCT02687412|11879924|FG000|COMPLETED|Overall Study||50
10714363|NCT02687412|11879925|FG001|COMPLETED|Overall Study||57
10714364|NCT02687412|11879924|FG000|NOT COMPLETED|Overall Study||0
10714365|NCT02687412|11879925|FG001|NOT COMPLETED|Overall Study||0
10714366|NCT02687451|11879937|FG000|STARTED|Overall Study||6
10714367|NCT02687451|11879938|FG001|STARTED|Overall Study||5
10714368|NCT02687451|11879939|FG002|STARTED|Overall Study||5
10714369|NCT02687451|11879940|FG003|STARTED|Overall Study||5
10714370|NCT02687451|11879941|FG004|STARTED|Overall Study||4
10811803|NCT03748979|11973632|FG001|NOT COMPLETED|Overall Study||0
10654832|NCT02204982|11815639|FG001|COMPLETED|Overall Study||0
10654833|NCT02204982|11815638|FG000|NOT COMPLETED|Overall Study||4
10714371|NCT02687451|11879942|FG005|STARTED|Overall Study||3
10811804|NCT03748979|11973633|FG002|NOT COMPLETED|Overall Study||0
10811805|NCT03748979|11973634|FG003|NOT COMPLETED|Overall Study||0
10811806|NCT03748979|11973635|FG004|NOT COMPLETED|Overall Study||0
10811807|NCT03748979|11973636|FG005|NOT COMPLETED|Overall Study||0
10811808|NCT03748979|11973637|FG006|NOT COMPLETED|Overall Study||0
10811809|NCT03748979|11973638|FG007|NOT COMPLETED|Overall Study||0
10811810|NCT03748979|11973639|FG008|NOT COMPLETED|Overall Study||0
10811811|NCT03748979|11973640|FG009|NOT COMPLETED|Overall Study||0
10811812|NCT03748979|11973641|FG010|NOT COMPLETED|Overall Study||0
10811813|NCT03748758|11973681|FG000|STARTED|Overall Study||12
10811814|NCT03748758|11973682|FG001|STARTED|Overall Study||12
10811815|NCT03748758|11973683|FG002|STARTED|Overall Study||6
10811816|NCT03748758|11973681|FG000|COMPLETED|Overall Study||12
10811817|NCT03748758|11973682|FG001|COMPLETED|Overall Study||12
10811818|NCT03748758|11973683|FG002|COMPLETED|Overall Study||5
10811819|NCT03748758|11973681|FG000|NOT COMPLETED|Overall Study||0
10811820|NCT03748758|11973682|FG001|NOT COMPLETED|Overall Study||0
10811821|NCT03748758|11973683|FG002|NOT COMPLETED|Overall Study||1
10811822|NCT03748706|11973713|FG000|STARTED|Overall Study||13
10811823|NCT03748706|11973713|FG000|COMPLETED|Overall Study||12
10811824|NCT03748706|11973713|FG000|NOT COMPLETED|Overall Study||1
10811825|NCT03748264|11973720|FG000|STARTED|Overall Study||21
10811826|NCT03748264|11973721|FG001|STARTED|Overall Study||21
10811827|NCT03748264|11973722|FG002|STARTED|Overall Study||20
10811828|NCT03748264|11973720|FG000|COMPLETED|Overall Study||21
10811829|NCT03748264|11973721|FG001|COMPLETED|Overall Study||21
10811830|NCT03748264|11973722|FG002|COMPLETED|Overall Study||20
10811831|NCT03748264|11973720|FG000|NOT COMPLETED|Overall Study||0
10811832|NCT03748264|11973721|FG001|NOT COMPLETED|Overall Study||0
10811833|NCT03748264|11973722|FG002|NOT COMPLETED|Overall Study||0
10811834|NCT03747497|11973732|FG000|STARTED|Overall Study||131
10811835|NCT03747497|11973733|FG001|STARTED|Overall Study||65
10811836|NCT03747497|11973732|FG000|COMPLETED|Overall Study||106
10811837|NCT03747497|11973733|FG001|COMPLETED|Overall Study||55
10811838|NCT03747497|11973732|FG000|NOT COMPLETED|Overall Study||25
10811839|NCT03747497|11973733|FG001|NOT COMPLETED|Overall Study||10
10811840|NCT03746405|11973741|FG000|STARTED|Overall Study||10
10811841|NCT03746405|11973742|FG001|STARTED|Overall Study||8
10811842|NCT03746405|11973741|FG000|COMPLETED|Overall Study||7
10811843|NCT03746405|11973742|FG001|COMPLETED|Overall Study||6
10654834|NCT02204982|11815639|FG001|NOT COMPLETED|Overall Study||7
10654835|NCT02205177|11815647|FG000|STARTED|Overall Study||8
10654836|NCT02205177|11815648|FG001|STARTED|Overall Study||2
10654837|NCT02205177|11815647|FG000|COMPLETED|Overall Study||6
10654838|NCT02205177|11815648|FG001|COMPLETED|Overall Study||2
10654839|NCT02205177|11815647|FG000|NOT COMPLETED|Overall Study||2
10302336|NCT00068718|11435127|FG000|NOT COMPLETED|Overall Study||0
10302337|NCT00068770|11435133|FG000|STARTED|Overall Study||13
10302338|NCT00068770|11435134|FG001|STARTED|Overall Study||22
10302339|NCT00068770|11435133|FG000|COMPLETED|Overall Study||13
10302340|NCT00068770|11435134|FG001|COMPLETED|Overall Study||22
10302341|NCT00068770|11435133|FG000|NOT COMPLETED|Overall Study||0
10302342|NCT00068770|11435134|FG001|NOT COMPLETED|Overall Study||0
10811844|NCT03746405|11973741|FG000|NOT COMPLETED|Overall Study||3
10811845|NCT03746405|11973742|FG001|NOT COMPLETED|Overall Study||2
10811846|NCT03745937|11973752|FG000|STARTED|Overall Study||2
10811847|NCT03745937|11973753|FG001|STARTED|Overall Study||6
10811848|NCT03745937|11973754|FG002|STARTED|Overall Study||3
10811849|NCT03745937|11973755|FG003|STARTED|Overall Study||9
10811850|NCT03745937|11973752|FG000|COMPLETED|Overall Study||2
10302343|NCT00068822|11435144|FG000|STARTED|First Randomized Intervention||68
10302344|NCT00068822|11435145|FG001|STARTED|First Randomized Intervention||63
10302345|NCT00068822|11435144|FG000|COMPLETED|First Randomized Intervention||67
10302346|NCT00068822|11435145|FG001|COMPLETED|First Randomized Intervention||61
10811851|NCT03745937|11973753|FG001|COMPLETED|Overall Study||5
10811852|NCT03745937|11973754|FG002|COMPLETED|Overall Study||3
10302347|NCT00068822|11435144|FG000|NOT COMPLETED|First Randomized Intervention||1
10302348|NCT00068822|11435145|FG001|NOT COMPLETED|First Randomized Intervention||2
10654840|NCT02205177|11815648|FG001|NOT COMPLETED|Overall Study||0
10811853|NCT03745937|11973755|FG003|COMPLETED|Overall Study||7
10811854|NCT03745937|11973752|FG000|NOT COMPLETED|Overall Study||0
10811855|NCT03745937|11973753|FG001|NOT COMPLETED|Overall Study||1
10339823|NCT00374907|11476709|FG001|COMPLETED|116-Week Short-term + Long-term Period||2
10529676|NCT01401543|11682019|FG001|STARTED|Third Intervention||6
10529677|NCT01401543|11682020|FG002|STARTED|Third Intervention||6
10529678|NCT01401543|11682021|FG003|STARTED|Third Intervention||6
10811856|NCT03745937|11973754|FG002|NOT COMPLETED|Overall Study||0
10811857|NCT03745937|11973755|FG003|NOT COMPLETED|Overall Study||2
10811858|NCT03745222|11973769|FG000|STARTED|Overall Study||0
10811859|NCT03745222|11973770|FG001|STARTED|Overall Study||1
10811860|NCT03745222|11973771|FG002|STARTED|Overall Study||0
10811861|NCT03745222|11973769|FG000|COMPLETED|Overall Study||0
10811862|NCT03745222|11973770|FG001|COMPLETED|Overall Study||0
10811863|NCT03745222|11973771|FG002|COMPLETED|Overall Study||0
10811864|NCT03745222|11973769|FG000|NOT COMPLETED|Overall Study||0
10811865|NCT03745222|11973770|FG001|NOT COMPLETED|Overall Study||1
10811866|NCT03745222|11973771|FG002|NOT COMPLETED|Overall Study||0
10811867|NCT03745092|11973781|FG000|STARTED|Overall Study||26
10529679|NCT01401543|11682018|FG000|COMPLETED|Third Intervention||6
10529680|NCT01401543|11682019|FG001|COMPLETED|Third Intervention||6
10529681|NCT01401543|11682020|FG002|COMPLETED|Third Intervention||6
10529682|NCT01401543|11682021|FG003|COMPLETED|Third Intervention||6
10529683|NCT01401543|11682018|FG000|NOT COMPLETED|Third Intervention||0
10529684|NCT01401543|11682019|FG001|NOT COMPLETED|Third Intervention||0
10529685|NCT01401543|11682020|FG002|NOT COMPLETED|Third Intervention||0
10529686|NCT01401543|11682021|FG003|NOT COMPLETED|Third Intervention||0
10529687|NCT01401543|11682018|FG000|STARTED|Third Washout Period of 1 Week||6
10529688|NCT01401543|11682019|FG001|STARTED|Third Washout Period of 1 Week||6
10529689|NCT01401543|11682020|FG002|STARTED|Third Washout Period of 1 Week||6
10529690|NCT01401543|11682021|FG003|STARTED|Third Washout Period of 1 Week||6
10529691|NCT01401543|11682018|FG000|COMPLETED|Third Washout Period of 1 Week||6
10529692|NCT01401543|11682019|FG001|COMPLETED|Third Washout Period of 1 Week||6
10529693|NCT01401543|11682020|FG002|COMPLETED|Third Washout Period of 1 Week||6
10529694|NCT01401543|11682021|FG003|COMPLETED|Third Washout Period of 1 Week||6
10529695|NCT01401543|11682018|FG000|NOT COMPLETED|Third Washout Period of 1 Week||0
10529696|NCT01401543|11682019|FG001|NOT COMPLETED|Third Washout Period of 1 Week||0
10529697|NCT01401543|11682020|FG002|NOT COMPLETED|Third Washout Period of 1 Week||0
10529698|NCT01401543|11682021|FG003|NOT COMPLETED|Third Washout Period of 1 Week||0
10529699|NCT01401543|11682018|FG000|STARTED|Fourth Intervention||6
10529700|NCT01401543|11682019|FG001|STARTED|Fourth Intervention||6
10529701|NCT01401543|11682020|FG002|STARTED|Fourth Intervention||6
10529702|NCT01401543|11682021|FG003|STARTED|Fourth Intervention||6
10529703|NCT01401543|11682018|FG000|COMPLETED|Fourth Intervention||6
10529704|NCT01401543|11682019|FG001|COMPLETED|Fourth Intervention||6
10529705|NCT01401543|11682020|FG002|COMPLETED|Fourth Intervention||6
10529706|NCT01401543|11682021|FG003|COMPLETED|Fourth Intervention||6
10529707|NCT01401543|11682018|FG000|NOT COMPLETED|Fourth Intervention||0
10529708|NCT01401543|11682019|FG001|NOT COMPLETED|Fourth Intervention||0
10529709|NCT01401543|11682020|FG002|NOT COMPLETED|Fourth Intervention||0
10529710|NCT01401543|11682021|FG003|NOT COMPLETED|Fourth Intervention||0
10529711|NCT01401582|11682037|FG000|STARTED|Overall Study||226
10529712|NCT01401582|11682038|FG001|STARTED|Overall Study||408
10529713|NCT01401582|11682037|FG000|Baseline Completed|Overall Study||168
10529714|NCT01401582|11682038|FG001|Baseline Completed|Overall Study||348
10529715|NCT01401582|11682037|FG000|COMPLETED|Overall Study||116
10529716|NCT01401582|11682038|FG001|COMPLETED|Overall Study||291
10529717|NCT01401582|11682037|FG000|NOT COMPLETED|Overall Study||110
10529718|NCT01401582|11682038|FG001|NOT COMPLETED|Overall Study||117
10529719|NCT01401595|11682049|FG000|STARTED|Recruitment and Screening|Of 345 calls, 75 potential NES subjects attended the screening visit and provided informed consent.|75
10529720|NCT01401595|11682050|FG001|STARTED|Recruitment and Screening|Of 32 calls, 12 control subjects attended an initial screening visit.|12
10529721|NCT01401595|11682049|FG000|COMPLETED|Recruitment and Screening|Of the 75, 32 remained interested/eligible after the initial screening period.|32
10529722|NCT01401595|11682050|FG001|COMPLETED|Recruitment and Screening|10 of the 12 remained eligible/interested after the initial screening visit.|10
10529723|NCT01401595|11682049|FG000|NOT COMPLETED|Recruitment and Screening||43
10529724|NCT01401595|11682050|FG001|NOT COMPLETED|Recruitment and Screening||2
10529725|NCT01401595|11682049|FG000|STARTED|Imaging and Treatment (for NE Arm)||32
10529726|NCT01401595|11682050|FG001|STARTED|Imaging and Treatment (for NE Arm)||10
10529727|NCT01401595|11682049|FG000|COMPLETED|Imaging and Treatment (for NE Arm)||18
10529728|NCT01401595|11682050|FG001|COMPLETED|Imaging and Treatment (for NE Arm)||10
10529729|NCT01401595|11682049|FG000|NOT COMPLETED|Imaging and Treatment (for NE Arm)||14
10529730|NCT01401595|11682050|FG001|NOT COMPLETED|Imaging and Treatment (for NE Arm)||0
10529731|NCT01401647|11682060|FG000|STARTED|Overall Study||972
10529732|NCT01401647|11682061|FG001|STARTED|Overall Study||993
10529733|NCT01401647|11682062|FG002|STARTED|Overall Study||1059
10529734|NCT01401647|11682060|FG000|COMPLETED|Overall Study||968
10529735|NCT01401647|11682061|FG001|COMPLETED|Overall Study||985
10529736|NCT01401647|11682062|FG002|COMPLETED|Overall Study||1056
10529737|NCT01401647|11682060|FG000|NOT COMPLETED|Overall Study||4
10529738|NCT01401647|11682061|FG001|NOT COMPLETED|Overall Study||8
10529739|NCT01401647|11682062|FG002|NOT COMPLETED|Overall Study||3
10654841|NCT02205307|11815656|FG000|STARTED|Overall Study||178
10654842|NCT02205307|11815657|FG001|STARTED|Overall Study||169
10654843|NCT02205307|11815656|FG000|COMPLETED|Overall Study||161
10339824|NCT00374907|11476708|FG000|NOT COMPLETED|116-Week Short-term + Long-term Period||13
10339825|NCT00374907|11476709|FG001|NOT COMPLETED|116-Week Short-term + Long-term Period||14
10339826|NCT00375167|11476719|FG000|STARTED|Overall Study|Clients were already receiving ACT services and this continued after study completion|16
10339827|NCT00375167|11476720|FG001|STARTED|Overall Study|Participants were already clients of ACT and continued receiving services following this period|17
10339828|NCT00375167|11476719|FG000|COMPLETED|Overall Study||16
10339829|NCT00375167|11476720|FG001|COMPLETED|Overall Study||17
10339830|NCT00375167|11476719|FG000|NOT COMPLETED|Overall Study||0
10339831|NCT00375167|11476720|FG001|NOT COMPLETED|Overall Study||0
10339832|NCT00375219|11476731|FG000|STARTED|Overall Study||62
10339833|NCT00375219|11476732|FG001|STARTED|Overall Study||20
10339834|NCT00375219|11476733|FG002|STARTED|Overall Study||21
10339835|NCT00375219|11476731|FG000|COMPLETED|Overall Study||3
10339836|NCT00375219|11476732|FG001|COMPLETED|Overall Study||0
10339837|NCT00375219|11476733|FG002|COMPLETED|Overall Study||0
10339838|NCT00375219|11476731|FG000|NOT COMPLETED|Overall Study||59
10339839|NCT00375219|11476732|FG001|NOT COMPLETED|Overall Study||20
10339840|NCT00375219|11476733|FG002|NOT COMPLETED|Overall Study||21
10302349|NCT00068822|11435144|FG000|STARTED|Optional Crossover Intervention||9
10302350|NCT00068822|11435145|FG001|STARTED|Optional Crossover Intervention||29
10302351|NCT00068822|11435144|FG000|Crossover at Month 1|Optional Crossover Intervention||1
10302352|NCT00068822|11435145|FG001|Crossover at Month 1|Optional Crossover Intervention||2
10302353|NCT00068822|11435144|FG000|Crossover at Month 3|Optional Crossover Intervention||8
10302354|NCT00068822|11435145|FG001|Crossover at Month 3|Optional Crossover Intervention||27
10302355|NCT00068822|11435144|FG000|COMPLETED|Optional Crossover Intervention||9
10302356|NCT00068822|11435145|FG001|COMPLETED|Optional Crossover Intervention||29
10302357|NCT00068822|11435144|FG000|NOT COMPLETED|Optional Crossover Intervention||0
10302358|NCT00068822|11435145|FG001|NOT COMPLETED|Optional Crossover Intervention||0
10302359|NCT00069095|11435157|FG000|STARTED|Primary Treatment Phase||317
10302360|NCT00069095|11435158|FG001|STARTED|Primary Treatment Phase||317
10302361|NCT00069095|11435159|FG002|STARTED|Primary Treatment Phase||350
10302362|NCT00069095|11435160|FG003|STARTED|Primary Treatment Phase||351
10302363|NCT00069095|11435161|FG004|STARTED|Primary Treatment Phase||350
10302364|NCT00069095|11435162|FG005|STARTED|Primary Treatment Phase||349
10302365|NCT00069095|11435157|FG000|COMPLETED|Primary Treatment Phase||22
10302366|NCT00069095|11435158|FG001|COMPLETED|Primary Treatment Phase||15
10302367|NCT00069095|11435159|FG002|COMPLETED|Primary Treatment Phase||36
10302368|NCT00069095|11435160|FG003|COMPLETED|Primary Treatment Phase||31
10302369|NCT00069095|11435161|FG004|COMPLETED|Primary Treatment Phase||48
10302370|NCT00069095|11435162|FG005|COMPLETED|Primary Treatment Phase||48
10302371|NCT00069095|11435157|FG000|NOT COMPLETED|Primary Treatment Phase||295
10302372|NCT00069095|11435158|FG001|NOT COMPLETED|Primary Treatment Phase||302
10302373|NCT00069095|11435159|FG002|NOT COMPLETED|Primary Treatment Phase||314
10302374|NCT00069095|11435160|FG003|NOT COMPLETED|Primary Treatment Phase||320
10302375|NCT00069095|11435161|FG004|NOT COMPLETED|Primary Treatment Phase||302
10302376|NCT00069095|11435162|FG005|NOT COMPLETED|Primary Treatment Phase||301
10302377|NCT00069095|11435157|FG000|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|8
10302378|NCT00069095|11435158|FG001|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|13
10302379|NCT00069095|11435159|FG002|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|21
10302380|NCT00069095|11435160|FG003|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|17
10302381|NCT00069095|11435161|FG004|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|36
10302382|NCT00069095|11435162|FG005|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|29
10302383|NCT00069095|11435157|FG000|COMPLETED|Post-study Treatment Phase||0
10302384|NCT00069095|11435158|FG001|COMPLETED|Post-study Treatment Phase||0
10302385|NCT00069095|11435159|FG002|COMPLETED|Post-study Treatment Phase||0
10302386|NCT00069095|11435160|FG003|COMPLETED|Post-study Treatment Phase||0
10302387|NCT00069095|11435161|FG004|COMPLETED|Post-study Treatment Phase||0
10302388|NCT00069095|11435162|FG005|COMPLETED|Post-study Treatment Phase||0
10302389|NCT00069095|11435157|FG000|NOT COMPLETED|Post-study Treatment Phase||8
10302390|NCT00069095|11435158|FG001|NOT COMPLETED|Post-study Treatment Phase||13
10302391|NCT00069095|11435159|FG002|NOT COMPLETED|Post-study Treatment Phase||21
10302392|NCT00069095|11435160|FG003|NOT COMPLETED|Post-study Treatment Phase||17
10302393|NCT00069095|11435161|FG004|NOT COMPLETED|Post-study Treatment Phase||36
10302394|NCT00069095|11435162|FG005|NOT COMPLETED|Post-study Treatment Phase||29
10714372|NCT02687451|11879937|FG000|COMPLETED|Overall Study||5
10714373|NCT02687451|11879938|FG001|COMPLETED|Overall Study||5
10714374|NCT02687451|11879939|FG002|COMPLETED|Overall Study||5
10714375|NCT02687451|11879940|FG003|COMPLETED|Overall Study||5
10714376|NCT02687451|11879941|FG004|COMPLETED|Overall Study||4
10302395|NCT00069095|11435157|FG000|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|284
10302396|NCT00069095|11435158|FG001|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|299
10714377|NCT02687451|11879942|FG005|COMPLETED|Overall Study||2
10714378|NCT02687451|11879937|FG000|NOT COMPLETED|Overall Study||1
10302397|NCT00069095|11435159|FG002|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|298
10302398|NCT00069095|11435160|FG003|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|299
10302399|NCT00069095|11435161|FG004|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|278
10302400|NCT00069095|11435162|FG005|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|272
10302401|NCT00069095|11435157|FG000|COMPLETED|Follow-up Phase||110
10302402|NCT00069095|11435158|FG001|COMPLETED|Follow-up Phase||93
10302403|NCT00069095|11435159|FG002|COMPLETED|Follow-up Phase||178
10302404|NCT00069095|11435160|FG003|COMPLETED|Follow-up Phase||187
10302405|NCT00069095|11435161|FG004|COMPLETED|Follow-up Phase||186
10302406|NCT00069095|11435162|FG005|COMPLETED|Follow-up Phase||171
10302407|NCT00069095|11435157|FG000|NOT COMPLETED|Follow-up Phase||174
10302408|NCT00069095|11435158|FG001|NOT COMPLETED|Follow-up Phase||206
10302409|NCT00069095|11435159|FG002|NOT COMPLETED|Follow-up Phase||120
10302410|NCT00069095|11435160|FG003|NOT COMPLETED|Follow-up Phase||112
10302411|NCT00069095|11435161|FG004|NOT COMPLETED|Follow-up Phase||92
10302412|NCT00069095|11435162|FG005|NOT COMPLETED|Follow-up Phase||101
10302413|NCT00069108|11435176|FG000|STARTED|Overall Study||313
10302414|NCT00069108|11435177|FG001|STARTED|Overall Study||314
10302415|NCT00069108|11435176|FG000|COMPLETED|Overall Study||100
10302416|NCT00069108|11435177|FG001|COMPLETED|Overall Study||95
10302417|NCT00069108|11435176|FG000|NOT COMPLETED|Overall Study||213
10302418|NCT00069108|11435177|FG001|NOT COMPLETED|Overall Study||219
10302419|NCT00069121|11435186|FG000|STARTED|Overall Study||942
10302420|NCT00069121|11435187|FG001|STARTED|Overall Study||944
10302421|NCT00069121|11435186|FG000|Received Treatment|Overall Study|Safety Population|926
10529740|NCT01401699|11682070|FG000|STARTED|Overall Study||109
10529741|NCT01401699|11682070|FG000|COMPLETED|Overall Study||109
10529742|NCT01401699|11682070|FG000|NOT COMPLETED|Overall Study||0
10529743|NCT01401842|11682076|FG000|STARTED|Overall Study||298
10529744|NCT01401842|11682077|FG001|STARTED|Overall Study||284
10529745|NCT01401842|11682076|FG000|COMPLETED|Overall Study||230
10302422|NCT00069121|11435187|FG001|Received Treatment|Overall Study|Safety Population|938
10302423|NCT00069121|11435186|FG000|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|575
10302424|NCT00069121|11435187|FG001|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|619
10302425|NCT00069121|11435186|FG000|NOT COMPLETED|Overall Study||367
10302426|NCT00069121|11435187|FG001|NOT COMPLETED|Overall Study||325
10302427|NCT00069160|11435199|FG000|STARTED|Overall Study||23
10302428|NCT00069160|11435200|FG001|STARTED|Overall Study||25
10302429|NCT00069160|11435199|FG000|COMPLETED|Overall Study||23
10302430|NCT00069160|11435200|FG001|COMPLETED|Overall Study||25
10302431|NCT00069160|11435199|FG000|NOT COMPLETED|Overall Study||0
10302432|NCT00069160|11435200|FG001|NOT COMPLETED|Overall Study||0
10302433|NCT00069264|11435209|FG000|STARTED|Overall Study||32
10302434|NCT00069264|11435209|FG000|COMPLETED|Overall Study||0
10302435|NCT00069264|11435209|FG000|NOT COMPLETED|Overall Study||32
10302436|NCT00069277|11435213|FG000|STARTED|Overall Study||21
10302437|NCT00069277|11435213|FG000|COMPLETED|Overall Study||0
10302438|NCT00069277|11435213|FG000|NOT COMPLETED|Overall Study||21
10302439|NCT00069329|11435217|FG000|STARTED|Overall Study||43
10302440|NCT00069329|11435217|FG000|COMPLETED|Overall Study||41
10339841|NCT00375427|11476742|FG000|STARTED|Overall Study|Total enrollment was 430 but five patients were screened but not treated.|209
10339842|NCT00375427|11476743|FG001|STARTED|Overall Study||216
10339843|NCT00375427|11476742|FG000|COMPLETED|Overall Study||149
10339844|NCT00375427|11476743|FG001|COMPLETED|Overall Study||142
10339845|NCT00375427|11476742|FG000|NOT COMPLETED|Overall Study||60
10339846|NCT00375427|11476743|FG001|NOT COMPLETED|Overall Study||74
10339847|NCT00375492|11476751|FG000|STARTED|Overall Study||96
10339848|NCT00375492|11476752|FG001|STARTED|Overall Study||98
10339849|NCT00375492|11476751|FG000|COMPLETED|Overall Study||70
10339850|NCT00375492|11476752|FG001|COMPLETED|Overall Study||72
10339851|NCT00375492|11476751|FG000|NOT COMPLETED|Overall Study||26
10339852|NCT00375492|11476752|FG001|NOT COMPLETED|Overall Study||26
10714379|NCT02687451|11879938|FG001|NOT COMPLETED|Overall Study||0
10714380|NCT02687451|11879939|FG002|NOT COMPLETED|Overall Study||0
10714381|NCT02687451|11879940|FG003|NOT COMPLETED|Overall Study||0
10714382|NCT02687451|11879941|FG004|NOT COMPLETED|Overall Study||0
10714383|NCT02687451|11879942|FG005|NOT COMPLETED|Overall Study||1
10714384|NCT02687529|11879960|FG000|STARTED|Overall Study||34
10714385|NCT02687529|11879961|FG001|STARTED|Overall Study||32
10714386|NCT02687529|11879960|FG000|COMPLETED|Overall Study||34
10714387|NCT02687529|11879961|FG001|COMPLETED|Overall Study||32
10714388|NCT02687529|11879960|FG000|NOT COMPLETED|Overall Study||0
10714389|NCT02687529|11879961|FG001|NOT COMPLETED|Overall Study||0
10714390|NCT02687542|11879972|FG000|STARTED|Overall Study||23
10714391|NCT02687542|11879973|FG001|STARTED|Overall Study||13
10714392|NCT02687542|11879974|FG002|STARTED|Overall Study||15
10714393|NCT02687542|11879975|FG003|STARTED|Overall Study||13
10714394|NCT02687542|11879976|FG004|STARTED|Overall Study||44
10714395|NCT02687542|11879972|FG000|COMPLETED|Overall Study||15
10714396|NCT02687542|11879973|FG001|COMPLETED|Overall Study||1
10714397|NCT02687542|11879974|FG002|COMPLETED|Overall Study||1
10714398|NCT02687542|11879975|FG003|COMPLETED|Overall Study||3
10714399|NCT02687542|11879976|FG004|COMPLETED|Overall Study||24
10714400|NCT02687542|11879972|FG000|NOT COMPLETED|Overall Study||8
10714401|NCT02687542|11879973|FG001|NOT COMPLETED|Overall Study||12
10714402|NCT02687542|11879974|FG002|NOT COMPLETED|Overall Study||14
10714403|NCT02687542|11879975|FG003|NOT COMPLETED|Overall Study||10
10714404|NCT02687542|11879976|FG004|NOT COMPLETED|Overall Study||20
10714405|NCT02687711|11879988|FG000|STARTED|Overall Study||544
10714406|NCT02687711|11879988|FG000|COMPLETED|Overall Study||332
10714407|NCT02687711|11879988|FG000|NOT COMPLETED|Overall Study||212
10714408|NCT02687815|11879994|FG000|STARTED|Overall Study||96
10339853|NCT00375505|11476760|FG000|STARTED|Overall Study||36
10339854|NCT00375505|11476761|FG001|STARTED|Overall Study||34
10339855|NCT00375505|11476760|FG000|COMPLETED|Overall Study||35
10339856|NCT00375505|11476761|FG001|COMPLETED|Overall Study||32
10339857|NCT00375505|11476760|FG000|NOT COMPLETED|Overall Study||1
10714409|NCT02687815|11879995|FG001|STARTED|Overall Study||96
10714410|NCT02687815|11879994|FG000|COMPLETED|Overall Study||92
10714411|NCT02687815|11879995|FG001|COMPLETED|Overall Study||88
10714412|NCT02687815|11879994|FG000|NOT COMPLETED|Overall Study||4
10714413|NCT02687815|11879995|FG001|NOT COMPLETED|Overall Study||8
10714414|NCT02687919|11880003|FG000|STARTED|Overall Study||16
10302441|NCT00069329|11435217|FG000|NOT COMPLETED|Overall Study||2
10302442|NCT00069576|11435223|FG000|STARTED|Original Trial||485
10302443|NCT00069576|11435224|FG001|STARTED|Original Trial||473
10302444|NCT00069576|11435223|FG000|COMPLETED|Original Trial||460
10339858|NCT00375505|11476761|FG001|NOT COMPLETED|Overall Study||2
10714415|NCT02687919|11880004|FG001|STARTED|Overall Study||15
10714416|NCT02687919|11880003|FG000|COMPLETED|Overall Study||8
10714417|NCT02687919|11880004|FG001|COMPLETED|Overall Study||9
10714418|NCT02687919|11880003|FG000|NOT COMPLETED|Overall Study||8
10714419|NCT02687919|11880004|FG001|NOT COMPLETED|Overall Study||6
10714420|NCT02688153|11880012|FG000|STARTED|Overall Study||62
10714421|NCT02688153|11880013|FG001|STARTED|Overall Study||58
10714422|NCT02688153|11880012|FG000|Final Randomized Arm/Group|Overall Study||59
10714423|NCT02688153|11880013|FG001|Final Randomized Arm/Group|Overall Study||61
10302445|NCT00069576|11435224|FG001|COMPLETED|Original Trial||440
10302446|NCT00069576|11435223|FG000|NOT COMPLETED|Original Trial||25
10302447|NCT00069576|11435224|FG001|NOT COMPLETED|Original Trial||33
10302448|NCT00069576|11435223|FG000|STARTED|Follow-up Study at 5-10 Years||460
10302449|NCT00069576|11435224|FG001|STARTED|Follow-up Study at 5-10 Years||440
10302450|NCT00069576|11435223|FG000|COMPLETED|Follow-up Study at 5-10 Years||264
10302451|NCT00069576|11435224|FG001|COMPLETED|Follow-up Study at 5-10 Years||236
10302452|NCT00069576|11435223|FG000|NOT COMPLETED|Follow-up Study at 5-10 Years||196
10302453|NCT00069576|11435224|FG001|NOT COMPLETED|Follow-up Study at 5-10 Years||204
10302454|NCT00069641|11435233|FG000|STARTED|Overall Study||32
10302455|NCT00069641|11435234|FG001|STARTED|Overall Study||32
10302456|NCT00069641|11435235|FG002|STARTED|Overall Study||32
10302457|NCT00069641|11435233|FG000|COMPLETED|Overall Study||31
10302458|NCT00069641|11435234|FG001|COMPLETED|Overall Study||32
10302459|NCT00069641|11435235|FG002|COMPLETED|Overall Study||31
10302460|NCT00069641|11435233|FG000|NOT COMPLETED|Overall Study||1
10302461|NCT00069641|11435234|FG001|NOT COMPLETED|Overall Study||0
10302462|NCT00069641|11435235|FG002|NOT COMPLETED|Overall Study||1
10302463|NCT00069784|11435246|FG000|STARTED|Overall Study|randomized participants = intent-to-treat (ITT) population|6264
10339859|NCT00375518|11476769|FG000|STARTED|Overall Study||80
10339860|NCT00375518|11476770|FG001|STARTED|Overall Study||82
10339861|NCT00375518|11476769|FG000|COMPLETED|Overall Study||72
10339862|NCT00375518|11476770|FG001|COMPLETED|Overall Study||65
10529746|NCT01401842|11682077|FG001|COMPLETED|Overall Study||217
10529747|NCT01401842|11682076|FG000|NOT COMPLETED|Overall Study||68
10529748|NCT01401842|11682077|FG001|NOT COMPLETED|Overall Study||67
10529749|NCT01401907|11682085|FG000|STARTED|Overall Study||175
10714424|NCT02688153|11880012|FG000|COMPLETED|Overall Study||47
10714425|NCT02688153|11880013|FG001|COMPLETED|Overall Study||51
10714426|NCT02688153|11880012|FG000|NOT COMPLETED|Overall Study||15
10339863|NCT00375518|11476769|FG000|NOT COMPLETED|Overall Study||8
10339864|NCT00375518|11476770|FG001|NOT COMPLETED|Overall Study||17
10339865|NCT00375609|11476779|FG000|STARTED|Overall Study||88
10529750|NCT01401907|11682086|FG001|STARTED|Overall Study||175
10529751|NCT01401907|11682085|FG000|12 Week Outcomes|Overall Study||148
10529752|NCT01401907|11682086|FG001|12 Week Outcomes|Overall Study||153
10529753|NCT01401907|11682085|FG000|COMPLETED|Overall Study||118
10654844|NCT02205307|11815657|FG001|COMPLETED|Overall Study||163
10654845|NCT02205307|11815656|FG000|NOT COMPLETED|Overall Study||17
10654846|NCT02205307|11815657|FG001|NOT COMPLETED|Overall Study||6
10654847|NCT02205333|11815673|FG000|STARTED|Overall Study||8
10654848|NCT02205333|11815674|FG001|STARTED|Overall Study||6
10339866|NCT00375609|11476780|FG001|STARTED|Overall Study||84
10339867|NCT00375609|11476781|FG002|STARTED|Overall Study||43
10339868|NCT00375609|11476779|FG000|COMPLETED|Overall Study||84
10339869|NCT00375609|11476780|FG001|COMPLETED|Overall Study||77
10339870|NCT00375609|11476781|FG002|COMPLETED|Overall Study||42
10339871|NCT00375609|11476779|FG000|NOT COMPLETED|Overall Study||4
10339872|NCT00375609|11476780|FG001|NOT COMPLETED|Overall Study||7
10339873|NCT00375609|11476781|FG002|NOT COMPLETED|Overall Study||1
10339874|NCT00375674|11476791|FG000|STARTED|Overall Study||309
10339875|NCT00375674|11476792|FG001|STARTED|Overall Study||306
10339876|NCT00375674|11476791|FG000|Intent-to-Treat Population|Overall Study||309
10339877|NCT00375674|11476792|FG001|Intent-to-Treat Population|Overall Study||306
10529754|NCT01401907|11682086|FG001|COMPLETED|Overall Study||124
10654849|NCT02205333|11815675|FG002|STARTED|Overall Study||3
10654850|NCT02205333|11815676|FG003|STARTED|Overall Study||7
10654851|NCT02205333|11815677|FG004|STARTED|Overall Study||6
10654852|NCT02205333|11815678|FG005|STARTED|Overall Study||7
10654853|NCT02205333|11815679|FG006|STARTED|Overall Study||7
10654854|NCT02205333|11815680|FG007|STARTED|Overall Study||3
10714427|NCT02688153|11880013|FG001|NOT COMPLETED|Overall Study||7
10714428|NCT02688192|11880022|FG000|STARTED|Overall Study||25
10302464|NCT00069784|11435247|FG001|STARTED|Overall Study|randomized participants = intent-to-treat (ITT) population|6273
10302465|NCT00069784|11435246|FG000|Safety Population (Treated)|Overall Study|randomized patients who received at least one dose of insulin glargine|6231
10302466|NCT00069784|11435247|FG001|Safety Population (Treated)|Overall Study|patients randomized to standard care arm|6273
10302467|NCT00069784|11435246|FG000|COMPLETED|Overall Study|completed study treatment|5052
10302468|NCT00069784|11435247|FG001|COMPLETED|Overall Study|not applicable (no treatment)|6273
10302469|NCT00069784|11435246|FG000|NOT COMPLETED|Overall Study||1212
10302470|NCT00069784|11435247|FG001|NOT COMPLETED|Overall Study||0
10302471|NCT00069823|11435255|FG000|STARTED|Overall Study|The design was for 200 participants per group, the study did not exactly meet the design.|199
10302472|NCT00069823|11435256|FG001|STARTED|Overall Study|The design was for 200 participants per group, the study did not exactly meet the design.|203
10302473|NCT00069823|11435255|FG000|COMPLETED|Overall Study||193
10302474|NCT00069823|11435256|FG001|COMPLETED|Overall Study||200
10302475|NCT00069823|11435255|FG000|NOT COMPLETED|Overall Study||6
10302476|NCT00069823|11435256|FG001|NOT COMPLETED|Overall Study||3
10302477|NCT00069953|11435262|FG000|STARTED|Overall Study||43
10302478|NCT00069953|11435262|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study|41
10302479|NCT00069953|11435262|FG000|NOT COMPLETED|Overall Study||2
10302480|NCT00070070|11435270|FG000|STARTED|Overall Study||1
10302481|NCT00070070|11435271|FG001|STARTED|Overall Study||0
10302482|NCT00070070|11435272|FG002|STARTED|Overall Study||0
10302483|NCT00070070|11435273|FG003|STARTED|Overall Study||5
10302484|NCT00070070|11435270|FG000|COMPLETED|Overall Study||1
10302485|NCT00070070|11435271|FG001|COMPLETED|Overall Study||0
10302486|NCT00070070|11435272|FG002|COMPLETED|Overall Study||0
10302487|NCT00070070|11435273|FG003|COMPLETED|Overall Study||5
10302488|NCT00070070|11435270|FG000|NOT COMPLETED|Overall Study||0
10302489|NCT00070070|11435271|FG001|NOT COMPLETED|Overall Study||0
10302490|NCT00070070|11435272|FG002|NOT COMPLETED|Overall Study||0
10302491|NCT00070070|11435273|FG003|NOT COMPLETED|Overall Study||0
10302492|NCT00070109|11435288|FG000|STARTED|Overall Study||8
10302493|NCT00070109|11435289|FG001|STARTED|Overall Study||6
10302494|NCT00070109|11435290|FG002|STARTED|Overall Study||8
10302495|NCT00070109|11435291|FG003|STARTED|Overall Study||20
10302496|NCT00070109|11435292|FG004|STARTED|Overall Study||8
10302497|NCT00070109|11435288|FG000|COMPLETED|Overall Study||0
10302498|NCT00070109|11435289|FG001|COMPLETED|Overall Study||0
10302499|NCT00070109|11435290|FG002|COMPLETED|Overall Study||0
10302500|NCT00070109|11435291|FG003|COMPLETED|Overall Study||0
10302501|NCT00070109|11435292|FG004|COMPLETED|Overall Study||0
10302502|NCT00070109|11435288|FG000|NOT COMPLETED|Overall Study||8
10302503|NCT00070109|11435289|FG001|NOT COMPLETED|Overall Study||6
10302504|NCT00070109|11435290|FG002|NOT COMPLETED|Overall Study||8
10302505|NCT00070109|11435291|FG003|NOT COMPLETED|Overall Study||20
10302506|NCT00070109|11435292|FG004|NOT COMPLETED|Overall Study||8
10302507|NCT00070135|11435311|FG000|STARTED|Overall Study||114
10302508|NCT00070135|11435311|FG000|COMPLETED|Overall Study||114
10302509|NCT00070135|11435311|FG000|NOT COMPLETED|Overall Study||0
10302510|NCT00070291|11435315|FG000|STARTED|Step 1||4
10302511|NCT00070291|11435315|FG000|Treated|Step 1||3
10302512|NCT00070291|11435315|FG000|COMPLETED|Step 1||2
10302513|NCT00070291|11435315|FG000|NOT COMPLETED|Step 1||2
10302514|NCT00070291|11435315|FG000|STARTED|Step 2|One patient completed step 1, but opted to get alternative therapy. One patient entered step 2.|1
10302515|NCT00070291|11435315|FG000|COMPLETED|Step 2||0
10302516|NCT00070291|11435315|FG000|NOT COMPLETED|Step 2||1
10302517|NCT00070317|11435319|FG000|STARTED|Overall Study||102
10302518|NCT00070317|11435319|FG000|COMPLETED|Overall Study||89
10302519|NCT00070317|11435319|FG000|NOT COMPLETED|Overall Study||13
10302520|NCT00070941|11435326|FG000|STARTED|Overall Study||12
10302521|NCT00070941|11435327|FG001|STARTED|Overall Study||11
10302522|NCT00070941|11435328|FG002|STARTED|Overall Study||6
10302523|NCT00070941|11435326|FG000|COMPLETED|Overall Study||2
10302524|NCT00070941|11435327|FG001|COMPLETED|Overall Study||3
10302525|NCT00070941|11435328|FG002|COMPLETED|Overall Study||2
10302526|NCT00070941|11435326|FG000|NOT COMPLETED|Overall Study||10
10302527|NCT00070941|11435327|FG001|NOT COMPLETED|Overall Study||8
10339878|NCT00375674|11476791|FG000|As-Treated Population|Overall Study|3 were randomized but not treated: 2 refused treatment & 1 withdrew before receiving study drug|306
10339879|NCT00375674|11476792|FG001|As-Treated Population|Overall Study|2 were randomized but not treated: 1 was screening failure & 1 discontinued due to new liver lesions|304
10339880|NCT00375674|11476791|FG000|COMPLETED|Overall Study||165
10339881|NCT00375674|11476792|FG001|COMPLETED|Overall Study||165
10339882|NCT00375674|11476791|FG000|NOT COMPLETED|Overall Study||144
10714429|NCT02688192|11880023|FG001|STARTED|Overall Study||24
10714430|NCT02688192|11880022|FG000|COMPLETED|Overall Study||13
10339883|NCT00375674|11476792|FG001|NOT COMPLETED|Overall Study||141
10339884|NCT00375713|11476800|FG000|STARTED|Overall Study|Randomized population (N=232).|232
10339885|NCT00375713|11476801|FG001|STARTED|Overall Study|Randomized population (N=234).|234
10714431|NCT02688192|11880023|FG001|COMPLETED|Overall Study||19
10714432|NCT02688192|11880022|FG000|NOT COMPLETED|Overall Study||12
10714433|NCT02688192|11880023|FG001|NOT COMPLETED|Overall Study||5
10714434|NCT02688218|11880032|FG000|STARTED|First Exercise Intervention (2 Hours)||24
10714435|NCT02688218|11880033|FG001|STARTED|First Exercise Intervention (2 Hours)||6
10714436|NCT02688218|11880032|FG000|COMPLETED|First Exercise Intervention (2 Hours)||24
10339886|NCT00375713|11476800|FG000|COMPLETED|Overall Study|20 Patients were not treated or discontinued after randomization in Levocetirizine group.|212
10339887|NCT00375713|11476801|FG001|COMPLETED|Overall Study|23 Patients were not treated or discontinued after randomization in Cetirizine group.|211
10339888|NCT00375713|11476800|FG000|NOT COMPLETED|Overall Study||20
10339889|NCT00375713|11476801|FG001|NOT COMPLETED|Overall Study||23
10339890|NCT00375752|11476809|FG000|STARTED|Overall Study||79
10339891|NCT00375752|11476810|FG001|STARTED|Overall Study||89
10339892|NCT00375752|11476809|FG000|COMPLETED|Overall Study||67
10339893|NCT00375752|11476810|FG001|COMPLETED|Overall Study||74
10339894|NCT00375752|11476809|FG000|NOT COMPLETED|Overall Study||12
10339895|NCT00375752|11476810|FG001|NOT COMPLETED|Overall Study||15
10339896|NCT00375830|11476819|FG000|STARTED|Overall Study||10
10339897|NCT00375830|11476820|FG001|STARTED|Overall Study||30
10339898|NCT00375830|11476821|FG002|STARTED|Overall Study||74
10654855|NCT02205333|11815681|FG008|STARTED|Overall Study||1
10654856|NCT02205333|11815673|FG000|COMPLETED|Overall Study||2
10654857|NCT02205333|11815674|FG001|COMPLETED|Overall Study||0
10654858|NCT02205333|11815675|FG002|COMPLETED|Overall Study||1
10302528|NCT00070941|11435328|FG002|NOT COMPLETED|Overall Study||4
10302529|NCT00071006|11435336|FG000|STARTED|Overall Study||12
10302530|NCT00071006|11435336|FG000|COMPLETED|Overall Study||0
10302531|NCT00071006|11435336|FG000|NOT COMPLETED|Overall Study||12
10302532|NCT00071032|11435342|FG000|STARTED|Overall Study||1007
10302533|NCT00071032|11435343|FG001|STARTED|Overall Study||1009
10302534|NCT00071032|11435342|FG000|COMPLETED|Overall Study||998
10302535|NCT00071032|11435343|FG001|COMPLETED|Overall Study||1001
10302536|NCT00071032|11435342|FG000|NOT COMPLETED|Overall Study||9
10302537|NCT00071032|11435343|FG001|NOT COMPLETED|Overall Study||8
10302538|NCT00071058|11435350|FG000|STARTED|Overall Study||50
10302539|NCT00071058|11435350|FG000|COMPLETED|Overall Study||49
10302540|NCT00071058|11435350|FG000|NOT COMPLETED|Overall Study||1
10302541|NCT00071110|11435357|FG000|STARTED|Overall Study||28
10302542|NCT00071110|11435358|FG001|STARTED|Overall Study||29
10302543|NCT00071110|11435357|FG000|COMPLETED|Overall Study||28
10302544|NCT00071110|11435358|FG001|COMPLETED|Overall Study||25
10302545|NCT00071110|11435357|FG000|NOT COMPLETED|Overall Study||0
10302546|NCT00071110|11435358|FG001|NOT COMPLETED|Overall Study||4
10302547|NCT00071396|11435364|FG000|STARTED|Overall Study||44
10302548|NCT00071396|11435364|FG000|COMPLETED|Overall Study|Evaluable for response.|41
10302549|NCT00071396|11435364|FG000|NOT COMPLETED|Overall Study||3
10302550|NCT00071487|11435372|FG000|STARTED|52-Week Double-Blind Period||113
10302551|NCT00071487|11435373|FG001|STARTED|52-Week Double-Blind Period||114
10302552|NCT00071487|11435374|FG002|STARTED|52-Week Double-Blind Period||111
10302553|NCT00071487|11435375|FG003|STARTED|52-Week Double-Blind Period||111
10302554|NCT00071487|11435372|FG000|COMPLETED|52-Week Double-Blind Period||93
10302555|NCT00071487|11435373|FG001|COMPLETED|52-Week Double-Blind Period||87
10302556|NCT00071487|11435374|FG002|COMPLETED|52-Week Double-Blind Period||94
10302557|NCT00071487|11435375|FG003|COMPLETED|52-Week Double-Blind Period||90
10302558|NCT00071487|11435372|FG000|NOT COMPLETED|52-Week Double-Blind Period||20
10302559|NCT00071487|11435373|FG001|NOT COMPLETED|52-Week Double-Blind Period||27
10302560|NCT00071487|11435374|FG002|NOT COMPLETED|52-Week Double-Blind Period||17
10339899|NCT00375830|11476819|FG000|COMPLETED|Overall Study||10
10339900|NCT00375830|11476820|FG001|COMPLETED|Overall Study||30
10339901|NCT00375830|11476821|FG002|COMPLETED|Overall Study||74
10339902|NCT00375830|11476819|FG000|NOT COMPLETED|Overall Study||0
10339903|NCT00375830|11476820|FG001|NOT COMPLETED|Overall Study||0
10339904|NCT00375830|11476821|FG002|NOT COMPLETED|Overall Study||0
10339905|NCT00375934|11476843|FG000|STARTED|Overall Study||99
10339906|NCT00375934|11476844|FG001|STARTED|Overall Study||101
10339907|NCT00375934|11476843|FG000|COMPLETED|Overall Study||96
10339908|NCT00375934|11476844|FG001|COMPLETED|Overall Study||95
10339909|NCT00375934|11476843|FG000|NOT COMPLETED|Overall Study||3
10339910|NCT00375934|11476844|FG001|NOT COMPLETED|Overall Study||6
10339911|NCT00375973|11476852|FG000|STARTED|Overall Study||30
10339912|NCT00375973|11476853|FG001|STARTED|Overall Study||30
10339913|NCT00375973|11476852|FG000|COMPLETED|Overall Study||20
10339914|NCT00375973|11476853|FG001|COMPLETED|Overall Study||28
10339915|NCT00375973|11476852|FG000|NOT COMPLETED|Overall Study||10
10339916|NCT00375973|11476853|FG001|NOT COMPLETED|Overall Study||2
10339917|NCT00375999|11476859|FG000|STARTED|Overall Study||34
10339918|NCT00375999|11476859|FG000|COMPLETED|Overall Study||32
10339919|NCT00375999|11476859|FG000|NOT COMPLETED|Overall Study||2
10339920|NCT00376168|11476865|FG000|STARTED|Overall Study||16
10339921|NCT00376168|11476866|FG001|STARTED|Overall Study|One patient randomized but not treated|16
10339922|NCT00376168|11476865|FG000|COMPLETED|Overall Study||14
10339923|NCT00376168|11476866|FG001|COMPLETED|Overall Study||15
10339924|NCT00376168|11476865|FG000|NOT COMPLETED|Overall Study||2
10339925|NCT00376168|11476866|FG001|NOT COMPLETED|Overall Study||1
10339926|NCT00376220|11476874|FG000|STARTED|Overall Study||47
10339927|NCT00376220|11476875|FG001|STARTED|Overall Study||47
10339928|NCT00376220|11476874|FG000|COMPLETED|Overall Study||37
10339929|NCT00376220|11476875|FG001|COMPLETED|Overall Study||35
10339930|NCT00376220|11476874|FG000|NOT COMPLETED|Overall Study||10
10339931|NCT00376220|11476875|FG001|NOT COMPLETED|Overall Study||12
10339932|NCT00376246|11476881|FG000|STARTED|First Intervention (2 Weeks)||14
10339933|NCT00376246|11476882|FG001|STARTED|First Intervention (2 Weeks)||14
10339934|NCT00376246|11476881|FG000|COMPLETED|First Intervention (2 Weeks)||10
10339935|NCT00376246|11476882|FG001|COMPLETED|First Intervention (2 Weeks)||12
10339936|NCT00376246|11476881|FG000|NOT COMPLETED|First Intervention (2 Weeks)||4
10339937|NCT00376246|11476882|FG001|NOT COMPLETED|First Intervention (2 Weeks)||2
10339938|NCT00376246|11476881|FG000|STARTED|Washout (2 Weeks)||10
10302561|NCT00071487|11435375|FG003|NOT COMPLETED|52-Week Double-Blind Period||21
10302562|NCT00071487|11435372|FG000|STARTED|24-Week Open-Label Extension Period|Of 93: 88 switched to 10 mg/kg; 5 elected not to continue in the open-label extension period.|0
10302563|NCT00071487|11435373|FG001|STARTED|24-Week Open-Label Extension Period|Of 87: 65 switched to 10 mg/kg; 3 elected not to continue in the open-label extension period.|19
10302564|NCT00071487|11435374|FG002|STARTED|24-Week Open-Label Extension Period|Of 94: 64 switched to 10 mg/kg; 6 elected not to continue in the open-label extension period.|24
10302565|NCT00071487|11435375|FG003|STARTED|24-Week Open-Label Extension Period|Of 90: 85 continued with 10 mg/kg; 5 elected not to continue in the open-label extension period.|302
10302566|NCT00071487|11435372|FG000|COMPLETED|24-Week Open-Label Extension Period||0
10302567|NCT00071487|11435373|FG001|COMPLETED|24-Week Open-Label Extension Period||19
10302568|NCT00071487|11435374|FG002|COMPLETED|24-Week Open-Label Extension Period||23
10302569|NCT00071487|11435375|FG003|COMPLETED|24-Week Open-Label Extension Period||279
10302570|NCT00071487|11435372|FG000|NOT COMPLETED|24-Week Open-Label Extension Period||0
10302571|NCT00071487|11435373|FG001|NOT COMPLETED|24-Week Open-Label Extension Period||0
10302572|NCT00071487|11435374|FG002|NOT COMPLETED|24-Week Open-Label Extension Period||1
10302573|NCT00071487|11435375|FG003|NOT COMPLETED|24-Week Open-Label Extension Period||23
10302574|NCT00071513|11435389|FG000|STARTED|Intervention Component||241
10302575|NCT00071513|11435390|FG001|STARTED|Intervention Component||256
10302576|NCT00071513|11435389|FG000|COMPLETED|Intervention Component||239
10302577|NCT00071513|11435390|FG001|COMPLETED|Intervention Component||253
10302578|NCT00071513|11435389|FG000|NOT COMPLETED|Intervention Component||2
10302579|NCT00071513|11435390|FG001|NOT COMPLETED|Intervention Component||3
10302580|NCT00071513|11435389|FG000|STARTED|Follow-up Assessment||239
10302581|NCT00071513|11435390|FG001|STARTED|Follow-up Assessment||253
10302582|NCT00071513|11435389|FG000|COMPLETED|Follow-up Assessment||233
10302583|NCT00071513|11435390|FG001|COMPLETED|Follow-up Assessment||247
10302584|NCT00071513|11435389|FG000|NOT COMPLETED|Follow-up Assessment||6
10302585|NCT00071513|11435390|FG001|NOT COMPLETED|Follow-up Assessment||6
10529755|NCT01401907|11682085|FG000|NOT COMPLETED|Overall Study||57
10529756|NCT01401907|11682086|FG001|NOT COMPLETED|Overall Study||51
10529757|NCT01401959|11682097|FG000|STARTED|Enrolled||54
10529758|NCT01401959|11682098|FG001|STARTED|Enrolled||42
10529759|NCT01401959|11682099|FG002|STARTED|Enrolled||31
10654859|NCT02205333|11815676|FG003|COMPLETED|Overall Study||0
10654860|NCT02205333|11815677|FG004|COMPLETED|Overall Study||1
10654861|NCT02205333|11815678|FG005|COMPLETED|Overall Study||4
10654862|NCT02205333|11815679|FG006|COMPLETED|Overall Study||2
10654863|NCT02205333|11815680|FG007|COMPLETED|Overall Study||1
10777205|NCT03337490|11939130|FG002|NOT COMPLETED|Overall Study||35
10654864|NCT02205333|11815681|FG008|COMPLETED|Overall Study||1
10714437|NCT02688218|11880033|FG001|COMPLETED|First Exercise Intervention (2 Hours)||6
10714438|NCT02688218|11880032|FG000|NOT COMPLETED|First Exercise Intervention (2 Hours)||0
10714439|NCT02688218|11880033|FG001|NOT COMPLETED|First Exercise Intervention (2 Hours)||0
10714440|NCT02688218|11880032|FG000|STARTED|Washout (30 Minutes)||24
10714441|NCT02688218|11880033|FG001|STARTED|Washout (30 Minutes)||6
10714442|NCT02688218|11880032|FG000|COMPLETED|Washout (30 Minutes)||24
10714443|NCT02688218|11880033|FG001|COMPLETED|Washout (30 Minutes)||6
10714444|NCT02688218|11880032|FG000|NOT COMPLETED|Washout (30 Minutes)||0
10529760|NCT01401959|11682097|FG000|COMPLETED|Enrolled||53
10529761|NCT01401959|11682098|FG001|COMPLETED|Enrolled||42
10529762|NCT01401959|11682099|FG002|COMPLETED|Enrolled||31
10529763|NCT01401959|11682097|FG000|NOT COMPLETED|Enrolled||1
10529764|NCT01401959|11682098|FG001|NOT COMPLETED|Enrolled||0
10529765|NCT01401959|11682099|FG002|NOT COMPLETED|Enrolled||0
10529766|NCT01401959|11682097|FG000|STARTED|Treated||53
10529767|NCT01401959|11682098|FG001|STARTED|Treated||42
10529768|NCT01401959|11682099|FG002|STARTED|Treated||31
10529769|NCT01401959|11682097|FG000|COMPLETED|Treated||46
10529770|NCT01401959|11682098|FG001|COMPLETED|Treated||34
10654865|NCT02205333|11815673|FG000|NOT COMPLETED|Overall Study||6
10654866|NCT02205333|11815674|FG001|NOT COMPLETED|Overall Study||6
10654867|NCT02205333|11815675|FG002|NOT COMPLETED|Overall Study||2
10654868|NCT02205333|11815676|FG003|NOT COMPLETED|Overall Study||7
10654869|NCT02205333|11815677|FG004|NOT COMPLETED|Overall Study||5
10654870|NCT02205333|11815678|FG005|NOT COMPLETED|Overall Study||3
10654871|NCT02205333|11815679|FG006|NOT COMPLETED|Overall Study||5
10654872|NCT02205333|11815680|FG007|NOT COMPLETED|Overall Study||2
10654873|NCT02205333|11815681|FG008|NOT COMPLETED|Overall Study||0
10654874|NCT02205476|11815703|FG000|STARTED|Overall Study||7
10654875|NCT02205476|11815704|FG001|STARTED|Overall Study||3
10654876|NCT02205476|11815703|FG000|COMPLETED|Overall Study||0
10654877|NCT02205476|11815704|FG001|COMPLETED|Overall Study||0
10654878|NCT02205476|11815703|FG000|NOT COMPLETED|Overall Study||7
10654879|NCT02205476|11815704|FG001|NOT COMPLETED|Overall Study||3
10654880|NCT02205801|11815720|FG000|STARTED|Overall Study||11
10654881|NCT02205801|11815721|FG001|STARTED|Overall Study||8
10654882|NCT02205801|11815722|FG002|STARTED|Overall Study||9
10654883|NCT02205801|11815723|FG003|STARTED|Overall Study||8
10654884|NCT02205801|11815720|FG000|COMPLETED|Overall Study||11
10654885|NCT02205801|11815721|FG001|COMPLETED|Overall Study||8
10654886|NCT02205801|11815722|FG002|COMPLETED|Overall Study||9
10654887|NCT02205801|11815723|FG003|COMPLETED|Overall Study||8
10654888|NCT02205801|11815720|FG000|NOT COMPLETED|Overall Study||0
10654889|NCT02205801|11815721|FG001|NOT COMPLETED|Overall Study||0
10654890|NCT02205801|11815722|FG002|NOT COMPLETED|Overall Study||0
10654891|NCT02205801|11815723|FG003|NOT COMPLETED|Overall Study||0
10654892|NCT02205814|11815737|FG000|STARTED|Overall Study||110
10654893|NCT02205814|11815738|FG001|STARTED|Overall Study||110
10654894|NCT02205814|11815739|FG002|STARTED|Overall Study||108
10654895|NCT02205814|11815740|FG003|STARTED|Overall Study||108
10654896|NCT02205814|11815737|FG000|COMPLETED|Overall Study||108
10654897|NCT02205814|11815738|FG001|COMPLETED|Overall Study||109
10654898|NCT02205814|11815739|FG002|COMPLETED|Overall Study||103
10654899|NCT02205814|11815740|FG003|COMPLETED|Overall Study||104
10654900|NCT02205814|11815737|FG000|NOT COMPLETED|Overall Study||2
10654901|NCT02205814|11815738|FG001|NOT COMPLETED|Overall Study||1
10714445|NCT02688218|11880033|FG001|NOT COMPLETED|Washout (30 Minutes)||0
10714446|NCT02688218|11880032|FG000|STARTED|Second Exercise Intervention (2 Hours)||24
10714447|NCT02688218|11880033|FG001|STARTED|Second Exercise Intervention (2 Hours)||6
10714448|NCT02688218|11880032|FG000|COMPLETED|Second Exercise Intervention (2 Hours)||24
10654902|NCT02205814|11815739|FG002|NOT COMPLETED|Overall Study||5
10654903|NCT02205814|11815740|FG003|NOT COMPLETED|Overall Study||4
10654904|NCT02205983|11815754|FG000|STARTED|Overall Study||12
10654905|NCT02205983|11815755|FG001|STARTED|Overall Study||12
10529771|NCT01401959|11682099|FG002|COMPLETED|Treated||26
10654906|NCT02205983|11815756|FG002|STARTED|Overall Study||13
10654907|NCT02205983|11815757|FG003|STARTED|Overall Study||13
10654908|NCT02205983|11815754|FG000|COMPLETED|Overall Study||12
10654909|NCT02205983|11815755|FG001|COMPLETED|Overall Study||12
10714449|NCT02688218|11880033|FG001|COMPLETED|Second Exercise Intervention (2 Hours)||6
10654910|NCT02205983|11815756|FG002|COMPLETED|Overall Study||13
10654911|NCT02205983|11815757|FG003|COMPLETED|Overall Study||13
10302586|NCT00071721|11435400|FG000|STARTED|Overall Study||153
10302587|NCT00071721|11435401|FG001|STARTED|Overall Study||160
10302588|NCT00071721|11435400|FG000|COMPLETED|Overall Study||81
10302589|NCT00071721|11435401|FG001|COMPLETED|Overall Study||69
10302590|NCT00071721|11435400|FG000|NOT COMPLETED|Overall Study||72
10302591|NCT00071721|11435401|FG001|NOT COMPLETED|Overall Study||91
10302592|NCT00071760|11435407|FG000|STARTED|Overall Study||54
10302593|NCT00071760|11435407|FG000|Ongoing|Overall Study||25
10302594|NCT00071760|11435407|FG000|COMPLETED|Overall Study||0
10302595|NCT00071760|11435407|FG000|NOT COMPLETED|Overall Study||54
10302596|NCT00071799|11435419|FG000|STARTED|Overall Study||179
10302597|NCT00071799|11435420|FG001|STARTED|Overall Study|Best supportive care: 105, Low-dose cytarabine: 49, Standard chemotherapy: 25 patients|179
10302598|NCT00071799|11435419|FG000|COMPLETED|Overall Study|Includes those who died or transformed to AML, or receiving drug + eligible for extension period.|109
10302599|NCT00071799|11435420|FG001|COMPLETED|Overall Study|Includes patients who died or transformed to AML during treatment, or were still receiving drug.|81
10302600|NCT00071799|11435419|FG000|NOT COMPLETED|Overall Study||70
10302601|NCT00071799|11435420|FG001|NOT COMPLETED|Overall Study||98
10302602|NCT00071812|11435436|FG000|STARTED|24-Week Double-Blind Period||69
10302603|NCT00071812|11435437|FG001|STARTED|24-Week Double-Blind Period||72
10302604|NCT00071812|11435438|FG002|STARTED|24-Week Double-Blind Period||71
10302605|NCT00071812|11435439|FG003|STARTED|24-Week Double-Blind Period||71
10302606|NCT00071812|11435436|FG000|COMPLETED|24-Week Double-Blind Period||59
10302607|NCT00071812|11435437|FG001|COMPLETED|24-Week Double-Blind Period||66
10302608|NCT00071812|11435438|FG002|COMPLETED|24-Week Double-Blind Period||63
10302609|NCT00071812|11435439|FG003|COMPLETED|24-Week Double-Blind Period||60
10302610|NCT00071812|11435436|FG000|NOT COMPLETED|24-Week Double-Blind Period||10
10302611|NCT00071812|11435437|FG001|NOT COMPLETED|24-Week Double-Blind Period||6
10302612|NCT00071812|11435438|FG002|NOT COMPLETED|24-Week Double-Blind Period||8
10302613|NCT00071812|11435439|FG003|NOT COMPLETED|24-Week Double-Blind Period||11
10302614|NCT00071812|11435436|FG000|STARTED|24-Week Open-Label Extension Period|Of 59: 56 switched to 10 mg/kg; 3 elected not to continue in the open-label extension.|0
10302615|NCT00071812|11435437|FG001|STARTED|24-Week Open-Label Extension Period|Of 66: 53 switched to 10 mg/kg; 2 elected not continue in the open-label extension.|11
10302616|NCT00071812|11435438|FG002|STARTED|24-Week Open-Label Extension Period|Of 63: 53 switched to 10 mg/kg; 2 elected not continue in the open-label extension.|8
10302617|NCT00071812|11435439|FG003|STARTED|24-Week Open-Label Extension Period|Of 60: 56 continued with 10 mg/kg; 4 elected not to continue in the open-label extension.|218
10302618|NCT00071812|11435436|FG000|COMPLETED|24-Week Open-Label Extension Period||0
10302619|NCT00071812|11435437|FG001|COMPLETED|24-Week Open-Label Extension Period||11
10302620|NCT00071812|11435438|FG002|COMPLETED|24-Week Open-Label Extension Period||7
10302621|NCT00071812|11435439|FG003|COMPLETED|24-Week Open-Label Extension Period||178
10302622|NCT00071812|11435436|FG000|NOT COMPLETED|24-Week Open-Label Extension Period||0
10302623|NCT00071812|11435437|FG001|NOT COMPLETED|24-Week Open-Label Extension Period||0
10302624|NCT00071812|11435438|FG002|NOT COMPLETED|24-Week Open-Label Extension Period||1
10302625|NCT00071812|11435439|FG003|NOT COMPLETED|24-Week Open-Label Extension Period||40
10302626|NCT00071890|11435453|FG000|STARTED|Overall Study|3 patients did not received Interleukin-2|81
10302627|NCT00071890|11435454|FG001|STARTED|Overall Study|1 patients stopped HAART at week 0|67
10302628|NCT00071890|11435453|FG000|COMPLETED|Overall Study|"1 withdrawal~1 death 81 patients analysed"|81
10529772|NCT01401959|11682097|FG000|NOT COMPLETED|Treated||7
10529773|NCT01401959|11682098|FG001|NOT COMPLETED|Treated||8
10529774|NCT01401959|11682099|FG002|NOT COMPLETED|Treated||5
10529775|NCT01402011|11682112|FG000|STARTED|Delayed Treatment Period||29
10529776|NCT01402011|11682113|FG001|STARTED|Delayed Treatment Period||23
10529777|NCT01402011|11682114|FG002|STARTED|Delayed Treatment Period||26
10529778|NCT01402011|11682112|FG000|COMPLETED|Delayed Treatment Period|One patient with needle phobia declined to be treated before the 1st set of injections|28
10529779|NCT01402011|11682113|FG001|COMPLETED|Delayed Treatment Period||23
10714450|NCT02688218|11880032|FG000|NOT COMPLETED|Second Exercise Intervention (2 Hours)||0
10714451|NCT02688218|11880033|FG001|NOT COMPLETED|Second Exercise Intervention (2 Hours)||0
10714452|NCT02688387|11880043|FG000|STARTED|Part 1, Period 1 (up to 6 Days)||3
10714453|NCT02688387|11880044|FG001|STARTED|Part 1, Period 1 (up to 6 Days)||3
10714454|NCT02688387|11880045|FG002|STARTED|Part 1, Period 1 (up to 6 Days)||4
10714455|NCT02688387|11880046|FG003|STARTED|Part 1, Period 1 (up to 6 Days)||3
10714456|NCT02688387|11880047|FG004|STARTED|Part 1, Period 1 (up to 6 Days)||3
10714457|NCT02688387|11880048|FG005|STARTED|Part 1, Period 1 (up to 6 Days)||2
10714458|NCT02688387|11880049|FG006|STARTED|Part 1, Period 1 (up to 6 Days)||2
10714459|NCT02688387|11880050|FG007|STARTED|Part 1, Period 1 (up to 6 Days)||2
10714460|NCT02688387|11880051|FG008|STARTED|Part 1, Period 1 (up to 6 Days)||2
10714461|NCT02688387|11880052|FG009|STARTED|Part 1, Period 1 (up to 6 Days)||2
10714462|NCT02688387|11880053|FG010|STARTED|Part 1, Period 1 (up to 6 Days)||0
10714463|NCT02688387|11880054|FG011|STARTED|Part 1, Period 1 (up to 6 Days)||0
10714464|NCT02688387|11880055|FG012|STARTED|Part 1, Period 1 (up to 6 Days)||0
10714465|NCT02688387|11880056|FG013|STARTED|Part 1, Period 1 (up to 6 Days)||0
10714466|NCT02688387|11880057|FG014|STARTED|Part 1, Period 1 (up to 6 Days)||0
10714467|NCT02688387|11880058|FG015|STARTED|Part 1, Period 1 (up to 6 Days)||0
10714468|NCT02688387|11880059|FG016|STARTED|Part 1, Period 1 (up to 6 Days)||0
10714469|NCT02688387|11880060|FG017|STARTED|Part 1, Period 1 (up to 6 Days)||0
10714470|NCT02688387|11880061|FG018|STARTED|Part 1, Period 1 (up to 6 Days)||0
10714471|NCT02688387|11880062|FG019|STARTED|Part 1, Period 1 (up to 6 Days)||0
10714472|NCT02688387|11880063|FG020|STARTED|Part 1, Period 1 (up to 6 Days)||0
10714473|NCT02688387|11880064|FG021|STARTED|Part 1, Period 1 (up to 6 Days)||0
10714474|NCT02688387|11880043|FG000|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
10714475|NCT02688387|11880044|FG001|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
10714476|NCT02688387|11880045|FG002|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
10714477|NCT02688387|11880046|FG003|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
10714478|NCT02688387|11880047|FG004|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
10714479|NCT02688387|11880048|FG005|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
10714480|NCT02688387|11880049|FG006|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
10714481|NCT02688387|11880050|FG007|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
10714482|NCT02688387|11880051|FG008|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
10714483|NCT02688387|11880052|FG009|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
10714484|NCT02688387|11880053|FG010|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10302629|NCT00071890|11435454|FG001|COMPLETED|Overall Study|"1 withdrawal~1 lost of follow-up~1 death 67 patients analysed"|67
10302630|NCT00071890|11435453|FG000|NOT COMPLETED|Overall Study||0
10302631|NCT00071890|11435454|FG001|NOT COMPLETED|Overall Study||0
10302632|NCT00071981|11435464|FG000|STARTED|Overall Study||47
10302633|NCT00071981|11435465|FG001|STARTED|Overall Study||43
10302634|NCT00071981|11435466|FG002|STARTED|Overall Study||37
10302635|NCT00071981|11435467|FG003|STARTED|Overall Study||48
10302636|NCT00071981|11435464|FG000|Eligible|Overall Study||43
10302637|NCT00071981|11435465|FG001|Eligible|Overall Study||36
10302638|NCT00071981|11435466|FG002|Eligible|Overall Study||33
10302639|NCT00071981|11435467|FG003|Eligible|Overall Study||42
10302640|NCT00071981|11435464|FG000|Treated|Overall Study||45
10302641|NCT00071981|11435465|FG001|Treated|Overall Study||38
10302642|NCT00071981|11435466|FG002|Treated|Overall Study||36
10302643|NCT00071981|11435467|FG003|Treated|Overall Study||48
10339939|NCT00376246|11476882|FG001|STARTED|Washout (2 Weeks)||12
10339940|NCT00376246|11476881|FG000|COMPLETED|Washout (2 Weeks)||10
10339941|NCT00376246|11476882|FG001|COMPLETED|Washout (2 Weeks)||12
10339942|NCT00376246|11476881|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10339943|NCT00376246|11476882|FG001|NOT COMPLETED|Washout (2 Weeks)||0
10339944|NCT00376246|11476881|FG000|STARTED|Second Intervention (2 Weeks)||10
10339945|NCT00376246|11476882|FG001|STARTED|Second Intervention (2 Weeks)||12
10339946|NCT00376246|11476881|FG000|COMPLETED|Second Intervention (2 Weeks)||10
10339947|NCT00376246|11476882|FG001|COMPLETED|Second Intervention (2 Weeks)||12
10339948|NCT00376246|11476881|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
10339949|NCT00376246|11476882|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
10339950|NCT00376259|11476892|FG000|STARTED|Overall Study||22
10339951|NCT00376259|11476893|FG001|STARTED|Overall Study||21
10339952|NCT00376259|11476892|FG000|Received Study Drug|Overall Study||21
10339953|NCT00376259|11476893|FG001|Received Study Drug|Overall Study||21
10339954|NCT00376259|11476892|FG000|COMPLETED|Overall Study||0
10339955|NCT00376259|11476893|FG001|COMPLETED|Overall Study||0
10339956|NCT00376259|11476892|FG000|NOT COMPLETED|Overall Study||22
10339957|NCT00376259|11476893|FG001|NOT COMPLETED|Overall Study||21
10339958|NCT00376363|11476901|FG000|STARTED|Overall Study||143
10339959|NCT00376363|11476902|FG001|STARTED|Overall Study||133
10339960|NCT00376363|11476901|FG000|COMPLETED|Overall Study||87
10339961|NCT00376363|11476902|FG001|COMPLETED|Overall Study||87
10339962|NCT00376363|11476901|FG000|NOT COMPLETED|Overall Study||56
10339963|NCT00376363|11476902|FG001|NOT COMPLETED|Overall Study||46
10339964|NCT00376506|11476910|FG000|STARTED|Overall Study||4
10339965|NCT00376506|11476911|FG001|STARTED|Overall Study||6
10339966|NCT00376506|11476910|FG000|COMPLETED|Overall Study||4
10714485|NCT02688387|11880054|FG011|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10714486|NCT02688387|11880055|FG012|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10714487|NCT02688387|11880056|FG013|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10714488|NCT02688387|11880057|FG014|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10714489|NCT02688387|11880058|FG015|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10339967|NCT00376506|11476911|FG001|COMPLETED|Overall Study||4
10339968|NCT00376506|11476910|FG000|NOT COMPLETED|Overall Study||0
10339969|NCT00376506|11476911|FG001|NOT COMPLETED|Overall Study||2
10339970|NCT00376532|11476922|FG000|STARTED|Overall Study|Subjects with an event were enrolled beginning 09/14/2006.|31
10339971|NCT00376532|11476923|FG001|STARTED|Overall Study|Subjects without an event were enrolled beginning 09/15/2006.|32
10339972|NCT00376532|11476922|FG000|COMPLETED|Overall Study|Last event subject enrolled 2/22/2008|25
10339973|NCT00376532|11476923|FG001|COMPLETED|Overall Study|Last non-event subject enrolled 3/18/2008.|26
10339974|NCT00376532|11476922|FG000|NOT COMPLETED|Overall Study||6
10339975|NCT00376532|11476923|FG001|NOT COMPLETED|Overall Study||6
10339976|NCT00376558|11476931|FG000|STARTED|Overall Study||25
10339977|NCT00376558|11476932|FG001|STARTED|Overall Study||25
10339978|NCT00376558|11476931|FG000|COMPLETED|Overall Study||25
10339979|NCT00376558|11476932|FG001|COMPLETED|Overall Study||25
10339980|NCT00376558|11476931|FG000|NOT COMPLETED|Overall Study||0
10339981|NCT00376558|11476932|FG001|NOT COMPLETED|Overall Study||0
10339982|NCT00376597|11476941|FG000|STARTED|Overall Study||253
10339983|NCT00376597|11476942|FG001|STARTED|Overall Study||315
10339984|NCT00376597|11476941|FG000|COMPLETED|Overall Study||242
10339985|NCT00376597|11476942|FG001|COMPLETED|Overall Study||312
10302644|NCT00071981|11435464|FG000|Eligible and Treated|Overall Study||41
10302645|NCT00071981|11435465|FG001|Eligible and Treated|Overall Study||33
10339986|NCT00376597|11476941|FG000|NOT COMPLETED|Overall Study||11
10529780|NCT01402011|11682114|FG002|COMPLETED|Delayed Treatment Period||26
10529781|NCT01402011|11682112|FG000|NOT COMPLETED|Delayed Treatment Period||1
10302646|NCT00071981|11435466|FG002|Eligible and Treated|Overall Study||32
10302647|NCT00071981|11435467|FG003|Eligible and Treated|Overall Study||42
10302648|NCT00071981|11435464|FG000|Have CTL Response Data|Overall Study||40
10302649|NCT00071981|11435465|FG001|Have CTL Response Data|Overall Study||30
10302650|NCT00071981|11435466|FG002|Have CTL Response Data|Overall Study||29
10302651|NCT00071981|11435467|FG003|Have CTL Response Data|Overall Study||41
10302652|NCT00071981|11435464|FG000|Have Helper T Cell Response Data|Overall Study||37
10302653|NCT00071981|11435465|FG001|Have Helper T Cell Response Data|Overall Study||27
10302654|NCT00071981|11435466|FG002|Have Helper T Cell Response Data|Overall Study||25
10302655|NCT00071981|11435467|FG003|Have Helper T Cell Response Data|Overall Study||39
10302656|NCT00071981|11435464|FG000|COMPLETED|Overall Study||1
10302657|NCT00071981|11435465|FG001|COMPLETED|Overall Study||2
10302658|NCT00071981|11435466|FG002|COMPLETED|Overall Study||0
10302659|NCT00071981|11435467|FG003|COMPLETED|Overall Study||3
10302660|NCT00071981|11435464|FG000|NOT COMPLETED|Overall Study||46
10302661|NCT00071981|11435465|FG001|NOT COMPLETED|Overall Study||41
10302662|NCT00071981|11435466|FG002|NOT COMPLETED|Overall Study||37
10302663|NCT00071981|11435467|FG003|NOT COMPLETED|Overall Study||45
10302664|NCT00072176|11435479|FG000|STARTED|Overall Study||34
10302665|NCT00072176|11435480|FG001|STARTED|Overall Study||28
10302666|NCT00072176|11435479|FG000|COMPLETED|Overall Study||33
10302667|NCT00072176|11435480|FG001|COMPLETED|Overall Study||27
10302668|NCT00072176|11435479|FG000|NOT COMPLETED|Overall Study||1
10302669|NCT00072176|11435480|FG001|NOT COMPLETED|Overall Study||1
10302670|NCT00072189|11435486|FG000|STARTED|Overall Study||17
10302671|NCT00072189|11435486|FG000|COMPLETED|Overall Study||16
10302672|NCT00072189|11435486|FG000|NOT COMPLETED|Overall Study||1
10302673|NCT00072280|11435492|FG000|STARTED|Treatment||3
10302674|NCT00072280|11435493|FG001|STARTED|Treatment||4
10302675|NCT00072280|11435492|FG000|COMPLETED|Treatment||2
10302676|NCT00072280|11435493|FG001|COMPLETED|Treatment||2
10302677|NCT00072280|11435492|FG000|NOT COMPLETED|Treatment||1
10302678|NCT00072280|11435493|FG001|NOT COMPLETED|Treatment||2
10302679|NCT00072280|11435492|FG000|STARTED|Follow-up||2
10302680|NCT00072280|11435493|FG001|STARTED|Follow-up||2
10302681|NCT00072280|11435492|FG000|COMPLETED|Follow-up||0
10302682|NCT00072280|11435493|FG001|COMPLETED|Follow-up||0
10302683|NCT00072280|11435492|FG000|NOT COMPLETED|Follow-up||2
10529782|NCT01402011|11682113|FG001|NOT COMPLETED|Delayed Treatment Period||0
10529783|NCT01402011|11682114|FG002|NOT COMPLETED|Delayed Treatment Period||0
10529784|NCT01402011|11682112|FG000|STARTED|Active Treatment Period||28
10529785|NCT01402011|11682113|FG001|STARTED|Active Treatment Period||23
10529786|NCT01402011|11682114|FG002|STARTED|Active Treatment Period||26
10529787|NCT01402011|11682112|FG000|COMPLETED|Active Treatment Period||27
10529788|NCT01402011|11682113|FG001|COMPLETED|Active Treatment Period||20
10529789|NCT01402011|11682114|FG002|COMPLETED|Active Treatment Period||26
10529790|NCT01402011|11682112|FG000|NOT COMPLETED|Active Treatment Period||1
10529791|NCT01402011|11682113|FG001|NOT COMPLETED|Active Treatment Period||3
10529792|NCT01402011|11682114|FG002|NOT COMPLETED|Active Treatment Period||0
10529793|NCT01402011|11682112|FG000|STARTED|Nine Month Follow-up||27
10529794|NCT01402011|11682113|FG001|STARTED|Nine Month Follow-up||20
10529795|NCT01402011|11682114|FG002|STARTED|Nine Month Follow-up||26
10529796|NCT01402011|11682112|FG000|COMPLETED|Nine Month Follow-up||27
10529797|NCT01402011|11682113|FG001|COMPLETED|Nine Month Follow-up||19
10529798|NCT01402011|11682114|FG002|COMPLETED|Nine Month Follow-up||26
10529799|NCT01402011|11682112|FG000|NOT COMPLETED|Nine Month Follow-up||0
10529800|NCT01402011|11682113|FG001|NOT COMPLETED|Nine Month Follow-up||1
10529801|NCT01402011|11682114|FG002|NOT COMPLETED|Nine Month Follow-up||0
10529802|NCT01402050|11682127|FG000|STARTED|Overall Study||185
10529803|NCT01402050|11682128|FG001|STARTED|Overall Study||191
10529804|NCT01402050|11682127|FG000|COMPLETED|Overall Study||185
10529805|NCT01402050|11682128|FG001|COMPLETED|Overall Study||191
10529806|NCT01402050|11682127|FG000|NOT COMPLETED|Overall Study||0
10529807|NCT01402050|11682128|FG001|NOT COMPLETED|Overall Study||0
10529808|NCT01402063|11682136|FG000|STARTED|Overall Study||42
10529809|NCT01402063|11682137|FG001|STARTED|Overall Study||21
10654912|NCT02205983|11815754|FG000|NOT COMPLETED|Overall Study||0
10654913|NCT02205983|11815755|FG001|NOT COMPLETED|Overall Study||0
10654914|NCT02205983|11815756|FG002|NOT COMPLETED|Overall Study||0
10654915|NCT02205983|11815757|FG003|NOT COMPLETED|Overall Study||0
10654916|NCT02206061|11815770|FG000|STARTED|Overall Study||149
10302684|NCT00072280|11435493|FG001|NOT COMPLETED|Follow-up||2
10529810|NCT01402063|11682136|FG000|COMPLETED|Overall Study||39
10529811|NCT01402063|11682137|FG001|COMPLETED|Overall Study||18
10529812|NCT01402063|11682136|FG000|NOT COMPLETED|Overall Study||3
10654917|NCT02206061|11815771|FG001|STARTED|Overall Study||142
10654918|NCT02206061|11815772|FG002|STARTED|Overall Study||139
10654919|NCT02206061|11815770|FG000|COMPLETED|Overall Study||131
10302685|NCT00072293|11435500|FG000|STARTED|Overall Study||465
10302686|NCT00072293|11435501|FG001|STARTED|Overall Study||469
10302687|NCT00072293|11435500|FG000|COMPLETED|Overall Study||464
10302688|NCT00072293|11435501|FG001|COMPLETED|Overall Study||467
10302689|NCT00072293|11435500|FG000|NOT COMPLETED|Overall Study||1
10302690|NCT00072293|11435501|FG001|NOT COMPLETED|Overall Study||2
10302691|NCT00072384|11435507|FG000|STARTED|Overall Study||30
10302692|NCT00072384|11435507|FG000|COMPLETED|Overall Study||21
10302693|NCT00072384|11435507|FG000|NOT COMPLETED|Overall Study||9
10302694|NCT00072449|11435513|FG000|STARTED|Overall Study||12
10302695|NCT00072449|11435513|FG000|COMPLETED|Overall Study||12
10302696|NCT00072449|11435513|FG000|NOT COMPLETED|Overall Study||0
10302697|NCT00072475|11435517|FG000|STARTED|Overall Study||142
10302698|NCT00072475|11435517|FG000|COMPLETED|Overall Study||45
10302699|NCT00072475|11435517|FG000|NOT COMPLETED|Overall Study||97
10302700|NCT00072514|11435521|FG000|STARTED|Overall Study||55
10302701|NCT00072514|11435521|FG000|COMPLETED|Overall Study||51
10339987|NCT00376597|11476942|FG001|NOT COMPLETED|Overall Study||3
10339988|NCT00376675|11476952|FG000|STARTED|Overall Study||69
10339989|NCT00376675|11476953|FG001|STARTED|Overall Study||70
10339990|NCT00376675|11476952|FG000|COMPLETED|Overall Study||49
10339991|NCT00376675|11476953|FG001|COMPLETED|Overall Study||56
10339992|NCT00376675|11476952|FG000|NOT COMPLETED|Overall Study||20
10339993|NCT00376675|11476953|FG001|NOT COMPLETED|Overall Study||14
10339994|NCT00376688|11476959|FG000|STARTED|Overall Study||31
10339995|NCT00376688|11476959|FG000|COMPLETED|Overall Study||27
10339996|NCT00376688|11476959|FG000|NOT COMPLETED|Overall Study||4
10339997|NCT00376805|11476963|FG000|STARTED|Overall Study||6
10339998|NCT00376805|11476963|FG000|COMPLETED|Overall Study||6
10339999|NCT00376805|11476963|FG000|NOT COMPLETED|Overall Study||0
10340000|NCT00376935|11476971|FG000|STARTED|Overall Study||25
10340001|NCT00376935|11476972|FG001|STARTED|Overall Study||25
10340002|NCT00376935|11476973|FG002|STARTED|Overall Study||25
10340003|NCT00376935|11476974|FG003|STARTED|Overall Study||24
10340004|NCT00376935|11476971|FG000|COMPLETED|Overall Study||25
10340005|NCT00376935|11476972|FG001|COMPLETED|Overall Study||25
10340006|NCT00376935|11476973|FG002|COMPLETED|Overall Study||25
10340007|NCT00376935|11476974|FG003|COMPLETED|Overall Study||24
10340008|NCT00376935|11476971|FG000|NOT COMPLETED|Overall Study||0
10529813|NCT01402063|11682137|FG001|NOT COMPLETED|Overall Study||3
10529814|NCT01402102|11682145|FG000|STARTED|Overall Study||30
10529815|NCT01402102|11682146|FG001|STARTED|Overall Study||30
10529816|NCT01402102|11682145|FG000|COMPLETED|Overall Study||28
10529817|NCT01402102|11682146|FG001|COMPLETED|Overall Study||27
10529818|NCT01402102|11682145|FG000|NOT COMPLETED|Overall Study||2
10340009|NCT00376935|11476972|FG001|NOT COMPLETED|Overall Study||0
10340010|NCT00376935|11476973|FG002|NOT COMPLETED|Overall Study||0
10340011|NCT00376935|11476974|FG003|NOT COMPLETED|Overall Study||0
10340012|NCT00376948|11476984|FG000|STARTED|Overall Study||20
10340013|NCT00376948|11476984|FG000|COMPLETED|Overall Study||20
10340014|NCT00376948|11476984|FG000|NOT COMPLETED|Overall Study||0
10340015|NCT00376961|11476988|FG000|STARTED|Initial Registration||68
10340016|NCT00376961|11476989|FG001|STARTED|Initial Registration||0
10340017|NCT00376961|11476988|FG000|Eligible|Initial Registration||65
10340018|NCT00376961|11476989|FG001|Eligible|Initial Registration||0
10529819|NCT01402102|11682146|FG001|NOT COMPLETED|Overall Study||3
10529820|NCT01402115|11682156|FG000|STARTED|Overall Study||30
10529821|NCT01402115|11682157|FG001|STARTED|Overall Study||30
10529822|NCT01402115|11682156|FG000|COMPLETED|Overall Study||29
10529823|NCT01402115|11682157|FG001|COMPLETED|Overall Study||29
10529824|NCT01402115|11682156|FG000|NOT COMPLETED|Overall Study||1
10529825|NCT01402115|11682157|FG001|NOT COMPLETED|Overall Study||1
10529826|NCT01402128|11682165|FG000|STARTED|Overall Study||40
10529827|NCT01402128|11682166|FG001|STARTED|Overall Study||40
10529828|NCT01402128|11682165|FG000|COMPLETED|Overall Study||39
10529829|NCT01402128|11682166|FG001|COMPLETED|Overall Study||40
10529830|NCT01402128|11682165|FG000|NOT COMPLETED|Overall Study||1
10529831|NCT01402128|11682166|FG001|NOT COMPLETED|Overall Study||0
10529832|NCT01402141|11682174|FG000|STARTED|Overall Study||30
10529833|NCT01402141|11682175|FG001|STARTED|Overall Study||30
10529834|NCT01402141|11682174|FG000|COMPLETED|Overall Study||29
10302702|NCT00072514|11435521|FG000|NOT COMPLETED|Overall Study||4
10302703|NCT00072566|11435525|FG000|STARTED|Overall Study||70
10340019|NCT00376961|11476988|FG000|COMPLETED|Initial Registration||61
10340020|NCT00376961|11476989|FG001|COMPLETED|Initial Registration||0
10340021|NCT00376961|11476988|FG000|NOT COMPLETED|Initial Registration||7
10340022|NCT00376961|11476989|FG001|NOT COMPLETED|Initial Registration||0
10340023|NCT00376961|11476988|FG000|STARTED|Maintenance||0
10340024|NCT00376961|11476989|FG001|STARTED|Maintenance||50
10340025|NCT00376961|11476988|FG000|Eligible|Maintenance||0
10340026|NCT00376961|11476989|FG001|Eligible|Maintenance||47
10340027|NCT00376961|11476988|FG000|COMPLETED|Maintenance||0
10340028|NCT00376961|11476989|FG001|COMPLETED|Maintenance||27
10340029|NCT00376961|11476988|FG000|NOT COMPLETED|Maintenance||0
10340030|NCT00376961|11476989|FG001|NOT COMPLETED|Maintenance||23
10529835|NCT01402141|11682175|FG001|COMPLETED|Overall Study||28
10529836|NCT01402141|11682174|FG000|NOT COMPLETED|Overall Study||1
10529837|NCT01402141|11682175|FG001|NOT COMPLETED|Overall Study||2
10529838|NCT01402284|11682182|FG000|STARTED|Overall Study||45
10302704|NCT00072566|11435525|FG000|COMPLETED|Overall Study||70
10302705|NCT00072566|11435525|FG000|NOT COMPLETED|Overall Study||0
10302706|NCT00072761|11435531|FG000|STARTED|Overall Study||99
10302707|NCT00072761|11435532|FG001|STARTED|Overall Study||97
10302708|NCT00072761|11435531|FG000|COMPLETED|Overall Study||90
10302709|NCT00072761|11435532|FG001|COMPLETED|Overall Study||95
10302710|NCT00072761|11435531|FG000|NOT COMPLETED|Overall Study||9
10302711|NCT00072761|11435532|FG001|NOT COMPLETED|Overall Study||2
10302712|NCT00073008|11435540|FG000|STARTED|Overall Study||65
10302713|NCT00073008|11435541|FG001|STARTED|Overall Study||66
10302714|NCT00073008|11435540|FG000|COMPLETED|Overall Study||3
10302715|NCT00073008|11435541|FG001|COMPLETED|Overall Study||3
10302716|NCT00073008|11435540|FG000|NOT COMPLETED|Overall Study||62
10302717|NCT00073008|11435541|FG001|NOT COMPLETED|Overall Study||63
10302718|NCT00073021|11435549|FG000|STARTED|Overall Study|Subjects with Moderate Disease [PGA = 2] at Baseline|139
10302719|NCT00073021|11435550|FG001|STARTED|Overall Study|Subjects with Moderate Disease [PGA = 2] at Baseline|129
10302720|NCT00073021|11435549|FG000|COMPLETED|Overall Study||113
10302721|NCT00073021|11435550|FG001|COMPLETED|Overall Study||113
10302722|NCT00073021|11435549|FG000|NOT COMPLETED|Overall Study||26
10302723|NCT00073021|11435550|FG001|NOT COMPLETED|Overall Study||16
10302724|NCT00073073|11435556|FG000|STARTED|Overall Study||46
10302725|NCT00073073|11435556|FG000|COMPLETED|Overall Study||42
10302726|NCT00073073|11435556|FG000|NOT COMPLETED|Overall Study||4
10302727|NCT00073307|11435562|FG000|STARTED|Double-Blind (DB, as of ~31May2005)||451
10302728|NCT00073307|11435563|FG001|STARTED|Double-Blind (DB, as of ~31May2005)||452
10302729|NCT00073307|11435564|FG002|STARTED|Double-Blind (DB, as of ~31May2005)||0
10302730|NCT00073307|11435562|FG000|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||451
10302731|NCT00073307|11435563|FG001|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||451
10302732|NCT00073307|11435564|FG002|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||0
10302733|NCT00073307|11435562|FG000|COMPLETED|Double-Blind (DB, as of ~31May2005)||254
10302734|NCT00073307|11435563|FG001|COMPLETED|Double-Blind (DB, as of ~31May2005)||299
10302735|NCT00073307|11435564|FG002|COMPLETED|Double-Blind (DB, as of ~31May2005)||0
10302736|NCT00073307|11435562|FG000|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||197
10302737|NCT00073307|11435563|FG001|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||153
10302738|NCT00073307|11435564|FG002|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||0
10302739|NCT00073307|11435562|FG000|STARTED|Open Label-Sorafenib Only [30Jun2008]||254
10302740|NCT00073307|11435563|FG001|STARTED|Open Label-Sorafenib Only [30Jun2008]|Placebo treatment ended ~ 31May2005. Those who continued, switched to receive Sorafenib.|0
10340037|NCT00377234|11477010|FG000|STARTED|Overall Study||180
10340038|NCT00377234|11477011|FG001|STARTED|Overall Study||176
10302741|NCT00073307|11435564|FG002|STARTED|Open Label-Sorafenib Only [30Jun2008]||299
10302742|NCT00073307|11435562|FG000|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||219
10302743|NCT00073307|11435563|FG001|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||0
10302744|NCT00073307|11435564|FG002|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||216
10302745|NCT00073307|11435562|FG000|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||120
10302746|NCT00073307|11435563|FG001|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||0
10302747|NCT00073307|11435564|FG002|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||143
10302748|NCT00073307|11435562|FG000|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||134
10302749|NCT00073307|11435563|FG001|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||0
10302750|NCT00073307|11435564|FG002|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||156
10302751|NCT00073333|11435576|FG000|STARTED|Overall Study||46
10302752|NCT00073333|11435577|FG001|STARTED|Overall Study||41
10302753|NCT00073333|11435578|FG002|STARTED|Overall Study||19
10302754|NCT00073333|11435576|FG000|COMPLETED|Overall Study||32
10302755|NCT00073333|11435577|FG001|COMPLETED|Overall Study||27
10302756|NCT00073333|11435578|FG002|COMPLETED|Overall Study||19
10302757|NCT00073333|11435576|FG000|NOT COMPLETED|Overall Study||14
10302758|NCT00073333|11435577|FG001|NOT COMPLETED|Overall Study||14
10302759|NCT00073333|11435578|FG002|NOT COMPLETED|Overall Study||0
10302760|NCT00073528|11435588|FG000|STARTED|Overall Study||644
10302761|NCT00073528|11435589|FG001|STARTED|Overall Study||642
10302762|NCT00073528|11435588|FG000|COMPLETED|Overall Study||14
10302763|NCT00073528|11435589|FG001|COMPLETED|Overall Study||14
10302764|NCT00073528|11435588|FG000|NOT COMPLETED|Overall Study||630
10302765|NCT00073528|11435589|FG001|NOT COMPLETED|Overall Study||628
10302766|NCT00073749|11435602|FG000|STARTED|Overall Study||2
10302767|NCT00073749|11435603|FG001|STARTED|Overall Study||5
10302768|NCT00073749|11435604|FG002|STARTED|Overall Study||11
10302769|NCT00073749|11435605|FG003|STARTED|Overall Study||6
10302770|NCT00073749|11435606|FG004|STARTED|Overall Study||6
10302771|NCT00073749|11435607|FG005|STARTED|Overall Study||6
10302772|NCT00073749|11435608|FG006|STARTED|Overall Study||43
10302773|NCT00073749|11435602|FG000|COMPLETED|Overall Study||0
10302774|NCT00073749|11435603|FG001|COMPLETED|Overall Study||0
10302775|NCT00073749|11435604|FG002|COMPLETED|Overall Study||0
10302776|NCT00073749|11435605|FG003|COMPLETED|Overall Study||0
10302777|NCT00073749|11435606|FG004|COMPLETED|Overall Study||0
10302778|NCT00073749|11435607|FG005|COMPLETED|Overall Study||0
10302779|NCT00073749|11435608|FG006|COMPLETED|Overall Study||3
10302780|NCT00073749|11435602|FG000|NOT COMPLETED|Overall Study||2
10302781|NCT00073749|11435603|FG001|NOT COMPLETED|Overall Study||5
10302782|NCT00073749|11435604|FG002|NOT COMPLETED|Overall Study||11
10302783|NCT00073749|11435605|FG003|NOT COMPLETED|Overall Study||6
10302784|NCT00073749|11435606|FG004|NOT COMPLETED|Overall Study||6
10302785|NCT00073749|11435607|FG005|NOT COMPLETED|Overall Study||6
10302786|NCT00073749|11435608|FG006|NOT COMPLETED|Overall Study||40
10302787|NCT00073918|11435627|FG000|STARTED|Overall Study||111
10302788|NCT00073918|11435627|FG000|COMPLETED|Overall Study||107
10302789|NCT00073918|11435627|FG000|NOT COMPLETED|Overall Study||4
10302790|NCT00073957|11435631|FG000|STARTED|Overall Study||25
10302791|NCT00073957|11435631|FG000|COMPLETED|Overall Study||25
10302792|NCT00073957|11435631|FG000|NOT COMPLETED|Overall Study||0
10302793|NCT00073983|11435637|FG000|STARTED|Overall Study||54
10302794|NCT00073983|11435637|FG000|COMPLETED|Overall Study|One patient in the chondrosarcoma subtype was not evaluable.|53
10302795|NCT00073983|11435637|FG000|NOT COMPLETED|Overall Study||1
10302796|NCT00074035|11435643|FG000|STARTED|Overall Study||38
10302797|NCT00074035|11435643|FG000|COMPLETED|Overall Study||38
10302798|NCT00074035|11435643|FG000|NOT COMPLETED|Overall Study||0
10302799|NCT00074152|11435649|FG000|STARTED|Overall Study||77
10302800|NCT00074152|11435650|FG001|STARTED|Overall Study||85
10302801|NCT00074152|11435649|FG000|COMPLETED|Overall Study||22
10302802|NCT00074152|11435650|FG001|COMPLETED|Overall Study||52
10302803|NCT00074152|11435649|FG000|NOT COMPLETED|Overall Study||55
10302804|NCT00074152|11435650|FG001|NOT COMPLETED|Overall Study||33
10302805|NCT00074165|11435657|FG000|STARTED|Overall Study||17
10302806|NCT00074165|11435657|FG000|COMPLETED|Overall Study||17
10302807|NCT00074165|11435657|FG000|NOT COMPLETED|Overall Study||0
10302808|NCT00074269|11435661|FG000|STARTED|Overall Study||5
10302809|NCT00074269|11435661|FG000|COMPLETED|Overall Study||5
10302810|NCT00074269|11435661|FG000|NOT COMPLETED|Overall Study||0
10302811|NCT00074282|11435669|FG000|STARTED|Step 1||102
10302812|NCT00074282|11435670|FG001|STARTED|Step 1||0
10302813|NCT00074282|11435671|FG002|STARTED|Step 1||0
10302814|NCT00074282|11435669|FG000|Eligible|Step 1||98
10811868|NCT03745092|11973782|FG001|STARTED|Overall Study||23
10811869|NCT03745092|11973781|FG000|COMPLETED|Overall Study||26
10811870|NCT03745092|11973782|FG001|COMPLETED|Overall Study||23
10811871|NCT03745092|11973781|FG000|NOT COMPLETED|Overall Study||0
10811872|NCT03745092|11973782|FG001|NOT COMPLETED|Overall Study||0
10811873|NCT03744780|11973788|FG000|STARTED|Overall Study||32
10714490|NCT02688387|11880059|FG016|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10714491|NCT02688387|11880060|FG017|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10714492|NCT02688387|11880061|FG018|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10714493|NCT02688387|11880062|FG019|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10714494|NCT02688387|11880063|FG020|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10714495|NCT02688387|11880064|FG021|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10714496|NCT02688387|11880043|FG000|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10714497|NCT02688387|11880044|FG001|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10714498|NCT02688387|11880045|FG002|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||1
10714499|NCT02688387|11880046|FG003|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||1
10714500|NCT02688387|11880047|FG004|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10302815|NCT00074282|11435670|FG001|Eligible|Step 1||0
10302816|NCT00074282|11435671|FG002|Eligible|Step 1||0
10302817|NCT00074282|11435669|FG000|Started Treatment|Step 1||96
10302818|NCT00074282|11435670|FG001|Started Treatment|Step 1||0
10302819|NCT00074282|11435671|FG002|Started Treatment|Step 1||0
10302820|NCT00074282|11435669|FG000|COMPLETED|Step 1||44
10302821|NCT00074282|11435670|FG001|COMPLETED|Step 1||0
10302822|NCT00074282|11435671|FG002|COMPLETED|Step 1||0
10302823|NCT00074282|11435669|FG000|NOT COMPLETED|Step 1||58
10302824|NCT00074282|11435670|FG001|NOT COMPLETED|Step 1||0
10302825|NCT00074282|11435671|FG002|NOT COMPLETED|Step 1||0
10302826|NCT00074282|11435669|FG000|STARTED|Step 2||0
10302827|NCT00074282|11435670|FG001|STARTED|Step 2||9
10302828|NCT00074282|11435671|FG002|STARTED|Step 2||31
10302829|NCT00074282|11435669|FG000|COMPLETED|Step 2||0
10302830|NCT00074282|11435670|FG001|COMPLETED|Step 2||7
10302831|NCT00074282|11435671|FG002|COMPLETED|Step 2||7
10302832|NCT00074282|11435669|FG000|NOT COMPLETED|Step 2||0
10302833|NCT00074282|11435670|FG001|NOT COMPLETED|Step 2||2
10302834|NCT00074282|11435671|FG002|NOT COMPLETED|Step 2||24
10302835|NCT00074308|11435681|FG000|STARTED|Overall Study||3
10302836|NCT00074308|11435682|FG001|STARTED|Overall Study||3
10302837|NCT00074308|11435683|FG002|STARTED|Overall Study||3
10302838|NCT00074308|11435684|FG003|STARTED|Overall Study||8
10302839|NCT00074308|11435685|FG004|STARTED|Overall Study||23
10302840|NCT00074308|11435681|FG000|COMPLETED|Overall Study||3
10302841|NCT00074308|11435682|FG001|COMPLETED|Overall Study||3
10302842|NCT00074308|11435683|FG002|COMPLETED|Overall Study||3
10302843|NCT00074308|11435684|FG003|COMPLETED|Overall Study||8
10302844|NCT00074308|11435685|FG004|COMPLETED|Overall Study||23
10302845|NCT00074308|11435681|FG000|NOT COMPLETED|Overall Study||0
10302846|NCT00074308|11435682|FG001|NOT COMPLETED|Overall Study||0
10302847|NCT00074308|11435683|FG002|NOT COMPLETED|Overall Study||0
10714501|NCT02688387|11880048|FG005|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10714502|NCT02688387|11880049|FG006|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10302848|NCT00074308|11435684|FG003|NOT COMPLETED|Overall Study||0
10302849|NCT00074308|11435685|FG004|NOT COMPLETED|Overall Study||0
10529839|NCT01402284|11682182|FG000|COMPLETED|Overall Study||31
10529840|NCT01402284|11682182|FG000|NOT COMPLETED|Overall Study||14
10529841|NCT01402375|11682192|FG000|STARTED|Overall Study||120
10529842|NCT01402375|11682193|FG001|STARTED|Overall Study||120
10529843|NCT01402375|11682194|FG002|STARTED|Overall Study||120
10529844|NCT01402375|11682195|FG003|STARTED|Overall Study||120
10529845|NCT01402375|11682196|FG004|STARTED|Overall Study||120
10529846|NCT01402375|11682197|FG005|STARTED|Overall Study||120
10529847|NCT01402375|11682192|FG000|COMPLETED|Overall Study||120
10529848|NCT01402375|11682193|FG001|COMPLETED|Overall Study||120
10529849|NCT01402375|11682194|FG002|COMPLETED|Overall Study||120
10529850|NCT01402375|11682195|FG003|COMPLETED|Overall Study||120
10529851|NCT01402375|11682196|FG004|COMPLETED|Overall Study||120
10529852|NCT01402375|11682197|FG005|COMPLETED|Overall Study||120
10529853|NCT01402375|11682192|FG000|NOT COMPLETED|Overall Study||0
10529854|NCT01402375|11682193|FG001|NOT COMPLETED|Overall Study||0
10529855|NCT01402375|11682194|FG002|NOT COMPLETED|Overall Study||0
10529856|NCT01402375|11682195|FG003|NOT COMPLETED|Overall Study||0
10529857|NCT01402375|11682196|FG004|NOT COMPLETED|Overall Study||0
10654920|NCT02206061|11815771|FG001|COMPLETED|Overall Study||128
10654921|NCT02206061|11815772|FG002|COMPLETED|Overall Study||118
10654922|NCT02206061|11815770|FG000|NOT COMPLETED|Overall Study||18
10654923|NCT02206061|11815771|FG001|NOT COMPLETED|Overall Study||14
10654924|NCT02206061|11815772|FG002|NOT COMPLETED|Overall Study||21
10654925|NCT02206152|11815780|FG000|STARTED|Pre-Randomization||22
10654926|NCT02206152|11815780|FG000|COMPLETED|Pre-Randomization||20
10654927|NCT02206152|11815780|FG000|NOT COMPLETED|Pre-Randomization||2
10654928|NCT02206152|11815780|FG000|STARTED|Placebo, Then NAC||10
10654929|NCT02206152|11815780|FG000|COMPLETED|Placebo, Then NAC||10
10654930|NCT02206152|11815780|FG000|NOT COMPLETED|Placebo, Then NAC||0
10654931|NCT02206152|11815780|FG000|STARTED|NAC, Then Placebo||10
10654932|NCT02206152|11815780|FG000|COMPLETED|NAC, Then Placebo||10
10654933|NCT02206152|11815780|FG000|NOT COMPLETED|NAC, Then Placebo||0
10654934|NCT02206217|11815788|FG000|STARTED|Overall Study||90
10654935|NCT02206217|11815789|FG001|STARTED|Overall Study||93
10654936|NCT02206217|11815788|FG000|COMPLETED|Overall Study||81
10654937|NCT02206217|11815789|FG001|COMPLETED|Overall Study||79
10654938|NCT02206217|11815788|FG000|NOT COMPLETED|Overall Study||9
10654939|NCT02206217|11815789|FG001|NOT COMPLETED|Overall Study||14
10654940|NCT02206607|11815795|FG000|STARTED|Open-Label Run-In||42
10654941|NCT02206607|11815796|FG001|STARTED|Open-Label Run-In||0
10654942|NCT02206607|11815797|FG002|STARTED|Open-Label Run-In||0
10654943|NCT02206607|11815798|FG003|STARTED|Open-Label Run-In||0
10654944|NCT02206607|11815799|FG004|STARTED|Open-Label Run-In||0
10654945|NCT02206607|11815795|FG000|COMPLETED|Open-Label Run-In||39
10654946|NCT02206607|11815796|FG001|COMPLETED|Open-Label Run-In||0
10654947|NCT02206607|11815797|FG002|COMPLETED|Open-Label Run-In||0
10654948|NCT02206607|11815798|FG003|COMPLETED|Open-Label Run-In||0
10654949|NCT02206607|11815799|FG004|COMPLETED|Open-Label Run-In||0
10654950|NCT02206607|11815795|FG000|NOT COMPLETED|Open-Label Run-In||3
10654951|NCT02206607|11815796|FG001|NOT COMPLETED|Open-Label Run-In||0
10654952|NCT02206607|11815797|FG002|NOT COMPLETED|Open-Label Run-In||0
10654953|NCT02206607|11815798|FG003|NOT COMPLETED|Open-Label Run-In||0
10811874|NCT03744780|11973788|FG000|COMPLETED|Overall Study||32
10811875|NCT03744780|11973788|FG000|NOT COMPLETED|Overall Study||0
10811876|NCT03743311|11973795|FG000|STARTED|Overall Study||311
10811877|NCT03743311|11973796|FG001|STARTED|Overall Study||298
10811878|NCT03743311|11973797|FG002|STARTED|Overall Study||423
10811879|NCT03743311|11973795|FG000|COMPLETED|Overall Study||311
10529858|NCT01402375|11682197|FG005|NOT COMPLETED|Overall Study||0
10529859|NCT01402427|11682213|FG000|STARTED|Overall Study||297
10529860|NCT01402427|11682214|FG001|STARTED|Overall Study||294
10529861|NCT01402427|11682213|FG000|COMPLETED|Overall Study||297
10529862|NCT01402427|11682214|FG001|COMPLETED|Overall Study||294
10529863|NCT01402427|11682213|FG000|NOT COMPLETED|Overall Study||0
10529864|NCT01402427|11682214|FG001|NOT COMPLETED|Overall Study||0
10529865|NCT01402492|11682223|FG000|STARTED|Overall Study||100
10529866|NCT01402492|11682224|FG001|STARTED|Overall Study||100
10529867|NCT01402492|11682225|FG002|STARTED|Overall Study||102
10529868|NCT01402492|11682223|FG000|COMPLETED|Overall Study||79
10529869|NCT01402492|11682224|FG001|COMPLETED|Overall Study||83
10529870|NCT01402492|11682225|FG002|COMPLETED|Overall Study||86
10529871|NCT01402492|11682223|FG000|NOT COMPLETED|Overall Study||21
10529872|NCT01402492|11682224|FG001|NOT COMPLETED|Overall Study||17
10529873|NCT01402492|11682225|FG002|NOT COMPLETED|Overall Study||16
10529874|NCT01402544|11682233|FG000|STARTED|Overall Study||12
10529875|NCT01402544|11682233|FG000|COMPLETED|Overall Study||6
10529876|NCT01402544|11682233|FG000|NOT COMPLETED|Overall Study||6
10529877|NCT01402570|11682237|FG000|STARTED|Overall Study||20
10529878|NCT01402570|11682237|FG000|COMPLETED|Overall Study||19
10529879|NCT01402570|11682237|FG000|NOT COMPLETED|Overall Study||1
10340039|NCT00377234|11477010|FG000|Randomized|Overall Study||180
10340040|NCT00377234|11477011|FG001|Randomized|Overall Study||176
10340041|NCT00377234|11477010|FG000|Did Not Receive Study Treatment|Overall Study||3
10340042|NCT00377234|11477011|FG001|Did Not Receive Study Treatment|Overall Study||2
10340043|NCT00377234|11477010|FG000|Received Treatment|Overall Study||177
10340044|NCT00377234|11477011|FG001|Received Treatment|Overall Study||174
10340045|NCT00377234|11477010|FG000|Safety Analysis Set: Period 1|Overall Study||177
10340046|NCT00377234|11477011|FG001|Safety Analysis Set: Period 1|Overall Study||174
10340047|NCT00377234|11477010|FG000|Safety Analysis Set: Period 2|Overall Study||153
10340048|NCT00377234|11477011|FG001|Safety Analysis Set: Period 2|Overall Study||150
10340049|NCT00377234|11477010|FG000|Safety Analysis Set: Ibandronate|Overall Study||177
10340050|NCT00377234|11477011|FG001|Safety Analysis Set: Ibandronate|Overall Study||150
10340051|NCT00377234|11477010|FG000|Safety Analysis Set: Risedronate|Overall Study||153
10340052|NCT00377234|11477011|FG001|Safety Analysis Set: Risedronate|Overall Study||174
10340053|NCT00377234|11477010|FG000|COMPLETED|Overall Study||146
10340054|NCT00377234|11477011|FG001|COMPLETED|Overall Study||145
10340055|NCT00377234|11477010|FG000|NOT COMPLETED|Overall Study||34
10340056|NCT00377234|11477011|FG001|NOT COMPLETED|Overall Study||31
10340057|NCT00377260|11477025|FG000|STARTED|Overall Study||144
10340058|NCT00377260|11477026|FG001|STARTED|Overall Study||147
10340059|NCT00377260|11477025|FG000|COMPLETED|Overall Study|A child is considered a completer if he/she had at least one visit after the end of therapy.|142
10340060|NCT00377260|11477026|FG001|COMPLETED|Overall Study|A child is considered a completer if he/she had at least one visit after the end of therapy.|142
10340061|NCT00377260|11477025|FG000|NOT COMPLETED|Overall Study||2
10340062|NCT00377260|11477026|FG001|NOT COMPLETED|Overall Study||5
10340063|NCT00377299|11477034|FG000|STARTED|Overall Study||32
10340064|NCT00377299|11477035|FG001|STARTED|Overall Study||28
10340065|NCT00377299|11477034|FG000|COMPLETED|Overall Study||13
10340066|NCT00377299|11477035|FG001|COMPLETED|Overall Study||4
10340067|NCT00377299|11477034|FG000|NOT COMPLETED|Overall Study||19
10340068|NCT00377299|11477035|FG001|NOT COMPLETED|Overall Study||24
10340069|NCT00377312|11477044|FG000|STARTED|Overall Study||6
10340070|NCT00377312|11477045|FG001|STARTED|Overall Study||5
10340071|NCT00377312|11477044|FG000|COMPLETED|Overall Study||5
10340072|NCT00377312|11477045|FG001|COMPLETED|Overall Study||4
10340073|NCT00377312|11477044|FG000|NOT COMPLETED|Overall Study||1
10340074|NCT00377312|11477045|FG001|NOT COMPLETED|Overall Study||1
10340075|NCT00377364|11477053|FG000|STARTED|Overall Study||16
10340076|NCT00377364|11477054|FG001|STARTED|Overall Study||14
10340077|NCT00377364|11477053|FG000|COMPLETED|Overall Study||14
10340078|NCT00377364|11477054|FG001|COMPLETED|Overall Study||14
10340079|NCT00377364|11477053|FG000|NOT COMPLETED|Overall Study||2
10340080|NCT00377364|11477054|FG001|NOT COMPLETED|Overall Study||0
10340081|NCT00377403|11477064|FG000|STARTED|Overall Study||85
10340082|NCT00377403|11477065|FG001|STARTED|Overall Study||81
10340083|NCT00377403|11477064|FG000|Day -3 Assessment|Overall Study||81
10340084|NCT00377403|11477065|FG001|Day -3 Assessment|Overall Study||74
10340085|NCT00377403|11477064|FG000|Day 7 Assessment|Overall Study||80
10340086|NCT00377403|11477065|FG001|Day 7 Assessment|Overall Study||75
10340087|NCT00377403|11477064|FG000|Day 10 Assessment|Overall Study||81
10340088|NCT00377403|11477065|FG001|Day 10 Assessment|Overall Study||71
10340089|NCT00377403|11477064|FG000|Day 28 Assessment|Overall Study||82
10340090|NCT00377403|11477065|FG001|Day 28 Assessment|Overall Study||77
10340091|NCT00377403|11477064|FG000|COMPLETED|Overall Study|The number varied by day of follow-up from 80 to 82 in the intervention group.|81
10340092|NCT00377403|11477065|FG001|COMPLETED|Overall Study|The number varied by day of follow-up from 71 to 77 in the symptomatic treatment only group.|74
10340093|NCT00377403|11477064|FG000|NOT COMPLETED|Overall Study||4
10340094|NCT00377403|11477065|FG001|NOT COMPLETED|Overall Study||7
10340095|NCT00377429|11477071|FG000|STARTED|Overall Study|Treated|47
10529880|NCT01402700|11682242|FG000|STARTED|Overall Study||75
10529881|NCT01402700|11682242|FG000|COMPLETED|Overall Study||68
10529882|NCT01402700|11682242|FG000|NOT COMPLETED|Overall Study||7
10714503|NCT02688387|11880050|FG007|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10714504|NCT02688387|11880051|FG008|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10529883|NCT01402817|11682246|FG000|STARTED|Overall Study||19
10529884|NCT01402817|11682246|FG000|COMPLETED|Overall Study||8
10529885|NCT01402817|11682246|FG000|NOT COMPLETED|Overall Study||11
10529886|NCT01402869|11682254|FG000|STARTED|Overall Study||30
10529887|NCT01402869|11682255|FG001|STARTED|Overall Study||30
10529888|NCT01402869|11682256|FG002|STARTED|Overall Study||31
10529889|NCT01402869|11682254|FG000|COMPLETED|Overall Study||30
10529890|NCT01402869|11682255|FG001|COMPLETED|Overall Study||30
10714505|NCT02688387|11880052|FG009|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10529891|NCT01402869|11682256|FG002|COMPLETED|Overall Study||30
10302870|NCT00074490|11435710|FG000|STARTED|Overall Study||1
10302871|NCT00074490|11435711|FG001|STARTED|Overall Study||34
10302872|NCT00074490|11435712|FG002|STARTED|Overall Study||40
10302873|NCT00074490|11435713|FG003|STARTED|Overall Study||44
10302874|NCT00074490|11435714|FG004|STARTED|Overall Study||45
10302875|NCT00074490|11435715|FG005|STARTED|Overall Study||221
10302876|NCT00074490|11435710|FG000|COMPLETED|Overall Study||1
10302877|NCT00074490|11435711|FG001|COMPLETED|Overall Study||27
10302878|NCT00074490|11435712|FG002|COMPLETED|Overall Study||40
10302879|NCT00074490|11435713|FG003|COMPLETED|Overall Study||44
10302880|NCT00074490|11435714|FG004|COMPLETED|Overall Study||42
10302881|NCT00074490|11435715|FG005|COMPLETED|Overall Study||221
10302882|NCT00074490|11435710|FG000|NOT COMPLETED|Overall Study||0
10302883|NCT00074490|11435711|FG001|NOT COMPLETED|Overall Study||7
10302884|NCT00074490|11435712|FG002|NOT COMPLETED|Overall Study||0
10302885|NCT00074490|11435713|FG003|NOT COMPLETED|Overall Study||0
10302886|NCT00074490|11435714|FG004|NOT COMPLETED|Overall Study||3
10302887|NCT00074490|11435715|FG005|NOT COMPLETED|Overall Study||0
10315102|NCT00174252|11448881|FG000|COMPLETED|Overall Study||55
10315103|NCT00174252|11448881|FG000|NOT COMPLETED|Overall Study||2
10315104|NCT00174291|11448889|FG000|STARTED|Overall Study||11
10315105|NCT00174291|11448890|FG001|STARTED|Overall Study||10
10315106|NCT00174291|11448889|FG000|COMPLETED|Overall Study||6
10315107|NCT00174291|11448890|FG001|COMPLETED|Overall Study||4
10315108|NCT00174291|11448889|FG000|NOT COMPLETED|Overall Study||5
10315109|NCT00174291|11448890|FG001|NOT COMPLETED|Overall Study||6
10315110|NCT00174382|11448896|FG000|STARTED|Overall Study|148 are summarized below: 1 subject entered the study but was lost to follow up.|149
10340096|NCT00377429|11477071|FG000|COMPLETED|Overall Study|Completed main study|32
10340097|NCT00377429|11477071|FG000|NOT COMPLETED|Overall Study||15
10340098|NCT00377520|11477075|FG000|STARTED|Overall Study||27
10340099|NCT00377520|11477075|FG000|COMPLETED|Overall Study|Completed means the patient was evaluable for response.|26
10340100|NCT00377520|11477075|FG000|NOT COMPLETED|Overall Study||1
10340101|NCT00377572|11477081|FG000|STARTED|Overall Study||208
10340102|NCT00377572|11477082|FG001|STARTED|Overall Study||211
10340103|NCT00377572|11477081|FG000|COMPLETED|Overall Study||155
10340104|NCT00377572|11477082|FG001|COMPLETED|Overall Study||157
10340105|NCT00377572|11477081|FG000|NOT COMPLETED|Overall Study||53
10340106|NCT00377572|11477082|FG001|NOT COMPLETED|Overall Study||54
10340107|NCT00377611|11477090|FG000|STARTED|Overall Study||1047
10340108|NCT00377611|11477091|FG001|STARTED|Overall Study||2007
10340109|NCT00377611|11477090|FG000|COMPLETED|Overall Study||1025
10340110|NCT00377611|11477091|FG001|COMPLETED|Overall Study||1974
10340111|NCT00377611|11477090|FG000|NOT COMPLETED|Overall Study||22
10340112|NCT00377611|11477091|FG001|NOT COMPLETED|Overall Study||33
10340113|NCT00377637|11477102|FG000|STARTED|Induction Phase|Intent-To-Treat|185
10340114|NCT00377637|11477103|FG001|STARTED|Induction Phase|Intent-To-Treat|185
10340115|NCT00377637|11477104|FG002|STARTED|Induction Phase||0
10340116|NCT00377637|11477105|FG003|STARTED|Induction Phase||0
10340117|NCT00377637|11477102|FG000|Safety Population|Induction Phase||180
10340118|NCT00377637|11477103|FG001|Safety Population|Induction Phase||184
10340119|NCT00377637|11477104|FG002|Safety Population|Induction Phase||0
10340120|NCT00377637|11477105|FG003|Safety Population|Induction Phase||0
10714506|NCT02688387|11880053|FG010|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10714507|NCT02688387|11880054|FG011|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10714508|NCT02688387|11880055|FG012|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10714509|NCT02688387|11880056|FG013|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10714510|NCT02688387|11880057|FG014|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10714511|NCT02688387|11880058|FG015|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10714512|NCT02688387|11880059|FG016|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10714513|NCT02688387|11880060|FG017|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10714514|NCT02688387|11880061|FG018|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10714515|NCT02688387|11880062|FG019|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10714516|NCT02688387|11880063|FG020|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10714517|NCT02688387|11880064|FG021|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
10714518|NCT02688387|11880043|FG000|STARTED|Part 1, Washout Period 1 (7 Days)||3
10714519|NCT02688387|11880044|FG001|STARTED|Part 1, Washout Period 1 (7 Days)||3
10714520|NCT02688387|11880045|FG002|STARTED|Part 1, Washout Period 1 (7 Days)||3
10340121|NCT00377637|11477102|FG000|COMPLETED|Induction Phase||156
10340122|NCT00377637|11477103|FG001|COMPLETED|Induction Phase||150
10714521|NCT02688387|11880046|FG003|STARTED|Part 1, Washout Period 1 (7 Days)||2
10714522|NCT02688387|11880047|FG004|STARTED|Part 1, Washout Period 1 (7 Days)||3
10714523|NCT02688387|11880048|FG005|STARTED|Part 1, Washout Period 1 (7 Days)||2
10714524|NCT02688387|11880049|FG006|STARTED|Part 1, Washout Period 1 (7 Days)||2
10714525|NCT02688387|11880050|FG007|STARTED|Part 1, Washout Period 1 (7 Days)||2
10714526|NCT02688387|11880051|FG008|STARTED|Part 1, Washout Period 1 (7 Days)||2
10714527|NCT02688387|11880052|FG009|STARTED|Part 1, Washout Period 1 (7 Days)||2
10714528|NCT02688387|11880053|FG010|STARTED|Part 1, Washout Period 1 (7 Days)||0
10714529|NCT02688387|11880054|FG011|STARTED|Part 1, Washout Period 1 (7 Days)||0
10714530|NCT02688387|11880055|FG012|STARTED|Part 1, Washout Period 1 (7 Days)||0
10714531|NCT02688387|11880056|FG013|STARTED|Part 1, Washout Period 1 (7 Days)||0
10714532|NCT02688387|11880057|FG014|STARTED|Part 1, Washout Period 1 (7 Days)||0
10714533|NCT02688387|11880058|FG015|STARTED|Part 1, Washout Period 1 (7 Days)||0
10714534|NCT02688387|11880059|FG016|STARTED|Part 1, Washout Period 1 (7 Days)||0
10714535|NCT02688387|11880060|FG017|STARTED|Part 1, Washout Period 1 (7 Days)||0
10714536|NCT02688387|11880061|FG018|STARTED|Part 1, Washout Period 1 (7 Days)||0
10714537|NCT02688387|11880062|FG019|STARTED|Part 1, Washout Period 1 (7 Days)||0
10714538|NCT02688387|11880063|FG020|STARTED|Part 1, Washout Period 1 (7 Days)||0
10714539|NCT02688387|11880064|FG021|STARTED|Part 1, Washout Period 1 (7 Days)||0
10714540|NCT02688387|11880043|FG000|COMPLETED|Part 1, Washout Period 1 (7 Days)||3
10714541|NCT02688387|11880044|FG001|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
10714542|NCT02688387|11880045|FG002|COMPLETED|Part 1, Washout Period 1 (7 Days)||3
10340123|NCT00377637|11477104|FG002|COMPLETED|Induction Phase||0
10340124|NCT00377637|11477105|FG003|COMPLETED|Induction Phase||0
10340125|NCT00377637|11477102|FG000|NOT COMPLETED|Induction Phase||29
10340126|NCT00377637|11477103|FG001|NOT COMPLETED|Induction Phase||35
10340127|NCT00377637|11477104|FG002|NOT COMPLETED|Induction Phase||0
10340128|NCT00377637|11477105|FG003|NOT COMPLETED|Induction Phase||0
10340129|NCT00377637|11477102|FG000|STARTED|Maintenance Phase||0
10340130|NCT00377637|11477103|FG001|STARTED|Maintenance Phase||0
10340131|NCT00377637|11477104|FG002|STARTED|Maintenance Phase||116
10340132|NCT00377637|11477105|FG003|STARTED|Maintenance Phase||111
10340133|NCT00377637|11477102|FG000|COMPLETED|Maintenance Phase||0
10340134|NCT00377637|11477103|FG001|COMPLETED|Maintenance Phase||0
10340135|NCT00377637|11477104|FG002|COMPLETED|Maintenance Phase||73
10340136|NCT00377637|11477105|FG003|COMPLETED|Maintenance Phase||54
10340137|NCT00377637|11477102|FG000|NOT COMPLETED|Maintenance Phase||0
10340138|NCT00377637|11477103|FG001|NOT COMPLETED|Maintenance Phase||0
10340139|NCT00377637|11477104|FG002|NOT COMPLETED|Maintenance Phase||43
10340140|NCT00377637|11477105|FG003|NOT COMPLETED|Maintenance Phase||57
10340141|NCT00377676|11477121|FG000|STARTED|Overall Study|25 subjects did not receive study drug - thus 3070 were randomized and received drug|2054
10340142|NCT00377676|11477122|FG001|STARTED|Overall Study||1016
10340143|NCT00377676|11477121|FG000|COMPLETED|Overall Study||1093
10714543|NCT02688387|11880046|FG003|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
10714544|NCT02688387|11880047|FG004|COMPLETED|Part 1, Washout Period 1 (7 Days)||3
10714545|NCT02688387|11880048|FG005|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
10714546|NCT02688387|11880049|FG006|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
10714547|NCT02688387|11880050|FG007|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
10714548|NCT02688387|11880051|FG008|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
10714549|NCT02688387|11880052|FG009|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
10714550|NCT02688387|11880053|FG010|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10714551|NCT02688387|11880054|FG011|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10340144|NCT00377676|11477122|FG001|COMPLETED|Overall Study||694
10340145|NCT00377676|11477121|FG000|NOT COMPLETED|Overall Study||961
10340146|NCT00377676|11477122|FG001|NOT COMPLETED|Overall Study||322
10340147|NCT00377741|11477130|FG000|STARTED|Overall Study||16
10340148|NCT00377741|11477131|FG001|STARTED|Overall Study||15
10340149|NCT00377741|11477130|FG000|COMPLETED|Overall Study||16
10340150|NCT00377741|11477131|FG001|COMPLETED|Overall Study||15
10340151|NCT00377741|11477130|FG000|NOT COMPLETED|Overall Study||0
10340152|NCT00377741|11477131|FG001|NOT COMPLETED|Overall Study||0
10340153|NCT00377819|11477139|FG000|STARTED|Overall Study||251
10340154|NCT00377819|11477140|FG001|STARTED|Overall Study||253
10340155|NCT00377819|11477139|FG000|Received Study Medication|Overall Study||249
10340156|NCT00377819|11477140|FG001|Received Study Medication|Overall Study||253
10340157|NCT00377819|11477139|FG000|COMPLETED|Overall Study||238
10340158|NCT00377819|11477140|FG001|COMPLETED|Overall Study||243
10340159|NCT00377819|11477139|FG000|NOT COMPLETED|Overall Study||13
10340160|NCT00377819|11477140|FG001|NOT COMPLETED|Overall Study||10
10340161|NCT00377832|11477148|FG000|STARTED|Overall Study||7
10340162|NCT00377832|11477149|FG001|STARTED|Overall Study||6
10340163|NCT00377832|11477148|FG000|COMPLETED|Overall Study||7
10340164|NCT00377832|11477149|FG001|COMPLETED|Overall Study||6
10340165|NCT00377832|11477148|FG000|NOT COMPLETED|Overall Study||0
10340166|NCT00377832|11477149|FG001|NOT COMPLETED|Overall Study||0
10340167|NCT00377858|11477160|FG000|STARTED|Overall Study||242
10340168|NCT00377858|11477161|FG001|STARTED|Overall Study||242
10340169|NCT00377858|11477160|FG000|Had at Least One Post-Baseline Value|Overall Study||239
10340170|NCT00377858|11477161|FG001|Had at Least One Post-Baseline Value|Overall Study||240
10340171|NCT00377858|11477160|FG000|COMPLETED|Overall Study||211
10340172|NCT00377858|11477161|FG001|COMPLETED|Overall Study||215
10340173|NCT00377858|11477160|FG000|NOT COMPLETED|Overall Study||31
10340174|NCT00377858|11477161|FG001|NOT COMPLETED|Overall Study||27
10340175|NCT00377962|11477169|FG000|STARTED|Core Study: 0-12 Months||140
10340176|NCT00377962|11477170|FG001|STARTED|Core Study: 0-12 Months||142
10340177|NCT00377962|11477169|FG000|COMPLETED|Core Study: 0-12 Months||112
10340178|NCT00377962|11477170|FG001|COMPLETED|Core Study: 0-12 Months||133
10340179|NCT00377962|11477169|FG000|NOT COMPLETED|Core Study: 0-12 Months||28
10340180|NCT00377962|11477170|FG001|NOT COMPLETED|Core Study: 0-12 Months||9
10340181|NCT00377962|11477169|FG000|STARTED|Extension Study: 12-24 Months||108
10340182|NCT00377962|11477170|FG001|STARTED|Extension Study: 12-24 Months||127
10714552|NCT02688387|11880055|FG012|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10714553|NCT02688387|11880056|FG013|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10714554|NCT02688387|11880057|FG014|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10714555|NCT02688387|11880058|FG015|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10714556|NCT02688387|11880059|FG016|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10714557|NCT02688387|11880060|FG017|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10811880|NCT03743311|11973796|FG001|COMPLETED|Overall Study||298
10714558|NCT02688387|11880061|FG018|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10714559|NCT02688387|11880062|FG019|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10714560|NCT02688387|11880063|FG020|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10714561|NCT02688387|11880064|FG021|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10714562|NCT02688387|11880043|FG000|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10714563|NCT02688387|11880044|FG001|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||1
10302888|NCT00074581|11435730|FG000|STARTED|Overall Study|886 HIV-infected index cases and 903 HIV-uninfected partners|1789
10302889|NCT00074581|11435731|FG001|STARTED|Overall Study|877 HIV-infected index cases and 890 HIV-uninfected partners|1767
10302890|NCT00074581|11435730|FG000|COMPLETED|Overall Study||1545
10302891|NCT00074581|11435731|FG001|COMPLETED|Overall Study||1541
10302892|NCT00074581|11435730|FG000|NOT COMPLETED|Overall Study||244
10714564|NCT02688387|11880045|FG002|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10714565|NCT02688387|11880046|FG003|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10714566|NCT02688387|11880047|FG004|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10714567|NCT02688387|11880048|FG005|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10714568|NCT02688387|11880049|FG006|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10714569|NCT02688387|11880050|FG007|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10714570|NCT02688387|11880051|FG008|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10302893|NCT00074581|11435731|FG001|NOT COMPLETED|Overall Study||226
10302894|NCT00074711|11435739|FG000|STARTED|Overall Study||120
10714571|NCT02688387|11880052|FG009|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10714572|NCT02688387|11880053|FG010|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10714573|NCT02688387|11880054|FG011|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10714574|NCT02688387|11880055|FG012|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10714575|NCT02688387|11880056|FG013|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10714576|NCT02688387|11880057|FG014|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10714577|NCT02688387|11880058|FG015|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10714578|NCT02688387|11880059|FG016|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10714579|NCT02688387|11880060|FG017|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10714580|NCT02688387|11880061|FG018|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10714581|NCT02688387|11880062|FG019|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10714582|NCT02688387|11880063|FG020|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10714583|NCT02688387|11880064|FG021|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10714584|NCT02688387|11880043|FG000|STARTED|Part 1, Period 2 (up to 6 Days)||3
10714585|NCT02688387|11880044|FG001|STARTED|Part 1, Period 2 (up to 6 Days)||2
10714586|NCT02688387|11880045|FG002|STARTED|Part 1, Period 2 (up to 6 Days)||3
10714587|NCT02688387|11880046|FG003|STARTED|Part 1, Period 2 (up to 6 Days)||2
10714588|NCT02688387|11880047|FG004|STARTED|Part 1, Period 2 (up to 6 Days)||3
10714589|NCT02688387|11880048|FG005|STARTED|Part 1, Period 2 (up to 6 Days)||2
10714590|NCT02688387|11880049|FG006|STARTED|Part 1, Period 2 (up to 6 Days)||2
10714591|NCT02688387|11880050|FG007|STARTED|Part 1, Period 2 (up to 6 Days)||2
10714592|NCT02688387|11880051|FG008|STARTED|Part 1, Period 2 (up to 6 Days)||2
10714593|NCT02688387|11880052|FG009|STARTED|Part 1, Period 2 (up to 6 Days)||2
10811881|NCT03743311|11973797|FG002|COMPLETED|Overall Study||423
10811882|NCT03743311|11973795|FG000|NOT COMPLETED|Overall Study||0
10714594|NCT02688387|11880053|FG010|STARTED|Part 1, Period 2 (up to 6 Days)||0
10714595|NCT02688387|11880054|FG011|STARTED|Part 1, Period 2 (up to 6 Days)||0
10714596|NCT02688387|11880055|FG012|STARTED|Part 1, Period 2 (up to 6 Days)||0
10714597|NCT02688387|11880056|FG013|STARTED|Part 1, Period 2 (up to 6 Days)||0
10714598|NCT02688387|11880057|FG014|STARTED|Part 1, Period 2 (up to 6 Days)||0
10714599|NCT02688387|11880058|FG015|STARTED|Part 1, Period 2 (up to 6 Days)||0
10714600|NCT02688387|11880059|FG016|STARTED|Part 1, Period 2 (up to 6 Days)||0
10714601|NCT02688387|11880060|FG017|STARTED|Part 1, Period 2 (up to 6 Days)||0
10714602|NCT02688387|11880061|FG018|STARTED|Part 1, Period 2 (up to 6 Days)||0
10714603|NCT02688387|11880062|FG019|STARTED|Part 1, Period 2 (up to 6 Days)||0
10714604|NCT02688387|11880063|FG020|STARTED|Part 1, Period 2 (up to 6 Days)||0
10714605|NCT02688387|11880064|FG021|STARTED|Part 1, Period 2 (up to 6 Days)||0
10714606|NCT02688387|11880043|FG000|COMPLETED|Part 1, Period 2 (up to 6 Days)||3
10714607|NCT02688387|11880044|FG001|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
10714608|NCT02688387|11880045|FG002|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
10714609|NCT02688387|11880046|FG003|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
10714610|NCT02688387|11880047|FG004|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
10714611|NCT02688387|11880048|FG005|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
10714612|NCT02688387|11880049|FG006|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
10714613|NCT02688387|11880050|FG007|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
10714614|NCT02688387|11880051|FG008|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
10714615|NCT02688387|11880052|FG009|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
10714616|NCT02688387|11880053|FG010|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10714617|NCT02688387|11880054|FG011|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10714618|NCT02688387|11880055|FG012|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10714619|NCT02688387|11880056|FG013|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10714620|NCT02688387|11880057|FG014|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10714621|NCT02688387|11880058|FG015|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10302895|NCT00074711|11435740|FG001|STARTED|Overall Study||121
10302896|NCT00074711|11435739|FG000|COMPLETED|Overall Study||105
10302897|NCT00074711|11435740|FG001|COMPLETED|Overall Study||106
10302898|NCT00074711|11435739|FG000|NOT COMPLETED|Overall Study||15
10302899|NCT00074711|11435740|FG001|NOT COMPLETED|Overall Study||15
10302900|NCT00074802|11435748|FG000|STARTED|Overall Study||29
10302901|NCT00074802|11435749|FG001|STARTED|Overall Study||32
10302902|NCT00074802|11435748|FG000|COMPLETED|Overall Study||20
10302903|NCT00074802|11435749|FG001|COMPLETED|Overall Study||25
10302904|NCT00074802|11435748|FG000|NOT COMPLETED|Overall Study||9
10302905|NCT00074802|11435749|FG001|NOT COMPLETED|Overall Study||7
10302906|NCT00074815|11435758|FG000|STARTED|Overall Study||42
10302907|NCT00074815|11435759|FG001|STARTED|Overall Study||40
10302908|NCT00074815|11435760|FG002|STARTED|Overall Study||42
10302909|NCT00074815|11435758|FG000|COMPLETED|Overall Study||37
10302910|NCT00074815|11435759|FG001|COMPLETED|Overall Study||34
10302911|NCT00074815|11435760|FG002|COMPLETED|Overall Study||30
10302912|NCT00074815|11435758|FG000|NOT COMPLETED|Overall Study||5
10302913|NCT00074815|11435759|FG001|NOT COMPLETED|Overall Study||6
10302914|NCT00074815|11435760|FG002|NOT COMPLETED|Overall Study||12
10302915|NCT00074958|11435768|FG000|STARTED|Overall Study||16
10302916|NCT00074958|11435768|FG000|COMPLETED|Overall Study||15
10302917|NCT00074958|11435768|FG000|NOT COMPLETED|Overall Study||1
10302918|NCT00074984|11435774|FG000|STARTED|Overall Study||31
10302919|NCT00074984|11435775|FG001|STARTED|Overall Study||51
10302920|NCT00074984|11435774|FG000|COMPLETED|Overall Study||28
10302921|NCT00074984|11435775|FG001|COMPLETED|Overall Study||43
10302922|NCT00074984|11435774|FG000|NOT COMPLETED|Overall Study||3
10302923|NCT00074984|11435775|FG001|NOT COMPLETED|Overall Study||8
10302924|NCT00075023|11435784|FG000|STARTED|Pilot Study||5
10302925|NCT00075023|11435785|FG001|STARTED|Pilot Study||5
10302926|NCT00075023|11435784|FG000|COMPLETED|Pilot Study||3
10302927|NCT00075023|11435785|FG001|COMPLETED|Pilot Study||3
10302928|NCT00075023|11435784|FG000|NOT COMPLETED|Pilot Study||2
10302929|NCT00075023|11435785|FG001|NOT COMPLETED|Pilot Study||2
10302930|NCT00075023|11435784|FG000|STARTED|Part Two|Study was terminated after the pilot study. No participants entered Part Two.|0
10302931|NCT00075023|11435785|FG001|STARTED|Part Two|Study was terminated after the pilot study. No participants entered Part Two.|0
10302932|NCT00075023|11435784|FG000|COMPLETED|Part Two||0
10302933|NCT00075023|11435785|FG001|COMPLETED|Part Two||0
10302934|NCT00075023|11435784|FG000|NOT COMPLETED|Part Two||0
10302935|NCT00075023|11435785|FG001|NOT COMPLETED|Part Two||0
10302936|NCT00075088|11435794|FG000|STARTED|Overall Study||403
10302937|NCT00075088|11435795|FG001|STARTED|Overall Study||391
10302938|NCT00075088|11435794|FG000|COMPLETED|Overall Study||403
10302939|NCT00075088|11435795|FG001|COMPLETED|Overall Study||391
10302940|NCT00075088|11435794|FG000|NOT COMPLETED|Overall Study||0
10302941|NCT00075088|11435795|FG001|NOT COMPLETED|Overall Study||0
10302942|NCT00075218|11435804|FG000|STARTED|Double-Blind Treatment|Intent To Treat Population (ITT)|243
10302943|NCT00075218|11435805|FG001|STARTED|Double-Blind Treatment|Intent To Treat Population (ITT)|118
10302944|NCT00075218|11435806|FG002|STARTED|Double-Blind Treatment||0
10302945|NCT00075218|11435804|FG000|Received Double-Blind Treatment|Double-Blind Treatment|As Treated Population (AT)|228
10302946|NCT00075218|11435805|FG001|Received Double-Blind Treatment|Double-Blind Treatment|As Treated Population (AT)|114
10302947|NCT00075218|11435806|FG002|Received Double-Blind Treatment|Double-Blind Treatment||0
10302948|NCT00075218|11435804|FG000|Crossed Over to Open-Label Treatment|Double-Blind Treatment||152
10302949|NCT00075218|11435805|FG001|Crossed Over to Open-Label Treatment|Double-Blind Treatment||103
10302950|NCT00075218|11435806|FG002|Crossed Over to Open-Label Treatment|Double-Blind Treatment||0
10302951|NCT00075218|11435804|FG000|COMPLETED|Double-Blind Treatment|Defined:subjects completed double-blind treatment phase and/or entered open-label treatment phase.|152
10302952|NCT00075218|11435805|FG001|COMPLETED|Double-Blind Treatment|Defined:subjects completed double-blind treatment phase and/or entered open-label treatment phase.|103
10302953|NCT00075218|11435806|FG002|COMPLETED|Double-Blind Treatment||0
10302954|NCT00075218|11435804|FG000|NOT COMPLETED|Double-Blind Treatment||91
10302955|NCT00075218|11435805|FG001|NOT COMPLETED|Double-Blind Treatment||15
10302956|NCT00075218|11435806|FG002|NOT COMPLETED|Double-Blind Treatment||0
10302957|NCT00075218|11435804|FG000|STARTED|Open-Label Treatment||0
10302958|NCT00075218|11435805|FG001|STARTED|Open-Label Treatment||0
10302959|NCT00075218|11435806|FG002|STARTED|Open-Label Treatment||255
10302960|NCT00075218|11435804|FG000|COMPLETED|Open-Label Treatment||0
10302961|NCT00075218|11435805|FG001|COMPLETED|Open-Label Treatment||0
10302962|NCT00075218|11435806|FG002|COMPLETED|Open-Label Treatment||0
10302963|NCT00075218|11435804|FG000|NOT COMPLETED|Open-Label Treatment||0
10302964|NCT00075218|11435805|FG001|NOT COMPLETED|Open-Label Treatment||0
10302965|NCT00075218|11435806|FG002|NOT COMPLETED|Open-Label Treatment||255
10302966|NCT00075270|11435815|FG000|STARTED|Overall Study||291
10302967|NCT00075270|11435816|FG001|STARTED|Overall Study||288
10302968|NCT00075270|11435815|FG000|Missing|Overall Study|These participants have no completion status information recorded on the case report forms.|26
10302969|NCT00075270|11435816|FG001|Missing|Overall Study|These participants have no completion status information recorded on the case report forms.|13
10302970|NCT00075270|11435815|FG000|COMPLETED|Overall Study||5
10302971|NCT00075270|11435816|FG001|COMPLETED|Overall Study||4
10529892|NCT01402869|11682254|FG000|NOT COMPLETED|Overall Study||0
10529893|NCT01402869|11682255|FG001|NOT COMPLETED|Overall Study||0
10529894|NCT01402869|11682256|FG002|NOT COMPLETED|Overall Study||1
10529895|NCT01402947|11682266|FG000|STARTED|First Intervention||15
10529896|NCT01402947|11682267|FG001|STARTED|First Intervention||15
10529897|NCT01402947|11682266|FG000|COMPLETED|First Intervention||15
10529898|NCT01402947|11682267|FG001|COMPLETED|First Intervention||14
10529899|NCT01402947|11682266|FG000|NOT COMPLETED|First Intervention||0
10529900|NCT01402947|11682267|FG001|NOT COMPLETED|First Intervention||1
10529901|NCT01402947|11682266|FG000|STARTED|Second Intervention||15
10529902|NCT01402947|11682267|FG001|STARTED|Second Intervention||14
10529903|NCT01402947|11682266|FG000|COMPLETED|Second Intervention||15
10529904|NCT01402947|11682267|FG001|COMPLETED|Second Intervention||14
10529905|NCT01402947|11682266|FG000|NOT COMPLETED|Second Intervention||0
10529906|NCT01402947|11682267|FG001|NOT COMPLETED|Second Intervention||0
10529907|NCT01402986|11682277|FG000|STARTED|Overall Study||76
10529908|NCT01402986|11682278|FG001|STARTED|Overall Study||150
10529909|NCT01402986|11682279|FG002|STARTED|Overall Study||75
10529910|NCT01402986|11682280|FG003|STARTED|Overall Study||151
10302972|NCT00075270|11435815|FG000|NOT COMPLETED|Overall Study||286
10302973|NCT00075270|11435816|FG001|NOT COMPLETED|Overall Study||284
10302974|NCT00075335|11435823|FG000|STARTED|Overall Study||8
10302975|NCT00075335|11435823|FG000|COMPLETED|Overall Study||8
10302976|NCT00075335|11435823|FG000|NOT COMPLETED|Overall Study||0
10302977|NCT00075400|11435827|FG000|STARTED|Overall Study||26
10302978|NCT00075400|11435827|FG000|COMPLETED|Overall Study|Eligible and treated patients.|23
10302979|NCT00075400|11435827|FG000|NOT COMPLETED|Overall Study||3
10302980|NCT00075478|11435838|FG000|STARTED|Overall Study||42
10302981|NCT00075478|11435839|FG001|STARTED|Overall Study||45
10529911|NCT01402986|11682277|FG000|COMPLETED|Overall Study||67
10529912|NCT01402986|11682278|FG001|COMPLETED|Overall Study||135
10529913|NCT01402986|11682279|FG002|COMPLETED|Overall Study||67
10529914|NCT01402986|11682280|FG003|COMPLETED|Overall Study||129
10529915|NCT01402986|11682277|FG000|NOT COMPLETED|Overall Study||9
10529916|NCT01402986|11682278|FG001|NOT COMPLETED|Overall Study||15
10529917|NCT01402986|11682279|FG002|NOT COMPLETED|Overall Study||8
10529918|NCT01402986|11682280|FG003|NOT COMPLETED|Overall Study||22
10529919|NCT01403051|11682292|FG000|STARTED|Overall Study||81
10529920|NCT01403051|11682293|FG001|STARTED|Overall Study||86
10529921|NCT01403051|11682292|FG000|Initiated Study Treatment|Overall Study||81
10529922|NCT01403051|11682293|FG001|Initiated Study Treatment|Overall Study||86
10529923|NCT01403051|11682292|FG000|COMPLETED|Overall Study||71
10529924|NCT01403051|11682293|FG001|COMPLETED|Overall Study||80
10529925|NCT01403051|11682292|FG000|NOT COMPLETED|Overall Study||10
10529926|NCT01403051|11682293|FG001|NOT COMPLETED|Overall Study||6
10529927|NCT01403064|11682304|FG000|STARTED|Overall Study||24
10529928|NCT01403064|11682305|FG001|STARTED|Overall Study||7
10529929|NCT01403064|11682306|FG002|STARTED|Overall Study||23
10529930|NCT01403064|11682307|FG003|STARTED|Overall Study||22
10302982|NCT00075478|11435838|FG000|COMPLETED|Overall Study||41
10302983|NCT00075478|11435839|FG001|COMPLETED|Overall Study||44
10302984|NCT00075478|11435838|FG000|NOT COMPLETED|Overall Study||1
10302985|NCT00075478|11435839|FG001|NOT COMPLETED|Overall Study||1
10302986|NCT00075504|11435847|FG000|STARTED|Overall Study||23
10302987|NCT00075504|11435848|FG001|STARTED|Overall Study||10
10302988|NCT00075504|11435847|FG000|COMPLETED|Overall Study||14
10529931|NCT01403064|11682304|FG000|COMPLETED|Overall Study||23
10529932|NCT01403064|11682305|FG001|COMPLETED|Overall Study||7
10529933|NCT01403064|11682306|FG002|COMPLETED|Overall Study||19
10529934|NCT01403064|11682307|FG003|COMPLETED|Overall Study||19
10529935|NCT01403064|11682304|FG000|NOT COMPLETED|Overall Study||1
10811883|NCT03743311|11973796|FG001|NOT COMPLETED|Overall Study||0
10811884|NCT03743311|11973797|FG002|NOT COMPLETED|Overall Study||0
10811885|NCT03743038|11973806|FG000|STARTED|Overall Study||12
10811886|NCT03743038|11973806|FG000|Test Article A|Overall Study||12
10811887|NCT03743038|11973806|FG000|Test Article B|Overall Study||12
10340183|NCT00377962|11477169|FG000|COMPLETED|Extension Study: 12-24 Months||98
10811888|NCT03743038|11973806|FG000|COMPLETED|Overall Study||11
10714622|NCT02688387|11880059|FG016|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10714623|NCT02688387|11880060|FG017|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10714624|NCT02688387|11880061|FG018|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10714625|NCT02688387|11880062|FG019|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10714626|NCT02688387|11880063|FG020|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10714627|NCT02688387|11880064|FG021|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10714628|NCT02688387|11880043|FG000|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10714629|NCT02688387|11880044|FG001|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10714630|NCT02688387|11880045|FG002|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||1
10714631|NCT02688387|11880046|FG003|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10714632|NCT02688387|11880047|FG004|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||1
10714633|NCT02688387|11880048|FG005|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10714634|NCT02688387|11880049|FG006|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10714635|NCT02688387|11880050|FG007|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10714636|NCT02688387|11880051|FG008|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10714637|NCT02688387|11880052|FG009|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10714638|NCT02688387|11880053|FG010|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10714639|NCT02688387|11880054|FG011|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10340184|NCT00377962|11477170|FG001|COMPLETED|Extension Study: 12-24 Months||123
10340185|NCT00377962|11477169|FG000|NOT COMPLETED|Extension Study: 12-24 Months||10
10340186|NCT00377962|11477170|FG001|NOT COMPLETED|Extension Study: 12-24 Months||4
10714640|NCT02688387|11880055|FG012|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10714641|NCT02688387|11880056|FG013|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10714642|NCT02688387|11880057|FG014|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10714643|NCT02688387|11880058|FG015|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10714644|NCT02688387|11880059|FG016|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10714645|NCT02688387|11880060|FG017|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10714646|NCT02688387|11880061|FG018|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10714647|NCT02688387|11880062|FG019|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10714648|NCT02688387|11880063|FG020|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10714649|NCT02688387|11880064|FG021|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
10714650|NCT02688387|11880043|FG000|STARTED|Part 1, Washout Period 2 (7 Days)||3
10714651|NCT02688387|11880044|FG001|STARTED|Part 1, Washout Period 2 (7 Days)||2
10714652|NCT02688387|11880045|FG002|STARTED|Part 1, Washout Period 2 (7 Days)||2
10714653|NCT02688387|11880046|FG003|STARTED|Part 1, Washout Period 2 (7 Days)||2
10714654|NCT02688387|11880047|FG004|STARTED|Part 1, Washout Period 2 (7 Days)||2
10714655|NCT02688387|11880048|FG005|STARTED|Part 1, Washout Period 2 (7 Days)||2
10714656|NCT02688387|11880049|FG006|STARTED|Part 1, Washout Period 2 (7 Days)||2
10714657|NCT02688387|11880050|FG007|STARTED|Part 1, Washout Period 2 (7 Days)||2
10714658|NCT02688387|11880051|FG008|STARTED|Part 1, Washout Period 2 (7 Days)||2
10340187|NCT00378014|11477184|FG000|STARTED|Core (Randomization to Month 11)||101
10340188|NCT00378014|11477185|FG001|STARTED|Core (Randomization to Month 11)||102
10529936|NCT01403064|11682305|FG001|NOT COMPLETED|Overall Study||0
10529937|NCT01403064|11682306|FG002|NOT COMPLETED|Overall Study||4
10529938|NCT01403064|11682307|FG003|NOT COMPLETED|Overall Study||3
10529939|NCT01403090|11682322|FG000|STARTED|Overall Study||8
10529940|NCT01403090|11682322|FG000|COMPLETED|Overall Study||8
10654954|NCT02206607|11815799|FG004|NOT COMPLETED|Open-Label Run-In||0
10302989|NCT00075504|11435848|FG001|COMPLETED|Overall Study||3
10302990|NCT00075504|11435847|FG000|NOT COMPLETED|Overall Study||9
10302991|NCT00075504|11435848|FG001|NOT COMPLETED|Overall Study||7
10302992|NCT00075582|11435856|FG000|STARTED|Overall Study||305
10302993|NCT00075582|11435857|FG001|STARTED|Overall Study||85
10302994|NCT00075582|11435856|FG000|COMPLETED|Overall Study||255
10302995|NCT00075582|11435857|FG001|COMPLETED|Overall Study||50
10302996|NCT00075582|11435856|FG000|NOT COMPLETED|Overall Study||50
10302997|NCT00075582|11435857|FG001|NOT COMPLETED|Overall Study||35
10302998|NCT00075725|11435879|FG000|STARTED|Overall Study||246
10302999|NCT00075725|11435880|FG001|STARTED|Overall Study||106
10303000|NCT00075725|11435881|FG002|STARTED|Overall Study||296
10303001|NCT00075725|11435882|FG003|STARTED|Overall Study||246
10303002|NCT00075725|11435883|FG004|STARTED|Overall Study||232
10654955|NCT02206607|11815795|FG000|STARTED|First Intervention Period||0
10303003|NCT00075725|11435884|FG005|STARTED|Overall Study||710
10303004|NCT00075725|11435885|FG006|STARTED|Overall Study||246
10303005|NCT00075725|11435886|FG007|STARTED|Overall Study||696
10303006|NCT00075725|11435887|FG008|STARTED|Overall Study||302
10303007|NCT00075725|11435888|FG009|STARTED|Overall Study||34
10529941|NCT01403090|11682322|FG000|NOT COMPLETED|Overall Study||0
10303008|NCT00075725|11435889|FG010|STARTED|Overall Study||12
10303009|NCT00075725|11435890|FG011|STARTED|Overall Study||28
10303010|NCT00075725|11435879|FG000|COMPLETED|Overall Study||172
10303011|NCT00075725|11435880|FG001|COMPLETED|Overall Study||57
10340189|NCT00378014|11477184|FG000|Intent-to-treat (ITT) Population|Core (Randomization to Month 11)|ITT contained all randomized patients who had at least one post baseline GFR measurement.|96
10340190|NCT00378014|11477185|FG001|Intent-to-treat (ITT) Population|Core (Randomization to Month 11)|ITT contained all randomized patients who had at least one post baseline GFR measurement.|98
10340191|NCT00378014|11477184|FG000|COMPLETED|Core (Randomization to Month 11)||87
10340192|NCT00378014|11477185|FG001|COMPLETED|Core (Randomization to Month 11)||90
10340193|NCT00378014|11477184|FG000|NOT COMPLETED|Core (Randomization to Month 11)||14
10303012|NCT00075725|11435881|FG002|COMPLETED|Overall Study||175
10303013|NCT00075725|11435882|FG003|COMPLETED|Overall Study||168
10303014|NCT00075725|11435883|FG004|COMPLETED|Overall Study||166
10303015|NCT00075725|11435884|FG005|COMPLETED|Overall Study||397
10303016|NCT00075725|11435885|FG006|COMPLETED|Overall Study||171
10303017|NCT00075725|11435886|FG007|COMPLETED|Overall Study||401
10303018|NCT00075725|11435887|FG008|COMPLETED|Overall Study||185
10303019|NCT00075725|11435888|FG009|COMPLETED|Overall Study||16
10303020|NCT00075725|11435889|FG010|COMPLETED|Overall Study||3
10303021|NCT00075725|11435890|FG011|COMPLETED|Overall Study||10
10303022|NCT00075725|11435879|FG000|NOT COMPLETED|Overall Study||74
10303023|NCT00075725|11435880|FG001|NOT COMPLETED|Overall Study||49
10303024|NCT00075725|11435881|FG002|NOT COMPLETED|Overall Study||121
10303025|NCT00075725|11435882|FG003|NOT COMPLETED|Overall Study||78
10303026|NCT00075725|11435883|FG004|NOT COMPLETED|Overall Study||66
10303027|NCT00075725|11435884|FG005|NOT COMPLETED|Overall Study||313
10303028|NCT00075725|11435885|FG006|NOT COMPLETED|Overall Study||75
10303029|NCT00075725|11435886|FG007|NOT COMPLETED|Overall Study||295
10303030|NCT00075725|11435887|FG008|NOT COMPLETED|Overall Study||117
10303031|NCT00075725|11435888|FG009|NOT COMPLETED|Overall Study||18
10303032|NCT00075725|11435889|FG010|NOT COMPLETED|Overall Study||9
10303033|NCT00075725|11435890|FG011|NOT COMPLETED|Overall Study||18
10303034|NCT00075764|11435923|FG000|STARTED|Overall Study||345
10303035|NCT00075764|11435924|FG001|STARTED|Overall Study||349
10303036|NCT00075764|11435923|FG000|COMPLETED|Overall Study||0
10303037|NCT00075764|11435924|FG001|COMPLETED|Overall Study||0
10303038|NCT00075764|11435923|FG000|NOT COMPLETED|Overall Study||345
10303039|NCT00075764|11435924|FG001|NOT COMPLETED|Overall Study||349
10303040|NCT00075803|11435934|FG000|STARTED|Overall Study||295
10303041|NCT00075803|11435935|FG001|STARTED|Overall Study||305
10303042|NCT00075803|11435934|FG000|COMPLETED|Overall Study||295
10303043|NCT00075803|11435935|FG001|COMPLETED|Overall Study||305
10303044|NCT00075803|11435934|FG000|NOT COMPLETED|Overall Study||0
10303045|NCT00075803|11435935|FG001|NOT COMPLETED|Overall Study||0
10303046|NCT00075816|11435943|FG000|STARTED|Overall Study||278
10303047|NCT00075816|11435944|FG001|STARTED|Overall Study||273
10303048|NCT00075816|11435943|FG000|COMPLETED|Overall Study||264
10303049|NCT00075816|11435944|FG001|COMPLETED|Overall Study||262
10303050|NCT00075816|11435943|FG000|NOT COMPLETED|Overall Study||14
10303051|NCT00075816|11435944|FG001|NOT COMPLETED|Overall Study||11
10303052|NCT00075829|11435956|FG000|STARTED|Overall Study||436
10303053|NCT00075829|11435957|FG001|STARTED|Overall Study||189
10303054|NCT00075829|11435958|FG002|STARTED|Overall Study||48
10303055|NCT00075829|11435959|FG003|STARTED|Overall Study||37
10303056|NCT00075829|11435956|FG000|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|178
10303057|NCT00075829|11435957|FG001|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|71
10303058|NCT00075829|11435958|FG002|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|14
10303059|NCT00075829|11435959|FG003|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|13
10303060|NCT00075829|11435956|FG000|NOT COMPLETED|Overall Study||258
10303061|NCT00075829|11435957|FG001|NOT COMPLETED|Overall Study||118
10303062|NCT00075829|11435958|FG002|NOT COMPLETED|Overall Study||34
10303063|NCT00075829|11435959|FG003|NOT COMPLETED|Overall Study||24
10303064|NCT00075881|11435972|FG000|STARTED|Overall Study||44
10303065|NCT00075881|11435972|FG000|Eligible|Overall Study||43
10303066|NCT00075881|11435972|FG000|Treated|Overall Study||42
10303067|NCT00075881|11435972|FG000|Induction Treatment|Overall Study||42
10303068|NCT00075881|11435972|FG000|Maintenance Treatment|Overall Study||15
10303069|NCT00075881|11435972|FG000|Reinduction Treatment|Overall Study||7
10303070|NCT00075881|11435972|FG000|COMPLETED|Overall Study||1
10303071|NCT00075881|11435972|FG000|NOT COMPLETED|Overall Study||43
10303072|NCT00076011|11435978|FG000|STARTED|Overall Study||52
10303073|NCT00076011|11435978|FG000|COMPLETED|Overall Study||0
10340194|NCT00378014|11477185|FG001|NOT COMPLETED|Core (Randomization to Month 11)||12
10303074|NCT00076011|11435978|FG000|NOT COMPLETED|Overall Study||52
10303075|NCT00076024|11435985|FG000|STARTED|Phase 1, Lead-in||6
10303076|NCT00076024|11435986|FG001|STARTED|Phase 1, Lead-in||0
10303077|NCT00076024|11435987|FG002|STARTED|Phase 1, Lead-in||0
10303078|NCT00076024|11435988|FG003|STARTED|Phase 1, Lead-in||0
10303079|NCT00076024|11435985|FG000|COMPLETED|Phase 1, Lead-in||0
10303080|NCT00076024|11435986|FG001|COMPLETED|Phase 1, Lead-in||0
10303081|NCT00076024|11435987|FG002|COMPLETED|Phase 1, Lead-in||0
10303082|NCT00076024|11435988|FG003|COMPLETED|Phase 1, Lead-in||0
10303083|NCT00076024|11435985|FG000|NOT COMPLETED|Phase 1, Lead-in||6
10303084|NCT00076024|11435986|FG001|NOT COMPLETED|Phase 1, Lead-in||0
10303085|NCT00076024|11435987|FG002|NOT COMPLETED|Phase 1, Lead-in||0
10303086|NCT00076024|11435988|FG003|NOT COMPLETED|Phase 1, Lead-in||0
10303087|NCT00076024|11435985|FG000|STARTED|Phase 2, Double-blind||0
10303088|NCT00076024|11435986|FG001|STARTED|Phase 2, Double-blind||112
10303089|NCT00076024|11435987|FG002|STARTED|Phase 2, Double-blind||56
10303090|NCT00076024|11435988|FG003|STARTED|Phase 2, Double-blind||0
10303091|NCT00076024|11435985|FG000|Treated|Phase 2, Double-blind||0
10303092|NCT00076024|11435986|FG001|Treated|Phase 2, Double-blind||111
10340195|NCT00378014|11477184|FG000|STARTED|Extension (Month 12 to Month 59)||41
10340196|NCT00378014|11477185|FG001|STARTED|Extension (Month 12 to Month 59)||40
10340197|NCT00378014|11477184|FG000|COMPLETED|Extension (Month 12 to Month 59)||27
10340198|NCT00378014|11477185|FG001|COMPLETED|Extension (Month 12 to Month 59)||26
10340199|NCT00378014|11477184|FG000|NOT COMPLETED|Extension (Month 12 to Month 59)||14
10340200|NCT00378014|11477185|FG001|NOT COMPLETED|Extension (Month 12 to Month 59)||14
10340201|NCT00378079|11477196|FG000|STARTED|Overall Study||70
10340202|NCT00378079|11477197|FG001|STARTED|Overall Study||70
10340203|NCT00378079|11477198|FG002|STARTED|Overall Study||71
10340204|NCT00378079|11477196|FG000|COMPLETED|Overall Study||64
10340205|NCT00378079|11477197|FG001|COMPLETED|Overall Study||69
10340206|NCT00378079|11477198|FG002|COMPLETED|Overall Study||71
10340207|NCT00378079|11477196|FG000|NOT COMPLETED|Overall Study||6
10340208|NCT00378079|11477197|FG001|NOT COMPLETED|Overall Study||1
10340209|NCT00378079|11477198|FG002|NOT COMPLETED|Overall Study||0
10340210|NCT00378105|11477208|FG000|STARTED|Overall Study|Out of 33 enrolled, two patients went off study before start of therapy.|31
10340211|NCT00378105|11477209|FG001|STARTED|Overall Study||35
10340212|NCT00378105|11477208|FG000|COMPLETED|Overall Study||11
10529942|NCT01403116|11682328|FG000|STARTED|Overall Study||161
10529943|NCT01403116|11682329|FG001|STARTED|Overall Study||160
10529944|NCT01403116|11682328|FG000|Randomized|Overall Study||162
10529945|NCT01403116|11682329|FG001|Randomized|Overall Study||163
10529946|NCT01403116|11682328|FG000|Randomized in Error/ No Treatment Recvd|Overall Study||1
10529947|NCT01403116|11682329|FG001|Randomized in Error/ No Treatment Recvd|Overall Study||3
10529948|NCT01403116|11682328|FG000|COMPLETED|Overall Study||129
10529949|NCT01403116|11682329|FG001|COMPLETED|Overall Study||133
10529950|NCT01403116|11682328|FG000|NOT COMPLETED|Overall Study||32
10529951|NCT01403116|11682329|FG001|NOT COMPLETED|Overall Study||27
10529952|NCT01403246|11682335|FG000|STARTED|Overall Study||9
10529953|NCT01403246|11682335|FG000|COMPLETED|Overall Study||9
10529954|NCT01403246|11682335|FG000|NOT COMPLETED|Overall Study||0
10529955|NCT01403376|11682342|FG000|STARTED|Overall Study||41
10529956|NCT01403376|11682343|FG001|STARTED|Overall Study||41
10529957|NCT01403376|11682344|FG002|STARTED|Overall Study||46
10529958|NCT01403376|11682342|FG000|COMPLETED|Overall Study||41
10529959|NCT01403376|11682343|FG001|COMPLETED|Overall Study||41
10529960|NCT01403376|11682344|FG002|COMPLETED|Overall Study||46
10529961|NCT01403376|11682342|FG000|NOT COMPLETED|Overall Study||0
10529962|NCT01403376|11682343|FG001|NOT COMPLETED|Overall Study||0
10529963|NCT01403376|11682344|FG002|NOT COMPLETED|Overall Study||0
10529964|NCT01403441|11682352|FG000|STARTED|Overall Study||3
10529965|NCT01403441|11682352|FG000|COMPLETED|Overall Study||3
10529966|NCT01403441|11682352|FG000|NOT COMPLETED|Overall Study||0
10529967|NCT01403584|11682358|FG000|STARTED|First Intervention (1 Night)||11
10529968|NCT01403584|11682359|FG001|STARTED|First Intervention (1 Night)||10
10529969|NCT01403584|11682358|FG000|COMPLETED|First Intervention (1 Night)||11
10529970|NCT01403584|11682359|FG001|COMPLETED|First Intervention (1 Night)||10
10529971|NCT01403584|11682358|FG000|NOT COMPLETED|First Intervention (1 Night)||0
10529972|NCT01403584|11682359|FG001|NOT COMPLETED|First Intervention (1 Night)||0
10529973|NCT01403584|11682358|FG000|STARTED|Second Intervention(1 Night)||10
10529974|NCT01403584|11682359|FG001|STARTED|Second Intervention(1 Night)||11
10529975|NCT01403584|11682358|FG000|COMPLETED|Second Intervention(1 Night)||10
10529976|NCT01403584|11682359|FG001|COMPLETED|Second Intervention(1 Night)||11
10529977|NCT01403584|11682358|FG000|NOT COMPLETED|Second Intervention(1 Night)||0
10529978|NCT01403584|11682359|FG001|NOT COMPLETED|Second Intervention(1 Night)||0
10529979|NCT01403610|11682369|FG000|STARTED|Overall Study||5
10529980|NCT01403610|11682370|FG001|STARTED|Overall Study||6
10529981|NCT01403610|11682371|FG002|STARTED|Overall Study||4
10303093|NCT00076024|11435987|FG002|Treated|Phase 2, Double-blind||56
10303094|NCT00076024|11435988|FG003|Treated|Phase 2, Double-blind||0
10340213|NCT00378105|11477209|FG001|COMPLETED|Overall Study||5
10340214|NCT00378105|11477208|FG000|NOT COMPLETED|Overall Study||20
10811889|NCT03743038|11973806|FG000|NOT COMPLETED|Overall Study||1
10811890|NCT03742973|11973814|FG000|STARTED|Overall Study||0
10811891|NCT03742973|11973815|FG001|STARTED|Overall Study||0
10811892|NCT03742973|11973814|FG000|COMPLETED|Overall Study||0
10811893|NCT03742973|11973815|FG001|COMPLETED|Overall Study||0
10811894|NCT03742973|11973814|FG000|NOT COMPLETED|Overall Study||0
10811895|NCT03742973|11973815|FG001|NOT COMPLETED|Overall Study||0
10811896|NCT03742440|11973821|FG000|STARTED|Overall Study||40
10811897|NCT03742440|11973821|FG000|COMPLETED|Overall Study||40
10714659|NCT02688387|11880052|FG009|STARTED|Part 1, Washout Period 2 (7 Days)||2
10714660|NCT02688387|11880053|FG010|STARTED|Part 1, Washout Period 2 (7 Days)||0
10714661|NCT02688387|11880054|FG011|STARTED|Part 1, Washout Period 2 (7 Days)||0
10714662|NCT02688387|11880055|FG012|STARTED|Part 1, Washout Period 2 (7 Days)||0
10714663|NCT02688387|11880056|FG013|STARTED|Part 1, Washout Period 2 (7 Days)||0
10714664|NCT02688387|11880057|FG014|STARTED|Part 1, Washout Period 2 (7 Days)||0
10714665|NCT02688387|11880058|FG015|STARTED|Part 1, Washout Period 2 (7 Days)||0
10811898|NCT03742440|11973821|FG000|NOT COMPLETED|Overall Study||0
10811899|NCT03742427|11973825|FG000|STARTED|Overall Study||50
10811900|NCT03742427|11973825|FG000|COMPLETED|Overall Study||50
10811901|NCT03742427|11973825|FG000|NOT COMPLETED|Overall Study||0
10811902|NCT03742271|11973829|FG000|STARTED|Overall Study||127
10811903|NCT03742271|11973829|FG000|COMPLETED|Overall Study||115
10811904|NCT03742271|11973829|FG000|NOT COMPLETED|Overall Study||12
10811905|NCT03742154|11973835|FG000|STARTED|Overall Study||50
10714666|NCT02688387|11880059|FG016|STARTED|Part 1, Washout Period 2 (7 Days)||0
10714667|NCT02688387|11880060|FG017|STARTED|Part 1, Washout Period 2 (7 Days)||0
10714668|NCT02688387|11880061|FG018|STARTED|Part 1, Washout Period 2 (7 Days)||0
10811906|NCT03742154|11973836|FG001|STARTED|Overall Study||49
10811907|NCT03742154|11973835|FG000|COMPLETED|Overall Study||50
10811908|NCT03742154|11973836|FG001|COMPLETED|Overall Study||49
10340215|NCT00378105|11477209|FG001|NOT COMPLETED|Overall Study||30
10426370|NCT00847288|11572028|FG001|COMPLETED|Overall Study||780
10714669|NCT02688387|11880062|FG019|STARTED|Part 1, Washout Period 2 (7 Days)||0
10714670|NCT02688387|11880063|FG020|STARTED|Part 1, Washout Period 2 (7 Days)||0
10714671|NCT02688387|11880064|FG021|STARTED|Part 1, Washout Period 2 (7 Days)||0
10714672|NCT02688387|11880043|FG000|COMPLETED|Part 1, Washout Period 2 (7 Days)||3
10714673|NCT02688387|11880044|FG001|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
10714674|NCT02688387|11880045|FG002|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
10714675|NCT02688387|11880046|FG003|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
10714676|NCT02688387|11880047|FG004|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
10714677|NCT02688387|11880048|FG005|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
10714678|NCT02688387|11880049|FG006|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
10714679|NCT02688387|11880050|FG007|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
10714680|NCT02688387|11880051|FG008|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
10714681|NCT02688387|11880052|FG009|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
10714682|NCT02688387|11880053|FG010|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10714683|NCT02688387|11880054|FG011|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10714684|NCT02688387|11880055|FG012|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10714685|NCT02688387|11880056|FG013|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10714686|NCT02688387|11880057|FG014|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10714687|NCT02688387|11880058|FG015|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10714688|NCT02688387|11880059|FG016|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10714689|NCT02688387|11880060|FG017|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10714690|NCT02688387|11880061|FG018|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10714691|NCT02688387|11880062|FG019|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10714692|NCT02688387|11880063|FG020|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10714693|NCT02688387|11880064|FG021|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10714694|NCT02688387|11880043|FG000|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10303170|NCT00076622|11436071|FG002|STARTED|Overall Study||40
10714695|NCT02688387|11880044|FG001|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10714696|NCT02688387|11880045|FG002|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10714697|NCT02688387|11880046|FG003|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10714698|NCT02688387|11880047|FG004|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10714699|NCT02688387|11880048|FG005|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10811909|NCT03742154|11973835|FG000|NOT COMPLETED|Overall Study||0
10811910|NCT03742154|11973836|FG001|NOT COMPLETED|Overall Study||0
10811911|NCT03741725|11973845|FG000|STARTED|Overall Study||101
10811912|NCT03741725|11973846|FG001|STARTED|Overall Study||100
10811913|NCT03741725|11973847|FG002|STARTED|Overall Study||100
10303095|NCT00076024|11435985|FG000|COMPLETED|Phase 2, Double-blind||0
10303096|NCT00076024|11435986|FG001|COMPLETED|Phase 2, Double-blind||0
10303097|NCT00076024|11435987|FG002|COMPLETED|Phase 2, Double-blind||0
10303098|NCT00076024|11435988|FG003|COMPLETED|Phase 2, Double-blind||0
10303099|NCT00076024|11435985|FG000|NOT COMPLETED|Phase 2, Double-blind||0
10303100|NCT00076024|11435986|FG001|NOT COMPLETED|Phase 2, Double-blind||112
10303101|NCT00076024|11435987|FG002|NOT COMPLETED|Phase 2, Double-blind||56
10303102|NCT00076024|11435988|FG003|NOT COMPLETED|Phase 2, Double-blind||0
10303103|NCT00076024|11435985|FG000|STARTED|Phase 2, Open-label||0
10303104|NCT00076024|11435986|FG001|STARTED|Phase 2, Open-label||0
10303105|NCT00076024|11435987|FG002|STARTED|Phase 2, Open-label||0
10303106|NCT00076024|11435988|FG003|STARTED|Phase 2, Open-label||16
10303107|NCT00076024|11435985|FG000|COMPLETED|Phase 2, Open-label||0
10303108|NCT00076024|11435986|FG001|COMPLETED|Phase 2, Open-label||0
10303109|NCT00076024|11435987|FG002|COMPLETED|Phase 2, Open-label||0
10303110|NCT00076024|11435988|FG003|COMPLETED|Phase 2, Open-label||0
10303111|NCT00076024|11435985|FG000|NOT COMPLETED|Phase 2, Open-label||0
10303112|NCT00076024|11435986|FG001|NOT COMPLETED|Phase 2, Open-label||0
10303113|NCT00076024|11435987|FG002|NOT COMPLETED|Phase 2, Open-label||0
10303114|NCT00076024|11435988|FG003|NOT COMPLETED|Phase 2, Open-label||16
10303115|NCT00076050|11435999|FG000|STARTED|Overall Study||122
10303116|NCT00076050|11436000|FG001|STARTED|Overall Study||126
10303117|NCT00076050|11435999|FG000|COMPLETED|Overall Study||99
10303118|NCT00076050|11436000|FG001|COMPLETED|Overall Study||83
10303119|NCT00076050|11435999|FG000|NOT COMPLETED|Overall Study||23
10303120|NCT00076050|11436000|FG001|NOT COMPLETED|Overall Study||43
10303121|NCT00076102|11436006|FG000|STARTED|Overall Study||36
10303122|NCT00076102|11436006|FG000|COMPLETED|Overall Study||31
10303123|NCT00076102|11436006|FG000|NOT COMPLETED|Overall Study||5
10303124|NCT00076219|11436014|FG000|STARTED|Overall Study||563
10303125|NCT00076219|11436015|FG001|STARTED|Overall Study||561
10303126|NCT00076219|11436014|FG000|COMPLETED|Overall Study||545
10303127|NCT00076219|11436015|FG001|COMPLETED|Overall Study||550
10303128|NCT00076219|11436014|FG000|NOT COMPLETED|Overall Study||18
10303129|NCT00076219|11436015|FG001|NOT COMPLETED|Overall Study||11
10303130|NCT00076245|11436025|FG000|STARTED|Overall Study||16
10303131|NCT00076245|11436026|FG001|STARTED|Overall Study||15
10303132|NCT00076245|11436027|FG002|STARTED|Overall Study||15
10303133|NCT00076245|11436028|FG003|STARTED|Overall Study||15
10303134|NCT00076245|11436025|FG000|COMPLETED|Overall Study||16
10303135|NCT00076245|11436026|FG001|COMPLETED|Overall Study||15
10303136|NCT00076245|11436027|FG002|COMPLETED|Overall Study||15
10303137|NCT00076245|11436028|FG003|COMPLETED|Overall Study||14
10303138|NCT00076245|11436025|FG000|NOT COMPLETED|Overall Study||0
10303139|NCT00076245|11436026|FG001|NOT COMPLETED|Overall Study||0
10303140|NCT00076245|11436027|FG002|NOT COMPLETED|Overall Study||0
10303141|NCT00076245|11436028|FG003|NOT COMPLETED|Overall Study||1
10303142|NCT00076258|11436040|FG000|STARTED|Overall Study||62
10303143|NCT00076258|11436041|FG001|STARTED|Overall Study||64
10303144|NCT00076258|11436040|FG000|COMPLETED|Overall Study||61
10303145|NCT00076258|11436041|FG001|COMPLETED|Overall Study||61
10303146|NCT00076258|11436040|FG000|NOT COMPLETED|Overall Study||1
10340216|NCT00378209|11477216|FG000|STARTED|Overall Study|1 patient who never started treatment was excluded in the analysis.|64
10303147|NCT00076258|11436041|FG001|NOT COMPLETED|Overall Study||3
10303148|NCT00076336|11436049|FG000|STARTED|Overall Study||116
10303149|NCT00076336|11436050|FG001|STARTED|Overall Study||116
10303150|NCT00076336|11436049|FG000|Safety Population|Overall Study|1 patient was randomized but never received study drug and not included in safety population.|115
10303151|NCT00076336|11436050|FG001|Safety Population|Overall Study||116
10303152|NCT00076336|11436049|FG000|Intent to Treat (ITT) Population|Overall Study|1 patient had no HBV DNA assessments after baseline and was excluded from ITT population.|114
10303153|NCT00076336|11436050|FG001|Intent to Treat (ITT) Population|Overall Study|2 patients had no HBV DNA assessments after baseline and were excluded from ITT population.|114
10303154|NCT00076336|11436049|FG000|Completed Week 52|Overall Study||97
10303155|NCT00076336|11436050|FG001|Completed Week 52|Overall Study||94
10303156|NCT00076336|11436049|FG000|Completed Week 104|Overall Study||70
10303157|NCT00076336|11436050|FG001|Completed Week 104|Overall Study||62
10303158|NCT00076336|11436049|FG000|COMPLETED|Overall Study||64
10303159|NCT00076336|11436050|FG001|COMPLETED|Overall Study||60
10303160|NCT00076336|11436049|FG000|NOT COMPLETED|Overall Study||52
10303161|NCT00076336|11436050|FG001|NOT COMPLETED|Overall Study||56
10303162|NCT00076570|11436058|FG000|STARTED|Overall Study||15
10303163|NCT00076570|11436059|FG001|STARTED|Overall Study||16
10303164|NCT00076570|11436058|FG000|COMPLETED|Overall Study||7
10303165|NCT00076570|11436059|FG001|COMPLETED|Overall Study||8
10303166|NCT00076570|11436058|FG000|NOT COMPLETED|Overall Study||8
10303167|NCT00076570|11436059|FG001|NOT COMPLETED|Overall Study||8
10303168|NCT00076622|11436069|FG000|STARTED|Overall Study||23
10303169|NCT00076622|11436070|FG001|STARTED|Overall Study||13
10303171|NCT00076622|11436072|FG003|STARTED|Overall Study||18
10303172|NCT00076622|11436069|FG000|COMPLETED|Overall Study||23
10303173|NCT00076622|11436070|FG001|COMPLETED|Overall Study||13
10303174|NCT00076622|11436071|FG002|COMPLETED|Overall Study||40
10303175|NCT00076622|11436072|FG003|COMPLETED|Overall Study||18
10303176|NCT00076622|11436069|FG000|NOT COMPLETED|Overall Study||0
10303177|NCT00076622|11436070|FG001|NOT COMPLETED|Overall Study||0
10303178|NCT00076622|11436071|FG002|NOT COMPLETED|Overall Study||0
10303179|NCT00076622|11436072|FG003|NOT COMPLETED|Overall Study||0
10303180|NCT00076687|11436089|FG000|STARTED|Overall Study||48
10303181|NCT00076687|11436090|FG001|STARTED|Overall Study||52
10303182|NCT00076687|11436091|FG002|STARTED|Overall Study||55
10303183|NCT00076687|11436089|FG000|COMPLETED|Overall Study||42
10303184|NCT00076687|11436090|FG001|COMPLETED|Overall Study||47
10303185|NCT00076687|11436091|FG002|COMPLETED|Overall Study||51
10303186|NCT00076687|11436089|FG000|NOT COMPLETED|Overall Study||6
10303187|NCT00076687|11436090|FG001|NOT COMPLETED|Overall Study||5
10303188|NCT00076687|11436091|FG002|NOT COMPLETED|Overall Study||4
10303189|NCT00076752|11436099|FG000|STARTED|Overall Study||9
10303190|NCT00076752|11436099|FG000|COMPLETED|Overall Study||6
10303191|NCT00076752|11436099|FG000|NOT COMPLETED|Overall Study||3
10303192|NCT00076804|11436106|FG000|STARTED|Overall Study||137
10303193|NCT00076804|11436107|FG001|STARTED|Overall Study||137
10303194|NCT00076804|11436106|FG000|COMPLETED|Overall Study|111 completed week 48, 77 completed week 96.|77
10303195|NCT00076804|11436107|FG001|COMPLETED|Overall Study|102 completed week 48, 68 completed week 96|68
10303196|NCT00076804|11436106|FG000|NOT COMPLETED|Overall Study||60
10303197|NCT00076804|11436107|FG001|NOT COMPLETED|Overall Study||69
10303198|NCT00076999|11436117|FG000|STARTED|Overall Study||25
10303199|NCT00076999|11436118|FG001|STARTED|Overall Study||31
10303200|NCT00076999|11436119|FG002|STARTED|Overall Study||19
10303201|NCT00076999|11436120|FG003|STARTED|Overall Study||6
10303202|NCT00076999|11436121|FG004|STARTED|Overall Study||34
10303203|NCT00076999|11436117|FG000|COMPLETED|Overall Study||13
10303204|NCT00076999|11436118|FG001|COMPLETED|Overall Study||7
10303205|NCT00076999|11436119|FG002|COMPLETED|Overall Study||2
10303206|NCT00076999|11436120|FG003|COMPLETED|Overall Study||5
10303207|NCT00076999|11436121|FG004|COMPLETED|Overall Study||9
10303208|NCT00076999|11436117|FG000|NOT COMPLETED|Overall Study||12
10303209|NCT00076999|11436118|FG001|NOT COMPLETED|Overall Study||24
10303210|NCT00076999|11436119|FG002|NOT COMPLETED|Overall Study||17
10303211|NCT00076999|11436120|FG003|NOT COMPLETED|Overall Study||1
10303212|NCT00076999|11436121|FG004|NOT COMPLETED|Overall Study||25
10303213|NCT00077064|11436136|FG000|STARTED|Overall Study||17
10303214|NCT00077064|11436137|FG001|STARTED|Overall Study||16
10303215|NCT00077064|11436136|FG000|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|17
10303216|NCT00077064|11436137|FG001|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|10
10303217|NCT00077064|11436136|FG000|NOT COMPLETED|Overall Study||0
10303218|NCT00077064|11436137|FG001|NOT COMPLETED|Overall Study||6
10303219|NCT00077207|11436144|FG000|STARTED|Overall Study||66
10303220|NCT00077207|11436144|FG000|COMPLETED|Overall Study||36
10303221|NCT00077207|11436144|FG000|NOT COMPLETED|Overall Study||30
10340217|NCT00378209|11477216|FG000|COMPLETED|Overall Study|This included patients who completed at least 8 cycles of combination therapy with all drugs.|42
10303222|NCT00077376|11436149|FG000|STARTED|Overall Study||61
10303223|NCT00077376|11436149|FG000|Treated|Overall Study||59
10303224|NCT00077376|11436149|FG000|HER2+ in Central Testing|Overall Study||39
10714700|NCT02688387|11880049|FG006|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10303225|NCT00077376|11436149|FG000|COMPLETED|Overall Study||39
10303226|NCT00077376|11436149|FG000|NOT COMPLETED|Overall Study||22
10303227|NCT00077610|11436156|FG000|STARTED|Overall Study||223
10303228|NCT00077610|11436157|FG001|STARTED|Overall Study||224
10303229|NCT00077610|11436158|FG002|STARTED|Overall Study||226
10303230|NCT00077610|11436156|FG000|Started Treatment|Overall Study||221
10303231|NCT00077610|11436157|FG001|Started Treatment|Overall Study||220
10303232|NCT00077610|11436158|FG002|Started Treatment|Overall Study||225
10303233|NCT00077610|11436156|FG000|COMPLETED|Overall Study||169
10303234|NCT00077610|11436157|FG001|COMPLETED|Overall Study||168
10303235|NCT00077610|11436158|FG002|COMPLETED|Overall Study||180
10303236|NCT00077610|11436156|FG000|NOT COMPLETED|Overall Study||54
10303237|NCT00077610|11436157|FG001|NOT COMPLETED|Overall Study||56
10303238|NCT00077610|11436158|FG002|NOT COMPLETED|Overall Study||46
10303239|NCT00077623|11436174|FG000|STARTED|Overall Study||190
10303240|NCT00077623|11436175|FG001|STARTED|Overall Study||191
10303241|NCT00077623|11436176|FG002|STARTED|Overall Study||191
10303242|NCT00077623|11436174|FG000|COMPLETED|Overall Study||154
10303243|NCT00077623|11436175|FG001|COMPLETED|Overall Study||148
10303244|NCT00077623|11436176|FG002|COMPLETED|Overall Study||159
10303245|NCT00077623|11436174|FG000|NOT COMPLETED|Overall Study||36
10303246|NCT00077623|11436175|FG001|NOT COMPLETED|Overall Study||43
10303247|NCT00077623|11436176|FG002|NOT COMPLETED|Overall Study||32
10303248|NCT00077636|11436186|FG000|STARTED|Overall Study||736
10303249|NCT00077636|11436187|FG001|STARTED|Overall Study||733
10303250|NCT00077636|11436186|FG000|COMPLETED|Overall Study||692
10529982|NCT01403610|11682372|FG003|STARTED|Overall Study||13
10529983|NCT01403610|11682369|FG000|COMPLETED|Overall Study||3
10529984|NCT01403610|11682370|FG001|COMPLETED|Overall Study||3
10529985|NCT01403610|11682371|FG002|COMPLETED|Overall Study||4
10654956|NCT02206607|11815796|FG001|STARTED|First Intervention Period||9
10654957|NCT02206607|11815797|FG002|STARTED|First Intervention Period||9
10654958|NCT02206607|11815798|FG003|STARTED|First Intervention Period||11
10654959|NCT02206607|11815799|FG004|STARTED|First Intervention Period||10
10654960|NCT02206607|11815795|FG000|COMPLETED|First Intervention Period||0
10303251|NCT00077636|11436187|FG001|COMPLETED|Overall Study||641
10303252|NCT00077636|11436186|FG000|NOT COMPLETED|Overall Study||44
10303253|NCT00077636|11436187|FG001|NOT COMPLETED|Overall Study||92
10303254|NCT00077649|11436198|FG000|STARTED|Overall Study||47
10303255|NCT00077649|11436199|FG001|STARTED|Overall Study||47
10303256|NCT00077649|11436200|FG002|STARTED|Overall Study||47
10303257|NCT00077649|11436201|FG003|STARTED|Overall Study||47
10303258|NCT00077649|11436198|FG000|Completed 24 Weeks of Follow-up|Overall Study||36
10303259|NCT00077649|11436199|FG001|Completed 24 Weeks of Follow-up|Overall Study||40
10303260|NCT00077649|11436200|FG002|Completed 24 Weeks of Follow-up|Overall Study||36
10303261|NCT00077649|11436201|FG003|Completed 24 Weeks of Follow-up|Overall Study||31
10303262|NCT00077649|11436198|FG000|COMPLETED|Overall Study||33
10303263|NCT00077649|11436199|FG001|COMPLETED|Overall Study||38
10303264|NCT00077649|11436200|FG002|COMPLETED|Overall Study||32
10303265|NCT00077649|11436201|FG003|COMPLETED|Overall Study||30
10303266|NCT00077649|11436198|FG000|NOT COMPLETED|Overall Study||14
10303267|NCT00077649|11436199|FG001|NOT COMPLETED|Overall Study||9
10303268|NCT00077649|11436200|FG002|NOT COMPLETED|Overall Study||15
10303269|NCT00077649|11436201|FG003|NOT COMPLETED|Overall Study||17
10303270|NCT00077675|11436217|FG000|STARTED|Overall Study||103
10303271|NCT00077675|11436218|FG001|STARTED|Overall Study||98
10303272|NCT00077675|11436217|FG000|COMPLETED|Overall Study||92
10303273|NCT00077675|11436218|FG001|COMPLETED|Overall Study||89
10303274|NCT00077675|11436217|FG000|NOT COMPLETED|Overall Study||11
10303275|NCT00077675|11436218|FG001|NOT COMPLETED|Overall Study||9
10303276|NCT00077766|11436226|FG000|STARTED|Overall Study||157
10303277|NCT00077766|11436227|FG001|STARTED|Overall Study||156
10303278|NCT00077766|11436226|FG000|COMPLETED|Overall Study||118
10303279|NCT00077766|11436227|FG001|COMPLETED|Overall Study||131
10303280|NCT00077766|11436226|FG000|NOT COMPLETED|Overall Study||39
10303281|NCT00077766|11436227|FG001|NOT COMPLETED|Overall Study||25
10529986|NCT01403610|11682372|FG003|COMPLETED|Overall Study||13
10654961|NCT02206607|11815796|FG001|COMPLETED|First Intervention Period||9
10654962|NCT02206607|11815797|FG002|COMPLETED|First Intervention Period||9
10654963|NCT02206607|11815798|FG003|COMPLETED|First Intervention Period||11
10654964|NCT02206607|11815799|FG004|COMPLETED|First Intervention Period||10
10529987|NCT01403610|11682369|FG000|NOT COMPLETED|Overall Study||2
10529988|NCT01403610|11682370|FG001|NOT COMPLETED|Overall Study||3
10303282|NCT00077857|11436236|FG000|STARTED|Overall Study||235
10303283|NCT00077857|11436237|FG001|STARTED|Overall Study||235
10303284|NCT00077857|11436236|FG000|Received Study Drug|Overall Study||231
10303285|NCT00077857|11436237|FG001|Received Study Drug|Overall Study||234
10303286|NCT00077857|11436236|FG000|Safety Population: Actual Dose Received|Overall Study|14 patients in the 1250 dose arm received a lower dose and were included in the 825 arm for Safety.|217
10303287|NCT00077857|11436237|FG001|Safety Population: Actual Dose Received|Overall Study||248
10303288|NCT00077857|11436236|FG000|COMPLETED|Overall Study||34
10303289|NCT00077857|11436237|FG001|COMPLETED|Overall Study||31
10303290|NCT00077857|11436236|FG000|NOT COMPLETED|Overall Study||201
10303291|NCT00077857|11436237|FG001|NOT COMPLETED|Overall Study||204
10303292|NCT00077922|11436243|FG000|STARTED|Overall Study||15
10303293|NCT00077922|11436243|FG000|COMPLETED|Overall Study||15
10303294|NCT00077922|11436243|FG000|NOT COMPLETED|Overall Study||0
10303295|NCT00077974|11436247|FG000|STARTED|Overall Study||106
10303296|NCT00077974|11436247|FG000|COMPLETED|Overall Study||2
10303297|NCT00077974|11436247|FG000|NOT COMPLETED|Overall Study||104
10303298|NCT00078286|11436253|FG000|STARTED|Overall Study||234
10303299|NCT00078286|11436254|FG001|STARTED|Overall Study||235
10303300|NCT00078286|11436253|FG000|COMPLETED|Overall Study||138
10303301|NCT00078286|11436254|FG001|COMPLETED|Overall Study||152
10303302|NCT00078286|11436253|FG000|NOT COMPLETED|Overall Study||96
10303303|NCT00078286|11436254|FG001|NOT COMPLETED|Overall Study||83
10303304|NCT00078312|11436260|FG000|STARTED|Overall Study||328
10303305|NCT00078312|11436260|FG000|COMPLETED|Overall Study||151
10303306|NCT00078312|11436260|FG000|NOT COMPLETED|Overall Study||177
10303307|NCT00078325|11436267|FG000|STARTED|Overall Study||131
10303308|NCT00078325|11436268|FG001|STARTED|Overall Study||133
10303309|NCT00078325|11436269|FG002|STARTED|Overall Study||131
10303310|NCT00078325|11436267|FG000|COMPLETED|Overall Study||110
10303311|NCT00078325|11436268|FG001|COMPLETED|Overall Study||114
10303312|NCT00078325|11436269|FG002|COMPLETED|Overall Study||120
10303313|NCT00078325|11436267|FG000|NOT COMPLETED|Overall Study||21
10303314|NCT00078325|11436268|FG001|NOT COMPLETED|Overall Study||19
10303315|NCT00078325|11436269|FG002|NOT COMPLETED|Overall Study||11
10303316|NCT00078338|11436279|FG000|STARTED|Overall Study||386
10303317|NCT00078338|11436280|FG001|STARTED|Overall Study||378
10303318|NCT00078338|11436279|FG000|Safety Population|Overall Study|Safety population=subjects who received at least 1 dose of treatment and had followup safety data.|381
10303319|NCT00078338|11436280|FG001|Safety Population|Overall Study|Safety population=subjects who received at least 1 dose of treatment and had followup safety data.|375
10303320|NCT00078338|11436279|FG000|COMPLETED|Overall Study||301
10303321|NCT00078338|11436280|FG001|COMPLETED|Overall Study||324
10529989|NCT01403610|11682371|FG002|NOT COMPLETED|Overall Study||0
10529990|NCT01403610|11682372|FG003|NOT COMPLETED|Overall Study||0
10529991|NCT01403805|11682384|FG000|STARTED|Overall Study||94
10529992|NCT01403805|11682385|FG001|STARTED|Overall Study||105
10529993|NCT01403805|11682384|FG000|Pneumonia Diagnosis|Overall Study||21
10303322|NCT00078338|11436279|FG000|NOT COMPLETED|Overall Study||85
10303323|NCT00078338|11436280|FG001|NOT COMPLETED|Overall Study||54
10303324|NCT00078377|11436289|FG000|STARTED|Overall Study||67
10303325|NCT00078377|11436290|FG001|STARTED|Overall Study||65
10303326|NCT00078377|11436291|FG002|STARTED|Overall Study||64
10529994|NCT01403805|11682385|FG001|Pneumonia Diagnosis|Overall Study||2
10529995|NCT01403805|11682384|FG000|COMPLETED|Overall Study||94
10303327|NCT00078377|11436289|FG000|COMPLETED|Overall Study||56
10303328|NCT00078377|11436290|FG001|COMPLETED|Overall Study||49
10303329|NCT00078377|11436291|FG002|COMPLETED|Overall Study||55
10303330|NCT00078377|11436289|FG000|NOT COMPLETED|Overall Study||11
10303331|NCT00078377|11436290|FG001|NOT COMPLETED|Overall Study||16
10303332|NCT00078377|11436291|FG002|NOT COMPLETED|Overall Study||9
10315111|NCT00174382|11448896|FG000|COMPLETED|Overall Study||116
10714701|NCT02688387|11880050|FG007|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10714702|NCT02688387|11880051|FG008|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10714703|NCT02688387|11880052|FG009|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10714704|NCT02688387|11880053|FG010|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10714705|NCT02688387|11880054|FG011|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10714706|NCT02688387|11880055|FG012|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10714707|NCT02688387|11880056|FG013|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10714708|NCT02688387|11880057|FG014|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10714709|NCT02688387|11880058|FG015|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10714710|NCT02688387|11880059|FG016|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10714711|NCT02688387|11880060|FG017|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10714712|NCT02688387|11880061|FG018|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10714713|NCT02688387|11880062|FG019|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10714714|NCT02688387|11880063|FG020|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10714715|NCT02688387|11880064|FG021|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10714716|NCT02688387|11880043|FG000|STARTED|Part 1, Period 3 (up to 6 Days)||3
10714717|NCT02688387|11880044|FG001|STARTED|Part 1, Period 3 (up to 6 Days)||2
10714718|NCT02688387|11880045|FG002|STARTED|Part 1, Period 3 (up to 6 Days)||2
10714719|NCT02688387|11880046|FG003|STARTED|Part 1, Period 3 (up to 6 Days)||2
10714720|NCT02688387|11880047|FG004|STARTED|Part 1, Period 3 (up to 6 Days)||2
10714721|NCT02688387|11880048|FG005|STARTED|Part 1, Period 3 (up to 6 Days)||2
10714722|NCT02688387|11880049|FG006|STARTED|Part 1, Period 3 (up to 6 Days)||2
10714723|NCT02688387|11880050|FG007|STARTED|Part 1, Period 3 (up to 6 Days)||2
10714724|NCT02688387|11880051|FG008|STARTED|Part 1, Period 3 (up to 6 Days)||2
10714725|NCT02688387|11880052|FG009|STARTED|Part 1, Period 3 (up to 6 Days)||2
10714726|NCT02688387|11880053|FG010|STARTED|Part 1, Period 3 (up to 6 Days)||0
10714727|NCT02688387|11880054|FG011|STARTED|Part 1, Period 3 (up to 6 Days)||0
10714728|NCT02688387|11880055|FG012|STARTED|Part 1, Period 3 (up to 6 Days)||0
10714729|NCT02688387|11880056|FG013|STARTED|Part 1, Period 3 (up to 6 Days)||0
10714730|NCT02688387|11880057|FG014|STARTED|Part 1, Period 3 (up to 6 Days)||0
10714731|NCT02688387|11880058|FG015|STARTED|Part 1, Period 3 (up to 6 Days)||0
10714732|NCT02688387|11880059|FG016|STARTED|Part 1, Period 3 (up to 6 Days)||0
10714733|NCT02688387|11880060|FG017|STARTED|Part 1, Period 3 (up to 6 Days)||0
10714734|NCT02688387|11880061|FG018|STARTED|Part 1, Period 3 (up to 6 Days)||0
10714735|NCT02688387|11880062|FG019|STARTED|Part 1, Period 3 (up to 6 Days)||0
10714736|NCT02688387|11880063|FG020|STARTED|Part 1, Period 3 (up to 6 Days)||0
10714737|NCT02688387|11880064|FG021|STARTED|Part 1, Period 3 (up to 6 Days)||0
10714738|NCT02688387|11880043|FG000|COMPLETED|Part 1, Period 3 (up to 6 Days)||3
10714739|NCT02688387|11880044|FG001|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
10714740|NCT02688387|11880045|FG002|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
10714741|NCT02688387|11880046|FG003|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
10714742|NCT02688387|11880047|FG004|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
10714743|NCT02688387|11880048|FG005|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
10714744|NCT02688387|11880049|FG006|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
10714745|NCT02688387|11880050|FG007|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
10714746|NCT02688387|11880051|FG008|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
10714747|NCT02688387|11880052|FG009|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
10714748|NCT02688387|11880053|FG010|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10714749|NCT02688387|11880054|FG011|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10714750|NCT02688387|11880055|FG012|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10714751|NCT02688387|11880056|FG013|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10714752|NCT02688387|11880057|FG014|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10811914|NCT03741725|11973845|FG000|COMPLETED|Overall Study||101
10811915|NCT03741725|11973846|FG001|COMPLETED|Overall Study||100
10811916|NCT03741725|11973847|FG002|COMPLETED|Overall Study||100
10811917|NCT03741725|11973845|FG000|NOT COMPLETED|Overall Study||0
10811918|NCT03741725|11973846|FG001|NOT COMPLETED|Overall Study||0
10811919|NCT03741725|11973847|FG002|NOT COMPLETED|Overall Study||0
10811920|NCT03741088|11973858|FG000|STARTED|Overall Study||8
10811921|NCT03741088|11973858|FG000|COMPLETED|Overall Study||5
10811922|NCT03741088|11973858|FG000|NOT COMPLETED|Overall Study||3
10811923|NCT03741062|11973864|FG000|STARTED|Overall Study||5
10811924|NCT03741062|11973865|FG001|STARTED|Overall Study||6
10714753|NCT02688387|11880058|FG015|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10714754|NCT02688387|11880059|FG016|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10714755|NCT02688387|11880060|FG017|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10714756|NCT02688387|11880061|FG018|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10714757|NCT02688387|11880062|FG019|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10714758|NCT02688387|11880063|FG020|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10714759|NCT02688387|11880064|FG021|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10714760|NCT02688387|11880043|FG000|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10714761|NCT02688387|11880044|FG001|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10714762|NCT02688387|11880045|FG002|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10714763|NCT02688387|11880046|FG003|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10714764|NCT02688387|11880047|FG004|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10714765|NCT02688387|11880048|FG005|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10714766|NCT02688387|11880049|FG006|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10714767|NCT02688387|11880050|FG007|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10714768|NCT02688387|11880051|FG008|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10714769|NCT02688387|11880052|FG009|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10714770|NCT02688387|11880053|FG010|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10811925|NCT03741062|11973864|FG000|COMPLETED|Overall Study||4
10811926|NCT03741062|11973865|FG001|COMPLETED|Overall Study||6
10811927|NCT03741062|11973864|FG000|NOT COMPLETED|Overall Study||1
10811928|NCT03741062|11973865|FG001|NOT COMPLETED|Overall Study||0
10811929|NCT03740659|11973874|FG000|STARTED|Overall Study||42
10811930|NCT03740659|11973875|FG001|STARTED|Overall Study||42
10811931|NCT03740659|11973876|FG002|STARTED|Overall Study||41
10811932|NCT03740659|11973874|FG000|COMPLETED|Overall Study||42
10811933|NCT03740659|11973875|FG001|COMPLETED|Overall Study||42
10811934|NCT03740659|11973876|FG002|COMPLETED|Overall Study||41
10714771|NCT02688387|11880054|FG011|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10714772|NCT02688387|11880055|FG012|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10714773|NCT02688387|11880056|FG013|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10714774|NCT02688387|11880057|FG014|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10714775|NCT02688387|11880058|FG015|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10714776|NCT02688387|11880059|FG016|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10714777|NCT02688387|11880060|FG017|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10714778|NCT02688387|11880061|FG018|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10714779|NCT02688387|11880062|FG019|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10714780|NCT02688387|11880063|FG020|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10714781|NCT02688387|11880064|FG021|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
10714782|NCT02688387|11880043|FG000|STARTED|Part 1, Washout Period 3 (7 Days)||3
10714783|NCT02688387|11880044|FG001|STARTED|Part 1, Washout Period 3 (7 Days)||2
10714784|NCT02688387|11880045|FG002|STARTED|Part 1, Washout Period 3 (7 Days)||2
10811935|NCT03740659|11973874|FG000|NOT COMPLETED|Overall Study||0
10811936|NCT03740659|11973875|FG001|NOT COMPLETED|Overall Study||0
10811937|NCT03740659|11973876|FG002|NOT COMPLETED|Overall Study||0
10811938|NCT03740152|11973884|FG000|STARTED|Overall Study||10
10811939|NCT03740152|11973884|FG000|COMPLETED|Overall Study||10
10811940|NCT03740152|11973884|FG000|NOT COMPLETED|Overall Study||0
10811941|NCT03739866|11973896|FG000|STARTED|Overall Study||6
10811942|NCT03739866|11973897|FG001|STARTED|Overall Study||6
10811943|NCT03739866|11973898|FG002|STARTED|Overall Study||7
10811944|NCT03739866|11973899|FG003|STARTED|Overall Study||6
10811945|NCT03739866|11973900|FG004|STARTED|Overall Study||6
10811946|NCT03739866|11973901|FG005|STARTED|Overall Study||10
10811947|NCT03739866|11973902|FG006|STARTED|Overall Study||7
10811948|NCT03739866|11973903|FG007|STARTED|Overall Study||5
10811949|NCT03739866|11973896|FG000|COMPLETED|Overall Study||6
10811950|NCT03739866|11973897|FG001|COMPLETED|Overall Study||6
10811951|NCT03739866|11973898|FG002|COMPLETED|Overall Study||6
10811952|NCT03739866|11973899|FG003|COMPLETED|Overall Study||5
10811953|NCT03739866|11973900|FG004|COMPLETED|Overall Study||5
10811954|NCT03739866|11973901|FG005|COMPLETED|Overall Study||10
10714785|NCT02688387|11880046|FG003|STARTED|Part 1, Washout Period 3 (7 Days)||2
10714786|NCT02688387|11880047|FG004|STARTED|Part 1, Washout Period 3 (7 Days)||2
10714787|NCT02688387|11880048|FG005|STARTED|Part 1, Washout Period 3 (7 Days)||2
10811955|NCT03739866|11973902|FG006|COMPLETED|Overall Study||7
10811956|NCT03739866|11973903|FG007|COMPLETED|Overall Study||5
10811957|NCT03739866|11973896|FG000|NOT COMPLETED|Overall Study||0
10811958|NCT03739866|11973897|FG001|NOT COMPLETED|Overall Study||0
10811959|NCT03739866|11973898|FG002|NOT COMPLETED|Overall Study||1
10811960|NCT03739866|11973899|FG003|NOT COMPLETED|Overall Study||1
10811961|NCT03739866|11973900|FG004|NOT COMPLETED|Overall Study||1
10811962|NCT03739866|11973901|FG005|NOT COMPLETED|Overall Study||0
10811963|NCT03739866|11973902|FG006|NOT COMPLETED|Overall Study||0
10811964|NCT03739866|11973903|FG007|NOT COMPLETED|Overall Study||0
10811965|NCT03739684|11973925|FG000|STARTED|Overall Study||208
10811966|NCT03739684|11973925|FG000|COMPLETED|Overall Study||195
10811967|NCT03739684|11973925|FG000|NOT COMPLETED|Overall Study||13
10811968|NCT03739528|11973931|FG000|STARTED|Overall Study||403
10811969|NCT03739528|11973932|FG001|STARTED|Overall Study||405
10811970|NCT03739528|11973931|FG000|Received at Least One Treatment|Overall Study||395
10811971|NCT03739528|11973932|FG001|Received at Least One Treatment|Overall Study||393
10811972|NCT03739528|11973931|FG000|COMPLETED|Overall Study||388
10811973|NCT03739528|11973932|FG001|COMPLETED|Overall Study||388
10811974|NCT03739528|11973931|FG000|NOT COMPLETED|Overall Study||15
10811975|NCT03739528|11973932|FG001|NOT COMPLETED|Overall Study||17
10811976|NCT03739242|11973943|FG000|STARTED|Overall Study||44
10811977|NCT03739242|11973944|FG001|STARTED|Overall Study||44
10811978|NCT03739242|11973943|FG000|COMPLETED|Overall Study||43
10811979|NCT03739242|11973944|FG001|COMPLETED|Overall Study||42
10811980|NCT03739242|11973943|FG000|NOT COMPLETED|Overall Study||1
10811981|NCT03739242|11973944|FG001|NOT COMPLETED|Overall Study||2
10811982|NCT03738865|11973952|FG000|STARTED|Overall Study||66
10811983|NCT03738865|11973953|FG001|STARTED|Overall Study||66
10811984|NCT03738865|11973952|FG000|COMPLETED|Overall Study||61
10811985|NCT03738865|11973953|FG001|COMPLETED|Overall Study||62
10811986|NCT03738865|11973952|FG000|NOT COMPLETED|Overall Study||5
10811987|NCT03738865|11973953|FG001|NOT COMPLETED|Overall Study||4
10811988|NCT03738826|11973961|FG000|STARTED|Overall Study||130
10811989|NCT03738826|11973962|FG001|STARTED|Overall Study||5
10811990|NCT03738826|11973961|FG000|COMPLETED|Overall Study||130
10811991|NCT03738826|11973962|FG001|COMPLETED|Overall Study||5
10811992|NCT03738826|11973961|FG000|NOT COMPLETED|Overall Study||0
10811993|NCT03738826|11973962|FG001|NOT COMPLETED|Overall Study||0
10811994|NCT03738475|11973970|FG000|STARTED|Overall Study||16
10811995|NCT03738475|11973971|FG001|STARTED|Overall Study||18
10811996|NCT03738475|11973970|FG000|COMPLETED|Overall Study||15
10811997|NCT03738475|11973971|FG001|COMPLETED|Overall Study||18
10811998|NCT03738475|11973970|FG000|NOT COMPLETED|Overall Study||1
10811999|NCT03738475|11973971|FG001|NOT COMPLETED|Overall Study||0
10812000|NCT03738241|11973987|FG000|STARTED|Overall Study||38
10812001|NCT03738241|11973988|FG001|STARTED|Overall Study||40
10812002|NCT03738241|11973989|FG002|STARTED|Overall Study||24
10812003|NCT03738241|11973990|FG003|STARTED|Overall Study||18
10812004|NCT03738241|11973991|FG004|STARTED|Overall Study||40
10812005|NCT03738241|11973992|FG005|STARTED|Overall Study||44
10812006|NCT03738241|11973993|FG006|STARTED|Overall Study||20
10812007|NCT03738241|11973994|FG007|STARTED|Overall Study||16
10812008|NCT03738241|11973995|FG008|STARTED|Overall Study||29
10812009|NCT03738241|11973996|FG009|STARTED|Overall Study||35
10812010|NCT03738241|11973987|FG000|COMPLETED|Overall Study||37
10812011|NCT03738241|11973988|FG001|COMPLETED|Overall Study||40
10812012|NCT03738241|11973989|FG002|COMPLETED|Overall Study||24
10812013|NCT03738241|11973990|FG003|COMPLETED|Overall Study||18
10812014|NCT03738241|11973991|FG004|COMPLETED|Overall Study||40
10812015|NCT03738241|11973992|FG005|COMPLETED|Overall Study||44
10812016|NCT03738241|11973993|FG006|COMPLETED|Overall Study||20
10812017|NCT03738241|11973994|FG007|COMPLETED|Overall Study||16
10812018|NCT03738241|11973995|FG008|COMPLETED|Overall Study||28
10812019|NCT03738241|11973996|FG009|COMPLETED|Overall Study||34
10812020|NCT03738241|11973987|FG000|NOT COMPLETED|Overall Study||1
10812021|NCT03738241|11973988|FG001|NOT COMPLETED|Overall Study||0
10340218|NCT00378209|11477216|FG000|NOT COMPLETED|Overall Study||22
10340219|NCT00378326|11477221|FG000|STARTED|Overall Study||26
10340220|NCT00378326|11477221|FG000|COMPLETED|Overall Study||26
10340221|NCT00378326|11477221|FG000|NOT COMPLETED|Overall Study||0
10340222|NCT00378352|11477229|FG000|STARTED|Dose Escalation 15,000 Units||20
10340223|NCT00378352|11477230|FG001|STARTED|Dose Escalation 15,000 Units||0
10340224|NCT00378352|11477231|FG002|STARTED|Dose Escalation 15,000 Units||0
10340225|NCT00378352|11477232|FG003|STARTED|Dose Escalation 15,000 Units||11
10812022|NCT03738241|11973989|FG002|NOT COMPLETED|Overall Study||0
10812023|NCT03738241|11973990|FG003|NOT COMPLETED|Overall Study||0
10340226|NCT00378352|11477233|FG004|STARTED|Dose Escalation 15,000 Units||0
10340227|NCT00378352|11477234|FG005|STARTED|Dose Escalation 15,000 Units||0
10812024|NCT03738241|11973991|FG004|NOT COMPLETED|Overall Study||0
10812025|NCT03738241|11973992|FG005|NOT COMPLETED|Overall Study||0
10812026|NCT03738241|11973993|FG006|NOT COMPLETED|Overall Study||0
10812027|NCT03738241|11973994|FG007|NOT COMPLETED|Overall Study||0
10812028|NCT03738241|11973995|FG008|NOT COMPLETED|Overall Study||1
10812029|NCT03738241|11973996|FG009|NOT COMPLETED|Overall Study||1
10340228|NCT00378352|11477229|FG000|Safety Analysis|Dose Escalation 15,000 Units||19
10303333|NCT00078403|11436303|FG000|STARTED|Overall Study|Eligible at pre-assignment (40), direct (2), Arm C week 36 non-response (1), EVR inadvertently (1).|44
10303334|NCT00078403|11436304|FG001|STARTED|Overall Study|Eligible at pre-assignment (40), direct (1), Arm C week 36 non-response (1).|42
10303335|NCT00078403|11436305|FG002|STARTED|Overall Study||169
10303336|NCT00078403|11436303|FG000|COMPLETED|Overall Study||26
10303337|NCT00078403|11436304|FG001|COMPLETED|Overall Study||26
10303338|NCT00078403|11436305|FG002|COMPLETED|Overall Study||141
10303339|NCT00078403|11436303|FG000|NOT COMPLETED|Overall Study||18
10303340|NCT00078403|11436304|FG001|NOT COMPLETED|Overall Study||16
10303341|NCT00078403|11436305|FG002|NOT COMPLETED|Overall Study||28
10303342|NCT00078559|11436314|FG000|STARTED|Overall Study||10
10303343|NCT00078559|11436314|FG000|COMPLETED|Overall Study|1 subject stopped study drug due to a severe but non-serious AE, and completed the trial|10
10303344|NCT00078559|11436314|FG000|NOT COMPLETED|Overall Study||0
10303345|NCT00078715|11436321|FG000|STARTED|First Intervention||2
10303346|NCT00078715|11436322|FG001|STARTED|First Intervention||4
10303347|NCT00078715|11436321|FG000|COMPLETED|First Intervention||2
10303348|NCT00078715|11436322|FG001|COMPLETED|First Intervention||4
10303349|NCT00078715|11436321|FG000|NOT COMPLETED|First Intervention||0
10303350|NCT00078715|11436322|FG001|NOT COMPLETED|First Intervention||0
10303351|NCT00078715|11436321|FG000|STARTED|Second Intervention||2
10426371|NCT00847288|11572027|FG000|NOT COMPLETED|Overall Study||30
10303352|NCT00078715|11436322|FG001|STARTED|Second Intervention||4
10303353|NCT00078715|11436321|FG000|COMPLETED|Second Intervention||2
10303354|NCT00078715|11436322|FG001|COMPLETED|Second Intervention||4
10303355|NCT00078715|11436321|FG000|NOT COMPLETED|Second Intervention||0
10303356|NCT00078715|11436322|FG001|NOT COMPLETED|Second Intervention||0
10303357|NCT00078728|11436330|FG000|STARTED|Overall Study||20
10303358|NCT00078728|11436331|FG001|STARTED|Overall Study||20
10303359|NCT00078728|11436330|FG000|COMPLETED|Overall Study||16
10303360|NCT00078728|11436331|FG001|COMPLETED|Overall Study||17
10529996|NCT01403805|11682385|FG001|COMPLETED|Overall Study||98
10529997|NCT01403805|11682384|FG000|NOT COMPLETED|Overall Study||0
10529998|NCT01403805|11682385|FG001|NOT COMPLETED|Overall Study||7
10812030|NCT03738163|11974018|FG000|STARTED|Overall Study||121
10812031|NCT03738163|11974018|FG000|COMPLETED|Overall Study||114
10812032|NCT03738163|11974018|FG000|NOT COMPLETED|Overall Study||7
10812033|NCT03738020|11974022|FG000|STARTED|Overall Study||58
10812034|NCT03738020|11974022|FG000|COMPLETED|Overall Study||57
10812035|NCT03738020|11974022|FG000|NOT COMPLETED|Overall Study||1
10303361|NCT00078728|11436330|FG000|NOT COMPLETED|Overall Study||4
10303362|NCT00078728|11436331|FG001|NOT COMPLETED|Overall Study||3
10303363|NCT00078754|11436341|FG000|STARTED|Overall Study||29
10303364|NCT00078754|11436342|FG001|STARTED|Overall Study||30
10303365|NCT00078754|11436343|FG002|STARTED|Overall Study||31
10303366|NCT00078754|11436341|FG000|COMPLETED|Overall Study||14
10303367|NCT00078754|11436342|FG001|COMPLETED|Overall Study||11
10303368|NCT00078754|11436343|FG002|COMPLETED|Overall Study||16
10303369|NCT00078754|11436341|FG000|NOT COMPLETED|Overall Study||15
10303370|NCT00078754|11436342|FG001|NOT COMPLETED|Overall Study||19
10303371|NCT00078754|11436343|FG002|NOT COMPLETED|Overall Study||15
10303372|NCT00078767|11436356|FG000|STARTED|Overall Study||12
10303373|NCT00078767|11436357|FG001|STARTED|Overall Study||12
10303374|NCT00078767|11436356|FG000|COMPLETED|Overall Study||11
10303375|NCT00078767|11436357|FG001|COMPLETED|Overall Study||11
10303376|NCT00078767|11436356|FG000|NOT COMPLETED|Overall Study||1
10303377|NCT00078767|11436357|FG001|NOT COMPLETED|Overall Study||1
10303378|NCT00078819|11436365|FG000|STARTED|Double-blind Treatment Period: Week 1-12||105
10303379|NCT00078819|11436366|FG001|STARTED|Double-blind Treatment Period: Week 1-12||106
10303380|NCT00078819|11436367|FG002|STARTED|Double-blind Treatment Period: Week 1-12||0
10303381|NCT00078819|11436368|FG003|STARTED|Double-blind Treatment Period: Week 1-12||0
10303382|NCT00078819|11436365|FG000|Entered Escape|Double-blind Treatment Period: Week 1-12||27
10303383|NCT00078819|11436366|FG001|Entered Escape|Double-blind Treatment Period: Week 1-12||5
10303384|NCT00078819|11436367|FG002|Entered Escape|Double-blind Treatment Period: Week 1-12||0
10303385|NCT00078819|11436368|FG003|Entered Escape|Double-blind Treatment Period: Week 1-12||0
10303386|NCT00078819|11436365|FG000|COMPLETED|Double-blind Treatment Period: Week 1-12||104
10303387|NCT00078819|11436366|FG001|COMPLETED|Double-blind Treatment Period: Week 1-12||105
10303388|NCT00078819|11436367|FG002|COMPLETED|Double-blind Treatment Period: Week 1-12||0
10303389|NCT00078819|11436368|FG003|COMPLETED|Double-blind Treatment Period: Week 1-12||0
10340229|NCT00378352|11477230|FG001|Safety Analysis|Dose Escalation 15,000 Units||0
10340230|NCT00378352|11477231|FG002|Safety Analysis|Dose Escalation 15,000 Units||0
10340231|NCT00378352|11477232|FG003|Safety Analysis|Dose Escalation 15,000 Units||11
10340232|NCT00378352|11477233|FG004|Safety Analysis|Dose Escalation 15,000 Units||0
10340233|NCT00378352|11477234|FG005|Safety Analysis|Dose Escalation 15,000 Units||0
10340234|NCT00378352|11477229|FG000|COMPLETED|Dose Escalation 15,000 Units||15
10340235|NCT00378352|11477230|FG001|COMPLETED|Dose Escalation 15,000 Units||0
10340236|NCT00378352|11477231|FG002|COMPLETED|Dose Escalation 15,000 Units||0
10340237|NCT00378352|11477232|FG003|COMPLETED|Dose Escalation 15,000 Units||10
10340238|NCT00378352|11477233|FG004|COMPLETED|Dose Escalation 15,000 Units||0
10340239|NCT00378352|11477234|FG005|COMPLETED|Dose Escalation 15,000 Units||0
10340240|NCT00378352|11477229|FG000|NOT COMPLETED|Dose Escalation 15,000 Units||5
10340241|NCT00378352|11477230|FG001|NOT COMPLETED|Dose Escalation 15,000 Units||0
10340242|NCT00378352|11477231|FG002|NOT COMPLETED|Dose Escalation 15,000 Units||0
10340243|NCT00378352|11477232|FG003|NOT COMPLETED|Dose Escalation 15,000 Units||1
10340244|NCT00378352|11477233|FG004|NOT COMPLETED|Dose Escalation 15,000 Units||0
10340245|NCT00378352|11477234|FG005|NOT COMPLETED|Dose Escalation 15,000 Units||0
10340246|NCT00378352|11477229|FG000|STARTED|Dose Escalation 30,000 Units||0
10340247|NCT00378352|11477230|FG001|STARTED|Dose Escalation 30,000 Units||19
10340248|NCT00378352|11477231|FG002|STARTED|Dose Escalation 30,000 Units||0
10340249|NCT00378352|11477232|FG003|STARTED|Dose Escalation 30,000 Units||11
10340250|NCT00378352|11477233|FG004|STARTED|Dose Escalation 30,000 Units||0
10340251|NCT00378352|11477234|FG005|STARTED|Dose Escalation 30,000 Units||0
10340252|NCT00378352|11477229|FG000|Safety Analysis|Dose Escalation 30,000 Units||0
10340253|NCT00378352|11477230|FG001|Safety Analysis|Dose Escalation 30,000 Units|One participant randomized to 60,000 units received 30,000 units|20
10340254|NCT00378352|11477231|FG002|Safety Analysis|Dose Escalation 30,000 Units||0
10340255|NCT00378352|11477232|FG003|Safety Analysis|Dose Escalation 30,000 Units||11
10340256|NCT00378352|11477233|FG004|Safety Analysis|Dose Escalation 30,000 Units||0
10340257|NCT00378352|11477234|FG005|Safety Analysis|Dose Escalation 30,000 Units||0
10340258|NCT00378352|11477229|FG000|COMPLETED|Dose Escalation 30,000 Units||0
10340259|NCT00378352|11477230|FG001|COMPLETED|Dose Escalation 30,000 Units||16
10340260|NCT00378352|11477231|FG002|COMPLETED|Dose Escalation 30,000 Units||0
10340261|NCT00378352|11477232|FG003|COMPLETED|Dose Escalation 30,000 Units||9
10340262|NCT00378352|11477233|FG004|COMPLETED|Dose Escalation 30,000 Units||0
10340263|NCT00378352|11477234|FG005|COMPLETED|Dose Escalation 30,000 Units||0
10340264|NCT00378352|11477229|FG000|NOT COMPLETED|Dose Escalation 30,000 Units||0
10340265|NCT00378352|11477230|FG001|NOT COMPLETED|Dose Escalation 30,000 Units||3
10340266|NCT00378352|11477231|FG002|NOT COMPLETED|Dose Escalation 30,000 Units||0
10340267|NCT00378352|11477232|FG003|NOT COMPLETED|Dose Escalation 30,000 Units||2
10340268|NCT00378352|11477233|FG004|NOT COMPLETED|Dose Escalation 30,000 Units||0
10340269|NCT00378352|11477234|FG005|NOT COMPLETED|Dose Escalation 30,000 Units||0
10340270|NCT00378352|11477229|FG000|STARTED|Dose Escalation 60,000 Units||0
10340271|NCT00378352|11477230|FG001|STARTED|Dose Escalation 60,000 Units||0
10340272|NCT00378352|11477231|FG002|STARTED|Dose Escalation 60,000 Units||20
10340273|NCT00378352|11477232|FG003|STARTED|Dose Escalation 60,000 Units||11
10340274|NCT00378352|11477233|FG004|STARTED|Dose Escalation 60,000 Units||0
10340275|NCT00378352|11477234|FG005|STARTED|Dose Escalation 60,000 Units||0
10340276|NCT00378352|11477229|FG000|Safety Analysis|Dose Escalation 60,000 Units||0
10340277|NCT00378352|11477230|FG001|Safety Analysis|Dose Escalation 60,000 Units||0
10340278|NCT00378352|11477231|FG002|Safety Analysis|Dose Escalation 60,000 Units||19
10340279|NCT00378352|11477232|FG003|Safety Analysis|Dose Escalation 60,000 Units||11
10340280|NCT00378352|11477233|FG004|Safety Analysis|Dose Escalation 60,000 Units||0
10340281|NCT00378352|11477234|FG005|Safety Analysis|Dose Escalation 60,000 Units||0
10340282|NCT00378352|11477229|FG000|COMPLETED|Dose Escalation 60,000 Units||0
10340283|NCT00378352|11477230|FG001|COMPLETED|Dose Escalation 60,000 Units||0
10340284|NCT00378352|11477231|FG002|COMPLETED|Dose Escalation 60,000 Units||17
10340285|NCT00378352|11477232|FG003|COMPLETED|Dose Escalation 60,000 Units||10
10340286|NCT00378352|11477233|FG004|COMPLETED|Dose Escalation 60,000 Units||0
10340287|NCT00378352|11477234|FG005|COMPLETED|Dose Escalation 60,000 Units||0
10340288|NCT00378352|11477229|FG000|NOT COMPLETED|Dose Escalation 60,000 Units||0
10340289|NCT00378352|11477230|FG001|NOT COMPLETED|Dose Escalation 60,000 Units||0
10340290|NCT00378352|11477231|FG002|NOT COMPLETED|Dose Escalation 60,000 Units||3
10340291|NCT00378352|11477232|FG003|NOT COMPLETED|Dose Escalation 60,000 Units||1
10340292|NCT00378352|11477233|FG004|NOT COMPLETED|Dose Escalation 60,000 Units||0
10340293|NCT00378352|11477234|FG005|NOT COMPLETED|Dose Escalation 60,000 Units||0
10340294|NCT00378352|11477229|FG000|STARTED|Efficacy Phase||0
10340295|NCT00378352|11477230|FG001|STARTED|Efficacy Phase||0
10340296|NCT00378352|11477231|FG002|STARTED|Efficacy Phase||0
10340297|NCT00378352|11477232|FG003|STARTED|Efficacy Phase||0
10340298|NCT00378352|11477233|FG004|STARTED|Efficacy Phase||65
10340299|NCT00378352|11477234|FG005|STARTED|Efficacy Phase||66
10340300|NCT00378352|11477229|FG000|Safety Analysis|Efficacy Phase||0
10340301|NCT00378352|11477230|FG001|Safety Analysis|Efficacy Phase||0
10340302|NCT00378352|11477231|FG002|Safety Analysis|Efficacy Phase||0
10340303|NCT00378352|11477232|FG003|Safety Analysis|Efficacy Phase||0
10340304|NCT00378352|11477233|FG004|Safety Analysis|Efficacy Phase|Two participants randomized to placebo received 60,000 units Epoetin alfa|67
10340305|NCT00378352|11477234|FG005|Safety Analysis|Efficacy Phase||64
10340306|NCT00378352|11477229|FG000|COMPLETED|Efficacy Phase||0
10340307|NCT00378352|11477230|FG001|COMPLETED|Efficacy Phase||0
10340308|NCT00378352|11477231|FG002|COMPLETED|Efficacy Phase||0
10340309|NCT00378352|11477232|FG003|COMPLETED|Efficacy Phase||0
10340310|NCT00378352|11477233|FG004|COMPLETED|Efficacy Phase||54
10340311|NCT00378352|11477234|FG005|COMPLETED|Efficacy Phase||59
10340312|NCT00378352|11477229|FG000|NOT COMPLETED|Efficacy Phase||0
10340313|NCT00378352|11477230|FG001|NOT COMPLETED|Efficacy Phase||0
10340314|NCT00378352|11477231|FG002|NOT COMPLETED|Efficacy Phase||0
10340315|NCT00378352|11477232|FG003|NOT COMPLETED|Efficacy Phase||0
10340316|NCT00378352|11477233|FG004|NOT COMPLETED|Efficacy Phase||11
10340317|NCT00378352|11477234|FG005|NOT COMPLETED|Efficacy Phase||7
10340318|NCT00378508|11477244|FG000|STARTED|Overall Study||29
10340319|NCT00378508|11477245|FG001|STARTED|Overall Study||34
10340320|NCT00378508|11477244|FG000|Randomized|Overall Study||29
10340321|NCT00378508|11477245|FG001|Randomized|Overall Study||34
10340322|NCT00378508|11477244|FG000|Received Intervention/Placebo|Overall Study||28
10340323|NCT00378508|11477245|FG001|Received Intervention/Placebo|Overall Study||31
10340324|NCT00378508|11477244|FG000|COMPLETED|Overall Study||27
10340325|NCT00378508|11477245|FG001|COMPLETED|Overall Study||31
10340326|NCT00378508|11477244|FG000|NOT COMPLETED|Overall Study||2
10340327|NCT00378508|11477245|FG001|NOT COMPLETED|Overall Study||3
10340328|NCT00378534|11477254|FG000|STARTED|Overall Study||58
10340329|NCT00378534|11477255|FG001|STARTED|Overall Study||58
10340330|NCT00378534|11477254|FG000|COMPLETED|Overall Study||55
10340331|NCT00378534|11477255|FG001|COMPLETED|Overall Study||58
10340332|NCT00378534|11477254|FG000|NOT COMPLETED|Overall Study||3
10340333|NCT00378534|11477255|FG001|NOT COMPLETED|Overall Study||0
10340334|NCT00378560|11477262|FG000|STARTED|Overall Study||509
10340335|NCT00378560|11477263|FG001|STARTED|Overall Study||512
10340336|NCT00378560|11477262|FG000|Vaccinated|Overall Study||509
10340337|NCT00378560|11477263|FG001|Vaccinated|Overall Study||512
10340338|NCT00378560|11477262|FG000|COMPLETED|Overall Study||453
10340339|NCT00378560|11477263|FG001|COMPLETED|Overall Study||454
10340340|NCT00378560|11477262|FG000|NOT COMPLETED|Overall Study||56
10340341|NCT00378560|11477263|FG001|NOT COMPLETED|Overall Study||58
10340342|NCT00378573|11477269|FG000|STARTED|Treatment Period||17
10340343|NCT00378573|11477269|FG000|COMPLETED|Treatment Period|Patients who did not complete treatment moved directly to the follow-up phase of the study.|0
10340344|NCT00378573|11477269|FG000|NOT COMPLETED|Treatment Period||17
10340345|NCT00378573|11477269|FG000|STARTED|Follow-up||17
10340346|NCT00378573|11477269|FG000|COMPLETED|Follow-up||3
10340347|NCT00378573|11477269|FG000|NOT COMPLETED|Follow-up||14
10340348|NCT00378599|11477273|FG000|STARTED|Overall Study||125
10340349|NCT00378599|11477273|FG000|COMPLETED|Overall Study||73
10340350|NCT00378599|11477273|FG000|NOT COMPLETED|Overall Study||52
10340351|NCT00378703|11477281|FG000|STARTED|Overall Study|Number of patients randomized to this treatment arm.|89
10340352|NCT00378703|11477282|FG001|STARTED|Overall Study|Number of patients randomized to this treatment arm.|91
10340353|NCT00378703|11477283|FG002|STARTED|Overall Study|Number of patients randomized to this treatment arm.|90
10340354|NCT00378703|11477284|FG003|STARTED|Overall Study|Number of patients randomized to this treatment arm.|91
10340355|NCT00378703|11477281|FG000|Treated|Overall Study|Number of patients included in the toxicity analysis.|88
10340356|NCT00378703|11477282|FG001|Treated|Overall Study|Number of patients included in the toxicity analysis.|86
10340357|NCT00378703|11477283|FG002|Treated|Overall Study|Number of patients included in the toxicity analysis.|90
10340358|NCT00378703|11477284|FG003|Treated|Overall Study|Number of patients included in the toxicity analysis.|91
10340359|NCT00378703|11477281|FG000|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|84
10340360|NCT00378703|11477282|FG001|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|80
10340361|NCT00378703|11477283|FG002|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|83
10340362|NCT00378703|11477284|FG003|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|84
10340363|NCT00378703|11477281|FG000|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
10340364|NCT00378703|11477282|FG001|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
10340365|NCT00378703|11477283|FG002|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
10340366|NCT00378703|11477284|FG003|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
10340367|NCT00378703|11477281|FG000|NOT COMPLETED|Overall Study||89
10340368|NCT00378703|11477282|FG001|NOT COMPLETED|Overall Study||91
10340369|NCT00378703|11477283|FG002|NOT COMPLETED|Overall Study||90
10340370|NCT00378703|11477284|FG003|NOT COMPLETED|Overall Study||91
10340371|NCT00378898|11477296|FG000|STARTED|Overall Study||22
10340372|NCT00378898|11477297|FG001|STARTED|Overall Study||17
10340373|NCT00378898|11477296|FG000|COMPLETED|Overall Study||11
10340374|NCT00378898|11477297|FG001|COMPLETED|Overall Study||11
10340375|NCT00378898|11477296|FG000|NOT COMPLETED|Overall Study||11
10340376|NCT00378898|11477297|FG001|NOT COMPLETED|Overall Study||6
10340377|NCT00379080|11477308|FG000|STARTED|Overall Study||6
10340378|NCT00379080|11477309|FG001|STARTED|Overall Study||19
10340379|NCT00379080|11477310|FG002|STARTED|Overall Study||31
10340380|NCT00379080|11477308|FG000|COMPLETED|Overall Study||6
10340381|NCT00379080|11477309|FG001|COMPLETED|Overall Study||15
10340382|NCT00379080|11477310|FG002|COMPLETED|Overall Study||31
10340383|NCT00379080|11477308|FG000|NOT COMPLETED|Overall Study||0
10340384|NCT00379080|11477309|FG001|NOT COMPLETED|Overall Study||4
10340385|NCT00379080|11477310|FG002|NOT COMPLETED|Overall Study||0
10340386|NCT00379145|11477333|FG000|STARTED|Overall Study||20
10340387|NCT00379145|11477333|FG000|COMPLETED|Overall Study||20
10340388|NCT00379145|11477333|FG000|NOT COMPLETED|Overall Study||0
10340389|NCT00379197|11477342|FG000|STARTED|Overall Study||13
10340390|NCT00379197|11477342|FG000|COMPLETED|Overall Study||8
10529999|NCT01403987|11682398|FG000|STARTED|Overall Study||34
10530000|NCT01403987|11682399|FG001|STARTED|Overall Study||34
10530001|NCT01403987|11682400|FG002|STARTED|Overall Study||68
10530002|NCT01403987|11682398|FG000|COMPLETED|Overall Study||16
10530003|NCT01403987|11682399|FG001|COMPLETED|Overall Study||17
10812051|NCT03736785|11974053|FG000|STARTED|Overall Study||135
10812052|NCT03736785|11974054|FG001|STARTED|Overall Study||132
10812053|NCT03736785|11974055|FG002|STARTED|Overall Study||132
10812054|NCT03736785|11974053|FG000|COMPLETED|Overall Study||118
10812055|NCT03736785|11974054|FG001|COMPLETED|Overall Study||115
10812056|NCT03736785|11974055|FG002|COMPLETED|Overall Study||118
10812057|NCT03736785|11974053|FG000|NOT COMPLETED|Overall Study||17
10812058|NCT03736785|11974054|FG001|NOT COMPLETED|Overall Study||17
10812059|NCT03736785|11974055|FG002|NOT COMPLETED|Overall Study||14
10812060|NCT03736031|11974066|FG000|STARTED|Overall Study||56
10812061|NCT03736031|11974067|FG001|STARTED|Overall Study||46
10812062|NCT03736031|11974066|FG000|COMPLETED|Overall Study||24
10812063|NCT03736031|11974067|FG001|COMPLETED|Overall Study||40
10812064|NCT03736031|11974066|FG000|NOT COMPLETED|Overall Study||32
10812065|NCT03736031|11974067|FG001|NOT COMPLETED|Overall Study||6
10812066|NCT03735862|11974073|FG000|STARTED|Overall Study||73
10812067|NCT03735862|11974073|FG000|COMPLETED|Overall Study||73
10812068|NCT03735862|11974073|FG000|NOT COMPLETED|Overall Study||0
10812069|NCT03734991|11974079|FG000|STARTED|Overall Study||249
10812070|NCT03734991|11974080|FG001|STARTED|Overall Study||127
10812071|NCT03734991|11974079|FG000|Withdrawn Before Treatment|Overall Study||2
10812072|NCT03734991|11974080|FG001|Withdrawn Before Treatment|Overall Study||3
10812073|NCT03734991|11974079|FG000|Withdrawn Before TOC|Overall Study||59
10812074|NCT03734991|11974080|FG001|Withdrawn Before TOC|Overall Study||41
10812075|NCT03734991|11974079|FG000|Completed the TOC Visit|Overall Study||188
10812076|NCT03734991|11974080|FG001|Completed the TOC Visit|Overall Study||83
10812077|NCT03734991|11974079|FG000|Withdrawn At or After the TOC Visit|Overall Study||5
10812078|NCT03734991|11974080|FG001|Withdrawn At or After the TOC Visit|Overall Study||3
10812079|NCT03734991|11974079|FG000|COMPLETED|Overall Study||183
10812080|NCT03734991|11974080|FG001|COMPLETED|Overall Study||80
10812081|NCT03734991|11974079|FG000|NOT COMPLETED|Overall Study||66
10812082|NCT03734991|11974080|FG001|NOT COMPLETED|Overall Study||47
10812083|NCT03734822|11974086|FG000|STARTED|Overall Study||47
10812084|NCT03734822|11974086|FG000|COMPLETED|Overall Study||47
10812085|NCT03734822|11974086|FG000|NOT COMPLETED|Overall Study||0
10812086|NCT03734601|11974090|FG000|STARTED|Overall Study||22
10812087|NCT03734601|11974090|FG000|COMPLETED|Overall Study||22
10530004|NCT01403987|11682400|FG002|COMPLETED|Overall Study||50
10530005|NCT01403987|11682398|FG000|NOT COMPLETED|Overall Study||18
10530006|NCT01403987|11682399|FG001|NOT COMPLETED|Overall Study||17
10812088|NCT03734601|11974090|FG000|NOT COMPLETED|Overall Study||0
10812089|NCT03733899|11974094|FG000|STARTED|Period 1||3
10812090|NCT03733899|11974095|FG001|STARTED|Period 1||3
10340391|NCT00379197|11477342|FG000|NOT COMPLETED|Overall Study||5
10340392|NCT00379210|11477349|FG000|STARTED|Overall Study||30
10340393|NCT00379210|11477350|FG001|STARTED|Overall Study||30
10340394|NCT00379210|11477349|FG000|COMPLETED|Overall Study||20
10340395|NCT00379210|11477350|FG001|COMPLETED|Overall Study||23
10340396|NCT00379210|11477349|FG000|NOT COMPLETED|Overall Study||10
10340397|NCT00379210|11477350|FG001|NOT COMPLETED|Overall Study||7
10340398|NCT00379236|11477358|FG000|STARTED|Double-blind||293
10340399|NCT00379236|11477359|FG001|STARTED|Double-blind||295
10340400|NCT00379236|11477360|FG002|STARTED|Double-blind||0
10340401|NCT00379236|11477358|FG000|COMPLETED|Double-blind|Data could not be retrieved for two participants|257
10340402|NCT00379236|11477359|FG001|COMPLETED|Double-blind|Data could not be retrieved for two participants|259
10340403|NCT00379236|11477360|FG002|COMPLETED|Double-blind||0
10340404|NCT00379236|11477358|FG000|NOT COMPLETED|Double-blind||36
10340405|NCT00379236|11477359|FG001|NOT COMPLETED|Double-blind||36
10340406|NCT00379236|11477360|FG002|NOT COMPLETED|Double-blind||0
10340407|NCT00379236|11477358|FG000|STARTED|Open-label Extension||0
10530007|NCT01403987|11682400|FG002|NOT COMPLETED|Overall Study||18
10530008|NCT01404039|11682417|FG000|STARTED|Overall Study||5
10530009|NCT01404039|11682418|FG001|STARTED|Overall Study||5
10530010|NCT01404039|11682419|FG002|STARTED|Overall Study||5
10530011|NCT01404039|11682420|FG003|STARTED|Overall Study||10
10530012|NCT01404039|11682421|FG004|STARTED|Overall Study||10
10530013|NCT01404039|11682422|FG005|STARTED|Overall Study||10
10530014|NCT01404039|11682423|FG006|STARTED|Overall Study||10
10530015|NCT01404039|11682424|FG007|STARTED|Overall Study||15
10530016|NCT01404039|11682425|FG008|STARTED|Overall Study||15
10530017|NCT01404039|11682426|FG009|STARTED|Overall Study||15
10530018|NCT01404039|11682427|FG010|STARTED|Overall Study||15
10530019|NCT01404039|11682428|FG011|STARTED|Overall Study||0
10530020|NCT01404039|11682429|FG012|STARTED|Overall Study||0
10530021|NCT01404039|11682417|FG000|COMPLETED|Overall Study||4
10654965|NCT02206607|11815795|FG000|NOT COMPLETED|First Intervention Period||0
10654966|NCT02206607|11815796|FG001|NOT COMPLETED|First Intervention Period||0
10654967|NCT02206607|11815797|FG002|NOT COMPLETED|First Intervention Period||0
10654968|NCT02206607|11815798|FG003|NOT COMPLETED|First Intervention Period||0
10654969|NCT02206607|11815799|FG004|NOT COMPLETED|First Intervention Period||0
10654970|NCT02206607|11815795|FG000|STARTED|First Washout Period 5 to 10 Days||0
10654971|NCT02206607|11815796|FG001|STARTED|First Washout Period 5 to 10 Days||9
10654972|NCT02206607|11815797|FG002|STARTED|First Washout Period 5 to 10 Days||9
10654973|NCT02206607|11815798|FG003|STARTED|First Washout Period 5 to 10 Days||11
10654974|NCT02206607|11815799|FG004|STARTED|First Washout Period 5 to 10 Days||10
10654975|NCT02206607|11815795|FG000|COMPLETED|First Washout Period 5 to 10 Days||0
10654976|NCT02206607|11815796|FG001|COMPLETED|First Washout Period 5 to 10 Days||9
10654977|NCT02206607|11815797|FG002|COMPLETED|First Washout Period 5 to 10 Days||9
10654978|NCT02206607|11815798|FG003|COMPLETED|First Washout Period 5 to 10 Days||11
10654979|NCT02206607|11815799|FG004|COMPLETED|First Washout Period 5 to 10 Days||10
10654980|NCT02206607|11815795|FG000|NOT COMPLETED|First Washout Period 5 to 10 Days||0
10654981|NCT02206607|11815796|FG001|NOT COMPLETED|First Washout Period 5 to 10 Days||0
10654982|NCT02206607|11815797|FG002|NOT COMPLETED|First Washout Period 5 to 10 Days||0
10654983|NCT02206607|11815798|FG003|NOT COMPLETED|First Washout Period 5 to 10 Days||0
10654984|NCT02206607|11815799|FG004|NOT COMPLETED|First Washout Period 5 to 10 Days||0
10654985|NCT02206607|11815795|FG000|STARTED|Second Intervention Period||0
10654986|NCT02206607|11815796|FG001|STARTED|Second Intervention Period||9
10654987|NCT02206607|11815797|FG002|STARTED|Second Intervention Period||9
10654988|NCT02206607|11815798|FG003|STARTED|Second Intervention Period||11
10654989|NCT02206607|11815799|FG004|STARTED|Second Intervention Period||10
10654990|NCT02206607|11815795|FG000|COMPLETED|Second Intervention Period||0
10654991|NCT02206607|11815796|FG001|COMPLETED|Second Intervention Period||9
10654992|NCT02206607|11815797|FG002|COMPLETED|Second Intervention Period||9
10654993|NCT02206607|11815798|FG003|COMPLETED|Second Intervention Period||10
10654994|NCT02206607|11815799|FG004|COMPLETED|Second Intervention Period||10
10654995|NCT02206607|11815795|FG000|NOT COMPLETED|Second Intervention Period||0
10714788|NCT02688387|11880049|FG006|STARTED|Part 1, Washout Period 3 (7 Days)||2
10714789|NCT02688387|11880050|FG007|STARTED|Part 1, Washout Period 3 (7 Days)||2
10714790|NCT02688387|11880051|FG008|STARTED|Part 1, Washout Period 3 (7 Days)||2
10714791|NCT02688387|11880052|FG009|STARTED|Part 1, Washout Period 3 (7 Days)||2
10714792|NCT02688387|11880053|FG010|STARTED|Part 1, Washout Period 3 (7 Days)||0
10714793|NCT02688387|11880054|FG011|STARTED|Part 1, Washout Period 3 (7 Days)||0
10714794|NCT02688387|11880055|FG012|STARTED|Part 1, Washout Period 3 (7 Days)||0
10714795|NCT02688387|11880056|FG013|STARTED|Part 1, Washout Period 3 (7 Days)||0
10714796|NCT02688387|11880057|FG014|STARTED|Part 1, Washout Period 3 (7 Days)||0
10340408|NCT00379236|11477359|FG001|STARTED|Open-label Extension||0
10340409|NCT00379236|11477360|FG002|STARTED|Open-label Extension||433
10340410|NCT00379236|11477358|FG000|COMPLETED|Open-label Extension||0
10340411|NCT00379236|11477359|FG001|COMPLETED|Open-label Extension||0
10340412|NCT00379236|11477360|FG002|COMPLETED|Open-label Extension||378
10340413|NCT00379236|11477358|FG000|NOT COMPLETED|Open-label Extension||0
10340414|NCT00379236|11477359|FG001|NOT COMPLETED|Open-label Extension||0
10340415|NCT00379236|11477360|FG002|NOT COMPLETED|Open-label Extension||55
10530022|NCT01404039|11682418|FG001|COMPLETED|Overall Study||5
10530023|NCT01404039|11682419|FG002|COMPLETED|Overall Study||5
10530024|NCT01404039|11682420|FG003|COMPLETED|Overall Study||10
10530025|NCT01404039|11682421|FG004|COMPLETED|Overall Study||10
10812091|NCT03733899|11974096|FG002|STARTED|Period 1||3
10812092|NCT03733899|11974097|FG003|STARTED|Period 1||4
10812093|NCT03733899|11974098|FG004|STARTED|Period 1||4
10812094|NCT03733899|11974099|FG005|STARTED|Period 1||3
10812095|NCT03733899|11974094|FG000|COMPLETED|Period 1||3
10812096|NCT03733899|11974095|FG001|COMPLETED|Period 1||3
10812097|NCT03733899|11974096|FG002|COMPLETED|Period 1||3
10812098|NCT03733899|11974097|FG003|COMPLETED|Period 1||4
10812099|NCT03733899|11974098|FG004|COMPLETED|Period 1||4
10812100|NCT03733899|11974099|FG005|COMPLETED|Period 1||2
10812101|NCT03733899|11974094|FG000|NOT COMPLETED|Period 1||0
10812102|NCT03733899|11974095|FG001|NOT COMPLETED|Period 1||0
10812103|NCT03733899|11974096|FG002|NOT COMPLETED|Period 1||0
10812104|NCT03733899|11974097|FG003|NOT COMPLETED|Period 1||0
10812105|NCT03733899|11974098|FG004|NOT COMPLETED|Period 1||0
10812106|NCT03733899|11974099|FG005|NOT COMPLETED|Period 1||1
10812107|NCT03733899|11974094|FG000|STARTED|Period 2||3
10812108|NCT03733899|11974095|FG001|STARTED|Period 2||3
10812109|NCT03733899|11974096|FG002|STARTED|Period 2||3
10812110|NCT03733899|11974097|FG003|STARTED|Period 2||4
10812111|NCT03733899|11974098|FG004|STARTED|Period 2||4
10812112|NCT03733899|11974099|FG005|STARTED|Period 2||2
10812113|NCT03733899|11974094|FG000|COMPLETED|Period 2||3
10812114|NCT03733899|11974095|FG001|COMPLETED|Period 2||2
10812115|NCT03733899|11974096|FG002|COMPLETED|Period 2||3
10812116|NCT03733899|11974097|FG003|COMPLETED|Period 2||4
10812117|NCT03733899|11974098|FG004|COMPLETED|Period 2||4
10812118|NCT03733899|11974099|FG005|COMPLETED|Period 2||2
10812119|NCT03733899|11974094|FG000|NOT COMPLETED|Period 2||0
10812120|NCT03733899|11974095|FG001|NOT COMPLETED|Period 2||1
10812121|NCT03733899|11974096|FG002|NOT COMPLETED|Period 2||0
10812122|NCT03733899|11974097|FG003|NOT COMPLETED|Period 2||0
10812123|NCT03733899|11974098|FG004|NOT COMPLETED|Period 2||0
10812124|NCT03733899|11974099|FG005|NOT COMPLETED|Period 2||0
10812125|NCT03733899|11974094|FG000|STARTED|Period 3||3
10812126|NCT03733899|11974095|FG001|STARTED|Period 3||2
10812127|NCT03733899|11974096|FG002|STARTED|Period 3||3
10812128|NCT03733899|11974097|FG003|STARTED|Period 3||4
10812129|NCT03733899|11974098|FG004|STARTED|Period 3||4
10812130|NCT03733899|11974099|FG005|STARTED|Period 3||2
10530026|NCT01404039|11682422|FG005|COMPLETED|Overall Study||10
10530027|NCT01404039|11682423|FG006|COMPLETED|Overall Study||10
10530028|NCT01404039|11682424|FG007|COMPLETED|Overall Study||15
10530029|NCT01404039|11682425|FG008|COMPLETED|Overall Study||15
10530030|NCT01404039|11682426|FG009|COMPLETED|Overall Study||14
10530031|NCT01404039|11682427|FG010|COMPLETED|Overall Study||14
10530032|NCT01404039|11682428|FG011|COMPLETED|Overall Study||0
10530033|NCT01404039|11682429|FG012|COMPLETED|Overall Study||0
10530034|NCT01404039|11682417|FG000|NOT COMPLETED|Overall Study||1
10530035|NCT01404039|11682418|FG001|NOT COMPLETED|Overall Study||0
10530036|NCT01404039|11682419|FG002|NOT COMPLETED|Overall Study||0
10530037|NCT01404039|11682420|FG003|NOT COMPLETED|Overall Study||0
10530038|NCT01404039|11682421|FG004|NOT COMPLETED|Overall Study||0
10530039|NCT01404039|11682422|FG005|NOT COMPLETED|Overall Study||0
10530040|NCT01404039|11682423|FG006|NOT COMPLETED|Overall Study||0
10530041|NCT01404039|11682424|FG007|NOT COMPLETED|Overall Study||0
10530042|NCT01404039|11682425|FG008|NOT COMPLETED|Overall Study||0
10530043|NCT01404039|11682426|FG009|NOT COMPLETED|Overall Study||1
10530044|NCT01404039|11682427|FG010|NOT COMPLETED|Overall Study||1
10530045|NCT01404039|11682428|FG011|NOT COMPLETED|Overall Study||0
10530046|NCT01404039|11682429|FG012|NOT COMPLETED|Overall Study||0
10530047|NCT01404078|11682455|FG000|STARTED|Overall Study|725 Started on Phase 1 run in low dose polycap 645 started on phase 2 run in full dose polycap|261
10812131|NCT03733899|11974094|FG000|COMPLETED|Period 3||2
10812132|NCT03733899|11974095|FG001|COMPLETED|Period 3||2
10812133|NCT03733899|11974096|FG002|COMPLETED|Period 3||3
10812134|NCT03733899|11974097|FG003|COMPLETED|Period 3||4
10812135|NCT03733899|11974098|FG004|COMPLETED|Period 3||4
10812136|NCT03733899|11974099|FG005|COMPLETED|Period 3||2
10812137|NCT03733899|11974094|FG000|NOT COMPLETED|Period 3||1
10812138|NCT03733899|11974095|FG001|NOT COMPLETED|Period 3||0
10547855|NCT01515410|11701637|FG001|NOT COMPLETED|Overall Study||0
10812139|NCT03733899|11974096|FG002|NOT COMPLETED|Period 3||0
10812140|NCT03733899|11974097|FG003|NOT COMPLETED|Period 3||0
10812141|NCT03733899|11974098|FG004|NOT COMPLETED|Period 3||0
10812142|NCT03733899|11974099|FG005|NOT COMPLETED|Period 3||0
10812143|NCT03733483|11974112|FG000|STARTED|Overall Study||12
10654996|NCT02206607|11815796|FG001|NOT COMPLETED|Second Intervention Period||0
10654997|NCT02206607|11815797|FG002|NOT COMPLETED|Second Intervention Period||0
10812144|NCT03733483|11974112|FG000|COMPLETED|Overall Study||12
10812145|NCT03733483|11974112|FG000|NOT COMPLETED|Overall Study||0
10812146|NCT03733470|11974118|FG000|STARTED|Overall Study||8
10812147|NCT03733470|11974119|FG001|STARTED|Overall Study||11
10654998|NCT02206607|11815798|FG003|NOT COMPLETED|Second Intervention Period||1
10654999|NCT02206607|11815799|FG004|NOT COMPLETED|Second Intervention Period||0
10655000|NCT02206607|11815795|FG000|STARTED|Second Washout Period 5 to 10 Days||0
10655001|NCT02206607|11815796|FG001|STARTED|Second Washout Period 5 to 10 Days||9
10714797|NCT02688387|11880058|FG015|STARTED|Part 1, Washout Period 3 (7 Days)||0
10714798|NCT02688387|11880059|FG016|STARTED|Part 1, Washout Period 3 (7 Days)||0
10714799|NCT02688387|11880060|FG017|STARTED|Part 1, Washout Period 3 (7 Days)||0
10714800|NCT02688387|11880061|FG018|STARTED|Part 1, Washout Period 3 (7 Days)||0
10714801|NCT02688387|11880062|FG019|STARTED|Part 1, Washout Period 3 (7 Days)||0
10714802|NCT02688387|11880063|FG020|STARTED|Part 1, Washout Period 3 (7 Days)||0
10714803|NCT02688387|11880064|FG021|STARTED|Part 1, Washout Period 3 (7 Days)||0
10714804|NCT02688387|11880043|FG000|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
10714805|NCT02688387|11880044|FG001|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
10714806|NCT02688387|11880045|FG002|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
10714807|NCT02688387|11880046|FG003|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
10714808|NCT02688387|11880047|FG004|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
10530048|NCT01404078|11682456|FG001|STARTED|Overall Study|725 Started on Phase 1 run in low dose polycap 645 started on phase 2 run in full dose polycap|257
10530049|NCT01404078|11682455|FG000|COMPLETED|Overall Study||243
10530050|NCT01404078|11682456|FG001|COMPLETED|Overall Study||237
10530051|NCT01404078|11682455|FG000|NOT COMPLETED|Overall Study||18
10530052|NCT01404078|11682456|FG001|NOT COMPLETED|Overall Study||20
10530053|NCT01404208|11682464|FG000|STARTED|Overall Study||70
10530054|NCT01404208|11682465|FG001|STARTED|Overall Study||72
10714809|NCT02688387|11880048|FG005|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
10714810|NCT02688387|11880049|FG006|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
10530055|NCT01404208|11682464|FG000|COMPLETED|Overall Study||67
10530056|NCT01404208|11682465|FG001|COMPLETED|Overall Study||72
10777206|NCT03337542|11939138|FG000|STARTED|Overall Study||243
10777207|NCT03337542|11939138|FG000|Safety Population|Overall Study||242
10777208|NCT03337542|11939138|FG000|COMPLETED|Overall Study||222
10530057|NCT01404208|11682464|FG000|NOT COMPLETED|Overall Study||3
10777209|NCT03337542|11939138|FG000|NOT COMPLETED|Overall Study||21
10777210|NCT03338010|11939145|FG000|STARTED|Overall Study||359
10777211|NCT03338010|11939146|FG001|STARTED|Overall Study||177
10777212|NCT03338010|11939145|FG000|Received at Least One Dose of Study Drug|Overall Study||359
10777213|NCT03338010|11939146|FG001|Received at Least One Dose of Study Drug|Overall Study||177
10777214|NCT03338010|11939145|FG000|COMPLETED|Overall Study||336
10777215|NCT03338010|11939146|FG001|COMPLETED|Overall Study||159
10777216|NCT03338010|11939145|FG000|NOT COMPLETED|Overall Study||23
10777217|NCT03338010|11939146|FG001|NOT COMPLETED|Overall Study||18
10777218|NCT03338023|11939154|FG000|STARTED|Overall Study||137
10777219|NCT03338023|11939155|FG001|STARTED|Overall Study||135
10777220|NCT03338023|11939154|FG000|Received at Least One Dose of Study Drug|Overall Study||137
10777221|NCT03338023|11939155|FG001|Received at Least One Dose of Study Drug|Overall Study||135
10777222|NCT03338023|11939154|FG000|COMPLETED|Overall Study||128
10777223|NCT03338023|11939155|FG001|COMPLETED|Overall Study||125
10777224|NCT03338023|11939154|FG000|NOT COMPLETED|Overall Study||9
10777225|NCT03338023|11939155|FG001|NOT COMPLETED|Overall Study||10
10340416|NCT00379353|11477374|FG000|STARTED|Overall Study||16
10340417|NCT00379353|11477375|FG001|STARTED|Overall Study||15
10340418|NCT00379353|11477374|FG000|COMPLETED|Overall Study||5
10340419|NCT00379353|11477375|FG001|COMPLETED|Overall Study||9
10340420|NCT00379353|11477374|FG000|NOT COMPLETED|Overall Study||11
10340421|NCT00379353|11477375|FG001|NOT COMPLETED|Overall Study||6
10340422|NCT00379574|11477391|FG000|STARTED|Overall Study|Phase I (9) + Phase II (40)|49
10340423|NCT00379574|11477391|FG000|COMPLETED|Overall Study|Phase I (9) + Phase II (40)|49
10340424|NCT00379574|11477391|FG000|NOT COMPLETED|Overall Study||0
10340425|NCT00379587|11477395|FG000|STARTED|Overall Study||65
10340426|NCT00379587|11477395|FG000|COMPLETED|Overall Study||63
10340427|NCT00379587|11477395|FG000|NOT COMPLETED|Overall Study||2
10340428|NCT00379639|11477404|FG000|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|7
10340429|NCT00379639|11477405|FG001|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|7
10340430|NCT00379639|11477406|FG002|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|10
10340431|NCT00379639|11477407|FG003|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|6
10340432|NCT00379639|11477408|FG004|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|6
10340433|NCT00379639|11477404|FG000|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|6
10340434|NCT00379639|11477405|FG001|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|7
10340435|NCT00379639|11477406|FG002|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|7
10340436|NCT00379639|11477407|FG003|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|4
10340437|NCT00379639|11477408|FG004|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|3
10340438|NCT00379639|11477404|FG000|Completed 6 Cycles of Therapy|Overall Study||4
10340439|NCT00379639|11477405|FG001|Completed 6 Cycles of Therapy|Overall Study||2
10340440|NCT00379639|11477406|FG002|Completed 6 Cycles of Therapy|Overall Study||1
10340441|NCT00379639|11477407|FG003|Completed 6 Cycles of Therapy|Overall Study||0
10340442|NCT00379639|11477408|FG004|Completed 6 Cycles of Therapy|Overall Study||0
10340518|NCT00379808|11477481|FG001|COMPLETED|Intervention Period 2 (4 Weeks)||10
10340443|NCT00379639|11477404|FG000|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|4
10340444|NCT00379639|11477405|FG001|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|2
10340445|NCT00379639|11477406|FG002|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|1
10340446|NCT00379639|11477407|FG003|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|0
10340447|NCT00379639|11477408|FG004|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|0
10340448|NCT00379639|11477404|FG000|NOT COMPLETED|Overall Study||3
10340449|NCT00379639|11477405|FG001|NOT COMPLETED|Overall Study||5
10340450|NCT00379639|11477406|FG002|NOT COMPLETED|Overall Study||9
10340451|NCT00379639|11477407|FG003|NOT COMPLETED|Overall Study||6
10340452|NCT00379639|11477408|FG004|NOT COMPLETED|Overall Study||6
10340453|NCT00379769|11477424|FG000|STARTED|Main Study||1117
10340454|NCT00379769|11477425|FG001|STARTED|Main Study||1105
10340455|NCT00379769|11477426|FG002|STARTED|Main Study||1103
10340456|NCT00379769|11477427|FG003|STARTED|Main Study||1122
10340457|NCT00379769|11477428|FG004|STARTED|Main Study||0
10340458|NCT00379769|11477429|FG005|STARTED|Main Study||0
10340459|NCT00379769|11477424|FG000|COMPLETED|Main Study||939
10340460|NCT00379769|11477425|FG001|COMPLETED|Main Study||906
10340461|NCT00379769|11477426|FG002|COMPLETED|Main Study||896
10340462|NCT00379769|11477427|FG003|COMPLETED|Main Study||892
10340463|NCT00379769|11477428|FG004|COMPLETED|Main Study||0
10340464|NCT00379769|11477429|FG005|COMPLETED|Main Study||0
10340465|NCT00379769|11477424|FG000|NOT COMPLETED|Main Study||178
10340466|NCT00379769|11477425|FG001|NOT COMPLETED|Main Study||199
10340467|NCT00379769|11477426|FG002|NOT COMPLETED|Main Study||207
10340468|NCT00379769|11477427|FG003|NOT COMPLETED|Main Study||230
10340469|NCT00379769|11477428|FG004|NOT COMPLETED|Main Study||0
10340470|NCT00379769|11477429|FG005|NOT COMPLETED|Main Study||0
10340471|NCT00379769|11477424|FG000|STARTED|Observational Follow-up||0
10340472|NCT00379769|11477425|FG001|STARTED|Observational Follow-up||0
10340473|NCT00379769|11477426|FG002|STARTED|Observational Follow-up||0
10340474|NCT00379769|11477427|FG003|STARTED|Observational Follow-up||0
10340475|NCT00379769|11477428|FG004|STARTED|Observational Follow-up|"665 from RSG in Addition to Background MET arm; 615 from RGS in Addition to Background SU arm."|1280
10340476|NCT00379769|11477429|FG005|STARTED|Observational Follow-up|"647 from SU in Addition to Background MET arm; 603 from MET in Addition to Background SU arm."|1250
10340477|NCT00379769|11477424|FG000|COMPLETED|Observational Follow-up||0
10340478|NCT00379769|11477425|FG001|COMPLETED|Observational Follow-up||0
10340479|NCT00379769|11477426|FG002|COMPLETED|Observational Follow-up||0
10340480|NCT00379769|11477427|FG003|COMPLETED|Observational Follow-up||0
10340481|NCT00379769|11477428|FG004|COMPLETED|Observational Follow-up||1131
10340482|NCT00379769|11477429|FG005|COMPLETED|Observational Follow-up||1102
10340483|NCT00379769|11477424|FG000|NOT COMPLETED|Observational Follow-up||0
10340484|NCT00379769|11477425|FG001|NOT COMPLETED|Observational Follow-up||0
10340485|NCT00379769|11477426|FG002|NOT COMPLETED|Observational Follow-up||0
10340486|NCT00379769|11477427|FG003|NOT COMPLETED|Observational Follow-up||0
10340487|NCT00379769|11477428|FG004|NOT COMPLETED|Observational Follow-up||149
10340488|NCT00379769|11477429|FG005|NOT COMPLETED|Observational Follow-up||148
10340489|NCT00379795|11477461|FG000|STARTED|Overall Study||526
10340490|NCT00379795|11477462|FG001|STARTED|Overall Study||74
10340491|NCT00379795|11477463|FG002|STARTED|Overall Study||116
10340492|NCT00379795|11477464|FG003|STARTED|Overall Study||74
10340493|NCT00379795|11477465|FG004|STARTED|Overall Study||63
10340494|NCT00379795|11477461|FG000|Received Ranibizumab in Extension Study|Overall Study||377
10340495|NCT00379795|11477462|FG001|Received Ranibizumab in Extension Study|Overall Study||41
10340496|NCT00379795|11477463|FG002|Received Ranibizumab in Extension Study|Overall Study||113
10340497|NCT00379795|11477464|FG003|Received Ranibizumab in Extension Study|Overall Study||55
10340498|NCT00379795|11477465|FG004|Received Ranibizumab in Extension Study|Overall Study||0
10340499|NCT00379795|11477461|FG000|COMPLETED|Overall Study||50
10340500|NCT00379795|11477462|FG001|COMPLETED|Overall Study||23
10340501|NCT00379795|11477463|FG002|COMPLETED|Overall Study||23
10340502|NCT00379795|11477464|FG003|COMPLETED|Overall Study||6
10340503|NCT00379795|11477465|FG004|COMPLETED|Overall Study||14
10340504|NCT00379795|11477461|FG000|NOT COMPLETED|Overall Study||476
10340505|NCT00379795|11477462|FG001|NOT COMPLETED|Overall Study||51
10340506|NCT00379795|11477463|FG002|NOT COMPLETED|Overall Study||93
10340507|NCT00379795|11477464|FG003|NOT COMPLETED|Overall Study||68
10340508|NCT00379795|11477465|FG004|NOT COMPLETED|Overall Study||49
10340509|NCT00379808|11477480|FG000|STARTED|Intervention Period 1 (4 Weeks)||11
10340510|NCT00379808|11477481|FG001|STARTED|Intervention Period 1 (4 Weeks)||11
10340511|NCT00379808|11477480|FG000|COMPLETED|Intervention Period 1 (4 Weeks)||11
10340512|NCT00379808|11477481|FG001|COMPLETED|Intervention Period 1 (4 Weeks)||11
10340513|NCT00379808|11477480|FG000|NOT COMPLETED|Intervention Period 1 (4 Weeks)||0
10340514|NCT00379808|11477481|FG001|NOT COMPLETED|Intervention Period 1 (4 Weeks)||0
10340515|NCT00379808|11477480|FG000|STARTED|Intervention Period 2 (4 Weeks)||11
10530058|NCT01404208|11682465|FG001|NOT COMPLETED|Overall Study||0
10530059|NCT01404234|11682471|FG000|STARTED|Overall Study||61
10530060|NCT01404234|11682471|FG000|COMPLETED|Overall Study||59
10812148|NCT03733470|11974118|FG000|COMPLETED|Overall Study||7
10812149|NCT03733470|11974119|FG001|COMPLETED|Overall Study||10
10812150|NCT03733470|11974118|FG000|NOT COMPLETED|Overall Study||1
10812151|NCT03733470|11974119|FG001|NOT COMPLETED|Overall Study||1
10812152|NCT03733301|11974128|FG000|STARTED|Overall Study||109
10340516|NCT00379808|11477481|FG001|STARTED|Intervention Period 2 (4 Weeks)||11
10340517|NCT00379808|11477480|FG000|COMPLETED|Intervention Period 2 (4 Weeks)||11
10340519|NCT00379808|11477480|FG000|NOT COMPLETED|Intervention Period 2 (4 Weeks)||0
10340520|NCT00379808|11477481|FG001|NOT COMPLETED|Intervention Period 2 (4 Weeks)||1
10340521|NCT00379821|11477491|FG000|STARTED|Overall Study||160
10340522|NCT00379821|11477492|FG001|STARTED|Overall Study||160
10340523|NCT00379821|11477493|FG002|STARTED|Overall Study||160
10340524|NCT00379821|11477494|FG003|STARTED|Overall Study||160
10340525|NCT00379821|11477491|FG000|COMPLETED|Overall Study||87
10340526|NCT00379821|11477492|FG001|COMPLETED|Overall Study||71
10340527|NCT00379821|11477493|FG002|COMPLETED|Overall Study||93
10340528|NCT00379821|11477494|FG003|COMPLETED|Overall Study||81
10340529|NCT00379821|11477491|FG000|NOT COMPLETED|Overall Study||73
10340530|NCT00379821|11477492|FG001|NOT COMPLETED|Overall Study||89
10340531|NCT00379821|11477493|FG002|NOT COMPLETED|Overall Study||67
10340532|NCT00379821|11477494|FG003|NOT COMPLETED|Overall Study||79
10340533|NCT00379834|11477511|FG000|STARTED|Overall Study||10
10340534|NCT00379834|11477511|FG000|COMPLETED|Overall Study||8
10340535|NCT00379834|11477511|FG000|NOT COMPLETED|Overall Study||2
10340536|NCT00379899|11477517|FG000|STARTED|Overall Study||180
10340537|NCT00379899|11477518|FG001|STARTED|Overall Study||180
10340538|NCT00379899|11477517|FG000|COMPLETED|Overall Study||140
10340539|NCT00379899|11477518|FG001|COMPLETED|Overall Study||140
10340540|NCT00379899|11477517|FG000|NOT COMPLETED|Overall Study||40
10530061|NCT01404234|11682471|FG000|NOT COMPLETED|Overall Study||2
10530062|NCT01404260|11682477|FG000|STARTED|Overall Study||109
10530063|NCT01404260|11682478|FG001|STARTED|Overall Study||110
10530064|NCT01404260|11682477|FG000|COMPLETED|Overall Study||106
10530065|NCT01404260|11682478|FG001|COMPLETED|Overall Study||101
10530066|NCT01404260|11682477|FG000|NOT COMPLETED|Overall Study||3
10530067|NCT01404260|11682478|FG001|NOT COMPLETED|Overall Study||9
10340541|NCT00379899|11477518|FG001|NOT COMPLETED|Overall Study||40
10340542|NCT00379912|11477526|FG000|STARTED|Overall Study||7
10530068|NCT01404325|11682486|FG000|STARTED|Overall Study||67
10340543|NCT00379912|11477527|FG001|STARTED|Overall Study||8
10340544|NCT00379912|11477526|FG000|COMPLETED|Overall Study||6
10340545|NCT00379912|11477527|FG001|COMPLETED|Overall Study||8
10340546|NCT00379912|11477526|FG000|NOT COMPLETED|Overall Study||1
10340547|NCT00379912|11477527|FG001|NOT COMPLETED|Overall Study||0
10340548|NCT00380029|11477539|FG000|STARTED|Overall Study||20
10340549|NCT00380029|11477539|FG000|COMPLETED|Overall Study||20
10530069|NCT01404325|11682487|FG001|STARTED|Overall Study||63
10530070|NCT01404325|11682486|FG000|COMPLETED|Overall Study||63
10530071|NCT01404325|11682487|FG001|COMPLETED|Overall Study||61
10812153|NCT03733301|11974129|FG001|STARTED|Overall Study||109
10812154|NCT03733301|11974130|FG002|STARTED|Overall Study||111
10812155|NCT03733301|11974128|FG000|Received One Dose of Study Drug|Overall Study||108
10340550|NCT00380029|11477539|FG000|NOT COMPLETED|Overall Study||0
10340551|NCT00380068|11477547|FG000|STARTED|Overall Study||224
10340552|NCT00380068|11477547|FG000|COMPLETED|Overall Study||155
10340553|NCT00380068|11477547|FG000|NOT COMPLETED|Overall Study||69
10812156|NCT03733301|11974129|FG001|Received One Dose of Study Drug|Overall Study||109
10812157|NCT03733301|11974130|FG002|Received One Dose of Study Drug|Overall Study||111
10714811|NCT02688387|11880050|FG007|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
10714812|NCT02688387|11880051|FG008|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
10714813|NCT02688387|11880052|FG009|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
10714814|NCT02688387|11880053|FG010|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10714815|NCT02688387|11880054|FG011|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10714816|NCT02688387|11880055|FG012|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10714817|NCT02688387|11880056|FG013|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10426372|NCT00847288|11572028|FG001|NOT COMPLETED|Overall Study||47
10426373|NCT00847301|11572034|FG000|STARTED|Overall Study||428
10426374|NCT00847301|11572034|FG000|COMPLETED|Overall Study||374
10426375|NCT00847301|11572034|FG000|NOT COMPLETED|Overall Study||54
10426376|NCT00847379|11572041|FG000|STARTED|Overall Study||59
10426377|NCT00847379|11572042|FG001|STARTED|Overall Study||57
10426378|NCT00847379|11572043|FG002|STARTED|Overall Study||57
10426379|NCT00847379|11572041|FG000|As-treated Population|Overall Study||59
10426380|NCT00847379|11572042|FG001|As-treated Population|Overall Study||57
10426381|NCT00847379|11572043|FG002|As-treated Population|Overall Study||57
10426382|NCT00847379|11572041|FG000|COMPLETED|Overall Study||0
10426383|NCT00847379|11572042|FG001|COMPLETED|Overall Study||0
10426384|NCT00847379|11572043|FG002|COMPLETED|Overall Study||0
10426385|NCT00847379|11572041|FG000|NOT COMPLETED|Overall Study||59
10426386|NCT00847379|11572042|FG001|NOT COMPLETED|Overall Study||57
10426387|NCT00847379|11572043|FG002|NOT COMPLETED|Overall Study||57
10426388|NCT00847522|11572053|FG000|STARTED|Overall Study||90
10426389|NCT00847522|11572053|FG000|Phase I|Overall Study||10
10426390|NCT00847522|11572053|FG000|Phase II|Overall Study||80
10426391|NCT00847522|11572053|FG000|COMPLETED|Overall Study||90
10426392|NCT00847522|11572053|FG000|NOT COMPLETED|Overall Study||0
10426393|NCT00847535|11572057|FG000|STARTED|Overall Study||24
10426394|NCT00847535|11572058|FG001|STARTED|Overall Study||24
10426395|NCT00847535|11572059|FG002|STARTED|Overall Study||16
10426396|NCT00847535|11572057|FG000|10 Million AMDC|Overall Study||8
10426397|NCT00847535|11572058|FG001|10 Million AMDC|Overall Study||8
10426398|NCT00847535|11572059|FG002|10 Million AMDC|Overall Study||0
10426399|NCT00847535|11572057|FG000|50 Million AMDC|Overall Study||8
10714818|NCT02688387|11880057|FG014|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10714819|NCT02688387|11880058|FG015|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10714820|NCT02688387|11880059|FG016|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10426400|NCT00847535|11572058|FG001|50 Million AMDC|Overall Study||8
10426401|NCT00847535|11572059|FG002|50 Million AMDC|Overall Study||0
10426402|NCT00847535|11572057|FG000|100 Million AMDC|Overall Study||8
10426403|NCT00847535|11572058|FG001|100 Million AMDC|Overall Study||8
10426404|NCT00847535|11572059|FG002|100 Million AMDC|Overall Study||8
10812158|NCT03733301|11974128|FG000|COMPLETED|Overall Study||102
10426405|NCT00847535|11572057|FG000|200 Million AMDC|Overall Study||0
10426406|NCT00847535|11572058|FG001|200 Million AMDC|Overall Study||0
10340554|NCT00380081|11477557|FG000|STARTED|Overall Study||14
10340555|NCT00380081|11477558|FG001|STARTED|Overall Study||13
10340556|NCT00380081|11477559|FG002|STARTED|Overall Study||13
10340557|NCT00380081|11477560|FG003|STARTED|Overall Study||15
10340558|NCT00380081|11477561|FG004|STARTED|Overall Study||13
10340559|NCT00380081|11477562|FG005|STARTED|Overall Study||14
10340560|NCT00380081|11477557|FG000|COMPLETED|Overall Study||14
10340561|NCT00380081|11477558|FG001|COMPLETED|Overall Study||13
10340562|NCT00380081|11477559|FG002|COMPLETED|Overall Study||13
10340563|NCT00380081|11477560|FG003|COMPLETED|Overall Study||15
10340564|NCT00380081|11477561|FG004|COMPLETED|Overall Study||12
10340565|NCT00380081|11477562|FG005|COMPLETED|Overall Study||13
10340566|NCT00380081|11477557|FG000|NOT COMPLETED|Overall Study||0
10340567|NCT00380081|11477558|FG001|NOT COMPLETED|Overall Study||0
10340568|NCT00380081|11477559|FG002|NOT COMPLETED|Overall Study||0
10340569|NCT00380081|11477560|FG003|NOT COMPLETED|Overall Study||0
10340570|NCT00380081|11477561|FG004|NOT COMPLETED|Overall Study||1
10340571|NCT00380081|11477562|FG005|NOT COMPLETED|Overall Study||1
10340572|NCT00380250|11477572|FG000|STARTED|Overall Study||396
10340573|NCT00380250|11477573|FG001|STARTED|Overall Study||194
10340574|NCT00380250|11477572|FG000|COMPLETED|Overall Study||297
10340575|NCT00380250|11477573|FG001|COMPLETED|Overall Study||139
10340576|NCT00380250|11477572|FG000|NOT COMPLETED|Overall Study||99
10340577|NCT00380250|11477573|FG001|NOT COMPLETED|Overall Study||55
10714821|NCT02688387|11880060|FG017|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10714822|NCT02688387|11880061|FG018|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10714823|NCT02688387|11880062|FG019|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10714824|NCT02688387|11880063|FG020|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10714825|NCT02688387|11880064|FG021|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10714826|NCT02688387|11880043|FG000|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||1
10714827|NCT02688387|11880044|FG001|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10714828|NCT02688387|11880045|FG002|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10714829|NCT02688387|11880046|FG003|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10714830|NCT02688387|11880047|FG004|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10714831|NCT02688387|11880048|FG005|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10714832|NCT02688387|11880049|FG006|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10714833|NCT02688387|11880050|FG007|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10340578|NCT00380367|11477579|FG000|STARTED|Overall Study||110
10340579|NCT00380367|11477579|FG000|COMPLETED|Overall Study||108
10340580|NCT00380367|11477579|FG000|NOT COMPLETED|Overall Study||2
10340581|NCT00380393|11477585|FG000|STARTED|Month 8 (Cross-sectional Visit)||447
10340582|NCT00380393|11477586|FG001|STARTED|Month 8 (Cross-sectional Visit)||447
10340583|NCT00380393|11477585|FG000|COMPLETED|Month 8 (Cross-sectional Visit)||398
10340584|NCT00380393|11477586|FG001|COMPLETED|Month 8 (Cross-sectional Visit)||407
10340585|NCT00380393|11477585|FG000|NOT COMPLETED|Month 8 (Cross-sectional Visit)||49
10340586|NCT00380393|11477586|FG001|NOT COMPLETED|Month 8 (Cross-sectional Visit)||40
10340587|NCT00380393|11477585|FG000|STARTED|Month 14||447
10340588|NCT00380393|11477586|FG001|STARTED|Month 14||447
10340589|NCT00380393|11477585|FG000|COMPLETED|Month 14||390
10340590|NCT00380393|11477586|FG001|COMPLETED|Month 14||391
10340591|NCT00380393|11477585|FG000|NOT COMPLETED|Month 14||57
10340592|NCT00380393|11477586|FG001|NOT COMPLETED|Month 14||56
10340593|NCT00380588|11477594|FG000|STARTED|Overall Study||42
10340594|NCT00380588|11477595|FG001|STARTED|Overall Study||42
10340595|NCT00380588|11477594|FG000|Received at Least One Dose of Study Drug|Overall Study||41
10340596|NCT00380588|11477595|FG001|Received at Least One Dose of Study Drug|Overall Study||42
10340597|NCT00380588|11477594|FG000|COMPLETED|Overall Study|Treatment period reached 48 week maximum.|3
10340598|NCT00380588|11477595|FG001|COMPLETED|Overall Study|Treatment period reached 48 week maximum.|2
10340599|NCT00380588|11477594|FG000|NOT COMPLETED|Overall Study||39
10340600|NCT00380588|11477595|FG001|NOT COMPLETED|Overall Study||40
10340601|NCT00380692|11477603|FG000|STARTED|Study Period II - Double Blind||48
10340602|NCT00380692|11477604|FG001|STARTED|Study Period II - Double Blind||49
10340603|NCT00380692|11477603|FG000|COMPLETED|Study Period II - Double Blind||43
10340604|NCT00380692|11477604|FG001|COMPLETED|Study Period II - Double Blind||46
10340605|NCT00380692|11477603|FG000|NOT COMPLETED|Study Period II - Double Blind||5
10340606|NCT00380692|11477604|FG001|NOT COMPLETED|Study Period II - Double Blind||3
10340607|NCT00380692|11477603|FG000|STARTED|Study Period III - Open Label|One patient who completed Study Period II did not enter Study Period III.|42
10340608|NCT00380692|11477604|FG001|STARTED|Study Period III - Open Label||46
10340609|NCT00380692|11477603|FG000|COMPLETED|Study Period III - Open Label||36
10340610|NCT00380692|11477604|FG001|COMPLETED|Study Period III - Open Label||34
10340611|NCT00380692|11477603|FG000|NOT COMPLETED|Study Period III - Open Label||6
10340612|NCT00380692|11477604|FG001|NOT COMPLETED|Study Period III - Open Label||12
10340613|NCT00380718|11477610|FG000|STARTED|Overall Study||33
10340614|NCT00380718|11477610|FG000|Received at Least One Dose of Study Drug|Overall Study||33
10340615|NCT00380718|11477610|FG000|Received Escalated Dose in Cycle 2|Overall Study||25
10340616|NCT00380718|11477610|FG000|COMPLETED|Overall Study||15
10340617|NCT00380718|11477610|FG000|NOT COMPLETED|Overall Study||18
10340618|NCT00380744|11477621|FG000|STARTED|Overall Study||20
10340619|NCT00380744|11477622|FG001|STARTED|Overall Study||4
10340620|NCT00380744|11477623|FG002|STARTED|Overall Study||20
10340621|NCT00380744|11477624|FG003|STARTED|Overall Study||4
10340622|NCT00380744|11477625|FG004|STARTED|Overall Study||23
10340623|NCT00380744|11477626|FG005|STARTED|Overall Study||25
10340624|NCT00380744|11477627|FG006|STARTED|Overall Study||25
10340625|NCT00380744|11477621|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20
10530072|NCT01404325|11682486|FG000|NOT COMPLETED|Overall Study||4
10530073|NCT01404325|11682487|FG001|NOT COMPLETED|Overall Study||2
10530074|NCT01404429|11682495|FG000|STARTED|Overall Study||47
10530075|NCT01404429|11682496|FG001|STARTED|Overall Study||53
10530076|NCT01404429|11682495|FG000|COMPLETED|Overall Study||38
10530077|NCT01404429|11682496|FG001|COMPLETED|Overall Study||46
10530078|NCT01404429|11682495|FG000|NOT COMPLETED|Overall Study||9
10530079|NCT01404429|11682496|FG001|NOT COMPLETED|Overall Study||7
10530080|NCT01404559|11682506|FG000|STARTED|Overall Study||5
10530081|NCT01404559|11682507|FG001|STARTED|Overall Study||5
10530082|NCT01404559|11682508|FG002|STARTED|Overall Study||4
10530083|NCT01404559|11682509|FG003|STARTED|Overall Study||14
10530084|NCT01404559|11682506|FG000|COMPLETED|Overall Study||5
10530085|NCT01404559|11682507|FG001|COMPLETED|Overall Study||5
10530086|NCT01404559|11682508|FG002|COMPLETED|Overall Study||4
10530087|NCT01404559|11682509|FG003|COMPLETED|Overall Study||14
10530088|NCT01404559|11682506|FG000|NOT COMPLETED|Overall Study||0
10530089|NCT01404559|11682507|FG001|NOT COMPLETED|Overall Study||0
10530090|NCT01404559|11682508|FG002|NOT COMPLETED|Overall Study||0
10714834|NCT02688387|11880051|FG008|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10714835|NCT02688387|11880052|FG009|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10714836|NCT02688387|11880053|FG010|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10714837|NCT02688387|11880054|FG011|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10530091|NCT01404559|11682509|FG003|NOT COMPLETED|Overall Study||0
10530092|NCT01404572|11682516|FG000|STARTED|Overall Study||4
10530093|NCT01404572|11682517|FG001|STARTED|Overall Study||4
10530094|NCT01404572|11682518|FG002|STARTED|Overall Study||4
10530095|NCT01404572|11682516|FG000|COMPLETED|Overall Study||4
10530096|NCT01404572|11682517|FG001|COMPLETED|Overall Study||4
10530097|NCT01404572|11682518|FG002|COMPLETED|Overall Study||4
10530098|NCT01404572|11682516|FG000|NOT COMPLETED|Overall Study||0
10530099|NCT01404572|11682517|FG001|NOT COMPLETED|Overall Study||0
10530100|NCT01404572|11682518|FG002|NOT COMPLETED|Overall Study||0
10530101|NCT01404611|11682532|FG000|STARTED|Overall Study||112
10530102|NCT01404611|11682533|FG001|STARTED|Overall Study||108
10530103|NCT01404611|11682534|FG002|STARTED|Overall Study||111
10530104|NCT01404611|11682532|FG000|COMPLETED|Overall Study||104
10530105|NCT01404611|11682533|FG001|COMPLETED|Overall Study||89
10530106|NCT01404611|11682534|FG002|COMPLETED|Overall Study||106
10530107|NCT01404611|11682532|FG000|NOT COMPLETED|Overall Study||8
10530108|NCT01404611|11682533|FG001|NOT COMPLETED|Overall Study||19
10530109|NCT01404611|11682534|FG002|NOT COMPLETED|Overall Study||5
10530110|NCT01404650|11682542|FG000|STARTED|Overall Study|Twenty-five patients received a median of 2 cycles of AUY922.|25
10530111|NCT01404650|11682542|FG000|COMPLETED|Overall Study||25
10530112|NCT01404650|11682542|FG000|NOT COMPLETED|Overall Study||0
10530113|NCT01404832|11682546|FG000|STARTED|Overall Study||21
10530114|NCT01404832|11682546|FG000|COMPLETED|Overall Study||21
10530115|NCT01404832|11682546|FG000|NOT COMPLETED|Overall Study||0
10530116|NCT01404923|11682552|FG000|STARTED|Overall Study||222
10530117|NCT01404923|11682553|FG001|STARTED|Overall Study||214
10530118|NCT01404923|11682552|FG000|COMPLETED|Overall Study||199
10530119|NCT01404923|11682553|FG001|COMPLETED|Overall Study||197
10530120|NCT01404923|11682552|FG000|NOT COMPLETED|Overall Study||23
10530121|NCT01404923|11682553|FG001|NOT COMPLETED|Overall Study||17
10530122|NCT01404936|11682559|FG000|STARTED|Overall Study||30
10530123|NCT01404936|11682559|FG000|COMPLETED|Overall Study||30
10530124|NCT01404936|11682559|FG000|NOT COMPLETED|Overall Study||0
10530125|NCT01404949|11682563|FG000|STARTED|Overall Study||17
10530126|NCT01404949|11682563|FG000|COMPLETED|Overall Study||16
10530127|NCT01404949|11682563|FG000|NOT COMPLETED|Overall Study||1
10530128|NCT01404988|11682570|FG000|STARTED|Overall Study||33
10530129|NCT01404988|11682571|FG001|STARTED|Overall Study||33
10530130|NCT01404988|11682572|FG002|STARTED|Overall Study||33
10530131|NCT01404988|11682570|FG000|COMPLETED|Overall Study||27
10530132|NCT01404988|11682571|FG001|COMPLETED|Overall Study||29
10530133|NCT01404988|11682572|FG002|COMPLETED|Overall Study||30
10530134|NCT01404988|11682570|FG000|NOT COMPLETED|Overall Study||6
10530135|NCT01404988|11682571|FG001|NOT COMPLETED|Overall Study||4
10530136|NCT01404988|11682572|FG002|NOT COMPLETED|Overall Study||3
10530137|NCT01405027|11682585|FG000|STARTED|Overall Study||84
10530138|NCT01405027|11682586|FG001|STARTED|Overall Study||113
10530139|NCT01405027|11682585|FG000|COMPLETED|Overall Study||52
10530140|NCT01405027|11682586|FG001|COMPLETED|Overall Study||62
10530141|NCT01405027|11682585|FG000|NOT COMPLETED|Overall Study||32
10530142|NCT01405027|11682586|FG001|NOT COMPLETED|Overall Study||51
10530143|NCT01405053|11682596|FG000|STARTED|Overall Study||25
10530144|NCT01405053|11682597|FG001|STARTED|Overall Study||12
10530145|NCT01405053|11682596|FG000|COMPLETED|Overall Study||15
10340626|NCT00380744|11477622|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4
10340627|NCT00380744|11477623|FG002|Received at Least 1 Dose of Study Drug|Overall Study||20
10340628|NCT00380744|11477624|FG003|Received at Least 1 Dose of Study Drug|Overall Study||4
10340629|NCT00380744|11477625|FG004|Received at Least 1 Dose of Study Drug|Overall Study||23
10340630|NCT00380744|11477626|FG005|Received at Least 1 Dose of Study Drug|Overall Study||25
10340631|NCT00380744|11477627|FG006|Received at Least 1 Dose of Study Drug|Overall Study||25
10340632|NCT00380744|11477621|FG000|COMPLETED|Overall Study||19
10340633|NCT00380744|11477622|FG001|COMPLETED|Overall Study||4
10340634|NCT00380744|11477623|FG002|COMPLETED|Overall Study||20
10340635|NCT00380744|11477624|FG003|COMPLETED|Overall Study||4
10340636|NCT00380744|11477625|FG004|COMPLETED|Overall Study||23
10340637|NCT00380744|11477626|FG005|COMPLETED|Overall Study||25
10340638|NCT00380744|11477627|FG006|COMPLETED|Overall Study||24
10340639|NCT00380744|11477621|FG000|NOT COMPLETED|Overall Study||1
10340640|NCT00380744|11477622|FG001|NOT COMPLETED|Overall Study||0
10340641|NCT00380744|11477623|FG002|NOT COMPLETED|Overall Study||0
10340642|NCT00380744|11477624|FG003|NOT COMPLETED|Overall Study||0
10340643|NCT00380744|11477625|FG004|NOT COMPLETED|Overall Study||0
10340644|NCT00380744|11477626|FG005|NOT COMPLETED|Overall Study||0
10340645|NCT00380744|11477627|FG006|NOT COMPLETED|Overall Study||1
10340646|NCT00380861|11477646|FG000|STARTED|Overall Study||93
10340647|NCT00380861|11477647|FG001|STARTED|Overall Study|Two subjects received the PFC Sigma RP-F device but not the RP and their results are not included.|91
10340648|NCT00380861|11477646|FG000|COMPLETED|Overall Study||75
10340649|NCT00380861|11477647|FG001|COMPLETED|Overall Study||74
10340650|NCT00380861|11477646|FG000|NOT COMPLETED|Overall Study||18
10340651|NCT00380861|11477647|FG001|NOT COMPLETED|Overall Study||17
10340652|NCT00380874|11477655|FG000|STARTED|Overall Study||32
10340653|NCT00380874|11477656|FG001|STARTED|Overall Study||29
10340654|NCT00380874|11477655|FG000|COMPLETED|Overall Study||19
10340655|NCT00380874|11477656|FG001|COMPLETED|Overall Study||19
10340656|NCT00380874|11477655|FG000|NOT COMPLETED|Overall Study||13
10340657|NCT00380874|11477656|FG001|NOT COMPLETED|Overall Study||10
10340658|NCT00380978|11477664|FG000|STARTED|Overall Study||408
10340659|NCT00380978|11477665|FG001|STARTED|Overall Study||410
10340660|NCT00380978|11477664|FG000|COMPLETED|Overall Study||406
10340661|NCT00380978|11477665|FG001|COMPLETED|Overall Study||400
10340662|NCT00380978|11477664|FG000|NOT COMPLETED|Overall Study||2
10340663|NCT00380978|11477665|FG001|NOT COMPLETED|Overall Study||10
10340664|NCT00381004|11477671|FG000|STARTED|Overall Study||60
10340665|NCT00381004|11477671|FG000|COMPLETED|Overall Study||60
10340666|NCT00381004|11477671|FG000|NOT COMPLETED|Overall Study||0
10340667|NCT00381043|11477677|FG000|STARTED|Overall Study||51
10340668|NCT00381043|11477678|FG001|STARTED|Overall Study||49
10340669|NCT00381043|11477677|FG000|COMPLETED|Overall Study||39
10340670|NCT00381043|11477678|FG001|COMPLETED|Overall Study||41
10340671|NCT00381043|11477677|FG000|NOT COMPLETED|Overall Study||12
10340672|NCT00381043|11477678|FG001|NOT COMPLETED|Overall Study||8
10340673|NCT00381095|11477686|FG000|STARTED|Overall Study||72
10340674|NCT00381095|11477687|FG001|STARTED|Overall Study||80
10714838|NCT02688387|11880055|FG012|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10714839|NCT02688387|11880056|FG013|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10714840|NCT02688387|11880057|FG014|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10714841|NCT02688387|11880058|FG015|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10714842|NCT02688387|11880059|FG016|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10714843|NCT02688387|11880060|FG017|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10714844|NCT02688387|11880061|FG018|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10714845|NCT02688387|11880062|FG019|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10714846|NCT02688387|11880063|FG020|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10714847|NCT02688387|11880064|FG021|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
10714848|NCT02688387|11880043|FG000|STARTED|Part 1, Period 4 (up to 6 Days)||2
10714849|NCT02688387|11880044|FG001|STARTED|Part 1, Period 4 (up to 6 Days)||2
10714850|NCT02688387|11880045|FG002|STARTED|Part 1, Period 4 (up to 6 Days)||2
10714851|NCT02688387|11880046|FG003|STARTED|Part 1, Period 4 (up to 6 Days)||2
10714852|NCT02688387|11880047|FG004|STARTED|Part 1, Period 4 (up to 6 Days)||2
10714853|NCT02688387|11880048|FG005|STARTED|Part 1, Period 4 (up to 6 Days)||2
10714854|NCT02688387|11880049|FG006|STARTED|Part 1, Period 4 (up to 6 Days)||2
10714855|NCT02688387|11880050|FG007|STARTED|Part 1, Period 4 (up to 6 Days)||2
10812159|NCT03733301|11974129|FG001|COMPLETED|Overall Study||100
10812160|NCT03733301|11974130|FG002|COMPLETED|Overall Study||107
10812161|NCT03733301|11974128|FG000|NOT COMPLETED|Overall Study||7
10812162|NCT03733301|11974129|FG001|NOT COMPLETED|Overall Study||9
10812163|NCT03733301|11974130|FG002|NOT COMPLETED|Overall Study||4
10812164|NCT03732638|11974141|FG000|STARTED|Overall Study||370
10812165|NCT03732638|11974142|FG001|STARTED|Overall Study||371
10812166|NCT03732638|11974141|FG000|COMPLETED|Overall Study||316
10812167|NCT03732638|11974142|FG001|COMPLETED|Overall Study||310
10812168|NCT03732638|11974141|FG000|NOT COMPLETED|Overall Study||54
10812169|NCT03732638|11974142|FG001|NOT COMPLETED|Overall Study||61
10812170|NCT03732248|11974151|FG000|STARTED|Overall Study||11
10340675|NCT00381095|11477686|FG000|COMPLETED|Overall Study||59
10340676|NCT00381095|11477687|FG001|COMPLETED|Overall Study||59
10340677|NCT00381095|11477686|FG000|NOT COMPLETED|Overall Study||13
10340678|NCT00381095|11477687|FG001|NOT COMPLETED|Overall Study||21
10340679|NCT00381238|11477693|FG000|STARTED|Overall Study||33
10812171|NCT03732248|11974152|FG001|STARTED|Overall Study||10
10812172|NCT03732248|11974151|FG000|COMPLETED|Overall Study||10
10340680|NCT00381238|11477693|FG000|COMPLETED|Overall Study||21
10340681|NCT00381238|11477693|FG000|NOT COMPLETED|Overall Study||12
10340682|NCT00381303|11477699|FG000|STARTED|Overall Study||287
10340683|NCT00381303|11477700|FG001|STARTED|Overall Study||142
10340684|NCT00381303|11477699|FG000|COMPLETED|Overall Study||193
10340685|NCT00381303|11477700|FG001|COMPLETED|Overall Study||109
10340686|NCT00381303|11477699|FG000|NOT COMPLETED|Overall Study||94
10340687|NCT00381303|11477700|FG001|NOT COMPLETED|Overall Study||33
10340688|NCT00381550|11477718|FG000|STARTED|Overall Study||35
10340689|NCT00381550|11477718|FG000|COMPLETED|Overall Study||35
10340690|NCT00381550|11477718|FG000|NOT COMPLETED|Overall Study||0
10340691|NCT00381563|11477724|FG000|STARTED|Overall Study||41
10340692|NCT00381563|11477725|FG001|STARTED|Overall Study||39
10340693|NCT00381563|11477724|FG000|COMPLETED|Overall Study||34
10340694|NCT00381563|11477725|FG001|COMPLETED|Overall Study||33
10340695|NCT00381563|11477724|FG000|NOT COMPLETED|Overall Study||7
10340696|NCT00381563|11477725|FG001|NOT COMPLETED|Overall Study||6
10340697|NCT00381615|11477734|FG000|STARTED|Overall Study||48
10340698|NCT00381615|11477735|FG001|STARTED|Overall Study||50
10340699|NCT00381615|11477736|FG002|STARTED|Overall Study||25
10340700|NCT00381615|11477737|FG003|STARTED|Overall Study||24
10340701|NCT00381615|11477734|FG000|COMPLETED|Overall Study||44
10340702|NCT00381615|11477735|FG001|COMPLETED|Overall Study||45
10340703|NCT00381615|11477736|FG002|COMPLETED|Overall Study||24
10340704|NCT00381615|11477737|FG003|COMPLETED|Overall Study||22
10340705|NCT00381615|11477734|FG000|NOT COMPLETED|Overall Study||4
10340706|NCT00381615|11477735|FG001|NOT COMPLETED|Overall Study||5
10340707|NCT00381615|11477736|FG002|NOT COMPLETED|Overall Study||1
10340708|NCT00381615|11477737|FG003|NOT COMPLETED|Overall Study||2
10340709|NCT00381628|11477753|FG000|STARTED|Overall Study||18
10340710|NCT00381628|11477754|FG001|STARTED|Overall Study||27
10340711|NCT00381628|11477755|FG002|STARTED|Overall Study||0
10340712|NCT00381628|11477756|FG003|STARTED|Overall Study||14
10340713|NCT00381628|11477753|FG000|COMPLETED|Overall Study||18
10340714|NCT00381628|11477754|FG001|COMPLETED|Overall Study||27
10340715|NCT00381628|11477755|FG002|COMPLETED|Overall Study||0
10340716|NCT00381628|11477756|FG003|COMPLETED|Overall Study||14
10340717|NCT00381628|11477753|FG000|NOT COMPLETED|Overall Study||0
10340718|NCT00381628|11477754|FG001|NOT COMPLETED|Overall Study||0
10340719|NCT00381628|11477755|FG002|NOT COMPLETED|Overall Study||0
10340720|NCT00381628|11477756|FG003|NOT COMPLETED|Overall Study||0
10340721|NCT00381680|11477768|FG000|STARTED|Overall Study||206
10340722|NCT00381680|11477769|FG001|STARTED|Overall Study||69
10340723|NCT00381680|11477768|FG000|COMPLETED|Overall Study||81
10340724|NCT00381680|11477769|FG001|COMPLETED|Overall Study||19
10340725|NCT00381680|11477768|FG000|NOT COMPLETED|Overall Study||125
10340726|NCT00381680|11477769|FG001|NOT COMPLETED|Overall Study||50
10340727|NCT00381693|11477779|FG000|STARTED|Overall Study||10
10340728|NCT00381693|11477779|FG000|COMPLETED|Overall Study||2
10340729|NCT00381693|11477779|FG000|NOT COMPLETED|Overall Study||8
10340730|NCT00381706|11477789|FG000|STARTED|Overall Study||82
10340731|NCT00381706|11477790|FG001|STARTED|Overall Study||83
10340732|NCT00381706|11477791|FG002|STARTED|Overall Study||80
10340733|NCT00381706|11477789|FG000|COMPLETED|Overall Study||75
10530146|NCT01405053|11682597|FG001|COMPLETED|Overall Study||4
10530147|NCT01405053|11682596|FG000|NOT COMPLETED|Overall Study||10
10530148|NCT01405053|11682597|FG001|NOT COMPLETED|Overall Study||8
10530149|NCT01405196|11682607|FG000|STARTED|Overall Study||45
10530150|NCT01405196|11682608|FG001|STARTED|Overall Study||47
10530151|NCT01405196|11682609|FG002|STARTED|Overall Study||46
10530152|NCT01405196|11682610|FG003|STARTED|Overall Study||45
10340734|NCT00381706|11477790|FG001|COMPLETED|Overall Study||81
10340735|NCT00381706|11477791|FG002|COMPLETED|Overall Study||79
10340736|NCT00381706|11477789|FG000|NOT COMPLETED|Overall Study||7
10340737|NCT00381706|11477790|FG001|NOT COMPLETED|Overall Study||2
10340738|NCT00381706|11477791|FG002|NOT COMPLETED|Overall Study||1
10340739|NCT00381797|11477810|FG000|STARTED|Overall Study||18
10340740|NCT00381797|11477811|FG001|STARTED|Overall Study||17
10340741|NCT00381797|11477812|FG002|STARTED|Overall Study||10
10340742|NCT00381797|11477813|FG003|STARTED|Overall Study||15
10340743|NCT00381797|11477814|FG004|STARTED|Overall Study||37
10340744|NCT00381797|11477810|FG000|COMPLETED|Overall Study||17
10340745|NCT00381797|11477811|FG001|COMPLETED|Overall Study||16
10340746|NCT00381797|11477812|FG002|COMPLETED|Overall Study||10
10340747|NCT00381797|11477813|FG003|COMPLETED|Overall Study||14
10340748|NCT00381797|11477814|FG004|COMPLETED|Overall Study||35
10340749|NCT00381797|11477810|FG000|NOT COMPLETED|Overall Study||1
10340750|NCT00381797|11477811|FG001|NOT COMPLETED|Overall Study||1
10340751|NCT00381797|11477812|FG002|NOT COMPLETED|Overall Study||0
10340752|NCT00381797|11477813|FG003|NOT COMPLETED|Overall Study||1
10340753|NCT00381797|11477814|FG004|NOT COMPLETED|Overall Study||2
10340754|NCT00381810|11477847|FG000|STARTED|Treatment and Safety Follow-up||31
10340755|NCT00381810|11477847|FG000|COMPLETED|Treatment and Safety Follow-up||16
10340756|NCT00381810|11477847|FG000|NOT COMPLETED|Treatment and Safety Follow-up||15
10340757|NCT00381810|11477847|FG000|STARTED|B Cell Follow-up|Participants only entered the B cell follow-up period if their peripheral B cells were depleted.|7
10340758|NCT00381810|11477847|FG000|COMPLETED|B Cell Follow-up||0
10340759|NCT00381810|11477847|FG000|NOT COMPLETED|B Cell Follow-up||7
10340760|NCT00381849|11477853|FG000|STARTED|First Intervention||10
10340761|NCT00381849|11477854|FG001|STARTED|First Intervention||10
10340762|NCT00381849|11477853|FG000|COMPLETED|First Intervention||10
10340763|NCT00381849|11477854|FG001|COMPLETED|First Intervention||10
10340764|NCT00381849|11477853|FG000|NOT COMPLETED|First Intervention||0
10340765|NCT00381849|11477854|FG001|NOT COMPLETED|First Intervention||0
10340766|NCT00381849|11477853|FG000|STARTED|Wash Out||10
10340767|NCT00381849|11477854|FG001|STARTED|Wash Out||10
10340768|NCT00381849|11477853|FG000|COMPLETED|Wash Out||10
10340769|NCT00381849|11477854|FG001|COMPLETED|Wash Out||9
10340770|NCT00381849|11477853|FG000|NOT COMPLETED|Wash Out||0
10340771|NCT00381849|11477854|FG001|NOT COMPLETED|Wash Out||1
10340772|NCT00381849|11477853|FG000|STARTED|Second Intervention||10
10340773|NCT00381849|11477854|FG001|STARTED|Second Intervention||9
10340774|NCT00381849|11477853|FG000|COMPLETED|Second Intervention||10
10340775|NCT00381849|11477854|FG001|COMPLETED|Second Intervention||9
10340776|NCT00381849|11477853|FG000|NOT COMPLETED|Second Intervention||0
10340777|NCT00381849|11477854|FG001|NOT COMPLETED|Second Intervention||0
10340778|NCT00381849|11477853|FG000|STARTED|Open-label||10
10340779|NCT00381849|11477854|FG001|STARTED|Open-label||9
10340780|NCT00381849|11477853|FG000|COMPLETED|Open-label||10
10530153|NCT01405196|11682607|FG000|COMPLETED|Overall Study||34
10530154|NCT01405196|11682608|FG001|COMPLETED|Overall Study||35
10530155|NCT01405196|11682609|FG002|COMPLETED|Overall Study||23
10530156|NCT01405196|11682610|FG003|COMPLETED|Overall Study||36
10530157|NCT01405196|11682607|FG000|NOT COMPLETED|Overall Study||11
10530158|NCT01405196|11682608|FG001|NOT COMPLETED|Overall Study||12
10530159|NCT01405196|11682609|FG002|NOT COMPLETED|Overall Study||23
10530160|NCT01405196|11682610|FG003|NOT COMPLETED|Overall Study||9
10530161|NCT01405313|11682621|FG000|STARTED|Overall Study||21
10530162|NCT01405313|11682621|FG000|COMPLETED|Overall Study||21
10530163|NCT01405313|11682621|FG000|NOT COMPLETED|Overall Study||0
10530164|NCT01405456|11682631|FG000|STARTED|Overall Study||25
10530165|NCT01405456|11682632|FG001|STARTED|Overall Study||21
10530166|NCT01405456|11682631|FG000|COMPLETED|Overall Study||22
10530167|NCT01405456|11682632|FG001|COMPLETED|Overall Study||20
10530168|NCT01405456|11682631|FG000|NOT COMPLETED|Overall Study||3
10530169|NCT01405456|11682632|FG001|NOT COMPLETED|Overall Study||1
10530170|NCT01405469|11682638|FG000|STARTED|Overall Study||16
10530171|NCT01405469|11682638|FG000|COMPLETED|Overall Study||16
10530172|NCT01405469|11682638|FG000|NOT COMPLETED|Overall Study||0
10655002|NCT02206607|11815797|FG002|STARTED|Second Washout Period 5 to 10 Days||9
10655003|NCT02206607|11815798|FG003|STARTED|Second Washout Period 5 to 10 Days||10
10655004|NCT02206607|11815799|FG004|STARTED|Second Washout Period 5 to 10 Days||10
10655005|NCT02206607|11815795|FG000|COMPLETED|Second Washout Period 5 to 10 Days||0
10655006|NCT02206607|11815796|FG001|COMPLETED|Second Washout Period 5 to 10 Days||9
10655007|NCT02206607|11815797|FG002|COMPLETED|Second Washout Period 5 to 10 Days||9
10655008|NCT02206607|11815798|FG003|COMPLETED|Second Washout Period 5 to 10 Days||10
10655009|NCT02206607|11815799|FG004|COMPLETED|Second Washout Period 5 to 10 Days||10
10655010|NCT02206607|11815795|FG000|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
10655011|NCT02206607|11815796|FG001|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
10655012|NCT02206607|11815797|FG002|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
10655013|NCT02206607|11815798|FG003|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
10655014|NCT02206607|11815799|FG004|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
10655015|NCT02206607|11815795|FG000|STARTED|Third Intervention Period||0
10655016|NCT02206607|11815796|FG001|STARTED|Third Intervention Period||9
10655017|NCT02206607|11815797|FG002|STARTED|Third Intervention Period||9
10655018|NCT02206607|11815798|FG003|STARTED|Third Intervention Period||10
10655019|NCT02206607|11815799|FG004|STARTED|Third Intervention Period||10
10655020|NCT02206607|11815795|FG000|COMPLETED|Third Intervention Period||0
10655021|NCT02206607|11815796|FG001|COMPLETED|Third Intervention Period||9
10655022|NCT02206607|11815797|FG002|COMPLETED|Third Intervention Period||9
10655023|NCT02206607|11815798|FG003|COMPLETED|Third Intervention Period||10
10655024|NCT02206607|11815799|FG004|COMPLETED|Third Intervention Period||10
10714856|NCT02688387|11880051|FG008|STARTED|Part 1, Period 4 (up to 6 Days)||2
10530173|NCT01405508|11682647|FG000|STARTED|Overall Study||26
10655025|NCT02206607|11815795|FG000|NOT COMPLETED|Third Intervention Period||0
10714857|NCT02688387|11880052|FG009|STARTED|Part 1, Period 4 (up to 6 Days)||2
10530174|NCT01405508|11682648|FG001|STARTED|Overall Study||26
10530175|NCT01405508|11682649|FG002|STARTED|Overall Study||27
10530176|NCT01405508|11682650|FG003|STARTED|Overall Study||26
10655026|NCT02206607|11815796|FG001|NOT COMPLETED|Third Intervention Period||0
10655027|NCT02206607|11815797|FG002|NOT COMPLETED|Third Intervention Period||0
10714858|NCT02688387|11880053|FG010|STARTED|Part 1, Period 4 (up to 6 Days)||0
10714859|NCT02688387|11880054|FG011|STARTED|Part 1, Period 4 (up to 6 Days)||0
10714860|NCT02688387|11880055|FG012|STARTED|Part 1, Period 4 (up to 6 Days)||0
10714861|NCT02688387|11880056|FG013|STARTED|Part 1, Period 4 (up to 6 Days)||0
10714862|NCT02688387|11880057|FG014|STARTED|Part 1, Period 4 (up to 6 Days)||0
10714863|NCT02688387|11880058|FG015|STARTED|Part 1, Period 4 (up to 6 Days)||0
10340781|NCT00381849|11477854|FG001|COMPLETED|Open-label||9
10340782|NCT00381849|11477853|FG000|NOT COMPLETED|Open-label||0
10340783|NCT00381849|11477854|FG001|NOT COMPLETED|Open-label||0
10340784|NCT00381862|11477860|FG000|STARTED|Overall Study||54
10340785|NCT00381862|11477860|FG000|COMPLETED|Overall Study||44
10340786|NCT00381862|11477860|FG000|NOT COMPLETED|Overall Study||10
10340787|NCT00381888|11477864|FG000|STARTED|Overall Study||44
10340788|NCT00381888|11477864|FG000|COMPLETED|Overall Study||27
10340789|NCT00381888|11477864|FG000|NOT COMPLETED|Overall Study||17
10340790|NCT00381940|11477868|FG000|STARTED|Overall Study||26
10340791|NCT00381940|11477868|FG000|COMPLETED|Overall Study||21
10340792|NCT00381940|11477868|FG000|NOT COMPLETED|Overall Study||5
10340793|NCT00381966|11477872|FG000|STARTED|Overall Study||5
10340794|NCT00381966|11477872|FG000|COMPLETED|Overall Study||5
10340795|NCT00381966|11477872|FG000|NOT COMPLETED|Overall Study||0
10340796|NCT00382018|11477880|FG000|STARTED|Overall Study||276
10340797|NCT00382018|11477881|FG001|STARTED|Overall Study||165
10340798|NCT00382018|11477882|FG002|STARTED|Overall Study||64
10340799|NCT00382018|11477883|FG003|STARTED|Overall Study||59
10530212|NCT01405820|11682695|FG003|STARTED|Randomized Treatment Period||54
10340800|NCT00382018|11477880|FG000|COMPLETED|Overall Study|This group of patients did not receive protocol treatment.|276
10340801|NCT00382018|11477881|FG001|COMPLETED|Overall Study||0
10340802|NCT00382018|11477882|FG002|COMPLETED|Overall Study||0
10340803|NCT00382018|11477883|FG003|COMPLETED|Overall Study||0
10340804|NCT00382018|11477880|FG000|NOT COMPLETED|Overall Study||0
10340805|NCT00382018|11477881|FG001|NOT COMPLETED|Overall Study||165
10340806|NCT00382018|11477882|FG002|NOT COMPLETED|Overall Study||64
10340807|NCT00382018|11477883|FG003|NOT COMPLETED|Overall Study||59
10340808|NCT00382031|11477898|FG000|STARTED|Overall Study|Of the 191 randomized patients 189 received at least one infusion of zalutumumab|191
10340809|NCT00382031|11477899|FG001|STARTED|Overall Study|Of the 95 randomized patients 94 attended Visit2.|95
10340810|NCT00382031|11477898|FG000|COMPLETED|Overall Study||191
10340811|NCT00382031|11477899|FG001|COMPLETED|Overall Study||95
10340812|NCT00382031|11477898|FG000|NOT COMPLETED|Overall Study||0
10340813|NCT00382031|11477899|FG001|NOT COMPLETED|Overall Study||0
10340814|NCT00382070|11477907|FG000|STARTED|Overall Study||1983
10340815|NCT00382070|11477908|FG001|STARTED|Overall Study||1983
10340816|NCT00382070|11477907|FG000|COMPLETED|Overall Study||1950
10340817|NCT00382070|11477908|FG001|COMPLETED|Overall Study||1953
10340818|NCT00382070|11477907|FG000|NOT COMPLETED|Overall Study||33
10340819|NCT00382070|11477908|FG001|NOT COMPLETED|Overall Study||30
10340820|NCT00382109|11477916|FG000|STARTED|Overall Study||76
10340821|NCT00382109|11477917|FG001|STARTED|Overall Study||70
10340822|NCT00382109|11477916|FG000|COMPLETED|Overall Study||64
10340823|NCT00382109|11477917|FG001|COMPLETED|Overall Study||66
10340824|NCT00382109|11477916|FG000|NOT COMPLETED|Overall Study||12
10714864|NCT02688387|11880059|FG016|STARTED|Part 1, Period 4 (up to 6 Days)||0
10714865|NCT02688387|11880060|FG017|STARTED|Part 1, Period 4 (up to 6 Days)||0
10340825|NCT00382109|11477917|FG001|NOT COMPLETED|Overall Study||4
10340826|NCT00382148|11477928|FG000|STARTED|Overall Study||4
10340827|NCT00382148|11477929|FG001|STARTED|Overall Study||7
10340828|NCT00382148|11477928|FG000|COMPLETED|Overall Study||3
10340829|NCT00382148|11477929|FG001|COMPLETED|Overall Study||7
10340830|NCT00382148|11477928|FG000|NOT COMPLETED|Overall Study||1
10714866|NCT02688387|11880061|FG018|STARTED|Part 1, Period 4 (up to 6 Days)||0
10714867|NCT02688387|11880062|FG019|STARTED|Part 1, Period 4 (up to 6 Days)||0
10714868|NCT02688387|11880063|FG020|STARTED|Part 1, Period 4 (up to 6 Days)||0
10714869|NCT02688387|11880064|FG021|STARTED|Part 1, Period 4 (up to 6 Days)||0
10714870|NCT02688387|11880043|FG000|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
10714871|NCT02688387|11880044|FG001|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
10714872|NCT02688387|11880045|FG002|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
10714873|NCT02688387|11880046|FG003|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
10714874|NCT02688387|11880047|FG004|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
10340831|NCT00382148|11477929|FG001|NOT COMPLETED|Overall Study||0
10530177|NCT01405508|11682647|FG000|COMPLETED|Overall Study||25
10530178|NCT01405508|11682648|FG001|COMPLETED|Overall Study||25
10530179|NCT01405508|11682649|FG002|COMPLETED|Overall Study||27
10530180|NCT01405508|11682650|FG003|COMPLETED|Overall Study||26
10530181|NCT01405508|11682647|FG000|NOT COMPLETED|Overall Study||1
10530182|NCT01405508|11682648|FG001|NOT COMPLETED|Overall Study||1
10530183|NCT01405508|11682649|FG002|NOT COMPLETED|Overall Study||0
10530184|NCT01405508|11682650|FG003|NOT COMPLETED|Overall Study||0
10530185|NCT01405560|11682660|FG000|STARTED|Overall Study||42
10714875|NCT02688387|11880048|FG005|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
10714876|NCT02688387|11880049|FG006|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
10714877|NCT02688387|11880050|FG007|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
10714878|NCT02688387|11880051|FG008|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
10714879|NCT02688387|11880052|FG009|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
10714880|NCT02688387|11880053|FG010|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10714881|NCT02688387|11880054|FG011|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10714882|NCT02688387|11880055|FG012|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10530186|NCT01405560|11682660|FG000|COMPLETED|Overall Study||41
10530187|NCT01405560|11682660|FG000|NOT COMPLETED|Overall Study||1
10530188|NCT01405742|11682664|FG000|STARTED|Overall Study||2
10530189|NCT01405742|11682665|FG001|STARTED|Overall Study||2
10530190|NCT01405742|11682664|FG000|COMPLETED|Overall Study||1
10530191|NCT01405742|11682665|FG001|COMPLETED|Overall Study||2
10530192|NCT01405742|11682664|FG000|NOT COMPLETED|Overall Study||1
10530193|NCT01405742|11682665|FG001|NOT COMPLETED|Overall Study||0
10530194|NCT01405768|11682673|FG000|STARTED|Overall Study||28
10530195|NCT01405768|11682674|FG001|STARTED|Overall Study||28
10530196|NCT01405768|11682673|FG000|COMPLETED|Overall Study||24
10530197|NCT01405768|11682674|FG001|COMPLETED|Overall Study||28
10530198|NCT01405768|11682673|FG000|NOT COMPLETED|Overall Study||4
10530199|NCT01405768|11682674|FG001|NOT COMPLETED|Overall Study||0
10530200|NCT01405794|11682680|FG000|STARTED|First Dose Placebo (14 Days)||12
10530201|NCT01405794|11682680|FG000|COMPLETED|First Dose Placebo (14 Days)||12
10530202|NCT01405794|11682680|FG000|NOT COMPLETED|First Dose Placebo (14 Days)||0
10530203|NCT01405794|11682680|FG000|STARTED|72 hr Washout||12
10530204|NCT01405794|11682680|FG000|COMPLETED|72 hr Washout||12
10530205|NCT01405794|11682680|FG000|NOT COMPLETED|72 hr Washout||0
10530206|NCT01405794|11682680|FG000|STARTED|Second Dose 32ppm Oral Silver (14 Days)||12
10530207|NCT01405794|11682680|FG000|COMPLETED|Second Dose 32ppm Oral Silver (14 Days)||12
10530208|NCT01405794|11682680|FG000|NOT COMPLETED|Second Dose 32ppm Oral Silver (14 Days)||0
10530209|NCT01405820|11682692|FG000|STARTED|Randomized Treatment Period||54
10530210|NCT01405820|11682693|FG001|STARTED|Randomized Treatment Period||45
10530211|NCT01405820|11682694|FG002|STARTED|Randomized Treatment Period||52
10530213|NCT01405820|11682696|FG004|STARTED|Randomized Treatment Period||47
10530214|NCT01405820|11682697|FG005|STARTED|Randomized Treatment Period||38
10655028|NCT02206607|11815798|FG003|NOT COMPLETED|Third Intervention Period||0
10655029|NCT02206607|11815799|FG004|NOT COMPLETED|Third Intervention Period||0
10655030|NCT02206607|11815795|FG000|STARTED|Third Washout Period 5 to 10 Days||0
10655031|NCT02206607|11815796|FG001|STARTED|Third Washout Period 5 to 10 Days||9
10655032|NCT02206607|11815797|FG002|STARTED|Third Washout Period 5 to 10 Days||9
10655033|NCT02206607|11815798|FG003|STARTED|Third Washout Period 5 to 10 Days||10
10655034|NCT02206607|11815799|FG004|STARTED|Third Washout Period 5 to 10 Days||10
10655035|NCT02206607|11815795|FG000|COMPLETED|Third Washout Period 5 to 10 Days||0
10655036|NCT02206607|11815796|FG001|COMPLETED|Third Washout Period 5 to 10 Days||9
10655037|NCT02206607|11815797|FG002|COMPLETED|Third Washout Period 5 to 10 Days||9
10655038|NCT02206607|11815798|FG003|COMPLETED|Third Washout Period 5 to 10 Days||10
10655039|NCT02206607|11815799|FG004|COMPLETED|Third Washout Period 5 to 10 Days||10
10714883|NCT02688387|11880056|FG013|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10714884|NCT02688387|11880057|FG014|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10655040|NCT02206607|11815795|FG000|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
10655041|NCT02206607|11815796|FG001|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
10714885|NCT02688387|11880058|FG015|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10530215|NCT01405820|11682692|FG000|Safety Population|Randomized Treatment Period||54
10340832|NCT00382174|11477937|FG000|STARTED|Overall Study||18
10714886|NCT02688387|11880059|FG016|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10714887|NCT02688387|11880060|FG017|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10714888|NCT02688387|11880061|FG018|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10714889|NCT02688387|11880062|FG019|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10714890|NCT02688387|11880063|FG020|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10714891|NCT02688387|11880064|FG021|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10714892|NCT02688387|11880043|FG000|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10714893|NCT02688387|11880044|FG001|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10714894|NCT02688387|11880045|FG002|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10714895|NCT02688387|11880046|FG003|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10714896|NCT02688387|11880047|FG004|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10714897|NCT02688387|11880048|FG005|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10714898|NCT02688387|11880049|FG006|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10340833|NCT00382174|11477938|FG001|STARTED|Overall Study||54
10340834|NCT00382174|11477939|FG002|STARTED|Overall Study||72
10340835|NCT00382174|11477937|FG000|COMPLETED|Overall Study||14
10530216|NCT01405820|11682693|FG001|Safety Population|Randomized Treatment Period||45
10530217|NCT01405820|11682694|FG002|Safety Population|Randomized Treatment Period||52
10530218|NCT01405820|11682695|FG003|Safety Population|Randomized Treatment Period|1 participant did not receive any study medication.|53
10530219|NCT01405820|11682696|FG004|Safety Population|Randomized Treatment Period||47
10530220|NCT01405820|11682697|FG005|Safety Population|Randomized Treatment Period||38
10530221|NCT01405820|11682692|FG000|COMPLETED|Randomized Treatment Period||43
10530222|NCT01405820|11682693|FG001|COMPLETED|Randomized Treatment Period||35
10530223|NCT01405820|11682694|FG002|COMPLETED|Randomized Treatment Period||9
10530224|NCT01405820|11682695|FG003|COMPLETED|Randomized Treatment Period||3
10530225|NCT01405820|11682696|FG004|COMPLETED|Randomized Treatment Period||2
10530226|NCT01405820|11682697|FG005|COMPLETED|Randomized Treatment Period||1
10530227|NCT01405820|11682692|FG000|NOT COMPLETED|Randomized Treatment Period||11
10530228|NCT01405820|11682693|FG001|NOT COMPLETED|Randomized Treatment Period||10
10530229|NCT01405820|11682694|FG002|NOT COMPLETED|Randomized Treatment Period||43
10530230|NCT01405820|11682695|FG003|NOT COMPLETED|Randomized Treatment Period||51
10530231|NCT01405820|11682696|FG004|NOT COMPLETED|Randomized Treatment Period||45
10530232|NCT01405820|11682697|FG005|NOT COMPLETED|Randomized Treatment Period||37
10530233|NCT01405820|11682692|FG000|STARTED|Open-Label Treatment Period|1 participant discontinued randomized period due to an adverse event but entered open-label period.|44
10530234|NCT01405820|11682693|FG001|STARTED|Open-Label Treatment Period||35
10530235|NCT01405820|11682694|FG002|STARTED|Open-Label Treatment Period||42
10530236|NCT01405820|11682695|FG003|STARTED|Open-Label Treatment Period||42
10530237|NCT01405820|11682696|FG004|STARTED|Open-Label Treatment Period||42
10530238|NCT01405820|11682697|FG005|STARTED|Open-Label Treatment Period||32
10530239|NCT01405820|11682692|FG000|COMPLETED|Open-Label Treatment Period||40
10530240|NCT01405820|11682693|FG001|COMPLETED|Open-Label Treatment Period||33
10530241|NCT01405820|11682694|FG002|COMPLETED|Open-Label Treatment Period||39
10530242|NCT01405820|11682695|FG003|COMPLETED|Open-Label Treatment Period||37
10530243|NCT01405820|11682696|FG004|COMPLETED|Open-Label Treatment Period||40
10530244|NCT01405820|11682697|FG005|COMPLETED|Open-Label Treatment Period||30
10530245|NCT01405820|11682692|FG000|NOT COMPLETED|Open-Label Treatment Period||4
10530246|NCT01405820|11682693|FG001|NOT COMPLETED|Open-Label Treatment Period||2
10530247|NCT01405820|11682694|FG002|NOT COMPLETED|Open-Label Treatment Period||3
10530248|NCT01405820|11682695|FG003|NOT COMPLETED|Open-Label Treatment Period||5
10530249|NCT01405820|11682696|FG004|NOT COMPLETED|Open-Label Treatment Period||2
10530250|NCT01405820|11682697|FG005|NOT COMPLETED|Open-Label Treatment Period||2
10530251|NCT01405898|11682719|FG000|STARTED|Overall Study||34
10340836|NCT00382174|11477938|FG001|COMPLETED|Overall Study||37
10340837|NCT00382174|11477939|FG002|COMPLETED|Overall Study||51
10340838|NCT00382174|11477937|FG000|NOT COMPLETED|Overall Study||4
10340839|NCT00382174|11477938|FG001|NOT COMPLETED|Overall Study||17
10340840|NCT00382174|11477939|FG002|NOT COMPLETED|Overall Study||21
10340841|NCT00382265|11477949|FG000|STARTED|Overall Study||267
10340842|NCT00382265|11477950|FG001|STARTED|Overall Study||245
10340843|NCT00382265|11477949|FG000|COMPLETED|Overall Study||258
10340844|NCT00382265|11477950|FG001|COMPLETED|Overall Study||239
10340845|NCT00382265|11477949|FG000|NOT COMPLETED|Overall Study||9
10340846|NCT00382265|11477950|FG001|NOT COMPLETED|Overall Study||6
10340847|NCT00382291|11477963|FG000|STARTED|Overall Study||18
10340848|NCT00382291|11477964|FG001|STARTED|Overall Study||17
10340849|NCT00382291|11477965|FG002|STARTED|Overall Study||21
10340850|NCT00382291|11477963|FG000|COMPLETED|Overall Study||14
10340851|NCT00382291|11477964|FG001|COMPLETED|Overall Study||10
10340852|NCT00382291|11477965|FG002|COMPLETED|Overall Study||13
10340853|NCT00382291|11477963|FG000|NOT COMPLETED|Overall Study||4
10340854|NCT00382291|11477964|FG001|NOT COMPLETED|Overall Study||7
10340855|NCT00382291|11477965|FG002|NOT COMPLETED|Overall Study||8
10340856|NCT00382408|11477977|FG000|STARTED|Overall Study||3031
10340857|NCT00382408|11477978|FG001|STARTED|Overall Study||1009
10340858|NCT00382408|11477977|FG000|COMPLETED|Overall Study||2887
10340859|NCT00382408|11477978|FG001|COMPLETED|Overall Study||955
10340860|NCT00382408|11477977|FG000|NOT COMPLETED|Overall Study||144
10655042|NCT02206607|11815797|FG002|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
10655043|NCT02206607|11815798|FG003|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
10340861|NCT00382408|11477978|FG001|NOT COMPLETED|Overall Study||54
10340862|NCT00382590|11477986|FG000|STARTED|Overall Study||4
10340863|NCT00382590|11477987|FG001|STARTED|Overall Study||6
10340864|NCT00382590|11477986|FG000|COMPLETED|Overall Study||4
10340865|NCT00382590|11477987|FG001|COMPLETED|Overall Study||6
10340866|NCT00382590|11477986|FG000|NOT COMPLETED|Overall Study||0
10340867|NCT00382590|11477987|FG001|NOT COMPLETED|Overall Study||0
10340868|NCT00382720|11477996|FG000|STARTED|Overall Study||79
10340869|NCT00382720|11477997|FG001|STARTED|Overall Study||89
10340870|NCT00382720|11477998|FG002|STARTED|Overall Study||86
10655044|NCT02206607|11815799|FG004|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
10655045|NCT02206607|11815795|FG000|STARTED|Fourth Intervention Period||0
10340871|NCT00382720|11477996|FG000|Administered Non-Optimal Dose (Part I)|Overall Study||10
10340872|NCT00382720|11477997|FG001|Administered Non-Optimal Dose (Part I)|Overall Study||11
10340873|NCT00382720|11477998|FG002|Administered Non-Optimal Dose (Part I)|Overall Study||0
10340874|NCT00382720|11477996|FG000|Administered Optimal Dose (Parts I & II)|Overall Study||78
10340875|NCT00382720|11477997|FG001|Administered Optimal Dose (Parts I & II)|Overall Study||88
10340876|NCT00382720|11477998|FG002|Administered Optimal Dose (Parts I & II)|Overall Study||82
10340877|NCT00382720|11477996|FG000|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|78
10340878|NCT00382720|11477997|FG001|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|88
10340879|NCT00382720|11477998|FG002|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|82
10340880|NCT00382720|11477996|FG000|COMPLETED|Overall Study||0
10340881|NCT00382720|11477997|FG001|COMPLETED|Overall Study||0
10340882|NCT00382720|11477998|FG002|COMPLETED|Overall Study||0
10340883|NCT00382720|11477996|FG000|NOT COMPLETED|Overall Study||79
10340884|NCT00382720|11477997|FG001|NOT COMPLETED|Overall Study||89
10340885|NCT00382720|11477998|FG002|NOT COMPLETED|Overall Study||86
10340886|NCT00382733|11478006|FG000|STARTED|Overall Study||3
10340887|NCT00382733|11478007|FG001|STARTED|Overall Study||4
10340888|NCT00382733|11478008|FG002|STARTED|Overall Study||3
10340889|NCT00382733|11478009|FG003|STARTED|Overall Study||14
10340890|NCT00382733|11478010|FG004|STARTED|Overall Study||2
10340891|NCT00382733|11478006|FG000|COMPLETED|Overall Study||3
10340892|NCT00382733|11478007|FG001|COMPLETED|Overall Study|1 subject withdrew consent before completing Cycle 1 - that subject was replaced|3
10340893|NCT00382733|11478008|FG002|COMPLETED|Overall Study||3
10340894|NCT00382733|11478009|FG003|COMPLETED|Overall Study||14
10340895|NCT00382733|11478010|FG004|COMPLETED|Overall Study||2
10340896|NCT00382733|11478006|FG000|NOT COMPLETED|Overall Study||0
10340897|NCT00382733|11478007|FG001|NOT COMPLETED|Overall Study||1
10340898|NCT00382733|11478008|FG002|NOT COMPLETED|Overall Study||0
10340899|NCT00382733|11478009|FG003|NOT COMPLETED|Overall Study||0
10340900|NCT00382733|11478010|FG004|NOT COMPLETED|Overall Study||0
10340901|NCT00382785|11478025|FG000|STARTED|Overall Study||25
10340902|NCT00382785|11478026|FG001|STARTED|Overall Study||26
10340903|NCT00382785|11478025|FG000|COMPLETED|Overall Study||25
10340904|NCT00382785|11478026|FG001|COMPLETED|Overall Study||26
10340905|NCT00382785|11478025|FG000|NOT COMPLETED|Overall Study||0
10340906|NCT00382785|11478026|FG001|NOT COMPLETED|Overall Study||0
10340907|NCT00382824|11478034|FG000|STARTED|Overall Study||32
10340908|NCT00382824|11478035|FG001|STARTED|Overall Study||29
10340909|NCT00382824|11478034|FG000|COMPLETED|Overall Study||20
10340910|NCT00382824|11478035|FG001|COMPLETED|Overall Study||16
10340911|NCT00382824|11478034|FG000|NOT COMPLETED|Overall Study||12
10340912|NCT00382824|11478035|FG001|NOT COMPLETED|Overall Study||13
10340913|NCT00382863|11478043|FG000|STARTED|Overall Study||96
10340914|NCT00382863|11478044|FG001|STARTED|Overall Study||114
10340915|NCT00382863|11478043|FG000|COMPLETED|Overall Study||81
10340916|NCT00382863|11478044|FG001|COMPLETED|Overall Study||78
10340917|NCT00382863|11478043|FG000|NOT COMPLETED|Overall Study||15
10340918|NCT00382863|11478044|FG001|NOT COMPLETED|Overall Study||36
10340919|NCT00382928|11478052|FG000|STARTED|Overall Study||97
10340920|NCT00382928|11478053|FG001|STARTED|Overall Study||95
10340921|NCT00382928|11478052|FG000|COMPLETED|Overall Study||97
10340922|NCT00382928|11478053|FG001|COMPLETED|Overall Study||95
10340923|NCT00382928|11478052|FG000|NOT COMPLETED|Overall Study||0
10340924|NCT00382928|11478053|FG001|NOT COMPLETED|Overall Study||0
10530309|NCT01406444|11682797|FG001|STARTED|Overall Study||33
10340925|NCT00382967|11478066|FG000|STARTED|Overall Study|135 subjects enrolled at the start of the study, however, 13 subjects withdrew prior to dosing.|122
10340926|NCT00382967|11478067|FG001|STARTED|Overall Study||138
10340927|NCT00382967|11478066|FG000|COMPLETED|Overall Study|Patient lost to followup and the data was not recorded.|121
10340928|NCT00382967|11478067|FG001|COMPLETED|Overall Study|Subject dosed in error, should not have received Datscan product|137
10340929|NCT00382967|11478066|FG000|NOT COMPLETED|Overall Study||1
10340930|NCT00382967|11478067|FG001|NOT COMPLETED|Overall Study||1
10340931|NCT00382993|11478073|FG000|STARTED|Migraine Attack 1 (Period 1)||84
10340932|NCT00382993|11478074|FG001|STARTED|Migraine Attack 1 (Period 1)||85
10340933|NCT00382993|11478073|FG000|COMPLETED|Migraine Attack 1 (Period 1)|Participant considered to have completed period if treated a migraine with investigational product.|70
10340934|NCT00382993|11478074|FG001|COMPLETED|Migraine Attack 1 (Period 1)||67
10340935|NCT00382993|11478073|FG000|NOT COMPLETED|Migraine Attack 1 (Period 1)||14
10340936|NCT00382993|11478074|FG001|NOT COMPLETED|Migraine Attack 1 (Period 1)||18
10340937|NCT00382993|11478073|FG000|STARTED|Migraine Attack 2 (Period 2)||70
10340938|NCT00382993|11478074|FG001|STARTED|Migraine Attack 2 (Period 2)||67
10340939|NCT00382993|11478073|FG000|COMPLETED|Migraine Attack 2 (Period 2)||68
10340940|NCT00382993|11478074|FG001|COMPLETED|Migraine Attack 2 (Period 2)||63
10340941|NCT00382993|11478073|FG000|NOT COMPLETED|Migraine Attack 2 (Period 2)||2
10340942|NCT00382993|11478074|FG001|NOT COMPLETED|Migraine Attack 2 (Period 2)||4
10340943|NCT00383019|11478082|FG000|STARTED|Overall Study||144
10340944|NCT00383019|11478083|FG001|STARTED|Overall Study||145
10340945|NCT00383019|11478082|FG000|COMPLETED|Overall Study||139
10340946|NCT00383019|11478083|FG001|COMPLETED|Overall Study||143
10340947|NCT00383019|11478082|FG000|NOT COMPLETED|Overall Study||5
10340948|NCT00383019|11478083|FG001|NOT COMPLETED|Overall Study||2
10340949|NCT00383071|11478093|FG000|STARTED|Overall Study||25
10340950|NCT00383071|11478094|FG001|STARTED|Overall Study||25
10340951|NCT00383071|11478095|FG002|STARTED|Overall Study||51
10340952|NCT00383071|11478096|FG003|STARTED|Overall Study||25
10340953|NCT00383071|11478093|FG000|COMPLETED|Overall Study||25
10530252|NCT01405898|11682720|FG001|STARTED|Overall Study||34
10530253|NCT01405898|11682719|FG000|COMPLETED|Overall Study||32
10530254|NCT01405898|11682720|FG001|COMPLETED|Overall Study||32
10530255|NCT01405898|11682719|FG000|NOT COMPLETED|Overall Study||2
10530256|NCT01405898|11682720|FG001|NOT COMPLETED|Overall Study||2
10530257|NCT01405911|11682729|FG000|STARTED|Overall Study||83
10530258|NCT01405911|11682730|FG001|STARTED|Overall Study||82
10530259|NCT01405911|11682731|FG002|STARTED|Overall Study||77
10530260|NCT01405911|11682729|FG000|Treated|Overall Study||82
10530261|NCT01405911|11682730|FG001|Treated|Overall Study|1 participant received study drug but was discontinued due to pre-treatment lab AE.|82
10530262|NCT01405911|11682731|FG002|Treated|Overall Study||77
10530263|NCT01405911|11682729|FG000|COMPLETED|Overall Study||79
10530264|NCT01405911|11682730|FG001|COMPLETED|Overall Study||79
10530265|NCT01405911|11682731|FG002|COMPLETED|Overall Study||76
10530266|NCT01405911|11682729|FG000|NOT COMPLETED|Overall Study||4
10530267|NCT01405911|11682730|FG001|NOT COMPLETED|Overall Study||3
10530268|NCT01405911|11682731|FG002|NOT COMPLETED|Overall Study||1
10530269|NCT01405924|11682739|FG000|STARTED|Overall Study||111
10530270|NCT01405924|11682739|FG000|COMPLETED|Overall Study||101
10530271|NCT01405924|11682739|FG000|NOT COMPLETED|Overall Study||10
10530272|NCT01405937|11682747|FG000|STARTED|Overall Study||25
10530273|NCT01405937|11682748|FG001|STARTED|Overall Study||26
10530274|NCT01405937|11682747|FG000|COMPLETED|Overall Study||25
10530275|NCT01405937|11682748|FG001|COMPLETED|Overall Study||26
10530276|NCT01405937|11682747|FG000|NOT COMPLETED|Overall Study||0
10530277|NCT01405937|11682748|FG001|NOT COMPLETED|Overall Study||0
10530278|NCT01405950|11682756|FG000|STARTED|Overall Study||8
10530279|NCT01405950|11682757|FG001|STARTED|Overall Study||2
10530280|NCT01405950|11682758|FG002|STARTED|Overall Study||0
10530281|NCT01405950|11682759|FG003|STARTED|Overall Study||0
10530282|NCT01405950|11682756|FG000|COMPLETED|Overall Study||7
10530283|NCT01405950|11682757|FG001|COMPLETED|Overall Study||2
10530284|NCT01405950|11682758|FG002|COMPLETED|Overall Study||0
10530285|NCT01405950|11682759|FG003|COMPLETED|Overall Study||0
10340954|NCT00383071|11478094|FG001|COMPLETED|Overall Study||21
10530286|NCT01405950|11682756|FG000|NOT COMPLETED|Overall Study||1
10530287|NCT01405950|11682757|FG001|NOT COMPLETED|Overall Study||0
10530288|NCT01405950|11682758|FG002|NOT COMPLETED|Overall Study||0
10530289|NCT01405950|11682759|FG003|NOT COMPLETED|Overall Study||0
10530290|NCT01406015|11682769|FG000|STARTED|Overall Study||19
10530291|NCT01406015|11682770|FG001|STARTED|Overall Study||19
10530292|NCT01406015|11682769|FG000|COMPLETED|Overall Study||16
10530293|NCT01406015|11682770|FG001|COMPLETED|Overall Study||16
10530294|NCT01406015|11682769|FG000|NOT COMPLETED|Overall Study||3
10530295|NCT01406015|11682770|FG001|NOT COMPLETED|Overall Study||3
10530296|NCT01406223|11682780|FG000|STARTED|Overall Study||18
10530297|NCT01406223|11682781|FG001|STARTED|Overall Study||19
10530298|NCT01406223|11682782|FG002|STARTED|Overall Study||20
10530299|NCT01406223|11682783|FG003|STARTED|Overall Study||19
10530300|NCT01406223|11682780|FG000|COMPLETED|Overall Study||6
10530301|NCT01406223|11682781|FG001|COMPLETED|Overall Study||7
10530302|NCT01406223|11682782|FG002|COMPLETED|Overall Study||2
10530303|NCT01406223|11682783|FG003|COMPLETED|Overall Study||3
10530304|NCT01406223|11682780|FG000|NOT COMPLETED|Overall Study||12
10530305|NCT01406223|11682781|FG001|NOT COMPLETED|Overall Study||12
10530306|NCT01406223|11682782|FG002|NOT COMPLETED|Overall Study||18
10530307|NCT01406223|11682783|FG003|NOT COMPLETED|Overall Study||16
10530308|NCT01406444|11682796|FG000|STARTED|Overall Study||33
10530310|NCT01406444|11682798|FG002|STARTED|Overall Study||16
10530311|NCT01406444|11682796|FG000|COMPLETED|Overall Study||23
10530312|NCT01406444|11682797|FG001|COMPLETED|Overall Study||24
10530313|NCT01406444|11682798|FG002|COMPLETED|Overall Study||14
10530314|NCT01406444|11682796|FG000|NOT COMPLETED|Overall Study||10
10530315|NCT01406444|11682797|FG001|NOT COMPLETED|Overall Study||9
10530316|NCT01406444|11682798|FG002|NOT COMPLETED|Overall Study||2
10530317|NCT01406574|11682806|FG000|STARTED|Overall Study||7
10340955|NCT00383071|11478095|FG002|COMPLETED|Overall Study||44
10340956|NCT00383071|11478096|FG003|COMPLETED|Overall Study||22
10340957|NCT00383071|11478093|FG000|NOT COMPLETED|Overall Study||0
10340958|NCT00383071|11478094|FG001|NOT COMPLETED|Overall Study||4
10340959|NCT00383071|11478095|FG002|NOT COMPLETED|Overall Study||7
10340960|NCT00383071|11478096|FG003|NOT COMPLETED|Overall Study||3
10340961|NCT00383084|11478108|FG000|STARTED|Overall Study||46
10340962|NCT00383084|11478109|FG001|STARTED|Overall Study||38
10340963|NCT00383084|11478108|FG000|COMPLETED|Overall Study||34
10340964|NCT00383084|11478109|FG001|COMPLETED|Overall Study||28
10340965|NCT00383084|11478108|FG000|NOT COMPLETED|Overall Study||12
10340966|NCT00383084|11478109|FG001|NOT COMPLETED|Overall Study||10
10340967|NCT00383110|11478117|FG000|STARTED|Overall Study||150
10340968|NCT00383110|11478118|FG001|STARTED|Overall Study||150
10340969|NCT00383110|11478117|FG000|COMPLETED|Overall Study||150
10340970|NCT00383110|11478118|FG001|COMPLETED|Overall Study||150
10340971|NCT00383110|11478117|FG000|NOT COMPLETED|Overall Study||0
10340972|NCT00383110|11478118|FG001|NOT COMPLETED|Overall Study||0
10340973|NCT00383123|11478127|FG000|STARTED|Overall Study||2115
10340974|NCT00383123|11478128|FG001|STARTED|Overall Study||1210
10340975|NCT00383123|11478127|FG000|COMPLETED|Overall Study||2004
10340976|NCT00383123|11478128|FG001|COMPLETED|Overall Study||1124
10340977|NCT00383123|11478127|FG000|NOT COMPLETED|Overall Study||111
10340978|NCT00383123|11478128|FG001|NOT COMPLETED|Overall Study||86
10340979|NCT00383149|11478134|FG000|STARTED|Overall Study||54
10340980|NCT00383149|11478134|FG000|COMPLETED|Overall Study||0
10340981|NCT00383149|11478134|FG000|NOT COMPLETED|Overall Study||54
10340982|NCT00383162|11478140|FG000|STARTED|Migraine Attack 1 (Period 1)||87
10340983|NCT00383162|11478141|FG001|STARTED|Migraine Attack 1 (Period 1)||86
10340984|NCT00383162|11478140|FG000|COMPLETED|Migraine Attack 1 (Period 1)|Participants completing a period treated a migraine with investigational product.|67
10340985|NCT00383162|11478141|FG001|COMPLETED|Migraine Attack 1 (Period 1)|Participants not completing did not take investigational product.|73
10340986|NCT00383162|11478140|FG000|NOT COMPLETED|Migraine Attack 1 (Period 1)||20
10340987|NCT00383162|11478141|FG001|NOT COMPLETED|Migraine Attack 1 (Period 1)||13
10340988|NCT00383162|11478140|FG000|STARTED|Migraine Attack 2 (Period 2)||67
10340989|NCT00383162|11478141|FG001|STARTED|Migraine Attack 2 (Period 2)||73
10340990|NCT00383162|11478140|FG000|COMPLETED|Migraine Attack 2 (Period 2)||65
10340991|NCT00383162|11478141|FG001|COMPLETED|Migraine Attack 2 (Period 2)||66
10340992|NCT00383162|11478140|FG000|NOT COMPLETED|Migraine Attack 2 (Period 2)||2
10340993|NCT00383162|11478141|FG001|NOT COMPLETED|Migraine Attack 2 (Period 2)||7
10340994|NCT00383188|11478152|FG000|STARTED|Overall Study||69
10340995|NCT00383188|11478153|FG001|STARTED|Overall Study||74
10340996|NCT00383188|11478154|FG002|STARTED|Overall Study||44
10340997|NCT00383188|11478155|FG003|STARTED|Overall Study||40
10340998|NCT00383188|11478156|FG004|STARTED|Overall Study||75
10340999|NCT00383188|11478152|FG000|COMPLETED|Overall Study||52
10341000|NCT00383188|11478153|FG001|COMPLETED|Overall Study||63
10341001|NCT00383188|11478154|FG002|COMPLETED|Overall Study||31
10341002|NCT00383188|11478155|FG003|COMPLETED|Overall Study||28
10341003|NCT00383188|11478156|FG004|COMPLETED|Overall Study||52
10341004|NCT00383188|11478152|FG000|NOT COMPLETED|Overall Study||17
10341005|NCT00383188|11478153|FG001|NOT COMPLETED|Overall Study||11
10341006|NCT00383188|11478154|FG002|NOT COMPLETED|Overall Study||13
10341007|NCT00383188|11478155|FG003|NOT COMPLETED|Overall Study||12
10341008|NCT00383188|11478156|FG004|NOT COMPLETED|Overall Study||23
10341009|NCT00383266|11478170|FG000|STARTED|Overall Study||9
10341010|NCT00383266|11478170|FG000|COMPLETED|Overall Study||9
10341011|NCT00383266|11478170|FG000|NOT COMPLETED|Overall Study||0
10341012|NCT00383292|11478177|FG000|STARTED|Overall Study||68
10341013|NCT00383292|11478178|FG001|STARTED|Overall Study||32
10341014|NCT00383292|11478179|FG002|STARTED|Overall Study||30
10341015|NCT00383292|11478177|FG000|Received at Least One Dose of Study Drug|Overall Study||68
10341016|NCT00383292|11478178|FG001|Received at Least One Dose of Study Drug|Overall Study||32
10341017|NCT00383292|11478179|FG002|Received at Least One Dose of Study Drug|Overall Study||30
10341018|NCT00383292|11478177|FG000|COMPLETED|Overall Study||53
10341019|NCT00383292|11478178|FG001|COMPLETED|Overall Study||26
10341020|NCT00383292|11478179|FG002|COMPLETED|Overall Study||22
10341021|NCT00383292|11478177|FG000|NOT COMPLETED|Overall Study||15
10341022|NCT00383292|11478178|FG001|NOT COMPLETED|Overall Study||6
10341023|NCT00383292|11478179|FG002|NOT COMPLETED|Overall Study||8
10341024|NCT00383331|11478190|FG000|STARTED|Overall Study||10
10341025|NCT00383331|11478191|FG001|STARTED|Overall Study||9
10341026|NCT00383331|11478190|FG000|COMPLETED|Overall Study||10
10341027|NCT00383331|11478191|FG001|COMPLETED|Overall Study||8
10341028|NCT00383331|11478190|FG000|NOT COMPLETED|Overall Study||0
10341029|NCT00383331|11478191|FG001|NOT COMPLETED|Overall Study||1
10341030|NCT00383448|11478197|FG000|STARTED|Overall Study||38
10341031|NCT00383448|11478197|FG000|COMPLETED|Overall Study||38
10341032|NCT00383448|11478197|FG000|NOT COMPLETED|Overall Study||0
10341033|NCT00383500|11478205|FG000|STARTED|Overall Study||27
10341034|NCT00383500|11478206|FG001|STARTED|Overall Study||24
10341035|NCT00383500|11478207|FG002|STARTED|Overall Study||24
10341036|NCT00383500|11478205|FG000|COMPLETED|Overall Study||19
10341037|NCT00383500|11478206|FG001|COMPLETED|Overall Study||21
10341038|NCT00383500|11478207|FG002|COMPLETED|Overall Study||22
10341039|NCT00383500|11478205|FG000|NOT COMPLETED|Overall Study||8
10341040|NCT00383500|11478206|FG001|NOT COMPLETED|Overall Study||3
10341041|NCT00383500|11478207|FG002|NOT COMPLETED|Overall Study||2
10341042|NCT00383565|11478216|FG000|STARTED|Overall Study||9
10341043|NCT00383565|11478216|FG000|COMPLETED|Overall Study||9
10341044|NCT00383565|11478216|FG000|NOT COMPLETED|Overall Study||0
10341045|NCT00383643|11478223|FG000|STARTED|Overall Study||18
10341046|NCT00383643|11478224|FG001|STARTED|Overall Study||16
10341047|NCT00383643|11478225|FG002|STARTED|Overall Study||14
10341048|NCT00383643|11478223|FG000|COMPLETED|Overall Study||17
10341049|NCT00383643|11478224|FG001|COMPLETED|Overall Study||15
10341050|NCT00383643|11478225|FG002|COMPLETED|Overall Study||13
10341051|NCT00383643|11478223|FG000|NOT COMPLETED|Overall Study||1
10341052|NCT00383643|11478224|FG001|NOT COMPLETED|Overall Study||1
10341053|NCT00383643|11478225|FG002|NOT COMPLETED|Overall Study||1
10341054|NCT00383747|11478235|FG000|STARTED|Visit 1||14
10341055|NCT00383747|11478236|FG001|STARTED|Visit 1||14
10341056|NCT00383747|11478237|FG002|STARTED|Visit 1||16
10341057|NCT00383747|11478238|FG003|STARTED|Visit 1||16
10341058|NCT00383747|11478235|FG000|COMPLETED|Visit 1||14
10341059|NCT00383747|11478236|FG001|COMPLETED|Visit 1||14
10341060|NCT00383747|11478237|FG002|COMPLETED|Visit 1||16
10341061|NCT00383747|11478238|FG003|COMPLETED|Visit 1||16
10341062|NCT00383747|11478235|FG000|NOT COMPLETED|Visit 1||0
10341063|NCT00383747|11478236|FG001|NOT COMPLETED|Visit 1||0
10530318|NCT01406574|11682807|FG001|STARTED|Overall Study||4
10530319|NCT01406574|11682808|FG002|STARTED|Overall Study||7
10530320|NCT01406574|11682809|FG003|STARTED|Overall Study||5
10530321|NCT01406574|11682806|FG000|COMPLETED|Overall Study||6
10530322|NCT01406574|11682807|FG001|COMPLETED|Overall Study||3
10530323|NCT01406574|11682808|FG002|COMPLETED|Overall Study||6
10530324|NCT01406574|11682809|FG003|COMPLETED|Overall Study||1
10530325|NCT01406574|11682806|FG000|NOT COMPLETED|Overall Study||1
10530326|NCT01406574|11682807|FG001|NOT COMPLETED|Overall Study||1
10530327|NCT01406574|11682808|FG002|NOT COMPLETED|Overall Study||1
10530328|NCT01406574|11682809|FG003|NOT COMPLETED|Overall Study||4
10530329|NCT01406652|11682822|FG000|STARTED|Overall Study||109
10530330|NCT01406652|11682823|FG001|STARTED|Overall Study||115
10530331|NCT01406652|11682822|FG000|COMPLETED|Overall Study||89
10530332|NCT01406652|11682823|FG001|COMPLETED|Overall Study||95
10530333|NCT01406652|11682822|FG000|NOT COMPLETED|Overall Study||20
10530334|NCT01406652|11682823|FG001|NOT COMPLETED|Overall Study||20
10530335|NCT01406717|11682833|FG000|STARTED|Overall Study||180
10530336|NCT01406717|11682834|FG001|STARTED|Overall Study||180
10530337|NCT01406717|11682833|FG000|COMPLETED|Overall Study||137
10530338|NCT01406717|11682834|FG001|COMPLETED|Overall Study||149
10530339|NCT01406717|11682833|FG000|NOT COMPLETED|Overall Study||43
10530340|NCT01406717|11682834|FG001|NOT COMPLETED|Overall Study||31
10530341|NCT01406795|11682850|FG000|STARTED|Overall Study||1
10530342|NCT01406795|11682850|FG000|COMPLETED|Overall Study||0
10530343|NCT01406795|11682850|FG000|NOT COMPLETED|Overall Study||1
10530344|NCT01406873|11682856|FG000|STARTED|Overall Study||21
10530345|NCT01406873|11682857|FG001|STARTED|Overall Study||21
10530346|NCT01406873|11682856|FG000|COMPLETED|Overall Study||20
10530347|NCT01406873|11682857|FG001|COMPLETED|Overall Study||20
10530348|NCT01406873|11682856|FG000|NOT COMPLETED|Overall Study||1
10530349|NCT01406873|11682857|FG001|NOT COMPLETED|Overall Study||1
10530350|NCT01406938|11682875|FG000|STARTED|Induction Period||482
10530351|NCT01406938|11682876|FG001|STARTED|Induction Period||484
10341064|NCT00383747|11478237|FG002|NOT COMPLETED|Visit 1||0
10341065|NCT00383747|11478238|FG003|NOT COMPLETED|Visit 1||0
10341066|NCT00383747|11478235|FG000|STARTED|Visit 2||14
10341067|NCT00383747|11478236|FG001|STARTED|Visit 2||14
10341068|NCT00383747|11478237|FG002|STARTED|Visit 2||16
10341069|NCT00383747|11478238|FG003|STARTED|Visit 2||16
10341070|NCT00383747|11478235|FG000|COMPLETED|Visit 2||14
10341071|NCT00383747|11478236|FG001|COMPLETED|Visit 2||14
10341072|NCT00383747|11478237|FG002|COMPLETED|Visit 2||16
10341073|NCT00383747|11478238|FG003|COMPLETED|Visit 2||16
10341074|NCT00383747|11478235|FG000|NOT COMPLETED|Visit 2||0
10341075|NCT00383747|11478236|FG001|NOT COMPLETED|Visit 2||0
10341076|NCT00383747|11478237|FG002|NOT COMPLETED|Visit 2||0
10341077|NCT00383747|11478238|FG003|NOT COMPLETED|Visit 2||0
10341078|NCT00383760|11478251|FG000|STARTED|Overall Study||15
10341079|NCT00383760|11478251|FG000|COMPLETED|Overall Study||15
10341080|NCT00383760|11478251|FG000|NOT COMPLETED|Overall Study||0
10341081|NCT00383786|11478258|FG000|STARTED|Overall Study||22
10341082|NCT00383786|11478259|FG001|STARTED|Overall Study||25
10341083|NCT00383786|11478258|FG000|COMPLETED|Overall Study||18
10341084|NCT00383786|11478259|FG001|COMPLETED|Overall Study||13
10341085|NCT00383786|11478258|FG000|NOT COMPLETED|Overall Study||4
10341086|NCT00383786|11478259|FG001|NOT COMPLETED|Overall Study||12
10341087|NCT00383942|11478267|FG000|STARTED|Overall Study||40
10341088|NCT00383942|11478268|FG001|STARTED|Overall Study||40
10341089|NCT00383942|11478267|FG000|COMPLETED|Overall Study||40
10341090|NCT00383942|11478268|FG001|COMPLETED|Overall Study||40
10341091|NCT00383942|11478267|FG000|NOT COMPLETED|Overall Study||0
10341092|NCT00383942|11478268|FG001|NOT COMPLETED|Overall Study||0
10341093|NCT00384033|11478278|FG000|STARTED|Overall Study||164
10341094|NCT00384033|11478279|FG001|STARTED|Overall Study||155
10341095|NCT00384033|11478280|FG002|STARTED|Overall Study||160
10341096|NCT00384033|11478281|FG003|STARTED|Overall Study||159
10341097|NCT00384033|11478278|FG000|Treated|Overall Study||161
10341098|NCT00384033|11478279|FG001|Treated|Overall Study||148
10714899|NCT02688387|11880050|FG007|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10714900|NCT02688387|11880051|FG008|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10714901|NCT02688387|11880052|FG009|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10714902|NCT02688387|11880053|FG010|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10714903|NCT02688387|11880054|FG011|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10341099|NCT00384033|11478280|FG002|Treated|Overall Study||150
10341100|NCT00384033|11478281|FG003|Treated|Overall Study||157
10341101|NCT00384033|11478278|FG000|COMPLETED|Overall Study||123
10341102|NCT00384033|11478279|FG001|COMPLETED|Overall Study||120
10341103|NCT00384033|11478280|FG002|COMPLETED|Overall Study||117
10341104|NCT00384033|11478281|FG003|COMPLETED|Overall Study||119
10341105|NCT00384033|11478278|FG000|NOT COMPLETED|Overall Study||41
10341106|NCT00384033|11478279|FG001|NOT COMPLETED|Overall Study||35
10341107|NCT00384033|11478280|FG002|NOT COMPLETED|Overall Study||43
10714904|NCT02688387|11880055|FG012|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10714905|NCT02688387|11880056|FG013|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10714906|NCT02688387|11880057|FG014|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10714907|NCT02688387|11880058|FG015|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10714908|NCT02688387|11880059|FG016|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10812173|NCT03732248|11974152|FG001|COMPLETED|Overall Study||10
10714909|NCT02688387|11880060|FG017|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10714910|NCT02688387|11880061|FG018|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10714911|NCT02688387|11880062|FG019|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10714912|NCT02688387|11880063|FG020|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10812174|NCT03732248|11974151|FG000|NOT COMPLETED|Overall Study||1
10714913|NCT02688387|11880064|FG021|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
10303390|NCT00078819|11436365|FG000|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||1
10303391|NCT00078819|11436366|FG001|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||1
10303392|NCT00078819|11436367|FG002|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||0
10303393|NCT00078819|11436368|FG003|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||0
10303394|NCT00078819|11436365|FG000|STARTED|Open-label Treatment Period: Weeks 13-36|One participant discontinued before starting the open-label period|103
10303395|NCT00078819|11436366|FG001|STARTED|Open-label Treatment Period: Weeks 13-36||105
10303396|NCT00078819|11436367|FG002|STARTED|Open-label Treatment Period: Weeks 13-36||0
10303397|NCT00078819|11436368|FG003|STARTED|Open-label Treatment Period: Weeks 13-36||0
10303398|NCT00078819|11436365|FG000|COMPLETED|Open-label Treatment Period: Weeks 13-36||63
10303399|NCT00078819|11436366|FG001|COMPLETED|Open-label Treatment Period: Weeks 13-36||75
10303400|NCT00078819|11436367|FG002|COMPLETED|Open-label Treatment Period: Weeks 13-36||0
10341108|NCT00384033|11478281|FG003|NOT COMPLETED|Overall Study||40
10341109|NCT00384059|11478293|FG000|STARTED|Infant Series||141
10341110|NCT00384059|11478294|FG001|STARTED|Infant Series||145
10341111|NCT00384059|11478293|FG000|Vaccinated Dose 1|Infant Series||139
10341112|NCT00384059|11478294|FG001|Vaccinated Dose 1|Infant Series||139
10341113|NCT00384059|11478293|FG000|Vaccinated Dose 2|Infant Series||136
10341114|NCT00384059|11478294|FG001|Vaccinated Dose 2|Infant Series||135
10341115|NCT00384059|11478293|FG000|COMPLETED|Infant Series||135
10341116|NCT00384059|11478294|FG001|COMPLETED|Infant Series||132
10341117|NCT00384059|11478293|FG000|NOT COMPLETED|Infant Series||6
10341118|NCT00384059|11478294|FG001|NOT COMPLETED|Infant Series||13
10341119|NCT00384059|11478293|FG000|STARTED|After Infant Series||135
10341120|NCT00384059|11478294|FG001|STARTED|After Infant Series||132
10341121|NCT00384059|11478293|FG000|COMPLETED|After Infant Series||131
10341122|NCT00384059|11478294|FG001|COMPLETED|After Infant Series||122
10341123|NCT00384059|11478293|FG000|NOT COMPLETED|After Infant Series||4
10341124|NCT00384059|11478294|FG001|NOT COMPLETED|After Infant Series||10
10341125|NCT00384059|11478293|FG000|STARTED|Toddler Dose||131
10341126|NCT00384059|11478294|FG001|STARTED|Toddler Dose||122
10341127|NCT00384059|11478293|FG000|COMPLETED|Toddler Dose||130
10341128|NCT00384059|11478294|FG001|COMPLETED|Toddler Dose||120
10341129|NCT00384059|11478293|FG000|NOT COMPLETED|Toddler Dose||1
10341130|NCT00384059|11478294|FG001|NOT COMPLETED|Toddler Dose||2
10341131|NCT00384085|11478324|FG000|STARTED|Overall Study|Randomized|195
10341132|NCT00384085|11478325|FG001|STARTED|Overall Study|Randomized|196
10341133|NCT00384085|11478326|FG002|STARTED|Overall Study|Randomized|197
10341134|NCT00384085|11478324|FG000|Intent-To-Treat (ITT)|Overall Study||195
10341135|NCT00384085|11478325|FG001|Intent-To-Treat (ITT)|Overall Study||196
10341136|NCT00384085|11478326|FG002|Intent-To-Treat (ITT)|Overall Study||197
10341137|NCT00384085|11478324|FG000|Treated (Safety Population)|Overall Study||194
10341138|NCT00384085|11478325|FG001|Treated (Safety Population)|Overall Study||194
10341139|NCT00384085|11478326|FG002|Treated (Safety Population)|Overall Study||194
10341140|NCT00384085|11478324|FG000|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||187
10341141|NCT00384085|11478325|FG001|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||186
10341142|NCT00384085|11478326|FG002|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||189
10341143|NCT00384085|11478324|FG000|COMPLETED|Overall Study|Based on the entire ITT population|156
10341144|NCT00384085|11478325|FG001|COMPLETED|Overall Study|Based on the entire ITT population|150
10341145|NCT00384085|11478326|FG002|COMPLETED|Overall Study|Based on the entire ITT population|141
10341146|NCT00384085|11478324|FG000|NOT COMPLETED|Overall Study||39
10341147|NCT00384085|11478325|FG001|NOT COMPLETED|Overall Study||46
10341148|NCT00384085|11478326|FG002|NOT COMPLETED|Overall Study||56
10341149|NCT00384176|11478339|FG000|STARTED|Overall Study||709
10341150|NCT00384176|11478340|FG001|STARTED|Overall Study||713
10341151|NCT00384176|11478341|FG002|STARTED|Overall Study||192
10341152|NCT00384176|11478339|FG000|COMPLETED|Overall Study||397
10341153|NCT00384176|11478340|FG001|COMPLETED|Overall Study||394
10341154|NCT00384176|11478341|FG002|COMPLETED|Overall Study||60
10341155|NCT00384176|11478339|FG000|NOT COMPLETED|Overall Study||312
10341156|NCT00384176|11478340|FG001|NOT COMPLETED|Overall Study||319
10341157|NCT00384176|11478341|FG002|NOT COMPLETED|Overall Study||132
10341158|NCT00384189|11478353|FG000|STARTED|Overall Study||305
10341159|NCT00384189|11478354|FG001|STARTED|Overall Study||312
10341160|NCT00384189|11478355|FG002|STARTED|Overall Study||313
10341161|NCT00384189|11478356|FG003|STARTED|Overall Study||150
10341162|NCT00384189|11478353|FG000|Randomized, Not Treated|Overall Study||1
10341163|NCT00384189|11478354|FG001|Randomized, Not Treated|Overall Study||0
10341164|NCT00384189|11478355|FG002|Randomized, Not Treated|Overall Study||2
10341165|NCT00384189|11478356|FG003|Randomized, Not Treated|Overall Study||4
10341166|NCT00384189|11478353|FG000|Actual Treatment Received|Overall Study|1 participant randomized to 160 μg who actually received 40 μg is included.|305
10341167|NCT00384189|11478354|FG001|Actual Treatment Received|Overall Study||312
10341168|NCT00384189|11478355|FG002|Actual Treatment Received|Overall Study|1 participants in the 160 μg arm actually received 40 μg and is moved to that arm.|310
10341169|NCT00384189|11478356|FG003|Actual Treatment Received|Overall Study||146
10341170|NCT00384189|11478353|FG000|COMPLETED|Overall Study||255
10341171|NCT00384189|11478354|FG001|COMPLETED|Overall Study||255
10341172|NCT00384189|11478355|FG002|COMPLETED|Overall Study||255
10341173|NCT00384189|11478356|FG003|COMPLETED|Overall Study||110
10341174|NCT00384189|11478353|FG000|NOT COMPLETED|Overall Study||50
10341175|NCT00384189|11478354|FG001|NOT COMPLETED|Overall Study||57
10341176|NCT00384189|11478355|FG002|NOT COMPLETED|Overall Study||58
10341177|NCT00384189|11478356|FG003|NOT COMPLETED|Overall Study||40
10341178|NCT00384241|11478368|FG000|STARTED|Overall Study||500
10341179|NCT00384241|11478369|FG001|STARTED|Overall Study||599
10341180|NCT00384241|11478368|FG000|COMPLETED|Overall Study||500
10341181|NCT00384241|11478369|FG001|COMPLETED|Overall Study||599
10341182|NCT00384241|11478368|FG000|NOT COMPLETED|Overall Study||0
10341183|NCT00384241|11478369|FG001|NOT COMPLETED|Overall Study||0
10341184|NCT00384332|11478376|FG000|STARTED|Overall Study||13
10341185|NCT00384332|11478377|FG001|STARTED|Overall Study||10
10341186|NCT00384332|11478376|FG000|COMPLETED|Overall Study||9
10341187|NCT00384332|11478377|FG001|COMPLETED|Overall Study||10
10341188|NCT00384332|11478376|FG000|NOT COMPLETED|Overall Study||4
10341189|NCT00384332|11478377|FG001|NOT COMPLETED|Overall Study||0
10341190|NCT00384397|11478388|FG000|STARTED|Overall Study||407
10341191|NCT00384397|11478389|FG001|STARTED|Overall Study||293
10341192|NCT00384397|11478390|FG002|STARTED|Overall Study||418
10341193|NCT00384397|11478388|FG000|COMPLETED|Overall Study||375
10341194|NCT00384397|11478389|FG001|COMPLETED|Overall Study||247
10341195|NCT00384397|11478390|FG002|COMPLETED|Overall Study||385
10341196|NCT00384397|11478388|FG000|NOT COMPLETED|Overall Study||32
10341197|NCT00384397|11478389|FG001|NOT COMPLETED|Overall Study||46
10341198|NCT00384397|11478390|FG002|NOT COMPLETED|Overall Study||33
10341199|NCT00384449|11478398|FG000|STARTED|Overall Study||1
10341200|NCT00384449|11478398|FG000|COMPLETED|Overall Study||1
10341201|NCT00384449|11478398|FG000|NOT COMPLETED|Overall Study||0
10341202|NCT00384670|11478402|FG000|STARTED|Overall Study||7
10341203|NCT00384670|11478402|FG000|COMPLETED|Overall Study||7
10341204|NCT00384670|11478402|FG000|NOT COMPLETED|Overall Study||0
10341205|NCT00384748|11478408|FG000|STARTED|Overall Study||25
10341206|NCT00384748|11478409|FG001|STARTED|Overall Study||23
10303401|NCT00078819|11436368|FG003|COMPLETED|Open-label Treatment Period: Weeks 13-36||0
10303402|NCT00078819|11436365|FG000|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||40
10303403|NCT00078819|11436366|FG001|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||30
10303404|NCT00078819|11436367|FG002|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||0
10303405|NCT00078819|11436368|FG003|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||0
10303406|NCT00078819|11436365|FG000|STARTED|Withdrawal Period: Weeks 37-48||0
10303407|NCT00078819|11436366|FG001|STARTED|Withdrawal Period: Weeks 37-48||0
10303408|NCT00078819|11436367|FG002|STARTED|Withdrawal Period: Weeks 37-48|Participants who completed week 36 with a PASI response|69
10303409|NCT00078819|11436368|FG003|STARTED|Withdrawal Period: Weeks 37-48|Participants who completed week 36 with a PASI response|69
10303410|NCT00078819|11436365|FG000|Received Study Drug|Withdrawal Period: Weeks 37-48||0
10303411|NCT00078819|11436366|FG001|Received Study Drug|Withdrawal Period: Weeks 37-48||0
10303412|NCT00078819|11436367|FG002|Received Study Drug|Withdrawal Period: Weeks 37-48||69
10303413|NCT00078819|11436368|FG003|Received Study Drug|Withdrawal Period: Weeks 37-48||68
10303414|NCT00078819|11436365|FG000|COMPLETED|Withdrawal Period: Weeks 37-48||0
10303415|NCT00078819|11436366|FG001|COMPLETED|Withdrawal Period: Weeks 37-48||0
10341207|NCT00384748|11478408|FG000|COMPLETED|Overall Study||25
10341208|NCT00384748|11478409|FG001|COMPLETED|Overall Study||23
10341209|NCT00384748|11478408|FG000|NOT COMPLETED|Overall Study||0
10341210|NCT00384748|11478409|FG001|NOT COMPLETED|Overall Study||0
10341211|NCT00384774|11478422|FG000|STARTED|Overall Study||42
10341212|NCT00384774|11478423|FG001|STARTED|Overall Study||4
10341213|NCT00384774|11478424|FG002|STARTED|Overall Study||12
10341214|NCT00384774|11478425|FG003|STARTED|Overall Study||24
10341215|NCT00384774|11478426|FG004|STARTED|Overall Study||28
10341216|NCT00384774|11478427|FG005|STARTED|Overall Study||16
10341217|NCT00384774|11478428|FG006|STARTED|Overall Study||4
10341218|NCT00384774|11478422|FG000|Received at Least 1 Dose of Study Drug|Overall Study||42
10341219|NCT00384774|11478423|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4
10341220|NCT00384774|11478424|FG002|Received at Least 1 Dose of Study Drug|Overall Study||12
10341221|NCT00384774|11478425|FG003|Received at Least 1 Dose of Study Drug|Overall Study||24
10341222|NCT00384774|11478426|FG004|Received at Least 1 Dose of Study Drug|Overall Study||28
10341223|NCT00384774|11478427|FG005|Received at Least 1 Dose of Study Drug|Overall Study||16
10341224|NCT00384774|11478428|FG006|Received at Least 1 Dose of Study Drug|Overall Study||4
10341225|NCT00384774|11478422|FG000|COMPLETED|Overall Study||42
10341226|NCT00384774|11478423|FG001|COMPLETED|Overall Study||4
10341227|NCT00384774|11478424|FG002|COMPLETED|Overall Study||12
10341228|NCT00384774|11478425|FG003|COMPLETED|Overall Study||24
10341229|NCT00384774|11478426|FG004|COMPLETED|Overall Study||28
10303416|NCT00078819|11436367|FG002|COMPLETED|Withdrawal Period: Weeks 37-48|Defined as continuing to receive blinded study drug through week 48|40
10303417|NCT00078819|11436368|FG003|COMPLETED|Withdrawal Period: Weeks 37-48|Defined as continuing to receive blinded study drug through week 48|55
10303418|NCT00078819|11436365|FG000|NOT COMPLETED|Withdrawal Period: Weeks 37-48||0
10303419|NCT00078819|11436366|FG001|NOT COMPLETED|Withdrawal Period: Weeks 37-48||0
10303420|NCT00078819|11436367|FG002|NOT COMPLETED|Withdrawal Period: Weeks 37-48||29
10303421|NCT00078819|11436368|FG003|NOT COMPLETED|Withdrawal Period: Weeks 37-48||14
10303422|NCT00078819|11436365|FG000|STARTED|Re-treatment Period||0
10303423|NCT00078819|11436366|FG001|STARTED|Re-treatment Period||0
10303424|NCT00078819|11436367|FG002|STARTED|Re-treatment Period||29
10303425|NCT00078819|11436368|FG003|STARTED|Re-treatment Period||13
10341230|NCT00384774|11478427|FG005|COMPLETED|Overall Study||16
10341231|NCT00384774|11478428|FG006|COMPLETED|Overall Study||4
10341232|NCT00384774|11478422|FG000|NOT COMPLETED|Overall Study||0
10341233|NCT00384774|11478423|FG001|NOT COMPLETED|Overall Study||0
10530352|NCT01406938|11682877|FG002|STARTED|Induction Period||0
10530353|NCT01406938|11682878|FG003|STARTED|Induction Period||0
10530354|NCT01406938|11682879|FG004|STARTED|Induction Period||0
10341234|NCT00384774|11478424|FG002|NOT COMPLETED|Overall Study||0
10341235|NCT00384774|11478425|FG003|NOT COMPLETED|Overall Study||0
10341236|NCT00384774|11478426|FG004|NOT COMPLETED|Overall Study||0
10341237|NCT00384774|11478427|FG005|NOT COMPLETED|Overall Study||0
10341238|NCT00384774|11478428|FG006|NOT COMPLETED|Overall Study||0
10341239|NCT00384813|11478446|FG000|STARTED|Overall Study||23
10341240|NCT00384813|11478447|FG001|STARTED|Overall Study||20
10341241|NCT00384813|11478446|FG000|COMPLETED|Overall Study||21
10341242|NCT00384813|11478447|FG001|COMPLETED|Overall Study||20
10341243|NCT00384813|11478446|FG000|NOT COMPLETED|Overall Study||2
10341244|NCT00384813|11478447|FG001|NOT COMPLETED|Overall Study||0
10341245|NCT00384839|11478453|FG000|STARTED|Overall Study||36
10341246|NCT00384839|11478453|FG000|COMPLETED|Overall Study||28
10341247|NCT00384839|11478453|FG000|NOT COMPLETED|Overall Study||8
10341248|NCT00384865|11478461|FG000|STARTED|Overall Study||16
10341249|NCT00384865|11478462|FG001|STARTED|Overall Study||16
10341250|NCT00384865|11478463|FG002|STARTED|Overall Study||16
10341251|NCT00384865|11478464|FG003|STARTED|Overall Study||16
10341252|NCT00384865|11478461|FG000|Completed Six Month Assessment|Overall Study||11
10341253|NCT00384865|11478462|FG001|Completed Six Month Assessment|Overall Study||12
10341254|NCT00384865|11478463|FG002|Completed Six Month Assessment|Overall Study||15
10341255|NCT00384865|11478464|FG003|Completed Six Month Assessment|Overall Study||11
10341256|NCT00384865|11478461|FG000|COMPLETED|Overall Study||16
10341257|NCT00384865|11478462|FG001|COMPLETED|Overall Study||16
10341258|NCT00384865|11478463|FG002|COMPLETED|Overall Study||16
10530355|NCT01406938|11682880|FG005|STARTED|Induction Period||0
10530356|NCT01406938|11682875|FG000|FAS:Patients Assigned Study Treatment|Induction Period||482
10812175|NCT03732248|11974152|FG001|NOT COMPLETED|Overall Study||0
10812176|NCT03731182|11974160|FG000|STARTED|Overall Study||70
10341259|NCT00384865|11478464|FG003|COMPLETED|Overall Study||16
10341260|NCT00384865|11478461|FG000|NOT COMPLETED|Overall Study||0
10341261|NCT00384865|11478462|FG001|NOT COMPLETED|Overall Study||0
10341262|NCT00384865|11478463|FG002|NOT COMPLETED|Overall Study||0
10341263|NCT00384865|11478464|FG003|NOT COMPLETED|Overall Study||0
10341264|NCT00384930|11478479|FG000|STARTED|Overall Study||212
10341265|NCT00384930|11478480|FG001|STARTED|Overall Study||209
10341266|NCT00384930|11478481|FG002|STARTED|Overall Study||212
10303426|NCT00078819|11436365|FG000|Received Study Drug|Re-treatment Period||0
10303427|NCT00078819|11436366|FG001|Received Study Drug|Re-treatment Period||0
10303428|NCT00078819|11436367|FG002|Received Study Drug|Re-treatment Period|One additional participant received re-treatment without having disease relapse|30
10303429|NCT00078819|11436368|FG003|Received Study Drug|Re-treatment Period||12
10303430|NCT00078819|11436365|FG000|COMPLETED|Re-treatment Period||0
10303431|NCT00078819|11436366|FG001|COMPLETED|Re-treatment Period||0
10303432|NCT00078819|11436367|FG002|COMPLETED|Re-treatment Period||29
10303433|NCT00078819|11436368|FG003|COMPLETED|Re-treatment Period||13
10303434|NCT00078819|11436365|FG000|NOT COMPLETED|Re-treatment Period||0
10303435|NCT00078819|11436366|FG001|NOT COMPLETED|Re-treatment Period||0
10303436|NCT00078819|11436367|FG002|NOT COMPLETED|Re-treatment Period||0
10303437|NCT00078819|11436368|FG003|NOT COMPLETED|Re-treatment Period||0
10303438|NCT00078897|11436387|FG000|STARTED|Overall Study||809
10303439|NCT00078897|11436388|FG001|STARTED|Overall Study||812
10303440|NCT00078897|11436387|FG000|COMPLETED|Overall Study||685
10303441|NCT00078897|11436388|FG001|COMPLETED|Overall Study||689
10303442|NCT00078897|11436387|FG000|NOT COMPLETED|Overall Study||124
10303443|NCT00078897|11436388|FG001|NOT COMPLETED|Overall Study||123
10303444|NCT00078949|11436398|FG000|STARTED|Overall Study||310
10303445|NCT00078949|11436399|FG001|STARTED|Overall Study||309
10303446|NCT00078949|11436400|FG002|STARTED|Overall Study||115
10303447|NCT00078949|11436401|FG003|STARTED|Overall Study||115
10303448|NCT00078949|11436398|FG000|COMPLETED|Overall Study||306
10303449|NCT00078949|11436399|FG001|COMPLETED|Overall Study||304
10303450|NCT00078949|11436400|FG002|COMPLETED|Overall Study||112
10303451|NCT00078949|11436401|FG003|COMPLETED|Overall Study||112
10303452|NCT00078949|11436398|FG000|NOT COMPLETED|Overall Study||4
10303453|NCT00078949|11436399|FG001|NOT COMPLETED|Overall Study||5
10303454|NCT00078949|11436400|FG002|NOT COMPLETED|Overall Study||3
10303455|NCT00078949|11436401|FG003|NOT COMPLETED|Overall Study||3
10303456|NCT00079001|11436415|FG000|STARTED|Overall Study||323
10303457|NCT00079001|11436416|FG001|STARTED|Overall Study||322
10303458|NCT00079001|11436415|FG000|COMPLETED|Overall Study||323
10303459|NCT00079001|11436416|FG001|COMPLETED|Overall Study||322
10303460|NCT00079001|11436415|FG000|NOT COMPLETED|Overall Study||0
10303461|NCT00079001|11436416|FG001|NOT COMPLETED|Overall Study||0
10303462|NCT00079040|11436422|FG000|STARTED|Overall Study||65
10303463|NCT00079040|11436422|FG000|COMPLETED|Overall Study||63
10303464|NCT00079040|11436422|FG000|NOT COMPLETED|Overall Study||2
10303465|NCT00079183|11436426|FG000|STARTED|Overall Study||44
10303466|NCT00079183|11436426|FG000|Drop Outs|Overall Study||7
10303467|NCT00079183|11436426|FG000|COMPLETED|Overall Study||37
10303468|NCT00079183|11436426|FG000|NOT COMPLETED|Overall Study||7
10303469|NCT00079274|11436438|FG000|STARTED|Overall Study||1402
10303470|NCT00079274|11436439|FG001|STARTED|Overall Study||111
10303471|NCT00079274|11436440|FG002|STARTED|Overall Study||111
10303472|NCT00079274|11436441|FG003|STARTED|Overall Study||1350
10303473|NCT00079274|11436442|FG004|STARTED|Overall Study||45
10303474|NCT00079274|11436443|FG005|STARTED|Overall Study||46
10303475|NCT00079274|11436444|FG006|STARTED|Overall Study||332
10303476|NCT00079274|11436438|FG000|COMPLETED|Overall Study||1081
10303477|NCT00079274|11436439|FG001|COMPLETED|Overall Study||84
10303478|NCT00079274|11436440|FG002|COMPLETED|Overall Study||84
10303479|NCT00079274|11436441|FG003|COMPLETED|Overall Study||906
10303480|NCT00079274|11436442|FG004|COMPLETED|Overall Study||30
10303481|NCT00079274|11436443|FG005|COMPLETED|Overall Study||26
10303482|NCT00079274|11436444|FG006|COMPLETED|Overall Study||332
10303483|NCT00079274|11436438|FG000|NOT COMPLETED|Overall Study||321
10303484|NCT00079274|11436439|FG001|NOT COMPLETED|Overall Study||27
10303485|NCT00079274|11436440|FG002|NOT COMPLETED|Overall Study||27
10303486|NCT00079274|11436441|FG003|NOT COMPLETED|Overall Study||444
10303487|NCT00079274|11436442|FG004|NOT COMPLETED|Overall Study||15
10303488|NCT00079274|11436443|FG005|NOT COMPLETED|Overall Study||20
10303489|NCT00079274|11436444|FG006|NOT COMPLETED|Overall Study||0
10303490|NCT00079326|11436459|FG000|STARTED|Overall Study||15
10303491|NCT00079326|11436460|FG001|STARTED|Overall Study||24
10303492|NCT00079326|11436459|FG000|COMPLETED|Overall Study||15
10303493|NCT00079326|11436460|FG001|COMPLETED|Overall Study||24
10303494|NCT00079326|11436459|FG000|NOT COMPLETED|Overall Study||0
10303495|NCT00079326|11436460|FG001|NOT COMPLETED|Overall Study||0
10303496|NCT00079339|11436468|FG000|STARTED|Overall Study||5
10303497|NCT00079339|11436469|FG001|STARTED|Overall Study||40
10303498|NCT00079339|11436470|FG002|STARTED|Overall Study||6
10303499|NCT00079339|11436468|FG000|Enrolled in Phase I|Overall Study||5
10303500|NCT00079339|11436469|FG001|Enrolled in Phase I|Overall Study||6
10303501|NCT00079339|11436470|FG002|Enrolled in Phase I|Overall Study||6
10303502|NCT00079339|11436468|FG000|Maximum Tolerated Dose (MTD) Estimation|Overall Study|2 participants enrolled in the phase I part did not complete the 8 week MTD estimation period.|3
10303503|NCT00079339|11436469|FG001|Maximum Tolerated Dose (MTD) Estimation|Overall Study||6
10303504|NCT00079339|11436470|FG002|Maximum Tolerated Dose (MTD) Estimation|Overall Study|One participant enrolled in the phase I part did not complete the 8 week MTD estimation period.|5
10303505|NCT00079339|11436468|FG000|Enrolled in Phase II|Overall Study|Participants treated at the 100 mg/m2 dose level did not participate in the phase II part.|0
10303506|NCT00079339|11436469|FG001|Enrolled in Phase II|Overall Study|This number includes the 6 patients enrolled on the phase I part.|40
10315112|NCT00174382|11448896|FG000|NOT COMPLETED|Overall Study||33
10714914|NCT02688387|11880043|FG000|STARTED|Part 1, Washout Period 4 (7 Days)||2
10315113|NCT00174447|11448900|FG000|STARTED|Overall Study||43
10341267|NCT00384930|11478482|FG003|STARTED|Overall Study||216
10341268|NCT00384930|11478483|FG004|STARTED|Overall Study||209
10341269|NCT00384930|11478479|FG000|Received Double-Blind Study Drug|Overall Study||211
10341270|NCT00384930|11478480|FG001|Received Double-Blind Study Drug|Overall Study||208
10341271|NCT00384930|11478481|FG002|Received Double-Blind Study Drug|Overall Study||212
10341272|NCT00384930|11478482|FG003|Received Double-Blind Study Drug|Overall Study||216
10341273|NCT00384930|11478483|FG004|Received Double-Blind Study Drug|Overall Study||209
10341274|NCT00384930|11478479|FG000|COMPLETED|Overall Study||185
10341275|NCT00384930|11478480|FG001|COMPLETED|Overall Study||182
10341276|NCT00384930|11478481|FG002|COMPLETED|Overall Study||182
10341277|NCT00384930|11478482|FG003|COMPLETED|Overall Study||175
10341278|NCT00384930|11478483|FG004|COMPLETED|Overall Study||162
10341279|NCT00384930|11478479|FG000|NOT COMPLETED|Overall Study||27
10341280|NCT00384930|11478480|FG001|NOT COMPLETED|Overall Study||27
10341281|NCT00384930|11478481|FG002|NOT COMPLETED|Overall Study||30
10341282|NCT00384930|11478482|FG003|NOT COMPLETED|Overall Study||41
10341283|NCT00384930|11478483|FG004|NOT COMPLETED|Overall Study||47
10341284|NCT00384956|11478498|FG000|STARTED|Overall Study||25
10341285|NCT00384956|11478498|FG000|COMPLETED|Overall Study||22
10341286|NCT00384956|11478498|FG000|NOT COMPLETED|Overall Study||3
10341287|NCT00385008|11478504|FG000|STARTED|Overall Study||10
10341288|NCT00385008|11478505|FG001|STARTED|Overall Study||10
10341289|NCT00385008|11478504|FG000|In Absence of Migraine|Overall Study||10
10341290|NCT00385008|11478505|FG001|In Absence of Migraine|Overall Study||10
10341291|NCT00385008|11478504|FG000|In Presence of Migraine|Overall Study||5
10341292|NCT00385008|11478505|FG001|In Presence of Migraine|Overall Study||5
10341293|NCT00385008|11478504|FG000|COMPLETED|Overall Study||10
10341294|NCT00385008|11478505|FG001|COMPLETED|Overall Study||10
10341295|NCT00385008|11478504|FG000|NOT COMPLETED|Overall Study||0
10341296|NCT00385008|11478505|FG001|NOT COMPLETED|Overall Study||0
10341297|NCT00385138|11478514|FG000|STARTED|Overall Study||2695
10341298|NCT00385138|11478515|FG001|STARTED|Overall Study||2669
10341299|NCT00385138|11478514|FG000|Intent-to-treat (ITT)|Overall Study|All patients randomized excluding two (2) who withdrew consent for using study data.|2693
10341300|NCT00385138|11478515|FG001|Intent-to-treat (ITT)|Overall Study||2669
10341301|NCT00385138|11478514|FG000|Modified Intent-to-treat (mITT)|Overall Study|Excludes 37 patients who either did not receive study drug or have PCI.|2656
10341302|NCT00385138|11478515|FG001|Modified Intent-to-treat (mITT)|Overall Study|Excludes 24 patients who either did not received study drug or have PCI.|2645
10341303|NCT00385138|11478514|FG000|Safety Population|Overall Study|Includes all randomized patients who received at least one dose of study drug.|2662
10341304|NCT00385138|11478515|FG001|Safety Population|Overall Study|Includes all randomized patients who received at least one dose of study drug.|2650
10341305|NCT00385138|11478514|FG000|COMPLETED|Overall Study|"Completed means patient completed scheduled visits or developed a primary endpoint event."|2665
10341306|NCT00385138|11478515|FG001|COMPLETED|Overall Study|"Completed means patient completed scheduled visits or developed a primary endpoint event."|2641
10341307|NCT00385138|11478514|FG000|NOT COMPLETED|Overall Study||30
10341308|NCT00385138|11478515|FG001|NOT COMPLETED|Overall Study||28
10341309|NCT00385203|11478523|FG000|STARTED|Overall Study||26
10341310|NCT00385203|11478524|FG001|STARTED|Overall Study||10
10341311|NCT00385203|11478523|FG000|COMPLETED|Overall Study||0
10341312|NCT00385203|11478524|FG001|COMPLETED|Overall Study||3
10341313|NCT00385203|11478523|FG000|NOT COMPLETED|Overall Study||26
10341314|NCT00385203|11478524|FG001|NOT COMPLETED|Overall Study||7
10341315|NCT00385216|11478531|FG000|STARTED|First Intervention||11
10341316|NCT00385216|11478532|FG001|STARTED|First Intervention||9
10341317|NCT00385216|11478531|FG000|COMPLETED|First Intervention||11
10341318|NCT00385216|11478532|FG001|COMPLETED|First Intervention||9
10341319|NCT00385216|11478531|FG000|NOT COMPLETED|First Intervention||0
10341320|NCT00385216|11478532|FG001|NOT COMPLETED|First Intervention||0
10341321|NCT00385216|11478531|FG000|STARTED|Second Intervention||11
10341322|NCT00385216|11478532|FG001|STARTED|Second Intervention||9
10341323|NCT00385216|11478531|FG000|COMPLETED|Second Intervention||11
10341324|NCT00385216|11478532|FG001|COMPLETED|Second Intervention||9
10341325|NCT00385216|11478531|FG000|NOT COMPLETED|Second Intervention||0
10341326|NCT00385216|11478532|FG001|NOT COMPLETED|Second Intervention||0
10341327|NCT00385255|11478540|FG000|STARTED|Overall Study||860
10341328|NCT00385255|11478541|FG001|STARTED|Overall Study||858
10341329|NCT00385255|11478540|FG000|≥ 65 Years of Age (YOA) Cohort|Overall Study||112
10341330|NCT00385255|11478541|FG001|≥ 65 Years of Age (YOA) Cohort|Overall Study||109
10341331|NCT00385255|11478540|FG000|19-64 Years of Age (YOA) Cohort|Overall Study||748
10341332|NCT00385255|11478541|FG001|19-64 Years of Age (YOA) Cohort|Overall Study||749
10341333|NCT00385255|11478540|FG000|COMPLETED|Overall Study||839
10341334|NCT00385255|11478541|FG001|COMPLETED|Overall Study||785
10341335|NCT00385255|11478540|FG000|NOT COMPLETED|Overall Study||21
10341336|NCT00385255|11478541|FG001|NOT COMPLETED|Overall Study||73
10341337|NCT00385268|11478553|FG000|STARTED|Overall Study||34
10341338|NCT00385268|11478554|FG001|STARTED|Overall Study||26
10341339|NCT00385268|11478553|FG000|COMPLETED|Overall Study||18
10341340|NCT00385268|11478554|FG001|COMPLETED|Overall Study||18
10341341|NCT00385268|11478553|FG000|NOT COMPLETED|Overall Study||16
10341342|NCT00385268|11478554|FG001|NOT COMPLETED|Overall Study||8
10341343|NCT00385541|11478562|FG000|STARTED|Overall Study||25
10341344|NCT00385541|11478563|FG001|STARTED|Overall Study||25
10341345|NCT00385541|11478562|FG000|COMPLETED|Overall Study||25
10341346|NCT00385541|11478563|FG001|COMPLETED|Overall Study||24
10341347|NCT00385541|11478562|FG000|NOT COMPLETED|Overall Study||0
10341348|NCT00385541|11478563|FG001|NOT COMPLETED|Overall Study||1
10341349|NCT00385580|11478571|FG000|STARTED|Overall Study|Number of participants treated.|48
10341350|NCT00385580|11478572|FG001|STARTED|Overall Study|Number of participants treated.|47
10341351|NCT00385580|11478571|FG000|COMPLETED|Overall Study|Completed=off study. Major reasons for being off study are disease progression, and study toxicity.|48
10341352|NCT00385580|11478572|FG001|COMPLETED|Overall Study|Completed=off study. Major reasons for being off study are disease progression, and study toxicity.|47
10341353|NCT00385580|11478571|FG000|NOT COMPLETED|Overall Study||0
10341354|NCT00385580|11478572|FG001|NOT COMPLETED|Overall Study||0
10530357|NCT01406938|11682876|FG001|FAS:Patients Assigned Study Treatment|Induction Period||483
10530358|NCT01406938|11682877|FG002|FAS:Patients Assigned Study Treatment|Induction Period||0
10530359|NCT01406938|11682878|FG003|FAS:Patients Assigned Study Treatment|Induction Period||0
10530360|NCT01406938|11682879|FG004|FAS:Patients Assigned Study Treatment|Induction Period||0
10530361|NCT01406938|11682880|FG005|FAS:Patients Assigned Study Treatment|Induction Period||0
10530362|NCT01406938|11682875|FG000|COMPLETED|Induction Period||464
10530363|NCT01406938|11682876|FG001|COMPLETED|Induction Period||464
10530364|NCT01406938|11682877|FG002|COMPLETED|Induction Period||0
10530365|NCT01406938|11682878|FG003|COMPLETED|Induction Period||0
10530366|NCT01406938|11682879|FG004|COMPLETED|Induction Period||0
10530367|NCT01406938|11682880|FG005|COMPLETED|Induction Period||0
10530368|NCT01406938|11682875|FG000|NOT COMPLETED|Induction Period||18
10530369|NCT01406938|11682876|FG001|NOT COMPLETED|Induction Period||20
10530370|NCT01406938|11682877|FG002|NOT COMPLETED|Induction Period||0
10530371|NCT01406938|11682878|FG003|NOT COMPLETED|Induction Period||0
10530372|NCT01406938|11682879|FG004|NOT COMPLETED|Induction Period||0
10530373|NCT01406938|11682880|FG005|NOT COMPLETED|Induction Period||0
10530374|NCT01406938|11682875|FG000|STARTED|Maintenance Period||0
10530375|NCT01406938|11682876|FG001|STARTED|Maintenance Period||0
10530376|NCT01406938|11682877|FG002|STARTED|Maintenance Period||203
10530377|NCT01406938|11682878|FG003|STARTED|Maintenance Period||217
10530378|NCT01406938|11682879|FG004|STARTED|Maintenance Period||206
10530379|NCT01406938|11682880|FG005|STARTED|Maintenance Period||217
10530380|NCT01406938|11682875|FG000|FAS: Patients Assigned Treatment Drug|Maintenance Period||0
10530381|NCT01406938|11682876|FG001|FAS: Patients Assigned Treatment Drug|Maintenance Period||0
10530382|NCT01406938|11682877|FG002|FAS: Patients Assigned Treatment Drug|Maintenance Period||203
10530383|NCT01406938|11682878|FG003|FAS: Patients Assigned Treatment Drug|Maintenance Period||216
10530384|NCT01406938|11682879|FG004|FAS: Patients Assigned Treatment Drug|Maintenance Period||206
10530385|NCT01406938|11682880|FG005|FAS: Patients Assigned Treatment Drug|Maintenance Period||217
10530386|NCT01406938|11682875|FG000|COMPLETED|Maintenance Period||0
10530387|NCT01406938|11682876|FG001|COMPLETED|Maintenance Period||0
10530388|NCT01406938|11682877|FG002|COMPLETED|Maintenance Period||186
10530389|NCT01406938|11682878|FG003|COMPLETED|Maintenance Period||199
10655046|NCT02206607|11815796|FG001|STARTED|Fourth Intervention Period||9
10655047|NCT02206607|11815797|FG002|STARTED|Fourth Intervention Period||9
10714915|NCT02688387|11880044|FG001|STARTED|Part 1, Washout Period 4 (7 Days)||2
10714916|NCT02688387|11880045|FG002|STARTED|Part 1, Washout Period 4 (7 Days)||2
10714917|NCT02688387|11880046|FG003|STARTED|Part 1, Washout Period 4 (7 Days)||2
10714918|NCT02688387|11880047|FG004|STARTED|Part 1, Washout Period 4 (7 Days)||2
10714919|NCT02688387|11880048|FG005|STARTED|Part 1, Washout Period 4 (7 Days)||2
10303507|NCT00079339|11436470|FG002|Enrolled in Phase II|Overall Study|Participants treated at the 150 mg/m2 dose level did not participate in the phase II part.|0
10303508|NCT00079339|11436468|FG000|COMPLETED|Overall Study||0
10303509|NCT00079339|11436469|FG001|COMPLETED|Overall Study||1
10303510|NCT00079339|11436470|FG002|COMPLETED|Overall Study||0
10303511|NCT00079339|11436468|FG000|NOT COMPLETED|Overall Study||5
10303512|NCT00079339|11436469|FG001|NOT COMPLETED|Overall Study||39
10303513|NCT00079339|11436470|FG002|NOT COMPLETED|Overall Study||6
10303514|NCT00079391|11436483|FG000|STARTED|Overall Study|1 of these withdrew after consent.|50
10303515|NCT00079391|11436483|FG000|COMPLETED|Overall Study||49
10303516|NCT00079391|11436483|FG000|NOT COMPLETED|Overall Study||1
10303517|NCT00079417|11436489|FG000|STARTED|Overall Study||28
10303518|NCT00079417|11436489|FG000|COMPLETED|Overall Study||19
10303519|NCT00079417|11436489|FG000|NOT COMPLETED|Overall Study||9
10303520|NCT00079677|11436495|FG000|STARTED|Overall Study||131
10303521|NCT00079677|11436496|FG001|STARTED|Overall Study||132
10303522|NCT00079677|11436495|FG000|COMPLETED|Overall Study||111
10303523|NCT00079677|11436496|FG001|COMPLETED|Overall Study||118
10303524|NCT00079677|11436495|FG000|NOT COMPLETED|Overall Study||20
10303525|NCT00079677|11436496|FG001|NOT COMPLETED|Overall Study||14
10303526|NCT00079781|11436505|FG000|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|45
10303527|NCT00079781|11436506|FG001|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|10
10303528|NCT00079781|11436507|FG002|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|15
10315114|NCT00174447|11448900|FG000|COMPLETED|Overall Study||5
10530390|NCT01406938|11682879|FG004|COMPLETED|Maintenance Period||181
10530391|NCT01406938|11682880|FG005|COMPLETED|Maintenance Period||201
10530392|NCT01406938|11682875|FG000|NOT COMPLETED|Maintenance Period||0
10655048|NCT02206607|11815798|FG003|STARTED|Fourth Intervention Period||10
10655049|NCT02206607|11815799|FG004|STARTED|Fourth Intervention Period||10
10714920|NCT02688387|11880049|FG006|STARTED|Part 1, Washout Period 4 (7 Days)||2
10714921|NCT02688387|11880050|FG007|STARTED|Part 1, Washout Period 4 (7 Days)||2
10714922|NCT02688387|11880051|FG008|STARTED|Part 1, Washout Period 4 (7 Days)||2
10714923|NCT02688387|11880052|FG009|STARTED|Part 1, Washout Period 4 (7 Days)||2
10341355|NCT00385593|11478590|FG000|STARTED|Overall Study||328
10341356|NCT00385593|11478591|FG001|STARTED|Overall Study||326
10341357|NCT00385593|11478590|FG000|COMPLETED|Overall Study||270
10341358|NCT00385593|11478591|FG001|COMPLETED|Overall Study||289
10341359|NCT00385593|11478590|FG000|NOT COMPLETED|Overall Study||58
10341360|NCT00385593|11478591|FG001|NOT COMPLETED|Overall Study||37
10341361|NCT00385671|11478600|FG000|STARTED|Overall Study||134
10341362|NCT00385671|11478601|FG001|STARTED|Overall Study||138
10341363|NCT00385671|11478602|FG002|STARTED|Overall Study||135
10341364|NCT00385671|11478600|FG000|COMPLETED|Overall Study||96
10341365|NCT00385671|11478601|FG001|COMPLETED|Overall Study||87
10341366|NCT00385671|11478602|FG002|COMPLETED|Overall Study||99
10341367|NCT00385671|11478600|FG000|NOT COMPLETED|Overall Study||38
10341368|NCT00385671|11478601|FG001|NOT COMPLETED|Overall Study||51
10341369|NCT00385671|11478602|FG002|NOT COMPLETED|Overall Study||36
10341370|NCT00385684|11478612|FG000|STARTED|FIRST INTERVENTION OF PHASE A||6
10341371|NCT00385684|11478613|FG001|STARTED|FIRST INTERVENTION OF PHASE A||5
10341372|NCT00385684|11478612|FG000|COMPLETED|FIRST INTERVENTION OF PHASE A||5
10341373|NCT00385684|11478613|FG001|COMPLETED|FIRST INTERVENTION OF PHASE A||5
10341374|NCT00385684|11478612|FG000|NOT COMPLETED|FIRST INTERVENTION OF PHASE A||1
10341375|NCT00385684|11478613|FG001|NOT COMPLETED|FIRST INTERVENTION OF PHASE A||0
10341376|NCT00385684|11478612|FG000|STARTED|SECOND INTERVENTION OF PHASE A||5
10341377|NCT00385684|11478613|FG001|STARTED|SECOND INTERVENTION OF PHASE A||5
10341378|NCT00385684|11478612|FG000|COMPLETED|SECOND INTERVENTION OF PHASE A||5
10341379|NCT00385684|11478613|FG001|COMPLETED|SECOND INTERVENTION OF PHASE A||3
10341380|NCT00385684|11478612|FG000|NOT COMPLETED|SECOND INTERVENTION OF PHASE A||0
10341381|NCT00385684|11478613|FG001|NOT COMPLETED|SECOND INTERVENTION OF PHASE A||2
10341382|NCT00385684|11478612|FG000|STARTED|PHASE B||5
10341383|NCT00385684|11478613|FG001|STARTED|PHASE B||3
10341384|NCT00385684|11478612|FG000|COMPLETED|PHASE B||5
10714924|NCT02688387|11880053|FG010|STARTED|Part 1, Washout Period 4 (7 Days)||0
10341385|NCT00385684|11478613|FG001|COMPLETED|PHASE B||3
10341386|NCT00385684|11478612|FG000|NOT COMPLETED|PHASE B||0
10341387|NCT00385684|11478613|FG001|NOT COMPLETED|PHASE B||0
10341388|NCT00385723|11478622|FG000|STARTED|Overall Study||46
10341389|NCT00385723|11478623|FG001|STARTED|Overall Study||46
10341390|NCT00385723|11478624|FG002|STARTED|Overall Study||46
10341391|NCT00385723|11478622|FG000|COMPLETED|Overall Study||44
10341392|NCT00385723|11478623|FG001|COMPLETED|Overall Study||45
10341393|NCT00385723|11478624|FG002|COMPLETED|Overall Study||44
10341394|NCT00385723|11478622|FG000|NOT COMPLETED|Overall Study||2
10341395|NCT00385723|11478623|FG001|NOT COMPLETED|Overall Study||1
10714925|NCT02688387|11880054|FG011|STARTED|Part 1, Washout Period 4 (7 Days)||0
10341396|NCT00385723|11478624|FG002|NOT COMPLETED|Overall Study||2
10426407|NCT00847535|11572059|FG002|200 Million AMDC|Overall Study||8
10341397|NCT00385736|11478635|FG000|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
10341398|NCT00385736|11478636|FG001|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
10341399|NCT00385736|11478637|FG002|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
10341400|NCT00385736|11478635|FG000|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|121
10341401|NCT00385736|11478636|FG001|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|118
10341402|NCT00385736|11478637|FG002|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|121
10341403|NCT00385736|11478635|FG000|NOT COMPLETED|Efficacy Analysis Set - Induction||9
10341404|NCT00385736|11478636|FG001|NOT COMPLETED|Efficacy Analysis Set - Induction||12
10341405|NCT00385736|11478637|FG002|NOT COMPLETED|Efficacy Analysis Set - Induction||9
10341406|NCT00385736|11478635|FG000|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|222
10341407|NCT00385736|11478636|FG001|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|130
10341408|NCT00385736|11478637|FG002|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|223
10341409|NCT00385736|11478635|FG000|COMPLETED|Efficacy Analysis Set - Maintenance||153
10341410|NCT00385736|11478636|FG001|COMPLETED|Efficacy Analysis Set - Maintenance||86
10341411|NCT00385736|11478637|FG002|COMPLETED|Efficacy Analysis Set - Maintenance||143
10341412|NCT00385736|11478635|FG000|NOT COMPLETED|Efficacy Analysis Set - Maintenance||69
10341413|NCT00385736|11478636|FG001|NOT COMPLETED|Efficacy Analysis Set - Maintenance||44
10341414|NCT00385736|11478637|FG002|NOT COMPLETED|Efficacy Analysis Set - Maintenance||80
10341415|NCT00385736|11478635|FG000|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|223
10341416|NCT00385736|11478636|FG001|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|130
10341417|NCT00385736|11478637|FG002|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|223
10341418|NCT00385736|11478635|FG000|COMPLETED|Safety Analysis Set||153
10341419|NCT00385736|11478636|FG001|COMPLETED|Safety Analysis Set||86
10341420|NCT00385736|11478637|FG002|COMPLETED|Safety Analysis Set||143
10341421|NCT00385736|11478635|FG000|NOT COMPLETED|Safety Analysis Set||70
10341422|NCT00385736|11478636|FG001|NOT COMPLETED|Safety Analysis Set||44
10341423|NCT00385736|11478637|FG002|NOT COMPLETED|Safety Analysis Set||80
10341424|NCT00385762|11478648|FG000|STARTED|Overall Study||35
10341425|NCT00385762|11478648|FG000|COMPLETED|Overall Study||33
10341426|NCT00385762|11478648|FG000|NOT COMPLETED|Overall Study||2
10341427|NCT00385788|11478654|FG000|STARTED|Overall Study||12
10341428|NCT00385788|11478655|FG001|STARTED|Overall Study||40
10341429|NCT00385788|11478654|FG000|COMPLETED|Overall Study||12
10341430|NCT00385788|11478655|FG001|COMPLETED|Overall Study||40
10530393|NCT01406938|11682876|FG001|NOT COMPLETED|Maintenance Period||0
10530394|NCT01406938|11682877|FG002|NOT COMPLETED|Maintenance Period||17
10530395|NCT01406938|11682878|FG003|NOT COMPLETED|Maintenance Period||18
10530396|NCT01406938|11682879|FG004|NOT COMPLETED|Maintenance Period||25
10530397|NCT01406938|11682880|FG005|NOT COMPLETED|Maintenance Period||16
10530398|NCT01406938|11682875|FG000|STARTED|Follow up||26
10530399|NCT01406938|11682876|FG001|STARTED|Follow up||23
10530400|NCT01406938|11682877|FG002|STARTED|Follow up||40
10530401|NCT01406938|11682878|FG003|STARTED|Follow up||39
10530402|NCT01406938|11682879|FG004|STARTED|Follow up||40
10530403|NCT01406938|11682880|FG005|STARTED|Follow up||35
10530404|NCT01406938|11682875|FG000|COMPLETED|Follow up||18
10530405|NCT01406938|11682876|FG001|COMPLETED|Follow up||18
10530406|NCT01406938|11682877|FG002|COMPLETED|Follow up||32
10530407|NCT01406938|11682878|FG003|COMPLETED|Follow up||36
10530408|NCT01406938|11682879|FG004|COMPLETED|Follow up||31
10530409|NCT01406938|11682880|FG005|COMPLETED|Follow up||32
10530410|NCT01406938|11682875|FG000|NOT COMPLETED|Follow up||8
10530411|NCT01406938|11682876|FG001|NOT COMPLETED|Follow up||5
10530412|NCT01406938|11682877|FG002|NOT COMPLETED|Follow up||8
10530413|NCT01406938|11682878|FG003|NOT COMPLETED|Follow up||3
10530414|NCT01406938|11682879|FG004|NOT COMPLETED|Follow up||9
10530415|NCT01406938|11682880|FG005|NOT COMPLETED|Follow up||3
10714926|NCT02688387|11880055|FG012|STARTED|Part 1, Washout Period 4 (7 Days)||0
10714927|NCT02688387|11880056|FG013|STARTED|Part 1, Washout Period 4 (7 Days)||0
10714928|NCT02688387|11880057|FG014|STARTED|Part 1, Washout Period 4 (7 Days)||0
10714929|NCT02688387|11880058|FG015|STARTED|Part 1, Washout Period 4 (7 Days)||0
10714930|NCT02688387|11880059|FG016|STARTED|Part 1, Washout Period 4 (7 Days)||0
10530416|NCT01406990|11682900|FG000|STARTED|Overall Study||15
10530417|NCT01406990|11682900|FG000|COMPLETED|Overall Study||15
10530418|NCT01406990|11682900|FG000|NOT COMPLETED|Overall Study||0
10530419|NCT01407068|11682904|FG000|STARTED|Overall Study||60
10530420|NCT01407068|11682904|FG000|COMPLETED|Overall Study||60
10530421|NCT01407068|11682904|FG000|NOT COMPLETED|Overall Study||0
10655050|NCT02206607|11815795|FG000|COMPLETED|Fourth Intervention Period||0
10655051|NCT02206607|11815796|FG001|COMPLETED|Fourth Intervention Period||9
10655052|NCT02206607|11815797|FG002|COMPLETED|Fourth Intervention Period||9
10530422|NCT01407094|11682913|FG000|STARTED|Stage 1|Stage 1 Sertraline (SERT): 34 exited|146
10714931|NCT02688387|11880060|FG017|STARTED|Part 1, Washout Period 4 (7 Days)||0
10714932|NCT02688387|11880061|FG018|STARTED|Part 1, Washout Period 4 (7 Days)||0
10714933|NCT02688387|11880062|FG019|STARTED|Part 1, Washout Period 4 (7 Days)||0
10530423|NCT01407094|11682914|FG001|STARTED|Stage 1|Stage 1 Placebo (PBO): 27 exited.|150
10530424|NCT01407094|11682915|FG002|STARTED|Stage 1|Bupropion (BUP) was used only in Stage 2 for non-responders to SERT.|0
10530425|NCT01407094|11682913|FG000|COMPLETED|Stage 1|One participant completed Stage 1 but did not continue to Stage 2.|112
10530426|NCT01407094|11682914|FG001|COMPLETED|Stage 1|Four participants completed Stage 1 but did not continue to Stage 2.|123
10530427|NCT01407094|11682915|FG002|COMPLETED|Stage 1||0
10530428|NCT01407094|11682913|FG000|NOT COMPLETED|Stage 1||34
10530429|NCT01407094|11682914|FG001|NOT COMPLETED|Stage 1||27
10530430|NCT01407094|11682915|FG002|NOT COMPLETED|Stage 1||0
10530431|NCT01407094|11682913|FG000|STARTED|Stage 2|Stage 2 SERT includes Stage 1 SERT responders (n=61) and Stage 1 PBO non-responders (n=73).|134
10530432|NCT01407094|11682914|FG001|STARTED|Stage 2|Stage 2 PBO includes Stage 1 PBO responders (n=47); 1 early exit (n=46).|46
10530433|NCT01407094|11682915|FG002|STARTED|Stage 2|Stage 2 BUP includes Stage 1 SERT non-responders (n=54); 1 early exit (n=53).|53
10530434|NCT01407094|11682913|FG000|COMPLETED|Stage 2||113
10530435|NCT01407094|11682914|FG001|COMPLETED|Stage 2||35
10530436|NCT01407094|11682915|FG002|COMPLETED|Stage 2||38
10530437|NCT01407094|11682913|FG000|NOT COMPLETED|Stage 2||21
10530438|NCT01407094|11682914|FG001|NOT COMPLETED|Stage 2||11
10530439|NCT01407094|11682915|FG002|NOT COMPLETED|Stage 2||15
10530440|NCT01407107|11682926|FG000|STARTED|Overall Study||7
10530441|NCT01407107|11682927|FG001|STARTED|Overall Study||3
10530442|NCT01407107|11682928|FG002|STARTED|Overall Study||3
10530443|NCT01407107|11682926|FG000|COMPLETED|Overall Study||7
10530444|NCT01407107|11682927|FG001|COMPLETED|Overall Study||3
10530445|NCT01407107|11682928|FG002|COMPLETED|Overall Study||3
10530446|NCT01407107|11682926|FG000|NOT COMPLETED|Overall Study||0
10530447|NCT01407107|11682927|FG001|NOT COMPLETED|Overall Study||0
10530448|NCT01407107|11682928|FG002|NOT COMPLETED|Overall Study||0
10530449|NCT01407276|11682944|FG000|STARTED|Overall Study||6
10530450|NCT01407276|11682945|FG001|STARTED|Overall Study||6
10530451|NCT01407276|11682946|FG002|STARTED|Overall Study||6
10530452|NCT01407276|11682947|FG003|STARTED|Overall Study||6
10530453|NCT01407276|11682948|FG004|STARTED|Overall Study||6
10530454|NCT01407276|11682949|FG005|STARTED|Overall Study||6
10530455|NCT01407276|11682950|FG006|STARTED|Overall Study||6
10530456|NCT01407276|11682951|FG007|STARTED|Overall Study||7
10530457|NCT01407276|11682944|FG000|COMPLETED|Overall Study||6
10530458|NCT01407276|11682945|FG001|COMPLETED|Overall Study||6
10530459|NCT01407276|11682946|FG002|COMPLETED|Overall Study||6
10530460|NCT01407276|11682947|FG003|COMPLETED|Overall Study||6
10530461|NCT01407276|11682948|FG004|COMPLETED|Overall Study||6
10530462|NCT01407276|11682949|FG005|COMPLETED|Overall Study||6
10530463|NCT01407276|11682950|FG006|COMPLETED|Overall Study||6
10530464|NCT01407276|11682951|FG007|COMPLETED|Overall Study||6
10530465|NCT01407276|11682944|FG000|NOT COMPLETED|Overall Study||0
10530466|NCT01407276|11682945|FG001|NOT COMPLETED|Overall Study||0
10530467|NCT01407276|11682946|FG002|NOT COMPLETED|Overall Study||0
10530468|NCT01407276|11682947|FG003|NOT COMPLETED|Overall Study||0
10530469|NCT01407276|11682948|FG004|NOT COMPLETED|Overall Study||0
10530470|NCT01407276|11682949|FG005|NOT COMPLETED|Overall Study||0
10530471|NCT01407276|11682950|FG006|NOT COMPLETED|Overall Study||0
10303529|NCT00079781|11436505|FG000|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|42
10315115|NCT00174447|11448900|FG000|NOT COMPLETED|Overall Study||38
10530472|NCT01407276|11682951|FG007|NOT COMPLETED|Overall Study||1
10714934|NCT02688387|11880063|FG020|STARTED|Part 1, Washout Period 4 (7 Days)||0
10714935|NCT02688387|11880064|FG021|STARTED|Part 1, Washout Period 4 (7 Days)||0
10341431|NCT00385788|11478654|FG000|NOT COMPLETED|Overall Study||0
10341432|NCT00385788|11478655|FG001|NOT COMPLETED|Overall Study||0
10341433|NCT00385801|11478663|FG000|STARTED|Overall Study||15
10341434|NCT00385801|11478664|FG001|STARTED|Overall Study||16
10341435|NCT00385801|11478663|FG000|COMPLETED|Overall Study||6
10341436|NCT00385801|11478664|FG001|COMPLETED|Overall Study||8
10341437|NCT00385801|11478663|FG000|NOT COMPLETED|Overall Study||9
10714936|NCT02688387|11880043|FG000|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
10714937|NCT02688387|11880044|FG001|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
10714938|NCT02688387|11880045|FG002|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
10714939|NCT02688387|11880046|FG003|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
10303530|NCT00079781|11436506|FG001|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|9
10303531|NCT00079781|11436507|FG002|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|14
10303532|NCT00079781|11436505|FG000|NOT COMPLETED|Pre-implant Period||3
10303533|NCT00079781|11436506|FG001|NOT COMPLETED|Pre-implant Period||1
10303534|NCT00079781|11436507|FG002|NOT COMPLETED|Pre-implant Period||1
10303535|NCT00079781|11436505|FG000|STARTED|Evaluation Period||42
10303536|NCT00079781|11436506|FG001|STARTED|Evaluation Period||9
10303537|NCT00079781|11436507|FG002|STARTED|Evaluation Period||14
10303538|NCT00079781|11436505|FG000|COMPLETED|Evaluation Period||42
10303539|NCT00079781|11436506|FG001|COMPLETED|Evaluation Period||9
10303540|NCT00079781|11436507|FG002|COMPLETED|Evaluation Period||14
10303541|NCT00079781|11436505|FG000|NOT COMPLETED|Evaluation Period||0
10303542|NCT00079781|11436506|FG001|NOT COMPLETED|Evaluation Period||0
10303543|NCT00079781|11436507|FG002|NOT COMPLETED|Evaluation Period||0
10303544|NCT00079781|11436505|FG000|STARTED|Follow-up Period||42
10303545|NCT00079781|11436506|FG001|STARTED|Follow-up Period||9
10303546|NCT00079781|11436507|FG002|STARTED|Follow-up Period||14
10303547|NCT00079781|11436505|FG000|COMPLETED|Follow-up Period||38
10303548|NCT00079781|11436506|FG001|COMPLETED|Follow-up Period||9
10303549|NCT00079781|11436507|FG002|COMPLETED|Follow-up Period||12
10303550|NCT00079781|11436505|FG000|NOT COMPLETED|Follow-up Period||4
10303551|NCT00079781|11436506|FG001|NOT COMPLETED|Follow-up Period||0
10303552|NCT00079781|11436507|FG002|NOT COMPLETED|Follow-up Period||2
10303553|NCT00079937|11436515|FG000|STARTED|Overall Study||421
10303554|NCT00079937|11436516|FG001|STARTED|Overall Study||207
10303555|NCT00079937|11436515|FG000|COMPLETED|Overall Study||352
10303556|NCT00079937|11436516|FG001|COMPLETED|Overall Study||175
10303557|NCT00079937|11436515|FG000|NOT COMPLETED|Overall Study||69
10303558|NCT00079937|11436516|FG001|NOT COMPLETED|Overall Study||32
10303559|NCT00080119|11436526|FG000|STARTED|Overall Study||403
10303560|NCT00080119|11436527|FG001|STARTED|Overall Study||401
10303561|NCT00080119|11436528|FG002|STARTED|Overall Study||273
10303562|NCT00080119|11436529|FG003|STARTED|Overall Study||274
10303563|NCT00080119|11436526|FG000|COMPLETED|Overall Study||347
10303564|NCT00080119|11436527|FG001|COMPLETED|Overall Study||339
10303565|NCT00080119|11436528|FG002|COMPLETED|Overall Study||108
10303566|NCT00080119|11436529|FG003|COMPLETED|Overall Study||111
10303567|NCT00080119|11436526|FG000|NOT COMPLETED|Overall Study||56
10303568|NCT00080119|11436527|FG001|NOT COMPLETED|Overall Study||62
10303569|NCT00080119|11436528|FG002|NOT COMPLETED|Overall Study||165
10303570|NCT00080119|11436529|FG003|NOT COMPLETED|Overall Study||163
10303571|NCT00080223|11436541|FG000|STARTED|Overall Study||83
10303572|NCT00080223|11436541|FG000|COMPLETED|Overall Study||7
10303573|NCT00080223|11436541|FG000|NOT COMPLETED|Overall Study||76
10303574|NCT00080288|11436547|FG000|STARTED|Overall Study||127
10303575|NCT00080288|11436548|FG001|STARTED|Overall Study||127
10303576|NCT00080288|11436547|FG000|COMPLETED|Overall Study||97
10303577|NCT00080288|11436548|FG001|COMPLETED|Overall Study||89
10303578|NCT00080288|11436547|FG000|NOT COMPLETED|Overall Study||30
10303579|NCT00080288|11436548|FG001|NOT COMPLETED|Overall Study||38
10303580|NCT00080301|11436556|FG000|STARTED|Overall Study||375
10303581|NCT00080301|11436557|FG001|STARTED|Overall Study||377
10303582|NCT00080301|11436556|FG000|Never Treated|Overall Study||5
10303583|NCT00080301|11436557|FG001|Never Treated|Overall Study||10
10303584|NCT00080301|11436556|FG000|Still on Treatment|Overall Study||0
10303585|NCT00080301|11436557|FG001|Still on Treatment|Overall Study||1
10303586|NCT00080301|11436556|FG000|COMPLETED|Overall Study|Participants who are off treatment|370
10303587|NCT00080301|11436557|FG001|COMPLETED|Overall Study|Participants who are off treatment|366
10303588|NCT00080301|11436556|FG000|NOT COMPLETED|Overall Study||5
10303589|NCT00080301|11436557|FG001|NOT COMPLETED|Overall Study||11
10303590|NCT00080470|11436566|FG000|STARTED|Overall Study||45
10303591|NCT00080470|11436567|FG001|STARTED|Overall Study||42
10303592|NCT00080470|11436566|FG000|COMPLETED|Overall Study||11
10303593|NCT00080470|11436567|FG001|COMPLETED|Overall Study||14
10303594|NCT00080470|11436566|FG000|NOT COMPLETED|Overall Study||34
10303595|NCT00080470|11436567|FG001|NOT COMPLETED|Overall Study||28
10303596|NCT00080483|11436577|FG000|STARTED|Overall Study||17
10303597|NCT00080483|11436578|FG001|STARTED|Overall Study||18
10303598|NCT00080483|11436577|FG000|COMPLETED|Overall Study||15
10303599|NCT00080483|11436578|FG001|COMPLETED|Overall Study||16
10303600|NCT00080483|11436577|FG000|NOT COMPLETED|Overall Study||2
10303601|NCT00080483|11436578|FG001|NOT COMPLETED|Overall Study||2
10303602|NCT00080535|11436584|FG000|STARTED|Overall Study||10
10303603|NCT00080535|11436584|FG000|COMPLETED|Overall Study||10
10303604|NCT00080535|11436584|FG000|NOT COMPLETED|Overall Study||0
10303605|NCT00080899|11436588|FG000|STARTED|Overall Study||23
10714940|NCT02688387|11880047|FG004|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
10714941|NCT02688387|11880048|FG005|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
10714942|NCT02688387|11880049|FG006|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
10303606|NCT00080899|11436588|FG000|COMPLETED|Overall Study||22
10303607|NCT00080899|11436588|FG000|NOT COMPLETED|Overall Study||1
10303608|NCT00080912|11436594|FG000|STARTED|Overall Study||425
10303609|NCT00080912|11436595|FG001|STARTED|Overall Study||425
10303610|NCT00080912|11436594|FG000|COMPLETED|Overall Study||425
10303611|NCT00080912|11436595|FG001|COMPLETED|Overall Study||425
10303612|NCT00080912|11436594|FG000|NOT COMPLETED|Overall Study||0
10303613|NCT00080912|11436595|FG001|NOT COMPLETED|Overall Study||0
10303614|NCT00080938|11436601|FG000|STARTED|Overall Study||26
10303615|NCT00080938|11436601|FG000|Began Protocol Therapy|Overall Study||25
10303616|NCT00080938|11436601|FG000|Eligible and Treated|Overall Study||21
10303617|NCT00080938|11436601|FG000|COMPLETED|Overall Study||2
10303618|NCT00080938|11436601|FG000|NOT COMPLETED|Overall Study||24
10341438|NCT00385801|11478664|FG001|NOT COMPLETED|Overall Study||8
10426408|NCT00847535|11572057|FG000|COMPLETED|Overall Study||22
10426409|NCT00847535|11572058|FG001|COMPLETED|Overall Study||22
10426410|NCT00847535|11572059|FG002|COMPLETED|Overall Study||15
10426411|NCT00847535|11572057|FG000|NOT COMPLETED|Overall Study||2
10426412|NCT00847535|11572058|FG001|NOT COMPLETED|Overall Study||2
10426413|NCT00847535|11572059|FG002|NOT COMPLETED|Overall Study||1
10426414|NCT00847561|11572066|FG000|STARTED|Overall Study||70
10426415|NCT00847561|11572067|FG001|STARTED|Overall Study||66
10426416|NCT00847561|11572066|FG000|COMPLETED|Overall Study||57
10426417|NCT00847561|11572067|FG001|COMPLETED|Overall Study||62
10426418|NCT00847561|11572066|FG000|NOT COMPLETED|Overall Study||13
10426419|NCT00847561|11572067|FG001|NOT COMPLETED|Overall Study||4
10426420|NCT00847587|11572075|FG000|STARTED|Overall Study||35
10426421|NCT00847587|11572076|FG001|STARTED|Overall Study||34
10426422|NCT00847587|11572075|FG000|COMPLETED|Overall Study|Patient declined study after randomization.|34
10426423|NCT00847587|11572076|FG001|COMPLETED|Overall Study||34
10426424|NCT00847587|11572075|FG000|NOT COMPLETED|Overall Study||1
10426425|NCT00847587|11572076|FG001|NOT COMPLETED|Overall Study||0
10426426|NCT00847613|11572086|FG000|STARTED|Overall Study||321
10426427|NCT00847613|11572087|FG001|STARTED|Overall Study||319
10426428|NCT00847613|11572088|FG002|STARTED|Overall Study||81
10426429|NCT00847613|11572089|FG003|STARTED|Overall Study||79
10426430|NCT00847613|11572086|FG000|Treated|Overall Study||321
10426431|NCT00847613|11572087|FG001|Treated|Overall Study||316
10426432|NCT00847613|11572088|FG002|Treated|Overall Study||81
10426433|NCT00847613|11572089|FG003|Treated|Overall Study||79
10426434|NCT00847613|11572086|FG000|COMPLETED|Overall Study||0
10426435|NCT00847613|11572087|FG001|COMPLETED|Overall Study||0
10426436|NCT00847613|11572088|FG002|COMPLETED|Overall Study||0
10426437|NCT00847613|11572089|FG003|COMPLETED|Overall Study||0
10426438|NCT00847613|11572086|FG000|NOT COMPLETED|Overall Study||321
10426439|NCT00847613|11572087|FG001|NOT COMPLETED|Overall Study||319
10426440|NCT00847613|11572088|FG002|NOT COMPLETED|Overall Study||81
10426441|NCT00847613|11572089|FG003|NOT COMPLETED|Overall Study||79
10426442|NCT00847626|11572117|FG000|STARTED|Overall Study||156
10426443|NCT00847626|11572118|FG001|STARTED|Overall Study||154
10426444|NCT00847626|11572119|FG002|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|147
10426445|NCT00847626|11572120|FG003|STARTED|Overall Study||156
10426446|NCT00847626|11572121|FG004|STARTED|Overall Study||153
10426447|NCT00847626|11572122|FG005|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|162
10426448|NCT00847626|11572123|FG006|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|157
10426449|NCT00847626|11572124|FG007|STARTED|Overall Study|Includes participant who was treated with double-blind study medication but not randomized.|160
10426450|NCT00847626|11572125|FG008|STARTED|Overall Study||155
10426451|NCT00847626|11572126|FG009|STARTED|Overall Study||153
10426452|NCT00847626|11572127|FG010|STARTED|Overall Study||162
10426453|NCT00847626|11572117|FG000|COMPLETED|Overall Study||135
10426454|NCT00847626|11572118|FG001|COMPLETED|Overall Study||131
10426455|NCT00847626|11572119|FG002|COMPLETED|Overall Study||131
10426456|NCT00847626|11572120|FG003|COMPLETED|Overall Study||125
10426457|NCT00847626|11572121|FG004|COMPLETED|Overall Study||125
10426458|NCT00847626|11572122|FG005|COMPLETED|Overall Study||125
10426459|NCT00847626|11572123|FG006|COMPLETED|Overall Study||135
10426460|NCT00847626|11572124|FG007|COMPLETED|Overall Study||141
10426461|NCT00847626|11572125|FG008|COMPLETED|Overall Study||141
10426462|NCT00847626|11572126|FG009|COMPLETED|Overall Study||139
10426463|NCT00847626|11572127|FG010|COMPLETED|Overall Study||142
10426464|NCT00847626|11572117|FG000|NOT COMPLETED|Overall Study||21
10426465|NCT00847626|11572118|FG001|NOT COMPLETED|Overall Study||23
10426466|NCT00847626|11572119|FG002|NOT COMPLETED|Overall Study||16
10426467|NCT00847626|11572120|FG003|NOT COMPLETED|Overall Study||31
10426468|NCT00847626|11572121|FG004|NOT COMPLETED|Overall Study||28
10426469|NCT00847626|11572122|FG005|NOT COMPLETED|Overall Study||37
10426470|NCT00847626|11572123|FG006|NOT COMPLETED|Overall Study||22
10426471|NCT00847626|11572124|FG007|NOT COMPLETED|Overall Study||19
10426472|NCT00847626|11572125|FG008|NOT COMPLETED|Overall Study||14
10426473|NCT00847626|11572126|FG009|NOT COMPLETED|Overall Study||14
10812177|NCT03731182|11974161|FG001|STARTED|Overall Study||34
10426474|NCT00847626|11572127|FG010|NOT COMPLETED|Overall Study||20
10426475|NCT00847665|11572156|FG000|STARTED|Overall Study||165
10812178|NCT03731182|11974160|FG000|V114 or Prevnar 13™ Vaccination (Day 1)|Overall Study||69
10812179|NCT03731182|11974161|FG001|V114 or Prevnar 13™ Vaccination (Day 1)|Overall Study||34
10812180|NCT03731182|11974160|FG000|COMPLETED|Overall Study||65
10812181|NCT03731182|11974161|FG001|COMPLETED|Overall Study||34
10812182|NCT03731182|11974160|FG000|NOT COMPLETED|Overall Study||5
10812183|NCT03731182|11974161|FG001|NOT COMPLETED|Overall Study||0
10812184|NCT03730961|11974170|FG000|STARTED|Overall Study||12
10812185|NCT03730961|11974171|FG001|STARTED|Overall Study||11
10341439|NCT00385827|11478674|FG000|STARTED|Part 1||9
10341440|NCT00385827|11478675|FG001|STARTED|Part 1||0
10341441|NCT00385827|11478676|FG002|STARTED|Part 1||0
10341442|NCT00385827|11478674|FG000|Treated|Part 1||9
10341443|NCT00385827|11478675|FG001|Treated|Part 1||0
10341444|NCT00385827|11478676|FG002|Treated|Part 1||0
10341445|NCT00385827|11478674|FG000|COMPLETED|Part 1||0
10341446|NCT00385827|11478675|FG001|COMPLETED|Part 1||0
10341447|NCT00385827|11478676|FG002|COMPLETED|Part 1||0
10341448|NCT00385827|11478674|FG000|NOT COMPLETED|Part 1||9
10341449|NCT00385827|11478675|FG001|NOT COMPLETED|Part 1||0
10341450|NCT00385827|11478676|FG002|NOT COMPLETED|Part 1||0
10341451|NCT00385827|11478674|FG000|STARTED|Part 2||0
10341452|NCT00385827|11478675|FG001|STARTED|Part 2||49
10341453|NCT00385827|11478676|FG002|STARTED|Part 2||48
10341454|NCT00385827|11478674|FG000|Treated|Part 2||0
10341455|NCT00385827|11478675|FG001|Treated|Part 2||47
10341456|NCT00385827|11478676|FG002|Treated|Part 2||46
10341457|NCT00385827|11478674|FG000|COMPLETED|Part 2||0
10341458|NCT00385827|11478675|FG001|COMPLETED|Part 2||16
10341459|NCT00385827|11478676|FG002|COMPLETED|Part 2||0
10341460|NCT00385827|11478674|FG000|NOT COMPLETED|Part 2||0
10341461|NCT00385827|11478675|FG001|NOT COMPLETED|Part 2||33
10341462|NCT00385827|11478676|FG002|NOT COMPLETED|Part 2||48
10341463|NCT00385840|11478688|FG000|STARTED|Overall Study||133
10341464|NCT00385840|11478689|FG001|STARTED|Overall Study||545
10341465|NCT00385840|11478688|FG000|COMPLETED|Overall Study||129
10341466|NCT00385840|11478689|FG001|COMPLETED|Overall Study||531
10341467|NCT00385840|11478688|FG000|NOT COMPLETED|Overall Study||4
10341468|NCT00385840|11478689|FG001|NOT COMPLETED|Overall Study||14
10341469|NCT00385918|11478697|FG000|STARTED|Feasibility & Baseline Measurement Phase||0
10341470|NCT00385918|11478698|FG001|STARTED|Feasibility & Baseline Measurement Phase||0
10341471|NCT00385918|11478699|FG002|STARTED|Feasibility & Baseline Measurement Phase|Total # of subjects screened.The screening occurred before randomization.|35
10341472|NCT00385918|11478697|FG000|Number Eligible|Feasibility & Baseline Measurement Phase||0
10530473|NCT01407354|11682976|FG000|STARTED|First Intervention||20
10530474|NCT01407354|11682977|FG001|STARTED|First Intervention||17
10530475|NCT01407354|11682976|FG000|COMPLETED|First Intervention||18
10530476|NCT01407354|11682977|FG001|COMPLETED|First Intervention||15
10655053|NCT02206607|11815798|FG003|COMPLETED|Fourth Intervention Period||10
10655054|NCT02206607|11815799|FG004|COMPLETED|Fourth Intervention Period||10
10655055|NCT02206607|11815795|FG000|NOT COMPLETED|Fourth Intervention Period||0
10655056|NCT02206607|11815796|FG001|NOT COMPLETED|Fourth Intervention Period||0
10655057|NCT02206607|11815797|FG002|NOT COMPLETED|Fourth Intervention Period||0
10655058|NCT02206607|11815798|FG003|NOT COMPLETED|Fourth Intervention Period||0
10655059|NCT02206607|11815799|FG004|NOT COMPLETED|Fourth Intervention Period||0
10655060|NCT02206620|11815815|FG000|STARTED|Phase I - First Intervention (6 Weeks)||22
10655061|NCT02206620|11815816|FG001|STARTED|Phase I - First Intervention (6 Weeks)||27
10655062|NCT02206620|11815815|FG000|COMPLETED|Phase I - First Intervention (6 Weeks)||21
10655063|NCT02206620|11815816|FG001|COMPLETED|Phase I - First Intervention (6 Weeks)||26
10655064|NCT02206620|11815815|FG000|NOT COMPLETED|Phase I - First Intervention (6 Weeks)||1
10655065|NCT02206620|11815816|FG001|NOT COMPLETED|Phase I - First Intervention (6 Weeks)||1
10655066|NCT02206620|11815815|FG000|STARTED|Washout (6 Weeks)||21
10655067|NCT02206620|11815816|FG001|STARTED|Washout (6 Weeks)||26
10655068|NCT02206620|11815815|FG000|COMPLETED|Washout (6 Weeks)||21
10655069|NCT02206620|11815816|FG001|COMPLETED|Washout (6 Weeks)||26
10655070|NCT02206620|11815815|FG000|NOT COMPLETED|Washout (6 Weeks)||0
10655071|NCT02206620|11815816|FG001|NOT COMPLETED|Washout (6 Weeks)||0
10303619|NCT00081159|11436607|FG000|STARTED|Overall Study||39
10303620|NCT00081159|11436608|FG001|STARTED|Overall Study||40
10341473|NCT00385918|11478698|FG001|Number Eligible|Feasibility & Baseline Measurement Phase||0
10341474|NCT00385918|11478699|FG002|Number Eligible|Feasibility & Baseline Measurement Phase|8 subjects failed screening.|27
10341475|NCT00385918|11478697|FG000|Completed Baseline Tests|Feasibility & Baseline Measurement Phase||0
10530477|NCT01407354|11682976|FG000|NOT COMPLETED|First Intervention||2
10530478|NCT01407354|11682977|FG001|NOT COMPLETED|First Intervention||2
10655072|NCT02206620|11815815|FG000|STARTED|Phase II - Second Intervention (6 Weeks)||21
10303621|NCT00081159|11436607|FG000|COMPLETED|Overall Study||37
10303622|NCT00081159|11436608|FG001|COMPLETED|Overall Study||35
10303623|NCT00081159|11436607|FG000|NOT COMPLETED|Overall Study||2
10303624|NCT00081159|11436608|FG001|NOT COMPLETED|Overall Study||5
10303625|NCT00081263|11436616|FG000|STARTED|Overall Study||67
10303626|NCT00081263|11436617|FG001|STARTED|Overall Study||63
10341476|NCT00385918|11478698|FG001|Completed Baseline Tests|Feasibility & Baseline Measurement Phase||0
10530479|NCT01407354|11682976|FG000|STARTED|Second Intervention||18
10303627|NCT00081263|11436616|FG000|COMPLETED|Overall Study||50
10303628|NCT00081263|11436617|FG001|COMPLETED|Overall Study||41
10341477|NCT00385918|11478699|FG002|Completed Baseline Tests|Feasibility & Baseline Measurement Phase|6 subjects did not complete all baseline tests.|21
10341478|NCT00385918|11478697|FG000|COMPLETED|Feasibility & Baseline Measurement Phase||0
10341479|NCT00385918|11478698|FG001|COMPLETED|Feasibility & Baseline Measurement Phase||0
10530480|NCT01407354|11682977|FG001|STARTED|Second Intervention||15
10530481|NCT01407354|11682976|FG000|COMPLETED|Second Intervention||18
10530482|NCT01407354|11682977|FG001|COMPLETED|Second Intervention||13
10530483|NCT01407354|11682976|FG000|NOT COMPLETED|Second Intervention||0
10530484|NCT01407354|11682977|FG001|NOT COMPLETED|Second Intervention||2
10530485|NCT01407367|11682986|FG000|STARTED|Overall Study||108
10530486|NCT01407367|11682987|FG001|STARTED|Overall Study||242
10530487|NCT01407367|11682986|FG000|COMPLETED|Overall Study||68
10530488|NCT01407367|11682987|FG001|COMPLETED|Overall Study||164
10530489|NCT01407367|11682986|FG000|NOT COMPLETED|Overall Study||40
10530490|NCT01407367|11682987|FG001|NOT COMPLETED|Overall Study||78
10530491|NCT01407523|11682996|FG000|STARTED|Overall Study||16
10530492|NCT01407523|11682996|FG000|COMPLETED|Overall Study||16
10530493|NCT01407523|11682996|FG000|NOT COMPLETED|Overall Study||0
10530494|NCT01407575|11683002|FG000|STARTED|Overall Study||7
10530495|NCT01407575|11683003|FG001|STARTED|Overall Study||6
10530496|NCT01407575|11683002|FG000|COMPLETED|Overall Study||5
10530497|NCT01407575|11683003|FG001|COMPLETED|Overall Study||5
10530498|NCT01407575|11683002|FG000|NOT COMPLETED|Overall Study||2
10530499|NCT01407575|11683003|FG001|NOT COMPLETED|Overall Study||1
10530500|NCT01407926|11683011|FG000|STARTED|Overall Study||142
10530501|NCT01407926|11683011|FG000|COMPLETED|Overall Study||87
10530502|NCT01407926|11683011|FG000|NOT COMPLETED|Overall Study||55
10530503|NCT01407952|11683018|FG000|STARTED|Overall Study||297
10530504|NCT01407952|11683019|FG001|STARTED|Overall Study||303
10530505|NCT01407952|11683018|FG000|COMPLETED|Overall Study||251
10530506|NCT01407952|11683019|FG001|COMPLETED|Overall Study||266
10530507|NCT01407952|11683018|FG000|NOT COMPLETED|Overall Study||46
10530508|NCT01407952|11683019|FG001|NOT COMPLETED|Overall Study||37
10530509|NCT01408030|11683029|FG000|STARTED|Treatment Phase (on Drug)||29
10530510|NCT01408030|11683030|FG001|STARTED|Treatment Phase (on Drug)||31
10655073|NCT02206620|11815816|FG001|STARTED|Phase II - Second Intervention (6 Weeks)||26
10655074|NCT02206620|11815815|FG000|COMPLETED|Phase II - Second Intervention (6 Weeks)||21
10655075|NCT02206620|11815816|FG001|COMPLETED|Phase II - Second Intervention (6 Weeks)||24
10655076|NCT02206620|11815815|FG000|NOT COMPLETED|Phase II - Second Intervention (6 Weeks)||0
10655077|NCT02206620|11815816|FG001|NOT COMPLETED|Phase II - Second Intervention (6 Weeks)||2
10655078|NCT02206685|11815830|FG000|STARTED|Overall Study||37
10303629|NCT00081263|11436616|FG000|NOT COMPLETED|Overall Study||17
10303630|NCT00081263|11436617|FG001|NOT COMPLETED|Overall Study||22
10303631|NCT00081289|11436625|FG000|STARTED|Overall Study||73
10303632|NCT00081289|11436626|FG001|STARTED|Overall Study||73
10303633|NCT00081289|11436625|FG000|Primary Endpoint Population|Overall Study||48
10303634|NCT00081289|11436626|FG001|Primary Endpoint Population|Overall Study||48
10303635|NCT00081289|11436625|FG000|General Analysis Population|Overall Study||52
10303636|NCT00081289|11436626|FG001|General Analysis Population|Overall Study||52
10303637|NCT00081289|11436625|FG000|Full AE Population|Overall Study||70
10303638|NCT00081289|11436626|FG001|Full AE Population|Overall Study||68
10303639|NCT00081289|11436625|FG000|Surgery|Overall Study||47
10303640|NCT00081289|11436626|FG001|Surgery|Overall Study||51
10303641|NCT00081289|11436625|FG000|Global Health Status Score at End of CR|Overall Study|European Organization for Research & Treatment of Cancer Quality of Life Questionnaire [EORTC QLQ]|34
10303642|NCT00081289|11436626|FG001|Global Health Status Score at End of CR|Overall Study||32
10303643|NCT00081289|11436625|FG000|GHS at End of Post-op CT|Overall Study||20
10303644|NCT00081289|11436626|FG001|GHS at End of Post-op CT|Overall Study||28
10303645|NCT00081289|11436625|FG000|GHS at Two Years|Overall Study||21
10303646|NCT00081289|11436626|FG001|GHS at Two Years|Overall Study||20
10303647|NCT00081289|11436625|FG000|GI Symptom Score at End of CR|Overall Study||34
10303648|NCT00081289|11436626|FG001|GI Symptom Score at End of CR|Overall Study||33
10303649|NCT00081289|11436625|FG000|GI Symptom Score at End of Post-op CT|Overall Study||22
10303650|NCT00081289|11436626|FG001|GI Symptom Score at End of Post-op CT|Overall Study||27
10303651|NCT00081289|11436625|FG000|GI Symptom Score at Two Years|Overall Study||21
10303652|NCT00081289|11436626|FG001|GI Symptom Score at Two Years|Overall Study||20
10303653|NCT00081289|11436625|FG000|Defecation Symptom Score at End of CR|Overall Study||32
10303654|NCT00081289|11436626|FG001|Defecation Symptom Score at End of CR|Overall Study||32
10303655|NCT00081289|11436625|FG000|DS Score at End of Post-op CT|Overall Study||12
10303656|NCT00081289|11436626|FG001|DS Score at End of Post-op CT|Overall Study||14
10303657|NCT00081289|11436625|FG000|Defecation Symptom Score at Two Years|Overall Study||13
10303658|NCT00081289|11436626|FG001|Defecation Symptom Score at Two Years|Overall Study||15
10303659|NCT00081289|11436625|FG000|COMPLETED|Overall Study||52
10303660|NCT00081289|11436626|FG001|COMPLETED|Overall Study||52
10303661|NCT00081289|11436625|FG000|NOT COMPLETED|Overall Study||21
10303662|NCT00081289|11436626|FG001|NOT COMPLETED|Overall Study||21
10303663|NCT00081328|11436636|FG000|STARTED|Overall Study||232
10303664|NCT00081328|11436637|FG001|STARTED|Overall Study||233
10303665|NCT00081328|11436638|FG002|STARTED|Overall Study||234
10303666|NCT00081328|11436636|FG000|COMPLETED|Overall Study||232
10303667|NCT00081328|11436637|FG001|COMPLETED|Overall Study||233
10303668|NCT00081328|11436638|FG002|COMPLETED|Overall Study||234
10303669|NCT00081328|11436636|FG000|NOT COMPLETED|Overall Study||0
10303670|NCT00081328|11436637|FG001|NOT COMPLETED|Overall Study||0
10303671|NCT00081328|11436638|FG002|NOT COMPLETED|Overall Study||0
10303672|NCT00081458|11436650|FG000|STARTED|Overall Study||16
10303673|NCT00081458|11436651|FG001|STARTED|Overall Study||35
10303674|NCT00081458|11436652|FG002|STARTED|Overall Study||33
10303675|NCT00081458|11436650|FG000|Received Treatment|Overall Study||16
10303676|NCT00081458|11436651|FG001|Received Treatment|Overall Study||35
10303677|NCT00081458|11436652|FG002|Received Treatment|Overall Study|1 subject was randomized but did not receive the study drug|32
10303678|NCT00081458|11436650|FG000|COMPLETED|Overall Study||15
10303679|NCT00081458|11436651|FG001|COMPLETED|Overall Study||27
10303680|NCT00081458|11436652|FG002|COMPLETED|Overall Study||29
10303681|NCT00081458|11436650|FG000|NOT COMPLETED|Overall Study||1
10303682|NCT00081458|11436651|FG001|NOT COMPLETED|Overall Study||8
10303683|NCT00081458|11436652|FG002|NOT COMPLETED|Overall Study||4
10303684|NCT00081497|11436663|FG000|STARTED|Overall Study|Patients who were randomized to placebo in AGAL-008-00 (NCT00074984).|28
10303685|NCT00081497|11436664|FG001|STARTED|Overall Study|Patients who were randomized to Fabrazyme in AGAL-008-00 (NCT00074984).|39
10303686|NCT00081497|11436663|FG000|COMPLETED|Overall Study||25
10303687|NCT00081497|11436664|FG001|COMPLETED|Overall Study||37
10303688|NCT00081497|11436663|FG000|NOT COMPLETED|Overall Study||3
10303689|NCT00081497|11436664|FG001|NOT COMPLETED|Overall Study||2
10303690|NCT00081653|11436678|FG000|STARTED|Overall Study|Patients entering Study MA17903 from Study BM16549|358
10303691|NCT00081653|11436679|FG001|STARTED|Overall Study|Patients entering Study MA17903 from Study BM16549|361
10303692|NCT00081653|11436678|FG000|COMPLETED|Overall Study|Completed 3 years of treatment|311
10341480|NCT00385918|11478699|FG002|COMPLETED|Feasibility & Baseline Measurement Phase||21
10341481|NCT00385918|11478697|FG000|NOT COMPLETED|Feasibility & Baseline Measurement Phase||0
10341482|NCT00385918|11478698|FG001|NOT COMPLETED|Feasibility & Baseline Measurement Phase||0
10341483|NCT00385918|11478699|FG002|NOT COMPLETED|Feasibility & Baseline Measurement Phase||14
10341484|NCT00385918|11478697|FG000|STARTED|Intervention Phase After Randomization|Participant successfully completed screening; this is the number in the Lokomat training arm.|15
10341485|NCT00385918|11478698|FG001|STARTED|Intervention Phase After Randomization|Participants successfully completed screening; this is the number in the home stretching arm.|6
10530511|NCT01408030|11683031|FG002|STARTED|Treatment Phase (on Drug)||33
10530512|NCT01408030|11683032|FG003|STARTED|Treatment Phase (on Drug)||28
10530513|NCT01408030|11683029|FG000|COMPLETED|Treatment Phase (on Drug)||26
10530514|NCT01408030|11683030|FG001|COMPLETED|Treatment Phase (on Drug)||24
10530515|NCT01408030|11683031|FG002|COMPLETED|Treatment Phase (on Drug)||32
10530516|NCT01408030|11683032|FG003|COMPLETED|Treatment Phase (on Drug)||25
10303693|NCT00081653|11436679|FG001|COMPLETED|Overall Study|Completed 3 years of treatment|324
10303694|NCT00081653|11436678|FG000|NOT COMPLETED|Overall Study||47
10303695|NCT00081653|11436679|FG001|NOT COMPLETED|Overall Study||37
10303696|NCT00081731|11436688|FG000|STARTED|Overall Study||480
10303697|NCT00081731|11436689|FG001|STARTED|Overall Study||467
10303698|NCT00081731|11436688|FG000|COMPLETED|Overall Study||472
10303699|NCT00081731|11436689|FG001|COMPLETED|Overall Study||459
10303700|NCT00081731|11436688|FG000|NOT COMPLETED|Overall Study||8
10303701|NCT00081731|11436689|FG001|NOT COMPLETED|Overall Study||8
10303702|NCT00081770|11436698|FG000|STARTED|Overall Study||1019
10303703|NCT00081770|11436699|FG001|STARTED|Overall Study||1016
10303704|NCT00081770|11436700|FG002|STARTED|Overall Study||1035
10303705|NCT00081770|11436698|FG000|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|517
10303706|NCT00081770|11436699|FG001|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|470
10303707|NCT00081770|11436700|FG002|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|579
10303708|NCT00081770|11436698|FG000|NOT COMPLETED|Overall Study||502
10303709|NCT00081770|11436699|FG001|NOT COMPLETED|Overall Study||546
10303710|NCT00081770|11436700|FG002|NOT COMPLETED|Overall Study||456
10303711|NCT00081861|11436708|FG000|STARTED|Overall Study||13
10303712|NCT00081861|11436708|FG000|COMPLETED|Overall Study||13
10303713|NCT00081861|11436708|FG000|NOT COMPLETED|Overall Study||0
10303714|NCT00081939|11436712|FG000|STARTED|Overall Study||303
10303715|NCT00081939|11436712|FG000|COMPLETED|Overall Study||303
10303716|NCT00081939|11436712|FG000|NOT COMPLETED|Overall Study||0
10530517|NCT01408030|11683029|FG000|NOT COMPLETED|Treatment Phase (on Drug)||3
10530518|NCT01408030|11683030|FG001|NOT COMPLETED|Treatment Phase (on Drug)||7
10530519|NCT01408030|11683031|FG002|NOT COMPLETED|Treatment Phase (on Drug)||1
10530520|NCT01408030|11683032|FG003|NOT COMPLETED|Treatment Phase (on Drug)||3
10530521|NCT01408030|11683029|FG000|STARTED|Observation Phase (Off Drug)||26
10530522|NCT01408030|11683030|FG001|STARTED|Observation Phase (Off Drug)||24
10530523|NCT01408030|11683031|FG002|STARTED|Observation Phase (Off Drug)||32
10530524|NCT01408030|11683032|FG003|STARTED|Observation Phase (Off Drug)||25
10530525|NCT01408030|11683029|FG000|COMPLETED|Observation Phase (Off Drug)||22
10530526|NCT01408030|11683030|FG001|COMPLETED|Observation Phase (Off Drug)||18
10530527|NCT01408030|11683031|FG002|COMPLETED|Observation Phase (Off Drug)||26
10530528|NCT01408030|11683032|FG003|COMPLETED|Observation Phase (Off Drug)||21
10530529|NCT01408030|11683029|FG000|NOT COMPLETED|Observation Phase (Off Drug)||4
10530530|NCT01408030|11683030|FG001|NOT COMPLETED|Observation Phase (Off Drug)||6
10530531|NCT01408030|11683031|FG002|NOT COMPLETED|Observation Phase (Off Drug)||6
10303717|NCT00082017|11436716|FG000|STARTED|Overall Study||11
10303718|NCT00082017|11436717|FG001|STARTED|Overall Study||9
10303719|NCT00082017|11436716|FG000|COMPLETED|Overall Study||11
10303720|NCT00082017|11436717|FG001|COMPLETED|Overall Study||9
10303721|NCT00082017|11436716|FG000|NOT COMPLETED|Overall Study||0
10303722|NCT00082017|11436717|FG001|NOT COMPLETED|Overall Study||0
10714943|NCT02688387|11880050|FG007|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
10714944|NCT02688387|11880051|FG008|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
10714945|NCT02688387|11880052|FG009|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
10714946|NCT02688387|11880053|FG010|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10714947|NCT02688387|11880054|FG011|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10714948|NCT02688387|11880055|FG012|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10714949|NCT02688387|11880056|FG013|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10714950|NCT02688387|11880057|FG014|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10714951|NCT02688387|11880058|FG015|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10714952|NCT02688387|11880059|FG016|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10714953|NCT02688387|11880060|FG017|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10714954|NCT02688387|11880061|FG018|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10714955|NCT02688387|11880062|FG019|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10714956|NCT02688387|11880063|FG020|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10714957|NCT02688387|11880064|FG021|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10714958|NCT02688387|11880043|FG000|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10714959|NCT02688387|11880044|FG001|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10714960|NCT02688387|11880045|FG002|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10714961|NCT02688387|11880046|FG003|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10812186|NCT03730961|11974170|FG000|Period 1 Completion|Overall Study||12
10812187|NCT03730961|11974171|FG001|Period 1 Completion|Overall Study||11
10812188|NCT03730961|11974170|FG000|Period 2 Completion|Overall Study|1 participant did not complete Period 2 due to hypotension but remained in the study|11
10812189|NCT03730961|11974171|FG001|Period 2 Completion|Overall Study|1 participant discontinued study due to AE|10
10812190|NCT03730961|11974170|FG000|COMPLETED|Overall Study||12
10812191|NCT03730961|11974171|FG001|COMPLETED|Overall Study||10
10714962|NCT02688387|11880047|FG004|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10812192|NCT03730961|11974170|FG000|NOT COMPLETED|Overall Study||0
10812193|NCT03730961|11974171|FG001|NOT COMPLETED|Overall Study||1
10530532|NCT01408030|11683032|FG003|NOT COMPLETED|Observation Phase (Off Drug)||4
10530533|NCT01408043|11683042|FG000|STARTED|Overall Study||25
10530534|NCT01408043|11683042|FG000|COMPLETED|Overall Study||24
10530535|NCT01408043|11683042|FG000|NOT COMPLETED|Overall Study||1
10530536|NCT01408147|11683048|FG000|STARTED|Overall Study|174 participants|174
10530537|NCT01408147|11683049|FG001|STARTED|Overall Study|197 participants|197
10530538|NCT01408147|11683048|FG000|COMPLETED|Overall Study|1 clinic withdrew due to low census|174
10530539|NCT01408147|11683049|FG001|COMPLETED|Overall Study||196
10530540|NCT01408147|11683048|FG000|NOT COMPLETED|Overall Study||0
10530541|NCT01408147|11683049|FG001|NOT COMPLETED|Overall Study||1
10530542|NCT01408277|11683057|FG000|STARTED|Overall Study||28
10530543|NCT01408277|11683058|FG001|STARTED|Overall Study||27
10530544|NCT01408277|11683057|FG000|COMPLETED|Overall Study||20
10530545|NCT01408277|11683058|FG001|COMPLETED|Overall Study||23
10530546|NCT01408277|11683057|FG000|NOT COMPLETED|Overall Study||8
10530547|NCT01408277|11683058|FG001|NOT COMPLETED|Overall Study||4
10530548|NCT01408303|11683067|FG000|STARTED|Overall Study||215
10530549|NCT01408303|11683068|FG001|STARTED|Overall Study||216
10530550|NCT01408303|11683069|FG002|STARTED|Overall Study||216
10530551|NCT01408303|11683067|FG000|COMPLETED|Overall Study||209
10530552|NCT01408303|11683068|FG001|COMPLETED|Overall Study||204
10530553|NCT01408303|11683069|FG002|COMPLETED|Overall Study||210
10530554|NCT01408303|11683067|FG000|NOT COMPLETED|Overall Study||6
10530555|NCT01408303|11683068|FG001|NOT COMPLETED|Overall Study||12
10530556|NCT01408303|11683069|FG002|NOT COMPLETED|Overall Study||6
10530557|NCT01408329|11683079|FG000|STARTED|Overall Study||13
10530558|NCT01408329|11683080|FG001|STARTED|Overall Study||15
10530559|NCT01408329|11683079|FG000|COMPLETED|Overall Study||10
10530560|NCT01408329|11683080|FG001|COMPLETED|Overall Study||11
10530561|NCT01408329|11683079|FG000|NOT COMPLETED|Overall Study||3
10530562|NCT01408329|11683080|FG001|NOT COMPLETED|Overall Study||4
10530563|NCT01408459|11683088|FG000|STARTED|Overall Study||22
10530564|NCT01408459|11683089|FG001|STARTED|Overall Study||15
10530565|NCT01408459|11683088|FG000|COMPLETED|Overall Study||21
10530566|NCT01408459|11683089|FG001|COMPLETED|Overall Study||14
10530567|NCT01408459|11683088|FG000|NOT COMPLETED|Overall Study||1
10530568|NCT01408459|11683089|FG001|NOT COMPLETED|Overall Study||1
10547856|NCT01515423|11701645|FG000|STARTED|Open Label Phase||1429
10547857|NCT01515423|11701646|FG001|STARTED|Open Label Phase||0
10547858|NCT01515423|11701647|FG002|STARTED|Open Label Phase||0
10547859|NCT01515423|11701645|FG000|COMPLETED|Open Label Phase||1016
10547860|NCT01515423|11701646|FG001|COMPLETED|Open Label Phase||0
10547861|NCT01515423|11701647|FG002|COMPLETED|Open Label Phase||0
10547862|NCT01515423|11701645|FG000|NOT COMPLETED|Open Label Phase||413
10547863|NCT01515423|11701646|FG001|NOT COMPLETED|Open Label Phase||0
10547864|NCT01515423|11701647|FG002|NOT COMPLETED|Open Label Phase||0
10547865|NCT01515423|11701645|FG000|STARTED|DOUBLE BLIND||0
10547866|NCT01515423|11701646|FG001|STARTED|DOUBLE BLIND||504
10547867|NCT01515423|11701647|FG002|STARTED|DOUBLE BLIND||512
10547868|NCT01515423|11701645|FG000|COMPLETED|DOUBLE BLIND||0
10547869|NCT01515423|11701646|FG001|COMPLETED|DOUBLE BLIND||422
10547870|NCT01515423|11701647|FG002|COMPLETED|DOUBLE BLIND||420
10547871|NCT01515423|11701645|FG000|NOT COMPLETED|DOUBLE BLIND||0
10547872|NCT01515423|11701646|FG001|NOT COMPLETED|DOUBLE BLIND||82
10547873|NCT01515423|11701647|FG002|NOT COMPLETED|DOUBLE BLIND||92
10547874|NCT01515475|11701658|FG000|STARTED|Overall Study||61
10547875|NCT01515475|11701659|FG001|STARTED|Overall Study||58
10547876|NCT01515475|11701660|FG002|STARTED|Overall Study||65
10547877|NCT01515475|11701661|FG003|STARTED|Overall Study||65
10547878|NCT01515475|11701658|FG000|COMPLETED|Overall Study||41
10547879|NCT01515475|11701659|FG001|COMPLETED|Overall Study||43
10547880|NCT01515475|11701660|FG002|COMPLETED|Overall Study||53
10547881|NCT01515475|11701661|FG003|COMPLETED|Overall Study||53
10547882|NCT01515475|11701658|FG000|NOT COMPLETED|Overall Study||20
10547883|NCT01515475|11701659|FG001|NOT COMPLETED|Overall Study||15
10547884|NCT01515475|11701660|FG002|NOT COMPLETED|Overall Study||12
10547885|NCT01515475|11701661|FG003|NOT COMPLETED|Overall Study||12
10547886|NCT01515488|11701673|FG000|STARTED|Overall Study||200
10547887|NCT01515488|11701674|FG001|STARTED|Overall Study||200
10547888|NCT01515488|11701673|FG000|COMPLETED|Overall Study||200
10547889|NCT01515488|11701674|FG001|COMPLETED|Overall Study||200
10547890|NCT01515488|11701673|FG000|NOT COMPLETED|Overall Study||0
10655079|NCT02206685|11815831|FG001|STARTED|Overall Study||37
10655080|NCT02206685|11815830|FG000|COMPLETED|Overall Study||32
10655081|NCT02206685|11815831|FG001|COMPLETED|Overall Study||30
10655082|NCT02206685|11815830|FG000|NOT COMPLETED|Overall Study||5
10547891|NCT01515488|11701674|FG001|NOT COMPLETED|Overall Study||0
10547892|NCT01515540|11701682|FG000|STARTED|Overall Study||20
10547893|NCT01515540|11701683|FG001|STARTED|Overall Study||18
10547894|NCT01515540|11701682|FG000|COMPLETED|Overall Study||15
10547895|NCT01515540|11701683|FG001|COMPLETED|Overall Study||15
10303723|NCT00082173|11436725|FG000|STARTED|Overall Study||74
10303724|NCT00082173|11436726|FG001|STARTED|Overall Study||72
10303725|NCT00082173|11436725|FG000|COMPLETED|Overall Study||64
10303726|NCT00082173|11436726|FG001|COMPLETED|Overall Study||61
10303727|NCT00082173|11436725|FG000|NOT COMPLETED|Overall Study||10
10303728|NCT00082173|11436726|FG001|NOT COMPLETED|Overall Study||11
10303729|NCT00082329|11436732|FG000|STARTED|Overall Study||9
10303730|NCT00082329|11436732|FG000|COMPLETED|Overall Study||9
10303731|NCT00082329|11436732|FG000|NOT COMPLETED|Overall Study||0
10303732|NCT00082342|11436738|FG000|STARTED|Overall Study||13
10303733|NCT00082342|11436739|FG001|STARTED|Overall Study||12
10303734|NCT00082342|11436738|FG000|COMPLETED|Overall Study||13
10303735|NCT00082342|11436739|FG001|COMPLETED|Overall Study||12
10303736|NCT00082342|11436738|FG000|NOT COMPLETED|Overall Study||0
10303737|NCT00082342|11436739|FG001|NOT COMPLETED|Overall Study||0
10303738|NCT00082355|11436759|FG000|STARTED|Initial Results of Thrombolytic Therapy||30
10303739|NCT00082355|11436759|FG000|COMPLETED|Initial Results of Thrombolytic Therapy||28
10303740|NCT00082355|11436759|FG000|NOT COMPLETED|Initial Results of Thrombolytic Therapy||2
10303741|NCT00082355|11436759|FG000|STARTED|5 Year Recurrent Thromboembolism Rate||28
10303742|NCT00082355|11436759|FG000|COMPLETED|5 Year Recurrent Thromboembolism Rate|data will not be complied until 2014|0
10303743|NCT00082355|11436759|FG000|NOT COMPLETED|5 Year Recurrent Thromboembolism Rate||28
10303744|NCT00082368|11436763|FG000|STARTED|Overall Study||12
10303745|NCT00082368|11436763|FG000|COMPLETED|Overall Study||11
10303746|NCT00082368|11436763|FG000|NOT COMPLETED|Overall Study||1
10303747|NCT00082381|11436769|FG000|STARTED|Overall Study||283
10303748|NCT00082381|11436770|FG001|STARTED|Overall Study||268
10303749|NCT00082381|11436769|FG000|Received Treatment (Intent to Treat)|Overall Study||282
10303750|NCT00082381|11436770|FG001|Received Treatment (Intent to Treat)|Overall Study||267
10303751|NCT00082381|11436769|FG000|COMPLETED|Overall Study||228
10303752|NCT00082381|11436770|FG001|COMPLETED|Overall Study||242
10303753|NCT00082381|11436769|FG000|NOT COMPLETED|Overall Study||55
10303754|NCT00082381|11436770|FG001|NOT COMPLETED|Overall Study||26
10315116|NCT00174460|11448906|FG000|STARTED|Overall Study||18
10315117|NCT00174460|11448907|FG001|STARTED|Overall Study||15
10315118|NCT00174460|11448906|FG000|Received Study Treatment|Overall Study||18
10315119|NCT00174460|11448907|FG001|Received Study Treatment|Overall Study||14
10315120|NCT00174460|11448906|FG000|COMPLETED|Overall Study||18
10315121|NCT00174460|11448907|FG001|COMPLETED|Overall Study||14
10315122|NCT00174460|11448906|FG000|NOT COMPLETED|Overall Study||0
10315123|NCT00174460|11448907|FG001|NOT COMPLETED|Overall Study||1
10315124|NCT00174785|11448916|FG000|STARTED|Overall Study|randomized patients; among them, 10 patients did not receive any study drug in the dronedarone group|2301
10315125|NCT00174785|11448917|FG001|STARTED|Overall Study|randomized patients; among them, 14 patients did not receive any study drug in the placebo group|2327
10315126|NCT00174785|11448916|FG000|COMPLETED|Overall Study|completed study drug|1605
10315127|NCT00174785|11448917|FG001|COMPLETED|Overall Study|completed study drug|1611
10315128|NCT00174785|11448916|FG000|NOT COMPLETED|Overall Study||696
10315129|NCT00174785|11448917|FG001|NOT COMPLETED|Overall Study||716
10315130|NCT00174915|11448928|FG000|STARTED|Overall Study||267
10315131|NCT00174915|11448929|FG001|STARTED|Overall Study||269
10315132|NCT00174915|11448930|FG002|STARTED|Overall Study||134
10315133|NCT00174915|11448931|FG003|STARTED|Overall Study||268
10315134|NCT00174915|11448932|FG004|STARTED|Overall Study||134
10315135|NCT00174915|11448928|FG000|COMPLETED|Overall Study||174
10315136|NCT00174915|11448929|FG001|COMPLETED|Overall Study||200
10315137|NCT00174915|11448930|FG002|COMPLETED|Overall Study||86
10315138|NCT00174915|11448931|FG003|COMPLETED|Overall Study||211
10315139|NCT00174915|11448932|FG004|COMPLETED|Overall Study||101
10315140|NCT00174915|11448928|FG000|NOT COMPLETED|Overall Study||93
10315141|NCT00174915|11448929|FG001|NOT COMPLETED|Overall Study||69
10315142|NCT00174915|11448930|FG002|NOT COMPLETED|Overall Study||48
10315143|NCT00174915|11448931|FG003|NOT COMPLETED|Overall Study||57
10315144|NCT00174915|11448932|FG004|NOT COMPLETED|Overall Study||33
10315145|NCT00174941|11448947|FG000|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|8
10315146|NCT00174941|11448948|FG001|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|79
10315147|NCT00174941|11448949|FG002|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|29
10341486|NCT00385918|11478699|FG002|STARTED|Intervention Phase After Randomization||0
10341487|NCT00385918|11478697|FG000|COMPLETED|Intervention Phase After Randomization|Participants completed the 3-month training intervention|12
10341488|NCT00385918|11478698|FG001|COMPLETED|Intervention Phase After Randomization|Participants completed the 3-month home-base intervention|6
10341489|NCT00385918|11478699|FG002|COMPLETED|Intervention Phase After Randomization||0
10315148|NCT00174941|11448950|FG003|STARTED|Overall Study||116
10315149|NCT00174941|11448947|FG000|COMPLETED|Overall Study||6
10315150|NCT00174941|11448948|FG001|COMPLETED|Overall Study||41
10315151|NCT00174941|11448949|FG002|COMPLETED|Overall Study||11
10315152|NCT00174941|11448950|FG003|COMPLETED|Overall Study||58
10315153|NCT00174941|11448947|FG000|NOT COMPLETED|Overall Study||2
10315154|NCT00174941|11448948|FG001|NOT COMPLETED|Overall Study||38
10812194|NCT03730116|11974177|FG000|STARTED|Inclusion|Planned to include 1920 pts, included 1909|1909
10812195|NCT03730116|11974177|FG000|FVFP|Inclusion||1909
10812196|NCT03730116|11974177|FG000|COMPLETED|Inclusion||1909
10812197|NCT03730116|11974177|FG000|NOT COMPLETED|Inclusion||0
10812198|NCT03730116|11974177|FG000|STARTED|1 Month After Inclusion||1909
10812199|NCT03730116|11974177|FG000|1 Month After Inclusion|1 Month After Inclusion||1909
10812200|NCT03730116|11974177|FG000|COMPLETED|1 Month After Inclusion||1909
10812201|NCT03730116|11974177|FG000|NOT COMPLETED|1 Month After Inclusion||0
10812202|NCT03730116|11974177|FG000|STARTED|3 Month After Inclusion||1909
10812203|NCT03730116|11974177|FG000|3 Month After Inclusion|3 Month After Inclusion||1909
10812204|NCT03730116|11974177|FG000|COMPLETED|3 Month After Inclusion||1892
10341490|NCT00385918|11478697|FG000|NOT COMPLETED|Intervention Phase After Randomization||3
10341491|NCT00385918|11478698|FG001|NOT COMPLETED|Intervention Phase After Randomization||0
10341492|NCT00385918|11478699|FG002|NOT COMPLETED|Intervention Phase After Randomization||0
10341493|NCT00385944|11478708|FG000|STARTED|Loading Dose||0
10341494|NCT00385944|11478709|FG001|STARTED|Loading Dose||0
10341495|NCT00385944|11478710|FG002|STARTED|Loading Dose||56
10341496|NCT00385944|11478708|FG000|COMPLETED|Loading Dose||0
10341497|NCT00385944|11478709|FG001|COMPLETED|Loading Dose||0
10341498|NCT00385944|11478710|FG002|COMPLETED|Loading Dose||56
10341499|NCT00385944|11478708|FG000|NOT COMPLETED|Loading Dose||0
10341500|NCT00385944|11478709|FG001|NOT COMPLETED|Loading Dose||0
10341501|NCT00385944|11478710|FG002|NOT COMPLETED|Loading Dose||0
10341502|NCT00385944|11478708|FG000|STARTED|1st Maintenance Dose Period||29
10341503|NCT00385944|11478709|FG001|STARTED|1st Maintenance Dose Period|Two patients withdrew from the study after randomization but prior to receiving the 1st MD.|25
10341504|NCT00385944|11478710|FG002|STARTED|1st Maintenance Dose Period||0
10341505|NCT00385944|11478708|FG000|COMPLETED|1st Maintenance Dose Period||25
10714963|NCT02688387|11880048|FG005|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10714964|NCT02688387|11880049|FG006|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10714965|NCT02688387|11880050|FG007|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10714966|NCT02688387|11880051|FG008|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10341506|NCT00385944|11478709|FG001|COMPLETED|1st Maintenance Dose Period||24
10341507|NCT00385944|11478710|FG002|COMPLETED|1st Maintenance Dose Period||0
10714967|NCT02688387|11880052|FG009|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10303755|NCT00082407|11436778|FG000|STARTED|Overall Study||255
10303756|NCT00082407|11436779|FG001|STARTED|Overall Study||250
10303757|NCT00082407|11436778|FG000|Received Treatment (Intent to Treat)|Overall Study||253
10303758|NCT00082407|11436779|FG001|Received Treatment (Intent to Treat)|Overall Study||248
10303759|NCT00082407|11436778|FG000|COMPLETED|Overall Study||199
10303760|NCT00082407|11436779|FG001|COMPLETED|Overall Study||223
10303761|NCT00082407|11436778|FG000|NOT COMPLETED|Overall Study||56
10303762|NCT00082407|11436779|FG001|NOT COMPLETED|Overall Study||27
10303763|NCT00082433|11436787|FG000|STARTED|Overall Study||609
10303764|NCT00082433|11436788|FG001|STARTED|Overall Study||612
10303765|NCT00082433|11436787|FG000|COMPLETED|Overall Study|Participants who received 18 or more cycles of treatment.|15
10303766|NCT00082433|11436788|FG001|COMPLETED|Overall Study|Participants who received 18 or more cycles of treatment.|15
10303767|NCT00082433|11436787|FG000|NOT COMPLETED|Overall Study||594
10303768|NCT00082433|11436788|FG001|NOT COMPLETED|Overall Study||597
10303769|NCT00082628|11436796|FG000|STARTED|Treatment Period I (Week 1 to Week 12)||81
10303770|NCT00082628|11436797|FG001|STARTED|Treatment Period I (Week 1 to Week 12)||245
10303771|NCT00082628|11436798|FG002|STARTED|Treatment Period I (Week 1 to Week 12)||0
10303772|NCT00082628|11436799|FG003|STARTED|Treatment Period I (Week 1 to Week 12)||0
10303773|NCT00082628|11436800|FG004|STARTED|Treatment Period I (Week 1 to Week 12)||0
10303774|NCT00082628|11436796|FG000|COMPLETED|Treatment Period I (Week 1 to Week 12)||73
10303775|NCT00082628|11436797|FG001|COMPLETED|Treatment Period I (Week 1 to Week 12)||185
10303776|NCT00082628|11436798|FG002|COMPLETED|Treatment Period I (Week 1 to Week 12)||0
10303777|NCT00082628|11436799|FG003|COMPLETED|Treatment Period I (Week 1 to Week 12)||0
10303778|NCT00082628|11436800|FG004|COMPLETED|Treatment Period I (Week 1 to Week 12)||0
10303779|NCT00082628|11436796|FG000|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||8
10303780|NCT00082628|11436797|FG001|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||60
10303781|NCT00082628|11436798|FG002|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0
10303782|NCT00082628|11436799|FG003|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0
10303783|NCT00082628|11436800|FG004|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0
10303784|NCT00082628|11436796|FG000|STARTED|Treatment Period II: Week 12 to Week 36||0
10303785|NCT00082628|11436797|FG001|STARTED|Treatment Period II: Week 12 to Week 36||0
10303786|NCT00082628|11436798|FG002|STARTED|Treatment Period II: Week 12 to Week 36||93
10714968|NCT02688387|11880053|FG010|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10714969|NCT02688387|11880054|FG011|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10714970|NCT02688387|11880055|FG012|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10714971|NCT02688387|11880056|FG013|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10714972|NCT02688387|11880057|FG014|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10714973|NCT02688387|11880058|FG015|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10714974|NCT02688387|11880059|FG016|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10714975|NCT02688387|11880060|FG017|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10714976|NCT02688387|11880061|FG018|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10714977|NCT02688387|11880062|FG019|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10714978|NCT02688387|11880063|FG020|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10714979|NCT02688387|11880064|FG021|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
10714980|NCT02688387|11880043|FG000|STARTED|Part 1, Period 5 (up to 6 Days)||2
10714981|NCT02688387|11880044|FG001|STARTED|Part 1, Period 5 (up to 6 Days)||2
10714982|NCT02688387|11880045|FG002|STARTED|Part 1, Period 5 (up to 6 Days)||2
10714983|NCT02688387|11880046|FG003|STARTED|Part 1, Period 5 (up to 6 Days)||2
10714984|NCT02688387|11880047|FG004|STARTED|Part 1, Period 5 (up to 6 Days)||2
10714985|NCT02688387|11880048|FG005|STARTED|Part 1, Period 5 (up to 6 Days)||2
10714986|NCT02688387|11880049|FG006|STARTED|Part 1, Period 5 (up to 6 Days)||2
10714987|NCT02688387|11880050|FG007|STARTED|Part 1, Period 5 (up to 6 Days)||2
10714988|NCT02688387|11880051|FG008|STARTED|Part 1, Period 5 (up to 6 Days)||2
10714989|NCT02688387|11880052|FG009|STARTED|Part 1, Period 5 (up to 6 Days)||2
10714990|NCT02688387|11880053|FG010|STARTED|Part 1, Period 5 (up to 6 Days)||0
10714991|NCT02688387|11880054|FG011|STARTED|Part 1, Period 5 (up to 6 Days)||0
10714992|NCT02688387|11880055|FG012|STARTED|Part 1, Period 5 (up to 6 Days)||0
10303787|NCT00082628|11436799|FG003|STARTED|Treatment Period II: Week 12 to Week 36||92
10303788|NCT00082628|11436800|FG004|STARTED|Treatment Period II: Week 12 to Week 36||73
10303789|NCT00082628|11436796|FG000|COMPLETED|Treatment Period II: Week 12 to Week 36||0
10303790|NCT00082628|11436797|FG001|COMPLETED|Treatment Period II: Week 12 to Week 36||0
10303791|NCT00082628|11436798|FG002|COMPLETED|Treatment Period II: Week 12 to Week 36||78
10303792|NCT00082628|11436799|FG003|COMPLETED|Treatment Period II: Week 12 to Week 36||76
10303793|NCT00082628|11436800|FG004|COMPLETED|Treatment Period II: Week 12 to Week 36||55
10303794|NCT00082628|11436796|FG000|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||0
10303795|NCT00082628|11436797|FG001|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||0
10303796|NCT00082628|11436798|FG002|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||15
10812205|NCT03730116|11974177|FG000|NOT COMPLETED|3 Month After Inclusion||17
10812206|NCT03730103|11974187|FG000|STARTED|Overall Study||61
10812207|NCT03730103|11974188|FG001|STARTED|Overall Study||52
10812208|NCT03730103|11974187|FG000|COMPLETED|Overall Study||61
10812209|NCT03730103|11974188|FG001|COMPLETED|Overall Study||47
10812210|NCT03730103|11974187|FG000|NOT COMPLETED|Overall Study||0
10812211|NCT03730103|11974188|FG001|NOT COMPLETED|Overall Study||5
10812212|NCT03729960|11974194|FG000|STARTED|Overall Study||20
10812213|NCT03729960|11974194|FG000|COMPLETED|Overall Study||20
10812214|NCT03729960|11974194|FG000|NOT COMPLETED|Overall Study||0
10812215|NCT03729024|11974199|FG000|STARTED|Overall Study||21
10812216|NCT03729024|11974199|FG000|COMPLETED|Overall Study||21
10812217|NCT03729024|11974199|FG000|NOT COMPLETED|Overall Study||0
10812218|NCT03728790|11974205|FG000|STARTED|Overall Study||112
10812219|NCT03728790|11974206|FG001|STARTED|Overall Study||101
10812220|NCT03728790|11974205|FG000|COMPLETED|Overall Study||112
10812221|NCT03728790|11974206|FG001|COMPLETED|Overall Study||101
10812222|NCT03728790|11974205|FG000|NOT COMPLETED|Overall Study||0
10812223|NCT03728790|11974206|FG001|NOT COMPLETED|Overall Study||0
10812224|NCT03728348|11974212|FG000|STARTED|Overall Study||983
10812225|NCT03728348|11974212|FG000|Did Not Complete Study Procedures|Overall Study||107
10812226|NCT03728348|11974212|FG000|Multi-target DNA Test Excluded|Overall Study||15
10812227|NCT03728348|11974212|FG000|Colonoscopy Excluded|Overall Study||19
10812228|NCT03728348|11974212|FG000|COMPLETED|Overall Study||842
10812229|NCT03728348|11974212|FG000|NOT COMPLETED|Overall Study||141
10303797|NCT00082628|11436799|FG003|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||16
10303798|NCT00082628|11436800|FG004|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||18
10303799|NCT00082641|11436814|FG000|STARTED|Overall Study||11
10303800|NCT00082641|11436815|FG001|STARTED|Overall Study||12
10303801|NCT00082641|11436814|FG000|COMPLETED|Overall Study||11
10303802|NCT00082641|11436815|FG001|COMPLETED|Overall Study||12
10303803|NCT00082641|11436814|FG000|NOT COMPLETED|Overall Study||0
10303804|NCT00082641|11436815|FG001|NOT COMPLETED|Overall Study||0
10341508|NCT00385944|11478708|FG000|NOT COMPLETED|1st Maintenance Dose Period||4
10341509|NCT00385944|11478709|FG001|NOT COMPLETED|1st Maintenance Dose Period||1
10341510|NCT00385944|11478710|FG002|NOT COMPLETED|1st Maintenance Dose Period||0
10341511|NCT00385944|11478708|FG000|STARTED|2nd Maintenance Dose Period|1 patient discontinued prior to the 2nd MD Period (Sponsor decision due to early study termination)|24
10341512|NCT00385944|11478709|FG001|STARTED|2nd Maintenance Dose Period|2 patients discontinued prior to the 2nd MD Period (Sponsor decision due to early study termination)|22
10341513|NCT00385944|11478710|FG002|STARTED|2nd Maintenance Dose Period||0
10341514|NCT00385944|11478708|FG000|COMPLETED|2nd Maintenance Dose Period||22
10341515|NCT00385944|11478709|FG001|COMPLETED|2nd Maintenance Dose Period||19
10341516|NCT00385944|11478710|FG002|COMPLETED|2nd Maintenance Dose Period||0
10341517|NCT00385944|11478708|FG000|NOT COMPLETED|2nd Maintenance Dose Period||2
10341518|NCT00385944|11478709|FG001|NOT COMPLETED|2nd Maintenance Dose Period||3
10341519|NCT00385944|11478710|FG002|NOT COMPLETED|2nd Maintenance Dose Period||0
10341520|NCT00385996|11478725|FG000|STARTED|Overall Study||22
10341521|NCT00385996|11478725|FG000|COMPLETED|Overall Study||22
10303805|NCT00082758|11436825|FG000|STARTED|Overall Study||15
10303806|NCT00082758|11436826|FG001|STARTED|Overall Study||24
10303807|NCT00082758|11436827|FG002|STARTED|Overall Study||0
10303808|NCT00082758|11436825|FG000|COMPLETED|Overall Study||0
10303809|NCT00082758|11436826|FG001|COMPLETED|Overall Study||7
10303810|NCT00082758|11436827|FG002|COMPLETED|Overall Study||0
10303811|NCT00082758|11436825|FG000|NOT COMPLETED|Overall Study||15
10303812|NCT00082758|11436826|FG001|NOT COMPLETED|Overall Study||17
10303813|NCT00082758|11436827|FG002|NOT COMPLETED|Overall Study||0
10341522|NCT00385996|11478725|FG000|NOT COMPLETED|Overall Study||0
10341523|NCT00386009|11478732|FG000|STARTED|Overall Study||101
10341524|NCT00386009|11478733|FG001|STARTED|Overall Study||99
10341525|NCT00386009|11478732|FG000|COMPLETED|Overall Study||92
10341526|NCT00386009|11478733|FG001|COMPLETED|Overall Study||89
10303814|NCT00082810|11436835|FG000|STARTED|Overall Study||33
10303815|NCT00082810|11436835|FG000|COMPLETED|Overall Study||2
10303816|NCT00082810|11436835|FG000|NOT COMPLETED|Overall Study||31
10303817|NCT00082888|11436843|FG000|STARTED|Overall Study||42
10303818|NCT00082888|11436844|FG001|STARTED|Overall Study||15
10341527|NCT00386009|11478732|FG000|NOT COMPLETED|Overall Study||9
10341528|NCT00386009|11478733|FG001|NOT COMPLETED|Overall Study||10
10341529|NCT00386022|11478741|FG000|STARTED|Baseline||10
10341530|NCT00386022|11478742|FG001|STARTED|Baseline||9
10341531|NCT00386022|11478741|FG000|All Doses of GnRH|Baseline||10
10341532|NCT00386022|11478742|FG001|All Doses of GnRH|Baseline||9
10341533|NCT00386022|11478741|FG000|COMPLETED|Baseline||10
10341534|NCT00386022|11478742|FG001|COMPLETED|Baseline||9
10341535|NCT00386022|11478741|FG000|NOT COMPLETED|Baseline||0
10341536|NCT00386022|11478742|FG001|NOT COMPLETED|Baseline||0
10341537|NCT00386022|11478741|FG000|STARTED|Plus Estrogen||10
10341538|NCT00386022|11478742|FG001|STARTED|Plus Estrogen||9
10341539|NCT00386022|11478741|FG000|Estrogen Patch|Plus Estrogen||8
10341540|NCT00386022|11478742|FG001|Estrogen Patch|Plus Estrogen||9
10341541|NCT00386022|11478741|FG000|All Doses GnRH|Plus Estrogen||8
10341542|NCT00386022|11478742|FG001|All Doses GnRH|Plus Estrogen||8
10341543|NCT00386022|11478741|FG000|COMPLETED|Plus Estrogen||8
10341544|NCT00386022|11478742|FG001|COMPLETED|Plus Estrogen||8
10341545|NCT00386022|11478741|FG000|NOT COMPLETED|Plus Estrogen||2
10341546|NCT00386022|11478742|FG001|NOT COMPLETED|Plus Estrogen||1
10341547|NCT00386100|11478752|FG000|STARTED|Overall Study||340
10341548|NCT00386100|11478753|FG001|STARTED|Overall Study||348
10341549|NCT00386100|11478752|FG000|COMPLETED|Overall Study||186
10341550|NCT00386100|11478753|FG001|COMPLETED|Overall Study||217
10341551|NCT00386100|11478752|FG000|NOT COMPLETED|Overall Study||154
10341552|NCT00386100|11478753|FG001|NOT COMPLETED|Overall Study||131
10341553|NCT00386152|11478762|FG000|STARTED|Overall Study|number of subjects treated|75
10341554|NCT00386152|11478763|FG001|STARTED|Overall Study|number of subjects treated|77
10341555|NCT00386152|11478764|FG002|STARTED|Overall Study|number of subjects treated|75
10341556|NCT00386152|11478762|FG000|COMPLETED|Overall Study||31
10341557|NCT00386152|11478763|FG001|COMPLETED|Overall Study||37
10341558|NCT00386152|11478764|FG002|COMPLETED|Overall Study||42
10341559|NCT00386152|11478762|FG000|NOT COMPLETED|Overall Study||44
10341560|NCT00386152|11478763|FG001|NOT COMPLETED|Overall Study||40
10341561|NCT00386152|11478764|FG002|NOT COMPLETED|Overall Study||33
10341562|NCT00386243|11478774|FG000|STARTED|Overall Study||121
10341563|NCT00386243|11478775|FG001|STARTED|Overall Study||121
10341564|NCT00386243|11478774|FG000|COMPLETED|Overall Study||114
10341565|NCT00386243|11478775|FG001|COMPLETED|Overall Study||108
10341566|NCT00386243|11478774|FG000|NOT COMPLETED|Overall Study||7
10341567|NCT00386243|11478775|FG001|NOT COMPLETED|Overall Study||13
10341568|NCT00386256|11478785|FG000|STARTED|Overall Study||16
10341569|NCT00386256|11478786|FG001|STARTED|Overall Study||15
10303819|NCT00082888|11436845|FG002|STARTED|Overall Study||36
10303820|NCT00082888|11436843|FG000|COMPLETED|Overall Study||41
10303821|NCT00082888|11436844|FG001|COMPLETED|Overall Study||15
10303822|NCT00082888|11436845|FG002|COMPLETED|Overall Study||36
10303823|NCT00082888|11436843|FG000|NOT COMPLETED|Overall Study||1
10303824|NCT00082888|11436844|FG001|NOT COMPLETED|Overall Study||0
10303825|NCT00082888|11436845|FG002|NOT COMPLETED|Overall Study||0
10303826|NCT00083122|11436856|FG000|STARTED|Overall Study||40
10303827|NCT00083122|11436857|FG001|STARTED|Overall Study||5
10303828|NCT00083122|11436856|FG000|COMPLETED|Overall Study||40
10303829|NCT00083122|11436857|FG001|COMPLETED|Overall Study||5
10303830|NCT00083122|11436856|FG000|NOT COMPLETED|Overall Study||0
10303831|NCT00083122|11436857|FG001|NOT COMPLETED|Overall Study||0
10303832|NCT00083174|11436865|FG000|STARTED|Randomization Period||2285
10303833|NCT00083174|11436866|FG001|STARTED|Randomization Period||2275
10303834|NCT00083174|11436867|FG002|STARTED|Randomization Period||0
10303835|NCT00083174|11436865|FG000|COMPLETED|Randomization Period|All women randomized were included in the analysis based on intent-to-treat principle.|2285
10303836|NCT00083174|11436866|FG001|COMPLETED|Randomization Period|All women randomized were included in the analysis based on intent-to-treat principle.|2275
10303837|NCT00083174|11436867|FG002|COMPLETED|Randomization Period||0
10303838|NCT00083174|11436865|FG000|NOT COMPLETED|Randomization Period||0
10303839|NCT00083174|11436866|FG001|NOT COMPLETED|Randomization Period||0
10303840|NCT00083174|11436867|FG002|NOT COMPLETED|Randomization Period||0
10303841|NCT00083174|11436865|FG000|STARTED|Open-label Extension||0
10303842|NCT00083174|11436866|FG001|STARTED|Open-label Extension||0
10303843|NCT00083174|11436867|FG002|STARTED|Open-label Extension||2831
10303844|NCT00083174|11436865|FG000|COMPLETED|Open-label Extension||0
10303845|NCT00083174|11436866|FG001|COMPLETED|Open-label Extension||0
10303846|NCT00083174|11436867|FG002|COMPLETED|Open-label Extension||2831
10303847|NCT00083174|11436865|FG000|NOT COMPLETED|Open-label Extension||0
10303848|NCT00083174|11436866|FG001|NOT COMPLETED|Open-label Extension||0
10303849|NCT00083174|11436867|FG002|NOT COMPLETED|Open-label Extension||0
10303850|NCT00083226|11436877|FG000|STARTED|Overall Study||42
10714993|NCT02688387|11880056|FG013|STARTED|Part 1, Period 5 (up to 6 Days)||0
10714994|NCT02688387|11880057|FG014|STARTED|Part 1, Period 5 (up to 6 Days)||0
10714995|NCT02688387|11880058|FG015|STARTED|Part 1, Period 5 (up to 6 Days)||0
10714996|NCT02688387|11880059|FG016|STARTED|Part 1, Period 5 (up to 6 Days)||0
10714997|NCT02688387|11880060|FG017|STARTED|Part 1, Period 5 (up to 6 Days)||0
10714998|NCT02688387|11880061|FG018|STARTED|Part 1, Period 5 (up to 6 Days)||0
10714999|NCT02688387|11880062|FG019|STARTED|Part 1, Period 5 (up to 6 Days)||0
10715000|NCT02688387|11880063|FG020|STARTED|Part 1, Period 5 (up to 6 Days)||0
10715001|NCT02688387|11880064|FG021|STARTED|Part 1, Period 5 (up to 6 Days)||0
10715002|NCT02688387|11880043|FG000|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
10715003|NCT02688387|11880044|FG001|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
10715004|NCT02688387|11880045|FG002|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
10303851|NCT00083226|11436877|FG000|COMPLETED|Overall Study||0
10303852|NCT00083226|11436877|FG000|NOT COMPLETED|Overall Study||42
10303853|NCT00083382|11436881|FG000|STARTED|Overall Study||83
10303854|NCT00083382|11436881|FG000|COMPLETED|Overall Study||83
10303855|NCT00083382|11436881|FG000|NOT COMPLETED|Overall Study||0
10303856|NCT00083551|11436887|FG000|STARTED|Overall Study||323
10303857|NCT00083551|11436888|FG001|STARTED|Overall Study||345
10303858|NCT00083551|11436887|FG000|COMPLETED|Overall Study||323
10303859|NCT00083551|11436888|FG001|COMPLETED|Overall Study||345
10303860|NCT00083551|11436887|FG000|NOT COMPLETED|Overall Study||0
10303861|NCT00083551|11436888|FG001|NOT COMPLETED|Overall Study||0
10303862|NCT00083616|11436894|FG000|STARTED|Overall Study||185
10303863|NCT00083616|11436894|FG000|Received Study Medication|Overall Study||182
10303864|NCT00083616|11436894|FG000|COMPLETED|Overall Study|Completed safety followup or died on study as of the data cut-off date of 22 December 2006|154
10303865|NCT00083616|11436894|FG000|NOT COMPLETED|Overall Study||31
10303866|NCT00083720|11436898|FG000|STARTED|Overall Study|Patients analyzed for efficacy who met the epidermal growth factor receptor (EGFR) negative criteria|85
10303867|NCT00083720|11436898|FG000|COMPLETED|Overall Study|Two patients died prior to receiving cetuximab.|85
10303868|NCT00083720|11436898|FG000|NOT COMPLETED|Overall Study||0
10303869|NCT00083889|11436904|FG000|STARTED|Overall Study||375
10303870|NCT00083889|11436905|FG001|STARTED|Overall Study||375
10303871|NCT00083889|11436904|FG000|Received Treatment|Overall Study||375
10303872|NCT00083889|11436905|FG001|Received Treatment|Overall Study|15 subjects randomized to IFN-α discontinued before receiving their first dose of study medication.|360
10303873|NCT00083889|11436904|FG000|COMPLETED|Overall Study||0
10303874|NCT00083889|11436905|FG001|COMPLETED|Overall Study|Discontinuation crossover subjects: AEs 5,consent withdrawn 2, lack efficacy 13, sponsor decision 5.|0
10303875|NCT00083889|11436904|FG000|NOT COMPLETED|Overall Study||375
10303876|NCT00083889|11436905|FG001|NOT COMPLETED|Overall Study||375
10303877|NCT00084084|11436914|FG000|STARTED|Phase 1 (Treatment With Replagal RB)||17
10303878|NCT00084084|11436914|FG000|COMPLETED|Phase 1 (Treatment With Replagal RB)||16
10303879|NCT00084084|11436914|FG000|NOT COMPLETED|Phase 1 (Treatment With Replagal RB)||1
10303880|NCT00084084|11436914|FG000|STARTED|Phase 2 (Transition to Replagal AF)|The 11 patients remaining in TKT029 at the time Replagal AF was made available continued to Phase 2.|11
10715005|NCT02688387|11880046|FG003|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
10715006|NCT02688387|11880047|FG004|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
10715007|NCT02688387|11880048|FG005|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
10341570|NCT00386256|11478787|FG002|STARTED|Overall Study||4
10341571|NCT00386256|11478788|FG003|STARTED|Overall Study||3
10341572|NCT00386256|11478785|FG000|COMPLETED|Overall Study||16
10341573|NCT00386256|11478786|FG001|COMPLETED|Overall Study||15
10341574|NCT00386256|11478787|FG002|COMPLETED|Overall Study||4
10341575|NCT00386256|11478788|FG003|COMPLETED|Overall Study||3
10341576|NCT00386256|11478785|FG000|NOT COMPLETED|Overall Study||0
10341577|NCT00386256|11478786|FG001|NOT COMPLETED|Overall Study||0
10341578|NCT00386256|11478787|FG002|NOT COMPLETED|Overall Study||0
10341579|NCT00386256|11478788|FG003|NOT COMPLETED|Overall Study||0
10341580|NCT00386308|11478800|FG000|STARTED|Overall Study||123
10341581|NCT00386308|11478801|FG001|STARTED|Overall Study||73
10341582|NCT00386308|11478800|FG000|Intent to Treat Population|Overall Study||117
10341583|NCT00386308|11478801|FG001|Intent to Treat Population|Overall Study||72
10341584|NCT00386308|11478800|FG000|Modified Intent to Treat Population|Overall Study||115
10341585|NCT00386308|11478801|FG001|Modified Intent to Treat Population|Overall Study||72
10341586|NCT00386308|11478800|FG000|COMPLETED|Overall Study||94
10341587|NCT00386308|11478801|FG001|COMPLETED|Overall Study||54
10341588|NCT00386308|11478800|FG000|NOT COMPLETED|Overall Study||29
10341589|NCT00386308|11478801|FG001|NOT COMPLETED|Overall Study||19
10341590|NCT00386334|11478809|FG000|STARTED|Double Blind Period||194
10341591|NCT00386334|11478810|FG001|STARTED|Double Blind Period||194
10341592|NCT00386334|11478809|FG000|COMPLETED|Double Blind Period||148
10341593|NCT00386334|11478810|FG001|COMPLETED|Double Blind Period||147
10341594|NCT00386334|11478809|FG000|NOT COMPLETED|Double Blind Period||46
10341595|NCT00386334|11478810|FG001|NOT COMPLETED|Double Blind Period||47
10341596|NCT00386334|11478809|FG000|STARTED|Follow up:2 Week Placebo, 2 Week no Drug|Two subjects withdrew consent prior to starting the follow up period.|146
10341597|NCT00386334|11478810|FG001|STARTED|Follow up:2 Week Placebo, 2 Week no Drug|Two subjects withdrew consent prior to starting the follow up period.|145
10341598|NCT00386334|11478809|FG000|COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||143
10341599|NCT00386334|11478810|FG001|COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||144
10341600|NCT00386334|11478809|FG000|NOT COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||3
10812230|NCT03728140|11974218|FG000|STARTED|Overall Study|embryo transfer with self-spent culture medium|160
10812231|NCT03728140|11974219|FG001|STARTED|Overall Study|embryo transfer with new culture medium|175
10812232|NCT03728140|11974218|FG000|COMPLETED|Overall Study||150
10812233|NCT03728140|11974219|FG001|COMPLETED|Overall Study||168
10812234|NCT03728140|11974218|FG000|NOT COMPLETED|Overall Study||10
10812235|NCT03728140|11974219|FG001|NOT COMPLETED|Overall Study||7
10715008|NCT02688387|11880049|FG006|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
10715009|NCT02688387|11880050|FG007|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
10715010|NCT02688387|11880051|FG008|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
10715011|NCT02688387|11880052|FG009|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
10715012|NCT02688387|11880053|FG010|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10715013|NCT02688387|11880054|FG011|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10715014|NCT02688387|11880055|FG012|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10715015|NCT02688387|11880056|FG013|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10715016|NCT02688387|11880057|FG014|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10715017|NCT02688387|11880058|FG015|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10715018|NCT02688387|11880059|FG016|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10715019|NCT02688387|11880060|FG017|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10715020|NCT02688387|11880061|FG018|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10715021|NCT02688387|11880062|FG019|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10812236|NCT03727854|11974227|FG000|STARTED|Overall Study||20
10812237|NCT03727854|11974228|FG001|STARTED|Overall Study||20
10812238|NCT03727854|11974227|FG000|COMPLETED|Overall Study||20
10812239|NCT03727854|11974228|FG001|COMPLETED|Overall Study||20
10715022|NCT02688387|11880063|FG020|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10715023|NCT02688387|11880064|FG021|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10812240|NCT03727854|11974227|FG000|NOT COMPLETED|Overall Study||0
10812241|NCT03727854|11974228|FG001|NOT COMPLETED|Overall Study||0
10812242|NCT03727425|11974234|FG000|STARTED|Overall Study||55
10812243|NCT03727425|11974234|FG000|COMPLETED|Overall Study||55
10812244|NCT03727425|11974234|FG000|NOT COMPLETED|Overall Study||0
10812245|NCT03727347|11974238|FG000|STARTED|Overall Study||50
10812246|NCT03727347|11974238|FG000|2-week Evaluation|Overall Study||50
10812247|NCT03727347|11974238|FG000|4-week Evaluation|Overall Study||50
10812248|NCT03727347|11974238|FG000|12-week Primary Endpoint Evaluation|Overall Study||50
10812249|NCT03727347|11974238|FG000|26-week Evaluation|Overall Study||48
10812250|NCT03727347|11974238|FG000|52-week Evaluation|Overall Study||47
10530569|NCT01408485|11683096|FG000|STARTED|Overall Study||200
10530570|NCT01408485|11683096|FG000|COMPLETED|Overall Study||179
10530571|NCT01408485|11683096|FG000|NOT COMPLETED|Overall Study||21
10530572|NCT01408537|11683100|FG000|STARTED|Overall Study||152
10530573|NCT01408537|11683100|FG000|COMPLETED|Overall Study||144
10530574|NCT01408537|11683100|FG000|NOT COMPLETED|Overall Study||8
10530575|NCT01408563|11683115|FG000|STARTED|Overall Study||33
10303881|NCT00084084|11436914|FG000|COMPLETED|Phase 2 (Transition to Replagal AF)||10
10303882|NCT00084084|11436914|FG000|NOT COMPLETED|Phase 2 (Transition to Replagal AF)||1
10303883|NCT00084136|11436922|FG000|STARTED|PI Comparison||519
10303884|NCT00084136|11436923|FG001|STARTED|PI Comparison||526
10303885|NCT00084136|11436924|FG002|STARTED|PI Comparison||0
10303886|NCT00084136|11436922|FG000|COMPLETED|PI Comparison|Follow-up was until ddI+FTC+ATV arm was closed per DSMB recommendation on May 23, 2008.|464
10303887|NCT00084136|11436923|FG001|COMPLETED|PI Comparison|Follow-up was until ddI+FTC+ATV arm was closed per DSMB recommendation on May 23, 2008.|479
10303888|NCT00084136|11436924|FG002|COMPLETED|PI Comparison||0
10303889|NCT00084136|11436922|FG000|NOT COMPLETED|PI Comparison||55
10303890|NCT00084136|11436923|FG001|NOT COMPLETED|PI Comparison||47
10303891|NCT00084136|11436924|FG002|NOT COMPLETED|PI Comparison||0
10303892|NCT00084136|11436922|FG000|STARTED|NRTI Comparison||519
10303893|NCT00084136|11436923|FG001|STARTED|NRTI Comparison||0
10303894|NCT00084136|11436924|FG002|STARTED|NRTI Comparison||526
10530576|NCT01408563|11683115|FG000|Received Transplant|Overall Study||31
10530577|NCT01408563|11683115|FG000|COMPLETED|Overall Study||31
10530578|NCT01408563|11683115|FG000|NOT COMPLETED|Overall Study||2
10530579|NCT01408576|11683122|FG000|STARTED|Overall Study||244
10341601|NCT00386334|11478810|FG001|NOT COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||1
10341602|NCT00386360|11478818|FG000|STARTED|Overall Study||49
10341603|NCT00386360|11478819|FG001|STARTED|Overall Study||112
10341604|NCT00386360|11478818|FG000|Intent to Treat Population (ITT)|Overall Study|Includes all patients randomized and took at least one dose of study drug.|49
10341605|NCT00386360|11478819|FG001|Intent to Treat Population (ITT)|Overall Study||110
10341606|NCT00386360|11478818|FG000|Primary Efficacy|Overall Study|Per-protocol patients with evaluable BVTV (trabecular bone volume/tissue volume) at baseline & M12.|36
10341607|NCT00386360|11478819|FG001|Primary Efficacy|Overall Study||77
10341608|NCT00386360|11478818|FG000|COMPLETED|Overall Study||40
10341609|NCT00386360|11478819|FG001|COMPLETED|Overall Study||95
10715024|NCT02688387|11880043|FG000|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10341610|NCT00386360|11478818|FG000|NOT COMPLETED|Overall Study||9
10341611|NCT00386360|11478819|FG001|NOT COMPLETED|Overall Study||17
10341612|NCT00386425|11478828|FG000|STARTED|Overall Study|51 severe protein C deficiency; 176 moderate protein C deficiency|227
10341613|NCT00386425|11478829|FG001|STARTED|Overall Study|33 severe protein C deficiency; 173 moderate protein C deficiency|206
10341614|NCT00386425|11478830|FG002|STARTED|Overall Study||53
10341615|NCT00386425|11478828|FG000|Received Study Drug|Overall Study||227
10341616|NCT00386425|11478829|FG001|Received Study Drug|Overall Study||206
10341617|NCT00386425|11478830|FG002|Received Study Drug|Overall Study||53
10341618|NCT00386425|11478828|FG000|COMPLETED|Overall Study|51 severe protein C deficiency; 173 moderate protein C deficiency|224
10341619|NCT00386425|11478829|FG001|COMPLETED|Overall Study|33 severe protein C deficiency; 172 moderate protein C deficiency|205
10341620|NCT00386425|11478830|FG002|COMPLETED|Overall Study||53
10341621|NCT00386425|11478828|FG000|NOT COMPLETED|Overall Study||3
10341622|NCT00386425|11478829|FG001|NOT COMPLETED|Overall Study||1
10341623|NCT00386425|11478830|FG002|NOT COMPLETED|Overall Study||0
10341624|NCT00386477|11478844|FG000|STARTED|Overall Study||155
10341625|NCT00386477|11478845|FG001|STARTED|Overall Study||145
10341626|NCT00386477|11478844|FG000|COMPLETED|Overall Study||155
10341627|NCT00386477|11478845|FG001|COMPLETED|Overall Study||145
10341628|NCT00386477|11478844|FG000|NOT COMPLETED|Overall Study||0
10341629|NCT00386477|11478845|FG001|NOT COMPLETED|Overall Study||0
10341630|NCT00386607|11478851|FG000|STARTED|Core||601
10341631|NCT00386607|11478852|FG001|STARTED|Core||0
10341632|NCT00386607|11478851|FG000|COMPLETED|Core||486
10341633|NCT00386607|11478852|FG001|COMPLETED|Core||0
10341634|NCT00386607|11478851|FG000|NOT COMPLETED|Core||115
10341635|NCT00386607|11478852|FG001|NOT COMPLETED|Core||0
10341636|NCT00386607|11478851|FG000|STARTED|Extension||0
10341637|NCT00386607|11478852|FG001|STARTED|Extension||162
10341638|NCT00386607|11478851|FG000|COMPLETED|Extension||0
10341639|NCT00386607|11478852|FG001|COMPLETED|Extension||145
10341640|NCT00386607|11478851|FG000|NOT COMPLETED|Extension||0
10341641|NCT00386607|11478852|FG001|NOT COMPLETED|Extension||17
10341642|NCT00386776|11478864|FG000|STARTED|Overall Study||40
10341643|NCT00386776|11478864|FG000|COMPLETED|Overall Study||32
10341644|NCT00386776|11478864|FG000|NOT COMPLETED|Overall Study||8
10341645|NCT00386880|11478870|FG000|STARTED|Overall Study||30
10341646|NCT00386880|11478871|FG001|STARTED|Overall Study||8
10341647|NCT00386880|11478870|FG000|COMPLETED|Overall Study||30
10341648|NCT00386880|11478871|FG001|COMPLETED|Overall Study||8
10341649|NCT00386880|11478870|FG000|NOT COMPLETED|Overall Study||0
10341650|NCT00386880|11478871|FG001|NOT COMPLETED|Overall Study||0
10341651|NCT00387010|11478876|FG000|STARTED|Dose Titration Period||218
10341652|NCT00387010|11478876|FG000|COMPLETED|Dose Titration Period||180
10341653|NCT00387010|11478876|FG000|NOT COMPLETED|Dose Titration Period||38
10341654|NCT00387010|11478876|FG000|STARTED|Treatment Period||180
10426476|NCT00847665|11572157|FG001|STARTED|Overall Study||165
10426477|NCT00847665|11572156|FG000|COMPLETED|Overall Study||164
10530580|NCT01408576|11683123|FG001|STARTED|Overall Study||498
10530581|NCT01408576|11683124|FG002|STARTED|Overall Study||508
10530582|NCT01408576|11683122|FG000|COMPLETED|Overall Study||56
10530583|NCT01408576|11683123|FG001|COMPLETED|Overall Study||0
10530584|NCT01408576|11683124|FG002|COMPLETED|Overall Study||0
10530585|NCT01408576|11683122|FG000|NOT COMPLETED|Overall Study||188
10530586|NCT01408576|11683123|FG001|NOT COMPLETED|Overall Study||498
10530587|NCT01408576|11683124|FG002|NOT COMPLETED|Overall Study||508
10530588|NCT01408628|11683144|FG000|STARTED|Consented||51
10530589|NCT01408628|11683144|FG000|COMPLETED|Consented||39
10530590|NCT01408628|11683144|FG000|NOT COMPLETED|Consented||12
10530591|NCT01408628|11683144|FG000|STARTED|Started Classes/Intervention||39
10530592|NCT01408628|11683144|FG000|COMPLETED|Started Classes/Intervention||39
10530593|NCT01408628|11683144|FG000|NOT COMPLETED|Started Classes/Intervention||0
10530594|NCT01408628|11683144|FG000|STARTED|Completed 6 Month Follow-Up||39
10530595|NCT01408628|11683144|FG000|COMPLETED|Completed 6 Month Follow-Up||25
10530596|NCT01408628|11683144|FG000|NOT COMPLETED|Completed 6 Month Follow-Up||14
10530597|NCT01408706|11683151|FG000|STARTED|Overall Study||30
10530598|NCT01408706|11683152|FG001|STARTED|Overall Study||30
10530599|NCT01408706|11683151|FG000|COMPLETED|Overall Study||29
10530600|NCT01408706|11683152|FG001|COMPLETED|Overall Study||30
10530601|NCT01408706|11683151|FG000|NOT COMPLETED|Overall Study||1
10530602|NCT01408706|11683152|FG001|NOT COMPLETED|Overall Study||0
10530603|NCT01408719|11683180|FG000|STARTED|First Intervention (35 Days)||2
10530604|NCT01408719|11683181|FG001|STARTED|First Intervention (35 Days)||3
10530605|NCT01408719|11683182|FG002|STARTED|First Intervention (35 Days)||2
10530606|NCT01408719|11683183|FG003|STARTED|First Intervention (35 Days)||2
10530607|NCT01408719|11683184|FG004|STARTED|First Intervention (35 Days)||4
10530608|NCT01408719|11683185|FG005|STARTED|First Intervention (35 Days)||3
10530609|NCT01408719|11683186|FG006|STARTED|First Intervention (35 Days)||2
10530610|NCT01408719|11683187|FG007|STARTED|First Intervention (35 Days)||3
10530611|NCT01408719|11683188|FG008|STARTED|First Intervention (35 Days)||2
10530612|NCT01408719|11683189|FG009|STARTED|First Intervention (35 Days)||1
10530613|NCT01408719|11683190|FG010|STARTED|First Intervention (35 Days)||2
10530614|NCT01408719|11683191|FG011|STARTED|First Intervention (35 Days)||2
10530615|NCT01408719|11683192|FG012|STARTED|First Intervention (35 Days)||2
10530616|NCT01408719|11683193|FG013|STARTED|First Intervention (35 Days)||5
10530617|NCT01408719|11683194|FG014|STARTED|First Intervention (35 Days)||1
10530618|NCT01408719|11683195|FG015|STARTED|First Intervention (35 Days)||2
10530619|NCT01408719|11683196|FG016|STARTED|First Intervention (35 Days)||3
10530620|NCT01408719|11683197|FG017|STARTED|First Intervention (35 Days)||2
10530621|NCT01408719|11683198|FG018|STARTED|First Intervention (35 Days)||1
10530622|NCT01408719|11683199|FG019|STARTED|First Intervention (35 Days)||1
10530623|NCT01408719|11683180|FG000|COMPLETED|First Intervention (35 Days)||2
10530624|NCT01408719|11683181|FG001|COMPLETED|First Intervention (35 Days)||3
10303895|NCT00084136|11436922|FG000|COMPLETED|NRTI Comparison|Follow-up though study closeout period (final visit between April 1 and May 31, 2010).|418
10303896|NCT00084136|11436923|FG001|COMPLETED|NRTI Comparison||0
10303897|NCT00084136|11436924|FG002|COMPLETED|NRTI Comparison|Follow-up though study closeout period (final visit between April 1 and May 31, 2010).|444
10303898|NCT00084136|11436922|FG000|NOT COMPLETED|NRTI Comparison||101
10303899|NCT00084136|11436923|FG001|NOT COMPLETED|NRTI Comparison||0
10303900|NCT00084136|11436924|FG002|NOT COMPLETED|NRTI Comparison||82
10303901|NCT00084149|11436935|FG000|STARTED|Overall Study||36
10303902|NCT00084149|11436936|FG001|STARTED|Overall Study||18
10303903|NCT00084149|11436935|FG000|COMPLETED|Overall Study||28
10303904|NCT00084149|11436936|FG001|COMPLETED|Overall Study||13
10303905|NCT00084149|11436935|FG000|NOT COMPLETED|Overall Study||8
10303906|NCT00084149|11436936|FG001|NOT COMPLETED|Overall Study||5
10303907|NCT00084266|11436948|FG000|STARTED|Overall Study||618
10303908|NCT00084266|11436949|FG001|STARTED|Overall Study||607
10303909|NCT00084266|11436948|FG000|Treated|Overall Study||597
10303910|NCT00084266|11436949|FG001|Treated|Overall Study||587
10303911|NCT00084266|11436948|FG000|COMPLETED|Overall Study||177
10303912|NCT00084266|11436949|FG001|COMPLETED|Overall Study||184
10303913|NCT00084266|11436948|FG000|NOT COMPLETED|Overall Study||441
10303914|NCT00084266|11436949|FG001|NOT COMPLETED|Overall Study||423
10303915|NCT00084318|11436957|FG000|STARTED|Overall Study||119
10303916|NCT00084318|11436958|FG001|STARTED|Overall Study||119
10303917|NCT00084318|11436957|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|97
10303918|NCT00084318|11436958|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|106
10303919|NCT00084318|11436957|FG000|NOT COMPLETED|Overall Study||22
10303920|NCT00084318|11436958|FG001|NOT COMPLETED|Overall Study||13
10303921|NCT00084383|11436966|FG000|STARTED|Overall Study||60
10303922|NCT00084383|11436966|FG000|COMPLETED|Overall Study||13
10303923|NCT00084383|11436966|FG000|NOT COMPLETED|Overall Study||47
10303924|NCT00084409|11436972|FG000|STARTED|Overall Study|40 Current, 35 former|75
10303925|NCT00084409|11436973|FG001|STARTED|Overall Study|41 current, 36 former|77
10303926|NCT00084409|11436972|FG000|COMPLETED|Overall Study|9 current, 6 former|60
10303927|NCT00084409|11436973|FG001|COMPLETED|Overall Study|4 Current, 8 former|65
10303928|NCT00084409|11436972|FG000|NOT COMPLETED|Overall Study||15
10303929|NCT00084409|11436973|FG001|NOT COMPLETED|Overall Study||12
10303930|NCT00084487|11436981|FG000|STARTED|Overall Study||21
10303931|NCT00084487|11436981|FG000|COMPLETED|Overall Study||20
10303932|NCT00084487|11436981|FG000|NOT COMPLETED|Overall Study||1
10303933|NCT00084552|11436987|FG000|STARTED|Overall Study||54
10303934|NCT00084552|11436988|FG001|STARTED|Overall Study||62
10303935|NCT00084552|11436987|FG000|COMPLETED|Overall Study||54
10303936|NCT00084552|11436988|FG001|COMPLETED|Overall Study||62
10303937|NCT00084552|11436987|FG000|NOT COMPLETED|Overall Study||0
10303938|NCT00084552|11436988|FG001|NOT COMPLETED|Overall Study||0
10303939|NCT00084617|11436994|FG000|STARTED|Overall Study||39
10303940|NCT00084617|11436994|FG000|COMPLETED|Overall Study||30
10303941|NCT00084617|11436994|FG000|NOT COMPLETED|Overall Study||9
10303942|NCT00084682|11436998|FG000|STARTED|Overall Study||14
10303943|NCT00084682|11436998|FG000|COMPLETED|Overall Study||13
10341655|NCT00387010|11478876|FG000|Full Analysis Set|Treatment Period|FAS: treated patients with at least 1 paired baseline and post baseline efficacy assessment|175
10341656|NCT00387010|11478876|FG000|COMPLETED|Treatment Period||169
10341657|NCT00387010|11478876|FG000|NOT COMPLETED|Treatment Period||11
10341658|NCT00387023|11478880|FG000|STARTED|Overall Study||12
10341659|NCT00387023|11478880|FG000|COMPLETED|Overall Study||12
10341660|NCT00387023|11478880|FG000|NOT COMPLETED|Overall Study||0
10341661|NCT00387036|11478884|FG000|STARTED|2-Week First Intervention||6
10341662|NCT00387036|11478885|FG001|STARTED|2-Week First Intervention||6
10341663|NCT00387036|11478884|FG000|COMPLETED|2-Week First Intervention||6
10341664|NCT00387036|11478885|FG001|COMPLETED|2-Week First Intervention||6
10341665|NCT00387036|11478884|FG000|NOT COMPLETED|2-Week First Intervention||0
10341666|NCT00387036|11478885|FG001|NOT COMPLETED|2-Week First Intervention||0
10341667|NCT00387036|11478884|FG000|STARTED|2-Week Placebo Washout||6
10341668|NCT00387036|11478885|FG001|STARTED|2-Week Placebo Washout||6
10341669|NCT00387036|11478884|FG000|COMPLETED|2-Week Placebo Washout||6
10341670|NCT00387036|11478885|FG001|COMPLETED|2-Week Placebo Washout||6
10341671|NCT00387036|11478884|FG000|NOT COMPLETED|2-Week Placebo Washout||0
10341672|NCT00387036|11478885|FG001|NOT COMPLETED|2-Week Placebo Washout||0
10341673|NCT00387036|11478884|FG000|STARTED|2-Week Crossover Second Intervention||6
10341674|NCT00387036|11478885|FG001|STARTED|2-Week Crossover Second Intervention||6
10341675|NCT00387036|11478884|FG000|COMPLETED|2-Week Crossover Second Intervention||6
10341676|NCT00387036|11478885|FG001|COMPLETED|2-Week Crossover Second Intervention||6
10341677|NCT00387036|11478884|FG000|NOT COMPLETED|2-Week Crossover Second Intervention||0
10303944|NCT00084682|11436998|FG000|NOT COMPLETED|Overall Study||1
10341678|NCT00387036|11478885|FG001|NOT COMPLETED|2-Week Crossover Second Intervention||0
10341679|NCT00387088|11478893|FG000|STARTED|Overall Study||1989
10341680|NCT00387088|11478894|FG001|STARTED|Overall Study||2002
10341681|NCT00387088|11478893|FG000|COMPLETED|Overall Study||1671
10812251|NCT03727347|11974238|FG000|COMPLETED|Overall Study||47
10812252|NCT03727347|11974238|FG000|NOT COMPLETED|Overall Study||3
10812253|NCT03726996|11974251|FG000|STARTED|Overall Study||4
10812254|NCT03726996|11974251|FG000|COMPLETED|Overall Study||0
10812255|NCT03726996|11974251|FG000|NOT COMPLETED|Overall Study||4
10812256|NCT03726164|11974257|FG000|STARTED|Overall Study||310
10812257|NCT03726164|11974258|FG001|STARTED|Overall Study||316
10303945|NCT00084747|11437003|FG000|STARTED|Overall Study||30
10303946|NCT00084747|11437003|FG000|COMPLETED|Overall Study||17
10303947|NCT00084747|11437003|FG000|NOT COMPLETED|Overall Study||13
10303948|NCT00084838|11437008|FG000|STARTED|Overall Study||25
10303949|NCT00084838|11437008|FG000|Eligible and Treated|Overall Study|4 ineligible pts upon central path review (n=3) and per DFCI IRB (n=1); 1 pt withdrew before rcv trt|20
10303950|NCT00084838|11437008|FG000|COMPLETED|Overall Study||12
10303951|NCT00084838|11437008|FG000|NOT COMPLETED|Overall Study||13
10303952|NCT00084864|11437018|FG000|STARTED|Overall Study||10
10303953|NCT00084864|11437019|FG001|STARTED|Overall Study||7
10303954|NCT00084864|11437020|FG002|STARTED|Overall Study||4
10303955|NCT00084864|11437021|FG003|STARTED|Overall Study||4
10303956|NCT00084864|11437018|FG000|COMPLETED|Overall Study||9
10303957|NCT00084864|11437019|FG001|COMPLETED|Overall Study||7
10530625|NCT01408719|11683182|FG002|COMPLETED|First Intervention (35 Days)||1
10530626|NCT01408719|11683183|FG003|COMPLETED|First Intervention (35 Days)||2
10530627|NCT01408719|11683184|FG004|COMPLETED|First Intervention (35 Days)||3
10530628|NCT01408719|11683185|FG005|COMPLETED|First Intervention (35 Days)||3
10530629|NCT01408719|11683186|FG006|COMPLETED|First Intervention (35 Days)||2
10530630|NCT01408719|11683187|FG007|COMPLETED|First Intervention (35 Days)||3
10530631|NCT01408719|11683188|FG008|COMPLETED|First Intervention (35 Days)||1
10530632|NCT01408719|11683189|FG009|COMPLETED|First Intervention (35 Days)||1
10530633|NCT01408719|11683190|FG010|COMPLETED|First Intervention (35 Days)||2
10530634|NCT01408719|11683191|FG011|COMPLETED|First Intervention (35 Days)||2
10530635|NCT01408719|11683192|FG012|COMPLETED|First Intervention (35 Days)||2
10530636|NCT01408719|11683193|FG013|COMPLETED|First Intervention (35 Days)||4
10530637|NCT01408719|11683194|FG014|COMPLETED|First Intervention (35 Days)||1
10530638|NCT01408719|11683195|FG015|COMPLETED|First Intervention (35 Days)||2
10530639|NCT01408719|11683196|FG016|COMPLETED|First Intervention (35 Days)||2
10530640|NCT01408719|11683197|FG017|COMPLETED|First Intervention (35 Days)||2
10530641|NCT01408719|11683198|FG018|COMPLETED|First Intervention (35 Days)||0
10530642|NCT01408719|11683199|FG019|COMPLETED|First Intervention (35 Days)||1
10530643|NCT01408719|11683180|FG000|NOT COMPLETED|First Intervention (35 Days)||0
10530644|NCT01408719|11683181|FG001|NOT COMPLETED|First Intervention (35 Days)||0
10530645|NCT01408719|11683182|FG002|NOT COMPLETED|First Intervention (35 Days)||1
10530646|NCT01408719|11683183|FG003|NOT COMPLETED|First Intervention (35 Days)||0
10530647|NCT01408719|11683184|FG004|NOT COMPLETED|First Intervention (35 Days)||1
10530648|NCT01408719|11683185|FG005|NOT COMPLETED|First Intervention (35 Days)||0
10655083|NCT02206685|11815831|FG001|NOT COMPLETED|Overall Study||7
10530649|NCT01408719|11683186|FG006|NOT COMPLETED|First Intervention (35 Days)||0
10530650|NCT01408719|11683187|FG007|NOT COMPLETED|First Intervention (35 Days)||0
10530651|NCT01408719|11683188|FG008|NOT COMPLETED|First Intervention (35 Days)||1
10530652|NCT01408719|11683189|FG009|NOT COMPLETED|First Intervention (35 Days)||0
10530653|NCT01408719|11683190|FG010|NOT COMPLETED|First Intervention (35 Days)||0
10530654|NCT01408719|11683191|FG011|NOT COMPLETED|First Intervention (35 Days)||0
10530655|NCT01408719|11683192|FG012|NOT COMPLETED|First Intervention (35 Days)||0
10530656|NCT01408719|11683193|FG013|NOT COMPLETED|First Intervention (35 Days)||1
10530657|NCT01408719|11683194|FG014|NOT COMPLETED|First Intervention (35 Days)||0
10530658|NCT01408719|11683195|FG015|NOT COMPLETED|First Intervention (35 Days)||0
10530659|NCT01408719|11683196|FG016|NOT COMPLETED|First Intervention (35 Days)||1
10530660|NCT01408719|11683197|FG017|NOT COMPLETED|First Intervention (35 Days)||0
10530661|NCT01408719|11683198|FG018|NOT COMPLETED|First Intervention (35 Days)||1
10530662|NCT01408719|11683199|FG019|NOT COMPLETED|First Intervention (35 Days)||0
10530663|NCT01408719|11683180|FG000|STARTED|Washout Period (28 Days)||2
10530664|NCT01408719|11683181|FG001|STARTED|Washout Period (28 Days)||3
10530665|NCT01408719|11683182|FG002|STARTED|Washout Period (28 Days)||1
10530666|NCT01408719|11683183|FG003|STARTED|Washout Period (28 Days)||2
10530667|NCT01408719|11683184|FG004|STARTED|Washout Period (28 Days)||3
10530668|NCT01408719|11683185|FG005|STARTED|Washout Period (28 Days)||3
10530669|NCT01408719|11683186|FG006|STARTED|Washout Period (28 Days)||2
10530670|NCT01408719|11683187|FG007|STARTED|Washout Period (28 Days)||3
10530671|NCT01408719|11683188|FG008|STARTED|Washout Period (28 Days)||1
10530672|NCT01408719|11683189|FG009|STARTED|Washout Period (28 Days)||1
10530673|NCT01408719|11683190|FG010|STARTED|Washout Period (28 Days)||2
10530674|NCT01408719|11683191|FG011|STARTED|Washout Period (28 Days)||2
10530675|NCT01408719|11683192|FG012|STARTED|Washout Period (28 Days)||2
10530676|NCT01408719|11683193|FG013|STARTED|Washout Period (28 Days)||4
10530677|NCT01408719|11683194|FG014|STARTED|Washout Period (28 Days)||1
10530678|NCT01408719|11683195|FG015|STARTED|Washout Period (28 Days)||2
10530679|NCT01408719|11683196|FG016|STARTED|Washout Period (28 Days)||2
10530680|NCT01408719|11683197|FG017|STARTED|Washout Period (28 Days)||2
10530681|NCT01408719|11683198|FG018|STARTED|Washout Period (28 Days)||0
10530682|NCT01408719|11683199|FG019|STARTED|Washout Period (28 Days)||1
10530683|NCT01408719|11683180|FG000|COMPLETED|Washout Period (28 Days)||2
10530684|NCT01408719|11683181|FG001|COMPLETED|Washout Period (28 Days)||3
10530685|NCT01408719|11683182|FG002|COMPLETED|Washout Period (28 Days)||1
10530686|NCT01408719|11683183|FG003|COMPLETED|Washout Period (28 Days)||2
10530687|NCT01408719|11683184|FG004|COMPLETED|Washout Period (28 Days)||3
10530688|NCT01408719|11683185|FG005|COMPLETED|Washout Period (28 Days)||3
10530689|NCT01408719|11683186|FG006|COMPLETED|Washout Period (28 Days)||2
10530690|NCT01408719|11683187|FG007|COMPLETED|Washout Period (28 Days)||3
10530691|NCT01408719|11683188|FG008|COMPLETED|Washout Period (28 Days)||1
10530692|NCT01408719|11683189|FG009|COMPLETED|Washout Period (28 Days)||1
10530693|NCT01408719|11683190|FG010|COMPLETED|Washout Period (28 Days)||2
10530694|NCT01408719|11683191|FG011|COMPLETED|Washout Period (28 Days)||2
10530695|NCT01408719|11683192|FG012|COMPLETED|Washout Period (28 Days)||2
10530696|NCT01408719|11683193|FG013|COMPLETED|Washout Period (28 Days)||4
10530697|NCT01408719|11683194|FG014|COMPLETED|Washout Period (28 Days)||1
10530698|NCT01408719|11683195|FG015|COMPLETED|Washout Period (28 Days)||2
10530699|NCT01408719|11683196|FG016|COMPLETED|Washout Period (28 Days)||2
10530700|NCT01408719|11683197|FG017|COMPLETED|Washout Period (28 Days)||2
10530701|NCT01408719|11683198|FG018|COMPLETED|Washout Period (28 Days)||0
10530702|NCT01408719|11683199|FG019|COMPLETED|Washout Period (28 Days)||1
10530703|NCT01408719|11683180|FG000|NOT COMPLETED|Washout Period (28 Days)||0
10530704|NCT01408719|11683181|FG001|NOT COMPLETED|Washout Period (28 Days)||0
10530705|NCT01408719|11683182|FG002|NOT COMPLETED|Washout Period (28 Days)||0
10530706|NCT01408719|11683183|FG003|NOT COMPLETED|Washout Period (28 Days)||0
10530707|NCT01408719|11683184|FG004|NOT COMPLETED|Washout Period (28 Days)||0
10530708|NCT01408719|11683185|FG005|NOT COMPLETED|Washout Period (28 Days)||0
10530709|NCT01408719|11683186|FG006|NOT COMPLETED|Washout Period (28 Days)||0
10530710|NCT01408719|11683187|FG007|NOT COMPLETED|Washout Period (28 Days)||0
10530711|NCT01408719|11683188|FG008|NOT COMPLETED|Washout Period (28 Days)||0
10530712|NCT01408719|11683189|FG009|NOT COMPLETED|Washout Period (28 Days)||0
10530713|NCT01408719|11683190|FG010|NOT COMPLETED|Washout Period (28 Days)||0
10530714|NCT01408719|11683191|FG011|NOT COMPLETED|Washout Period (28 Days)||0
10530715|NCT01408719|11683192|FG012|NOT COMPLETED|Washout Period (28 Days)||0
10530716|NCT01408719|11683193|FG013|NOT COMPLETED|Washout Period (28 Days)||0
10530717|NCT01408719|11683194|FG014|NOT COMPLETED|Washout Period (28 Days)||0
10530718|NCT01408719|11683195|FG015|NOT COMPLETED|Washout Period (28 Days)||0
10530719|NCT01408719|11683196|FG016|NOT COMPLETED|Washout Period (28 Days)||0
10530720|NCT01408719|11683197|FG017|NOT COMPLETED|Washout Period (28 Days)||0
10341682|NCT00387088|11478894|FG001|COMPLETED|Overall Study||1629
10341683|NCT00387088|11478893|FG000|NOT COMPLETED|Overall Study||318
10341684|NCT00387088|11478894|FG001|NOT COMPLETED|Overall Study||373
10341685|NCT00387127|11478902|FG000|STARTED|Overall Study||33
10341686|NCT00387127|11478903|FG001|STARTED|Overall Study||34
10341687|NCT00387127|11478902|FG000|COMPLETED|Overall Study||0
10341688|NCT00387127|11478903|FG001|COMPLETED|Overall Study||0
10341689|NCT00387127|11478902|FG000|NOT COMPLETED|Overall Study||33
10341690|NCT00387127|11478903|FG001|NOT COMPLETED|Overall Study||34
10341691|NCT00387153|11478911|FG000|STARTED|Overall Study||8
10341692|NCT00387153|11478911|FG000|COMPLETED|Overall Study||0
10341693|NCT00387153|11478911|FG000|NOT COMPLETED|Overall Study||8
10341694|NCT00387335|11478917|FG000|STARTED|Overall Study||15
10341695|NCT00387335|11478918|FG001|STARTED|Overall Study||7
10341696|NCT00387335|11478917|FG000|COMPLETED|Overall Study||15
10341697|NCT00387335|11478918|FG001|COMPLETED|Overall Study||7
10341698|NCT00387335|11478917|FG000|NOT COMPLETED|Overall Study||0
10341699|NCT00387335|11478918|FG001|NOT COMPLETED|Overall Study||0
10341700|NCT00387348|11478927|FG000|STARTED|Overall Study||8
10341701|NCT00387348|11478928|FG001|STARTED|Overall Study||5
10341702|NCT00387348|11478929|FG002|STARTED|Overall Study||11
10341703|NCT00387348|11478927|FG000|COMPLETED|Overall Study||5
10341704|NCT00387348|11478928|FG001|COMPLETED|Overall Study||2
10341705|NCT00387348|11478929|FG002|COMPLETED|Overall Study||7
10341706|NCT00387348|11478927|FG000|NOT COMPLETED|Overall Study||3
10341707|NCT00387348|11478928|FG001|NOT COMPLETED|Overall Study||3
10341708|NCT00387348|11478929|FG002|NOT COMPLETED|Overall Study||4
10341709|NCT00387426|11478942|FG000|STARTED|Overall Study||14
10341710|NCT00387426|11478942|FG000|COMPLETED|Overall Study||0
10341711|NCT00387426|11478942|FG000|NOT COMPLETED|Overall Study||14
10341712|NCT00387465|11478949|FG000|STARTED|Overall Study||3
10341713|NCT00387465|11478950|FG001|STARTED|Overall Study||7
10341714|NCT00387465|11478951|FG002|STARTED|Overall Study||35
10341715|NCT00387465|11478949|FG000|COMPLETED|Overall Study||3
10341716|NCT00387465|11478950|FG001|COMPLETED|Overall Study||6
10341717|NCT00387465|11478951|FG002|COMPLETED|Overall Study||35
10341718|NCT00387465|11478949|FG000|NOT COMPLETED|Overall Study||0
10341719|NCT00387465|11478950|FG001|NOT COMPLETED|Overall Study||1
10341720|NCT00387465|11478951|FG002|NOT COMPLETED|Overall Study||0
10341721|NCT00387621|11478962|FG000|STARTED|First Intervention||29
10341722|NCT00387621|11478963|FG001|STARTED|First Intervention||29
10341723|NCT00387621|11478962|FG000|COMPLETED|First Intervention||29
10341724|NCT00387621|11478963|FG001|COMPLETED|First Intervention||29
10341725|NCT00387621|11478962|FG000|NOT COMPLETED|First Intervention||0
10341726|NCT00387621|11478963|FG001|NOT COMPLETED|First Intervention||0
10341727|NCT00387621|11478962|FG000|STARTED|Washout Period of 2 Weeks||29
10341728|NCT00387621|11478963|FG001|STARTED|Washout Period of 2 Weeks||29
10341729|NCT00387621|11478962|FG000|COMPLETED|Washout Period of 2 Weeks||29
10341730|NCT00387621|11478963|FG001|COMPLETED|Washout Period of 2 Weeks||29
10341731|NCT00387621|11478962|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
10341732|NCT00387621|11478963|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
10341733|NCT00387621|11478962|FG000|STARTED|Second Intervention||29
10341734|NCT00387621|11478963|FG001|STARTED|Second Intervention||29
10341735|NCT00387621|11478962|FG000|COMPLETED|Second Intervention||29
10341736|NCT00387621|11478963|FG001|COMPLETED|Second Intervention||29
10341737|NCT00387621|11478962|FG000|NOT COMPLETED|Second Intervention||0
10341738|NCT00387621|11478963|FG001|NOT COMPLETED|Second Intervention||0
10341739|NCT00387647|11478975|FG000|STARTED|Overall Study||24
10341740|NCT00387647|11478975|FG000|COMPLETED|Overall Study||6
10341741|NCT00387647|11478975|FG000|NOT COMPLETED|Overall Study||18
10341742|NCT00387660|11478981|FG000|STARTED|Overall Study||40
10341743|NCT00387660|11478982|FG001|STARTED|Overall Study||40
10341744|NCT00387660|11478981|FG000|COMPLETED|Overall Study||40
10341745|NCT00387660|11478982|FG001|COMPLETED|Overall Study||40
10341746|NCT00387660|11478981|FG000|NOT COMPLETED|Overall Study||0
10341747|NCT00387660|11478982|FG001|NOT COMPLETED|Overall Study||0
10341748|NCT00387712|11478990|FG000|STARTED|Overall Study||47
10341749|NCT00387712|11478991|FG001|STARTED|Overall Study||52
10341750|NCT00387712|11478990|FG000|COMPLETED|Overall Study||18
10341751|NCT00387712|11478991|FG001|COMPLETED|Overall Study||16
10341752|NCT00387712|11478990|FG000|NOT COMPLETED|Overall Study||29
10341753|NCT00387712|11478991|FG001|NOT COMPLETED|Overall Study||36
10341754|NCT00387725|11479001|FG000|STARTED|Overall Study||21
10341755|NCT00387725|11479002|FG001|STARTED|Overall Study||16
10341756|NCT00387725|11479003|FG002|STARTED|Overall Study||45
10341757|NCT00387725|11479004|FG003|STARTED|Overall Study||45
10341758|NCT00387725|11479001|FG000|COMPLETED|Overall Study||20
10341759|NCT00387725|11479002|FG001|COMPLETED|Overall Study||15
10341760|NCT00387725|11479003|FG002|COMPLETED|Overall Study||43
10341761|NCT00387725|11479004|FG003|COMPLETED|Overall Study||43
10341762|NCT00387725|11479001|FG000|NOT COMPLETED|Overall Study||1
10341763|NCT00387725|11479002|FG001|NOT COMPLETED|Overall Study||1
10303958|NCT00084864|11437020|FG002|COMPLETED|Overall Study||4
10303959|NCT00084864|11437021|FG003|COMPLETED|Overall Study||4
10303960|NCT00084864|11437018|FG000|NOT COMPLETED|Overall Study||1
10303961|NCT00084864|11437019|FG001|NOT COMPLETED|Overall Study||0
10303962|NCT00084864|11437020|FG002|NOT COMPLETED|Overall Study||0
10303963|NCT00084864|11437021|FG003|NOT COMPLETED|Overall Study||0
10303964|NCT00084929|11437031|FG000|STARTED|Overall Study||2600
10303965|NCT00084929|11437031|FG000|COMPLETED|Overall Study||2531
10303966|NCT00084929|11437031|FG000|NOT COMPLETED|Overall Study||69
10303967|NCT00085098|11437041|FG000|STARTED|Overall Study||11
10303968|NCT00085098|11437042|FG001|STARTED|Overall Study||13
10303969|NCT00085098|11437041|FG000|COMPLETED|Overall Study||10
10341764|NCT00387725|11479003|FG002|NOT COMPLETED|Overall Study||2
10341765|NCT00387725|11479004|FG003|NOT COMPLETED|Overall Study||2
10341766|NCT00387751|11479014|FG000|STARTED|Overall Study||14
10341767|NCT00387751|11479014|FG000|COMPLETED|Overall Study||14
10341768|NCT00387751|11479014|FG000|NOT COMPLETED|Overall Study||0
10341769|NCT00387764|11479020|FG000|STARTED|Overall Study||80
10341770|NCT00387764|11479020|FG000|COMPLETED|Overall Study|Participants completed treatment (until disease progression), but may not have completed the study.|49
10341771|NCT00387764|11479020|FG000|NOT COMPLETED|Overall Study||31
10341772|NCT00387790|11479024|FG000|STARTED|Overall Study||64
10341773|NCT00387790|11479024|FG000|COMPLETED|Overall Study||50
10341774|NCT00387790|11479024|FG000|NOT COMPLETED|Overall Study||14
10341775|NCT00387829|11479030|FG000|STARTED|Safety Population||178
10341776|NCT00387829|11479031|FG001|STARTED|Safety Population||169
10341777|NCT00387829|11479030|FG000|COMPLETED|Safety Population||139
10341778|NCT00387829|11479031|FG001|COMPLETED|Safety Population||136
10341779|NCT00387829|11479030|FG000|NOT COMPLETED|Safety Population||39
10341780|NCT00387829|11479031|FG001|NOT COMPLETED|Safety Population||33
10341781|NCT00387829|11479030|FG000|STARTED|Intent-to-treat Population||177
10341782|NCT00387829|11479031|FG001|STARTED|Intent-to-treat Population||166
10341783|NCT00387829|11479030|FG000|COMPLETED|Intent-to-treat Population||139
10341784|NCT00387829|11479031|FG001|COMPLETED|Intent-to-treat Population||136
10341785|NCT00387829|11479030|FG000|NOT COMPLETED|Intent-to-treat Population||38
10341786|NCT00387829|11479031|FG001|NOT COMPLETED|Intent-to-treat Population||30
10341787|NCT00387881|11479039|FG000|STARTED|Overall Study||334
10341788|NCT00387881|11479040|FG001|STARTED|Overall Study||345
10341789|NCT00387881|11479039|FG000|COMPLETED|Overall Study||245
10341790|NCT00387881|11479040|FG001|COMPLETED|Overall Study||243
10341791|NCT00387881|11479039|FG000|NOT COMPLETED|Overall Study||89
10341792|NCT00387881|11479040|FG001|NOT COMPLETED|Overall Study||102
10341793|NCT00387894|11479046|FG000|STARTED|Overall Study||6
10341794|NCT00387894|11479046|FG000|COMPLETED|Overall Study||5
10341795|NCT00387894|11479046|FG000|NOT COMPLETED|Overall Study||1
10341796|NCT00387959|11479050|FG000|STARTED|Overall Study||17
10341797|NCT00387959|11479050|FG000|COMPLETED|Overall Study||16
10341798|NCT00387959|11479050|FG000|NOT COMPLETED|Overall Study||1
10341799|NCT00388037|11479054|FG000|STARTED|Overall Study||31
10341800|NCT00388037|11479054|FG000|COMPLETED|Overall Study||30
10341801|NCT00388037|11479054|FG000|NOT COMPLETED|Overall Study||1
10341802|NCT00388154|11479058|FG000|STARTED|Overall Study||21
10341803|NCT00388154|11479058|FG000|COMPLETED|Overall Study||20
10341804|NCT00388154|11479058|FG000|NOT COMPLETED|Overall Study||1
10341805|NCT00388297|11479066|FG000|STARTED|Overall Study||339
10341806|NCT00388297|11479067|FG001|STARTED|Overall Study||338
10341807|NCT00388297|11479068|FG002|STARTED|Overall Study||265
10341808|NCT00388297|11479069|FG003|STARTED|Overall Study||261
10341809|NCT00388297|11479066|FG000|COMPLETED|Overall Study||323
10341810|NCT00388297|11479067|FG001|COMPLETED|Overall Study||326
10341811|NCT00388297|11479068|FG002|COMPLETED|Overall Study||254
10341812|NCT00388297|11479069|FG003|COMPLETED|Overall Study||253
10341813|NCT00388297|11479066|FG000|NOT COMPLETED|Overall Study||16
10341814|NCT00388297|11479067|FG001|NOT COMPLETED|Overall Study||12
10341815|NCT00388297|11479068|FG002|NOT COMPLETED|Overall Study||11
10530721|NCT01408719|11683198|FG018|NOT COMPLETED|Washout Period (28 Days)||0
10530722|NCT01408719|11683199|FG019|NOT COMPLETED|Washout Period (28 Days)||0
10530723|NCT01408719|11683180|FG000|STARTED|Second Intervention (35 Days)||2
10530724|NCT01408719|11683181|FG001|STARTED|Second Intervention (35 Days)||3
10530725|NCT01408719|11683182|FG002|STARTED|Second Intervention (35 Days)||1
10530726|NCT01408719|11683183|FG003|STARTED|Second Intervention (35 Days)||2
10530727|NCT01408719|11683184|FG004|STARTED|Second Intervention (35 Days)||3
10530728|NCT01408719|11683185|FG005|STARTED|Second Intervention (35 Days)||3
10530729|NCT01408719|11683186|FG006|STARTED|Second Intervention (35 Days)||2
10303970|NCT00085098|11437042|FG001|COMPLETED|Overall Study||11
10341816|NCT00388297|11479069|FG003|NOT COMPLETED|Overall Study||8
10341817|NCT00388349|11479079|FG000|STARTED|Phase I Dose Escalation||3
10341818|NCT00388349|11479080|FG001|STARTED|Phase I Dose Escalation||4
10341819|NCT00388349|11479079|FG000|COMPLETED|Phase I Dose Escalation||3
10341820|NCT00388349|11479080|FG001|COMPLETED|Phase I Dose Escalation||1
10341821|NCT00388349|11479079|FG000|NOT COMPLETED|Phase I Dose Escalation||0
10303971|NCT00085098|11437041|FG000|NOT COMPLETED|Overall Study||1
10303972|NCT00085098|11437042|FG001|NOT COMPLETED|Overall Study||2
10303973|NCT00085254|11437054|FG000|STARTED|Overall Study||18
10303974|NCT00085254|11437055|FG001|STARTED|Overall Study||46
10303975|NCT00085254|11437056|FG002|STARTED|Overall Study||48
10303976|NCT00085254|11437054|FG000|COMPLETED|Overall Study||18
10303977|NCT00085254|11437055|FG001|COMPLETED|Overall Study||46
10303978|NCT00085254|11437056|FG002|COMPLETED|Overall Study||48
10303979|NCT00085254|11437054|FG000|NOT COMPLETED|Overall Study||0
10303980|NCT00085254|11437055|FG001|NOT COMPLETED|Overall Study||0
10303981|NCT00085254|11437056|FG002|NOT COMPLETED|Overall Study||0
10303982|NCT00085293|11437070|FG000|STARTED|Overall Study||12
10303983|NCT00085293|11437070|FG000|COMPLETED|Overall Study||12
10303984|NCT00085293|11437070|FG000|NOT COMPLETED|Overall Study||0
10303985|NCT00085410|11437074|FG000|STARTED|Overall Study||20
10303986|NCT00085410|11437074|FG000|COMPLETED|Overall Study||20
10303987|NCT00085410|11437074|FG000|NOT COMPLETED|Overall Study||0
10303988|NCT00085423|11437079|FG000|STARTED|Overall Study||20
10303989|NCT00085423|11437079|FG000|COMPLETED|Overall Study||18
10303990|NCT00085423|11437079|FG000|NOT COMPLETED|Overall Study||2
10303991|NCT00085436|11437083|FG000|STARTED|Overall Study||18
10303992|NCT00085436|11437083|FG000|COMPLETED|Overall Study||18
10303993|NCT00085436|11437083|FG000|NOT COMPLETED|Overall Study||0
10303994|NCT00085540|11437090|FG000|STARTED|Overall Study||8
10715025|NCT02688387|11880044|FG001|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10715026|NCT02688387|11880045|FG002|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10715027|NCT02688387|11880046|FG003|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10715028|NCT02688387|11880047|FG004|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10715029|NCT02688387|11880048|FG005|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10715030|NCT02688387|11880049|FG006|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10303995|NCT00085540|11437091|FG001|STARTED|Overall Study||42
10303996|NCT00085540|11437090|FG000|COMPLETED|Overall Study||8
10303997|NCT00085540|11437091|FG001|COMPLETED|Overall Study||40
10303998|NCT00085540|11437090|FG000|NOT COMPLETED|Overall Study||0
10303999|NCT00085540|11437091|FG001|NOT COMPLETED|Overall Study||2
10304000|NCT00085566|11437100|FG000|STARTED|Overall Study||3
10341822|NCT00388349|11479080|FG001|NOT COMPLETED|Phase I Dose Escalation||3
10341823|NCT00388349|11479079|FG000|STARTED|Phase 2 Dose Expansion|Includes the three phase 1 participants who received 1250 mg/m2 gemcitabine (MTD)|139
10341824|NCT00388349|11479080|FG001|STARTED|Phase 2 Dose Expansion|No participants were treated in Phase 2 at 1500 mg/m2 gemcitabine (MTD exceeded)|0
10341825|NCT00388349|11479079|FG000|COMPLETED|Phase 2 Dose Expansion||139
10341826|NCT00388349|11479080|FG001|COMPLETED|Phase 2 Dose Expansion||0
10341827|NCT00388349|11479079|FG000|NOT COMPLETED|Phase 2 Dose Expansion||0
10341828|NCT00388349|11479080|FG001|NOT COMPLETED|Phase 2 Dose Expansion||0
10341829|NCT00388362|11479088|FG000|STARTED|Enrolled||36
10341830|NCT00388362|11479088|FG000|COMPLETED|Enrolled||23
10341831|NCT00388362|11479088|FG000|NOT COMPLETED|Enrolled||13
10341832|NCT00388362|11479088|FG000|STARTED|Remained on Study Median of 514 Days||23
10341833|NCT00388362|11479088|FG000|COMPLETED|Remained on Study Median of 514 Days||21
10341834|NCT00388362|11479088|FG000|NOT COMPLETED|Remained on Study Median of 514 Days||2
10341835|NCT00388414|11479094|FG000|STARTED|First Intervention (8 Weeks)||7
10341836|NCT00388414|11479095|FG001|STARTED|First Intervention (8 Weeks)||7
10341837|NCT00388414|11479094|FG000|COMPLETED|First Intervention (8 Weeks)||7
10341838|NCT00388414|11479095|FG001|COMPLETED|First Intervention (8 Weeks)||7
10341839|NCT00388414|11479094|FG000|NOT COMPLETED|First Intervention (8 Weeks)||0
10341840|NCT00388414|11479095|FG001|NOT COMPLETED|First Intervention (8 Weeks)||0
10341841|NCT00388414|11479094|FG000|STARTED|Washout (1 Week)||7
10341842|NCT00388414|11479095|FG001|STARTED|Washout (1 Week)||7
10341843|NCT00388414|11479094|FG000|COMPLETED|Washout (1 Week)||7
10341844|NCT00388414|11479095|FG001|COMPLETED|Washout (1 Week)||7
10715031|NCT02688387|11880050|FG007|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10715032|NCT02688387|11880051|FG008|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10715033|NCT02688387|11880052|FG009|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10715034|NCT02688387|11880053|FG010|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10715035|NCT02688387|11880054|FG011|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10715036|NCT02688387|11880055|FG012|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10341845|NCT00388414|11479094|FG000|NOT COMPLETED|Washout (1 Week)||0
10341846|NCT00388414|11479095|FG001|NOT COMPLETED|Washout (1 Week)||0
10341847|NCT00388414|11479094|FG000|STARTED|Second Intervention (8 Weeks)||7
10341848|NCT00388414|11479095|FG001|STARTED|Second Intervention (8 Weeks)||7
10304001|NCT00085566|11437101|FG001|STARTED|Overall Study||3
10304002|NCT00085566|11437102|FG002|STARTED|Overall Study||57
10304003|NCT00085566|11437100|FG000|COMPLETED|Overall Study||3
10715037|NCT02688387|11880056|FG013|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10715038|NCT02688387|11880057|FG014|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10715039|NCT02688387|11880058|FG015|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10715040|NCT02688387|11880059|FG016|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10715041|NCT02688387|11880060|FG017|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10715042|NCT02688387|11880061|FG018|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10715043|NCT02688387|11880062|FG019|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10715044|NCT02688387|11880063|FG020|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10715045|NCT02688387|11880064|FG021|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
10715046|NCT02688387|11880043|FG000|STARTED|Part 2, Period 1 (up to 6 Days)||0
10715047|NCT02688387|11880044|FG001|STARTED|Part 2, Period 1 (up to 6 Days)||0
10304004|NCT00085566|11437101|FG001|COMPLETED|Overall Study||3
10304005|NCT00085566|11437102|FG002|COMPLETED|Overall Study||43
10304006|NCT00085566|11437100|FG000|NOT COMPLETED|Overall Study||0
10304007|NCT00085566|11437101|FG001|NOT COMPLETED|Overall Study||0
10304008|NCT00085566|11437102|FG002|NOT COMPLETED|Overall Study||14
10304009|NCT00085644|11437112|FG000|STARTED|Double-Blind Period||208
10304010|NCT00085644|11437113|FG001|STARTED|Double-Blind Period||107
10304011|NCT00085644|11437114|FG002|STARTED|Double-Blind Period|This treatment group is not applicable to the Double-Blind Period.|0
10304012|NCT00085644|11437112|FG000|COMPLETED|Double-Blind Period||195
10304013|NCT00085644|11437113|FG001|COMPLETED|Double-Blind Period||101
10304014|NCT00085644|11437114|FG002|COMPLETED|Double-Blind Period||0
10304015|NCT00085644|11437112|FG000|NOT COMPLETED|Double-Blind Period||13
10304016|NCT00085644|11437113|FG001|NOT COMPLETED|Double-Blind Period||6
10304017|NCT00085644|11437114|FG002|NOT COMPLETED|Double-Blind Period||0
10304018|NCT00085644|11437112|FG000|STARTED|Open-Label Period|This treatment group is not applicable to the Open-Label Period.|0
10304019|NCT00085644|11437113|FG001|STARTED|Open-Label Period|This treatment group is not applicable to the Open-Label Period.|0
10304020|NCT00085644|11437114|FG002|STARTED|Open-Label Period|1 subject who discontinued for personal reasons subsequently died 450 days after last dose.|311
10304021|NCT00085644|11437112|FG000|COMPLETED|Open-Label Period||0
10304022|NCT00085644|11437113|FG001|COMPLETED|Open-Label Period||0
10304023|NCT00085644|11437114|FG002|COMPLETED|Open-Label Period||202
10304024|NCT00085644|11437112|FG000|NOT COMPLETED|Open-Label Period||0
10530730|NCT01408719|11683187|FG007|STARTED|Second Intervention (35 Days)||3
10530731|NCT01408719|11683188|FG008|STARTED|Second Intervention (35 Days)||1
10655084|NCT02206776|11815839|FG000|STARTED|Overall Study||1
10655085|NCT02206776|11815840|FG001|STARTED|Overall Study||1
10655086|NCT02206776|11815839|FG000|COMPLETED|Overall Study||1
10341849|NCT00388414|11479094|FG000|COMPLETED|Second Intervention (8 Weeks)||7
10341850|NCT00388414|11479095|FG001|COMPLETED|Second Intervention (8 Weeks)||7
10341851|NCT00388414|11479094|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||0
10341852|NCT00388414|11479095|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0
10341853|NCT00388453|11479106|FG000|STARTED|Overall Study||20
10341854|NCT00388453|11479107|FG001|STARTED|Overall Study||17
10341855|NCT00388453|11479108|FG002|STARTED|Overall Study||10
10341856|NCT00388453|11479106|FG000|COMPLETED|Overall Study||20
10341857|NCT00388453|11479107|FG001|COMPLETED|Overall Study||17
10341858|NCT00388453|11479108|FG002|COMPLETED|Overall Study||10
10341859|NCT00388453|11479106|FG000|NOT COMPLETED|Overall Study||0
10341860|NCT00388453|11479107|FG001|NOT COMPLETED|Overall Study||0
10341861|NCT00388453|11479108|FG002|NOT COMPLETED|Overall Study||0
10341862|NCT00388505|11479118|FG000|STARTED|Overall Study|Randomized patients who received any amount of study medication|308
10341863|NCT00388505|11479119|FG001|STARTED|Overall Study|Randomized patients who received any amount of study medication|209
10341864|NCT00388505|11479118|FG000|COMPLETED|Overall Study||225
10341865|NCT00388505|11479119|FG001|COMPLETED|Overall Study||171
10341866|NCT00388505|11479118|FG000|NOT COMPLETED|Overall Study||83
10341867|NCT00388505|11479119|FG001|NOT COMPLETED|Overall Study||38
10341868|NCT00388583|11479127|FG000|STARTED|Overall Study||407
10341869|NCT00388583|11479128|FG001|STARTED|Overall Study||410
10341870|NCT00388583|11479127|FG000|COMPLETED|Overall Study||401
10341871|NCT00388583|11479128|FG001|COMPLETED|Overall Study||406
10341872|NCT00388583|11479127|FG000|NOT COMPLETED|Overall Study||6
10341873|NCT00388583|11479128|FG001|NOT COMPLETED|Overall Study||4
10341874|NCT00388674|11479136|FG000|STARTED|Initial Treatment||6216
10341875|NCT00388674|11479137|FG001|STARTED|Initial Treatment||6162
10341876|NCT00388674|11479136|FG000|COMPLETED|Initial Treatment|Completed=Reason of 'successful treatment', 'other: successful treatment' or 'other: end of study'|4388
10341877|NCT00388674|11479137|FG001|COMPLETED|Initial Treatment|"Completed=discontinued initial treatment reason of successful treatment or end of study"|3576
10341878|NCT00388674|11479136|FG000|NOT COMPLETED|Initial Treatment||1828
10341879|NCT00388674|11479137|FG001|NOT COMPLETED|Initial Treatment||2586
10341880|NCT00388674|11479136|FG000|STARTED|End of Study||6216
10341881|NCT00388674|11479137|FG001|STARTED|End of Study||6162
10341882|NCT00388674|11479136|FG000|COMPLETED|End of Study|Completed=Reason of 'other: end of study'|4482
10341883|NCT00388674|11479137|FG001|COMPLETED|End of Study|Completed=Reason of 'other: end of study'|3993
10655087|NCT02206776|11815840|FG001|COMPLETED|Overall Study||1
10655088|NCT02206776|11815839|FG000|NOT COMPLETED|Overall Study||0
10655089|NCT02206776|11815840|FG001|NOT COMPLETED|Overall Study||0
10655090|NCT02206828|11815846|FG000|STARTED|Overall Study||100
10655091|NCT02206828|11815846|FG000|COMPLETED|Overall Study||93
10655092|NCT02206828|11815846|FG000|NOT COMPLETED|Overall Study||7
10655093|NCT02207088|11815873|FG000|STARTED|Overall Study||68
10655094|NCT02207088|11815873|FG000|COMPLETED|Overall Study||66
10655095|NCT02207088|11815873|FG000|NOT COMPLETED|Overall Study||2
10655096|NCT02207231|11815880|FG000|STARTED|Placebo Controlled Period: Week 0 - 16||174
10655097|NCT02207231|11815881|FG001|STARTED|Placebo Controlled Period: Week 0 - 16||329
10655098|NCT02207231|11815882|FG002|STARTED|Placebo Controlled Period: Week 0 - 16||334
10655099|NCT02207231|11815883|FG003|STARTED|Placebo Controlled Period: Week 0 - 16||0
10655100|NCT02207231|11815880|FG000|Treated|Placebo Controlled Period: Week 0 - 16||174
10304025|NCT00085644|11437113|FG001|NOT COMPLETED|Open-Label Period||0
10304026|NCT00085644|11437114|FG002|NOT COMPLETED|Open-Label Period||109
10304027|NCT00085709|11437123|FG000|STARTED|Overall Study||317
10304028|NCT00085709|11437124|FG001|STARTED|Overall Study||320
10304029|NCT00085709|11437123|FG000|Eligible|Overall Study||298
10304030|NCT00085709|11437124|FG001|Eligible|Overall Study||301
10304031|NCT00085709|11437123|FG000|Eligible and Did Not Withdraw Consent|Overall Study||296
10304032|NCT00085709|11437124|FG001|Eligible and Did Not Withdraw Consent|Overall Study||300
10304033|NCT00085709|11437123|FG000|COMPLETED|Overall Study||264
10304034|NCT00085709|11437124|FG001|COMPLETED|Overall Study||270
10304035|NCT00085709|11437123|FG000|NOT COMPLETED|Overall Study||53
10304036|NCT00085709|11437124|FG001|NOT COMPLETED|Overall Study||50
10304037|NCT00085839|11437140|FG000|STARTED|Overall Study||52
10304038|NCT00085839|11437141|FG001|STARTED|Overall Study||51
10304039|NCT00085839|11437140|FG000|COMPLETED|Overall Study||52
10304040|NCT00085839|11437141|FG001|COMPLETED|Overall Study||51
10304041|NCT00085839|11437140|FG000|NOT COMPLETED|Overall Study||0
10304042|NCT00085839|11437141|FG001|NOT COMPLETED|Overall Study||0
10304043|NCT00085917|11437149|FG000|STARTED|Overall Study||15
10304044|NCT00085917|11437150|FG001|STARTED|Overall Study||14
10304045|NCT00085917|11437149|FG000|COMPLETED|Overall Study||11
10304046|NCT00085917|11437150|FG001|COMPLETED|Overall Study||11
10304047|NCT00085917|11437149|FG000|NOT COMPLETED|Overall Study||4
10304048|NCT00085917|11437150|FG001|NOT COMPLETED|Overall Study||3
10304049|NCT00086047|11437158|FG000|STARTED|Overall Study||57
10304050|NCT00086047|11437159|FG001|STARTED|Overall Study||57
10304051|NCT00086047|11437158|FG000|COMPLETED|Overall Study||50
10304052|NCT00086047|11437159|FG001|COMPLETED|Overall Study||50
10304053|NCT00086047|11437158|FG000|NOT COMPLETED|Overall Study||7
10304054|NCT00086047|11437159|FG001|NOT COMPLETED|Overall Study||7
10304055|NCT00086138|11437167|FG000|STARTED|Overall Study||64
10304056|NCT00086138|11437168|FG001|STARTED|Overall Study||67
10304057|NCT00086138|11437167|FG000|COMPLETED|Overall Study||60
10304058|NCT00086138|11437168|FG001|COMPLETED|Overall Study||64
10304059|NCT00086138|11437167|FG000|NOT COMPLETED|Overall Study||4
10304060|NCT00086138|11437168|FG001|NOT COMPLETED|Overall Study||3
10341884|NCT00388674|11479136|FG000|NOT COMPLETED|End of Study||1734
10341885|NCT00388674|11479137|FG001|NOT COMPLETED|End of Study||2169
10341886|NCT00388726|11479145|FG000|STARTED|Overall Study||508
10341887|NCT00388726|11479146|FG001|STARTED|Overall Study||254
10341888|NCT00388726|11479145|FG000|COMPLETED|Overall Study||24
10341889|NCT00388726|11479146|FG001|COMPLETED|Overall Study||10
10341890|NCT00388726|11479145|FG000|NOT COMPLETED|Overall Study||484
10341891|NCT00388726|11479146|FG001|NOT COMPLETED|Overall Study||244
10341892|NCT00388804|11479154|FG000|STARTED|Overall Study||17
10341893|NCT00388804|11479155|FG001|STARTED|Overall Study||21
10341894|NCT00388804|11479154|FG000|COMPLETED|Overall Study||17
10341895|NCT00388804|11479155|FG001|COMPLETED|Overall Study||21
10341896|NCT00388804|11479154|FG000|NOT COMPLETED|Overall Study||0
10341897|NCT00388804|11479155|FG001|NOT COMPLETED|Overall Study||0
10341898|NCT00388947|11479161|FG000|STARTED|Overall Study||1590
10341899|NCT00388947|11479161|FG000|COMPLETED|Overall Study|47 patients excluded because no AMS prolapse device was noted.|1543
10341900|NCT00388947|11479161|FG000|NOT COMPLETED|Overall Study||47
10304061|NCT00086190|11437177|FG000|STARTED|Overall Study||42
10304062|NCT00086190|11437178|FG001|STARTED|Overall Study||34
10304063|NCT00086190|11437179|FG002|STARTED|Overall Study||39
10341901|NCT00388973|11479167|FG000|STARTED|Overall Study|Randomized|166
10341902|NCT00388973|11479168|FG001|STARTED|Overall Study|Randomized|172
10304064|NCT00086190|11437177|FG000|COMPLETED|Overall Study||34
10304065|NCT00086190|11437178|FG001|COMPLETED|Overall Study||30
10304066|NCT00086190|11437179|FG002|COMPLETED|Overall Study||33
10304067|NCT00086190|11437177|FG000|NOT COMPLETED|Overall Study||8
10304068|NCT00086190|11437178|FG001|NOT COMPLETED|Overall Study||4
10304069|NCT00086190|11437179|FG002|NOT COMPLETED|Overall Study||6
10304070|NCT00086281|11437202|FG000|STARTED|Phase 1||11
10304071|NCT00086281|11437203|FG001|STARTED|Phase 1||12
10304072|NCT00086281|11437204|FG002|STARTED|Phase 1||8
10304073|NCT00086281|11437205|FG003|STARTED|Phase 1||11
10304074|NCT00086281|11437206|FG004|STARTED|Phase 1||1
10304075|NCT00086281|11437207|FG005|STARTED|Phase 1||3
10304076|NCT00086281|11437208|FG006|STARTED|Phase 1||1
10304077|NCT00086281|11437209|FG007|STARTED|Phase 1||1
10304078|NCT00086281|11437210|FG008|STARTED|Phase 1||2
10304079|NCT00086281|11437211|FG009|STARTED|Phase 1||1
10304080|NCT00086281|11437212|FG010|STARTED|Phase 1||3
10304081|NCT00086281|11437213|FG011|STARTED|Phase 1||1
10304082|NCT00086281|11437214|FG012|STARTED|Phase 1||1
10304083|NCT00086281|11437215|FG013|STARTED|Phase 1||1
10304084|NCT00086281|11437216|FG014|STARTED|Phase 1||3
10304085|NCT00086281|11437202|FG000|COMPLETED|Phase 1||11
10304086|NCT00086281|11437203|FG001|COMPLETED|Phase 1||12
10304087|NCT00086281|11437204|FG002|COMPLETED|Phase 1||8
10304088|NCT00086281|11437205|FG003|COMPLETED|Phase 1||11
10304089|NCT00086281|11437206|FG004|COMPLETED|Phase 1||1
10304090|NCT00086281|11437207|FG005|COMPLETED|Phase 1||3
10304091|NCT00086281|11437208|FG006|COMPLETED|Phase 1||1
10304092|NCT00086281|11437209|FG007|COMPLETED|Phase 1||1
10304093|NCT00086281|11437210|FG008|COMPLETED|Phase 1||2
10304094|NCT00086281|11437211|FG009|COMPLETED|Phase 1||0
10304095|NCT00086281|11437212|FG010|COMPLETED|Phase 1||0
10304096|NCT00086281|11437213|FG011|COMPLETED|Phase 1||0
10304097|NCT00086281|11437214|FG012|COMPLETED|Phase 1||0
10715048|NCT02688387|11880045|FG002|STARTED|Part 2, Period 1 (up to 6 Days)||0
10715049|NCT02688387|11880046|FG003|STARTED|Part 2, Period 1 (up to 6 Days)||0
10715050|NCT02688387|11880047|FG004|STARTED|Part 2, Period 1 (up to 6 Days)||0
10304098|NCT00086281|11437215|FG013|COMPLETED|Phase 1||0
10304099|NCT00086281|11437216|FG014|COMPLETED|Phase 1||0
10304100|NCT00086281|11437202|FG000|NOT COMPLETED|Phase 1||0
10304101|NCT00086281|11437203|FG001|NOT COMPLETED|Phase 1||0
10304102|NCT00086281|11437204|FG002|NOT COMPLETED|Phase 1||0
10304103|NCT00086281|11437205|FG003|NOT COMPLETED|Phase 1||0
10304104|NCT00086281|11437206|FG004|NOT COMPLETED|Phase 1||0
10304105|NCT00086281|11437207|FG005|NOT COMPLETED|Phase 1||0
10304106|NCT00086281|11437208|FG006|NOT COMPLETED|Phase 1||0
10304107|NCT00086281|11437209|FG007|NOT COMPLETED|Phase 1||0
10304108|NCT00086281|11437210|FG008|NOT COMPLETED|Phase 1||0
10304109|NCT00086281|11437211|FG009|NOT COMPLETED|Phase 1||1
10304110|NCT00086281|11437212|FG010|NOT COMPLETED|Phase 1||3
10304111|NCT00086281|11437213|FG011|NOT COMPLETED|Phase 1||1
10304112|NCT00086281|11437214|FG012|NOT COMPLETED|Phase 1||1
10304113|NCT00086281|11437215|FG013|NOT COMPLETED|Phase 1||1
10530732|NCT01408719|11683189|FG009|STARTED|Second Intervention (35 Days)||1
10530733|NCT01408719|11683190|FG010|STARTED|Second Intervention (35 Days)||2
10715051|NCT02688387|11880048|FG005|STARTED|Part 2, Period 1 (up to 6 Days)||0
10530734|NCT01408719|11683191|FG011|STARTED|Second Intervention (35 Days)||2
10530735|NCT01408719|11683192|FG012|STARTED|Second Intervention (35 Days)||2
10530736|NCT01408719|11683193|FG013|STARTED|Second Intervention (35 Days)||4
10341903|NCT00388973|11479167|FG000|Completed Study|Overall Study||110
10341904|NCT00388973|11479168|FG001|Completed Study|Overall Study||114
10341905|NCT00388973|11479167|FG000|COMPLETED|Overall Study|Completed 9-week treatment and 2 week follow-up|110
10341906|NCT00388973|11479168|FG001|COMPLETED|Overall Study|Completed 9-week treatment and 2 week follow-up|114
10341907|NCT00388973|11479167|FG000|NOT COMPLETED|Overall Study||56
10341908|NCT00388973|11479168|FG001|NOT COMPLETED|Overall Study||58
10341909|NCT00389064|11479176|FG000|STARTED|Overall Study||223
10341910|NCT00389064|11479177|FG001|STARTED|Overall Study||227
10341911|NCT00389064|11479176|FG000|COMPLETED|Overall Study||178
10341912|NCT00389064|11479177|FG001|COMPLETED|Overall Study||168
10341913|NCT00389064|11479176|FG000|NOT COMPLETED|Overall Study||45
10341914|NCT00389064|11479177|FG001|NOT COMPLETED|Overall Study||59
10341915|NCT00389168|11479185|FG000|STARTED|Overall Study||56
10341916|NCT00389168|11479186|FG001|STARTED|Overall Study||58
10341917|NCT00389168|11479185|FG000|COMPLETED|Overall Study||47
10341918|NCT00389168|11479186|FG001|COMPLETED|Overall Study||53
10341919|NCT00389168|11479185|FG000|NOT COMPLETED|Overall Study||9
10341920|NCT00389168|11479186|FG001|NOT COMPLETED|Overall Study||5
10341921|NCT00389207|11479195|FG000|STARTED|Overall Study|3 patients were randomized to NVP QD but not treated and so not part of the Full Analysis Set (FAS)|188
10341922|NCT00389207|11479196|FG001|STARTED|Overall Study|4 patients were randomized to NVP BID but not treated and so are not part of the FAS|188
10341923|NCT00389207|11479197|FG002|STARTED|Overall Study||193
10341924|NCT00389207|11479195|FG000|COMPLETED|Overall Study||125
10341925|NCT00389207|11479196|FG001|COMPLETED|Overall Study||116
10341926|NCT00389207|11479197|FG002|COMPLETED|Overall Study||152
10341927|NCT00389207|11479195|FG000|NOT COMPLETED|Overall Study||63
10341928|NCT00389207|11479196|FG001|NOT COMPLETED|Overall Study||72
10341929|NCT00389207|11479197|FG002|NOT COMPLETED|Overall Study||41
10341930|NCT00389324|11479210|FG000|STARTED|Run-In Phase||21
10341931|NCT00389324|11479210|FG000|COMPLETED|Run-In Phase||18
10341932|NCT00389324|11479210|FG000|NOT COMPLETED|Run-In Phase||3
10341933|NCT00389324|11479210|FG000|STARTED|Intravenous Phase|18 subjects entered from the Run-in Phase and 14 new participants entered directly|32
10341934|NCT00389324|11479210|FG000|COMPLETED|Intravenous Phase||32
10341935|NCT00389324|11479210|FG000|NOT COMPLETED|Intravenous Phase||0
10341936|NCT00389324|11479210|FG000|STARTED|Subcutaneous Phase||32
10341937|NCT00389324|11479210|FG000|COMPLETED|Subcutaneous Phase||25
10341938|NCT00389324|11479210|FG000|NOT COMPLETED|Subcutaneous Phase||7
10341939|NCT00389441|11479217|FG000|STARTED|Overall Study||52
10341940|NCT00389441|11479217|FG000|COMPLETED|Overall Study||0
10341941|NCT00389441|11479217|FG000|NOT COMPLETED|Overall Study||52
10341942|NCT00389467|11479225|FG000|STARTED|Overall Study||34
10341943|NCT00389467|11479226|FG001|STARTED|Overall Study||34
10341944|NCT00389467|11479227|FG002|STARTED|Overall Study||30
10341945|NCT00389467|11479228|FG003|STARTED|Overall Study||20
10341946|NCT00389467|11479225|FG000|COMPLETED|Overall Study||34
10341947|NCT00389467|11479226|FG001|COMPLETED|Overall Study||34
10341948|NCT00389467|11479227|FG002|COMPLETED|Overall Study||30
10341949|NCT00389467|11479228|FG003|COMPLETED|Overall Study||20
10341950|NCT00389467|11479225|FG000|NOT COMPLETED|Overall Study||0
10341951|NCT00389467|11479226|FG001|NOT COMPLETED|Overall Study||0
10341952|NCT00389467|11479227|FG002|NOT COMPLETED|Overall Study||0
10341953|NCT00389467|11479228|FG003|NOT COMPLETED|Overall Study||0
10341954|NCT00389493|11479242|FG000|STARTED|Overall Study||40
10341955|NCT00389493|11479243|FG001|STARTED|Overall Study||40
10341956|NCT00389493|11479244|FG002|STARTED|Overall Study||20
10341957|NCT00389493|11479242|FG000|COMPLETED|Overall Study||37
10341958|NCT00389493|11479243|FG001|COMPLETED|Overall Study||32
10341959|NCT00389493|11479244|FG002|COMPLETED|Overall Study||17
10341960|NCT00389493|11479242|FG000|NOT COMPLETED|Overall Study||3
10341961|NCT00389493|11479243|FG001|NOT COMPLETED|Overall Study||8
10341962|NCT00389493|11479244|FG002|NOT COMPLETED|Overall Study||3
10341963|NCT00389519|11479259|FG000|STARTED|Placebo Run-In||422
10341964|NCT00389519|11479260|FG001|STARTED|Placebo Run-In||0
10341965|NCT00389519|11479261|FG002|STARTED|Placebo Run-In||0
10341966|NCT00389519|11479262|FG003|STARTED|Placebo Run-In||0
10341967|NCT00389519|11479259|FG000|COMPLETED|Placebo Run-In||244
10341968|NCT00389519|11479260|FG001|COMPLETED|Placebo Run-In||0
10341969|NCT00389519|11479261|FG002|COMPLETED|Placebo Run-In||0
10341970|NCT00389519|11479262|FG003|COMPLETED|Placebo Run-In||0
10341971|NCT00389519|11479259|FG000|NOT COMPLETED|Placebo Run-In||178
10341972|NCT00389519|11479260|FG001|NOT COMPLETED|Placebo Run-In||0
10304114|NCT00086281|11437216|FG014|NOT COMPLETED|Phase 1||3
10304115|NCT00086281|11437202|FG000|STARTED|Phase 2||0
10304116|NCT00086281|11437203|FG001|STARTED|Phase 2||0
10304117|NCT00086281|11437204|FG002|STARTED|Phase 2||0
10530737|NCT01408719|11683194|FG014|STARTED|Second Intervention (35 Days)||1
10530738|NCT01408719|11683195|FG015|STARTED|Second Intervention (35 Days)||2
10530739|NCT01408719|11683196|FG016|STARTED|Second Intervention (35 Days)||2
10530740|NCT01408719|11683197|FG017|STARTED|Second Intervention (35 Days)||2
10530741|NCT01408719|11683198|FG018|STARTED|Second Intervention (35 Days)||0
10530742|NCT01408719|11683199|FG019|STARTED|Second Intervention (35 Days)||1
10530743|NCT01408719|11683180|FG000|COMPLETED|Second Intervention (35 Days)||2
10530744|NCT01408719|11683181|FG001|COMPLETED|Second Intervention (35 Days)||3
10530745|NCT01408719|11683182|FG002|COMPLETED|Second Intervention (35 Days)||1
10530746|NCT01408719|11683183|FG003|COMPLETED|Second Intervention (35 Days)||2
10530747|NCT01408719|11683184|FG004|COMPLETED|Second Intervention (35 Days)||3
10530748|NCT01408719|11683185|FG005|COMPLETED|Second Intervention (35 Days)||3
10530749|NCT01408719|11683186|FG006|COMPLETED|Second Intervention (35 Days)||2
10530750|NCT01408719|11683187|FG007|COMPLETED|Second Intervention (35 Days)||3
10530751|NCT01408719|11683188|FG008|COMPLETED|Second Intervention (35 Days)||1
10530752|NCT01408719|11683189|FG009|COMPLETED|Second Intervention (35 Days)||1
10530753|NCT01408719|11683190|FG010|COMPLETED|Second Intervention (35 Days)||2
10304118|NCT00086281|11437205|FG003|STARTED|Phase 2||0
10304119|NCT00086281|11437206|FG004|STARTED|Phase 2||0
10304120|NCT00086281|11437207|FG005|STARTED|Phase 2||0
10530754|NCT01408719|11683191|FG011|COMPLETED|Second Intervention (35 Days)||2
10341973|NCT00389519|11479261|FG002|NOT COMPLETED|Placebo Run-In||0
10341974|NCT00389519|11479262|FG003|NOT COMPLETED|Placebo Run-In||0
10341975|NCT00389519|11479259|FG000|STARTED|Randomized||83
10341976|NCT00389519|11479260|FG001|STARTED|Randomized||41
10341977|NCT00389519|11479261|FG002|STARTED|Randomized||40
10341978|NCT00389519|11479262|FG003|STARTED|Randomized||80
10341979|NCT00389519|11479259|FG000|COMPLETED|Randomized||81
10341980|NCT00389519|11479260|FG001|COMPLETED|Randomized||41
10341981|NCT00389519|11479261|FG002|COMPLETED|Randomized||40
10341982|NCT00389519|11479262|FG003|COMPLETED|Randomized||80
10341983|NCT00389519|11479259|FG000|NOT COMPLETED|Randomized||2
10341984|NCT00389519|11479260|FG001|NOT COMPLETED|Randomized||0
10341985|NCT00389519|11479261|FG002|NOT COMPLETED|Randomized||0
10341986|NCT00389519|11479262|FG003|NOT COMPLETED|Randomized||0
10341987|NCT00389519|11479259|FG000|STARTED|Treated||81
10341988|NCT00389519|11479260|FG001|STARTED|Treated||41
10341989|NCT00389519|11479261|FG002|STARTED|Treated||40
10341990|NCT00389519|11479262|FG003|STARTED|Treated||80
10341991|NCT00389519|11479259|FG000|COMPLETED|Treated||79
10341992|NCT00389519|11479260|FG001|COMPLETED|Treated||40
10341993|NCT00389519|11479261|FG002|COMPLETED|Treated||40
10341994|NCT00389519|11479262|FG003|COMPLETED|Treated||76
10341995|NCT00389519|11479259|FG000|NOT COMPLETED|Treated||2
10341996|NCT00389519|11479260|FG001|NOT COMPLETED|Treated||1
10341997|NCT00389519|11479261|FG002|NOT COMPLETED|Treated||0
10341998|NCT00389519|11479262|FG003|NOT COMPLETED|Treated||4
10341999|NCT00389532|11479274|FG000|STARTED|Overall Study||60
10342000|NCT00389532|11479275|FG001|STARTED|Overall Study||56
10342001|NCT00389532|11479274|FG000|COMPLETED|Overall Study|3 of the participants did not have valid post-vaccination serological results|60
10342002|NCT00389532|11479275|FG001|COMPLETED|Overall Study||56
10342003|NCT00389532|11479274|FG000|NOT COMPLETED|Overall Study||0
10342004|NCT00389532|11479275|FG001|NOT COMPLETED|Overall Study||0
10342005|NCT00389597|11479285|FG000|STARTED|Overall Study||164
10342006|NCT00389597|11479286|FG001|STARTED|Overall Study||81
10342007|NCT00389597|11479287|FG002|STARTED|Overall Study||225
10342008|NCT00389597|11479288|FG003|STARTED|Overall Study||105
10342009|NCT00389597|11479285|FG000|24 mo|Overall Study||156
10342010|NCT00389597|11479286|FG001|24 mo|Overall Study||75
10342011|NCT00389597|11479287|FG002|24 mo|Overall Study||221
10342012|NCT00389597|11479288|FG003|24 mo|Overall Study||99
10342013|NCT00389597|11479285|FG000|COMPLETED|Overall Study||156
10342014|NCT00389597|11479286|FG001|COMPLETED|Overall Study||75
10342015|NCT00389597|11479287|FG002|COMPLETED|Overall Study||221
10342016|NCT00389597|11479288|FG003|COMPLETED|Overall Study||99
10342017|NCT00389597|11479285|FG000|NOT COMPLETED|Overall Study||8
10342018|NCT00389597|11479286|FG001|NOT COMPLETED|Overall Study||6
10342019|NCT00389597|11479287|FG002|NOT COMPLETED|Overall Study||4
10342020|NCT00389597|11479288|FG003|NOT COMPLETED|Overall Study||6
10342021|NCT00389805|11479300|FG000|STARTED|Phase I||15
10342022|NCT00389805|11479301|FG001|STARTED|Phase I||12
10342023|NCT00389805|11479300|FG000|COMPLETED|Phase I||15
10342024|NCT00389805|11479301|FG001|COMPLETED|Phase I||12
10342025|NCT00389805|11479300|FG000|NOT COMPLETED|Phase I||0
10342026|NCT00389805|11479301|FG001|NOT COMPLETED|Phase I||0
10342027|NCT00389805|11479300|FG000|STARTED|Phase II|The Phase II study was not conducted.|0
10342028|NCT00389805|11479301|FG001|STARTED|Phase II|The Phase II study was not conducted.|0
10304121|NCT00086281|11437208|FG006|STARTED|Phase 2||0
10304122|NCT00086281|11437209|FG007|STARTED|Phase 2||0
10304123|NCT00086281|11437210|FG008|STARTED|Phase 2||0
10304124|NCT00086281|11437211|FG009|STARTED|Phase 2||0
10304125|NCT00086281|11437212|FG010|STARTED|Phase 2||0
10304126|NCT00086281|11437213|FG011|STARTED|Phase 2||0
10304127|NCT00086281|11437214|FG012|STARTED|Phase 2||23
10304128|NCT00086281|11437215|FG013|STARTED|Phase 2||27
10304129|NCT00086281|11437216|FG014|STARTED|Phase 2||0
10304130|NCT00086281|11437202|FG000|COMPLETED|Phase 2||0
10304131|NCT00086281|11437203|FG001|COMPLETED|Phase 2||0
10304132|NCT00086281|11437204|FG002|COMPLETED|Phase 2||0
10304133|NCT00086281|11437205|FG003|COMPLETED|Phase 2||0
10304134|NCT00086281|11437206|FG004|COMPLETED|Phase 2||0
10304135|NCT00086281|11437207|FG005|COMPLETED|Phase 2||0
10304136|NCT00086281|11437208|FG006|COMPLETED|Phase 2||0
10304137|NCT00086281|11437209|FG007|COMPLETED|Phase 2||0
10304138|NCT00086281|11437210|FG008|COMPLETED|Phase 2||0
10304139|NCT00086281|11437211|FG009|COMPLETED|Phase 2||0
10304140|NCT00086281|11437212|FG010|COMPLETED|Phase 2||0
10304141|NCT00086281|11437213|FG011|COMPLETED|Phase 2||0
10304142|NCT00086281|11437214|FG012|COMPLETED|Phase 2||22
10304143|NCT00086281|11437215|FG013|COMPLETED|Phase 2||26
10715052|NCT02688387|11880049|FG006|STARTED|Part 2, Period 1 (up to 6 Days)||0
10715053|NCT02688387|11880050|FG007|STARTED|Part 2, Period 1 (up to 6 Days)||0
10715054|NCT02688387|11880051|FG008|STARTED|Part 2, Period 1 (up to 6 Days)||0
10715055|NCT02688387|11880052|FG009|STARTED|Part 2, Period 1 (up to 6 Days)||0
10715056|NCT02688387|11880053|FG010|STARTED|Part 2, Period 1 (up to 6 Days)||6
10715057|NCT02688387|11880054|FG011|STARTED|Part 2, Period 1 (up to 6 Days)||5
10715058|NCT02688387|11880055|FG012|STARTED|Part 2, Period 1 (up to 6 Days)||5
10304144|NCT00086281|11437216|FG014|COMPLETED|Phase 2||0
10304145|NCT00086281|11437202|FG000|NOT COMPLETED|Phase 2||0
10304146|NCT00086281|11437203|FG001|NOT COMPLETED|Phase 2||0
10304147|NCT00086281|11437204|FG002|NOT COMPLETED|Phase 2||0
10304148|NCT00086281|11437205|FG003|NOT COMPLETED|Phase 2||0
10304149|NCT00086281|11437206|FG004|NOT COMPLETED|Phase 2||0
10304150|NCT00086281|11437207|FG005|NOT COMPLETED|Phase 2||0
10715059|NCT02688387|11880056|FG013|STARTED|Part 2, Period 1 (up to 6 Days)||5
10715060|NCT02688387|11880057|FG014|STARTED|Part 2, Period 1 (up to 6 Days)||0
10715061|NCT02688387|11880058|FG015|STARTED|Part 2, Period 1 (up to 6 Days)||0
10715062|NCT02688387|11880059|FG016|STARTED|Part 2, Period 1 (up to 6 Days)||0
10304151|NCT00086281|11437208|FG006|NOT COMPLETED|Phase 2||0
10304152|NCT00086281|11437209|FG007|NOT COMPLETED|Phase 2||0
10304153|NCT00086281|11437210|FG008|NOT COMPLETED|Phase 2||0
10304154|NCT00086281|11437211|FG009|NOT COMPLETED|Phase 2||0
10304155|NCT00086281|11437212|FG010|NOT COMPLETED|Phase 2||0
10304156|NCT00086281|11437213|FG011|NOT COMPLETED|Phase 2||0
10304157|NCT00086281|11437214|FG012|NOT COMPLETED|Phase 2||1
10304158|NCT00086281|11437215|FG013|NOT COMPLETED|Phase 2||1
10304159|NCT00086281|11437216|FG014|NOT COMPLETED|Phase 2||0
10304160|NCT00086307|11437229|FG000|STARTED|Overall Study||13
10304161|NCT00086307|11437230|FG001|STARTED|Overall Study||13
10304162|NCT00086307|11437231|FG002|STARTED|Overall Study||13
10304163|NCT00086307|11437229|FG000|COMPLETED|Overall Study||11
10304164|NCT00086307|11437230|FG001|COMPLETED|Overall Study||12
10304165|NCT00086307|11437231|FG002|COMPLETED|Overall Study||5
10304166|NCT00086307|11437229|FG000|NOT COMPLETED|Overall Study||2
10304167|NCT00086307|11437230|FG001|NOT COMPLETED|Overall Study||1
10304168|NCT00086307|11437231|FG002|NOT COMPLETED|Overall Study||8
10304169|NCT00086346|11437241|FG000|STARTED|Randomization||393
10304170|NCT00086346|11437242|FG001|STARTED|Randomization||214
10304171|NCT00086346|11437241|FG000|COMPLETED|Randomization||389
10304172|NCT00086346|11437242|FG001|COMPLETED|Randomization||210
10304173|NCT00086346|11437241|FG000|NOT COMPLETED|Randomization||4
10304174|NCT00086346|11437242|FG001|NOT COMPLETED|Randomization||4
10304175|NCT00086346|11437241|FG000|STARTED|Patients Dosed With Test Article||389
10304176|NCT00086346|11437242|FG001|STARTED|Patients Dosed With Test Article||210
10304177|NCT00086346|11437241|FG000|COMPLETED|Patients Dosed With Test Article||249
10304178|NCT00086346|11437242|FG001|COMPLETED|Patients Dosed With Test Article||187
10304179|NCT00086346|11437241|FG000|NOT COMPLETED|Patients Dosed With Test Article||140
10304180|NCT00086346|11437242|FG001|NOT COMPLETED|Patients Dosed With Test Article||23
10304181|NCT00086385|11437252|FG000|STARTED|Overall Study||100
10304182|NCT00086385|11437253|FG001|STARTED|Overall Study||99
10304183|NCT00086385|11437254|FG002|STARTED|Overall Study||104
10304184|NCT00086385|11437255|FG003|STARTED|Overall Study||99
10304185|NCT00086385|11437252|FG000|COMPLETED|Overall Study||98
10304186|NCT00086385|11437253|FG001|COMPLETED|Overall Study||97
10304187|NCT00086385|11437254|FG002|COMPLETED|Overall Study||103
10304188|NCT00086385|11437255|FG003|COMPLETED|Overall Study||98
10304189|NCT00086385|11437252|FG000|NOT COMPLETED|Overall Study||2
10304190|NCT00086385|11437253|FG001|NOT COMPLETED|Overall Study||2
10304191|NCT00086385|11437254|FG002|NOT COMPLETED|Overall Study||1
10304192|NCT00086385|11437255|FG003|NOT COMPLETED|Overall Study||1
10304193|NCT00086411|11437269|FG000|STARTED|Overall Study||70
10304194|NCT00086411|11437270|FG001|STARTED|Overall Study||63
10304195|NCT00086411|11437271|FG002|STARTED|Overall Study||62
10304196|NCT00086411|11437272|FG003|STARTED|Overall Study||65
10304197|NCT00086411|11437269|FG000|COMPLETED|Overall Study||59
10304198|NCT00086411|11437270|FG001|COMPLETED|Overall Study||52
10304199|NCT00086411|11437271|FG002|COMPLETED|Overall Study||49
10304200|NCT00086411|11437272|FG003|COMPLETED|Overall Study||53
10304201|NCT00086411|11437269|FG000|NOT COMPLETED|Overall Study||11
10304202|NCT00086411|11437270|FG001|NOT COMPLETED|Overall Study||11
10304203|NCT00086411|11437271|FG002|NOT COMPLETED|Overall Study||13
10304204|NCT00086411|11437272|FG003|NOT COMPLETED|Overall Study||12
10304205|NCT00086450|11437285|FG000|STARTED|Overall Study||953
10304206|NCT00086450|11437286|FG001|STARTED|Overall Study||947
10304207|NCT00086450|11437285|FG000|COMPLETED|Overall Study||953
10304208|NCT00086450|11437286|FG001|COMPLETED|Overall Study||947
10304209|NCT00086450|11437285|FG000|NOT COMPLETED|Overall Study||0
10304210|NCT00086450|11437286|FG001|NOT COMPLETED|Overall Study||0
10304211|NCT00086502|11437294|FG000|STARTED|Overall Study||175
10304212|NCT00086502|11437295|FG001|STARTED|Overall Study||178
10304213|NCT00086502|11437294|FG000|COMPLETED|Overall Study||149
10304214|NCT00086502|11437295|FG001|COMPLETED|Overall Study||158
10304215|NCT00086502|11437294|FG000|NOT COMPLETED|Overall Study||26
10304216|NCT00086502|11437295|FG001|NOT COMPLETED|Overall Study||20
10304217|NCT00086515|11437303|FG000|STARTED|Phase A (Weeks 0-24)||464
10304218|NCT00086515|11437304|FG001|STARTED|Phase A (Weeks 0-24)||237
10304219|NCT00086515|11437303|FG000|COMPLETED|Phase A (Weeks 0-24)||415
10304220|NCT00086515|11437304|FG001|COMPLETED|Phase A (Weeks 0-24)||192
10304221|NCT00086515|11437303|FG000|NOT COMPLETED|Phase A (Weeks 0-24)||49
10304222|NCT00086515|11437304|FG001|NOT COMPLETED|Phase A (Weeks 0-24)||45
10304223|NCT00086515|11437303|FG000|STARTED|Phase A to Phase B Transition Period||415
10304224|NCT00086515|11437304|FG001|STARTED|Phase A to Phase B Transition Period||192
10304225|NCT00086515|11437303|FG000|COMPLETED|Phase A to Phase B Transition Period||391
10304226|NCT00086515|11437304|FG001|COMPLETED|Phase A to Phase B Transition Period||164
10304227|NCT00086515|11437303|FG000|NOT COMPLETED|Phase A to Phase B Transition Period||24
10304228|NCT00086515|11437304|FG001|NOT COMPLETED|Phase A to Phase B Transition Period||28
10304229|NCT00086515|11437303|FG000|STARTED|Phase B (Weeks 24-104)||391
10304230|NCT00086515|11437304|FG001|STARTED|Phase B (Weeks 24-104)||164
10304231|NCT00086515|11437303|FG000|COMPLETED|Phase B (Weeks 24-104)||201
10304232|NCT00086515|11437304|FG001|COMPLETED|Phase B (Weeks 24-104)||109
10304233|NCT00086515|11437303|FG000|NOT COMPLETED|Phase B (Weeks 24-104)||190
10304234|NCT00086515|11437304|FG001|NOT COMPLETED|Phase B (Weeks 24-104)||55
10304235|NCT00086580|11437312|FG000|STARTED|Treatment Period||168
10304236|NCT00086580|11437313|FG001|STARTED|Treatment Period||167
10304237|NCT00086580|11437312|FG000|Safety Population|Treatment Period|Four participants did not receive treatment|164
10304238|NCT00086580|11437313|FG001|Safety Population|Treatment Period|Two participants did not receive treatment|165
10304239|NCT00086580|11437312|FG000|COMPLETED|Treatment Period|Finished 6 cycles of study drugs|103
10304240|NCT00086580|11437313|FG001|COMPLETED|Treatment Period|Finished 6 cycles of study drug|107
10304241|NCT00086580|11437312|FG000|NOT COMPLETED|Treatment Period||65
10304242|NCT00086580|11437313|FG001|NOT COMPLETED|Treatment Period||60
10304243|NCT00086580|11437312|FG000|STARTED|Follow-up Period||141
10304244|NCT00086580|11437313|FG001|STARTED|Follow-up Period||137
10304245|NCT00086580|11437312|FG000|COMPLETED|Follow-up Period||37
10304246|NCT00086580|11437313|FG001|COMPLETED|Follow-up Period||18
10304247|NCT00086580|11437312|FG000|NOT COMPLETED|Follow-up Period||104
10304248|NCT00086580|11437313|FG001|NOT COMPLETED|Follow-up Period||119
10304249|NCT00086580|11437312|FG000|STARTED|Observation Period||95
10715063|NCT02688387|11880060|FG017|STARTED|Part 2, Period 1 (up to 6 Days)||0
10812258|NCT03726164|11974257|FG000|COMPLETED|Overall Study||99
10812259|NCT03726164|11974258|FG001|COMPLETED|Overall Study||119
10812260|NCT03726164|11974257|FG000|NOT COMPLETED|Overall Study||211
10812261|NCT03726164|11974258|FG001|NOT COMPLETED|Overall Study||197
10812262|NCT03725852|11974266|FG000|STARTED|Overall Study||45
10812263|NCT03725852|11974267|FG001|STARTED|Overall Study||23
10812264|NCT03725852|11974266|FG000|COMPLETED|Overall Study||41
10812265|NCT03725852|11974267|FG001|COMPLETED|Overall Study||23
10812266|NCT03725852|11974266|FG000|NOT COMPLETED|Overall Study||4
10812267|NCT03725852|11974267|FG001|NOT COMPLETED|Overall Study||0
10812268|NCT03725722|11974278|FG000|STARTED|Overall Study||49
10812269|NCT03725722|11974279|FG001|STARTED|Overall Study||50
10812270|NCT03725722|11974280|FG002|STARTED|Overall Study||50
10812271|NCT03725722|11974281|FG003|STARTED|Overall Study||52
10812272|NCT03725722|11974282|FG004|STARTED|Overall Study||50
10812273|NCT03725722|11974278|FG000|COMPLETED|Overall Study||38
10812274|NCT03725722|11974279|FG001|COMPLETED|Overall Study||44
10812275|NCT03725722|11974280|FG002|COMPLETED|Overall Study||44
10812276|NCT03725722|11974281|FG003|COMPLETED|Overall Study||46
10812277|NCT03725722|11974282|FG004|COMPLETED|Overall Study||36
10812278|NCT03725722|11974278|FG000|NOT COMPLETED|Overall Study||11
10812279|NCT03725722|11974279|FG001|NOT COMPLETED|Overall Study||6
10812280|NCT03725722|11974280|FG002|NOT COMPLETED|Overall Study||6
10812281|NCT03725722|11974281|FG003|NOT COMPLETED|Overall Study||6
10812282|NCT03725722|11974282|FG004|NOT COMPLETED|Overall Study||14
10812283|NCT03725098|11974296|FG000|STARTED|Overall Study||53
10812284|NCT03725098|11974297|FG001|STARTED|Overall Study||52
10812285|NCT03725098|11974296|FG000|COMPLETED|Overall Study||53
10812286|NCT03725098|11974297|FG001|COMPLETED|Overall Study||52
10812287|NCT03725098|11974296|FG000|NOT COMPLETED|Overall Study||0
10812288|NCT03725098|11974297|FG001|NOT COMPLETED|Overall Study||0
10812289|NCT03725085|11974303|FG000|STARTED|Overall Study||552
10812290|NCT03725085|11974303|FG000|COMPLETED|Overall Study||550
10812291|NCT03725085|11974303|FG000|NOT COMPLETED|Overall Study||2
10812292|NCT03725033|11974310|FG000|STARTED|Overall Study||105
10812293|NCT03725033|11974311|FG001|STARTED|Overall Study||97
10812294|NCT03725033|11974310|FG000|COMPLETED|Overall Study||105
10812295|NCT03725033|11974311|FG001|COMPLETED|Overall Study||97
10812296|NCT03725033|11974310|FG000|NOT COMPLETED|Overall Study||0
10812297|NCT03725033|11974311|FG001|NOT COMPLETED|Overall Study||0
10812298|NCT03724981|11974319|FG000|STARTED|First Device||156
10812299|NCT03724981|11974320|FG001|STARTED|First Device||156
10812300|NCT03724981|11974319|FG000|COMPLETED|First Device||155
10812301|NCT03724981|11974320|FG001|COMPLETED|First Device||155
10812302|NCT03724981|11974319|FG000|NOT COMPLETED|First Device||1
10812303|NCT03724981|11974320|FG001|NOT COMPLETED|First Device||1
10812304|NCT03724981|11974319|FG000|STARTED|Second Device||155
10715064|NCT02688387|11880061|FG018|STARTED|Part 2, Period 1 (up to 6 Days)||0
10715065|NCT02688387|11880062|FG019|STARTED|Part 2, Period 1 (up to 6 Days)||0
10715066|NCT02688387|11880063|FG020|STARTED|Part 2, Period 1 (up to 6 Days)||0
10715067|NCT02688387|11880064|FG021|STARTED|Part 2, Period 1 (up to 6 Days)||0
10715068|NCT02688387|11880043|FG000|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10715069|NCT02688387|11880044|FG001|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10715070|NCT02688387|11880045|FG002|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10715071|NCT02688387|11880046|FG003|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10715072|NCT02688387|11880047|FG004|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10715073|NCT02688387|11880048|FG005|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10812305|NCT03724981|11974320|FG001|STARTED|Second Device||155
10812306|NCT03724981|11974319|FG000|COMPLETED|Second Device||155
10812307|NCT03724981|11974320|FG001|COMPLETED|Second Device||155
10812308|NCT03724981|11974319|FG000|NOT COMPLETED|Second Device||0
10812309|NCT03724981|11974320|FG001|NOT COMPLETED|Second Device||0
10812310|NCT03724968|11974330|FG000|STARTED|Overall Study||0
10812311|NCT03724968|11974331|FG001|STARTED|Overall Study||2
10304250|NCT00086580|11437313|FG001|STARTED|Observation Period||121
10304251|NCT00086580|11437312|FG000|COMPLETED|Observation Period||49
10304252|NCT00086580|11437313|FG001|COMPLETED|Observation Period||56
10304253|NCT00086580|11437312|FG000|NOT COMPLETED|Observation Period||46
10304254|NCT00086580|11437313|FG001|NOT COMPLETED|Observation Period||65
10304255|NCT00086619|11437321|FG000|STARTED|Overall Study||40
10304256|NCT00086619|11437322|FG001|STARTED|Overall Study||40
10304257|NCT00086619|11437321|FG000|Completed Baseline Visit|Overall Study||34
10304258|NCT00086619|11437322|FG001|Completed Baseline Visit|Overall Study||36
10304259|NCT00086619|11437321|FG000|Completed 12 Month Visit|Overall Study||26
10304260|NCT00086619|11437322|FG001|Completed 12 Month Visit|Overall Study||26
10304261|NCT00086619|11437321|FG000|COMPLETED|Overall Study||25
10304262|NCT00086619|11437322|FG001|COMPLETED|Overall Study||23
10304263|NCT00086619|11437321|FG000|NOT COMPLETED|Overall Study||15
10304264|NCT00086619|11437322|FG001|NOT COMPLETED|Overall Study||17
10304265|NCT00086684|11437331|FG000|STARTED|Overall Study||118
10304266|NCT00086684|11437332|FG001|STARTED|Overall Study||129
10342029|NCT00389805|11479300|FG000|COMPLETED|Phase II||0
10342030|NCT00389805|11479301|FG001|COMPLETED|Phase II||0
10342031|NCT00389805|11479300|FG000|NOT COMPLETED|Phase II||0
10342032|NCT00389805|11479301|FG001|NOT COMPLETED|Phase II||0
10342033|NCT00389818|11479307|FG000|STARTED|Overall Study||43
10342034|NCT00389818|11479307|FG000|COMPLETED|Overall Study||40
10342035|NCT00389818|11479307|FG000|NOT COMPLETED|Overall Study||3
10342036|NCT00389831|11479313|FG000|STARTED|Overall Study||10
10342037|NCT00389831|11479314|FG001|STARTED|Overall Study||34
10342038|NCT00389831|11479313|FG000|COMPLETED|Overall Study||10
10342039|NCT00389831|11479314|FG001|COMPLETED|Overall Study||27
10342040|NCT00389831|11479313|FG000|NOT COMPLETED|Overall Study||0
10342041|NCT00389831|11479314|FG001|NOT COMPLETED|Overall Study||7
10342042|NCT00389857|11479334|FG000|STARTED|Overall Study||14
10342043|NCT00389857|11479335|FG001|STARTED|Overall Study||17
10342044|NCT00389857|11479334|FG000|COMPLETED|Overall Study||14
10342045|NCT00389857|11479335|FG001|COMPLETED|Overall Study||17
10342046|NCT00389857|11479334|FG000|NOT COMPLETED|Overall Study||0
10342047|NCT00389857|11479335|FG001|NOT COMPLETED|Overall Study||0
10342048|NCT00389974|11479341|FG000|STARTED|Overall Study||19
10342049|NCT00389974|11479341|FG000|COMPLETED|Overall Study||19
10342050|NCT00389974|11479341|FG000|NOT COMPLETED|Overall Study||0
10342051|NCT00390013|11479348|FG000|STARTED|Phase 1||0
10342052|NCT00390013|11479349|FG001|STARTED|Phase 1||0
10342053|NCT00390013|11479350|FG002|STARTED|Phase 1||2
10342054|NCT00390013|11479351|FG003|STARTED|Phase 1||2
10342055|NCT00390013|11479348|FG000|COMPLETED|Phase 1||0
10342056|NCT00390013|11479349|FG001|COMPLETED|Phase 1||0
10342057|NCT00390013|11479350|FG002|COMPLETED|Phase 1||2
10342058|NCT00390013|11479351|FG003|COMPLETED|Phase 1||1
10342059|NCT00390013|11479348|FG000|NOT COMPLETED|Phase 1||0
10342060|NCT00390013|11479349|FG001|NOT COMPLETED|Phase 1||0
10342061|NCT00390013|11479350|FG002|NOT COMPLETED|Phase 1||0
10342062|NCT00390013|11479351|FG003|NOT COMPLETED|Phase 1||1
10342063|NCT00390013|11479348|FG000|STARTED|Phase 2 First Treatment||3
10342064|NCT00390013|11479349|FG001|STARTED|Phase 2 First Treatment||2
10342065|NCT00390013|11479350|FG002|STARTED|Phase 2 First Treatment||0
10342066|NCT00390013|11479351|FG003|STARTED|Phase 2 First Treatment||0
10342067|NCT00390013|11479348|FG000|COMPLETED|Phase 2 First Treatment||2
10342068|NCT00390013|11479349|FG001|COMPLETED|Phase 2 First Treatment||1
10342069|NCT00390013|11479350|FG002|COMPLETED|Phase 2 First Treatment||0
10342070|NCT00390013|11479351|FG003|COMPLETED|Phase 2 First Treatment||0
10342071|NCT00390013|11479348|FG000|NOT COMPLETED|Phase 2 First Treatment||1
10342072|NCT00390013|11479349|FG001|NOT COMPLETED|Phase 2 First Treatment||1
10342073|NCT00390013|11479350|FG002|NOT COMPLETED|Phase 2 First Treatment||0
10304267|NCT00086684|11437333|FG002|STARTED|Overall Study||122
10304268|NCT00086684|11437331|FG000|COMPLETED|Overall Study||63
10304269|NCT00086684|11437332|FG001|COMPLETED|Overall Study||74
10304270|NCT00086684|11437333|FG002|COMPLETED|Overall Study||69
10304271|NCT00086684|11437331|FG000|NOT COMPLETED|Overall Study||55
10304272|NCT00086684|11437332|FG001|NOT COMPLETED|Overall Study||55
10304273|NCT00086684|11437333|FG002|NOT COMPLETED|Overall Study||53
10304274|NCT00086957|11437341|FG000|STARTED|Overall Study||2
10304275|NCT00086957|11437342|FG001|STARTED|Overall Study||7
10342074|NCT00390013|11479351|FG003|NOT COMPLETED|Phase 2 First Treatment||0
10342075|NCT00390013|11479348|FG000|STARTED|Phase 2 Second Treatment||2
10342076|NCT00390013|11479349|FG001|STARTED|Phase 2 Second Treatment||1
10342077|NCT00390013|11479350|FG002|STARTED|Phase 2 Second Treatment||0
10342078|NCT00390013|11479351|FG003|STARTED|Phase 2 Second Treatment||0
10304276|NCT00086957|11437343|FG002|STARTED|Overall Study||22
10342079|NCT00390013|11479348|FG000|COMPLETED|Phase 2 Second Treatment||2
10304277|NCT00086957|11437341|FG000|COMPLETED|Overall Study||2
10304278|NCT00086957|11437342|FG001|COMPLETED|Overall Study||7
10304279|NCT00086957|11437343|FG002|COMPLETED|Overall Study||22
10304280|NCT00086957|11437341|FG000|NOT COMPLETED|Overall Study||0
10304281|NCT00086957|11437342|FG001|NOT COMPLETED|Overall Study||0
10304282|NCT00086957|11437343|FG002|NOT COMPLETED|Overall Study||0
10304283|NCT00086996|11437352|FG000|STARTED|Overall Study||98
10304284|NCT00086996|11437352|FG000|Eligible|Overall Study||93
10304285|NCT00086996|11437352|FG000|Eligible and Began Protocol Therapy|Overall Study||93
10304286|NCT00086996|11437352|FG000|COMPLETED|Overall Study||34
10304287|NCT00086996|11437352|FG000|NOT COMPLETED|Overall Study||64
10304288|NCT00087022|11437358|FG000|STARTED|Overall Study||433
10304289|NCT00087022|11437359|FG001|STARTED|Overall Study||431
10304290|NCT00087022|11437358|FG000|Treated (Safety Population)|Overall Study||431
10304291|NCT00087022|11437359|FG001|Treated (Safety Population)|Overall Study||424
10304292|NCT00087022|11437358|FG000|COMPLETED|Overall Study||379
10304293|NCT00087022|11437359|FG001|COMPLETED|Overall Study||376
10304294|NCT00087022|11437358|FG000|NOT COMPLETED|Overall Study||54
10304295|NCT00087022|11437359|FG001|NOT COMPLETED|Overall Study||55
10304296|NCT00087126|11437365|FG000|STARTED|Overall Study||27
10304297|NCT00087126|11437365|FG000|COMPLETED|Overall Study||25
10304298|NCT00087126|11437365|FG000|NOT COMPLETED|Overall Study||2
10304299|NCT00087139|11437377|FG000|STARTED|Overall Study||39
10304300|NCT00087139|11437378|FG001|STARTED|Overall Study||49
10304301|NCT00087139|11437379|FG002|STARTED|Overall Study||36
10304302|NCT00087139|11437377|FG000|Treated|Overall Study||39
10304303|NCT00087139|11437378|FG001|Treated|Overall Study||48
10304304|NCT00087139|11437379|FG002|Treated|Overall Study||36
10304305|NCT00087139|11437377|FG000|Eligible and Treated|Overall Study||35
10304306|NCT00087139|11437378|FG001|Eligible and Treated|Overall Study||42
10304307|NCT00087139|11437379|FG002|Eligible and Treated|Overall Study||32
10304308|NCT00087139|11437377|FG000|Patients for the Analysis of PSA Respons|Overall Study||30
10304309|NCT00087139|11437378|FG001|Patients for the Analysis of PSA Respons|Overall Study||34
10304310|NCT00087139|11437379|FG002|Patients for the Analysis of PSA Respons|Overall Study||22
10304311|NCT00087139|11437377|FG000|Patients With Measurable Disease|Overall Study||22
10304312|NCT00087139|11437378|FG001|Patients With Measurable Disease|Overall Study||25
10304313|NCT00087139|11437379|FG002|Patients With Measurable Disease|Overall Study||24
10304314|NCT00087139|11437377|FG000|Patients With PSA Response|Overall Study||10
10304315|NCT00087139|11437378|FG001|Patients With PSA Response|Overall Study||8
10304316|NCT00087139|11437379|FG002|Patients With PSA Response|Overall Study||4
10304317|NCT00087139|11437377|FG000|Patients w/ Measurable Disease Response|Overall Study||5
10304318|NCT00087139|11437378|FG001|Patients w/ Measurable Disease Response|Overall Study||2
10304319|NCT00087139|11437379|FG002|Patients w/ Measurable Disease Response|Overall Study||0
10304320|NCT00087139|11437377|FG000|COMPLETED|Overall Study||0
10304321|NCT00087139|11437378|FG001|COMPLETED|Overall Study||0
10304322|NCT00087139|11437379|FG002|COMPLETED|Overall Study||0
10304323|NCT00087139|11437377|FG000|NOT COMPLETED|Overall Study||39
10304324|NCT00087139|11437378|FG001|NOT COMPLETED|Overall Study||49
10304325|NCT00087139|11437379|FG002|NOT COMPLETED|Overall Study||36
10304326|NCT00087152|11437385|FG000|STARTED|Overall Study||27
10304327|NCT00087152|11437385|FG000|COMPLETED|Overall Study||21
10304328|NCT00087152|11437385|FG000|NOT COMPLETED|Overall Study||6
10304329|NCT00087438|11437390|FG000|STARTED|Overall Study||59
10342080|NCT00390013|11479349|FG001|COMPLETED|Phase 2 Second Treatment||1
10342081|NCT00390013|11479350|FG002|COMPLETED|Phase 2 Second Treatment||0
10342082|NCT00390013|11479351|FG003|COMPLETED|Phase 2 Second Treatment||0
10342083|NCT00390013|11479348|FG000|NOT COMPLETED|Phase 2 Second Treatment||0
10342084|NCT00390013|11479349|FG001|NOT COMPLETED|Phase 2 Second Treatment||0
10342085|NCT00390013|11479350|FG002|NOT COMPLETED|Phase 2 Second Treatment||0
10342086|NCT00390013|11479351|FG003|NOT COMPLETED|Phase 2 Second Treatment||0
10342087|NCT00390182|11479357|FG000|STARTED|Overall Study||38
10342088|NCT00390182|11479357|FG000|COMPLETED|Overall Study||33
10342089|NCT00390182|11479357|FG000|NOT COMPLETED|Overall Study||5
10342090|NCT00390221|11479364|FG000|STARTED|Overall Study||204
10342091|NCT00390221|11479365|FG001|STARTED|Overall Study||208
10342092|NCT00390221|11479366|FG002|STARTED|Overall Study||209
10342093|NCT00390221|11479364|FG000|COMPLETED|Overall Study||186
10342094|NCT00390221|11479365|FG001|COMPLETED|Overall Study||188
10342095|NCT00390221|11479366|FG002|COMPLETED|Overall Study||194
10342096|NCT00390221|11479364|FG000|NOT COMPLETED|Overall Study||18
10342097|NCT00390221|11479365|FG001|NOT COMPLETED|Overall Study||20
10342098|NCT00390221|11479366|FG002|NOT COMPLETED|Overall Study||15
10342099|NCT00390234|11479375|FG000|STARTED|Overall Study||63
10342100|NCT00390234|11479375|FG000|COMPLETED|Overall Study||63
10342101|NCT00390234|11479375|FG000|NOT COMPLETED|Overall Study||0
10342102|NCT00390299|11479385|FG000|STARTED|Overall Study||4
10342103|NCT00390299|11479386|FG001|STARTED|Overall Study||3
10342104|NCT00390299|11479387|FG002|STARTED|Overall Study||3
10342105|NCT00390299|11479388|FG003|STARTED|Overall Study||3
10342106|NCT00390299|11479389|FG004|STARTED|Overall Study||10
10342107|NCT00390299|11479385|FG000|COMPLETED|Overall Study||3
10342108|NCT00390299|11479386|FG001|COMPLETED|Overall Study||3
10342109|NCT00390299|11479387|FG002|COMPLETED|Overall Study||3
10342110|NCT00390299|11479388|FG003|COMPLETED|Overall Study||3
10342111|NCT00390299|11479389|FG004|COMPLETED|Overall Study||10
10342112|NCT00390299|11479385|FG000|NOT COMPLETED|Overall Study||1
10342113|NCT00390299|11479386|FG001|NOT COMPLETED|Overall Study||0
10342114|NCT00390299|11479387|FG002|NOT COMPLETED|Overall Study||0
10342115|NCT00390299|11479388|FG003|NOT COMPLETED|Overall Study||0
10342116|NCT00390299|11479389|FG004|NOT COMPLETED|Overall Study||0
10342117|NCT00390364|11479403|FG000|STARTED|Overall Study||1
10342118|NCT00390364|11479403|FG000|COMPLETED|Overall Study||1
10342119|NCT00390364|11479403|FG000|NOT COMPLETED|Overall Study||0
10342120|NCT00390416|11479407|FG000|STARTED|Overall Study||48
10342121|NCT00390416|11479407|FG000|COMPLETED|Overall Study||44
10342122|NCT00390416|11479407|FG000|NOT COMPLETED|Overall Study||4
10342123|NCT00390429|11479414|FG000|STARTED|Overall Study||5
10342124|NCT00390429|11479415|FG001|STARTED|Overall Study||12
10342125|NCT00390429|11479416|FG002|STARTED|Overall Study||25
10342126|NCT00390429|11479417|FG003|STARTED|Overall Study||39
10342127|NCT00390429|11479414|FG000|COMPLETED|Overall Study||5
10342128|NCT00390429|11479415|FG001|COMPLETED|Overall Study||12
10342129|NCT00390429|11479416|FG002|COMPLETED|Overall Study||25
10342130|NCT00390429|11479417|FG003|COMPLETED|Overall Study||39
10530755|NCT01408719|11683192|FG012|COMPLETED|Second Intervention (35 Days)||2
10655101|NCT02207231|11815881|FG001|Treated|Placebo Controlled Period: Week 0 - 16||329
10655102|NCT02207231|11815882|FG002|Treated|Placebo Controlled Period: Week 0 - 16||333
10655103|NCT02207231|11815883|FG003|Treated|Placebo Controlled Period: Week 0 - 16||0
10342131|NCT00390429|11479414|FG000|NOT COMPLETED|Overall Study||0
10342132|NCT00390429|11479415|FG001|NOT COMPLETED|Overall Study||0
10342133|NCT00390429|11479416|FG002|NOT COMPLETED|Overall Study||0
10342134|NCT00390429|11479417|FG003|NOT COMPLETED|Overall Study||0
10655104|NCT02207231|11815880|FG000|COMPLETED|Placebo Controlled Period: Week 0 - 16||167
10655105|NCT02207231|11815881|FG001|COMPLETED|Placebo Controlled Period: Week 0 - 16||322
10342135|NCT00390455|11479430|FG000|STARTED|Overall Study||148
10655106|NCT02207231|11815882|FG002|COMPLETED|Placebo Controlled Period: Week 0 - 16||324
10655107|NCT02207231|11815883|FG003|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
10342136|NCT00390455|11479431|FG001|STARTED|Overall Study||147
10342137|NCT00390455|11479430|FG000|COMPLETED|Overall Study||116
10342138|NCT00390455|11479431|FG001|COMPLETED|Overall Study||124
10304330|NCT00087438|11437390|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|55
10304331|NCT00087438|11437390|FG000|NOT COMPLETED|Overall Study||4
10304332|NCT00087490|11437398|FG000|STARTED|Overall Study||544
10304333|NCT00087490|11437399|FG001|STARTED|Overall Study||533
10304334|NCT00087490|11437398|FG000|Treated|Overall Study||537
10304335|NCT00087490|11437399|FG001|Treated|Overall Study||515
10304336|NCT00087490|11437398|FG000|COMPLETED|Overall Study||286
10304337|NCT00087490|11437399|FG001|COMPLETED|Overall Study||264
10304338|NCT00087490|11437398|FG000|NOT COMPLETED|Overall Study||258
10304339|NCT00087490|11437399|FG001|NOT COMPLETED|Overall Study||269
10304340|NCT00087516|11437408|FG000|STARTED|Overall Study||238
10304341|NCT00087516|11437409|FG001|STARTED|Overall Study||250
10304342|NCT00087516|11437410|FG002|STARTED|Overall Study||130
10304343|NCT00087516|11437411|FG003|STARTED|Overall Study||123
10304344|NCT00087516|11437408|FG000|COMPLETED|Overall Study||77
10304345|NCT00087516|11437409|FG001|COMPLETED|Overall Study||81
10304346|NCT00087516|11437410|FG002|COMPLETED|Overall Study||33
10304347|NCT00087516|11437411|FG003|COMPLETED|Overall Study||38
10304348|NCT00087516|11437408|FG000|NOT COMPLETED|Overall Study||161
10304349|NCT00087516|11437409|FG001|NOT COMPLETED|Overall Study||169
10304350|NCT00087516|11437410|FG002|NOT COMPLETED|Overall Study||97
10304351|NCT00087516|11437411|FG003|NOT COMPLETED|Overall Study||85
10342139|NCT00390455|11479430|FG000|NOT COMPLETED|Overall Study||32
10342140|NCT00390455|11479431|FG001|NOT COMPLETED|Overall Study||23
10342141|NCT00390468|11479437|FG000|STARTED|Overall Study||18
10342142|NCT00390468|11479437|FG000|COMPLETED|Overall Study||15
10342143|NCT00390468|11479437|FG000|NOT COMPLETED|Overall Study||3
10342144|NCT00390546|11479443|FG000|STARTED|Overall Study||33
10342145|NCT00390546|11479444|FG001|STARTED|Overall Study||39
10342146|NCT00390546|11479443|FG000|COMPLETED|Overall Study||27
10342147|NCT00390546|11479444|FG001|COMPLETED|Overall Study||34
10342148|NCT00390546|11479443|FG000|NOT COMPLETED|Overall Study||6
10342149|NCT00390546|11479444|FG001|NOT COMPLETED|Overall Study||5
10342150|NCT00390559|11479451|FG000|STARTED|Overall Study||124
10342151|NCT00390559|11479451|FG000|Received PlaceboP/Active C|Overall Study||93
10342152|NCT00390559|11479451|FG000|ActiveP/ActiveC|Overall Study||87
10342153|NCT00390559|11479451|FG000|PlaceboP/PlaceboC|Overall Study||93
10342154|NCT00390559|11479451|FG000|ActiveP/PlaceboC|Overall Study||90
10342155|NCT00390559|11479451|FG000|COMPLETED|Overall Study||80
10342156|NCT00390559|11479451|FG000|NOT COMPLETED|Overall Study||44
10342157|NCT00390572|11479463|FG000|STARTED|Overall Study||68
10342158|NCT00390572|11479464|FG001|STARTED|Overall Study||69
10342159|NCT00390572|11479463|FG000|COMPLETED|Overall Study||60
10342160|NCT00390572|11479464|FG001|COMPLETED|Overall Study||64
10342161|NCT00390572|11479463|FG000|NOT COMPLETED|Overall Study||8
10342162|NCT00390572|11479464|FG001|NOT COMPLETED|Overall Study||5
10342163|NCT00390611|11479472|FG000|STARTED|6 Cycles of Study Treatment||43
10342164|NCT00390611|11479473|FG001|STARTED|6 Cycles of Study Treatment||42
10342165|NCT00390611|11479472|FG000|COMPLETED|6 Cycles of Study Treatment||34
10342166|NCT00390611|11479473|FG001|COMPLETED|6 Cycles of Study Treatment||37
10342167|NCT00390611|11479472|FG000|NOT COMPLETED|6 Cycles of Study Treatment||9
10342168|NCT00390611|11479473|FG001|NOT COMPLETED|6 Cycles of Study Treatment||5
10342169|NCT00390611|11479472|FG000|STARTED|Maintenance Sorafenib to Month 12|11 patients came off-study between the end of cycle 6 and the start of maintenance|23
10342170|NCT00390611|11479473|FG001|STARTED|Maintenance Sorafenib to Month 12|Patients in the Paclitaxel/carboplatin arm did not recieve maintenance sorafenib|0
10342171|NCT00390611|11479472|FG000|COMPLETED|Maintenance Sorafenib to Month 12||13
10342172|NCT00390611|11479473|FG001|COMPLETED|Maintenance Sorafenib to Month 12||0
10342173|NCT00390611|11479472|FG000|NOT COMPLETED|Maintenance Sorafenib to Month 12||10
10342174|NCT00390611|11479473|FG001|NOT COMPLETED|Maintenance Sorafenib to Month 12||0
10342175|NCT00390689|11479484|FG000|STARTED|Overall Study||48
10342176|NCT00390689|11479485|FG001|STARTED|Overall Study||53
10342177|NCT00390689|11479486|FG002|STARTED|Overall Study||53
10342178|NCT00390689|11479484|FG000|COMPLETED|Overall Study||43
10342179|NCT00390689|11479485|FG001|COMPLETED|Overall Study||48
10530756|NCT01408719|11683193|FG013|COMPLETED|Second Intervention (35 Days)||3
10530757|NCT01408719|11683194|FG014|COMPLETED|Second Intervention (35 Days)||1
10530758|NCT01408719|11683195|FG015|COMPLETED|Second Intervention (35 Days)||2
10530759|NCT01408719|11683196|FG016|COMPLETED|Second Intervention (35 Days)||2
10530760|NCT01408719|11683197|FG017|COMPLETED|Second Intervention (35 Days)||2
10530761|NCT01408719|11683198|FG018|COMPLETED|Second Intervention (35 Days)||0
10530762|NCT01408719|11683199|FG019|COMPLETED|Second Intervention (35 Days)||1
10655108|NCT02207231|11815880|FG000|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||7
10342180|NCT00390689|11479486|FG002|COMPLETED|Overall Study||50
10342181|NCT00390689|11479484|FG000|NOT COMPLETED|Overall Study||5
10304352|NCT00087529|11437427|FG000|STARTED|Overall Study||147
10304353|NCT00087529|11437428|FG001|STARTED|Overall Study||292
10304354|NCT00087529|11437427|FG000|COMPLETED|Overall Study||116
10304355|NCT00087529|11437428|FG001|COMPLETED|Overall Study||224
10304356|NCT00087529|11437427|FG000|NOT COMPLETED|Overall Study||31
10304357|NCT00087529|11437428|FG001|NOT COMPLETED|Overall Study||68
10304358|NCT00087555|11437437|FG000|STARTED|Overall Study||66
10715074|NCT02688387|11880049|FG006|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10715075|NCT02688387|11880050|FG007|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10715076|NCT02688387|11880051|FG008|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10715077|NCT02688387|11880052|FG009|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10715078|NCT02688387|11880053|FG010|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
10715079|NCT02688387|11880054|FG011|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
10715080|NCT02688387|11880055|FG012|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
10715081|NCT02688387|11880056|FG013|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
10715082|NCT02688387|11880057|FG014|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10715083|NCT02688387|11880058|FG015|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10715084|NCT02688387|11880059|FG016|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10715085|NCT02688387|11880060|FG017|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10715086|NCT02688387|11880061|FG018|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10715087|NCT02688387|11880062|FG019|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10715088|NCT02688387|11880063|FG020|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10304359|NCT00087555|11437438|FG001|STARTED|Overall Study||62
10304360|NCT00087555|11437439|FG002|STARTED|Overall Study||67
10304361|NCT00087555|11437437|FG000|Treated|Overall Study||65
10304362|NCT00087555|11437438|FG001|Treated|Overall Study||60
10304363|NCT00087555|11437439|FG002|Treated|Overall Study||67
10304364|NCT00087555|11437437|FG000|COMPLETED|Overall Study||54
10304365|NCT00087555|11437438|FG001|COMPLETED|Overall Study||51
10304366|NCT00087555|11437439|FG002|COMPLETED|Overall Study||46
10304367|NCT00087555|11437437|FG000|NOT COMPLETED|Overall Study||12
10715089|NCT02688387|11880064|FG021|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10715090|NCT02688387|11880043|FG000|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10304368|NCT00087555|11437438|FG001|NOT COMPLETED|Overall Study||11
10342182|NCT00390689|11479485|FG001|NOT COMPLETED|Overall Study||5
10342183|NCT00390689|11479486|FG002|NOT COMPLETED|Overall Study||3
10342184|NCT00390780|11479505|FG000|STARTED|Overall Study||291
10342185|NCT00390780|11479506|FG001|STARTED|Overall Study||287
10342186|NCT00390780|11479505|FG000|Treatment|Overall Study|One patient randomized to miconazole lost study drug, never started treatment, and was discontinued.|290
10342187|NCT00390780|11479506|FG001|Treatment|Overall Study||287
10342188|NCT00390780|11479505|FG000|COMPLETED|Overall Study||268
10715091|NCT02688387|11880044|FG001|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10304369|NCT00087555|11437439|FG002|NOT COMPLETED|Overall Study||21
10304370|NCT00087568|11437449|FG000|STARTED|Overall Study||32
10715092|NCT02688387|11880045|FG002|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10304371|NCT00087568|11437450|FG001|STARTED|Overall Study||25
10304372|NCT00087568|11437449|FG000|COMPLETED|Overall Study||2
10304373|NCT00087568|11437450|FG001|COMPLETED|Overall Study||23
10304374|NCT00087568|11437449|FG000|NOT COMPLETED|Overall Study||30
10304375|NCT00087568|11437450|FG001|NOT COMPLETED|Overall Study||2
10304376|NCT00087594|11437458|FG000|STARTED|Overall Study||24
10304377|NCT00087594|11437459|FG001|STARTED|Overall Study||24
10304378|NCT00087594|11437458|FG000|COMPLETED|Overall Study||16
10304379|NCT00087594|11437459|FG001|COMPLETED|Overall Study||12
10304380|NCT00087594|11437458|FG000|NOT COMPLETED|Overall Study||8
10304381|NCT00087594|11437459|FG001|NOT COMPLETED|Overall Study||12
10304382|NCT00087607|11437467|FG000|STARTED|Overall Study||192
10304383|NCT00087607|11437468|FG001|STARTED|Overall Study||193
10304384|NCT00087607|11437467|FG000|COMPLETED|Overall Study||70
10342189|NCT00390780|11479506|FG001|COMPLETED|Overall Study||260
10342190|NCT00390780|11479505|FG000|NOT COMPLETED|Overall Study||23
10342191|NCT00390780|11479506|FG001|NOT COMPLETED|Overall Study||27
10342192|NCT00390806|11479514|FG000|STARTED|Overall Study||236
10342193|NCT00390806|11479515|FG001|STARTED|Overall Study||236
10342194|NCT00390806|11479514|FG000|Ongoing|Overall Study||4
10342195|NCT00390806|11479515|FG001|Ongoing|Overall Study||2
10342196|NCT00390806|11479514|FG000|COMPLETED|Overall Study||206
10342197|NCT00390806|11479515|FG001|COMPLETED|Overall Study||204
10342198|NCT00390806|11479514|FG000|NOT COMPLETED|Overall Study||30
10342199|NCT00390806|11479515|FG001|NOT COMPLETED|Overall Study||32
10342200|NCT00390858|11479523|FG000|STARTED|Overall Study|20 participants started the Core Study|20
10342201|NCT00390858|11479524|FG001|STARTED|Overall Study|20 Participants started the Core Study|20
10342202|NCT00390858|11479523|FG000|Completed Core & Entered Extension Study|Overall Study||19
10342203|NCT00390858|11479524|FG001|Completed Core & Entered Extension Study|Overall Study||20
10342204|NCT00390858|11479523|FG000|COMPLETED|Overall Study|11 participants Completed the Extension Study|11
10342205|NCT00390858|11479524|FG001|COMPLETED|Overall Study|13 Participants completed the Extension Study|13
10342206|NCT00390858|11479523|FG000|NOT COMPLETED|Overall Study||9
10342207|NCT00390858|11479524|FG001|NOT COMPLETED|Overall Study||7
10342208|NCT00390884|11479532|FG000|STARTED|Overall Study||116
10342209|NCT00390884|11479533|FG001|STARTED|Overall Study||57
10342210|NCT00390884|11479532|FG000|COMPLETED|Overall Study||114
10342211|NCT00390884|11479533|FG001|COMPLETED|Overall Study||55
10342212|NCT00390884|11479532|FG000|NOT COMPLETED|Overall Study||2
10342213|NCT00390884|11479533|FG001|NOT COMPLETED|Overall Study||2
10342214|NCT00390910|11479542|FG000|STARTED|Overall Study||50
10342215|NCT00390910|11479543|FG001|STARTED|Overall Study||87
10342216|NCT00390910|11479544|FG002|STARTED|Overall Study||149
10342217|NCT00390910|11479542|FG000|COMPLETED|Overall Study||48
10342218|NCT00390910|11479543|FG001|COMPLETED|Overall Study||83
10342219|NCT00390910|11479544|FG002|COMPLETED|Overall Study||139
10342220|NCT00390910|11479542|FG000|NOT COMPLETED|Overall Study||2
10342221|NCT00390910|11479543|FG001|NOT COMPLETED|Overall Study||4
10342222|NCT00390910|11479544|FG002|NOT COMPLETED|Overall Study||10
10342223|NCT00390949|11479556|FG000|STARTED|Overall Study||4662
10342224|NCT00390949|11479557|FG001|STARTED|Overall Study||4792
10342225|NCT00390949|11479556|FG000|COMPLETED|Overall Study||2564
10342226|NCT00390949|11479557|FG001|COMPLETED|Overall Study||2664
10342227|NCT00390949|11479556|FG000|NOT COMPLETED|Overall Study||2098
10342228|NCT00390949|11479557|FG001|NOT COMPLETED|Overall Study||2128
10342229|NCT00391027|11479565|FG000|STARTED|Overall Study|Full Analysis Set = 134; 1 subject excluded; missing a baseline or postbaseline HbA1c measurement.|135
10342230|NCT00391027|11479566|FG001|STARTED|Overall Study|Full Analysis Set = 121; 1 subject excluded; missing a baseline or postbaseline HbA1c measurement.|122
10342231|NCT00391027|11479565|FG000|COMPLETED|Overall Study||110
10342232|NCT00391027|11479566|FG001|COMPLETED|Overall Study||110
10342233|NCT00391027|11479565|FG000|NOT COMPLETED|Overall Study||25
10342234|NCT00391027|11479566|FG001|NOT COMPLETED|Overall Study||12
10342235|NCT00391053|11479576|FG000|STARTED|Overall Study||857
10715093|NCT02688387|11880046|FG003|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10715094|NCT02688387|11880047|FG004|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10715095|NCT02688387|11880048|FG005|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10715096|NCT02688387|11880049|FG006|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10715097|NCT02688387|11880050|FG007|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10715098|NCT02688387|11880051|FG008|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10715099|NCT02688387|11880052|FG009|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10715100|NCT02688387|11880053|FG010|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||1
10715101|NCT02688387|11880054|FG011|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10715102|NCT02688387|11880055|FG012|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10715103|NCT02688387|11880056|FG013|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10715104|NCT02688387|11880057|FG014|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10715105|NCT02688387|11880058|FG015|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10715106|NCT02688387|11880059|FG016|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10715107|NCT02688387|11880060|FG017|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10715108|NCT02688387|11880061|FG018|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10715109|NCT02688387|11880062|FG019|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10715110|NCT02688387|11880063|FG020|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10715111|NCT02688387|11880064|FG021|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
10715112|NCT02688387|11880043|FG000|STARTED|Part 2, Washout Period 1 (10 Days)||0
10342236|NCT00391053|11479577|FG001|STARTED|Overall Study||848
10342237|NCT00391053|11479578|FG002|STARTED|Overall Study||870
10715113|NCT02688387|11880044|FG001|STARTED|Part 2, Washout Period 1 (10 Days)||0
10715114|NCT02688387|11880045|FG002|STARTED|Part 2, Washout Period 1 (10 Days)||0
10715115|NCT02688387|11880046|FG003|STARTED|Part 2, Washout Period 1 (10 Days)||0
10715116|NCT02688387|11880047|FG004|STARTED|Part 2, Washout Period 1 (10 Days)||0
10715117|NCT02688387|11880048|FG005|STARTED|Part 2, Washout Period 1 (10 Days)||0
10715118|NCT02688387|11880049|FG006|STARTED|Part 2, Washout Period 1 (10 Days)||0
10715119|NCT02688387|11880050|FG007|STARTED|Part 2, Washout Period 1 (10 Days)||0
10715120|NCT02688387|11880051|FG008|STARTED|Part 2, Washout Period 1 (10 Days)||0
10715121|NCT02688387|11880052|FG009|STARTED|Part 2, Washout Period 1 (10 Days)||0
10715122|NCT02688387|11880053|FG010|STARTED|Part 2, Washout Period 1 (10 Days)||5
10715123|NCT02688387|11880054|FG011|STARTED|Part 2, Washout Period 1 (10 Days)||5
10715124|NCT02688387|11880055|FG012|STARTED|Part 2, Washout Period 1 (10 Days)||5
10715125|NCT02688387|11880056|FG013|STARTED|Part 2, Washout Period 1 (10 Days)||5
10715126|NCT02688387|11880057|FG014|STARTED|Part 2, Washout Period 1 (10 Days)||0
10715127|NCT02688387|11880058|FG015|STARTED|Part 2, Washout Period 1 (10 Days)||0
10715128|NCT02688387|11880059|FG016|STARTED|Part 2, Washout Period 1 (10 Days)||0
10715129|NCT02688387|11880060|FG017|STARTED|Part 2, Washout Period 1 (10 Days)||0
10715130|NCT02688387|11880061|FG018|STARTED|Part 2, Washout Period 1 (10 Days)||0
10715131|NCT02688387|11880062|FG019|STARTED|Part 2, Washout Period 1 (10 Days)||0
10715132|NCT02688387|11880063|FG020|STARTED|Part 2, Washout Period 1 (10 Days)||0
10715133|NCT02688387|11880064|FG021|STARTED|Part 2, Washout Period 1 (10 Days)||0
10715134|NCT02688387|11880043|FG000|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10715135|NCT02688387|11880044|FG001|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10715136|NCT02688387|11880045|FG002|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10715137|NCT02688387|11880046|FG003|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10715138|NCT02688387|11880047|FG004|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10715139|NCT02688387|11880048|FG005|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10715140|NCT02688387|11880049|FG006|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10715141|NCT02688387|11880050|FG007|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10715142|NCT02688387|11880051|FG008|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10715143|NCT02688387|11880052|FG009|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10715144|NCT02688387|11880053|FG010|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
10715145|NCT02688387|11880054|FG011|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
10715146|NCT02688387|11880055|FG012|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
10715147|NCT02688387|11880056|FG013|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
10715148|NCT02688387|11880057|FG014|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10715149|NCT02688387|11880058|FG015|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10715150|NCT02688387|11880059|FG016|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10715151|NCT02688387|11880060|FG017|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10715152|NCT02688387|11880061|FG018|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10715153|NCT02688387|11880062|FG019|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10715154|NCT02688387|11880063|FG020|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10715155|NCT02688387|11880064|FG021|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10715156|NCT02688387|11880043|FG000|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10715157|NCT02688387|11880044|FG001|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10715158|NCT02688387|11880045|FG002|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10715159|NCT02688387|11880046|FG003|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10715160|NCT02688387|11880047|FG004|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10715161|NCT02688387|11880048|FG005|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10715162|NCT02688387|11880049|FG006|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10715163|NCT02688387|11880050|FG007|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10715164|NCT02688387|11880051|FG008|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10715165|NCT02688387|11880052|FG009|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10715166|NCT02688387|11880053|FG010|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10715167|NCT02688387|11880054|FG011|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10715168|NCT02688387|11880055|FG012|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10715169|NCT02688387|11880056|FG013|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10715170|NCT02688387|11880057|FG014|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10715171|NCT02688387|11880058|FG015|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10715172|NCT02688387|11880059|FG016|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10715173|NCT02688387|11880060|FG017|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10304385|NCT00087607|11437468|FG001|COMPLETED|Overall Study||71
10304386|NCT00087607|11437467|FG000|NOT COMPLETED|Overall Study||122
10304387|NCT00087607|11437468|FG001|NOT COMPLETED|Overall Study||122
10304388|NCT00087633|11437480|FG000|STARTED|Overall Study|Randomized|55
10304389|NCT00087633|11437481|FG001|STARTED|Overall Study|Randomized|60
10304390|NCT00087633|11437480|FG000|COMPLETED|Overall Study|Completed 48 weeks of treatment/observation|31
10304391|NCT00087633|11437481|FG001|COMPLETED|Overall Study|Completed 48 weeks of treatment/observation|43
10304392|NCT00087633|11437480|FG000|NOT COMPLETED|Overall Study||24
10304393|NCT00087633|11437481|FG001|NOT COMPLETED|Overall Study||17
10304394|NCT00087646|11437491|FG000|STARTED|Overall Study||317
10342238|NCT00391053|11479579|FG003|STARTED|Overall Study||1262
10342239|NCT00391053|11479576|FG000|COMPLETED|Overall Study||848
10342240|NCT00391053|11479577|FG001|COMPLETED|Overall Study||847
10342241|NCT00391053|11479578|FG002|COMPLETED|Overall Study||868
10715174|NCT02688387|11880061|FG018|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10715175|NCT02688387|11880062|FG019|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10715176|NCT02688387|11880063|FG020|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10715177|NCT02688387|11880064|FG021|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
10715178|NCT02688387|11880043|FG000|STARTED|Part 2, Period 2 (up to 6 Days)||0
10715179|NCT02688387|11880044|FG001|STARTED|Part 2, Period 2 (up to 6 Days)||0
10715180|NCT02688387|11880045|FG002|STARTED|Part 2, Period 2 (up to 6 Days)||0
10715181|NCT02688387|11880046|FG003|STARTED|Part 2, Period 2 (up to 6 Days)||0
10715182|NCT02688387|11880047|FG004|STARTED|Part 2, Period 2 (up to 6 Days)||0
10715183|NCT02688387|11880048|FG005|STARTED|Part 2, Period 2 (up to 6 Days)||0
10715184|NCT02688387|11880049|FG006|STARTED|Part 2, Period 2 (up to 6 Days)||0
10715185|NCT02688387|11880050|FG007|STARTED|Part 2, Period 2 (up to 6 Days)||0
10715186|NCT02688387|11880051|FG008|STARTED|Part 2, Period 2 (up to 6 Days)||0
10715187|NCT02688387|11880052|FG009|STARTED|Part 2, Period 2 (up to 6 Days)||0
10715188|NCT02688387|11880053|FG010|STARTED|Part 2, Period 2 (up to 6 Days)||5
10715189|NCT02688387|11880054|FG011|STARTED|Part 2, Period 2 (up to 6 Days)||5
10715190|NCT02688387|11880055|FG012|STARTED|Part 2, Period 2 (up to 6 Days)||5
10715191|NCT02688387|11880056|FG013|STARTED|Part 2, Period 2 (up to 6 Days)||5
10715192|NCT02688387|11880057|FG014|STARTED|Part 2, Period 2 (up to 6 Days)||0
10715193|NCT02688387|11880058|FG015|STARTED|Part 2, Period 2 (up to 6 Days)||0
10715194|NCT02688387|11880059|FG016|STARTED|Part 2, Period 2 (up to 6 Days)||0
10715195|NCT02688387|11880060|FG017|STARTED|Part 2, Period 2 (up to 6 Days)||0
10715196|NCT02688387|11880061|FG018|STARTED|Part 2, Period 2 (up to 6 Days)||0
10715197|NCT02688387|11880062|FG019|STARTED|Part 2, Period 2 (up to 6 Days)||0
10715198|NCT02688387|11880063|FG020|STARTED|Part 2, Period 2 (up to 6 Days)||0
10715199|NCT02688387|11880064|FG021|STARTED|Part 2, Period 2 (up to 6 Days)||0
10715200|NCT02688387|11880043|FG000|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10715201|NCT02688387|11880044|FG001|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10715202|NCT02688387|11880045|FG002|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10715203|NCT02688387|11880046|FG003|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10715204|NCT02688387|11880047|FG004|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10715205|NCT02688387|11880048|FG005|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10715206|NCT02688387|11880049|FG006|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10715207|NCT02688387|11880050|FG007|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10715208|NCT02688387|11880051|FG008|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10715209|NCT02688387|11880052|FG009|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10715210|NCT02688387|11880053|FG010|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
10715211|NCT02688387|11880054|FG011|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
10715212|NCT02688387|11880055|FG012|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
10715213|NCT02688387|11880056|FG013|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
10715214|NCT02688387|11880057|FG014|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10715215|NCT02688387|11880058|FG015|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10715216|NCT02688387|11880059|FG016|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10715217|NCT02688387|11880060|FG017|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10715218|NCT02688387|11880061|FG018|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10715219|NCT02688387|11880062|FG019|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10715220|NCT02688387|11880063|FG020|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10715221|NCT02688387|11880064|FG021|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10715222|NCT02688387|11880043|FG000|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10715223|NCT02688387|11880044|FG001|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10715224|NCT02688387|11880045|FG002|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10715225|NCT02688387|11880046|FG003|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10715226|NCT02688387|11880047|FG004|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10715227|NCT02688387|11880048|FG005|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10715228|NCT02688387|11880049|FG006|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10715229|NCT02688387|11880050|FG007|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10715230|NCT02688387|11880051|FG008|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10715231|NCT02688387|11880052|FG009|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10715232|NCT02688387|11880053|FG010|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10715233|NCT02688387|11880054|FG011|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10715234|NCT02688387|11880055|FG012|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10715235|NCT02688387|11880056|FG013|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10715236|NCT02688387|11880057|FG014|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10715237|NCT02688387|11880058|FG015|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10715238|NCT02688387|11880059|FG016|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10715239|NCT02688387|11880060|FG017|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10715240|NCT02688387|11880061|FG018|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10715241|NCT02688387|11880062|FG019|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10715242|NCT02688387|11880063|FG020|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10715243|NCT02688387|11880064|FG021|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
10715244|NCT02688387|11880043|FG000|STARTED|Part 2, Washout Period 2 (10 Days)||0
10715245|NCT02688387|11880044|FG001|STARTED|Part 2, Washout Period 2 (10 Days)||0
10715246|NCT02688387|11880045|FG002|STARTED|Part 2, Washout Period 2 (10 Days)||0
10715247|NCT02688387|11880046|FG003|STARTED|Part 2, Washout Period 2 (10 Days)||0
10715248|NCT02688387|11880047|FG004|STARTED|Part 2, Washout Period 2 (10 Days)||0
10715249|NCT02688387|11880048|FG005|STARTED|Part 2, Washout Period 2 (10 Days)||0
10715250|NCT02688387|11880049|FG006|STARTED|Part 2, Washout Period 2 (10 Days)||0
10715251|NCT02688387|11880050|FG007|STARTED|Part 2, Washout Period 2 (10 Days)||0
10715252|NCT02688387|11880051|FG008|STARTED|Part 2, Washout Period 2 (10 Days)||0
10715253|NCT02688387|11880052|FG009|STARTED|Part 2, Washout Period 2 (10 Days)||0
10715254|NCT02688387|11880053|FG010|STARTED|Part 2, Washout Period 2 (10 Days)||5
10715255|NCT02688387|11880054|FG011|STARTED|Part 2, Washout Period 2 (10 Days)||5
10715256|NCT02688387|11880055|FG012|STARTED|Part 2, Washout Period 2 (10 Days)||5
10715257|NCT02688387|11880056|FG013|STARTED|Part 2, Washout Period 2 (10 Days)||5
10715258|NCT02688387|11880057|FG014|STARTED|Part 2, Washout Period 2 (10 Days)||0
10715259|NCT02688387|11880058|FG015|STARTED|Part 2, Washout Period 2 (10 Days)||0
10715260|NCT02688387|11880059|FG016|STARTED|Part 2, Washout Period 2 (10 Days)||0
10715261|NCT02688387|11880060|FG017|STARTED|Part 2, Washout Period 2 (10 Days)||0
10715262|NCT02688387|11880061|FG018|STARTED|Part 2, Washout Period 2 (10 Days)||0
10715263|NCT02688387|11880062|FG019|STARTED|Part 2, Washout Period 2 (10 Days)||0
10715264|NCT02688387|11880063|FG020|STARTED|Part 2, Washout Period 2 (10 Days)||0
10715265|NCT02688387|11880064|FG021|STARTED|Part 2, Washout Period 2 (10 Days)||0
10715266|NCT02688387|11880043|FG000|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10715267|NCT02688387|11880044|FG001|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10715268|NCT02688387|11880045|FG002|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10715269|NCT02688387|11880046|FG003|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10715270|NCT02688387|11880047|FG004|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10715271|NCT02688387|11880048|FG005|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10715272|NCT02688387|11880049|FG006|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10715273|NCT02688387|11880050|FG007|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10715274|NCT02688387|11880051|FG008|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10715275|NCT02688387|11880052|FG009|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10715276|NCT02688387|11880053|FG010|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
10715277|NCT02688387|11880054|FG011|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
10715278|NCT02688387|11880055|FG012|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
10715279|NCT02688387|11880056|FG013|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
10715280|NCT02688387|11880057|FG014|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10715281|NCT02688387|11880058|FG015|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10715282|NCT02688387|11880059|FG016|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10715283|NCT02688387|11880060|FG017|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10715284|NCT02688387|11880061|FG018|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10715285|NCT02688387|11880062|FG019|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10715286|NCT02688387|11880063|FG020|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10304395|NCT00087646|11437492|FG001|STARTED|Overall Study||156
10304396|NCT00087646|11437493|FG002|STARTED|Overall Study||156
10304397|NCT00087646|11437494|FG003|STARTED|Overall Study||313
10304398|NCT00087646|11437491|FG000|COMPLETED|Overall Study||182
10304399|NCT00087646|11437492|FG001|COMPLETED|Overall Study||114
10304400|NCT00087646|11437493|FG002|COMPLETED|Overall Study||91
10304401|NCT00087646|11437494|FG003|COMPLETED|Overall Study||229
10304402|NCT00087646|11437491|FG000|NOT COMPLETED|Overall Study||135
10304403|NCT00087646|11437492|FG001|NOT COMPLETED|Overall Study||42
10304404|NCT00087646|11437493|FG002|NOT COMPLETED|Overall Study||65
10304405|NCT00087646|11437494|FG003|NOT COMPLETED|Overall Study||84
10304406|NCT00087672|11437509|FG000|STARTED|Overall Study||41
10304407|NCT00087672|11437509|FG000|COMPLETED|Overall Study||41
10304408|NCT00087672|11437509|FG000|NOT COMPLETED|Overall Study||0
10304409|NCT00087685|11437513|FG000|STARTED|Overall Study||35
10304410|NCT00087685|11437513|FG000|COMPLETED|Overall Study||21
10304411|NCT00087685|11437513|FG000|NOT COMPLETED|Overall Study||14
10304412|NCT00087698|11437517|FG000|STARTED|Overall Study||77
10304413|NCT00087698|11437517|FG000|COMPLETED|Overall Study||41
10304414|NCT00087698|11437517|FG000|NOT COMPLETED|Overall Study||36
10304415|NCT00088153|11437523|FG000|STARTED|Overall Study||55
10304416|NCT00088153|11437524|FG001|STARTED|Overall Study||55
10304417|NCT00088153|11437523|FG000|COMPLETED|Overall Study||31
10304418|NCT00088153|11437524|FG001|COMPLETED|Overall Study||30
10304419|NCT00088153|11437523|FG000|NOT COMPLETED|Overall Study||24
10304420|NCT00088153|11437524|FG001|NOT COMPLETED|Overall Study||25
10304421|NCT00088166|11437532|FG000|STARTED|Overall Study||100
10304422|NCT00088166|11437533|FG001|STARTED|Overall Study||100
10304423|NCT00088166|11437532|FG000|COMPLETED|Overall Study||47
10304424|NCT00088166|11437533|FG001|COMPLETED|Overall Study||39
10304425|NCT00088166|11437532|FG000|NOT COMPLETED|Overall Study||53
10715287|NCT02688387|11880064|FG021|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10715288|NCT02688387|11880043|FG000|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10715289|NCT02688387|11880044|FG001|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10715290|NCT02688387|11880045|FG002|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10304426|NCT00088166|11437533|FG001|NOT COMPLETED|Overall Study||61
10304427|NCT00088205|11437539|FG000|STARTED|Overall Study||60
10304428|NCT00088205|11437539|FG000|Received at Least 1 Dose of Study Drug|Overall Study||60
10304429|NCT00088205|11437539|FG000|Efficacy Population|Overall Study|Participants with diagnosis of relapsed mantle cell lymphoma.|59
10304430|NCT00088205|11437539|FG000|COMPLETED|Overall Study||0
10304431|NCT00088205|11437539|FG000|NOT COMPLETED|Overall Study||60
10304432|NCT00088218|11437545|FG000|STARTED|Overall Study||16
10304433|NCT00088218|11437546|FG001|STARTED|Overall Study||79
10304434|NCT00088218|11437545|FG000|COMPLETED|Overall Study||16
10715291|NCT02688387|11880046|FG003|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10715292|NCT02688387|11880047|FG004|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10715293|NCT02688387|11880048|FG005|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10715294|NCT02688387|11880049|FG006|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10715295|NCT02688387|11880050|FG007|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10715296|NCT02688387|11880051|FG008|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10715297|NCT02688387|11880052|FG009|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10715298|NCT02688387|11880053|FG010|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10715299|NCT02688387|11880054|FG011|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10715300|NCT02688387|11880055|FG012|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10715301|NCT02688387|11880056|FG013|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10715302|NCT02688387|11880057|FG014|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10715303|NCT02688387|11880058|FG015|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10715304|NCT02688387|11880059|FG016|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10812312|NCT03724968|11974330|FG000|COMPLETED|Overall Study||0
10812313|NCT03724968|11974331|FG001|COMPLETED|Overall Study||0
10715305|NCT02688387|11880060|FG017|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10715306|NCT02688387|11880061|FG018|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10812314|NCT03724968|11974330|FG000|NOT COMPLETED|Overall Study||0
10812315|NCT03724968|11974331|FG001|NOT COMPLETED|Overall Study||2
10812316|NCT03724877|11974339|FG000|STARTED|Overall Study||6921
10812317|NCT03724877|11974340|FG001|STARTED|Overall Study||1932
10812318|NCT03724877|11974339|FG000|COMPLETED|Overall Study||6921
10812319|NCT03724877|11974340|FG001|COMPLETED|Overall Study||1932
10812320|NCT03724877|11974339|FG000|NOT COMPLETED|Overall Study||0
10812321|NCT03724877|11974340|FG001|NOT COMPLETED|Overall Study||0
10812322|NCT03724253|11974351|FG000|STARTED|Overall Study||5
10812323|NCT03724253|11974352|FG001|STARTED|Overall Study||5
10812324|NCT03724253|11974353|FG002|STARTED|Overall Study||5
10812325|NCT03724253|11974354|FG003|STARTED|Overall Study||3
10812326|NCT03724253|11974355|FG004|STARTED|Overall Study||1
10304435|NCT00088218|11437546|FG001|COMPLETED|Overall Study||79
10304436|NCT00088218|11437545|FG000|NOT COMPLETED|Overall Study||0
10304437|NCT00088218|11437546|FG001|NOT COMPLETED|Overall Study||0
10304438|NCT00088374|11437552|FG000|STARTED|Overall Study||9
10304439|NCT00088374|11437552|FG000|COMPLETED|Overall Study||7
10304440|NCT00088374|11437552|FG000|NOT COMPLETED|Overall Study||2
10304441|NCT00088413|11437560|FG000|STARTED|Overall Study||10
10304442|NCT00088413|11437561|FG001|STARTED|Overall Study||15
10304443|NCT00088413|11437562|FG002|STARTED|Overall Study||12
10304444|NCT00088413|11437563|FG003|STARTED|Overall Study||14
10304445|NCT00088413|11437560|FG000|COMPLETED|Overall Study||0
10304446|NCT00088413|11437561|FG001|COMPLETED|Overall Study||0
10304447|NCT00088413|11437562|FG002|COMPLETED|Overall Study||0
10342242|NCT00391053|11479579|FG003|COMPLETED|Overall Study||1252
10342243|NCT00391053|11479576|FG000|NOT COMPLETED|Overall Study||9
10342244|NCT00391053|11479577|FG001|NOT COMPLETED|Overall Study||1
10342245|NCT00391053|11479578|FG002|NOT COMPLETED|Overall Study||2
10342246|NCT00391053|11479579|FG003|NOT COMPLETED|Overall Study||10
10342247|NCT00391079|11479591|FG000|STARTED|Overall Study||167
10342248|NCT00391079|11479592|FG001|STARTED|Overall Study||172
10342249|NCT00391079|11479591|FG000|COMPLETED|Overall Study||141
10342250|NCT00391079|11479592|FG001|COMPLETED|Overall Study||156
10342251|NCT00391079|11479591|FG000|NOT COMPLETED|Overall Study||26
10342252|NCT00391079|11479592|FG001|NOT COMPLETED|Overall Study||16
10342253|NCT00391092|11479600|FG000|STARTED|Overall Study||208
10342254|NCT00391092|11479601|FG001|STARTED|Overall Study||216
10342255|NCT00391092|11479600|FG000|Received Treatment|Overall Study||206
10342256|NCT00391092|11479601|FG001|Received Treatment|Overall Study||215
10342257|NCT00391092|11479600|FG000|COMPLETED|Overall Study|This was using a data cutoff of 30 June 2011.|0
10342258|NCT00391092|11479601|FG001|COMPLETED|Overall Study|This was using a data cutoff of 30 June 2011.|0
10342259|NCT00391092|11479600|FG000|NOT COMPLETED|Overall Study||208
10342260|NCT00391092|11479601|FG001|NOT COMPLETED|Overall Study||216
10342261|NCT00391118|11479610|FG000|STARTED|Overall Study||11
10342262|NCT00391118|11479611|FG001|STARTED|Overall Study||69
10342263|NCT00391118|11479612|FG002|STARTED|Overall Study||73
10342264|NCT00391118|11479610|FG000|Received ≥1 Dose of Assigned Study Drug|Overall Study||11
10342265|NCT00391118|11479611|FG001|Received ≥1 Dose of Assigned Study Drug|Overall Study||67
10342266|NCT00391118|11479612|FG002|Received ≥1 Dose of Assigned Study Drug|Overall Study||72
10342267|NCT00391118|11479610|FG000|COMPLETED|Overall Study||0
10715307|NCT02688387|11880062|FG019|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10715308|NCT02688387|11880063|FG020|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10715309|NCT02688387|11880064|FG021|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
10715310|NCT02688387|11880043|FG000|STARTED|Part 2, Period 3 (up to 6 Days)||0
10715311|NCT02688387|11880044|FG001|STARTED|Part 2, Period 3 (up to 6 Days)||0
10715312|NCT02688387|11880045|FG002|STARTED|Part 2, Period 3 (up to 6 Days)||0
10715313|NCT02688387|11880046|FG003|STARTED|Part 2, Period 3 (up to 6 Days)||0
10715314|NCT02688387|11880047|FG004|STARTED|Part 2, Period 3 (up to 6 Days)||0
10715315|NCT02688387|11880048|FG005|STARTED|Part 2, Period 3 (up to 6 Days)||0
10715316|NCT02688387|11880049|FG006|STARTED|Part 2, Period 3 (up to 6 Days)||0
10715317|NCT02688387|11880050|FG007|STARTED|Part 2, Period 3 (up to 6 Days)||0
10715318|NCT02688387|11880051|FG008|STARTED|Part 2, Period 3 (up to 6 Days)||0
10342268|NCT00391118|11479611|FG001|COMPLETED|Overall Study||14
10342269|NCT00391118|11479612|FG002|COMPLETED|Overall Study||15
10342270|NCT00391118|11479610|FG000|NOT COMPLETED|Overall Study||11
10342271|NCT00391118|11479611|FG001|NOT COMPLETED|Overall Study||55
10342272|NCT00391118|11479612|FG002|NOT COMPLETED|Overall Study||58
10342273|NCT00391222|11479626|FG000|STARTED|Period II (Open-label Risperidone LAI)||0
10342274|NCT00391222|11479627|FG001|STARTED|Period II (Open-label Risperidone LAI)||0
10342275|NCT00391222|11479628|FG002|STARTED|Period II (Open-label Risperidone LAI)||0
10342276|NCT00391222|11479629|FG003|STARTED|Period II (Open-label Risperidone LAI)|The 25 patients at the site of Dr. Parikh were excluded from the analysis due to GCP non-compliance|560
10342277|NCT00391222|11479626|FG000|COMPLETED|Period II (Open-label Risperidone LAI)||0
10342278|NCT00391222|11479627|FG001|COMPLETED|Period II (Open-label Risperidone LAI)||0
10342279|NCT00391222|11479628|FG002|COMPLETED|Period II (Open-label Risperidone LAI)||0
10342280|NCT00391222|11479629|FG003|COMPLETED|Period II (Open-label Risperidone LAI)||398
10342281|NCT00391222|11479626|FG000|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
10715319|NCT02688387|11880052|FG009|STARTED|Part 2, Period 3 (up to 6 Days)||0
10715320|NCT02688387|11880053|FG010|STARTED|Part 2, Period 3 (up to 6 Days)||5
10715321|NCT02688387|11880054|FG011|STARTED|Part 2, Period 3 (up to 6 Days)||5
10304448|NCT00088413|11437563|FG003|COMPLETED|Overall Study||0
10304449|NCT00088413|11437560|FG000|NOT COMPLETED|Overall Study||10
10304450|NCT00088413|11437561|FG001|NOT COMPLETED|Overall Study||15
10304451|NCT00088413|11437562|FG002|NOT COMPLETED|Overall Study||12
10304452|NCT00088413|11437563|FG003|NOT COMPLETED|Overall Study||14
10304453|NCT00088452|11437578|FG000|STARTED|Overall Study||156
10304454|NCT00088452|11437579|FG001|STARTED|Overall Study||149
10304455|NCT00088452|11437580|FG002|STARTED|Overall Study||148
10342282|NCT00391222|11479627|FG001|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
10342283|NCT00391222|11479628|FG002|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
10342284|NCT00391222|11479629|FG003|NOT COMPLETED|Period II (Open-label Risperidone LAI)||162
10342285|NCT00391222|11479626|FG000|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|132
10342286|NCT00391222|11479627|FG001|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|135
10342287|NCT00391222|11479628|FG002|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|131
10342288|NCT00391222|11479629|FG003|STARTED|Period III (Double-Blind Treatment)||0
10342289|NCT00391222|11479626|FG000|COMPLETED|Period III (Double-Blind Treatment)||104
10342290|NCT00391222|11479627|FG001|COMPLETED|Period III (Double-Blind Treatment)||113
10342291|NCT00391222|11479628|FG002|COMPLETED|Period III (Double-Blind Treatment)||108
10342292|NCT00391222|11479629|FG003|COMPLETED|Period III (Double-Blind Treatment)||0
10342293|NCT00391222|11479626|FG000|NOT COMPLETED|Period III (Double-Blind Treatment)||28
10530763|NCT01408719|11683180|FG000|NOT COMPLETED|Second Intervention (35 Days)||0
10530764|NCT01408719|11683181|FG001|NOT COMPLETED|Second Intervention (35 Days)||0
10530765|NCT01408719|11683182|FG002|NOT COMPLETED|Second Intervention (35 Days)||0
10530766|NCT01408719|11683183|FG003|NOT COMPLETED|Second Intervention (35 Days)||0
10530767|NCT01408719|11683184|FG004|NOT COMPLETED|Second Intervention (35 Days)||0
10530768|NCT01408719|11683185|FG005|NOT COMPLETED|Second Intervention (35 Days)||0
10530769|NCT01408719|11683186|FG006|NOT COMPLETED|Second Intervention (35 Days)||0
10530770|NCT01408719|11683187|FG007|NOT COMPLETED|Second Intervention (35 Days)||0
10530771|NCT01408719|11683188|FG008|NOT COMPLETED|Second Intervention (35 Days)||0
10530772|NCT01408719|11683189|FG009|NOT COMPLETED|Second Intervention (35 Days)||0
10530773|NCT01408719|11683190|FG010|NOT COMPLETED|Second Intervention (35 Days)||0
10530774|NCT01408719|11683191|FG011|NOT COMPLETED|Second Intervention (35 Days)||0
10530775|NCT01408719|11683192|FG012|NOT COMPLETED|Second Intervention (35 Days)||0
10530776|NCT01408719|11683193|FG013|NOT COMPLETED|Second Intervention (35 Days)||1
10530777|NCT01408719|11683194|FG014|NOT COMPLETED|Second Intervention (35 Days)||0
10530778|NCT01408719|11683195|FG015|NOT COMPLETED|Second Intervention (35 Days)||0
10530779|NCT01408719|11683196|FG016|NOT COMPLETED|Second Intervention (35 Days)||0
10530780|NCT01408719|11683197|FG017|NOT COMPLETED|Second Intervention (35 Days)||0
10715322|NCT02688387|11880055|FG012|STARTED|Part 2, Period 3 (up to 6 Days)||5
10715323|NCT02688387|11880056|FG013|STARTED|Part 2, Period 3 (up to 6 Days)||5
10715324|NCT02688387|11880057|FG014|STARTED|Part 2, Period 3 (up to 6 Days)||0
10715325|NCT02688387|11880058|FG015|STARTED|Part 2, Period 3 (up to 6 Days)||0
10715326|NCT02688387|11880059|FG016|STARTED|Part 2, Period 3 (up to 6 Days)||0
10715327|NCT02688387|11880060|FG017|STARTED|Part 2, Period 3 (up to 6 Days)||0
10715328|NCT02688387|11880061|FG018|STARTED|Part 2, Period 3 (up to 6 Days)||0
10715329|NCT02688387|11880062|FG019|STARTED|Part 2, Period 3 (up to 6 Days)||0
10715330|NCT02688387|11880063|FG020|STARTED|Part 2, Period 3 (up to 6 Days)||0
10715331|NCT02688387|11880064|FG021|STARTED|Part 2, Period 3 (up to 6 Days)||0
10715332|NCT02688387|11880043|FG000|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10715333|NCT02688387|11880044|FG001|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10715334|NCT02688387|11880045|FG002|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10342294|NCT00391222|11479627|FG001|NOT COMPLETED|Period III (Double-Blind Treatment)||22
10342295|NCT00391222|11479628|FG002|NOT COMPLETED|Period III (Double-Blind Treatment)||23
10342296|NCT00391222|11479629|FG003|NOT COMPLETED|Period III (Double-Blind Treatment)||0
10342297|NCT00391274|11479641|FG000|STARTED|Overall Study||107
10342298|NCT00391274|11479642|FG001|STARTED|Overall Study||104
10342299|NCT00391274|11479641|FG000|Received at Least One Dose of Study Drug|Overall Study||106
10715335|NCT02688387|11880046|FG003|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10342300|NCT00391274|11479642|FG001|Received at Least One Dose of Study Drug|Overall Study||102
10342301|NCT00391274|11479641|FG000|COMPLETED|Overall Study||46
10342302|NCT00391274|11479642|FG001|COMPLETED|Overall Study||47
10342303|NCT00391274|11479641|FG000|NOT COMPLETED|Overall Study||61
10342304|NCT00391274|11479642|FG001|NOT COMPLETED|Overall Study||57
10342305|NCT00391391|11479652|FG000|STARTED|Overall Study|1 participant was not vaccinated.|98
10342306|NCT00391391|11479653|FG001|STARTED|Overall Study||97
10342307|NCT00391391|11479654|FG002|STARTED|Overall Study|1 participant was not vaccinated.|161
10342308|NCT00391391|11479655|FG003|STARTED|Overall Study|1 participant was not vaccinated.|164
10342309|NCT00391391|11479652|FG000|COMPLETED|Overall Study||89
10342310|NCT00391391|11479653|FG001|COMPLETED|Overall Study||87
10342311|NCT00391391|11479654|FG002|COMPLETED|Overall Study||138
10342312|NCT00391391|11479655|FG003|COMPLETED|Overall Study||145
10342313|NCT00391391|11479652|FG000|NOT COMPLETED|Overall Study||9
10342314|NCT00391391|11479653|FG001|NOT COMPLETED|Overall Study||10
10342315|NCT00391391|11479654|FG002|NOT COMPLETED|Overall Study||23
10342316|NCT00391391|11479655|FG003|NOT COMPLETED|Overall Study||19
10342317|NCT00391443|11479667|FG000|STARTED|Overall Study|1 patient in the bosentan arm did not receive treatment & was excluded from the Safety Population.|209
10342318|NCT00391443|11479668|FG001|STARTED|Overall Study||407
10342319|NCT00391443|11479667|FG000|COMPLETED|Overall Study||209
10342320|NCT00391443|11479668|FG001|COMPLETED|Overall Study||407
10342321|NCT00391443|11479667|FG000|NOT COMPLETED|Overall Study||0
10342322|NCT00391443|11479668|FG001|NOT COMPLETED|Overall Study||0
10426478|NCT00847665|11572157|FG001|COMPLETED|Overall Study||165
10426479|NCT00847665|11572156|FG000|NOT COMPLETED|Overall Study||1
10426480|NCT00847665|11572157|FG001|NOT COMPLETED|Overall Study||0
10304456|NCT00088452|11437578|FG000|COMPLETED|Overall Study||155
10304457|NCT00088452|11437579|FG001|COMPLETED|Overall Study||149
10304458|NCT00088452|11437580|FG002|COMPLETED|Overall Study||147
10304459|NCT00088452|11437578|FG000|NOT COMPLETED|Overall Study||1
10304460|NCT00088452|11437579|FG001|NOT COMPLETED|Overall Study||0
10304461|NCT00088452|11437580|FG002|NOT COMPLETED|Overall Study||1
10304462|NCT00088465|11437588|FG000|STARTED|Overall Study||931
10304463|NCT00088465|11437588|FG000|COMPLETED|Overall Study||370
10304464|NCT00088465|11437588|FG000|NOT COMPLETED|Overall Study||561
10304465|NCT00088530|11437594|FG000|STARTED|Overall Study||70
10304466|NCT00088530|11437595|FG001|STARTED|Overall Study||70
10304467|NCT00088530|11437594|FG000|COMPLETED|Overall Study||20
10715336|NCT02688387|11880047|FG004|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10715337|NCT02688387|11880048|FG005|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10304468|NCT00088530|11437595|FG001|COMPLETED|Overall Study||16
10304469|NCT00088530|11437594|FG000|NOT COMPLETED|Overall Study||50
10304470|NCT00088530|11437595|FG001|NOT COMPLETED|Overall Study||54
10304471|NCT00088595|11437601|FG000|STARTED|Overall Study||45
10304472|NCT00088595|11437601|FG000|COMPLETED|Overall Study||17
10304473|NCT00088595|11437601|FG000|NOT COMPLETED|Overall Study||28
10304474|NCT00088621|11437615|FG000|STARTED|Overall Study||61
10304475|NCT00088621|11437615|FG000|COMPLETED|Overall Study||7
10304476|NCT00088621|11437615|FG000|NOT COMPLETED|Overall Study||54
10304477|NCT00088634|11437621|FG000|STARTED|Overall Study||90
10304478|NCT00088634|11437622|FG001|STARTED|Overall Study||90
10304479|NCT00088634|11437621|FG000|COMPLETED|Overall Study||52
10304480|NCT00088634|11437622|FG001|COMPLETED|Overall Study||47
10304481|NCT00088634|11437621|FG000|NOT COMPLETED|Overall Study||38
10304482|NCT00088634|11437622|FG001|NOT COMPLETED|Overall Study||43
10304483|NCT00088699|11437630|FG000|STARTED|Infusion 1||23
10304484|NCT00088699|11437631|FG001|STARTED|Infusion 1||19
10304485|NCT00088699|11437632|FG002|STARTED|Infusion 1||13
10530781|NCT01408719|11683198|FG018|NOT COMPLETED|Second Intervention (35 Days)||0
10530782|NCT01408719|11683199|FG019|NOT COMPLETED|Second Intervention (35 Days)||0
10530783|NCT01408719|11683180|FG000|STARTED|Washout Period (28 Days)||2
10530784|NCT01408719|11683181|FG001|STARTED|Washout Period (28 Days)||3
10530785|NCT01408719|11683182|FG002|STARTED|Washout Period (28 Days)||1
10530786|NCT01408719|11683183|FG003|STARTED|Washout Period (28 Days)||2
10530787|NCT01408719|11683184|FG004|STARTED|Washout Period (28 Days)||3
10530788|NCT01408719|11683185|FG005|STARTED|Washout Period (28 Days)||3
10530789|NCT01408719|11683186|FG006|STARTED|Washout Period (28 Days)||2
10530790|NCT01408719|11683187|FG007|STARTED|Washout Period (28 Days)||3
10530791|NCT01408719|11683188|FG008|STARTED|Washout Period (28 Days)||1
10530792|NCT01408719|11683189|FG009|STARTED|Washout Period (28 Days)||1
10530793|NCT01408719|11683190|FG010|STARTED|Washout Period (28 Days)||2
10530794|NCT01408719|11683191|FG011|STARTED|Washout Period (28 Days)||2
10530795|NCT01408719|11683192|FG012|STARTED|Washout Period (28 Days)||2
10530796|NCT01408719|11683193|FG013|STARTED|Washout Period (28 Days)||3
10530797|NCT01408719|11683194|FG014|STARTED|Washout Period (28 Days)||1
10530798|NCT01408719|11683195|FG015|STARTED|Washout Period (28 Days)||1
10530799|NCT01408719|11683196|FG016|STARTED|Washout Period (28 Days)||2
10530800|NCT01408719|11683197|FG017|STARTED|Washout Period (28 Days)||2
10530801|NCT01408719|11683198|FG018|STARTED|Washout Period (28 Days)||0
10530802|NCT01408719|11683199|FG019|STARTED|Washout Period (28 Days)||1
10530803|NCT01408719|11683180|FG000|COMPLETED|Washout Period (28 Days)||2
10530804|NCT01408719|11683181|FG001|COMPLETED|Washout Period (28 Days)||3
10530805|NCT01408719|11683182|FG002|COMPLETED|Washout Period (28 Days)||1
10530806|NCT01408719|11683183|FG003|COMPLETED|Washout Period (28 Days)||2
10530807|NCT01408719|11683184|FG004|COMPLETED|Washout Period (28 Days)||3
10530808|NCT01408719|11683185|FG005|COMPLETED|Washout Period (28 Days)||3
10530809|NCT01408719|11683186|FG006|COMPLETED|Washout Period (28 Days)||2
10530810|NCT01408719|11683187|FG007|COMPLETED|Washout Period (28 Days)||3
10530811|NCT01408719|11683188|FG008|COMPLETED|Washout Period (28 Days)||1
10530812|NCT01408719|11683189|FG009|COMPLETED|Washout Period (28 Days)||1
10530813|NCT01408719|11683190|FG010|COMPLETED|Washout Period (28 Days)||2
10530814|NCT01408719|11683191|FG011|COMPLETED|Washout Period (28 Days)||2
10530815|NCT01408719|11683192|FG012|COMPLETED|Washout Period (28 Days)||2
10530816|NCT01408719|11683193|FG013|COMPLETED|Washout Period (28 Days)||3
10530817|NCT01408719|11683194|FG014|COMPLETED|Washout Period (28 Days)||1
10530818|NCT01408719|11683195|FG015|COMPLETED|Washout Period (28 Days)||1
10530819|NCT01408719|11683196|FG016|COMPLETED|Washout Period (28 Days)||2
10530820|NCT01408719|11683197|FG017|COMPLETED|Washout Period (28 Days)||2
10530821|NCT01408719|11683198|FG018|COMPLETED|Washout Period (28 Days)||0
10530822|NCT01408719|11683199|FG019|COMPLETED|Washout Period (28 Days)||1
10530823|NCT01408719|11683180|FG000|NOT COMPLETED|Washout Period (28 Days)||0
10530824|NCT01408719|11683181|FG001|NOT COMPLETED|Washout Period (28 Days)||0
10530825|NCT01408719|11683182|FG002|NOT COMPLETED|Washout Period (28 Days)||0
10530826|NCT01408719|11683183|FG003|NOT COMPLETED|Washout Period (28 Days)||0
10530827|NCT01408719|11683184|FG004|NOT COMPLETED|Washout Period (28 Days)||0
10304486|NCT00088699|11437633|FG003|STARTED|Infusion 1||12
10304487|NCT00088699|11437630|FG000|COMPLETED|Infusion 1||22
10304488|NCT00088699|11437631|FG001|COMPLETED|Infusion 1||19
10304489|NCT00088699|11437632|FG002|COMPLETED|Infusion 1||12
10304490|NCT00088699|11437633|FG003|COMPLETED|Infusion 1||10
10304491|NCT00088699|11437630|FG000|NOT COMPLETED|Infusion 1||1
10342323|NCT00391469|11479678|FG000|STARTED|Overall Study||688
10342324|NCT00391469|11479679|FG001|STARTED|Overall Study||671
10342325|NCT00391469|11479678|FG000|COMPLETED|Overall Study|5 patients were found to be incarcerated at time of randomization, thus data was not included|688
10342326|NCT00391469|11479679|FG001|COMPLETED|Overall Study||671
10342327|NCT00391469|11479678|FG000|NOT COMPLETED|Overall Study||0
10342328|NCT00391469|11479679|FG001|NOT COMPLETED|Overall Study||0
10342329|NCT00391586|11479687|FG000|STARTED|Overall Study||45
10342330|NCT00391586|11479687|FG000|Received First-line Erlotinib|Overall Study|These patients received at least one dose of on-study first-line erlotinib|43
10342331|NCT00391586|11479687|FG000|Received Platinum-based Chemotherapy|Overall Study|Total number of patients who received platinum-based chemotherapy after erlotinib treatment|10
10342332|NCT00391586|11479687|FG000|COMPLETED|Overall Study|These patients received at least 2 cycles of erlotinib|21
10342333|NCT00391586|11479687|FG000|NOT COMPLETED|Overall Study||24
10342334|NCT00391599|11479693|FG000|STARTED|Overall Study||65
10342335|NCT00391599|11479694|FG001|STARTED|Overall Study||65
10342336|NCT00391599|11479693|FG000|COMPLETED|Overall Study||65
10342337|NCT00391599|11479694|FG001|COMPLETED|Overall Study||65
10342338|NCT00391599|11479693|FG000|NOT COMPLETED|Overall Study||0
10342339|NCT00391599|11479694|FG001|NOT COMPLETED|Overall Study||0
10342340|NCT00391625|11479702|FG000|STARTED|Baseline||10
10342341|NCT00391625|11479702|FG000|COMPLETED|Baseline||10
10342342|NCT00391625|11479702|FG000|NOT COMPLETED|Baseline||0
10342343|NCT00391625|11479702|FG000|STARTED|Month 14||10
10342344|NCT00391625|11479702|FG000|COMPLETED|Month 14||9
10342345|NCT00391625|11479702|FG000|NOT COMPLETED|Month 14||1
10342346|NCT00391625|11479702|FG000|STARTED|Month 50||9
10342347|NCT00391625|11479702|FG000|COMPLETED|Month 50||8
10342348|NCT00391625|11479702|FG000|NOT COMPLETED|Month 50||1
10342349|NCT00391625|11479702|FG000|STARTED|Month 84||8
10342350|NCT00391625|11479702|FG000|COMPLETED|Month 84||8
10342351|NCT00391625|11479702|FG000|NOT COMPLETED|Month 84||0
10342352|NCT00391716|11479732|FG000|STARTED|Overall Study||54
10342353|NCT00391716|11479733|FG001|STARTED|Overall Study||47
10342354|NCT00391716|11479734|FG002|STARTED|Overall Study||49
10342355|NCT00391716|11479732|FG000|COMPLETED|Overall Study||27
10342356|NCT00391716|11479733|FG001|COMPLETED|Overall Study||28
10342357|NCT00391716|11479734|FG002|COMPLETED|Overall Study||30
10342358|NCT00391716|11479732|FG000|NOT COMPLETED|Overall Study||27
10342359|NCT00391716|11479733|FG001|NOT COMPLETED|Overall Study||19
10342360|NCT00391716|11479734|FG002|NOT COMPLETED|Overall Study||19
10342361|NCT00391768|11479749|FG000|STARTED|Overall Study||12
10342362|NCT00391768|11479750|FG001|STARTED|Overall Study||3
10304492|NCT00088699|11437631|FG001|NOT COMPLETED|Infusion 1||0
10304493|NCT00088699|11437632|FG002|NOT COMPLETED|Infusion 1||1
10304494|NCT00088699|11437633|FG003|NOT COMPLETED|Infusion 1||2
10304495|NCT00088699|11437630|FG000|STARTED|Infusion 2||19
10304496|NCT00088699|11437631|FG001|STARTED|Infusion 2||18
10304497|NCT00088699|11437632|FG002|STARTED|Infusion 2||11
10304498|NCT00088699|11437633|FG003|STARTED|Infusion 2||11
10342363|NCT00391768|11479751|FG002|STARTED|Overall Study||7
10342364|NCT00391768|11479752|FG003|STARTED|Overall Study||8
10342365|NCT00391768|11479753|FG004|STARTED|Overall Study||24
10342366|NCT00391768|11479754|FG005|STARTED|Overall Study||10
10304499|NCT00088699|11437630|FG000|COMPLETED|Infusion 2||19
10342367|NCT00391768|11479755|FG006|STARTED|Overall Study||23
10304500|NCT00088699|11437631|FG001|COMPLETED|Infusion 2||18
10304501|NCT00088699|11437632|FG002|COMPLETED|Infusion 2||11
10304502|NCT00088699|11437633|FG003|COMPLETED|Infusion 2||10
10304503|NCT00088699|11437630|FG000|NOT COMPLETED|Infusion 2||0
10530828|NCT01408719|11683185|FG005|NOT COMPLETED|Washout Period (28 Days)||0
10530829|NCT01408719|11683186|FG006|NOT COMPLETED|Washout Period (28 Days)||0
10530830|NCT01408719|11683187|FG007|NOT COMPLETED|Washout Period (28 Days)||0
10530831|NCT01408719|11683188|FG008|NOT COMPLETED|Washout Period (28 Days)||0
10530832|NCT01408719|11683189|FG009|NOT COMPLETED|Washout Period (28 Days)||0
10530833|NCT01408719|11683190|FG010|NOT COMPLETED|Washout Period (28 Days)||0
10530834|NCT01408719|11683191|FG011|NOT COMPLETED|Washout Period (28 Days)||0
10530835|NCT01408719|11683192|FG012|NOT COMPLETED|Washout Period (28 Days)||0
10530836|NCT01408719|11683193|FG013|NOT COMPLETED|Washout Period (28 Days)||0
10530837|NCT01408719|11683194|FG014|NOT COMPLETED|Washout Period (28 Days)||0
10530838|NCT01408719|11683195|FG015|NOT COMPLETED|Washout Period (28 Days)||0
10530839|NCT01408719|11683196|FG016|NOT COMPLETED|Washout Period (28 Days)||0
10530840|NCT01408719|11683197|FG017|NOT COMPLETED|Washout Period (28 Days)||0
10530841|NCT01408719|11683198|FG018|NOT COMPLETED|Washout Period (28 Days)||0
10530842|NCT01408719|11683199|FG019|NOT COMPLETED|Washout Period (28 Days)||0
10530843|NCT01408719|11683180|FG000|STARTED|Third Intervention (35 Days)||2
10530844|NCT01408719|11683181|FG001|STARTED|Third Intervention (35 Days)||3
10530845|NCT01408719|11683182|FG002|STARTED|Third Intervention (35 Days)||1
10530846|NCT01408719|11683183|FG003|STARTED|Third Intervention (35 Days)||2
10530847|NCT01408719|11683184|FG004|STARTED|Third Intervention (35 Days)||3
10530848|NCT01408719|11683185|FG005|STARTED|Third Intervention (35 Days)||3
10530849|NCT01408719|11683186|FG006|STARTED|Third Intervention (35 Days)||2
10530850|NCT01408719|11683187|FG007|STARTED|Third Intervention (35 Days)||3
10530851|NCT01408719|11683188|FG008|STARTED|Third Intervention (35 Days)||1
10530852|NCT01408719|11683189|FG009|STARTED|Third Intervention (35 Days)||1
10530853|NCT01408719|11683190|FG010|STARTED|Third Intervention (35 Days)||2
10530854|NCT01408719|11683191|FG011|STARTED|Third Intervention (35 Days)||2
10530855|NCT01408719|11683192|FG012|STARTED|Third Intervention (35 Days)||2
10530856|NCT01408719|11683193|FG013|STARTED|Third Intervention (35 Days)||3
10530857|NCT01408719|11683194|FG014|STARTED|Third Intervention (35 Days)||1
10530858|NCT01408719|11683195|FG015|STARTED|Third Intervention (35 Days)||1
10530859|NCT01408719|11683196|FG016|STARTED|Third Intervention (35 Days)||2
10530860|NCT01408719|11683197|FG017|STARTED|Third Intervention (35 Days)||2
10530861|NCT01408719|11683198|FG018|STARTED|Third Intervention (35 Days)||0
10530862|NCT01408719|11683199|FG019|STARTED|Third Intervention (35 Days)||1
10530863|NCT01408719|11683180|FG000|COMPLETED|Third Intervention (35 Days)||2
10530864|NCT01408719|11683181|FG001|COMPLETED|Third Intervention (35 Days)||3
10530865|NCT01408719|11683182|FG002|COMPLETED|Third Intervention (35 Days)||1
10530866|NCT01408719|11683183|FG003|COMPLETED|Third Intervention (35 Days)||2
10530867|NCT01408719|11683184|FG004|COMPLETED|Third Intervention (35 Days)||3
10530868|NCT01408719|11683185|FG005|COMPLETED|Third Intervention (35 Days)||3
10530869|NCT01408719|11683186|FG006|COMPLETED|Third Intervention (35 Days)||2
10530870|NCT01408719|11683187|FG007|COMPLETED|Third Intervention (35 Days)||2
10530871|NCT01408719|11683188|FG008|COMPLETED|Third Intervention (35 Days)||1
10530872|NCT01408719|11683189|FG009|COMPLETED|Third Intervention (35 Days)||1
10530873|NCT01408719|11683190|FG010|COMPLETED|Third Intervention (35 Days)||2
10530874|NCT01408719|11683191|FG011|COMPLETED|Third Intervention (35 Days)||2
10530875|NCT01408719|11683192|FG012|COMPLETED|Third Intervention (35 Days)||2
10530876|NCT01408719|11683193|FG013|COMPLETED|Third Intervention (35 Days)||3
10530877|NCT01408719|11683194|FG014|COMPLETED|Third Intervention (35 Days)||1
10530878|NCT01408719|11683195|FG015|COMPLETED|Third Intervention (35 Days)||1
10530879|NCT01408719|11683196|FG016|COMPLETED|Third Intervention (35 Days)||2
10530880|NCT01408719|11683197|FG017|COMPLETED|Third Intervention (35 Days)||2
10530881|NCT01408719|11683198|FG018|COMPLETED|Third Intervention (35 Days)||0
10715338|NCT02688387|11880049|FG006|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10715339|NCT02688387|11880050|FG007|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10715340|NCT02688387|11880051|FG008|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10342368|NCT00391768|11479749|FG000|COMPLETED|Overall Study||12
10342369|NCT00391768|11479750|FG001|COMPLETED|Overall Study||3
10342370|NCT00391768|11479751|FG002|COMPLETED|Overall Study||6
10342371|NCT00391768|11479752|FG003|COMPLETED|Overall Study||7
10342372|NCT00391768|11479753|FG004|COMPLETED|Overall Study||22
10342373|NCT00391768|11479754|FG005|COMPLETED|Overall Study||7
10342374|NCT00391768|11479755|FG006|COMPLETED|Overall Study||19
10342375|NCT00391768|11479749|FG000|NOT COMPLETED|Overall Study||0
10342376|NCT00391768|11479750|FG001|NOT COMPLETED|Overall Study||0
10342377|NCT00391768|11479751|FG002|NOT COMPLETED|Overall Study||1
10342378|NCT00391768|11479752|FG003|NOT COMPLETED|Overall Study||1
10342379|NCT00391768|11479753|FG004|NOT COMPLETED|Overall Study||2
10342380|NCT00391768|11479754|FG005|NOT COMPLETED|Overall Study||3
10342381|NCT00391768|11479755|FG006|NOT COMPLETED|Overall Study||4
10342382|NCT00391807|11479789|FG000|STARTED|Overall Study||1683
10342383|NCT00391807|11479789|FG000|COMPLETED|Overall Study||968
10342384|NCT00391807|11479789|FG000|NOT COMPLETED|Overall Study||715
10342385|NCT00391846|11479795|FG000|STARTED|Overall Study|Of the 127 randomised patients 8 were discontinued|127
10342386|NCT00391846|11479796|FG001|STARTED|Overall Study|Of th 125 randomised patients 7 were discontinued|125
10342387|NCT00391846|11479795|FG000|COMPLETED|Overall Study|119 completed patients includes 4 CV related deaths|119
10342388|NCT00391846|11479796|FG001|COMPLETED|Overall Study|118 completed patients includes 5 CV related deaths|118
10342389|NCT00391846|11479795|FG000|NOT COMPLETED|Overall Study||8
10342390|NCT00391846|11479796|FG001|NOT COMPLETED|Overall Study||7
10342391|NCT00391872|11479804|FG000|STARTED|Overall Study||9333
10342392|NCT00391872|11479805|FG001|STARTED|Overall Study||9291
10342393|NCT00391872|11479804|FG000|COMPLETED|Overall Study||9026
10342394|NCT00391872|11479805|FG001|COMPLETED|Overall Study||9036
10342395|NCT00391872|11479804|FG000|NOT COMPLETED|Overall Study||307
10342396|NCT00391872|11479805|FG001|NOT COMPLETED|Overall Study||255
10342397|NCT00391898|11479813|FG000|STARTED|Overall Study|Safety population for Levodopa/carbidopa/entacapone is 45, for Levodopa/carbidopa, per randomized.|46
10342398|NCT00391898|11479814|FG001|STARTED|Overall Study||49
10342399|NCT00391898|11479813|FG000|COMPLETED|Overall Study||35
10342400|NCT00391898|11479814|FG001|COMPLETED|Overall Study||39
10342401|NCT00391898|11479813|FG000|NOT COMPLETED|Overall Study||11
10342402|NCT00391898|11479814|FG001|NOT COMPLETED|Overall Study||10
10342403|NCT00391976|11479823|FG000|STARTED|Overall Study|Started indicates all patients who were enrolled at Visit 1|45
10342404|NCT00391976|11479824|FG001|STARTED|Overall Study||43
10342405|NCT00391976|11479825|FG002|STARTED|Overall Study||35
10342406|NCT00391976|11479823|FG000|Randomized|Overall Study|Randomization occurred after 28 days of treatment & negative antibody test aeruginosa antibody test|45
10342407|NCT00391976|11479824|FG001|Randomized|Overall Study||43
10342408|NCT00391976|11479825|FG002|Randomized|Overall Study||0
10342409|NCT00391976|11479823|FG000|Safety Population|Overall Study|Patients who were enrolled and received at least one dose of study medication.|44
10342410|NCT00391976|11479824|FG001|Safety Population|Overall Study||43
10342411|NCT00391976|11479825|FG002|Safety Population|Overall Study||35
10342412|NCT00391976|11479823|FG000|COMPLETED|Overall Study||18
10342413|NCT00391976|11479824|FG001|COMPLETED|Overall Study||18
10342414|NCT00391976|11479825|FG002|COMPLETED|Overall Study||0
10342415|NCT00391976|11479823|FG000|NOT COMPLETED|Overall Study||27
10342416|NCT00391976|11479824|FG001|NOT COMPLETED|Overall Study||25
10342417|NCT00391976|11479825|FG002|NOT COMPLETED|Overall Study||35
10342418|NCT00391989|11479835|FG000|STARTED|Overall Study||55
10342419|NCT00391989|11479835|FG000|COMPLETED|Overall Study||53
10342420|NCT00391989|11479835|FG000|NOT COMPLETED|Overall Study||2
10342421|NCT00392015|11479845|FG000|STARTED|Overall Study||6
10342422|NCT00392015|11479846|FG001|STARTED|Overall Study||6
10342423|NCT00392015|11479847|FG002|STARTED|Overall Study||20
10342424|NCT00392015|11479848|FG003|STARTED|Overall Study||6
10342425|NCT00392015|11479849|FG004|STARTED|Overall Study||15
10342426|NCT00392015|11479850|FG005|STARTED|Overall Study||6
10342427|NCT00392015|11479845|FG000|COMPLETED|Overall Study||4
10342428|NCT00392015|11479846|FG001|COMPLETED|Overall Study||6
10342429|NCT00392015|11479847|FG002|COMPLETED|Overall Study||16
10342430|NCT00392015|11479848|FG003|COMPLETED|Overall Study||5
10342431|NCT00392015|11479849|FG004|COMPLETED|Overall Study||12
10342432|NCT00392015|11479850|FG005|COMPLETED|Overall Study||6
10715341|NCT02688387|11880052|FG009|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10342433|NCT00392015|11479845|FG000|NOT COMPLETED|Overall Study||2
10342434|NCT00392015|11479846|FG001|NOT COMPLETED|Overall Study||0
10342435|NCT00392015|11479847|FG002|NOT COMPLETED|Overall Study||4
10342436|NCT00392015|11479848|FG003|NOT COMPLETED|Overall Study||1
10342437|NCT00392015|11479849|FG004|NOT COMPLETED|Overall Study||3
10342438|NCT00392015|11479850|FG005|NOT COMPLETED|Overall Study||0
10812327|NCT03724253|11974351|FG000|COMPLETED|Overall Study||5
10812328|NCT03724253|11974352|FG001|COMPLETED|Overall Study||5
10812329|NCT03724253|11974353|FG002|COMPLETED|Overall Study||5
10812330|NCT03724253|11974354|FG003|COMPLETED|Overall Study||3
10342439|NCT00392041|11479871|FG000|STARTED|First 4 Weeks||19
10342440|NCT00392041|11479872|FG001|STARTED|First 4 Weeks||17
10812331|NCT03724253|11974355|FG004|COMPLETED|Overall Study||1
10715342|NCT02688387|11880053|FG010|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
10715343|NCT02688387|11880054|FG011|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
10715344|NCT02688387|11880055|FG012|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
10715345|NCT02688387|11880056|FG013|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
10715346|NCT02688387|11880057|FG014|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10342441|NCT00392041|11479871|FG000|COMPLETED|First 4 Weeks||11
10342442|NCT00392041|11479872|FG001|COMPLETED|First 4 Weeks||14
10342443|NCT00392041|11479871|FG000|NOT COMPLETED|First 4 Weeks||8
10342444|NCT00392041|11479872|FG001|NOT COMPLETED|First 4 Weeks||3
10342445|NCT00392041|11479871|FG000|STARTED|Weeks 5 - 12||11
10342446|NCT00392041|11479872|FG001|STARTED|Weeks 5 - 12||14
10342447|NCT00392041|11479871|FG000|COMPLETED|Weeks 5 - 12||7
10342448|NCT00392041|11479872|FG001|COMPLETED|Weeks 5 - 12||9
10342449|NCT00392041|11479871|FG000|NOT COMPLETED|Weeks 5 - 12||4
10342450|NCT00392041|11479872|FG001|NOT COMPLETED|Weeks 5 - 12||5
10342451|NCT00392054|11479880|FG000|STARTED|Overall Study|All participants randomized are included in final analysis|66
10342452|NCT00392054|11479881|FG001|STARTED|Overall Study|All participants randomized are included in final analysis|61
10342453|NCT00392054|11479880|FG000|Received Allocated Intervention|Overall Study||65
10342454|NCT00392054|11479881|FG001|Received Allocated Intervention|Overall Study||60
10342455|NCT00392054|11479880|FG000|COMPLETED|Overall Study||66
10342456|NCT00392054|11479881|FG001|COMPLETED|Overall Study||61
10342457|NCT00392054|11479880|FG000|NOT COMPLETED|Overall Study||0
10342458|NCT00392054|11479881|FG001|NOT COMPLETED|Overall Study||0
10342459|NCT00392171|11479891|FG000|STARTED|Overall Study||120
10342460|NCT00392171|11479891|FG000|COMPLETED|Overall Study||15
10342461|NCT00392171|11479891|FG000|NOT COMPLETED|Overall Study||105
10342462|NCT00392197|11479897|FG000|STARTED|Overall Study||48
10342463|NCT00392197|11479898|FG001|STARTED|Overall Study||63
10342464|NCT00392197|11479897|FG000|COMPLETED|Overall Study||27
10342465|NCT00392197|11479898|FG001|COMPLETED|Overall Study||33
10342466|NCT00392197|11479897|FG000|NOT COMPLETED|Overall Study||21
10342467|NCT00392197|11479898|FG001|NOT COMPLETED|Overall Study||30
10342468|NCT00392210|11479906|FG000|STARTED|First Voiding Trial||36
10342469|NCT00392210|11479907|FG001|STARTED|First Voiding Trial||33
10342470|NCT00392210|11479906|FG000|COMPLETED|First Voiding Trial||34
10342471|NCT00392210|11479907|FG001|COMPLETED|First Voiding Trial||31
10342472|NCT00392210|11479906|FG000|NOT COMPLETED|First Voiding Trial||2
10342473|NCT00392210|11479907|FG001|NOT COMPLETED|First Voiding Trial||2
10342474|NCT00392210|11479906|FG000|STARTED|Second Voiding Trial||34
10342475|NCT00392210|11479907|FG001|STARTED|Second Voiding Trial||31
10342476|NCT00392210|11479906|FG000|COMPLETED|Second Voiding Trial||34
10342477|NCT00392210|11479907|FG001|COMPLETED|Second Voiding Trial||31
10342478|NCT00392210|11479906|FG000|NOT COMPLETED|Second Voiding Trial||0
10342479|NCT00392210|11479907|FG001|NOT COMPLETED|Second Voiding Trial||0
10342480|NCT00392223|11479915|FG000|STARTED|Overall Study||58
10342481|NCT00392223|11479916|FG001|STARTED|Overall Study||60
10342482|NCT00392223|11479915|FG000|COMPLETED|Overall Study||49
10530882|NCT01408719|11683199|FG019|COMPLETED|Third Intervention (35 Days)||1
10530883|NCT01408719|11683180|FG000|NOT COMPLETED|Third Intervention (35 Days)||0
10530884|NCT01408719|11683181|FG001|NOT COMPLETED|Third Intervention (35 Days)||0
10530885|NCT01408719|11683182|FG002|NOT COMPLETED|Third Intervention (35 Days)||0
10530886|NCT01408719|11683183|FG003|NOT COMPLETED|Third Intervention (35 Days)||0
10530887|NCT01408719|11683184|FG004|NOT COMPLETED|Third Intervention (35 Days)||0
10530888|NCT01408719|11683185|FG005|NOT COMPLETED|Third Intervention (35 Days)||0
10530889|NCT01408719|11683186|FG006|NOT COMPLETED|Third Intervention (35 Days)||0
10547896|NCT01515540|11701682|FG000|NOT COMPLETED|Overall Study||5
10655109|NCT02207231|11815881|FG001|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||7
10655110|NCT02207231|11815882|FG002|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||10
10655111|NCT02207231|11815883|FG003|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
10655112|NCT02207231|11815880|FG000|STARTED|Active Controlled Period: Week 16 - 48|2 participants did not cross-over.|165
10715347|NCT02688387|11880058|FG015|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10342483|NCT00392223|11479916|FG001|COMPLETED|Overall Study||47
10304504|NCT00088699|11437631|FG001|NOT COMPLETED|Infusion 2||0
10304505|NCT00088699|11437632|FG002|NOT COMPLETED|Infusion 2||0
10304506|NCT00088699|11437633|FG003|NOT COMPLETED|Infusion 2||1
10304507|NCT00088881|11437643|FG000|STARTED|Step 1 - R-CHOP||62
10304508|NCT00088881|11437643|FG000|Eligible and Treated|Step 1 - R-CHOP||53
10304509|NCT00088881|11437643|FG000|COMPLETED|Step 1 - R-CHOP||48
10304510|NCT00088881|11437643|FG000|NOT COMPLETED|Step 1 - R-CHOP||14
10304511|NCT00088881|11437643|FG000|STARTED|Step 2 - Zevalin™ Radioimmunotherapy|This includes all patients who received step 2 treatment regardless of eligibility.|56
10304512|NCT00088881|11437643|FG000|Eligible and Treated|Step 2 - Zevalin™ Radioimmunotherapy||48
10304513|NCT00088881|11437643|FG000|COMPLETED|Step 2 - Zevalin™ Radioimmunotherapy||45
10304514|NCT00088881|11437643|FG000|NOT COMPLETED|Step 2 - Zevalin™ Radioimmunotherapy||11
10304515|NCT00088881|11437643|FG000|STARTED|Step 3 - Radiation Therapy||1
10304516|NCT00088881|11437643|FG000|COMPLETED|Step 3 - Radiation Therapy||1
10304517|NCT00088881|11437643|FG000|NOT COMPLETED|Step 3 - Radiation Therapy||0
10304518|NCT00088907|11437651|FG000|STARTED|Randomized Study (Step 1)||136
10304519|NCT00088907|11437652|FG001|STARTED|Randomized Study (Step 1)||134
10304520|NCT00088907|11437651|FG000|Treated|Randomized Study (Step 1)||129
10304521|NCT00088907|11437652|FG001|Treated|Randomized Study (Step 1)||124
10304522|NCT00088907|11437651|FG000|Eligible|Randomized Study (Step 1)||117
10304523|NCT00088907|11437652|FG001|Eligible|Randomized Study (Step 1)||122
10304524|NCT00088907|11437651|FG000|Eligible and Treated|Randomized Study (Step 1)||117
10304525|NCT00088907|11437652|FG001|Eligible and Treated|Randomized Study (Step 1)||122
10304526|NCT00088907|11437651|FG000|COMPLETED|Randomized Study (Step 1)|Treatment would continue until disease progression, no certain fixed number of cycles.|0
10304527|NCT00088907|11437652|FG001|COMPLETED|Randomized Study (Step 1)|Treatment would continue until disease progression, no certain fixed number of cycles|0
10304528|NCT00088907|11437651|FG000|NOT COMPLETED|Randomized Study (Step 1)||136
10304529|NCT00088907|11437652|FG001|NOT COMPLETED|Randomized Study (Step 1)||134
10304530|NCT00088907|11437651|FG000|STARTED|Single Gefitinib Treatment (Step 2)|Patients on Arm I could cross over to gefitinib after disease progression on step 1.|24
10304531|NCT00088907|11437652|FG001|STARTED|Single Gefitinib Treatment (Step 2)|Cross over to single gefitinib therapy at progression was allowed for patients on Arm I only.|0
10304532|NCT00088907|11437651|FG000|Treated|Single Gefitinib Treatment (Step 2)||19
10304533|NCT00088907|11437652|FG001|Treated|Single Gefitinib Treatment (Step 2)||0
10304534|NCT00088907|11437651|FG000|COMPLETED|Single Gefitinib Treatment (Step 2)||0
10304535|NCT00088907|11437652|FG001|COMPLETED|Single Gefitinib Treatment (Step 2)||0
10304536|NCT00088907|11437651|FG000|NOT COMPLETED|Single Gefitinib Treatment (Step 2)||24
10304537|NCT00088907|11437652|FG001|NOT COMPLETED|Single Gefitinib Treatment (Step 2)||0
10342484|NCT00392223|11479915|FG000|NOT COMPLETED|Overall Study||9
10342485|NCT00392223|11479916|FG001|NOT COMPLETED|Overall Study||13
10342486|NCT00392236|11479924|FG000|STARTED|Overall Study|1 subject post randomization was found to not meet inclusion criteria|20
10342487|NCT00392236|11479925|FG001|STARTED|Overall Study|1 subject post randomization was found to not meet inclusion criteria|18
10342488|NCT00392236|11479924|FG000|COMPLETED|Overall Study|Defined as having adherence data for month 6 of the study.|8
10342489|NCT00392236|11479925|FG001|COMPLETED|Overall Study|Defined as having adherence data for month 6 of the study.|12
10342490|NCT00392236|11479924|FG000|NOT COMPLETED|Overall Study||12
10342491|NCT00392236|11479925|FG001|NOT COMPLETED|Overall Study||6
10342492|NCT00392288|11479934|FG000|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|175
10342493|NCT00392288|11479935|FG001|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|177
10342494|NCT00392288|11479936|FG002|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|176
10342495|NCT00392288|11479934|FG000|Treatment Period|Overall Study||172
10342496|NCT00392288|11479935|FG001|Treatment Period|Overall Study||174
10342497|NCT00392288|11479936|FG002|Treatment Period|Overall Study||175
10342498|NCT00392288|11479934|FG000|COMPLETED|Overall Study|ITT set = 163 patients|143
10342499|NCT00392288|11479935|FG001|COMPLETED|Overall Study|ITT set = 166 patients|155
10342500|NCT00392288|11479936|FG002|COMPLETED|Overall Study|ITT set = 172 patients|159
10342501|NCT00392288|11479934|FG000|NOT COMPLETED|Overall Study||32
10342502|NCT00392288|11479935|FG001|NOT COMPLETED|Overall Study||22
10342503|NCT00392288|11479936|FG002|NOT COMPLETED|Overall Study||17
10342504|NCT00392379|11479946|FG000|STARTED|Overall Study|Medication period|136
10342505|NCT00392379|11479947|FG001|STARTED|Overall Study|Medication period|134
10342506|NCT00392379|11479946|FG000|COMPLETED|Overall Study|Medication period|114
10342507|NCT00392379|11479947|FG001|COMPLETED|Overall Study|Medication period|96
10342508|NCT00392379|11479946|FG000|NOT COMPLETED|Overall Study||22
10342509|NCT00392379|11479947|FG001|NOT COMPLETED|Overall Study||38
10342510|NCT00392392|11479953|FG000|STARTED|Overall Study||29
10342511|NCT00392392|11479953|FG000|COMPLETED|Overall Study||9
10342512|NCT00392392|11479953|FG000|NOT COMPLETED|Overall Study||20
10342513|NCT00392444|11479957|FG000|STARTED|Overall Study||39
10342514|NCT00392444|11479957|FG000|COMPLETED|Overall Study||39
10342515|NCT00392444|11479957|FG000|NOT COMPLETED|Overall Study||0
10342516|NCT00392496|11479961|FG000|STARTED|Overall Study||19
10342517|NCT00392496|11479961|FG000|COMPLETED|Overall Study||19
10342518|NCT00392496|11479961|FG000|NOT COMPLETED|Overall Study||0
10342519|NCT00392665|11479967|FG000|STARTED|Overall Study||18
10342520|NCT00392665|11479968|FG001|STARTED|Overall Study||18
10342521|NCT00392665|11479967|FG000|COMPLETED|Overall Study||1
10342522|NCT00392665|11479968|FG001|COMPLETED|Overall Study||3
10342523|NCT00392665|11479967|FG000|NOT COMPLETED|Overall Study||17
10342524|NCT00392665|11479968|FG001|NOT COMPLETED|Overall Study||15
10304538|NCT00088985|11437659|FG000|STARTED|Overall Study||7
10304539|NCT00088985|11437659|FG000|COMPLETED|Overall Study||4
10304540|NCT00088985|11437659|FG000|NOT COMPLETED|Overall Study||3
10304541|NCT00089011|11437665|FG000|STARTED|Overall Study||100
10304542|NCT00089011|11437666|FG001|STARTED|Overall Study||50
10304543|NCT00089011|11437665|FG000|COMPLETED|Overall Study||100
10304544|NCT00089011|11437666|FG001|COMPLETED|Overall Study||50
10304545|NCT00089011|11437665|FG000|NOT COMPLETED|Overall Study||0
10304546|NCT00089011|11437666|FG001|NOT COMPLETED|Overall Study||0
10304547|NCT00089024|11437672|FG000|STARTED|Overall Study||29
10304548|NCT00089024|11437672|FG000|Treated Subjects|Overall Study||29
10304549|NCT00089024|11437672|FG000|COMPLETED|Overall Study||24
10304550|NCT00089024|11437672|FG000|NOT COMPLETED|Overall Study||5
10304551|NCT00089076|11437676|FG000|STARTED|Overall Study||18
10304552|NCT00089076|11437676|FG000|COMPLETED|Overall Study||8
10304553|NCT00089076|11437676|FG000|NOT COMPLETED|Overall Study||10
10304554|NCT00089102|11437680|FG000|STARTED|Overall Study||9
10304555|NCT00089102|11437680|FG000|COMPLETED|Overall Study||9
10304556|NCT00089102|11437680|FG000|NOT COMPLETED|Overall Study||0
10304557|NCT00089284|11437689|FG000|STARTED|Overall Study||7
10304558|NCT00089284|11437690|FG001|STARTED|Overall Study||3
10304559|NCT00089284|11437691|FG002|STARTED|Overall Study||6
10304560|NCT00089284|11437692|FG003|STARTED|Overall Study||6
10315155|NCT00174941|11448949|FG002|NOT COMPLETED|Overall Study||18
10342525|NCT00392678|11479978|FG000|STARTED|Overall Study||27
10812332|NCT03724253|11974351|FG000|NOT COMPLETED|Overall Study||0
10812333|NCT03724253|11974352|FG001|NOT COMPLETED|Overall Study||0
10812334|NCT03724253|11974353|FG002|NOT COMPLETED|Overall Study||0
10812335|NCT03724253|11974354|FG003|NOT COMPLETED|Overall Study||0
10812336|NCT03724253|11974355|FG004|NOT COMPLETED|Overall Study||0
10812337|NCT03723980|11974369|FG000|STARTED|Overall Study||40
10304561|NCT00089284|11437693|FG004|STARTED|Overall Study|No patients were accrued to this cohort of 6-24% involvement due to lack of eligible patients.|0
10304562|NCT00089284|11437694|FG005|STARTED|Overall Study|No patients were accrued to this cohort of 6-24% involvement due to lack of eligible patients.|0
10304563|NCT00089284|11437695|FG006|STARTED|Overall Study||8
10304564|NCT00089284|11437689|FG000|COMPLETED|Overall Study||7
10530890|NCT01408719|11683187|FG007|NOT COMPLETED|Third Intervention (35 Days)||1
10530891|NCT01408719|11683188|FG008|NOT COMPLETED|Third Intervention (35 Days)||0
10530892|NCT01408719|11683189|FG009|NOT COMPLETED|Third Intervention (35 Days)||0
10530893|NCT01408719|11683190|FG010|NOT COMPLETED|Third Intervention (35 Days)||0
10530894|NCT01408719|11683191|FG011|NOT COMPLETED|Third Intervention (35 Days)||0
10530895|NCT01408719|11683192|FG012|NOT COMPLETED|Third Intervention (35 Days)||0
10530896|NCT01408719|11683193|FG013|NOT COMPLETED|Third Intervention (35 Days)||0
10530897|NCT01408719|11683194|FG014|NOT COMPLETED|Third Intervention (35 Days)||0
10530898|NCT01408719|11683195|FG015|NOT COMPLETED|Third Intervention (35 Days)||0
10530899|NCT01408719|11683196|FG016|NOT COMPLETED|Third Intervention (35 Days)||0
10530900|NCT01408719|11683197|FG017|NOT COMPLETED|Third Intervention (35 Days)||0
10530901|NCT01408719|11683198|FG018|NOT COMPLETED|Third Intervention (35 Days)||0
10530902|NCT01408719|11683199|FG019|NOT COMPLETED|Third Intervention (35 Days)||0
10530903|NCT01408719|11683180|FG000|STARTED|Washout Period (28 Days)||2
10530904|NCT01408719|11683181|FG001|STARTED|Washout Period (28 Days)||3
10530905|NCT01408719|11683182|FG002|STARTED|Washout Period (28 Days)||1
10530906|NCT01408719|11683183|FG003|STARTED|Washout Period (28 Days)||2
10530907|NCT01408719|11683184|FG004|STARTED|Washout Period (28 Days)||3
10530908|NCT01408719|11683185|FG005|STARTED|Washout Period (28 Days)||3
10530909|NCT01408719|11683186|FG006|STARTED|Washout Period (28 Days)||2
10530910|NCT01408719|11683187|FG007|STARTED|Washout Period (28 Days)||2
10655113|NCT02207231|11815881|FG001|STARTED|Active Controlled Period: Week 16 - 48||322
10655114|NCT02207231|11815882|FG002|STARTED|Active Controlled Period: Week 16 - 48||324
10655115|NCT02207231|11815883|FG003|STARTED|Active Controlled Period: Week 16 - 48||0
10655116|NCT02207231|11815880|FG000|COMPLETED|Active Controlled Period: Week 16 - 48||162
10655117|NCT02207231|11815881|FG001|COMPLETED|Active Controlled Period: Week 16 - 48||301
10655118|NCT02207231|11815882|FG002|COMPLETED|Active Controlled Period: Week 16 - 48||281
10655119|NCT02207231|11815883|FG003|COMPLETED|Active Controlled Period: Week 16 - 48||0
10655120|NCT02207231|11815880|FG000|NOT COMPLETED|Active Controlled Period: Week 16 - 48||3
10655121|NCT02207231|11815881|FG001|NOT COMPLETED|Active Controlled Period: Week 16 - 48||21
10655122|NCT02207231|11815882|FG002|NOT COMPLETED|Active Controlled Period: Week 16 - 48||43
10655123|NCT02207231|11815883|FG003|NOT COMPLETED|Active Controlled Period: Week 16 - 48||0
10655124|NCT02207231|11815880|FG000|STARTED|Open-label Guselkumab: Week 48 - 264||0
10655125|NCT02207231|11815881|FG001|STARTED|Open-label Guselkumab: Week 48 - 264||0
10655126|NCT02207231|11815882|FG002|STARTED|Open-label Guselkumab: Week 48 - 264|One participant did not crossover at Week 52 due to adverse event.|280
10655127|NCT02207231|11815883|FG003|STARTED|Open-label Guselkumab: Week 48 - 264|162 + 301= 463|463
10655128|NCT02207231|11815880|FG000|COMPLETED|Open-label Guselkumab: Week 48 - 264||0
10655129|NCT02207231|11815881|FG001|COMPLETED|Open-label Guselkumab: Week 48 - 264||0
10655130|NCT02207231|11815882|FG002|COMPLETED|Open-label Guselkumab: Week 48 - 264||242
10655131|NCT02207231|11815883|FG003|COMPLETED|Open-label Guselkumab: Week 48 - 264||380
10655132|NCT02207231|11815880|FG000|NOT COMPLETED|Open-label Guselkumab: Week 48 - 264||0
10655133|NCT02207231|11815881|FG001|NOT COMPLETED|Open-label Guselkumab: Week 48 - 264||0
10655134|NCT02207231|11815882|FG002|NOT COMPLETED|Open-label Guselkumab: Week 48 - 264||38
10655135|NCT02207231|11815883|FG003|NOT COMPLETED|Open-label Guselkumab: Week 48 - 264||83
10655136|NCT02207244|11815904|FG000|STARTED|Placebo Controlled Period: Week 0-16||248
10655137|NCT02207244|11815905|FG001|STARTED|Placebo Controlled Period: Week 0-16||496
10655138|NCT02207244|11815906|FG002|STARTED|Placebo Controlled Period: Week 0-16||248
10655139|NCT02207244|11815907|FG003|STARTED|Placebo Controlled Period: Week 0-16||0
10655140|NCT02207244|11815908|FG004|STARTED|Placebo Controlled Period: Week 0-16||0
10655141|NCT02207244|11815909|FG005|STARTED|Placebo Controlled Period: Week 0-16||0
10655142|NCT02207244|11815910|FG006|STARTED|Placebo Controlled Period: Week 0-16||0
10655143|NCT02207244|11815911|FG007|STARTED|Placebo Controlled Period: Week 0-16||0
10655144|NCT02207244|11815912|FG008|STARTED|Placebo Controlled Period: Week 0-16||0
10655145|NCT02207244|11815913|FG009|STARTED|Placebo Controlled Period: Week 0-16||0
10655146|NCT02207244|11815914|FG010|STARTED|Placebo Controlled Period: Week 0-16||0
10655147|NCT02207244|11815904|FG000|Treated|Placebo Controlled Period: Week 0-16||248
10655148|NCT02207244|11815905|FG001|Treated|Placebo Controlled Period: Week 0-16||494
10655149|NCT02207244|11815906|FG002|Treated|Placebo Controlled Period: Week 0-16||248
10655150|NCT02207244|11815907|FG003|Treated|Placebo Controlled Period: Week 0-16||0
10655151|NCT02207244|11815908|FG004|Treated|Placebo Controlled Period: Week 0-16||0
10655152|NCT02207244|11815909|FG005|Treated|Placebo Controlled Period: Week 0-16||0
10655153|NCT02207244|11815910|FG006|Treated|Placebo Controlled Period: Week 0-16||0
10655154|NCT02207244|11815911|FG007|Treated|Placebo Controlled Period: Week 0-16||0
10655155|NCT02207244|11815912|FG008|Treated|Placebo Controlled Period: Week 0-16||0
10304565|NCT00089284|11437690|FG001|COMPLETED|Overall Study||3
10304566|NCT00089284|11437691|FG002|COMPLETED|Overall Study||6
10304567|NCT00089284|11437692|FG003|COMPLETED|Overall Study||6
10342526|NCT00392678|11479979|FG001|STARTED|Overall Study||27
10342527|NCT00392678|11479980|FG002|STARTED|Overall Study||27
10342528|NCT00392678|11479981|FG003|STARTED|Overall Study||27
10342529|NCT00392678|11479978|FG000|COMPLETED|Overall Study||27
10342530|NCT00392678|11479979|FG001|COMPLETED|Overall Study||26
10342531|NCT00392678|11479980|FG002|COMPLETED|Overall Study||25
10342532|NCT00392678|11479981|FG003|COMPLETED|Overall Study||26
10342533|NCT00392678|11479978|FG000|NOT COMPLETED|Overall Study||0
10342534|NCT00392678|11479979|FG001|NOT COMPLETED|Overall Study||1
10342535|NCT00392678|11479980|FG002|NOT COMPLETED|Overall Study||2
10342536|NCT00392678|11479981|FG003|NOT COMPLETED|Overall Study||1
10342537|NCT00392704|11480000|FG000|STARTED|Neoadjuvant Chemotherapy||60
10342538|NCT00392704|11480000|FG000|COMPLETED|Neoadjuvant Chemotherapy||54
10342539|NCT00392704|11480000|FG000|NOT COMPLETED|Neoadjuvant Chemotherapy||6
10342540|NCT00392704|11480000|FG000|STARTED|Combined Modality Therapy||54
10342541|NCT00392704|11480000|FG000|COMPLETED|Combined Modality Therapy||49
10342542|NCT00392704|11480000|FG000|NOT COMPLETED|Combined Modality Therapy||5
10342543|NCT00392769|11480004|FG000|STARTED|Overall Study||33
10342544|NCT00392769|11480004|FG000|COMPLETED|Overall Study||23
10342545|NCT00392769|11480004|FG000|NOT COMPLETED|Overall Study||10
10342546|NCT00392782|11480008|FG000|STARTED|Overall Study||24
10342547|NCT00392782|11480008|FG000|COMPLETED|Overall Study||24
10342548|NCT00392782|11480008|FG000|NOT COMPLETED|Overall Study||0
10342549|NCT00392808|11480016|FG000|STARTED|Overall Study||87
10342550|NCT00392808|11480017|FG001|STARTED|Overall Study||89
10342551|NCT00392808|11480018|FG002|STARTED|Overall Study||109
10342552|NCT00392808|11480019|FG003|STARTED|Overall Study||104
10342553|NCT00392808|11480016|FG000|COMPLETED|Overall Study||81
10342554|NCT00392808|11480017|FG001|COMPLETED|Overall Study||86
10342555|NCT00392808|11480018|FG002|COMPLETED|Overall Study||107
10342556|NCT00392808|11480019|FG003|COMPLETED|Overall Study||100
10342557|NCT00392808|11480016|FG000|NOT COMPLETED|Overall Study||6
10342558|NCT00392808|11480017|FG001|NOT COMPLETED|Overall Study||3
10342559|NCT00392808|11480018|FG002|NOT COMPLETED|Overall Study||2
10342560|NCT00392808|11480019|FG003|NOT COMPLETED|Overall Study||4
10342561|NCT00392834|11480031|FG000|STARTED|Overall Study||2
10342562|NCT00392834|11480032|FG001|STARTED|Overall Study||32
10342563|NCT00392834|11480031|FG000|COMPLETED|Overall Study||2
10342564|NCT00392834|11480032|FG001|COMPLETED|Overall Study||32
10342565|NCT00392834|11480031|FG000|NOT COMPLETED|Overall Study||0
10342566|NCT00392834|11480032|FG001|NOT COMPLETED|Overall Study||0
10342567|NCT00392925|11480042|FG000|STARTED|4 Week Lead-In Period - Non-Randomized||177
10342568|NCT00392925|11480043|FG001|STARTED|4 Week Lead-In Period - Non-Randomized||0
10342569|NCT00392925|11480044|FG002|STARTED|4 Week Lead-In Period - Non-Randomized||0
10342570|NCT00392925|11480045|FG003|STARTED|4 Week Lead-In Period - Non-Randomized||0
10342571|NCT00392925|11480042|FG000|COMPLETED|4 Week Lead-In Period - Non-Randomized||139
10342572|NCT00392925|11480043|FG001|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
10342573|NCT00392925|11480044|FG002|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
10342574|NCT00392925|11480045|FG003|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
10342575|NCT00392925|11480042|FG000|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||38
10342576|NCT00392925|11480043|FG001|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
10342577|NCT00392925|11480044|FG002|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
10342578|NCT00392925|11480045|FG003|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
10426481|NCT00847704|11572163|FG000|STARTED|Overall Study||3
10715348|NCT02688387|11880059|FG016|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10342579|NCT00392925|11480042|FG000|STARTED|Randomization to Treatment Group Period||0
10342580|NCT00392925|11480043|FG001|STARTED|Randomization to Treatment Group Period||27
10342581|NCT00392925|11480044|FG002|STARTED|Randomization to Treatment Group Period||56
10342582|NCT00392925|11480045|FG003|STARTED|Randomization to Treatment Group Period||56
10342583|NCT00392925|11480042|FG000|COMPLETED|Randomization to Treatment Group Period||0
10342584|NCT00392925|11480043|FG001|COMPLETED|Randomization to Treatment Group Period|AT Week 20|19
10342585|NCT00392925|11480044|FG002|COMPLETED|Randomization to Treatment Group Period|At Week 20|37
10342586|NCT00392925|11480045|FG003|COMPLETED|Randomization to Treatment Group Period|At Week 20|38
10342587|NCT00392925|11480042|FG000|NOT COMPLETED|Randomization to Treatment Group Period||0
10342588|NCT00392925|11480043|FG001|NOT COMPLETED|Randomization to Treatment Group Period||8
10342589|NCT00392925|11480044|FG002|NOT COMPLETED|Randomization to Treatment Group Period||19
10342590|NCT00392925|11480045|FG003|NOT COMPLETED|Randomization to Treatment Group Period||18
10342591|NCT00392951|11480061|FG000|STARTED|Overall Study||30
10342592|NCT00392951|11480061|FG000|COMPLETED|Overall Study||30
10342593|NCT00392951|11480061|FG000|NOT COMPLETED|Overall Study||0
10342594|NCT00392990|11480067|FG000|STARTED|Treatment on Study||20
10342595|NCT00392990|11480068|FG001|STARTED|Treatment on Study||5
10342596|NCT00392990|11480067|FG000|COMPLETED|Treatment on Study||17
10342597|NCT00392990|11480068|FG001|COMPLETED|Treatment on Study||4
10342598|NCT00392990|11480067|FG000|NOT COMPLETED|Treatment on Study||3
10342599|NCT00392990|11480068|FG001|NOT COMPLETED|Treatment on Study||1
10342600|NCT00392990|11480067|FG000|STARTED|Follow up for 2 Years||20
10342601|NCT00392990|11480068|FG001|STARTED|Follow up for 2 Years||5
10342602|NCT00392990|11480067|FG000|COMPLETED|Follow up for 2 Years||16
10342603|NCT00392990|11480068|FG001|COMPLETED|Follow up for 2 Years||5
10342604|NCT00392990|11480067|FG000|NOT COMPLETED|Follow up for 2 Years||4
10342605|NCT00392990|11480068|FG001|NOT COMPLETED|Follow up for 2 Years||0
10342606|NCT00393029|11480076|FG000|STARTED|Overall Study||2
10342607|NCT00393029|11480077|FG001|STARTED|Overall Study||10
10342608|NCT00393029|11480076|FG000|COMPLETED|Overall Study||2
10342609|NCT00393029|11480077|FG001|COMPLETED|Overall Study||9
10342610|NCT00393029|11480076|FG000|NOT COMPLETED|Overall Study||0
10342611|NCT00393029|11480077|FG001|NOT COMPLETED|Overall Study||1
10342612|NCT00393042|11480084|FG000|STARTED|First Intervention||31
10342613|NCT00393042|11480085|FG001|STARTED|First Intervention||33
10342614|NCT00393042|11480084|FG000|Completed the Placebo Dosage|First Intervention||27
10342615|NCT00393042|11480085|FG001|Completed the Placebo Dosage|First Intervention||29
10342616|NCT00393042|11480084|FG000|Completed 10mg Dosage|First Intervention||29
10342617|NCT00393042|11480085|FG001|Completed 10mg Dosage|First Intervention||29
10342618|NCT00393042|11480084|FG000|Completed 20 mg Dosage|First Intervention||26
10342619|NCT00393042|11480085|FG001|Completed 20 mg Dosage|First Intervention||28
10342620|NCT00393042|11480084|FG000|Completed 25/30mg Dosage|First Intervention||27
10342621|NCT00393042|11480085|FG001|Completed 25/30mg Dosage|First Intervention||27
10342622|NCT00393042|11480084|FG000|COMPLETED|First Intervention||26
10342623|NCT00393042|11480085|FG001|COMPLETED|First Intervention||27
10342624|NCT00393042|11480084|FG000|NOT COMPLETED|First Intervention||5
10342625|NCT00393042|11480085|FG001|NOT COMPLETED|First Intervention||6
10342626|NCT00393042|11480084|FG000|STARTED|Second Intervetion||26
10342627|NCT00393042|11480085|FG001|STARTED|Second Intervetion||27
10342628|NCT00393042|11480084|FG000|Completed Placebo Dosage|Second Intervetion||25
10342629|NCT00393042|11480085|FG001|Completed Placebo Dosage|Second Intervetion||21
10342630|NCT00393042|11480084|FG000|Completed 10 mg Dosage|Second Intervetion||26
10342631|NCT00393042|11480085|FG001|Completed 10 mg Dosage|Second Intervetion||24
10342632|NCT00393042|11480084|FG000|Completed the 20mg Dosage|Second Intervetion||24
10342633|NCT00393042|11480085|FG001|Completed the 20mg Dosage|Second Intervetion||21
10342634|NCT00393042|11480084|FG000|Completed 25/30 mg Dosage|Second Intervetion||24
10342635|NCT00393042|11480085|FG001|Completed 25/30 mg Dosage|Second Intervetion||20
10342636|NCT00393042|11480084|FG000|COMPLETED|Second Intervetion||24
10342637|NCT00393042|11480085|FG001|COMPLETED|Second Intervetion||19
10342638|NCT00393042|11480084|FG000|NOT COMPLETED|Second Intervetion||2
10342639|NCT00393042|11480085|FG001|NOT COMPLETED|Second Intervetion||8
10342640|NCT00393094|11480139|FG000|STARTED|Period1Bevacizumab & Irinotecan Patients||31
10342641|NCT00393094|11480139|FG000|COMPLETED|Period1Bevacizumab & Irinotecan Patients||30
10342642|NCT00393094|11480139|FG000|NOT COMPLETED|Period1Bevacizumab & Irinotecan Patients||1
10342643|NCT00393094|11480139|FG000|STARTED|Disease Progression After Trtmt: Onstudy||30
10715349|NCT02688387|11880060|FG017|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10715350|NCT02688387|11880061|FG018|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10715351|NCT02688387|11880062|FG019|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10715352|NCT02688387|11880063|FG020|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10715353|NCT02688387|11880064|FG021|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10530911|NCT01408719|11683188|FG008|STARTED|Washout Period (28 Days)||1
10530912|NCT01408719|11683189|FG009|STARTED|Washout Period (28 Days)||1
10530913|NCT01408719|11683190|FG010|STARTED|Washout Period (28 Days)||2
10530914|NCT01408719|11683191|FG011|STARTED|Washout Period (28 Days)||2
10530915|NCT01408719|11683192|FG012|STARTED|Washout Period (28 Days)||1
10530916|NCT01408719|11683193|FG013|STARTED|Washout Period (28 Days)||3
10530917|NCT01408719|11683194|FG014|STARTED|Washout Period (28 Days)||1
10530918|NCT01408719|11683195|FG015|STARTED|Washout Period (28 Days)||1
10530919|NCT01408719|11683196|FG016|STARTED|Washout Period (28 Days)||2
10530920|NCT01408719|11683197|FG017|STARTED|Washout Period (28 Days)||2
10530921|NCT01408719|11683198|FG018|STARTED|Washout Period (28 Days)||0
10530922|NCT01408719|11683199|FG019|STARTED|Washout Period (28 Days)||1
10530923|NCT01408719|11683180|FG000|COMPLETED|Washout Period (28 Days)||2
10530924|NCT01408719|11683181|FG001|COMPLETED|Washout Period (28 Days)||3
10530925|NCT01408719|11683182|FG002|COMPLETED|Washout Period (28 Days)||1
10530926|NCT01408719|11683183|FG003|COMPLETED|Washout Period (28 Days)||2
10530927|NCT01408719|11683184|FG004|COMPLETED|Washout Period (28 Days)||3
10530928|NCT01408719|11683185|FG005|COMPLETED|Washout Period (28 Days)||3
10530929|NCT01408719|11683186|FG006|COMPLETED|Washout Period (28 Days)||2
10530930|NCT01408719|11683187|FG007|COMPLETED|Washout Period (28 Days)||2
10530931|NCT01408719|11683188|FG008|COMPLETED|Washout Period (28 Days)||1
10530932|NCT01408719|11683189|FG009|COMPLETED|Washout Period (28 Days)||1
10530933|NCT01408719|11683190|FG010|COMPLETED|Washout Period (28 Days)||2
10530934|NCT01408719|11683191|FG011|COMPLETED|Washout Period (28 Days)||2
10530935|NCT01408719|11683192|FG012|COMPLETED|Washout Period (28 Days)||1
10530936|NCT01408719|11683193|FG013|COMPLETED|Washout Period (28 Days)||3
10530937|NCT01408719|11683194|FG014|COMPLETED|Washout Period (28 Days)||1
10530938|NCT01408719|11683195|FG015|COMPLETED|Washout Period (28 Days)||1
10530939|NCT01408719|11683196|FG016|COMPLETED|Washout Period (28 Days)||2
10530940|NCT01408719|11683197|FG017|COMPLETED|Washout Period (28 Days)||2
10655156|NCT02207244|11815913|FG009|Treated|Placebo Controlled Period: Week 0-16||0
10530941|NCT01408719|11683198|FG018|COMPLETED|Washout Period (28 Days)||0
10530942|NCT01408719|11683199|FG019|COMPLETED|Washout Period (28 Days)||1
10530943|NCT01408719|11683180|FG000|NOT COMPLETED|Washout Period (28 Days)||0
10530944|NCT01408719|11683181|FG001|NOT COMPLETED|Washout Period (28 Days)||0
10530945|NCT01408719|11683182|FG002|NOT COMPLETED|Washout Period (28 Days)||0
10715354|NCT02688387|11880043|FG000|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10715355|NCT02688387|11880044|FG001|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10715356|NCT02688387|11880045|FG002|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10715357|NCT02688387|11880046|FG003|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10530946|NCT01408719|11683183|FG003|NOT COMPLETED|Washout Period (28 Days)||0
10530947|NCT01408719|11683184|FG004|NOT COMPLETED|Washout Period (28 Days)||0
10530948|NCT01408719|11683185|FG005|NOT COMPLETED|Washout Period (28 Days)||0
10530949|NCT01408719|11683186|FG006|NOT COMPLETED|Washout Period (28 Days)||0
10530950|NCT01408719|11683187|FG007|NOT COMPLETED|Washout Period (28 Days)||0
10530951|NCT01408719|11683188|FG008|NOT COMPLETED|Washout Period (28 Days)||0
10530952|NCT01408719|11683189|FG009|NOT COMPLETED|Washout Period (28 Days)||0
10530953|NCT01408719|11683190|FG010|NOT COMPLETED|Washout Period (28 Days)||0
10530954|NCT01408719|11683191|FG011|NOT COMPLETED|Washout Period (28 Days)||0
10530955|NCT01408719|11683192|FG012|NOT COMPLETED|Washout Period (28 Days)||0
10530956|NCT01408719|11683193|FG013|NOT COMPLETED|Washout Period (28 Days)||0
10530957|NCT01408719|11683194|FG014|NOT COMPLETED|Washout Period (28 Days)||0
10530958|NCT01408719|11683195|FG015|NOT COMPLETED|Washout Period (28 Days)||0
10655157|NCT02207244|11815914|FG010|Treated|Placebo Controlled Period: Week 0-16||0
10531086|NCT01408901|11683244|FG002|NOT COMPLETED|26-Week Follow-Up||0
10655158|NCT02207244|11815904|FG000|COMPLETED|Placebo Controlled Period: Week 0-16||233
10655159|NCT02207244|11815905|FG001|COMPLETED|Placebo Controlled Period: Week 0-16||478
10655160|NCT02207244|11815906|FG002|COMPLETED|Placebo Controlled Period: Week 0-16||237
10655161|NCT02207244|11815907|FG003|COMPLETED|Placebo Controlled Period: Week 0-16||0
10655162|NCT02207244|11815908|FG004|COMPLETED|Placebo Controlled Period: Week 0-16||0
10655163|NCT02207244|11815909|FG005|COMPLETED|Placebo Controlled Period: Week 0-16||0
10655164|NCT02207244|11815910|FG006|COMPLETED|Placebo Controlled Period: Week 0-16||0
10655165|NCT02207244|11815911|FG007|COMPLETED|Placebo Controlled Period: Week 0-16||0
10655166|NCT02207244|11815912|FG008|COMPLETED|Placebo Controlled Period: Week 0-16||0
10655167|NCT02207244|11815913|FG009|COMPLETED|Placebo Controlled Period: Week 0-16||0
10655168|NCT02207244|11815914|FG010|COMPLETED|Placebo Controlled Period: Week 0-16||0
10655169|NCT02207244|11815904|FG000|NOT COMPLETED|Placebo Controlled Period: Week 0-16||15
10655170|NCT02207244|11815905|FG001|NOT COMPLETED|Placebo Controlled Period: Week 0-16||18
10655171|NCT02207244|11815906|FG002|NOT COMPLETED|Placebo Controlled Period: Week 0-16||11
10655172|NCT02207244|11815907|FG003|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
10655173|NCT02207244|11815908|FG004|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
10655174|NCT02207244|11815909|FG005|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
10655175|NCT02207244|11815910|FG006|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
10655176|NCT02207244|11815911|FG007|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
10655177|NCT02207244|11815912|FG008|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
10655178|NCT02207244|11815913|FG009|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
10655179|NCT02207244|11815914|FG010|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
10655180|NCT02207244|11815904|FG000|STARTED|Placebo Crossover and ACP: Week 16-28||0
10530959|NCT01408719|11683196|FG016|NOT COMPLETED|Washout Period (28 Days)||0
10530960|NCT01408719|11683197|FG017|NOT COMPLETED|Washout Period (28 Days)||0
10530961|NCT01408719|11683198|FG018|NOT COMPLETED|Washout Period (28 Days)||0
10530962|NCT01408719|11683199|FG019|NOT COMPLETED|Washout Period (28 Days)||0
10530963|NCT01408719|11683180|FG000|STARTED|Fourth Intervention (35 Days)||2
10530964|NCT01408719|11683181|FG001|STARTED|Fourth Intervention (35 Days)||3
10530965|NCT01408719|11683182|FG002|STARTED|Fourth Intervention (35 Days)||1
10530966|NCT01408719|11683183|FG003|STARTED|Fourth Intervention (35 Days)||2
10530967|NCT01408719|11683184|FG004|STARTED|Fourth Intervention (35 Days)||3
10530968|NCT01408719|11683185|FG005|STARTED|Fourth Intervention (35 Days)||3
10530969|NCT01408719|11683186|FG006|STARTED|Fourth Intervention (35 Days)||2
10530970|NCT01408719|11683187|FG007|STARTED|Fourth Intervention (35 Days)||2
10530971|NCT01408719|11683188|FG008|STARTED|Fourth Intervention (35 Days)||1
10530972|NCT01408719|11683189|FG009|STARTED|Fourth Intervention (35 Days)||1
10530973|NCT01408719|11683190|FG010|STARTED|Fourth Intervention (35 Days)||2
10530974|NCT01408719|11683191|FG011|STARTED|Fourth Intervention (35 Days)||2
10530975|NCT01408719|11683192|FG012|STARTED|Fourth Intervention (35 Days)||1
10530976|NCT01408719|11683193|FG013|STARTED|Fourth Intervention (35 Days)||3
10530977|NCT01408719|11683194|FG014|STARTED|Fourth Intervention (35 Days)||1
10530978|NCT01408719|11683195|FG015|STARTED|Fourth Intervention (35 Days)||1
10530979|NCT01408719|11683196|FG016|STARTED|Fourth Intervention (35 Days)||2
10530980|NCT01408719|11683197|FG017|STARTED|Fourth Intervention (35 Days)||2
10530981|NCT01408719|11683198|FG018|STARTED|Fourth Intervention (35 Days)||0
10530982|NCT01408719|11683199|FG019|STARTED|Fourth Intervention (35 Days)||1
10530983|NCT01408719|11683180|FG000|COMPLETED|Fourth Intervention (35 Days)||2
10530984|NCT01408719|11683181|FG001|COMPLETED|Fourth Intervention (35 Days)||3
10530985|NCT01408719|11683182|FG002|COMPLETED|Fourth Intervention (35 Days)||1
10530986|NCT01408719|11683183|FG003|COMPLETED|Fourth Intervention (35 Days)||2
10530987|NCT01408719|11683184|FG004|COMPLETED|Fourth Intervention (35 Days)||3
10530988|NCT01408719|11683185|FG005|COMPLETED|Fourth Intervention (35 Days)||3
10530989|NCT01408719|11683186|FG006|COMPLETED|Fourth Intervention (35 Days)||2
10530990|NCT01408719|11683187|FG007|COMPLETED|Fourth Intervention (35 Days)||2
10530991|NCT01408719|11683188|FG008|COMPLETED|Fourth Intervention (35 Days)||1
10530992|NCT01408719|11683189|FG009|COMPLETED|Fourth Intervention (35 Days)||1
10530993|NCT01408719|11683190|FG010|COMPLETED|Fourth Intervention (35 Days)||2
10530994|NCT01408719|11683191|FG011|COMPLETED|Fourth Intervention (35 Days)||2
10530995|NCT01408719|11683192|FG012|COMPLETED|Fourth Intervention (35 Days)||1
10530996|NCT01408719|11683193|FG013|COMPLETED|Fourth Intervention (35 Days)||3
10530997|NCT01408719|11683194|FG014|COMPLETED|Fourth Intervention (35 Days)||1
10530998|NCT01408719|11683195|FG015|COMPLETED|Fourth Intervention (35 Days)||1
10530999|NCT01408719|11683196|FG016|COMPLETED|Fourth Intervention (35 Days)||2
10531000|NCT01408719|11683197|FG017|COMPLETED|Fourth Intervention (35 Days)||2
10531001|NCT01408719|11683198|FG018|COMPLETED|Fourth Intervention (35 Days)||0
10531002|NCT01408719|11683199|FG019|COMPLETED|Fourth Intervention (35 Days)||1
10531003|NCT01408719|11683180|FG000|NOT COMPLETED|Fourth Intervention (35 Days)||0
10531004|NCT01408719|11683181|FG001|NOT COMPLETED|Fourth Intervention (35 Days)||0
10531005|NCT01408719|11683182|FG002|NOT COMPLETED|Fourth Intervention (35 Days)||0
10531006|NCT01408719|11683183|FG003|NOT COMPLETED|Fourth Intervention (35 Days)||0
10531007|NCT01408719|11683184|FG004|NOT COMPLETED|Fourth Intervention (35 Days)||0
10531008|NCT01408719|11683185|FG005|NOT COMPLETED|Fourth Intervention (35 Days)||0
10531009|NCT01408719|11683186|FG006|NOT COMPLETED|Fourth Intervention (35 Days)||0
10531010|NCT01408719|11683187|FG007|NOT COMPLETED|Fourth Intervention (35 Days)||0
10531011|NCT01408719|11683188|FG008|NOT COMPLETED|Fourth Intervention (35 Days)||0
10531012|NCT01408719|11683189|FG009|NOT COMPLETED|Fourth Intervention (35 Days)||0
10531013|NCT01408719|11683190|FG010|NOT COMPLETED|Fourth Intervention (35 Days)||0
10531014|NCT01408719|11683191|FG011|NOT COMPLETED|Fourth Intervention (35 Days)||0
10531015|NCT01408719|11683192|FG012|NOT COMPLETED|Fourth Intervention (35 Days)||0
10715358|NCT02688387|11880047|FG004|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10715359|NCT02688387|11880048|FG005|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10715360|NCT02688387|11880049|FG006|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10715361|NCT02688387|11880050|FG007|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10715362|NCT02688387|11880051|FG008|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10531016|NCT01408719|11683193|FG013|NOT COMPLETED|Fourth Intervention (35 Days)||0
10531017|NCT01408719|11683194|FG014|NOT COMPLETED|Fourth Intervention (35 Days)||0
10531018|NCT01408719|11683195|FG015|NOT COMPLETED|Fourth Intervention (35 Days)||0
10531019|NCT01408719|11683196|FG016|NOT COMPLETED|Fourth Intervention (35 Days)||0
10531020|NCT01408719|11683197|FG017|NOT COMPLETED|Fourth Intervention (35 Days)||0
10531021|NCT01408719|11683198|FG018|NOT COMPLETED|Fourth Intervention (35 Days)||0
10531022|NCT01408719|11683199|FG019|NOT COMPLETED|Fourth Intervention (35 Days)||0
10531023|NCT01408732|11683209|FG000|STARTED|Overall Study||9
10531024|NCT01408732|11683210|FG001|STARTED|Overall Study||9
10715363|NCT02688387|11880052|FG009|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10531025|NCT01408732|11683209|FG000|COMPLETED|Overall Study||7
10531026|NCT01408732|11683210|FG001|COMPLETED|Overall Study||7
10531027|NCT01408732|11683209|FG000|NOT COMPLETED|Overall Study||2
10531028|NCT01408732|11683210|FG001|NOT COMPLETED|Overall Study||2
10531029|NCT01408862|11683216|FG000|STARTED|Overall Study||20
10531030|NCT01408862|11683216|FG000|COMPLETED|Overall Study||20
10531031|NCT01408862|11683216|FG000|NOT COMPLETED|Overall Study||0
10531032|NCT01408888|11683221|FG000|STARTED|First Intervention||18
10531033|NCT01408888|11683222|FG001|STARTED|First Intervention||11
10531034|NCT01408888|11683221|FG000|Received at Least 1 Dose of Drug|First Intervention||18
10531035|NCT01408888|11683222|FG001|Received at Least 1 Dose of Drug|First Intervention||11
10531036|NCT01408888|11683221|FG000|COMPLETED|First Intervention||18
10531037|NCT01408888|11683222|FG001|COMPLETED|First Intervention||8
10531038|NCT01408888|11683221|FG000|NOT COMPLETED|First Intervention||0
10531039|NCT01408888|11683222|FG001|NOT COMPLETED|First Intervention||3
10531040|NCT01408888|11683221|FG000|STARTED|Washout of at Least 21 Days||18
10531041|NCT01408888|11683222|FG001|STARTED|Washout of at Least 21 Days||8
10531042|NCT01408888|11683221|FG000|COMPLETED|Washout of at Least 21 Days||18
10531043|NCT01408888|11683222|FG001|COMPLETED|Washout of at Least 21 Days||8
10531044|NCT01408888|11683221|FG000|NOT COMPLETED|Washout of at Least 21 Days||0
10531045|NCT01408888|11683222|FG001|NOT COMPLETED|Washout of at Least 21 Days||0
10531046|NCT01408888|11683221|FG000|STARTED|Second Intervention||18
10655181|NCT02207244|11815905|FG001|STARTED|Placebo Crossover and ACP: Week 16-28||0
10655182|NCT02207244|11815906|FG002|STARTED|Placebo Crossover and ACP: Week 16-28||0
10655183|NCT02207244|11815907|FG003|STARTED|Placebo Crossover and ACP: Week 16-28||233
10655184|NCT02207244|11815908|FG004|STARTED|Placebo Crossover and ACP: Week 16-28||478
10655185|NCT02207244|11815909|FG005|STARTED|Placebo Crossover and ACP: Week 16-28||237
10531047|NCT01408888|11683222|FG001|STARTED|Second Intervention||8
10531048|NCT01408888|11683221|FG000|COMPLETED|Second Intervention||16
10531049|NCT01408888|11683222|FG001|COMPLETED|Second Intervention||8
10531050|NCT01408888|11683221|FG000|NOT COMPLETED|Second Intervention||2
10531051|NCT01408888|11683222|FG001|NOT COMPLETED|Second Intervention||0
10531052|NCT01408901|11683242|FG000|STARTED|6-Week Follow-Up||53
10531053|NCT01408901|11683243|FG001|STARTED|6-Week Follow-Up||53
10531054|NCT01408901|11683244|FG002|STARTED|6-Week Follow-Up||53
10531055|NCT01408901|11683245|FG003|STARTED|6-Week Follow-Up||51
10531056|NCT01408901|11683242|FG000|COMPLETED|6-Week Follow-Up||50
10531057|NCT01408901|11683243|FG001|COMPLETED|6-Week Follow-Up||51
10531058|NCT01408901|11683244|FG002|COMPLETED|6-Week Follow-Up||50
10531059|NCT01408901|11683245|FG003|COMPLETED|6-Week Follow-Up||47
10531060|NCT01408901|11683242|FG000|NOT COMPLETED|6-Week Follow-Up||3
10531061|NCT01408901|11683243|FG001|NOT COMPLETED|6-Week Follow-Up||2
10531062|NCT01408901|11683244|FG002|NOT COMPLETED|6-Week Follow-Up||3
10531063|NCT01408901|11683245|FG003|NOT COMPLETED|6-Week Follow-Up||4
10531064|NCT01408901|11683242|FG000|STARTED|12-Week Follow-Up (Primary Endpoint)||50
10531065|NCT01408901|11683243|FG001|STARTED|12-Week Follow-Up (Primary Endpoint)||52
10531066|NCT01408901|11683244|FG002|STARTED|12-Week Follow-Up (Primary Endpoint)||50
10531067|NCT01408901|11683245|FG003|STARTED|12-Week Follow-Up (Primary Endpoint)||49
10531068|NCT01408901|11683242|FG000|COMPLETED|12-Week Follow-Up (Primary Endpoint)||49
10531069|NCT01408901|11683243|FG001|COMPLETED|12-Week Follow-Up (Primary Endpoint)||50
10531070|NCT01408901|11683244|FG002|COMPLETED|12-Week Follow-Up (Primary Endpoint)||50
10531071|NCT01408901|11683245|FG003|COMPLETED|12-Week Follow-Up (Primary Endpoint)||46
10531072|NCT01408901|11683242|FG000|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||1
10531073|NCT01408901|11683243|FG001|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||2
10531074|NCT01408901|11683244|FG002|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||0
10531075|NCT01408901|11683245|FG003|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||3
10531076|NCT01408901|11683242|FG000|STARTED|26-Week Follow-Up||49
10531077|NCT01408901|11683243|FG001|STARTED|26-Week Follow-Up||52
10531078|NCT01408901|11683244|FG002|STARTED|26-Week Follow-Up||50
10531079|NCT01408901|11683245|FG003|STARTED|26-Week Follow-Up||47
10531080|NCT01408901|11683242|FG000|COMPLETED|26-Week Follow-Up||48
10531081|NCT01408901|11683243|FG001|COMPLETED|26-Week Follow-Up||50
10531082|NCT01408901|11683244|FG002|COMPLETED|26-Week Follow-Up||50
10531083|NCT01408901|11683245|FG003|COMPLETED|26-Week Follow-Up||46
10531084|NCT01408901|11683242|FG000|NOT COMPLETED|26-Week Follow-Up||1
10531085|NCT01408901|11683243|FG001|NOT COMPLETED|26-Week Follow-Up||2
10531087|NCT01408901|11683245|FG003|NOT COMPLETED|26-Week Follow-Up||1
10531088|NCT01408914|11683260|FG000|STARTED|Overall Study||60
10531089|NCT01408914|11683261|FG001|STARTED|Overall Study||60
10531090|NCT01408914|11683262|FG002|STARTED|Overall Study||60
10531091|NCT01408914|11683260|FG000|COMPLETED|Overall Study||48
10531092|NCT01408914|11683261|FG001|COMPLETED|Overall Study||48
10531093|NCT01408914|11683262|FG002|COMPLETED|Overall Study||47
10531094|NCT01408914|11683260|FG000|NOT COMPLETED|Overall Study||12
10531095|NCT01408914|11683261|FG001|NOT COMPLETED|Overall Study||12
10531096|NCT01408914|11683262|FG002|NOT COMPLETED|Overall Study||13
10531097|NCT01408992|11683270|FG000|STARTED|Overall Study||558
10531098|NCT01408992|11683270|FG000|COMPLETED|Overall Study||558
10531099|NCT01408992|11683270|FG000|NOT COMPLETED|Overall Study||0
10531100|NCT01409096|11683284|FG000|STARTED|Overall Study||40
10531101|NCT01409096|11683285|FG001|STARTED|Overall Study||40
10531102|NCT01409096|11683284|FG000|COMPLETED|Overall Study||38
10531103|NCT01409096|11683285|FG001|COMPLETED|Overall Study||35
10531104|NCT01409096|11683284|FG000|NOT COMPLETED|Overall Study||2
10531105|NCT01409096|11683285|FG001|NOT COMPLETED|Overall Study||5
10531106|NCT01409213|11683291|FG000|STARTED|Overall Study||1523
10531107|NCT01409213|11683291|FG000|COMPLETED|Overall Study||1523
10531108|NCT01409213|11683291|FG000|NOT COMPLETED|Overall Study||0
10531109|NCT01409239|11683297|FG000|STARTED|Overall Study||16
10531110|NCT01409239|11683298|FG001|STARTED|Overall Study||17
10531111|NCT01409239|11683297|FG000|COMPLETED|Overall Study||16
10531112|NCT01409239|11683298|FG001|COMPLETED|Overall Study||17
10531113|NCT01409239|11683297|FG000|NOT COMPLETED|Overall Study||0
10531114|NCT01409239|11683298|FG001|NOT COMPLETED|Overall Study||0
10531115|NCT01409291|11683306|FG000|STARTED|Overall Study||36
10531116|NCT01409291|11683307|FG001|STARTED|Overall Study||28
10531117|NCT01409291|11683306|FG000|COMPLETED|Overall Study||29
10531118|NCT01409291|11683307|FG001|COMPLETED|Overall Study||19
10531119|NCT01409291|11683306|FG000|NOT COMPLETED|Overall Study||7
10531120|NCT01409291|11683307|FG001|NOT COMPLETED|Overall Study||9
10531121|NCT01409382|11683315|FG000|STARTED|Overall Study||240
10531122|NCT01409382|11683316|FG001|STARTED|Overall Study||240
10531123|NCT01409382|11683315|FG000|COMPLETED|Overall Study||159
10531124|NCT01409382|11683316|FG001|COMPLETED|Overall Study||160
10531125|NCT01409382|11683315|FG000|NOT COMPLETED|Overall Study||81
10531126|NCT01409382|11683316|FG001|NOT COMPLETED|Overall Study||80
10531127|NCT01409434|11683326|FG000|STARTED|Overall Study||44
10531128|NCT01409434|11683326|FG000|COMPLETED|Overall Study||40
10531129|NCT01409434|11683326|FG000|NOT COMPLETED|Overall Study||4
10531130|NCT01409564|11683332|FG000|STARTED|Overall Study||23
10531131|NCT01409564|11683333|FG001|STARTED|Overall Study||23
10531132|NCT01409564|11683332|FG000|COMPLETED|Overall Study||18
10342644|NCT00393094|11480139|FG000|COMPLETED|Disease Progression After Trtmt: Onstudy||29
10342645|NCT00393094|11480139|FG000|NOT COMPLETED|Disease Progression After Trtmt: Onstudy||1
10342646|NCT00393367|11480147|FG000|STARTED|Overall Study||91
10342647|NCT00393367|11480148|FG001|STARTED|Overall Study||88
10342648|NCT00393367|11480147|FG000|COMPLETED|Overall Study||89
10342649|NCT00393367|11480148|FG001|COMPLETED|Overall Study||81
10342650|NCT00393367|11480147|FG000|NOT COMPLETED|Overall Study||2
10342651|NCT00393367|11480148|FG001|NOT COMPLETED|Overall Study||7
10342652|NCT00393380|11480156|FG000|STARTED|Overall Study||13
10342653|NCT00393380|11480156|FG000|COMPLETED|Overall Study||13
10342654|NCT00393380|11480156|FG000|NOT COMPLETED|Overall Study||0
10342655|NCT00393458|11480164|FG000|STARTED|Overall Study||437
10342656|NCT00393458|11480165|FG001|STARTED|Overall Study||428
10342657|NCT00393458|11480166|FG002|STARTED|Overall Study||435
10342658|NCT00393458|11480167|FG003|STARTED|Overall Study||432
10342659|NCT00393458|11480164|FG000|Exposed to Study Medication or Placebo|Overall Study||437
10342660|NCT00393458|11480165|FG001|Exposed to Study Medication or Placebo|Overall Study||425
10342661|NCT00393458|11480166|FG002|Exposed to Study Medication or Placebo|Overall Study||434
10342662|NCT00393458|11480167|FG003|Exposed to Study Medication or Placebo|Overall Study||432
10342663|NCT00393458|11480164|FG000|COMPLETED|Overall Study||338
10342664|NCT00393458|11480165|FG001|COMPLETED|Overall Study||326
10342665|NCT00393458|11480166|FG002|COMPLETED|Overall Study||323
10342666|NCT00393458|11480167|FG003|COMPLETED|Overall Study||295
10342667|NCT00393458|11480164|FG000|NOT COMPLETED|Overall Study||99
10342668|NCT00393458|11480165|FG001|NOT COMPLETED|Overall Study||102
10342669|NCT00393458|11480166|FG002|NOT COMPLETED|Overall Study||112
10531133|NCT01409564|11683333|FG001|COMPLETED|Overall Study||18
10531134|NCT01409564|11683332|FG000|NOT COMPLETED|Overall Study||5
10531135|NCT01409564|11683333|FG001|NOT COMPLETED|Overall Study||5
10531136|NCT01409707|11683346|FG000|STARTED|Overall Study||41
10531137|NCT01409707|11683347|FG001|STARTED|Overall Study||45
10531138|NCT01409707|11683348|FG002|STARTED|Overall Study||40
10531139|NCT01409707|11683346|FG000|COMPLETED|Overall Study||36
10531140|NCT01409707|11683347|FG001|COMPLETED|Overall Study||28
10342670|NCT00393458|11480167|FG003|NOT COMPLETED|Overall Study||137
10342671|NCT00393484|11480179|FG000|STARTED|Double-blind Period (Day 1 to Week 96)|Number treated|56
10531141|NCT01409707|11683348|FG002|COMPLETED|Overall Study||24
10531142|NCT01409707|11683346|FG000|NOT COMPLETED|Overall Study||5
10531143|NCT01409707|11683347|FG001|NOT COMPLETED|Overall Study||17
10531144|NCT01409707|11683348|FG002|NOT COMPLETED|Overall Study||16
10531145|NCT01409811|11683355|FG000|STARTED|Overall Study||9
10531146|NCT01409811|11683355|FG000|COMPLETED|Overall Study||8
10531147|NCT01409811|11683355|FG000|NOT COMPLETED|Overall Study||1
10531148|NCT01409837|11683361|FG000|STARTED|Overall Study||17
10531149|NCT01409837|11683362|FG001|STARTED|Overall Study||16
10531150|NCT01409837|11683361|FG000|6th Week|Overall Study||17
10531151|NCT01409837|11683362|FG001|6th Week|Overall Study||16
10531152|NCT01409837|11683361|FG000|12th Week|Overall Study|Moved away to another location|16
10531153|NCT01409837|11683362|FG001|12th Week|Overall Study||16
10531154|NCT01409837|11683361|FG000|24th Week|Overall Study||16
10531155|NCT01409837|11683362|FG001|24th Week|Overall Study|Diagnosed with Lymphocytic Lymphoma and withdrawn|15
10531156|NCT01409837|11683361|FG000|48th Week|Overall Study|Lost to follow-up|15
10531157|NCT01409837|11683362|FG001|48th Week|Overall Study||15
10531158|NCT01409837|11683361|FG000|96th Week|Overall Study||15
10531159|NCT01409837|11683362|FG001|96th Week|Overall Study||15
10531160|NCT01409837|11683361|FG000|102nd Week|Overall Study||15
10531161|NCT01409837|11683362|FG001|102nd Week|Overall Study|Married another wife|14
10531162|NCT01409837|11683361|FG000|114th Week|Overall Study||15
10531163|NCT01409837|11683362|FG001|114th Week|Overall Study||14
10531164|NCT01409837|11683361|FG000|138th Week|Overall Study||15
10531165|NCT01409837|11683362|FG001|138th Week|Overall Study||14
10531166|NCT01409837|11683361|FG000|186th Week|Overall Study|Moved away to another location|14
10531167|NCT01409837|11683362|FG001|186th Week|Overall Study||14
10531168|NCT01409837|11683361|FG000|282nd Week|Overall Study||14
10531169|NCT01409837|11683362|FG001|282nd Week|Overall Study||14
10531170|NCT01409837|11683361|FG000|COMPLETED|Overall Study||14
10531171|NCT01409837|11683362|FG001|COMPLETED|Overall Study||14
10531172|NCT01409837|11683361|FG000|NOT COMPLETED|Overall Study||3
10531173|NCT01409837|11683362|FG001|NOT COMPLETED|Overall Study||2
10531174|NCT01409915|11683372|FG000|STARTED|Overall Study||21
10531175|NCT01409915|11683373|FG001|STARTED|Overall Study||23
10531176|NCT01409915|11683372|FG000|COMPLETED|Overall Study||20
10531177|NCT01409915|11683373|FG001|COMPLETED|Overall Study||20
10531178|NCT01409915|11683372|FG000|NOT COMPLETED|Overall Study||1
10531179|NCT01409915|11683373|FG001|NOT COMPLETED|Overall Study||3
10531180|NCT01409928|11683379|FG000|STARTED|Overall Study||16
10531181|NCT01409928|11683379|FG000|COMPLETED|Overall Study||4
10531182|NCT01409928|11683379|FG000|NOT COMPLETED|Overall Study||12
10531183|NCT01409993|11683385|FG000|STARTED|Overall Study||25
10531184|NCT01409993|11683386|FG001|STARTED|Overall Study||26
10531185|NCT01409993|11683387|FG002|STARTED|Overall Study||14
10531186|NCT01409993|11683388|FG003|STARTED|Overall Study||13
10531187|NCT01409993|11683385|FG000|COMPLETED|Overall Study||21
10531188|NCT01409993|11683386|FG001|COMPLETED|Overall Study||21
10531189|NCT01409993|11683387|FG002|COMPLETED|Overall Study||11
10531190|NCT01409993|11683388|FG003|COMPLETED|Overall Study||8
10531191|NCT01409993|11683385|FG000|NOT COMPLETED|Overall Study||4
10531192|NCT01409993|11683386|FG001|NOT COMPLETED|Overall Study||5
10531193|NCT01409993|11683387|FG002|NOT COMPLETED|Overall Study||3
10531194|NCT01409993|11683388|FG003|NOT COMPLETED|Overall Study||5
10531195|NCT01410058|11683404|FG000|STARTED|Washout Day 0||13
10531196|NCT01410058|11683405|FG001|STARTED|Washout Day 0||6
10531197|NCT01410058|11683404|FG000|COMPLETED|Washout Day 0||13
10531198|NCT01410058|11683405|FG001|COMPLETED|Washout Day 0||6
10531199|NCT01410058|11683404|FG000|NOT COMPLETED|Washout Day 0||0
10531200|NCT01410058|11683405|FG001|NOT COMPLETED|Washout Day 0||0
10531201|NCT01410058|11683404|FG000|STARTED|Baseline Day 22||13
10531202|NCT01410058|11683405|FG001|STARTED|Baseline Day 22||6
10531203|NCT01410058|11683404|FG000|COMPLETED|Baseline Day 22||13
10531204|NCT01410058|11683405|FG001|COMPLETED|Baseline Day 22||6
10531205|NCT01410058|11683404|FG000|NOT COMPLETED|Baseline Day 22||0
10531206|NCT01410058|11683405|FG001|NOT COMPLETED|Baseline Day 22||0
10531207|NCT01410058|11683404|FG000|STARTED|Day 35||13
10531208|NCT01410058|11683405|FG001|STARTED|Day 35||6
10531209|NCT01410058|11683404|FG000|COMPLETED|Day 35||13
10531210|NCT01410058|11683405|FG001|COMPLETED|Day 35||6
10655186|NCT02207244|11815910|FG006|STARTED|Placebo Crossover and ACP: Week 16-28||0
10531211|NCT01410058|11683404|FG000|NOT COMPLETED|Day 35||0
10531212|NCT01410058|11683405|FG001|NOT COMPLETED|Day 35||0
10531213|NCT01410084|11683415|FG000|STARTED|Overall Study||38
10531214|NCT01410084|11683416|FG001|STARTED|Overall Study||30
10531215|NCT01410084|11683415|FG000|COMPLETED|Overall Study||37
10531216|NCT01410084|11683416|FG001|COMPLETED|Overall Study||27
10531217|NCT01410084|11683415|FG000|NOT COMPLETED|Overall Study||1
10531218|NCT01410084|11683416|FG001|NOT COMPLETED|Overall Study||3
10531219|NCT01410097|11683424|FG000|STARTED|Overall Study||556
10531220|NCT01410097|11683425|FG001|STARTED|Overall Study||533
10531221|NCT01410097|11683424|FG000|COMPLETED|Overall Study||551
10531222|NCT01410097|11683425|FG001|COMPLETED|Overall Study||530
10531223|NCT01410097|11683424|FG000|NOT COMPLETED|Overall Study||5
10531224|NCT01410097|11683425|FG001|NOT COMPLETED|Overall Study||3
10531225|NCT01410110|11683433|FG000|STARTED|Overall Study||24
10531226|NCT01410110|11683434|FG001|STARTED|Overall Study||24
10531227|NCT01410110|11683433|FG000|Randomization|Overall Study||24
10531228|NCT01410110|11683434|FG001|Randomization|Overall Study||24
10531229|NCT01410110|11683433|FG000|3 Months (End of Intervention)|Overall Study||20
10531230|NCT01410110|11683434|FG001|3 Months (End of Intervention)|Overall Study||22
10531231|NCT01410110|11683433|FG000|6 Month Follow-up|Overall Study||20
10531232|NCT01410110|11683434|FG001|6 Month Follow-up|Overall Study||22
10531233|NCT01410110|11683433|FG000|COMPLETED|Overall Study||20
10531234|NCT01410110|11683434|FG001|COMPLETED|Overall Study||22
10531235|NCT01410110|11683433|FG000|NOT COMPLETED|Overall Study||4
10531236|NCT01410110|11683434|FG001|NOT COMPLETED|Overall Study||2
10531237|NCT01410227|11683440|FG000|STARTED|Overall Study||8
10531238|NCT01410227|11683441|FG001|STARTED|Overall Study||8
10531239|NCT01410227|11683442|FG002|STARTED|Overall Study||15
10531240|NCT01410227|11683443|FG003|STARTED|Overall Study||6
10531241|NCT01410227|11683440|FG000|COMPLETED|Overall Study||4
10531242|NCT01410227|11683441|FG001|COMPLETED|Overall Study||8
10531243|NCT01410227|11683442|FG002|COMPLETED|Overall Study||13
10531244|NCT01410227|11683443|FG003|COMPLETED|Overall Study||5
10531245|NCT01410227|11683440|FG000|NOT COMPLETED|Overall Study||4
10531246|NCT01410227|11683441|FG001|NOT COMPLETED|Overall Study||0
10531247|NCT01410227|11683442|FG002|NOT COMPLETED|Overall Study||2
10531248|NCT01410227|11683443|FG003|NOT COMPLETED|Overall Study||1
10531249|NCT01410240|11683456|FG000|STARTED|Overall Study||53
10531250|NCT01410240|11683457|FG001|STARTED|Overall Study||53
10531251|NCT01410240|11683458|FG002|STARTED|Overall Study||12
10531252|NCT01410240|11683456|FG000|COMPLETED|Overall Study||52
10531253|NCT01410240|11683457|FG001|COMPLETED|Overall Study||52
10531254|NCT01410240|11683458|FG002|COMPLETED|Overall Study||10
10531255|NCT01410240|11683456|FG000|NOT COMPLETED|Overall Study||1
10531256|NCT01410240|11683457|FG001|NOT COMPLETED|Overall Study||1
10531257|NCT01410240|11683458|FG002|NOT COMPLETED|Overall Study||2
10531258|NCT01410344|11683467|FG000|STARTED|Overall Study||20
10531259|NCT01410344|11683467|FG000|COMPLETED|Overall Study||17
10531260|NCT01410344|11683467|FG000|NOT COMPLETED|Overall Study||3
10531261|NCT01410357|11683475|FG000|STARTED|Overall Study||100
10531262|NCT01410357|11683476|FG001|STARTED|Overall Study||100
10531263|NCT01410357|11683475|FG000|COMPLETED|Overall Study||74
10531264|NCT01410357|11683476|FG001|COMPLETED|Overall Study||76
10531265|NCT01410357|11683475|FG000|NOT COMPLETED|Overall Study||26
10531266|NCT01410357|11683476|FG001|NOT COMPLETED|Overall Study||24
10531267|NCT01410409|11683486|FG000|STARTED|Overall Study||50
10531268|NCT01410409|11683487|FG001|STARTED|Overall Study||50
10531269|NCT01410409|11683486|FG000|COMPLETED|Overall Study||49
10531270|NCT01410409|11683487|FG001|COMPLETED|Overall Study||46
10531271|NCT01410409|11683486|FG000|NOT COMPLETED|Overall Study||1
10531272|NCT01410409|11683487|FG001|NOT COMPLETED|Overall Study||4
10531273|NCT01410448|11683495|FG000|STARTED|Overall Study||193
10531274|NCT01410448|11683496|FG001|STARTED|Overall Study||190
10531275|NCT01410448|11683495|FG000|Intent-to Treat (ITT) Analysis Set|Overall Study||193
10531276|NCT01410448|11683496|FG001|Intent-to Treat (ITT) Analysis Set|Overall Study||190
10531277|NCT01410448|11683495|FG000|Modified ITT Analysis Set|Overall Study||161
10531278|NCT01410448|11683496|FG001|Modified ITT Analysis Set|Overall Study||149
10531279|NCT01410448|11683495|FG000|COMPLETED|Overall Study||181
10531280|NCT01410448|11683496|FG001|COMPLETED|Overall Study||155
10531281|NCT01410448|11683495|FG000|NOT COMPLETED|Overall Study||12
10531282|NCT01410448|11683496|FG001|NOT COMPLETED|Overall Study||35
10655187|NCT02207244|11815911|FG007|STARTED|Placebo Crossover and ACP: Week 16-28||0
10655188|NCT02207244|11815912|FG008|STARTED|Placebo Crossover and ACP: Week 16-28||0
10655189|NCT02207244|11815913|FG009|STARTED|Placebo Crossover and ACP: Week 16-28||0
10655190|NCT02207244|11815914|FG010|STARTED|Placebo Crossover and ACP: Week 16-28||0
10531283|NCT01410474|11683504|FG000|STARTED|Overall Study||173
10531284|NCT01410474|11683505|FG001|STARTED|Overall Study||168
10531285|NCT01410474|11683504|FG000|COMPLETED|Overall Study||173
10531286|NCT01410474|11683505|FG001|COMPLETED|Overall Study||167
10531287|NCT01410474|11683504|FG000|NOT COMPLETED|Overall Study||0
10531288|NCT01410474|11683505|FG001|NOT COMPLETED|Overall Study||1
10531289|NCT01410552|11683518|FG000|STARTED|Overall Study||1013
10531290|NCT01410552|11683518|FG000|COMPLETED|Overall Study||877
10531291|NCT01410552|11683518|FG000|NOT COMPLETED|Overall Study||136
10531292|NCT01410565|11683524|FG000|STARTED|Open Label Phase Apaziquone||0
10531293|NCT01410565|11683525|FG001|STARTED|Open Label Phase Apaziquone||0
10531294|NCT01410565|11683526|FG002|STARTED|Open Label Phase Apaziquone||66
10531295|NCT01410565|11683524|FG000|COMPLETED|Open Label Phase Apaziquone||0
10531296|NCT01410565|11683525|FG001|COMPLETED|Open Label Phase Apaziquone||0
10531297|NCT01410565|11683526|FG002|COMPLETED|Open Label Phase Apaziquone||58
10531298|NCT01410565|11683524|FG000|NOT COMPLETED|Open Label Phase Apaziquone||0
10531299|NCT01410565|11683525|FG001|NOT COMPLETED|Open Label Phase Apaziquone||0
10531300|NCT01410565|11683526|FG002|NOT COMPLETED|Open Label Phase Apaziquone||8
10655191|NCT02207244|11815904|FG000|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
10655192|NCT02207244|11815905|FG001|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
10655193|NCT02207244|11815906|FG002|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
10655194|NCT02207244|11815907|FG003|COMPLETED|Placebo Crossover and ACP: Week 16-28||227
10655195|NCT02207244|11815908|FG004|COMPLETED|Placebo Crossover and ACP: Week 16-28||470
10655196|NCT02207244|11815909|FG005|COMPLETED|Placebo Crossover and ACP: Week 16-28||228
10655197|NCT02207244|11815910|FG006|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
10655198|NCT02207244|11815911|FG007|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
10655199|NCT02207244|11815912|FG008|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
10655200|NCT02207244|11815913|FG009|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
10655201|NCT02207244|11815914|FG010|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
10655202|NCT02207244|11815904|FG000|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
10655203|NCT02207244|11815905|FG001|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
10655204|NCT02207244|11815906|FG002|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
10655205|NCT02207244|11815907|FG003|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||6
10655206|NCT02207244|11815908|FG004|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||8
10655207|NCT02207244|11815909|FG005|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||9
10655208|NCT02207244|11815910|FG006|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
10655209|NCT02207244|11815911|FG007|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
10655210|NCT02207244|11815912|FG008|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
10304594|NCT00089505|11437737|FG003|STARTED|Overall Study||251
10655211|NCT02207244|11815913|FG009|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
10655212|NCT02207244|11815914|FG010|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
10655213|NCT02207244|11815904|FG000|STARTED|Withdrawal and Re-treatment: Week 28-72||0
10655214|NCT02207244|11815905|FG001|STARTED|Withdrawal and Re-treatment: Week 28-72||0
10655215|NCT02207244|11815906|FG002|STARTED|Withdrawal and Re-treatment: Week 28-72||0
10655216|NCT02207244|11815907|FG003|STARTED|Withdrawal and Re-treatment: Week 28-72||0
10655217|NCT02207244|11815908|FG004|STARTED|Withdrawal and Re-treatment: Week 28-72||0
10655218|NCT02207244|11815909|FG005|STARTED|Withdrawal and Re-treatment: Week 28-72||0
10655219|NCT02207244|11815910|FG006|STARTED|Withdrawal and Re-treatment: Week 28-72||227
10655220|NCT02207244|11815911|FG007|STARTED|Withdrawal and Re-treatment: Week 28-72||470
10655221|NCT02207244|11815912|FG008|STARTED|Withdrawal and Re-treatment: Week 28-72||220
10531301|NCT01410565|11683524|FG000|STARTED|Double Blind Phase|All 66 patients received one dose of Apaziquone in the open label phase.|13
10531302|NCT01410565|11683525|FG001|STARTED|Double Blind Phase||15
10531303|NCT01410565|11683526|FG002|STARTED|Double Blind Phase||0
10531304|NCT01410565|11683524|FG000|COMPLETED|Double Blind Phase||0
10531305|NCT01410565|11683525|FG001|COMPLETED|Double Blind Phase||0
10531306|NCT01410565|11683526|FG002|COMPLETED|Double Blind Phase||0
10531307|NCT01410565|11683524|FG000|NOT COMPLETED|Double Blind Phase||13
10655222|NCT02207244|11815913|FG009|STARTED|Withdrawal and Re-treatment: Week 28-72||8
10655223|NCT02207244|11815914|FG010|STARTED|Withdrawal and Re-treatment: Week 28-72||0
10655224|NCT02207244|11815904|FG000|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
10655225|NCT02207244|11815905|FG001|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
10655226|NCT02207244|11815906|FG002|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
10655227|NCT02207244|11815907|FG003|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
10655228|NCT02207244|11815908|FG004|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
10655229|NCT02207244|11815909|FG005|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
10655230|NCT02207244|11815910|FG006|Nonresponders|Withdrawal and Re-treatment: Week 28-72||80
10655231|NCT02207244|11815911|FG007|Nonresponders|Withdrawal and Re-treatment: Week 28-72||95
10655232|NCT02207244|11815912|FG008|Nonresponders|Withdrawal and Re-treatment: Week 28-72||112
10655233|NCT02207244|11815913|FG009|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
10655234|NCT02207244|11815914|FG010|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
10655235|NCT02207244|11815904|FG000|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
10655236|NCT02207244|11815905|FG001|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
10655237|NCT02207244|11815906|FG002|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
10655238|NCT02207244|11815907|FG003|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
10655239|NCT02207244|11815908|FG004|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
10655240|NCT02207244|11815909|FG005|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
10655241|NCT02207244|11815910|FG006|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
10655242|NCT02207244|11815911|FG007|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72|Participants randomized to withdrawal=182 and maintenance= 193|375
10655243|NCT02207244|11815912|FG008|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
10655244|NCT02207244|11815913|FG009|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
10655245|NCT02207244|11815914|FG010|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
10655246|NCT02207244|11815904|FG000|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
10655247|NCT02207244|11815905|FG001|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
10655248|NCT02207244|11815906|FG002|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
10715364|NCT02688387|11880053|FG010|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10304568|NCT00089284|11437693|FG004|COMPLETED|Overall Study||0
10304569|NCT00089284|11437694|FG005|COMPLETED|Overall Study||0
10304570|NCT00089284|11437695|FG006|COMPLETED|Overall Study||7
10304571|NCT00089284|11437689|FG000|NOT COMPLETED|Overall Study||0
10304572|NCT00089284|11437690|FG001|NOT COMPLETED|Overall Study||0
10304573|NCT00089284|11437691|FG002|NOT COMPLETED|Overall Study||0
10304574|NCT00089284|11437692|FG003|NOT COMPLETED|Overall Study||0
10304575|NCT00089284|11437693|FG004|NOT COMPLETED|Overall Study||0
10304576|NCT00089284|11437694|FG005|NOT COMPLETED|Overall Study||0
10304577|NCT00089284|11437695|FG006|NOT COMPLETED|Overall Study||1
10304578|NCT00089297|11437717|FG000|STARTED|Overall Study||74
10304579|NCT00089297|11437717|FG000|Treated|Overall Study||70
10304580|NCT00089297|11437717|FG000|Eligible|Overall Study||63
10304581|NCT00089297|11437717|FG000|COMPLETED|Overall Study||36
10304582|NCT00089297|11437717|FG000|NOT COMPLETED|Overall Study||38
10304583|NCT00089479|11437723|FG000|STARTED|Overall Study||1304
10304584|NCT00089479|11437724|FG001|STARTED|Overall Study||1307
10304585|NCT00089479|11437723|FG000|Received Treatment|Overall Study|Safety Population (includes 19 patients randomized to ACXT, who received ACT)|1305
10304586|NCT00089479|11437724|FG001|Received Treatment|Overall Study|Safety Population (includes 5 patients randomized to ACT, who received ACXT)|1283
10304587|NCT00089479|11437723|FG000|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|973
10304588|NCT00089479|11437724|FG001|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|1018
10304589|NCT00089479|11437723|FG000|NOT COMPLETED|Overall Study||331
10304590|NCT00089479|11437724|FG001|NOT COMPLETED|Overall Study||289
10304591|NCT00089505|11437734|FG000|STARTED|Overall Study|2 women never started treatment and per protocol, were not followed and not included in analysis.|121
10304592|NCT00089505|11437735|FG001|STARTED|Overall Study||120
10304593|NCT00089505|11437736|FG002|STARTED|Overall Study|2 women never started treatment and per protocol, were not followed and not included in analysis.|249
10315156|NCT00174941|11448950|FG003|NOT COMPLETED|Overall Study||58
10531308|NCT01410565|11683525|FG001|NOT COMPLETED|Double Blind Phase||15
10531309|NCT01410565|11683526|FG002|NOT COMPLETED|Double Blind Phase||0
10531310|NCT01410604|11683534|FG000|STARTED|Overall Study||15
10531311|NCT01410604|11683535|FG001|STARTED|Overall Study||16
10531312|NCT01410604|11683534|FG000|COMPLETED|Overall Study||12
10531313|NCT01410604|11683535|FG001|COMPLETED|Overall Study||14
10531314|NCT01410604|11683534|FG000|NOT COMPLETED|Overall Study||3
10531315|NCT01410604|11683535|FG001|NOT COMPLETED|Overall Study||2
10531316|NCT01410773|11683541|FG000|STARTED|Overall Study||110
10531317|NCT01410773|11683541|FG000|COMPLETED|Overall Study||110
10531318|NCT01410773|11683541|FG000|NOT COMPLETED|Overall Study||0
10531319|NCT01410812|11683548|FG000|STARTED|Overall Study||75
10531320|NCT01410812|11683549|FG001|STARTED|Overall Study||75
10655249|NCT02207244|11815907|FG003|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
10655250|NCT02207244|11815908|FG004|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
10655251|NCT02207244|11815909|FG005|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
10655252|NCT02207244|11815910|FG006|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||147
10655253|NCT02207244|11815911|FG007|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
10655254|NCT02207244|11815912|FG008|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||108
10655255|NCT02207244|11815913|FG009|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
10655256|NCT02207244|11815914|FG010|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
10655257|NCT02207244|11815904|FG000|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
10655258|NCT02207244|11815905|FG001|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
10655259|NCT02207244|11815906|FG002|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
10715365|NCT02688387|11880054|FG011|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10715366|NCT02688387|11880055|FG012|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10531321|NCT01410812|11683550|FG002|STARTED|Overall Study||76
10531322|NCT01410812|11683548|FG000|COMPLETED|Overall Study||75
10315157|NCT00174954|11448960|FG000|STARTED|Overall Study||32
10315158|NCT00174954|11448960|FG000|COMPLETED|Overall Study||28
10315159|NCT00174954|11448960|FG000|NOT COMPLETED|Overall Study||4
10315160|NCT00174967|11448968|FG000|STARTED|Overall Study||37
10315161|NCT00174967|11448969|FG001|STARTED|Overall Study||40
10315162|NCT00174967|11448970|FG002|STARTED|Overall Study||38
10315163|NCT00174967|11448971|FG003|STARTED|Overall Study||38
10315164|NCT00174967|11448968|FG000|COMPLETED|Overall Study||36
10315165|NCT00174967|11448969|FG001|COMPLETED|Overall Study||37
10315166|NCT00174967|11448970|FG002|COMPLETED|Overall Study||36
10715367|NCT02688387|11880056|FG013|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10715368|NCT02688387|11880057|FG014|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10715369|NCT02688387|11880058|FG015|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10715370|NCT02688387|11880059|FG016|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10715371|NCT02688387|11880060|FG017|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10715372|NCT02688387|11880061|FG018|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10715373|NCT02688387|11880062|FG019|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10715374|NCT02688387|11880063|FG020|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10715375|NCT02688387|11880064|FG021|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
10715376|NCT02688387|11880043|FG000|STARTED|Part 2, Washout Period 3 (10 Days)||0
10715377|NCT02688387|11880044|FG001|STARTED|Part 2, Washout Period 3 (10 Days)||0
10715378|NCT02688387|11880045|FG002|STARTED|Part 2, Washout Period 3 (10 Days)||0
10715379|NCT02688387|11880046|FG003|STARTED|Part 2, Washout Period 3 (10 Days)||0
10715380|NCT02688387|11880047|FG004|STARTED|Part 2, Washout Period 3 (10 Days)||0
10715381|NCT02688387|11880048|FG005|STARTED|Part 2, Washout Period 3 (10 Days)||0
10715382|NCT02688387|11880049|FG006|STARTED|Part 2, Washout Period 3 (10 Days)||0
10715383|NCT02688387|11880050|FG007|STARTED|Part 2, Washout Period 3 (10 Days)||0
10715384|NCT02688387|11880051|FG008|STARTED|Part 2, Washout Period 3 (10 Days)||0
10715385|NCT02688387|11880052|FG009|STARTED|Part 2, Washout Period 3 (10 Days)||0
10812338|NCT03723980|11974370|FG001|STARTED|Overall Study||40
10342672|NCT00393484|11480180|FG001|STARTED|Double-blind Period (Day 1 to Week 96)|Number treated|64
10342673|NCT00393484|11480179|FG000|Participants Excluded From Analysis|Double-blind Period (Day 1 to Week 96)||1
10342674|NCT00393484|11480180|FG001|Participants Excluded From Analysis|Double-blind Period (Day 1 to Week 96)||1
10342675|NCT00393484|11480179|FG000|COMPLETED|Double-blind Period (Day 1 to Week 96)||54
10342676|NCT00393484|11480180|FG001|COMPLETED|Double-blind Period (Day 1 to Week 96)||52
10342677|NCT00393484|11480179|FG000|NOT COMPLETED|Double-blind Period (Day 1 to Week 96)||2
10342678|NCT00393484|11480180|FG001|NOT COMPLETED|Double-blind Period (Day 1 to Week 96)||12
10342679|NCT00393484|11480179|FG000|STARTED|Open-label Period (Weeks 96 to 240)||48
10342680|NCT00393484|11480180|FG001|STARTED|Open-label Period (Weeks 96 to 240)||44
10342681|NCT00393484|11480179|FG000|Withdrew Consent|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|6
10342682|NCT00393484|11480180|FG001|Withdrew Consent|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|6
10342683|NCT00393484|11480179|FG000|Lack of Efficacy|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|0
10715386|NCT02688387|11880053|FG010|STARTED|Part 2, Washout Period 3 (10 Days)||5
10812339|NCT03723980|11974369|FG000|COMPLETED|Overall Study||33
10812340|NCT03723980|11974370|FG001|COMPLETED|Overall Study||35
10715387|NCT02688387|11880054|FG011|STARTED|Part 2, Washout Period 3 (10 Days)||5
10715388|NCT02688387|11880055|FG012|STARTED|Part 2, Washout Period 3 (10 Days)||5
10715389|NCT02688387|11880056|FG013|STARTED|Part 2, Washout Period 3 (10 Days)||5
10715390|NCT02688387|11880057|FG014|STARTED|Part 2, Washout Period 3 (10 Days)||0
10715391|NCT02688387|11880058|FG015|STARTED|Part 2, Washout Period 3 (10 Days)||0
10715392|NCT02688387|11880059|FG016|STARTED|Part 2, Washout Period 3 (10 Days)||0
10531323|NCT01410812|11683549|FG001|COMPLETED|Overall Study||75
10531324|NCT01410812|11683550|FG002|COMPLETED|Overall Study||76
10531325|NCT01410812|11683548|FG000|NOT COMPLETED|Overall Study||0
10531326|NCT01410812|11683549|FG001|NOT COMPLETED|Overall Study||0
10531327|NCT01410812|11683550|FG002|NOT COMPLETED|Overall Study||0
10531328|NCT01411085|11683558|FG000|STARTED|Overall Study||10
10655260|NCT02207244|11815907|FG003|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
10655261|NCT02207244|11815908|FG004|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
10531329|NCT01411085|11683558|FG000|COMPLETED|Overall Study||7
10531330|NCT01411085|11683558|FG000|NOT COMPLETED|Overall Study||3
10531331|NCT01411137|11683562|FG000|STARTED|Part 1: Dose Conversion||43
10531332|NCT01411137|11683562|FG000|COMPLETED|Part 1: Dose Conversion||33
10531333|NCT01411137|11683562|FG000|NOT COMPLETED|Part 1: Dose Conversion||10
10547897|NCT01515540|11701683|FG001|NOT COMPLETED|Overall Study||3
10655262|NCT02207244|11815909|FG005|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
10655263|NCT02207244|11815910|FG006|COMPLETED|Withdrawal and Re-treatment: Week 28-72||213
10531334|NCT01411137|11683562|FG000|STARTED|Part 2: Open-Label Extension|1 subject who completed Part 1 did not elect to continue into Part 2.|32
10531335|NCT01411137|11683562|FG000|COMPLETED|Part 2: Open-Label Extension||25
10531336|NCT01411137|11683562|FG000|NOT COMPLETED|Part 2: Open-Label Extension||7
10531337|NCT01411137|11683562|FG000|STARTED|Part 3: Open-Label Extension|Two sites with 11 completers of Part 2 did not participate in Part 3. Two subjects lost contact.|12
10531338|NCT01411137|11683562|FG000|COMPLETED|Part 3: Open-Label Extension||12
10531339|NCT01411137|11683562|FG000|NOT COMPLETED|Part 3: Open-Label Extension||0
10531340|NCT01411215|11683579|FG000|STARTED|Overall Study||69
10531341|NCT01411215|11683580|FG001|STARTED|Overall Study||91
10531342|NCT01411215|11683579|FG000|Treated|Overall Study||69
10531343|NCT01411215|11683580|FG001|Treated|Overall Study|1 participant was considered as screen failure and therefore not treated.|90
10531344|NCT01411215|11683579|FG000|COMPLETED|Overall Study||3
10531345|NCT01411215|11683580|FG001|COMPLETED|Overall Study||7
10531346|NCT01411215|11683579|FG000|NOT COMPLETED|Overall Study||66
10531347|NCT01411215|11683580|FG001|NOT COMPLETED|Overall Study||84
10531348|NCT01411228|11683589|FG000|STARTED|Overall Study||5
10531349|NCT01411228|11683590|FG001|STARTED|Overall Study||5
10531350|NCT01411228|11683591|FG002|STARTED|Overall Study||5
10531351|NCT01411228|11683589|FG000|COMPLETED|Overall Study||4
10531352|NCT01411228|11683590|FG001|COMPLETED|Overall Study||5
10531353|NCT01411228|11683591|FG002|COMPLETED|Overall Study||4
10531354|NCT01411228|11683589|FG000|NOT COMPLETED|Overall Study||1
10531355|NCT01411228|11683590|FG001|NOT COMPLETED|Overall Study||0
10531356|NCT01411228|11683591|FG002|NOT COMPLETED|Overall Study||1
10531357|NCT01411319|11683599|FG000|STARTED|Overall Study||25
10531358|NCT01411319|11683599|FG000|COMPLETED|Overall Study||24
10531359|NCT01411319|11683599|FG000|NOT COMPLETED|Overall Study||1
10531360|NCT01411488|11683605|FG000|STARTED|Overall Study||41
10531361|NCT01411488|11683606|FG001|STARTED|Overall Study||38
10531362|NCT01411488|11683605|FG000|COMPLETED|Overall Study||41
10531363|NCT01411488|11683606|FG001|COMPLETED|Overall Study||38
10531364|NCT01411488|11683605|FG000|NOT COMPLETED|Overall Study||0
10531365|NCT01411488|11683606|FG001|NOT COMPLETED|Overall Study||0
10531366|NCT01411501|11683616|FG000|STARTED|Overall Study||168
10531367|NCT01411501|11683617|FG001|STARTED|Overall Study||172
10531368|NCT01411501|11683618|FG002|STARTED|Overall Study||165
10531369|NCT01411501|11683619|FG003|STARTED|Overall Study||170
10531370|NCT01411501|11683616|FG000|COMPLETED|Overall Study||158
10531371|NCT01411501|11683617|FG001|COMPLETED|Overall Study||166
10531372|NCT01411501|11683618|FG002|COMPLETED|Overall Study||159
10531373|NCT01411501|11683619|FG003|COMPLETED|Overall Study||163
10531374|NCT01411501|11683616|FG000|NOT COMPLETED|Overall Study||10
10531375|NCT01411501|11683617|FG001|NOT COMPLETED|Overall Study||6
10531376|NCT01411501|11683618|FG002|NOT COMPLETED|Overall Study||6
10531377|NCT01411501|11683619|FG003|NOT COMPLETED|Overall Study||7
10531378|NCT01411527|11683631|FG000|STARTED|Overall Study||1864
10531379|NCT01411527|11683632|FG001|STARTED|Overall Study||93
10531380|NCT01411527|11683631|FG000|COMPLETED|Overall Study||1864
10531381|NCT01411527|11683632|FG001|COMPLETED|Overall Study||93
10531382|NCT01411527|11683631|FG000|NOT COMPLETED|Overall Study||0
10531383|NCT01411527|11683632|FG001|NOT COMPLETED|Overall Study||0
10531384|NCT01411592|11683639|FG000|STARTED|Overall Study||14
10655264|NCT02207244|11815911|FG007|COMPLETED|Withdrawal and Re-treatment: Week 28-72||443
10655265|NCT02207244|11815912|FG008|COMPLETED|Withdrawal and Re-treatment: Week 28-72||211
10531385|NCT01411592|11683640|FG001|STARTED|Overall Study||16
10531386|NCT01411592|11683639|FG000|5-Year Time Frame|Overall Study||14
10531387|NCT01411592|11683640|FG001|5-Year Time Frame|Overall Study||16
10531388|NCT01411592|11683639|FG000|COMPLETED|Overall Study||14
10531389|NCT01411592|11683640|FG001|COMPLETED|Overall Study||16
10655266|NCT02207244|11815913|FG009|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
10342684|NCT00393484|11480180|FG001|Lack of Efficacy|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|2
10342685|NCT00393484|11480179|FG000|COMPLETED|Open-label Period (Weeks 96 to 240)||40
10342686|NCT00393484|11480180|FG001|COMPLETED|Open-label Period (Weeks 96 to 240)||21
10342687|NCT00393484|11480179|FG000|NOT COMPLETED|Open-label Period (Weeks 96 to 240)||8
10342688|NCT00393484|11480180|FG001|NOT COMPLETED|Open-label Period (Weeks 96 to 240)||23
10342689|NCT00393510|11480190|FG000|STARTED|Overall Study||40
10342690|NCT00393510|11480191|FG001|STARTED|Overall Study||40
10342691|NCT00393510|11480190|FG000|COMPLETED|Overall Study||37
10342692|NCT00393510|11480191|FG001|COMPLETED|Overall Study||31
10342693|NCT00393510|11480190|FG000|NOT COMPLETED|Overall Study||3
10342694|NCT00393510|11480191|FG001|NOT COMPLETED|Overall Study||9
10342695|NCT00393523|11480202|FG000|STARTED|Overall Study||376
10342696|NCT00393523|11480203|FG001|STARTED|Overall Study||375
10342697|NCT00393523|11480204|FG002|STARTED|Overall Study||353
10342698|NCT00393523|11480205|FG003|STARTED|Overall Study||354
10342699|NCT00393523|11480206|FG004|STARTED|Overall Study||20
10342700|NCT00393523|11480202|FG000|Vaccination Visit 1|Overall Study||374
10342701|NCT00393523|11480203|FG001|Vaccination Visit 1|Overall Study||375
10342702|NCT00393523|11480204|FG002|Vaccination Visit 1|Overall Study||349
10342703|NCT00393523|11480205|FG003|Vaccination Visit 1|Overall Study||352
10655267|NCT02207244|11815914|FG010|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
10655268|NCT02207244|11815904|FG000|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
10342704|NCT00393523|11480206|FG004|Vaccination Visit 1|Overall Study||20
10342705|NCT00393523|11480202|FG000|COMPLETED|Overall Study||364
10342706|NCT00393523|11480203|FG001|COMPLETED|Overall Study||366
10342707|NCT00393523|11480204|FG002|COMPLETED|Overall Study||349
10342708|NCT00393523|11480205|FG003|COMPLETED|Overall Study||348
10342709|NCT00393523|11480206|FG004|COMPLETED|Overall Study||19
10342710|NCT00393523|11480202|FG000|NOT COMPLETED|Overall Study||12
10342711|NCT00393523|11480203|FG001|NOT COMPLETED|Overall Study||9
10342712|NCT00393523|11480204|FG002|NOT COMPLETED|Overall Study||4
10342713|NCT00393523|11480205|FG003|NOT COMPLETED|Overall Study||6
10342714|NCT00393523|11480206|FG004|NOT COMPLETED|Overall Study||1
10342715|NCT00393705|11480219|FG000|STARTED|Overall Study||151
10342716|NCT00393705|11480220|FG001|STARTED|Overall Study||151
10342717|NCT00393705|11480219|FG000|Received at Least One Dose of Study Drug|Overall Study||139
10342718|NCT00393705|11480220|FG001|Received at Least One Dose of Study Drug|Overall Study||139
10342719|NCT00393705|11480219|FG000|COMPLETED|Overall Study||128
10342720|NCT00393705|11480220|FG001|COMPLETED|Overall Study||128
10342721|NCT00393705|11480219|FG000|NOT COMPLETED|Overall Study||23
10342722|NCT00393705|11480220|FG001|NOT COMPLETED|Overall Study||23
10342723|NCT00393718|11480228|FG000|STARTED|Overall Study||268
10342724|NCT00393718|11480229|FG001|STARTED|Overall Study||132
10342725|NCT00393718|11480228|FG000|COMPLETED|Overall Study||225
10342726|NCT00393718|11480229|FG001|COMPLETED|Overall Study||110
10342727|NCT00393718|11480228|FG000|NOT COMPLETED|Overall Study||43
10342728|NCT00393718|11480229|FG001|NOT COMPLETED|Overall Study||22
10342729|NCT00393796|11480237|FG000|STARTED|Double Blind Period||26
10342730|NCT00393796|11480238|FG001|STARTED|Double Blind Period||28
10342731|NCT00393796|11480237|FG000|COMPLETED|Double Blind Period||26
10342732|NCT00393796|11480238|FG001|COMPLETED|Double Blind Period||28
10342733|NCT00393796|11480237|FG000|NOT COMPLETED|Double Blind Period||0
10342734|NCT00393796|11480238|FG001|NOT COMPLETED|Double Blind Period||0
10342735|NCT00393796|11480237|FG000|STARTED|Open Label Period - Placebo to SUTENT||0
10342736|NCT00393796|11480238|FG001|STARTED|Open Label Period - Placebo to SUTENT||16
10342737|NCT00393796|11480237|FG000|COMPLETED|Open Label Period - Placebo to SUTENT||0
10342738|NCT00393796|11480238|FG001|COMPLETED|Open Label Period - Placebo to SUTENT||16
10342739|NCT00393796|11480237|FG000|NOT COMPLETED|Open Label Period - Placebo to SUTENT||0
10342740|NCT00393796|11480238|FG001|NOT COMPLETED|Open Label Period - Placebo to SUTENT||0
10342741|NCT00393848|11480248|FG000|STARTED|Overall Study||16
10342742|NCT00393848|11480249|FG001|STARTED|Overall Study||9
10342743|NCT00393848|11480250|FG002|STARTED|Overall Study||6
10342744|NCT00393848|11480251|FG003|STARTED|Overall Study||9
10342745|NCT00393848|11480248|FG000|COMPLETED|Overall Study||16
10342746|NCT00393848|11480249|FG001|COMPLETED|Overall Study||9
10342747|NCT00393848|11480250|FG002|COMPLETED|Overall Study||4
10342748|NCT00393848|11480251|FG003|COMPLETED|Overall Study||8
10342749|NCT00393848|11480248|FG000|NOT COMPLETED|Overall Study||0
10342750|NCT00393848|11480249|FG001|NOT COMPLETED|Overall Study||0
10342751|NCT00393848|11480250|FG002|NOT COMPLETED|Overall Study||2
10342752|NCT00393848|11480251|FG003|NOT COMPLETED|Overall Study||1
10342753|NCT00393861|11480262|FG000|STARTED|Overall Study||29
10342754|NCT00393861|11480262|FG000|COMPLETED|Overall Study||3
10342755|NCT00393861|11480262|FG000|NOT COMPLETED|Overall Study||26
10655269|NCT02207244|11815905|FG001|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
10304595|NCT00089505|11437734|FG000|COMPLETED|Overall Study|The results for NVP/NVP were through database cutoff for DSMB review (by 6 October 2008).|112
10304596|NCT00089505|11437735|FG001|COMPLETED|Overall Study|The results for NVP/LPV_r were through database cutoff for DSMB review (by 6 October 2008).|118
10304597|NCT00089505|11437736|FG002|COMPLETED|Overall Study||228
10304598|NCT00089505|11437737|FG003|COMPLETED|Overall Study||230
10304599|NCT00089505|11437734|FG000|NOT COMPLETED|Overall Study||9
10304600|NCT00089505|11437735|FG001|NOT COMPLETED|Overall Study||2
10304601|NCT00089505|11437736|FG002|NOT COMPLETED|Overall Study||21
10304602|NCT00089505|11437737|FG003|NOT COMPLETED|Overall Study||21
10304603|NCT00089544|11437749|FG000|STARTED|Overall Study||16
10304604|NCT00089544|11437750|FG001|STARTED|Overall Study||7
10304605|NCT00089544|11437749|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|15
10304606|NCT00089544|11437750|FG001|COMPLETED|Overall Study||7
10304607|NCT00089544|11437749|FG000|NOT COMPLETED|Overall Study||1
10304608|NCT00089544|11437750|FG001|NOT COMPLETED|Overall Study||0
10315167|NCT00174967|11448971|FG003|COMPLETED|Overall Study||36
10315168|NCT00174967|11448968|FG000|NOT COMPLETED|Overall Study||1
10315169|NCT00174967|11448969|FG001|NOT COMPLETED|Overall Study||3
10315170|NCT00174967|11448970|FG002|NOT COMPLETED|Overall Study||2
10315171|NCT00174967|11448971|FG003|NOT COMPLETED|Overall Study||2
10315172|NCT00175006|11448981|FG000|STARTED|Overall Study||13
10315173|NCT00175006|11448981|FG000|COMPLETED|Overall Study||13
10315174|NCT00175006|11448981|FG000|NOT COMPLETED|Overall Study||0
10315175|NCT00175019|11448988|FG000|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|606
10315176|NCT00175019|11448989|FG001|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|388
10315177|NCT00175019|11448990|FG002|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|92
10315178|NCT00175019|11448988|FG000|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|412
10315179|NCT00175019|11448989|FG001|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|217
10315180|NCT00175019|11448990|FG002|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|35
10315181|NCT00175019|11448988|FG000|NOT COMPLETED|Overall Study||194
10315182|NCT00175019|11448989|FG001|NOT COMPLETED|Overall Study||171
10315183|NCT00175019|11448990|FG002|NOT COMPLETED|Overall Study||57
10315184|NCT00175825|11449002|FG000|STARTED|Overall Study||54
10315185|NCT00175825|11449003|FG001|STARTED|Overall Study||50
10315186|NCT00175825|11449004|FG002|STARTED|Overall Study||52
10315187|NCT00175825|11449005|FG003|STARTED|Overall Study||52
10315188|NCT00175825|11449002|FG000|COMPLETED|Overall Study||49
10315189|NCT00175825|11449003|FG001|COMPLETED|Overall Study||46
10315190|NCT00175825|11449004|FG002|COMPLETED|Overall Study||51
10315191|NCT00175825|11449005|FG003|COMPLETED|Overall Study||51
10315192|NCT00175825|11449002|FG000|NOT COMPLETED|Overall Study||5
10315193|NCT00175825|11449003|FG001|NOT COMPLETED|Overall Study||4
10315194|NCT00175825|11449004|FG002|NOT COMPLETED|Overall Study||1
10315195|NCT00175825|11449005|FG003|NOT COMPLETED|Overall Study||1
10315196|NCT00175877|11449015|FG000|STARTED|Overall Study||846
10315197|NCT00175877|11449015|FG000|COMPLETED|Overall Study||497
10315198|NCT00175877|11449015|FG000|NOT COMPLETED|Overall Study||349
10315199|NCT00175916|11449019|FG000|STARTED|Overall Study||853
10315200|NCT00175916|11449019|FG000|COMPLETED|Overall Study||234
10315201|NCT00175916|11449019|FG000|NOT COMPLETED|Overall Study||619
10315202|NCT00176202|11449026|FG000|STARTED|Overall Study||32
10315203|NCT00176202|11449027|FG001|STARTED|Overall Study||33
10315204|NCT00176202|11449026|FG000|COMPLETED|Overall Study||27
10315205|NCT00176202|11449027|FG001|COMPLETED|Overall Study||17
10315206|NCT00176202|11449026|FG000|NOT COMPLETED|Overall Study||5
10315207|NCT00176202|11449027|FG001|NOT COMPLETED|Overall Study||16
10315208|NCT00176228|11449035|FG000|STARTED|Overall Study|When study began|48
10315209|NCT00176228|11449035|FG000|COMPLETED|Overall Study|Study ended|46
10315210|NCT00176228|11449035|FG000|NOT COMPLETED|Overall Study||2
10315211|NCT00176254|11449040|FG000|STARTED|Overall Study||40
10315212|NCT00176254|11449040|FG000|COMPLETED|Overall Study|1 patient only received 1 cycle and refused further induction, another progressed in neck nodes|39
10315213|NCT00176254|11449040|FG000|NOT COMPLETED|Overall Study||1
10315214|NCT00176306|11449044|FG000|STARTED|Overall Study||15
10315215|NCT00176306|11449044|FG000|COMPLETED|Overall Study||15
10655270|NCT02207244|11815906|FG002|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
10655271|NCT02207244|11815907|FG003|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
10315216|NCT00176306|11449044|FG000|NOT COMPLETED|Overall Study||0
10315217|NCT00176423|11449050|FG000|STARTED|Overall Study||42
10655272|NCT02207244|11815908|FG004|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
10655273|NCT02207244|11815909|FG005|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
10315218|NCT00176423|11449051|FG001|STARTED|Overall Study||44
10315219|NCT00176423|11449050|FG000|COMPLETED|Overall Study||35
10315220|NCT00176423|11449051|FG001|COMPLETED|Overall Study||38
10315221|NCT00176423|11449050|FG000|NOT COMPLETED|Overall Study||7
10304609|NCT00089583|11437758|FG000|STARTED|Overall Study||20
10304610|NCT00089583|11437759|FG001|STARTED|Overall Study||89
10304611|NCT00089583|11437758|FG000|COMPLETED|Overall Study||13
10304612|NCT00089583|11437759|FG001|COMPLETED|Overall Study||51
10304613|NCT00089583|11437758|FG000|NOT COMPLETED|Overall Study||7
10304614|NCT00089583|11437759|FG001|NOT COMPLETED|Overall Study||38
10304615|NCT00089609|11437773|FG000|STARTED|Overall Study||60
10304616|NCT00089609|11437774|FG001|STARTED|Overall Study||13
10304617|NCT00089609|11437773|FG000|COMPLETED|Overall Study||57
10304618|NCT00089609|11437774|FG001|COMPLETED|Overall Study||12
10304619|NCT00089609|11437773|FG000|NOT COMPLETED|Overall Study||3
10304620|NCT00089609|11437774|FG001|NOT COMPLETED|Overall Study||1
10304621|NCT00089635|11437783|FG000|STARTED|Overall Study||203
10304622|NCT00089635|11437783|FG000|COMPLETED|Overall Study||160
10304623|NCT00089635|11437783|FG000|NOT COMPLETED|Overall Study||43
10304624|NCT00089648|11437787|FG000|STARTED|Overall Study||61
10304625|NCT00089648|11437787|FG000|COMPLETED|Overall Study||20
10304626|NCT00089648|11437787|FG000|NOT COMPLETED|Overall Study||41
10304627|NCT00089661|11437793|FG000|STARTED|Overall Study||127
10304628|NCT00089661|11437794|FG001|STARTED|Overall Study||125
10304629|NCT00089661|11437793|FG000|COMPLETED|Overall Study||106
10304630|NCT00089661|11437794|FG001|COMPLETED|Overall Study||99
10304631|NCT00089661|11437793|FG000|NOT COMPLETED|Overall Study||21
10304632|NCT00089661|11437794|FG001|NOT COMPLETED|Overall Study||26
10304633|NCT00089674|11437802|FG000|STARTED|Overall Study||734
10304634|NCT00089674|11437803|FG001|STARTED|Overall Study||734
10304635|NCT00089674|11437802|FG000|Received Study Drug|Overall Study||730
10304636|NCT00089674|11437803|FG001|Received Study Drug|Overall Study||726
10304637|NCT00089674|11437802|FG000|COMPLETED|Overall Study||445
10304638|NCT00089674|11437803|FG001|COMPLETED|Overall Study||467
10304639|NCT00089674|11437802|FG000|NOT COMPLETED|Overall Study||289
10304640|NCT00089674|11437803|FG001|NOT COMPLETED|Overall Study||267
10304641|NCT00089752|11437811|FG000|STARTED|Overall Study||141
10304642|NCT00089752|11437812|FG001|STARTED|Overall Study||140
10304643|NCT00089752|11437811|FG000|COMPLETED|Overall Study||121
10304644|NCT00089752|11437812|FG001|COMPLETED|Overall Study||118
10304645|NCT00089752|11437811|FG000|NOT COMPLETED|Overall Study||20
10304646|NCT00089752|11437812|FG001|NOT COMPLETED|Overall Study||22
10304647|NCT00089778|11437823|FG000|STARTED|Overall Study||2
10304648|NCT00089778|11437824|FG001|STARTED|Overall Study||1
10304649|NCT00089778|11437825|FG002|STARTED|Overall Study||8
10304650|NCT00089778|11437823|FG000|COMPLETED|Overall Study||2
10304651|NCT00089778|11437824|FG001|COMPLETED|Overall Study||1
10304652|NCT00089778|11437825|FG002|COMPLETED|Overall Study||7
10304653|NCT00089778|11437823|FG000|NOT COMPLETED|Overall Study||0
10304654|NCT00089778|11437824|FG001|NOT COMPLETED|Overall Study||0
10304655|NCT00089778|11437825|FG002|NOT COMPLETED|Overall Study||1
10304656|NCT00089843|11437839|FG000|STARTED|Overall Study||19
10304657|NCT00089843|11437840|FG001|STARTED|Overall Study||20
10304658|NCT00089843|11437841|FG002|STARTED|Overall Study||20
10304659|NCT00089843|11437842|FG003|STARTED|Overall Study||18
10304660|NCT00089843|11437839|FG000|COMPLETED|Overall Study||17
10304661|NCT00089843|11437840|FG001|COMPLETED|Overall Study||16
10304662|NCT00089843|11437841|FG002|COMPLETED|Overall Study||15
10304663|NCT00089843|11437842|FG003|COMPLETED|Overall Study||11
10304664|NCT00089843|11437839|FG000|NOT COMPLETED|Overall Study||2
10304665|NCT00089843|11437840|FG001|NOT COMPLETED|Overall Study||4
10304666|NCT00089843|11437841|FG002|NOT COMPLETED|Overall Study||5
10304667|NCT00089843|11437842|FG003|NOT COMPLETED|Overall Study||7
10304668|NCT00089973|11437852|FG000|STARTED|Overall Study||50
10304669|NCT00089973|11437852|FG000|COMPLETED|Overall Study||0
10304670|NCT00089973|11437852|FG000|NOT COMPLETED|Overall Study||50
10304671|NCT00089986|11437859|FG000|STARTED|Overall Study||599
10304672|NCT00089986|11437860|FG001|STARTED|Overall Study||598
10304673|NCT00089986|11437861|FG002|STARTED|Overall Study||182
10304674|NCT00089986|11437859|FG000|COMPLETED|Overall Study||584
10304675|NCT00089986|11437860|FG001|COMPLETED|Overall Study||574
10304676|NCT00089986|11437861|FG002|COMPLETED|Overall Study||172
10304677|NCT00089986|11437859|FG000|NOT COMPLETED|Overall Study||15
10304678|NCT00089986|11437860|FG001|NOT COMPLETED|Overall Study||24
10304679|NCT00089986|11437861|FG002|NOT COMPLETED|Overall Study||10
10304680|NCT00089999|11437871|FG000|STARTED|Overall Study||69
10304681|NCT00089999|11437872|FG001|STARTED|Overall Study||69
10304682|NCT00089999|11437871|FG000|COMPLETED|Overall Study||0
10304683|NCT00089999|11437872|FG001|COMPLETED|Overall Study||0
10304684|NCT00089999|11437871|FG000|NOT COMPLETED|Overall Study||69
10304685|NCT00089999|11437872|FG001|NOT COMPLETED|Overall Study||69
10304686|NCT00090051|11437881|FG000|STARTED|Overall Study||276
10304687|NCT00090051|11437882|FG001|STARTED|Overall Study||276
10304688|NCT00090051|11437881|FG000|Safety Population; Received Study Drug|Overall Study||272
10304689|NCT00090051|11437882|FG001|Safety Population; Received Study Drug|Overall Study||274
10304690|NCT00090051|11437881|FG000|COMPLETED|Overall Study|Completed 6 Cycles of Treatment|167
10304691|NCT00090051|11437882|FG001|COMPLETED|Overall Study|Completed 6 Cycles of Treatment|181
10304692|NCT00090051|11437881|FG000|NOT COMPLETED|Overall Study||109
10304693|NCT00090051|11437882|FG001|NOT COMPLETED|Overall Study||95
10812341|NCT03723980|11974369|FG000|NOT COMPLETED|Overall Study||7
10342756|NCT00393874|11480269|FG000|STARTED|Overall Study||18
10342757|NCT00393874|11480270|FG001|STARTED|Overall Study||17
10342758|NCT00393874|11480271|FG002|STARTED|Overall Study||15
10342759|NCT00393874|11480269|FG000|COMPLETED|Overall Study||15
10342760|NCT00393874|11480270|FG001|COMPLETED|Overall Study||13
10342761|NCT00393874|11480271|FG002|COMPLETED|Overall Study||13
10342762|NCT00393874|11480269|FG000|NOT COMPLETED|Overall Study||3
10342763|NCT00393874|11480270|FG001|NOT COMPLETED|Overall Study||4
10342764|NCT00393874|11480271|FG002|NOT COMPLETED|Overall Study||2
10342765|NCT00393887|11480284|FG000|STARTED|Overall Study||50
10342766|NCT00393887|11480285|FG001|STARTED|Overall Study||50
10342767|NCT00393887|11480284|FG000|1 Year|Overall Study||45
10342768|NCT00393887|11480285|FG001|1 Year|Overall Study||50
10342769|NCT00393887|11480284|FG000|COMPLETED|Overall Study||34
10342770|NCT00393887|11480285|FG001|COMPLETED|Overall Study||41
10342771|NCT00393887|11480284|FG000|NOT COMPLETED|Overall Study||16
10342772|NCT00393887|11480285|FG001|NOT COMPLETED|Overall Study||9
10342773|NCT00393913|11480291|FG000|STARTED|Initial Assessment||144
10342774|NCT00393913|11480291|FG000|COMPLETED|Initial Assessment||107
10342775|NCT00393913|11480291|FG000|NOT COMPLETED|Initial Assessment||37
10342776|NCT00393913|11480291|FG000|STARTED|CPAP|Excludes normal volunteers without OSA|100
10342777|NCT00393913|11480291|FG000|COMPLETED|CPAP||93
10342778|NCT00393913|11480291|FG000|NOT COMPLETED|CPAP||7
10342779|NCT00393913|11480291|FG000|STARTED|CPAP Withdrawal|Includes only subjects with good CPAP adherence|42
10342780|NCT00393913|11480291|FG000|CPAP Compliance|CPAP Withdrawal|Only subjects with sufficient CPAP complaince (>4 hrs/night) were included.|42
10342781|NCT00393913|11480291|FG000|COMPLETED|CPAP Withdrawal||42
10342782|NCT00393913|11480291|FG000|NOT COMPLETED|CPAP Withdrawal||0
10342783|NCT00393939|11480298|FG000|STARTED|Overall Study||296
10342784|NCT00393939|11480299|FG001|STARTED|Overall Study||297
10342785|NCT00393939|11480298|FG000|Treated|Overall Study||295
10342786|NCT00393939|11480299|FG001|Treated|Overall Study||293
10342787|NCT00393939|11480298|FG000|COMPLETED|Overall Study||0
10342788|NCT00393939|11480299|FG001|COMPLETED|Overall Study||0
10342789|NCT00393939|11480298|FG000|NOT COMPLETED|Overall Study||296
10342790|NCT00393939|11480299|FG001|NOT COMPLETED|Overall Study||297
10342791|NCT00393978|11480307|FG000|STARTED|Overall Study||37
10342792|NCT00393978|11480308|FG001|STARTED|Overall Study||38
10342793|NCT00393978|11480307|FG000|COMPLETED|Overall Study||21
10342794|NCT00393978|11480308|FG001|COMPLETED|Overall Study||18
10342795|NCT00393978|11480307|FG000|NOT COMPLETED|Overall Study||16
10531390|NCT01411592|11683639|FG000|NOT COMPLETED|Overall Study||0
10531391|NCT01411592|11683640|FG001|NOT COMPLETED|Overall Study||0
10531392|NCT01411696|11683646|FG000|STARTED|Overall Study||289
10531393|NCT01411696|11683646|FG000|COMPLETED|Overall Study||289
10531394|NCT01411696|11683646|FG000|NOT COMPLETED|Overall Study||0
10531395|NCT01411774|11683652|FG000|STARTED|Overall Study||72
10531396|NCT01411774|11683653|FG001|STARTED|Overall Study||70
10531397|NCT01411774|11683652|FG000|COMPLETED|Overall Study||72
10531398|NCT01411774|11683653|FG001|COMPLETED|Overall Study||67
10531399|NCT01411774|11683652|FG000|NOT COMPLETED|Overall Study||0
10531400|NCT01411774|11683653|FG001|NOT COMPLETED|Overall Study||3
10531401|NCT01411839|11683661|FG000|STARTED|Overall Study||20
10531402|NCT01411839|11683662|FG001|STARTED|Overall Study||20
10531403|NCT01411839|11683661|FG000|COMPLETED|Overall Study||16
10531404|NCT01411839|11683662|FG001|COMPLETED|Overall Study||17
10342796|NCT00393978|11480308|FG001|NOT COMPLETED|Overall Study||20
10342797|NCT00394082|11480314|FG000|STARTED|Overall Study||50
10531405|NCT01411839|11683661|FG000|NOT COMPLETED|Overall Study||4
10531406|NCT01411839|11683662|FG001|NOT COMPLETED|Overall Study||3
10547898|NCT01515566|11701691|FG000|STARTED|Overall Study||10
10812342|NCT03723980|11974370|FG001|NOT COMPLETED|Overall Study||5
10812343|NCT03723603|11974382|FG000|STARTED|Overall Study||8
10812344|NCT03723603|11974382|FG000|COMPLETED|Overall Study||5
10812345|NCT03723603|11974382|FG000|NOT COMPLETED|Overall Study||3
10812346|NCT03723447|11974388|FG000|STARTED|Overall Study||50
10304700|NCT00090103|11437903|FG000|STARTED|Four-Year Double-Blind Treatment Period||1610
10304701|NCT00090103|11437904|FG001|STARTED|Four-Year Double-Blind Treatment Period||1623
10304702|NCT00090103|11437905|FG002|STARTED|Four-Year Double-Blind Treatment Period||1611
10304703|NCT00090103|11437903|FG000|COMPLETED|Four-Year Double-Blind Treatment Period||1113
10304704|NCT00090103|11437904|FG001|COMPLETED|Four-Year Double-Blind Treatment Period||1093
10304705|NCT00090103|11437905|FG002|COMPLETED|Four-Year Double-Blind Treatment Period||989
10304706|NCT00090103|11437903|FG000|NOT COMPLETED|Four-Year Double-Blind Treatment Period||497
10304707|NCT00090103|11437904|FG001|NOT COMPLETED|Four-Year Double-Blind Treatment Period||530
10304708|NCT00090103|11437905|FG002|NOT COMPLETED|Four-Year Double-Blind Treatment Period||622
10304709|NCT00090103|11437903|FG000|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1598
10304710|NCT00090103|11437904|FG001|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1615
10342798|NCT00394082|11480314|FG000|At Least One Response Assessment|Overall Study||43
10342799|NCT00394082|11480314|FG000|COMPLETED|Overall Study|Treatment completed upon disease progression|24
10342800|NCT00394082|11480314|FG000|NOT COMPLETED|Overall Study||26
10342801|NCT00394095|11480320|FG000|STARTED|Overall Study||17
10342802|NCT00394095|11480321|FG001|STARTED|Overall Study||14
10342803|NCT00394095|11480320|FG000|Screened|Overall Study||17
10342804|NCT00394095|11480321|FG001|Screened|Overall Study||14
10342805|NCT00394095|11480320|FG000|COMPLETED|Overall Study||16
10342806|NCT00394095|11480321|FG001|COMPLETED|Overall Study||14
10342807|NCT00394095|11480320|FG000|NOT COMPLETED|Overall Study||1
10342808|NCT00394095|11480321|FG001|NOT COMPLETED|Overall Study||0
10342809|NCT00394212|11480330|FG000|STARTED|Overall Study|2 subjects assigned to suturing underwent sham procedure, results based on Intent-To-Treat (ITT)|50
10342810|NCT00394212|11480331|FG001|STARTED|Overall Study||27
10342811|NCT00394212|11480330|FG000|6 Week Follow-up|Overall Study||45
10342812|NCT00394212|11480331|FG001|6 Week Follow-up|Overall Study||26
10342813|NCT00394212|11480330|FG000|3 Month Follow-up|Overall Study||45
10342814|NCT00394212|11480331|FG001|3 Month Follow-up|Overall Study||26
10342815|NCT00394212|11480330|FG000|6 Month Follow-up|Overall Study||43
10342816|NCT00394212|11480331|FG001|6 Month Follow-up|Overall Study||26
10342817|NCT00394212|11480330|FG000|COMPLETED|Overall Study||43
10342818|NCT00394212|11480331|FG001|COMPLETED|Overall Study||26
10342819|NCT00394212|11480330|FG000|NOT COMPLETED|Overall Study||7
10342820|NCT00394212|11480331|FG001|NOT COMPLETED|Overall Study||1
10342821|NCT00394251|11480339|FG000|STARTED|Overall Study||98
10342822|NCT00394251|11480340|FG001|STARTED|Overall Study||99
10342823|NCT00394251|11480339|FG000|At Least One Dose of Taxane|Overall Study||93
10342824|NCT00394251|11480340|FG001|At Least One Dose of Taxane|Overall Study||93
10342825|NCT00394251|11480339|FG000|COMPLETED|Overall Study||61
10342826|NCT00394251|11480340|FG001|COMPLETED|Overall Study||61
10342827|NCT00394251|11480339|FG000|NOT COMPLETED|Overall Study||37
10342828|NCT00394251|11480340|FG001|NOT COMPLETED|Overall Study||38
10342829|NCT00394277|11480354|FG000|STARTED|Overall Study||195
10342830|NCT00394277|11480355|FG001|STARTED|Overall Study||196
10342831|NCT00394277|11480356|FG002|STARTED|Overall Study||393
10715393|NCT02688387|11880060|FG017|STARTED|Part 2, Washout Period 3 (10 Days)||0
10715394|NCT02688387|11880061|FG018|STARTED|Part 2, Washout Period 3 (10 Days)||0
10715395|NCT02688387|11880062|FG019|STARTED|Part 2, Washout Period 3 (10 Days)||0
10715396|NCT02688387|11880063|FG020|STARTED|Part 2, Washout Period 3 (10 Days)||0
10715397|NCT02688387|11880064|FG021|STARTED|Part 2, Washout Period 3 (10 Days)||0
10715398|NCT02688387|11880043|FG000|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10715399|NCT02688387|11880044|FG001|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10342832|NCT00394277|11480357|FG003|STARTED|Overall Study||391
10342833|NCT00394277|11480354|FG000|COMPLETED|Overall Study||137
10342834|NCT00394277|11480355|FG001|COMPLETED|Overall Study||136
10342835|NCT00394277|11480356|FG002|COMPLETED|Overall Study||273
10342836|NCT00394277|11480357|FG003|COMPLETED|Overall Study||266
10342837|NCT00394277|11480354|FG000|NOT COMPLETED|Overall Study||58
10655274|NCT02207244|11815910|FG006|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||14
10655275|NCT02207244|11815911|FG007|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||27
10715400|NCT02688387|11880045|FG002|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10304711|NCT00090103|11437905|FG002|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1600
10304712|NCT00090103|11437903|FG000|COMPLETED|16-Week Safety Follow-up Period||1224
10304713|NCT00090103|11437904|FG001|COMPLETED|16-Week Safety Follow-up Period||1205
10304714|NCT00090103|11437905|FG002|COMPLETED|16-Week Safety Follow-up Period||1143
10304715|NCT00090103|11437903|FG000|NOT COMPLETED|16-Week Safety Follow-up Period||374
10304716|NCT00090103|11437904|FG001|NOT COMPLETED|16-Week Safety Follow-up Period||410
10304717|NCT00090103|11437905|FG002|NOT COMPLETED|16-Week Safety Follow-up Period||457
10304718|NCT00090220|11437915|FG000|STARTED|Base Study Vaccination Period||1911
10304719|NCT00090220|11437916|FG001|STARTED|Base Study Vaccination Period||1908
10304720|NCT00090220|11437917|FG002|STARTED|Base Study Vaccination Period||0
10304721|NCT00090220|11437918|FG003|STARTED|Base Study Vaccination Period||0
10304722|NCT00090220|11437919|FG004|STARTED|Base Study Vaccination Period||0
10304723|NCT00090220|11437920|FG005|STARTED|Base Study Vaccination Period||0
10304724|NCT00090220|11437915|FG000|Vaccinated|Base Study Vaccination Period||1910
10304725|NCT00090220|11437916|FG001|Vaccinated|Base Study Vaccination Period||1907
10304726|NCT00090220|11437917|FG002|Vaccinated|Base Study Vaccination Period||0
10304727|NCT00090220|11437918|FG003|Vaccinated|Base Study Vaccination Period||0
10304728|NCT00090220|11437919|FG004|Vaccinated|Base Study Vaccination Period||0
10304729|NCT00090220|11437920|FG005|Vaccinated|Base Study Vaccination Period||0
10304730|NCT00090220|11437915|FG000|COMPLETED|Base Study Vaccination Period||1847
10304731|NCT00090220|11437916|FG001|COMPLETED|Base Study Vaccination Period||1845
10304732|NCT00090220|11437917|FG002|COMPLETED|Base Study Vaccination Period||0
10304733|NCT00090220|11437918|FG003|COMPLETED|Base Study Vaccination Period||0
10304734|NCT00090220|11437919|FG004|COMPLETED|Base Study Vaccination Period||0
10304735|NCT00090220|11437920|FG005|COMPLETED|Base Study Vaccination Period||0
10304736|NCT00090220|11437915|FG000|NOT COMPLETED|Base Study Vaccination Period||64
10304737|NCT00090220|11437916|FG001|NOT COMPLETED|Base Study Vaccination Period||63
10304738|NCT00090220|11437917|FG002|NOT COMPLETED|Base Study Vaccination Period||0
10304739|NCT00090220|11437918|FG003|NOT COMPLETED|Base Study Vaccination Period||0
10304740|NCT00090220|11437919|FG004|NOT COMPLETED|Base Study Vaccination Period||0
10304741|NCT00090220|11437920|FG005|NOT COMPLETED|Base Study Vaccination Period||0
10304742|NCT00090220|11437915|FG000|STARTED|Base Study Follow-up Period|8 participants did not complete the Vaccination Period but entered the Follow-up Period.|1855
10304743|NCT00090220|11437916|FG001|STARTED|Base Study Follow-up Period|5 participants did not complete the Vaccination Period but entered the Follow-up Period.|1851
10304744|NCT00090220|11437917|FG002|STARTED|Base Study Follow-up Period||0
10304745|NCT00090220|11437918|FG003|STARTED|Base Study Follow-up Period||0
10304746|NCT00090220|11437919|FG004|STARTED|Base Study Follow-up Period||0
10304747|NCT00090220|11437920|FG005|STARTED|Base Study Follow-up Period||0
10304748|NCT00090220|11437915|FG000|COMPLETED|Base Study Follow-up Period||1695
10304749|NCT00090220|11437916|FG001|COMPLETED|Base Study Follow-up Period||1687
10304750|NCT00090220|11437917|FG002|COMPLETED|Base Study Follow-up Period||0
10304751|NCT00090220|11437918|FG003|COMPLETED|Base Study Follow-up Period||0
10304752|NCT00090220|11437919|FG004|COMPLETED|Base Study Follow-up Period||0
10342838|NCT00394277|11480355|FG001|NOT COMPLETED|Overall Study||60
10342839|NCT00394277|11480356|FG002|NOT COMPLETED|Overall Study||120
10715401|NCT02688387|11880046|FG003|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10715402|NCT02688387|11880047|FG004|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10715403|NCT02688387|11880048|FG005|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10715404|NCT02688387|11880049|FG006|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10715405|NCT02688387|11880050|FG007|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10715406|NCT02688387|11880051|FG008|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10715407|NCT02688387|11880052|FG009|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10715408|NCT02688387|11880053|FG010|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
10715409|NCT02688387|11880054|FG011|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
10715410|NCT02688387|11880055|FG012|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
10715411|NCT02688387|11880056|FG013|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
10715412|NCT02688387|11880057|FG014|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10715413|NCT02688387|11880058|FG015|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10715414|NCT02688387|11880059|FG016|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10715415|NCT02688387|11880060|FG017|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10715416|NCT02688387|11880061|FG018|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10715417|NCT02688387|11880062|FG019|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10715418|NCT02688387|11880063|FG020|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10715419|NCT02688387|11880064|FG021|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10715420|NCT02688387|11880043|FG000|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10715421|NCT02688387|11880044|FG001|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10715422|NCT02688387|11880045|FG002|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10342844|NCT00394329|11480374|FG003|STARTED|Overall Study||74
10715423|NCT02688387|11880046|FG003|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10715424|NCT02688387|11880047|FG004|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10715425|NCT02688387|11880048|FG005|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10715426|NCT02688387|11880049|FG006|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10715427|NCT02688387|11880050|FG007|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10715428|NCT02688387|11880051|FG008|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10715429|NCT02688387|11880052|FG009|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10715430|NCT02688387|11880053|FG010|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10715431|NCT02688387|11880054|FG011|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10715432|NCT02688387|11880055|FG012|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10715433|NCT02688387|11880056|FG013|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10715434|NCT02688387|11880057|FG014|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10715435|NCT02688387|11880058|FG015|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10715436|NCT02688387|11880059|FG016|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10715437|NCT02688387|11880060|FG017|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10715438|NCT02688387|11880061|FG018|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10715439|NCT02688387|11880062|FG019|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10715440|NCT02688387|11880063|FG020|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10715441|NCT02688387|11880064|FG021|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
10715442|NCT02688387|11880043|FG000|STARTED|Part 2, Period 4 (up to 6 Days)||0
10715443|NCT02688387|11880044|FG001|STARTED|Part 2, Period 4 (up to 6 Days)||0
10715444|NCT02688387|11880045|FG002|STARTED|Part 2, Period 4 (up to 6 Days)||0
10715445|NCT02688387|11880046|FG003|STARTED|Part 2, Period 4 (up to 6 Days)||0
10531407|NCT01411852|11683670|FG000|STARTED|Prehospital Intervention Phase|1 patient randomized to 2000 mL bolus arm but received 250 mL bolus. Analyzed in 2000 mL arm.|95
10531408|NCT01411852|11683671|FG001|STARTED|Prehospital Intervention Phase|One patient was in police custody at the time of enrollment. Patient's data omitted from analyses.|96
10531409|NCT01411852|11683670|FG000|COMPLETED|Prehospital Intervention Phase|12 patients had the intervention stopped prior to hospital arrival|83
10715446|NCT02688387|11880047|FG004|STARTED|Part 2, Period 4 (up to 6 Days)||0
10715447|NCT02688387|11880048|FG005|STARTED|Part 2, Period 4 (up to 6 Days)||0
10715448|NCT02688387|11880049|FG006|STARTED|Part 2, Period 4 (up to 6 Days)||0
10715449|NCT02688387|11880050|FG007|STARTED|Part 2, Period 4 (up to 6 Days)||0
10715450|NCT02688387|11880051|FG008|STARTED|Part 2, Period 4 (up to 6 Days)||0
10715451|NCT02688387|11880052|FG009|STARTED|Part 2, Period 4 (up to 6 Days)||0
10531410|NCT01411852|11683671|FG001|COMPLETED|Prehospital Intervention Phase|7 patients had intervention stopped prior to hospital arrival|89
10531411|NCT01411852|11683670|FG000|NOT COMPLETED|Prehospital Intervention Phase||12
10531412|NCT01411852|11683671|FG001|NOT COMPLETED|Prehospital Intervention Phase||7
10531413|NCT01411852|11683670|FG000|STARTED|Hospital Intervention Phase||83
10531414|NCT01411852|11683671|FG001|STARTED|Hospital Intervention Phase||89
10531415|NCT01411852|11683670|FG000|COMPLETED|Hospital Intervention Phase|24 patients had intervention stopped prior to 2 hours after arrival or hemorrhage control|59
10531416|NCT01411852|11683671|FG001|COMPLETED|Hospital Intervention Phase|18 patients had intervention stopped prior to 2 hours after arrival or hemorrhage control|71
10531417|NCT01411852|11683670|FG000|NOT COMPLETED|Hospital Intervention Phase||24
10531418|NCT01411852|11683671|FG001|NOT COMPLETED|Hospital Intervention Phase||18
10531419|NCT01411891|11683681|FG000|STARTED|Overall Study||50
10531420|NCT01411891|11683682|FG001|STARTED|Overall Study||50
10655276|NCT02207244|11815912|FG008|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||9
10655277|NCT02207244|11815913|FG009|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||8
10655278|NCT02207244|11815914|FG010|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
10655279|NCT02207244|11815904|FG000|STARTED|Open-label Guselkumab: Week 72-264||0
10655280|NCT02207244|11815905|FG001|STARTED|Open-label Guselkumab: Week 72-264||0
10655281|NCT02207244|11815906|FG002|STARTED|Open-label Guselkumab: Week 72-264||0
10655282|NCT02207244|11815907|FG003|STARTED|Open-label Guselkumab: Week 72-264||0
10655283|NCT02207244|11815908|FG004|STARTED|Open-label Guselkumab: Week 72-264||0
10655284|NCT02207244|11815909|FG005|STARTED|Open-label Guselkumab: Week 72-264||0
10655285|NCT02207244|11815910|FG006|STARTED|Open-label Guselkumab: Week 72-264||0
10655286|NCT02207244|11815911|FG007|STARTED|Open-label Guselkumab: Week 72-264||0
10655287|NCT02207244|11815912|FG008|STARTED|Open-label Guselkumab: Week 72-264||211
10655288|NCT02207244|11815913|FG009|STARTED|Open-label Guselkumab: Week 72-264||0
10655289|NCT02207244|11815914|FG010|STARTED|Open-label Guselkumab: Week 72-264||656
10655290|NCT02207244|11815904|FG000|COMPLETED|Open-label Guselkumab: Week 72-264||0
10655291|NCT02207244|11815905|FG001|COMPLETED|Open-label Guselkumab: Week 72-264||0
10655292|NCT02207244|11815906|FG002|COMPLETED|Open-label Guselkumab: Week 72-264||0
10655293|NCT02207244|11815907|FG003|COMPLETED|Open-label Guselkumab: Week 72-264||0
10655294|NCT02207244|11815908|FG004|COMPLETED|Open-label Guselkumab: Week 72-264||0
10655295|NCT02207244|11815909|FG005|COMPLETED|Open-label Guselkumab: Week 72-264||0
10655296|NCT02207244|11815910|FG006|COMPLETED|Open-label Guselkumab: Week 72-264||0
10655297|NCT02207244|11815911|FG007|COMPLETED|Open-label Guselkumab: Week 72-264||0
10655298|NCT02207244|11815912|FG008|COMPLETED|Open-label Guselkumab: Week 72-264||173
10655299|NCT02207244|11815913|FG009|COMPLETED|Open-label Guselkumab: Week 72-264||0
10655300|NCT02207244|11815914|FG010|COMPLETED|Open-label Guselkumab: Week 72-264||554
10655301|NCT02207244|11815904|FG000|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
10342840|NCT00394277|11480357|FG003|NOT COMPLETED|Overall Study||125
10342841|NCT00394329|11480371|FG000|STARTED|Overall Study||71
10342842|NCT00394329|11480372|FG001|STARTED|Overall Study||72
10342843|NCT00394329|11480373|FG002|STARTED|Overall Study||71
10342845|NCT00394329|11480371|FG000|COMPLETED|Overall Study||63
10342846|NCT00394329|11480372|FG001|COMPLETED|Overall Study||63
10342847|NCT00394329|11480373|FG002|COMPLETED|Overall Study||58
10342848|NCT00394329|11480374|FG003|COMPLETED|Overall Study||50
10342849|NCT00394329|11480371|FG000|NOT COMPLETED|Overall Study||8
10342850|NCT00394329|11480372|FG001|NOT COMPLETED|Overall Study||9
10342851|NCT00394329|11480373|FG002|NOT COMPLETED|Overall Study||13
10342852|NCT00394329|11480374|FG003|NOT COMPLETED|Overall Study||24
10342853|NCT00394433|11480390|FG000|STARTED|Overall Study||38
10342854|NCT00394433|11480390|FG000|Evaluable and Treated|Overall Study||35
10342855|NCT00394433|11480390|FG000|COMPLETED|Overall Study||35
10342856|NCT00394433|11480390|FG000|NOT COMPLETED|Overall Study||3
10342857|NCT00394472|11480396|FG000|STARTED|Overall Study||122
10342858|NCT00394472|11480397|FG001|STARTED|Overall Study||122
10342859|NCT00394472|11480396|FG000|COMPLETED|Overall Study||113
10342860|NCT00394472|11480397|FG001|COMPLETED|Overall Study||111
10342861|NCT00394472|11480396|FG000|NOT COMPLETED|Overall Study||9
10342862|NCT00394472|11480397|FG001|NOT COMPLETED|Overall Study||11
10304753|NCT00090220|11437920|FG005|COMPLETED|Base Study Follow-up Period||0
10304754|NCT00090220|11437915|FG000|NOT COMPLETED|Base Study Follow-up Period||160
10304755|NCT00090220|11437916|FG001|NOT COMPLETED|Base Study Follow-up Period||164
10304756|NCT00090220|11437917|FG002|NOT COMPLETED|Base Study Follow-up Period||0
10304757|NCT00090220|11437918|FG003|NOT COMPLETED|Base Study Follow-up Period||0
10304758|NCT00090220|11437919|FG004|NOT COMPLETED|Base Study Follow-up Period||0
10304759|NCT00090220|11437920|FG005|NOT COMPLETED|Base Study Follow-up Period||0
10304760|NCT00090220|11437915|FG000|STARTED|Extension 1 (EXT1)||0
10304761|NCT00090220|11437916|FG001|STARTED|Extension 1 (EXT1)||0
10304762|NCT00090220|11437917|FG002|STARTED|Extension 1 (EXT1)|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|1322
10304763|NCT00090220|11437918|FG003|STARTED|Extension 1 (EXT1)|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|7
10304764|NCT00090220|11437919|FG004|STARTED|Extension 1 (EXT1)||0
10304765|NCT00090220|11437920|FG005|STARTED|Extension 1 (EXT1)||0
10304766|NCT00090220|11437915|FG000|Vaccinated|Extension 1 (EXT1)||0
10304767|NCT00090220|11437916|FG001|Vaccinated|Extension 1 (EXT1)||0
10304768|NCT00090220|11437917|FG002|Vaccinated|Extension 1 (EXT1)||1321
10304769|NCT00090220|11437918|FG003|Vaccinated|Extension 1 (EXT1)||7
10304770|NCT00090220|11437919|FG004|Vaccinated|Extension 1 (EXT1)||0
10304771|NCT00090220|11437920|FG005|Vaccinated|Extension 1 (EXT1)||0
10304772|NCT00090220|11437915|FG000|COMPLETED|Extension 1 (EXT1)||0
10304773|NCT00090220|11437916|FG001|COMPLETED|Extension 1 (EXT1)||0
10304774|NCT00090220|11437917|FG002|COMPLETED|Extension 1 (EXT1)||1267
10304775|NCT00090220|11437918|FG003|COMPLETED|Extension 1 (EXT1)||5
10304776|NCT00090220|11437919|FG004|COMPLETED|Extension 1 (EXT1)||0
10304777|NCT00090220|11437920|FG005|COMPLETED|Extension 1 (EXT1)||0
10304778|NCT00090220|11437915|FG000|NOT COMPLETED|Extension 1 (EXT1)||0
10304779|NCT00090220|11437916|FG001|NOT COMPLETED|Extension 1 (EXT1)||0
10304780|NCT00090220|11437917|FG002|NOT COMPLETED|Extension 1 (EXT1)||55
10304781|NCT00090220|11437918|FG003|NOT COMPLETED|Extension 1 (EXT1)||2
10304782|NCT00090220|11437919|FG004|NOT COMPLETED|Extension 1 (EXT1)||0
10304783|NCT00090220|11437920|FG005|NOT COMPLETED|Extension 1 (EXT1)||0
10304784|NCT00090220|11437915|FG000|STARTED|Long-term Follow-up (EXT2)||0
10304785|NCT00090220|11437916|FG001|STARTED|Long-term Follow-up (EXT2)||0
10304786|NCT00090220|11437917|FG002|STARTED|Long-term Follow-up (EXT2)||0
10304787|NCT00090220|11437918|FG003|STARTED|Long-term Follow-up (EXT2)||0
10304788|NCT00090220|11437919|FG004|STARTED|Long-term Follow-up (EXT2)|Participation in LTFU was voluntary; not all participants eligible for LTFU enrolled.|685
10304789|NCT00090220|11437920|FG005|STARTED|Long-term Follow-up (EXT2)|Participation in LTFU was voluntary; not all participants eligible for LTFU enrolled.|651
10304790|NCT00090220|11437915|FG000|COMPLETED|Long-term Follow-up (EXT2)||0
10304791|NCT00090220|11437916|FG001|COMPLETED|Long-term Follow-up (EXT2)||0
10304792|NCT00090220|11437917|FG002|COMPLETED|Long-term Follow-up (EXT2)||0
10304793|NCT00090220|11437918|FG003|COMPLETED|Long-term Follow-up (EXT2)||0
10304794|NCT00090220|11437919|FG004|COMPLETED|Long-term Follow-up (EXT2)||641
10304795|NCT00090220|11437920|FG005|COMPLETED|Long-term Follow-up (EXT2)||623
10304796|NCT00090220|11437915|FG000|NOT COMPLETED|Long-term Follow-up (EXT2)||0
10304797|NCT00090220|11437916|FG001|NOT COMPLETED|Long-term Follow-up (EXT2)||0
10304798|NCT00090220|11437917|FG002|NOT COMPLETED|Long-term Follow-up (EXT2)||0
10304799|NCT00090220|11437918|FG003|NOT COMPLETED|Long-term Follow-up (EXT2)||0
10304800|NCT00090220|11437919|FG004|NOT COMPLETED|Long-term Follow-up (EXT2)||44
10304801|NCT00090220|11437920|FG005|NOT COMPLETED|Long-term Follow-up (EXT2)||28
10304802|NCT00090233|11437939|FG000|STARTED|Overall Study|Evaluated by data safety monitoring board (DSMB) when they recommended stopping enrollment|34644
10304803|NCT00090233|11437940|FG001|STARTED|Overall Study|Evaluated by data safety monitoring board when they recommended stopping enrollment|34630
10304804|NCT00090233|11437939|FG000|Vaccinated at Visit 1|Overall Study|Randomized Not vaccinated 609|34035
10304805|NCT00090233|11437940|FG001|Vaccinated at Visit 1|Overall Study|Randomized Not vaccinated 627|34003
10715452|NCT02688387|11880053|FG010|STARTED|Part 2, Period 4 (up to 6 Days)||5
10715453|NCT02688387|11880054|FG011|STARTED|Part 2, Period 4 (up to 6 Days)||5
10715454|NCT02688387|11880055|FG012|STARTED|Part 2, Period 4 (up to 6 Days)||5
10715455|NCT02688387|11880056|FG013|STARTED|Part 2, Period 4 (up to 6 Days)||5
10715456|NCT02688387|11880057|FG014|STARTED|Part 2, Period 4 (up to 6 Days)||0
10715457|NCT02688387|11880058|FG015|STARTED|Part 2, Period 4 (up to 6 Days)||0
10715458|NCT02688387|11880059|FG016|STARTED|Part 2, Period 4 (up to 6 Days)||0
10715459|NCT02688387|11880060|FG017|STARTED|Part 2, Period 4 (up to 6 Days)||0
10715460|NCT02688387|11880061|FG018|STARTED|Part 2, Period 4 (up to 6 Days)||0
10715461|NCT02688387|11880062|FG019|STARTED|Part 2, Period 4 (up to 6 Days)||0
10304806|NCT00090233|11437939|FG000|Vaccinated at Visit 2|Overall Study||31052
10304807|NCT00090233|11437940|FG001|Vaccinated at Visit 2|Overall Study||31066
10304808|NCT00090233|11437939|FG000|Vaccinated at Visit 3|Overall Study||29667
10304809|NCT00090233|11437940|FG001|Vaccinated at Visit 3|Overall Study||29598
10304810|NCT00090233|11437939|FG000|COMPLETED|Overall Study|Does not include participants who discontinued prior to the 42 day safety follow-up|29645
10304811|NCT00090233|11437940|FG001|COMPLETED|Overall Study|Does not include participants who discontinued prior to the 42 day safety follow-up|29565
10304812|NCT00090233|11437939|FG000|NOT COMPLETED|Overall Study||4999
10304813|NCT00090233|11437940|FG001|NOT COMPLETED|Overall Study||5065
10304814|NCT00090285|11437952|FG000|STARTED|Base Study Vaccination Period||2032
10304815|NCT00090285|11437953|FG001|STARTED|Base Study Vaccination Period||2033
10304816|NCT00090285|11437954|FG002|STARTED|Base Study Vaccination Period||0
10304817|NCT00090285|11437955|FG003|STARTED|Base Study Vaccination Period||0
10304818|NCT00090285|11437956|FG004|STARTED|Base Study Vaccination Period||0
10304819|NCT00090285|11437957|FG005|STARTED|Base Study Vaccination Period||0
10304820|NCT00090285|11437952|FG000|Vaccinated|Base Study Vaccination Period||2025
10304821|NCT00090285|11437953|FG001|Vaccinated|Base Study Vaccination Period||2030
10304822|NCT00090285|11437954|FG002|Vaccinated|Base Study Vaccination Period||0
10304823|NCT00090285|11437955|FG003|Vaccinated|Base Study Vaccination Period||0
10304824|NCT00090285|11437956|FG004|Vaccinated|Base Study Vaccination Period||0
10304825|NCT00090285|11437957|FG005|Vaccinated|Base Study Vaccination Period||0
10304826|NCT00090285|11437952|FG000|COMPLETED|Base Study Vaccination Period||1818
10304827|NCT00090285|11437953|FG001|COMPLETED|Base Study Vaccination Period||1814
10304828|NCT00090285|11437954|FG002|COMPLETED|Base Study Vaccination Period||0
10304829|NCT00090285|11437955|FG003|COMPLETED|Base Study Vaccination Period||0
10304830|NCT00090285|11437956|FG004|COMPLETED|Base Study Vaccination Period||0
10304831|NCT00090285|11437957|FG005|COMPLETED|Base Study Vaccination Period||0
10304832|NCT00090285|11437952|FG000|NOT COMPLETED|Base Study Vaccination Period||214
10304833|NCT00090285|11437953|FG001|NOT COMPLETED|Base Study Vaccination Period||219
10304834|NCT00090285|11437954|FG002|NOT COMPLETED|Base Study Vaccination Period||0
10304835|NCT00090285|11437955|FG003|NOT COMPLETED|Base Study Vaccination Period||0
10304836|NCT00090285|11437956|FG004|NOT COMPLETED|Base Study Vaccination Period||0
10304837|NCT00090285|11437957|FG005|NOT COMPLETED|Base Study Vaccination Period||0
10304838|NCT00090285|11437952|FG000|STARTED|Base Study Follow-up Period|4 subjects who did not receive 3 doses of vaccine in base study continued into the Follow-up Period|1822
10304839|NCT00090285|11437953|FG001|STARTED|Base Study Follow-up Period|7 subjects who did not receive 3 doses of placebo in base study continued into the Follow-up Period|1821
10304840|NCT00090285|11437954|FG002|STARTED|Base Study Follow-up Period||0
10304841|NCT00090285|11437955|FG003|STARTED|Base Study Follow-up Period||0
10304842|NCT00090285|11437956|FG004|STARTED|Base Study Follow-up Period||0
10304843|NCT00090285|11437957|FG005|STARTED|Base Study Follow-up Period||0
10304844|NCT00090285|11437952|FG000|COMPLETED|Base Study Follow-up Period||1487
10304845|NCT00090285|11437953|FG001|COMPLETED|Base Study Follow-up Period||1479
10304846|NCT00090285|11437954|FG002|COMPLETED|Base Study Follow-up Period||0
10304847|NCT00090285|11437955|FG003|COMPLETED|Base Study Follow-up Period||0
10304848|NCT00090285|11437956|FG004|COMPLETED|Base Study Follow-up Period||0
10304849|NCT00090285|11437957|FG005|COMPLETED|Base Study Follow-up Period||0
10304850|NCT00090285|11437952|FG000|NOT COMPLETED|Base Study Follow-up Period||335
10304851|NCT00090285|11437953|FG001|NOT COMPLETED|Base Study Follow-up Period||342
10304852|NCT00090285|11437954|FG002|NOT COMPLETED|Base Study Follow-up Period||0
10304853|NCT00090285|11437955|FG003|NOT COMPLETED|Base Study Follow-up Period||0
10304854|NCT00090285|11437956|FG004|NOT COMPLETED|Base Study Follow-up Period||0
10304855|NCT00090285|11437957|FG005|NOT COMPLETED|Base Study Follow-up Period||0
10304856|NCT00090285|11437952|FG000|STARTED|Extension 1||0
10304857|NCT00090285|11437953|FG001|STARTED|Extension 1||0
10304858|NCT00090285|11437954|FG002|STARTED|Extension 1|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|1098
10304859|NCT00090285|11437955|FG003|STARTED|Extension 1|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|16
10304860|NCT00090285|11437956|FG004|STARTED|Extension 1||0
10304861|NCT00090285|11437957|FG005|STARTED|Extension 1||0
10304862|NCT00090285|11437952|FG000|COMPLETED|Extension 1||0
10304863|NCT00090285|11437953|FG001|COMPLETED|Extension 1||0
10342863|NCT00394524|11480405|FG000|STARTED|Overall Study||80
10342864|NCT00394524|11480406|FG001|STARTED|Overall Study||80
10342865|NCT00394524|11480405|FG000|COMPLETED|Overall Study||77
10342866|NCT00394524|11480406|FG001|COMPLETED|Overall Study||76
10342867|NCT00394524|11480405|FG000|NOT COMPLETED|Overall Study||3
10342868|NCT00394524|11480406|FG001|NOT COMPLETED|Overall Study||4
10342869|NCT00394589|11480417|FG000|STARTED|Overall Study||14
10342870|NCT00394589|11480418|FG001|STARTED|Overall Study||11
10342871|NCT00394589|11480419|FG002|STARTED|Overall Study||18
10342872|NCT00394589|11480417|FG000|COMPLETED|Overall Study||6
10342873|NCT00394589|11480418|FG001|COMPLETED|Overall Study||8
10342874|NCT00394589|11480419|FG002|COMPLETED|Overall Study||11
10342875|NCT00394589|11480417|FG000|NOT COMPLETED|Overall Study||8
10342876|NCT00394589|11480418|FG001|NOT COMPLETED|Overall Study||3
10342877|NCT00394589|11480419|FG002|NOT COMPLETED|Overall Study||7
10342878|NCT00394654|11480429|FG000|STARTED|Overall Study||15
10342879|NCT00394654|11480430|FG001|STARTED|Overall Study||15
10342880|NCT00394654|11480429|FG000|COMPLETED|Overall Study||13
10342881|NCT00394654|11480430|FG001|COMPLETED|Overall Study||15
10342882|NCT00394654|11480429|FG000|NOT COMPLETED|Overall Study||2
10342883|NCT00394654|11480430|FG001|NOT COMPLETED|Overall Study||0
10342884|NCT00394706|11480444|FG000|STARTED|Overall Study||1819
10342885|NCT00394706|11480445|FG001|STARTED|Overall Study||1862
10342886|NCT00394706|11480446|FG002|STARTED|Overall Study||1624
10342887|NCT00394706|11480447|FG003|STARTED|Overall Study||1633
10342888|NCT00394706|11480448|FG004|STARTED|Overall Study||1636
10342889|NCT00394706|11480449|FG005|STARTED|Overall Study||1384
10342890|NCT00394706|11480450|FG006|STARTED|Overall Study||929
10342891|NCT00394706|11480451|FG007|STARTED|Overall Study||851
10342892|NCT00394706|11480444|FG000|COMPLETED|Overall Study||1815
10342893|NCT00394706|11480445|FG001|COMPLETED|Overall Study||1860
10342894|NCT00394706|11480446|FG002|COMPLETED|Overall Study||1615
10342895|NCT00394706|11480447|FG003|COMPLETED|Overall Study||1632
10342896|NCT00394706|11480448|FG004|COMPLETED|Overall Study||1634
10342897|NCT00394706|11480449|FG005|COMPLETED|Overall Study||1377
10342898|NCT00394706|11480450|FG006|COMPLETED|Overall Study||926
10342899|NCT00394706|11480451|FG007|COMPLETED|Overall Study||851
10342900|NCT00394706|11480444|FG000|NOT COMPLETED|Overall Study||4
10342901|NCT00394706|11480445|FG001|NOT COMPLETED|Overall Study||2
10342902|NCT00394706|11480446|FG002|NOT COMPLETED|Overall Study||9
10342903|NCT00394706|11480447|FG003|NOT COMPLETED|Overall Study||1
10342904|NCT00394706|11480448|FG004|NOT COMPLETED|Overall Study||2
10342905|NCT00394706|11480449|FG005|NOT COMPLETED|Overall Study||7
10342906|NCT00394706|11480450|FG006|NOT COMPLETED|Overall Study||3
10342907|NCT00394706|11480451|FG007|NOT COMPLETED|Overall Study||0
10342908|NCT00394771|11480469|FG000|STARTED|Overall Study|Safety population of treated participants|140
10342909|NCT00394771|11480470|FG001|STARTED|Overall Study|Safety population of treated participants|136
10342910|NCT00394771|11480471|FG002|STARTED|Overall Study|Safety population of treated participants|143
10342911|NCT00394771|11480472|FG003|STARTED|Overall Study|Safety population of treated participants|148
10342912|NCT00394771|11480469|FG000|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|110
10342913|NCT00394771|11480470|FG001|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|110
10342914|NCT00394771|11480471|FG002|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|108
10342915|NCT00394771|11480472|FG003|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|120
10342916|NCT00394771|11480469|FG000|COMPLETED|Overall Study||99
10342917|NCT00394771|11480470|FG001|COMPLETED|Overall Study||102
10342918|NCT00394771|11480471|FG002|COMPLETED|Overall Study||96
10342919|NCT00394771|11480472|FG003|COMPLETED|Overall Study||109
10342920|NCT00394771|11480469|FG000|NOT COMPLETED|Overall Study||41
10342921|NCT00394771|11480470|FG001|NOT COMPLETED|Overall Study||34
10342922|NCT00394771|11480471|FG002|NOT COMPLETED|Overall Study||47
10342923|NCT00394771|11480472|FG003|NOT COMPLETED|Overall Study||39
10342924|NCT00394836|11480484|FG000|STARTED|Teatment or Follow-up Phase||30
10342925|NCT00394836|11480485|FG001|STARTED|Teatment or Follow-up Phase||86
10342926|NCT00394836|11480484|FG000|Early Follow-up Entry|Teatment or Follow-up Phase|Did not complete treatment.|4
10342927|NCT00394836|11480485|FG001|Early Follow-up Entry|Teatment or Follow-up Phase|Did not complete treatment.|8
10342928|NCT00394836|11480484|FG000|COMPLETED|Teatment or Follow-up Phase||2
10342929|NCT00394836|11480485|FG001|COMPLETED|Teatment or Follow-up Phase||8
10342930|NCT00394836|11480484|FG000|NOT COMPLETED|Teatment or Follow-up Phase||28
10342931|NCT00394836|11480485|FG001|NOT COMPLETED|Teatment or Follow-up Phase||78
10342932|NCT00394836|11480484|FG000|STARTED|Extended Follow-up Phase (2-5 Years)|Not all participants went into extended follow up per protocol.|20
10342933|NCT00394836|11480485|FG001|STARTED|Extended Follow-up Phase (2-5 Years)|Not all participants went into extended follow up per protocol.|58
10342934|NCT00394836|11480484|FG000|COMPLETED|Extended Follow-up Phase (2-5 Years)||0
10426482|NCT00847704|11572163|FG000|COMPLETED|Overall Study||2
10655302|NCT02207244|11815905|FG001|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
10655303|NCT02207244|11815906|FG002|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
10655304|NCT02207244|11815907|FG003|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
10655305|NCT02207244|11815908|FG004|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
10655306|NCT02207244|11815909|FG005|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
10342935|NCT00394836|11480485|FG001|COMPLETED|Extended Follow-up Phase (2-5 Years)||5
10342936|NCT00394836|11480484|FG000|NOT COMPLETED|Extended Follow-up Phase (2-5 Years)||20
10342937|NCT00394836|11480485|FG001|NOT COMPLETED|Extended Follow-up Phase (2-5 Years)||53
10342938|NCT00394888|11480496|FG000|STARTED|Overall Study||108
10342939|NCT00394888|11480497|FG001|STARTED|Overall Study||48
10342940|NCT00394888|11480498|FG002|STARTED|Overall Study||201
10342941|NCT00394888|11480496|FG000|COMPLETED|Overall Study||108
10342942|NCT00394888|11480497|FG001|COMPLETED|Overall Study||48
10342943|NCT00394888|11480498|FG002|COMPLETED|Overall Study||201
10342944|NCT00394888|11480496|FG000|NOT COMPLETED|Overall Study||0
10342945|NCT00394888|11480497|FG001|NOT COMPLETED|Overall Study||0
10342946|NCT00394888|11480498|FG002|NOT COMPLETED|Overall Study||0
10342947|NCT00394901|11480508|FG000|STARTED|Baseline Phase|Subjects randomized|98
10342948|NCT00394901|11480509|FG001|STARTED|Baseline Phase|Subjects randomized|87
10342949|NCT00394901|11480510|FG002|STARTED|Baseline Phase|Subjects randomized|90
10342950|NCT00394901|11480511|FG003|STARTED|Baseline Phase|Subjects randomized|97
10342951|NCT00394901|11480508|FG000|COMPLETED|Baseline Phase||98
10342952|NCT00394901|11480509|FG001|COMPLETED|Baseline Phase||87
10342953|NCT00394901|11480510|FG002|COMPLETED|Baseline Phase||89
10342954|NCT00394901|11480511|FG003|COMPLETED|Baseline Phase||97
10342955|NCT00394901|11480508|FG000|NOT COMPLETED|Baseline Phase||0
10342956|NCT00394901|11480509|FG001|NOT COMPLETED|Baseline Phase||0
10342957|NCT00394901|11480510|FG002|NOT COMPLETED|Baseline Phase||1
10342958|NCT00394901|11480511|FG003|NOT COMPLETED|Baseline Phase||0
10342959|NCT00394901|11480508|FG000|STARTED|Double-blind Phase|Subjects treated with the study drug.|98
10342960|NCT00394901|11480509|FG001|STARTED|Double-blind Phase|Subjects treated with the study drug.|87
10342961|NCT00394901|11480510|FG002|STARTED|Double-blind Phase|Subjects treated with the study drug.|89
10342962|NCT00394901|11480511|FG003|STARTED|Double-blind Phase|Subjects treated with the study drug.|97
10715462|NCT02688387|11880063|FG020|STARTED|Part 2, Period 4 (up to 6 Days)||0
10715463|NCT02688387|11880064|FG021|STARTED|Part 2, Period 4 (up to 6 Days)||0
10304864|NCT00090285|11437954|FG002|COMPLETED|Extension 1||1041
10304865|NCT00090285|11437955|FG003|COMPLETED|Extension 1||15
10304866|NCT00090285|11437956|FG004|COMPLETED|Extension 1||0
10304867|NCT00090285|11437957|FG005|COMPLETED|Extension 1||0
10304868|NCT00090285|11437952|FG000|NOT COMPLETED|Extension 1||0
10304869|NCT00090285|11437953|FG001|NOT COMPLETED|Extension 1||0
10304870|NCT00090285|11437954|FG002|NOT COMPLETED|Extension 1||57
10304871|NCT00090285|11437955|FG003|NOT COMPLETED|Extension 1||1
10304872|NCT00090285|11437956|FG004|NOT COMPLETED|Extension 1||0
10304873|NCT00090285|11437957|FG005|NOT COMPLETED|Extension 1||0
10304874|NCT00090285|11437952|FG000|STARTED|Long-term Follow-up (EXT2)||0
10304875|NCT00090285|11437953|FG001|STARTED|Long-term Follow-up (EXT2)||0
10304876|NCT00090285|11437954|FG002|STARTED|Long-term Follow-up (EXT2)||0
10304877|NCT00090285|11437955|FG003|STARTED|Long-term Follow-up (EXT2)||0
10304878|NCT00090285|11437956|FG004|STARTED|Long-term Follow-up (EXT2)|Not all eligible participants enrolled in LTFU (EXT2)|936
10304879|NCT00090285|11437957|FG005|STARTED|Long-term Follow-up (EXT2)|Not all eligible participants enrolled in LTFU (EXT2)|867
10304880|NCT00090285|11437952|FG000|COMPLETED|Long-term Follow-up (EXT2)||0
10304881|NCT00090285|11437953|FG001|COMPLETED|Long-term Follow-up (EXT2)||0
10304882|NCT00090285|11437954|FG002|COMPLETED|Long-term Follow-up (EXT2)||0
10304883|NCT00090285|11437955|FG003|COMPLETED|Long-term Follow-up (EXT2)||0
10304884|NCT00090285|11437956|FG004|COMPLETED|Long-term Follow-up (EXT2)||709
10304885|NCT00090285|11437957|FG005|COMPLETED|Long-term Follow-up (EXT2)||664
10304886|NCT00090285|11437952|FG000|NOT COMPLETED|Long-term Follow-up (EXT2)||0
10304887|NCT00090285|11437953|FG001|NOT COMPLETED|Long-term Follow-up (EXT2)||0
10304888|NCT00090285|11437954|FG002|NOT COMPLETED|Long-term Follow-up (EXT2)||0
10304889|NCT00090285|11437955|FG003|NOT COMPLETED|Long-term Follow-up (EXT2)||0
10304890|NCT00090285|11437956|FG004|NOT COMPLETED|Long-term Follow-up (EXT2)||227
10304891|NCT00090285|11437957|FG005|NOT COMPLETED|Long-term Follow-up (EXT2)||203
10304892|NCT00090363|11437975|FG000|STARTED|Overall Study||107
10304893|NCT00090363|11437976|FG001|STARTED|Overall Study||107
10304894|NCT00090363|11437977|FG002|STARTED|Overall Study||98
10304895|NCT00090363|11437975|FG000|Received Study Treatment.|Overall Study||107
10304896|NCT00090363|11437976|FG001|Received Study Treatment.|Overall Study||107
10304897|NCT00090363|11437977|FG002|Received Study Treatment.|Overall Study||98
10304898|NCT00090363|11437975|FG000|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|1
10304899|NCT00090363|11437976|FG001|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|0
10304900|NCT00090363|11437977|FG002|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|2
10531421|NCT01411891|11683681|FG000|COMPLETED|Overall Study||47
10531422|NCT01411891|11683682|FG001|COMPLETED|Overall Study||48
10531423|NCT01411891|11683681|FG000|NOT COMPLETED|Overall Study||3
10531424|NCT01411891|11683682|FG001|NOT COMPLETED|Overall Study||2
10531425|NCT01411917|11683690|FG000|STARTED|Overall Study||32
10531426|NCT01411917|11683691|FG001|STARTED|Overall Study||37
10531427|NCT01411917|11683690|FG000|COMPLETED|Overall Study||32
10531428|NCT01411917|11683691|FG001|COMPLETED|Overall Study||36
10531429|NCT01411917|11683690|FG000|NOT COMPLETED|Overall Study||0
10531430|NCT01411917|11683691|FG001|NOT COMPLETED|Overall Study||1
10531431|NCT01411995|11683699|FG000|STARTED|Overall Study||100
10531432|NCT01411995|11683700|FG001|STARTED|Overall Study||100
10531433|NCT01411995|11683699|FG000|COMPLETED|Overall Study||100
10531434|NCT01411995|11683700|FG001|COMPLETED|Overall Study||99
10531435|NCT01411995|11683699|FG000|NOT COMPLETED|Overall Study||0
10531436|NCT01411995|11683700|FG001|NOT COMPLETED|Overall Study||1
10531437|NCT01412021|11683706|FG000|STARTED|Overall Study||375
10715464|NCT02688387|11880043|FG000|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10715465|NCT02688387|11880044|FG001|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10304901|NCT00090363|11437975|FG000|NOT COMPLETED|Overall Study||106
10304902|NCT00090363|11437976|FG001|NOT COMPLETED|Overall Study||107
10304903|NCT00090363|11437977|FG002|NOT COMPLETED|Overall Study||96
10304904|NCT00090402|11437988|FG000|STARTED|Overall Study||13
10304905|NCT00090402|11437989|FG001|STARTED|Overall Study||13
10304906|NCT00090402|11437990|FG002|STARTED|Overall Study||13
10531438|NCT01412021|11683706|FG000|Case Report Forms Locked|Overall Study||368
10531439|NCT01412021|11683706|FG000|COMPLETED|Overall Study||356
10531440|NCT01412021|11683706|FG000|NOT COMPLETED|Overall Study||19
10342963|NCT00394901|11480508|FG000|COMPLETED|Double-blind Phase||83
10342964|NCT00394901|11480509|FG001|COMPLETED|Double-blind Phase||73
10342965|NCT00394901|11480510|FG002|COMPLETED|Double-blind Phase||71
10342966|NCT00394901|11480511|FG003|COMPLETED|Double-blind Phase||70
10304907|NCT00090402|11437988|FG000|COMPLETED|Overall Study||11
10304908|NCT00090402|11437989|FG001|COMPLETED|Overall Study||11
10304909|NCT00090402|11437990|FG002|COMPLETED|Overall Study||12
10304910|NCT00090402|11437988|FG000|NOT COMPLETED|Overall Study||2
10304911|NCT00090402|11437989|FG001|NOT COMPLETED|Overall Study||2
10304912|NCT00090402|11437990|FG002|NOT COMPLETED|Overall Study||1
10304913|NCT00090493|11438001|FG000|STARTED|Overall Study||4
10304914|NCT00090493|11438001|FG000|COMPLETED|Overall Study||2
10304915|NCT00090493|11438001|FG000|NOT COMPLETED|Overall Study||2
10304916|NCT00090519|11438007|FG000|STARTED|Overall Study||371
10304917|NCT00090519|11438008|FG001|STARTED|Overall Study||360
10304918|NCT00090519|11438007|FG000|COMPLETED|Overall Study||298
10304919|NCT00090519|11438008|FG001|COMPLETED|Overall Study||285
10304920|NCT00090519|11438007|FG000|NOT COMPLETED|Overall Study||73
10304921|NCT00090519|11438008|FG001|NOT COMPLETED|Overall Study||75
10715466|NCT02688387|11880045|FG002|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10715467|NCT02688387|11880046|FG003|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10304922|NCT00090545|11438016|FG000|STARTED|Overall Study||22
10304923|NCT00090545|11438017|FG001|STARTED|Overall Study||24
10304924|NCT00090545|11438016|FG000|COMPLETED|Overall Study||0
10304925|NCT00090545|11438017|FG001|COMPLETED|Overall Study||0
10304926|NCT00090545|11438016|FG000|NOT COMPLETED|Overall Study||22
10304927|NCT00090545|11438017|FG001|NOT COMPLETED|Overall Study||24
10304928|NCT00090584|11438027|FG000|STARTED|Baseline to 10 Weeks||154
10304929|NCT00090584|11438028|FG001|STARTED|Baseline to 10 Weeks||153
10304930|NCT00090584|11438027|FG000|COMPLETED|Baseline to 10 Weeks||139
10304931|NCT00090584|11438028|FG001|COMPLETED|Baseline to 10 Weeks||141
10304932|NCT00090584|11438027|FG000|NOT COMPLETED|Baseline to 10 Weeks||15
10304933|NCT00090584|11438028|FG001|NOT COMPLETED|Baseline to 10 Weeks||12
10304934|NCT00090584|11438027|FG000|STARTED|Baseline to 8 Months||154
10304935|NCT00090584|11438028|FG001|STARTED|Baseline to 8 Months||153
10304936|NCT00090584|11438027|FG000|COMPLETED|Baseline to 8 Months||110
10304937|NCT00090584|11438028|FG001|COMPLETED|Baseline to 8 Months||112
10304938|NCT00090584|11438027|FG000|NOT COMPLETED|Baseline to 8 Months||44
10304939|NCT00090584|11438028|FG001|NOT COMPLETED|Baseline to 8 Months||41
10304940|NCT00090610|11438044|FG000|STARTED|Overall Study||75
10304941|NCT00090610|11438045|FG001|STARTED|Overall Study||75
10304942|NCT00090610|11438044|FG000|COMPLETED|Overall Study||74
10304943|NCT00090610|11438045|FG001|COMPLETED|Overall Study||74
10304944|NCT00090610|11438044|FG000|NOT COMPLETED|Overall Study||1
10304945|NCT00090610|11438045|FG001|NOT COMPLETED|Overall Study||1
10304946|NCT00090753|11438053|FG000|STARTED|First Treatment Period||748
10304947|NCT00090753|11438054|FG001|STARTED|First Treatment Period||480
10304948|NCT00090753|11438053|FG000|COMPLETED|First Treatment Period||492
10304949|NCT00090753|11438054|FG001|COMPLETED|First Treatment Period||302
10304950|NCT00090753|11438053|FG000|NOT COMPLETED|First Treatment Period||256
10304951|NCT00090753|11438054|FG001|NOT COMPLETED|First Treatment Period||178
10304952|NCT00090753|11438053|FG000|STARTED|Extended Treatment Period|39 patients who completed the first treatment period refused to enter the extended treatment period.|453
10304953|NCT00090753|11438054|FG001|STARTED|Extended Treatment Period|52 patients who completed the first treatment period refused to enter the extended treatment period.|250
10304954|NCT00090753|11438053|FG000|COMPLETED|Extended Treatment Period||94
10715468|NCT02688387|11880047|FG004|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10715469|NCT02688387|11880048|FG005|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10304955|NCT00090753|11438054|FG001|COMPLETED|Extended Treatment Period||59
10304956|NCT00090753|11438053|FG000|NOT COMPLETED|Extended Treatment Period||359
10304957|NCT00090753|11438054|FG001|NOT COMPLETED|Extended Treatment Period||191
10304958|NCT00090766|11438063|FG000|STARTED|Overall Study||17
10715470|NCT02688387|11880049|FG006|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10304959|NCT00090766|11438064|FG001|STARTED|Overall Study||21
10304960|NCT00090766|11438065|FG002|STARTED|Overall Study||25
10304961|NCT00090766|11438063|FG000|COMPLETED|Overall Study||14
10304962|NCT00090766|11438064|FG001|COMPLETED|Overall Study||19
10304963|NCT00090766|11438065|FG002|COMPLETED|Overall Study||22
10304964|NCT00090766|11438063|FG000|NOT COMPLETED|Overall Study||3
10304965|NCT00090766|11438064|FG001|NOT COMPLETED|Overall Study||2
10304966|NCT00090766|11438065|FG002|NOT COMPLETED|Overall Study||3
10655307|NCT02207244|11815910|FG006|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
10655308|NCT02207244|11815911|FG007|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
10655309|NCT02207244|11815912|FG008|NOT COMPLETED|Open-label Guselkumab: Week 72-264||38
10655310|NCT02207244|11815913|FG009|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
10655311|NCT02207244|11815914|FG010|NOT COMPLETED|Open-label Guselkumab: Week 72-264||102
10655312|NCT02207322|11815945|FG000|STARTED|Overall Study||79
10655313|NCT02207322|11815946|FG001|STARTED|Overall Study||81
10655314|NCT02207322|11815945|FG000|Week-2|Overall Study||77
10655315|NCT02207322|11815946|FG001|Week-2|Overall Study||80
10655316|NCT02207322|11815945|FG000|3-month|Overall Study||74
10655317|NCT02207322|11815946|FG001|3-month|Overall Study||75
10655318|NCT02207322|11815945|FG000|COMPLETED|Overall Study|6-month|70
10304967|NCT00090779|11438077|FG000|STARTED|Step 1||66
10304968|NCT00090779|11438078|FG001|STARTED|Step 1||64
10304969|NCT00090779|11438077|FG000|COMPLETED|Step 1|Results are based on the database frozen on July 2, 2009 per DSMB recommendation of study closure.|55
10304970|NCT00090779|11438078|FG001|COMPLETED|Step 1|Results are based on the database frozen on July 2, 2009 per DSMB recommendation of study closure.|49
10304971|NCT00090779|11438077|FG000|NOT COMPLETED|Step 1||11
10304972|NCT00090779|11438078|FG001|NOT COMPLETED|Step 1||15
10304973|NCT00090779|11438077|FG000|STARTED|Step 2|One subject who had two consecutive CD4<350cells/mm^3 did not enter step 2.|6
10304974|NCT00090779|11438078|FG001|STARTED|Step 2|Three with two consecutive CD4<350cells/mm^3 and one with CDC category B event didn't enter step 2.|19
10304975|NCT00090779|11438077|FG000|COMPLETED|Step 2||0
10304976|NCT00090779|11438078|FG001|COMPLETED|Step 2||1
10304977|NCT00090779|11438077|FG000|NOT COMPLETED|Step 2||6
10304978|NCT00090779|11438078|FG001|NOT COMPLETED|Step 2||18
10304979|NCT00090779|11438077|FG000|STARTED|Step 3||7
10304980|NCT00090779|11438078|FG001|STARTED|Step 3||5
10304981|NCT00090779|11438077|FG000|COMPLETED|Step 3||0
10715471|NCT02688387|11880050|FG007|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10715472|NCT02688387|11880051|FG008|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10715473|NCT02688387|11880052|FG009|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10715474|NCT02688387|11880053|FG010|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
10304982|NCT00090779|11438078|FG001|COMPLETED|Step 3||0
10304983|NCT00090779|11438077|FG000|NOT COMPLETED|Step 3||7
10304984|NCT00090779|11438078|FG001|NOT COMPLETED|Step 3||5
10304985|NCT00090844|11438086|FG000|STARTED|Overall Study||27
10304986|NCT00090844|11438087|FG001|STARTED|Overall Study||22
10304987|NCT00090844|11438086|FG000|COMPLETED|Overall Study||26
10304988|NCT00090844|11438087|FG001|COMPLETED|Overall Study||21
10304989|NCT00090844|11438086|FG000|NOT COMPLETED|Overall Study||1
10304990|NCT00090844|11438087|FG001|NOT COMPLETED|Overall Study||1
10304991|NCT00090857|11438096|FG000|STARTED|Overall Study||33
10304992|NCT00090857|11438097|FG001|STARTED|Overall Study||16
10304993|NCT00090857|11438096|FG000|COMPLETED|Overall Study||29
10304994|NCT00090857|11438097|FG001|COMPLETED|Overall Study||13
10304995|NCT00090857|11438096|FG000|NOT COMPLETED|Overall Study||4
10304996|NCT00090857|11438097|FG001|NOT COMPLETED|Overall Study||3
10304997|NCT00090987|11438103|FG000|STARTED|Overall Study||30
10304998|NCT00090987|11438103|FG000|COMPLETED|Overall Study||9
10304999|NCT00090987|11438103|FG000|NOT COMPLETED|Overall Study||21
10305000|NCT00091026|11438109|FG000|STARTED|Overall Study||72
10305001|NCT00091026|11438110|FG001|STARTED|Overall Study||71
10305002|NCT00091026|11438109|FG000|COMPLETED|Overall Study||71
10305003|NCT00091026|11438110|FG001|COMPLETED|Overall Study||68
10305004|NCT00091026|11438109|FG000|NOT COMPLETED|Overall Study||1
10305005|NCT00091026|11438110|FG001|NOT COMPLETED|Overall Study||3
10531441|NCT01412060|11683710|FG000|STARTED|Open-label Run-in Period (RIP)||765
10531442|NCT01412060|11683711|FG001|STARTED|Open-label Run-in Period (RIP)||0
10531443|NCT01412060|11683712|FG002|STARTED|Open-label Run-in Period (RIP)||0
10531444|NCT01412060|11683710|FG000|COMPLETED|Open-label Run-in Period (RIP)||418
10531445|NCT01412060|11683711|FG001|COMPLETED|Open-label Run-in Period (RIP)||0
10531446|NCT01412060|11683712|FG002|COMPLETED|Open-label Run-in Period (RIP)||0
10531447|NCT01412060|11683710|FG000|NOT COMPLETED|Open-label Run-in Period (RIP)||347
10531448|NCT01412060|11683711|FG001|NOT COMPLETED|Open-label Run-in Period (RIP)||0
10531449|NCT01412060|11683712|FG002|NOT COMPLETED|Open-label Run-in Period (RIP)||0
10305006|NCT00091169|11438118|FG000|STARTED|Overall Study||189
10305007|NCT00091169|11438119|FG001|STARTED|Overall Study||187
10305008|NCT00091169|11438118|FG000|Treated|Overall Study||163
10305009|NCT00091169|11438119|FG001|Treated|Overall Study||170
10305010|NCT00091169|11438118|FG000|COMPLETED|Overall Study||132
10305011|NCT00091169|11438119|FG001|COMPLETED|Overall Study||134
10305012|NCT00091169|11438118|FG000|NOT COMPLETED|Overall Study||57
10531450|NCT01412060|11683710|FG000|STARTED|Period Between RIP and SP||418
10305013|NCT00091169|11438119|FG001|NOT COMPLETED|Overall Study||53
10305014|NCT00091260|11438127|FG000|STARTED|Overall Study||82
10305015|NCT00091260|11438127|FG000|COMPLETED|Overall Study||82
10305016|NCT00091260|11438127|FG000|NOT COMPLETED|Overall Study||0
10305017|NCT00091273|11438132|FG000|STARTED|Overall Study||9
10305018|NCT00091273|11438132|FG000|COMPLETED|Overall Study||9
10531451|NCT01412060|11683711|FG001|STARTED|Period Between RIP and SP||0
10531452|NCT01412060|11683712|FG002|STARTED|Period Between RIP and SP||0
10531453|NCT01412060|11683710|FG000|COMPLETED|Period Between RIP and SP||364
10531454|NCT01412060|11683711|FG001|COMPLETED|Period Between RIP and SP||0
10531455|NCT01412060|11683712|FG002|COMPLETED|Period Between RIP and SP||0
10531456|NCT01412060|11683710|FG000|NOT COMPLETED|Period Between RIP and SP||54
10531457|NCT01412060|11683711|FG001|NOT COMPLETED|Period Between RIP and SP||0
10531458|NCT01412060|11683712|FG002|NOT COMPLETED|Period Between RIP and SP||0
10531459|NCT01412060|11683710|FG000|STARTED|Open-label Stabilization Period (SP)||364
10531460|NCT01412060|11683711|FG001|STARTED|Open-label Stabilization Period (SP)||0
10531461|NCT01412060|11683712|FG002|STARTED|Open-label Stabilization Period (SP)||0
10531462|NCT01412060|11683710|FG000|COMPLETED|Open-label Stabilization Period (SP)||264
10531463|NCT01412060|11683711|FG001|COMPLETED|Open-label Stabilization Period (SP)||0
10531464|NCT01412060|11683712|FG002|COMPLETED|Open-label Stabilization Period (SP)||0
10531465|NCT01412060|11683710|FG000|NOT COMPLETED|Open-label Stabilization Period (SP)||100
10531466|NCT01412060|11683711|FG001|NOT COMPLETED|Open-label Stabilization Period (SP)||0
10531467|NCT01412060|11683712|FG002|NOT COMPLETED|Open-label Stabilization Period (SP)||0
10531468|NCT01412060|11683710|FG000|STARTED|Period Between SP and DBP||264
10531469|NCT01412060|11683711|FG001|STARTED|Period Between SP and DBP||0
10531470|NCT01412060|11683712|FG002|STARTED|Period Between SP and DBP||0
10531471|NCT01412060|11683710|FG000|COMPLETED|Period Between SP and DBP||200
10531472|NCT01412060|11683711|FG001|COMPLETED|Period Between SP and DBP||0
10531473|NCT01412060|11683712|FG002|COMPLETED|Period Between SP and DBP||0
10531474|NCT01412060|11683710|FG000|NOT COMPLETED|Period Between SP and DBP||64
10531475|NCT01412060|11683711|FG001|NOT COMPLETED|Period Between SP and DBP||0
10531476|NCT01412060|11683712|FG002|NOT COMPLETED|Period Between SP and DBP||0
10531477|NCT01412060|11683710|FG000|STARTED|Double-blind Treatment Phase (DBP)||0
10531478|NCT01412060|11683711|FG001|STARTED|Double-blind Treatment Phase (DBP)||99
10531479|NCT01412060|11683712|FG002|STARTED|Double-blind Treatment Phase (DBP)||101
10531480|NCT01412060|11683710|FG000|COMPLETED|Double-blind Treatment Phase (DBP)||0
10531481|NCT01412060|11683711|FG001|COMPLETED|Double-blind Treatment Phase (DBP)||16
10531482|NCT01412060|11683712|FG002|COMPLETED|Double-blind Treatment Phase (DBP)||18
10531483|NCT01412060|11683710|FG000|NOT COMPLETED|Double-blind Treatment Phase (DBP)||0
10531484|NCT01412060|11683711|FG001|NOT COMPLETED|Double-blind Treatment Phase (DBP)||83
10531485|NCT01412060|11683712|FG002|NOT COMPLETED|Double-blind Treatment Phase (DBP)||83
10531486|NCT01412086|11683722|FG000|STARTED|Overall Study||112
10531487|NCT01412086|11683722|FG000|COMPLETED|Overall Study||112
10531488|NCT01412086|11683722|FG000|NOT COMPLETED|Overall Study||0
10531489|NCT01412151|11683726|FG000|STARTED|Week 0 - 306 - Treatment Period||10
10531490|NCT01412151|11683726|FG000|COMPLETED|Week 0 - 306 - Treatment Period||5
10531491|NCT01412151|11683726|FG000|NOT COMPLETED|Week 0 - 306 - Treatment Period||5
10531492|NCT01412151|11683726|FG000|STARTED|Week 306 - 310 - Washout Period||5
10531493|NCT01412151|11683726|FG000|COMPLETED|Week 306 - 310 - Washout Period||3
10531494|NCT01412151|11683726|FG000|NOT COMPLETED|Week 306 - 310 - Washout Period||2
10531495|NCT01412164|11683732|FG000|STARTED|Overall Study||730
10531496|NCT01412164|11683732|FG000|COMPLETED|Overall Study||683
10531497|NCT01412164|11683732|FG000|NOT COMPLETED|Overall Study||47
10531498|NCT01412229|11683736|FG000|STARTED|Overall Study||39
10531499|NCT01412229|11683736|FG000|COMPLETED|Overall Study||38
10531500|NCT01412229|11683736|FG000|NOT COMPLETED|Overall Study||1
10531501|NCT01412281|11683745|FG000|STARTED|Overall Study||110
10531502|NCT01412281|11683746|FG001|STARTED|Overall Study||110
10531503|NCT01412281|11683747|FG002|STARTED|Overall Study||110
10531504|NCT01412281|11683748|FG003|STARTED|Overall Study||110
10531505|NCT01412281|11683745|FG000|COMPLETED|Overall Study||110
10531506|NCT01412281|11683746|FG001|COMPLETED|Overall Study||110
10531507|NCT01412281|11683747|FG002|COMPLETED|Overall Study||110
10531508|NCT01412281|11683748|FG003|COMPLETED|Overall Study||110
10531509|NCT01412281|11683745|FG000|NOT COMPLETED|Overall Study||0
10531510|NCT01412281|11683746|FG001|NOT COMPLETED|Overall Study||0
10531511|NCT01412281|11683747|FG002|NOT COMPLETED|Overall Study||0
10531512|NCT01412281|11683748|FG003|NOT COMPLETED|Overall Study||0
10531513|NCT01412372|11683760|FG000|STARTED|Overall Study||30
10531514|NCT01412372|11683761|FG001|STARTED|Overall Study||31
10531515|NCT01412372|11683760|FG000|COMPLETED|Overall Study||26
10531516|NCT01412372|11683761|FG001|COMPLETED|Overall Study||28
10531517|NCT01412372|11683760|FG000|NOT COMPLETED|Overall Study||4
10531518|NCT01412372|11683761|FG001|NOT COMPLETED|Overall Study||3
10531519|NCT01412424|11683767|FG000|STARTED|Core Treatment Period||155
10531520|NCT01412424|11683767|FG000|COMPLETED|Core Treatment Period||102
10531521|NCT01412424|11683767|FG000|NOT COMPLETED|Core Treatment Period||53
10531522|NCT01412424|11683767|FG000|STARTED|Extension Treatment Period|86% of participants who completed the core period voluntarily entered the optional extension period.|88
10531523|NCT01412424|11683767|FG000|COMPLETED|Extension Treatment Period||82
10531524|NCT01412424|11683767|FG000|NOT COMPLETED|Extension Treatment Period||6
10342967|NCT00394901|11480508|FG000|NOT COMPLETED|Double-blind Phase||15
10342968|NCT00394901|11480509|FG001|NOT COMPLETED|Double-blind Phase||14
10342969|NCT00394901|11480510|FG002|NOT COMPLETED|Double-blind Phase||18
10342970|NCT00394901|11480511|FG003|NOT COMPLETED|Double-blind Phase||27
10342971|NCT00394914|11480526|FG000|STARTED|Screening Period||311
10342972|NCT00394914|11480527|FG001|STARTED|Screening Period||0
10342973|NCT00394914|11480528|FG002|STARTED|Screening Period||0
10342974|NCT00394914|11480526|FG000|COMPLETED|Screening Period||311
10342975|NCT00394914|11480527|FG001|COMPLETED|Screening Period||0
10342976|NCT00394914|11480528|FG002|COMPLETED|Screening Period||0
10342977|NCT00394914|11480526|FG000|NOT COMPLETED|Screening Period||0
10342978|NCT00394914|11480527|FG001|NOT COMPLETED|Screening Period||0
10342979|NCT00394914|11480528|FG002|NOT COMPLETED|Screening Period||0
10342980|NCT00394914|11480526|FG000|STARTED|Pre-exposure Period||311
10342981|NCT00394914|11480527|FG001|STARTED|Pre-exposure Period||0
10342982|NCT00394914|11480528|FG002|STARTED|Pre-exposure Period||0
10342983|NCT00394914|11480526|FG000|COMPLETED|Pre-exposure Period||311
10342984|NCT00394914|11480527|FG001|COMPLETED|Pre-exposure Period||0
10342985|NCT00394914|11480528|FG002|COMPLETED|Pre-exposure Period||0
10342986|NCT00394914|11480526|FG000|NOT COMPLETED|Pre-exposure Period||0
10342987|NCT00394914|11480527|FG001|NOT COMPLETED|Pre-exposure Period||0
10342988|NCT00394914|11480528|FG002|NOT COMPLETED|Pre-exposure Period||0
10342989|NCT00394914|11480526|FG000|STARTED|Treatment Period||0
10342990|NCT00394914|11480527|FG001|STARTED|Treatment Period||154
10342991|NCT00394914|11480528|FG002|STARTED|Treatment Period||157
10342992|NCT00394914|11480526|FG000|COMPLETED|Treatment Period||0
10342993|NCT00394914|11480527|FG001|COMPLETED|Treatment Period||144
10342994|NCT00394914|11480528|FG002|COMPLETED|Treatment Period||151
10342995|NCT00394914|11480526|FG000|NOT COMPLETED|Treatment Period||0
10342996|NCT00394914|11480527|FG001|NOT COMPLETED|Treatment Period||10
10342997|NCT00394914|11480528|FG002|NOT COMPLETED|Treatment Period||6
10342998|NCT00394953|11480536|FG000|STARTED|First Treatment Period||245
10342999|NCT00394953|11480537|FG001|STARTED|First Treatment Period||244
10343000|NCT00394953|11480536|FG000|COMPLETED|First Treatment Period||216
10343001|NCT00394953|11480537|FG001|COMPLETED|First Treatment Period||222
10343002|NCT00394953|11480536|FG000|NOT COMPLETED|First Treatment Period||29
10343003|NCT00394953|11480537|FG001|NOT COMPLETED|First Treatment Period||22
10343004|NCT00394953|11480536|FG000|STARTED|Second Treatment Period||216
10343005|NCT00394953|11480537|FG001|STARTED|Second Treatment Period||222
10343006|NCT00394953|11480536|FG000|COMPLETED|Second Treatment Period||187
10343007|NCT00394953|11480537|FG001|COMPLETED|Second Treatment Period||148
10343008|NCT00394953|11480536|FG000|NOT COMPLETED|Second Treatment Period||29
10343009|NCT00394953|11480537|FG001|NOT COMPLETED|Second Treatment Period||74
10343010|NCT00395018|11480543|FG000|STARTED|On-Treatment|Started = treated (participants who received at least 1 dose of study therapy)|65
10343011|NCT00395018|11480543|FG000|DISCONTINUED PRIOR TO WEEK 72 VISIT|On-Treatment||10
10343012|NCT00395018|11480543|FG000|DISCONTINUED AT OR AFTER WEEK 72 VISIT|On-Treatment||0
10343013|NCT00395018|11480543|FG000|COMPLETED|On-Treatment|"Completed means received treatment through Week 72"|55
10343014|NCT00395018|11480543|FG000|NOT COMPLETED|On-Treatment||10
10343015|NCT00395018|11480543|FG000|STARTED|Off-Treatment Follow-up|Treated participants who discontinued =<72 weeks and did not start other anti-HBV therapy|5
10343016|NCT00395018|11480543|FG000|COMPLETED|Off-Treatment Follow-up|"Completed means completed the study"|1
10343017|NCT00395018|11480543|FG000|NOT COMPLETED|Off-Treatment Follow-up||4
10343018|NCT00395044|11480549|FG000|STARTED|Overall Study||25
10343019|NCT00395044|11480550|FG001|STARTED|Overall Study||25
10343020|NCT00395044|11480549|FG000|COMPLETED|Overall Study||7
10343021|NCT00395044|11480550|FG001|COMPLETED|Overall Study||11
10343022|NCT00395044|11480549|FG000|NOT COMPLETED|Overall Study||18
10343023|NCT00395044|11480550|FG001|NOT COMPLETED|Overall Study||14
10343024|NCT00395057|11480560|FG000|STARTED|Overall Study||34
10343025|NCT00395057|11480561|FG001|STARTED|Overall Study||35
10343026|NCT00395057|11480562|FG002|STARTED|Overall Study||35
10343027|NCT00395057|11480563|FG003|STARTED|Overall Study||34
10343028|NCT00395057|11480560|FG000|COMPLETED|Overall Study||2
10343029|NCT00395057|11480561|FG001|COMPLETED|Overall Study||1
10343030|NCT00395057|11480562|FG002|COMPLETED|Overall Study||2
10343031|NCT00395057|11480563|FG003|COMPLETED|Overall Study||1
10343032|NCT00395057|11480560|FG000|NOT COMPLETED|Overall Study||32
10343033|NCT00395057|11480561|FG001|NOT COMPLETED|Overall Study||34
10343034|NCT00395057|11480562|FG002|NOT COMPLETED|Overall Study||33
10343035|NCT00395057|11480563|FG003|NOT COMPLETED|Overall Study||33
10343036|NCT00395083|11480575|FG000|STARTED|Overall Study||217
10343037|NCT00395083|11480576|FG001|STARTED|Overall Study||209
10343038|NCT00395083|11480575|FG000|COMPLETED|Overall Study||207
10343039|NCT00395083|11480576|FG001|COMPLETED|Overall Study||201
10343040|NCT00395083|11480575|FG000|NOT COMPLETED|Overall Study||10
10343041|NCT00395083|11480576|FG001|NOT COMPLETED|Overall Study||8
10343042|NCT00395135|11480584|FG000|STARTED|Year 1||1595
10343043|NCT00395135|11480585|FG001|STARTED|Year 1||1587
10343044|NCT00395135|11480586|FG002|STARTED|Year 1||0
10343045|NCT00395135|11480587|FG003|STARTED|Year 1||0
10343046|NCT00395135|11480588|FG004|STARTED|Year 1||0
10343047|NCT00395135|11480584|FG000|COMPLETED|Year 1||883
10343048|NCT00395135|11480585|FG001|COMPLETED|Year 1||716
10343049|NCT00395135|11480586|FG002|COMPLETED|Year 1||0
10343050|NCT00395135|11480587|FG003|COMPLETED|Year 1||0
10343051|NCT00395135|11480588|FG004|COMPLETED|Year 1||0
10343052|NCT00395135|11480584|FG000|NOT COMPLETED|Year 1||712
10343053|NCT00395135|11480585|FG001|NOT COMPLETED|Year 1||871
10343054|NCT00395135|11480586|FG002|NOT COMPLETED|Year 1||0
10715475|NCT02688387|11880054|FG011|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
10715476|NCT02688387|11880055|FG012|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
10715477|NCT02688387|11880056|FG013|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
10715478|NCT02688387|11880057|FG014|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10715479|NCT02688387|11880058|FG015|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10715480|NCT02688387|11880059|FG016|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10715481|NCT02688387|11880060|FG017|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10715482|NCT02688387|11880061|FG018|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10343055|NCT00395135|11480587|FG003|NOT COMPLETED|Year 1||0
10343056|NCT00395135|11480588|FG004|NOT COMPLETED|Year 1||0
10343057|NCT00395135|11480584|FG000|STARTED|Year 2||0
10715483|NCT02688387|11880062|FG019|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10715484|NCT02688387|11880063|FG020|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10715485|NCT02688387|11880064|FG021|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10715486|NCT02688387|11880043|FG000|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10715487|NCT02688387|11880044|FG001|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10715488|NCT02688387|11880045|FG002|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10715489|NCT02688387|11880046|FG003|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10715490|NCT02688387|11880047|FG004|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10715491|NCT02688387|11880048|FG005|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10715492|NCT02688387|11880049|FG006|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10715493|NCT02688387|11880050|FG007|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10715494|NCT02688387|11880051|FG008|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10715495|NCT02688387|11880052|FG009|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10715496|NCT02688387|11880053|FG010|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10715497|NCT02688387|11880054|FG011|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10715498|NCT02688387|11880055|FG012|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10715499|NCT02688387|11880056|FG013|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10715500|NCT02688387|11880057|FG014|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10715501|NCT02688387|11880058|FG015|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10715502|NCT02688387|11880059|FG016|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10715503|NCT02688387|11880060|FG017|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10715504|NCT02688387|11880061|FG018|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10715505|NCT02688387|11880062|FG019|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10715506|NCT02688387|11880063|FG020|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10715507|NCT02688387|11880064|FG021|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
10715508|NCT02688387|11880043|FG000|STARTED|Part 3A, Period 1 (up to 6 Days)||0
10715509|NCT02688387|11880044|FG001|STARTED|Part 3A, Period 1 (up to 6 Days)||0
10715510|NCT02688387|11880045|FG002|STARTED|Part 3A, Period 1 (up to 6 Days)||0
10715511|NCT02688387|11880046|FG003|STARTED|Part 3A, Period 1 (up to 6 Days)||0
10715512|NCT02688387|11880047|FG004|STARTED|Part 3A, Period 1 (up to 6 Days)||0
10715513|NCT02688387|11880048|FG005|STARTED|Part 3A, Period 1 (up to 6 Days)||0
10715514|NCT02688387|11880049|FG006|STARTED|Part 3A, Period 1 (up to 6 Days)||0
10715515|NCT02688387|11880050|FG007|STARTED|Part 3A, Period 1 (up to 6 Days)||0
10715516|NCT02688387|11880051|FG008|STARTED|Part 3A, Period 1 (up to 6 Days)||0
10715517|NCT02688387|11880052|FG009|STARTED|Part 3A, Period 1 (up to 6 Days)||0
10715518|NCT02688387|11880053|FG010|STARTED|Part 3A, Period 1 (up to 6 Days)||0
10715519|NCT02688387|11880054|FG011|STARTED|Part 3A, Period 1 (up to 6 Days)||0
10715520|NCT02688387|11880055|FG012|STARTED|Part 3A, Period 1 (up to 6 Days)||0
10715521|NCT02688387|11880056|FG013|STARTED|Part 3A, Period 1 (up to 6 Days)||0
10715522|NCT02688387|11880057|FG014|STARTED|Part 3A, Period 1 (up to 6 Days)||9
10715523|NCT02688387|11880058|FG015|STARTED|Part 3A, Period 1 (up to 6 Days)||8
10715524|NCT02688387|11880059|FG016|STARTED|Part 3A, Period 1 (up to 6 Days)||8
10715525|NCT02688387|11880060|FG017|STARTED|Part 3A, Period 1 (up to 6 Days)||8
10715526|NCT02688387|11880061|FG018|STARTED|Part 3A, Period 1 (up to 6 Days)||0
10715527|NCT02688387|11880062|FG019|STARTED|Part 3A, Period 1 (up to 6 Days)||0
10715528|NCT02688387|11880063|FG020|STARTED|Part 3A, Period 1 (up to 6 Days)||0
10715529|NCT02688387|11880064|FG021|STARTED|Part 3A, Period 1 (up to 6 Days)||0
10715530|NCT02688387|11880043|FG000|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10715531|NCT02688387|11880044|FG001|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10715532|NCT02688387|11880045|FG002|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10715533|NCT02688387|11880046|FG003|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10715534|NCT02688387|11880047|FG004|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10715535|NCT02688387|11880048|FG005|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10715536|NCT02688387|11880049|FG006|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10715537|NCT02688387|11880050|FG007|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10715538|NCT02688387|11880051|FG008|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10715539|NCT02688387|11880052|FG009|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10715540|NCT02688387|11880053|FG010|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10715541|NCT02688387|11880054|FG011|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10715542|NCT02688387|11880055|FG012|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10715543|NCT02688387|11880056|FG013|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10715544|NCT02688387|11880057|FG014|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
10715545|NCT02688387|11880058|FG015|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
10715546|NCT02688387|11880059|FG016|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
10715547|NCT02688387|11880060|FG017|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
10715548|NCT02688387|11880061|FG018|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10715549|NCT02688387|11880062|FG019|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10715550|NCT02688387|11880063|FG020|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10715551|NCT02688387|11880064|FG021|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10715552|NCT02688387|11880043|FG000|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10715553|NCT02688387|11880044|FG001|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10715554|NCT02688387|11880045|FG002|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10715555|NCT02688387|11880046|FG003|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10715556|NCT02688387|11880047|FG004|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10715557|NCT02688387|11880048|FG005|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10715558|NCT02688387|11880049|FG006|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10305019|NCT00091273|11438132|FG000|NOT COMPLETED|Overall Study||0
10305020|NCT00091390|11438136|FG000|STARTED|Overall Study||129
10305021|NCT00091390|11438136|FG000|Eligible and Started Study Treatment|Overall Study||125
10305022|NCT00091390|11438136|FG000|Eligible, Started Treatment, Has AE Data|Overall Study||115
10305023|NCT00091390|11438136|FG000|COMPLETED|Overall Study|Subjects contributing data to results are considered to have completed the study.|125
10305024|NCT00091390|11438136|FG000|NOT COMPLETED|Overall Study||4
10305025|NCT00091442|11438142|FG000|STARTED|Overall Study||373
10715559|NCT02688387|11880050|FG007|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10715560|NCT02688387|11880051|FG008|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10305026|NCT00091442|11438143|FG001|STARTED|Overall Study||378
10305027|NCT00091442|11438142|FG000|COMPLETED|Overall Study|Indicates number of participants on study treatment at time of the primary objective|4
10305028|NCT00091442|11438143|FG001|COMPLETED|Overall Study|Indicates number of participants on study treatment at time of the primary objective|5
10305029|NCT00091442|11438142|FG000|NOT COMPLETED|Overall Study||369
10715561|NCT02688387|11880052|FG009|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10715562|NCT02688387|11880053|FG010|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10715563|NCT02688387|11880054|FG011|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10715564|NCT02688387|11880055|FG012|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10715565|NCT02688387|11880056|FG013|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10715566|NCT02688387|11880057|FG014|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||1
10715567|NCT02688387|11880058|FG015|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10715568|NCT02688387|11880059|FG016|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10715569|NCT02688387|11880060|FG017|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10715570|NCT02688387|11880061|FG018|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10715571|NCT02688387|11880062|FG019|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10715572|NCT02688387|11880063|FG020|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10715573|NCT02688387|11880064|FG021|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
10715574|NCT02688387|11880043|FG000|STARTED|Part 3A, Washout Period 1 (10 Days)||0
10715575|NCT02688387|11880044|FG001|STARTED|Part 3A, Washout Period 1 (10 Days)||0
10715576|NCT02688387|11880045|FG002|STARTED|Part 3A, Washout Period 1 (10 Days)||0
10715577|NCT02688387|11880046|FG003|STARTED|Part 3A, Washout Period 1 (10 Days)||0
10715578|NCT02688387|11880047|FG004|STARTED|Part 3A, Washout Period 1 (10 Days)||0
10715579|NCT02688387|11880048|FG005|STARTED|Part 3A, Washout Period 1 (10 Days)||0
10715580|NCT02688387|11880049|FG006|STARTED|Part 3A, Washout Period 1 (10 Days)||0
10715581|NCT02688387|11880050|FG007|STARTED|Part 3A, Washout Period 1 (10 Days)||0
10715582|NCT02688387|11880051|FG008|STARTED|Part 3A, Washout Period 1 (10 Days)||0
10715583|NCT02688387|11880052|FG009|STARTED|Part 3A, Washout Period 1 (10 Days)||0
10715584|NCT02688387|11880053|FG010|STARTED|Part 3A, Washout Period 1 (10 Days)||0
10305030|NCT00091442|11438143|FG001|NOT COMPLETED|Overall Study||373
10305031|NCT00091507|11438151|FG000|STARTED|Overall Study||432
10305032|NCT00091507|11438152|FG001|STARTED|Overall Study||479
10305033|NCT00091507|11438151|FG000|COMPLETED|Overall Study||411
10305034|NCT00091507|11438152|FG001|COMPLETED|Overall Study||460
10305035|NCT00091507|11438151|FG000|NOT COMPLETED|Overall Study||21
10305036|NCT00091507|11438152|FG001|NOT COMPLETED|Overall Study||19
10343058|NCT00395135|11480585|FG001|STARTED|Year 2||0
10343059|NCT00395135|11480586|FG002|STARTED|Year 2||573
10343060|NCT00395135|11480587|FG003|STARTED|Year 2||283
10343061|NCT00395135|11480588|FG004|STARTED|Year 2||697
10343062|NCT00395135|11480584|FG000|COMPLETED|Year 2||0
10343063|NCT00395135|11480585|FG001|COMPLETED|Year 2||0
10343064|NCT00395135|11480586|FG002|COMPLETED|Year 2||426
10343065|NCT00395135|11480587|FG003|COMPLETED|Year 2||195
10343066|NCT00395135|11480588|FG004|COMPLETED|Year 2||507
10343067|NCT00395135|11480584|FG000|NOT COMPLETED|Year 2||0
10343068|NCT00395135|11480585|FG001|NOT COMPLETED|Year 2||0
10343069|NCT00395135|11480586|FG002|NOT COMPLETED|Year 2||147
10343070|NCT00395135|11480587|FG003|NOT COMPLETED|Year 2||88
10343071|NCT00395135|11480588|FG004|NOT COMPLETED|Year 2||190
10343072|NCT00395161|11480604|FG000|STARTED|Overall Study||149
10343073|NCT00395161|11480605|FG001|STARTED|Overall Study||144
10343074|NCT00395161|11480604|FG000|COMPLETED|Overall Study||149
10343075|NCT00395161|11480605|FG001|COMPLETED|Overall Study||144
10343076|NCT00395161|11480604|FG000|NOT COMPLETED|Overall Study||0
10343077|NCT00395161|11480605|FG001|NOT COMPLETED|Overall Study||0
10343078|NCT00395226|11480615|FG000|STARTED|Overall Study||26
10343079|NCT00395226|11480616|FG001|STARTED|Overall Study||27
10343080|NCT00395226|11480615|FG000|COMPLETED|Overall Study||22
10343081|NCT00395226|11480616|FG001|COMPLETED|Overall Study||22
10343082|NCT00395226|11480615|FG000|NOT COMPLETED|Overall Study||4
10343083|NCT00395226|11480616|FG001|NOT COMPLETED|Overall Study||5
10343084|NCT00395291|11480622|FG000|STARTED|First Intervention||17
10343085|NCT00395291|11480623|FG001|STARTED|First Intervention||9
10343086|NCT00395291|11480622|FG000|COMPLETED|First Intervention||15
10343087|NCT00395291|11480623|FG001|COMPLETED|First Intervention||9
10343088|NCT00395291|11480622|FG000|NOT COMPLETED|First Intervention||2
10343089|NCT00395291|11480623|FG001|NOT COMPLETED|First Intervention||0
10343090|NCT00395291|11480622|FG000|STARTED|Washout Period for 30 Days||15
10343091|NCT00395291|11480623|FG001|STARTED|Washout Period for 30 Days||9
10343092|NCT00395291|11480622|FG000|COMPLETED|Washout Period for 30 Days||13
10343093|NCT00395291|11480623|FG001|COMPLETED|Washout Period for 30 Days||9
10343094|NCT00395291|11480622|FG000|NOT COMPLETED|Washout Period for 30 Days||2
10343095|NCT00395291|11480623|FG001|NOT COMPLETED|Washout Period for 30 Days||0
10343096|NCT00395291|11480622|FG000|STARTED|Second Intervention||13
10531525|NCT01412541|11683779|FG000|STARTED|Overall Study||372
10812347|NCT03723447|11974389|FG001|STARTED|Overall Study||51
10812348|NCT03723447|11974388|FG000|COMPLETED|Overall Study||50
10812349|NCT03723447|11974389|FG001|COMPLETED|Overall Study||51
10812350|NCT03723447|11974388|FG000|NOT COMPLETED|Overall Study||0
10812351|NCT03723447|11974389|FG001|NOT COMPLETED|Overall Study||0
10812352|NCT03723070|11974395|FG000|STARTED|Overall Study||88
10812353|NCT03723070|11974395|FG000|COMPLETED|Overall Study||79
10812354|NCT03723070|11974395|FG000|NOT COMPLETED|Overall Study||9
10812355|NCT03720210|11974399|FG000|STARTED|Overall Study||1
10812356|NCT03720210|11974399|FG000|COMPLETED|Overall Study||0
10812357|NCT03720210|11974399|FG000|NOT COMPLETED|Overall Study||1
10343097|NCT00395291|11480623|FG001|STARTED|Second Intervention||9
10343098|NCT00395291|11480622|FG000|COMPLETED|Second Intervention||13
10343099|NCT00395291|11480623|FG001|COMPLETED|Second Intervention||9
10343100|NCT00395291|11480622|FG000|NOT COMPLETED|Second Intervention||0
10343101|NCT00395291|11480623|FG001|NOT COMPLETED|Second Intervention||0
10343102|NCT00395304|11480629|FG000|STARTED|Treatment Period 1||31
10343103|NCT00395304|11480630|FG001|STARTED|Treatment Period 1||30
10343104|NCT00395304|11480631|FG002|STARTED|Treatment Period 1||30
10343105|NCT00395304|11480632|FG003|STARTED|Treatment Period 1||31
10343106|NCT00395304|11480633|FG004|STARTED|Treatment Period 1||28
10343107|NCT00395304|11480634|FG005|STARTED|Treatment Period 1||32
10343108|NCT00395304|11480629|FG000|COMPLETED|Treatment Period 1||30
10305037|NCT00091572|11438160|FG000|STARTED|Overall Study|10 subjects in temozolomide group not treated.|429
10305038|NCT00091572|11438161|FG001|STARTED|Overall Study|9 subjects in dacarbazine group not treated.|430
10305039|NCT00091572|11438160|FG000|COMPLETED|Overall Study|Progressive disease/relapse/death due to progressive disease|334
10305040|NCT00091572|11438161|FG001|COMPLETED|Overall Study|Progressive disease/relapse/death due to progressive disease|348
10305041|NCT00091572|11438160|FG000|NOT COMPLETED|Overall Study||95
10305042|NCT00091572|11438161|FG001|NOT COMPLETED|Overall Study||82
10305043|NCT00091793|11438169|FG000|STARTED|Overall Study||166
10305044|NCT00091793|11438170|FG001|STARTED|Overall Study||166
10305045|NCT00091793|11438169|FG000|COMPLETED|Overall Study||142
10305046|NCT00091793|11438170|FG001|COMPLETED|Overall Study||144
10305047|NCT00091793|11438169|FG000|NOT COMPLETED|Overall Study||24
10305048|NCT00091793|11438170|FG001|NOT COMPLETED|Overall Study||22
10305049|NCT00091819|11438178|FG000|STARTED|Overall Study||429
10305050|NCT00091819|11438179|FG001|STARTED|Overall Study||433
10305051|NCT00091819|11438178|FG000|COMPLETED|Overall Study||387
10305052|NCT00091819|11438179|FG001|COMPLETED|Overall Study||387
10305053|NCT00091819|11438178|FG000|NOT COMPLETED|Overall Study||42
10305054|NCT00091819|11438179|FG001|NOT COMPLETED|Overall Study||46
10305055|NCT00091832|11438191|FG000|STARTED|Overall Study||43
10305056|NCT00091832|11438192|FG001|STARTED|Overall Study||42
10305057|NCT00091832|11438193|FG002|STARTED|Overall Study||42
10305058|NCT00091832|11438194|FG003|STARTED|Overall Study||43
10305059|NCT00091832|11438195|FG004|STARTED|Overall Study||42
10305060|NCT00091832|11438196|FG005|STARTED|Overall Study||43
10305061|NCT00091832|11438191|FG000|Received Study Medication|Overall Study||43
10305062|NCT00091832|11438192|FG001|Received Study Medication|Overall Study||42
10655319|NCT02207322|11815946|FG001|COMPLETED|Overall Study|6-month|71
10655320|NCT02207322|11815945|FG000|NOT COMPLETED|Overall Study||9
10305063|NCT00091832|11438193|FG002|Received Study Medication|Overall Study||41
10305064|NCT00091832|11438194|FG003|Received Study Medication|Overall Study||43
10305065|NCT00091832|11438195|FG004|Received Study Medication|Overall Study||42
10305066|NCT00091832|11438196|FG005|Received Study Medication|Overall Study||43
10305067|NCT00091832|11438191|FG000|COMPLETED|Overall Study||29
10305068|NCT00091832|11438192|FG001|COMPLETED|Overall Study||31
10305069|NCT00091832|11438193|FG002|COMPLETED|Overall Study||30
10305070|NCT00091832|11438194|FG003|COMPLETED|Overall Study||29
10305071|NCT00091832|11438195|FG004|COMPLETED|Overall Study||27
10305072|NCT00091832|11438196|FG005|COMPLETED|Overall Study||32
10305073|NCT00091832|11438191|FG000|NOT COMPLETED|Overall Study||14
10305074|NCT00091832|11438192|FG001|NOT COMPLETED|Overall Study||11
10305075|NCT00091832|11438193|FG002|NOT COMPLETED|Overall Study||12
10305076|NCT00091832|11438194|FG003|NOT COMPLETED|Overall Study||14
10305077|NCT00091832|11438195|FG004|NOT COMPLETED|Overall Study||15
10305078|NCT00091832|11438196|FG005|NOT COMPLETED|Overall Study||11
10305079|NCT00091949|11438212|FG000|STARTED|Overall Study||1939
10305080|NCT00091949|11438213|FG001|STARTED|Overall Study||1937
10305081|NCT00091949|11438212|FG000|COMPLETED|Overall Study||1764
10305082|NCT00091949|11438213|FG001|COMPLETED|Overall Study||1786
10305083|NCT00091949|11438212|FG000|NOT COMPLETED|Overall Study||175
10305084|NCT00091949|11438213|FG001|NOT COMPLETED|Overall Study||151
10305085|NCT00091962|11438222|FG000|STARTED|Overall Study||150
10305086|NCT00091962|11438223|FG001|STARTED|Overall Study||152
10305087|NCT00091962|11438224|FG002|STARTED|Overall Study||151
10305088|NCT00091962|11438222|FG000|COMPLETED|Overall Study||150
10305089|NCT00091962|11438223|FG001|COMPLETED|Overall Study||152
10305090|NCT00091962|11438224|FG002|COMPLETED|Overall Study||151
10305091|NCT00091962|11438222|FG000|NOT COMPLETED|Overall Study||0
10305092|NCT00091962|11438223|FG001|NOT COMPLETED|Overall Study||0
10305093|NCT00091962|11438224|FG002|NOT COMPLETED|Overall Study||0
10305094|NCT00092417|11438237|FG000|STARTED|Overall Study|Started Period Group 1|464
10305095|NCT00092417|11438238|FG001|STARTED|Overall Study|Started Period Group 2|234
10315222|NCT00176423|11449051|FG001|NOT COMPLETED|Overall Study||6
10343109|NCT00395304|11480630|FG001|COMPLETED|Treatment Period 1||26
10343110|NCT00395304|11480631|FG002|COMPLETED|Treatment Period 1||30
10343111|NCT00395304|11480632|FG003|COMPLETED|Treatment Period 1||28
10343112|NCT00395304|11480633|FG004|COMPLETED|Treatment Period 1||27
10655321|NCT02207322|11815946|FG001|NOT COMPLETED|Overall Study||10
10655322|NCT02207374|11815955|FG000|STARTED|Overall Study||239
10343113|NCT00395304|11480634|FG005|COMPLETED|Treatment Period 1||30
10655323|NCT02207374|11815956|FG001|STARTED|Overall Study||241
10715585|NCT02688387|11880054|FG011|STARTED|Part 3A, Washout Period 1 (10 Days)||0
10715586|NCT02688387|11880055|FG012|STARTED|Part 3A, Washout Period 1 (10 Days)||0
10343114|NCT00395304|11480629|FG000|NOT COMPLETED|Treatment Period 1||1
10343115|NCT00395304|11480630|FG001|NOT COMPLETED|Treatment Period 1||4
10343116|NCT00395304|11480631|FG002|NOT COMPLETED|Treatment Period 1||0
10343117|NCT00395304|11480632|FG003|NOT COMPLETED|Treatment Period 1||3
10343118|NCT00395304|11480633|FG004|NOT COMPLETED|Treatment Period 1||1
10343119|NCT00395304|11480634|FG005|NOT COMPLETED|Treatment Period 1||2
10343120|NCT00395304|11480629|FG000|STARTED|Treatment Period 2||30
10343121|NCT00395304|11480630|FG001|STARTED|Treatment Period 2||26
10343122|NCT00395304|11480631|FG002|STARTED|Treatment Period 2||30
10343123|NCT00395304|11480632|FG003|STARTED|Treatment Period 2||28
10343124|NCT00395304|11480633|FG004|STARTED|Treatment Period 2||27
10343125|NCT00395304|11480634|FG005|STARTED|Treatment Period 2||30
10343126|NCT00395304|11480629|FG000|COMPLETED|Treatment Period 2||30
10343127|NCT00395304|11480630|FG001|COMPLETED|Treatment Period 2||22
10343128|NCT00395304|11480631|FG002|COMPLETED|Treatment Period 2||29
10343129|NCT00395304|11480632|FG003|COMPLETED|Treatment Period 2||27
10343130|NCT00395304|11480633|FG004|COMPLETED|Treatment Period 2||27
10343131|NCT00395304|11480634|FG005|COMPLETED|Treatment Period 2||28
10343132|NCT00395304|11480629|FG000|NOT COMPLETED|Treatment Period 2||0
10343133|NCT00395304|11480630|FG001|NOT COMPLETED|Treatment Period 2||4
10343134|NCT00395304|11480631|FG002|NOT COMPLETED|Treatment Period 2||1
10343135|NCT00395304|11480632|FG003|NOT COMPLETED|Treatment Period 2||1
10343136|NCT00395304|11480633|FG004|NOT COMPLETED|Treatment Period 2||0
10343137|NCT00395304|11480634|FG005|NOT COMPLETED|Treatment Period 2||2
10343138|NCT00395304|11480629|FG000|STARTED|Treatment Period 3||30
10343139|NCT00395304|11480630|FG001|STARTED|Treatment Period 3||22
10343140|NCT00395304|11480631|FG002|STARTED|Treatment Period 3||29
10343141|NCT00395304|11480632|FG003|STARTED|Treatment Period 3||27
10343142|NCT00395304|11480633|FG004|STARTED|Treatment Period 3||27
10343143|NCT00395304|11480634|FG005|STARTED|Treatment Period 3||28
10343144|NCT00395304|11480629|FG000|COMPLETED|Treatment Period 3||29
10343145|NCT00395304|11480630|FG001|COMPLETED|Treatment Period 3||20
10343146|NCT00395304|11480631|FG002|COMPLETED|Treatment Period 3||29
10343147|NCT00395304|11480632|FG003|COMPLETED|Treatment Period 3||25
10715587|NCT02688387|11880056|FG013|STARTED|Part 3A, Washout Period 1 (10 Days)||0
10715588|NCT02688387|11880057|FG014|STARTED|Part 3A, Washout Period 1 (10 Days)||8
10343148|NCT00395304|11480633|FG004|COMPLETED|Treatment Period 3||27
10343149|NCT00395304|11480634|FG005|COMPLETED|Treatment Period 3||27
10343150|NCT00395304|11480629|FG000|NOT COMPLETED|Treatment Period 3||1
10343151|NCT00395304|11480630|FG001|NOT COMPLETED|Treatment Period 3||2
10343152|NCT00395304|11480631|FG002|NOT COMPLETED|Treatment Period 3||0
10343153|NCT00395304|11480632|FG003|NOT COMPLETED|Treatment Period 3||2
10343154|NCT00395304|11480633|FG004|NOT COMPLETED|Treatment Period 3||0
10343155|NCT00395304|11480634|FG005|NOT COMPLETED|Treatment Period 3||1
10343156|NCT00395343|11480643|FG000|STARTED|Overall Study||322
10343157|NCT00395343|11480644|FG001|STARTED|Overall Study||319
10343158|NCT00395343|11480643|FG000|COMPLETED|Overall Study||281
10343159|NCT00395343|11480644|FG001|COMPLETED|Overall Study||283
10343160|NCT00395343|11480643|FG000|NOT COMPLETED|Overall Study||41
10343161|NCT00395343|11480644|FG001|NOT COMPLETED|Overall Study||36
10343162|NCT00395447|11480652|FG000|STARTED|Overall Study||1031
10343163|NCT00395447|11480653|FG001|STARTED|Overall Study||713
10343164|NCT00395447|11480652|FG000|COMPLETED|Overall Study||910
10343165|NCT00395447|11480653|FG001|COMPLETED|Overall Study||602
10343166|NCT00395447|11480652|FG000|NOT COMPLETED|Overall Study||121
10343167|NCT00395447|11480653|FG001|NOT COMPLETED|Overall Study||111
10343168|NCT00395460|11480661|FG000|STARTED|Overall Study||72
10531526|NCT01412541|11683780|FG001|STARTED|Overall Study||160
10531527|NCT01412541|11683779|FG000|COMPLETED|Overall Study||246
10531528|NCT01412541|11683780|FG001|COMPLETED|Overall Study||117
10531529|NCT01412541|11683779|FG000|NOT COMPLETED|Overall Study||126
10531530|NCT01412541|11683780|FG001|NOT COMPLETED|Overall Study||43
10531531|NCT01412554|11683789|FG000|STARTED|Overall Study|103 persons re-examined in 2012-13 out of 158 persons originally examined in 1991-96.|103
10531532|NCT01412554|11683789|FG000|COMPLETED|Overall Study||103
10531533|NCT01412554|11683789|FG000|NOT COMPLETED|Overall Study||0
10531534|NCT01412710|11683795|FG000|STARTED|Overall Study||50
10531535|NCT01412710|11683796|FG001|STARTED|Overall Study||27
10531536|NCT01412710|11683795|FG000|COMPLETED|Overall Study||46
10531537|NCT01412710|11683796|FG001|COMPLETED|Overall Study||22
10531538|NCT01412710|11683795|FG000|NOT COMPLETED|Overall Study||4
10531539|NCT01412710|11683796|FG001|NOT COMPLETED|Overall Study||5
10531540|NCT01412801|11683808|FG000|STARTED|Overall Study||91
10531541|NCT01412801|11683809|FG001|STARTED|Overall Study||89
10531542|NCT01412801|11683810|FG002|STARTED|Overall Study||90
10531543|NCT01412801|11683811|FG003|STARTED|Overall Study||91
10531544|NCT01412801|11683812|FG004|STARTED|Overall Study||88
10531545|NCT01412801|11683813|FG005|STARTED|Overall Study||87
10531546|NCT01412801|11683808|FG000|COMPLETED|Overall Study||87
10305096|NCT00092417|11438237|FG000|Vaccinated|Overall Study|3 participants were allocated,not vaccinated; they are not reported in the Baseline Characteristics|461
10305097|NCT00092417|11438238|FG001|Vaccinated|Overall Study||234
10305098|NCT00092417|11438237|FG000|COMPLETED|Overall Study|Received the higher potency zoster vaccine & completed 42 days of safety follow-up post vaccination|459
10305099|NCT00092417|11438238|FG001|COMPLETED|Overall Study|Received the lower potency zoster vaccine & completed 42 days of safety follow-up post vaccination|233
10305100|NCT00092417|11438237|FG000|NOT COMPLETED|Overall Study||5
10305101|NCT00092417|11438238|FG001|NOT COMPLETED|Overall Study||1
10305102|NCT00092443|11438246|FG000|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|651
10305103|NCT00092443|11438247|FG001|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|661
10305104|NCT00092443|11438246|FG000|Vaccinated at Visit 1|Overall Study||650
10343169|NCT00395460|11480662|FG001|STARTED|Overall Study||75
10343170|NCT00395460|11480661|FG000|Received Treatment|Overall Study|1 participant withdrew consent prior to study drug injection and did not receive any study drug.|71
10343171|NCT00395460|11480662|FG001|Received Treatment|Overall Study||75
10343172|NCT00395460|11480661|FG000|COMPLETED|Overall Study||71
10531547|NCT01412801|11683809|FG001|COMPLETED|Overall Study||84
10305105|NCT00092443|11438247|FG001|Vaccinated at Visit 1|Overall Study||660
10305106|NCT00092443|11438246|FG000|Vaccinated at Visit 2|Overall Study||618
10305107|NCT00092443|11438247|FG001|Vaccinated at Visit 2|Overall Study||627
10305108|NCT00092443|11438246|FG000|Vaccinated at Visit 3|Overall Study||593
10305109|NCT00092443|11438247|FG001|Vaccinated at Visit 3|Overall Study||608
10305110|NCT00092443|11438246|FG000|COMPLETED|Overall Study|Subjects vaccinated and followed up 42 days after each dose, thru 1st rotavirus season post study|593
10305111|NCT00092443|11438247|FG001|COMPLETED|Overall Study|Subjects vaccinated and followed up 42 days after each dose, thru 1st rotavirus season post study|607
10305112|NCT00092443|11438246|FG000|NOT COMPLETED|Overall Study||58
10305113|NCT00092443|11438247|FG001|NOT COMPLETED|Overall Study||54
10305114|NCT00092456|11438267|FG000|STARTED|Overall Study|Subject assigned to ~8.81 X 10^7 IU/Dose of RotaTeq™ - Lot 1|226
10305115|NCT00092456|11438268|FG001|STARTED|Overall Study|Subject assigned to ~8.01 X 10^7 IU/Dose of RotaTeq™ - Lot 2|225
10305116|NCT00092456|11438269|FG002|STARTED|Overall Study|Subject assigned to ~6.91 X 10^7 IU/Dose of RotaTeq™ - Lot 3|229
10305117|NCT00092456|11438270|FG003|STARTED|Overall Study|Subjects assigned to Placebo-matching RotaTeq™|113
10305118|NCT00092456|11438267|FG000|Vaccinated at Visit 1|Overall Study||226
10305119|NCT00092456|11438268|FG001|Vaccinated at Visit 1|Overall Study||225
10305120|NCT00092456|11438269|FG002|Vaccinated at Visit 1|Overall Study||229
10343173|NCT00395460|11480662|FG001|COMPLETED|Overall Study||75
10343174|NCT00395460|11480661|FG000|NOT COMPLETED|Overall Study||1
10343175|NCT00395460|11480662|FG001|NOT COMPLETED|Overall Study||0
10343176|NCT00395486|11480670|FG000|STARTED|Overall Study|Randomized subjects|132
10343177|NCT00395486|11480671|FG001|STARTED|Overall Study|Randomized subjects|126
10343178|NCT00395486|11480670|FG000|COMPLETED|Overall Study|Completed subjects|126
10343179|NCT00395486|11480671|FG001|COMPLETED|Overall Study|Completed subjects|121
10343180|NCT00395486|11480670|FG000|NOT COMPLETED|Overall Study||6
10343181|NCT00395486|11480671|FG001|NOT COMPLETED|Overall Study||5
10343182|NCT00395512|11480681|FG000|STARTED|Overall Study||164
10343183|NCT00395512|11480682|FG001|STARTED|Overall Study||163
10343184|NCT00395512|11480683|FG002|STARTED|Overall Study||164
10343185|NCT00395512|11480684|FG003|STARTED|Overall Study||164
10343186|NCT00395512|11480681|FG000|Safety Set|Overall Study||164
10343187|NCT00395512|11480682|FG001|Safety Set|Overall Study||163
10343188|NCT00395512|11480683|FG002|Safety Set|Overall Study||164
10343189|NCT00395512|11480684|FG003|Safety Set|Overall Study|1 participant was lost to follow-up post visit 1. It is unknown if they took any study medication.|163
10343190|NCT00395512|11480681|FG000|COMPLETED|Overall Study||126
10343191|NCT00395512|11480682|FG001|COMPLETED|Overall Study||126
10343192|NCT00395512|11480683|FG002|COMPLETED|Overall Study||136
10343193|NCT00395512|11480684|FG003|COMPLETED|Overall Study||126
10343194|NCT00395512|11480681|FG000|NOT COMPLETED|Overall Study||38
10343195|NCT00395512|11480682|FG001|NOT COMPLETED|Overall Study||37
10343196|NCT00395512|11480683|FG002|NOT COMPLETED|Overall Study||28
10343197|NCT00395512|11480684|FG003|NOT COMPLETED|Overall Study||38
10343198|NCT00395538|11480697|FG000|STARTED|Overall Study||8
10343199|NCT00395538|11480698|FG001|STARTED|Overall Study||15
10343200|NCT00395538|11480699|FG002|STARTED|Overall Study||23
10343201|NCT00395538|11480697|FG000|Signed Consent to the New Protocol|Overall Study||7
10343202|NCT00395538|11480698|FG001|Signed Consent to the New Protocol|Overall Study||5
10343203|NCT00395538|11480699|FG002|Signed Consent to the New Protocol|Overall Study||23
10343204|NCT00395538|11480697|FG000|Received HPTH on New Protocol|Overall Study||7
10343205|NCT00395538|11480698|FG001|Received HPTH on New Protocol|Overall Study||5
10343206|NCT00395538|11480699|FG002|Received HPTH on New Protocol|Overall Study||19
10343207|NCT00395538|11480697|FG000|Randomized to Bone Biopsy Year 1|Overall Study||0
10343208|NCT00395538|11480698|FG001|Randomized to Bone Biopsy Year 1|Overall Study||1
10343209|NCT00395538|11480699|FG002|Randomized to Bone Biopsy Year 1|Overall Study||5
10343210|NCT00395538|11480697|FG000|Randomized to Bone Biopsy Year 2|Overall Study||0
10343211|NCT00395538|11480698|FG001|Randomized to Bone Biopsy Year 2|Overall Study||2
10343212|NCT00395538|11480699|FG002|Randomized to Bone Biopsy Year 2|Overall Study||6
10343213|NCT00395538|11480697|FG000|Randomized to Bone Biospy Year 4|Overall Study||0
10343214|NCT00395538|11480698|FG001|Randomized to Bone Biospy Year 4|Overall Study||2
10343215|NCT00395538|11480699|FG002|Randomized to Bone Biospy Year 4|Overall Study||8
10343216|NCT00395538|11480697|FG000|Completed Bone Biopsy Year 1|Overall Study||0
10305121|NCT00092456|11438270|FG003|Vaccinated at Visit 1|Overall Study||113
10305122|NCT00092456|11438267|FG000|Vaccinated at Visit 2|Overall Study||208
10305123|NCT00092456|11438268|FG001|Vaccinated at Visit 2|Overall Study||217
10305124|NCT00092456|11438269|FG002|Vaccinated at Visit 2|Overall Study||210
10343217|NCT00395538|11480698|FG001|Completed Bone Biopsy Year 1|Overall Study||1
10343218|NCT00395538|11480699|FG002|Completed Bone Biopsy Year 1|Overall Study||4
10343219|NCT00395538|11480697|FG000|Completed Bone Biopsy Year 2|Overall Study||0
10343220|NCT00395538|11480698|FG001|Completed Bone Biopsy Year 2|Overall Study||2
10343221|NCT00395538|11480699|FG002|Completed Bone Biopsy Year 2|Overall Study||3
10343222|NCT00395538|11480697|FG000|Completed Bone Biopsy Year 4|Overall Study||0
10343223|NCT00395538|11480698|FG001|Completed Bone Biopsy Year 4|Overall Study||1
10343224|NCT00395538|11480699|FG002|Completed Bone Biopsy Year 4|Overall Study||1
10343225|NCT00395538|11480697|FG000|COMPLETED|Overall Study||5
10343226|NCT00395538|11480698|FG001|COMPLETED|Overall Study||2
10343227|NCT00395538|11480699|FG002|COMPLETED|Overall Study||0
10343228|NCT00395538|11480697|FG000|NOT COMPLETED|Overall Study||3
10343229|NCT00395538|11480698|FG001|NOT COMPLETED|Overall Study||13
10343230|NCT00395538|11480699|FG002|NOT COMPLETED|Overall Study||23
10343231|NCT00395629|11480710|FG000|STARTED|Core Study||11
10343232|NCT00395629|11480711|FG001|STARTED|Core Study||15
10343233|NCT00395629|11480712|FG002|STARTED|Core Study||23
10343234|NCT00395629|11480710|FG000|COMPLETED|Core Study||10
10343235|NCT00395629|11480711|FG001|COMPLETED|Core Study||11
10343236|NCT00395629|11480712|FG002|COMPLETED|Core Study||16
10343237|NCT00395629|11480710|FG000|NOT COMPLETED|Core Study||1
10343238|NCT00395629|11480711|FG001|NOT COMPLETED|Core Study||4
10343239|NCT00395629|11480712|FG002|NOT COMPLETED|Core Study||7
10715589|NCT02688387|11880058|FG015|STARTED|Part 3A, Washout Period 1 (10 Days)||8
10715590|NCT02688387|11880059|FG016|STARTED|Part 3A, Washout Period 1 (10 Days)||8
10715591|NCT02688387|11880060|FG017|STARTED|Part 3A, Washout Period 1 (10 Days)||8
10343240|NCT00395629|11480710|FG000|STARTED|Extension Study||9
10343241|NCT00395629|11480711|FG001|STARTED|Extension Study||6
10343242|NCT00395629|11480712|FG002|STARTED|Extension Study||11
10343243|NCT00395629|11480710|FG000|COMPLETED|Extension Study||9
10343244|NCT00395629|11480711|FG001|COMPLETED|Extension Study||6
10343245|NCT00395629|11480712|FG002|COMPLETED|Extension Study||8
10343246|NCT00395629|11480710|FG000|NOT COMPLETED|Extension Study||0
10343247|NCT00395629|11480711|FG001|NOT COMPLETED|Extension Study||0
10343248|NCT00395629|11480712|FG002|NOT COMPLETED|Extension Study||3
10343249|NCT00395642|11480723|FG000|STARTED|Overall Study||66
10343250|NCT00395642|11480723|FG000|COMPLETED|Overall Study||53
10343251|NCT00395642|11480723|FG000|NOT COMPLETED|Overall Study||13
10531558|NCT01412866|11683838|FG000|STARTED|Overall Study||58
10343252|NCT00395694|11480729|FG000|STARTED|Escalation Phase + Maintenance Phase||51
10343253|NCT00395694|11480730|FG001|STARTED|Escalation Phase + Maintenance Phase||51
10343254|NCT00395694|11480729|FG000|COMPLETED|Escalation Phase + Maintenance Phase||50
10343255|NCT00395694|11480730|FG001|COMPLETED|Escalation Phase + Maintenance Phase||49
10343256|NCT00395694|11480729|FG000|NOT COMPLETED|Escalation Phase + Maintenance Phase||1
10343257|NCT00395694|11480730|FG001|NOT COMPLETED|Escalation Phase + Maintenance Phase||2
10343258|NCT00395694|11480729|FG000|STARTED|Continuation Phase|One participant completing the Escalation/Maintenance Phase did not start the Continuation Phase.|49
10343259|NCT00395694|11480730|FG001|STARTED|Continuation Phase|One participant completing the Escalation/Maintenance Phase did not start the Continuation Phase.|48
10343260|NCT00395694|11480729|FG000|COMPLETED|Continuation Phase||34
10343261|NCT00395694|11480730|FG001|COMPLETED|Continuation Phase||35
10343262|NCT00395694|11480729|FG000|NOT COMPLETED|Continuation Phase||15
10343263|NCT00395694|11480730|FG001|NOT COMPLETED|Continuation Phase||13
10343264|NCT00395733|11480741|FG000|STARTED|Period 1||41
10343265|NCT00395733|11480742|FG001|STARTED|Period 1||42
10343266|NCT00395733|11480741|FG000|COMPLETED|Period 1||41
10343267|NCT00395733|11480742|FG001|COMPLETED|Period 1||42
10343268|NCT00395733|11480741|FG000|NOT COMPLETED|Period 1||0
10343269|NCT00395733|11480742|FG001|NOT COMPLETED|Period 1||0
10343270|NCT00395733|11480741|FG000|STARTED|Period 2||41
10343271|NCT00395733|11480742|FG001|STARTED|Period 2||42
10343272|NCT00395733|11480741|FG000|COMPLETED|Period 2||39
10343273|NCT00395733|11480742|FG001|COMPLETED|Period 2||37
10343274|NCT00395733|11480741|FG000|NOT COMPLETED|Period 2||2
10343275|NCT00395733|11480742|FG001|NOT COMPLETED|Period 2||5
10343276|NCT00395746|11480751|FG000|STARTED|Overall Study|Exposed to study drug|88
10343277|NCT00395746|11480752|FG001|STARTED|Overall Study|Exposed to study drug|88
10343278|NCT00395746|11480753|FG002|STARTED|Overall Study|Exposed to study drug|88
10343279|NCT00395746|11480751|FG000|COMPLETED|Overall Study|Completed 52 weeks treatment|78
10343280|NCT00395746|11480752|FG001|COMPLETED|Overall Study|Completed 52 weeks treatment|84
10343281|NCT00395746|11480753|FG002|COMPLETED|Overall Study|Completed 52 weeks treatment|66
10343282|NCT00395746|11480751|FG000|NOT COMPLETED|Overall Study||10
10343283|NCT00395746|11480752|FG001|NOT COMPLETED|Overall Study||4
10343284|NCT00395746|11480753|FG002|NOT COMPLETED|Overall Study||22
10715592|NCT02688387|11880061|FG018|STARTED|Part 3A, Washout Period 1 (10 Days)||0
10426483|NCT00847704|11572163|FG000|NOT COMPLETED|Overall Study||1
10343285|NCT00395850|11480765|FG000|STARTED|Pre-randomization Baseline/Induction|Pre-randomization and disulfiram (disulf) administration|118
10343286|NCT00395850|11480766|FG001|STARTED|Pre-randomization Baseline/Induction||0
10343287|NCT00395850|11480767|FG002|STARTED|Pre-randomization Baseline/Induction||0
10343288|NCT00395850|11480768|FG003|STARTED|Pre-randomization Baseline/Induction||0
10343289|NCT00395850|11480765|FG000|COMPLETED|Pre-randomization Baseline/Induction||107
10343290|NCT00395850|11480766|FG001|COMPLETED|Pre-randomization Baseline/Induction||0
10343291|NCT00395850|11480767|FG002|COMPLETED|Pre-randomization Baseline/Induction||0
10343292|NCT00395850|11480768|FG003|COMPLETED|Pre-randomization Baseline/Induction||0
10343293|NCT00395850|11480765|FG000|NOT COMPLETED|Pre-randomization Baseline/Induction||11
10343294|NCT00395850|11480766|FG001|NOT COMPLETED|Pre-randomization Baseline/Induction||0
10343295|NCT00395850|11480767|FG002|NOT COMPLETED|Pre-randomization Baseline/Induction||0
10343296|NCT00395850|11480768|FG003|NOT COMPLETED|Pre-randomization Baseline/Induction||0
10343297|NCT00395850|11480765|FG000|STARTED|Randomization to Disulfiram/ Pre-admin||27
10343298|NCT00395850|11480766|FG001|STARTED|Randomization to Disulfiram/ Pre-admin||25
10343299|NCT00395850|11480767|FG002|STARTED|Randomization to Disulfiram/ Pre-admin||30
10343300|NCT00395850|11480768|FG003|STARTED|Randomization to Disulfiram/ Pre-admin||25
10343301|NCT00395850|11480765|FG000|COMPLETED|Randomization to Disulfiram/ Pre-admin||22
10343302|NCT00395850|11480766|FG001|COMPLETED|Randomization to Disulfiram/ Pre-admin||23
10343303|NCT00395850|11480767|FG002|COMPLETED|Randomization to Disulfiram/ Pre-admin||24
10343304|NCT00395850|11480768|FG003|COMPLETED|Randomization to Disulfiram/ Pre-admin||21
10343305|NCT00395850|11480765|FG000|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||5
10343306|NCT00395850|11480766|FG001|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||2
10343307|NCT00395850|11480767|FG002|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||6
10343308|NCT00395850|11480768|FG003|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||4
10343309|NCT00395850|11480765|FG000|STARTED|Disulfiram/Placebo Treatment|Received >= 1 disulfiram dose. Two baseline/randomized subjects dropped out before receiving disulf|20
10343310|NCT00395850|11480766|FG001|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|23
10343311|NCT00395850|11480767|FG002|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|24
10343312|NCT00395850|11480768|FG003|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|21
10343313|NCT00395850|11480765|FG000|COMPLETED|Disulfiram/Placebo Treatment||11
10343314|NCT00395850|11480766|FG001|COMPLETED|Disulfiram/Placebo Treatment||9
10343315|NCT00395850|11480767|FG002|COMPLETED|Disulfiram/Placebo Treatment||5
10343316|NCT00395850|11480768|FG003|COMPLETED|Disulfiram/Placebo Treatment||8
10531548|NCT01412801|11683810|FG002|COMPLETED|Overall Study||83
10531549|NCT01412801|11683811|FG003|COMPLETED|Overall Study||87
10531550|NCT01412801|11683812|FG004|COMPLETED|Overall Study||85
10531551|NCT01412801|11683813|FG005|COMPLETED|Overall Study||84
10531552|NCT01412801|11683808|FG000|NOT COMPLETED|Overall Study||4
10531553|NCT01412801|11683809|FG001|NOT COMPLETED|Overall Study||5
10531554|NCT01412801|11683810|FG002|NOT COMPLETED|Overall Study||7
10531555|NCT01412801|11683811|FG003|NOT COMPLETED|Overall Study||4
10531556|NCT01412801|11683812|FG004|NOT COMPLETED|Overall Study||3
10531557|NCT01412801|11683813|FG005|NOT COMPLETED|Overall Study||3
10531559|NCT01412866|11683839|FG001|STARTED|Overall Study||66
10531560|NCT01412866|11683838|FG000|COMPLETED|Overall Study||57
10531561|NCT01412866|11683839|FG001|COMPLETED|Overall Study||64
10531562|NCT01412866|11683838|FG000|NOT COMPLETED|Overall Study||1
10531563|NCT01412866|11683839|FG001|NOT COMPLETED|Overall Study||2
10531564|NCT01412879|11683847|FG000|STARTED|Initial Registration (Induction Therapy)||18
10531565|NCT01412879|11683848|FG001|STARTED|Initial Registration (Induction Therapy)||35
10531566|NCT01412879|11683849|FG002|STARTED|Initial Registration (Induction Therapy)||0
10531567|NCT01412879|11683847|FG000|Treatment Started|Initial Registration (Induction Therapy)||17
10531568|NCT01412879|11683848|FG001|Treatment Started|Initial Registration (Induction Therapy)||35
10531569|NCT01412879|11683849|FG002|Treatment Started|Initial Registration (Induction Therapy)||0
10531570|NCT01412879|11683847|FG000|COMPLETED|Initial Registration (Induction Therapy)||5
10531571|NCT01412879|11683848|FG001|COMPLETED|Initial Registration (Induction Therapy)||27
10655324|NCT02207374|11815957|FG002|STARTED|Overall Study||121
10655325|NCT02207374|11815955|FG000|Exposed|Overall Study||239
10655326|NCT02207374|11815956|FG001|Exposed|Overall Study||241
10655327|NCT02207374|11815957|FG002|Exposed|Overall Study||120
10655328|NCT02207374|11815955|FG000|COMPLETED|Overall Study||233
10655329|NCT02207374|11815956|FG001|COMPLETED|Overall Study||231
10655330|NCT02207374|11815957|FG002|COMPLETED|Overall Study||115
10655331|NCT02207374|11815955|FG000|NOT COMPLETED|Overall Study||6
10655332|NCT02207374|11815956|FG001|NOT COMPLETED|Overall Study||10
10655333|NCT02207374|11815957|FG002|NOT COMPLETED|Overall Study||6
10655334|NCT02207400|11815967|FG000|STARTED|Overall Study||123
10655335|NCT02207400|11815968|FG001|STARTED|Overall Study||123
10343317|NCT00395850|11480765|FG000|NOT COMPLETED|Disulfiram/Placebo Treatment||9
10305125|NCT00092456|11438270|FG003|Vaccinated at Visit 2|Overall Study||104
10305126|NCT00092456|11438267|FG000|Vaccinated at Visit 3|Overall Study||202
10305127|NCT00092456|11438268|FG001|Vaccinated at Visit 3|Overall Study||210
10305128|NCT00092456|11438269|FG002|Vaccinated at Visit 3|Overall Study||200
10305129|NCT00092456|11438270|FG003|Vaccinated at Visit 3|Overall Study||98
10305130|NCT00092456|11438267|FG000|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|201
10305131|NCT00092456|11438268|FG001|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|208
10305132|NCT00092456|11438269|FG002|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|200
10305133|NCT00092456|11438270|FG003|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|97
10305134|NCT00092456|11438267|FG000|NOT COMPLETED|Overall Study||25
10305135|NCT00092456|11438268|FG001|NOT COMPLETED|Overall Study||17
10305136|NCT00092456|11438269|FG002|NOT COMPLETED|Overall Study||29
10305137|NCT00092456|11438270|FG003|NOT COMPLETED|Overall Study||16
10305138|NCT00092495|11438284|FG000|STARTED|Base Study Vaccination Period||504
10305139|NCT00092495|11438285|FG001|STARTED|Base Study Vaccination Period||514
10305140|NCT00092495|11438286|FG002|STARTED|Base Study Vaccination Period||508
10305141|NCT00092495|11438287|FG003|STARTED|Base Study Vaccination Period||1529
10305142|NCT00092495|11438288|FG004|STARTED|Base Study Vaccination Period||0
10305143|NCT00092495|11438284|FG000|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|2
10305144|NCT00092495|11438285|FG001|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|2
10305145|NCT00092495|11438286|FG002|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|6
10305146|NCT00092495|11438287|FG003|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|10
10305147|NCT00092495|11438288|FG004|With Long-term Follow-up *|Base Study Vaccination Period||0
10305148|NCT00092495|11438284|FG000|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|34
10305149|NCT00092495|11438285|FG001|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|20
10305150|NCT00092495|11438286|FG002|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|28
10305151|NCT00092495|11438287|FG003|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|73
10305152|NCT00092495|11438288|FG004|Without Long-term Follow-up|Base Study Vaccination Period||0
10305153|NCT00092495|11438284|FG000|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|467
10305154|NCT00092495|11438285|FG001|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|492
10305155|NCT00092495|11438286|FG002|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|474
10305156|NCT00092495|11438287|FG003|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|1441
10305157|NCT00092495|11438288|FG004|COMPLETED|Base Study Vaccination Period||0
10305158|NCT00092495|11438284|FG000|NOT COMPLETED|Base Study Vaccination Period||37
10305159|NCT00092495|11438285|FG001|NOT COMPLETED|Base Study Vaccination Period||22
10305160|NCT00092495|11438286|FG002|NOT COMPLETED|Base Study Vaccination Period||34
10531572|NCT01412879|11683849|FG002|COMPLETED|Initial Registration (Induction Therapy)||0
10531573|NCT01412879|11683847|FG000|NOT COMPLETED|Initial Registration (Induction Therapy)||13
10531574|NCT01412879|11683848|FG001|NOT COMPLETED|Initial Registration (Induction Therapy)||8
10531575|NCT01412879|11683849|FG002|NOT COMPLETED|Initial Registration (Induction Therapy)||0
10531576|NCT01412879|11683847|FG000|STARTED|Consolidation Therapy||0
10343318|NCT00395850|11480766|FG001|NOT COMPLETED|Disulfiram/Placebo Treatment||14
10343319|NCT00395850|11480767|FG002|NOT COMPLETED|Disulfiram/Placebo Treatment||19
10343320|NCT00395850|11480768|FG003|NOT COMPLETED|Disulfiram/Placebo Treatment||13
10343321|NCT00395863|11480780|FG000|STARTED|Overall Study||23
10343322|NCT00395863|11480781|FG001|STARTED|Overall Study||23
10343323|NCT00395863|11480780|FG000|COMPLETED|Overall Study||21
10343324|NCT00395863|11480781|FG001|COMPLETED|Overall Study||20
10343325|NCT00395863|11480780|FG000|NOT COMPLETED|Overall Study||2
10343326|NCT00395863|11480781|FG001|NOT COMPLETED|Overall Study||3
10343327|NCT00395876|11480792|FG000|STARTED|Overall Study||50
10343328|NCT00395876|11480793|FG001|STARTED|Overall Study||50
10343329|NCT00395876|11480792|FG000|COMPLETED|Overall Study||47
10343330|NCT00395876|11480793|FG001|COMPLETED|Overall Study||50
10343331|NCT00395876|11480792|FG000|NOT COMPLETED|Overall Study||3
10343332|NCT00395876|11480793|FG001|NOT COMPLETED|Overall Study||0
10343333|NCT00395967|11480799|FG000|STARTED|Treatment Period||5
10343334|NCT00395967|11480799|FG000|COMPLETED|Treatment Period|Failed mobilization due to <2 fold yield after one day of plerixafor treatment|4
10343335|NCT00395967|11480799|FG000|NOT COMPLETED|Treatment Period||1
10343336|NCT00395967|11480799|FG000|STARTED|Follow-up Period|Participants who had transplants.|5
10343337|NCT00395967|11480799|FG000|COMPLETED|Follow-up Period||3
10343338|NCT00395967|11480799|FG000|NOT COMPLETED|Follow-up Period||2
10343339|NCT00395993|11480805|FG000|STARTED|Overall Study||246
10343340|NCT00395993|11480806|FG001|STARTED|Overall Study||231
10343341|NCT00395993|11480805|FG000|COMPLETED|Overall Study||211
10343342|NCT00395993|11480806|FG001|COMPLETED|Overall Study||212
10343343|NCT00395993|11480805|FG000|NOT COMPLETED|Overall Study||35
10343344|NCT00395993|11480806|FG001|NOT COMPLETED|Overall Study||19
10343345|NCT00396006|11480812|FG000|STARTED|Overall Study||13
10343346|NCT00396006|11480812|FG000|COMPLETED|Overall Study||13
10343347|NCT00396006|11480812|FG000|NOT COMPLETED|Overall Study||0
10343348|NCT00396019|11480820|FG000|STARTED|Overall Study||27
10343349|NCT00396019|11480821|FG001|STARTED|Overall Study||29
10343350|NCT00396019|11480822|FG002|STARTED|Overall Study||30
10343351|NCT00396019|11480820|FG000|COMPLETED|Overall Study||27
10343352|NCT00396019|11480821|FG001|COMPLETED|Overall Study||26
10343353|NCT00396019|11480822|FG002|COMPLETED|Overall Study||29
10343354|NCT00396019|11480820|FG000|NOT COMPLETED|Overall Study||0
10343355|NCT00396019|11480821|FG001|NOT COMPLETED|Overall Study||3
10343356|NCT00396019|11480822|FG002|NOT COMPLETED|Overall Study||1
10343357|NCT00396032|11480833|FG000|STARTED|Overall Study||74
10343358|NCT00396032|11480834|FG001|STARTED|Overall Study||76
10343359|NCT00396032|11480833|FG000|COMPLETED|Overall Study||70
10343360|NCT00396032|11480834|FG001|COMPLETED|Overall Study||71
10343361|NCT00396032|11480833|FG000|NOT COMPLETED|Overall Study||4
10343362|NCT00396032|11480834|FG001|NOT COMPLETED|Overall Study||5
10426487|NCT00847808|11572171|FG000|STARTED|Overall Study||178
10426488|NCT00847808|11572171|FG000|COMPLETED|Overall Study||163
10426489|NCT00847808|11572171|FG000|NOT COMPLETED|Overall Study||15
10426490|NCT00847886|11572177|FG000|STARTED|Overall Study||12
10426491|NCT00847886|11572178|FG001|STARTED|Overall Study||4
10426492|NCT00847886|11572177|FG000|COMPLETED|Overall Study||12
10426493|NCT00847886|11572178|FG001|COMPLETED|Overall Study||3
10426494|NCT00847886|11572177|FG000|NOT COMPLETED|Overall Study||0
10426495|NCT00847886|11572178|FG001|NOT COMPLETED|Overall Study||1
10426496|NCT00847912|11572186|FG000|STARTED|Overall Study||477
10426497|NCT00847912|11572187|FG001|STARTED|Overall Study||477
10426498|NCT00847912|11572186|FG000|COMPLETED|Overall Study||468
10426499|NCT00847912|11572187|FG001|COMPLETED|Overall Study||464
10426500|NCT00847912|11572186|FG000|NOT COMPLETED|Overall Study||9
10426501|NCT00847912|11572187|FG001|NOT COMPLETED|Overall Study||13
10426502|NCT00847938|11572198|FG000|STARTED|Overall Study||16
10426503|NCT00847938|11572199|FG001|STARTED|Overall Study||15
10426504|NCT00847938|11572200|FG002|STARTED|Overall Study||16
10426505|NCT00847938|11572201|FG003|STARTED|Overall Study||15
10426506|NCT00847938|11572198|FG000|COMPLETED|Overall Study||16
10426507|NCT00847938|11572199|FG001|COMPLETED|Overall Study||14
10426508|NCT00847938|11572200|FG002|COMPLETED|Overall Study||15
10426509|NCT00847938|11572201|FG003|COMPLETED|Overall Study||15
10531577|NCT01412879|11683848|FG001|STARTED|Consolidation Therapy||0
10547899|NCT01515566|11701692|FG001|STARTED|Overall Study||10
10426510|NCT00847938|11572198|FG000|NOT COMPLETED|Overall Study||0
10426511|NCT00847938|11572199|FG001|NOT COMPLETED|Overall Study||1
10343363|NCT00396084|11480846|FG000|STARTED|Overall Study||10
10343364|NCT00396084|11480847|FG001|STARTED|Overall Study||10
10343365|NCT00396084|11480848|FG002|STARTED|Overall Study||10
10343366|NCT00396084|11480849|FG003|STARTED|Overall Study||10
10343367|NCT00396084|11480850|FG004|STARTED|Overall Study||10
10343368|NCT00396084|11480851|FG005|STARTED|Overall Study||20
10343369|NCT00396084|11480846|FG000|COMPLETED|Overall Study||10
10343370|NCT00396084|11480847|FG001|COMPLETED|Overall Study||10
10531578|NCT01412879|11683849|FG002|STARTED|Consolidation Therapy|Only eligible patients who are able to have stem cell harvested receive consolidation therapy.|26
10531579|NCT01412879|11683847|FG000|COMPLETED|Consolidation Therapy||0
10531580|NCT01412879|11683848|FG001|COMPLETED|Consolidation Therapy||0
10531581|NCT01412879|11683849|FG002|COMPLETED|Consolidation Therapy||26
10531582|NCT01412879|11683847|FG000|NOT COMPLETED|Consolidation Therapy||0
10531583|NCT01412879|11683848|FG001|NOT COMPLETED|Consolidation Therapy||0
10531584|NCT01412879|11683849|FG002|NOT COMPLETED|Consolidation Therapy||0
10531585|NCT01412918|11683861|FG000|STARTED|Overall Study||20
10531586|NCT01412918|11683862|FG001|STARTED|Overall Study||1
10531587|NCT01412918|11683861|FG000|COMPLETED|Overall Study||20
10531588|NCT01412918|11683862|FG001|COMPLETED|Overall Study||1
10531589|NCT01412918|11683861|FG000|NOT COMPLETED|Overall Study||0
10531590|NCT01412918|11683862|FG001|NOT COMPLETED|Overall Study||0
10343371|NCT00396084|11480848|FG002|COMPLETED|Overall Study||10
10343372|NCT00396084|11480849|FG003|COMPLETED|Overall Study||9
10343373|NCT00396084|11480850|FG004|COMPLETED|Overall Study||9
10343374|NCT00396084|11480851|FG005|COMPLETED|Overall Study||18
10343375|NCT00396084|11480846|FG000|NOT COMPLETED|Overall Study||0
10343376|NCT00396084|11480847|FG001|NOT COMPLETED|Overall Study||0
10343377|NCT00396084|11480848|FG002|NOT COMPLETED|Overall Study||0
10343378|NCT00396084|11480849|FG003|NOT COMPLETED|Overall Study||1
10343379|NCT00396084|11480850|FG004|NOT COMPLETED|Overall Study||1
10343380|NCT00396084|11480851|FG005|NOT COMPLETED|Overall Study||2
10343381|NCT00396097|11480871|FG000|STARTED|Overall Study|4 participants randomized to Individualized Dose, received Standard Dose throughout the study.|114
10343382|NCT00396097|11480872|FG001|STARTED|Overall Study||202
10343383|NCT00396097|11480871|FG000|COMPLETED|Overall Study||88
10343384|NCT00396097|11480872|FG001|COMPLETED|Overall Study||156
10343385|NCT00396097|11480871|FG000|NOT COMPLETED|Overall Study||26
10343386|NCT00396097|11480872|FG001|NOT COMPLETED|Overall Study||46
10343387|NCT00396136|11480882|FG000|STARTED|Overall Study||221
10343388|NCT00396136|11480882|FG000|COMPLETED|Overall Study||96
10343389|NCT00396136|11480882|FG000|NOT COMPLETED|Overall Study||125
10343390|NCT00396162|11480888|FG000|STARTED|Overall Study||39
10343391|NCT00396162|11480889|FG001|STARTED|Overall Study||38
10343392|NCT00396162|11480888|FG000|COMPLETED|Overall Study||37
10343393|NCT00396162|11480889|FG001|COMPLETED|Overall Study||35
10343394|NCT00396162|11480888|FG000|NOT COMPLETED|Overall Study||2
10343395|NCT00396162|11480889|FG001|NOT COMPLETED|Overall Study||3
10343396|NCT00396201|11480899|FG000|STARTED|Treatment Period||22
10343397|NCT00396201|11480899|FG000|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|22
10343398|NCT00396201|11480899|FG000|NOT COMPLETED|Treatment Period||0
10343399|NCT00396201|11480899|FG000|STARTED|Follow-up Period|Participants who had transplants. One had insufficient collection of cells so no transplant.|21
10343400|NCT00396201|11480899|FG000|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|21
10343401|NCT00396201|11480899|FG000|NOT COMPLETED|Follow-up Period||0
10343402|NCT00396253|11480904|FG000|STARTED|Overall Study||223
10343403|NCT00396253|11480904|FG000|COMPLETED|Overall Study||210
10343404|NCT00396253|11480904|FG000|NOT COMPLETED|Overall Study||13
10343405|NCT00396266|11480910|FG000|STARTED|Overall Study||8
10343406|NCT00396266|11480911|FG001|STARTED|Overall Study||14
10343407|NCT00396266|11480910|FG000|COMPLETED|Overall Study||8
10343408|NCT00396266|11480911|FG001|COMPLETED|Overall Study||14
10343409|NCT00396266|11480910|FG000|NOT COMPLETED|Overall Study||0
10343410|NCT00396266|11480911|FG001|NOT COMPLETED|Overall Study||0
10343411|NCT00396279|11480921|FG000|STARTED|Overall Study||37
10343412|NCT00396279|11480921|FG000|COMPLETED|Overall Study|Defined as participants with a complete resection|7
10343413|NCT00396279|11480921|FG000|NOT COMPLETED|Overall Study||30
10343414|NCT00396292|11480927|FG000|STARTED|Overall Study||174
10343415|NCT00396292|11480928|FG001|STARTED|Overall Study||178
10343416|NCT00396292|11480927|FG000|COMPLETED|Overall Study||165
10343417|NCT00396292|11480928|FG001|COMPLETED|Overall Study||162
10343418|NCT00396292|11480927|FG000|NOT COMPLETED|Overall Study||9
10343419|NCT00396292|11480928|FG001|NOT COMPLETED|Overall Study||16
10343420|NCT00396318|11480934|FG000|STARTED|At Least One Dose of Tenecteplase (MITT)||246
10343421|NCT00396318|11480934|FG000|COMPLETED|At Least One Dose of Tenecteplase (MITT)||241
10343422|NCT00396318|11480934|FG000|NOT COMPLETED|At Least One Dose of Tenecteplase (MITT)||5
10343423|NCT00396318|11480934|FG000|STARTED|48- to 96-Hour Follow-Up Period||246
10655336|NCT02207400|11815967|FG000|COMPLETED|Overall Study||107
10655337|NCT02207400|11815968|FG001|COMPLETED|Overall Study||109
10655338|NCT02207400|11815967|FG000|NOT COMPLETED|Overall Study||16
10655339|NCT02207400|11815968|FG001|NOT COMPLETED|Overall Study||14
10812358|NCT03718455|11974403|FG000|STARTED|Overall Study||1
10305161|NCT00092495|11438287|FG003|NOT COMPLETED|Base Study Vaccination Period||88
10305162|NCT00092495|11438288|FG004|NOT COMPLETED|Base Study Vaccination Period||0
10655340|NCT02207413|11815983|FG000|STARTED|Overall Study||60
10655341|NCT02207413|11815984|FG001|STARTED|Overall Study||60
10655342|NCT02207413|11815985|FG002|STARTED|Overall Study||410
10305163|NCT00092495|11438284|FG000|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|115
10315223|NCT00176462|11449059|FG000|STARTED|Induction (4 Weeks)||21
10812359|NCT03718455|11974403|FG000|COMPLETED|Overall Study||1
10343424|NCT00396318|11480934|FG000|COMPLETED|48- to 96-Hour Follow-Up Period||241
10343425|NCT00396318|11480934|FG000|NOT COMPLETED|48- to 96-Hour Follow-Up Period||5
10343426|NCT00396318|11480934|FG000|STARTED|7-Day Post-Treatment Contact||241
10343427|NCT00396318|11480934|FG000|COMPLETED|7-Day Post-Treatment Contact||240
10343428|NCT00396318|11480934|FG000|NOT COMPLETED|7-Day Post-Treatment Contact||1
10343429|NCT00396331|11480942|FG000|STARTED|Overall Study||100
10343430|NCT00396331|11480942|FG000|Number of Participants Treated|Overall Study||100
10343431|NCT00396331|11480942|FG000|Number of Participants Transplanted|Overall Study|7 participants had two transplants|87
10343432|NCT00396331|11480942|FG000|COMPLETED|Overall Study||68
10343433|NCT00396331|11480942|FG000|NOT COMPLETED|Overall Study||32
10343434|NCT00396383|11480954|FG000|STARTED|Overall Study||9
10343435|NCT00396383|11480954|FG000|COMPLETED|Overall Study||6
10531591|NCT01412944|11683871|FG000|STARTED|IV: Per Previous CAIN457A2304 Treatment||0
10531592|NCT01412944|11683872|FG001|STARTED|IV: Per Previous CAIN457A2304 Treatment||0
10531593|NCT01412944|11683873|FG002|STARTED|IV: Per Previous CAIN457A2304 Treatment||15
10531594|NCT01412944|11683874|FG003|STARTED|IV: Per Previous CAIN457A2304 Treatment||6
10531595|NCT01412944|11683875|FG004|STARTED|IV: Per Previous CAIN457A2304 Treatment||14
10531596|NCT01412944|11683876|FG005|STARTED|IV: Per Previous CAIN457A2304 Treatment||8
10531597|NCT01412944|11683871|FG000|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
10531598|NCT01412944|11683872|FG001|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
10531599|NCT01412944|11683873|FG002|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||14
10531600|NCT01412944|11683874|FG003|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||6
10531601|NCT01412944|11683875|FG004|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||14
10531602|NCT01412944|11683876|FG005|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||6
10531603|NCT01412944|11683871|FG000|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
10531604|NCT01412944|11683872|FG001|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
10531605|NCT01412944|11683873|FG002|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||1
10531606|NCT01412944|11683874|FG003|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
10655343|NCT02207413|11815986|FG003|STARTED|Overall Study||411
10655344|NCT02207413|11815987|FG004|STARTED|Overall Study||466
10655345|NCT02207413|11815988|FG005|STARTED|Overall Study||474
10343436|NCT00396383|11480954|FG000|NOT COMPLETED|Overall Study||3
10305164|NCT00092495|11438285|FG001|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|125
10305165|NCT00092495|11438286|FG002|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|130
10305166|NCT00092495|11438287|FG003|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|460
10305167|NCT00092495|11438288|FG004|STARTED|Base Study Follow-up Period||0
10305168|NCT00092495|11438284|FG000|COMPLETED|Base Study Follow-up Period||112
10305169|NCT00092495|11438285|FG001|COMPLETED|Base Study Follow-up Period||122
10305170|NCT00092495|11438286|FG002|COMPLETED|Base Study Follow-up Period||126
10305171|NCT00092495|11438287|FG003|COMPLETED|Base Study Follow-up Period||446
10305172|NCT00092495|11438288|FG004|COMPLETED|Base Study Follow-up Period||0
10305173|NCT00092495|11438284|FG000|NOT COMPLETED|Base Study Follow-up Period||3
10305174|NCT00092495|11438285|FG001|NOT COMPLETED|Base Study Follow-up Period||3
10305175|NCT00092495|11438286|FG002|NOT COMPLETED|Base Study Follow-up Period||4
10305176|NCT00092495|11438287|FG003|NOT COMPLETED|Base Study Follow-up Period||14
10305177|NCT00092495|11438288|FG004|NOT COMPLETED|Base Study Follow-up Period||0
10305178|NCT00092495|11438284|FG000|STARTED|Extension Study||0
10305179|NCT00092495|11438285|FG001|STARTED|Extension Study||0
10305180|NCT00092495|11438286|FG002|STARTED|Extension Study||0
10305181|NCT00092495|11438287|FG003|STARTED|Extension Study||0
10305182|NCT00092495|11438288|FG004|STARTED|Extension Study||12
10305183|NCT00092495|11438284|FG000|COMPLETED|Extension Study||0
10305184|NCT00092495|11438285|FG001|COMPLETED|Extension Study||0
10305185|NCT00092495|11438286|FG002|COMPLETED|Extension Study||0
10305186|NCT00092495|11438287|FG003|COMPLETED|Extension Study||0
10305187|NCT00092495|11438288|FG004|COMPLETED|Extension Study||12
10305188|NCT00092495|11438284|FG000|NOT COMPLETED|Extension Study||0
10305189|NCT00092495|11438285|FG001|NOT COMPLETED|Extension Study||0
10305190|NCT00092495|11438286|FG002|NOT COMPLETED|Extension Study||0
10305191|NCT00092495|11438287|FG003|NOT COMPLETED|Extension Study||0
10305192|NCT00092495|11438288|FG004|NOT COMPLETED|Extension Study||0
10305193|NCT00092521|11438304|FG000|STARTED|Vaccination (Day 1 Through Month 7)||2723
10305194|NCT00092521|11438305|FG001|STARTED|Vaccination (Day 1 Through Month 7)||304
10305195|NCT00092521|11438306|FG002|STARTED|Vaccination (Day 1 Through Month 7)||2732
10305196|NCT00092521|11438307|FG003|STARTED|Vaccination (Day 1 Through Month 7)||0
10305197|NCT00092521|11438304|FG000|COMPLETED|Vaccination (Day 1 Through Month 7)||2583
10305198|NCT00092521|11438305|FG001|COMPLETED|Vaccination (Day 1 Through Month 7)||290
10305199|NCT00092521|11438306|FG002|COMPLETED|Vaccination (Day 1 Through Month 7)||2586
10305200|NCT00092521|11438307|FG003|COMPLETED|Vaccination (Day 1 Through Month 7)||0
10305201|NCT00092521|11438304|FG000|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||140
10305202|NCT00092521|11438305|FG001|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||14
10305203|NCT00092521|11438306|FG002|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||146
10305204|NCT00092521|11438307|FG003|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||0
10305205|NCT00092521|11438304|FG000|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|2599
10305206|NCT00092521|11438305|FG001|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|291
10315224|NCT00176462|11449060|FG001|STARTED|Induction (4 Weeks)||39
10343437|NCT00396409|11480960|FG000|STARTED|Period 1 - 2007||65
10343438|NCT00396409|11480961|FG001|STARTED|Period 1 - 2007||63
10305207|NCT00092521|11438306|FG002|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|2607
10305208|NCT00092521|11438307|FG003|STARTED|Follow-Up (After Month 7)||0
10305209|NCT00092521|11438304|FG000|COMPLETED|Follow-Up (After Month 7)||2353
10305210|NCT00092521|11438305|FG001|COMPLETED|Follow-Up (After Month 7)||155
10305211|NCT00092521|11438306|FG002|COMPLETED|Follow-Up (After Month 7)||1959
10305212|NCT00092521|11438307|FG003|COMPLETED|Follow-Up (After Month 7)||0
10305213|NCT00092521|11438304|FG000|NOT COMPLETED|Follow-Up (After Month 7)||246
10305214|NCT00092521|11438305|FG001|NOT COMPLETED|Follow-Up (After Month 7)||136
10305215|NCT00092521|11438306|FG002|NOT COMPLETED|Follow-Up (After Month 7)||648
10305216|NCT00092521|11438307|FG003|NOT COMPLETED|Follow-Up (After Month 7)||0
10305217|NCT00092521|11438304|FG000|STARTED|Extension Study (Group 4)||0
10305218|NCT00092521|11438305|FG001|STARTED|Extension Study (Group 4)||0
10305219|NCT00092521|11438306|FG002|STARTED|Extension Study (Group 4)||0
10305220|NCT00092521|11438307|FG003|STARTED|Extension Study (Group 4)||844
10305221|NCT00092521|11438304|FG000|Initiated Extension Study|Extension Study (Group 4)||0
10305222|NCT00092521|11438305|FG001|Initiated Extension Study|Extension Study (Group 4)||0
10305223|NCT00092521|11438306|FG002|Initiated Extension Study|Extension Study (Group 4)||0
10305224|NCT00092521|11438307|FG003|Initiated Extension Study|Extension Study (Group 4)||829
10305225|NCT00092521|11438304|FG000|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
10305226|NCT00092521|11438305|FG001|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
10305227|NCT00092521|11438306|FG002|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
10305228|NCT00092521|11438307|FG003|Received >=1 Dose in Extension Study|Extension Study (Group 4)||801
10305229|NCT00092521|11438304|FG000|COMPLETED|Extension Study (Group 4)||0
10305230|NCT00092521|11438305|FG001|COMPLETED|Extension Study (Group 4)||0
10305231|NCT00092521|11438306|FG002|COMPLETED|Extension Study (Group 4)||0
10305232|NCT00092521|11438307|FG003|COMPLETED|Extension Study (Group 4)||635
10305233|NCT00092521|11438304|FG000|NOT COMPLETED|Extension Study (Group 4)||0
10305234|NCT00092521|11438305|FG001|NOT COMPLETED|Extension Study (Group 4)||0
10305235|NCT00092521|11438306|FG002|NOT COMPLETED|Extension Study (Group 4)||0
10305236|NCT00092521|11438307|FG003|NOT COMPLETED|Extension Study (Group 4)||209
10343439|NCT00396409|11480960|FG000|COMPLETED|Period 1 - 2007||62
10343440|NCT00396409|11480961|FG001|COMPLETED|Period 1 - 2007||57
10343441|NCT00396409|11480960|FG000|NOT COMPLETED|Period 1 - 2007||3
10531607|NCT01412944|11683875|FG004|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
10531608|NCT01412944|11683876|FG005|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||2
10531609|NCT01412944|11683871|FG000|STARTED|IV: Per CAIN457A2307||21
10531610|NCT01412944|11683872|FG001|STARTED|IV: Per CAIN457A2307||22
10531611|NCT01412944|11683873|FG002|STARTED|IV: Per CAIN457A2307||0
10531612|NCT01412944|11683874|FG003|STARTED|IV: Per CAIN457A2307||0
10531613|NCT01412944|11683875|FG004|STARTED|IV: Per CAIN457A2307||0
10531614|NCT01412944|11683876|FG005|STARTED|IV: Per CAIN457A2307||0
10531615|NCT01412944|11683871|FG000|COMPLETED|IV: Per CAIN457A2307||20
10531616|NCT01412944|11683872|FG001|COMPLETED|IV: Per CAIN457A2307||20
10531617|NCT01412944|11683873|FG002|COMPLETED|IV: Per CAIN457A2307||0
10531618|NCT01412944|11683874|FG003|COMPLETED|IV: Per CAIN457A2307||0
10531619|NCT01412944|11683875|FG004|COMPLETED|IV: Per CAIN457A2307||0
10531620|NCT01412944|11683876|FG005|COMPLETED|IV: Per CAIN457A2307||0
10531621|NCT01412944|11683871|FG000|NOT COMPLETED|IV: Per CAIN457A2307||1
10343442|NCT00396409|11480961|FG001|NOT COMPLETED|Period 1 - 2007||6
10343443|NCT00396409|11480960|FG000|STARTED|Between Period 1 and Period 2||62
10343444|NCT00396409|11480961|FG001|STARTED|Between Period 1 and Period 2||57
10343445|NCT00396409|11480960|FG000|COMPLETED|Between Period 1 and Period 2||59
10343446|NCT00396409|11480961|FG001|COMPLETED|Between Period 1 and Period 2||55
10343447|NCT00396409|11480960|FG000|NOT COMPLETED|Between Period 1 and Period 2||3
10343448|NCT00396409|11480961|FG001|NOT COMPLETED|Between Period 1 and Period 2||2
10343449|NCT00396409|11480960|FG000|STARTED|Period 2 - 2008||59
10343450|NCT00396409|11480961|FG001|STARTED|Period 2 - 2008||55
10343451|NCT00396409|11480960|FG000|COMPLETED|Period 2 - 2008||52
10343452|NCT00396409|11480961|FG001|COMPLETED|Period 2 - 2008||53
10343453|NCT00396409|11480960|FG000|NOT COMPLETED|Period 2 - 2008||7
10343454|NCT00396409|11480961|FG001|NOT COMPLETED|Period 2 - 2008||2
10343455|NCT00396565|11480972|FG000|STARTED|Overall Study||136
10343456|NCT00396565|11480973|FG001|STARTED|Overall Study||138
10343457|NCT00396565|11480974|FG002|STARTED|Overall Study||47
10343458|NCT00396565|11480972|FG000|COMPLETED|Overall Study||88
10343459|NCT00396565|11480973|FG001|COMPLETED|Overall Study||47
10343460|NCT00396565|11480974|FG002|COMPLETED|Overall Study||30
10343461|NCT00396565|11480972|FG000|NOT COMPLETED|Overall Study||48
10343462|NCT00396565|11480973|FG001|NOT COMPLETED|Overall Study||91
10343463|NCT00396565|11480974|FG002|NOT COMPLETED|Overall Study||17
10343464|NCT00396591|11480982|FG000|STARTED|Overall Study||16
10343465|NCT00396591|11480982|FG000|COMPLETED|Overall Study||0
10343466|NCT00396591|11480982|FG000|NOT COMPLETED|Overall Study||16
10343467|NCT00396630|11480988|FG000|STARTED|Overall Study||100
10343468|NCT00396630|11480989|FG001|STARTED|Overall Study||100
10343469|NCT00396630|11480988|FG000|COMPLETED|Overall Study|Completed Visit 4 (Week 17).|95
10343470|NCT00396630|11480989|FG001|COMPLETED|Overall Study|Completed Visit 4 (Week 17).|95
10343471|NCT00396630|11480988|FG000|NOT COMPLETED|Overall Study||5
10343472|NCT00396630|11480989|FG001|NOT COMPLETED|Overall Study||5
10343473|NCT00396656|11480996|FG000|STARTED|First Treatment Period||15
10343474|NCT00396656|11480997|FG001|STARTED|First Treatment Period||15
10343475|NCT00396656|11480996|FG000|COMPLETED|First Treatment Period||15
10343476|NCT00396656|11480997|FG001|COMPLETED|First Treatment Period||13
10343477|NCT00396656|11480996|FG000|NOT COMPLETED|First Treatment Period||0
10343478|NCT00396656|11480997|FG001|NOT COMPLETED|First Treatment Period||2
10343479|NCT00396656|11480996|FG000|STARTED|Second Treatment Period||15
10343480|NCT00396656|11480997|FG001|STARTED|Second Treatment Period||13
10343481|NCT00396656|11480996|FG000|COMPLETED|Second Treatment Period||15
10343482|NCT00396656|11480997|FG001|COMPLETED|Second Treatment Period||12
10343483|NCT00396656|11480996|FG000|NOT COMPLETED|Second Treatment Period||0
10343484|NCT00396656|11480997|FG001|NOT COMPLETED|Second Treatment Period||1
10343485|NCT00396812|11481003|FG000|STARTED|Overall Study||4
10426512|NCT00847938|11572200|FG002|NOT COMPLETED|Overall Study||1
10715593|NCT02688387|11880062|FG019|STARTED|Part 3A, Washout Period 1 (10 Days)||0
10715594|NCT02688387|11880063|FG020|STARTED|Part 3A, Washout Period 1 (10 Days)||0
10715595|NCT02688387|11880064|FG021|STARTED|Part 3A, Washout Period 1 (10 Days)||0
10715596|NCT02688387|11880043|FG000|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10715597|NCT02688387|11880044|FG001|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10715598|NCT02688387|11880045|FG002|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10715599|NCT02688387|11880046|FG003|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10305312|NCT00092547|11438333|FG000|STARTED|Base Vaccine Phase (Day 1 to Month 7)||1184
10305313|NCT00092547|11438334|FG001|STARTED|Base Vaccine Phase (Day 1 to Month 7)||597
10305314|NCT00092547|11438335|FG002|STARTED|Base Vaccine Phase (Day 1 to Month 7)||0
10305315|NCT00092547|11438333|FG000|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||1179
10305316|NCT00092547|11438334|FG001|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||596
10305317|NCT00092547|11438335|FG002|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||0
10305318|NCT00092547|11438333|FG000|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||1121
10305319|NCT00092547|11438334|FG001|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||561
10305320|NCT00092547|11438335|FG002|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||0
10305321|NCT00092547|11438333|FG000|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||63
10305322|NCT00092547|11438334|FG001|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||36
10305323|NCT00092547|11438335|FG002|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||0
10305324|NCT00092547|11438333|FG000|STARTED|Base Follow-up Phase (Month 7 to 18)|Includes participants continuing and who previously discontinued who re-entered the study|1128
10305325|NCT00092547|11438334|FG001|STARTED|Base Follow-up Phase (Month 7 to 18)|Includes participants continuing and who previously discontinued who re-entered the study|565
10305326|NCT00092547|11438335|FG002|STARTED|Base Follow-up Phase (Month 7 to 18)||0
10305327|NCT00092547|11438333|FG000|COMPLETED|Base Follow-up Phase (Month 7 to 18)||1108
10305328|NCT00092547|11438334|FG001|COMPLETED|Base Follow-up Phase (Month 7 to 18)||551
10305329|NCT00092547|11438335|FG002|COMPLETED|Base Follow-up Phase (Month 7 to 18)||0
10305330|NCT00092547|11438333|FG000|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||20
10305331|NCT00092547|11438334|FG001|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||14
10305332|NCT00092547|11438335|FG002|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||0
10305333|NCT00092547|11438333|FG000|STARTED|Base Follow-up Phase (Month 18 to 30)|Includes participants continuing and who previously discontinued who re-entered the study|964
10305334|NCT00092547|11438334|FG001|STARTED|Base Follow-up Phase (Month 18 to 30)|Includes participants continuing and who previously discontinued who re-entered the study|490
10305335|NCT00092547|11438335|FG002|STARTED|Base Follow-up Phase (Month 18 to 30)||0
10305336|NCT00092547|11438333|FG000|COMPLETED|Base Follow-up Phase (Month 18 to 30)||956
10305337|NCT00092547|11438334|FG001|COMPLETED|Base Follow-up Phase (Month 18 to 30)||485
10305338|NCT00092547|11438335|FG002|COMPLETED|Base Follow-up Phase (Month 18 to 30)||0
10305339|NCT00092547|11438333|FG000|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||8
10305340|NCT00092547|11438334|FG001|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||5
10305341|NCT00092547|11438335|FG002|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||0
10305342|NCT00092547|11438333|FG000|STARTED|Extension Vaccine Phase (Month 30 to 37)|Includes participants continuing and who previously discontinued who re-entered the study|956
10305343|NCT00092547|11438334|FG001|STARTED|Extension Vaccine Phase (Month 30 to 37)||0
10305344|NCT00092547|11438335|FG002|STARTED|Extension Vaccine Phase (Month 30 to 37)|Includes participants continuing and who previously discontinued who re-entered the study|485
10305345|NCT00092547|11438333|FG000|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||0
10305346|NCT00092547|11438334|FG001|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||0
10305347|NCT00092547|11438335|FG002|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||482
10305348|NCT00092547|11438333|FG000|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||933
10305349|NCT00092547|11438334|FG001|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||0
10305350|NCT00092547|11438335|FG002|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||469
10305351|NCT00092547|11438333|FG000|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||23
10305352|NCT00092547|11438334|FG001|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||0
10305353|NCT00092547|11438335|FG002|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||16
10305354|NCT00092547|11438333|FG000|STARTED|Long-term Follow-up (Month 42 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|612
10305355|NCT00092547|11438334|FG001|STARTED|Long-term Follow-up (Month 42 Visit)||0
10315225|NCT00176462|11449059|FG000|COMPLETED|Induction (4 Weeks)||20
10343486|NCT00396812|11481003|FG000|COMPLETED|Overall Study|4 subjects completed treatment, but 1 subject terminated early due to disease progression|3
10343487|NCT00396812|11481003|FG000|NOT COMPLETED|Overall Study||1
10343488|NCT00396877|11481009|FG000|STARTED|Overall Study|Randomized|439
10343489|NCT00396877|11481010|FG001|STARTED|Overall Study|Randomized|467
10343490|NCT00396877|11481009|FG000|Treated|Overall Study||436
10343491|NCT00396877|11481010|FG001|Treated|Overall Study||464
10343492|NCT00396877|11481009|FG000|Completed Treatment|Overall Study||356
10343493|NCT00396877|11481010|FG001|Completed Treatment|Overall Study||352
10343494|NCT00396877|11481009|FG000|COMPLETED|Overall Study|Completed follow-up|433
10343495|NCT00396877|11481010|FG001|COMPLETED|Overall Study|Completed follow-up|459
10343496|NCT00396877|11481009|FG000|NOT COMPLETED|Overall Study||6
10343497|NCT00396877|11481010|FG001|NOT COMPLETED|Overall Study||8
10343498|NCT00396981|11481018|FG000|STARTED|Overall Study||311
10343499|NCT00396981|11481019|FG001|STARTED|Overall Study||315
10343500|NCT00396981|11481018|FG000|COMPLETED|Overall Study||296
10343501|NCT00396981|11481019|FG001|COMPLETED|Overall Study||306
10343502|NCT00396981|11481018|FG000|NOT COMPLETED|Overall Study||15
10343503|NCT00396981|11481019|FG001|NOT COMPLETED|Overall Study||9
10343504|NCT00397020|11481027|FG000|STARTED|Overall Study||14
10343505|NCT00397020|11481028|FG001|STARTED|Overall Study||16
10343506|NCT00397020|11481027|FG000|COMPLETED|Overall Study||13
10343507|NCT00397020|11481028|FG001|COMPLETED|Overall Study||15
10343508|NCT00397020|11481027|FG000|NOT COMPLETED|Overall Study||1
10343509|NCT00397020|11481028|FG001|NOT COMPLETED|Overall Study||1
10343510|NCT00397033|11481037|FG000|STARTED|Overall Study||107
10343511|NCT00397033|11481038|FG001|STARTED|Overall Study||109
10343512|NCT00397033|11481039|FG002|STARTED|Overall Study||100
10343513|NCT00397033|11481037|FG000|Safety Population: >= 1 Dose of Drug|Overall Study||107
10343514|NCT00397033|11481038|FG001|Safety Population: >= 1 Dose of Drug|Overall Study||108
10343515|NCT00397033|11481039|FG002|Safety Population: >= 1 Dose of Drug|Overall Study||98
10343516|NCT00397033|11481037|FG000|ITT Population|Overall Study||107
10343517|NCT00397033|11481038|FG001|ITT Population|Overall Study||105
10343518|NCT00397033|11481039|FG002|ITT Population|Overall Study||98
10343519|NCT00397033|11481037|FG000|COMPLETED|Overall Study||63
10343520|NCT00397033|11481038|FG001|COMPLETED|Overall Study||72
10343521|NCT00397033|11481039|FG002|COMPLETED|Overall Study||77
10343522|NCT00397033|11481037|FG000|NOT COMPLETED|Overall Study||44
10343523|NCT00397033|11481038|FG001|NOT COMPLETED|Overall Study||37
10343524|NCT00397033|11481039|FG002|NOT COMPLETED|Overall Study||23
10343525|NCT00397046|11481051|FG000|STARTED|Overall Study||3
10343526|NCT00397046|11481052|FG001|STARTED|Overall Study||3
10343527|NCT00397046|11481053|FG002|STARTED|Overall Study||10
10343528|NCT00397046|11481054|FG003|STARTED|Overall Study||5
10343529|NCT00397046|11481051|FG000|COMPLETED|Overall Study||0
10343530|NCT00397046|11481052|FG001|COMPLETED|Overall Study||0
10343531|NCT00397046|11481053|FG002|COMPLETED|Overall Study||0
10343532|NCT00397046|11481054|FG003|COMPLETED|Overall Study||0
10343533|NCT00397046|11481051|FG000|NOT COMPLETED|Overall Study||3
10343534|NCT00397046|11481052|FG001|NOT COMPLETED|Overall Study||3
10343535|NCT00397046|11481053|FG002|NOT COMPLETED|Overall Study||10
10343536|NCT00397046|11481054|FG003|NOT COMPLETED|Overall Study||5
10343537|NCT00397150|11481067|FG000|STARTED|Overall Study||1323
10343538|NCT00397150|11481068|FG001|STARTED|Overall Study||1256
10343539|NCT00397150|11481067|FG000|COMPLETED|Overall Study||1188
10343540|NCT00397150|11481068|FG001|COMPLETED|Overall Study||1111
10343541|NCT00397150|11481067|FG000|NOT COMPLETED|Overall Study||135
10531622|NCT01412944|11683872|FG001|NOT COMPLETED|IV: Per CAIN457A2307||2
10531623|NCT01412944|11683873|FG002|NOT COMPLETED|IV: Per CAIN457A2307||0
10531624|NCT01412944|11683874|FG003|NOT COMPLETED|IV: Per CAIN457A2307||0
10531625|NCT01412944|11683875|FG004|NOT COMPLETED|IV: Per CAIN457A2307||0
10531626|NCT01412944|11683876|FG005|NOT COMPLETED|IV: Per CAIN457A2307||0
10531627|NCT01412944|11683871|FG000|STARTED|Entire: IV + Maintenance||0
10531628|NCT01412944|11683872|FG001|STARTED|Entire: IV + Maintenance||0
10531629|NCT01412944|11683873|FG002|STARTED|Entire: IV + Maintenance||15
10531630|NCT01412944|11683874|FG003|STARTED|Entire: IV + Maintenance||6
10531631|NCT01412944|11683875|FG004|STARTED|Entire: IV + Maintenance||14
10531632|NCT01412944|11683876|FG005|STARTED|Entire: IV + Maintenance||8
10531633|NCT01412944|11683871|FG000|COMPLETED|Entire: IV + Maintenance||0
10531634|NCT01412944|11683872|FG001|COMPLETED|Entire: IV + Maintenance||0
10531635|NCT01412944|11683873|FG002|COMPLETED|Entire: IV + Maintenance||14
10531636|NCT01412944|11683874|FG003|COMPLETED|Entire: IV + Maintenance||5
10531637|NCT01412944|11683875|FG004|COMPLETED|Entire: IV + Maintenance||11
10531638|NCT01412944|11683876|FG005|COMPLETED|Entire: IV + Maintenance||6
10531639|NCT01412944|11683871|FG000|NOT COMPLETED|Entire: IV + Maintenance||0
10531640|NCT01412944|11683872|FG001|NOT COMPLETED|Entire: IV + Maintenance||0
10531641|NCT01412944|11683873|FG002|NOT COMPLETED|Entire: IV + Maintenance||1
10531642|NCT01412944|11683874|FG003|NOT COMPLETED|Entire: IV + Maintenance||1
10531643|NCT01412944|11683875|FG004|NOT COMPLETED|Entire: IV + Maintenance||3
10531644|NCT01412944|11683876|FG005|NOT COMPLETED|Entire: IV + Maintenance||2
10531645|NCT01412944|11683871|FG000|STARTED|Entire: IV + Maintenance||21
10715600|NCT02688387|11880047|FG004|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10715601|NCT02688387|11880048|FG005|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10305356|NCT00092547|11438335|FG002|STARTED|Long-term Follow-up (Month 42 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|308
10305357|NCT00092547|11438333|FG000|COMPLETED|Long-term Follow-up (Month 42 Visit)||611
10305358|NCT00092547|11438334|FG001|COMPLETED|Long-term Follow-up (Month 42 Visit)||0
10305359|NCT00092547|11438335|FG002|COMPLETED|Long-term Follow-up (Month 42 Visit)||308
10305360|NCT00092547|11438333|FG000|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||1
10305361|NCT00092547|11438334|FG001|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||0
10305362|NCT00092547|11438335|FG002|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||0
10305363|NCT00092547|11438333|FG000|STARTED|Long-term Follow-up (Month 72 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|550
10305364|NCT00092547|11438334|FG001|STARTED|Long-term Follow-up (Month 72 Visit)||0
10305365|NCT00092547|11438335|FG002|STARTED|Long-term Follow-up (Month 72 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|276
10305366|NCT00092547|11438333|FG000|COMPLETED|Long-term Follow-up (Month 72 Visit)||550
10305367|NCT00092547|11438334|FG001|COMPLETED|Long-term Follow-up (Month 72 Visit)||0
10305368|NCT00092547|11438335|FG002|COMPLETED|Long-term Follow-up (Month 72 Visit)||276
10305369|NCT00092547|11438333|FG000|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
10305370|NCT00092547|11438334|FG001|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
10343542|NCT00397150|11481068|FG001|NOT COMPLETED|Overall Study||145
10343543|NCT00397189|11481076|FG000|STARTED|3 Weeks Period||394
10343544|NCT00397189|11481077|FG001|STARTED|3 Weeks Period||395
10715602|NCT02688387|11880049|FG006|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10343545|NCT00397189|11481076|FG000|COMPLETED|3 Weeks Period|out of 373, 360 were included in the ITT population detailed in the Baseline Characteristics.|373
10343546|NCT00397189|11481077|FG001|COMPLETED|3 Weeks Period|out of 373, 362 were included in the ITT population detailed in the Baseline Characteristics|373
10343547|NCT00397189|11481076|FG000|NOT COMPLETED|3 Weeks Period||21
10343548|NCT00397189|11481077|FG001|NOT COMPLETED|3 Weeks Period||22
10343549|NCT00397189|11481076|FG000|STARTED|Extension Period|Not all completers continued to extension as only patients who wished to proceed were randomized.|534
10343550|NCT00397189|11481077|FG001|STARTED|Extension Period|Please note randomization ratio in extension is 3:1|177
10343551|NCT00397189|11481076|FG000|COMPLETED|Extension Period||421
10343552|NCT00397189|11481077|FG001|COMPLETED|Extension Period||134
10343553|NCT00397189|11481076|FG000|NOT COMPLETED|Extension Period||113
10343554|NCT00397189|11481077|FG001|NOT COMPLETED|Extension Period||43
10343555|NCT00397215|11481089|FG000|STARTED|Month 0 (Day 0)||165
10343556|NCT00397215|11481090|FG001|STARTED|Month 0 (Day 0)||61
10343557|NCT00397215|11481091|FG002|STARTED|Month 0 (Day 0)||159
10343558|NCT00397215|11481092|FG003|STARTED|Month 0 (Day 0)||52
10343559|NCT00397215|11481089|FG000|COMPLETED|Month 0 (Day 0)||158
10343560|NCT00397215|11481090|FG001|COMPLETED|Month 0 (Day 0)||56
10343561|NCT00397215|11481091|FG002|COMPLETED|Month 0 (Day 0)||153
10343562|NCT00397215|11481092|FG003|COMPLETED|Month 0 (Day 0)||48
10343563|NCT00397215|11481089|FG000|NOT COMPLETED|Month 0 (Day 0)||7
10343564|NCT00397215|11481090|FG001|NOT COMPLETED|Month 0 (Day 0)||5
10812360|NCT03718455|11974403|FG000|NOT COMPLETED|Overall Study||0
10812361|NCT03718143|11974407|FG000|STARTED|Overall Study||3
10812362|NCT03718143|11974408|FG001|STARTED|Overall Study||2
10812363|NCT03718143|11974409|FG002|STARTED|Overall Study||1
10812364|NCT03718143|11974407|FG000|COMPLETED|Overall Study||0
10812365|NCT03718143|11974408|FG001|COMPLETED|Overall Study||0
10343565|NCT00397215|11481091|FG002|NOT COMPLETED|Month 0 (Day 0)||6
10343566|NCT00397215|11481092|FG003|NOT COMPLETED|Month 0 (Day 0)||4
10305371|NCT00092547|11438335|FG002|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
10305372|NCT00092547|11438333|FG000|STARTED|Long-term Follow-up (Month 96 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|508
10305373|NCT00092547|11438334|FG001|STARTED|Long-term Follow-up (Month 96 Visit)||0
10305374|NCT00092547|11438335|FG002|STARTED|Long-term Follow-up (Month 96 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|267
10305375|NCT00092547|11438333|FG000|COMPLETED|Long-term Follow-up (Month 96 Visit)||508
10305376|NCT00092547|11438334|FG001|COMPLETED|Long-term Follow-up (Month 96 Visit)||0
10305377|NCT00092547|11438335|FG002|COMPLETED|Long-term Follow-up (Month 96 Visit)||267
10305378|NCT00092547|11438333|FG000|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
10305379|NCT00092547|11438334|FG001|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
10305380|NCT00092547|11438335|FG002|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
10305381|NCT00092547|11438333|FG000|STARTED|Long-term Follow-up (Month 126 Visit)||454
10305382|NCT00092547|11438334|FG001|STARTED|Long-term Follow-up (Month 126 Visit)||0
10305383|NCT00092547|11438335|FG002|STARTED|Long-term Follow-up (Month 126 Visit)||211
10305384|NCT00092547|11438333|FG000|COMPLETED|Long-term Follow-up (Month 126 Visit)||454
10305385|NCT00092547|11438334|FG001|COMPLETED|Long-term Follow-up (Month 126 Visit)||0
10305386|NCT00092547|11438335|FG002|COMPLETED|Long-term Follow-up (Month 126 Visit)||211
10305387|NCT00092547|11438333|FG000|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
10305388|NCT00092547|11438334|FG001|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
10305389|NCT00092547|11438335|FG002|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
10305398|NCT00093041|11438361|FG000|STARTED|Overall Study||4
10305399|NCT00093041|11438362|FG001|STARTED|Overall Study||4
10305400|NCT00093041|11438363|FG002|STARTED|Overall Study||5
10305401|NCT00093041|11438364|FG003|STARTED|Overall Study||4
10305402|NCT00093041|11438365|FG004|STARTED|Overall Study||4
10305403|NCT00093041|11438366|FG005|STARTED|Overall Study||7
10305404|NCT00093041|11438361|FG000|COMPLETED|Overall Study|One discontinued during single dose period and one during multiple dose period|2
10305405|NCT00093041|11438362|FG001|COMPLETED|Overall Study|Three discontinued during single dose period|1
10305406|NCT00093041|11438363|FG002|COMPLETED|Overall Study|Two discontinued during single dose period|3
10305407|NCT00093041|11438364|FG003|COMPLETED|Overall Study|One discontinued during single dose period|3
10305408|NCT00093041|11438365|FG004|COMPLETED|Overall Study|One discontinued during multiple dose period|3
10305409|NCT00093041|11438366|FG005|COMPLETED|Overall Study|Three discontinued during multiple dose period|4
10305410|NCT00093041|11438361|FG000|NOT COMPLETED|Overall Study||2
10305411|NCT00093041|11438362|FG001|NOT COMPLETED|Overall Study||3
10305412|NCT00093041|11438363|FG002|NOT COMPLETED|Overall Study||2
10305413|NCT00093041|11438364|FG003|NOT COMPLETED|Overall Study||1
10305414|NCT00093041|11438365|FG004|NOT COMPLETED|Overall Study||1
10305415|NCT00093041|11438366|FG005|NOT COMPLETED|Overall Study||3
10305416|NCT00093145|11438380|FG000|STARTED|Overall Study||32
10305417|NCT00093145|11438380|FG000|At Least One Response Assessment|Overall Study||31
10343574|NCT00397215|11481092|FG003|COMPLETED|Month 6 (Day 180)||51
10305418|NCT00093145|11438380|FG000|COMPLETED|Overall Study|Treatment completed upon progressive disease|15
10305419|NCT00093145|11438380|FG000|NOT COMPLETED|Overall Study||17
10305420|NCT00093379|11438384|FG000|STARTED|Overall Study||20
10305421|NCT00093379|11438384|FG000|COMPLETED|Overall Study||20
10305422|NCT00093379|11438384|FG000|NOT COMPLETED|Overall Study||0
10305423|NCT00093470|11438390|FG000|STARTED|Overall Study||73
10305424|NCT00093470|11438391|FG001|STARTED|Overall Study||71
10305425|NCT00093470|11438390|FG000|Treated|Overall Study||72
10305426|NCT00093470|11438391|FG001|Treated|Overall Study||71
10305427|NCT00093470|11438390|FG000|Patients With Toxicity Assessment|Overall Study||72
10315226|NCT00176462|11449060|FG001|COMPLETED|Induction (4 Weeks)||34
10531646|NCT01412944|11683872|FG001|STARTED|Entire: IV + Maintenance||22
10531647|NCT01412944|11683873|FG002|STARTED|Entire: IV + Maintenance||0
10531648|NCT01412944|11683874|FG003|STARTED|Entire: IV + Maintenance||0
10531649|NCT01412944|11683875|FG004|STARTED|Entire: IV + Maintenance||0
10531650|NCT01412944|11683876|FG005|STARTED|Entire: IV + Maintenance||0
10531651|NCT01412944|11683871|FG000|COMPLETED|Entire: IV + Maintenance||19
10531652|NCT01412944|11683872|FG001|COMPLETED|Entire: IV + Maintenance||17
10531653|NCT01412944|11683873|FG002|COMPLETED|Entire: IV + Maintenance||0
10531654|NCT01412944|11683874|FG003|COMPLETED|Entire: IV + Maintenance||0
10531655|NCT01412944|11683875|FG004|COMPLETED|Entire: IV + Maintenance||0
10531656|NCT01412944|11683876|FG005|COMPLETED|Entire: IV + Maintenance||0
10531657|NCT01412944|11683871|FG000|NOT COMPLETED|Entire: IV + Maintenance||2
10531658|NCT01412944|11683872|FG001|NOT COMPLETED|Entire: IV + Maintenance||5
10531659|NCT01412944|11683873|FG002|NOT COMPLETED|Entire: IV + Maintenance||0
10655346|NCT02207413|11815983|FG000|COMPLETED|Overall Study||59
10655347|NCT02207413|11815984|FG001|COMPLETED|Overall Study||60
10655348|NCT02207413|11815985|FG002|COMPLETED|Overall Study|Primed subjects: 309; Unprimed subjects: 101|410
10655349|NCT02207413|11815986|FG003|COMPLETED|Overall Study|Primed subjects: 312; Unprimed subjects: 98|410
10655350|NCT02207413|11815987|FG004|COMPLETED|Overall Study|Primed subjects: 40; Unprimed subjects: 419|459
10655351|NCT02207413|11815988|FG005|COMPLETED|Overall Study|Primed subjects: 41; Unprimed subjects: 420|461
10655352|NCT02207413|11815983|FG000|NOT COMPLETED|Overall Study||1
10655353|NCT02207413|11815984|FG001|NOT COMPLETED|Overall Study||0
10655354|NCT02207413|11815985|FG002|NOT COMPLETED|Overall Study||0
10655355|NCT02207413|11815986|FG003|NOT COMPLETED|Overall Study||1
10655356|NCT02207413|11815987|FG004|NOT COMPLETED|Overall Study||7
10655357|NCT02207413|11815988|FG005|NOT COMPLETED|Overall Study||13
10655358|NCT02207478|11816010|FG000|STARTED|Overall Study||40
10655359|NCT02207478|11816011|FG001|STARTED|Overall Study||46
10655360|NCT02207478|11816010|FG000|COMPLETED|Overall Study||40
10655361|NCT02207478|11816011|FG001|COMPLETED|Overall Study||46
10655362|NCT02207478|11816010|FG000|NOT COMPLETED|Overall Study||0
10655363|NCT02207478|11816011|FG001|NOT COMPLETED|Overall Study||0
10655364|NCT02207491|11816019|FG000|STARTED|Overall Study||202
10655365|NCT02207491|11816020|FG001|STARTED|Overall Study||209
10655366|NCT02207491|11816019|FG000|COMPLETED|Overall Study||171
10655367|NCT02207491|11816020|FG001|COMPLETED|Overall Study||196
10655368|NCT02207491|11816019|FG000|NOT COMPLETED|Overall Study||31
10655369|NCT02207491|11816020|FG001|NOT COMPLETED|Overall Study||13
10655370|NCT02207530|11816026|FG000|STARTED|Overall Study||112
10655371|NCT02207530|11816026|FG000|COMPLETED|Overall Study||21
10655372|NCT02207530|11816026|FG000|NOT COMPLETED|Overall Study||91
10655373|NCT02207556|11816032|FG000|STARTED|Overall Study||7
10655374|NCT02207556|11816033|FG001|STARTED|Overall Study||25
10655375|NCT02207556|11816032|FG000|COMPLETED|Overall Study||5
10655376|NCT02207556|11816033|FG001|COMPLETED|Overall Study||20
10655377|NCT02207556|11816032|FG000|NOT COMPLETED|Overall Study||2
10655378|NCT02207556|11816033|FG001|NOT COMPLETED|Overall Study||5
10715603|NCT02688387|11880050|FG007|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10715604|NCT02688387|11880051|FG008|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10715605|NCT02688387|11880052|FG009|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10715606|NCT02688387|11880053|FG010|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10715607|NCT02688387|11880054|FG011|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10715608|NCT02688387|11880055|FG012|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10715609|NCT02688387|11880056|FG013|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10715610|NCT02688387|11880057|FG014|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
10715611|NCT02688387|11880058|FG015|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
10715612|NCT02688387|11880059|FG016|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
10715613|NCT02688387|11880060|FG017|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
10715614|NCT02688387|11880061|FG018|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10715615|NCT02688387|11880062|FG019|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10715616|NCT02688387|11880063|FG020|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10715617|NCT02688387|11880064|FG021|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10715618|NCT02688387|11880043|FG000|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10715619|NCT02688387|11880044|FG001|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10715620|NCT02688387|11880045|FG002|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10715621|NCT02688387|11880046|FG003|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10343567|NCT00397215|11481089|FG000|STARTED|Month 6 (Day 180)||164
10343568|NCT00397215|11481090|FG001|STARTED|Month 6 (Day 180)||58
10343569|NCT00397215|11481091|FG002|STARTED|Month 6 (Day 180)||158
10343570|NCT00397215|11481092|FG003|STARTED|Month 6 (Day 180)||51
10343571|NCT00397215|11481089|FG000|COMPLETED|Month 6 (Day 180)||162
10343572|NCT00397215|11481090|FG001|COMPLETED|Month 6 (Day 180)||55
10343573|NCT00397215|11481091|FG002|COMPLETED|Month 6 (Day 180)||153
10343575|NCT00397215|11481089|FG000|NOT COMPLETED|Month 6 (Day 180)||2
10343576|NCT00397215|11481090|FG001|NOT COMPLETED|Month 6 (Day 180)||3
10343577|NCT00397215|11481091|FG002|NOT COMPLETED|Month 6 (Day 180)||5
10343578|NCT00397215|11481092|FG003|NOT COMPLETED|Month 6 (Day 180)||0
10715622|NCT02688387|11880047|FG004|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10715623|NCT02688387|11880048|FG005|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10715624|NCT02688387|11880049|FG006|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10343579|NCT00397215|11481089|FG000|STARTED|Month 12 (Day 360)||130
10343580|NCT00397215|11481090|FG001|STARTED|Month 12 (Day 360)||48
10343581|NCT00397215|11481091|FG002|STARTED|Month 12 (Day 360)||125
10531660|NCT01412944|11683874|FG003|NOT COMPLETED|Entire: IV + Maintenance||0
10531661|NCT01412944|11683875|FG004|NOT COMPLETED|Entire: IV + Maintenance||0
10531662|NCT01412944|11683876|FG005|NOT COMPLETED|Entire: IV + Maintenance||0
10531663|NCT01412944|11683871|FG000|STARTED|Follow-up||0
10531664|NCT01412944|11683872|FG001|STARTED|Follow-up||0
10531665|NCT01412944|11683873|FG002|STARTED|Follow-up||2
10531666|NCT01412944|11683874|FG003|STARTED|Follow-up||1
10531667|NCT01412944|11683875|FG004|STARTED|Follow-up||2
10531668|NCT01412944|11683876|FG005|STARTED|Follow-up||0
10531669|NCT01412944|11683871|FG000|COMPLETED|Follow-up||0
10531670|NCT01412944|11683872|FG001|COMPLETED|Follow-up||0
10531671|NCT01412944|11683873|FG002|COMPLETED|Follow-up||2
10531672|NCT01412944|11683874|FG003|COMPLETED|Follow-up||1
10531673|NCT01412944|11683875|FG004|COMPLETED|Follow-up||2
10531674|NCT01412944|11683876|FG005|COMPLETED|Follow-up||0
10531675|NCT01412944|11683871|FG000|NOT COMPLETED|Follow-up||0
10531676|NCT01412944|11683872|FG001|NOT COMPLETED|Follow-up||0
10531677|NCT01412944|11683873|FG002|NOT COMPLETED|Follow-up||0
10531678|NCT01412944|11683874|FG003|NOT COMPLETED|Follow-up||0
10531679|NCT01412944|11683875|FG004|NOT COMPLETED|Follow-up||0
10531680|NCT01412944|11683876|FG005|NOT COMPLETED|Follow-up||0
10531681|NCT01412957|11683894|FG000|STARTED|Overall Study||189
10531682|NCT01412957|11683895|FG001|STARTED|Overall Study||188
10531683|NCT01412957|11683894|FG000|COMPLETED|Overall Study|Participants continuing study at the time of data cut-off|40
10343582|NCT00397215|11481092|FG003|STARTED|Month 12 (Day 360)||42
10343583|NCT00397215|11481089|FG000|COMPLETED|Month 12 (Day 360)||130
10343584|NCT00397215|11481090|FG001|COMPLETED|Month 12 (Day 360)||48
10715625|NCT02688387|11880050|FG007|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10343585|NCT00397215|11481091|FG002|COMPLETED|Month 12 (Day 360)||125
10343586|NCT00397215|11481092|FG003|COMPLETED|Month 12 (Day 360)||42
10343587|NCT00397215|11481089|FG000|NOT COMPLETED|Month 12 (Day 360)||0
10531684|NCT01412957|11683895|FG001|COMPLETED|Overall Study|Participants continuing study at the time of data cut-off|31
10343588|NCT00397215|11481090|FG001|NOT COMPLETED|Month 12 (Day 360)||0
10531685|NCT01412957|11683894|FG000|NOT COMPLETED|Overall Study||149
10531686|NCT01412957|11683895|FG001|NOT COMPLETED|Overall Study||157
10531687|NCT01412983|11683901|FG000|STARTED|1st Period||50
10305428|NCT00093470|11438391|FG001|Patients With Toxicity Assessment|Overall Study||69
10305429|NCT00093470|11438390|FG000|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
10305430|NCT00093470|11438391|FG001|COMPLETED|Overall Study|Patients underwent observation only.|71
10305431|NCT00093470|11438390|FG000|NOT COMPLETED|Overall Study||73
10305432|NCT00093470|11438391|FG001|NOT COMPLETED|Overall Study||0
10305433|NCT00093496|11438399|FG000|STARTED|Overall Study||15
10305434|NCT00093496|11438400|FG001|STARTED|Overall Study||14
10305435|NCT00093496|11438399|FG000|COMPLETED|Overall Study||14
10305436|NCT00093496|11438400|FG001|COMPLETED|Overall Study||11
10305437|NCT00093496|11438399|FG000|NOT COMPLETED|Overall Study||1
10305438|NCT00093496|11438400|FG001|NOT COMPLETED|Overall Study||3
10305439|NCT00093756|11438407|FG000|STARTED|Overall Study||27
10305440|NCT00093756|11438408|FG001|STARTED|Overall Study||21
10305441|NCT00093756|11438407|FG000|COMPLETED|Overall Study||27
10305442|NCT00093756|11438408|FG001|COMPLETED|Overall Study||21
10343589|NCT00397215|11481091|FG002|NOT COMPLETED|Month 12 (Day 360)||0
10343590|NCT00397215|11481092|FG003|NOT COMPLETED|Month 12 (Day 360)||0
10343591|NCT00397215|11481089|FG000|STARTED|Month 24 (Day 720)||122
10343592|NCT00397215|11481090|FG001|STARTED|Month 24 (Day 720)||45
10531688|NCT01412983|11683902|FG001|STARTED|1st Period||50
10531689|NCT01412983|11683901|FG000|COMPLETED|1st Period||50
10531690|NCT01412983|11683902|FG001|COMPLETED|1st Period||46
10655406|NCT02207608|11816048|FG000|STARTED|Overall Study||15
10655407|NCT02207608|11816049|FG001|STARTED|Overall Study||15
10655408|NCT02207608|11816048|FG000|COMPLETED|Overall Study||14
10655409|NCT02207608|11816049|FG001|COMPLETED|Overall Study||15
10655410|NCT02207608|11816048|FG000|NOT COMPLETED|Overall Study||1
10655411|NCT02207608|11816049|FG001|NOT COMPLETED|Overall Study||0
10655412|NCT02207621|11816058|FG000|STARTED|Overall Study||251
10655413|NCT02207621|11816059|FG001|STARTED|Overall Study||251
10655414|NCT02207621|11816060|FG002|STARTED|Overall Study||254
10655415|NCT02207621|11816058|FG000|COMPLETED|Overall Study||146
10655416|NCT02207621|11816059|FG001|COMPLETED|Overall Study||204
10655417|NCT02207621|11816060|FG002|COMPLETED|Overall Study||86
10655418|NCT02207621|11816058|FG000|NOT COMPLETED|Overall Study||105
10305443|NCT00093756|11438407|FG000|NOT COMPLETED|Overall Study||0
10305444|NCT00093756|11438408|FG001|NOT COMPLETED|Overall Study||0
10305445|NCT00093782|11438416|FG000|STARTED|Overall Study||36
10655419|NCT02207621|11816059|FG001|NOT COMPLETED|Overall Study||47
10655420|NCT02207621|11816060|FG002|NOT COMPLETED|Overall Study||168
10655421|NCT02207634|11816071|FG000|STARTED|Overall Study||990
10655422|NCT02207634|11816072|FG001|STARTED|Overall Study||984
10655423|NCT02207634|11816071|FG000|Received Treatment|Overall Study||990
10655424|NCT02207634|11816072|FG001|Received Treatment|Overall Study||983
10305446|NCT00093782|11438416|FG000|COMPLETED|Overall Study||36
10305447|NCT00093782|11438416|FG000|NOT COMPLETED|Overall Study||0
10655425|NCT02207634|11816071|FG000|COMPLETED|Overall Study||968
10655426|NCT02207634|11816072|FG001|COMPLETED|Overall Study||953
10655427|NCT02207634|11816071|FG000|NOT COMPLETED|Overall Study||22
10655428|NCT02207634|11816072|FG001|NOT COMPLETED|Overall Study||31
10655429|NCT02207725|11816082|FG000|STARTED|Overall Study||9
10343593|NCT00397215|11481091|FG002|STARTED|Month 24 (Day 720)||117
10343594|NCT00397215|11481092|FG003|STARTED|Month 24 (Day 720)||36
10343595|NCT00397215|11481089|FG000|COMPLETED|Month 24 (Day 720)||122
10343596|NCT00397215|11481090|FG001|COMPLETED|Month 24 (Day 720)||45
10343597|NCT00397215|11481091|FG002|COMPLETED|Month 24 (Day 720)||117
10343598|NCT00397215|11481092|FG003|COMPLETED|Month 24 (Day 720)||36
10343599|NCT00397215|11481089|FG000|NOT COMPLETED|Month 24 (Day 720)||0
10343600|NCT00397215|11481090|FG001|NOT COMPLETED|Month 24 (Day 720)||0
10343601|NCT00397215|11481091|FG002|NOT COMPLETED|Month 24 (Day 720)||0
10343602|NCT00397215|11481092|FG003|NOT COMPLETED|Month 24 (Day 720)||0
10343603|NCT00397462|11481108|FG000|STARTED|Overall Study||16
10343604|NCT00397462|11481109|FG001|STARTED|Overall Study||13
10343605|NCT00397462|11481110|FG002|STARTED|Overall Study||15
10343606|NCT00397462|11481108|FG000|COMPLETED|Overall Study||16
10343607|NCT00397462|11481109|FG001|COMPLETED|Overall Study||13
10343608|NCT00397462|11481110|FG002|COMPLETED|Overall Study||15
10343609|NCT00397462|11481108|FG000|NOT COMPLETED|Overall Study||0
10305448|NCT00093795|11438423|FG000|STARTED|Overall Study||1630
10305449|NCT00093795|11438424|FG001|STARTED|Overall Study||1634
10305450|NCT00093795|11438425|FG002|STARTED|Overall Study||1630
10305451|NCT00093795|11438423|FG000|COMPLETED|Overall Study||1610
10305452|NCT00093795|11438424|FG001|COMPLETED|Overall Study||1618
10305453|NCT00093795|11438425|FG002|COMPLETED|Overall Study||1613
10305454|NCT00093795|11438423|FG000|NOT COMPLETED|Overall Study||20
10305455|NCT00093795|11438424|FG001|NOT COMPLETED|Overall Study||16
10305456|NCT00093795|11438425|FG002|NOT COMPLETED|Overall Study||17
10305457|NCT00093808|11438433|FG000|STARTED|Overall Study||47
10305458|NCT00093808|11438433|FG000|COMPLETED|Overall Study||45
10305459|NCT00093808|11438433|FG000|NOT COMPLETED|Overall Study||2
10305460|NCT00093847|11438439|FG000|STARTED|Overall Study||39
10305461|NCT00093847|11438440|FG001|STARTED|Overall Study||34
10305462|NCT00093847|11438439|FG000|COMPLETED|Overall Study||31
10305463|NCT00093847|11438440|FG001|COMPLETED|Overall Study||24
10305464|NCT00093847|11438439|FG000|NOT COMPLETED|Overall Study||8
10305465|NCT00093847|11438440|FG001|NOT COMPLETED|Overall Study||10
10305466|NCT00093964|11438448|FG000|STARTED|Overall Study||41
10305467|NCT00093964|11438449|FG001|STARTED|Overall Study||40
10305468|NCT00093964|11438448|FG000|COMPLETED|Overall Study||41
10305469|NCT00093964|11438449|FG001|COMPLETED|Overall Study||40
10305470|NCT00093964|11438448|FG000|NOT COMPLETED|Overall Study||0
10305471|NCT00093964|11438449|FG001|NOT COMPLETED|Overall Study||0
10305472|NCT00094055|11438457|FG000|STARTED|Overall Study||60
10305473|NCT00094055|11438457|FG000|COMPLETED|Overall Study||0
10305474|NCT00094055|11438457|FG000|NOT COMPLETED|Overall Study||60
10305475|NCT00094094|11438461|FG000|STARTED|Overall Study||32
10305476|NCT00094094|11438461|FG000|COMPLETED|Overall Study||0
10305477|NCT00094094|11438461|FG000|NOT COMPLETED|Overall Study||32
10305478|NCT00094107|11438465|FG000|STARTED|Overall Study||32
10305479|NCT00094107|11438465|FG000|COMPLETED|Overall Study||0
10305480|NCT00094107|11438465|FG000|NOT COMPLETED|Overall Study||32
10305481|NCT00094172|11438471|FG000|STARTED|Overall Study|Safety Sample: 49; Intent-to-Treat Sample: 49; Per Protocol Sample: 39|50
10305482|NCT00094172|11438472|FG001|STARTED|Overall Study|Safety Sample: 32; Intent-to-Treat Sample: 32; Per Protocol Sample: 28|32
10305483|NCT00094172|11438471|FG000|COMPLETED|Overall Study||36
10305484|NCT00094172|11438472|FG001|COMPLETED|Overall Study||25
10305485|NCT00094172|11438471|FG000|NOT COMPLETED|Overall Study||14
10305486|NCT00094172|11438472|FG001|NOT COMPLETED|Overall Study||7
10305487|NCT00094211|11438482|FG000|STARTED|Overall Study||221
10305488|NCT00094211|11438483|FG001|STARTED|Overall Study||259
10305489|NCT00094211|11438484|FG002|STARTED|Overall Study||230
10305490|NCT00094211|11438485|FG003|STARTED|Overall Study||186
10305491|NCT00094211|11438482|FG000|COMPLETED|Overall Study||212
10305492|NCT00094211|11438483|FG001|COMPLETED|Overall Study||251
10305493|NCT00094211|11438484|FG002|COMPLETED|Overall Study||220
10305494|NCT00094211|11438485|FG003|COMPLETED|Overall Study||179
10305495|NCT00094211|11438482|FG000|NOT COMPLETED|Overall Study||9
10305496|NCT00094211|11438483|FG001|NOT COMPLETED|Overall Study||8
10305497|NCT00094211|11438484|FG002|NOT COMPLETED|Overall Study||10
10305498|NCT00094211|11438485|FG003|NOT COMPLETED|Overall Study||7
10305499|NCT00094302|11438501|FG000|STARTED|Overall Study||1723
10305500|NCT00094302|11438502|FG001|STARTED|Overall Study||1722
10305501|NCT00094302|11438501|FG000|COMPLETED|Overall Study||1306
10305502|NCT00094302|11438502|FG001|COMPLETED|Overall Study||1316
10305503|NCT00094302|11438501|FG000|NOT COMPLETED|Overall Study||417
10305504|NCT00094302|11438502|FG001|NOT COMPLETED|Overall Study||406
10305505|NCT00094328|11438508|FG000|STARTED|Overall Study|Received treatment|14
10305506|NCT00094328|11438508|FG000|COMPLETED|Overall Study|Completed 12 months on treatment|13
10305507|NCT00094328|11438508|FG000|NOT COMPLETED|Overall Study||1
10305508|NCT00094445|11438512|FG000|STARTED|Overall Study||50
10305509|NCT00094445|11438512|FG000|COMPLETED|Overall Study||44
10305510|NCT00094445|11438512|FG000|NOT COMPLETED|Overall Study||6
10305511|NCT00094458|11438519|FG000|STARTED|Main Study: Through Week 30||170
10305512|NCT00094458|11438520|FG001|STARTED|Main Study: Through Week 30||169
10305513|NCT00094458|11438521|FG002|STARTED|Main Study: Through Week 30||169
10305514|NCT00094458|11438522|FG003|STARTED|Main Study: Through Week 30||0
10305515|NCT00094458|11438523|FG004|STARTED|Main Study: Through Week 30||0
10305516|NCT00094458|11438524|FG005|STARTED|Main Study: Through Week 30||0
10305517|NCT00094458|11438519|FG000|COMPLETED|Main Study: Through Week 30||86
10305518|NCT00094458|11438520|FG001|COMPLETED|Main Study: Through Week 30||111
10305519|NCT00094458|11438521|FG002|COMPLETED|Main Study: Through Week 30||121
10305520|NCT00094458|11438522|FG003|COMPLETED|Main Study: Through Week 30||0
10305521|NCT00094458|11438523|FG004|COMPLETED|Main Study: Through Week 30||0
10305522|NCT00094458|11438524|FG005|COMPLETED|Main Study: Through Week 30||0
10305523|NCT00094458|11438519|FG000|NOT COMPLETED|Main Study: Through Week 30||84
10812366|NCT03718143|11974409|FG002|COMPLETED|Overall Study||0
10812367|NCT03718143|11974407|FG000|NOT COMPLETED|Overall Study||3
10812368|NCT03718143|11974408|FG001|NOT COMPLETED|Overall Study||2
10305524|NCT00094458|11438520|FG001|NOT COMPLETED|Main Study: Through Week 30||58
10305525|NCT00094458|11438521|FG002|NOT COMPLETED|Main Study: Through Week 30||48
10305526|NCT00094458|11438522|FG003|NOT COMPLETED|Main Study: Through Week 30||0
10343610|NCT00397462|11481109|FG001|NOT COMPLETED|Overall Study||0
10343611|NCT00397462|11481110|FG002|NOT COMPLETED|Overall Study||0
10343612|NCT00397488|11481118|FG000|STARTED|Overall Study||78
10343613|NCT00397488|11481118|FG000|COMPLETED|Overall Study||71
10343614|NCT00397488|11481118|FG000|NOT COMPLETED|Overall Study||7
10715626|NCT02688387|11880051|FG008|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10715627|NCT02688387|11880052|FG009|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10715628|NCT02688387|11880053|FG010|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10715629|NCT02688387|11880054|FG011|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10715630|NCT02688387|11880055|FG012|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10715631|NCT02688387|11880056|FG013|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10715632|NCT02688387|11880057|FG014|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10305527|NCT00094458|11438523|FG004|NOT COMPLETED|Main Study: Through Week 30||0
10343615|NCT00397514|11481122|FG000|STARTED|Overall Study||34
10343616|NCT00397514|11481122|FG000|COMPLETED|Overall Study||25
10343617|NCT00397514|11481122|FG000|NOT COMPLETED|Overall Study||9
10343618|NCT00397540|11481134|FG000|STARTED|Overall Study||60
10343619|NCT00397540|11481135|FG001|STARTED|Overall Study||85
10343620|NCT00397540|11481134|FG000|COMPLETED|Overall Study||59
10343621|NCT00397540|11481135|FG001|COMPLETED|Overall Study||85
10343622|NCT00397540|11481134|FG000|NOT COMPLETED|Overall Study||1
10343623|NCT00397540|11481135|FG001|NOT COMPLETED|Overall Study||0
10343624|NCT00397579|11481142|FG000|STARTED|Overall Study||11
10343625|NCT00397579|11481142|FG000|COMPLETED|Overall Study||11
10343626|NCT00397579|11481142|FG000|NOT COMPLETED|Overall Study||0
10343627|NCT00397631|11481148|FG000|STARTED|Overall Study|Randomization ratio was 1:1|261
10343628|NCT00397631|11481149|FG001|STARTED|Overall Study||259
10343629|NCT00397631|11481148|FG000|COMPLETED|Overall Study||231
10343630|NCT00397631|11481149|FG001|COMPLETED|Overall Study||215
10343631|NCT00397631|11481148|FG000|NOT COMPLETED|Overall Study||30
10343632|NCT00397631|11481149|FG001|NOT COMPLETED|Overall Study||44
10343633|NCT00397813|11481161|FG000|STARTED|Overall Study||36
10343634|NCT00397813|11481162|FG001|STARTED|Overall Study||0
10343635|NCT00397813|11481163|FG002|STARTED|Overall Study||0
10343636|NCT00397813|11481164|FG003|STARTED|Overall Study||12
10343637|NCT00397813|11481165|FG004|STARTED|Overall Study||5
10343638|NCT00397813|11481166|FG005|STARTED|Overall Study||24
10343639|NCT00397813|11481161|FG000|COMPLETED|Overall Study||36
10343640|NCT00397813|11481162|FG001|COMPLETED|Overall Study||0
10343641|NCT00397813|11481163|FG002|COMPLETED|Overall Study||0
10343642|NCT00397813|11481164|FG003|COMPLETED|Overall Study||12
10343643|NCT00397813|11481165|FG004|COMPLETED|Overall Study||5
10305528|NCT00094458|11438524|FG005|NOT COMPLETED|Main Study: Through Week 30||0
10343644|NCT00397813|11481166|FG005|COMPLETED|Overall Study||24
10305529|NCT00094458|11438519|FG000|STARTED|Study Extension: Week 30 Through Week 50||75
10305530|NCT00094458|11438520|FG001|STARTED|Study Extension: Week 30 Through Week 50||97
10343645|NCT00397813|11481161|FG000|NOT COMPLETED|Overall Study||0
10343646|NCT00397813|11481162|FG001|NOT COMPLETED|Overall Study||0
10343647|NCT00397813|11481163|FG002|NOT COMPLETED|Overall Study||0
10305531|NCT00094458|11438521|FG002|STARTED|Study Extension: Week 30 Through Week 50||108
10305532|NCT00094458|11438522|FG003|STARTED|Study Extension: Week 30 Through Week 50||0
10305533|NCT00094458|11438523|FG004|STARTED|Study Extension: Week 30 Through Week 50||0
10315227|NCT00176462|11449059|FG000|NOT COMPLETED|Induction (4 Weeks)||1
10343648|NCT00397813|11481164|FG003|NOT COMPLETED|Overall Study||0
10343649|NCT00397813|11481165|FG004|NOT COMPLETED|Overall Study||0
10343650|NCT00397813|11481166|FG005|NOT COMPLETED|Overall Study||0
10343651|NCT00397839|11481182|FG000|STARTED|Overall Study||48
10343652|NCT00397839|11481183|FG001|STARTED|Overall Study||87
10343653|NCT00397839|11481182|FG000|COMPLETED|Overall Study||41
10343654|NCT00397839|11481183|FG001|COMPLETED|Overall Study||69
10343655|NCT00397839|11481182|FG000|NOT COMPLETED|Overall Study||7
10343656|NCT00397839|11481183|FG001|NOT COMPLETED|Overall Study||18
10343657|NCT00397878|11481189|FG000|STARTED|Overall Study||10
10343658|NCT00397878|11481189|FG000|COMPLETED|Overall Study||10
10343659|NCT00397878|11481189|FG000|NOT COMPLETED|Overall Study||0
10343660|NCT00397891|11481198|FG000|STARTED|Overall Study||6
10343661|NCT00397891|11481199|FG001|STARTED|Overall Study||6
10343662|NCT00397891|11481200|FG002|STARTED|Overall Study||6
10343663|NCT00397891|11481201|FG003|STARTED|Overall Study||6
10343664|NCT00397891|11481202|FG004|STARTED|Overall Study||8
10343665|NCT00397891|11481198|FG000|COMPLETED|Overall Study||5
10343666|NCT00397891|11481199|FG001|COMPLETED|Overall Study||6
10343667|NCT00397891|11481200|FG002|COMPLETED|Overall Study||6
10343668|NCT00397891|11481201|FG003|COMPLETED|Overall Study||6
10343669|NCT00397891|11481202|FG004|COMPLETED|Overall Study||7
10343670|NCT00397891|11481198|FG000|NOT COMPLETED|Overall Study||1
10343671|NCT00397891|11481199|FG001|NOT COMPLETED|Overall Study||0
10343672|NCT00397891|11481200|FG002|NOT COMPLETED|Overall Study||0
10343673|NCT00397891|11481201|FG003|NOT COMPLETED|Overall Study||0
10343674|NCT00397891|11481202|FG004|NOT COMPLETED|Overall Study||1
10343675|NCT00397904|11481214|FG000|STARTED|Overall Study||16
10343676|NCT00397904|11481214|FG000|COMPLETED|Overall Study||16
10343677|NCT00397904|11481214|FG000|NOT COMPLETED|Overall Study||0
10343678|NCT00397930|11481220|FG000|STARTED|Overall Study||206
10343679|NCT00397930|11481221|FG001|STARTED|Overall Study||204
10343680|NCT00397930|11481220|FG000|COMPLETED|Overall Study||168
10343681|NCT00397930|11481221|FG001|COMPLETED|Overall Study||153
10343682|NCT00397930|11481220|FG000|NOT COMPLETED|Overall Study||38
10343683|NCT00397930|11481221|FG001|NOT COMPLETED|Overall Study||51
10343684|NCT00397943|11481232|FG000|STARTED|Overall Study||40
10343685|NCT00397943|11481233|FG001|STARTED|Overall Study||40
10343686|NCT00397943|11481234|FG002|STARTED|Overall Study||10
10343687|NCT00397943|11481235|FG003|STARTED|Overall Study||10
10343688|NCT00397943|11481236|FG004|STARTED|Overall Study||10
10343689|NCT00397943|11481232|FG000|COMPLETED|Overall Study||28
10343690|NCT00397943|11481233|FG001|COMPLETED|Overall Study||31
10343691|NCT00397943|11481234|FG002|COMPLETED|Overall Study||10
10343692|NCT00397943|11481235|FG003|COMPLETED|Overall Study||10
10343693|NCT00397943|11481236|FG004|COMPLETED|Overall Study||10
10343694|NCT00397943|11481232|FG000|NOT COMPLETED|Overall Study||12
10343695|NCT00397943|11481233|FG001|NOT COMPLETED|Overall Study||9
10343696|NCT00397943|11481234|FG002|NOT COMPLETED|Overall Study||0
10343697|NCT00397943|11481235|FG003|NOT COMPLETED|Overall Study||0
10343698|NCT00397943|11481236|FG004|NOT COMPLETED|Overall Study||0
10343699|NCT00397982|11481248|FG000|STARTED|Overall Study||17
10343700|NCT00397982|11481248|FG000|COMPLETED|Overall Study||13
10343701|NCT00397982|11481248|FG000|NOT COMPLETED|Overall Study||4
10343702|NCT00398047|11481253|FG000|STARTED|Overall Study||3
10343703|NCT00398047|11481253|FG000|COMPLETED|Overall Study|all three patients progressed before completing|0
10343704|NCT00398047|11481253|FG000|NOT COMPLETED|Overall Study||3
10343705|NCT00398073|11481260|FG000|STARTED|Overall Study||18
10343706|NCT00398073|11481261|FG001|STARTED|Overall Study||17
10343707|NCT00398073|11481260|FG000|COMPLETED|Overall Study||17
10343708|NCT00398073|11481261|FG001|COMPLETED|Overall Study||17
10343709|NCT00398073|11481260|FG000|NOT COMPLETED|Overall Study||1
10343710|NCT00398073|11481261|FG001|NOT COMPLETED|Overall Study||0
10343711|NCT00398086|11481270|FG000|STARTED|Overall Study||20
10343712|NCT00398086|11481271|FG001|STARTED|Overall Study||44
10343713|NCT00398086|11481272|FG002|STARTED|Overall Study||3
10343714|NCT00398086|11481270|FG000|Phase 1, Dose Escalation Population|Overall Study||20
10343715|NCT00398086|11481271|FG001|Phase 1, Dose Escalation Population|Overall Study||7
10343716|NCT00398086|11481272|FG002|Phase 1, Dose Escalation Population|Overall Study||3
10343717|NCT00398086|11481270|FG000|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|11
10343718|NCT00398086|11481271|FG001|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|21
10343719|NCT00398086|11481272|FG002|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|1
10343720|NCT00398086|11481270|FG000|NOT COMPLETED|Overall Study||9
10343721|NCT00398086|11481271|FG001|NOT COMPLETED|Overall Study||23
10343722|NCT00398086|11481272|FG002|NOT COMPLETED|Overall Study||2
10343723|NCT00398112|11481280|FG000|STARTED|Overall Study||18
10343724|NCT00398112|11481280|FG000|COMPLETED|Overall Study||0
10343725|NCT00398112|11481280|FG000|NOT COMPLETED|Overall Study||18
10343726|NCT00398138|11481284|FG000|STARTED|Overall Study||12
10343727|NCT00398138|11481284|FG000|COMPLETED|Overall Study||10
10343728|NCT00398138|11481284|FG000|NOT COMPLETED|Overall Study||2
10343729|NCT00398216|11481293|FG000|STARTED|Overall Study||192
10343730|NCT00398216|11481294|FG001|STARTED|Overall Study||170
10343731|NCT00398216|11481295|FG002|STARTED|Overall Study||185
10343732|NCT00398216|11481296|FG003|STARTED|Overall Study||177
10343733|NCT00398216|11481297|FG004|STARTED|Overall Study||172
10343734|NCT00398216|11481293|FG000|COMPLETED|Overall Study||181
10343735|NCT00398216|11481294|FG001|COMPLETED|Overall Study||151
10343736|NCT00398216|11481295|FG002|COMPLETED|Overall Study||164
10343737|NCT00398216|11481296|FG003|COMPLETED|Overall Study||155
10343738|NCT00398216|11481297|FG004|COMPLETED|Overall Study||157
10343739|NCT00398216|11481293|FG000|NOT COMPLETED|Overall Study||11
10343740|NCT00398216|11481294|FG001|NOT COMPLETED|Overall Study||19
10343741|NCT00398216|11481295|FG002|NOT COMPLETED|Overall Study||21
10343742|NCT00398216|11481296|FG003|NOT COMPLETED|Overall Study||22
10343743|NCT00398216|11481297|FG004|NOT COMPLETED|Overall Study||15
10343744|NCT00398320|11481309|FG000|STARTED|Overall Study||40
10343745|NCT00398320|11481309|FG000|COMPLETED|Overall Study||34
10343746|NCT00398320|11481309|FG000|NOT COMPLETED|Overall Study||6
10343747|NCT00398398|11481313|FG000|STARTED|Overall Study||44
10343748|NCT00398398|11481313|FG000|COMPLETED|Overall Study||44
10343749|NCT00398398|11481313|FG000|NOT COMPLETED|Overall Study||0
10343750|NCT00398411|11481319|FG000|STARTED|Overall Study||34
10343751|NCT00398411|11481320|FG001|STARTED|Overall Study||32
10343752|NCT00398411|11481319|FG000|COMPLETED|Overall Study||34
10343753|NCT00398411|11481320|FG001|COMPLETED|Overall Study||31
10343754|NCT00398411|11481319|FG000|NOT COMPLETED|Overall Study||0
10343755|NCT00398411|11481320|FG001|NOT COMPLETED|Overall Study||1
10343756|NCT00398476|11481326|FG000|STARTED|Treatment Period 1||63
10343757|NCT00398476|11481327|FG001|STARTED|Treatment Period 1||64
10343758|NCT00398476|11481326|FG000|COMPLETED|Treatment Period 1||63
10343759|NCT00398476|11481327|FG001|COMPLETED|Treatment Period 1||64
10343760|NCT00398476|11481326|FG000|NOT COMPLETED|Treatment Period 1||0
10343761|NCT00398476|11481327|FG001|NOT COMPLETED|Treatment Period 1||0
10343762|NCT00398476|11481326|FG000|STARTED|Washout Period (20 Minutes)||63
10343763|NCT00398476|11481327|FG001|STARTED|Washout Period (20 Minutes)||64
10343764|NCT00398476|11481326|FG000|COMPLETED|Washout Period (20 Minutes)||63
10531691|NCT01412983|11683901|FG000|NOT COMPLETED|1st Period||0
10531692|NCT01412983|11683902|FG001|NOT COMPLETED|1st Period||4
10531693|NCT01412983|11683901|FG000|STARTED|2nd Period||50
10531694|NCT01412983|11683902|FG001|STARTED|2nd Period||46
10531695|NCT01412983|11683901|FG000|COMPLETED|2nd Period||50
10531696|NCT01412983|11683902|FG001|COMPLETED|2nd Period||46
10531697|NCT01412983|11683901|FG000|NOT COMPLETED|2nd Period||0
10531698|NCT01412983|11683902|FG001|NOT COMPLETED|2nd Period||0
10531699|NCT01413087|11683911|FG000|STARTED|Overall Study||6
10531700|NCT01413087|11683912|FG001|STARTED|Overall Study||6
10531701|NCT01413087|11683911|FG000|COMPLETED|Overall Study||6
10531702|NCT01413087|11683912|FG001|COMPLETED|Overall Study||6
10531703|NCT01413087|11683911|FG000|NOT COMPLETED|Overall Study||0
10531704|NCT01413087|11683912|FG001|NOT COMPLETED|Overall Study||0
10531705|NCT01413178|11683920|FG000|STARTED|Overall Study||105
10531706|NCT01413178|11683921|FG001|STARTED|Overall Study||100
10531707|NCT01413178|11683920|FG000|COMPLETED|Overall Study||104
10531708|NCT01413178|11683921|FG001|COMPLETED|Overall Study||98
10531709|NCT01413178|11683920|FG000|NOT COMPLETED|Overall Study||1
10531710|NCT01413178|11683921|FG001|NOT COMPLETED|Overall Study||2
10531711|NCT01413191|11683927|FG000|STARTED|Overall Study||18
10531712|NCT01413191|11683927|FG000|COMPLETED|Overall Study||7
10531713|NCT01413191|11683927|FG000|NOT COMPLETED|Overall Study||11
10531714|NCT01413204|11683934|FG000|STARTED|Overall Study||90
10531715|NCT01413204|11683935|FG001|STARTED|Overall Study||89
10531716|NCT01413204|11683936|FG002|STARTED|Overall Study||93
10531717|NCT01413204|11683934|FG000|COMPLETED|Overall Study||84
10531718|NCT01413204|11683935|FG001|COMPLETED|Overall Study||83
10531719|NCT01413204|11683936|FG002|COMPLETED|Overall Study||74
10531720|NCT01413204|11683934|FG000|NOT COMPLETED|Overall Study||6
10531721|NCT01413204|11683935|FG001|NOT COMPLETED|Overall Study||6
10531722|NCT01413204|11683936|FG002|NOT COMPLETED|Overall Study||19
10531723|NCT01413360|11683944|FG000|STARTED|Overall Study||10
10531724|NCT01413360|11683944|FG000|COMPLETED|Overall Study||7
10531725|NCT01413360|11683944|FG000|NOT COMPLETED|Overall Study||3
10531726|NCT01413503|11683948|FG000|STARTED|Overall Study||50
10531727|NCT01413503|11683948|FG000|COMPLETED|Overall Study||49
10531728|NCT01413503|11683948|FG000|NOT COMPLETED|Overall Study||1
10343765|NCT00398476|11481327|FG001|COMPLETED|Washout Period (20 Minutes)||64
10343766|NCT00398476|11481326|FG000|NOT COMPLETED|Washout Period (20 Minutes)||0
10343767|NCT00398476|11481327|FG001|NOT COMPLETED|Washout Period (20 Minutes)||0
10343768|NCT00398476|11481326|FG000|STARTED|Treatment Period 2||63
10343769|NCT00398476|11481327|FG001|STARTED|Treatment Period 2||64
10343770|NCT00398476|11481326|FG000|COMPLETED|Treatment Period 2||63
10343771|NCT00398476|11481327|FG001|COMPLETED|Treatment Period 2||64
10343772|NCT00398476|11481326|FG000|NOT COMPLETED|Treatment Period 2||0
10343773|NCT00398476|11481327|FG001|NOT COMPLETED|Treatment Period 2||0
10343774|NCT00398567|11481338|FG000|STARTED|Overall Study||4
10531729|NCT01413516|11683954|FG000|STARTED|Overall Study||8
10531730|NCT01413516|11683955|FG001|STARTED|Overall Study||9
10531731|NCT01413516|11683954|FG000|COMPLETED|Overall Study||8
10531732|NCT01413516|11683955|FG001|COMPLETED|Overall Study||9
10531733|NCT01413516|11683954|FG000|NOT COMPLETED|Overall Study||0
10343775|NCT00398567|11481339|FG001|STARTED|Overall Study||4
10343776|NCT00398567|11481340|FG002|STARTED|Overall Study||37
10343777|NCT00398567|11481338|FG000|COMPLETED|Overall Study||0
10343778|NCT00398567|11481339|FG001|COMPLETED|Overall Study||0
10343779|NCT00398567|11481340|FG002|COMPLETED|Overall Study||3
10343780|NCT00398567|11481338|FG000|NOT COMPLETED|Overall Study||4
10343781|NCT00398567|11481339|FG001|NOT COMPLETED|Overall Study||4
10343782|NCT00398567|11481340|FG002|NOT COMPLETED|Overall Study||34
10343783|NCT00398632|11481346|FG000|STARTED|Overall Study||6
10343784|NCT00398632|11481346|FG000|COMPLETED|Overall Study|2/6 subjects withdrew at end of week 6; 1 for lack of efficacy, 1 because of time constraints.|4
10343785|NCT00398632|11481346|FG000|NOT COMPLETED|Overall Study||2
10343786|NCT00398866|11481354|FG000|STARTED|Overall Study||66
10343787|NCT00398866|11481355|FG001|STARTED|Overall Study||68
10343788|NCT00398866|11481356|FG002|STARTED|Overall Study||66
10343789|NCT00398866|11481354|FG000|COMPLETED|Overall Study||52
10343790|NCT00398866|11481355|FG001|COMPLETED|Overall Study||60
10343791|NCT00398866|11481356|FG002|COMPLETED|Overall Study||58
10343792|NCT00398866|11481354|FG000|NOT COMPLETED|Overall Study||14
10343793|NCT00398866|11481355|FG001|NOT COMPLETED|Overall Study||8
10343794|NCT00398866|11481356|FG002|NOT COMPLETED|Overall Study||8
10343795|NCT00398918|11481365|FG000|STARTED|Overall Study||10
10343796|NCT00398918|11481365|FG000|COMPLETED|Overall Study||10
10343797|NCT00398918|11481365|FG000|NOT COMPLETED|Overall Study||0
10343798|NCT00398983|11481371|FG000|STARTED|Overall Study||20
10343799|NCT00398983|11481372|FG001|STARTED|Overall Study||25
10343800|NCT00398983|11481371|FG000|COMPLETED|Overall Study||20
10343801|NCT00398983|11481372|FG001|COMPLETED|Overall Study||25
10343802|NCT00398983|11481371|FG000|NOT COMPLETED|Overall Study||0
10343803|NCT00398983|11481372|FG001|NOT COMPLETED|Overall Study||0
10343804|NCT00399035|11481381|FG000|STARTED|Overall Study||502
10343805|NCT00399035|11481382|FG001|STARTED|Overall Study||216
10343806|NCT00399035|11481383|FG002|STARTED|Overall Study||358
10343807|NCT00399035|11481381|FG000|COMPLETED|Overall Study||189
10343808|NCT00399035|11481382|FG001|COMPLETED|Overall Study||58
10343809|NCT00399035|11481383|FG002|COMPLETED|Overall Study||106
10343810|NCT00399035|11481381|FG000|NOT COMPLETED|Overall Study||313
10343811|NCT00399035|11481382|FG001|NOT COMPLETED|Overall Study||158
10343812|NCT00399035|11481383|FG002|NOT COMPLETED|Overall Study||252
10343813|NCT00399308|11481393|FG000|STARTED|Overall Study||13
10343814|NCT00399308|11481394|FG001|STARTED|Overall Study||15
10343815|NCT00399308|11481395|FG002|STARTED|Overall Study||12
10343816|NCT00399308|11481393|FG000|COMPLETED|Overall Study||13
10343817|NCT00399308|11481394|FG001|COMPLETED|Overall Study||15
10343818|NCT00399308|11481395|FG002|COMPLETED|Overall Study|One patient withdrew: did not want to comply with study requirements|11
10343819|NCT00399308|11481393|FG000|NOT COMPLETED|Overall Study||0
10343820|NCT00399308|11481394|FG001|NOT COMPLETED|Overall Study||0
10343821|NCT00399308|11481395|FG002|NOT COMPLETED|Overall Study||1
10343822|NCT00399360|11481407|FG000|STARTED|Overall Study||11
10343823|NCT00399360|11481408|FG001|STARTED|Overall Study||11
10343824|NCT00399360|11481409|FG002|STARTED|Overall Study||13
10343825|NCT00399360|11481410|FG003|STARTED|Overall Study||15
10343826|NCT00399360|11481407|FG000|COMPLETED|Overall Study||9
10343827|NCT00399360|11481408|FG001|COMPLETED|Overall Study||8
10343828|NCT00399360|11481409|FG002|COMPLETED|Overall Study||10
10343829|NCT00399360|11481410|FG003|COMPLETED|Overall Study||9
10343830|NCT00399360|11481407|FG000|NOT COMPLETED|Overall Study||2
10343831|NCT00399360|11481408|FG001|NOT COMPLETED|Overall Study||3
10343832|NCT00399360|11481409|FG002|NOT COMPLETED|Overall Study||3
10343833|NCT00399360|11481410|FG003|NOT COMPLETED|Overall Study||6
10343834|NCT00399490|11481425|FG000|STARTED|Overall Study||281
10343835|NCT00399490|11481425|FG000|COMPLETED|Overall Study||183
10343836|NCT00399490|11481425|FG000|NOT COMPLETED|Overall Study||98
10343837|NCT00399516|11481431|FG000|STARTED|Overall Study||21
10343838|NCT00399516|11481431|FG000|COMPLETED|Overall Study||19
10343839|NCT00399516|11481431|FG000|NOT COMPLETED|Overall Study||2
10343840|NCT00399529|11481435|FG000|STARTED|Overall Study||22
10343841|NCT00399529|11481435|FG000|COMPLETED|Overall Study||20
10343842|NCT00399529|11481435|FG000|NOT COMPLETED|Overall Study||2
10343843|NCT00399542|11481442|FG000|STARTED|Overall Study||387
10343844|NCT00399542|11481443|FG001|STARTED|Overall Study||194
10343845|NCT00399542|11481442|FG000|COMPLETED|Overall Study||303
10343846|NCT00399542|11481443|FG001|COMPLETED|Overall Study||151
10343847|NCT00399542|11481442|FG000|NOT COMPLETED|Overall Study||84
10343848|NCT00399542|11481443|FG001|NOT COMPLETED|Overall Study||43
10655430|NCT02207725|11816083|FG001|STARTED|Overall Study||25
10655431|NCT02207725|11816084|FG002|STARTED|Overall Study||9
10343849|NCT00399568|11481451|FG000|STARTED|Overall Study||166
10343850|NCT00399568|11481452|FG001|STARTED|Overall Study||165
10343851|NCT00399568|11481451|FG000|COMPLETED|Overall Study||154
10343852|NCT00399568|11481452|FG001|COMPLETED|Overall Study||156
10343853|NCT00399568|11481451|FG000|NOT COMPLETED|Overall Study||12
10343854|NCT00399568|11481452|FG001|NOT COMPLETED|Overall Study||9
10343855|NCT00399763|11481462|FG000|STARTED|Overall Study||35
10343856|NCT00399763|11481463|FG001|STARTED|Overall Study||35
10343857|NCT00399763|11481462|FG000|COMPLETED|Overall Study||33
10343858|NCT00399763|11481463|FG001|COMPLETED|Overall Study||32
10343859|NCT00399763|11481462|FG000|NOT COMPLETED|Overall Study||2
10343860|NCT00399763|11481463|FG001|NOT COMPLETED|Overall Study||3
10343861|NCT00399802|11481471|FG000|STARTED|Overall Study||14
10343862|NCT00399802|11481472|FG001|STARTED|Overall Study||29
10343863|NCT00399802|11481471|FG000|COMPLETED|Overall Study||14
10343864|NCT00399802|11481472|FG001|COMPLETED|Overall Study||26
10715633|NCT02688387|11880058|FG015|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10715634|NCT02688387|11880059|FG016|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10715635|NCT02688387|11880060|FG017|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10715636|NCT02688387|11880061|FG018|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10343865|NCT00399802|11481471|FG000|NOT COMPLETED|Overall Study||0
10531734|NCT01413516|11683955|FG001|NOT COMPLETED|Overall Study||0
10531735|NCT01413542|11683963|FG000|STARTED|Overall Study||6
10531736|NCT01413542|11683964|FG001|STARTED|Overall Study||6
10531737|NCT01413542|11683965|FG002|STARTED|Overall Study||9
10531738|NCT01413542|11683966|FG003|STARTED|Overall Study||8
10531739|NCT01413542|11683963|FG000|COMPLETED|Overall Study||5
10531740|NCT01413542|11683964|FG001|COMPLETED|Overall Study||6
10531741|NCT01413542|11683965|FG002|COMPLETED|Overall Study||6
10531742|NCT01413542|11683966|FG003|COMPLETED|Overall Study||7
10531743|NCT01413542|11683963|FG000|NOT COMPLETED|Overall Study||1
10531744|NCT01413542|11683964|FG001|NOT COMPLETED|Overall Study||0
10531745|NCT01413542|11683965|FG002|NOT COMPLETED|Overall Study||3
10531746|NCT01413542|11683966|FG003|NOT COMPLETED|Overall Study||1
10531747|NCT01413750|11683982|FG000|STARTED|Overall Study||6
10531748|NCT01413750|11683983|FG001|STARTED|Overall Study||6
10531749|NCT01413750|11683984|FG002|STARTED|Overall Study||4
10531750|NCT01413750|11683985|FG003|STARTED|Overall Study||7
10531751|NCT01413750|11683982|FG000|COMPLETED|Overall Study||6
10531752|NCT01413750|11683983|FG001|COMPLETED|Overall Study||6
10531753|NCT01413750|11683984|FG002|COMPLETED|Overall Study||4
10531754|NCT01413750|11683985|FG003|COMPLETED|Overall Study||7
10531755|NCT01413750|11683982|FG000|NOT COMPLETED|Overall Study||0
10531756|NCT01413750|11683983|FG001|NOT COMPLETED|Overall Study||0
10531757|NCT01413750|11683984|FG002|NOT COMPLETED|Overall Study||0
10531758|NCT01413750|11683985|FG003|NOT COMPLETED|Overall Study||0
10531759|NCT01413958|11683998|FG000|STARTED|Overall Study||288
10531760|NCT01413958|11683999|FG001|STARTED|Overall Study||287
10531761|NCT01413958|11683998|FG000|COMPLETED|Overall Study||288
10531762|NCT01413958|11683999|FG001|COMPLETED|Overall Study||286
10531763|NCT01413958|11683998|FG000|NOT COMPLETED|Overall Study||0
10531764|NCT01413958|11683999|FG001|NOT COMPLETED|Overall Study||1
10531765|NCT01414010|11684010|FG000|STARTED|Overall Study||8
10531766|NCT01414010|11684011|FG001|STARTED|Overall Study||8
10531767|NCT01414010|11684012|FG002|STARTED|Overall Study||8
10531768|NCT01414010|11684013|FG003|STARTED|Overall Study||8
10531769|NCT01414010|11684010|FG000|COMPLETED|Overall Study||6
10531770|NCT01414010|11684011|FG001|COMPLETED|Overall Study||8
10531771|NCT01414010|11684012|FG002|COMPLETED|Overall Study||8
10531772|NCT01414010|11684013|FG003|COMPLETED|Overall Study||8
10531773|NCT01414010|11684010|FG000|NOT COMPLETED|Overall Study||2
10531774|NCT01414010|11684011|FG001|NOT COMPLETED|Overall Study||0
10531775|NCT01414010|11684012|FG002|NOT COMPLETED|Overall Study||0
10531776|NCT01414010|11684013|FG003|NOT COMPLETED|Overall Study||0
10531777|NCT01414036|11684031|FG000|STARTED|Received Allocated Intervention||23
10531778|NCT01414036|11684032|FG001|STARTED|Received Allocated Intervention||24
10531779|NCT01414036|11684031|FG000|COMPLETED|Received Allocated Intervention||23
10531780|NCT01414036|11684032|FG001|COMPLETED|Received Allocated Intervention||11
10531781|NCT01414036|11684031|FG000|NOT COMPLETED|Received Allocated Intervention||0
10531782|NCT01414036|11684032|FG001|NOT COMPLETED|Received Allocated Intervention||13
10531783|NCT01414036|11684031|FG000|STARTED|Completed 3 Month Survey||23
10531784|NCT01414036|11684032|FG001|STARTED|Completed 3 Month Survey||24
10531785|NCT01414036|11684031|FG000|COMPLETED|Completed 3 Month Survey||14
10531786|NCT01414036|11684032|FG001|COMPLETED|Completed 3 Month Survey||19
10531787|NCT01414036|11684031|FG000|NOT COMPLETED|Completed 3 Month Survey||9
10531788|NCT01414036|11684032|FG001|NOT COMPLETED|Completed 3 Month Survey||5
10531789|NCT01414075|11684042|FG000|STARTED|Overall Study||24
10531790|NCT01414075|11684043|FG001|STARTED|Overall Study||12
10531791|NCT01414075|11684044|FG002|STARTED|Overall Study||12
10531792|NCT01414075|11684045|FG003|STARTED|Overall Study||12
10715637|NCT02688387|11880062|FG019|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10715638|NCT02688387|11880063|FG020|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10715639|NCT02688387|11880064|FG021|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
10715640|NCT02688387|11880043|FG000|STARTED|Part 3A, Period 2 (up to 6 Days)||0
10715641|NCT02688387|11880044|FG001|STARTED|Part 3A, Period 2 (up to 6 Days)||0
10343866|NCT00399802|11481472|FG001|NOT COMPLETED|Overall Study||3
10715642|NCT02688387|11880045|FG002|STARTED|Part 3A, Period 2 (up to 6 Days)||0
10715643|NCT02688387|11880046|FG003|STARTED|Part 3A, Period 2 (up to 6 Days)||0
10715644|NCT02688387|11880047|FG004|STARTED|Part 3A, Period 2 (up to 6 Days)||0
10715645|NCT02688387|11880048|FG005|STARTED|Part 3A, Period 2 (up to 6 Days)||0
10715646|NCT02688387|11880049|FG006|STARTED|Part 3A, Period 2 (up to 6 Days)||0
10715647|NCT02688387|11880050|FG007|STARTED|Part 3A, Period 2 (up to 6 Days)||0
10715648|NCT02688387|11880051|FG008|STARTED|Part 3A, Period 2 (up to 6 Days)||0
10715649|NCT02688387|11880052|FG009|STARTED|Part 3A, Period 2 (up to 6 Days)||0
10715650|NCT02688387|11880053|FG010|STARTED|Part 3A, Period 2 (up to 6 Days)||0
10531793|NCT01414075|11684042|FG000|Efficacy Evaluable (EE) Population|Overall Study||23
10531794|NCT01414075|11684043|FG001|Efficacy Evaluable (EE) Population|Overall Study||12
10531795|NCT01414075|11684044|FG002|Efficacy Evaluable (EE) Population|Overall Study||10
10531796|NCT01414075|11684045|FG003|Efficacy Evaluable (EE) Population|Overall Study||10
10531797|NCT01414075|11684042|FG000|COMPLETED|Overall Study||21
10531798|NCT01414075|11684043|FG001|COMPLETED|Overall Study||12
10715651|NCT02688387|11880054|FG011|STARTED|Part 3A, Period 2 (up to 6 Days)||0
10343867|NCT00399880|11481480|FG000|STARTED|Overall Study||65
10343868|NCT00399880|11481481|FG001|STARTED|Overall Study||65
10343869|NCT00399880|11481480|FG000|COMPLETED|Overall Study||65
10343870|NCT00399880|11481481|FG001|COMPLETED|Overall Study||65
10343871|NCT00399880|11481480|FG000|NOT COMPLETED|Overall Study||0
10343872|NCT00399880|11481481|FG001|NOT COMPLETED|Overall Study||0
10343873|NCT00399893|11481489|FG000|STARTED|Overall Study||2
10343874|NCT00399893|11481490|FG001|STARTED|Overall Study||3
10343875|NCT00399893|11481489|FG000|COMPLETED|Overall Study|Participant withdrew after 3 months but was included in results|1
10343876|NCT00399893|11481490|FG001|COMPLETED|Overall Study||3
10343877|NCT00399893|11481489|FG000|NOT COMPLETED|Overall Study||1
10343878|NCT00399893|11481490|FG001|NOT COMPLETED|Overall Study||0
10343879|NCT00400153|11481499|FG000|STARTED|Overall Study||486
10343880|NCT00400153|11481500|FG001|STARTED|Overall Study||491
10343881|NCT00400153|11481501|FG002|STARTED|Overall Study||483
10343882|NCT00400153|11481499|FG000|COMPLETED|Overall Study||438
10343883|NCT00400153|11481500|FG001|COMPLETED|Overall Study||436
10343884|NCT00400153|11481501|FG002|COMPLETED|Overall Study||422
10343885|NCT00400153|11481499|FG000|NOT COMPLETED|Overall Study||48
10343886|NCT00400153|11481500|FG001|NOT COMPLETED|Overall Study||55
10343887|NCT00400153|11481501|FG002|NOT COMPLETED|Overall Study||61
10343888|NCT00400179|11481516|FG000|STARTED|Overall Study|Signed informed consent form and randomized|527
10343889|NCT00400179|11481517|FG001|STARTED|Overall Study||526
10343890|NCT00400179|11481516|FG000|COMPLETED|Overall Study|Received Treatment|521
10343891|NCT00400179|11481517|FG001|COMPLETED|Overall Study||508
10343892|NCT00400179|11481516|FG000|NOT COMPLETED|Overall Study||6
10343893|NCT00400179|11481517|FG001|NOT COMPLETED|Overall Study||18
10343894|NCT00400205|11481523|FG000|STARTED|Overall Study||14
10343895|NCT00400205|11481523|FG000|COMPLETED|Overall Study||9
10343896|NCT00400205|11481523|FG000|NOT COMPLETED|Overall Study||5
10343897|NCT00400400|11481530|FG000|STARTED|Overall Study||200
10343898|NCT00400400|11481531|FG001|STARTED|Overall Study||200
10343899|NCT00400400|11481530|FG000|Intent-to-Treat Population|Overall Study|Participants who received study drug.|199
10343900|NCT00400400|11481531|FG001|Intent-to-Treat Population|Overall Study||197
10343901|NCT00400400|11481530|FG000|COMPLETED|Overall Study||186
10343902|NCT00400400|11481531|FG001|COMPLETED|Overall Study||185
10343903|NCT00400400|11481530|FG000|NOT COMPLETED|Overall Study||14
10343904|NCT00400400|11481531|FG001|NOT COMPLETED|Overall Study||15
10343905|NCT00400439|11481539|FG000|STARTED|Overall Study||52
10343906|NCT00400439|11481540|FG001|STARTED|Overall Study||25
10343907|NCT00400439|11481539|FG000|COMPLETED|Overall Study||47
10343908|NCT00400439|11481540|FG001|COMPLETED|Overall Study||23
10343909|NCT00400439|11481539|FG000|NOT COMPLETED|Overall Study||5
10343910|NCT00400439|11481540|FG001|NOT COMPLETED|Overall Study||2
10343911|NCT00400517|11481546|FG000|STARTED|Overall Study|1 pt w/d consent. 1 pt found to have unresectable dx at time of sx and is exc. in tissue analysis.|28
10343912|NCT00400517|11481546|FG000|COMPLETED|Overall Study||26
10343913|NCT00400517|11481546|FG000|NOT COMPLETED|Overall Study||2
10343914|NCT00400569|11481550|FG000|STARTED|Overall Study||48
10343915|NCT00400569|11481550|FG000|COMPLETED|Overall Study||47
10343916|NCT00400569|11481550|FG000|NOT COMPLETED|Overall Study||1
10343917|NCT00400634|11481559|FG000|STARTED|Overall Study||38
10343918|NCT00400634|11481560|FG001|STARTED|Overall Study||20
10343919|NCT00400634|11481559|FG000|COMPLETED|Overall Study||34
10343920|NCT00400634|11481560|FG001|COMPLETED|Overall Study||19
10343921|NCT00400634|11481559|FG000|NOT COMPLETED|Overall Study||4
10343922|NCT00400634|11481560|FG001|NOT COMPLETED|Overall Study||1
10343923|NCT00400686|11481566|FG000|STARTED|Overall Study||31
10343924|NCT00400686|11481566|FG000|COMPLETED|Overall Study||31
10343925|NCT00400686|11481566|FG000|NOT COMPLETED|Overall Study||0
10343926|NCT00400712|11481572|FG000|STARTED|Overall Study||52
10343927|NCT00400712|11481573|FG001|STARTED|Overall Study||51
10343928|NCT00400712|11481572|FG000|COMPLETED|Overall Study||35
10343929|NCT00400712|11481573|FG001|COMPLETED|Overall Study||35
10343930|NCT00400712|11481572|FG000|NOT COMPLETED|Overall Study||17
10343931|NCT00400712|11481573|FG001|NOT COMPLETED|Overall Study||16
10343932|NCT00400764|11481586|FG000|STARTED|Phase Ib||6
10531799|NCT01414075|11684044|FG002|COMPLETED|Overall Study||10
10531800|NCT01414075|11684045|FG003|COMPLETED|Overall Study||10
10531801|NCT01414075|11684042|FG000|NOT COMPLETED|Overall Study||3
10531802|NCT01414075|11684043|FG001|NOT COMPLETED|Overall Study||0
10531803|NCT01414075|11684044|FG002|NOT COMPLETED|Overall Study||2
10531804|NCT01414075|11684045|FG003|NOT COMPLETED|Overall Study||2
10531805|NCT01414114|11684055|FG000|STARTED|Overall Study||37
10531806|NCT01414114|11684055|FG000|COMPLETED|Overall Study|Completed 12-week treatment period|32
10531807|NCT01414114|11684055|FG000|NOT COMPLETED|Overall Study||5
10531808|NCT01414153|11684065|FG000|STARTED|Overall Study||38
10531809|NCT01414153|11684066|FG001|STARTED|Overall Study||40
10531810|NCT01414153|11684067|FG002|STARTED|Overall Study||39
10655432|NCT02207725|11816085|FG003|STARTED|Overall Study||25
10343933|NCT00400764|11481587|FG001|STARTED|Phase Ib||6
10343934|NCT00400764|11481588|FG002|STARTED|Phase Ib||0
10343935|NCT00400764|11481589|FG003|STARTED|Phase Ib||0
10343936|NCT00400764|11481590|FG004|STARTED|Phase Ib||0
10531811|NCT01414153|11684068|FG003|STARTED|Overall Study||41
10531812|NCT01414153|11684065|FG000|COMPLETED|Overall Study||30
10531813|NCT01414153|11684066|FG001|COMPLETED|Overall Study||38
10531814|NCT01414153|11684067|FG002|COMPLETED|Overall Study||35
10343937|NCT00400764|11481586|FG000|Treated|Phase Ib||6
10343938|NCT00400764|11481587|FG001|Treated|Phase Ib||6
10343939|NCT00400764|11481588|FG002|Treated|Phase Ib||0
10343940|NCT00400764|11481589|FG003|Treated|Phase Ib||0
10343941|NCT00400764|11481590|FG004|Treated|Phase Ib||0
10343942|NCT00400764|11481586|FG000|COMPLETED|Phase Ib|One patient reported as discontinued due to an AE should have been reported as death.|0
10343943|NCT00400764|11481587|FG001|COMPLETED|Phase Ib||2
10343944|NCT00400764|11481588|FG002|COMPLETED|Phase Ib||0
10343945|NCT00400764|11481589|FG003|COMPLETED|Phase Ib||0
10343946|NCT00400764|11481590|FG004|COMPLETED|Phase Ib||0
10343947|NCT00400764|11481586|FG000|NOT COMPLETED|Phase Ib||6
10343948|NCT00400764|11481587|FG001|NOT COMPLETED|Phase Ib||4
10343949|NCT00400764|11481588|FG002|NOT COMPLETED|Phase Ib||0
10343950|NCT00400764|11481589|FG003|NOT COMPLETED|Phase Ib||0
10343951|NCT00400764|11481590|FG004|NOT COMPLETED|Phase Ib||0
10343952|NCT00400764|11481586|FG000|STARTED|Phase II||0
10343953|NCT00400764|11481587|FG001|STARTED|Phase II||0
10343954|NCT00400764|11481588|FG002|STARTED|Phase II||23
10343955|NCT00400764|11481589|FG003|STARTED|Phase II||26
10531815|NCT01414153|11684068|FG003|COMPLETED|Overall Study||37
10531816|NCT01414153|11684065|FG000|NOT COMPLETED|Overall Study||8
10531817|NCT01414153|11684066|FG001|NOT COMPLETED|Overall Study||2
10531818|NCT01414153|11684067|FG002|NOT COMPLETED|Overall Study||4
10343956|NCT00400764|11481590|FG004|STARTED|Phase II||11
10343957|NCT00400764|11481586|FG000|Treated|Phase II||0
10343958|NCT00400764|11481587|FG001|Treated|Phase II||0
10343959|NCT00400764|11481588|FG002|Treated|Phase II|One patient in the Rituximab arm withdrew prior to treatment|22
10343960|NCT00400764|11481589|FG003|Treated|Phase II||26
10343961|NCT00400764|11481590|FG004|Treated|Phase II||11
10343962|NCT00400764|11481586|FG000|COMPLETED|Phase II||0
10343963|NCT00400764|11481587|FG001|COMPLETED|Phase II||0
10343964|NCT00400764|11481588|FG002|COMPLETED|Phase II||0
10343965|NCT00400764|11481589|FG003|COMPLETED|Phase II||0
10343966|NCT00400764|11481590|FG004|COMPLETED|Phase II||0
10343967|NCT00400764|11481586|FG000|NOT COMPLETED|Phase II||0
10343968|NCT00400764|11481587|FG001|NOT COMPLETED|Phase II||0
10343969|NCT00400764|11481588|FG002|NOT COMPLETED|Phase II||23
10343970|NCT00400764|11481589|FG003|NOT COMPLETED|Phase II||26
10343971|NCT00400764|11481590|FG004|NOT COMPLETED|Phase II||11
10343972|NCT00400803|11481607|FG000|STARTED|Overall Study||35
10343973|NCT00400803|11481607|FG000|COMPLETED|Overall Study||35
10343974|NCT00400803|11481607|FG000|NOT COMPLETED|Overall Study||0
10343975|NCT00400829|11481615|FG000|STARTED|Overall Study||66
10343976|NCT00400829|11481615|FG000|COMPLETED|Overall Study||66
10343977|NCT00400829|11481615|FG000|NOT COMPLETED|Overall Study||0
10343978|NCT00400881|11481621|FG000|STARTED|Overall Study||62
10343979|NCT00400881|11481622|FG001|STARTED|Overall Study||60
10343980|NCT00400881|11481621|FG000|COMPLETED|Overall Study||62
10343981|NCT00400881|11481622|FG001|COMPLETED|Overall Study||60
10343982|NCT00400881|11481621|FG000|NOT COMPLETED|Overall Study||0
10343983|NCT00400881|11481622|FG001|NOT COMPLETED|Overall Study||0
10343984|NCT00400985|11481629|FG000|STARTED|Overall Study||501
10343985|NCT00400985|11481629|FG000|COMPLETED|Overall Study||449
10343986|NCT00400985|11481629|FG000|NOT COMPLETED|Overall Study||52
10343987|NCT00401102|11481633|FG000|STARTED|Overall Study||12
10343988|NCT00401102|11481633|FG000|COMPLETED|Overall Study||5
10343989|NCT00401102|11481633|FG000|NOT COMPLETED|Overall Study||7
10343990|NCT00401193|11481640|FG000|STARTED|Overall Study||118
10343991|NCT00401193|11481641|FG001|STARTED|Overall Study||117
10343992|NCT00401193|11481642|FG002|STARTED|Overall Study||69
10343993|NCT00401193|11481640|FG000|Intent to Treat Population|Overall Study||115
10343994|NCT00401193|11481641|FG001|Intent to Treat Population|Overall Study||115
10343995|NCT00401193|11481642|FG002|Intent to Treat Population|Overall Study||67
10343996|NCT00401193|11481640|FG000|Modified Intent to Treat Population|Overall Study||112
10343997|NCT00401193|11481641|FG001|Modified Intent to Treat Population|Overall Study||115
10343998|NCT00401193|11481642|FG002|Modified Intent to Treat Population|Overall Study||67
10343999|NCT00401193|11481640|FG000|COMPLETED|Overall Study||103
10344000|NCT00401193|11481641|FG001|COMPLETED|Overall Study||106
10344001|NCT00401193|11481642|FG002|COMPLETED|Overall Study||63
10344002|NCT00401193|11481640|FG000|NOT COMPLETED|Overall Study||15
10344003|NCT00401193|11481641|FG001|NOT COMPLETED|Overall Study||11
10344004|NCT00401193|11481642|FG002|NOT COMPLETED|Overall Study||6
10344005|NCT00401245|11481655|FG000|STARTED|Double Blind Titration Phase||126
10344006|NCT00401245|11481656|FG001|STARTED|Double Blind Titration Phase||121
10344007|NCT00401245|11481657|FG002|STARTED|Double Blind Titration Phase||124
10344008|NCT00401245|11481658|FG003|STARTED|Double Blind Titration Phase||122
10344009|NCT00401245|11481659|FG004|STARTED|Double Blind Titration Phase||0
10344010|NCT00401245|11481660|FG005|STARTED|Double Blind Titration Phase||0
10344011|NCT00401245|11481661|FG006|STARTED|Double Blind Titration Phase||0
10344012|NCT00401245|11481662|FG007|STARTED|Double Blind Titration Phase||0
10344013|NCT00401245|11481655|FG000|COMPLETED|Double Blind Titration Phase||122
10344014|NCT00401245|11481656|FG001|COMPLETED|Double Blind Titration Phase||118
10344015|NCT00401245|11481657|FG002|COMPLETED|Double Blind Titration Phase||118
10344016|NCT00401245|11481658|FG003|COMPLETED|Double Blind Titration Phase||107
10344017|NCT00401245|11481659|FG004|COMPLETED|Double Blind Titration Phase||0
10344018|NCT00401245|11481660|FG005|COMPLETED|Double Blind Titration Phase||0
10344019|NCT00401245|11481661|FG006|COMPLETED|Double Blind Titration Phase||0
10344020|NCT00401245|11481662|FG007|COMPLETED|Double Blind Titration Phase||0
10344021|NCT00401245|11481655|FG000|NOT COMPLETED|Double Blind Titration Phase||4
10344022|NCT00401245|11481656|FG001|NOT COMPLETED|Double Blind Titration Phase||3
10344023|NCT00401245|11481657|FG002|NOT COMPLETED|Double Blind Titration Phase||6
10531819|NCT01414153|11684068|FG003|NOT COMPLETED|Overall Study||4
10531820|NCT01414205|11684080|FG000|STARTED|Overall Study||41
10344024|NCT00401245|11481658|FG003|NOT COMPLETED|Double Blind Titration Phase||15
10344025|NCT00401245|11481659|FG004|NOT COMPLETED|Double Blind Titration Phase||0
10344026|NCT00401245|11481660|FG005|NOT COMPLETED|Double Blind Titration Phase||0
10344027|NCT00401245|11481661|FG006|NOT COMPLETED|Double Blind Titration Phase||0
10344028|NCT00401245|11481662|FG007|NOT COMPLETED|Double Blind Titration Phase||0
10344029|NCT00401245|11481655|FG000|STARTED|Between Titration and Open Label Phase||122
10344030|NCT00401245|11481656|FG001|STARTED|Between Titration and Open Label Phase||118
10344031|NCT00401245|11481657|FG002|STARTED|Between Titration and Open Label Phase||118
10344032|NCT00401245|11481658|FG003|STARTED|Between Titration and Open Label Phase||107
10344033|NCT00401245|11481659|FG004|STARTED|Between Titration and Open Label Phase||0
10344034|NCT00401245|11481660|FG005|STARTED|Between Titration and Open Label Phase||0
10344035|NCT00401245|11481661|FG006|STARTED|Between Titration and Open Label Phase||0
10344036|NCT00401245|11481662|FG007|STARTED|Between Titration and Open Label Phase||0
10344037|NCT00401245|11481655|FG000|COMPLETED|Between Titration and Open Label Phase||122
10344038|NCT00401245|11481656|FG001|COMPLETED|Between Titration and Open Label Phase||116
10344039|NCT00401245|11481657|FG002|COMPLETED|Between Titration and Open Label Phase||118
10344040|NCT00401245|11481658|FG003|COMPLETED|Between Titration and Open Label Phase||105
10344041|NCT00401245|11481659|FG004|COMPLETED|Between Titration and Open Label Phase||0
10344042|NCT00401245|11481660|FG005|COMPLETED|Between Titration and Open Label Phase||0
10344043|NCT00401245|11481661|FG006|COMPLETED|Between Titration and Open Label Phase||0
10344044|NCT00401245|11481662|FG007|COMPLETED|Between Titration and Open Label Phase||0
10344045|NCT00401245|11481655|FG000|NOT COMPLETED|Between Titration and Open Label Phase||0
10344046|NCT00401245|11481656|FG001|NOT COMPLETED|Between Titration and Open Label Phase||2
10344047|NCT00401245|11481657|FG002|NOT COMPLETED|Between Titration and Open Label Phase||0
10344048|NCT00401245|11481658|FG003|NOT COMPLETED|Between Titration and Open Label Phase||2
10344049|NCT00401245|11481659|FG004|NOT COMPLETED|Between Titration and Open Label Phase||0
10344050|NCT00401245|11481660|FG005|NOT COMPLETED|Between Titration and Open Label Phase||0
10344051|NCT00401245|11481661|FG006|NOT COMPLETED|Between Titration and Open Label Phase||0
10344052|NCT00401245|11481662|FG007|NOT COMPLETED|Between Titration and Open Label Phase||0
10344053|NCT00401245|11481655|FG000|STARTED|Open Label Phase||122
10344054|NCT00401245|11481656|FG001|STARTED|Open Label Phase||116
10344055|NCT00401245|11481657|FG002|STARTED|Open Label Phase||118
10344056|NCT00401245|11481658|FG003|STARTED|Open Label Phase||105
10344057|NCT00401245|11481659|FG004|STARTED|Open Label Phase||0
10344058|NCT00401245|11481660|FG005|STARTED|Open Label Phase||0
10344059|NCT00401245|11481661|FG006|STARTED|Open Label Phase||0
10344060|NCT00401245|11481662|FG007|STARTED|Open Label Phase||0
10344061|NCT00401245|11481655|FG000|COMPLETED|Open Label Phase||101
10344062|NCT00401245|11481656|FG001|COMPLETED|Open Label Phase||81
10344063|NCT00401245|11481657|FG002|COMPLETED|Open Label Phase||95
10344064|NCT00401245|11481658|FG003|COMPLETED|Open Label Phase||84
10344065|NCT00401245|11481659|FG004|COMPLETED|Open Label Phase||0
10344066|NCT00401245|11481660|FG005|COMPLETED|Open Label Phase||0
10344067|NCT00401245|11481661|FG006|COMPLETED|Open Label Phase||0
10344068|NCT00401245|11481662|FG007|COMPLETED|Open Label Phase||0
10344069|NCT00401245|11481655|FG000|NOT COMPLETED|Open Label Phase||21
10344070|NCT00401245|11481656|FG001|NOT COMPLETED|Open Label Phase||35
10344071|NCT00401245|11481657|FG002|NOT COMPLETED|Open Label Phase||23
10344072|NCT00401245|11481658|FG003|NOT COMPLETED|Open Label Phase||21
10344073|NCT00401245|11481659|FG004|NOT COMPLETED|Open Label Phase||0
10344074|NCT00401245|11481660|FG005|NOT COMPLETED|Open Label Phase||0
10344075|NCT00401245|11481661|FG006|NOT COMPLETED|Open Label Phase||0
10344076|NCT00401245|11481662|FG007|NOT COMPLETED|Open Label Phase||0
10344077|NCT00401245|11481655|FG000|STARTED|Double Blind Tapering Phase||0
10344078|NCT00401245|11481656|FG001|STARTED|Double Blind Tapering Phase||0
10344079|NCT00401245|11481657|FG002|STARTED|Double Blind Tapering Phase||0
10344080|NCT00401245|11481658|FG003|STARTED|Double Blind Tapering Phase||0
10344081|NCT00401245|11481659|FG004|STARTED|Double Blind Tapering Phase||101
10344082|NCT00401245|11481660|FG005|STARTED|Double Blind Tapering Phase||94
10344083|NCT00401245|11481661|FG006|STARTED|Double Blind Tapering Phase||87
10344084|NCT00401245|11481662|FG007|STARTED|Double Blind Tapering Phase||102
10344085|NCT00401245|11481655|FG000|COMPLETED|Double Blind Tapering Phase||0
10344086|NCT00401245|11481656|FG001|COMPLETED|Double Blind Tapering Phase||0
10344087|NCT00401245|11481657|FG002|COMPLETED|Double Blind Tapering Phase||0
10344088|NCT00401245|11481658|FG003|COMPLETED|Double Blind Tapering Phase||0
10344089|NCT00401245|11481659|FG004|COMPLETED|Double Blind Tapering Phase||97
10344090|NCT00401245|11481660|FG005|COMPLETED|Double Blind Tapering Phase||90
10344091|NCT00401245|11481661|FG006|COMPLETED|Double Blind Tapering Phase||80
10344092|NCT00401245|11481662|FG007|COMPLETED|Double Blind Tapering Phase||95
10344093|NCT00401245|11481655|FG000|NOT COMPLETED|Double Blind Tapering Phase||0
10344094|NCT00401245|11481656|FG001|NOT COMPLETED|Double Blind Tapering Phase||0
10715652|NCT02688387|11880055|FG012|STARTED|Part 3A, Period 2 (up to 6 Days)||0
10715653|NCT02688387|11880056|FG013|STARTED|Part 3A, Period 2 (up to 6 Days)||0
10715654|NCT02688387|11880057|FG014|STARTED|Part 3A, Period 2 (up to 6 Days)||8
10344095|NCT00401245|11481657|FG002|NOT COMPLETED|Double Blind Tapering Phase||0
10344096|NCT00401245|11481658|FG003|NOT COMPLETED|Double Blind Tapering Phase||0
10344097|NCT00401245|11481659|FG004|NOT COMPLETED|Double Blind Tapering Phase||4
10715655|NCT02688387|11880058|FG015|STARTED|Part 3A, Period 2 (up to 6 Days)||8
10344098|NCT00401245|11481660|FG005|NOT COMPLETED|Double Blind Tapering Phase||4
10344099|NCT00401245|11481661|FG006|NOT COMPLETED|Double Blind Tapering Phase||7
10344100|NCT00401245|11481662|FG007|NOT COMPLETED|Double Blind Tapering Phase||7
10344101|NCT00401258|11481682|FG000|STARTED|Overall Study||15
10344102|NCT00401258|11481682|FG000|COMPLETED|Overall Study||8
10344103|NCT00401258|11481682|FG000|NOT COMPLETED|Overall Study||7
10344104|NCT00401375|11481689|FG000|STARTED|Overall Study||174
10344105|NCT00401375|11481690|FG001|STARTED|Overall Study||176
10344106|NCT00401375|11481691|FG002|STARTED|Overall Study||174
10344107|NCT00401375|11481689|FG000|Received at Least 1 Dose of Study Drug|Overall Study||171
10344108|NCT00401375|11481690|FG001|Received at Least 1 Dose of Study Drug|Overall Study||173
10344109|NCT00401375|11481691|FG002|Received at Least 1 Dose of Study Drug|Overall Study||171
10344110|NCT00401375|11481689|FG000|COMPLETED|Overall Study||152
10344111|NCT00401375|11481690|FG001|COMPLETED|Overall Study||151
10344112|NCT00401375|11481691|FG002|COMPLETED|Overall Study||149
10344113|NCT00401375|11481689|FG000|NOT COMPLETED|Overall Study||22
10344114|NCT00401375|11481690|FG001|NOT COMPLETED|Overall Study||25
10344115|NCT00401375|11481691|FG002|NOT COMPLETED|Overall Study||25
10344116|NCT00401401|11481703|FG000|STARTED|Overall Study||6
10344117|NCT00401401|11481704|FG001|STARTED|Overall Study||6
10344118|NCT00401401|11481705|FG002|STARTED|Overall Study||6
10344119|NCT00401401|11481706|FG003|STARTED|Overall Study||12
10344120|NCT00401401|11481703|FG000|COMPLETED|Overall Study||6
10344121|NCT00401401|11481704|FG001|COMPLETED|Overall Study||6
10344122|NCT00401401|11481705|FG002|COMPLETED|Overall Study||5
10344123|NCT00401401|11481706|FG003|COMPLETED|Overall Study||9
10344124|NCT00401401|11481703|FG000|NOT COMPLETED|Overall Study||0
10344125|NCT00401401|11481704|FG001|NOT COMPLETED|Overall Study||0
10344126|NCT00401401|11481705|FG002|NOT COMPLETED|Overall Study||1
10344127|NCT00401401|11481706|FG003|NOT COMPLETED|Overall Study||3
10344128|NCT00401414|11481723|FG000|STARTED|Overall Study||118
10344129|NCT00401414|11481724|FG001|STARTED|Overall Study||147
10344130|NCT00401414|11481725|FG002|STARTED|Overall Study||79
10344131|NCT00401414|11481723|FG000|COMPLETED|Overall Study||118
10344132|NCT00401414|11481724|FG001|COMPLETED|Overall Study||147
10344133|NCT00401414|11481725|FG002|COMPLETED|Overall Study||79
10344134|NCT00401414|11481723|FG000|NOT COMPLETED|Overall Study||0
10344135|NCT00401414|11481724|FG001|NOT COMPLETED|Overall Study||0
10344136|NCT00401414|11481725|FG002|NOT COMPLETED|Overall Study||0
10344137|NCT00401518|11481738|FG000|STARTED|Overall Study||46
10344138|NCT00401518|11481739|FG001|STARTED|Overall Study||227
10344139|NCT00401518|11481740|FG002|STARTED|Overall Study||117
10344140|NCT00401518|11481738|FG000|COMPLETED|Overall Study||40
10344141|NCT00401518|11481739|FG001|COMPLETED|Overall Study||190
10344142|NCT00401518|11481740|FG002|COMPLETED|Overall Study||94
10344143|NCT00401518|11481738|FG000|NOT COMPLETED|Overall Study||6
10344144|NCT00401518|11481739|FG001|NOT COMPLETED|Overall Study||37
10344145|NCT00401518|11481740|FG002|NOT COMPLETED|Overall Study||23
10344146|NCT00401531|11481750|FG000|STARTED|Overall Study||206
10344147|NCT00401531|11481751|FG001|STARTED|Overall Study||206
10344148|NCT00401531|11481750|FG000|COMPLETED|Overall Study||197
10344149|NCT00401531|11481751|FG001|COMPLETED|Overall Study||196
10344150|NCT00401531|11481750|FG000|NOT COMPLETED|Overall Study||9
10344151|NCT00401531|11481751|FG001|NOT COMPLETED|Overall Study||10
10344152|NCT00401544|11481761|FG000|STARTED|Overall Study|Randomized and treated|56
10344153|NCT00401544|11481762|FG001|STARTED|Overall Study|Randomized and treated|62
10344154|NCT00401544|11481763|FG002|STARTED|Overall Study|Randomized and treated|60
10344155|NCT00401544|11481764|FG003|STARTED|Overall Study|Randomized and treated|60
10344156|NCT00401544|11481761|FG000|COMPLETED|Overall Study||38
10344157|NCT00401544|11481762|FG001|COMPLETED|Overall Study||44
10344158|NCT00401544|11481763|FG002|COMPLETED|Overall Study||48
10344159|NCT00401544|11481764|FG003|COMPLETED|Overall Study||44
10344160|NCT00401544|11481761|FG000|NOT COMPLETED|Overall Study||18
10344161|NCT00401544|11481762|FG001|NOT COMPLETED|Overall Study||18
10344162|NCT00401544|11481763|FG002|NOT COMPLETED|Overall Study||12
10344163|NCT00401544|11481764|FG003|NOT COMPLETED|Overall Study||16
10344164|NCT00401622|11481781|FG000|STARTED|Overall Study||160
10344165|NCT00401622|11481782|FG001|STARTED|Overall Study||160
10344166|NCT00401622|11481781|FG000|COMPLETED|Overall Study||126
10344167|NCT00401622|11481782|FG001|COMPLETED|Overall Study||117
10344168|NCT00401622|11481781|FG000|NOT COMPLETED|Overall Study||34
10344169|NCT00401622|11481782|FG001|NOT COMPLETED|Overall Study||43
10344170|NCT00401726|11481790|FG000|STARTED|Overall Study||269
10531821|NCT01414205|11684081|FG001|STARTED|Overall Study||39
10531822|NCT01414205|11684080|FG000|Received Study Drug|Overall Study||40
10344171|NCT00401726|11481791|FG001|STARTED|Overall Study||268
10344172|NCT00401726|11481790|FG000|COMPLETED|Overall Study||172
10344173|NCT00401726|11481791|FG001|COMPLETED|Overall Study||156
10344174|NCT00401726|11481790|FG000|NOT COMPLETED|Overall Study||97
10344175|NCT00401726|11481791|FG001|NOT COMPLETED|Overall Study||112
10344176|NCT00401752|11481799|FG000|STARTED|Overall Study||107
10344177|NCT00401752|11481800|FG001|STARTED|Overall Study||112
10344178|NCT00401752|11481799|FG000|Number of Patients Received Treatment|Overall Study||107
10344179|NCT00401752|11481800|FG001|Number of Patients Received Treatment|Overall Study||111
10344180|NCT00401752|11481799|FG000|Patients Included in ITT Population|Overall Study||106
10344181|NCT00401752|11481800|FG001|Patients Included in ITT Population|Overall Study||111
10344182|NCT00401752|11481799|FG000|Patients Included in Safety Population|Overall Study||107
10344183|NCT00401752|11481800|FG001|Patients Included in Safety Population|Overall Study||110
10344184|NCT00401752|11481799|FG000|Patients Included in Per-Protocol Popula|Overall Study||100
10344185|NCT00401752|11481800|FG001|Patients Included in Per-Protocol Popula|Overall Study||99
10344186|NCT00401752|11481799|FG000|COMPLETED|Overall Study||97
10531823|NCT01414205|11684081|FG001|Received Study Drug|Overall Study||38
10531824|NCT01414205|11684080|FG000|COMPLETED|Overall Study||34
10531825|NCT01414205|11684081|FG001|COMPLETED|Overall Study||32
10655433|NCT02207725|11816082|FG000|COMPLETED|Overall Study||9
10655434|NCT02207725|11816083|FG001|COMPLETED|Overall Study||24
10655435|NCT02207725|11816084|FG002|COMPLETED|Overall Study||8
10655436|NCT02207725|11816085|FG003|COMPLETED|Overall Study||24
10655437|NCT02207725|11816082|FG000|NOT COMPLETED|Overall Study||0
10655438|NCT02207725|11816083|FG001|NOT COMPLETED|Overall Study||1
10655439|NCT02207725|11816084|FG002|NOT COMPLETED|Overall Study||1
10655440|NCT02207725|11816085|FG003|NOT COMPLETED|Overall Study||1
10655441|NCT02207803|11816099|FG000|STARTED|Overall Study||125
10655442|NCT02207803|11816100|FG001|STARTED|Overall Study||125
10655443|NCT02207803|11816099|FG000|COMPLETED|Overall Study||110
10655444|NCT02207803|11816100|FG001|COMPLETED|Overall Study||108
10655445|NCT02207803|11816099|FG000|NOT COMPLETED|Overall Study||15
10655446|NCT02207803|11816100|FG001|NOT COMPLETED|Overall Study||17
10655447|NCT02207816|11816109|FG000|STARTED|Overall Study||1046
10655448|NCT02207816|11816110|FG001|STARTED|Overall Study||1010
10655449|NCT02207816|11816111|FG002|STARTED|Overall Study||1028
10655450|NCT02207816|11816109|FG000|COMPLETED|Overall Study||995
10655451|NCT02207816|11816110|FG001|COMPLETED|Overall Study||924
10655452|NCT02207816|11816111|FG002|COMPLETED|Overall Study||961
10655453|NCT02207816|11816109|FG000|NOT COMPLETED|Overall Study||51
10655454|NCT02207816|11816110|FG001|NOT COMPLETED|Overall Study||86
10655455|NCT02207816|11816111|FG002|NOT COMPLETED|Overall Study||67
10655456|NCT02207829|11816124|FG000|STARTED|Overall Study||509
10655457|NCT02207829|11816125|FG001|STARTED|Overall Study||508
10655458|NCT02207829|11816124|FG000|COMPLETED|Overall Study||467
10655459|NCT02207829|11816125|FG001|COMPLETED|Overall Study||474
10655460|NCT02207829|11816124|FG000|NOT COMPLETED|Overall Study||42
10655461|NCT02207829|11816125|FG001|NOT COMPLETED|Overall Study||34
10655462|NCT02207907|11816133|FG000|STARTED|Overall Study||124
10655463|NCT02207907|11816134|FG001|STARTED|Overall Study||123
10655464|NCT02207907|11816133|FG000|COMPLETED|Overall Study||113
10655465|NCT02207907|11816134|FG001|COMPLETED|Overall Study||115
10655466|NCT02207907|11816133|FG000|NOT COMPLETED|Overall Study||11
10655467|NCT02207907|11816134|FG001|NOT COMPLETED|Overall Study||8
10655468|NCT02207946|11816143|FG000|STARTED|Overall Study||19
10655469|NCT02207946|11816144|FG001|STARTED|Overall Study||11
10655470|NCT02207946|11816143|FG000|COMPLETED|Overall Study||18
10655471|NCT02207946|11816144|FG001|COMPLETED|Overall Study||10
10655472|NCT02207946|11816143|FG000|NOT COMPLETED|Overall Study||1
10655473|NCT02207946|11816144|FG001|NOT COMPLETED|Overall Study||1
10715656|NCT02688387|11880059|FG016|STARTED|Part 3A, Period 2 (up to 6 Days)||8
10715657|NCT02688387|11880060|FG017|STARTED|Part 3A, Period 2 (up to 6 Days)||8
10715658|NCT02688387|11880061|FG018|STARTED|Part 3A, Period 2 (up to 6 Days)||0
10715659|NCT02688387|11880062|FG019|STARTED|Part 3A, Period 2 (up to 6 Days)||0
10655474|NCT02207972|11816153|FG000|STARTED|Overall Study||22
10655475|NCT02207972|11816154|FG001|STARTED|Overall Study||24
10655476|NCT02207972|11816153|FG000|COMPLETED|Overall Study||22
10655477|NCT02207972|11816154|FG001|COMPLETED|Overall Study||24
10655478|NCT02207972|11816153|FG000|NOT COMPLETED|Overall Study||0
10655479|NCT02207972|11816154|FG001|NOT COMPLETED|Overall Study||0
10655480|NCT02208037|11816164|FG000|STARTED|Overall Study||93
10655481|NCT02208037|11816165|FG001|STARTED|Overall Study||93
10655482|NCT02208037|11816166|FG002|STARTED|Overall Study||93
10655483|NCT02208037|11816164|FG000|COMPLETED|Overall Study||89
10655484|NCT02208037|11816165|FG001|COMPLETED|Overall Study||92
10655485|NCT02208037|11816166|FG002|COMPLETED|Overall Study||92
10655486|NCT02208037|11816164|FG000|NOT COMPLETED|Overall Study||4
10655487|NCT02208037|11816165|FG001|NOT COMPLETED|Overall Study||1
10655488|NCT02208037|11816166|FG002|NOT COMPLETED|Overall Study||1
10655489|NCT02208050|11816176|FG000|STARTED|Baseline Assessment Period: 2 Weeks||36
10655490|NCT02208050|11816177|FG001|STARTED|Baseline Assessment Period: 2 Weeks||28
10715660|NCT02688387|11880063|FG020|STARTED|Part 3A, Period 2 (up to 6 Days)||0
10715661|NCT02688387|11880064|FG021|STARTED|Part 3A, Period 2 (up to 6 Days)||0
10715662|NCT02688387|11880043|FG000|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10344187|NCT00401752|11481800|FG001|COMPLETED|Overall Study||94
10655491|NCT02208050|11816176|FG000|COMPLETED|Baseline Assessment Period: 2 Weeks||36
10655492|NCT02208050|11816177|FG001|COMPLETED|Baseline Assessment Period: 2 Weeks||28
10655493|NCT02208050|11816176|FG000|NOT COMPLETED|Baseline Assessment Period: 2 Weeks||0
10655494|NCT02208050|11816177|FG001|NOT COMPLETED|Baseline Assessment Period: 2 Weeks||0
10655495|NCT02208050|11816176|FG000|STARTED|Treatment Period 1: 8 Weeks Treatment||36
10655496|NCT02208050|11816177|FG001|STARTED|Treatment Period 1: 8 Weeks Treatment||28
10655497|NCT02208050|11816176|FG000|COMPLETED|Treatment Period 1: 8 Weeks Treatment||36
10344188|NCT00401752|11481799|FG000|NOT COMPLETED|Overall Study||10
10344189|NCT00401752|11481800|FG001|NOT COMPLETED|Overall Study||18
10344190|NCT00401778|11481809|FG000|STARTED|Overall Study||10
10344191|NCT00401778|11481810|FG001|STARTED|Overall Study||12
10344192|NCT00401778|11481811|FG002|STARTED|Overall Study||11
10344193|NCT00401778|11481809|FG000|COMPLETED|Overall Study||9
10344194|NCT00401778|11481810|FG001|COMPLETED|Overall Study||11
10344195|NCT00401778|11481811|FG002|COMPLETED|Overall Study||10
10344196|NCT00401778|11481809|FG000|NOT COMPLETED|Overall Study||1
10344197|NCT00401778|11481810|FG001|NOT COMPLETED|Overall Study||1
10344198|NCT00401778|11481811|FG002|NOT COMPLETED|Overall Study||1
10344199|NCT00401817|11481819|FG000|STARTED|Overall Study||11
10344200|NCT00401817|11481819|FG000|COMPLETED|Overall Study||11
10344201|NCT00401817|11481819|FG000|NOT COMPLETED|Overall Study||0
10344202|NCT00401830|11481826|FG000|STARTED|Overall Study||81
10344203|NCT00401830|11481827|FG001|STARTED|Overall Study||78
10344204|NCT00401830|11481826|FG000|COMPLETED|Overall Study||50
10344205|NCT00401830|11481827|FG001|COMPLETED|Overall Study||46
10344206|NCT00401830|11481826|FG000|NOT COMPLETED|Overall Study||31
10344207|NCT00401830|11481827|FG001|NOT COMPLETED|Overall Study||32
10344208|NCT00401843|11481836|FG000|STARTED|Overall Study||21
10344209|NCT00401843|11481837|FG001|STARTED|Overall Study||144
10344210|NCT00401843|11481838|FG002|STARTED|Overall Study||142
10344211|NCT00401843|11481836|FG000|Treated|Overall Study||21
10344212|NCT00401843|11481837|FG001|Treated|Overall Study||142
10344213|NCT00401843|11481838|FG002|Treated|Overall Study||139
10344214|NCT00401843|11481836|FG000|COMPLETED|Overall Study||0
10344215|NCT00401843|11481837|FG001|COMPLETED|Overall Study||0
10344216|NCT00401843|11481838|FG002|COMPLETED|Overall Study||0
10344217|NCT00401843|11481836|FG000|NOT COMPLETED|Overall Study||21
10344218|NCT00401843|11481837|FG001|NOT COMPLETED|Overall Study||144
10344219|NCT00401843|11481838|FG002|NOT COMPLETED|Overall Study||142
10344220|NCT00401882|11481850|FG000|STARTED|Overall Study||2
10344221|NCT00401882|11481851|FG001|STARTED|Overall Study||5
10344222|NCT00401882|11481850|FG000|COMPLETED|Overall Study||2
10344223|NCT00401882|11481851|FG001|COMPLETED|Overall Study||5
10344224|NCT00401882|11481850|FG000|NOT COMPLETED|Overall Study||0
10344225|NCT00401882|11481851|FG001|NOT COMPLETED|Overall Study||0
10426513|NCT00847938|11572201|FG003|NOT COMPLETED|Overall Study||0
10426514|NCT00848016|11572211|FG000|STARTED|Overall Study||29
10426515|NCT00848016|11572211|FG000|COMPLETED|Overall Study||29
10426516|NCT00848016|11572211|FG000|NOT COMPLETED|Overall Study||0
10426517|NCT00848042|11572218|FG000|STARTED|Overall Study||5
10426518|NCT00848042|11572219|FG001|STARTED|Overall Study||5
10426519|NCT00848042|11572220|FG002|STARTED|Overall Study||1
10426520|NCT00848042|11572218|FG000|Day 1|Overall Study||5
10426521|NCT00848042|11572219|FG001|Day 1|Overall Study||5
10426522|NCT00848042|11572220|FG002|Day 1|Overall Study||1
10426523|NCT00848042|11572218|FG000|Day 2|Overall Study||5
10426524|NCT00848042|11572219|FG001|Day 2|Overall Study||5
10426525|NCT00848042|11572220|FG002|Day 2|Overall Study||1
10426526|NCT00848042|11572218|FG000|Day 3|Overall Study||5
10426527|NCT00848042|11572219|FG001|Day 3|Overall Study||5
10715663|NCT02688387|11880044|FG001|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10715664|NCT02688387|11880045|FG002|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10426528|NCT00848042|11572220|FG002|Day 3|Overall Study||1
10426529|NCT00848042|11572218|FG000|Day 8|Overall Study||5
10426530|NCT00848042|11572219|FG001|Day 8|Overall Study||5
10426531|NCT00848042|11572220|FG002|Day 8|Overall Study||1
10426532|NCT00848042|11572218|FG000|Day 15|Overall Study||4
10426533|NCT00848042|11572219|FG001|Day 15|Overall Study||5
10426534|NCT00848042|11572220|FG002|Day 15|Overall Study||1
10426535|NCT00848042|11572218|FG000|Month 1|Overall Study||4
10426536|NCT00848042|11572219|FG001|Month 1|Overall Study||5
10426537|NCT00848042|11572220|FG002|Month 1|Overall Study||1
10426538|NCT00848042|11572218|FG000|Month 2|Overall Study||1
10426539|NCT00848042|11572219|FG001|Month 2|Overall Study||5
10426540|NCT00848042|11572220|FG002|Month 2|Overall Study||1
10426541|NCT00848042|11572218|FG000|Month 3|Overall Study||1
10426542|NCT00848042|11572219|FG001|Month 3|Overall Study||4
10426543|NCT00848042|11572220|FG002|Month 3|Overall Study||1
10426544|NCT00848042|11572218|FG000|Month 4|Overall Study||1
10426545|NCT00848042|11572219|FG001|Month 4|Overall Study||4
10426546|NCT00848042|11572220|FG002|Month 4|Overall Study||1
10426547|NCT00848042|11572218|FG000|Month 5|Overall Study||1
10426548|NCT00848042|11572219|FG001|Month 5|Overall Study||3
10426549|NCT00848042|11572220|FG002|Month 5|Overall Study||1
10426550|NCT00848042|11572218|FG000|Month 6|Overall Study||1
10426551|NCT00848042|11572219|FG001|Month 6|Overall Study||3
10426552|NCT00848042|11572220|FG002|Month 6|Overall Study||1
10715665|NCT02688387|11880046|FG003|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10426553|NCT00848042|11572218|FG000|COMPLETED|Overall Study||1
10426554|NCT00848042|11572219|FG001|COMPLETED|Overall Study||3
10426555|NCT00848042|11572220|FG002|COMPLETED|Overall Study||1
10426556|NCT00848042|11572218|FG000|NOT COMPLETED|Overall Study||4
10426557|NCT00848042|11572219|FG001|NOT COMPLETED|Overall Study||2
10426558|NCT00848042|11572220|FG002|NOT COMPLETED|Overall Study||0
10426559|NCT00848081|11572230|FG000|STARTED|Overall Study||160
10426560|NCT00848081|11572231|FG001|STARTED|Overall Study||158
10426561|NCT00848081|11572230|FG000|COMPLETED|Overall Study||140
10426562|NCT00848081|11572231|FG001|COMPLETED|Overall Study||140
10426563|NCT00848081|11572230|FG000|NOT COMPLETED|Overall Study||20
10426564|NCT00848081|11572231|FG001|NOT COMPLETED|Overall Study||18
10426565|NCT00848107|11572237|FG000|STARTED|Overall Study||115
10344226|NCT00401960|11481865|FG000|STARTED|Overall Study||5
10344227|NCT00401960|11481866|FG001|STARTED|Overall Study||1
10344228|NCT00401960|11481865|FG000|COMPLETED|Overall Study||0
10344229|NCT00401960|11481866|FG001|COMPLETED|Overall Study||1
10344230|NCT00401960|11481865|FG000|NOT COMPLETED|Overall Study||5
10344231|NCT00401960|11481866|FG001|NOT COMPLETED|Overall Study||0
10344232|NCT00401973|11481877|FG000|STARTED|Overall Study||50
10344233|NCT00401973|11481878|FG001|STARTED|Overall Study||76
10344234|NCT00401973|11481879|FG002|STARTED|Overall Study||73
10344235|NCT00401973|11481877|FG000|COMPLETED|Overall Study||39
10344236|NCT00401973|11481878|FG001|COMPLETED|Overall Study||50
10344237|NCT00401973|11481879|FG002|COMPLETED|Overall Study||50
10344238|NCT00401973|11481877|FG000|NOT COMPLETED|Overall Study||11
10344239|NCT00401973|11481878|FG001|NOT COMPLETED|Overall Study||26
10344240|NCT00401973|11481879|FG002|NOT COMPLETED|Overall Study||23
10344241|NCT00401986|11481889|FG000|STARTED|Overall Study||14
10344242|NCT00401986|11481889|FG000|COMPLETED|Overall Study||12
10344243|NCT00401986|11481889|FG000|NOT COMPLETED|Overall Study||2
10344244|NCT00402025|11481901|FG000|STARTED|Overall Study||3
10344245|NCT00402025|11481902|FG001|STARTED|Overall Study||4
10344246|NCT00402025|11481903|FG002|STARTED|Overall Study||10
10344247|NCT00402025|11481901|FG000|COMPLETED|Overall Study||1
10344248|NCT00402025|11481902|FG001|COMPLETED|Overall Study||1
10344249|NCT00402025|11481903|FG002|COMPLETED|Overall Study||0
10344250|NCT00402025|11481901|FG000|NOT COMPLETED|Overall Study||2
10344251|NCT00402025|11481902|FG001|NOT COMPLETED|Overall Study||3
10344252|NCT00402025|11481903|FG002|NOT COMPLETED|Overall Study||10
10531826|NCT01414205|11684080|FG000|NOT COMPLETED|Overall Study||7
10531827|NCT01414205|11684081|FG001|NOT COMPLETED|Overall Study||7
10531828|NCT01414244|11684089|FG000|STARTED|Overall Study||54
10531829|NCT01414244|11684090|FG001|STARTED|Overall Study||52
10531830|NCT01414244|11684089|FG000|COMPLETED|Overall Study||54
10531831|NCT01414244|11684090|FG001|COMPLETED|Overall Study||52
10531832|NCT01414244|11684089|FG000|NOT COMPLETED|Overall Study||0
10531833|NCT01414244|11684090|FG001|NOT COMPLETED|Overall Study||0
10531834|NCT01414257|11684096|FG000|STARTED|Overall Study||2860
10531835|NCT01414257|11684096|FG000|COMPLETED|Overall Study||2838
10531836|NCT01414257|11684096|FG000|NOT COMPLETED|Overall Study||22
10531837|NCT01414413|11684102|FG000|STARTED|Overall Study|Adult population denominator for cluster randomised trial|8194
10531838|NCT01414413|11684103|FG001|STARTED|Overall Study|Adult population denominator for cluster randomised trial|8466
10531839|NCT01414413|11684102|FG000|COMPLETED|Overall Study|Adult population denominator for cluster randomised trial|8194
10531840|NCT01414413|11684103|FG001|COMPLETED|Overall Study|Adult population denominator for cluster randomised trial|8466
10531841|NCT01414413|11684102|FG000|NOT COMPLETED|Overall Study||0
10531842|NCT01414413|11684103|FG001|NOT COMPLETED|Overall Study||0
10531843|NCT01414426|11684111|FG000|STARTED|Overall Study||10
10531844|NCT01414426|11684112|FG001|STARTED|Overall Study||10
10531845|NCT01414426|11684111|FG000|COMPLETED|Overall Study||9
10531846|NCT01414426|11684112|FG001|COMPLETED|Overall Study||8
10531847|NCT01414426|11684111|FG000|NOT COMPLETED|Overall Study||1
10531848|NCT01414426|11684112|FG001|NOT COMPLETED|Overall Study||2
10531849|NCT01414634|11684118|FG000|STARTED|Overall Study||1
10531850|NCT01414634|11684119|FG001|STARTED|Overall Study||1
10531851|NCT01414634|11684120|FG002|STARTED|Overall Study||1
10531852|NCT01414634|11684121|FG003|STARTED|Overall Study||1
10531853|NCT01414634|11684122|FG004|STARTED|Overall Study||1
10531854|NCT01414634|11684123|FG005|STARTED|Overall Study||2
10531855|NCT01414634|11684124|FG006|STARTED|Overall Study||1
10531856|NCT01414634|11684125|FG007|STARTED|Overall Study||1
10531857|NCT01414634|11684118|FG000|COMPLETED|Overall Study||1
10531858|NCT01414634|11684119|FG001|COMPLETED|Overall Study||1
10531859|NCT01414634|11684120|FG002|COMPLETED|Overall Study||1
10531860|NCT01414634|11684121|FG003|COMPLETED|Overall Study||1
10531861|NCT01414634|11684122|FG004|COMPLETED|Overall Study||1
10531862|NCT01414634|11684123|FG005|COMPLETED|Overall Study||2
10531863|NCT01414634|11684124|FG006|COMPLETED|Overall Study||1
10531864|NCT01414634|11684125|FG007|COMPLETED|Overall Study||1
10531865|NCT01414634|11684118|FG000|NOT COMPLETED|Overall Study||0
10531866|NCT01414634|11684119|FG001|NOT COMPLETED|Overall Study||0
10531867|NCT01414634|11684120|FG002|NOT COMPLETED|Overall Study||0
10531868|NCT01414634|11684121|FG003|NOT COMPLETED|Overall Study||0
10531869|NCT01414634|11684122|FG004|NOT COMPLETED|Overall Study||0
10531870|NCT01414634|11684123|FG005|NOT COMPLETED|Overall Study||0
10531871|NCT01414634|11684124|FG006|NOT COMPLETED|Overall Study||0
10531872|NCT01414634|11684125|FG007|NOT COMPLETED|Overall Study||0
10531873|NCT01414738|11684136|FG000|STARTED|Overall Study||49
10531874|NCT01414738|11684136|FG000|Follow-up (3 Months)|Overall Study||18
10655498|NCT02208050|11816177|FG001|COMPLETED|Treatment Period 1: 8 Weeks Treatment||28
10344253|NCT00402051|11481913|FG000|STARTED|Overall Study||66
10344254|NCT00402051|11481914|FG001|STARTED|Overall Study||67
10344255|NCT00402051|11481913|FG000|Received Treatment|Overall Study||65
10344256|NCT00402051|11481914|FG001|Received Treatment|Overall Study||65
10531875|NCT01414738|11684136|FG000|Follow-up (6 Months)|Overall Study||8
10531876|NCT01414738|11684136|FG000|Follow-up (9 Months)|Overall Study||5
10531877|NCT01414738|11684136|FG000|COMPLETED|Overall Study||5
10531878|NCT01414738|11684136|FG000|NOT COMPLETED|Overall Study||44
10531879|NCT01414855|11684140|FG000|STARTED|Overall Study||100
10344257|NCT00402051|11481913|FG000|COMPLETED|Overall Study|Completed 6 treatment cycles and 30 days of follow-up after last dose of study drug|28
10426566|NCT00848107|11572237|FG000|COMPLETED|Overall Study||94
10531880|NCT01414855|11684140|FG000|COMPLETED|Overall Study||71
10344258|NCT00402051|11481914|FG001|COMPLETED|Overall Study|Completed 6 treatment cycles and 30 days of follow-up after last dose of study drug|32
10344259|NCT00402051|11481913|FG000|NOT COMPLETED|Overall Study||38
10344260|NCT00402051|11481914|FG001|NOT COMPLETED|Overall Study||35
10344261|NCT00402103|11481922|FG000|STARTED|Overall Study||470
10344262|NCT00402103|11481923|FG001|STARTED|Overall Study||86
10344263|NCT00402103|11481922|FG000|COMPLETED|Overall Study||379
10344264|NCT00402103|11481923|FG001|COMPLETED|Overall Study||73
10344265|NCT00402103|11481922|FG000|NOT COMPLETED|Overall Study||91
10344266|NCT00402103|11481923|FG001|NOT COMPLETED|Overall Study||13
10344267|NCT00402116|11481936|FG000|STARTED|Overall Study||6
10344268|NCT00402116|11481937|FG001|STARTED|Overall Study||6
10344269|NCT00402116|11481938|FG002|STARTED|Overall Study||60
10344270|NCT00402116|11481936|FG000|COMPLETED|Overall Study||3
10344271|NCT00402116|11481937|FG001|COMPLETED|Overall Study||0
10344272|NCT00402116|11481938|FG002|COMPLETED|Overall Study||5
10344273|NCT00402116|11481936|FG000|NOT COMPLETED|Overall Study||3
10344274|NCT00402116|11481937|FG001|NOT COMPLETED|Overall Study||6
10344275|NCT00402116|11481938|FG002|NOT COMPLETED|Overall Study||55
10344276|NCT00402168|11481968|FG000|STARTED|Randomized||84
10344277|NCT00402168|11481969|FG001|STARTED|Randomized||89
10344278|NCT00402168|11481968|FG000|COMPLETED|Randomized||83
10344279|NCT00402168|11481969|FG001|COMPLETED|Randomized||88
10344280|NCT00402168|11481968|FG000|NOT COMPLETED|Randomized||1
10344281|NCT00402168|11481969|FG001|NOT COMPLETED|Randomized||1
10344282|NCT00402168|11481968|FG000|STARTED|Treatment (up to 12 Months)||83
10344283|NCT00402168|11481969|FG001|STARTED|Treatment (up to 12 Months)||88
10344284|NCT00402168|11481968|FG000|COMPLETED|Treatment (up to 12 Months)||81
10344285|NCT00402168|11481969|FG001|COMPLETED|Treatment (up to 12 Months)||86
10344286|NCT00402168|11481968|FG000|NOT COMPLETED|Treatment (up to 12 Months)||2
10344287|NCT00402168|11481969|FG001|NOT COMPLETED|Treatment (up to 12 Months)||2
10344288|NCT00402168|11481968|FG000|STARTED|Long Term (LT)||81
10344289|NCT00402168|11481969|FG001|STARTED|Long Term (LT)|5 completed 12 months, did not enter long term: 1 AE, 1 lack of efficacy, 3 other(non-specified).|81
10344290|NCT00402168|11481968|FG000|COMPLETED|Long Term (LT)||70
10344291|NCT00402168|11481969|FG001|COMPLETED|Long Term (LT)||64
10344292|NCT00402168|11481968|FG000|NOT COMPLETED|Long Term (LT)||11
10344293|NCT00402168|11481969|FG001|NOT COMPLETED|Long Term (LT)||17
10344294|NCT00402168|11481968|FG000|STARTED|Switched From CNI to Belatacept in LT|Participants switched from CNI to Belatacept during LT period.|38
10344295|NCT00402168|11481969|FG001|STARTED|Switched From CNI to Belatacept in LT|Out of 81 starting LT period in CNI group, 38 switched from CNI to Belatacept during the LT period.|0
10344296|NCT00402168|11481968|FG000|COMPLETED|Switched From CNI to Belatacept in LT||32
10344297|NCT00402168|11481969|FG001|COMPLETED|Switched From CNI to Belatacept in LT||0
10344298|NCT00402168|11481968|FG000|NOT COMPLETED|Switched From CNI to Belatacept in LT||6
10344299|NCT00402168|11481969|FG001|NOT COMPLETED|Switched From CNI to Belatacept in LT||0
10344300|NCT00402194|11481985|FG000|STARTED|Overall Study||9
10344301|NCT00402194|11481986|FG001|STARTED|Overall Study||8
10344302|NCT00402194|11481985|FG000|COMPLETED|Overall Study||9
10344303|NCT00402194|11481986|FG001|COMPLETED|Overall Study||8
10344304|NCT00402194|11481985|FG000|NOT COMPLETED|Overall Study||0
10344305|NCT00402194|11481986|FG001|NOT COMPLETED|Overall Study||0
10344306|NCT00402233|11481996|FG000|STARTED|Overall Study||77
10344307|NCT00402233|11481997|FG001|STARTED|Overall Study||80
10344308|NCT00402233|11481998|FG002|STARTED|Overall Study||81
10344309|NCT00402233|11481999|FG003|STARTED|Overall Study||73
10344310|NCT00402233|11481996|FG000|COMPLETED|Overall Study||72
10344311|NCT00402233|11481997|FG001|COMPLETED|Overall Study||70
10344312|NCT00402233|11481998|FG002|COMPLETED|Overall Study||70
10344313|NCT00402233|11481999|FG003|COMPLETED|Overall Study||62
10344314|NCT00402233|11481996|FG000|NOT COMPLETED|Overall Study||5
10344315|NCT00402233|11481997|FG001|NOT COMPLETED|Overall Study||10
10344316|NCT00402233|11481998|FG002|NOT COMPLETED|Overall Study||11
10344317|NCT00402233|11481999|FG003|NOT COMPLETED|Overall Study||11
10344318|NCT00402246|11482011|FG000|STARTED|Overall Study||1014
10344319|NCT00402246|11482012|FG001|STARTED|Overall Study||983
10344320|NCT00402246|11482011|FG000|COMPLETED|Overall Study||794
10344321|NCT00402246|11482012|FG001|COMPLETED|Overall Study||749
10344322|NCT00402246|11482011|FG000|NOT COMPLETED|Overall Study||220
10344323|NCT00402246|11482012|FG001|NOT COMPLETED|Overall Study||234
10344324|NCT00402285|11482023|FG000|STARTED|Overall Study||29
10344325|NCT00402285|11482024|FG001|STARTED|Overall Study||27
10344326|NCT00402285|11482025|FG002|STARTED|Overall Study||28
10344327|NCT00402285|11482023|FG000|COMPLETED|Overall Study||22
10344328|NCT00402285|11482024|FG001|COMPLETED|Overall Study||21
10344329|NCT00402285|11482025|FG002|COMPLETED|Overall Study||26
10344330|NCT00402285|11482023|FG000|NOT COMPLETED|Overall Study||7
10344331|NCT00402285|11482024|FG001|NOT COMPLETED|Overall Study||6
10344332|NCT00402285|11482025|FG002|NOT COMPLETED|Overall Study||2
10812369|NCT03718143|11974409|FG002|NOT COMPLETED|Overall Study||1
10812370|NCT03709576|11974417|FG000|STARTED|Overall Study||3
10812371|NCT03709576|11974417|FG000|COMPLETED|Overall Study||2
10812372|NCT03709576|11974417|FG000|NOT COMPLETED|Overall Study||1
10812373|NCT03704636|11974422|FG000|STARTED|Overall Study||23
10812374|NCT03704636|11974422|FG000|COMPLETED|Overall Study||20
10344339|NCT00402324|11482042|FG000|STARTED|Overall Study||101
10344340|NCT00402324|11482043|FG001|STARTED|Overall Study||101
10344341|NCT00402324|11482042|FG000|COMPLETED|Overall Study||58
10344342|NCT00402324|11482043|FG001|COMPLETED|Overall Study||60
10344343|NCT00402324|11482042|FG000|NOT COMPLETED|Overall Study||43
10344344|NCT00402324|11482043|FG001|NOT COMPLETED|Overall Study||41
10344345|NCT00402337|11482054|FG000|STARTED|Overall Study||59
10344346|NCT00402337|11482055|FG001|STARTED|Overall Study||57
10344347|NCT00402337|11482056|FG002|STARTED|Overall Study||62
10344348|NCT00402337|11482057|FG003|STARTED|Overall Study||63
10344349|NCT00402337|11482058|FG004|STARTED|Overall Study||69
10344350|NCT00402337|11482054|FG000|COMPLETED|Overall Study||54
10344351|NCT00402337|11482055|FG001|COMPLETED|Overall Study||51
10344352|NCT00402337|11482056|FG002|COMPLETED|Overall Study||58
10344353|NCT00402337|11482057|FG003|COMPLETED|Overall Study||51
10344354|NCT00402337|11482058|FG004|COMPLETED|Overall Study||61
10344355|NCT00402337|11482054|FG000|NOT COMPLETED|Overall Study||5
10344356|NCT00402337|11482055|FG001|NOT COMPLETED|Overall Study||6
10344357|NCT00402337|11482056|FG002|NOT COMPLETED|Overall Study||4
10344358|NCT00402337|11482057|FG003|NOT COMPLETED|Overall Study||12
10344359|NCT00402337|11482058|FG004|NOT COMPLETED|Overall Study||8
10344360|NCT00402363|11482074|FG000|STARTED|Overall Study||266
10344361|NCT00402363|11482075|FG001|STARTED|Overall Study||276
10344362|NCT00402363|11482076|FG002|STARTED|Overall Study||66
10344363|NCT00402363|11482077|FG003|STARTED|Overall Study||55
10344364|NCT00402363|11482074|FG000|COMPLETED|Overall Study||233
10344365|NCT00402363|11482075|FG001|COMPLETED|Overall Study||246
10344366|NCT00402363|11482076|FG002|COMPLETED|Overall Study||60
10344367|NCT00402363|11482077|FG003|COMPLETED|Overall Study||45
10344368|NCT00402363|11482074|FG000|NOT COMPLETED|Overall Study||33
10344369|NCT00402363|11482075|FG001|NOT COMPLETED|Overall Study||30
10344370|NCT00402363|11482076|FG002|NOT COMPLETED|Overall Study||6
10344371|NCT00402363|11482077|FG003|NOT COMPLETED|Overall Study||10
10344372|NCT00402597|11482098|FG000|STARTED|Overall Study||1153
10344373|NCT00402597|11482099|FG001|STARTED|Overall Study||307
10344374|NCT00402597|11482100|FG002|STARTED|Overall Study||1046
10344375|NCT00402597|11482101|FG003|STARTED|Overall Study||353
10344376|NCT00402597|11482102|FG004|STARTED|Overall Study||603
10344377|NCT00402597|11482098|FG000|COMPLETED|Overall Study||962
10344378|NCT00402597|11482099|FG001|COMPLETED|Overall Study||261
10344379|NCT00402597|11482100|FG002|COMPLETED|Overall Study||834
10344380|NCT00402597|11482101|FG003|COMPLETED|Overall Study||279
10344381|NCT00402597|11482102|FG004|COMPLETED|Overall Study||479
10344382|NCT00402597|11482098|FG000|NOT COMPLETED|Overall Study||191
10344383|NCT00402597|11482099|FG001|NOT COMPLETED|Overall Study||46
10344384|NCT00402597|11482100|FG002|NOT COMPLETED|Overall Study||212
10344385|NCT00402597|11482101|FG003|NOT COMPLETED|Overall Study||74
10344386|NCT00402597|11482102|FG004|NOT COMPLETED|Overall Study||124
10344387|NCT00402649|11482114|FG000|STARTED|Overall Study||35
10344388|NCT00402649|11482114|FG000|COMPLETED|Overall Study||33
10344389|NCT00402649|11482114|FG000|NOT COMPLETED|Overall Study||2
10344390|NCT00402688|11482121|FG000|STARTED|Overall Study||81
10344391|NCT00402688|11482122|FG001|STARTED|Overall Study||81
10344392|NCT00402688|11482123|FG002|STARTED|Overall Study||80
10344393|NCT00402688|11482121|FG000|COMPLETED|Overall Study||60
10344394|NCT00402688|11482122|FG001|COMPLETED|Overall Study||65
10344395|NCT00402688|11482123|FG002|COMPLETED|Overall Study||65
10344396|NCT00402688|11482121|FG000|NOT COMPLETED|Overall Study||21
10344397|NCT00402688|11482122|FG001|NOT COMPLETED|Overall Study||16
10344398|NCT00402688|11482123|FG002|NOT COMPLETED|Overall Study||15
10344399|NCT00402714|11482133|FG000|STARTED|Overall Study||3
10344400|NCT00402714|11482134|FG001|STARTED|Overall Study||11
10344401|NCT00402714|11482133|FG000|COMPLETED|Overall Study||3
10344402|NCT00402714|11482134|FG001|COMPLETED|Overall Study||11
10344403|NCT00402714|11482133|FG000|NOT COMPLETED|Overall Study||0
10344404|NCT00402714|11482134|FG001|NOT COMPLETED|Overall Study||0
10344405|NCT00402727|11482144|FG000|STARTED|Overall Study||432
10344406|NCT00402727|11482145|FG001|STARTED|Overall Study||381
10344407|NCT00402727|11482144|FG000|Achieving End Of Treatment (EOT)|Overall Study||408
10344408|NCT00402727|11482145|FG001|Achieving End Of Treatment (EOT)|Overall Study||355
10344409|NCT00402727|11482144|FG000|Achieving Test Of Cure (TOC)|Overall Study||390
10344410|NCT00402727|11482145|FG001|Achieving Test Of Cure (TOC)|Overall Study||347
10344411|NCT00402727|11482144|FG000|COMPLETED|Overall Study||390
10344412|NCT00402727|11482145|FG001|COMPLETED|Overall Study||347
10344413|NCT00402727|11482144|FG000|NOT COMPLETED|Overall Study||42
10344414|NCT00402727|11482145|FG001|NOT COMPLETED|Overall Study||34
10344415|NCT00402740|11482151|FG000|STARTED|Overall Study||322
10344416|NCT00402740|11482151|FG000|COMPLETED|Overall Study||242
10344417|NCT00402740|11482151|FG000|NOT COMPLETED|Overall Study||80
10344418|NCT00402779|11482161|FG000|STARTED|Overall Study||152
10344419|NCT00402779|11482162|FG001|STARTED|Overall Study||151
10344420|NCT00402779|11482161|FG000|COMPLETED|Overall Study||75
10344421|NCT00402779|11482162|FG001|COMPLETED|Overall Study||75
10344422|NCT00402779|11482161|FG000|NOT COMPLETED|Overall Study||77
10344423|NCT00402779|11482162|FG001|NOT COMPLETED|Overall Study||76
10344424|NCT00402831|11482170|FG000|STARTED|Overall Study||202
10344425|NCT00402831|11482171|FG001|STARTED|Overall Study||203
10344426|NCT00402831|11482170|FG000|ProQuad® Dose 1 (Day 1)|Overall Study||202
10344427|NCT00402831|11482171|FG001|ProQuad® Dose 1 (Day 1)|Overall Study||203
10344428|NCT00402831|11482170|FG000|ProQuad® Dose 1 (Day 30)|Overall Study||202
10344429|NCT00402831|11482171|FG001|ProQuad® Dose 1 (Day 30)|Overall Study||203
10344430|NCT00402831|11482170|FG000|COMPLETED|Overall Study||201
10344431|NCT00402831|11482171|FG001|COMPLETED|Overall Study||200
10344432|NCT00402831|11482170|FG000|NOT COMPLETED|Overall Study||1
10344433|NCT00402831|11482171|FG001|NOT COMPLETED|Overall Study||3
10344434|NCT00402896|11482179|FG000|STARTED|Overall Study||20
10344435|NCT00402896|11482179|FG000|COMPLETED|Overall Study||20
10344436|NCT00402896|11482179|FG000|NOT COMPLETED|Overall Study||0
10344437|NCT00402987|11482187|FG000|STARTED|Overall Study||90
10344438|NCT00402987|11482188|FG001|STARTED|Overall Study||45
10344439|NCT00402987|11482189|FG002|STARTED|Overall Study||45
10344440|NCT00402987|11482190|FG003|STARTED|Overall Study||89
10344441|NCT00402987|11482187|FG000|COMPLETED|Overall Study||90
10344442|NCT00402987|11482188|FG001|COMPLETED|Overall Study||45
10344443|NCT00402987|11482189|FG002|COMPLETED|Overall Study||44
10344444|NCT00402987|11482190|FG003|COMPLETED|Overall Study||89
10344445|NCT00402987|11482187|FG000|NOT COMPLETED|Overall Study||0
10344446|NCT00402987|11482188|FG001|NOT COMPLETED|Overall Study||0
10344447|NCT00402987|11482189|FG002|NOT COMPLETED|Overall Study||1
10344448|NCT00402987|11482190|FG003|NOT COMPLETED|Overall Study||0
10344449|NCT00403117|11482214|FG000|STARTED|Overall Study||49
10344450|NCT00403117|11482214|FG000|COMPLETED|Overall Study||29
10344451|NCT00403117|11482214|FG000|NOT COMPLETED|Overall Study||20
10344452|NCT00403130|11482245|FG000|STARTED|2 Years From Start of Treatment||31
10344453|NCT00403130|11482245|FG000|COMPLETED|2 Years From Start of Treatment||26
10344454|NCT00403130|11482245|FG000|NOT COMPLETED|2 Years From Start of Treatment||5
10344455|NCT00403130|11482245|FG000|STARTED|Survival Follow-up up to 6 Years||26
10344456|NCT00403130|11482245|FG000|COMPLETED|Survival Follow-up up to 6 Years||16
10344457|NCT00403130|11482245|FG000|NOT COMPLETED|Survival Follow-up up to 6 Years||10
10344458|NCT00403234|11482253|FG000|STARTED|Overall Study||2
10344459|NCT00403234|11482254|FG001|STARTED|Overall Study||3
10344460|NCT00403234|11482255|FG002|STARTED|Overall Study||3
10344461|NCT00403234|11482256|FG003|STARTED|Overall Study||2
10344462|NCT00403234|11482253|FG000|COMPLETED|Overall Study||1
10344463|NCT00403234|11482254|FG001|COMPLETED|Overall Study||2
10344464|NCT00403234|11482255|FG002|COMPLETED|Overall Study||2
10344465|NCT00403234|11482256|FG003|COMPLETED|Overall Study||2
10344466|NCT00403234|11482253|FG000|NOT COMPLETED|Overall Study||1
10344467|NCT00403234|11482254|FG001|NOT COMPLETED|Overall Study||1
10344468|NCT00403234|11482255|FG002|NOT COMPLETED|Overall Study||1
10344469|NCT00403234|11482256|FG003|NOT COMPLETED|Overall Study||0
10344470|NCT00403260|11482268|FG000|STARTED|Overall Study|Patients randomized and treated.|848
10344471|NCT00403260|11482269|FG001|STARTED|Overall Study|Patients randomized and treated.|423
10344472|NCT00403260|11482268|FG000|COMPLETED|Overall Study||723
10344473|NCT00403260|11482269|FG001|COMPLETED|Overall Study||357
10344474|NCT00403260|11482268|FG000|NOT COMPLETED|Overall Study||125
10344475|NCT00403260|11482269|FG001|NOT COMPLETED|Overall Study||66
10344476|NCT00403273|11482277|FG000|STARTED|Overall Study||25
10344477|NCT00403273|11482278|FG001|STARTED|Overall Study||29
10344478|NCT00403273|11482277|FG000|COMPLETED|Overall Study||22
10344479|NCT00403273|11482278|FG001|COMPLETED|Overall Study||25
10344480|NCT00403273|11482277|FG000|NOT COMPLETED|Overall Study||3
10344481|NCT00403273|11482278|FG001|NOT COMPLETED|Overall Study||4
10344482|NCT00403390|11482288|FG000|STARTED|Overall Study||16
10344483|NCT00403390|11482289|FG001|STARTED|Overall Study||18
10344484|NCT00403390|11482288|FG000|COMPLETED|Overall Study||13
10344485|NCT00403390|11482289|FG001|COMPLETED|Overall Study||18
10344486|NCT00403390|11482288|FG000|NOT COMPLETED|Overall Study||3
10344487|NCT00403390|11482289|FG001|NOT COMPLETED|Overall Study||0
10344488|NCT00403403|11482297|FG000|STARTED|Overall Study||50
10344489|NCT00403403|11482298|FG001|STARTED|Overall Study||52
10344490|NCT00403403|11482297|FG000|Safety-Evaluable Patients|Overall Study||47
10344491|NCT00403403|11482298|FG001|Safety-Evaluable Patients|Overall Study||51
10344492|NCT00403403|11482297|FG000|COMPLETED|Overall Study||50
10344493|NCT00403403|11482298|FG001|COMPLETED|Overall Study||52
10344494|NCT00403403|11482297|FG000|NOT COMPLETED|Overall Study||0
10344495|NCT00403403|11482298|FG001|NOT COMPLETED|Overall Study||0
10344496|NCT00403455|11482304|FG000|STARTED|Overall Study||38
10344497|NCT00403455|11482304|FG000|COMPLETED|Overall Study||37
10344498|NCT00403455|11482304|FG000|NOT COMPLETED|Overall Study||1
10344499|NCT00403481|11482308|FG000|STARTED|Olmesartan Medoxomil (Olm) 20 mg||192
10344500|NCT00403481|11482308|FG000|COMPLETED|Olmesartan Medoxomil (Olm) 20 mg||186
10344501|NCT00403481|11482308|FG000|NOT COMPLETED|Olmesartan Medoxomil (Olm) 20 mg||6
10344502|NCT00403481|11482308|FG000|STARTED|Olm 40 mg|186 -4 met their blood pressure goal (remained on olmesartan 20 mg) = 182|182
10344503|NCT00403481|11482308|FG000|COMPLETED|Olm 40 mg||177
10344504|NCT00403481|11482308|FG000|NOT COMPLETED|Olm 40 mg||5
10344505|NCT00403481|11482308|FG000|STARTED|Olm 40 mg + Hydrochlorothiazide 12.5 mg|177 -4 met their blood pressure goal (remained on olmesartan 40 mg)= 173|173
10715666|NCT02688387|11880047|FG004|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10715667|NCT02688387|11880048|FG005|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10715668|NCT02688387|11880049|FG006|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10344506|NCT00403481|11482308|FG000|COMPLETED|Olm 40 mg + Hydrochlorothiazide 12.5 mg||168
10344507|NCT00403481|11482308|FG000|NOT COMPLETED|Olm 40 mg + Hydrochlorothiazide 12.5 mg||5
10344508|NCT00403481|11482308|FG000|STARTED|Olm 40 mg + Hydrochlorothiazide 25 mg|168 -24 met their blood pressure goal (remained on olmesartan 40 mg/hydrochlorothiazide 12.5mg)= 144|144
10344509|NCT00403481|11482308|FG000|COMPLETED|Olm 40 mg + Hydrochlorothiazide 25 mg||142
10344510|NCT00403481|11482308|FG000|NOT COMPLETED|Olm 40 mg + Hydrochlorothiazide 25 mg||2
10344511|NCT00403494|11482317|FG000|STARTED|Overall Study||96
10344512|NCT00403494|11482318|FG001|STARTED|Overall Study||94
10344513|NCT00403494|11482317|FG000|Intent to Treat|Overall Study||87
10344514|NCT00403494|11482318|FG001|Intent to Treat|Overall Study||83
10344515|NCT00403494|11482317|FG000|Per-protocol|Overall Study||69
10715669|NCT02688387|11880050|FG007|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10715670|NCT02688387|11880051|FG008|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10344516|NCT00403494|11482318|FG001|Per-protocol|Overall Study||69
10344517|NCT00403494|11482317|FG000|Safety Population|Overall Study||97
10344518|NCT00403494|11482318|FG001|Safety Population|Overall Study||91
10344519|NCT00403494|11482317|FG000|COMPLETED|Overall Study||81
10344520|NCT00403494|11482318|FG001|COMPLETED|Overall Study||80
10344521|NCT00403494|11482317|FG000|NOT COMPLETED|Overall Study||15
10344522|NCT00403494|11482318|FG001|NOT COMPLETED|Overall Study||14
10344523|NCT00403546|11482328|FG000|STARTED|Signed Informed Consent/Open-Label||131
10344524|NCT00403546|11482329|FG001|STARTED|Signed Informed Consent/Open-Label||0
10344525|NCT00403546|11482330|FG002|STARTED|Signed Informed Consent/Open-Label||0
10344526|NCT00403546|11482328|FG000|COMPLETED|Signed Informed Consent/Open-Label||103
10344527|NCT00403546|11482329|FG001|COMPLETED|Signed Informed Consent/Open-Label||0
10344528|NCT00403546|11482330|FG002|COMPLETED|Signed Informed Consent/Open-Label||0
10344529|NCT00403546|11482328|FG000|NOT COMPLETED|Signed Informed Consent/Open-Label||28
10344530|NCT00403546|11482329|FG001|NOT COMPLETED|Signed Informed Consent/Open-Label||0
10344531|NCT00403546|11482330|FG002|NOT COMPLETED|Signed Informed Consent/Open-Label||0
10344532|NCT00403546|11482328|FG000|STARTED|Screening Phase||103
10344533|NCT00403546|11482329|FG001|STARTED|Screening Phase||0
10344534|NCT00403546|11482330|FG002|STARTED|Screening Phase||0
10344535|NCT00403546|11482328|FG000|COMPLETED|Screening Phase|All participants who completed Screening were randomized to the High-Dose and Placebo arms.|75
10344536|NCT00403546|11482329|FG001|COMPLETED|Screening Phase||0
10344537|NCT00403546|11482330|FG002|COMPLETED|Screening Phase||0
10344538|NCT00403546|11482328|FG000|NOT COMPLETED|Screening Phase||28
10344539|NCT00403546|11482329|FG001|NOT COMPLETED|Screening Phase||0
10344540|NCT00403546|11482330|FG002|NOT COMPLETED|Screening Phase||0
10344541|NCT00403546|11482328|FG000|STARTED|Randomized Trial|All participants who completed Screening were randomized to the High-Dose and Placebo arms.|0
10344542|NCT00403546|11482329|FG001|STARTED|Randomized Trial||38
10344543|NCT00403546|11482330|FG002|STARTED|Randomized Trial||37
10344544|NCT00403546|11482328|FG000|COMPLETED|Randomized Trial||0
10344545|NCT00403546|11482329|FG001|COMPLETED|Randomized Trial||21
10344546|NCT00403546|11482330|FG002|COMPLETED|Randomized Trial||21
10344547|NCT00403546|11482328|FG000|NOT COMPLETED|Randomized Trial||0
10344548|NCT00403546|11482329|FG001|NOT COMPLETED|Randomized Trial||17
10344549|NCT00403546|11482330|FG002|NOT COMPLETED|Randomized Trial||16
10344550|NCT00403585|11482339|FG000|STARTED|Initial Treatment Phase||104
10344551|NCT00403585|11482339|FG000|COMPLETED|Initial Treatment Phase||102
10344552|NCT00403585|11482339|FG000|NOT COMPLETED|Initial Treatment Phase||2
10344553|NCT00403585|11482339|FG000|STARTED|Open-Label Phase; Extension Study|80 of 102 participants completing Study 103814 enrolled in extension (22 didn't continue medication)|80
10344554|NCT00403585|11482339|FG000|COMPLETED|Open-Label Phase; Extension Study||74
10344555|NCT00403585|11482339|FG000|NOT COMPLETED|Open-Label Phase; Extension Study||6
10344556|NCT00403754|11482343|FG000|STARTED|Core Treatment Period 1||11
10344557|NCT00403754|11482344|FG001|STARTED|Core Treatment Period 1||10
10344558|NCT00403754|11482345|FG002|STARTED|Core Treatment Period 1||9
10344559|NCT00403754|11482346|FG003|STARTED|Core Treatment Period 1||11
10344560|NCT00403754|11482343|FG000|COMPLETED|Core Treatment Period 1||11
10344561|NCT00403754|11482344|FG001|COMPLETED|Core Treatment Period 1||9
10344562|NCT00403754|11482345|FG002|COMPLETED|Core Treatment Period 1||9
10344563|NCT00403754|11482346|FG003|COMPLETED|Core Treatment Period 1||11
10344564|NCT00403754|11482343|FG000|NOT COMPLETED|Core Treatment Period 1||0
10531881|NCT01414855|11684140|FG000|NOT COMPLETED|Overall Study||29
10547900|NCT01515566|11701691|FG000|COMPLETED|Overall Study||10
10715671|NCT02688387|11880052|FG009|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10715672|NCT02688387|11880053|FG010|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10715673|NCT02688387|11880054|FG011|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10715674|NCT02688387|11880055|FG012|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10715675|NCT02688387|11880056|FG013|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10715676|NCT02688387|11880057|FG014|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
10715677|NCT02688387|11880058|FG015|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
10715678|NCT02688387|11880059|FG016|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
10715679|NCT02688387|11880060|FG017|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
10715680|NCT02688387|11880061|FG018|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10715681|NCT02688387|11880062|FG019|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10344565|NCT00403754|11482344|FG001|NOT COMPLETED|Core Treatment Period 1||1
10344566|NCT00403754|11482345|FG002|NOT COMPLETED|Core Treatment Period 1||0
10344567|NCT00403754|11482346|FG003|NOT COMPLETED|Core Treatment Period 1||0
10344568|NCT00403754|11482343|FG000|STARTED|Core Treatment Period 2||11
10344569|NCT00403754|11482344|FG001|STARTED|Core Treatment Period 2||9
10344570|NCT00403754|11482345|FG002|STARTED|Core Treatment Period 2||9
10344571|NCT00403754|11482346|FG003|STARTED|Core Treatment Period 2||11
10344572|NCT00403754|11482343|FG000|COMPLETED|Core Treatment Period 2||11
10547901|NCT01515566|11701692|FG001|COMPLETED|Overall Study||10
10344573|NCT00403754|11482344|FG001|COMPLETED|Core Treatment Period 2||9
10344574|NCT00403754|11482345|FG002|COMPLETED|Core Treatment Period 2||8
10344575|NCT00403754|11482346|FG003|COMPLETED|Core Treatment Period 2||11
10344576|NCT00403754|11482343|FG000|NOT COMPLETED|Core Treatment Period 2||0
10344577|NCT00403754|11482344|FG001|NOT COMPLETED|Core Treatment Period 2||0
10344578|NCT00403754|11482345|FG002|NOT COMPLETED|Core Treatment Period 2||1
10344579|NCT00403754|11482346|FG003|NOT COMPLETED|Core Treatment Period 2||0
10344580|NCT00403754|11482343|FG000|STARTED|Core Treatment Period 3||11
10344581|NCT00403754|11482344|FG001|STARTED|Core Treatment Period 3||9
10344582|NCT00403754|11482345|FG002|STARTED|Core Treatment Period 3||8
10344583|NCT00403754|11482346|FG003|STARTED|Core Treatment Period 3||11
10344584|NCT00403754|11482343|FG000|COMPLETED|Core Treatment Period 3||11
10344585|NCT00403754|11482344|FG001|COMPLETED|Core Treatment Period 3||9
10344586|NCT00403754|11482345|FG002|COMPLETED|Core Treatment Period 3||8
10344587|NCT00403754|11482346|FG003|COMPLETED|Core Treatment Period 3||11
10344588|NCT00403754|11482343|FG000|NOT COMPLETED|Core Treatment Period 3||0
10344589|NCT00403754|11482344|FG001|NOT COMPLETED|Core Treatment Period 3||0
10344590|NCT00403754|11482345|FG002|NOT COMPLETED|Core Treatment Period 3||0
10344591|NCT00403754|11482346|FG003|NOT COMPLETED|Core Treatment Period 3||0
10344592|NCT00403754|11482343|FG000|STARTED|Core Treatment Period 4||11
10344593|NCT00403754|11482344|FG001|STARTED|Core Treatment Period 4||9
10344594|NCT00403754|11482345|FG002|STARTED|Core Treatment Period 4||8
10344595|NCT00403754|11482346|FG003|STARTED|Core Treatment Period 4||11
10344596|NCT00403754|11482343|FG000|COMPLETED|Core Treatment Period 4||11
10344597|NCT00403754|11482344|FG001|COMPLETED|Core Treatment Period 4||9
10344598|NCT00403754|11482345|FG002|COMPLETED|Core Treatment Period 4||8
10344599|NCT00403754|11482346|FG003|COMPLETED|Core Treatment Period 4||11
10344600|NCT00403754|11482343|FG000|NOT COMPLETED|Core Treatment Period 4||0
10344601|NCT00403754|11482344|FG001|NOT COMPLETED|Core Treatment Period 4||0
10344602|NCT00403754|11482345|FG002|NOT COMPLETED|Core Treatment Period 4||0
10344603|NCT00403754|11482346|FG003|NOT COMPLETED|Core Treatment Period 4||0
10344604|NCT00403754|11482343|FG000|STARTED|Open Label: Salmeterol||11
10344605|NCT00403754|11482344|FG001|STARTED|Open Label: Salmeterol||9
10344606|NCT00403754|11482345|FG002|STARTED|Open Label: Salmeterol||8
10344607|NCT00403754|11482346|FG003|STARTED|Open Label: Salmeterol||11
10344608|NCT00403754|11482343|FG000|COMPLETED|Open Label: Salmeterol||11
10344609|NCT00403754|11482344|FG001|COMPLETED|Open Label: Salmeterol||9
10344610|NCT00403754|11482345|FG002|COMPLETED|Open Label: Salmeterol||8
10344611|NCT00403754|11482346|FG003|COMPLETED|Open Label: Salmeterol||11
10531882|NCT01415232|11684144|FG000|STARTED|Overall Study||160
10531883|NCT01415232|11684144|FG000|COMPLETED|Overall Study||160
10531884|NCT01415232|11684144|FG000|NOT COMPLETED|Overall Study||0
10531885|NCT01415349|11684148|FG000|STARTED|Treatment Period 1||21
10531886|NCT01415349|11684149|FG001|STARTED|Treatment Period 1||21
10531887|NCT01415349|11684148|FG000|COMPLETED|Treatment Period 1||21
10531888|NCT01415349|11684149|FG001|COMPLETED|Treatment Period 1||19
10531889|NCT01415349|11684148|FG000|NOT COMPLETED|Treatment Period 1||0
10531890|NCT01415349|11684149|FG001|NOT COMPLETED|Treatment Period 1||2
10531891|NCT01415349|11684148|FG000|STARTED|Treatment Period 2||21
10531892|NCT01415349|11684149|FG001|STARTED|Treatment Period 2||19
10531893|NCT01415349|11684148|FG000|COMPLETED|Treatment Period 2||21
10531894|NCT01415349|11684149|FG001|COMPLETED|Treatment Period 2||19
10531895|NCT01415349|11684148|FG000|NOT COMPLETED|Treatment Period 2||0
10531896|NCT01415349|11684149|FG001|NOT COMPLETED|Treatment Period 2||0
10531897|NCT01415401|11684155|FG000|STARTED|Overall Study||54
10531898|NCT01415401|11684155|FG000|COMPLETED|Overall Study||47
10531899|NCT01415401|11684155|FG000|NOT COMPLETED|Overall Study||7
10531900|NCT01415427|11684163|FG000|STARTED|Overall Study||29
10531901|NCT01415427|11684164|FG001|STARTED|Overall Study||29
10531902|NCT01415427|11684165|FG002|STARTED|Overall Study||59
10531903|NCT01415427|11684166|FG003|STARTED|Overall Study||56
10531904|NCT01415427|11684163|FG000|COMPLETED|Overall Study||0
10531905|NCT01415427|11684164|FG001|COMPLETED|Overall Study||0
10531906|NCT01415427|11684165|FG002|COMPLETED|Overall Study||1
10531907|NCT01415427|11684166|FG003|COMPLETED|Overall Study||0
10531908|NCT01415427|11684163|FG000|NOT COMPLETED|Overall Study||29
10531909|NCT01415427|11684164|FG001|NOT COMPLETED|Overall Study||29
10531910|NCT01415427|11684165|FG002|NOT COMPLETED|Overall Study||58
10531911|NCT01415427|11684166|FG003|NOT COMPLETED|Overall Study||56
10715682|NCT02688387|11880063|FG020|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10715683|NCT02688387|11880064|FG021|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10715684|NCT02688387|11880043|FG000|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10344612|NCT00403754|11482343|FG000|NOT COMPLETED|Open Label: Salmeterol||0
10344613|NCT00403754|11482344|FG001|NOT COMPLETED|Open Label: Salmeterol||0
10344614|NCT00403754|11482345|FG002|NOT COMPLETED|Open Label: Salmeterol||0
10344615|NCT00403754|11482346|FG003|NOT COMPLETED|Open Label: Salmeterol||0
10344616|NCT00403767|11482360|FG000|STARTED|Overall Study||7111
10344617|NCT00403767|11482361|FG001|STARTED|Overall Study||7125
10344618|NCT00403767|11482360|FG000|COMPLETED|Overall Study||4591
10344619|NCT00403767|11482361|FG001|COMPLETED|Overall Study||4657
10344620|NCT00403767|11482360|FG000|NOT COMPLETED|Overall Study||2520
10344621|NCT00403767|11482361|FG001|NOT COMPLETED|Overall Study||2468
10344622|NCT00403845|11482367|FG000|STARTED|Treatment Period 1||12
10344623|NCT00403845|11482368|FG001|STARTED|Treatment Period 1||13
10344624|NCT00403845|11482369|FG002|STARTED|Treatment Period 1||11
10344625|NCT00403845|11482370|FG003|STARTED|Treatment Period 1||14
10715685|NCT02688387|11880044|FG001|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10715686|NCT02688387|11880045|FG002|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10715687|NCT02688387|11880046|FG003|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10715688|NCT02688387|11880047|FG004|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10715689|NCT02688387|11880048|FG005|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10344626|NCT00403845|11482367|FG000|COMPLETED|Treatment Period 1||11
10344627|NCT00403845|11482368|FG001|COMPLETED|Treatment Period 1||13
10344628|NCT00403845|11482369|FG002|COMPLETED|Treatment Period 1||11
10344629|NCT00403845|11482370|FG003|COMPLETED|Treatment Period 1||13
10344630|NCT00403845|11482367|FG000|NOT COMPLETED|Treatment Period 1||1
10344631|NCT00403845|11482368|FG001|NOT COMPLETED|Treatment Period 1||0
10344632|NCT00403845|11482369|FG002|NOT COMPLETED|Treatment Period 1||0
10344633|NCT00403845|11482370|FG003|NOT COMPLETED|Treatment Period 1||1
10344634|NCT00403845|11482367|FG000|STARTED|Treatment Period 2||11
10344635|NCT00403845|11482368|FG001|STARTED|Treatment Period 2||13
10344636|NCT00403845|11482369|FG002|STARTED|Treatment Period 2||11
10344637|NCT00403845|11482370|FG003|STARTED|Treatment Period 2||13
10344638|NCT00403845|11482367|FG000|COMPLETED|Treatment Period 2||10
10344639|NCT00403845|11482368|FG001|COMPLETED|Treatment Period 2||13
10344640|NCT00403845|11482369|FG002|COMPLETED|Treatment Period 2||11
10344641|NCT00403845|11482370|FG003|COMPLETED|Treatment Period 2||13
10344642|NCT00403845|11482367|FG000|NOT COMPLETED|Treatment Period 2||1
10344643|NCT00403845|11482368|FG001|NOT COMPLETED|Treatment Period 2||0
10344644|NCT00403845|11482369|FG002|NOT COMPLETED|Treatment Period 2||0
10344645|NCT00403845|11482370|FG003|NOT COMPLETED|Treatment Period 2||0
10344646|NCT00403845|11482367|FG000|STARTED|Treatment Period 3||10
10344647|NCT00403845|11482368|FG001|STARTED|Treatment Period 3||13
10344648|NCT00403845|11482369|FG002|STARTED|Treatment Period 3||11
10344649|NCT00403845|11482370|FG003|STARTED|Treatment Period 3||13
10344650|NCT00403845|11482367|FG000|COMPLETED|Treatment Period 3||10
10344651|NCT00403845|11482368|FG001|COMPLETED|Treatment Period 3||13
10344652|NCT00403845|11482369|FG002|COMPLETED|Treatment Period 3||11
10344653|NCT00403845|11482370|FG003|COMPLETED|Treatment Period 3||11
10344654|NCT00403845|11482367|FG000|NOT COMPLETED|Treatment Period 3||0
10344655|NCT00403845|11482368|FG001|NOT COMPLETED|Treatment Period 3||0
10344656|NCT00403845|11482369|FG002|NOT COMPLETED|Treatment Period 3||0
10344657|NCT00403845|11482370|FG003|NOT COMPLETED|Treatment Period 3||2
10344658|NCT00403845|11482367|FG000|STARTED|Treatment Period 4||10
10344659|NCT00403845|11482368|FG001|STARTED|Treatment Period 4||13
10344660|NCT00403845|11482369|FG002|STARTED|Treatment Period 4||11
10344661|NCT00403845|11482370|FG003|STARTED|Treatment Period 4||11
10344662|NCT00403845|11482367|FG000|COMPLETED|Treatment Period 4||10
10344663|NCT00403845|11482368|FG001|COMPLETED|Treatment Period 4||13
10344664|NCT00403845|11482369|FG002|COMPLETED|Treatment Period 4||11
10344665|NCT00403845|11482370|FG003|COMPLETED|Treatment Period 4||11
10344666|NCT00403845|11482367|FG000|NOT COMPLETED|Treatment Period 4||0
10344667|NCT00403845|11482368|FG001|NOT COMPLETED|Treatment Period 4||0
10344668|NCT00403845|11482369|FG002|NOT COMPLETED|Treatment Period 4||0
10344669|NCT00403845|11482370|FG003|NOT COMPLETED|Treatment Period 4||0
10344746|NCT00404352|11482463|FG004|COMPLETED|Double Blind (up to 24 Month)||0
10344670|NCT00404066|11482380|FG000|STARTED|Overall Study|1 subject started but withdrew after adriamycin+cytoxan, but before study drugs lapatinib+docetaxel.|21
10344671|NCT00404066|11482380|FG000|COMPLETED|Overall Study||18
10344672|NCT00404066|11482380|FG000|NOT COMPLETED|Overall Study||3
10344673|NCT00404079|11482386|FG000|STARTED|Overall Study||125
10344674|NCT00404079|11482387|FG001|STARTED|Overall Study||125
10344675|NCT00404079|11482386|FG000|COMPLETED|Overall Study||103
10344676|NCT00404079|11482387|FG001|COMPLETED|Overall Study||105
10344677|NCT00404079|11482386|FG000|NOT COMPLETED|Overall Study||22
10531921|NCT01415453|11684190|FG000|STARTED|Overall Study||1
10531922|NCT01415453|11684190|FG000|Imaging Study|Overall Study||1
10531923|NCT01415453|11684190|FG000|COMPLETED|Overall Study||1
10531924|NCT01415453|11684190|FG000|NOT COMPLETED|Overall Study||0
10531925|NCT01415518|11684196|FG000|STARTED|Overall Study||292
10531926|NCT01415518|11684197|FG001|STARTED|Overall Study||292
10344678|NCT00404079|11482387|FG001|NOT COMPLETED|Overall Study||20
10344679|NCT00404092|11482397|FG000|STARTED|Overall Study||9
10344680|NCT00404092|11482398|FG001|STARTED|Overall Study||8
10344681|NCT00404092|11482399|FG002|STARTED|Overall Study||9
10344682|NCT00404092|11482400|FG003|STARTED|Overall Study||20
10344683|NCT00404092|11482397|FG000|COMPLETED|Overall Study||8
10344684|NCT00404092|11482398|FG001|COMPLETED|Overall Study||8
10344685|NCT00404092|11482399|FG002|COMPLETED|Overall Study||8
10344686|NCT00404092|11482400|FG003|COMPLETED|Overall Study||20
10344687|NCT00404092|11482397|FG000|NOT COMPLETED|Overall Study||1
10344688|NCT00404092|11482398|FG001|NOT COMPLETED|Overall Study||0
10344689|NCT00404092|11482399|FG002|NOT COMPLETED|Overall Study||1
10344690|NCT00404092|11482400|FG003|NOT COMPLETED|Overall Study||0
10344691|NCT00404235|11482412|FG000|STARTED|Overall Study||35
10344692|NCT00404235|11482413|FG001|STARTED|Overall Study||41
10344693|NCT00404235|11482412|FG000|COMPLETED|Overall Study||34
10344694|NCT00404235|11482413|FG001|COMPLETED|Overall Study||39
10812375|NCT03704636|11974422|FG000|NOT COMPLETED|Overall Study||3
10812376|NCT03703791|11974428|FG000|STARTED|Overall Study||0
10812377|NCT03703791|11974429|FG001|STARTED|Overall Study||1
10812378|NCT03703791|11974428|FG000|COMPLETED|Overall Study||0
10812379|NCT03703791|11974429|FG001|COMPLETED|Overall Study||0
10812380|NCT03703791|11974428|FG000|NOT COMPLETED|Overall Study||0
10812381|NCT03703791|11974429|FG001|NOT COMPLETED|Overall Study||1
10344695|NCT00404235|11482412|FG000|NOT COMPLETED|Overall Study||1
10344696|NCT00404235|11482413|FG001|NOT COMPLETED|Overall Study||2
10344697|NCT00404248|11482422|FG000|STARTED|Overall Study||3
10344698|NCT00404248|11482423|FG001|STARTED|Overall Study||4
10344699|NCT00404248|11482424|FG002|STARTED|Overall Study||5
10344700|NCT00404248|11482425|FG003|STARTED|Overall Study||2
10344701|NCT00404248|11482426|FG004|STARTED|Overall Study||3
10344702|NCT00404248|11482427|FG005|STARTED|Overall Study||3
10344703|NCT00404248|11482428|FG006|STARTED|Overall Study||6
10344704|NCT00404248|11482429|FG007|STARTED|Overall Study||6
10344705|NCT00404248|11482430|FG008|STARTED|Overall Study||3
10344706|NCT00404248|11482422|FG000|COMPLETED|Overall Study||3
10344707|NCT00404248|11482423|FG001|COMPLETED|Overall Study||3
10344708|NCT00404248|11482424|FG002|COMPLETED|Overall Study||5
10344709|NCT00404248|11482425|FG003|COMPLETED|Overall Study||2
10344710|NCT00404248|11482426|FG004|COMPLETED|Overall Study||3
10344711|NCT00404248|11482427|FG005|COMPLETED|Overall Study||3
10344712|NCT00404248|11482428|FG006|COMPLETED|Overall Study||6
10344713|NCT00404248|11482429|FG007|COMPLETED|Overall Study||6
10344714|NCT00404248|11482430|FG008|COMPLETED|Overall Study||3
10344715|NCT00404248|11482422|FG000|NOT COMPLETED|Overall Study||0
10344716|NCT00404248|11482423|FG001|NOT COMPLETED|Overall Study||1
10344717|NCT00404248|11482424|FG002|NOT COMPLETED|Overall Study||0
10344718|NCT00404248|11482425|FG003|NOT COMPLETED|Overall Study||0
10344719|NCT00404248|11482426|FG004|NOT COMPLETED|Overall Study||0
10344720|NCT00404248|11482427|FG005|NOT COMPLETED|Overall Study||0
10344721|NCT00404248|11482428|FG006|NOT COMPLETED|Overall Study||0
10344722|NCT00404248|11482429|FG007|NOT COMPLETED|Overall Study||0
10344723|NCT00404248|11482430|FG008|NOT COMPLETED|Overall Study||0
10344724|NCT00404352|11482459|FG000|STARTED|Double Blind (up to 24 Month)||171
10344725|NCT00404352|11482460|FG001|STARTED|Double Blind (up to 24 Month)||175
10344726|NCT00404352|11482461|FG002|STARTED|Double Blind (up to 24 Month)||171
10344727|NCT00404352|11482462|FG003|STARTED|Double Blind (up to 24 Month)||0
10344728|NCT00404352|11482463|FG004|STARTED|Double Blind (up to 24 Month)||0
10344729|NCT00404352|11482464|FG005|STARTED|Double Blind (up to 24 Month)||0
10344730|NCT00404352|11482465|FG006|STARTED|Double Blind (up to 24 Month)||0
10344731|NCT00404352|11482466|FG007|STARTED|Double Blind (up to 24 Month)||0
10344732|NCT00404352|11482467|FG008|STARTED|Double Blind (up to 24 Month)||0
10344733|NCT00404352|11482459|FG000|Treated|Double Blind (up to 24 Month)||171
10344734|NCT00404352|11482460|FG001|Treated|Double Blind (up to 24 Month)||173
10344735|NCT00404352|11482461|FG002|Treated|Double Blind (up to 24 Month)||171
10344736|NCT00404352|11482462|FG003|Treated|Double Blind (up to 24 Month)||0
10344737|NCT00404352|11482463|FG004|Treated|Double Blind (up to 24 Month)||0
10344738|NCT00404352|11482464|FG005|Treated|Double Blind (up to 24 Month)||0
10344739|NCT00404352|11482465|FG006|Treated|Double Blind (up to 24 Month)||0
10344740|NCT00404352|11482466|FG007|Treated|Double Blind (up to 24 Month)||0
10344741|NCT00404352|11482467|FG008|Treated|Double Blind (up to 24 Month)||0
10344742|NCT00404352|11482459|FG000|COMPLETED|Double Blind (up to 24 Month)||119
10344743|NCT00404352|11482460|FG001|COMPLETED|Double Blind (up to 24 Month)||128
10344744|NCT00404352|11482461|FG002|COMPLETED|Double Blind (up to 24 Month)||92
10344745|NCT00404352|11482462|FG003|COMPLETED|Double Blind (up to 24 Month)||0
10344747|NCT00404352|11482464|FG005|COMPLETED|Double Blind (up to 24 Month)||0
10344748|NCT00404352|11482465|FG006|COMPLETED|Double Blind (up to 24 Month)||0
10344749|NCT00404352|11482466|FG007|COMPLETED|Double Blind (up to 24 Month)||0
10344750|NCT00404352|11482467|FG008|COMPLETED|Double Blind (up to 24 Month)||0
10344751|NCT00404352|11482459|FG000|NOT COMPLETED|Double Blind (up to 24 Month)||52
10344752|NCT00404352|11482460|FG001|NOT COMPLETED|Double Blind (up to 24 Month)||47
10344753|NCT00404352|11482461|FG002|NOT COMPLETED|Double Blind (up to 24 Month)||79
10344754|NCT00404352|11482462|FG003|NOT COMPLETED|Double Blind (up to 24 Month)||0
10344755|NCT00404352|11482463|FG004|NOT COMPLETED|Double Blind (up to 24 Month)||0
10344756|NCT00404352|11482464|FG005|NOT COMPLETED|Double Blind (up to 24 Month)||0
10344757|NCT00404352|11482465|FG006|NOT COMPLETED|Double Blind (up to 24 Month)||0
10344758|NCT00404352|11482466|FG007|NOT COMPLETED|Double Blind (up to 24 Month)||0
10344759|NCT00404352|11482467|FG008|NOT COMPLETED|Double Blind (up to 24 Month)||0
10344760|NCT00404352|11482459|FG000|STARTED|Open Label (up to 24 Month)||0
10344761|NCT00404352|11482460|FG001|STARTED|Open Label (up to 24 Month)||0
10344762|NCT00404352|11482461|FG002|STARTED|Open Label (up to 24 Month)||0
10344763|NCT00404352|11482462|FG003|STARTED|Open Label (up to 24 Month)|From DB period, 31 participants converted to CDMS and switched to OL period in this study|31
10344764|NCT00404352|11482463|FG004|STARTED|Open Label (up to 24 Month)|From DB period, 30 participants converted to CDMS and switched to OL period in this study|30
10344765|NCT00404352|11482464|FG005|STARTED|Open Label (up to 24 Month)|From DB period, 59 participants converted to CDMS and switched to OL period in this study|59
10344766|NCT00404352|11482465|FG006|STARTED|Open Label (up to 24 Month)||0
10344767|NCT00404352|11482466|FG007|STARTED|Open Label (up to 24 Month)||0
10812382|NCT03701295|11974435|FG000|STARTED|Overall Study||1
10812383|NCT03701295|11974435|FG000|COMPLETED|Overall Study||1
10344768|NCT00404352|11482467|FG008|STARTED|Open Label (up to 24 Month)||0
10344769|NCT00404352|11482459|FG000|COMPLETED|Open Label (up to 24 Month)||0
10344770|NCT00404352|11482460|FG001|COMPLETED|Open Label (up to 24 Month)||0
10344771|NCT00404352|11482461|FG002|COMPLETED|Open Label (up to 24 Month)||0
10344772|NCT00404352|11482462|FG003|COMPLETED|Open Label (up to 24 Month)||28
10344773|NCT00404352|11482463|FG004|COMPLETED|Open Label (up to 24 Month)||28
10344774|NCT00404352|11482464|FG005|COMPLETED|Open Label (up to 24 Month)||52
10344775|NCT00404352|11482465|FG006|COMPLETED|Open Label (up to 24 Month)||0
10344776|NCT00404352|11482466|FG007|COMPLETED|Open Label (up to 24 Month)||0
10344777|NCT00404352|11482467|FG008|COMPLETED|Open Label (up to 24 Month)||0
10344778|NCT00404352|11482459|FG000|NOT COMPLETED|Open Label (up to 24 Month)||0
10344779|NCT00404352|11482460|FG001|NOT COMPLETED|Open Label (up to 24 Month)||0
10344780|NCT00404352|11482461|FG002|NOT COMPLETED|Open Label (up to 24 Month)||0
10344781|NCT00404352|11482462|FG003|NOT COMPLETED|Open Label (up to 24 Month)||3
10344782|NCT00404352|11482463|FG004|NOT COMPLETED|Open Label (up to 24 Month)||2
10344783|NCT00404352|11482464|FG005|NOT COMPLETED|Open Label (up to 24 Month)||7
10344784|NCT00404352|11482465|FG006|NOT COMPLETED|Open Label (up to 24 Month)||0
10344785|NCT00404352|11482466|FG007|NOT COMPLETED|Open Label (up to 24 Month)||0
10344786|NCT00404352|11482467|FG008|NOT COMPLETED|Open Label (up to 24 Month)||0
10344787|NCT00404352|11482459|FG000|STARTED|Open Label Extension (up to 36 Months)||0
10344788|NCT00404352|11482460|FG001|STARTED|Open Label Extension (up to 36 Months)||0
10344789|NCT00404352|11482461|FG002|STARTED|Open Label Extension (up to 36 Months)||0
10344790|NCT00404352|11482462|FG003|STARTED|Open Label Extension (up to 36 Months)||0
10344791|NCT00404352|11482463|FG004|STARTED|Open Label Extension (up to 36 Months)||0
10344792|NCT00404352|11482464|FG005|STARTED|Open Label Extension (up to 36 Months)||0
10344793|NCT00404352|11482465|FG006|STARTED|Open Label Extension (up to 36 Months)|4 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|4
10344794|NCT00404352|11482466|FG007|STARTED|Open Label Extension (up to 36 Months)|5 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|5
10344795|NCT00404352|11482467|FG008|STARTED|Open Label Extension (up to 36 Months)|11 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|11
10344796|NCT00404352|11482459|FG000|COMPLETED|Open Label Extension (up to 36 Months)||0
10344797|NCT00404352|11482460|FG001|COMPLETED|Open Label Extension (up to 36 Months)||0
10426567|NCT00848107|11572237|FG000|NOT COMPLETED|Overall Study||21
10531927|NCT01415518|11684196|FG000|Patients Who Received Study Treatment|Overall Study||290
10531928|NCT01415518|11684197|FG001|Patients Who Received Study Treatment|Overall Study||292
10531929|NCT01415518|11684196|FG000|Pts With Correct Randomized Treatment|Overall Study|Efficacy analysis used 290 patients. Safety analysis used 290+3=293 patients.|290
10531930|NCT01415518|11684197|FG001|Pts With Correct Randomized Treatment|Overall Study|Efficacy analysis used 292 patients. Safety analysis used 292-3=289 patients.|289
10531931|NCT01415518|11684196|FG000|COMPLETED|Overall Study||276
10531932|NCT01415518|11684197|FG001|COMPLETED|Overall Study||261
10531933|NCT01415518|11684196|FG000|NOT COMPLETED|Overall Study||16
10531934|NCT01415518|11684197|FG001|NOT COMPLETED|Overall Study||31
10531935|NCT01415531|11684205|FG000|STARTED|Overall Study||214
10531936|NCT01415531|11684206|FG001|STARTED|Overall Study||427
10531937|NCT01415531|11684205|FG000|COMPLETED|Overall Study||189
10655499|NCT02208050|11816176|FG000|NOT COMPLETED|Treatment Period 1: 8 Weeks Treatment||0
10655500|NCT02208050|11816177|FG001|NOT COMPLETED|Treatment Period 1: 8 Weeks Treatment||0
10655501|NCT02208050|11816176|FG000|STARTED|Washout Period 1: 2 Weeks||36
10655502|NCT02208050|11816177|FG001|STARTED|Washout Period 1: 2 Weeks||28
10655503|NCT02208050|11816176|FG000|COMPLETED|Washout Period 1: 2 Weeks||35
10655504|NCT02208050|11816177|FG001|COMPLETED|Washout Period 1: 2 Weeks||28
10655505|NCT02208050|11816176|FG000|NOT COMPLETED|Washout Period 1: 2 Weeks||1
10655506|NCT02208050|11816177|FG001|NOT COMPLETED|Washout Period 1: 2 Weeks||0
10655507|NCT02208050|11816176|FG000|STARTED|Treatment Period 2: 8 Weeks Treatment||35
10655508|NCT02208050|11816177|FG001|STARTED|Treatment Period 2: 8 Weeks Treatment||28
10655509|NCT02208050|11816176|FG000|COMPLETED|Treatment Period 2: 8 Weeks Treatment||33
10655510|NCT02208050|11816177|FG001|COMPLETED|Treatment Period 2: 8 Weeks Treatment||28
10655511|NCT02208050|11816176|FG000|NOT COMPLETED|Treatment Period 2: 8 Weeks Treatment||2
10655512|NCT02208050|11816177|FG001|NOT COMPLETED|Treatment Period 2: 8 Weeks Treatment||0
10655513|NCT02208050|11816176|FG000|STARTED|Washout Period 2: 2 Weeks Washout.||33
10655514|NCT02208050|11816177|FG001|STARTED|Washout Period 2: 2 Weeks Washout.||28
10655515|NCT02208050|11816176|FG000|COMPLETED|Washout Period 2: 2 Weeks Washout.||33
10655516|NCT02208050|11816177|FG001|COMPLETED|Washout Period 2: 2 Weeks Washout.||28
10655517|NCT02208050|11816176|FG000|NOT COMPLETED|Washout Period 2: 2 Weeks Washout.||0
10655518|NCT02208050|11816177|FG001|NOT COMPLETED|Washout Period 2: 2 Weeks Washout.||0
10655519|NCT02208063|11816199|FG000|STARTED|Overall Study||60
10655520|NCT02208063|11816200|FG001|STARTED|Overall Study||61
10655521|NCT02208063|11816199|FG000|Randomized and Treated|Overall Study||58
10655522|NCT02208063|11816200|FG001|Randomized and Treated|Overall Study||60
10655523|NCT02208063|11816199|FG000|Microbiological All Treated|Overall Study||47
10655524|NCT02208063|11816200|FG001|Microbiological All Treated|Overall Study||52
10655525|NCT02208063|11816199|FG000|COMPLETED|Overall Study||48
10655526|NCT02208063|11816200|FG001|COMPLETED|Overall Study||50
10655527|NCT02208063|11816199|FG000|NOT COMPLETED|Overall Study||12
10655528|NCT02208063|11816200|FG001|NOT COMPLETED|Overall Study||11
10655529|NCT02208089|11816208|FG000|STARTED|Overall Study||47
10655530|NCT02208089|11816209|FG001|STARTED|Overall Study||47
10655531|NCT02208089|11816208|FG000|COMPLETED|Overall Study||40
10344798|NCT00404352|11482461|FG002|COMPLETED|Open Label Extension (up to 36 Months)||0
10344799|NCT00404352|11482462|FG003|COMPLETED|Open Label Extension (up to 36 Months)||0
10344800|NCT00404352|11482463|FG004|COMPLETED|Open Label Extension (up to 36 Months)||0
10344801|NCT00404352|11482464|FG005|COMPLETED|Open Label Extension (up to 36 Months)||0
10344802|NCT00404352|11482465|FG006|COMPLETED|Open Label Extension (up to 36 Months)||3
10344803|NCT00404352|11482466|FG007|COMPLETED|Open Label Extension (up to 36 Months)||4
10344804|NCT00404352|11482467|FG008|COMPLETED|Open Label Extension (up to 36 Months)||9
10344805|NCT00404352|11482459|FG000|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
10344806|NCT00404352|11482460|FG001|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
10344807|NCT00404352|11482461|FG002|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
10344808|NCT00404352|11482462|FG003|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
10344809|NCT00404352|11482463|FG004|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
10344810|NCT00404352|11482464|FG005|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
10344811|NCT00404352|11482465|FG006|NOT COMPLETED|Open Label Extension (up to 36 Months)||1
10344812|NCT00404352|11482466|FG007|NOT COMPLETED|Open Label Extension (up to 36 Months)||1
10344813|NCT00404352|11482467|FG008|NOT COMPLETED|Open Label Extension (up to 36 Months)||2
10344814|NCT00404495|11482486|FG000|STARTED|Overall Study||66
10344815|NCT00404495|11482487|FG001|STARTED|Overall Study||17
10531938|NCT01415531|11684206|FG001|COMPLETED|Overall Study||390
10531939|NCT01415531|11684205|FG000|NOT COMPLETED|Overall Study||25
10531940|NCT01415531|11684206|FG001|NOT COMPLETED|Overall Study||37
10531941|NCT01415583|11684214|FG000|STARTED|Overall Study||157
10531942|NCT01415583|11684215|FG001|STARTED|Overall Study||157
10531943|NCT01415583|11684214|FG000|COMPLETED|Overall Study||157
10531944|NCT01415583|11684215|FG001|COMPLETED|Overall Study||157
10531945|NCT01415583|11684214|FG000|NOT COMPLETED|Overall Study||0
10531946|NCT01415583|11684215|FG001|NOT COMPLETED|Overall Study||0
10531947|NCT01415908|11684223|FG000|STARTED|Overall Study||11
10531948|NCT01415908|11684224|FG001|STARTED|Overall Study||4
10531949|NCT01415908|11684223|FG000|COMPLETED|Overall Study||10
10531950|NCT01415908|11684224|FG001|COMPLETED|Overall Study||4
10531951|NCT01415908|11684223|FG000|NOT COMPLETED|Overall Study||1
10531952|NCT01415908|11684224|FG001|NOT COMPLETED|Overall Study||0
10531953|NCT01415921|11684232|FG000|STARTED|Overall Study||16
10531954|NCT01415921|11684233|FG001|STARTED|Overall Study||17
10531955|NCT01415921|11684232|FG000|COMPLETED|Overall Study||13
10531956|NCT01415921|11684233|FG001|COMPLETED|Overall Study||14
10531957|NCT01415921|11684232|FG000|NOT COMPLETED|Overall Study||3
10531958|NCT01415921|11684233|FG001|NOT COMPLETED|Overall Study||3
10531959|NCT01415934|11684241|FG000|STARTED|Overall Study||192
10531960|NCT01415934|11684242|FG001|STARTED|Overall Study||189
10531961|NCT01415934|11684241|FG000|COMPLETED|Overall Study||189
10531962|NCT01415934|11684242|FG001|COMPLETED|Overall Study||182
10531963|NCT01415934|11684241|FG000|NOT COMPLETED|Overall Study||3
10531964|NCT01415934|11684242|FG001|NOT COMPLETED|Overall Study||7
10531965|NCT01415960|11684248|FG000|STARTED|Overall Study||163
10531966|NCT01415960|11684248|FG000|ITT|Overall Study||161
10531967|NCT01415960|11684248|FG000|PK Subgroup|Overall Study||30
10531968|NCT01415960|11684248|FG000|COMPLETED|Overall Study|Patients completed Study (151) Per protocol Patients (146)|151
10531969|NCT01415960|11684248|FG000|NOT COMPLETED|Overall Study||12
10531970|NCT01416025|11684254|FG000|STARTED|Overall Study||14
10531971|NCT01416025|11684255|FG001|STARTED|Overall Study||15
10531972|NCT01416025|11684254|FG000|COMPLETED|Overall Study||14
10531973|NCT01416025|11684255|FG001|COMPLETED|Overall Study||15
10531974|NCT01416025|11684254|FG000|NOT COMPLETED|Overall Study||0
10531975|NCT01416025|11684255|FG001|NOT COMPLETED|Overall Study||0
10531976|NCT01416129|11684263|FG000|STARTED|Control Condition: Ischial Containment||5
10531977|NCT01416129|11684264|FG001|STARTED|Control Condition: Ischial Containment||5
10531978|NCT01416129|11684263|FG000|COMPLETED|Control Condition: Ischial Containment||5
10531979|NCT01416129|11684264|FG001|COMPLETED|Control Condition: Ischial Containment||5
10531980|NCT01416129|11684263|FG000|NOT COMPLETED|Control Condition: Ischial Containment||0
10531981|NCT01416129|11684264|FG001|NOT COMPLETED|Control Condition: Ischial Containment||0
10531982|NCT01416129|11684263|FG000|STARTED|Experimental Condition: Brimless||5
10531983|NCT01416129|11684264|FG001|STARTED|Experimental Condition: Brimless||5
10531984|NCT01416129|11684263|FG000|COMPLETED|Experimental Condition: Brimless||5
10531985|NCT01416129|11684264|FG001|COMPLETED|Experimental Condition: Brimless||5
10531986|NCT01416129|11684263|FG000|NOT COMPLETED|Experimental Condition: Brimless||0
10531987|NCT01416129|11684264|FG001|NOT COMPLETED|Experimental Condition: Brimless||0
10531988|NCT01416142|11684270|FG000|STARTED|Cross Over at Movie Intermission||32
10531989|NCT01416142|11684271|FG001|STARTED|Cross Over at Movie Intermission||31
10531990|NCT01416142|11684272|FG002|STARTED|Cross Over at Movie Intermission||0
10531991|NCT01416142|11684270|FG000|COMPLETED|Cross Over at Movie Intermission||32
10531992|NCT01416142|11684271|FG001|COMPLETED|Cross Over at Movie Intermission||31
10531993|NCT01416142|11684272|FG002|COMPLETED|Cross Over at Movie Intermission||0
10531994|NCT01416142|11684270|FG000|NOT COMPLETED|Cross Over at Movie Intermission||0
10531995|NCT01416142|11684271|FG001|NOT COMPLETED|Cross Over at Movie Intermission||0
10531996|NCT01416142|11684272|FG002|NOT COMPLETED|Cross Over at Movie Intermission||0
10531997|NCT01416142|11684270|FG000|STARTED|PureVision2 HD||0
10531998|NCT01416142|11684271|FG001|STARTED|PureVision2 HD||0
10531999|NCT01416142|11684272|FG002|STARTED|PureVision2 HD||63
10532000|NCT01416142|11684270|FG000|COMPLETED|PureVision2 HD||0
10532001|NCT01416142|11684271|FG001|COMPLETED|PureVision2 HD||0
10532002|NCT01416142|11684272|FG002|COMPLETED|PureVision2 HD||62
10344816|NCT00404495|11482486|FG000|COMPLETED|Overall Study||22
10715690|NCT02688387|11880049|FG006|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10715691|NCT02688387|11880050|FG007|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10715692|NCT02688387|11880051|FG008|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10344817|NCT00404495|11482487|FG001|COMPLETED|Overall Study||6
10344818|NCT00404495|11482486|FG000|NOT COMPLETED|Overall Study||44
10344819|NCT00404495|11482487|FG001|NOT COMPLETED|Overall Study||11
10344820|NCT00404547|11482495|FG000|STARTED|Overall Study||762
10344821|NCT00404547|11482496|FG001|STARTED|Overall Study||359
10344822|NCT00404547|11482495|FG000|COMPLETED|Overall Study||672
10715693|NCT02688387|11880052|FG009|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10715694|NCT02688387|11880053|FG010|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10715695|NCT02688387|11880054|FG011|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10344823|NCT00404547|11482496|FG001|COMPLETED|Overall Study||334
10344824|NCT00404547|11482495|FG000|NOT COMPLETED|Overall Study||90
10344825|NCT00404547|11482496|FG001|NOT COMPLETED|Overall Study||25
10344826|NCT00404651|11482506|FG000|STARTED|Overall Study||340
10344827|NCT00404651|11482507|FG001|STARTED|Overall Study||343
10344828|NCT00404651|11482508|FG002|STARTED|Overall Study||339
10344829|NCT00404651|11482509|FG003|STARTED|Overall Study||167
10344830|NCT00404651|11482506|FG000|COMPLETED|Overall Study||301
10344831|NCT00404651|11482507|FG001|COMPLETED|Overall Study||315
10344832|NCT00404651|11482508|FG002|COMPLETED|Overall Study||294
10344833|NCT00404651|11482509|FG003|COMPLETED|Overall Study||146
10344834|NCT00404651|11482506|FG000|NOT COMPLETED|Overall Study||39
10344835|NCT00404651|11482507|FG001|NOT COMPLETED|Overall Study||28
10344836|NCT00404651|11482508|FG002|NOT COMPLETED|Overall Study||45
10344837|NCT00404651|11482509|FG003|NOT COMPLETED|Overall Study||21
10344838|NCT00404755|11482519|FG000|STARTED|Phase I (Bupropion)|3 went directly into Phase II (intolerant of bupropion), 1 withdrew consent and 4 did not return|17
10344839|NCT00404755|11482519|FG000|COMPLETED|Phase I (Bupropion)||13
10344840|NCT00404755|11482519|FG000|NOT COMPLETED|Phase I (Bupropion)||4
10344841|NCT00404755|11482519|FG000|STARTED|Phase II (Escitalopram)||11
10344842|NCT00404755|11482519|FG000|COMPLETED|Phase II (Escitalopram)||9
10532003|NCT01416142|11684270|FG000|NOT COMPLETED|PureVision2 HD||0
10532004|NCT01416142|11684271|FG001|NOT COMPLETED|PureVision2 HD||0
10532005|NCT01416142|11684272|FG002|NOT COMPLETED|PureVision2 HD||1
10532006|NCT01416155|11684280|FG000|STARTED|Overall Study||97
10532007|NCT01416155|11684280|FG000|COMPLETED|Overall Study||39
10532008|NCT01416155|11684280|FG000|NOT COMPLETED|Overall Study||58
10532009|NCT01416181|11684286|FG000|STARTED|Part 1||449
10532010|NCT01416181|11684287|FG001|STARTED|Part 1||440
10532011|NCT01416181|11684286|FG000|Withdrew Prior to Dosing|Part 1||0
10532012|NCT01416181|11684287|FG001|Withdrew Prior to Dosing|Part 1||1
10532013|NCT01416181|11684286|FG000|COMPLETED|Part 1|Completed Study through Week 108|312
10532014|NCT01416181|11684287|FG001|COMPLETED|Part 1|Completed Study through Week 108|326
10532015|NCT01416181|11684286|FG000|NOT COMPLETED|Part 1||137
10532016|NCT01416181|11684287|FG001|NOT COMPLETED|Part 1||114
10532017|NCT01416181|11684286|FG000|STARTED|Part 2||274
10532018|NCT01416181|11684287|FG001|STARTED|Part 2||292
10532019|NCT01416181|11684286|FG000|Completed Treatment for 48 Weeks|Part 2|completed study treatment for 48 weeks in Part 2|98
10532020|NCT01416181|11684287|FG001|Completed Treatment for 48 Weeks|Part 2|completed study treatment for 48 weeks in Part 2|111
10532021|NCT01416181|11684286|FG000|Completed Treatment for 96 Weeks|Part 2|completed study treatment for 96 weeks in Part 2|1
10532022|NCT01416181|11684287|FG001|Completed Treatment for 96 Weeks|Part 2|completed study treatment for 96 weeks in Part 2|0
10532023|NCT01416181|11684286|FG000|Completed Treatment for > 96 Weeks|Part 2||1
10532024|NCT01416181|11684287|FG001|Completed Treatment for > 96 Weeks|Part 2||0
10532025|NCT01416181|11684286|FG000|COMPLETED|Part 2||3
10532026|NCT01416181|11684287|FG001|COMPLETED|Part 2||6
10532027|NCT01416181|11684286|FG000|NOT COMPLETED|Part 2||271
10532028|NCT01416181|11684287|FG001|NOT COMPLETED|Part 2||286
10532029|NCT01416194|11684296|FG000|STARTED|Overall Study||1111
10715696|NCT02688387|11880055|FG012|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10715697|NCT02688387|11880056|FG013|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10715698|NCT02688387|11880057|FG014|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10715699|NCT02688387|11880058|FG015|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10715700|NCT02688387|11880059|FG016|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10715701|NCT02688387|11880060|FG017|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10344843|NCT00404755|11482519|FG000|NOT COMPLETED|Phase II (Escitalopram)||2
10344844|NCT00404755|11482519|FG000|STARTED|Phase III (Imipramine)||3
10344845|NCT00404755|11482519|FG000|COMPLETED|Phase III (Imipramine)||3
10532030|NCT01416194|11684297|FG001|STARTED|Overall Study||2720
10532031|NCT01416194|11684298|FG002|STARTED|Overall Study||6666
10532032|NCT01416194|11684296|FG000|COMPLETED|Overall Study||1111
10532033|NCT01416194|11684297|FG001|COMPLETED|Overall Study||2720
10532034|NCT01416194|11684298|FG002|COMPLETED|Overall Study||6666
10532035|NCT01416194|11684296|FG000|NOT COMPLETED|Overall Study||0
10532036|NCT01416194|11684297|FG001|NOT COMPLETED|Overall Study||0
10532037|NCT01416194|11684298|FG002|NOT COMPLETED|Overall Study||0
10532038|NCT01416389|11684310|FG000|STARTED|Overall Study||26
10532039|NCT01416389|11684311|FG001|STARTED|Overall Study||13
10715702|NCT02688387|11880061|FG018|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10715703|NCT02688387|11880062|FG019|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10344846|NCT00404755|11482519|FG000|NOT COMPLETED|Phase III (Imipramine)||0
10344847|NCT00404768|11482531|FG000|STARTED|Part A and B||20
10344848|NCT00404768|11482532|FG001|STARTED|Part A and B||9
10344849|NCT00404768|11482533|FG002|STARTED|Part A and B||0
10344850|NCT00404768|11482534|FG003|STARTED|Part A and B||0
10344851|NCT00404768|11482531|FG000|COMPLETED|Part A and B||19
10344852|NCT00404768|11482532|FG001|COMPLETED|Part A and B||8
10344853|NCT00404768|11482533|FG002|COMPLETED|Part A and B||0
10344854|NCT00404768|11482534|FG003|COMPLETED|Part A and B||0
10344855|NCT00404768|11482531|FG000|NOT COMPLETED|Part A and B||1
10344856|NCT00404768|11482532|FG001|NOT COMPLETED|Part A and B||1
10344857|NCT00404768|11482533|FG002|NOT COMPLETED|Part A and B||0
10344858|NCT00404768|11482534|FG003|NOT COMPLETED|Part A and B||0
10344859|NCT00404768|11482531|FG000|STARTED|Part C||0
10344860|NCT00404768|11482532|FG001|STARTED|Part C||0
10344861|NCT00404768|11482533|FG002|STARTED|Part C||30
10344862|NCT00404768|11482534|FG003|STARTED|Part C||34
10344863|NCT00404768|11482531|FG000|COMPLETED|Part C||0
10344864|NCT00404768|11482532|FG001|COMPLETED|Part C||0
10344865|NCT00404768|11482533|FG002|COMPLETED|Part C||22
10344866|NCT00404768|11482534|FG003|COMPLETED|Part C||20
10344867|NCT00404768|11482531|FG000|NOT COMPLETED|Part C||0
10344868|NCT00404768|11482532|FG001|NOT COMPLETED|Part C||0
10344869|NCT00404768|11482533|FG002|NOT COMPLETED|Part C||8
10344870|NCT00404768|11482534|FG003|NOT COMPLETED|Part C||14
10344871|NCT00404820|11482551|FG000|STARTED|Overall Study||408
10344872|NCT00404820|11482552|FG001|STARTED|Overall Study||196
10344873|NCT00404820|11482551|FG000|Started Treatment|Overall Study||408
10344874|NCT00404820|11482552|FG001|Started Treatment|Overall Study|The reason why 2 patients did not start treatment is unavailable.|194
10344875|NCT00404820|11482551|FG000|COMPLETED|Overall Study||389
10344876|NCT00404820|11482552|FG001|COMPLETED|Overall Study||172
10344877|NCT00404820|11482551|FG000|NOT COMPLETED|Overall Study||19
10344878|NCT00404820|11482552|FG001|NOT COMPLETED|Overall Study||24
10344879|NCT00404924|11482560|FG000|STARTED|Overall Study|randomised patients|617
10344880|NCT00404924|11482561|FG001|STARTED|Overall Study|randomised patients|307
10344881|NCT00404924|11482560|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|14
10344882|NCT00404924|11482561|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|1
10344883|NCT00404924|11482560|FG000|NOT COMPLETED|Overall Study||603
10344884|NCT00404924|11482561|FG001|NOT COMPLETED|Overall Study||306
10344885|NCT00405067|11482570|FG000|STARTED|Overall Study||28
10344886|NCT00405067|11482571|FG001|STARTED|Overall Study||28
10344887|NCT00405067|11482572|FG002|STARTED|Overall Study||29
10344888|NCT00405067|11482570|FG000|COMPLETED|Overall Study||24
10344889|NCT00405067|11482571|FG001|COMPLETED|Overall Study||19
10344890|NCT00405067|11482572|FG002|COMPLETED|Overall Study||24
10344891|NCT00405067|11482570|FG000|NOT COMPLETED|Overall Study||4
10344892|NCT00405067|11482571|FG001|NOT COMPLETED|Overall Study||9
10344893|NCT00405067|11482572|FG002|NOT COMPLETED|Overall Study||5
10344894|NCT00405275|11482582|FG000|STARTED|Overall Study||178
10344895|NCT00405275|11482583|FG001|STARTED|Overall Study||175
10344896|NCT00405275|11482582|FG000|24 Weeks (Total)|Overall Study||163
10344897|NCT00405275|11482583|FG001|24 Weeks (Total)|Overall Study||165
10344898|NCT00405275|11482582|FG000|24 Week (no Switch)|Overall Study||119
10344899|NCT00405275|11482583|FG001|24 Week (no Switch)|Overall Study||121
10344900|NCT00405275|11482582|FG000|24 Week (Switch)|Overall Study||44
10344901|NCT00405275|11482583|FG001|24 Week (Switch)|Overall Study||44
10344902|NCT00405275|11482582|FG000|COMPLETED|Overall Study||155
10344903|NCT00405275|11482583|FG001|COMPLETED|Overall Study||156
10344904|NCT00405275|11482582|FG000|NOT COMPLETED|Overall Study||23
10344905|NCT00405275|11482583|FG001|NOT COMPLETED|Overall Study||19
10344906|NCT00405288|11482591|FG000|STARTED|Overall Study||204
10344907|NCT00405288|11482592|FG001|STARTED|Overall Study||204
10344908|NCT00405288|11482591|FG000|COMPLETED|Overall Study||204
10344909|NCT00405288|11482592|FG001|COMPLETED|Overall Study||204
10715704|NCT02688387|11880063|FG020|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10715705|NCT02688387|11880064|FG021|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
10715706|NCT02688387|11880043|FG000|STARTED|Part 3A, Washout Period 2 (10 Days)||0
10715707|NCT02688387|11880044|FG001|STARTED|Part 3A, Washout Period 2 (10 Days)||0
10715708|NCT02688387|11880045|FG002|STARTED|Part 3A, Washout Period 2 (10 Days)||0
10344910|NCT00405288|11482591|FG000|NOT COMPLETED|Overall Study||0
10344911|NCT00405288|11482592|FG001|NOT COMPLETED|Overall Study||0
10344912|NCT00405353|11482598|FG000|STARTED|Overall Study||10
10344913|NCT00405353|11482598|FG000|COMPLETED|Overall Study||10
10344914|NCT00405353|11482598|FG000|NOT COMPLETED|Overall Study||0
10715709|NCT02688387|11880046|FG003|STARTED|Part 3A, Washout Period 2 (10 Days)||0
10715710|NCT02688387|11880047|FG004|STARTED|Part 3A, Washout Period 2 (10 Days)||0
10715711|NCT02688387|11880048|FG005|STARTED|Part 3A, Washout Period 2 (10 Days)||0
10715712|NCT02688387|11880049|FG006|STARTED|Part 3A, Washout Period 2 (10 Days)||0
10715713|NCT02688387|11880050|FG007|STARTED|Part 3A, Washout Period 2 (10 Days)||0
10715714|NCT02688387|11880051|FG008|STARTED|Part 3A, Washout Period 2 (10 Days)||0
10344915|NCT00405392|11482604|FG000|STARTED|Overall Study||183
10344916|NCT00405392|11482605|FG001|STARTED|Overall Study||182
10344917|NCT00405392|11482604|FG000|COMPLETED|Overall Study||153
10344918|NCT00405392|11482605|FG001|COMPLETED|Overall Study||155
10344919|NCT00405392|11482604|FG000|NOT COMPLETED|Overall Study||30
10344920|NCT00405392|11482605|FG001|NOT COMPLETED|Overall Study||27
10344921|NCT00405509|11482613|FG000|STARTED|Overall Study||11
10344922|NCT00405509|11482614|FG001|STARTED|Overall Study||22
10344923|NCT00405509|11482613|FG000|COMPLETED|Overall Study||11
10344924|NCT00405509|11482614|FG001|COMPLETED|Overall Study||22
10344925|NCT00405509|11482613|FG000|NOT COMPLETED|Overall Study||0
10344926|NCT00405509|11482614|FG001|NOT COMPLETED|Overall Study||0
10344927|NCT00405522|11482622|FG000|STARTED|Overall Study||17
10344928|NCT00405522|11482623|FG001|STARTED|Overall Study||17
10344929|NCT00405522|11482622|FG000|COMPLETED|Overall Study||17
10344930|NCT00405522|11482623|FG001|COMPLETED|Overall Study||17
10344931|NCT00405522|11482622|FG000|NOT COMPLETED|Overall Study||0
10344932|NCT00405522|11482623|FG001|NOT COMPLETED|Overall Study||0
10344933|NCT00405548|11482631|FG000|STARTED|Overall Study||28
10344934|NCT00405548|11482632|FG001|STARTED|Overall Study||13
10344935|NCT00405548|11482631|FG000|COMPLETED|Overall Study||24
10344936|NCT00405548|11482632|FG001|COMPLETED|Overall Study||12
10344937|NCT00405548|11482631|FG000|NOT COMPLETED|Overall Study||4
10344938|NCT00405548|11482632|FG001|NOT COMPLETED|Overall Study||1
10344939|NCT00405587|11482642|FG000|STARTED|Overall Study||26
10344940|NCT00405587|11482643|FG001|STARTED|Overall Study||30
10344941|NCT00405587|11482644|FG002|STARTED|Overall Study||32
10344942|NCT00405587|11482645|FG003|STARTED|Overall Study||21
10344943|NCT00405587|11482642|FG000|COMPLETED|Overall Study||0
10344944|NCT00405587|11482643|FG001|COMPLETED|Overall Study||2
10344945|NCT00405587|11482644|FG002|COMPLETED|Overall Study||10
10344946|NCT00405587|11482645|FG003|COMPLETED|Overall Study||1
10344947|NCT00405587|11482642|FG000|NOT COMPLETED|Overall Study||26
10344948|NCT00405587|11482643|FG001|NOT COMPLETED|Overall Study||28
10344949|NCT00405587|11482644|FG002|NOT COMPLETED|Overall Study||22
10344950|NCT00405587|11482645|FG003|NOT COMPLETED|Overall Study||20
10344951|NCT00405639|11482683|FG000|STARTED|Overall Study||25
10344952|NCT00405639|11482684|FG001|STARTED|Overall Study||12
10344953|NCT00405639|11482683|FG000|COMPLETED|Overall Study||22
10344954|NCT00405639|11482684|FG001|COMPLETED|Overall Study||12
10344955|NCT00405639|11482683|FG000|NOT COMPLETED|Overall Study||3
10344956|NCT00405639|11482684|FG001|NOT COMPLETED|Overall Study||0
10344957|NCT00405652|11482690|FG000|STARTED|Overall Study||34
10344958|NCT00405652|11482690|FG000|COMPLETED|Overall Study||30
10344959|NCT00405652|11482690|FG000|NOT COMPLETED|Overall Study||4
10344960|NCT00405704|11482696|FG000|STARTED|Overall Study||302
10344961|NCT00405704|11482697|FG001|STARTED|Overall Study||305
10344962|NCT00405704|11482696|FG000|Completed Outcome Renal Scan|Overall Study||227
10344963|NCT00405704|11482697|FG001|Completed Outcome Renal Scan|Overall Study||235
10344964|NCT00405704|11482696|FG000|Completed Assessments for New Scarring|Overall Study||220
10344965|NCT00405704|11482697|FG001|Completed Assessments for New Scarring|Overall Study||227
10344966|NCT00405704|11482696|FG000|Outcome Stool Assessed|Overall Study||203
10344967|NCT00405704|11482697|FG001|Outcome Stool Assessed|Overall Study||210
10344968|NCT00405704|11482696|FG000|Recurrent UTI With E. Coli|Overall Study||30
10344969|NCT00405704|11482697|FG001|Recurrent UTI With E. Coli|Overall Study||57
10344970|NCT00405704|11482696|FG000|Recurrent UTI With TMP-SMZ Panel|Overall Study||38
10344971|NCT00405704|11482697|FG001|Recurrent UTI With TMP-SMZ Panel|Overall Study||69
10344972|NCT00405704|11482696|FG000|COMPLETED|Overall Study||261
10344973|NCT00405704|11482697|FG001|COMPLETED|Overall Study||259
10344974|NCT00405704|11482696|FG000|NOT COMPLETED|Overall Study||41
10344975|NCT00405704|11482697|FG001|NOT COMPLETED|Overall Study||46
10344976|NCT00405756|11482707|FG000|STARTED|Double-blind Treatment|Intent to treat population of all randomized participants|152
10344977|NCT00405756|11482708|FG001|STARTED|Double-blind Treatment||153
10344978|NCT00405756|11482709|FG002|STARTED|Double-blind Treatment||154
10344979|NCT00405756|11482707|FG000|Safety Population|Double-blind Treatment|Participants who took at least one dose of study drug.|150
10344980|NCT00405756|11482708|FG001|Safety Population|Double-blind Treatment||152
10344981|NCT00405756|11482709|FG002|Safety Population|Double-blind Treatment||153
10344982|NCT00405756|11482707|FG000|COMPLETED|Double-blind Treatment|Double-blind Treatment Period had no defined completion.|0
10344983|NCT00405756|11482708|FG001|COMPLETED|Double-blind Treatment||0
10344984|NCT00405756|11482709|FG002|COMPLETED|Double-blind Treatment||0
10344985|NCT00405756|11482707|FG000|NOT COMPLETED|Double-blind Treatment||152
10344986|NCT00405756|11482708|FG001|NOT COMPLETED|Double-blind Treatment||153
10344987|NCT00405756|11482709|FG002|NOT COMPLETED|Double-blind Treatment||154
10344988|NCT00405756|11482707|FG000|STARTED|Open-label Extension||19
10344989|NCT00405756|11482708|FG001|STARTED|Open-label Extension||47
10344990|NCT00405756|11482709|FG002|STARTED|Open-label Extension||72
10344991|NCT00405756|11482707|FG000|COMPLETED|Open-label Extension|Participants continue until disease progression or other reason for discontinuing.|0
10344992|NCT00405756|11482708|FG001|COMPLETED|Open-label Extension||0
10344993|NCT00405756|11482709|FG002|COMPLETED|Open-label Extension||0
10344994|NCT00405756|11482707|FG000|NOT COMPLETED|Open-label Extension||19
10344995|NCT00405756|11482708|FG001|NOT COMPLETED|Open-label Extension||47
10344996|NCT00405756|11482709|FG002|NOT COMPLETED|Open-label Extension||72
10344997|NCT00405756|11482707|FG000|STARTED|Follow-up|66 participants from Double-blind and 9 from the Open Label Extension|75
10426568|NCT00848120|11572241|FG000|STARTED|Overall Study||29
10344998|NCT00405756|11482708|FG001|STARTED|Follow-up|65 participants from the Double-blind and 25 from the Open Label Extension|90
10344999|NCT00405756|11482709|FG002|STARTED|Follow-up|52 participants from the Double-blind and 36 from the Open Label Extension|88
10345000|NCT00405756|11482707|FG000|COMPLETED|Follow-up||0
10345001|NCT00405756|11482708|FG001|COMPLETED|Follow-up||0
10345002|NCT00405756|11482709|FG002|COMPLETED|Follow-up||0
10345003|NCT00405756|11482707|FG000|NOT COMPLETED|Follow-up||75
10345004|NCT00405756|11482708|FG001|NOT COMPLETED|Follow-up||90
10345005|NCT00405756|11482709|FG002|NOT COMPLETED|Follow-up||88
10345006|NCT00405821|11482719|FG000|STARTED|Overall Study||220
10345007|NCT00405821|11482720|FG001|STARTED|Overall Study||220
10345008|NCT00405821|11482719|FG000|COMPLETED|Overall Study||198
10345009|NCT00405821|11482720|FG001|COMPLETED|Overall Study||198
10345010|NCT00405821|11482719|FG000|NOT COMPLETED|Overall Study||22
10345011|NCT00405821|11482720|FG001|NOT COMPLETED|Overall Study||22
10345012|NCT00405912|11482729|FG000|STARTED|Overall Study||39
10345013|NCT00405912|11482730|FG001|STARTED|Overall Study||40
10345014|NCT00405912|11482731|FG002|STARTED|Overall Study||39
10345015|NCT00405912|11482729|FG000|COMPLETED|Overall Study||23
10345016|NCT00405912|11482730|FG001|COMPLETED|Overall Study||21
10345017|NCT00405912|11482731|FG002|COMPLETED|Overall Study||23
10345018|NCT00405912|11482729|FG000|NOT COMPLETED|Overall Study||16
10345019|NCT00405912|11482730|FG001|NOT COMPLETED|Overall Study||19
10345020|NCT00405912|11482731|FG002|NOT COMPLETED|Overall Study||16
10345021|NCT00405938|11482741|FG000|STARTED|Overall Study||38
10345022|NCT00405938|11482742|FG001|STARTED|Overall Study||41
10345023|NCT00405938|11482741|FG000|COMPLETED|Overall Study||38
10345024|NCT00405938|11482742|FG001|COMPLETED|Overall Study||41
10345025|NCT00405938|11482741|FG000|NOT COMPLETED|Overall Study||0
10345026|NCT00405938|11482742|FG001|NOT COMPLETED|Overall Study||0
10345027|NCT00406029|11482753|FG000|STARTED|Overall Study||49
10345028|NCT00406029|11482754|FG001|STARTED|Overall Study||49
10345029|NCT00406029|11482755|FG002|STARTED|Overall Study||49
10345030|NCT00406029|11482756|FG003|STARTED|Overall Study||57
10345031|NCT00406029|11482757|FG004|STARTED|Overall Study||49
10345032|NCT00406029|11482753|FG000|Treated|Overall Study||49
10345033|NCT00406029|11482754|FG001|Treated|Overall Study||49
10345034|NCT00406029|11482755|FG002|Treated|Overall Study||47
10345035|NCT00406029|11482756|FG003|Treated|Overall Study||54
10345036|NCT00406029|11482757|FG004|Treated|Overall Study||47
10345037|NCT00406029|11482753|FG000|COMPLETED|Overall Study||33
10345038|NCT00406029|11482754|FG001|COMPLETED|Overall Study||41
10345039|NCT00406029|11482755|FG002|COMPLETED|Overall Study||39
10345040|NCT00406029|11482756|FG003|COMPLETED|Overall Study||40
10345041|NCT00406029|11482757|FG004|COMPLETED|Overall Study||41
10345042|NCT00406029|11482753|FG000|NOT COMPLETED|Overall Study||16
10345043|NCT00406029|11482754|FG001|NOT COMPLETED|Overall Study||8
10345044|NCT00406029|11482755|FG002|NOT COMPLETED|Overall Study||10
10345045|NCT00406029|11482756|FG003|NOT COMPLETED|Overall Study||17
10345046|NCT00406029|11482757|FG004|NOT COMPLETED|Overall Study||8
10345047|NCT00406107|11482771|FG000|STARTED|Overall Study||15
10345048|NCT00406107|11482772|FG001|STARTED|Overall Study||5
10345049|NCT00406107|11482771|FG000|COMPLETED|Overall Study||14
10345050|NCT00406107|11482772|FG001|COMPLETED|Overall Study||4
10345051|NCT00406107|11482771|FG000|NOT COMPLETED|Overall Study||1
10345052|NCT00406107|11482772|FG001|NOT COMPLETED|Overall Study||1
10345053|NCT00406133|11482783|FG000|STARTED|Phase 1 (First 26 Week Period)||165
10345054|NCT00406133|11482784|FG001|STARTED|Phase 1 (First 26 Week Period)||157
10345055|NCT00406133|11482785|FG002|STARTED|Phase 1 (First 26 Week Period)||67
10345056|NCT00406133|11482786|FG003|STARTED|Phase 1 (First 26 Week Period)||62
10345057|NCT00406133|11482783|FG000|COMPLETED|Phase 1 (First 26 Week Period)||162
10345058|NCT00406133|11482784|FG001|COMPLETED|Phase 1 (First 26 Week Period)||155
10345059|NCT00406133|11482785|FG002|COMPLETED|Phase 1 (First 26 Week Period)||67
10345060|NCT00406133|11482786|FG003|COMPLETED|Phase 1 (First 26 Week Period)||60
10345061|NCT00406133|11482783|FG000|NOT COMPLETED|Phase 1 (First 26 Week Period)||3
10345062|NCT00406133|11482784|FG001|NOT COMPLETED|Phase 1 (First 26 Week Period)||2
10345063|NCT00406133|11482785|FG002|NOT COMPLETED|Phase 1 (First 26 Week Period)||0
10345064|NCT00406133|11482786|FG003|NOT COMPLETED|Phase 1 (First 26 Week Period)||2
10345065|NCT00406133|11482783|FG000|STARTED|Phase 2 (Second 26 Week Period)|3 subjects completed phase 1 but elected not to go into phase 2.|159
10345066|NCT00406133|11482784|FG001|STARTED|Phase 2 (Second 26 Week Period)||155
10345067|NCT00406133|11482785|FG002|STARTED|Phase 2 (Second 26 Week Period)||67
10345068|NCT00406133|11482786|FG003|STARTED|Phase 2 (Second 26 Week Period)||60
10345069|NCT00406133|11482783|FG000|COMPLETED|Phase 2 (Second 26 Week Period)||157
10345070|NCT00406133|11482784|FG001|COMPLETED|Phase 2 (Second 26 Week Period)||152
10345071|NCT00406133|11482785|FG002|COMPLETED|Phase 2 (Second 26 Week Period)||67
10345072|NCT00406133|11482786|FG003|COMPLETED|Phase 2 (Second 26 Week Period)||60
10345073|NCT00406133|11482783|FG000|NOT COMPLETED|Phase 2 (Second 26 Week Period)||2
10345074|NCT00406133|11482784|FG001|NOT COMPLETED|Phase 2 (Second 26 Week Period)||3
10345075|NCT00406133|11482785|FG002|NOT COMPLETED|Phase 2 (Second 26 Week Period)||0
10345076|NCT00406133|11482786|FG003|NOT COMPLETED|Phase 2 (Second 26 Week Period)||0
10345077|NCT00406276|11482801|FG000|STARTED|Overall Study||28
10345078|NCT00406276|11482801|FG000|COMPLETED|Overall Study||24
10345079|NCT00406276|11482801|FG000|NOT COMPLETED|Overall Study||4
10345080|NCT00406315|11482806|FG000|STARTED|Overall Study|Started = Treated|241
10345081|NCT00406315|11482806|FG000|COMPLETED|Overall Study||100
10345082|NCT00406315|11482806|FG000|NOT COMPLETED|Overall Study||141
10345083|NCT00406354|11482813|FG000|STARTED|All Randomized Patients||60
10345084|NCT00406354|11482814|FG001|STARTED|All Randomized Patients||61
10345085|NCT00406354|11482815|FG002|STARTED|All Randomized Patients||60
10345086|NCT00406354|11482813|FG000|COMPLETED|All Randomized Patients||60
10345087|NCT00406354|11482814|FG001|COMPLETED|All Randomized Patients||61
10345088|NCT00406354|11482815|FG002|COMPLETED|All Randomized Patients|One patient was randomized but never received study treatment.|59
10345089|NCT00406354|11482813|FG000|NOT COMPLETED|All Randomized Patients||0
10345090|NCT00406354|11482814|FG001|NOT COMPLETED|All Randomized Patients||0
10345091|NCT00406354|11482815|FG002|NOT COMPLETED|All Randomized Patients||1
10345092|NCT00406354|11482813|FG000|STARTED|All Randomized and Treated Patients||60
10345093|NCT00406354|11482814|FG001|STARTED|All Randomized and Treated Patients||61
10345094|NCT00406354|11482815|FG002|STARTED|All Randomized and Treated Patients||59
10345095|NCT00406354|11482813|FG000|COMPLETED|All Randomized and Treated Patients||44
10345096|NCT00406354|11482814|FG001|COMPLETED|All Randomized and Treated Patients||48
10345097|NCT00406354|11482815|FG002|COMPLETED|All Randomized and Treated Patients||37
10345098|NCT00406354|11482813|FG000|NOT COMPLETED|All Randomized and Treated Patients||16
10345099|NCT00406354|11482814|FG001|NOT COMPLETED|All Randomized and Treated Patients||13
10345100|NCT00406354|11482815|FG002|NOT COMPLETED|All Randomized and Treated Patients||22
10345101|NCT00406367|11482825|FG000|STARTED|Main Period - 6 to 20 Weeks||75
10345102|NCT00406367|11482826|FG001|STARTED|Main Period - 6 to 20 Weeks||34
10345103|NCT00406367|11482825|FG000|COMPLETED|Main Period - 6 to 20 Weeks||70
10345104|NCT00406367|11482826|FG001|COMPLETED|Main Period - 6 to 20 Weeks||32
10345105|NCT00406367|11482825|FG000|NOT COMPLETED|Main Period - 6 to 20 Weeks||5
10345106|NCT00406367|11482826|FG001|NOT COMPLETED|Main Period - 6 to 20 Weeks||2
10345107|NCT00406367|11482825|FG000|STARTED|Open-Label Ext. Period - up to 68 Weeks||102
10345108|NCT00406367|11482826|FG001|STARTED|Open-Label Ext. Period - up to 68 Weeks|In the Open-Label Extension Period no placebo treatment arm was given.|0
10345109|NCT00406367|11482825|FG000|COMPLETED|Open-Label Ext. Period - up to 68 Weeks||82
10345110|NCT00406367|11482826|FG001|COMPLETED|Open-Label Ext. Period - up to 68 Weeks||0
10345111|NCT00406367|11482825|FG000|NOT COMPLETED|Open-Label Ext. Period - up to 68 Weeks||20
10345112|NCT00406367|11482826|FG001|NOT COMPLETED|Open-Label Ext. Period - up to 68 Weeks||0
10345113|NCT00406393|11482834|FG000|STARTED|Overall Study||151
10715715|NCT02688387|11880052|FG009|STARTED|Part 3A, Washout Period 2 (10 Days)||0
10345114|NCT00406393|11482835|FG001|STARTED|Overall Study||153
10345115|NCT00406393|11482834|FG000|COMPLETED|Overall Study||149
10345116|NCT00406393|11482835|FG001|COMPLETED|Overall Study||152
10345117|NCT00406393|11482834|FG000|NOT COMPLETED|Overall Study||2
10345118|NCT00406393|11482835|FG001|NOT COMPLETED|Overall Study||1
10345119|NCT00406419|11482844|FG000|STARTED|Overall Study||324
10345120|NCT00406419|11482845|FG001|STARTED|Overall Study||344
10345121|NCT00406419|11482846|FG002|STARTED|Overall Study||347
10345122|NCT00406419|11482844|FG000|COMPLETED|Overall Study||0
10345123|NCT00406419|11482845|FG001|COMPLETED|Overall Study||0
10345124|NCT00406419|11482846|FG002|COMPLETED|Overall Study||0
10345125|NCT00406419|11482844|FG000|NOT COMPLETED|Overall Study||324
10345126|NCT00406419|11482845|FG001|NOT COMPLETED|Overall Study||344
10345127|NCT00406419|11482846|FG002|NOT COMPLETED|Overall Study||347
10345128|NCT00406640|11482856|FG000|STARTED|Acute Phase||296
10345129|NCT00406640|11482857|FG001|STARTED|Acute Phase||299
10345130|NCT00406640|11482856|FG000|COMPLETED|Acute Phase||245
10345131|NCT00406640|11482857|FG001|COMPLETED|Acute Phase||256
10345132|NCT00406640|11482856|FG000|NOT COMPLETED|Acute Phase||51
10345133|NCT00406640|11482857|FG001|NOT COMPLETED|Acute Phase||43
10345134|NCT00406640|11482856|FG000|STARTED|DB Continuation Phase for Responders||172
10345135|NCT00406640|11482857|FG001|STARTED|DB Continuation Phase for Responders||188
10345136|NCT00406640|11482856|FG000|COMPLETED|DB Continuation Phase for Responders||139
10345137|NCT00406640|11482857|FG001|COMPLETED|DB Continuation Phase for Responders||151
10345138|NCT00406640|11482856|FG000|NOT COMPLETED|DB Continuation Phase for Responders||33
10345139|NCT00406640|11482857|FG001|NOT COMPLETED|DB Continuation Phase for Responders||37
10345140|NCT00406640|11482856|FG000|STARTED|OL Extension Phase for Non-Responders||69
10345141|NCT00406640|11482857|FG001|STARTED|OL Extension Phase for Non-Responders||60
10345142|NCT00406640|11482856|FG000|COMPLETED|OL Extension Phase for Non-Responders||47
10345143|NCT00406640|11482857|FG001|COMPLETED|OL Extension Phase for Non-Responders||36
10345144|NCT00406640|11482856|FG000|NOT COMPLETED|OL Extension Phase for Non-Responders||22
10345145|NCT00406640|11482857|FG001|NOT COMPLETED|OL Extension Phase for Non-Responders||24
10655532|NCT02208089|11816209|FG001|COMPLETED|Overall Study||47
10345146|NCT00406653|11482873|FG000|STARTED|Induction Period||65
10345147|NCT00406653|11482874|FG001|STARTED|Induction Period||128
10345148|NCT00406653|11482875|FG002|STARTED|Induction Period||130
10345149|NCT00406653|11482876|FG003|STARTED|Induction Period||128
10345150|NCT00406653|11482877|FG004|STARTED|Induction Period||0
10345151|NCT00406653|11482878|FG005|STARTED|Induction Period||0
10655533|NCT02208089|11816208|FG000|NOT COMPLETED|Overall Study||7
10715716|NCT02688387|11880053|FG010|STARTED|Part 3A, Washout Period 2 (10 Days)||0
10715717|NCT02688387|11880054|FG011|STARTED|Part 3A, Washout Period 2 (10 Days)||0
10715718|NCT02688387|11880055|FG012|STARTED|Part 3A, Washout Period 2 (10 Days)||0
10345152|NCT00406653|11482879|FG006|STARTED|Induction Period||0
10345153|NCT00406653|11482873|FG000|COMPLETED|Induction Period||50
10345154|NCT00406653|11482874|FG001|COMPLETED|Induction Period||94
10345155|NCT00406653|11482875|FG002|COMPLETED|Induction Period||112
10345156|NCT00406653|11482876|FG003|COMPLETED|Induction Period||102
10345157|NCT00406653|11482877|FG004|COMPLETED|Induction Period||0
10345158|NCT00406653|11482878|FG005|COMPLETED|Induction Period||0
10345159|NCT00406653|11482879|FG006|COMPLETED|Induction Period||0
10345160|NCT00406653|11482873|FG000|NOT COMPLETED|Induction Period||15
10345161|NCT00406653|11482874|FG001|NOT COMPLETED|Induction Period||34
10345162|NCT00406653|11482875|FG002|NOT COMPLETED|Induction Period||18
10345163|NCT00406653|11482876|FG003|NOT COMPLETED|Induction Period||26
10345164|NCT00406653|11482877|FG004|NOT COMPLETED|Induction Period||0
10345165|NCT00406653|11482878|FG005|NOT COMPLETED|Induction Period||0
10345166|NCT00406653|11482879|FG006|NOT COMPLETED|Induction Period||0
10345167|NCT00406653|11482873|FG000|STARTED|Maintenance Period||0
10345168|NCT00406653|11482874|FG001|STARTED|Maintenance Period||0
10345169|NCT00406653|11482875|FG002|STARTED|Maintenance Period||0
10345170|NCT00406653|11482876|FG003|STARTED|Maintenance Period||0
10345171|NCT00406653|11482877|FG004|STARTED|Maintenance Period|At end of IP, 44 participants met response criteria and were randomly assigned to abatacept in MP.|44
10345172|NCT00406653|11482878|FG005|STARTED|Maintenance Period|At end of IP, 46 participants met response criteria and were randomly assigned to placebo in MP.|46
10345173|NCT00406653|11482879|FG006|STARTED|Maintenance Period||0
10345174|NCT00406653|11482873|FG000|COMPLETED|Maintenance Period||0
10345175|NCT00406653|11482874|FG001|COMPLETED|Maintenance Period||0
10345176|NCT00406653|11482875|FG002|COMPLETED|Maintenance Period||0
10345177|NCT00406653|11482876|FG003|COMPLETED|Maintenance Period||0
10345178|NCT00406653|11482877|FG004|COMPLETED|Maintenance Period||14
10345179|NCT00406653|11482878|FG005|COMPLETED|Maintenance Period||10
10345180|NCT00406653|11482879|FG006|COMPLETED|Maintenance Period||0
10345181|NCT00406653|11482873|FG000|NOT COMPLETED|Maintenance Period||0
10345182|NCT00406653|11482874|FG001|NOT COMPLETED|Maintenance Period||0
10345183|NCT00406653|11482875|FG002|NOT COMPLETED|Maintenance Period||0
10345184|NCT00406653|11482876|FG003|NOT COMPLETED|Maintenance Period||0
10345185|NCT00406653|11482877|FG004|NOT COMPLETED|Maintenance Period||30
10345186|NCT00406653|11482878|FG005|NOT COMPLETED|Maintenance Period||36
10345187|NCT00406653|11482879|FG006|NOT COMPLETED|Maintenance Period||0
10345188|NCT00406653|11482873|FG000|STARTED|Open-Label Period||0
10345189|NCT00406653|11482874|FG001|STARTED|Open-Label Period||0
10345190|NCT00406653|11482875|FG002|STARTED|Open-Label Period||0
10345191|NCT00406653|11482876|FG003|STARTED|Open-Label Period||0
10345192|NCT00406653|11482877|FG004|STARTED|Open-Label Period||0
10345193|NCT00406653|11482878|FG005|STARTED|Open-Label Period||0
10345194|NCT00406653|11482879|FG006|STARTED|Open-Label Period|All completing IP but failing response criteria and those completing or relapsing on MP entered OL.|324
10345195|NCT00406653|11482873|FG000|COMPLETED|Open-Label Period||0
10345196|NCT00406653|11482874|FG001|COMPLETED|Open-Label Period||0
10345197|NCT00406653|11482875|FG002|COMPLETED|Open-Label Period||0
10715719|NCT02688387|11880056|FG013|STARTED|Part 3A, Washout Period 2 (10 Days)||0
10715720|NCT02688387|11880057|FG014|STARTED|Part 3A, Washout Period 2 (10 Days)||8
10715721|NCT02688387|11880058|FG015|STARTED|Part 3A, Washout Period 2 (10 Days)||8
10345198|NCT00406653|11482876|FG003|COMPLETED|Open-Label Period||0
10345199|NCT00406653|11482877|FG004|COMPLETED|Open-Label Period||0
10345200|NCT00406653|11482878|FG005|COMPLETED|Open-Label Period||0
10345201|NCT00406653|11482879|FG006|COMPLETED|Open-Label Period||0
10345202|NCT00406653|11482873|FG000|NOT COMPLETED|Open-Label Period||0
10345203|NCT00406653|11482874|FG001|NOT COMPLETED|Open-Label Period||0
10345204|NCT00406653|11482875|FG002|NOT COMPLETED|Open-Label Period||0
10345205|NCT00406653|11482876|FG003|NOT COMPLETED|Open-Label Period||0
10345206|NCT00406653|11482877|FG004|NOT COMPLETED|Open-Label Period||0
10345207|NCT00406653|11482878|FG005|NOT COMPLETED|Open-Label Period||0
10345208|NCT00406653|11482879|FG006|NOT COMPLETED|Open-Label Period||324
10345209|NCT00406692|11482899|FG000|STARTED|Overall Study||16
10345210|NCT00406692|11482899|FG000|COMPLETED|Overall Study||9
10345211|NCT00406692|11482899|FG000|NOT COMPLETED|Overall Study||7
10345212|NCT00406718|11482906|FG000|STARTED|Overall Study||47
10345213|NCT00406718|11482907|FG001|STARTED|Overall Study||48
10345214|NCT00406718|11482908|FG002|STARTED|Overall Study||47
10345215|NCT00406718|11482906|FG000|COMPLETED|Overall Study||43
10345216|NCT00406718|11482907|FG001|COMPLETED|Overall Study||34
10345217|NCT00406718|11482908|FG002|COMPLETED|Overall Study||39
10345218|NCT00406718|11482906|FG000|NOT COMPLETED|Overall Study||4
10345219|NCT00406718|11482907|FG001|NOT COMPLETED|Overall Study||14
10345220|NCT00406718|11482908|FG002|NOT COMPLETED|Overall Study||8
10345221|NCT00406848|11482920|FG000|STARTED|Overall Study|Represents full safety analysis population. Efficacy analysis population (c,d,e) N=204.|249
10345222|NCT00406848|11482921|FG001|STARTED|Overall Study|Represents full safety analysis population. Efficacy analysis population (c,d,e) N=95.|121
10345223|NCT00406848|11482920|FG000|COMPLETED|Overall Study||156
10345224|NCT00406848|11482921|FG001|COMPLETED|Overall Study||67
10345225|NCT00406848|11482920|FG000|NOT COMPLETED|Overall Study||93
10345226|NCT00406848|11482921|FG001|NOT COMPLETED|Overall Study||54
10812384|NCT03701295|11974435|FG000|NOT COMPLETED|Overall Study||0
10812385|NCT03697551|11974439|FG000|STARTED|Overall Study||4
10812386|NCT03697551|11974439|FG000|COMPLETED|Overall Study||4
10345227|NCT00407030|11482933|FG000|STARTED|Main Period - 8 to 20 Weeks||81
10345228|NCT00407030|11482934|FG001|STARTED|Main Period - 8 to 20 Weeks||78
10345229|NCT00407030|11482935|FG002|STARTED|Main Period - 8 to 20 Weeks||74
10345230|NCT00407030|11482933|FG000|COMPLETED|Main Period - 8 to 20 Weeks||76
10345231|NCT00407030|11482934|FG001|COMPLETED|Main Period - 8 to 20 Weeks||75
10345232|NCT00407030|11482935|FG002|COMPLETED|Main Period - 8 to 20 Weeks||68
10345233|NCT00407030|11482933|FG000|NOT COMPLETED|Main Period - 8 to 20 Weeks||5
10345234|NCT00407030|11482934|FG001|NOT COMPLETED|Main Period - 8 to 20 Weeks||3
10345235|NCT00407030|11482935|FG002|NOT COMPLETED|Main Period - 8 to 20 Weeks||6
10345236|NCT00407030|11482933|FG000|STARTED|Extension Period - up to 68 Weeks|2 subjects did not enter the Ext. Period, 3 subjects never expressed any need for a new injection|111
10345237|NCT00407030|11482934|FG001|STARTED|Extension Period - up to 68 Weeks|2 subjects did not enter the Ext. Period, 3 subjects never expressed any need for a new injection|103
10345238|NCT00407030|11482935|FG002|STARTED|Extension Period - up to 68 Weeks|After the Main Period all patients were randomly assigned to the 2 active treatment arms.|0
10345239|NCT00407030|11482933|FG000|COMPLETED|Extension Period - up to 68 Weeks||84
10345240|NCT00407030|11482934|FG001|COMPLETED|Extension Period - up to 68 Weeks||74
10345241|NCT00407030|11482935|FG002|COMPLETED|Extension Period - up to 68 Weeks||0
10345242|NCT00407030|11482933|FG000|NOT COMPLETED|Extension Period - up to 68 Weeks||27
10345243|NCT00407030|11482934|FG001|NOT COMPLETED|Extension Period - up to 68 Weeks||29
10345244|NCT00407030|11482935|FG002|NOT COMPLETED|Extension Period - up to 68 Weeks||0
10345245|NCT00407355|11482947|FG000|STARTED|Overall Study||20
10345246|NCT00407355|11482948|FG001|STARTED|Overall Study||20
10345247|NCT00407355|11482947|FG000|COMPLETED|Overall Study||10
10345248|NCT00407355|11482948|FG001|COMPLETED|Overall Study||9
10345249|NCT00407355|11482947|FG000|NOT COMPLETED|Overall Study||10
10345250|NCT00407355|11482948|FG001|NOT COMPLETED|Overall Study||11
10345251|NCT00407381|11482957|FG000|STARTED|Overall Study||42
10345252|NCT00407381|11482958|FG001|STARTED|Overall Study||42
10345253|NCT00407381|11482959|FG002|STARTED|Overall Study||42
10345254|NCT00407381|11482957|FG000|COMPLETED|Overall Study||39
10345255|NCT00407381|11482958|FG001|COMPLETED|Overall Study||38
10345256|NCT00407381|11482959|FG002|COMPLETED|Overall Study||40
10345257|NCT00407381|11482957|FG000|NOT COMPLETED|Overall Study||3
10345258|NCT00407381|11482958|FG001|NOT COMPLETED|Overall Study||4
10345259|NCT00407381|11482959|FG002|NOT COMPLETED|Overall Study||2
10345260|NCT00407420|11482969|FG000|STARTED|Overall Study||54
10345261|NCT00407420|11482970|FG001|STARTED|Overall Study||52
10345262|NCT00407420|11482969|FG000|COMPLETED|Overall Study||45
10345263|NCT00407420|11482970|FG001|COMPLETED|Overall Study||46
10345264|NCT00407420|11482969|FG000|NOT COMPLETED|Overall Study||9
10345265|NCT00407420|11482970|FG001|NOT COMPLETED|Overall Study||6
10345266|NCT00407485|11482978|FG000|STARTED|Overall Study||22
10345267|NCT00407485|11482978|FG000|COMPLETED|Overall Study||22
10345268|NCT00407485|11482978|FG000|NOT COMPLETED|Overall Study||0
10345269|NCT00407511|11482983|FG000|STARTED|Overall Study||121
10345270|NCT00407511|11482983|FG000|COMPLETED|Overall Study||99
10345271|NCT00407511|11482983|FG000|NOT COMPLETED|Overall Study||22
10345272|NCT00407537|11482989|FG000|STARTED|Overall Study||779
10345273|NCT00407537|11482990|FG001|STARTED|Overall Study|4 participants assigned to Caduet treatment received usual care only during the study|682
10345274|NCT00407537|11482989|FG000|Eligible for Efficacy Analysis|Overall Study||760
10345275|NCT00407537|11482990|FG001|Eligible for Efficacy Analysis|Overall Study||657
10812387|NCT03697551|11974439|FG000|NOT COMPLETED|Overall Study||0
10345276|NCT00407537|11482989|FG000|COMPLETED|Overall Study||686
10345277|NCT00407537|11482990|FG001|COMPLETED|Overall Study||638
10345278|NCT00407537|11482989|FG000|NOT COMPLETED|Overall Study||93
10345279|NCT00407537|11482990|FG001|NOT COMPLETED|Overall Study||44
10345280|NCT00407550|11482998|FG000|STARTED|Overall Study||10
10345281|NCT00407550|11482999|FG001|STARTED|Overall Study||9
10345282|NCT00407550|11482998|FG000|COMPLETED|Overall Study||7
10345283|NCT00407550|11482999|FG001|COMPLETED|Overall Study||5
10345284|NCT00407550|11482998|FG000|NOT COMPLETED|Overall Study||3
10345285|NCT00407550|11482999|FG001|NOT COMPLETED|Overall Study||4
10345286|NCT00407563|11483005|FG000|STARTED|Overall Study||48
10345287|NCT00407563|11483005|FG000|COMPLETED|Overall Study|One patient remains on study treatment.|47
10345288|NCT00407563|11483005|FG000|NOT COMPLETED|Overall Study||1
10345289|NCT00407654|11483009|FG000|STARTED|Overall Study||75
10345290|NCT00407654|11483009|FG000|COMPLETED|Overall Study||75
10345291|NCT00407654|11483009|FG000|NOT COMPLETED|Overall Study||0
10345292|NCT00407745|11483016|FG000|STARTED|Overall Study||112
10345293|NCT00407745|11483017|FG001|STARTED|Overall Study||108
10345294|NCT00407745|11483016|FG000|Treated|Overall Study||112
10345295|NCT00407745|11483017|FG001|Treated|Overall Study||107
10345296|NCT00407745|11483016|FG000|COMPLETED|Overall Study||93
10345297|NCT00407745|11483017|FG001|COMPLETED|Overall Study||91
10345298|NCT00407745|11483016|FG000|NOT COMPLETED|Overall Study||19
10345299|NCT00407745|11483017|FG001|NOT COMPLETED|Overall Study||17
10345300|NCT00407758|11483023|FG000|STARTED|Overall Study||28
10345301|NCT00407758|11483023|FG000|COMPLETED|Overall Study||27
10345302|NCT00407758|11483023|FG000|NOT COMPLETED|Overall Study||1
10345303|NCT00407797|11483027|FG000|STARTED|Overall Study||136
10345304|NCT00407797|11483027|FG000|Full Analysis Set|Overall Study|At least 1 dose of study medication and had a baseline and at least 1 post-baseline measurement.|135
10345305|NCT00407797|11483027|FG000|COMPLETED|Overall Study||118
10345306|NCT00407797|11483027|FG000|NOT COMPLETED|Overall Study||18
10345307|NCT00407888|11483031|FG000|STARTED|Overall Study||60
10345308|NCT00407888|11483031|FG000|COMPLETED|Overall Study||60
10345309|NCT00407888|11483031|FG000|NOT COMPLETED|Overall Study||0
10345310|NCT00407966|11483035|FG000|STARTED|Overall Study||45
10345311|NCT00407966|11483035|FG000|CR|Overall Study||30
10345312|NCT00407966|11483035|FG000|COMPLETED|Overall Study||45
10345313|NCT00407966|11483035|FG000|NOT COMPLETED|Overall Study||0
10345314|NCT00408070|11483039|FG000|STARTED|Overall Study||5
10345315|NCT00408070|11483039|FG000|COMPLETED|Overall Study||5
10345316|NCT00408070|11483039|FG000|NOT COMPLETED|Overall Study||0
10426569|NCT00848120|11572241|FG000|COMPLETED|Overall Study||28
10426570|NCT00848120|11572241|FG000|NOT COMPLETED|Overall Study||1
10426571|NCT00848172|11572247|FG000|STARTED|Visit 2 - Drug Administration||10
10426572|NCT00848172|11572248|FG001|STARTED|Visit 2 - Drug Administration||9
10426573|NCT00848172|11572247|FG000|COMPLETED|Visit 2 - Drug Administration||10
10426574|NCT00848172|11572248|FG001|COMPLETED|Visit 2 - Drug Administration||8
10426575|NCT00848172|11572247|FG000|NOT COMPLETED|Visit 2 - Drug Administration||0
10426576|NCT00848172|11572248|FG001|NOT COMPLETED|Visit 2 - Drug Administration||1
10426577|NCT00848172|11572247|FG000|STARTED|Visit 3 - Follow Up||10
10426578|NCT00848172|11572248|FG001|STARTED|Visit 3 - Follow Up||8
10426579|NCT00848172|11572247|FG000|COMPLETED|Visit 3 - Follow Up||10
10426580|NCT00848172|11572248|FG001|COMPLETED|Visit 3 - Follow Up||8
10426581|NCT00848172|11572247|FG000|NOT COMPLETED|Visit 3 - Follow Up||0
10426582|NCT00848172|11572248|FG001|NOT COMPLETED|Visit 3 - Follow Up||0
10426583|NCT00848185|11572260|FG000|STARTED|Overall Study||32
10426584|NCT00848185|11572261|FG001|STARTED|Overall Study||32
10426585|NCT00848185|11572262|FG002|STARTED|Overall Study||32
10426586|NCT00848185|11572260|FG000|COMPLETED|Overall Study||32
10426587|NCT00848185|11572261|FG001|COMPLETED|Overall Study||32
10426588|NCT00848185|11572262|FG002|COMPLETED|Overall Study||32
10426589|NCT00848185|11572260|FG000|NOT COMPLETED|Overall Study||0
10812388|NCT03694821|11974446|FG000|STARTED|Overall Study||4
10812389|NCT03694821|11974447|FG001|STARTED|Overall Study||8
10812390|NCT03694821|11974448|FG002|STARTED|Overall Study||6
10812391|NCT03694821|11974446|FG000|COMPLETED|Overall Study||0
10812392|NCT03694821|11974447|FG001|COMPLETED|Overall Study||0
10812393|NCT03694821|11974448|FG002|COMPLETED|Overall Study||2
10426590|NCT00848185|11572261|FG001|NOT COMPLETED|Overall Study||0
10426591|NCT00848185|11572262|FG002|NOT COMPLETED|Overall Study||0
10426592|NCT00848198|11572270|FG000|STARTED|Overall Study||314
10426593|NCT00848198|11572270|FG000|COMPLETED|Overall Study||299
10426594|NCT00848198|11572270|FG000|NOT COMPLETED|Overall Study||15
10812394|NCT03694821|11974446|FG000|NOT COMPLETED|Overall Study||4
10812395|NCT03694821|11974447|FG001|NOT COMPLETED|Overall Study||8
10812396|NCT03694821|11974448|FG002|NOT COMPLETED|Overall Study||4
10812397|NCT03686969|11974458|FG000|STARTED|Overall Study||1
10812398|NCT03686969|11974459|FG001|STARTED|Overall Study||0
10812399|NCT03686969|11974458|FG000|COMPLETED|Overall Study||0
10426595|NCT00848211|11572282|FG000|STARTED|Overall Study||6
10426596|NCT00848211|11572283|FG001|STARTED|Overall Study||7
10426597|NCT00848211|11572284|FG002|STARTED|Overall Study||6
10426598|NCT00848211|11572285|FG003|STARTED|Overall Study||5
10426599|NCT00848211|11572282|FG000|COMPLETED|Overall Study||6
10426600|NCT00848211|11572283|FG001|COMPLETED|Overall Study||6
10812400|NCT03686969|11974459|FG001|COMPLETED|Overall Study||0
10812401|NCT03686969|11974458|FG000|NOT COMPLETED|Overall Study||1
10812402|NCT03686969|11974459|FG001|NOT COMPLETED|Overall Study||0
10812403|NCT03682367|11974467|FG000|STARTED|Overall Study||4
10812404|NCT03682367|11974468|FG001|STARTED|Overall Study||4
10345317|NCT00408200|11483045|FG000|STARTED|Overall Study||57
10345318|NCT00408200|11483046|FG001|STARTED|Overall Study||53
10345319|NCT00408200|11483045|FG000|COMPLETED|Overall Study||57
10345320|NCT00408200|11483046|FG001|COMPLETED|Overall Study||53
10345321|NCT00408200|11483045|FG000|NOT COMPLETED|Overall Study||0
10345322|NCT00408200|11483046|FG001|NOT COMPLETED|Overall Study||0
10345323|NCT00408317|11483052|FG000|STARTED|First Intervention Period||14
10345324|NCT00408317|11483053|FG001|STARTED|First Intervention Period||17
10345325|NCT00408317|11483052|FG000|COMPLETED|First Intervention Period||14
10345326|NCT00408317|11483053|FG001|COMPLETED|First Intervention Period||16
10345327|NCT00408317|11483052|FG000|NOT COMPLETED|First Intervention Period||0
10345328|NCT00408317|11483053|FG001|NOT COMPLETED|First Intervention Period||1
10345329|NCT00408317|11483052|FG000|STARTED|Second Intervention Period||14
10345330|NCT00408317|11483053|FG001|STARTED|Second Intervention Period||16
10345331|NCT00408317|11483052|FG000|COMPLETED|Second Intervention Period||12
10345332|NCT00408317|11483053|FG001|COMPLETED|Second Intervention Period||14
10345333|NCT00408317|11483052|FG000|NOT COMPLETED|Second Intervention Period||2
10345334|NCT00408317|11483053|FG001|NOT COMPLETED|Second Intervention Period||2
10345335|NCT00408408|11483065|FG000|STARTED|Overall Study||201
10345336|NCT00408408|11483066|FG001|STARTED|Overall Study||199
10345337|NCT00408408|11483067|FG002|STARTED|Overall Study||204
10345338|NCT00408408|11483068|FG003|STARTED|Overall Study||201
10345339|NCT00408408|11483069|FG004|STARTED|Overall Study||197
10345340|NCT00408408|11483070|FG005|STARTED|Overall Study||204
10345341|NCT00408408|11483065|FG000|COMPLETED|Overall Study||199
10345342|NCT00408408|11483066|FG001|COMPLETED|Overall Study||196
10345343|NCT00408408|11483067|FG002|COMPLETED|Overall Study||204
10345344|NCT00408408|11483068|FG003|COMPLETED|Overall Study||194
10345345|NCT00408408|11483069|FG004|COMPLETED|Overall Study||192
10345346|NCT00408408|11483070|FG005|COMPLETED|Overall Study||201
10345347|NCT00408408|11483065|FG000|NOT COMPLETED|Overall Study||2
10345348|NCT00408408|11483066|FG001|NOT COMPLETED|Overall Study||3
10532040|NCT01416389|11684310|FG000|Received at Least 1 Dose of Study Drug|Overall Study||26
10532101|NCT01417156|11684400|FG000|NOT COMPLETED|Overall Study||14
10532041|NCT01416389|11684311|FG001|Received at Least 1 Dose of Study Drug|Overall Study||13
10532042|NCT01416389|11684310|FG000|COMPLETED|Overall Study||23
10532043|NCT01416389|11684311|FG001|COMPLETED|Overall Study||13
10532044|NCT01416389|11684310|FG000|NOT COMPLETED|Overall Study||3
10532045|NCT01416389|11684311|FG001|NOT COMPLETED|Overall Study||0
10532046|NCT01416441|11684319|FG000|STARTED|Overall Study||170
10532047|NCT01416441|11684319|FG000|COMPLETED|Overall Study||89
10532048|NCT01416441|11684319|FG000|NOT COMPLETED|Overall Study||81
10532049|NCT01416571|11684323|FG000|STARTED|Overall Study||78
10532050|NCT01416571|11684323|FG000|COMPLETED|Overall Study|Number of subjects completed at Day 385.|76
10532051|NCT01416571|11684323|FG000|NOT COMPLETED|Overall Study||2
10532052|NCT01416584|11684330|FG000|STARTED|Overall Study||30
10532053|NCT01416584|11684331|FG001|STARTED|Overall Study||35
10532054|NCT01416584|11684332|FG002|STARTED|Overall Study||33
10532055|NCT01416584|11684330|FG000|COMPLETED|Overall Study||27
10532056|NCT01416584|11684331|FG001|COMPLETED|Overall Study||33
10532057|NCT01416584|11684332|FG002|COMPLETED|Overall Study||32
10532058|NCT01416584|11684330|FG000|NOT COMPLETED|Overall Study||3
10532059|NCT01416584|11684331|FG001|NOT COMPLETED|Overall Study||2
10532060|NCT01416584|11684332|FG002|NOT COMPLETED|Overall Study||1
10532061|NCT01416610|11684346|FG000|STARTED|Overall Study||88
10532062|NCT01416610|11684346|FG000|Intention to Treat|Overall Study||88
10532063|NCT01416610|11684346|FG000|Safety Population|Overall Study||86
10532064|NCT01416610|11684346|FG000|Per Protocol|Overall Study||83
10532065|NCT01416610|11684346|FG000|Completed Treatment|Overall Study||47
10532066|NCT01416610|11684346|FG000|Completed Follow-up|Overall Study||45
10532067|NCT01416610|11684346|FG000|COMPLETED|Overall Study||45
10532068|NCT01416610|11684346|FG000|NOT COMPLETED|Overall Study||43
10532069|NCT01416805|11684356|FG000|STARTED|Overall Study||49
10532070|NCT01416805|11684357|FG001|STARTED|Overall Study||51
10532071|NCT01416805|11684356|FG000|COMPLETED|Overall Study||45
10532072|NCT01416805|11684357|FG001|COMPLETED|Overall Study||47
10532073|NCT01416805|11684356|FG000|NOT COMPLETED|Overall Study||4
10532074|NCT01416805|11684357|FG001|NOT COMPLETED|Overall Study||4
10532075|NCT01416987|11684363|FG000|STARTED|Overall Study||600
10532076|NCT01416987|11684363|FG000|COMPLETED|Overall Study||600
10345349|NCT00408408|11483067|FG002|NOT COMPLETED|Overall Study||0
10345350|NCT00408408|11483068|FG003|NOT COMPLETED|Overall Study||7
10345351|NCT00408408|11483069|FG004|NOT COMPLETED|Overall Study||5
10345352|NCT00408408|11483070|FG005|NOT COMPLETED|Overall Study||3
10345353|NCT00408421|11483086|FG000|STARTED|Treatment Initial Randomization||120
10345354|NCT00408421|11483087|FG001|STARTED|Treatment Initial Randomization||111
10345355|NCT00408421|11483088|FG002|STARTED|Treatment Initial Randomization||0
10345356|NCT00408421|11483086|FG000|COMPLETED|Treatment Initial Randomization|Pre-Re-Randomization (Visit 4)|103
10345357|NCT00408421|11483087|FG001|COMPLETED|Treatment Initial Randomization|Pre-Re-Randomization (Visit 4)|89
10345358|NCT00408421|11483088|FG002|COMPLETED|Treatment Initial Randomization|Patients weren't randomized to Duloxetine 120 mg until Visit 4.|0
10345359|NCT00408421|11483086|FG000|NOT COMPLETED|Treatment Initial Randomization||17
10345360|NCT00408421|11483087|FG001|NOT COMPLETED|Treatment Initial Randomization||22
10345361|NCT00408421|11483088|FG002|NOT COMPLETED|Treatment Initial Randomization||0
10345362|NCT00408421|11483086|FG000|STARTED|Treatment Re-Randomization||103
10345363|NCT00408421|11483087|FG001|STARTED|Treatment Re-Randomization||46
10345364|NCT00408421|11483088|FG002|STARTED|Treatment Re-Randomization||43
10345365|NCT00408421|11483086|FG000|COMPLETED|Treatment Re-Randomization||96
10345366|NCT00408421|11483087|FG001|COMPLETED|Treatment Re-Randomization||39
10345367|NCT00408421|11483088|FG002|COMPLETED|Treatment Re-Randomization||38
10345368|NCT00408421|11483086|FG000|NOT COMPLETED|Treatment Re-Randomization||7
10345369|NCT00408421|11483087|FG001|NOT COMPLETED|Treatment Re-Randomization||7
10345370|NCT00408421|11483088|FG002|NOT COMPLETED|Treatment Re-Randomization||5
10532077|NCT01416987|11684363|FG000|NOT COMPLETED|Overall Study||0
10532078|NCT01417000|11684369|FG000|STARTED|Overall Study|62 subjects randomized into Cy/GVAX + CRS-207 arm; 61 subjects received ≥ 1 protocol-specified drug.|61
10532079|NCT01417000|11684370|FG001|STARTED|Overall Study|31 subjects randomized into Cy/GVAX arm; 29 subjects received ≥ 1 protocol-specified drug.|29
10532080|NCT01417000|11684369|FG000|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/death/study close, so no subjects completed study."|0
10532081|NCT01417000|11684370|FG001|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/death/study close, so no subjects completed study."|0
10532082|NCT01417000|11684369|FG000|NOT COMPLETED|Overall Study||61
10532083|NCT01417000|11684370|FG001|NOT COMPLETED|Overall Study||29
10532084|NCT01417026|11684378|FG000|STARTED|Overall Study||16
10532085|NCT01417026|11684379|FG001|STARTED|Overall Study||13
10532086|NCT01417026|11684378|FG000|COMPLETED|Overall Study||14
10532087|NCT01417026|11684379|FG001|COMPLETED|Overall Study||13
10532088|NCT01417026|11684378|FG000|NOT COMPLETED|Overall Study||2
10532089|NCT01417026|11684379|FG001|NOT COMPLETED|Overall Study||0
10532090|NCT01417078|11684385|FG000|STARTED|Overall Study||31
10532091|NCT01417078|11684385|FG000|COMPLETED|Overall Study||30
10532092|NCT01417078|11684385|FG000|NOT COMPLETED|Overall Study||1
10532093|NCT01417104|11684393|FG000|STARTED|Overall Study||34
10532094|NCT01417104|11684394|FG001|STARTED|Overall Study||37
10532095|NCT01417104|11684393|FG000|COMPLETED|Overall Study||28
10345371|NCT00408434|11483103|FG000|STARTED|Overall Study||6
10532096|NCT01417104|11684394|FG001|COMPLETED|Overall Study||35
10532097|NCT01417104|11684393|FG000|NOT COMPLETED|Overall Study||6
10532098|NCT01417104|11684394|FG001|NOT COMPLETED|Overall Study||2
10532099|NCT01417156|11684400|FG000|STARTED|Overall Study||20
10532100|NCT01417156|11684400|FG000|COMPLETED|Overall Study||6
10532102|NCT01417195|11684406|FG000|STARTED|Overall Study||60
10532103|NCT01417195|11684407|FG001|STARTED|Overall Study||62
10532104|NCT01417195|11684406|FG000|COMPLETED|Overall Study||57
10532105|NCT01417195|11684407|FG001|COMPLETED|Overall Study||61
10532106|NCT01417195|11684406|FG000|NOT COMPLETED|Overall Study||3
10532107|NCT01417195|11684407|FG001|NOT COMPLETED|Overall Study||1
10532111|NCT01417455|11684426|FG000|STARTED|Overall Study||16
10532112|NCT01417455|11684427|FG001|STARTED|Overall Study||16
10532113|NCT01417455|11684428|FG002|STARTED|Overall Study||17
10532114|NCT01417455|11684429|FG003|STARTED|Overall Study||17
10532115|NCT01417455|11684430|FG004|STARTED|Overall Study||30
10532116|NCT01417455|11684431|FG005|STARTED|Overall Study||13
10532117|NCT01417455|11684432|FG006|STARTED|Overall Study||13
10532118|NCT01417455|11684433|FG007|STARTED|Overall Study||25
10532119|NCT01417455|11684426|FG000|COMPLETED|Overall Study||16
10532120|NCT01417455|11684427|FG001|COMPLETED|Overall Study||16
10532121|NCT01417455|11684428|FG002|COMPLETED|Overall Study||17
10532122|NCT01417455|11684429|FG003|COMPLETED|Overall Study||17
10532123|NCT01417455|11684430|FG004|COMPLETED|Overall Study||30
10532124|NCT01417455|11684431|FG005|COMPLETED|Overall Study||13
10532125|NCT01417455|11684432|FG006|COMPLETED|Overall Study||13
10532126|NCT01417455|11684433|FG007|COMPLETED|Overall Study||25
10345372|NCT00408434|11483104|FG001|STARTED|Overall Study||3
10345373|NCT00408434|11483105|FG002|STARTED|Overall Study||6
10345374|NCT00408434|11483106|FG003|STARTED|Overall Study||3
10345375|NCT00408434|11483107|FG004|STARTED|Overall Study||6
10345376|NCT00408434|11483108|FG005|STARTED|Overall Study||3
10345377|NCT00408434|11483109|FG006|STARTED|Overall Study||4
10345378|NCT00408434|11483103|FG000|COMPLETED|Overall Study||0
10345379|NCT00408434|11483104|FG001|COMPLETED|Overall Study||0
10345380|NCT00408434|11483105|FG002|COMPLETED|Overall Study||0
10345381|NCT00408434|11483106|FG003|COMPLETED|Overall Study||0
10345382|NCT00408434|11483107|FG004|COMPLETED|Overall Study||0
10345383|NCT00408434|11483108|FG005|COMPLETED|Overall Study||0
10345384|NCT00408434|11483109|FG006|COMPLETED|Overall Study||0
10345385|NCT00408434|11483103|FG000|NOT COMPLETED|Overall Study||6
10345386|NCT00408434|11483104|FG001|NOT COMPLETED|Overall Study||3
10345387|NCT00408434|11483105|FG002|NOT COMPLETED|Overall Study||6
10345388|NCT00408434|11483106|FG003|NOT COMPLETED|Overall Study||3
10345389|NCT00408434|11483107|FG004|NOT COMPLETED|Overall Study||6
10532127|NCT01417455|11684426|FG000|NOT COMPLETED|Overall Study||0
10532128|NCT01417455|11684427|FG001|NOT COMPLETED|Overall Study||0
10532129|NCT01417455|11684428|FG002|NOT COMPLETED|Overall Study||0
10532130|NCT01417455|11684429|FG003|NOT COMPLETED|Overall Study||0
10532131|NCT01417455|11684430|FG004|NOT COMPLETED|Overall Study||0
10532132|NCT01417455|11684431|FG005|NOT COMPLETED|Overall Study||0
10532133|NCT01417455|11684432|FG006|NOT COMPLETED|Overall Study||0
10532134|NCT01417455|11684433|FG007|NOT COMPLETED|Overall Study||0
10532135|NCT01417481|11684453|FG000|STARTED|First Intervention (8 Weeks)||8
10655534|NCT02208089|11816209|FG001|NOT COMPLETED|Overall Study||0
10655535|NCT02208297|11816218|FG000|STARTED|Overall Study||163
10655536|NCT02208297|11816219|FG001|STARTED|Overall Study||163
10655537|NCT02208297|11816218|FG000|COMPLETED|Overall Study||141
10655538|NCT02208297|11816219|FG001|COMPLETED|Overall Study||107
10655539|NCT02208297|11816218|FG000|NOT COMPLETED|Overall Study||22
10655540|NCT02208297|11816219|FG001|NOT COMPLETED|Overall Study||56
10655541|NCT02208310|11816227|FG000|STARTED|Overall Study||6
10655542|NCT02208310|11816228|FG001|STARTED|Overall Study||5
10655543|NCT02208310|11816227|FG000|Day 180|Overall Study||0
10655544|NCT02208310|11816228|FG001|Day 180|Overall Study||1
10655545|NCT02208310|11816227|FG000|COMPLETED|Overall Study||0
10655546|NCT02208310|11816228|FG001|COMPLETED|Overall Study||0
10655547|NCT02208310|11816227|FG000|NOT COMPLETED|Overall Study||6
10655548|NCT02208310|11816228|FG001|NOT COMPLETED|Overall Study||5
10655549|NCT02208349|11816236|FG000|STARTED|Initial 6 Months||16
10655550|NCT02208349|11816237|FG001|STARTED|Initial 6 Months||9
10655551|NCT02208349|11816236|FG000|COMPLETED|Initial 6 Months||16
10655552|NCT02208349|11816237|FG001|COMPLETED|Initial 6 Months||9
10655553|NCT02208349|11816236|FG000|NOT COMPLETED|Initial 6 Months||0
10655554|NCT02208349|11816237|FG001|NOT COMPLETED|Initial 6 Months||0
10655555|NCT02208349|11816236|FG000|STARTED|Second 6 Months||11
10655556|NCT02208349|11816237|FG001|STARTED|Second 6 Months||7
10655557|NCT02208349|11816236|FG000|COMPLETED|Second 6 Months||11
10655558|NCT02208349|11816237|FG001|COMPLETED|Second 6 Months||7
10655559|NCT02208349|11816236|FG000|NOT COMPLETED|Second 6 Months||0
10655560|NCT02208349|11816237|FG001|NOT COMPLETED|Second 6 Months||0
10655561|NCT02208349|11816236|FG000|STARTED|Third 6 Month||6
10655562|NCT02208349|11816237|FG001|STARTED|Third 6 Month||3
10655563|NCT02208349|11816236|FG000|COMPLETED|Third 6 Month||6
10655564|NCT02208349|11816237|FG001|COMPLETED|Third 6 Month||3
10655565|NCT02208349|11816236|FG000|NOT COMPLETED|Third 6 Month||0
10655566|NCT02208349|11816237|FG001|NOT COMPLETED|Third 6 Month||0
10655567|NCT02208349|11816236|FG000|STARTED|Fourth 6 Month||14
10655568|NCT02208349|11816237|FG001|STARTED|Fourth 6 Month||2
10655569|NCT02208349|11816236|FG000|COMPLETED|Fourth 6 Month||14
10655570|NCT02208349|11816237|FG001|COMPLETED|Fourth 6 Month||2
10655571|NCT02208349|11816236|FG000|NOT COMPLETED|Fourth 6 Month||0
10655572|NCT02208349|11816237|FG001|NOT COMPLETED|Fourth 6 Month||0
10655573|NCT02208349|11816236|FG000|STARTED|Fifth 6 Month||7
10655574|NCT02208349|11816237|FG001|STARTED|Fifth 6 Month||2
10655575|NCT02208349|11816236|FG000|COMPLETED|Fifth 6 Month||7
10655576|NCT02208349|11816237|FG001|COMPLETED|Fifth 6 Month||2
10655577|NCT02208349|11816236|FG000|NOT COMPLETED|Fifth 6 Month||0
10655578|NCT02208349|11816237|FG001|NOT COMPLETED|Fifth 6 Month||0
10655579|NCT02208349|11816236|FG000|STARTED|Sixth 6 Month||3
10655580|NCT02208349|11816237|FG001|STARTED|Sixth 6 Month||2
10655581|NCT02208349|11816236|FG000|COMPLETED|Sixth 6 Month||3
10655582|NCT02208349|11816237|FG001|COMPLETED|Sixth 6 Month||2
10655583|NCT02208349|11816236|FG000|NOT COMPLETED|Sixth 6 Month||0
10655584|NCT02208349|11816237|FG001|NOT COMPLETED|Sixth 6 Month||0
10655585|NCT02208466|11816248|FG000|STARTED|Overall Study||9
10655586|NCT02208466|11816249|FG001|STARTED|Overall Study||10
10655587|NCT02208466|11816250|FG002|STARTED|Overall Study||8
10655588|NCT02208466|11816248|FG000|COMPLETED|Overall Study||9
10655589|NCT02208466|11816249|FG001|COMPLETED|Overall Study||10
10655590|NCT02208466|11816250|FG002|COMPLETED|Overall Study||8
10655591|NCT02208466|11816248|FG000|NOT COMPLETED|Overall Study||0
10345390|NCT00408434|11483108|FG005|NOT COMPLETED|Overall Study||3
10345391|NCT00408434|11483109|FG006|NOT COMPLETED|Overall Study||4
10345392|NCT00408460|11483126|FG000|STARTED|Overall Study||34
10345393|NCT00408460|11483126|FG000|COMPLETED|Overall Study||34
10345394|NCT00408460|11483126|FG000|NOT COMPLETED|Overall Study||0
10345395|NCT00408499|11483130|FG000|STARTED|Phase 1: Dose Levels 1-4||4
10345396|NCT00408499|11483131|FG001|STARTED|Phase 1: Dose Levels 1-4||7
10655592|NCT02208466|11816249|FG001|NOT COMPLETED|Overall Study||0
10345397|NCT00408499|11483132|FG002|STARTED|Phase 1: Dose Levels 1-4||3
10345398|NCT00408499|11483133|FG003|STARTED|Phase 1: Dose Levels 1-4||6
10345399|NCT00408499|11483134|FG004|STARTED|Phase 1: Dose Levels 1-4||0
10345400|NCT00408499|11483130|FG000|COMPLETED|Phase 1: Dose Levels 1-4||2
10345401|NCT00408499|11483131|FG001|COMPLETED|Phase 1: Dose Levels 1-4||5
10345402|NCT00408499|11483132|FG002|COMPLETED|Phase 1: Dose Levels 1-4||2
10345403|NCT00408499|11483133|FG003|COMPLETED|Phase 1: Dose Levels 1-4||6
10345404|NCT00408499|11483134|FG004|COMPLETED|Phase 1: Dose Levels 1-4||0
10345405|NCT00408499|11483130|FG000|NOT COMPLETED|Phase 1: Dose Levels 1-4||2
10345406|NCT00408499|11483131|FG001|NOT COMPLETED|Phase 1: Dose Levels 1-4||2
10345407|NCT00408499|11483132|FG002|NOT COMPLETED|Phase 1: Dose Levels 1-4||1
10345408|NCT00408499|11483133|FG003|NOT COMPLETED|Phase 1: Dose Levels 1-4||0
10345409|NCT00408499|11483134|FG004|NOT COMPLETED|Phase 1: Dose Levels 1-4||0
10345410|NCT00408499|11483130|FG000|STARTED|Phase II- MTD Expansion||0
10345411|NCT00408499|11483131|FG001|STARTED|Phase II- MTD Expansion||0
10345412|NCT00408499|11483132|FG002|STARTED|Phase II- MTD Expansion||0
10345413|NCT00408499|11483133|FG003|STARTED|Phase II- MTD Expansion||0
10345414|NCT00408499|11483134|FG004|STARTED|Phase II- MTD Expansion||44
10345415|NCT00408499|11483130|FG000|COMPLETED|Phase II- MTD Expansion||0
10345416|NCT00408499|11483131|FG001|COMPLETED|Phase II- MTD Expansion||0
10345417|NCT00408499|11483132|FG002|COMPLETED|Phase II- MTD Expansion||0
10345418|NCT00408499|11483133|FG003|COMPLETED|Phase II- MTD Expansion||0
10345419|NCT00408499|11483134|FG004|COMPLETED|Phase II- MTD Expansion||24
10345420|NCT00408499|11483130|FG000|NOT COMPLETED|Phase II- MTD Expansion||0
10345421|NCT00408499|11483131|FG001|NOT COMPLETED|Phase II- MTD Expansion||0
10345422|NCT00408499|11483132|FG002|NOT COMPLETED|Phase II- MTD Expansion||0
10345423|NCT00408499|11483133|FG003|NOT COMPLETED|Phase II- MTD Expansion||0
10345424|NCT00408499|11483134|FG004|NOT COMPLETED|Phase II- MTD Expansion||20
10345425|NCT00408564|11483143|FG000|STARTED|Overall Study||39
10345426|NCT00408564|11483143|FG000|COMPLETED|Overall Study||39
10345427|NCT00408564|11483143|FG000|NOT COMPLETED|Overall Study||0
10345428|NCT00408590|11483150|FG000|STARTED|Overall Study||3
10345429|NCT00408590|11483151|FG001|STARTED|Overall Study||3
10345430|NCT00408590|11483152|FG002|STARTED|Overall Study||3
10345431|NCT00408590|11483153|FG003|STARTED|Overall Study||3
10345432|NCT00408590|11483154|FG004|STARTED|Overall Study||3
10345433|NCT00408590|11483155|FG005|STARTED|Overall Study||3
10345434|NCT00408590|11483156|FG006|STARTED|Overall Study||3
10345435|NCT00408590|11483157|FG007|STARTED|Overall Study||3
10345436|NCT00408590|11483158|FG008|STARTED|Overall Study||13
10345437|NCT00408590|11483150|FG000|COMPLETED|Overall Study||3
10345438|NCT00408590|11483151|FG001|COMPLETED|Overall Study||3
10345439|NCT00408590|11483152|FG002|COMPLETED|Overall Study||3
10345440|NCT00408590|11483153|FG003|COMPLETED|Overall Study||3
10345441|NCT00408590|11483154|FG004|COMPLETED|Overall Study||3
10345442|NCT00408590|11483155|FG005|COMPLETED|Overall Study||3
10345443|NCT00408590|11483156|FG006|COMPLETED|Overall Study||3
10345444|NCT00408590|11483157|FG007|COMPLETED|Overall Study||3
10345445|NCT00408590|11483158|FG008|COMPLETED|Overall Study||13
10345446|NCT00408590|11483150|FG000|NOT COMPLETED|Overall Study||0
10345447|NCT00408590|11483151|FG001|NOT COMPLETED|Overall Study||0
10345448|NCT00408590|11483152|FG002|NOT COMPLETED|Overall Study||0
10345449|NCT00408590|11483153|FG003|NOT COMPLETED|Overall Study||0
10345450|NCT00408590|11483154|FG004|NOT COMPLETED|Overall Study||0
10345451|NCT00408590|11483155|FG005|NOT COMPLETED|Overall Study||0
10345452|NCT00408590|11483156|FG006|NOT COMPLETED|Overall Study||0
10345453|NCT00408590|11483157|FG007|NOT COMPLETED|Overall Study||0
10345454|NCT00408590|11483158|FG008|NOT COMPLETED|Overall Study||0
10345455|NCT00408603|11483176|FG000|STARTED|Overall Study||69
10345456|NCT00408603|11483177|FG001|STARTED|Overall Study||39
10345457|NCT00408603|11483178|FG002|STARTED|Overall Study||75
10345458|NCT00408603|11483176|FG000|COMPLETED|Overall Study||65
10345459|NCT00408603|11483177|FG001|COMPLETED|Overall Study||37
10345460|NCT00408603|11483178|FG002|COMPLETED|Overall Study||35
10345461|NCT00408603|11483176|FG000|NOT COMPLETED|Overall Study||4
10345462|NCT00408603|11483177|FG001|NOT COMPLETED|Overall Study||2
10345463|NCT00408603|11483178|FG002|NOT COMPLETED|Overall Study||40
10345464|NCT00408629|11483190|FG000|STARTED|Overall Study|10 ADA recipients from 3 noncompliant clinical sites in Safety, but not in Efficacy analyses (248).|258
10345465|NCT00408629|11483191|FG001|STARTED|Overall Study|14 PLB recipients from 3 noncompliant clinical sites in Safety, but not in Efficacy analyses (246).|260
10345466|NCT00408629|11483190|FG000|COMPLETED|Overall Study|1 ADA recipient did not receive study drug and discontinued due to other reasons.|161
10345467|NCT00408629|11483191|FG001|COMPLETED|Overall Study||135
10345468|NCT00408629|11483190|FG000|NOT COMPLETED|Overall Study||97
10345469|NCT00408629|11483191|FG001|NOT COMPLETED|Overall Study||125
10345470|NCT00408681|11483198|FG000|STARTED|Overall Study||20
10345471|NCT00408681|11483198|FG000|COMPLETED|Overall Study|Completion was defined as administration of the study product for at least 28 days.|11
10345472|NCT00408681|11483198|FG000|NOT COMPLETED|Overall Study||9
10345473|NCT00408694|11483203|FG000|STARTED|Overall Study||46
10345474|NCT00408694|11483203|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
10345475|NCT00408694|11483203|FG000|NOT COMPLETED|Overall Study||2
10345476|NCT00408876|11483211|FG000|STARTED|Overall Study||59
10345477|NCT00408876|11483212|FG001|STARTED|Overall Study||116
10345478|NCT00408876|11483213|FG002|STARTED|Overall Study||112
10345479|NCT00408876|11483214|FG003|STARTED|Overall Study||117
10345480|NCT00408876|11483211|FG000|COMPLETED|Overall Study||43
10345481|NCT00408876|11483212|FG001|COMPLETED|Overall Study||80
10345482|NCT00408876|11483213|FG002|COMPLETED|Overall Study||62
10345483|NCT00408876|11483214|FG003|COMPLETED|Overall Study||82
10345484|NCT00408876|11483211|FG000|NOT COMPLETED|Overall Study||16
10345485|NCT00408876|11483212|FG001|NOT COMPLETED|Overall Study||36
10345486|NCT00408876|11483213|FG002|NOT COMPLETED|Overall Study||50
10345487|NCT00408876|11483214|FG003|NOT COMPLETED|Overall Study||35
10345488|NCT00408902|11483224|FG000|STARTED|Overall Study||10
10345489|NCT00408902|11483224|FG000|COMPLETED|Overall Study||0
10345490|NCT00408902|11483224|FG000|NOT COMPLETED|Overall Study||10
10345491|NCT00408928|11483229|FG000|STARTED|Overall Study||11
10345492|NCT00408928|11483229|FG000|COMPLETED|Overall Study||8
10345493|NCT00408928|11483229|FG000|NOT COMPLETED|Overall Study||3
10345494|NCT00408993|11483235|FG000|STARTED|Overall Study||106
10345495|NCT00408993|11483236|FG001|STARTED|Overall Study||109
10345496|NCT00408993|11483235|FG000|COMPLETED|Overall Study||87
10345497|NCT00408993|11483236|FG001|COMPLETED|Overall Study||92
10345498|NCT00408993|11483235|FG000|NOT COMPLETED|Overall Study||19
10345499|NCT00408993|11483236|FG001|NOT COMPLETED|Overall Study||17
10345500|NCT00409006|11483248|FG000|STARTED|Overall Study||39
10345501|NCT00409006|11483249|FG001|STARTED|Overall Study||31
10345502|NCT00409006|11483248|FG000|COMPLETED|Overall Study||19
10345503|NCT00409006|11483249|FG001|COMPLETED|Overall Study||19
10345504|NCT00409006|11483248|FG000|NOT COMPLETED|Overall Study||20
10345505|NCT00409006|11483249|FG001|NOT COMPLETED|Overall Study||12
10345506|NCT00409175|11483257|FG000|STARTED|Overall Study||65
10345507|NCT00409175|11483258|FG001|STARTED|Overall Study||63
10345508|NCT00409175|11483257|FG000|COMPLETED|Overall Study||47
10345509|NCT00409175|11483258|FG001|COMPLETED|Overall Study||44
10345510|NCT00409175|11483257|FG000|NOT COMPLETED|Overall Study||18
10345511|NCT00409175|11483258|FG001|NOT COMPLETED|Overall Study||19
10345512|NCT00409188|11483266|FG000|STARTED|Overall Study||1006
10345513|NCT00409188|11483267|FG001|STARTED|Overall Study||507
10345514|NCT00409188|11483266|FG000|COMPLETED|Overall Study||623
10345515|NCT00409188|11483267|FG001|COMPLETED|Overall Study||332
10345516|NCT00409188|11483266|FG000|NOT COMPLETED|Overall Study||383
10345517|NCT00409188|11483267|FG001|NOT COMPLETED|Overall Study||175
10345518|NCT00409240|11483275|FG000|STARTED|Overall Study||53
10345519|NCT00409240|11483276|FG001|STARTED|Overall Study||50
10345520|NCT00409240|11483275|FG000|COMPLETED|Overall Study||50
10345521|NCT00409240|11483276|FG001|COMPLETED|Overall Study||49
10345522|NCT00409240|11483275|FG000|NOT COMPLETED|Overall Study||3
10345523|NCT00409240|11483276|FG001|NOT COMPLETED|Overall Study||1
10345524|NCT00409292|11483282|FG000|STARTED|Overall Study||33
10345525|NCT00409292|11483282|FG000|COMPLETED|Overall Study||33
10345526|NCT00409292|11483282|FG000|NOT COMPLETED|Overall Study||0
10345527|NCT00409409|11483290|FG000|STARTED|Overall Study||139
10345528|NCT00409409|11483291|FG001|STARTED|Overall Study||139
10345529|NCT00409409|11483290|FG000|COMPLETED|Overall Study||131
10345530|NCT00409409|11483291|FG001|COMPLETED|Overall Study||135
10345531|NCT00409409|11483290|FG000|NOT COMPLETED|Overall Study||8
10345532|NCT00409409|11483291|FG001|NOT COMPLETED|Overall Study||4
10345533|NCT00409539|11483302|FG000|STARTED|Overall Study||111
10345534|NCT00409539|11483303|FG001|STARTED|Overall Study||111
10345535|NCT00409539|11483304|FG002|STARTED|Overall Study||109
10345536|NCT00409539|11483305|FG003|STARTED|Overall Study||109
10345537|NCT00409539|11483306|FG004|STARTED|Overall Study||110
10345538|NCT00409539|11483302|FG000|COMPLETED|Overall Study||100
10345539|NCT00409539|11483303|FG001|COMPLETED|Overall Study||100
10345540|NCT00409539|11483304|FG002|COMPLETED|Overall Study||95
10345541|NCT00409539|11483305|FG003|COMPLETED|Overall Study||97
10345542|NCT00409539|11483306|FG004|COMPLETED|Overall Study||85
10345543|NCT00409539|11483302|FG000|NOT COMPLETED|Overall Study||11
10345544|NCT00409539|11483303|FG001|NOT COMPLETED|Overall Study||11
10345545|NCT00409539|11483304|FG002|NOT COMPLETED|Overall Study||14
10345546|NCT00409539|11483305|FG003|NOT COMPLETED|Overall Study||12
10345547|NCT00409539|11483306|FG004|NOT COMPLETED|Overall Study||25
10345548|NCT00409565|11483318|FG000|STARTED|Overall Study||46
10345549|NCT00409565|11483318|FG000|Overall Response Rate|Overall Study||7
10345550|NCT00409565|11483318|FG000|COMPLETED|Overall Study||45
10345551|NCT00409565|11483318|FG000|NOT COMPLETED|Overall Study||1
10345552|NCT00409578|11483326|FG000|STARTED|Overall Study||280
10345553|NCT00409578|11483327|FG001|STARTED|Overall Study||271
10345554|NCT00409578|11483328|FG002|STARTED|Overall Study||269
10345555|NCT00409578|11483329|FG003|STARTED|Overall Study||281
10345556|NCT00409578|11483326|FG000|COMPLETED|Overall Study||228
10345557|NCT00409578|11483327|FG001|COMPLETED|Overall Study||201
10532136|NCT01417481|11684454|FG001|STARTED|First Intervention (8 Weeks)||7
10345558|NCT00409578|11483328|FG002|COMPLETED|Overall Study||215
10345559|NCT00409578|11483329|FG003|COMPLETED|Overall Study||214
10345560|NCT00409578|11483326|FG000|NOT COMPLETED|Overall Study||52
10532137|NCT01417481|11684453|FG000|COMPLETED|First Intervention (8 Weeks)||8
10345561|NCT00409578|11483327|FG001|NOT COMPLETED|Overall Study||70
10345562|NCT00409578|11483328|FG002|NOT COMPLETED|Overall Study||54
10345563|NCT00409578|11483329|FG003|NOT COMPLETED|Overall Study||67
10345564|NCT00409617|11483339|FG000|STARTED|Overall Study||945
10345565|NCT00409617|11483339|FG000|COMPLETED|Overall Study||785
10345566|NCT00409617|11483339|FG000|NOT COMPLETED|Overall Study||160
10345567|NCT00409682|11483346|FG000|STARTED|Open-label Induction Period||192
10345568|NCT00409682|11483347|FG001|STARTED|Open-label Induction Period||0
10345569|NCT00409682|11483348|FG002|STARTED|Open-label Induction Period||0
10345570|NCT00409682|11483346|FG000|COMPLETED|Open-label Induction Period||188
10345571|NCT00409682|11483347|FG001|COMPLETED|Open-label Induction Period||0
10345572|NCT00409682|11483348|FG002|COMPLETED|Open-label Induction Period||0
10345573|NCT00409682|11483346|FG000|NOT COMPLETED|Open-label Induction Period||4
10345574|NCT00409682|11483347|FG001|NOT COMPLETED|Open-label Induction Period||0
10345575|NCT00409682|11483348|FG002|NOT COMPLETED|Open-label Induction Period||0
10345576|NCT00409682|11483346|FG000|STARTED|EOW Double-blind Maintenance Period||0
10345577|NCT00409682|11483347|FG001|STARTED|EOW Double-blind Maintenance Period||95
10345578|NCT00409682|11483348|FG002|STARTED|EOW Double-blind Maintenance Period||93
10345579|NCT00409682|11483346|FG000|COMPLETED|EOW Double-blind Maintenance Period||0
10345580|NCT00409682|11483347|FG001|COMPLETED|EOW Double-blind Maintenance Period||58
10345581|NCT00409682|11483348|FG002|COMPLETED|EOW Double-blind Maintenance Period||66
10345582|NCT00409682|11483346|FG000|NOT COMPLETED|EOW Double-blind Maintenance Period||0
10345583|NCT00409682|11483347|FG001|NOT COMPLETED|EOW Double-blind Maintenance Period||37
10345584|NCT00409682|11483348|FG002|NOT COMPLETED|EOW Double-blind Maintenance Period||27
10345585|NCT00409708|11483357|FG000|STARTED|Treatment|A total of 142 participants were screened for the study but only 109 were randomized to treatment|53
10345586|NCT00409708|11483358|FG001|STARTED|Treatment||56
10345587|NCT00409708|11483357|FG000|COMPLETED|Treatment||38
10345588|NCT00409708|11483358|FG001|COMPLETED|Treatment||39
10345589|NCT00409708|11483357|FG000|NOT COMPLETED|Treatment||15
10345590|NCT00409708|11483358|FG001|NOT COMPLETED|Treatment||17
10345591|NCT00409708|11483357|FG000|STARTED|Washout||38
10345592|NCT00409708|11483358|FG001|STARTED|Washout||39
10345593|NCT00409708|11483357|FG000|COMPLETED|Washout||17
10345594|NCT00409708|11483358|FG001|COMPLETED|Washout||29
10345595|NCT00409708|11483357|FG000|NOT COMPLETED|Washout||21
10345596|NCT00409708|11483358|FG001|NOT COMPLETED|Washout||10
10345597|NCT00409747|11483364|FG000|STARTED|Overall Study||11
10345598|NCT00409747|11483364|FG000|COMPLETED|Overall Study||10
10345599|NCT00409747|11483364|FG000|NOT COMPLETED|Overall Study||1
10345600|NCT00409786|11483368|FG000|STARTED|Overall Study||50
10345601|NCT00409786|11483368|FG000|COMPLETED|Overall Study||47
10345602|NCT00409786|11483368|FG000|NOT COMPLETED|Overall Study||3
10345603|NCT00409825|11483372|FG000|STARTED|Overall Study||61
10345604|NCT00409825|11483372|FG000|COMPLETED|Overall Study||61
10345605|NCT00409825|11483372|FG000|NOT COMPLETED|Overall Study||0
10345606|NCT00409838|11483378|FG000|STARTED|Short-term Period|Randomized|56
10345607|NCT00409838|11483379|FG001|STARTED|Short-term Period|Randomized|57
10345608|NCT00409838|11483378|FG000|Treated (Baseline) Population|Short-term Period||55
10345609|NCT00409838|11483379|FG001|Treated (Baseline) Population|Short-term Period||57
10345610|NCT00409838|11483378|FG000|COMPLETED|Short-term Period||53
10345611|NCT00409838|11483379|FG001|COMPLETED|Short-term Period|Participants who received placebo in this period received abatacept in next period.|52
10345612|NCT00409838|11483378|FG000|NOT COMPLETED|Short-term Period||3
10345613|NCT00409838|11483379|FG001|NOT COMPLETED|Short-term Period||5
10345614|NCT00409838|11483378|FG000|STARTED|Long-term Extension Period||105
10345615|NCT00409838|11483379|FG001|STARTED|Long-term Extension Period||0
10345616|NCT00409838|11483378|FG000|COMPLETED|Long-term Extension Period||87
10345617|NCT00409838|11483379|FG001|COMPLETED|Long-term Extension Period||0
10345618|NCT00409838|11483378|FG000|NOT COMPLETED|Long-term Extension Period||18
10345619|NCT00409838|11483379|FG001|NOT COMPLETED|Long-term Extension Period||0
10345620|NCT00410046|11483402|FG000|STARTED|Overall Study||84
10345621|NCT00410046|11483402|FG000|COMPLETED|Overall Study||79
10345622|NCT00410046|11483402|FG000|NOT COMPLETED|Overall Study||5
10345623|NCT00410059|11483407|FG000|STARTED|Overall Study||59
10345624|NCT00410059|11483407|FG000|COMPLETED|Overall Study||59
10345625|NCT00410059|11483407|FG000|NOT COMPLETED|Overall Study||0
10345626|NCT00410072|11483413|FG000|STARTED|Day 1 to Week 48|Number of participants randomized and treated; 4 more were randomized but not treated.|182
10345627|NCT00410072|11483414|FG001|STARTED|Day 1 to Week 48|Number of participants randomized and treated; 1 more was randomized but not treated.|197
10345628|NCT00410072|11483413|FG000|COMPLETED|Day 1 to Week 48||176
10345629|NCT00410072|11483414|FG001|COMPLETED|Day 1 to Week 48||185
10345630|NCT00410072|11483413|FG000|NOT COMPLETED|Day 1 to Week 48||6
10345631|NCT00410072|11483414|FG001|NOT COMPLETED|Day 1 to Week 48||12
10345632|NCT00410072|11483413|FG000|STARTED|After Week 48 to Week 96||176
10345633|NCT00410072|11483414|FG001|STARTED|After Week 48 to Week 96||185
10345634|NCT00410072|11483413|FG000|COMPLETED|After Week 48 to Week 96||170
10345635|NCT00410072|11483414|FG001|COMPLETED|After Week 48 to Week 96||174
10345636|NCT00410072|11483413|FG000|NOT COMPLETED|After Week 48 to Week 96||6
10345637|NCT00410072|11483414|FG001|NOT COMPLETED|After Week 48 to Week 96||11
10345638|NCT00410124|11483422|FG000|STARTED|Core Phase Double Blind (15 Months)|Started indicates randomized (FAS) and treated|277
10345639|NCT00410124|11483423|FG001|STARTED|Core Phase Double Blind (15 Months)||139
10345640|NCT00410124|11483422|FG000|Ongoing|Core Phase Double Blind (15 Months)||13
10345641|NCT00410124|11483423|FG001|Ongoing|Core Phase Double Blind (15 Months)||4
10345642|NCT00410124|11483422|FG000|Completed Double Blind Treatment|Core Phase Double Blind (15 Months)||62
10532138|NCT01417481|11684454|FG001|COMPLETED|First Intervention (8 Weeks)||5
10345643|NCT00410124|11483423|FG001|Completed Double Blind Treatment|Core Phase Double Blind (15 Months)||2
10345644|NCT00410124|11483422|FG000|COMPLETED|Core Phase Double Blind (15 Months)|Patients ongoing/completed double blind phase had option entering extension phase continuing RAD001.|75
10532139|NCT01417481|11684453|FG000|NOT COMPLETED|First Intervention (8 Weeks)||0
10532140|NCT01417481|11684454|FG001|NOT COMPLETED|First Intervention (8 Weeks)||2
10345645|NCT00410124|11483423|FG001|COMPLETED|Core Phase Double Blind (15 Months)|All patients ongoing/completed/not completed in core had option to enter extension taking RAD001.|6
10345646|NCT00410124|11483422|FG000|NOT COMPLETED|Core Phase Double Blind (15 Months)||202
10345647|NCT00410124|11483423|FG001|NOT COMPLETED|Core Phase Double Blind (15 Months)||133
10345648|NCT00410124|11483422|FG000|STARTED|Extension Phase - Open Label (45 Months)||67
10345649|NCT00410124|11483423|FG001|STARTED|Extension Phase - Open Label (45 Months)|Patients on placebo in core received RAD001 in extension phase.|111
10345650|NCT00410124|11483422|FG000|COMPLETED|Extension Phase - Open Label (45 Months)||0
10345651|NCT00410124|11483423|FG001|COMPLETED|Extension Phase - Open Label (45 Months)||0
10345652|NCT00410124|11483422|FG000|NOT COMPLETED|Extension Phase - Open Label (45 Months)||67
10345653|NCT00410124|11483423|FG001|NOT COMPLETED|Extension Phase - Open Label (45 Months)||111
10345654|NCT00410150|11483435|FG000|STARTED|Overall Study||22
10345655|NCT00410150|11483436|FG001|STARTED|Overall Study||20
10345656|NCT00410150|11483435|FG000|COMPLETED|Overall Study|2 study withdrawals (analyzed by intention-to-treat)|20
10345657|NCT00410150|11483436|FG001|COMPLETED|Overall Study|3 study withdrawals (analyzed by intention-to-treat0|17
10345658|NCT00410150|11483435|FG000|NOT COMPLETED|Overall Study||2
10345659|NCT00410150|11483436|FG001|NOT COMPLETED|Overall Study||3
10345660|NCT00410163|11483444|FG000|STARTED|Treatment and Follow-up Phase (2 Years)||31
10345661|NCT00410163|11483445|FG001|STARTED|Treatment and Follow-up Phase (2 Years)||30
10345662|NCT00410163|11483444|FG000|COMPLETED|Treatment and Follow-up Phase (2 Years)||19
10345663|NCT00410163|11483445|FG001|COMPLETED|Treatment and Follow-up Phase (2 Years)||19
10345664|NCT00410163|11483444|FG000|NOT COMPLETED|Treatment and Follow-up Phase (2 Years)||12
10345665|NCT00410163|11483445|FG001|NOT COMPLETED|Treatment and Follow-up Phase (2 Years)||11
10345666|NCT00410163|11483444|FG000|STARTED|Extended Follow-up (FU) Phase (2-5 Years|Participants who withdrew from the Treatment Phase were eligible to enter the Extended FU Phase.|20
10345667|NCT00410163|11483445|FG001|STARTED|Extended Follow-up (FU) Phase (2-5 Years|Participants who withdrew from the Treatment Phase were eligible to enter the Extended FU Phase.|21
10345668|NCT00410163|11483444|FG000|COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
10345669|NCT00410163|11483445|FG001|COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||11
10345670|NCT00410163|11483444|FG000|NOT COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
10345671|NCT00410163|11483445|FG001|NOT COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
10345672|NCT00410189|11483455|FG000|STARTED|Overall Study||54
10345673|NCT00410189|11483455|FG000|COMPLETED|Overall Study||54
10345674|NCT00410189|11483455|FG000|NOT COMPLETED|Overall Study||0
10345675|NCT00410202|11483462|FG000|STARTED|On-Treatment||138
10345676|NCT00410202|11483463|FG001|STARTED|On-Treatment||140
10345677|NCT00410202|11483464|FG002|STARTED|On-Treatment||137
10345678|NCT00410202|11483462|FG000|Discontinued Prior to Week 48 Visit|On-Treatment||4
10345679|NCT00410202|11483463|FG001|Discontinued Prior to Week 48 Visit|On-Treatment||2
10345680|NCT00410202|11483464|FG002|Discontinued Prior to Week 48 Visit|On-Treatment||2
10345681|NCT00410202|11483462|FG000|Discontinued at or After Week 48 Visit|On-Treatment||2
10345682|NCT00410202|11483463|FG001|Discontinued at or After Week 48 Visit|On-Treatment||6
10345683|NCT00410202|11483464|FG002|Discontinued at or After Week 48 Visit|On-Treatment||3
10345684|NCT00410202|11483462|FG000|COMPLETED|On-Treatment|Completed the 100 week dosing|63
10345685|NCT00410202|11483463|FG001|COMPLETED|On-Treatment|Completed the 100 week dosing|61
10345686|NCT00410202|11483464|FG002|COMPLETED|On-Treatment|Completed the 100 week dosing|66
10345687|NCT00410202|11483462|FG000|NOT COMPLETED|On-Treatment||75
10345688|NCT00410202|11483463|FG001|NOT COMPLETED|On-Treatment||79
10345689|NCT00410202|11483464|FG002|NOT COMPLETED|On-Treatment||71
10345690|NCT00410202|11483462|FG000|STARTED|Off-treatment Follow up||15
10345691|NCT00410202|11483463|FG001|STARTED|Off-treatment Follow up||8
10345692|NCT00410202|11483464|FG002|STARTED|Off-treatment Follow up||14
10345693|NCT00410202|11483462|FG000|COMPLETED|Off-treatment Follow up||1
10345694|NCT00410202|11483463|FG001|COMPLETED|Off-treatment Follow up||0
10345695|NCT00410202|11483464|FG002|COMPLETED|Off-treatment Follow up||2
10345696|NCT00410202|11483462|FG000|NOT COMPLETED|Off-treatment Follow up||14
10345697|NCT00410202|11483463|FG001|NOT COMPLETED|Off-treatment Follow up||8
10345698|NCT00410202|11483464|FG002|NOT COMPLETED|Off-treatment Follow up||12
10345699|NCT00410280|11483475|FG000|STARTED|Overall Study||14
10345700|NCT00410280|11483476|FG001|STARTED|Overall Study||13
10345701|NCT00410280|11483475|FG000|COMPLETED|Overall Study||14
10345702|NCT00410280|11483476|FG001|COMPLETED|Overall Study||13
10345703|NCT00410280|11483475|FG000|NOT COMPLETED|Overall Study||0
10345704|NCT00410280|11483476|FG001|NOT COMPLETED|Overall Study||0
10345705|NCT00410384|11483485|FG000|STARTED|Overall Study||275
10345706|NCT00410384|11483486|FG001|STARTED|Overall Study||271
10345707|NCT00410384|11483487|FG002|STARTED|Overall Study||273
10345708|NCT00410384|11483485|FG000|COMPLETED|Overall Study||186
10345709|NCT00410384|11483486|FG001|COMPLETED|Overall Study||199
10345710|NCT00410384|11483487|FG002|COMPLETED|Overall Study||191
10345711|NCT00410384|11483485|FG000|NOT COMPLETED|Overall Study||89
10345712|NCT00410384|11483486|FG001|NOT COMPLETED|Overall Study||72
10345713|NCT00410384|11483487|FG002|NOT COMPLETED|Overall Study||82
10345714|NCT00410410|11483501|FG000|STARTED|Induction Period (IP)||141
10345715|NCT00410410|11483502|FG001|STARTED|Induction Period (IP)||139
10532141|NCT01417481|11684453|FG000|STARTED|Washout (2 Weeks)||8
10345716|NCT00410410|11483503|FG002|STARTED|Induction Period (IP)||70
10345717|NCT00410410|11483504|FG003|STARTED|Induction Period (IP)||140
10345718|NCT00410410|11483505|FG004|STARTED|Induction Period (IP)||51
10345719|NCT00410410|11483506|FG005|STARTED|Induction Period (IP)||50
10345720|NCT00410410|11483507|FG006|STARTED|Induction Period (IP)||0
10345721|NCT00410410|11483508|FG007|STARTED|Induction Period (IP)||0
10345722|NCT00410410|11483509|FG008|STARTED|Induction Period (IP)||0
10345723|NCT00410410|11483501|FG000|COMPLETED|Induction Period (IP)||106
10345724|NCT00410410|11483502|FG001|COMPLETED|Induction Period (IP)||104
10345725|NCT00410410|11483503|FG002|COMPLETED|Induction Period (IP)||53
10345726|NCT00410410|11483504|FG003|COMPLETED|Induction Period (IP)||120
10345727|NCT00410410|11483505|FG004|COMPLETED|Induction Period (IP)||19
10345728|NCT00410410|11483506|FG005|COMPLETED|Induction Period (IP)||21
10345729|NCT00410410|11483507|FG006|COMPLETED|Induction Period (IP)||0
10345730|NCT00410410|11483508|FG007|COMPLETED|Induction Period (IP)||0
10345731|NCT00410410|11483509|FG008|COMPLETED|Induction Period (IP)||0
10345732|NCT00410410|11483501|FG000|NOT COMPLETED|Induction Period (IP)||35
10345733|NCT00410410|11483502|FG001|NOT COMPLETED|Induction Period (IP)||35
10345734|NCT00410410|11483503|FG002|NOT COMPLETED|Induction Period (IP)||17
10345735|NCT00410410|11483504|FG003|NOT COMPLETED|Induction Period (IP)||20
10345736|NCT00410410|11483505|FG004|NOT COMPLETED|Induction Period (IP)||32
10345737|NCT00410410|11483506|FG005|NOT COMPLETED|Induction Period (IP)||29
10345738|NCT00410410|11483507|FG006|NOT COMPLETED|Induction Period (IP)||0
10345739|NCT00410410|11483508|FG007|NOT COMPLETED|Induction Period (IP)||0
10345740|NCT00410410|11483509|FG008|NOT COMPLETED|Induction Period (IP)||0
10345741|NCT00410410|11483501|FG000|STARTED|Maintenance Period (MP)||0
10345742|NCT00410410|11483502|FG001|STARTED|Maintenance Period (MP)||0
10345743|NCT00410410|11483503|FG002|STARTED|Maintenance Period (MP)||0
10345744|NCT00410410|11483504|FG003|STARTED|Maintenance Period (MP)||0
10345745|NCT00410410|11483505|FG004|STARTED|Maintenance Period (MP)||0
10345746|NCT00410410|11483506|FG005|STARTED|Maintenance Period (MP)||0
10345747|NCT00410410|11483507|FG006|STARTED|Maintenance Period (MP)|At end of IP, 65 participants met response criteria and were randomly assigned to abatacept in MP.|65
10345748|NCT00410410|11483508|FG007|STARTED|Maintenance Period (MP)|At end of IP, 66 participants met response criteria and were randomly assigned to placebo in MP.|66
10345749|NCT00410410|11483509|FG008|STARTED|Maintenance Period (MP)||0
10345750|NCT00410410|11483501|FG000|COMPLETED|Maintenance Period (MP)||0
10345751|NCT00410410|11483502|FG001|COMPLETED|Maintenance Period (MP)||0
10345752|NCT00410410|11483503|FG002|COMPLETED|Maintenance Period (MP)||0
10345753|NCT00410410|11483504|FG003|COMPLETED|Maintenance Period (MP)||0
10345754|NCT00410410|11483505|FG004|COMPLETED|Maintenance Period (MP)||0
10345755|NCT00410410|11483506|FG005|COMPLETED|Maintenance Period (MP)||0
10345756|NCT00410410|11483507|FG006|COMPLETED|Maintenance Period (MP)||15
10345757|NCT00410410|11483508|FG007|COMPLETED|Maintenance Period (MP)||11
10345758|NCT00410410|11483509|FG008|COMPLETED|Maintenance Period (MP)||0
10345759|NCT00410410|11483501|FG000|NOT COMPLETED|Maintenance Period (MP)||0
10345760|NCT00410410|11483502|FG001|NOT COMPLETED|Maintenance Period (MP)||0
10345761|NCT00410410|11483503|FG002|NOT COMPLETED|Maintenance Period (MP)||0
10345762|NCT00410410|11483504|FG003|NOT COMPLETED|Maintenance Period (MP)||0
10345763|NCT00410410|11483505|FG004|NOT COMPLETED|Maintenance Period (MP)||0
10345764|NCT00410410|11483506|FG005|NOT COMPLETED|Maintenance Period (MP)||0
10345765|NCT00410410|11483507|FG006|NOT COMPLETED|Maintenance Period (MP)||50
10345766|NCT00410410|11483508|FG007|NOT COMPLETED|Maintenance Period (MP)||55
10345767|NCT00410410|11483509|FG008|NOT COMPLETED|Maintenance Period (MP)||0
10345768|NCT00410410|11483501|FG000|STARTED|Open-Label Period (OL)||0
10345769|NCT00410410|11483502|FG001|STARTED|Open-Label Period (OL)||0
10345770|NCT00410410|11483503|FG002|STARTED|Open-Label Period (OL)||0
10345771|NCT00410410|11483504|FG003|STARTED|Open-Label Period (OL)||0
10345772|NCT00410410|11483505|FG004|STARTED|Open-Label Period (OL)||0
10345773|NCT00410410|11483506|FG005|STARTED|Open-Label Period (OL)||0
10345774|NCT00410410|11483507|FG006|STARTED|Open-Label Period (OL)||0
10345775|NCT00410410|11483508|FG007|STARTED|Open-Label Period (OL)||0
10345776|NCT00410410|11483509|FG008|STARTED|Open-Label Period (OL)|349 entered OL (those who completed IP but failed response criteria, or completed/relapsed on MP).|349
10345777|NCT00410410|11483501|FG000|COMPLETED|Open-Label Period (OL)||0
10345778|NCT00410410|11483502|FG001|COMPLETED|Open-Label Period (OL)||0
10345779|NCT00410410|11483503|FG002|COMPLETED|Open-Label Period (OL)||0
10345780|NCT00410410|11483504|FG003|COMPLETED|Open-Label Period (OL)||0
10345781|NCT00410410|11483505|FG004|COMPLETED|Open-Label Period (OL)||0
10345782|NCT00410410|11483506|FG005|COMPLETED|Open-Label Period (OL)||0
10345783|NCT00410410|11483507|FG006|COMPLETED|Open-Label Period (OL)||0
10345784|NCT00410410|11483508|FG007|COMPLETED|Open-Label Period (OL)||0
10345785|NCT00410410|11483509|FG008|COMPLETED|Open-Label Period (OL)||0
10345786|NCT00410410|11483501|FG000|NOT COMPLETED|Open-Label Period (OL)||0
10345787|NCT00410410|11483502|FG001|NOT COMPLETED|Open-Label Period (OL)||0
10345788|NCT00410410|11483503|FG002|NOT COMPLETED|Open-Label Period (OL)||0
10345789|NCT00410410|11483504|FG003|NOT COMPLETED|Open-Label Period (OL)||0
10345790|NCT00410410|11483505|FG004|NOT COMPLETED|Open-Label Period (OL)||0
10345791|NCT00410410|11483506|FG005|NOT COMPLETED|Open-Label Period (OL)||0
10345792|NCT00410410|11483507|FG006|NOT COMPLETED|Open-Label Period (OL)||0
10345793|NCT00410410|11483508|FG007|NOT COMPLETED|Open-Label Period (OL)||0
10345794|NCT00410410|11483509|FG008|NOT COMPLETED|Open-Label Period (OL)||349
10345795|NCT00410423|11483544|FG000|STARTED|Phase 1 - Dose Level 1||3
10345796|NCT00410423|11483545|FG001|STARTED|Phase 1 - Dose Level 1||0
10345797|NCT00410423|11483546|FG002|STARTED|Phase 1 - Dose Level 1||0
10345798|NCT00410423|11483547|FG003|STARTED|Phase 1 - Dose Level 1||0
10345799|NCT00410423|11483544|FG000|COMPLETED|Phase 1 - Dose Level 1||3
10345800|NCT00410423|11483545|FG001|COMPLETED|Phase 1 - Dose Level 1||0
10345801|NCT00410423|11483546|FG002|COMPLETED|Phase 1 - Dose Level 1||0
10345802|NCT00410423|11483547|FG003|COMPLETED|Phase 1 - Dose Level 1||0
10345803|NCT00410423|11483544|FG000|NOT COMPLETED|Phase 1 - Dose Level 1||0
10345804|NCT00410423|11483545|FG001|NOT COMPLETED|Phase 1 - Dose Level 1||0
10345805|NCT00410423|11483546|FG002|NOT COMPLETED|Phase 1 - Dose Level 1||0
10345806|NCT00410423|11483547|FG003|NOT COMPLETED|Phase 1 - Dose Level 1||0
10345807|NCT00410423|11483544|FG000|STARTED|Phase 1 - Dose Level 2||0
10345808|NCT00410423|11483545|FG001|STARTED|Phase 1 - Dose Level 2||5
10345809|NCT00410423|11483546|FG002|STARTED|Phase 1 - Dose Level 2||0
10345810|NCT00410423|11483547|FG003|STARTED|Phase 1 - Dose Level 2||0
10345811|NCT00410423|11483544|FG000|COMPLETED|Phase 1 - Dose Level 2||0
10345812|NCT00410423|11483545|FG001|COMPLETED|Phase 1 - Dose Level 2||5
10345813|NCT00410423|11483546|FG002|COMPLETED|Phase 1 - Dose Level 2||0
10345814|NCT00410423|11483547|FG003|COMPLETED|Phase 1 - Dose Level 2||0
10345815|NCT00410423|11483544|FG000|NOT COMPLETED|Phase 1 - Dose Level 2||0
10345816|NCT00410423|11483545|FG001|NOT COMPLETED|Phase 1 - Dose Level 2||0
10345817|NCT00410423|11483546|FG002|NOT COMPLETED|Phase 1 - Dose Level 2||0
10345818|NCT00410423|11483547|FG003|NOT COMPLETED|Phase 1 - Dose Level 2||0
10345819|NCT00410423|11483544|FG000|STARTED|Phase 1 - Dose Level 3||0
10345820|NCT00410423|11483545|FG001|STARTED|Phase 1 - Dose Level 3||0
10345821|NCT00410423|11483546|FG002|STARTED|Phase 1 - Dose Level 3||3
10345822|NCT00410423|11483547|FG003|STARTED|Phase 1 - Dose Level 3||0
10345823|NCT00410423|11483544|FG000|COMPLETED|Phase 1 - Dose Level 3||0
10345824|NCT00410423|11483545|FG001|COMPLETED|Phase 1 - Dose Level 3||0
10345825|NCT00410423|11483546|FG002|COMPLETED|Phase 1 - Dose Level 3||3
10345826|NCT00410423|11483547|FG003|COMPLETED|Phase 1 - Dose Level 3||0
10345827|NCT00410423|11483544|FG000|NOT COMPLETED|Phase 1 - Dose Level 3||0
10345828|NCT00410423|11483545|FG001|NOT COMPLETED|Phase 1 - Dose Level 3||0
10345829|NCT00410423|11483546|FG002|NOT COMPLETED|Phase 1 - Dose Level 3||0
10345830|NCT00410423|11483547|FG003|NOT COMPLETED|Phase 1 - Dose Level 3||0
10345831|NCT00410423|11483544|FG000|STARTED|Phase 2||0
10345832|NCT00410423|11483545|FG001|STARTED|Phase 2||0
10345833|NCT00410423|11483546|FG002|STARTED|Phase 2||0
10345834|NCT00410423|11483547|FG003|STARTED|Phase 2||44
10345835|NCT00410423|11483544|FG000|COMPLETED|Phase 2||0
10345836|NCT00410423|11483545|FG001|COMPLETED|Phase 2||0
10345837|NCT00410423|11483546|FG002|COMPLETED|Phase 2||0
10345838|NCT00410423|11483547|FG003|COMPLETED|Phase 2||44
10345839|NCT00410423|11483544|FG000|NOT COMPLETED|Phase 2||0
10345840|NCT00410423|11483545|FG001|NOT COMPLETED|Phase 2||0
10345841|NCT00410423|11483546|FG002|NOT COMPLETED|Phase 2||0
10345842|NCT00410423|11483547|FG003|NOT COMPLETED|Phase 2||0
10345843|NCT00410488|11483556|FG000|STARTED|Overall Study||16
10345844|NCT00410488|11483557|FG001|STARTED|Overall Study||34
10345845|NCT00410488|11483556|FG000|COMPLETED|Overall Study||16
10345846|NCT00410488|11483557|FG001|COMPLETED|Overall Study||34
10345847|NCT00410488|11483556|FG000|NOT COMPLETED|Overall Study||0
10345848|NCT00410488|11483557|FG001|NOT COMPLETED|Overall Study||0
10345849|NCT00410514|11483565|FG000|STARTED|Overall Study||65
10345850|NCT00410514|11483566|FG001|STARTED|Overall Study||70
10345851|NCT00410514|11483567|FG002|STARTED|Overall Study||65
10345852|NCT00410514|11483565|FG000|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|65
10345853|NCT00410514|11483566|FG001|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|70
10345854|NCT00410514|11483567|FG002|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|65
10345855|NCT00410514|11483565|FG000|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|63
10345856|NCT00410514|11483566|FG001|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|64
10345857|NCT00410514|11483567|FG002|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|58
10345858|NCT00410514|11483565|FG000|COMPLETED|Overall Study||63
10345859|NCT00410514|11483566|FG001|COMPLETED|Overall Study||67
10345860|NCT00410514|11483567|FG002|COMPLETED|Overall Study||58
10345861|NCT00410514|11483565|FG000|NOT COMPLETED|Overall Study||2
10345862|NCT00410514|11483566|FG001|NOT COMPLETED|Overall Study||3
10345863|NCT00410514|11483567|FG002|NOT COMPLETED|Overall Study||7
10345864|NCT00410605|11483575|FG000|STARTED|Overall Study||39
10345865|NCT00410605|11483575|FG000|COMPLETED|Overall Study||14
10345866|NCT00410605|11483575|FG000|NOT COMPLETED|Overall Study||25
10345867|NCT00410761|11483581|FG000|STARTED|Overall Study|randomised patients|231
10345868|NCT00410761|11483582|FG001|STARTED|Overall Study|randomised patients|100
10345869|NCT00410761|11483581|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|111
10345870|NCT00410761|11483582|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|28
10345871|NCT00410761|11483581|FG000|NOT COMPLETED|Overall Study||120
10345872|NCT00410761|11483582|FG001|NOT COMPLETED|Overall Study||72
10345873|NCT00410813|11483590|FG000|STARTED|Overall Study||43
10345874|NCT00410813|11483591|FG001|STARTED|Overall Study||42
10345875|NCT00410813|11483590|FG000|Eligible|Overall Study||41
10345876|NCT00410813|11483591|FG001|Eligible|Overall Study||38
10345877|NCT00410813|11483590|FG000|COMPLETED|Overall Study|Patients treated until progression.|0
10345878|NCT00410813|11483591|FG001|COMPLETED|Overall Study||0
10345879|NCT00410813|11483590|FG000|NOT COMPLETED|Overall Study||43
10345880|NCT00410813|11483591|FG001|NOT COMPLETED|Overall Study||42
10345881|NCT00410826|11483622|FG000|STARTED|Overall Study||105
10345882|NCT00410826|11483623|FG001|STARTED|Overall Study||99
10345883|NCT00410826|11483622|FG000|COMPLETED|Overall Study||96
10345884|NCT00410826|11483623|FG001|COMPLETED|Overall Study||95
10345885|NCT00410826|11483622|FG000|NOT COMPLETED|Overall Study||9
10345886|NCT00410826|11483623|FG001|NOT COMPLETED|Overall Study||4
10345887|NCT00410891|11483629|FG000|STARTED|Overall Study||129
10345888|NCT00410891|11483629|FG000|COMPLETED|Overall Study||129
10345889|NCT00410891|11483629|FG000|NOT COMPLETED|Overall Study||0
10345890|NCT00410904|11483635|FG000|STARTED|Overall Study||40
10345891|NCT00410904|11483636|FG001|STARTED|Overall Study||20
10345892|NCT00410904|11483635|FG000|COMPLETED|Overall Study||40
10345893|NCT00410904|11483636|FG001|COMPLETED|Overall Study||20
10345894|NCT00410904|11483635|FG000|NOT COMPLETED|Overall Study||0
10345895|NCT00410904|11483636|FG001|NOT COMPLETED|Overall Study||0
10345896|NCT00411086|11483643|FG000|STARTED|Overall Study||52
10345897|NCT00411086|11483643|FG000|COMPLETED|Overall Study||52
10345898|NCT00411086|11483643|FG000|NOT COMPLETED|Overall Study||0
10345899|NCT00411151|11483647|FG000|STARTED|Overall Study||52
10345900|NCT00411151|11483647|FG000|COMPLETED|Overall Study||5
10345901|NCT00411151|11483647|FG000|NOT COMPLETED|Overall Study||47
10345902|NCT00411216|11483653|FG000|STARTED|Overall Study||13
10345903|NCT00411216|11483654|FG001|STARTED|Overall Study||10
10345904|NCT00411216|11483653|FG000|COMPLETED|Overall Study||13
10345905|NCT00411216|11483654|FG001|COMPLETED|Overall Study||8
10345906|NCT00411216|11483653|FG000|NOT COMPLETED|Overall Study||0
10345907|NCT00411216|11483654|FG001|NOT COMPLETED|Overall Study||2
10345908|NCT00411398|11483660|FG000|STARTED|Overall Study||15
10345909|NCT00411398|11483660|FG000|COMPLETED|Overall Study||10
10345910|NCT00411398|11483660|FG000|NOT COMPLETED|Overall Study||5
10345911|NCT00411411|11483666|FG000|STARTED|Overall Study||24
10345912|NCT00411411|11483667|FG001|STARTED|Overall Study||25
10345913|NCT00411411|11483666|FG000|COMPLETED|Overall Study||24
10345914|NCT00411411|11483667|FG001|COMPLETED|Overall Study||25
10345915|NCT00411411|11483666|FG000|NOT COMPLETED|Overall Study||0
10345916|NCT00411411|11483667|FG001|NOT COMPLETED|Overall Study||0
10345917|NCT00411450|11483674|FG000|STARTED|Overall Study||116
10345918|NCT00411450|11483674|FG000|Received Treatment|Overall Study||115
10345919|NCT00411450|11483674|FG000|COMPLETED|Overall Study|Ended second-line treatment|113
10345920|NCT00411450|11483674|FG000|NOT COMPLETED|Overall Study||3
10345921|NCT00411463|11483682|FG000|STARTED|Overall Study||14
10345922|NCT00411463|11483683|FG001|STARTED|Overall Study||11
10345923|NCT00411463|11483682|FG000|COMPLETED|Overall Study||11
10345924|NCT00411463|11483683|FG001|COMPLETED|Overall Study||8
10345925|NCT00411463|11483682|FG000|NOT COMPLETED|Overall Study||3
10345926|NCT00411463|11483683|FG001|NOT COMPLETED|Overall Study||3
10345927|NCT00411554|11483694|FG000|STARTED|Overall Study|Study enrolled slightly more than the target of N=155|163
10345928|NCT00411554|11483695|FG001|STARTED|Overall Study|Study enrolled slightly more than the target of N=155|156
10345929|NCT00411554|11483694|FG000|COMPLETED|Overall Study||155
10345930|NCT00411554|11483695|FG001|COMPLETED|Overall Study||147
10345931|NCT00411554|11483694|FG000|NOT COMPLETED|Overall Study||8
10345932|NCT00411554|11483695|FG001|NOT COMPLETED|Overall Study||9
10345933|NCT00411619|11483701|FG000|STARTED|Overall Study||28
10345934|NCT00411619|11483701|FG000|COMPLETED|Overall Study||22
10345935|NCT00411619|11483701|FG000|NOT COMPLETED|Overall Study||6
10345936|NCT00411632|11483706|FG000|STARTED|Overall Study||37
10345937|NCT00411632|11483706|FG000|COMPLETED|Overall Study||36
10345938|NCT00411632|11483706|FG000|NOT COMPLETED|Overall Study||1
10345939|NCT00411645|11483712|FG000|STARTED|Overall Study||227
10345940|NCT00411645|11483713|FG001|STARTED|Overall Study||454
10345941|NCT00411645|11483712|FG000|COMPLETED|Overall Study||146
10345942|NCT00411645|11483713|FG001|COMPLETED|Overall Study||290
10345943|NCT00411645|11483712|FG000|NOT COMPLETED|Overall Study||81
10345944|NCT00411645|11483713|FG001|NOT COMPLETED|Overall Study||164
10345945|NCT00411671|11483720|FG000|STARTED|Overall Study||105
10345946|NCT00411671|11483720|FG000|COMPLETED|Overall Study||85
10345947|NCT00411671|11483720|FG000|NOT COMPLETED|Overall Study||20
10345948|NCT00411684|11483724|FG000|STARTED|Overall Study||1533
10345949|NCT00411684|11483724|FG000|COMPLETED|Overall Study||1241
10345950|NCT00411684|11483724|FG000|NOT COMPLETED|Overall Study||292
10345951|NCT00411749|11483730|FG000|STARTED|Overall Study||82
10345952|NCT00411749|11483731|FG001|STARTED|Overall Study||25
10345953|NCT00411749|11483730|FG000|Vaccinated|Overall Study||82
10345954|NCT00411749|11483731|FG001|Vaccinated|Overall Study||25
10345955|NCT00411749|11483730|FG000|COMPLETED|Overall Study|Completed at 24 month after vaccination series (Month 30). Subjects were followed until Month 30|82
10345956|NCT00411749|11483731|FG001|COMPLETED|Overall Study|Completed at 1 month after vaccination series (Month 7). Subjects were followed until Month 7|25
10345957|NCT00411749|11483730|FG000|NOT COMPLETED|Overall Study||0
10345958|NCT00411749|11483731|FG001|NOT COMPLETED|Overall Study||0
10345959|NCT00411762|11483741|FG000|STARTED|Overall Study||25
10345960|NCT00411762|11483741|FG000|COMPLETED|Overall Study||20
10345961|NCT00411762|11483741|FG000|NOT COMPLETED|Overall Study||5
10345962|NCT00411788|11483745|FG000|STARTED|Overall Study||11
10345963|NCT00411788|11483745|FG000|COMPLETED|Overall Study||9
10345964|NCT00411788|11483745|FG000|NOT COMPLETED|Overall Study||2
10345965|NCT00412061|11483751|FG000|STARTED|Double Blind Phase||216
10345966|NCT00412061|11483752|FG001|STARTED|Double Blind Phase||213
10426601|NCT00848211|11572284|FG002|COMPLETED|Overall Study||5
10345967|NCT00412061|11483751|FG000|Safety Set|Double Blind Phase|1 patient did not provide at laest one valid post baseline safety assessment.|215
10345968|NCT00412061|11483752|FG001|Safety Set|Double Blind Phase|1 pt randomized never took drug Another randomized did not have valid post BL safety assessment|211
10345969|NCT00412061|11483751|FG000|COMPLETED|Double Blind Phase||0
10345970|NCT00412061|11483752|FG001|COMPLETED|Double Blind Phase||0
10345971|NCT00412061|11483751|FG000|NOT COMPLETED|Double Blind Phase||216
10345972|NCT00412061|11483752|FG001|NOT COMPLETED|Double Blind Phase||213
10345973|NCT00412061|11483751|FG000|STARTED|Open Label Phase||0
10345974|NCT00412061|11483752|FG001|STARTED|Open Label Phase||170
10345975|NCT00412061|11483751|FG000|COMPLETED|Open Label Phase||0
10345976|NCT00412061|11483752|FG001|COMPLETED|Open Label Phase||0
10345977|NCT00412061|11483751|FG000|NOT COMPLETED|Open Label Phase||0
10345978|NCT00412061|11483752|FG001|NOT COMPLETED|Open Label Phase||170
10345979|NCT00412074|11483764|FG000|STARTED|Overall Study||199
10345980|NCT00412074|11483765|FG001|STARTED|Overall Study||66
10345981|NCT00412074|11483766|FG002|STARTED|Overall Study||195
10345982|NCT00412074|11483764|FG000|COMPLETED|Overall Study||122
10345983|NCT00412074|11483765|FG001|COMPLETED|Overall Study||44
10345984|NCT00412074|11483766|FG002|COMPLETED|Overall Study||128
10345985|NCT00412074|11483764|FG000|NOT COMPLETED|Overall Study||77
10345986|NCT00412074|11483765|FG001|NOT COMPLETED|Overall Study||22
10345987|NCT00412074|11483766|FG002|NOT COMPLETED|Overall Study||67
10345988|NCT00412087|11483779|FG000|STARTED|Overall Study||134
10345989|NCT00412087|11483780|FG001|STARTED|Overall Study||131
10345990|NCT00412087|11483779|FG000|COMPLETED|Overall Study||72
10345991|NCT00412087|11483780|FG001|COMPLETED|Overall Study||66
10345992|NCT00412087|11483779|FG000|NOT COMPLETED|Overall Study||62
10345993|NCT00412087|11483780|FG001|NOT COMPLETED|Overall Study||65
10345994|NCT00412113|11483788|FG000|STARTED|Overall Study|15-January-2007|123
10345995|NCT00412113|11483789|FG001|STARTED|Overall Study|15-January-2007|122
10345996|NCT00412113|11483788|FG000|Received Treatment|Overall Study|One subject assigned to Norvasc and TLC did not receive treatment and was excluded from all analyses|122
10345997|NCT00412113|11483789|FG001|Received Treatment|Overall Study||122
10345998|NCT00412113|11483788|FG000|COMPLETED|Overall Study|15-April-2008|111
10345999|NCT00412113|11483789|FG001|COMPLETED|Overall Study|15-April-2008|107
10346000|NCT00412113|11483788|FG000|NOT COMPLETED|Overall Study||12
10346001|NCT00412113|11483789|FG001|NOT COMPLETED|Overall Study||15
10346002|NCT00412217|11483797|FG000|STARTED|Overall Study||46
10346003|NCT00412217|11483798|FG001|STARTED|Overall Study||48
10346004|NCT00412217|11483797|FG000|COMPLETED|Overall Study||0
10346005|NCT00412217|11483798|FG001|COMPLETED|Overall Study||0
10346006|NCT00412217|11483797|FG000|NOT COMPLETED|Overall Study||46
10346007|NCT00412217|11483798|FG001|NOT COMPLETED|Overall Study||48
10346008|NCT00412243|11483804|FG000|STARTED|Overall Study||50
10346009|NCT00412243|11483804|FG000|COMPLETED|Overall Study||50
10346010|NCT00412243|11483804|FG000|NOT COMPLETED|Overall Study||0
10346011|NCT00412360|11483810|FG000|STARTED|Overall Study||113
10346012|NCT00412360|11483811|FG001|STARTED|Overall Study||111
10346013|NCT00412360|11483810|FG000|COMPLETED|Overall Study||112
10346014|NCT00412360|11483811|FG001|COMPLETED|Overall Study||108
10346015|NCT00412360|11483810|FG000|NOT COMPLETED|Overall Study||1
10346016|NCT00412360|11483811|FG001|NOT COMPLETED|Overall Study||3
10346017|NCT00412373|11483819|FG000|STARTED|Overall Study|Number of Subjects in Intent-to-Treat Analysis Set.|93
10346018|NCT00412373|11483820|FG001|STARTED|Overall Study|Number of Subjects Intent-to-Treat Analysis Set.|211
10346019|NCT00412373|11483819|FG000|COMPLETED|Overall Study|Number of Subjects Who Completed Double-Blind Treatment.|52
10346020|NCT00412373|11483820|FG001|COMPLETED|Overall Study|Number of Subjects Who Completed Double-Blind Treatment..|134
10346021|NCT00412373|11483819|FG000|NOT COMPLETED|Overall Study||41
10346022|NCT00412373|11483820|FG001|NOT COMPLETED|Overall Study||77
10346023|NCT00412425|11483828|FG000|STARTED|Overall Study||15
10346024|NCT00412425|11483829|FG001|STARTED|Overall Study||15
10346025|NCT00412425|11483828|FG000|COMPLETED|Overall Study||15
10346026|NCT00412425|11483829|FG001|COMPLETED|Overall Study||15
10346027|NCT00412425|11483828|FG000|NOT COMPLETED|Overall Study||0
10346028|NCT00412425|11483829|FG001|NOT COMPLETED|Overall Study||0
10346029|NCT00412451|11483839|FG000|STARTED|Overall Study||8
10346030|NCT00412451|11483840|FG001|STARTED|Overall Study||15
10346031|NCT00412451|11483841|FG002|STARTED|Overall Study||15
10346032|NCT00412451|11483842|FG003|STARTED|Overall Study||13
10346033|NCT00412451|11483839|FG000|COMPLETED|Overall Study||8
10346034|NCT00412451|11483840|FG001|COMPLETED|Overall Study||15
10346035|NCT00412451|11483841|FG002|COMPLETED|Overall Study||14
10346036|NCT00412451|11483842|FG003|COMPLETED|Overall Study||11
10346037|NCT00412451|11483839|FG000|NOT COMPLETED|Overall Study||0
10346038|NCT00412451|11483840|FG001|NOT COMPLETED|Overall Study||0
10346039|NCT00412451|11483841|FG002|NOT COMPLETED|Overall Study||1
10346040|NCT00412451|11483842|FG003|NOT COMPLETED|Overall Study||2
10346041|NCT00412464|11483852|FG000|STARTED|Overall Study|Age Groups: 1-5 Years (10); 6-12 Years (7); 13-18 years (7)|24
10532218|NCT01418378|11684542|FG001|COMPLETED|Overall Study||83
10346042|NCT00412464|11483852|FG000|COMPLETED|Overall Study|Age Groups: 1-5 Years (10); 6-12 Years (7); 13-18 years (7)|24
10346043|NCT00412464|11483852|FG000|NOT COMPLETED|Overall Study||0
10346044|NCT00412516|11483859|FG000|STARTED|Overall Study||93
10346045|NCT00412516|11483860|FG001|STARTED|Overall Study||212
10346046|NCT00412516|11483861|FG002|STARTED|Overall Study||214
10346047|NCT00412516|11483859|FG000|COMPLETED|Overall Study||93
10346048|NCT00412516|11483860|FG001|COMPLETED|Overall Study||212
10346049|NCT00412516|11483861|FG002|COMPLETED|Overall Study||214
10346050|NCT00412516|11483859|FG000|NOT COMPLETED|Overall Study||0
10346051|NCT00412516|11483860|FG001|NOT COMPLETED|Overall Study||0
10346052|NCT00412516|11483861|FG002|NOT COMPLETED|Overall Study||0
10532142|NCT01417481|11684454|FG001|STARTED|Washout (2 Weeks)||5
10532143|NCT01417481|11684453|FG000|COMPLETED|Washout (2 Weeks)||8
10532144|NCT01417481|11684454|FG001|COMPLETED|Washout (2 Weeks)||5
10532145|NCT01417481|11684453|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10532146|NCT01417481|11684454|FG001|NOT COMPLETED|Washout (2 Weeks)||0
10532147|NCT01417481|11684453|FG000|STARTED|Second Period (8 Weeks)||8
10532148|NCT01417481|11684454|FG001|STARTED|Second Period (8 Weeks)||5
10532149|NCT01417481|11684453|FG000|COMPLETED|Second Period (8 Weeks)||8
10532150|NCT01417481|11684454|FG001|COMPLETED|Second Period (8 Weeks)||5
10532151|NCT01417481|11684453|FG000|NOT COMPLETED|Second Period (8 Weeks)||0
10532152|NCT01417481|11684454|FG001|NOT COMPLETED|Second Period (8 Weeks)||0
10532153|NCT01417741|11684462|FG000|STARTED|Overall Study||75
10532154|NCT01417741|11684463|FG001|STARTED|Overall Study||86
10532155|NCT01417741|11684462|FG000|COMPLETED|Overall Study||75
10532156|NCT01417741|11684463|FG001|COMPLETED|Overall Study|only 73 received the post op day phone phone call|86
10532157|NCT01417741|11684462|FG000|NOT COMPLETED|Overall Study||0
10532158|NCT01417741|11684463|FG001|NOT COMPLETED|Overall Study||0
10532159|NCT01417780|11684472|FG000|STARTED|Overall Study||15
10532160|NCT01417780|11684473|FG001|STARTED|Overall Study||17
10532161|NCT01417780|11684474|FG002|STARTED|Overall Study||11
10532162|NCT01417780|11684472|FG000|COMPLETED|Overall Study||14
10532163|NCT01417780|11684473|FG001|COMPLETED|Overall Study||14
10532164|NCT01417780|11684474|FG002|COMPLETED|Overall Study||9
10532165|NCT01417780|11684472|FG000|NOT COMPLETED|Overall Study||1
10532166|NCT01417780|11684473|FG001|NOT COMPLETED|Overall Study||3
10532167|NCT01417780|11684474|FG002|NOT COMPLETED|Overall Study||2
10532168|NCT01417936|11684482|FG000|STARTED|Overall Study||26
10532169|NCT01417936|11684482|FG000|COMPLETED|Overall Study||26
10532170|NCT01417936|11684482|FG000|NOT COMPLETED|Overall Study||0
10532171|NCT01418001|11684486|FG000|STARTED|Overall Study||5
10532172|NCT01418001|11684486|FG000|COMPLETED|Overall Study||5
10532173|NCT01418001|11684486|FG000|NOT COMPLETED|Overall Study||0
10532174|NCT01418209|11684494|FG000|STARTED|Overall Study||97
10532175|NCT01418209|11684495|FG001|STARTED|Overall Study||96
10532176|NCT01418209|11684496|FG002|STARTED|Overall Study||146
10532177|NCT01418209|11684494|FG000|COMPLETED|Overall Study||95
10532178|NCT01418209|11684495|FG001|COMPLETED|Overall Study||93
10532179|NCT01418209|11684496|FG002|COMPLETED|Overall Study||142
10532180|NCT01418209|11684494|FG000|NOT COMPLETED|Overall Study||2
10532181|NCT01418209|11684495|FG001|NOT COMPLETED|Overall Study||3
10532182|NCT01418209|11684496|FG002|NOT COMPLETED|Overall Study||4
10532183|NCT01418339|11684506|FG000|STARTED|Overall Study||90
10532184|NCT01418339|11684507|FG001|STARTED|Overall Study||45
10532185|NCT01418339|11684506|FG000|COMPLETED|Overall Study||78
10532186|NCT01418339|11684507|FG001|COMPLETED|Overall Study||35
10532187|NCT01418339|11684506|FG000|NOT COMPLETED|Overall Study||12
10532188|NCT01418339|11684507|FG001|NOT COMPLETED|Overall Study||10
10532189|NCT01418352|11684517|FG000|STARTED|Overall Study||20
10532190|NCT01418352|11684518|FG001|STARTED|Overall Study||21
10532191|NCT01418352|11684519|FG002|STARTED|Overall Study||21
10532192|NCT01418352|11684520|FG003|STARTED|Overall Study||21
10532193|NCT01418352|11684517|FG000|COMPLETED|Overall Study||17
10532194|NCT01418352|11684518|FG001|COMPLETED|Overall Study||17
10532195|NCT01418352|11684519|FG002|COMPLETED|Overall Study||16
10532196|NCT01418352|11684520|FG003|COMPLETED|Overall Study||18
10532197|NCT01418352|11684517|FG000|NOT COMPLETED|Overall Study||3
10532198|NCT01418352|11684518|FG001|NOT COMPLETED|Overall Study||4
10532199|NCT01418352|11684519|FG002|NOT COMPLETED|Overall Study||5
10532200|NCT01418352|11684520|FG003|NOT COMPLETED|Overall Study||3
10532201|NCT01418365|11684532|FG000|STARTED|First Intervention||15
10532202|NCT01418365|11684533|FG001|STARTED|First Intervention||15
10532203|NCT01418365|11684532|FG000|COMPLETED|First Intervention||14
10532204|NCT01418365|11684533|FG001|COMPLETED|First Intervention||14
10532205|NCT01418365|11684532|FG000|NOT COMPLETED|First Intervention||1
10532206|NCT01418365|11684533|FG001|NOT COMPLETED|First Intervention||1
10532207|NCT01418365|11684532|FG000|STARTED|Second Intervention||14
10532208|NCT01418365|11684533|FG001|STARTED|Second Intervention||14
10532209|NCT01418365|11684532|FG000|COMPLETED|Second Intervention||14
10532210|NCT01418365|11684533|FG001|COMPLETED|Second Intervention||13
10532211|NCT01418365|11684532|FG000|NOT COMPLETED|Second Intervention||0
10532212|NCT01418365|11684533|FG001|NOT COMPLETED|Second Intervention||1
10532213|NCT01418378|11684541|FG000|STARTED|Overall Study|A total of 191 subjects were enrolled into the study. 13/191 did not receive a study implant|90
10532214|NCT01418378|11684542|FG001|STARTED|Overall Study|A total of 191 subjects were enrolled into the study. 13/191 did not receive a study implant|88
10532215|NCT01418378|11684541|FG000|Subjects Who Received Study Implant|Overall Study|the number of subjects implanted with study implant|90
10532216|NCT01418378|11684542|FG001|Subjects Who Received Study Implant|Overall Study|the number of subjects implanted with study implant|88
10532217|NCT01418378|11684541|FG000|COMPLETED|Overall Study||89
10532219|NCT01418378|11684541|FG000|NOT COMPLETED|Overall Study||1
10532220|NCT01418378|11684542|FG001|NOT COMPLETED|Overall Study||5
10532221|NCT01418482|11684548|FG000|STARTED|Overall Study||15
10532222|NCT01418482|11684548|FG000|COMPLETED|Overall Study||15
10346053|NCT00412529|11483871|FG000|STARTED|Overall Study||23
10532223|NCT01418482|11684548|FG000|NOT COMPLETED|Overall Study||0
10532224|NCT01418703|11684554|FG000|STARTED|Overall Study||13
10532225|NCT01418703|11684555|FG001|STARTED|Overall Study||13
10532226|NCT01418703|11684556|FG002|STARTED|Overall Study||6
10346054|NCT00412529|11483872|FG001|STARTED|Overall Study||21
10346055|NCT00412529|11483871|FG000|COMPLETED|Overall Study||23
10346056|NCT00412529|11483872|FG001|COMPLETED|Overall Study||21
10346057|NCT00412529|11483871|FG000|NOT COMPLETED|Overall Study||0
10346058|NCT00412529|11483872|FG001|NOT COMPLETED|Overall Study||0
10346059|NCT00412542|11483880|FG000|STARTED|Overall Study||33
10346060|NCT00412542|11483881|FG001|STARTED|Overall Study||45
10346061|NCT00412542|11483880|FG000|COMPLETED|Overall Study||33
10346062|NCT00412542|11483881|FG001|COMPLETED|Overall Study||42
10346063|NCT00412542|11483880|FG000|NOT COMPLETED|Overall Study||0
10346064|NCT00412542|11483881|FG001|NOT COMPLETED|Overall Study||3
10346065|NCT00412607|11483885|FG000|STARTED|Overall Study||249
10346066|NCT00412607|11483885|FG000|Started Study Catheter|Overall Study||233
10346067|NCT00412607|11483885|FG000|COMPLETED|Overall Study||145
10346068|NCT00412607|11483885|FG000|NOT COMPLETED|Overall Study||104
10346069|NCT00412737|11483894|FG000|STARTED|Overall Study||237
10346070|NCT00412737|11483895|FG001|STARTED|Overall Study||238
10346071|NCT00412737|11483894|FG000|COMPLETED|Overall Study||221
10346072|NCT00412737|11483895|FG001|COMPLETED|Overall Study||232
10346073|NCT00412737|11483894|FG000|NOT COMPLETED|Overall Study||16
10346074|NCT00412737|11483895|FG001|NOT COMPLETED|Overall Study||6
10346075|NCT00412750|11483904|FG000|STARTED|Overall Study||50
10346076|NCT00412750|11483905|FG001|STARTED|Overall Study||55
10346077|NCT00412750|11483906|FG002|STARTED|Overall Study||54
10346078|NCT00412750|11483904|FG000|COMPLETED|Overall Study||19
10346079|NCT00412750|11483905|FG001|COMPLETED|Overall Study||34
10346080|NCT00412750|11483906|FG002|COMPLETED|Overall Study||31
10346081|NCT00412750|11483904|FG000|NOT COMPLETED|Overall Study||31
10346082|NCT00412750|11483905|FG001|NOT COMPLETED|Overall Study||21
10346083|NCT00412750|11483906|FG002|NOT COMPLETED|Overall Study||23
10346084|NCT00412841|11483918|FG000|STARTED|Overall Study||22
10346085|NCT00412841|11483919|FG001|STARTED|Overall Study||21
10346086|NCT00412841|11483918|FG000|COMPLETED|Overall Study||12
10346087|NCT00412841|11483919|FG001|COMPLETED|Overall Study||16
10346088|NCT00412841|11483918|FG000|NOT COMPLETED|Overall Study||10
10346089|NCT00412841|11483919|FG001|NOT COMPLETED|Overall Study||5
10346090|NCT00412854|11483928|FG000|STARTED|Overall Study||330
10346091|NCT00412854|11483929|FG001|STARTED|Overall Study||330
10346092|NCT00412854|11483928|FG000|COMPLETED|Overall Study||316
10346093|NCT00412854|11483929|FG001|COMPLETED|Overall Study||314
10346094|NCT00412854|11483928|FG000|NOT COMPLETED|Overall Study||14
10346095|NCT00412854|11483929|FG001|NOT COMPLETED|Overall Study||16
10346096|NCT00412867|11483935|FG000|STARTED|Overall Study||58
10346097|NCT00412867|11483935|FG000|COMPLETED|Overall Study||58
10346098|NCT00412867|11483935|FG000|NOT COMPLETED|Overall Study||0
10346099|NCT00412893|11483942|FG000|STARTED|Overall Study||263
10346100|NCT00412893|11483943|FG001|STARTED|Overall Study||264
10346101|NCT00412893|11483942|FG000|Received Treatment|Overall Study|One participant randomized to this group received voriconazole treatment for the first 7 days|258
10346102|NCT00412893|11483943|FG001|Received Treatment|Overall Study||258
10346103|NCT00412893|11483942|FG000|COMPLETED|Overall Study|Defined as completed treatment|118
10346104|NCT00412893|11483943|FG001|COMPLETED|Overall Study|Defined as completed treatment|120
10346105|NCT00412893|11483942|FG000|NOT COMPLETED|Overall Study||145
10346106|NCT00412893|11483943|FG001|NOT COMPLETED|Overall Study||144
10346107|NCT00412958|11483953|FG000|STARTED|Overall Study||29
10346108|NCT00412958|11483954|FG001|STARTED|Overall Study||33
10346109|NCT00412958|11483955|FG002|STARTED|Overall Study||32
10346110|NCT00412958|11483956|FG003|STARTED|Overall Study||31
10346111|NCT00412958|11483953|FG000|COMPLETED|Overall Study||26
10346112|NCT00412958|11483954|FG001|COMPLETED|Overall Study||29
10346113|NCT00412958|11483955|FG002|COMPLETED|Overall Study||32
10346114|NCT00412958|11483956|FG003|COMPLETED|Overall Study||30
10346115|NCT00412958|11483953|FG000|NOT COMPLETED|Overall Study||3
10346116|NCT00412958|11483954|FG001|NOT COMPLETED|Overall Study||4
10346117|NCT00412958|11483955|FG002|NOT COMPLETED|Overall Study||0
10346118|NCT00412958|11483956|FG003|NOT COMPLETED|Overall Study||1
10346119|NCT00412971|11483968|FG000|STARTED|Overall Study||115
10346120|NCT00412971|11483969|FG001|STARTED|Overall Study||118
10346121|NCT00412971|11483968|FG000|COMPLETED|Overall Study||85
10346122|NCT00412971|11483969|FG001|COMPLETED|Overall Study||108
10346123|NCT00412971|11483968|FG000|NOT COMPLETED|Overall Study||30
10346124|NCT00412971|11483969|FG001|NOT COMPLETED|Overall Study||10
10346125|NCT00412984|11483977|FG000|STARTED|Overall Study|Randomized participants|9120
10346126|NCT00412984|11483978|FG001|STARTED|Overall Study|Randomized participants|9081
10346127|NCT00412984|11483977|FG000|COMPLETED|Overall Study||6810
10346128|NCT00412984|11483978|FG001|COMPLETED|Overall Study||6588
10346129|NCT00412984|11483977|FG000|NOT COMPLETED|Overall Study||2310
10346130|NCT00412984|11483978|FG001|NOT COMPLETED|Overall Study||2493
10346131|NCT00413010|11483986|FG000|STARTED|Overall Study||180
10346132|NCT00413010|11483987|FG001|STARTED|Overall Study||176
10346133|NCT00413010|11483986|FG000|COMPLETED|Overall Study||108
10346134|NCT00413010|11483987|FG001|COMPLETED|Overall Study||113
10346135|NCT00413010|11483986|FG000|NOT COMPLETED|Overall Study||72
10346136|NCT00413010|11483987|FG001|NOT COMPLETED|Overall Study||63
10346137|NCT00413036|11483993|FG000|STARTED|Overall Study||217
10346138|NCT00413036|11483993|FG000|COMPLETED|Overall Study|Participants remain on study drug until progressive disease or unacceptable adverse events develop.|0
10346139|NCT00413036|11483993|FG000|NOT COMPLETED|Overall Study||217
10346140|NCT00413049|11483999|FG000|STARTED|Overall Study||349
10346141|NCT00413049|11484000|FG001|STARTED|Overall Study||349
10346142|NCT00413049|11483999|FG000|COMPLETED|Overall Study||325
10346143|NCT00413049|11484000|FG001|COMPLETED|Overall Study||331
10346144|NCT00413049|11483999|FG000|NOT COMPLETED|Overall Study||24
10346145|NCT00413049|11484000|FG001|NOT COMPLETED|Overall Study||18
10346146|NCT00413153|11484008|FG000|STARTED|Overall Study||7
10532227|NCT01418703|11684557|FG003|STARTED|Overall Study||6
10532228|NCT01418703|11684554|FG000|COMPLETED|Overall Study||13
10532229|NCT01418703|11684555|FG001|COMPLETED|Overall Study||13
10532230|NCT01418703|11684556|FG002|COMPLETED|Overall Study||6
10532231|NCT01418703|11684557|FG003|COMPLETED|Overall Study||6
10532232|NCT01418703|11684554|FG000|NOT COMPLETED|Overall Study||0
10532233|NCT01418703|11684555|FG001|NOT COMPLETED|Overall Study||0
10532234|NCT01418703|11684556|FG002|NOT COMPLETED|Overall Study||0
10532235|NCT01418703|11684557|FG003|NOT COMPLETED|Overall Study||0
10532236|NCT01418937|11684564|FG000|STARTED|Overall Study||164
10532237|NCT01418937|11684564|FG000|COMPLETED|Overall Study||156
10532238|NCT01418937|11684564|FG000|NOT COMPLETED|Overall Study||8
10532239|NCT01419015|11684568|FG000|STARTED|Overall Study||17
10532240|NCT01419015|11684568|FG000|COMPLETED|Overall Study||15
10532241|NCT01419015|11684568|FG000|NOT COMPLETED|Overall Study||2
10532242|NCT01419028|11684572|FG000|STARTED|Overall Study||48
10532243|NCT01419028|11684572|FG000|COMPLETED|Overall Study||48
10532244|NCT01419028|11684572|FG000|NOT COMPLETED|Overall Study||0
10532245|NCT01419171|11684576|FG000|STARTED|Overall Study||328
10532246|NCT01419171|11684576|FG000|COMPLETED|Overall Study||328
10532247|NCT01419171|11684576|FG000|NOT COMPLETED|Overall Study||0
10532248|NCT01419184|11684582|FG000|STARTED|Overall Study||128
10532249|NCT01419184|11684583|FG001|STARTED|Overall Study||121
10532250|NCT01419184|11684582|FG000|Received at Least 1 Dose of Study Drug|Overall Study||118
10532251|NCT01419184|11684583|FG001|Received at Least 1 Dose of Study Drug|Overall Study||106
10532252|NCT01419184|11684582|FG000|COMPLETED|Overall Study|6 participants did not complete the study due to no valid infection-related length of stay (IRLOS)|118
10532253|NCT01419184|11684583|FG001|COMPLETED|Overall Study|13 participants did not complete the study due to no valid infection-related length of stay (IRLOS)|106
10532254|NCT01419184|11684582|FG000|NOT COMPLETED|Overall Study||10
10532255|NCT01419184|11684583|FG001|NOT COMPLETED|Overall Study||15
10532256|NCT01419197|11684591|FG000|STARTED|Overall Study||404
10532257|NCT01419197|11684592|FG001|STARTED|Overall Study||198
10532258|NCT01419197|11684591|FG000|Switched to Trastuzumab Emtansine|Overall Study||0
10532259|NCT01419197|11684592|FG001|Switched to Trastuzumab Emtansine|Overall Study||94
10532260|NCT01419197|11684591|FG000|COMPLETED|Overall Study||0
10532261|NCT01419197|11684592|FG001|COMPLETED|Overall Study||0
10532262|NCT01419197|11684591|FG000|NOT COMPLETED|Overall Study||404
10532263|NCT01419197|11684592|FG001|NOT COMPLETED|Overall Study||198
10532264|NCT01419236|11684601|FG000|STARTED|Overall Study||36
10532265|NCT01419236|11684602|FG001|STARTED|Overall Study||40
10532266|NCT01419236|11684601|FG000|Received at Least 1 Dose of Study Drug|Overall Study||35
10532267|NCT01419236|11684602|FG001|Received at Least 1 Dose of Study Drug|Overall Study||39
10532268|NCT01419236|11684601|FG000|COMPLETED|Overall Study||31
10532269|NCT01419236|11684602|FG001|COMPLETED|Overall Study||35
10532270|NCT01419236|11684601|FG000|NOT COMPLETED|Overall Study||5
10532271|NCT01419236|11684602|FG001|NOT COMPLETED|Overall Study||5
10532272|NCT01419249|11684610|FG000|STARTED|Overall Study||318
10532273|NCT01419249|11684611|FG001|STARTED|Overall Study||140
10532274|NCT01419249|11684610|FG000|COMPLETED|Overall Study||318
10532275|NCT01419249|11684611|FG001|COMPLETED|Overall Study||140
10532276|NCT01419249|11684610|FG000|NOT COMPLETED|Overall Study||0
10532277|NCT01419249|11684611|FG001|NOT COMPLETED|Overall Study||0
10532278|NCT01419275|11684618|FG000|STARTED|Overall Study||126
10532279|NCT01419275|11684618|FG000|COMPLETED|Overall Study||126
10532280|NCT01419275|11684618|FG000|NOT COMPLETED|Overall Study||0
10532281|NCT01419314|11684624|FG000|STARTED|Start of Study|minor comfort issues were reported within the first 2 weeks of the trial|23
10532282|NCT01419314|11684625|FG001|STARTED|Start of Study|No comfort issues reported.|22
10532283|NCT01419314|11684624|FG000|COMPLETED|Start of Study||23
10532284|NCT01419314|11684625|FG001|COMPLETED|Start of Study||22
10532285|NCT01419314|11684624|FG000|NOT COMPLETED|Start of Study||0
10532286|NCT01419314|11684625|FG001|NOT COMPLETED|Start of Study||0
10532287|NCT01419314|11684624|FG000|STARTED|Follow-up at Week 3 of the Trial|3 participants discontinued the trial, 3 failed to return for additional follow-ups.|23
10532288|NCT01419314|11684625|FG001|STARTED|Follow-up at Week 3 of the Trial|one participant failed to return for the 3 week follow-up|22
10532289|NCT01419314|11684624|FG000|COMPLETED|Follow-up at Week 3 of the Trial||17
10532290|NCT01419314|11684625|FG001|COMPLETED|Follow-up at Week 3 of the Trial||21
10532291|NCT01419314|11684624|FG000|NOT COMPLETED|Follow-up at Week 3 of the Trial||6
10655593|NCT02208466|11816250|FG002|NOT COMPLETED|Overall Study||0
10346147|NCT00413153|11484009|FG001|STARTED|Overall Study||8
10346148|NCT00413153|11484008|FG000|COMPLETED|Overall Study||5
10346149|NCT00413153|11484009|FG001|COMPLETED|Overall Study||7
10346150|NCT00413153|11484008|FG000|NOT COMPLETED|Overall Study||2
10346151|NCT00413153|11484009|FG001|NOT COMPLETED|Overall Study||1
10346152|NCT00413166|11484018|FG000|STARTED|Overall Study||57
10346153|NCT00413166|11484019|FG001|STARTED|Overall Study||5
10346154|NCT00413166|11484020|FG002|STARTED|Overall Study||16
10346155|NCT00413166|11484018|FG000|COMPLETED|Overall Study||57
10346156|NCT00413166|11484019|FG001|COMPLETED|Overall Study||5
10346157|NCT00413166|11484020|FG002|COMPLETED|Overall Study||16
10346158|NCT00413166|11484018|FG000|NOT COMPLETED|Overall Study||0
10346159|NCT00413166|11484019|FG001|NOT COMPLETED|Overall Study||0
10346160|NCT00413166|11484020|FG002|NOT COMPLETED|Overall Study||0
10346161|NCT00413192|11484032|FG000|STARTED|Overall Study||37
10346162|NCT00413192|11484033|FG001|STARTED|Overall Study||40
10346163|NCT00413192|11484034|FG002|STARTED|Overall Study||19
10346164|NCT00413192|11484035|FG003|STARTED|Overall Study||32
10346165|NCT00413192|11484032|FG000|COMPLETED|Overall Study||0
10346166|NCT00413192|11484033|FG001|COMPLETED|Overall Study||0
10346167|NCT00413192|11484034|FG002|COMPLETED|Overall Study||0
10346168|NCT00413192|11484035|FG003|COMPLETED|Overall Study||0
10346169|NCT00413192|11484032|FG000|NOT COMPLETED|Overall Study||37
10346170|NCT00413192|11484033|FG001|NOT COMPLETED|Overall Study||40
10346171|NCT00413192|11484034|FG002|NOT COMPLETED|Overall Study||19
10346172|NCT00413192|11484035|FG003|NOT COMPLETED|Overall Study||32
10346173|NCT00413218|11484047|FG000|STARTED|Overall Study||223
10346174|NCT00413218|11484048|FG001|STARTED|Overall Study||227
10346175|NCT00413218|11484047|FG000|Intent to Treat Population (ITT)|Overall Study||221
10346176|NCT00413218|11484048|FG001|Intent to Treat Population (ITT)|Overall Study||219
10346177|NCT00413218|11484047|FG000|COMPLETED|Overall Study||120
10346178|NCT00413218|11484048|FG001|COMPLETED|Overall Study||131
10346179|NCT00413218|11484047|FG000|NOT COMPLETED|Overall Study||103
10346180|NCT00413218|11484048|FG001|NOT COMPLETED|Overall Study||96
10426602|NCT00848211|11572285|FG003|COMPLETED|Overall Study||5
10426603|NCT00848211|11572282|FG000|NOT COMPLETED|Overall Study||0
10426604|NCT00848211|11572283|FG001|NOT COMPLETED|Overall Study||1
10426605|NCT00848211|11572284|FG002|NOT COMPLETED|Overall Study||1
10426606|NCT00848211|11572285|FG003|NOT COMPLETED|Overall Study||0
10426607|NCT00848237|11572295|FG000|STARTED|Overall Study||5521
10426608|NCT00848237|11572295|FG000|COMPLETED|Overall Study||4982
10426609|NCT00848237|11572295|FG000|NOT COMPLETED|Overall Study||539
10426610|NCT00848250|11572301|FG000|STARTED|Overall Study||11
10426611|NCT00848250|11572302|FG001|STARTED|Overall Study||10
10426612|NCT00848250|11572301|FG000|COMPLETED|Overall Study||11
10426613|NCT00848250|11572302|FG001|COMPLETED|Overall Study||9
10426614|NCT00848250|11572301|FG000|NOT COMPLETED|Overall Study||0
10426615|NCT00848250|11572302|FG001|NOT COMPLETED|Overall Study||1
10426616|NCT00848354|11572311|FG000|STARTED|Phase 1|One participant was randomized to the Etanercept + Methotrexate group but received SSZ in error.|281
10426617|NCT00848354|11572312|FG001|STARTED|Phase 1||143
10426618|NCT00848354|11572311|FG000|COMPLETED|Phase 1||269
10426619|NCT00848354|11572312|FG001|COMPLETED|Phase 1||129
10426620|NCT00848354|11572311|FG000|NOT COMPLETED|Phase 1||12
10426621|NCT00848354|11572312|FG001|NOT COMPLETED|Phase 1||14
10426622|NCT00848354|11572311|FG000|STARTED|Phase 2 Year 1|Randomized Phase 1 treatment assignment. 9 participants discontinued between Phase 1 and Phase 2.|260
10426623|NCT00848354|11572312|FG001|STARTED|Phase 2 Year 1|Randomized Phase 1 treatment assignment. 3 participants discontinued between Phase 1 and Phase 2.|126
10426624|NCT00848354|11572311|FG000|COMPLETED|Phase 2 Year 1||242
10426625|NCT00848354|11572312|FG001|COMPLETED|Phase 2 Year 1||120
10426626|NCT00848354|11572311|FG000|NOT COMPLETED|Phase 2 Year 1||18
10426627|NCT00848354|11572312|FG001|NOT COMPLETED|Phase 2 Year 1||6
10426628|NCT00848354|11572311|FG000|STARTED|Phase 2 Year 2|"Randomized Phase 1 treatment assignment.~1 participant discontinued between Year 1 and Year 2."|241
10426629|NCT00848354|11572312|FG001|STARTED|Phase 2 Year 2|Randomized Phase 1 treatment assignment.|120
10426630|NCT00848354|11572311|FG000|COMPLETED|Phase 2 Year 2||218
10426631|NCT00848354|11572312|FG001|COMPLETED|Phase 2 Year 2||113
10426632|NCT00848354|11572311|FG000|NOT COMPLETED|Phase 2 Year 2||23
10426633|NCT00848354|11572312|FG001|NOT COMPLETED|Phase 2 Year 2||7
10426634|NCT00848367|11572324|FG000|STARTED|Overall Study||52
10426635|NCT00848367|11572325|FG001|STARTED|Overall Study||50
10426636|NCT00848367|11572324|FG000|COMPLETED|Overall Study||43
10426637|NCT00848367|11572325|FG001|COMPLETED|Overall Study||41
10426638|NCT00848367|11572324|FG000|NOT COMPLETED|Overall Study||9
10426639|NCT00848367|11572325|FG001|NOT COMPLETED|Overall Study||9
10426640|NCT00848393|11572336|FG000|STARTED|Overall Study||17
10426641|NCT00848393|11572337|FG001|STARTED|Overall Study||16
10426642|NCT00848393|11572338|FG002|STARTED|Overall Study||18
10426643|NCT00848393|11572336|FG000|COMPLETED|Overall Study||17
10426644|NCT00848393|11572337|FG001|COMPLETED|Overall Study||16
10426645|NCT00848393|11572338|FG002|COMPLETED|Overall Study||15
10426646|NCT00848393|11572336|FG000|NOT COMPLETED|Overall Study||0
10426647|NCT00848393|11572337|FG001|NOT COMPLETED|Overall Study||0
10426648|NCT00848393|11572338|FG002|NOT COMPLETED|Overall Study||3
10426649|NCT00848484|11572352|FG000|STARTED|First Intervention (Treatment Period 1)||27
10426650|NCT00848484|11572353|FG001|STARTED|First Intervention (Treatment Period 1)||27
10426651|NCT00848484|11572352|FG000|With Reduced Dose at Treatment Period 1|First Intervention (Treatment Period 1)||2
10426652|NCT00848484|11572353|FG001|With Reduced Dose at Treatment Period 1|First Intervention (Treatment Period 1)||1
10426653|NCT00848484|11572352|FG000|COMPLETED|First Intervention (Treatment Period 1)||25
10426654|NCT00848484|11572353|FG001|COMPLETED|First Intervention (Treatment Period 1)||24
10426655|NCT00848484|11572352|FG000|NOT COMPLETED|First Intervention (Treatment Period 1)||2
10426656|NCT00848484|11572353|FG001|NOT COMPLETED|First Intervention (Treatment Period 1)||3
10426657|NCT00848484|11572352|FG000|STARTED|Washout Period of Two Weeks||25
10426658|NCT00848484|11572353|FG001|STARTED|Washout Period of Two Weeks||24
10426659|NCT00848484|11572352|FG000|COMPLETED|Washout Period of Two Weeks||25
10426660|NCT00848484|11572353|FG001|COMPLETED|Washout Period of Two Weeks||21
10426661|NCT00848484|11572352|FG000|NOT COMPLETED|Washout Period of Two Weeks||0
10426662|NCT00848484|11572353|FG001|NOT COMPLETED|Washout Period of Two Weeks||3
10426663|NCT00848484|11572352|FG000|STARTED|Second Intervention (Treatment Period 2)||25
10426664|NCT00848484|11572353|FG001|STARTED|Second Intervention (Treatment Period 2)||21
10426665|NCT00848484|11572352|FG000|With Reduced Dose at Treatment Period 2|Second Intervention (Treatment Period 2)||0
10346181|NCT00413231|11484055|FG000|STARTED|0 to 30-day Post Treatment||160
10346182|NCT00413231|11484055|FG000|COMPLETED|0 to 30-day Post Treatment||152
10346183|NCT00413231|11484055|FG000|NOT COMPLETED|0 to 30-day Post Treatment||8
10346184|NCT00413231|11484055|FG000|STARTED|30-day to 365-day Post Treatment||152
10346185|NCT00413231|11484055|FG000|COMPLETED|30-day to 365-day Post Treatment||139
10346186|NCT00413231|11484055|FG000|NOT COMPLETED|30-day to 365-day Post Treatment||13
10346187|NCT00413231|11484055|FG000|STARTED|365-day to 60-month Post Treatment||139
10346188|NCT00413231|11484055|FG000|COMPLETED|365-day to 60-month Post Treatment||93
10346189|NCT00413231|11484055|FG000|NOT COMPLETED|365-day to 60-month Post Treatment||46
10346190|NCT00413244|11484062|FG000|STARTED|Overall Study||31
10346191|NCT00413244|11484063|FG001|STARTED|Overall Study||20
10346192|NCT00413244|11484062|FG000|COMPLETED|Overall Study||21
10346193|NCT00413244|11484063|FG001|COMPLETED|Overall Study||19
10346194|NCT00413244|11484062|FG000|NOT COMPLETED|Overall Study||10
10346195|NCT00413244|11484063|FG001|NOT COMPLETED|Overall Study||1
10346196|NCT00413283|11484073|FG000|STARTED|Overall Study||12
10346197|NCT00413283|11484074|FG001|STARTED|Overall Study||16
10346198|NCT00413283|11484075|FG002|STARTED|Overall Study||18
10346199|NCT00413283|11484076|FG003|STARTED|Overall Study||17
10346200|NCT00413283|11484073|FG000|Received Study Drug|Overall Study||12
10346201|NCT00413283|11484074|FG001|Received Study Drug|Overall Study||16
10346202|NCT00413283|11484075|FG002|Received Study Drug|Overall Study||18
10346203|NCT00413283|11484076|FG003|Received Study Drug|Overall Study||16
10346204|NCT00413283|11484073|FG000|COMPLETED|Overall Study||11
10346205|NCT00413283|11484074|FG001|COMPLETED|Overall Study||13
10346206|NCT00413283|11484075|FG002|COMPLETED|Overall Study||16
10346207|NCT00413283|11484076|FG003|COMPLETED|Overall Study||13
10346208|NCT00413283|11484073|FG000|NOT COMPLETED|Overall Study||1
10346209|NCT00413283|11484074|FG001|NOT COMPLETED|Overall Study||3
10346210|NCT00413283|11484075|FG002|NOT COMPLETED|Overall Study||2
10346211|NCT00413283|11484076|FG003|NOT COMPLETED|Overall Study||4
10346212|NCT00413335|11484088|FG000|STARTED|Overall Study||12
10346213|NCT00413335|11484089|FG001|STARTED|Overall Study||9
10346214|NCT00413335|11484088|FG000|COMPLETED|Overall Study||12
10346215|NCT00413335|11484089|FG001|COMPLETED|Overall Study||9
10346216|NCT00413335|11484088|FG000|NOT COMPLETED|Overall Study||0
10346217|NCT00413335|11484089|FG001|NOT COMPLETED|Overall Study||0
10346218|NCT00413374|11484097|FG000|STARTED|Overall Study||40
10346219|NCT00413374|11484098|FG001|STARTED|Overall Study||80
10346220|NCT00413374|11484097|FG000|COMPLETED|Overall Study||34
10346221|NCT00413374|11484098|FG001|COMPLETED|Overall Study||80
10346222|NCT00413374|11484097|FG000|NOT COMPLETED|Overall Study||6
10346223|NCT00413374|11484098|FG001|NOT COMPLETED|Overall Study||0
10346224|NCT00413400|11484109|FG000|STARTED|Overall Study||24
10346225|NCT00413400|11484110|FG001|STARTED|Overall Study||16
10346226|NCT00413400|11484109|FG000|3 Month Visit|Overall Study||22
10346227|NCT00413400|11484110|FG001|3 Month Visit|Overall Study||12
10346228|NCT00413400|11484109|FG000|COMPLETED|Overall Study||22
10346229|NCT00413400|11484110|FG001|COMPLETED|Overall Study||12
10346230|NCT00413400|11484109|FG000|NOT COMPLETED|Overall Study||2
10346231|NCT00413400|11484110|FG001|NOT COMPLETED|Overall Study||4
10346232|NCT00413413|11484119|FG000|STARTED|Single-Blind|In single-blind period participants were only enrolled to Valsartan 80 mg arm.|0
10346233|NCT00413413|11484120|FG001|STARTED|Single-Blind||1134
10346234|NCT00413413|11484121|FG002|STARTED|Single-Blind|In single-blind period participants were only enrolled to Valsartan 80 mg arm.|0
10346235|NCT00413413|11484119|FG000|COMPLETED|Single-Blind||0
10346236|NCT00413413|11484120|FG001|COMPLETED|Single-Blind||918
10346237|NCT00413413|11484121|FG002|COMPLETED|Single-Blind||0
10346238|NCT00413413|11484119|FG000|NOT COMPLETED|Single-Blind||0
10346239|NCT00413413|11484120|FG001|NOT COMPLETED|Single-Blind||216
10346240|NCT00413413|11484121|FG002|NOT COMPLETED|Single-Blind||0
10346241|NCT00413413|11484119|FG000|STARTED|Double-Blind||308
10346242|NCT00413413|11484120|FG001|STARTED|Double-Blind||307
10346243|NCT00413413|11484121|FG002|STARTED|Double-Blind||303
10346244|NCT00413413|11484119|FG000|COMPLETED|Double-Blind||293
10346245|NCT00413413|11484120|FG001|COMPLETED|Double-Blind||293
10346246|NCT00413413|11484121|FG002|COMPLETED|Double-Blind||285
10346247|NCT00413413|11484119|FG000|NOT COMPLETED|Double-Blind||15
10346248|NCT00413413|11484120|FG001|NOT COMPLETED|Double-Blind||14
10655594|NCT02208843|11816258|FG000|STARTED|Overall Study||60
10812405|NCT03682367|11974467|FG000|COMPLETED|Overall Study|Withdrawn due to non-compliance|2
10812406|NCT03682367|11974468|FG001|COMPLETED|Overall Study|Patients withdrawn due to confounding neuropathic pain or exited early from study.|0
10812407|NCT03682367|11974467|FG000|NOT COMPLETED|Overall Study||2
10812408|NCT03682367|11974468|FG001|NOT COMPLETED|Overall Study||4
10812409|NCT03680911|11974476|FG000|STARTED|Visit 1 (Baseline)||3
10812410|NCT03680911|11974477|FG001|STARTED|Visit 1 (Baseline)||4
10812411|NCT03680911|11974476|FG000|COMPLETED|Visit 1 (Baseline)||3
10812412|NCT03680911|11974477|FG001|COMPLETED|Visit 1 (Baseline)||4
10346249|NCT00413413|11484121|FG002|NOT COMPLETED|Double-Blind||18
10346250|NCT00413478|11484129|FG000|STARTED|Overall Study||9
10346251|NCT00413478|11484129|FG000|COMPLETED|Overall Study||9
10346252|NCT00413478|11484129|FG000|NOT COMPLETED|Overall Study||0
10346253|NCT00413582|11484135|FG000|STARTED|Overall Study|all enrolled completed|55
10346254|NCT00413582|11484136|FG001|STARTED|Overall Study|all enrolled completed|55
10346255|NCT00413582|11484135|FG000|Completion of Study|Overall Study|all enrolled completed|55
10429794|NCT00866359|11575868|FG000|COMPLETED|Observational Follow-Up Phase||0
10655595|NCT02208843|11816258|FG000|COMPLETED|Overall Study||0
10346256|NCT00413582|11484136|FG001|Completion of Study|Overall Study|all enrolled completed|55
10715722|NCT02688387|11880059|FG016|STARTED|Part 3A, Washout Period 2 (10 Days)||8
10715723|NCT02688387|11880060|FG017|STARTED|Part 3A, Washout Period 2 (10 Days)||8
10715724|NCT02688387|11880061|FG018|STARTED|Part 3A, Washout Period 2 (10 Days)||0
10715725|NCT02688387|11880062|FG019|STARTED|Part 3A, Washout Period 2 (10 Days)||0
10715726|NCT02688387|11880063|FG020|STARTED|Part 3A, Washout Period 2 (10 Days)||0
10346257|NCT00413582|11484135|FG000|COMPLETED|Overall Study|all enrolled completed|55
10346258|NCT00413582|11484136|FG001|COMPLETED|Overall Study|all enrolled completed|55
10346259|NCT00413582|11484135|FG000|NOT COMPLETED|Overall Study||0
10346260|NCT00413582|11484136|FG001|NOT COMPLETED|Overall Study||0
10346261|NCT00413634|11484144|FG000|STARTED|Overall Study||12
10346262|NCT00413634|11484145|FG001|STARTED|Overall Study||12
10346263|NCT00413634|11484144|FG000|COMPLETED|Overall Study||12
10346264|NCT00413634|11484145|FG001|COMPLETED|Overall Study||12
10346265|NCT00413634|11484144|FG000|NOT COMPLETED|Overall Study||0
10346266|NCT00413634|11484145|FG001|NOT COMPLETED|Overall Study||0
10346267|NCT00413660|11484160|FG000|STARTED|Up To Week 12||71
10346268|NCT00413660|11484161|FG001|STARTED|Up To Week 12||68
10346269|NCT00413660|11484162|FG002|STARTED|Up To Week 12||71
10346270|NCT00413660|11484163|FG003|STARTED|Up To Week 12||75
10346271|NCT00413660|11484164|FG004|STARTED|Up To Week 12||75
10346272|NCT00413660|11484165|FG005|STARTED|Up To Week 12||80
10346273|NCT00413660|11484166|FG006|STARTED|Up To Week 12||69
10346274|NCT00413660|11484167|FG007|STARTED|Up To Week 12||0
10346275|NCT00413660|11484168|FG008|STARTED|Up To Week 12||0
10346276|NCT00413660|11484169|FG009|STARTED|Up To Week 12||0
10346277|NCT00413660|11484170|FG010|STARTED|Up To Week 12||0
10346278|NCT00413660|11484160|FG000|Treated|Up To Week 12||70
10346279|NCT00413660|11484161|FG001|Treated|Up To Week 12||68
10346280|NCT00413660|11484162|FG002|Treated|Up To Week 12||71
10346281|NCT00413660|11484163|FG003|Treated|Up To Week 12||74
10346282|NCT00413660|11484164|FG004|Treated|Up To Week 12||75
10346283|NCT00413660|11484165|FG005|Treated|Up To Week 12||80
10346284|NCT00413660|11484166|FG006|Treated|Up To Week 12||69
10346285|NCT00413660|11484167|FG007|Treated|Up To Week 12||0
10346286|NCT00413660|11484168|FG008|Treated|Up To Week 12||0
10346287|NCT00413660|11484169|FG009|Treated|Up To Week 12||0
10346288|NCT00413660|11484170|FG010|Treated|Up To Week 12||0
10346289|NCT00413660|11484160|FG000|COMPLETED|Up To Week 12||64
10346290|NCT00413660|11484161|FG001|COMPLETED|Up To Week 12||61
10346291|NCT00413660|11484162|FG002|COMPLETED|Up To Week 12||64
10346292|NCT00413660|11484163|FG003|COMPLETED|Up To Week 12||67
10346293|NCT00413660|11484164|FG004|COMPLETED|Up To Week 12||66
10346294|NCT00413660|11484165|FG005|COMPLETED|Up To Week 12||70
10346295|NCT00413660|11484166|FG006|COMPLETED|Up To Week 12||58
10346296|NCT00413660|11484167|FG007|COMPLETED|Up To Week 12||0
10346297|NCT00413660|11484168|FG008|COMPLETED|Up To Week 12||0
10346298|NCT00413660|11484169|FG009|COMPLETED|Up To Week 12||0
10346299|NCT00413660|11484170|FG010|COMPLETED|Up To Week 12||0
10346300|NCT00413660|11484160|FG000|NOT COMPLETED|Up To Week 12||7
10346301|NCT00413660|11484161|FG001|NOT COMPLETED|Up To Week 12||7
10346302|NCT00413660|11484162|FG002|NOT COMPLETED|Up To Week 12||7
10346303|NCT00413660|11484163|FG003|NOT COMPLETED|Up To Week 12||8
10346304|NCT00413660|11484164|FG004|NOT COMPLETED|Up To Week 12||9
10346305|NCT00413660|11484165|FG005|NOT COMPLETED|Up To Week 12||10
10346306|NCT00413660|11484166|FG006|NOT COMPLETED|Up To Week 12||11
10346307|NCT00413660|11484167|FG007|NOT COMPLETED|Up To Week 12||0
10346308|NCT00413660|11484168|FG008|NOT COMPLETED|Up To Week 12||0
10346309|NCT00413660|11484169|FG009|NOT COMPLETED|Up To Week 12||0
10346310|NCT00413660|11484170|FG010|NOT COMPLETED|Up To Week 12||0
10346311|NCT00413660|11484160|FG000|STARTED|Post Week 12||43
10346312|NCT00413660|11484161|FG001|STARTED|Post Week 12||48
10346313|NCT00413660|11484162|FG002|STARTED|Post Week 12||64
10346314|NCT00413660|11484163|FG003|STARTED|Post Week 12||67
10346315|NCT00413660|11484164|FG004|STARTED|Post Week 12||66
10346316|NCT00413660|11484165|FG005|STARTED|Post Week 12||57
10346317|NCT00413660|11484166|FG006|STARTED|Post Week 12||40
10346318|NCT00413660|11484167|FG007|STARTED|Post Week 12||21
10346319|NCT00413660|11484168|FG008|STARTED|Post Week 12||13
10346320|NCT00413660|11484169|FG009|STARTED|Post Week 12||13
10346321|NCT00413660|11484170|FG010|STARTED|Post Week 12||18
10346322|NCT00413660|11484160|FG000|COMPLETED|Post Week 12||40
10346323|NCT00413660|11484161|FG001|COMPLETED|Post Week 12||44
10346324|NCT00413660|11484162|FG002|COMPLETED|Post Week 12||56
10715727|NCT02688387|11880064|FG021|STARTED|Part 3A, Washout Period 2 (10 Days)||0
10715728|NCT02688387|11880043|FG000|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10346325|NCT00413660|11484163|FG003|COMPLETED|Post Week 12||66
10346326|NCT00413660|11484164|FG004|COMPLETED|Post Week 12||60
10346327|NCT00413660|11484165|FG005|COMPLETED|Post Week 12||54
10346328|NCT00413660|11484166|FG006|COMPLETED|Post Week 12||37
10346329|NCT00413660|11484167|FG007|COMPLETED|Post Week 12||21
10346330|NCT00413660|11484168|FG008|COMPLETED|Post Week 12||13
10346331|NCT00413660|11484169|FG009|COMPLETED|Post Week 12||12
10346332|NCT00413660|11484170|FG010|COMPLETED|Post Week 12||17
10346333|NCT00413660|11484160|FG000|NOT COMPLETED|Post Week 12||3
10346334|NCT00413660|11484161|FG001|NOT COMPLETED|Post Week 12||4
10346335|NCT00413660|11484162|FG002|NOT COMPLETED|Post Week 12||8
10346336|NCT00413660|11484163|FG003|NOT COMPLETED|Post Week 12||1
10715729|NCT02688387|11880044|FG001|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10346337|NCT00413660|11484164|FG004|NOT COMPLETED|Post Week 12||6
10346338|NCT00413660|11484165|FG005|NOT COMPLETED|Post Week 12||3
10346339|NCT00413660|11484166|FG006|NOT COMPLETED|Post Week 12||3
10346340|NCT00413660|11484167|FG007|NOT COMPLETED|Post Week 12||0
10346341|NCT00413660|11484168|FG008|NOT COMPLETED|Post Week 12||0
10346342|NCT00413660|11484169|FG009|NOT COMPLETED|Post Week 12||1
10346343|NCT00413660|11484170|FG010|NOT COMPLETED|Post Week 12||1
10346344|NCT00413777|11484202|FG000|STARTED|Fixed-dose Period||22
10346345|NCT00413777|11484203|FG001|STARTED|Fixed-dose Period||24
10346346|NCT00413777|11484202|FG000|COMPLETED|Fixed-dose Period||18
10346347|NCT00413777|11484203|FG001|COMPLETED|Fixed-dose Period||21
10346348|NCT00413777|11484202|FG000|NOT COMPLETED|Fixed-dose Period||4
10346349|NCT00413777|11484203|FG001|NOT COMPLETED|Fixed-dose Period||3
10346350|NCT00413777|11484202|FG000|STARTED|Extension Period||17
10346351|NCT00413777|11484203|FG001|STARTED|Extension Period||18
10346352|NCT00413777|11484202|FG000|COMPLETED|Extension Period||17
10346353|NCT00413777|11484203|FG001|COMPLETED|Extension Period||18
10346354|NCT00413777|11484202|FG000|NOT COMPLETED|Extension Period||0
10346355|NCT00413777|11484203|FG001|NOT COMPLETED|Extension Period||0
10346356|NCT00413894|11484209|FG000|STARTED|Overall Study||424
10346357|NCT00413894|11484209|FG000|COMPLETED|Overall Study||344
10346358|NCT00413894|11484209|FG000|NOT COMPLETED|Overall Study||80
10346359|NCT00413920|11484218|FG000|STARTED|Overall Study||112
10346360|NCT00413920|11484219|FG001|STARTED|Overall Study||110
10346361|NCT00413920|11484218|FG000|COMPLETED|Overall Study||84
10346362|NCT00413920|11484219|FG001|COMPLETED|Overall Study||82
10532292|NCT01419314|11684625|FG001|NOT COMPLETED|Follow-up at Week 3 of the Trial||1
10532293|NCT01419314|11684624|FG000|STARTED|Follow-up at Week 6 of the Trial||17
10532294|NCT01419314|11684625|FG001|STARTED|Follow-up at Week 6 of the Trial|2 participants did not return for their final follow-up|21
10532295|NCT01419314|11684624|FG000|COMPLETED|Follow-up at Week 6 of the Trial|2 people who missed the first follow-up, returned for the final follow-up at week 6 (n=18).|16
10532296|NCT01419314|11684625|FG001|COMPLETED|Follow-up at Week 6 of the Trial||19
10532297|NCT01419314|11684624|FG000|NOT COMPLETED|Follow-up at Week 6 of the Trial||1
10532298|NCT01419314|11684625|FG001|NOT COMPLETED|Follow-up at Week 6 of the Trial||2
10532299|NCT01419535|11684637|FG000|STARTED|Overall Study||9
10532300|NCT01419535|11684638|FG001|STARTED|Overall Study||10
10532301|NCT01419535|11684637|FG000|COMPLETED|Overall Study||8
10532302|NCT01419535|11684638|FG001|COMPLETED|Overall Study||8
10532303|NCT01419535|11684637|FG000|NOT COMPLETED|Overall Study||1
10532304|NCT01419535|11684638|FG001|NOT COMPLETED|Overall Study||2
10532305|NCT01419626|11684647|FG000|STARTED|Overall Study||46
10532306|NCT01419626|11684648|FG001|STARTED|Overall Study||47
10532307|NCT01419626|11684649|FG002|STARTED|Overall Study||47
10532308|NCT01419626|11684647|FG000|COMPLETED|Overall Study||42
10532309|NCT01419626|11684648|FG001|COMPLETED|Overall Study||44
10655596|NCT02208843|11816258|FG000|NOT COMPLETED|Overall Study||60
10346363|NCT00413920|11484218|FG000|NOT COMPLETED|Overall Study||28
10346364|NCT00413920|11484219|FG001|NOT COMPLETED|Overall Study||28
10346365|NCT00413959|11484225|FG000|STARTED|Overall Study||12
10346366|NCT00413959|11484225|FG000|COMPLETED|Overall Study||11
10346367|NCT00413959|11484225|FG000|NOT COMPLETED|Overall Study||1
10346368|NCT00414011|11484229|FG000|STARTED|Overall Study||40
10346369|NCT00414011|11484229|FG000|COMPLETED|Overall Study||35
10346370|NCT00414011|11484229|FG000|NOT COMPLETED|Overall Study||5
10346371|NCT00414050|11484238|FG000|STARTED|Overall Study||431
10346372|NCT00414050|11484239|FG001|STARTED|Overall Study||427
10346373|NCT00414050|11484240|FG002|STARTED|Overall Study||429
10346374|NCT00414050|11484241|FG003|STARTED|Overall Study||431
10346375|NCT00414050|11484238|FG000|Received Vaccination 1|Overall Study||431
10346376|NCT00414050|11484239|FG001|Received Vaccination 1|Overall Study||426
10346377|NCT00414050|11484240|FG002|Received Vaccination 1|Overall Study||429
10346378|NCT00414050|11484241|FG003|Received Vaccination 1|Overall Study||431
10346379|NCT00414050|11484238|FG000|Received Vaccination 2|Overall Study||425
10346380|NCT00414050|11484239|FG001|Received Vaccination 2|Overall Study||421
10346381|NCT00414050|11484240|FG002|Received Vaccination 2|Overall Study||425
10346382|NCT00414050|11484241|FG003|Received Vaccination 2|Overall Study||425
10346383|NCT00414050|11484238|FG000|Received Vaccination 3|Overall Study||424
10346384|NCT00414050|11484239|FG001|Received Vaccination 3|Overall Study||419
10346385|NCT00414050|11484240|FG002|Received Vaccination 3|Overall Study||425
10346386|NCT00414050|11484241|FG003|Received Vaccination 3|Overall Study||424
10346387|NCT00414050|11484238|FG000|COMPLETED|Overall Study||422
10346388|NCT00414050|11484239|FG001|COMPLETED|Overall Study||419
10346389|NCT00414050|11484240|FG002|COMPLETED|Overall Study||423
10346390|NCT00414050|11484241|FG003|COMPLETED|Overall Study||423
10346391|NCT00414050|11484238|FG000|NOT COMPLETED|Overall Study||9
10346392|NCT00414050|11484239|FG001|NOT COMPLETED|Overall Study||8
10346393|NCT00414050|11484240|FG002|NOT COMPLETED|Overall Study||6
10346394|NCT00414050|11484241|FG003|NOT COMPLETED|Overall Study||8
10346395|NCT00414076|11484253|FG000|STARTED|Overall Study||4
10346396|NCT00414076|11484254|FG001|STARTED|Overall Study||5
10346397|NCT00414076|11484253|FG000|COMPLETED|Overall Study||1
10346398|NCT00414076|11484254|FG001|COMPLETED|Overall Study||0
10346399|NCT00414076|11484253|FG000|NOT COMPLETED|Overall Study||3
10532310|NCT01419626|11684649|FG002|COMPLETED|Overall Study||44
10532311|NCT01419626|11684647|FG000|NOT COMPLETED|Overall Study||4
10655597|NCT02208999|11816264|FG000|STARTED|Overall Study||106
10346400|NCT00414076|11484254|FG001|NOT COMPLETED|Overall Study||5
10346401|NCT00414167|11484262|FG000|STARTED|Overall Study||31
10346402|NCT00414167|11484263|FG001|STARTED|Overall Study||30
10346403|NCT00414167|11484262|FG000|COMPLETED|Overall Study||27
10346404|NCT00414167|11484263|FG001|COMPLETED|Overall Study||27
10346405|NCT00414167|11484262|FG000|NOT COMPLETED|Overall Study||4
10346406|NCT00414167|11484263|FG001|NOT COMPLETED|Overall Study||3
10346407|NCT00414206|11484274|FG000|STARTED|Overall Study||115
10346408|NCT00414206|11484275|FG001|STARTED|Overall Study||114
10346409|NCT00414206|11484276|FG002|STARTED|Overall Study||114
10346410|NCT00414206|11484274|FG000|COMPLETED|Overall Study||57
10346411|NCT00414206|11484275|FG001|COMPLETED|Overall Study||58
10346412|NCT00414206|11484276|FG002|COMPLETED|Overall Study||59
10346413|NCT00414206|11484274|FG000|NOT COMPLETED|Overall Study||58
10346414|NCT00414206|11484275|FG001|NOT COMPLETED|Overall Study||56
10346415|NCT00414206|11484276|FG002|NOT COMPLETED|Overall Study||55
10346416|NCT00414271|11484284|FG000|STARTED|Overall Study||18
10346417|NCT00414271|11484284|FG000|COMPLETED|Overall Study||18
10346418|NCT00414271|11484284|FG000|NOT COMPLETED|Overall Study||0
10346419|NCT00414310|11484290|FG000|STARTED|Overall Study||71
10346420|NCT00414310|11484291|FG001|STARTED|Overall Study||79
10346421|NCT00414310|11484290|FG000|COMPLETED|Overall Study||70
10346422|NCT00414310|11484291|FG001|COMPLETED|Overall Study||79
10346423|NCT00414310|11484290|FG000|NOT COMPLETED|Overall Study||1
10346424|NCT00414310|11484291|FG001|NOT COMPLETED|Overall Study||0
10346425|NCT00414388|11484299|FG000|STARTED|Overall Study||22
10346426|NCT00414388|11484299|FG000|COMPLETED|Overall Study||21
10346427|NCT00414388|11484299|FG000|NOT COMPLETED|Overall Study||1
10346428|NCT00414440|11484306|FG000|STARTED|Core Period|Core period|214
10346429|NCT00414440|11484307|FG001|STARTED|Core Period|Core period|217
10346430|NCT00414440|11484306|FG000|COMPLETED|Core Period|Core period|144
10346431|NCT00414440|11484307|FG001|COMPLETED|Core Period|Core period|185
10346432|NCT00414440|11484306|FG000|NOT COMPLETED|Core Period||70
10346433|NCT00414440|11484307|FG001|NOT COMPLETED|Core Period||32
10346434|NCT00414440|11484306|FG000|STARTED|Extension Period|Extension|214
10346435|NCT00414440|11484307|FG001|STARTED|Extension Period|Extension|217
10346436|NCT00414440|11484306|FG000|COMPLETED|Extension Period|Extension|64
10346437|NCT00414440|11484307|FG001|COMPLETED|Extension Period|Extension|77
10346438|NCT00414440|11484306|FG000|NOT COMPLETED|Extension Period||150
10346439|NCT00414440|11484307|FG001|NOT COMPLETED|Extension Period||140
10346440|NCT00414466|11484317|FG000|STARTED|Overall Study||44
10346441|NCT00414466|11484318|FG001|STARTED|Overall Study||42
10346442|NCT00414466|11484319|FG002|STARTED|Overall Study||41
10346443|NCT00414466|11484320|FG003|STARTED|Overall Study||43
10346444|NCT00414466|11484317|FG000|COMPLETED|Overall Study||42
10346445|NCT00414466|11484318|FG001|COMPLETED|Overall Study||42
10346446|NCT00414466|11484319|FG002|COMPLETED|Overall Study||40
10346447|NCT00414466|11484320|FG003|COMPLETED|Overall Study||42
10346448|NCT00414466|11484317|FG000|NOT COMPLETED|Overall Study||2
10346449|NCT00414466|11484318|FG001|NOT COMPLETED|Overall Study||0
10346450|NCT00414466|11484319|FG002|NOT COMPLETED|Overall Study||1
10346451|NCT00414466|11484320|FG003|NOT COMPLETED|Overall Study||1
10346452|NCT00414518|11484335|FG000|STARTED|Overall Study||7
10346453|NCT00414518|11484336|FG001|STARTED|Overall Study||9
10346454|NCT00414518|11484335|FG000|COMPLETED|Overall Study||7
10346455|NCT00414518|11484336|FG001|COMPLETED|Overall Study||9
10346456|NCT00414518|11484335|FG000|NOT COMPLETED|Overall Study||0
10346457|NCT00414518|11484336|FG001|NOT COMPLETED|Overall Study||0
10346458|NCT00414544|11484346|FG000|STARTED|Overall Study||145
10346459|NCT00414544|11484346|FG000|COMPLETED|Overall Study||131
10346460|NCT00414544|11484346|FG000|NOT COMPLETED|Overall Study||14
10346461|NCT00414596|11484352|FG000|STARTED|Overall Study|December 2006|20
10346462|NCT00414596|11484352|FG000|COMPLETED|Overall Study|April 2007|18
10346463|NCT00414596|11484352|FG000|NOT COMPLETED|Overall Study||2
10346464|NCT00414609|11484358|FG000|STARTED|Core Study||397
10346465|NCT00414609|11484359|FG001|STARTED|Core Study||423
10346466|NCT00414609|11484360|FG002|STARTED|Core Study||0
10346467|NCT00414609|11484358|FG000|Received Study Drug|Core Study||397
10346468|NCT00414609|11484359|FG001|Received Study Drug|Core Study||422
10346469|NCT00414609|11484360|FG002|Received Study Drug|Core Study||0
10346470|NCT00414609|11484358|FG000|Echocardiogram Evaluable Set|Core Study||330
10346471|NCT00414609|11484359|FG001|Echocardiogram Evaluable Set|Core Study||343
10346472|NCT00414609|11484360|FG002|Echocardiogram Evaluable Set|Core Study||0
10346473|NCT00414609|11484358|FG000|COMPLETED|Core Study||363
10346474|NCT00414609|11484359|FG001|COMPLETED|Core Study||378
10346475|NCT00414609|11484360|FG002|COMPLETED|Core Study||0
10346476|NCT00414609|11484358|FG000|NOT COMPLETED|Core Study||34
10346477|NCT00414609|11484359|FG001|NOT COMPLETED|Core Study||45
10346478|NCT00414609|11484360|FG002|NOT COMPLETED|Core Study||0
10346479|NCT00414609|11484358|FG000|STARTED|Extension Study||0
10346480|NCT00414609|11484359|FG001|STARTED|Extension Study||0
10346481|NCT00414609|11484360|FG002|STARTED|Extension Study|Patients of both core arms who completed core study and signed informed consent form for extension.|422
10346482|NCT00414609|11484358|FG000|Echocardiogram (ECHO) Analysis Set|Extension Study||0
10346483|NCT00414609|11484359|FG001|Echocardiogram (ECHO) Analysis Set|Extension Study||0
10346484|NCT00414609|11484360|FG002|Echocardiogram (ECHO) Analysis Set|Extension Study||400
10346485|NCT00414609|11484358|FG000|COMPLETED|Extension Study||0
10346486|NCT00414609|11484359|FG001|COMPLETED|Extension Study||0
10346487|NCT00414609|11484360|FG002|COMPLETED|Extension Study||365
10346488|NCT00414609|11484358|FG000|NOT COMPLETED|Extension Study||0
10346489|NCT00414609|11484359|FG001|NOT COMPLETED|Extension Study||0
10346490|NCT00414609|11484360|FG002|NOT COMPLETED|Extension Study||57
10346491|NCT00414635|11484371|FG000|STARTED|Overall Study||30
10346492|NCT00414635|11484372|FG001|STARTED|Overall Study||30
10346493|NCT00414635|11484371|FG000|COMPLETED|Overall Study||25
10346494|NCT00414635|11484372|FG001|COMPLETED|Overall Study||28
10346495|NCT00414635|11484371|FG000|NOT COMPLETED|Overall Study||5
10346496|NCT00414635|11484372|FG001|NOT COMPLETED|Overall Study||2
10346497|NCT00414661|11484382|FG000|STARTED|Overall Study||48
10346498|NCT00414661|11484383|FG001|STARTED|Overall Study||89
10346499|NCT00414661|11484384|FG002|STARTED|Overall Study||22
10346500|NCT00414661|11484385|FG003|STARTED|Overall Study||3
10715730|NCT02688387|11880045|FG002|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10715731|NCT02688387|11880046|FG003|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10715732|NCT02688387|11880047|FG004|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10715733|NCT02688387|11880048|FG005|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10715734|NCT02688387|11880049|FG006|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10346501|NCT00414661|11484382|FG000|COMPLETED|Overall Study||34
10346502|NCT00414661|11484383|FG001|COMPLETED|Overall Study||75
10346503|NCT00414661|11484384|FG002|COMPLETED|Overall Study||20
10346504|NCT00414661|11484385|FG003|COMPLETED|Overall Study||0
10346505|NCT00414661|11484382|FG000|NOT COMPLETED|Overall Study||14
10346506|NCT00414661|11484383|FG001|NOT COMPLETED|Overall Study||14
10346507|NCT00414661|11484384|FG002|NOT COMPLETED|Overall Study||2
10346508|NCT00414661|11484385|FG003|NOT COMPLETED|Overall Study||3
10346509|NCT00414700|11484397|FG000|STARTED|Overall Study||57
10346510|NCT00414700|11484398|FG001|STARTED|Overall Study||61
10346511|NCT00414700|11484397|FG000|COMPLETED|Overall Study||51
10346512|NCT00414700|11484398|FG001|COMPLETED|Overall Study||58
10346513|NCT00414700|11484397|FG000|NOT COMPLETED|Overall Study||6
10346514|NCT00414700|11484398|FG001|NOT COMPLETED|Overall Study||3
10346515|NCT00414726|11484406|FG000|STARTED|Overall Study||43
10346516|NCT00414726|11484407|FG001|STARTED|Overall Study||42
10346517|NCT00414726|11484406|FG000|COMPLETED|Overall Study||43
10346518|NCT00414726|11484407|FG001|COMPLETED|Overall Study||41
10346519|NCT00414726|11484406|FG000|NOT COMPLETED|Overall Study||0
10346520|NCT00414726|11484407|FG001|NOT COMPLETED|Overall Study||1
10346521|NCT00414765|11484415|FG000|STARTED|Overall Study||7
10346522|NCT00414765|11484416|FG001|STARTED|Overall Study||19
10346523|NCT00414765|11484415|FG000|Completed Study|Overall Study||7
10346524|NCT00414765|11484416|FG001|Completed Study|Overall Study||18
10346525|NCT00414765|11484415|FG000|Completed Cycle 1|Overall Study||7
10346526|NCT00414765|11484416|FG001|Completed Cycle 1|Overall Study||19
10346527|NCT00414765|11484415|FG000|Completed Cycle 2|Overall Study||4
10346528|NCT00414765|11484416|FG001|Completed Cycle 2|Overall Study||16
10346529|NCT00414765|11484415|FG000|COMPLETED|Overall Study||1
10346530|NCT00414765|11484416|FG001|COMPLETED|Overall Study||8
10346531|NCT00414765|11484415|FG000|NOT COMPLETED|Overall Study||6
10346532|NCT00414765|11484416|FG001|NOT COMPLETED|Overall Study||11
10346533|NCT00414817|11484424|FG000|STARTED|Overall Study||7033
10346534|NCT00414817|11484425|FG001|STARTED|Overall Study||7031
10346535|NCT00414817|11484424|FG000|Never Started on ICS|Overall Study|Not initial users of ICS and not starting during study, hence don't qualify for analysis sample.|1465
10346536|NCT00414817|11484425|FG001|Never Started on ICS|Overall Study|Not initial users of ICS and not starting during study, hence don't qualify for analysis sample.|1392
10346537|NCT00414817|11484424|FG000|Died or Left Health Plan|Overall Study|These individuals died or terminated Health Plan membership prior to ever qualifying for a call.|451
10346538|NCT00414817|11484425|FG001|Died or Left Health Plan|Overall Study|These individuals died or terminated Health Plan membership prior to ever qualifying for a call.|417
10346539|NCT00414817|11484424|FG000|Adherent ICS User|Overall Study|Fully adherent ICS users who never qualified for an intervention call.|922
10346540|NCT00414817|11484425|FG001|Adherent ICS User|Overall Study|Fully adherent ICS users who never qualified for an intervention call.|900
10346541|NCT00414817|11484424|FG000|Daily Oral Steroid User|Overall Study|qualified for analysis sample, but excluded due to subsequent determination of oral steroid use.|117
10346542|NCT00414817|11484425|FG001|Daily Oral Steroid User|Overall Study|qualified for analysis sample, but excluded due to subsequent determination of oral steroid use.|123
10346543|NCT00414817|11484424|FG000|<3 Months Follow-up|Overall Study|qualified for analysis sample, but excluded since follow-up too short to assess adherence reliably.|175
10346544|NCT00414817|11484425|FG001|<3 Months Follow-up|Overall Study|qualified for analysis sample, but excluded since follow-up too short to assess adherence reliably.|184
10346545|NCT00414817|11484424|FG000|COMPLETED|Overall Study|Qualified for primary analysis (3171 prior ICS users) or secondary analysis (732 new users) samples.|3903
10346546|NCT00414817|11484425|FG001|COMPLETED|Overall Study|Qualified for primary analysis (3260 prior ICS users) or secondary analysis (755 new users) samples.|4015
10346547|NCT00414817|11484424|FG000|NOT COMPLETED|Overall Study||3130
10346548|NCT00414817|11484425|FG001|NOT COMPLETED|Overall Study||3016
10346549|NCT00414908|11484433|FG000|STARTED|Overall Study||25
10346550|NCT00414908|11484434|FG001|STARTED|Overall Study||29
10346551|NCT00414908|11484433|FG000|COMPLETED|Overall Study||24
10346552|NCT00414908|11484434|FG001|COMPLETED|Overall Study||28
10346553|NCT00414908|11484433|FG000|NOT COMPLETED|Overall Study||1
10346554|NCT00414908|11484434|FG001|NOT COMPLETED|Overall Study||1
10532312|NCT01419626|11684648|FG001|NOT COMPLETED|Overall Study||3
10532313|NCT01419626|11684649|FG002|NOT COMPLETED|Overall Study||3
10532314|NCT01419639|11684657|FG000|STARTED|Overall Study||10
10532315|NCT01419639|11684657|FG000|COMPLETED|Overall Study||9
10532316|NCT01419639|11684657|FG000|NOT COMPLETED|Overall Study||1
10532317|NCT01419665|11684663|FG000|STARTED|Combination Treatment||312
10532318|NCT01419665|11684664|FG001|STARTED|Combination Treatment||315
10532319|NCT01419665|11684663|FG000|COMPLETED|Combination Treatment||274
10532320|NCT01419665|11684664|FG001|COMPLETED|Combination Treatment||274
10715735|NCT02688387|11880050|FG007|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10346555|NCT00414960|11484444|FG000|STARTED|Overall Study||25
10346556|NCT00414960|11484445|FG001|STARTED|Overall Study||15
10346557|NCT00414960|11484444|FG000|Received at Least One Dose of Study Drug|Overall Study||24
10346558|NCT00414960|11484445|FG001|Received at Least One Dose of Study Drug|Overall Study||15
10346559|NCT00414960|11484444|FG000|COMPLETED|Overall Study||18
10346560|NCT00414960|11484445|FG001|COMPLETED|Overall Study||14
10346561|NCT00414960|11484444|FG000|NOT COMPLETED|Overall Study||7
10346562|NCT00414960|11484445|FG001|NOT COMPLETED|Overall Study||1
10346563|NCT00414973|11484455|FG000|STARTED|Overall Study||218
10346564|NCT00414973|11484456|FG001|STARTED|Overall Study||109
10346565|NCT00414973|11484457|FG002|STARTED|Overall Study||24
10346566|NCT00414973|11484458|FG003|STARTED|Overall Study||11
10346567|NCT00414973|11484455|FG000|COMPLETED|Overall Study||190
10346568|NCT00414973|11484456|FG001|COMPLETED|Overall Study||99
10346569|NCT00414973|11484457|FG002|COMPLETED|Overall Study||21
10346570|NCT00414973|11484458|FG003|COMPLETED|Overall Study||11
10346571|NCT00414973|11484455|FG000|NOT COMPLETED|Overall Study||28
10346572|NCT00414973|11484456|FG001|NOT COMPLETED|Overall Study||10
10346573|NCT00414973|11484457|FG002|NOT COMPLETED|Overall Study||3
10346574|NCT00414973|11484458|FG003|NOT COMPLETED|Overall Study||0
10346575|NCT00415051|11484468|FG000|STARTED|Overall Study||20
10346576|NCT00415051|11484468|FG000|COMPLETED|Overall Study||19
10346577|NCT00415051|11484468|FG000|NOT COMPLETED|Overall Study||1
10346578|NCT00415168|11484472|FG000|STARTED|Overall Study||53
10346579|NCT00415168|11484472|FG000|Completed Treatment|Overall Study||15
10346580|NCT00415168|11484472|FG000|COMPLETED|Overall Study||1
10346581|NCT00415168|11484472|FG000|NOT COMPLETED|Overall Study||52
10346582|NCT00415194|11484478|FG000|STARTED|Overall Study||398
10346583|NCT00415194|11484479|FG001|STARTED|Overall Study||397
10346584|NCT00415194|11484478|FG000|Received at Least 1 Dose of Study Drug|Overall Study||392
10346585|NCT00415194|11484479|FG001|Received at Least 1 Dose of Study Drug|Overall Study||385
10346586|NCT00415194|11484478|FG000|COMPLETED|Overall Study||70
10346587|NCT00415194|11484479|FG001|COMPLETED|Overall Study||55
10346588|NCT00415194|11484478|FG000|NOT COMPLETED|Overall Study||328
10346589|NCT00415194|11484479|FG001|NOT COMPLETED|Overall Study||342
10346590|NCT00415363|11484487|FG000|STARTED|Overall Study||55
10346591|NCT00415363|11484488|FG001|STARTED|Overall Study||54
10346592|NCT00415363|11484487|FG000|Safety Population|Overall Study||54
10346593|NCT00415363|11484488|FG001|Safety Population|Overall Study||53
10346594|NCT00415363|11484487|FG000|COMPLETED|Overall Study||0
10346595|NCT00415363|11484488|FG001|COMPLETED|Overall Study||0
10346596|NCT00415363|11484487|FG000|NOT COMPLETED|Overall Study||55
10346597|NCT00415363|11484488|FG001|NOT COMPLETED|Overall Study||54
10346598|NCT00415493|11484497|FG000|STARTED|Overall Study||12
10346599|NCT00415493|11484498|FG001|STARTED|Overall Study||12
10346600|NCT00415493|11484497|FG000|COMPLETED|Overall Study||12
10346601|NCT00415493|11484498|FG001|COMPLETED|Overall Study||12
10346602|NCT00415493|11484497|FG000|NOT COMPLETED|Overall Study||0
10346603|NCT00415493|11484498|FG001|NOT COMPLETED|Overall Study||0
10346604|NCT00415506|11484506|FG000|STARTED|Overall Study||12
10346605|NCT00415506|11484507|FG001|STARTED|Overall Study||10
10346606|NCT00415506|11484506|FG000|COMPLETED|Overall Study||9
10346607|NCT00415506|11484507|FG001|COMPLETED|Overall Study||9
10346608|NCT00415506|11484506|FG000|NOT COMPLETED|Overall Study||3
10346609|NCT00415506|11484507|FG001|NOT COMPLETED|Overall Study||1
10346610|NCT00415519|11484515|FG000|STARTED|Overall Study||13
10532321|NCT01419665|11684663|FG000|NOT COMPLETED|Combination Treatment||38
10532322|NCT01419665|11684664|FG001|NOT COMPLETED|Combination Treatment||41
10532323|NCT01419665|11684663|FG000|STARTED|Maintenance Treatment and/or Follow up||254
10532324|NCT01419665|11684664|FG001|STARTED|Maintenance Treatment and/or Follow up||252
10532325|NCT01419665|11684663|FG000|COMPLETED|Maintenance Treatment and/or Follow up||132
10532326|NCT01419665|11684664|FG001|COMPLETED|Maintenance Treatment and/or Follow up||150
10532327|NCT01419665|11684663|FG000|NOT COMPLETED|Maintenance Treatment and/or Follow up||122
10532328|NCT01419665|11684664|FG001|NOT COMPLETED|Maintenance Treatment and/or Follow up||102
10532329|NCT01419665|11684663|FG000|STARTED|Open Label Phase||44
10532330|NCT01419665|11684664|FG001|STARTED|Open Label Phase||39
10532331|NCT01419665|11684663|FG000|COMPLETED|Open Label Phase||43
10532332|NCT01419665|11684664|FG001|COMPLETED|Open Label Phase||38
10532333|NCT01419665|11684663|FG000|NOT COMPLETED|Open Label Phase||1
10532334|NCT01419665|11684664|FG001|NOT COMPLETED|Open Label Phase||1
10532335|NCT01419717|11684672|FG000|STARTED|Overall Study||129
10532336|NCT01419717|11684672|FG000|Received Denosumab|Overall Study||128
10532337|NCT01419717|11684672|FG000|COMPLETED|Overall Study||4
10532338|NCT01419717|11684672|FG000|NOT COMPLETED|Overall Study||125
10532339|NCT01419769|11684676|FG000|STARTED|Overall Study||33
10532340|NCT01419769|11684676|FG000|COMPLETED|Overall Study||29
10532341|NCT01419769|11684676|FG000|NOT COMPLETED|Overall Study||4
10532342|NCT01419795|11684682|FG000|STARTED|Overall Study||3
10532343|NCT01419795|11684683|FG001|STARTED|Overall Study||0
10655598|NCT02208999|11816264|FG000|COMPLETED|Overall Study||105
10655599|NCT02208999|11816264|FG000|NOT COMPLETED|Overall Study||1
10655600|NCT02209064|11816283|FG000|STARTED|Overall Study||25
10655601|NCT02209064|11816283|FG000|COMPLETED|Overall Study||25
10532344|NCT01419795|11684682|FG000|COMPLETED|Overall Study||3
10532345|NCT01419795|11684683|FG001|COMPLETED|Overall Study||0
10655602|NCT02209064|11816283|FG000|NOT COMPLETED|Overall Study||0
10655603|NCT02209181|11816292|FG000|STARTED|Overall Study||67
10655604|NCT02209181|11816293|FG001|STARTED|Overall Study||67
10346611|NCT00415519|11484516|FG001|STARTED|Overall Study||12
10532346|NCT01419795|11684682|FG000|NOT COMPLETED|Overall Study||0
10346612|NCT00415519|11484515|FG000|COMPLETED|Overall Study||9
10346613|NCT00415519|11484516|FG001|COMPLETED|Overall Study||12
10346614|NCT00415519|11484515|FG000|NOT COMPLETED|Overall Study||4
10346615|NCT00415519|11484516|FG001|NOT COMPLETED|Overall Study||0
10346632|NCT00415597|11484531|FG000|STARTED|Enrollment||467
10346633|NCT00415597|11484531|FG000|COMPLETED|Enrollment||465
10346634|NCT00415597|11484531|FG000|NOT COMPLETED|Enrollment||2
10346635|NCT00415597|11484531|FG000|STARTED|Treatment||465
10346636|NCT00415597|11484531|FG000|COMPLETED|Treatment||160
10346637|NCT00415597|11484531|FG000|NOT COMPLETED|Treatment||305
10346638|NCT00415610|11484538|FG000|STARTED|Overall Study||18
10346639|NCT00415610|11484539|FG001|STARTED|Overall Study||20
10346640|NCT00415610|11484540|FG002|STARTED|Overall Study||22
10346641|NCT00415610|11484538|FG000|COMPLETED|Overall Study||15
10346642|NCT00415610|11484539|FG001|COMPLETED|Overall Study||18
10346643|NCT00415610|11484540|FG002|COMPLETED|Overall Study||17
10346644|NCT00415610|11484538|FG000|NOT COMPLETED|Overall Study||3
10346645|NCT00415610|11484539|FG001|NOT COMPLETED|Overall Study||2
10346646|NCT00415610|11484540|FG002|NOT COMPLETED|Overall Study||5
10346647|NCT00415636|11484554|FG000|STARTED|Overall Study||3
10346648|NCT00415636|11484555|FG001|STARTED|Overall Study||3
10346649|NCT00415636|11484556|FG002|STARTED|Overall Study||3
10346650|NCT00415636|11484557|FG003|STARTED|Overall Study||13
10346651|NCT00415636|11484558|FG004|STARTED|Overall Study||6
10346652|NCT00415636|11484559|FG005|STARTED|Overall Study||3
10346653|NCT00415636|11484554|FG000|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|2
10346654|NCT00415636|11484555|FG001|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|3
10346655|NCT00415636|11484556|FG002|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|2
10346656|NCT00415636|11484557|FG003|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|7
10346657|NCT00415636|11484558|FG004|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|4
10346658|NCT00415636|11484559|FG005|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|1
10346659|NCT00415636|11484554|FG000|NOT COMPLETED|Overall Study||1
10346660|NCT00415636|11484555|FG001|NOT COMPLETED|Overall Study||0
10346661|NCT00415636|11484556|FG002|NOT COMPLETED|Overall Study||1
10346662|NCT00415636|11484557|FG003|NOT COMPLETED|Overall Study||6
10346663|NCT00415636|11484558|FG004|NOT COMPLETED|Overall Study||2
10346664|NCT00415636|11484559|FG005|NOT COMPLETED|Overall Study||2
10346665|NCT00415857|11484583|FG000|STARTED|Overall Study||2
10346666|NCT00415857|11484584|FG001|STARTED|Overall Study||3
10346667|NCT00415857|11484583|FG000|COMPLETED|Overall Study||2
10346668|NCT00415857|11484584|FG001|COMPLETED|Overall Study||3
10346669|NCT00415857|11484583|FG000|NOT COMPLETED|Overall Study||0
10346670|NCT00415857|11484584|FG001|NOT COMPLETED|Overall Study||0
10346671|NCT00415870|11484592|FG000|STARTED|Overall Study||32
10346672|NCT00415870|11484593|FG001|STARTED|Overall Study||33
10346673|NCT00415870|11484592|FG000|COMPLETED|Overall Study||26
10346674|NCT00415870|11484593|FG001|COMPLETED|Overall Study||26
10346675|NCT00415870|11484592|FG000|NOT COMPLETED|Overall Study||6
10346676|NCT00415870|11484593|FG001|NOT COMPLETED|Overall Study||7
10346677|NCT00415909|11484599|FG000|STARTED|Overall Study||3
10346678|NCT00415909|11484599|FG000|COMPLETED|Overall Study||0
10346679|NCT00415909|11484599|FG000|NOT COMPLETED|Overall Study||3
10346680|NCT00416078|11484605|FG000|STARTED|Overall Study||29
10346681|NCT00416078|11484606|FG001|STARTED|Overall Study||24
10346682|NCT00416078|11484605|FG000|COMPLETED|Overall Study||18
10346683|NCT00416078|11484606|FG001|COMPLETED|Overall Study||16
10346684|NCT00416078|11484605|FG000|NOT COMPLETED|Overall Study||11
10346685|NCT00416078|11484606|FG001|NOT COMPLETED|Overall Study||8
10346686|NCT00416182|11484614|FG000|STARTED|Overall Study||8
10346687|NCT00416182|11484615|FG001|STARTED|Overall Study||8
10346688|NCT00416182|11484614|FG000|COMPLETED|Overall Study||5
10346689|NCT00416182|11484615|FG001|COMPLETED|Overall Study||6
10346690|NCT00416182|11484614|FG000|NOT COMPLETED|Overall Study||3
10346691|NCT00416182|11484615|FG001|NOT COMPLETED|Overall Study||2
10346692|NCT00416195|11484629|FG000|STARTED|Overall Study||10
10346693|NCT00416195|11484630|FG001|STARTED|Overall Study||38
10346694|NCT00416195|11484629|FG000|COMPLETED|Overall Study||8
10346695|NCT00416195|11484630|FG001|COMPLETED|Overall Study||34
10346696|NCT00416195|11484629|FG000|NOT COMPLETED|Overall Study||2
10346697|NCT00416195|11484630|FG001|NOT COMPLETED|Overall Study||4
10346698|NCT00416312|11484636|FG000|STARTED|Overall Study||9
10346699|NCT00416312|11484636|FG000|Conventional Dosimetry|Overall Study||9
10346700|NCT00416312|11484636|FG000|Patient-specific Dosimetry|Overall Study||9
10346701|NCT00416312|11484636|FG000|COMPLETED|Overall Study||7
10715736|NCT02688387|11880051|FG008|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10715737|NCT02688387|11880052|FG009|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10715738|NCT02688387|11880053|FG010|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10346702|NCT00416312|11484636|FG000|NOT COMPLETED|Overall Study||2
10346703|NCT00416455|11484642|FG000|STARTED|Overall Study|This is a diagnostic imaging study.|169
10346704|NCT00416455|11484643|FG001|STARTED|Overall Study|This is a diagnostic imaging study.|215
10346705|NCT00416455|11484642|FG000|COMPLETED|Overall Study|Number of patients with adequate imaging and pathology|153
10346706|NCT00416455|11484643|FG001|COMPLETED|Overall Study|Number of patients with adequate imaging and pathology|207
10346707|NCT00416455|11484642|FG000|NOT COMPLETED|Overall Study||16
10346708|NCT00416455|11484643|FG001|NOT COMPLETED|Overall Study||8
10346709|NCT00416494|11484662|FG000|STARTED|Overall Study||19
10346710|NCT00416494|11484663|FG001|STARTED|Overall Study||31
10346711|NCT00416494|11484662|FG000|COMPLETED|Overall Study||19
10346712|NCT00416494|11484663|FG001|COMPLETED|Overall Study||31
10346713|NCT00416494|11484662|FG000|NOT COMPLETED|Overall Study||0
10346714|NCT00416494|11484663|FG001|NOT COMPLETED|Overall Study||0
10346715|NCT00416520|11484671|FG000|STARTED|Open-label Period||165
10346716|NCT00416520|11484672|FG001|STARTED|Open-label Period||171
10346717|NCT00416520|11484673|FG002|STARTED|Open-label Period||0
10346718|NCT00416520|11484674|FG003|STARTED|Open-label Period||0
10346719|NCT00416520|11484671|FG000|COMPLETED|Open-label Period||105
10346720|NCT00416520|11484672|FG001|COMPLETED|Open-label Period||139
10346721|NCT00416520|11484673|FG002|COMPLETED|Open-label Period||0
10346722|NCT00416520|11484674|FG003|COMPLETED|Open-label Period||0
10346723|NCT00416520|11484671|FG000|NOT COMPLETED|Open-label Period||60
10346724|NCT00416520|11484672|FG001|NOT COMPLETED|Open-label Period||32
10346725|NCT00416520|11484673|FG002|NOT COMPLETED|Open-label Period||0
10346726|NCT00416520|11484674|FG003|NOT COMPLETED|Open-label Period||0
10346727|NCT00416520|11484671|FG000|STARTED|Placebo-controlled Withdrawal Period||0
10346728|NCT00416520|11484672|FG001|STARTED|Placebo-controlled Withdrawal Period||0
10346729|NCT00416520|11484673|FG002|STARTED|Placebo-controlled Withdrawal Period||50
10346730|NCT00416520|11484674|FG003|STARTED|Placebo-controlled Withdrawal Period||54
10346731|NCT00416520|11484671|FG000|COMPLETED|Placebo-controlled Withdrawal Period||0
10346732|NCT00416520|11484672|FG001|COMPLETED|Placebo-controlled Withdrawal Period||0
10346733|NCT00416520|11484673|FG002|COMPLETED|Placebo-controlled Withdrawal Period||49
10346734|NCT00416520|11484674|FG003|COMPLETED|Placebo-controlled Withdrawal Period||49
10346735|NCT00416520|11484671|FG000|NOT COMPLETED|Placebo-controlled Withdrawal Period||0
10346736|NCT00416520|11484672|FG001|NOT COMPLETED|Placebo-controlled Withdrawal Period||0
10346737|NCT00416520|11484673|FG002|NOT COMPLETED|Placebo-controlled Withdrawal Period||1
10346738|NCT00416520|11484674|FG003|NOT COMPLETED|Placebo-controlled Withdrawal Period||5
10346739|NCT00416572|11484687|FG000|STARTED|Overall Study||83
10346740|NCT00416572|11484688|FG001|STARTED|Overall Study||85
10346741|NCT00416572|11484689|FG002|STARTED|Overall Study||84
10346742|NCT00416572|11484687|FG000|COMPLETED|Overall Study||70
10346743|NCT00416572|11484688|FG001|COMPLETED|Overall Study||78
10346744|NCT00416572|11484689|FG002|COMPLETED|Overall Study||76
10346745|NCT00416572|11484687|FG000|NOT COMPLETED|Overall Study||13
10346746|NCT00416572|11484688|FG001|NOT COMPLETED|Overall Study||7
10346747|NCT00416572|11484689|FG002|NOT COMPLETED|Overall Study||8
10346748|NCT00416598|11484697|FG000|STARTED|Induction & Intensification||546
10346749|NCT00416598|11484697|FG000|COMPLETED|Induction & Intensification||134
10346750|NCT00416598|11484697|FG000|NOT COMPLETED|Induction & Intensification||412
10346751|NCT00416598|11484697|FG000|STARTED|Decitabine Maintenance||134
10346752|NCT00416598|11484697|FG000|COMPLETED|Decitabine Maintenance||62
10346753|NCT00416598|11484697|FG000|NOT COMPLETED|Decitabine Maintenance||72
10346754|NCT00416624|11484705|FG000|STARTED|Overall Study||61
10346755|NCT00416624|11484706|FG001|STARTED|Overall Study||60
10346756|NCT00416624|11484707|FG002|STARTED|Overall Study||58
10346757|NCT00416624|11484708|FG003|STARTED|Overall Study||57
10346758|NCT00416624|11484705|FG000|COMPLETED|Overall Study||39
10346759|NCT00416624|11484706|FG001|COMPLETED|Overall Study||33
10346760|NCT00416624|11484707|FG002|COMPLETED|Overall Study||40
10346761|NCT00416624|11484708|FG003|COMPLETED|Overall Study||40
10346762|NCT00416624|11484705|FG000|NOT COMPLETED|Overall Study||22
10346763|NCT00416624|11484706|FG001|NOT COMPLETED|Overall Study||27
10346764|NCT00416624|11484707|FG002|NOT COMPLETED|Overall Study||18
10346765|NCT00416624|11484708|FG003|NOT COMPLETED|Overall Study||17
10715739|NCT02688387|11880054|FG011|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10346766|NCT00416715|11484718|FG000|STARTED|Overall Study||100
10346767|NCT00416715|11484718|FG000|COMPLETED|Overall Study||85
10346768|NCT00416715|11484718|FG000|NOT COMPLETED|Overall Study||15
10346769|NCT00416793|11484725|FG000|STARTED|Overall Study||9
10346770|NCT00416793|11484725|FG000|COMPLETED|Overall Study||9
10346771|NCT00416793|11484725|FG000|NOT COMPLETED|Overall Study||0
10346772|NCT00416884|11484729|FG000|STARTED|Overall Study||1
10346773|NCT00416884|11484729|FG000|COMPLETED|Overall Study||0
10346774|NCT00416884|11484729|FG000|NOT COMPLETED|Overall Study||1
10346775|NCT00416949|11484733|FG000|STARTED|Overall Study||9
10346776|NCT00416949|11484733|FG000|COMPLETED|Overall Study||4
10346777|NCT00416949|11484733|FG000|NOT COMPLETED|Overall Study||5
10346778|NCT00417027|11484740|FG000|STARTED|Overall Study||66
10346779|NCT00417027|11484741|FG001|STARTED|Overall Study||65
10346780|NCT00417027|11484742|FG002|STARTED|Overall Study||59
10346781|NCT00417027|11484740|FG000|COMPLETED|Overall Study||66
10346782|NCT00417027|11484741|FG001|COMPLETED|Overall Study||60
10346783|NCT00417027|11484742|FG002|COMPLETED|Overall Study||54
10346784|NCT00417027|11484740|FG000|NOT COMPLETED|Overall Study||0
10346785|NCT00417027|11484741|FG001|NOT COMPLETED|Overall Study||5
10346786|NCT00417027|11484742|FG002|NOT COMPLETED|Overall Study||5
10346787|NCT00417079|11484752|FG000|STARTED|Overall Study|Randomized patients|377
10346788|NCT00417079|11484753|FG001|STARTED|Overall Study|Randomized patients|378
10346789|NCT00417079|11484752|FG000|COMPLETED|Overall Study|Randomized patients|46
10346790|NCT00417079|11484753|FG001|COMPLETED|Overall Study|Randomized patients|105
10346791|NCT00417079|11484752|FG000|NOT COMPLETED|Overall Study||331
10346792|NCT00417079|11484753|FG001|NOT COMPLETED|Overall Study||273
10346793|NCT00417170|11484761|FG000|STARTED|Overall Study|"Started indicates Safety population."|23
10346794|NCT00417170|11484762|FG001|STARTED|Overall Study||25
10346795|NCT00417170|11484761|FG000|Pharmacodynamics Population|Overall Study||21
10346796|NCT00417170|11484762|FG001|Pharmacodynamics Population|Overall Study||23
10346797|NCT00417170|11484761|FG000|COMPLETED|Overall Study||21
10346798|NCT00417170|11484762|FG001|COMPLETED|Overall Study||22
10346799|NCT00417170|11484761|FG000|NOT COMPLETED|Overall Study||2
10346800|NCT00417170|11484762|FG001|NOT COMPLETED|Overall Study||3
10346801|NCT00417274|11484768|FG000|STARTED|Overall Study||31
10346802|NCT00417274|11484768|FG000|COMPLETED|Overall Study||31
10346803|NCT00417274|11484768|FG000|NOT COMPLETED|Overall Study||0
10346804|NCT00417417|11484774|FG000|STARTED|Overall Study||4
10346805|NCT00417417|11484775|FG001|STARTED|Overall Study||6
10346806|NCT00417417|11484774|FG000|COMPLETED|Overall Study||4
10346807|NCT00417417|11484775|FG001|COMPLETED|Overall Study||6
10346808|NCT00417417|11484774|FG000|NOT COMPLETED|Overall Study||0
10346809|NCT00417417|11484775|FG001|NOT COMPLETED|Overall Study||0
10346810|NCT00417482|11484786|FG000|STARTED|Phase B 1st 16 Weeks|Risperidone 16 weeks.|32
10532347|NCT01419795|11684683|FG001|NOT COMPLETED|Overall Study||0
10532348|NCT01419977|11684691|FG000|STARTED|Overall Study||16
10532349|NCT01419977|11684692|FG001|STARTED|Overall Study||13
10532350|NCT01419977|11684691|FG000|COMPLETED|Overall Study||16
10532351|NCT01419977|11684692|FG001|COMPLETED|Overall Study||13
10532352|NCT01419977|11684691|FG000|NOT COMPLETED|Overall Study||0
10532353|NCT01419977|11684692|FG001|NOT COMPLETED|Overall Study||0
10532354|NCT01420016|11684700|FG000|STARTED|Primary Analysis||6970
10532355|NCT01420016|11684701|FG001|STARTED|Primary Analysis||6411
10532356|NCT01420016|11684702|FG002|STARTED|Primary Analysis||0
10655605|NCT02209181|11816294|FG002|STARTED|Overall Study||69
10655606|NCT02209181|11816295|FG003|STARTED|Overall Study||66
10655607|NCT02209181|11816292|FG000|COMPLETED|Overall Study||66
10655608|NCT02209181|11816293|FG001|COMPLETED|Overall Study||66
10655609|NCT02209181|11816294|FG002|COMPLETED|Overall Study||68
10655610|NCT02209181|11816295|FG003|COMPLETED|Overall Study||66
10655611|NCT02209181|11816292|FG000|NOT COMPLETED|Overall Study||1
10655612|NCT02209181|11816293|FG001|NOT COMPLETED|Overall Study||1
10655613|NCT02209181|11816294|FG002|NOT COMPLETED|Overall Study||1
10655614|NCT02209181|11816295|FG003|NOT COMPLETED|Overall Study||0
10655615|NCT02209259|11816308|FG000|STARTED|Overall Study||56
10655616|NCT02209259|11816309|FG001|STARTED|Overall Study||56
10715740|NCT02688387|11880055|FG012|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10346811|NCT00417482|11484787|FG001|STARTED|Phase B 1st 16 Weeks|Risperidone 16 weeks.|38
10346812|NCT00417482|11484788|FG002|STARTED|Phase B 1st 16 Weeks|Placebo 16 weeks.|40
10532357|NCT01420016|11684703|FG003|STARTED|Primary Analysis||0
10532358|NCT01420016|11684700|FG000|COMPLETED|Primary Analysis|Reflects patient participants included in final analysis.|4043
10532359|NCT01420016|11684701|FG001|COMPLETED|Primary Analysis|Reflects patient participants included in final analysis.|3871
10532360|NCT01420016|11684702|FG002|COMPLETED|Primary Analysis||0
10532361|NCT01420016|11684703|FG003|COMPLETED|Primary Analysis||0
10532362|NCT01420016|11684700|FG000|NOT COMPLETED|Primary Analysis||2927
10532363|NCT01420016|11684701|FG001|NOT COMPLETED|Primary Analysis||2540
10715741|NCT02688387|11880056|FG013|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10346813|NCT00417482|11484786|FG000|COMPLETED|Phase B 1st 16 Weeks||13
10532364|NCT01420016|11684702|FG002|NOT COMPLETED|Primary Analysis||0
10655617|NCT02209259|11816310|FG002|STARTED|Overall Study||56
10346814|NCT00417482|11484787|FG001|COMPLETED|Phase B 1st 16 Weeks||27
10346815|NCT00417482|11484788|FG002|COMPLETED|Phase B 1st 16 Weeks||13
10346816|NCT00417482|11484786|FG000|NOT COMPLETED|Phase B 1st 16 Weeks||19
10346817|NCT00417482|11484787|FG001|NOT COMPLETED|Phase B 1st 16 Weeks||11
10346818|NCT00417482|11484788|FG002|NOT COMPLETED|Phase B 1st 16 Weeks||27
10346819|NCT00417482|11484786|FG000|STARTED|Phase B 2nd 16 Weeks|Risperidone for 16 weeks.|13
10346820|NCT00417482|11484787|FG001|STARTED|Phase B 2nd 16 Weeks|Placebo for 16 weeks.|27
10346821|NCT00417482|11484788|FG002|STARTED|Phase B 2nd 16 Weeks|Placebo for 16 weeks.|13
10346822|NCT00417482|11484786|FG000|COMPLETED|Phase B 2nd 16 Weeks||10
10346823|NCT00417482|11484787|FG001|COMPLETED|Phase B 2nd 16 Weeks||14
10346824|NCT00417482|11484788|FG002|COMPLETED|Phase B 2nd 16 Weeks||10
10346825|NCT00417482|11484786|FG000|NOT COMPLETED|Phase B 2nd 16 Weeks||3
10346826|NCT00417482|11484787|FG001|NOT COMPLETED|Phase B 2nd 16 Weeks||13
10346827|NCT00417482|11484788|FG002|NOT COMPLETED|Phase B 2nd 16 Weeks||3
10346828|NCT00417612|11484804|FG000|STARTED|Overall Study||22
10346829|NCT00417612|11484805|FG001|STARTED|Overall Study||11
10346830|NCT00417612|11484804|FG000|COMPLETED|Overall Study||19
10346831|NCT00417612|11484805|FG001|COMPLETED|Overall Study||8
10346832|NCT00417612|11484804|FG000|NOT COMPLETED|Overall Study||3
10346833|NCT00417612|11484805|FG001|NOT COMPLETED|Overall Study||3
10346834|NCT00417859|11484815|FG000|STARTED|Overall Study||26
10346835|NCT00417859|11484816|FG001|STARTED|Overall Study||30
10346836|NCT00417859|11484815|FG000|COMPLETED|Overall Study||26
10346837|NCT00417859|11484816|FG001|COMPLETED|Overall Study||29
10346838|NCT00417859|11484815|FG000|NOT COMPLETED|Overall Study||0
10346839|NCT00417859|11484816|FG001|NOT COMPLETED|Overall Study||1
10346840|NCT00417885|11484824|FG000|STARTED|Overall Study||6
10346841|NCT00417885|11484824|FG000|COMPLETED|Overall Study||0
10346842|NCT00417885|11484824|FG000|NOT COMPLETED|Overall Study||6
10346843|NCT00417963|11484828|FG000|STARTED|Overall Study|79 participants were enrolled in the roll-in cohort and 407 in the pivotal cohort.|486
10346844|NCT00417963|11484828|FG000|COMPLETED|Overall Study|79 subjects completed in the roll-in cohort and 371 in the pivotal cohort.|445
10346845|NCT00417963|11484828|FG000|NOT COMPLETED|Overall Study||41
10346846|NCT00417976|11484837|FG000|STARTED|Overall Study||42
10346847|NCT00417976|11484837|FG000|COMPLETED|Overall Study||39
10346848|NCT00417976|11484837|FG000|NOT COMPLETED|Overall Study||3
10346849|NCT00417989|11484844|FG000|STARTED|Overall Study|Intent to Treat include safety population & subjects with baseline & 1 post baseline A1C measurement|244
10346850|NCT00417989|11484845|FG001|STARTED|Overall Study||241
10346851|NCT00417989|11484844|FG000|COMPLETED|Overall Study||224
10346852|NCT00417989|11484845|FG001|COMPLETED|Overall Study||219
10346853|NCT00417989|11484844|FG000|NOT COMPLETED|Overall Study||20
10346854|NCT00417989|11484845|FG001|NOT COMPLETED|Overall Study||22
10346855|NCT00418015|11484857|FG000|STARTED|Overall Study||144
10346856|NCT00418015|11484858|FG001|STARTED|Overall Study||46
10346857|NCT00418015|11484859|FG002|STARTED|Overall Study||78
10346858|NCT00418015|11484860|FG003|STARTED|Overall Study||25
10346859|NCT00418015|11484857|FG000|COMPLETED|Overall Study||144
10346860|NCT00418015|11484858|FG001|COMPLETED|Overall Study||46
10346861|NCT00418015|11484859|FG002|COMPLETED|Overall Study||78
10346862|NCT00418015|11484860|FG003|COMPLETED|Overall Study||25
10346863|NCT00418015|11484857|FG000|NOT COMPLETED|Overall Study||0
10346864|NCT00418015|11484858|FG001|NOT COMPLETED|Overall Study||0
10346865|NCT00418015|11484859|FG002|NOT COMPLETED|Overall Study||0
10346866|NCT00418015|11484860|FG003|NOT COMPLETED|Overall Study||0
10346867|NCT00418028|11484872|FG000|STARTED|Overall Study||97
10346868|NCT00418028|11484873|FG001|STARTED|Overall Study||98
10346869|NCT00418028|11484872|FG000|COMPLETED|Overall Study||95
10346870|NCT00418028|11484873|FG001|COMPLETED|Overall Study||97
10346871|NCT00418028|11484872|FG000|NOT COMPLETED|Overall Study||2
10346872|NCT00418028|11484873|FG001|NOT COMPLETED|Overall Study||1
10346873|NCT00418093|11484879|FG000|STARTED|Overall Study||19
10346874|NCT00418093|11484879|FG000|Completed Study|Overall Study||19
10346875|NCT00418093|11484879|FG000|COMPLETED|Overall Study||19
10346876|NCT00418093|11484879|FG000|NOT COMPLETED|Overall Study||0
10346877|NCT00418184|11484885|FG000|STARTED|Double-blind Phase||137
10346878|NCT00418184|11484886|FG001|STARTED|Double-blind Phase||63
10346879|NCT00418184|11484885|FG000|COMPLETED|Double-blind Phase||110
10346880|NCT00418184|11484886|FG001|COMPLETED|Double-blind Phase||52
10346881|NCT00418184|11484885|FG000|NOT COMPLETED|Double-blind Phase||27
10346882|NCT00418184|11484886|FG001|NOT COMPLETED|Double-blind Phase||11
10346883|NCT00418184|11484885|FG000|STARTED|Open-label Phase|3 were not included due to low compliance in the double blind phase, 5 didn't want to participate.|102
10346884|NCT00418184|11484886|FG001|STARTED|Open-label Phase|1 was not included due to low compliance in the double blind phase, 3 didn't want to participate.|48
10346885|NCT00418184|11484885|FG000|COMPLETED|Open-label Phase|5 dropped out|97
10346886|NCT00418184|11484886|FG001|COMPLETED|Open-label Phase|5 dropped out|43
10346887|NCT00418184|11484885|FG000|NOT COMPLETED|Open-label Phase||5
10346888|NCT00418184|11484886|FG001|NOT COMPLETED|Open-label Phase||5
10346889|NCT00418262|11484892|FG000|STARTED|Visits 1 (Baseline) Thru 5||27
10346890|NCT00418262|11484892|FG000|COMPLETED|Visits 1 (Baseline) Thru 5||25
10346891|NCT00418262|11484892|FG000|NOT COMPLETED|Visits 1 (Baseline) Thru 5||2
10346892|NCT00418262|11484892|FG000|STARTED|Visits 5 Thru 8||25
10346893|NCT00418262|11484892|FG000|COMPLETED|Visits 5 Thru 8||16
10346894|NCT00418262|11484892|FG000|NOT COMPLETED|Visits 5 Thru 8||9
10346895|NCT00418262|11484892|FG000|STARTED|Visits 8 Thru 10||16
10346896|NCT00418262|11484892|FG000|COMPLETED|Visits 8 Thru 10||11
10346897|NCT00418262|11484892|FG000|NOT COMPLETED|Visits 8 Thru 10||5
10346898|NCT00418314|11484902|FG000|STARTED|Overall Study||817
10346899|NCT00418314|11484903|FG001|STARTED|Overall Study||830
10346900|NCT00418314|11484902|FG000|COMPLETED|Overall Study||816
10346901|NCT00418314|11484903|FG001|COMPLETED|Overall Study||828
10346902|NCT00418314|11484902|FG000|NOT COMPLETED|Overall Study||1
10346903|NCT00418314|11484903|FG001|NOT COMPLETED|Overall Study||2
10346904|NCT00418379|11484912|FG000|STARTED|Year 1||207
10346905|NCT00418379|11484913|FG001|STARTED|Year 1||207
10346906|NCT00418379|11484914|FG002|STARTED|Year 1||219
10346907|NCT00418379|11484912|FG000|COMPLETED|Year 1||189
10346908|NCT00418379|11484913|FG001|COMPLETED|Year 1||179
10346909|NCT00418379|11484914|FG002|COMPLETED|Year 1||204
10346910|NCT00418379|11484912|FG000|NOT COMPLETED|Year 1||18
10346911|NCT00418379|11484913|FG001|NOT COMPLETED|Year 1||28
10346912|NCT00418379|11484914|FG002|NOT COMPLETED|Year 1||15
10346913|NCT00418379|11484912|FG000|STARTED|Year 2|22 patients withdrew between Year 1 and Year 2 treatment periods.|167
10346914|NCT00418379|11484913|FG001|STARTED|Year 2|20 patients withdrew between Year 1 and Year 2 treatment periods.|159
10346915|NCT00418379|11484914|FG002|STARTED|Year 2|22 patients withdrew between Year 1 and Year 2 treatment periods.|182
10346916|NCT00418379|11484912|FG000|COMPLETED|Year 2||159
10346917|NCT00418379|11484913|FG001|COMPLETED|Year 2||155
10346918|NCT00418379|11484914|FG002|COMPLETED|Year 2||172
10346919|NCT00418379|11484912|FG000|NOT COMPLETED|Year 2||8
10346920|NCT00418379|11484913|FG001|NOT COMPLETED|Year 2||4
10346921|NCT00418379|11484914|FG002|NOT COMPLETED|Year 2||10
10346922|NCT00418379|11484912|FG000|STARTED|Year 3|8 patients withdrew between Year 2 and Year 3 treatment periods.|151
10346923|NCT00418379|11484913|FG001|STARTED|Year 3|7 patients withdrew between Year 2 and Year 3 treatment periods.|148
10346924|NCT00418379|11484914|FG002|STARTED|Year 3|6 patients withdrew between Year 2 and Year 3 treatment periods.|166
10346925|NCT00418379|11484912|FG000|COMPLETED|Year 3||148
10346926|NCT00418379|11484913|FG001|COMPLETED|Year 3||146
10346927|NCT00418379|11484914|FG002|COMPLETED|Year 3||163
10346928|NCT00418379|11484912|FG000|NOT COMPLETED|Year 3||3
10346929|NCT00418379|11484913|FG001|NOT COMPLETED|Year 3||2
10346930|NCT00418379|11484914|FG002|NOT COMPLETED|Year 3||3
10346931|NCT00418379|11484912|FG000|STARTED|Year 4|3 patients withdrew between Year 3 and Year 4 study periods.|145
10346932|NCT00418379|11484913|FG001|STARTED|Year 4|5 patients withdrew between Year 3 and Year 4 study periods.|141
10346933|NCT00418379|11484914|FG002|STARTED|Year 4|7 patients withdrew between Year 3 and Year 4 study periods.|156
10346934|NCT00418379|11484912|FG000|COMPLETED|Year 4||142
10346935|NCT00418379|11484913|FG001|COMPLETED|Year 4||136
10346936|NCT00418379|11484914|FG002|COMPLETED|Year 4||154
10346937|NCT00418379|11484912|FG000|NOT COMPLETED|Year 4||3
10346938|NCT00418379|11484913|FG001|NOT COMPLETED|Year 4||5
10346939|NCT00418379|11484914|FG002|NOT COMPLETED|Year 4||2
10346940|NCT00418379|11484912|FG000|STARTED|Year 5|14 patients withdrew between Year 4 and Year 5 study periods.|128
10346941|NCT00418379|11484913|FG001|STARTED|Year 5|16 patients withdrew between Year 4 and Year 5 study periods.|120
10346942|NCT00418379|11484914|FG002|STARTED|Year 5|20 patients withdrew between Year 4 and Year 5 study periods.|134
10346943|NCT00418379|11484912|FG000|COMPLETED|Year 5||126
10346944|NCT00418379|11484913|FG001|COMPLETED|Year 5||115
10346945|NCT00418379|11484914|FG002|COMPLETED|Year 5||131
10346946|NCT00418379|11484912|FG000|NOT COMPLETED|Year 5||2
10346947|NCT00418379|11484913|FG001|NOT COMPLETED|Year 5||5
10346948|NCT00418379|11484914|FG002|NOT COMPLETED|Year 5||3
10346949|NCT00418457|11484924|FG000|STARTED|Overall Study||1065
10346950|NCT00418457|11484925|FG001|STARTED|Overall Study||1043
10346951|NCT00418457|11484924|FG000|COMPLETED|Overall Study||1065
10346952|NCT00418457|11484925|FG001|COMPLETED|Overall Study||1043
10346953|NCT00418457|11484924|FG000|NOT COMPLETED|Overall Study||0
10346954|NCT00418457|11484925|FG001|NOT COMPLETED|Overall Study||0
10346955|NCT00418522|11484933|FG000|STARTED|Overall Study||219
10346956|NCT00418522|11484934|FG001|STARTED|Overall Study||194
10346957|NCT00418522|11484933|FG000|Received Treatment|Overall Study||212
10346958|NCT00418522|11484934|FG001|Received Treatment|Overall Study||190
10346959|NCT00418522|11484933|FG000|COMPLETED|Overall Study||136
10532365|NCT01420016|11684703|FG003|NOT COMPLETED|Primary Analysis||0
10532366|NCT01420016|11684700|FG000|STARTED|Safety Analysis||0
10532367|NCT01420016|11684701|FG001|STARTED|Safety Analysis||0
10532368|NCT01420016|11684702|FG002|STARTED|Safety Analysis||6392
10532369|NCT01420016|11684703|FG003|STARTED|Safety Analysis||5159
10532370|NCT01420016|11684700|FG000|COMPLETED|Safety Analysis||0
10532371|NCT01420016|11684701|FG001|COMPLETED|Safety Analysis||0
10532372|NCT01420016|11684702|FG002|COMPLETED|Safety Analysis||6392
10532373|NCT01420016|11684703|FG003|COMPLETED|Safety Analysis||5159
10532374|NCT01420016|11684700|FG000|NOT COMPLETED|Safety Analysis||0
10532375|NCT01420016|11684701|FG001|NOT COMPLETED|Safety Analysis||0
10532376|NCT01420016|11684702|FG002|NOT COMPLETED|Safety Analysis||0
10532377|NCT01420016|11684703|FG003|NOT COMPLETED|Safety Analysis||0
10532378|NCT01420068|11684711|FG000|STARTED|Overall Study||51
10532379|NCT01420068|11684712|FG001|STARTED|Overall Study||55
10532380|NCT01420068|11684711|FG000|COMPLETED|Overall Study||49
10532381|NCT01420068|11684712|FG001|COMPLETED|Overall Study||50
10532382|NCT01420068|11684711|FG000|NOT COMPLETED|Overall Study||2
10346960|NCT00418522|11484934|FG001|COMPLETED|Overall Study||152
10532383|NCT01420068|11684712|FG001|NOT COMPLETED|Overall Study||5
10532384|NCT01420081|11684727|FG000|STARTED|Overall Study||3
10532385|NCT01420081|11684728|FG001|STARTED|Overall Study||1
10346961|NCT00418522|11484933|FG000|NOT COMPLETED|Overall Study||83
10346962|NCT00418522|11484934|FG001|NOT COMPLETED|Overall Study||42
10346963|NCT00418561|11484943|FG000|STARTED|Overall Study||4
10346964|NCT00418561|11484944|FG001|STARTED|Overall Study||5
10532386|NCT01420081|11684729|FG002|STARTED|Overall Study||11
10346965|NCT00418561|11484945|FG002|STARTED|Overall Study||4
10346966|NCT00418561|11484943|FG000|COMPLETED|Overall Study||4
10346967|NCT00418561|11484944|FG001|COMPLETED|Overall Study||4
10346968|NCT00418561|11484945|FG002|COMPLETED|Overall Study||4
10346969|NCT00418561|11484943|FG000|NOT COMPLETED|Overall Study||0
10346970|NCT00418561|11484944|FG001|NOT COMPLETED|Overall Study||1
10346971|NCT00418561|11484945|FG002|NOT COMPLETED|Overall Study||0
10346972|NCT00418574|11484955|FG000|STARTED|Overall Study||593
10346973|NCT00418574|11484956|FG001|STARTED|Overall Study||295
10346974|NCT00418574|11484955|FG000|TREATED|Overall Study||592
10346975|NCT00418574|11484956|FG001|TREATED|Overall Study||294
10346976|NCT00418574|11484955|FG000|COMPLETED|Overall Study||545
10346977|NCT00418574|11484956|FG001|COMPLETED|Overall Study||272
10346978|NCT00418574|11484955|FG000|NOT COMPLETED|Overall Study||48
10346979|NCT00418574|11484956|FG001|NOT COMPLETED|Overall Study||23
10346980|NCT00418665|11484965|FG000|STARTED|Treatment Period||12
10346981|NCT00418665|11484966|FG001|STARTED|Treatment Period||14
10346982|NCT00418665|11484967|FG002|STARTED|Treatment Period||13
10346983|NCT00418665|11484965|FG000|Received Study Medication|Treatment Period||11
10346984|NCT00418665|11484966|FG001|Received Study Medication|Treatment Period||13
10346985|NCT00418665|11484967|FG002|Received Study Medication|Treatment Period||13
10346986|NCT00418665|11484965|FG000|COMPLETED|Treatment Period||7
10346987|NCT00418665|11484966|FG001|COMPLETED|Treatment Period||8
10346988|NCT00418665|11484967|FG002|COMPLETED|Treatment Period||9
10346989|NCT00418665|11484965|FG000|NOT COMPLETED|Treatment Period||5
10346990|NCT00418665|11484966|FG001|NOT COMPLETED|Treatment Period||6
10346991|NCT00418665|11484967|FG002|NOT COMPLETED|Treatment Period||4
10346992|NCT00418665|11484965|FG000|STARTED|Treatment Extension||7
10346993|NCT00418665|11484966|FG001|STARTED|Treatment Extension||8
10346994|NCT00418665|11484967|FG002|STARTED|Treatment Extension||9
10346995|NCT00418665|11484965|FG000|COMPLETED|Treatment Extension||1
10346996|NCT00418665|11484966|FG001|COMPLETED|Treatment Extension||4
10346997|NCT00418665|11484967|FG002|COMPLETED|Treatment Extension||7
10346998|NCT00418665|11484965|FG000|NOT COMPLETED|Treatment Extension||6
10346999|NCT00418665|11484966|FG001|NOT COMPLETED|Treatment Extension||4
10347000|NCT00418665|11484967|FG002|NOT COMPLETED|Treatment Extension||2
10347001|NCT00418691|11484978|FG000|STARTED|Overall Study||11
10347002|NCT00418691|11484979|FG001|STARTED|Overall Study||12
10347003|NCT00418691|11484980|FG002|STARTED|Overall Study||10
10347004|NCT00418691|11484978|FG000|COMPLETED|Overall Study||9
10347005|NCT00418691|11484979|FG001|COMPLETED|Overall Study||10
10347006|NCT00418691|11484980|FG002|COMPLETED|Overall Study||5
10347007|NCT00418691|11484978|FG000|NOT COMPLETED|Overall Study||2
10347008|NCT00418691|11484979|FG001|NOT COMPLETED|Overall Study||2
10347009|NCT00418691|11484980|FG002|NOT COMPLETED|Overall Study||5
10347010|NCT00418717|11484988|FG000|STARTED|Treatment Period A - Weeks 1-4||42
10347011|NCT00418717|11484988|FG000|COMPLETED|Treatment Period A - Weeks 1-4||41
10347012|NCT00418717|11484988|FG000|NOT COMPLETED|Treatment Period A - Weeks 1-4||1
10347013|NCT00418717|11484988|FG000|STARTED|Treatment Period B - Weeks 5-12||41
10347014|NCT00418717|11484988|FG000|COMPLETED|Treatment Period B - Weeks 5-12||39
10347015|NCT00418717|11484988|FG000|NOT COMPLETED|Treatment Period B - Weeks 5-12||2
10347016|NCT00418886|11484994|FG000|STARTED|Overall Study|randomised patients|256
10347017|NCT00418886|11484995|FG001|STARTED|Overall Study|randomised patients|278
10347018|NCT00418886|11484994|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|30
10347019|NCT00418886|11484995|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|23
10347020|NCT00418886|11484994|FG000|NOT COMPLETED|Overall Study||226
10347021|NCT00418886|11484995|FG001|NOT COMPLETED|Overall Study||255
10347022|NCT00418938|11485003|FG000|STARTED|Overall Study||133
10347023|NCT00418938|11485004|FG001|STARTED|Overall Study||131
10347024|NCT00418938|11485003|FG000|COMPLETED|Overall Study||109
10347025|NCT00418938|11485004|FG001|COMPLETED|Overall Study||108
10347026|NCT00418938|11485003|FG000|NOT COMPLETED|Overall Study||24
10347027|NCT00418938|11485004|FG001|NOT COMPLETED|Overall Study||23
10347028|NCT00418951|11485013|FG000|STARTED|Overall Study||39
10532387|NCT01420081|11684730|FG003|STARTED|Overall Study||3
10532388|NCT01420081|11684731|FG004|STARTED|Overall Study||20
10532389|NCT01420081|11684732|FG005|STARTED|Overall Study||20
10532390|NCT01420081|11684733|FG006|STARTED|Overall Study||3
10532391|NCT01420081|11684734|FG007|STARTED|Overall Study||3
10532392|NCT01420081|11684735|FG008|STARTED|Overall Study||3
10655618|NCT02209259|11816308|FG000|COMPLETED|Overall Study||56
10655619|NCT02209259|11816309|FG001|COMPLETED|Overall Study||56
10655620|NCT02209259|11816310|FG002|COMPLETED|Overall Study||56
10655621|NCT02209259|11816308|FG000|NOT COMPLETED|Overall Study||0
10655622|NCT02209259|11816309|FG001|NOT COMPLETED|Overall Study||0
10655623|NCT02209259|11816310|FG002|NOT COMPLETED|Overall Study||0
10655624|NCT02209272|11816320|FG000|STARTED|Overall Study||32
10655625|NCT02209272|11816321|FG001|STARTED|Overall Study||36
10655626|NCT02209272|11816320|FG000|COMPLETED|Overall Study||32
10532393|NCT01420081|11684727|FG000|COMPLETED|Overall Study||0
10532394|NCT01420081|11684728|FG001|COMPLETED|Overall Study||0
10655627|NCT02209272|11816321|FG001|COMPLETED|Overall Study||36
10655628|NCT02209272|11816320|FG000|NOT COMPLETED|Overall Study||0
10655629|NCT02209272|11816321|FG001|NOT COMPLETED|Overall Study||0
10347029|NCT00418951|11485014|FG001|STARTED|Overall Study||33
10347030|NCT00418951|11485015|FG002|STARTED|Overall Study||40
10347031|NCT00418951|11485013|FG000|COMPLETED|Overall Study||39
10347032|NCT00418951|11485014|FG001|COMPLETED|Overall Study||33
10532395|NCT01420081|11684729|FG002|COMPLETED|Overall Study||0
10532396|NCT01420081|11684730|FG003|COMPLETED|Overall Study||0
10347033|NCT00418951|11485015|FG002|COMPLETED|Overall Study||40
10347034|NCT00418951|11485013|FG000|NOT COMPLETED|Overall Study||0
10347035|NCT00418951|11485014|FG001|NOT COMPLETED|Overall Study||0
10347036|NCT00418951|11485015|FG002|NOT COMPLETED|Overall Study||0
10347037|NCT00418964|11485026|FG000|STARTED|Overall Study||22
10347038|NCT00418964|11485027|FG001|STARTED|Overall Study||20
10347039|NCT00418964|11485028|FG002|STARTED|Overall Study||20
10347040|NCT00418964|11485026|FG000|COMPLETED|Overall Study||21
10347041|NCT00418964|11485027|FG001|COMPLETED|Overall Study||17
10347042|NCT00418964|11485028|FG002|COMPLETED|Overall Study||14
10347043|NCT00418964|11485026|FG000|NOT COMPLETED|Overall Study||1
10347044|NCT00418964|11485027|FG001|NOT COMPLETED|Overall Study||3
10347045|NCT00418964|11485028|FG002|NOT COMPLETED|Overall Study||6
10347046|NCT00418977|11485038|FG000|STARTED|Overall Study||43
10347047|NCT00418977|11485039|FG001|STARTED|Overall Study||16
10347048|NCT00418977|11485038|FG000|COMPLETED|Overall Study||40
10347049|NCT00418977|11485039|FG001|COMPLETED|Overall Study||13
10347050|NCT00418977|11485038|FG000|NOT COMPLETED|Overall Study||3
10347051|NCT00418977|11485039|FG001|NOT COMPLETED|Overall Study||3
10347052|NCT00419003|11485047|FG000|STARTED|Phase I, Ketamine Infusion||13
10347053|NCT00419003|11485048|FG001|STARTED|Phase I, Ketamine Infusion||13
10347054|NCT00419003|11485047|FG000|COMPLETED|Phase I, Ketamine Infusion||7
10347055|NCT00419003|11485048|FG001|COMPLETED|Phase I, Ketamine Infusion||7
10347056|NCT00419003|11485047|FG000|NOT COMPLETED|Phase I, Ketamine Infusion||6
10347057|NCT00419003|11485048|FG001|NOT COMPLETED|Phase I, Ketamine Infusion||6
10347058|NCT00419003|11485047|FG000|STARTED|Phase 2, Riluzole/Placebo Follow-Up|14 completers of phase I didn't split up evenly (same way as phase I) in the riluzole/placebo phase.|6
10347059|NCT00419003|11485048|FG001|STARTED|Phase 2, Riluzole/Placebo Follow-Up|14 completers of phase I didn't split up evenly (same way as phase I) in the riluzole/placebo phase.|8
10347060|NCT00419003|11485047|FG000|COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||5
10347061|NCT00419003|11485048|FG001|COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||8
10347062|NCT00419003|11485047|FG000|NOT COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||1
10347063|NCT00419003|11485048|FG001|NOT COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||0
10347064|NCT00419094|11485059|FG000|STARTED|Overall Study|Number started refers to number randomized; 303 subjects were screened/enrolled and 228 randomized.|57
10347065|NCT00419094|11485060|FG001|STARTED|Overall Study||171
10347066|NCT00419094|11485059|FG000|COMPLETED|Overall Study||50
10347067|NCT00419094|11485060|FG001|COMPLETED|Overall Study||141
10347068|NCT00419094|11485059|FG000|NOT COMPLETED|Overall Study||7
10347069|NCT00419094|11485060|FG001|NOT COMPLETED|Overall Study||30
10347070|NCT00419120|11485066|FG000|STARTED|Primary Study Period||10
10347071|NCT00419120|11485066|FG000|COMPLETED|Primary Study Period||10
10347072|NCT00419120|11485066|FG000|NOT COMPLETED|Primary Study Period||0
10347073|NCT00419120|11485066|FG000|STARTED|Long Term Follow up Period|10 patients are being followed in long term follow up.|10
10347074|NCT00419120|11485066|FG000|COMPLETED|Long Term Follow up Period||0
10347075|NCT00419120|11485066|FG000|NOT COMPLETED|Long Term Follow up Period||10
10426666|NCT00848484|11572353|FG001|With Reduced Dose at Treatment Period 2|Second Intervention (Treatment Period 2)||0
10426667|NCT00848484|11572352|FG000|COMPLETED|Second Intervention (Treatment Period 2)||25
10426668|NCT00848484|11572353|FG001|COMPLETED|Second Intervention (Treatment Period 2)||20
10426669|NCT00848484|11572352|FG000|NOT COMPLETED|Second Intervention (Treatment Period 2)||0
10426670|NCT00848484|11572353|FG001|NOT COMPLETED|Second Intervention (Treatment Period 2)||1
10426671|NCT00848497|11572361|FG000|STARTED|Overall Study||2
10426672|NCT00848497|11572362|FG001|STARTED|Overall Study|Completed Visit 4|1
10426673|NCT00848497|11572361|FG000|COMPLETED|Overall Study||0
10426674|NCT00848497|11572362|FG001|COMPLETED|Overall Study||0
10426675|NCT00848497|11572361|FG000|NOT COMPLETED|Overall Study||2
10426676|NCT00848497|11572362|FG001|NOT COMPLETED|Overall Study||1
10426677|NCT00848510|11572374|FG000|STARTED|Overall Study||10
10426678|NCT00848510|11572375|FG001|STARTED|Overall Study||13
10426679|NCT00848510|11572376|FG002|STARTED|Overall Study||8
10426680|NCT00848510|11572377|FG003|STARTED|Overall Study||10
10426681|NCT00848510|11572374|FG000|COMPLETED|Overall Study||10
10426682|NCT00848510|11572375|FG001|COMPLETED|Overall Study||13
10426683|NCT00848510|11572376|FG002|COMPLETED|Overall Study||8
10426684|NCT00848510|11572377|FG003|COMPLETED|Overall Study||10
10426685|NCT00848510|11572374|FG000|NOT COMPLETED|Overall Study||0
10426686|NCT00848510|11572375|FG001|NOT COMPLETED|Overall Study||0
10426687|NCT00848510|11572376|FG002|NOT COMPLETED|Overall Study||0
10426688|NCT00848510|11572377|FG003|NOT COMPLETED|Overall Study||0
10426689|NCT00848536|11572389|FG000|STARTED|Overall Study||185
10426690|NCT00848536|11572390|FG001|STARTED|Overall Study||186
10426691|NCT00848536|11572389|FG000|COMPLETED|Overall Study||181
10426692|NCT00848536|11572390|FG001|COMPLETED|Overall Study||179
10426693|NCT00848536|11572389|FG000|NOT COMPLETED|Overall Study||4
10426694|NCT00848536|11572390|FG001|NOT COMPLETED|Overall Study||7
10426695|NCT00848549|11572398|FG000|STARTED|E2090-E044-310 (Base Study) Disposition||282
10426696|NCT00848549|11572399|FG001|STARTED|E2090-E044-310 (Base Study) Disposition||301
10426697|NCT00848549|11572398|FG000|COMPLETED|E2090-E044-310 (Base Study) Disposition||161
10426698|NCT00848549|11572399|FG001|COMPLETED|E2090-E044-310 (Base Study) Disposition||192
10426699|NCT00848549|11572398|FG000|NOT COMPLETED|E2090-E044-310 (Base Study) Disposition||121
10426700|NCT00848549|11572399|FG001|NOT COMPLETED|E2090-E044-310 (Base Study) Disposition||109
10426701|NCT00848549|11572398|FG000|STARTED|E2090-E044-310 (Base Study) Transition||161
10426702|NCT00848549|11572399|FG001|STARTED|E2090-E044-310 (Base Study) Transition||192
10426703|NCT00848549|11572398|FG000|COMPLETED|E2090-E044-310 (Base Study) Transition||137
10347076|NCT00419159|11485072|FG000|STARTED|Overall Study|Full Analysis Set|99
10347077|NCT00419159|11485073|FG001|STARTED|Overall Study||100
10347078|NCT00419159|11485072|FG000|COMPLETED|Overall Study||0
10347079|NCT00419159|11485073|FG001|COMPLETED|Overall Study||0
10347080|NCT00419159|11485072|FG000|NOT COMPLETED|Overall Study||99
10347081|NCT00419159|11485073|FG001|NOT COMPLETED|Overall Study||100
10347082|NCT00419263|11485090|FG000|STARTED|Overall Study||115
10347083|NCT00419263|11485091|FG001|STARTED|Overall Study||114
10347084|NCT00419263|11485092|FG002|STARTED|Overall Study||115
10347085|NCT00419263|11485090|FG000|COMPLETED|Overall Study||112
10347086|NCT00419263|11485091|FG001|COMPLETED|Overall Study||112
10347087|NCT00419263|11485092|FG002|COMPLETED|Overall Study||112
10347088|NCT00419263|11485090|FG000|NOT COMPLETED|Overall Study||3
10347089|NCT00419263|11485091|FG001|NOT COMPLETED|Overall Study||2
10347090|NCT00419263|11485092|FG002|NOT COMPLETED|Overall Study||3
10347091|NCT00419315|11485103|FG000|STARTED|Overall Study||85
10347092|NCT00419315|11485104|FG001|STARTED|Overall Study||78
10347093|NCT00419315|11485103|FG000|COMPLETED|Overall Study||85
10347094|NCT00419315|11485104|FG001|COMPLETED|Overall Study||78
10347095|NCT00419315|11485103|FG000|NOT COMPLETED|Overall Study||0
10347096|NCT00419315|11485104|FG001|NOT COMPLETED|Overall Study||0
10347097|NCT00419341|11485110|FG000|STARTED|Wash in/Wash Out Period||49
10347098|NCT00419341|11485110|FG000|COMPLETED|Wash in/Wash Out Period||38
10347099|NCT00419341|11485110|FG000|NOT COMPLETED|Wash in/Wash Out Period||11
10347100|NCT00419341|11485110|FG000|STARTED|Efficacy Period||38
10347101|NCT00419341|11485110|FG000|COMPLETED|Efficacy Period||28
10347102|NCT00419341|11485110|FG000|NOT COMPLETED|Efficacy Period||10
10347103|NCT00419380|11485118|FG000|STARTED|Overall Study||19
10347104|NCT00419380|11485119|FG001|STARTED|Overall Study||22
10347105|NCT00419380|11485118|FG000|COMPLETED|Overall Study||18
10347106|NCT00419380|11485119|FG001|COMPLETED|Overall Study||12
10347107|NCT00419380|11485118|FG000|NOT COMPLETED|Overall Study||1
10347108|NCT00419380|11485119|FG001|NOT COMPLETED|Overall Study||10
10347109|NCT00419393|11485125|FG000|STARTED|Overall Study|One subject did not receive medication|190
10347110|NCT00419393|11485125|FG000|COMPLETED|Overall Study||166
10347111|NCT00419393|11485125|FG000|NOT COMPLETED|Overall Study||24
10347112|NCT00419445|11485132|FG000|STARTED|Overall Study||8
10347113|NCT00419445|11485133|FG001|STARTED|Overall Study||16
10347114|NCT00419445|11485134|FG002|STARTED|Overall Study||8
10347115|NCT00419445|11485132|FG000|COMPLETED|Overall Study||7
10347116|NCT00419445|11485133|FG001|COMPLETED|Overall Study||14
10347117|NCT00419445|11485134|FG002|COMPLETED|Overall Study||7
10347118|NCT00419445|11485132|FG000|NOT COMPLETED|Overall Study||1
10347119|NCT00419445|11485133|FG001|NOT COMPLETED|Overall Study||2
10347120|NCT00419445|11485134|FG002|NOT COMPLETED|Overall Study||1
10347121|NCT00419562|11485144|FG000|STARTED|Overall Study||283
10347122|NCT00419562|11485145|FG001|STARTED|Overall Study||277
10347123|NCT00419562|11485144|FG000|COMPLETED|Overall Study||250
10347124|NCT00419562|11485145|FG001|COMPLETED|Overall Study||246
10347125|NCT00419562|11485144|FG000|NOT COMPLETED|Overall Study||33
10347126|NCT00419562|11485145|FG001|NOT COMPLETED|Overall Study||31
10347127|NCT00419666|11485151|FG000|STARTED|Overall Study||25
10347128|NCT00419666|11485151|FG000|COMPLETED|Overall Study||25
10347129|NCT00419666|11485151|FG000|NOT COMPLETED|Overall Study||0
10347130|NCT00419744|11485158|FG000|STARTED|Overall Study||407
10347131|NCT00419744|11485159|FG001|STARTED|Overall Study||408
10347132|NCT00419744|11485160|FG002|STARTED|Overall Study||404
10347133|NCT00419744|11485158|FG000|COMPLETED|Overall Study||290
10347134|NCT00419744|11485159|FG001|COMPLETED|Overall Study||290
10347135|NCT00419744|11485160|FG002|COMPLETED|Overall Study||271
10347136|NCT00419744|11485158|FG000|NOT COMPLETED|Overall Study||117
10347137|NCT00419744|11485159|FG001|NOT COMPLETED|Overall Study||118
10347138|NCT00419744|11485160|FG002|NOT COMPLETED|Overall Study||133
10347139|NCT00419757|11485170|FG000|STARTED|Overall Study|Randomized patients|127
10347140|NCT00419757|11485171|FG001|STARTED|Overall Study|Randomized patients|123
10347141|NCT00419757|11485170|FG000|COMPLETED|Overall Study|Randomized patients|109
10347142|NCT00419757|11485171|FG001|COMPLETED|Overall Study|Randomized patients|102
10347143|NCT00419757|11485170|FG000|NOT COMPLETED|Overall Study||18
10347144|NCT00419757|11485171|FG001|NOT COMPLETED|Overall Study||21
10532397|NCT01420081|11684731|FG004|COMPLETED|Overall Study||0
10532398|NCT01420081|11684732|FG005|COMPLETED|Overall Study||0
10532399|NCT01420081|11684733|FG006|COMPLETED|Overall Study||0
10532400|NCT01420081|11684734|FG007|COMPLETED|Overall Study||0
10347145|NCT00419770|11485181|FG000|STARTED|Overall Study||11
10347146|NCT00419770|11485182|FG001|STARTED|Overall Study||9
10347147|NCT00419770|11485181|FG000|COMPLETED|Overall Study||6
10347148|NCT00419770|11485182|FG001|COMPLETED|Overall Study||8
10347149|NCT00419770|11485181|FG000|NOT COMPLETED|Overall Study||5
10347150|NCT00419770|11485182|FG001|NOT COMPLETED|Overall Study||1
10347151|NCT00419926|11485190|FG000|STARTED|Overall Study|Intention to treat population, 150 is safety population.|155
10347152|NCT00419926|11485191|FG001|STARTED|Overall Study|Intention to treat population, 154 is safety population.|158
10532401|NCT01420081|11684735|FG008|COMPLETED|Overall Study||0
10532402|NCT01420081|11684727|FG000|NOT COMPLETED|Overall Study||3
10532403|NCT01420081|11684728|FG001|NOT COMPLETED|Overall Study||1
10347153|NCT00419926|11485190|FG000|COMPLETED|Overall Study||141
10347154|NCT00419926|11485191|FG001|COMPLETED|Overall Study||148
10347155|NCT00419926|11485190|FG000|NOT COMPLETED|Overall Study||14
10347156|NCT00419926|11485191|FG001|NOT COMPLETED|Overall Study||10
10347157|NCT00419952|11485199|FG000|STARTED|Overall Study||377
10347158|NCT00419952|11485200|FG001|STARTED|Overall Study||365
10347159|NCT00419952|11485199|FG000|COMPLETED|Overall Study||228
10347160|NCT00419952|11485200|FG001|COMPLETED|Overall Study||240
10347161|NCT00419952|11485199|FG000|NOT COMPLETED|Overall Study||149
10347162|NCT00419952|11485200|FG001|NOT COMPLETED|Overall Study||125
10347163|NCT00420004|11485209|FG000|STARTED|Overall Study||269
10347164|NCT00420004|11485210|FG001|STARTED|Overall Study||138
10347165|NCT00420004|11485211|FG002|STARTED|Overall Study||62
10347166|NCT00420004|11485209|FG000|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|249
10347167|NCT00420004|11485210|FG001|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|122
10347168|NCT00420004|11485211|FG002|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|54
10347169|NCT00420004|11485209|FG000|COMPLETED|Overall Study||140
10347170|NCT00420004|11485210|FG001|COMPLETED|Overall Study||67
10347171|NCT00420004|11485211|FG002|COMPLETED|Overall Study||30
10347172|NCT00420004|11485209|FG000|NOT COMPLETED|Overall Study||129
10347173|NCT00420004|11485210|FG001|NOT COMPLETED|Overall Study||71
10347174|NCT00420004|11485211|FG002|NOT COMPLETED|Overall Study||32
10347175|NCT00420017|11485225|FG000|STARTED|Overall Study||40
10347176|NCT00420017|11485226|FG001|STARTED|Overall Study||40
10347177|NCT00420017|11485225|FG000|COMPLETED|Overall Study|40 completed analysis|38
10347178|NCT00420017|11485226|FG001|COMPLETED|Overall Study||40
10347179|NCT00420017|11485225|FG000|NOT COMPLETED|Overall Study||2
10347180|NCT00420017|11485226|FG001|NOT COMPLETED|Overall Study||0
10347181|NCT00420056|11485232|FG000|STARTED|Overall Study||17
10347182|NCT00420056|11485232|FG000|COMPLETED|Overall Study||0
10347183|NCT00420056|11485232|FG000|NOT COMPLETED|Overall Study||17
10347184|NCT00420095|11485238|FG000|STARTED|Overall Study||57
10347185|NCT00420095|11485239|FG001|STARTED|Overall Study||60
10347186|NCT00420095|11485238|FG000|COMPLETED|Overall Study||54
10347187|NCT00420095|11485239|FG001|COMPLETED|Overall Study||59
10347188|NCT00420095|11485238|FG000|NOT COMPLETED|Overall Study||3
10347189|NCT00420095|11485239|FG001|NOT COMPLETED|Overall Study||1
10347190|NCT00420147|11485247|FG000|STARTED|Overall Study||19
10347191|NCT00420147|11485248|FG001|STARTED|Overall Study||19
10347192|NCT00420147|11485247|FG000|COMPLETED|Overall Study||19
10347193|NCT00420147|11485248|FG001|COMPLETED|Overall Study||19
10347194|NCT00420147|11485247|FG000|NOT COMPLETED|Overall Study||0
10347195|NCT00420147|11485248|FG001|NOT COMPLETED|Overall Study||0
10347196|NCT00420199|11485256|FG000|STARTED|Overall Study||27
10347197|NCT00420199|11485257|FG001|STARTED|Overall Study||23
10347198|NCT00420199|11485256|FG000|COMPLETED|Overall Study||26
10347199|NCT00420199|11485257|FG001|COMPLETED|Overall Study||23
10347200|NCT00420199|11485256|FG000|NOT COMPLETED|Overall Study||1
10347201|NCT00420199|11485257|FG001|NOT COMPLETED|Overall Study||0
10347202|NCT00420212|11485271|FG000|STARTED|Overall Study|408 participants were dosed; 410 participants were randomized|408
10347203|NCT00420212|11485272|FG001|STARTED|Overall Study|410 participants were dosed; 411 participants were randomized|410
10347204|NCT00420212|11485273|FG002|STARTED|Overall Study|416 participants were dosed; 416 participants were randomized|416
10347205|NCT00420212|11485271|FG000|COMPLETED|Overall Study||317
10347206|NCT00420212|11485272|FG001|COMPLETED|Overall Study||315
10347207|NCT00420212|11485273|FG002|COMPLETED|Overall Study||320
10347208|NCT00420212|11485271|FG000|NOT COMPLETED|Overall Study||91
10347209|NCT00420212|11485272|FG001|NOT COMPLETED|Overall Study||95
10347210|NCT00420212|11485273|FG002|NOT COMPLETED|Overall Study||96
10347211|NCT00420238|11485286|FG000|STARTED|12 Week Double-Blind Treatment Period 1||39
10347212|NCT00420238|11485287|FG001|STARTED|12 Week Double-Blind Treatment Period 1||43
10347213|NCT00420238|11485286|FG000|COMPLETED|12 Week Double-Blind Treatment Period 1||38
10347214|NCT00420238|11485287|FG001|COMPLETED|12 Week Double-Blind Treatment Period 1||39
10347215|NCT00420238|11485286|FG000|NOT COMPLETED|12 Week Double-Blind Treatment Period 1||1
10347216|NCT00420238|11485287|FG001|NOT COMPLETED|12 Week Double-Blind Treatment Period 1||4
10347217|NCT00420238|11485286|FG000|STARTED|12 Week Open-Label Treatment Period 2||38
10347218|NCT00420238|11485287|FG001|STARTED|12 Week Open-Label Treatment Period 2||39
10347219|NCT00420238|11485286|FG000|COMPLETED|12 Week Open-Label Treatment Period 2||36
10347220|NCT00420238|11485287|FG001|COMPLETED|12 Week Open-Label Treatment Period 2||38
10347221|NCT00420238|11485286|FG000|NOT COMPLETED|12 Week Open-Label Treatment Period 2||2
10347222|NCT00420238|11485287|FG001|NOT COMPLETED|12 Week Open-Label Treatment Period 2||1
10347223|NCT00420290|11485301|FG000|STARTED|Overall Study||11
10347224|NCT00420290|11485302|FG001|STARTED|Overall Study||11
10347225|NCT00420290|11485301|FG000|COMPLETED|Overall Study||7
10347226|NCT00420290|11485302|FG001|COMPLETED|Overall Study||7
10347227|NCT00420290|11485301|FG000|NOT COMPLETED|Overall Study||4
10347228|NCT00420290|11485302|FG001|NOT COMPLETED|Overall Study||4
10347229|NCT00420303|11485310|FG000|STARTED|Overall Study||12
10347230|NCT00420303|11485311|FG001|STARTED|Overall Study||12
10347231|NCT00420303|11485310|FG000|COMPLETED|Overall Study||11
10347232|NCT00420303|11485311|FG001|COMPLETED|Overall Study||8
10347233|NCT00420303|11485310|FG000|NOT COMPLETED|Overall Study||1
10347234|NCT00420303|11485311|FG001|NOT COMPLETED|Overall Study||4
10347235|NCT00420316|11485319|FG000|STARTED|Overall Study||1082
10347236|NCT00420316|11485320|FG001|STARTED|Overall Study||531
10347237|NCT00420316|11485319|FG000|COMPLETED|Overall Study||1070
10347238|NCT00420316|11485320|FG001|COMPLETED|Overall Study||522
10347239|NCT00420316|11485319|FG000|NOT COMPLETED|Overall Study||12
10347240|NCT00420316|11485320|FG001|NOT COMPLETED|Overall Study||9
10347241|NCT00420342|11485329|FG000|STARTED|Overall Study||30
10347242|NCT00420342|11485330|FG001|STARTED|Overall Study||33
10347243|NCT00420342|11485331|FG002|STARTED|Overall Study||29
10347244|NCT00420342|11485329|FG000|Received Treatment|Overall Study|1 subject did not confirm if she ever took the study medication.|29
10347245|NCT00420342|11485330|FG001|Received Treatment|Overall Study|1 subject did not confirm if she ever took the study medication.|32
10347246|NCT00420342|11485331|FG002|Received Treatment|Overall Study||29
10347247|NCT00420342|11485329|FG000|COMPLETED|Overall Study||29
10347248|NCT00420342|11485330|FG001|COMPLETED|Overall Study||31
10347249|NCT00420342|11485331|FG002|COMPLETED|Overall Study||28
10347250|NCT00420342|11485329|FG000|NOT COMPLETED|Overall Study||1
10347251|NCT00420342|11485330|FG001|NOT COMPLETED|Overall Study||2
10347252|NCT00420342|11485331|FG002|NOT COMPLETED|Overall Study||1
10347253|NCT00420381|11485339|FG000|STARTED|Overall Study||28
10347254|NCT00420381|11485339|FG000|Received at Least One Dose of Study Drug|Overall Study||27
10347255|NCT00420381|11485339|FG000|COMPLETED|Overall Study||27
10347256|NCT00420381|11485339|FG000|NOT COMPLETED|Overall Study||1
10347257|NCT00420407|11485345|FG000|STARTED|Overall Study||41
10347258|NCT00420407|11485346|FG001|STARTED|Overall Study||40
10347259|NCT00420407|11485345|FG000|COMPLETED|Overall Study||37
10347260|NCT00420407|11485346|FG001|COMPLETED|Overall Study||34
10347261|NCT00420407|11485345|FG000|NOT COMPLETED|Overall Study||4
10347262|NCT00420407|11485346|FG001|NOT COMPLETED|Overall Study||6
10347263|NCT00420420|11485355|FG000|STARTED|Overall Study|Number of patients randomized.|73
10347264|NCT00420420|11485356|FG001|STARTED|Overall Study|Number of patients randomized.|71
10347265|NCT00420420|11485355|FG000|COMPLETED|Overall Study|One patient from the MK-0249 arm discontinued the trial due to an AE prior to receiving study drug.|65
10347266|NCT00420420|11485356|FG001|COMPLETED|Overall Study||67
10347267|NCT00420420|11485355|FG000|NOT COMPLETED|Overall Study||8
10347268|NCT00420420|11485356|FG001|NOT COMPLETED|Overall Study||4
10347269|NCT00420459|11485362|FG000|STARTED|Overall Study||12
10347270|NCT00420459|11485362|FG000|COMPLETED|Overall Study||12
10347271|NCT00420459|11485362|FG000|NOT COMPLETED|Overall Study||0
10347272|NCT00420511|11485370|FG000|STARTED|Overall Study||10
10347273|NCT00420511|11485371|FG001|STARTED|Overall Study||11
10347274|NCT00420511|11485370|FG000|COMPLETED|Overall Study||8
10347275|NCT00420511|11485371|FG001|COMPLETED|Overall Study||10
10347276|NCT00420511|11485370|FG000|NOT COMPLETED|Overall Study||2
10347277|NCT00420511|11485371|FG001|NOT COMPLETED|Overall Study||1
10347278|NCT00420628|11485381|FG000|STARTED|Overall Study||72
10347279|NCT00420628|11485382|FG001|STARTED|Overall Study||36
10347280|NCT00420628|11485381|FG000|COMPLETED|Overall Study||63
10347281|NCT00420628|11485382|FG001|COMPLETED|Overall Study||32
10347282|NCT00420628|11485381|FG000|NOT COMPLETED|Overall Study||9
10347283|NCT00420628|11485382|FG001|NOT COMPLETED|Overall Study||4
10347284|NCT00420641|11485391|FG000|STARTED|Overall Study||160
10532404|NCT01420081|11684729|FG002|NOT COMPLETED|Overall Study||11
10532405|NCT01420081|11684730|FG003|NOT COMPLETED|Overall Study||3
10532406|NCT01420081|11684731|FG004|NOT COMPLETED|Overall Study||20
10532407|NCT01420081|11684732|FG005|NOT COMPLETED|Overall Study||20
10532408|NCT01420081|11684733|FG006|NOT COMPLETED|Overall Study||3
10715742|NCT02688387|11880057|FG014|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
10715743|NCT02688387|11880058|FG015|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
10715744|NCT02688387|11880059|FG016|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
10715745|NCT02688387|11880060|FG017|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
10715746|NCT02688387|11880061|FG018|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10715747|NCT02688387|11880062|FG019|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10532409|NCT01420081|11684734|FG007|NOT COMPLETED|Overall Study||3
10532410|NCT01420081|11684735|FG008|NOT COMPLETED|Overall Study||3
10532411|NCT01420146|11684751|FG000|STARTED|Overall Study||20
10532412|NCT01420146|11684751|FG000|COMPLETED|Overall Study||20
10532413|NCT01420146|11684751|FG000|NOT COMPLETED|Overall Study||0
10532414|NCT01420289|11684757|FG000|STARTED|Overall Study||18
10715748|NCT02688387|11880063|FG020|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10715749|NCT02688387|11880064|FG021|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10715750|NCT02688387|11880043|FG000|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10715751|NCT02688387|11880044|FG001|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10715752|NCT02688387|11880045|FG002|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10715753|NCT02688387|11880046|FG003|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10532415|NCT01420289|11684758|FG001|STARTED|Overall Study||16
10347285|NCT00420641|11485392|FG001|STARTED|Overall Study||172
10347286|NCT00420641|11485393|FG002|STARTED|Overall Study||172
10347287|NCT00420641|11485391|FG000|COMPLETED|Overall Study||115
10347288|NCT00420641|11485392|FG001|COMPLETED|Overall Study||100
10347289|NCT00420641|11485393|FG002|COMPLETED|Overall Study||128
10347290|NCT00420641|11485391|FG000|NOT COMPLETED|Overall Study||45
10347291|NCT00420641|11485392|FG001|NOT COMPLETED|Overall Study||72
10347292|NCT00420641|11485393|FG002|NOT COMPLETED|Overall Study||44
10347293|NCT00420745|11485403|FG000|STARTED|Overall Study||670
10347294|NCT00420745|11485404|FG001|STARTED|Overall Study||339
10347295|NCT00420745|11485403|FG000|COMPLETED|Overall Study||655
10532416|NCT01420289|11684757|FG000|COMPLETED|Overall Study||18
10532417|NCT01420289|11684758|FG001|COMPLETED|Overall Study||16
10532418|NCT01420289|11684757|FG000|NOT COMPLETED|Overall Study||0
10532419|NCT01420289|11684758|FG001|NOT COMPLETED|Overall Study||0
10532420|NCT01420536|11684766|FG000|STARTED|Period 1 (30 Days)||22
10532421|NCT01420536|11684767|FG001|STARTED|Period 1 (30 Days)||22
10532422|NCT01420536|11684766|FG000|COMPLETED|Period 1 (30 Days)|Participants declined to participate further before changing interventions.|19
10347296|NCT00420745|11485404|FG001|COMPLETED|Overall Study||333
10347297|NCT00420745|11485403|FG000|NOT COMPLETED|Overall Study||15
10347298|NCT00420745|11485404|FG001|NOT COMPLETED|Overall Study||6
10347299|NCT00420771|11485412|FG000|STARTED|Overall Study||8
10347300|NCT00420771|11485413|FG001|STARTED|Overall Study||11
10347301|NCT00420771|11485412|FG000|COMPLETED|Overall Study||5
10347302|NCT00420771|11485413|FG001|COMPLETED|Overall Study||7
10347303|NCT00420771|11485412|FG000|NOT COMPLETED|Overall Study||3
10347304|NCT00420771|11485413|FG001|NOT COMPLETED|Overall Study||4
10347305|NCT00420784|11485423|FG000|STARTED|Overall Study||115
10347306|NCT00420784|11485424|FG001|STARTED|Overall Study||113
10347307|NCT00420784|11485425|FG002|STARTED|Overall Study||111
10347308|NCT00420784|11485426|FG003|STARTED|Overall Study||114
10347309|NCT00420784|11485423|FG000|COMPLETED|Overall Study||86
10347310|NCT00420784|11485424|FG001|COMPLETED|Overall Study||55
10347311|NCT00420784|11485425|FG002|COMPLETED|Overall Study||58
10347312|NCT00420784|11485426|FG003|COMPLETED|Overall Study||36
10347313|NCT00420784|11485423|FG000|NOT COMPLETED|Overall Study||29
10347314|NCT00420784|11485424|FG001|NOT COMPLETED|Overall Study||58
10347315|NCT00420784|11485425|FG002|NOT COMPLETED|Overall Study||53
10347316|NCT00420784|11485426|FG003|NOT COMPLETED|Overall Study||78
10347317|NCT00420849|11485437|FG000|STARTED|Overall Study||587
10347318|NCT00420849|11485437|FG000|COMPLETED|Overall Study|Participants completed the study upon commercial availability of lenalidomide|256
10347319|NCT00420849|11485437|FG000|NOT COMPLETED|Overall Study||331
10347320|NCT00420927|11485451|FG000|STARTED|Period 1||515
10347321|NCT00420927|11485452|FG001|STARTED|Period 1||517
10347322|NCT00420927|11485453|FG002|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
10347323|NCT00420927|11485454|FG003|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
10347324|NCT00420927|11485455|FG004|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
10347325|NCT00420927|11485456|FG005|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
10347326|NCT00420927|11485457|FG006|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
10347327|NCT00420927|11485451|FG000|COMPLETED|Period 1||466
10532423|NCT01420536|11684767|FG001|COMPLETED|Period 1 (30 Days)||22
10532424|NCT01420536|11684766|FG000|NOT COMPLETED|Period 1 (30 Days)||3
10532425|NCT01420536|11684767|FG001|NOT COMPLETED|Period 1 (30 Days)||0
10532426|NCT01420536|11684766|FG000|STARTED|Period 2 (30 Days)||19
10532427|NCT01420536|11684767|FG001|STARTED|Period 2 (30 Days)||22
10532428|NCT01420536|11684766|FG000|COMPLETED|Period 2 (30 Days)||19
10532429|NCT01420536|11684767|FG001|COMPLETED|Period 2 (30 Days)||22
10532430|NCT01420536|11684766|FG000|NOT COMPLETED|Period 2 (30 Days)||0
10532431|NCT01420536|11684767|FG001|NOT COMPLETED|Period 2 (30 Days)||0
10532432|NCT01420549|11684777|FG000|STARTED|Overall Study||66
10532433|NCT01420549|11684778|FG001|STARTED|Overall Study||63
10532434|NCT01420549|11684777|FG000|COMPLETED|Overall Study||59
10532435|NCT01420549|11684778|FG001|COMPLETED|Overall Study||58
10532436|NCT01420549|11684777|FG000|NOT COMPLETED|Overall Study||7
10532437|NCT01420549|11684778|FG001|NOT COMPLETED|Overall Study||5
10532438|NCT01420627|11684784|FG000|STARTED|Adagen Lead-in Period||7
10532439|NCT01420627|11684784|FG000|COMPLETED|Adagen Lead-in Period||7
10532440|NCT01420627|11684784|FG000|NOT COMPLETED|Adagen Lead-in Period||0
10532441|NCT01420627|11684784|FG000|STARTED|EZN-2279 Treatment Period||7
10532442|NCT01420627|11684784|FG000|COMPLETED|EZN-2279 Treatment Period||6
10532443|NCT01420627|11684784|FG000|NOT COMPLETED|EZN-2279 Treatment Period||1
10532444|NCT01420627|11684784|FG000|STARTED|EZN-2279 Maintenance Period||6
10532445|NCT01420627|11684784|FG000|COMPLETED|EZN-2279 Maintenance Period||6
10532446|NCT01420627|11684784|FG000|NOT COMPLETED|EZN-2279 Maintenance Period||0
10532447|NCT01420653|11684796|FG000|STARTED|Overall Study||110
10532448|NCT01420653|11684797|FG001|STARTED|Overall Study||111
10532449|NCT01420653|11684798|FG002|STARTED|Overall Study||112
10532450|NCT01420653|11684799|FG003|STARTED|Overall Study||75
10532451|NCT01420653|11684796|FG000|COMPLETED|Overall Study||107
10532452|NCT01420653|11684797|FG001|COMPLETED|Overall Study||108
10532453|NCT01420653|11684798|FG002|COMPLETED|Overall Study||108
10532454|NCT01420653|11684799|FG003|COMPLETED|Overall Study||68
10532455|NCT01420653|11684796|FG000|NOT COMPLETED|Overall Study||3
10532456|NCT01420653|11684797|FG001|NOT COMPLETED|Overall Study||3
10532457|NCT01420653|11684798|FG002|NOT COMPLETED|Overall Study||4
10532458|NCT01420653|11684799|FG003|NOT COMPLETED|Overall Study||7
10532459|NCT01420679|11684811|FG000|STARTED|Overall Study||14
10532460|NCT01420679|11684812|FG001|STARTED|Overall Study||7
10532461|NCT01420679|11684811|FG000|COMPLETED|Overall Study||0
10532462|NCT01420679|11684812|FG001|COMPLETED|Overall Study||0
10715754|NCT02688387|11880047|FG004|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10715755|NCT02688387|11880048|FG005|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10532463|NCT01420679|11684811|FG000|NOT COMPLETED|Overall Study||14
10347328|NCT00420927|11485452|FG001|COMPLETED|Period 1||460
10532464|NCT01420679|11684812|FG001|NOT COMPLETED|Overall Study||7
10532465|NCT01420848|11684821|FG000|STARTED|Overall Study||24
10532466|NCT01420848|11684822|FG001|STARTED|Overall Study||25
10532467|NCT01420848|11684823|FG002|STARTED|Overall Study||22
10532468|NCT01420848|11684821|FG000|COMPLETED|Overall Study||24
10532469|NCT01420848|11684822|FG001|COMPLETED|Overall Study||25
10532470|NCT01420848|11684823|FG002|COMPLETED|Overall Study||22
10532471|NCT01420848|11684821|FG000|NOT COMPLETED|Overall Study||0
10532472|NCT01420848|11684822|FG001|NOT COMPLETED|Overall Study||0
10532473|NCT01420848|11684823|FG002|NOT COMPLETED|Overall Study||0
10532474|NCT01421017|11684834|FG000|STARTED|Overall Study||12
10532475|NCT01421017|11684835|FG001|STARTED|Overall Study||12
10347329|NCT00420927|11485453|FG002|COMPLETED|Period 1||0
10347330|NCT00420927|11485454|FG003|COMPLETED|Period 1||0
10347331|NCT00420927|11485455|FG004|COMPLETED|Period 1||0
10347332|NCT00420927|11485456|FG005|COMPLETED|Period 1||0
10347333|NCT00420927|11485457|FG006|COMPLETED|Period 1||0
10347334|NCT00420927|11485451|FG000|NOT COMPLETED|Period 1||49
10347335|NCT00420927|11485452|FG001|NOT COMPLETED|Period 1||57
10347336|NCT00420927|11485453|FG002|NOT COMPLETED|Period 1||0
10347337|NCT00420927|11485454|FG003|NOT COMPLETED|Period 1||0
10347338|NCT00420927|11485455|FG004|NOT COMPLETED|Period 1||0
10347339|NCT00420927|11485456|FG005|NOT COMPLETED|Period 1||0
10347340|NCT00420927|11485457|FG006|NOT COMPLETED|Period 1||0
10347341|NCT00420927|11485451|FG000|STARTED|Period 2|This treatment group is not relevant to Period 2.|0
10347342|NCT00420927|11485452|FG001|STARTED|Period 2|This treatment group is not relevant to Period 2.|0
10347343|NCT00420927|11485453|FG002|STARTED|Period 2||102
10347344|NCT00420927|11485454|FG003|STARTED|Period 2||105
10347345|NCT00420927|11485455|FG004|STARTED|Period 2||259
10347346|NCT00420927|11485456|FG005|STARTED|Period 2||112
10347347|NCT00420927|11485457|FG006|STARTED|Period 2||348
10347348|NCT00420927|11485451|FG000|COMPLETED|Period 2||0
10347349|NCT00420927|11485452|FG001|COMPLETED|Period 2||0
10347350|NCT00420927|11485453|FG002|COMPLETED|Period 2||89
10347351|NCT00420927|11485454|FG003|COMPLETED|Period 2||95
10347352|NCT00420927|11485455|FG004|COMPLETED|Period 2||216
10347353|NCT00420927|11485456|FG005|COMPLETED|Period 2||97
10347354|NCT00420927|11485457|FG006|COMPLETED|Period 2||295
10347355|NCT00420927|11485451|FG000|NOT COMPLETED|Period 2||0
10347356|NCT00420927|11485452|FG001|NOT COMPLETED|Period 2||0
10347357|NCT00420927|11485453|FG002|NOT COMPLETED|Period 2||13
10347358|NCT00420927|11485454|FG003|NOT COMPLETED|Period 2||10
10347359|NCT00420927|11485455|FG004|NOT COMPLETED|Period 2||43
10347360|NCT00420927|11485456|FG005|NOT COMPLETED|Period 2||15
10347361|NCT00420927|11485457|FG006|NOT COMPLETED|Period 2||53
10347362|NCT00420992|11485473|FG000|STARTED|Titration Phase|All patients received ALO-01 during open-label titration phase|547
10347363|NCT00420992|11485474|FG001|STARTED|Titration Phase||0
10347364|NCT00420992|11485473|FG000|COMPLETED|Titration Phase||344
10347365|NCT00420992|11485474|FG001|COMPLETED|Titration Phase||0
10347366|NCT00420992|11485473|FG000|NOT COMPLETED|Titration Phase||203
10347367|NCT00420992|11485474|FG001|NOT COMPLETED|Titration Phase||0
10347368|NCT00420992|11485473|FG000|STARTED|Maintenance Phase||171
10347369|NCT00420992|11485474|FG001|STARTED|Maintenance Phase||173
10347370|NCT00420992|11485473|FG000|COMPLETED|Maintenance Phase||110
10347371|NCT00420992|11485474|FG001|COMPLETED|Maintenance Phase||98
10347372|NCT00420992|11485473|FG000|NOT COMPLETED|Maintenance Phase||61
10347373|NCT00420992|11485474|FG001|NOT COMPLETED|Maintenance Phase||75
10347374|NCT00421148|11485501|FG000|STARTED|Overall Study||2
10347375|NCT00421148|11485502|FG001|STARTED|Overall Study||2
10347376|NCT00421148|11485503|FG002|STARTED|Overall Study||2
10347377|NCT00421148|11485504|FG003|STARTED|Overall Study||1
10347378|NCT00421148|11485505|FG004|STARTED|Overall Study||1
10347379|NCT00421148|11485506|FG005|STARTED|Overall Study||5
10347380|NCT00421148|11485507|FG006|STARTED|Overall Study||6
10347381|NCT00421148|11485508|FG007|STARTED|Overall Study||5
10347382|NCT00421148|11485509|FG008|STARTED|Overall Study||5
10347383|NCT00421148|11485510|FG009|STARTED|Overall Study||5
10347384|NCT00421148|11485511|FG010|STARTED|Overall Study||6
10347385|NCT00421148|11485512|FG011|STARTED|Overall Study||6
10347386|NCT00421148|11485513|FG012|STARTED|Overall Study||6
10347387|NCT00421148|11485514|FG013|STARTED|Overall Study||6
10347388|NCT00421148|11485515|FG014|STARTED|Overall Study||6
10347389|NCT00421148|11485516|FG015|STARTED|Overall Study||6
10347390|NCT00421148|11485517|FG016|STARTED|Overall Study||6
10347391|NCT00421148|11485518|FG017|STARTED|Overall Study||6
10347392|NCT00421148|11485519|FG018|STARTED|Overall Study||6
10347393|NCT00421148|11485520|FG019|STARTED|Overall Study||6
10347394|NCT00421148|11485501|FG000|Treated|Overall Study||2
10347395|NCT00421148|11485502|FG001|Treated|Overall Study||2
10347396|NCT00421148|11485503|FG002|Treated|Overall Study||2
10347397|NCT00421148|11485504|FG003|Treated|Overall Study||1
10347398|NCT00421148|11485505|FG004|Treated|Overall Study||1
10347399|NCT00421148|11485506|FG005|Treated|Overall Study|1 additional participant discontinued prior to receiving study treatment|4
10347400|NCT00421148|11485507|FG006|Treated|Overall Study||6
10347401|NCT00421148|11485508|FG007|Treated|Overall Study||5
10347402|NCT00421148|11485509|FG008|Treated|Overall Study||5
10347403|NCT00421148|11485510|FG009|Treated|Overall Study|Includes 1 participant who was inadvertently randomized to group but was an adolescent|5
10347404|NCT00421148|11485511|FG010|Treated|Overall Study||6
10347405|NCT00421148|11485512|FG011|Treated|Overall Study|Includes 1 participant who was inadvertently randomized to group but received 5 mg/kg sugammadex|6
10347406|NCT00421148|11485513|FG012|Treated|Overall Study||6
10347407|NCT00421148|11485514|FG013|Treated|Overall Study||6
10655630|NCT02209454|11816327|FG000|STARTED|First Period||13
10347408|NCT00421148|11485515|FG014|Treated|Overall Study||6
10347409|NCT00421148|11485516|FG015|Treated|Overall Study||6
10347410|NCT00421148|11485517|FG016|Treated|Overall Study||6
10347411|NCT00421148|11485518|FG017|Treated|Overall Study|1 additional participant discontinued prior to receiving study treatment|5
10347412|NCT00421148|11485519|FG018|Treated|Overall Study|1 additional participant discontinued prior to receiving study treatment|5
10655631|NCT02209454|11816328|FG001|STARTED|First Period||13
10347413|NCT00421148|11485520|FG019|Treated|Overall Study||6
10347414|NCT00421148|11485501|FG000|COMPLETED|Overall Study||2
10347415|NCT00421148|11485502|FG001|COMPLETED|Overall Study||2
10347416|NCT00421148|11485503|FG002|COMPLETED|Overall Study||2
10347417|NCT00421148|11485504|FG003|COMPLETED|Overall Study||1
10347418|NCT00421148|11485505|FG004|COMPLETED|Overall Study||1
10347419|NCT00421148|11485506|FG005|COMPLETED|Overall Study||4
10347420|NCT00421148|11485507|FG006|COMPLETED|Overall Study||6
10347421|NCT00421148|11485508|FG007|COMPLETED|Overall Study||5
10347422|NCT00421148|11485509|FG008|COMPLETED|Overall Study||5
10347423|NCT00421148|11485510|FG009|COMPLETED|Overall Study||5
10347424|NCT00421148|11485511|FG010|COMPLETED|Overall Study||6
10347425|NCT00421148|11485512|FG011|COMPLETED|Overall Study||6
10347426|NCT00421148|11485513|FG012|COMPLETED|Overall Study||6
10347427|NCT00421148|11485514|FG013|COMPLETED|Overall Study||6
10347428|NCT00421148|11485515|FG014|COMPLETED|Overall Study||6
10347429|NCT00421148|11485516|FG015|COMPLETED|Overall Study||6
10347430|NCT00421148|11485517|FG016|COMPLETED|Overall Study||6
10347431|NCT00421148|11485518|FG017|COMPLETED|Overall Study||4
10347432|NCT00421148|11485519|FG018|COMPLETED|Overall Study||5
10347433|NCT00421148|11485520|FG019|COMPLETED|Overall Study||6
10347434|NCT00421148|11485501|FG000|NOT COMPLETED|Overall Study||0
10347435|NCT00421148|11485502|FG001|NOT COMPLETED|Overall Study||0
10347436|NCT00421148|11485503|FG002|NOT COMPLETED|Overall Study||0
10347437|NCT00421148|11485504|FG003|NOT COMPLETED|Overall Study||0
10347438|NCT00421148|11485505|FG004|NOT COMPLETED|Overall Study||0
10347439|NCT00421148|11485506|FG005|NOT COMPLETED|Overall Study||1
10347440|NCT00421148|11485507|FG006|NOT COMPLETED|Overall Study||0
10347441|NCT00421148|11485508|FG007|NOT COMPLETED|Overall Study||0
10347442|NCT00421148|11485509|FG008|NOT COMPLETED|Overall Study||0
10347443|NCT00421148|11485510|FG009|NOT COMPLETED|Overall Study||0
10347444|NCT00421148|11485511|FG010|NOT COMPLETED|Overall Study||0
10347445|NCT00421148|11485512|FG011|NOT COMPLETED|Overall Study||0
10347446|NCT00421148|11485513|FG012|NOT COMPLETED|Overall Study||0
10347447|NCT00421148|11485514|FG013|NOT COMPLETED|Overall Study||0
10347448|NCT00421148|11485515|FG014|NOT COMPLETED|Overall Study||0
10347449|NCT00421148|11485516|FG015|NOT COMPLETED|Overall Study||0
10347450|NCT00421148|11485517|FG016|NOT COMPLETED|Overall Study||0
10347451|NCT00421148|11485518|FG017|NOT COMPLETED|Overall Study||2
10347452|NCT00421148|11485519|FG018|NOT COMPLETED|Overall Study||1
10347453|NCT00421148|11485520|FG019|NOT COMPLETED|Overall Study||0
10347454|NCT00421174|11485564|FG000|STARTED|Overall Study||18
10347455|NCT00421174|11485565|FG001|STARTED|Overall Study||19
10532476|NCT01421017|11684836|FG002|STARTED|Overall Study||7
10532477|NCT01421017|11684834|FG000|COMPLETED|Overall Study||10
10532478|NCT01421017|11684835|FG001|COMPLETED|Overall Study||6
10532479|NCT01421017|11684836|FG002|COMPLETED|Overall Study||4
10532480|NCT01421017|11684834|FG000|NOT COMPLETED|Overall Study||2
10532481|NCT01421017|11684835|FG001|NOT COMPLETED|Overall Study||6
10532482|NCT01421017|11684836|FG002|NOT COMPLETED|Overall Study||3
10532483|NCT01421134|11684846|FG000|STARTED|Overall Study||109
10532484|NCT01421134|11684847|FG001|STARTED|Overall Study||102
10532485|NCT01421134|11684846|FG000|COMPLETED|Overall Study||102
10532486|NCT01421134|11684847|FG001|COMPLETED|Overall Study||87
10532487|NCT01421134|11684846|FG000|NOT COMPLETED|Overall Study||7
10532488|NCT01421134|11684847|FG001|NOT COMPLETED|Overall Study||15
10532489|NCT01421147|11684855|FG000|STARTED|Treatment Period||269
10532490|NCT01421147|11684856|FG001|STARTED|Treatment Period||267
10532491|NCT01421147|11684855|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||268
10532492|NCT01421147|11684856|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||267
10532493|NCT01421147|11684855|FG000|COMPLETED|Treatment Period||253
10532494|NCT01421147|11684856|FG001|COMPLETED|Treatment Period||256
10532495|NCT01421147|11684855|FG000|NOT COMPLETED|Treatment Period||16
10532496|NCT01421147|11684856|FG001|NOT COMPLETED|Treatment Period||11
10532497|NCT01421147|11684855|FG000|STARTED|Extension Period||253
10532498|NCT01421147|11684856|FG001|STARTED|Extension Period||256
10532499|NCT01421147|11684855|FG000|COMPLETED|Extension Period||245
10532500|NCT01421147|11684856|FG001|COMPLETED|Extension Period||245
10532501|NCT01421147|11684855|FG000|NOT COMPLETED|Extension Period||8
10532502|NCT01421147|11684856|FG001|NOT COMPLETED|Extension Period||11
10347456|NCT00421174|11485564|FG000|COMPLETED|Overall Study||16
10347457|NCT00421174|11485565|FG001|COMPLETED|Overall Study||18
10347458|NCT00421174|11485564|FG000|NOT COMPLETED|Overall Study||2
10347459|NCT00421174|11485565|FG001|NOT COMPLETED|Overall Study||1
10347460|NCT00421304|11485574|FG000|STARTED|Overall Study||40
10532503|NCT01421186|11684867|FG000|STARTED|Overall Study||31
10532504|NCT01421186|11684868|FG001|STARTED|Overall Study||4
10532505|NCT01421186|11684869|FG002|STARTED|Overall Study||18
10532506|NCT01421186|11684870|FG003|STARTED|Overall Study||21
10347461|NCT00421304|11485575|FG001|STARTED|Overall Study||39
10347462|NCT00421304|11485576|FG002|STARTED|Overall Study||39
10347463|NCT00421304|11485574|FG000|COMPLETED|Overall Study||32
10347464|NCT00421304|11485575|FG001|COMPLETED|Overall Study||35
10347465|NCT00421304|11485576|FG002|COMPLETED|Overall Study||31
10347466|NCT00421304|11485574|FG000|NOT COMPLETED|Overall Study||8
10347467|NCT00421304|11485575|FG001|NOT COMPLETED|Overall Study||4
10347468|NCT00421304|11485576|FG002|NOT COMPLETED|Overall Study||8
10347469|NCT00421343|11485586|FG000|STARTED|Overall Study||29
10347470|NCT00421343|11485586|FG000|COMPLETED|Overall Study||23
10347471|NCT00421343|11485586|FG000|NOT COMPLETED|Overall Study||6
10347472|NCT00421408|11485592|FG000|STARTED|Overall Study||102
10347473|NCT00421408|11485593|FG001|STARTED|Overall Study||106
10347474|NCT00421408|11485592|FG000|COMPLETED|Overall Study||60
10347475|NCT00421408|11485593|FG001|COMPLETED|Overall Study||61
10347476|NCT00421408|11485592|FG000|NOT COMPLETED|Overall Study||42
10347477|NCT00421408|11485593|FG001|NOT COMPLETED|Overall Study||45
10347478|NCT00421603|11485601|FG000|STARTED|Overall Study||39
10347479|NCT00421603|11485602|FG001|STARTED|Overall Study||42
10347480|NCT00421603|11485601|FG000|COMPLETED|Overall Study|Completed all 14 week sof trial|28
10347481|NCT00421603|11485602|FG001|COMPLETED|Overall Study|Completed all 14 week sof trial|30
10347482|NCT00421603|11485601|FG000|NOT COMPLETED|Overall Study||11
10347483|NCT00421603|11485602|FG001|NOT COMPLETED|Overall Study||12
10347484|NCT00421707|11485610|FG000|STARTED|Period 1: Treatment Period 1||67
10347485|NCT00421707|11485611|FG001|STARTED|Period 1: Treatment Period 1||65
10347486|NCT00421707|11485610|FG000|COMPLETED|Period 1: Treatment Period 1||56
10347487|NCT00421707|11485611|FG001|COMPLETED|Period 1: Treatment Period 1||56
10347488|NCT00421707|11485610|FG000|NOT COMPLETED|Period 1: Treatment Period 1||11
10347489|NCT00421707|11485611|FG001|NOT COMPLETED|Period 1: Treatment Period 1||9
10347490|NCT00421707|11485610|FG000|STARTED|Period 2: Washout||56
10347491|NCT00421707|11485611|FG001|STARTED|Period 2: Washout||56
10347492|NCT00421707|11485610|FG000|COMPLETED|Period 2: Washout||55
10347493|NCT00421707|11485611|FG001|COMPLETED|Period 2: Washout||52
10347494|NCT00421707|11485610|FG000|NOT COMPLETED|Period 2: Washout||1
10347495|NCT00421707|11485611|FG001|NOT COMPLETED|Period 2: Washout||4
10347496|NCT00421707|11485610|FG000|STARTED|Period 3:Treatment Period 2||55
10347497|NCT00421707|11485611|FG001|STARTED|Period 3:Treatment Period 2||52
10347498|NCT00421707|11485610|FG000|COMPLETED|Period 3:Treatment Period 2||53
10347499|NCT00421707|11485611|FG001|COMPLETED|Period 3:Treatment Period 2||49
10347500|NCT00421707|11485610|FG000|NOT COMPLETED|Period 3:Treatment Period 2||2
10347501|NCT00421707|11485611|FG001|NOT COMPLETED|Period 3:Treatment Period 2||3
10347502|NCT00421733|11485623|FG000|STARTED|Overall Study||93
10347503|NCT00421733|11485624|FG001|STARTED|Overall Study||95
10347504|NCT00421733|11485625|FG002|STARTED|Overall Study||93
10347505|NCT00421733|11485623|FG000|COMPLETED|Overall Study||78
10347506|NCT00421733|11485624|FG001|COMPLETED|Overall Study||69
10347507|NCT00421733|11485625|FG002|COMPLETED|Overall Study||73
10347508|NCT00421733|11485623|FG000|NOT COMPLETED|Overall Study||15
10347509|NCT00421733|11485624|FG001|NOT COMPLETED|Overall Study||26
10347510|NCT00421733|11485625|FG002|NOT COMPLETED|Overall Study||20
10347511|NCT00421889|11485646|FG000|STARTED|Overall Study||5
10347512|NCT00421889|11485647|FG001|STARTED|Overall Study||5
10347513|NCT00421889|11485648|FG002|STARTED|Overall Study||3
10347514|NCT00421889|11485649|FG003|STARTED|Overall Study||4
10347515|NCT00421889|11485650|FG004|STARTED|Overall Study||6
10347516|NCT00421889|11485651|FG005|STARTED|Overall Study||35
10347517|NCT00421889|11485652|FG006|STARTED|Overall Study||4
10347518|NCT00421889|11485653|FG007|STARTED|Overall Study||3
10347519|NCT00421889|11485654|FG008|STARTED|Overall Study||15
10347520|NCT00421889|11485646|FG000|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.20|0
10347521|NCT00421889|11485647|FG001|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 8.20|0
10347522|NCT00421889|11485648|FG002|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 3.33|0
10347523|NCT00421889|11485649|FG003|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 9.25|0
10347524|NCT00421889|11485650|FG004|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.00|0
10347525|NCT00421889|11485651|FG005|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 7.69|0
10347526|NCT00421889|11485652|FG006|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.50|0
10347527|NCT00421889|11485653|FG007|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 3.33|1
10347528|NCT00421889|11485654|FG008|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 4.27|4
10347529|NCT00421889|11485646|FG000|NOT COMPLETED|Overall Study||5
10347530|NCT00421889|11485647|FG001|NOT COMPLETED|Overall Study||5
10347531|NCT00421889|11485648|FG002|NOT COMPLETED|Overall Study||3
10347532|NCT00421889|11485649|FG003|NOT COMPLETED|Overall Study||4
10347533|NCT00421889|11485650|FG004|NOT COMPLETED|Overall Study||6
10347534|NCT00421889|11485651|FG005|NOT COMPLETED|Overall Study||35
10347535|NCT00421889|11485652|FG006|NOT COMPLETED|Overall Study||4
10347536|NCT00421889|11485653|FG007|NOT COMPLETED|Overall Study||2
10347537|NCT00421889|11485654|FG008|NOT COMPLETED|Overall Study||11
10347538|NCT00421928|11485681|FG000|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug|344
10347539|NCT00421928|11485682|FG001|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug. One subject was enrolled twice.|342
10347540|NCT00421928|11485683|FG002|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug|337
10347541|NCT00421928|11485681|FG000|COMPLETED|Overall Study||181
10347542|NCT00421928|11485682|FG001|COMPLETED|Overall Study||118
10347543|NCT00421928|11485683|FG002|COMPLETED|Overall Study||203
10347544|NCT00421928|11485681|FG000|NOT COMPLETED|Overall Study||163
10347545|NCT00421928|11485682|FG001|NOT COMPLETED|Overall Study||224
10347546|NCT00421928|11485683|FG002|NOT COMPLETED|Overall Study||134
10347547|NCT00421993|11485695|FG000|STARTED|Overall Study||419
10347548|NCT00421993|11485696|FG001|STARTED|Overall Study||418
10347549|NCT00421993|11485697|FG002|STARTED|Overall Study||415
10347550|NCT00421993|11485698|FG003|STARTED|Overall Study||418
10347551|NCT00421993|11485695|FG000|COMPLETED|Overall Study||366
10347552|NCT00421993|11485696|FG001|COMPLETED|Overall Study||369
10347553|NCT00421993|11485697|FG002|COMPLETED|Overall Study||363
10347554|NCT00421993|11485698|FG003|COMPLETED|Overall Study||361
10347555|NCT00421993|11485695|FG000|NOT COMPLETED|Overall Study||53
10347556|NCT00421993|11485696|FG001|NOT COMPLETED|Overall Study||49
10347557|NCT00421993|11485697|FG002|NOT COMPLETED|Overall Study||52
10347558|NCT00421993|11485698|FG003|NOT COMPLETED|Overall Study||57
10347559|NCT00422032|11485710|FG000|STARTED|Overall Study||37
10347560|NCT00422032|11485711|FG001|STARTED|Overall Study||21
10347561|NCT00422032|11485710|FG000|COMPLETED|Overall Study||37
10347562|NCT00422032|11485711|FG001|COMPLETED|Overall Study||21
10347563|NCT00422032|11485710|FG000|NOT COMPLETED|Overall Study||0
10347564|NCT00422032|11485711|FG001|NOT COMPLETED|Overall Study||0
10347565|NCT00422058|11485723|FG000|STARTED|Double-Blind, Week 0-20||98
10347566|NCT00422058|11485724|FG001|STARTED|Double-Blind, Week 0-20||95
10347567|NCT00422058|11485725|FG002|STARTED|Double-Blind, Week 0-20||90
10347568|NCT00422058|11485726|FG003|STARTED|Double-Blind, Week 0-20||93
10347569|NCT00422058|11485727|FG004|STARTED|Double-Blind, Week 0-20||93
10347570|NCT00422058|11485728|FG005|STARTED|Double-Blind, Week 0-20||95
10347571|NCT00422058|11485723|FG000|COMPLETED|Double-Blind, Week 0-20||79
10347572|NCT00422058|11485724|FG001|COMPLETED|Double-Blind, Week 0-20||85
10347573|NCT00422058|11485725|FG002|COMPLETED|Double-Blind, Week 0-20||74
10347574|NCT00422058|11485726|FG003|COMPLETED|Double-Blind, Week 0-20||73
10347575|NCT00422058|11485727|FG004|COMPLETED|Double-Blind, Week 0-20||82
10347576|NCT00422058|11485728|FG005|COMPLETED|Double-Blind, Week 0-20||79
10347577|NCT00422058|11485723|FG000|NOT COMPLETED|Double-Blind, Week 0-20||19
10347578|NCT00422058|11485724|FG001|NOT COMPLETED|Double-Blind, Week 0-20||10
10347579|NCT00422058|11485725|FG002|NOT COMPLETED|Double-Blind, Week 0-20||16
10347580|NCT00422058|11485726|FG003|NOT COMPLETED|Double-Blind, Week 0-20||20
10347581|NCT00422058|11485727|FG004|NOT COMPLETED|Double-Blind, Week 0-20||11
10347582|NCT00422058|11485728|FG005|NOT COMPLETED|Double-Blind, Week 0-20||16
10347583|NCT00422058|11485723|FG000|STARTED|Open-Label Extension, Week 20-104||79
10347584|NCT00422058|11485724|FG001|STARTED|Open-Label Extension, Week 20-104||85
10347585|NCT00422058|11485725|FG002|STARTED|Open-Label Extension, Week 20-104||74
10347586|NCT00422058|11485726|FG003|STARTED|Open-Label Extension, Week 20-104||73
10347587|NCT00422058|11485727|FG004|STARTED|Open-Label Extension, Week 20-104||82
10347588|NCT00422058|11485728|FG005|STARTED|Open-Label Extension, Week 20-104||79
10347589|NCT00422058|11485723|FG000|Enrolled in Extension|Open-Label Extension, Week 20-104||67
10347590|NCT00422058|11485724|FG001|Enrolled in Extension|Open-Label Extension, Week 20-104||68
10347591|NCT00422058|11485725|FG002|Enrolled in Extension|Open-Label Extension, Week 20-104||59
10347592|NCT00422058|11485726|FG003|Enrolled in Extension|Open-Label Extension, Week 20-104||65
10347593|NCT00422058|11485727|FG004|Enrolled in Extension|Open-Label Extension, Week 20-104||72
10347594|NCT00422058|11485728|FG005|Enrolled in Extension|Open-Label Extension, Week 20-104||67
10347595|NCT00422058|11485723|FG000|COMPLETED|Open-Label Extension, Week 20-104||47
10347596|NCT00422058|11485724|FG001|COMPLETED|Open-Label Extension, Week 20-104||46
10347597|NCT00422058|11485725|FG002|COMPLETED|Open-Label Extension, Week 20-104||38
10347598|NCT00422058|11485726|FG003|COMPLETED|Open-Label Extension, Week 20-104||45
10347599|NCT00422058|11485727|FG004|COMPLETED|Open-Label Extension, Week 20-104||47
10347600|NCT00422058|11485728|FG005|COMPLETED|Open-Label Extension, Week 20-104||45
10347601|NCT00422058|11485723|FG000|NOT COMPLETED|Open-Label Extension, Week 20-104||32
10347602|NCT00422058|11485724|FG001|NOT COMPLETED|Open-Label Extension, Week 20-104||39
10347603|NCT00422058|11485725|FG002|NOT COMPLETED|Open-Label Extension, Week 20-104||36
10347604|NCT00422058|11485726|FG003|NOT COMPLETED|Open-Label Extension, Week 20-104||28
10347605|NCT00422058|11485727|FG004|NOT COMPLETED|Open-Label Extension, Week 20-104||35
10347606|NCT00422058|11485728|FG005|NOT COMPLETED|Open-Label Extension, Week 20-104||34
10347607|NCT00422084|11485744|FG000|STARTED|Overall Study||849
10347608|NCT00422084|11485745|FG001|STARTED|Overall Study||423
10347609|NCT00422084|11485744|FG000|COMPLETED|Overall Study||751
10347610|NCT00422084|11485745|FG001|COMPLETED|Overall Study||347
10347611|NCT00422084|11485744|FG000|NOT COMPLETED|Overall Study||98
10347612|NCT00422084|11485745|FG001|NOT COMPLETED|Overall Study||76
10347613|NCT00422097|11485757|FG000|STARTED|Dose Level 1||3
10347614|NCT00422097|11485758|FG001|STARTED|Dose Level 1||0
10347615|NCT00422097|11485759|FG002|STARTED|Dose Level 1||0
10347616|NCT00422097|11485760|FG003|STARTED|Dose Level 1||0
10347617|NCT00422097|11485761|FG004|STARTED|Dose Level 1||0
10347618|NCT00422097|11485762|FG005|STARTED|Dose Level 1||0
10347619|NCT00422097|11485763|FG006|STARTED|Dose Level 1||0
10347620|NCT00422097|11485764|FG007|STARTED|Dose Level 1||0
10347621|NCT00422097|11485757|FG000|COMPLETED|Dose Level 1||3
10347622|NCT00422097|11485758|FG001|COMPLETED|Dose Level 1||0
10347623|NCT00422097|11485759|FG002|COMPLETED|Dose Level 1||0
10347624|NCT00422097|11485760|FG003|COMPLETED|Dose Level 1||0
10347625|NCT00422097|11485761|FG004|COMPLETED|Dose Level 1||0
10347626|NCT00422097|11485762|FG005|COMPLETED|Dose Level 1||0
10347627|NCT00422097|11485763|FG006|COMPLETED|Dose Level 1||0
10347628|NCT00422097|11485764|FG007|COMPLETED|Dose Level 1||0
10347629|NCT00422097|11485757|FG000|NOT COMPLETED|Dose Level 1||0
10347630|NCT00422097|11485758|FG001|NOT COMPLETED|Dose Level 1||0
10347631|NCT00422097|11485759|FG002|NOT COMPLETED|Dose Level 1||0
10347632|NCT00422097|11485760|FG003|NOT COMPLETED|Dose Level 1||0
10347633|NCT00422097|11485761|FG004|NOT COMPLETED|Dose Level 1||0
10347634|NCT00422097|11485762|FG005|NOT COMPLETED|Dose Level 1||0
10347635|NCT00422097|11485763|FG006|NOT COMPLETED|Dose Level 1||0
10532507|NCT01421186|11684871|FG004|STARTED|Overall Study||17
10347636|NCT00422097|11485764|FG007|NOT COMPLETED|Dose Level 1||0
10347637|NCT00422097|11485757|FG000|STARTED|Dose Level 2||0
10347638|NCT00422097|11485758|FG001|STARTED|Dose Level 2||6
10347639|NCT00422097|11485759|FG002|STARTED|Dose Level 2||0
10347640|NCT00422097|11485760|FG003|STARTED|Dose Level 2||0
10347641|NCT00422097|11485761|FG004|STARTED|Dose Level 2||0
10347642|NCT00422097|11485762|FG005|STARTED|Dose Level 2||0
10347643|NCT00422097|11485763|FG006|STARTED|Dose Level 2||0
10347644|NCT00422097|11485764|FG007|STARTED|Dose Level 2||0
10347645|NCT00422097|11485757|FG000|COMPLETED|Dose Level 2||0
10347646|NCT00422097|11485758|FG001|COMPLETED|Dose Level 2||5
10347647|NCT00422097|11485759|FG002|COMPLETED|Dose Level 2||0
10532508|NCT01421186|11684867|FG000|COMPLETED|Overall Study||31
10532509|NCT01421186|11684868|FG001|COMPLETED|Overall Study||4
10532510|NCT01421186|11684869|FG002|COMPLETED|Overall Study||18
10532511|NCT01421186|11684870|FG003|COMPLETED|Overall Study||21
10532512|NCT01421186|11684871|FG004|COMPLETED|Overall Study||17
10532513|NCT01421186|11684867|FG000|NOT COMPLETED|Overall Study||0
10532514|NCT01421186|11684868|FG001|NOT COMPLETED|Overall Study||0
10532515|NCT01421186|11684869|FG002|NOT COMPLETED|Overall Study||0
10532516|NCT01421186|11684870|FG003|NOT COMPLETED|Overall Study||0
10532517|NCT01421186|11684871|FG004|NOT COMPLETED|Overall Study||0
10532518|NCT01421225|11684891|FG000|STARTED|Overall Study||4
10532519|NCT01421225|11684892|FG001|STARTED|Overall Study||6
10532520|NCT01421225|11684891|FG000|COMPLETED|Overall Study||4
10532521|NCT01421225|11684892|FG001|COMPLETED|Overall Study||5
10532522|NCT01421225|11684891|FG000|NOT COMPLETED|Overall Study||0
10532523|NCT01421225|11684892|FG001|NOT COMPLETED|Overall Study||1
10532524|NCT01421277|11684901|FG000|STARTED|Overall Study||25
10532525|NCT01421277|11684902|FG001|STARTED|Overall Study||191
10532526|NCT01421277|11684901|FG000|COMPLETED|Overall Study|Completed the online survey for at least one migraine attack.|25
10532527|NCT01421277|11684902|FG001|COMPLETED|Overall Study|Completed the online survey for at least one migraine attack.|99
10532528|NCT01421277|11684901|FG000|NOT COMPLETED|Overall Study||0
10532529|NCT01421277|11684902|FG001|NOT COMPLETED|Overall Study||92
10532530|NCT01421303|11684908|FG000|STARTED|Overall Study||80
10532531|NCT01421303|11684908|FG000|COMPLETED|Overall Study||58
10532532|NCT01421303|11684908|FG000|NOT COMPLETED|Overall Study||22
10655632|NCT02209454|11816327|FG000|COMPLETED|First Period||13
10655633|NCT02209454|11816328|FG001|COMPLETED|First Period||13
10655634|NCT02209454|11816327|FG000|NOT COMPLETED|First Period||0
10655635|NCT02209454|11816328|FG001|NOT COMPLETED|First Period||0
10655636|NCT02209454|11816327|FG000|STARTED|Washout Period a Minimum of a 7 Day||13
10655637|NCT02209454|11816328|FG001|STARTED|Washout Period a Minimum of a 7 Day||13
10655638|NCT02209454|11816327|FG000|COMPLETED|Washout Period a Minimum of a 7 Day||13
10655639|NCT02209454|11816328|FG001|COMPLETED|Washout Period a Minimum of a 7 Day||13
10655640|NCT02209454|11816327|FG000|NOT COMPLETED|Washout Period a Minimum of a 7 Day||0
10655641|NCT02209454|11816328|FG001|NOT COMPLETED|Washout Period a Minimum of a 7 Day||0
10655642|NCT02209454|11816327|FG000|STARTED|Second Period||13
10655643|NCT02209454|11816328|FG001|STARTED|Second Period||13
10655644|NCT02209454|11816327|FG000|COMPLETED|Second Period||12
10655645|NCT02209454|11816328|FG001|COMPLETED|Second Period||13
10655646|NCT02209454|11816327|FG000|NOT COMPLETED|Second Period||1
10655647|NCT02209454|11816328|FG001|NOT COMPLETED|Second Period||0
10655648|NCT02209506|11816339|FG000|STARTED|Overall Study||3
10655649|NCT02209506|11816340|FG001|STARTED|Overall Study||6
10655650|NCT02209506|11816341|FG002|STARTED|Overall Study||6
10655651|NCT02209506|11816342|FG003|STARTED|Overall Study||2
10655652|NCT02209506|11816343|FG004|STARTED|Overall Study||6
10655653|NCT02209506|11816339|FG000|COMPLETED|Overall Study||3
10655654|NCT02209506|11816340|FG001|COMPLETED|Overall Study||6
10655655|NCT02209506|11816341|FG002|COMPLETED|Overall Study||6
10655656|NCT02209506|11816342|FG003|COMPLETED|Overall Study||2
10655657|NCT02209506|11816343|FG004|COMPLETED|Overall Study||5
10655658|NCT02209506|11816339|FG000|NOT COMPLETED|Overall Study||0
10347648|NCT00422097|11485760|FG003|COMPLETED|Dose Level 2||0
10347649|NCT00422097|11485761|FG004|COMPLETED|Dose Level 2||0
10347650|NCT00422097|11485762|FG005|COMPLETED|Dose Level 2||0
10532533|NCT01421342|11684915|FG000|STARTED|Acute Treatment Phase (12 Weeks)||511
10532534|NCT01421342|11684916|FG001|STARTED|Acute Treatment Phase (12 Weeks)||506
10532535|NCT01421342|11684917|FG002|STARTED|Acute Treatment Phase (12 Weeks)||505
10532536|NCT01421342|11684915|FG000|COMPLETED|Acute Treatment Phase (12 Weeks)||353
10532537|NCT01421342|11684916|FG001|COMPLETED|Acute Treatment Phase (12 Weeks)||378
10532538|NCT01421342|11684917|FG002|COMPLETED|Acute Treatment Phase (12 Weeks)||406
10532539|NCT01421342|11684915|FG000|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||158
10532540|NCT01421342|11684916|FG001|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||128
10532541|NCT01421342|11684917|FG002|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||99
10532542|NCT01421342|11684915|FG000|STARTED|Completed to Week 12 But Then Withdrawn||353
10655659|NCT02209506|11816340|FG001|NOT COMPLETED|Overall Study||0
10655660|NCT02209506|11816341|FG002|NOT COMPLETED|Overall Study||0
10655661|NCT02209506|11816342|FG003|NOT COMPLETED|Overall Study||0
10655662|NCT02209506|11816343|FG004|NOT COMPLETED|Overall Study||1
10347651|NCT00422097|11485763|FG006|COMPLETED|Dose Level 2||0
10532543|NCT01421342|11684916|FG001|STARTED|Completed to Week 12 But Then Withdrawn||378
10532544|NCT01421342|11684917|FG002|STARTED|Completed to Week 12 But Then Withdrawn||406
10532545|NCT01421342|11684915|FG000|COMPLETED|Completed to Week 12 But Then Withdrawn||204
10532546|NCT01421342|11684916|FG001|COMPLETED|Completed to Week 12 But Then Withdrawn||253
10532547|NCT01421342|11684917|FG002|COMPLETED|Completed to Week 12 But Then Withdrawn||268
10347652|NCT00422097|11485764|FG007|COMPLETED|Dose Level 2||0
10347653|NCT00422097|11485757|FG000|NOT COMPLETED|Dose Level 2||0
10347654|NCT00422097|11485758|FG001|NOT COMPLETED|Dose Level 2||1
10347655|NCT00422097|11485759|FG002|NOT COMPLETED|Dose Level 2||0
10347656|NCT00422097|11485760|FG003|NOT COMPLETED|Dose Level 2||0
10347657|NCT00422097|11485761|FG004|NOT COMPLETED|Dose Level 2||0
10347658|NCT00422097|11485762|FG005|NOT COMPLETED|Dose Level 2||0
10347659|NCT00422097|11485763|FG006|NOT COMPLETED|Dose Level 2||0
10347660|NCT00422097|11485764|FG007|NOT COMPLETED|Dose Level 2||0
10347661|NCT00422097|11485757|FG000|STARTED|Dose Level 3||0
10347662|NCT00422097|11485758|FG001|STARTED|Dose Level 3||0
10347663|NCT00422097|11485759|FG002|STARTED|Dose Level 3||3
10347664|NCT00422097|11485760|FG003|STARTED|Dose Level 3||0
10347665|NCT00422097|11485761|FG004|STARTED|Dose Level 3||0
10347666|NCT00422097|11485762|FG005|STARTED|Dose Level 3||0
10347667|NCT00422097|11485763|FG006|STARTED|Dose Level 3||0
10347668|NCT00422097|11485764|FG007|STARTED|Dose Level 3||0
10347669|NCT00422097|11485757|FG000|COMPLETED|Dose Level 3||0
10347670|NCT00422097|11485758|FG001|COMPLETED|Dose Level 3||0
10347671|NCT00422097|11485759|FG002|COMPLETED|Dose Level 3||3
10347672|NCT00422097|11485760|FG003|COMPLETED|Dose Level 3||0
10347673|NCT00422097|11485761|FG004|COMPLETED|Dose Level 3||0
10347674|NCT00422097|11485762|FG005|COMPLETED|Dose Level 3||0
10347675|NCT00422097|11485763|FG006|COMPLETED|Dose Level 3||0
10347676|NCT00422097|11485764|FG007|COMPLETED|Dose Level 3||0
10305534|NCT00094458|11438524|FG005|STARTED|Study Extension: Week 30 Through Week 50||0
10305535|NCT00094458|11438519|FG000|COMPLETED|Study Extension: Week 30 Through Week 50||67
10305536|NCT00094458|11438520|FG001|COMPLETED|Study Extension: Week 30 Through Week 50||85
10305537|NCT00094458|11438521|FG002|COMPLETED|Study Extension: Week 30 Through Week 50||90
10305538|NCT00094458|11438522|FG003|COMPLETED|Study Extension: Week 30 Through Week 50||0
10305539|NCT00094458|11438523|FG004|COMPLETED|Study Extension: Week 30 Through Week 50||0
10305540|NCT00094458|11438524|FG005|COMPLETED|Study Extension: Week 30 Through Week 50||0
10305541|NCT00094458|11438519|FG000|NOT COMPLETED|Study Extension: Week 30 Through Week 50||8
10305542|NCT00094458|11438520|FG001|NOT COMPLETED|Study Extension: Week 30 Through Week 50||12
10305543|NCT00094458|11438521|FG002|NOT COMPLETED|Study Extension: Week 30 Through Week 50||18
10305544|NCT00094458|11438522|FG003|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
10305545|NCT00094458|11438523|FG004|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
10305546|NCT00094458|11438524|FG005|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
10305547|NCT00094458|11438519|FG000|STARTED|OLE: Open-Label Extension||0
10305548|NCT00094458|11438520|FG001|STARTED|OLE: Open-Label Extension||0
10305549|NCT00094458|11438521|FG002|STARTED|OLE: Open-Label Extension||0
10305550|NCT00094458|11438522|FG003|STARTED|OLE: Open-Label Extension||8
10305551|NCT00094458|11438523|FG004|STARTED|OLE: Open-Label Extension||18
10305552|NCT00094458|11438524|FG005|STARTED|OLE: Open-Label Extension||17
10305553|NCT00094458|11438519|FG000|COMPLETED|OLE: Open-Label Extension||0
10305554|NCT00094458|11438520|FG001|COMPLETED|OLE: Open-Label Extension||0
10305555|NCT00094458|11438521|FG002|COMPLETED|OLE: Open-Label Extension||0
10305556|NCT00094458|11438522|FG003|COMPLETED|OLE: Open-Label Extension||7
10305557|NCT00094458|11438523|FG004|COMPLETED|OLE: Open-Label Extension||13
10305558|NCT00094458|11438524|FG005|COMPLETED|OLE: Open-Label Extension||13
10305559|NCT00094458|11438519|FG000|NOT COMPLETED|OLE: Open-Label Extension||0
10305560|NCT00094458|11438520|FG001|NOT COMPLETED|OLE: Open-Label Extension||0
10305561|NCT00094458|11438521|FG002|NOT COMPLETED|OLE: Open-Label Extension||0
10305562|NCT00094458|11438522|FG003|NOT COMPLETED|OLE: Open-Label Extension||1
10305563|NCT00094458|11438523|FG004|NOT COMPLETED|OLE: Open-Label Extension||5
10305564|NCT00094458|11438524|FG005|NOT COMPLETED|OLE: Open-Label Extension||4
10305565|NCT00094497|11438540|FG000|STARTED|Overall Study||151
10305566|NCT00094497|11438541|FG001|STARTED|Overall Study||153
10305567|NCT00094497|11438540|FG000|Treated|Overall Study||148
10305568|NCT00094497|11438541|FG001|Treated|Overall Study||149
10305569|NCT00094497|11438540|FG000|Received Second Line Therapy|Overall Study||84
10305570|NCT00094497|11438541|FG001|Received Second Line Therapy|Overall Study||101
10347677|NCT00422097|11485757|FG000|NOT COMPLETED|Dose Level 3||0
10347678|NCT00422097|11485758|FG001|NOT COMPLETED|Dose Level 3||0
10347679|NCT00422097|11485759|FG002|NOT COMPLETED|Dose Level 3||0
10347680|NCT00422097|11485760|FG003|NOT COMPLETED|Dose Level 3||0
10347681|NCT00422097|11485761|FG004|NOT COMPLETED|Dose Level 3||0
10347682|NCT00422097|11485762|FG005|NOT COMPLETED|Dose Level 3||0
10347683|NCT00422097|11485763|FG006|NOT COMPLETED|Dose Level 3||0
10347684|NCT00422097|11485764|FG007|NOT COMPLETED|Dose Level 3||0
10347685|NCT00422097|11485757|FG000|STARTED|Dose Level 4||0
10347686|NCT00422097|11485758|FG001|STARTED|Dose Level 4||0
10347687|NCT00422097|11485759|FG002|STARTED|Dose Level 4||0
10347688|NCT00422097|11485760|FG003|STARTED|Dose Level 4||3
10347689|NCT00422097|11485761|FG004|STARTED|Dose Level 4||0
10347690|NCT00422097|11485762|FG005|STARTED|Dose Level 4||0
10347691|NCT00422097|11485763|FG006|STARTED|Dose Level 4||0
10347692|NCT00422097|11485764|FG007|STARTED|Dose Level 4||0
10347693|NCT00422097|11485757|FG000|COMPLETED|Dose Level 4||0
10347694|NCT00422097|11485758|FG001|COMPLETED|Dose Level 4||0
10347695|NCT00422097|11485759|FG002|COMPLETED|Dose Level 4||0
10347696|NCT00422097|11485760|FG003|COMPLETED|Dose Level 4||3
10347697|NCT00422097|11485761|FG004|COMPLETED|Dose Level 4||0
10347698|NCT00422097|11485762|FG005|COMPLETED|Dose Level 4||0
10347699|NCT00422097|11485763|FG006|COMPLETED|Dose Level 4||0
10347700|NCT00422097|11485764|FG007|COMPLETED|Dose Level 4||0
10347701|NCT00422097|11485757|FG000|NOT COMPLETED|Dose Level 4||0
10347702|NCT00422097|11485758|FG001|NOT COMPLETED|Dose Level 4||0
10715756|NCT02688387|11880049|FG006|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10715757|NCT02688387|11880050|FG007|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10715758|NCT02688387|11880051|FG008|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10715759|NCT02688387|11880052|FG009|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10715760|NCT02688387|11880053|FG010|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10812413|NCT03680911|11974476|FG000|NOT COMPLETED|Visit 1 (Baseline)||0
10812414|NCT03680911|11974477|FG001|NOT COMPLETED|Visit 1 (Baseline)||0
10812415|NCT03680911|11974476|FG000|STARTED|At Home Treatment||3
10812416|NCT03680911|11974477|FG001|STARTED|At Home Treatment||4
10347703|NCT00422097|11485759|FG002|NOT COMPLETED|Dose Level 4||0
10347704|NCT00422097|11485760|FG003|NOT COMPLETED|Dose Level 4||0
10347705|NCT00422097|11485761|FG004|NOT COMPLETED|Dose Level 4||0
10347706|NCT00422097|11485762|FG005|NOT COMPLETED|Dose Level 4||0
10532548|NCT01421342|11684915|FG000|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||149
10655663|NCT02209519|11816360|FG000|STARTED|Overall Study||107
10812417|NCT03680911|11974476|FG000|COMPLETED|At Home Treatment||0
10812418|NCT03680911|11974477|FG001|COMPLETED|At Home Treatment||1
10812419|NCT03680911|11974476|FG000|NOT COMPLETED|At Home Treatment||3
10812420|NCT03680911|11974477|FG001|NOT COMPLETED|At Home Treatment||3
10812421|NCT03680911|11974476|FG000|STARTED|Visit 2 (1 Month Follow up)||0
10812422|NCT03680911|11974477|FG001|STARTED|Visit 2 (1 Month Follow up)||1
10812423|NCT03680911|11974476|FG000|COMPLETED|Visit 2 (1 Month Follow up)||0
10812424|NCT03680911|11974477|FG001|COMPLETED|Visit 2 (1 Month Follow up)||1
10812425|NCT03680911|11974476|FG000|NOT COMPLETED|Visit 2 (1 Month Follow up)||0
10347707|NCT00422097|11485763|FG006|NOT COMPLETED|Dose Level 4||0
10347708|NCT00422097|11485764|FG007|NOT COMPLETED|Dose Level 4||0
10347709|NCT00422097|11485757|FG000|STARTED|Dose Level 5||0
10347710|NCT00422097|11485758|FG001|STARTED|Dose Level 5||0
10347711|NCT00422097|11485759|FG002|STARTED|Dose Level 5||0
10347712|NCT00422097|11485760|FG003|STARTED|Dose Level 5||0
10655664|NCT02209519|11816361|FG001|STARTED|Overall Study||107
10655665|NCT02209519|11816360|FG000|COMPLETED|Overall Study||107
10655666|NCT02209519|11816361|FG001|COMPLETED|Overall Study||107
10655667|NCT02209519|11816360|FG000|NOT COMPLETED|Overall Study||0
10655668|NCT02209519|11816361|FG001|NOT COMPLETED|Overall Study||0
10655669|NCT02209532|11816370|FG000|STARTED|Overall Study||90
10655670|NCT02209532|11816371|FG001|STARTED|Overall Study||90
10655671|NCT02209532|11816370|FG000|COMPLETED|Overall Study||87
10655672|NCT02209532|11816371|FG001|COMPLETED|Overall Study||89
10655673|NCT02209532|11816370|FG000|NOT COMPLETED|Overall Study||3
10655674|NCT02209532|11816371|FG001|NOT COMPLETED|Overall Study||1
10532549|NCT01421342|11684916|FG001|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||125
10532550|NCT01421342|11684917|FG002|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||138
10532551|NCT01421342|11684915|FG000|STARTED|Continuation of Treatment (Week 12 - 36)||204
10532552|NCT01421342|11684916|FG001|STARTED|Continuation of Treatment (Week 12 - 36)||253
10532553|NCT01421342|11684917|FG002|STARTED|Continuation of Treatment (Week 12 - 36)||268
10655675|NCT02209597|11816378|FG000|STARTED|Phase 1 Current Tx (Non-randomized)||74
10655676|NCT02209597|11816378|FG000|COMPLETED|Phase 1 Current Tx (Non-randomized)||71
10655677|NCT02209597|11816378|FG000|NOT COMPLETED|Phase 1 Current Tx (Non-randomized)||3
10655678|NCT02209597|11816378|FG000|STARTED|Phase 2 (Randomized: 1 Brand, 3 Generic)||71
10655679|NCT02209597|11816378|FG000|COMPLETED|Phase 2 (Randomized: 1 Brand, 3 Generic)||67
10655680|NCT02209597|11816378|FG000|NOT COMPLETED|Phase 2 (Randomized: 1 Brand, 3 Generic)||4
10655681|NCT02209597|11816378|FG000|STARTED|Phase 3 (Randomized: 1 Brand, 3 Generic)||67
10655682|NCT02209597|11816378|FG000|COMPLETED|Phase 3 (Randomized: 1 Brand, 3 Generic)||67
10655683|NCT02209597|11816378|FG000|NOT COMPLETED|Phase 3 (Randomized: 1 Brand, 3 Generic)||0
10715761|NCT02688387|11880054|FG011|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10715762|NCT02688387|11880055|FG012|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10715763|NCT02688387|11880056|FG013|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10715764|NCT02688387|11880057|FG014|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10715765|NCT02688387|11880058|FG015|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10532554|NCT01421342|11684915|FG000|COMPLETED|Continuation of Treatment (Week 12 - 36)||152
10532555|NCT01421342|11684916|FG001|COMPLETED|Continuation of Treatment (Week 12 - 36)||194
10347713|NCT00422097|11485761|FG004|STARTED|Dose Level 5||23
10347714|NCT00422097|11485762|FG005|STARTED|Dose Level 5||0
10347715|NCT00422097|11485763|FG006|STARTED|Dose Level 5||0
10347716|NCT00422097|11485764|FG007|STARTED|Dose Level 5||0
10347717|NCT00422097|11485757|FG000|COMPLETED|Dose Level 5||0
10347718|NCT00422097|11485758|FG001|COMPLETED|Dose Level 5||0
10347719|NCT00422097|11485759|FG002|COMPLETED|Dose Level 5||0
10347720|NCT00422097|11485760|FG003|COMPLETED|Dose Level 5||0
10347721|NCT00422097|11485761|FG004|COMPLETED|Dose Level 5||23
10347722|NCT00422097|11485762|FG005|COMPLETED|Dose Level 5||0
10347723|NCT00422097|11485763|FG006|COMPLETED|Dose Level 5||0
10347724|NCT00422097|11485764|FG007|COMPLETED|Dose Level 5||0
10347725|NCT00422097|11485757|FG000|NOT COMPLETED|Dose Level 5||0
10347726|NCT00422097|11485758|FG001|NOT COMPLETED|Dose Level 5||0
10347727|NCT00422097|11485759|FG002|NOT COMPLETED|Dose Level 5||0
10347728|NCT00422097|11485760|FG003|NOT COMPLETED|Dose Level 5||0
10347729|NCT00422097|11485761|FG004|NOT COMPLETED|Dose Level 5||0
10347730|NCT00422097|11485762|FG005|NOT COMPLETED|Dose Level 5||0
10347731|NCT00422097|11485763|FG006|NOT COMPLETED|Dose Level 5||0
10347732|NCT00422097|11485764|FG007|NOT COMPLETED|Dose Level 5||0
10347733|NCT00422097|11485757|FG000|STARTED|Dose Level 6||0
10347734|NCT00422097|11485758|FG001|STARTED|Dose Level 6||0
10347735|NCT00422097|11485759|FG002|STARTED|Dose Level 6||0
10347736|NCT00422097|11485760|FG003|STARTED|Dose Level 6||0
10347737|NCT00422097|11485761|FG004|STARTED|Dose Level 6||0
10347738|NCT00422097|11485762|FG005|STARTED|Dose Level 6||6
10347739|NCT00422097|11485763|FG006|STARTED|Dose Level 6||0
10347740|NCT00422097|11485764|FG007|STARTED|Dose Level 6||0
10347741|NCT00422097|11485757|FG000|COMPLETED|Dose Level 6||0
10347742|NCT00422097|11485758|FG001|COMPLETED|Dose Level 6||0
10347743|NCT00422097|11485759|FG002|COMPLETED|Dose Level 6||0
10347744|NCT00422097|11485760|FG003|COMPLETED|Dose Level 6||0
10347745|NCT00422097|11485761|FG004|COMPLETED|Dose Level 6||0
10347746|NCT00422097|11485762|FG005|COMPLETED|Dose Level 6||6
10347747|NCT00422097|11485763|FG006|COMPLETED|Dose Level 6||0
10347748|NCT00422097|11485764|FG007|COMPLETED|Dose Level 6||0
10347749|NCT00422097|11485757|FG000|NOT COMPLETED|Dose Level 6||0
10347750|NCT00422097|11485758|FG001|NOT COMPLETED|Dose Level 6||0
10347751|NCT00422097|11485759|FG002|NOT COMPLETED|Dose Level 6||0
10347752|NCT00422097|11485760|FG003|NOT COMPLETED|Dose Level 6||0
10347753|NCT00422097|11485761|FG004|NOT COMPLETED|Dose Level 6||0
10347754|NCT00422097|11485762|FG005|NOT COMPLETED|Dose Level 6||0
10347755|NCT00422097|11485763|FG006|NOT COMPLETED|Dose Level 6||0
10347756|NCT00422097|11485764|FG007|NOT COMPLETED|Dose Level 6||0
10347757|NCT00422097|11485757|FG000|STARTED|Ixabepilone With Famotidine or Food||0
10347758|NCT00422097|11485758|FG001|STARTED|Ixabepilone With Famotidine or Food||0
10347759|NCT00422097|11485759|FG002|STARTED|Ixabepilone With Famotidine or Food||0
10347760|NCT00422097|11485760|FG003|STARTED|Ixabepilone With Famotidine or Food||0
10347761|NCT00422097|11485761|FG004|STARTED|Ixabepilone With Famotidine or Food||0
10347762|NCT00422097|11485762|FG005|STARTED|Ixabepilone With Famotidine or Food||0
10347763|NCT00422097|11485763|FG006|STARTED|Ixabepilone With Famotidine or Food||8
10347764|NCT00422097|11485764|FG007|STARTED|Ixabepilone With Famotidine or Food||7
10347765|NCT00422097|11485757|FG000|COMPLETED|Ixabepilone With Famotidine or Food||0
10347766|NCT00422097|11485758|FG001|COMPLETED|Ixabepilone With Famotidine or Food||0
10347767|NCT00422097|11485759|FG002|COMPLETED|Ixabepilone With Famotidine or Food||0
10715766|NCT02688387|11880059|FG016|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10715767|NCT02688387|11880060|FG017|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10715768|NCT02688387|11880061|FG018|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10715769|NCT02688387|11880062|FG019|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10715770|NCT02688387|11880063|FG020|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10347768|NCT00422097|11485760|FG003|COMPLETED|Ixabepilone With Famotidine or Food||0
10347769|NCT00422097|11485761|FG004|COMPLETED|Ixabepilone With Famotidine or Food||0
10347770|NCT00422097|11485762|FG005|COMPLETED|Ixabepilone With Famotidine or Food||0
10347771|NCT00422097|11485763|FG006|COMPLETED|Ixabepilone With Famotidine or Food||8
10347772|NCT00422097|11485764|FG007|COMPLETED|Ixabepilone With Famotidine or Food||7
10347773|NCT00422097|11485757|FG000|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
10347774|NCT00422097|11485758|FG001|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
10347775|NCT00422097|11485759|FG002|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
10347776|NCT00422097|11485760|FG003|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
10347777|NCT00422097|11485761|FG004|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
10347778|NCT00422097|11485762|FG005|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
10347779|NCT00422097|11485763|FG006|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
10347780|NCT00422097|11485764|FG007|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
10347781|NCT00422162|11485790|FG000|STARTED|Overall Study||167
10347782|NCT00422162|11485791|FG001|STARTED|Overall Study||172
10347783|NCT00422162|11485790|FG000|Received Treatment|Overall Study||167
10347784|NCT00422162|11485791|FG001|Received Treatment|Overall Study||171
10347785|NCT00422162|11485790|FG000|COMPLETED|Overall Study||143
10347786|NCT00422162|11485791|FG001|COMPLETED|Overall Study||142
10347787|NCT00422162|11485790|FG000|NOT COMPLETED|Overall Study||24
10347788|NCT00422162|11485791|FG001|NOT COMPLETED|Overall Study||30
10347789|NCT00422201|11485807|FG000|STARTED|Overall Study||18
10347790|NCT00422201|11485807|FG000|COMPLETED|Overall Study||7
10347791|NCT00422201|11485807|FG000|NOT COMPLETED|Overall Study||11
10347792|NCT00422227|11485814|FG000|STARTED|Overall Study||197
10347793|NCT00422227|11485815|FG001|STARTED|Overall Study||103
10347794|NCT00422227|11485814|FG000|COMPLETED|Overall Study||193
10347795|NCT00422227|11485815|FG001|COMPLETED|Overall Study||88
10347796|NCT00422227|11485814|FG000|NOT COMPLETED|Overall Study||4
10347797|NCT00422227|11485815|FG001|NOT COMPLETED|Overall Study||15
10347798|NCT00422279|11485823|FG000|STARTED|Overall Study||2
10347799|NCT00422279|11485824|FG001|STARTED|Overall Study||2
10347800|NCT00422279|11485823|FG000|24 Month After Loading Period|Overall Study||2
10347801|NCT00422279|11485824|FG001|24 Month After Loading Period|Overall Study||2
10347802|NCT00422279|11485823|FG000|COMPLETED|Overall Study||2
10347803|NCT00422279|11485824|FG001|COMPLETED|Overall Study||2
10347804|NCT00422279|11485823|FG000|NOT COMPLETED|Overall Study||0
10347805|NCT00422279|11485824|FG001|NOT COMPLETED|Overall Study||0
10347806|NCT00422292|11485836|FG000|STARTED|Overall Study||257
10347807|NCT00422292|11485837|FG001|STARTED|Overall Study||664
10347808|NCT00422292|11485838|FG002|STARTED|Overall Study||246
10347809|NCT00422292|11485839|FG003|STARTED|Overall Study||476
10347810|NCT00422292|11485836|FG000|COMPLETED|Overall Study||239
10347811|NCT00422292|11485837|FG001|COMPLETED|Overall Study||598
10347812|NCT00422292|11485838|FG002|COMPLETED|Overall Study||224
10347813|NCT00422292|11485839|FG003|COMPLETED|Overall Study||452
10347814|NCT00422292|11485836|FG000|NOT COMPLETED|Overall Study||18
10347815|NCT00422292|11485837|FG001|NOT COMPLETED|Overall Study||66
10347816|NCT00422292|11485838|FG002|NOT COMPLETED|Overall Study||22
10347817|NCT00422292|11485839|FG003|NOT COMPLETED|Overall Study||24
10347818|NCT00422383|11485854|FG000|STARTED|Overall Study||134
10347819|NCT00422383|11485855|FG001|STARTED|Overall Study||120
10347820|NCT00422383|11485856|FG002|STARTED|Overall Study||93
10347821|NCT00422383|11485857|FG003|STARTED|Overall Study||6
10347822|NCT00422383|11485858|FG004|STARTED|Overall Study||25
10347823|NCT00422383|11485854|FG000|COMPLETED|Overall Study||119
10347824|NCT00422383|11485855|FG001|COMPLETED|Overall Study||106
10347825|NCT00422383|11485856|FG002|COMPLETED|Overall Study||89
10347826|NCT00422383|11485857|FG003|COMPLETED|Overall Study||4
10347827|NCT00422383|11485858|FG004|COMPLETED|Overall Study||22
10347828|NCT00422383|11485854|FG000|NOT COMPLETED|Overall Study||15
10347829|NCT00422383|11485855|FG001|NOT COMPLETED|Overall Study||14
10347830|NCT00422383|11485856|FG002|NOT COMPLETED|Overall Study||4
10347831|NCT00422383|11485857|FG003|NOT COMPLETED|Overall Study||2
10347832|NCT00422383|11485858|FG004|NOT COMPLETED|Overall Study||3
10347833|NCT00422422|11485876|FG000|STARTED|Overall Study||100
10347834|NCT00422422|11485876|FG000|COMPLETED|Overall Study||90
10347835|NCT00422422|11485876|FG000|NOT COMPLETED|Overall Study||10
10347836|NCT00422448|11485882|FG000|STARTED|Overall Study|22 prospectively enrolled during study period and 21 retrospectively enrolled|43
10347837|NCT00422448|11485882|FG000|COMPLETED|Overall Study||43
10347838|NCT00422448|11485882|FG000|NOT COMPLETED|Overall Study||0
10347839|NCT00422461|11485890|FG000|STARTED|Overall Study||35
10347840|NCT00422461|11485891|FG001|STARTED|Overall Study||35
10347841|NCT00422461|11485892|FG002|STARTED|Overall Study||32
10347842|NCT00422461|11485893|FG003|STARTED|Overall Study||33
10347843|NCT00422461|11485890|FG000|Treated|Overall Study||34
10347844|NCT00422461|11485891|FG001|Treated|Overall Study||34
10347845|NCT00422461|11485892|FG002|Treated|Overall Study||32
10347846|NCT00422461|11485893|FG003|Treated|Overall Study||33
10347847|NCT00422461|11485890|FG000|Full Analysis Set|Overall Study||34
10347848|NCT00422461|11485891|FG001|Full Analysis Set|Overall Study||34
10347849|NCT00422461|11485892|FG002|Full Analysis Set|Overall Study||31
10347850|NCT00422461|11485893|FG003|Full Analysis Set|Overall Study||33
10347851|NCT00422461|11485890|FG000|COMPLETED|Overall Study||32
10347852|NCT00422461|11485891|FG001|COMPLETED|Overall Study||32
10347853|NCT00422461|11485892|FG002|COMPLETED|Overall Study||31
10347854|NCT00422461|11485893|FG003|COMPLETED|Overall Study||30
10347855|NCT00422461|11485890|FG000|NOT COMPLETED|Overall Study||3
10347856|NCT00422461|11485891|FG001|NOT COMPLETED|Overall Study||3
10347857|NCT00422461|11485892|FG002|NOT COMPLETED|Overall Study||1
10347858|NCT00422461|11485893|FG003|NOT COMPLETED|Overall Study||3
10347859|NCT00422513|11485905|FG000|STARTED|Overall Study||130
10347860|NCT00422513|11485906|FG001|STARTED|Overall Study||130
10347861|NCT00422513|11485905|FG000|COMPLETED|Overall Study||23
10347862|NCT00422513|11485906|FG001|COMPLETED|Overall Study||24
10347863|NCT00422513|11485905|FG000|NOT COMPLETED|Overall Study||107
10347864|NCT00422513|11485906|FG001|NOT COMPLETED|Overall Study||106
10347865|NCT00422591|11485912|FG000|STARTED|Overall Study||175
10347866|NCT00422591|11485912|FG000|COMPLETED|Overall Study||169
10347867|NCT00422591|11485912|FG000|NOT COMPLETED|Overall Study||6
10347868|NCT00422656|11485916|FG000|STARTED|Overall Study||37
10347869|NCT00422656|11485916|FG000|COMPLETED|Overall Study||37
10347870|NCT00422656|11485916|FG000|NOT COMPLETED|Overall Study||0
10347871|NCT00422695|11485922|FG000|STARTED|Overall Study||105
10347872|NCT00422695|11485923|FG001|STARTED|Overall Study||38
10347873|NCT00422695|11485922|FG000|COMPLETED|Overall Study||105
10347874|NCT00422695|11485923|FG001|COMPLETED|Overall Study||38
10347875|NCT00422695|11485922|FG000|NOT COMPLETED|Overall Study||0
10347876|NCT00422695|11485923|FG001|NOT COMPLETED|Overall Study||0
10347877|NCT00422734|11485931|FG000|STARTED|Overall Study||78
10347878|NCT00422734|11485932|FG001|STARTED|Overall Study||264
10347879|NCT00422734|11485931|FG000|COMPLETED|Overall Study||64
10347880|NCT00422734|11485932|FG001|COMPLETED|Overall Study||243
10347881|NCT00422734|11485931|FG000|NOT COMPLETED|Overall Study||14
10347882|NCT00422734|11485932|FG001|NOT COMPLETED|Overall Study||21
10347883|NCT00422799|11485938|FG000|STARTED|Overall Study||63
10347884|NCT00422799|11485938|FG000|COMPLETED|Overall Study||50
10347885|NCT00422799|11485938|FG000|NOT COMPLETED|Overall Study||13
10347886|NCT00422812|11485946|FG000|STARTED|Overall Study||98
10347887|NCT00422812|11485947|FG001|STARTED|Overall Study||104
10347888|NCT00422812|11485948|FG002|STARTED|Overall Study||93
10347889|NCT00422812|11485949|FG003|STARTED|Overall Study||105
10347890|NCT00422812|11485946|FG000|COMPLETED|Overall Study||98
10347891|NCT00422812|11485947|FG001|COMPLETED|Overall Study||103
10347892|NCT00422812|11485948|FG002|COMPLETED|Overall Study||91
10347893|NCT00422812|11485949|FG003|COMPLETED|Overall Study||103
10347894|NCT00422812|11485946|FG000|NOT COMPLETED|Overall Study||0
10347895|NCT00422812|11485947|FG001|NOT COMPLETED|Overall Study||1
10347896|NCT00422812|11485948|FG002|NOT COMPLETED|Overall Study||2
10347897|NCT00422812|11485949|FG003|NOT COMPLETED|Overall Study||2
10347898|NCT00422903|11485961|FG000|STARTED|Overall Study||49
10347899|NCT00422903|11485962|FG001|STARTED|Overall Study||43
10347900|NCT00422903|11485961|FG000|COMPLETED|Overall Study||45
10347901|NCT00422903|11485962|FG001|COMPLETED|Overall Study||38
10347902|NCT00422903|11485961|FG000|NOT COMPLETED|Overall Study||4
10347903|NCT00422903|11485962|FG001|NOT COMPLETED|Overall Study||5
10347904|NCT00423046|11485970|FG000|STARTED|Overall Study||553
10347905|NCT00423046|11485971|FG001|STARTED|Overall Study||553
10347906|NCT00423046|11485970|FG000|COMPLETED|Overall Study|Completed until Month 60|213
10347907|NCT00423046|11485971|FG001|COMPLETED|Overall Study|Completed until Month 60|208
10347908|NCT00423046|11485970|FG000|NOT COMPLETED|Overall Study||340
10347909|NCT00423046|11485971|FG001|NOT COMPLETED|Overall Study||345
10347910|NCT00423085|11485982|FG000|STARTED|24-Week Double-Blind Treatment Phase||288
10347911|NCT00423085|11485983|FG001|STARTED|24-Week Double-Blind Treatment Phase||284
10347912|NCT00423085|11485984|FG002|STARTED|24-Week Double-Blind Treatment Phase||287
10347913|NCT00423085|11485985|FG003|STARTED|24-Week Double-Blind Treatment Phase||0
10347914|NCT00423085|11485982|FG000|COMPLETED|24-Week Double-Blind Treatment Phase||242
10347915|NCT00423085|11485983|FG001|COMPLETED|24-Week Double-Blind Treatment Phase||220
10347916|NCT00423085|11485984|FG002|COMPLETED|24-Week Double-Blind Treatment Phase||228
10347917|NCT00423085|11485985|FG003|COMPLETED|24-Week Double-Blind Treatment Phase||0
10347918|NCT00423085|11485982|FG000|NOT COMPLETED|24-Week Double-Blind Treatment Phase||46
10347919|NCT00423085|11485983|FG001|NOT COMPLETED|24-Week Double-Blind Treatment Phase||64
10347920|NCT00423085|11485984|FG002|NOT COMPLETED|24-Week Double-Blind Treatment Phase||59
10347921|NCT00423085|11485985|FG003|NOT COMPLETED|24-Week Double-Blind Treatment Phase||0
10347922|NCT00423085|11485982|FG000|STARTED|52-Week Open-Label Extension Phase||0
10347923|NCT00423085|11485983|FG001|STARTED|52-Week Open-Label Extension Phase||0
10347924|NCT00423085|11485984|FG002|STARTED|52-Week Open-Label Extension Phase||0
10347925|NCT00423085|11485985|FG003|STARTED|52-Week Open-Label Extension Phase|Patients who completed the 24-wk treatment phase were eligible to enroll in the open-label extension|637
10347926|NCT00423085|11485982|FG000|COMPLETED|52-Week Open-Label Extension Phase||0
10347927|NCT00423085|11485983|FG001|COMPLETED|52-Week Open-Label Extension Phase||0
10347928|NCT00423085|11485984|FG002|COMPLETED|52-Week Open-Label Extension Phase||0
10347929|NCT00423085|11485985|FG003|COMPLETED|52-Week Open-Label Extension Phase||474
10347930|NCT00423085|11485982|FG000|NOT COMPLETED|52-Week Open-Label Extension Phase||0
10347931|NCT00423085|11485983|FG001|NOT COMPLETED|52-Week Open-Label Extension Phase||0
10347932|NCT00423085|11485984|FG002|NOT COMPLETED|52-Week Open-Label Extension Phase||0
10347933|NCT00423085|11485985|FG003|NOT COMPLETED|52-Week Open-Label Extension Phase||163
10347934|NCT00423098|11485997|FG000|STARTED|Overall Study|Total number of patients screened was 90, but the total number of randomized patients was 81.|42
10347935|NCT00423098|11485998|FG001|STARTED|Overall Study||39
10347936|NCT00423098|11485997|FG000|COMPLETED|Overall Study|Completed 24 weeks of study medication.|39
10347937|NCT00423098|11485998|FG001|COMPLETED|Overall Study||35
10347938|NCT00423098|11485997|FG000|NOT COMPLETED|Overall Study||3
10347939|NCT00423098|11485998|FG001|NOT COMPLETED|Overall Study||4
10347940|NCT00423137|11486008|FG000|STARTED|Overall Study||11
10347941|NCT00423137|11486009|FG001|STARTED|Overall Study||12
10347942|NCT00423137|11486010|FG002|STARTED|Overall Study||13
10347943|NCT00423137|11486011|FG003|STARTED|Overall Study||12
10347944|NCT00423137|11486008|FG000|COMPLETED|Overall Study||10
10347945|NCT00423137|11486009|FG001|COMPLETED|Overall Study||12
10347946|NCT00423137|11486010|FG002|COMPLETED|Overall Study||7
10347947|NCT00423137|11486011|FG003|COMPLETED|Overall Study||10
10347948|NCT00423137|11486008|FG000|NOT COMPLETED|Overall Study||1
10347949|NCT00423137|11486009|FG001|NOT COMPLETED|Overall Study||0
10347950|NCT00423137|11486010|FG002|NOT COMPLETED|Overall Study||6
10347951|NCT00423137|11486011|FG003|NOT COMPLETED|Overall Study||2
10347952|NCT00423150|11486024|FG000|STARTED|Overall Study||86
10347953|NCT00423150|11486024|FG000|COMPLETED|Overall Study||0
10347954|NCT00423150|11486024|FG000|NOT COMPLETED|Overall Study||86
10347955|NCT00423189|11486031|FG000|STARTED|Overall Study||2
10347956|NCT00423189|11486032|FG001|STARTED|Overall Study||3
10347957|NCT00423189|11486033|FG002|STARTED|Overall Study||2
10347958|NCT00423189|11486031|FG000|COMPLETED|Overall Study||2
10347959|NCT00423189|11486032|FG001|COMPLETED|Overall Study||2
10347960|NCT00423189|11486033|FG002|COMPLETED|Overall Study||2
10347961|NCT00423189|11486031|FG000|NOT COMPLETED|Overall Study||0
10347962|NCT00423189|11486032|FG001|NOT COMPLETED|Overall Study||1
10347963|NCT00423189|11486033|FG002|NOT COMPLETED|Overall Study||0
10347964|NCT00423267|11486048|FG000|STARTED|Period A||9
10347965|NCT00423267|11486049|FG001|STARTED|Period A||7
10347966|NCT00423267|11486048|FG000|COMPLETED|Period A||7
10347967|NCT00423267|11486049|FG001|COMPLETED|Period A||6
10347968|NCT00423267|11486048|FG000|NOT COMPLETED|Period A||2
10347969|NCT00423267|11486049|FG001|NOT COMPLETED|Period A||1
10347970|NCT00423267|11486048|FG000|STARTED|Period B||12
10347971|NCT00423267|11486049|FG001|STARTED|Period B||0
10347972|NCT00423267|11486048|FG000|COMPLETED|Period B||12
10347973|NCT00423267|11486049|FG001|COMPLETED|Period B||0
10347974|NCT00423267|11486048|FG000|NOT COMPLETED|Period B||0
10347975|NCT00423267|11486049|FG001|NOT COMPLETED|Period B||0
10347976|NCT00423293|11486057|FG000|STARTED|Overall Study||63
10347977|NCT00423293|11486057|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|52
10347978|NCT00423293|11486057|FG000|NOT COMPLETED|Overall Study||11
10347979|NCT00423319|11486063|FG000|STARTED|Overall Study|Randomized|2708
10347980|NCT00423319|11486064|FG001|STARTED|Overall Study|Randomized|2699
10347981|NCT00423319|11486063|FG000|Participants Who Received Treatment|Overall Study||2673
10347982|NCT00423319|11486064|FG001|Participants Who Received Treatment|Overall Study||2659
10347983|NCT00423319|11486063|FG000|COMPLETED|Overall Study||2484
10347984|NCT00423319|11486064|FG001|COMPLETED|Overall Study||2447
10347985|NCT00423319|11486063|FG000|NOT COMPLETED|Overall Study||224
10347986|NCT00423319|11486064|FG001|NOT COMPLETED|Overall Study||252
10347987|NCT00423332|11486073|FG000|STARTED|Overall Study|Randomised|53
10347988|NCT00423332|11486074|FG001|STARTED|Overall Study|Number randomised|18
10347989|NCT00423332|11486073|FG000|Continuing After Unblinding|Overall Study|Number starting/ continuing AZD2171 after unblinding|44
10347990|NCT00423332|11486074|FG001|Continuing After Unblinding|Overall Study|Number starting/ continuing AZD2171 after unblinding|14
10347991|NCT00423332|11486073|FG000|Ongoing at Data Cut Off (8th March 2009)|Overall Study|Number ongoing at data cut off (8th March 2009)|22
10347992|NCT00423332|11486074|FG001|Ongoing at Data Cut Off (8th March 2009)|Overall Study|Number ongoing at data cut off (8th March 2009)|4
10347993|NCT00423332|11486073|FG000|COMPLETED|Overall Study|Number completing 12 weeks blinded randomised treatment|44
10347994|NCT00423332|11486074|FG001|COMPLETED|Overall Study|Number completing 12 weeks blinded randomised treatment|11
10347995|NCT00423332|11486073|FG000|NOT COMPLETED|Overall Study||9
10347996|NCT00423332|11486074|FG001|NOT COMPLETED|Overall Study||7
10347997|NCT00423358|11486083|FG000|STARTED|Overall Study||11
10347998|NCT00423358|11486084|FG001|STARTED|Overall Study||11
10347999|NCT00423358|11486083|FG000|COMPLETED|Overall Study||11
10348000|NCT00423358|11486084|FG001|COMPLETED|Overall Study||11
10348001|NCT00423358|11486083|FG000|NOT COMPLETED|Overall Study||0
10348002|NCT00423358|11486084|FG001|NOT COMPLETED|Overall Study||0
10348003|NCT00423436|11486092|FG000|STARTED|Overall Study||35
10348004|NCT00423436|11486093|FG001|STARTED|Overall Study||33
10348005|NCT00423436|11486092|FG000|COMPLETED|Overall Study||35
10348006|NCT00423436|11486093|FG001|COMPLETED|Overall Study||33
10348007|NCT00423436|11486092|FG000|NOT COMPLETED|Overall Study||0
10348008|NCT00423436|11486093|FG001|NOT COMPLETED|Overall Study||0
10348009|NCT00423449|11486099|FG000|STARTED|Overall Study||4
10348010|NCT00423449|11486100|FG001|STARTED|Overall Study||6
10348011|NCT00423449|11486101|FG002|STARTED|Overall Study||17
10348012|NCT00423449|11486102|FG003|STARTED|Overall Study||27
10348013|NCT00423449|11486103|FG004|STARTED|Overall Study||7
10348014|NCT00423449|11486099|FG000|COMPLETED|Overall Study||1
10348015|NCT00423449|11486100|FG001|COMPLETED|Overall Study||2
10348016|NCT00423449|11486101|FG002|COMPLETED|Overall Study||2
10348017|NCT00423449|11486102|FG003|COMPLETED|Overall Study||5
10348018|NCT00423449|11486103|FG004|COMPLETED|Overall Study||0
10348019|NCT00423449|11486099|FG000|NOT COMPLETED|Overall Study||3
10348020|NCT00423449|11486100|FG001|NOT COMPLETED|Overall Study||4
10348021|NCT00423449|11486101|FG002|NOT COMPLETED|Overall Study||15
10348022|NCT00423449|11486102|FG003|NOT COMPLETED|Overall Study||22
10348023|NCT00423449|11486103|FG004|NOT COMPLETED|Overall Study||7
10348024|NCT00423592|11486116|FG000|STARTED|Overall Study|Enrolled|36
10348025|NCT00423592|11486116|FG000|Completed Preliminary Analysis Cut-off|Overall Study|Preliminary analysis cut-off at Week 12 for primary/secondary endpoint analysis|34
10348026|NCT00423592|11486116|FG000|COMPLETED|Overall Study|Completed study|29
10348027|NCT00423592|11486116|FG000|NOT COMPLETED|Overall Study||7
10348028|NCT00423605|11486120|FG000|STARTED|Overall Study||560
10348029|NCT00423605|11486120|FG000|COMPLETED|Overall Study||319
10348030|NCT00423605|11486120|FG000|NOT COMPLETED|Overall Study||241
10348031|NCT00423657|11486126|FG000|STARTED|Overall Study||342
10348032|NCT00423657|11486127|FG001|STARTED|Overall Study||338
10348033|NCT00423657|11486126|FG000|COMPLETED|Overall Study||316
10348034|NCT00423657|11486127|FG001|COMPLETED|Overall Study||313
10348035|NCT00423657|11486126|FG000|NOT COMPLETED|Overall Study||26
10348036|NCT00423657|11486127|FG001|NOT COMPLETED|Overall Study||25
10348037|NCT00423670|11486140|FG000|STARTED|Treatment Period||104
10348038|NCT00423670|11486141|FG001|STARTED|Treatment Period||107
10348039|NCT00423670|11486142|FG002|STARTED|Treatment Period||103
10348040|NCT00423670|11486143|FG003|STARTED|Treatment Period||103
10348041|NCT00423670|11486144|FG004|STARTED|Treatment Period||103
10348042|NCT00423670|11486145|FG005|STARTED|Treatment Period||16
10348043|NCT00423670|11486146|FG006|STARTED|Treatment Period||59
10348044|NCT00423670|11486147|FG007|STARTED|Treatment Period|Arm 8 were Arm 1 participants that were positive for HCV-RNA at TW 24 and had the option to switch.|36
10348045|NCT00423670|11486140|FG000|COMPLETED|Treatment Period||52
10348046|NCT00423670|11486141|FG001|COMPLETED|Treatment Period||77
10348047|NCT00423670|11486142|FG002|COMPLETED|Treatment Period||76
10348048|NCT00423670|11486143|FG003|COMPLETED|Treatment Period||63
10348049|NCT00423670|11486144|FG004|COMPLETED|Treatment Period||76
10348050|NCT00423670|11486145|FG005|COMPLETED|Treatment Period||8
10348051|NCT00423670|11486146|FG006|COMPLETED|Treatment Period||28
10348052|NCT00423670|11486147|FG007|COMPLETED|Treatment Period||15
10348053|NCT00423670|11486140|FG000|NOT COMPLETED|Treatment Period||52
10348054|NCT00423670|11486141|FG001|NOT COMPLETED|Treatment Period||30
10348055|NCT00423670|11486142|FG002|NOT COMPLETED|Treatment Period||27
10348056|NCT00423670|11486143|FG003|NOT COMPLETED|Treatment Period||40
10348057|NCT00423670|11486144|FG004|NOT COMPLETED|Treatment Period||27
10348058|NCT00423670|11486145|FG005|NOT COMPLETED|Treatment Period||8
10348059|NCT00423670|11486146|FG006|NOT COMPLETED|Treatment Period||31
10348060|NCT00423670|11486147|FG007|NOT COMPLETED|Treatment Period||21
10348061|NCT00423670|11486140|FG000|STARTED|Follow-up Period||97
10348062|NCT00423670|11486141|FG001|STARTED|Follow-up Period||100
10348063|NCT00423670|11486142|FG002|STARTED|Follow-up Period||96
10348064|NCT00423670|11486143|FG003|STARTED|Follow-up Period||96
10348065|NCT00423670|11486144|FG004|STARTED|Follow-up Period||91
10348066|NCT00423670|11486145|FG005|STARTED|Follow-up Period||14
10348067|NCT00423670|11486146|FG006|STARTED|Follow-up Period||50
10348068|NCT00423670|11486147|FG007|STARTED|Follow-up Period||35
10348069|NCT00423670|11486140|FG000|COMPLETED|Follow-up Period||94
10348070|NCT00423670|11486141|FG001|COMPLETED|Follow-up Period||84
10348071|NCT00423670|11486142|FG002|COMPLETED|Follow-up Period||85
10348072|NCT00423670|11486143|FG003|COMPLETED|Follow-up Period||91
10348073|NCT00423670|11486144|FG004|COMPLETED|Follow-up Period||89
10348074|NCT00423670|11486145|FG005|COMPLETED|Follow-up Period||14
10348075|NCT00423670|11486146|FG006|COMPLETED|Follow-up Period||41
10348076|NCT00423670|11486147|FG007|COMPLETED|Follow-up Period||32
10348077|NCT00423670|11486140|FG000|NOT COMPLETED|Follow-up Period||3
10348078|NCT00423670|11486141|FG001|NOT COMPLETED|Follow-up Period||16
10348079|NCT00423670|11486142|FG002|NOT COMPLETED|Follow-up Period||11
10348080|NCT00423670|11486143|FG003|NOT COMPLETED|Follow-up Period||5
10348081|NCT00423670|11486144|FG004|NOT COMPLETED|Follow-up Period||2
10348082|NCT00423670|11486145|FG005|NOT COMPLETED|Follow-up Period||0
10348083|NCT00423670|11486146|FG006|NOT COMPLETED|Follow-up Period||9
10348084|NCT00423670|11486147|FG007|NOT COMPLETED|Follow-up Period||3
10348085|NCT00423683|11486170|FG000|STARTED|Overall Study||31
10348086|NCT00423683|11486171|FG001|STARTED|Overall Study||33
10348087|NCT00423683|11486170|FG000|COMPLETED|Overall Study||30
10348088|NCT00423683|11486171|FG001|COMPLETED|Overall Study||33
10348089|NCT00423683|11486170|FG000|NOT COMPLETED|Overall Study||1
10348090|NCT00423683|11486171|FG001|NOT COMPLETED|Overall Study||0
10348091|NCT00423722|11486181|FG000|STARTED|Overall Study||63
10348092|NCT00423722|11486182|FG001|STARTED|Overall Study||66
10348093|NCT00423722|11486181|FG000|COMPLETED|Overall Study||49
10348094|NCT00423722|11486182|FG001|COMPLETED|Overall Study||53
10348095|NCT00423722|11486181|FG000|NOT COMPLETED|Overall Study||14
10348096|NCT00423722|11486182|FG001|NOT COMPLETED|Overall Study||13
10348097|NCT00423735|11486197|FG000|STARTED|Overall Study||29
10348098|NCT00423735|11486198|FG001|STARTED|Overall Study||35
10348099|NCT00423735|11486199|FG002|STARTED|Overall Study||0
10348100|NCT00423735|11486197|FG000|COMPLETED|Overall Study||21
10348101|NCT00423735|11486198|FG001|COMPLETED|Overall Study||29
10348102|NCT00423735|11486199|FG002|COMPLETED|Overall Study||0
10348103|NCT00423735|11486197|FG000|NOT COMPLETED|Overall Study||8
10348104|NCT00423735|11486198|FG001|NOT COMPLETED|Overall Study||6
10348105|NCT00423735|11486199|FG002|NOT COMPLETED|Overall Study||0
10348106|NCT00423800|11486211|FG000|STARTED|Overall Study||3
10348107|NCT00423800|11486212|FG001|STARTED|Overall Study||2
10348108|NCT00423800|11486211|FG000|COMPLETED|Overall Study||3
10348109|NCT00423800|11486212|FG001|COMPLETED|Overall Study||1
10348110|NCT00423800|11486211|FG000|NOT COMPLETED|Overall Study||0
10348111|NCT00423800|11486212|FG001|NOT COMPLETED|Overall Study||1
10348112|NCT00423813|11486222|FG000|STARTED|Overall Study||188
10348113|NCT00423813|11486223|FG001|STARTED|Overall Study||195
10348114|NCT00423813|11486224|FG002|STARTED|Overall Study||190
10348115|NCT00423813|11486222|FG000|Treated|Overall Study||188
10348116|NCT00423813|11486223|FG001|Treated|Overall Study||194
10348117|NCT00423813|11486224|FG002|Treated|Overall Study||189
10348118|NCT00423813|11486222|FG000|COMPLETED|Overall Study||131
10348119|NCT00423813|11486223|FG001|COMPLETED|Overall Study||129
10348120|NCT00423813|11486224|FG002|COMPLETED|Overall Study||116
10348121|NCT00423813|11486222|FG000|NOT COMPLETED|Overall Study||57
10348122|NCT00423813|11486223|FG001|NOT COMPLETED|Overall Study||66
10348123|NCT00423813|11486224|FG002|NOT COMPLETED|Overall Study||74
10348124|NCT00423852|11486232|FG000|STARTED|Overall Study||26
10348125|NCT00423852|11486232|FG000|COMPLETED|Overall Study||23
10348126|NCT00423852|11486232|FG000|NOT COMPLETED|Overall Study||3
10348127|NCT00423878|11486238|FG000|STARTED|Overall Study||109
10348128|NCT00423878|11486239|FG001|STARTED|Overall Study||106
10348129|NCT00423878|11486238|FG000|COMPLETED|Overall Study||89
10348130|NCT00423878|11486239|FG001|COMPLETED|Overall Study||98
10348131|NCT00423878|11486238|FG000|NOT COMPLETED|Overall Study||20
10348132|NCT00423878|11486239|FG001|NOT COMPLETED|Overall Study||8
10348133|NCT00423891|11486248|FG000|STARTED|Enrolled||35
10348134|NCT00423891|11486249|FG001|STARTED|Enrolled||21
10348135|NCT00423891|11486250|FG002|STARTED|Enrolled||8
10348136|NCT00423891|11486248|FG000|COMPLETED|Enrolled||24
10348137|NCT00423891|11486249|FG001|COMPLETED|Enrolled||19
10348138|NCT00423891|11486250|FG002|COMPLETED|Enrolled||5
10348139|NCT00423891|11486248|FG000|NOT COMPLETED|Enrolled||11
10348140|NCT00423891|11486249|FG001|NOT COMPLETED|Enrolled||2
10348141|NCT00423891|11486250|FG002|NOT COMPLETED|Enrolled||3
10348142|NCT00423891|11486248|FG000|STARTED|Treatment||24
10348143|NCT00423891|11486249|FG001|STARTED|Treatment||19
10348144|NCT00423891|11486250|FG002|STARTED|Treatment||5
10348145|NCT00423891|11486248|FG000|COMPLETED|Treatment||22
10348146|NCT00423891|11486249|FG001|COMPLETED|Treatment||19
10348147|NCT00423891|11486250|FG002|COMPLETED|Treatment||5
10348148|NCT00423891|11486248|FG000|NOT COMPLETED|Treatment||2
10348149|NCT00423891|11486249|FG001|NOT COMPLETED|Treatment||0
10348150|NCT00423891|11486250|FG002|NOT COMPLETED|Treatment||0
10348151|NCT00423891|11486248|FG000|STARTED|Post-Dosing Follow Up||22
10348152|NCT00423891|11486249|FG001|STARTED|Post-Dosing Follow Up||18
10348153|NCT00423891|11486250|FG002|STARTED|Post-Dosing Follow Up||5
10348154|NCT00423891|11486248|FG000|COMPLETED|Post-Dosing Follow Up||20
10348155|NCT00423891|11486249|FG001|COMPLETED|Post-Dosing Follow Up||15
10348156|NCT00423891|11486250|FG002|COMPLETED|Post-Dosing Follow Up||3
10348157|NCT00423891|11486248|FG000|NOT COMPLETED|Post-Dosing Follow Up||2
10348158|NCT00423891|11486249|FG001|NOT COMPLETED|Post-Dosing Follow Up||3
10348159|NCT00423891|11486250|FG002|NOT COMPLETED|Post-Dosing Follow Up||2
10348160|NCT00423917|11486260|FG000|STARTED|Overall Study||36
10348161|NCT00423917|11486260|FG000|COMPLETED|Overall Study||33
10348162|NCT00423917|11486260|FG000|NOT COMPLETED|Overall Study||3
10348163|NCT00423930|11486264|FG000|STARTED|Overall Study||44
10348164|NCT00423930|11486264|FG000|COMPLETED|Overall Study||42
10348165|NCT00423930|11486264|FG000|NOT COMPLETED|Overall Study||2
10348166|NCT00423943|11486270|FG000|STARTED|Overall Study||19
10348167|NCT00423943|11486271|FG001|STARTED|Overall Study||14
10348168|NCT00423943|11486270|FG000|COMPLETED|Overall Study||16
10348169|NCT00423943|11486271|FG001|COMPLETED|Overall Study||13
10348170|NCT00423943|11486270|FG000|NOT COMPLETED|Overall Study||3
10348171|NCT00423943|11486271|FG001|NOT COMPLETED|Overall Study||1
10532556|NCT01421342|11684917|FG002|COMPLETED|Continuation of Treatment (Week 12 - 36)||203
10532557|NCT01421342|11684915|FG000|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||52
10532558|NCT01421342|11684916|FG001|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||59
10532559|NCT01421342|11684917|FG002|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||65
10532560|NCT01421355|11684925|FG000|STARTED|Overall Study||21
10532561|NCT01421355|11684925|FG000|COMPLETED|Overall Study||15
10532562|NCT01421355|11684925|FG000|NOT COMPLETED|Overall Study||6
10532563|NCT01421459|11684931|FG000|STARTED|Overall Study||379
10532564|NCT01421459|11684932|FG001|STARTED|Overall Study||380
10532565|NCT01421459|11684931|FG000|Received at Least 1 Dose of Study Drug|Overall Study||376
10655684|NCT02209597|11816378|FG000|STARTED|Phase 4 (Randomized: 1 Brand, 3 Generic)||67
10655685|NCT02209597|11816378|FG000|COMPLETED|Phase 4 (Randomized: 1 Brand, 3 Generic)||67
10655686|NCT02209597|11816378|FG000|NOT COMPLETED|Phase 4 (Randomized: 1 Brand, 3 Generic)||0
10655687|NCT02209610|11816390|FG000|STARTED|Overall Study||16
10655688|NCT02209610|11816391|FG001|STARTED|Overall Study||16
10655689|NCT02209610|11816390|FG000|COMPLETED|Overall Study||16
10655690|NCT02209610|11816391|FG001|COMPLETED|Overall Study||16
10655691|NCT02209610|11816390|FG000|NOT COMPLETED|Overall Study||0
10655692|NCT02209610|11816391|FG001|NOT COMPLETED|Overall Study||0
10655693|NCT02209766|11816402|FG000|STARTED|Overall Study||6
10655694|NCT02209766|11816403|FG001|STARTED|Overall Study||3
10655695|NCT02209766|11816404|FG002|STARTED|Overall Study||6
10655696|NCT02209766|11816405|FG003|STARTED|Overall Study||3
10655697|NCT02209766|11816406|FG004|STARTED|Overall Study||6
10655698|NCT02209766|11816402|FG000|COMPLETED|Overall Study||6
10655699|NCT02209766|11816403|FG001|COMPLETED|Overall Study||3
10655700|NCT02209766|11816404|FG002|COMPLETED|Overall Study||6
10655701|NCT02209766|11816405|FG003|COMPLETED|Overall Study||2
10655702|NCT02209766|11816406|FG004|COMPLETED|Overall Study||6
10655703|NCT02209766|11816402|FG000|NOT COMPLETED|Overall Study||0
10655704|NCT02209766|11816403|FG001|NOT COMPLETED|Overall Study||0
10655705|NCT02209766|11816404|FG002|NOT COMPLETED|Overall Study||0
10655706|NCT02209766|11816405|FG003|NOT COMPLETED|Overall Study||1
10655707|NCT02209766|11816406|FG004|NOT COMPLETED|Overall Study||0
10655708|NCT02209948|11816418|FG000|STARTED|Overall Study||80
10655709|NCT02209948|11816419|FG001|STARTED|Overall Study||79
10655710|NCT02209948|11816418|FG000|Recieved Alocated Intervention|Overall Study||80
10655711|NCT02209948|11816419|FG001|Recieved Alocated Intervention|Overall Study||79
10655712|NCT02209948|11816418|FG000|Lost to Follow up|Overall Study||0
10655713|NCT02209948|11816419|FG001|Lost to Follow up|Overall Study||1
10655714|NCT02209948|11816418|FG000|Discontinued Due to Progression|Overall Study||31
10655715|NCT02209948|11816419|FG001|Discontinued Due to Progression|Overall Study||39
10655716|NCT02209948|11816418|FG000|COMPLETED|Overall Study||80
10655717|NCT02209948|11816419|FG001|COMPLETED|Overall Study||79
10655718|NCT02209948|11816418|FG000|NOT COMPLETED|Overall Study||0
10655719|NCT02209948|11816419|FG001|NOT COMPLETED|Overall Study||0
10715771|NCT02688387|11880064|FG021|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
10348172|NCT00424021|11486281|FG000|STARTED|NCT00046319 Study Period||16
10348173|NCT00424021|11486282|FG001|STARTED|NCT00046319 Study Period||19
10655720|NCT02210000|11816427|FG000|STARTED|Overall Study||57
10655721|NCT02210000|11816428|FG001|STARTED|Overall Study||57
10655722|NCT02210000|11816427|FG000|COMPLETED|Overall Study||38
10655723|NCT02210000|11816428|FG001|COMPLETED|Overall Study||36
10655724|NCT02210000|11816427|FG000|NOT COMPLETED|Overall Study||19
10655725|NCT02210000|11816428|FG001|NOT COMPLETED|Overall Study||21
10655726|NCT02210039|11816434|FG000|STARTED|Overall Study||6
10655727|NCT02210039|11816434|FG000|COMPLETED|Overall Study||6
10655728|NCT02210039|11816434|FG000|NOT COMPLETED|Overall Study||0
10348174|NCT00424021|11486283|FG002|STARTED|NCT00046319 Study Period||16
10532566|NCT01421459|11684932|FG001|Received at Least 1 Dose of Study Drug|Overall Study||380
10532567|NCT01421459|11684931|FG000|COMPLETED|Overall Study||334
10532568|NCT01421459|11684932|FG001|COMPLETED|Overall Study||328
10532569|NCT01421459|11684931|FG000|NOT COMPLETED|Overall Study||45
10532570|NCT01421459|11684932|FG001|NOT COMPLETED|Overall Study||52
10348175|NCT00424021|11486284|FG003|STARTED|NCT00046319 Study Period||13
10348176|NCT00424021|11486281|FG000|COMPLETED|NCT00046319 Study Period||15
10348177|NCT00424021|11486282|FG001|COMPLETED|NCT00046319 Study Period||16
10348178|NCT00424021|11486283|FG002|COMPLETED|NCT00046319 Study Period||15
10348179|NCT00424021|11486284|FG003|COMPLETED|NCT00046319 Study Period||12
10348180|NCT00424021|11486281|FG000|NOT COMPLETED|NCT00046319 Study Period||1
10348181|NCT00424021|11486282|FG001|NOT COMPLETED|NCT00046319 Study Period||3
10348182|NCT00424021|11486283|FG002|NOT COMPLETED|NCT00046319 Study Period||1
10348183|NCT00424021|11486284|FG003|NOT COMPLETED|NCT00046319 Study Period||1
10348184|NCT00424021|11486281|FG000|STARTED|AMB-220-E Study Period||2
10348185|NCT00424021|11486282|FG001|STARTED|AMB-220-E Study Period||7
10348186|NCT00424021|11486283|FG002|STARTED|AMB-220-E Study Period||19
10348187|NCT00424021|11486284|FG003|STARTED|AMB-220-E Study Period||26
10348188|NCT00424021|11486281|FG000|COMPLETED|AMB-220-E Study Period||1
10348189|NCT00424021|11486282|FG001|COMPLETED|AMB-220-E Study Period||5
10348190|NCT00424021|11486283|FG002|COMPLETED|AMB-220-E Study Period||14
10348191|NCT00424021|11486284|FG003|COMPLETED|AMB-220-E Study Period||16
10348192|NCT00424021|11486281|FG000|NOT COMPLETED|AMB-220-E Study Period||1
10348193|NCT00424021|11486282|FG001|NOT COMPLETED|AMB-220-E Study Period||2
10348194|NCT00424021|11486283|FG002|NOT COMPLETED|AMB-220-E Study Period||5
10348195|NCT00424021|11486284|FG003|NOT COMPLETED|AMB-220-E Study Period||10
10426704|NCT00848549|11572399|FG001|COMPLETED|E2090-E044-310 (Base Study) Transition||158
10426705|NCT00848549|11572398|FG000|NOT COMPLETED|E2090-E044-310 (Base Study) Transition||24
10426706|NCT00848549|11572399|FG001|NOT COMPLETED|E2090-E044-310 (Base Study) Transition||34
10426707|NCT00848549|11572398|FG000|STARTED|E2090-E044-314 (Extension Study)||137
10426708|NCT00848549|11572399|FG001|STARTED|E2090-E044-314 (Extension Study)||158
10426709|NCT00848549|11572398|FG000|COMPLETED|E2090-E044-314 (Extension Study)||120
10426710|NCT00848549|11572399|FG001|COMPLETED|E2090-E044-314 (Extension Study)||134
10426711|NCT00848549|11572398|FG000|NOT COMPLETED|E2090-E044-314 (Extension Study)||17
10426712|NCT00848549|11572399|FG001|NOT COMPLETED|E2090-E044-314 (Extension Study)||24
10426713|NCT00848718|11572420|FG000|STARTED|Overall Study||7
10426714|NCT00848718|11572421|FG001|STARTED|Overall Study||9
10426715|NCT00848718|11572422|FG002|STARTED|Overall Study||6
10426716|NCT00848718|11572423|FG003|STARTED|Overall Study||5
10426717|NCT00848718|11572424|FG004|STARTED|Overall Study||6
10426718|NCT00848718|11572425|FG005|STARTED|Overall Study||5
10426719|NCT00848718|11572426|FG006|STARTED|Overall Study||3
10426720|NCT00848718|11572427|FG007|STARTED|Overall Study||5
10426721|NCT00848718|11572428|FG008|STARTED|Overall Study||4
10426722|NCT00848718|11572429|FG009|STARTED|Overall Study||9
10426723|NCT00848718|11572430|FG010|STARTED|Overall Study||4
10426724|NCT00848718|11572431|FG011|STARTED|Overall Study||6
10426725|NCT00848718|11572432|FG012|STARTED|Overall Study||8
10426726|NCT00848718|11572420|FG000|Treated|Overall Study|1 participant was allocated but did not receive treatment due to progression of disease|6
10532571|NCT01421472|11684942|FG000|STARTED|Overall Study||67
10532572|NCT01421472|11684943|FG001|STARTED|Overall Study||33
10532573|NCT01421472|11684944|FG002|STARTED|Overall Study||64
10532574|NCT01421472|11684945|FG003|STARTED|Overall Study||32
10532575|NCT01421472|11684942|FG000|COMPLETED|Overall Study||67
10532576|NCT01421472|11684943|FG001|COMPLETED|Overall Study||33
10532577|NCT01421472|11684944|FG002|COMPLETED|Overall Study||64
10532578|NCT01421472|11684945|FG003|COMPLETED|Overall Study||32
10532579|NCT01421472|11684942|FG000|NOT COMPLETED|Overall Study||0
10532580|NCT01421472|11684943|FG001|NOT COMPLETED|Overall Study||0
10532581|NCT01421472|11684944|FG002|NOT COMPLETED|Overall Study||0
10532582|NCT01421472|11684945|FG003|NOT COMPLETED|Overall Study||0
10532583|NCT01421498|11684957|FG000|STARTED|Overall Study||293
10532584|NCT01421498|11684958|FG001|STARTED|Overall Study||295
10655729|NCT02210052|11816438|FG000|STARTED|Overall Study||6
10715772|NCT02688387|11880043|FG000|STARTED|Part 3A, Period 3 (up to 6 Days)||0
10715773|NCT02688387|11880044|FG001|STARTED|Part 3A, Period 3 (up to 6 Days)||0
10426727|NCT00848718|11572421|FG001|Treated|Overall Study||9
10426728|NCT00848718|11572422|FG002|Treated|Overall Study|1 participant was allocated but did not receive treatment due to progression of disease|5
10426729|NCT00848718|11572423|FG003|Treated|Overall Study||5
10426730|NCT00848718|11572424|FG004|Treated|Overall Study||6
10426731|NCT00848718|11572425|FG005|Treated|Overall Study||5
10426732|NCT00848718|11572426|FG006|Treated|Overall Study||3
10426733|NCT00848718|11572427|FG007|Treated|Overall Study|1 participant was allocated but did not receive treatment due to progression of disease|4
10426734|NCT00848718|11572428|FG008|Treated|Overall Study||4
10426735|NCT00848718|11572429|FG009|Treated|Overall Study||9
10532585|NCT01421498|11684957|FG000|COMPLETED|Overall Study||281
10532586|NCT01421498|11684958|FG001|COMPLETED|Overall Study||284
10532587|NCT01421498|11684957|FG000|NOT COMPLETED|Overall Study||12
10532588|NCT01421498|11684958|FG001|NOT COMPLETED|Overall Study||11
10532589|NCT01421511|11684966|FG000|STARTED|Overall Study||332
10532590|NCT01421511|11684967|FG001|STARTED|Overall Study||334
10532591|NCT01421511|11684966|FG000|COMPLETED|Overall Study||313
10532592|NCT01421511|11684967|FG001|COMPLETED|Overall Study||306
10532593|NCT01421511|11684966|FG000|NOT COMPLETED|Overall Study||19
10532594|NCT01421511|11684967|FG001|NOT COMPLETED|Overall Study||28
10532595|NCT01421589|11684974|FG000|STARTED|Overall Study||15
10532596|NCT01421589|11684974|FG000|COMPLETED|Overall Study||15
10532597|NCT01421589|11684974|FG000|NOT COMPLETED|Overall Study||0
10532598|NCT01421641|11684981|FG000|STARTED|Overall Study||37
10532599|NCT01421641|11684982|FG001|STARTED|Overall Study||37
10532600|NCT01421641|11684981|FG000|COMPLETED|Overall Study||35
10348196|NCT00424047|11486303|FG000|STARTED|Blinded Treatment (Up to 03 Aug 2005)||176
10348197|NCT00424047|11486304|FG001|STARTED|Blinded Treatment (Up to 03 Aug 2005)||175
10348198|NCT00424047|11486303|FG000|Safety Population|Blinded Treatment (Up to 03 Aug 2005)|Includes those who took at least one dose of study medication regimen|176
10348199|NCT00424047|11486304|FG001|Safety Population|Blinded Treatment (Up to 03 Aug 2005)|Includes those who took at least one dose of study medication regimen|175
10348200|NCT00424047|11486303|FG000|Evaluable Population|Blinded Treatment (Up to 03 Aug 2005)|1 participant excluded because they had no baseline M-protein assessment|175
10348201|NCT00424047|11486304|FG001|Evaluable Population|Blinded Treatment (Up to 03 Aug 2005)|4 participants excluded because they had no baseline M-protein assessment|171
10348202|NCT00424047|11486303|FG000|COMPLETED|Blinded Treatment (Up to 03 Aug 2005)|54 participants ongoing and continuing on lenalidomide/dexamethasone treatment|54
10348203|NCT00424047|11486304|FG001|COMPLETED|Blinded Treatment (Up to 03 Aug 2005)|Ongoing and includes 15 participants who crossed over to lenalidomide/dexamethasone after unblinding|19
10348204|NCT00424047|11486303|FG000|NOT COMPLETED|Blinded Treatment (Up to 03 Aug 2005)||122
10348205|NCT00424047|11486304|FG001|NOT COMPLETED|Blinded Treatment (Up to 03 Aug 2005)||156
10348206|NCT00424047|11486303|FG000|STARTED|On Study at Time of Unblinding|Refers to original treatment group assignment in the study.|176
10348207|NCT00424047|11486304|FG001|STARTED|On Study at Time of Unblinding||175
10348208|NCT00424047|11486303|FG000|COMPLETED|On Study at Time of Unblinding|Participants completed = those continuing on long term Lenalidomide and dexamethasone|21
10348209|NCT00424047|11486304|FG001|COMPLETED|On Study at Time of Unblinding|Participants completed = those continuing on long term dexamethasone|8
10348210|NCT00424047|11486303|FG000|NOT COMPLETED|On Study at Time of Unblinding||155
10348211|NCT00424047|11486304|FG001|NOT COMPLETED|On Study at Time of Unblinding||167
10348212|NCT00424047|11486303|FG000|STARTED|Long Term Extension (Up to 25 Jun 2013)||21
10348213|NCT00424047|11486304|FG001|STARTED|Long Term Extension (Up to 25 Jun 2013)|2 participants opted to receive dex alone, 3 crossed over to Len/Dex and 3 added Len at a later date|8
10348214|NCT00424047|11486303|FG000|COMPLETED|Long Term Extension (Up to 25 Jun 2013)||0
10348215|NCT00424047|11486304|FG001|COMPLETED|Long Term Extension (Up to 25 Jun 2013)||0
10348216|NCT00424047|11486303|FG000|NOT COMPLETED|Long Term Extension (Up to 25 Jun 2013)||21
10348217|NCT00424047|11486304|FG001|NOT COMPLETED|Long Term Extension (Up to 25 Jun 2013)||8
10348218|NCT00424177|11486315|FG000|STARTED|Cycle 1: Eltrombopag 50 mg Starting Dose||66
10348219|NCT00424177|11486315|FG000|COMPLETED|Cycle 1: Eltrombopag 50 mg Starting Dose||55
10348220|NCT00424177|11486315|FG000|NOT COMPLETED|Cycle 1: Eltrombopag 50 mg Starting Dose||11
10348221|NCT00424177|11486315|FG000|STARTED|Cycle 2: Eltrombopag 50 or 75 mg||55
10348222|NCT00424177|11486315|FG000|COMPLETED|Cycle 2: Eltrombopag 50 or 75 mg||51
10348223|NCT00424177|11486315|FG000|NOT COMPLETED|Cycle 2: Eltrombopag 50 or 75 mg||4
10348224|NCT00424177|11486315|FG000|STARTED|Cycle 3: Eltrombopag 50 or 75 mg||51
10348225|NCT00424177|11486315|FG000|COMPLETED|Cycle 3: Eltrombopag 50 or 75 mg||48
10348226|NCT00424177|11486315|FG000|NOT COMPLETED|Cycle 3: Eltrombopag 50 or 75 mg||3
10348227|NCT00424190|11486329|FG000|STARTED|Overall Study||351
10348228|NCT00424190|11486330|FG001|STARTED|Overall Study||347
10348229|NCT00424190|11486329|FG000|COMPLETED|Overall Study||329
10348230|NCT00424190|11486330|FG001|COMPLETED|Overall Study||317
10348231|NCT00424190|11486329|FG000|NOT COMPLETED|Overall Study||22
10348232|NCT00424190|11486330|FG001|NOT COMPLETED|Overall Study||30
10348233|NCT00424255|11486338|FG000|STARTED|Overall Study||342
10348234|NCT00424255|11486339|FG001|STARTED|Overall Study||346
10348235|NCT00424255|11486338|FG000|COMPLETED|Overall Study||0
10348236|NCT00424255|11486339|FG001|COMPLETED|Overall Study||0
10348237|NCT00424255|11486338|FG000|NOT COMPLETED|Overall Study||342
10348238|NCT00424255|11486339|FG001|NOT COMPLETED|Overall Study||346
10348239|NCT00424268|11486347|FG000|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|371
10348240|NCT00424268|11486348|FG001|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|372
10348241|NCT00424268|11486347|FG000|COMPLETED|Overall Study||309
10348242|NCT00424268|11486348|FG001|COMPLETED|Overall Study||333
10348243|NCT00424268|11486347|FG000|NOT COMPLETED|Overall Study||62
10348244|NCT00424268|11486348|FG001|NOT COMPLETED|Overall Study||39
10348245|NCT00424294|11486356|FG000|STARTED|Overall Study||36
10348246|NCT00424294|11486357|FG001|STARTED|Overall Study||34
10348247|NCT00424294|11486356|FG000|Treated|Overall Study||35
10348248|NCT00424294|11486357|FG001|Treated|Overall Study||34
10348249|NCT00424294|11486356|FG000|COMPLETED|Overall Study||28
10348250|NCT00424294|11486357|FG001|COMPLETED|Overall Study||19
10348251|NCT00424294|11486356|FG000|NOT COMPLETED|Overall Study||8
10348252|NCT00424294|11486357|FG001|NOT COMPLETED|Overall Study||15
10348253|NCT00424346|11486367|FG000|STARTED|Core Study||71
10348254|NCT00424346|11486368|FG001|STARTED|Core Study||64
10348255|NCT00424346|11486369|FG002|STARTED|Core Study||69
10348256|NCT00424346|11486370|FG003|STARTED|Core Study||70
10348257|NCT00424346|11486367|FG000|COMPLETED|Core Study||62
10348258|NCT00424346|11486368|FG001|COMPLETED|Core Study||56
10348259|NCT00424346|11486369|FG002|COMPLETED|Core Study||65
10348260|NCT00424346|11486370|FG003|COMPLETED|Core Study||63
10348261|NCT00424346|11486367|FG000|NOT COMPLETED|Core Study||9
10348262|NCT00424346|11486368|FG001|NOT COMPLETED|Core Study||8
10348263|NCT00424346|11486369|FG002|NOT COMPLETED|Core Study||4
10348264|NCT00424346|11486370|FG003|NOT COMPLETED|Core Study||7
10348265|NCT00424346|11486367|FG000|STARTED|Extension Phase|Participants are represented in the Canakinumab 300 mg q2wk treatment group.|0
10348266|NCT00424346|11486368|FG001|STARTED|Extension Phase|Includes participants who completed the Core phase in the Canakinumab 600 mg IV + 300 mg q2wk group.|110
10348267|NCT00424346|11486369|FG002|STARTED|Extension Phase||59
10348268|NCT00424346|11486370|FG003|STARTED|Extension Phase||58
10348269|NCT00424346|11486367|FG000|COMPLETED|Extension Phase||0
10348270|NCT00424346|11486368|FG001|COMPLETED|Extension Phase||8
10348271|NCT00424346|11486369|FG002|COMPLETED|Extension Phase||4
10348272|NCT00424346|11486370|FG003|COMPLETED|Extension Phase||3
10532601|NCT01421641|11684982|FG001|COMPLETED|Overall Study||35
10532602|NCT01421641|11684981|FG000|NOT COMPLETED|Overall Study||2
10532603|NCT01421641|11684982|FG001|NOT COMPLETED|Overall Study||2
10715774|NCT02688387|11880045|FG002|STARTED|Part 3A, Period 3 (up to 6 Days)||0
10715775|NCT02688387|11880046|FG003|STARTED|Part 3A, Period 3 (up to 6 Days)||0
10348273|NCT00424346|11486367|FG000|NOT COMPLETED|Extension Phase||0
10532604|NCT01421654|11684990|FG000|STARTED|Overall Study||11
10532605|NCT01421654|11684991|FG001|STARTED|Overall Study||9
10532606|NCT01421654|11684990|FG000|COMPLETED|Overall Study||11
10532607|NCT01421654|11684991|FG001|COMPLETED|Overall Study|10 subjects completed study, but 1 subject was found to not meet IEC at the end; data was not used.|9
10532608|NCT01421654|11684990|FG000|NOT COMPLETED|Overall Study||0
10532609|NCT01421654|11684991|FG001|NOT COMPLETED|Overall Study||0
10532610|NCT01421667|11685001|FG000|STARTED|Overall Study||35
10532611|NCT01421667|11685002|FG001|STARTED|Overall Study||68
10532612|NCT01421667|11685003|FG002|STARTED|Overall Study||53
10532613|NCT01421667|11685004|FG003|STARTED|Overall Study||16
10532614|NCT01421667|11685001|FG000|COMPLETED|Overall Study|Completed per protocol due to death [24] or study termination by sponsor [11]|35
10532615|NCT01421667|11685002|FG001|COMPLETED|Overall Study|Completed per protocol due to death [45] or study termination by sponsor [21]|66
10532616|NCT01421667|11685003|FG002|COMPLETED|Overall Study|Completed per protocol due to death [33] or study termination by sponsor [18]|51
10532617|NCT01421667|11685004|FG003|COMPLETED|Overall Study|Completed per protocol due to death [7] or study termination by sponsor [8]|15
10532618|NCT01421667|11685001|FG000|NOT COMPLETED|Overall Study||0
10532619|NCT01421667|11685002|FG001|NOT COMPLETED|Overall Study||2
10532620|NCT01421667|11685003|FG002|NOT COMPLETED|Overall Study||2
10532621|NCT01421667|11685004|FG003|NOT COMPLETED|Overall Study||1
10532622|NCT01421719|11685022|FG000|STARTED|Overall Study||20
10532623|NCT01421719|11685022|FG000|COMPLETED|Overall Study||16
10348274|NCT00424346|11486368|FG001|NOT COMPLETED|Extension Phase||102
10532624|NCT01421719|11685022|FG000|NOT COMPLETED|Overall Study||4
10532625|NCT01422070|11685029|FG000|STARTED|Overall Study|Number of patients admitted to 140 intensive care units|5031
10532626|NCT01422070|11685030|FG001|STARTED|Overall Study|Number of patients admitted to 27 intensive care units.|803
10532627|NCT01422070|11685029|FG000|COMPLETED|Overall Study||5031
10532628|NCT01422070|11685030|FG001|COMPLETED|Overall Study||803
10532629|NCT01422070|11685029|FG000|NOT COMPLETED|Overall Study||0
10532630|NCT01422070|11685030|FG001|NOT COMPLETED|Overall Study||0
10532631|NCT01422135|11685035|FG000|STARTED|Overall Study||4
10532632|NCT01422135|11685036|FG001|STARTED|Overall Study||4
10532633|NCT01422135|11685037|FG002|STARTED|Overall Study||4
10532634|NCT01422135|11685038|FG003|STARTED|Overall Study||4
10532635|NCT01422135|11685039|FG004|STARTED|Overall Study||4
10532636|NCT01422135|11685040|FG005|STARTED|Overall Study||4
10532637|NCT01422135|11685035|FG000|COMPLETED|Overall Study||4
10532638|NCT01422135|11685036|FG001|COMPLETED|Overall Study||4
10532639|NCT01422135|11685037|FG002|COMPLETED|Overall Study||3
10532640|NCT01422135|11685038|FG003|COMPLETED|Overall Study||4
10532641|NCT01422135|11685039|FG004|COMPLETED|Overall Study||4
10532642|NCT01422135|11685040|FG005|COMPLETED|Overall Study||3
10532643|NCT01422135|11685035|FG000|NOT COMPLETED|Overall Study||0
10532644|NCT01422135|11685036|FG001|NOT COMPLETED|Overall Study||0
10532645|NCT01422135|11685037|FG002|NOT COMPLETED|Overall Study||1
10532646|NCT01422135|11685038|FG003|NOT COMPLETED|Overall Study||0
10532647|NCT01422135|11685039|FG004|NOT COMPLETED|Overall Study||0
10532648|NCT01422135|11685040|FG005|NOT COMPLETED|Overall Study||1
10532649|NCT01422161|11685048|FG000|STARTED|Overall Study||10
10532650|NCT01422161|11685049|FG001|STARTED|Overall Study||6
10532651|NCT01422161|11685048|FG000|COMPLETED|Overall Study||10
10532652|NCT01422161|11685049|FG001|COMPLETED|Overall Study||6
10532653|NCT01422161|11685048|FG000|NOT COMPLETED|Overall Study||0
10532654|NCT01422161|11685049|FG001|NOT COMPLETED|Overall Study||0
10532655|NCT01422187|11685066|FG000|STARTED|Overall Study||8
10532656|NCT01422187|11685067|FG001|STARTED|Overall Study||9
10532657|NCT01422187|11685068|FG002|STARTED|Overall Study||2
10532658|NCT01422187|11685066|FG000|COMPLETED|Overall Study||7
10532659|NCT01422187|11685067|FG001|COMPLETED|Overall Study||8
10532660|NCT01422187|11685068|FG002|COMPLETED|Overall Study||2
10532661|NCT01422187|11685066|FG000|NOT COMPLETED|Overall Study||1
10532662|NCT01422187|11685067|FG001|NOT COMPLETED|Overall Study||1
10532663|NCT01422187|11685068|FG002|NOT COMPLETED|Overall Study||0
10348275|NCT00424346|11486369|FG002|NOT COMPLETED|Extension Phase||55
10348276|NCT00424346|11486370|FG003|NOT COMPLETED|Extension Phase||55
10348277|NCT00424372|11486383|FG000|STARTED|Overall Study||126
10348278|NCT00424372|11486383|FG000|COMPLETED|Overall Study||95
10348279|NCT00424372|11486383|FG000|NOT COMPLETED|Overall Study||31
10348280|NCT00424385|11486387|FG000|STARTED|Cohort 0||12
10348281|NCT00424385|11486387|FG000|COMPLETED|Cohort 0||6
10348282|NCT00424385|11486387|FG000|NOT COMPLETED|Cohort 0||6
10348283|NCT00424385|11486387|FG000|STARTED|Cohort 1||5
10532664|NCT01422200|11685078|FG000|STARTED|Overall Study||11
10532665|NCT01422200|11685079|FG001|STARTED|Overall Study||11
10715776|NCT02688387|11880047|FG004|STARTED|Part 3A, Period 3 (up to 6 Days)||0
10715777|NCT02688387|11880048|FG005|STARTED|Part 3A, Period 3 (up to 6 Days)||0
10348284|NCT00424385|11486387|FG000|COMPLETED|Cohort 1||4
10348285|NCT00424385|11486387|FG000|NOT COMPLETED|Cohort 1||1
10348286|NCT00424398|11486396|FG000|STARTED|Overall Study||35
10348287|NCT00424398|11486397|FG001|STARTED|Overall Study||36
10348288|NCT00424398|11486398|FG002|STARTED|Overall Study||36
10348289|NCT00424398|11486396|FG000|COMPLETED|Overall Study||32
10348290|NCT00424398|11486397|FG001|COMPLETED|Overall Study||35
10348291|NCT00424398|11486398|FG002|COMPLETED|Overall Study||36
10348292|NCT00424398|11486396|FG000|NOT COMPLETED|Overall Study||3
10348293|NCT00424398|11486397|FG001|NOT COMPLETED|Overall Study||1
10348294|NCT00424398|11486398|FG002|NOT COMPLETED|Overall Study||0
10348295|NCT00424463|11486409|FG000|STARTED|Overall Study||45
10348296|NCT00424463|11486410|FG001|STARTED|Overall Study||48
10348297|NCT00424463|11486411|FG002|STARTED|Overall Study||88
10348298|NCT00424463|11486409|FG000|COMPLETED|Overall Study||38
10348299|NCT00424463|11486410|FG001|COMPLETED|Overall Study||34
10348300|NCT00424463|11486411|FG002|COMPLETED|Overall Study||72
10348301|NCT00424463|11486409|FG000|NOT COMPLETED|Overall Study||7
10348302|NCT00424463|11486410|FG001|NOT COMPLETED|Overall Study||14
10348303|NCT00424463|11486411|FG002|NOT COMPLETED|Overall Study||16
10348304|NCT00424476|11486422|FG000|STARTED|Overall Study||287
10348305|NCT00424476|11486423|FG001|STARTED|Overall Study||288
10348306|NCT00424476|11486424|FG002|STARTED|Overall Study||290
10348307|NCT00424476|11486422|FG000|COMPLETED|Overall Study||226
10348308|NCT00424476|11486423|FG001|COMPLETED|Overall Study||240
10348309|NCT00424476|11486424|FG002|COMPLETED|Overall Study||241
10348310|NCT00424476|11486422|FG000|NOT COMPLETED|Overall Study||61
10348311|NCT00424476|11486423|FG001|NOT COMPLETED|Overall Study||48
10348312|NCT00424476|11486424|FG002|NOT COMPLETED|Overall Study||49
10348313|NCT00424489|11486432|FG000|STARTED|Overall Study||9
10348314|NCT00424489|11486432|FG000|COMPLETED|Overall Study||6
10348315|NCT00424489|11486432|FG000|NOT COMPLETED|Overall Study||3
10348316|NCT00424502|11486436|FG000|STARTED|Overall Study||20
10348317|NCT00424502|11486436|FG000|COMPLETED|Overall Study||20
10348318|NCT00424502|11486436|FG000|NOT COMPLETED|Overall Study||0
10348319|NCT00424515|11486442|FG000|STARTED|Overall Study||11
10348320|NCT00424515|11486443|FG001|STARTED|Overall Study||13
10348321|NCT00424515|11486442|FG000|COMPLETED|Overall Study||0
10348322|NCT00424515|11486443|FG001|COMPLETED|Overall Study||0
10348323|NCT00424515|11486442|FG000|NOT COMPLETED|Overall Study||11
10348324|NCT00424515|11486443|FG001|NOT COMPLETED|Overall Study||13
10348325|NCT00424528|11486452|FG000|STARTED|Overall Study||76
10348326|NCT00424528|11486453|FG001|STARTED|Overall Study||80
10348327|NCT00424528|11486454|FG002|STARTED|Overall Study||78
10348328|NCT00424528|11486452|FG000|COMPLETED|Overall Study||71
10348329|NCT00424528|11486453|FG001|COMPLETED|Overall Study||76
10348330|NCT00424528|11486454|FG002|COMPLETED|Overall Study||74
10348331|NCT00424528|11486452|FG000|NOT COMPLETED|Overall Study||5
10348332|NCT00424528|11486453|FG001|NOT COMPLETED|Overall Study||4
10348333|NCT00424528|11486454|FG002|NOT COMPLETED|Overall Study||4
10348334|NCT00424554|11486464|FG000|STARTED|Overall Study||34
10348335|NCT00424554|11486465|FG001|STARTED|Overall Study||6
10348336|NCT00424554|11486464|FG000|COMPLETED|Overall Study||34
10348337|NCT00424554|11486465|FG001|COMPLETED|Overall Study||6
10348338|NCT00424554|11486464|FG000|NOT COMPLETED|Overall Study||0
10348339|NCT00424554|11486465|FG001|NOT COMPLETED|Overall Study||0
10348340|NCT00424593|11486473|FG000|STARTED|Acute Double-Blind Period||115
10348341|NCT00424593|11486474|FG001|STARTED|Acute Double-Blind Period||121
10348342|NCT00424593|11486473|FG000|COMPLETED|Acute Double-Blind Period||84
10715778|NCT02688387|11880049|FG006|STARTED|Part 3A, Period 3 (up to 6 Days)||0
10715779|NCT02688387|11880050|FG007|STARTED|Part 3A, Period 3 (up to 6 Days)||0
10348343|NCT00424593|11486474|FG001|COMPLETED|Acute Double-Blind Period||98
10348344|NCT00424593|11486473|FG000|NOT COMPLETED|Acute Double-Blind Period||31
10348345|NCT00424593|11486474|FG001|NOT COMPLETED|Acute Double-Blind Period||23
10348346|NCT00424593|11486473|FG000|STARTED|Dose-Blind Extension Period|83 duloxetine patients from the acute phase entered the dose-blind period.|181
10348347|NCT00424593|11486474|FG001|STARTED|Dose-Blind Extension Period|98 placebo patients from acute phase entered dose-blind period and received duloxetine.|0
10348348|NCT00424593|11486473|FG000|COMPLETED|Dose-Blind Extension Period||117
10348349|NCT00424593|11486474|FG001|COMPLETED|Dose-Blind Extension Period||0
10348350|NCT00424593|11486473|FG000|NOT COMPLETED|Dose-Blind Extension Period||64
10348351|NCT00424593|11486474|FG001|NOT COMPLETED|Dose-Blind Extension Period||0
10348352|NCT00424619|11486483|FG000|STARTED|Baseline||22
10348353|NCT00424619|11486484|FG001|STARTED|Baseline||22
10348354|NCT00424619|11486485|FG002|STARTED|Baseline|n=21 but one participant was lost as a screen failure|21
10348355|NCT00424619|11486483|FG000|COMPLETED|Baseline||22
10348356|NCT00424619|11486484|FG001|COMPLETED|Baseline||22
10348357|NCT00424619|11486485|FG002|COMPLETED|Baseline||20
10348358|NCT00424619|11486483|FG000|NOT COMPLETED|Baseline||0
10348359|NCT00424619|11486484|FG001|NOT COMPLETED|Baseline||0
10348360|NCT00424619|11486485|FG002|NOT COMPLETED|Baseline||1
10348361|NCT00424619|11486483|FG000|STARTED|4 Week||18
10348362|NCT00424619|11486484|FG001|STARTED|4 Week||17
10348363|NCT00424619|11486485|FG002|STARTED|4 Week||17
10348364|NCT00424619|11486483|FG000|COMPLETED|4 Week||18
10348365|NCT00424619|11486484|FG001|COMPLETED|4 Week||17
10348366|NCT00424619|11486485|FG002|COMPLETED|4 Week||17
10348367|NCT00424619|11486483|FG000|NOT COMPLETED|4 Week||0
10348368|NCT00424619|11486484|FG001|NOT COMPLETED|4 Week||0
10348369|NCT00424619|11486485|FG002|NOT COMPLETED|4 Week||0
10348370|NCT00424619|11486483|FG000|STARTED|3 Month||12
10348371|NCT00424619|11486484|FG001|STARTED|3 Month||18
10348372|NCT00424619|11486485|FG002|STARTED|3 Month||17
10348373|NCT00424619|11486483|FG000|COMPLETED|3 Month||12
10348374|NCT00424619|11486484|FG001|COMPLETED|3 Month||18
10348375|NCT00424619|11486485|FG002|COMPLETED|3 Month||17
10348376|NCT00424619|11486483|FG000|NOT COMPLETED|3 Month||0
10348377|NCT00424619|11486484|FG001|NOT COMPLETED|3 Month||0
10348378|NCT00424619|11486485|FG002|NOT COMPLETED|3 Month||0
10348379|NCT00424632|11486495|FG000|STARTED|Overall Study||1
10348380|NCT00424632|11486496|FG001|STARTED|Overall Study||1
10348381|NCT00424632|11486497|FG002|STARTED|Overall Study||1
10348382|NCT00424632|11486498|FG003|STARTED|Overall Study||4
10348383|NCT00424632|11486499|FG004|STARTED|Overall Study||3
10348384|NCT00424632|11486500|FG005|STARTED|Overall Study||15
10348385|NCT00424632|11486501|FG006|STARTED|Overall Study||7
10348386|NCT00424632|11486502|FG007|STARTED|Overall Study||3
10348387|NCT00424632|11486503|FG008|STARTED|Overall Study||16
10348388|NCT00424632|11486504|FG009|STARTED|Overall Study||6
10348389|NCT00424632|11486495|FG000|COMPLETED|Overall Study||0
10348390|NCT00424632|11486496|FG001|COMPLETED|Overall Study||0
10348391|NCT00424632|11486497|FG002|COMPLETED|Overall Study||0
10348392|NCT00424632|11486498|FG003|COMPLETED|Overall Study||0
10348393|NCT00424632|11486499|FG004|COMPLETED|Overall Study||0
10348394|NCT00424632|11486500|FG005|COMPLETED|Overall Study||0
10348395|NCT00424632|11486501|FG006|COMPLETED|Overall Study||0
10348396|NCT00424632|11486502|FG007|COMPLETED|Overall Study||0
10348397|NCT00424632|11486503|FG008|COMPLETED|Overall Study||0
10348398|NCT00424632|11486504|FG009|COMPLETED|Overall Study||0
10348399|NCT00424632|11486495|FG000|NOT COMPLETED|Overall Study||1
10348400|NCT00424632|11486496|FG001|NOT COMPLETED|Overall Study||1
10348401|NCT00424632|11486497|FG002|NOT COMPLETED|Overall Study||1
10348402|NCT00424632|11486498|FG003|NOT COMPLETED|Overall Study||4
10348403|NCT00424632|11486499|FG004|NOT COMPLETED|Overall Study||3
10348404|NCT00424632|11486500|FG005|NOT COMPLETED|Overall Study||15
10348405|NCT00424632|11486501|FG006|NOT COMPLETED|Overall Study||7
10348406|NCT00424632|11486502|FG007|NOT COMPLETED|Overall Study||3
10348407|NCT00424632|11486503|FG008|NOT COMPLETED|Overall Study||16
10348408|NCT00424632|11486504|FG009|NOT COMPLETED|Overall Study||6
10348409|NCT00424749|11486535|FG000|STARTED|Overall Study||4
10348410|NCT00424749|11486535|FG000|COMPLETED|Overall Study||3
10348411|NCT00424749|11486535|FG000|NOT COMPLETED|Overall Study||1
10348412|NCT00424762|11486541|FG000|STARTED|Overall Study||74
10348413|NCT00424762|11486542|FG001|STARTED|Overall Study||76
10348414|NCT00424762|11486541|FG000|COMPLETED|Overall Study||54
10348415|NCT00424762|11486542|FG001|COMPLETED|Overall Study||54
10348416|NCT00424762|11486541|FG000|NOT COMPLETED|Overall Study||20
10348417|NCT00424762|11486542|FG001|NOT COMPLETED|Overall Study||22
10348418|NCT00424775|11486548|FG000|STARTED|Overall Study||3
10348419|NCT00424775|11486549|FG001|STARTED|Overall Study||0
10348420|NCT00424775|11486548|FG000|COMPLETED|Overall Study||0
10348421|NCT00424775|11486549|FG001|COMPLETED|Overall Study||0
10348422|NCT00424775|11486548|FG000|NOT COMPLETED|Overall Study||3
10348423|NCT00424775|11486549|FG001|NOT COMPLETED|Overall Study||0
10348424|NCT00424827|11486553|FG000|STARTED|Overall Study||11
10348425|NCT00424827|11486553|FG000|COMPLETED|Overall Study||10
10348426|NCT00424827|11486553|FG000|NOT COMPLETED|Overall Study||1
10348427|NCT00424840|11486558|FG000|STARTED|Overall Study||3
10348428|NCT00424840|11486559|FG001|STARTED|Overall Study||4
10348429|NCT00424840|11486560|FG002|STARTED|Overall Study||5
10348430|NCT00424840|11486558|FG000|COMPLETED|Overall Study||3
10348431|NCT00424840|11486559|FG001|COMPLETED|Overall Study||4
10348432|NCT00424840|11486560|FG002|COMPLETED|Overall Study||5
10348433|NCT00424840|11486558|FG000|NOT COMPLETED|Overall Study||0
10348434|NCT00424840|11486559|FG001|NOT COMPLETED|Overall Study||0
10348435|NCT00424840|11486560|FG002|NOT COMPLETED|Overall Study||0
10348436|NCT00425061|11486573|FG000|STARTED|Overall Study||16
10348437|NCT00425061|11486574|FG001|STARTED|Overall Study||17
10348438|NCT00425061|11486575|FG002|STARTED|Overall Study||16
10348439|NCT00425061|11486576|FG003|STARTED|Overall Study||16
10348440|NCT00425061|11486577|FG004|STARTED|Overall Study||45
10348441|NCT00425061|11486578|FG005|STARTED|Overall Study||4
10348442|NCT00425061|11486579|FG006|STARTED|Overall Study||45
10348443|NCT00425061|11486573|FG000|COMPLETED|Overall Study||14
10348444|NCT00425061|11486574|FG001|COMPLETED|Overall Study||15
10348445|NCT00425061|11486575|FG002|COMPLETED|Overall Study||16
10348446|NCT00425061|11486576|FG003|COMPLETED|Overall Study||14
10348447|NCT00425061|11486577|FG004|COMPLETED|Overall Study||19
10348448|NCT00425061|11486578|FG005|COMPLETED|Overall Study||0
10348449|NCT00425061|11486579|FG006|COMPLETED|Overall Study||26
10348450|NCT00425061|11486573|FG000|NOT COMPLETED|Overall Study||2
10348451|NCT00425061|11486574|FG001|NOT COMPLETED|Overall Study||2
10348452|NCT00425061|11486575|FG002|NOT COMPLETED|Overall Study||0
10348453|NCT00425061|11486576|FG003|NOT COMPLETED|Overall Study||2
10348454|NCT00425061|11486577|FG004|NOT COMPLETED|Overall Study||26
10348455|NCT00425061|11486578|FG005|NOT COMPLETED|Overall Study||4
10348456|NCT00425061|11486579|FG006|NOT COMPLETED|Overall Study||19
10348457|NCT00425113|11486599|FG000|STARTED|Overall Study||17
10348458|NCT00425113|11486600|FG001|STARTED|Overall Study||18
10348459|NCT00425113|11486599|FG000|Exposed to Study Drug|Overall Study||16
10348460|NCT00425113|11486600|FG001|Exposed to Study Drug|Overall Study||17
10348461|NCT00425113|11486599|FG000|COMPLETED|Overall Study|Included in modified intent-to-treat analysis|15
10348462|NCT00425113|11486600|FG001|COMPLETED|Overall Study|Included in modified intent-to-treat analysis|16
10348463|NCT00425113|11486599|FG000|NOT COMPLETED|Overall Study||2
10348464|NCT00425113|11486600|FG001|NOT COMPLETED|Overall Study||2
10348465|NCT00425269|11486609|FG000|STARTED|Overall Study||101
10348466|NCT00425269|11486610|FG001|STARTED|Overall Study||97
10348467|NCT00425269|11486609|FG000|COMPLETED|Overall Study||82
10348468|NCT00425269|11486610|FG001|COMPLETED|Overall Study||77
10348469|NCT00425269|11486609|FG000|NOT COMPLETED|Overall Study||19
10348470|NCT00425269|11486610|FG001|NOT COMPLETED|Overall Study||20
10348471|NCT00425308|11486618|FG000|STARTED|Overall Study||15
10348472|NCT00425308|11486619|FG001|STARTED|Overall Study||15
10348473|NCT00425308|11486618|FG000|COMPLETED|Overall Study||11
10348474|NCT00425308|11486619|FG001|COMPLETED|Overall Study||14
10348475|NCT00425308|11486618|FG000|NOT COMPLETED|Overall Study||4
10348476|NCT00425308|11486619|FG001|NOT COMPLETED|Overall Study||1
10348477|NCT00425373|11486634|FG000|STARTED|Overall Study||159
10348478|NCT00425373|11486635|FG001|STARTED|Overall Study||167
10348479|NCT00425373|11486636|FG002|STARTED|Overall Study||160
10348480|NCT00425373|11486637|FG003|STARTED|Overall Study||162
10348481|NCT00425373|11486638|FG004|STARTED|Overall Study||169
10348482|NCT00425373|11486639|FG005|STARTED|Overall Study||163
10348483|NCT00425373|11486640|FG006|STARTED|Overall Study||161
10348484|NCT00425373|11486641|FG007|STARTED|Overall Study||161
10348485|NCT00425373|11486642|FG008|STARTED|Overall Study||166
10348486|NCT00425373|11486634|FG000|COMPLETED|Overall Study||154
10348487|NCT00425373|11486635|FG001|COMPLETED|Overall Study||164
10348488|NCT00425373|11486636|FG002|COMPLETED|Overall Study||157
10348489|NCT00425373|11486637|FG003|COMPLETED|Overall Study||160
10348490|NCT00425373|11486638|FG004|COMPLETED|Overall Study||159
10348491|NCT00425373|11486639|FG005|COMPLETED|Overall Study||154
10348492|NCT00425373|11486640|FG006|COMPLETED|Overall Study||154
10532666|NCT01422200|11685078|FG000|COMPLETED|Overall Study||11
10532667|NCT01422200|11685079|FG001|COMPLETED|Overall Study||11
10532668|NCT01422200|11685078|FG000|NOT COMPLETED|Overall Study||0
10532669|NCT01422200|11685079|FG001|NOT COMPLETED|Overall Study||0
10532670|NCT01422213|11685090|FG000|STARTED|Overall Study||196
10532671|NCT01422213|11685091|FG001|STARTED|Overall Study||195
10532672|NCT01422213|11685092|FG002|STARTED|Overall Study||207
10532673|NCT01422213|11685090|FG000|COMPLETED|Overall Study||163
10532674|NCT01422213|11685091|FG001|COMPLETED|Overall Study||173
10532675|NCT01422213|11685092|FG002|COMPLETED|Overall Study||178
10532676|NCT01422213|11685090|FG000|NOT COMPLETED|Overall Study||33
10532677|NCT01422213|11685091|FG001|NOT COMPLETED|Overall Study||22
10348493|NCT00425373|11486641|FG007|COMPLETED|Overall Study||151
10348494|NCT00425373|11486642|FG008|COMPLETED|Overall Study||148
10532678|NCT01422213|11685092|FG002|NOT COMPLETED|Overall Study||29
10532679|NCT01422226|11685102|FG000|STARTED|Overall Study||1
10532680|NCT01422226|11685103|FG001|STARTED|Overall Study||2
10532681|NCT01422226|11685102|FG000|COMPLETED|Overall Study||1
10532682|NCT01422226|11685103|FG001|COMPLETED|Overall Study||2
10532683|NCT01422226|11685102|FG000|NOT COMPLETED|Overall Study||0
10532684|NCT01422226|11685103|FG001|NOT COMPLETED|Overall Study||0
10547902|NCT01515566|11701691|FG000|NOT COMPLETED|Overall Study||0
10547903|NCT01515566|11701692|FG001|NOT COMPLETED|Overall Study||0
10547904|NCT01515657|11701698|FG000|STARTED|First Intervention||14
10547905|NCT01515657|11701699|FG001|STARTED|First Intervention||13
10547906|NCT01515657|11701700|FG002|STARTED|First Intervention||13
10547907|NCT01515657|11701698|FG000|COMPLETED|First Intervention||14
10547908|NCT01515657|11701699|FG001|COMPLETED|First Intervention||12
10547909|NCT01515657|11701700|FG002|COMPLETED|First Intervention||13
10547910|NCT01515657|11701698|FG000|NOT COMPLETED|First Intervention||0
10547911|NCT01515657|11701699|FG001|NOT COMPLETED|First Intervention||1
10547912|NCT01515657|11701700|FG002|NOT COMPLETED|First Intervention||0
10547913|NCT01515657|11701698|FG000|STARTED|Second Intervention||14
10547914|NCT01515657|11701699|FG001|STARTED|Second Intervention||12
10547915|NCT01515657|11701700|FG002|STARTED|Second Intervention||13
10547916|NCT01515657|11701698|FG000|COMPLETED|Second Intervention||14
10547917|NCT01515657|11701699|FG001|COMPLETED|Second Intervention||11
10547918|NCT01515657|11701700|FG002|COMPLETED|Second Intervention||13
10547919|NCT01515657|11701698|FG000|NOT COMPLETED|Second Intervention||0
10547920|NCT01515657|11701699|FG001|NOT COMPLETED|Second Intervention||1
10547921|NCT01515657|11701700|FG002|NOT COMPLETED|Second Intervention||0
10547922|NCT01515657|11701698|FG000|STARTED|Third Intervention||14
10547923|NCT01515657|11701699|FG001|STARTED|Third Intervention||11
10547924|NCT01515657|11701700|FG002|STARTED|Third Intervention||13
10547925|NCT01515657|11701698|FG000|COMPLETED|Third Intervention||13
10547926|NCT01515657|11701699|FG001|COMPLETED|Third Intervention||11
10547927|NCT01515657|11701700|FG002|COMPLETED|Third Intervention||13
10348495|NCT00425373|11486634|FG000|NOT COMPLETED|Overall Study||5
10348496|NCT00425373|11486635|FG001|NOT COMPLETED|Overall Study||3
10348497|NCT00425373|11486636|FG002|NOT COMPLETED|Overall Study||3
10348498|NCT00425373|11486637|FG003|NOT COMPLETED|Overall Study||2
10348499|NCT00425373|11486638|FG004|NOT COMPLETED|Overall Study||10
10348500|NCT00425373|11486639|FG005|NOT COMPLETED|Overall Study||9
10348501|NCT00425373|11486640|FG006|NOT COMPLETED|Overall Study||7
10348502|NCT00425373|11486641|FG007|NOT COMPLETED|Overall Study||10
10348503|NCT00425373|11486642|FG008|NOT COMPLETED|Overall Study||18
10348504|NCT00425386|11486662|FG000|STARTED|Overall Study||46
10348505|NCT00425386|11486662|FG000|COMPLETED|Overall Study||43
10348506|NCT00425386|11486662|FG000|NOT COMPLETED|Overall Study||3
10348507|NCT00425477|11486666|FG000|STARTED|Overall Study||26
10348508|NCT00425477|11486666|FG000|COMPLETED|Overall Study||13
10348509|NCT00425477|11486666|FG000|NOT COMPLETED|Overall Study||13
10348510|NCT00425503|11486670|FG000|STARTED|Overall Study||40
10348511|NCT00425503|11486670|FG000|COMPLETED|Overall Study||37
10348512|NCT00425503|11486670|FG000|NOT COMPLETED|Overall Study||3
10348513|NCT00425555|11486676|FG000|STARTED|Overall Study||79
10348514|NCT00425555|11486677|FG001|STARTED|Overall Study||60
10348515|NCT00425555|11486676|FG000|COMPLETED|Overall Study||0
10348516|NCT00425555|11486677|FG001|COMPLETED|Overall Study||0
10348517|NCT00425555|11486676|FG000|NOT COMPLETED|Overall Study||79
10348518|NCT00425555|11486677|FG001|NOT COMPLETED|Overall Study||60
10348519|NCT00425607|11486686|FG000|STARTED|Overall Study||29
10348520|NCT00425607|11486686|FG000|Received Treatment|Overall Study||28
10348521|NCT00425607|11486686|FG000|COMPLETED|Overall Study||27
10348522|NCT00425607|11486686|FG000|NOT COMPLETED|Overall Study||2
10348523|NCT00425672|11486690|FG000|STARTED|Overall Study||15
10348524|NCT00425672|11486690|FG000|COMPLETED|Overall Study||14
10348525|NCT00425672|11486690|FG000|NOT COMPLETED|Overall Study||1
10348526|NCT00425698|11486696|FG000|STARTED|Overall Study||44
10348527|NCT00425698|11486697|FG001|STARTED|Overall Study||44
10348528|NCT00425698|11486696|FG000|COMPLETED|Overall Study||41
10348529|NCT00425698|11486697|FG001|COMPLETED|Overall Study||42
10348530|NCT00425698|11486696|FG000|NOT COMPLETED|Overall Study||3
10348531|NCT00425698|11486697|FG001|NOT COMPLETED|Overall Study||2
10348532|NCT00425750|11486703|FG000|STARTED|Overall Study||25
10348533|NCT00425750|11486703|FG000|COMPLETED|Overall Study||0
10348534|NCT00425750|11486703|FG000|NOT COMPLETED|Overall Study||25
10348535|NCT00425802|11486707|FG000|STARTED|Overall Study||61
10348536|NCT00425802|11486707|FG000|COMPLETED|Overall Study||61
10348537|NCT00425802|11486707|FG000|NOT COMPLETED|Overall Study||0
10348538|NCT00425854|11486713|FG000|STARTED|Overall Study|Treated|29
10348539|NCT00425854|11486714|FG001|STARTED|Overall Study|Treated|21
10348540|NCT00425854|11486713|FG000|COMPLETED|Overall Study|On treatment at analysis cut-off date (30 Sep 2009)|0
10348541|NCT00425854|11486714|FG001|COMPLETED|Overall Study|On treatment at analysis cut-off date (30 Sep 2009)|0
10348542|NCT00425854|11486713|FG000|NOT COMPLETED|Overall Study||29
10348543|NCT00425854|11486714|FG001|NOT COMPLETED|Overall Study||21
10348544|NCT00425945|11486723|FG000|STARTED|Overall Study||64
10348545|NCT00425945|11486724|FG001|STARTED|Overall Study||66
10348546|NCT00425945|11486723|FG000|COMPLETED|Overall Study||60
10348547|NCT00425945|11486724|FG001|COMPLETED|Overall Study||61
10348548|NCT00425945|11486723|FG000|NOT COMPLETED|Overall Study||4
10348549|NCT00425945|11486724|FG001|NOT COMPLETED|Overall Study||5
10348550|NCT00426127|11486732|FG000|STARTED|Overall Study||2
10348551|NCT00426127|11486732|FG000|COMPLETED|Overall Study||0
10348552|NCT00426127|11486732|FG000|NOT COMPLETED|Overall Study||2
10348553|NCT00426153|11486738|FG000|STARTED|Overall Study|Participants were randomized in a 2:1 ratio, Octreotide LAR depot: Placebo|28
10348554|NCT00426153|11486739|FG001|STARTED|Overall Study||14
10348555|NCT00426153|11486738|FG000|COMPLETED|Overall Study||28
10348556|NCT00426153|11486739|FG001|COMPLETED|Overall Study||14
10348557|NCT00426153|11486738|FG000|NOT COMPLETED|Overall Study||0
10348558|NCT00426153|11486739|FG001|NOT COMPLETED|Overall Study||0
10348559|NCT00426231|11486747|FG000|STARTED|Overall Study||36
10348560|NCT00426231|11486748|FG001|STARTED|Overall Study||37
10348561|NCT00426231|11486747|FG000|COMPLETED|Overall Study|For the 6 month endpoint|27
10348562|NCT00426231|11486748|FG001|COMPLETED|Overall Study|For the 6-month endpoint|25
10348563|NCT00426231|11486747|FG000|NOT COMPLETED|Overall Study||9
10348564|NCT00426231|11486748|FG001|NOT COMPLETED|Overall Study||12
10348565|NCT00426270|11486754|FG000|STARTED|Overall Study||116
10348566|NCT00426270|11486754|FG000|COMPLETED|Overall Study||110
10348567|NCT00426270|11486754|FG000|NOT COMPLETED|Overall Study||6
10348568|NCT00426283|11486760|FG000|STARTED|Overall Study||28
10348569|NCT00426283|11486761|FG001|STARTED|Overall Study||14
10348570|NCT00426283|11486760|FG000|COMPLETED|Overall Study||23
10348571|NCT00426283|11486761|FG001|COMPLETED|Overall Study||13
10348572|NCT00426283|11486760|FG000|NOT COMPLETED|Overall Study||5
10348573|NCT00426283|11486761|FG001|NOT COMPLETED|Overall Study||1
10348574|NCT00426361|11486774|FG000|STARTED|Overall Study||248
10348575|NCT00426361|11486775|FG001|STARTED|Overall Study||255
10348576|NCT00426361|11486776|FG002|STARTED|Overall Study||248
10348577|NCT00426361|11486774|FG000|COMPLETED|Overall Study||244
10348578|NCT00426361|11486775|FG001|COMPLETED|Overall Study||250
10348579|NCT00426361|11486776|FG002|COMPLETED|Overall Study||243
10348580|NCT00426361|11486774|FG000|NOT COMPLETED|Overall Study||4
10348581|NCT00426361|11486775|FG001|NOT COMPLETED|Overall Study||5
10348582|NCT00426361|11486776|FG002|NOT COMPLETED|Overall Study||5
10348583|NCT00426517|11486788|FG000|STARTED|Overall Study||7
10348584|NCT00426517|11486789|FG001|STARTED|Overall Study||36
10348585|NCT00426517|11486790|FG002|STARTED|Overall Study||3
10348586|NCT00426517|11486791|FG003|STARTED|Overall Study||2
10348587|NCT00426517|11486788|FG000|COMPLETED|Overall Study||7
10348588|NCT00426517|11486789|FG001|COMPLETED|Overall Study||36
10348589|NCT00426517|11486790|FG002|COMPLETED|Overall Study||3
10348590|NCT00426517|11486791|FG003|COMPLETED|Overall Study||2
10348591|NCT00426517|11486788|FG000|NOT COMPLETED|Overall Study||0
10348592|NCT00426517|11486789|FG001|NOT COMPLETED|Overall Study||0
10348593|NCT00426517|11486790|FG002|NOT COMPLETED|Overall Study||0
10348594|NCT00426517|11486791|FG003|NOT COMPLETED|Overall Study||0
10348595|NCT00426556|11486805|FG000|STARTED|Phase I - Core Phase||6
10348596|NCT00426556|11486806|FG001|STARTED|Phase I - Core Phase||17
10348597|NCT00426556|11486807|FG002|STARTED|Phase I - Core Phase||10
10348598|NCT00426556|11486808|FG003|STARTED|Phase I - Core Phase||0
10348599|NCT00426556|11486805|FG000|COMPLETED|Phase I - Core Phase||5
10348600|NCT00426556|11486806|FG001|COMPLETED|Phase I - Core Phase||7
10348601|NCT00426556|11486807|FG002|COMPLETED|Phase I - Core Phase||7
10348602|NCT00426556|11486808|FG003|COMPLETED|Phase I - Core Phase||0
10348603|NCT00426556|11486805|FG000|NOT COMPLETED|Phase I - Core Phase||1
10348604|NCT00426556|11486806|FG001|NOT COMPLETED|Phase I - Core Phase||10
10348605|NCT00426556|11486807|FG002|NOT COMPLETED|Phase I - Core Phase||3
10348606|NCT00426556|11486808|FG003|NOT COMPLETED|Phase I - Core Phase||0
10348607|NCT00426556|11486805|FG000|STARTED|Phase I - Extension Phase||5
10348608|NCT00426556|11486806|FG001|STARTED|Phase I - Extension Phase||7
10348609|NCT00426556|11486807|FG002|STARTED|Phase I - Extension Phase||7
10348610|NCT00426556|11486808|FG003|STARTED|Phase I - Extension Phase||0
10348611|NCT00426556|11486805|FG000|COMPLETED|Phase I - Extension Phase||0
10348612|NCT00426556|11486806|FG001|COMPLETED|Phase I - Extension Phase||1
10348613|NCT00426556|11486807|FG002|COMPLETED|Phase I - Extension Phase||0
10348614|NCT00426556|11486808|FG003|COMPLETED|Phase I - Extension Phase||0
10348615|NCT00426556|11486805|FG000|NOT COMPLETED|Phase I - Extension Phase||5
10348616|NCT00426556|11486806|FG001|NOT COMPLETED|Phase I - Extension Phase||6
10348617|NCT00426556|11486807|FG002|NOT COMPLETED|Phase I - Extension Phase||7
10348618|NCT00426556|11486808|FG003|NOT COMPLETED|Phase I - Extension Phase||0
10348619|NCT00426556|11486805|FG000|STARTED|Phase II - Core Phase||0
10348620|NCT00426556|11486806|FG001|STARTED|Phase II - Core Phase||0
10348621|NCT00426556|11486807|FG002|STARTED|Phase II - Core Phase||0
10348622|NCT00426556|11486808|FG003|STARTED|Phase II - Core Phase||55
10348623|NCT00426556|11486805|FG000|COMPLETED|Phase II - Core Phase||0
10348624|NCT00426556|11486806|FG001|COMPLETED|Phase II - Core Phase||0
10348625|NCT00426556|11486807|FG002|COMPLETED|Phase II - Core Phase||0
10348626|NCT00426556|11486808|FG003|COMPLETED|Phase II - Core Phase||28
10348627|NCT00426556|11486805|FG000|NOT COMPLETED|Phase II - Core Phase||0
10348628|NCT00426556|11486806|FG001|NOT COMPLETED|Phase II - Core Phase||0
10348629|NCT00426556|11486807|FG002|NOT COMPLETED|Phase II - Core Phase||0
10348630|NCT00426556|11486808|FG003|NOT COMPLETED|Phase II - Core Phase||27
10348631|NCT00426556|11486805|FG000|STARTED|Phase II - Extension Phase||0
10348632|NCT00426556|11486806|FG001|STARTED|Phase II - Extension Phase||0
10348633|NCT00426556|11486807|FG002|STARTED|Phase II - Extension Phase||0
10348634|NCT00426556|11486808|FG003|STARTED|Phase II - Extension Phase|4 patients did not enter the Extension phase.|24
10348635|NCT00426556|11486805|FG000|COMPLETED|Phase II - Extension Phase||0
10348636|NCT00426556|11486806|FG001|COMPLETED|Phase II - Extension Phase||0
10348637|NCT00426556|11486807|FG002|COMPLETED|Phase II - Extension Phase||0
10348638|NCT00426556|11486808|FG003|COMPLETED|Phase II - Extension Phase|Completed means 'Ongoing'|1
10348639|NCT00426556|11486805|FG000|NOT COMPLETED|Phase II - Extension Phase||0
10348640|NCT00426556|11486806|FG001|NOT COMPLETED|Phase II - Extension Phase||0
10348641|NCT00426556|11486807|FG002|NOT COMPLETED|Phase II - Extension Phase||0
10348642|NCT00426556|11486808|FG003|NOT COMPLETED|Phase II - Extension Phase||23
10348643|NCT00426660|11486818|FG000|STARTED|Overall Study||1047
10348644|NCT00426660|11486818|FG000|Treated|Overall Study||1032
10348645|NCT00426660|11486818|FG000|Safety Analysis Set|Overall Study||1032
10348646|NCT00426660|11486818|FG000|COMPLETED|Overall Study||916
10348647|NCT00426660|11486818|FG000|NOT COMPLETED|Overall Study||131
10348648|NCT00426751|11486824|FG000|STARTED|Overall Study||226
10348649|NCT00426751|11486825|FG001|STARTED|Overall Study||203
10348650|NCT00426751|11486824|FG000|COMPLETED|Overall Study||204
10348651|NCT00426751|11486825|FG001|COMPLETED|Overall Study||183
10348652|NCT00426751|11486824|FG000|NOT COMPLETED|Overall Study||22
10348653|NCT00426751|11486825|FG001|NOT COMPLETED|Overall Study||20
10348654|NCT00426764|11486831|FG000|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|131
10348655|NCT00426764|11486831|FG000|Discontinued Prior to or During Cycle 6|Overall Study||98
10348656|NCT00426764|11486831|FG000|Discontinued at End of or After Cycle 6|Overall Study||33
10348657|NCT00426764|11486831|FG000|COMPLETED|Overall Study||0
10348658|NCT00426764|11486831|FG000|NOT COMPLETED|Overall Study||131
10348659|NCT00426842|11486841|FG000|STARTED|Overall Study||11
10348660|NCT00426842|11486841|FG000|COMPLETED|Overall Study||10
10348661|NCT00426842|11486841|FG000|NOT COMPLETED|Overall Study||1
10348662|NCT00426855|11486847|FG000|STARTED|Overall Study||12
10348663|NCT00426855|11486847|FG000|COMPLETED|Overall Study||12
10348664|NCT00426855|11486847|FG000|NOT COMPLETED|Overall Study||0
10348665|NCT00427011|11486851|FG000|STARTED|Overall Study||25
10348666|NCT00427011|11486851|FG000|COMPLETED|Overall Study||0
10348667|NCT00427011|11486851|FG000|NOT COMPLETED|Overall Study||25
10348668|NCT00427037|11486858|FG000|STARTED|Overall Study||17
10348669|NCT00427037|11486859|FG001|STARTED|Overall Study||17
10348670|NCT00427037|11486858|FG000|COMPLETED|Overall Study||10
10348671|NCT00427037|11486859|FG001|COMPLETED|Overall Study||10
10348672|NCT00427037|11486858|FG000|NOT COMPLETED|Overall Study||7
10348673|NCT00427037|11486859|FG001|NOT COMPLETED|Overall Study||7
10348674|NCT00427297|11486869|FG000|STARTED|Overall Study||17
10348675|NCT00427297|11486870|FG001|STARTED|Overall Study||17
10348676|NCT00427297|11486869|FG000|COMPLETED|Overall Study||17
10348677|NCT00427297|11486870|FG001|COMPLETED|Overall Study||17
10348678|NCT00427297|11486869|FG000|NOT COMPLETED|Overall Study||0
10348679|NCT00427297|11486870|FG001|NOT COMPLETED|Overall Study||0
10348680|NCT00427336|11486876|FG000|STARTED|Overall Study||9
10348681|NCT00427336|11486876|FG000|COMPLETED|Overall Study||9
10348682|NCT00427336|11486876|FG000|NOT COMPLETED|Overall Study||0
10348683|NCT00427349|11486880|FG000|STARTED|Overall Study||46
10348684|NCT00427349|11486880|FG000|Eligible|Overall Study||45
10348685|NCT00427349|11486880|FG000|Treated|Overall Study||45
10348686|NCT00427349|11486880|FG000|Eligible and Treated|Overall Study||44
10348687|NCT00427349|11486880|FG000|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity|0
10348688|NCT00427349|11486880|FG000|NOT COMPLETED|Overall Study||46
10348689|NCT00427557|11486884|FG000|STARTED|Overall Study||30
10348690|NCT00427557|11486884|FG000|COMPLETED|Overall Study||30
10348691|NCT00427557|11486884|FG000|NOT COMPLETED|Overall Study||0
10348692|NCT00427635|11486890|FG000|STARTED|Treatment Phase|Randomised|26
10348693|NCT00427635|11486891|FG001|STARTED|Treatment Phase|Randomised|26
10348694|NCT00427635|11486890|FG000|COMPLETED|Treatment Phase|ITT population. One voluntary discontinuation by parent/guardian|25
10348695|NCT00427635|11486891|FG001|COMPLETED|Treatment Phase|ITT population|26
10348696|NCT00427635|11486890|FG000|NOT COMPLETED|Treatment Phase||1
10348697|NCT00427635|11486891|FG001|NOT COMPLETED|Treatment Phase||0
10348698|NCT00427635|11486890|FG000|STARTED|Study Completion to Safety Follow-up||25
10348699|NCT00427635|11486891|FG001|STARTED|Study Completion to Safety Follow-up||26
10348700|NCT00427635|11486890|FG000|COMPLETED|Study Completion to Safety Follow-up||25
10348701|NCT00427635|11486891|FG001|COMPLETED|Study Completion to Safety Follow-up|One participant lost to follow-up|25
10348702|NCT00427635|11486890|FG000|NOT COMPLETED|Study Completion to Safety Follow-up||0
10348703|NCT00427635|11486891|FG001|NOT COMPLETED|Study Completion to Safety Follow-up||1
10348704|NCT00427648|11486899|FG000|STARTED|Overall Study||12
10348705|NCT00427648|11486900|FG001|STARTED|Overall Study||10
10348706|NCT00427648|11486899|FG000|COMPLETED|Overall Study||11
10348707|NCT00427648|11486900|FG001|COMPLETED|Overall Study||7
10348708|NCT00427648|11486899|FG000|NOT COMPLETED|Overall Study||1
10348709|NCT00427648|11486900|FG001|NOT COMPLETED|Overall Study||3
10348710|NCT00427661|11486908|FG000|STARTED|Overall Study||8
10348711|NCT00427661|11486908|FG000|COMPLETED|Overall Study||8
10348712|NCT00427661|11486908|FG000|NOT COMPLETED|Overall Study||0
10348713|NCT00427700|11486915|FG000|STARTED|Overall Study||40
10348714|NCT00427700|11486916|FG001|STARTED|Overall Study||42
10348715|NCT00427700|11486915|FG000|COMPLETED|Overall Study||37
10348716|NCT00427700|11486916|FG001|COMPLETED|Overall Study||31
10348717|NCT00427700|11486915|FG000|NOT COMPLETED|Overall Study||3
10348718|NCT00427700|11486916|FG001|NOT COMPLETED|Overall Study||11
10348719|NCT00427765|11486923|FG000|STARTED|Overall Study||164
10348720|NCT00427765|11486923|FG000|COMPLETED|Overall Study||164
10348721|NCT00427765|11486923|FG000|NOT COMPLETED|Overall Study||0
10348722|NCT00427778|11486927|FG000|STARTED|First Intervention (4 Weeks)||14
10348723|NCT00427778|11486928|FG001|STARTED|First Intervention (4 Weeks)||15
10348724|NCT00427778|11486927|FG000|COMPLETED|First Intervention (4 Weeks)||10
10348725|NCT00427778|11486928|FG001|COMPLETED|First Intervention (4 Weeks)||14
10348726|NCT00427778|11486927|FG000|NOT COMPLETED|First Intervention (4 Weeks)||4
10348727|NCT00427778|11486928|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1
10348728|NCT00427778|11486927|FG000|STARTED|Wash Out (2 Weeks)||10
10348729|NCT00427778|11486928|FG001|STARTED|Wash Out (2 Weeks)||14
10348730|NCT00427778|11486927|FG000|COMPLETED|Wash Out (2 Weeks)||10
10348731|NCT00427778|11486928|FG001|COMPLETED|Wash Out (2 Weeks)||14
10348732|NCT00427778|11486927|FG000|NOT COMPLETED|Wash Out (2 Weeks)||0
10348733|NCT00427778|11486928|FG001|NOT COMPLETED|Wash Out (2 Weeks)||0
10348734|NCT00427778|11486927|FG000|STARTED|Second Intervention (4 Weeks)||10
10348735|NCT00427778|11486928|FG001|STARTED|Second Intervention (4 Weeks)||14
10348736|NCT00427778|11486927|FG000|COMPLETED|Second Intervention (4 Weeks)||10
10348737|NCT00427778|11486928|FG001|COMPLETED|Second Intervention (4 Weeks)||14
10348738|NCT00427778|11486927|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
10348739|NCT00427778|11486928|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
10348740|NCT00427791|11486949|FG000|STARTED|Overall Study||10
10348741|NCT00427791|11486950|FG001|STARTED|Overall Study||13
10348742|NCT00427791|11486949|FG000|COMPLETED|Overall Study||10
10348743|NCT00427791|11486950|FG001|COMPLETED|Overall Study||13
10348744|NCT00427791|11486949|FG000|NOT COMPLETED|Overall Study||0
10348745|NCT00427791|11486950|FG001|NOT COMPLETED|Overall Study||0
10348746|NCT00427804|11486958|FG000|STARTED|Overall Study||4
10348747|NCT00427804|11486959|FG001|STARTED|Overall Study||5
10348748|NCT00427804|11486958|FG000|COMPLETED|Overall Study||4
10348749|NCT00427804|11486959|FG001|COMPLETED|Overall Study||5
10348750|NCT00427804|11486958|FG000|NOT COMPLETED|Overall Study||0
10348751|NCT00427804|11486959|FG001|NOT COMPLETED|Overall Study||0
10348752|NCT00427895|11486969|FG000|STARTED|Between 6-Month Follow-up - Year 1||411
10348753|NCT00427895|11486970|FG001|STARTED|Between 6-Month Follow-up - Year 1||411
10348754|NCT00427895|11486971|FG002|STARTED|Between 6-Month Follow-up - Year 1||392
10348755|NCT00427895|11486972|FG003|STARTED|Between 6-Month Follow-up - Year 1||854
10348756|NCT00427895|11486973|FG004|STARTED|Between 6-Month Follow-up - Year 1||0
10348757|NCT00427895|11486974|FG005|STARTED|Between 6-Month Follow-up - Year 1||0
10348758|NCT00427895|11486975|FG006|STARTED|Between 6-Month Follow-up - Year 1||0
10348759|NCT00427895|11486976|FG007|STARTED|Between 6-Month Follow-up - Year 1||0
10348760|NCT00427895|11486969|FG000|COMPLETED|Between 6-Month Follow-up - Year 1||411
10348761|NCT00427895|11486970|FG001|COMPLETED|Between 6-Month Follow-up - Year 1||411
10348762|NCT00427895|11486971|FG002|COMPLETED|Between 6-Month Follow-up - Year 1||392
10348763|NCT00427895|11486972|FG003|COMPLETED|Between 6-Month Follow-up - Year 1||502
10348764|NCT00427895|11486973|FG004|COMPLETED|Between 6-Month Follow-up - Year 1||0
10348765|NCT00427895|11486974|FG005|COMPLETED|Between 6-Month Follow-up - Year 1||0
10348766|NCT00427895|11486975|FG006|COMPLETED|Between 6-Month Follow-up - Year 1||0
10348767|NCT00427895|11486976|FG007|COMPLETED|Between 6-Month Follow-up - Year 1||0
10348768|NCT00427895|11486969|FG000|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
10348769|NCT00427895|11486970|FG001|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
10426736|NCT00848718|11572430|FG010|Treated|Overall Study||4
10348770|NCT00427895|11486971|FG002|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
10348771|NCT00427895|11486972|FG003|NOT COMPLETED|Between 6-Month Follow-up - Year 1||352
10348772|NCT00427895|11486973|FG004|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
10348773|NCT00427895|11486974|FG005|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
10348774|NCT00427895|11486975|FG006|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
10348775|NCT00427895|11486976|FG007|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
10348776|NCT00427895|11486969|FG000|STARTED|Vax 2/Year 3 to 4||0
10348777|NCT00427895|11486970|FG001|STARTED|Vax 2/Year 3 to 4||0
10348778|NCT00427895|11486971|FG002|STARTED|Vax 2/Year 3 to 4||0
10348779|NCT00427895|11486972|FG003|STARTED|Vax 2/Year 3 to 4||0
10348780|NCT00427895|11486973|FG004|STARTED|Vax 2/Year 3 to 4||108
10348781|NCT00427895|11486974|FG005|STARTED|Vax 2/Year 3 to 4||108
10348782|NCT00427895|11486975|FG006|STARTED|Vax 2/Year 3 to 4||189
10348783|NCT00427895|11486976|FG007|STARTED|Vax 2/Year 3 to 4||214
10348784|NCT00427895|11486969|FG000|COMPLETED|Vax 2/Year 3 to 4||0
10348785|NCT00427895|11486970|FG001|COMPLETED|Vax 2/Year 3 to 4||0
10348786|NCT00427895|11486971|FG002|COMPLETED|Vax 2/Year 3 to 4||0
10348787|NCT00427895|11486972|FG003|COMPLETED|Vax 2/Year 3 to 4||0
10348788|NCT00427895|11486973|FG004|COMPLETED|Vax 2/Year 3 to 4||107
10348789|NCT00427895|11486974|FG005|COMPLETED|Vax 2/Year 3 to 4||108
10348790|NCT00427895|11486975|FG006|COMPLETED|Vax 2/Year 3 to 4||189
10348791|NCT00427895|11486976|FG007|COMPLETED|Vax 2/Year 3 to 4||212
10348792|NCT00427895|11486969|FG000|NOT COMPLETED|Vax 2/Year 3 to 4||0
10348793|NCT00427895|11486970|FG001|NOT COMPLETED|Vax 2/Year 3 to 4||0
10348794|NCT00427895|11486971|FG002|NOT COMPLETED|Vax 2/Year 3 to 4||0
10348795|NCT00427895|11486972|FG003|NOT COMPLETED|Vax 2/Year 3 to 4||0
10348796|NCT00427895|11486973|FG004|NOT COMPLETED|Vax 2/Year 3 to 4||1
10348797|NCT00427895|11486974|FG005|NOT COMPLETED|Vax 2/Year 3 to 4||0
10348798|NCT00427895|11486975|FG006|NOT COMPLETED|Vax 2/Year 3 to 4||0
10348799|NCT00427895|11486976|FG007|NOT COMPLETED|Vax 2/Year 3 to 4||2
10348800|NCT00427895|11486969|FG000|STARTED|Vax 1 Baseline/6-Month Follow-up||418
10348801|NCT00427895|11486970|FG001|STARTED|Vax 1 Baseline/6-Month Follow-up||417
10348802|NCT00427895|11486971|FG002|STARTED|Vax 1 Baseline/6-Month Follow-up||406
10348803|NCT00427895|11486972|FG003|STARTED|Vax 1 Baseline/6-Month Follow-up||900
10715780|NCT02688387|11880051|FG008|STARTED|Part 3A, Period 3 (up to 6 Days)||0
10715781|NCT02688387|11880052|FG009|STARTED|Part 3A, Period 3 (up to 6 Days)||0
10715782|NCT02688387|11880053|FG010|STARTED|Part 3A, Period 3 (up to 6 Days)||0
10348804|NCT00427895|11486973|FG004|STARTED|Vax 1 Baseline/6-Month Follow-up||0
10348805|NCT00427895|11486974|FG005|STARTED|Vax 1 Baseline/6-Month Follow-up||0
10348806|NCT00427895|11486975|FG006|STARTED|Vax 1 Baseline/6-Month Follow-up||0
10348807|NCT00427895|11486976|FG007|STARTED|Vax 1 Baseline/6-Month Follow-up||0
10348808|NCT00427895|11486969|FG000|Vaccinated|Vax 1 Baseline/6-Month Follow-up||417
10348809|NCT00427895|11486970|FG001|Vaccinated|Vax 1 Baseline/6-Month Follow-up||414
10348810|NCT00427895|11486971|FG002|Vaccinated|Vax 1 Baseline/6-Month Follow-up||404
10348811|NCT00427895|11486972|FG003|Vaccinated|Vax 1 Baseline/6-Month Follow-up||899
10348812|NCT00427895|11486973|FG004|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
10348813|NCT00427895|11486974|FG005|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
10348814|NCT00427895|11486975|FG006|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
10348815|NCT00427895|11486976|FG007|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
10348816|NCT00427895|11486969|FG000|COMPLETED|Vax 1 Baseline/6-Month Follow-up||411
10348817|NCT00427895|11486970|FG001|COMPLETED|Vax 1 Baseline/6-Month Follow-up||411
10348818|NCT00427895|11486971|FG002|COMPLETED|Vax 1 Baseline/6-Month Follow-up||392
10348900|NCT00427908|11487019|FG000|NOT COMPLETED|Persistence Phase Year 1||0
10348819|NCT00427895|11486972|FG003|COMPLETED|Vax 1 Baseline/6-Month Follow-up||854
10348820|NCT00427895|11486973|FG004|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
10348821|NCT00427895|11486974|FG005|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
10348822|NCT00427895|11486975|FG006|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
10348823|NCT00427895|11486976|FG007|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
10348824|NCT00427895|11486969|FG000|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||7
10348825|NCT00427895|11486970|FG001|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||6
10348826|NCT00427895|11486971|FG002|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||14
10348827|NCT00427895|11486972|FG003|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||46
10348828|NCT00427895|11486973|FG004|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
10348829|NCT00427895|11486974|FG005|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
10348830|NCT00427895|11486975|FG006|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
10348831|NCT00427895|11486976|FG007|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
10348832|NCT00427895|11486969|FG000|STARTED|Vax 1/Year 1 Follow-up||411
10348833|NCT00427895|11486970|FG001|STARTED|Vax 1/Year 1 Follow-up||411
10348834|NCT00427895|11486971|FG002|STARTED|Vax 1/Year 1 Follow-up||392
10348835|NCT00427895|11486972|FG003|STARTED|Vax 1/Year 1 Follow-up||502
10348836|NCT00427895|11486973|FG004|STARTED|Vax 1/Year 1 Follow-up||0
10348837|NCT00427895|11486974|FG005|STARTED|Vax 1/Year 1 Follow-up||0
10348838|NCT00427895|11486975|FG006|STARTED|Vax 1/Year 1 Follow-up||0
10348839|NCT00427895|11486976|FG007|STARTED|Vax 1/Year 1 Follow-up||0
10348840|NCT00427895|11486969|FG000|COMPLETED|Vax 1/Year 1 Follow-up||404
10348841|NCT00427895|11486970|FG001|COMPLETED|Vax 1/Year 1 Follow-up||396
10348842|NCT00427895|11486971|FG002|COMPLETED|Vax 1/Year 1 Follow-up||373
10348843|NCT00427895|11486972|FG003|COMPLETED|Vax 1/Year 1 Follow-up||469
10348844|NCT00427895|11486973|FG004|COMPLETED|Vax 1/Year 1 Follow-up||0
10348845|NCT00427895|11486974|FG005|COMPLETED|Vax 1/Year 1 Follow-up||0
10348846|NCT00427895|11486975|FG006|COMPLETED|Vax 1/Year 1 Follow-up||0
10348847|NCT00427895|11486976|FG007|COMPLETED|Vax 1/Year 1 Follow-up||0
10348848|NCT00427895|11486969|FG000|NOT COMPLETED|Vax 1/Year 1 Follow-up||7
10348849|NCT00427895|11486970|FG001|NOT COMPLETED|Vax 1/Year 1 Follow-up||15
10348850|NCT00427895|11486971|FG002|NOT COMPLETED|Vax 1/Year 1 Follow-up||19
10348851|NCT00427895|11486972|FG003|NOT COMPLETED|Vax 1/Year 1 Follow-up||33
10348852|NCT00427895|11486973|FG004|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
10348853|NCT00427895|11486974|FG005|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
10348854|NCT00427895|11486975|FG006|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
10348855|NCT00427895|11486976|FG007|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
10348856|NCT00427895|11486969|FG000|STARTED|Between Year 1 - Vax 2/Year 3 to 4||404
10348857|NCT00427895|11486970|FG001|STARTED|Between Year 1 - Vax 2/Year 3 to 4||396
10348858|NCT00427895|11486971|FG002|STARTED|Between Year 1 - Vax 2/Year 3 to 4||373
10348859|NCT00427895|11486972|FG003|STARTED|Between Year 1 - Vax 2/Year 3 to 4||469
10348860|NCT00427895|11486973|FG004|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
10348861|NCT00427895|11486974|FG005|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
10348862|NCT00427895|11486975|FG006|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
10348863|NCT00427895|11486976|FG007|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
10348864|NCT00427895|11486969|FG000|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||216
10348865|NCT00427895|11486970|FG001|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||189
10348866|NCT00427895|11486971|FG002|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||214
10348867|NCT00427895|11486972|FG003|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
10348868|NCT00427895|11486973|FG004|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
10348869|NCT00427895|11486974|FG005|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
10348870|NCT00427895|11486975|FG006|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
10348871|NCT00427895|11486976|FG007|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
10348872|NCT00427895|11486969|FG000|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||188
10348873|NCT00427895|11486970|FG001|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||207
10348874|NCT00427895|11486971|FG002|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||159
10348875|NCT00427895|11486972|FG003|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||469
10348876|NCT00427895|11486973|FG004|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
10348877|NCT00427895|11486974|FG005|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
10348878|NCT00427895|11486975|FG006|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
10348879|NCT00427895|11486976|FG007|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
10348880|NCT00427908|11487019|FG000|STARTED|Primary Phase||229
10348881|NCT00427908|11487020|FG001|STARTED|Primary Phase||231
10348882|NCT00427908|11487021|FG002|STARTED|Primary Phase||75
10348883|NCT00427908|11487022|FG003|STARTED|Primary Phase||78
10348884|NCT00427908|11487019|FG000|COMPLETED|Primary Phase||224
10348885|NCT00427908|11487020|FG001|COMPLETED|Primary Phase||228
10348886|NCT00427908|11487021|FG002|COMPLETED|Primary Phase||72
10348887|NCT00427908|11487022|FG003|COMPLETED|Primary Phase||78
10348888|NCT00427908|11487019|FG000|NOT COMPLETED|Primary Phase||5
10348889|NCT00427908|11487020|FG001|NOT COMPLETED|Primary Phase||3
10348890|NCT00427908|11487021|FG002|NOT COMPLETED|Primary Phase||3
10348891|NCT00427908|11487022|FG003|NOT COMPLETED|Primary Phase||0
10348892|NCT00427908|11487019|FG000|STARTED|Persistence Phase Year 1||222
10348893|NCT00427908|11487020|FG001|STARTED|Persistence Phase Year 1||221
10348894|NCT00427908|11487021|FG002|STARTED|Persistence Phase Year 1||71
10348895|NCT00427908|11487022|FG003|STARTED|Persistence Phase Year 1||78
10348896|NCT00427908|11487019|FG000|COMPLETED|Persistence Phase Year 1||222
10348897|NCT00427908|11487020|FG001|COMPLETED|Persistence Phase Year 1||221
10348898|NCT00427908|11487021|FG002|COMPLETED|Persistence Phase Year 1||71
10348899|NCT00427908|11487022|FG003|COMPLETED|Persistence Phase Year 1||78
10348901|NCT00427908|11487020|FG001|NOT COMPLETED|Persistence Phase Year 1||0
10348902|NCT00427908|11487021|FG002|NOT COMPLETED|Persistence Phase Year 1||0
10348903|NCT00427908|11487022|FG003|NOT COMPLETED|Persistence Phase Year 1||0
10348904|NCT00427908|11487019|FG000|STARTED|Persistence Phase Year 2||208
10348905|NCT00427908|11487020|FG001|STARTED|Persistence Phase Year 2||215
10348906|NCT00427908|11487021|FG002|STARTED|Persistence Phase Year 2||53
10348907|NCT00427908|11487022|FG003|STARTED|Persistence Phase Year 2||61
10348908|NCT00427908|11487019|FG000|COMPLETED|Persistence Phase Year 2||208
10348909|NCT00427908|11487020|FG001|COMPLETED|Persistence Phase Year 2||215
10348910|NCT00427908|11487021|FG002|COMPLETED|Persistence Phase Year 2||53
10348911|NCT00427908|11487022|FG003|COMPLETED|Persistence Phase Year 2||61
10348912|NCT00427908|11487019|FG000|NOT COMPLETED|Persistence Phase Year 2||0
10348913|NCT00427908|11487020|FG001|NOT COMPLETED|Persistence Phase Year 2||0
10348914|NCT00427908|11487021|FG002|NOT COMPLETED|Persistence Phase Year 2||0
10348915|NCT00427908|11487022|FG003|NOT COMPLETED|Persistence Phase Year 2||0
10348916|NCT00427908|11487019|FG000|STARTED|Persistence Phase Year 3||185
10348917|NCT00427908|11487020|FG001|STARTED|Persistence Phase Year 3||201
10348918|NCT00427908|11487021|FG002|STARTED|Persistence Phase Year 3||38
10348919|NCT00427908|11487022|FG003|STARTED|Persistence Phase Year 3||38
10348920|NCT00427908|11487019|FG000|COMPLETED|Persistence Phase Year 3||185
10348921|NCT00427908|11487020|FG001|COMPLETED|Persistence Phase Year 3||201
10348922|NCT00427908|11487021|FG002|COMPLETED|Persistence Phase Year 3||38
10348923|NCT00427908|11487022|FG003|COMPLETED|Persistence Phase Year 3||38
10348924|NCT00427908|11487019|FG000|NOT COMPLETED|Persistence Phase Year 3||0
10348925|NCT00427908|11487020|FG001|NOT COMPLETED|Persistence Phase Year 3||0
10348926|NCT00427908|11487021|FG002|NOT COMPLETED|Persistence Phase Year 3||0
10348927|NCT00427908|11487022|FG003|NOT COMPLETED|Persistence Phase Year 3||0
10348928|NCT00427908|11487019|FG000|STARTED|Persistence Phase Year 4||165
10348929|NCT00427908|11487020|FG001|STARTED|Persistence Phase Year 4||192
10348930|NCT00427908|11487021|FG002|STARTED|Persistence Phase Year 4||34
10348931|NCT00427908|11487022|FG003|STARTED|Persistence Phase Year 4||32
10348932|NCT00427908|11487019|FG000|COMPLETED|Persistence Phase Year 4||165
10348933|NCT00427908|11487020|FG001|COMPLETED|Persistence Phase Year 4||192
10348934|NCT00427908|11487021|FG002|COMPLETED|Persistence Phase Year 4||34
10348935|NCT00427908|11487022|FG003|COMPLETED|Persistence Phase Year 4||32
10348936|NCT00427908|11487019|FG000|NOT COMPLETED|Persistence Phase Year 4||0
10348937|NCT00427908|11487020|FG001|NOT COMPLETED|Persistence Phase Year 4||0
10348938|NCT00427908|11487021|FG002|NOT COMPLETED|Persistence Phase Year 4||0
10348939|NCT00427908|11487022|FG003|NOT COMPLETED|Persistence Phase Year 4||0
10348940|NCT00427908|11487019|FG000|STARTED|Persistence Phase Year 5||52
10348941|NCT00427908|11487020|FG001|STARTED|Persistence Phase Year 5||99
10348942|NCT00427908|11487021|FG002|STARTED|Persistence Phase Year 5||12
10348943|NCT00427908|11487022|FG003|STARTED|Persistence Phase Year 5||13
10348944|NCT00427908|11487019|FG000|COMPLETED|Persistence Phase Year 5||52
10348945|NCT00427908|11487020|FG001|COMPLETED|Persistence Phase Year 5||99
10348946|NCT00427908|11487021|FG002|COMPLETED|Persistence Phase Year 5||12
10348947|NCT00427908|11487022|FG003|COMPLETED|Persistence Phase Year 5||13
10348948|NCT00427908|11487019|FG000|NOT COMPLETED|Persistence Phase Year 5||0
10348949|NCT00427908|11487020|FG001|NOT COMPLETED|Persistence Phase Year 5||0
10348950|NCT00427908|11487021|FG002|NOT COMPLETED|Persistence Phase Year 5||0
10348951|NCT00427908|11487022|FG003|NOT COMPLETED|Persistence Phase Year 5||0
10348952|NCT00427921|11487057|FG000|STARTED|Overall Study||304
10348953|NCT00427921|11487057|FG000|COMPLETED|Overall Study||254
10348954|NCT00427921|11487057|FG000|NOT COMPLETED|Overall Study||50
10348955|NCT00427934|11487065|FG000|STARTED|Overall Study||8
10348956|NCT00427934|11487066|FG001|STARTED|Overall Study||8
10348957|NCT00427934|11487067|FG002|STARTED|Overall Study||78
10348958|NCT00427934|11487068|FG003|STARTED|Overall Study||34
10348959|NCT00427934|11487065|FG000|Treated|Overall Study||8
10348960|NCT00427934|11487066|FG001|Treated|Overall Study||8
10348961|NCT00427934|11487067|FG002|Treated|Overall Study||77
10348962|NCT00427934|11487068|FG003|Treated|Overall Study||33
10348963|NCT00427934|11487065|FG000|COMPLETED|Overall Study||7
10348964|NCT00427934|11487066|FG001|COMPLETED|Overall Study||8
10348965|NCT00427934|11487067|FG002|COMPLETED|Overall Study||55
10348966|NCT00427934|11487068|FG003|COMPLETED|Overall Study||19
10348967|NCT00427934|11487065|FG000|NOT COMPLETED|Overall Study||1
10348968|NCT00427934|11487066|FG001|NOT COMPLETED|Overall Study||0
10348969|NCT00427934|11487067|FG002|NOT COMPLETED|Overall Study||23
10348970|NCT00427934|11487068|FG003|NOT COMPLETED|Overall Study||15
10348971|NCT00427960|11487082|FG000|STARTED|Overall Study||30
10348972|NCT00427960|11487083|FG001|STARTED|Overall Study||25
10348973|NCT00427960|11487082|FG000|COMPLETED|Overall Study||28
10348974|NCT00427960|11487083|FG001|COMPLETED|Overall Study||21
10348975|NCT00427960|11487082|FG000|NOT COMPLETED|Overall Study||2
10348976|NCT00427960|11487083|FG001|NOT COMPLETED|Overall Study||4
10348977|NCT00427973|11487089|FG000|STARTED|Overall Study||17
10348978|NCT00427973|11487089|FG000|COMPLETED|Overall Study||17
10348979|NCT00427973|11487089|FG000|NOT COMPLETED|Overall Study||0
10348980|NCT00427999|11487093|FG000|STARTED|Overall Study||65
10348981|NCT00427999|11487093|FG000|Intent to Treat (ITT)|Overall Study||61
10348982|NCT00427999|11487093|FG000|Extension Follow-up|Overall Study||19
10348983|NCT00427999|11487093|FG000|COMPLETED|Overall Study||33
10348984|NCT00427999|11487093|FG000|NOT COMPLETED|Overall Study||32
10348985|NCT00428077|11487098|FG000|STARTED|Overall Study||4
10348986|NCT00428077|11487098|FG000|COMPLETED|Overall Study||4
10348987|NCT00428077|11487098|FG000|NOT COMPLETED|Overall Study||0
10348988|NCT00428090|11487106|FG000|STARTED|Overall Study||165
10348989|NCT00428090|11487107|FG001|STARTED|Overall Study||166
10348990|NCT00428090|11487108|FG002|STARTED|Overall Study||165
10348991|NCT00428090|11487109|FG003|STARTED|Overall Study||83
10348992|NCT00428090|11487106|FG000|COMPLETED|Overall Study||131
10348993|NCT00428090|11487107|FG001|COMPLETED|Overall Study||135
10348994|NCT00428090|11487108|FG002|COMPLETED|Overall Study||127
10348995|NCT00428090|11487109|FG003|COMPLETED|Overall Study||55
10348996|NCT00428090|11487106|FG000|NOT COMPLETED|Overall Study||34
10348997|NCT00428090|11487107|FG001|NOT COMPLETED|Overall Study||31
10348998|NCT00428090|11487108|FG002|NOT COMPLETED|Overall Study||38
10348999|NCT00428090|11487109|FG003|NOT COMPLETED|Overall Study||28
10349000|NCT00428116|11487129|FG000|STARTED|Overall Study||21
10349001|NCT00428116|11487130|FG001|STARTED|Overall Study||21
10349002|NCT00428116|11487129|FG000|COMPLETED|Overall Study||18
10349003|NCT00428116|11487130|FG001|COMPLETED|Overall Study||21
10349004|NCT00428116|11487129|FG000|NOT COMPLETED|Overall Study||3
10349005|NCT00428116|11487130|FG001|NOT COMPLETED|Overall Study||0
10349006|NCT00428220|11487137|FG000|STARTED|Overall Study||223
10349007|NCT00428220|11487137|FG000|COMPLETED|Overall Study||0
10349008|NCT00428220|11487137|FG000|NOT COMPLETED|Overall Study||223
10349009|NCT00428246|11487155|FG000|STARTED|Overall Study||8
10349010|NCT00428246|11487156|FG001|STARTED|Overall Study||8
10349011|NCT00428246|11487157|FG002|STARTED|Overall Study||8
10349012|NCT00428246|11487155|FG000|COMPLETED|Overall Study||7
10349013|NCT00428246|11487156|FG001|COMPLETED|Overall Study||8
10349014|NCT00428246|11487157|FG002|COMPLETED|Overall Study||7
10349015|NCT00428246|11487155|FG000|NOT COMPLETED|Overall Study||1
10349016|NCT00428246|11487156|FG001|NOT COMPLETED|Overall Study||0
10349017|NCT00428246|11487157|FG002|NOT COMPLETED|Overall Study||1
10349018|NCT00428298|11487167|FG000|STARTED|Overall Study||30
10349019|NCT00428298|11487168|FG001|STARTED|Overall Study||30
10349020|NCT00428298|11487167|FG000|Second RBANS at Study Exit|Overall Study||3
10305571|NCT00094497|11438540|FG000|COMPLETED|Overall Study||151
10305572|NCT00094497|11438541|FG001|COMPLETED|Overall Study||153
10305573|NCT00094497|11438540|FG000|NOT COMPLETED|Overall Study||0
10305574|NCT00094497|11438541|FG001|NOT COMPLETED|Overall Study||0
10305575|NCT00094536|11438547|FG000|STARTED|Inclusion Exclusion Evaluation||106
10305576|NCT00094536|11438547|FG000|COMPLETED|Inclusion Exclusion Evaluation||82
10305577|NCT00094536|11438547|FG000|NOT COMPLETED|Inclusion Exclusion Evaluation||24
10305578|NCT00094536|11438547|FG000|STARTED|Treatment and Follow-up|82 subjects qualified for and underwent the study treatment.|82
10305579|NCT00094536|11438547|FG000|12 Month Follow-up|Treatment and Follow-up|69 subjects were evaluated at 1-year post-treatment for the primary endpoint of success.|69
10305580|NCT00094536|11438547|FG000|24 Month Follow-up|Treatment and Follow-up||53
10305581|NCT00094536|11438547|FG000|36 Month Follow-up|Treatment and Follow-up||51
10305582|NCT00094536|11438547|FG000|COMPLETED|Treatment and Follow-up|51 subjects successfully completed the study.|51
10305583|NCT00094536|11438547|FG000|NOT COMPLETED|Treatment and Follow-up||31
10349021|NCT00428298|11487168|FG001|Second RBANS at Study Exit|Overall Study||3
10349022|NCT00428298|11487167|FG000|COMPLETED|Overall Study||16
10349023|NCT00428298|11487168|FG001|COMPLETED|Overall Study||19
10349024|NCT00428298|11487167|FG000|NOT COMPLETED|Overall Study||14
10349025|NCT00428298|11487168|FG001|NOT COMPLETED|Overall Study||11
10349026|NCT00428389|11487178|FG000|STARTED|Core Phase||131
10349027|NCT00428389|11487179|FG001|STARTED|Core Phase||131
10349028|NCT00428389|11487178|FG000|Intent-to-treat Population|Core Phase||131
10349029|NCT00428389|11487179|FG001|Intent-to-treat Population|Core Phase|1 patient was discontinued from the study the same day as randomization & excluded from all analyses|130
10349030|NCT00428389|11487178|FG000|COMPLETED|Core Phase||120
10349031|NCT00428389|11487179|FG001|COMPLETED|Core Phase||120
10349032|NCT00428389|11487178|FG000|NOT COMPLETED|Core Phase||11
10349033|NCT00428389|11487179|FG001|NOT COMPLETED|Core Phase||11
10349034|NCT00428389|11487178|FG000|STARTED|Extension Phase|Participants were required to sign a separate informed consent prior to entering the extension phase|117
10349035|NCT00428389|11487179|FG001|STARTED|Extension Phase||117
10349036|NCT00428389|11487178|FG000|COMPLETED|Extension Phase||85
10349037|NCT00428389|11487179|FG001|COMPLETED|Extension Phase||91
10349038|NCT00428389|11487178|FG000|NOT COMPLETED|Extension Phase||32
10349039|NCT00428389|11487179|FG001|NOT COMPLETED|Extension Phase||26
10349040|NCT00428441|11487185|FG000|STARTED|Overall Study||75
10349041|NCT00428441|11487185|FG000|COMPLETED|Overall Study||74
10349042|NCT00428441|11487185|FG000|NOT COMPLETED|Overall Study||1
10349043|NCT00428584|11487191|FG000|STARTED|Comparative Phase||65
10349044|NCT00428584|11487192|FG001|STARTED|Comparative Phase||64
10349045|NCT00428584|11487191|FG000|COMPLETED|Comparative Phase|Comparator Phase - new formulation of rebif and Betaseron|56
10349046|NCT00428584|11487192|FG001|COMPLETED|Comparative Phase||63
10349047|NCT00428584|11487191|FG000|NOT COMPLETED|Comparative Phase||9
10349048|NCT00428584|11487192|FG001|NOT COMPLETED|Comparative Phase||1
10349049|NCT00428584|11487191|FG000|STARTED|Extension Phase|Extension Phase - new formulation of rebif to new formulation of rebif|56
10349050|NCT00428584|11487192|FG001|STARTED|Extension Phase||63
10349051|NCT00428584|11487191|FG000|COMPLETED|Extension Phase||35
10349052|NCT00428584|11487192|FG001|COMPLETED|Extension Phase||34
10349053|NCT00428584|11487191|FG000|NOT COMPLETED|Extension Phase||21
10349054|NCT00428584|11487192|FG001|NOT COMPLETED|Extension Phase||29
10349055|NCT00428597|11487204|FG000|STARTED|Overall Study||86
10349056|NCT00428597|11487205|FG001|STARTED|Overall Study||85
10349057|NCT00428597|11487204|FG000|Received Treatment|Overall Study||83
10349058|NCT00428597|11487205|FG001|Received Treatment|Overall Study||82
10349059|NCT00428597|11487204|FG000|COMPLETED|Overall Study||0
10349060|NCT00428597|11487205|FG001|COMPLETED|Overall Study||0
10349061|NCT00428597|11487204|FG000|NOT COMPLETED|Overall Study||86
10349062|NCT00428597|11487205|FG001|NOT COMPLETED|Overall Study||85
10349063|NCT00428610|11487214|FG000|STARTED|Overall Study||53
10349064|NCT00428610|11487215|FG001|STARTED|Overall Study||18
10349065|NCT00428610|11487216|FG002|STARTED|Overall Study||32
10349066|NCT00428610|11487214|FG000|Received at Least One Dose of Study Drug|Overall Study||53
10349067|NCT00428610|11487215|FG001|Received at Least One Dose of Study Drug|Overall Study||18
10349068|NCT00428610|11487216|FG002|Received at Least One Dose of Study Drug|Overall Study||32
10349069|NCT00428610|11487214|FG000|COMPLETED|Overall Study||0
10349070|NCT00428610|11487215|FG001|COMPLETED|Overall Study||0
10349071|NCT00428610|11487216|FG002|COMPLETED|Overall Study||0
10349072|NCT00428610|11487214|FG000|NOT COMPLETED|Overall Study||53
10349073|NCT00428610|11487215|FG001|NOT COMPLETED|Overall Study||18
10349074|NCT00428610|11487216|FG002|NOT COMPLETED|Overall Study||32
10349075|NCT00428714|11487226|FG000|STARTED|Overall Study||31
10349076|NCT00428714|11487227|FG001|STARTED|Overall Study||42
10349077|NCT00428714|11487226|FG000|Received at Least 1 Dose of Study Drug|Overall Study||31
10349078|NCT00428714|11487227|FG001|Received at Least 1 Dose of Study Drug|Overall Study||42
10349079|NCT00428714|11487226|FG000|COMPLETED|Overall Study||0
10349080|NCT00428714|11487227|FG001|COMPLETED|Overall Study||0
10349081|NCT00428714|11487226|FG000|NOT COMPLETED|Overall Study||31
10349082|NCT00428714|11487227|FG001|NOT COMPLETED|Overall Study||42
10349083|NCT00428792|11487236|FG000|STARTED|Overall Study||80
10349084|NCT00428792|11487237|FG001|STARTED|Overall Study||70
10349085|NCT00428792|11487236|FG000|COMPLETED|Overall Study|Information is not available during which cross-over period patients discontinued.|79
10349086|NCT00428792|11487237|FG001|COMPLETED|Overall Study|Information is not available during which cross-over period patients discontinued.|66
10349087|NCT00428792|11487236|FG000|NOT COMPLETED|Overall Study||1
10349088|NCT00428792|11487237|FG001|NOT COMPLETED|Overall Study||4
10349089|NCT00428844|11487246|FG000|STARTED|Completed Study Drug Treatment||25
10349090|NCT00428844|11487247|FG001|STARTED|Completed Study Drug Treatment||24
10349091|NCT00428844|11487248|FG002|STARTED|Completed Study Drug Treatment||26
10305584|NCT00094575|11438553|FG000|STARTED|Overall Study||444
10305585|NCT00094575|11438554|FG001|STARTED|Overall Study||437
10305586|NCT00094575|11438553|FG000|COMPLETED|Overall Study||298
10349092|NCT00428844|11487246|FG000|Received First Dose|Completed Study Drug Treatment||25
10349093|NCT00428844|11487247|FG001|Received First Dose|Completed Study Drug Treatment||24
10349094|NCT00428844|11487248|FG002|Received First Dose|Completed Study Drug Treatment||25
10349095|NCT00428844|11487246|FG000|COMPLETED|Completed Study Drug Treatment||23
10532685|NCT01422239|11685111|FG000|STARTED|Overall Study||14
10532686|NCT01422239|11685112|FG001|STARTED|Overall Study||6
10532687|NCT01422239|11685111|FG000|COMPLETED|Overall Study||10
10532688|NCT01422239|11685112|FG001|COMPLETED|Overall Study||3
10532689|NCT01422239|11685111|FG000|NOT COMPLETED|Overall Study||4
10532690|NCT01422239|11685112|FG001|NOT COMPLETED|Overall Study||3
10532691|NCT01422304|11685120|FG000|STARTED|Overall Study|Randomized|598
10532692|NCT01422304|11685121|FG001|STARTED|Overall Study|Randomized|600
10655730|NCT02210052|11816438|FG000|COMPLETED|Overall Study||6
10655731|NCT02210052|11816438|FG000|NOT COMPLETED|Overall Study||0
10655732|NCT02210065|11816442|FG000|STARTED|Overall Study||1
10655733|NCT02210065|11816442|FG000|COMPLETED|Overall Study||1
10655734|NCT02210065|11816442|FG000|NOT COMPLETED|Overall Study||0
10655735|NCT02210091|11816448|FG000|STARTED|Overall Study||32
10655736|NCT02210091|11816449|FG001|STARTED|Overall Study||34
10655737|NCT02210091|11816448|FG000|COMPLETED|Overall Study||32
10655738|NCT02210091|11816449|FG001|COMPLETED|Overall Study||32
10655739|NCT02210091|11816448|FG000|NOT COMPLETED|Overall Study||0
10655740|NCT02210091|11816449|FG001|NOT COMPLETED|Overall Study||2
10655741|NCT02210195|11816473|FG000|STARTED|Overall Study||10
10655742|NCT02210195|11816474|FG001|STARTED|Overall Study||10
10655743|NCT02210195|11816473|FG000|COMPLETED|Overall Study||6
10655744|NCT02210195|11816474|FG001|COMPLETED|Overall Study||10
10655745|NCT02210195|11816473|FG000|NOT COMPLETED|Overall Study||4
10655746|NCT02210195|11816474|FG001|NOT COMPLETED|Overall Study||0
10655747|NCT02210208|11816480|FG000|STARTED|Period A (Graft Site)||25
10655748|NCT02210208|11816480|FG000|COMPLETED|Period A (Graft Site)||23
10655749|NCT02210208|11816480|FG000|NOT COMPLETED|Period A (Graft Site)||2
10655750|NCT02210208|11816480|FG000|STARTED|Period B (Donor Site)|6 subjects was decided by the Physician not to be included in the Part B.|19
10655751|NCT02210208|11816480|FG000|COMPLETED|Period B (Donor Site)||12
10655752|NCT02210208|11816480|FG000|NOT COMPLETED|Period B (Donor Site)||7
10655753|NCT02210221|11816486|FG000|STARTED|Overall Study||4559
10655754|NCT02210221|11816486|FG000|COMPLETED|Overall Study||4509
10655755|NCT02210221|11816486|FG000|NOT COMPLETED|Overall Study||50
10655756|NCT02210247|11816500|FG000|STARTED|Overall Study||12
10655757|NCT02210247|11816501|FG001|STARTED|Overall Study||12
10655758|NCT02210247|11816502|FG002|STARTED|Overall Study||12
10655759|NCT02210247|11816503|FG003|STARTED|Overall Study||12
10655760|NCT02210247|11816504|FG004|STARTED|Overall Study||12
10655761|NCT02210247|11816500|FG000|COMPLETED|Overall Study||12
10655762|NCT02210247|11816501|FG001|COMPLETED|Overall Study||12
10655763|NCT02210247|11816502|FG002|COMPLETED|Overall Study||12
10655764|NCT02210247|11816503|FG003|COMPLETED|Overall Study||12
10655765|NCT02210247|11816504|FG004|COMPLETED|Overall Study||12
10655766|NCT02210247|11816500|FG000|NOT COMPLETED|Overall Study||0
10655767|NCT02210247|11816501|FG001|NOT COMPLETED|Overall Study||0
10655768|NCT02210247|11816502|FG002|NOT COMPLETED|Overall Study||0
10655769|NCT02210247|11816503|FG003|NOT COMPLETED|Overall Study||0
10655770|NCT02210247|11816504|FG004|NOT COMPLETED|Overall Study||0
10655771|NCT02210286|11816521|FG000|STARTED|Overall Study||17
10655772|NCT02210286|11816521|FG000|COMPLETED|Overall Study||15
10655773|NCT02210286|11816521|FG000|NOT COMPLETED|Overall Study||2
10655774|NCT02210689|11816532|FG000|STARTED|Overall Study||242
10655775|NCT02210689|11816533|FG001|STARTED|Overall Study||240
10715783|NCT02688387|11880054|FG011|STARTED|Part 3A, Period 3 (up to 6 Days)||0
10715784|NCT02688387|11880055|FG012|STARTED|Part 3A, Period 3 (up to 6 Days)||0
10715785|NCT02688387|11880056|FG013|STARTED|Part 3A, Period 3 (up to 6 Days)||0
10715786|NCT02688387|11880057|FG014|STARTED|Part 3A, Period 3 (up to 6 Days)||8
10715787|NCT02688387|11880058|FG015|STARTED|Part 3A, Period 3 (up to 6 Days)||8
10715788|NCT02688387|11880059|FG016|STARTED|Part 3A, Period 3 (up to 6 Days)||8
10715789|NCT02688387|11880060|FG017|STARTED|Part 3A, Period 3 (up to 6 Days)||8
10715790|NCT02688387|11880061|FG018|STARTED|Part 3A, Period 3 (up to 6 Days)||0
10715791|NCT02688387|11880062|FG019|STARTED|Part 3A, Period 3 (up to 6 Days)||0
10715792|NCT02688387|11880063|FG020|STARTED|Part 3A, Period 3 (up to 6 Days)||0
10715793|NCT02688387|11880064|FG021|STARTED|Part 3A, Period 3 (up to 6 Days)||0
10715794|NCT02688387|11880043|FG000|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10715795|NCT02688387|11880044|FG001|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10715796|NCT02688387|11880045|FG002|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10715797|NCT02688387|11880046|FG003|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10349096|NCT00428844|11487247|FG001|COMPLETED|Completed Study Drug Treatment||18
10715798|NCT02688387|11880047|FG004|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10715799|NCT02688387|11880048|FG005|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10715800|NCT02688387|11880049|FG006|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10532693|NCT01422304|11685120|FG000|Treated|Overall Study||595
10532694|NCT01422304|11685121|FG001|Treated|Overall Study|1 given sugammadex; thus All Participants as Treated (APaT) Ns are 596 Sugammadex, 588 Usual Care|589
10655776|NCT02210689|11816534|FG002|STARTED|Overall Study||122
10655777|NCT02210689|11816532|FG000|Safety Population|Overall Study||233
10532695|NCT01422304|11685120|FG000|COMPLETED|Overall Study||574
10655778|NCT02210689|11816533|FG001|Safety Population|Overall Study||236
10655779|NCT02210689|11816534|FG002|Safety Population|Overall Study||122
10655780|NCT02210689|11816532|FG000|mITT Population|Overall Study||199
10655781|NCT02210689|11816533|FG001|mITT Population|Overall Study||207
10349097|NCT00428844|11487248|FG002|COMPLETED|Completed Study Drug Treatment||19
10349098|NCT00428844|11487246|FG000|NOT COMPLETED|Completed Study Drug Treatment||2
10349099|NCT00428844|11487247|FG001|NOT COMPLETED|Completed Study Drug Treatment||6
10349100|NCT00428844|11487248|FG002|NOT COMPLETED|Completed Study Drug Treatment||7
10349101|NCT00428844|11487246|FG000|STARTED|Completed Test of Cure (TOC) Visit||23
10349102|NCT00428844|11487247|FG001|STARTED|Completed Test of Cure (TOC) Visit||18
10349103|NCT00428844|11487248|FG002|STARTED|Completed Test of Cure (TOC) Visit||19
10349104|NCT00428844|11487246|FG000|COMPLETED|Completed Test of Cure (TOC) Visit||20
10349105|NCT00428844|11487247|FG001|COMPLETED|Completed Test of Cure (TOC) Visit||16
10349106|NCT00428844|11487248|FG002|COMPLETED|Completed Test of Cure (TOC) Visit||17
10349107|NCT00428844|11487246|FG000|NOT COMPLETED|Completed Test of Cure (TOC) Visit||3
10715801|NCT02688387|11880050|FG007|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10715802|NCT02688387|11880051|FG008|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10715803|NCT02688387|11880052|FG009|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10349108|NCT00428844|11487247|FG001|NOT COMPLETED|Completed Test of Cure (TOC) Visit||2
10349109|NCT00428844|11487248|FG002|NOT COMPLETED|Completed Test of Cure (TOC) Visit||2
10349110|NCT00428922|11487256|FG000|STARTED|Overall Study||26
10349111|NCT00428922|11487256|FG000|COMPLETED|Overall Study||26
10349112|NCT00428922|11487256|FG000|NOT COMPLETED|Overall Study||0
10349113|NCT00428948|11487262|FG000|STARTED|Overall Study||961
10349114|NCT00428948|11487263|FG001|STARTED|Overall Study||484
10349115|NCT00428948|11487262|FG000|Received Treatment|Overall Study||961
10349116|NCT00428948|11487263|FG001|Received Treatment|Overall Study||483
10349117|NCT00428948|11487262|FG000|COMPLETED|Overall Study||740
10349118|NCT00428948|11487263|FG001|COMPLETED|Overall Study||417
10349119|NCT00428948|11487262|FG000|NOT COMPLETED|Overall Study||221
10349120|NCT00428948|11487263|FG001|NOT COMPLETED|Overall Study||67
10349121|NCT00428974|11487273|FG000|STARTED|Overall Study|one patient was randomized but never received study treatment|25
10349122|NCT00428974|11487274|FG001|STARTED|Overall Study||17
10349123|NCT00428974|11487275|FG002|STARTED|Overall Study||15
10349124|NCT00428974|11487276|FG003|STARTED|Overall Study||19
10349125|NCT00428974|11487273|FG000|COMPLETED|Overall Study||17
10349126|NCT00428974|11487274|FG001|COMPLETED|Overall Study||17
10349127|NCT00428974|11487275|FG002|COMPLETED|Overall Study||14
10349128|NCT00428974|11487276|FG003|COMPLETED|Overall Study||16
10349129|NCT00428974|11487273|FG000|NOT COMPLETED|Overall Study||8
10532696|NCT01422304|11685121|FG001|COMPLETED|Overall Study||563
10532697|NCT01422304|11685120|FG000|NOT COMPLETED|Overall Study||24
10532698|NCT01422304|11685121|FG001|NOT COMPLETED|Overall Study||37
10532699|NCT01422356|11685127|FG000|STARTED|Overall Study||200
10532700|NCT01422356|11685127|FG000|COMPLETED|Overall Study||169
10715804|NCT02688387|11880053|FG010|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10715805|NCT02688387|11880054|FG011|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10715806|NCT02688387|11880055|FG012|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10715807|NCT02688387|11880056|FG013|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10715808|NCT02688387|11880057|FG014|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
10715809|NCT02688387|11880058|FG015|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
10532701|NCT01422356|11685127|FG000|NOT COMPLETED|Overall Study||31
10532702|NCT01422369|11685131|FG000|STARTED|NK-104 4mg QD||28
10532703|NCT01422369|11685131|FG000|COMPLETED|NK-104 4mg QD||28
10532704|NCT01422369|11685131|FG000|NOT COMPLETED|NK-104 4mg QD||0
10532705|NCT01422369|11685131|FG000|STARTED|Prezista 800mg/100mg QD||28
10532706|NCT01422369|11685131|FG000|COMPLETED|Prezista 800mg/100mg QD||28
10532707|NCT01422369|11685131|FG000|NOT COMPLETED|Prezista 800mg/100mg QD||0
10532708|NCT01422369|11685131|FG000|STARTED|NK-104 4mg QD & Prezista 800mg/100mg QD||28
10532709|NCT01422369|11685131|FG000|COMPLETED|NK-104 4mg QD & Prezista 800mg/100mg QD||27
10532710|NCT01422369|11685131|FG000|NOT COMPLETED|NK-104 4mg QD & Prezista 800mg/100mg QD||1
10532711|NCT01422382|11685136|FG000|STARTED|NK-104 4mg Once Daily (QD)||28
10532712|NCT01422382|11685136|FG000|COMPLETED|NK-104 4mg Once Daily (QD)||28
10532713|NCT01422382|11685136|FG000|NOT COMPLETED|NK-104 4mg Once Daily (QD)||0
10532714|NCT01422382|11685136|FG000|STARTED|Diltiazem 240 mg QD||28
10532715|NCT01422382|11685136|FG000|COMPLETED|Diltiazem 240 mg QD||28
10532716|NCT01422382|11685136|FG000|NOT COMPLETED|Diltiazem 240 mg QD||0
10532717|NCT01422382|11685136|FG000|STARTED|NK-104 4mg QD and Diltiazem 240 mg QD||28
10715810|NCT02688387|11880059|FG016|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
10715811|NCT02688387|11880060|FG017|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
10715812|NCT02688387|11880061|FG018|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10715813|NCT02688387|11880062|FG019|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10715814|NCT02688387|11880063|FG020|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10715815|NCT02688387|11880064|FG021|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10715816|NCT02688387|11880043|FG000|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10715817|NCT02688387|11880044|FG001|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10715818|NCT02688387|11880045|FG002|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10715819|NCT02688387|11880046|FG003|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10715820|NCT02688387|11880047|FG004|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10715821|NCT02688387|11880048|FG005|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10715822|NCT02688387|11880049|FG006|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10532718|NCT01422382|11685136|FG000|COMPLETED|NK-104 4mg QD and Diltiazem 240 mg QD||27
10532719|NCT01422382|11685136|FG000|NOT COMPLETED|NK-104 4mg QD and Diltiazem 240 mg QD||1
10532720|NCT01422408|11685140|FG000|STARTED|Overall Study||34
10532721|NCT01422408|11685140|FG000|COMPLETED|Overall Study||30
10715823|NCT02688387|11880050|FG007|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10715824|NCT02688387|11880051|FG008|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10715825|NCT02688387|11880052|FG009|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10715826|NCT02688387|11880053|FG010|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10715827|NCT02688387|11880054|FG011|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10715828|NCT02688387|11880055|FG012|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10715829|NCT02688387|11880056|FG013|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10715830|NCT02688387|11880057|FG014|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10715831|NCT02688387|11880058|FG015|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10349130|NCT00428974|11487274|FG001|NOT COMPLETED|Overall Study||0
10349131|NCT00428974|11487275|FG002|NOT COMPLETED|Overall Study||1
10349132|NCT00428974|11487276|FG003|NOT COMPLETED|Overall Study||3
10349133|NCT00429104|11487287|FG000|STARTED|Overall Study||18
10349134|NCT00429104|11487287|FG000|COMPLETED|Overall Study||17
10349135|NCT00429104|11487287|FG000|NOT COMPLETED|Overall Study||1
10349136|NCT00429143|11487291|FG000|STARTED|Overall Study||27
10349137|NCT00429143|11487291|FG000|COMPLETED|Overall Study||27
10349138|NCT00429143|11487291|FG000|NOT COMPLETED|Overall Study||0
10349139|NCT00429169|11487297|FG000|STARTED|Overall Study||38
10349140|NCT00429169|11487298|FG001|STARTED|Overall Study||40
10349141|NCT00429169|11487297|FG000|COMPLETED|Overall Study|2 subjects excluded due to re-diagnosis/ineligibility.|36
10349142|NCT00429169|11487298|FG001|COMPLETED|Overall Study|2 subjects excluded: re-diagnosis/ineligibility (1), and did not return after randomization (1).|38
10349143|NCT00429169|11487297|FG000|NOT COMPLETED|Overall Study||2
10349144|NCT00429169|11487298|FG001|NOT COMPLETED|Overall Study||2
10349145|NCT00429182|11487306|FG000|STARTED|Overall Study||32
10349146|NCT00429182|11487306|FG000|COMPLETED|Overall Study||25
10349147|NCT00429182|11487306|FG000|NOT COMPLETED|Overall Study||7
10349148|NCT00429273|11487313|FG000|STARTED|Overall Study||68
10349149|NCT00429273|11487314|FG001|STARTED|Overall Study||69
10349150|NCT00429273|11487315|FG002|STARTED|Overall Study||70
10349151|NCT00429273|11487313|FG000|COMPLETED|Overall Study||60
10349152|NCT00429273|11487314|FG001|COMPLETED|Overall Study||61
10349153|NCT00429273|11487315|FG002|COMPLETED|Overall Study||61
10349154|NCT00429273|11487313|FG000|NOT COMPLETED|Overall Study||8
10349155|NCT00429273|11487314|FG001|NOT COMPLETED|Overall Study||8
10349156|NCT00429273|11487315|FG002|NOT COMPLETED|Overall Study||9
10349157|NCT00429299|11487326|FG000|STARTED|Overall Study||36
10349158|NCT00429299|11487327|FG001|STARTED|Overall Study||39
10349159|NCT00429299|11487328|FG002|STARTED|Overall Study||46
10349160|NCT00429299|11487326|FG000|COMPLETED|Overall Study||32
10349161|NCT00429299|11487327|FG001|COMPLETED|Overall Study||32
10349162|NCT00429299|11487328|FG002|COMPLETED|Overall Study||42
10349163|NCT00429299|11487326|FG000|NOT COMPLETED|Overall Study||4
10349164|NCT00429299|11487327|FG001|NOT COMPLETED|Overall Study||7
10349165|NCT00429299|11487328|FG002|NOT COMPLETED|Overall Study||4
10349166|NCT00429364|11487338|FG000|STARTED|Overall Study||303
10349167|NCT00429364|11487339|FG001|STARTED|Overall Study||305
10349168|NCT00429364|11487338|FG000|COMPLETED|Overall Study||271
10349169|NCT00429364|11487339|FG001|COMPLETED|Overall Study||272
10349170|NCT00429364|11487338|FG000|NOT COMPLETED|Overall Study||32
10349171|NCT00429364|11487339|FG001|NOT COMPLETED|Overall Study||33
10349172|NCT00429403|11487347|FG000|STARTED|Overall Study||1
10349173|NCT00429403|11487348|FG001|STARTED|Overall Study||0
10349174|NCT00429403|11487347|FG000|COMPLETED|Overall Study||1
10349175|NCT00429403|11487348|FG001|COMPLETED|Overall Study||0
10349176|NCT00429403|11487347|FG000|NOT COMPLETED|Overall Study||0
10349177|NCT00429403|11487348|FG001|NOT COMPLETED|Overall Study||0
10426737|NCT00848718|11572431|FG011|Treated|Overall Study||6
10426738|NCT00848718|11572432|FG012|Treated|Overall Study|2 participants were allocated but did not receive treatment due to progression of disease|6
10426739|NCT00848718|11572420|FG000|COMPLETED|Overall Study||0
10426740|NCT00848718|11572421|FG001|COMPLETED|Overall Study||0
10426741|NCT00848718|11572422|FG002|COMPLETED|Overall Study||0
10426742|NCT00848718|11572423|FG003|COMPLETED|Overall Study||0
10426743|NCT00848718|11572424|FG004|COMPLETED|Overall Study||0
10426744|NCT00848718|11572425|FG005|COMPLETED|Overall Study||0
10426745|NCT00848718|11572426|FG006|COMPLETED|Overall Study||0
10426746|NCT00848718|11572427|FG007|COMPLETED|Overall Study||0
10426747|NCT00848718|11572428|FG008|COMPLETED|Overall Study||0
10426748|NCT00848718|11572429|FG009|COMPLETED|Overall Study||0
10426749|NCT00848718|11572430|FG010|COMPLETED|Overall Study||0
10426750|NCT00848718|11572431|FG011|COMPLETED|Overall Study||0
10426751|NCT00848718|11572432|FG012|COMPLETED|Overall Study||0
10426752|NCT00848718|11572420|FG000|NOT COMPLETED|Overall Study||7
10426753|NCT00848718|11572421|FG001|NOT COMPLETED|Overall Study||9
10426754|NCT00848718|11572422|FG002|NOT COMPLETED|Overall Study||6
10426755|NCT00848718|11572423|FG003|NOT COMPLETED|Overall Study||5
10426756|NCT00848718|11572424|FG004|NOT COMPLETED|Overall Study||6
10426757|NCT00848718|11572425|FG005|NOT COMPLETED|Overall Study||5
10426758|NCT00848718|11572426|FG006|NOT COMPLETED|Overall Study||3
10426759|NCT00848718|11572427|FG007|NOT COMPLETED|Overall Study||5
10426760|NCT00848718|11572428|FG008|NOT COMPLETED|Overall Study||4
10426761|NCT00848718|11572429|FG009|NOT COMPLETED|Overall Study||9
10426762|NCT00848718|11572430|FG010|NOT COMPLETED|Overall Study||4
10426763|NCT00848718|11572431|FG011|NOT COMPLETED|Overall Study||6
10426764|NCT00848718|11572432|FG012|NOT COMPLETED|Overall Study||8
10426765|NCT00848744|11572466|FG000|STARTED|Overall Study||10
10426766|NCT00848744|11572466|FG000|COMPLETED|Overall Study||10
10426767|NCT00848744|11572466|FG000|NOT COMPLETED|Overall Study||0
10349178|NCT00429416|11487354|FG000|STARTED|Overall Study||14
10349179|NCT00429416|11487354|FG000|COMPLETED|Overall Study||13
10349180|NCT00429416|11487354|FG000|NOT COMPLETED|Overall Study||1
10349181|NCT00429494|11487358|FG000|STARTED|Overall Study||59
10349182|NCT00429494|11487358|FG000|COMPLETED|Overall Study||44
10349183|NCT00429494|11487358|FG000|NOT COMPLETED|Overall Study||15
10349184|NCT00429507|11487362|FG000|STARTED|Overall Study||12
10349185|NCT00429507|11487362|FG000|COMPLETED|Overall Study||12
10349186|NCT00429507|11487362|FG000|NOT COMPLETED|Overall Study||0
10349187|NCT00429572|11487366|FG000|STARTED|Overall Study||19
10349188|NCT00429572|11487366|FG000|COMPLETED|Overall Study||18
10349189|NCT00429572|11487366|FG000|NOT COMPLETED|Overall Study||1
10349190|NCT00429585|11487372|FG000|STARTED|Overall Study||52
10349191|NCT00429585|11487373|FG001|STARTED|Overall Study||47
10349192|NCT00429585|11487372|FG000|COMPLETED|Overall Study||22
10349193|NCT00429585|11487373|FG001|COMPLETED|Overall Study||27
10349194|NCT00429585|11487372|FG000|NOT COMPLETED|Overall Study||30
10349195|NCT00429585|11487373|FG001|NOT COMPLETED|Overall Study||20
10349196|NCT00429663|11487381|FG000|STARTED|Overall Study||76
10349197|NCT00429663|11487382|FG001|STARTED|Overall Study||80
10349198|NCT00429663|11487381|FG000|COMPLETED|Overall Study||40
10349199|NCT00429663|11487382|FG001|COMPLETED|Overall Study||41
10349200|NCT00429663|11487381|FG000|NOT COMPLETED|Overall Study||36
10349201|NCT00429663|11487382|FG001|NOT COMPLETED|Overall Study||39
10349202|NCT00429702|11487390|FG000|STARTED|Overall Study||3
10349203|NCT00429702|11487391|FG001|STARTED|Overall Study||4
10349204|NCT00429702|11487390|FG000|COMPLETED|Overall Study||3
10349205|NCT00429702|11487391|FG001|COMPLETED|Overall Study||4
10349206|NCT00429702|11487390|FG000|NOT COMPLETED|Overall Study||0
10349207|NCT00429702|11487391|FG001|NOT COMPLETED|Overall Study||0
10349208|NCT00429793|11487397|FG000|STARTED|Overall Study||60
10349209|NCT00429793|11487397|FG000|COMPLETED|Overall Study||54
10349210|NCT00429793|11487397|FG000|NOT COMPLETED|Overall Study||6
10349211|NCT00429949|11487406|FG000|STARTED|Overall Study||21
10349212|NCT00429949|11487406|FG000|COMPLETED|Overall Study||21
10349213|NCT00429949|11487406|FG000|NOT COMPLETED|Overall Study||0
10349214|NCT00430183|11487414|FG000|STARTED|Overall Study||391
10349215|NCT00430183|11487415|FG001|STARTED|Overall Study||397
10349216|NCT00430183|11487414|FG000|COMPLETED|Overall Study||391
10349217|NCT00430183|11487415|FG001|COMPLETED|Overall Study||397
10349218|NCT00430183|11487414|FG000|NOT COMPLETED|Overall Study||0
10349219|NCT00430183|11487415|FG001|NOT COMPLETED|Overall Study||0
10349220|NCT00430248|11487424|FG000|STARTED|Overall Study||757
10349221|NCT00430248|11487425|FG001|STARTED|Overall Study||756
10349222|NCT00430248|11487426|FG002|STARTED|Overall Study||756
10349223|NCT00430248|11487424|FG000|COMPLETED|Overall Study||632
10349224|NCT00430248|11487425|FG001|COMPLETED|Overall Study||598
10349225|NCT00430248|11487426|FG002|COMPLETED|Overall Study||621
10349226|NCT00430248|11487424|FG000|NOT COMPLETED|Overall Study||125
10349227|NCT00430248|11487425|FG001|NOT COMPLETED|Overall Study||158
10349228|NCT00430248|11487426|FG002|NOT COMPLETED|Overall Study||135
10349229|NCT00430300|11487438|FG000|STARTED|Overall Study||17
10349230|NCT00430300|11487439|FG001|STARTED|Overall Study||18
10349231|NCT00430300|11487440|FG002|STARTED|Overall Study||35
10349232|NCT00430300|11487441|FG003|STARTED|Overall Study||17
10349233|NCT00430300|11487438|FG000|COMPLETED|Overall Study||15
10349234|NCT00430300|11487439|FG001|COMPLETED|Overall Study||16
10349235|NCT00430300|11487440|FG002|COMPLETED|Overall Study||29
10349236|NCT00430300|11487441|FG003|COMPLETED|Overall Study||15
10349237|NCT00430300|11487438|FG000|NOT COMPLETED|Overall Study||2
10349238|NCT00430300|11487439|FG001|NOT COMPLETED|Overall Study||2
10349239|NCT00430300|11487440|FG002|NOT COMPLETED|Overall Study||6
10349240|NCT00430300|11487441|FG003|NOT COMPLETED|Overall Study||2
10349241|NCT00430352|11487451|FG000|STARTED|Overall Study||545
10349242|NCT00430352|11487451|FG000|COMPLETED|Overall Study||407
10349243|NCT00430352|11487451|FG000|NOT COMPLETED|Overall Study||138
10349244|NCT00430482|11487457|FG000|STARTED|Completed Treatment||41
10349245|NCT00430482|11487458|FG001|STARTED|Completed Treatment||37
10349246|NCT00430482|11487457|FG000|Completed ASI at Midpoint|Completed Treatment||35
10349247|NCT00430482|11487458|FG001|Completed ASI at Midpoint|Completed Treatment||29
10349248|NCT00430482|11487457|FG000|COMPLETED|Completed Treatment||34
10349249|NCT00430482|11487458|FG001|COMPLETED|Completed Treatment||26
10349250|NCT00430482|11487457|FG000|NOT COMPLETED|Completed Treatment||7
10349251|NCT00430482|11487458|FG001|NOT COMPLETED|Completed Treatment||11
10349252|NCT00430482|11487457|FG000|STARTED|Completed 2 Follow-Up Visits||34
10349253|NCT00430482|11487458|FG001|STARTED|Completed 2 Follow-Up Visits||26
10349254|NCT00430482|11487457|FG000|Completed ASI at Follow-Up #1|Completed 2 Follow-Up Visits||27
10349255|NCT00430482|11487458|FG001|Completed ASI at Follow-Up #1|Completed 2 Follow-Up Visits||20
10349256|NCT00430482|11487457|FG000|Completed ASI at Follow-Up #2|Completed 2 Follow-Up Visits||29
10349257|NCT00430482|11487458|FG001|Completed ASI at Follow-Up #2|Completed 2 Follow-Up Visits||20
10349258|NCT00430482|11487457|FG000|COMPLETED|Completed 2 Follow-Up Visits||29
10349259|NCT00430482|11487458|FG001|COMPLETED|Completed 2 Follow-Up Visits||20
10349260|NCT00430482|11487457|FG000|NOT COMPLETED|Completed 2 Follow-Up Visits||5
10349261|NCT00430482|11487458|FG001|NOT COMPLETED|Completed 2 Follow-Up Visits||6
10349262|NCT00430495|11487468|FG000|STARTED|Overall Study||64
10349263|NCT00430495|11487469|FG001|STARTED|Overall Study||66
10349264|NCT00430495|11487470|FG002|STARTED|Overall Study||62
10349265|NCT00430495|11487471|FG003|STARTED|Overall Study||64
10349266|NCT00430495|11487468|FG000|Treated|Overall Study||62
10349267|NCT00430495|11487469|FG001|Treated|Overall Study||66
10349268|NCT00430495|11487470|FG002|Treated|Overall Study||62
10349269|NCT00430495|11487471|FG003|Treated|Overall Study||64
10349270|NCT00430495|11487468|FG000|COMPLETED|Overall Study||50
10349271|NCT00430495|11487469|FG001|COMPLETED|Overall Study||59
10349272|NCT00430495|11487470|FG002|COMPLETED|Overall Study||49
10349273|NCT00430495|11487471|FG003|COMPLETED|Overall Study||60
10349274|NCT00430495|11487468|FG000|NOT COMPLETED|Overall Study||14
10349275|NCT00430495|11487469|FG001|NOT COMPLETED|Overall Study||7
10349276|NCT00430495|11487470|FG002|NOT COMPLETED|Overall Study||13
10349277|NCT00430495|11487471|FG003|NOT COMPLETED|Overall Study||4
10349278|NCT00430521|11487489|FG000|STARTED|Overall Study||63
10349279|NCT00430521|11487490|FG001|STARTED|Overall Study||66
10349280|NCT00430521|11487491|FG002|STARTED|Overall Study||64
10349281|NCT00430521|11487492|FG003|STARTED|Overall Study||63
10349282|NCT00430521|11487493|FG004|STARTED|Overall Study||64
10349283|NCT00430521|11487494|FG005|STARTED|Overall Study||64
10349284|NCT00430521|11487495|FG006|STARTED|Overall Study||65
10349285|NCT00430521|11487496|FG007|STARTED|Overall Study||63
10349286|NCT00430521|11487489|FG000|COMPLETED|Overall Study||52
10349287|NCT00430521|11487490|FG001|COMPLETED|Overall Study||57
10349288|NCT00430521|11487491|FG002|COMPLETED|Overall Study||61
10349289|NCT00430521|11487492|FG003|COMPLETED|Overall Study||55
10349290|NCT00430521|11487493|FG004|COMPLETED|Overall Study||59
10349291|NCT00430521|11487494|FG005|COMPLETED|Overall Study||59
10349292|NCT00430521|11487495|FG006|COMPLETED|Overall Study||55
10349293|NCT00430521|11487496|FG007|COMPLETED|Overall Study||51
10349294|NCT00430521|11487489|FG000|NOT COMPLETED|Overall Study||11
10532722|NCT01422408|11685140|FG000|NOT COMPLETED|Overall Study||4
10532723|NCT01422434|11685147|FG000|STARTED|Overall Study||227
10532724|NCT01422434|11685148|FG001|STARTED|Overall Study||226
10532725|NCT01422434|11685149|FG002|STARTED|Overall Study||223
10532726|NCT01422434|11685147|FG000|COMPLETED|Overall Study||216
10532727|NCT01422434|11685148|FG001|COMPLETED|Overall Study||221
10532728|NCT01422434|11685149|FG002|COMPLETED|Overall Study||217
10532729|NCT01422434|11685147|FG000|NOT COMPLETED|Overall Study||11
10532730|NCT01422434|11685148|FG001|NOT COMPLETED|Overall Study||5
10532731|NCT01422434|11685149|FG002|NOT COMPLETED|Overall Study||6
10532732|NCT01422538|11685160|FG000|STARTED|Overall Study||10
10532733|NCT01422538|11685161|FG001|STARTED|Overall Study||10
10532734|NCT01422538|11685162|FG002|STARTED|Overall Study||10
10532735|NCT01422538|11685160|FG000|COMPLETED|Overall Study||10
10532736|NCT01422538|11685161|FG001|COMPLETED|Overall Study||8
10532737|NCT01422538|11685162|FG002|COMPLETED|Overall Study||8
10532738|NCT01422538|11685160|FG000|NOT COMPLETED|Overall Study||0
10532739|NCT01422538|11685161|FG001|NOT COMPLETED|Overall Study||2
10532740|NCT01422538|11685162|FG002|NOT COMPLETED|Overall Study||2
10532741|NCT01422720|11685171|FG000|STARTED|Overall Study||72
10532742|NCT01422720|11685171|FG000|Safety Set|Overall Study||72
10532743|NCT01422720|11685171|FG000|Full Analysis Set (FAS)|Overall Study||71
10532744|NCT01422720|11685171|FG000|Per-Protocol Set (PPS)|Overall Study||55
10532745|NCT01422720|11685171|FG000|COMPLETED|Overall Study||50
10532746|NCT01422720|11685171|FG000|NOT COMPLETED|Overall Study||22
10532747|NCT01422824|11685179|FG000|STARTED|Overall Study||185
10532748|NCT01422824|11685179|FG000|Treated|Overall Study||184
10532749|NCT01422824|11685179|FG000|COMPLETED|Overall Study||147
10532750|NCT01422824|11685179|FG000|NOT COMPLETED|Overall Study||38
10532751|NCT01422850|11685183|FG000|STARTED|Overall Study||21
10532752|NCT01422850|11685183|FG000|Week 4 - First Treatment|Overall Study||21
10349295|NCT00430521|11487490|FG001|NOT COMPLETED|Overall Study||9
10349296|NCT00430521|11487491|FG002|NOT COMPLETED|Overall Study||3
10349297|NCT00430521|11487492|FG003|NOT COMPLETED|Overall Study||8
10349298|NCT00430521|11487493|FG004|NOT COMPLETED|Overall Study||5
10532753|NCT01422850|11685183|FG000|Week 5|Overall Study|One patient withdrawn by PI due to progressive disease|20
10532754|NCT01422850|11685183|FG000|Week 9 - Second Treatment|Overall Study||20
10532755|NCT01422850|11685183|FG000|Week 14 - Third Treatment|Overall Study|One patient withdrawn by PI and referred to external radiotherapy due to progressive disease.|19
10532756|NCT01422850|11685183|FG000|Week 15|Overall Study|One patient withdrawn by PI due to increased PSA. Started bicalutamide treatment.|18
10532757|NCT01422850|11685183|FG000|COMPLETED|Overall Study||18
10532758|NCT01422850|11685183|FG000|NOT COMPLETED|Overall Study||3
10532759|NCT01422876|11685199|FG000|STARTED|Week 24||137
10532760|NCT01422876|11685200|FG001|STARTED|Week 24||136
10532761|NCT01422876|11685201|FG002|STARTED|Week 24||141
10532762|NCT01422876|11685202|FG003|STARTED|Week 24||140
10532763|NCT01422876|11685203|FG004|STARTED|Week 24||132
10532764|NCT01422876|11685204|FG005|STARTED|Week 24||137
10532765|NCT01422876|11685205|FG006|STARTED|Week 24||136
10532766|NCT01422876|11685206|FG007|STARTED|Week 24||135
10532767|NCT01422876|11685207|FG008|STARTED|Week 24||134
10349299|NCT00430521|11487494|FG005|NOT COMPLETED|Overall Study||5
10349300|NCT00430521|11487495|FG006|NOT COMPLETED|Overall Study||10
10349301|NCT00430521|11487496|FG007|NOT COMPLETED|Overall Study||12
10349302|NCT00430573|11487527|FG000|STARTED|Overall Study||10
10349303|NCT00430573|11487527|FG000|COMPLETED|Overall Study|Only 5 took study drug on at least one occasion and 8 completed the baseline ASI.|5
10532768|NCT01422876|11685208|FG009|STARTED|Week 24||135
10532769|NCT01422876|11685199|FG000|COMPLETED|Week 24||131
10532770|NCT01422876|11685200|FG001|COMPLETED|Week 24||133
10532771|NCT01422876|11685201|FG002|COMPLETED|Week 24||136
10532772|NCT01422876|11685202|FG003|COMPLETED|Week 24||132
10532773|NCT01422876|11685203|FG004|COMPLETED|Week 24||125
10532774|NCT01422876|11685204|FG005|COMPLETED|Week 24||131
10532775|NCT01422876|11685205|FG006|COMPLETED|Week 24||130
10349304|NCT00430573|11487527|FG000|NOT COMPLETED|Overall Study||5
10349305|NCT00430625|11487534|FG000|STARTED|Overall Study||13
10349306|NCT00430625|11487535|FG001|STARTED|Overall Study||12
10349307|NCT00430625|11487534|FG000|COMPLETED|Overall Study||13
10349308|NCT00430625|11487535|FG001|COMPLETED|Overall Study||12
10349309|NCT00430625|11487534|FG000|NOT COMPLETED|Overall Study||0
10349310|NCT00430625|11487535|FG001|NOT COMPLETED|Overall Study||0
10349311|NCT00430638|11487544|FG000|STARTED|Overall Study||138
10349312|NCT00430638|11487545|FG001|STARTED|Overall Study|2 participants were erroneously assigned to olmesartan 40 mg instead of 20 mg|140
10349313|NCT00430638|11487544|FG000|COMPLETED|Overall Study||60
10349314|NCT00430638|11487545|FG001|COMPLETED|Overall Study||92
10349315|NCT00430638|11487544|FG000|NOT COMPLETED|Overall Study||78
10349316|NCT00430638|11487545|FG001|NOT COMPLETED|Overall Study||48
10349317|NCT00430677|11487558|FG000|STARTED|Short-term Period|1 participant died before receiving the first dose of study medication|99
10349318|NCT00430677|11487559|FG001|STARTED|Short-term Period|1 participant took infliximab on day 1 and was discontinued before receiving study medication.|99
10349319|NCT00430677|11487560|FG002|STARTED|Short-term Period||100
10349320|NCT00430677|11487558|FG000|COMPLETED|Short-term Period|Completed the short-term period|76
10349321|NCT00430677|11487559|FG001|COMPLETED|Short-term Period|Completed the short-term period|74
10349322|NCT00430677|11487560|FG002|COMPLETED|Short-term Period|Completed the short-term period|78
10349323|NCT00430677|11487558|FG000|NOT COMPLETED|Short-term Period||23
10349324|NCT00430677|11487559|FG001|NOT COMPLETED|Short-term Period||25
10349325|NCT00430677|11487560|FG002|NOT COMPLETED|Short-term Period||22
10349326|NCT00430677|11487558|FG000|STARTED|Long-term Extension Period||70
10349327|NCT00430677|11487559|FG001|STARTED|Long-term Extension Period||67
10349328|NCT00430677|11487560|FG002|STARTED|Long-term Extension Period||74
10349329|NCT00430677|11487558|FG000|COMPLETED|Long-term Extension Period|Completed the long-term extension period|10
10532776|NCT01422876|11685206|FG007|COMPLETED|Week 24||128
10532777|NCT01422876|11685207|FG008|COMPLETED|Week 24||128
10532778|NCT01422876|11685208|FG009|COMPLETED|Week 24||125
10532779|NCT01422876|11685199|FG000|NOT COMPLETED|Week 24||6
10532780|NCT01422876|11685200|FG001|NOT COMPLETED|Week 24||3
10532781|NCT01422876|11685201|FG002|NOT COMPLETED|Week 24||5
10532782|NCT01422876|11685202|FG003|NOT COMPLETED|Week 24||8
10532783|NCT01422876|11685203|FG004|NOT COMPLETED|Week 24||7
10532784|NCT01422876|11685204|FG005|NOT COMPLETED|Week 24||6
10532785|NCT01422876|11685205|FG006|NOT COMPLETED|Week 24||6
10532786|NCT01422876|11685206|FG007|NOT COMPLETED|Week 24||7
10532787|NCT01422876|11685207|FG008|NOT COMPLETED|Week 24||6
10532788|NCT01422876|11685208|FG009|NOT COMPLETED|Week 24||10
10532789|NCT01422876|11685199|FG000|STARTED|Week 52||137
10532790|NCT01422876|11685200|FG001|STARTED|Week 52||136
10532791|NCT01422876|11685201|FG002|STARTED|Week 52||141
10532792|NCT01422876|11685202|FG003|STARTED|Week 52||140
10532793|NCT01422876|11685203|FG004|STARTED|Week 52||132
10532794|NCT01422876|11685204|FG005|STARTED|Week 52||137
10532795|NCT01422876|11685205|FG006|STARTED|Week 52||136
10532796|NCT01422876|11685206|FG007|STARTED|Week 52||135
10532797|NCT01422876|11685207|FG008|STARTED|Week 52||134
10532798|NCT01422876|11685208|FG009|STARTED|Week 52||135
10532799|NCT01422876|11685199|FG000|COMPLETED|Week 52||125
10532800|NCT01422876|11685200|FG001|COMPLETED|Week 52||126
10532801|NCT01422876|11685201|FG002|COMPLETED|Week 52||128
10532802|NCT01422876|11685202|FG003|COMPLETED|Week 52||122
10532803|NCT01422876|11685203|FG004|COMPLETED|Week 52||117
10532804|NCT01422876|11685204|FG005|COMPLETED|Week 52||120
10532805|NCT01422876|11685205|FG006|COMPLETED|Week 52||120
10532806|NCT01422876|11685206|FG007|COMPLETED|Week 52||112
10532807|NCT01422876|11685207|FG008|COMPLETED|Week 52||113
10532808|NCT01422876|11685208|FG009|COMPLETED|Week 52||118
10532809|NCT01422876|11685199|FG000|NOT COMPLETED|Week 52||12
10532810|NCT01422876|11685200|FG001|NOT COMPLETED|Week 52||10
10532811|NCT01422876|11685201|FG002|NOT COMPLETED|Week 52||13
10532812|NCT01422876|11685202|FG003|NOT COMPLETED|Week 52||18
10532813|NCT01422876|11685203|FG004|NOT COMPLETED|Week 52||15
10532814|NCT01422876|11685204|FG005|NOT COMPLETED|Week 52||17
10532815|NCT01422876|11685205|FG006|NOT COMPLETED|Week 52||16
10532816|NCT01422876|11685206|FG007|NOT COMPLETED|Week 52||23
10532817|NCT01422876|11685207|FG008|NOT COMPLETED|Week 52||21
10532818|NCT01422876|11685208|FG009|NOT COMPLETED|Week 52||17
10532819|NCT01422889|11685226|FG000|STARTED|Overall Study||1120
10349330|NCT00430677|11487559|FG001|COMPLETED|Long-term Extension Period|Completed the long-term extension period|9
10349331|NCT00430677|11487560|FG002|COMPLETED|Long-term Extension Period|Completed the long-term extension period|11
10532820|NCT01422889|11685226|FG000|COMPLETED|Overall Study|9 subjects did not receive a study stent therefore 1111 subjects were eligible for follow up.|1111
10532821|NCT01422889|11685226|FG000|NOT COMPLETED|Overall Study||9
10532822|NCT01422915|11685230|FG000|STARTED|Overall Study|1 subject with abnormal liver chemistries removed during the first period.|4
10532823|NCT01422915|11685230|FG000|COMPLETED|Overall Study||3
10532824|NCT01422915|11685230|FG000|NOT COMPLETED|Overall Study||1
10532825|NCT01423084|11685237|FG000|STARTED|Overall Study||170
10532826|NCT01423084|11685238|FG001|STARTED|Overall Study||174
10532827|NCT01423084|11685237|FG000|COMPLETED|Overall Study||168
10532828|NCT01423084|11685238|FG001|COMPLETED|Overall Study||170
10532829|NCT01423084|11685237|FG000|NOT COMPLETED|Overall Study||2
10532830|NCT01423084|11685238|FG001|NOT COMPLETED|Overall Study||4
10532831|NCT01423162|11685247|FG000|STARTED|Overall Study||11
10532832|NCT01423162|11685248|FG001|STARTED|Overall Study||9
10532833|NCT01423162|11685247|FG000|COMPLETED|Overall Study|Crossover design: All subjects (n=20) completed both arms|11
10532834|NCT01423162|11685248|FG001|COMPLETED|Overall Study|Crossover design: All subjects (n=20) completed both arms|9
10349332|NCT00430677|11487558|FG000|NOT COMPLETED|Long-term Extension Period||60
10349333|NCT00430677|11487559|FG001|NOT COMPLETED|Long-term Extension Period||58
10349334|NCT00430677|11487560|FG002|NOT COMPLETED|Long-term Extension Period||63
10349335|NCT00430716|11487589|FG000|STARTED|Double Blind Phase||42
10349336|NCT00430716|11487590|FG001|STARTED|Double Blind Phase||43
10349337|NCT00430716|11487591|FG002|STARTED|Double Blind Phase||45
10349338|NCT00430716|11487589|FG000|Treated|Double Blind Phase||41
10349339|NCT00430716|11487590|FG001|Treated|Double Blind Phase||43
10349340|NCT00430716|11487591|FG002|Treated|Double Blind Phase||45
10349341|NCT00430716|11487589|FG000|COMPLETED|Double Blind Phase||36
10349342|NCT00430716|11487590|FG001|COMPLETED|Double Blind Phase||38
10349343|NCT00430716|11487591|FG002|COMPLETED|Double Blind Phase||39
10349344|NCT00430716|11487589|FG000|NOT COMPLETED|Double Blind Phase||6
10349345|NCT00430716|11487590|FG001|NOT COMPLETED|Double Blind Phase||5
10349346|NCT00430716|11487591|FG002|NOT COMPLETED|Double Blind Phase||6
10349347|NCT00430716|11487589|FG000|STARTED|Open Label Phase||36
10349348|NCT00430716|11487590|FG001|STARTED|Open Label Phase||38
10349349|NCT00430716|11487591|FG002|STARTED|Open Label Phase||39
10349350|NCT00430716|11487589|FG000|COMPLETED|Open Label Phase||27
10349351|NCT00430716|11487590|FG001|COMPLETED|Open Label Phase||31
10349352|NCT00430716|11487591|FG002|COMPLETED|Open Label Phase||32
10349353|NCT00430716|11487589|FG000|NOT COMPLETED|Open Label Phase||9
10349354|NCT00430716|11487590|FG001|NOT COMPLETED|Open Label Phase||7
10349355|NCT00430716|11487591|FG002|NOT COMPLETED|Open Label Phase||7
10349356|NCT00430755|11487599|FG000|STARTED|Overall Study||98
10349357|NCT00430755|11487599|FG000|COMPLETED|Overall Study||45
10349358|NCT00430755|11487599|FG000|NOT COMPLETED|Overall Study||53
10349359|NCT00430768|11487606|FG000|STARTED|Overall Study||3
10349360|NCT00430768|11487607|FG001|STARTED|Overall Study||3
10349361|NCT00430768|11487608|FG002|STARTED|Overall Study||3
10349362|NCT00430768|11487606|FG000|COMPLETED|Overall Study||3
10349363|NCT00430768|11487607|FG001|COMPLETED|Overall Study||3
10349364|NCT00430768|11487608|FG002|COMPLETED|Overall Study||3
10349365|NCT00430768|11487606|FG000|NOT COMPLETED|Overall Study||0
10349366|NCT00430768|11487607|FG001|NOT COMPLETED|Overall Study||0
10349367|NCT00430768|11487608|FG002|NOT COMPLETED|Overall Study||0
10349368|NCT00430781|11487625|FG000|STARTED|Interim Analysis; 11 February 2008||59
10349369|NCT00430781|11487626|FG001|STARTED|Interim Analysis; 11 February 2008||58
10349370|NCT00430781|11487627|FG002|STARTED|Interim Analysis; 11 February 2008||60
10349371|NCT00430781|11487625|FG000|Ongoing|Interim Analysis; 11 February 2008||23
10349372|NCT00430781|11487626|FG001|Ongoing|Interim Analysis; 11 February 2008||20
10532835|NCT01423162|11685247|FG000|NOT COMPLETED|Overall Study||0
10532836|NCT01423162|11685248|FG001|NOT COMPLETED|Overall Study||0
10532837|NCT01423253|11685254|FG000|STARTED|Overall Study||48
10532838|NCT01423253|11685254|FG000|COMPLETED|Overall Study||39
10532839|NCT01423253|11685254|FG000|NOT COMPLETED|Overall Study||9
10532840|NCT01423604|11685261|FG000|STARTED|Safety Run-In||9
10532841|NCT01423604|11685262|FG001|STARTED|Safety Run-In||0
10532842|NCT01423604|11685261|FG000|COMPLETED|Safety Run-In||0
10532843|NCT01423604|11685262|FG001|COMPLETED|Safety Run-In||0
10532844|NCT01423604|11685261|FG000|NOT COMPLETED|Safety Run-In||9
10532845|NCT01423604|11685262|FG001|NOT COMPLETED|Safety Run-In||0
10532846|NCT01423604|11685261|FG000|STARTED|Randomized||64
10532847|NCT01423604|11685262|FG001|STARTED|Randomized||63
10532848|NCT01423604|11685261|FG000|COMPLETED|Randomized|As of 07August2015, 1 subject was receiving treatment in the randomized portion.|1
10532849|NCT01423604|11685262|FG001|COMPLETED|Randomized||0
10532850|NCT01423604|11685261|FG000|NOT COMPLETED|Randomized||63
10532851|NCT01423604|11685262|FG001|NOT COMPLETED|Randomized||63
10532852|NCT01423617|11685271|FG000|STARTED|Overall Study||46
10532853|NCT01423617|11685272|FG001|STARTED|Overall Study||46
10532854|NCT01423617|11685271|FG000|COMPLETED|Overall Study||46
10532855|NCT01423617|11685272|FG001|COMPLETED|Overall Study||45
10532856|NCT01423617|11685271|FG000|NOT COMPLETED|Overall Study||0
10532857|NCT01423617|11685272|FG001|NOT COMPLETED|Overall Study||1
10532858|NCT01423760|11685280|FG000|STARTED|Overall Study||14
10532859|NCT01423760|11685281|FG001|STARTED|Overall Study||13
10532860|NCT01423760|11685280|FG000|Number of Tecemotide Subjects|Overall Study||12
10532861|NCT01423760|11685281|FG001|Number of Tecemotide Subjects|Overall Study||8
10532862|NCT01423760|11685280|FG000|Number of Non-treatment Subjects|Overall Study||2
10532863|NCT01423760|11685281|FG001|Number of Non-treatment Subjects|Overall Study||5
10532864|NCT01423760|11685280|FG000|Safety Analysis Set|Overall Study||12
10532865|NCT01423760|11685281|FG001|Safety Analysis Set|Overall Study||8
10532866|NCT01423760|11685280|FG000|COMPLETED|Overall Study||14
10532867|NCT01423760|11685281|FG001|COMPLETED|Overall Study||13
10532868|NCT01423760|11685280|FG000|NOT COMPLETED|Overall Study||0
10532869|NCT01423760|11685281|FG001|NOT COMPLETED|Overall Study||0
10532870|NCT01423773|11685287|FG000|STARTED|Period One, 2 Days||10
10532871|NCT01423773|11685288|FG001|STARTED|Period One, 2 Days||10
10532872|NCT01423773|11685287|FG000|COMPLETED|Period One, 2 Days||10
10532873|NCT01423773|11685288|FG001|COMPLETED|Period One, 2 Days||10
10349373|NCT00430781|11487627|FG002|Ongoing|Interim Analysis; 11 February 2008||25
10349374|NCT00430781|11487625|FG000|COMPLETED|Interim Analysis; 11 February 2008||0
10349375|NCT00430781|11487626|FG001|COMPLETED|Interim Analysis; 11 February 2008||0
10349376|NCT00430781|11487627|FG002|COMPLETED|Interim Analysis; 11 February 2008||0
10426768|NCT00848783|11572474|FG000|STARTED|Overall Study||4
10532874|NCT01423773|11685287|FG000|NOT COMPLETED|Period One, 2 Days||0
10532875|NCT01423773|11685288|FG001|NOT COMPLETED|Period One, 2 Days||0
10349377|NCT00430781|11487625|FG000|NOT COMPLETED|Interim Analysis; 11 February 2008||59
10349378|NCT00430781|11487626|FG001|NOT COMPLETED|Interim Analysis; 11 February 2008||58
10349379|NCT00430781|11487627|FG002|NOT COMPLETED|Interim Analysis; 11 February 2008||60
10349380|NCT00430781|11487625|FG000|STARTED|Final Analysis; 31 July 2008||0
10349381|NCT00430781|11487626|FG001|STARTED|Final Analysis; 31 July 2008||78
10349382|NCT00430781|11487627|FG002|STARTED|Final Analysis; 31 July 2008||74
10349383|NCT00430781|11487625|FG000|Ongoing|Final Analysis; 31 July 2008||0
10349384|NCT00430781|11487626|FG001|Ongoing|Final Analysis; 31 July 2008||29
10349385|NCT00430781|11487627|FG002|Ongoing|Final Analysis; 31 July 2008||32
10349386|NCT00430781|11487625|FG000|COMPLETED|Final Analysis; 31 July 2008||0
10349387|NCT00430781|11487626|FG001|COMPLETED|Final Analysis; 31 July 2008||39
10349388|NCT00430781|11487627|FG002|COMPLETED|Final Analysis; 31 July 2008||26
10349389|NCT00430781|11487625|FG000|NOT COMPLETED|Final Analysis; 31 July 2008||0
10349390|NCT00430781|11487626|FG001|NOT COMPLETED|Final Analysis; 31 July 2008||39
10349391|NCT00430781|11487627|FG002|NOT COMPLETED|Final Analysis; 31 July 2008||48
10349392|NCT00430781|11487625|FG000|STARTED|End-of-Study Analysis; 28 July 2011|Enrollment continued in this arm after data cut for Interim Analysis and before arm closed.|77
10349393|NCT00430781|11487626|FG001|STARTED|End-of-Study Analysis; 28 July 2011|1 participant randomized to lapatinib (final analysis table) actually received combination therapy.|77
10349394|NCT00430781|11487627|FG002|STARTED|End-of-Study Analysis; 28 July 2011||74
10349395|NCT00430781|11487625|FG000|COMPLETED|End-of-Study Analysis; 28 July 2011||53
10349396|NCT00430781|11487626|FG001|COMPLETED|End-of-Study Analysis; 28 July 2011||59
10349397|NCT00430781|11487627|FG002|COMPLETED|End-of-Study Analysis; 28 July 2011||54
10349398|NCT00430781|11487625|FG000|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||24
10349399|NCT00430781|11487626|FG001|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||18
10349400|NCT00430781|11487627|FG002|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||20
10349401|NCT00430937|11487640|FG000|STARTED|Overall Study|Additional 5 participants were randomized; however, they were not exposed to study drug by mistake.|97
10349402|NCT00430937|11487641|FG001|STARTED|Overall Study||92
10349403|NCT00430937|11487640|FG000|COMPLETED|Overall Study||70
10349404|NCT00430937|11487641|FG001|COMPLETED|Overall Study||64
10349405|NCT00430937|11487640|FG000|NOT COMPLETED|Overall Study||27
10349406|NCT00430937|11487641|FG001|NOT COMPLETED|Overall Study||28
10349407|NCT00430989|11487649|FG000|STARTED|Overall Study||3543
10349408|NCT00430989|11487650|FG001|STARTED|Overall Study||3569
10349409|NCT00430989|11487649|FG000|COMPLETED|Overall Study||3483
10349410|NCT00430989|11487650|FG001|COMPLETED|Overall Study||3509
10349411|NCT00430989|11487649|FG000|NOT COMPLETED|Overall Study||60
10349412|NCT00430989|11487650|FG001|NOT COMPLETED|Overall Study||60
10349413|NCT00431041|11487660|FG000|STARTED|Overall Study|Data represents Intention To Treat(ITT) Population: All randomized subjects|68
10349414|NCT00431041|11487661|FG001|STARTED|Overall Study|Data represents ITT Population: All randomized subjects|64
10349415|NCT00431041|11487660|FG000|COMPLETED|Overall Study||52
10349416|NCT00431041|11487661|FG001|COMPLETED|Overall Study||40
10349417|NCT00431041|11487660|FG000|NOT COMPLETED|Overall Study||16
10349418|NCT00431041|11487661|FG001|NOT COMPLETED|Overall Study||24
10349419|NCT00431067|11487667|FG000|STARTED|Overall Study|52 patients screened, 41 treated|41
10349420|NCT00431067|11487667|FG000|COMPLETED|Overall Study|On treatment at analysis cut-off date (22-Sep-2009)|0
10349421|NCT00431067|11487667|FG000|NOT COMPLETED|Overall Study||41
10349422|NCT00431132|11487671|FG000|STARTED|Overall Study||336
10349423|NCT00431132|11487671|FG000|COMPLETED|Overall Study||292
10349424|NCT00431132|11487671|FG000|NOT COMPLETED|Overall Study||44
10349425|NCT00431184|11487677|FG000|STARTED|1st Intervention (Day 1)||10
10349426|NCT00431184|11487678|FG001|STARTED|1st Intervention (Day 1)||9
10349427|NCT00431184|11487677|FG000|COMPLETED|1st Intervention (Day 1)||10
10349428|NCT00431184|11487678|FG001|COMPLETED|1st Intervention (Day 1)||9
10349429|NCT00431184|11487677|FG000|NOT COMPLETED|1st Intervention (Day 1)||0
10349430|NCT00431184|11487678|FG001|NOT COMPLETED|1st Intervention (Day 1)||0
10349431|NCT00431184|11487677|FG000|STARTED|Second Intervention (Day 2)||10
10349432|NCT00431184|11487678|FG001|STARTED|Second Intervention (Day 2)||9
10349433|NCT00431184|11487677|FG000|COMPLETED|Second Intervention (Day 2)||10
10349434|NCT00431184|11487678|FG001|COMPLETED|Second Intervention (Day 2)||9
10349435|NCT00431184|11487677|FG000|NOT COMPLETED|Second Intervention (Day 2)||0
10349436|NCT00431184|11487678|FG001|NOT COMPLETED|Second Intervention (Day 2)||0
10349437|NCT00431444|11487688|FG000|STARTED|Overall Study||56
10349438|NCT00431444|11487689|FG001|STARTED|Overall Study|"Initially 110 randomized, 1 participant of Raloxifene group never took study drug."|53
10349439|NCT00431444|11487688|FG000|COMPLETED|Overall Study||51
10349440|NCT00431444|11487689|FG001|COMPLETED|Overall Study||46
10349441|NCT00431444|11487688|FG000|NOT COMPLETED|Overall Study||5
10349442|NCT00431444|11487689|FG001|NOT COMPLETED|Overall Study||7
10349443|NCT00431496|11487695|FG000|STARTED|Overall Study||71
10349444|NCT00431496|11487695|FG000|COMPLETED|Overall Study||60
10349445|NCT00431496|11487695|FG000|NOT COMPLETED|Overall Study||11
10349446|NCT00431626|11487701|FG000|STARTED|Overall Study||4
10349447|NCT00431626|11487702|FG001|STARTED|Overall Study||0
10349448|NCT00431626|11487701|FG000|COMPLETED|Overall Study||4
10349449|NCT00431626|11487702|FG001|COMPLETED|Overall Study||0
10349450|NCT00431626|11487701|FG000|NOT COMPLETED|Overall Study||0
10349451|NCT00431626|11487702|FG001|NOT COMPLETED|Overall Study||0
10349452|NCT00431834|11487708|FG000|STARTED|Overall Study||75
10349453|NCT00431834|11487708|FG000|COMPLETED|Overall Study||62
10349454|NCT00431834|11487708|FG000|NOT COMPLETED|Overall Study||13
10349455|NCT00431847|11487719|FG000|STARTED|Overall Study||132
10349456|NCT00431847|11487720|FG001|STARTED|Overall Study||45
10349457|NCT00431847|11487721|FG002|STARTED|Overall Study||24
10349458|NCT00431847|11487722|FG003|STARTED|Overall Study||184
10349459|NCT00431847|11487723|FG004|STARTED|Overall Study||1
10349460|NCT00431847|11487719|FG000|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|126
10349461|NCT00431847|11487720|FG001|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|42
10349462|NCT00431847|11487721|FG002|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|20
10349463|NCT00431847|11487722|FG003|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|170
10349464|NCT00431847|11487723|FG004|COMPLETED|Overall Study||0
10349465|NCT00431847|11487719|FG000|NOT COMPLETED|Overall Study||6
10349466|NCT00431847|11487720|FG001|NOT COMPLETED|Overall Study||3
10349467|NCT00431847|11487721|FG002|NOT COMPLETED|Overall Study||4
10349468|NCT00431847|11487722|FG003|NOT COMPLETED|Overall Study||14
10349469|NCT00431847|11487723|FG004|NOT COMPLETED|Overall Study||1
10349470|NCT00431951|11487737|FG000|STARTED|Overall Study||8
10349471|NCT00431951|11487738|FG001|STARTED|Overall Study||8
10349472|NCT00431951|11487739|FG002|STARTED|Overall Study||8
10349473|NCT00431951|11487740|FG003|STARTED|Overall Study||6
10349474|NCT00431951|11487737|FG000|COMPLETED|Overall Study||7
10349475|NCT00431951|11487738|FG001|COMPLETED|Overall Study||6
10349476|NCT00431951|11487739|FG002|COMPLETED|Overall Study||6
10349477|NCT00431951|11487740|FG003|COMPLETED|Overall Study||4
10349478|NCT00431951|11487737|FG000|NOT COMPLETED|Overall Study||1
10349479|NCT00431951|11487738|FG001|NOT COMPLETED|Overall Study||2
10349480|NCT00431951|11487739|FG002|NOT COMPLETED|Overall Study||2
10349481|NCT00431951|11487740|FG003|NOT COMPLETED|Overall Study||2
10349482|NCT00431964|11487756|FG000|STARTED|Overall Study||131
10349483|NCT00431964|11487757|FG001|STARTED|Overall Study||132
10349484|NCT00431964|11487756|FG000|Randomized/Received Drug|Overall Study||131
10349485|NCT00431964|11487757|FG001|Randomized/Received Drug|Overall Study||129
10349486|NCT00431964|11487756|FG000|Did Not Receive Drug|Overall Study||0
10349487|NCT00431964|11487757|FG001|Did Not Receive Drug|Overall Study||3
10349488|NCT00431964|11487756|FG000|Withdrew From Study|Overall Study||6
10349489|NCT00431964|11487757|FG001|Withdrew From Study|Overall Study||5
10349490|NCT00431964|11487756|FG000|COMPLETED|Overall Study||125
10349491|NCT00431964|11487757|FG001|COMPLETED|Overall Study||124
10349492|NCT00431964|11487756|FG000|NOT COMPLETED|Overall Study||6
10349493|NCT00431964|11487757|FG001|NOT COMPLETED|Overall Study||8
10349494|NCT00432042|11487766|FG000|STARTED|Overall Study|Number randomized.|479
10349495|NCT00432042|11487767|FG001|STARTED|Overall Study|Number randomized.|235
10349496|NCT00432042|11487768|FG002|STARTED|Overall Study|Number randomized.|241
10349497|NCT00432042|11487766|FG000|Vaccinated|Overall Study||477
10349498|NCT00432042|11487767|FG001|Vaccinated|Overall Study||235
10349499|NCT00432042|11487768|FG002|Vaccinated|Overall Study||240
10349500|NCT00432042|11487766|FG000|COMPLETED|Overall Study||472
10349501|NCT00432042|11487767|FG001|COMPLETED|Overall Study||234
10349502|NCT00432042|11487768|FG002|COMPLETED|Overall Study||239
10349503|NCT00432042|11487766|FG000|NOT COMPLETED|Overall Study||7
10349504|NCT00432042|11487767|FG001|NOT COMPLETED|Overall Study||1
10349505|NCT00432042|11487768|FG002|NOT COMPLETED|Overall Study||2
10349506|NCT00432159|11487781|FG000|STARTED|Overall Study||185
10349507|NCT00432159|11487782|FG001|STARTED|Overall Study||167
10349508|NCT00432159|11487783|FG002|STARTED|Overall Study||39
10349509|NCT00432159|11487784|FG003|STARTED|Overall Study||20
10349510|NCT00432159|11487785|FG004|STARTED|Overall Study||89
10349511|NCT00432159|11487781|FG000|COMPLETED|Overall Study|Actual (Complete efficacy)|163
10349512|NCT00432159|11487782|FG001|COMPLETED|Overall Study|Actual (Complete efficacy)|137
10349513|NCT00432159|11487783|FG002|COMPLETED|Overall Study|Actual (Complete efficacy)|35
10349514|NCT00432159|11487784|FG003|COMPLETED|Overall Study|Actual (Complete efficacy)|15
10349515|NCT00432159|11487785|FG004|COMPLETED|Overall Study|Actual (Complete efficacy)|79
10349516|NCT00432159|11487781|FG000|NOT COMPLETED|Overall Study||22
10349517|NCT00432159|11487782|FG001|NOT COMPLETED|Overall Study||30
10349518|NCT00432159|11487783|FG002|NOT COMPLETED|Overall Study||4
10349519|NCT00432159|11487784|FG003|NOT COMPLETED|Overall Study||5
10349520|NCT00432159|11487785|FG004|NOT COMPLETED|Overall Study||10
10349521|NCT00432172|11487801|FG000|STARTED|Overall Study||47
10349522|NCT00432172|11487802|FG001|STARTED|Overall Study||48
10349523|NCT00432172|11487803|FG002|STARTED|Overall Study||46
10349524|NCT00432172|11487804|FG003|STARTED|Overall Study||48
10349525|NCT00432172|11487801|FG000|COMPLETED|Overall Study||41
10349526|NCT00432172|11487802|FG001|COMPLETED|Overall Study||41
10349527|NCT00432172|11487803|FG002|COMPLETED|Overall Study||35
10349528|NCT00432172|11487804|FG003|COMPLETED|Overall Study||41
10349529|NCT00432172|11487801|FG000|NOT COMPLETED|Overall Study||6
10349530|NCT00432172|11487802|FG001|NOT COMPLETED|Overall Study||7
10349531|NCT00432172|11487803|FG002|NOT COMPLETED|Overall Study||11
10349532|NCT00432172|11487804|FG003|NOT COMPLETED|Overall Study||7
10349533|NCT00432237|11487820|FG000|STARTED|Overall Study|1 patient in the MK0974 50 mg group was treated but withdrew consent.|244
10349534|NCT00432237|11487821|FG001|STARTED|Overall Study||485
10349535|NCT00432237|11487822|FG002|STARTED|Overall Study|1 patient in the MK0974 300 mg group was treated but withdrew consent.|484
10349536|NCT00432237|11487823|FG003|STARTED|Overall Study||490
10349537|NCT00432237|11487820|FG000|Completed--With Data|Overall Study||176
10349538|NCT00432237|11487821|FG001|Completed--With Data|Overall Study||381
10349539|NCT00432237|11487822|FG002|Completed--With Data|Overall Study||370
10349540|NCT00432237|11487823|FG003|Completed--With Data|Overall Study||365
10349541|NCT00432237|11487820|FG000|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|1
10349542|NCT00432237|11487821|FG001|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|3
10349543|NCT00432237|11487822|FG002|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|5
10349544|NCT00432237|11487823|FG003|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|1
10349545|NCT00432237|11487820|FG000|COMPLETED|Overall Study||177
10349546|NCT00432237|11487821|FG001|COMPLETED|Overall Study||384
10349547|NCT00432237|11487822|FG002|COMPLETED|Overall Study||375
10349548|NCT00432237|11487823|FG003|COMPLETED|Overall Study||366
10349549|NCT00432237|11487820|FG000|NOT COMPLETED|Overall Study||67
10349550|NCT00432237|11487821|FG001|NOT COMPLETED|Overall Study||101
10349551|NCT00432237|11487822|FG002|NOT COMPLETED|Overall Study||109
10349552|NCT00432237|11487823|FG003|NOT COMPLETED|Overall Study||124
10349553|NCT00432276|11487835|FG000|STARTED|Overall Study||404
10349554|NCT00432276|11487836|FG001|STARTED|Overall Study||399
10349555|NCT00432276|11487835|FG000|Per Protocol Set|Overall Study|Patients who received at least 1 dose of study medication and who had no major protocol violations.|303
10349556|NCT00432276|11487836|FG001|Per Protocol Set|Overall Study||306
10349557|NCT00432276|11487835|FG000|COMPLETED|Overall Study||283
10349558|NCT00432276|11487836|FG001|COMPLETED|Overall Study||243
10349559|NCT00432276|11487835|FG000|NOT COMPLETED|Overall Study||121
10349560|NCT00432276|11487836|FG001|NOT COMPLETED|Overall Study||156
10349561|NCT00432341|11487844|FG000|STARTED|Overall Study||24
10349562|NCT00432341|11487845|FG001|STARTED|Overall Study||30
10349563|NCT00432341|11487844|FG000|COMPLETED|Overall Study||24
10349564|NCT00432341|11487845|FG001|COMPLETED|Overall Study||30
10349565|NCT00432341|11487844|FG000|NOT COMPLETED|Overall Study||0
10349566|NCT00432341|11487845|FG001|NOT COMPLETED|Overall Study||0
10349567|NCT00432380|11487854|FG000|STARTED|Overall Study||150
10349568|NCT00432380|11487855|FG001|STARTED|Overall Study||150
10349569|NCT00432380|11487856|FG002|STARTED|Overall Study||75
10349570|NCT00432380|11487854|FG000|COMPLETED|Overall Study||146
10349571|NCT00432380|11487855|FG001|COMPLETED|Overall Study||146
10349572|NCT00432380|11487856|FG002|COMPLETED|Overall Study||74
10349573|NCT00432380|11487854|FG000|NOT COMPLETED|Overall Study||4
10349574|NCT00432380|11487855|FG001|NOT COMPLETED|Overall Study||4
10349575|NCT00432380|11487856|FG002|NOT COMPLETED|Overall Study||1
10349576|NCT00432458|11487867|FG000|STARTED|Overall Study||35
10349577|NCT00432458|11487868|FG001|STARTED|Overall Study||33
10349578|NCT00432458|11487867|FG000|COMPLETED|Overall Study||30
10349579|NCT00432458|11487868|FG001|COMPLETED|Overall Study||32
10349580|NCT00432458|11487867|FG000|NOT COMPLETED|Overall Study||5
10349581|NCT00432458|11487868|FG001|NOT COMPLETED|Overall Study||1
10349582|NCT00432562|11487876|FG000|STARTED|Overall Study||16
10349583|NCT00432562|11487877|FG001|STARTED|Overall Study||15
10349584|NCT00432562|11487876|FG000|COMPLETED|Overall Study||13
10349585|NCT00432562|11487877|FG001|COMPLETED|Overall Study||15
10349586|NCT00432562|11487876|FG000|NOT COMPLETED|Overall Study||3
10349587|NCT00432562|11487877|FG001|NOT COMPLETED|Overall Study||0
10349588|NCT00432601|11487885|FG000|STARTED|Time 1 to Time 2||510
10349589|NCT00432601|11487886|FG001|STARTED|Time 1 to Time 2||512
10349590|NCT00432601|11487885|FG000|COMPLETED|Time 1 to Time 2|There is large drop-off as only one-third of subjects enrolled were eligible to continue the study|141
10349591|NCT00432601|11487886|FG001|COMPLETED|Time 1 to Time 2|There is large drop-off as only one-third of subjects enrolled were eligible to continue the study|144
10349592|NCT00432601|11487885|FG000|NOT COMPLETED|Time 1 to Time 2||369
10349593|NCT00432601|11487886|FG001|NOT COMPLETED|Time 1 to Time 2||368
10349594|NCT00432601|11487885|FG000|STARTED|Time 2 to Time 3||141
10349595|NCT00432601|11487886|FG001|STARTED|Time 2 to Time 3||144
10349596|NCT00432601|11487885|FG000|COMPLETED|Time 2 to Time 3||122
10349597|NCT00432601|11487886|FG001|COMPLETED|Time 2 to Time 3||122
10349598|NCT00432601|11487885|FG000|NOT COMPLETED|Time 2 to Time 3||19
10349599|NCT00432601|11487886|FG001|NOT COMPLETED|Time 2 to Time 3||22
10349600|NCT00432666|11487894|FG000|STARTED|Main Period||73
10349601|NCT00432666|11487895|FG001|STARTED|Main Period||75
10349602|NCT00432666|11487894|FG000|COMPLETED|Main Period||71
10349603|NCT00432666|11487895|FG001|COMPLETED|Main Period||74
10349604|NCT00432666|11487894|FG000|NOT COMPLETED|Main Period||2
10349605|NCT00432666|11487895|FG001|NOT COMPLETED|Main Period||1
10349606|NCT00432666|11487894|FG000|STARTED|Open-Label Extension Period||145
10349607|NCT00432666|11487895|FG001|STARTED|Open-Label Extension Period|In the Open-Label Extension Period no placebo treatment arm was given.|0
10349608|NCT00432666|11487894|FG000|COMPLETED|Open-Label Extension Period||120
10349609|NCT00432666|11487895|FG001|COMPLETED|Open-Label Extension Period||0
10349610|NCT00432666|11487894|FG000|NOT COMPLETED|Open-Label Extension Period||25
10349611|NCT00432666|11487895|FG001|NOT COMPLETED|Open-Label Extension Period||0
10349612|NCT00432679|11487903|FG000|STARTED|Overall Study||74
10349613|NCT00432679|11487904|FG001|STARTED|Overall Study||75
10349614|NCT00432679|11487903|FG000|COMPLETED|Overall Study||69
10349615|NCT00432679|11487904|FG001|COMPLETED|Overall Study||72
10349616|NCT00432679|11487903|FG000|NOT COMPLETED|Overall Study||5
10349617|NCT00432679|11487904|FG001|NOT COMPLETED|Overall Study||3
10349618|NCT00432744|11487912|FG000|STARTED|Months 0-6||12
10349619|NCT00432744|11487913|FG001|STARTED|Months 0-6||12
10349620|NCT00432744|11487912|FG000|COMPLETED|Months 0-6||7
10349621|NCT00432744|11487913|FG001|COMPLETED|Months 0-6|"One patient in period 1 other reason for loss became too disabled to complete the 6 month test."|8
10349622|NCT00432744|11487912|FG000|NOT COMPLETED|Months 0-6||5
10349623|NCT00432744|11487913|FG001|NOT COMPLETED|Months 0-6||4
10349624|NCT00432744|11487912|FG000|STARTED|Months 7 - 12||7
10349625|NCT00432744|11487913|FG001|STARTED|Months 7 - 12||8
10349626|NCT00432744|11487912|FG000|COMPLETED|Months 7 - 12||6
10349627|NCT00432744|11487913|FG001|COMPLETED|Months 7 - 12||7
10349628|NCT00432744|11487912|FG000|NOT COMPLETED|Months 7 - 12||1
10349629|NCT00432744|11487913|FG001|NOT COMPLETED|Months 7 - 12||1
10349630|NCT00432809|11487922|FG000|STARTED|1 Year Follow-up||50
10349631|NCT00432809|11487923|FG001|STARTED|1 Year Follow-up||50
10349632|NCT00432809|11487924|FG002|STARTED|1 Year Follow-up||50
10349633|NCT00432809|11487922|FG000|COMPLETED|1 Year Follow-up||41
10349634|NCT00432809|11487923|FG001|COMPLETED|1 Year Follow-up||50
10349635|NCT00432809|11487924|FG002|COMPLETED|1 Year Follow-up||49
10349636|NCT00432809|11487922|FG000|NOT COMPLETED|1 Year Follow-up||9
10349637|NCT00432809|11487923|FG001|NOT COMPLETED|1 Year Follow-up||0
10349638|NCT00432809|11487924|FG002|NOT COMPLETED|1 Year Follow-up||1
10349639|NCT00432809|11487922|FG000|STARTED|2 Year Sub-study||20
10349640|NCT00432809|11487923|FG001|STARTED|2 Year Sub-study||20
10349641|NCT00432809|11487924|FG002|STARTED|2 Year Sub-study||20
10349642|NCT00432809|11487922|FG000|COMPLETED|2 Year Sub-study||17
10349643|NCT00432809|11487923|FG001|COMPLETED|2 Year Sub-study||18
10349644|NCT00432809|11487924|FG002|COMPLETED|2 Year Sub-study||19
10349645|NCT00432809|11487922|FG000|NOT COMPLETED|2 Year Sub-study||3
10349646|NCT00432809|11487923|FG001|NOT COMPLETED|2 Year Sub-study||2
10349647|NCT00432809|11487924|FG002|NOT COMPLETED|2 Year Sub-study||1
10349648|NCT00432835|11487934|FG000|STARTED|Overall Study||28
10349649|NCT00432835|11487935|FG001|STARTED|Overall Study||30
10349650|NCT00432835|11487934|FG000|Completed 1st Intervention|Overall Study||22
10349651|NCT00432835|11487935|FG001|Completed 1st Intervention|Overall Study||23
10349652|NCT00432835|11487934|FG000|Completed 2nd Intervention|Overall Study||22
10349653|NCT00432835|11487935|FG001|Completed 2nd Intervention|Overall Study||23
10349654|NCT00432835|11487934|FG000|COMPLETED|Overall Study|These 22 patients completed the entire 8 day protocol.|22
10349655|NCT00432835|11487935|FG001|COMPLETED|Overall Study|These 23 patients completed the entire 8 day protocol.|23
10349656|NCT00432835|11487934|FG000|NOT COMPLETED|Overall Study||6
10349657|NCT00432835|11487935|FG001|NOT COMPLETED|Overall Study||7
10349664|NCT00432991|11487952|FG000|STARTED|Overall Study||22
10349665|NCT00432991|11487953|FG001|STARTED|Overall Study||31
10349666|NCT00432991|11487952|FG000|COMPLETED|Overall Study||15
10349667|NCT00432991|11487953|FG001|COMPLETED|Overall Study||19
10349668|NCT00432991|11487952|FG000|NOT COMPLETED|Overall Study||7
10349669|NCT00432991|11487953|FG001|NOT COMPLETED|Overall Study||12
10349670|NCT00433004|11487961|FG000|STARTED|Overall Study||27
10349671|NCT00433004|11487962|FG001|STARTED|Overall Study||23
10349672|NCT00433004|11487961|FG000|COMPLETED|Overall Study||22
10349673|NCT00433004|11487962|FG001|COMPLETED|Overall Study||16
10349674|NCT00433004|11487961|FG000|NOT COMPLETED|Overall Study||5
10349675|NCT00433004|11487962|FG001|NOT COMPLETED|Overall Study||7
10349676|NCT00433017|11487970|FG000|STARTED|Overall Study||122
10349677|NCT00433017|11487971|FG001|STARTED|Overall Study||133
10349678|NCT00433017|11487970|FG000|Completed 12 Month Phase|Overall Study||114
10349679|NCT00433017|11487971|FG001|Completed 12 Month Phase|Overall Study||126
10349680|NCT00433017|11487970|FG000|COMPLETED|Overall Study||26
10349681|NCT00433017|11487971|FG001|COMPLETED|Overall Study||32
10349682|NCT00433017|11487970|FG000|NOT COMPLETED|Overall Study||96
10349683|NCT00433017|11487971|FG001|NOT COMPLETED|Overall Study||101
10349684|NCT00433147|11487981|FG000|STARTED|Overall Study||7
10349685|NCT00433147|11487982|FG001|STARTED|Overall Study||7
10349686|NCT00433147|11487983|FG002|STARTED|Overall Study||9
10349687|NCT00433147|11487984|FG003|STARTED|Overall Study||7
10349688|NCT00433147|11487981|FG000|Safety Population|Overall Study||7
10349689|NCT00433147|11487982|FG001|Safety Population|Overall Study||7
10349690|NCT00433147|11487983|FG002|Safety Population|Overall Study||9
10349691|NCT00433147|11487984|FG003|Safety Population|Overall Study||7
10349692|NCT00433147|11487981|FG000|PD Population|Overall Study||7
10349693|NCT00433147|11487982|FG001|PD Population|Overall Study||6
10349694|NCT00433147|11487983|FG002|PD Population|Overall Study||9
10349695|NCT00433147|11487984|FG003|PD Population|Overall Study||7
10349696|NCT00433147|11487981|FG000|Received at Least One Dose of Study Drug|Overall Study||7
10349697|NCT00433147|11487982|FG001|Received at Least One Dose of Study Drug|Overall Study||7
10349698|NCT00433147|11487983|FG002|Received at Least One Dose of Study Drug|Overall Study||9
10349699|NCT00433147|11487984|FG003|Received at Least One Dose of Study Drug|Overall Study||7
10349700|NCT00433147|11487981|FG000|COMPLETED|Overall Study||7
10349701|NCT00433147|11487982|FG001|COMPLETED|Overall Study||6
10349702|NCT00433147|11487983|FG002|COMPLETED|Overall Study||9
10349703|NCT00433147|11487984|FG003|COMPLETED|Overall Study||7
10349704|NCT00433147|11487981|FG000|NOT COMPLETED|Overall Study||0
10349705|NCT00433147|11487982|FG001|NOT COMPLETED|Overall Study||1
10349706|NCT00433147|11487983|FG002|NOT COMPLETED|Overall Study||0
10349707|NCT00433147|11487984|FG003|NOT COMPLETED|Overall Study||0
10349708|NCT00433160|11487996|FG000|STARTED|52-Week Double-Blind (DB) Period||137
10349709|NCT00433160|11487997|FG001|STARTED|52-Week Double-Blind (DB) Period||70
10349710|NCT00433160|11487996|FG000|Received Treatment|52-Week Double-Blind (DB) Period||136
10349711|NCT00433160|11487997|FG001|Received Treatment|52-Week Double-Blind (DB) Period||68
10349712|NCT00433160|11487996|FG000|COMPLETED|52-Week Double-Blind (DB) Period||120
10349713|NCT00433160|11487997|FG001|COMPLETED|52-Week Double-Blind (DB) Period||60
10349714|NCT00433160|11487996|FG000|NOT COMPLETED|52-Week Double-Blind (DB) Period||17
10349715|NCT00433160|11487997|FG001|NOT COMPLETED|52-Week Double-Blind (DB) Period||10
10349716|NCT00433160|11487996|FG000|STARTED|76 Weeks, 24-Week Open Label (OL) Period|One participant did not continue to first OL period due to adverse event after completing DB period.|119
10349717|NCT00433160|11487997|FG001|STARTED|76 Weeks, 24-Week Open Label (OL) Period|One participant did not continue to first OL period due to adverse event after completing DB period.|59
10349718|NCT00433160|11487996|FG000|Received Treatment|76 Weeks, 24-Week Open Label (OL) Period||119
10349719|NCT00433160|11487997|FG001|Received Treatment|76 Weeks, 24-Week Open Label (OL) Period||59
10349720|NCT00433160|11487996|FG000|COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||113
10349721|NCT00433160|11487997|FG001|COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||55
10349722|NCT00433160|11487996|FG000|NOT COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||6
10349723|NCT00433160|11487997|FG001|NOT COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||4
10349724|NCT00433160|11487996|FG000|STARTED|104 Weeks, 28-Week OL Period|Eleven participants withdrew at end of first OL period and did not continue on to second OL period.|102
10349725|NCT00433160|11487997|FG001|STARTED|104 Weeks, 28-Week OL Period|Five participants withdrew at end of first OL period and did not continue on to second OL period.|50
10349726|NCT00433160|11487996|FG000|Received Treatment|104 Weeks, 28-Week OL Period||102
10349727|NCT00433160|11487997|FG001|Received Treatment|104 Weeks, 28-Week OL Period||50
10349728|NCT00433160|11487996|FG000|COMPLETED|104 Weeks, 28-Week OL Period||92
10349729|NCT00433160|11487997|FG001|COMPLETED|104 Weeks, 28-Week OL Period||47
10349730|NCT00433160|11487996|FG000|NOT COMPLETED|104 Weeks, 28-Week OL Period||10
10349731|NCT00433160|11487997|FG001|NOT COMPLETED|104 Weeks, 28-Week OL Period||3
10349732|NCT00433199|11488009|FG000|STARTED|Double-Blind Period||40
10349733|NCT00433199|11488010|FG001|STARTED|Double-Blind Period||234
10349734|NCT00433199|11488009|FG000|COMPLETED|Double-Blind Period||28
10349735|NCT00433199|11488010|FG001|COMPLETED|Double-Blind Period||168
10349736|NCT00433199|11488009|FG000|NOT COMPLETED|Double-Blind Period||12
10349737|NCT00433199|11488010|FG001|NOT COMPLETED|Double-Blind Period||66
10349738|NCT00433199|11488009|FG000|STARTED|Open-Label Period||0
10349739|NCT00433199|11488010|FG001|STARTED|Open-Label Period||219
10349740|NCT00433199|11488009|FG000|COMPLETED|Open-Label Period||0
10349741|NCT00433199|11488010|FG001|COMPLETED|Open-Label Period||185
10349742|NCT00433199|11488009|FG000|NOT COMPLETED|Open-Label Period||0
10349743|NCT00433199|11488010|FG001|NOT COMPLETED|Open-Label Period||34
10349744|NCT00433290|11488023|FG000|STARTED|Overall Study||128
10349745|NCT00433290|11488024|FG001|STARTED|Overall Study||128
10349746|NCT00433290|11488023|FG000|COMPLETED|Overall Study||93
10349747|NCT00433290|11488024|FG001|COMPLETED|Overall Study||111
10349748|NCT00433290|11488023|FG000|NOT COMPLETED|Overall Study||35
10349749|NCT00433290|11488024|FG001|NOT COMPLETED|Overall Study||17
10349750|NCT00433329|11488030|FG000|STARTED|Overall Study||100
10349751|NCT00433329|11488030|FG000|COMPLETED|Overall Study||79
10349752|NCT00433329|11488030|FG000|NOT COMPLETED|Overall Study||21
10349753|NCT00433381|11488036|FG000|STARTED|Overall Study||63
10349754|NCT00433381|11488037|FG001|STARTED|Overall Study||60
10349755|NCT00433381|11488036|FG000|COMPLETED|Overall Study|Subjects contributing data to [the primary] analysis are considered to have completed the study.|60
10349756|NCT00433381|11488037|FG001|COMPLETED|Overall Study||57
10349757|NCT00433381|11488036|FG000|NOT COMPLETED|Overall Study||3
10349758|NCT00433381|11488037|FG001|NOT COMPLETED|Overall Study||3
10349759|NCT00433446|11488051|FG000|STARTED|Overall Study||62
10349760|NCT00433446|11488051|FG000|Eligible|Overall Study||53
10349761|NCT00433446|11488051|FG000|Eligible and Began Protocol Therapy|Overall Study||53
10349762|NCT00433446|11488051|FG000|COMPLETED|Overall Study||1
10349763|NCT00433446|11488051|FG000|NOT COMPLETED|Overall Study||61
10349764|NCT00433537|11488055|FG000|STARTED|Step 1 - VcR-CVAD Induction||45
10349765|NCT00433537|11488056|FG001|STARTED|Step 1 - VcR-CVAD Induction||22
10349766|NCT00433537|11488057|FG002|STARTED|Step 1 - VcR-CVAD Induction||10
10349767|NCT00433537|11488055|FG000|Eligible and Treated|Step 1 - VcR-CVAD Induction||44
10349768|NCT00433537|11488056|FG001|Eligible and Treated|Step 1 - VcR-CVAD Induction||22
10349769|NCT00433537|11488057|FG002|Eligible and Treated|Step 1 - VcR-CVAD Induction||9
10349770|NCT00433537|11488055|FG000|COMPLETED|Step 1 - VcR-CVAD Induction||44
10349771|NCT00433537|11488056|FG001|COMPLETED|Step 1 - VcR-CVAD Induction||22
10349772|NCT00433537|11488057|FG002|COMPLETED|Step 1 - VcR-CVAD Induction||1
10349773|NCT00433537|11488055|FG000|NOT COMPLETED|Step 1 - VcR-CVAD Induction||1
10349774|NCT00433537|11488056|FG001|NOT COMPLETED|Step 1 - VcR-CVAD Induction||0
10349775|NCT00433537|11488057|FG002|NOT COMPLETED|Step 1 - VcR-CVAD Induction||9
10349776|NCT00433537|11488055|FG000|STARTED|Step 2 - Maintenance Rituximab or ASCT|This included all treated patients regardless of eligibility.|45
10349777|NCT00433537|11488056|FG001|STARTED|Step 2 - Maintenance Rituximab or ASCT||22
10349778|NCT00433537|11488057|FG002|STARTED|Step 2 - Maintenance Rituximab or ASCT|One patient completed VcR-CVAD and then withdrew from the study.|0
10349779|NCT00433537|11488055|FG000|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||44
10349780|NCT00433537|11488056|FG001|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||22
10715832|NCT02688387|11880059|FG016|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10349781|NCT00433537|11488057|FG002|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||0
10349782|NCT00433537|11488055|FG000|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||29
10426769|NCT00848783|11572475|FG001|STARTED|Overall Study||3
10349783|NCT00433537|11488056|FG001|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||22
10349784|NCT00433537|11488057|FG002|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
10349785|NCT00433537|11488055|FG000|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||16
10349786|NCT00433537|11488056|FG001|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
10349787|NCT00433537|11488057|FG002|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
10349788|NCT00433550|11488067|FG000|STARTED|Overall Study||17
10349789|NCT00433550|11488068|FG001|STARTED|Overall Study||10
10349790|NCT00433550|11488069|FG002|STARTED|Overall Study||6
10349791|NCT00433550|11488067|FG000|COMPLETED|Overall Study||17
10349792|NCT00433550|11488068|FG001|COMPLETED|Overall Study||10
10349793|NCT00433550|11488069|FG002|COMPLETED|Overall Study||6
10349794|NCT00433550|11488067|FG000|NOT COMPLETED|Overall Study||0
10349795|NCT00433550|11488068|FG001|NOT COMPLETED|Overall Study||0
10349796|NCT00433550|11488069|FG002|NOT COMPLETED|Overall Study||0
10349797|NCT00433654|11488079|FG000|STARTED|Overall Study||258
10349798|NCT00433654|11488080|FG001|STARTED|Overall Study||206
10349799|NCT00433654|11488079|FG000|COMPLETED|Overall Study|Subjects completing the 4-month follow-up.|243
10349800|NCT00433654|11488080|FG001|COMPLETED|Overall Study|Subjects completing the 4-month follow-up.|201
10349801|NCT00433654|11488079|FG000|NOT COMPLETED|Overall Study||15
10349802|NCT00433654|11488080|FG001|NOT COMPLETED|Overall Study||5
10349803|NCT00433745|11488092|FG000|STARTED|Overall Study||4
10349804|NCT00433745|11488092|FG000|COMPLETED|Overall Study||4
10349805|NCT00433745|11488092|FG000|NOT COMPLETED|Overall Study||0
10349806|NCT00433771|11488097|FG000|STARTED|Overall Study|74 enrolled patients(signed an Informed Consent Form)were screened.58 were eligible(intent to treat)|74
10349807|NCT00433771|11488097|FG000|COMPLETED|Overall Study|55 out of 58 patients were evaluable(had a stent placed and had at least 1 week of follow up)|55
10349808|NCT00433771|11488097|FG000|NOT COMPLETED|Overall Study||19
10349809|NCT00433836|11488103|FG000|STARTED|Overall Study||151
10349810|NCT00433836|11488104|FG001|STARTED|Overall Study||149
10349811|NCT00433836|11488103|FG000|COMPLETED|Overall Study||138
10349812|NCT00433836|11488104|FG001|COMPLETED|Overall Study||143
10349813|NCT00433836|11488103|FG000|NOT COMPLETED|Overall Study||13
10349814|NCT00433836|11488104|FG001|NOT COMPLETED|Overall Study||6
10349815|NCT00433914|11488112|FG000|STARTED|Overall Study||30
10349816|NCT00433914|11488113|FG001|STARTED|Overall Study||30
10349817|NCT00433914|11488112|FG000|COMPLETED|Overall Study||30
10349818|NCT00433914|11488113|FG001|COMPLETED|Overall Study||27
10349819|NCT00433914|11488112|FG000|NOT COMPLETED|Overall Study||0
10349820|NCT00433914|11488113|FG001|NOT COMPLETED|Overall Study||3
10349821|NCT00433966|11488121|FG000|STARTED|Pharmacology Intervention/Randomization||1800
10349822|NCT00433966|11488122|FG001|STARTED|Pharmacology Intervention/Randomization||1802
10349823|NCT00433966|11488123|FG002|STARTED|Pharmacology Intervention/Randomization||0
10349824|NCT00433966|11488124|FG003|STARTED|Pharmacology Intervention/Randomization||0
10349825|NCT00433966|11488121|FG000|30-Day Follow-up|Pharmacology Intervention/Randomization||1787
10349826|NCT00433966|11488122|FG001|30-Day Follow-up|Pharmacology Intervention/Randomization||1791
10349827|NCT00433966|11488123|FG002|30-Day Follow-up|Pharmacology Intervention/Randomization||0
10349828|NCT00433966|11488124|FG003|30-Day Follow-up|Pharmacology Intervention/Randomization||0
10349829|NCT00433966|11488121|FG000|1-Year Follow-up|Pharmacology Intervention/Randomization||1696
10349830|NCT00433966|11488122|FG001|1-Year Follow-up|Pharmacology Intervention/Randomization||1702
10349831|NCT00433966|11488123|FG002|1-Year Follow-up|Pharmacology Intervention/Randomization||0
10349832|NCT00433966|11488124|FG003|1-Year Follow-up|Pharmacology Intervention/Randomization||0
10349833|NCT00433966|11488121|FG000|3-Year Follow-up|Pharmacology Intervention/Randomization||1634
10349834|NCT00433966|11488122|FG001|3-Year Follow-up|Pharmacology Intervention/Randomization||1628
10349835|NCT00433966|11488123|FG002|3-Year Follow-up|Pharmacology Intervention/Randomization||0
10349900|NCT00434148|11488179|FG001|COMPLETED|Overall Study||7
10349836|NCT00433966|11488124|FG003|3-Year Follow-up|Pharmacology Intervention/Randomization||0
10349837|NCT00433966|11488121|FG000|COMPLETED|Pharmacology Intervention/Randomization||1634
10349838|NCT00433966|11488122|FG001|COMPLETED|Pharmacology Intervention/Randomization||1628
10349839|NCT00433966|11488123|FG002|COMPLETED|Pharmacology Intervention/Randomization||0
10349840|NCT00433966|11488124|FG003|COMPLETED|Pharmacology Intervention/Randomization||0
10349841|NCT00433966|11488121|FG000|NOT COMPLETED|Pharmacology Intervention/Randomization||166
10349842|NCT00433966|11488122|FG001|NOT COMPLETED|Pharmacology Intervention/Randomization||174
10349843|NCT00433966|11488123|FG002|NOT COMPLETED|Pharmacology Intervention/Randomization||0
10349844|NCT00433966|11488124|FG003|NOT COMPLETED|Pharmacology Intervention/Randomization||0
10349845|NCT00433966|11488121|FG000|STARTED|Stent Intervention/Randomization||0
10349846|NCT00433966|11488122|FG001|STARTED|Stent Intervention/Randomization||0
10349847|NCT00433966|11488123|FG002|STARTED|Stent Intervention/Randomization||2257
10349848|NCT00433966|11488124|FG003|STARTED|Stent Intervention/Randomization||749
10349849|NCT00433966|11488121|FG000|1-Year Follow-up|Stent Intervention/Randomization||0
10349850|NCT00433966|11488122|FG001|1-Year Follow-up|Stent Intervention/Randomization||0
10349851|NCT00433966|11488123|FG002|1-Year Follow-up|Stent Intervention/Randomization||2186
10349852|NCT00433966|11488124|FG003|1-Year Follow-up|Stent Intervention/Randomization||715
10349853|NCT00433966|11488121|FG000|3-Year Follow-up|Stent Intervention/Randomization||0
10349854|NCT00433966|11488122|FG001|3-Year Follow-up|Stent Intervention/Randomization||0
10349855|NCT00433966|11488123|FG002|3-Year Follow-up|Stent Intervention/Randomization||2103
10349856|NCT00433966|11488124|FG003|3-Year Follow-up|Stent Intervention/Randomization||687
10349857|NCT00433966|11488121|FG000|COMPLETED|Stent Intervention/Randomization||0
10349858|NCT00433966|11488122|FG001|COMPLETED|Stent Intervention/Randomization||0
10349859|NCT00433966|11488123|FG002|COMPLETED|Stent Intervention/Randomization||2103
10349860|NCT00433966|11488124|FG003|COMPLETED|Stent Intervention/Randomization||687
10349861|NCT00433966|11488121|FG000|NOT COMPLETED|Stent Intervention/Randomization||0
10349862|NCT00433966|11488122|FG001|NOT COMPLETED|Stent Intervention/Randomization||0
10349863|NCT00433966|11488123|FG002|NOT COMPLETED|Stent Intervention/Randomization||154
10349864|NCT00433966|11488124|FG003|NOT COMPLETED|Stent Intervention/Randomization||62
10349865|NCT00433992|11488136|FG000|STARTED|Overall Study||28
10349866|NCT00433992|11488137|FG001|STARTED|Overall Study||28
10349867|NCT00433992|11488136|FG000|COMPLETED|Overall Study||19
10349868|NCT00433992|11488137|FG001|COMPLETED|Overall Study||20
10349869|NCT00433992|11488136|FG000|NOT COMPLETED|Overall Study||9
10349870|NCT00433992|11488137|FG001|NOT COMPLETED|Overall Study||8
10349871|NCT00434018|11488149|FG000|STARTED|Overall Study||69
10349872|NCT00434018|11488150|FG001|STARTED|Overall Study||69
10349873|NCT00434018|11488149|FG000|COMPLETED|Overall Study||52
10349874|NCT00434018|11488150|FG001|COMPLETED|Overall Study||57
10349875|NCT00434018|11488149|FG000|NOT COMPLETED|Overall Study||17
10349876|NCT00434018|11488150|FG001|NOT COMPLETED|Overall Study||12
10349877|NCT00434057|11488157|FG000|STARTED|Overall Study||1383
10349878|NCT00434057|11488157|FG000|COMPLETED|Overall Study|One patient withdrew from the study after signing the Informed Consent Form|1382
10532876|NCT01423773|11685287|FG000|STARTED|Period 2, 2 Days||10
10532877|NCT01423773|11685288|FG001|STARTED|Period 2, 2 Days||10
10532878|NCT01423773|11685287|FG000|COMPLETED|Period 2, 2 Days||10
10532879|NCT01423773|11685288|FG001|COMPLETED|Period 2, 2 Days||10
10532880|NCT01423773|11685287|FG000|NOT COMPLETED|Period 2, 2 Days||0
10532881|NCT01423773|11685288|FG001|NOT COMPLETED|Period 2, 2 Days||0
10532882|NCT01423812|11685296|FG000|STARTED|Overall Study||30
10532883|NCT01423812|11685297|FG001|STARTED|Overall Study||30
10532884|NCT01423812|11685296|FG000|COMPLETED|Overall Study||27
10532885|NCT01423812|11685297|FG001|COMPLETED|Overall Study||26
10532886|NCT01423812|11685296|FG000|NOT COMPLETED|Overall Study||3
10532887|NCT01423812|11685297|FG001|NOT COMPLETED|Overall Study||4
10532888|NCT01423916|11685308|FG000|STARTED|Overall Study||74
10349879|NCT00434057|11488157|FG000|NOT COMPLETED|Overall Study||1
10349880|NCT00434109|11488161|FG000|STARTED|Overall Study||39
10532889|NCT01423916|11685309|FG001|STARTED|Overall Study||73
10532890|NCT01423916|11685310|FG002|STARTED|Overall Study||71
10532891|NCT01423916|11685308|FG000|COMPLETED|Overall Study||63
10349881|NCT00434109|11488161|FG000|COMPLETED|Overall Study|Patients completing the maximum eight cycles of sunitinib.|21
10349882|NCT00434109|11488161|FG000|NOT COMPLETED|Overall Study||18
10349883|NCT00434122|11488167|FG000|STARTED|Overall Study|Randomised|42
10349884|NCT00434122|11488168|FG001|STARTED|Overall Study|Randomised|43
10349885|NCT00434122|11488167|FG000|Intention-to-treat (ITT) Population|Overall Study|All randomised and exposed subjects not withdrawn before Stimulation Day 1.|39
10349886|NCT00434122|11488168|FG001|Intention-to-treat (ITT) Population|Overall Study|All randomised and exposed subjects not withdrawn before Stimulation Day 1.|39
10349887|NCT00434122|11488167|FG000|COMPLETED|Overall Study||36
10349888|NCT00434122|11488168|FG001|COMPLETED|Overall Study||36
10349889|NCT00434122|11488167|FG000|NOT COMPLETED|Overall Study||6
10349890|NCT00434122|11488168|FG001|NOT COMPLETED|Overall Study||7
10349891|NCT00434148|11488178|FG000|STARTED|Overall Study|"Started indicates Full Analysis Set. Patients randomized and treated."|82
10349892|NCT00434148|11488179|FG001|STARTED|Overall Study||80
10349893|NCT00434148|11488178|FG000|Completed Month 12|Overall Study||39
10349894|NCT00434148|11488179|FG001|Completed Month 12|Overall Study||39
10349895|NCT00434148|11488178|FG000|Completed m. 12; Did Not Enter Extension|Overall Study||13
10349896|NCT00434148|11488179|FG001|Completed m. 12; Did Not Enter Extension|Overall Study||7
10349897|NCT00434148|11488178|FG000|Completed Month 12; Entered Extension|Overall Study||26
10349898|NCT00434148|11488179|FG001|Completed Month 12; Entered Extension|Overall Study||32
10349899|NCT00434148|11488178|FG000|COMPLETED|Overall Study||13
10349901|NCT00434148|11488178|FG000|NOT COMPLETED|Overall Study||69
10349902|NCT00434148|11488179|FG001|NOT COMPLETED|Overall Study||73
10349903|NCT00434161|11488188|FG000|STARTED|Overall Study||109
10349904|NCT00434161|11488189|FG001|STARTED|Overall Study||57
10349905|NCT00434161|11488190|FG002|STARTED|Overall Study||115
10349906|NCT00434161|11488188|FG000|COMPLETED|Overall Study||99
10349907|NCT00434161|11488189|FG001|COMPLETED|Overall Study||54
10349908|NCT00434161|11488190|FG002|COMPLETED|Overall Study||104
10349909|NCT00434161|11488188|FG000|NOT COMPLETED|Overall Study||10
10349910|NCT00434161|11488189|FG001|NOT COMPLETED|Overall Study||3
10349911|NCT00434161|11488190|FG002|NOT COMPLETED|Overall Study||11
10349912|NCT00434213|11488205|FG000|STARTED|Overall Study||309
10349913|NCT00434213|11488205|FG000|COMPLETED|Overall Study||260
10349914|NCT00434213|11488205|FG000|NOT COMPLETED|Overall Study||49
10349915|NCT00434252|11488211|FG000|STARTED|Overall Study||71
10349916|NCT00434252|11488212|FG001|STARTED|Overall Study||143
10349917|NCT00434252|11488211|FG000|Treated|Overall Study|One patient died and one patient withdrew prior to receiving study treatment|69
10349918|NCT00434252|11488212|FG001|Treated|Overall Study||143
10349919|NCT00434252|11488211|FG000|COMPLETED|Overall Study|Continuing study drug treatment at the time of the data cutoff.|7
10349920|NCT00434252|11488212|FG001|COMPLETED|Overall Study|Continuing study drug treatment at the time of the data cutoff.|12
10349921|NCT00434252|11488211|FG000|NOT COMPLETED|Overall Study||64
10349922|NCT00434252|11488212|FG001|NOT COMPLETED|Overall Study||131
10349923|NCT00434278|11488220|FG000|STARTED|Overall Study||14
10349924|NCT00434278|11488221|FG001|STARTED|Overall Study||13
10349925|NCT00434278|11488220|FG000|COMPLETED|Overall Study||12
10349926|NCT00434278|11488221|FG001|COMPLETED|Overall Study||13
10349927|NCT00434278|11488220|FG000|NOT COMPLETED|Overall Study||2
10349928|NCT00434278|11488221|FG001|NOT COMPLETED|Overall Study||0
10715833|NCT02688387|11880060|FG017|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10715834|NCT02688387|11880061|FG018|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10715835|NCT02688387|11880062|FG019|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10349929|NCT00434304|11488227|FG000|STARTED|Overall Study||62
10349930|NCT00434304|11488227|FG000|COMPLETED|Overall Study||42
10349931|NCT00434304|11488227|FG000|NOT COMPLETED|Overall Study||20
10349932|NCT00434330|11488238|FG000|STARTED|Overall Study||15
10349933|NCT00434330|11488239|FG001|STARTED|Overall Study||15
10349934|NCT00434330|11488240|FG002|STARTED|Overall Study||16
10349935|NCT00434330|11488241|FG003|STARTED|Overall Study||15
10349936|NCT00434330|11488242|FG004|STARTED|Overall Study||15
10349937|NCT00434330|11488243|FG005|STARTED|Overall Study||15
10349938|NCT00434330|11488238|FG000|COMPLETED|Overall Study||14
10349939|NCT00434330|11488239|FG001|COMPLETED|Overall Study||15
10349940|NCT00434330|11488240|FG002|COMPLETED|Overall Study||13
10349941|NCT00434330|11488241|FG003|COMPLETED|Overall Study||13
10349942|NCT00434330|11488242|FG004|COMPLETED|Overall Study||14
10349943|NCT00434330|11488243|FG005|COMPLETED|Overall Study||14
10349944|NCT00434330|11488238|FG000|NOT COMPLETED|Overall Study||1
10349945|NCT00434330|11488239|FG001|NOT COMPLETED|Overall Study||0
10349946|NCT00434330|11488240|FG002|NOT COMPLETED|Overall Study||3
10349947|NCT00434330|11488241|FG003|NOT COMPLETED|Overall Study||2
10349948|NCT00434330|11488242|FG004|NOT COMPLETED|Overall Study||1
10349949|NCT00434330|11488243|FG005|NOT COMPLETED|Overall Study||1
10349950|NCT00434356|11488259|FG000|STARTED|Overall Study||23
10349951|NCT00434356|11488260|FG001|STARTED|Overall Study||23
10349952|NCT00434356|11488259|FG000|COMPLETED|Overall Study||0
10349953|NCT00434356|11488260|FG001|COMPLETED|Overall Study||0
10349954|NCT00434356|11488259|FG000|NOT COMPLETED|Overall Study||23
10349955|NCT00434356|11488260|FG001|NOT COMPLETED|Overall Study||23
10715836|NCT02688387|11880063|FG020|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10349956|NCT00434421|11488266|FG000|STARTED|Overall Study||28
10349957|NCT00434421|11488266|FG000|COMPLETED|Overall Study||26
10349958|NCT00434421|11488266|FG000|NOT COMPLETED|Overall Study||2
10349959|NCT00434434|11488273|FG000|STARTED|Overall Study||23
10349960|NCT00434434|11488274|FG001|STARTED|Overall Study||24
10349961|NCT00434434|11488275|FG002|STARTED|Overall Study||14
10349962|NCT00434434|11488273|FG000|COMPLETED|Overall Study||21
10349963|NCT00434434|11488274|FG001|COMPLETED|Overall Study||24
10349964|NCT00434434|11488275|FG002|COMPLETED|Overall Study||13
10349965|NCT00434434|11488273|FG000|NOT COMPLETED|Overall Study||2
10349966|NCT00434434|11488274|FG001|NOT COMPLETED|Overall Study||0
10349967|NCT00434434|11488275|FG002|NOT COMPLETED|Overall Study||1
10349968|NCT00434512|11488289|FG000|STARTED|Overall Study||10
10349969|NCT00434512|11488290|FG001|STARTED|Overall Study||10
10349970|NCT00434512|11488291|FG002|STARTED|Overall Study||10
10349971|NCT00434512|11488292|FG003|STARTED|Overall Study||50
10349972|NCT00434512|11488293|FG004|STARTED|Overall Study||50
10349973|NCT00434512|11488294|FG005|STARTED|Overall Study||50
10349974|NCT00434512|11488289|FG000|COMPLETED|Overall Study||10
10349975|NCT00434512|11488290|FG001|COMPLETED|Overall Study||9
10349976|NCT00434512|11488291|FG002|COMPLETED|Overall Study||10
10349977|NCT00434512|11488292|FG003|COMPLETED|Overall Study||49
10349978|NCT00434512|11488293|FG004|COMPLETED|Overall Study||49
10349979|NCT00434512|11488294|FG005|COMPLETED|Overall Study||49
10349980|NCT00434512|11488289|FG000|NOT COMPLETED|Overall Study||0
10349981|NCT00434512|11488290|FG001|NOT COMPLETED|Overall Study||1
10349982|NCT00434512|11488291|FG002|NOT COMPLETED|Overall Study||0
10349983|NCT00434512|11488292|FG003|NOT COMPLETED|Overall Study||1
10349984|NCT00434512|11488293|FG004|NOT COMPLETED|Overall Study||1
10349985|NCT00434512|11488294|FG005|NOT COMPLETED|Overall Study||1
10349986|NCT00434577|11488317|FG000|STARTED|Months 0-3||164
10349987|NCT00434577|11488318|FG001|STARTED|Months 0-3||166
10349988|NCT00434577|11488319|FG002|STARTED|Months 0-3||165
10349989|NCT00434577|11488320|FG003|STARTED|Months 0-3||165
10349990|NCT00434577|11488321|FG004|STARTED|Months 0-3||54
10349991|NCT00434577|11488317|FG000|COMPLETED|Months 0-3||161
10349992|NCT00434577|11488318|FG001|COMPLETED|Months 0-3||164
10349993|NCT00434577|11488319|FG002|COMPLETED|Months 0-3||161
10349994|NCT00434577|11488320|FG003|COMPLETED|Months 0-3||164
10349995|NCT00434577|11488321|FG004|COMPLETED|Months 0-3||51
10349996|NCT00434577|11488317|FG000|NOT COMPLETED|Months 0-3||3
10349997|NCT00434577|11488318|FG001|NOT COMPLETED|Months 0-3||2
10349998|NCT00434577|11488319|FG002|NOT COMPLETED|Months 0-3||4
10349999|NCT00434577|11488320|FG003|NOT COMPLETED|Months 0-3||1
10350000|NCT00434577|11488321|FG004|NOT COMPLETED|Months 0-3||3
10715837|NCT02688387|11880064|FG021|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
10715838|NCT02688387|11880043|FG000|STARTED|Part 3A, Washout Period 3 (10 Days)||0
10715839|NCT02688387|11880044|FG001|STARTED|Part 3A, Washout Period 3 (10 Days)||0
10715840|NCT02688387|11880045|FG002|STARTED|Part 3A, Washout Period 3 (10 Days)||0
10715841|NCT02688387|11880046|FG003|STARTED|Part 3A, Washout Period 3 (10 Days)||0
10715842|NCT02688387|11880047|FG004|STARTED|Part 3A, Washout Period 3 (10 Days)||0
10715843|NCT02688387|11880048|FG005|STARTED|Part 3A, Washout Period 3 (10 Days)||0
10715844|NCT02688387|11880049|FG006|STARTED|Part 3A, Washout Period 3 (10 Days)||0
10350001|NCT00434577|11488317|FG000|STARTED|Month 12||156
10350002|NCT00434577|11488318|FG001|STARTED|Month 12||159
10350003|NCT00434577|11488319|FG002|STARTED|Month 12||159
10350004|NCT00434577|11488320|FG003|STARTED|Month 12||161
10350005|NCT00434577|11488321|FG004|STARTED|Month 12||50
10350006|NCT00434577|11488317|FG000|COMPLETED|Month 12||156
10350007|NCT00434577|11488318|FG001|COMPLETED|Month 12||159
10350008|NCT00434577|11488319|FG002|COMPLETED|Month 12||159
10350009|NCT00434577|11488320|FG003|COMPLETED|Month 12||161
10350010|NCT00434577|11488321|FG004|COMPLETED|Month 12||50
10350011|NCT00434577|11488317|FG000|NOT COMPLETED|Month 12||0
10350012|NCT00434577|11488318|FG001|NOT COMPLETED|Month 12||0
10350013|NCT00434577|11488319|FG002|NOT COMPLETED|Month 12||0
10350014|NCT00434577|11488320|FG003|NOT COMPLETED|Month 12||0
10350015|NCT00434577|11488321|FG004|NOT COMPLETED|Month 12||0
10350016|NCT00434577|11488317|FG000|STARTED|Month 24||150
10350017|NCT00434577|11488318|FG001|STARTED|Month 24||155
10350018|NCT00434577|11488319|FG002|STARTED|Month 24||154
10350019|NCT00434577|11488320|FG003|STARTED|Month 24||157
10350020|NCT00434577|11488321|FG004|STARTED|Month 24||49
10350021|NCT00434577|11488317|FG000|COMPLETED|Month 24||150
10350022|NCT00434577|11488318|FG001|COMPLETED|Month 24||155
10350023|NCT00434577|11488319|FG002|COMPLETED|Month 24||154
10350024|NCT00434577|11488320|FG003|COMPLETED|Month 24||157
10350025|NCT00434577|11488321|FG004|COMPLETED|Month 24||49
10350026|NCT00434577|11488317|FG000|NOT COMPLETED|Month 24||0
10350027|NCT00434577|11488318|FG001|NOT COMPLETED|Month 24||0
10350028|NCT00434577|11488319|FG002|NOT COMPLETED|Month 24||0
10350029|NCT00434577|11488320|FG003|NOT COMPLETED|Month 24||0
10350030|NCT00434577|11488321|FG004|NOT COMPLETED|Month 24||0
10350031|NCT00434577|11488317|FG000|STARTED|Month 36||147
10350032|NCT00434577|11488318|FG001|STARTED|Month 36||147
10350033|NCT00434577|11488319|FG002|STARTED|Month 36||150
10350034|NCT00434577|11488320|FG003|STARTED|Month 36||155
10350035|NCT00434577|11488321|FG004|STARTED|Month 36||47
10350036|NCT00434577|11488317|FG000|COMPLETED|Month 36||147
10350037|NCT00434577|11488318|FG001|COMPLETED|Month 36||147
10350038|NCT00434577|11488319|FG002|COMPLETED|Month 36||150
10350039|NCT00434577|11488320|FG003|COMPLETED|Month 36||155
10350040|NCT00434577|11488321|FG004|COMPLETED|Month 36||47
10350041|NCT00434577|11488317|FG000|NOT COMPLETED|Month 36||0
10350042|NCT00434577|11488318|FG001|NOT COMPLETED|Month 36||0
10350043|NCT00434577|11488319|FG002|NOT COMPLETED|Month 36||0
10350044|NCT00434577|11488320|FG003|NOT COMPLETED|Month 36||0
10350045|NCT00434577|11488321|FG004|NOT COMPLETED|Month 36||0
10350046|NCT00434642|11488335|FG000|STARTED|Blinded Treatment Phase||242
10350047|NCT00434642|11488336|FG001|STARTED|Blinded Treatment Phase||242
10350048|NCT00434642|11488335|FG000|COMPLETED|Blinded Treatment Phase||0
10350049|NCT00434642|11488336|FG001|COMPLETED|Blinded Treatment Phase||13
10350050|NCT00434642|11488335|FG000|NOT COMPLETED|Blinded Treatment Phase||242
10350051|NCT00434642|11488336|FG001|NOT COMPLETED|Blinded Treatment Phase||229
10350052|NCT00434642|11488335|FG000|STARTED|Open-label Treatment Phase||0
10715845|NCT02688387|11880050|FG007|STARTED|Part 3A, Washout Period 3 (10 Days)||0
10715846|NCT02688387|11880051|FG008|STARTED|Part 3A, Washout Period 3 (10 Days)||0
10715847|NCT02688387|11880052|FG009|STARTED|Part 3A, Washout Period 3 (10 Days)||0
10715848|NCT02688387|11880053|FG010|STARTED|Part 3A, Washout Period 3 (10 Days)||0
10715849|NCT02688387|11880054|FG011|STARTED|Part 3A, Washout Period 3 (10 Days)||0
10715850|NCT02688387|11880055|FG012|STARTED|Part 3A, Washout Period 3 (10 Days)||0
10715851|NCT02688387|11880056|FG013|STARTED|Part 3A, Washout Period 3 (10 Days)||0
10715852|NCT02688387|11880057|FG014|STARTED|Part 3A, Washout Period 3 (10 Days)||8
10715853|NCT02688387|11880058|FG015|STARTED|Part 3A, Washout Period 3 (10 Days)||8
10715854|NCT02688387|11880059|FG016|STARTED|Part 3A, Washout Period 3 (10 Days)||8
10715855|NCT02688387|11880060|FG017|STARTED|Part 3A, Washout Period 3 (10 Days)||8
10715856|NCT02688387|11880061|FG018|STARTED|Part 3A, Washout Period 3 (10 Days)||0
10715857|NCT02688387|11880062|FG019|STARTED|Part 3A, Washout Period 3 (10 Days)||0
10715858|NCT02688387|11880063|FG020|STARTED|Part 3A, Washout Period 3 (10 Days)||0
10350053|NCT00434642|11488336|FG001|STARTED|Open-label Treatment Phase|One participant did not continue into the open-label treatment phase.|12
10350054|NCT00434642|11488335|FG000|COMPLETED|Open-label Treatment Phase||0
10350055|NCT00434642|11488336|FG001|COMPLETED|Open-label Treatment Phase||1
10350056|NCT00434642|11488335|FG000|NOT COMPLETED|Open-label Treatment Phase||0
10350057|NCT00434642|11488336|FG001|NOT COMPLETED|Open-label Treatment Phase||11
10350058|NCT00434759|11488344|FG000|STARTED|Overall Study||46
10350059|NCT00434759|11488345|FG001|STARTED|Overall Study||43
10350060|NCT00434759|11488344|FG000|COMPLETED|Overall Study||22
10350061|NCT00434759|11488345|FG001|COMPLETED|Overall Study||38
10350062|NCT00434759|11488344|FG000|NOT COMPLETED|Overall Study||24
10350063|NCT00434759|11488345|FG001|NOT COMPLETED|Overall Study||5
10350064|NCT00434876|11488355|FG000|STARTED|Overall Study||11
10350065|NCT00434876|11488356|FG001|STARTED|Overall Study||11
10350066|NCT00434876|11488355|FG000|COMPLETED|Overall Study||10
10350067|NCT00434876|11488356|FG001|COMPLETED|Overall Study||10
10350068|NCT00434876|11488355|FG000|NOT COMPLETED|Overall Study||1
10350069|NCT00434876|11488356|FG001|NOT COMPLETED|Overall Study||1
10350070|NCT00434954|11488364|FG000|STARTED|Overall Study||248
10350071|NCT00434954|11488365|FG001|STARTED|Overall Study||246
10350072|NCT00434954|11488364|FG000|Started - Previous Treatment MET Only|Overall Study||182
10350073|NCT00434954|11488365|FG001|Started - Previous Treatment MET Only|Overall Study||181
10350074|NCT00434954|11488364|FG000|Started - Previous Treatment MET + SU|Overall Study||66
10350075|NCT00434954|11488365|FG001|Started - Previous Treatment MET + SU|Overall Study||65
10715859|NCT02688387|11880064|FG021|STARTED|Part 3A, Washout Period 3 (10 Days)||0
10715860|NCT02688387|11880043|FG000|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10350076|NCT00434954|11488364|FG000|Full Analysis Set (FAS) Overall|Overall Study|FAS=received >=1 dose of study drug. Adverse event data reported for Overall FAS.|247
10350077|NCT00434954|11488365|FG001|Full Analysis Set (FAS) Overall|Overall Study|FAS=received >=1 dose of study drug. Adverse event data reported for Overall FAS.|233
10715861|NCT02688387|11880044|FG001|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10350078|NCT00434954|11488364|FG000|FAS - Previous Treatment MET Only|Overall Study|"Baseline and efficacy data reported for FAS-Previous Treatment MET Only group."|181
10350079|NCT00434954|11488365|FG001|FAS - Previous Treatment MET Only|Overall Study|"Baseline and efficacy data reported for FAS-Previous Treatment MET Only group."|173
10350080|NCT00434954|11488364|FG000|FAS - Previous Treatment MET + SU|Overall Study||66
10350081|NCT00434954|11488365|FG001|FAS - Previous Treatment MET + SU|Overall Study||60
10350082|NCT00434954|11488364|FG000|Completed - Previous Treatment MET Only|Overall Study||135
10350083|NCT00434954|11488365|FG001|Completed - Previous Treatment MET Only|Overall Study||137
10715862|NCT02688387|11880045|FG002|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10715863|NCT02688387|11880046|FG003|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10715864|NCT02688387|11880047|FG004|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10715865|NCT02688387|11880048|FG005|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10715866|NCT02688387|11880049|FG006|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10715867|NCT02688387|11880050|FG007|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10715868|NCT02688387|11880051|FG008|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10715869|NCT02688387|11880052|FG009|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10350084|NCT00434954|11488364|FG000|Completed - Previous Treatment MET + SU|Overall Study||31
10350085|NCT00434954|11488365|FG001|Completed - Previous Treatment MET + SU|Overall Study||38
10350086|NCT00434954|11488364|FG000|COMPLETED|Overall Study||166
10350087|NCT00434954|11488365|FG001|COMPLETED|Overall Study||175
10350088|NCT00434954|11488364|FG000|NOT COMPLETED|Overall Study||82
10350089|NCT00434954|11488365|FG001|NOT COMPLETED|Overall Study||71
10350090|NCT00434967|11488375|FG000|STARTED|Overall Study||97
10350091|NCT00434967|11488376|FG001|STARTED|Overall Study||465
10350092|NCT00434967|11488377|FG002|STARTED|Overall Study||470
10350093|NCT00434967|11488378|FG003|STARTED|Overall Study||492
10350094|NCT00434967|11488375|FG000|COMPLETED|Overall Study||90
10350095|NCT00434967|11488376|FG001|COMPLETED|Overall Study||457
10350096|NCT00434967|11488377|FG002|COMPLETED|Overall Study||461
10350097|NCT00434967|11488378|FG003|COMPLETED|Overall Study||478
10350098|NCT00434967|11488375|FG000|NOT COMPLETED|Overall Study||7
10350099|NCT00434967|11488376|FG001|NOT COMPLETED|Overall Study||8
10350100|NCT00434967|11488377|FG002|NOT COMPLETED|Overall Study||9
10350101|NCT00434967|11488378|FG003|NOT COMPLETED|Overall Study||14
10350102|NCT00434993|11488390|FG000|STARTED|Overall Study||152
10350103|NCT00434993|11488391|FG001|STARTED|Overall Study||130
10350104|NCT00434993|11488390|FG000|COMPLETED|Overall Study||152
10350105|NCT00434993|11488391|FG001|COMPLETED|Overall Study||130
10350106|NCT00434993|11488390|FG000|NOT COMPLETED|Overall Study||0
10350107|NCT00434993|11488391|FG001|NOT COMPLETED|Overall Study||0
10350108|NCT00435019|11488399|FG000|STARTED|Overall Study|Randomised|177
10350109|NCT00435019|11488400|FG001|STARTED|Overall Study|Randomised|171
10350110|NCT00435019|11488399|FG000|Exposed to Study Drug|Overall Study||177
10350111|NCT00435019|11488400|FG001|Exposed to Study Drug|Overall Study|One subject withdrew before receiving study drug, and thus not included in the full analysis set.|170
10350112|NCT00435019|11488399|FG000|COMPLETED|Overall Study||164
10350113|NCT00435019|11488400|FG001|COMPLETED|Overall Study||161
10350114|NCT00435019|11488399|FG000|NOT COMPLETED|Overall Study||13
10350115|NCT00435019|11488400|FG001|NOT COMPLETED|Overall Study||10
10350116|NCT00435045|11488408|FG000|STARTED|Weeks 1-8 / 10 mg Dose Level||123
10350117|NCT00435045|11488409|FG001|STARTED|Weeks 1-8 / 10 mg Dose Level||122
10350118|NCT00435045|11488408|FG000|COMPLETED|Weeks 1-8 / 10 mg Dose Level||118
10350119|NCT00435045|11488409|FG001|COMPLETED|Weeks 1-8 / 10 mg Dose Level||118
10350120|NCT00435045|11488408|FG000|NOT COMPLETED|Weeks 1-8 / 10 mg Dose Level||5
10350121|NCT00435045|11488409|FG001|NOT COMPLETED|Weeks 1-8 / 10 mg Dose Level||4
10350122|NCT00435045|11488408|FG000|STARTED|Weeks 9-12 / 20mg Dose Level||118
10350123|NCT00435045|11488409|FG001|STARTED|Weeks 9-12 / 20mg Dose Level||118
10350124|NCT00435045|11488408|FG000|COMPLETED|Weeks 9-12 / 20mg Dose Level||113
10350125|NCT00435045|11488409|FG001|COMPLETED|Weeks 9-12 / 20mg Dose Level||113
10350126|NCT00435045|11488408|FG000|NOT COMPLETED|Weeks 9-12 / 20mg Dose Level||5
10350127|NCT00435045|11488409|FG001|NOT COMPLETED|Weeks 9-12 / 20mg Dose Level||5
10350128|NCT00435045|11488408|FG000|STARTED|Weeks 13-16 / 40mg Dose Level||113
10350129|NCT00435045|11488409|FG001|STARTED|Weeks 13-16 / 40mg Dose Level||113
10350130|NCT00435045|11488408|FG000|COMPLETED|Weeks 13-16 / 40mg Dose Level||108
10350131|NCT00435045|11488409|FG001|COMPLETED|Weeks 13-16 / 40mg Dose Level||111
10532892|NCT01423916|11685309|FG001|COMPLETED|Overall Study||53
10532893|NCT01423916|11685310|FG002|COMPLETED|Overall Study||64
10532894|NCT01423916|11685308|FG000|NOT COMPLETED|Overall Study||11
10532895|NCT01423916|11685309|FG001|NOT COMPLETED|Overall Study||20
10532896|NCT01423916|11685310|FG002|NOT COMPLETED|Overall Study||7
10532897|NCT01424033|11685329|FG000|STARTED|Overall Study||5
10532898|NCT01424033|11685329|FG000|COMPLETED|Overall Study||0
10532899|NCT01424033|11685329|FG000|NOT COMPLETED|Overall Study||5
10532900|NCT01424072|11685336|FG000|STARTED|Overall Study||27
10532901|NCT01424072|11685337|FG001|STARTED|Overall Study||26
10532902|NCT01424072|11685338|FG002|STARTED|Overall Study||22
10532903|NCT01424072|11685336|FG000|COMPLETED|Overall Study||27
10532904|NCT01424072|11685337|FG001|COMPLETED|Overall Study||26
10532905|NCT01424072|11685338|FG002|COMPLETED|Overall Study||22
10532906|NCT01424072|11685336|FG000|NOT COMPLETED|Overall Study||0
10532907|NCT01424072|11685337|FG001|NOT COMPLETED|Overall Study||0
10532908|NCT01424072|11685338|FG002|NOT COMPLETED|Overall Study||0
10532909|NCT01424189|11685348|FG000|STARTED|Overall Study||386
10532910|NCT01424189|11685349|FG001|STARTED|Overall Study||188
10715870|NCT02688387|11880053|FG010|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10715871|NCT02688387|11880054|FG011|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10350132|NCT00435045|11488408|FG000|NOT COMPLETED|Weeks 13-16 / 40mg Dose Level||5
10350133|NCT00435045|11488409|FG001|NOT COMPLETED|Weeks 13-16 / 40mg Dose Level||2
10350134|NCT00435162|11488418|FG000|STARTED|Period 1 (6 Weeks)||15
10532911|NCT01424189|11685348|FG000|COMPLETED|Overall Study||373
10532912|NCT01424189|11685349|FG001|COMPLETED|Overall Study||182
10532913|NCT01424189|11685348|FG000|NOT COMPLETED|Overall Study||13
10532914|NCT01424189|11685349|FG001|NOT COMPLETED|Overall Study||6
10532915|NCT01424215|11685357|FG000|STARTED|Overall Study||50
10350135|NCT00435162|11488419|FG001|STARTED|Period 1 (6 Weeks)||15
10350136|NCT00435162|11488420|FG002|STARTED|Period 1 (6 Weeks)||6
10350137|NCT00435162|11488421|FG003|STARTED|Period 1 (6 Weeks)||8
10350138|NCT00435162|11488422|FG004|STARTED|Period 1 (6 Weeks)||15
10350139|NCT00435162|11488423|FG005|STARTED|Period 1 (6 Weeks)||15
10350140|NCT00435162|11488418|FG000|COMPLETED|Period 1 (6 Weeks)||15
10350141|NCT00435162|11488419|FG001|COMPLETED|Period 1 (6 Weeks)||15
10350142|NCT00435162|11488420|FG002|COMPLETED|Period 1 (6 Weeks)||6
10350143|NCT00435162|11488421|FG003|COMPLETED|Period 1 (6 Weeks)||8
10350144|NCT00435162|11488422|FG004|COMPLETED|Period 1 (6 Weeks)||15
10350145|NCT00435162|11488423|FG005|COMPLETED|Period 1 (6 Weeks)||15
10350146|NCT00435162|11488418|FG000|NOT COMPLETED|Period 1 (6 Weeks)||0
10350147|NCT00435162|11488419|FG001|NOT COMPLETED|Period 1 (6 Weeks)||0
10350148|NCT00435162|11488420|FG002|NOT COMPLETED|Period 1 (6 Weeks)||0
10350149|NCT00435162|11488421|FG003|NOT COMPLETED|Period 1 (6 Weeks)||0
10350150|NCT00435162|11488422|FG004|NOT COMPLETED|Period 1 (6 Weeks)||0
10532916|NCT01424215|11685358|FG001|STARTED|Overall Study||50
10532917|NCT01424215|11685357|FG000|COMPLETED|Overall Study||50
10532918|NCT01424215|11685358|FG001|COMPLETED|Overall Study||50
10532919|NCT01424215|11685357|FG000|NOT COMPLETED|Overall Study||0
10532920|NCT01424215|11685358|FG001|NOT COMPLETED|Overall Study||0
10532921|NCT01424228|11685366|FG000|STARTED|Overall Study||182
10532922|NCT01424228|11685367|FG001|STARTED|Overall Study||182
10532923|NCT01424228|11685366|FG000|COMPLETED|Overall Study||126
10532924|NCT01424228|11685367|FG001|COMPLETED|Overall Study||135
10532925|NCT01424228|11685366|FG000|NOT COMPLETED|Overall Study||56
10532926|NCT01424228|11685367|FG001|NOT COMPLETED|Overall Study||47
10532927|NCT01424293|11685373|FG000|STARTED|Overall Study||7
10532928|NCT01424293|11685373|FG000|COMPLETED|Overall Study||7
10532929|NCT01424293|11685373|FG000|NOT COMPLETED|Overall Study||0
10532930|NCT01424306|11685377|FG000|STARTED|Overall Study||4
10532931|NCT01424306|11685378|FG001|STARTED|Overall Study||4
10715872|NCT02688387|11880055|FG012|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10715873|NCT02688387|11880056|FG013|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10715874|NCT02688387|11880057|FG014|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
10715875|NCT02688387|11880058|FG015|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
10715876|NCT02688387|11880059|FG016|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
10715877|NCT02688387|11880060|FG017|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
10715878|NCT02688387|11880061|FG018|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10715879|NCT02688387|11880062|FG019|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10715880|NCT02688387|11880063|FG020|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10715881|NCT02688387|11880064|FG021|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10777238|NCT03338062|11939178|FG000|STARTED|Overall Study||10
10350151|NCT00435162|11488423|FG005|NOT COMPLETED|Period 1 (6 Weeks)||0
10532932|NCT01424306|11685379|FG002|STARTED|Overall Study||3
10532933|NCT01424306|11685380|FG003|STARTED|Overall Study||3
10532934|NCT01424306|11685381|FG004|STARTED|Overall Study||5
10532935|NCT01424306|11685382|FG005|STARTED|Overall Study||6
10532936|NCT01424306|11685377|FG000|COMPLETED|Overall Study||4
10532937|NCT01424306|11685378|FG001|COMPLETED|Overall Study||4
10532938|NCT01424306|11685379|FG002|COMPLETED|Overall Study||3
10532939|NCT01424306|11685380|FG003|COMPLETED|Overall Study||3
10532940|NCT01424306|11685381|FG004|COMPLETED|Overall Study||4
10532941|NCT01424306|11685382|FG005|COMPLETED|Overall Study||6
10532942|NCT01424306|11685377|FG000|NOT COMPLETED|Overall Study||0
10532943|NCT01424306|11685378|FG001|NOT COMPLETED|Overall Study||0
10532944|NCT01424306|11685379|FG002|NOT COMPLETED|Overall Study||0
10532945|NCT01424306|11685380|FG003|NOT COMPLETED|Overall Study||0
10532946|NCT01424306|11685381|FG004|NOT COMPLETED|Overall Study||1
10532947|NCT01424306|11685382|FG005|NOT COMPLETED|Overall Study||0
10532948|NCT01424397|11685426|FG000|STARTED|Period-1 (8 Days)||7
10532949|NCT01424397|11685427|FG001|STARTED|Period-1 (8 Days)||8
10532950|NCT01424397|11685428|FG002|STARTED|Period-1 (8 Days)||8
10532951|NCT01424397|11685429|FG003|STARTED|Period-1 (8 Days)||8
10532952|NCT01424397|11685430|FG004|STARTED|Period-1 (8 Days)||8
10532953|NCT01424397|11685431|FG005|STARTED|Period-1 (8 Days)||8
10532954|NCT01424397|11685432|FG006|STARTED|Period-1 (8 Days)||4
10532955|NCT01424397|11685433|FG007|STARTED|Period-1 (8 Days)||4
10532956|NCT01424397|11685434|FG008|STARTED|Period-1 (8 Days)||4
10532957|NCT01424397|11685435|FG009|STARTED|Period-1 (8 Days)||3
10532958|NCT01424397|11685436|FG010|STARTED|Period-1 (8 Days)||4
10532959|NCT01424397|11685437|FG011|STARTED|Period-1 (8 Days)||4
10532960|NCT01424397|11685426|FG000|COMPLETED|Period-1 (8 Days)||7
10532961|NCT01424397|11685427|FG001|COMPLETED|Period-1 (8 Days)||8
10532962|NCT01424397|11685428|FG002|COMPLETED|Period-1 (8 Days)||8
10532963|NCT01424397|11685429|FG003|COMPLETED|Period-1 (8 Days)||8
10532964|NCT01424397|11685430|FG004|COMPLETED|Period-1 (8 Days)||8
10532965|NCT01424397|11685431|FG005|COMPLETED|Period-1 (8 Days)||8
10532966|NCT01424397|11685432|FG006|COMPLETED|Period-1 (8 Days)||4
10532967|NCT01424397|11685433|FG007|COMPLETED|Period-1 (8 Days)||4
10532968|NCT01424397|11685434|FG008|COMPLETED|Period-1 (8 Days)||4
10532969|NCT01424397|11685435|FG009|COMPLETED|Period-1 (8 Days)||3
10532970|NCT01424397|11685436|FG010|COMPLETED|Period-1 (8 Days)||4
10532971|NCT01424397|11685437|FG011|COMPLETED|Period-1 (8 Days)||4
10532972|NCT01424397|11685426|FG000|NOT COMPLETED|Period-1 (8 Days)||0
10532973|NCT01424397|11685427|FG001|NOT COMPLETED|Period-1 (8 Days)||0
10532974|NCT01424397|11685428|FG002|NOT COMPLETED|Period-1 (8 Days)||0
10532975|NCT01424397|11685429|FG003|NOT COMPLETED|Period-1 (8 Days)||0
10350152|NCT00435162|11488418|FG000|STARTED|Period 2 (2 Weeks)||15
10350153|NCT00435162|11488419|FG001|STARTED|Period 2 (2 Weeks)||15
10350154|NCT00435162|11488420|FG002|STARTED|Period 2 (2 Weeks)||6
10350155|NCT00435162|11488421|FG003|STARTED|Period 2 (2 Weeks)||8
10350156|NCT00435162|11488422|FG004|STARTED|Period 2 (2 Weeks)||15
10350157|NCT00435162|11488423|FG005|STARTED|Period 2 (2 Weeks)||15
10350158|NCT00435162|11488418|FG000|COMPLETED|Period 2 (2 Weeks)||15
10350159|NCT00435162|11488419|FG001|COMPLETED|Period 2 (2 Weeks)||14
10350160|NCT00435162|11488420|FG002|COMPLETED|Period 2 (2 Weeks)||6
10350161|NCT00435162|11488421|FG003|COMPLETED|Period 2 (2 Weeks)||8
10350162|NCT00435162|11488422|FG004|COMPLETED|Period 2 (2 Weeks)||15
10350163|NCT00435162|11488423|FG005|COMPLETED|Period 2 (2 Weeks)||15
10350164|NCT00435162|11488418|FG000|NOT COMPLETED|Period 2 (2 Weeks)||0
10350165|NCT00435162|11488419|FG001|NOT COMPLETED|Period 2 (2 Weeks)||1
10350166|NCT00435162|11488420|FG002|NOT COMPLETED|Period 2 (2 Weeks)||0
10350167|NCT00435162|11488421|FG003|NOT COMPLETED|Period 2 (2 Weeks)||0
10350168|NCT00435162|11488422|FG004|NOT COMPLETED|Period 2 (2 Weeks)||0
10350169|NCT00435162|11488423|FG005|NOT COMPLETED|Period 2 (2 Weeks)||0
10350170|NCT00435188|11488438|FG000|STARTED|Overall Study||199
10350171|NCT00435188|11488439|FG001|STARTED|Overall Study||199
10350172|NCT00435188|11488438|FG000|COMPLETED|Overall Study||177
10350173|NCT00435188|11488439|FG001|COMPLETED|Overall Study||176
10350174|NCT00435188|11488438|FG000|NOT COMPLETED|Overall Study||22
10350175|NCT00435188|11488439|FG001|NOT COMPLETED|Overall Study||23
10350176|NCT00435370|11488449|FG000|STARTED|Overall Study||90
10350177|NCT00435370|11488450|FG001|STARTED|Overall Study|The recruitment restarted in August, 2010.|89
10350178|NCT00435370|11488449|FG000|COMPLETED|Overall Study||68
10350179|NCT00435370|11488450|FG001|COMPLETED|Overall Study|The entire recruitment has been completed in December, 2011.|69
10350180|NCT00435370|11488449|FG000|NOT COMPLETED|Overall Study||22
10350181|NCT00435370|11488450|FG001|NOT COMPLETED|Overall Study||20
10350182|NCT00435409|11488458|FG000|STARTED|Overall Study||221
10350183|NCT00435409|11488459|FG001|STARTED|Overall Study||143
10350184|NCT00435409|11488460|FG002|STARTED|Overall Study||78
10350185|NCT00435409|11488458|FG000|Treated|Overall Study||217
10350186|NCT00435409|11488459|FG001|Treated|Overall Study||139
10350187|NCT00435409|11488460|FG002|Treated|Overall Study||78
10350188|NCT00435409|11488458|FG000|COMPLETED|Overall Study||0
10350189|NCT00435409|11488459|FG001|COMPLETED|Overall Study||0
10350190|NCT00435409|11488460|FG002|COMPLETED|Overall Study||0
10350191|NCT00435409|11488458|FG000|NOT COMPLETED|Overall Study||221
10350192|NCT00435409|11488459|FG001|NOT COMPLETED|Overall Study||143
10350193|NCT00435409|11488460|FG002|NOT COMPLETED|Overall Study||78
10426770|NCT00848783|11572476|FG002|STARTED|Overall Study||1
10426771|NCT00848783|11572474|FG000|COMPLETED|Overall Study||1
10426772|NCT00848783|11572475|FG001|COMPLETED|Overall Study||1
10426773|NCT00848783|11572476|FG002|COMPLETED|Overall Study||1
10426774|NCT00848783|11572474|FG000|NOT COMPLETED|Overall Study||3
10426775|NCT00848783|11572475|FG001|NOT COMPLETED|Overall Study||2
10426776|NCT00848783|11572476|FG002|NOT COMPLETED|Overall Study||0
10426777|NCT00848926|11572483|FG000|STARTED|Treatment Period||102
10426778|NCT00848926|11572483|FG000|COMPLETED|Treatment Period|Number who completed 16 cycles of treatment|18
10426779|NCT00848926|11572483|FG000|NOT COMPLETED|Treatment Period||84
10655799|NCT02211014|11816554|FG001|STARTED|Overall Study||14
10426780|NCT00848926|11572483|FG000|STARTED|Follow-up Period|All participants were to be followed after treatment|102
10426781|NCT00848926|11572483|FG000|COMPLETED|Follow-up Period|Completed survival follow-up due to death [57] or study termination by sponsor [33]|90
10426782|NCT00848926|11572483|FG000|NOT COMPLETED|Follow-up Period||12
10426783|NCT00848965|11572487|FG000|STARTED|Overall Study||59
10426784|NCT00848965|11572487|FG000|COMPLETED|Overall Study||57
10426785|NCT00848965|11572487|FG000|NOT COMPLETED|Overall Study||2
10426786|NCT00849017|11572502|FG000|STARTED|Treatment Period (156 Weeks)||101
10426787|NCT00849017|11572503|FG001|STARTED|Treatment Period (156 Weeks)||101
10426788|NCT00849017|11572504|FG002|STARTED|Treatment Period (156 Weeks)||99
10426789|NCT00849017|11572502|FG000|COMPLETED|Treatment Period (156 Weeks)||58
10426790|NCT00849017|11572503|FG001|COMPLETED|Treatment Period (156 Weeks)||68
10426791|NCT00849017|11572504|FG002|COMPLETED|Treatment Period (156 Weeks)||57
10426792|NCT00849017|11572502|FG000|NOT COMPLETED|Treatment Period (156 Weeks)||43
10426793|NCT00849017|11572503|FG001|NOT COMPLETED|Treatment Period (156 Weeks)||33
10426794|NCT00849017|11572504|FG002|NOT COMPLETED|Treatment Period (156 Weeks)||42
10426795|NCT00849017|11572502|FG000|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
10426796|NCT00849017|11572503|FG001|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
10426797|NCT00849017|11572504|FG002|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|99
10426798|NCT00849017|11572502|FG000|COMPLETED|Follow-up Period (8 Weeks)||76
10715882|NCT02688387|11880043|FG000|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10715883|NCT02688387|11880044|FG001|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10426799|NCT00849017|11572503|FG001|COMPLETED|Follow-up Period (8 Weeks)||83
10426800|NCT00849017|11572504|FG002|COMPLETED|Follow-up Period (8 Weeks)||74
10426801|NCT00849017|11572502|FG000|NOT COMPLETED|Follow-up Period (8 Weeks)||25
10426802|NCT00849017|11572503|FG001|NOT COMPLETED|Follow-up Period (8 Weeks)||18
10426803|NCT00849017|11572504|FG002|NOT COMPLETED|Follow-up Period (8 Weeks)||25
10426804|NCT00849056|11572518|FG000|STARTED|Treatment Period (TP) (156 Weeks)||151
10426805|NCT00849056|11572519|FG001|STARTED|Treatment Period (TP) (156 Weeks)||150
10426806|NCT00849056|11572518|FG000|COMPLETED|Treatment Period (TP) (156 Weeks)||88
10426807|NCT00849056|11572519|FG001|COMPLETED|Treatment Period (TP) (156 Weeks)||100
10350194|NCT00435461|11488469|FG000|STARTED|Overall Study||313
10350195|NCT00435461|11488470|FG001|STARTED|Overall Study||312
10350196|NCT00435461|11488471|FG002|STARTED|Overall Study||311
10350197|NCT00435461|11488469|FG000|COMPLETED|Overall Study||290
10350198|NCT00435461|11488470|FG001|COMPLETED|Overall Study||298
10350199|NCT00435461|11488471|FG002|COMPLETED|Overall Study||287
10350200|NCT00435461|11488469|FG000|NOT COMPLETED|Overall Study||23
10350201|NCT00435461|11488470|FG001|NOT COMPLETED|Overall Study||14
10350202|NCT00435461|11488471|FG002|NOT COMPLETED|Overall Study||24
10350203|NCT00435487|11488481|FG000|STARTED|Overall Study|87 subjects were randomized however one additional subject originally randomized to UFH was treated.|88
10350204|NCT00435487|11488482|FG001|STARTED|Overall Study||86
10350205|NCT00435487|11488481|FG000|TREATED|Overall Study|One additional subject originally randomized to Unfractioned Heparin was treated with Dalteparin.|88
10350206|NCT00435487|11488482|FG001|TREATED|Overall Study|One subject was mistakenly treated with Dalteparin, two subjects withdrew consent before treatment.|83
10350207|NCT00435487|11488481|FG000|COMPLETED|Overall Study||76
10532976|NCT01424397|11685430|FG004|NOT COMPLETED|Period-1 (8 Days)||0
10532977|NCT01424397|11685431|FG005|NOT COMPLETED|Period-1 (8 Days)||0
10532978|NCT01424397|11685432|FG006|NOT COMPLETED|Period-1 (8 Days)||0
10532979|NCT01424397|11685433|FG007|NOT COMPLETED|Period-1 (8 Days)||0
10532980|NCT01424397|11685434|FG008|NOT COMPLETED|Period-1 (8 Days)||0
10532981|NCT01424397|11685435|FG009|NOT COMPLETED|Period-1 (8 Days)||0
10532982|NCT01424397|11685436|FG010|NOT COMPLETED|Period-1 (8 Days)||0
10532983|NCT01424397|11685437|FG011|NOT COMPLETED|Period-1 (8 Days)||0
10532984|NCT01424397|11685426|FG000|STARTED|Washout Period-1 (14-20 Days)||7
10532985|NCT01424397|11685427|FG001|STARTED|Washout Period-1 (14-20 Days)||8
10532986|NCT01424397|11685428|FG002|STARTED|Washout Period-1 (14-20 Days)||8
10532987|NCT01424397|11685429|FG003|STARTED|Washout Period-1 (14-20 Days)||8
10532988|NCT01424397|11685430|FG004|STARTED|Washout Period-1 (14-20 Days)||8
10532989|NCT01424397|11685431|FG005|STARTED|Washout Period-1 (14-20 Days)||8
10532990|NCT01424397|11685432|FG006|STARTED|Washout Period-1 (14-20 Days)||4
10532991|NCT01424397|11685433|FG007|STARTED|Washout Period-1 (14-20 Days)||4
10532992|NCT01424397|11685434|FG008|STARTED|Washout Period-1 (14-20 Days)||4
10532993|NCT01424397|11685435|FG009|STARTED|Washout Period-1 (14-20 Days)||3
10655782|NCT02210689|11816534|FG002|mITT Population|Overall Study||107
10655783|NCT02210689|11816532|FG000|PP Population|Overall Study||164
10655784|NCT02210689|11816533|FG001|PP Population|Overall Study||169
10655785|NCT02210689|11816534|FG002|PP Population|Overall Study||84
10655786|NCT02210689|11816532|FG000|COMPLETED|Overall Study||190
10655787|NCT02210689|11816533|FG001|COMPLETED|Overall Study||193
10655788|NCT02210689|11816534|FG002|COMPLETED|Overall Study||99
10655789|NCT02210689|11816532|FG000|NOT COMPLETED|Overall Study||52
10655790|NCT02210689|11816533|FG001|NOT COMPLETED|Overall Study||47
10655791|NCT02210689|11816534|FG002|NOT COMPLETED|Overall Study||23
10655792|NCT02210780|11816544|FG000|STARTED|Overall Study||97
10655793|NCT02210780|11816545|FG001|STARTED|Overall Study||97
10655794|NCT02210780|11816544|FG000|COMPLETED|Overall Study||92
10655795|NCT02210780|11816545|FG001|COMPLETED|Overall Study||89
10655796|NCT02210780|11816544|FG000|NOT COMPLETED|Overall Study||5
10655797|NCT02210780|11816545|FG001|NOT COMPLETED|Overall Study||8
10655798|NCT02211014|11816553|FG000|STARTED|Overall Study||13
10655800|NCT02211014|11816553|FG000|COMPLETED|Overall Study||11
10655801|NCT02211014|11816554|FG001|COMPLETED|Overall Study||8
10655802|NCT02211014|11816553|FG000|NOT COMPLETED|Overall Study||2
10655803|NCT02211014|11816554|FG001|NOT COMPLETED|Overall Study||6
10655804|NCT02211261|11816587|FG000|STARTED|Overall Study||9
10655805|NCT02211261|11816588|FG001|STARTED|Overall Study||6
10655806|NCT02211261|11816589|FG002|STARTED|Overall Study||6
10305587|NCT00094575|11438554|FG001|COMPLETED|Overall Study||291
10305588|NCT00094575|11438553|FG000|NOT COMPLETED|Overall Study||146
10305589|NCT00094575|11438554|FG001|NOT COMPLETED|Overall Study||146
10305590|NCT00094653|11438565|FG000|STARTED|Overall Study||403
10305591|NCT00094653|11438566|FG001|STARTED|Overall Study||137
10305592|NCT00094653|11438567|FG002|STARTED|Overall Study||136
10305593|NCT00094653|11438565|FG000|Treated|Overall Study||381
10305594|NCT00094653|11438566|FG001|Treated|Overall Study||131
10305595|NCT00094653|11438567|FG002|Treated|Overall Study||131
10305596|NCT00094653|11438565|FG000|COMPLETED|Overall Study||82
10305597|NCT00094653|11438566|FG001|COMPLETED|Overall Study||31
10305598|NCT00094653|11438567|FG002|COMPLETED|Overall Study||10
10305599|NCT00094653|11438565|FG000|NOT COMPLETED|Overall Study||321
10655807|NCT02211261|11816590|FG003|STARTED|Overall Study||6
10655808|NCT02211261|11816591|FG004|STARTED|Overall Study||9
10655809|NCT02211261|11816592|FG005|STARTED|Overall Study||2
10655810|NCT02211261|11816593|FG006|STARTED|Overall Study||6
10655811|NCT02211261|11816594|FG007|STARTED|Overall Study||8
10655812|NCT02211261|11816595|FG008|STARTED|Overall Study||8
10305600|NCT00094653|11438566|FG001|NOT COMPLETED|Overall Study||106
10655813|NCT02211261|11816596|FG009|STARTED|Overall Study||16
10655814|NCT02211261|11816597|FG010|STARTED|Overall Study||8
10655815|NCT02211261|11816587|FG000|COMPLETED|Overall Study||9
10350208|NCT00435487|11488482|FG001|COMPLETED|Overall Study||71
10350209|NCT00435487|11488481|FG000|NOT COMPLETED|Overall Study||12
10350210|NCT00435487|11488482|FG001|NOT COMPLETED|Overall Study||15
10350211|NCT00435539|11488493|FG000|STARTED|Overall Study||12
10350212|NCT00435539|11488494|FG001|STARTED|Overall Study||13
10350213|NCT00435539|11488495|FG002|STARTED|Overall Study||11
10350214|NCT00435539|11488496|FG003|STARTED|Overall Study||12
10350215|NCT00435539|11488497|FG004|STARTED|Overall Study||12
10350216|NCT00435539|11488493|FG000|COMPLETED|Overall Study||12
10350217|NCT00435539|11488494|FG001|COMPLETED|Overall Study||13
10350218|NCT00435539|11488495|FG002|COMPLETED|Overall Study||11
10350219|NCT00435539|11488496|FG003|COMPLETED|Overall Study||12
10350220|NCT00435539|11488497|FG004|COMPLETED|Overall Study||12
10532994|NCT01424397|11685436|FG010|STARTED|Washout Period-1 (14-20 Days)||4
10532995|NCT01424397|11685437|FG011|STARTED|Washout Period-1 (14-20 Days)||4
10532996|NCT01424397|11685426|FG000|COMPLETED|Washout Period-1 (14-20 Days)||7
10532997|NCT01424397|11685427|FG001|COMPLETED|Washout Period-1 (14-20 Days)||8
10532998|NCT01424397|11685428|FG002|COMPLETED|Washout Period-1 (14-20 Days)||8
10532999|NCT01424397|11685429|FG003|COMPLETED|Washout Period-1 (14-20 Days)||8
10533000|NCT01424397|11685430|FG004|COMPLETED|Washout Period-1 (14-20 Days)||8
10533001|NCT01424397|11685431|FG005|COMPLETED|Washout Period-1 (14-20 Days)||8
10533002|NCT01424397|11685432|FG006|COMPLETED|Washout Period-1 (14-20 Days)||4
10533003|NCT01424397|11685433|FG007|COMPLETED|Washout Period-1 (14-20 Days)||4
10533004|NCT01424397|11685434|FG008|COMPLETED|Washout Period-1 (14-20 Days)||4
10533005|NCT01424397|11685435|FG009|COMPLETED|Washout Period-1 (14-20 Days)||3
10533006|NCT01424397|11685436|FG010|COMPLETED|Washout Period-1 (14-20 Days)||4
10533007|NCT01424397|11685437|FG011|COMPLETED|Washout Period-1 (14-20 Days)||4
10533008|NCT01424397|11685426|FG000|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
10533009|NCT01424397|11685427|FG001|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
10533010|NCT01424397|11685428|FG002|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
10533011|NCT01424397|11685429|FG003|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
10533012|NCT01424397|11685430|FG004|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
10533013|NCT01424397|11685431|FG005|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
10533014|NCT01424397|11685432|FG006|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
10533015|NCT01424397|11685433|FG007|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
10533016|NCT01424397|11685434|FG008|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
10533017|NCT01424397|11685435|FG009|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
10533018|NCT01424397|11685436|FG010|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
10533019|NCT01424397|11685437|FG011|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
10533020|NCT01424397|11685426|FG000|STARTED|Period-2 (8 Days)||7
10533021|NCT01424397|11685427|FG001|STARTED|Period-2 (8 Days)||8
10533022|NCT01424397|11685428|FG002|STARTED|Period-2 (8 Days)||8
10533023|NCT01424397|11685429|FG003|STARTED|Period-2 (8 Days)||8
10533024|NCT01424397|11685430|FG004|STARTED|Period-2 (8 Days)||8
10533025|NCT01424397|11685431|FG005|STARTED|Period-2 (8 Days)||8
10533026|NCT01424397|11685432|FG006|STARTED|Period-2 (8 Days)||4
10533027|NCT01424397|11685433|FG007|STARTED|Period-2 (8 Days)||4
10533028|NCT01424397|11685434|FG008|STARTED|Period-2 (8 Days)||4
10533029|NCT01424397|11685435|FG009|STARTED|Period-2 (8 Days)||3
10533030|NCT01424397|11685436|FG010|STARTED|Period-2 (8 Days)||4
10533031|NCT01424397|11685437|FG011|STARTED|Period-2 (8 Days)||4
10533032|NCT01424397|11685426|FG000|COMPLETED|Period-2 (8 Days)||7
10533033|NCT01424397|11685427|FG001|COMPLETED|Period-2 (8 Days)||8
10533034|NCT01424397|11685428|FG002|COMPLETED|Period-2 (8 Days)||7
10533035|NCT01424397|11685429|FG003|COMPLETED|Period-2 (8 Days)||8
10533036|NCT01424397|11685430|FG004|COMPLETED|Period-2 (8 Days)||8
10655816|NCT02211261|11816588|FG001|COMPLETED|Overall Study||6
10350221|NCT00435539|11488493|FG000|NOT COMPLETED|Overall Study||0
10350222|NCT00435539|11488494|FG001|NOT COMPLETED|Overall Study||0
10350223|NCT00435539|11488495|FG002|NOT COMPLETED|Overall Study||0
10350224|NCT00435539|11488496|FG003|NOT COMPLETED|Overall Study||0
10655817|NCT02211261|11816589|FG002|COMPLETED|Overall Study||5
10655818|NCT02211261|11816590|FG003|COMPLETED|Overall Study||6
10655819|NCT02211261|11816591|FG004|COMPLETED|Overall Study||7
10655820|NCT02211261|11816592|FG005|COMPLETED|Overall Study||1
10655821|NCT02211261|11816593|FG006|COMPLETED|Overall Study||6
10655822|NCT02211261|11816594|FG007|COMPLETED|Overall Study||7
10655823|NCT02211261|11816595|FG008|COMPLETED|Overall Study||8
10655824|NCT02211261|11816596|FG009|COMPLETED|Overall Study||14
10655825|NCT02211261|11816597|FG010|COMPLETED|Overall Study||8
10655826|NCT02211261|11816587|FG000|NOT COMPLETED|Overall Study||0
10655827|NCT02211261|11816588|FG001|NOT COMPLETED|Overall Study||0
10655828|NCT02211261|11816589|FG002|NOT COMPLETED|Overall Study||1
10655829|NCT02211261|11816590|FG003|NOT COMPLETED|Overall Study||0
10655830|NCT02211261|11816591|FG004|NOT COMPLETED|Overall Study||2
10655831|NCT02211261|11816592|FG005|NOT COMPLETED|Overall Study||1
10655832|NCT02211261|11816593|FG006|NOT COMPLETED|Overall Study||0
10655833|NCT02211261|11816594|FG007|NOT COMPLETED|Overall Study||1
10350225|NCT00435539|11488497|FG004|NOT COMPLETED|Overall Study||0
10350226|NCT00435591|11488512|FG000|STARTED|Overall Study||30
10350227|NCT00435591|11488513|FG001|STARTED|Overall Study||31
10350228|NCT00435591|11488514|FG002|STARTED|Overall Study||30
10533037|NCT01424397|11685431|FG005|COMPLETED|Period-2 (8 Days)||8
10533038|NCT01424397|11685432|FG006|COMPLETED|Period-2 (8 Days)||4
10533039|NCT01424397|11685433|FG007|COMPLETED|Period-2 (8 Days)||4
10533040|NCT01424397|11685434|FG008|COMPLETED|Period-2 (8 Days)||4
10533041|NCT01424397|11685435|FG009|COMPLETED|Period-2 (8 Days)||3
10533042|NCT01424397|11685436|FG010|COMPLETED|Period-2 (8 Days)||4
10350229|NCT00435591|11488515|FG003|STARTED|Overall Study||30
10350230|NCT00435591|11488512|FG000|Safety Analysis Set|Overall Study||28
10350231|NCT00435591|11488513|FG001|Safety Analysis Set|Overall Study||30
10350232|NCT00435591|11488514|FG002|Safety Analysis Set|Overall Study||30
10350233|NCT00435591|11488515|FG003|Safety Analysis Set|Overall Study||29
10350234|NCT00435591|11488512|FG000|Full Analysis Set|Overall Study||28
10350235|NCT00435591|11488513|FG001|Full Analysis Set|Overall Study||29
10350236|NCT00435591|11488514|FG002|Full Analysis Set|Overall Study||30
10350237|NCT00435591|11488515|FG003|Full Analysis Set|Overall Study||29
10350238|NCT00435591|11488512|FG000|End of Treatment|Overall Study||25
10350239|NCT00435591|11488513|FG001|End of Treatment|Overall Study||27
10350240|NCT00435591|11488514|FG002|End of Treatment|Overall Study||27
10350241|NCT00435591|11488515|FG003|End of Treatment|Overall Study||23
10350242|NCT00435591|11488512|FG000|COMPLETED|Overall Study||23
10350243|NCT00435591|11488513|FG001|COMPLETED|Overall Study||27
10350244|NCT00435591|11488514|FG002|COMPLETED|Overall Study||25
10350245|NCT00435591|11488515|FG003|COMPLETED|Overall Study||19
10350246|NCT00435591|11488512|FG000|NOT COMPLETED|Overall Study||7
10350247|NCT00435591|11488513|FG001|NOT COMPLETED|Overall Study||4
10350248|NCT00435591|11488514|FG002|NOT COMPLETED|Overall Study||5
10350249|NCT00435591|11488515|FG003|NOT COMPLETED|Overall Study||11
10350250|NCT00435812|11488530|FG000|STARTED|Overall Study||1820
10350251|NCT00435812|11488531|FG001|STARTED|Overall Study||608
10350252|NCT00435812|11488530|FG000|COMPLETED|Overall Study||1757
10350253|NCT00435812|11488531|FG001|COMPLETED|Overall Study||590
10350254|NCT00435812|11488530|FG000|NOT COMPLETED|Overall Study||63
10350255|NCT00435812|11488531|FG001|NOT COMPLETED|Overall Study||18
10350256|NCT00435825|11488541|FG000|STARTED|Overall Study||141
10350257|NCT00435825|11488542|FG001|STARTED|Overall Study||136
10350258|NCT00435825|11488543|FG002|STARTED|Overall Study||138
10350259|NCT00435825|11488544|FG003|STARTED|Overall Study||136
10350260|NCT00435825|11488541|FG000|Received Study Drug|Overall Study||140
10350261|NCT00435825|11488542|FG001|Received Study Drug|Overall Study||136
10350262|NCT00435825|11488543|FG002|Received Study Drug|Overall Study||136
10350263|NCT00435825|11488544|FG003|Received Study Drug|Overall Study||136
10350264|NCT00435825|11488541|FG000|Entered Follow-up|Overall Study||140
10350265|NCT00435825|11488542|FG001|Entered Follow-up|Overall Study||132
10350266|NCT00435825|11488543|FG002|Entered Follow-up|Overall Study||135
10350267|NCT00435825|11488544|FG003|Entered Follow-up|Overall Study||133
10350268|NCT00435825|11488541|FG000|Completed 24 Weeks Treatment|Overall Study||128
10350269|NCT00435825|11488542|FG001|Completed 24 Weeks Treatment|Overall Study||126
10350270|NCT00435825|11488543|FG002|Completed 24 Weeks Treatment|Overall Study||134
10350271|NCT00435825|11488544|FG003|Completed 24 Weeks Treatment|Overall Study||131
10350272|NCT00435825|11488541|FG000|Completed 48 Weeks Treatment|Overall Study||0
10350273|NCT00435825|11488542|FG001|Completed 48 Weeks Treatment|Overall Study||0
10350274|NCT00435825|11488543|FG002|Completed 48 Weeks Treatment|Overall Study||124
10350275|NCT00435825|11488544|FG003|Completed 48 Weeks Treatment|Overall Study||117
10350276|NCT00435825|11488541|FG000|COMPLETED|Overall Study|Completed is the number of participants who received study treatment and completed follow-up.|123
10350277|NCT00435825|11488542|FG001|COMPLETED|Overall Study||124
10350278|NCT00435825|11488543|FG002|COMPLETED|Overall Study||127
10350279|NCT00435825|11488544|FG003|COMPLETED|Overall Study||120
10350280|NCT00435825|11488541|FG000|NOT COMPLETED|Overall Study||18
10350281|NCT00435825|11488542|FG001|NOT COMPLETED|Overall Study||12
10350282|NCT00435825|11488543|FG002|NOT COMPLETED|Overall Study||11
10350283|NCT00435825|11488544|FG003|NOT COMPLETED|Overall Study||16
10350284|NCT00435929|11488556|FG000|STARTED|Overall Study||7
10350285|NCT00435929|11488557|FG001|STARTED|Overall Study||9
10350286|NCT00435929|11488556|FG000|COMPLETED|Overall Study||7
10350287|NCT00435929|11488557|FG001|COMPLETED|Overall Study||9
10350288|NCT00435929|11488556|FG000|NOT COMPLETED|Overall Study||0
10350289|NCT00435929|11488557|FG001|NOT COMPLETED|Overall Study||0
10350290|NCT00435942|11488565|FG000|STARTED|Overall Study||120
10715884|NCT02688387|11880045|FG002|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10715885|NCT02688387|11880046|FG003|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10715886|NCT02688387|11880047|FG004|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10715887|NCT02688387|11880048|FG005|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10715888|NCT02688387|11880049|FG006|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10715889|NCT02688387|11880050|FG007|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10715890|NCT02688387|11880051|FG008|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10715891|NCT02688387|11880052|FG009|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10350291|NCT00435942|11488566|FG001|STARTED|Overall Study||60
10350292|NCT00435942|11488565|FG000|COMPLETED|Overall Study||97
10350293|NCT00435942|11488566|FG001|COMPLETED|Overall Study||33
10350294|NCT00435942|11488565|FG000|NOT COMPLETED|Overall Study||23
10350295|NCT00435942|11488566|FG001|NOT COMPLETED|Overall Study||27
10350296|NCT00435994|11488575|FG000|STARTED|Overall Study||22
10350297|NCT00435994|11488576|FG001|STARTED|Overall Study||25
10350298|NCT00435994|11488577|FG002|STARTED|Overall Study||12
10350299|NCT00435994|11488575|FG000|COMPLETED|Overall Study|7 of the subjects were consented and did not complete the study procedures.|15
10350300|NCT00435994|11488576|FG001|COMPLETED|Overall Study||25
10350301|NCT00435994|11488577|FG002|COMPLETED|Overall Study||12
10350302|NCT00435994|11488575|FG000|NOT COMPLETED|Overall Study||7
10350303|NCT00435994|11488576|FG001|NOT COMPLETED|Overall Study||0
10350304|NCT00435994|11488577|FG002|NOT COMPLETED|Overall Study||0
10350305|NCT00436007|11488589|FG000|STARTED|Overall Study||170
10350306|NCT00436007|11488590|FG001|STARTED|Overall Study||170
10350307|NCT00436007|11488591|FG002|STARTED|Overall Study||171
10350308|NCT00436007|11488589|FG000|COMPLETED|Overall Study||151
10350309|NCT00436007|11488590|FG001|COMPLETED|Overall Study||156
10350310|NCT00436007|11488591|FG002|COMPLETED|Overall Study||148
10350311|NCT00436007|11488589|FG000|NOT COMPLETED|Overall Study||19
10350312|NCT00436007|11488590|FG001|NOT COMPLETED|Overall Study||14
10350313|NCT00436007|11488591|FG002|NOT COMPLETED|Overall Study||23
10350314|NCT00436046|11488607|FG000|STARTED|Overall Study||32
10350315|NCT00436046|11488608|FG001|STARTED|Overall Study||32
10350316|NCT00436046|11488609|FG002|STARTED|Overall Study||31
10350317|NCT00436046|11488607|FG000|COMPLETED|Overall Study||32
10350318|NCT00436046|11488608|FG001|COMPLETED|Overall Study||32
10350319|NCT00436046|11488609|FG002|COMPLETED|Overall Study||31
10350320|NCT00436046|11488607|FG000|NOT COMPLETED|Overall Study||0
10350321|NCT00436046|11488608|FG001|NOT COMPLETED|Overall Study||0
10350322|NCT00436046|11488609|FG002|NOT COMPLETED|Overall Study||0
10350323|NCT00436163|11488617|FG000|STARTED|Overall Study||39
10350324|NCT00436163|11488617|FG000|COMPLETED|Overall Study||36
10350325|NCT00436163|11488617|FG000|NOT COMPLETED|Overall Study||3
10350326|NCT00436215|11488622|FG000|STARTED|Overall Study||55
10350327|NCT00436215|11488622|FG000|COMPLETED|Overall Study||51
10350328|NCT00436215|11488622|FG000|NOT COMPLETED|Overall Study||4
10350329|NCT00436280|11488626|FG000|STARTED|Period 1: Induction||68
10350330|NCT00436280|11488626|FG000|Received at Least 1 Dose of Study Drug|Period 1: Induction||68
10350331|NCT00436280|11488626|FG000|COMPLETED|Period 1: Induction||40
10350332|NCT00436280|11488626|FG000|NOT COMPLETED|Period 1: Induction||28
10350333|NCT00436280|11488626|FG000|STARTED|Period 2: Consolidation||40
10350334|NCT00436280|11488626|FG000|COMPLETED|Period 2: Consolidation||23
10350335|NCT00436280|11488626|FG000|NOT COMPLETED|Period 2: Consolidation||17
10350336|NCT00436280|11488626|FG000|STARTED|Period 3: Maintenance||23
10350337|NCT00436280|11488626|FG000|COMPLETED|Period 3: Maintenance||5
10350338|NCT00436280|11488626|FG000|NOT COMPLETED|Period 3: Maintenance||18
10350339|NCT00436332|11488630|FG000|STARTED|Overall Study||84
10350340|NCT00436332|11488630|FG000|Eligible|Overall Study||82
10350341|NCT00436332|11488630|FG000|Eligible and Began Protocol Therapy|Overall Study||79
10350342|NCT00436332|11488630|FG000|COMPLETED|Overall Study||1
10350343|NCT00436332|11488630|FG000|NOT COMPLETED|Overall Study||83
10350344|NCT00436345|11488636|FG000|STARTED|Overall Study||21
10350345|NCT00436345|11488637|FG001|STARTED|Overall Study||18
10350346|NCT00436345|11488636|FG000|COMPLETED|Overall Study||18
10350347|NCT00436345|11488637|FG001|COMPLETED|Overall Study||18
10350348|NCT00436345|11488636|FG000|NOT COMPLETED|Overall Study||3
10350349|NCT00436345|11488637|FG001|NOT COMPLETED|Overall Study||0
10350350|NCT00436436|11488644|FG000|STARTED|Overall Study||12
10350351|NCT00436436|11488644|FG000|COMPLETED|Overall Study||0
10350352|NCT00436436|11488644|FG000|NOT COMPLETED|Overall Study||12
10350353|NCT00436475|11488652|FG000|STARTED|Overall Study||23
10350354|NCT00436475|11488653|FG001|STARTED|Overall Study||23
10350355|NCT00436475|11488654|FG002|STARTED|Overall Study||22
10350356|NCT00436475|11488655|FG003|STARTED|Overall Study||24
10350357|NCT00436475|11488652|FG000|COMPLETED|Overall Study||23
10350358|NCT00436475|11488653|FG001|COMPLETED|Overall Study||22
10350359|NCT00436475|11488654|FG002|COMPLETED|Overall Study||21
10350360|NCT00436475|11488655|FG003|COMPLETED|Overall Study||22
10350361|NCT00436475|11488652|FG000|NOT COMPLETED|Overall Study||0
10350362|NCT00436475|11488653|FG001|NOT COMPLETED|Overall Study||1
10350363|NCT00436475|11488654|FG002|NOT COMPLETED|Overall Study||1
10350364|NCT00436475|11488655|FG003|NOT COMPLETED|Overall Study||2
10350365|NCT00436501|11488667|FG000|STARTED|Complete Study Participation|Phase 1 opened on January 17, 2007 and closed to new patient entry on March 7, 2008.|9
10350366|NCT00436501|11488668|FG001|STARTED|Complete Study Participation|After toxicity observations, Phase 2 opened June 4, 2008 and closed September 27, 2010.|49
10350367|NCT00436501|11488667|FG000|COMPLETED|Complete Study Participation||9
10350368|NCT00436501|11488668|FG001|COMPLETED|Complete Study Participation||49
10350369|NCT00436501|11488667|FG000|NOT COMPLETED|Complete Study Participation||0
10350370|NCT00436501|11488668|FG001|NOT COMPLETED|Complete Study Participation||0
10350371|NCT00436501|11488667|FG000|STARTED|Phase 1: VEGF Trap Escalating Dose|Phase 1 opened on January 17, 2007 and closed to new patient entry on March 7, 2008.|9
10350372|NCT00436501|11488668|FG001|STARTED|Phase 1: VEGF Trap Escalating Dose|Participants registered in next period.|0
10350373|NCT00436501|11488667|FG000|COMPLETED|Phase 1: VEGF Trap Escalating Dose||9
10350374|NCT00436501|11488668|FG001|COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
10350375|NCT00436501|11488667|FG000|NOT COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
10350376|NCT00436501|11488668|FG001|NOT COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
10350377|NCT00436501|11488667|FG000|STARTED|Phase 2: MTD VEGF Trap + Docetaxel||0
10350378|NCT00436501|11488668|FG001|STARTED|Phase 2: MTD VEGF Trap + Docetaxel|After toxicity observations Phase 2 opened June 4, 2008 and closed to entry September 27, 2010.|49
10350379|NCT00436501|11488667|FG000|COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||0
10350380|NCT00436501|11488668|FG001|COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||46
10350381|NCT00436501|11488667|FG000|NOT COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||0
10350382|NCT00436501|11488668|FG001|NOT COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||3
10350383|NCT00436553|11488678|FG000|STARTED|Overall Study|"The table shows 12 month data. Started indicates Randomized set of population."|104
10350384|NCT00436553|11488679|FG001|STARTED|Overall Study||105
10350385|NCT00436553|11488680|FG002|STARTED|Overall Study||112
10350386|NCT00436553|11488678|FG000|COMPLETED|Overall Study|Completed the 12 month study phase.|91
10350387|NCT00436553|11488679|FG001|COMPLETED|Overall Study||93
10350388|NCT00436553|11488680|FG002|COMPLETED|Overall Study||102
10350389|NCT00436553|11488678|FG000|NOT COMPLETED|Overall Study||13
10350390|NCT00436553|11488679|FG001|NOT COMPLETED|Overall Study||12
10350391|NCT00436553|11488680|FG002|NOT COMPLETED|Overall Study||10
10350395|NCT00436605|11488692|FG000|STARTED|Overall Study||39
10350396|NCT00436605|11488692|FG000|COMPLETED|Overall Study||36
10350397|NCT00436605|11488692|FG000|NOT COMPLETED|Overall Study||3
10350398|NCT00436618|11488699|FG000|STARTED|Overall Study||114
10350399|NCT00436618|11488700|FG001|STARTED|Overall Study||55
10350400|NCT00436618|11488701|FG002|STARTED|Overall Study||107
10350401|NCT00436618|11488699|FG000|COMPLETED|Overall Study||84
10350402|NCT00436618|11488700|FG001|COMPLETED|Overall Study||28
10350403|NCT00436618|11488701|FG002|COMPLETED|Overall Study||46
10350404|NCT00436618|11488699|FG000|NOT COMPLETED|Overall Study||30
10350405|NCT00436618|11488700|FG001|NOT COMPLETED|Overall Study||27
10350406|NCT00436618|11488701|FG002|NOT COMPLETED|Overall Study||61
10350407|NCT00436644|11488709|FG000|STARTED|Overall Study||18
10350408|NCT00436644|11488709|FG000|COMPLETED|Overall Study||15
10350409|NCT00436644|11488709|FG000|NOT COMPLETED|Overall Study||3
10350410|NCT00436748|11488715|FG000|STARTED|Overall Study||59
10350411|NCT00436748|11488716|FG001|STARTED|Overall Study||57
10350412|NCT00436748|11488715|FG000|Received Treatment|Overall Study||58
10350413|NCT00436748|11488716|FG001|Received Treatment|Overall Study||56
10350414|NCT00436748|11488715|FG000|COMPLETED|Overall Study||48
10350415|NCT00436748|11488716|FG001|COMPLETED|Overall Study||45
10350416|NCT00436748|11488715|FG000|NOT COMPLETED|Overall Study||11
10350417|NCT00436748|11488716|FG001|NOT COMPLETED|Overall Study||12
10350418|NCT00436852|11488724|FG000|STARTED|Overall Study||45
10350419|NCT00436852|11488725|FG001|STARTED|Overall Study||47
10350420|NCT00436852|11488724|FG000|COMPLETED|Overall Study||10
10350421|NCT00436852|11488725|FG001|COMPLETED|Overall Study||2
10350422|NCT00436852|11488724|FG000|NOT COMPLETED|Overall Study||35
10350423|NCT00436852|11488725|FG001|NOT COMPLETED|Overall Study||45
10350424|NCT00436904|11488734|FG000|STARTED|Overall Study||30
10350425|NCT00436904|11488734|FG000|COMPLETED|Overall Study||30
10350426|NCT00436904|11488734|FG000|NOT COMPLETED|Overall Study||0
10350427|NCT00436917|11488738|FG000|STARTED|Overall Study|7 participants (1 cancellation, 1 major violation, 5 ineligibles) were excluded from all analysis.|53
10350428|NCT00436917|11488738|FG000|COMPLETED|Overall Study||32
10350429|NCT00436917|11488738|FG000|NOT COMPLETED|Overall Study||21
10350430|NCT00436956|11488742|FG000|STARTED|Overall Study||36
10350431|NCT00436956|11488743|FG001|STARTED|Overall Study||23
10350432|NCT00436956|11488742|FG000|COMPLETED|Overall Study|One pt was not evaluable due to a cord compression on day 2 of therapy; was removed from the trial.|35
10350433|NCT00436956|11488743|FG001|COMPLETED|Overall Study||23
10350434|NCT00436956|11488742|FG000|NOT COMPLETED|Overall Study||1
10350435|NCT00436956|11488743|FG001|NOT COMPLETED|Overall Study||0
10350436|NCT00436969|11488752|FG000|STARTED|Overall Study||88
10350437|NCT00436969|11488753|FG001|STARTED|Overall Study||186
10350438|NCT00436969|11488752|FG000|Randomized But Not Treated|Overall Study||1
10350439|NCT00436969|11488753|FG001|Randomized But Not Treated|Overall Study||3
10350440|NCT00436969|11488752|FG000|COMPLETED|Overall Study||66
10350441|NCT00436969|11488753|FG001|COMPLETED|Overall Study||134
10350442|NCT00436969|11488752|FG000|NOT COMPLETED|Overall Study||22
10350443|NCT00436969|11488753|FG001|NOT COMPLETED|Overall Study||52
10350444|NCT00436982|11488761|FG000|STARTED|Overall Study||30
10350445|NCT00436982|11488762|FG001|STARTED|Overall Study||30
10350446|NCT00436982|11488761|FG000|COMPLETED|Overall Study||26
10350447|NCT00436982|11488762|FG001|COMPLETED|Overall Study||26
10350448|NCT00436982|11488761|FG000|NOT COMPLETED|Overall Study||4
10350449|NCT00436982|11488762|FG001|NOT COMPLETED|Overall Study||4
10350450|NCT00437034|11488772|FG000|STARTED|Overall Study||6
10350451|NCT00437034|11488772|FG000|COMPLETED|Overall Study||0
10350452|NCT00437034|11488772|FG000|NOT COMPLETED|Overall Study||6
10350453|NCT00437073|11488778|FG000|STARTED|Overall Study||13
10350454|NCT00437073|11488779|FG001|STARTED|Overall Study||9
10350455|NCT00437073|11488778|FG000|COMPLETED|Overall Study||12
10350456|NCT00437073|11488779|FG001|COMPLETED|Overall Study||8
10350457|NCT00437073|11488778|FG000|NOT COMPLETED|Overall Study||1
10350458|NCT00437073|11488779|FG001|NOT COMPLETED|Overall Study||1
10350459|NCT00437125|11488785|FG000|STARTED|Overall Study||151
10350460|NCT00437125|11488785|FG000|COMPLETED|Overall Study||119
10350461|NCT00437125|11488785|FG000|NOT COMPLETED|Overall Study||32
10350462|NCT00437203|11488799|FG000|STARTED|Overall Study||6
10350463|NCT00437203|11488800|FG001|STARTED|Overall Study||8
10350464|NCT00437203|11488801|FG002|STARTED|Overall Study||3
10350465|NCT00437203|11488802|FG003|STARTED|Overall Study||3
10350466|NCT00437203|11488803|FG004|STARTED|Overall Study||3
10350467|NCT00437203|11488804|FG005|STARTED|Overall Study||3
10350468|NCT00437203|11488805|FG006|STARTED|Overall Study||7
10350469|NCT00437203|11488806|FG007|STARTED|Overall Study||3
10350470|NCT00437203|11488807|FG008|STARTED|Overall Study||3
10350471|NCT00437203|11488808|FG009|STARTED|Overall Study||4
10350472|NCT00437203|11488799|FG000|COMPLETED|Overall Study||0
10350473|NCT00437203|11488800|FG001|COMPLETED|Overall Study||0
10350474|NCT00437203|11488801|FG002|COMPLETED|Overall Study||0
10350475|NCT00437203|11488802|FG003|COMPLETED|Overall Study||0
10350476|NCT00437203|11488803|FG004|COMPLETED|Overall Study||0
10350477|NCT00437203|11488804|FG005|COMPLETED|Overall Study||0
10350478|NCT00437203|11488805|FG006|COMPLETED|Overall Study||0
10350479|NCT00437203|11488806|FG007|COMPLETED|Overall Study||0
10350480|NCT00437203|11488807|FG008|COMPLETED|Overall Study||0
10350481|NCT00437203|11488808|FG009|COMPLETED|Overall Study||0
10350482|NCT00437203|11488799|FG000|NOT COMPLETED|Overall Study||6
10350483|NCT00437203|11488800|FG001|NOT COMPLETED|Overall Study||8
10350484|NCT00437203|11488801|FG002|NOT COMPLETED|Overall Study||3
10350485|NCT00437203|11488802|FG003|NOT COMPLETED|Overall Study||3
10350486|NCT00437203|11488803|FG004|NOT COMPLETED|Overall Study||3
10350487|NCT00437203|11488804|FG005|NOT COMPLETED|Overall Study||3
10350488|NCT00437203|11488805|FG006|NOT COMPLETED|Overall Study||7
10350489|NCT00437203|11488806|FG007|NOT COMPLETED|Overall Study||3
10350490|NCT00437203|11488807|FG008|NOT COMPLETED|Overall Study||3
10350491|NCT00437203|11488808|FG009|NOT COMPLETED|Overall Study||4
10350492|NCT00437268|11488841|FG000|STARTED|Overall Study||13
10350493|NCT00437268|11488842|FG001|STARTED|Overall Study||13
10350494|NCT00437268|11488841|FG000|Received at Least 1 Dose of Study Drug|Overall Study||13
10350495|NCT00437268|11488842|FG001|Received at Least 1 Dose of Study Drug|Overall Study||13
10350496|NCT00437268|11488841|FG000|Protocol Qualified (PQ) Participant|Overall Study|PQ population: randomized participants without an immune reaction to cetuximab after the first dose|13
10350497|NCT00437268|11488842|FG001|Protocol Qualified (PQ) Participant|Overall Study|PQ population: randomized participants without an immune reaction to cetuximab after the first dose|12
10350498|NCT00437268|11488841|FG000|COMPLETED|Overall Study||0
10350499|NCT00437268|11488842|FG001|COMPLETED|Overall Study||0
10350500|NCT00437268|11488841|FG000|NOT COMPLETED|Overall Study||13
10350501|NCT00437268|11488842|FG001|NOT COMPLETED|Overall Study||13
10350502|NCT00437281|11488870|FG000|STARTED|Overall Study||3
10350503|NCT00437281|11488871|FG001|STARTED|Overall Study||3
10350504|NCT00437281|11488872|FG002|STARTED|Overall Study||3
10350505|NCT00437281|11488873|FG003|STARTED|Overall Study||3
10350506|NCT00437281|11488874|FG004|STARTED|Overall Study||4
10350507|NCT00437281|11488875|FG005|STARTED|Overall Study||4
10350508|NCT00437281|11488876|FG006|STARTED|Overall Study||3
10350509|NCT00437281|11488877|FG007|STARTED|Overall Study||3
10350510|NCT00437281|11488878|FG008|STARTED|Overall Study||3
10350511|NCT00437281|11488879|FG009|STARTED|Overall Study||5
10350512|NCT00437281|11488880|FG010|STARTED|Overall Study||3
10350513|NCT00437281|11488881|FG011|STARTED|Overall Study||3
10350514|NCT00437281|11488882|FG012|STARTED|Overall Study||2
10350515|NCT00437281|11488883|FG013|STARTED|Overall Study||3
10350516|NCT00437281|11488884|FG014|STARTED|Overall Study||5
10350517|NCT00437281|11488885|FG015|STARTED|Overall Study||3
10350518|NCT00437281|11488886|FG016|STARTED|Overall Study||3
10350519|NCT00437281|11488887|FG017|STARTED|Overall Study||4
10350520|NCT00437281|11488888|FG018|STARTED|Overall Study||2
10350521|NCT00437281|11488889|FG019|STARTED|Overall Study||3
10350522|NCT00437281|11488870|FG000|COMPLETED|Overall Study||3
10350523|NCT00437281|11488871|FG001|COMPLETED|Overall Study||3
10350524|NCT00437281|11488872|FG002|COMPLETED|Overall Study||3
10350525|NCT00437281|11488873|FG003|COMPLETED|Overall Study||2
10350526|NCT00437281|11488874|FG004|COMPLETED|Overall Study||4
10350527|NCT00437281|11488875|FG005|COMPLETED|Overall Study||3
10350528|NCT00437281|11488876|FG006|COMPLETED|Overall Study||3
10350529|NCT00437281|11488877|FG007|COMPLETED|Overall Study||3
10350530|NCT00437281|11488878|FG008|COMPLETED|Overall Study||3
10350531|NCT00437281|11488879|FG009|COMPLETED|Overall Study||4
10350532|NCT00437281|11488880|FG010|COMPLETED|Overall Study||3
10350533|NCT00437281|11488881|FG011|COMPLETED|Overall Study||3
10350534|NCT00437281|11488882|FG012|COMPLETED|Overall Study||2
10350535|NCT00437281|11488883|FG013|COMPLETED|Overall Study||2
10350536|NCT00437281|11488884|FG014|COMPLETED|Overall Study||4
10350537|NCT00437281|11488885|FG015|COMPLETED|Overall Study||3
10350538|NCT00437281|11488886|FG016|COMPLETED|Overall Study||3
10350539|NCT00437281|11488887|FG017|COMPLETED|Overall Study||4
10350540|NCT00437281|11488888|FG018|COMPLETED|Overall Study||1
10350541|NCT00437281|11488889|FG019|COMPLETED|Overall Study||2
10350542|NCT00437281|11488870|FG000|NOT COMPLETED|Overall Study||0
10350543|NCT00437281|11488871|FG001|NOT COMPLETED|Overall Study||0
10350544|NCT00437281|11488872|FG002|NOT COMPLETED|Overall Study||0
10350545|NCT00437281|11488873|FG003|NOT COMPLETED|Overall Study||1
10350546|NCT00437281|11488874|FG004|NOT COMPLETED|Overall Study||0
10350547|NCT00437281|11488875|FG005|NOT COMPLETED|Overall Study||1
10350548|NCT00437281|11488876|FG006|NOT COMPLETED|Overall Study||0
10655834|NCT02211261|11816595|FG008|NOT COMPLETED|Overall Study||0
10655835|NCT02211261|11816596|FG009|NOT COMPLETED|Overall Study||2
10655836|NCT02211261|11816597|FG010|NOT COMPLETED|Overall Study||0
10350549|NCT00437281|11488877|FG007|NOT COMPLETED|Overall Study||0
10350550|NCT00437281|11488878|FG008|NOT COMPLETED|Overall Study||0
10350551|NCT00437281|11488879|FG009|NOT COMPLETED|Overall Study||1
10350552|NCT00437281|11488880|FG010|NOT COMPLETED|Overall Study||0
10350553|NCT00437281|11488881|FG011|NOT COMPLETED|Overall Study||0
10350554|NCT00437281|11488882|FG012|NOT COMPLETED|Overall Study||0
10655837|NCT02211313|11816632|FG000|STARTED|Overall Study||18
10655838|NCT02211313|11816633|FG001|STARTED|Overall Study||23
10350555|NCT00437281|11488883|FG013|NOT COMPLETED|Overall Study||1
10350556|NCT00437281|11488884|FG014|NOT COMPLETED|Overall Study||1
10350557|NCT00437281|11488885|FG015|NOT COMPLETED|Overall Study||0
10350558|NCT00437281|11488886|FG016|NOT COMPLETED|Overall Study||0
10350559|NCT00437281|11488887|FG017|NOT COMPLETED|Overall Study||0
10350560|NCT00437281|11488888|FG018|NOT COMPLETED|Overall Study||1
10350561|NCT00437281|11488889|FG019|NOT COMPLETED|Overall Study||1
10350562|NCT00437294|11488963|FG000|STARTED|Overall Study||43
10350563|NCT00437294|11488964|FG001|STARTED|Overall Study||43
10350564|NCT00437294|11488963|FG000|Received at Least 1 Dose of Study Drug|Overall Study||42
10350565|NCT00437294|11488964|FG001|Received at Least 1 Dose of Study Drug|Overall Study||43
10350566|NCT00437294|11488963|FG000|COMPLETED|Overall Study||0
10350567|NCT00437294|11488964|FG001|COMPLETED|Overall Study||0
10350568|NCT00437294|11488963|FG000|NOT COMPLETED|Overall Study||43
10350569|NCT00437294|11488964|FG001|NOT COMPLETED|Overall Study||43
10350570|NCT00437489|11488978|FG000|STARTED|Overall Study||25
10350571|NCT00437489|11488979|FG001|STARTED|Overall Study||24
10350572|NCT00437489|11488978|FG000|COMPLETED|Overall Study|2 subjects completed prior to study termination.|2
10350573|NCT00437489|11488979|FG001|COMPLETED|Overall Study|2 subjects completed prior to study termination.|2
10350574|NCT00437489|11488978|FG000|NOT COMPLETED|Overall Study||23
10350575|NCT00437489|11488979|FG001|NOT COMPLETED|Overall Study||22
10350576|NCT00437645|11488987|FG000|STARTED|Overall Study||592
10350577|NCT00437645|11488988|FG001|STARTED|Overall Study||591
10350578|NCT00437645|11488987|FG000|COMPLETED|Overall Study||557
10350579|NCT00437645|11488988|FG001|COMPLETED|Overall Study||476
10350580|NCT00437645|11488987|FG000|NOT COMPLETED|Overall Study||35
10350581|NCT00437645|11488988|FG001|NOT COMPLETED|Overall Study||115
10350582|NCT00437658|11488997|FG000|STARTED|Treatment Period (24 Weeks)||84
10350583|NCT00437658|11488998|FG001|STARTED|Treatment Period (24 Weeks)||84
10350584|NCT00437658|11488999|FG002|STARTED|Treatment Period (24 Weeks)||84
10350585|NCT00437658|11488997|FG000|Received Study Drug|Treatment Period (24 Weeks)||84
10350586|NCT00437658|11488998|FG001|Received Study Drug|Treatment Period (24 Weeks)||84
10350587|NCT00437658|11488999|FG002|Received Study Drug|Treatment Period (24 Weeks)||84
10350588|NCT00437658|11488997|FG000|COMPLETED|Treatment Period (24 Weeks)||56
10350589|NCT00437658|11488998|FG001|COMPLETED|Treatment Period (24 Weeks)||62
10350590|NCT00437658|11488999|FG002|COMPLETED|Treatment Period (24 Weeks)||51
10350591|NCT00437658|11488997|FG000|NOT COMPLETED|Treatment Period (24 Weeks)||28
10350592|NCT00437658|11488998|FG001|NOT COMPLETED|Treatment Period (24 Weeks)||22
10350593|NCT00437658|11488999|FG002|NOT COMPLETED|Treatment Period (24 Weeks)||33
10350594|NCT00437658|11488997|FG000|STARTED|Post-treatment Period (24 Weeks)||56
10350595|NCT00437658|11488998|FG001|STARTED|Post-treatment Period (24 Weeks)||62
10350596|NCT00437658|11488999|FG002|STARTED|Post-treatment Period (24 Weeks)||51
10350597|NCT00437658|11488997|FG000|COMPLETED|Post-treatment Period (24 Weeks)||32
10350598|NCT00437658|11488998|FG001|COMPLETED|Post-treatment Period (24 Weeks)||54
10350599|NCT00437658|11488999|FG002|COMPLETED|Post-treatment Period (24 Weeks)||37
10350600|NCT00437658|11488997|FG000|NOT COMPLETED|Post-treatment Period (24 Weeks)||24
10350601|NCT00437658|11488998|FG001|NOT COMPLETED|Post-treatment Period (24 Weeks)||8
10350602|NCT00437658|11488999|FG002|NOT COMPLETED|Post-treatment Period (24 Weeks)||14
10350603|NCT00437983|11489009|FG000|STARTED|Overall Study||79
10350604|NCT00437983|11489010|FG001|STARTED|Overall Study||78
10350605|NCT00437983|11489009|FG000|COMPLETED|Overall Study||66
10350606|NCT00437983|11489010|FG001|COMPLETED|Overall Study||65
10350607|NCT00437983|11489009|FG000|NOT COMPLETED|Overall Study||13
10350608|NCT00437983|11489010|FG001|NOT COMPLETED|Overall Study||13
10350609|NCT00438100|11489018|FG000|STARTED|Overall Study||73
10350610|NCT00438100|11489019|FG001|STARTED|Overall Study||69
10350611|NCT00438100|11489018|FG000|COMPLETED|Overall Study||71
10350612|NCT00438100|11489019|FG001|COMPLETED|Overall Study||65
10350613|NCT00438100|11489018|FG000|NOT COMPLETED|Overall Study||2
10350614|NCT00438100|11489019|FG001|NOT COMPLETED|Overall Study||4
10350615|NCT00438191|11489027|FG000|STARTED|Overall Study||43
10350616|NCT00438191|11489028|FG001|STARTED|Overall Study||40
10350617|NCT00438191|11489027|FG000|COMPLETED|Overall Study||32
10350618|NCT00438191|11489028|FG001|COMPLETED|Overall Study||26
10350619|NCT00438191|11489027|FG000|NOT COMPLETED|Overall Study||11
10350620|NCT00438191|11489028|FG001|NOT COMPLETED|Overall Study||14
10350621|NCT00438204|11489034|FG000|STARTED|Overall Study||39
10350622|NCT00438204|11489034|FG000|COMPLETED|Overall Study||39
10350623|NCT00438204|11489034|FG000|NOT COMPLETED|Overall Study||0
10350624|NCT00438256|11489039|FG000|STARTED|Overall Study||3
10350625|NCT00438256|11489040|FG001|STARTED|Overall Study||3
10350626|NCT00438256|11489041|FG002|STARTED|Overall Study||3
10350627|NCT00438256|11489042|FG003|STARTED|Overall Study||41
10350628|NCT00438256|11489039|FG000|Surgical Resection|Overall Study||1
10350629|NCT00438256|11489040|FG001|Surgical Resection|Overall Study||2
10350630|NCT00438256|11489041|FG002|Surgical Resection|Overall Study||2
10350631|NCT00438256|11489042|FG003|Surgical Resection|Overall Study||34
10350632|NCT00438256|11489039|FG000|COMPLETED|Overall Study||1
10350633|NCT00438256|11489040|FG001|COMPLETED|Overall Study||2
10350634|NCT00438256|11489041|FG002|COMPLETED|Overall Study||2
10350635|NCT00438256|11489042|FG003|COMPLETED|Overall Study||32
10350636|NCT00438256|11489039|FG000|NOT COMPLETED|Overall Study||2
10350637|NCT00438256|11489040|FG001|NOT COMPLETED|Overall Study||1
10350638|NCT00438256|11489041|FG002|NOT COMPLETED|Overall Study||1
10350639|NCT00438256|11489042|FG003|NOT COMPLETED|Overall Study||9
10350640|NCT00438360|11489057|FG000|STARTED|Overall Study|"Started indicates randomized patients."|162
10350641|NCT00438360|11489058|FG001|STARTED|Overall Study||81
10350642|NCT00438360|11489057|FG000|Intention to Treat (ITT) Population|Overall Study|These numbers are different from those started (randomized) as 2 pts from each arm never took drug.|160
10350643|NCT00438360|11489058|FG001|Intention to Treat (ITT) Population|Overall Study||79
10350644|NCT00438360|11489057|FG000|COMPLETED|Overall Study||90
10350645|NCT00438360|11489058|FG001|COMPLETED|Overall Study||38
10350646|NCT00438360|11489057|FG000|NOT COMPLETED|Overall Study||72
10350647|NCT00438360|11489058|FG001|NOT COMPLETED|Overall Study||43
10350648|NCT00438399|11489067|FG000|STARTED|Overall Study||38
10350649|NCT00438399|11489068|FG001|STARTED|Overall Study||40
10350650|NCT00438399|11489069|FG002|STARTED|Overall Study||35
10350651|NCT00438399|11489070|FG003|STARTED|Overall Study||36
10350652|NCT00438399|11489071|FG004|STARTED|Overall Study||33
10350653|NCT00438399|11489072|FG005|STARTED|Overall Study||37
10350654|NCT00438399|11489067|FG000|TREATED & ANALYZED|Overall Study||30
10350655|NCT00438399|11489068|FG001|TREATED & ANALYZED|Overall Study||32
10350656|NCT00438399|11489069|FG002|TREATED & ANALYZED|Overall Study||28
10350657|NCT00438399|11489070|FG003|TREATED & ANALYZED|Overall Study||32
10350658|NCT00438399|11489071|FG004|TREATED & ANALYZED|Overall Study||30
10350659|NCT00438399|11489072|FG005|TREATED & ANALYZED|Overall Study||31
10350660|NCT00438399|11489067|FG000|COMPLETED|Overall Study||30
10350661|NCT00438399|11489068|FG001|COMPLETED|Overall Study||32
10350662|NCT00438399|11489069|FG002|COMPLETED|Overall Study||28
10350663|NCT00438399|11489070|FG003|COMPLETED|Overall Study||32
10350664|NCT00438399|11489071|FG004|COMPLETED|Overall Study||30
10350665|NCT00438399|11489072|FG005|COMPLETED|Overall Study||31
10350666|NCT00438399|11489067|FG000|NOT COMPLETED|Overall Study||8
10350667|NCT00438399|11489068|FG001|NOT COMPLETED|Overall Study||8
10350668|NCT00438399|11489069|FG002|NOT COMPLETED|Overall Study||7
10350669|NCT00438399|11489070|FG003|NOT COMPLETED|Overall Study||4
10350670|NCT00438399|11489071|FG004|NOT COMPLETED|Overall Study||3
10350671|NCT00438399|11489072|FG005|NOT COMPLETED|Overall Study||6
10350672|NCT00438451|11489084|FG000|STARTED|Overall Study||122
10350673|NCT00438451|11489085|FG001|STARTED|Overall Study||121
10350674|NCT00438451|11489086|FG002|STARTED|Overall Study||118
10350675|NCT00438451|11489084|FG000|Safety Population|Overall Study||122
10350676|NCT00438451|11489085|FG001|Safety Population|Overall Study||121
10350677|NCT00438451|11489086|FG002|Safety Population|Overall Study||117
10350678|NCT00438451|11489084|FG000|ITT Population|Overall Study||122
10350679|NCT00438451|11489085|FG001|ITT Population|Overall Study||120
10350680|NCT00438451|11489086|FG002|ITT Population|Overall Study||117
10350681|NCT00438451|11489084|FG000|Maintenance Phase (Week 7-58)|Overall Study||93
10350682|NCT00438451|11489085|FG001|Maintenance Phase (Week 7-58)|Overall Study||89
10350683|NCT00438451|11489086|FG002|Maintenance Phase (Week 7-58)|Overall Study||93
10350684|NCT00438451|11489084|FG000|COMPLETED|Overall Study||75
10350685|NCT00438451|11489085|FG001|COMPLETED|Overall Study||55
10350686|NCT00438451|11489086|FG002|COMPLETED|Overall Study||65
10350687|NCT00438451|11489084|FG000|NOT COMPLETED|Overall Study||47
10350688|NCT00438451|11489085|FG001|NOT COMPLETED|Overall Study||66
10350689|NCT00438451|11489086|FG002|NOT COMPLETED|Overall Study||53
10350690|NCT00438464|11489096|FG000|STARTED|Overall Study||103
10533043|NCT01424397|11685437|FG011|COMPLETED|Period-2 (8 Days)||4
10533044|NCT01424397|11685426|FG000|NOT COMPLETED|Period-2 (8 Days)||0
10350691|NCT00438464|11489097|FG001|STARTED|Overall Study||101
10350692|NCT00438464|11489096|FG000|Received Assigned Intervention|Overall Study||89
10350693|NCT00438464|11489097|FG001|Received Assigned Intervention|Overall Study||94
10350694|NCT00438464|11489096|FG000|COMPLETED|Overall Study||89
10350695|NCT00438464|11489097|FG001|COMPLETED|Overall Study||94
10350696|NCT00438464|11489096|FG000|NOT COMPLETED|Overall Study||14
10350697|NCT00438464|11489097|FG001|NOT COMPLETED|Overall Study||7
10350698|NCT00438490|11489117|FG000|STARTED|Overall Study||12
10350699|NCT00438490|11489118|FG001|STARTED|Overall Study||9
10350700|NCT00438490|11489117|FG000|COMPLETED|Overall Study||12
10350701|NCT00438490|11489118|FG001|COMPLETED|Overall Study||9
10350702|NCT00438490|11489117|FG000|NOT COMPLETED|Overall Study||0
10350703|NCT00438490|11489118|FG001|NOT COMPLETED|Overall Study||0
10350704|NCT00438633|11489130|FG000|STARTED|Overall Study||32
10350705|NCT00438633|11489131|FG001|STARTED|Overall Study||31
10350706|NCT00438633|11489130|FG000|3-month Follow-up|Overall Study||26
10350707|NCT00438633|11489131|FG001|3-month Follow-up|Overall Study||24
10350708|NCT00438633|11489130|FG000|COMPLETED|Overall Study||16
10350709|NCT00438633|11489131|FG001|COMPLETED|Overall Study||14
10350710|NCT00438633|11489130|FG000|NOT COMPLETED|Overall Study||16
10350711|NCT00438633|11489131|FG001|NOT COMPLETED|Overall Study||17
10350712|NCT00438659|11489139|FG000|STARTED|Overall Study||90
10350713|NCT00438659|11489140|FG001|STARTED|Overall Study||86
10350714|NCT00438659|11489139|FG000|COMPLETED|Overall Study||84
10350715|NCT00438659|11489140|FG001|COMPLETED|Overall Study||82
10350716|NCT00438659|11489139|FG000|NOT COMPLETED|Overall Study||6
10350717|NCT00438659|11489140|FG001|NOT COMPLETED|Overall Study||4
10350718|NCT00438672|11489149|FG000|STARTED|Overall Study||31
10350719|NCT00438672|11489150|FG001|STARTED|Overall Study||33
10350720|NCT00438672|11489149|FG000|COMPLETED|Overall Study||24
10350721|NCT00438672|11489150|FG001|COMPLETED|Overall Study||24
10350722|NCT00438672|11489149|FG000|NOT COMPLETED|Overall Study||7
10350723|NCT00438672|11489150|FG001|NOT COMPLETED|Overall Study||9
10350724|NCT00438750|11489158|FG000|STARTED|Overall Study||48
10350725|NCT00438750|11489159|FG001|STARTED|Overall Study||46
10350726|NCT00438750|11489158|FG000|COMPLETED|Overall Study||39
10350727|NCT00438750|11489159|FG001|COMPLETED|Overall Study||37
10350728|NCT00438750|11489158|FG000|NOT COMPLETED|Overall Study||9
10350729|NCT00438750|11489159|FG001|NOT COMPLETED|Overall Study||9
10350730|NCT00438802|11489168|FG000|STARTED|Overall Study||6
10350731|NCT00438802|11489169|FG001|STARTED|Overall Study||8
10350732|NCT00438802|11489170|FG002|STARTED|Overall Study||9
10350733|NCT00438802|11489168|FG000|COMPLETED|Overall Study||6
10350734|NCT00438802|11489169|FG001|COMPLETED|Overall Study||8
10350735|NCT00438802|11489170|FG002|COMPLETED|Overall Study||9
10350736|NCT00438802|11489168|FG000|NOT COMPLETED|Overall Study||0
10350737|NCT00438802|11489169|FG001|NOT COMPLETED|Overall Study||0
10350738|NCT00438802|11489170|FG002|NOT COMPLETED|Overall Study||0
10350739|NCT00438815|11489180|FG000|STARTED|Overall Study||113
10350740|NCT00438815|11489180|FG000|COMPLETED|Overall Study||43
10350741|NCT00438815|11489180|FG000|NOT COMPLETED|Overall Study||70
10350742|NCT00438854|11489184|FG000|STARTED|Overall Study||15
10350743|NCT00438854|11489184|FG000|COMPLETED|Overall Study||15
10350744|NCT00438854|11489184|FG000|NOT COMPLETED|Overall Study||0
10350745|NCT00438880|11489190|FG000|STARTED|Overall Study||30
10350746|NCT00438880|11489191|FG001|STARTED|Overall Study||8
10350747|NCT00438880|11489190|FG000|COMPLETED|Overall Study||30
10350748|NCT00438880|11489191|FG001|COMPLETED|Overall Study||8
10350749|NCT00438880|11489190|FG000|NOT COMPLETED|Overall Study||0
10350750|NCT00438880|11489191|FG001|NOT COMPLETED|Overall Study||0
10350751|NCT00438932|11489201|FG000|STARTED|Overall Study||4
10350752|NCT00438932|11489202|FG001|STARTED|Overall Study||4
10350753|NCT00438932|11489203|FG002|STARTED|Overall Study||4
10350754|NCT00438932|11489204|FG003|STARTED|Overall Study||4
10350755|NCT00438932|11489201|FG000|COMPLETED|Overall Study||4
10350756|NCT00438932|11489202|FG001|COMPLETED|Overall Study||4
10350757|NCT00438932|11489203|FG002|COMPLETED|Overall Study||4
10350758|NCT00438932|11489204|FG003|COMPLETED|Overall Study||4
10715892|NCT02688387|11880053|FG010|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10715893|NCT02688387|11880054|FG011|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10715894|NCT02688387|11880055|FG012|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10715895|NCT02688387|11880056|FG013|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10715896|NCT02688387|11880057|FG014|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10715897|NCT02688387|11880058|FG015|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10350759|NCT00438932|11489201|FG000|NOT COMPLETED|Overall Study||0
10350760|NCT00438932|11489202|FG001|NOT COMPLETED|Overall Study||0
10350761|NCT00438932|11489203|FG002|NOT COMPLETED|Overall Study||0
10350762|NCT00438932|11489204|FG003|NOT COMPLETED|Overall Study||0
10350763|NCT00438971|11489214|FG000|STARTED|Overall Study||17
10350764|NCT00438971|11489214|FG000|COMPLETED|Overall Study||15
10350765|NCT00438971|11489214|FG000|NOT COMPLETED|Overall Study||2
10350766|NCT00439140|11489222|FG000|STARTED|Treatment Cycle 1||15
10350767|NCT00439140|11489223|FG001|STARTED|Treatment Cycle 1||14
10350768|NCT00439140|11489224|FG002|STARTED|Treatment Cycle 1||12
10350769|NCT00439140|11489222|FG000|COMPLETED|Treatment Cycle 1||14
10350770|NCT00439140|11489223|FG001|COMPLETED|Treatment Cycle 1||10
10350771|NCT00439140|11489224|FG002|COMPLETED|Treatment Cycle 1|5 patients did not enter Cycle 2. 6 patients received botulinum toxin Type A in Cycle 2.|11
10350772|NCT00439140|11489222|FG000|NOT COMPLETED|Treatment Cycle 1||1
10350773|NCT00439140|11489223|FG001|NOT COMPLETED|Treatment Cycle 1||4
10350774|NCT00439140|11489224|FG002|NOT COMPLETED|Treatment Cycle 1||1
10350775|NCT00439140|11489222|FG000|STARTED|Treatment Cycle 2|8 patients from the 200U arm plus 5 patients from the placebo arm in Cycle 1 entered Cycle 2.|13
10350776|NCT00439140|11489223|FG001|STARTED|Treatment Cycle 2|6 patients from the 300U arm plus 1 patient from the placebo arm in Cycle 1 entered Cycle 2.|7
10350777|NCT00439140|11489224|FG002|STARTED|Treatment Cycle 2|No patients received placebo in Cycle 2.|0
10350778|NCT00439140|11489222|FG000|COMPLETED|Treatment Cycle 2||11
10350779|NCT00439140|11489223|FG001|COMPLETED|Treatment Cycle 2||6
10350780|NCT00439140|11489224|FG002|COMPLETED|Treatment Cycle 2||0
10350781|NCT00439140|11489222|FG000|NOT COMPLETED|Treatment Cycle 2||2
10350782|NCT00439140|11489223|FG001|NOT COMPLETED|Treatment Cycle 2||1
10715898|NCT02688387|11880059|FG016|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10715899|NCT02688387|11880060|FG017|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10715900|NCT02688387|11880061|FG018|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10350783|NCT00439140|11489224|FG002|NOT COMPLETED|Treatment Cycle 2||0
10350784|NCT00439179|11489236|FG000|STARTED|Overall Study|1 with biliary|3
10350785|NCT00439179|11489237|FG001|STARTED|Overall Study|2 with biliary|13
10350786|NCT00439179|11489238|FG002|STARTED|Overall Study|2 with biliary|6
10350787|NCT00439179|11489239|FG003|STARTED|Overall Study|2 with biliry|5
10350788|NCT00439179|11489236|FG000|COMPLETED|Overall Study||3
10350789|NCT00439179|11489237|FG001|COMPLETED|Overall Study||11
10350790|NCT00439179|11489238|FG002|COMPLETED|Overall Study||6
10350791|NCT00439179|11489239|FG003|COMPLETED|Overall Study||5
10350792|NCT00439179|11489236|FG000|NOT COMPLETED|Overall Study||0
10350793|NCT00439179|11489237|FG001|NOT COMPLETED|Overall Study||2
10350794|NCT00439179|11489238|FG002|NOT COMPLETED|Overall Study||0
10350795|NCT00439179|11489239|FG003|NOT COMPLETED|Overall Study||0
10350796|NCT00439218|11489252|FG000|STARTED|Cohort 1 (500 mg/kg/Day)||4
10350797|NCT00439218|11489252|FG000|COMPLETED|Cohort 1 (500 mg/kg/Day)|3 subjects completed the study in Cohort 1. Cohort 2 was then opened for new enrollments.|3
10350798|NCT00439218|11489252|FG000|NOT COMPLETED|Cohort 1 (500 mg/kg/Day)||1
10350799|NCT00439218|11489252|FG000|STARTED|Cohort 2 (500 mg/kg/Day)|One new subject was enrolled into the study after Cohort 1 completed the study.|1
10350800|NCT00439218|11489252|FG000|COMPLETED|Cohort 2 (500 mg/kg/Day)||1
10350801|NCT00439218|11489252|FG000|NOT COMPLETED|Cohort 2 (500 mg/kg/Day)||0
10350802|NCT00439231|11489256|FG000|STARTED|Overall Study||33
10350803|NCT00439231|11489256|FG000|COMPLETED|Overall Study|5 subjects had a partial response, 0 complete response, 28 completed off study,|5
10350804|NCT00439231|11489256|FG000|NOT COMPLETED|Overall Study||28
10350805|NCT00439244|11489263|FG000|STARTED|Overall Study|"Started indicates randomized as well as intent to treat (ITT) population enrolled to study."|137
10350806|NCT00439244|11489264|FG001|STARTED|Overall Study||137
10715901|NCT02688387|11880062|FG019|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10715902|NCT02688387|11880063|FG020|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10350807|NCT00439244|11489265|FG002|STARTED|Overall Study||138
10350808|NCT00439244|11489263|FG000|Safety Population|Overall Study|Total safety population is 411. One patient was randomized, but never received any study medication.|137
10350809|NCT00439244|11489264|FG001|Safety Population|Overall Study||137
10350810|NCT00439244|11489265|FG002|Safety Population|Overall Study||137
10350811|NCT00439244|11489263|FG000|COMPLETED|Overall Study||126
10350812|NCT00439244|11489264|FG001|COMPLETED|Overall Study||131
10350813|NCT00439244|11489265|FG002|COMPLETED|Overall Study||131
10350814|NCT00439244|11489263|FG000|NOT COMPLETED|Overall Study||11
10350815|NCT00439244|11489264|FG001|NOT COMPLETED|Overall Study||6
10350816|NCT00439244|11489265|FG002|NOT COMPLETED|Overall Study||7
10350817|NCT00439270|11489278|FG000|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
10350818|NCT00439270|11489279|FG001|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
10350819|NCT00439270|11489280|FG002|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
10350820|NCT00439270|11489281|FG003|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|4
10350821|NCT00439270|11489282|FG004|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
10350822|NCT00439270|11489278|FG000|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
10350823|NCT00439270|11489279|FG001|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
10350824|NCT00439270|11489280|FG002|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
10350825|NCT00439270|11489281|FG003|COMPLETED|Phase 1 (18.1 Months)|Remained on study|4
10350826|NCT00439270|11489282|FG004|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
10350827|NCT00439270|11489278|FG000|NOT COMPLETED|Phase 1 (18.1 Months)||3
10350828|NCT00439270|11489279|FG001|NOT COMPLETED|Phase 1 (18.1 Months)||3
10350829|NCT00439270|11489280|FG002|NOT COMPLETED|Phase 1 (18.1 Months)||3
10350830|NCT00439270|11489281|FG003|NOT COMPLETED|Phase 1 (18.1 Months)||0
10350831|NCT00439270|11489282|FG004|NOT COMPLETED|Phase 1 (18.1 Months)||3
10350832|NCT00439270|11489278|FG000|STARTED|Phase 2 (51.6 Months)||0
10350833|NCT00439270|11489279|FG001|STARTED|Phase 2 (51.6 Months)||0
10350834|NCT00439270|11489280|FG002|STARTED|Phase 2 (51.6 Months)||0
10350835|NCT00439270|11489281|FG003|STARTED|Phase 2 (51.6 Months)|Includes 4 patients who completed Phase 1|34
10350836|NCT00439270|11489282|FG004|STARTED|Phase 2 (51.6 Months)||0
10350837|NCT00439270|11489278|FG000|COMPLETED|Phase 2 (51.6 Months)||0
10350838|NCT00439270|11489279|FG001|COMPLETED|Phase 2 (51.6 Months)||0
10350839|NCT00439270|11489280|FG002|COMPLETED|Phase 2 (51.6 Months)||0
10350840|NCT00439270|11489281|FG003|COMPLETED|Phase 2 (51.6 Months)||0
10350841|NCT00439270|11489282|FG004|COMPLETED|Phase 2 (51.6 Months)||0
10350842|NCT00439270|11489278|FG000|NOT COMPLETED|Phase 2 (51.6 Months)||0
10350843|NCT00439270|11489279|FG001|NOT COMPLETED|Phase 2 (51.6 Months)||0
10350844|NCT00439270|11489280|FG002|NOT COMPLETED|Phase 2 (51.6 Months)||0
10350845|NCT00439270|11489281|FG003|NOT COMPLETED|Phase 2 (51.6 Months)||34
10350846|NCT00439270|11489282|FG004|NOT COMPLETED|Phase 2 (51.6 Months)||0
10350847|NCT00439296|11489303|FG000|STARTED|Overall Study||5
10350848|NCT00439296|11489304|FG001|STARTED|Overall Study||4
10350849|NCT00439296|11489303|FG000|Treatment Course 1|Overall Study||5
10350850|NCT00439296|11489304|FG001|Treatment Course 1|Overall Study||3
10350851|NCT00439296|11489303|FG000|Treatment Course 2|Overall Study||1
10350852|NCT00439296|11489304|FG001|Treatment Course 2|Overall Study||1
10715903|NCT02688387|11880064|FG021|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
10350853|NCT00439296|11489303|FG000|COMPLETED|Overall Study||5
10350854|NCT00439296|11489304|FG001|COMPLETED|Overall Study||4
10350855|NCT00439296|11489303|FG000|NOT COMPLETED|Overall Study||0
10715904|NCT02688387|11880043|FG000|STARTED|Part 3A, Period 4 (up to 6 Days)||0
10715905|NCT02688387|11880044|FG001|STARTED|Part 3A, Period 4 (up to 6 Days)||0
10350856|NCT00439296|11489304|FG001|NOT COMPLETED|Overall Study||0
10350857|NCT00439309|11489312|FG000|STARTED|Treatment||54
10350858|NCT00439309|11489313|FG001|STARTED|Treatment||15
10350859|NCT00439309|11489312|FG000|COMPLETED|Treatment||54
10350860|NCT00439309|11489313|FG001|COMPLETED|Treatment||15
10350861|NCT00439309|11489312|FG000|NOT COMPLETED|Treatment||0
10350862|NCT00439309|11489313|FG001|NOT COMPLETED|Treatment||0
10350863|NCT00439309|11489312|FG000|STARTED|Follow-Up||54
10350864|NCT00439309|11489313|FG001|STARTED|Follow-Up||15
10350865|NCT00439309|11489312|FG000|COMPLETED|Follow-Up||51
10350866|NCT00439309|11489313|FG001|COMPLETED|Follow-Up||13
10350867|NCT00439309|11489312|FG000|NOT COMPLETED|Follow-Up||3
10350868|NCT00439309|11489313|FG001|NOT COMPLETED|Follow-Up||2
10350869|NCT00439335|11489321|FG000|STARTED|Overall Study||113
10350870|NCT00439335|11489322|FG001|STARTED|Overall Study||114
10350871|NCT00439335|11489321|FG000|COMPLETED|Overall Study||111
10350872|NCT00439335|11489322|FG001|COMPLETED|Overall Study||114
10350873|NCT00439335|11489321|FG000|NOT COMPLETED|Overall Study||2
10350874|NCT00439335|11489322|FG001|NOT COMPLETED|Overall Study||0
10350875|NCT00439374|11489330|FG000|STARTED|Overall Study||327
10350876|NCT00439374|11489331|FG001|STARTED|Overall Study||330
10350877|NCT00439374|11489330|FG000|COMPLETED|Overall Study||327
10350878|NCT00439374|11489331|FG001|COMPLETED|Overall Study||330
10350879|NCT00439374|11489330|FG000|NOT COMPLETED|Overall Study||0
10350880|NCT00439374|11489331|FG001|NOT COMPLETED|Overall Study||0
10350881|NCT00439413|11489339|FG000|STARTED|Overall Study||121
10350882|NCT00439413|11489340|FG001|STARTED|Overall Study||125
10715906|NCT02688387|11880045|FG002|STARTED|Part 3A, Period 4 (up to 6 Days)||0
10715907|NCT02688387|11880046|FG003|STARTED|Part 3A, Period 4 (up to 6 Days)||0
10350883|NCT00439413|11489339|FG000|COMPLETED|Overall Study||90
10350884|NCT00439413|11489340|FG001|COMPLETED|Overall Study||88
10350885|NCT00439413|11489339|FG000|NOT COMPLETED|Overall Study||31
10350886|NCT00439413|11489340|FG001|NOT COMPLETED|Overall Study||37
10350887|NCT00439465|11489348|FG000|STARTED|Overall Study||23
10350888|NCT00439465|11489348|FG000|COMPLETED|Overall Study||19
10350889|NCT00439465|11489348|FG000|NOT COMPLETED|Overall Study||4
10350890|NCT00439517|11489357|FG000|STARTED|Overall Study||152
10350891|NCT00439517|11489358|FG001|STARTED|Overall Study||150
10350892|NCT00439517|11489357|FG000|COMPLETED|Overall Study||150
10350893|NCT00439517|11489358|FG001|COMPLETED|Overall Study||150
10350894|NCT00439517|11489357|FG000|NOT COMPLETED|Overall Study||2
10350895|NCT00439517|11489358|FG001|NOT COMPLETED|Overall Study||0
10350896|NCT00439556|11489367|FG000|STARTED|Overall Study||36
10350897|NCT00439556|11489368|FG001|STARTED|Overall Study||4
10350898|NCT00439556|11489369|FG002|STARTED|Overall Study||0
10350899|NCT00439556|11489367|FG000|COMPLETED|Overall Study||36
10350900|NCT00439556|11489368|FG001|COMPLETED|Overall Study||3
10350901|NCT00439556|11489369|FG002|COMPLETED|Overall Study||0
10350902|NCT00439556|11489367|FG000|NOT COMPLETED|Overall Study||0
10350903|NCT00439556|11489368|FG001|NOT COMPLETED|Overall Study||1
10350904|NCT00439556|11489369|FG002|NOT COMPLETED|Overall Study||0
10350905|NCT00439608|11489378|FG000|STARTED|Overall Study||60
10350906|NCT00439608|11489378|FG000|COMPLETED|Overall Study||60
10350907|NCT00439608|11489378|FG000|NOT COMPLETED|Overall Study||0
10350908|NCT00439647|11489384|FG000|STARTED|Overall Study|"Started indicates intent to treat (ITT) and safety set."|588
10350909|NCT00439647|11489385|FG001|STARTED|Overall Study||611
10350910|NCT00439647|11489384|FG000|Modified Intent to Treat (mITT)|Overall Study||553
10350911|NCT00439647|11489385|FG001|Modified Intent to Treat (mITT)|Overall Study||574
10350912|NCT00439647|11489384|FG000|COMPLETED|Overall Study||530
10350913|NCT00439647|11489385|FG001|COMPLETED|Overall Study||540
10350914|NCT00439647|11489384|FG000|NOT COMPLETED|Overall Study||58
10350915|NCT00439647|11489385|FG001|NOT COMPLETED|Overall Study||71
10350916|NCT00439673|11489391|FG000|STARTED|Overall Study||62
10350917|NCT00439673|11489391|FG000|COMPLETED|Overall Study||26
10350918|NCT00439673|11489391|FG000|NOT COMPLETED|Overall Study||36
10350919|NCT00439725|11489397|FG000|STARTED|Treatment Period||602
10350920|NCT00439725|11489398|FG001|STARTED|Treatment Period||595
10350921|NCT00439725|11489397|FG000|Participants Received Treatment|Treatment Period|Safety population|598
10350922|NCT00439725|11489398|FG001|Participants Received Treatment|Treatment Period|Safety population|590
10350923|NCT00439725|11489397|FG000|COMPLETED|Treatment Period||366
10350924|NCT00439725|11489398|FG001|COMPLETED|Treatment Period||349
10350925|NCT00439725|11489397|FG000|NOT COMPLETED|Treatment Period||236
10350926|NCT00439725|11489398|FG001|NOT COMPLETED|Treatment Period||246
10350927|NCT00439725|11489397|FG000|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|577
10350928|NCT00439725|11489398|FG001|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|560
10350929|NCT00439725|11489397|FG000|COMPLETED|Observational Period||569
10350930|NCT00439725|11489398|FG001|COMPLETED|Observational Period||553
10350931|NCT00439725|11489397|FG000|NOT COMPLETED|Observational Period||8
10533045|NCT01424397|11685427|FG001|NOT COMPLETED|Period-2 (8 Days)||0
10533046|NCT01424397|11685428|FG002|NOT COMPLETED|Period-2 (8 Days)||1
10533047|NCT01424397|11685429|FG003|NOT COMPLETED|Period-2 (8 Days)||0
10533048|NCT01424397|11685430|FG004|NOT COMPLETED|Period-2 (8 Days)||0
10533049|NCT01424397|11685431|FG005|NOT COMPLETED|Period-2 (8 Days)||0
10533050|NCT01424397|11685432|FG006|NOT COMPLETED|Period-2 (8 Days)||0
10533051|NCT01424397|11685433|FG007|NOT COMPLETED|Period-2 (8 Days)||0
10533052|NCT01424397|11685434|FG008|NOT COMPLETED|Period-2 (8 Days)||0
10533053|NCT01424397|11685435|FG009|NOT COMPLETED|Period-2 (8 Days)||0
10533054|NCT01424397|11685436|FG010|NOT COMPLETED|Period-2 (8 Days)||0
10533055|NCT01424397|11685437|FG011|NOT COMPLETED|Period-2 (8 Days)||0
10533056|NCT01424397|11685426|FG000|STARTED|Washout Period-2 (14-20 Days)||7
10533057|NCT01424397|11685427|FG001|STARTED|Washout Period-2 (14-20 Days)||8
10533058|NCT01424397|11685428|FG002|STARTED|Washout Period-2 (14-20 Days)||7
10533059|NCT01424397|11685429|FG003|STARTED|Washout Period-2 (14-20 Days)||8
10533060|NCT01424397|11685430|FG004|STARTED|Washout Period-2 (14-20 Days)||8
10533061|NCT01424397|11685431|FG005|STARTED|Washout Period-2 (14-20 Days)||8
10533062|NCT01424397|11685432|FG006|STARTED|Washout Period-2 (14-20 Days)||4
10655839|NCT02211313|11816632|FG000|COMPLETED|Overall Study||12
10655840|NCT02211313|11816633|FG001|COMPLETED|Overall Study||20
10655841|NCT02211313|11816632|FG000|NOT COMPLETED|Overall Study||6
10655842|NCT02211313|11816633|FG001|NOT COMPLETED|Overall Study||3
10655843|NCT02211456|11816639|FG000|STARTED|Overall Study||15
10655844|NCT02211456|11816639|FG000|COMPLETED|Overall Study||15
10655845|NCT02211456|11816639|FG000|NOT COMPLETED|Overall Study||0
10655846|NCT02211495|11816645|FG000|STARTED|Overall Study||4
10655847|NCT02211495|11816646|FG001|STARTED|Overall Study||4
10655848|NCT02211495|11816645|FG000|COMPLETED|Overall Study||4
10655849|NCT02211495|11816646|FG001|COMPLETED|Overall Study||4
10655850|NCT02211495|11816645|FG000|NOT COMPLETED|Overall Study||0
10655851|NCT02211495|11816646|FG001|NOT COMPLETED|Overall Study||0
10350932|NCT00439725|11489398|FG001|NOT COMPLETED|Observational Period||7
10350933|NCT00439777|11489406|FG000|STARTED|Treatment Period||2420
10350934|NCT00439777|11489407|FG001|STARTED|Treatment Period||2413
10350935|NCT00439777|11489406|FG000|Participants Received Treatment|Treatment Period||2412
10350936|NCT00439777|11489407|FG001|Participants Received Treatment|Treatment Period||2405
10533063|NCT01424397|11685433|FG007|STARTED|Washout Period-2 (14-20 Days)||4
10533064|NCT01424397|11685434|FG008|STARTED|Washout Period-2 (14-20 Days)||4
10655852|NCT02211534|11816658|FG000|STARTED|Overall Study||24
10655853|NCT02211534|11816659|FG001|STARTED|Overall Study||11
10655854|NCT02211534|11816658|FG000|COMPLETED|Overall Study||11
10350937|NCT00439777|11489406|FG000|COMPLETED|Treatment Period||2001
10350938|NCT00439777|11489407|FG001|COMPLETED|Treatment Period||1954
10350939|NCT00439777|11489406|FG000|NOT COMPLETED|Treatment Period||419
10350940|NCT00439777|11489407|FG001|NOT COMPLETED|Treatment Period||459
10350941|NCT00439777|11489406|FG000|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|2206
10350942|NCT00439777|11489407|FG001|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|2197
10350943|NCT00439777|11489406|FG000|COMPLETED|Observational Period||2165
10350944|NCT00439777|11489407|FG001|COMPLETED|Observational Period||2156
10350945|NCT00439777|11489406|FG000|NOT COMPLETED|Observational Period||41
10350946|NCT00439777|11489407|FG001|NOT COMPLETED|Observational Period||41
10350947|NCT00439946|11489413|FG000|STARTED|Overall Study||8
10350948|NCT00439946|11489413|FG000|COMPLETED|Overall Study||8
10350949|NCT00439946|11489413|FG000|NOT COMPLETED|Overall Study||0
10350950|NCT00440011|11489419|FG000|STARTED|Overall Study||131
10350951|NCT00440011|11489420|FG001|STARTED|Overall Study||135
10350952|NCT00440011|11489419|FG000|COMPLETED|Overall Study||127
10350953|NCT00440011|11489420|FG001|COMPLETED|Overall Study||132
10350954|NCT00440011|11489419|FG000|NOT COMPLETED|Overall Study||4
10350955|NCT00440011|11489420|FG001|NOT COMPLETED|Overall Study||3
10350956|NCT00440037|11489426|FG000|STARTED|Overall Study||44
10350957|NCT00440037|11489426|FG000|COMPLETED|Overall Study||35
10350958|NCT00440037|11489426|FG000|NOT COMPLETED|Overall Study||9
10350959|NCT00440050|11489432|FG000|STARTED|Overall Study||164
10350960|NCT00440050|11489433|FG001|STARTED|Overall Study||238
10350961|NCT00440050|11489432|FG000|COMPLETED|Overall Study||124
10350962|NCT00440050|11489433|FG001|COMPLETED|Overall Study||171
10350963|NCT00440050|11489432|FG000|NOT COMPLETED|Overall Study||40
10350964|NCT00440050|11489433|FG001|NOT COMPLETED|Overall Study||67
10350965|NCT00440115|11489442|FG000|STARTED|Overall Study||251
10350966|NCT00440115|11489443|FG001|STARTED|Overall Study||249
10350967|NCT00440115|11489444|FG002|STARTED|Overall Study||250
10350968|NCT00440115|11489442|FG000|COMPLETED|Overall Study||244
10350969|NCT00440115|11489443|FG001|COMPLETED|Overall Study||238
10350970|NCT00440115|11489444|FG002|COMPLETED|Overall Study||244
10350971|NCT00440115|11489442|FG000|NOT COMPLETED|Overall Study||7
10350972|NCT00440115|11489443|FG001|NOT COMPLETED|Overall Study||11
10350973|NCT00440115|11489444|FG002|NOT COMPLETED|Overall Study||6
10350974|NCT00440180|11489454|FG000|STARTED|Overall Study||10
10350975|NCT00440180|11489455|FG001|STARTED|Overall Study||10
10350976|NCT00440180|11489454|FG000|COMPLETED|Overall Study||10
10350977|NCT00440180|11489455|FG001|COMPLETED|Overall Study||10
10350978|NCT00440180|11489454|FG000|NOT COMPLETED|Overall Study||0
10350979|NCT00440180|11489455|FG001|NOT COMPLETED|Overall Study||0
10350980|NCT00440193|11489463|FG000|STARTED|Treatment Period||1731
10350981|NCT00440193|11489464|FG001|STARTED|Treatment Period||1718
10350982|NCT00440193|11489463|FG000|Participants Received Treatment|Treatment Period||1718
10350983|NCT00440193|11489464|FG001|Participants Received Treatment|Treatment Period||1711
10350984|NCT00440193|11489463|FG000|COMPLETED|Treatment Period||1426
10350985|NCT00440193|11489464|FG001|COMPLETED|Treatment Period||1367
10350986|NCT00440193|11489463|FG000|NOT COMPLETED|Treatment Period||305
10350987|NCT00440193|11489464|FG001|NOT COMPLETED|Treatment Period||351
10350988|NCT00440193|11489463|FG000|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|1425
10350989|NCT00440193|11489464|FG001|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|1407
10350990|NCT00440193|11489463|FG000|COMPLETED|Observational Period||1380
10350991|NCT00440193|11489464|FG001|COMPLETED|Observational Period||1369
10350992|NCT00440193|11489463|FG000|NOT COMPLETED|Observational Period||45
10350993|NCT00440193|11489464|FG001|NOT COMPLETED|Observational Period||38
10350994|NCT00440232|11489472|FG000|STARTED|Overall Study||36
10350995|NCT00440232|11489473|FG001|STARTED|Overall Study||38
10350996|NCT00440232|11489472|FG000|COMPLETED|Overall Study||33
10533065|NCT01424397|11685435|FG009|STARTED|Washout Period-2 (14-20 Days)||3
10533066|NCT01424397|11685436|FG010|STARTED|Washout Period-2 (14-20 Days)||4
10533067|NCT01424397|11685437|FG011|STARTED|Washout Period-2 (14-20 Days)||4
10533068|NCT01424397|11685426|FG000|COMPLETED|Washout Period-2 (14-20 Days)||7
10533069|NCT01424397|11685427|FG001|COMPLETED|Washout Period-2 (14-20 Days)||8
10533070|NCT01424397|11685428|FG002|COMPLETED|Washout Period-2 (14-20 Days)||7
10533071|NCT01424397|11685429|FG003|COMPLETED|Washout Period-2 (14-20 Days)||8
10533072|NCT01424397|11685430|FG004|COMPLETED|Washout Period-2 (14-20 Days)||8
10533073|NCT01424397|11685431|FG005|COMPLETED|Washout Period-2 (14-20 Days)||8
10533074|NCT01424397|11685432|FG006|COMPLETED|Washout Period-2 (14-20 Days)||4
10533075|NCT01424397|11685433|FG007|COMPLETED|Washout Period-2 (14-20 Days)||4
10533076|NCT01424397|11685434|FG008|COMPLETED|Washout Period-2 (14-20 Days)||4
10533077|NCT01424397|11685435|FG009|COMPLETED|Washout Period-2 (14-20 Days)||3
10533078|NCT01424397|11685436|FG010|COMPLETED|Washout Period-2 (14-20 Days)||4
10533079|NCT01424397|11685437|FG011|COMPLETED|Washout Period-2 (14-20 Days)||4
10533080|NCT01424397|11685426|FG000|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
10350997|NCT00440232|11489473|FG001|COMPLETED|Overall Study||34
10350998|NCT00440232|11489472|FG000|NOT COMPLETED|Overall Study||3
10350999|NCT00440232|11489473|FG001|NOT COMPLETED|Overall Study||4
10533081|NCT01424397|11685427|FG001|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
10533082|NCT01424397|11685428|FG002|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
10351000|NCT00440297|11489481|FG000|STARTED|Overall Study||139
10351001|NCT00440297|11489482|FG001|STARTED|Overall Study||138
10351002|NCT00440297|11489481|FG000|Vaccination Visit 1|Overall Study||138
10351003|NCT00440297|11489482|FG001|Vaccination Visit 1|Overall Study||138
10351004|NCT00440297|11489481|FG000|Vaccination Visit 2|Overall Study||136
10351005|NCT00440297|11489482|FG001|Vaccination Visit 2|Overall Study||134
10351006|NCT00440297|11489481|FG000|Vaccination Visit 3|Overall Study||124
10351007|NCT00440297|11489482|FG001|Vaccination Visit 3|Overall Study||125
10351008|NCT00440297|11489481|FG000|Vaccination Visit 4|Overall Study||116
10351009|NCT00440297|11489482|FG001|Vaccination Visit 4|Overall Study||122
10351010|NCT00440297|11489481|FG000|COMPLETED|Overall Study||116
10351011|NCT00440297|11489482|FG001|COMPLETED|Overall Study||120
10351012|NCT00440297|11489481|FG000|NOT COMPLETED|Overall Study||23
10351013|NCT00440297|11489482|FG001|NOT COMPLETED|Overall Study||18
10351014|NCT00440310|11489490|FG000|STARTED|Overall Study||244
10351015|NCT00440310|11489491|FG001|STARTED|Overall Study||239
10351016|NCT00440310|11489490|FG000|Treated|Overall Study||222
10351017|NCT00440310|11489491|FG001|Treated|Overall Study||232
10351018|NCT00440310|11489490|FG000|COMPLETED|Overall Study||216
10351019|NCT00440310|11489491|FG001|COMPLETED|Overall Study||209
10351020|NCT00440310|11489490|FG000|NOT COMPLETED|Overall Study||28
10351021|NCT00440310|11489491|FG001|NOT COMPLETED|Overall Study||30
10351022|NCT00440401|11489499|FG000|STARTED|Overall Study||59
10351023|NCT00440401|11489500|FG001|STARTED|Overall Study||60
10351024|NCT00440401|11489499|FG000|COMPLETED|Overall Study||55
10351025|NCT00440401|11489500|FG001|COMPLETED|Overall Study||54
10351026|NCT00440401|11489499|FG000|NOT COMPLETED|Overall Study||4
10351027|NCT00440401|11489500|FG001|NOT COMPLETED|Overall Study||6
10351028|NCT00440466|11489509|FG000|STARTED|Overall Study||108
10351029|NCT00440466|11489510|FG001|STARTED|Overall Study||107
10351030|NCT00440466|11489511|FG002|STARTED|Overall Study||215
10351031|NCT00440466|11489509|FG000|COMPLETED|Overall Study||95
10351032|NCT00440466|11489510|FG001|COMPLETED|Overall Study||92
10351033|NCT00440466|11489511|FG002|COMPLETED|Overall Study||174
10351034|NCT00440466|11489509|FG000|NOT COMPLETED|Overall Study||13
10351035|NCT00440466|11489510|FG001|NOT COMPLETED|Overall Study||15
10351036|NCT00440466|11489511|FG002|NOT COMPLETED|Overall Study||41
10351037|NCT00440505|11489519|FG000|STARTED|First Intervention||5
10351038|NCT00440505|11489520|FG001|STARTED|First Intervention||2
10351039|NCT00440505|11489521|FG002|STARTED|First Intervention||1
10351040|NCT00440505|11489522|FG003|STARTED|First Intervention||2
10351041|NCT00440505|11489523|FG004|STARTED|First Intervention||5
10351042|NCT00440505|11489524|FG005|STARTED|First Intervention||5
10351043|NCT00440505|11489519|FG000|COMPLETED|First Intervention||5
10351044|NCT00440505|11489520|FG001|COMPLETED|First Intervention||2
10351045|NCT00440505|11489521|FG002|COMPLETED|First Intervention||1
10351046|NCT00440505|11489522|FG003|COMPLETED|First Intervention||2
10351047|NCT00440505|11489523|FG004|COMPLETED|First Intervention||5
10715908|NCT02688387|11880047|FG004|STARTED|Part 3A, Period 4 (up to 6 Days)||0
10715909|NCT02688387|11880048|FG005|STARTED|Part 3A, Period 4 (up to 6 Days)||0
10715910|NCT02688387|11880049|FG006|STARTED|Part 3A, Period 4 (up to 6 Days)||0
10715911|NCT02688387|11880050|FG007|STARTED|Part 3A, Period 4 (up to 6 Days)||0
10351048|NCT00440505|11489524|FG005|COMPLETED|First Intervention||5
10351049|NCT00440505|11489519|FG000|NOT COMPLETED|First Intervention||0
10351050|NCT00440505|11489520|FG001|NOT COMPLETED|First Intervention||0
10351051|NCT00440505|11489521|FG002|NOT COMPLETED|First Intervention||0
10351052|NCT00440505|11489522|FG003|NOT COMPLETED|First Intervention||0
10351053|NCT00440505|11489523|FG004|NOT COMPLETED|First Intervention||0
10351054|NCT00440505|11489524|FG005|NOT COMPLETED|First Intervention||0
10351055|NCT00440505|11489519|FG000|STARTED|Second Intervention||5
10351056|NCT00440505|11489520|FG001|STARTED|Second Intervention||2
10351057|NCT00440505|11489521|FG002|STARTED|Second Intervention||1
10351058|NCT00440505|11489522|FG003|STARTED|Second Intervention||2
10351059|NCT00440505|11489523|FG004|STARTED|Second Intervention||5
10351060|NCT00440505|11489524|FG005|STARTED|Second Intervention||5
10351061|NCT00440505|11489519|FG000|COMPLETED|Second Intervention||5
10351062|NCT00440505|11489520|FG001|COMPLETED|Second Intervention||2
10351063|NCT00440505|11489521|FG002|COMPLETED|Second Intervention||1
10351064|NCT00440505|11489522|FG003|COMPLETED|Second Intervention||2
10351065|NCT00440505|11489523|FG004|COMPLETED|Second Intervention||5
10351066|NCT00440505|11489524|FG005|COMPLETED|Second Intervention||5
10351067|NCT00440505|11489519|FG000|NOT COMPLETED|Second Intervention||0
10351068|NCT00440505|11489520|FG001|NOT COMPLETED|Second Intervention||0
10351069|NCT00440505|11489521|FG002|NOT COMPLETED|Second Intervention||0
10351070|NCT00440505|11489522|FG003|NOT COMPLETED|Second Intervention||0
10715912|NCT02688387|11880051|FG008|STARTED|Part 3A, Period 4 (up to 6 Days)||0
10351071|NCT00440505|11489523|FG004|NOT COMPLETED|Second Intervention||0
10351072|NCT00440505|11489524|FG005|NOT COMPLETED|Second Intervention||0
10351073|NCT00440505|11489519|FG000|STARTED|Third Intervention||5
10351074|NCT00440505|11489520|FG001|STARTED|Third Intervention||2
10351075|NCT00440505|11489521|FG002|STARTED|Third Intervention||1
10351076|NCT00440505|11489522|FG003|STARTED|Third Intervention||2
10351077|NCT00440505|11489523|FG004|STARTED|Third Intervention||5
10351078|NCT00440505|11489524|FG005|STARTED|Third Intervention||5
10351079|NCT00440505|11489519|FG000|COMPLETED|Third Intervention||5
10351080|NCT00440505|11489520|FG001|COMPLETED|Third Intervention||2
10351081|NCT00440505|11489521|FG002|COMPLETED|Third Intervention||1
10351082|NCT00440505|11489522|FG003|COMPLETED|Third Intervention||1
10351083|NCT00440505|11489523|FG004|COMPLETED|Third Intervention||5
10351084|NCT00440505|11489524|FG005|COMPLETED|Third Intervention||5
10351085|NCT00440505|11489519|FG000|NOT COMPLETED|Third Intervention||0
10351086|NCT00440505|11489520|FG001|NOT COMPLETED|Third Intervention||0
10351087|NCT00440505|11489521|FG002|NOT COMPLETED|Third Intervention||0
10351088|NCT00440505|11489522|FG003|NOT COMPLETED|Third Intervention||1
10351089|NCT00440505|11489523|FG004|NOT COMPLETED|Third Intervention||0
10351090|NCT00440505|11489524|FG005|NOT COMPLETED|Third Intervention||0
10351091|NCT00440518|11489535|FG000|STARTED|Randomized /Titration Period||72
10351092|NCT00440518|11489536|FG001|STARTED|Randomized /Titration Period||72
10351093|NCT00440518|11489537|FG002|STARTED|Randomized /Titration Period||74
10351094|NCT00440518|11489535|FG000|COMPLETED|Randomized /Titration Period||59
10351095|NCT00440518|11489536|FG001|COMPLETED|Randomized /Titration Period||63
10351096|NCT00440518|11489537|FG002|COMPLETED|Randomized /Titration Period||70
10351097|NCT00440518|11489535|FG000|NOT COMPLETED|Randomized /Titration Period||13
10351098|NCT00440518|11489536|FG001|NOT COMPLETED|Randomized /Titration Period||9
10351099|NCT00440518|11489537|FG002|NOT COMPLETED|Randomized /Titration Period||4
10351100|NCT00440518|11489535|FG000|STARTED|Maintenance and Safety Follow-up Periods||59
10351101|NCT00440518|11489536|FG001|STARTED|Maintenance and Safety Follow-up Periods||63
10351102|NCT00440518|11489537|FG002|STARTED|Maintenance and Safety Follow-up Periods||70
10351103|NCT00440518|11489535|FG000|COMPLETED|Maintenance and Safety Follow-up Periods||52
10351104|NCT00440518|11489536|FG001|COMPLETED|Maintenance and Safety Follow-up Periods||51
10351105|NCT00440518|11489537|FG002|COMPLETED|Maintenance and Safety Follow-up Periods||55
10351106|NCT00440518|11489535|FG000|NOT COMPLETED|Maintenance and Safety Follow-up Periods||7
10351107|NCT00440518|11489536|FG001|NOT COMPLETED|Maintenance and Safety Follow-up Periods||12
10351108|NCT00440518|11489537|FG002|NOT COMPLETED|Maintenance and Safety Follow-up Periods||15
10351109|NCT00440557|11489548|FG000|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|123
10351110|NCT00440557|11489549|FG001|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|125
10351111|NCT00440557|11489550|FG002|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|125
10351112|NCT00440557|11489548|FG000|COMPLETED|Overall Study||98
10351113|NCT00440557|11489549|FG001|COMPLETED|Overall Study||96
10351114|NCT00440557|11489550|FG002|COMPLETED|Overall Study||90
10351115|NCT00440557|11489548|FG000|NOT COMPLETED|Overall Study||25
10351116|NCT00440557|11489549|FG001|NOT COMPLETED|Overall Study||29
10351117|NCT00440557|11489550|FG002|NOT COMPLETED|Overall Study||35
10351118|NCT00440596|11489560|FG000|STARTED|Overall Study||28
10351119|NCT00440596|11489561|FG001|STARTED|Overall Study||28
10351120|NCT00440596|11489560|FG000|COMPLETED|Overall Study||21
10351121|NCT00440596|11489561|FG001|COMPLETED|Overall Study||17
10351122|NCT00440596|11489560|FG000|NOT COMPLETED|Overall Study||7
10351123|NCT00440596|11489561|FG001|NOT COMPLETED|Overall Study||11
10351124|NCT00440700|11489572|FG000|STARTED|Overall Study||122
10351125|NCT00440700|11489573|FG001|STARTED|Overall Study||118
10351126|NCT00440700|11489574|FG002|STARTED|Overall Study||124
10351127|NCT00440700|11489572|FG000|COMPLETED|Overall Study||114
10351128|NCT00440700|11489573|FG001|COMPLETED|Overall Study||110
10351129|NCT00440700|11489574|FG002|COMPLETED|Overall Study||120
10351130|NCT00440700|11489572|FG000|NOT COMPLETED|Overall Study||8
10351131|NCT00440700|11489573|FG001|NOT COMPLETED|Overall Study||8
10351132|NCT00440700|11489574|FG002|NOT COMPLETED|Overall Study||4
10351133|NCT00440726|11489585|FG000|STARTED|Phase 1||4
10351134|NCT00440726|11489586|FG001|STARTED|Phase 1||6
10351135|NCT00440726|11489587|FG002|STARTED|Phase 1||0
10351136|NCT00440726|11489585|FG000|COMPLETED|Phase 1||3
10351137|NCT00440726|11489586|FG001|COMPLETED|Phase 1||5
10351138|NCT00440726|11489587|FG002|COMPLETED|Phase 1||0
10351139|NCT00440726|11489585|FG000|NOT COMPLETED|Phase 1||1
10351140|NCT00440726|11489586|FG001|NOT COMPLETED|Phase 1||1
10351141|NCT00440726|11489587|FG002|NOT COMPLETED|Phase 1||0
10351142|NCT00440726|11489585|FG000|STARTED|Phase 2||0
10351143|NCT00440726|11489586|FG001|STARTED|Phase 2||0
10351144|NCT00440726|11489587|FG002|STARTED|Phase 2||22
10351145|NCT00440726|11489585|FG000|COMPLETED|Phase 2||0
10351146|NCT00440726|11489586|FG001|COMPLETED|Phase 2||0
10351147|NCT00440726|11489587|FG002|COMPLETED|Phase 2||20
10351148|NCT00440726|11489585|FG000|NOT COMPLETED|Phase 2||0
10351149|NCT00440726|11489586|FG001|NOT COMPLETED|Phase 2||0
10351150|NCT00440726|11489587|FG002|NOT COMPLETED|Phase 2||2
10351151|NCT00440830|11489602|FG000|STARTED|Overall Study||20
10351152|NCT00440830|11489603|FG001|STARTED|Overall Study||8
10351153|NCT00440830|11489604|FG002|STARTED|Overall Study||30
10351154|NCT00440830|11489605|FG003|STARTED|Overall Study||10
10533083|NCT01424397|11685429|FG003|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
10533084|NCT01424397|11685430|FG004|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
10533085|NCT01424397|11685431|FG005|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
10533086|NCT01424397|11685432|FG006|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
10533087|NCT01424397|11685433|FG007|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
10533088|NCT01424397|11685434|FG008|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
10533089|NCT01424397|11685435|FG009|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
10533090|NCT01424397|11685436|FG010|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
10533091|NCT01424397|11685437|FG011|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
10533092|NCT01424397|11685426|FG000|STARTED|Period-3 (8 Days)||7
10351155|NCT00440830|11489602|FG000|COMPLETED|Overall Study||20
10351156|NCT00440830|11489603|FG001|COMPLETED|Overall Study||8
10351157|NCT00440830|11489604|FG002|COMPLETED|Overall Study||30
10351158|NCT00440830|11489605|FG003|COMPLETED|Overall Study||10
10351159|NCT00440830|11489602|FG000|NOT COMPLETED|Overall Study||0
10351160|NCT00440830|11489603|FG001|NOT COMPLETED|Overall Study||0
10351161|NCT00440830|11489604|FG002|NOT COMPLETED|Overall Study||0
10533093|NCT01424397|11685427|FG001|STARTED|Period-3 (8 Days)||8
10351162|NCT00440830|11489605|FG003|NOT COMPLETED|Overall Study||0
10351163|NCT00440947|11489619|FG000|STARTED|36-Week Induction Phase||515
10351164|NCT00440947|11489620|FG001|STARTED|36-Week Induction Phase||0
10351165|NCT00440947|11489621|FG002|STARTED|36-Week Induction Phase||0
10351166|NCT00440947|11489622|FG003|STARTED|36-Week Induction Phase||0
10351167|NCT00440947|11489623|FG004|STARTED|36-Week Induction Phase||0
10715913|NCT02688387|11880052|FG009|STARTED|Part 3A, Period 4 (up to 6 Days)||0
10715914|NCT02688387|11880053|FG010|STARTED|Part 3A, Period 4 (up to 6 Days)||0
10715915|NCT02688387|11880054|FG011|STARTED|Part 3A, Period 4 (up to 6 Days)||0
10351168|NCT00440947|11489619|FG000|COMPLETED|36-Week Induction Phase|23 PAR without confirmed HIV-RNA<50c/mL prior to Wk 36 couldn't be randomized but weren't withdrawn.|442
10351169|NCT00440947|11489620|FG001|COMPLETED|36-Week Induction Phase||0
10351170|NCT00440947|11489621|FG002|COMPLETED|36-Week Induction Phase||0
10351171|NCT00440947|11489622|FG003|COMPLETED|36-Week Induction Phase||0
10351172|NCT00440947|11489623|FG004|COMPLETED|36-Week Induction Phase||0
10351173|NCT00440947|11489619|FG000|NOT COMPLETED|36-Week Induction Phase||73
10351174|NCT00440947|11489620|FG001|NOT COMPLETED|36-Week Induction Phase||0
10351175|NCT00440947|11489621|FG002|NOT COMPLETED|36-Week Induction Phase||0
10351176|NCT00440947|11489622|FG003|NOT COMPLETED|36-Week Induction Phase||0
10715916|NCT02688387|11880055|FG012|STARTED|Part 3A, Period 4 (up to 6 Days)||0
10351177|NCT00440947|11489623|FG004|NOT COMPLETED|36-Week Induction Phase||0
10351178|NCT00440947|11489619|FG000|STARTED|48-Week Randomization Phase||0
10351179|NCT00440947|11489620|FG001|STARTED|48-Week Randomization Phase||210
10351180|NCT00440947|11489621|FG002|STARTED|48-Week Randomization Phase||209
10351181|NCT00440947|11489622|FG003|STARTED|48-Week Randomization Phase||0
10351182|NCT00440947|11489623|FG004|STARTED|48-Week Randomization Phase||0
10351183|NCT00440947|11489619|FG000|COMPLETED|48-Week Randomization Phase||0
10351184|NCT00440947|11489620|FG001|COMPLETED|48-Week Randomization Phase||194
10351185|NCT00440947|11489621|FG002|COMPLETED|48-Week Randomization Phase||185
10351186|NCT00440947|11489622|FG003|COMPLETED|48-Week Randomization Phase||0
10351187|NCT00440947|11489623|FG004|COMPLETED|48-Week Randomization Phase||0
10351188|NCT00440947|11489619|FG000|NOT COMPLETED|48-Week Randomization Phase||0
10351189|NCT00440947|11489620|FG001|NOT COMPLETED|48-Week Randomization Phase||16
10351190|NCT00440947|11489621|FG002|NOT COMPLETED|48-Week Randomization Phase||24
10351191|NCT00440947|11489622|FG003|NOT COMPLETED|48-Week Randomization Phase||0
10351192|NCT00440947|11489623|FG004|NOT COMPLETED|48-Week Randomization Phase||0
10351193|NCT00440947|11489619|FG000|STARTED|Optional 60-Week Extension Phase||0
10351194|NCT00440947|11489620|FG001|STARTED|Optional 60-Week Extension Phase||0
10351195|NCT00440947|11489621|FG002|STARTED|Optional 60-Week Extension Phase||0
10351196|NCT00440947|11489622|FG003|STARTED|Optional 60-Week Extension Phase||189
10351197|NCT00440947|11489623|FG004|STARTED|Optional 60-Week Extension Phase||180
10351198|NCT00440947|11489619|FG000|COMPLETED|Optional 60-Week Extension Phase||0
10351199|NCT00440947|11489620|FG001|COMPLETED|Optional 60-Week Extension Phase||0
10351200|NCT00440947|11489621|FG002|COMPLETED|Optional 60-Week Extension Phase||0
10351201|NCT00440947|11489622|FG003|COMPLETED|Optional 60-Week Extension Phase||160
10351202|NCT00440947|11489623|FG004|COMPLETED|Optional 60-Week Extension Phase||154
10351203|NCT00440947|11489619|FG000|NOT COMPLETED|Optional 60-Week Extension Phase||0
10351204|NCT00440947|11489620|FG001|NOT COMPLETED|Optional 60-Week Extension Phase||0
10351205|NCT00440947|11489621|FG002|NOT COMPLETED|Optional 60-Week Extension Phase||0
10351206|NCT00440947|11489622|FG003|NOT COMPLETED|Optional 60-Week Extension Phase||29
10351207|NCT00440947|11489623|FG004|NOT COMPLETED|Optional 60-Week Extension Phase||26
10426808|NCT00849056|11572518|FG000|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||63
10426809|NCT00849056|11572519|FG001|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||50
10426810|NCT00849056|11572518|FG000|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Two par. did not participate in the FUP.|149
10426811|NCT00849056|11572519|FG001|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. One par. did not participate in the FUP.|149
10426812|NCT00849056|11572518|FG000|COMPLETED|Follow-up Period (FUP) (8 Weeks)||122
10426813|NCT00849056|11572519|FG001|COMPLETED|Follow-up Period (FUP) (8 Weeks)||124
10426814|NCT00849056|11572518|FG000|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||27
10426815|NCT00849056|11572519|FG001|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||25
10426816|NCT00849108|11572528|FG000|STARTED|Cohort 1 Dose Ranging and Dose Interval||33
10426817|NCT00849108|11572529|FG001|STARTED|Cohort 1 Dose Ranging and Dose Interval|Cohort 2(Pharm Stress) subjects did not participate in dose range, dose frequency|0
10426818|NCT00849108|11572528|FG000|COMPLETED|Cohort 1 Dose Ranging and Dose Interval||32
10426819|NCT00849108|11572529|FG001|COMPLETED|Cohort 1 Dose Ranging and Dose Interval||0
10426820|NCT00849108|11572528|FG000|NOT COMPLETED|Cohort 1 Dose Ranging and Dose Interval||1
10426821|NCT00849108|11572529|FG001|NOT COMPLETED|Cohort 1 Dose Ranging and Dose Interval||0
10426822|NCT00849108|11572528|FG000|STARTED|Cohort 2 Efficacy|Cohort 1 subjects did not participate in period 2: efficacy|0
10426823|NCT00849108|11572529|FG001|STARTED|Cohort 2 Efficacy||143
10426824|NCT00849108|11572528|FG000|COMPLETED|Cohort 2 Efficacy||0
10426825|NCT00849108|11572529|FG001|COMPLETED|Cohort 2 Efficacy||133
10426826|NCT00849108|11572528|FG000|NOT COMPLETED|Cohort 2 Efficacy||0
10426827|NCT00849108|11572529|FG001|NOT COMPLETED|Cohort 2 Efficacy||10
10426828|NCT00849121|11572539|FG000|STARTED|Overall Study||8
10426829|NCT00849121|11572540|FG001|STARTED|Overall Study||9
10426830|NCT00849121|11572539|FG000|COMPLETED|Overall Study||8
10426831|NCT00849121|11572540|FG001|COMPLETED|Overall Study||9
10426832|NCT00849121|11572539|FG000|NOT COMPLETED|Overall Study||0
10426833|NCT00849121|11572540|FG001|NOT COMPLETED|Overall Study||0
10533094|NCT01424397|11685428|FG002|STARTED|Period-3 (8 Days)||7
10533095|NCT01424397|11685429|FG003|STARTED|Period-3 (8 Days)||8
10533096|NCT01424397|11685430|FG004|STARTED|Period-3 (8 Days)||8
10533097|NCT01424397|11685431|FG005|STARTED|Period-3 (8 Days)||8
10533098|NCT01424397|11685432|FG006|STARTED|Period-3 (8 Days)||4
10533099|NCT01424397|11685433|FG007|STARTED|Period-3 (8 Days)||4
10533100|NCT01424397|11685434|FG008|STARTED|Period-3 (8 Days)||4
10533101|NCT01424397|11685435|FG009|STARTED|Period-3 (8 Days)||3
10533102|NCT01424397|11685436|FG010|STARTED|Period-3 (8 Days)||4
10533103|NCT01424397|11685437|FG011|STARTED|Period-3 (8 Days)||4
10533104|NCT01424397|11685426|FG000|COMPLETED|Period-3 (8 Days)||7
10715917|NCT02688387|11880056|FG013|STARTED|Part 3A, Period 4 (up to 6 Days)||0
10715918|NCT02688387|11880057|FG014|STARTED|Part 3A, Period 4 (up to 6 Days)||8
10715919|NCT02688387|11880058|FG015|STARTED|Part 3A, Period 4 (up to 6 Days)||8
10533105|NCT01424397|11685427|FG001|COMPLETED|Period-3 (8 Days)||8
10533106|NCT01424397|11685428|FG002|COMPLETED|Period-3 (8 Days)||7
10533107|NCT01424397|11685429|FG003|COMPLETED|Period-3 (8 Days)||8
10533108|NCT01424397|11685430|FG004|COMPLETED|Period-3 (8 Days)||8
10533109|NCT01424397|11685431|FG005|COMPLETED|Period-3 (8 Days)||8
10533110|NCT01424397|11685432|FG006|COMPLETED|Period-3 (8 Days)||4
10533111|NCT01424397|11685433|FG007|COMPLETED|Period-3 (8 Days)||4
10533112|NCT01424397|11685434|FG008|COMPLETED|Period-3 (8 Days)||4
10533113|NCT01424397|11685435|FG009|COMPLETED|Period-3 (8 Days)||3
10533114|NCT01424397|11685436|FG010|COMPLETED|Period-3 (8 Days)||4
10533115|NCT01424397|11685437|FG011|COMPLETED|Period-3 (8 Days)||4
10533116|NCT01424397|11685426|FG000|NOT COMPLETED|Period-3 (8 Days)||0
10533117|NCT01424397|11685427|FG001|NOT COMPLETED|Period-3 (8 Days)||0
10533118|NCT01424397|11685428|FG002|NOT COMPLETED|Period-3 (8 Days)||0
10533119|NCT01424397|11685429|FG003|NOT COMPLETED|Period-3 (8 Days)||0
10533120|NCT01424397|11685430|FG004|NOT COMPLETED|Period-3 (8 Days)||0
10533121|NCT01424397|11685431|FG005|NOT COMPLETED|Period-3 (8 Days)||0
10533122|NCT01424397|11685432|FG006|NOT COMPLETED|Period-3 (8 Days)||0
10533123|NCT01424397|11685433|FG007|NOT COMPLETED|Period-3 (8 Days)||0
10533124|NCT01424397|11685434|FG008|NOT COMPLETED|Period-3 (8 Days)||0
10533125|NCT01424397|11685435|FG009|NOT COMPLETED|Period-3 (8 Days)||0
10533126|NCT01424397|11685436|FG010|NOT COMPLETED|Period-3 (8 Days)||0
10533127|NCT01424397|11685437|FG011|NOT COMPLETED|Period-3 (8 Days)||0
10533128|NCT01424501|11685457|FG000|STARTED|Overall Study||7
10533129|NCT01424501|11685458|FG001|STARTED|Overall Study||6
10715920|NCT02688387|11880059|FG016|STARTED|Part 3A, Period 4 (up to 6 Days)||8
10715921|NCT02688387|11880060|FG017|STARTED|Part 3A, Period 4 (up to 6 Days)||8
10715922|NCT02688387|11880061|FG018|STARTED|Part 3A, Period 4 (up to 6 Days)||0
10305601|NCT00094653|11438567|FG002|NOT COMPLETED|Overall Study||126
10305602|NCT00094757|11438579|FG000|STARTED|Overall Study||205
10305603|NCT00094757|11438580|FG001|STARTED|Overall Study||206
10305604|NCT00094757|11438581|FG002|STARTED|Overall Study||110
10305605|NCT00094757|11438579|FG000|COMPLETED|Overall Study||152
10305606|NCT00094757|11438580|FG001|COMPLETED|Overall Study||144
10305607|NCT00094757|11438581|FG002|COMPLETED|Overall Study||80
10305608|NCT00094757|11438579|FG000|NOT COMPLETED|Overall Study||53
10305609|NCT00094757|11438580|FG001|NOT COMPLETED|Overall Study||62
10305610|NCT00094757|11438581|FG002|NOT COMPLETED|Overall Study||30
10305611|NCT00094770|11438591|FG000|STARTED|Year 1 ( Week 0 to Week 52)||588
10305612|NCT00094770|11438592|FG001|STARTED|Year 1 ( Week 0 to Week 52)||584
10315228|NCT00176462|11449060|FG001|NOT COMPLETED|Induction (4 Weeks)||5
10351208|NCT00440999|11489637|FG000|STARTED|Overall Study||228
10351209|NCT00440999|11489638|FG001|STARTED|Overall Study||228
10351210|NCT00440999|11489637|FG000|COMPLETED|Overall Study||193
10351211|NCT00440999|11489638|FG001|COMPLETED|Overall Study||187
10351212|NCT00440999|11489637|FG000|NOT COMPLETED|Overall Study||35
10351213|NCT00440999|11489638|FG001|NOT COMPLETED|Overall Study||41
10351214|NCT00441012|11489648|FG000|STARTED|Overall Study||270
10351215|NCT00441012|11489649|FG001|STARTED|Overall Study||276
10351216|NCT00441012|11489648|FG000|Vaccination Visit 1|Overall Study|1 participant was randomized but not vaccinated in the Modified Process Vaccine group|269
10351217|NCT00441012|11489649|FG001|Vaccination Visit 1|Overall Study|3 participants were vaccinated but were never randomized in the COMVAX™ group|276
10351218|NCT00441012|11489648|FG000|Vaccination Visit 2|Overall Study||267
10351219|NCT00441012|11489649|FG001|Vaccination Visit 2|Overall Study||272
10351220|NCT00441012|11489648|FG000|Vaccination Visit 3|Overall Study||265
10351221|NCT00441012|11489649|FG001|Vaccination Visit 3|Overall Study||269
10351222|NCT00441012|11489648|FG000|COMPLETED|Overall Study||252
10351223|NCT00441012|11489649|FG001|COMPLETED|Overall Study||263
10351224|NCT00441012|11489648|FG000|NOT COMPLETED|Overall Study||18
10351225|NCT00441012|11489649|FG001|NOT COMPLETED|Overall Study||13
10351226|NCT00441064|11489657|FG000|STARTED|Overall Study||69
10351227|NCT00441064|11489658|FG001|STARTED|Overall Study||63
10351228|NCT00441064|11489657|FG000|Safety Population (SP)|Overall Study||69
10351229|NCT00441064|11489658|FG001|Safety Population (SP)|Overall Study||63
10351230|NCT00441064|11489657|FG000|Intent-to-treat (ITT) Population|Overall Study||61
10351231|NCT00441064|11489658|FG001|Intent-to-treat (ITT) Population|Overall Study||57
10351232|NCT00441064|11489657|FG000|COMPLETED|Overall Study||59
10351233|NCT00441064|11489658|FG001|COMPLETED|Overall Study||56
10351234|NCT00441064|11489657|FG000|NOT COMPLETED|Overall Study||10
10351235|NCT00441064|11489658|FG001|NOT COMPLETED|Overall Study||7
10351236|NCT00441090|11489669|FG000|STARTED|Overall Study||15
10351237|NCT00441090|11489670|FG001|STARTED|Overall Study||15
10351238|NCT00441090|11489671|FG002|STARTED|Overall Study||14
10351239|NCT00441090|11489672|FG003|STARTED|Overall Study||15
10351240|NCT00441090|11489673|FG004|STARTED|Overall Study||5
10351241|NCT00441090|11489669|FG000|COMPLETED|Overall Study||13
10351242|NCT00441090|11489670|FG001|COMPLETED|Overall Study||14
10351243|NCT00441090|11489671|FG002|COMPLETED|Overall Study||12
10351244|NCT00441090|11489672|FG003|COMPLETED|Overall Study||13
10351245|NCT00441090|11489673|FG004|COMPLETED|Overall Study||5
10351246|NCT00441090|11489669|FG000|NOT COMPLETED|Overall Study||2
10351247|NCT00441090|11489670|FG001|NOT COMPLETED|Overall Study||1
10351248|NCT00441090|11489671|FG002|NOT COMPLETED|Overall Study||2
10351249|NCT00441090|11489672|FG003|NOT COMPLETED|Overall Study||2
10351250|NCT00441090|11489673|FG004|NOT COMPLETED|Overall Study||0
10351251|NCT00441103|11489687|FG000|STARTED|Overall Study|Intent to treat (ITT) population: all participants who received at least one dose of study drug.|120
10351252|NCT00441103|11489688|FG001|STARTED|Overall Study|Intent to treat (ITT) population: all participants who received at least one dose of study drug.|60
10351253|NCT00441103|11489687|FG000|COMPLETED|Overall Study||109
10351254|NCT00441103|11489688|FG001|COMPLETED|Overall Study||56
10351255|NCT00441103|11489687|FG000|NOT COMPLETED|Overall Study||11
10351256|NCT00441103|11489688|FG001|NOT COMPLETED|Overall Study||4
10351257|NCT00441116|11489697|FG000|STARTED|Overall Study||76
10351258|NCT00441116|11489698|FG001|STARTED|Overall Study||77
10351259|NCT00441116|11489697|FG000|COMPLETED|Overall Study||73
10351260|NCT00441116|11489698|FG001|COMPLETED|Overall Study||75
10351261|NCT00441116|11489697|FG000|NOT COMPLETED|Overall Study||3
10351262|NCT00441116|11489698|FG001|NOT COMPLETED|Overall Study||2
10351263|NCT00441129|11489706|FG000|STARTED|Overall Study||60
10351264|NCT00441129|11489707|FG001|STARTED|Overall Study||55
10351265|NCT00441129|11489706|FG000|COMPLETED|Overall Study||54
10351266|NCT00441129|11489707|FG001|COMPLETED|Overall Study||41
10351267|NCT00441129|11489706|FG000|NOT COMPLETED|Overall Study||6
10351268|NCT00441129|11489707|FG001|NOT COMPLETED|Overall Study||14
10351269|NCT00441142|11489717|FG000|STARTED|Overall Study||6
10351270|NCT00441142|11489718|FG001|STARTED|Overall Study||7
10351271|NCT00441142|11489719|FG002|STARTED|Overall Study||29
10351272|NCT00441142|11489720|FG003|STARTED|Overall Study||69
10351273|NCT00441142|11489717|FG000|COMPLETED|Overall Study||0
10351274|NCT00441142|11489718|FG001|COMPLETED|Overall Study||0
10351275|NCT00441142|11489719|FG002|COMPLETED|Overall Study||7
10351276|NCT00441142|11489720|FG003|COMPLETED|Overall Study||1
10351277|NCT00441142|11489717|FG000|NOT COMPLETED|Overall Study||6
10351278|NCT00441142|11489718|FG001|NOT COMPLETED|Overall Study||7
10351279|NCT00441142|11489719|FG002|NOT COMPLETED|Overall Study||22
10351280|NCT00441142|11489720|FG003|NOT COMPLETED|Overall Study||68
10351281|NCT00441168|11489734|FG000|STARTED|Treatment Period||17
10351282|NCT00441168|11489735|FG001|STARTED|Treatment Period||13
10655855|NCT02211534|11816659|FG001|COMPLETED|Overall Study||6
10655856|NCT02211534|11816658|FG000|NOT COMPLETED|Overall Study||13
10351283|NCT00441168|11489734|FG000|TREATED|Treatment Period||16
10351284|NCT00441168|11489735|FG001|TREATED|Treatment Period||13
10351285|NCT00441168|11489734|FG000|COMPLETED|Treatment Period||6
10351286|NCT00441168|11489735|FG001|COMPLETED|Treatment Period||7
10351287|NCT00441168|11489734|FG000|NOT COMPLETED|Treatment Period||11
10351288|NCT00441168|11489735|FG001|NOT COMPLETED|Treatment Period||6
10351289|NCT00441168|11489734|FG000|STARTED|Follow-up Period|Subjects who did not complete the treatment period could be entered into the follow-up period|17
10655857|NCT02211534|11816659|FG001|NOT COMPLETED|Overall Study||5
10655858|NCT02211638|11816665|FG000|STARTED|Overall Study||18113
10715923|NCT02688387|11880062|FG019|STARTED|Part 3A, Period 4 (up to 6 Days)||0
10351290|NCT00441168|11489735|FG001|STARTED|Follow-up Period|Subjects who did not complete the treatment period could be entered into the follow-up period|13
10351291|NCT00441168|11489734|FG000|COMPLETED|Follow-up Period||5
10351292|NCT00441168|11489735|FG001|COMPLETED|Follow-up Period||4
10351293|NCT00441168|11489734|FG000|NOT COMPLETED|Follow-up Period||12
10351294|NCT00441168|11489735|FG001|NOT COMPLETED|Follow-up Period||9
10351295|NCT00441259|11489743|FG000|STARTED|Overall Study||48
10351296|NCT00441259|11489744|FG001|STARTED|Overall Study||48
10351297|NCT00441259|11489743|FG000|COMPLETED|Overall Study||48
10351298|NCT00441259|11489744|FG001|COMPLETED|Overall Study||48
10351299|NCT00441259|11489743|FG000|NOT COMPLETED|Overall Study||0
10351300|NCT00441259|11489744|FG001|NOT COMPLETED|Overall Study||0
10351301|NCT00441285|11489755|FG000|STARTED|Overall Study||16
10351302|NCT00441285|11489756|FG001|STARTED|Overall Study||16
10351303|NCT00441285|11489757|FG002|STARTED|Overall Study||41
10351304|NCT00441285|11489758|FG003|STARTED|Overall Study||40
10351305|NCT00441285|11489759|FG004|STARTED|Overall Study||43
10351306|NCT00441285|11489755|FG000|COMPLETED|Overall Study||16
10351307|NCT00441285|11489756|FG001|COMPLETED|Overall Study||16
10351308|NCT00441285|11489757|FG002|COMPLETED|Overall Study||41
10351309|NCT00441285|11489758|FG003|COMPLETED|Overall Study||40
10351310|NCT00441285|11489759|FG004|COMPLETED|Overall Study||43
10351311|NCT00441285|11489755|FG000|NOT COMPLETED|Overall Study||0
10351312|NCT00441285|11489756|FG001|NOT COMPLETED|Overall Study||0
10351313|NCT00441285|11489757|FG002|NOT COMPLETED|Overall Study||0
10351314|NCT00441285|11489758|FG003|NOT COMPLETED|Overall Study||0
10351315|NCT00441285|11489759|FG004|NOT COMPLETED|Overall Study||0
10351316|NCT00441337|11489775|FG000|STARTED|Overall Study||6
10351317|NCT00441337|11489776|FG001|STARTED|Overall Study||6
10351318|NCT00441337|11489777|FG002|STARTED|Overall Study||6
10351319|NCT00441337|11489778|FG003|STARTED|Overall Study||21
10351320|NCT00441337|11489775|FG000|COMPLETED|Overall Study||0
10351321|NCT00441337|11489776|FG001|COMPLETED|Overall Study||0
10351322|NCT00441337|11489777|FG002|COMPLETED|Overall Study||0
10351323|NCT00441337|11489778|FG003|COMPLETED|Overall Study||0
10351324|NCT00441337|11489775|FG000|NOT COMPLETED|Overall Study||6
10351325|NCT00441337|11489776|FG001|NOT COMPLETED|Overall Study||6
10351326|NCT00441337|11489777|FG002|NOT COMPLETED|Overall Study||6
10351327|NCT00441337|11489778|FG003|NOT COMPLETED|Overall Study||21
10351328|NCT00441350|11489798|FG000|STARTED|Phase A: Randomization to Week 8||285
10351329|NCT00441350|11489799|FG001|STARTED|Phase A: Randomization to Week 8||561
10351330|NCT00441350|11489800|FG002|STARTED|Phase A: Randomization to Week 8||0
10351331|NCT00441350|11489801|FG003|STARTED|Phase A: Randomization to Week 8||0
10351332|NCT00441350|11489802|FG004|STARTED|Phase A: Randomization to Week 8||0
10351333|NCT00441350|11489803|FG005|STARTED|Phase A: Randomization to Week 8||0
10351334|NCT00441350|11489798|FG000|COMPLETED|Phase A: Randomization to Week 8||268
10351335|NCT00441350|11489799|FG001|COMPLETED|Phase A: Randomization to Week 8||524
10351336|NCT00441350|11489800|FG002|COMPLETED|Phase A: Randomization to Week 8||0
10351337|NCT00441350|11489801|FG003|COMPLETED|Phase A: Randomization to Week 8||0
10351338|NCT00441350|11489802|FG004|COMPLETED|Phase A: Randomization to Week 8||0
10351339|NCT00441350|11489803|FG005|COMPLETED|Phase A: Randomization to Week 8||0
10351340|NCT00441350|11489798|FG000|NOT COMPLETED|Phase A: Randomization to Week 8||17
10351341|NCT00441350|11489799|FG001|NOT COMPLETED|Phase A: Randomization to Week 8||37
10351342|NCT00441350|11489800|FG002|NOT COMPLETED|Phase A: Randomization to Week 8||0
10351343|NCT00441350|11489801|FG003|NOT COMPLETED|Phase A: Randomization to Week 8||0
10351344|NCT00441350|11489802|FG004|NOT COMPLETED|Phase A: Randomization to Week 8||0
10351345|NCT00441350|11489803|FG005|NOT COMPLETED|Phase A: Randomization to Week 8||0
10351346|NCT00441350|11489798|FG000|STARTED|Phase B: Week 8 to Week 16||0
10351347|NCT00441350|11489799|FG001|STARTED|Phase B: Week 8 to Week 16||0
10351348|NCT00441350|11489800|FG002|STARTED|Phase B: Week 8 to Week 16||129
10351349|NCT00441350|11489801|FG003|STARTED|Phase B: Week 8 to Week 16||139
10351350|NCT00441350|11489802|FG004|STARTED|Phase B: Week 8 to Week 16||336
10351351|NCT00441350|11489803|FG005|STARTED|Phase B: Week 8 to Week 16||188
10351352|NCT00441350|11489798|FG000|COMPLETED|Phase B: Week 8 to Week 16||0
10351353|NCT00441350|11489799|FG001|COMPLETED|Phase B: Week 8 to Week 16||0
10351354|NCT00441350|11489800|FG002|COMPLETED|Phase B: Week 8 to Week 16||128
10351355|NCT00441350|11489801|FG003|COMPLETED|Phase B: Week 8 to Week 16||137
10351356|NCT00441350|11489802|FG004|COMPLETED|Phase B: Week 8 to Week 16||333
10351357|NCT00441350|11489803|FG005|COMPLETED|Phase B: Week 8 to Week 16||186
10351358|NCT00441350|11489798|FG000|NOT COMPLETED|Phase B: Week 8 to Week 16||0
10351359|NCT00441350|11489799|FG001|NOT COMPLETED|Phase B: Week 8 to Week 16||0
10351360|NCT00441350|11489800|FG002|NOT COMPLETED|Phase B: Week 8 to Week 16||1
10351361|NCT00441350|11489801|FG003|NOT COMPLETED|Phase B: Week 8 to Week 16||2
10351362|NCT00441350|11489802|FG004|NOT COMPLETED|Phase B: Week 8 to Week 16||3
10351363|NCT00441350|11489803|FG005|NOT COMPLETED|Phase B: Week 8 to Week 16||2
10351364|NCT00441363|11489819|FG000|STARTED|Overall Study||32
10351365|NCT00441363|11489820|FG001|STARTED|Overall Study||34
10351366|NCT00441363|11489819|FG000|COMPLETED|Overall Study|no subject withdrew early since the trial was terminated|15
10351367|NCT00441363|11489820|FG001|COMPLETED|Overall Study||19
10351368|NCT00441363|11489819|FG000|NOT COMPLETED|Overall Study||17
10351369|NCT00441363|11489820|FG001|NOT COMPLETED|Overall Study||15
10351370|NCT00441441|11489828|FG000|STARTED|Overall Study||173
10351371|NCT00441441|11489829|FG001|STARTED|Overall Study||177
10351372|NCT00441441|11489828|FG000|COMPLETED|Overall Study||162
10351373|NCT00441441|11489829|FG001|COMPLETED|Overall Study||163
10351374|NCT00441441|11489828|FG000|NOT COMPLETED|Overall Study||11
10351375|NCT00441441|11489829|FG001|NOT COMPLETED|Overall Study||14
10351376|NCT00441467|11489849|FG000|STARTED|Overall Study||22
10351377|NCT00441467|11489849|FG000|2 Cycles|Overall Study||17
10351378|NCT00441467|11489849|FG000|4 Cycles|Overall Study||7
10351379|NCT00441467|11489849|FG000|COMPLETED|Overall Study||4
10351380|NCT00441467|11489849|FG000|NOT COMPLETED|Overall Study||18
10351381|NCT00441480|11489855|FG000|STARTED|Overall Study||46
10351382|NCT00441480|11489856|FG001|STARTED|Overall Study||45
10351383|NCT00441480|11489855|FG000|COMPLETED|Overall Study||43
10351384|NCT00441480|11489856|FG001|COMPLETED|Overall Study||41
10351385|NCT00441480|11489855|FG000|NOT COMPLETED|Overall Study||3
10351386|NCT00441480|11489856|FG001|NOT COMPLETED|Overall Study||4
10351387|NCT00441545|11489862|FG000|STARTED|First Intervention||95
10351388|NCT00441545|11489863|FG001|STARTED|First Intervention||87
10351389|NCT00441545|11489862|FG000|COMPLETED|First Intervention||77
10351390|NCT00441545|11489863|FG001|COMPLETED|First Intervention||75
10351391|NCT00441545|11489862|FG000|NOT COMPLETED|First Intervention||18
10351392|NCT00441545|11489863|FG001|NOT COMPLETED|First Intervention||12
10351393|NCT00441545|11489862|FG000|STARTED|Washout||77
10351394|NCT00441545|11489863|FG001|STARTED|Washout||75
10351395|NCT00441545|11489862|FG000|COMPLETED|Washout||77
10351396|NCT00441545|11489863|FG001|COMPLETED|Washout||75
10351397|NCT00441545|11489862|FG000|NOT COMPLETED|Washout||0
10351398|NCT00441545|11489863|FG001|NOT COMPLETED|Washout||0
10351399|NCT00441545|11489862|FG000|STARTED|Second Intervention||77
10351400|NCT00441545|11489863|FG001|STARTED|Second Intervention||75
10351401|NCT00441545|11489862|FG000|COMPLETED|Second Intervention||65
10351402|NCT00441545|11489863|FG001|COMPLETED|Second Intervention||68
10351403|NCT00441545|11489862|FG000|NOT COMPLETED|Second Intervention||12
10351404|NCT00441545|11489863|FG001|NOT COMPLETED|Second Intervention||7
10351405|NCT00441558|11489869|FG000|STARTED|Overall Study||1723
10351406|NCT00441558|11489869|FG000|COMPLETED|Overall Study||667
10351407|NCT00441558|11489869|FG000|NOT COMPLETED|Overall Study||1056
10351408|NCT00441584|11489873|FG000|STARTED|Overall Study||117
10351409|NCT00441584|11489873|FG000|COMPLETED|Overall Study||12
10351410|NCT00441584|11489873|FG000|NOT COMPLETED|Overall Study||105
10351411|NCT00441701|11489887|FG000|STARTED|Overall Study||22
10351412|NCT00441701|11489888|FG001|STARTED|Overall Study||11
10351413|NCT00441701|11489889|FG002|STARTED|Overall Study||22
10351414|NCT00441701|11489890|FG003|STARTED|Overall Study||11
10351415|NCT00441701|11489891|FG004|STARTED|Overall Study||22
10351416|NCT00441701|11489892|FG005|STARTED|Overall Study||11
10351417|NCT00441701|11489893|FG006|STARTED|Overall Study||0
10351418|NCT00441701|11489894|FG007|STARTED|Overall Study||0
10351419|NCT00441701|11489895|FG008|STARTED|Overall Study||0
10351420|NCT00441701|11489896|FG009|STARTED|Overall Study||0
10351421|NCT00441701|11489887|FG000|COMPLETED|Overall Study||17
10351422|NCT00441701|11489888|FG001|COMPLETED|Overall Study||7
10351423|NCT00441701|11489889|FG002|COMPLETED|Overall Study||18
10351424|NCT00441701|11489890|FG003|COMPLETED|Overall Study||8
10351425|NCT00441701|11489891|FG004|COMPLETED|Overall Study||20
10351426|NCT00441701|11489892|FG005|COMPLETED|Overall Study||8
10351427|NCT00441701|11489893|FG006|COMPLETED|Overall Study||0
10351428|NCT00441701|11489894|FG007|COMPLETED|Overall Study||0
10351429|NCT00441701|11489895|FG008|COMPLETED|Overall Study||0
10351430|NCT00441701|11489896|FG009|COMPLETED|Overall Study||0
10351431|NCT00441701|11489887|FG000|NOT COMPLETED|Overall Study||5
10351432|NCT00441701|11489888|FG001|NOT COMPLETED|Overall Study||4
10351433|NCT00441701|11489889|FG002|NOT COMPLETED|Overall Study||4
10351434|NCT00441701|11489890|FG003|NOT COMPLETED|Overall Study||3
10351435|NCT00441701|11489891|FG004|NOT COMPLETED|Overall Study||2
10351436|NCT00441701|11489892|FG005|NOT COMPLETED|Overall Study||3
10351437|NCT00441701|11489893|FG006|NOT COMPLETED|Overall Study||0
10351438|NCT00441701|11489894|FG007|NOT COMPLETED|Overall Study||0
10351439|NCT00441701|11489895|FG008|NOT COMPLETED|Overall Study||0
10351440|NCT00441701|11489896|FG009|NOT COMPLETED|Overall Study||0
10351441|NCT00441727|11489917|FG000|STARTED|Overall Study|ITT/randomised|817
10351442|NCT00441727|11489918|FG001|STARTED|Overall Study|ITT/randomised|804
10351443|NCT00441727|11489919|FG002|STARTED|Overall Study|ITT/randomised|805
10351444|NCT00441727|11489917|FG000|COMPLETED|Overall Study|ITT/randomised|711
10351445|NCT00441727|11489918|FG001|COMPLETED|Overall Study|ITT/randomised|686
10351446|NCT00441727|11489919|FG002|COMPLETED|Overall Study|ITT/randomised|637
10351447|NCT00441727|11489917|FG000|NOT COMPLETED|Overall Study||106
10351448|NCT00441727|11489918|FG001|NOT COMPLETED|Overall Study||118
10351449|NCT00441727|11489919|FG002|NOT COMPLETED|Overall Study||168
10351450|NCT00441766|11489936|FG000|STARTED|Overall Study||53
10351451|NCT00441766|11489937|FG001|STARTED|Overall Study||53
10351452|NCT00441766|11489938|FG002|STARTED|Overall Study||53
10351453|NCT00441766|11489939|FG003|STARTED|Overall Study||54
10351454|NCT00441766|11489936|FG000|COMPLETED|Overall Study||39
10351455|NCT00441766|11489937|FG001|COMPLETED|Overall Study||46
10351456|NCT00441766|11489938|FG002|COMPLETED|Overall Study||44
10351457|NCT00441766|11489939|FG003|COMPLETED|Overall Study||48
10351458|NCT00441766|11489936|FG000|NOT COMPLETED|Overall Study||14
10351459|NCT00441766|11489937|FG001|NOT COMPLETED|Overall Study||7
10351460|NCT00441766|11489938|FG002|NOT COMPLETED|Overall Study||9
10351461|NCT00441766|11489939|FG003|NOT COMPLETED|Overall Study||6
10351462|NCT00441792|11489951|FG000|STARTED|Overall Study||59
10351463|NCT00441792|11489952|FG001|STARTED|Overall Study||63
10351464|NCT00441792|11489951|FG000|COMPLETED|Overall Study||59
10426834|NCT00849147|11572546|FG000|STARTED|Overall Study||55
10351465|NCT00441792|11489952|FG001|COMPLETED|Overall Study|2 patients lost to follow up in Etomidate arm due to transfer to outside hospital.|61
10351466|NCT00441792|11489951|FG000|NOT COMPLETED|Overall Study||0
10351467|NCT00441792|11489952|FG001|NOT COMPLETED|Overall Study||2
10351468|NCT00441883|11489963|FG000|STARTED|Overall Study||43
10351469|NCT00441883|11489964|FG001|STARTED|Overall Study||32
10351470|NCT00441883|11489965|FG002|STARTED|Overall Study||28
10351471|NCT00441883|11489966|FG003|STARTED|Overall Study||28
10351472|NCT00441883|11489967|FG004|STARTED|Overall Study||45
10351473|NCT00441883|11489963|FG000|ITT Population|Overall Study||43
10351474|NCT00441883|11489964|FG001|ITT Population|Overall Study||30
10351475|NCT00441883|11489965|FG002|ITT Population|Overall Study||30
10351476|NCT00441883|11489966|FG003|ITT Population|Overall Study||30
10351477|NCT00441883|11489967|FG004|ITT Population|Overall Study||43
10351478|NCT00441883|11489963|FG000|Per Protocol Population|Overall Study||38
10351479|NCT00441883|11489964|FG001|Per Protocol Population|Overall Study||29
10351480|NCT00441883|11489965|FG002|Per Protocol Population|Overall Study||25
10351481|NCT00441883|11489966|FG003|Per Protocol Population|Overall Study||24
10351482|NCT00441883|11489967|FG004|Per Protocol Population|Overall Study||38
10351483|NCT00441883|11489963|FG000|Safety Population|Overall Study||43
10351484|NCT00441883|11489964|FG001|Safety Population|Overall Study||32
10351485|NCT00441883|11489965|FG002|Safety Population|Overall Study||28
10351486|NCT00441883|11489966|FG003|Safety Population|Overall Study||28
10351487|NCT00441883|11489967|FG004|Safety Population|Overall Study||45
10351488|NCT00441883|11489963|FG000|COMPLETED|Overall Study||42
10351489|NCT00441883|11489964|FG001|COMPLETED|Overall Study||32
10351490|NCT00441883|11489965|FG002|COMPLETED|Overall Study||28
10351491|NCT00441883|11489966|FG003|COMPLETED|Overall Study||28
10351492|NCT00441883|11489967|FG004|COMPLETED|Overall Study||43
10351493|NCT00441883|11489963|FG000|NOT COMPLETED|Overall Study||1
10351494|NCT00441883|11489964|FG001|NOT COMPLETED|Overall Study||0
10351495|NCT00441883|11489965|FG002|NOT COMPLETED|Overall Study||0
10351496|NCT00441883|11489966|FG003|NOT COMPLETED|Overall Study||0
10351497|NCT00441883|11489967|FG004|NOT COMPLETED|Overall Study||2
10351498|NCT00441974|11489979|FG000|STARTED|Overall Study||1470
10351499|NCT00441974|11489979|FG000|COMPLETED|Overall Study||1342
10351500|NCT00441974|11489979|FG000|NOT COMPLETED|Overall Study||128
10351501|NCT00442013|11489988|FG000|STARTED|Overall Study||157
10351502|NCT00442013|11489989|FG001|STARTED|Overall Study||149
10351503|NCT00442013|11489988|FG000|COMPLETED|Overall Study||131
10351504|NCT00442013|11489989|FG001|COMPLETED|Overall Study||132
10351505|NCT00442013|11489988|FG000|NOT COMPLETED|Overall Study||26
10351506|NCT00442013|11489989|FG001|NOT COMPLETED|Overall Study||17
10351507|NCT00442169|11490002|FG000|STARTED|Part 1||17
10351508|NCT00442169|11490003|FG001|STARTED|Part 1||24
10351509|NCT00442169|11490004|FG002|STARTED|Part 1||40
10351510|NCT00442169|11490005|FG003|STARTED|Part 1||31
10351511|NCT00442169|11490006|FG004|STARTED|Part 1|Participants in Part 2 are not the same as those in Part 1|0
10351512|NCT00442169|11490007|FG005|STARTED|Part 1|Participants in Part 2 are not the same as those in Part 1|0
10351513|NCT00442169|11490002|FG000|COMPLETED|Part 1||17
10351514|NCT00442169|11490003|FG001|COMPLETED|Part 1||24
10351515|NCT00442169|11490004|FG002|COMPLETED|Part 1||40
10351516|NCT00442169|11490005|FG003|COMPLETED|Part 1||31
10351517|NCT00442169|11490006|FG004|COMPLETED|Part 1||0
10351518|NCT00442169|11490007|FG005|COMPLETED|Part 1||0
10351519|NCT00442169|11490002|FG000|NOT COMPLETED|Part 1||0
10351520|NCT00442169|11490003|FG001|NOT COMPLETED|Part 1||0
10351521|NCT00442169|11490004|FG002|NOT COMPLETED|Part 1||0
10351522|NCT00442169|11490005|FG003|NOT COMPLETED|Part 1||0
10351523|NCT00442169|11490006|FG004|NOT COMPLETED|Part 1||0
10351524|NCT00442169|11490007|FG005|NOT COMPLETED|Part 1||0
10351525|NCT00442169|11490002|FG000|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
10351526|NCT00442169|11490003|FG001|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
10351527|NCT00442169|11490004|FG002|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
10351528|NCT00442169|11490005|FG003|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
10351529|NCT00442169|11490006|FG004|STARTED|Part 2||25
10351530|NCT00442169|11490007|FG005|STARTED|Part 2||57
10351531|NCT00442169|11490002|FG000|COMPLETED|Part 2||0
10351532|NCT00442169|11490003|FG001|COMPLETED|Part 2||0
10351533|NCT00442169|11490004|FG002|COMPLETED|Part 2||0
10351534|NCT00442169|11490005|FG003|COMPLETED|Part 2||0
10351535|NCT00442169|11490006|FG004|COMPLETED|Part 2||25
10351536|NCT00442169|11490007|FG005|COMPLETED|Part 2||57
10351537|NCT00442169|11490002|FG000|NOT COMPLETED|Part 2||0
10351538|NCT00442169|11490003|FG001|NOT COMPLETED|Part 2||0
10351539|NCT00442169|11490004|FG002|NOT COMPLETED|Part 2||0
10351540|NCT00442169|11490005|FG003|NOT COMPLETED|Part 2||0
10351541|NCT00442169|11490006|FG004|NOT COMPLETED|Part 2||0
10351542|NCT00442169|11490007|FG005|NOT COMPLETED|Part 2||0
10351543|NCT00442286|11490024|FG000|STARTED|Overall Study||181
10351544|NCT00442286|11490025|FG001|STARTED|Overall Study||84
10351545|NCT00442286|11490024|FG000|6 Months|Overall Study||177
10351546|NCT00442286|11490025|FG001|6 Months|Overall Study||83
10351547|NCT00442286|11490024|FG000|12 Months|Overall Study||174
10351548|NCT00442286|11490025|FG001|12 Months|Overall Study||82
10351549|NCT00442286|11490024|FG000|COMPLETED|Overall Study||174
10351550|NCT00442286|11490025|FG001|COMPLETED|Overall Study||82
10351551|NCT00442286|11490024|FG000|NOT COMPLETED|Overall Study||7
10351552|NCT00442286|11490025|FG001|NOT COMPLETED|Overall Study||2
10351553|NCT00442364|11490033|FG000|STARTED|Overall Study||60
10351554|NCT00442364|11490033|FG000|COMPLETED|Overall Study||60
10351555|NCT00442364|11490033|FG000|NOT COMPLETED|Overall Study||0
10351556|NCT00442416|11490039|FG000|STARTED|Overall Study||39
10351557|NCT00442416|11490040|FG001|STARTED|Overall Study||41
10351558|NCT00442416|11490039|FG000|COMPLETED|Overall Study||2
10351559|NCT00442416|11490040|FG001|COMPLETED|Overall Study||2
10351560|NCT00442416|11490039|FG000|NOT COMPLETED|Overall Study||37
10351561|NCT00442416|11490040|FG001|NOT COMPLETED|Overall Study||39
10351562|NCT00442468|11490046|FG000|STARTED|Overall Study||1283
10351563|NCT00442468|11490046|FG000|COMPLETED|Overall Study||1100
10351564|NCT00442468|11490046|FG000|NOT COMPLETED|Overall Study||183
10351565|NCT00442507|11490050|FG000|STARTED|Overall Study||6
10351566|NCT00442507|11490050|FG000|COMPLETED|Overall Study||6
10351567|NCT00442507|11490050|FG000|NOT COMPLETED|Overall Study||0
10351568|NCT00442572|11490056|FG000|STARTED|Overall Study||17
10305613|NCT00094770|11438591|FG000|COMPLETED|Year 1 ( Week 0 to Week 52)|4 Participants who Completed Week 52, Did NOT Enter second year|386
10305614|NCT00094770|11438592|FG001|COMPLETED|Year 1 ( Week 0 to Week 52)|11 Participants who Completed Week 52, Did NOT Enter second year|412
10305615|NCT00094770|11438591|FG000|NOT COMPLETED|Year 1 ( Week 0 to Week 52)||202
10305616|NCT00094770|11438592|FG001|NOT COMPLETED|Year 1 ( Week 0 to Week 52)||172
10305617|NCT00094770|11438591|FG000|STARTED|Year 2 (Week 0 to Week 104)||588
10305618|NCT00094770|11438592|FG001|STARTED|Year 2 (Week 0 to Week 104)||584
10305619|NCT00094770|11438591|FG000|COMPLETED|Year 2 (Week 0 to Week 104)||255
10351569|NCT00442572|11490057|FG001|STARTED|Overall Study||4
10351570|NCT00442572|11490056|FG000|COMPLETED|Overall Study||9
10351571|NCT00442572|11490057|FG001|COMPLETED|Overall Study||1
10351572|NCT00442572|11490056|FG000|NOT COMPLETED|Overall Study||8
10351573|NCT00442572|11490057|FG001|NOT COMPLETED|Overall Study||3
10351574|NCT00442598|11490067|FG000|STARTED|Overall Study||7
10351575|NCT00442598|11490068|FG001|STARTED|Overall Study||10
10351576|NCT00442598|11490069|FG002|STARTED|Overall Study||0
10351577|NCT00442598|11490067|FG000|Two Cycles|Overall Study||5
10351578|NCT00442598|11490068|FG001|Two Cycles|Overall Study||6
10351579|NCT00442598|11490069|FG002|Two Cycles|Overall Study||0
10351580|NCT00442598|11490067|FG000|COMPLETED|Overall Study||1
10351581|NCT00442598|11490068|FG001|COMPLETED|Overall Study||2
10351582|NCT00442598|11490069|FG002|COMPLETED|Overall Study||0
10351583|NCT00442598|11490067|FG000|NOT COMPLETED|Overall Study||6
10351584|NCT00442598|11490068|FG001|NOT COMPLETED|Overall Study||8
10351585|NCT00442598|11490069|FG002|NOT COMPLETED|Overall Study||0
10351586|NCT00442611|11490078|FG000|STARTED|Overall Study||7
10351587|NCT00442611|11490079|FG001|STARTED|Overall Study||3
10351588|NCT00442611|11490078|FG000|COMPLETED|Overall Study||6
10351589|NCT00442611|11490079|FG001|COMPLETED|Overall Study||3
10305620|NCT00094770|11438592|FG001|COMPLETED|Year 2 (Week 0 to Week 104)||264
10305621|NCT00094770|11438591|FG000|NOT COMPLETED|Year 2 (Week 0 to Week 104)||333
10305622|NCT00094770|11438592|FG001|NOT COMPLETED|Year 2 (Week 0 to Week 104)||320
10305623|NCT00094809|11438600|FG000|STARTED|Overall Study||126
10305624|NCT00094809|11438601|FG001|STARTED|Overall Study||126
10305625|NCT00094809|11438600|FG000|Received Study Drug|Overall Study||124
10305626|NCT00094809|11438601|FG001|Received Study Drug|Overall Study||118
10305627|NCT00094809|11438600|FG000|Properly Consented; Received Study Drug|Overall Study||123
10305628|NCT00094809|11438601|FG001|Properly Consented; Received Study Drug|Overall Study||118
10305629|NCT00094809|11438600|FG000|Completed All 4 Cycles of Treatment|Overall Study||98
10305630|NCT00094809|11438601|FG001|Completed All 4 Cycles of Treatment|Overall Study||90
10305631|NCT00094809|11438600|FG000|COMPLETED|Overall Study|Subjects who completed treatment and Long term follow up (LTFU)|74
10305632|NCT00094809|11438601|FG001|COMPLETED|Overall Study|Subjects who completed treatment and LTFU|61
10305633|NCT00094809|11438600|FG000|NOT COMPLETED|Overall Study||52
10305634|NCT00094809|11438601|FG001|NOT COMPLETED|Overall Study||65
10305635|NCT00094835|11438614|FG000|STARTED|Overall Study||9
10305636|NCT00094835|11438615|FG001|STARTED|Overall Study||11
10351590|NCT00442611|11490078|FG000|NOT COMPLETED|Overall Study||1
10351591|NCT00442611|11490079|FG001|NOT COMPLETED|Overall Study||0
10351592|NCT00442689|11490088|FG000|STARTED|Overall Study||21
10351593|NCT00442689|11490089|FG001|STARTED|Overall Study||24
10351594|NCT00442689|11490090|FG002|STARTED|Overall Study||22
10351595|NCT00442689|11490088|FG000|COMPLETED|Overall Study||11
10351596|NCT00442689|11490089|FG001|COMPLETED|Overall Study||13
10351597|NCT00442689|11490090|FG002|COMPLETED|Overall Study||13
10351598|NCT00442689|11490088|FG000|NOT COMPLETED|Overall Study||10
10351599|NCT00442689|11490089|FG001|NOT COMPLETED|Overall Study||11
10351600|NCT00442689|11490090|FG002|NOT COMPLETED|Overall Study||9
10351601|NCT00442702|11490100|FG000|STARTED|Titration Period||114
10305637|NCT00094835|11438616|FG002|STARTED|Overall Study||7
10351602|NCT00442702|11490101|FG001|STARTED|Titration Period||114
10351603|NCT00442702|11490100|FG000|Safety Population|Titration Period|One patient was randomized to darbepoetin alfa but treated by mistake with Mircera|115
10351604|NCT00442702|11490101|FG001|Safety Population|Titration Period||113
10351605|NCT00442702|11490100|FG000|COMPLETED|Titration Period||102
10351606|NCT00442702|11490101|FG001|COMPLETED|Titration Period||111
10351607|NCT00442702|11490100|FG000|NOT COMPLETED|Titration Period||12
10351608|NCT00442702|11490101|FG001|NOT COMPLETED|Titration Period||3
10351609|NCT00442702|11490100|FG000|STARTED|Evaluation Period||102
10351610|NCT00442702|11490101|FG001|STARTED|Evaluation Period||111
10351611|NCT00442702|11490100|FG000|COMPLETED|Evaluation Period||97
10351612|NCT00442702|11490101|FG001|COMPLETED|Evaluation Period||107
10351613|NCT00442702|11490100|FG000|NOT COMPLETED|Evaluation Period||5
10351614|NCT00442702|11490101|FG001|NOT COMPLETED|Evaluation Period||4
10351615|NCT00442767|11490107|FG000|STARTED|Overall Study||8
10351616|NCT00442767|11490107|FG000|COMPLETED|Overall Study||8
10351617|NCT00442767|11490107|FG000|NOT COMPLETED|Overall Study||0
10351618|NCT00442936|11490117|FG000|STARTED|Overall Study||333
10351619|NCT00442936|11490118|FG001|STARTED|Overall Study||354
10351620|NCT00442936|11490119|FG002|STARTED|Overall Study||345
10351621|NCT00442936|11490120|FG003|STARTED|Overall Study||348
10351622|NCT00442936|11490117|FG000|COMPLETED|Overall Study||332
10351623|NCT00442936|11490118|FG001|COMPLETED|Overall Study||354
10351624|NCT00442936|11490119|FG002|COMPLETED|Overall Study||344
10351625|NCT00442936|11490120|FG003|COMPLETED|Overall Study||347
10351626|NCT00442936|11490117|FG000|NOT COMPLETED|Overall Study||1
10351627|NCT00442936|11490118|FG001|NOT COMPLETED|Overall Study||0
10351628|NCT00442936|11490119|FG002|NOT COMPLETED|Overall Study||1
10351629|NCT00442936|11490120|FG003|NOT COMPLETED|Overall Study||1
10351630|NCT00442962|11490130|FG000|STARTED|Overall Study||54
10351631|NCT00442962|11490130|FG000|Primary Outcome Evaluation|Overall Study|Primary outcome evaluation at week 24.|52
10351632|NCT00442962|11490130|FG000|COMPLETED|Overall Study|Completed 48 weeks of follow-up.|46
10351633|NCT00442962|11490130|FG000|NOT COMPLETED|Overall Study||8
10351634|NCT00443053|11490136|FG000|STARTED|Overall Study||1502
10351635|NCT00443053|11490137|FG001|STARTED|Overall Study||1500
10812426|NCT03680911|11974477|FG001|NOT COMPLETED|Visit 2 (1 Month Follow up)||0
10351636|NCT00443053|11490136|FG000|COMPLETED|Overall Study||1481
10351637|NCT00443053|11490137|FG001|COMPLETED|Overall Study||1467
10351638|NCT00443053|11490136|FG000|NOT COMPLETED|Overall Study||21
10351639|NCT00443053|11490137|FG001|NOT COMPLETED|Overall Study||33
10351640|NCT00443079|11490145|FG000|STARTED|Overall Study||3
10351641|NCT00443079|11490146|FG001|STARTED|Overall Study||3
10351642|NCT00443079|11490145|FG000|COMPLETED|Overall Study||3
10351643|NCT00443079|11490146|FG001|COMPLETED|Overall Study||2
10351644|NCT00443079|11490145|FG000|NOT COMPLETED|Overall Study||0
10351645|NCT00443079|11490146|FG001|NOT COMPLETED|Overall Study||1
10351646|NCT00443118|11490157|FG000|STARTED|Overall Study||515
10351647|NCT00443118|11490158|FG001|STARTED|Overall Study||291
10351648|NCT00443118|11490159|FG002|STARTED|Overall Study||226
10351649|NCT00443118|11490157|FG000|COMPLETED|Overall Study||511
10351650|NCT00443118|11490158|FG001|COMPLETED|Overall Study||290
10351651|NCT00443118|11490159|FG002|COMPLETED|Overall Study||226
10351652|NCT00443118|11490157|FG000|NOT COMPLETED|Overall Study||4
10351653|NCT00443118|11490158|FG001|NOT COMPLETED|Overall Study||1
10351654|NCT00443118|11490159|FG002|NOT COMPLETED|Overall Study||0
10351655|NCT00443209|11490187|FG000|STARTED|Months 1 to 12 Treatment Period||712
10351656|NCT00443209|11490188|FG001|STARTED|Months 1 to 12 Treatment Period||356
10351657|NCT00443209|11490187|FG000|Treated|Months 1 to 12 Treatment Period||641
10351658|NCT00443209|11490188|FG001|Treated|Months 1 to 12 Treatment Period||313
10351659|NCT00443209|11490187|FG000|COMPLETED|Months 1 to 12 Treatment Period|Trial terminated used for participants not completing 12 months of treatment due to trial completion|367
10351660|NCT00443209|11490188|FG001|COMPLETED|Months 1 to 12 Treatment Period|Trial terminated used for participants not completing 12 months of treatment due to trial completion|202
10351661|NCT00443209|11490187|FG000|NOT COMPLETED|Months 1 to 12 Treatment Period||345
10351662|NCT00443209|11490188|FG001|NOT COMPLETED|Months 1 to 12 Treatment Period||154
10351663|NCT00443209|11490187|FG000|STARTED|Months 13 to 18 Treatment Period|The Months 13 to 18 Treatment Period.was optional. 181 participants chose not to continue.|186
10351664|NCT00443209|11490188|FG001|STARTED|Months 13 to 18 Treatment Period|The Months 13 to 18 Treatment Period was optional. 116 participants chose not to continue.|86
10351665|NCT00443209|11490187|FG000|COMPLETED|Months 13 to 18 Treatment Period|Trial terminated used for participants not completing 18 months of treatment due to trial completion|87
10351666|NCT00443209|11490188|FG001|COMPLETED|Months 13 to 18 Treatment Period|Trial terminated used for participants not completing 18 months of treatment due to trial completion|39
10351667|NCT00443209|11490187|FG000|NOT COMPLETED|Months 13 to 18 Treatment Period||99
10351668|NCT00443209|11490188|FG001|NOT COMPLETED|Months 13 to 18 Treatment Period||47
10351669|NCT00443261|11490194|FG000|STARTED|Overall Study||1
10426835|NCT00849147|11572546|FG000|COMPLETED|Overall Study||50
10533130|NCT01424501|11685459|FG002|STARTED|Overall Study||24
10533131|NCT01424501|11685460|FG003|STARTED|Overall Study||25
10533132|NCT01424501|11685461|FG004|STARTED|Overall Study||40
10533133|NCT01424501|11685462|FG005|STARTED|Overall Study||40
10533134|NCT01424501|11685457|FG000|COMPLETED|Overall Study||6
10533135|NCT01424501|11685458|FG001|COMPLETED|Overall Study||5
10533136|NCT01424501|11685459|FG002|COMPLETED|Overall Study||22
10533137|NCT01424501|11685460|FG003|COMPLETED|Overall Study||25
10533138|NCT01424501|11685461|FG004|COMPLETED|Overall Study||40
10533139|NCT01424501|11685462|FG005|COMPLETED|Overall Study||40
10533140|NCT01424501|11685457|FG000|NOT COMPLETED|Overall Study||1
10533141|NCT01424501|11685458|FG001|NOT COMPLETED|Overall Study||1
10533142|NCT01424501|11685459|FG002|NOT COMPLETED|Overall Study||2
10533143|NCT01424501|11685460|FG003|NOT COMPLETED|Overall Study||0
10533144|NCT01424501|11685461|FG004|NOT COMPLETED|Overall Study||0
10351670|NCT00443261|11490194|FG000|Accrual in 10 Months|Overall Study|Patient died due to progressive disease after cycle 1 of treatment|1
10351671|NCT00443261|11490194|FG000|COMPLETED|Overall Study|Study terminated due to poor accrual and only patient enrolled died|0
10351672|NCT00443261|11490194|FG000|NOT COMPLETED|Overall Study||1
10351673|NCT00443352|11490198|FG000|STARTED|Overall Study||27
10351674|NCT00443352|11490198|FG000|COMPLETED|Overall Study||22
10533145|NCT01424501|11685462|FG005|NOT COMPLETED|Overall Study||0
10533146|NCT01424514|11685477|FG000|STARTED|Period 1:Intervention Period 1 (14 Days)||20
10533147|NCT01424514|11685478|FG001|STARTED|Period 1:Intervention Period 1 (14 Days)||20
10533148|NCT01424514|11685477|FG000|COMPLETED|Period 1:Intervention Period 1 (14 Days)||19
10533149|NCT01424514|11685478|FG001|COMPLETED|Period 1:Intervention Period 1 (14 Days)||19
10533150|NCT01424514|11685477|FG000|NOT COMPLETED|Period 1:Intervention Period 1 (14 Days)||1
10533151|NCT01424514|11685478|FG001|NOT COMPLETED|Period 1:Intervention Period 1 (14 Days)||1
10533152|NCT01424514|11685477|FG000|STARTED|Period 2:Washout Period (4 Weeks)||19
10533153|NCT01424514|11685478|FG001|STARTED|Period 2:Washout Period (4 Weeks)||19
10533154|NCT01424514|11685477|FG000|COMPLETED|Period 2:Washout Period (4 Weeks)||19
10533155|NCT01424514|11685478|FG001|COMPLETED|Period 2:Washout Period (4 Weeks)||19
10533156|NCT01424514|11685477|FG000|NOT COMPLETED|Period 2:Washout Period (4 Weeks)||0
10533157|NCT01424514|11685478|FG001|NOT COMPLETED|Period 2:Washout Period (4 Weeks)||0
10533158|NCT01424514|11685477|FG000|STARTED|Period 3:Intervention Period 2 (14 Days)||19
10533159|NCT01424514|11685478|FG001|STARTED|Period 3:Intervention Period 2 (14 Days)||19
10533160|NCT01424514|11685477|FG000|COMPLETED|Period 3:Intervention Period 2 (14 Days)||18
10533161|NCT01424514|11685478|FG001|COMPLETED|Period 3:Intervention Period 2 (14 Days)||19
10533162|NCT01424514|11685477|FG000|NOT COMPLETED|Period 3:Intervention Period 2 (14 Days)||1
10533163|NCT01424514|11685478|FG001|NOT COMPLETED|Period 3:Intervention Period 2 (14 Days)||0
10533164|NCT01424566|11685489|FG000|STARTED|Single-blind Treatment||406
10533165|NCT01424566|11685490|FG001|STARTED|Single-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|0
10533166|NCT01424566|11685491|FG002|STARTED|Single-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|0
10533167|NCT01424566|11685489|FG000|Received at Least 1 Dose of Study Drug|Single-blind Treatment|Two participants did not administer any study drug.|404
10533168|NCT01424566|11685490|FG001|Received at Least 1 Dose of Study Drug|Single-blind Treatment||0
10533169|NCT01424566|11685491|FG002|Received at Least 1 Dose of Study Drug|Single-blind Treatment||0
10533170|NCT01424566|11685489|FG000|Single-blind Safety Population|Single-blind Treatment||404
10533171|NCT01424566|11685490|FG001|Single-blind Safety Population|Single-blind Treatment||0
10533172|NCT01424566|11685491|FG002|Single-blind Safety Population|Single-blind Treatment||0
10533173|NCT01424566|11685489|FG000|Met Randomization Criteria|Single-blind Treatment||206
10533174|NCT01424566|11685490|FG001|Met Randomization Criteria|Single-blind Treatment||0
10533175|NCT01424566|11685491|FG002|Met Randomization Criteria|Single-blind Treatment||0
10533176|NCT01424566|11685489|FG000|COMPLETED|Single-blind Treatment||206
10533177|NCT01424566|11685490|FG001|COMPLETED|Single-blind Treatment||0
10533178|NCT01424566|11685491|FG002|COMPLETED|Single-blind Treatment||0
10533179|NCT01424566|11685489|FG000|NOT COMPLETED|Single-blind Treatment||200
10533180|NCT01424566|11685490|FG001|NOT COMPLETED|Single-blind Treatment||0
10533181|NCT01424566|11685491|FG002|NOT COMPLETED|Single-blind Treatment||0
10533182|NCT01424566|11685489|FG000|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the double-blind period.|0
10533183|NCT01424566|11685490|FG001|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|103
10533184|NCT01424566|11685491|FG002|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|103
10533185|NCT01424566|11685489|FG000|Received at Least 1 Dose of Study Drug|Double-blind Treatment||0
10533186|NCT01424566|11685490|FG001|Received at Least 1 Dose of Study Drug|Double-blind Treatment||103
10533187|NCT01424566|11685491|FG002|Received at Least 1 Dose of Study Drug|Double-blind Treatment||103
10533188|NCT01424566|11685489|FG000|Randomized Safety Population|Double-blind Treatment||0
10533189|NCT01424566|11685490|FG001|Randomized Safety Population|Double-blind Treatment||103
10533190|NCT01424566|11685491|FG002|Randomized Safety Population|Double-blind Treatment||103
10533191|NCT01424566|11685489|FG000|ITT Population|Double-blind Treatment||0
10533192|NCT01424566|11685490|FG001|ITT Population|Double-blind Treatment||103
10533193|NCT01424566|11685491|FG002|ITT Population|Double-blind Treatment||103
10533194|NCT01424566|11685489|FG000|COMPLETED|Double-blind Treatment||0
10533195|NCT01424566|11685490|FG001|COMPLETED|Double-blind Treatment||78
10533196|NCT01424566|11685491|FG002|COMPLETED|Double-blind Treatment||88
10533197|NCT01424566|11685489|FG000|NOT COMPLETED|Double-blind Treatment||0
10533198|NCT01424566|11685490|FG001|NOT COMPLETED|Double-blind Treatment||25
10533199|NCT01424566|11685491|FG002|NOT COMPLETED|Double-blind Treatment||15
10533200|NCT01424644|11685500|FG000|STARTED|Overall Study||402
10533201|NCT01424644|11685501|FG001|STARTED|Overall Study||399
10533202|NCT01424644|11685500|FG000|COMPLETED|Overall Study||369
10533203|NCT01424644|11685501|FG001|COMPLETED|Overall Study||372
10533204|NCT01424644|11685500|FG000|NOT COMPLETED|Overall Study||33
10533205|NCT01424644|11685501|FG001|NOT COMPLETED|Overall Study||27
10533206|NCT01424670|11685509|FG000|STARTED|6-Month Intensive Period (182 Days)||341
10533207|NCT01424670|11685510|FG001|STARTED|6-Month Intensive Period (182 Days)||170
10533208|NCT01424670|11685509|FG000|Received at Least 1 Dose of Study Drug|6-Month Intensive Period (182 Days)||341
10533209|NCT01424670|11685510|FG001|Received at Least 1 Dose of Study Drug|6-Month Intensive Period (182 Days)||170
10533210|NCT01424670|11685509|FG000|COMPLETED|6-Month Intensive Period (182 Days)||322
10351675|NCT00443352|11490198|FG000|NOT COMPLETED|Overall Study||5
10351676|NCT00443430|11490204|FG000|STARTED|Overall Study||43
10351677|NCT00443430|11490205|FG001|STARTED|Overall Study||42
10351678|NCT00443430|11490204|FG000|COMPLETED|Overall Study||39
10351679|NCT00443430|11490205|FG001|COMPLETED|Overall Study||38
10715924|NCT02688387|11880063|FG020|STARTED|Part 3A, Period 4 (up to 6 Days)||0
10715925|NCT02688387|11880064|FG021|STARTED|Part 3A, Period 4 (up to 6 Days)||0
10351680|NCT00443430|11490204|FG000|NOT COMPLETED|Overall Study||4
10351681|NCT00443430|11490205|FG001|NOT COMPLETED|Overall Study||4
10351682|NCT00443456|11490211|FG000|STARTED|Overall Study||134
10351683|NCT00443456|11490211|FG000|COMPLETED|Overall Study||116
10351684|NCT00443456|11490211|FG000|NOT COMPLETED|Overall Study||18
10351685|NCT00443534|11490219|FG000|STARTED|Overall Study||123
10351686|NCT00443534|11490219|FG000|Treated|Overall Study||122
10351687|NCT00443534|11490219|FG000|COMPLETED|Overall Study||0
10351688|NCT00443534|11490219|FG000|NOT COMPLETED|Overall Study||123
10351689|NCT00443547|11490227|FG000|STARTED|Overall Study|Enrolled and Treated Per Protocol|89
10351690|NCT00443547|11490228|FG001|STARTED|Overall Study|Enrolled and Treated Per Protocol|88
10351691|NCT00443547|11490229|FG002|STARTED|Overall Study|Enrolled and Treated Per Protocol|48
10351692|NCT00443547|11490230|FG003|STARTED|Overall Study|Enrolled and Treated Per Protocol|6
10351693|NCT00443547|11490227|FG000|Evaluated at 12 Months|Overall Study||58
10351694|NCT00443547|11490228|FG001|Evaluated at 12 Months|Overall Study||55
10351695|NCT00443547|11490229|FG002|Evaluated at 12 Months|Overall Study||37
10351696|NCT00443547|11490230|FG003|Evaluated at 12 Months|Overall Study||5
10351697|NCT00443547|11490227|FG000|COMPLETED|Overall Study||44
10351698|NCT00443547|11490228|FG001|COMPLETED|Overall Study||46
10351699|NCT00443547|11490229|FG002|COMPLETED|Overall Study||27
10351700|NCT00443547|11490230|FG003|COMPLETED|Overall Study||4
10351701|NCT00443547|11490227|FG000|NOT COMPLETED|Overall Study||45
10351702|NCT00443547|11490228|FG001|NOT COMPLETED|Overall Study||42
10351703|NCT00443547|11490229|FG002|NOT COMPLETED|Overall Study||21
10351704|NCT00443547|11490230|FG003|NOT COMPLETED|Overall Study||2
10351705|NCT00443560|11490242|FG000|STARTED|Overall Study||1081
10351706|NCT00443560|11490243|FG001|STARTED|Overall Study||1081
10351707|NCT00443560|11490242|FG000|COMPLETED|Overall Study||1021
10351708|NCT00443560|11490243|FG001|COMPLETED|Overall Study||1051
10351709|NCT00443560|11490242|FG000|NOT COMPLETED|Overall Study||60
10351710|NCT00443560|11490243|FG001|NOT COMPLETED|Overall Study||30
10351717|NCT00443651|11490260|FG000|STARTED|Overall Study||401
10351718|NCT00443651|11490261|FG001|STARTED|Overall Study||176
10351719|NCT00443651|11490260|FG000|Week 24|Overall Study||376
10351720|NCT00443651|11490261|FG001|Week 24|Overall Study||160
10351721|NCT00443651|11490260|FG000|Week 48|Overall Study||338
10351722|NCT00443651|11490261|FG001|Week 48|Overall Study||134
10351723|NCT00443651|11490260|FG000|COMPLETED|Overall Study|Completed the study or the safety follow-up period.|306
10351724|NCT00443651|11490261|FG001|COMPLETED|Overall Study|Completed the study or the safety follow-up period.|118
10351725|NCT00443651|11490260|FG000|NOT COMPLETED|Overall Study||95
10351726|NCT00443651|11490261|FG001|NOT COMPLETED|Overall Study||58
10351727|NCT00443703|11490269|FG000|STARTED|Overall Study||177
10351728|NCT00443703|11490270|FG001|STARTED|Overall Study||175
10351729|NCT00443703|11490269|FG000|Treated|Overall Study||174
10351730|NCT00443703|11490270|FG001|Treated|Overall Study||174
10351731|NCT00443703|11490269|FG000|COMPLETED|Overall Study||149
10351732|NCT00443703|11490270|FG001|COMPLETED|Overall Study||157
10351733|NCT00443703|11490269|FG000|NOT COMPLETED|Overall Study||28
10351734|NCT00443703|11490270|FG001|NOT COMPLETED|Overall Study||18
10351735|NCT00443729|11490278|FG000|STARTED|Overall Study||176
10351736|NCT00443729|11490279|FG001|STARTED|Overall Study||179
10351737|NCT00443729|11490278|FG000|Treated|Overall Study||176
10351738|NCT00443729|11490279|FG001|Treated|Overall Study||178
10351739|NCT00443729|11490278|FG000|COMPLETED|Overall Study||166
10351740|NCT00443729|11490279|FG001|COMPLETED|Overall Study||172
10351741|NCT00443729|11490278|FG000|NOT COMPLETED|Overall Study||10
10351742|NCT00443729|11490279|FG001|NOT COMPLETED|Overall Study||7
10351743|NCT00443755|11490287|FG000|STARTED|Overall Study||14
10351744|NCT00443755|11490288|FG001|STARTED|Overall Study||14
10351745|NCT00443755|11490287|FG000|COMPLETED|Overall Study||12
10351746|NCT00443755|11490288|FG001|COMPLETED|Overall Study||13
10351747|NCT00443755|11490287|FG000|NOT COMPLETED|Overall Study||2
10351748|NCT00443755|11490288|FG001|NOT COMPLETED|Overall Study||1
10351749|NCT00443781|11490294|FG000|STARTED|Overall Study||62
10351750|NCT00443781|11490294|FG000|COMPLETED|Overall Study||37
10351751|NCT00443781|11490294|FG000|NOT COMPLETED|Overall Study||25
10533211|NCT01424670|11685510|FG001|COMPLETED|6-Month Intensive Period (182 Days)||156
10533212|NCT01424670|11685509|FG000|NOT COMPLETED|6-Month Intensive Period (182 Days)||19
10533213|NCT01424670|11685510|FG001|NOT COMPLETED|6-Month Intensive Period (182 Days)||14
10533214|NCT01424670|11685509|FG000|STARTED|Continuation Period||322
10715926|NCT02688387|11880043|FG000|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10351752|NCT00443820|11490302|FG000|STARTED|Overall Study||133
10351753|NCT00443820|11490303|FG001|STARTED|Overall Study||130
10351754|NCT00443820|11490304|FG002|STARTED|Overall Study||135
10351755|NCT00443820|11490305|FG003|STARTED|Overall Study||128
10351756|NCT00443820|11490302|FG000|Safety Population|Overall Study|Participants who received study drug and had at least one post-baseline safety assessment.|131
10351757|NCT00443820|11490303|FG001|Safety Population|Overall Study||129
10351758|NCT00443820|11490304|FG002|Safety Population|Overall Study||134
10351759|NCT00443820|11490305|FG003|Safety Population|Overall Study||126
10351760|NCT00443820|11490302|FG000|COMPLETED|Overall Study||112
10351761|NCT00443820|11490303|FG001|COMPLETED|Overall Study|A participant from this gr. discont'ed due to renal failure, was counted as an AE and also as a SAE.|111
10351762|NCT00443820|11490304|FG002|COMPLETED|Overall Study||117
10351763|NCT00443820|11490305|FG003|COMPLETED|Overall Study||111
10351764|NCT00443820|11490302|FG000|NOT COMPLETED|Overall Study||21
10351765|NCT00443820|11490303|FG001|NOT COMPLETED|Overall Study||19
10351766|NCT00443820|11490304|FG002|NOT COMPLETED|Overall Study||18
10351767|NCT00443820|11490305|FG003|NOT COMPLETED|Overall Study||17
10351768|NCT00443846|11490317|FG000|STARTED|Overall Study||124
10351769|NCT00443846|11490318|FG001|STARTED|Overall Study||123
10351770|NCT00443846|11490317|FG000|Vaccinated|Overall Study||116
10351771|NCT00443846|11490318|FG001|Vaccinated|Overall Study||123
10351772|NCT00443846|11490317|FG000|COMPLETED|Overall Study||113
10351773|NCT00443846|11490318|FG001|COMPLETED|Overall Study||117
10351774|NCT00443846|11490317|FG000|NOT COMPLETED|Overall Study||11
10351775|NCT00443846|11490318|FG001|NOT COMPLETED|Overall Study||6
10351776|NCT00443872|11490324|FG000|STARTED|Overall Study||77
10351777|NCT00443872|11490324|FG000|COMPLETED|Overall Study||60
10351778|NCT00443872|11490324|FG000|NOT COMPLETED|Overall Study||17
10351779|NCT00443898|11490341|FG000|STARTED|Overall Study||126
10351780|NCT00443898|11490342|FG001|STARTED|Overall Study||128
10351781|NCT00443898|11490343|FG002|STARTED|Overall Study||136
10351782|NCT00443898|11490344|FG003|STARTED|Overall Study||128
10351783|NCT00443898|11490341|FG000|COMPLETED|Overall Study||102
10351784|NCT00443898|11490342|FG001|COMPLETED|Overall Study||103
10351785|NCT00443898|11490343|FG002|COMPLETED|Overall Study||107
10351786|NCT00443898|11490344|FG003|COMPLETED|Overall Study||110
10351787|NCT00443898|11490341|FG000|NOT COMPLETED|Overall Study||24
10351788|NCT00443898|11490342|FG001|NOT COMPLETED|Overall Study||25
10351789|NCT00443898|11490343|FG002|NOT COMPLETED|Overall Study||29
10351790|NCT00443898|11490344|FG003|NOT COMPLETED|Overall Study||18
10351791|NCT00444028|11490360|FG000|STARTED|Overall Study||14
10351792|NCT00444028|11490361|FG001|STARTED|Overall Study||7
10351793|NCT00444028|11490362|FG002|STARTED|Overall Study||8
10351794|NCT00444028|11490363|FG003|STARTED|Overall Study||6
10351795|NCT00444028|11490364|FG004|STARTED|Overall Study||7
10351796|NCT00444028|11490365|FG005|STARTED|Overall Study||8
10351797|NCT00444028|11490360|FG000|COMPLETED|Overall Study||14
10351798|NCT00444028|11490361|FG001|COMPLETED|Overall Study||7
10351799|NCT00444028|11490362|FG002|COMPLETED|Overall Study||8
10351800|NCT00444028|11490363|FG003|COMPLETED|Overall Study||6
10351801|NCT00444028|11490364|FG004|COMPLETED|Overall Study||7
10351802|NCT00444028|11490365|FG005|COMPLETED|Overall Study||8
10351803|NCT00444028|11490360|FG000|NOT COMPLETED|Overall Study||0
10351804|NCT00444028|11490361|FG001|NOT COMPLETED|Overall Study||0
10351805|NCT00444028|11490362|FG002|NOT COMPLETED|Overall Study||0
10351806|NCT00444028|11490363|FG003|NOT COMPLETED|Overall Study||0
10351807|NCT00444028|11490364|FG004|NOT COMPLETED|Overall Study||0
10351808|NCT00444028|11490365|FG005|NOT COMPLETED|Overall Study||0
10351809|NCT00444067|11490380|FG000|STARTED|Overall Study||74
10351810|NCT00444067|11490381|FG001|STARTED|Overall Study||24
10351811|NCT00444067|11490380|FG000|COMPLETED|Overall Study||74
10351812|NCT00444067|11490381|FG001|COMPLETED|Overall Study||23
10351813|NCT00444067|11490380|FG000|NOT COMPLETED|Overall Study||0
10351814|NCT00444067|11490381|FG001|NOT COMPLETED|Overall Study||1
10351815|NCT00444080|11490389|FG000|STARTED|Overall Study||61
10351816|NCT00444080|11490390|FG001|STARTED|Overall Study||59
10351817|NCT00444080|11490389|FG000|COMPLETED|Overall Study||61
10351818|NCT00444080|11490390|FG001|COMPLETED|Overall Study||59
10351819|NCT00444080|11490389|FG000|NOT COMPLETED|Overall Study||0
10351820|NCT00444080|11490390|FG001|NOT COMPLETED|Overall Study||0
10351821|NCT00444106|11490402|FG000|STARTED|Overall Study||159
10351822|NCT00444106|11490403|FG001|STARTED|Overall Study||53
10351823|NCT00444106|11490404|FG002|STARTED|Overall Study||53
10533215|NCT01424670|11685510|FG001|STARTED|Continuation Period||156
10533216|NCT01424670|11685509|FG000|COMPLETED|Continuation Period||288
10351824|NCT00444106|11490402|FG000|Completed Treatment Period|Overall Study||159
10351825|NCT00444106|11490403|FG001|Completed Treatment Period|Overall Study||53
10351826|NCT00444106|11490404|FG002|Completed Treatment Period|Overall Study||53
10351827|NCT00444106|11490402|FG000|COMPLETED|Overall Study||157
10351828|NCT00444106|11490403|FG001|COMPLETED|Overall Study||52
10351829|NCT00444106|11490404|FG002|COMPLETED|Overall Study||52
10351830|NCT00444106|11490402|FG000|NOT COMPLETED|Overall Study||2
10351831|NCT00444106|11490403|FG001|NOT COMPLETED|Overall Study||1
10351832|NCT00444106|11490404|FG002|NOT COMPLETED|Overall Study||1
10351833|NCT00444145|11490415|FG000|STARTED|Overall Study||38
10351834|NCT00444145|11490415|FG000|COMPLETED|Overall Study||19
10351835|NCT00444145|11490415|FG000|NOT COMPLETED|Overall Study||19
10351836|NCT00444275|11490422|FG000|STARTED|Initial Treatment Phase||2156
10351837|NCT00444275|11490423|FG001|STARTED|Initial Treatment Phase||873
10351838|NCT00444275|11490424|FG002|STARTED|Initial Treatment Phase||0
10351839|NCT00444275|11490425|FG003|STARTED|Initial Treatment Phase||0
10533217|NCT01424670|11685510|FG001|COMPLETED|Continuation Period||142
10351840|NCT00444275|11490426|FG004|STARTED|Initial Treatment Phase||0
10351841|NCT00444275|11490422|FG000|COMPLETED|Initial Treatment Phase||1908
10351842|NCT00444275|11490423|FG001|COMPLETED|Initial Treatment Phase||777
10351843|NCT00444275|11490424|FG002|COMPLETED|Initial Treatment Phase||0
10351844|NCT00444275|11490425|FG003|COMPLETED|Initial Treatment Phase||0
10351845|NCT00444275|11490426|FG004|COMPLETED|Initial Treatment Phase||0
10351846|NCT00444275|11490422|FG000|NOT COMPLETED|Initial Treatment Phase||248
10351847|NCT00444275|11490423|FG001|NOT COMPLETED|Initial Treatment Phase||96
10351848|NCT00444275|11490424|FG002|NOT COMPLETED|Initial Treatment Phase||0
10351849|NCT00444275|11490425|FG003|NOT COMPLETED|Initial Treatment Phase||0
10351850|NCT00444275|11490426|FG004|NOT COMPLETED|Initial Treatment Phase||0
10351851|NCT00444275|11490422|FG000|STARTED|Maintenance Treatment Phase||0
10351852|NCT00444275|11490423|FG001|STARTED|Maintenance Treatment Phase||0
10351853|NCT00444275|11490424|FG002|STARTED|Maintenance Treatment Phase||908
10351854|NCT00444275|11490425|FG003|STARTED|Maintenance Treatment Phase||897
10351855|NCT00444275|11490426|FG004|STARTED|Maintenance Treatment Phase||880
10351856|NCT00444275|11490422|FG000|COMPLETED|Maintenance Treatment Phase||0
10351857|NCT00444275|11490423|FG001|COMPLETED|Maintenance Treatment Phase||0
10351858|NCT00444275|11490424|FG002|COMPLETED|Maintenance Treatment Phase||747
10351859|NCT00444275|11490425|FG003|COMPLETED|Maintenance Treatment Phase||764
10351860|NCT00444275|11490426|FG004|COMPLETED|Maintenance Treatment Phase||701
10351861|NCT00444275|11490422|FG000|NOT COMPLETED|Maintenance Treatment Phase||0
10351862|NCT00444275|11490423|FG001|NOT COMPLETED|Maintenance Treatment Phase||0
10351863|NCT00444275|11490424|FG002|NOT COMPLETED|Maintenance Treatment Phase||161
10351864|NCT00444275|11490425|FG003|NOT COMPLETED|Maintenance Treatment Phase||133
10351865|NCT00444275|11490426|FG004|NOT COMPLETED|Maintenance Treatment Phase||179
10351866|NCT00444457|11490445|FG000|STARTED|Infant Series||489
10351867|NCT00444457|11490446|FG001|STARTED|Infant Series||488
10351868|NCT00444457|11490447|FG002|STARTED|Infant Series||489
10351869|NCT00444457|11490448|FG003|STARTED|Infant Series||246
10351870|NCT00444457|11490445|FG000|Vaccinated Dose 1|Infant Series||486
10351871|NCT00444457|11490446|FG001|Vaccinated Dose 1|Infant Series||484
10351872|NCT00444457|11490447|FG002|Vaccinated Dose 1|Infant Series||485
10351873|NCT00444457|11490448|FG003|Vaccinated Dose 1|Infant Series||244
10351874|NCT00444457|11490445|FG000|Vaccinated Dose 2|Infant Series||455
10351875|NCT00444457|11490446|FG001|Vaccinated Dose 2|Infant Series||447
10351876|NCT00444457|11490447|FG002|Vaccinated Dose 2|Infant Series||455
10351877|NCT00444457|11490448|FG003|Vaccinated Dose 2|Infant Series||228
10351878|NCT00444457|11490445|FG000|Vaccinated Dose 3|Infant Series||442
10351879|NCT00444457|11490446|FG001|Vaccinated Dose 3|Infant Series||435
10351880|NCT00444457|11490447|FG002|Vaccinated Dose 3|Infant Series||438
10351881|NCT00444457|11490448|FG003|Vaccinated Dose 3|Infant Series||225
10351882|NCT00444457|11490445|FG000|COMPLETED|Infant Series||435
10351883|NCT00444457|11490446|FG001|COMPLETED|Infant Series||427
10351884|NCT00444457|11490447|FG002|COMPLETED|Infant Series||428
10351885|NCT00444457|11490448|FG003|COMPLETED|Infant Series||218
10351886|NCT00444457|11490445|FG000|NOT COMPLETED|Infant Series||54
10351887|NCT00444457|11490446|FG001|NOT COMPLETED|Infant Series||61
10351888|NCT00444457|11490447|FG002|NOT COMPLETED|Infant Series||61
10351889|NCT00444457|11490448|FG003|NOT COMPLETED|Infant Series||28
10351890|NCT00444457|11490445|FG000|STARTED|After Infant Series||435
10351891|NCT00444457|11490446|FG001|STARTED|After Infant Series||427
10351892|NCT00444457|11490447|FG002|STARTED|After Infant Series||427
10351893|NCT00444457|11490448|FG003|STARTED|After Infant Series||218
10351894|NCT00444457|11490445|FG000|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|415
10351895|NCT00444457|11490446|FG001|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|397
10351896|NCT00444457|11490447|FG002|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|408
10351897|NCT00444457|11490448|FG003|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|208
10351898|NCT00444457|11490445|FG000|NOT COMPLETED|After Infant Series||20
10351899|NCT00444457|11490446|FG001|NOT COMPLETED|After Infant Series||30
10351900|NCT00444457|11490447|FG002|NOT COMPLETED|After Infant Series||19
10351901|NCT00444457|11490448|FG003|NOT COMPLETED|After Infant Series||10
10351902|NCT00444457|11490445|FG000|STARTED|Toddler Dose|Vaccinated toddler dose|415
10351903|NCT00444457|11490446|FG001|STARTED|Toddler Dose|Vaccinated toddler dose|397
10351904|NCT00444457|11490447|FG002|STARTED|Toddler Dose|Vaccinated toddler dose|408
10351905|NCT00444457|11490448|FG003|STARTED|Toddler Dose|Vaccinated toddler dose|208
10351906|NCT00444457|11490445|FG000|COMPLETED|Toddler Dose||408
10351907|NCT00444457|11490446|FG001|COMPLETED|Toddler Dose||391
10351908|NCT00444457|11490447|FG002|COMPLETED|Toddler Dose||404
10351909|NCT00444457|11490448|FG003|COMPLETED|Toddler Dose||200
10351910|NCT00444457|11490445|FG000|NOT COMPLETED|Toddler Dose||7
10351911|NCT00444457|11490446|FG001|NOT COMPLETED|Toddler Dose||6
10351912|NCT00444457|11490447|FG002|NOT COMPLETED|Toddler Dose||4
10351913|NCT00444457|11490448|FG003|NOT COMPLETED|Toddler Dose||8
10351914|NCT00444535|11490469|FG000|STARTED|Overall Study||52
10351915|NCT00444535|11490469|FG000|COMPLETED|Overall Study||39
10351916|NCT00444535|11490469|FG000|NOT COMPLETED|Overall Study||13
10351917|NCT00444587|11490475|FG000|STARTED|Overall Study||93
10351918|NCT00444587|11490476|FG001|STARTED|Overall Study||16
10351919|NCT00444587|11490475|FG000|COMPLETED|Overall Study||10
10351920|NCT00444587|11490476|FG001|COMPLETED|Overall Study||1
10351921|NCT00444587|11490475|FG000|NOT COMPLETED|Overall Study||83
10351922|NCT00444587|11490476|FG001|NOT COMPLETED|Overall Study||15
10351923|NCT00444600|11490488|FG000|STARTED|Overall Study|Number of eyes|293
10351924|NCT00444600|11490489|FG001|STARTED|Overall Study|Number of eyes|187
10655859|NCT02211638|11816665|FG000|COMPLETED|Overall Study||17130
10655860|NCT02211638|11816665|FG000|NOT COMPLETED|Overall Study||983
10655861|NCT02212028|11816671|FG000|STARTED|Overall Study||26
10351925|NCT00444600|11490490|FG002|STARTED|Overall Study|Number of eyes|188
10351926|NCT00444600|11490491|FG003|STARTED|Overall Study|Number of eyes|186
10351927|NCT00444600|11490488|FG000|COMPLETED|Overall Study|Number of eyes|274
10351928|NCT00444600|11490489|FG001|COMPLETED|Overall Study|Number of eyes|171
10351929|NCT00444600|11490490|FG002|COMPLETED|Overall Study|Number of eyes|178
10351930|NCT00444600|11490491|FG003|COMPLETED|Overall Study|Number of eyes|176
10351931|NCT00444600|11490488|FG000|NOT COMPLETED|Overall Study||19
10351932|NCT00444600|11490489|FG001|NOT COMPLETED|Overall Study||16
10351933|NCT00444600|11490490|FG002|NOT COMPLETED|Overall Study||10
10351934|NCT00444600|11490491|FG003|NOT COMPLETED|Overall Study||10
10351935|NCT00444626|11490507|FG000|STARTED|Initial Treatment Period||140
10351936|NCT00444626|11490507|FG000|COMPLETED|Initial Treatment Period||128
10351937|NCT00444626|11490507|FG000|NOT COMPLETED|Initial Treatment Period||12
10351938|NCT00444626|11490507|FG000|STARTED|Repeat Treatment Period|23 subjects withdrew after completing the Initial Treatment and did not enter the Repeat Treatment|105
10351939|NCT00444626|11490507|FG000|COMPLETED|Repeat Treatment Period||105
10351940|NCT00444626|11490507|FG000|NOT COMPLETED|Repeat Treatment Period||0
10351941|NCT00444678|11490520|FG000|STARTED|Overall Study||36
10351942|NCT00444678|11490520|FG000|COMPLETED|Overall Study||5
10351943|NCT00444678|11490520|FG000|NOT COMPLETED|Overall Study||31
10351944|NCT00444795|11490524|FG000|STARTED|Overall Study||620
10351945|NCT00444795|11490524|FG000|COMPLETED|Overall Study|Refer to the Safety Analysis Set.|617
10351946|NCT00444795|11490524|FG000|NOT COMPLETED|Overall Study||3
10351947|NCT00444821|11490530|FG000|STARTED|Overall Study||362
10351948|NCT00444821|11490531|FG001|STARTED|Overall Study||366
10351949|NCT00444821|11490530|FG000|Received AAA Repair|Overall Study|Crossed over to AAA repair|122
10351950|NCT00444821|11490531|FG001|Received AAA Repair|Overall Study|Underwent AAA repair per protocol|326
10351951|NCT00444821|11490530|FG000|COMPLETED|Overall Study||0
10351952|NCT00444821|11490531|FG001|COMPLETED|Overall Study||0
10351953|NCT00444821|11490530|FG000|NOT COMPLETED|Overall Study||362
10351954|NCT00444821|11490531|FG001|NOT COMPLETED|Overall Study||366
10351955|NCT00444912|11490539|FG000|STARTED|Overall Study||15
10351956|NCT00444912|11490540|FG001|STARTED|Overall Study||15
10351957|NCT00444912|11490539|FG000|Received Plerixafor|Overall Study||15
10351958|NCT00444912|11490540|FG001|Received Plerixafor|Overall Study||15
10351959|NCT00444912|11490539|FG000|Received Transplant|Overall Study||14
10351960|NCT00444912|11490540|FG001|Received Transplant|Overall Study||14
10351961|NCT00444912|11490539|FG000|COMPLETED|Overall Study||12
10351962|NCT00444912|11490540|FG001|COMPLETED|Overall Study||13
10715927|NCT02688387|11880044|FG001|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10305638|NCT00094835|11438617|FG003|STARTED|Overall Study||5
10305639|NCT00094835|11438618|FG004|STARTED|Overall Study||7
10305640|NCT00094835|11438619|FG005|STARTED|Overall Study||6
10305641|NCT00094835|11438620|FG006|STARTED|Overall Study||6
10305642|NCT00094835|11438614|FG000|Treated With Motesanib|Overall Study||6
10305643|NCT00094835|11438615|FG001|Treated With Motesanib|Overall Study||11
10305644|NCT00094835|11438616|FG002|Treated With Motesanib|Overall Study||6
10305645|NCT00094835|11438617|FG003|Treated With Motesanib|Overall Study||4
10305646|NCT00094835|11438618|FG004|Treated With Motesanib|Overall Study||7
10351963|NCT00444912|11490539|FG000|NOT COMPLETED|Overall Study||3
10351964|NCT00444912|11490540|FG001|NOT COMPLETED|Overall Study||2
10351965|NCT00444925|11490549|FG000|STARTED|Single-blind Placebo Run-In Period||2446
10351966|NCT00444925|11490550|FG001|STARTED|Single-blind Placebo Run-In Period||0
10351967|NCT00444925|11490551|FG002|STARTED|Single-blind Placebo Run-In Period||0
10715928|NCT02688387|11880045|FG002|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10305647|NCT00094835|11438619|FG005|Treated With Motesanib|Overall Study||5
10426836|NCT00849147|11572546|FG000|NOT COMPLETED|Overall Study||5
10305648|NCT00094835|11438620|FG006|Treated With Motesanib|Overall Study||6
10305649|NCT00094835|11438614|FG000|COMPLETED|Overall Study||5
10305650|NCT00094835|11438615|FG001|COMPLETED|Overall Study||8
10305651|NCT00094835|11438616|FG002|COMPLETED|Overall Study||4
10305652|NCT00094835|11438617|FG003|COMPLETED|Overall Study||4
10305653|NCT00094835|11438618|FG004|COMPLETED|Overall Study||3
10305654|NCT00094835|11438619|FG005|COMPLETED|Overall Study||3
10305655|NCT00094835|11438620|FG006|COMPLETED|Overall Study||4
10351968|NCT00444925|11490549|FG000|COMPLETED|Single-blind Placebo Run-In Period|progressed to randomization in double-blind treatment period|1712
10351969|NCT00444925|11490550|FG001|COMPLETED|Single-blind Placebo Run-In Period||0
10351970|NCT00444925|11490551|FG002|COMPLETED|Single-blind Placebo Run-In Period||0
10351971|NCT00444925|11490549|FG000|NOT COMPLETED|Single-blind Placebo Run-In Period||734
10351972|NCT00444925|11490550|FG001|NOT COMPLETED|Single-blind Placebo Run-In Period||0
10351973|NCT00444925|11490551|FG002|NOT COMPLETED|Single-blind Placebo Run-In Period||0
10715929|NCT02688387|11880046|FG003|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10715930|NCT02688387|11880047|FG004|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10777239|NCT03338062|11939179|FG001|STARTED|Overall Study||5
10351974|NCT00444925|11490549|FG000|STARTED|Randomized to Double-blind Treatment||337
10351975|NCT00444925|11490550|FG001|STARTED|Randomized to Double-blind Treatment||690
10351976|NCT00444925|11490551|FG002|STARTED|Randomized to Double-blind Treatment||685
10351977|NCT00444925|11490549|FG000|COMPLETED|Randomized to Double-blind Treatment||334
10351978|NCT00444925|11490550|FG001|COMPLETED|Randomized to Double-blind Treatment||684
10351979|NCT00444925|11490551|FG002|COMPLETED|Randomized to Double-blind Treatment||679
10351980|NCT00444925|11490549|FG000|NOT COMPLETED|Randomized to Double-blind Treatment||3
10351981|NCT00444925|11490550|FG001|NOT COMPLETED|Randomized to Double-blind Treatment||6
10351982|NCT00444925|11490551|FG002|NOT COMPLETED|Randomized to Double-blind Treatment||6
10351983|NCT00444925|11490549|FG000|STARTED|Double-blind Treatment Period||334
10351984|NCT00444925|11490550|FG001|STARTED|Double-blind Treatment Period||684
10351985|NCT00444925|11490551|FG002|STARTED|Double-blind Treatment Period||679
10351986|NCT00444925|11490549|FG000|COMPLETED|Double-blind Treatment Period||304
10351987|NCT00444925|11490550|FG001|COMPLETED|Double-blind Treatment Period||628
10351988|NCT00444925|11490551|FG002|COMPLETED|Double-blind Treatment Period||598
10351989|NCT00444925|11490549|FG000|NOT COMPLETED|Double-blind Treatment Period||30
10351990|NCT00444925|11490550|FG001|NOT COMPLETED|Double-blind Treatment Period||56
10351991|NCT00444925|11490551|FG002|NOT COMPLETED|Double-blind Treatment Period||81
10351992|NCT00444951|11490562|FG000|STARTED|Overall Study||145
10351993|NCT00444951|11490563|FG001|STARTED|Overall Study||142
10351994|NCT00444951|11490564|FG002|STARTED|Overall Study||163
10351995|NCT00444951|11490562|FG000|COMPLETED|Overall Study||140
10351996|NCT00444951|11490563|FG001|COMPLETED|Overall Study||136
10351997|NCT00444951|11490564|FG002|COMPLETED|Overall Study||160
10351998|NCT00444951|11490562|FG000|NOT COMPLETED|Overall Study||5
10351999|NCT00444951|11490563|FG001|NOT COMPLETED|Overall Study||6
10352000|NCT00444951|11490564|FG002|NOT COMPLETED|Overall Study||3
10352001|NCT00444964|11490572|FG000|STARTED|Overall Study||11
10352002|NCT00444964|11490572|FG000|COMPLETED|Overall Study||11
10352003|NCT00444964|11490572|FG000|NOT COMPLETED|Overall Study||0
10352004|NCT00445003|11490579|FG000|STARTED|Overall Study||123
10352005|NCT00445003|11490580|FG001|STARTED|Overall Study||113
10352006|NCT00445003|11490581|FG002|STARTED|Overall Study||109
10352007|NCT00445003|11490579|FG000|COMPLETED|Overall Study||118
10352008|NCT00445003|11490580|FG001|COMPLETED|Overall Study||103
10352009|NCT00445003|11490581|FG002|COMPLETED|Overall Study||105
10352010|NCT00445003|11490579|FG000|NOT COMPLETED|Overall Study||5
10352011|NCT00445003|11490580|FG001|NOT COMPLETED|Overall Study||10
10352012|NCT00445003|11490581|FG002|NOT COMPLETED|Overall Study||4
10352013|NCT00445068|11490589|FG000|STARTED|Overall Study||38
10352014|NCT00445068|11490589|FG000|COMPLETED|Overall Study||2
10352015|NCT00445068|11490589|FG000|NOT COMPLETED|Overall Study||36
10352016|NCT00445146|11490593|FG000|STARTED|Overall Study||192
10352017|NCT00445146|11490593|FG000|COMPLETED|Overall Study||73
10352018|NCT00445146|11490593|FG000|NOT COMPLETED|Overall Study||119
10352019|NCT00445211|11490599|FG000|STARTED|Overall Study||23
10352020|NCT00445211|11490600|FG001|STARTED|Overall Study||23
10352021|NCT00445211|11490599|FG000|COMPLETED|Overall Study||23
10352022|NCT00445211|11490600|FG001|COMPLETED|Overall Study||23
10352023|NCT00445211|11490599|FG000|NOT COMPLETED|Overall Study||0
10352024|NCT00445211|11490600|FG001|NOT COMPLETED|Overall Study||0
10352025|NCT00445224|11490608|FG000|STARTED|Specific Exercises||17
10352026|NCT00445224|11490609|FG001|STARTED|Specific Exercises||16
10533218|NCT01424670|11685509|FG000|NOT COMPLETED|Continuation Period||34
10533219|NCT01424670|11685510|FG001|NOT COMPLETED|Continuation Period||14
10533220|NCT01424722|11685518|FG000|STARTED|Overall Study||2258
10533221|NCT01424722|11685518|FG000|COMPLETED|Overall Study||0
10533222|NCT01424722|11685518|FG000|NOT COMPLETED|Overall Study||2258
10533223|NCT01424813|11685524|FG000|STARTED|Overall Study||79
10533224|NCT01424813|11685525|FG001|STARTED|Overall Study||79
10533225|NCT01424813|11685524|FG000|Treated|Overall Study|Safety set and full analysis set|79
10533226|NCT01424813|11685525|FG001|Treated|Overall Study|Safety set and full analysis set|78
10715931|NCT02688387|11880048|FG005|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10715932|NCT02688387|11880049|FG006|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10715933|NCT02688387|11880050|FG007|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10715934|NCT02688387|11880051|FG008|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10533227|NCT01424813|11685524|FG000|COMPLETED|Overall Study||74
10533228|NCT01424813|11685525|FG001|COMPLETED|Overall Study||77
10533229|NCT01424813|11685524|FG000|NOT COMPLETED|Overall Study||5
10533230|NCT01424813|11685525|FG001|NOT COMPLETED|Overall Study||2
10533231|NCT01424930|11685533|FG000|STARTED|Overall Study||7
10533232|NCT01424930|11685534|FG001|STARTED|Overall Study||18
10533233|NCT01424930|11685533|FG000|Completed Food Safety Evaluation|Overall Study||6
10533234|NCT01424930|11685534|FG001|Completed Food Safety Evaluation|Overall Study||18
10533235|NCT01424930|11685533|FG000|COMPLETED|Overall Study||3
10533236|NCT01424930|11685534|FG001|COMPLETED|Overall Study||4
10533237|NCT01424930|11685533|FG000|NOT COMPLETED|Overall Study||4
10533238|NCT01424930|11685534|FG001|NOT COMPLETED|Overall Study||14
10533239|NCT01424943|11685542|FG000|STARTED|Overall Study||25
10533240|NCT01424943|11685543|FG001|STARTED|Overall Study||24
10533241|NCT01424943|11685542|FG000|COMPLETED|Overall Study||12
10533242|NCT01424943|11685543|FG001|COMPLETED|Overall Study||23
10533243|NCT01424943|11685542|FG000|NOT COMPLETED|Overall Study||13
10533244|NCT01424943|11685543|FG001|NOT COMPLETED|Overall Study||1
10533245|NCT01425190|11685552|FG000|STARTED|Overall Study||16
10533246|NCT01425190|11685553|FG001|STARTED|Overall Study|The study was terminated prior to enrolling participants in Cohort 2.|0
10533247|NCT01425190|11685554|FG002|STARTED|Overall Study|The study was terminated prior to enrolling participants in Cohort 3.|0
10533248|NCT01425190|11685552|FG000|COMPLETED|Overall Study||15
10533249|NCT01425190|11685553|FG001|COMPLETED|Overall Study||0
10533250|NCT01425190|11685554|FG002|COMPLETED|Overall Study||0
10533251|NCT01425190|11685552|FG000|NOT COMPLETED|Overall Study||1
10533252|NCT01425190|11685553|FG001|NOT COMPLETED|Overall Study||0
10533253|NCT01425190|11685554|FG002|NOT COMPLETED|Overall Study||0
10533254|NCT01425203|11685564|FG000|STARTED|Treatment Phase||159
10533255|NCT01425203|11685565|FG001|STARTED|Treatment Phase||79
10533256|NCT01425203|11685566|FG002|STARTED|Treatment Phase||0
10533257|NCT01425203|11685564|FG000|Treated (FAS)|Treatment Phase||159
10533258|NCT01425203|11685565|FG001|Treated (FAS)|Treatment Phase||78
10533259|NCT01425203|11685566|FG002|Treated (FAS)|Treatment Phase||0
10533260|NCT01425203|11685564|FG000|COMPLETED|Treatment Phase||132
10533261|NCT01425203|11685565|FG001|COMPLETED|Treatment Phase||42
10533262|NCT01425203|11685566|FG002|COMPLETED|Treatment Phase||0
10533263|NCT01425203|11685564|FG000|NOT COMPLETED|Treatment Phase||27
10533264|NCT01425203|11685565|FG001|NOT COMPLETED|Treatment Phase||37
10533265|NCT01425203|11685566|FG002|NOT COMPLETED|Treatment Phase||0
10547928|NCT01515657|11701698|FG000|NOT COMPLETED|Third Intervention||1
10715935|NCT02688387|11880052|FG009|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10352027|NCT00445224|11490608|FG000|Baseline|Specific Exercises||17
10352028|NCT00445224|11490609|FG001|Baseline|Specific Exercises||16
10352029|NCT00445224|11490608|FG000|4 Weeks|Specific Exercises|Participants withdrew due to time conflicts|14
10352030|NCT00445224|11490609|FG001|4 Weeks|Specific Exercises|Participants withdrew due to time conflicts|13
10352031|NCT00445224|11490608|FG000|COMPLETED|Specific Exercises|No adverse event occurred|13
10352032|NCT00445224|11490609|FG001|COMPLETED|Specific Exercises|No adverse event occurred|13
10352033|NCT00445224|11490608|FG000|NOT COMPLETED|Specific Exercises||4
10655862|NCT02212028|11816672|FG001|STARTED|Overall Study||26
10655863|NCT02212028|11816671|FG000|COMPLETED|Overall Study||26
10655864|NCT02212028|11816672|FG001|COMPLETED|Overall Study||26
10655865|NCT02212028|11816671|FG000|NOT COMPLETED|Overall Study||0
10655866|NCT02212028|11816672|FG001|NOT COMPLETED|Overall Study||0
10655867|NCT02212106|11816680|FG000|STARTED|Overall Study||302
10655868|NCT02212106|11816681|FG001|STARTED|Overall Study||100
10655869|NCT02212106|11816680|FG000|COMPLETED|Overall Study||292
10655870|NCT02212106|11816681|FG001|COMPLETED|Overall Study||96
10655871|NCT02212106|11816680|FG000|NOT COMPLETED|Overall Study||10
10655872|NCT02212106|11816681|FG001|NOT COMPLETED|Overall Study||4
10655873|NCT02212197|11816691|FG000|STARTED|Overall Study||19
10655874|NCT02212197|11816692|FG001|STARTED|Overall Study||15
10655875|NCT02212197|11816693|FG002|STARTED|Overall Study||17
10655876|NCT02212197|11816691|FG000|COMPLETED|Overall Study||18
10655877|NCT02212197|11816692|FG001|COMPLETED|Overall Study||15
10655878|NCT02212197|11816693|FG002|COMPLETED|Overall Study||17
10655879|NCT02212197|11816691|FG000|NOT COMPLETED|Overall Study||1
10655880|NCT02212197|11816692|FG001|NOT COMPLETED|Overall Study||0
10655881|NCT02212197|11816693|FG002|NOT COMPLETED|Overall Study||0
10655882|NCT02212301|11816701|FG000|STARTED|Period 1||21
10655883|NCT02212301|11816702|FG001|STARTED|Period 1||22
10655884|NCT02212301|11816701|FG000|COMPLETED|Period 1||21
10655885|NCT02212301|11816702|FG001|COMPLETED|Period 1||21
10655886|NCT02212301|11816701|FG000|NOT COMPLETED|Period 1||0
10655887|NCT02212301|11816702|FG001|NOT COMPLETED|Period 1||1
10655888|NCT02212301|11816701|FG000|STARTED|Period 2||21
10655889|NCT02212301|11816702|FG001|STARTED|Period 2||21
10655890|NCT02212301|11816701|FG000|COMPLETED|Period 2||21
10655891|NCT02212301|11816702|FG001|COMPLETED|Period 2||21
10655892|NCT02212301|11816701|FG000|NOT COMPLETED|Period 2||0
10655893|NCT02212301|11816702|FG001|NOT COMPLETED|Period 2||0
10655894|NCT02212379|11816709|FG000|STARTED|From Baseline to Week 48||165
10655895|NCT02212379|11816709|FG000|COMPLETED|From Baseline to Week 48||156
10655896|NCT02212379|11816709|FG000|NOT COMPLETED|From Baseline to Week 48||9
10655897|NCT02212379|11816709|FG000|STARTED|From Week 48 to Week 96||156
10655898|NCT02212379|11816709|FG000|COMPLETED|From Week 48 to Week 96||152
10655899|NCT02212379|11816709|FG000|NOT COMPLETED|From Week 48 to Week 96||4
10655900|NCT02212457|11816722|FG000|STARTED|Overall Study||228
10655901|NCT02212457|11816723|FG001|STARTED|Overall Study||232
10655902|NCT02212457|11816724|FG002|STARTED|Overall Study||157
10655903|NCT02212457|11816725|FG003|STARTED|Overall Study||134
10655904|NCT02212457|11816726|FG004|STARTED|Overall Study||152
10655905|NCT02212457|11816727|FG005|STARTED|Overall Study||160
10655906|NCT02212457|11816722|FG000|COMPLETED|Overall Study||209
10655907|NCT02212457|11816723|FG001|COMPLETED|Overall Study||211
10655908|NCT02212457|11816724|FG002|COMPLETED|Overall Study||141
10655909|NCT02212457|11816725|FG003|COMPLETED|Overall Study||123
10715936|NCT02688387|11880053|FG010|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10715937|NCT02688387|11880054|FG011|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10715938|NCT02688387|11880055|FG012|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10715939|NCT02688387|11880056|FG013|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10715940|NCT02688387|11880057|FG014|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
10715941|NCT02688387|11880058|FG015|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
10715942|NCT02688387|11880059|FG016|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
10715943|NCT02688387|11880060|FG017|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
10715944|NCT02688387|11880061|FG018|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10715945|NCT02688387|11880062|FG019|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10715946|NCT02688387|11880063|FG020|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10715947|NCT02688387|11880064|FG021|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10715948|NCT02688387|11880043|FG000|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10715949|NCT02688387|11880044|FG001|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10715950|NCT02688387|11880045|FG002|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10715951|NCT02688387|11880046|FG003|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10715952|NCT02688387|11880047|FG004|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10715953|NCT02688387|11880048|FG005|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10715954|NCT02688387|11880049|FG006|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10715955|NCT02688387|11880050|FG007|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10655910|NCT02212457|11816726|FG004|COMPLETED|Overall Study||137
10655911|NCT02212457|11816727|FG005|COMPLETED|Overall Study||147
10655912|NCT02212457|11816722|FG000|NOT COMPLETED|Overall Study||19
10655913|NCT02212457|11816723|FG001|NOT COMPLETED|Overall Study||21
10655914|NCT02212457|11816724|FG002|NOT COMPLETED|Overall Study||16
10655915|NCT02212457|11816725|FG003|NOT COMPLETED|Overall Study||11
10655916|NCT02212457|11816726|FG004|NOT COMPLETED|Overall Study||15
10655917|NCT02212457|11816727|FG005|NOT COMPLETED|Overall Study||13
10655918|NCT02212587|11816748|FG000|STARTED|Overall Study||10
10655919|NCT02212587|11816748|FG000|COMPLETED|Overall Study||9
10655920|NCT02212587|11816748|FG000|NOT COMPLETED|Overall Study||1
10655921|NCT02212678|11816752|FG000|STARTED|Overall Study||8
10655922|NCT02212678|11816752|FG000|COMPLETED|Overall Study||7
10655923|NCT02212678|11816752|FG000|NOT COMPLETED|Overall Study||1
10655924|NCT02212730|11816758|FG000|STARTED|Overall Study||6
10655925|NCT02212730|11816759|FG001|STARTED|Overall Study||4
10655926|NCT02212730|11816758|FG000|Received Neoadjuvant Pembrolizumab|Overall Study||4
10655927|NCT02212730|11816759|FG001|Received Neoadjuvant Pembrolizumab|Overall Study||0
10655928|NCT02212730|11816758|FG000|Underwent RCC|Overall Study||4
10655929|NCT02212730|11816759|FG001|Underwent RCC|Overall Study||3
10655930|NCT02212730|11816758|FG000|Received Post-RCC Pembrolizumab|Overall Study||1
10655931|NCT02212730|11816759|FG001|Received Post-RCC Pembrolizumab|Overall Study||1
10655932|NCT02212730|11816758|FG000|COMPLETED|Overall Study||4
10655933|NCT02212730|11816759|FG001|COMPLETED|Overall Study||3
10655934|NCT02212730|11816758|FG000|NOT COMPLETED|Overall Study||2
10655935|NCT02212730|11816759|FG001|NOT COMPLETED|Overall Study||1
10655936|NCT02212834|11816769|FG000|STARTED|Overall Study||33938
10655937|NCT02212834|11816770|FG001|STARTED|Overall Study||2506
10655938|NCT02212834|11816769|FG000|COMPLETED|Overall Study||33938
10655939|NCT02212834|11816770|FG001|COMPLETED|Overall Study||2506
10655940|NCT02212834|11816769|FG000|NOT COMPLETED|Overall Study||0
10715956|NCT02688387|11880051|FG008|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10352058|NCT00445302|11490631|FG003|NOT COMPLETED|Overall Study||0
10352059|NCT00445315|11490646|FG000|STARTED|Overall Study||6
10533266|NCT01425203|11685564|FG000|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|0
10533267|NCT01425203|11685565|FG001|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|0
10533268|NCT01425203|11685566|FG002|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|27
10533269|NCT01425203|11685564|FG000|COMPLETED|Crossover Phase||0
10533270|NCT01425203|11685565|FG001|COMPLETED|Crossover Phase||0
10533271|NCT01425203|11685566|FG002|COMPLETED|Crossover Phase||21
10533272|NCT01425203|11685564|FG000|NOT COMPLETED|Crossover Phase||0
10533273|NCT01425203|11685565|FG001|NOT COMPLETED|Crossover Phase||0
10533274|NCT01425203|11685566|FG002|NOT COMPLETED|Crossover Phase||6
10533275|NCT01425203|11685564|FG000|STARTED|Follow-up Phase|6 participants who started treatment in RGT BOC + PR arm did not enter follow-up.|153
10533276|NCT01425203|11685565|FG001|STARTED|Follow-up Phase|27 starting treatment in PBO+PR Control arm switched to Crossover arm and 2 did not enter follow-up|49
10533277|NCT01425203|11685566|FG002|STARTED|Follow-up Phase|All participants treated in crossover arm entered follow-up.|27
10533278|NCT01425203|11685564|FG000|COMPLETED|Follow-up Phase||153
10533279|NCT01425203|11685565|FG001|COMPLETED|Follow-up Phase||49
10533280|NCT01425203|11685566|FG002|COMPLETED|Follow-up Phase||27
10533281|NCT01425203|11685564|FG000|NOT COMPLETED|Follow-up Phase||0
10533282|NCT01425203|11685565|FG001|NOT COMPLETED|Follow-up Phase||0
10533283|NCT01425203|11685566|FG002|NOT COMPLETED|Follow-up Phase||0
10533284|NCT01425229|11685574|FG000|STARTED|Bosentan Single Dose||16
10533285|NCT01425229|11685574|FG000|COMPLETED|Bosentan Single Dose||16
10533286|NCT01425229|11685574|FG000|NOT COMPLETED|Bosentan Single Dose||0
10533287|NCT01425229|11685574|FG000|STARTED|Bosentan Steady-state||16
10533288|NCT01425229|11685574|FG000|COMPLETED|Bosentan Steady-state||16
10533289|NCT01425229|11685574|FG000|NOT COMPLETED|Bosentan Steady-state||0
10533290|NCT01425229|11685574|FG000|STARTED|Bosentan During Clarithromycin||16
10533291|NCT01425229|11685574|FG000|COMPLETED|Bosentan During Clarithromycin||16
10533292|NCT01425229|11685574|FG000|NOT COMPLETED|Bosentan During Clarithromycin||0
10533293|NCT01425268|11685584|FG000|STARTED|Overall Study|106 Subjects Randomized to AeroForm Arm / 98 Subjects Treated (Implanted)|106
10533294|NCT01425268|11685585|FG001|STARTED|Overall Study|52 Subjects Randomized to Saline Arm / 52 Subjects Treated (Implanted)|52
10533295|NCT01425268|11685584|FG000|COMPLETED|Overall Study||98
10533296|NCT01425268|11685585|FG001|COMPLETED|Overall Study||52
10533297|NCT01425268|11685584|FG000|NOT COMPLETED|Overall Study||8
10533298|NCT01425268|11685585|FG001|NOT COMPLETED|Overall Study||0
10533299|NCT01425307|11685593|FG000|STARTED|Overall Study|Randomized Sample: 61; Intention-to Treat Sample:61|61
10533300|NCT01425307|11685594|FG001|STARTED|Overall Study|Randomized Sample: 60; Intention-to Treat Sample:60|60
10533301|NCT01425307|11685593|FG000|COMPLETED|Overall Study|Treatment Phase: 42; 6-Month Follow up: 58|42
10533302|NCT01425307|11685594|FG001|COMPLETED|Overall Study|Treatment Phase: 41; 6-Month Follow-up:59|41
10715957|NCT02688387|11880052|FG009|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10715958|NCT02688387|11880053|FG010|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10533303|NCT01425307|11685593|FG000|NOT COMPLETED|Overall Study||19
10655941|NCT02212834|11816770|FG001|NOT COMPLETED|Overall Study||0
10655942|NCT02212977|11816778|FG000|STARTED|Overall Study||55
10655943|NCT02212977|11816779|FG001|STARTED|Overall Study||54
10655944|NCT02212977|11816778|FG000|COMPLETED|Overall Study||50
10655945|NCT02212977|11816779|FG001|COMPLETED|Overall Study||48
10715959|NCT02688387|11880054|FG011|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10715960|NCT02688387|11880055|FG012|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10655946|NCT02212977|11816778|FG000|NOT COMPLETED|Overall Study||5
10655947|NCT02212977|11816779|FG001|NOT COMPLETED|Overall Study||6
10655948|NCT02213042|11816788|FG000|STARTED|Overall Study||17
10655949|NCT02213042|11816789|FG001|STARTED|Overall Study||15
10655950|NCT02213042|11816790|FG002|STARTED|Overall Study||10
10655951|NCT02213042|11816788|FG000|Total Deaths|Overall Study||11
10655952|NCT02213042|11816789|FG001|Total Deaths|Overall Study||9
10655953|NCT02213042|11816790|FG002|Total Deaths|Overall Study||6
10655954|NCT02213042|11816788|FG000|COMPLETED|Overall Study||0
10655955|NCT02213042|11816789|FG001|COMPLETED|Overall Study||0
10352034|NCT00445224|11490609|FG001|NOT COMPLETED|Specific Exercises||3
10352035|NCT00445224|11490608|FG000|STARTED|Combined Exercises||13
10352036|NCT00445224|11490609|FG001|STARTED|Combined Exercises||13
10352037|NCT00445224|11490608|FG000|COMPLETED|Combined Exercises||13
10352038|NCT00445224|11490609|FG001|COMPLETED|Combined Exercises||13
10352039|NCT00445224|11490608|FG000|NOT COMPLETED|Combined Exercises||0
10352040|NCT00445224|11490609|FG001|NOT COMPLETED|Combined Exercises||0
10352041|NCT00445263|11490617|FG000|STARTED|Overall Study||83
10352042|NCT00445263|11490618|FG001|STARTED|Overall Study||87
10352043|NCT00445263|11490617|FG000|COMPLETED|Overall Study||83
10352044|NCT00445263|11490618|FG001|COMPLETED|Overall Study||86
10352045|NCT00445263|11490617|FG000|NOT COMPLETED|Overall Study||0
10352046|NCT00445263|11490618|FG001|NOT COMPLETED|Overall Study||1
10352047|NCT00445302|11490628|FG000|STARTED|Overall Study||6
10352048|NCT00445302|11490629|FG001|STARTED|Overall Study||5
10352049|NCT00445302|11490630|FG002|STARTED|Overall Study||6
10352050|NCT00445302|11490631|FG003|STARTED|Overall Study||6
10352051|NCT00445302|11490628|FG000|COMPLETED|Overall Study||6
10352052|NCT00445302|11490629|FG001|COMPLETED|Overall Study||5
10352053|NCT00445302|11490630|FG002|COMPLETED|Overall Study||6
10352054|NCT00445302|11490631|FG003|COMPLETED|Overall Study||6
10352055|NCT00445302|11490628|FG000|NOT COMPLETED|Overall Study||0
10352056|NCT00445302|11490629|FG001|NOT COMPLETED|Overall Study||0
10352057|NCT00445302|11490630|FG002|NOT COMPLETED|Overall Study||0
10352060|NCT00445315|11490647|FG001|STARTED|Overall Study||6
10352061|NCT00445315|11490648|FG002|STARTED|Overall Study||6
10352062|NCT00445315|11490649|FG003|STARTED|Overall Study||6
10352063|NCT00445315|11490650|FG004|STARTED|Overall Study||8
10352064|NCT00445315|11490646|FG000|COMPLETED|Overall Study||6
10352065|NCT00445315|11490647|FG001|COMPLETED|Overall Study||6
10352066|NCT00445315|11490648|FG002|COMPLETED|Overall Study||6
10352067|NCT00445315|11490649|FG003|COMPLETED|Overall Study||6
10352068|NCT00445315|11490650|FG004|COMPLETED|Overall Study||8
10352069|NCT00445315|11490646|FG000|NOT COMPLETED|Overall Study||0
10352070|NCT00445315|11490647|FG001|NOT COMPLETED|Overall Study||0
10352071|NCT00445315|11490648|FG002|NOT COMPLETED|Overall Study||0
10352072|NCT00445315|11490649|FG003|NOT COMPLETED|Overall Study||0
10352073|NCT00445315|11490650|FG004|NOT COMPLETED|Overall Study||0
10352074|NCT00445328|11490665|FG000|STARTED|Overall Study||42
10352075|NCT00445328|11490666|FG001|STARTED|Overall Study||42
10352076|NCT00445328|11490665|FG000|Received Treatment|Overall Study|1 subject discontinued after enrollment but prior to study treatment.|41
10352077|NCT00445328|11490666|FG001|Received Treatment|Overall Study||42
10352078|NCT00445328|11490665|FG000|COMPLETED|Overall Study||39
10352079|NCT00445328|11490666|FG001|COMPLETED|Overall Study||36
10352080|NCT00445328|11490665|FG000|NOT COMPLETED|Overall Study||3
10352081|NCT00445328|11490666|FG001|NOT COMPLETED|Overall Study||6
10352082|NCT00445341|11490672|FG000|STARTED|Overall Study||28
10352083|NCT00445341|11490672|FG000|COMPLETED|Overall Study||26
10352084|NCT00445341|11490672|FG000|NOT COMPLETED|Overall Study||2
10352085|NCT00445432|11490679|FG000|STARTED|Through Week 52 of NCT00445432 (M06-837)||25
10352086|NCT00445432|11490680|FG001|STARTED|Through Week 52 of NCT00445432 (M06-837)||25
10352087|NCT00445432|11490681|FG002|STARTED|Through Week 52 of NCT00445432 (M06-837)||32
10352088|NCT00445432|11490682|FG003|STARTED|Through Week 52 of NCT00445432 (M06-837)|This treatment group is not applicable for this period.|0
10352089|NCT00445432|11490679|FG000|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||10
10352090|NCT00445432|11490680|FG001|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||2
10352091|NCT00445432|11490681|FG002|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||21
10352092|NCT00445432|11490682|FG003|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||0
10352093|NCT00445432|11490679|FG000|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||15
10352094|NCT00445432|11490680|FG001|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||23
10352095|NCT00445432|11490681|FG002|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||11
10352096|NCT00445432|11490682|FG003|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||0
10352097|NCT00445432|11490679|FG000|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
10352098|NCT00445432|11490680|FG001|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
10352099|NCT00445432|11490681|FG002|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
10352100|NCT00445432|11490682|FG003|STARTED|148 Weeks of Adalimumab Treatment|3 participants discontinued while receiving double-blind placebo and never received any adalimumab|79
10655956|NCT02213042|11816790|FG002|COMPLETED|Overall Study||0
10655957|NCT02213042|11816788|FG000|NOT COMPLETED|Overall Study||17
10655958|NCT02213042|11816789|FG001|NOT COMPLETED|Overall Study||15
10655959|NCT02213042|11816790|FG002|NOT COMPLETED|Overall Study||10
10655960|NCT02213055|11816802|FG000|STARTED|Overall Study||97
10655961|NCT02213055|11816803|FG001|STARTED|Overall Study||0
10655962|NCT02213055|11816802|FG000|COMPLETED|Overall Study||58
10352101|NCT00445432|11490679|FG000|COMPLETED|148 Weeks of Adalimumab Treatment||0
10352102|NCT00445432|11490680|FG001|COMPLETED|148 Weeks of Adalimumab Treatment||0
10352103|NCT00445432|11490681|FG002|COMPLETED|148 Weeks of Adalimumab Treatment||0
10352104|NCT00445432|11490682|FG003|COMPLETED|148 Weeks of Adalimumab Treatment||35
10352105|NCT00445432|11490679|FG000|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
10352106|NCT00445432|11490680|FG001|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
10352107|NCT00445432|11490681|FG002|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
10352108|NCT00445432|11490682|FG003|NOT COMPLETED|148 Weeks of Adalimumab Treatment||44
10352109|NCT00445458|11490697|FG000|STARTED|Overall Study||3
10715961|NCT02688387|11880056|FG013|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10715962|NCT02688387|11880057|FG014|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10715963|NCT02688387|11880058|FG015|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10715964|NCT02688387|11880059|FG016|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10715965|NCT02688387|11880060|FG017|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10715966|NCT02688387|11880061|FG018|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10352110|NCT00445458|11490698|FG001|STARTED|Overall Study||5
10352111|NCT00445458|11490699|FG002|STARTED|Overall Study||71
10352112|NCT00445458|11490700|FG003|STARTED|Overall Study||31
10352113|NCT00445458|11490697|FG000|COMPLETED|Overall Study||0
10352114|NCT00445458|11490698|FG001|COMPLETED|Overall Study||0
10352115|NCT00445458|11490699|FG002|COMPLETED|Overall Study||3
10352116|NCT00445458|11490700|FG003|COMPLETED|Overall Study||3
10352117|NCT00445458|11490697|FG000|NOT COMPLETED|Overall Study||3
10352118|NCT00445458|11490698|FG001|NOT COMPLETED|Overall Study||5
10352119|NCT00445458|11490699|FG002|NOT COMPLETED|Overall Study||68
10352120|NCT00445458|11490700|FG003|NOT COMPLETED|Overall Study||28
10352121|NCT00445484|11490715|FG000|STARTED|Overall Study||11
10352122|NCT00445484|11490716|FG001|STARTED|Overall Study||11
10352123|NCT00445484|11490715|FG000|COMPLETED|Overall Study||7
10352124|NCT00445484|11490716|FG001|COMPLETED|Overall Study||10
10352125|NCT00445484|11490715|FG000|NOT COMPLETED|Overall Study||4
10352126|NCT00445484|11490716|FG001|NOT COMPLETED|Overall Study||1
10352127|NCT00445549|11490722|FG000|STARTED|Overall Study||12
10352128|NCT00445549|11490722|FG000|COMPLETED|Overall Study||0
10352129|NCT00445549|11490722|FG000|NOT COMPLETED|Overall Study||12
10352130|NCT00445588|11490726|FG000|STARTED|Overall Study||56
10352131|NCT00445588|11490726|FG000|COMPLETED|Overall Study||56
10352132|NCT00445588|11490726|FG000|NOT COMPLETED|Overall Study||0
10352133|NCT00445601|11490733|FG000|STARTED|Overall Study||201
10352134|NCT00445601|11490734|FG001|STARTED|Overall Study||205
10352135|NCT00445601|11490733|FG000|Received TURBT|Overall Study||190
10352136|NCT00445601|11490734|FG001|Received TURBT|Overall Study||193
10352137|NCT00445601|11490733|FG000|COMPLETED|Overall Study||168
10352138|NCT00445601|11490734|FG001|COMPLETED|Overall Study||177
10352139|NCT00445601|11490733|FG000|NOT COMPLETED|Overall Study||33
10352140|NCT00445601|11490734|FG001|NOT COMPLETED|Overall Study||28
10352141|NCT00445679|11490748|FG000|STARTED|Overall Study||203
10352142|NCT00445679|11490749|FG001|STARTED|Overall Study||203
10352143|NCT00445679|11490750|FG002|STARTED|Overall Study||205
10352144|NCT00445679|11490751|FG003|STARTED|Overall Study||196
10352145|NCT00445679|11490748|FG000|COMPLETED|Overall Study||155
10352146|NCT00445679|11490749|FG001|COMPLETED|Overall Study||157
10352147|NCT00445679|11490750|FG002|COMPLETED|Overall Study||139
10352148|NCT00445679|11490751|FG003|COMPLETED|Overall Study||149
10352149|NCT00445679|11490748|FG000|NOT COMPLETED|Overall Study||48
10352150|NCT00445679|11490749|FG001|NOT COMPLETED|Overall Study||46
10352151|NCT00445679|11490750|FG002|NOT COMPLETED|Overall Study||66
10352152|NCT00445679|11490751|FG003|NOT COMPLETED|Overall Study||47
10352153|NCT00445692|11490761|FG000|STARTED|Overall Study||31
10352154|NCT00445692|11490761|FG000|COMPLETED|Overall Study||15
10352155|NCT00445692|11490761|FG000|NOT COMPLETED|Overall Study||16
10352156|NCT00445705|11490771|FG000|STARTED|Overall Study||53
10352157|NCT00445705|11490772|FG001|STARTED|Overall Study||53
10352158|NCT00445705|11490773|FG002|STARTED|Overall Study||52
10352159|NCT00445705|11490774|FG003|STARTED|Overall Study||53
10352160|NCT00445705|11490771|FG000|COMPLETED|Overall Study||44
10352161|NCT00445705|11490772|FG001|COMPLETED|Overall Study||42
10352162|NCT00445705|11490773|FG002|COMPLETED|Overall Study||41
10352163|NCT00445705|11490774|FG003|COMPLETED|Overall Study||39
10352164|NCT00445705|11490771|FG000|NOT COMPLETED|Overall Study||9
10352165|NCT00445705|11490772|FG001|NOT COMPLETED|Overall Study||11
10352166|NCT00445705|11490773|FG002|NOT COMPLETED|Overall Study||11
10715967|NCT02688387|11880062|FG019|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10715968|NCT02688387|11880063|FG020|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10715969|NCT02688387|11880064|FG021|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
10305656|NCT00094835|11438614|FG000|NOT COMPLETED|Overall Study||4
10305657|NCT00094835|11438615|FG001|NOT COMPLETED|Overall Study||3
10305658|NCT00094835|11438616|FG002|NOT COMPLETED|Overall Study||3
10305659|NCT00094835|11438617|FG003|NOT COMPLETED|Overall Study||1
10305660|NCT00094835|11438618|FG004|NOT COMPLETED|Overall Study||4
10305661|NCT00094835|11438619|FG005|NOT COMPLETED|Overall Study||3
10305662|NCT00094835|11438620|FG006|NOT COMPLETED|Overall Study||2
10305663|NCT00094861|11438643|FG000|STARTED|Overall Study||46
10305664|NCT00094861|11438644|FG001|STARTED|Overall Study||49
10305665|NCT00094861|11438643|FG000|Participants Treated|Overall Study||46
10305666|NCT00094861|11438644|FG001|Participants Treated|Overall Study||48
10305667|NCT00094861|11438643|FG000|COMPLETED|Overall Study|Participants who completed the acute dysphagia evaluation phase|28
10305668|NCT00094861|11438644|FG001|COMPLETED|Overall Study|Participants who completed the acute dysphagia evaluation phase|40
10305669|NCT00094861|11438643|FG000|NOT COMPLETED|Overall Study||18
10305670|NCT00094861|11438644|FG001|NOT COMPLETED|Overall Study||9
10305671|NCT00094887|11438652|FG000|STARTED|Overall Study||75
10305672|NCT00094887|11438653|FG001|STARTED|Overall Study||75
10305673|NCT00094887|11438652|FG000|Safety Population|Overall Study||75
10305674|NCT00094887|11438653|FG001|Safety Population|Overall Study||75
10305675|NCT00094887|11438652|FG000|Intent to Treat Population|Overall Study||75
10305676|NCT00094887|11438653|FG001|Intent to Treat Population|Overall Study||75
10305677|NCT00094887|11438652|FG000|Per Protocol Analysis Set|Overall Study||71
10305678|NCT00094887|11438653|FG001|Per Protocol Analysis Set|Overall Study||71
10305679|NCT00094887|11438652|FG000|Primary Efficacy Population|Overall Study||65
10305680|NCT00094887|11438653|FG001|Primary Efficacy Population|Overall Study||64
10305681|NCT00094887|11438652|FG000|COMPLETED|Overall Study||71
10305682|NCT00094887|11438653|FG001|COMPLETED|Overall Study||71
10305683|NCT00094887|11438652|FG000|NOT COMPLETED|Overall Study||4
10305684|NCT00094887|11438653|FG001|NOT COMPLETED|Overall Study||4
10305685|NCT00094900|11438659|FG000|STARTED|Overall Study||11
10305686|NCT00094900|11438659|FG000|COMPLETED|Overall Study||10
10305687|NCT00094900|11438659|FG000|NOT COMPLETED|Overall Study||1
10305688|NCT00095056|11438665|FG000|STARTED|Phase A (Weeks 0-12)||65
10305689|NCT00095056|11438666|FG001|STARTED|Phase A (Weeks 0-12)||26
10305690|NCT00095056|11438665|FG000|COMPLETED|Phase A (Weeks 0-12)||58
10305691|NCT00095056|11438666|FG001|COMPLETED|Phase A (Weeks 0-12)||25
10305692|NCT00095056|11438665|FG000|NOT COMPLETED|Phase A (Weeks 0-12)||7
10305693|NCT00095056|11438666|FG001|NOT COMPLETED|Phase A (Weeks 0-12)||1
10305694|NCT00095056|11438665|FG000|STARTED|Phase B (Weeks 12-54)|2 randomized patients completed Period 1 but did not enter Period 2.|56
10305695|NCT00095056|11438666|FG001|STARTED|Phase B (Weeks 12-54)||25
10305696|NCT00095056|11438665|FG000|COMPLETED|Phase B (Weeks 12-54)||46
10305697|NCT00095056|11438666|FG001|COMPLETED|Phase B (Weeks 12-54)||20
10305698|NCT00095056|11438665|FG000|NOT COMPLETED|Phase B (Weeks 12-54)||10
10305699|NCT00095056|11438666|FG001|NOT COMPLETED|Phase B (Weeks 12-54)||5
10305700|NCT00095121|11438674|FG000|STARTED|Double-Blind (Study Weeks 0 Through 48)||115
10305701|NCT00095121|11438675|FG001|STARTED|Double-Blind (Study Weeks 0 Through 48)||58
10305702|NCT00095121|11438674|FG000|COMPLETED|Double-Blind (Study Weeks 0 Through 48)||112
10305703|NCT00095121|11438675|FG001|COMPLETED|Double-Blind (Study Weeks 0 Through 48)||58
10305704|NCT00095121|11438674|FG000|NOT COMPLETED|Double-Blind (Study Weeks 0 Through 48)||3
10305705|NCT00095121|11438675|FG001|NOT COMPLETED|Double-Blind (Study Weeks 0 Through 48)||0
10305706|NCT00095121|11438674|FG000|STARTED|Open-Label (Study Weeks 49 Through 240)||108
10305707|NCT00095121|11438675|FG001|STARTED|Open-Label (Study Weeks 49 Through 240)||54
10305708|NCT00095121|11438674|FG000|Received Lamivudine (LAM) After Week 96|Open-Label (Study Weeks 49 Through 240)||21
10305709|NCT00095121|11438675|FG001|Received Lamivudine (LAM) After Week 96|Open-Label (Study Weeks 49 Through 240)||11
10305710|NCT00095121|11438674|FG000|COMPLETED|Open-Label (Study Weeks 49 Through 240)|Completed the 240-week study period either on or off treatment at Week 240.|46
10352167|NCT00445705|11490774|FG003|NOT COMPLETED|Overall Study||14
10352168|NCT00445744|11490784|FG000|STARTED|Overall Study||52
10352169|NCT00445744|11490784|FG000|COMPLETED|Overall Study||51
10352170|NCT00445744|11490784|FG000|NOT COMPLETED|Overall Study||1
10426837|NCT00849186|11572550|FG000|STARTED|Overall Study||26
10426838|NCT00849186|11572550|FG000|COMPLETED|Overall Study||16
10426839|NCT00849186|11572550|FG000|NOT COMPLETED|Overall Study||10
10426840|NCT00849212|11572555|FG000|STARTED|Overall Study||30
10426841|NCT00849212|11572555|FG000|COMPLETED|Overall Study||23
10426842|NCT00849212|11572555|FG000|NOT COMPLETED|Overall Study||7
10426843|NCT00849251|11572559|FG000|STARTED|Overall Study||6
10426844|NCT00849251|11572560|FG001|STARTED|Overall Study||25
10426845|NCT00849251|11572559|FG000|COMPLETED|Overall Study||5
10426846|NCT00849251|11572560|FG001|COMPLETED|Overall Study||24
10426847|NCT00849251|11572559|FG000|NOT COMPLETED|Overall Study||1
10426848|NCT00849251|11572560|FG001|NOT COMPLETED|Overall Study||1
10426849|NCT00849290|11572566|FG000|STARTED|Overall Study||113
10426850|NCT00849290|11572566|FG000|COMPLETED|Overall Study||58
10426851|NCT00849290|11572566|FG000|NOT COMPLETED|Overall Study||55
10426852|NCT00849381|11572570|FG000|STARTED|Overall Study|Out of the subjects who started, 243 were enrolled at the center having compliance issues.|1237
10426853|NCT00849381|11572570|FG000|COMPLETED|Overall Study|Out of the subjects who completed, 167 were enrolled at the center having compliance issues.|1092
10426854|NCT00849381|11572570|FG000|NOT COMPLETED|Overall Study||145
10426855|NCT00849472|11572574|FG000|STARTED|Doxorubicin and Cyclophosphamide (AC)||101
10426856|NCT00849472|11572574|FG000|COMPLETED|Doxorubicin and Cyclophosphamide (AC)||95
10426857|NCT00849472|11572574|FG000|NOT COMPLETED|Doxorubicin and Cyclophosphamide (AC)||6
10426858|NCT00849472|11572574|FG000|STARTED|Weekly Paclitaxel|One par. was deemed ineligible after completing AC therapy and did not start paclitaxel+pazopanib.|94
10426859|NCT00849472|11572574|FG000|COMPLETED|Weekly Paclitaxel||78
10426860|NCT00849472|11572574|FG000|NOT COMPLETED|Weekly Paclitaxel||16
10426861|NCT00849472|11572574|FG000|STARTED|Pazopanib Presurgery Treatment (PPT)||94
10426862|NCT00849472|11572574|FG000|COMPLETED|Pazopanib Presurgery Treatment (PPT)||36
10426863|NCT00849472|11572574|FG000|NOT COMPLETED|Pazopanib Presurgery Treatment (PPT)||58
10426864|NCT00849472|11572574|FG000|STARTED|Pazopanib Postsurgery Treatment|36 participants completed PPT; 7 participants who discontinued PPT resumed treatment postsurgery.|42
10426865|NCT00849472|11572574|FG000|COMPLETED|Pazopanib Postsurgery Treatment||16
10426866|NCT00849472|11572574|FG000|NOT COMPLETED|Pazopanib Postsurgery Treatment||26
10426867|NCT00849680|11572587|FG000|STARTED|Overall Study||27
10533304|NCT01425307|11685594|FG001|NOT COMPLETED|Overall Study||19
10533305|NCT01425359|11685604|FG000|STARTED|Overall Study||476
10533306|NCT01425359|11685605|FG001|STARTED|Overall Study||473
10533307|NCT01425359|11685604|FG000|COMPLETED|Overall Study||457
10533308|NCT01425359|11685605|FG001|COMPLETED|Overall Study||451
10533309|NCT01425359|11685604|FG000|NOT COMPLETED|Overall Study||19
10533310|NCT01425359|11685605|FG001|NOT COMPLETED|Overall Study||22
10533311|NCT01425463|11685614|FG000|STARTED|Overall Study||130
10533312|NCT01425463|11685615|FG001|STARTED|Overall Study||126
10533313|NCT01425463|11685614|FG000|Safety Set|Overall Study||126
10533314|NCT01425463|11685615|FG001|Safety Set|Overall Study||122
10533315|NCT01425463|11685614|FG000|Full Analysis Set|Overall Study||122
10533316|NCT01425463|11685615|FG001|Full Analysis Set|Overall Study||116
10533317|NCT01425463|11685614|FG000|COMPLETED|Overall Study||106
10533318|NCT01425463|11685615|FG001|COMPLETED|Overall Study||102
10533319|NCT01425463|11685614|FG000|NOT COMPLETED|Overall Study||24
10533320|NCT01425463|11685615|FG001|NOT COMPLETED|Overall Study||24
10533321|NCT01425528|11685623|FG000|STARTED|Overall Study||6
10533322|NCT01425528|11685624|FG001|STARTED|Overall Study||6
10533323|NCT01425528|11685623|FG000|COMPLETED|Overall Study||5
10533324|NCT01425528|11685624|FG001|COMPLETED|Overall Study||5
10533325|NCT01425528|11685623|FG000|NOT COMPLETED|Overall Study||1
10533326|NCT01425528|11685624|FG001|NOT COMPLETED|Overall Study||1
10533327|NCT01425281|11685632|FG000|STARTED|At 30-day Clinical Follow-up|Intent-to-Treat (ITT) Population|335
10533328|NCT01425281|11685633|FG001|STARTED|At 30-day Clinical Follow-up|Intent-to-Treat (ITT) Population|166
10533329|NCT01425281|11685632|FG000|COMPLETED|At 30-day Clinical Follow-up||334
10533330|NCT01425281|11685633|FG001|COMPLETED|At 30-day Clinical Follow-up||166
10533331|NCT01425281|11685632|FG000|NOT COMPLETED|At 30-day Clinical Follow-up||1
10533332|NCT01425281|11685633|FG001|NOT COMPLETED|At 30-day Clinical Follow-up||0
10715970|NCT02688387|11880043|FG000|STARTED|Part 3B, Period 1 (up to 6 Days)||0
10715971|NCT02688387|11880044|FG001|STARTED|Part 3B, Period 1 (up to 6 Days)||0
10715972|NCT02688387|11880045|FG002|STARTED|Part 3B, Period 1 (up to 6 Days)||0
10715973|NCT02688387|11880046|FG003|STARTED|Part 3B, Period 1 (up to 6 Days)||0
10715974|NCT02688387|11880047|FG004|STARTED|Part 3B, Period 1 (up to 6 Days)||0
10715975|NCT02688387|11880048|FG005|STARTED|Part 3B, Period 1 (up to 6 Days)||0
10715976|NCT02688387|11880049|FG006|STARTED|Part 3B, Period 1 (up to 6 Days)||0
10715977|NCT02688387|11880050|FG007|STARTED|Part 3B, Period 1 (up to 6 Days)||0
10715978|NCT02688387|11880051|FG008|STARTED|Part 3B, Period 1 (up to 6 Days)||0
10715979|NCT02688387|11880052|FG009|STARTED|Part 3B, Period 1 (up to 6 Days)||0
10715980|NCT02688387|11880053|FG010|STARTED|Part 3B, Period 1 (up to 6 Days)||0
10715981|NCT02688387|11880054|FG011|STARTED|Part 3B, Period 1 (up to 6 Days)||0
10533333|NCT01425281|11685632|FG000|STARTED|At 180-day Clinical Follow-up||334
10533334|NCT01425281|11685633|FG001|STARTED|At 180-day Clinical Follow-up||166
10533335|NCT01425281|11685632|FG000|COMPLETED|At 180-day Clinical Follow-up||331
10533336|NCT01425281|11685633|FG001|COMPLETED|At 180-day Clinical Follow-up||165
10547929|NCT01515657|11701699|FG001|NOT COMPLETED|Third Intervention||0
10715982|NCT02688387|11880055|FG012|STARTED|Part 3B, Period 1 (up to 6 Days)||0
10352171|NCT00445770|11490791|FG000|STARTED|Overall Study||176
10352172|NCT00445770|11490792|FG001|STARTED|Overall Study||192
10352173|NCT00445770|11490793|FG002|STARTED|Overall Study||182
10352174|NCT00445770|11490791|FG000|COMPLETED|Overall Study||123
10352175|NCT00445770|11490792|FG001|COMPLETED|Overall Study||157
10352176|NCT00445770|11490793|FG002|COMPLETED|Overall Study||151
10352177|NCT00445770|11490791|FG000|NOT COMPLETED|Overall Study||53
10352178|NCT00445770|11490792|FG001|NOT COMPLETED|Overall Study||35
10352179|NCT00445770|11490793|FG002|NOT COMPLETED|Overall Study||31
10352180|NCT00445848|11490803|FG000|STARTED|Overall Study||85
10352181|NCT00445848|11490803|FG000|COMPLETED|Overall Study||0
10352182|NCT00445848|11490803|FG000|NOT COMPLETED|Overall Study||85
10352183|NCT00445887|11490809|FG000|STARTED|Overall Study||33
10352184|NCT00445887|11490810|FG001|STARTED|Overall Study||31
10352185|NCT00445887|11490809|FG000|COMPLETED|Overall Study||33
10352186|NCT00445887|11490810|FG001|COMPLETED|Overall Study||31
10352187|NCT00445887|11490809|FG000|NOT COMPLETED|Overall Study||0
10352188|NCT00445887|11490810|FG001|NOT COMPLETED|Overall Study||0
10352189|NCT00445939|11490829|FG000|STARTED|Period A - Week 0 - Week 4||33
10352190|NCT00445939|11490830|FG001|STARTED|Period A - Week 0 - Week 4||34
10352191|NCT00445939|11490831|FG002|STARTED|Period A - Week 0 - Week 4||23
10352192|NCT00445939|11490832|FG003|STARTED|Period A - Week 0 - Week 4||0
10352193|NCT00445939|11490829|FG000|COMPLETED|Period A - Week 0 - Week 4|23 rated as responders and 9 rated as non-responders in evaluation on Week 4.|32
10352194|NCT00445939|11490830|FG001|COMPLETED|Period A - Week 0 - Week 4|20 rated as responders and 12 rated as non-responders in evaluation on Week 4.|32
10352195|NCT00445939|11490831|FG002|COMPLETED|Period A - Week 0 - Week 4|7 rated as responders and 16 rated as non-responders in evaluation on Week 4.|23
10352196|NCT00445939|11490832|FG003|COMPLETED|Period A - Week 0 - Week 4||0
10352197|NCT00445939|11490829|FG000|NOT COMPLETED|Period A - Week 0 - Week 4||1
10352198|NCT00445939|11490830|FG001|NOT COMPLETED|Period A - Week 0 - Week 4||2
10352199|NCT00445939|11490831|FG002|NOT COMPLETED|Period A - Week 0 - Week 4||0
10352200|NCT00445939|11490832|FG003|NOT COMPLETED|Period A - Week 0 - Week 4||0
10352201|NCT00445939|11490829|FG000|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 16 placebo subjects allocated to 160/80 mg group.|16
10352202|NCT00445939|11490830|FG001|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 80/40 mg subjects allocated to 40/40 mg group.|0
10352203|NCT00445939|11490831|FG002|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous placebo subjects allocated to 160/80 mg group.|0
10352204|NCT00445939|11490832|FG003|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 160/80 and 80/40 subjects allocated to 40/40 group.|21
10352205|NCT00445939|11490829|FG000|COMPLETED|Period B - Week 4 - Week 8||14
10352206|NCT00445939|11490830|FG001|COMPLETED|Period B - Week 4 - Week 8||0
10352207|NCT00445939|11490831|FG002|COMPLETED|Period B - Week 4 - Week 8||0
10352208|NCT00445939|11490832|FG003|COMPLETED|Period B - Week 4 - Week 8||20
10352209|NCT00445939|11490829|FG000|NOT COMPLETED|Period B - Week 4 - Week 8||2
10352210|NCT00445939|11490830|FG001|NOT COMPLETED|Period B - Week 4 - Week 8||0
10352211|NCT00445939|11490831|FG002|NOT COMPLETED|Period B - Week 4 - Week 8||0
10352212|NCT00445939|11490832|FG003|NOT COMPLETED|Period B - Week 4 - Week 8||1
10352213|NCT00445978|11490852|FG000|STARTED|Week 0 - Week 4 (2.5 mg/kg/Day)||32
10352214|NCT00445978|11490852|FG000|COMPLETED|Week 0 - Week 4 (2.5 mg/kg/Day)||29
10352215|NCT00445978|11490852|FG000|NOT COMPLETED|Week 0 - Week 4 (2.5 mg/kg/Day)||3
10352216|NCT00445978|11490852|FG000|STARTED|Week 4 - Week 8 (5 mg/kg/Day)||29
10533337|NCT01425281|11685632|FG000|NOT COMPLETED|At 180-day Clinical Follow-up||3
10352217|NCT00445978|11490852|FG000|Received Escalated Dose|Week 4 - Week 8 (5 mg/kg/Day)||29
10352218|NCT00445978|11490852|FG000|COMPLETED|Week 4 - Week 8 (5 mg/kg/Day)||25
10352219|NCT00445978|11490852|FG000|NOT COMPLETED|Week 4 - Week 8 (5 mg/kg/Day)||4
10352220|NCT00445978|11490852|FG000|STARTED|Week 8 - Week 12 (10 mg/kg/Day)||25
10352221|NCT00445978|11490852|FG000|Received Escalated Dose|Week 8 - Week 12 (10 mg/kg/Day)||25
10352222|NCT00445978|11490852|FG000|COMPLETED|Week 8 - Week 12 (10 mg/kg/Day)||24
10352223|NCT00445978|11490852|FG000|NOT COMPLETED|Week 8 - Week 12 (10 mg/kg/Day)||1
10352224|NCT00445978|11490852|FG000|STARTED|Week 12 - Week 16 (20 mg/kg/Day)||24
10352225|NCT00445978|11490852|FG000|Received Escalated Dose|Week 12 - Week 16 (20 mg/kg/Day)||21
10352226|NCT00445978|11490852|FG000|COMPLETED|Week 12 - Week 16 (20 mg/kg/Day)||23
10352227|NCT00445978|11490852|FG000|NOT COMPLETED|Week 12 - Week 16 (20 mg/kg/Day)||1
10352228|NCT00446030|11490865|FG000|STARTED|TREATMENT (up to 52 Weeks)||93
10352229|NCT00446030|11490866|FG001|STARTED|TREATMENT (up to 52 Weeks)||34
10352230|NCT00446030|11490865|FG000|RECEIVED TREATMENT|TREATMENT (up to 52 Weeks)||92
10352231|NCT00446030|11490866|FG001|RECEIVED TREATMENT|TREATMENT (up to 52 Weeks)||34
10352232|NCT00446030|11490865|FG000|COMPLETED|TREATMENT (up to 52 Weeks)|Participants who completed treatment|49
10352233|NCT00446030|11490866|FG001|COMPLETED|TREATMENT (up to 52 Weeks)|Participants who completed treatment|25
10352234|NCT00446030|11490865|FG000|NOT COMPLETED|TREATMENT (up to 52 Weeks)||44
10352235|NCT00446030|11490866|FG001|NOT COMPLETED|TREATMENT (up to 52 Weeks)||9
10352236|NCT00446030|11490865|FG000|STARTED|FOLLOW-UP (up to 2-years)|All participants, including those who discontinued treatment, continued to the follow-up period.|93
10352237|NCT00446030|11490866|FG001|STARTED|FOLLOW-UP (up to 2-years)||34
10352238|NCT00446030|11490865|FG000|COMPLETED|FOLLOW-UP (up to 2-years)||63
10352239|NCT00446030|11490866|FG001|COMPLETED|FOLLOW-UP (up to 2-years)||25
10352240|NCT00446030|11490865|FG000|NOT COMPLETED|FOLLOW-UP (up to 2-years)||30
10812427|NCT03680911|11974476|FG000|STARTED|Visit 3 (4 Month Follow up)||0
10352241|NCT00446030|11490866|FG001|NOT COMPLETED|FOLLOW-UP (up to 2-years)||9
10352242|NCT00446095|11490877|FG000|STARTED|Phase II (8 Weeks)||23
10352243|NCT00446095|11490878|FG001|STARTED|Phase II (8 Weeks)||21
10812428|NCT03680911|11974477|FG001|STARTED|Visit 3 (4 Month Follow up)||1
10812429|NCT03680911|11974476|FG000|COMPLETED|Visit 3 (4 Month Follow up)||0
10812430|NCT03680911|11974477|FG001|COMPLETED|Visit 3 (4 Month Follow up)||0
10812431|NCT03680911|11974476|FG000|NOT COMPLETED|Visit 3 (4 Month Follow up)||0
10812432|NCT03680911|11974477|FG001|NOT COMPLETED|Visit 3 (4 Month Follow up)||1
10812433|NCT03656692|11974483|FG000|STARTED|Overall Study||5
10812434|NCT03656692|11974483|FG000|COMPLETED|Overall Study||2
10812435|NCT03656692|11974483|FG000|NOT COMPLETED|Overall Study||3
10812436|NCT03648983|11974487|FG000|STARTED|Overall Study||95
10812437|NCT03648983|11974487|FG000|COMPLETED|Overall Study||0
10812438|NCT03648983|11974487|FG000|NOT COMPLETED|Overall Study||95
10812439|NCT03643159|11974494|FG000|STARTED|Overall Study||2
10812440|NCT03643159|11974494|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||2
10812441|NCT03643159|11974494|FG000|COMPLETED|Overall Study||0
10812442|NCT03643159|11974494|FG000|NOT COMPLETED|Overall Study||2
10812443|NCT03632655|11974501|FG000|STARTED|Overall Study||22
10812444|NCT03632655|11974502|FG001|STARTED|Overall Study||16
10352244|NCT00446095|11490879|FG002|STARTED|Phase II (8 Weeks)||24
10352245|NCT00446095|11490880|FG003|STARTED|Phase II (8 Weeks)||0
10352246|NCT00446095|11490881|FG004|STARTED|Phase II (8 Weeks)||0
10352247|NCT00446095|11490877|FG000|COMPLETED|Phase II (8 Weeks)||11
10352248|NCT00446095|11490878|FG001|COMPLETED|Phase II (8 Weeks)||18
10352249|NCT00446095|11490879|FG002|COMPLETED|Phase II (8 Weeks)||21
10352250|NCT00446095|11490880|FG003|COMPLETED|Phase II (8 Weeks)||0
10352251|NCT00446095|11490881|FG004|COMPLETED|Phase II (8 Weeks)||0
10352252|NCT00446095|11490877|FG000|NOT COMPLETED|Phase II (8 Weeks)||12
10352253|NCT00446095|11490878|FG001|NOT COMPLETED|Phase II (8 Weeks)||3
10352254|NCT00446095|11490879|FG002|NOT COMPLETED|Phase II (8 Weeks)||3
10352255|NCT00446095|11490880|FG003|NOT COMPLETED|Phase II (8 Weeks)||0
10352256|NCT00446095|11490881|FG004|NOT COMPLETED|Phase II (8 Weeks)||0
10352257|NCT00446095|11490877|FG000|STARTED|Phase I (28 Days)||0
10352258|NCT00446095|11490878|FG001|STARTED|Phase I (28 Days)||0
10352259|NCT00446095|11490879|FG002|STARTED|Phase I (28 Days)||0
10352260|NCT00446095|11490880|FG003|STARTED|Phase I (28 Days)||6
10352261|NCT00446095|11490881|FG004|STARTED|Phase I (28 Days)||7
10352262|NCT00446095|11490877|FG000|COMPLETED|Phase I (28 Days)||0
10352263|NCT00446095|11490878|FG001|COMPLETED|Phase I (28 Days)||0
10352264|NCT00446095|11490879|FG002|COMPLETED|Phase I (28 Days)||0
10352265|NCT00446095|11490880|FG003|COMPLETED|Phase I (28 Days)||5
10352266|NCT00446095|11490881|FG004|COMPLETED|Phase I (28 Days)||4
10352267|NCT00446095|11490877|FG000|NOT COMPLETED|Phase I (28 Days)||0
10352268|NCT00446095|11490878|FG001|NOT COMPLETED|Phase I (28 Days)||0
10352269|NCT00446095|11490879|FG002|NOT COMPLETED|Phase I (28 Days)||0
10352270|NCT00446095|11490880|FG003|NOT COMPLETED|Phase I (28 Days)||1
10352271|NCT00446095|11490881|FG004|NOT COMPLETED|Phase I (28 Days)||3
10352272|NCT00446134|11490896|FG000|STARTED|Overall Study|Includes 2 patients who did not receive study drug and was not included in any other analysis|69
10352273|NCT00446134|11490897|FG001|STARTED|Overall Study||70
10352274|NCT00446134|11490898|FG002|STARTED|Overall Study|Includes 1 patient who did not receive study drug and was not included in any other analysis|69
10352275|NCT00446134|11490899|FG003|STARTED|Overall Study||70
10352276|NCT00446134|11490896|FG000|COMPLETED|Overall Study||35
10352277|NCT00446134|11490897|FG001|COMPLETED|Overall Study||25
10352278|NCT00446134|11490898|FG002|COMPLETED|Overall Study||26
10352279|NCT00446134|11490899|FG003|COMPLETED|Overall Study||25
10352280|NCT00446134|11490896|FG000|NOT COMPLETED|Overall Study||34
10352281|NCT00446134|11490897|FG001|NOT COMPLETED|Overall Study||45
10352282|NCT00446134|11490898|FG002|NOT COMPLETED|Overall Study||43
10352283|NCT00446134|11490899|FG003|NOT COMPLETED|Overall Study||45
10352284|NCT00446147|11490911|FG000|STARTED|Overall Study||195
10352285|NCT00446147|11490912|FG001|STARTED|Overall Study||194
10352286|NCT00446147|11490911|FG000|COMPLETED|Overall Study||180
10352287|NCT00446147|11490912|FG001|COMPLETED|Overall Study||180
10352288|NCT00446147|11490911|FG000|NOT COMPLETED|Overall Study||15
10352289|NCT00446147|11490912|FG001|NOT COMPLETED|Overall Study||14
10352290|NCT00446199|11490922|FG000|STARTED|Overall Study||183
10352291|NCT00446199|11490923|FG001|STARTED|Overall Study||184
10352292|NCT00446199|11490924|FG002|STARTED|Overall Study||185
10352293|NCT00446199|11490925|FG003|STARTED|Overall Study||183
10352294|NCT00446199|11490922|FG000|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|181
10352295|NCT00446199|11490923|FG001|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|183
10352296|NCT00446199|11490924|FG002|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|182
10352297|NCT00446199|11490925|FG003|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|180
10812472|NCT03615144|11974542|FG000|COMPLETED|Overall Study||0
10352298|NCT00446199|11490922|FG000|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|178
10352299|NCT00446199|11490923|FG001|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|177
10352300|NCT00446199|11490924|FG002|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|179
10352301|NCT00446199|11490925|FG003|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|176
10352302|NCT00446199|11490922|FG000|COMPLETED|Overall Study||160
10352303|NCT00446199|11490923|FG001|COMPLETED|Overall Study||164
10352304|NCT00446199|11490924|FG002|COMPLETED|Overall Study||158
10352305|NCT00446199|11490925|FG003|COMPLETED|Overall Study||153
10352306|NCT00446199|11490922|FG000|NOT COMPLETED|Overall Study||23
10352307|NCT00446199|11490923|FG001|NOT COMPLETED|Overall Study||20
10352308|NCT00446199|11490924|FG002|NOT COMPLETED|Overall Study||27
10352309|NCT00446199|11490925|FG003|NOT COMPLETED|Overall Study||30
10352310|NCT00446251|11490935|FG000|STARTED|Overall Study|14 subjects were enrolled in this Rituximab-mycophenolic mofetil group.|14
10352311|NCT00446251|11490935|FG000|COMPLETED|Overall Study||9
10352312|NCT00446251|11490935|FG000|NOT COMPLETED|Overall Study||5
10352313|NCT00446264|11490939|FG000|STARTED|Overall Study||14
10352314|NCT00446264|11490939|FG000|COMPLETED|Overall Study||14
10352315|NCT00446264|11490939|FG000|NOT COMPLETED|Overall Study||0
10352316|NCT00446290|11490943|FG000|STARTED|Overall Study||22
10352317|NCT00446290|11490943|FG000|COMPLETED|Overall Study||22
10352318|NCT00446290|11490943|FG000|NOT COMPLETED|Overall Study||0
10352319|NCT00446446|11490947|FG000|STARTED|Overall Study||52
10352320|NCT00446446|11490947|FG000|COMPLETED|Overall Study|Participants who completed the 60-day safety visit|28
10352321|NCT00446446|11490947|FG000|NOT COMPLETED|Overall Study||24
10352322|NCT00446459|11490951|FG000|STARTED|8 Months|34 subjects received any amount of MMF.|34
10352323|NCT00446459|11490951|FG000|COMPLETED|8 Months|22 subjects were on study at month 8.|22
10352324|NCT00446459|11490951|FG000|NOT COMPLETED|8 Months||12
10352325|NCT00446459|11490951|FG000|STARTED|12 Months|22 subjects remained on-study at month 8|22
10352326|NCT00446459|11490951|FG000|COMPLETED|12 Months|4 subjects remained at month 12|4
10352327|NCT00446459|11490951|FG000|NOT COMPLETED|12 Months||18
10352328|NCT00446511|11490959|FG000|STARTED|Overall Study||21
10352329|NCT00446511|11490960|FG001|STARTED|Overall Study||17
10352330|NCT00446511|11490961|FG002|STARTED|Overall Study||103
10352331|NCT00446511|11490962|FG003|STARTED|Overall Study||109
10715983|NCT02688387|11880056|FG013|STARTED|Part 3B, Period 1 (up to 6 Days)||0
10715984|NCT02688387|11880057|FG014|STARTED|Part 3B, Period 1 (up to 6 Days)||0
10715985|NCT02688387|11880058|FG015|STARTED|Part 3B, Period 1 (up to 6 Days)||0
10715986|NCT02688387|11880059|FG016|STARTED|Part 3B, Period 1 (up to 6 Days)||0
10812445|NCT03632655|11974501|FG000|COMPLETED|Overall Study||0
10812446|NCT03632655|11974502|FG001|COMPLETED|Overall Study||0
10812447|NCT03632655|11974501|FG000|NOT COMPLETED|Overall Study||22
10812448|NCT03632655|11974502|FG001|NOT COMPLETED|Overall Study||16
10812449|NCT03630120|11974512|FG000|STARTED|Overall Study||2
10812450|NCT03630120|11974513|FG001|STARTED|Overall Study||2
10812451|NCT03630120|11974514|FG002|STARTED|Overall Study||1
10812452|NCT03630120|11974515|FG003|STARTED|Overall Study||1
10812453|NCT03630120|11974512|FG000|COMPLETED|Overall Study||2
10812454|NCT03630120|11974513|FG001|COMPLETED|Overall Study||1
10812455|NCT03630120|11974514|FG002|COMPLETED|Overall Study||0
10812456|NCT03630120|11974515|FG003|COMPLETED|Overall Study||0
10812457|NCT03630120|11974512|FG000|NOT COMPLETED|Overall Study||0
10812458|NCT03630120|11974513|FG001|NOT COMPLETED|Overall Study||1
10812459|NCT03630120|11974514|FG002|NOT COMPLETED|Overall Study||1
10812460|NCT03630120|11974515|FG003|NOT COMPLETED|Overall Study||1
10812461|NCT03621657|11974528|FG000|STARTED|Overall Study||0
10812462|NCT03621657|11974529|FG001|STARTED|Overall Study||0
10812463|NCT03621657|11974530|FG002|STARTED|Overall Study||1
10812464|NCT03621657|11974528|FG000|COMPLETED|Overall Study||0
10812465|NCT03621657|11974529|FG001|COMPLETED|Overall Study||0
10812466|NCT03621657|11974530|FG002|COMPLETED|Overall Study||1
10715987|NCT02688387|11880060|FG017|STARTED|Part 3B, Period 1 (up to 6 Days)||0
10715988|NCT02688387|11880061|FG018|STARTED|Part 3B, Period 1 (up to 6 Days)||8
10715989|NCT02688387|11880062|FG019|STARTED|Part 3B, Period 1 (up to 6 Days)||8
10715990|NCT02688387|11880063|FG020|STARTED|Part 3B, Period 1 (up to 6 Days)||8
10715991|NCT02688387|11880064|FG021|STARTED|Part 3B, Period 1 (up to 6 Days)||8
10715992|NCT02688387|11880043|FG000|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10715993|NCT02688387|11880044|FG001|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10715994|NCT02688387|11880045|FG002|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10715995|NCT02688387|11880046|FG003|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10715996|NCT02688387|11880047|FG004|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10715997|NCT02688387|11880048|FG005|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10715998|NCT02688387|11880049|FG006|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10715999|NCT02688387|11880050|FG007|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10716000|NCT02688387|11880051|FG008|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10716001|NCT02688387|11880052|FG009|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10716002|NCT02688387|11880053|FG010|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10812467|NCT03621657|11974528|FG000|NOT COMPLETED|Overall Study||0
10812468|NCT03621657|11974529|FG001|NOT COMPLETED|Overall Study||0
10812469|NCT03621657|11974530|FG002|NOT COMPLETED|Overall Study||0
10812470|NCT03615144|11974542|FG000|STARTED|Overall Study||1
10812471|NCT03615144|11974543|FG001|STARTED|Overall Study||0
10812473|NCT03615144|11974543|FG001|COMPLETED|Overall Study||0
10812474|NCT03615144|11974542|FG000|NOT COMPLETED|Overall Study||1
10812475|NCT03615144|11974543|FG001|NOT COMPLETED|Overall Study||0
10812476|NCT03605303|11974549|FG000|STARTED|Period 1||2
10812477|NCT03605303|11974550|FG001|STARTED|Period 1||1
10352332|NCT00446511|11490959|FG000|COMPLETED|Overall Study||11
10352333|NCT00446511|11490960|FG001|COMPLETED|Overall Study||15
10352334|NCT00446511|11490961|FG002|COMPLETED|Overall Study||96
10352335|NCT00446511|11490962|FG003|COMPLETED|Overall Study||103
10352336|NCT00446511|11490959|FG000|NOT COMPLETED|Overall Study||10
10352337|NCT00446511|11490960|FG001|NOT COMPLETED|Overall Study||2
10352338|NCT00446511|11490961|FG002|NOT COMPLETED|Overall Study||7
10352339|NCT00446511|11490962|FG003|NOT COMPLETED|Overall Study||6
10352340|NCT00446550|11490976|FG000|STARTED|Overall Study||11
10352341|NCT00446550|11490977|FG001|STARTED|Overall Study||8
10352342|NCT00446550|11490976|FG000|Safety Population|Overall Study||11
10352343|NCT00446550|11490977|FG001|Safety Population|Overall Study||8
10352344|NCT00446550|11490976|FG000|PD Population|Overall Study||11
10352345|NCT00446550|11490977|FG001|PD Population|Overall Study||8
10352346|NCT00446550|11490976|FG000|COMPLETED|Overall Study||10
10352347|NCT00446550|11490977|FG001|COMPLETED|Overall Study||8
10352348|NCT00446550|11490976|FG000|NOT COMPLETED|Overall Study||1
10352349|NCT00446550|11490977|FG001|NOT COMPLETED|Overall Study||0
10352350|NCT00446563|11490986|FG000|STARTED|Overall Study||43
10352351|NCT00446563|11490987|FG001|STARTED|Overall Study||47
10352352|NCT00446563|11490986|FG000|COMPLETED|Overall Study||36
10352353|NCT00446563|11490987|FG001|COMPLETED|Overall Study||38
10352354|NCT00446563|11490986|FG000|NOT COMPLETED|Overall Study||7
10352355|NCT00446563|11490987|FG001|NOT COMPLETED|Overall Study||9
10352356|NCT00446641|11490995|FG000|STARTED|Overall Study||125
10352357|NCT00446641|11490996|FG001|STARTED|Overall Study||119
10352358|NCT00446641|11490995|FG000|COMPLETED|Overall Study||108
10352359|NCT00446641|11490996|FG001|COMPLETED|Overall Study||109
10352360|NCT00446641|11490995|FG000|NOT COMPLETED|Overall Study||17
10352361|NCT00446641|11490996|FG001|NOT COMPLETED|Overall Study||10
10352362|NCT00446654|11491004|FG000|STARTED|Overall Study||21
10352363|NCT00446654|11491005|FG001|STARTED|Overall Study||22
10352364|NCT00446654|11491004|FG000|COMPLETED|Overall Study||19
10352365|NCT00446654|11491005|FG001|COMPLETED|Overall Study||22
10352366|NCT00446654|11491004|FG000|NOT COMPLETED|Overall Study||2
10352367|NCT00446654|11491005|FG001|NOT COMPLETED|Overall Study||0
10352368|NCT00446797|11491013|FG000|STARTED|Overall Study||141
10352369|NCT00446797|11491014|FG001|STARTED|Overall Study||137
10352370|NCT00446797|11491013|FG000|COMPLETED|Overall Study||133
10352371|NCT00446797|11491014|FG001|COMPLETED|Overall Study||125
10352372|NCT00446797|11491013|FG000|NOT COMPLETED|Overall Study||8
10352373|NCT00446797|11491014|FG001|NOT COMPLETED|Overall Study||12
10352374|NCT00446849|11491020|FG000|STARTED|Acute Phase||138
10352375|NCT00446849|11491020|FG000|COMPLETED|Acute Phase||56
10352376|NCT00446849|11491020|FG000|NOT COMPLETED|Acute Phase||82
10352377|NCT00446849|11491020|FG000|STARTED|Maintenance Phase||208
10352378|NCT00446849|11491020|FG000|COMPLETED|Maintenance Phase||138
10352379|NCT00446849|11491020|FG000|NOT COMPLETED|Maintenance Phase||70
10352380|NCT00446966|11491027|FG000|STARTED|Overall Study||130
10352381|NCT00446966|11491028|FG001|STARTED|Overall Study||130
10352382|NCT00446966|11491027|FG000|COMPLETED|Overall Study||120
10352383|NCT00446966|11491028|FG001|COMPLETED|Overall Study||123
10352384|NCT00446966|11491027|FG000|NOT COMPLETED|Overall Study||10
10352385|NCT00446966|11491028|FG001|NOT COMPLETED|Overall Study||7
10352386|NCT00446992|11491034|FG000|STARTED|Overall Study|Beginning of Intervention|30
10352387|NCT00446992|11491034|FG000|COMPLETED|Overall Study|Intervention Completion|14
10352388|NCT00446992|11491034|FG000|NOT COMPLETED|Overall Study||16
10352389|NCT00447005|11491038|FG000|STARTED|Overall Study||12
10352390|NCT00447005|11491038|FG000|COMPLETED|Overall Study||0
10352391|NCT00447005|11491038|FG000|NOT COMPLETED|Overall Study||12
10352392|NCT00447057|11491046|FG000|STARTED|Overall Study||83
10352393|NCT00447057|11491047|FG001|STARTED|Overall Study||76
10352394|NCT00447057|11491048|FG002|STARTED|Overall Study||19
10352395|NCT00447057|11491049|FG003|STARTED|Overall Study||26
10352396|NCT00447057|11491046|FG000|COMPLETED|Overall Study||0
10352397|NCT00447057|11491047|FG001|COMPLETED|Overall Study||3
10352398|NCT00447057|11491048|FG002|COMPLETED|Overall Study||0
10352399|NCT00447057|11491049|FG003|COMPLETED|Overall Study||0
10352400|NCT00447057|11491046|FG000|NOT COMPLETED|Overall Study||83
10533338|NCT01425281|11685633|FG001|NOT COMPLETED|At 180-day Clinical Follow-up||1
10533339|NCT01425281|11685632|FG000|STARTED|At 1-year Clinical Follow-up||331
10352401|NCT00447057|11491047|FG001|NOT COMPLETED|Overall Study||73
10352402|NCT00447057|11491048|FG002|NOT COMPLETED|Overall Study||19
10352403|NCT00447057|11491049|FG003|NOT COMPLETED|Overall Study||26
10533340|NCT01425281|11685633|FG001|STARTED|At 1-year Clinical Follow-up||165
10533341|NCT01425281|11685632|FG000|COMPLETED|At 1-year Clinical Follow-up||329
10533342|NCT01425281|11685633|FG001|COMPLETED|At 1-year Clinical Follow-up||164
10533343|NCT01425281|11685632|FG000|NOT COMPLETED|At 1-year Clinical Follow-up||2
10533344|NCT01425281|11685633|FG001|NOT COMPLETED|At 1-year Clinical Follow-up||1
10533345|NCT01425281|11685632|FG000|STARTED|At 2-year Clinical Follow-up||329
10533346|NCT01425281|11685633|FG001|STARTED|At 2-year Clinical Follow-up||164
10352404|NCT00447083|11491059|FG000|STARTED|Phase I||10
10352405|NCT00447083|11491060|FG001|STARTED|Phase I||9
10352406|NCT00447083|11491061|FG002|STARTED|Phase I||0
10352407|NCT00447083|11491062|FG003|STARTED|Phase I||0
10352408|NCT00447083|11491059|FG000|COMPLETED|Phase I|2 participants did not acclimate to phase II|10
10352409|NCT00447083|11491060|FG001|COMPLETED|Phase I|1 participant did not acclimate to phase II|9
10352410|NCT00447083|11491061|FG002|COMPLETED|Phase I||0
10352411|NCT00447083|11491062|FG003|COMPLETED|Phase I||0
10352412|NCT00447083|11491059|FG000|NOT COMPLETED|Phase I||0
10352413|NCT00447083|11491060|FG001|NOT COMPLETED|Phase I||0
10352414|NCT00447083|11491061|FG002|NOT COMPLETED|Phase I||0
10352415|NCT00447083|11491062|FG003|NOT COMPLETED|Phase I||0
10352416|NCT00447083|11491059|FG000|STARTED|Phase II|Participants in this group will then be randomized to a phase 2 group in phase2|0
10352417|NCT00447083|11491060|FG001|STARTED|Phase II|Participants in this group will then be randomized to a phase 2 group in phase2|0
10352418|NCT00447083|11491061|FG002|STARTED|Phase II|Only 8 participants qualified from the end of phase 1|8
10352419|NCT00447083|11491062|FG003|STARTED|Phase II|Only 8 participants qualified from the end of phase 1|8
10352420|NCT00447083|11491059|FG000|COMPLETED|Phase II||0
10352421|NCT00447083|11491060|FG001|COMPLETED|Phase II||0
10352422|NCT00447083|11491061|FG002|COMPLETED|Phase II||7
10352423|NCT00447083|11491062|FG003|COMPLETED|Phase II||7
10352424|NCT00447083|11491059|FG000|NOT COMPLETED|Phase II||0
10352425|NCT00447083|11491060|FG001|NOT COMPLETED|Phase II||0
10352426|NCT00447083|11491061|FG002|NOT COMPLETED|Phase II||1
10352427|NCT00447083|11491062|FG003|NOT COMPLETED|Phase II||1
10352428|NCT00447226|11491070|FG000|STARTED|12-Week Open-label Phase||0
10352429|NCT00447226|11491071|FG001|STARTED|12-Week Open-label Phase||32
10352430|NCT00447226|11491070|FG000|COMPLETED|12-Week Open-label Phase||0
10352431|NCT00447226|11491071|FG001|COMPLETED|12-Week Open-label Phase||7
10352432|NCT00447226|11491070|FG000|NOT COMPLETED|12-Week Open-label Phase||0
10352433|NCT00447226|11491071|FG001|NOT COMPLETED|12-Week Open-label Phase||25
10352434|NCT00447226|11491070|FG000|STARTED|Double-blind Phase||4
10352435|NCT00447226|11491071|FG001|STARTED|Double-blind Phase||3
10352436|NCT00447226|11491070|FG000|COMPLETED|Double-blind Phase||0
10352437|NCT00447226|11491071|FG001|COMPLETED|Double-blind Phase||0
10352438|NCT00447226|11491070|FG000|NOT COMPLETED|Double-blind Phase||4
10352439|NCT00447226|11491071|FG001|NOT COMPLETED|Double-blind Phase||3
10352440|NCT00447265|11491086|FG000|STARTED|Overall Study||1
10352441|NCT00447265|11491087|FG001|STARTED|Overall Study||0
10352442|NCT00447265|11491086|FG000|COMPLETED|Overall Study|The participant completed treatment and discontinued follow-up at week 39 after randomization|0
10352443|NCT00447265|11491087|FG001|COMPLETED|Overall Study||0
10352444|NCT00447265|11491086|FG000|NOT COMPLETED|Overall Study||1
10352445|NCT00447265|11491087|FG001|NOT COMPLETED|Overall Study||0
10352446|NCT00447278|11491093|FG000|STARTED|Period II (6 Month Open-Label)||199
10352447|NCT00447278|11491094|FG001|STARTED|Period II (6 Month Open-Label)||200
10352448|NCT00447278|11491093|FG000|Received at Least One Dose of Study Drug|Period II (6 Month Open-Label)||199
10352449|NCT00447278|11491094|FG001|Received at Least One Dose of Study Drug|Period II (6 Month Open-Label)|1 patient withdrew due to parent/guardian decision prior to receiving study drug.|199
10352450|NCT00447278|11491093|FG000|COMPLETED|Period II (6 Month Open-Label)||157
10352451|NCT00447278|11491094|FG001|COMPLETED|Period II (6 Month Open-Label)||171
10352452|NCT00447278|11491093|FG000|NOT COMPLETED|Period II (6 Month Open-Label)||42
10352453|NCT00447278|11491094|FG001|NOT COMPLETED|Period II (6 Month Open-Label)||29
10352454|NCT00447278|11491093|FG000|STARTED|Period III (Optional 6 Month Extension)|18 choose not to enter this optional period.|139
10352455|NCT00447278|11491094|FG001|STARTED|Period III (Optional 6 Month Extension)|16 choose not to enter this optional period.|155
10352456|NCT00447278|11491093|FG000|COMPLETED|Period III (Optional 6 Month Extension)||109
10352457|NCT00447278|11491094|FG001|COMPLETED|Period III (Optional 6 Month Extension)||140
10352458|NCT00447278|11491093|FG000|NOT COMPLETED|Period III (Optional 6 Month Extension)||30
10352459|NCT00447278|11491094|FG001|NOT COMPLETED|Period III (Optional 6 Month Extension)||15
10352460|NCT00447330|11491101|FG000|STARTED|Overall Study|2 subjects signed the ICF, but were withdrawn from study prior to receiving any study drug|60
10352461|NCT00447330|11491101|FG000|COMPLETED|Overall Study||58
10352462|NCT00447330|11491101|FG000|NOT COMPLETED|Overall Study||2
10352463|NCT00447382|11491108|FG000|STARTED|Overall Study||164
10352464|NCT00447382|11491109|FG001|STARTED|Overall Study||166
10352465|NCT00447382|11491108|FG000|COMPLETED|Overall Study||158
10352466|NCT00447382|11491109|FG001|COMPLETED|Overall Study||160
10352467|NCT00447382|11491108|FG000|NOT COMPLETED|Overall Study||6
10352468|NCT00447382|11491109|FG001|NOT COMPLETED|Overall Study||6
10352469|NCT00447499|11491115|FG000|STARTED|Overall Study||59
10352470|NCT00447499|11491115|FG000|COMPLETED|Overall Study||52
10352471|NCT00447499|11491115|FG000|NOT COMPLETED|Overall Study||7
10352472|NCT00447590|11491121|FG000|STARTED|Overall Study|153 participants were treated with the LAP-BAND System.|153
10352473|NCT00447590|11491121|FG000|COMPLETED|Overall Study|Completing the study was defined as the number of participants in the study at month 60 (5 years).|93
10352474|NCT00447590|11491121|FG000|NOT COMPLETED|Overall Study||60
10352475|NCT00447694|11491125|FG000|STARTED|Overall Study||28
10352476|NCT00447694|11491125|FG000|COMPLETED|Overall Study||22
10352477|NCT00447694|11491125|FG000|NOT COMPLETED|Overall Study||6
10352478|NCT00447772|11491129|FG000|STARTED|Overall Study||516
10352479|NCT00447772|11491129|FG000|COMPLETED|Overall Study||489
10352480|NCT00447772|11491129|FG000|NOT COMPLETED|Overall Study||27
10352481|NCT00447876|11491138|FG000|STARTED|Overall Study||20
10352482|NCT00447876|11491139|FG001|STARTED|Overall Study||20
10352483|NCT00447876|11491138|FG000|COMPLETED|Overall Study||17
10352484|NCT00447876|11491139|FG001|COMPLETED|Overall Study||16
10352485|NCT00447876|11491138|FG000|NOT COMPLETED|Overall Study||3
10352486|NCT00447876|11491139|FG001|NOT COMPLETED|Overall Study||4
10352487|NCT00447902|11491147|FG000|STARTED|Overall Study||5
10352488|NCT00447902|11491148|FG001|STARTED|Overall Study||6
10352489|NCT00447902|11491147|FG000|COMPLETED|Overall Study||1
10352490|NCT00447902|11491148|FG001|COMPLETED|Overall Study||0
10352491|NCT00447902|11491147|FG000|NOT COMPLETED|Overall Study||4
10352492|NCT00447902|11491148|FG001|NOT COMPLETED|Overall Study||6
10352493|NCT00448019|11491154|FG000|STARTED|Overall Study||64
10352494|NCT00448019|11491154|FG000|COMPLETED|Overall Study||57
10352495|NCT00448019|11491154|FG000|NOT COMPLETED|Overall Study||7
10352496|NCT00448123|11491160|FG000|STARTED|Overall Study||62
10352497|NCT00448123|11491161|FG001|STARTED|Overall Study||65
10352498|NCT00448123|11491160|FG000|COMPLETED|Overall Study||47
10352499|NCT00448123|11491161|FG001|COMPLETED|Overall Study||53
10352500|NCT00448123|11491160|FG000|NOT COMPLETED|Overall Study||15
10352501|NCT00448123|11491161|FG001|NOT COMPLETED|Overall Study||12
10352502|NCT00448136|11491172|FG000|STARTED|Overall Study||34
10352503|NCT00448136|11491173|FG001|STARTED|Overall Study||49
10352504|NCT00448136|11491172|FG000|COMPLETED|Overall Study||30
10352505|NCT00448136|11491173|FG001|COMPLETED|Overall Study||41
10352506|NCT00448136|11491172|FG000|NOT COMPLETED|Overall Study||4
10352507|NCT00448136|11491173|FG001|NOT COMPLETED|Overall Study||8
10352508|NCT00448175|11491181|FG000|STARTED|12 Weeks PTNS vs. Drug||50
10352509|NCT00448175|11491182|FG001|STARTED|12 Weeks PTNS vs. Drug||50
10352510|NCT00448175|11491181|FG000|COMPLETED|12 Weeks PTNS vs. Drug||41
10352511|NCT00448175|11491182|FG001|COMPLETED|12 Weeks PTNS vs. Drug||43
10352512|NCT00448175|11491181|FG000|NOT COMPLETED|12 Weeks PTNS vs. Drug||9
10352513|NCT00448175|11491182|FG001|NOT COMPLETED|12 Weeks PTNS vs. Drug||7
10352514|NCT00448175|11491181|FG000|STARTED|Continued PTNS Through 12 Months||35
10352515|NCT00448175|11491182|FG001|STARTED|Continued PTNS Through 12 Months||0
10352516|NCT00448175|11491181|FG000|COMPLETED|Continued PTNS Through 12 Months||25
10352517|NCT00448175|11491182|FG001|COMPLETED|Continued PTNS Through 12 Months||0
10352518|NCT00448175|11491181|FG000|NOT COMPLETED|Continued PTNS Through 12 Months||10
10352519|NCT00448175|11491182|FG001|NOT COMPLETED|Continued PTNS Through 12 Months||0
10352520|NCT00448201|11491188|FG000|STARTED|Overall Study||71
10352521|NCT00448201|11491188|FG000|COMPLETED|Overall Study||71
10352522|NCT00448201|11491188|FG000|NOT COMPLETED|Overall Study||0
10352523|NCT00448227|11491194|FG000|STARTED|Overall Study||18
10352524|NCT00448227|11491194|FG000|COMPLETED|Overall Study||18
10352525|NCT00448227|11491194|FG000|NOT COMPLETED|Overall Study||0
10352526|NCT00448279|11491203|FG000|STARTED|Overall Study||29
10352527|NCT00448279|11491204|FG001|STARTED|Overall Study||29
10352528|NCT00448279|11491203|FG000|COMPLETED|Overall Study||0
10352529|NCT00448279|11491204|FG001|COMPLETED|Overall Study||0
10352530|NCT00448279|11491203|FG000|NOT COMPLETED|Overall Study||29
10352531|NCT00448279|11491204|FG001|NOT COMPLETED|Overall Study||29
10533347|NCT01425281|11685632|FG000|COMPLETED|At 2-year Clinical Follow-up||323
10655963|NCT02213055|11816803|FG001|COMPLETED|Overall Study||0
10655964|NCT02213055|11816802|FG000|NOT COMPLETED|Overall Study||39
10655965|NCT02213055|11816803|FG001|NOT COMPLETED|Overall Study||0
10352532|NCT00448344|11491212|FG000|STARTED|Overall Study||235
10352533|NCT00448344|11491213|FG001|STARTED|Overall Study||236
10352534|NCT00448344|11491212|FG000|COMPLETED|Overall Study||205
10352535|NCT00448344|11491213|FG001|COMPLETED|Overall Study||200
10352536|NCT00448344|11491212|FG000|NOT COMPLETED|Overall Study||30
10352537|NCT00448344|11491213|FG001|NOT COMPLETED|Overall Study||36
10352538|NCT00448357|11491219|FG000|STARTED|Overall Study||54
10352539|NCT00448357|11491219|FG000|COMPLETED|Overall Study||54
10352540|NCT00448357|11491219|FG000|NOT COMPLETED|Overall Study||0
10352541|NCT00448435|11491235|FG000|STARTED|Treatment Period I - 4 Weeks||26
10352542|NCT00448435|11491236|FG001|STARTED|Treatment Period I - 4 Weeks||25
10352543|NCT00448435|11491235|FG000|COMPLETED|Treatment Period I - 4 Weeks||26
10352544|NCT00448435|11491236|FG001|COMPLETED|Treatment Period I - 4 Weeks||25
10352545|NCT00448435|11491235|FG000|NOT COMPLETED|Treatment Period I - 4 Weeks||0
10352546|NCT00448435|11491236|FG001|NOT COMPLETED|Treatment Period I - 4 Weeks||0
10352547|NCT00448435|11491235|FG000|STARTED|Washout Period - 2 Weeks||26
10352548|NCT00448435|11491236|FG001|STARTED|Washout Period - 2 Weeks||25
10352549|NCT00448435|11491235|FG000|COMPLETED|Washout Period - 2 Weeks||25
10352550|NCT00448435|11491236|FG001|COMPLETED|Washout Period - 2 Weeks||25
10352551|NCT00448435|11491235|FG000|NOT COMPLETED|Washout Period - 2 Weeks||1
10352552|NCT00448435|11491236|FG001|NOT COMPLETED|Washout Period - 2 Weeks||0
10352553|NCT00448435|11491235|FG000|STARTED|Treatment Period II - 4 Weeks||25
10352554|NCT00448435|11491236|FG001|STARTED|Treatment Period II - 4 Weeks||25
10352555|NCT00448435|11491235|FG000|COMPLETED|Treatment Period II - 4 Weeks||25
10352556|NCT00448435|11491236|FG001|COMPLETED|Treatment Period II - 4 Weeks||25
10352557|NCT00448435|11491235|FG000|NOT COMPLETED|Treatment Period II - 4 Weeks||0
10352558|NCT00448435|11491236|FG001|NOT COMPLETED|Treatment Period II - 4 Weeks||0
10352559|NCT00448435|11491235|FG000|STARTED|Extension Period - 20 Weeks||50
10352560|NCT00448435|11491236|FG001|STARTED|Extension Period - 20 Weeks||0
10352561|NCT00448435|11491235|FG000|COMPLETED|Extension Period - 20 Weeks||50
10352562|NCT00448435|11491236|FG001|COMPLETED|Extension Period - 20 Weeks||0
10352563|NCT00448435|11491235|FG000|NOT COMPLETED|Extension Period - 20 Weeks||0
10352564|NCT00448435|11491236|FG001|NOT COMPLETED|Extension Period - 20 Weeks||0
10352565|NCT00448448|11491247|FG000|STARTED|Overall Study||246
10352566|NCT00448448|11491248|FG001|STARTED|Overall Study||137
10352567|NCT00448448|11491247|FG000|COMPLETED|Overall Study||146
10352568|NCT00448448|11491248|FG001|COMPLETED|Overall Study||96
10352569|NCT00448448|11491247|FG000|NOT COMPLETED|Overall Study||100
10352570|NCT00448448|11491248|FG001|NOT COMPLETED|Overall Study||41
10352571|NCT00448539|11491256|FG000|STARTED|Overall Study||134
10352572|NCT00448539|11491257|FG001|STARTED|Overall Study||152
10812478|NCT03605303|11974549|FG000|COMPLETED|Period 1||0
10812479|NCT03605303|11974550|FG001|COMPLETED|Period 1||0
10812480|NCT03605303|11974549|FG000|NOT COMPLETED|Period 1||2
10812481|NCT03605303|11974550|FG001|NOT COMPLETED|Period 1||1
10812482|NCT03605303|11974549|FG000|STARTED|Period 2||0
10305711|NCT00095121|11438675|FG001|COMPLETED|Open-Label (Study Weeks 49 Through 240)|Completed the 240-week study period either on or off treatment at Week 240.|35
10305712|NCT00095121|11438674|FG000|NOT COMPLETED|Open-Label (Study Weeks 49 Through 240)||62
10305713|NCT00095121|11438675|FG001|NOT COMPLETED|Open-Label (Study Weeks 49 Through 240)||19
10305714|NCT00095147|11438694|FG000|STARTED|Double-blind Period 1 (Days 1-197)||156
10305715|NCT00095147|11438695|FG001|STARTED|Double-blind Period 1 (Days 1-197)||165
10305716|NCT00095147|11438696|FG002|STARTED|Double-blind Period 1 (Days 1-197)||110
10305717|NCT00095147|11438697|FG003|STARTED|Double-blind Period 1 (Days 1-197)||0
10305718|NCT00095147|11438698|FG004|STARTED|Double-blind Period 1 (Days 1-197)||0
10305719|NCT00095147|11438694|FG000|COMPLETED|Double-blind Period 1 (Days 1-197)||147
10305720|NCT00095147|11438695|FG001|COMPLETED|Double-blind Period 1 (Days 1-197)||152
10305721|NCT00095147|11438696|FG002|COMPLETED|Double-blind Period 1 (Days 1-197)||107
10305722|NCT00095147|11438697|FG003|COMPLETED|Double-blind Period 1 (Days 1-197)||0
10305723|NCT00095147|11438698|FG004|COMPLETED|Double-blind Period 1 (Days 1-197)||0
10305724|NCT00095147|11438694|FG000|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||9
10305725|NCT00095147|11438695|FG001|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||13
10305726|NCT00095147|11438696|FG002|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||3
10305727|NCT00095147|11438697|FG003|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||0
10305728|NCT00095147|11438698|FG004|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||0
10305729|NCT00095147|11438694|FG000|STARTED|Double-blind Period 2 (Days 198-365)||147
10812483|NCT03605303|11974550|FG001|STARTED|Period 2||0
10352573|NCT00448539|11491256|FG000|COMPLETED|Overall Study||0
10352574|NCT00448539|11491257|FG001|COMPLETED|Overall Study||0
10352575|NCT00448539|11491256|FG000|NOT COMPLETED|Overall Study||134
10352576|NCT00448539|11491257|FG001|NOT COMPLETED|Overall Study||152
10352577|NCT00448591|11491263|FG000|STARTED|Overall Study||2296
10352578|NCT00448591|11491263|FG000|COMPLETED|Overall Study||0
10812484|NCT03605303|11974549|FG000|COMPLETED|Period 2||0
10812485|NCT03605303|11974550|FG001|COMPLETED|Period 2||0
10352579|NCT00448591|11491263|FG000|NOT COMPLETED|Overall Study||2296
10352580|NCT00448669|11491271|FG000|STARTED|Overall Study||611
10352581|NCT00448669|11491272|FG001|STARTED|Overall Study||608
10352582|NCT00448669|11491271|FG000|COMPLETED|Overall Study||393
10352583|NCT00448669|11491272|FG001|COMPLETED|Overall Study||410
10352584|NCT00448669|11491271|FG000|NOT COMPLETED|Overall Study||218
10352585|NCT00448669|11491272|FG001|NOT COMPLETED|Overall Study||198
10352586|NCT00448708|11491282|FG000|STARTED|Overall Study||112
10352587|NCT00448708|11491283|FG001|STARTED|Overall Study||110
10352588|NCT00448708|11491282|FG000|COMPLETED|Overall Study||77
10352589|NCT00448708|11491283|FG001|COMPLETED|Overall Study||79
10352590|NCT00448708|11491282|FG000|NOT COMPLETED|Overall Study||35
10352591|NCT00448708|11491283|FG001|NOT COMPLETED|Overall Study||31
10352592|NCT00448747|11491291|FG000|STARTED|Overall Study||53
10352593|NCT00448747|11491292|FG001|STARTED|Overall Study||48
10352594|NCT00448747|11491291|FG000|Received First Drug Administration|Overall Study||53
10352595|NCT00448747|11491292|FG001|Received First Drug Administration|Overall Study||48
10352596|NCT00448747|11491291|FG000|Received Second Drug Administration|Overall Study||42
10352597|NCT00448747|11491292|FG001|Received Second Drug Administration|Overall Study||10
10352598|NCT00448747|11491291|FG000|Received AEZS-130|Overall Study||52
10352599|NCT00448747|11491292|FG001|Received AEZS-130|Overall Study||48
10352600|NCT00448747|11491291|FG000|Received L-ARG-GHRH|Overall Study||43
10352601|NCT00448747|11491292|FG001|Received L-ARG-GHRH|Overall Study||10
10352602|NCT00448747|11491291|FG000|Received L-ARG-GHRH and AEZS-130|Overall Study||42
10352603|NCT00448747|11491292|FG001|Received L-ARG-GHRH and AEZS-130|Overall Study||10
10352604|NCT00448747|11491291|FG000|Per Protocol Population (PPS)|Overall Study||50
10352605|NCT00448747|11491292|FG001|Per Protocol Population (PPS)|Overall Study||48
10352606|NCT00448747|11491291|FG000|COMPLETED|Overall Study||52
10352607|NCT00448747|11491292|FG001|COMPLETED|Overall Study||48
10352608|NCT00448747|11491291|FG000|NOT COMPLETED|Overall Study||1
10352609|NCT00448747|11491292|FG001|NOT COMPLETED|Overall Study||0
10352610|NCT00448760|11491308|FG000|STARTED|Overall Study||29
10352611|NCT00448760|11491308|FG000|COMPLETED|Overall Study||26
10352612|NCT00448760|11491308|FG000|NOT COMPLETED|Overall Study||3
10352613|NCT00448812|11491314|FG000|STARTED|Year 1||45
10352614|NCT00448812|11491315|FG001|STARTED|Year 1||24
10352615|NCT00448812|11491314|FG000|COMPLETED|Year 1||45
10352616|NCT00448812|11491315|FG001|COMPLETED|Year 1||24
10352617|NCT00448812|11491314|FG000|NOT COMPLETED|Year 1||0
10352618|NCT00448812|11491315|FG001|NOT COMPLETED|Year 1||0
10352619|NCT00448812|11491314|FG000|STARTED|Year 2||45
10352620|NCT00448812|11491315|FG001|STARTED|Year 2||24
10352621|NCT00448812|11491314|FG000|COMPLETED|Year 2||41
10352622|NCT00448812|11491315|FG001|COMPLETED|Year 2||23
10352623|NCT00448812|11491314|FG000|NOT COMPLETED|Year 2||4
10352624|NCT00448812|11491315|FG001|NOT COMPLETED|Year 2||1
10352625|NCT00448812|11491314|FG000|STARTED|Year 3||45
10352626|NCT00448812|11491315|FG001|STARTED|Year 3||24
10352627|NCT00448812|11491314|FG000|COMPLETED|Year 3||41
10352628|NCT00448812|11491315|FG001|COMPLETED|Year 3||21
10352629|NCT00448812|11491314|FG000|NOT COMPLETED|Year 3||4
10352630|NCT00448812|11491315|FG001|NOT COMPLETED|Year 3||3
10352631|NCT00448812|11491314|FG000|STARTED|Year 4||43
10352632|NCT00448812|11491315|FG001|STARTED|Year 4|Control group subjects exited from study after completing Year 3 evaluation.|0
10352633|NCT00448812|11491314|FG000|COMPLETED|Year 4||43
10352634|NCT00448812|11491315|FG001|COMPLETED|Year 4|Control group subjects exited from study after completing Year 3 evaluation.|0
10352635|NCT00448812|11491314|FG000|NOT COMPLETED|Year 4||0
10352636|NCT00448812|11491315|FG001|NOT COMPLETED|Year 4||0
10352637|NCT00448812|11491314|FG000|STARTED|Year 5||43
10352638|NCT00448812|11491315|FG001|STARTED|Year 5|Control group subjects exited from study after completing Year 3 evaluation.|0
10352639|NCT00448812|11491314|FG000|COMPLETED|Year 5||42
10352640|NCT00448812|11491315|FG001|COMPLETED|Year 5|Control group subjects exited from study after completing Year 3 evaluation.|0
10352641|NCT00448812|11491314|FG000|NOT COMPLETED|Year 5||1
10352642|NCT00448812|11491315|FG001|NOT COMPLETED|Year 5||0
10352643|NCT00448864|11491336|FG000|STARTED|Overall Study||27
10352644|NCT00448864|11491337|FG001|STARTED|Overall Study||29
10352645|NCT00448864|11491338|FG002|STARTED|Overall Study||19
10352646|NCT00448864|11491336|FG000|Received at Least 1 Dose of Study Drug|Overall Study||26
10352647|NCT00448864|11491337|FG001|Received at Least 1 Dose of Study Drug|Overall Study||25
10352648|NCT00448864|11491338|FG002|Received at Least 1 Dose of Study Drug|Overall Study||18
10352649|NCT00448864|11491336|FG000|Started Post-operative Period|Overall Study||26
10352650|NCT00448864|11491337|FG001|Started Post-operative Period|Overall Study||25
10352651|NCT00448864|11491338|FG002|Started Post-operative Period|Overall Study||18
10352652|NCT00448864|11491336|FG000|Completed Post-operative Period|Overall Study||26
10352653|NCT00448864|11491337|FG001|Completed Post-operative Period|Overall Study||25
10352654|NCT00448864|11491338|FG002|Completed Post-operative Period|Overall Study||18
10352655|NCT00448864|11491336|FG000|COMPLETED|Overall Study||22
10352656|NCT00448864|11491337|FG001|COMPLETED|Overall Study||24
10352657|NCT00448864|11491338|FG002|COMPLETED|Overall Study||18
10352658|NCT00448864|11491336|FG000|NOT COMPLETED|Overall Study||5
10352659|NCT00448864|11491337|FG001|NOT COMPLETED|Overall Study||5
10352660|NCT00448864|11491338|FG002|NOT COMPLETED|Overall Study||1
10352661|NCT00448916|11491352|FG000|STARTED|Overall Study||16
10352662|NCT00448916|11491353|FG001|STARTED|Overall Study||15
10352663|NCT00448916|11491354|FG002|STARTED|Overall Study||12
10352664|NCT00448916|11491355|FG003|STARTED|Overall Study||11
10352665|NCT00448916|11491352|FG000|COMPLETED|Overall Study||9
10352666|NCT00448916|11491353|FG001|COMPLETED|Overall Study||9
10533348|NCT01425281|11685633|FG001|COMPLETED|At 2-year Clinical Follow-up||163
10533349|NCT01425281|11685632|FG000|NOT COMPLETED|At 2-year Clinical Follow-up||6
10533350|NCT01425281|11685633|FG001|NOT COMPLETED|At 2-year Clinical Follow-up||1
10533351|NCT01425281|11685632|FG000|STARTED|At 3-year Clinical Follow-up||323
10533352|NCT01425281|11685633|FG001|STARTED|At 3-year Clinical Follow-up||163
10533353|NCT01425281|11685632|FG000|COMPLETED|At 3-year Clinical Follow-up||318
10352667|NCT00448916|11491354|FG002|COMPLETED|Overall Study||6
10352668|NCT00448916|11491355|FG003|COMPLETED|Overall Study||5
10352669|NCT00448916|11491352|FG000|NOT COMPLETED|Overall Study||7
10352670|NCT00448916|11491353|FG001|NOT COMPLETED|Overall Study||6
10352671|NCT00448916|11491354|FG002|NOT COMPLETED|Overall Study||6
10352672|NCT00448916|11491355|FG003|NOT COMPLETED|Overall Study||6
10352673|NCT00449007|11491369|FG000|STARTED|Overall Study||2
10352674|NCT00449007|11491370|FG001|STARTED|Overall Study||3
10352675|NCT00449007|11491369|FG000|COMPLETED|Overall Study||2
10352676|NCT00449007|11491370|FG001|COMPLETED|Overall Study||3
10352677|NCT00449007|11491369|FG000|NOT COMPLETED|Overall Study||0
10352678|NCT00449007|11491370|FG001|NOT COMPLETED|Overall Study||0
10352679|NCT00449033|11491380|FG000|STARTED|Treatment Period||452
10352680|NCT00449033|11491381|FG001|STARTED|Treatment Period|Reasons for not treated: Adverse event (N=1); Consent withdrawn (N=1); Reason missing (N=1)|452
10352681|NCT00449033|11491380|FG000|Received Treatment|Treatment Period||452
10352682|NCT00449033|11491381|FG001|Received Treatment|Treatment Period||449
10352683|NCT00449033|11491380|FG000|COMPLETED|Treatment Period||0
10352684|NCT00449033|11491381|FG001|COMPLETED|Treatment Period||0
10352685|NCT00449033|11491380|FG000|NOT COMPLETED|Treatment Period||452
10352686|NCT00449033|11491381|FG001|NOT COMPLETED|Treatment Period||452
10352687|NCT00449033|11491380|FG000|STARTED|Follow-up Period|425 entered, comprising 452 randomized less 21 deaths & 6 ongoing on treatment|425
10352688|NCT00449033|11491381|FG001|STARTED|Follow-up Period|434 entered, comprising 452 randomized less 12 deaths, 2 lost to follow-up & 4 ongoing on treatment|434
10352689|NCT00449033|11491380|FG000|COMPLETED|Follow-up Period||0
10352690|NCT00449033|11491381|FG001|COMPLETED|Follow-up Period||0
10352691|NCT00449033|11491380|FG000|NOT COMPLETED|Follow-up Period||425
10352692|NCT00449033|11491381|FG001|NOT COMPLETED|Follow-up Period||434
10352693|NCT00449046|11491387|FG000|STARTED|Overall Study||40
10352694|NCT00449046|11491387|FG000|COMPLETED|Overall Study||40
10352695|NCT00449046|11491387|FG000|NOT COMPLETED|Overall Study||0
10352696|NCT00449072|11491393|FG000|STARTED|Overall Study||148
10352697|NCT00449072|11491394|FG001|STARTED|Overall Study||151
10352698|NCT00449072|11491393|FG000|COMPLETED|Overall Study||107
10352699|NCT00449072|11491394|FG001|COMPLETED|Overall Study||109
10352700|NCT00449072|11491393|FG000|NOT COMPLETED|Overall Study||41
10352701|NCT00449072|11491394|FG001|NOT COMPLETED|Overall Study||42
10352702|NCT00449150|11491403|FG000|STARTED|Overall Study||219
10352703|NCT00449150|11491404|FG001|STARTED|Overall Study||230
10352704|NCT00449150|11491405|FG002|STARTED|Overall Study||218
10352705|NCT00449150|11491403|FG000|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|173
10352706|NCT00449150|11491404|FG001|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|177
10352707|NCT00449150|11491405|FG002|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|171
10352708|NCT00449150|11491403|FG000|NOT COMPLETED|Overall Study||46
10352709|NCT00449150|11491404|FG001|NOT COMPLETED|Overall Study||53
10352710|NCT00449150|11491405|FG002|NOT COMPLETED|Overall Study||47
10352711|NCT00449163|11491416|FG000|STARTED|Overall Study||25
10352712|NCT00449163|11491416|FG000|COMPLETED|Overall Study||22
10352713|NCT00449163|11491416|FG000|NOT COMPLETED|Overall Study||3
10352714|NCT00449176|11491423|FG000|STARTED|Overall Study|3 randomly assigned to this treatment group did not take drug (of 321 subjects initially randomized)|318
10352715|NCT00449176|11491424|FG001|STARTED|Overall Study|6 randomly assigned to this treatment group did not take drug (of 334 subjects initially randomized)|328
10352716|NCT00449176|11491425|FG002|STARTED|Overall Study|5 randomly assigned to this group did not receive drug, 2 enrolled twice(of 326 subjects randomized)|319
10352717|NCT00449176|11491423|FG000|COMPLETED|Overall Study||166
10352718|NCT00449176|11491424|FG001|COMPLETED|Overall Study||133
10352719|NCT00449176|11491425|FG002|COMPLETED|Overall Study||152
10352720|NCT00449176|11491423|FG000|NOT COMPLETED|Overall Study||152
10352721|NCT00449176|11491424|FG001|NOT COMPLETED|Overall Study||195
10352722|NCT00449176|11491425|FG002|NOT COMPLETED|Overall Study||167
10352723|NCT00449540|11491435|FG000|STARTED|Pretreatment Phase||267
10352724|NCT00449540|11491436|FG001|STARTED|Pretreatment Phase||0
10352725|NCT00449540|11491437|FG002|STARTED|Pretreatment Phase||0
10352726|NCT00449540|11491435|FG000|COMPLETED|Pretreatment Phase||201
10352727|NCT00449540|11491436|FG001|COMPLETED|Pretreatment Phase||0
10352728|NCT00449540|11491437|FG002|COMPLETED|Pretreatment Phase||0
10352729|NCT00449540|11491435|FG000|NOT COMPLETED|Pretreatment Phase||66
10352730|NCT00449540|11491436|FG001|NOT COMPLETED|Pretreatment Phase||0
10352731|NCT00449540|11491437|FG002|NOT COMPLETED|Pretreatment Phase||0
10352732|NCT00449540|11491435|FG000|STARTED|Treatment Phase||0
10352733|NCT00449540|11491436|FG001|STARTED|Treatment Phase||102
10352734|NCT00449540|11491437|FG002|STARTED|Treatment Phase||99
10352735|NCT00449540|11491435|FG000|COMPLETED|Treatment Phase||0
10352736|NCT00449540|11491436|FG001|COMPLETED|Treatment Phase||82
10352737|NCT00449540|11491437|FG002|COMPLETED|Treatment Phase||82
10352738|NCT00449540|11491435|FG000|NOT COMPLETED|Treatment Phase||0
10352739|NCT00449540|11491436|FG001|NOT COMPLETED|Treatment Phase||20
10352740|NCT00449540|11491437|FG002|NOT COMPLETED|Treatment Phase||17
10352741|NCT00449644|11491449|FG000|STARTED|Overall Study||23
10352742|NCT00449644|11491450|FG001|STARTED|Overall Study||24
10352743|NCT00449644|11491451|FG002|STARTED|Overall Study||79
10352744|NCT00449644|11491452|FG003|STARTED|Overall Study||81
10352745|NCT00449644|11491449|FG000|Rollover|Overall Study||0
10352746|NCT00449644|11491450|FG001|Rollover|Overall Study||0
10352747|NCT00449644|11491451|FG002|Rollover|Overall Study||0
10352748|NCT00449644|11491452|FG003|Rollover|Overall Study||1
10352749|NCT00449644|11491449|FG000|COMPLETED|Overall Study||13
10352750|NCT00449644|11491450|FG001|COMPLETED|Overall Study||11
10352751|NCT00449644|11491451|FG002|COMPLETED|Overall Study||50
10352752|NCT00449644|11491452|FG003|COMPLETED|Overall Study|After Week 24, 1 patient rolled over to treatment with TMC207 and was not completed or discontinued.|49
10352753|NCT00449644|11491449|FG000|NOT COMPLETED|Overall Study||10
10352754|NCT00449644|11491450|FG001|NOT COMPLETED|Overall Study||13
10352755|NCT00449644|11491451|FG002|NOT COMPLETED|Overall Study||29
10352756|NCT00449644|11491452|FG003|NOT COMPLETED|Overall Study||32
10716003|NCT02688387|11880054|FG011|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10716004|NCT02688387|11880055|FG012|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10352757|NCT00449670|11491467|FG000|STARTED|Primary Phase (Study no.109630)||961
10352758|NCT00449670|11491468|FG001|STARTED|Primary Phase (Study no.109630)||245
10352759|NCT00449670|11491467|FG000|COMPLETED|Primary Phase (Study no.109630)||947
10352760|NCT00449670|11491468|FG001|COMPLETED|Primary Phase (Study no.109630)||243
10352761|NCT00449670|11491467|FG000|NOT COMPLETED|Primary Phase (Study no.109630)||14
10352762|NCT00449670|11491468|FG001|NOT COMPLETED|Primary Phase (Study no.109630)||2
10352763|NCT00449670|11491467|FG000|STARTED|Booster Phase (Study no.109873)||265
10352764|NCT00449670|11491468|FG001|STARTED|Booster Phase (Study no.109873)||236
10352765|NCT00449670|11491467|FG000|COMPLETED|Booster Phase (Study no.109873)||265
10352766|NCT00449670|11491468|FG001|COMPLETED|Booster Phase (Study no.109873)||233
10352767|NCT00449670|11491467|FG000|NOT COMPLETED|Booster Phase (Study no.109873)||0
10352768|NCT00449670|11491468|FG001|NOT COMPLETED|Booster Phase (Study no.109873)||3
10352769|NCT00449696|11491483|FG000|STARTED|Overall Study||251
10352770|NCT00449696|11491484|FG001|STARTED|Overall Study||128
10352771|NCT00449696|11491483|FG000|Received Injection|Overall Study||249
10716005|NCT02688387|11880056|FG013|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10716006|NCT02688387|11880057|FG014|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10352772|NCT00449696|11491484|FG001|Received Injection|Overall Study||128
10352773|NCT00449696|11491483|FG000|Analyzed Participants|Overall Study|2 subjects removed from ITT analyses because of no post treatment data (pre-defined criteria).|247
10716007|NCT02688387|11880058|FG015|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10352774|NCT00449696|11491484|FG001|Analyzed Participants|Overall Study||128
10352775|NCT00449696|11491483|FG000|COMPLETED|Overall Study||231
10352776|NCT00449696|11491484|FG001|COMPLETED|Overall Study||119
10352777|NCT00449696|11491483|FG000|NOT COMPLETED|Overall Study||20
10352778|NCT00449696|11491484|FG001|NOT COMPLETED|Overall Study||9
10352779|NCT00449748|11491490|FG000|STARTED|Overall Study||10
10352780|NCT00449748|11491490|FG000|COMPLETED|Overall Study||10
10352781|NCT00449748|11491490|FG000|NOT COMPLETED|Overall Study||0
10352782|NCT00449761|11491494|FG000|STARTED|Overall Study||27
10352783|NCT00449761|11491494|FG000|COMPLETED|Overall Study||9
10352784|NCT00449761|11491494|FG000|NOT COMPLETED|Overall Study||18
10352785|NCT00449787|11491501|FG000|STARTED|Overall Study||203
10352786|NCT00449787|11491502|FG001|STARTED|Overall Study||198
10352787|NCT00449787|11491501|FG000|COMPLETED|Overall Study||98
10352788|NCT00449787|11491502|FG001|COMPLETED|Overall Study||98
10352789|NCT00449787|11491501|FG000|NOT COMPLETED|Overall Study||105
10352790|NCT00449787|11491502|FG001|NOT COMPLETED|Overall Study||100
10352791|NCT00449865|11491512|FG000|STARTED|Overall Study||867
10716008|NCT02688387|11880059|FG016|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10716009|NCT02688387|11880060|FG017|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10716010|NCT02688387|11880061|FG018|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
10716011|NCT02688387|11880062|FG019|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
10305730|NCT00095147|11438695|FG001|STARTED|Double-blind Period 2 (Days 198-365)||152
10305731|NCT00095147|11438696|FG002|STARTED|Double-blind Period 2 (Days 198-365)||0
10305732|NCT00095147|11438697|FG003|STARTED|Double-blind Period 2 (Days 198-365)||107
10305733|NCT00095147|11438698|FG004|STARTED|Double-blind Period 2 (Days 198-365)||0
10305734|NCT00095147|11438694|FG000|COMPLETED|Double-blind Period 2 (Days 198-365)||139
10305735|NCT00095147|11438695|FG001|COMPLETED|Double-blind Period 2 (Days 198-365)||141
10305736|NCT00095147|11438696|FG002|COMPLETED|Double-blind Period 2 (Days 198-365)||0
10305737|NCT00095147|11438697|FG003|COMPLETED|Double-blind Period 2 (Days 198-365)||104
10352792|NCT00449865|11491513|FG001|STARTED|Overall Study||874
10352793|NCT00449865|11491512|FG000|Completed Year 1|Overall Study|867 Expected at Year 1|802
10352794|NCT00449865|11491513|FG001|Completed Year 1|Overall Study|874 Expected at Year 1|822
10352795|NCT00449865|11491512|FG000|Completed Year 2|Overall Study|867 Expected at Year 2|768
10352796|NCT00449865|11491513|FG001|Completed Year 2|Overall Study|874 Expected at Year 2|766
10426868|NCT00849680|11572588|FG001|STARTED|Overall Study||13
10777240|NCT03338062|11939178|FG000|COMPLETED|Overall Study||9
10352797|NCT00449865|11491512|FG000|Completed Year 3|Overall Study|867 Expected at Year 3|719
10352798|NCT00449865|11491513|FG001|Completed Year 3|Overall Study|874 Expected at Year 3|715
10352799|NCT00449865|11491512|FG000|Completed Year 4|Overall Study|679 Expected at Year 4|521
10352800|NCT00449865|11491513|FG001|Completed Year 4|Overall Study|686 Expected at Year 4|523
10352801|NCT00449865|11491512|FG000|COMPLETED|Overall Study|478 Expected at Year 5|345
10352802|NCT00449865|11491513|FG001|COMPLETED|Overall Study|477 Expected at Year 5|340
10352803|NCT00449865|11491512|FG000|NOT COMPLETED|Overall Study||522
10352804|NCT00449865|11491513|FG001|NOT COMPLETED|Overall Study||534
10352805|NCT00449930|11491521|FG000|STARTED|Overall Study||528
10352806|NCT00449930|11491522|FG001|STARTED|Overall Study||522
10352807|NCT00449930|11491521|FG000|COMPLETED|Overall Study||467
10352808|NCT00449930|11491522|FG001|COMPLETED|Overall Study||447
10352809|NCT00449930|11491521|FG000|NOT COMPLETED|Overall Study||61
10352810|NCT00449930|11491522|FG001|NOT COMPLETED|Overall Study||75
10352811|NCT00449956|11491531|FG000|STARTED|Overall Study||189
10533354|NCT01425281|11685633|FG001|COMPLETED|At 3-year Clinical Follow-up||157
10533355|NCT01425281|11685632|FG000|NOT COMPLETED|At 3-year Clinical Follow-up||5
10533356|NCT01425281|11685633|FG001|NOT COMPLETED|At 3-year Clinical Follow-up||6
10533357|NCT01425281|11685632|FG000|STARTED|At 4-year Clinical Follow-up||318
10533358|NCT01425281|11685633|FG001|STARTED|At 4-year Clinical Follow-up||157
10655975|NCT02213094|11816824|FG000|STARTED|Overall Study||5
10352812|NCT00449956|11491532|FG001|STARTED|Overall Study||92
10352813|NCT00449956|11491533|FG002|STARTED|Overall Study||193
10533359|NCT01425281|11685632|FG000|COMPLETED|At 4-year Clinical Follow-up||288
10533360|NCT01425281|11685633|FG001|COMPLETED|At 4-year Clinical Follow-up||136
10533361|NCT01425281|11685632|FG000|NOT COMPLETED|At 4-year Clinical Follow-up||30
10533362|NCT01425281|11685633|FG001|NOT COMPLETED|At 4-year Clinical Follow-up||21
10533363|NCT01425281|11685632|FG000|STARTED|At 5-year Clinical Follow-up||288
10655976|NCT02213094|11816825|FG001|STARTED|Overall Study||5
10655977|NCT02213094|11816824|FG000|COMPLETED|Overall Study|One subject stopped study agent early because of elevation in LFTs > 3x ULN|4
10655978|NCT02213094|11816825|FG001|COMPLETED|Overall Study||5
10352814|NCT00449956|11491531|FG000|COMPLETED|Overall Study||179
10352815|NCT00449956|11491532|FG001|COMPLETED|Overall Study||88
10352816|NCT00449956|11491533|FG002|COMPLETED|Overall Study||184
10352817|NCT00449956|11491531|FG000|NOT COMPLETED|Overall Study||10
10352818|NCT00449956|11491532|FG001|NOT COMPLETED|Overall Study||4
10352819|NCT00449956|11491533|FG002|NOT COMPLETED|Overall Study||9
10352820|NCT00450073|11491544|FG000|STARTED|Overall Study||10
10352821|NCT00450073|11491545|FG001|STARTED|Overall Study||10
10352822|NCT00450073|11491546|FG002|STARTED|Overall Study||10
10352823|NCT00450073|11491544|FG000|COMPLETED|Overall Study||9
10352824|NCT00450073|11491545|FG001|COMPLETED|Overall Study||10
10352825|NCT00450073|11491546|FG002|COMPLETED|Overall Study||9
10352826|NCT00450073|11491544|FG000|NOT COMPLETED|Overall Study||1
10352827|NCT00450073|11491545|FG001|NOT COMPLETED|Overall Study||0
10352828|NCT00450073|11491546|FG002|NOT COMPLETED|Overall Study||1
10352829|NCT00450112|11491556|FG000|STARTED|Overall Study||125
10352830|NCT00450112|11491557|FG001|STARTED|Overall Study||77
10352831|NCT00450112|11491556|FG000|Received Injection|Overall Study||125
10352832|NCT00450112|11491557|FG001|Received Injection|Overall Study||74
10352833|NCT00450112|11491556|FG000|Analyzed Participants|Overall Study|3 subjects removed from ITT analyses because of no post treatment data (pre-defined criteria).|122
10352834|NCT00450112|11491557|FG001|Analyzed Participants|Overall Study||74
10352835|NCT00450112|11491556|FG000|COMPLETED|Overall Study||112
10352836|NCT00450112|11491557|FG001|COMPLETED|Overall Study||71
10352837|NCT00450112|11491556|FG000|NOT COMPLETED|Overall Study||13
10352838|NCT00450112|11491557|FG001|NOT COMPLETED|Overall Study||6
10352839|NCT00450177|11491565|FG000|STARTED|Overall Study||97
10352840|NCT00450177|11491566|FG001|STARTED|Overall Study||103
10352841|NCT00450177|11491565|FG000|COMPLETED|Overall Study||88
10352842|NCT00450177|11491566|FG001|COMPLETED|Overall Study||92
10352843|NCT00450177|11491565|FG000|NOT COMPLETED|Overall Study||9
10352844|NCT00450177|11491566|FG001|NOT COMPLETED|Overall Study||11
10352845|NCT00450190|11491572|FG000|STARTED|Overall Study||20
10352846|NCT00450190|11491572|FG000|COMPLETED|Overall Study||18
10352847|NCT00450190|11491572|FG000|NOT COMPLETED|Overall Study||2
10352848|NCT00450216|11491578|FG000|STARTED|Overall Study||607
10352849|NCT00450216|11491579|FG001|STARTED|Overall Study||299
10352850|NCT00450216|11491578|FG000|COMPLETED|Overall Study||433
10352851|NCT00450216|11491579|FG001|COMPLETED|Overall Study||170
10352852|NCT00450216|11491578|FG000|NOT COMPLETED|Overall Study||174
10352853|NCT00450216|11491579|FG001|NOT COMPLETED|Overall Study||129
10352854|NCT00450242|11491587|FG000|STARTED|Overall Study||7
10352855|NCT00450242|11491588|FG001|STARTED|Overall Study||7
10352856|NCT00450242|11491587|FG000|COMPLETED|Overall Study||4
10352857|NCT00450242|11491588|FG001|COMPLETED|Overall Study||6
10352858|NCT00450242|11491587|FG000|NOT COMPLETED|Overall Study||3
10352859|NCT00450242|11491588|FG001|NOT COMPLETED|Overall Study||1
10352860|NCT00450255|11491596|FG000|STARTED|Overall Study||41
10352861|NCT00450255|11491596|FG000|COMPLETED|Overall Study||40
10352862|NCT00450255|11491596|FG000|NOT COMPLETED|Overall Study||1
10352863|NCT00450294|11491601|FG000|STARTED|Overall Study||10
10352864|NCT00450294|11491601|FG000|COMPLETED|Overall Study||10
10352865|NCT00450294|11491601|FG000|NOT COMPLETED|Overall Study||0
10352866|NCT00450372|11491606|FG000|STARTED|Overall Study||38
10352867|NCT00450372|11491606|FG000|COMPLETED|Overall Study||37
10352868|NCT00450372|11491606|FG000|NOT COMPLETED|Overall Study||1
10352869|NCT00450385|11491613|FG000|STARTED|Overall Study||57
10352870|NCT00450385|11491613|FG000|COMPLETED|Overall Study||44
10352871|NCT00450385|11491613|FG000|NOT COMPLETED|Overall Study||13
10352872|NCT00450424|11491620|FG000|STARTED|Overall Study||122
10352873|NCT00450424|11491621|FG001|STARTED|Overall Study||117
10812486|NCT03605303|11974549|FG000|NOT COMPLETED|Period 2||0
10812487|NCT03605303|11974550|FG001|NOT COMPLETED|Period 2||0
10812488|NCT03600740|11974556|FG000|STARTED|Overall Study||1
10352874|NCT00450424|11491620|FG000|COMPLETED|Overall Study||102
10352875|NCT00450424|11491621|FG001|COMPLETED|Overall Study||106
10352876|NCT00450424|11491620|FG000|NOT COMPLETED|Overall Study||20
10352877|NCT00450424|11491621|FG001|NOT COMPLETED|Overall Study||11
10352878|NCT00450437|11491629|FG000|STARTED|Overall Study||1640
10352879|NCT00450437|11491630|FG001|STARTED|Overall Study||540
10352880|NCT00450437|11491631|FG002|STARTED|Overall Study||1023
10352881|NCT00450437|11491632|FG003|STARTED|Overall Study||336
10352882|NCT00450437|11491629|FG000|COMPLETED|Overall Study||1594
10812489|NCT03600740|11974556|FG000|COMPLETED|Overall Study||0
10812490|NCT03600740|11974556|FG000|NOT COMPLETED|Overall Study||1
10352883|NCT00450437|11491630|FG001|COMPLETED|Overall Study||524
10352884|NCT00450437|11491631|FG002|COMPLETED|Overall Study||999
10352885|NCT00450437|11491632|FG003|COMPLETED|Overall Study||325
10352886|NCT00450437|11491629|FG000|NOT COMPLETED|Overall Study||46
10352887|NCT00450437|11491630|FG001|NOT COMPLETED|Overall Study||16
10352888|NCT00450437|11491631|FG002|NOT COMPLETED|Overall Study||24
10352889|NCT00450437|11491632|FG003|NOT COMPLETED|Overall Study||11
10352890|NCT00450463|11491648|FG000|STARTED|Initial Drug Administration||33
10352891|NCT00450463|11491649|FG001|STARTED|Initial Drug Administration||31
10352892|NCT00450463|11491648|FG000|COMPLETED|Initial Drug Administration||33
10352893|NCT00450463|11491649|FG001|COMPLETED|Initial Drug Administration||31
10812491|NCT03598140|11974562|FG000|STARTED|Overall Study||10
10352894|NCT00450463|11491648|FG000|NOT COMPLETED|Initial Drug Administration||0
10352895|NCT00450463|11491649|FG001|NOT COMPLETED|Initial Drug Administration||0
10352896|NCT00450463|11491648|FG000|STARTED|Progressed to Receive Vaccine Alone||11
10352897|NCT00450463|11491649|FG001|STARTED|Progressed to Receive Vaccine Alone||0
10352898|NCT00450463|11491648|FG000|COMPLETED|Progressed to Receive Vaccine Alone||11
10352899|NCT00450463|11491649|FG001|COMPLETED|Progressed to Receive Vaccine Alone||0
10352900|NCT00450463|11491648|FG000|NOT COMPLETED|Progressed to Receive Vaccine Alone||0
10352901|NCT00450463|11491649|FG001|NOT COMPLETED|Progressed to Receive Vaccine Alone||0
10352902|NCT00450580|11491660|FG000|STARTED|Overall Study||106
10352903|NCT00450580|11491661|FG001|STARTED|Overall Study||106
10352904|NCT00450580|11491660|FG000|COMPLETED|Overall Study||90
10352905|NCT00450580|11491661|FG001|COMPLETED|Overall Study||90
10352906|NCT00450580|11491660|FG000|NOT COMPLETED|Overall Study||16
10352907|NCT00450580|11491661|FG001|NOT COMPLETED|Overall Study||16
10352908|NCT00450619|11491669|FG000|STARTED|Overall Study||22
10352909|NCT00450619|11491670|FG001|STARTED|Overall Study||22
10352910|NCT00450619|11491669|FG000|COMPLETED|Overall Study||18
10352911|NCT00450619|11491670|FG001|COMPLETED|Overall Study||21
10352912|NCT00450619|11491669|FG000|NOT COMPLETED|Overall Study||4
10352913|NCT00450619|11491670|FG001|NOT COMPLETED|Overall Study||1
10352914|NCT00450658|11491679|FG000|STARTED|Overall Study||415
10352915|NCT00450658|11491680|FG001|STARTED|Overall Study||212
10352916|NCT00450658|11491679|FG000|COMPLETED|Overall Study||272
10352917|NCT00450658|11491680|FG001|COMPLETED|Overall Study||122
10352918|NCT00450658|11491679|FG000|NOT COMPLETED|Overall Study||143
10352919|NCT00450658|11491680|FG001|NOT COMPLETED|Overall Study||90
10352920|NCT00450723|11491686|FG000|STARTED|Overall Study||39
10352921|NCT00450723|11491686|FG000|COMPLETED|Overall Study||34
10352922|NCT00450723|11491686|FG000|NOT COMPLETED|Overall Study||5
10352923|NCT00450749|11491694|FG000|STARTED|Overall Study||3
10352924|NCT00450749|11491695|FG001|STARTED|Overall Study||3
10352925|NCT00450749|11491696|FG002|STARTED|Overall Study||4
10352926|NCT00450749|11491694|FG000|COMPLETED|Overall Study||3
10352927|NCT00450749|11491695|FG001|COMPLETED|Overall Study||2
10352928|NCT00450749|11491696|FG002|COMPLETED|Overall Study||2
10352929|NCT00450749|11491694|FG000|NOT COMPLETED|Overall Study||0
10352930|NCT00450749|11491695|FG001|NOT COMPLETED|Overall Study||1
10352931|NCT00450749|11491696|FG002|NOT COMPLETED|Overall Study||2
10352932|NCT00450801|11491704|FG000|STARTED|Overall Study||22
10352933|NCT00450801|11491704|FG000|COMPLETED|Overall Study||21
10352934|NCT00450801|11491704|FG000|NOT COMPLETED|Overall Study||1
10352935|NCT00450814|11491723|FG000|STARTED|Overall Study||3
10352936|NCT00450814|11491724|FG001|STARTED|Overall Study||3
10352937|NCT00450814|11491725|FG002|STARTED|Overall Study||3
10352938|NCT00450814|11491726|FG003|STARTED|Overall Study||4
10352939|NCT00450814|11491727|FG004|STARTED|Overall Study||4
10352940|NCT00450814|11491728|FG005|STARTED|Overall Study||7
10352941|NCT00450814|11491729|FG006|STARTED|Overall Study||3
10352942|NCT00450814|11491730|FG007|STARTED|Overall Study||3
10352943|NCT00450814|11491731|FG008|STARTED|Overall Study||2
10352944|NCT00450814|11491732|FG009|STARTED|Overall Study||12
10352945|NCT00450814|11491733|FG010|STARTED|Overall Study||4
10352946|NCT00450814|11491723|FG000|COMPLETED|Overall Study||3
10352947|NCT00450814|11491724|FG001|COMPLETED|Overall Study||3
10352948|NCT00450814|11491725|FG002|COMPLETED|Overall Study||3
10352949|NCT00450814|11491726|FG003|COMPLETED|Overall Study||3
10352950|NCT00450814|11491727|FG004|COMPLETED|Overall Study||3
10352951|NCT00450814|11491728|FG005|COMPLETED|Overall Study||6
10352952|NCT00450814|11491729|FG006|COMPLETED|Overall Study||3
10352953|NCT00450814|11491730|FG007|COMPLETED|Overall Study||3
10352954|NCT00450814|11491731|FG008|COMPLETED|Overall Study||2
10352955|NCT00450814|11491732|FG009|COMPLETED|Overall Study||11
10352956|NCT00450814|11491733|FG010|COMPLETED|Overall Study||4
10352957|NCT00450814|11491723|FG000|NOT COMPLETED|Overall Study||0
10352958|NCT00450814|11491724|FG001|NOT COMPLETED|Overall Study||0
10352959|NCT00450814|11491725|FG002|NOT COMPLETED|Overall Study||0
10352960|NCT00450814|11491726|FG003|NOT COMPLETED|Overall Study||1
10352961|NCT00450814|11491727|FG004|NOT COMPLETED|Overall Study||1
10352962|NCT00450814|11491728|FG005|NOT COMPLETED|Overall Study||1
10352963|NCT00450814|11491729|FG006|NOT COMPLETED|Overall Study||0
10352964|NCT00450814|11491730|FG007|NOT COMPLETED|Overall Study||0
10352965|NCT00450814|11491731|FG008|NOT COMPLETED|Overall Study||0
10352966|NCT00450814|11491732|FG009|NOT COMPLETED|Overall Study||1
10352967|NCT00450814|11491733|FG010|NOT COMPLETED|Overall Study||0
10352968|NCT00450866|11491758|FG000|STARTED|Overall Study||45
10352969|NCT00450866|11491759|FG001|STARTED|Overall Study||10
10352970|NCT00450866|11491758|FG000|COMPLETED|Overall Study||38
10352971|NCT00450866|11491759|FG001|COMPLETED|Overall Study||7
10352972|NCT00450866|11491758|FG000|NOT COMPLETED|Overall Study||7
10352973|NCT00450866|11491759|FG001|NOT COMPLETED|Overall Study||3
10352974|NCT00450983|11491765|FG000|STARTED|Overall Study||1
10352975|NCT00450983|11491765|FG000|COMPLETED|Overall Study||1
10352976|NCT00450983|11491765|FG000|NOT COMPLETED|Overall Study||0
10352977|NCT00451035|11491769|FG000|STARTED|Overall Study||29
10352978|NCT00451035|11491769|FG000|COMPLETED|Overall Study||12
10352979|NCT00451035|11491769|FG000|NOT COMPLETED|Overall Study||17
10352980|NCT00451048|11491774|FG000|STARTED|Overall Study||10
10352981|NCT00451048|11491774|FG000|COMPLETED|Overall Study||10
10352982|NCT00451048|11491774|FG000|NOT COMPLETED|Overall Study||0
10352983|NCT00451178|11491780|FG000|STARTED|Chemotherapy (Up To Six 21-Day Cycles)||58
10352984|NCT00451178|11491781|FG001|STARTED|Chemotherapy (Up To Six 21-Day Cycles)||43
10352985|NCT00451178|11491780|FG000|Received At Least 1 Dose Study Treatment|Chemotherapy (Up To Six 21-Day Cycles)||57
10352986|NCT00451178|11491781|FG001|Received At Least 1 Dose Study Treatment|Chemotherapy (Up To Six 21-Day Cycles)||43
10352987|NCT00451178|11491780|FG000|COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||40
10352988|NCT00451178|11491781|FG001|COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||26
10352989|NCT00451178|11491780|FG000|NOT COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||18
10352990|NCT00451178|11491781|FG001|NOT COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||17
10352991|NCT00451178|11491780|FG000|STARTED|Prior to Maintenance Therapy||40
10352992|NCT00451178|11491781|FG001|STARTED|Prior to Maintenance Therapy|R-CHOP participants were excluded from maintenance therapy and went directly to long-term follow-up.|0
10352993|NCT00451178|11491780|FG000|COMPLETED|Prior to Maintenance Therapy||36
10352994|NCT00451178|11491781|FG001|COMPLETED|Prior to Maintenance Therapy||0
10352995|NCT00451178|11491780|FG000|NOT COMPLETED|Prior to Maintenance Therapy||4
10352996|NCT00451178|11491781|FG001|NOT COMPLETED|Prior to Maintenance Therapy||0
10352997|NCT00451178|11491780|FG000|STARTED|Maintenance Therapy (up to 3 Years)||36
10352998|NCT00451178|11491781|FG001|STARTED|Maintenance Therapy (up to 3 Years)|R-CHOP participants were excluded from maintenance therapy and went directly to long-term follow-up.|0
10352999|NCT00451178|11491780|FG000|COMPLETED|Maintenance Therapy (up to 3 Years)||6
10353000|NCT00451178|11491781|FG001|COMPLETED|Maintenance Therapy (up to 3 Years)||0
10353001|NCT00451178|11491780|FG000|NOT COMPLETED|Maintenance Therapy (up to 3 Years)||30
10353002|NCT00451178|11491781|FG001|NOT COMPLETED|Maintenance Therapy (up to 3 Years)||0
10353003|NCT00451178|11491780|FG000|STARTED|Long-Term Follow-Up (Up to 2 Years)||6
10353004|NCT00451178|11491781|FG001|STARTED|Long-Term Follow-Up (Up to 2 Years)||26
10353005|NCT00451178|11491780|FG000|COMPLETED|Long-Term Follow-Up (Up to 2 Years)||0
10353006|NCT00451178|11491781|FG001|COMPLETED|Long-Term Follow-Up (Up to 2 Years)||0
10353007|NCT00451178|11491780|FG000|NOT COMPLETED|Long-Term Follow-Up (Up to 2 Years)||6
10353008|NCT00451178|11491781|FG001|NOT COMPLETED|Long-Term Follow-Up (Up to 2 Years)||26
10426869|NCT00849680|11572589|FG002|STARTED|Overall Study||42
10426870|NCT00849680|11572590|FG003|STARTED|Overall Study||42
10426871|NCT00849680|11572591|FG004|STARTED|Overall Study||42
10426872|NCT00849680|11572592|FG005|STARTED|Overall Study||42
10426873|NCT00849680|11572593|FG006|STARTED|Overall Study||78
10426874|NCT00849680|11572594|FG007|STARTED|Overall Study||31
10426875|NCT00849680|11572587|FG000|COMPLETED|Overall Study||16
10426876|NCT00849680|11572588|FG001|COMPLETED|Overall Study||10
10426877|NCT00849680|11572589|FG002|COMPLETED|Overall Study||27
10426878|NCT00849680|11572590|FG003|COMPLETED|Overall Study||28
10426879|NCT00849680|11572591|FG004|COMPLETED|Overall Study||32
10426880|NCT00849680|11572592|FG005|COMPLETED|Overall Study||27
10426881|NCT00849680|11572593|FG006|COMPLETED|Overall Study||61
10426882|NCT00849680|11572594|FG007|COMPLETED|Overall Study||23
10426883|NCT00849680|11572587|FG000|NOT COMPLETED|Overall Study||11
10426884|NCT00849680|11572588|FG001|NOT COMPLETED|Overall Study||3
10426885|NCT00849680|11572589|FG002|NOT COMPLETED|Overall Study||15
10426886|NCT00849680|11572590|FG003|NOT COMPLETED|Overall Study||14
10426887|NCT00849680|11572591|FG004|NOT COMPLETED|Overall Study||10
10426888|NCT00849680|11572592|FG005|NOT COMPLETED|Overall Study||15
10426889|NCT00849680|11572593|FG006|NOT COMPLETED|Overall Study||17
10426890|NCT00849680|11572594|FG007|NOT COMPLETED|Overall Study||8
10426891|NCT00849693|11572616|FG000|STARTED|Acute Treatment Phase||108
10426892|NCT00849693|11572617|FG001|STARTED|Acute Treatment Phase||116
10426893|NCT00849693|11572618|FG002|STARTED|Acute Treatment Phase||117
10426894|NCT00849693|11572619|FG003|STARTED|Acute Treatment Phase||122
10426895|NCT00849693|11572616|FG000|COMPLETED|Acute Treatment Phase|2 didn't enter extension phase.|75
10426896|NCT00849693|11572617|FG001|COMPLETED|Acute Treatment Phase|1 didn't enter extension phase|81
10426897|NCT00849693|11572618|FG002|COMPLETED|Acute Treatment Phase||84
10426898|NCT00849693|11572619|FG003|COMPLETED|Acute Treatment Phase|3 didn't enter extension phase|85
10426899|NCT00849693|11572616|FG000|NOT COMPLETED|Acute Treatment Phase||33
10426900|NCT00849693|11572617|FG001|NOT COMPLETED|Acute Treatment Phase||35
10426901|NCT00849693|11572618|FG002|NOT COMPLETED|Acute Treatment Phase||33
10426902|NCT00849693|11572619|FG003|NOT COMPLETED|Acute Treatment Phase||37
10426903|NCT00849693|11572616|FG000|STARTED|Extension Phase||73
10426904|NCT00849693|11572617|FG001|STARTED|Extension Phase||80
10426905|NCT00849693|11572618|FG002|STARTED|Extension Phase||84
10426906|NCT00849693|11572619|FG003|STARTED|Extension Phase||82
10426907|NCT00849693|11572616|FG000|COMPLETED|Extension Phase||43
10426908|NCT00849693|11572617|FG001|COMPLETED|Extension Phase||50
10426909|NCT00849693|11572618|FG002|COMPLETED|Extension Phase||49
10426910|NCT00849693|11572619|FG003|COMPLETED|Extension Phase||44
10426911|NCT00849693|11572616|FG000|NOT COMPLETED|Extension Phase||30
10426912|NCT00849693|11572617|FG001|NOT COMPLETED|Extension Phase||30
10533364|NCT01425281|11685633|FG001|STARTED|At 5-year Clinical Follow-up||136
10533365|NCT01425281|11685632|FG000|COMPLETED|At 5-year Clinical Follow-up||256
10533366|NCT01425281|11685633|FG001|COMPLETED|At 5-year Clinical Follow-up||125
10533367|NCT01425281|11685632|FG000|NOT COMPLETED|At 5-year Clinical Follow-up||32
10533368|NCT01425281|11685633|FG001|NOT COMPLETED|At 5-year Clinical Follow-up||11
10533369|NCT01425632|11685643|FG000|STARTED|Overall Study||161
10533370|NCT01425632|11685644|FG001|STARTED|Overall Study||166
10426913|NCT00849693|11572618|FG002|NOT COMPLETED|Extension Phase||35
10533371|NCT01425632|11685645|FG002|STARTED|Overall Study||163
10533372|NCT01425632|11685643|FG000|COMPLETED|Overall Study||160
10353009|NCT00451191|11491793|FG000|STARTED|Overall Study||68
10533373|NCT01425632|11685644|FG001|COMPLETED|Overall Study||165
10533374|NCT01425632|11685645|FG002|COMPLETED|Overall Study||159
10533375|NCT01425632|11685643|FG000|NOT COMPLETED|Overall Study||1
10533376|NCT01425632|11685644|FG001|NOT COMPLETED|Overall Study||1
10533377|NCT01425632|11685645|FG002|NOT COMPLETED|Overall Study||4
10533378|NCT01425723|11685655|FG000|STARTED|Overall Study|13 participants in <6 Years Old Age Cohort and 14 participants in 6 to <12 Years Old Age Cohort.|27
10533379|NCT01425723|11685656|FG001|STARTED|Overall Study||93
10533380|NCT01425723|11685655|FG000|Weekly Prophylaxis|Overall Study||23
10533381|NCT01425723|11685656|FG001|Weekly Prophylaxis|Overall Study||51
10533382|NCT01425723|11685655|FG000|Individualized Prophylaxis|Overall Study||5
10533383|NCT01425723|11685656|FG001|Individualized Prophylaxis|Overall Study||31
10533384|NCT01425723|11685655|FG000|Personalized Prophylaxis|Overall Study||2
10533385|NCT01425723|11685656|FG001|Personalized Prophylaxis|Overall Study||17
10533386|NCT01425723|11685655|FG000|Episodic|Overall Study||0
10533387|NCT01425723|11685656|FG001|Episodic|Overall Study||15
10533388|NCT01425723|11685655|FG000|Surgery Subgroup|Overall Study||1
10533389|NCT01425723|11685656|FG001|Surgery Subgroup|Overall Study||15
10533390|NCT01425723|11685655|FG000|COMPLETED|Overall Study||23
10353010|NCT00451191|11491794|FG001|STARTED|Overall Study||66
10353011|NCT00451191|11491793|FG000|COMPLETED|Overall Study||53
10353012|NCT00451191|11491794|FG001|COMPLETED|Overall Study||55
10353013|NCT00451191|11491793|FG000|NOT COMPLETED|Overall Study||15
10353014|NCT00451191|11491794|FG001|NOT COMPLETED|Overall Study||11
10353015|NCT00451204|11491802|FG000|STARTED|Overall Study||82
10353016|NCT00451204|11491803|FG001|STARTED|Overall Study||76
10353017|NCT00451204|11491802|FG000|COMPLETED|Overall Study|60 completed the study but 3 stopped study drug(s) early|60
10353018|NCT00451204|11491803|FG001|COMPLETED|Overall Study||56
10353019|NCT00451204|11491802|FG000|NOT COMPLETED|Overall Study||22
10353020|NCT00451204|11491803|FG001|NOT COMPLETED|Overall Study||20
10353021|NCT00451217|11491816|FG000|STARTED|Overall Study||49
10353022|NCT00451217|11491817|FG001|STARTED|Overall Study||49
10353023|NCT00451217|11491818|FG002|STARTED|Overall Study||51
10533391|NCT01425723|11685656|FG001|COMPLETED|Overall Study||75
10305738|NCT00095147|11438698|FG004|COMPLETED|Double-blind Period 2 (Days 198-365)||0
10305739|NCT00095147|11438694|FG000|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||8
10305740|NCT00095147|11438695|FG001|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||11
10305741|NCT00095147|11438696|FG002|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||0
10305742|NCT00095147|11438697|FG003|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||3
10305743|NCT00095147|11438698|FG004|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||0
10305744|NCT00095147|11438694|FG000|STARTED|Long-term Extension Period||0
10305745|NCT00095147|11438695|FG001|STARTED|Long-term Extension Period||0
10305746|NCT00095147|11438696|FG002|STARTED|Long-term Extension Period||0
10305747|NCT00095147|11438697|FG003|STARTED|Long-term Extension Period||0
10305748|NCT00095147|11438698|FG004|STARTED|Long-term Extension Period||372
10305749|NCT00095147|11438694|FG000|COMPLETED|Long-term Extension Period||0
10305750|NCT00095147|11438695|FG001|COMPLETED|Long-term Extension Period||0
10305751|NCT00095147|11438696|FG002|COMPLETED|Long-term Extension Period||0
10305752|NCT00095147|11438697|FG003|COMPLETED|Long-term Extension Period||0
10305753|NCT00095147|11438698|FG004|COMPLETED|Long-term Extension Period||327
10305754|NCT00095147|11438694|FG000|NOT COMPLETED|Long-term Extension Period||0
10305755|NCT00095147|11438695|FG001|NOT COMPLETED|Long-term Extension Period||0
10305756|NCT00095147|11438696|FG002|NOT COMPLETED|Long-term Extension Period||0
10305757|NCT00095147|11438697|FG003|NOT COMPLETED|Long-term Extension Period||0
10305758|NCT00095147|11438698|FG004|NOT COMPLETED|Long-term Extension Period||45
10305759|NCT00095173|11438716|FG000|STARTED|Open-Label Lead-In Phase (Period A)||190
10305760|NCT00095173|11438717|FG001|STARTED|Open-Label Lead-In Phase (Period A)||0
10305761|NCT00095173|11438718|FG002|STARTED|Open-Label Lead-In Phase (Period A)||0
10305762|NCT00095173|11438719|FG003|STARTED|Open-Label Lead-In Phase (Period A)||0
10305763|NCT00095173|11438720|FG004|STARTED|Open-Label Lead-In Phase (Period A)||0
10305764|NCT00095173|11438721|FG005|STARTED|Open-Label Lead-In Phase (Period A)||0
10305765|NCT00095173|11438716|FG000|COMPLETED|Open-Label Lead-In Phase (Period A)||170
10305766|NCT00095173|11438717|FG001|COMPLETED|Open-Label Lead-In Phase (Period A)||0
10305767|NCT00095173|11438718|FG002|COMPLETED|Open-Label Lead-In Phase (Period A)||0
10305768|NCT00095173|11438719|FG003|COMPLETED|Open-Label Lead-In Phase (Period A)||0
10305769|NCT00095173|11438720|FG004|COMPLETED|Open-Label Lead-In Phase (Period A)||0
10305770|NCT00095173|11438721|FG005|COMPLETED|Open-Label Lead-In Phase (Period A)||0
10305771|NCT00095173|11438716|FG000|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||20
10353024|NCT00451217|11491819|FG003|STARTED|Overall Study||49
10533392|NCT01425723|11685655|FG000|NOT COMPLETED|Overall Study||4
10533393|NCT01425723|11685656|FG001|NOT COMPLETED|Overall Study||18
10533394|NCT01425749|11685673|FG000|STARTED|Overall Study||13
10353025|NCT00451217|11491816|FG000|Treated|Overall Study||48
10353026|NCT00451217|11491817|FG001|Treated|Overall Study||48
10353027|NCT00451217|11491818|FG002|Treated|Overall Study||48
10353028|NCT00451217|11491819|FG003|Treated|Overall Study||45
10353029|NCT00451217|11491816|FG000|COMPLETED|Overall Study||47
10353030|NCT00451217|11491817|FG001|COMPLETED|Overall Study||47
10353031|NCT00451217|11491818|FG002|COMPLETED|Overall Study||47
10353032|NCT00451217|11491819|FG003|COMPLETED|Overall Study||44
10353033|NCT00451217|11491816|FG000|NOT COMPLETED|Overall Study||2
10353034|NCT00451217|11491817|FG001|NOT COMPLETED|Overall Study||2
10353035|NCT00451217|11491818|FG002|NOT COMPLETED|Overall Study||4
10353036|NCT00451217|11491819|FG003|NOT COMPLETED|Overall Study||5
10353037|NCT00451282|11491831|FG000|STARTED|Overall Study||46
10353038|NCT00451282|11491832|FG001|STARTED|Overall Study||39
10353039|NCT00451282|11491831|FG000|COMPLETED|Overall Study||40
10353040|NCT00451282|11491832|FG001|COMPLETED|Overall Study||34
10812492|NCT03598140|11974563|FG001|STARTED|Overall Study||11
10812493|NCT03598140|11974562|FG000|COMPLETED|Overall Study||9
10353041|NCT00451282|11491831|FG000|NOT COMPLETED|Overall Study||6
10353042|NCT00451282|11491832|FG001|NOT COMPLETED|Overall Study||5
10353043|NCT00451321|11491846|FG000|STARTED|Overall Study||8
10353044|NCT00451321|11491847|FG001|STARTED|Overall Study||15
10353045|NCT00451321|11491848|FG002|STARTED|Overall Study||18
10353046|NCT00451321|11491849|FG003|STARTED|Overall Study||19
10353047|NCT00451321|11491850|FG004|STARTED|Overall Study||7
10353048|NCT00451321|11491851|FG005|STARTED|Overall Study||9
10353049|NCT00451321|11491852|FG006|STARTED|Overall Study||6
10353050|NCT00451321|11491853|FG007|STARTED|Overall Study||6
10353051|NCT00451321|11491846|FG000|COMPLETED|Overall Study||1
10353052|NCT00451321|11491847|FG001|COMPLETED|Overall Study||10
10353053|NCT00451321|11491848|FG002|COMPLETED|Overall Study||0
10353054|NCT00451321|11491849|FG003|COMPLETED|Overall Study||7
10353055|NCT00451321|11491850|FG004|COMPLETED|Overall Study||0
10353056|NCT00451321|11491851|FG005|COMPLETED|Overall Study||0
10353057|NCT00451321|11491852|FG006|COMPLETED|Overall Study||0
10353058|NCT00451321|11491853|FG007|COMPLETED|Overall Study||0
10353059|NCT00451321|11491846|FG000|NOT COMPLETED|Overall Study||7
10353060|NCT00451321|11491847|FG001|NOT COMPLETED|Overall Study||5
10353061|NCT00451321|11491848|FG002|NOT COMPLETED|Overall Study||18
10353062|NCT00451321|11491849|FG003|NOT COMPLETED|Overall Study||12
10353063|NCT00451321|11491850|FG004|NOT COMPLETED|Overall Study||7
10353064|NCT00451321|11491851|FG005|NOT COMPLETED|Overall Study||9
10353065|NCT00451321|11491852|FG006|NOT COMPLETED|Overall Study||6
10353066|NCT00451321|11491853|FG007|NOT COMPLETED|Overall Study||6
10353067|NCT00451451|11491875|FG000|STARTED|Overall Study|363 participants were dosed; 363 participants were randomized|363
10353068|NCT00451451|11491876|FG001|STARTED|Overall Study|359 participants were dosed; 362 participants were randomized|359
10353069|NCT00451451|11491877|FG002|STARTED|Overall Study|345 participants were dosed; 345 participants were randomized|345
10353070|NCT00451451|11491878|FG003|STARTED|Overall Study|350 participants were dosed; 360 participants were randomized|350
10353071|NCT00451451|11491875|FG000|COMPLETED|Overall Study||278
10353072|NCT00451451|11491876|FG001|COMPLETED|Overall Study||284
10353073|NCT00451451|11491877|FG002|COMPLETED|Overall Study||273
10353074|NCT00451451|11491878|FG003|COMPLETED|Overall Study||292
10353075|NCT00451451|11491875|FG000|NOT COMPLETED|Overall Study||85
10353076|NCT00451451|11491876|FG001|NOT COMPLETED|Overall Study||75
10353077|NCT00451451|11491877|FG002|NOT COMPLETED|Overall Study||72
10353078|NCT00451451|11491878|FG003|NOT COMPLETED|Overall Study||58
10353079|NCT00451555|11491893|FG000|STARTED|Overall Study||96
10353080|NCT00451555|11491894|FG001|STARTED|Overall Study||60
10353081|NCT00451555|11491893|FG000|Received at Least One Dose of Study Drug|Overall Study||94
10353082|NCT00451555|11491894|FG001|Received at Least One Dose of Study Drug|Overall Study||58
10353083|NCT00451555|11491893|FG000|Enzastaurin Twice Daily Dosing (BID)|Overall Study||39
10353084|NCT00451555|11491894|FG001|Enzastaurin Twice Daily Dosing (BID)|Overall Study||0
10353085|NCT00451555|11491893|FG000|Enzastaurin Once Daily Dosing (QD)|Overall Study||55
10353086|NCT00451555|11491894|FG001|Enzastaurin Once Daily Dosing (QD)|Overall Study||0
10353087|NCT00451555|11491893|FG000|Progressive Disease|Overall Study||75
10812494|NCT03598140|11974563|FG001|COMPLETED|Overall Study||11
10812495|NCT03598140|11974562|FG000|NOT COMPLETED|Overall Study||1
10812496|NCT03598140|11974563|FG001|NOT COMPLETED|Overall Study||0
10812497|NCT03598036|11974571|FG000|STARTED|Overall Study||5
10353088|NCT00451555|11491894|FG001|Progressive Disease|Overall Study||54
10353089|NCT00451555|11491893|FG000|Death|Overall Study||2
10353090|NCT00451555|11491894|FG001|Death|Overall Study||0
10353091|NCT00451555|11491893|FG000|COMPLETED|Overall Study||83
10353092|NCT00451555|11491894|FG001|COMPLETED|Overall Study||56
10353093|NCT00451555|11491893|FG000|NOT COMPLETED|Overall Study||13
10353094|NCT00451555|11491894|FG001|NOT COMPLETED|Overall Study||4
10353095|NCT00451698|11491911|FG000|STARTED|Overall Study||3
10353096|NCT00451698|11491912|FG001|STARTED|Overall Study||6
10353097|NCT00451698|11491911|FG000|COMPLETED|Overall Study||3
10353098|NCT00451698|11491912|FG001|COMPLETED|Overall Study||6
10353099|NCT00451698|11491911|FG000|NOT COMPLETED|Overall Study||0
10353100|NCT00451698|11491912|FG001|NOT COMPLETED|Overall Study||0
10353101|NCT00451906|11491920|FG000|STARTED|Overall Study||2252
10353102|NCT00451906|11491920|FG000|COMPLETED|Overall Study||13
10353103|NCT00451906|11491920|FG000|NOT COMPLETED|Overall Study||2239
10353104|NCT00451958|11491928|FG000|STARTED|CS21 (NCT00295750)|CS21 intention-to-treat (ITT) population.|210
10353105|NCT00451958|11491929|FG001|STARTED|CS21 (NCT00295750)|CS21 ITT population.|206
10353106|NCT00451958|11491930|FG002|STARTED|CS21 (NCT00295750)|Participants were switched from the leuprolide 7.5 mg group when CS21 was completed.|0
10353107|NCT00451958|11491931|FG003|STARTED|CS21 (NCT00295750)|Participants were switched from the leuprolide 7.5 mg group when CS21 was completed.|0
10353108|NCT00451958|11491932|FG004|STARTED|CS21 (NCT00295750)||204
10353109|NCT00451958|11491928|FG000|COMPLETED|CS21 (NCT00295750)||169
10353110|NCT00451958|11491929|FG001|COMPLETED|CS21 (NCT00295750)||163
10353111|NCT00451958|11491930|FG002|COMPLETED|CS21 (NCT00295750)||0
10353112|NCT00451958|11491931|FG003|COMPLETED|CS21 (NCT00295750)||0
10353113|NCT00451958|11491932|FG004|COMPLETED|CS21 (NCT00295750)||172
10812498|NCT03598036|11974572|FG001|STARTED|Overall Study|Trial ended prematurely before any patients were enrolled into Cohort 2|0
10812499|NCT03598036|11974571|FG000|Week 1: 7.9 mg Twice Daily|Overall Study||5
10812500|NCT03598036|11974572|FG001|Week 1: 7.9 mg Twice Daily|Overall Study||0
10812501|NCT03598036|11974571|FG000|Week 2: 15.9 mg Twice Daily|Overall Study||5
10812502|NCT03598036|11974572|FG001|Week 2: 15.9 mg Twice Daily|Overall Study||0
10353114|NCT00451958|11491928|FG000|NOT COMPLETED|CS21 (NCT00295750)||41
10353115|NCT00451958|11491929|FG001|NOT COMPLETED|CS21 (NCT00295750)||43
10353116|NCT00451958|11491930|FG002|NOT COMPLETED|CS21 (NCT00295750)||0
10353117|NCT00451958|11491931|FG003|NOT COMPLETED|CS21 (NCT00295750)||0
10353118|NCT00451958|11491932|FG004|NOT COMPLETED|CS21 (NCT00295750)||32
10353119|NCT00451958|11491928|FG000|STARTED|CS21A (NCT00451958)|CS21A intention-to-treat (ITT) population.|125
10353120|NCT00451958|11491929|FG001|STARTED|CS21A (NCT00451958)|CS21A ITT population.|126
10353121|NCT00451958|11491930|FG002|STARTED|CS21A (NCT00451958)|CS21A ITT population.|69
10353122|NCT00451958|11491931|FG003|STARTED|CS21A (NCT00451958)|One of the enrolled participants never received any treatment, i.e. the CS21A ITT population=65.|66
10353123|NCT00451958|11491932|FG004|STARTED|CS21A (NCT00451958)|Participants were switched to the degarelix groups when CS21 was completed.|0
10353124|NCT00451958|11491928|FG000|COMPLETED|CS21A (NCT00451958)||60
10353125|NCT00451958|11491929|FG001|COMPLETED|CS21A (NCT00451958)||49
10716012|NCT02688387|11880063|FG020|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
10305772|NCT00095173|11438717|FG001|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
10305773|NCT00095173|11438718|FG002|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
10305774|NCT00095173|11438719|FG003|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
10305775|NCT00095173|11438720|FG004|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
10305776|NCT00095173|11438721|FG005|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
10305777|NCT00095173|11438716|FG000|STARTED|Double-Blind Phase (Period B)|All participants did not continue; responders entered Period B; non-responders re-entered Period C.|0
10305778|NCT00095173|11438717|FG001|STARTED|Double-Blind Phase (Period B)|123 responders from Period A qualified;122 entered and were randomized to abatacept and placebo.|60
10305779|NCT00095173|11438718|FG002|STARTED|Double-Blind Phase (Period B)|123 responders from Period A qualified;122 entered and were randomized to abatacept and placebo.|62
10305780|NCT00095173|11438719|FG003|STARTED|Double-Blind Phase (Period B)||0
10305781|NCT00095173|11438720|FG004|STARTED|Double-Blind Phase (Period B)||0
10305782|NCT00095173|11438721|FG005|STARTED|Double-Blind Phase (Period B)||0
10305783|NCT00095173|11438716|FG000|COMPLETED|Double-Blind Phase (Period B)||0
10305784|NCT00095173|11438717|FG001|COMPLETED|Double-Blind Phase (Period B)||49
10305785|NCT00095173|11438718|FG002|COMPLETED|Double-Blind Phase (Period B)||31
10305786|NCT00095173|11438719|FG003|COMPLETED|Double-Blind Phase (Period B)||0
10305787|NCT00095173|11438720|FG004|COMPLETED|Double-Blind Phase (Period B)||0
10305788|NCT00095173|11438721|FG005|COMPLETED|Double-Blind Phase (Period B)||0
10305789|NCT00095173|11438716|FG000|NOT COMPLETED|Double-Blind Phase (Period B)||0
10353126|NCT00451958|11491930|FG002|COMPLETED|CS21A (NCT00451958)||27
10353127|NCT00451958|11491931|FG003|COMPLETED|CS21A (NCT00451958)||27
10353128|NCT00451958|11491932|FG004|COMPLETED|CS21A (NCT00451958)||0
10353129|NCT00451958|11491928|FG000|NOT COMPLETED|CS21A (NCT00451958)||65
10353130|NCT00451958|11491929|FG001|NOT COMPLETED|CS21A (NCT00451958)||77
10353131|NCT00451958|11491930|FG002|NOT COMPLETED|CS21A (NCT00451958)||42
10533395|NCT01425749|11685674|FG001|STARTED|Overall Study||12
10533396|NCT01425749|11685673|FG000|COMPLETED|Overall Study||13
10533397|NCT01425749|11685674|FG001|COMPLETED|Overall Study||11
10533398|NCT01425749|11685673|FG000|NOT COMPLETED|Overall Study||0
10533399|NCT01425749|11685674|FG001|NOT COMPLETED|Overall Study||1
10533400|NCT01425801|11685683|FG000|STARTED|Period 1||9
10533401|NCT01425801|11685684|FG001|STARTED|Period 1||9
10533402|NCT01425801|11685685|FG002|STARTED|Period 1||9
10655979|NCT02213094|11816824|FG000|NOT COMPLETED|Overall Study||1
10655980|NCT02213094|11816825|FG001|NOT COMPLETED|Overall Study||0
10655981|NCT02213133|11816834|FG000|STARTED|Overall Study||37
10655982|NCT02213133|11816835|FG001|STARTED|Overall Study||5
10655983|NCT02213133|11816836|FG002|STARTED|Overall Study||3
10655984|NCT02213133|11816834|FG000|Treated|Overall Study||33
10655985|NCT02213133|11816835|FG001|Treated|Overall Study||4
10655986|NCT02213133|11816836|FG002|Treated|Overall Study||1
10655987|NCT02213133|11816834|FG000|COMPLETED|Overall Study||0
10655988|NCT02213133|11816835|FG001|COMPLETED|Overall Study||0
10655989|NCT02213133|11816836|FG002|COMPLETED|Overall Study||0
10655990|NCT02213133|11816834|FG000|NOT COMPLETED|Overall Study||37
10655991|NCT02213133|11816835|FG001|NOT COMPLETED|Overall Study||5
10655992|NCT02213133|11816836|FG002|NOT COMPLETED|Overall Study||3
10655993|NCT02213198|11816847|FG000|STARTED|Baseline||306
10655994|NCT02213198|11816848|FG001|STARTED|Baseline||159
10655995|NCT02213198|11816847|FG000|COMPLETED|Baseline||218
10655996|NCT02213198|11816848|FG001|COMPLETED|Baseline||108
10655997|NCT02213198|11816847|FG000|NOT COMPLETED|Baseline||88
10655998|NCT02213198|11816848|FG001|NOT COMPLETED|Baseline||51
10655999|NCT02213198|11816847|FG000|STARTED|Follow up 1 3 Mos Post BL End of TCC tx||218
10656000|NCT02213198|11816848|FG001|STARTED|Follow up 1 3 Mos Post BL End of TCC tx||108
10656001|NCT02213198|11816847|FG000|COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||125
10656002|NCT02213198|11816848|FG001|COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||67
10656003|NCT02213198|11816847|FG000|NOT COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||93
10656004|NCT02213198|11816848|FG001|NOT COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||41
10716013|NCT02688387|11880064|FG021|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
10716014|NCT02688387|11880043|FG000|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10716015|NCT02688387|11880044|FG001|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10716016|NCT02688387|11880045|FG002|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10716017|NCT02688387|11880046|FG003|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10716018|NCT02688387|11880047|FG004|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10716019|NCT02688387|11880048|FG005|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10353132|NCT00451958|11491931|FG003|NOT COMPLETED|CS21A (NCT00451958)||39
10353133|NCT00451958|11491932|FG004|NOT COMPLETED|CS21A (NCT00451958)||0
10353134|NCT00452114|11491948|FG000|STARTED|Overall Study||15
10353135|NCT00452114|11491949|FG001|STARTED|Overall Study||13
10353136|NCT00452114|11491948|FG000|COMPLETED|Overall Study||12
10353137|NCT00452114|11491949|FG001|COMPLETED|Overall Study||10
10353138|NCT00452114|11491948|FG000|NOT COMPLETED|Overall Study||3
10353139|NCT00452114|11491949|FG001|NOT COMPLETED|Overall Study||3
10353140|NCT00452335|11491958|FG000|STARTED|Overall Study||27
10353141|NCT00452335|11491959|FG001|STARTED|Overall Study||65
10353142|NCT00452335|11491960|FG002|STARTED|Overall Study||32
10353143|NCT00452335|11491958|FG000|COMPLETED|Overall Study||25
10353144|NCT00452335|11491959|FG001|COMPLETED|Overall Study||61
10533403|NCT01425801|11685686|FG003|STARTED|Period 1||12
10533404|NCT01425801|11685687|FG004|STARTED|Period 1||13
10716020|NCT02688387|11880049|FG006|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10716021|NCT02688387|11880050|FG007|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10716022|NCT02688387|11880051|FG008|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10716023|NCT02688387|11880052|FG009|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10716024|NCT02688387|11880053|FG010|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10716025|NCT02688387|11880054|FG011|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10533405|NCT01425801|11685688|FG005|STARTED|Period 1||10
10353145|NCT00452335|11491960|FG002|COMPLETED|Overall Study||23
10353146|NCT00452335|11491958|FG000|NOT COMPLETED|Overall Study||2
10353147|NCT00452335|11491959|FG001|NOT COMPLETED|Overall Study||4
10353148|NCT00452335|11491960|FG002|NOT COMPLETED|Overall Study||9
10305790|NCT00095173|11438717|FG001|NOT COMPLETED|Double-Blind Phase (Period B)||11
10305791|NCT00095173|11438718|FG002|NOT COMPLETED|Double-Blind Phase (Period B)||31
10305792|NCT00095173|11438719|FG003|NOT COMPLETED|Double-Blind Phase (Period B)||0
10305793|NCT00095173|11438720|FG004|NOT COMPLETED|Double-Blind Phase (Period B)||0
10305794|NCT00095173|11438721|FG005|NOT COMPLETED|Double-Blind Phase (Period B)||0
10305795|NCT00095173|11438716|FG000|STARTED|Open-Label Extension Phase (Period C)||0
10305796|NCT00095173|11438717|FG001|STARTED|Open-Label Extension Phase (Period C)||0
10305797|NCT00095173|11438718|FG002|STARTED|Open-Label Extension Phase (Period C)||0
10305798|NCT00095173|11438719|FG003|STARTED|Open-Label Extension Phase (Period C)|Participants were non-responders from Period A who re-entered in Period C.|36
10353196|NCT00452439|11492036|FG000|COMPLETED|Overall Study||22
10305799|NCT00095173|11438720|FG004|STARTED|Open-Label Extension Phase (Period C)|Includes 47 who completed Period B with no flare and 11 who discontinued Period B due to a flare|58
10305800|NCT00095173|11438721|FG005|STARTED|Open-Label Extension Phase (Period C)|Includes 33 who discontinued Period B due to a flare and 26 who completed Period B with no flare|59
10305801|NCT00095173|11438716|FG000|COMPLETED|Open-Label Extension Phase (Period C)||0
10305802|NCT00095173|11438717|FG001|COMPLETED|Open-Label Extension Phase (Period C)||0
10305803|NCT00095173|11438718|FG002|COMPLETED|Open-Label Extension Phase (Period C)||0
10305804|NCT00095173|11438719|FG003|COMPLETED|Open-Label Extension Phase (Period C)||13
10305805|NCT00095173|11438720|FG004|COMPLETED|Open-Label Extension Phase (Period C)||29
10305806|NCT00095173|11438721|FG005|COMPLETED|Open-Label Extension Phase (Period C)||27
10305807|NCT00095173|11438716|FG000|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
10305808|NCT00095173|11438717|FG001|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
10305809|NCT00095173|11438718|FG002|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
10305810|NCT00095173|11438719|FG003|NOT COMPLETED|Open-Label Extension Phase (Period C)||23
10305811|NCT00095173|11438720|FG004|NOT COMPLETED|Open-Label Extension Phase (Period C)||29
10305812|NCT00095173|11438721|FG005|NOT COMPLETED|Open-Label Extension Phase (Period C)||32
10305813|NCT00095199|11438739|FG000|STARTED|Overall Study|1 participant has no data in database; not included in analyses. Data was lost/destroyed at site.|302
10305814|NCT00095199|11438740|FG001|STARTED|Overall Study||304
10305815|NCT00095199|11438741|FG002|STARTED|Overall Study||167
10305816|NCT00095199|11438742|FG003|STARTED|Overall Study||166
10305817|NCT00095199|11438739|FG000|COMPLETED|Overall Study||6
10305818|NCT00095199|11438740|FG001|COMPLETED|Overall Study||62
10305819|NCT00095199|11438741|FG002|COMPLETED|Overall Study||7
10305820|NCT00095199|11438742|FG003|COMPLETED|Overall Study||23
10305821|NCT00095199|11438739|FG000|NOT COMPLETED|Overall Study||296
10305822|NCT00095199|11438740|FG001|NOT COMPLETED|Overall Study||242
10305823|NCT00095199|11438741|FG002|NOT COMPLETED|Overall Study||160
10305824|NCT00095199|11438742|FG003|NOT COMPLETED|Overall Study||143
10305825|NCT00095212|11438759|FG000|STARTED|Overall Study||13
10305826|NCT00095212|11438760|FG001|STARTED|Overall Study||12
10305827|NCT00095212|11438759|FG000|COMPLETED|Overall Study||12
10305828|NCT00095212|11438760|FG001|COMPLETED|Overall Study||9
10305829|NCT00095212|11438759|FG000|NOT COMPLETED|Overall Study||1
10305830|NCT00095212|11438760|FG001|NOT COMPLETED|Overall Study||3
10305831|NCT00095238|11438768|FG000|STARTED|Overall Study|number randomized|2067
10305832|NCT00095238|11438769|FG001|STARTED|Overall Study|number randomized|2061
10305833|NCT00095238|11438768|FG000|Safety (Treated) Population|Overall Study|Two participants were randomized but not treated; 1 randomized to irbesartan received placebo|2064
10305834|NCT00095238|11438769|FG001|Safety (Treated) Population|Overall Study|One participant randomized to irbesartan received placebo.|2062
10353149|NCT00452348|11491973|FG000|STARTED|Overall Study||310
10353150|NCT00452348|11491974|FG001|STARTED|Overall Study||318
10353151|NCT00452348|11491973|FG000|COMPLETED|Overall Study||231
10353152|NCT00452348|11491974|FG001|COMPLETED|Overall Study||234
10353153|NCT00452348|11491973|FG000|NOT COMPLETED|Overall Study||79
10353154|NCT00452348|11491974|FG001|NOT COMPLETED|Overall Study||84
10353155|NCT00452374|11491980|FG000|STARTED|Overall Study||48
10353156|NCT00452374|11491980|FG000|COMPLETED|Overall Study||48
10353157|NCT00452374|11491980|FG000|NOT COMPLETED|Overall Study||0
10353158|NCT00452387|11491984|FG000|STARTED|Overall Study||22
10353159|NCT00452387|11491984|FG000|COMPLETED|Overall Study||22
10353160|NCT00452387|11491984|FG000|NOT COMPLETED|Overall Study||0
10353161|NCT00452400|11491995|FG000|STARTED|Overall Study||79
10353162|NCT00452400|11491996|FG001|STARTED|Overall Study||81
10353163|NCT00452400|11491997|FG002|STARTED|Overall Study||80
10353164|NCT00452400|11491998|FG003|STARTED|Overall Study||86
10353165|NCT00452400|11491999|FG004|STARTED|Overall Study||79
10353166|NCT00452400|11491995|FG000|COMPLETED|Overall Study||74
10353167|NCT00452400|11491996|FG001|COMPLETED|Overall Study||80
10353168|NCT00452400|11491997|FG002|COMPLETED|Overall Study||73
10353169|NCT00452400|11491998|FG003|COMPLETED|Overall Study||85
10353170|NCT00452400|11491999|FG004|COMPLETED|Overall Study||76
10353171|NCT00452400|11491995|FG000|NOT COMPLETED|Overall Study||5
10353172|NCT00452400|11491996|FG001|NOT COMPLETED|Overall Study||1
10353173|NCT00452400|11491997|FG002|NOT COMPLETED|Overall Study||7
10353174|NCT00452400|11491998|FG003|NOT COMPLETED|Overall Study||1
10353175|NCT00452400|11491999|FG004|NOT COMPLETED|Overall Study||3
10353176|NCT00452413|11492014|FG000|STARTED|Overall Study||4
10353177|NCT00452413|11492015|FG001|STARTED|Overall Study||12
10353178|NCT00452413|11492016|FG002|STARTED|Overall Study||49
10353179|NCT00452413|11492014|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
10353180|NCT00452413|11492015|FG001|Received at Least 1 Dose of Study Drug|Overall Study||12
10353181|NCT00452413|11492016|FG002|Received at Least 1 Dose of Study Drug|Overall Study||49
10353182|NCT00452413|11492014|FG000|COMPLETED|Overall Study||0
10353183|NCT00452413|11492015|FG001|COMPLETED|Overall Study||0
10353184|NCT00452413|11492016|FG002|COMPLETED|Overall Study||0
10353185|NCT00452413|11492014|FG000|NOT COMPLETED|Overall Study||4
10353186|NCT00452413|11492015|FG001|NOT COMPLETED|Overall Study||12
10353187|NCT00452413|11492016|FG002|NOT COMPLETED|Overall Study||49
10353188|NCT00452426|11492027|FG000|STARTED|Overall Study||496
10353189|NCT00452426|11492028|FG001|STARTED|Overall Study||504
10353190|NCT00452426|11492027|FG000|COMPLETED|Overall Study||489
10353191|NCT00452426|11492028|FG001|COMPLETED|Overall Study||493
10353192|NCT00452426|11492027|FG000|NOT COMPLETED|Overall Study||7
10353193|NCT00452426|11492028|FG001|NOT COMPLETED|Overall Study||11
10353194|NCT00452439|11492036|FG000|STARTED|Overall Study||36
10353195|NCT00452439|11492037|FG001|STARTED|Overall Study||36
10353197|NCT00452439|11492037|FG001|COMPLETED|Overall Study||29
10353198|NCT00452439|11492036|FG000|NOT COMPLETED|Overall Study||14
10353199|NCT00452439|11492037|FG001|NOT COMPLETED|Overall Study||7
10353200|NCT00452452|11492046|FG000|STARTED|Overall Study||90
10353201|NCT00452452|11492047|FG001|STARTED|Overall Study||112
10353202|NCT00452452|11492048|FG002|STARTED|Overall Study||153
10353203|NCT00452452|11492046|FG000|Vaccinated Dose 1|Overall Study||90
10353204|NCT00452452|11492047|FG001|Vaccinated Dose 1|Overall Study||112
10353205|NCT00452452|11492048|FG002|Vaccinated Dose 1|Overall Study||152
10353206|NCT00452452|11492046|FG000|Vaccinated Dose 2|Overall Study||90
10353207|NCT00452452|11492047|FG001|Vaccinated Dose 2|Overall Study||112
10353208|NCT00452452|11492048|FG002|Vaccinated Dose 2|Overall Study||0
10353209|NCT00452452|11492046|FG000|Vaccinated Dose 3|Overall Study||89
10353210|NCT00452452|11492047|FG001|Vaccinated Dose 3|Overall Study||0
10353211|NCT00452452|11492048|FG002|Vaccinated Dose 3|Overall Study||0
10353212|NCT00452452|11492046|FG000|COMPLETED|Overall Study||88
10353213|NCT00452452|11492047|FG001|COMPLETED|Overall Study||112
10353214|NCT00452452|11492048|FG002|COMPLETED|Overall Study||152
10353215|NCT00452452|11492046|FG000|NOT COMPLETED|Overall Study||2
10533406|NCT01425801|11685683|FG000|COMPLETED|Period 1||9
10533407|NCT01425801|11685684|FG001|COMPLETED|Period 1||9
10533408|NCT01425801|11685685|FG002|COMPLETED|Period 1||9
10533409|NCT01425801|11685686|FG003|COMPLETED|Period 1||12
10533410|NCT01425801|11685687|FG004|COMPLETED|Period 1||12
10533411|NCT01425801|11685688|FG005|COMPLETED|Period 1||10
10533412|NCT01425801|11685683|FG000|NOT COMPLETED|Period 1||0
10533413|NCT01425801|11685684|FG001|NOT COMPLETED|Period 1||0
10533414|NCT01425801|11685685|FG002|NOT COMPLETED|Period 1||0
10656005|NCT02213198|11816847|FG000|STARTED|Follow up 2 6 Months Post TCC Treatment||125
10353216|NCT00452452|11492047|FG001|NOT COMPLETED|Overall Study||0
10533415|NCT01425801|11685686|FG003|NOT COMPLETED|Period 1||0
10533416|NCT01425801|11685687|FG004|NOT COMPLETED|Period 1||1
10533417|NCT01425801|11685688|FG005|NOT COMPLETED|Period 1||0
10353217|NCT00452452|11492048|FG002|NOT COMPLETED|Overall Study||1
10353218|NCT00452530|11492064|FG000|STARTED|Overall Study|Randomized|1528
10533418|NCT01425801|11685683|FG000|STARTED|Period 2||9
10533419|NCT01425801|11685684|FG001|STARTED|Period 2||9
10533420|NCT01425801|11685685|FG002|STARTED|Period 2||9
10533421|NCT01425801|11685686|FG003|STARTED|Period 2||12
10353219|NCT00452530|11492065|FG001|STARTED|Overall Study|Randomized|1529
10353220|NCT00452530|11492064|FG000|Received Treatment|Overall Study||1501
10353221|NCT00452530|11492065|FG001|Received Treatment|Overall Study||1508
10353222|NCT00452530|11492064|FG000|Evaluable Participants|Overall Study||907
10533422|NCT01425801|11685687|FG004|STARTED|Period 2||12
10533423|NCT01425801|11685688|FG005|STARTED|Period 2||10
10353223|NCT00452530|11492065|FG001|Evaluable Participants|Overall Study||921
10353224|NCT00452530|11492064|FG000|Primary Participants|Overall Study||976
10353225|NCT00452530|11492065|FG001|Primary Participants|Overall Study||997
10353226|NCT00452530|11492064|FG000|COMPLETED|Overall Study||1392
10353227|NCT00452530|11492065|FG001|COMPLETED|Overall Study||1393
10533424|NCT01425801|11685683|FG000|COMPLETED|Period 2||9
10353228|NCT00452530|11492064|FG000|NOT COMPLETED|Overall Study||136
10353229|NCT00452530|11492065|FG001|NOT COMPLETED|Overall Study||136
10353230|NCT00452543|11492077|FG000|STARTED|Overall Study||12
10353231|NCT00452543|11492078|FG001|STARTED|Overall Study||11
10353232|NCT00452543|11492077|FG000|COMPLETED|Overall Study||7
10533425|NCT01425801|11685684|FG001|COMPLETED|Period 2||9
10353233|NCT00452543|11492078|FG001|COMPLETED|Overall Study||5
10353234|NCT00452543|11492077|FG000|NOT COMPLETED|Overall Study||5
10353235|NCT00452543|11492078|FG001|NOT COMPLETED|Overall Study||6
10353236|NCT00452673|11492088|FG000|STARTED|Dose Escalation Period||7
10353237|NCT00452673|11492089|FG001|STARTED|Dose Escalation Period||9
10353238|NCT00452673|11492090|FG002|STARTED|Dose Escalation Period||6
10353239|NCT00452673|11492091|FG003|STARTED|Dose Escalation Period||9
10305835|NCT00095238|11438768|FG000|COMPLETED|Overall Study|completed double-blind therapy|1210
10305836|NCT00095238|11438769|FG001|COMPLETED|Overall Study|completed double-blind therapy|1209
10305837|NCT00095238|11438768|FG000|NOT COMPLETED|Overall Study||857
10305838|NCT00095238|11438769|FG001|NOT COMPLETED|Overall Study||852
10305839|NCT00095303|11438809|FG000|STARTED|Main Study||245
10305840|NCT00095303|11438810|FG001|STARTED|Main Study||235
10305841|NCT00095303|11438809|FG000|COMPLETED|Main Study||154
10305842|NCT00095303|11438810|FG001|COMPLETED|Main Study||148
10305843|NCT00095303|11438809|FG000|NOT COMPLETED|Main Study||91
10305844|NCT00095303|11438810|FG001|NOT COMPLETED|Main Study||87
10305845|NCT00095303|11438809|FG000|STARTED|Follow Up Study|199 (BSFT) gave permission for future contact; not a requirement to finish Main to start Follow up|199
10305846|NCT00095303|11438810|FG001|STARTED|Follow Up Study|179 (TAU) gave permission for future contact; not a requirement to finish Main to start Follow up|179
10305847|NCT00095303|11438809|FG000|COMPLETED|Follow Up Study||140
10305848|NCT00095303|11438810|FG001|COMPLETED|Follow Up Study||121
10305849|NCT00095303|11438809|FG000|NOT COMPLETED|Follow Up Study||59
10305850|NCT00095303|11438810|FG001|NOT COMPLETED|Follow Up Study||58
10305851|NCT00095498|11438819|FG000|STARTED|Overall Study||76
10305852|NCT00095498|11438820|FG001|STARTED|Overall Study||73
10305853|NCT00095498|11438821|FG002|STARTED|Overall Study||78
10305854|NCT00095498|11438819|FG000|Received Investigational Product|Overall Study||72
10305855|NCT00095498|11438820|FG001|Received Investigational Product|Overall Study||71
10305856|NCT00095498|11438821|FG002|Received Investigational Product|Overall Study||75
10305857|NCT00095498|11438819|FG000|COMPLETED|Overall Study||39
10305858|NCT00095498|11438820|FG001|COMPLETED|Overall Study||38
10305859|NCT00095498|11438821|FG002|COMPLETED|Overall Study||39
10305860|NCT00095498|11438819|FG000|NOT COMPLETED|Overall Study||37
10305861|NCT00095498|11438820|FG001|NOT COMPLETED|Overall Study||35
10305862|NCT00095498|11438821|FG002|NOT COMPLETED|Overall Study||39
10305863|NCT00095563|11438829|FG000|STARTED|Overall Study||39
10305864|NCT00095563|11438829|FG000|COMPLETED|Overall Study||39
10305865|NCT00095563|11438829|FG000|NOT COMPLETED|Overall Study||0
10305866|NCT00095576|11438835|FG000|STARTED|Overall Study||1484
10305867|NCT00095576|11438836|FG001|STARTED|Overall Study||1495
10305868|NCT00095576|11438835|FG000|VACCINATED AT VISIT 2 (Dose 1)|Overall Study||1484
10305869|NCT00095576|11438836|FG001|VACCINATED AT VISIT 2 (Dose 1)|Overall Study||1495
10305870|NCT00095576|11438835|FG000|VACCINATED AT VISIT 4 (Dose 2)|Overall Study||1426
10305871|NCT00095576|11438836|FG001|VACCINATED AT VISIT 4 (Dose 2)|Overall Study||1443
10305872|NCT00095576|11438835|FG000|VACCINATED AT VISIT 7 (Dose 3)|Overall Study||1328
10305873|NCT00095576|11438836|FG001|VACCINATED AT VISIT 7 (Dose 3)|Overall Study||1361
10305874|NCT00095576|11438835|FG000|COMPLETED|Overall Study|Subjects not completing entire study were eligible for observational long term follow up in V520-030|9
10305875|NCT00095576|11438836|FG001|COMPLETED|Overall Study|Subjects not completing entire study were eligible for observational long term follow up in V520-030|14
10305876|NCT00095576|11438835|FG000|NOT COMPLETED|Overall Study||1475
10305877|NCT00095576|11438836|FG001|NOT COMPLETED|Overall Study||1481
10305878|NCT00095628|11438842|FG000|STARTED|Overall Study||21
10305879|NCT00095628|11438842|FG000|COMPLETED|Overall Study||20
10305880|NCT00095628|11438842|FG000|NOT COMPLETED|Overall Study||1
10305881|NCT00095836|11438846|FG000|STARTED|Overall Study||27
10305882|NCT00095836|11438846|FG000|COMPLETED|Overall Study||23
10305883|NCT00095836|11438846|FG000|NOT COMPLETED|Overall Study||4
10305884|NCT00095875|11438852|FG000|STARTED|Overall Study||70
10305885|NCT00095875|11438853|FG001|STARTED|Overall Study||75
10305886|NCT00095875|11438852|FG000|COMPLETED|Overall Study||56
10353240|NCT00452673|11492092|FG004|STARTED|Dose Escalation Period||0
10305887|NCT00095875|11438853|FG001|COMPLETED|Overall Study||66
10305888|NCT00095875|11438852|FG000|NOT COMPLETED|Overall Study||14
10305889|NCT00095875|11438853|FG001|NOT COMPLETED|Overall Study||9
10305890|NCT00095940|11438866|FG000|STARTED|Molecular Biology Phase||2
10305891|NCT00095940|11438867|FG001|STARTED|Molecular Biology Phase||2
10305892|NCT00095940|11438868|FG002|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
10353241|NCT00452673|11492088|FG000|COMPLETED|Dose Escalation Period||0
10353242|NCT00452673|11492089|FG001|COMPLETED|Dose Escalation Period||0
10353243|NCT00452673|11492090|FG002|COMPLETED|Dose Escalation Period||0
10353244|NCT00452673|11492091|FG003|COMPLETED|Dose Escalation Period||0
10353245|NCT00452673|11492092|FG004|COMPLETED|Dose Escalation Period||0
10353246|NCT00452673|11492088|FG000|NOT COMPLETED|Dose Escalation Period||7
10353247|NCT00452673|11492089|FG001|NOT COMPLETED|Dose Escalation Period||9
10353248|NCT00452673|11492090|FG002|NOT COMPLETED|Dose Escalation Period||6
10353249|NCT00452673|11492091|FG003|NOT COMPLETED|Dose Escalation Period||9
10353250|NCT00452673|11492092|FG004|NOT COMPLETED|Dose Escalation Period||0
10353251|NCT00452673|11492088|FG000|STARTED|Dose Expansion Period||0
10353252|NCT00452673|11492089|FG001|STARTED|Dose Expansion Period||0
10353253|NCT00452673|11492090|FG002|STARTED|Dose Expansion Period||0
10353254|NCT00452673|11492091|FG003|STARTED|Dose Expansion Period||0
10353255|NCT00452673|11492092|FG004|STARTED|Dose Expansion Period|The last dose level arm in the escalation period was selected for the dose expansion period.|21
10353256|NCT00452673|11492088|FG000|COMPLETED|Dose Expansion Period||0
10353257|NCT00452673|11492089|FG001|COMPLETED|Dose Expansion Period||0
10353258|NCT00452673|11492090|FG002|COMPLETED|Dose Expansion Period||0
10353259|NCT00452673|11492091|FG003|COMPLETED|Dose Expansion Period||0
10353260|NCT00452673|11492092|FG004|COMPLETED|Dose Expansion Period||0
10353261|NCT00452673|11492088|FG000|NOT COMPLETED|Dose Expansion Period||0
10353262|NCT00452673|11492089|FG001|NOT COMPLETED|Dose Expansion Period||0
10353263|NCT00452673|11492090|FG002|NOT COMPLETED|Dose Expansion Period||0
10353264|NCT00452673|11492091|FG003|NOT COMPLETED|Dose Expansion Period||0
10353265|NCT00452673|11492092|FG004|NOT COMPLETED|Dose Expansion Period||21
10353266|NCT00452699|11492105|FG000|STARTED|Overall Study||306
10353267|NCT00452699|11492106|FG001|STARTED|Overall Study||315
10353268|NCT00452699|11492105|FG000|COMPLETED|Overall Study||225
10353269|NCT00452699|11492106|FG001|COMPLETED|Overall Study||242
10656006|NCT02213198|11816848|FG001|STARTED|Follow up 2 6 Months Post TCC Treatment||67
10656007|NCT02213198|11816847|FG000|COMPLETED|Follow up 2 6 Months Post TCC Treatment||102
10656008|NCT02213198|11816848|FG001|COMPLETED|Follow up 2 6 Months Post TCC Treatment||60
10656009|NCT02213198|11816847|FG000|NOT COMPLETED|Follow up 2 6 Months Post TCC Treatment||23
10656010|NCT02213198|11816848|FG001|NOT COMPLETED|Follow up 2 6 Months Post TCC Treatment||7
10656011|NCT02213250|11816854|FG000|STARTED|Overall Study||4
10656012|NCT02213250|11816855|FG001|STARTED|Overall Study||8
10656013|NCT02213250|11816854|FG000|COMPLETED|Overall Study||4
10656014|NCT02213250|11816855|FG001|COMPLETED|Overall Study||8
10353270|NCT00452699|11492105|FG000|NOT COMPLETED|Overall Study||81
10353271|NCT00452699|11492106|FG001|NOT COMPLETED|Overall Study||73
10353272|NCT00452790|11492114|FG000|STARTED|Infant Series||354
10353273|NCT00452790|11492115|FG001|STARTED|Infant Series||355
10353274|NCT00452790|11492114|FG000|Vaccinated Dose 1|Infant Series||353
10353275|NCT00452790|11492115|FG001|Vaccinated Dose 1|Infant Series||353
10656015|NCT02213250|11816854|FG000|NOT COMPLETED|Overall Study||0
10656016|NCT02213250|11816855|FG001|NOT COMPLETED|Overall Study||0
10656017|NCT02213263|11816864|FG000|STARTED|Overall Study||198
10353276|NCT00452790|11492114|FG000|Vaccinated Dose 2|Infant Series||300
10353277|NCT00452790|11492115|FG001|Vaccinated Dose 2|Infant Series||300
10353278|NCT00452790|11492114|FG000|Vaccinated Dose 3|Infant Series||221
10353279|NCT00452790|11492115|FG001|Vaccinated Dose 3|Infant Series||218
10353280|NCT00452790|11492114|FG000|COMPLETED|Infant Series||219
10353281|NCT00452790|11492115|FG001|COMPLETED|Infant Series||214
10353282|NCT00452790|11492114|FG000|NOT COMPLETED|Infant Series||135
10353283|NCT00452790|11492115|FG001|NOT COMPLETED|Infant Series||141
10353284|NCT00452790|11492114|FG000|STARTED|After Infant Series||219
10353285|NCT00452790|11492115|FG001|STARTED|After Infant Series||214
10353286|NCT00452790|11492114|FG000|COMPLETED|After Infant Series||198
10353287|NCT00452790|11492115|FG001|COMPLETED|After Infant Series||200
10353288|NCT00452790|11492114|FG000|NOT COMPLETED|After Infant Series||21
10353289|NCT00452790|11492115|FG001|NOT COMPLETED|After Infant Series||14
10353290|NCT00452790|11492114|FG000|STARTED|Toddler Dose||198
10353291|NCT00452790|11492115|FG001|STARTED|Toddler Dose||200
10353292|NCT00452790|11492114|FG000|COMPLETED|Toddler Dose||198
10353293|NCT00452790|11492115|FG001|COMPLETED|Toddler Dose||198
10353294|NCT00452790|11492114|FG000|NOT COMPLETED|Toddler Dose||0
10353295|NCT00452790|11492115|FG001|NOT COMPLETED|Toddler Dose||2
10353296|NCT00452868|11492125|FG000|STARTED|Overall Study||13
10353297|NCT00452868|11492125|FG000|COMPLETED|Overall Study||11
10353298|NCT00452868|11492125|FG000|NOT COMPLETED|Overall Study||2
10353299|NCT00453102|11492129|FG000|STARTED|Overall Study||18
10353300|NCT00453102|11492129|FG000|COMPLETED|Overall Study||16
10353301|NCT00453102|11492129|FG000|NOT COMPLETED|Overall Study||2
10353302|NCT00453154|11492136|FG000|STARTED|Combination Chemotherapy||12
10353303|NCT00453154|11492137|FG001|STARTED|Combination Chemotherapy||144
10353304|NCT00453154|11492138|FG002|STARTED|Combination Chemotherapy||0
10353305|NCT00453154|11492139|FG003|STARTED|Combination Chemotherapy||0
10353306|NCT00453154|11492136|FG000|COMPLETED|Combination Chemotherapy||12
10353307|NCT00453154|11492137|FG001|COMPLETED|Combination Chemotherapy||95
10353308|NCT00453154|11492138|FG002|COMPLETED|Combination Chemotherapy||0
10353309|NCT00453154|11492139|FG003|COMPLETED|Combination Chemotherapy||0
10353310|NCT00453154|11492136|FG000|NOT COMPLETED|Combination Chemotherapy||0
10353311|NCT00453154|11492137|FG001|NOT COMPLETED|Combination Chemotherapy||49
10353312|NCT00453154|11492138|FG002|NOT COMPLETED|Combination Chemotherapy||0
10353313|NCT00453154|11492139|FG003|NOT COMPLETED|Combination Chemotherapy||0
10353314|NCT00453154|11492136|FG000|STARTED|Double BIind Maintenance||0
10353315|NCT00453154|11492137|FG001|STARTED|Double BIind Maintenance||0
10353316|NCT00453154|11492138|FG002|STARTED|Double BIind Maintenance||46
10353317|NCT00453154|11492139|FG003|STARTED|Double BIind Maintenance||49
10353318|NCT00453154|11492136|FG000|COMPLETED|Double BIind Maintenance||0
10353319|NCT00453154|11492137|FG001|COMPLETED|Double BIind Maintenance||0
10353320|NCT00453154|11492138|FG002|COMPLETED|Double BIind Maintenance||0
10353321|NCT00453154|11492139|FG003|COMPLETED|Double BIind Maintenance||0
10353322|NCT00453154|11492136|FG000|NOT COMPLETED|Double BIind Maintenance||0
10716026|NCT02688387|11880055|FG012|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10353323|NCT00453154|11492137|FG001|NOT COMPLETED|Double BIind Maintenance||0
10716027|NCT02688387|11880056|FG013|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10716028|NCT02688387|11880057|FG014|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10353324|NCT00453154|11492138|FG002|NOT COMPLETED|Double BIind Maintenance||46
10353325|NCT00453154|11492139|FG003|NOT COMPLETED|Double BIind Maintenance||49
10353326|NCT00453154|11492136|FG000|STARTED|Open Label Sunitinib Crossover||0
10353327|NCT00453154|11492137|FG001|STARTED|Open Label Sunitinib Crossover||0
10353328|NCT00453154|11492138|FG002|STARTED|Open Label Sunitinib Crossover||18
10353329|NCT00453154|11492139|FG003|STARTED|Open Label Sunitinib Crossover||0
10353330|NCT00453154|11492136|FG000|COMPLETED|Open Label Sunitinib Crossover||0
10353331|NCT00453154|11492137|FG001|COMPLETED|Open Label Sunitinib Crossover||0
10353332|NCT00453154|11492138|FG002|COMPLETED|Open Label Sunitinib Crossover||18
10353333|NCT00453154|11492139|FG003|COMPLETED|Open Label Sunitinib Crossover||0
10353334|NCT00453154|11492136|FG000|NOT COMPLETED|Open Label Sunitinib Crossover||0
10353335|NCT00453154|11492137|FG001|NOT COMPLETED|Open Label Sunitinib Crossover||0
10353336|NCT00453154|11492138|FG002|NOT COMPLETED|Open Label Sunitinib Crossover||0
10353337|NCT00453154|11492139|FG003|NOT COMPLETED|Open Label Sunitinib Crossover||0
10353338|NCT00453180|11492150|FG000|STARTED|Overall Study||16
10353339|NCT00453180|11492151|FG001|STARTED|Overall Study||15
10716029|NCT02688387|11880058|FG015|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10716030|NCT02688387|11880059|FG016|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10716031|NCT02688387|11880060|FG017|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10716032|NCT02688387|11880061|FG018|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10716033|NCT02688387|11880062|FG019|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10716034|NCT02688387|11880063|FG020|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10716035|NCT02688387|11880064|FG021|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
10716036|NCT02688387|11880043|FG000|STARTED|Part 3B, Washout Period 1 (10 Days)||0
10353340|NCT00453180|11492150|FG000|COMPLETED|Overall Study||13
10353341|NCT00453180|11492151|FG001|COMPLETED|Overall Study||12
10353342|NCT00453180|11492150|FG000|NOT COMPLETED|Overall Study||3
10353343|NCT00453180|11492151|FG001|NOT COMPLETED|Overall Study||3
10353344|NCT00453193|11492157|FG000|STARTED|Overall Study||24
10353345|NCT00453193|11492157|FG000|COMPLETED|Overall Study||24
10353346|NCT00453193|11492157|FG000|NOT COMPLETED|Overall Study||0
10353347|NCT00453206|11492161|FG000|STARTED|Overall Study||66
10353348|NCT00453206|11492161|FG000|COMPLETED|Overall Study||65
10353349|NCT00453206|11492161|FG000|NOT COMPLETED|Overall Study||1
10353350|NCT00453310|11492165|FG000|STARTED|Overall Study||10
10353351|NCT00453310|11492165|FG000|COMPLETED|Overall Study||0
10353352|NCT00453310|11492165|FG000|NOT COMPLETED|Overall Study||10
10353353|NCT00453336|11492169|FG000|STARTED|Overall Study||45
10353354|NCT00453336|11492169|FG000|COMPLETED|Overall Study||45
10353355|NCT00453336|11492169|FG000|NOT COMPLETED|Overall Study||0
10353356|NCT00453349|11492175|FG000|STARTED|Randomized||228
10353357|NCT00453349|11492176|FG001|STARTED|Randomized||232
10353358|NCT00453349|11492175|FG000|COMPLETED|Randomized||203
10353359|NCT00453349|11492176|FG001|COMPLETED|Randomized||209
10353360|NCT00453349|11492175|FG000|NOT COMPLETED|Randomized||25
10353361|NCT00453349|11492176|FG001|NOT COMPLETED|Randomized||23
10353362|NCT00453349|11492175|FG000|STARTED|Reaching of Primary Endpoint (TOC)|Subjects who attended the TOC visit or at least had a clinical evaluation at TOC|225
10353363|NCT00453349|11492176|FG001|STARTED|Reaching of Primary Endpoint (TOC)|i.e. the ITT population|230
10353364|NCT00453349|11492175|FG000|Valid for Primary Efficacy Analysis|Reaching of Primary Endpoint (TOC)||194
10353365|NCT00453349|11492176|FG001|Valid for Primary Efficacy Analysis|Reaching of Primary Endpoint (TOC)||190
10353366|NCT00453349|11492175|FG000|COMPLETED|Reaching of Primary Endpoint (TOC)|All PP patients and ITT patients with a clinical response with no missing information|215
10353367|NCT00453349|11492176|FG001|COMPLETED|Reaching of Primary Endpoint (TOC)||219
10353368|NCT00453349|11492175|FG000|NOT COMPLETED|Reaching of Primary Endpoint (TOC)||10
10353369|NCT00453349|11492176|FG001|NOT COMPLETED|Reaching of Primary Endpoint (TOC)||11
10353370|NCT00453349|11492175|FG000|STARTED|Completed Study||228
10353371|NCT00453349|11492176|FG001|STARTED|Completed Study||232
10353372|NCT00453349|11492175|FG000|Completed Study Treatment|Completed Study|25 terminated prematurely|203
10353373|NCT00453349|11492176|FG001|Completed Study Treatment|Completed Study|23 terminated prematurely|209
10353374|NCT00453349|11492175|FG000|COMPLETED|Completed Study|had follow-up assessment or alternative antibiotic assessment|201
10353375|NCT00453349|11492176|FG001|COMPLETED|Completed Study|had follow-up assessment or alternative antibiotic assessment|198
10353376|NCT00453349|11492175|FG000|NOT COMPLETED|Completed Study||27
10353377|NCT00453349|11492176|FG001|NOT COMPLETED|Completed Study||34
10353378|NCT00453362|11492182|FG000|STARTED|Overall Study|14 participants consented but did not receive drug and are not represented in the baseline data|88
10353379|NCT00453362|11492182|FG000|Treated With Erlotinib|Overall Study||74
10716037|NCT02688387|11880044|FG001|STARTED|Part 3B, Washout Period 1 (10 Days)||0
10716038|NCT02688387|11880045|FG002|STARTED|Part 3B, Washout Period 1 (10 Days)||0
10353380|NCT00453362|11492182|FG000|FDG-PET Evaluable|Overall Study|Participants who completed all FDG-PET scans through day 56.|51
10353381|NCT00453362|11492182|FG000|FLT-PET Evaluable|Overall Study|Participants who completed all FLT-PET scans through day 56.|50
10353382|NCT00453362|11492182|FG000|COMPLETED|Overall Study||1
10353383|NCT00453362|11492182|FG000|NOT COMPLETED|Overall Study||87
10353384|NCT00453388|11492202|FG000|STARTED|Overall Study||0
10353385|NCT00453388|11492203|FG001|STARTED|Overall Study||5
10353386|NCT00453388|11492204|FG002|STARTED|Overall Study||1
10353387|NCT00453388|11492205|FG003|STARTED|Overall Study||0
10353388|NCT00453388|11492202|FG000|COMPLETED|Overall Study||0
10353389|NCT00453388|11492203|FG001|COMPLETED|Overall Study||5
10353390|NCT00453388|11492204|FG002|COMPLETED|Overall Study||1
10353391|NCT00453388|11492205|FG003|COMPLETED|Overall Study||0
10353392|NCT00453388|11492202|FG000|NOT COMPLETED|Overall Study||0
10353393|NCT00453388|11492203|FG001|NOT COMPLETED|Overall Study||0
10353394|NCT00453388|11492204|FG002|NOT COMPLETED|Overall Study||0
10353395|NCT00453388|11492205|FG003|NOT COMPLETED|Overall Study||0
10353396|NCT00453479|11492218|FG000|STARTED|Overall Study||6
10353397|NCT00453479|11492219|FG001|STARTED|Overall Study||9
10353398|NCT00453479|11492220|FG002|STARTED|Overall Study||8
10353399|NCT00453479|11492218|FG000|COMPLETED|Overall Study||6
10353400|NCT00453479|11492219|FG001|COMPLETED|Overall Study||9
10353401|NCT00453479|11492220|FG002|COMPLETED|Overall Study||8
10353402|NCT00453479|11492218|FG000|NOT COMPLETED|Overall Study||0
10353403|NCT00453479|11492219|FG001|NOT COMPLETED|Overall Study||0
10353404|NCT00453479|11492220|FG002|NOT COMPLETED|Overall Study||0
10353405|NCT00453895|11492230|FG000|STARTED|Overall Study||39
10353406|NCT00453895|11492230|FG000|COMPLETED|Overall Study||39
10353407|NCT00453895|11492230|FG000|NOT COMPLETED|Overall Study||0
10353408|NCT00453921|11492238|FG000|STARTED|Overall Study||19
10353409|NCT00453921|11492239|FG001|STARTED|Overall Study||18
10353410|NCT00453921|11492240|FG002|STARTED|Overall Study||20
10353411|NCT00453921|11492241|FG003|STARTED|Overall Study||19
10353412|NCT00453921|11492238|FG000|COMPLETED|Overall Study||18
10353413|NCT00453921|11492239|FG001|COMPLETED|Overall Study||17
10353414|NCT00453921|11492240|FG002|COMPLETED|Overall Study||18
10353415|NCT00453921|11492241|FG003|COMPLETED|Overall Study||18
10353416|NCT00453921|11492238|FG000|NOT COMPLETED|Overall Study||1
10353417|NCT00453921|11492239|FG001|NOT COMPLETED|Overall Study||1
10353418|NCT00453921|11492240|FG002|NOT COMPLETED|Overall Study||2
10353419|NCT00453921|11492241|FG003|NOT COMPLETED|Overall Study||1
10353420|NCT00453973|11492257|FG000|STARTED|Overall Study||51
10353421|NCT00453973|11492258|FG001|STARTED|Overall Study||63
10353422|NCT00453973|11492257|FG000|COMPLETED|Overall Study||0
10353423|NCT00453973|11492258|FG001|COMPLETED|Overall Study||15
10353424|NCT00453973|11492257|FG000|NOT COMPLETED|Overall Study||51
10353425|NCT00453973|11492258|FG001|NOT COMPLETED|Overall Study||48
10353426|NCT00453986|11492269|FG000|STARTED|Overall Study||311
10353427|NCT00453986|11492270|FG001|STARTED|Overall Study||311
10353428|NCT00453986|11492271|FG002|STARTED|Overall Study||313
10353429|NCT00453986|11492272|FG003|STARTED|Overall Study||312
10353430|NCT00453986|11492273|FG004|STARTED|Overall Study||105
10353431|NCT00453986|11492269|FG000|COMPLETED|Overall Study||305
10353432|NCT00453986|11492270|FG001|COMPLETED|Overall Study||306
10353433|NCT00453986|11492271|FG002|COMPLETED|Overall Study||307
10353434|NCT00453986|11492272|FG003|COMPLETED|Overall Study||310
10353435|NCT00453986|11492273|FG004|COMPLETED|Overall Study||105
10353436|NCT00453986|11492269|FG000|NOT COMPLETED|Overall Study||6
10353437|NCT00453986|11492270|FG001|NOT COMPLETED|Overall Study||5
10353438|NCT00453986|11492271|FG002|NOT COMPLETED|Overall Study||6
10353439|NCT00453986|11492272|FG003|NOT COMPLETED|Overall Study||2
10353440|NCT00453986|11492273|FG004|NOT COMPLETED|Overall Study||0
10353441|NCT00453999|11492292|FG000|STARTED|Overall Study||45
10353442|NCT00453999|11492293|FG001|STARTED|Overall Study||46
10353443|NCT00453999|11492294|FG002|STARTED|Overall Study||46
10353444|NCT00453999|11492292|FG000|COMPLETED|Overall Study||40
10353445|NCT00453999|11492293|FG001|COMPLETED|Overall Study||41
10353446|NCT00453999|11492294|FG002|COMPLETED|Overall Study||43
10353447|NCT00453999|11492292|FG000|NOT COMPLETED|Overall Study||5
10353448|NCT00453999|11492293|FG001|NOT COMPLETED|Overall Study||5
10353449|NCT00453999|11492294|FG002|NOT COMPLETED|Overall Study||3
10353450|NCT00454051|11492305|FG000|STARTED|Overall Study||20
10353451|NCT00454051|11492306|FG001|STARTED|Overall Study||11
10353452|NCT00454051|11492305|FG000|COMPLETED|Overall Study||17
10353453|NCT00454051|11492306|FG001|COMPLETED|Overall Study||8
10353454|NCT00454051|11492305|FG000|NOT COMPLETED|Overall Study||3
10353455|NCT00454051|11492306|FG001|NOT COMPLETED|Overall Study||3
10353456|NCT00454116|11492315|FG000|STARTED|Overall Study|randomised patients|35
10353457|NCT00454116|11492316|FG001|STARTED|Overall Study|randomised patients|36
10353458|NCT00454116|11492317|FG002|STARTED|Overall Study|randomised patients|35
10353459|NCT00454116|11492315|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|8
10353460|NCT00454116|11492316|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|7
10353461|NCT00454116|11492317|FG002|COMPLETED|Overall Study|ongoing study treatment at data cut-off|7
10353462|NCT00454116|11492315|FG000|NOT COMPLETED|Overall Study||27
10353463|NCT00454116|11492316|FG001|NOT COMPLETED|Overall Study||29
10353464|NCT00454116|11492317|FG002|NOT COMPLETED|Overall Study||28
10353465|NCT00454142|11492325|FG000|STARTED|Overall Study||33
10353466|NCT00454142|11492325|FG000|COMPLETED|Overall Study||32
10353467|NCT00454142|11492325|FG000|NOT COMPLETED|Overall Study||1
10353468|NCT00454181|11492333|FG000|STARTED|Overall Study||45
10353469|NCT00454181|11492334|FG001|STARTED|Overall Study||14
10353470|NCT00454181|11492333|FG000|COMPLETED|Overall Study||30
10353471|NCT00454181|11492334|FG001|COMPLETED|Overall Study||11
10353472|NCT00454181|11492333|FG000|NOT COMPLETED|Overall Study||15
10353473|NCT00454181|11492334|FG001|NOT COMPLETED|Overall Study||3
10353474|NCT00454194|11492342|FG000|STARTED|Overall Study||47
10353475|NCT00454194|11492343|FG001|STARTED|Overall Study||51
10353476|NCT00454194|11492342|FG000|COMPLETED|Overall Study||25
10353477|NCT00454194|11492343|FG001|COMPLETED|Overall Study||37
10353478|NCT00454194|11492342|FG000|NOT COMPLETED|Overall Study||22
10353479|NCT00454194|11492343|FG001|NOT COMPLETED|Overall Study||14
10353480|NCT00454207|11492351|FG000|STARTED|Overall Study||21
10353481|NCT00454207|11492352|FG001|STARTED|Overall Study||23
10353482|NCT00454207|11492351|FG000|COMPLETED|Overall Study|19 participants completed Part I period. 17 of 19 participants continued from part I into Part II.|17
10353483|NCT00454207|11492352|FG001|COMPLETED|Overall Study||21
10353484|NCT00454207|11492351|FG000|NOT COMPLETED|Overall Study||4
10353485|NCT00454207|11492352|FG001|NOT COMPLETED|Overall Study||2
10353486|NCT00454246|11492373|FG000|STARTED|Overall Study||73
10353487|NCT00454246|11492374|FG001|STARTED|Overall Study||29
10353488|NCT00454246|11492375|FG002|STARTED|Overall Study||9
10353489|NCT00454246|11492373|FG000|COMPLETED|Overall Study||0
10353490|NCT00454246|11492374|FG001|COMPLETED|Overall Study||0
10353491|NCT00454246|11492375|FG002|COMPLETED|Overall Study||0
10353492|NCT00454246|11492373|FG000|NOT COMPLETED|Overall Study||73
10353493|NCT00454246|11492374|FG001|NOT COMPLETED|Overall Study||29
10353494|NCT00454246|11492375|FG002|NOT COMPLETED|Overall Study||9
10353495|NCT00454324|11492385|FG000|STARTED|Overall Study||14
10353496|NCT00454324|11492386|FG001|STARTED|Overall Study||13
10353497|NCT00454324|11492385|FG000|COMPLETED|Overall Study||14
10353498|NCT00454324|11492386|FG001|COMPLETED|Overall Study||13
10353499|NCT00454324|11492385|FG000|NOT COMPLETED|Overall Study||0
10353500|NCT00454324|11492386|FG001|NOT COMPLETED|Overall Study||0
10353501|NCT00454363|11492394|FG000|STARTED|Overall Study||20
10353502|NCT00454363|11492395|FG001|STARTED|Overall Study||31
10353503|NCT00454363|11492394|FG000|COMPLETED|Overall Study||15
10353504|NCT00454363|11492395|FG001|COMPLETED|Overall Study||29
10353505|NCT00454363|11492394|FG000|NOT COMPLETED|Overall Study||5
10353506|NCT00454363|11492395|FG001|NOT COMPLETED|Overall Study||2
10353507|NCT00454532|11492404|FG000|STARTED|Overall Study||11
10353508|NCT00454532|11492405|FG001|STARTED|Overall Study||6
10353509|NCT00454532|11492406|FG002|STARTED|Overall Study||3
10353510|NCT00454532|11492407|FG003|STARTED|Overall Study||7
10353511|NCT00454532|11492404|FG000|COMPLETED|Overall Study||11
10353512|NCT00454532|11492405|FG001|COMPLETED|Overall Study||6
10353513|NCT00454532|11492406|FG002|COMPLETED|Overall Study||3
10353514|NCT00454532|11492407|FG003|COMPLETED|Overall Study||7
10353515|NCT00454532|11492404|FG000|NOT COMPLETED|Overall Study||0
10353516|NCT00454532|11492405|FG001|NOT COMPLETED|Overall Study||0
10353517|NCT00454532|11492406|FG002|NOT COMPLETED|Overall Study||0
10353518|NCT00454532|11492407|FG003|NOT COMPLETED|Overall Study||0
10353519|NCT00454584|11492420|FG000|STARTED|Controlled Period||347
10353520|NCT00454584|11492421|FG001|STARTED|Controlled Period||209
10353521|NCT00454584|11492422|FG002|STARTED|Controlled Period||347
10353522|NCT00454584|11492423|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
10353523|NCT00454584|11492424|FG004|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
10353524|NCT00454584|11492425|FG005|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
10353525|NCT00454584|11492420|FG000|COMPLETED|Controlled Period||336
10353526|NCT00454584|11492421|FG001|COMPLETED|Controlled Period||201
10353527|NCT00454584|11492422|FG002|COMPLETED|Controlled Period||342
10353528|NCT00454584|11492423|FG003|COMPLETED|Controlled Period||0
10353529|NCT00454584|11492424|FG004|COMPLETED|Controlled Period||0
10353530|NCT00454584|11492425|FG005|COMPLETED|Controlled Period||0
10353531|NCT00454584|11492420|FG000|NOT COMPLETED|Controlled Period||11
10353532|NCT00454584|11492421|FG001|NOT COMPLETED|Controlled Period||8
10353533|NCT00454584|11492422|FG002|NOT COMPLETED|Controlled Period||5
10353534|NCT00454584|11492423|FG003|NOT COMPLETED|Controlled Period||0
10353535|NCT00454584|11492424|FG004|NOT COMPLETED|Controlled Period||0
10353536|NCT00454584|11492425|FG005|NOT COMPLETED|Controlled Period||0
10353537|NCT00454584|11492420|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
10353538|NCT00454584|11492421|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
10353539|NCT00454584|11492422|FG002|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
10353540|NCT00454584|11492423|FG003|STARTED|After Controlled Period||336
10353541|NCT00454584|11492424|FG004|STARTED|After Controlled Period||201
10353542|NCT00454584|11492425|FG005|STARTED|After Controlled Period||342
10353543|NCT00454584|11492420|FG000|COMPLETED|After Controlled Period||0
10353544|NCT00454584|11492421|FG001|COMPLETED|After Controlled Period||0
10353545|NCT00454584|11492422|FG002|COMPLETED|After Controlled Period||0
10353546|NCT00454584|11492423|FG003|COMPLETED|After Controlled Period||310
10353547|NCT00454584|11492424|FG004|COMPLETED|After Controlled Period||189
10353548|NCT00454584|11492425|FG005|COMPLETED|After Controlled Period||310
10353549|NCT00454584|11492420|FG000|NOT COMPLETED|After Controlled Period||0
10353550|NCT00454584|11492421|FG001|NOT COMPLETED|After Controlled Period||0
10353551|NCT00454584|11492422|FG002|NOT COMPLETED|After Controlled Period||0
10353552|NCT00454584|11492423|FG003|NOT COMPLETED|After Controlled Period||26
10353553|NCT00454584|11492424|FG004|NOT COMPLETED|After Controlled Period||12
10353554|NCT00454584|11492425|FG005|NOT COMPLETED|After Controlled Period||32
10353555|NCT00454636|11492443|FG000|STARTED|Overall Study||41
10353556|NCT00454636|11492444|FG001|STARTED|Overall Study||32
10353557|NCT00454636|11492445|FG002|STARTED|Overall Study||27
10353558|NCT00454636|11492446|FG003|STARTED|Overall Study||58
10353559|NCT00454636|11492443|FG000|COMPLETED|Overall Study||10
10353560|NCT00454636|11492444|FG001|COMPLETED|Overall Study||9
10353561|NCT00454636|11492445|FG002|COMPLETED|Overall Study||7
10353562|NCT00454636|11492446|FG003|COMPLETED|Overall Study||26
10353563|NCT00454636|11492443|FG000|NOT COMPLETED|Overall Study||31
10353564|NCT00454636|11492444|FG001|NOT COMPLETED|Overall Study||23
10353565|NCT00454636|11492445|FG002|NOT COMPLETED|Overall Study||20
10353566|NCT00454636|11492446|FG003|NOT COMPLETED|Overall Study||32
10353567|NCT00454649|11492466|FG000|STARTED|Overall Study||3
10353568|NCT00454649|11492467|FG001|STARTED|Overall Study||5
10353569|NCT00454649|11492468|FG002|STARTED|Overall Study||20
10353570|NCT00454649|11492469|FG003|STARTED|Overall Study||7
10353571|NCT00454649|11492470|FG004|STARTED|Overall Study||1
10353572|NCT00454649|11492471|FG005|STARTED|Overall Study||7
10353573|NCT00454649|11492472|FG006|STARTED|Overall Study||9
10353574|NCT00454649|11492473|FG007|STARTED|Overall Study||19
10353575|NCT00454649|11492474|FG008|STARTED|Overall Study||21
10353576|NCT00454649|11492475|FG009|STARTED|Overall Study||6
10353577|NCT00454649|11492466|FG000|COMPLETED|Overall Study||0
10353578|NCT00454649|11492467|FG001|COMPLETED|Overall Study||1
10353579|NCT00454649|11492468|FG002|COMPLETED|Overall Study||1
10353580|NCT00454649|11492469|FG003|COMPLETED|Overall Study||1
10353581|NCT00454649|11492470|FG004|COMPLETED|Overall Study||0
10353582|NCT00454649|11492471|FG005|COMPLETED|Overall Study||0
10353583|NCT00454649|11492472|FG006|COMPLETED|Overall Study||0
10353584|NCT00454649|11492473|FG007|COMPLETED|Overall Study||0
10353585|NCT00454649|11492474|FG008|COMPLETED|Overall Study||1
10353586|NCT00454649|11492475|FG009|COMPLETED|Overall Study||1
10353587|NCT00454649|11492466|FG000|NOT COMPLETED|Overall Study||3
10353588|NCT00454649|11492467|FG001|NOT COMPLETED|Overall Study||4
10353589|NCT00454649|11492468|FG002|NOT COMPLETED|Overall Study||19
10353590|NCT00454649|11492469|FG003|NOT COMPLETED|Overall Study||6
10353591|NCT00454649|11492470|FG004|NOT COMPLETED|Overall Study||1
10353592|NCT00454649|11492471|FG005|NOT COMPLETED|Overall Study||7
10353593|NCT00454649|11492472|FG006|NOT COMPLETED|Overall Study||9
10353594|NCT00454649|11492473|FG007|NOT COMPLETED|Overall Study||19
10353595|NCT00454649|11492474|FG008|NOT COMPLETED|Overall Study||20
10353596|NCT00454649|11492475|FG009|NOT COMPLETED|Overall Study||5
10353597|NCT00454779|11492518|FG000|STARTED|First-line Treatment Phase||56
10353598|NCT00454779|11492519|FG001|STARTED|First-line Treatment Phase||57
10353599|NCT00454779|11492518|FG000|Received Study Medication|First-line Treatment Phase||56
10353600|NCT00454779|11492519|FG001|Received Study Medication|First-line Treatment Phase||55
10353601|NCT00454779|11492518|FG000|COMPLETED|First-line Treatment Phase|Disease progression (radiographically determined) or death|51
10353602|NCT00454779|11492519|FG001|COMPLETED|First-line Treatment Phase|Disease progression (radiographically determined) or death|49
10353603|NCT00454779|11492518|FG000|NOT COMPLETED|First-line Treatment Phase||5
10353604|NCT00454779|11492519|FG001|NOT COMPLETED|First-line Treatment Phase||8
10353605|NCT00454779|11492518|FG000|STARTED|Second-line Treatment Phase|Subjects in this arm do not have second-line treatment period|0
10353606|NCT00454779|11492519|FG001|STARTED|Second-line Treatment Phase|Second-line Panitumumab Monotherapy|30
10353607|NCT00454779|11492518|FG000|COMPLETED|Second-line Treatment Phase|Disease progression (radiographically determined) or death|0
10353608|NCT00454779|11492519|FG001|COMPLETED|Second-line Treatment Phase|Disease progression (radiographically determined) or death|27
10353609|NCT00454779|11492518|FG000|NOT COMPLETED|Second-line Treatment Phase||0
10353610|NCT00454779|11492519|FG001|NOT COMPLETED|Second-line Treatment Phase||3
10353611|NCT00454805|11492527|FG000|STARTED|Overall Study|Randomised|31
10353612|NCT00454805|11492528|FG001|STARTED|Overall Study|Randomised|31
10353613|NCT00454805|11492527|FG000|COMPLETED|Overall Study|Ongoing at data cut-off|5
10353614|NCT00454805|11492528|FG001|COMPLETED|Overall Study|Ongoing at data cut-off|8
10353615|NCT00454805|11492527|FG000|NOT COMPLETED|Overall Study||26
10353616|NCT00454805|11492528|FG001|NOT COMPLETED|Overall Study||23
10353617|NCT00454818|11492542|FG000|STARTED|Phase I: Open-label Dose-escalation||3
10353618|NCT00454818|11492543|FG001|STARTED|Phase I: Open-label Dose-escalation||3
10353619|NCT00454818|11492544|FG002|STARTED|Phase I: Open-label Dose-escalation||3
10533426|NCT01425801|11685685|FG002|COMPLETED|Period 2||9
10533427|NCT01425801|11685686|FG003|COMPLETED|Period 2||12
10533428|NCT01425801|11685687|FG004|COMPLETED|Period 2||11
10533429|NCT01425801|11685688|FG005|COMPLETED|Period 2||10
10353620|NCT00454818|11492545|FG003|STARTED|Phase I: Open-label Dose-escalation||3
10353621|NCT00454818|11492546|FG004|STARTED|Phase I: Open-label Dose-escalation||0
10353622|NCT00454818|11492542|FG000|COMPLETED|Phase I: Open-label Dose-escalation||2
10533430|NCT01425801|11685683|FG000|NOT COMPLETED|Period 2||0
10426914|NCT00849693|11572619|FG003|NOT COMPLETED|Extension Phase||38
10353623|NCT00454818|11492543|FG001|COMPLETED|Phase I: Open-label Dose-escalation||2
10353624|NCT00454818|11492544|FG002|COMPLETED|Phase I: Open-label Dose-escalation||2
10353625|NCT00454818|11492545|FG003|COMPLETED|Phase I: Open-label Dose-escalation||2
10353626|NCT00454818|11492546|FG004|COMPLETED|Phase I: Open-label Dose-escalation||0
10353627|NCT00454818|11492542|FG000|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
10353628|NCT00454818|11492543|FG001|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
10353629|NCT00454818|11492544|FG002|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
10353630|NCT00454818|11492545|FG003|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
10353631|NCT00454818|11492546|FG004|NOT COMPLETED|Phase I: Open-label Dose-escalation||0
10353632|NCT00454818|11492542|FG000|STARTED|Phase 2: Randomized Double-blind||0
10353633|NCT00454818|11492543|FG001|STARTED|Phase 2: Randomized Double-blind||8
10353634|NCT00454818|11492544|FG002|STARTED|Phase 2: Randomized Double-blind||8
10353635|NCT00454818|11492545|FG003|STARTED|Phase 2: Randomized Double-blind||9
10353636|NCT00454818|11492546|FG004|STARTED|Phase 2: Randomized Double-blind||14
10353637|NCT00454818|11492542|FG000|COMPLETED|Phase 2: Randomized Double-blind||0
10353638|NCT00454818|11492543|FG001|COMPLETED|Phase 2: Randomized Double-blind||6
10353639|NCT00454818|11492544|FG002|COMPLETED|Phase 2: Randomized Double-blind||5
10353640|NCT00454818|11492545|FG003|COMPLETED|Phase 2: Randomized Double-blind||8
10353641|NCT00454818|11492546|FG004|COMPLETED|Phase 2: Randomized Double-blind||10
10353642|NCT00454818|11492542|FG000|NOT COMPLETED|Phase 2: Randomized Double-blind||0
10353643|NCT00454818|11492543|FG001|NOT COMPLETED|Phase 2: Randomized Double-blind||2
10353644|NCT00454818|11492544|FG002|NOT COMPLETED|Phase 2: Randomized Double-blind||3
10353645|NCT00454818|11492545|FG003|NOT COMPLETED|Phase 2: Randomized Double-blind||1
10353646|NCT00454818|11492546|FG004|NOT COMPLETED|Phase 2: Randomized Double-blind||4
10353647|NCT00454857|11492563|FG000|STARTED|Overall Study||326
10353648|NCT00454857|11492563|FG000|Completed Retrospective Chart Review|Overall Study||324
10353649|NCT00454857|11492563|FG000|Completed ≥1 Observational Study Visit|Overall Study||319
10716039|NCT02688387|11880046|FG003|STARTED|Part 3B, Washout Period 1 (10 Days)||0
10353650|NCT00454857|11492563|FG000|COMPLETED|Overall Study||272
10353651|NCT00454857|11492563|FG000|NOT COMPLETED|Overall Study||54
10353652|NCT00454909|11492570|FG000|STARTED|Overall Study||587
10353653|NCT00454909|11492571|FG001|STARTED|Overall Study||197
10353654|NCT00454909|11492572|FG002|STARTED|Overall Study||88
10353655|NCT00454909|11492570|FG000|COMPLETED|Overall Study||580
10353656|NCT00454909|11492571|FG001|COMPLETED|Overall Study||194
10353657|NCT00454909|11492572|FG002|COMPLETED|Overall Study||86
10353658|NCT00454909|11492570|FG000|NOT COMPLETED|Overall Study||7
10353659|NCT00454909|11492571|FG001|NOT COMPLETED|Overall Study||3
10353660|NCT00454909|11492572|FG002|NOT COMPLETED|Overall Study||2
10353661|NCT00454987|11492584|FG000|STARTED|Booster Period (NCT00258700)||359
10353662|NCT00454987|11492585|FG001|STARTED|Booster Period (NCT00258700)||117
10353663|NCT00454987|11492586|FG002|STARTED|Booster Period (NCT00258700)||0
10533431|NCT01425801|11685684|FG001|NOT COMPLETED|Period 2||0
10533432|NCT01425801|11685685|FG002|NOT COMPLETED|Period 2||0
10533433|NCT01425801|11685686|FG003|NOT COMPLETED|Period 2||0
10533434|NCT01425801|11685687|FG004|NOT COMPLETED|Period 2||1
10533435|NCT01425801|11685688|FG005|NOT COMPLETED|Period 2||0
10533436|NCT01425801|11685683|FG000|STARTED|Period 3||9
10533437|NCT01425801|11685684|FG001|STARTED|Period 3||9
10533438|NCT01425801|11685685|FG002|STARTED|Period 3||9
10533439|NCT01425801|11685686|FG003|STARTED|Period 3||12
10533440|NCT01425801|11685687|FG004|STARTED|Period 3||11
10533441|NCT01425801|11685688|FG005|STARTED|Period 3||10
10533442|NCT01425801|11685683|FG000|COMPLETED|Period 3||9
10533443|NCT01425801|11685684|FG001|COMPLETED|Period 3||9
10533444|NCT01425801|11685685|FG002|COMPLETED|Period 3||8
10533445|NCT01425801|11685686|FG003|COMPLETED|Period 3||12
10656018|NCT02213263|11816865|FG001|STARTED|Overall Study||196
10656019|NCT02213263|11816864|FG000|Treated|Overall Study||197
10656020|NCT02213263|11816865|FG001|Treated|Overall Study||196
10656021|NCT02213263|11816864|FG000|COMPLETED|Overall Study||170
10656022|NCT02213263|11816865|FG001|COMPLETED|Overall Study||170
10353664|NCT00454987|11492584|FG000|COMPLETED|Booster Period (NCT00258700)||357
10353665|NCT00454987|11492585|FG001|COMPLETED|Booster Period (NCT00258700)||116
10353666|NCT00454987|11492586|FG002|COMPLETED|Booster Period (NCT00258700)||0
10353667|NCT00454987|11492584|FG000|NOT COMPLETED|Booster Period (NCT00258700)||2
10353668|NCT00454987|11492585|FG001|NOT COMPLETED|Booster Period (NCT00258700)||1
10533446|NCT01425801|11685687|FG004|COMPLETED|Period 3||11
10656023|NCT02213263|11816864|FG000|NOT COMPLETED|Overall Study||28
10656024|NCT02213263|11816865|FG001|NOT COMPLETED|Overall Study||26
10656025|NCT02213289|11816873|FG000|STARTED|Overall Study||68
10656026|NCT02213289|11816874|FG001|STARTED|Overall Study||12
10656027|NCT02213289|11816873|FG000|Immuno-oncology|Overall Study||5
10533447|NCT01425801|11685688|FG005|COMPLETED|Period 3||10
10533448|NCT01425801|11685683|FG000|NOT COMPLETED|Period 3||0
10533449|NCT01425801|11685684|FG001|NOT COMPLETED|Period 3||0
10533450|NCT01425801|11685685|FG002|NOT COMPLETED|Period 3||1
10533451|NCT01425801|11685686|FG003|NOT COMPLETED|Period 3||0
10533452|NCT01425801|11685687|FG004|NOT COMPLETED|Period 3||0
10656028|NCT02213289|11816874|FG001|Immuno-oncology|Overall Study||0
10533453|NCT01425801|11685688|FG005|NOT COMPLETED|Period 3||0
10656029|NCT02213289|11816873|FG000|HER2 Amplified|Overall Study||16
10656030|NCT02213289|11816874|FG001|HER2 Amplified|Overall Study||0
10656031|NCT02213289|11816873|FG000|EGFR Amplified|Overall Study||8
10656032|NCT02213289|11816874|FG001|EGFR Amplified|Overall Study||0
10656033|NCT02213289|11816873|FG000|FGFR2 Amplified|Overall Study||1
10353669|NCT00454987|11492586|FG002|NOT COMPLETED|Booster Period (NCT00258700)||0
10353670|NCT00454987|11492584|FG000|STARTED|Year 1 (NCT00454987)||221
10353671|NCT00454987|11492585|FG001|STARTED|Year 1 (NCT00454987)||67
10353672|NCT00454987|11492586|FG002|STARTED|Year 1 (NCT00454987)||0
10353673|NCT00454987|11492584|FG000|COMPLETED|Year 1 (NCT00454987)||221
10353674|NCT00454987|11492585|FG001|COMPLETED|Year 1 (NCT00454987)||67
10353675|NCT00454987|11492586|FG002|COMPLETED|Year 1 (NCT00454987)||0
10353676|NCT00454987|11492584|FG000|NOT COMPLETED|Year 1 (NCT00454987)||0
10353677|NCT00454987|11492585|FG001|NOT COMPLETED|Year 1 (NCT00454987)||0
10353678|NCT00454987|11492586|FG002|NOT COMPLETED|Year 1 (NCT00454987)||0
10353679|NCT00454987|11492584|FG000|STARTED|Year 2 (NCT00454987)||235
10353680|NCT00454987|11492585|FG001|STARTED|Year 2 (NCT00454987)||77
10353681|NCT00454987|11492586|FG002|STARTED|Year 2 (NCT00454987)||74
10353682|NCT00454987|11492584|FG000|COMPLETED|Year 2 (NCT00454987)||235
10353683|NCT00454987|11492585|FG001|COMPLETED|Year 2 (NCT00454987)||77
10353684|NCT00454987|11492586|FG002|COMPLETED|Year 2 (NCT00454987)||74
10353685|NCT00454987|11492584|FG000|NOT COMPLETED|Year 2 (NCT00454987)||0
10353686|NCT00454987|11492585|FG001|NOT COMPLETED|Year 2 (NCT00454987)||0
10353687|NCT00454987|11492586|FG002|NOT COMPLETED|Year 2 (NCT00454987)||0
10353688|NCT00454987|11492584|FG000|STARTED|Year 4 (NCT00454987)||206
10353689|NCT00454987|11492585|FG001|STARTED|Year 4 (NCT00454987)||62
10353690|NCT00454987|11492586|FG002|STARTED|Year 4 (NCT00454987)||0
10353691|NCT00454987|11492584|FG000|COMPLETED|Year 4 (NCT00454987)||206
10353692|NCT00454987|11492585|FG001|COMPLETED|Year 4 (NCT00454987)||62
10353693|NCT00454987|11492586|FG002|COMPLETED|Year 4 (NCT00454987)||0
10353694|NCT00454987|11492584|FG000|NOT COMPLETED|Year 4 (NCT00454987)||0
10353695|NCT00454987|11492585|FG001|NOT COMPLETED|Year 4 (NCT00454987)||0
10353696|NCT00454987|11492586|FG002|NOT COMPLETED|Year 4 (NCT00454987)||0
10353697|NCT00455013|11492598|FG000|STARTED|Short Term Period|35 randomized, 33 transplanted and treated.|33
10353698|NCT00455013|11492599|FG001|STARTED|Short Term Period|27 randomized, 26 transplanted and treated.|26
10353699|NCT00455013|11492600|FG002|STARTED|Short Term Period|31 randomized, 30 transplanted and treated|30
10353700|NCT00455013|11492598|FG000|COMPLETED|Short Term Period|5 discontinued belatacept by Month 6 (1 more by Month 12), 2 switched from MMF to sirolimus.|27
10353701|NCT00455013|11492599|FG001|COMPLETED|Short Term Period|5 discontinued belatacept by Month 6; 10 additional switched from sirolimus to MMF.|21
10353702|NCT00455013|11492600|FG002|COMPLETED|Short Term Period|1 discontinued tacrolimus by Month 6 and 2 discontinued by Month 12 (1 more by Month 12)|28
10353703|NCT00455013|11492598|FG000|NOT COMPLETED|Short Term Period||6
10353704|NCT00455013|11492599|FG001|NOT COMPLETED|Short Term Period||5
10353705|NCT00455013|11492600|FG002|NOT COMPLETED|Short Term Period||2
10353706|NCT00455013|11492598|FG000|STARTED|Long Term Extension (LTE)||27
10353707|NCT00455013|11492599|FG001|STARTED|Long Term Extension (LTE)|2 Participants chose not to enter the LTE.|19
10353708|NCT00455013|11492600|FG002|STARTED|Long Term Extension (LTE)|1 Participant chose not to enter the LTE.|27
10353709|NCT00455013|11492598|FG000|COMPLETED|Long Term Extension (LTE)||25
10353710|NCT00455013|11492599|FG001|COMPLETED|Long Term Extension (LTE)||16
10353711|NCT00455013|11492600|FG002|COMPLETED|Long Term Extension (LTE)||20
10353712|NCT00455013|11492598|FG000|NOT COMPLETED|Long Term Extension (LTE)||2
10353713|NCT00455013|11492599|FG001|NOT COMPLETED|Long Term Extension (LTE)||3
10353714|NCT00455013|11492600|FG002|NOT COMPLETED|Long Term Extension (LTE)||7
10353715|NCT00455195|11492610|FG000|STARTED|Double-blind Study AGLU02704|Patients randomized to alglucosidase alfa treatment group in AGLU02704 (NCT00158600).|60
10353716|NCT00455195|11492611|FG001|STARTED|Double-blind Study AGLU02704|See study AGLU02704 (NCT00158600) for results while on placebo.|30
10353717|NCT00455195|11492610|FG000|COMPLETED|Double-blind Study AGLU02704||55
10353718|NCT00455195|11492611|FG001|COMPLETED|Double-blind Study AGLU02704||26
10353719|NCT00455195|11492610|FG000|NOT COMPLETED|Double-blind Study AGLU02704||5
10353720|NCT00455195|11492611|FG001|NOT COMPLETED|Double-blind Study AGLU02704||4
10353721|NCT00455195|11492610|FG000|STARTED|Extension Study AGLU03206||55
10353722|NCT00455195|11492611|FG001|STARTED|Extension Study AGLU03206|These 26 participants completed placebo double-blind treatment in the AGLU02704 (NCT00158600) study.|26
10353723|NCT00455195|11492610|FG000|COMPLETED|Extension Study AGLU03206||55
10353724|NCT00455195|11492611|FG001|COMPLETED|Extension Study AGLU03206||26
10353725|NCT00455195|11492610|FG000|NOT COMPLETED|Extension Study AGLU03206||0
10353726|NCT00455195|11492611|FG001|NOT COMPLETED|Extension Study AGLU03206||0
10353727|NCT00455312|11492619|FG000|STARTED|Overall Study||15
10353728|NCT00455312|11492620|FG001|STARTED|Overall Study||21
10353729|NCT00455312|11492619|FG000|COMPLETED|Overall Study||15
10353730|NCT00455312|11492620|FG001|COMPLETED|Overall Study||20
10353731|NCT00455312|11492619|FG000|NOT COMPLETED|Overall Study||0
10353732|NCT00455312|11492620|FG001|NOT COMPLETED|Overall Study||1
10353733|NCT00455429|11492630|FG000|STARTED|Overall Study||18
10353734|NCT00455429|11492631|FG001|STARTED|Overall Study||15
10353735|NCT00455429|11492632|FG002|STARTED|Overall Study||17
10353736|NCT00455429|11492633|FG003|STARTED|Overall Study||34
10353737|NCT00455429|11492630|FG000|Treated|Overall Study||18
10353738|NCT00455429|11492631|FG001|Treated|Overall Study||15
10353739|NCT00455429|11492632|FG002|Treated|Overall Study||17
10353740|NCT00455429|11492633|FG003|Treated|Overall Study||32
10353741|NCT00455429|11492630|FG000|COMPLETED|Overall Study||16
10353742|NCT00455429|11492631|FG001|COMPLETED|Overall Study||10
10353743|NCT00455429|11492632|FG002|COMPLETED|Overall Study||16
10353744|NCT00455429|11492633|FG003|COMPLETED|Overall Study||20
10353745|NCT00455429|11492630|FG000|NOT COMPLETED|Overall Study||2
10353746|NCT00455429|11492631|FG001|NOT COMPLETED|Overall Study||5
10353747|NCT00455429|11492632|FG002|NOT COMPLETED|Overall Study||1
10353748|NCT00455429|11492633|FG003|NOT COMPLETED|Overall Study||14
10353749|NCT00455455|11492646|FG000|STARTED|Washout||25
10353750|NCT00455455|11492647|FG001|STARTED|Washout||25
10353751|NCT00455455|11492646|FG000|COMPLETED|Washout||25
10353752|NCT00455455|11492647|FG001|COMPLETED|Washout||24
10353753|NCT00455455|11492646|FG000|NOT COMPLETED|Washout||0
10353754|NCT00455455|11492647|FG001|NOT COMPLETED|Washout||1
10353755|NCT00455455|11492646|FG000|STARTED|First Intervention||25
10353756|NCT00455455|11492647|FG001|STARTED|First Intervention||24
10353757|NCT00455455|11492646|FG000|COMPLETED|First Intervention||25
10353758|NCT00455455|11492647|FG001|COMPLETED|First Intervention||24
10353759|NCT00455455|11492646|FG000|NOT COMPLETED|First Intervention||0
10353760|NCT00455455|11492647|FG001|NOT COMPLETED|First Intervention||0
10353761|NCT00455455|11492646|FG000|STARTED|Washout||25
10353762|NCT00455455|11492647|FG001|STARTED|Washout||24
10353763|NCT00455455|11492646|FG000|COMPLETED|Washout||24
10353764|NCT00455455|11492647|FG001|COMPLETED|Washout||24
10353765|NCT00455455|11492646|FG000|NOT COMPLETED|Washout||1
10353766|NCT00455455|11492647|FG001|NOT COMPLETED|Washout||0
10353767|NCT00455455|11492646|FG000|STARTED|Second Intervention||24
10353768|NCT00455455|11492647|FG001|STARTED|Second Intervention||24
10353769|NCT00455455|11492646|FG000|COMPLETED|Second Intervention||24
10353770|NCT00455455|11492647|FG001|COMPLETED|Second Intervention||24
10353771|NCT00455455|11492646|FG000|NOT COMPLETED|Second Intervention||0
10353772|NCT00455455|11492647|FG001|NOT COMPLETED|Second Intervention||0
10353773|NCT00455520|11492658|FG000|STARTED|Open Label Tapentadol Extended Release||591
10353774|NCT00455520|11492659|FG001|STARTED|Open Label Tapentadol Extended Release||0
10353775|NCT00455520|11492658|FG000|COMPLETED|Open Label Tapentadol Extended Release||395
10353776|NCT00455520|11492659|FG001|COMPLETED|Open Label Tapentadol Extended Release||0
10353777|NCT00455520|11492658|FG000|NOT COMPLETED|Open Label Tapentadol Extended Release||196
10353778|NCT00455520|11492659|FG001|NOT COMPLETED|Open Label Tapentadol Extended Release||0
10353779|NCT00455520|11492658|FG000|STARTED|Double Blind Tapentadol ER vs Placebo|2 subjects enrolled two separate times in this study, 1 subject did not receive study medication|196
10353780|NCT00455520|11492659|FG001|STARTED|Double Blind Tapentadol ER vs Placebo|1 subject enrolled two separate times in this study, 2 subjects did not receive study medication|193
10353781|NCT00455520|11492658|FG000|COMPLETED|Double Blind Tapentadol ER vs Placebo||133
10353782|NCT00455520|11492659|FG001|COMPLETED|Double Blind Tapentadol ER vs Placebo||131
10353783|NCT00455520|11492658|FG000|NOT COMPLETED|Double Blind Tapentadol ER vs Placebo||63
10353784|NCT00455520|11492659|FG001|NOT COMPLETED|Double Blind Tapentadol ER vs Placebo||62
10353785|NCT00455533|11492667|FG000|STARTED|Period One: Initial Chemotherapy||313
10353786|NCT00455533|11492668|FG001|STARTED|Period One: Initial Chemotherapy||0
10353787|NCT00455533|11492669|FG002|STARTED|Period One: Initial Chemotherapy||0
10353788|NCT00455533|11492667|FG000|COMPLETED|Period One: Initial Chemotherapy||295
10353789|NCT00455533|11492668|FG001|COMPLETED|Period One: Initial Chemotherapy||0
10353790|NCT00455533|11492669|FG002|COMPLETED|Period One: Initial Chemotherapy||0
10353791|NCT00455533|11492667|FG000|NOT COMPLETED|Period One: Initial Chemotherapy||18
10353792|NCT00455533|11492668|FG001|NOT COMPLETED|Period One: Initial Chemotherapy||0
10353793|NCT00455533|11492669|FG002|NOT COMPLETED|Period One: Initial Chemotherapy||0
10353794|NCT00455533|11492667|FG000|STARTED|Period Two: Randomized Period||0
10353795|NCT00455533|11492668|FG001|STARTED|Period Two: Randomized Period|148 randomized, 145 randomized and treated with ixabepilone|145
10353796|NCT00455533|11492669|FG002|STARTED|Period Two: Randomized Period|147 randomized, 144 randomized and treated with paclitaxel|144
10353797|NCT00455533|11492667|FG000|COMPLETED|Period Two: Randomized Period||0
10353798|NCT00455533|11492668|FG001|COMPLETED|Period Two: Randomized Period||139
10353799|NCT00455533|11492669|FG002|COMPLETED|Period Two: Randomized Period||138
10353800|NCT00455533|11492667|FG000|NOT COMPLETED|Period Two: Randomized Period||0
10353801|NCT00455533|11492668|FG001|NOT COMPLETED|Period Two: Randomized Period||6
10353802|NCT00455533|11492669|FG002|NOT COMPLETED|Period Two: Randomized Period||6
10353803|NCT00455650|11492679|FG000|STARTED|Week 1||10
10353804|NCT00455650|11492680|FG001|STARTED|Week 1||10
10353805|NCT00455650|11492681|FG002|STARTED|Week 1||10
10353806|NCT00455650|11492682|FG003|STARTED|Week 1||14
10353807|NCT00455650|11492683|FG004|STARTED|Week 1||14
10353808|NCT00455650|11492684|FG005|STARTED|Week 1||13
10353809|NCT00455650|11492679|FG000|COMPLETED|Week 1||10
10353810|NCT00455650|11492680|FG001|COMPLETED|Week 1||10
10353811|NCT00455650|11492681|FG002|COMPLETED|Week 1||10
10353812|NCT00455650|11492682|FG003|COMPLETED|Week 1||14
10353813|NCT00455650|11492683|FG004|COMPLETED|Week 1||14
10353814|NCT00455650|11492684|FG005|COMPLETED|Week 1||13
10353815|NCT00455650|11492679|FG000|NOT COMPLETED|Week 1||0
10353816|NCT00455650|11492680|FG001|NOT COMPLETED|Week 1||0
10353817|NCT00455650|11492681|FG002|NOT COMPLETED|Week 1||0
10353818|NCT00455650|11492682|FG003|NOT COMPLETED|Week 1||0
10353819|NCT00455650|11492683|FG004|NOT COMPLETED|Week 1||0
10353820|NCT00455650|11492684|FG005|NOT COMPLETED|Week 1||0
10353821|NCT00455650|11492679|FG000|STARTED|Week 2||10
10353822|NCT00455650|11492680|FG001|STARTED|Week 2||10
10353823|NCT00455650|11492681|FG002|STARTED|Week 2||10
10353824|NCT00455650|11492682|FG003|STARTED|Week 2||14
10353825|NCT00455650|11492683|FG004|STARTED|Week 2||14
10353826|NCT00455650|11492684|FG005|STARTED|Week 2||13
10353827|NCT00455650|11492679|FG000|COMPLETED|Week 2||10
10353828|NCT00455650|11492680|FG001|COMPLETED|Week 2||10
10353829|NCT00455650|11492681|FG002|COMPLETED|Week 2||10
10353830|NCT00455650|11492682|FG003|COMPLETED|Week 2||14
10353831|NCT00455650|11492683|FG004|COMPLETED|Week 2||14
10353832|NCT00455650|11492684|FG005|COMPLETED|Week 2||13
10353833|NCT00455650|11492679|FG000|NOT COMPLETED|Week 2||0
10353834|NCT00455650|11492680|FG001|NOT COMPLETED|Week 2||0
10353835|NCT00455650|11492681|FG002|NOT COMPLETED|Week 2||0
10353836|NCT00455650|11492682|FG003|NOT COMPLETED|Week 2||0
10353837|NCT00455650|11492683|FG004|NOT COMPLETED|Week 2||0
10353838|NCT00455650|11492684|FG005|NOT COMPLETED|Week 2||0
10353839|NCT00455650|11492679|FG000|STARTED|Week 3||10
10353840|NCT00455650|11492680|FG001|STARTED|Week 3||10
10353841|NCT00455650|11492681|FG002|STARTED|Week 3||10
10353842|NCT00455650|11492682|FG003|STARTED|Week 3||14
10353843|NCT00455650|11492683|FG004|STARTED|Week 3||14
10353844|NCT00455650|11492684|FG005|STARTED|Week 3||13
10353845|NCT00455650|11492679|FG000|COMPLETED|Week 3||10
10353846|NCT00455650|11492680|FG001|COMPLETED|Week 3||10
10353847|NCT00455650|11492681|FG002|COMPLETED|Week 3||10
10353848|NCT00455650|11492682|FG003|COMPLETED|Week 3||14
10353849|NCT00455650|11492683|FG004|COMPLETED|Week 3||14
10353850|NCT00455650|11492684|FG005|COMPLETED|Week 3||13
10353851|NCT00455650|11492679|FG000|NOT COMPLETED|Week 3||0
10716040|NCT02688387|11880047|FG004|STARTED|Part 3B, Washout Period 1 (10 Days)||0
10716041|NCT02688387|11880048|FG005|STARTED|Part 3B, Washout Period 1 (10 Days)||0
10353852|NCT00455650|11492680|FG001|NOT COMPLETED|Week 3||0
10353853|NCT00455650|11492681|FG002|NOT COMPLETED|Week 3||0
10353854|NCT00455650|11492682|FG003|NOT COMPLETED|Week 3||0
10353855|NCT00455650|11492683|FG004|NOT COMPLETED|Week 3||0
10353856|NCT00455650|11492684|FG005|NOT COMPLETED|Week 3||0
10353857|NCT00455663|11492697|FG000|STARTED|Overall Study||37
10353858|NCT00455663|11492698|FG001|STARTED|Overall Study||36
10353859|NCT00455663|11492699|FG002|STARTED|Overall Study||32
10353860|NCT00455663|11492697|FG000|COMPLETED|Overall Study||34
10353861|NCT00455663|11492698|FG001|COMPLETED|Overall Study||32
10353862|NCT00455663|11492699|FG002|COMPLETED|Overall Study||29
10353863|NCT00455663|11492697|FG000|NOT COMPLETED|Overall Study||3
10353864|NCT00455663|11492698|FG001|NOT COMPLETED|Overall Study||4
10353865|NCT00455663|11492699|FG002|NOT COMPLETED|Overall Study||3
10353866|NCT00455689|11492713|FG000|STARTED|Overall Study||14
10353867|NCT00455689|11492714|FG001|STARTED|Overall Study||6
10353868|NCT00455689|11492713|FG000|COMPLETED|Overall Study||14
10353869|NCT00455689|11492714|FG001|COMPLETED|Overall Study||6
10353870|NCT00455689|11492713|FG000|NOT COMPLETED|Overall Study||0
10353871|NCT00455689|11492714|FG001|NOT COMPLETED|Overall Study||0
10353872|NCT00455702|11492721|FG000|STARTED|Overall Study||19
10353873|NCT00455702|11492722|FG001|STARTED|Overall Study||19
10353874|NCT00455702|11492721|FG000|COMPLETED|Overall Study||16
10353875|NCT00455702|11492722|FG001|COMPLETED|Overall Study||16
10353876|NCT00455702|11492721|FG000|NOT COMPLETED|Overall Study||3
10353877|NCT00455702|11492722|FG001|NOT COMPLETED|Overall Study||3
10353878|NCT00455741|11492732|FG000|STARTED|Overall Study||13
10353879|NCT00455741|11492733|FG001|STARTED|Overall Study||12
10353880|NCT00455741|11492732|FG000|COMPLETED|Overall Study||13
10353881|NCT00455741|11492733|FG001|COMPLETED|Overall Study||11
10353882|NCT00455741|11492732|FG000|NOT COMPLETED|Overall Study||0
10353883|NCT00455741|11492733|FG001|NOT COMPLETED|Overall Study||1
10353884|NCT00455858|11492749|FG000|STARTED|Overall Study|Enrolled in study and exposed to study drug|87
10353885|NCT00455858|11492749|FG000|COMPLETED|Overall Study||81
10353886|NCT00455858|11492749|FG000|NOT COMPLETED|Overall Study||6
10353887|NCT00455923|11492755|FG000|STARTED|Overall Study||50
10353888|NCT00455923|11492756|FG001|STARTED|Overall Study||50
10353889|NCT00455923|11492755|FG000|COMPLETED|Overall Study||47
10353890|NCT00455923|11492756|FG001|COMPLETED|Overall Study||47
10533454|NCT01425801|11685683|FG000|STARTED|Period 4||9
10533455|NCT01425801|11685684|FG001|STARTED|Period 4||9
10533456|NCT01425801|11685685|FG002|STARTED|Period 4||8
10533457|NCT01425801|11685686|FG003|STARTED|Period 4||12
10533458|NCT01425801|11685687|FG004|STARTED|Period 4||11
10533459|NCT01425801|11685688|FG005|STARTED|Period 4||10
10533460|NCT01425801|11685683|FG000|COMPLETED|Period 4||9
10533461|NCT01425801|11685684|FG001|COMPLETED|Period 4||9
10533462|NCT01425801|11685685|FG002|COMPLETED|Period 4||7
10533463|NCT01425801|11685686|FG003|COMPLETED|Period 4||12
10533464|NCT01425801|11685687|FG004|COMPLETED|Period 4||11
10533465|NCT01425801|11685688|FG005|COMPLETED|Period 4||10
10533466|NCT01425801|11685683|FG000|NOT COMPLETED|Period 4||0
10533467|NCT01425801|11685684|FG001|NOT COMPLETED|Period 4||0
10533468|NCT01425801|11685685|FG002|NOT COMPLETED|Period 4||1
10533469|NCT01425801|11685686|FG003|NOT COMPLETED|Period 4||0
10533470|NCT01425801|11685687|FG004|NOT COMPLETED|Period 4||0
10533471|NCT01425801|11685688|FG005|NOT COMPLETED|Period 4||0
10533472|NCT01425801|11685683|FG000|STARTED|Period 5||9
10533473|NCT01425801|11685684|FG001|STARTED|Period 5||9
10533474|NCT01425801|11685685|FG002|STARTED|Period 5||7
10716042|NCT02688387|11880049|FG006|STARTED|Part 3B, Washout Period 1 (10 Days)||0
10533475|NCT01425801|11685686|FG003|STARTED|Period 5||12
10533476|NCT01425801|11685687|FG004|STARTED|Period 5||11
10533477|NCT01425801|11685688|FG005|STARTED|Period 5||10
10533478|NCT01425801|11685683|FG000|COMPLETED|Period 5||9
10533479|NCT01425801|11685684|FG001|COMPLETED|Period 5||9
10353891|NCT00455923|11492755|FG000|NOT COMPLETED|Overall Study||3
10353892|NCT00455923|11492756|FG001|NOT COMPLETED|Overall Study||3
10353893|NCT00455962|11492764|FG000|STARTED|Overall Study||10
10533480|NCT01425801|11685685|FG002|COMPLETED|Period 5||7
10533481|NCT01425801|11685686|FG003|COMPLETED|Period 5||12
10353894|NCT00455962|11492765|FG001|STARTED|Overall Study||13
10353895|NCT00455962|11492764|FG000|COMPLETED|Overall Study||10
10353896|NCT00455962|11492765|FG001|COMPLETED|Overall Study||13
10533482|NCT01425801|11685687|FG004|COMPLETED|Period 5||11
10533483|NCT01425801|11685688|FG005|COMPLETED|Period 5||10
10353897|NCT00455962|11492764|FG000|NOT COMPLETED|Overall Study||0
10353898|NCT00455962|11492765|FG001|NOT COMPLETED|Overall Study||0
10353899|NCT00455975|11492773|FG000|STARTED|Overall Study||58
10353900|NCT00455975|11492774|FG001|STARTED|Overall Study||61
10353901|NCT00455975|11492773|FG000|COMPLETED|Overall Study||40
10353902|NCT00455975|11492774|FG001|COMPLETED|Overall Study||40
10353903|NCT00455975|11492773|FG000|NOT COMPLETED|Overall Study||18
10353904|NCT00455975|11492774|FG001|NOT COMPLETED|Overall Study||21
10353905|NCT00456014|11492780|FG000|STARTED|SSRI Phase||37
10353906|NCT00456014|11492780|FG000|COMPLETED|SSRI Phase||28
10353907|NCT00456014|11492780|FG000|NOT COMPLETED|SSRI Phase||9
10353908|NCT00456014|11492780|FG000|STARTED|Tricyclic Phase|Only non-remitters from phase 1 were eligible for phase 2, and not all those eligible continued.|4
10353909|NCT00456014|11492780|FG000|COMPLETED|Tricyclic Phase||1
10353910|NCT00456014|11492780|FG000|NOT COMPLETED|Tricyclic Phase||3
10353911|NCT00456092|11492789|FG000|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|46
10353912|NCT00456092|11492790|FG001|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|40
10353913|NCT00456092|11492791|FG002|STARTED|Extension Phase||0
10353914|NCT00456092|11492792|FG003|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|20
10353915|NCT00456092|11492793|FG004|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|20
10353916|NCT00456092|11492789|FG000|COMPLETED|Extension Phase||35
10353917|NCT00456092|11492790|FG001|COMPLETED|Extension Phase||36
10353918|NCT00456092|11492791|FG002|COMPLETED|Extension Phase||0
10353919|NCT00456092|11492792|FG003|COMPLETED|Extension Phase||19
10353920|NCT00456092|11492793|FG004|COMPLETED|Extension Phase||13
10353921|NCT00456092|11492789|FG000|NOT COMPLETED|Extension Phase||11
10353922|NCT00456092|11492790|FG001|NOT COMPLETED|Extension Phase||4
10353923|NCT00456092|11492791|FG002|NOT COMPLETED|Extension Phase||0
10353924|NCT00456092|11492792|FG003|NOT COMPLETED|Extension Phase||1
10353925|NCT00456092|11492793|FG004|NOT COMPLETED|Extension Phase||7
10353926|NCT00456092|11492789|FG000|STARTED|Treatment Phase (12 Weeks)||67
10353927|NCT00456092|11492790|FG001|STARTED|Treatment Phase (12 Weeks)||69
10353928|NCT00456092|11492791|FG002|STARTED|Treatment Phase (12 Weeks)||68
10353929|NCT00456092|11492792|FG003|STARTED|Treatment Phase (12 Weeks)||0
10353930|NCT00456092|11492793|FG004|STARTED|Treatment Phase (12 Weeks)||0
10353931|NCT00456092|11492789|FG000|COMPLETED|Treatment Phase (12 Weeks)||60
10353932|NCT00456092|11492790|FG001|COMPLETED|Treatment Phase (12 Weeks)||55
10353933|NCT00456092|11492791|FG002|COMPLETED|Treatment Phase (12 Weeks)||50
10353934|NCT00456092|11492792|FG003|COMPLETED|Treatment Phase (12 Weeks)||0
10353935|NCT00456092|11492793|FG004|COMPLETED|Treatment Phase (12 Weeks)||0
10353936|NCT00456092|11492789|FG000|NOT COMPLETED|Treatment Phase (12 Weeks)||7
10353937|NCT00456092|11492790|FG001|NOT COMPLETED|Treatment Phase (12 Weeks)||14
10353938|NCT00456092|11492791|FG002|NOT COMPLETED|Treatment Phase (12 Weeks)||18
10353939|NCT00456092|11492792|FG003|NOT COMPLETED|Treatment Phase (12 Weeks)||0
10353940|NCT00456092|11492793|FG004|NOT COMPLETED|Treatment Phase (12 Weeks)||0
10353941|NCT00456300|11492807|FG000|STARTED|Overall Study||5
10353942|NCT00456300|11492808|FG001|STARTED|Overall Study||4
10353943|NCT00456300|11492807|FG000|COMPLETED|Overall Study||4
10353944|NCT00456300|11492808|FG001|COMPLETED|Overall Study||4
10353945|NCT00456300|11492807|FG000|NOT COMPLETED|Overall Study||1
10353946|NCT00456300|11492808|FG001|NOT COMPLETED|Overall Study||0
10533484|NCT01425801|11685683|FG000|NOT COMPLETED|Period 5||0
10533485|NCT01425801|11685684|FG001|NOT COMPLETED|Period 5||0
10533486|NCT01425801|11685685|FG002|NOT COMPLETED|Period 5||0
10533487|NCT01425801|11685686|FG003|NOT COMPLETED|Period 5||0
10533488|NCT01425801|11685687|FG004|NOT COMPLETED|Period 5||0
10716043|NCT02688387|11880050|FG007|STARTED|Part 3B, Washout Period 1 (10 Days)||0
10716044|NCT02688387|11880051|FG008|STARTED|Part 3B, Washout Period 1 (10 Days)||0
10716045|NCT02688387|11880052|FG009|STARTED|Part 3B, Washout Period 1 (10 Days)||0
10353947|NCT00456365|11492818|FG000|STARTED|Overall Study||56
10533489|NCT01425801|11685688|FG005|NOT COMPLETED|Period 5||0
10716046|NCT02688387|11880053|FG010|STARTED|Part 3B, Washout Period 1 (10 Days)||0
10716047|NCT02688387|11880054|FG011|STARTED|Part 3B, Washout Period 1 (10 Days)||0
10716048|NCT02688387|11880055|FG012|STARTED|Part 3B, Washout Period 1 (10 Days)||0
10716049|NCT02688387|11880056|FG013|STARTED|Part 3B, Washout Period 1 (10 Days)||0
10716050|NCT02688387|11880057|FG014|STARTED|Part 3B, Washout Period 1 (10 Days)||0
10716051|NCT02688387|11880058|FG015|STARTED|Part 3B, Washout Period 1 (10 Days)||0
10716052|NCT02688387|11880059|FG016|STARTED|Part 3B, Washout Period 1 (10 Days)||0
10716053|NCT02688387|11880060|FG017|STARTED|Part 3B, Washout Period 1 (10 Days)||0
10716054|NCT02688387|11880061|FG018|STARTED|Part 3B, Washout Period 1 (10 Days)||8
10812503|NCT03598036|11974571|FG000|Weeks 3 - 24: 23.7 mg Twice Daily|Overall Study|1 subject withdrew at Week 12|5
10812504|NCT03598036|11974572|FG001|Weeks 3 - 24: 23.7 mg Twice Daily|Overall Study||0
10812505|NCT03598036|11974571|FG000|COMPLETED|Overall Study||4
10812506|NCT03598036|11974572|FG001|COMPLETED|Overall Study||0
10812507|NCT03598036|11974571|FG000|NOT COMPLETED|Overall Study||1
10812508|NCT03598036|11974572|FG001|NOT COMPLETED|Overall Study||0
10533490|NCT01425801|11685683|FG000|STARTED|Period 6||9
10533491|NCT01425801|11685684|FG001|STARTED|Period 6||9
10812509|NCT03591458|11974582|FG000|STARTED|Overall Study||1
10812510|NCT03591458|11974583|FG001|STARTED|Overall Study||1
10812511|NCT03591458|11974582|FG000|COMPLETED|Overall Study||1
10812512|NCT03591458|11974583|FG001|COMPLETED|Overall Study||1
10533492|NCT01425801|11685685|FG002|STARTED|Period 6||7
10353948|NCT00456365|11492819|FG001|STARTED|Overall Study||54
10353949|NCT00456365|11492818|FG000|COMPLETED|Overall Study||49
10353950|NCT00456365|11492819|FG001|COMPLETED|Overall Study||42
10353951|NCT00456365|11492818|FG000|NOT COMPLETED|Overall Study||7
10353952|NCT00456365|11492819|FG001|NOT COMPLETED|Overall Study||12
10353953|NCT00456495|11492827|FG000|STARTED|Overall Study||5
10353954|NCT00456495|11492827|FG000|COMPLETED|Overall Study||3
10353955|NCT00456495|11492827|FG000|NOT COMPLETED|Overall Study||2
10353956|NCT00456508|11492832|FG000|STARTED|Overall Study||147
10353957|NCT00456508|11492832|FG000|COMPLETED|Overall Study||147
10353958|NCT00456508|11492832|FG000|NOT COMPLETED|Overall Study||0
10353959|NCT00456521|11492838|FG000|STARTED|Overall Study||591
10353960|NCT00456521|11492839|FG001|STARTED|Overall Study||202
10353961|NCT00456521|11492838|FG000|COMPLETED|Overall Study||342
10353962|NCT00456521|11492839|FG001|COMPLETED|Overall Study||118
10353963|NCT00456521|11492838|FG000|NOT COMPLETED|Overall Study||249
10353964|NCT00456521|11492839|FG001|NOT COMPLETED|Overall Study||84
10353965|NCT00456547|11492848|FG000|STARTED|Overall Study||12
10353966|NCT00456547|11492849|FG001|STARTED|Overall Study||12
10353967|NCT00456547|11492848|FG000|COMPLETED|Overall Study||12
10353968|NCT00456547|11492849|FG001|COMPLETED|Overall Study||12
10353969|NCT00456547|11492848|FG000|NOT COMPLETED|Overall Study||0
10353970|NCT00456547|11492849|FG001|NOT COMPLETED|Overall Study||0
10353971|NCT00456599|11492855|FG000|STARTED|Overall Study||71
10353972|NCT00456599|11492855|FG000|Completed Cycle 1|Overall Study|Of the 71 patients, 1 was removed for noncompliance; 2 withdrew; 2 did not complete cycle 1.|66
10353973|NCT00456599|11492855|FG000|Initiated Cycle 2|Overall Study|5 patients were removed from study prior to initiation of a second cycle.|61
10353974|NCT00456599|11492855|FG000|Completed Protocol Surgery|Overall Study|Forty-eight patients (71%) underwent laparotomy according to the protocol.|48
10353975|NCT00456599|11492855|FG000|Completed Resection|Overall Study|43 patients underwent resection.|43
10353976|NCT00456599|11492855|FG000|Post-Surgery Adjuvent Therapy|Overall Study|After resection, 26 patients (68%) initiated adjuvant therapy.|26
10353977|NCT00456599|11492855|FG000|Completed 4th Cycle of Chemotherapy|Overall Study|24 patients (63%) completed a fourth cycle of chemotherapy.|24
10353978|NCT00456599|11492855|FG000|COMPLETED|Overall Study||68
10353979|NCT00456599|11492855|FG000|NOT COMPLETED|Overall Study||3
10353980|NCT00456625|11492859|FG000|STARTED|Overall Study||76
10353981|NCT00456625|11492859|FG000|COMPLETED|Overall Study||76
10353982|NCT00456625|11492859|FG000|NOT COMPLETED|Overall Study||0
10353983|NCT00456755|11492865|FG000|STARTED|Overall Study||63
10533493|NCT01425801|11685686|FG003|STARTED|Period 6||12
10533494|NCT01425801|11685687|FG004|STARTED|Period 6||11
10533495|NCT01425801|11685688|FG005|STARTED|Period 6||10
10533496|NCT01425801|11685683|FG000|COMPLETED|Period 6||9
10533497|NCT01425801|11685684|FG001|COMPLETED|Period 6||9
10533498|NCT01425801|11685685|FG002|COMPLETED|Period 6||7
10533499|NCT01425801|11685686|FG003|COMPLETED|Period 6||12
10533500|NCT01425801|11685687|FG004|COMPLETED|Period 6||11
10533501|NCT01425801|11685688|FG005|COMPLETED|Period 6||10
10533502|NCT01425801|11685683|FG000|NOT COMPLETED|Period 6||0
10533503|NCT01425801|11685684|FG001|NOT COMPLETED|Period 6||0
10533504|NCT01425801|11685685|FG002|NOT COMPLETED|Period 6||0
10533505|NCT01425801|11685686|FG003|NOT COMPLETED|Period 6||0
10533506|NCT01425801|11685687|FG004|NOT COMPLETED|Period 6||0
10533507|NCT01425801|11685688|FG005|NOT COMPLETED|Period 6||0
10533508|NCT01425814|11685702|FG000|STARTED|Period 1||12
10533509|NCT01425814|11685703|FG001|STARTED|Period 1||11
10533510|NCT01425814|11685704|FG002|STARTED|Period 1||12
10533511|NCT01425814|11685705|FG003|STARTED|Period 1||10
10533512|NCT01425814|11685706|FG004|STARTED|Period 1||12
10533513|NCT01425814|11685707|FG005|STARTED|Period 1||13
10533514|NCT01425814|11685702|FG000|COMPLETED|Period 1||12
10533515|NCT01425814|11685703|FG001|COMPLETED|Period 1||10
10533516|NCT01425814|11685704|FG002|COMPLETED|Period 1||12
10533517|NCT01425814|11685705|FG003|COMPLETED|Period 1||10
10533518|NCT01425814|11685706|FG004|COMPLETED|Period 1||12
10533519|NCT01425814|11685707|FG005|COMPLETED|Period 1||13
10533520|NCT01425814|11685702|FG000|NOT COMPLETED|Period 1||0
10533521|NCT01425814|11685703|FG001|NOT COMPLETED|Period 1||1
10533522|NCT01425814|11685704|FG002|NOT COMPLETED|Period 1||0
10533523|NCT01425814|11685705|FG003|NOT COMPLETED|Period 1||0
10533524|NCT01425814|11685706|FG004|NOT COMPLETED|Period 1||0
10533525|NCT01425814|11685707|FG005|NOT COMPLETED|Period 1||0
10533526|NCT01425814|11685702|FG000|STARTED|Period 2||12
10533527|NCT01425814|11685703|FG001|STARTED|Period 2||10
10533528|NCT01425814|11685704|FG002|STARTED|Period 2||12
10533529|NCT01425814|11685705|FG003|STARTED|Period 2||10
10716055|NCT02688387|11880062|FG019|STARTED|Part 3B, Washout Period 1 (10 Days)||8
10353984|NCT00456755|11492866|FG001|STARTED|Overall Study||63
10353985|NCT00456755|11492865|FG000|COMPLETED|Overall Study||61
10533530|NCT01425814|11685706|FG004|STARTED|Period 2||12
10533531|NCT01425814|11685707|FG005|STARTED|Period 2||13
10533532|NCT01425814|11685702|FG000|COMPLETED|Period 2||12
10533533|NCT01425814|11685703|FG001|COMPLETED|Period 2||9
10533534|NCT01425814|11685704|FG002|COMPLETED|Period 2||12
10533535|NCT01425814|11685705|FG003|COMPLETED|Period 2||10
10533536|NCT01425814|11685706|FG004|COMPLETED|Period 2||12
10533537|NCT01425814|11685707|FG005|COMPLETED|Period 2||13
10533538|NCT01425814|11685702|FG000|NOT COMPLETED|Period 2||0
10533539|NCT01425814|11685703|FG001|NOT COMPLETED|Period 2||1
10533540|NCT01425814|11685704|FG002|NOT COMPLETED|Period 2||0
10533541|NCT01425814|11685705|FG003|NOT COMPLETED|Period 2||0
10533542|NCT01425814|11685706|FG004|NOT COMPLETED|Period 2||0
10533543|NCT01425814|11685707|FG005|NOT COMPLETED|Period 2||0
10533544|NCT01425814|11685702|FG000|STARTED|Period 3||12
10353986|NCT00456755|11492866|FG001|COMPLETED|Overall Study||62
10353987|NCT00456755|11492865|FG000|NOT COMPLETED|Overall Study||2
10353988|NCT00456755|11492866|FG001|NOT COMPLETED|Overall Study||1
10353989|NCT00456807|11492874|FG000|STARTED|Overall Study||53
10353990|NCT00456807|11492875|FG001|STARTED|Overall Study||47
10353991|NCT00456807|11492874|FG000|COMPLETED|Overall Study||52
10353992|NCT00456807|11492875|FG001|COMPLETED|Overall Study||47
10353993|NCT00456807|11492874|FG000|NOT COMPLETED|Overall Study||1
10353994|NCT00456807|11492875|FG001|NOT COMPLETED|Overall Study||0
10353995|NCT00456846|11492883|FG000|STARTED|Overall Study||47
10353996|NCT00456846|11492884|FG001|STARTED|Overall Study||76
10353997|NCT00456846|11492883|FG000|COMPLETED|Overall Study|Treatment considered completed upon disease progression|31
10353998|NCT00456846|11492884|FG001|COMPLETED|Overall Study|Treatment considered completed upon disease progression|48
10353999|NCT00456846|11492883|FG000|NOT COMPLETED|Overall Study||16
10354000|NCT00456846|11492884|FG001|NOT COMPLETED|Overall Study||28
10354001|NCT00456885|11492890|FG000|STARTED|First Treatment Period, 16 Weeks||24
10354002|NCT00456885|11492891|FG001|STARTED|First Treatment Period, 16 Weeks||17
10354003|NCT00456885|11492890|FG000|COMPLETED|First Treatment Period, 16 Weeks||24
10354004|NCT00456885|11492891|FG001|COMPLETED|First Treatment Period, 16 Weeks||17
10354005|NCT00456885|11492890|FG000|NOT COMPLETED|First Treatment Period, 16 Weeks||0
10354006|NCT00456885|11492891|FG001|NOT COMPLETED|First Treatment Period, 16 Weeks||0
10354007|NCT00456885|11492890|FG000|STARTED|Washout, 3 Weeks||24
10354008|NCT00456885|11492891|FG001|STARTED|Washout, 3 Weeks||17
10354009|NCT00456885|11492890|FG000|COMPLETED|Washout, 3 Weeks||24
10354010|NCT00456885|11492891|FG001|COMPLETED|Washout, 3 Weeks||17
10354011|NCT00456885|11492890|FG000|NOT COMPLETED|Washout, 3 Weeks||0
10354012|NCT00456885|11492891|FG001|NOT COMPLETED|Washout, 3 Weeks||0
10354013|NCT00456885|11492890|FG000|STARTED|Second Treatment Period, 16 Weeks||24
10354014|NCT00456885|11492891|FG001|STARTED|Second Treatment Period, 16 Weeks||17
10354015|NCT00456885|11492890|FG000|COMPLETED|Second Treatment Period, 16 Weeks||23
10354016|NCT00456885|11492891|FG001|COMPLETED|Second Treatment Period, 16 Weeks||17
10354017|NCT00456885|11492890|FG000|NOT COMPLETED|Second Treatment Period, 16 Weeks||1
10354018|NCT00456885|11492891|FG001|NOT COMPLETED|Second Treatment Period, 16 Weeks||0
10354019|NCT00457002|11492898|FG000|STARTED|Overall Study||3255
10354020|NCT00457002|11492899|FG001|STARTED|Overall Study||3273
10354021|NCT00457002|11492898|FG000|COMPLETED|Overall Study||2442
10354022|NCT00457002|11492899|FG001|COMPLETED|Overall Study||2516
10354023|NCT00457002|11492898|FG000|NOT COMPLETED|Overall Study||813
10354024|NCT00457002|11492899|FG001|NOT COMPLETED|Overall Study||757
10354025|NCT00457015|11492907|FG000|STARTED|Overall Study||48
10354026|NCT00457015|11492908|FG001|STARTED|Overall Study||48
10354027|NCT00457015|11492907|FG000|COMPLETED|Overall Study||48
10354028|NCT00457015|11492908|FG001|COMPLETED|Overall Study||47
10354029|NCT00457015|11492907|FG000|NOT COMPLETED|Overall Study||0
10354030|NCT00457015|11492908|FG001|NOT COMPLETED|Overall Study||1
10354031|NCT00457197|11492916|FG000|STARTED|Overall Study||45
10354032|NCT00457197|11492917|FG001|STARTED|Overall Study||45
10354033|NCT00457197|11492916|FG000|COMPLETED|Overall Study||44
10354034|NCT00457197|11492917|FG001|COMPLETED|Overall Study||44
10354035|NCT00457197|11492916|FG000|NOT COMPLETED|Overall Study||1
10354036|NCT00457197|11492917|FG001|NOT COMPLETED|Overall Study||1
10354037|NCT00457249|11492925|FG000|STARTED|Overall Study||1170
10354038|NCT00457249|11492926|FG001|STARTED|Overall Study||391
10354039|NCT00457249|11492925|FG000|COMPLETED|Overall Study||1158
10354040|NCT00457249|11492926|FG001|COMPLETED|Overall Study||389
10354041|NCT00457249|11492925|FG000|NOT COMPLETED|Overall Study||12
10354042|NCT00457249|11492926|FG001|NOT COMPLETED|Overall Study||2
10354043|NCT00457301|11492936|FG000|STARTED|Overall Study||105
10354044|NCT00457301|11492937|FG001|STARTED|Overall Study||108
10354045|NCT00457301|11492936|FG000|COMPLETED|Overall Study||82
10354046|NCT00457301|11492937|FG001|COMPLETED|Overall Study||84
10354047|NCT00457301|11492936|FG000|NOT COMPLETED|Overall Study||23
10354048|NCT00457301|11492937|FG001|NOT COMPLETED|Overall Study||24
10354049|NCT00457366|11492945|FG000|STARTED|Overall Study||40
10354050|NCT00457366|11492946|FG001|STARTED|Overall Study||32
10354051|NCT00457366|11492945|FG000|COMPLETED|Overall Study||40
10354052|NCT00457366|11492946|FG001|COMPLETED|Overall Study||32
10354053|NCT00457366|11492945|FG000|NOT COMPLETED|Overall Study||0
10354054|NCT00457366|11492946|FG001|NOT COMPLETED|Overall Study||0
10354055|NCT00457392|11492954|FG000|STARTED|Overall Study||480
10354056|NCT00457392|11492955|FG001|STARTED|Overall Study||480
10354057|NCT00457392|11492954|FG000|Treated|Overall Study||473
10354058|NCT00457392|11492955|FG001|Treated|Overall Study||477
10354059|NCT00457392|11492954|FG000|COMPLETED|Overall Study||0
10354060|NCT00457392|11492955|FG001|COMPLETED|Overall Study||0
10354061|NCT00457392|11492954|FG000|NOT COMPLETED|Overall Study||480
10354062|NCT00457392|11492955|FG001|NOT COMPLETED|Overall Study||480
10354063|NCT00457418|11492961|FG000|STARTED|Pharmacokinetic (PK) Sampling Phase||32
10354064|NCT00457418|11492961|FG000|COMPLETED|Pharmacokinetic (PK) Sampling Phase||27
10354065|NCT00457418|11492961|FG000|NOT COMPLETED|Pharmacokinetic (PK) Sampling Phase||5
10354066|NCT00457418|11492961|FG000|STARTED|Post PK Maintenance|4 participants didn't complete the PK sampling phase but continued to post PK maintenance treatment.|31
10354067|NCT00457418|11492961|FG000|COMPLETED|Post PK Maintenance||3
10354068|NCT00457418|11492961|FG000|NOT COMPLETED|Post PK Maintenance||28
10354069|NCT00457626|11492965|FG000|STARTED|Overall Study||66
10354070|NCT00457626|11492965|FG000|COMPLETED|Overall Study||60
10354071|NCT00457626|11492965|FG000|NOT COMPLETED|Overall Study||6
10426915|NCT00849810|11572641|FG000|STARTED|Overall Study||1
10716056|NCT02688387|11880063|FG020|STARTED|Part 3B, Washout Period 1 (10 Days)||8
10716057|NCT02688387|11880064|FG021|STARTED|Part 3B, Washout Period 1 (10 Days)||8
10716058|NCT02688387|11880043|FG000|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10354072|NCT00457639|11492969|FG000|STARTED|Intervention 1 (6 Months)|6 months on Cholic Acid and crossover to Placebo for 6 months|9
10354073|NCT00457639|11492970|FG001|STARTED|Intervention 1 (6 Months)|6 months on Placebo and crossover to cholic acid for 6 months|9
10354074|NCT00457639|11492969|FG000|COMPLETED|Intervention 1 (6 Months)|Number of Patients completing Cholic Acid Phase|6
10354075|NCT00457639|11492970|FG001|COMPLETED|Intervention 1 (6 Months)|Number of patients completing Placebo Phase|7
10354076|NCT00457639|11492969|FG000|NOT COMPLETED|Intervention 1 (6 Months)||3
10354077|NCT00457639|11492970|FG001|NOT COMPLETED|Intervention 1 (6 Months)||2
10354078|NCT00457639|11492969|FG000|STARTED|Intervention 2 (6 Months)||6
10354079|NCT00457639|11492970|FG001|STARTED|Intervention 2 (6 Months)||7
10354080|NCT00457639|11492969|FG000|COMPLETED|Intervention 2 (6 Months)||6
10354081|NCT00457639|11492970|FG001|COMPLETED|Intervention 2 (6 Months)||6
10354082|NCT00457639|11492969|FG000|NOT COMPLETED|Intervention 2 (6 Months)||0
10354083|NCT00457639|11492970|FG001|NOT COMPLETED|Intervention 2 (6 Months)||1
10354084|NCT00457665|11492978|FG000|STARTED|12 Months||28
10354085|NCT00457665|11492979|FG001|STARTED|12 Months||28
10354086|NCT00457665|11492978|FG000|COMPLETED|12 Months||20
10354087|NCT00457665|11492979|FG001|COMPLETED|12 Months||19
10354088|NCT00457665|11492978|FG000|NOT COMPLETED|12 Months||8
10354089|NCT00457665|11492979|FG001|NOT COMPLETED|12 Months||9
10354090|NCT00457665|11492978|FG000|STARTED|24 Months||20
10354091|NCT00457665|11492979|FG001|STARTED|24 Months||19
10354092|NCT00457665|11492978|FG000|COMPLETED|24 Months||15
10354093|NCT00457665|11492979|FG001|COMPLETED|24 Months||11
10354094|NCT00457665|11492978|FG000|NOT COMPLETED|24 Months||5
10354095|NCT00457665|11492979|FG001|NOT COMPLETED|24 Months||8
10354096|NCT00457691|11492987|FG000|STARTED|Overall Study||386
10354097|NCT00457691|11492988|FG001|STARTED|Overall Study||382
10354098|NCT00457691|11492987|FG000|COMPLETED|Overall Study||0
10354099|NCT00457691|11492988|FG001|COMPLETED|Overall Study||0
10354100|NCT00457691|11492987|FG000|NOT COMPLETED|Overall Study||386
10716059|NCT02688387|11880044|FG001|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10716060|NCT02688387|11880045|FG002|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10716061|NCT02688387|11880046|FG003|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10354101|NCT00457691|11492988|FG001|NOT COMPLETED|Overall Study||382
10354102|NCT00457730|11492996|FG000|STARTED|Overall Study||18
10354103|NCT00457730|11492997|FG001|STARTED|Overall Study||20
10354104|NCT00457730|11492996|FG000|COMPLETED|Overall Study||14
10354105|NCT00457730|11492997|FG001|COMPLETED|Overall Study||19
10354106|NCT00457730|11492996|FG000|NOT COMPLETED|Overall Study||4
10354107|NCT00457730|11492997|FG001|NOT COMPLETED|Overall Study||1
10354108|NCT00457743|11493010|FG000|STARTED|Overall Study|Overall study|3
10354109|NCT00457743|11493011|FG001|STARTED|Overall Study|Overall study|30
10354110|NCT00457743|11493012|FG002|STARTED|Overall Study|Overall study|3
10354111|NCT00457743|11493010|FG000|Enrolled in Phase 1|Overall Study||3
10354112|NCT00457743|11493011|FG001|Enrolled in Phase 1|Overall Study||6
10354113|NCT00457743|11493012|FG002|Enrolled in Phase 1|Overall Study||3
10354114|NCT00457743|11493010|FG000|Completed Phase 1|Overall Study||3
10354115|NCT00457743|11493011|FG001|Completed Phase 1|Overall Study||6
10354116|NCT00457743|11493012|FG002|Completed Phase 1|Overall Study||3
10354117|NCT00457743|11493010|FG000|Enrolled in Phase 2|Overall Study|Three subjects who completed Phase 1 entered Phase 2.|3
10354118|NCT00457743|11493011|FG001|Enrolled in Phase 2|Overall Study|Six subjects who completed Phase 1 entered Phase 2, and 24 subjects were newly enrolled.|30
10354119|NCT00457743|11493012|FG002|Enrolled in Phase 2|Overall Study|Three subjects who completed Phase 1 entered Phase 2.|3
10354120|NCT00457743|11493010|FG000|COMPLETED|Overall Study|However, all 3 subjects enrolled were included in analysis (Intent-to treat population).|0
10354121|NCT00457743|11493011|FG001|COMPLETED|Overall Study|However, all 30 subjects enrolled were included in analysis(Intent-to treat population).|3
10354122|NCT00457743|11493012|FG002|COMPLETED|Overall Study|However, all 3 subjects enrolled were included in analysis(Intent-to treat population).|0
10354123|NCT00457743|11493010|FG000|NOT COMPLETED|Overall Study||3
10354124|NCT00457743|11493011|FG001|NOT COMPLETED|Overall Study||27
10354125|NCT00457743|11493012|FG002|NOT COMPLETED|Overall Study||3
10354126|NCT00457795|11493021|FG000|STARTED|Overall Study||15
10354127|NCT00457795|11493021|FG000|COMPLETED|Overall Study||15
10354128|NCT00457795|11493021|FG000|NOT COMPLETED|Overall Study||0
10354129|NCT00457821|11493033|FG000|STARTED|Part 1|Number of subjects randomized|4
10354130|NCT00457821|11493034|FG001|STARTED|Part 1|Number of subjects randomized|4
10354131|NCT00457821|11493035|FG002|STARTED|Part 1|Number of subjects randomized|5
10354132|NCT00457821|11493036|FG003|STARTED|Part 1|Number of subjects randomized|4
10354133|NCT00457821|11493037|FG004|STARTED|Part 1|Number of subjects randomized|4
10354134|NCT00457821|11493038|FG005|STARTED|Part 1|Arm in Part 2 only|0
10354135|NCT00457821|11493039|FG006|STARTED|Part 1|Arm in Part 2 only|0
10354136|NCT00457821|11493040|FG007|STARTED|Part 1|Arm in Part 2 only|0
10354137|NCT00457821|11493033|FG000|COMPLETED|Part 1||4
10354138|NCT00457821|11493034|FG001|COMPLETED|Part 1||4
10354139|NCT00457821|11493035|FG002|COMPLETED|Part 1||4
10354140|NCT00457821|11493036|FG003|COMPLETED|Part 1||4
10354141|NCT00457821|11493037|FG004|COMPLETED|Part 1||4
10354142|NCT00457821|11493038|FG005|COMPLETED|Part 1||0
10354143|NCT00457821|11493039|FG006|COMPLETED|Part 1||0
10354144|NCT00457821|11493040|FG007|COMPLETED|Part 1||0
10354145|NCT00457821|11493033|FG000|NOT COMPLETED|Part 1||0
10716062|NCT02688387|11880047|FG004|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10354146|NCT00457821|11493034|FG001|NOT COMPLETED|Part 1||0
10354147|NCT00457821|11493035|FG002|NOT COMPLETED|Part 1||1
10354148|NCT00457821|11493036|FG003|NOT COMPLETED|Part 1||0
10354149|NCT00457821|11493037|FG004|NOT COMPLETED|Part 1||0
10354150|NCT00457821|11493038|FG005|NOT COMPLETED|Part 1||0
10354151|NCT00457821|11493039|FG006|NOT COMPLETED|Part 1||0
10354152|NCT00457821|11493040|FG007|NOT COMPLETED|Part 1||0
10354153|NCT00457821|11493033|FG000|STARTED|Part 2|Arm in Part 1 only|0
10354154|NCT00457821|11493034|FG001|STARTED|Part 2|Arm in Part 1 only|0
10354155|NCT00457821|11493035|FG002|STARTED|Part 2|Arm in Part 1 only|0
10354156|NCT00457821|11493036|FG003|STARTED|Part 2|Arm in Part 1 only|0
10354157|NCT00457821|11493037|FG004|STARTED|Part 2|Arm in Part 1 only|0
10354158|NCT00457821|11493038|FG005|STARTED|Part 2|All subjects who received at least 1 dose of study drug (ivacaftor).|8
10354159|NCT00457821|11493039|FG006|STARTED|Part 2|All subjects who received at least 1 dose of study drug (ivacaftor).|7
10354160|NCT00457821|11493040|FG007|STARTED|Part 2|All subjects who received at least 1 dose of study drug (placebo).|5
10354161|NCT00457821|11493033|FG000|Completed Study Drug Treatment|Part 2||0
10354162|NCT00457821|11493034|FG001|Completed Study Drug Treatment|Part 2||0
10354163|NCT00457821|11493035|FG002|Completed Study Drug Treatment|Part 2||0
10354164|NCT00457821|11493036|FG003|Completed Study Drug Treatment|Part 2||0
10354165|NCT00457821|11493037|FG004|Completed Study Drug Treatment|Part 2||0
10354166|NCT00457821|11493038|FG005|Completed Study Drug Treatment|Part 2||8
10354167|NCT00457821|11493039|FG006|Completed Study Drug Treatment|Part 2|1 subject missed a 250-mg dose of ivacaftor on Day 28 of Part 2.|7
10354168|NCT00457821|11493040|FG007|Completed Study Drug Treatment|Part 2||4
10354169|NCT00457821|11493033|FG000|COMPLETED|Part 2||0
10354170|NCT00457821|11493034|FG001|COMPLETED|Part 2||0
10354171|NCT00457821|11493035|FG002|COMPLETED|Part 2||0
10354172|NCT00457821|11493036|FG003|COMPLETED|Part 2||0
10354173|NCT00457821|11493037|FG004|COMPLETED|Part 2||0
10354174|NCT00457821|11493038|FG005|COMPLETED|Part 2||8
10354175|NCT00457821|11493039|FG006|COMPLETED|Part 2||7
10354176|NCT00457821|11493040|FG007|COMPLETED|Part 2||4
10354177|NCT00457821|11493033|FG000|NOT COMPLETED|Part 2||0
10716063|NCT02688387|11880048|FG005|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10716064|NCT02688387|11880049|FG006|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10716065|NCT02688387|11880050|FG007|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10716066|NCT02688387|11880051|FG008|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10716067|NCT02688387|11880052|FG009|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10716068|NCT02688387|11880053|FG010|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10716069|NCT02688387|11880054|FG011|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10716070|NCT02688387|11880055|FG012|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10716071|NCT02688387|11880056|FG013|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10716072|NCT02688387|11880057|FG014|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10716073|NCT02688387|11880058|FG015|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10716074|NCT02688387|11880059|FG016|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10716075|NCT02688387|11880060|FG017|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10716076|NCT02688387|11880061|FG018|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
10716077|NCT02688387|11880062|FG019|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
10716078|NCT02688387|11880063|FG020|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
10716079|NCT02688387|11880064|FG021|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
10716080|NCT02688387|11880043|FG000|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10716081|NCT02688387|11880044|FG001|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10716082|NCT02688387|11880045|FG002|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10716083|NCT02688387|11880046|FG003|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10812513|NCT03591458|11974582|FG000|NOT COMPLETED|Overall Study||0
10812514|NCT03591458|11974583|FG001|NOT COMPLETED|Overall Study||0
10812515|NCT03590743|11974591|FG000|STARTED|Overall Study||2
10812516|NCT03590743|11974592|FG001|STARTED|Overall Study||3
10812517|NCT03590743|11974591|FG000|COMPLETED|Overall Study||2
10812518|NCT03590743|11974592|FG001|COMPLETED|Overall Study||2
10812519|NCT03590743|11974591|FG000|NOT COMPLETED|Overall Study||0
10812520|NCT03590743|11974592|FG001|NOT COMPLETED|Overall Study||1
10812521|NCT03580382|11974600|FG000|STARTED|Overall Study||0
10812522|NCT03580382|11974601|FG001|STARTED|Overall Study||3
10354178|NCT00457821|11493034|FG001|NOT COMPLETED|Part 2||0
10533545|NCT01425814|11685703|FG001|STARTED|Period 3||9
10533546|NCT01425814|11685704|FG002|STARTED|Period 3||12
10533547|NCT01425814|11685705|FG003|STARTED|Period 3||10
10533548|NCT01425814|11685706|FG004|STARTED|Period 3||12
10533549|NCT01425814|11685707|FG005|STARTED|Period 3||13
10533550|NCT01425814|11685702|FG000|COMPLETED|Period 3||12
10533551|NCT01425814|11685703|FG001|COMPLETED|Period 3||9
10533552|NCT01425814|11685704|FG002|COMPLETED|Period 3||12
10533553|NCT01425814|11685705|FG003|COMPLETED|Period 3||10
10533554|NCT01425814|11685706|FG004|COMPLETED|Period 3||12
10354179|NCT00457821|11493035|FG002|NOT COMPLETED|Part 2||0
10354180|NCT00457821|11493036|FG003|NOT COMPLETED|Part 2||0
10354181|NCT00457821|11493037|FG004|NOT COMPLETED|Part 2||0
10354182|NCT00457821|11493038|FG005|NOT COMPLETED|Part 2||0
10354183|NCT00457821|11493039|FG006|NOT COMPLETED|Part 2||0
10533555|NCT01425814|11685707|FG005|COMPLETED|Period 3||12
10533556|NCT01425814|11685702|FG000|NOT COMPLETED|Period 3||0
10533557|NCT01425814|11685703|FG001|NOT COMPLETED|Period 3||0
10533558|NCT01425814|11685704|FG002|NOT COMPLETED|Period 3||0
10533559|NCT01425814|11685705|FG003|NOT COMPLETED|Period 3||0
10533560|NCT01425814|11685706|FG004|NOT COMPLETED|Period 3||0
10533561|NCT01425814|11685707|FG005|NOT COMPLETED|Period 3||1
10354184|NCT00457821|11493040|FG007|NOT COMPLETED|Part 2||1
10354185|NCT00457977|11493059|FG000|STARTED|Overall Study||90
10354186|NCT00457977|11493060|FG001|STARTED|Overall Study||91
10354187|NCT00457977|11493059|FG000|1-Month|Overall Study||88
10354188|NCT00457977|11493060|FG001|1-Month|Overall Study||87
10354189|NCT00457977|11493059|FG000|1-Year|Overall Study||69
10354190|NCT00457977|11493060|FG001|1-Year|Overall Study||76
10354191|NCT00457977|11493059|FG000|2-Year|Overall Study||62
10354192|NCT00457977|11493060|FG001|2-Year|Overall Study||66
10354193|NCT00457977|11493059|FG000|COMPLETED|Overall Study||62
10354194|NCT00457977|11493060|FG001|COMPLETED|Overall Study||66
10354195|NCT00457977|11493059|FG000|NOT COMPLETED|Overall Study||28
10354196|NCT00457977|11493060|FG001|NOT COMPLETED|Overall Study||25
10354197|NCT00458211|11493066|FG000|STARTED|Overall Study||40
10354198|NCT00458211|11493066|FG000|COMPLETED|Overall Study|12 early termination 2 protocol violation 2 ( from Rochester) withdrawn from further analysis|24
10354199|NCT00458211|11493066|FG000|NOT COMPLETED|Overall Study||16
10354200|NCT00458237|11493077|FG000|STARTED|Overall Study||3
10354201|NCT00458237|11493078|FG001|STARTED|Overall Study||3
10354202|NCT00458237|11493079|FG002|STARTED|Overall Study||5
10354203|NCT00458237|11493077|FG000|COMPLETED|Overall Study||3
10354204|NCT00458237|11493078|FG001|COMPLETED|Overall Study||3
10354205|NCT00458237|11493079|FG002|COMPLETED|Overall Study||5
10354206|NCT00458237|11493077|FG000|NOT COMPLETED|Overall Study||0
10354207|NCT00458237|11493078|FG001|NOT COMPLETED|Overall Study||0
10354208|NCT00458237|11493079|FG002|NOT COMPLETED|Overall Study||0
10354209|NCT00458302|11493090|FG000|STARTED|Overall Study||129
10354210|NCT00458302|11493091|FG001|STARTED|Overall Study||127
10354211|NCT00458302|11493090|FG000|COMPLETED|Overall Study||109
10354212|NCT00458302|11493091|FG001|COMPLETED|Overall Study||103
10354213|NCT00458302|11493090|FG000|NOT COMPLETED|Overall Study||20
10354214|NCT00458302|11493091|FG001|NOT COMPLETED|Overall Study||24
10354215|NCT00458341|11493100|FG000|STARTED|Cycle 1||15
10354216|NCT00458341|11493101|FG001|STARTED|Cycle 1||15
10354217|NCT00458341|11493100|FG000|Received at Least 1 Dose of Study Drug|Cycle 1||15
10354218|NCT00458341|11493101|FG001|Received at Least 1 Dose of Study Drug|Cycle 1||15
10354219|NCT00458341|11493100|FG000|COMPLETED|Cycle 1|1 participant did not complete Cycle 1 since all procedures were not performed due to adverse event.|14
10354220|NCT00458341|11493101|FG001|COMPLETED|Cycle 1||15
10354221|NCT00458341|11493100|FG000|NOT COMPLETED|Cycle 1||1
10354222|NCT00458341|11493101|FG001|NOT COMPLETED|Cycle 1||0
10354223|NCT00458341|11493100|FG000|STARTED|Cycle 2|The participant who did not complete Cycle 1 was eligible for Cycle 2 and completed Cycle 2.|15
10354224|NCT00458341|11493101|FG001|STARTED|Cycle 2||15
10354225|NCT00458341|11493100|FG000|Received at Least 1 Dose of Study Drug|Cycle 2||15
10354226|NCT00458341|11493101|FG001|Received at Least 1 Dose of Study Drug|Cycle 2||15
10354227|NCT00458341|11493100|FG000|COMPLETED|Cycle 2||15
10354228|NCT00458341|11493101|FG001|COMPLETED|Cycle 2||15
10354229|NCT00458341|11493100|FG000|NOT COMPLETED|Cycle 2||0
10354230|NCT00458341|11493101|FG001|NOT COMPLETED|Cycle 2||0
10354231|NCT00458393|11493109|FG000|STARTED|Overall Study||1251
10354232|NCT00458393|11493110|FG001|STARTED|Overall Study||1248
10354233|NCT00458393|11493109|FG000|COMPLETED|Overall Study||942
10354234|NCT00458393|11493110|FG001|COMPLETED|Overall Study||953
10354235|NCT00458393|11493109|FG000|NOT COMPLETED|Overall Study||309
10354236|NCT00458393|11493110|FG001|NOT COMPLETED|Overall Study||295
10354237|NCT00458406|11493120|FG000|STARTED|Month 1||43
10354238|NCT00458406|11493121|FG001|STARTED|Month 1||13
10354239|NCT00458406|11493120|FG000|COMPLETED|Month 1||43
10354240|NCT00458406|11493121|FG001|COMPLETED|Month 1||13
10354241|NCT00458406|11493120|FG000|NOT COMPLETED|Month 1||0
10354242|NCT00458406|11493121|FG001|NOT COMPLETED|Month 1||0
10354243|NCT00458406|11493120|FG000|STARTED|Month 3||43
10354244|NCT00458406|11493121|FG001|STARTED|Month 3||13
10354245|NCT00458406|11493120|FG000|COMPLETED|Month 3||43
10354246|NCT00458406|11493121|FG001|COMPLETED|Month 3||13
10354247|NCT00458406|11493120|FG000|NOT COMPLETED|Month 3||0
10354248|NCT00458406|11493121|FG001|NOT COMPLETED|Month 3||0
10354249|NCT00458484|11493141|FG000|STARTED|Overall Study||4
10354250|NCT00458484|11493142|FG001|STARTED|Overall Study||6
10354251|NCT00458484|11493143|FG002|STARTED|Overall Study||3
10354252|NCT00458484|11493144|FG003|STARTED|Overall Study||6
10354253|NCT00458484|11493145|FG004|STARTED|Overall Study||4
10354254|NCT00458484|11493146|FG005|STARTED|Overall Study||5
10354255|NCT00458484|11493147|FG006|STARTED|Overall Study||3
10354256|NCT00458484|11493141|FG000|COMPLETED|Overall Study||4
10354257|NCT00458484|11493142|FG001|COMPLETED|Overall Study||6
10354258|NCT00458484|11493143|FG002|COMPLETED|Overall Study||3
10354259|NCT00458484|11493144|FG003|COMPLETED|Overall Study||6
10354260|NCT00458484|11493145|FG004|COMPLETED|Overall Study||4
10354261|NCT00458484|11493146|FG005|COMPLETED|Overall Study||4
10354262|NCT00458484|11493147|FG006|COMPLETED|Overall Study||3
10354263|NCT00458484|11493141|FG000|NOT COMPLETED|Overall Study||0
10354264|NCT00458484|11493142|FG001|NOT COMPLETED|Overall Study||0
10354265|NCT00458484|11493143|FG002|NOT COMPLETED|Overall Study||0
10354266|NCT00458484|11493144|FG003|NOT COMPLETED|Overall Study||0
10354267|NCT00458484|11493145|FG004|NOT COMPLETED|Overall Study||0
10354268|NCT00458484|11493146|FG005|NOT COMPLETED|Overall Study||1
10354269|NCT00458484|11493147|FG006|NOT COMPLETED|Overall Study||0
10354270|NCT00458705|11493172|FG000|STARTED|Overall Study||45
10354271|NCT00458705|11493172|FG000|COMPLETED|Overall Study||40
10354272|NCT00458705|11493172|FG000|NOT COMPLETED|Overall Study||5
10354273|NCT00458783|11493178|FG000|STARTED|Overall Study||1914
10354274|NCT00458783|11493179|FG001|STARTED|Overall Study||1921
10354275|NCT00458783|11493178|FG000|COMPLETED|Overall Study||686
10354276|NCT00458783|11493179|FG001|COMPLETED|Overall Study||701
10354277|NCT00458783|11493178|FG000|NOT COMPLETED|Overall Study||1228
10354278|NCT00458783|11493179|FG001|NOT COMPLETED|Overall Study||1220
10354279|NCT00458822|11493185|FG000|STARTED|Overall Study||40
10354280|NCT00458822|11493185|FG000|COMPLETED|Overall Study||40
10354281|NCT00458822|11493185|FG000|NOT COMPLETED|Overall Study||0
10354282|NCT00458848|11493189|FG000|STARTED|Overall Study||51
10354283|NCT00458848|11493189|FG000|COMPLETED|Overall Study||51
10354284|NCT00458848|11493189|FG000|NOT COMPLETED|Overall Study||0
10354285|NCT00458952|11493195|FG000|STARTED|Overall Study||7
10354286|NCT00458952|11493196|FG001|STARTED|Overall Study||14
10354287|NCT00458952|11493195|FG000|COMPLETED|Overall Study||5
10354288|NCT00458952|11493196|FG001|COMPLETED|Overall Study||9
10354289|NCT00458952|11493195|FG000|NOT COMPLETED|Overall Study||2
10354290|NCT00458952|11493196|FG001|NOT COMPLETED|Overall Study||5
10354291|NCT00459043|11493202|FG000|STARTED|Overall Study||15
10354292|NCT00459043|11493203|FG001|STARTED|Overall Study||15
10354293|NCT00459043|11493202|FG000|COMPLETED|Overall Study||14
10354294|NCT00459043|11493203|FG001|COMPLETED|Overall Study||15
10354295|NCT00459043|11493202|FG000|NOT COMPLETED|Overall Study||1
10354296|NCT00459043|11493203|FG001|NOT COMPLETED|Overall Study||0
10354297|NCT00459056|11493211|FG000|STARTED|First Intervention (First Three Months)||10
10354298|NCT00459056|11493212|FG001|STARTED|First Intervention (First Three Months)||15
10354299|NCT00459056|11493211|FG000|COMPLETED|First Intervention (First Three Months)||9
10354300|NCT00459056|11493212|FG001|COMPLETED|First Intervention (First Three Months)||14
10354301|NCT00459056|11493211|FG000|NOT COMPLETED|First Intervention (First Three Months)||1
10354302|NCT00459056|11493212|FG001|NOT COMPLETED|First Intervention (First Three Months)||1
10354303|NCT00459056|11493211|FG000|STARTED|Washout (1 Month)||9
10354304|NCT00459056|11493212|FG001|STARTED|Washout (1 Month)||14
10354305|NCT00459056|11493211|FG000|COMPLETED|Washout (1 Month)||9
10354306|NCT00459056|11493212|FG001|COMPLETED|Washout (1 Month)||14
10354307|NCT00459056|11493211|FG000|NOT COMPLETED|Washout (1 Month)||0
10354308|NCT00459056|11493212|FG001|NOT COMPLETED|Washout (1 Month)||0
10354309|NCT00459056|11493211|FG000|STARTED|Second Intervention (Final Three Months)||9
10354310|NCT00459056|11493212|FG001|STARTED|Second Intervention (Final Three Months)||14
10354311|NCT00459056|11493211|FG000|COMPLETED|Second Intervention (Final Three Months)||9
10354312|NCT00459056|11493212|FG001|COMPLETED|Second Intervention (Final Three Months)||14
10354313|NCT00459056|11493211|FG000|NOT COMPLETED|Second Intervention (Final Three Months)||0
10354314|NCT00459056|11493212|FG001|NOT COMPLETED|Second Intervention (Final Three Months)||0
10354315|NCT00459108|11493218|FG000|STARTED|Overall Study||25
10354316|NCT00459108|11493218|FG000|COMPLETED|Overall Study||14
10354317|NCT00459108|11493218|FG000|NOT COMPLETED|Overall Study||11
10354318|NCT00459134|11493225|FG000|STARTED|Overall Study||94
10354319|NCT00459134|11493226|FG001|STARTED|Overall Study||92
10354320|NCT00459134|11493225|FG000|COMPLETED|Overall Study||71
10354321|NCT00459134|11493226|FG001|COMPLETED|Overall Study||67
10354322|NCT00459134|11493225|FG000|NOT COMPLETED|Overall Study||23
10354323|NCT00459134|11493226|FG001|NOT COMPLETED|Overall Study||25
10354324|NCT00459186|11493232|FG000|STARTED|Single Agent RAD001||19
10354325|NCT00459186|11493232|FG000|COMPLETED|Single Agent RAD001||18
10354326|NCT00459186|11493232|FG000|NOT COMPLETED|Single Agent RAD001||1
10354327|NCT00459186|11493232|FG000|STARTED|PET Imaging and Assessment||18
10354328|NCT00459186|11493232|FG000|COMPLETED|PET Imaging and Assessment||15
10354329|NCT00459186|11493232|FG000|NOT COMPLETED|PET Imaging and Assessment||3
10354330|NCT00459186|11493232|FG000|STARTED|Combination RAD001 + Docetaxel||15
10354331|NCT00459186|11493232|FG000|COMPLETED|Combination RAD001 + Docetaxel||15
10354332|NCT00459186|11493232|FG000|NOT COMPLETED|Combination RAD001 + Docetaxel||0
10354333|NCT00459290|11493236|FG000|STARTED|Overall Study||24
10354334|NCT00459290|11493236|FG000|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|19
10354335|NCT00459290|11493236|FG000|NOT COMPLETED|Overall Study||5
10354336|NCT00459303|11493247|FG000|STARTED|Overall Study||20
10354337|NCT00459303|11493247|FG000|COMPLETED|Overall Study||20
10354338|NCT00459303|11493247|FG000|NOT COMPLETED|Overall Study||0
10354339|NCT00459316|11493259|FG000|STARTED|Steps 1 & 2||280
10354340|NCT00459316|11493260|FG001|STARTED|Steps 1 & 2||39
10354341|NCT00459316|11493261|FG002|STARTED|Steps 1 & 2||59
10354342|NCT00459316|11493259|FG000|COMPLETED|Steps 1 & 2||259
10354343|NCT00459316|11493260|FG001|COMPLETED|Steps 1 & 2||32
10354344|NCT00459316|11493261|FG002|COMPLETED|Steps 1 & 2||57
10354345|NCT00459316|11493259|FG000|NOT COMPLETED|Steps 1 & 2||21
10354346|NCT00459316|11493260|FG001|NOT COMPLETED|Steps 1 & 2||7
10354347|NCT00459316|11493261|FG002|NOT COMPLETED|Steps 1 & 2||2
10354348|NCT00459316|11493259|FG000|STARTED|Step 3|Not all participants from Steps 1/2 were eligible for Step 3|152
10354349|NCT00459316|11493260|FG001|STARTED|Step 3|Group 2 participants were not eligible for Step 3|0
10354350|NCT00459316|11493261|FG002|STARTED|Step 3|Not all participants from Steps 1/2 were eligible for Step 3|40
10354351|NCT00459316|11493259|FG000|COMPLETED|Step 3||149
10354352|NCT00459316|11493260|FG001|COMPLETED|Step 3||0
10354353|NCT00459316|11493261|FG002|COMPLETED|Step 3||39
10354354|NCT00459316|11493259|FG000|NOT COMPLETED|Step 3||3
10354355|NCT00459316|11493260|FG001|NOT COMPLETED|Step 3||0
10354356|NCT00459316|11493261|FG002|NOT COMPLETED|Step 3||1
10354357|NCT00459342|11493284|FG000|STARTED|Overall Study||35
10354358|NCT00459342|11493284|FG000|COMPLETED|Overall Study||34
10354359|NCT00459342|11493284|FG000|NOT COMPLETED|Overall Study||1
10354360|NCT00459355|11493290|FG000|STARTED|Overall Study|Includes 70 dyads, caregiver/care-recipient|140
10354361|NCT00459355|11493291|FG001|STARTED|Overall Study|Includes 57 dyads, caregiver + care-recipient|114
10354362|NCT00459355|11493290|FG000|COMPLETED|Overall Study|Includes 60 dyads, caregiver + care-recipient|120
10354363|NCT00459355|11493291|FG001|COMPLETED|Overall Study|Includes 48 dyads, caregiver + care-recipient|96
10354364|NCT00459355|11493290|FG000|NOT COMPLETED|Overall Study||20
10354365|NCT00459355|11493291|FG001|NOT COMPLETED|Overall Study||18
10354366|NCT00459368|11493303|FG000|STARTED|Overall Study||1335
10354367|NCT00459368|11493304|FG001|STARTED|Overall Study||1363
10354368|NCT00459368|11493303|FG000|COMPLETED|Overall Study||1040
10354369|NCT00459368|11493304|FG001|COMPLETED|Overall Study||1034
10354370|NCT00459368|11493303|FG000|NOT COMPLETED|Overall Study||295
10354371|NCT00459368|11493304|FG001|NOT COMPLETED|Overall Study||329
10354372|NCT00459381|11493310|FG000|STARTED|Overall Study||35
10354373|NCT00459381|11493310|FG000|COMPLETED|Overall Study||35
10354374|NCT00459381|11493310|FG000|NOT COMPLETED|Overall Study||0
10354375|NCT00459537|11493316|FG000|STARTED|Overall Study||507
10354376|NCT00459537|11493317|FG001|STARTED|Overall Study||522
10354377|NCT00459537|11493316|FG000|Safety Population|Overall Study|Participants who had at least one dose of study drug and one post-baseline safety assessment.|493
10354378|NCT00459537|11493317|FG001|Safety Population|Overall Study||512
10354379|NCT00459537|11493316|FG000|COMPLETED|Overall Study||441
10354380|NCT00459537|11493317|FG001|COMPLETED|Overall Study||446
10354381|NCT00459537|11493316|FG000|NOT COMPLETED|Overall Study||66
10354382|NCT00459537|11493317|FG001|NOT COMPLETED|Overall Study||76
10354383|NCT00459667|11493326|FG000|STARTED|Overall Study||592
10354384|NCT00459667|11493327|FG001|STARTED|Overall Study||647
10354385|NCT00459667|11493328|FG002|STARTED|Overall Study||181
10354386|NCT00459667|11493326|FG000|Study Medication Dispensed|Overall Study||586
10354387|NCT00459667|11493327|FG001|Study Medication Dispensed|Overall Study||645
10354388|NCT00459667|11493328|FG002|Study Medication Dispensed|Overall Study||180
10354389|NCT00459667|11493326|FG000|Started Treatment|Overall Study||586
10354390|NCT00459667|11493327|FG001|Started Treatment|Overall Study||644
10354391|NCT00459667|11493328|FG002|Started Treatment|Overall Study||180
10354392|NCT00459667|11493326|FG000|COMPLETED|Overall Study||554
10354393|NCT00459667|11493327|FG001|COMPLETED|Overall Study||600
10354394|NCT00459667|11493328|FG002|COMPLETED|Overall Study||161
10354395|NCT00459667|11493326|FG000|NOT COMPLETED|Overall Study||38
10354396|NCT00459667|11493327|FG001|NOT COMPLETED|Overall Study||47
10354397|NCT00459667|11493328|FG002|NOT COMPLETED|Overall Study||20
10354398|NCT00459706|11493338|FG000|STARTED|Overall Study||325
10354399|NCT00459706|11493339|FG001|STARTED|Overall Study||315
10354400|NCT00459706|11493338|FG000|MODIFIED INTENT-TO-TREAT POPULATION|Overall Study|1 participant had no evaluation after the first injection|324
10354401|NCT00459706|11493339|FG001|MODIFIED INTENT-TO-TREAT POPULATION|Overall Study|2 participants withdrew consent before the first injection|313
10354402|NCT00459706|11493338|FG000|COMPLETED|Overall Study||299
10354403|NCT00459706|11493339|FG001|COMPLETED|Overall Study||294
10354404|NCT00459706|11493338|FG000|NOT COMPLETED|Overall Study||26
10354405|NCT00459706|11493339|FG001|NOT COMPLETED|Overall Study||21
10354406|NCT00459732|11493347|FG000|STARTED|Overall Study||23
10354407|NCT00459732|11493348|FG001|STARTED|Overall Study||17
10354408|NCT00459732|11493347|FG000|COMPLETED|Overall Study|4 on zn dropped: 1 pregnant and 1 nausea after baseline, 1 lost to followup, 1 exited after 12 month|19
10354409|NCT00459732|11493348|FG001|COMPLETED|Overall Study|3 on placebo dropped: 1 pregnant after 12 mo, 1 lost to followup, one died after 12 month timepoint|14
10354410|NCT00459732|11493347|FG000|NOT COMPLETED|Overall Study||4
10354411|NCT00459732|11493348|FG001|NOT COMPLETED|Overall Study||3
10354412|NCT00459810|11493354|FG000|STARTED|Overall Study||21
10354413|NCT00459810|11493354|FG000|COMPLETED|Overall Study||21
10354414|NCT00459810|11493354|FG000|NOT COMPLETED|Overall Study||0
10354415|NCT00459862|11493358|FG000|STARTED|Overall Study||34
10354416|NCT00459862|11493358|FG000|COMPLETED|Overall Study||34
10354417|NCT00459862|11493358|FG000|NOT COMPLETED|Overall Study||0
10354418|NCT00459875|11493362|FG000|STARTED|Overall Study||24
10354419|NCT00459875|11493362|FG000|COMPLETED|Overall Study||21
10354420|NCT00459875|11493362|FG000|NOT COMPLETED|Overall Study||3
10354421|NCT00459953|11493368|FG000|STARTED|Overall Study||72
10354422|NCT00459953|11493369|FG001|STARTED|Overall Study||71
10354423|NCT00459953|11493368|FG000|COMPLETED|Overall Study||71
10354424|NCT00459953|11493369|FG001|COMPLETED|Overall Study||70
10354425|NCT00459953|11493368|FG000|NOT COMPLETED|Overall Study||1
10354426|NCT00459953|11493369|FG001|NOT COMPLETED|Overall Study||1
10354427|NCT00459979|11493375|FG000|STARTED|Overall Study||30
10354428|NCT00459979|11493375|FG000|COMPLETED|Overall Study||28
10354429|NCT00459979|11493375|FG000|NOT COMPLETED|Overall Study||2
10354430|NCT00460031|11493379|FG000|STARTED|Overall Study||34
10354431|NCT00460031|11493379|FG000|COMPLETED|Overall Study||23
10354432|NCT00460031|11493379|FG000|NOT COMPLETED|Overall Study||11
10354433|NCT00460109|11493383|FG000|STARTED|Overall Study||24
10354434|NCT00460109|11493383|FG000|COMPLETED|Overall Study||23
10354435|NCT00460109|11493383|FG000|NOT COMPLETED|Overall Study||1
10354436|NCT00460239|11493387|FG000|STARTED|Overall Study||0
10656034|NCT02213289|11816874|FG001|FGFR2 Amplified|Overall Study||0
10354437|NCT00460239|11493388|FG001|STARTED|Overall Study||3
10354438|NCT00460239|11493389|FG002|STARTED|Overall Study||1
10354439|NCT00460239|11493390|FG003|STARTED|Overall Study||0
10354440|NCT00460239|11493391|FG004|STARTED|Overall Study||1
10354441|NCT00460239|11493392|FG005|STARTED|Overall Study||4
10656035|NCT02213289|11816873|FG000|MAPK/PIK3CA Aberrant|Overall Study||20
10656036|NCT02213289|11816874|FG001|MAPK/PIK3CA Aberrant|Overall Study||0
10656037|NCT02213289|11816873|FG000|EGFR Expressing|Overall Study||9
10354442|NCT00460239|11493393|FG006|STARTED|Overall Study||1
10354443|NCT00460239|11493394|FG007|STARTED|Overall Study||1
10354444|NCT00460239|11493395|FG008|STARTED|Overall Study||1
10354445|NCT00460239|11493387|FG000|COMPLETED|Overall Study||0
10354446|NCT00460239|11493388|FG001|COMPLETED|Overall Study||2
10354447|NCT00460239|11493389|FG002|COMPLETED|Overall Study||1
10354448|NCT00460239|11493390|FG003|COMPLETED|Overall Study||0
10354449|NCT00460239|11493391|FG004|COMPLETED|Overall Study||1
10354450|NCT00460239|11493392|FG005|COMPLETED|Overall Study||1
10354451|NCT00460239|11493393|FG006|COMPLETED|Overall Study||1
10354452|NCT00460239|11493394|FG007|COMPLETED|Overall Study||1
10354453|NCT00460239|11493395|FG008|COMPLETED|Overall Study||1
10354454|NCT00460239|11493387|FG000|NOT COMPLETED|Overall Study||0
10354455|NCT00460239|11493388|FG001|NOT COMPLETED|Overall Study||1
10354456|NCT00460239|11493389|FG002|NOT COMPLETED|Overall Study||0
10354457|NCT00460239|11493390|FG003|NOT COMPLETED|Overall Study||0
10354458|NCT00460239|11493391|FG004|NOT COMPLETED|Overall Study||0
10354459|NCT00460239|11493392|FG005|NOT COMPLETED|Overall Study||3
10354460|NCT00460239|11493393|FG006|NOT COMPLETED|Overall Study||0
10354461|NCT00460239|11493394|FG007|NOT COMPLETED|Overall Study||0
10354462|NCT00460239|11493395|FG008|NOT COMPLETED|Overall Study||0
10354463|NCT00460265|11493410|FG000|STARTED|Overall Study||328
10354464|NCT00460265|11493411|FG001|STARTED|Overall Study||330
10354465|NCT00460265|11493410|FG000|Randomized While Alive|Overall Study|1 subject was randomized by error after death|327
10354466|NCT00460265|11493411|FG001|Randomized While Alive|Overall Study||330
10354467|NCT00460265|11493410|FG000|Received Study Medication|Overall Study||325
10354468|NCT00460265|11493411|FG001|Received Study Medication|Overall Study||325
10354469|NCT00460265|11493410|FG000|COMPLETED|Overall Study|Completed study=death|243
10354470|NCT00460265|11493411|FG001|COMPLETED|Overall Study|Completed study=death|241
10354471|NCT00460265|11493410|FG000|NOT COMPLETED|Overall Study||85
10354472|NCT00460265|11493411|FG001|NOT COMPLETED|Overall Study||89
10354473|NCT00460408|11493421|FG000|STARTED|Overall Study||403
10354474|NCT00460408|11493422|FG001|STARTED|Overall Study||16
10354475|NCT00460408|11493423|FG002|STARTED|Overall Study||75
10354476|NCT00460408|11493424|FG003|STARTED|Overall Study||7
10354477|NCT00460408|11493421|FG000|COMPLETED|Overall Study||336
10354478|NCT00460408|11493422|FG001|COMPLETED|Overall Study||13
10354479|NCT00460408|11493423|FG002|COMPLETED|Overall Study||69
10354480|NCT00460408|11493424|FG003|COMPLETED|Overall Study||7
10354481|NCT00460408|11493421|FG000|NOT COMPLETED|Overall Study||67
10354482|NCT00460408|11493422|FG001|NOT COMPLETED|Overall Study||3
10656038|NCT02213289|11816874|FG001|EGFR Expressing|Overall Study||0
10656039|NCT02213289|11816873|FG000|All Negative|Overall Study||9
10656040|NCT02213289|11816874|FG001|All Negative|Overall Study||0
10656041|NCT02213289|11816873|FG000|Other (Non-ITT)|Overall Study||0
10656042|NCT02213289|11816874|FG001|Other (Non-ITT)|Overall Study||12
10656043|NCT02213289|11816873|FG000|COMPLETED|Overall Study||68
10354483|NCT00460408|11493423|FG002|NOT COMPLETED|Overall Study||6
10354484|NCT00460408|11493424|FG003|NOT COMPLETED|Overall Study||0
10354485|NCT00460421|11493437|FG000|STARTED|Overall Study||9
10354486|NCT00460421|11493438|FG001|STARTED|Overall Study||9
10354487|NCT00460421|11493439|FG002|STARTED|Overall Study||9
10354488|NCT00460421|11493437|FG000|COMPLETED|Overall Study||9
10354489|NCT00460421|11493438|FG001|COMPLETED|Overall Study||9
10354490|NCT00460421|11493439|FG002|COMPLETED|Overall Study||9
10354491|NCT00460421|11493437|FG000|NOT COMPLETED|Overall Study||0
10354492|NCT00460421|11493438|FG001|NOT COMPLETED|Overall Study||0
10354493|NCT00460421|11493439|FG002|NOT COMPLETED|Overall Study||0
10354494|NCT00460434|11493448|FG000|STARTED|Overall Study||165
10354495|NCT00460434|11493449|FG001|STARTED|Overall Study||172
10354496|NCT00460434|11493448|FG000|3 Months|Overall Study||163
10354497|NCT00460434|11493449|FG001|3 Months|Overall Study||171
10354498|NCT00460434|11493448|FG000|12 Months|Overall Study||162
10354499|NCT00460434|11493449|FG001|12 Months|Overall Study||165
10354500|NCT00460434|11493448|FG000|COMPLETED|Overall Study||162
10354501|NCT00460434|11493449|FG001|COMPLETED|Overall Study||165
10354502|NCT00460434|11493448|FG000|NOT COMPLETED|Overall Study||3
10354503|NCT00460434|11493449|FG001|NOT COMPLETED|Overall Study||7
10354504|NCT00460525|11493457|FG000|STARTED|Overall Study||201
10354505|NCT00460525|11493458|FG001|STARTED|Overall Study||199
10354506|NCT00460525|11493457|FG000|COMPLETED|Overall Study||190
10354507|NCT00460525|11493458|FG001|COMPLETED|Overall Study||194
10354508|NCT00460525|11493457|FG000|NOT COMPLETED|Overall Study||11
10656044|NCT02213289|11816874|FG001|COMPLETED|Overall Study||12
10656045|NCT02213289|11816873|FG000|NOT COMPLETED|Overall Study||0
10354509|NCT00460525|11493458|FG001|NOT COMPLETED|Overall Study||5
10354510|NCT00460551|11493464|FG000|STARTED|Overall Study||13
10354511|NCT00460551|11493464|FG000|COMPLETED|Overall Study|The trial was terminated after Period 1A. Only safety was measured.|13
10354512|NCT00460551|11493464|FG000|NOT COMPLETED|Overall Study||0
10354513|NCT00460564|11493472|FG000|STARTED|Double-Blind Phase (12 Weeks)||51
10354514|NCT00460564|11493473|FG001|STARTED|Double-Blind Phase (12 Weeks)||26
10354515|NCT00460564|11493474|FG002|STARTED|Double-Blind Phase (12 Weeks)||21
10354516|NCT00460564|11493475|FG003|STARTED|Double-Blind Phase (12 Weeks)||11
10656046|NCT02213289|11816874|FG001|NOT COMPLETED|Overall Study||0
10656047|NCT02213458|11816886|FG000|STARTED|Overall Study||1024
10354517|NCT00460564|11493476|FG004|STARTED|Double-Blind Phase (12 Weeks)||0
10354518|NCT00460564|11493477|FG005|STARTED|Double-Blind Phase (12 Weeks)||0
10354519|NCT00460564|11493478|FG006|STARTED|Double-Blind Phase (12 Weeks)||0
10354520|NCT00460564|11493479|FG007|STARTED|Double-Blind Phase (12 Weeks)||0
10354521|NCT00460564|11493472|FG000|COMPLETED|Double-Blind Phase (12 Weeks)||47
10354522|NCT00460564|11493473|FG001|COMPLETED|Double-Blind Phase (12 Weeks)||25
10354523|NCT00460564|11493474|FG002|COMPLETED|Double-Blind Phase (12 Weeks)||21
10354524|NCT00460564|11493475|FG003|COMPLETED|Double-Blind Phase (12 Weeks)||11
10354525|NCT00460564|11493476|FG004|COMPLETED|Double-Blind Phase (12 Weeks)||0
10354526|NCT00460564|11493477|FG005|COMPLETED|Double-Blind Phase (12 Weeks)||0
10354527|NCT00460564|11493478|FG006|COMPLETED|Double-Blind Phase (12 Weeks)||0
10354528|NCT00460564|11493479|FG007|COMPLETED|Double-Blind Phase (12 Weeks)||0
10354529|NCT00460564|11493472|FG000|NOT COMPLETED|Double-Blind Phase (12 Weeks)||4
10354530|NCT00460564|11493473|FG001|NOT COMPLETED|Double-Blind Phase (12 Weeks)||1
10354531|NCT00460564|11493474|FG002|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
10354532|NCT00460564|11493475|FG003|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
10354533|NCT00460564|11493476|FG004|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
10354534|NCT00460564|11493477|FG005|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
10354535|NCT00460564|11493478|FG006|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
10354536|NCT00460564|11493479|FG007|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
10354537|NCT00460564|11493472|FG000|STARTED|Open-Label Phase (36 Weeks)||0
10354538|NCT00460564|11493473|FG001|STARTED|Open-Label Phase (36 Weeks)||0
10354539|NCT00460564|11493474|FG002|STARTED|Open-Label Phase (36 Weeks)||0
10354540|NCT00460564|11493475|FG003|STARTED|Open-Label Phase (36 Weeks)||0
10354541|NCT00460564|11493476|FG004|STARTED|Open-Label Phase (36 Weeks)||47
10354542|NCT00460564|11493477|FG005|STARTED|Open-Label Phase (36 Weeks)||25
10354543|NCT00460564|11493478|FG006|STARTED|Open-Label Phase (36 Weeks)||21
10354544|NCT00460564|11493479|FG007|STARTED|Open-Label Phase (36 Weeks)||11
10354545|NCT00460564|11493472|FG000|COMPLETED|Open-Label Phase (36 Weeks)||0
10354546|NCT00460564|11493473|FG001|COMPLETED|Open-Label Phase (36 Weeks)||0
10354547|NCT00460564|11493474|FG002|COMPLETED|Open-Label Phase (36 Weeks)||0
10354548|NCT00460564|11493475|FG003|COMPLETED|Open-Label Phase (36 Weeks)||0
10354549|NCT00460564|11493476|FG004|COMPLETED|Open-Label Phase (36 Weeks)||38
10354550|NCT00460564|11493477|FG005|COMPLETED|Open-Label Phase (36 Weeks)||19
10354551|NCT00460564|11493478|FG006|COMPLETED|Open-Label Phase (36 Weeks)||19
10354552|NCT00460564|11493479|FG007|COMPLETED|Open-Label Phase (36 Weeks)||11
10354553|NCT00460564|11493472|FG000|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
10354554|NCT00460564|11493473|FG001|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
10354555|NCT00460564|11493474|FG002|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
10354556|NCT00460564|11493475|FG003|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
10354557|NCT00460564|11493476|FG004|NOT COMPLETED|Open-Label Phase (36 Weeks)||9
10354558|NCT00460564|11493477|FG005|NOT COMPLETED|Open-Label Phase (36 Weeks)||6
10354559|NCT00460564|11493478|FG006|NOT COMPLETED|Open-Label Phase (36 Weeks)||2
10354560|NCT00460564|11493479|FG007|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
10354561|NCT00460577|11493501|FG000|STARTED|Overall Study|148 patients were screened; however, 22 did not consent and 66 did not meet inclusion/exclusion.|30
10354562|NCT00460577|11493502|FG001|STARTED|Overall Study||30
10354563|NCT00460577|11493501|FG000|COMPLETED|Overall Study||28
10354564|NCT00460577|11493502|FG001|COMPLETED|Overall Study||24
10354565|NCT00460577|11493501|FG000|NOT COMPLETED|Overall Study||2
10354566|NCT00460577|11493502|FG001|NOT COMPLETED|Overall Study||6
10354567|NCT00460603|11493520|FG000|STARTED|Phase 1||6
10354568|NCT00460603|11493521|FG001|STARTED|Phase 1||6
10354569|NCT00460603|11493522|FG002|STARTED|Phase 1||4
10354570|NCT00460603|11493523|FG003|STARTED|Phase 1||8
10354571|NCT00460603|11493524|FG004|STARTED|Phase 1||6
10354572|NCT00460603|11493525|FG005|STARTED|Phase 1||4
10354573|NCT00460603|11493526|FG006|STARTED|Phase 1||6
10354574|NCT00460603|11493527|FG007|STARTED|Phase 1||3
10354575|NCT00460603|11493528|FG008|STARTED|Phase 1||18
10354576|NCT00460603|11493529|FG009|STARTED|Phase 1||0
10354577|NCT00460603|11493530|FG010|STARTED|Phase 1||0
10354578|NCT00460603|11493531|FG011|STARTED|Phase 1||0
10354579|NCT00460603|11493520|FG000|COMPLETED|Phase 1||0
10354580|NCT00460603|11493521|FG001|COMPLETED|Phase 1||0
10354581|NCT00460603|11493522|FG002|COMPLETED|Phase 1||0
10354582|NCT00460603|11493523|FG003|COMPLETED|Phase 1||0
10354583|NCT00460603|11493524|FG004|COMPLETED|Phase 1||0
10354584|NCT00460603|11493525|FG005|COMPLETED|Phase 1||0
10354585|NCT00460603|11493526|FG006|COMPLETED|Phase 1||0
10354586|NCT00460603|11493527|FG007|COMPLETED|Phase 1||0
10354587|NCT00460603|11493528|FG008|COMPLETED|Phase 1||0
10354588|NCT00460603|11493529|FG009|COMPLETED|Phase 1||0
10354589|NCT00460603|11493530|FG010|COMPLETED|Phase 1||0
10354590|NCT00460603|11493531|FG011|COMPLETED|Phase 1||0
10354591|NCT00460603|11493520|FG000|NOT COMPLETED|Phase 1||6
10354592|NCT00460603|11493521|FG001|NOT COMPLETED|Phase 1||6
10354593|NCT00460603|11493522|FG002|NOT COMPLETED|Phase 1||4
10354594|NCT00460603|11493523|FG003|NOT COMPLETED|Phase 1||8
10354595|NCT00460603|11493524|FG004|NOT COMPLETED|Phase 1||6
10354596|NCT00460603|11493525|FG005|NOT COMPLETED|Phase 1||4
10354597|NCT00460603|11493526|FG006|NOT COMPLETED|Phase 1||6
10354598|NCT00460603|11493527|FG007|NOT COMPLETED|Phase 1||3
10354599|NCT00460603|11493528|FG008|NOT COMPLETED|Phase 1||18
10354600|NCT00460603|11493529|FG009|NOT COMPLETED|Phase 1||0
10354601|NCT00460603|11493530|FG010|NOT COMPLETED|Phase 1||0
10354602|NCT00460603|11493531|FG011|NOT COMPLETED|Phase 1||0
10354603|NCT00460603|11493520|FG000|STARTED|Phase 2||0
10354604|NCT00460603|11493521|FG001|STARTED|Phase 2||0
10354605|NCT00460603|11493522|FG002|STARTED|Phase 2||0
10354606|NCT00460603|11493523|FG003|STARTED|Phase 2||0
10354607|NCT00460603|11493524|FG004|STARTED|Phase 2||0
10354608|NCT00460603|11493525|FG005|STARTED|Phase 2||0
10354609|NCT00460603|11493526|FG006|STARTED|Phase 2||0
10354610|NCT00460603|11493527|FG007|STARTED|Phase 2||0
10354611|NCT00460603|11493528|FG008|STARTED|Phase 2||0
10354612|NCT00460603|11493529|FG009|STARTED|Phase 2||42
10354613|NCT00460603|11493530|FG010|STARTED|Phase 2||43
10354614|NCT00460603|11493531|FG011|STARTED|Phase 2||41
10354615|NCT00460603|11493520|FG000|Treated|Phase 2||0
10354616|NCT00460603|11493521|FG001|Treated|Phase 2||0
10354617|NCT00460603|11493522|FG002|Treated|Phase 2||0
10354618|NCT00460603|11493523|FG003|Treated|Phase 2||0
10354619|NCT00460603|11493524|FG004|Treated|Phase 2||0
10354620|NCT00460603|11493525|FG005|Treated|Phase 2||0
10354621|NCT00460603|11493526|FG006|Treated|Phase 2||0
10354622|NCT00460603|11493527|FG007|Treated|Phase 2||0
10354623|NCT00460603|11493528|FG008|Treated|Phase 2||0
10354624|NCT00460603|11493529|FG009|Treated|Phase 2||39
10354625|NCT00460603|11493530|FG010|Treated|Phase 2||43
10354626|NCT00460603|11493531|FG011|Treated|Phase 2||41
10354627|NCT00460603|11493520|FG000|COMPLETED|Phase 2||0
10354628|NCT00460603|11493521|FG001|COMPLETED|Phase 2||0
10354629|NCT00460603|11493522|FG002|COMPLETED|Phase 2||0
10354630|NCT00460603|11493523|FG003|COMPLETED|Phase 2||0
10354631|NCT00460603|11493524|FG004|COMPLETED|Phase 2||0
10354632|NCT00460603|11493525|FG005|COMPLETED|Phase 2||0
10354633|NCT00460603|11493526|FG006|COMPLETED|Phase 2||0
10354634|NCT00460603|11493527|FG007|COMPLETED|Phase 2||0
10354635|NCT00460603|11493528|FG008|COMPLETED|Phase 2||0
10354636|NCT00460603|11493529|FG009|COMPLETED|Phase 2||0
10354637|NCT00460603|11493530|FG010|COMPLETED|Phase 2||0
10354638|NCT00460603|11493531|FG011|COMPLETED|Phase 2||0
10354639|NCT00460603|11493520|FG000|NOT COMPLETED|Phase 2||0
10354640|NCT00460603|11493521|FG001|NOT COMPLETED|Phase 2||0
10354641|NCT00460603|11493522|FG002|NOT COMPLETED|Phase 2||0
10354642|NCT00460603|11493523|FG003|NOT COMPLETED|Phase 2||0
10354643|NCT00460603|11493524|FG004|NOT COMPLETED|Phase 2||0
10354644|NCT00460603|11493525|FG005|NOT COMPLETED|Phase 2||0
10354645|NCT00460603|11493526|FG006|NOT COMPLETED|Phase 2||0
10354646|NCT00460603|11493527|FG007|NOT COMPLETED|Phase 2||0
10354647|NCT00460603|11493528|FG008|NOT COMPLETED|Phase 2||0
10354648|NCT00460603|11493529|FG009|NOT COMPLETED|Phase 2||42
10354649|NCT00460603|11493530|FG010|NOT COMPLETED|Phase 2||43
10354650|NCT00460603|11493531|FG011|NOT COMPLETED|Phase 2||41
10354651|NCT00460655|11493559|FG000|STARTED|Double-Blind Phase (12 Weeks)||58
10354652|NCT00460655|11493560|FG001|STARTED|Double-Blind Phase (12 Weeks)||62
10354653|NCT00460655|11493561|FG002|STARTED|Double-Blind Phase (12 Weeks)||0
10354654|NCT00460655|11493562|FG003|STARTED|Double-Blind Phase (12 Weeks)||0
10354655|NCT00460655|11493559|FG000|COMPLETED|Double-Blind Phase (12 Weeks)||52
10354656|NCT00460655|11493560|FG001|COMPLETED|Double-Blind Phase (12 Weeks)||61
10354657|NCT00460655|11493561|FG002|COMPLETED|Double-Blind Phase (12 Weeks)||0
10354658|NCT00460655|11493562|FG003|COMPLETED|Double-Blind Phase (12 Weeks)||0
10354659|NCT00460655|11493559|FG000|NOT COMPLETED|Double-Blind Phase (12 Weeks)||6
10354660|NCT00460655|11493560|FG001|NOT COMPLETED|Double-Blind Phase (12 Weeks)||1
10354661|NCT00460655|11493561|FG002|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
10354662|NCT00460655|11493562|FG003|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
10354663|NCT00460655|11493559|FG000|STARTED|Open-Label Phase (36 Weeks)||0
10354664|NCT00460655|11493560|FG001|STARTED|Open-Label Phase (36 Weeks)||0
10354665|NCT00460655|11493561|FG002|STARTED|Open-Label Phase (36 Weeks)||52
10354666|NCT00460655|11493562|FG003|STARTED|Open-Label Phase (36 Weeks)||61
10354667|NCT00460655|11493559|FG000|COMPLETED|Open-Label Phase (36 Weeks)||0
10354668|NCT00460655|11493560|FG001|COMPLETED|Open-Label Phase (36 Weeks)||0
10354669|NCT00460655|11493561|FG002|COMPLETED|Open-Label Phase (36 Weeks)||45
10354670|NCT00460655|11493562|FG003|COMPLETED|Open-Label Phase (36 Weeks)||52
10354671|NCT00460655|11493559|FG000|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
10533562|NCT01425814|11685702|FG000|STARTED|Period 4||12
10533563|NCT01425814|11685703|FG001|STARTED|Period 4||9
10533564|NCT01425814|11685704|FG002|STARTED|Period 4||12
10533565|NCT01425814|11685705|FG003|STARTED|Period 4||10
10533566|NCT01425814|11685706|FG004|STARTED|Period 4||12
10716084|NCT02688387|11880047|FG004|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10716085|NCT02688387|11880048|FG005|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10533567|NCT01425814|11685707|FG005|STARTED|Period 4||12
10533568|NCT01425814|11685702|FG000|COMPLETED|Period 4||11
10533569|NCT01425814|11685703|FG001|COMPLETED|Period 4||9
10533570|NCT01425814|11685704|FG002|COMPLETED|Period 4||11
10533571|NCT01425814|11685705|FG003|COMPLETED|Period 4||10
10533572|NCT01425814|11685706|FG004|COMPLETED|Period 4||12
10533573|NCT01425814|11685707|FG005|COMPLETED|Period 4||12
10533574|NCT01425814|11685702|FG000|NOT COMPLETED|Period 4||1
10354672|NCT00460655|11493560|FG001|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
10354673|NCT00460655|11493561|FG002|NOT COMPLETED|Open-Label Phase (36 Weeks)||7
10354674|NCT00460655|11493562|FG003|NOT COMPLETED|Open-Label Phase (36 Weeks)||9
10354675|NCT00460746|11493572|FG000|STARTED|Overall Study||10
10354676|NCT00460746|11493572|FG000|COMPLETED|Overall Study||8
10354677|NCT00460746|11493572|FG000|NOT COMPLETED|Overall Study||2
10354678|NCT00460798|11493576|FG000|STARTED|Overall Study||448
10354679|NCT00460798|11493576|FG000|Treated|Overall Study|Subjects with complete dosing information were recorded as 'Treated'|421
10354680|NCT00460798|11493576|FG000|COMPLETED|Overall Study||108
10354681|NCT00460798|11493576|FG000|NOT COMPLETED|Overall Study||340
10354682|NCT00460811|11493585|FG000|STARTED|Overall Study||79
10354683|NCT00460811|11493586|FG001|STARTED|Overall Study||82
10354684|NCT00460811|11493587|FG002|STARTED|Overall Study||85
10354685|NCT00460811|11493588|FG003|STARTED|Overall Study||89
10354686|NCT00460811|11493589|FG004|STARTED|Overall Study||85
10533575|NCT01425814|11685703|FG001|NOT COMPLETED|Period 4||0
10533576|NCT01425814|11685704|FG002|NOT COMPLETED|Period 4||1
10354687|NCT00460811|11493585|FG000|COMPLETED|Overall Study||63
10354688|NCT00460811|11493586|FG001|COMPLETED|Overall Study||67
10354689|NCT00460811|11493587|FG002|COMPLETED|Overall Study||71
10354690|NCT00460811|11493588|FG003|COMPLETED|Overall Study||71
10354691|NCT00460811|11493589|FG004|COMPLETED|Overall Study||65
10354692|NCT00460811|11493585|FG000|NOT COMPLETED|Overall Study||16
10354693|NCT00460811|11493586|FG001|NOT COMPLETED|Overall Study||15
10354694|NCT00460811|11493587|FG002|NOT COMPLETED|Overall Study||14
10354695|NCT00460811|11493588|FG003|NOT COMPLETED|Overall Study||18
10354696|NCT00460811|11493589|FG004|NOT COMPLETED|Overall Study||20
10354697|NCT00460993|11493608|FG000|STARTED|Phase 1 (6 Days)||14
10354698|NCT00460993|11493609|FG001|STARTED|Phase 1 (6 Days)||17
10354699|NCT00460993|11493608|FG000|COMPLETED|Phase 1 (6 Days)||14
10354700|NCT00460993|11493609|FG001|COMPLETED|Phase 1 (6 Days)||17
10354701|NCT00460993|11493608|FG000|NOT COMPLETED|Phase 1 (6 Days)||0
10354702|NCT00460993|11493609|FG001|NOT COMPLETED|Phase 1 (6 Days)||0
10354703|NCT00460993|11493608|FG000|STARTED|Phase 2 (6 Days)||14
10354704|NCT00460993|11493609|FG001|STARTED|Phase 2 (6 Days)||17
10354705|NCT00460993|11493608|FG000|COMPLETED|Phase 2 (6 Days)||14
10354706|NCT00460993|11493609|FG001|COMPLETED|Phase 2 (6 Days)||17
10354707|NCT00460993|11493608|FG000|NOT COMPLETED|Phase 2 (6 Days)||0
10354708|NCT00460993|11493609|FG001|NOT COMPLETED|Phase 2 (6 Days)||0
10354709|NCT00461045|11493615|FG000|STARTED|Overall Study||15
10354710|NCT00461045|11493615|FG000|COMPLETED|Overall Study||15
10354711|NCT00461045|11493615|FG000|NOT COMPLETED|Overall Study||0
10354712|NCT00461097|11493621|FG000|STARTED|Overall Study||40
10354713|NCT00461097|11493622|FG001|STARTED|Overall Study||15
10354714|NCT00461097|11493621|FG000|Had Month 10 (Wk 44) Oral Food Challenge|Overall Study||35
10354715|NCT00461097|11493622|FG001|Had Month 10 (Wk 44) Oral Food Challenge|Overall Study||13
10354716|NCT00461097|11493621|FG000|Had Month 22 (Wk 96) Oral Food Challenge|Overall Study||34
10354717|NCT00461097|11493622|FG001|Had Month 22 (Wk 96) Oral Food Challenge|Overall Study||1
10354718|NCT00461097|11493621|FG000|Had Year 3 (Mnth 36) Oral Food Challenge|Overall Study||16
10354719|NCT00461097|11493622|FG001|Had Year 3 (Mnth 36) Oral Food Challenge|Overall Study||0
10354720|NCT00461097|11493621|FG000|Had Year 4 (Mnth 48) Oral Food Challenge|Overall Study||7
10354721|NCT00461097|11493622|FG001|Had Year 4 (Mnth 48) Oral Food Challenge|Overall Study||0
10354722|NCT00461097|11493621|FG000|COMPLETED|Overall Study|Completed: Participants who were assessed for the primary outcome measure and outcome measure #6.|40
10354723|NCT00461097|11493622|FG001|COMPLETED|Overall Study|Completed: Participants who were assessed for the primary outcome measure.|15
10354724|NCT00461097|11493621|FG000|NOT COMPLETED|Overall Study||0
10354725|NCT00461097|11493622|FG001|NOT COMPLETED|Overall Study||0
10354726|NCT00461123|11493631|FG000|STARTED|Overall Study||25
10354727|NCT00461123|11493632|FG001|STARTED|Overall Study||25
10354728|NCT00461123|11493631|FG000|COMPLETED|Overall Study||19
10354729|NCT00461123|11493632|FG001|COMPLETED|Overall Study||19
10354730|NCT00461123|11493631|FG000|NOT COMPLETED|Overall Study||6
10354731|NCT00461123|11493632|FG001|NOT COMPLETED|Overall Study||6
10354732|NCT00461175|11493640|FG000|STARTED|Overall Study|859 patients could not be assigned to a cohort and are therefore missing in the participant flow.|43600
10354733|NCT00461175|11493641|FG001|STARTED|Overall Study|859 patients could not be assigned to a cohort and are therefore missing in the participant flow.|18735
10354734|NCT00461175|11493640|FG000|COMPLETED|Overall Study||43078
10354735|NCT00461175|11493641|FG001|COMPLETED|Overall Study||18370
10354736|NCT00461175|11493640|FG000|NOT COMPLETED|Overall Study||522
10354737|NCT00461175|11493641|FG001|NOT COMPLETED|Overall Study||365
10354738|NCT00461253|11493649|FG000|STARTED|Overall Study|Identified cases|10093
10354739|NCT00461253|11493650|FG001|STARTED|Overall Study|Identified controls|40250
10354740|NCT00461253|11493649|FG000|COMPLETED|Overall Study|Analyzed cases|5113
10354741|NCT00461253|11493650|FG001|COMPLETED|Overall Study|Analyzed controls|20452
10354742|NCT00461253|11493649|FG000|NOT COMPLETED|Overall Study||4980
10354743|NCT00461253|11493650|FG001|NOT COMPLETED|Overall Study||19798
10354744|NCT00461292|11493659|FG000|STARTED|Treatment Cycle 1||91
10354745|NCT00461292|11493660|FG001|STARTED|Treatment Cycle 1||92
10354746|NCT00461292|11493661|FG002|STARTED|Treatment Cycle 1||92
10354747|NCT00461292|11493659|FG000|COMPLETED|Treatment Cycle 1||76
10354748|NCT00461292|11493660|FG001|COMPLETED|Treatment Cycle 1||80
10354749|NCT00461292|11493661|FG002|COMPLETED|Treatment Cycle 1||81
10354750|NCT00461292|11493659|FG000|NOT COMPLETED|Treatment Cycle 1||15
10354751|NCT00461292|11493660|FG001|NOT COMPLETED|Treatment Cycle 1||12
10354752|NCT00461292|11493661|FG002|NOT COMPLETED|Treatment Cycle 1||11
10354753|NCT00461292|11493659|FG000|STARTED|Treatment Cycle 2|32 from the 300U group + 31 from the Placebo group entered Cycle 2|63
10354754|NCT00461292|11493660|FG001|STARTED|Treatment Cycle 2|42 from the 200U group + 32 from the Placebo group entered Cycle 2|74
10354755|NCT00461292|11493661|FG002|STARTED|Treatment Cycle 2|Cycle 1 Placebo pts were randomized to receive 300U or 200 U in Cycle 2|0
10354756|NCT00461292|11493659|FG000|COMPLETED|Treatment Cycle 2||58
10354757|NCT00461292|11493660|FG001|COMPLETED|Treatment Cycle 2||72
10354758|NCT00461292|11493661|FG002|COMPLETED|Treatment Cycle 2||0
10354759|NCT00461292|11493659|FG000|NOT COMPLETED|Treatment Cycle 2||5
10354760|NCT00461292|11493660|FG001|NOT COMPLETED|Treatment Cycle 2||2
10354761|NCT00461292|11493661|FG002|NOT COMPLETED|Treatment Cycle 2||0
10354762|NCT00461305|11493671|FG000|STARTED|Treatment|Enrolled|355
10354763|NCT00461305|11493672|FG001|STARTED|Treatment|Enrolled|65
10354764|NCT00461305|11493671|FG000|Subjects Dispensed Drugs|Treatment||350
10354765|NCT00461305|11493672|FG001|Subjects Dispensed Drugs|Treatment||65
10354766|NCT00461305|11493671|FG000|Subjects Received Treatment|Treatment|FAS, safety population|349
10354767|NCT00461305|11493672|FG001|Subjects Received Treatment|Treatment|FAS, safety population|65
10354768|NCT00461305|11493671|FG000|COMPLETED|Treatment||254
10354769|NCT00461305|11493672|FG001|COMPLETED|Treatment||56
10354770|NCT00461305|11493671|FG000|NOT COMPLETED|Treatment||101
10354771|NCT00461305|11493672|FG001|NOT COMPLETED|Treatment||9
10354772|NCT00461305|11493671|FG000|STARTED|Continued Treatment|FAS, participants from previous treatment who were available to continue treatment|349
10354773|NCT00461305|11493672|FG001|STARTED|Continued Treatment|no participants were treated with the DRSP 3 mg/EE 30 μg combination beyond 6 cycles|0
10354774|NCT00461305|11493671|FG000|COMPLETED|Continued Treatment||254
10354775|NCT00461305|11493672|FG001|COMPLETED|Continued Treatment||0
10354776|NCT00461305|11493671|FG000|NOT COMPLETED|Continued Treatment||95
10354777|NCT00461305|11493672|FG001|NOT COMPLETED|Continued Treatment||0
10354778|NCT00461331|11493679|FG000|STARTED|Intervention 1||10
10354779|NCT00461331|11493680|FG001|STARTED|Intervention 1||10
10354780|NCT00461331|11493679|FG000|COMPLETED|Intervention 1||10
10354781|NCT00461331|11493680|FG001|COMPLETED|Intervention 1||10
10354782|NCT00461331|11493679|FG000|NOT COMPLETED|Intervention 1||0
10354783|NCT00461331|11493680|FG001|NOT COMPLETED|Intervention 1||0
10354784|NCT00461331|11493679|FG000|STARTED|Washout||10
10354785|NCT00461331|11493680|FG001|STARTED|Washout||10
10354786|NCT00461331|11493679|FG000|COMPLETED|Washout||10
10354787|NCT00461331|11493680|FG001|COMPLETED|Washout||10
10354788|NCT00461331|11493679|FG000|NOT COMPLETED|Washout||0
10354789|NCT00461331|11493680|FG001|NOT COMPLETED|Washout||0
10354790|NCT00461331|11493679|FG000|STARTED|Intervention 2||10
10354791|NCT00461331|11493680|FG001|STARTED|Intervention 2||10
10354792|NCT00461331|11493679|FG000|COMPLETED|Intervention 2||10
10354793|NCT00461331|11493680|FG001|COMPLETED|Intervention 2||10
10354794|NCT00461331|11493679|FG000|NOT COMPLETED|Intervention 2||0
10354795|NCT00461331|11493680|FG001|NOT COMPLETED|Intervention 2||0
10354796|NCT00461500|11493689|FG000|STARTED|Overall Study||37
10354797|NCT00461500|11493690|FG001|STARTED|Overall Study||44
10354798|NCT00461500|11493689|FG000|COMPLETED|Overall Study||30
10354799|NCT00461500|11493690|FG001|COMPLETED|Overall Study||38
10354800|NCT00461500|11493689|FG000|NOT COMPLETED|Overall Study||7
10354801|NCT00461500|11493690|FG001|NOT COMPLETED|Overall Study||6
10354802|NCT00461513|11493698|FG000|STARTED|Overall Study|6 patients dropped at time of randomization|187
10354803|NCT00461513|11493699|FG001|STARTED|Overall Study|2 patients dropped at time of randomization|197
10354804|NCT00461513|11493698|FG000|COMPLETED|Overall Study||165
10354805|NCT00461513|11493699|FG001|COMPLETED|Overall Study||172
10354806|NCT00461513|11493698|FG000|NOT COMPLETED|Overall Study||22
10354807|NCT00461513|11493699|FG001|NOT COMPLETED|Overall Study||25
10354808|NCT00461552|11493711|FG000|STARTED|Overall Study||7
10354809|NCT00461552|11493712|FG001|STARTED|Overall Study||7
10354810|NCT00461552|11493711|FG000|COMPLETED|Overall Study||7
10354811|NCT00461552|11493712|FG001|COMPLETED|Overall Study||5
10354812|NCT00461552|11493711|FG000|NOT COMPLETED|Overall Study||0
10354813|NCT00461552|11493712|FG001|NOT COMPLETED|Overall Study||2
10354814|NCT00461591|11493720|FG000|STARTED|Overall Study||406
10354815|NCT00461591|11493721|FG001|STARTED|Overall Study||396
10354816|NCT00461591|11493720|FG000|COMPLETED|Overall Study||317
10354817|NCT00461591|11493721|FG001|COMPLETED|Overall Study||311
10354818|NCT00461591|11493720|FG000|NOT COMPLETED|Overall Study||89
10354819|NCT00461591|11493721|FG001|NOT COMPLETED|Overall Study||85
10354820|NCT00461630|11493729|FG000|STARTED|Overall Study||12838
10354821|NCT00461630|11493730|FG001|STARTED|Overall Study||12835
10354822|NCT00461630|11493729|FG000|COMPLETED|Overall Study||11932
10354823|NCT00461630|11493730|FG001|COMPLETED|Overall Study||12008
10354824|NCT00461630|11493729|FG000|NOT COMPLETED|Overall Study||906
10354825|NCT00461630|11493730|FG001|NOT COMPLETED|Overall Study||827
10354826|NCT00461708|11493738|FG000|STARTED|Overall Study||115
10354827|NCT00461708|11493739|FG001|STARTED|Overall Study||38
10354828|NCT00461708|11493738|FG000|COMPLETED|Overall Study||0
10354829|NCT00461708|11493739|FG001|COMPLETED|Overall Study||0
10354830|NCT00461708|11493738|FG000|NOT COMPLETED|Overall Study||115
10354831|NCT00461708|11493739|FG001|NOT COMPLETED|Overall Study||38
10354832|NCT00461734|11493750|FG000|STARTED|Overall Study||120
10354833|NCT00461734|11493751|FG001|STARTED|Overall Study||120
10354834|NCT00461734|11493750|FG000|COMPLETED|Overall Study||62
10354835|NCT00461734|11493751|FG001|COMPLETED|Overall Study||60
10354836|NCT00461734|11493750|FG000|NOT COMPLETED|Overall Study||58
10354837|NCT00461734|11493751|FG001|NOT COMPLETED|Overall Study||60
10354838|NCT00461773|11493764|FG000|STARTED|Overall Study||3
10354839|NCT00461773|11493765|FG001|STARTED|Overall Study||2
10354840|NCT00461773|11493764|FG000|COMPLETED|Overall Study||3
10354841|NCT00461773|11493765|FG001|COMPLETED|Overall Study||2
10354842|NCT00461773|11493764|FG000|NOT COMPLETED|Overall Study||0
10354843|NCT00461773|11493765|FG001|NOT COMPLETED|Overall Study||0
10354844|NCT00461786|11493771|FG000|STARTED|Overall Study||51
10354845|NCT00461786|11493771|FG000|COMPLETED|Overall Study|Completed means the patient was evaluable for response.|48
10354846|NCT00461786|11493771|FG000|NOT COMPLETED|Overall Study||3
10354847|NCT00461851|11493775|FG000|STARTED|Overall Study||17
10354848|NCT00461851|11493775|FG000|COMPLETED|Overall Study||17
10354849|NCT00461851|11493775|FG000|NOT COMPLETED|Overall Study||0
10354850|NCT00461981|11493781|FG000|STARTED|Overall Study||50
10354851|NCT00461981|11493782|FG001|STARTED|Overall Study||51
10354852|NCT00461981|11493781|FG000|COMPLETED|Overall Study||39
10354853|NCT00461981|11493782|FG001|COMPLETED|Overall Study||42
10354854|NCT00461981|11493781|FG000|NOT COMPLETED|Overall Study||11
10354855|NCT00461981|11493782|FG001|NOT COMPLETED|Overall Study||9
10354856|NCT00462020|11493790|FG000|STARTED|Overall Study||52
10354857|NCT00462020|11493791|FG001|STARTED|Overall Study||50
10716086|NCT02688387|11880049|FG006|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10716087|NCT02688387|11880050|FG007|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10716088|NCT02688387|11880051|FG008|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10354858|NCT00462020|11493790|FG000|COMPLETED|Overall Study||52
10354859|NCT00462020|11493791|FG001|COMPLETED|Overall Study||50
10354860|NCT00462020|11493790|FG000|NOT COMPLETED|Overall Study||0
10716089|NCT02688387|11880052|FG009|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10716090|NCT02688387|11880053|FG010|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10716091|NCT02688387|11880054|FG011|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10716092|NCT02688387|11880055|FG012|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10716093|NCT02688387|11880056|FG013|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10716094|NCT02688387|11880057|FG014|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10354861|NCT00462020|11493791|FG001|NOT COMPLETED|Overall Study||0
10354862|NCT00462072|11493800|FG000|STARTED|Baseline (Week 0)||10
10354863|NCT00462072|11493801|FG001|STARTED|Baseline (Week 0)||12
10354864|NCT00462072|11493802|FG002|STARTED|Baseline (Week 0)||9
10354865|NCT00462072|11493800|FG000|COMPLETED|Baseline (Week 0)||10
10354866|NCT00462072|11493801|FG001|COMPLETED|Baseline (Week 0)||12
10354867|NCT00462072|11493802|FG002|COMPLETED|Baseline (Week 0)||9
10354868|NCT00462072|11493800|FG000|NOT COMPLETED|Baseline (Week 0)||0
10354869|NCT00462072|11493801|FG001|NOT COMPLETED|Baseline (Week 0)||0
10354870|NCT00462072|11493802|FG002|NOT COMPLETED|Baseline (Week 0)||0
10354871|NCT00462072|11493800|FG000|STARTED|Week 10||10
10354872|NCT00462072|11493801|FG001|STARTED|Week 10||12
10354873|NCT00462072|11493802|FG002|STARTED|Week 10||9
10354874|NCT00462072|11493800|FG000|COMPLETED|Week 10||10
10354875|NCT00462072|11493801|FG001|COMPLETED|Week 10||12
10354876|NCT00462072|11493802|FG002|COMPLETED|Week 10||9
10354877|NCT00462072|11493800|FG000|NOT COMPLETED|Week 10||0
10354878|NCT00462072|11493801|FG001|NOT COMPLETED|Week 10||0
10354879|NCT00462072|11493802|FG002|NOT COMPLETED|Week 10||0
10354880|NCT00462124|11493814|FG000|STARTED|Overall Study||7
10354881|NCT00462124|11493814|FG000|COMPLETED|Overall Study|One implant was misplaced and was disacitivated by puncture.|6
10354882|NCT00462124|11493814|FG000|NOT COMPLETED|Overall Study||1
10354883|NCT00462228|11493819|FG000|STARTED|Memantine or Placebo 12 Weeks||11
10354884|NCT00462228|11493819|FG000|COMPLETED|Memantine or Placebo 12 Weeks||11
10354885|NCT00462228|11493819|FG000|NOT COMPLETED|Memantine or Placebo 12 Weeks||0
10354886|NCT00462228|11493819|FG000|STARTED|No Treatment (Washout) 4 Weeks||11
10354887|NCT00462228|11493819|FG000|COMPLETED|No Treatment (Washout) 4 Weeks||11
10354888|NCT00462228|11493819|FG000|NOT COMPLETED|No Treatment (Washout) 4 Weeks||0
10354889|NCT00462228|11493819|FG000|STARTED|Placebo or Memantine 12 Weeks||11
10354890|NCT00462228|11493819|FG000|COMPLETED|Placebo or Memantine 12 Weeks||11
10354891|NCT00462228|11493819|FG000|NOT COMPLETED|Placebo or Memantine 12 Weeks||0
10354892|NCT00462228|11493819|FG000|STARTED|No Treatment (Washout) 4 Weeks||11
10354893|NCT00462228|11493819|FG000|COMPLETED|No Treatment (Washout) 4 Weeks||11
10354894|NCT00462228|11493819|FG000|NOT COMPLETED|No Treatment (Washout) 4 Weeks||0
10354895|NCT00462280|11493830|FG000|STARTED|Overall Study||34
10354896|NCT00462280|11493831|FG001|STARTED|Overall Study||32
10354897|NCT00462280|11493832|FG002|STARTED|Overall Study||7
10354898|NCT00462280|11493833|FG003|STARTED|Overall Study||7
10354899|NCT00462280|11493830|FG000|COMPLETED|Overall Study||24
10354900|NCT00462280|11493831|FG001|COMPLETED|Overall Study||25
10354901|NCT00462280|11493832|FG002|COMPLETED|Overall Study||7
10354902|NCT00462280|11493833|FG003|COMPLETED|Overall Study||4
10354903|NCT00462280|11493830|FG000|NOT COMPLETED|Overall Study||10
10354904|NCT00462280|11493831|FG001|NOT COMPLETED|Overall Study||7
10354905|NCT00462280|11493832|FG002|NOT COMPLETED|Overall Study||0
10354906|NCT00462280|11493833|FG003|NOT COMPLETED|Overall Study||3
10354907|NCT00462306|11493847|FG000|STARTED|Overall Study||4074
10354908|NCT00462306|11493848|FG001|STARTED|Overall Study||503
10354909|NCT00462306|11493847|FG000|COMPLETED|Overall Study||4074
10354910|NCT00462306|11493848|FG001|COMPLETED|Overall Study||490
10354911|NCT00462306|11493847|FG000|NOT COMPLETED|Overall Study||0
10354912|NCT00462306|11493848|FG001|NOT COMPLETED|Overall Study||13
10354913|NCT00462332|11493858|FG000|STARTED|Overall Study||45
10354914|NCT00462332|11493859|FG001|STARTED|Overall Study||41
10354915|NCT00462332|11493858|FG000|COMPLETED|Overall Study||45
10354916|NCT00462332|11493859|FG001|COMPLETED|Overall Study||41
10354917|NCT00462332|11493858|FG000|NOT COMPLETED|Overall Study||0
10354918|NCT00462332|11493859|FG001|NOT COMPLETED|Overall Study||0
10354919|NCT00462345|11493867|FG000|STARTED|Overall Study||40
10354920|NCT00462345|11493867|FG000|Completed First Course|Overall Study||38
10354921|NCT00462345|11493867|FG000|COMPLETED|Overall Study||37
10354922|NCT00462345|11493867|FG000|NOT COMPLETED|Overall Study||3
10354923|NCT00462384|11493871|FG000|STARTED|Overall Study||39
10354924|NCT00462384|11493871|FG000|COMPLETED|Overall Study||30
10354925|NCT00462384|11493871|FG000|NOT COMPLETED|Overall Study||9
10354926|NCT00462423|11493875|FG000|STARTED|Overall Study||50
10354927|NCT00462423|11493875|FG000|COMPLETED|Overall Study||50
10354928|NCT00462423|11493875|FG000|NOT COMPLETED|Overall Study||0
10354929|NCT00462449|11493882|FG000|STARTED|Overall Study||13
10354930|NCT00462449|11493883|FG001|STARTED|Overall Study||10
10354931|NCT00462449|11493882|FG000|COMPLETED|Overall Study||13
10354932|NCT00462449|11493883|FG001|COMPLETED|Overall Study||10
10354933|NCT00462449|11493882|FG000|NOT COMPLETED|Overall Study||0
10354934|NCT00462449|11493883|FG001|NOT COMPLETED|Overall Study||0
10354935|NCT00462462|11493891|FG000|STARTED|Overall Study||17
10354936|NCT00462462|11493892|FG001|STARTED|Overall Study||14
10354937|NCT00462462|11493891|FG000|COMPLETED|Overall Study||17
10354938|NCT00462462|11493892|FG001|COMPLETED|Overall Study||13
10354939|NCT00462462|11493891|FG000|NOT COMPLETED|Overall Study||0
10354940|NCT00462462|11493892|FG001|NOT COMPLETED|Overall Study||1
10354941|NCT00462488|11493902|FG000|STARTED|Overall Study||23
10354942|NCT00462488|11493903|FG001|STARTED|Overall Study||23
10354943|NCT00462488|11493902|FG000|Completed Induction Phase|Overall Study||22
10354944|NCT00462488|11493903|FG001|Completed Induction Phase|Overall Study||23
10354945|NCT00462488|11493902|FG000|Completed Induction 2/Maintenance 1|Overall Study||18
10354946|NCT00462488|11493903|FG001|Completed Induction 2/Maintenance 1|Overall Study||9
10354947|NCT00462488|11493902|FG000|Completed Maintenance 2|Overall Study||7
10354948|NCT00462488|11493903|FG001|Completed Maintenance 2|Overall Study||6
10354949|NCT00462488|11493902|FG000|COMPLETED|Overall Study||3
10354950|NCT00462488|11493903|FG001|COMPLETED|Overall Study||6
10354951|NCT00462488|11493902|FG000|NOT COMPLETED|Overall Study||20
10354952|NCT00462488|11493903|FG001|NOT COMPLETED|Overall Study||17
10354953|NCT00462501|11493909|FG000|STARTED|Overall Study||35
10354954|NCT00462501|11493909|FG000|COMPLETED|Overall Study||30
10354955|NCT00462501|11493909|FG000|NOT COMPLETED|Overall Study||5
10354956|NCT00462605|11493913|FG000|STARTED|Overall Study||24
10354957|NCT00462605|11493913|FG000|COMPLETED|Overall Study||10
10354958|NCT00462605|11493913|FG000|NOT COMPLETED|Overall Study||14
10354959|NCT00462644|11493919|FG000|STARTED|Overall Study||18
10354960|NCT00462644|11493920|FG001|STARTED|Overall Study||12
10354961|NCT00462644|11493919|FG000|COMPLETED|Overall Study||18
10354962|NCT00462644|11493920|FG001|COMPLETED|Overall Study||12
10354963|NCT00462644|11493919|FG000|NOT COMPLETED|Overall Study||0
10354964|NCT00462644|11493920|FG001|NOT COMPLETED|Overall Study||0
10354965|NCT00462670|11493928|FG000|STARTED|Overall Study||57
10354966|NCT00462670|11493929|FG001|STARTED|Overall Study||53
10354967|NCT00462670|11493928|FG000|COMPLETED|Overall Study||52
10354968|NCT00462670|11493929|FG001|COMPLETED|Overall Study||46
10354969|NCT00462670|11493928|FG000|NOT COMPLETED|Overall Study||5
10354970|NCT00462670|11493929|FG001|NOT COMPLETED|Overall Study||7
10354971|NCT00462709|11493935|FG000|STARTED|Overall Study||146
10354972|NCT00462709|11493935|FG000|COMPLETED|Overall Study||79
10354973|NCT00462709|11493935|FG000|NOT COMPLETED|Overall Study||67
10354974|NCT00462722|11493942|FG000|STARTED|Overall Study||50
10354975|NCT00462722|11493943|FG001|STARTED|Overall Study||55
10354976|NCT00462722|11493944|FG002|STARTED|Overall Study||54
10354977|NCT00462722|11493942|FG000|COMPLETED|Overall Study||37
10354978|NCT00462722|11493943|FG001|COMPLETED|Overall Study||51
10354979|NCT00462722|11493944|FG002|COMPLETED|Overall Study||42
10354980|NCT00462722|11493942|FG000|NOT COMPLETED|Overall Study||13
10354981|NCT00462722|11493943|FG001|NOT COMPLETED|Overall Study||4
10354982|NCT00462722|11493944|FG002|NOT COMPLETED|Overall Study||12
10354983|NCT00462735|11493952|FG000|STARTED|Overall Study||33
10354984|NCT00462735|11493952|FG000|COMPLETED|Overall Study||33
10354985|NCT00462735|11493952|FG000|NOT COMPLETED|Overall Study||0
10354986|NCT00462761|11493957|FG000|STARTED|Overall Study||76
10354987|NCT00462761|11493957|FG000|COMPLETED|Overall Study||0
10354988|NCT00462761|11493957|FG000|NOT COMPLETED|Overall Study||76
10354989|NCT00462826|11493989|FG000|STARTED|Overall Study||49
10354990|NCT00462826|11493989|FG000|COMPLETED|Overall Study||44
10354991|NCT00462826|11493989|FG000|NOT COMPLETED|Overall Study||5
10354992|NCT00462839|11494001|FG000|STARTED|Viewed First||53
10354993|NCT00462839|11494002|FG001|STARTED|Viewed First||53
10354994|NCT00462839|11494001|FG000|COMPLETED|Viewed First||53
10354995|NCT00462839|11494002|FG001|COMPLETED|Viewed First||53
10354996|NCT00462839|11494001|FG000|NOT COMPLETED|Viewed First||0
10354997|NCT00462839|11494002|FG001|NOT COMPLETED|Viewed First||0
10354998|NCT00462839|11494001|FG000|STARTED|Viewed Second||53
10354999|NCT00462839|11494002|FG001|STARTED|Viewed Second||53
10355000|NCT00462839|11494001|FG000|COMPLETED|Viewed Second||53
10355001|NCT00462839|11494002|FG001|COMPLETED|Viewed Second||53
10355002|NCT00462839|11494001|FG000|NOT COMPLETED|Viewed Second||0
10355003|NCT00462839|11494002|FG001|NOT COMPLETED|Viewed Second||0
10426916|NCT00849810|11572641|FG000|COMPLETED|Overall Study||1
10426917|NCT00849810|11572641|FG000|NOT COMPLETED|Overall Study||0
10426918|NCT00849875|11572648|FG000|STARTED|Overall Study||48
10426919|NCT00849875|11572648|FG000|COMPLETED|Overall Study||1
10426920|NCT00849875|11572648|FG000|NOT COMPLETED|Overall Study||47
10426921|NCT00849901|11572662|FG000|STARTED|Acute Treatment Phase||117
10426922|NCT00849901|11572663|FG001|STARTED|Acute Treatment Phase||117
10426923|NCT00849901|11572664|FG002|STARTED|Acute Treatment Phase||103
10426924|NCT00849901|11572662|FG000|COMPLETED|Acute Treatment Phase|4 didn't enter extension phase.|87
10426925|NCT00849901|11572663|FG001|COMPLETED|Acute Treatment Phase||91
10426926|NCT00849901|11572664|FG002|COMPLETED|Acute Treatment Phase|1 didn't enter extension phase.|87
10426927|NCT00849901|11572662|FG000|NOT COMPLETED|Acute Treatment Phase||30
10426928|NCT00849901|11572663|FG001|NOT COMPLETED|Acute Treatment Phase||26
10426929|NCT00849901|11572664|FG002|NOT COMPLETED|Acute Treatment Phase||16
10426930|NCT00849901|11572662|FG000|STARTED|Extension Phase||83
10426931|NCT00849901|11572663|FG001|STARTED|Extension Phase||91
10426932|NCT00849901|11572664|FG002|STARTED|Extension Phase||86
10426933|NCT00849901|11572662|FG000|COMPLETED|Extension Phase||56
10426934|NCT00849901|11572663|FG001|COMPLETED|Extension Phase||65
10426935|NCT00849901|11572664|FG002|COMPLETED|Extension Phase||69
10426936|NCT00849901|11572662|FG000|NOT COMPLETED|Extension Phase||27
10426937|NCT00849901|11572663|FG001|NOT COMPLETED|Extension Phase||26
10426938|NCT00849901|11572664|FG002|NOT COMPLETED|Extension Phase||17
10426939|NCT00849940|11572678|FG000|STARTED|Overall Study||72
10355004|NCT00462865|11494008|FG000|STARTED|Overall Study|18 pts enrolled,1 pt experienced a SAE infection normal ANC (gr 3) and did not begin study,see SAE|18
10355005|NCT00462865|11494008|FG000|COMPLETED|Overall Study||17
10355006|NCT00462865|11494008|FG000|NOT COMPLETED|Overall Study||1
10355007|NCT00462917|11494016|FG000|STARTED|Overall Study||72
10355008|NCT00462917|11494017|FG001|STARTED|Overall Study||75
10355009|NCT00462917|11494018|FG002|STARTED|Overall Study||66
10355010|NCT00462917|11494019|FG003|STARTED|Overall Study||77
10355011|NCT00462917|11494016|FG000|Met With Genetic Counselor|Overall Study||66
10355012|NCT00462917|11494017|FG001|Met With Genetic Counselor|Overall Study||71
10355013|NCT00462917|11494018|FG002|Met With Genetic Counselor|Overall Study||56
10355014|NCT00462917|11494019|FG003|Met With Genetic Counselor|Overall Study||71
10355015|NCT00462917|11494016|FG000|Received Risk Information|Overall Study||64
10355016|NCT00462917|11494017|FG001|Received Risk Information|Overall Study||70
10355017|NCT00462917|11494018|FG002|Received Risk Information|Overall Study||55
10355018|NCT00462917|11494019|FG003|Received Risk Information|Overall Study||68
10355019|NCT00462917|11494016|FG000|Completed 6 Week Follow-up|Overall Study||63
10355020|NCT00462917|11494017|FG001|Completed 6 Week Follow-up|Overall Study||70
10355021|NCT00462917|11494018|FG002|Completed 6 Week Follow-up|Overall Study||55
10355022|NCT00462917|11494019|FG003|Completed 6 Week Follow-up|Overall Study||68
10355023|NCT00462917|11494016|FG000|Completed 6 Month Follow-up|Overall Study||63
10355024|NCT00462917|11494017|FG001|Completed 6 Month Follow-up|Overall Study||68
10355025|NCT00462917|11494018|FG002|Completed 6 Month Follow-up|Overall Study||55
10355026|NCT00462917|11494019|FG003|Completed 6 Month Follow-up|Overall Study||66
10355027|NCT00462917|11494016|FG000|COMPLETED|Overall Study||62
10355028|NCT00462917|11494017|FG001|COMPLETED|Overall Study||65
10355029|NCT00462917|11494018|FG002|COMPLETED|Overall Study||54
10355030|NCT00462917|11494019|FG003|COMPLETED|Overall Study||66
10355031|NCT00462917|11494016|FG000|NOT COMPLETED|Overall Study||10
10355032|NCT00462917|11494017|FG001|NOT COMPLETED|Overall Study||10
10355033|NCT00462917|11494018|FG002|NOT COMPLETED|Overall Study||12
10355034|NCT00462917|11494019|FG003|NOT COMPLETED|Overall Study||11
10355035|NCT00462982|11494029|FG000|STARTED|Overall Study||8
10355036|NCT00462982|11494029|FG000|COMPLETED|Overall Study||5
10355037|NCT00462982|11494029|FG000|NOT COMPLETED|Overall Study||3
10355038|NCT00463047|11494033|FG000|STARTED|Titration Period 1|323 subjects entered study period but 3 discontinued before being randomized to treatment|160
10355039|NCT00463047|11494034|FG001|STARTED|Titration Period 1||160
10355040|NCT00463047|11494033|FG000|COMPLETED|Titration Period 1||123
10355041|NCT00463047|11494034|FG001|COMPLETED|Titration Period 1||121
10355042|NCT00463047|11494033|FG000|NOT COMPLETED|Titration Period 1||37
10355043|NCT00463047|11494034|FG001|NOT COMPLETED|Titration Period 1||39
10355044|NCT00463047|11494033|FG000|STARTED|Titration Period 2||123
10355045|NCT00463047|11494034|FG001|STARTED|Titration Period 2||121
10355046|NCT00463047|11494033|FG000|COMPLETED|Titration Period 2||93
10355047|NCT00463047|11494034|FG001|COMPLETED|Titration Period 2||98
10355048|NCT00463047|11494033|FG000|NOT COMPLETED|Titration Period 2||30
10355049|NCT00463047|11494034|FG001|NOT COMPLETED|Titration Period 2||23
10355050|NCT00463047|11494033|FG000|STARTED|Double-Blind Treatment Period 1|After completion of titration period subjects were re-randomized to these two treatment arms|96
10355051|NCT00463047|11494034|FG001|STARTED|Double-Blind Treatment Period 1|After completion of titration period subjects were re-randomized to these two treatment arms|94
10355052|NCT00463047|11494033|FG000|COMPLETED|Double-Blind Treatment Period 1||93
10355053|NCT00463047|11494034|FG001|COMPLETED|Double-Blind Treatment Period 1||90
10355054|NCT00463047|11494033|FG000|NOT COMPLETED|Double-Blind Treatment Period 1||3
10355055|NCT00463047|11494034|FG001|NOT COMPLETED|Double-Blind Treatment Period 1||4
10355056|NCT00463047|11494033|FG000|STARTED|Double-Blind Treatment Period 2||93
10355057|NCT00463047|11494034|FG001|STARTED|Double-Blind Treatment Period 2||90
10355058|NCT00463047|11494033|FG000|COMPLETED|Double-Blind Treatment Period 2||92
10355059|NCT00463047|11494034|FG001|COMPLETED|Double-Blind Treatment Period 2||88
10355060|NCT00463047|11494033|FG000|NOT COMPLETED|Double-Blind Treatment Period 2||1
10355061|NCT00463047|11494034|FG001|NOT COMPLETED|Double-Blind Treatment Period 2||2
10355062|NCT00463060|11494043|FG000|STARTED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||3
10355063|NCT00463060|11494043|FG000|COMPLETED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||3
10355064|NCT00463060|11494043|FG000|NOT COMPLETED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||0
10355065|NCT00463060|11494043|FG000|STARTED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||3
10355066|NCT00463060|11494043|FG000|COMPLETED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||3
10355067|NCT00463060|11494043|FG000|NOT COMPLETED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||0
10355068|NCT00463060|11494043|FG000|STARTED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||10
10355069|NCT00463060|11494043|FG000|COMPLETED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||10
10355070|NCT00463060|11494043|FG000|NOT COMPLETED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||0
10355071|NCT00463060|11494043|FG000|STARTED|Phase 1-Radiation 50Gy +Sunitinib 50mg||5
10355072|NCT00463060|11494043|FG000|COMPLETED|Phase 1-Radiation 50Gy +Sunitinib 50mg||0
10355073|NCT00463060|11494043|FG000|NOT COMPLETED|Phase 1-Radiation 50Gy +Sunitinib 50mg||5
10355074|NCT00463060|11494043|FG000|STARTED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Not all patients participated in both Phase 1 and Phase II|26
10355075|NCT00463060|11494043|FG000|COMPLETED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg||25
10355076|NCT00463060|11494043|FG000|NOT COMPLETED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg||1
10355077|NCT00463151|11494056|FG000|STARTED|Overall Study||35
10355078|NCT00463151|11494057|FG001|STARTED|Overall Study||29
10355079|NCT00463151|11494058|FG002|STARTED|Overall Study||29
10355080|NCT00463151|11494059|FG003|STARTED|Overall Study||31
10355081|NCT00463151|11494056|FG000|COMPLETED|Overall Study||33
10355082|NCT00463151|11494057|FG001|COMPLETED|Overall Study||24
10355083|NCT00463151|11494058|FG002|COMPLETED|Overall Study||26
10355084|NCT00463151|11494059|FG003|COMPLETED|Overall Study||24
10355085|NCT00463151|11494056|FG000|NOT COMPLETED|Overall Study||2
10355086|NCT00463151|11494057|FG001|NOT COMPLETED|Overall Study||5
10355087|NCT00463151|11494058|FG002|NOT COMPLETED|Overall Study||3
10355088|NCT00463151|11494059|FG003|NOT COMPLETED|Overall Study||7
10355089|NCT00463229|11494071|FG000|STARTED|Overall Study||52
10355090|NCT00463229|11494072|FG001|STARTED|Overall Study||49
10355091|NCT00463229|11494071|FG000|COMPLETED|Overall Study||43
10355092|NCT00463229|11494072|FG001|COMPLETED|Overall Study||39
10355093|NCT00463229|11494071|FG000|NOT COMPLETED|Overall Study||9
10355094|NCT00463229|11494072|FG001|NOT COMPLETED|Overall Study||10
10355095|NCT00463346|11494081|FG000|STARTED|Overall Study||12
10355096|NCT00463346|11494082|FG001|STARTED|Overall Study||11
10355097|NCT00463346|11494081|FG000|COMPLETED|Overall Study||9
10355098|NCT00463346|11494082|FG001|COMPLETED|Overall Study||8
10355099|NCT00463346|11494081|FG000|NOT COMPLETED|Overall Study||3
10355100|NCT00463346|11494082|FG001|NOT COMPLETED|Overall Study||3
10355101|NCT00463385|11494094|FG000|STARTED|Overall Study||22
10355102|NCT00463385|11494095|FG001|STARTED|Overall Study||22
10355103|NCT00463385|11494096|FG002|STARTED|Overall Study||22
10355104|NCT00463385|11494097|FG003|STARTED|Overall Study||22
10355105|NCT00463385|11494094|FG000|Treated|Overall Study||22
10355106|NCT00463385|11494095|FG001|Treated|Overall Study||22
10355107|NCT00463385|11494096|FG002|Treated|Overall Study||19
10355108|NCT00463385|11494097|FG003|Treated|Overall Study||22
10355109|NCT00463385|11494094|FG000|COMPLETED|Overall Study||0
10355110|NCT00463385|11494095|FG001|COMPLETED|Overall Study||0
10355111|NCT00463385|11494096|FG002|COMPLETED|Overall Study||0
10355112|NCT00463385|11494097|FG003|COMPLETED|Overall Study||0
10355113|NCT00463385|11494094|FG000|NOT COMPLETED|Overall Study||22
10355114|NCT00463385|11494095|FG001|NOT COMPLETED|Overall Study||22
10355115|NCT00463385|11494096|FG002|NOT COMPLETED|Overall Study||22
10355116|NCT00463385|11494097|FG003|NOT COMPLETED|Overall Study||22
10355117|NCT00463437|11494119|FG000|STARTED|Overall Study||359
10355118|NCT00463437|11494120|FG001|STARTED|Overall Study||363
10355119|NCT00463437|11494121|FG002|STARTED|Overall Study||358
10355120|NCT00463437|11494122|FG003|STARTED|Overall Study||357
10355121|NCT00463437|11494119|FG000|COMPLETED|Overall Study||355
10355122|NCT00463437|11494120|FG001|COMPLETED|Overall Study||352
10355123|NCT00463437|11494121|FG002|COMPLETED|Overall Study||352
10355124|NCT00463437|11494122|FG003|COMPLETED|Overall Study||350
10355125|NCT00463437|11494119|FG000|NOT COMPLETED|Overall Study||4
10355126|NCT00463437|11494120|FG001|NOT COMPLETED|Overall Study||11
10355127|NCT00463437|11494121|FG002|NOT COMPLETED|Overall Study||6
10355128|NCT00463437|11494122|FG003|NOT COMPLETED|Overall Study||7
10355129|NCT00463476|11494134|FG000|STARTED|Overall Study||151
10355130|NCT00463476|11494135|FG001|STARTED|Overall Study||154
10355131|NCT00463476|11494134|FG000|COMPLETED|Overall Study||149
10355132|NCT00463476|11494135|FG001|COMPLETED|Overall Study||151
10355133|NCT00463476|11494134|FG000|NOT COMPLETED|Overall Study||2
10355134|NCT00463476|11494135|FG001|NOT COMPLETED|Overall Study||3
10355135|NCT00463567|11494148|FG000|STARTED|Overall Study|Randomized Participants|420
10355136|NCT00463567|11494149|FG001|STARTED|Overall Study||418
10355137|NCT00463567|11494150|FG002|STARTED|Overall Study||420
10355138|NCT00463567|11494151|FG003|STARTED|Overall Study||425
10355139|NCT00463567|11494152|FG004|STARTED|Overall Study||130
10355140|NCT00463567|11494153|FG005|STARTED|Overall Study||123
10355141|NCT00463567|11494154|FG006|STARTED|Overall Study||123
10355142|NCT00463567|11494148|FG000|Safety Population: Received Study Drug|Overall Study||416
10355143|NCT00463567|11494149|FG001|Safety Population: Received Study Drug|Overall Study||416
10355144|NCT00463567|11494150|FG002|Safety Population: Received Study Drug|Overall Study||415
10355145|NCT00463567|11494151|FG003|Safety Population: Received Study Drug|Overall Study||418
10355146|NCT00463567|11494152|FG004|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|127
10355147|NCT00463567|11494153|FG005|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|122
10355148|NCT00463567|11494154|FG006|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|122
10355149|NCT00463567|11494148|FG000|COMPLETED|Overall Study||325
10355150|NCT00463567|11494149|FG001|COMPLETED|Overall Study||341
10355151|NCT00463567|11494150|FG002|COMPLETED|Overall Study||331
10355152|NCT00463567|11494151|FG003|COMPLETED|Overall Study||294
10355153|NCT00463567|11494152|FG004|COMPLETED|Overall Study||107
10355154|NCT00463567|11494153|FG005|COMPLETED|Overall Study||102
10355155|NCT00463567|11494154|FG006|COMPLETED|Overall Study||112
10355156|NCT00463567|11494148|FG000|NOT COMPLETED|Overall Study||95
10355157|NCT00463567|11494149|FG001|NOT COMPLETED|Overall Study||77
10355158|NCT00463567|11494150|FG002|NOT COMPLETED|Overall Study||89
10355159|NCT00463567|11494151|FG003|NOT COMPLETED|Overall Study||131
10355160|NCT00463567|11494152|FG004|NOT COMPLETED|Overall Study||23
10355161|NCT00463567|11494153|FG005|NOT COMPLETED|Overall Study||21
10355162|NCT00463567|11494154|FG006|NOT COMPLETED|Overall Study||11
10355163|NCT00463580|11494178|FG000|STARTED|Overall Study||30
10355164|NCT00463580|11494179|FG001|STARTED|Overall Study||30
10656048|NCT02213458|11816887|FG001|STARTED|Overall Study||536
10355165|NCT00463580|11494178|FG000|COMPLETED|Overall Study||27
10355166|NCT00463580|11494179|FG001|COMPLETED|Overall Study||28
10355167|NCT00463580|11494178|FG000|NOT COMPLETED|Overall Study||3
10355168|NCT00463580|11494179|FG001|NOT COMPLETED|Overall Study||2
10355169|NCT00463606|11494194|FG000|STARTED|Overall Study||253
10355170|NCT00463606|11494195|FG001|STARTED|Overall Study||254
10355171|NCT00463606|11494196|FG002|STARTED|Overall Study||251
10355172|NCT00463606|11494194|FG000|COMPLETED|Overall Study||212
10355173|NCT00463606|11494195|FG001|COMPLETED|Overall Study||220
10355174|NCT00463606|11494196|FG002|COMPLETED|Overall Study||231
10355175|NCT00463606|11494194|FG000|NOT COMPLETED|Overall Study||41
10355176|NCT00463606|11494195|FG001|NOT COMPLETED|Overall Study||34
10355177|NCT00463606|11494196|FG002|NOT COMPLETED|Overall Study||20
10355178|NCT00463684|11494204|FG000|STARTED|Overall Study||278
10355179|NCT00463684|11494204|FG000|COMPLETED|Overall Study||274
10355180|NCT00463684|11494204|FG000|NOT COMPLETED|Overall Study||4
10355181|NCT00463788|11494210|FG000|STARTED|Overall Study||115
10355182|NCT00463788|11494211|FG001|STARTED|Overall Study||58
10355183|NCT00463788|11494210|FG000|Treated|Overall Study||114
10355184|NCT00463788|11494211|FG001|Treated|Overall Study||57
10355185|NCT00463788|11494210|FG000|COMPLETED|Overall Study||6
10355186|NCT00463788|11494211|FG001|COMPLETED|Overall Study||4
10355187|NCT00463788|11494210|FG000|NOT COMPLETED|Overall Study||109
10355188|NCT00463788|11494211|FG001|NOT COMPLETED|Overall Study||54
10355189|NCT00463801|11494218|FG000|STARTED|Overall Study||52
10355190|NCT00463801|11494218|FG000|COMPLETED|Overall Study||39
10355191|NCT00463801|11494218|FG000|NOT COMPLETED|Overall Study||13
10355192|NCT00463840|11494222|FG000|STARTED|Overall Study||24
10355193|NCT00463840|11494222|FG000|COMPLETED|Overall Study||12
10355194|NCT00463840|11494222|FG000|NOT COMPLETED|Overall Study||12
10355195|NCT00463866|11494228|FG000|STARTED|Overall Study|4203 participants randomised. Out of these, 195 had no efficacy data after randomisation.|4008
10355196|NCT00463866|11494229|FG001|STARTED|Overall Study|4221 participants randomised. Out of these, 176 had no efficacy data after randomisation.|4045
10355197|NCT00463866|11494228|FG000|COMPLETED|Overall Study||3699
10355198|NCT00463866|11494229|FG001|COMPLETED|Overall Study||3705
10355199|NCT00463866|11494228|FG000|NOT COMPLETED|Overall Study||309
10355200|NCT00463866|11494229|FG001|NOT COMPLETED|Overall Study||340
10355201|NCT00464087|11494238|FG000|STARTED|Overall Study||49
10355202|NCT00464087|11494239|FG001|STARTED|Overall Study||51
10355203|NCT00464087|11494240|FG002|STARTED|Overall Study||29
10355204|NCT00464087|11494238|FG000|COMPLETED|Overall Study||49
10355205|NCT00464087|11494239|FG001|COMPLETED|Overall Study||51
10355206|NCT00464087|11494240|FG002|COMPLETED|Overall Study||0
10355207|NCT00464087|11494238|FG000|NOT COMPLETED|Overall Study||0
10355208|NCT00464087|11494239|FG001|NOT COMPLETED|Overall Study||0
10355209|NCT00464087|11494240|FG002|NOT COMPLETED|Overall Study||29
10355210|NCT00464204|11494250|FG000|STARTED|Overall Study||100
10355211|NCT00464204|11494251|FG001|STARTED|Overall Study||96
10355212|NCT00464204|11494250|FG000|Completed Treatment|Overall Study||81
10533577|NCT01425814|11685705|FG003|NOT COMPLETED|Period 4||0
10533578|NCT01425814|11685706|FG004|NOT COMPLETED|Period 4||0
10533579|NCT01425814|11685707|FG005|NOT COMPLETED|Period 4||0
10533580|NCT01425814|11685702|FG000|STARTED|Period 5||11
10533581|NCT01425814|11685703|FG001|STARTED|Period 5||9
10533582|NCT01425814|11685704|FG002|STARTED|Period 5||11
10533583|NCT01425814|11685705|FG003|STARTED|Period 5||10
10533584|NCT01425814|11685706|FG004|STARTED|Period 5||12
10533585|NCT01425814|11685707|FG005|STARTED|Period 5||12
10533586|NCT01425814|11685702|FG000|COMPLETED|Period 5||11
10533587|NCT01425814|11685703|FG001|COMPLETED|Period 5||9
10533588|NCT01425814|11685704|FG002|COMPLETED|Period 5||10
10533589|NCT01425814|11685705|FG003|COMPLETED|Period 5||10
10533590|NCT01425814|11685706|FG004|COMPLETED|Period 5||12
10533591|NCT01425814|11685707|FG005|COMPLETED|Period 5||11
10533592|NCT01425814|11685702|FG000|NOT COMPLETED|Period 5||0
10533593|NCT01425814|11685703|FG001|NOT COMPLETED|Period 5||0
10533594|NCT01425814|11685704|FG002|NOT COMPLETED|Period 5||1
10533595|NCT01425814|11685705|FG003|NOT COMPLETED|Period 5||0
10533596|NCT01425814|11685706|FG004|NOT COMPLETED|Period 5||0
10533597|NCT01425814|11685707|FG005|NOT COMPLETED|Period 5||1
10533598|NCT01425853|11685723|FG000|STARTED|Overall Study||304
10533599|NCT01425853|11685724|FG001|STARTED|Overall Study||302
10533600|NCT01425853|11685723|FG000|Safety Population|Overall Study||304
10533601|NCT01425853|11685724|FG001|Safety Population|Overall Study||299
10533602|NCT01425853|11685723|FG000|Per Protocol (PP)|Overall Study||264
10533603|NCT01425853|11685724|FG001|Per Protocol (PP)|Overall Study||258
10355213|NCT00464204|11494251|FG001|Completed Treatment|Overall Study||83
10355214|NCT00464204|11494250|FG000|Day 30 Follow-up Performed|Overall Study||89
10355215|NCT00464204|11494251|FG001|Day 30 Follow-up Performed|Overall Study||83
10355216|NCT00464204|11494250|FG000|Day 90 Follow-up Performed|Overall Study||69
10355217|NCT00464204|11494251|FG001|Day 90 Follow-up Performed|Overall Study||74
10533604|NCT01425853|11685723|FG000|COMPLETED|Overall Study||240
10533605|NCT01425853|11685724|FG001|COMPLETED|Overall Study||225
10533606|NCT01425853|11685723|FG000|NOT COMPLETED|Overall Study||64
10533607|NCT01425853|11685724|FG001|NOT COMPLETED|Overall Study||77
10533608|NCT01425879|11685731|FG000|STARTED|Overall Study||8
10533609|NCT01425879|11685731|FG000|COMPLETED|Overall Study||8
10355218|NCT00464204|11494250|FG000|Withdrawal Due to Discharge From ICU|Overall Study||18
10355219|NCT00464204|11494251|FG001|Withdrawal Due to Discharge From ICU|Overall Study||11
10355220|NCT00464204|11494250|FG000|COMPLETED|Overall Study|Completed=no withdrawal until day 8.|51
10426940|NCT00849940|11572678|FG000|COMPLETED|Overall Study||68
10533610|NCT01425879|11685731|FG000|NOT COMPLETED|Overall Study||0
10533611|NCT01426009|11685735|FG000|STARTED|Period 1-First Intervention (7 Days)||139
10533612|NCT01426009|11685735|FG000|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||23
10533613|NCT01426009|11685735|FG000|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||24
10355221|NCT00464204|11494251|FG001|COMPLETED|Overall Study|Completed=no withdrawal until day 8.|64
10355222|NCT00464204|11494250|FG000|NOT COMPLETED|Overall Study||49
10355223|NCT00464204|11494251|FG001|NOT COMPLETED|Overall Study||32
10355236|NCT00464308|11494281|FG000|STARTED|Overall Study||464
10355237|NCT00464308|11494282|FG001|STARTED|Overall Study||469
10305893|NCT00095940|11438869|FG003|STARTED|Molecular Biology Phase||0
10305894|NCT00095940|11438870|FG004|STARTED|Molecular Biology Phase||0
10305895|NCT00095940|11438871|FG005|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
10305896|NCT00095940|11438872|FG006|STARTED|Molecular Biology Phase||2
10305897|NCT00095940|11438873|FG007|STARTED|Molecular Biology Phase||2
10305898|NCT00095940|11438874|FG008|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
10305899|NCT00095940|11438866|FG000|COMPLETED|Molecular Biology Phase||2
10305900|NCT00095940|11438867|FG001|COMPLETED|Molecular Biology Phase||2
10305901|NCT00095940|11438868|FG002|COMPLETED|Molecular Biology Phase||0
10305902|NCT00095940|11438869|FG003|COMPLETED|Molecular Biology Phase||0
10305903|NCT00095940|11438870|FG004|COMPLETED|Molecular Biology Phase||0
10305904|NCT00095940|11438871|FG005|COMPLETED|Molecular Biology Phase||0
10305905|NCT00095940|11438872|FG006|COMPLETED|Molecular Biology Phase||2
10305906|NCT00095940|11438873|FG007|COMPLETED|Molecular Biology Phase||2
10305907|NCT00095940|11438874|FG008|COMPLETED|Molecular Biology Phase||0
10305908|NCT00095940|11438866|FG000|NOT COMPLETED|Molecular Biology Phase||0
10305909|NCT00095940|11438867|FG001|NOT COMPLETED|Molecular Biology Phase||0
10305910|NCT00095940|11438868|FG002|NOT COMPLETED|Molecular Biology Phase||0
10305911|NCT00095940|11438869|FG003|NOT COMPLETED|Molecular Biology Phase||0
10305912|NCT00095940|11438870|FG004|NOT COMPLETED|Molecular Biology Phase||0
10305913|NCT00095940|11438871|FG005|NOT COMPLETED|Molecular Biology Phase||0
10305914|NCT00095940|11438872|FG006|NOT COMPLETED|Molecular Biology Phase||0
10305915|NCT00095940|11438873|FG007|NOT COMPLETED|Molecular Biology Phase||0
10305916|NCT00095940|11438874|FG008|NOT COMPLETED|Molecular Biology Phase||0
10305917|NCT00095940|11438866|FG000|STARTED|Lapatinib Continuation/Phase II|Continued to receive lapatinib but were ineligible for the phase II.|2
10305918|NCT00095940|11438867|FG001|STARTED|Lapatinib Continuation/Phase II|No measurable disease post surgery - ineligible for the phase II. Continued to receive lapatinib.|2
10305919|NCT00095940|11438868|FG002|STARTED|Lapatinib Continuation/Phase II||17
10305920|NCT00095940|11438869|FG003|STARTED|Lapatinib Continuation/Phase II||0
10305921|NCT00095940|11438870|FG004|STARTED|Lapatinib Continuation/Phase II||0
10305922|NCT00095940|11438871|FG005|STARTED|Lapatinib Continuation/Phase II||13
10305923|NCT00095940|11438872|FG006|STARTED|Lapatinib Continuation/Phase II|Continued to receive lapatinib but were ineligible for the phase II.|2
10305924|NCT00095940|11438873|FG007|STARTED|Lapatinib Continuation/Phase II|No measurable disease post surgery - ineligible for the phase II. Continued to receive lapatinib.|2
10305925|NCT00095940|11438874|FG008|STARTED|Lapatinib Continuation/Phase II||14
10305926|NCT00095940|11438866|FG000|COMPLETED|Lapatinib Continuation/Phase II||0
10305927|NCT00095940|11438867|FG001|COMPLETED|Lapatinib Continuation/Phase II||0
10305928|NCT00095940|11438868|FG002|COMPLETED|Lapatinib Continuation/Phase II||1
10305929|NCT00095940|11438869|FG003|COMPLETED|Lapatinib Continuation/Phase II||0
10305930|NCT00095940|11438870|FG004|COMPLETED|Lapatinib Continuation/Phase II||0
10305931|NCT00095940|11438871|FG005|COMPLETED|Lapatinib Continuation/Phase II||0
10305932|NCT00095940|11438872|FG006|COMPLETED|Lapatinib Continuation/Phase II||0
10305933|NCT00095940|11438873|FG007|COMPLETED|Lapatinib Continuation/Phase II||0
10305934|NCT00095940|11438874|FG008|COMPLETED|Lapatinib Continuation/Phase II||1
10305935|NCT00095940|11438866|FG000|NOT COMPLETED|Lapatinib Continuation/Phase II||2
10305936|NCT00095940|11438867|FG001|NOT COMPLETED|Lapatinib Continuation/Phase II||2
10305937|NCT00095940|11438868|FG002|NOT COMPLETED|Lapatinib Continuation/Phase II||16
10305938|NCT00095940|11438869|FG003|NOT COMPLETED|Lapatinib Continuation/Phase II||0
10305939|NCT00095940|11438870|FG004|NOT COMPLETED|Lapatinib Continuation/Phase II||0
10305940|NCT00095940|11438871|FG005|NOT COMPLETED|Lapatinib Continuation/Phase II||13
10305941|NCT00095940|11438872|FG006|NOT COMPLETED|Lapatinib Continuation/Phase II||2
10355238|NCT00464308|11494283|FG002|STARTED|Overall Study||459
10355239|NCT00464308|11494281|FG000|COMPLETED|Overall Study||395
10355240|NCT00464308|11494282|FG001|COMPLETED|Overall Study||406
10533614|NCT01426009|11685735|FG000|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||22
10533615|NCT01426009|11685735|FG000|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||23
10533616|NCT01426009|11685735|FG000|Ipratropium Bromide|Period 1-First Intervention (7 Days)||23
10533617|NCT01426009|11685735|FG000|Placebo|Period 1-First Intervention (7 Days)||24
10533618|NCT01426009|11685735|FG000|COMPLETED|Period 1-First Intervention (7 Days)||137
10533619|NCT01426009|11685735|FG000|NOT COMPLETED|Period 1-First Intervention (7 Days)||2
10533620|NCT01426009|11685735|FG000|STARTED|Washout 1||137
10533621|NCT01426009|11685735|FG000|COMPLETED|Washout 1||135
10533622|NCT01426009|11685735|FG000|NOT COMPLETED|Washout 1||2
10533623|NCT01426009|11685735|FG000|STARTED|Period 2-Second Intervention (7 Days)||135
10533624|NCT01426009|11685735|FG000|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||22
10533625|NCT01426009|11685735|FG000|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||24
10533626|NCT01426009|11685735|FG000|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||24
10533627|NCT01426009|11685735|FG000|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||23
10533628|NCT01426009|11685735|FG000|Ipratropium Bromide|Period 2-Second Intervention (7 Days)||21
10533629|NCT01426009|11685735|FG000|Placebo|Period 2-Second Intervention (7 Days)||21
10533630|NCT01426009|11685735|FG000|COMPLETED|Period 2-Second Intervention (7 Days)||130
10533631|NCT01426009|11685735|FG000|NOT COMPLETED|Period 2-Second Intervention (7 Days)||5
10533632|NCT01426009|11685735|FG000|STARTED|Washout 2||130
10533633|NCT01426009|11685735|FG000|COMPLETED|Washout 2||129
10533634|NCT01426009|11685735|FG000|NOT COMPLETED|Washout 2||1
10533635|NCT01426009|11685735|FG000|STARTED|Period 3-Third Intervention (7 Days)||129
10533636|NCT01426009|11685735|FG000|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||19
10533637|NCT01426009|11685735|FG000|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||23
10533638|NCT01426009|11685735|FG000|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||22
10533639|NCT01426009|11685735|FG000|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||20
10533640|NCT01426009|11685735|FG000|Ipratropium Bromide|Period 3-Third Intervention (7 Days)||23
10533641|NCT01426009|11685735|FG000|Placebo|Period 3-Third Intervention (7 Days)||22
10533642|NCT01426009|11685735|FG000|COMPLETED|Period 3-Third Intervention (7 Days)||129
10533643|NCT01426009|11685735|FG000|NOT COMPLETED|Period 3-Third Intervention (7 Days)||0
10533644|NCT01426009|11685735|FG000|STARTED|Washout 3||129
10533645|NCT01426009|11685735|FG000|COMPLETED|Washout 3||128
10533646|NCT01426009|11685735|FG000|NOT COMPLETED|Washout 3||1
10533647|NCT01426009|11685735|FG000|STARTED|Period 4-Fourth Intervention (7 Days)||128
10533648|NCT01426009|11685735|FG000|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||10
10533649|NCT01426009|11685735|FG000|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||7
10533650|NCT01426009|11685735|FG000|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||8
10533651|NCT01426009|11685735|FG000|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||9
10533652|NCT01426009|11685735|FG000|Ipratropium Bromide|Period 4-Fourth Intervention (7 Days)||8
10533653|NCT01426009|11685735|FG000|Tiotropium Bromide|Period 4-Fourth Intervention (7 Days)||76
10533654|NCT01426009|11685735|FG000|Placebo|Period 4-Fourth Intervention (7 Days)||10
10533655|NCT01426009|11685735|FG000|COMPLETED|Period 4-Fourth Intervention (7 Days)||127
10533656|NCT01426009|11685735|FG000|NOT COMPLETED|Period 4-Fourth Intervention (7 Days)||1
10533657|NCT01426009|11685735|FG000|STARTED|Washout 4||127
10533658|NCT01426009|11685735|FG000|COMPLETED|Washout 4||126
10533659|NCT01426009|11685735|FG000|NOT COMPLETED|Washout 4||1
10533660|NCT01426191|11685751|FG000|STARTED|Overall Study||2032
10533661|NCT01426191|11685751|FG000|COMPLETED|Overall Study||2032
10533662|NCT01426191|11685751|FG000|NOT COMPLETED|Overall Study||0
10533663|NCT01426217|11685757|FG000|STARTED|Overall Study||314
10533664|NCT01426217|11685758|FG001|STARTED|Overall Study||280
10533665|NCT01426217|11685757|FG000|COMPLETED|Overall Study||306
10533666|NCT01426217|11685758|FG001|COMPLETED|Overall Study||266
10533667|NCT01426217|11685757|FG000|NOT COMPLETED|Overall Study||8
10533668|NCT01426217|11685758|FG001|NOT COMPLETED|Overall Study||14
10533669|NCT01426230|11685766|FG000|STARTED|Overall Study|90 patients were enrolled, but only 86 received study treatment.|86
10533670|NCT01426230|11685767|FG001|STARTED|Overall Study||111
10533671|NCT01426230|11685766|FG000|COMPLETED|Overall Study||55
10533672|NCT01426230|11685767|FG001|COMPLETED|Overall Study||84
10533673|NCT01426230|11685766|FG000|NOT COMPLETED|Overall Study||31
10533674|NCT01426230|11685767|FG001|NOT COMPLETED|Overall Study||27
10355241|NCT00464308|11494283|FG002|COMPLETED|Overall Study||400
10716095|NCT02688387|11880058|FG015|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10716096|NCT02688387|11880059|FG016|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10716097|NCT02688387|11880060|FG017|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10533702|NCT01426347|11685787|FG000|STARTED|Overall Study||41
10533703|NCT01426347|11685788|FG001|STARTED|Overall Study||42
10533704|NCT01426347|11685787|FG000|COMPLETED|Overall Study||34
10533705|NCT01426347|11685788|FG001|COMPLETED|Overall Study||39
10533706|NCT01426347|11685787|FG000|NOT COMPLETED|Overall Study||7
10533707|NCT01426347|11685788|FG001|NOT COMPLETED|Overall Study||3
10533708|NCT01426360|11685796|FG000|STARTED|Overall Study||38
10533709|NCT01426360|11685797|FG001|STARTED|Overall Study||41
10533710|NCT01426360|11685796|FG000|COMPLETED|Overall Study||38
10533711|NCT01426360|11685797|FG001|COMPLETED|Overall Study||41
10533712|NCT01426360|11685796|FG000|NOT COMPLETED|Overall Study||0
10533713|NCT01426360|11685797|FG001|NOT COMPLETED|Overall Study||0
10533714|NCT01426373|11685803|FG000|STARTED|Overall Study||165
10533715|NCT01426373|11685803|FG000|COMPLETED|Overall Study|Completed the last follow-up visit 12 months after last treatment|131
10533716|NCT01426373|11685803|FG000|NOT COMPLETED|Overall Study||34
10533717|NCT01426386|11685815|FG000|STARTED|Overall Study||42
10533718|NCT01426386|11685816|FG001|STARTED|Overall Study||45
10533719|NCT01426386|11685817|FG002|STARTED|Overall Study||44
10533720|NCT01426386|11685818|FG003|STARTED|Overall Study||44
10533721|NCT01426386|11685819|FG004|STARTED|Overall Study||47
10656049|NCT02213458|11816886|FG000|COMPLETED|Overall Study||970
10656050|NCT02213458|11816887|FG001|COMPLETED|Overall Study||526
10656051|NCT02213458|11816886|FG000|NOT COMPLETED|Overall Study||54
10656052|NCT02213458|11816887|FG001|NOT COMPLETED|Overall Study||10
10716098|NCT02688387|11880061|FG018|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10716099|NCT02688387|11880062|FG019|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10716100|NCT02688387|11880063|FG020|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10533722|NCT01426386|11685820|FG005|STARTED|Overall Study||43
10533723|NCT01426386|11685815|FG000|COMPLETED|Overall Study||39
10533724|NCT01426386|11685816|FG001|COMPLETED|Overall Study||39
10533725|NCT01426386|11685817|FG002|COMPLETED|Overall Study||42
10533726|NCT01426386|11685818|FG003|COMPLETED|Overall Study||44
10533727|NCT01426386|11685819|FG004|COMPLETED|Overall Study||43
10533728|NCT01426386|11685820|FG005|COMPLETED|Overall Study||42
10533729|NCT01426386|11685815|FG000|NOT COMPLETED|Overall Study||3
10533730|NCT01426386|11685816|FG001|NOT COMPLETED|Overall Study||6
10533731|NCT01426386|11685817|FG002|NOT COMPLETED|Overall Study||2
10656053|NCT02213510|11816895|FG000|STARTED|Overall Study||21
10656054|NCT02213510|11816896|FG001|STARTED|Overall Study||19
10656055|NCT02213510|11816895|FG000|COMPLETED|Overall Study||20
10656056|NCT02213510|11816896|FG001|COMPLETED|Overall Study||18
10656057|NCT02213510|11816895|FG000|NOT COMPLETED|Overall Study||1
10656058|NCT02213510|11816896|FG001|NOT COMPLETED|Overall Study||1
10656059|NCT02213666|11816902|FG000|STARTED|Overall Study||72
10656060|NCT02213666|11816902|FG000|COMPLETED|Overall Study||71
10656061|NCT02213666|11816902|FG000|NOT COMPLETED|Overall Study||1
10656062|NCT02213900|11816908|FG000|STARTED|Overall Study||68
10656063|NCT02213900|11816909|FG001|STARTED|Overall Study||67
10656064|NCT02213900|11816908|FG000|COMPLETED|Overall Study||68
10656065|NCT02213900|11816909|FG001|COMPLETED|Overall Study||67
10656066|NCT02213900|11816908|FG000|NOT COMPLETED|Overall Study||0
10656067|NCT02213900|11816909|FG001|NOT COMPLETED|Overall Study||0
10656068|NCT02214017|11816917|FG000|STARTED|Overall Study||22
10656069|NCT02214017|11816918|FG001|STARTED|Overall Study||18
10656070|NCT02214017|11816917|FG000|COMPLETED|Overall Study||22
10656071|NCT02214017|11816918|FG001|COMPLETED|Overall Study||18
10656072|NCT02214017|11816917|FG000|NOT COMPLETED|Overall Study||0
10656073|NCT02214017|11816918|FG001|NOT COMPLETED|Overall Study||0
10656074|NCT02214121|11816927|FG000|STARTED|Part A||46
10656075|NCT02214121|11816928|FG001|STARTED|Part A||0
10656076|NCT02214121|11816929|FG002|STARTED|Part A||0
10656077|NCT02214121|11816927|FG000|COMPLETED|Part A||39
10355242|NCT00464308|11494281|FG000|NOT COMPLETED|Overall Study||69
10355243|NCT00464308|11494282|FG001|NOT COMPLETED|Overall Study||63
10355244|NCT00464308|11494283|FG002|NOT COMPLETED|Overall Study||59
10355245|NCT00464334|11494302|FG000|STARTED|Overall Study||5
10355246|NCT00464334|11494303|FG001|STARTED|Overall Study||13
10355247|NCT00464334|11494304|FG002|STARTED|Overall Study||8
10355248|NCT00464334|11494305|FG003|STARTED|Overall Study||8
10355249|NCT00464334|11494306|FG004|STARTED|Overall Study||7
10355250|NCT00464334|11494307|FG005|STARTED|Overall Study||7
10355251|NCT00464334|11494308|FG006|STARTED|Overall Study||9
10355252|NCT00464334|11494309|FG007|STARTED|Overall Study||8
10355253|NCT00464334|11494310|FG008|STARTED|Overall Study||8
10355254|NCT00464334|11494311|FG009|STARTED|Overall Study||5
10355255|NCT00464334|11494312|FG010|STARTED|Overall Study||8
10355256|NCT00464334|11494302|FG000|COMPLETED|Overall Study||4
10355257|NCT00464334|11494303|FG001|COMPLETED|Overall Study||5
10355258|NCT00464334|11494304|FG002|COMPLETED|Overall Study||3
10355259|NCT00464334|11494305|FG003|COMPLETED|Overall Study||4
10355260|NCT00464334|11494306|FG004|COMPLETED|Overall Study||3
10355261|NCT00464334|11494307|FG005|COMPLETED|Overall Study||3
10355262|NCT00464334|11494308|FG006|COMPLETED|Overall Study||6
10355263|NCT00464334|11494309|FG007|COMPLETED|Overall Study||7
10355264|NCT00464334|11494310|FG008|COMPLETED|Overall Study||2
10355265|NCT00464334|11494311|FG009|COMPLETED|Overall Study||4
10355266|NCT00464334|11494312|FG010|COMPLETED|Overall Study||4
10355267|NCT00464334|11494302|FG000|NOT COMPLETED|Overall Study||1
10355268|NCT00464334|11494303|FG001|NOT COMPLETED|Overall Study||8
10355269|NCT00464334|11494304|FG002|NOT COMPLETED|Overall Study||5
10355270|NCT00464334|11494305|FG003|NOT COMPLETED|Overall Study||4
10355271|NCT00464334|11494306|FG004|NOT COMPLETED|Overall Study||4
10355272|NCT00464334|11494307|FG005|NOT COMPLETED|Overall Study||4
10355273|NCT00464334|11494308|FG006|NOT COMPLETED|Overall Study||3
10355274|NCT00464334|11494309|FG007|NOT COMPLETED|Overall Study||1
10355275|NCT00464334|11494310|FG008|NOT COMPLETED|Overall Study||6
10355276|NCT00464334|11494311|FG009|NOT COMPLETED|Overall Study||1
10355277|NCT00464334|11494312|FG010|NOT COMPLETED|Overall Study||4
10355278|NCT00464438|11494349|FG000|STARTED|Overall Study||85
10355279|NCT00464438|11494350|FG001|STARTED|Overall Study||86
10355280|NCT00464438|11494349|FG000|COMPLETED|Overall Study||83
10355281|NCT00464438|11494350|FG001|COMPLETED|Overall Study||80
10355282|NCT00464438|11494349|FG000|NOT COMPLETED|Overall Study||2
10355283|NCT00464438|11494350|FG001|NOT COMPLETED|Overall Study||6
10355284|NCT00464464|11494358|FG000|STARTED|Overall Study||41
10355285|NCT00464464|11494359|FG001|STARTED|Overall Study||39
10355286|NCT00464464|11494358|FG000|COMPLETED|Overall Study||36
10355287|NCT00464464|11494359|FG001|COMPLETED|Overall Study||36
10355288|NCT00464464|11494358|FG000|NOT COMPLETED|Overall Study||5
10355289|NCT00464464|11494359|FG001|NOT COMPLETED|Overall Study||3
10355290|NCT00464490|11494367|FG000|STARTED|Overall Study||21
10355291|NCT00464490|11494368|FG001|STARTED|Overall Study||21
10355292|NCT00464490|11494367|FG000|COMPLETED|Overall Study||10
10355293|NCT00464490|11494368|FG001|COMPLETED|Overall Study||10
10355294|NCT00464490|11494367|FG000|NOT COMPLETED|Overall Study||11
10355295|NCT00464490|11494368|FG001|NOT COMPLETED|Overall Study||11
10355296|NCT00464542|11494374|FG000|STARTED|Pre-treatment||12
10355297|NCT00464542|11494374|FG000|COMPLETED|Pre-treatment||10
10355298|NCT00464542|11494374|FG000|NOT COMPLETED|Pre-treatment||2
10355299|NCT00464542|11494374|FG000|STARTED|Post-treatment||10
10355300|NCT00464542|11494374|FG000|COMPLETED|Post-treatment||10
10355301|NCT00464542|11494374|FG000|NOT COMPLETED|Post-treatment||0
10355302|NCT00464568|11494378|FG000|STARTED|Overall Study||32
10355303|NCT00464568|11494378|FG000|COMPLETED|Overall Study||30
10355304|NCT00464568|11494378|FG000|NOT COMPLETED|Overall Study||2
10355305|NCT00464620|11494395|FG000|STARTED|Overall Study||50
10355306|NCT00464620|11494396|FG001|STARTED|Overall Study||200
10355307|NCT00464620|11494397|FG002|STARTED|Overall Study||116
10355308|NCT00464620|11494395|FG000|COMPLETED|Overall Study|48 patients were evaluable.|48
10355309|NCT00464620|11494396|FG001|COMPLETED|Overall Study||198
10355310|NCT00464620|11494397|FG002|COMPLETED|Overall Study||109
10355311|NCT00464620|11494395|FG000|NOT COMPLETED|Overall Study||2
10355312|NCT00464620|11494396|FG001|NOT COMPLETED|Overall Study||2
10355313|NCT00464620|11494397|FG002|NOT COMPLETED|Overall Study||7
10355314|NCT00464646|11494412|FG000|STARTED|Overall Study||76
10355315|NCT00464646|11494413|FG001|STARTED|Overall Study||29
10355316|NCT00464646|11494412|FG000|COMPLETED|Overall Study||76
10355317|NCT00464646|11494413|FG001|COMPLETED|Overall Study||29
10355318|NCT00464646|11494412|FG000|NOT COMPLETED|Overall Study||0
10355319|NCT00464646|11494413|FG001|NOT COMPLETED|Overall Study||0
10355320|NCT00464672|11494422|FG000|STARTED|Overall Study||460
10533732|NCT01426386|11685818|FG003|NOT COMPLETED|Overall Study||0
10533733|NCT01426386|11685819|FG004|NOT COMPLETED|Overall Study||4
10355321|NCT00464672|11494423|FG001|STARTED|Overall Study||232
10355322|NCT00464672|11494424|FG002|STARTED|Overall Study||400
10355323|NCT00464672|11494425|FG003|STARTED|Overall Study||200
10355324|NCT00464672|11494426|FG004|STARTED|Overall Study||402
10355325|NCT00464672|11494427|FG005|STARTED|Overall Study||199
10355326|NCT00464672|11494422|FG000|COMPLETED|Overall Study||435
10355327|NCT00464672|11494423|FG001|COMPLETED|Overall Study||222
10355328|NCT00464672|11494424|FG002|COMPLETED|Overall Study||400
10355329|NCT00464672|11494425|FG003|COMPLETED|Overall Study||199
10355330|NCT00464672|11494426|FG004|COMPLETED|Overall Study||392
10355331|NCT00464672|11494427|FG005|COMPLETED|Overall Study||195
10355332|NCT00464672|11494422|FG000|NOT COMPLETED|Overall Study||25
10355333|NCT00464672|11494423|FG001|NOT COMPLETED|Overall Study||10
10355334|NCT00464672|11494424|FG002|NOT COMPLETED|Overall Study||0
10355335|NCT00464672|11494425|FG003|NOT COMPLETED|Overall Study||1
10355336|NCT00464672|11494426|FG004|NOT COMPLETED|Overall Study||10
10355337|NCT00464672|11494427|FG005|NOT COMPLETED|Overall Study||4
10355338|NCT00464685|11494457|FG000|STARTED|Overall Study||126
10355339|NCT00464685|11494458|FG001|STARTED|Overall Study||127
10355340|NCT00464685|11494457|FG000|COMPLETED|Overall Study||103
10355341|NCT00464685|11494458|FG001|COMPLETED|Overall Study||94
10355342|NCT00464685|11494457|FG000|NOT COMPLETED|Overall Study||23
10355343|NCT00464685|11494458|FG001|NOT COMPLETED|Overall Study||33
10355344|NCT00464698|11494464|FG000|STARTED|Period 1: 30 mg||20
10355345|NCT00464698|11494464|FG000|COMPLETED|Period 1: 30 mg||17
10355346|NCT00464698|11494464|FG000|NOT COMPLETED|Period 1: 30 mg||3
10355347|NCT00464698|11494464|FG000|STARTED|Period 2: 60 mg||17
10355348|NCT00464698|11494464|FG000|COMPLETED|Period 2: 60 mg||17
10355349|NCT00464698|11494464|FG000|NOT COMPLETED|Period 2: 60 mg||0
10355350|NCT00464698|11494464|FG000|STARTED|Period 3: 120mg||14
10355351|NCT00464698|11494464|FG000|COMPLETED|Period 3: 120mg||12
10355352|NCT00464698|11494464|FG000|NOT COMPLETED|Period 3: 120mg||2
10355353|NCT00464711|11494470|FG000|STARTED|Overall Study||40
10355354|NCT00464711|11494470|FG000|COMPLETED|Overall Study||25
10355355|NCT00464711|11494470|FG000|NOT COMPLETED|Overall Study||15
10355356|NCT00464737|11494477|FG000|STARTED|Overall Study||82
10355357|NCT00464737|11494478|FG001|STARTED|Overall Study||74
10355358|NCT00464737|11494479|FG002|STARTED|Overall Study||74
10355359|NCT00464737|11494477|FG000|COMPLETED|Overall Study||50
10355360|NCT00464737|11494478|FG001|COMPLETED|Overall Study||42
10355361|NCT00464737|11494479|FG002|COMPLETED|Overall Study||19
10355362|NCT00464737|11494477|FG000|NOT COMPLETED|Overall Study||32
10355363|NCT00464737|11494478|FG001|NOT COMPLETED|Overall Study||32
10355364|NCT00464737|11494479|FG002|NOT COMPLETED|Overall Study||55
10355365|NCT00464815|11494489|FG000|STARTED|Overall Study||768
10355366|NCT00464815|11494490|FG001|STARTED|Overall Study||257
10355367|NCT00464815|11494489|FG000|COMPLETED|Overall Study||762
10355368|NCT00464815|11494490|FG001|COMPLETED|Overall Study||254
10355369|NCT00464815|11494489|FG000|NOT COMPLETED|Overall Study||6
10355370|NCT00464815|11494490|FG001|NOT COMPLETED|Overall Study||3
10355371|NCT00464945|11494498|FG000|STARTED|Infant Series||135
10355372|NCT00464945|11494499|FG001|STARTED|Infant Series||134
10355373|NCT00464945|11494498|FG000|Vaccinated Dose 1|Infant Series||134
10355374|NCT00464945|11494499|FG001|Vaccinated Dose 1|Infant Series||134
10355375|NCT00464945|11494498|FG000|Vaccinated Dose 2|Infant Series||132
10355376|NCT00464945|11494499|FG001|Vaccinated Dose 2|Infant Series||133
10355377|NCT00464945|11494498|FG000|Vaccinated Dose 3|Infant Series||132
10355378|NCT00464945|11494499|FG001|Vaccinated Dose 3|Infant Series||133
10355379|NCT00464945|11494498|FG000|COMPLETED|Infant Series||131
10355380|NCT00464945|11494499|FG001|COMPLETED|Infant Series||133
10355381|NCT00464945|11494498|FG000|NOT COMPLETED|Infant Series||4
10355382|NCT00464945|11494499|FG001|NOT COMPLETED|Infant Series||1
10355383|NCT00464945|11494498|FG000|STARTED|After Infant Series||131
10355384|NCT00464945|11494499|FG001|STARTED|After Infant Series||133
10355385|NCT00464945|11494498|FG000|COMPLETED|After Infant Series||131
10355386|NCT00464945|11494499|FG001|COMPLETED|After Infant Series||131
10355387|NCT00464945|11494498|FG000|NOT COMPLETED|After Infant Series||0
10355388|NCT00464945|11494499|FG001|NOT COMPLETED|After Infant Series||2
10355389|NCT00464945|11494498|FG000|STARTED|Toddler Dose||131
10355390|NCT00464945|11494499|FG001|STARTED|Toddler Dose||131
10355391|NCT00464945|11494498|FG000|COMPLETED|Toddler Dose||131
10355392|NCT00464945|11494499|FG001|COMPLETED|Toddler Dose||130
10355393|NCT00464945|11494498|FG000|NOT COMPLETED|Toddler Dose||0
10355394|NCT00464945|11494499|FG001|NOT COMPLETED|Toddler Dose||1
10355395|NCT00465088|11494523|FG000|STARTED|Overall Study|For both arms, started means treated.|114
10355396|NCT00465088|11494524|FG001|STARTED|Overall Study||79
10355397|NCT00465088|11494523|FG000|COMPLETED|Overall Study||82
10355398|NCT00465088|11494524|FG001|COMPLETED|Overall Study||70
10355399|NCT00465088|11494523|FG000|NOT COMPLETED|Overall Study||32
10355400|NCT00465088|11494524|FG001|NOT COMPLETED|Overall Study||9
10355401|NCT00465101|11494530|FG000|STARTED|Overall Study||150
10355402|NCT00465101|11494530|FG000|COMPLETED|Overall Study||91
10355403|NCT00465101|11494530|FG000|NOT COMPLETED|Overall Study||59
10355404|NCT00465179|11494556|FG000|STARTED|Overall Study||57
10355405|NCT00465179|11494556|FG000|COMPLETED|Overall Study||4
10355406|NCT00465179|11494556|FG000|NOT COMPLETED|Overall Study||53
10355407|NCT00465270|11494562|FG000|STARTED|Overall Study||499
10355408|NCT00465270|11494563|FG001|STARTED|Overall Study||481
10355409|NCT00465270|11494562|FG000|COMPLETED|Overall Study||395
10355410|NCT00465270|11494563|FG001|COMPLETED|Overall Study||321
10355411|NCT00465270|11494562|FG000|NOT COMPLETED|Overall Study||104
10355412|NCT00465270|11494563|FG001|NOT COMPLETED|Overall Study||160
10355413|NCT00465361|11494569|FG000|STARTED|Baseline Assessment||7
10355414|NCT00465361|11494569|FG000|COMPLETED|Baseline Assessment||3
10355415|NCT00465361|11494569|FG000|NOT COMPLETED|Baseline Assessment||4
10355416|NCT00465361|11494569|FG000|STARTED|Post-Intervention Assessment||3
10355417|NCT00465361|11494569|FG000|COMPLETED|Post-Intervention Assessment||3
10355418|NCT00465361|11494569|FG000|NOT COMPLETED|Post-Intervention Assessment||0
10355419|NCT00465530|11494575|FG000|STARTED|Overall Study||21
10355420|NCT00465530|11494576|FG001|STARTED|Overall Study||19
10355421|NCT00465530|11494575|FG000|COMPLETED|Overall Study||19
10355422|NCT00465530|11494576|FG001|COMPLETED|Overall Study||15
10355423|NCT00465530|11494575|FG000|NOT COMPLETED|Overall Study||2
10355424|NCT00465530|11494576|FG001|NOT COMPLETED|Overall Study||4
10355425|NCT00465569|11494584|FG000|STARTED|Overall Study||13
10355426|NCT00465569|11494585|FG001|STARTED|Overall Study||7
10533734|NCT01426386|11685820|FG005|NOT COMPLETED|Overall Study||1
10533735|NCT01426412|11685843|FG000|STARTED|Overall Study||6
10533736|NCT01426412|11685844|FG001|STARTED|Overall Study||6
10533737|NCT01426412|11685845|FG002|STARTED|Overall Study||6
10656078|NCT02214121|11816928|FG001|COMPLETED|Part A||0
10656079|NCT02214121|11816929|FG002|COMPLETED|Part A||0
10656080|NCT02214121|11816927|FG000|NOT COMPLETED|Part A||7
10656081|NCT02214121|11816928|FG001|NOT COMPLETED|Part A||0
10656082|NCT02214121|11816929|FG002|NOT COMPLETED|Part A||0
10656083|NCT02214121|11816927|FG000|STARTED|Part B||0
10656084|NCT02214121|11816928|FG001|STARTED|Part B||17
10656085|NCT02214121|11816929|FG002|STARTED|Part B||8
10656086|NCT02214121|11816927|FG000|COMPLETED|Part B||0
10656087|NCT02214121|11816928|FG001|COMPLETED|Part B||14
10656088|NCT02214121|11816929|FG002|COMPLETED|Part B||7
10656089|NCT02214121|11816927|FG000|NOT COMPLETED|Part B||0
10656090|NCT02214121|11816928|FG001|NOT COMPLETED|Part B||3
10656091|NCT02214121|11816929|FG002|NOT COMPLETED|Part B||1
10656092|NCT02214147|11816952|FG000|STARTED|Overall Study||16
10656093|NCT02214147|11816953|FG001|STARTED|Overall Study||12
10656094|NCT02214147|11816954|FG002|STARTED|Overall Study||8
10656095|NCT02214147|11816952|FG000|COMPLETED|Overall Study||16
10656096|NCT02214147|11816953|FG001|COMPLETED|Overall Study||12
10656097|NCT02214147|11816954|FG002|COMPLETED|Overall Study||8
10656098|NCT02214147|11816952|FG000|NOT COMPLETED|Overall Study||0
10656099|NCT02214147|11816953|FG001|NOT COMPLETED|Overall Study||0
10656100|NCT02214147|11816954|FG002|NOT COMPLETED|Overall Study||0
10656101|NCT02214186|11816964|FG000|STARTED|Overall Study||23
10656102|NCT02214186|11816965|FG001|STARTED|Overall Study||23
10656103|NCT02214186|11816964|FG000|COMPLETED|Overall Study||21
10656104|NCT02214186|11816965|FG001|COMPLETED|Overall Study||21
10656105|NCT02214186|11816964|FG000|NOT COMPLETED|Overall Study||2
10656106|NCT02214186|11816965|FG001|NOT COMPLETED|Overall Study||2
10656107|NCT02214212|11816973|FG000|STARTED|Overall Study||66
10656108|NCT02214212|11816974|FG001|STARTED|Overall Study||65
10656109|NCT02214212|11816973|FG000|COMPLETED|Overall Study||57
10656110|NCT02214212|11816974|FG001|COMPLETED|Overall Study||59
10656111|NCT02214212|11816973|FG000|NOT COMPLETED|Overall Study||9
10656112|NCT02214212|11816974|FG001|NOT COMPLETED|Overall Study||6
10656113|NCT02214225|11816988|FG000|STARTED|Overall Study||1741
10656114|NCT02214225|11816989|FG001|STARTED|Overall Study||871
10656115|NCT02214225|11816990|FG002|STARTED|Overall Study||872
10656116|NCT02214225|11816988|FG000|COMPLETED|Overall Study||1686
10656117|NCT02214225|11816989|FG001|COMPLETED|Overall Study||852
10656118|NCT02214225|11816990|FG002|COMPLETED|Overall Study||850
10656119|NCT02214225|11816988|FG000|NOT COMPLETED|Overall Study||55
10656120|NCT02214225|11816989|FG001|NOT COMPLETED|Overall Study||19
10656121|NCT02214225|11816990|FG002|NOT COMPLETED|Overall Study||22
10656122|NCT02214238|11817023|FG000|STARTED|Overall Study||26
10656123|NCT02214238|11817024|FG001|STARTED|Overall Study||23
10656124|NCT02214238|11817023|FG000|COMPLETED|Overall Study||20
10656125|NCT02214238|11817024|FG001|COMPLETED|Overall Study||17
10656126|NCT02214238|11817023|FG000|NOT COMPLETED|Overall Study||6
10656127|NCT02214238|11817024|FG001|NOT COMPLETED|Overall Study||6
10656128|NCT02214277|11817033|FG000|STARTED|Overall Study||123
10355427|NCT00465569|11494584|FG000|COMPLETED|Overall Study||12
10355428|NCT00465569|11494585|FG001|COMPLETED|Overall Study||7
10355429|NCT00465569|11494584|FG000|NOT COMPLETED|Overall Study||1
10533738|NCT01426412|11685846|FG003|STARTED|Overall Study||6
10533739|NCT01426412|11685847|FG004|STARTED|Overall Study||6
10533740|NCT01426412|11685848|FG005|STARTED|Overall Study||6
10533741|NCT01426412|11685849|FG006|STARTED|Overall Study||6
10533742|NCT01426412|11685850|FG007|STARTED|Overall Study||10
10533743|NCT01426412|11685851|FG008|STARTED|Overall Study||17
10533744|NCT01426412|11685843|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
10533745|NCT01426412|11685844|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
10533746|NCT01426412|11685845|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
10533747|NCT01426412|11685846|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
10533748|NCT01426412|11685847|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
10533749|NCT01426412|11685848|FG005|Received at Least 1 Dose of Study Drug|Overall Study||6
10533750|NCT01426412|11685849|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
10533751|NCT01426412|11685850|FG007|Received at Least 1 Dose of Study Drug|Overall Study||10
10533752|NCT01426412|11685851|FG008|Received at Least 1 Dose of Study Drug|Overall Study||17
10533753|NCT01426412|11685843|FG000|COMPLETED|Overall Study||5
10533754|NCT01426412|11685844|FG001|COMPLETED|Overall Study||6
10533755|NCT01426412|11685845|FG002|COMPLETED|Overall Study||6
10656129|NCT02214277|11817034|FG001|STARTED|Overall Study||121
10656130|NCT02214277|11817035|FG002|STARTED|Overall Study||119
10656131|NCT02214277|11817033|FG000|COMPLETED|Overall Study||104
10355430|NCT00465569|11494585|FG001|NOT COMPLETED|Overall Study||0
10656132|NCT02214277|11817034|FG001|COMPLETED|Overall Study||96
10656133|NCT02214277|11817035|FG002|COMPLETED|Overall Study||85
10656134|NCT02214277|11817033|FG000|NOT COMPLETED|Overall Study||19
10656135|NCT02214277|11817034|FG001|NOT COMPLETED|Overall Study||25
10656136|NCT02214277|11817035|FG002|NOT COMPLETED|Overall Study||34
10656137|NCT02214290|11817042|FG000|STARTED|First Intervention (7 Days)||8
10656138|NCT02214290|11817043|FG001|STARTED|First Intervention (7 Days)||8
10656139|NCT02214290|11817042|FG000|COMPLETED|First Intervention (7 Days)||8
10355431|NCT00465595|11494593|FG000|STARTED|Overall Study||27
10355432|NCT00465595|11494594|FG001|STARTED|Overall Study||29
10355433|NCT00465595|11494593|FG000|COMPLETED|Overall Study||22
10355434|NCT00465595|11494594|FG001|COMPLETED|Overall Study||24
10355435|NCT00465595|11494593|FG000|NOT COMPLETED|Overall Study||5
10355436|NCT00465595|11494594|FG001|NOT COMPLETED|Overall Study||5
10355437|NCT00465647|11494610|FG000|STARTED|Overall Study||39
10355438|NCT00465647|11494611|FG001|STARTED|Overall Study||23
10355439|NCT00465647|11494612|FG002|STARTED|Overall Study||29
10355440|NCT00465647|11494613|FG003|STARTED|Overall Study||25
10355441|NCT00465647|11494610|FG000|COMPLETED|Overall Study||26
10355442|NCT00465647|11494611|FG001|COMPLETED|Overall Study||15
10355443|NCT00465647|11494612|FG002|COMPLETED|Overall Study||18
10355444|NCT00465647|11494613|FG003|COMPLETED|Overall Study||12
10355445|NCT00465647|11494610|FG000|NOT COMPLETED|Overall Study||13
10355446|NCT00465647|11494611|FG001|NOT COMPLETED|Overall Study||8
10355447|NCT00465647|11494612|FG002|NOT COMPLETED|Overall Study||11
10355448|NCT00465647|11494613|FG003|NOT COMPLETED|Overall Study||13
10355449|NCT00465738|11494635|FG000|STARTED|Overall Study||97
10355450|NCT00465738|11494636|FG001|STARTED|Overall Study||95
10355451|NCT00465738|11494635|FG000|COMPLETED|Overall Study||91
10355452|NCT00465738|11494636|FG001|COMPLETED|Overall Study||89
10355453|NCT00465738|11494635|FG000|NOT COMPLETED|Overall Study||6
10355454|NCT00465738|11494636|FG001|NOT COMPLETED|Overall Study||6
10355455|NCT00465816|11494645|FG000|STARTED|Overall Study||367
10355456|NCT00465816|11494646|FG001|STARTED|Overall Study||122
10355457|NCT00465816|11494647|FG002|STARTED|Overall Study||122
10355458|NCT00465816|11494645|FG000|COMPLETED|Overall Study||367
10355459|NCT00465816|11494646|FG001|COMPLETED|Overall Study||122
10355460|NCT00465816|11494647|FG002|COMPLETED|Overall Study||120
10355461|NCT00465816|11494645|FG000|NOT COMPLETED|Overall Study||0
10355462|NCT00465816|11494646|FG001|NOT COMPLETED|Overall Study||0
10355463|NCT00465816|11494647|FG002|NOT COMPLETED|Overall Study||2
10355464|NCT00465894|11494658|FG000|STARTED|Treatment For 12 Weeks||30
10355465|NCT00465894|11494659|FG001|STARTED|Treatment For 12 Weeks||28
10355466|NCT00465894|11494658|FG000|COMPLETED|Treatment For 12 Weeks||25
10355467|NCT00465894|11494659|FG001|COMPLETED|Treatment For 12 Weeks||25
10355468|NCT00465894|11494658|FG000|NOT COMPLETED|Treatment For 12 Weeks||5
10355469|NCT00465894|11494659|FG001|NOT COMPLETED|Treatment For 12 Weeks||3
10355470|NCT00465894|11494658|FG000|STARTED|Treatment From 12 Weeks To 24 Weeks|We included data only from participants that had complete data sets.|14
10355471|NCT00465894|11494659|FG001|STARTED|Treatment From 12 Weeks To 24 Weeks|We included data only from participants that had complete data sets.|14
10355472|NCT00465894|11494658|FG000|COMPLETED|Treatment From 12 Weeks To 24 Weeks||14
10355473|NCT00465894|11494659|FG001|COMPLETED|Treatment From 12 Weeks To 24 Weeks||14
10355474|NCT00465894|11494658|FG000|NOT COMPLETED|Treatment From 12 Weeks To 24 Weeks||0
10355475|NCT00465894|11494659|FG001|NOT COMPLETED|Treatment From 12 Weeks To 24 Weeks||0
10355476|NCT00465894|11494658|FG000|STARTED|Treatment From 24 Weeks to 52 Weeks|We included data only from participants that had complete data sets.|11
10355477|NCT00465894|11494659|FG001|STARTED|Treatment From 24 Weeks to 52 Weeks||14
10355478|NCT00465894|11494658|FG000|COMPLETED|Treatment From 24 Weeks to 52 Weeks||11
10355479|NCT00465894|11494659|FG001|COMPLETED|Treatment From 24 Weeks to 52 Weeks||14
10355480|NCT00465894|11494658|FG000|NOT COMPLETED|Treatment From 24 Weeks to 52 Weeks||0
10355481|NCT00465894|11494659|FG001|NOT COMPLETED|Treatment From 24 Weeks to 52 Weeks||0
10355482|NCT00465972|11494683|FG000|STARTED|Overall Study||20
10355483|NCT00465972|11494684|FG001|STARTED|Overall Study||24
10355484|NCT00465972|11494683|FG000|COMPLETED|Overall Study||18
10355485|NCT00465972|11494684|FG001|COMPLETED|Overall Study||23
10355486|NCT00465972|11494683|FG000|NOT COMPLETED|Overall Study||2
10355487|NCT00465972|11494684|FG001|NOT COMPLETED|Overall Study||1
10355488|NCT00465985|11494692|FG000|STARTED|Part I - Open-label Treatment Period|All patients received treatment with ACZ885 in Part I of the study.|35
10355489|NCT00465985|11494693|FG001|STARTED|Part I - Open-label Treatment Period||0
10355490|NCT00465985|11494692|FG000|COMPLETED|Part I - Open-label Treatment Period|Only patients with a complete response completed Part I and entered Part II of the study.|31
10355491|NCT00465985|11494693|FG001|COMPLETED|Part I - Open-label Treatment Period||0
10355492|NCT00465985|11494692|FG000|NOT COMPLETED|Part I - Open-label Treatment Period||4
10355493|NCT00465985|11494693|FG001|NOT COMPLETED|Part I - Open-label Treatment Period||0
10355494|NCT00465985|11494692|FG000|STARTED|Part II - 1:1 ACZ885:Placebo|Patients with complete response to treatment entered Part II and were randomized to ACZ885 ,placebo.|15
10355495|NCT00465985|11494693|FG001|STARTED|Part II - 1:1 ACZ885:Placebo||16
10355496|NCT00465985|11494692|FG000|COMPLETED|Part II - 1:1 ACZ885:Placebo||15
10355497|NCT00465985|11494693|FG001|COMPLETED|Part II - 1:1 ACZ885:Placebo||4
10355498|NCT00465985|11494692|FG000|NOT COMPLETED|Part II - 1:1 ACZ885:Placebo||0
10355499|NCT00465985|11494693|FG001|NOT COMPLETED|Part II - 1:1 ACZ885:Placebo||12
10355500|NCT00465985|11494692|FG000|STARTED|Part III - Open-label Treatment Period|All patients received treatment with ACZ885 in Part III of the study.|31
10355501|NCT00465985|11494693|FG001|STARTED|Part III - Open-label Treatment Period||0
10355502|NCT00465985|11494692|FG000|COMPLETED|Part III - Open-label Treatment Period||29
10355503|NCT00465985|11494693|FG001|COMPLETED|Part III - Open-label Treatment Period||0
10355504|NCT00465985|11494692|FG000|NOT COMPLETED|Part III - Open-label Treatment Period||2
10355505|NCT00465985|11494693|FG001|NOT COMPLETED|Part III - Open-label Treatment Period||0
10355506|NCT00465998|11494702|FG000|STARTED|Overall Study||275
10355507|NCT00465998|11494702|FG000|COMPLETED|Overall Study||275
10355508|NCT00465998|11494702|FG000|NOT COMPLETED|Overall Study||0
10355509|NCT00466167|11494710|FG000|STARTED|Overall Study||165
10355510|NCT00466167|11494711|FG001|STARTED|Overall Study||175
10355511|NCT00466167|11494712|FG002|STARTED|Overall Study||178
10355512|NCT00466167|11494710|FG000|COMPLETED|Overall Study||145
10355513|NCT00466167|11494711|FG001|COMPLETED|Overall Study||163
10355514|NCT00466167|11494712|FG002|COMPLETED|Overall Study||157
10355515|NCT00466167|11494710|FG000|NOT COMPLETED|Overall Study||20
10355516|NCT00466167|11494711|FG001|NOT COMPLETED|Overall Study||12
10355517|NCT00466167|11494712|FG002|NOT COMPLETED|Overall Study||21
10355518|NCT00466193|11494722|FG000|STARTED|Overall Study||150
10355519|NCT00466193|11494723|FG001|STARTED|Overall Study||145
10355520|NCT00466193|11494722|FG000|COMPLETED|Overall Study||138
10355521|NCT00466193|11494723|FG001|COMPLETED|Overall Study|One patient did not report at least one Latency Sleep Onset following middle-of-the-night awakening.|137
10355522|NCT00466193|11494722|FG000|NOT COMPLETED|Overall Study||12
10355523|NCT00466193|11494723|FG001|NOT COMPLETED|Overall Study||8
10355524|NCT00466206|11494729|FG000|STARTED|Overall Study||10
10355525|NCT00466206|11494729|FG000|COMPLETED|Overall Study|One of 10 patients withdrawn from study but completed treatment under Compassionate Use Designation|10
10355526|NCT00466206|11494729|FG000|NOT COMPLETED|Overall Study||0
10355527|NCT00466310|11494739|FG000|STARTED|Overall Study||20
10355528|NCT00466310|11494740|FG001|STARTED|Overall Study||20
10355529|NCT00466310|11494741|FG002|STARTED|Overall Study||31
10355530|NCT00466310|11494739|FG000|COMPLETED|Overall Study||20
10355531|NCT00466310|11494740|FG001|COMPLETED|Overall Study||20
10355532|NCT00466310|11494741|FG002|COMPLETED|Overall Study||31
10355533|NCT00466310|11494739|FG000|NOT COMPLETED|Overall Study||0
10533756|NCT01426412|11685846|FG003|COMPLETED|Overall Study||6
10533757|NCT01426412|11685847|FG004|COMPLETED|Overall Study||5
10533758|NCT01426412|11685848|FG005|COMPLETED|Overall Study||6
10656140|NCT02214290|11817043|FG001|COMPLETED|First Intervention (7 Days)||8
10656141|NCT02214290|11817042|FG000|NOT COMPLETED|First Intervention (7 Days)||0
10656142|NCT02214290|11817043|FG001|NOT COMPLETED|First Intervention (7 Days)||0
10656143|NCT02214290|11817042|FG000|STARTED|Washout (14 Days)||8
10656144|NCT02214290|11817043|FG001|STARTED|Washout (14 Days)||8
10656145|NCT02214290|11817042|FG000|COMPLETED|Washout (14 Days)||8
10656146|NCT02214290|11817043|FG001|COMPLETED|Washout (14 Days)||8
10656147|NCT02214290|11817042|FG000|NOT COMPLETED|Washout (14 Days)||0
10656148|NCT02214290|11817043|FG001|NOT COMPLETED|Washout (14 Days)||0
10656149|NCT02214290|11817042|FG000|STARTED|Second Intervention (7 Days)||8
10656150|NCT02214290|11817043|FG001|STARTED|Second Intervention (7 Days)||8
10656151|NCT02214290|11817042|FG000|COMPLETED|Second Intervention (7 Days)||8
10656152|NCT02214290|11817043|FG001|COMPLETED|Second Intervention (7 Days)||8
10656153|NCT02214290|11817042|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
10656154|NCT02214290|11817043|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
10656155|NCT02214420|11817054|FG000|STARTED|Overall Study||14
10656156|NCT02214420|11817055|FG001|STARTED|Overall Study||10
10656157|NCT02214420|11817054|FG000|COMPLETED|Overall Study||13
10656158|NCT02214420|11817055|FG001|COMPLETED|Overall Study||10
10656159|NCT02214420|11817054|FG000|NOT COMPLETED|Overall Study||1
10656160|NCT02214420|11817055|FG001|NOT COMPLETED|Overall Study||0
10656161|NCT02214615|11817063|FG000|STARTED|First Intervention||1
10656162|NCT02214615|11817064|FG001|STARTED|First Intervention||1
10656163|NCT02214615|11817063|FG000|COMPLETED|First Intervention||1
10656164|NCT02214615|11817064|FG001|COMPLETED|First Intervention||1
10656165|NCT02214615|11817063|FG000|NOT COMPLETED|First Intervention||0
10656166|NCT02214615|11817064|FG001|NOT COMPLETED|First Intervention||0
10656167|NCT02214615|11817063|FG000|STARTED|Washout||1
10716101|NCT02688387|11880064|FG021|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
10716102|NCT02688387|11880043|FG000|STARTED|Part 3B, Period 2 (up to 6 Days)||0
10716103|NCT02688387|11880044|FG001|STARTED|Part 3B, Period 2 (up to 6 Days)||0
10656168|NCT02214615|11817064|FG001|STARTED|Washout||1
10656169|NCT02214615|11817063|FG000|COMPLETED|Washout||1
10656170|NCT02214615|11817064|FG001|COMPLETED|Washout||1
10656171|NCT02214615|11817063|FG000|NOT COMPLETED|Washout||0
10656172|NCT02214615|11817064|FG001|NOT COMPLETED|Washout||0
10656173|NCT02214615|11817063|FG000|STARTED|Second Intervention||1
10656174|NCT02214615|11817064|FG001|STARTED|Second Intervention||1
10656175|NCT02214615|11817063|FG000|COMPLETED|Second Intervention||1
10656176|NCT02214615|11817064|FG001|COMPLETED|Second Intervention||1
10656177|NCT02214615|11817063|FG000|NOT COMPLETED|Second Intervention||0
10656178|NCT02214615|11817064|FG001|NOT COMPLETED|Second Intervention||0
10656179|NCT02214628|11817072|FG000|STARTED|Overall Study||63
10656180|NCT02214628|11817073|FG001|STARTED|Overall Study||38
10716104|NCT02688387|11880045|FG002|STARTED|Part 3B, Period 2 (up to 6 Days)||0
10656181|NCT02214628|11817072|FG000|COMPLETED|Overall Study||36
10656182|NCT02214628|11817073|FG001|COMPLETED|Overall Study||9
10656183|NCT02214628|11817072|FG000|NOT COMPLETED|Overall Study||27
10656184|NCT02214628|11817073|FG001|NOT COMPLETED|Overall Study||29
10656185|NCT02215070|11817083|FG000|STARTED|Overall Study||26
10656186|NCT02215070|11817084|FG001|STARTED|Overall Study||52
10355534|NCT00466310|11494740|FG001|NOT COMPLETED|Overall Study||0
10355535|NCT00466310|11494741|FG002|NOT COMPLETED|Overall Study||0
10355536|NCT00466323|11494751|FG000|STARTED|Overall Study||117
10355537|NCT00466323|11494752|FG001|STARTED|Overall Study||115
10355538|NCT00466323|11494751|FG000|COMPLETED|Overall Study||89
10533759|NCT01426412|11685849|FG006|COMPLETED|Overall Study||6
10533760|NCT01426412|11685850|FG007|COMPLETED|Overall Study||7
10656187|NCT02215070|11817083|FG000|COMPLETED|Overall Study||20
10656188|NCT02215070|11817084|FG001|COMPLETED|Overall Study||52
10656189|NCT02215070|11817083|FG000|NOT COMPLETED|Overall Study||6
10355539|NCT00466323|11494752|FG001|COMPLETED|Overall Study||92
10355540|NCT00466323|11494751|FG000|NOT COMPLETED|Overall Study||28
10355541|NCT00466323|11494752|FG001|NOT COMPLETED|Overall Study||23
10355542|NCT00466440|11494761|FG000|STARTED|Overall Study||14
10355543|NCT00466440|11494762|FG001|STARTED|Overall Study||48
10355544|NCT00466440|11494763|FG002|STARTED|Overall Study||46
10355545|NCT00466440|11494761|FG000|Received at Least One Dose of Study Drug|Overall Study||14
10355546|NCT00466440|11494762|FG001|Received at Least One Dose of Study Drug|Overall Study||47
10355547|NCT00466440|11494763|FG002|Received at Least One Dose of Study Drug|Overall Study||41
10355548|NCT00466440|11494761|FG000|COMPLETED|Overall Study||0
10355549|NCT00466440|11494762|FG001|COMPLETED|Overall Study|Completed = completed 4 cycles of treatment|36
10355550|NCT00466440|11494763|FG002|COMPLETED|Overall Study|Completed = completed 4 cycles of treatment|34
10355551|NCT00466440|11494761|FG000|NOT COMPLETED|Overall Study||14
10355552|NCT00466440|11494762|FG001|NOT COMPLETED|Overall Study||12
10355553|NCT00466440|11494763|FG002|NOT COMPLETED|Overall Study||12
10355554|NCT00466505|11494780|FG000|STARTED|Overall Study||17
10355555|NCT00466505|11494780|FG000|COMPLETED|Overall Study||0
10355556|NCT00466505|11494780|FG000|NOT COMPLETED|Overall Study||17
10355557|NCT00466661|11494786|FG000|STARTED|Overall Study||16
10355558|NCT00466661|11494787|FG001|STARTED|Overall Study||17
10355559|NCT00466661|11494786|FG000|At Least 1 Postrandomization Visit|Overall Study||14
10355560|NCT00466661|11494787|FG001|At Least 1 Postrandomization Visit|Overall Study||16
10355561|NCT00466661|11494786|FG000|COMPLETED|Overall Study||12
10355562|NCT00466661|11494787|FG001|COMPLETED|Overall Study||11
10355563|NCT00466661|11494786|FG000|NOT COMPLETED|Overall Study||4
10355564|NCT00466661|11494787|FG001|NOT COMPLETED|Overall Study||6
10355565|NCT00466687|11494793|FG000|STARTED|Overall Study||34
10355566|NCT00466687|11494793|FG000|COMPLETED|Overall Study||0
10355567|NCT00466687|11494793|FG000|NOT COMPLETED|Overall Study||34
10355568|NCT00466726|11494799|FG000|STARTED|Overall Study||57
10355569|NCT00466726|11494799|FG000|COMPLETED|Overall Study||43
10355570|NCT00466726|11494799|FG000|NOT COMPLETED|Overall Study||14
10355571|NCT00466752|11494805|FG000|STARTED|Overall Study||5
10355572|NCT00466752|11494806|FG001|STARTED|Overall Study||0
10355573|NCT00466752|11494805|FG000|COMPLETED|Overall Study||5
10355574|NCT00466752|11494806|FG001|COMPLETED|Overall Study||0
10355575|NCT00466752|11494805|FG000|NOT COMPLETED|Overall Study||0
10355576|NCT00466752|11494806|FG001|NOT COMPLETED|Overall Study||0
10355577|NCT00466817|11494814|FG000|STARTED|Overall Study||49
10355578|NCT00466817|11494815|FG001|STARTED|Overall Study||47
10355579|NCT00466817|11494814|FG000|COMPLETED|Overall Study||44
10355580|NCT00466817|11494815|FG001|COMPLETED|Overall Study||43
10355581|NCT00466817|11494814|FG000|NOT COMPLETED|Overall Study||5
10355582|NCT00466817|11494815|FG001|NOT COMPLETED|Overall Study||4
10355583|NCT00466921|11494830|FG000|STARTED|First 3 Cycles of Treatment|One patient completed only a few days of treatment|33
10355584|NCT00466921|11494830|FG000|Completed 1 Cycle|First 3 Cycles of Treatment||32
10716105|NCT02688387|11880046|FG003|STARTED|Part 3B, Period 2 (up to 6 Days)||0
10716106|NCT02688387|11880047|FG004|STARTED|Part 3B, Period 2 (up to 6 Days)||0
10716107|NCT02688387|11880048|FG005|STARTED|Part 3B, Period 2 (up to 6 Days)||0
10716108|NCT02688387|11880049|FG006|STARTED|Part 3B, Period 2 (up to 6 Days)||0
10716109|NCT02688387|11880050|FG007|STARTED|Part 3B, Period 2 (up to 6 Days)||0
10716110|NCT02688387|11880051|FG008|STARTED|Part 3B, Period 2 (up to 6 Days)||0
10355585|NCT00466921|11494830|FG000|Started Cycle 2|First 3 Cycles of Treatment||31
10355586|NCT00466921|11494830|FG000|Completed 3 Cycles|First 3 Cycles of Treatment||26
10355587|NCT00466921|11494830|FG000|COMPLETED|First 3 Cycles of Treatment||26
10355588|NCT00466921|11494830|FG000|NOT COMPLETED|First 3 Cycles of Treatment||7
10355589|NCT00466921|11494830|FG000|STARTED|Completed 4 Cycles/Reached 1st Response||26
10355590|NCT00466921|11494830|FG000|Completed 4 Cycles/1st Response|Completed 4 Cycles/Reached 1st Response||21
10355591|NCT00466921|11494830|FG000|COMPLETED|Completed 4 Cycles/Reached 1st Response||21
10355592|NCT00466921|11494830|FG000|NOT COMPLETED|Completed 4 Cycles/Reached 1st Response||5
10355593|NCT00466921|11494830|FG000|STARTED|Continued Treatment||21
10355594|NCT00466921|11494830|FG000|COMPLETED|Continued Treatment||21
10355595|NCT00466921|11494830|FG000|NOT COMPLETED|Continued Treatment||0
10355596|NCT00466921|11494830|FG000|STARTED|Follow up for a Minimum of 1 Year||33
10355597|NCT00466921|11494830|FG000|COMPLETED|Follow up for a Minimum of 1 Year||27
10355598|NCT00466921|11494830|FG000|NOT COMPLETED|Follow up for a Minimum of 1 Year||6
10355599|NCT00466947|11494836|FG000|STARTED|Primary Outcome Analysis Period||11875
10355600|NCT00466947|11494837|FG001|STARTED|Primary Outcome Analysis Period||11863
10355601|NCT00466947|11494836|FG000|Ongoing|Primary Outcome Analysis Period||11875
10355602|NCT00466947|11494837|FG001|Ongoing|Primary Outcome Analysis Period||11863
10533761|NCT01426412|11685851|FG008|COMPLETED|Overall Study||16
10533762|NCT01426412|11685843|FG000|NOT COMPLETED|Overall Study||1
10533763|NCT01426412|11685844|FG001|NOT COMPLETED|Overall Study||0
10716111|NCT02688387|11880052|FG009|STARTED|Part 3B, Period 2 (up to 6 Days)||0
10716112|NCT02688387|11880053|FG010|STARTED|Part 3B, Period 2 (up to 6 Days)||0
10716113|NCT02688387|11880054|FG011|STARTED|Part 3B, Period 2 (up to 6 Days)||0
10716114|NCT02688387|11880055|FG012|STARTED|Part 3B, Period 2 (up to 6 Days)||0
10716115|NCT02688387|11880056|FG013|STARTED|Part 3B, Period 2 (up to 6 Days)||0
10716116|NCT02688387|11880057|FG014|STARTED|Part 3B, Period 2 (up to 6 Days)||0
10305942|NCT00095940|11438873|FG007|NOT COMPLETED|Lapatinib Continuation/Phase II||2
10305943|NCT00095940|11438874|FG008|NOT COMPLETED|Lapatinib Continuation/Phase II||13
10315229|NCT00176462|11449059|FG000|STARTED|Consolidation (12 Weeks)||20
10315230|NCT00176462|11449060|FG001|STARTED|Consolidation (12 Weeks)||34
10315231|NCT00176462|11449059|FG000|COMPLETED|Consolidation (12 Weeks)||20
10315232|NCT00176462|11449060|FG001|COMPLETED|Consolidation (12 Weeks)||29
10315233|NCT00176462|11449059|FG000|NOT COMPLETED|Consolidation (12 Weeks)||0
10315234|NCT00176462|11449060|FG001|NOT COMPLETED|Consolidation (12 Weeks)||5
10315235|NCT00176462|11449059|FG000|STARTED|Delayed Intensification (8 Weeks)||20
10315236|NCT00176462|11449060|FG001|STARTED|Delayed Intensification (8 Weeks)||29
10315237|NCT00176462|11449059|FG000|COMPLETED|Delayed Intensification (8 Weeks)||20
10315238|NCT00176462|11449060|FG001|COMPLETED|Delayed Intensification (8 Weeks)||29
10315239|NCT00176462|11449059|FG000|NOT COMPLETED|Delayed Intensification (8 Weeks)||0
10315240|NCT00176462|11449060|FG001|NOT COMPLETED|Delayed Intensification (8 Weeks)||0
10315241|NCT00176462|11449059|FG000|STARTED|Intensive Continuation (8X8-week Cycles)||20
10315242|NCT00176462|11449060|FG001|STARTED|Intensive Continuation (8X8-week Cycles)||29
10315243|NCT00176462|11449059|FG000|COMPLETED|Intensive Continuation (8X8-week Cycles)||19
10315244|NCT00176462|11449060|FG001|COMPLETED|Intensive Continuation (8X8-week Cycles)||26
10315245|NCT00176462|11449059|FG000|NOT COMPLETED|Intensive Continuation (8X8-week Cycles)||1
10315246|NCT00176462|11449060|FG001|NOT COMPLETED|Intensive Continuation (8X8-week Cycles)||3
10315247|NCT00176462|11449059|FG000|STARTED|Continuation -up to 30mos Post Remission||19
10315248|NCT00176462|11449060|FG001|STARTED|Continuation -up to 30mos Post Remission||26
10315249|NCT00176462|11449059|FG000|COMPLETED|Continuation -up to 30mos Post Remission||19
10315250|NCT00176462|11449060|FG001|COMPLETED|Continuation -up to 30mos Post Remission||26
10315251|NCT00176462|11449059|FG000|NOT COMPLETED|Continuation -up to 30mos Post Remission||0
10315252|NCT00176462|11449060|FG001|NOT COMPLETED|Continuation -up to 30mos Post Remission||0
10315253|NCT00176592|11449069|FG000|STARTED|Overall Study||36
10315254|NCT00176592|11449070|FG001|STARTED|Overall Study||39
10315255|NCT00176592|11449069|FG000|Followed for 1 Year|Overall Study||35
10315256|NCT00176592|11449070|FG001|Followed for 1 Year|Overall Study||35
10315257|NCT00176592|11449069|FG000|Followed for 2 Years|Overall Study||29
10315258|NCT00176592|11449070|FG001|Followed for 2 Years|Overall Study||35
10315259|NCT00176592|11449069|FG000|COMPLETED|Overall Study||36
10315260|NCT00176592|11449070|FG001|COMPLETED|Overall Study||39
10315261|NCT00176592|11449069|FG000|NOT COMPLETED|Overall Study||0
10315262|NCT00176592|11449070|FG001|NOT COMPLETED|Overall Study||0
10315263|NCT00176605|11449076|FG000|STARTED|Overall Study||15
10315264|NCT00176605|11449076|FG000|COMPLETED|Overall Study||13
10315265|NCT00176605|11449076|FG000|NOT COMPLETED|Overall Study||2
10315266|NCT00176644|11449080|FG000|STARTED|Overall Study||23
10315267|NCT00176644|11449080|FG000|COMPLETED|Overall Study||22
10315268|NCT00176644|11449080|FG000|NOT COMPLETED|Overall Study||1
10315269|NCT00176800|11449084|FG000|STARTED|Overall Study||69
10315270|NCT00176800|11449084|FG000|COMPLETED|Overall Study||69
10315271|NCT00176800|11449084|FG000|NOT COMPLETED|Overall Study||0
10315272|NCT00176826|11449088|FG000|STARTED|Overall Study||22
10315273|NCT00176826|11449088|FG000|COMPLETED|Overall Study||22
10315274|NCT00176826|11449088|FG000|NOT COMPLETED|Overall Study||0
10315275|NCT00176839|11449092|FG000|STARTED|Overall Study||11
10315276|NCT00176839|11449092|FG000|COMPLETED|Overall Study||11
10315277|NCT00176839|11449092|FG000|NOT COMPLETED|Overall Study||0
10315278|NCT00176852|11449099|FG000|STARTED|Overall Study||3
10315279|NCT00176852|11449100|FG001|STARTED|Overall Study||5
10315280|NCT00176852|11449101|FG002|STARTED|Overall Study||14
10315281|NCT00176852|11449099|FG000|COMPLETED|Overall Study||3
10315282|NCT00176852|11449100|FG001|COMPLETED|Overall Study||5
10315283|NCT00176852|11449101|FG002|COMPLETED|Overall Study||14
10315284|NCT00176852|11449099|FG000|NOT COMPLETED|Overall Study||0
10315285|NCT00176852|11449100|FG001|NOT COMPLETED|Overall Study||0
10315286|NCT00176852|11449101|FG002|NOT COMPLETED|Overall Study||0
10315287|NCT00176865|11449112|FG000|STARTED|Overall Study||3
10315288|NCT00176865|11449113|FG001|STARTED|Overall Study||10
10315289|NCT00176865|11449114|FG002|STARTED|Overall Study||6
10315290|NCT00176865|11449112|FG000|COMPLETED|Overall Study||3
10315291|NCT00176865|11449113|FG001|COMPLETED|Overall Study||10
10812523|NCT03580382|11974600|FG000|COMPLETED|Overall Study||0
10812524|NCT03580382|11974601|FG001|COMPLETED|Overall Study||0
10812525|NCT03580382|11974600|FG000|NOT COMPLETED|Overall Study||0
10355603|NCT00466947|11494836|FG000|COMPLETED|Primary Outcome Analysis Period|No data on study completion and withdrawal were available at first analysis as the study was ongoing|0
10355604|NCT00466947|11494837|FG001|COMPLETED|Primary Outcome Analysis Period|No data on study completion and withdrawal were available at first analysis as the study was ongoing|0
10355605|NCT00466947|11494836|FG000|NOT COMPLETED|Primary Outcome Analysis Period||11875
10355606|NCT00466947|11494837|FG001|NOT COMPLETED|Primary Outcome Analysis Period||11863
10355607|NCT00466947|11494836|FG000|STARTED|Study End Analysis Period||11798
10355608|NCT00466947|11494837|FG001|STARTED|Study End Analysis Period||11799
10355609|NCT00466947|11494836|FG000|COMPLETED|Study End Analysis Period||9302
10355610|NCT00466947|11494837|FG001|COMPLETED|Study End Analysis Period||9265
10355611|NCT00466947|11494836|FG000|NOT COMPLETED|Study End Analysis Period||2496
10355612|NCT00466947|11494837|FG001|NOT COMPLETED|Study End Analysis Period||2534
10355613|NCT00466960|11494844|FG000|STARTED|Overall Study||21
10355614|NCT00466960|11494844|FG000|COMPLETED|Overall Study||21
10355615|NCT00466960|11494844|FG000|NOT COMPLETED|Overall Study||0
10355616|NCT00467038|11494850|FG000|STARTED|Overall Study||11
10355617|NCT00467038|11494851|FG001|STARTED|Overall Study||11
10355618|NCT00467038|11494850|FG000|COMPLETED|Overall Study||11
10355619|NCT00467038|11494851|FG001|COMPLETED|Overall Study||11
10355620|NCT00467038|11494850|FG000|NOT COMPLETED|Overall Study||0
10355621|NCT00467038|11494851|FG001|NOT COMPLETED|Overall Study||0
10355622|NCT00467051|11494858|FG000|STARTED|Overall Study||20
10355623|NCT00467051|11494858|FG000|COMPLETED|Overall Study||18
10355624|NCT00467051|11494858|FG000|NOT COMPLETED|Overall Study||2
10355625|NCT00467077|11494863|FG000|STARTED|Overall Study||21
10355626|NCT00467077|11494863|FG000|COMPLETED|Overall Study||21
10355627|NCT00467077|11494863|FG000|NOT COMPLETED|Overall Study||0
10355628|NCT00467259|11494869|FG000|STARTED|Overall Study||251
10355629|NCT00467259|11494870|FG001|STARTED|Overall Study||1020
10355630|NCT00467259|11494869|FG000|ITT Population|Overall Study||251
10355631|NCT00467259|11494870|FG001|ITT Population|Overall Study|One subject did not take any study medication and was excluded from ITT population.|1019
10355632|NCT00467259|11494869|FG000|COMPLETED|Overall Study||176
10355633|NCT00467259|11494870|FG001|COMPLETED|Overall Study||778
10355634|NCT00467259|11494869|FG000|NOT COMPLETED|Overall Study||75
10355635|NCT00467259|11494870|FG001|NOT COMPLETED|Overall Study||242
10355636|NCT00467272|11494876|FG000|STARTED|Overall Study||41
10355637|NCT00467272|11494876|FG000|COMPLETED|Overall Study||38
10355638|NCT00467272|11494876|FG000|NOT COMPLETED|Overall Study||3
10355639|NCT00467285|11494882|FG000|STARTED|Overall Study||32
10355640|NCT00467285|11494883|FG001|STARTED|Overall Study||64
10355641|NCT00467285|11494882|FG000|COMPLETED|Overall Study||28
10355642|NCT00467285|11494883|FG001|COMPLETED|Overall Study||60
10355643|NCT00467285|11494882|FG000|NOT COMPLETED|Overall Study||4
10355644|NCT00467285|11494883|FG001|NOT COMPLETED|Overall Study||4
10355645|NCT00467298|11494893|FG000|STARTED|Overall Study||46
10355646|NCT00467298|11494894|FG001|STARTED|Overall Study||44
10355647|NCT00467298|11494893|FG000|COMPLETED|Overall Study||42
10355648|NCT00467298|11494894|FG001|COMPLETED|Overall Study||38
10355649|NCT00467298|11494893|FG000|NOT COMPLETED|Overall Study||4
10355650|NCT00467298|11494894|FG001|NOT COMPLETED|Overall Study||6
10355651|NCT00467350|11494902|FG000|STARTED|Overall Study||41
10355652|NCT00467350|11494903|FG001|STARTED|Overall Study||39
10355653|NCT00467350|11494902|FG000|COMPLETED|Overall Study||40
10355654|NCT00467350|11494903|FG001|COMPLETED|Overall Study||39
10355655|NCT00467350|11494902|FG000|NOT COMPLETED|Overall Study||1
10355656|NCT00467350|11494903|FG001|NOT COMPLETED|Overall Study||0
10355657|NCT00467363|11494911|FG000|STARTED|Overall Study||615
10355658|NCT00467363|11494912|FG001|STARTED|Overall Study||613
10355659|NCT00467363|11494911|FG000|COMPLETED|Overall Study||535
10355660|NCT00467363|11494912|FG001|COMPLETED|Overall Study||543
10355661|NCT00467363|11494911|FG000|NOT COMPLETED|Overall Study||80
10355662|NCT00467363|11494912|FG001|NOT COMPLETED|Overall Study||70
10355663|NCT00467389|11494918|FG000|STARTED|Overall Study||6
10355664|NCT00467389|11494919|FG001|STARTED|Overall Study||6
10355665|NCT00467389|11494918|FG000|COMPLETED|Overall Study||6
10355666|NCT00467389|11494919|FG001|COMPLETED|Overall Study||6
10355667|NCT00467389|11494918|FG000|NOT COMPLETED|Overall Study||0
10355668|NCT00467389|11494919|FG001|NOT COMPLETED|Overall Study||0
10355669|NCT00467519|11494927|FG000|STARTED|Overall Study||531
10355670|NCT00467519|11494928|FG001|STARTED|Overall Study||511
10355671|NCT00467519|11494927|FG000|COMPLETED|Overall Study||517
10355672|NCT00467519|11494928|FG001|COMPLETED|Overall Study||488
10355673|NCT00467519|11494927|FG000|NOT COMPLETED|Overall Study||14
10355674|NCT00467519|11494928|FG001|NOT COMPLETED|Overall Study||23
10355675|NCT00467558|11494936|FG000|STARTED|Overall Study||4
10355676|NCT00467558|11494937|FG001|STARTED|Overall Study||3
10355677|NCT00467558|11494936|FG000|COMPLETED|Overall Study||2
10355678|NCT00467558|11494937|FG001|COMPLETED|Overall Study||3
10355679|NCT00467558|11494936|FG000|NOT COMPLETED|Overall Study||2
10355680|NCT00467558|11494937|FG001|NOT COMPLETED|Overall Study||0
10533764|NCT01426412|11685845|FG002|NOT COMPLETED|Overall Study||0
10533765|NCT01426412|11685846|FG003|NOT COMPLETED|Overall Study||0
10355681|NCT00467584|11494946|FG000|STARTED|Overall Study||21
10355682|NCT00467584|11494947|FG001|STARTED|Overall Study||20
10355683|NCT00467584|11494948|FG002|STARTED|Overall Study||21
10355684|NCT00467584|11494946|FG000|COMPLETED|Overall Study||17
10355685|NCT00467584|11494947|FG001|COMPLETED|Overall Study||15
10355686|NCT00467584|11494948|FG002|COMPLETED|Overall Study||20
10355687|NCT00467584|11494946|FG000|NOT COMPLETED|Overall Study||4
10355688|NCT00467584|11494947|FG001|NOT COMPLETED|Overall Study||5
10355689|NCT00467584|11494948|FG002|NOT COMPLETED|Overall Study||1
10355690|NCT00467597|11494960|FG000|STARTED|Overall Study||26
10355691|NCT00467597|11494961|FG001|STARTED|Overall Study||6
10355692|NCT00467597|11494960|FG000|COMPLETED|Overall Study||24
10355693|NCT00467597|11494961|FG001|COMPLETED|Overall Study||6
10355694|NCT00467597|11494960|FG000|NOT COMPLETED|Overall Study||2
10355695|NCT00467597|11494961|FG001|NOT COMPLETED|Overall Study||0
10355696|NCT00467610|11494971|FG000|STARTED|Overall Study||6
10355697|NCT00467610|11494971|FG000|COMPLETED|Overall Study||5
10355698|NCT00467610|11494971|FG000|NOT COMPLETED|Overall Study||1
10355699|NCT00467649|11494977|FG000|STARTED|Phase 1 (Randomized Population)|One patient randomized to the SYMLIN group withdrew consent prior to receiving the first dose|57
10355700|NCT00467649|11494978|FG001|STARTED|Phase 1 (Randomized Population)||56
10355701|NCT00467649|11494979|FG002|STARTED|Phase 1 (Randomized Population)||0
10355702|NCT00467649|11494980|FG003|STARTED|Phase 1 (Randomized Population)||0
10355703|NCT00467649|11494981|FG004|STARTED|Phase 1 (Randomized Population)||0
10355704|NCT00467649|11494982|FG005|STARTED|Phase 1 (Randomized Population)||0
10355705|NCT00467649|11494977|FG000|Intent to Treat|Phase 1 (Randomized Population)||56
10355706|NCT00467649|11494978|FG001|Intent to Treat|Phase 1 (Randomized Population)||56
10355707|NCT00467649|11494979|FG002|Intent to Treat|Phase 1 (Randomized Population)||0
10355708|NCT00467649|11494980|FG003|Intent to Treat|Phase 1 (Randomized Population)||0
10355709|NCT00467649|11494981|FG004|Intent to Treat|Phase 1 (Randomized Population)||0
10355710|NCT00467649|11494982|FG005|Intent to Treat|Phase 1 (Randomized Population)||0
10355711|NCT00467649|11494977|FG000|COMPLETED|Phase 1 (Randomized Population)||48
10355712|NCT00467649|11494978|FG001|COMPLETED|Phase 1 (Randomized Population)||50
10355713|NCT00467649|11494979|FG002|COMPLETED|Phase 1 (Randomized Population)||0
10355714|NCT00467649|11494980|FG003|COMPLETED|Phase 1 (Randomized Population)||0
10355715|NCT00467649|11494981|FG004|COMPLETED|Phase 1 (Randomized Population)||0
10355716|NCT00467649|11494982|FG005|COMPLETED|Phase 1 (Randomized Population)||0
10355717|NCT00467649|11494977|FG000|NOT COMPLETED|Phase 1 (Randomized Population)||9
10355718|NCT00467649|11494978|FG001|NOT COMPLETED|Phase 1 (Randomized Population)||6
10355719|NCT00467649|11494979|FG002|NOT COMPLETED|Phase 1 (Randomized Population)||0
10355720|NCT00467649|11494980|FG003|NOT COMPLETED|Phase 1 (Randomized Population)||0
10355721|NCT00467649|11494981|FG004|NOT COMPLETED|Phase 1 (Randomized Population)||0
10355722|NCT00467649|11494982|FG005|NOT COMPLETED|Phase 1 (Randomized Population)||0
10355723|NCT00467649|11494977|FG000|STARTED|Phase 2 (Intent-to-Treat Population)||0
10355724|NCT00467649|11494978|FG001|STARTED|Phase 2 (Intent-to-Treat Population)||0
10355725|NCT00467649|11494979|FG002|STARTED|Phase 2 (Intent-to-Treat Population)||17
10355726|NCT00467649|11494980|FG003|STARTED|Phase 2 (Intent-to-Treat Population)||31
10355727|NCT00467649|11494981|FG004|STARTED|Phase 2 (Intent-to-Treat Population)||14
10355728|NCT00467649|11494982|FG005|STARTED|Phase 2 (Intent-to-Treat Population)||36
10355729|NCT00467649|11494977|FG000|COMPLETED|Phase 2 (Intent-to-Treat Population)||0
10355730|NCT00467649|11494978|FG001|COMPLETED|Phase 2 (Intent-to-Treat Population)||0
10355731|NCT00467649|11494979|FG002|COMPLETED|Phase 2 (Intent-to-Treat Population)||17
10355732|NCT00467649|11494980|FG003|COMPLETED|Phase 2 (Intent-to-Treat Population)||29
10355733|NCT00467649|11494981|FG004|COMPLETED|Phase 2 (Intent-to-Treat Population)||14
10355734|NCT00467649|11494982|FG005|COMPLETED|Phase 2 (Intent-to-Treat Population)||35
10355735|NCT00467649|11494977|FG000|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
10355736|NCT00467649|11494978|FG001|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
10355737|NCT00467649|11494979|FG002|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
10355738|NCT00467649|11494980|FG003|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||2
10355739|NCT00467649|11494981|FG004|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
10355740|NCT00467649|11494982|FG005|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||1
10355741|NCT00467740|11495005|FG000|STARTED|Overall Study||54
10355742|NCT00467740|11495006|FG001|STARTED|Overall Study||61
10355743|NCT00467740|11495007|FG002|STARTED|Overall Study||60
10355744|NCT00467740|11495008|FG003|STARTED|Overall Study||60
10355745|NCT00467740|11495009|FG004|STARTED|Overall Study||61
10355746|NCT00467740|11495005|FG000|COMPLETED|Overall Study||53
10355747|NCT00467740|11495006|FG001|COMPLETED|Overall Study||58
10355748|NCT00467740|11495007|FG002|COMPLETED|Overall Study||58
10355749|NCT00467740|11495008|FG003|COMPLETED|Overall Study||59
10355750|NCT00467740|11495009|FG004|COMPLETED|Overall Study||61
10355751|NCT00467740|11495005|FG000|NOT COMPLETED|Overall Study||1
10355752|NCT00467740|11495006|FG001|NOT COMPLETED|Overall Study||3
10355753|NCT00467740|11495007|FG002|NOT COMPLETED|Overall Study||2
10355754|NCT00467740|11495008|FG003|NOT COMPLETED|Overall Study||1
10355755|NCT00467740|11495009|FG004|NOT COMPLETED|Overall Study||0
10355756|NCT00467779|11495036|FG000|STARTED|Stage 1||4
10656190|NCT02215070|11817084|FG001|NOT COMPLETED|Overall Study||0
10656191|NCT02215161|11817090|FG000|STARTED|Overall Study||14
10656192|NCT02215161|11817090|FG000|COMPLETED|Overall Study||14
10656193|NCT02215161|11817090|FG000|NOT COMPLETED|Overall Study||0
10656194|NCT02215200|11817105|FG000|STARTED|Overall Study||29
10656195|NCT02215200|11817106|FG001|STARTED|Overall Study||29
10355757|NCT00467779|11495037|FG001|STARTED|Stage 1||3
10656196|NCT02215200|11817107|FG002|STARTED|Overall Study||31
10656197|NCT02215200|11817105|FG000|COMPLETED|Overall Study||29
10656198|NCT02215200|11817106|FG001|COMPLETED|Overall Study||28
10656199|NCT02215200|11817107|FG002|COMPLETED|Overall Study||30
10355758|NCT00467779|11495038|FG002|STARTED|Stage 1||3
10355759|NCT00467779|11495039|FG003|STARTED|Stage 1||3
10355760|NCT00467779|11495040|FG004|STARTED|Stage 1||3
10355761|NCT00467779|11495041|FG005|STARTED|Stage 1||6
10355762|NCT00467779|11495042|FG006|STARTED|Stage 1||7
10355763|NCT00467779|11495043|FG007|STARTED|Stage 1||7
10355764|NCT00467779|11495044|FG008|STARTED|Stage 1||0
10355765|NCT00467779|11495045|FG009|STARTED|Stage 1||0
10355766|NCT00467779|11495046|FG010|STARTED|Stage 1||0
10355767|NCT00467779|11495047|FG011|STARTED|Stage 1||0
10355768|NCT00467779|11495048|FG012|STARTED|Stage 1||0
10355769|NCT00467779|11495049|FG013|STARTED|Stage 1||0
10355770|NCT00467779|11495050|FG014|STARTED|Stage 1||0
10355771|NCT00467779|11495036|FG000|COMPLETED|Stage 1||0
10355772|NCT00467779|11495037|FG001|COMPLETED|Stage 1||0
10355773|NCT00467779|11495038|FG002|COMPLETED|Stage 1||0
10355774|NCT00467779|11495039|FG003|COMPLETED|Stage 1||0
10355775|NCT00467779|11495040|FG004|COMPLETED|Stage 1||0
10355776|NCT00467779|11495041|FG005|COMPLETED|Stage 1||1
10355777|NCT00467779|11495042|FG006|COMPLETED|Stage 1||0
10355778|NCT00467779|11495043|FG007|COMPLETED|Stage 1||0
10355779|NCT00467779|11495044|FG008|COMPLETED|Stage 1||0
10355780|NCT00467779|11495045|FG009|COMPLETED|Stage 1||0
10355781|NCT00467779|11495046|FG010|COMPLETED|Stage 1||0
10355782|NCT00467779|11495047|FG011|COMPLETED|Stage 1||0
10355783|NCT00467779|11495048|FG012|COMPLETED|Stage 1||0
10355784|NCT00467779|11495049|FG013|COMPLETED|Stage 1||0
10355785|NCT00467779|11495050|FG014|COMPLETED|Stage 1||0
10355786|NCT00467779|11495036|FG000|NOT COMPLETED|Stage 1||4
10355787|NCT00467779|11495037|FG001|NOT COMPLETED|Stage 1||3
10355788|NCT00467779|11495038|FG002|NOT COMPLETED|Stage 1||3
10355789|NCT00467779|11495039|FG003|NOT COMPLETED|Stage 1||3
10355790|NCT00467779|11495040|FG004|NOT COMPLETED|Stage 1||3
10355791|NCT00467779|11495041|FG005|NOT COMPLETED|Stage 1||5
10355792|NCT00467779|11495042|FG006|NOT COMPLETED|Stage 1||7
10656200|NCT02215200|11817105|FG000|NOT COMPLETED|Overall Study||0
10656201|NCT02215200|11817106|FG001|NOT COMPLETED|Overall Study||1
10355793|NCT00467779|11495043|FG007|NOT COMPLETED|Stage 1||7
10355794|NCT00467779|11495044|FG008|NOT COMPLETED|Stage 1||0
10355795|NCT00467779|11495045|FG009|NOT COMPLETED|Stage 1||0
10355796|NCT00467779|11495046|FG010|NOT COMPLETED|Stage 1||0
10355797|NCT00467779|11495047|FG011|NOT COMPLETED|Stage 1||0
10355798|NCT00467779|11495048|FG012|NOT COMPLETED|Stage 1||0
10355799|NCT00467779|11495049|FG013|NOT COMPLETED|Stage 1||0
10355800|NCT00467779|11495050|FG014|NOT COMPLETED|Stage 1||0
10355801|NCT00467779|11495036|FG000|STARTED|Stage 1A||0
10355802|NCT00467779|11495037|FG001|STARTED|Stage 1A||0
10355803|NCT00467779|11495038|FG002|STARTED|Stage 1A||0
10355804|NCT00467779|11495039|FG003|STARTED|Stage 1A||0
10355805|NCT00467779|11495040|FG004|STARTED|Stage 1A||0
10355806|NCT00467779|11495041|FG005|STARTED|Stage 1A||0
10355807|NCT00467779|11495042|FG006|STARTED|Stage 1A||0
10355808|NCT00467779|11495043|FG007|STARTED|Stage 1A||0
10355809|NCT00467779|11495044|FG008|STARTED|Stage 1A||0
10355810|NCT00467779|11495045|FG009|STARTED|Stage 1A||3
10355811|NCT00467779|11495046|FG010|STARTED|Stage 1A||3
10355812|NCT00467779|11495047|FG011|STARTED|Stage 1A||8
10355813|NCT00467779|11495048|FG012|STARTED|Stage 1A||6
10355814|NCT00467779|11495049|FG013|STARTED|Stage 1A||0
10355815|NCT00467779|11495050|FG014|STARTED|Stage 1A||0
10656202|NCT02215200|11817107|FG002|NOT COMPLETED|Overall Study||1
10355816|NCT00467779|11495036|FG000|COMPLETED|Stage 1A||0
10355817|NCT00467779|11495037|FG001|COMPLETED|Stage 1A||0
10355818|NCT00467779|11495038|FG002|COMPLETED|Stage 1A||0
10355819|NCT00467779|11495039|FG003|COMPLETED|Stage 1A||0
10355820|NCT00467779|11495040|FG004|COMPLETED|Stage 1A||0
10355821|NCT00467779|11495041|FG005|COMPLETED|Stage 1A||0
10355822|NCT00467779|11495042|FG006|COMPLETED|Stage 1A||0
10355823|NCT00467779|11495043|FG007|COMPLETED|Stage 1A||0
10355824|NCT00467779|11495044|FG008|COMPLETED|Stage 1A||0
10355825|NCT00467779|11495045|FG009|COMPLETED|Stage 1A||0
10355826|NCT00467779|11495046|FG010|COMPLETED|Stage 1A||0
10355827|NCT00467779|11495047|FG011|COMPLETED|Stage 1A||0
10355828|NCT00467779|11495048|FG012|COMPLETED|Stage 1A||0
10355829|NCT00467779|11495049|FG013|COMPLETED|Stage 1A||0
10355830|NCT00467779|11495050|FG014|COMPLETED|Stage 1A||0
10355831|NCT00467779|11495036|FG000|NOT COMPLETED|Stage 1A||0
10355832|NCT00467779|11495037|FG001|NOT COMPLETED|Stage 1A||0
10355833|NCT00467779|11495038|FG002|NOT COMPLETED|Stage 1A||0
10355834|NCT00467779|11495039|FG003|NOT COMPLETED|Stage 1A||0
10355835|NCT00467779|11495040|FG004|NOT COMPLETED|Stage 1A||0
10355836|NCT00467779|11495041|FG005|NOT COMPLETED|Stage 1A||0
10355837|NCT00467779|11495042|FG006|NOT COMPLETED|Stage 1A||0
10716117|NCT02688387|11880058|FG015|STARTED|Part 3B, Period 2 (up to 6 Days)||0
10716118|NCT02688387|11880059|FG016|STARTED|Part 3B, Period 2 (up to 6 Days)||0
10716119|NCT02688387|11880060|FG017|STARTED|Part 3B, Period 2 (up to 6 Days)||0
10716120|NCT02688387|11880061|FG018|STARTED|Part 3B, Period 2 (up to 6 Days)||8
10716121|NCT02688387|11880062|FG019|STARTED|Part 3B, Period 2 (up to 6 Days)||8
10355838|NCT00467779|11495043|FG007|NOT COMPLETED|Stage 1A||0
10355839|NCT00467779|11495044|FG008|NOT COMPLETED|Stage 1A||0
10355840|NCT00467779|11495045|FG009|NOT COMPLETED|Stage 1A||3
10355841|NCT00467779|11495046|FG010|NOT COMPLETED|Stage 1A||3
10355842|NCT00467779|11495047|FG011|NOT COMPLETED|Stage 1A||8
10355843|NCT00467779|11495048|FG012|NOT COMPLETED|Stage 1A||6
10355844|NCT00467779|11495049|FG013|NOT COMPLETED|Stage 1A||0
10355845|NCT00467779|11495050|FG014|NOT COMPLETED|Stage 1A||0
10355846|NCT00467779|11495036|FG000|STARTED|Stage 2||0
10355847|NCT00467779|11495037|FG001|STARTED|Stage 2||0
10355848|NCT00467779|11495038|FG002|STARTED|Stage 2||0
10355849|NCT00467779|11495039|FG003|STARTED|Stage 2||0
10355850|NCT00467779|11495040|FG004|STARTED|Stage 2||0
10355851|NCT00467779|11495041|FG005|STARTED|Stage 2||0
10355852|NCT00467779|11495042|FG006|STARTED|Stage 2||0
10355853|NCT00467779|11495043|FG007|STARTED|Stage 2||0
10355854|NCT00467779|11495044|FG008|STARTED|Stage 2||21
10355855|NCT00467779|11495045|FG009|STARTED|Stage 2||0
10355856|NCT00467779|11495046|FG010|STARTED|Stage 2||0
10355857|NCT00467779|11495047|FG011|STARTED|Stage 2||0
10355858|NCT00467779|11495048|FG012|STARTED|Stage 2||0
10355859|NCT00467779|11495049|FG013|STARTED|Stage 2||0
10355860|NCT00467779|11495050|FG014|STARTED|Stage 2||0
10355861|NCT00467779|11495036|FG000|COMPLETED|Stage 2||0
10533766|NCT01426412|11685847|FG004|NOT COMPLETED|Overall Study||1
10533767|NCT01426412|11685848|FG005|NOT COMPLETED|Overall Study||0
10533768|NCT01426412|11685849|FG006|NOT COMPLETED|Overall Study||0
10533769|NCT01426412|11685850|FG007|NOT COMPLETED|Overall Study||3
10533770|NCT01426412|11685851|FG008|NOT COMPLETED|Overall Study||1
10533771|NCT01426425|11685882|FG000|STARTED|Overall Study||572
10533772|NCT01426425|11685882|FG000|EP Study|Overall Study|EP study used to assess inclusion and exclusion criteria.|550
10533773|NCT01426425|11685882|FG000|Intent to Treat|Overall Study|Met all inclusion and no exclusion criteria.|399
10533774|NCT01426425|11685882|FG000|COMPLETED|Overall Study|The pre-specified modified intent-to-treat analysis set was used for the primary objectives.|397
10533775|NCT01426425|11685882|FG000|NOT COMPLETED|Overall Study||175
10533776|NCT01426438|11685889|FG000|STARTED|Overall Study||50
10533777|NCT01426438|11685890|FG001|STARTED|Overall Study||49
10533778|NCT01426438|11685889|FG000|COMPLETED|Overall Study||35
10533779|NCT01426438|11685890|FG001|COMPLETED|Overall Study||39
10533780|NCT01426438|11685889|FG000|NOT COMPLETED|Overall Study||15
10533781|NCT01426438|11685890|FG001|NOT COMPLETED|Overall Study||10
10533782|NCT01426581|11685898|FG000|STARTED|Overall Study||62
10533783|NCT01426581|11685899|FG001|STARTED|Overall Study||58
10533784|NCT01426581|11685898|FG000|COMPLETED|Overall Study||62
10533785|NCT01426581|11685899|FG001|COMPLETED|Overall Study||58
10533786|NCT01426581|11685898|FG000|NOT COMPLETED|Overall Study||0
10533787|NCT01426581|11685899|FG001|NOT COMPLETED|Overall Study||0
10533788|NCT01426763|11685909|FG000|STARTED|Overall Study||6
10533789|NCT01426763|11685910|FG001|STARTED|Overall Study||6
10533790|NCT01426763|11685909|FG000|COMPLETED|Overall Study||6
10533791|NCT01426763|11685910|FG001|COMPLETED|Overall Study||6
10533792|NCT01426763|11685909|FG000|NOT COMPLETED|Overall Study||0
10533793|NCT01426763|11685910|FG001|NOT COMPLETED|Overall Study||0
10533794|NCT01426789|11685920|FG000|STARTED|Part 1||68
10533795|NCT01426789|11685921|FG001|STARTED|Part 1||32
10533796|NCT01426789|11685922|FG002|STARTED|Part 1||0
10533797|NCT01426789|11685923|FG003|STARTED|Part 1||0
10533798|NCT01426789|11685924|FG004|STARTED|Part 1||0
10533799|NCT01426789|11685925|FG005|STARTED|Part 1||0
10533800|NCT01426789|11685920|FG000|COMPLETED|Part 1||62
10533801|NCT01426789|11685921|FG001|COMPLETED|Part 1||28
10533802|NCT01426789|11685922|FG002|COMPLETED|Part 1||0
10533803|NCT01426789|11685923|FG003|COMPLETED|Part 1||0
10533804|NCT01426789|11685924|FG004|COMPLETED|Part 1||0
10533805|NCT01426789|11685925|FG005|COMPLETED|Part 1||0
10533806|NCT01426789|11685920|FG000|NOT COMPLETED|Part 1||6
10533807|NCT01426789|11685921|FG001|NOT COMPLETED|Part 1||4
10533808|NCT01426789|11685922|FG002|NOT COMPLETED|Part 1||0
10355862|NCT00467779|11495037|FG001|COMPLETED|Stage 2||0
10355863|NCT00467779|11495038|FG002|COMPLETED|Stage 2||0
10355864|NCT00467779|11495039|FG003|COMPLETED|Stage 2||0
10533809|NCT01426789|11685923|FG003|NOT COMPLETED|Part 1||0
10533810|NCT01426789|11685924|FG004|NOT COMPLETED|Part 1||0
10533811|NCT01426789|11685925|FG005|NOT COMPLETED|Part 1||0
10533812|NCT01426789|11685920|FG000|STARTED|Part 2||0
10533813|NCT01426789|11685921|FG001|STARTED|Part 2||0
10533814|NCT01426789|11685922|FG002|STARTED|Part 2||49
10533815|NCT01426789|11685923|FG003|STARTED|Part 2||13
10533816|NCT01426789|11685924|FG004|STARTED|Part 2||27
10533817|NCT01426789|11685925|FG005|STARTED|Part 2||1
10533818|NCT01426789|11685920|FG000|COMPLETED|Part 2||0
10533819|NCT01426789|11685921|FG001|COMPLETED|Part 2||0
10355865|NCT00467779|11495040|FG004|COMPLETED|Stage 2||0
10355866|NCT00467779|11495041|FG005|COMPLETED|Stage 2||0
10355867|NCT00467779|11495042|FG006|COMPLETED|Stage 2||0
10716122|NCT02688387|11880063|FG020|STARTED|Part 3B, Period 2 (up to 6 Days)||8
10355868|NCT00467779|11495043|FG007|COMPLETED|Stage 2||0
10355869|NCT00467779|11495044|FG008|COMPLETED|Stage 2||0
10355870|NCT00467779|11495045|FG009|COMPLETED|Stage 2||0
10355871|NCT00467779|11495046|FG010|COMPLETED|Stage 2||0
10355872|NCT00467779|11495047|FG011|COMPLETED|Stage 2||0
10355873|NCT00467779|11495048|FG012|COMPLETED|Stage 2||0
10533820|NCT01426789|11685922|FG002|COMPLETED|Part 2||34
10355874|NCT00467779|11495049|FG013|COMPLETED|Stage 2||0
10355875|NCT00467779|11495050|FG014|COMPLETED|Stage 2||0
10355876|NCT00467779|11495036|FG000|NOT COMPLETED|Stage 2||0
10355877|NCT00467779|11495037|FG001|NOT COMPLETED|Stage 2||0
10355878|NCT00467779|11495038|FG002|NOT COMPLETED|Stage 2||0
10355879|NCT00467779|11495039|FG003|NOT COMPLETED|Stage 2||0
10355880|NCT00467779|11495040|FG004|NOT COMPLETED|Stage 2||0
10355881|NCT00467779|11495041|FG005|NOT COMPLETED|Stage 2||0
10355882|NCT00467779|11495042|FG006|NOT COMPLETED|Stage 2||0
10355883|NCT00467779|11495043|FG007|NOT COMPLETED|Stage 2||0
10355884|NCT00467779|11495044|FG008|NOT COMPLETED|Stage 2||21
10355885|NCT00467779|11495045|FG009|NOT COMPLETED|Stage 2||0
10355886|NCT00467779|11495046|FG010|NOT COMPLETED|Stage 2||0
10355887|NCT00467779|11495047|FG011|NOT COMPLETED|Stage 2||0
10355888|NCT00467779|11495048|FG012|NOT COMPLETED|Stage 2||0
10355889|NCT00467779|11495049|FG013|NOT COMPLETED|Stage 2||0
10355890|NCT00467779|11495050|FG014|NOT COMPLETED|Stage 2||0
10355891|NCT00467779|11495036|FG000|STARTED|Stage 2A||0
10355892|NCT00467779|11495037|FG001|STARTED|Stage 2A||0
10355893|NCT00467779|11495038|FG002|STARTED|Stage 2A||0
10355894|NCT00467779|11495039|FG003|STARTED|Stage 2A||0
10355895|NCT00467779|11495040|FG004|STARTED|Stage 2A||0
10355896|NCT00467779|11495041|FG005|STARTED|Stage 2A||0
10355897|NCT00467779|11495042|FG006|STARTED|Stage 2A||0
10355898|NCT00467779|11495043|FG007|STARTED|Stage 2A||0
10355899|NCT00467779|11495044|FG008|STARTED|Stage 2A||0
10355900|NCT00467779|11495045|FG009|STARTED|Stage 2A||0
10355901|NCT00467779|11495046|FG010|STARTED|Stage 2A||0
10355902|NCT00467779|11495047|FG011|STARTED|Stage 2A||0
10355903|NCT00467779|11495048|FG012|STARTED|Stage 2A||0
10355904|NCT00467779|11495049|FG013|STARTED|Stage 2A||22
10355905|NCT00467779|11495050|FG014|STARTED|Stage 2A||0
10355906|NCT00467779|11495036|FG000|COMPLETED|Stage 2A||0
10355907|NCT00467779|11495037|FG001|COMPLETED|Stage 2A||0
10355908|NCT00467779|11495038|FG002|COMPLETED|Stage 2A||0
10355909|NCT00467779|11495039|FG003|COMPLETED|Stage 2A||0
10355910|NCT00467779|11495040|FG004|COMPLETED|Stage 2A||0
10355911|NCT00467779|11495041|FG005|COMPLETED|Stage 2A||0
10355912|NCT00467779|11495042|FG006|COMPLETED|Stage 2A||0
10355913|NCT00467779|11495043|FG007|COMPLETED|Stage 2A||0
10355914|NCT00467779|11495044|FG008|COMPLETED|Stage 2A||0
10355915|NCT00467779|11495045|FG009|COMPLETED|Stage 2A||0
10355916|NCT00467779|11495046|FG010|COMPLETED|Stage 2A||0
10355917|NCT00467779|11495047|FG011|COMPLETED|Stage 2A||0
10355918|NCT00467779|11495048|FG012|COMPLETED|Stage 2A||0
10355919|NCT00467779|11495049|FG013|COMPLETED|Stage 2A||1
10355920|NCT00467779|11495050|FG014|COMPLETED|Stage 2A||0
10355921|NCT00467779|11495036|FG000|NOT COMPLETED|Stage 2A||0
10355922|NCT00467779|11495037|FG001|NOT COMPLETED|Stage 2A||0
10355923|NCT00467779|11495038|FG002|NOT COMPLETED|Stage 2A||0
10355924|NCT00467779|11495039|FG003|NOT COMPLETED|Stage 2A||0
10355925|NCT00467779|11495040|FG004|NOT COMPLETED|Stage 2A||0
10355926|NCT00467779|11495041|FG005|NOT COMPLETED|Stage 2A||0
10355927|NCT00467779|11495042|FG006|NOT COMPLETED|Stage 2A||0
10355928|NCT00467779|11495043|FG007|NOT COMPLETED|Stage 2A||0
10355929|NCT00467779|11495044|FG008|NOT COMPLETED|Stage 2A||0
10355930|NCT00467779|11495045|FG009|NOT COMPLETED|Stage 2A||0
10355931|NCT00467779|11495046|FG010|NOT COMPLETED|Stage 2A||0
10355932|NCT00467779|11495047|FG011|NOT COMPLETED|Stage 2A||0
10355933|NCT00467779|11495048|FG012|NOT COMPLETED|Stage 2A||0
10355934|NCT00467779|11495049|FG013|NOT COMPLETED|Stage 2A||21
10355935|NCT00467779|11495050|FG014|NOT COMPLETED|Stage 2A||0
10355936|NCT00467779|11495036|FG000|STARTED|Stage 3||0
10355937|NCT00467779|11495037|FG001|STARTED|Stage 3||0
10355938|NCT00467779|11495038|FG002|STARTED|Stage 3||0
10355939|NCT00467779|11495039|FG003|STARTED|Stage 3||0
10355940|NCT00467779|11495040|FG004|STARTED|Stage 3||0
10355941|NCT00467779|11495041|FG005|STARTED|Stage 3||0
10355942|NCT00467779|11495042|FG006|STARTED|Stage 3||0
10355943|NCT00467779|11495043|FG007|STARTED|Stage 3||0
10716123|NCT02688387|11880064|FG021|STARTED|Part 3B, Period 2 (up to 6 Days)||8
10716124|NCT02688387|11880043|FG000|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10355944|NCT00467779|11495044|FG008|STARTED|Stage 3||0
10355945|NCT00467779|11495045|FG009|STARTED|Stage 3||0
10355946|NCT00467779|11495046|FG010|STARTED|Stage 3||0
10355947|NCT00467779|11495047|FG011|STARTED|Stage 3||0
10355948|NCT00467779|11495048|FG012|STARTED|Stage 3||0
10355949|NCT00467779|11495049|FG013|STARTED|Stage 3||0
10355950|NCT00467779|11495050|FG014|STARTED|Stage 3||20
10355951|NCT00467779|11495036|FG000|COMPLETED|Stage 3||0
10355952|NCT00467779|11495037|FG001|COMPLETED|Stage 3||0
10355953|NCT00467779|11495038|FG002|COMPLETED|Stage 3||0
10355954|NCT00467779|11495039|FG003|COMPLETED|Stage 3||0
10355955|NCT00467779|11495040|FG004|COMPLETED|Stage 3||0
10355956|NCT00467779|11495041|FG005|COMPLETED|Stage 3||0
10533821|NCT01426789|11685923|FG003|COMPLETED|Part 2||12
10533822|NCT01426789|11685924|FG004|COMPLETED|Part 2||19
10533823|NCT01426789|11685925|FG005|COMPLETED|Part 2||1
10533824|NCT01426789|11685920|FG000|NOT COMPLETED|Part 2||0
10355957|NCT00467779|11495042|FG006|COMPLETED|Stage 3||0
10355958|NCT00467779|11495043|FG007|COMPLETED|Stage 3||0
10355959|NCT00467779|11495044|FG008|COMPLETED|Stage 3||0
10355960|NCT00467779|11495045|FG009|COMPLETED|Stage 3||0
10355961|NCT00467779|11495046|FG010|COMPLETED|Stage 3||0
10355962|NCT00467779|11495047|FG011|COMPLETED|Stage 3||0
10355963|NCT00467779|11495048|FG012|COMPLETED|Stage 3||0
10355964|NCT00467779|11495049|FG013|COMPLETED|Stage 3||0
10355965|NCT00467779|11495050|FG014|COMPLETED|Stage 3||3
10355966|NCT00467779|11495036|FG000|NOT COMPLETED|Stage 3||0
10355967|NCT00467779|11495037|FG001|NOT COMPLETED|Stage 3||0
10533825|NCT01426789|11685921|FG001|NOT COMPLETED|Part 2||0
10355968|NCT00467779|11495038|FG002|NOT COMPLETED|Stage 3||0
10355969|NCT00467779|11495039|FG003|NOT COMPLETED|Stage 3||0
10355970|NCT00467779|11495040|FG004|NOT COMPLETED|Stage 3||0
10355971|NCT00467779|11495041|FG005|NOT COMPLETED|Stage 3||0
10355972|NCT00467779|11495042|FG006|NOT COMPLETED|Stage 3||0
10355973|NCT00467779|11495043|FG007|NOT COMPLETED|Stage 3||0
10355974|NCT00467779|11495044|FG008|NOT COMPLETED|Stage 3||0
10355975|NCT00467779|11495045|FG009|NOT COMPLETED|Stage 3||0
10355976|NCT00467779|11495046|FG010|NOT COMPLETED|Stage 3||0
10355977|NCT00467779|11495047|FG011|NOT COMPLETED|Stage 3||0
10355978|NCT00467779|11495048|FG012|NOT COMPLETED|Stage 3||0
10355979|NCT00467779|11495049|FG013|NOT COMPLETED|Stage 3||0
10355980|NCT00467779|11495050|FG014|NOT COMPLETED|Stage 3||17
10355981|NCT00467818|11495090|FG000|STARTED|Overall Study||9
10355982|NCT00467818|11495091|FG001|STARTED|Overall Study||8
10355983|NCT00467818|11495090|FG000|COMPLETED|Overall Study||6
10355984|NCT00467818|11495091|FG001|COMPLETED|Overall Study||6
10355985|NCT00467818|11495090|FG000|NOT COMPLETED|Overall Study||3
10355986|NCT00467818|11495091|FG001|NOT COMPLETED|Overall Study||2
10355987|NCT00467831|11495099|FG000|STARTED|Overall Study||3
10355988|NCT00467831|11495099|FG000|COMPLETED|Overall Study||0
10355989|NCT00467831|11495099|FG000|NOT COMPLETED|Overall Study||3
10355990|NCT00467844|11495106|FG000|STARTED|Overall Study||53
10355991|NCT00467844|11495107|FG001|STARTED|Overall Study||54
10355992|NCT00467844|11495108|FG002|STARTED|Overall Study||52
10355993|NCT00467844|11495106|FG000|COMPLETED|Overall Study||34
10355994|NCT00467844|11495107|FG001|COMPLETED|Overall Study||34
10355995|NCT00467844|11495108|FG002|COMPLETED|Overall Study||38
10355996|NCT00467844|11495106|FG000|NOT COMPLETED|Overall Study||19
10355997|NCT00467844|11495107|FG001|NOT COMPLETED|Overall Study||20
10355998|NCT00467844|11495108|FG002|NOT COMPLETED|Overall Study||14
10355999|NCT00467857|11495121|FG000|STARTED|Overall Study||146
10356000|NCT00467857|11495122|FG001|STARTED|Overall Study||147
10356001|NCT00467857|11495121|FG000|COMPLETED|Overall Study||143
10356002|NCT00467857|11495122|FG001|COMPLETED|Overall Study||139
10356003|NCT00467857|11495121|FG000|NOT COMPLETED|Overall Study||3
10356004|NCT00467857|11495122|FG001|NOT COMPLETED|Overall Study||8
10356005|NCT00467870|11495134|FG000|STARTED|Overall Study||120
10356006|NCT00467870|11495135|FG001|STARTED|Overall Study||117
10356007|NCT00467870|11495136|FG002|STARTED|Overall Study||22
10356008|NCT00467870|11495137|FG003|STARTED|Overall Study||112
10356009|NCT00467870|11495138|FG004|STARTED|Overall Study||130
10356010|NCT00467870|11495139|FG005|STARTED|Overall Study||23
10356011|NCT00467870|11495134|FG000|COMPLETED|Overall Study||75
10356012|NCT00467870|11495135|FG001|COMPLETED|Overall Study||74
10356013|NCT00467870|11495136|FG002|COMPLETED|Overall Study||18
10356014|NCT00467870|11495137|FG003|COMPLETED|Overall Study||79
10356015|NCT00467870|11495138|FG004|COMPLETED|Overall Study||93
10356016|NCT00467870|11495139|FG005|COMPLETED|Overall Study||21
10356017|NCT00467870|11495134|FG000|NOT COMPLETED|Overall Study||45
10356018|NCT00467870|11495135|FG001|NOT COMPLETED|Overall Study||43
10356019|NCT00467870|11495136|FG002|NOT COMPLETED|Overall Study||4
10356020|NCT00467870|11495137|FG003|NOT COMPLETED|Overall Study||33
10356021|NCT00467870|11495138|FG004|NOT COMPLETED|Overall Study||37
10356022|NCT00467870|11495139|FG005|NOT COMPLETED|Overall Study||2
10356023|NCT00467896|11495149|FG000|STARTED|Overall Study||62
10356024|NCT00467896|11495149|FG000|COMPLETED|Overall Study||11
10356025|NCT00467896|11495149|FG000|NOT COMPLETED|Overall Study||51
10356026|NCT00467961|11495155|FG000|STARTED|Overall Study||31
10356027|NCT00467961|11495155|FG000|COMPLETED|Overall Study||24
10356028|NCT00467961|11495155|FG000|NOT COMPLETED|Overall Study||7
10356029|NCT00468052|11495161|FG000|STARTED|Overall Study|1 subject withdrew consent.Surgery was cancelled for 2. 4 subjects eliminated for break in protocol|68
10356030|NCT00468052|11495162|FG001|STARTED|Overall Study|One had an intraoperative complication and was withdrawn. 7 eliminated for a break in protocol.|69
10356031|NCT00468052|11495161|FG000|Target Enrollment|Overall Study||70
10356032|NCT00468052|11495162|FG001|Target Enrollment|Overall Study||70
10356033|NCT00468052|11495161|FG000|COMPLETED|Overall Study||61
10356034|NCT00468052|11495162|FG001|COMPLETED|Overall Study||61
10356035|NCT00468052|11495161|FG000|NOT COMPLETED|Overall Study||7
10356036|NCT00468052|11495162|FG001|NOT COMPLETED|Overall Study||8
10356037|NCT00468104|11495170|FG000|STARTED|First Intervention||54
10356038|NCT00468104|11495171|FG001|STARTED|First Intervention||46
10356039|NCT00468104|11495170|FG000|COMPLETED|First Intervention||45
10356040|NCT00468104|11495171|FG001|COMPLETED|First Intervention||45
10356041|NCT00468104|11495170|FG000|NOT COMPLETED|First Intervention||9
10356042|NCT00468104|11495171|FG001|NOT COMPLETED|First Intervention||1
10356043|NCT00468104|11495170|FG000|STARTED|Second Intervention|37 responded to Alteplase and did not go to the second intervention|8
10356044|NCT00468104|11495171|FG001|STARTED|Second Intervention|4 patients responded to Placebo and did not go to the second intervention|41
10356045|NCT00468104|11495170|FG000|COMPLETED|Second Intervention||3
10356046|NCT00468104|11495171|FG001|COMPLETED|Second Intervention||37
10356047|NCT00468104|11495170|FG000|NOT COMPLETED|Second Intervention||5
10356048|NCT00468104|11495171|FG001|NOT COMPLETED|Second Intervention||4
10356049|NCT00468143|11495180|FG000|STARTED|First Intervention (3 Weeks)||31
10356050|NCT00468143|11495181|FG001|STARTED|First Intervention (3 Weeks)||31
10356051|NCT00468143|11495180|FG000|COMPLETED|First Intervention (3 Weeks)||28
10356052|NCT00468143|11495181|FG001|COMPLETED|First Intervention (3 Weeks)||27
10356053|NCT00468143|11495180|FG000|NOT COMPLETED|First Intervention (3 Weeks)||3
10356054|NCT00468143|11495181|FG001|NOT COMPLETED|First Intervention (3 Weeks)||4
10356055|NCT00468143|11495180|FG000|STARTED|Second Intervention (3 Weeks)||28
10356056|NCT00468143|11495181|FG001|STARTED|Second Intervention (3 Weeks)||27
10356057|NCT00468143|11495180|FG000|COMPLETED|Second Intervention (3 Weeks)||25
10356058|NCT00468143|11495181|FG001|COMPLETED|Second Intervention (3 Weeks)||24
10356059|NCT00468143|11495180|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||3
10356060|NCT00468143|11495181|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||3
10356061|NCT00468169|11495189|FG000|STARTED|Overall Study||57
10356062|NCT00468169|11495190|FG001|STARTED|Overall Study||53
10356063|NCT00468169|11495189|FG000|COMPLETED|Overall Study||56
10356064|NCT00468169|11495190|FG001|COMPLETED|Overall Study||53
10356065|NCT00468169|11495189|FG000|NOT COMPLETED|Overall Study||1
10356066|NCT00468169|11495190|FG001|NOT COMPLETED|Overall Study||0
10356067|NCT00468208|11495198|FG000|STARTED|Overall Study||20
10356068|NCT00468208|11495198|FG000|COMPLETED|Overall Study|All patients reached common closing or early termination|20
10356069|NCT00468208|11495198|FG000|NOT COMPLETED|Overall Study||0
10356070|NCT00468286|11495204|FG000|STARTED|Overall Study|Started=Intention to treat (ITT) population.|67
10356071|NCT00468286|11495205|FG001|STARTED|Overall Study||66
10356072|NCT00468286|11495204|FG000|COMPLETED|Overall Study||60
10356073|NCT00468286|11495205|FG001|COMPLETED|Overall Study||54
10356074|NCT00468286|11495204|FG000|NOT COMPLETED|Overall Study||7
10356075|NCT00468286|11495205|FG001|NOT COMPLETED|Overall Study||12
10356076|NCT00468299|11495213|FG000|STARTED|Overall Study||9
10356077|NCT00468299|11495214|FG001|STARTED|Overall Study||8
10356078|NCT00468299|11495213|FG000|COMPLETED|Overall Study||9
10356079|NCT00468299|11495214|FG001|COMPLETED|Overall Study||7
10356080|NCT00468299|11495213|FG000|NOT COMPLETED|Overall Study||0
10356081|NCT00468299|11495214|FG001|NOT COMPLETED|Overall Study||1
10426941|NCT00849940|11572678|FG000|NOT COMPLETED|Overall Study||4
10426942|NCT00850031|11572682|FG000|STARTED|Overall Study||118
10426943|NCT00850031|11572682|FG000|COMPLETED|Overall Study||101
10426944|NCT00850031|11572682|FG000|NOT COMPLETED|Overall Study||17
10426945|NCT00850070|11572688|FG000|STARTED|Overall Study||23
10426946|NCT00850070|11572689|FG001|STARTED|Overall Study||23
10426947|NCT00850070|11572688|FG000|COMPLETED|Overall Study||20
10426948|NCT00850070|11572689|FG001|COMPLETED|Overall Study||22
10426949|NCT00850070|11572688|FG000|NOT COMPLETED|Overall Study||3
10426950|NCT00850070|11572689|FG001|NOT COMPLETED|Overall Study||1
10426951|NCT00850096|11572702|FG000|STARTED|Overall Study||47
10426952|NCT00850096|11572703|FG001|STARTED|Overall Study||47
10426953|NCT00850096|11572702|FG000|COMPLETED|Overall Study||44
10426954|NCT00850096|11572703|FG001|COMPLETED|Overall Study||45
10426955|NCT00850096|11572702|FG000|NOT COMPLETED|Overall Study||3
10426956|NCT00850096|11572703|FG001|NOT COMPLETED|Overall Study||2
10426957|NCT00850135|11572709|FG000|STARTED|Overall Study||57
10426958|NCT00850135|11572709|FG000|COMPLETED|Overall Study||56
10426959|NCT00850135|11572709|FG000|NOT COMPLETED|Overall Study||1
10426960|NCT00850200|11572715|FG000|STARTED|Overall Study||20
10426961|NCT00850200|11572715|FG000|COMPLETED|Overall Study||15
10426962|NCT00850200|11572715|FG000|NOT COMPLETED|Overall Study||5
10429795|NCT00866359|11575869|FG001|COMPLETED|Observational Follow-Up Phase||0
10429796|NCT00866359|11575870|FG002|COMPLETED|Observational Follow-Up Phase||54
10429797|NCT00866359|11575871|FG003|COMPLETED|Observational Follow-Up Phase||54
10429798|NCT00866359|11575868|FG000|NOT COMPLETED|Observational Follow-Up Phase||0
10429799|NCT00866359|11575869|FG001|NOT COMPLETED|Observational Follow-Up Phase||0
10429800|NCT00866359|11575870|FG002|NOT COMPLETED|Observational Follow-Up Phase||0
10429801|NCT00866359|11575871|FG003|NOT COMPLETED|Observational Follow-Up Phase||0
10429802|NCT00866606|11575898|FG000|STARTED|Overall Study||35
10429803|NCT00866606|11575898|FG000|COMPLETED|Overall Study||31
10429804|NCT00866606|11575898|FG000|NOT COMPLETED|Overall Study||4
10429805|NCT00866619|11575906|FG000|STARTED|Overall Study||5948
10429806|NCT00866619|11575907|FG001|STARTED|Overall Study||4358
10429807|NCT00866619|11575908|FG002|STARTED|Overall Study||2974
10429808|NCT00866619|11575909|FG003|STARTED|Overall Study||2179
10429809|NCT00866619|11575906|FG000|COMPLETED|Overall Study||4102
10429810|NCT00866619|11575907|FG001|COMPLETED|Overall Study||3088
10429811|NCT00866619|11575908|FG002|COMPLETED|Overall Study||2085
10429812|NCT00866619|11575909|FG003|COMPLETED|Overall Study||1549
10429813|NCT00866619|11575906|FG000|NOT COMPLETED|Overall Study||1846
10429814|NCT00866619|11575907|FG001|NOT COMPLETED|Overall Study||1270
10429815|NCT00866619|11575908|FG002|NOT COMPLETED|Overall Study||889
10429816|NCT00866619|11575909|FG003|NOT COMPLETED|Overall Study||630
10429817|NCT00866658|11575946|FG000|STARTED|Overall Study|Randomized.|157
10716125|NCT02688387|11880044|FG001|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10716126|NCT02688387|11880045|FG002|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10429818|NCT00866658|11575947|FG001|STARTED|Overall Study||154
10429819|NCT00866658|11575946|FG000|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|157
10716127|NCT02688387|11880046|FG003|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10429820|NCT00866658|11575947|FG001|Safety Population|Overall Study||154
10429821|NCT00866658|11575946|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|157
10429822|NCT00866658|11575947|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||154
10429823|NCT00866658|11575946|FG000|COMPLETED|Overall Study||144
10429824|NCT00866658|11575947|FG001|COMPLETED|Overall Study||133
10429825|NCT00866658|11575946|FG000|NOT COMPLETED|Overall Study||13
10429826|NCT00866658|11575947|FG001|NOT COMPLETED|Overall Study||21
10429827|NCT00866697|11575955|FG000|STARTED|Overall Study||468
10429828|NCT00866697|11575956|FG001|STARTED|Overall Study||472
10429829|NCT00866697|11575955|FG000|COMPLETED|Overall Study||254
10356082|NCT00468481|11495224|FG000|STARTED|Overall Study|6 of these randomized subjects did not take any study medication|291
10356083|NCT00468481|11495225|FG001|STARTED|Overall Study||94
10356084|NCT00468481|11495224|FG000|Subjects Treated|Overall Study||285
10356085|NCT00468481|11495225|FG001|Subjects Treated|Overall Study||94
10356086|NCT00468481|11495224|FG000|COMPLETED|Overall Study||203
10356087|NCT00468481|11495225|FG001|COMPLETED|Overall Study||70
10356088|NCT00468481|11495224|FG000|NOT COMPLETED|Overall Study||88
10356089|NCT00468481|11495225|FG001|NOT COMPLETED|Overall Study||24
10356090|NCT00468546|11495233|FG000|STARTED|Week 24 Analysis||208
10356091|NCT00468546|11495234|FG001|STARTED|Week 24 Analysis||308
10356092|NCT00468546|11495233|FG000|COMPLETED|Week 24 Analysis||111
10356093|NCT00468546|11495234|FG001|COMPLETED|Week 24 Analysis||253
10356094|NCT00468546|11495233|FG000|NOT COMPLETED|Week 24 Analysis||97
10356095|NCT00468546|11495234|FG001|NOT COMPLETED|Week 24 Analysis||55
10356096|NCT00468546|11495233|FG000|STARTED|Week 24 to Week 104 Analysis|Participants who completed/not completed Week (W) 24 analysis were entered in W24 to W104 analysis.|208
10356097|NCT00468546|11495234|FG001|STARTED|Week 24 to Week 104 Analysis|Participants who completed/not completed W24 analysis were entered in W24 to W104 analysis.|308
10356098|NCT00468546|11495233|FG000|COMPLETED|Week 24 to Week 104 Analysis||103
10356099|NCT00468546|11495234|FG001|COMPLETED|Week 24 to Week 104 Analysis||83
10716128|NCT02688387|11880047|FG004|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10716129|NCT02688387|11880048|FG005|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10716130|NCT02688387|11880049|FG006|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10716131|NCT02688387|11880050|FG007|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10356100|NCT00468546|11495233|FG000|NOT COMPLETED|Week 24 to Week 104 Analysis||105
10356101|NCT00468546|11495234|FG001|NOT COMPLETED|Week 24 to Week 104 Analysis||225
10356102|NCT00468559|11495242|FG000|STARTED|Open-label Treatment Phase|All participants received open-label esomeprazole during this phase of the study|98
10533826|NCT01426789|11685922|FG002|NOT COMPLETED|Part 2||15
10533827|NCT01426789|11685923|FG003|NOT COMPLETED|Part 2||1
10533828|NCT01426789|11685924|FG004|NOT COMPLETED|Part 2||8
10533829|NCT01426789|11685925|FG005|NOT COMPLETED|Part 2||0
10533830|NCT01426828|11685935|FG000|STARTED|Overall Study Evaluations||22
10533831|NCT01426828|11685936|FG001|STARTED|Overall Study Evaluations||18
10533832|NCT01426828|11685935|FG000|COMPLETED|Overall Study Evaluations||17
10533833|NCT01426828|11685936|FG001|COMPLETED|Overall Study Evaluations||15
10533834|NCT01426828|11685935|FG000|NOT COMPLETED|Overall Study Evaluations||5
10533835|NCT01426828|11685936|FG001|NOT COMPLETED|Overall Study Evaluations||3
10533836|NCT01426828|11685935|FG000|STARTED|Immune Response Analysis||17
10533837|NCT01426828|11685936|FG001|STARTED|Immune Response Analysis||15
10533838|NCT01426828|11685935|FG000|COMPLETED|Immune Response Analysis||8
10533839|NCT01426828|11685936|FG001|COMPLETED|Immune Response Analysis||8
10533840|NCT01426828|11685935|FG000|NOT COMPLETED|Immune Response Analysis||9
10533841|NCT01426828|11685936|FG001|NOT COMPLETED|Immune Response Analysis||7
10533842|NCT01426854|11685944|FG000|STARTED|Overall Study||131
10533843|NCT01426854|11685945|FG001|STARTED|Overall Study||129
10533844|NCT01426854|11685944|FG000|COMPLETED|Overall Study||119
10533845|NCT01426854|11685945|FG001|COMPLETED|Overall Study||98
10533846|NCT01426854|11685944|FG000|NOT COMPLETED|Overall Study||12
10533847|NCT01426854|11685945|FG001|NOT COMPLETED|Overall Study||31
10533848|NCT01426867|11685954|FG000|STARTED|Overall Study||33
10533849|NCT01426867|11685955|FG001|STARTED|Overall Study||34
10533850|NCT01426867|11685956|FG002|STARTED|Overall Study||34
10533851|NCT01426867|11685954|FG000|COMPLETED|Overall Study||33
10533852|NCT01426867|11685955|FG001|COMPLETED|Overall Study||34
10533853|NCT01426867|11685956|FG002|COMPLETED|Overall Study||34
10533854|NCT01426867|11685954|FG000|NOT COMPLETED|Overall Study||0
10533855|NCT01426867|11685955|FG001|NOT COMPLETED|Overall Study||0
10533856|NCT01426867|11685956|FG002|NOT COMPLETED|Overall Study||0
10533857|NCT01426958|11685964|FG000|STARTED|Overall Study||24
10533858|NCT01426958|11685964|FG000|COMPLETED|Overall Study||22
10533859|NCT01426958|11685964|FG000|NOT COMPLETED|Overall Study||2
10533860|NCT01427296|11685974|FG000|STARTED|Overall Study||1041
10533861|NCT01427296|11685975|FG001|STARTED|Overall Study||1051
10533862|NCT01427296|11685974|FG000|COMPLETED|Overall Study||1041
10716132|NCT02688387|11880051|FG008|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10533863|NCT01427296|11685975|FG001|COMPLETED|Overall Study||1051
10533864|NCT01427296|11685974|FG000|NOT COMPLETED|Overall Study||0
10533865|NCT01427296|11685975|FG001|NOT COMPLETED|Overall Study||0
10533866|NCT01427309|11685985|FG000|STARTED|Overall Study||7253
10533867|NCT01427309|11685986|FG001|STARTED|Overall Study||7244
10533868|NCT01427309|11685987|FG002|STARTED|Overall Study||8737
10533869|NCT01427309|11685988|FG003|STARTED|Overall Study||8749
10533870|NCT01427309|11685985|FG000|COMPLETED|Overall Study||6881
10533871|NCT01427309|11685986|FG001|COMPLETED|Overall Study||6837
10533872|NCT01427309|11685987|FG002|COMPLETED|Overall Study||8376
10533873|NCT01427309|11685988|FG003|COMPLETED|Overall Study||8373
10533874|NCT01427309|11685985|FG000|NOT COMPLETED|Overall Study||372
10533875|NCT01427309|11685986|FG001|NOT COMPLETED|Overall Study||407
10533876|NCT01427309|11685987|FG002|NOT COMPLETED|Overall Study||361
10533877|NCT01427309|11685988|FG003|NOT COMPLETED|Overall Study||376
10533878|NCT01427504|11686004|FG000|STARTED|Overall Study||4
10533879|NCT01427504|11686005|FG001|STARTED|Overall Study||3
10533880|NCT01427504|11686006|FG002|STARTED|Overall Study||4
10533881|NCT01427504|11686007|FG003|STARTED|Overall Study||6
10533882|NCT01427504|11686008|FG004|STARTED|Overall Study||3
10533883|NCT01427504|11686009|FG005|STARTED|Overall Study||6
10533884|NCT01427504|11686004|FG000|Received Boceprevir|Overall Study||4
10356103|NCT00468559|11495243|FG001|STARTED|Open-label Treatment Phase||0
10356104|NCT00468559|11495244|FG002|STARTED|Open-label Treatment Phase||0
10356105|NCT00468559|11495242|FG000|COMPLETED|Open-label Treatment Phase|18 patients discontinued (were not randomized into the double-blind treatment withdrawal phase)|80
10356106|NCT00468559|11495243|FG001|COMPLETED|Open-label Treatment Phase||0
10356107|NCT00468559|11495244|FG002|COMPLETED|Open-label Treatment Phase||0
10356108|NCT00468559|11495242|FG000|NOT COMPLETED|Open-label Treatment Phase||18
10356109|NCT00468559|11495243|FG001|NOT COMPLETED|Open-label Treatment Phase||0
10356110|NCT00468559|11495244|FG002|NOT COMPLETED|Open-label Treatment Phase||0
10356111|NCT00468559|11495242|FG000|STARTED|Double-blind, Treatment-withdrawal Phase||0
10356112|NCT00468559|11495243|FG001|STARTED|Double-blind, Treatment-withdrawal Phase||39
10356113|NCT00468559|11495244|FG002|STARTED|Double-blind, Treatment-withdrawal Phase||41
10356114|NCT00468559|11495242|FG000|COMPLETED|Double-blind, Treatment-withdrawal Phase||0
10356115|NCT00468559|11495243|FG001|COMPLETED|Double-blind, Treatment-withdrawal Phase||29
10356116|NCT00468559|11495244|FG002|COMPLETED|Double-blind, Treatment-withdrawal Phase||24
10356117|NCT00468559|11495242|FG000|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||0
10356118|NCT00468559|11495243|FG001|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||10
10356119|NCT00468559|11495244|FG002|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||17
10356120|NCT00468585|11495256|FG000|STARTED|Overall Study||4
10356121|NCT00468585|11495257|FG001|STARTED|Overall Study||3
10356122|NCT00468585|11495258|FG002|STARTED|Overall Study||50
10356123|NCT00468585|11495259|FG003|STARTED|Overall Study||6
10356124|NCT00468585|11495256|FG000|COMPLETED|Overall Study||3
10356125|NCT00468585|11495257|FG001|COMPLETED|Overall Study||3
10356126|NCT00468585|11495258|FG002|COMPLETED|Overall Study||45
10356127|NCT00468585|11495259|FG003|COMPLETED|Overall Study||5
10356128|NCT00468585|11495256|FG000|NOT COMPLETED|Overall Study||1
10356129|NCT00468585|11495257|FG001|NOT COMPLETED|Overall Study||0
10716133|NCT02688387|11880052|FG009|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10716134|NCT02688387|11880053|FG010|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10716135|NCT02688387|11880054|FG011|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10716136|NCT02688387|11880055|FG012|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10716137|NCT02688387|11880056|FG013|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10356130|NCT00468585|11495258|FG002|NOT COMPLETED|Overall Study||5
10356131|NCT00468585|11495259|FG003|NOT COMPLETED|Overall Study||1
10356132|NCT00468650|11495269|FG000|STARTED|Overall Study||117
10356133|NCT00468650|11495269|FG000|COMPLETED|Overall Study||110
10356134|NCT00468650|11495269|FG000|NOT COMPLETED|Overall Study||7
10356135|NCT00468676|11495276|FG000|STARTED|Overall Study||108
10356136|NCT00468676|11495277|FG001|STARTED|Overall Study||106
10356137|NCT00468676|11495276|FG000|COMPLETED|Overall Study||92
10356138|NCT00468676|11495277|FG001|COMPLETED|Overall Study||94
10356139|NCT00468676|11495276|FG000|NOT COMPLETED|Overall Study||16
10356140|NCT00468676|11495277|FG001|NOT COMPLETED|Overall Study||12
10356141|NCT00468728|11495287|FG000|STARTED|Enrollment||264
10356142|NCT00468728|11495288|FG001|STARTED|Enrollment||271
10356143|NCT00468728|11495287|FG000|COMPLETED|Enrollment|1 fidaxomicin subject received vancomycin, 11 subjects didn't take drug|260
10356144|NCT00468728|11495288|FG001|COMPLETED|Enrollment|1 fidaxomicin subject received vancomycin, 11 subjects didn't take drug|264
10356145|NCT00468728|11495287|FG000|NOT COMPLETED|Enrollment||4
10356146|NCT00468728|11495288|FG001|NOT COMPLETED|Enrollment||7
10356147|NCT00468728|11495287|FG000|STARTED|Treatment||260
10356148|NCT00468728|11495288|FG001|STARTED|Treatment||264
10356149|NCT00468728|11495287|FG000|COMPLETED|Treatment||256
10356150|NCT00468728|11495288|FG001|COMPLETED|Treatment||253
10356151|NCT00468728|11495287|FG000|NOT COMPLETED|Treatment||4
10356152|NCT00468728|11495288|FG001|NOT COMPLETED|Treatment||11
10356153|NCT00468728|11495287|FG000|STARTED|Follow-up||256
10356154|NCT00468728|11495288|FG001|STARTED|Follow-up||253
10356155|NCT00468728|11495287|FG000|COMPLETED|Follow-up||222
10356156|NCT00468728|11495288|FG001|COMPLETED|Follow-up||222
10356157|NCT00468728|11495287|FG000|NOT COMPLETED|Follow-up||34
10356158|NCT00468728|11495288|FG001|NOT COMPLETED|Follow-up||31
10356159|NCT00468819|11495299|FG000|STARTED|Overall Study|Enrolled participants|48
10716138|NCT02688387|11880057|FG014|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10305944|NCT00095979|11438892|FG000|STARTED|Overall Study||52
10305945|NCT00095979|11438892|FG000|COMPLETED|Overall Study||50
10305946|NCT00095979|11438892|FG000|NOT COMPLETED|Overall Study||2
10305947|NCT00096018|11438903|FG000|STARTED|Overall Study||13
10305948|NCT00096018|11438904|FG001|STARTED|Overall Study||30
10305949|NCT00096018|11438903|FG000|Treated With Study Therapy|Overall Study||13
10305950|NCT00096018|11438904|FG001|Treated With Study Therapy|Overall Study||25
10305951|NCT00096018|11438903|FG000|COMPLETED|Overall Study||11
10305952|NCT00096018|11438904|FG001|COMPLETED|Overall Study||16
10356160|NCT00468819|11495300|FG001|STARTED|Overall Study|Enrolled participants|44
10356161|NCT00468819|11495301|FG002|STARTED|Overall Study|Enrolled participants|48
10356162|NCT00468819|11495299|FG000|Treatment Received/ Safety Follow-up|Overall Study|FAS (Full Analysis Set)|46
10716139|NCT02688387|11880058|FG015|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10305953|NCT00096018|11438903|FG000|NOT COMPLETED|Overall Study||2
10426963|NCT00850343|11572726|FG000|STARTED|Overall Study||110
10777241|NCT03338062|11939179|FG001|COMPLETED|Overall Study||5
10356163|NCT00468819|11495300|FG001|Treatment Received/ Safety Follow-up|Overall Study|FAS|44
10356164|NCT00468819|11495301|FG002|Treatment Received/ Safety Follow-up|Overall Study|FAS|48
10356165|NCT00468819|11495299|FG000|COMPLETED|Overall Study||42
10356166|NCT00468819|11495300|FG001|COMPLETED|Overall Study||44
10356167|NCT00468819|11495301|FG002|COMPLETED|Overall Study||46
10356168|NCT00468819|11495299|FG000|NOT COMPLETED|Overall Study||6
10356169|NCT00468819|11495300|FG001|NOT COMPLETED|Overall Study||0
10356170|NCT00468819|11495301|FG002|NOT COMPLETED|Overall Study||2
10356171|NCT00468845|11495314|FG000|STARTED|Overall Study||162
10356172|NCT00468845|11495315|FG001|STARTED|Overall Study||170
10356173|NCT00468845|11495316|FG002|STARTED|Overall Study||169
10356174|NCT00468845|11495314|FG000|Received Treatment|Overall Study||161
10356175|NCT00468845|11495315|FG001|Received Treatment|Overall Study||166
10356176|NCT00468845|11495316|FG002|Received Treatment|Overall Study||167
10356177|NCT00468845|11495314|FG000|COMPLETED|Overall Study||141
10356178|NCT00468845|11495315|FG001|COMPLETED|Overall Study||136
10356179|NCT00468845|11495316|FG002|COMPLETED|Overall Study||139
10356180|NCT00468845|11495314|FG000|NOT COMPLETED|Overall Study||21
10356181|NCT00468845|11495315|FG001|NOT COMPLETED|Overall Study||34
10356182|NCT00468845|11495316|FG002|NOT COMPLETED|Overall Study||30
10356183|NCT00468858|11495327|FG000|STARTED|Overall Study||211
10356184|NCT00468858|11495328|FG001|STARTED|Overall Study||212
10356185|NCT00468858|11495329|FG002|STARTED|Overall Study||213
10356186|NCT00468858|11495327|FG000|COMPLETED|Overall Study||202
10356187|NCT00468858|11495328|FG001|COMPLETED|Overall Study||202
10356188|NCT00468858|11495329|FG002|COMPLETED|Overall Study||199
10356189|NCT00468858|11495327|FG000|NOT COMPLETED|Overall Study||9
10356190|NCT00468858|11495328|FG001|NOT COMPLETED|Overall Study||10
10356191|NCT00468858|11495329|FG002|NOT COMPLETED|Overall Study||14
10356192|NCT00468910|11495393|FG000|STARTED|Overall Study||40
10356193|NCT00468910|11495394|FG001|STARTED|Overall Study||39
10356194|NCT00468910|11495393|FG000|Randomization|Overall Study||40
10356195|NCT00468910|11495394|FG001|Randomization|Overall Study||39
10356196|NCT00468910|11495393|FG000|Treatment|Overall Study||36
10356197|NCT00468910|11495394|FG001|Treatment|Overall Study||36
10356198|NCT00468910|11495393|FG000|Post-Treatment Biopsy|Overall Study||36
10356199|NCT00468910|11495394|FG001|Post-Treatment Biopsy|Overall Study||36
10356200|NCT00468910|11495393|FG000|Follow-up|Overall Study||36
10356201|NCT00468910|11495394|FG001|Follow-up|Overall Study||36
10716140|NCT02688387|11880059|FG016|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10716141|NCT02688387|11880060|FG017|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10716142|NCT02688387|11880061|FG018|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
10716143|NCT02688387|11880062|FG019|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
10716144|NCT02688387|11880063|FG020|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
10356202|NCT00468910|11495393|FG000|COMPLETED|Overall Study||36
10356203|NCT00468910|11495394|FG001|COMPLETED|Overall Study||36
10356204|NCT00468910|11495393|FG000|NOT COMPLETED|Overall Study||4
10356205|NCT00468910|11495394|FG001|NOT COMPLETED|Overall Study||3
10356206|NCT00469014|11495405|FG000|STARTED|Initial Phase Randomization||5
10356207|NCT00469014|11495406|FG001|STARTED|Initial Phase Randomization||4
10356208|NCT00469014|11495407|FG002|STARTED|Initial Phase Randomization||5
10356209|NCT00469014|11495408|FG003|STARTED|Initial Phase Randomization||6
10356210|NCT00469014|11495405|FG000|COMPLETED|Initial Phase Randomization||4
10356211|NCT00469014|11495406|FG001|COMPLETED|Initial Phase Randomization||3
10356212|NCT00469014|11495407|FG002|COMPLETED|Initial Phase Randomization||4
10356213|NCT00469014|11495408|FG003|COMPLETED|Initial Phase Randomization||5
10356214|NCT00469014|11495405|FG000|NOT COMPLETED|Initial Phase Randomization||1
10356215|NCT00469014|11495406|FG001|NOT COMPLETED|Initial Phase Randomization||1
10356216|NCT00469014|11495407|FG002|NOT COMPLETED|Initial Phase Randomization||1
10356217|NCT00469014|11495408|FG003|NOT COMPLETED|Initial Phase Randomization||1
10356218|NCT00469014|11495405|FG000|STARTED|Adaptive Randomization||13
10356219|NCT00469014|11495406|FG001|STARTED|Adaptive Randomization||3
10356220|NCT00469014|11495407|FG002|STARTED|Adaptive Randomization||24
10356221|NCT00469014|11495408|FG003|STARTED|Adaptive Randomization||11
10356222|NCT00469014|11495405|FG000|COMPLETED|Adaptive Randomization||12
10356223|NCT00469014|11495406|FG001|COMPLETED|Adaptive Randomization||2
10356224|NCT00469014|11495407|FG002|COMPLETED|Adaptive Randomization||23
10356225|NCT00469014|11495408|FG003|COMPLETED|Adaptive Randomization||10
10356226|NCT00469014|11495405|FG000|NOT COMPLETED|Adaptive Randomization||1
10356227|NCT00469014|11495406|FG001|NOT COMPLETED|Adaptive Randomization||1
10356228|NCT00469014|11495407|FG002|NOT COMPLETED|Adaptive Randomization||1
10356229|NCT00469014|11495408|FG003|NOT COMPLETED|Adaptive Randomization||1
10356230|NCT00469079|11495421|FG000|STARTED|Overall Study||27
10356231|NCT00469079|11495422|FG001|STARTED|Overall Study||52
10356232|NCT00469079|11495423|FG002|STARTED|Overall Study||51
10356233|NCT00469079|11495421|FG000|COMPLETED|Overall Study||18
10356234|NCT00469079|11495422|FG001|COMPLETED|Overall Study||30
10356235|NCT00469079|11495423|FG002|COMPLETED|Overall Study||32
10356236|NCT00469079|11495421|FG000|NOT COMPLETED|Overall Study||9
10356237|NCT00469079|11495422|FG001|NOT COMPLETED|Overall Study||22
10356238|NCT00469079|11495423|FG002|NOT COMPLETED|Overall Study||19
10356239|NCT00469092|11495439|FG000|STARTED|Overall Study||239
10356240|NCT00469092|11495440|FG001|STARTED|Overall Study||241
10356241|NCT00469092|11495439|FG000|Exposed to Study Drug|Overall Study||231
10356242|NCT00469092|11495440|FG001|Exposed to Study Drug|Overall Study||238
10356243|NCT00469092|11495439|FG000|COMPLETED|Overall Study||213
10356244|NCT00469092|11495440|FG001|COMPLETED|Overall Study||220
10777242|NCT03338062|11939178|FG000|NOT COMPLETED|Overall Study||1
10356245|NCT00469092|11495439|FG000|NOT COMPLETED|Overall Study||26
10356246|NCT00469092|11495440|FG001|NOT COMPLETED|Overall Study||21
10356247|NCT00469144|11495448|FG000|STARTED|Overall Study|Eight assigned to Fixed Dose without randomization.|114
10356248|NCT00469144|11495449|FG001|STARTED|Overall Study||111
10356249|NCT00469144|11495448|FG000|COMPLETED|Overall Study||108
10356250|NCT00469144|11495449|FG001|COMPLETED|Overall Study||105
10356251|NCT00469144|11495448|FG000|NOT COMPLETED|Overall Study||6
10356252|NCT00469144|11495449|FG001|NOT COMPLETED|Overall Study||6
10356253|NCT00469209|11495462|FG000|STARTED|Overall Study||20
10356254|NCT00469209|11495463|FG001|STARTED|Overall Study||20
10356255|NCT00469209|11495464|FG002|STARTED|Overall Study||20
10356256|NCT00469209|11495462|FG000|COMPLETED|Overall Study||19
10356257|NCT00469209|11495463|FG001|COMPLETED|Overall Study||20
10356258|NCT00469209|11495464|FG002|COMPLETED|Overall Study||19
10356259|NCT00469209|11495462|FG000|NOT COMPLETED|Overall Study||1
10356260|NCT00469209|11495463|FG001|NOT COMPLETED|Overall Study||0
10356261|NCT00469209|11495464|FG002|NOT COMPLETED|Overall Study||1
10356262|NCT00469274|11495474|FG000|STARTED|Overall Study||44
10716145|NCT02688387|11880064|FG021|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
10716146|NCT02688387|11880043|FG000|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10716147|NCT02688387|11880044|FG001|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10716148|NCT02688387|11880045|FG002|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10716149|NCT02688387|11880046|FG003|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10716150|NCT02688387|11880047|FG004|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10356263|NCT00469274|11495475|FG001|STARTED|Overall Study||42
10356264|NCT00469274|11495474|FG000|COMPLETED|Overall Study||44
10356265|NCT00469274|11495475|FG001|COMPLETED|Overall Study||42
10356266|NCT00469274|11495474|FG000|NOT COMPLETED|Overall Study||0
10356267|NCT00469274|11495475|FG001|NOT COMPLETED|Overall Study||0
10356268|NCT00469391|11495483|FG000|STARTED|Overall Study||27
10356269|NCT00469391|11495484|FG001|STARTED|Overall Study||29
10356270|NCT00469391|11495483|FG000|Discontinued Prior to Procedure|Overall Study||2
10356271|NCT00469391|11495484|FG001|Discontinued Prior to Procedure|Overall Study||3
10356272|NCT00469391|11495483|FG000|Unsuccessful Implant Procedure|Overall Study||4
10356273|NCT00469391|11495484|FG001|Unsuccessful Implant Procedure|Overall Study||0
10356274|NCT00469391|11495483|FG000|Adverse Event|Overall Study||8
10356275|NCT00469391|11495484|FG001|Adverse Event|Overall Study||0
10356276|NCT00469391|11495483|FG000|Lost to Follow up|Overall Study||0
10356277|NCT00469391|11495484|FG001|Lost to Follow up|Overall Study||1
10356278|NCT00469391|11495483|FG000|Patient Preference|Overall Study||0
10356279|NCT00469391|11495484|FG001|Patient Preference|Overall Study||1
10356280|NCT00469391|11495483|FG000|COMPLETED|Overall Study||13
10356281|NCT00469391|11495484|FG001|COMPLETED|Overall Study||24
10356282|NCT00469391|11495483|FG000|NOT COMPLETED|Overall Study||14
10356283|NCT00469391|11495484|FG001|NOT COMPLETED|Overall Study||5
10356284|NCT00469456|11495492|FG000|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|129
10356285|NCT00469456|11495493|FG001|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug.|135
10356286|NCT00469456|11495492|FG000|COMPLETED|Overall Study||120
10356287|NCT00469456|11495493|FG001|COMPLETED|Overall Study||131
10356288|NCT00469456|11495492|FG000|NOT COMPLETED|Overall Study||9
10356289|NCT00469456|11495493|FG001|NOT COMPLETED|Overall Study||4
10356290|NCT00469508|11495501|FG000|STARTED|Overall Study||34
10356291|NCT00469508|11495502|FG001|STARTED|Overall Study||37
10356292|NCT00469508|11495501|FG000|COMPLETED|Overall Study||14
10356293|NCT00469508|11495502|FG001|COMPLETED|Overall Study||13
10656203|NCT02215252|11817118|FG000|STARTED|Overall Study||44
10656204|NCT02215252|11817119|FG001|STARTED|Overall Study||46
10656205|NCT02215252|11817120|FG002|STARTED|Overall Study||45
10656206|NCT02215252|11817118|FG000|COMPLETED|Overall Study||42
10656207|NCT02215252|11817119|FG001|COMPLETED|Overall Study||38
10656208|NCT02215252|11817120|FG002|COMPLETED|Overall Study||41
10656209|NCT02215252|11817118|FG000|NOT COMPLETED|Overall Study||2
10656210|NCT02215252|11817119|FG001|NOT COMPLETED|Overall Study||8
10656211|NCT02215252|11817120|FG002|NOT COMPLETED|Overall Study||4
10656212|NCT02215369|11817128|FG000|STARTED|Overall Study||112
10656213|NCT02215369|11817128|FG000|COMPLETED|Overall Study||70
10716151|NCT02688387|11880048|FG005|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10356294|NCT00469508|11495501|FG000|NOT COMPLETED|Overall Study||20
10356295|NCT00469508|11495502|FG001|NOT COMPLETED|Overall Study||24
10356296|NCT00469833|11495508|FG000|STARTED|Overall Study|17 subjects met inclusion criteria and consented for the study|17
10356297|NCT00469833|11495508|FG000|COMPLETED|Overall Study||15
10356298|NCT00469833|11495508|FG000|NOT COMPLETED|Overall Study||2
10356299|NCT00469859|11495520|FG000|STARTED|Overall Study||6
10356300|NCT00469859|11495521|FG001|STARTED|Overall Study||8
10356301|NCT00469859|11495520|FG000|COMPLETED|Overall Study||6
10356302|NCT00469859|11495521|FG001|COMPLETED|Overall Study||6
10356303|NCT00469859|11495520|FG000|NOT COMPLETED|Overall Study||0
10356304|NCT00469859|11495521|FG001|NOT COMPLETED|Overall Study||2
10356305|NCT00469898|11495527|FG000|STARTED|Overall Study||50
10356306|NCT00469898|11495527|FG000|COMPLETED|Overall Study||25
10356307|NCT00469898|11495527|FG000|NOT COMPLETED|Overall Study||25
10356308|NCT00469911|11495533|FG000|STARTED|Overall Study||8
10356309|NCT00469911|11495534|FG001|STARTED|Overall Study||10
10356310|NCT00469911|11495533|FG000|COMPLETED|Overall Study||8
10356311|NCT00469911|11495534|FG001|COMPLETED|Overall Study||10
10356312|NCT00469911|11495533|FG000|NOT COMPLETED|Overall Study||0
10656214|NCT02215369|11817128|FG000|NOT COMPLETED|Overall Study||42
10356313|NCT00469911|11495534|FG001|NOT COMPLETED|Overall Study||0
10356314|NCT00470054|11495539|FG000|STARTED|Overall Study||44
10356315|NCT00470054|11495539|FG000|COMPLETED|Overall Study||43
10356316|NCT00470054|11495539|FG000|NOT COMPLETED|Overall Study||1
10356317|NCT00470093|11495543|FG000|STARTED|Overall Study||2
10356318|NCT00470093|11495543|FG000|COMPLETED|Overall Study||0
10356319|NCT00470093|11495543|FG000|NOT COMPLETED|Overall Study||2
10356320|NCT00470106|11495551|FG000|STARTED|Overall Study||19
10356321|NCT00470106|11495552|FG001|STARTED|Overall Study||24
10716152|NCT02688387|11880049|FG006|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10716153|NCT02688387|11880050|FG007|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10716154|NCT02688387|11880051|FG008|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10356322|NCT00470106|11495553|FG002|STARTED|Overall Study||21
10356323|NCT00470106|11495554|FG003|STARTED|Overall Study||21
10356324|NCT00470106|11495551|FG000|COMPLETED|Overall Study||16
10356325|NCT00470106|11495552|FG001|COMPLETED|Overall Study||19
10356326|NCT00470106|11495553|FG002|COMPLETED|Overall Study||14
10356327|NCT00470106|11495554|FG003|COMPLETED|Overall Study||19
10356328|NCT00470106|11495551|FG000|NOT COMPLETED|Overall Study||3
10356329|NCT00470106|11495552|FG001|NOT COMPLETED|Overall Study||5
10356330|NCT00470106|11495553|FG002|NOT COMPLETED|Overall Study||7
10356331|NCT00470106|11495554|FG003|NOT COMPLETED|Overall Study||2
10356332|NCT00470158|11495573|FG000|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
10356333|NCT00470158|11495574|FG001|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|199
10356334|NCT00470158|11495575|FG002|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
10356335|NCT00470158|11495576|FG003|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|198
10356336|NCT00470158|11495577|FG004|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
10356337|NCT00470158|11495573|FG000|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
10533885|NCT01427504|11686005|FG001|Received Boceprevir|Overall Study||3
10533886|NCT01427504|11686006|FG002|Received Boceprevir|Overall Study||3
10533887|NCT01427504|11686007|FG003|Received Boceprevir|Overall Study||5
10533888|NCT01427504|11686008|FG004|Received Boceprevir|Overall Study||2
10533889|NCT01427504|11686009|FG005|Received Boceprevir|Overall Study||4
10533890|NCT01427504|11686004|FG000|Received Etravirine|Overall Study||4
10533891|NCT01427504|11686005|FG001|Received Etravirine|Overall Study||2
10533892|NCT01427504|11686006|FG002|Received Etravirine|Overall Study||4
10533893|NCT01427504|11686007|FG003|Received Etravirine|Overall Study||6
10533894|NCT01427504|11686008|FG004|Received Etravirine|Overall Study||2
10533895|NCT01427504|11686009|FG005|Received Etravirine|Overall Study||4
10533896|NCT01427504|11686004|FG000|Received Combination|Overall Study||4
10533897|NCT01427504|11686005|FG001|Received Combination|Overall Study||3
10533898|NCT01427504|11686006|FG002|Received Combination|Overall Study||3
10533899|NCT01427504|11686007|FG003|Received Combination|Overall Study||6
10533900|NCT01427504|11686008|FG004|Received Combination|Overall Study||3
10533901|NCT01427504|11686009|FG005|Received Combination|Overall Study||6
10533902|NCT01427504|11686004|FG000|COMPLETED|Overall Study||4
10533903|NCT01427504|11686005|FG001|COMPLETED|Overall Study||2
10533904|NCT01427504|11686006|FG002|COMPLETED|Overall Study||3
10533905|NCT01427504|11686007|FG003|COMPLETED|Overall Study||5
10533906|NCT01427504|11686008|FG004|COMPLETED|Overall Study||2
10533907|NCT01427504|11686009|FG005|COMPLETED|Overall Study||4
10533908|NCT01427504|11686004|FG000|NOT COMPLETED|Overall Study||0
10533909|NCT01427504|11686005|FG001|NOT COMPLETED|Overall Study||1
10533910|NCT01427504|11686006|FG002|NOT COMPLETED|Overall Study||1
10533911|NCT01427504|11686007|FG003|NOT COMPLETED|Overall Study||1
10533912|NCT01427504|11686008|FG004|NOT COMPLETED|Overall Study||1
10533913|NCT01427504|11686009|FG005|NOT COMPLETED|Overall Study||2
10656215|NCT02215616|11817136|FG000|STARTED|Overall Study||108
10656216|NCT02215616|11817137|FG001|STARTED|Overall Study||107
10656217|NCT02215616|11817138|FG002|STARTED|Overall Study||107
10656218|NCT02215616|11817139|FG003|STARTED|Overall Study||30
10656219|NCT02215616|11817136|FG000|Received at Least 1 Dose of Study Drug|Overall Study||108
10656220|NCT02215616|11817137|FG001|Received at Least 1 Dose of Study Drug|Overall Study||107
10656221|NCT02215616|11817138|FG002|Received at Least 1 Dose of Study Drug|Overall Study||106
10656222|NCT02215616|11817139|FG003|Received at Least 1 Dose of Study Drug|Overall Study||29
10656223|NCT02215616|11817136|FG000|COMPLETED|Overall Study||97
10656224|NCT02215616|11817137|FG001|COMPLETED|Overall Study||90
10656225|NCT02215616|11817138|FG002|COMPLETED|Overall Study||93
10656226|NCT02215616|11817139|FG003|COMPLETED|Overall Study||17
10716155|NCT02688387|11880052|FG009|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10716156|NCT02688387|11880053|FG010|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10356338|NCT00470158|11495574|FG001|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|191
10356339|NCT00470158|11495575|FG002|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
10356340|NCT00470158|11495576|FG003|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
10356341|NCT00470158|11495577|FG004|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|195
10356342|NCT00470158|11495573|FG000|NOT COMPLETED|Overall Study||8
10356343|NCT00470158|11495574|FG001|NOT COMPLETED|Overall Study||8
10533914|NCT01427517|11686029|FG000|STARTED|Overall Study||3
10533915|NCT01427517|11686030|FG001|STARTED|Overall Study||3
10533916|NCT01427517|11686031|FG002|STARTED|Overall Study||3
10533917|NCT01427517|11686029|FG000|COMPLETED|Overall Study||3
10356344|NCT00470158|11495575|FG002|NOT COMPLETED|Overall Study||8
10356345|NCT00470158|11495576|FG003|NOT COMPLETED|Overall Study||5
10356346|NCT00470158|11495577|FG004|NOT COMPLETED|Overall Study||6
10356347|NCT00470184|11495589|FG000|STARTED|Overall Study||41
10356348|NCT00470184|11495589|FG000|Treated With Study Therapy|Overall Study||36
10356349|NCT00470184|11495589|FG000|COMPLETED|Overall Study||19
10356350|NCT00470184|11495589|FG000|NOT COMPLETED|Overall Study||22
10356351|NCT00470262|11495596|FG000|STARTED|Overall Study||15
10356352|NCT00470262|11495597|FG001|STARTED|Overall Study||12
10356353|NCT00470262|11495596|FG000|COMPLETED|Overall Study||13
10356354|NCT00470262|11495597|FG001|COMPLETED|Overall Study||12
10356355|NCT00470262|11495596|FG000|NOT COMPLETED|Overall Study||2
10356356|NCT00470262|11495597|FG001|NOT COMPLETED|Overall Study||0
10356357|NCT00470275|11495604|FG000|STARTED|Overall Study||10
10356358|NCT00470275|11495604|FG000|COMPLETED|Overall Study||0
10356359|NCT00470275|11495604|FG000|NOT COMPLETED|Overall Study||10
10356360|NCT00470301|11495608|FG000|STARTED|Overall Study||60
10356361|NCT00470301|11495608|FG000|COMPLETED|Overall Study||55
10356362|NCT00470301|11495608|FG000|NOT COMPLETED|Overall Study||5
10356363|NCT00470366|11495613|FG000|STARTED|Overall Study||60
10356364|NCT00470366|11495613|FG000|COMPLETED|Overall Study||56
10356365|NCT00470366|11495613|FG000|NOT COMPLETED|Overall Study||4
10356366|NCT00470392|11495619|FG000|STARTED|Overall Study|Number of subjects enrolled, passed screening and assigned to this arm.|7
10356367|NCT00470392|11495620|FG001|STARTED|Overall Study|Number of subjects enrolled, passed screening and assigned to this arm.|2
10356368|NCT00470392|11495619|FG000|COMPLETED|Overall Study||7
10356369|NCT00470392|11495620|FG001|COMPLETED|Overall Study||2
10356370|NCT00470392|11495619|FG000|NOT COMPLETED|Overall Study||0
10356371|NCT00470392|11495620|FG001|NOT COMPLETED|Overall Study||0
10356372|NCT00470418|11495629|FG000|STARTED|Overall Study||7
10356373|NCT00470418|11495630|FG001|STARTED|Overall Study||3
10356374|NCT00470418|11495629|FG000|COMPLETED|Overall Study||6
10356375|NCT00470418|11495630|FG001|COMPLETED|Overall Study||3
10356376|NCT00470418|11495629|FG000|NOT COMPLETED|Overall Study||1
10356377|NCT00470418|11495630|FG001|NOT COMPLETED|Overall Study||0
10356378|NCT00470470|11495636|FG000|STARTED|Overall Study||30
10356379|NCT00470470|11495636|FG000|COMPLETED|Overall Study||25
10356380|NCT00470470|11495636|FG000|NOT COMPLETED|Overall Study||5
10356381|NCT00470535|11495640|FG000|STARTED|Overall Study||18
10356382|NCT00470535|11495640|FG000|COMPLETED|Overall Study||0
10356383|NCT00470535|11495640|FG000|NOT COMPLETED|Overall Study||18
10356384|NCT00470548|11495646|FG000|STARTED|Overall Study||3
10356385|NCT00470548|11495647|FG001|STARTED|Overall Study||3
10356386|NCT00470548|11495648|FG002|STARTED|Overall Study||6
10356387|NCT00470548|11495649|FG003|STARTED|Overall Study||37
10356388|NCT00470548|11495646|FG000|COMPLETED|Overall Study||3
10356389|NCT00470548|11495647|FG001|COMPLETED|Overall Study||3
10356390|NCT00470548|11495648|FG002|COMPLETED|Overall Study||6
10356391|NCT00470548|11495649|FG003|COMPLETED|Overall Study||37
10356392|NCT00470548|11495646|FG000|NOT COMPLETED|Overall Study||0
10356393|NCT00470548|11495647|FG001|NOT COMPLETED|Overall Study||0
10356394|NCT00470548|11495648|FG002|NOT COMPLETED|Overall Study||0
10356395|NCT00470548|11495649|FG003|NOT COMPLETED|Overall Study||0
10356396|NCT00470600|11495661|FG000|STARTED|Overall Study||86
10356397|NCT00470600|11495662|FG001|STARTED|Overall Study||99
10356398|NCT00470600|11495661|FG000|COMPLETED|Overall Study|Two subjects were randomized to incorrect stratification categories (weight).|86
10356399|NCT00470600|11495662|FG001|COMPLETED|Overall Study|One subject was randomized to incorrect stratification categories (weight).|99
10356400|NCT00470600|11495661|FG000|NOT COMPLETED|Overall Study||0
10356401|NCT00470600|11495662|FG001|NOT COMPLETED|Overall Study||0
10356402|NCT00470626|11495668|FG000|STARTED|Overall Study||129
10356403|NCT00470626|11495668|FG000|COMPLETED|Overall Study||112
10356404|NCT00470626|11495668|FG000|NOT COMPLETED|Overall Study||17
10356405|NCT00470717|11495672|FG000|STARTED|Overall Study|Each participant could be called up to 4 times weekly for 13 weeks (38x4x13)|38
10356406|NCT00470717|11495672|FG000|COMPLETED|Overall Study||38
10356407|NCT00470717|11495672|FG000|NOT COMPLETED|Overall Study||0
10356408|NCT00470834|11495678|FG000|STARTED|Treatment Period (18 Months)||65
10356409|NCT00470834|11495679|FG001|STARTED|Treatment Period (18 Months)||62
10356410|NCT00470834|11495678|FG000|COMPLETED|Treatment Period (18 Months)||27
10356411|NCT00470834|11495679|FG001|COMPLETED|Treatment Period (18 Months)||31
10356412|NCT00470834|11495678|FG000|NOT COMPLETED|Treatment Period (18 Months)||38
10356413|NCT00470834|11495679|FG001|NOT COMPLETED|Treatment Period (18 Months)||31
10356414|NCT00470834|11495678|FG000|STARTED|Extension Period (24 Months)|One participant who completed the Treatment Period did not participate in the Extension Period.|26
10356415|NCT00470834|11495679|FG001|STARTED|Extension Period (24 Months)|One participant who completed the Treatment Period did not participate in the Extension Period.|30
10356416|NCT00470834|11495678|FG000|COMPLETED|Extension Period (24 Months)||11
10356417|NCT00470834|11495679|FG001|COMPLETED|Extension Period (24 Months)||7
10356418|NCT00470834|11495678|FG000|NOT COMPLETED|Extension Period (24 Months)||15
10356419|NCT00470834|11495679|FG001|NOT COMPLETED|Extension Period (24 Months)||23
10356420|NCT00470847|11495685|FG000|STARTED|Overall Study||35
10533918|NCT01427517|11686030|FG001|COMPLETED|Overall Study||3
10533919|NCT01427517|11686031|FG002|COMPLETED|Overall Study||3
10356421|NCT00470847|11495685|FG000|COMPLETED|Overall Study||34
10356422|NCT00470847|11495685|FG000|NOT COMPLETED|Overall Study||1
10356423|NCT00471068|11495693|FG000|STARTED|Overall Study||21
10356424|NCT00471068|11495694|FG001|STARTED|Overall Study||25
10356425|NCT00471068|11495693|FG000|COMPLETED|Overall Study||20
10356426|NCT00471068|11495694|FG001|COMPLETED|Overall Study||24
10356427|NCT00471068|11495693|FG000|NOT COMPLETED|Overall Study||1
10356428|NCT00471068|11495694|FG001|NOT COMPLETED|Overall Study||1
10356429|NCT00471081|11495702|FG000|STARTED|Active Phase||160
10356430|NCT00471081|11495703|FG001|STARTED|Active Phase||189
10356431|NCT00471081|11495702|FG000|COMPLETED|Active Phase||158
10356432|NCT00471081|11495703|FG001|COMPLETED|Active Phase||176
10356433|NCT00471081|11495702|FG000|NOT COMPLETED|Active Phase||2
10356434|NCT00471081|11495703|FG001|NOT COMPLETED|Active Phase||13
10356435|NCT00471081|11495702|FG000|STARTED|Extended Safety Follow-Up||160
10356436|NCT00471081|11495703|FG001|STARTED|Extended Safety Follow-Up||189
10356437|NCT00471081|11495702|FG000|COMPLETED|Extended Safety Follow-Up||158
10356438|NCT00471081|11495703|FG001|COMPLETED|Extended Safety Follow-Up||176
10356439|NCT00471081|11495702|FG000|NOT COMPLETED|Extended Safety Follow-Up||2
10356440|NCT00471081|11495703|FG001|NOT COMPLETED|Extended Safety Follow-Up||13
10356441|NCT00471107|11495713|FG000|STARTED|Overall Study||15
10356442|NCT00471107|11495714|FG001|STARTED|Overall Study||15
10356443|NCT00471107|11495715|FG002|STARTED|Overall Study||15
10356444|NCT00471107|11495713|FG000|COMPLETED|Overall Study||12
10356445|NCT00471107|11495714|FG001|COMPLETED|Overall Study||14
10356446|NCT00471107|11495715|FG002|COMPLETED|Overall Study||12
10356447|NCT00471107|11495713|FG000|NOT COMPLETED|Overall Study||3
10356448|NCT00471107|11495714|FG001|NOT COMPLETED|Overall Study||1
10356449|NCT00471107|11495715|FG002|NOT COMPLETED|Overall Study||3
10356450|NCT00471146|11495725|FG000|STARTED|Overall Study||314
10356451|NCT00471146|11495726|FG001|STARTED|Overall Study||316
10356452|NCT00471146|11495725|FG000|Treated|Overall Study||305
10356453|NCT00471146|11495726|FG001|Treated|Overall Study||308
10356454|NCT00471146|11495725|FG000|COMPLETED|Overall Study||142
10356455|NCT00471146|11495726|FG001|COMPLETED|Overall Study||142
10356456|NCT00471146|11495725|FG000|NOT COMPLETED|Overall Study||172
10356457|NCT00471146|11495726|FG001|NOT COMPLETED|Overall Study||174
10356458|NCT00471237|11495739|FG000|STARTED|Overall Study||90
10356459|NCT00471237|11495740|FG001|STARTED|Overall Study||87
10356460|NCT00471237|11495741|FG002|STARTED|Overall Study||82
10356461|NCT00471237|11495742|FG003|STARTED|Overall Study||88
10356462|NCT00471237|11495743|FG004|STARTED|Overall Study||87
10356463|NCT00471237|11495744|FG005|STARTED|Overall Study||89
10356464|NCT00471237|11495745|FG006|STARTED|Overall Study||41
10356465|NCT00471237|11495739|FG000|COMPLETED|Overall Study||49
10356466|NCT00471237|11495740|FG001|COMPLETED|Overall Study||45
10356467|NCT00471237|11495741|FG002|COMPLETED|Overall Study||48
10356468|NCT00471237|11495742|FG003|COMPLETED|Overall Study||43
10356469|NCT00471237|11495743|FG004|COMPLETED|Overall Study||46
10356470|NCT00471237|11495744|FG005|COMPLETED|Overall Study||50
10356471|NCT00471237|11495745|FG006|COMPLETED|Overall Study||38
10356472|NCT00471237|11495739|FG000|NOT COMPLETED|Overall Study||41
10356473|NCT00471237|11495740|FG001|NOT COMPLETED|Overall Study||42
10356474|NCT00471237|11495741|FG002|NOT COMPLETED|Overall Study||34
10356475|NCT00471237|11495742|FG003|NOT COMPLETED|Overall Study||45
10356476|NCT00471237|11495743|FG004|NOT COMPLETED|Overall Study||41
10356477|NCT00471237|11495744|FG005|NOT COMPLETED|Overall Study||39
10356478|NCT00471237|11495745|FG006|NOT COMPLETED|Overall Study||3
10356479|NCT00471276|11495765|FG000|STARTED|Overall Study||83
10356480|NCT00471276|11495765|FG000|COMPLETED|Overall Study||0
10356481|NCT00471276|11495765|FG000|NOT COMPLETED|Overall Study||83
10356482|NCT00471315|11495769|FG000|STARTED|Overall Study||18
10356483|NCT00471315|11495769|FG000|COMPLETED|Overall Study||10
10356484|NCT00471315|11495769|FG000|NOT COMPLETED|Overall Study||8
10356485|NCT00471328|11495775|FG000|STARTED|Core Phase||165
10356486|NCT00471328|11495776|FG001|STARTED|Core Phase||83
10356487|NCT00471328|11495775|FG000|Crossover to Nilotinib:Started Extension|Core Phase||0
10356488|NCT00471328|11495776|FG001|Crossover to Nilotinib:Started Extension|Core Phase||53
10356489|NCT00471328|11495775|FG000|COMPLETED|Core Phase|Ongoing on treatment during completion of core.|58
10356490|NCT00471328|11495776|FG001|COMPLETED|Core Phase|Ongoing on treatment during completion of core|16
10356491|NCT00471328|11495775|FG000|NOT COMPLETED|Core Phase||107
10356492|NCT00471328|11495776|FG001|NOT COMPLETED|Core Phase||67
10533920|NCT01427517|11686029|FG000|NOT COMPLETED|Overall Study||0
10533921|NCT01427517|11686030|FG001|NOT COMPLETED|Overall Study||0
10533922|NCT01427517|11686031|FG002|NOT COMPLETED|Overall Study||0
10533923|NCT01427595|11686039|FG000|STARTED|Overall Study||25
10533924|NCT01427595|11686039|FG000|COMPLETED|Overall Study||12
10533925|NCT01427595|11686039|FG000|NOT COMPLETED|Overall Study||13
10533926|NCT01427608|11686045|FG000|STARTED|Overall Study||64
10533927|NCT01427608|11686046|FG001|STARTED|Overall Study||62
10533928|NCT01427608|11686045|FG000|COMPLETED|Overall Study||43
10533929|NCT01427608|11686046|FG001|COMPLETED|Overall Study||24
10356493|NCT00471328|11495775|FG000|STARTED|Extension Phase|Out of 58 ongoing patients, 17 patients had progression or died before they could enter extension|41
10356494|NCT00471328|11495776|FG001|STARTED|Extension Phase||67
10356495|NCT00471328|11495775|FG000|Started:CrossOver Before PrimaryAnalysis|Extension Phase||0
10356496|NCT00471328|11495776|FG001|Started:CrossOver Before PrimaryAnalysis|Extension Phase||53
10356497|NCT00471328|11495775|FG000|Started:CrossOver After PrimaryAnalysis|Extension Phase||0
10356498|NCT00471328|11495776|FG001|Started:CrossOver After PrimaryAnalysis|Extension Phase||4
10356499|NCT00471328|11495775|FG000|Started:CrossOver During Extension|Extension Phase||0
10356500|NCT00471328|11495776|FG001|Started:CrossOver During Extension|Extension Phase||10
10533930|NCT01427608|11686045|FG000|NOT COMPLETED|Overall Study||21
10533931|NCT01427608|11686046|FG001|NOT COMPLETED|Overall Study||38
10533932|NCT01427738|11686056|FG000|STARTED|Overall Study||110
10356501|NCT00471328|11495775|FG000|COMPLETED|Extension Phase||0
10356502|NCT00471328|11495776|FG001|COMPLETED|Extension Phase||0
10356503|NCT00471328|11495775|FG000|NOT COMPLETED|Extension Phase||41
10356504|NCT00471328|11495776|FG001|NOT COMPLETED|Extension Phase||67
10356505|NCT00471354|11495784|FG000|STARTED|Overall Study||228
10356506|NCT00471354|11495784|FG000|COMPLETED|Overall Study||176
10356507|NCT00471354|11495784|FG000|NOT COMPLETED|Overall Study||52
10356508|NCT00471380|11495788|FG000|STARTED|First Intervention||22
10356509|NCT00471380|11495789|FG001|STARTED|First Intervention||24
10356510|NCT00471380|11495788|FG000|COMPLETED|First Intervention||18
10356511|NCT00471380|11495789|FG001|COMPLETED|First Intervention||20
10356512|NCT00471380|11495788|FG000|NOT COMPLETED|First Intervention||4
10356513|NCT00471380|11495789|FG001|NOT COMPLETED|First Intervention||4
10356514|NCT00471380|11495788|FG000|STARTED|Second Intervention||18
10356515|NCT00471380|11495789|FG001|STARTED|Second Intervention||20
10356516|NCT00471380|11495788|FG000|COMPLETED|Second Intervention||18
10356517|NCT00471380|11495789|FG001|COMPLETED|Second Intervention||16
10356518|NCT00471380|11495788|FG000|NOT COMPLETED|Second Intervention||0
10356519|NCT00471380|11495789|FG001|NOT COMPLETED|Second Intervention||4
10356520|NCT00471380|11495788|FG000|STARTED|Third Intervention||18
10356521|NCT00471380|11495789|FG001|STARTED|Third Intervention||16
10356522|NCT00471380|11495788|FG000|COMPLETED|Third Intervention||17
10356523|NCT00471380|11495789|FG001|COMPLETED|Third Intervention||14
10356524|NCT00471380|11495788|FG000|NOT COMPLETED|Third Intervention||1
10356525|NCT00471380|11495789|FG001|NOT COMPLETED|Third Intervention||2
10356526|NCT00471445|11495797|FG000|STARTED|Overall Study||229
10356527|NCT00471445|11495798|FG001|STARTED|Overall Study||233
10356528|NCT00471445|11495797|FG000|COMPLETED|Overall Study||227
10356529|NCT00471445|11495798|FG001|COMPLETED|Overall Study||231
10356530|NCT00471445|11495797|FG000|NOT COMPLETED|Overall Study||2
10356531|NCT00471445|11495798|FG001|NOT COMPLETED|Overall Study||2
10356532|NCT00471497|11495807|FG000|STARTED|Core Treatment Phase||283
10356533|NCT00471497|11495808|FG001|STARTED|Core Treatment Phase||282
10356534|NCT00471497|11495809|FG002|STARTED|Core Treatment Phase||281
10356535|NCT00471497|11495807|FG000|Safety Analysis Set|Core Treatment Phase|Safety set contained patients who received at least one dose of study medication.|280
10356536|NCT00471497|11495808|FG001|Safety Analysis Set|Core Treatment Phase|Safety set contained patients who received at least one dose of study medication.|279
10356537|NCT00471497|11495809|FG002|Safety Analysis Set|Core Treatment Phase|Safety set contained patients who received at least one dose of study medication.|277
10356538|NCT00471497|11495807|FG000|Discon. Core/Did Not Enter Ext.|Core Treatment Phase||235
10356539|NCT00471497|11495808|FG001|Discon. Core/Did Not Enter Ext.|Core Treatment Phase||256
10356540|NCT00471497|11495809|FG002|Discon. Core/Did Not Enter Ext.|Core Treatment Phase||278
10356541|NCT00471497|11495807|FG000|Discontinued Core/Entered Ext.|Core Treatment Phase||48
10356542|NCT00471497|11495808|FG001|Discontinued Core/Entered Ext.|Core Treatment Phase||26
10356543|NCT00471497|11495809|FG002|Discontinued Core/Entered Ext.|Core Treatment Phase||3
10356544|NCT00471497|11495807|FG000|COMPLETED|Core Treatment Phase||99
10356545|NCT00471497|11495808|FG001|COMPLETED|Core Treatment Phase||107
10356546|NCT00471497|11495809|FG002|COMPLETED|Core Treatment Phase||99
10356547|NCT00471497|11495807|FG000|NOT COMPLETED|Core Treatment Phase||184
10356548|NCT00471497|11495808|FG001|NOT COMPLETED|Core Treatment Phase||175
10356549|NCT00471497|11495809|FG002|NOT COMPLETED|Core Treatment Phase||182
10356550|NCT00471497|11495807|FG000|STARTED|Extension Phase||48
10356551|NCT00471497|11495808|FG001|STARTED|Extension Phase||26
10356552|NCT00471497|11495809|FG002|STARTED|Extension Phase||3
10356553|NCT00471497|11495807|FG000|COMPLETED|Extension Phase||21
10356554|NCT00471497|11495808|FG001|COMPLETED|Extension Phase||12
10356555|NCT00471497|11495809|FG002|COMPLETED|Extension Phase||2
10533933|NCT01427738|11686057|FG001|STARTED|Overall Study||111
10533934|NCT01427738|11686056|FG000|COMPLETED|Overall Study||91
10533935|NCT01427738|11686057|FG001|COMPLETED|Overall Study||90
10533936|NCT01427738|11686056|FG000|NOT COMPLETED|Overall Study||19
10533937|NCT01427738|11686057|FG001|NOT COMPLETED|Overall Study||21
10533938|NCT01427751|11686065|FG000|STARTED|Overall Study||154
10533939|NCT01427751|11686066|FG001|STARTED|Overall Study||153
10533940|NCT01427751|11686065|FG000|COMPLETED|Overall Study||112
10533941|NCT01427751|11686066|FG001|COMPLETED|Overall Study||139
10533942|NCT01427751|11686065|FG000|NOT COMPLETED|Overall Study||42
10533943|NCT01427751|11686066|FG001|NOT COMPLETED|Overall Study||14
10533944|NCT01427803|11686074|FG000|STARTED|Overall Study||526
10533945|NCT01427803|11686075|FG001|STARTED|Overall Study||252
10533946|NCT01427803|11686074|FG000|Purchased Product|Overall Study|Only 516 participants used e-diary|525
10533947|NCT01427803|11686075|FG001|Purchased Product|Overall Study||252
10533948|NCT01427803|11686074|FG000|Baseline Assessment|Overall Study||516
10533949|NCT01427803|11686075|FG001|Baseline Assessment|Overall Study|only interviewed participants were assessed|130
10533950|NCT01427803|11686074|FG000|Took Product|Overall Study|Those who took at least one dose of investigational product. Only 502 qualified for data analysis.|508
10356634|NCT00472303|11495902|FG002|COMPLETED|Maintenance Phase||95
10533951|NCT01427803|11686075|FG001|Took Product|Overall Study|Those who took at least one dose of investigational product as logged in e diary & 1 on Health Log.|237
10533952|NCT01427803|11686074|FG000|COMPLETED|Overall Study||463
10533953|NCT01427803|11686075|FG001|COMPLETED|Overall Study|130 participants interviewed. Remaining subjects continued in trial to collect safety information.|226
10533954|NCT01427803|11686074|FG000|NOT COMPLETED|Overall Study||63
10356556|NCT00471497|11495807|FG000|NOT COMPLETED|Extension Phase||27
10356557|NCT00471497|11495808|FG001|NOT COMPLETED|Extension Phase||14
10356558|NCT00471497|11495809|FG002|NOT COMPLETED|Extension Phase||1
10356559|NCT00471536|11495820|FG000|STARTED|Overall Study||19
10356560|NCT00471536|11495820|FG000|COMPLETED|Overall Study||18
10356561|NCT00471536|11495820|FG000|NOT COMPLETED|Overall Study||1
10356562|NCT00471705|11495827|FG000|STARTED|Overall Study||145
10356563|NCT00471705|11495828|FG001|STARTED|Overall Study||143
10356564|NCT00471705|11495829|FG002|STARTED|Overall Study||149
10356565|NCT00471705|11495827|FG000|COMPLETED|Overall Study||121
10356566|NCT00471705|11495828|FG001|COMPLETED|Overall Study||121
10356567|NCT00471705|11495829|FG002|COMPLETED|Overall Study||134
10356568|NCT00471705|11495827|FG000|NOT COMPLETED|Overall Study||24
10356569|NCT00471705|11495828|FG001|NOT COMPLETED|Overall Study||22
10356570|NCT00471705|11495829|FG002|NOT COMPLETED|Overall Study||15
10356571|NCT00471718|11495837|FG000|STARTED|Overall Study||27
10356572|NCT00471718|11495837|FG000|COMPLETED|Overall Study||0
10356573|NCT00471718|11495837|FG000|NOT COMPLETED|Overall Study||27
10356574|NCT00471822|11495845|FG000|STARTED|Overall Study||9707
10356575|NCT00471822|11495845|FG000|Treated|Overall Study||9705
10356576|NCT00471822|11495845|FG000|COMPLETED|Overall Study||9705
10356577|NCT00471822|11495845|FG000|NOT COMPLETED|Overall Study||2
10356578|NCT00471848|11495849|FG000|STARTED|Overall Study||35
10356579|NCT00471848|11495849|FG000|COMPLETED|Overall Study|35 registered patients received the full 5-day Rabbit Antithymocyte Globuline (RATG) treatment|35
10356580|NCT00471848|11495849|FG000|NOT COMPLETED|Overall Study||0
10356581|NCT00471887|11495853|FG000|STARTED|Overall Study||32
10356582|NCT00471887|11495853|FG000|COMPLETED|Overall Study||23
10356583|NCT00471887|11495853|FG000|NOT COMPLETED|Overall Study||9
10356584|NCT00472030|11495859|FG000|STARTED|Overall Study||2
10356585|NCT00472030|11495860|FG001|STARTED|Overall Study||0
10356586|NCT00472030|11495859|FG000|COMPLETED|Overall Study||1
10356587|NCT00472030|11495860|FG001|COMPLETED|Overall Study||0
10356588|NCT00472030|11495859|FG000|NOT COMPLETED|Overall Study||1
10356589|NCT00472030|11495860|FG001|NOT COMPLETED|Overall Study||0
10356590|NCT00472056|11495874|FG000|STARTED|Overall Study||25
10356591|NCT00472056|11495875|FG001|STARTED|Overall Study||19
10356592|NCT00472056|11495876|FG002|STARTED|Overall Study||32
10356593|NCT00472056|11495877|FG003|STARTED|Overall Study||17
10356594|NCT00472056|11495874|FG000|COMPLETED|Overall Study||25
10356595|NCT00472056|11495875|FG001|COMPLETED|Overall Study||19
10356596|NCT00472056|11495876|FG002|COMPLETED|Overall Study||32
10356597|NCT00472056|11495877|FG003|COMPLETED|Overall Study||17
10356598|NCT00472056|11495874|FG000|NOT COMPLETED|Overall Study||0
10356599|NCT00472056|11495875|FG001|NOT COMPLETED|Overall Study||0
10356600|NCT00472056|11495876|FG002|NOT COMPLETED|Overall Study||0
10356601|NCT00472056|11495877|FG003|NOT COMPLETED|Overall Study||0
10356602|NCT00472199|11495887|FG000|STARTED|Overall Study||166
10356603|NCT00472199|11495888|FG001|STARTED|Overall Study||163
10356604|NCT00472199|11495887|FG000|COMPLETED|Overall Study||131
10356605|NCT00472199|11495888|FG001|COMPLETED|Overall Study||103
10356606|NCT00472199|11495887|FG000|NOT COMPLETED|Overall Study||35
10356607|NCT00472199|11495888|FG001|NOT COMPLETED|Overall Study||60
10356608|NCT00472290|11495894|FG000|STARTED|Overall Study||72
10356609|NCT00472290|11495894|FG000|COMPLETED|Overall Study||0
10356610|NCT00472290|11495894|FG000|NOT COMPLETED|Overall Study||72
10356611|NCT00472303|11495900|FG000|STARTED|Titration Phase||338
10356612|NCT00472303|11495901|FG001|STARTED|Titration Phase||158
10356613|NCT00472303|11495902|FG002|STARTED|Titration Phase|All participants in the titration phase were in the tapentadol arm during the titration phase.|0
10356614|NCT00472303|11495900|FG000|COMPLETED|Titration Phase||279
10356615|NCT00472303|11495901|FG001|COMPLETED|Titration Phase||129
10356616|NCT00472303|11495902|FG002|COMPLETED|Titration Phase||0
10356617|NCT00472303|11495900|FG000|NOT COMPLETED|Titration Phase||59
10356618|NCT00472303|11495901|FG001|NOT COMPLETED|Titration Phase||29
10356619|NCT00472303|11495902|FG002|NOT COMPLETED|Titration Phase||0
10356620|NCT00472303|11495900|FG000|STARTED|Discontinuations After Titration Phase||279
10356621|NCT00472303|11495901|FG001|STARTED|Discontinuations After Titration Phase||129
10356622|NCT00472303|11495902|FG002|STARTED|Discontinuations After Titration Phase||0
10356623|NCT00472303|11495900|FG000|COMPLETED|Discontinuations After Titration Phase|Participants meeting stabilization criteria on days 13-15 in the titration phase were re-randomized.|218
10356624|NCT00472303|11495901|FG001|COMPLETED|Discontinuations After Titration Phase|Participants meeting stabilization criteria on days 13-15 in the titration phase were re-randomized.|109
10356625|NCT00472303|11495902|FG002|COMPLETED|Discontinuations After Titration Phase||0
10356626|NCT00472303|11495900|FG000|NOT COMPLETED|Discontinuations After Titration Phase||61
10356627|NCT00472303|11495901|FG001|NOT COMPLETED|Discontinuations After Titration Phase||20
10356628|NCT00472303|11495902|FG002|NOT COMPLETED|Discontinuations After Titration Phase||0
10356629|NCT00472303|11495900|FG000|STARTED|Maintenance Phase|106 of 218 participants in the tapentadol titration arm were re-randomized and treated.|106
10356630|NCT00472303|11495901|FG001|STARTED|Maintenance Phase||109
10356631|NCT00472303|11495902|FG002|STARTED|Maintenance Phase|112 of 218 participants in the tapentadol titration arm were re-randomized and treated.|112
10356632|NCT00472303|11495900|FG000|COMPLETED|Maintenance Phase||89
10356633|NCT00472303|11495901|FG001|COMPLETED|Maintenance Phase||93
10356635|NCT00472303|11495900|FG000|NOT COMPLETED|Maintenance Phase||17
10356636|NCT00472303|11495901|FG001|NOT COMPLETED|Maintenance Phase||16
10356637|NCT00472303|11495902|FG002|NOT COMPLETED|Maintenance Phase||17
10356638|NCT00472420|11495930|FG000|STARTED|Induction Treatment Period||48
10356639|NCT00472420|11495930|FG000|COMPLETED|Induction Treatment Period||32
10356640|NCT00472420|11495930|FG000|NOT COMPLETED|Induction Treatment Period||16
10356641|NCT00472420|11495930|FG000|STARTED|Follow-up Period||32
10356642|NCT00472420|11495930|FG000|COMPLETED|Follow-up Period||15
10356643|NCT00472420|11495930|FG000|NOT COMPLETED|Follow-up Period||17
10356644|NCT00472446|11495938|FG000|STARTED|Overall Study||46
10356645|NCT00472446|11495939|FG001|STARTED|Overall Study||47
10356646|NCT00472446|11495940|FG002|STARTED|Overall Study||45
10356647|NCT00472446|11495941|FG003|STARTED|Overall Study||45
10356648|NCT00472446|11495938|FG000|COMPLETED|Overall Study||41
10356649|NCT00472446|11495939|FG001|COMPLETED|Overall Study||41
10356650|NCT00472446|11495940|FG002|COMPLETED|Overall Study||38
10356651|NCT00472446|11495941|FG003|COMPLETED|Overall Study||39
10356652|NCT00472446|11495938|FG000|NOT COMPLETED|Overall Study||5
10356653|NCT00472446|11495939|FG001|NOT COMPLETED|Overall Study||6
10356654|NCT00472446|11495940|FG002|NOT COMPLETED|Overall Study||7
10356655|NCT00472446|11495941|FG003|NOT COMPLETED|Overall Study||6
10356656|NCT00472576|11495953|FG000|STARTED|First Intervention||2
10356657|NCT00472576|11495954|FG001|STARTED|First Intervention||3
10356658|NCT00472576|11495953|FG000|COMPLETED|First Intervention||2
10356659|NCT00472576|11495954|FG001|COMPLETED|First Intervention||3
10356660|NCT00472576|11495953|FG000|NOT COMPLETED|First Intervention||0
10356661|NCT00472576|11495954|FG001|NOT COMPLETED|First Intervention||0
10356662|NCT00472576|11495953|FG000|STARTED|Second Intervention||2
10356663|NCT00472576|11495954|FG001|STARTED|Second Intervention||3
10356664|NCT00472576|11495953|FG000|COMPLETED|Second Intervention||2
10356665|NCT00472576|11495954|FG001|COMPLETED|Second Intervention||3
10356666|NCT00472576|11495953|FG000|NOT COMPLETED|Second Intervention||0
10356667|NCT00472576|11495954|FG001|NOT COMPLETED|Second Intervention||0
10356668|NCT00472641|11495960|FG000|STARTED|Overall Study||25
10356669|NCT00472641|11495960|FG000|COMPLETED|Overall Study||18
10356670|NCT00472641|11495960|FG000|NOT COMPLETED|Overall Study||7
10533955|NCT01427803|11686075|FG001|NOT COMPLETED|Overall Study||26
10533956|NCT01427881|11686079|FG000|STARTED|Overall Study||43
10533957|NCT01427881|11686079|FG000|COMPLETED|Overall Study||43
10533958|NCT01427881|11686079|FG000|NOT COMPLETED|Overall Study||0
10533959|NCT01427907|11686085|FG000|STARTED|Overall Study|Randomized|20
10533960|NCT01427907|11686086|FG001|STARTED|Overall Study|Randomized|18
10533961|NCT01427907|11686085|FG000|COMPLETED|Overall Study|Completed study|17
10533962|NCT01427907|11686086|FG001|COMPLETED|Overall Study|Completed study|14
10533963|NCT01427907|11686085|FG000|NOT COMPLETED|Overall Study||3
10533964|NCT01427907|11686086|FG001|NOT COMPLETED|Overall Study||4
10533965|NCT01427920|11686094|FG000|STARTED|Overall Study||174
10533966|NCT01427920|11686095|FG001|STARTED|Overall Study||174
10533967|NCT01427920|11686094|FG000|Exposed|Overall Study||174
10533968|NCT01427920|11686095|FG001|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|173
10533969|NCT01427920|11686094|FG000|COMPLETED|Overall Study||165
10533970|NCT01427920|11686095|FG001|COMPLETED|Overall Study||157
10533971|NCT01427920|11686094|FG000|NOT COMPLETED|Overall Study||9
10533972|NCT01427920|11686095|FG001|NOT COMPLETED|Overall Study||17
10533973|NCT01427933|11686103|FG000|STARTED|Overall Study||71
10533974|NCT01427933|11686104|FG001|STARTED|Overall Study||70
10533975|NCT01427933|11686103|FG000|Received at Least 1 Dose of Study Drug|Overall Study||69
10533976|NCT01427933|11686104|FG001|Received at Least 1 Dose of Study Drug|Overall Study||65
10533977|NCT01427933|11686103|FG000|COMPLETED|Overall Study||63
10533978|NCT01427933|11686104|FG001|COMPLETED|Overall Study||57
10533979|NCT01427933|11686103|FG000|NOT COMPLETED|Overall Study||8
10533980|NCT01427933|11686104|FG001|NOT COMPLETED|Overall Study||13
10533981|NCT01427972|11686123|FG000|STARTED|Treatment Period 1 (21 Days)||3
10533982|NCT01427972|11686124|FG001|STARTED|Treatment Period 1 (21 Days)||4
10533983|NCT01427972|11686125|FG002|STARTED|Treatment Period 1 (21 Days)||4
10533984|NCT01427972|11686126|FG003|STARTED|Treatment Period 1 (21 Days)||3
10533985|NCT01427972|11686127|FG004|STARTED|Treatment Period 1 (21 Days)||4
10533986|NCT01427972|11686128|FG005|STARTED|Treatment Period 1 (21 Days)||3
10533987|NCT01427972|11686129|FG006|STARTED|Treatment Period 1 (21 Days)||3
10533988|NCT01427972|11686130|FG007|STARTED|Treatment Period 1 (21 Days)||5
10533989|NCT01427972|11686131|FG008|STARTED|Treatment Period 1 (21 Days)||3
10533990|NCT01427972|11686132|FG009|STARTED|Treatment Period 1 (21 Days)||3
10656227|NCT02215616|11817136|FG000|NOT COMPLETED|Overall Study||11
10656228|NCT02215616|11817137|FG001|NOT COMPLETED|Overall Study||17
10656229|NCT02215616|11817138|FG002|NOT COMPLETED|Overall Study||14
10656230|NCT02215616|11817139|FG003|NOT COMPLETED|Overall Study||13
10656231|NCT02215954|11817152|FG000|STARTED|Overall Study||214
10656232|NCT02215954|11817153|FG001|STARTED|Overall Study||212
10656233|NCT02215954|11817154|FG002|STARTED|Overall Study||211
10656234|NCT02215954|11817152|FG000|Intention-To-Treat (ITT) Analysis Set|Overall Study||214
10656235|NCT02215954|11817153|FG001|Intention-To-Treat (ITT) Analysis Set|Overall Study||212
10656236|NCT02215954|11817154|FG002|Intention-To-Treat (ITT) Analysis Set|Overall Study||211
10656237|NCT02215954|11817152|FG000|Per Protocol (PP) Analysis Set|Overall Study||212
10656238|NCT02215954|11817153|FG001|Per Protocol (PP) Analysis Set|Overall Study||208
10656239|NCT02215954|11817154|FG002|Per Protocol (PP) Analysis Set|Overall Study||205
10356671|NCT00472732|11495966|FG000|STARTED|Overall Study||24
10356672|NCT00472732|11495967|FG001|STARTED|Overall Study||22
10356673|NCT00472732|11495966|FG000|COMPLETED|Overall Study||24
10356674|NCT00472732|11495967|FG001|COMPLETED|Overall Study||22
10356675|NCT00472732|11495966|FG000|NOT COMPLETED|Overall Study||0
10356676|NCT00472732|11495967|FG001|NOT COMPLETED|Overall Study||0
10356677|NCT00472797|11495975|FG000|STARTED|Overall Study||119
10356678|NCT00472797|11495976|FG001|STARTED|Overall Study||113
10356679|NCT00472797|11495975|FG000|COMPLETED|Overall Study||115
10356680|NCT00472797|11495976|FG001|COMPLETED|Overall Study||112
10356681|NCT00472797|11495975|FG000|NOT COMPLETED|Overall Study||4
10356682|NCT00472797|11495976|FG001|NOT COMPLETED|Overall Study||1
10356683|NCT00472849|11495987|FG000|STARTED|Overall Study||12
10356684|NCT00472849|11495988|FG001|STARTED|Overall Study||78
10356685|NCT00472849|11495987|FG000|COMPLETED|Overall Study||12
10356686|NCT00472849|11495988|FG001|COMPLETED|Overall Study||78
10356687|NCT00472849|11495987|FG000|NOT COMPLETED|Overall Study||0
10356688|NCT00472849|11495988|FG001|NOT COMPLETED|Overall Study||0
10356689|NCT00473083|11495997|FG000|STARTED|Overall Study||50
10356690|NCT00473083|11495998|FG001|STARTED|Overall Study||50
10356691|NCT00473083|11495999|FG002|STARTED|Overall Study||50
10356692|NCT00473083|11495997|FG000|COMPLETED|Overall Study|One patient (2%) from treatment arm 1 discontinued the study drug as a result of a TEAE (dizziness)|49
10356693|NCT00473083|11495998|FG001|COMPLETED|Overall Study||50
10356694|NCT00473083|11495999|FG002|COMPLETED|Overall Study||50
10356695|NCT00473083|11495997|FG000|NOT COMPLETED|Overall Study||1
10356696|NCT00473083|11495998|FG001|NOT COMPLETED|Overall Study||0
10356697|NCT00473083|11495999|FG002|NOT COMPLETED|Overall Study||0
10356698|NCT00473265|11496010|FG000|STARTED|Overall Study||68
10716157|NCT02688387|11880054|FG011|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10716158|NCT02688387|11880055|FG012|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10356699|NCT00473265|11496010|FG000|COMPLETED|Overall Study||48
10356700|NCT00473265|11496010|FG000|NOT COMPLETED|Overall Study||20
10356701|NCT00473330|11496017|FG000|STARTED|Core Study||125
10356702|NCT00473330|11496018|FG001|STARTED|Core Study||125
10356703|NCT00473330|11496019|FG002|STARTED|Core Study||127
10356704|NCT00473330|11496017|FG000|COMPLETED|Core Study||98
10356705|NCT00473330|11496018|FG001|COMPLETED|Core Study||100
10356706|NCT00473330|11496019|FG002|COMPLETED|Core Study||86
10356707|NCT00473330|11496017|FG000|NOT COMPLETED|Core Study||27
10356708|NCT00473330|11496018|FG001|NOT COMPLETED|Core Study||25
10356709|NCT00473330|11496019|FG002|NOT COMPLETED|Core Study||41
10356710|NCT00473330|11496017|FG000|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|89
10356711|NCT00473330|11496018|FG001|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|79
10356712|NCT00473330|11496019|FG002|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|77
10356713|NCT00473330|11496017|FG000|COMPLETED|Open-label Extension Through Month 48||63
10356714|NCT00473330|11496018|FG001|COMPLETED|Open-label Extension Through Month 48||59
10356715|NCT00473330|11496019|FG002|COMPLETED|Open-label Extension Through Month 48||50
10356716|NCT00473330|11496017|FG000|NOT COMPLETED|Open-label Extension Through Month 48||26
10356717|NCT00473330|11496018|FG001|NOT COMPLETED|Open-label Extension Through Month 48||20
10356718|NCT00473330|11496019|FG002|NOT COMPLETED|Open-label Extension Through Month 48||27
10356719|NCT00473330|11496017|FG000|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|89
10356720|NCT00473330|11496018|FG001|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|79
10356721|NCT00473330|11496019|FG002|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|77
10356722|NCT00473330|11496017|FG000|COMPLETED|Open-label Extension Through Month 60||1
10356723|NCT00473330|11496018|FG001|COMPLETED|Open-label Extension Through Month 60||1
10356724|NCT00473330|11496019|FG002|COMPLETED|Open-label Extension Through Month 60||0
10356725|NCT00473330|11496017|FG000|NOT COMPLETED|Open-label Extension Through Month 60||88
10356726|NCT00473330|11496018|FG001|NOT COMPLETED|Open-label Extension Through Month 60||78
10356727|NCT00473330|11496019|FG002|NOT COMPLETED|Open-label Extension Through Month 60||77
10356728|NCT00473382|11496050|FG000|STARTED|Core Study||130
10356729|NCT00473382|11496051|FG001|STARTED|Core Study||125
10356730|NCT00473382|11496052|FG002|STARTED|Core Study||127
10356731|NCT00473382|11496050|FG000|COMPLETED|Core Study||102
10356732|NCT00473382|11496051|FG001|COMPLETED|Core Study||98
10356733|NCT00473382|11496052|FG002|COMPLETED|Core Study||98
10356734|NCT00473382|11496050|FG000|NOT COMPLETED|Core Study||28
10356735|NCT00473382|11496051|FG001|NOT COMPLETED|Core Study||27
10356736|NCT00473382|11496052|FG002|NOT COMPLETED|Core Study||29
10356737|NCT00473382|11496050|FG000|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|88
10356738|NCT00473382|11496051|FG001|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|83
10356739|NCT00473382|11496052|FG002|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|84
10356740|NCT00473382|11496050|FG000|COMPLETED|Open-label Extension Through Month 48||38
10356741|NCT00473382|11496051|FG001|COMPLETED|Open-label Extension Through Month 48||42
10356742|NCT00473382|11496052|FG002|COMPLETED|Open-label Extension Through Month 48||37
10356743|NCT00473382|11496050|FG000|NOT COMPLETED|Open-label Extension Through Month 48||50
10356744|NCT00473382|11496051|FG001|NOT COMPLETED|Open-label Extension Through Month 48||41
10356745|NCT00473382|11496052|FG002|NOT COMPLETED|Open-label Extension Through Month 48||47
10356746|NCT00473382|11496050|FG000|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|88
10716159|NCT02688387|11880056|FG013|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10716160|NCT02688387|11880057|FG014|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10716161|NCT02688387|11880058|FG015|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10716162|NCT02688387|11880059|FG016|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10356747|NCT00473382|11496051|FG001|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|83
10356748|NCT00473382|11496052|FG002|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|84
10356749|NCT00473382|11496050|FG000|COMPLETED|Open-label Extension Through Month 60||2
10356750|NCT00473382|11496051|FG001|COMPLETED|Open-label Extension Through Month 60||1
10356751|NCT00473382|11496052|FG002|COMPLETED|Open-label Extension Through Month 60||2
10356752|NCT00473382|11496050|FG000|NOT COMPLETED|Open-label Extension Through Month 60||86
10356753|NCT00473382|11496051|FG001|NOT COMPLETED|Open-label Extension Through Month 60||82
10356754|NCT00473382|11496052|FG002|NOT COMPLETED|Open-label Extension Through Month 60||82
10356755|NCT00473434|11496078|FG000|STARTED|Overall Study||64
10356756|NCT00473434|11496078|FG000|COMPLETED|Overall Study||32
10356757|NCT00473434|11496078|FG000|NOT COMPLETED|Overall Study||32
10356758|NCT00473512|11496100|FG000|STARTED|Period 1 (Phase 1)||3
10356759|NCT00473512|11496101|FG001|STARTED|Period 1 (Phase 1)||3
10356760|NCT00473512|11496102|FG002|STARTED|Period 1 (Phase 1)||3
10356761|NCT00473512|11496103|FG003|STARTED|Period 1 (Phase 1)||42
10356762|NCT00473512|11496104|FG004|STARTED|Period 1 (Phase 1)||3
10356763|NCT00473512|11496100|FG000|COMPLETED|Period 1 (Phase 1)||2
10356764|NCT00473512|11496101|FG001|COMPLETED|Period 1 (Phase 1)||2
10356765|NCT00473512|11496102|FG002|COMPLETED|Period 1 (Phase 1)||3
10356766|NCT00473512|11496103|FG003|COMPLETED|Period 1 (Phase 1)||25
10356767|NCT00473512|11496104|FG004|COMPLETED|Period 1 (Phase 1)||2
10356768|NCT00473512|11496100|FG000|NOT COMPLETED|Period 1 (Phase 1)||1
10356769|NCT00473512|11496101|FG001|NOT COMPLETED|Period 1 (Phase 1)||1
10356770|NCT00473512|11496102|FG002|NOT COMPLETED|Period 1 (Phase 1)||0
10356771|NCT00473512|11496103|FG003|NOT COMPLETED|Period 1 (Phase 1)||17
10356772|NCT00473512|11496104|FG004|NOT COMPLETED|Period 1 (Phase 1)||1
10356773|NCT00473512|11496100|FG000|STARTED|Period 2 (Phase 2)|1 participant did not continue to Phase 2 of the study.|1
10356774|NCT00473512|11496101|FG001|STARTED|Period 2 (Phase 2)||2
10356775|NCT00473512|11496102|FG002|STARTED|Period 2 (Phase 2)|1 participant did not continue to Phase 2 of the study.|2
10356776|NCT00473512|11496103|FG003|STARTED|Period 2 (Phase 2)|2 participants did not continue to Phase 2 of the study.|23
10356777|NCT00473512|11496104|FG004|STARTED|Period 2 (Phase 2)||2
10356778|NCT00473512|11496100|FG000|COMPLETED|Period 2 (Phase 2)||0
10356779|NCT00473512|11496101|FG001|COMPLETED|Period 2 (Phase 2)||0
10356780|NCT00473512|11496102|FG002|COMPLETED|Period 2 (Phase 2)||0
10356781|NCT00473512|11496103|FG003|COMPLETED|Period 2 (Phase 2)||0
10356782|NCT00473512|11496104|FG004|COMPLETED|Period 2 (Phase 2)||0
10356783|NCT00473512|11496100|FG000|NOT COMPLETED|Period 2 (Phase 2)||1
10356784|NCT00473512|11496101|FG001|NOT COMPLETED|Period 2 (Phase 2)||2
10356785|NCT00473512|11496102|FG002|NOT COMPLETED|Period 2 (Phase 2)||2
10356786|NCT00473512|11496103|FG003|NOT COMPLETED|Period 2 (Phase 2)||23
10356787|NCT00473512|11496104|FG004|NOT COMPLETED|Period 2 (Phase 2)||2
10356788|NCT00473564|11496124|FG000|STARTED|Overall Study||170
10356789|NCT00473564|11496124|FG000|COMPLETED|Overall Study||147
10356790|NCT00473564|11496124|FG000|NOT COMPLETED|Overall Study||23
10356791|NCT00473590|11496130|FG000|STARTED|Overall Study||53
10356792|NCT00473590|11496131|FG001|STARTED|Overall Study||49
10356793|NCT00473590|11496130|FG000|Treated|Overall Study||52
10356794|NCT00473590|11496131|FG001|Treated|Overall Study||48
10356795|NCT00473590|11496130|FG000|Safety Population|Overall Study|2 patients received at least 1 bevacizumab dose & were analyzed as bevacizumab-treated patients|50
10356796|NCT00473590|11496131|FG001|Safety Population|Overall Study||50
10356797|NCT00473590|11496130|FG000|COMPLETED|Overall Study|Continuing on study as of the data cutoff date of 9 November 2009.|8
10356798|NCT00473590|11496131|FG001|COMPLETED|Overall Study|Continuing on study as of the data cutoff date of 9 November 2009.|11
10356799|NCT00473590|11496130|FG000|NOT COMPLETED|Overall Study||45
10356800|NCT00473590|11496131|FG001|NOT COMPLETED|Overall Study||38
10356801|NCT00473642|11496140|FG000|STARTED|Overall Study||10
10356802|NCT00473642|11496141|FG001|STARTED|Overall Study||11
10356803|NCT00473642|11496142|FG002|STARTED|Overall Study||10
10356804|NCT00473642|11496140|FG000|COMPLETED|Overall Study||8
10356805|NCT00473642|11496141|FG001|COMPLETED|Overall Study||10
10356806|NCT00473642|11496142|FG002|COMPLETED|Overall Study||8
10356807|NCT00473642|11496140|FG000|NOT COMPLETED|Overall Study||2
10356808|NCT00473642|11496141|FG001|NOT COMPLETED|Overall Study||1
10356809|NCT00473642|11496142|FG002|NOT COMPLETED|Overall Study||2
10356810|NCT00473655|11496156|FG000|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|111
10356811|NCT00473655|11496157|FG001|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|112
10356812|NCT00473655|11496158|FG002|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|111
10356813|NCT00473655|11496156|FG000|COMPLETED|Overall Study|9 participants were lost of follow up|102
10356814|NCT00473655|11496157|FG001|COMPLETED|Overall Study|5 participants were lost of follow up|107
10356815|NCT00473655|11496158|FG002|COMPLETED|Overall Study|8 participants were lost of follow up|103
10356816|NCT00473655|11496156|FG000|NOT COMPLETED|Overall Study||9
10356817|NCT00473655|11496157|FG001|NOT COMPLETED|Overall Study||5
10356818|NCT00473655|11496158|FG002|NOT COMPLETED|Overall Study||8
10356819|NCT00473668|11496169|FG000|STARTED|Overall Study||100
10356820|NCT00473668|11496170|FG001|STARTED|Overall Study||100
10356821|NCT00473668|11496171|FG002|STARTED|Overall Study||99
10356822|NCT00473668|11496169|FG000|COMPLETED|Overall Study||95
10356823|NCT00473668|11496170|FG001|COMPLETED|Overall Study||89
10356824|NCT00473668|11496171|FG002|COMPLETED|Overall Study||89
10356825|NCT00473668|11496169|FG000|NOT COMPLETED|Overall Study||5
10356826|NCT00473668|11496170|FG001|NOT COMPLETED|Overall Study||11
10356827|NCT00473668|11496171|FG002|NOT COMPLETED|Overall Study||10
10356828|NCT00473694|11496183|FG000|STARTED|Overall Study||48
10356829|NCT00473694|11496184|FG001|STARTED|Overall Study|Includes 1 participant randomized to vecuronium+sugammadex but treated with rocuronium+neostigmine|41
10812526|NCT03580382|11974601|FG001|NOT COMPLETED|Overall Study||3
10812527|NCT03571646|11974608|FG000|STARTED|Overall Study||3
10356830|NCT00473694|11496185|FG002|STARTED|Overall Study||51
10356831|NCT00473694|11496186|FG003|STARTED|Overall Study||42
10356832|NCT00473694|11496183|FG000|Treated|Overall Study|Number of participants treated was based on actual treatment received.|37
10356833|NCT00473694|11496184|FG001|Treated|Overall Study|Number of participants treated was based on actual treatment received.|38
10356834|NCT00473694|11496185|FG002|Treated|Overall Study|Number of participants treated was based on actual treatment received.|46
10356835|NCT00473694|11496186|FG003|Treated|Overall Study|Number of participants treated was based on actual treatment received.|36
10356836|NCT00473694|11496183|FG000|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|37
10356837|NCT00473694|11496184|FG001|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|37
10356838|NCT00473694|11496185|FG002|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|46
10356839|NCT00473694|11496186|FG003|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|35
10356840|NCT00473694|11496183|FG000|NOT COMPLETED|Overall Study||11
10356841|NCT00473694|11496184|FG001|NOT COMPLETED|Overall Study||4
10356842|NCT00473694|11496185|FG002|NOT COMPLETED|Overall Study||5
10356843|NCT00473694|11496186|FG003|NOT COMPLETED|Overall Study||7
10356844|NCT00473746|11496204|FG000|STARTED|Period 1 (Phase 1)||6
10356845|NCT00473746|11496205|FG001|STARTED|Period 1 (Phase 1)||9
10356846|NCT00473746|11496206|FG002|STARTED|Period 1 (Phase 1)||6
10356847|NCT00473746|11496207|FG003|STARTED|Period 1 (Phase 1)||12
10356848|NCT00473746|11496208|FG004|STARTED|Period 1 (Phase 1)||0
10356849|NCT00473746|11496204|FG000|COMPLETED|Period 1 (Phase 1)||0
10356850|NCT00473746|11496205|FG001|COMPLETED|Period 1 (Phase 1)||0
10356851|NCT00473746|11496206|FG002|COMPLETED|Period 1 (Phase 1)||0
10356852|NCT00473746|11496207|FG003|COMPLETED|Period 1 (Phase 1)|Treatment ongoing|2
10356853|NCT00473746|11496208|FG004|COMPLETED|Period 1 (Phase 1)||0
10356854|NCT00473746|11496204|FG000|NOT COMPLETED|Period 1 (Phase 1)||6
10356855|NCT00473746|11496205|FG001|NOT COMPLETED|Period 1 (Phase 1)||9
10356856|NCT00473746|11496206|FG002|NOT COMPLETED|Period 1 (Phase 1)||6
10356857|NCT00473746|11496207|FG003|NOT COMPLETED|Period 1 (Phase 1)||10
10356858|NCT00473746|11496208|FG004|NOT COMPLETED|Period 1 (Phase 1)||0
10356859|NCT00473746|11496204|FG000|STARTED|Period 2 (Phase 2)||0
10356860|NCT00473746|11496205|FG001|STARTED|Period 2 (Phase 2)||0
10356861|NCT00473746|11496206|FG002|STARTED|Period 2 (Phase 2)||0
10356862|NCT00473746|11496207|FG003|STARTED|Period 2 (Phase 2)||0
10356863|NCT00473746|11496208|FG004|STARTED|Period 2 (Phase 2)||33
10356864|NCT00473746|11496204|FG000|COMPLETED|Period 2 (Phase 2)||0
10356865|NCT00473746|11496205|FG001|COMPLETED|Period 2 (Phase 2)||0
10356866|NCT00473746|11496206|FG002|COMPLETED|Period 2 (Phase 2)||0
10356867|NCT00473746|11496207|FG003|COMPLETED|Period 2 (Phase 2)||0
10356868|NCT00473746|11496208|FG004|COMPLETED|Period 2 (Phase 2)||6
10356869|NCT00473746|11496204|FG000|NOT COMPLETED|Period 2 (Phase 2)||0
10356870|NCT00473746|11496205|FG001|NOT COMPLETED|Period 2 (Phase 2)||0
10356871|NCT00473746|11496206|FG002|NOT COMPLETED|Period 2 (Phase 2)||0
10356872|NCT00473746|11496207|FG003|NOT COMPLETED|Period 2 (Phase 2)||0
10356873|NCT00473746|11496208|FG004|NOT COMPLETED|Period 2 (Phase 2)||27
10356874|NCT00473824|11496224|FG000|STARTED|Overall Study||5
10356875|NCT00473824|11496225|FG001|STARTED|Overall Study||2
10356876|NCT00473824|11496224|FG000|COMPLETED|Overall Study|Study Completion/Early Termination Date|0
10356877|NCT00473824|11496225|FG001|COMPLETED|Overall Study|Study Completion/Early Termination Date|2
10356878|NCT00473824|11496224|FG000|NOT COMPLETED|Overall Study||5
10356879|NCT00473824|11496225|FG001|NOT COMPLETED|Overall Study||0
10356880|NCT00473837|11496233|FG000|STARTED|Overall Study||50
10356881|NCT00473837|11496234|FG001|STARTED|Overall Study||46
10356882|NCT00473837|11496233|FG000|COMPLETED|Overall Study||49
10356883|NCT00473837|11496234|FG001|COMPLETED|Overall Study||43
10356884|NCT00473837|11496233|FG000|NOT COMPLETED|Overall Study||1
10356885|NCT00473837|11496234|FG001|NOT COMPLETED|Overall Study||3
10356886|NCT00473876|11496242|FG000|STARTED|Overall Study||39
10356887|NCT00473876|11496243|FG001|STARTED|Overall Study||23
10356888|NCT00473876|11496242|FG000|COMPLETED|Overall Study||36
10356889|NCT00473876|11496243|FG001|COMPLETED|Overall Study||22
10356890|NCT00473876|11496242|FG000|NOT COMPLETED|Overall Study||3
10356891|NCT00473876|11496243|FG001|NOT COMPLETED|Overall Study||1
10356892|NCT00473889|11496253|FG000|STARTED|Overall Study||126
10356893|NCT00473889|11496254|FG001|STARTED|Overall Study||127
10356894|NCT00473889|11496253|FG000|COMPLETED|Overall Study||43
10356895|NCT00473889|11496254|FG001|COMPLETED|Overall Study||63
10356896|NCT00473889|11496253|FG000|NOT COMPLETED|Overall Study||83
10356897|NCT00473889|11496254|FG001|NOT COMPLETED|Overall Study||64
10356898|NCT00474045|11496262|FG000|STARTED|Overall Study||233
10356899|NCT00474045|11496263|FG001|STARTED|Overall Study||237
10356900|NCT00474045|11496262|FG000|Exposed-All Subjects|Overall Study||233
10812528|NCT03571646|11974609|FG001|STARTED|Overall Study||3
10356901|NCT00474045|11496263|FG001|Exposed-All Subjects|Overall Study|5 withdrawn before treatment initiation|232
10356902|NCT00474045|11496262|FG000|Exposed-Pregnant Subjects|Overall Study||152
10812529|NCT03571646|11974608|FG000|COMPLETED|Overall Study||1
10356903|NCT00474045|11496263|FG001|Exposed-Pregnant Subjects|Overall Study|3 withdrawn before treatment initiation|158
10356904|NCT00474045|11496262|FG000|Pregnancies (for Exposed-pregnant)|Overall Study||152
10356905|NCT00474045|11496263|FG001|Pregnancies (for Exposed-pregnant)|Overall Study|2 subjects had spontaneous abortion and became pregnant again|160
10356906|NCT00474045|11496262|FG000|COMPLETED|Overall Study||127
10356907|NCT00474045|11496263|FG001|COMPLETED|Overall Study||136
10356908|NCT00474045|11496262|FG000|NOT COMPLETED|Overall Study||106
10356909|NCT00474045|11496263|FG001|NOT COMPLETED|Overall Study||101
10356910|NCT00474058|11496271|FG000|STARTED|Overall Study||190
10356911|NCT00474058|11496272|FG001|STARTED|Overall Study||97
10356912|NCT00474058|11496271|FG000|COMPLETED|Overall Study||166
10356913|NCT00474058|11496272|FG001|COMPLETED|Overall Study||80
10356914|NCT00474058|11496271|FG000|NOT COMPLETED|Overall Study||24
10356915|NCT00474058|11496272|FG001|NOT COMPLETED|Overall Study||17
10356916|NCT00474123|11496280|FG000|STARTED|Overall Study||38
10356917|NCT00474123|11496281|FG001|STARTED|Overall Study||40
10356918|NCT00474123|11496280|FG000|COMPLETED|Overall Study||38
10356919|NCT00474123|11496281|FG001|COMPLETED|Overall Study||40
10356920|NCT00474123|11496280|FG000|NOT COMPLETED|Overall Study||0
10356921|NCT00474123|11496281|FG001|NOT COMPLETED|Overall Study||0
10356922|NCT00474175|11496290|FG000|STARTED|Overall Study||115
10356923|NCT00474175|11496291|FG001|STARTED|Overall Study||233
10356924|NCT00474175|11496292|FG002|STARTED|Overall Study||229
10356925|NCT00474175|11496290|FG000|Treated|Overall Study||115
10356926|NCT00474175|11496291|FG001|Treated|Overall Study||233
10356927|NCT00474175|11496292|FG002|Treated|Overall Study||228
10356928|NCT00474175|11496290|FG000|COMPLETED|Overall Study||114
10356929|NCT00474175|11496291|FG001|COMPLETED|Overall Study||226
10356930|NCT00474175|11496292|FG002|COMPLETED|Overall Study||225
10356931|NCT00474175|11496290|FG000|NOT COMPLETED|Overall Study||1
10356932|NCT00474175|11496291|FG001|NOT COMPLETED|Overall Study||7
10356933|NCT00474175|11496292|FG002|NOT COMPLETED|Overall Study||4
10356934|NCT00474201|11496300|FG000|STARTED|Overall Study||15
10356935|NCT00474201|11496300|FG000|COMPLETED|Overall Study||15
10356936|NCT00474201|11496300|FG000|NOT COMPLETED|Overall Study||0
10356937|NCT00474240|11496311|FG000|STARTED|Overall Study||27
10356938|NCT00474240|11496312|FG001|STARTED|Overall Study||26
10356939|NCT00474240|11496313|FG002|STARTED|Overall Study||26
10356940|NCT00474240|11496314|FG003|STARTED|Overall Study||26
10356941|NCT00474240|11496315|FG004|STARTED|Overall Study||26
10356942|NCT00474240|11496316|FG005|STARTED|Overall Study||26
10356943|NCT00474240|11496311|FG000|COMPLETED|Overall Study||26
10356944|NCT00474240|11496312|FG001|COMPLETED|Overall Study||25
10356945|NCT00474240|11496313|FG002|COMPLETED|Overall Study||17
10356946|NCT00474240|11496314|FG003|COMPLETED|Overall Study||10
10356947|NCT00474240|11496315|FG004|COMPLETED|Overall Study||18
10356948|NCT00474240|11496316|FG005|COMPLETED|Overall Study||8
10356949|NCT00474240|11496311|FG000|NOT COMPLETED|Overall Study||1
10356950|NCT00474240|11496312|FG001|NOT COMPLETED|Overall Study||1
10356951|NCT00474240|11496313|FG002|NOT COMPLETED|Overall Study||9
10356952|NCT00474240|11496314|FG003|NOT COMPLETED|Overall Study||16
10356953|NCT00474240|11496315|FG004|NOT COMPLETED|Overall Study||8
10356954|NCT00474240|11496316|FG005|NOT COMPLETED|Overall Study||18
10356955|NCT00474253|11496332|FG000|STARTED|Overall Study|Includes 2 participants randomized to succinylcholine group who received rocuronium + sugammadex.|58
10356956|NCT00474253|11496333|FG001|STARTED|Overall Study|Includes 1 participant randomized to rocuronium + sugammadex group who received succinylcholine.|57
10356957|NCT00474253|11496332|FG000|Treated|Overall Study|Based on actual treatment received.|56
10356958|NCT00474253|11496333|FG001|Treated|Overall Study|Based on actual treatment received.|54
10356959|NCT00474253|11496332|FG000|COMPLETED|Overall Study|Based on actual treatment received.|55
10356960|NCT00474253|11496333|FG001|COMPLETED|Overall Study|Based on actual treatment received.|53
10356961|NCT00474253|11496332|FG000|NOT COMPLETED|Overall Study||3
10356962|NCT00474253|11496333|FG001|NOT COMPLETED|Overall Study||4
10356963|NCT00474266|11496343|FG000|STARTED|Overall Study||375
10356964|NCT00474266|11496344|FG001|STARTED|Overall Study||374
10356965|NCT00474266|11496345|FG002|STARTED|Overall Study||126
10356966|NCT00474266|11496346|FG003|STARTED|Overall Study||125
10356967|NCT00474266|11496343|FG000|COMPLETED|Overall Study||368
10356968|NCT00474266|11496344|FG001|COMPLETED|Overall Study||354
10356969|NCT00474266|11496345|FG002|COMPLETED|Overall Study||122
10356970|NCT00474266|11496346|FG003|COMPLETED|Overall Study||118
10356971|NCT00474266|11496343|FG000|NOT COMPLETED|Overall Study||7
10356972|NCT00474266|11496344|FG001|NOT COMPLETED|Overall Study||20
10356973|NCT00474266|11496345|FG002|NOT COMPLETED|Overall Study||4
10356974|NCT00474266|11496346|FG003|NOT COMPLETED|Overall Study||7
10356975|NCT00474383|11496359|FG000|STARTED|Main Study||47
10356976|NCT00474383|11496360|FG001|STARTED|Main Study||0
10356977|NCT00474383|11496359|FG000|COMPLETED|Main Study||11
10716163|NCT02688387|11880060|FG017|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10716164|NCT02688387|11880061|FG018|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10716165|NCT02688387|11880062|FG019|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10356978|NCT00474383|11496360|FG001|COMPLETED|Main Study||0
10356979|NCT00474383|11496359|FG000|NOT COMPLETED|Main Study||36
10356980|NCT00474383|11496360|FG001|NOT COMPLETED|Main Study||0
10357013|NCT00474526|11496406|FG008|STARTED|Overall Study||150
10716166|NCT02688387|11880063|FG020|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10356981|NCT00474383|11496359|FG000|STARTED|Between Main Study and Extension||11
10356982|NCT00474383|11496360|FG001|STARTED|Between Main Study and Extension||0
10356983|NCT00474383|11496359|FG000|COMPLETED|Between Main Study and Extension||5
10356984|NCT00474383|11496360|FG001|COMPLETED|Between Main Study and Extension||0
10356985|NCT00474383|11496359|FG000|NOT COMPLETED|Between Main Study and Extension||6
10356986|NCT00474383|11496360|FG001|NOT COMPLETED|Between Main Study and Extension||0
10356987|NCT00474383|11496359|FG000|STARTED|Extension||0
10356988|NCT00474383|11496360|FG001|STARTED|Extension||5
10356989|NCT00474383|11496359|FG000|COMPLETED|Extension||0
10356990|NCT00474383|11496360|FG001|COMPLETED|Extension||0
10356991|NCT00474383|11496359|FG000|NOT COMPLETED|Extension||0
10356992|NCT00474383|11496360|FG001|NOT COMPLETED|Extension||5
10356993|NCT00474487|11496368|FG000|STARTED|Overall Study||1606
10356994|NCT00474487|11496369|FG001|STARTED|Overall Study||217
10356995|NCT00474487|11496370|FG002|STARTED|Overall Study||899
10356996|NCT00474487|11496371|FG003|STARTED|Overall Study||109
10356997|NCT00474487|11496368|FG000|COMPLETED|Overall Study||1576
10356998|NCT00474487|11496369|FG001|COMPLETED|Overall Study||215
10356999|NCT00474487|11496370|FG002|COMPLETED|Overall Study||885
10357000|NCT00474487|11496371|FG003|COMPLETED|Overall Study||109
10357001|NCT00474487|11496368|FG000|NOT COMPLETED|Overall Study||30
10357002|NCT00474487|11496369|FG001|NOT COMPLETED|Overall Study||2
10357003|NCT00474487|11496370|FG002|NOT COMPLETED|Overall Study||14
10716167|NCT02688387|11880064|FG021|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
10716168|NCT02688387|11880043|FG000|STARTED|Part 3B, Washout Period 2 (10 Days)||0
10716169|NCT02688387|11880044|FG001|STARTED|Part 3B, Washout Period 2 (10 Days)||0
10716170|NCT02688387|11880045|FG002|STARTED|Part 3B, Washout Period 2 (10 Days)||0
10716171|NCT02688387|11880046|FG003|STARTED|Part 3B, Washout Period 2 (10 Days)||0
10716172|NCT02688387|11880047|FG004|STARTED|Part 3B, Washout Period 2 (10 Days)||0
10716173|NCT02688387|11880048|FG005|STARTED|Part 3B, Washout Period 2 (10 Days)||0
10716174|NCT02688387|11880049|FG006|STARTED|Part 3B, Washout Period 2 (10 Days)||0
10716175|NCT02688387|11880050|FG007|STARTED|Part 3B, Washout Period 2 (10 Days)||0
10357004|NCT00474487|11496371|FG003|NOT COMPLETED|Overall Study||0
10426964|NCT00850343|11572727|FG001|STARTED|Overall Study||12
10426965|NCT00850343|11572728|FG002|STARTED|Overall Study||43
10426966|NCT00850343|11572729|FG003|STARTED|Overall Study||43
10426967|NCT00850343|11572726|FG000|Completed Week 24|Overall Study||94
10426968|NCT00850343|11572727|FG001|Completed Week 24|Overall Study||12
10426969|NCT00850343|11572728|FG002|Completed Week 24|Overall Study||39
10426970|NCT00850343|11572729|FG003|Completed Week 24|Overall Study||39
10426971|NCT00850343|11572726|FG000|Completed Week 52|Overall Study||88
10426972|NCT00850343|11572727|FG001|Completed Week 52|Overall Study||11
10426973|NCT00850343|11572728|FG002|Completed Week 52|Overall Study||37
10426974|NCT00850343|11572729|FG003|Completed Week 52|Overall Study||37
10426975|NCT00850343|11572726|FG000|COMPLETED|Overall Study||64
10426976|NCT00850343|11572727|FG001|COMPLETED|Overall Study||9
10426977|NCT00850343|11572728|FG002|COMPLETED|Overall Study||29
10426978|NCT00850343|11572729|FG003|COMPLETED|Overall Study||30
10426979|NCT00850343|11572726|FG000|NOT COMPLETED|Overall Study||46
10426980|NCT00850343|11572727|FG001|NOT COMPLETED|Overall Study||3
10426981|NCT00850343|11572728|FG002|NOT COMPLETED|Overall Study||14
10426982|NCT00850343|11572729|FG003|NOT COMPLETED|Overall Study||13
10426983|NCT00850395|11572739|FG000|STARTED|Overall Study||79
10426984|NCT00850395|11572739|FG000|COMPLETED|Overall Study||69
10426985|NCT00850395|11572739|FG000|NOT COMPLETED|Overall Study||10
10426986|NCT00850460|11572745|FG000|STARTED|Overall Study||7
10426987|NCT00850460|11572746|FG001|STARTED|Overall Study||7
10426988|NCT00850460|11572745|FG000|Started - Week 0|Overall Study||7
10533991|NCT01427972|11686133|FG010|STARTED|Treatment Period 1 (21 Days)||3
10533992|NCT01427972|11686134|FG011|STARTED|Treatment Period 1 (21 Days)||4
10533993|NCT01427972|11686123|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
10533994|NCT01427972|11686124|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
10533995|NCT01427972|11686125|FG002|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
10533996|NCT01427972|11686126|FG003|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
10533997|NCT01427972|11686127|FG004|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
10716176|NCT02688387|11880051|FG008|STARTED|Part 3B, Washout Period 2 (10 Days)||0
10716177|NCT02688387|11880052|FG009|STARTED|Part 3B, Washout Period 2 (10 Days)||0
10716178|NCT02688387|11880053|FG010|STARTED|Part 3B, Washout Period 2 (10 Days)||0
10716179|NCT02688387|11880054|FG011|STARTED|Part 3B, Washout Period 2 (10 Days)||0
10533998|NCT01427972|11686128|FG005|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
10533999|NCT01427972|11686129|FG006|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
10534000|NCT01427972|11686130|FG007|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||5
10426989|NCT00850460|11572746|FG001|Started - Week 0|Overall Study||7
10426990|NCT00850460|11572745|FG000|Completion - Week 8|Overall Study||3
10426991|NCT00850460|11572746|FG001|Completion - Week 8|Overall Study||3
10357005|NCT00474526|11496398|FG000|STARTED|Overall Study||154
10357006|NCT00474526|11496399|FG001|STARTED|Overall Study||166
10357007|NCT00474526|11496400|FG002|STARTED|Overall Study||159
10357008|NCT00474526|11496401|FG003|STARTED|Overall Study||680
10357009|NCT00474526|11496402|FG004|STARTED|Overall Study||76
10357010|NCT00474526|11496403|FG005|STARTED|Overall Study||70
10357011|NCT00474526|11496404|FG006|STARTED|Overall Study||203
10357012|NCT00474526|11496405|FG007|STARTED|Overall Study||151
10357014|NCT00474526|11496407|FG009|STARTED|Overall Study||148
10357015|NCT00474526|11496408|FG010|STARTED|Overall Study||151
10357016|NCT00474526|11496409|FG011|STARTED|Overall Study||150
10357017|NCT00474526|11496410|FG012|STARTED|Overall Study||150
10357018|NCT00474526|11496411|FG013|STARTED|Overall Study||1426
10357019|NCT00474526|11496412|FG014|STARTED|Overall Study||358
10357020|NCT00474526|11496413|FG015|STARTED|Overall Study||170
10357021|NCT00474526|11496414|FG016|STARTED|Overall Study||183
10357022|NCT00474526|11496398|FG000|COMPLETED|Overall Study||121
10357023|NCT00474526|11496399|FG001|COMPLETED|Overall Study||120
10357024|NCT00474526|11496400|FG002|COMPLETED|Overall Study||110
10357025|NCT00474526|11496401|FG003|COMPLETED|Overall Study||561
10357026|NCT00474526|11496402|FG004|COMPLETED|Overall Study||8
10357027|NCT00474526|11496403|FG005|COMPLETED|Overall Study||54
10357028|NCT00474526|11496404|FG006|COMPLETED|Overall Study||178
10357029|NCT00474526|11496405|FG007|COMPLETED|Overall Study||145
10357030|NCT00474526|11496406|FG008|COMPLETED|Overall Study||144
10357031|NCT00474526|11496407|FG009|COMPLETED|Overall Study||121
10357032|NCT00474526|11496408|FG010|COMPLETED|Overall Study||141
10357033|NCT00474526|11496409|FG011|COMPLETED|Overall Study||139
10357034|NCT00474526|11496410|FG012|COMPLETED|Overall Study||135
10357035|NCT00474526|11496411|FG013|COMPLETED|Overall Study||1270
10357036|NCT00474526|11496412|FG014|COMPLETED|Overall Study||281
10357037|NCT00474526|11496413|FG015|COMPLETED|Overall Study||152
10357038|NCT00474526|11496414|FG016|COMPLETED|Overall Study||174
10357039|NCT00474526|11496398|FG000|NOT COMPLETED|Overall Study||33
10357040|NCT00474526|11496399|FG001|NOT COMPLETED|Overall Study||46
10357041|NCT00474526|11496400|FG002|NOT COMPLETED|Overall Study||49
10357042|NCT00474526|11496401|FG003|NOT COMPLETED|Overall Study||119
10357043|NCT00474526|11496402|FG004|NOT COMPLETED|Overall Study||68
10357044|NCT00474526|11496403|FG005|NOT COMPLETED|Overall Study||16
10357045|NCT00474526|11496404|FG006|NOT COMPLETED|Overall Study||25
10357046|NCT00474526|11496405|FG007|NOT COMPLETED|Overall Study||6
10357047|NCT00474526|11496406|FG008|NOT COMPLETED|Overall Study||6
10357048|NCT00474526|11496407|FG009|NOT COMPLETED|Overall Study||27
10357049|NCT00474526|11496408|FG010|NOT COMPLETED|Overall Study||10
10357050|NCT00474526|11496409|FG011|NOT COMPLETED|Overall Study||11
10357051|NCT00474526|11496410|FG012|NOT COMPLETED|Overall Study||15
10357052|NCT00474526|11496411|FG013|NOT COMPLETED|Overall Study||156
10357053|NCT00474526|11496412|FG014|NOT COMPLETED|Overall Study||77
10357054|NCT00474526|11496413|FG015|NOT COMPLETED|Overall Study||18
10357055|NCT00474526|11496414|FG016|NOT COMPLETED|Overall Study||9
10357056|NCT00474539|11496502|FG000|STARTED|Infant Series|One participant was randomized to 7vPnC, but received 13vPnC.|223
10357057|NCT00474539|11496503|FG001|STARTED|Infant Series|One participant was randomized to 7vPnC, but received 13vPnC.|226
10357058|NCT00474539|11496502|FG000|Vaccinated Dose 1|Infant Series||218
10357059|NCT00474539|11496503|FG001|Vaccinated Dose 1|Infant Series||226
10357060|NCT00474539|11496502|FG000|Vaccinated Dose 2|Infant Series||217
10357061|NCT00474539|11496503|FG001|Vaccinated Dose 2|Infant Series||222
10357062|NCT00474539|11496502|FG000|Vaccinated Dose 3|Infant Series||214
10357063|NCT00474539|11496503|FG001|Vaccinated Dose 3|Infant Series||221
10357064|NCT00474539|11496502|FG000|COMPLETED|Infant Series||213
10357065|NCT00474539|11496503|FG001|COMPLETED|Infant Series||220
10357066|NCT00474539|11496502|FG000|NOT COMPLETED|Infant Series||10
10357067|NCT00474539|11496503|FG001|NOT COMPLETED|Infant Series||6
10357068|NCT00474539|11496502|FG000|STARTED|After Infant Series||213
10357069|NCT00474539|11496503|FG001|STARTED|After Infant Series||220
10357070|NCT00474539|11496502|FG000|COMPLETED|After Infant Series||209
10357071|NCT00474539|11496503|FG001|COMPLETED|After Infant Series||220
10357072|NCT00474539|11496502|FG000|NOT COMPLETED|After Infant Series||4
10357073|NCT00474539|11496503|FG001|NOT COMPLETED|After Infant Series||0
10357074|NCT00474539|11496502|FG000|STARTED|Toddler Dose||209
10357075|NCT00474539|11496503|FG001|STARTED|Toddler Dose||220
10357076|NCT00474539|11496502|FG000|COMPLETED|Toddler Dose||208
10357077|NCT00474539|11496503|FG001|COMPLETED|Toddler Dose||220
10357078|NCT00474539|11496502|FG000|NOT COMPLETED|Toddler Dose||1
10357079|NCT00474539|11496503|FG001|NOT COMPLETED|Toddler Dose||0
10357080|NCT00474617|11496537|FG000|STARTED|Overall Study||56
10357081|NCT00474617|11496538|FG001|STARTED|Overall Study||64
10357082|NCT00474617|11496539|FG002|STARTED|Overall Study||42
10357083|NCT00474617|11496537|FG000|Treated|Overall Study||48
10357084|NCT00474617|11496538|FG001|Treated|Overall Study||62
10357085|NCT00474617|11496539|FG002|Treated|Overall Study||40
10357086|NCT00474617|11496537|FG000|COMPLETED|Overall Study||48
10357087|NCT00474617|11496538|FG001|COMPLETED|Overall Study||61
10357088|NCT00474617|11496539|FG002|COMPLETED|Overall Study||40
10357089|NCT00474617|11496537|FG000|NOT COMPLETED|Overall Study||8
10357090|NCT00474617|11496538|FG001|NOT COMPLETED|Overall Study||3
10357091|NCT00474617|11496539|FG002|NOT COMPLETED|Overall Study||2
10357092|NCT00474630|11496549|FG000|STARTED|Overall Study||335
10357093|NCT00474630|11496550|FG001|STARTED|Overall Study||170
10357094|NCT00474630|11496549|FG000|COMPLETED|Overall Study||175
10357095|NCT00474630|11496550|FG001|COMPLETED|Overall Study||100
10357096|NCT00474630|11496549|FG000|NOT COMPLETED|Overall Study||160
10357097|NCT00474630|11496550|FG001|NOT COMPLETED|Overall Study||70
10357098|NCT00474708|11496559|FG000|STARTED|Overall Study||791
10357099|NCT00474708|11496560|FG001|STARTED|Overall Study||367
10357100|NCT00474708|11496559|FG000|COMPLETED|Overall Study||734
10357101|NCT00474708|11496560|FG001|COMPLETED|Overall Study||342
10357102|NCT00474708|11496559|FG000|NOT COMPLETED|Overall Study||57
10357103|NCT00474708|11496560|FG001|NOT COMPLETED|Overall Study||25
10357104|NCT00474760|11496573|FG000|STARTED|Overall Study||3
10357105|NCT00474760|11496574|FG001|STARTED|Overall Study||3
10357106|NCT00474760|11496575|FG002|STARTED|Overall Study||3
10357107|NCT00474760|11496576|FG003|STARTED|Overall Study||3
10357108|NCT00474760|11496577|FG004|STARTED|Overall Study||13
10357109|NCT00474760|11496578|FG005|STARTED|Overall Study||29
10357110|NCT00474760|11496579|FG006|STARTED|Overall Study||11
10357111|NCT00474760|11496573|FG000|COMPLETED|Overall Study||0
10357112|NCT00474760|11496574|FG001|COMPLETED|Overall Study||0
10357113|NCT00474760|11496575|FG002|COMPLETED|Overall Study||0
10357114|NCT00474760|11496576|FG003|COMPLETED|Overall Study||0
10357115|NCT00474760|11496577|FG004|COMPLETED|Overall Study||1
10357116|NCT00474760|11496578|FG005|COMPLETED|Overall Study||0
10357117|NCT00474760|11496579|FG006|COMPLETED|Overall Study||1
10357118|NCT00474760|11496573|FG000|NOT COMPLETED|Overall Study||3
10357119|NCT00474760|11496574|FG001|NOT COMPLETED|Overall Study||3
10357120|NCT00474760|11496575|FG002|NOT COMPLETED|Overall Study||3
10357121|NCT00474760|11496576|FG003|NOT COMPLETED|Overall Study||3
10357122|NCT00474760|11496577|FG004|NOT COMPLETED|Overall Study||12
10357123|NCT00474760|11496578|FG005|NOT COMPLETED|Overall Study||29
10357124|NCT00474760|11496579|FG006|NOT COMPLETED|Overall Study||10
10357125|NCT00474786|11496604|FG000|STARTED|Overall Study||259
10357126|NCT00474786|11496605|FG001|STARTED|Overall Study||253
10357127|NCT00474786|11496604|FG000|COMPLETED|Overall Study||0
10357128|NCT00474786|11496605|FG001|COMPLETED|Overall Study||0
10357129|NCT00474786|11496604|FG000|NOT COMPLETED|Overall Study||259
10357130|NCT00474786|11496605|FG001|NOT COMPLETED|Overall Study||253
10357131|NCT00474812|11496611|FG000|STARTED|Overall Study||51
10534001|NCT01427972|11686131|FG008|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
10534002|NCT01427972|11686132|FG009|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
10534003|NCT01427972|11686133|FG010|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
10534004|NCT01427972|11686134|FG011|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
10534005|NCT01427972|11686123|FG000|COMPLETED|Treatment Period 1 (21 Days)||3
10534006|NCT01427972|11686124|FG001|COMPLETED|Treatment Period 1 (21 Days)||4
10534007|NCT01427972|11686125|FG002|COMPLETED|Treatment Period 1 (21 Days)||4
10534008|NCT01427972|11686126|FG003|COMPLETED|Treatment Period 1 (21 Days)||3
10534009|NCT01427972|11686127|FG004|COMPLETED|Treatment Period 1 (21 Days)||4
10534010|NCT01427972|11686128|FG005|COMPLETED|Treatment Period 1 (21 Days)||3
10534011|NCT01427972|11686129|FG006|COMPLETED|Treatment Period 1 (21 Days)||3
10534012|NCT01427972|11686130|FG007|COMPLETED|Treatment Period 1 (21 Days)||4
10534013|NCT01427972|11686131|FG008|COMPLETED|Treatment Period 1 (21 Days)||3
10534014|NCT01427972|11686132|FG009|COMPLETED|Treatment Period 1 (21 Days)||3
10534015|NCT01427972|11686133|FG010|COMPLETED|Treatment Period 1 (21 Days)||3
10534016|NCT01427972|11686134|FG011|COMPLETED|Treatment Period 1 (21 Days)||4
10534017|NCT01427972|11686123|FG000|NOT COMPLETED|Treatment Period 1 (21 Days)||0
10534018|NCT01427972|11686124|FG001|NOT COMPLETED|Treatment Period 1 (21 Days)||0
10534019|NCT01427972|11686125|FG002|NOT COMPLETED|Treatment Period 1 (21 Days)||0
10534020|NCT01427972|11686126|FG003|NOT COMPLETED|Treatment Period 1 (21 Days)||0
10534021|NCT01427972|11686127|FG004|NOT COMPLETED|Treatment Period 1 (21 Days)||0
10534022|NCT01427972|11686128|FG005|NOT COMPLETED|Treatment Period 1 (21 Days)||0
10534023|NCT01427972|11686129|FG006|NOT COMPLETED|Treatment Period 1 (21 Days)||0
10534024|NCT01427972|11686130|FG007|NOT COMPLETED|Treatment Period 1 (21 Days)||1
10656240|NCT02215954|11817152|FG000|Safety Analysis Set|Overall Study||213
10534025|NCT01427972|11686131|FG008|NOT COMPLETED|Treatment Period 1 (21 Days)||0
10534026|NCT01427972|11686132|FG009|NOT COMPLETED|Treatment Period 1 (21 Days)||0
10534027|NCT01427972|11686133|FG010|NOT COMPLETED|Treatment Period 1 (21 Days)||0
10534028|NCT01427972|11686134|FG011|NOT COMPLETED|Treatment Period 1 (21 Days)||0
10534029|NCT01427972|11686123|FG000|STARTED|Washout (at Least 28 Days)||3
10534030|NCT01427972|11686124|FG001|STARTED|Washout (at Least 28 Days)||4
10656241|NCT02215954|11817153|FG001|Safety Analysis Set|Overall Study||211
10357132|NCT00474812|11496611|FG000|COMPLETED|Overall Study||44
10357133|NCT00474812|11496611|FG000|NOT COMPLETED|Overall Study||7
10357134|NCT00474851|11496617|FG000|STARTED|Overall Study||26
10357135|NCT00474851|11496618|FG001|STARTED|Overall Study||27
10357136|NCT00474851|11496617|FG000|Completed Baseline|Overall Study||25
10357137|NCT00474851|11496618|FG001|Completed Baseline|Overall Study||26
10357138|NCT00474851|11496617|FG000|COMPLETED|Overall Study||18
10357139|NCT00474851|11496618|FG001|COMPLETED|Overall Study||16
10357140|NCT00474851|11496617|FG000|NOT COMPLETED|Overall Study||8
10357141|NCT00474851|11496618|FG001|NOT COMPLETED|Overall Study||11
10357142|NCT00474903|11496628|FG000|STARTED|Overall Study||30
10357143|NCT00474903|11496629|FG001|STARTED|Overall Study||47
10357144|NCT00474903|11496630|FG002|STARTED|Overall Study||45
10357145|NCT00474903|11496628|FG000|COMPLETED|Overall Study||29
10357146|NCT00474903|11496629|FG001|COMPLETED|Overall Study||42
10357147|NCT00474903|11496630|FG002|COMPLETED|Overall Study||43
10357148|NCT00474903|11496628|FG000|NOT COMPLETED|Overall Study||1
10357149|NCT00474903|11496629|FG001|NOT COMPLETED|Overall Study||5
10357150|NCT00474903|11496630|FG002|NOT COMPLETED|Overall Study||2
10357151|NCT00474929|11496643|FG000|STARTED|Overall Study||6
10357152|NCT00474929|11496644|FG001|STARTED|Overall Study||6
10357153|NCT00474929|11496645|FG002|STARTED|Overall Study||7
10357154|NCT00474929|11496646|FG003|STARTED|Overall Study||7
10357155|NCT00474929|11496647|FG004|STARTED|Overall Study||77
10357156|NCT00474929|11496643|FG000|COMPLETED|Overall Study||6
10534031|NCT01427972|11686125|FG002|STARTED|Washout (at Least 28 Days)||4
10534032|NCT01427972|11686126|FG003|STARTED|Washout (at Least 28 Days)||3
10534033|NCT01427972|11686127|FG004|STARTED|Washout (at Least 28 Days)||4
10534034|NCT01427972|11686128|FG005|STARTED|Washout (at Least 28 Days)||3
10534035|NCT01427972|11686129|FG006|STARTED|Washout (at Least 28 Days)||3
10534036|NCT01427972|11686130|FG007|STARTED|Washout (at Least 28 Days)||4
10534037|NCT01427972|11686131|FG008|STARTED|Washout (at Least 28 Days)||3
10534038|NCT01427972|11686132|FG009|STARTED|Washout (at Least 28 Days)||3
10534039|NCT01427972|11686133|FG010|STARTED|Washout (at Least 28 Days)||3
10534040|NCT01427972|11686134|FG011|STARTED|Washout (at Least 28 Days)||4
10534041|NCT01427972|11686123|FG000|COMPLETED|Washout (at Least 28 Days)||3
10534042|NCT01427972|11686124|FG001|COMPLETED|Washout (at Least 28 Days)||4
10534043|NCT01427972|11686125|FG002|COMPLETED|Washout (at Least 28 Days)||4
10534044|NCT01427972|11686126|FG003|COMPLETED|Washout (at Least 28 Days)||3
10534045|NCT01427972|11686127|FG004|COMPLETED|Washout (at Least 28 Days)||4
10534046|NCT01427972|11686128|FG005|COMPLETED|Washout (at Least 28 Days)||1
10534047|NCT01427972|11686129|FG006|COMPLETED|Washout (at Least 28 Days)||3
10534048|NCT01427972|11686130|FG007|COMPLETED|Washout (at Least 28 Days)||4
10534049|NCT01427972|11686131|FG008|COMPLETED|Washout (at Least 28 Days)||3
10534050|NCT01427972|11686132|FG009|COMPLETED|Washout (at Least 28 Days)||3
10534051|NCT01427972|11686133|FG010|COMPLETED|Washout (at Least 28 Days)||3
10534052|NCT01427972|11686134|FG011|COMPLETED|Washout (at Least 28 Days)||4
10534053|NCT01427972|11686123|FG000|NOT COMPLETED|Washout (at Least 28 Days)||0
10534054|NCT01427972|11686124|FG001|NOT COMPLETED|Washout (at Least 28 Days)||0
10534055|NCT01427972|11686125|FG002|NOT COMPLETED|Washout (at Least 28 Days)||0
10534056|NCT01427972|11686126|FG003|NOT COMPLETED|Washout (at Least 28 Days)||0
10534057|NCT01427972|11686127|FG004|NOT COMPLETED|Washout (at Least 28 Days)||0
10534058|NCT01427972|11686128|FG005|NOT COMPLETED|Washout (at Least 28 Days)||2
10534059|NCT01427972|11686129|FG006|NOT COMPLETED|Washout (at Least 28 Days)||0
10534060|NCT01427972|11686130|FG007|NOT COMPLETED|Washout (at Least 28 Days)||0
10534061|NCT01427972|11686131|FG008|NOT COMPLETED|Washout (at Least 28 Days)||0
10534062|NCT01427972|11686132|FG009|NOT COMPLETED|Washout (at Least 28 Days)||0
10534063|NCT01427972|11686133|FG010|NOT COMPLETED|Washout (at Least 28 Days)||0
10534064|NCT01427972|11686134|FG011|NOT COMPLETED|Washout (at Least 28 Days)||0
10534065|NCT01427972|11686123|FG000|STARTED|Treatment Period 2 (21 Days)||3
10534066|NCT01427972|11686124|FG001|STARTED|Treatment Period 2 (21 Days)||4
10534067|NCT01427972|11686125|FG002|STARTED|Treatment Period 2 (21 Days)||4
10534068|NCT01427972|11686126|FG003|STARTED|Treatment Period 2 (21 Days)||3
10534069|NCT01427972|11686127|FG004|STARTED|Treatment Period 2 (21 Days)||4
10534070|NCT01427972|11686128|FG005|STARTED|Treatment Period 2 (21 Days)||1
10534071|NCT01427972|11686129|FG006|STARTED|Treatment Period 2 (21 Days)||3
10534072|NCT01427972|11686130|FG007|STARTED|Treatment Period 2 (21 Days)||4
10534073|NCT01427972|11686131|FG008|STARTED|Treatment Period 2 (21 Days)||3
10534074|NCT01427972|11686132|FG009|STARTED|Treatment Period 2 (21 Days)||3
10534075|NCT01427972|11686133|FG010|STARTED|Treatment Period 2 (21 Days)||3
10534076|NCT01427972|11686134|FG011|STARTED|Treatment Period 2 (21 Days)||4
10534077|NCT01427972|11686123|FG000|COMPLETED|Treatment Period 2 (21 Days)||3
10534078|NCT01427972|11686124|FG001|COMPLETED|Treatment Period 2 (21 Days)||3
10534079|NCT01427972|11686125|FG002|COMPLETED|Treatment Period 2 (21 Days)||4
10534080|NCT01427972|11686126|FG003|COMPLETED|Treatment Period 2 (21 Days)||3
10534081|NCT01427972|11686127|FG004|COMPLETED|Treatment Period 2 (21 Days)||4
10534082|NCT01427972|11686128|FG005|COMPLETED|Treatment Period 2 (21 Days)||1
10534083|NCT01427972|11686129|FG006|COMPLETED|Treatment Period 2 (21 Days)||3
10534084|NCT01427972|11686130|FG007|COMPLETED|Treatment Period 2 (21 Days)||4
10534085|NCT01427972|11686131|FG008|COMPLETED|Treatment Period 2 (21 Days)||3
10534086|NCT01427972|11686132|FG009|COMPLETED|Treatment Period 2 (21 Days)||3
10534087|NCT01427972|11686133|FG010|COMPLETED|Treatment Period 2 (21 Days)||3
10534088|NCT01427972|11686134|FG011|COMPLETED|Treatment Period 2 (21 Days)||4
10534089|NCT01427972|11686123|FG000|NOT COMPLETED|Treatment Period 2 (21 Days)||0
10534090|NCT01427972|11686124|FG001|NOT COMPLETED|Treatment Period 2 (21 Days)||1
10534091|NCT01427972|11686125|FG002|NOT COMPLETED|Treatment Period 2 (21 Days)||0
10357157|NCT00474929|11496644|FG001|COMPLETED|Overall Study||5
10357158|NCT00474929|11496645|FG002|COMPLETED|Overall Study||5
10357159|NCT00474929|11496646|FG003|COMPLETED|Overall Study||5
10357160|NCT00474929|11496647|FG004|COMPLETED|Overall Study||77
10357161|NCT00474929|11496643|FG000|NOT COMPLETED|Overall Study||0
10357162|NCT00474929|11496644|FG001|NOT COMPLETED|Overall Study||1
10357163|NCT00474929|11496645|FG002|NOT COMPLETED|Overall Study||2
10357164|NCT00474929|11496646|FG003|NOT COMPLETED|Overall Study||2
10357165|NCT00474929|11496647|FG004|NOT COMPLETED|Overall Study||0
10357166|NCT00474955|11496660|FG000|STARTED|Overall Study||27
10357167|NCT00474955|11496660|FG000|COMPLETED|Overall Study||19
10357168|NCT00474955|11496660|FG000|NOT COMPLETED|Overall Study||8
10357169|NCT00474968|11496666|FG000|STARTED|Overall Study||366
10357170|NCT00474968|11496667|FG001|STARTED|Overall Study||371
10357171|NCT00474968|11496666|FG000|COMPLETED|Overall Study||348
10357172|NCT00474968|11496667|FG001|COMPLETED|Overall Study||355
10357173|NCT00474968|11496666|FG000|NOT COMPLETED|Overall Study||18
10357174|NCT00474968|11496667|FG001|NOT COMPLETED|Overall Study||16
10357175|NCT00474994|11496673|FG000|STARTED|Overall Study||53
10357176|NCT00474994|11496673|FG000|COMPLETED|Overall Study||48
10357177|NCT00474994|11496673|FG000|NOT COMPLETED|Overall Study||5
10357178|NCT00475020|11496677|FG000|STARTED|Overall Study||63
10357179|NCT00475020|11496677|FG000|COMPLETED|Overall Study||58
10357180|NCT00475020|11496677|FG000|NOT COMPLETED|Overall Study||5
10357181|NCT00475033|11496683|FG000|STARTED|Infant Series||300
10357182|NCT00475033|11496684|FG001|STARTED|Infant Series||303
10716180|NCT02688387|11880055|FG012|STARTED|Part 3B, Washout Period 2 (10 Days)||0
10716181|NCT02688387|11880056|FG013|STARTED|Part 3B, Washout Period 2 (10 Days)||0
10357183|NCT00475033|11496683|FG000|Vaccinated Dose 1|Infant Series||300
10357184|NCT00475033|11496684|FG001|Vaccinated Dose 1|Infant Series||303
10357185|NCT00475033|11496683|FG000|Vaccinated Dose 2|Infant Series||297
10357186|NCT00475033|11496684|FG001|Vaccinated Dose 2|Infant Series||296
10357187|NCT00475033|11496683|FG000|Vaccinated Dose 3|Infant Series||293
10357188|NCT00475033|11496684|FG001|Vaccinated Dose 3|Infant Series||294
10357189|NCT00475033|11496683|FG000|COMPLETED|Infant Series||293
10357190|NCT00475033|11496684|FG001|COMPLETED|Infant Series||290
10357191|NCT00475033|11496683|FG000|NOT COMPLETED|Infant Series||7
10357192|NCT00475033|11496684|FG001|NOT COMPLETED|Infant Series||13
10357193|NCT00475033|11496683|FG000|STARTED|After the Infant Series||293
10357194|NCT00475033|11496684|FG001|STARTED|After the Infant Series||290
10357195|NCT00475033|11496683|FG000|Withdrawn After Infant Series|After the Infant Series||6
10357196|NCT00475033|11496684|FG001|Withdrawn After Infant Series|After the Infant Series||8
10357197|NCT00475033|11496683|FG000|COMPLETED|After the Infant Series||287
10357198|NCT00475033|11496684|FG001|COMPLETED|After the Infant Series||282
10357199|NCT00475033|11496683|FG000|NOT COMPLETED|After the Infant Series||6
10357200|NCT00475033|11496684|FG001|NOT COMPLETED|After the Infant Series||8
10357201|NCT00475033|11496683|FG000|STARTED|Toddler Dose|Vaccinated Toddler Dose|287
10357202|NCT00475033|11496684|FG001|STARTED|Toddler Dose|Vaccinated Toddler Dose|282
10357203|NCT00475033|11496683|FG000|COMPLETED|Toddler Dose||283
10357204|NCT00475033|11496684|FG001|COMPLETED|Toddler Dose||282
10357205|NCT00475033|11496683|FG000|NOT COMPLETED|Toddler Dose||4
10534092|NCT01427972|11686126|FG003|NOT COMPLETED|Treatment Period 2 (21 Days)||0
10534093|NCT01427972|11686127|FG004|NOT COMPLETED|Treatment Period 2 (21 Days)||0
10534094|NCT01427972|11686128|FG005|NOT COMPLETED|Treatment Period 2 (21 Days)||0
10534095|NCT01427972|11686129|FG006|NOT COMPLETED|Treatment Period 2 (21 Days)||0
10534096|NCT01427972|11686130|FG007|NOT COMPLETED|Treatment Period 2 (21 Days)||0
10534097|NCT01427972|11686131|FG008|NOT COMPLETED|Treatment Period 2 (21 Days)||0
10534098|NCT01427972|11686132|FG009|NOT COMPLETED|Treatment Period 2 (21 Days)||0
10534099|NCT01427972|11686133|FG010|NOT COMPLETED|Treatment Period 2 (21 Days)||0
10534100|NCT01427972|11686134|FG011|NOT COMPLETED|Treatment Period 2 (21 Days)||0
10534107|NCT01428063|11686167|FG000|STARTED|Overall Study||99
10534108|NCT01428063|11686168|FG001|STARTED|Overall Study||122
10534109|NCT01428063|11686169|FG002|STARTED|Overall Study||6
10534110|NCT01428063|11686167|FG000|COMPLETED|Overall Study||89
10534111|NCT01428063|11686168|FG001|COMPLETED|Overall Study||112
10534112|NCT01428063|11686169|FG002|COMPLETED|Overall Study||5
10534113|NCT01428063|11686167|FG000|NOT COMPLETED|Overall Study||10
10534114|NCT01428063|11686168|FG001|NOT COMPLETED|Overall Study||10
10534115|NCT01428063|11686169|FG002|NOT COMPLETED|Overall Study||1
10534116|NCT01428076|11686190|FG000|STARTED|Overall Study||9
10534117|NCT01428076|11686191|FG001|STARTED|Overall Study||12
10534118|NCT01428076|11686190|FG000|COMPLETED|Overall Study||9
10534119|NCT01428076|11686191|FG001|COMPLETED|Overall Study||11
10357206|NCT00475033|11496684|FG001|NOT COMPLETED|Toddler Dose||0
10357207|NCT00475085|11496701|FG000|STARTED|Overall Study||253
10357208|NCT00475085|11496702|FG001|STARTED|Overall Study||254
10357209|NCT00475085|11496703|FG002|STARTED|Overall Study||260
10357210|NCT00475085|11496704|FG003|STARTED|Overall Study||254
10357211|NCT00475085|11496701|FG000|COMPLETED|Overall Study||235
10357212|NCT00475085|11496702|FG001|COMPLETED|Overall Study||234
10357213|NCT00475085|11496703|FG002|COMPLETED|Overall Study||241
10357214|NCT00475085|11496704|FG003|COMPLETED|Overall Study||234
10534120|NCT01428076|11686190|FG000|NOT COMPLETED|Overall Study||0
10534121|NCT01428076|11686191|FG001|NOT COMPLETED|Overall Study||1
10534122|NCT01428115|11686199|FG000|STARTED|Overall Study||83
10534123|NCT01428115|11686199|FG000|COMPLETED|Overall Study||62
10534124|NCT01428115|11686199|FG000|NOT COMPLETED|Overall Study||21
10357215|NCT00475085|11496701|FG000|NOT COMPLETED|Overall Study||18
10357216|NCT00475085|11496702|FG001|NOT COMPLETED|Overall Study||20
10357217|NCT00475085|11496703|FG002|NOT COMPLETED|Overall Study||19
10357218|NCT00475085|11496704|FG003|NOT COMPLETED|Overall Study||20
10357219|NCT00475150|11496716|FG000|STARTED|Overall Study||23
10357220|NCT00475150|11496717|FG001|STARTED|Overall Study||16
10357221|NCT00475150|11496716|FG000|COMPLETED|Overall Study||23
10357222|NCT00475150|11496717|FG001|COMPLETED|Overall Study||16
10357223|NCT00475150|11496716|FG000|NOT COMPLETED|Overall Study||0
10357224|NCT00475150|11496717|FG001|NOT COMPLETED|Overall Study||0
10357225|NCT00475176|11496722|FG000|STARTED|Overall Study||24
10357226|NCT00475176|11496722|FG000|COMPLETED|Overall Study||20
10357227|NCT00475176|11496722|FG000|NOT COMPLETED|Overall Study||4
10357228|NCT00475215|11496728|FG000|STARTED|Overall Study||44
10357229|NCT00475215|11496729|FG001|STARTED|Overall Study||42
10357230|NCT00475215|11496728|FG000|Treated|Overall Study||39
10357231|NCT00475215|11496729|FG001|Treated|Overall Study||38
10357232|NCT00475215|11496728|FG000|COMPLETED|Overall Study||39
10357233|NCT00475215|11496729|FG001|COMPLETED|Overall Study||38
10357234|NCT00475215|11496728|FG000|NOT COMPLETED|Overall Study||5
10357235|NCT00475215|11496729|FG001|NOT COMPLETED|Overall Study||4
10357236|NCT00475228|11496737|FG000|STARTED|Overall Study||44
10357237|NCT00475228|11496738|FG001|STARTED|Overall Study||44
10357238|NCT00475228|11496737|FG000|COMPLETED|Overall Study||27
10357239|NCT00475228|11496738|FG001|COMPLETED|Overall Study||27
10357240|NCT00475228|11496737|FG000|NOT COMPLETED|Overall Study||17
10357241|NCT00475228|11496738|FG001|NOT COMPLETED|Overall Study||17
10357242|NCT00475241|11496750|FG000|STARTED|Overall Study||18
10357243|NCT00475241|11496751|FG001|STARTED|Overall Study||18
10357244|NCT00475241|11496750|FG000|COMPLETED|Overall Study||11
10357245|NCT00475241|11496751|FG001|COMPLETED|Overall Study||15
10357246|NCT00475241|11496750|FG000|NOT COMPLETED|Overall Study||7
10357247|NCT00475241|11496751|FG001|NOT COMPLETED|Overall Study||3
10357248|NCT00475306|11496762|FG000|STARTED|Overall Study||73
10357249|NCT00475306|11496763|FG001|STARTED|Overall Study||72
10357250|NCT00475306|11496764|FG002|STARTED|Overall Study||72
10357251|NCT00475306|11496765|FG003|STARTED|Overall Study||72
10357252|NCT00475306|11496762|FG000|COMPLETED|Overall Study|1 patient had resolution of nausea prior and did not receive the investigational medication|72
10357253|NCT00475306|11496763|FG001|COMPLETED|Overall Study|For 1 patient, data collection was incomplete and results could not be analyzed|71
10357254|NCT00475306|11496764|FG002|COMPLETED|Overall Study||72
10357255|NCT00475306|11496765|FG003|COMPLETED|Overall Study|1 patient's intravenous line infiltrated.|71
10357256|NCT00475306|11496762|FG000|NOT COMPLETED|Overall Study||1
10357257|NCT00475306|11496763|FG001|NOT COMPLETED|Overall Study||1
10357258|NCT00475306|11496764|FG002|NOT COMPLETED|Overall Study||0
10357259|NCT00475306|11496765|FG003|NOT COMPLETED|Overall Study||1
10357260|NCT00475319|11496778|FG000|STARTED|Overall Study||103
10357261|NCT00475319|11496779|FG001|STARTED|Overall Study||102
10357262|NCT00475319|11496780|FG002|STARTED|Overall Study||103
10716182|NCT02688387|11880057|FG014|STARTED|Part 3B, Washout Period 2 (10 Days)||0
10716183|NCT02688387|11880058|FG015|STARTED|Part 3B, Washout Period 2 (10 Days)||0
10716184|NCT02688387|11880059|FG016|STARTED|Part 3B, Washout Period 2 (10 Days)||0
10716185|NCT02688387|11880060|FG017|STARTED|Part 3B, Washout Period 2 (10 Days)||0
10716186|NCT02688387|11880061|FG018|STARTED|Part 3B, Washout Period 2 (10 Days)||8
10716187|NCT02688387|11880062|FG019|STARTED|Part 3B, Washout Period 2 (10 Days)||8
10357263|NCT00475319|11496778|FG000|COMPLETED|Overall Study||101
10357264|NCT00475319|11496779|FG001|COMPLETED|Overall Study||101
10357265|NCT00475319|11496780|FG002|COMPLETED|Overall Study||99
10357266|NCT00475319|11496778|FG000|NOT COMPLETED|Overall Study||2
10357267|NCT00475319|11496779|FG001|NOT COMPLETED|Overall Study||1
10357268|NCT00475319|11496780|FG002|NOT COMPLETED|Overall Study||4
10357269|NCT00475423|11496791|FG000|STARTED|Overall Study||122
10357270|NCT00475423|11496791|FG000|COMPLETED|Overall Study||90
10357271|NCT00475423|11496791|FG000|NOT COMPLETED|Overall Study||32
10357272|NCT00475501|11496799|FG000|STARTED|Overall Study||14
10357273|NCT00475501|11496800|FG001|STARTED|Overall Study||13
10357274|NCT00475501|11496801|FG002|STARTED|Overall Study||17
10357275|NCT00475501|11496802|FG003|STARTED|Overall Study||16
10357276|NCT00475501|11496799|FG000|COMPLETED|Overall Study||7
10357277|NCT00475501|11496800|FG001|COMPLETED|Overall Study||8
10357278|NCT00475501|11496801|FG002|COMPLETED|Overall Study||13
10357279|NCT00475501|11496802|FG003|COMPLETED|Overall Study||12
10357280|NCT00475501|11496799|FG000|NOT COMPLETED|Overall Study||7
10357281|NCT00475501|11496800|FG001|NOT COMPLETED|Overall Study||5
10357282|NCT00475501|11496801|FG002|NOT COMPLETED|Overall Study||4
10357283|NCT00475501|11496802|FG003|NOT COMPLETED|Overall Study||4
10357284|NCT00475644|11496844|FG000|STARTED|Overall Study||66
10357285|NCT00475644|11496844|FG000|Received at Least One Dose of Study Drug|Overall Study||66
10357286|NCT00475644|11496844|FG000|COMPLETED|Overall Study||53
10357287|NCT00475644|11496844|FG000|NOT COMPLETED|Overall Study||13
10357288|NCT00475670|11496850|FG000|STARTED|Overall Study||3
10357289|NCT00475670|11496851|FG001|STARTED|Overall Study||41
10357290|NCT00475670|11496850|FG000|COMPLETED|Overall Study|This cohort was closed prematurely (with only 3 participants) because of enrollment difficulties.|0
10357291|NCT00475670|11496851|FG001|COMPLETED|Overall Study||0
10357292|NCT00475670|11496850|FG000|NOT COMPLETED|Overall Study||3
10357293|NCT00475670|11496851|FG001|NOT COMPLETED|Overall Study||41
10357294|NCT00475709|11496857|FG000|STARTED|Overall Study||1022
10357295|NCT00475709|11496857|FG000|Eligible of Analysis|Overall Study|Excludes eight ineligible subjects|1014
10357296|NCT00475709|11496857|FG000|COMPLETED|Overall Study||946
10357297|NCT00475709|11496857|FG000|NOT COMPLETED|Overall Study||76
10357298|NCT00475722|11496863|FG000|STARTED|Overall Study||61
10357299|NCT00475722|11496864|FG001|STARTED|Overall Study||59
10357300|NCT00475722|11496863|FG000|COMPLETED|Overall Study||46
10357301|NCT00475722|11496864|FG001|COMPLETED|Overall Study||47
10357302|NCT00475722|11496863|FG000|NOT COMPLETED|Overall Study||15
10357303|NCT00475722|11496864|FG001|NOT COMPLETED|Overall Study||12
10357304|NCT00475735|11496876|FG000|STARTED|Treatment Period 1||14
10357305|NCT00475735|11496877|FG001|STARTED|Treatment Period 1||13
10357306|NCT00475735|11496878|FG002|STARTED|Treatment Period 1||7
10357307|NCT00475735|11496879|FG003|STARTED|Treatment Period 1||7
10357308|NCT00475735|11496880|FG004|STARTED|Treatment Period 1||16
10357309|NCT00475735|11496881|FG005|STARTED|Treatment Period 1||15
10357310|NCT00475735|11496876|FG000|COMPLETED|Treatment Period 1||10
10357311|NCT00475735|11496877|FG001|COMPLETED|Treatment Period 1||11
10357312|NCT00475735|11496878|FG002|COMPLETED|Treatment Period 1||7
10357313|NCT00475735|11496879|FG003|COMPLETED|Treatment Period 1||5
10357314|NCT00475735|11496880|FG004|COMPLETED|Treatment Period 1||14
10357315|NCT00475735|11496881|FG005|COMPLETED|Treatment Period 1||12
10357316|NCT00475735|11496876|FG000|NOT COMPLETED|Treatment Period 1||4
10357317|NCT00475735|11496877|FG001|NOT COMPLETED|Treatment Period 1||2
10357318|NCT00475735|11496878|FG002|NOT COMPLETED|Treatment Period 1||0
10357319|NCT00475735|11496879|FG003|NOT COMPLETED|Treatment Period 1||2
10357320|NCT00475735|11496880|FG004|NOT COMPLETED|Treatment Period 1||2
10357321|NCT00475735|11496881|FG005|NOT COMPLETED|Treatment Period 1||3
10357322|NCT00475735|11496876|FG000|STARTED|Treatment Washout||10
10357323|NCT00475735|11496877|FG001|STARTED|Treatment Washout|Includes 1 patient that discontinued Treatment Period 1 but continued the Study.|12
10357324|NCT00475735|11496878|FG002|STARTED|Treatment Washout||7
10357325|NCT00475735|11496879|FG003|STARTED|Treatment Washout|Includes 1 patient that discontinued Treatment Period 1 but continued the Study.|6
10357326|NCT00475735|11496880|FG004|STARTED|Treatment Washout|Includes 2 patients that discontinued Treatment Period 1 but continued the Study.|16
10357327|NCT00475735|11496881|FG005|STARTED|Treatment Washout|Includes 2 patients that discontinued Treatment Period 1 but continued the Study.|14
10357328|NCT00475735|11496876|FG000|COMPLETED|Treatment Washout||10
10357329|NCT00475735|11496877|FG001|COMPLETED|Treatment Washout||10
10357330|NCT00475735|11496878|FG002|COMPLETED|Treatment Washout||7
10357331|NCT00475735|11496879|FG003|COMPLETED|Treatment Washout||6
10357332|NCT00475735|11496880|FG004|COMPLETED|Treatment Washout||16
10357333|NCT00475735|11496881|FG005|COMPLETED|Treatment Washout||14
10357334|NCT00475735|11496876|FG000|NOT COMPLETED|Treatment Washout||0
10357335|NCT00475735|11496877|FG001|NOT COMPLETED|Treatment Washout||2
10357336|NCT00475735|11496878|FG002|NOT COMPLETED|Treatment Washout||0
10357337|NCT00475735|11496879|FG003|NOT COMPLETED|Treatment Washout||0
10357338|NCT00475735|11496880|FG004|NOT COMPLETED|Treatment Washout||0
10357339|NCT00475735|11496881|FG005|NOT COMPLETED|Treatment Washout||0
10357340|NCT00475735|11496876|FG000|STARTED|Treatment Period 2||10
10357341|NCT00475735|11496877|FG001|STARTED|Treatment Period 2||10
10357342|NCT00475735|11496878|FG002|STARTED|Treatment Period 2||7
10357343|NCT00475735|11496879|FG003|STARTED|Treatment Period 2||6
10357344|NCT00475735|11496880|FG004|STARTED|Treatment Period 2||16
10357345|NCT00475735|11496881|FG005|STARTED|Treatment Period 2||14
10357346|NCT00475735|11496876|FG000|COMPLETED|Treatment Period 2||10
10357347|NCT00475735|11496877|FG001|COMPLETED|Treatment Period 2||9
10357348|NCT00475735|11496878|FG002|COMPLETED|Treatment Period 2||7
10357349|NCT00475735|11496879|FG003|COMPLETED|Treatment Period 2||4
10357350|NCT00475735|11496880|FG004|COMPLETED|Treatment Period 2||15
10357351|NCT00475735|11496881|FG005|COMPLETED|Treatment Period 2||13
10357352|NCT00475735|11496876|FG000|NOT COMPLETED|Treatment Period 2||0
10357353|NCT00475735|11496877|FG001|NOT COMPLETED|Treatment Period 2||1
10357354|NCT00475735|11496878|FG002|NOT COMPLETED|Treatment Period 2||0
10357355|NCT00475735|11496879|FG003|NOT COMPLETED|Treatment Period 2||2
10357356|NCT00475735|11496880|FG004|NOT COMPLETED|Treatment Period 2||1
10357357|NCT00475735|11496881|FG005|NOT COMPLETED|Treatment Period 2||1
10357358|NCT00475787|11496891|FG000|STARTED|Overall Study||69
10357359|NCT00475787|11496892|FG001|STARTED|Overall Study||67
10357360|NCT00475787|11496891|FG000|COMPLETED|Overall Study||61
10357361|NCT00475787|11496892|FG001|COMPLETED|Overall Study||60
10357362|NCT00475787|11496891|FG000|NOT COMPLETED|Overall Study||8
10357363|NCT00475787|11496892|FG001|NOT COMPLETED|Overall Study||7
10357364|NCT00475852|11496902|FG000|STARTED|Overall Study||3564
10357365|NCT00475852|11496903|FG001|STARTED|Overall Study||3577
10357366|NCT00475852|11496902|FG000|COMPLETED|Overall Study||3047
10357367|NCT00475852|11496903|FG001|COMPLETED|Overall Study||3029
10357368|NCT00475852|11496902|FG000|NOT COMPLETED|Overall Study||517
10357369|NCT00475852|11496903|FG001|NOT COMPLETED|Overall Study||548
10357370|NCT00475865|11496912|FG000|STARTED|Overall Study|randomized|41
10357371|NCT00475865|11496913|FG001|STARTED|Overall Study|randomized|42
10357372|NCT00475865|11496914|FG002|STARTED|Overall Study|randomized|40
10357373|NCT00475865|11496912|FG000|Treated|Overall Study|completed treatment period|41
10357374|NCT00475865|11496913|FG001|Treated|Overall Study||42
10357375|NCT00475865|11496914|FG002|Treated|Overall Study||40
10357376|NCT00475865|11496912|FG000|COMPLETED|Overall Study||39
10357377|NCT00475865|11496913|FG001|COMPLETED|Overall Study|completed treatment period|37
10357378|NCT00475865|11496914|FG002|COMPLETED|Overall Study|completed treatment period|34
10357379|NCT00475865|11496912|FG000|NOT COMPLETED|Overall Study||2
10357380|NCT00475865|11496913|FG001|NOT COMPLETED|Overall Study||5
10534125|NCT01428128|11686204|FG000|STARTED|Overall Study||50
10534126|NCT01428128|11686204|FG000|COMPLETED|Overall Study||33
10534127|NCT01428128|11686204|FG000|NOT COMPLETED|Overall Study||17
10534128|NCT01428193|11686209|FG000|STARTED|Overall Study||4
10534129|NCT01428193|11686209|FG000|COMPLETED|Overall Study||2
10534130|NCT01428193|11686209|FG000|NOT COMPLETED|Overall Study||2
10534131|NCT01428219|11686213|FG000|STARTED|Overall Study||25
10534132|NCT01428219|11686213|FG000|COMPLETED|Overall Study||22
10534133|NCT01428219|11686213|FG000|NOT COMPLETED|Overall Study||3
10534134|NCT01428245|11686217|FG000|STARTED|Overall Study||1
10534135|NCT01428245|11686217|FG000|COMPLETED|Overall Study||1
10534136|NCT01428245|11686217|FG000|NOT COMPLETED|Overall Study||0
10534137|NCT01428258|11686223|FG000|STARTED|Intervention 1||17
10534138|NCT01428258|11686224|FG001|STARTED|Intervention 1||15
10534139|NCT01428258|11686223|FG000|COMPLETED|Intervention 1||15
10534140|NCT01428258|11686224|FG001|COMPLETED|Intervention 1||15
10534141|NCT01428258|11686223|FG000|NOT COMPLETED|Intervention 1||2
10534142|NCT01428258|11686224|FG001|NOT COMPLETED|Intervention 1||0
10534143|NCT01428258|11686223|FG000|STARTED|Intervention 2||15
10534144|NCT01428258|11686224|FG001|STARTED|Intervention 2||15
10534145|NCT01428258|11686223|FG000|COMPLETED|Intervention 2||15
10534146|NCT01428258|11686224|FG001|COMPLETED|Intervention 2||15
10534147|NCT01428258|11686223|FG000|NOT COMPLETED|Intervention 2||0
10534148|NCT01428258|11686224|FG001|NOT COMPLETED|Intervention 2||0
10534149|NCT01428336|11686240|FG000|STARTED|Overall Study||10
10534150|NCT01428336|11686241|FG001|STARTED|Overall Study||12
10534151|NCT01428336|11686240|FG000|COMPLETED|Overall Study||10
10534152|NCT01428336|11686241|FG001|COMPLETED|Overall Study||12
10534153|NCT01428336|11686240|FG000|NOT COMPLETED|Overall Study||0
10534154|NCT01428336|11686241|FG001|NOT COMPLETED|Overall Study||0
10534155|NCT01428453|11686252|FG000|STARTED|Overall Study||62
10534156|NCT01428453|11686253|FG001|STARTED|Overall Study||61
10534157|NCT01428453|11686252|FG000|COMPLETED|Overall Study||56
10534158|NCT01428453|11686253|FG001|COMPLETED|Overall Study||52
10534159|NCT01428453|11686252|FG000|NOT COMPLETED|Overall Study||6
10534160|NCT01428453|11686253|FG001|NOT COMPLETED|Overall Study||9
10547930|NCT01515657|11701700|FG002|NOT COMPLETED|Third Intervention||0
10547931|NCT01515696|11701710|FG000|STARTED|Overall Study||47
10547932|NCT01515696|11701711|FG001|STARTED|Overall Study||49
10547933|NCT01515696|11701710|FG000|COMPLETED|Overall Study||39
10547934|NCT01515696|11701711|FG001|COMPLETED|Overall Study||39
10547935|NCT01515696|11701710|FG000|NOT COMPLETED|Overall Study||8
10547936|NCT01515696|11701711|FG001|NOT COMPLETED|Overall Study||10
10547937|NCT01515865|11701717|FG000|STARTED|Part A (Open-label)||98
10547938|NCT01515865|11701718|FG001|STARTED|Part A (Open-label)||0
10547939|NCT01515865|11701719|FG002|STARTED|Part A (Open-label)||0
10547940|NCT01515865|11701717|FG000|COMPLETED|Part A (Open-label)||95
10656242|NCT02215954|11817154|FG002|Safety Analysis Set|Overall Study||208
10656243|NCT02215954|11817152|FG000|COMPLETED|Overall Study||213
10656244|NCT02215954|11817153|FG001|COMPLETED|Overall Study||211
10656245|NCT02215954|11817154|FG002|COMPLETED|Overall Study||205
10656246|NCT02215954|11817152|FG000|NOT COMPLETED|Overall Study||1
10656247|NCT02215954|11817153|FG001|NOT COMPLETED|Overall Study||1
10656248|NCT02215954|11817154|FG002|NOT COMPLETED|Overall Study||6
10656249|NCT02215967|11817167|FG000|STARTED|Overall Study||3
10656250|NCT02215967|11817168|FG001|STARTED|Overall Study||3
10656251|NCT02215967|11817169|FG002|STARTED|Overall Study||5
10656252|NCT02215967|11817170|FG003|STARTED|Overall Study||19
10656253|NCT02215967|11817167|FG000|COMPLETED|Overall Study||3
10656254|NCT02215967|11817168|FG001|COMPLETED|Overall Study||3
10656255|NCT02215967|11817169|FG002|COMPLETED|Overall Study||4
10656256|NCT02215967|11817170|FG003|COMPLETED|Overall Study||16
10656257|NCT02215967|11817167|FG000|NOT COMPLETED|Overall Study||0
10656258|NCT02215967|11817168|FG001|NOT COMPLETED|Overall Study||0
10656259|NCT02215967|11817169|FG002|NOT COMPLETED|Overall Study||1
10656260|NCT02215967|11817170|FG003|NOT COMPLETED|Overall Study||3
10656261|NCT02216071|11817182|FG000|STARTED|Overall Study||254
10656262|NCT02216071|11817183|FG001|STARTED|Overall Study||245
10357381|NCT00475865|11496914|FG002|NOT COMPLETED|Overall Study||6
10357382|NCT00475878|11496926|FG000|STARTED|Overall Study||75
10357383|NCT00475878|11496927|FG001|STARTED|Overall Study||72
10547941|NCT01515865|11701718|FG001|COMPLETED|Part A (Open-label)||0
10547942|NCT01515865|11701719|FG002|COMPLETED|Part A (Open-label)||0
10547943|NCT01515865|11701717|FG000|NOT COMPLETED|Part A (Open-label)||3
10547944|NCT01515865|11701718|FG001|NOT COMPLETED|Part A (Open-label)||0
10656263|NCT02216071|11817182|FG000|COMPLETED|Overall Study||239
10656264|NCT02216071|11817183|FG001|COMPLETED|Overall Study||233
10357384|NCT00475878|11496926|FG000|COMPLETED|Overall Study||75
10357385|NCT00475878|11496927|FG001|COMPLETED|Overall Study||72
10357386|NCT00475878|11496926|FG000|NOT COMPLETED|Overall Study||0
10357387|NCT00475878|11496927|FG001|NOT COMPLETED|Overall Study||0
10357388|NCT00475904|11496938|FG000|STARTED|Overall Study||140
10357389|NCT00475904|11496939|FG001|STARTED|Overall Study||144
10357390|NCT00475904|11496940|FG002|STARTED|Overall Study||76
10357391|NCT00475904|11496938|FG000|COMPLETED|Overall Study||125
10357392|NCT00475904|11496939|FG001|COMPLETED|Overall Study||131
10357393|NCT00475904|11496940|FG002|COMPLETED|Overall Study||72
10357394|NCT00475904|11496938|FG000|NOT COMPLETED|Overall Study||15
10357395|NCT00475904|11496939|FG001|NOT COMPLETED|Overall Study||13
10357396|NCT00475904|11496940|FG002|NOT COMPLETED|Overall Study||4
10357397|NCT00475982|11496950|FG000|STARTED|Overall Study||23
10357398|NCT00475982|11496951|FG001|STARTED|Overall Study||21
10357399|NCT00475982|11496950|FG000|COMPLETED|Overall Study||16
10357400|NCT00475982|11496951|FG001|COMPLETED|Overall Study||18
10357401|NCT00475982|11496950|FG000|NOT COMPLETED|Overall Study||7
10357402|NCT00475982|11496951|FG001|NOT COMPLETED|Overall Study||3
10357403|NCT00476008|11496959|FG000|STARTED|Overall Study||22
10357404|NCT00476008|11496960|FG001|STARTED|Overall Study||21
10357405|NCT00476008|11496959|FG000|6 Month Testing|Overall Study||15
10357406|NCT00476008|11496960|FG001|6 Month Testing|Overall Study||14
10357407|NCT00476008|11496959|FG000|COMPLETED|Overall Study||13
10357408|NCT00476008|11496960|FG001|COMPLETED|Overall Study||13
10357409|NCT00476008|11496959|FG000|NOT COMPLETED|Overall Study||9
10357410|NCT00476008|11496960|FG001|NOT COMPLETED|Overall Study||8
10357411|NCT00476021|11496972|FG000|STARTED|Overall Study||51
10357412|NCT00476021|11496973|FG001|STARTED|Overall Study||51
10357413|NCT00476021|11496972|FG000|COMPLETED|Overall Study||51
10357414|NCT00476021|11496973|FG001|COMPLETED|Overall Study||51
10357415|NCT00476021|11496972|FG000|NOT COMPLETED|Overall Study||0
10357416|NCT00476021|11496973|FG001|NOT COMPLETED|Overall Study||0
10357417|NCT00476047|11496985|FG000|STARTED|Overall Study||16
10357418|NCT00476047|11496985|FG000|Completed Treatment|Overall Study||16
10357419|NCT00476047|11496985|FG000|COMPLETED|Overall Study||15
10357420|NCT00476047|11496985|FG000|NOT COMPLETED|Overall Study||1
10357421|NCT00476086|11496991|FG000|STARTED|Overall Study||20
10357422|NCT00476086|11496991|FG000|Received Chemotherapy|Overall Study||19
10357423|NCT00476086|11496991|FG000|Received Radiation|Overall Study||15
10357424|NCT00476086|11496991|FG000|COMPLETED|Overall Study||15
10357425|NCT00476086|11496991|FG000|NOT COMPLETED|Overall Study||5
10357426|NCT00476151|11496999|FG000|STARTED|Overall Study||112
10357427|NCT00476151|11497000|FG001|STARTED|Overall Study||114
10357428|NCT00476151|11496999|FG000|COMPLETED|Overall Study||109
10357429|NCT00476151|11497000|FG001|COMPLETED|Overall Study||107
10357430|NCT00476151|11496999|FG000|NOT COMPLETED|Overall Study||3
10357431|NCT00476151|11497000|FG001|NOT COMPLETED|Overall Study||7
10357432|NCT00476229|11497006|FG000|STARTED|Overall Study||20
10357433|NCT00476229|11497006|FG000|COMPLETED|Overall Study||19
10357434|NCT00476229|11497006|FG000|NOT COMPLETED|Overall Study||1
10357435|NCT00476242|11497012|FG000|STARTED|Overall Study||27
10357436|NCT00476242|11497013|FG001|STARTED|Overall Study||28
10357437|NCT00476242|11497012|FG000|COMPLETED|Overall Study||19
10357438|NCT00476242|11497013|FG001|COMPLETED|Overall Study||12
10357439|NCT00476242|11497012|FG000|NOT COMPLETED|Overall Study||8
10357440|NCT00476242|11497013|FG001|NOT COMPLETED|Overall Study||16
10357441|NCT00476476|11497023|FG000|STARTED|Overall Study||17
10357442|NCT00476476|11497024|FG001|STARTED|Overall Study||24
10357443|NCT00476476|11497023|FG000|Response Evaluable|Overall Study||17
10357444|NCT00476476|11497024|FG001|Response Evaluable|Overall Study|One woman was unevaluable due to an allergic reaction that developed after the 2nd dose.|23
10357445|NCT00476476|11497023|FG000|COMPLETED|Overall Study||15
10357446|NCT00476476|11497024|FG001|COMPLETED|Overall Study|Treatment was not of fixed duration and thus pts are not considered to have 'Completed' treatment.|0
10357447|NCT00476476|11497023|FG000|NOT COMPLETED|Overall Study||2
10357448|NCT00476476|11497024|FG001|NOT COMPLETED|Overall Study||24
10357449|NCT00476593|11497033|FG000|STARTED|Overall Study||32
10357450|NCT00476593|11497034|FG001|STARTED|Overall Study||19
10357451|NCT00476593|11497035|FG002|STARTED|Overall Study||38
10357452|NCT00476593|11497036|FG003|STARTED|Overall Study||129
10357453|NCT00476593|11497033|FG000|COMPLETED|Overall Study|all subjects completed treatment in one eye. However, bilateral OCT scans included only in 22 cases|22
10357454|NCT00476593|11497034|FG001|COMPLETED|Overall Study|all subjects completed treatment in one eye. However, bilateral OCT scans included only in 17 cases|17
10357455|NCT00476593|11497035|FG002|COMPLETED|Overall Study||30
10357456|NCT00476593|11497036|FG003|COMPLETED|Overall Study||107
10357457|NCT00476593|11497033|FG000|NOT COMPLETED|Overall Study||10
10357458|NCT00476593|11497034|FG001|NOT COMPLETED|Overall Study||2
10357459|NCT00476593|11497035|FG002|NOT COMPLETED|Overall Study||8
10357460|NCT00476593|11497036|FG003|NOT COMPLETED|Overall Study||22
10357461|NCT00476645|11497046|FG000|STARTED|Overall Study||10
10357462|NCT00476645|11497046|FG000|COMPLETED|Overall Study||10
10357463|NCT00476645|11497046|FG000|NOT COMPLETED|Overall Study||0
10357464|NCT00476788|11497050|FG000|STARTED|Overall Study||14
10357465|NCT00476788|11497050|FG000|COMPLETED|Overall Study||11
10357466|NCT00476788|11497050|FG000|NOT COMPLETED|Overall Study||3
10357467|NCT00476957|11497056|FG000|STARTED|Overall Study||4357
10357468|NCT00476957|11497057|FG001|STARTED|Overall Study||4352
10357469|NCT00476957|11497056|FG000|COMPLETED|Overall Study||4181
10357470|NCT00476957|11497057|FG001|COMPLETED|Overall Study||4159
10357471|NCT00476957|11497056|FG000|NOT COMPLETED|Overall Study||176
10357472|NCT00476957|11497057|FG001|NOT COMPLETED|Overall Study||193
10357473|NCT00476996|11497066|FG000|STARTED|Blinded Treatment Phase (up to Week 48)||277
10357474|NCT00476996|11497067|FG001|STARTED|Blinded Treatment Phase (up to Week 48)||277
10357475|NCT00476996|11497068|FG002|STARTED|Blinded Treatment Phase (up to Week 48)||282
10357476|NCT00476996|11497069|FG003|STARTED|Blinded Treatment Phase (up to Week 48)||0
10357477|NCT00476996|11497066|FG000|COMPLETED|Blinded Treatment Phase (up to Week 48)||205
10357478|NCT00476996|11497067|FG001|COMPLETED|Blinded Treatment Phase (up to Week 48)||222
10357479|NCT00476996|11497068|FG002|COMPLETED|Blinded Treatment Phase (up to Week 48)||237
10357480|NCT00476996|11497069|FG003|COMPLETED|Blinded Treatment Phase (up to Week 48)||0
10357481|NCT00476996|11497066|FG000|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||72
10357482|NCT00476996|11497067|FG001|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||55
10357483|NCT00476996|11497068|FG002|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||45
10357484|NCT00476996|11497069|FG003|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||0
10357485|NCT00476996|11497066|FG000|STARTED|OLE Phase (From Week 48)||0
10357486|NCT00476996|11497067|FG001|STARTED|OLE Phase (From Week 48)||0
10357487|NCT00476996|11497068|FG002|STARTED|OLE Phase (From Week 48)||0
10357488|NCT00476996|11497069|FG003|STARTED|OLE Phase (From Week 48)||664
10357489|NCT00476996|11497066|FG000|COMPLETED|OLE Phase (From Week 48)||0
10357490|NCT00476996|11497067|FG001|COMPLETED|OLE Phase (From Week 48)||0
10357491|NCT00476996|11497068|FG002|COMPLETED|OLE Phase (From Week 48)||0
10357492|NCT00476996|11497069|FG003|COMPLETED|OLE Phase (From Week 48)||0
10357493|NCT00476996|11497066|FG000|NOT COMPLETED|OLE Phase (From Week 48)||0
10357494|NCT00476996|11497067|FG001|NOT COMPLETED|OLE Phase (From Week 48)||0
10357495|NCT00476996|11497068|FG002|NOT COMPLETED|OLE Phase (From Week 48)||0
10357496|NCT00476996|11497069|FG003|NOT COMPLETED|OLE Phase (From Week 48)||664
10357497|NCT00477087|11497078|FG000|STARTED|Overall Study||10
10357498|NCT00477087|11497078|FG000|COMPLETED|Overall Study||10
10357499|NCT00477087|11497078|FG000|NOT COMPLETED|Overall Study||0
10357500|NCT00477152|11497082|FG000|STARTED|Overall Study|One patient withdrawn prior to treatment, so not included in analyses.|52
10357501|NCT00477152|11497082|FG000|COMPLETED|Overall Study|Two patients treated, but assessments incomplete. All available data included in analyses for these.|49
10357502|NCT00477152|11497082|FG000|NOT COMPLETED|Overall Study||3
10357503|NCT00477165|11497088|FG000|STARTED|Overall Study||27
10357504|NCT00477165|11497089|FG001|STARTED|Overall Study||27
10357505|NCT00477165|11497088|FG000|COMPLETED|Overall Study||20
10357506|NCT00477165|11497089|FG001|COMPLETED|Overall Study||25
10357507|NCT00477165|11497088|FG000|NOT COMPLETED|Overall Study||7
10357508|NCT00477165|11497089|FG001|NOT COMPLETED|Overall Study||2
10357509|NCT00477191|11497095|FG000|STARTED|Overall Study||18
10357510|NCT00477191|11497095|FG000|COMPLETED|Overall Study||13
10357511|NCT00477191|11497095|FG000|NOT COMPLETED|Overall Study||5
10357512|NCT00477204|11497101|FG000|STARTED|Overall Study||4
10357513|NCT00477204|11497102|FG001|STARTED|Overall Study||5
10357514|NCT00477204|11497101|FG000|COMPLETED|Overall Study||4
10357515|NCT00477204|11497102|FG001|COMPLETED|Overall Study||5
10357516|NCT00477204|11497101|FG000|NOT COMPLETED|Overall Study||0
10357517|NCT00477204|11497102|FG001|NOT COMPLETED|Overall Study||0
10357518|NCT00477269|11497110|FG000|STARTED|Core Study||28
10357519|NCT00477269|11497111|FG001|STARTED|Core Study||31
10357520|NCT00477269|11497112|FG002|STARTED|Core Study||0
10357521|NCT00477269|11497110|FG000|COMPLETED|Core Study||19
10357522|NCT00477269|11497111|FG001|COMPLETED|Core Study||23
10357523|NCT00477269|11497112|FG002|COMPLETED|Core Study||0
10357524|NCT00477269|11497110|FG000|NOT COMPLETED|Core Study||9
10357525|NCT00477269|11497111|FG001|NOT COMPLETED|Core Study||8
10357526|NCT00477269|11497112|FG002|NOT COMPLETED|Core Study||0
10357527|NCT00477269|11497110|FG000|STARTED|Open Label Extension|Arm in the Core study not extension|0
10357528|NCT00477269|11497111|FG001|STARTED|Open Label Extension|Arm in the Core study not extension|0
10357529|NCT00477269|11497112|FG002|STARTED|Open Label Extension||22
10357530|NCT00477269|11497110|FG000|COMPLETED|Open Label Extension|Arm in the Core study not extension|0
10357531|NCT00477269|11497111|FG001|COMPLETED|Open Label Extension|Arm in the Core study not extension|0
10357532|NCT00477269|11497112|FG002|COMPLETED|Open Label Extension||9
10357533|NCT00477269|11497110|FG000|NOT COMPLETED|Open Label Extension||0
10357534|NCT00477269|11497111|FG001|NOT COMPLETED|Open Label Extension||0
10357535|NCT00477269|11497112|FG002|NOT COMPLETED|Open Label Extension||13
10357536|NCT00477295|11497122|FG000|STARTED|Overall Study||282
10357537|NCT00477295|11497123|FG001|STARTED|Overall Study||301
10357538|NCT00477295|11497122|FG000|COMPLETED|Overall Study||161
10357539|NCT00477295|11497123|FG001|COMPLETED|Overall Study||192
10357540|NCT00477295|11497122|FG000|NOT COMPLETED|Overall Study||121
10357541|NCT00477295|11497123|FG001|NOT COMPLETED|Overall Study||109
10357542|NCT00477334|11497133|FG000|STARTED|Overall Study||312
10357543|NCT00477334|11497134|FG001|STARTED|Overall Study||151
10357544|NCT00477334|11497133|FG000|Randomized and Took Study Drug|Overall Study||206
10357545|NCT00477334|11497134|FG001|Randomized and Took Study Drug|Overall Study||98
10357546|NCT00477334|11497133|FG000|Intent to Treat Population|Overall Study||201
10357547|NCT00477334|11497134|FG001|Intent to Treat Population|Overall Study||98
10357548|NCT00477334|11497133|FG000|Participants Completing First Recurrence|Overall Study||187
10357549|NCT00477334|11497134|FG001|Participants Completing First Recurrence|Overall Study||92
10357550|NCT00477334|11497133|FG000|Modified Intent to Treat Population|Overall Study||152
10357551|NCT00477334|11497134|FG001|Modified Intent to Treat Population|Overall Study||78
10357552|NCT00477334|11497133|FG000|COMPLETED|Overall Study|Participants completing the first recurrence and follow-up.|142
10357553|NCT00477334|11497134|FG001|COMPLETED|Overall Study|Participants completing the first recurrence and follow-up.|75
10357554|NCT00477334|11497133|FG000|NOT COMPLETED|Overall Study||170
10357555|NCT00477334|11497134|FG001|NOT COMPLETED|Overall Study||76
10357556|NCT00477386|11497146|FG000|STARTED|Overall Study||11
10357557|NCT00477386|11497147|FG001|STARTED|Overall Study||17
10357558|NCT00477386|11497146|FG000|COMPLETED|Overall Study||0
10357559|NCT00477386|11497147|FG001|COMPLETED|Overall Study||0
10357560|NCT00477386|11497146|FG000|NOT COMPLETED|Overall Study||11
10357561|NCT00477386|11497147|FG001|NOT COMPLETED|Overall Study||17
10357562|NCT00477451|11497157|FG000|STARTED|Overall Study||20
10357563|NCT00477451|11497158|FG001|STARTED|Overall Study||20
10357564|NCT00477451|11497159|FG002|STARTED|Overall Study||7
10357565|NCT00477451|11497160|FG003|STARTED|Overall Study||2
10357566|NCT00477451|11497157|FG000|COMPLETED|Overall Study||20
10357567|NCT00477451|11497158|FG001|COMPLETED|Overall Study||20
10357568|NCT00477451|11497159|FG002|COMPLETED|Overall Study||7
10357569|NCT00477451|11497160|FG003|COMPLETED|Overall Study||2
10357570|NCT00477451|11497157|FG000|NOT COMPLETED|Overall Study||0
10357571|NCT00477451|11497158|FG001|NOT COMPLETED|Overall Study||0
10357572|NCT00477451|11497159|FG002|NOT COMPLETED|Overall Study||0
10357573|NCT00477451|11497160|FG003|NOT COMPLETED|Overall Study||0
10357574|NCT00477464|11497168|FG000|STARTED|Overall Study||51
10357575|NCT00477464|11497168|FG000|COMPLETED|Overall Study||0
10357576|NCT00477464|11497168|FG000|NOT COMPLETED|Overall Study||51
10357577|NCT00477490|11497179|FG000|STARTED|Part I: 4 Week Efficacy||160
10357578|NCT00477490|11497180|FG001|STARTED|Part I: 4 Week Efficacy||163
10357579|NCT00477490|11497181|FG002|STARTED|Part I: 4 Week Efficacy||158
10357580|NCT00477490|11497182|FG003|STARTED|Part I: 4 Week Efficacy||158
10357581|NCT00477490|11497183|FG004|STARTED|Part I: 4 Week Efficacy||160
10357582|NCT00477490|11497184|FG005|STARTED|Part I: 4 Week Efficacy||0
10357583|NCT00477490|11497185|FG006|STARTED|Part I: 4 Week Efficacy||0
10357584|NCT00477490|11497186|FG007|STARTED|Part I: 4 Week Efficacy||0
10357585|NCT00477490|11497187|FG008|STARTED|Part I: 4 Week Efficacy||0
10357586|NCT00477490|11497179|FG000|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|156
10716188|NCT02688387|11880063|FG020|STARTED|Part 3B, Washout Period 2 (10 Days)||8
10716189|NCT02688387|11880064|FG021|STARTED|Part 3B, Washout Period 2 (10 Days)||8
10716190|NCT02688387|11880043|FG000|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10716191|NCT02688387|11880044|FG001|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10716192|NCT02688387|11880045|FG002|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10357587|NCT00477490|11497180|FG001|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|155
10357588|NCT00477490|11497181|FG002|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|152
10357589|NCT00477490|11497182|FG003|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|148
10357590|NCT00477490|11497183|FG004|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|146
10357591|NCT00477490|11497184|FG005|ITT Population|Part I: 4 Week Efficacy||0
10357592|NCT00477490|11497185|FG006|ITT Population|Part I: 4 Week Efficacy||0
10357593|NCT00477490|11497186|FG007|ITT Population|Part I: 4 Week Efficacy||0
10357594|NCT00477490|11497187|FG008|ITT Population|Part I: 4 Week Efficacy||0
10357595|NCT00477490|11497179|FG000|COMPLETED|Part I: 4 Week Efficacy||145
10357596|NCT00477490|11497180|FG001|COMPLETED|Part I: 4 Week Efficacy||144
10357597|NCT00477490|11497181|FG002|COMPLETED|Part I: 4 Week Efficacy||148
10357598|NCT00477490|11497182|FG003|COMPLETED|Part I: 4 Week Efficacy||138
10357599|NCT00477490|11497183|FG004|COMPLETED|Part I: 4 Week Efficacy||135
10357600|NCT00477490|11497184|FG005|COMPLETED|Part I: 4 Week Efficacy||0
10357601|NCT00477490|11497185|FG006|COMPLETED|Part I: 4 Week Efficacy||0
10357602|NCT00477490|11497186|FG007|COMPLETED|Part I: 4 Week Efficacy||0
10357603|NCT00477490|11497187|FG008|COMPLETED|Part I: 4 Week Efficacy||0
10357604|NCT00477490|11497179|FG000|NOT COMPLETED|Part I: 4 Week Efficacy||15
10357605|NCT00477490|11497180|FG001|NOT COMPLETED|Part I: 4 Week Efficacy||19
10357606|NCT00477490|11497181|FG002|NOT COMPLETED|Part I: 4 Week Efficacy||10
10357607|NCT00477490|11497182|FG003|NOT COMPLETED|Part I: 4 Week Efficacy||20
10357608|NCT00477490|11497183|FG004|NOT COMPLETED|Part I: 4 Week Efficacy||25
10357609|NCT00477490|11497184|FG005|NOT COMPLETED|Part I: 4 Week Efficacy||0
10357610|NCT00477490|11497185|FG006|NOT COMPLETED|Part I: 4 Week Efficacy||0
10357611|NCT00477490|11497186|FG007|NOT COMPLETED|Part I: 4 Week Efficacy||0
10357612|NCT00477490|11497187|FG008|NOT COMPLETED|Part I: 4 Week Efficacy||0
10357613|NCT00477490|11497179|FG000|STARTED|Part II: Extension Week 5 up to Day 169||0
10357614|NCT00477490|11497180|FG001|STARTED|Part II: Extension Week 5 up to Day 169||135
10357615|NCT00477490|11497181|FG002|STARTED|Part II: Extension Week 5 up to Day 169||135
10357616|NCT00477490|11497182|FG003|STARTED|Part II: Extension Week 5 up to Day 169||132
10357617|NCT00477490|11497183|FG004|STARTED|Part II: Extension Week 5 up to Day 169||127
10357618|NCT00477490|11497184|FG005|STARTED|Part II: Extension Week 5 up to Day 169||31
10357619|NCT00477490|11497185|FG006|STARTED|Part II: Extension Week 5 up to Day 169||37
10357620|NCT00477490|11497186|FG007|STARTED|Part II: Extension Week 5 up to Day 169||34
10357621|NCT00477490|11497187|FG008|STARTED|Part II: Extension Week 5 up to Day 169||34
10357622|NCT00477490|11497179|FG000|COMPLETED|Part II: Extension Week 5 up to Day 169||0
10357623|NCT00477490|11497180|FG001|COMPLETED|Part II: Extension Week 5 up to Day 169||107
10357624|NCT00477490|11497181|FG002|COMPLETED|Part II: Extension Week 5 up to Day 169||120
10357625|NCT00477490|11497182|FG003|COMPLETED|Part II: Extension Week 5 up to Day 169||120
10357626|NCT00477490|11497183|FG004|COMPLETED|Part II: Extension Week 5 up to Day 169||107
10357627|NCT00477490|11497184|FG005|COMPLETED|Part II: Extension Week 5 up to Day 169||25
10357628|NCT00477490|11497185|FG006|COMPLETED|Part II: Extension Week 5 up to Day 169||32
10357629|NCT00477490|11497186|FG007|COMPLETED|Part II: Extension Week 5 up to Day 169||29
10357630|NCT00477490|11497187|FG008|COMPLETED|Part II: Extension Week 5 up to Day 169||26
10357631|NCT00477490|11497179|FG000|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||0
10357632|NCT00477490|11497180|FG001|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||28
10357633|NCT00477490|11497181|FG002|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||15
10357634|NCT00477490|11497182|FG003|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||12
10357635|NCT00477490|11497183|FG004|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||20
10357636|NCT00477490|11497184|FG005|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||6
10357637|NCT00477490|11497185|FG006|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||5
10357638|NCT00477490|11497186|FG007|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||5
10357639|NCT00477490|11497187|FG008|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||8
10357640|NCT00477594|11497217|FG000|STARTED|Year 1 and Year 2||16
10357641|NCT00477594|11497218|FG001|STARTED|Year 1 and Year 2||5
10357642|NCT00477594|11497217|FG000|COMPLETED|Year 1 and Year 2||7
10357643|NCT00477594|11497218|FG001|COMPLETED|Year 1 and Year 2||1
10357644|NCT00477594|11497217|FG000|NOT COMPLETED|Year 1 and Year 2||9
10357645|NCT00477594|11497218|FG001|NOT COMPLETED|Year 1 and Year 2||4
10357646|NCT00477594|11497217|FG000|STARTED|Year 3||4
10357647|NCT00477594|11497218|FG001|STARTED|Year 3||0
10357648|NCT00477594|11497217|FG000|COMPLETED|Year 3||2
10357649|NCT00477594|11497218|FG001|COMPLETED|Year 3||0
10357650|NCT00477594|11497217|FG000|NOT COMPLETED|Year 3||2
10357651|NCT00477594|11497218|FG001|NOT COMPLETED|Year 3||0
10357652|NCT00477594|11497217|FG000|STARTED|Follow-up Period||16
10357653|NCT00477594|11497218|FG001|STARTED|Follow-up Period||5
10357654|NCT00477594|11497217|FG000|COMPLETED|Follow-up Period||13
10357655|NCT00477594|11497218|FG001|COMPLETED|Follow-up Period||4
10357656|NCT00477594|11497217|FG000|NOT COMPLETED|Follow-up Period||3
10357657|NCT00477594|11497218|FG001|NOT COMPLETED|Follow-up Period||1
10357658|NCT00477607|11497226|FG000|STARTED|Overall Study||19
10357659|NCT00477607|11497227|FG001|STARTED|Overall Study||20
10357660|NCT00477607|11497226|FG000|COMPLETED|Overall Study||12
10357661|NCT00477607|11497227|FG001|COMPLETED|Overall Study||13
10357662|NCT00477607|11497226|FG000|NOT COMPLETED|Overall Study||7
10357663|NCT00477607|11497227|FG001|NOT COMPLETED|Overall Study||7
10357664|NCT00477633|11497233|FG000|STARTED|Overall Study||1700
10357665|NCT00477633|11497233|FG000|COMPLETED|Overall Study||991
10357666|NCT00477633|11497233|FG000|NOT COMPLETED|Overall Study||709
10357667|NCT00477659|11497237|FG000|STARTED|Overall Study||14
10357668|NCT00477659|11497237|FG000|COMPLETED|Overall Study||14
10357669|NCT00477659|11497237|FG000|NOT COMPLETED|Overall Study||0
10357670|NCT00477672|11497244|FG000|STARTED|Overall Study||98
10357671|NCT00477672|11497245|FG001|STARTED|Overall Study||101
10357672|NCT00477672|11497246|FG002|STARTED|Overall Study||99
10357673|NCT00477672|11497244|FG000|COMPLETED|Overall Study||91
10357674|NCT00477672|11497245|FG001|COMPLETED|Overall Study||85
10357675|NCT00477672|11497246|FG002|COMPLETED|Overall Study||83
10357676|NCT00477672|11497244|FG000|NOT COMPLETED|Overall Study||7
10357677|NCT00477672|11497245|FG001|NOT COMPLETED|Overall Study||16
10357678|NCT00477672|11497246|FG002|NOT COMPLETED|Overall Study||16
10357679|NCT00477685|11497254|FG000|STARTED|Overall Study||10
10357680|NCT00477685|11497254|FG000|COMPLETED|Overall Study||10
10357681|NCT00477685|11497254|FG000|NOT COMPLETED|Overall Study||0
10357682|NCT00477750|11497258|FG000|STARTED|Overall Study||26
10357683|NCT00477750|11497258|FG000|COMPLETED|Overall Study||15
10357684|NCT00477750|11497258|FG000|NOT COMPLETED|Overall Study||11
10357685|NCT00477971|11497266|FG000|STARTED|Overall Study||34
10357686|NCT00477971|11497267|FG001|STARTED|Overall Study||55
10357687|NCT00477971|11497266|FG000|COMPLETED|Overall Study||17
10357688|NCT00477971|11497267|FG001|COMPLETED|Overall Study||49
10357689|NCT00477971|11497266|FG000|NOT COMPLETED|Overall Study||17
10357690|NCT00477971|11497267|FG001|NOT COMPLETED|Overall Study||6
10357691|NCT00478023|11497278|FG000|STARTED|Overall Study||170
10357692|NCT00478023|11497279|FG001|STARTED|Overall Study||168
10357693|NCT00478023|11497280|FG002|STARTED|Overall Study||171
10357694|NCT00478023|11497281|FG003|STARTED|Overall Study||176
10357695|NCT00478023|11497282|FG004|STARTED|Overall Study||169
10357696|NCT00478023|11497278|FG000|COMPLETED|Overall Study||135
10357697|NCT00478023|11497279|FG001|COMPLETED|Overall Study||144
10357698|NCT00478023|11497280|FG002|COMPLETED|Overall Study||151
10357699|NCT00478023|11497281|FG003|COMPLETED|Overall Study||146
10357700|NCT00478023|11497282|FG004|COMPLETED|Overall Study||114
10357701|NCT00478023|11497278|FG000|NOT COMPLETED|Overall Study||35
10357702|NCT00478023|11497279|FG001|NOT COMPLETED|Overall Study||24
10357703|NCT00478023|11497280|FG002|NOT COMPLETED|Overall Study||20
10357704|NCT00478023|11497281|FG003|NOT COMPLETED|Overall Study||30
10357705|NCT00478023|11497282|FG004|NOT COMPLETED|Overall Study||55
10357706|NCT00478036|11497297|FG000|STARTED|Overall Study||10
10357707|NCT00478036|11497298|FG001|STARTED|Overall Study||7
10357708|NCT00478036|11497299|FG002|STARTED|Overall Study||14
10357709|NCT00478036|11497297|FG000|COMPLETED|Overall Study||10
10357710|NCT00478036|11497298|FG001|COMPLETED|Overall Study||7
10357711|NCT00478036|11497299|FG002|COMPLETED|Overall Study||14
10357712|NCT00478036|11497297|FG000|NOT COMPLETED|Overall Study||0
10357713|NCT00478036|11497298|FG001|NOT COMPLETED|Overall Study||0
10357714|NCT00478036|11497299|FG002|NOT COMPLETED|Overall Study||0
10357715|NCT00478140|11497307|FG000|STARTED|Overall Study||4
10357716|NCT00478140|11497307|FG000|COMPLETED|Overall Study||3
10357717|NCT00478140|11497307|FG000|NOT COMPLETED|Overall Study||1
10357718|NCT00478192|11497314|FG000|STARTED|Overall Study||20
10357719|NCT00478192|11497315|FG001|STARTED|Overall Study||20
10357720|NCT00478192|11497316|FG002|STARTED|Overall Study||10
10357721|NCT00478192|11497314|FG000|Full Analysis Set / Safety Analysis Set|Overall Study||20
10357722|NCT00478192|11497315|FG001|Full Analysis Set / Safety Analysis Set|Overall Study||20
10357723|NCT00478192|11497316|FG002|Full Analysis Set / Safety Analysis Set|Overall Study||9
10357724|NCT00478192|11497314|FG000|End of Treatment|Overall Study||18
10357725|NCT00478192|11497315|FG001|End of Treatment|Overall Study||16
10716193|NCT02688387|11880046|FG003|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10716194|NCT02688387|11880047|FG004|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10716195|NCT02688387|11880048|FG005|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10716196|NCT02688387|11880049|FG006|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10716197|NCT02688387|11880050|FG007|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10716198|NCT02688387|11880051|FG008|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10357726|NCT00478192|11497316|FG002|End of Treatment|Overall Study||8
10357727|NCT00478192|11497314|FG000|COMPLETED|Overall Study||16
10357728|NCT00478192|11497315|FG001|COMPLETED|Overall Study||15
10357729|NCT00478192|11497316|FG002|COMPLETED|Overall Study||8
10534161|NCT01428583|11686261|FG000|STARTED|Overall Study||395
10534162|NCT01428583|11686261|FG000|COMPLETED|Overall Study||158
10534163|NCT01428583|11686261|FG000|NOT COMPLETED|Overall Study||237
10534164|NCT01428661|11686268|FG000|STARTED|Double-Masked Phase||254
10534165|NCT01428661|11686269|FG001|STARTED|Double-Masked Phase||253
10534166|NCT01428661|11686270|FG002|STARTED|Double-Masked Phase|Does not apply.|0
10534167|NCT01428661|11686268|FG000|COMPLETED|Double-Masked Phase||197
10534168|NCT01428661|11686269|FG001|COMPLETED|Double-Masked Phase||204
10534169|NCT01428661|11686270|FG002|COMPLETED|Double-Masked Phase|Does not apply.|0
10534170|NCT01428661|11686268|FG000|NOT COMPLETED|Double-Masked Phase||57
10534171|NCT01428661|11686269|FG001|NOT COMPLETED|Double-Masked Phase||49
10534172|NCT01428661|11686270|FG002|NOT COMPLETED|Double-Masked Phase||0
10534173|NCT01428661|11686268|FG000|STARTED|Open Label Extension|Does not apply.|0
10534174|NCT01428661|11686269|FG001|STARTED|Open Label Extension|Does not apply.|0
10534175|NCT01428661|11686270|FG002|STARTED|Open Label Extension||339
10534176|NCT01428661|11686268|FG000|COMPLETED|Open Label Extension|Does not apply.|0
10534177|NCT01428661|11686269|FG001|COMPLETED|Open Label Extension|Does not apply.|0
10534178|NCT01428661|11686270|FG002|COMPLETED|Open Label Extension||19
10534179|NCT01428661|11686268|FG000|NOT COMPLETED|Open Label Extension||0
10534180|NCT01428661|11686269|FG001|NOT COMPLETED|Open Label Extension||0
10534181|NCT01428661|11686270|FG002|NOT COMPLETED|Open Label Extension||320
10534182|NCT01428713|11686278|FG000|STARTED|Overall Study||9
10534183|NCT01428713|11686279|FG001|STARTED|Overall Study||8
10534184|NCT01428713|11686278|FG000|COMPLETED|Overall Study||6
10534185|NCT01428713|11686279|FG001|COMPLETED|Overall Study||3
10534186|NCT01428713|11686278|FG000|NOT COMPLETED|Overall Study||3
10534187|NCT01428713|11686279|FG001|NOT COMPLETED|Overall Study||5
10534188|NCT01428765|11686285|FG000|STARTED|Overall Study||1063
10534189|NCT01428765|11686285|FG000|COMPLETED|Overall Study||1063
10534190|NCT01428765|11686285|FG000|NOT COMPLETED|Overall Study||0
10534191|NCT01428882|11686291|FG000|STARTED|Overall Study||67
10534192|NCT01428882|11686292|FG001|STARTED|Overall Study||68
10534193|NCT01428882|11686291|FG000|COMPLETED|Overall Study||61
10534194|NCT01428882|11686292|FG001|COMPLETED|Overall Study||58
10534195|NCT01428882|11686291|FG000|NOT COMPLETED|Overall Study||6
10534196|NCT01428882|11686292|FG001|NOT COMPLETED|Overall Study||10
10534197|NCT01429051|11686298|FG000|STARTED|Titration Phase||45
10534198|NCT01429051|11686298|FG000|COMPLETED|Titration Phase||33
10534199|NCT01429051|11686298|FG000|NOT COMPLETED|Titration Phase||12
10534200|NCT01429051|11686298|FG000|STARTED|Efficacy Phase|Participants titrated to 200 or 400 μg INFS in Titration Phase|15
10534201|NCT01429051|11686298|FG000|COMPLETED|Efficacy Phase||13
10534202|NCT01429051|11686298|FG000|NOT COMPLETED|Efficacy Phase||2
10534203|NCT01429051|11686298|FG000|STARTED|Tolerability Phase|Participants entered directly from the Titration or Efficacy Phase|31
10534204|NCT01429051|11686298|FG000|COMPLETED|Tolerability Phase||16
10534205|NCT01429051|11686298|FG000|NOT COMPLETED|Tolerability Phase||15
10534206|NCT01429064|11686313|FG000|STARTED|Overall Study||19
10534207|NCT01429064|11686314|FG001|STARTED|Overall Study||22
10357730|NCT00478192|11497314|FG000|NOT COMPLETED|Overall Study||4
10357731|NCT00478192|11497315|FG001|NOT COMPLETED|Overall Study||5
10357732|NCT00478192|11497316|FG002|NOT COMPLETED|Overall Study||2
10534208|NCT01429064|11686315|FG002|STARTED|Overall Study||19
10357733|NCT00478205|11497327|FG000|STARTED|Overall Study||981
10357734|NCT00478205|11497328|FG001|STARTED|Overall Study||486
10357735|NCT00478205|11497327|FG000|COMPLETED|Overall Study||685
10357736|NCT00478205|11497328|FG001|COMPLETED|Overall Study||399
10357737|NCT00478205|11497327|FG000|NOT COMPLETED|Overall Study||296
10357738|NCT00478205|11497328|FG001|NOT COMPLETED|Overall Study||87
10357739|NCT00478218|11497336|FG000|STARTED|Overall Study||34
10357740|NCT00478218|11497337|FG001|STARTED|Overall Study||19
10357741|NCT00478218|11497336|FG000|COMPLETED|Overall Study||34
10357742|NCT00478218|11497337|FG001|COMPLETED|Overall Study||19
10357743|NCT00478218|11497336|FG000|NOT COMPLETED|Overall Study||0
10357744|NCT00478218|11497337|FG001|NOT COMPLETED|Overall Study||0
10357745|NCT00478231|11497343|FG000|STARTED|Overall Study||209
10357746|NCT00478231|11497343|FG000|Treated|Overall Study||206
10357747|NCT00478231|11497343|FG000|COMPLETED|Overall Study||125
10357748|NCT00478231|11497343|FG000|NOT COMPLETED|Overall Study||84
10357749|NCT00478244|11497347|FG000|STARTED|Overall Study||7
10357750|NCT00478244|11497347|FG000|COMPLETED|Overall Study||6
10357751|NCT00478244|11497347|FG000|NOT COMPLETED|Overall Study||1
10357752|NCT00478257|11497353|FG000|STARTED|Overall Study||23
10357753|NCT00478257|11497354|FG001|STARTED|Overall Study||16
10357754|NCT00478257|11497353|FG000|COMPLETED|Overall Study||15
10357755|NCT00478257|11497354|FG001|COMPLETED|Overall Study||13
10357756|NCT00478257|11497353|FG000|NOT COMPLETED|Overall Study||8
10357757|NCT00478257|11497354|FG001|NOT COMPLETED|Overall Study||3
10357758|NCT00478335|11497362|FG000|STARTED|Period 1 (4 Days)||2
10357759|NCT00478335|11497363|FG001|STARTED|Period 1 (4 Days)||2
10357760|NCT00478335|11497362|FG000|COMPLETED|Period 1 (4 Days)||2
10357761|NCT00478335|11497363|FG001|COMPLETED|Period 1 (4 Days)||2
10357762|NCT00478335|11497362|FG000|NOT COMPLETED|Period 1 (4 Days)||0
10357763|NCT00478335|11497363|FG001|NOT COMPLETED|Period 1 (4 Days)||0
10357764|NCT00478335|11497362|FG000|STARTED|Period 2 (4 Days)||2
10357765|NCT00478335|11497363|FG001|STARTED|Period 2 (4 Days)||2
10357766|NCT00478335|11497362|FG000|COMPLETED|Period 2 (4 Days)||2
10357767|NCT00478335|11497363|FG001|COMPLETED|Period 2 (4 Days)||2
10357768|NCT00478335|11497362|FG000|NOT COMPLETED|Period 2 (4 Days)||0
10357769|NCT00478335|11497363|FG001|NOT COMPLETED|Period 2 (4 Days)||0
10357770|NCT00478361|11497369|FG000|STARTED|Overall Study||39
10357771|NCT00478361|11497369|FG000|COMPLETED|Overall Study||39
10357772|NCT00478361|11497369|FG000|NOT COMPLETED|Overall Study||0
10357773|NCT00478426|11497373|FG000|STARTED|Overall Study||34
10357774|NCT00478426|11497373|FG000|COMPLETED|Overall Study||33
10357775|NCT00478426|11497373|FG000|NOT COMPLETED|Overall Study||1
10357776|NCT00478556|11497379|FG000|STARTED|Overall Study||151
10357777|NCT00478556|11497380|FG001|STARTED|Overall Study||149
10357778|NCT00478556|11497379|FG000|COMPLETED|Overall Study||151
10357779|NCT00478556|11497380|FG001|COMPLETED|Overall Study||149
10357780|NCT00478556|11497379|FG000|NOT COMPLETED|Overall Study||0
10357781|NCT00478556|11497380|FG001|NOT COMPLETED|Overall Study||0
10357782|NCT00478569|11497386|FG000|STARTED|Overall Study||1170
10357783|NCT00478569|11497386|FG000|COMPLETED|Overall Study||761
10357784|NCT00478569|11497386|FG000|NOT COMPLETED|Overall Study||409
10357785|NCT00478608|11497398|FG000|STARTED|Overall Study||79
10357786|NCT00478608|11497398|FG000|COMPLETED|Overall Study||59
10357787|NCT00478608|11497398|FG000|NOT COMPLETED|Overall Study||20
10357788|NCT00478647|11497402|FG000|STARTED|Overall Study||40
10357789|NCT00478647|11497402|FG000|COMPLETED|Overall Study|Intent-to-Treat (ITT)=participants who have received at least 1 full or partial dose of study drug.|38
10357790|NCT00478647|11497402|FG000|NOT COMPLETED|Overall Study||2
10357791|NCT00478673|11497406|FG000|STARTED|30-Days Post-Procedure||298
10357792|NCT00478673|11497406|FG000|COMPLETED|30-Days Post-Procedure|"7 participants who did not complete this Period due to Missed Visit still continued on to Period 2"|288
10357793|NCT00478673|11497406|FG000|NOT COMPLETED|30-Days Post-Procedure||10
10357794|NCT00478673|11497406|FG000|STARTED|12-Months Post-Procedure|3 participants who did not complete Period 1 due to death (2) and withdrawal (1) are not included.|295
10357795|NCT00478673|11497406|FG000|COMPLETED|12-Months Post-Procedure||231
10357796|NCT00478673|11497406|FG000|NOT COMPLETED|12-Months Post-Procedure||64
10357797|NCT00478777|11497410|FG000|STARTED|Overall Study||150
10357798|NCT00478777|11497410|FG000|Safety and Full Analysis Set (FAS)|Overall Study|6 enrolled participants did not receive lenalidomide.|144
10357799|NCT00478777|11497410|FG000|COMPLETED|Overall Study|10 participants had >= 6 months and 63 participants < 6 months treatment prior to study termination.|73
10357800|NCT00478777|11497410|FG000|NOT COMPLETED|Overall Study||77
10357801|NCT00478881|11497416|FG000|STARTED|Overall Study||199
10357802|NCT00478881|11497417|FG001|STARTED|Overall Study||198
10357803|NCT00478881|11497416|FG000|Received Medication|Overall Study||198
10357804|NCT00478881|11497417|FG001|Received Medication|Overall Study||198
10357805|NCT00478881|11497416|FG000|COMPLETED|Overall Study||160
10357806|NCT00478881|11497417|FG001|COMPLETED|Overall Study||176
10357807|NCT00478881|11497416|FG000|NOT COMPLETED|Overall Study||39
10357808|NCT00478881|11497417|FG001|NOT COMPLETED|Overall Study||22
10357809|NCT00478933|11497423|FG000|STARTED|Overall Study||1223
10357810|NCT00478933|11497423|FG000|COMPLETED|Overall Study||1145
10357811|NCT00478933|11497423|FG000|NOT COMPLETED|Overall Study||78
10357812|NCT00479037|11497449|FG000|STARTED|Overall Study||41
10357813|NCT00479037|11497450|FG001|STARTED|Overall Study||40
10357814|NCT00479037|11497449|FG000|COMPLETED|Overall Study||38
10357815|NCT00479037|11497450|FG001|COMPLETED|Overall Study||34
10357816|NCT00479037|11497449|FG000|NOT COMPLETED|Overall Study||3
10357817|NCT00479037|11497450|FG001|NOT COMPLETED|Overall Study||6
10357818|NCT00479089|11497458|FG000|STARTED|Overall Study||25
10357819|NCT00479089|11497459|FG001|STARTED|Overall Study||25
10357820|NCT00479089|11497458|FG000|COMPLETED|Overall Study||25
10357821|NCT00479089|11497459|FG001|COMPLETED|Overall Study||25
10357822|NCT00479089|11497458|FG000|NOT COMPLETED|Overall Study||0
10357823|NCT00479089|11497459|FG001|NOT COMPLETED|Overall Study||0
10357824|NCT00479115|11497465|FG000|STARTED|Overall Study||1
10357825|NCT00479115|11497465|FG000|COMPLETED|Overall Study||1
10357826|NCT00479115|11497465|FG000|NOT COMPLETED|Overall Study||0
10357827|NCT00479154|11497471|FG000|STARTED|Overall Study||3
10357828|NCT00479154|11497472|FG001|STARTED|Overall Study||3
10357829|NCT00479154|11497471|FG000|COMPLETED|Overall Study||3
10357830|NCT00479154|11497472|FG001|COMPLETED|Overall Study||3
10357831|NCT00479154|11497471|FG000|NOT COMPLETED|Overall Study||0
10357832|NCT00479154|11497472|FG001|NOT COMPLETED|Overall Study||0
10357833|NCT00479232|11497480|FG000|STARTED|Overall Study||3
10357834|NCT00479232|11497481|FG001|STARTED|Overall Study||3
10357835|NCT00479232|11497482|FG002|STARTED|Overall Study||28
10357836|NCT00479232|11497483|FG003|STARTED|Overall Study||3
10357837|NCT00479232|11497484|FG004|STARTED|Overall Study||4
10357838|NCT00479232|11497485|FG005|STARTED|Overall Study||30
10357839|NCT00479232|11497480|FG000|COMPLETED|Overall Study||0
10357840|NCT00479232|11497481|FG001|COMPLETED|Overall Study||0
10357841|NCT00479232|11497482|FG002|COMPLETED|Overall Study||0
10357842|NCT00479232|11497483|FG003|COMPLETED|Overall Study||0
10357843|NCT00479232|11497484|FG004|COMPLETED|Overall Study||0
10357844|NCT00479232|11497485|FG005|COMPLETED|Overall Study||0
10357845|NCT00479232|11497480|FG000|NOT COMPLETED|Overall Study||3
10357846|NCT00479232|11497481|FG001|NOT COMPLETED|Overall Study||3
10357847|NCT00479232|11497482|FG002|NOT COMPLETED|Overall Study||28
10357848|NCT00479232|11497483|FG003|NOT COMPLETED|Overall Study||3
10357849|NCT00479232|11497484|FG004|NOT COMPLETED|Overall Study||4
10357850|NCT00479232|11497485|FG005|NOT COMPLETED|Overall Study||30
10357851|NCT00479336|11497507|FG000|STARTED|Overall Study||27
10357852|NCT00479336|11497508|FG001|STARTED|Overall Study||26
10357853|NCT00479336|11497509|FG002|STARTED|Overall Study||25
10357854|NCT00479336|11497510|FG003|STARTED|Overall Study||26
10357855|NCT00479336|11497507|FG000|COMPLETED|Overall Study||23
10357856|NCT00479336|11497508|FG001|COMPLETED|Overall Study||20
10357857|NCT00479336|11497509|FG002|COMPLETED|Overall Study||24
10357858|NCT00479336|11497510|FG003|COMPLETED|Overall Study||21
10357859|NCT00479336|11497507|FG000|NOT COMPLETED|Overall Study||4
10357860|NCT00479336|11497508|FG001|NOT COMPLETED|Overall Study||6
10357861|NCT00479336|11497509|FG002|NOT COMPLETED|Overall Study||1
10357862|NCT00479336|11497510|FG003|NOT COMPLETED|Overall Study||5
10357863|NCT00479388|11497522|FG000|STARTED|Overall Study||606
10357864|NCT00479388|11497523|FG001|STARTED|Overall Study||610
10534209|NCT01429064|11686316|FG003|STARTED|Overall Study||16
10534210|NCT01429064|11686313|FG000|COMPLETED|Overall Study||19
10534211|NCT01429064|11686314|FG001|COMPLETED|Overall Study||22
10534212|NCT01429064|11686315|FG002|COMPLETED|Overall Study||19
10534213|NCT01429064|11686316|FG003|COMPLETED|Overall Study||16
10534214|NCT01429064|11686313|FG000|NOT COMPLETED|Overall Study||0
10534215|NCT01429064|11686314|FG001|NOT COMPLETED|Overall Study||0
10534216|NCT01429064|11686315|FG002|NOT COMPLETED|Overall Study||0
10534217|NCT01429064|11686316|FG003|NOT COMPLETED|Overall Study||0
10534218|NCT01429077|11686328|FG000|STARTED|Overall Study||19
10534219|NCT01429077|11686329|FG001|STARTED|Overall Study||17
10534220|NCT01429077|11686328|FG000|Completed 6-week Intervention|Overall Study||19
10534221|NCT01429077|11686329|FG001|Completed 6-week Intervention|Overall Study||17
10534222|NCT01429077|11686328|FG000|COMPLETED|Overall Study||19
10534223|NCT01429077|11686329|FG001|COMPLETED|Overall Study||14
10534224|NCT01429077|11686328|FG000|NOT COMPLETED|Overall Study||0
10534225|NCT01429077|11686329|FG001|NOT COMPLETED|Overall Study||3
10534226|NCT01429259|11686335|FG000|STARTED|Overall Study||30
10534227|NCT01429259|11686335|FG000|COMPLETED|Overall Study||30
10534228|NCT01429259|11686335|FG000|NOT COMPLETED|Overall Study||0
10534229|NCT01429272|11686343|FG000|STARTED|Overall Study||30
10534230|NCT01429272|11686344|FG001|STARTED|Overall Study||31
10534231|NCT01429272|11686345|FG002|STARTED|Overall Study||19
10534232|NCT01429272|11686346|FG003|STARTED|Overall Study||19
10534233|NCT01429272|11686343|FG000|COMPLETED|Overall Study||24
10534234|NCT01429272|11686344|FG001|COMPLETED|Overall Study||22
10534235|NCT01429272|11686345|FG002|COMPLETED|Overall Study||15
10534236|NCT01429272|11686346|FG003|COMPLETED|Overall Study||14
10534237|NCT01429272|11686343|FG000|NOT COMPLETED|Overall Study||6
10534238|NCT01429272|11686344|FG001|NOT COMPLETED|Overall Study||9
10534239|NCT01429272|11686345|FG002|NOT COMPLETED|Overall Study||4
10534240|NCT01429272|11686346|FG003|NOT COMPLETED|Overall Study||5
10534241|NCT01429285|11686358|FG000|STARTED|Overall Study||175
10534242|NCT01429285|11686359|FG001|STARTED|Overall Study||175
10534243|NCT01429285|11686358|FG000|Given IV Opioids|Overall Study|9 patients never given IV opioids|166
10534244|NCT01429285|11686359|FG001|Given IV Opioids|Overall Study|4 patients never given IV opioids|171
10357865|NCT00479388|11497522|FG000|COMPLETED|Overall Study||474
10357866|NCT00479388|11497523|FG001|COMPLETED|Overall Study||537
10357867|NCT00479388|11497522|FG000|NOT COMPLETED|Overall Study||132
10357868|NCT00479388|11497523|FG001|NOT COMPLETED|Overall Study||73
10357869|NCT00479401|11497532|FG000|STARTED|Overall Study||223
10357870|NCT00479401|11497533|FG001|STARTED|Overall Study||213
10357871|NCT00479401|11497534|FG002|STARTED|Overall Study||103
10357872|NCT00479401|11497532|FG000|COMPLETED|Overall Study||174
10357873|NCT00479401|11497533|FG001|COMPLETED|Overall Study||176
10357874|NCT00479401|11497534|FG002|COMPLETED|Overall Study||91
10534245|NCT01429285|11686358|FG000|Completed Primary Outcome Data|Overall Study|5 patients had missing data|161
10534246|NCT01429285|11686359|FG001|Completed Primary Outcome Data|Overall Study|3 patients had missing data|168
10547945|NCT01515865|11701719|FG002|NOT COMPLETED|Part A (Open-label)||0
10357875|NCT00479401|11497532|FG000|NOT COMPLETED|Overall Study||49
10357876|NCT00479401|11497533|FG001|NOT COMPLETED|Overall Study||37
10357877|NCT00479401|11497534|FG002|NOT COMPLETED|Overall Study||12
10357878|NCT00479466|11497548|FG000|STARTED|Overall Study||57
10357879|NCT00479466|11497549|FG001|STARTED|Overall Study||57
10357880|NCT00479466|11497550|FG002|STARTED|Overall Study||57
10357881|NCT00479466|11497551|FG003|STARTED|Overall Study||58
10357882|NCT00479466|11497552|FG004|STARTED|Overall Study||56
10357883|NCT00479466|11497553|FG005|STARTED|Overall Study||57
10357884|NCT00479466|11497548|FG000|COMPLETED|Overall Study||44
10357885|NCT00479466|11497549|FG001|COMPLETED|Overall Study||49
10357886|NCT00479466|11497550|FG002|COMPLETED|Overall Study||54
10357887|NCT00479466|11497551|FG003|COMPLETED|Overall Study||55
10357888|NCT00479466|11497552|FG004|COMPLETED|Overall Study||48
10357889|NCT00479466|11497553|FG005|COMPLETED|Overall Study||53
10357890|NCT00479466|11497548|FG000|NOT COMPLETED|Overall Study||13
10357891|NCT00479466|11497549|FG001|NOT COMPLETED|Overall Study||8
10357892|NCT00479466|11497550|FG002|NOT COMPLETED|Overall Study||3
10357893|NCT00479466|11497551|FG003|NOT COMPLETED|Overall Study||3
10357894|NCT00479466|11497552|FG004|NOT COMPLETED|Overall Study||8
10357895|NCT00479466|11497553|FG005|NOT COMPLETED|Overall Study||4
10357896|NCT00479557|11497574|FG000|STARTED|Overall Study||36
10357897|NCT00479557|11497575|FG001|STARTED|Overall Study||61
10357898|NCT00479557|11497576|FG002|STARTED|Overall Study||40
10357899|NCT00479557|11497577|FG003|STARTED|Overall Study||35
10357900|NCT00479557|11497578|FG004|STARTED|Overall Study||12
10357901|NCT00479557|11497579|FG005|STARTED|Overall Study||44
10357902|NCT00479557|11497580|FG006|STARTED|Overall Study||17
10357903|NCT00479557|11497574|FG000|Treated|Overall Study||36
10357904|NCT00479557|11497575|FG001|Treated|Overall Study|One participant discontinued due to an AE, with an outcome of death.|60
10357905|NCT00479557|11497576|FG002|Treated|Overall Study||40
10357906|NCT00479557|11497577|FG003|Treated|Overall Study||35
10357907|NCT00479557|11497578|FG004|Treated|Overall Study||12
10357908|NCT00479557|11497579|FG005|Treated|Overall Study||44
10357909|NCT00479557|11497580|FG006|Treated|Overall Study||17
10357910|NCT00479557|11497574|FG000|COMPLETED|Overall Study||26
10357911|NCT00479557|11497575|FG001|COMPLETED|Overall Study||51
10357912|NCT00479557|11497576|FG002|COMPLETED|Overall Study||32
10357913|NCT00479557|11497577|FG003|COMPLETED|Overall Study||30
10357914|NCT00479557|11497578|FG004|COMPLETED|Overall Study||8
10357915|NCT00479557|11497579|FG005|COMPLETED|Overall Study||31
10357916|NCT00479557|11497580|FG006|COMPLETED|Overall Study||15
10357917|NCT00479557|11497574|FG000|NOT COMPLETED|Overall Study||10
10357918|NCT00479557|11497575|FG001|NOT COMPLETED|Overall Study||10
10357919|NCT00479557|11497576|FG002|NOT COMPLETED|Overall Study||8
10357920|NCT00479557|11497577|FG003|NOT COMPLETED|Overall Study||5
10357921|NCT00479557|11497578|FG004|NOT COMPLETED|Overall Study||4
10357922|NCT00479557|11497579|FG005|NOT COMPLETED|Overall Study||13
10357923|NCT00479557|11497580|FG006|NOT COMPLETED|Overall Study||2
10426992|NCT00850460|11572745|FG000|COMPLETED|Overall Study||3
10426993|NCT00850460|11572746|FG001|COMPLETED|Overall Study||3
10426994|NCT00850460|11572745|FG000|NOT COMPLETED|Overall Study||4
10426995|NCT00850460|11572746|FG001|NOT COMPLETED|Overall Study||4
10426996|NCT00850473|11572752|FG000|STARTED|Overall Study||3
10426997|NCT00850473|11572752|FG000|COMPLETED|Overall Study||3
10426998|NCT00850473|11572752|FG000|NOT COMPLETED|Overall Study||0
10426999|NCT00850499|11572758|FG000|STARTED|Overall Study||4
10427000|NCT00850499|11572759|FG001|STARTED|Overall Study||8
10427001|NCT00850499|11572758|FG000|COMPLETED|Overall Study||1
10427002|NCT00850499|11572759|FG001|COMPLETED|Overall Study||6
10427003|NCT00850499|11572758|FG000|NOT COMPLETED|Overall Study||3
10427004|NCT00850499|11572759|FG001|NOT COMPLETED|Overall Study||2
10427005|NCT00850538|11572765|FG000|STARTED|Overall Study||101
10427006|NCT00850538|11572765|FG000|COMPLETED|Overall Study||60
10427007|NCT00850538|11572765|FG000|NOT COMPLETED|Overall Study||41
10656265|NCT02216071|11817182|FG000|NOT COMPLETED|Overall Study||15
10656266|NCT02216071|11817183|FG001|NOT COMPLETED|Overall Study||12
10656267|NCT02216097|11817191|FG000|STARTED|Overall Study||8
10427008|NCT00850564|11572769|FG000|STARTED|Overall Study||15
10427009|NCT00850564|11572769|FG000|COMPLETED|Overall Study||13
10427010|NCT00850564|11572769|FG000|NOT COMPLETED|Overall Study||2
10427011|NCT00850603|11572778|FG000|STARTED|Overall Study||34
10427012|NCT00850603|11572779|FG001|STARTED|Overall Study||34
10427013|NCT00850603|11572780|FG002|STARTED|Overall Study||34
10427014|NCT00850603|11572781|FG003|STARTED|Overall Study||34
10427015|NCT00850603|11572782|FG004|STARTED|Overall Study||34
10427016|NCT00850603|11572778|FG000|COMPLETED|Overall Study||34
10427017|NCT00850603|11572779|FG001|COMPLETED|Overall Study||34
10427018|NCT00850603|11572780|FG002|COMPLETED|Overall Study||34
10427019|NCT00850603|11572781|FG003|COMPLETED|Overall Study||34
10427020|NCT00850603|11572782|FG004|COMPLETED|Overall Study||34
10427021|NCT00850603|11572778|FG000|NOT COMPLETED|Overall Study||0
10427022|NCT00850603|11572779|FG001|NOT COMPLETED|Overall Study||0
10427023|NCT00850603|11572780|FG002|NOT COMPLETED|Overall Study||0
10427024|NCT00850603|11572781|FG003|NOT COMPLETED|Overall Study||0
10427025|NCT00850603|11572782|FG004|NOT COMPLETED|Overall Study||0
10427026|NCT00850642|11572796|FG000|STARTED|Overall Study||3
10427027|NCT00850642|11572797|FG001|STARTED|Overall Study||4
10427028|NCT00850642|11572796|FG000|COMPLETED|Overall Study||3
10427029|NCT00850642|11572797|FG001|COMPLETED|Overall Study||4
10427030|NCT00850642|11572796|FG000|NOT COMPLETED|Overall Study||0
10427031|NCT00850642|11572797|FG001|NOT COMPLETED|Overall Study||0
10357924|NCT00479674|11497602|FG000|STARTED|Overall Study||41
10357925|NCT00479674|11497602|FG000|COMPLETED|Overall Study||0
10357926|NCT00479674|11497602|FG000|NOT COMPLETED|Overall Study||41
10357927|NCT00479687|11497608|FG000|STARTED|Ph 1: Blinded, Randomized, Controlled||150
10357928|NCT00479687|11497609|FG001|STARTED|Ph 1: Blinded, Randomized, Controlled||150
10357929|NCT00479687|11497610|FG002|STARTED|Ph 1: Blinded, Randomized, Controlled||0
10357930|NCT00479687|11497608|FG000|COMPLETED|Ph 1: Blinded, Randomized, Controlled||125
10357931|NCT00479687|11497609|FG001|COMPLETED|Ph 1: Blinded, Randomized, Controlled||131
10357932|NCT00479687|11497610|FG002|COMPLETED|Ph 1: Blinded, Randomized, Controlled||0
10357933|NCT00479687|11497608|FG000|NOT COMPLETED|Ph 1: Blinded, Randomized, Controlled||25
10357934|NCT00479687|11497609|FG001|NOT COMPLETED|Ph 1: Blinded, Randomized, Controlled||19
10357935|NCT00479687|11497610|FG002|NOT COMPLETED|Ph 1: Blinded, Randomized, Controlled||0
10357936|NCT00479687|11497608|FG000|STARTED|Ph 2: Open Label, Single (Supartz) Arm||0
10357937|NCT00479687|11497609|FG001|STARTED|Ph 2: Open Label, Single (Supartz) Arm||0
10357938|NCT00479687|11497610|FG002|STARTED|Ph 2: Open Label, Single (Supartz) Arm|Four did not continue to Ph2; 224 received at least 1 inj. and 28 received no trt. (only follow-up)|224
10357939|NCT00479687|11497608|FG000|COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||0
10357940|NCT00479687|11497609|FG001|COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||0
10357941|NCT00479687|11497610|FG002|COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||215
10357942|NCT00479687|11497608|FG000|NOT COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||0
10357943|NCT00479687|11497609|FG001|NOT COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||0
10357944|NCT00479687|11497610|FG002|NOT COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||9
10357945|NCT00479856|11497617|FG000|STARTED|Overall Study||9
10357946|NCT00479856|11497617|FG000|COMPLETED|Overall Study||6
10357947|NCT00479856|11497617|FG000|NOT COMPLETED|Overall Study||3
10357948|NCT00479882|11497625|FG000|STARTED|Precrossover: Periods I/II (Weeks 1-12)||610
10357949|NCT00479882|11497626|FG001|STARTED|Precrossover: Periods I/II (Weeks 1-12)||602
10357950|NCT00479882|11497627|FG002|STARTED|Precrossover: Periods I/II (Weeks 1-12)||597
10357951|NCT00479882|11497628|FG003|STARTED|Precrossover: Periods I/II (Weeks 1-12)||605
10357952|NCT00479882|11497625|FG000|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||472
10357953|NCT00479882|11497626|FG001|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||440
10357954|NCT00479882|11497627|FG002|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||440
10357955|NCT00479882|11497628|FG003|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||465
10357956|NCT00479882|11497625|FG000|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||138
10357957|NCT00479882|11497626|FG001|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||162
10357958|NCT00479882|11497627|FG002|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||157
10357959|NCT00479882|11497628|FG003|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||140
10357960|NCT00479882|11497625|FG000|STARTED|Crossover: Period III (Weeks 13-20)||472
10357961|NCT00479882|11497626|FG001|STARTED|Crossover: Period III (Weeks 13-20)||440
10357962|NCT00479882|11497627|FG002|STARTED|Crossover: Period III (Weeks 13-20)||440
10357963|NCT00479882|11497628|FG003|STARTED|Crossover: Period III (Weeks 13-20)||465
10357964|NCT00479882|11497625|FG000|COMPLETED|Crossover: Period III (Weeks 13-20)||447
10357965|NCT00479882|11497626|FG001|COMPLETED|Crossover: Period III (Weeks 13-20)||419
10357966|NCT00479882|11497627|FG002|COMPLETED|Crossover: Period III (Weeks 13-20)||420
10357967|NCT00479882|11497628|FG003|COMPLETED|Crossover: Period III (Weeks 13-20)||447
10357968|NCT00479882|11497625|FG000|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||25
10357969|NCT00479882|11497626|FG001|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||21
10357970|NCT00479882|11497627|FG002|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||20
10357971|NCT00479882|11497628|FG003|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||18
10357972|NCT00480025|11497656|FG000|STARTED|Overall Study||1515
10357973|NCT00480025|11497657|FG001|STARTED|Overall Study||757
10357974|NCT00480025|11497656|FG000|COMPLETED|Overall Study||763
10357975|NCT00480025|11497657|FG001|COMPLETED|Overall Study||388
10357976|NCT00480025|11497656|FG000|NOT COMPLETED|Overall Study||752
10357977|NCT00480025|11497657|FG001|NOT COMPLETED|Overall Study||369
10357978|NCT00480077|11497671|FG000|STARTED|Overall Study||168
10357979|NCT00480077|11497672|FG001|STARTED|Overall Study||167
10357980|NCT00480077|11497671|FG000|COMPLETED|Overall Study||137
10357981|NCT00480077|11497672|FG001|COMPLETED|Overall Study||141
10357982|NCT00480077|11497671|FG000|NOT COMPLETED|Overall Study||31
10357983|NCT00480077|11497672|FG001|NOT COMPLETED|Overall Study||26
10357984|NCT00480324|11497680|FG000|STARTED|Overall Study||508
10357985|NCT00480324|11497681|FG001|STARTED|Overall Study||257
10357986|NCT00480324|11497680|FG000|COMPLETED|Overall Study||476
10357987|NCT00480324|11497681|FG001|COMPLETED|Overall Study||241
10357988|NCT00480324|11497680|FG000|NOT COMPLETED|Overall Study||32
10357989|NCT00480324|11497681|FG001|NOT COMPLETED|Overall Study||16
10716199|NCT02688387|11880052|FG009|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10716200|NCT02688387|11880053|FG010|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10716201|NCT02688387|11880054|FG011|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10716202|NCT02688387|11880055|FG012|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10716203|NCT02688387|11880056|FG013|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10357990|NCT00480441|11497689|FG000|STARTED|Screening||61
10357991|NCT00480441|11497690|FG001|STARTED|Screening|"Participants did not enter this arm until period 3 randomization"|0
10357992|NCT00480441|11497691|FG002|STARTED|Screening|"Participants did not enter this arm until period 3 randomization"|0
10357993|NCT00480441|11497689|FG000|COMPLETED|Screening||24
10357994|NCT00480441|11497690|FG001|COMPLETED|Screening|"Participants did not enter this arm until period 3 randomization"|0
10716204|NCT02688387|11880057|FG014|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10357995|NCT00480441|11497691|FG002|COMPLETED|Screening|"Participants did not enter this arm until period 3 randomization"|0
10357996|NCT00480441|11497689|FG000|NOT COMPLETED|Screening||37
10357997|NCT00480441|11497690|FG001|NOT COMPLETED|Screening||0
10357998|NCT00480441|11497691|FG002|NOT COMPLETED|Screening||0
10357999|NCT00480441|11497689|FG000|STARTED|Baseline Functional MRI|All non-randomized participants who also met specific eligibility for baseline functional MRI|24
10358000|NCT00480441|11497690|FG001|STARTED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
10358001|NCT00480441|11497691|FG002|STARTED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
10358002|NCT00480441|11497689|FG000|COMPLETED|Baseline Functional MRI||12
10358003|NCT00480441|11497690|FG001|COMPLETED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
10358004|NCT00480441|11497691|FG002|COMPLETED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
10358005|NCT00480441|11497689|FG000|NOT COMPLETED|Baseline Functional MRI||12
10358006|NCT00480441|11497690|FG001|NOT COMPLETED|Baseline Functional MRI||0
10358007|NCT00480441|11497691|FG002|NOT COMPLETED|Baseline Functional MRI||0
10358008|NCT00480441|11497689|FG000|STARTED|Randomization||0
10358009|NCT00480441|11497690|FG001|STARTED|Randomization||13
10358010|NCT00480441|11497691|FG002|STARTED|Randomization||11
10358011|NCT00480441|11497689|FG000|COMPLETED|Randomization||0
10358012|NCT00480441|11497690|FG001|COMPLETED|Randomization||6
10358013|NCT00480441|11497691|FG002|COMPLETED|Randomization||9
10358014|NCT00480441|11497689|FG000|NOT COMPLETED|Randomization||0
10358015|NCT00480441|11497690|FG001|NOT COMPLETED|Randomization||7
10358016|NCT00480441|11497691|FG002|NOT COMPLETED|Randomization||2
10358017|NCT00480493|11497700|FG000|STARTED|Overall Study||32
10358018|NCT00480493|11497701|FG001|STARTED|Overall Study||28
10358019|NCT00480493|11497700|FG000|Randomized|Overall Study||32
10358020|NCT00480493|11497701|FG001|Randomized|Overall Study||28
10358021|NCT00480493|11497700|FG000|COMPLETED|Overall Study||30
10358022|NCT00480493|11497701|FG001|COMPLETED|Overall Study||21
10358023|NCT00480493|11497700|FG000|NOT COMPLETED|Overall Study||2
10358024|NCT00480493|11497701|FG001|NOT COMPLETED|Overall Study||7
10358025|NCT00480532|11497713|FG000|STARTED|Overall Study||33
10358026|NCT00480532|11497714|FG001|STARTED|Overall Study||33
10358027|NCT00480532|11497715|FG002|STARTED|Overall Study||33
10358028|NCT00480532|11497716|FG003|STARTED|Overall Study||32
10358029|NCT00480532|11497713|FG000|COMPLETED|Overall Study||31
10358030|NCT00480532|11497714|FG001|COMPLETED|Overall Study||29
10358031|NCT00480532|11497715|FG002|COMPLETED|Overall Study||29
10358032|NCT00480532|11497716|FG003|COMPLETED|Overall Study||31
10358033|NCT00480532|11497713|FG000|NOT COMPLETED|Overall Study||2
10358034|NCT00480532|11497714|FG001|NOT COMPLETED|Overall Study||4
10358035|NCT00480532|11497715|FG002|NOT COMPLETED|Overall Study||4
10358036|NCT00480532|11497716|FG003|NOT COMPLETED|Overall Study||1
10358037|NCT00480636|11497726|FG000|STARTED|Overall Study||102
10358038|NCT00480636|11497726|FG000|COMPLETED|Overall Study||83
10358039|NCT00480636|11497726|FG000|NOT COMPLETED|Overall Study||19
10358040|NCT00480740|11497733|FG000|STARTED|Overall Study||26
10358041|NCT00480740|11497734|FG001|STARTED|Overall Study||9
10358042|NCT00480740|11497735|FG002|STARTED|Overall Study||6
10358043|NCT00480740|11497733|FG000|COMPLETED|Overall Study||26
10358044|NCT00480740|11497734|FG001|COMPLETED|Overall Study||9
10358045|NCT00480740|11497735|FG002|COMPLETED|Overall Study||6
10358046|NCT00480740|11497733|FG000|NOT COMPLETED|Overall Study||0
10358047|NCT00480740|11497734|FG001|NOT COMPLETED|Overall Study||0
10358048|NCT00480740|11497735|FG002|NOT COMPLETED|Overall Study||0
10358049|NCT00480779|11497745|FG000|STARTED|Overall Study||26
10358050|NCT00480779|11497746|FG001|STARTED|Overall Study||22
10358051|NCT00480779|11497745|FG000|COMPLETED|Overall Study||24
10358052|NCT00480779|11497746|FG001|COMPLETED|Overall Study||19
10358053|NCT00480779|11497745|FG000|NOT COMPLETED|Overall Study||2
10358054|NCT00480779|11497746|FG001|NOT COMPLETED|Overall Study||3
10358055|NCT00480857|11497752|FG000|STARTED|Overall Study||19
10358056|NCT00480857|11497752|FG000|COMPLETED|Overall Study||17
10358057|NCT00480857|11497752|FG000|NOT COMPLETED|Overall Study||2
10358058|NCT00480987|11497756|FG000|STARTED|Overall Study||27
10358059|NCT00480987|11497756|FG000|COMPLETED|Overall Study||27
10358060|NCT00480987|11497756|FG000|NOT COMPLETED|Overall Study||0
10358061|NCT00481065|11497768|FG000|STARTED|Overall Study||51
10358062|NCT00481065|11497769|FG001|STARTED|Overall Study||50
10358063|NCT00481065|11497770|FG002|STARTED|Overall Study||51
10358064|NCT00481065|11497771|FG003|STARTED|Overall Study||52
10358065|NCT00481065|11497772|FG004|STARTED|Overall Study||51
10358066|NCT00481065|11497773|FG005|STARTED|Overall Study||51
10358067|NCT00481065|11497774|FG006|STARTED|Overall Study||50
10358068|NCT00481065|11497775|FG007|STARTED|Overall Study||49
10358069|NCT00481065|11497768|FG000|COMPLETED|Overall Study||29
10358070|NCT00481065|11497769|FG001|COMPLETED|Overall Study||33
10358071|NCT00481065|11497770|FG002|COMPLETED|Overall Study||32
10358072|NCT00481065|11497771|FG003|COMPLETED|Overall Study||37
10358073|NCT00481065|11497772|FG004|COMPLETED|Overall Study||28
10358074|NCT00481065|11497773|FG005|COMPLETED|Overall Study||27
10358075|NCT00481065|11497774|FG006|COMPLETED|Overall Study||34
10358076|NCT00481065|11497775|FG007|COMPLETED|Overall Study||30
10358077|NCT00481065|11497768|FG000|NOT COMPLETED|Overall Study||22
10358078|NCT00481065|11497769|FG001|NOT COMPLETED|Overall Study||17
10358079|NCT00481065|11497770|FG002|NOT COMPLETED|Overall Study||19
10358080|NCT00481065|11497771|FG003|NOT COMPLETED|Overall Study||15
10358081|NCT00481065|11497772|FG004|NOT COMPLETED|Overall Study||23
10358082|NCT00481065|11497773|FG005|NOT COMPLETED|Overall Study||24
10358083|NCT00481065|11497774|FG006|NOT COMPLETED|Overall Study||16
10358084|NCT00481065|11497775|FG007|NOT COMPLETED|Overall Study||19
10358085|NCT00481078|11497797|FG000|STARTED|Overall Study||62
10358086|NCT00481078|11497798|FG001|STARTED|Overall Study||32
10358087|NCT00481078|11497797|FG000|COMPLETED|Overall Study||20
10358088|NCT00481078|11497798|FG001|COMPLETED|Overall Study||12
10358089|NCT00481078|11497797|FG000|NOT COMPLETED|Overall Study||42
10358090|NCT00481078|11497798|FG001|NOT COMPLETED|Overall Study||20
10358091|NCT00481195|11497806|FG000|STARTED|Overall Study|Two of these subjects were randomized but never received study medication.|128
10534247|NCT01429285|11686358|FG000|Confirmation of no Duplicate Enrollment|Overall Study|8 patients were enrolled twice at two separate ED visits, which was only noted at study conclusion.|153
10534248|NCT01429285|11686359|FG001|Confirmation of no Duplicate Enrollment|Overall Study|2 patients were enrolled twice, at two separate ED visits, which was only noted at study conclusion|166
10534249|NCT01429285|11686358|FG000|COMPLETED|Overall Study||153
10534250|NCT01429285|11686359|FG001|COMPLETED|Overall Study||166
10534251|NCT01429285|11686358|FG000|NOT COMPLETED|Overall Study||22
10534252|NCT01429285|11686359|FG001|NOT COMPLETED|Overall Study||9
10534253|NCT01429298|11686367|FG000|STARTED|Overall Study||175
10534254|NCT01429298|11686368|FG001|STARTED|Overall Study||175
10534255|NCT01429298|11686367|FG000|Given IV Opioids|Overall Study|4 never given IV opioids|171
10534256|NCT01429298|11686368|FG001|Given IV Opioids|Overall Study|6 never given IV opioids|169
10534257|NCT01429298|11686367|FG000|COMPLETED|Overall Study||171
10534258|NCT01429298|11686368|FG001|COMPLETED|Overall Study||169
10534259|NCT01429298|11686367|FG000|NOT COMPLETED|Overall Study||4
10534260|NCT01429298|11686368|FG001|NOT COMPLETED|Overall Study||6
10534261|NCT01429350|11686376|FG000|STARTED|Overall Study||53
10534262|NCT01429350|11686377|FG001|STARTED|Overall Study||55
10534263|NCT01429350|11686376|FG000|As-Treated|Overall Study||62
10534264|NCT01429350|11686377|FG001|As-Treated|Overall Study||43
10534265|NCT01429350|11686376|FG000|Per Protocol|Overall Study||41
10534266|NCT01429350|11686377|FG001|Per Protocol|Overall Study||37
10534267|NCT01429350|11686376|FG000|90 Day|Overall Study||46
10534268|NCT01429350|11686377|FG001|90 Day|Overall Study||50
10534269|NCT01429350|11686376|FG000|COMPLETED|Overall Study||46
10534270|NCT01429350|11686377|FG001|COMPLETED|Overall Study||50
10534271|NCT01429350|11686376|FG000|NOT COMPLETED|Overall Study||7
10534272|NCT01429350|11686377|FG001|NOT COMPLETED|Overall Study||5
10534273|NCT01429441|11686385|FG000|STARTED|Overall Study||146
10534274|NCT01429441|11686386|FG001|STARTED|Overall Study||74
10534275|NCT01429441|11686385|FG000|COMPLETED|Overall Study||108
10534276|NCT01429441|11686386|FG001|COMPLETED|Overall Study||51
10534277|NCT01429441|11686385|FG000|NOT COMPLETED|Overall Study||38
10534278|NCT01429441|11686386|FG001|NOT COMPLETED|Overall Study||23
10534279|NCT01429454|11686394|FG000|STARTED|Overall Study||62
10534280|NCT01429454|11686395|FG001|STARTED|Overall Study||65
10534281|NCT01429454|11686394|FG000|COMPLETED|Overall Study||35
10534282|NCT01429454|11686395|FG001|COMPLETED|Overall Study||35
10534283|NCT01429454|11686394|FG000|NOT COMPLETED|Overall Study||27
10534284|NCT01429454|11686395|FG001|NOT COMPLETED|Overall Study||30
10534285|NCT01429532|11686405|FG000|STARTED|Overall Study||40
10534286|NCT01429532|11686406|FG001|STARTED|Overall Study||40
10534287|NCT01429532|11686407|FG002|STARTED|Overall Study||40
10534288|NCT01429532|11686405|FG000|COMPLETED|Overall Study||40
10534289|NCT01429532|11686406|FG001|COMPLETED|Overall Study||40
10534290|NCT01429532|11686407|FG002|COMPLETED|Overall Study||40
10534291|NCT01429532|11686405|FG000|NOT COMPLETED|Overall Study||0
10534292|NCT01429532|11686406|FG001|NOT COMPLETED|Overall Study||0
10534293|NCT01429532|11686407|FG002|NOT COMPLETED|Overall Study||0
10534294|NCT01429584|11686417|FG000|STARTED|Overall Study||15
10534295|NCT01429584|11686418|FG001|STARTED|Overall Study||15
10534296|NCT01429584|11686417|FG000|COMPLETED|Overall Study||14
10534297|NCT01429584|11686418|FG001|COMPLETED|Overall Study||14
10534298|NCT01429584|11686417|FG000|NOT COMPLETED|Overall Study||1
10534299|NCT01429584|11686418|FG001|NOT COMPLETED|Overall Study||1
10534300|NCT01429623|11686426|FG000|STARTED|Overall Study|103 allocated, 1 withdrew consent prior to first dose, 4 lacked post baseline data|102
10534301|NCT01429623|11686427|FG001|STARTED|Overall Study|107 allocated, 4 lacked post baseline data|107
10534302|NCT01429623|11686426|FG000|Converted to Alzheimer's|Overall Study|14 of 99|14
10534303|NCT01429623|11686427|FG001|Converted to Alzheimer's|Overall Study|21 of 103|21
10534304|NCT01429623|11686426|FG000|COMPLETED|Overall Study||51
10534305|NCT01429623|11686427|FG001|COMPLETED|Overall Study||48
10534306|NCT01429623|11686426|FG000|NOT COMPLETED|Overall Study||51
10534307|NCT01429623|11686427|FG001|NOT COMPLETED|Overall Study||59
10534308|NCT01429792|11686433|FG000|STARTED|Overall Study||1013
10534309|NCT01429792|11686433|FG000|Genotype 1|Overall Study||687
10534310|NCT01429792|11686433|FG000|Genotype 2 & 3|Overall Study||305
10534311|NCT01429792|11686433|FG000|Genotype 4|Overall Study||5
10656268|NCT02216097|11817192|FG001|STARTED|Overall Study||6
10534312|NCT01429792|11686433|FG000|COMPLETED|Overall Study||607
10534313|NCT01429792|11686433|FG000|NOT COMPLETED|Overall Study||406
10534314|NCT01429987|11686441|FG000|STARTED|Overall Study||238
10534315|NCT01429987|11686442|FG001|STARTED|Overall Study||238
10534316|NCT01429987|11686443|FG002|STARTED|Overall Study||238
10534317|NCT01429987|11686444|FG003|STARTED|Overall Study||237
10534318|NCT01429987|11686441|FG000|COMPLETED|Overall Study||189
10534319|NCT01429987|11686442|FG001|COMPLETED|Overall Study||176
10534320|NCT01429987|11686443|FG002|COMPLETED|Overall Study||202
10534321|NCT01429987|11686444|FG003|COMPLETED|Overall Study||171
10534322|NCT01429987|11686441|FG000|NOT COMPLETED|Overall Study||49
10534323|NCT01429987|11686442|FG001|NOT COMPLETED|Overall Study||62
10716205|NCT02688387|11880058|FG015|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10716206|NCT02688387|11880059|FG016|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10812530|NCT03571646|11974609|FG001|COMPLETED|Overall Study||2
10812531|NCT03571646|11974608|FG000|NOT COMPLETED|Overall Study||2
10812532|NCT03571646|11974609|FG001|NOT COMPLETED|Overall Study||1
10812533|NCT03565328|11974615|FG000|STARTED|Overall Study||1
10812534|NCT03565328|11974615|FG000|COMPLETED|Overall Study||1
10812535|NCT03565328|11974615|FG000|NOT COMPLETED|Overall Study||0
10534324|NCT01429987|11686443|FG002|NOT COMPLETED|Overall Study||36
10534325|NCT01429987|11686444|FG003|NOT COMPLETED|Overall Study||66
10534326|NCT01430091|11686454|FG000|STARTED|Overall Study||18
10656269|NCT02216097|11817191|FG000|COMPLETED|Overall Study||8
10656270|NCT02216097|11817192|FG001|COMPLETED|Overall Study||6
10656271|NCT02216097|11817191|FG000|NOT COMPLETED|Overall Study||0
10812536|NCT03544242|11974622|FG000|STARTED|Overall Study||1
10812537|NCT03544242|11974623|FG001|STARTED|Overall Study||1
10534327|NCT01430091|11686454|FG000|COMPLETED|Overall Study||18
10534328|NCT01430091|11686454|FG000|NOT COMPLETED|Overall Study||0
10534329|NCT01430104|11686468|FG000|STARTED|14-Day Lead-In Period||30
10656272|NCT02216097|11817192|FG001|NOT COMPLETED|Overall Study||0
10656273|NCT02216123|11817200|FG000|STARTED|Overall Study||166
10656274|NCT02216123|11817201|FG001|STARTED|Overall Study||85
10656275|NCT02216123|11817200|FG000|COMPLETED|Overall Study||160
10656276|NCT02216123|11817201|FG001|COMPLETED|Overall Study||83
10656277|NCT02216123|11817200|FG000|NOT COMPLETED|Overall Study||6
10656278|NCT02216123|11817201|FG001|NOT COMPLETED|Overall Study||2
10656279|NCT02216136|11817214|FG000|STARTED|Overall Study||72
10656280|NCT02216136|11817215|FG001|STARTED|Overall Study||90
10656281|NCT02216136|11817216|FG002|STARTED|Overall Study||0
10656282|NCT02216136|11817214|FG000|COMPLETED|Overall Study||72
10656283|NCT02216136|11817215|FG001|COMPLETED|Overall Study||90
10656284|NCT02216136|11817216|FG002|COMPLETED|Overall Study||0
10656285|NCT02216136|11817214|FG000|NOT COMPLETED|Overall Study||0
10656286|NCT02216136|11817215|FG001|NOT COMPLETED|Overall Study||0
10656287|NCT02216136|11817216|FG002|NOT COMPLETED|Overall Study||0
10812538|NCT03544242|11974624|FG002|STARTED|Overall Study||2
10358092|NCT00481195|11497807|FG001|STARTED|Overall Study|Four of these subjects were randomized but never received study medication.|129
10358093|NCT00481195|11497806|FG000|COMPLETED|Overall Study||89
10358094|NCT00481195|11497807|FG001|COMPLETED|Overall Study||90
10358095|NCT00481195|11497806|FG000|NOT COMPLETED|Overall Study||39
10358096|NCT00481195|11497807|FG001|NOT COMPLETED|Overall Study||39
10358097|NCT00481247|11497815|FG000|STARTED|Overall Study|Randomized|259
10358098|NCT00481247|11497816|FG001|STARTED|Overall Study|Randomized|260
10358099|NCT00481247|11497815|FG000|Received Treatment|Overall Study||258
10358100|NCT00481247|11497816|FG001|Received Treatment|Overall Study||258
10358101|NCT00481247|11497815|FG000|COMPLETED|Overall Study||0
10358102|NCT00481247|11497816|FG001|COMPLETED|Overall Study||0
10358103|NCT00481247|11497815|FG000|NOT COMPLETED|Overall Study||259
10358104|NCT00481247|11497816|FG001|NOT COMPLETED|Overall Study||260
10358105|NCT00481351|11497824|FG000|STARTED|Overall Study||13
10358106|NCT00481351|11497825|FG001|STARTED|Overall Study||12
10358107|NCT00481351|11497824|FG000|COMPLETED|Overall Study||13
10358108|NCT00481351|11497825|FG001|COMPLETED|Overall Study||12
10358109|NCT00481351|11497824|FG000|NOT COMPLETED|Overall Study||0
10358110|NCT00481351|11497825|FG001|NOT COMPLETED|Overall Study||0
10358111|NCT00481507|11497833|FG000|STARTED|Overall Study||64
10358112|NCT00481507|11497834|FG001|STARTED|Overall Study||61
10358113|NCT00481507|11497833|FG000|COMPLETED|Overall Study||64
10358114|NCT00481507|11497834|FG001|COMPLETED|Overall Study||61
10358115|NCT00481507|11497833|FG000|NOT COMPLETED|Overall Study||0
10358116|NCT00481507|11497834|FG001|NOT COMPLETED|Overall Study||0
10358117|NCT00481676|11497842|FG000|STARTED|Overall Study||27
10358118|NCT00481676|11497843|FG001|STARTED|Overall Study||22
10358119|NCT00481676|11497842|FG000|COMPLETED|Overall Study||25
10358120|NCT00481676|11497843|FG001|COMPLETED|Overall Study||17
10358121|NCT00481676|11497842|FG000|NOT COMPLETED|Overall Study||2
10358122|NCT00481676|11497843|FG001|NOT COMPLETED|Overall Study||5
10358123|NCT00481767|11497851|FG000|STARTED|Overall Study||450
10358124|NCT00481767|11497852|FG001|STARTED|Overall Study||226
10358125|NCT00481767|11497851|FG000|COMPLETED|Overall Study||418
10358126|NCT00481767|11497852|FG001|COMPLETED|Overall Study||205
10358127|NCT00481767|11497851|FG000|NOT COMPLETED|Overall Study||32
10358128|NCT00481767|11497852|FG001|NOT COMPLETED|Overall Study||21
10358129|NCT00481832|11497858|FG000|STARTED|Enrollment||50
10358130|NCT00481832|11497858|FG000|COMPLETED|Enrollment||40
10358131|NCT00481832|11497858|FG000|NOT COMPLETED|Enrollment||10
10358132|NCT00481832|11497858|FG000|STARTED|Autologous Hematopoietic Cell Transplant||40
10358133|NCT00481832|11497858|FG000|COMPLETED|Autologous Hematopoietic Cell Transplant||40
10358134|NCT00481832|11497858|FG000|NOT COMPLETED|Autologous Hematopoietic Cell Transplant||0
10358135|NCT00481832|11497858|FG000|STARTED|Inter-transplant Period||40
10358136|NCT00481832|11497858|FG000|COMPLETED|Inter-transplant Period||13
10358137|NCT00481832|11497858|FG000|NOT COMPLETED|Inter-transplant Period||27
10358138|NCT00481832|11497858|FG000|STARTED|Allogenic Hematopoietic Cell Transplant||13
10358139|NCT00481832|11497858|FG000|COMPLETED|Allogenic Hematopoietic Cell Transplant||13
10358140|NCT00481832|11497858|FG000|NOT COMPLETED|Allogenic Hematopoietic Cell Transplant||0
10358141|NCT00481845|11497864|FG000|STARTED|Overall Study||1
10358142|NCT00481845|11497865|FG001|STARTED|Overall Study||0
10358143|NCT00481845|11497864|FG000|COMPLETED|Overall Study||1
10358144|NCT00481845|11497865|FG001|COMPLETED|Overall Study||0
10358145|NCT00481845|11497864|FG000|NOT COMPLETED|Overall Study||0
10358146|NCT00481845|11497865|FG001|NOT COMPLETED|Overall Study||0
10358147|NCT00481871|11497876|FG000|STARTED|Overall Study||7
10358148|NCT00481871|11497877|FG001|STARTED|Overall Study||10
10358149|NCT00481871|11497878|FG002|STARTED|Overall Study||18
10358150|NCT00481871|11497879|FG003|STARTED|Overall Study||38
10358151|NCT00481871|11497880|FG004|STARTED|Overall Study||34
10358152|NCT00481871|11497876|FG000|COMPLETED|Overall Study||7
10358153|NCT00481871|11497877|FG001|COMPLETED|Overall Study||10
10358154|NCT00481871|11497878|FG002|COMPLETED|Overall Study||17
10358155|NCT00481871|11497879|FG003|COMPLETED|Overall Study||38
10358156|NCT00481871|11497880|FG004|COMPLETED|Overall Study||34
10358157|NCT00481871|11497876|FG000|NOT COMPLETED|Overall Study||0
10358158|NCT00481871|11497877|FG001|NOT COMPLETED|Overall Study||0
10358159|NCT00481871|11497878|FG002|NOT COMPLETED|Overall Study||1
10358160|NCT00481871|11497879|FG003|NOT COMPLETED|Overall Study||0
10358161|NCT00481871|11497880|FG004|NOT COMPLETED|Overall Study||0
10358162|NCT00481988|11497890|FG000|STARTED|Overall Study||12
10358163|NCT00481988|11497891|FG001|STARTED|Overall Study|one patient was dropped from the study before randomization|9
10358164|NCT00481988|11497890|FG000|Crossover|Overall Study|patient dropped out of study after 5 sessions to pursue other treatment options|11
10358165|NCT00481988|11497891|FG001|Crossover|Overall Study|patient dropped out of study after 5 sessions to illness unrelated to study|8
10358166|NCT00481988|11497890|FG000|COMPLETED|Overall Study||11
10358167|NCT00481988|11497891|FG001|COMPLETED|Overall Study||8
10358168|NCT00481988|11497890|FG000|NOT COMPLETED|Overall Study||1
10358169|NCT00481988|11497891|FG001|NOT COMPLETED|Overall Study||1
10358170|NCT00482001|11497899|FG000|STARTED|Overall Study||11
10358171|NCT00482001|11497900|FG001|STARTED|Overall Study||11
10358172|NCT00482001|11497899|FG000|COMPLETED|Overall Study||10
10358173|NCT00482001|11497900|FG001|COMPLETED|Overall Study||10
10358174|NCT00482001|11497899|FG000|NOT COMPLETED|Overall Study||1
10358175|NCT00482001|11497900|FG001|NOT COMPLETED|Overall Study||1
10358176|NCT00482014|11497912|FG000|STARTED|Overall Study||9
10358177|NCT00482014|11497913|FG001|STARTED|Overall Study||13
10358178|NCT00482014|11497914|FG002|STARTED|Overall Study||46
10358179|NCT00482014|11497915|FG003|STARTED|Overall Study||52
10358180|NCT00482014|11497912|FG000|COMPLETED|Overall Study||2
10358181|NCT00482014|11497913|FG001|COMPLETED|Overall Study||7
10358182|NCT00482014|11497914|FG002|COMPLETED|Overall Study||35
10358183|NCT00482014|11497915|FG003|COMPLETED|Overall Study||29
10358184|NCT00482014|11497912|FG000|NOT COMPLETED|Overall Study||7
10358185|NCT00482014|11497913|FG001|NOT COMPLETED|Overall Study||6
10358186|NCT00482014|11497914|FG002|NOT COMPLETED|Overall Study||11
10358187|NCT00482014|11497915|FG003|NOT COMPLETED|Overall Study||23
10358188|NCT00482053|11497927|FG000|STARTED|Autologous Peripheral Stem Cells||3
10358189|NCT00482053|11497927|FG000|COMPLETED|Autologous Peripheral Stem Cells||3
10358190|NCT00482053|11497927|FG000|NOT COMPLETED|Autologous Peripheral Stem Cells||0
10358191|NCT00482053|11497927|FG000|STARTED|Inter-treatment Period||3
10358192|NCT00482053|11497927|FG000|COMPLETED|Inter-treatment Period||2
10358193|NCT00482053|11497927|FG000|NOT COMPLETED|Inter-treatment Period||1
10358194|NCT00482053|11497927|FG000|STARTED|Allogeneic Peripheral Stem Cells||2
10358195|NCT00482053|11497927|FG000|COMPLETED|Allogeneic Peripheral Stem Cells||2
10358196|NCT00482053|11497927|FG000|NOT COMPLETED|Allogeneic Peripheral Stem Cells||0
10358197|NCT00482170|11497933|FG000|STARTED|Overall Study||207
10358198|NCT00482170|11497934|FG001|STARTED|Overall Study||214
10358199|NCT00482170|11497933|FG000|Treated|Overall Study||207
10358200|NCT00482170|11497934|FG001|Treated|Overall Study||211
10358201|NCT00482170|11497933|FG000|COMPLETED|Overall Study||192
10716207|NCT02688387|11880060|FG017|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10716208|NCT02688387|11880061|FG018|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
10358202|NCT00482170|11497934|FG001|COMPLETED|Overall Study||194
10358203|NCT00482170|11497933|FG000|NOT COMPLETED|Overall Study||15
10358204|NCT00482170|11497934|FG001|NOT COMPLETED|Overall Study||20
10358205|NCT00482274|11497940|FG000|STARTED|Overall Study||3
10358206|NCT00482274|11497940|FG000|COMPLETED|Overall Study||2
10358207|NCT00482274|11497940|FG000|NOT COMPLETED|Overall Study||1
10358208|NCT00482391|11497944|FG000|STARTED|Overall Study||95
10358209|NCT00482391|11497944|FG000|COMPLETED|Overall Study||92
10358210|NCT00482391|11497944|FG000|NOT COMPLETED|Overall Study||3
10358211|NCT00482547|11497951|FG000|STARTED|Overall Study|599 subjects were enrolled in the silver-coated catheter group.|599
10358212|NCT00482547|11497952|FG001|STARTED|Overall Study|589 subjects were enrolled in the silicone-coated catheter group.|589
10358213|NCT00482547|11497951|FG000|Successful Catheterization|Overall Study|Out of the 599 AgCS subjects 565 (94.3%) had a successful catheterization.|565
10358214|NCT00482547|11497952|FG001|Successful Catheterization|Overall Study|Out of the 589 SiCS catheter subjects 568 (96.4%) had a successful catheterization.|568
10358215|NCT00482547|11497951|FG000|48 Hour Evaluation|Overall Study|426 went on to be included in the Silver-coated 48 hour efficacy evaluable population.|426
10358216|NCT00482547|11497952|FG001|48 Hour Evaluation|Overall Study|428 went on to be included in the Silicone-coated 48 hour efficacy evaluable population.|428
10358217|NCT00482547|11497951|FG000|COMPLETED|Overall Study||426
10358218|NCT00482547|11497952|FG001|COMPLETED|Overall Study||428
10358219|NCT00482547|11497951|FG000|NOT COMPLETED|Overall Study||173
10358220|NCT00482547|11497952|FG001|NOT COMPLETED|Overall Study||161
10358221|NCT00482612|11497962|FG000|STARTED|In-treatment Period||137
10358222|NCT00482612|11497963|FG001|STARTED|In-treatment Period||125
10358223|NCT00482612|11497964|FG002|STARTED|In-treatment Period||129
10358224|NCT00482612|11497965|FG003|STARTED|In-treatment Period||135
10358225|NCT00482612|11497962|FG000|Treated|In-treatment Period||137
10358226|NCT00482612|11497963|FG001|Treated|In-treatment Period||125
10358227|NCT00482612|11497964|FG002|Treated|In-treatment Period||128
10358228|NCT00482612|11497965|FG003|Treated|In-treatment Period||135
10358229|NCT00482612|11497962|FG000|COMPLETED|In-treatment Period||137
10716209|NCT02688387|11880062|FG019|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
10358230|NCT00482612|11497963|FG001|COMPLETED|In-treatment Period||125
10358231|NCT00482612|11497964|FG002|COMPLETED|In-treatment Period||128
10358232|NCT00482612|11497965|FG003|COMPLETED|In-treatment Period||135
10358233|NCT00482612|11497962|FG000|NOT COMPLETED|In-treatment Period||0
10358234|NCT00482612|11497963|FG001|NOT COMPLETED|In-treatment Period||0
10534330|NCT01430104|11686468|FG000|COMPLETED|14-Day Lead-In Period||30
10534331|NCT01430104|11686468|FG000|NOT COMPLETED|14-Day Lead-In Period||0
10534332|NCT01430104|11686468|FG000|STARTED|28-Day Teriparatide Treatment Period|1 participant withdrew from the study after completing the 14-day Lead-in Period.|29
10534333|NCT01430104|11686468|FG000|Received at Least 1 Dose of Teriparatide|28-Day Teriparatide Treatment Period||29
10534334|NCT01430104|11686468|FG000|COMPLETED|28-Day Teriparatide Treatment Period||28
10534335|NCT01430104|11686468|FG000|NOT COMPLETED|28-Day Teriparatide Treatment Period||1
10534336|NCT01430130|11686475|FG000|STARTED|Overall Study||12
10534337|NCT01430130|11686475|FG000|COMPLETED|Overall Study||10
10534338|NCT01430130|11686475|FG000|NOT COMPLETED|Overall Study||2
10534339|NCT01430169|11686481|FG000|STARTED|Overall Study||20
10656288|NCT02216214|11817226|FG000|STARTED|Overall Study||443
10656289|NCT02216214|11817227|FG001|STARTED|Overall Study||445
10656290|NCT02216214|11817226|FG000|Treated|Overall Study||442
10656291|NCT02216214|11817227|FG001|Treated|Overall Study||445
10656292|NCT02216214|11817226|FG000|COMPLETED|Overall Study||400
10656293|NCT02216214|11817227|FG001|COMPLETED|Overall Study||409
10656294|NCT02216214|11817226|FG000|NOT COMPLETED|Overall Study||43
10656295|NCT02216214|11817227|FG001|NOT COMPLETED|Overall Study||36
10656296|NCT02216357|11817235|FG000|STARTED|Overall Study||14
10656297|NCT02216357|11817236|FG001|STARTED|Overall Study||5
10656298|NCT02216357|11817235|FG000|COMPLETED|Overall Study||12
10656299|NCT02216357|11817236|FG001|COMPLETED|Overall Study||4
10656300|NCT02216357|11817235|FG000|NOT COMPLETED|Overall Study||2
10656301|NCT02216357|11817236|FG001|NOT COMPLETED|Overall Study||1
10656302|NCT02216422|11817242|FG000|STARTED|Overall Study||36
10656303|NCT02216422|11817242|FG000|COMPLETED|Overall Study||36
10656304|NCT02216422|11817242|FG000|NOT COMPLETED|Overall Study||0
10656305|NCT02216526|11817249|FG000|STARTED|Overall Study||45
10656306|NCT02216526|11817250|FG001|STARTED|Overall Study||44
10656307|NCT02216526|11817251|FG002|STARTED|Overall Study||44
10656308|NCT02216526|11817249|FG000|COMPLETED|Overall Study||40
10656309|NCT02216526|11817250|FG001|COMPLETED|Overall Study||41
10656310|NCT02216526|11817251|FG002|COMPLETED|Overall Study||36
10656311|NCT02216526|11817249|FG000|NOT COMPLETED|Overall Study||5
10656312|NCT02216526|11817250|FG001|NOT COMPLETED|Overall Study||3
10656313|NCT02216526|11817251|FG002|NOT COMPLETED|Overall Study||8
10656314|NCT02216591|11817261|FG000|STARTED|Overall Study||11
10656315|NCT02216591|11817262|FG001|STARTED|Overall Study||10
10656316|NCT02216591|11817261|FG000|COMPLETED|Overall Study||11
10656317|NCT02216591|11817262|FG001|COMPLETED|Overall Study||9
10656318|NCT02216591|11817261|FG000|NOT COMPLETED|Overall Study||0
10656319|NCT02216591|11817262|FG001|NOT COMPLETED|Overall Study||1
10656320|NCT02216695|11817268|FG000|STARTED|Overall Study||64882
10656321|NCT02216695|11817268|FG000|COMPLETED|Overall Study|This is a database study and hence, 64882 patients were finally included|64882
10656322|NCT02216695|11817268|FG000|NOT COMPLETED|Overall Study||0
10656323|NCT02216773|11817279|FG000|STARTED|Overall Study||28
10656324|NCT02216773|11817280|FG001|STARTED|Overall Study||29
10656325|NCT02216773|11817279|FG000|Underwent Procedure (PVE/RALPPS)|Overall Study||24
10656326|NCT02216773|11817280|FG001|Underwent Procedure (PVE/RALPPS)|Overall Study||26
10656327|NCT02216773|11817279|FG000|COMPLETED|Overall Study||16
10656328|NCT02216773|11817280|FG001|COMPLETED|Overall Study||24
10656329|NCT02216773|11817279|FG000|NOT COMPLETED|Overall Study||12
10656330|NCT02216773|11817280|FG001|NOT COMPLETED|Overall Study||5
10656331|NCT02216812|11817288|FG000|STARTED|Overall Study||67
10656332|NCT02216812|11817289|FG001|STARTED|Overall Study||67
10656333|NCT02216812|11817288|FG000|COMPLETED|Overall Study||57
10656334|NCT02216812|11817289|FG001|COMPLETED|Overall Study||62
10534340|NCT01430169|11686481|FG000|COMPLETED|Overall Study||20
10656335|NCT02216812|11817288|FG000|NOT COMPLETED|Overall Study||10
10656336|NCT02216812|11817289|FG001|NOT COMPLETED|Overall Study||5
10656343|NCT02217280|11817304|FG000|STARTED|Overall Study||20
10656344|NCT02217280|11817304|FG000|COMPLETED|Overall Study||16
10656345|NCT02217280|11817304|FG000|NOT COMPLETED|Overall Study||4
10656346|NCT02217332|11817309|FG000|STARTED|Overall Study|Safety Population|20
10656347|NCT02217332|11817309|FG000|COMPLETED|Overall Study|Subjects who continued to optional open-label treatment|13
10656348|NCT02217332|11817309|FG000|NOT COMPLETED|Overall Study||7
10656349|NCT02217410|11817316|FG000|STARTED|Overall Study||7
10656350|NCT02217410|11817317|FG001|STARTED|Overall Study||34
10656351|NCT02217410|11817318|FG002|STARTED|Overall Study||18
10656352|NCT02217410|11817316|FG000|COMPLETED|Overall Study||6
10656353|NCT02217410|11817317|FG001|COMPLETED|Overall Study||30
10656354|NCT02217410|11817318|FG002|COMPLETED|Overall Study||13
10656355|NCT02217410|11817316|FG000|NOT COMPLETED|Overall Study||1
10656356|NCT02217410|11817317|FG001|NOT COMPLETED|Overall Study||4
10656357|NCT02217410|11817318|FG002|NOT COMPLETED|Overall Study||5
10656358|NCT02217436|11817333|FG000|STARTED|Overall Study||40
10656359|NCT02217436|11817334|FG001|STARTED|Overall Study||40
10656360|NCT02217436|11817333|FG000|COMPLETED|Overall Study||39
10656361|NCT02217436|11817334|FG001|COMPLETED|Overall Study||38
10656362|NCT02217436|11817333|FG000|NOT COMPLETED|Overall Study||1
10358235|NCT00482612|11497964|FG002|NOT COMPLETED|In-treatment Period||1
10358236|NCT00482612|11497965|FG003|NOT COMPLETED|In-treatment Period||0
10358237|NCT00482612|11497962|FG000|STARTED|Follow-up Period||137
10358238|NCT00482612|11497963|FG001|STARTED|Follow-up Period||125
10358239|NCT00482612|11497964|FG002|STARTED|Follow-up Period||128
10358240|NCT00482612|11497965|FG003|STARTED|Follow-up Period||135
10358241|NCT00482612|11497962|FG000|COMPLETED|Follow-up Period||123
10358242|NCT00482612|11497963|FG001|COMPLETED|Follow-up Period||107
10358243|NCT00482612|11497964|FG002|COMPLETED|Follow-up Period||106
10358244|NCT00482612|11497965|FG003|COMPLETED|Follow-up Period||127
10358245|NCT00482612|11497962|FG000|NOT COMPLETED|Follow-up Period||14
10358246|NCT00482612|11497963|FG001|NOT COMPLETED|Follow-up Period||18
10358247|NCT00482612|11497964|FG002|NOT COMPLETED|Follow-up Period||22
10358248|NCT00482612|11497965|FG003|NOT COMPLETED|Follow-up Period||8
10358249|NCT00482625|11497979|FG000|STARTED|Overall Study||6
10358250|NCT00482625|11497979|FG000|COMPLETED|Overall Study||6
10358251|NCT00482625|11497979|FG000|NOT COMPLETED|Overall Study||0
10358252|NCT00482677|11497985|FG000|STARTED|Overall Study||281
10358253|NCT00482677|11497986|FG001|STARTED|Overall Study||281
10358254|NCT00482677|11497985|FG000|COMPLETED|Overall Study||281
10358255|NCT00482677|11497986|FG001|COMPLETED|Overall Study||281
10358256|NCT00482677|11497985|FG000|NOT COMPLETED|Overall Study||0
10358257|NCT00482677|11497986|FG001|NOT COMPLETED|Overall Study||0
10358258|NCT00482703|11497994|FG000|STARTED|Overall Study|number enrolled, randomized and treated|11
10358259|NCT00482703|11497995|FG001|STARTED|Overall Study|number enrolled, randomized and treated|12
10358260|NCT00482703|11497994|FG000|COMPLETED|Overall Study||10
10358261|NCT00482703|11497995|FG001|COMPLETED|Overall Study||12
10358262|NCT00482703|11497994|FG000|NOT COMPLETED|Overall Study||1
10358263|NCT00482703|11497995|FG001|NOT COMPLETED|Overall Study||0
10358264|NCT00482729|11498010|FG000|STARTED|Overall Study|Site 079011301 was identified as non-compliant and 1 patient was excluded from all analysis|626
10358265|NCT00482729|11498011|FG001|STARTED|Overall Study|Site 079011301 was identified as non-compliant and 3 patients were excluded from all analysis|624
10358266|NCT00482729|11498010|FG000|Completed Phase A|Overall Study||484
10358267|NCT00482729|11498011|FG001|Completed Phase A|Overall Study||482
10358268|NCT00482729|11498010|FG000|Completed Phase B|Overall Study||409
10358269|NCT00482729|11498011|FG001|Completed Phase B|Overall Study||406
10358270|NCT00482729|11498010|FG000|COMPLETED|Overall Study||409
10358271|NCT00482729|11498011|FG001|COMPLETED|Overall Study||406
10358272|NCT00482729|11498010|FG000|NOT COMPLETED|Overall Study||217
10358273|NCT00482729|11498011|FG001|NOT COMPLETED|Overall Study||218
10358274|NCT00482911|11498019|FG000|STARTED|Dosing Schedule 1: Len & Cyc|All received Dose A-QD in cycle 1|3
10358275|NCT00482911|11498020|FG001|STARTED|Dosing Schedule 1: Len & Cyc||0
10358276|NCT00482911|11498019|FG000|COMPLETED|Dosing Schedule 1: Len & Cyc||3
10358277|NCT00482911|11498020|FG001|COMPLETED|Dosing Schedule 1: Len & Cyc||0
10358278|NCT00482911|11498019|FG000|NOT COMPLETED|Dosing Schedule 1: Len & Cyc||0
10358279|NCT00482911|11498020|FG001|NOT COMPLETED|Dosing Schedule 1: Len & Cyc||0
10358280|NCT00482911|11498019|FG000|STARTED|Dosing Schedule 1: Len, Cyc, & Sun|All received Dose B-QD in cycle 2|3
10358281|NCT00482911|11498020|FG001|STARTED|Dosing Schedule 1: Len, Cyc, & Sun|All received Dose B-QD in cycle 1|2
10358282|NCT00482911|11498019|FG000|COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun|1 stopped at Dose B-QD, 1 stopped at Dose C-QD, 1 stopped at Dose C-QOD|3
10358283|NCT00482911|11498020|FG001|COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun|1 stopped at Dose B-QD, 1 stopped at Dose C-QOD|2
10358284|NCT00482911|11498019|FG000|NOT COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun||0
10358285|NCT00482911|11498020|FG001|NOT COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun||0
10358286|NCT00482911|11498019|FG000|STARTED|Dosing Schedule 2: Len, Cyc, & Sun||0
10358287|NCT00482911|11498020|FG001|STARTED|Dosing Schedule 2: Len, Cyc, & Sun|All received Dose D-QD in cycle 1|7
10358288|NCT00482911|11498019|FG000|COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
10358289|NCT00482911|11498020|FG001|COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun|5 stopped at Dose D-QOD, 2 stopped at Dose D-QD (1 after first increasing to Dose E-QD)|7
10358290|NCT00482911|11498019|FG000|NOT COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
10358291|NCT00482911|11498020|FG001|NOT COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
10358292|NCT00483002|11498026|FG000|STARTED|Overall Study||3719
10358293|NCT00483002|11498026|FG000|COMPLETED|Overall Study||1165
10358294|NCT00483002|11498026|FG000|NOT COMPLETED|Overall Study||2554
10358295|NCT00483041|11498032|FG000|STARTED|Overall Study||5
10358296|NCT00483041|11498033|FG001|STARTED|Overall Study||6
10358297|NCT00483041|11498032|FG000|COMPLETED|Overall Study||5
10358298|NCT00483041|11498033|FG001|COMPLETED|Overall Study||5
10358299|NCT00483041|11498032|FG000|NOT COMPLETED|Overall Study||0
10358300|NCT00483041|11498033|FG001|NOT COMPLETED|Overall Study||1
10358301|NCT00483184|11498042|FG000|STARTED|Overall Study||27
10358302|NCT00483184|11498043|FG001|STARTED|Overall Study||31
10358303|NCT00483184|11498044|FG002|STARTED|Overall Study||26
10358304|NCT00483184|11498042|FG000|COMPLETED|Overall Study||22
10358305|NCT00483184|11498043|FG001|COMPLETED|Overall Study||27
10358306|NCT00483184|11498044|FG002|COMPLETED|Overall Study||23
10358307|NCT00483184|11498042|FG000|NOT COMPLETED|Overall Study||5
10358308|NCT00483184|11498043|FG001|NOT COMPLETED|Overall Study||4
10358309|NCT00483184|11498044|FG002|NOT COMPLETED|Overall Study||3
10358310|NCT00483223|11498052|FG000|STARTED|Overall Study||86
10358311|NCT00483223|11498052|FG000|COMPLETED|Overall Study||86
10358312|NCT00483223|11498052|FG000|NOT COMPLETED|Overall Study||0
10358313|NCT00483262|11498058|FG000|STARTED|Overall Study||20
10358314|NCT00483262|11498059|FG001|STARTED|Overall Study||43
10358315|NCT00483262|11498058|FG000|COMPLETED|Overall Study||20
10358316|NCT00483262|11498059|FG001|COMPLETED|Overall Study||43
10358317|NCT00483262|11498058|FG000|NOT COMPLETED|Overall Study||0
10358318|NCT00483262|11498059|FG001|NOT COMPLETED|Overall Study||0
10358319|NCT00483327|11498069|FG000|STARTED|Overall Study||30
10358320|NCT00483327|11498069|FG000|COMPLETED|Overall Study||20
10358321|NCT00483327|11498069|FG000|NOT COMPLETED|Overall Study||10
10358322|NCT00483379|11498077|FG000|STARTED|Treatment Period||6
10358323|NCT00483379|11498078|FG001|STARTED|Treatment Period||7
10358324|NCT00483379|11498077|FG000|COMPLETED|Treatment Period||4
10358325|NCT00483379|11498078|FG001|COMPLETED|Treatment Period||7
10358326|NCT00483379|11498077|FG000|NOT COMPLETED|Treatment Period||2
10358327|NCT00483379|11498078|FG001|NOT COMPLETED|Treatment Period||0
10358328|NCT00483379|11498077|FG000|STARTED|Extension Period|Extension allowed late-onset participants access to treatment until commercially available.|1
10358329|NCT00483379|11498078|FG001|STARTED|Extension Period|Extension allowed late-onset participants access to treatment until commercially available.|2
10358330|NCT00483379|11498077|FG000|COMPLETED|Extension Period||1
10358331|NCT00483379|11498078|FG001|COMPLETED|Extension Period||2
10358332|NCT00483379|11498077|FG000|NOT COMPLETED|Extension Period||0
10358333|NCT00483379|11498078|FG001|NOT COMPLETED|Extension Period||0
10358334|NCT00483405|11498086|FG000|STARTED|Overall Study||28
10358335|NCT00483405|11498086|FG000|COMPLETED|Overall Study||0
10358336|NCT00483405|11498086|FG000|NOT COMPLETED|Overall Study||28
10358337|NCT00483496|11498090|FG000|STARTED|Overall Study||16
10358338|NCT00483496|11498090|FG000|COMPLETED|Overall Study||15
10358339|NCT00483496|11498090|FG000|NOT COMPLETED|Overall Study||1
10358340|NCT00483509|11498102|FG000|STARTED|Overall Study||28
10358341|NCT00483509|11498102|FG000|COMPLETED|Overall Study||28
10358342|NCT00483509|11498102|FG000|NOT COMPLETED|Overall Study||0
10358343|NCT00483548|11498108|FG000|STARTED|Overall Study||148
10358344|NCT00483548|11498109|FG001|STARTED|Overall Study||150
10358345|NCT00483548|11498108|FG000|Received Study Treatment|Overall Study|1 subject randomized but lost to follow up; no treatment data.|147
10358346|NCT00483548|11498109|FG001|Received Study Treatment|Overall Study|3 subjects randomized but not treated.|147
10358347|NCT00483548|11498108|FG000|COMPLETED|Overall Study||88
10358348|NCT00483548|11498109|FG001|COMPLETED|Overall Study||104
10358349|NCT00483548|11498108|FG000|NOT COMPLETED|Overall Study||60
10358350|NCT00483548|11498109|FG001|NOT COMPLETED|Overall Study||46
10358351|NCT00483561|11498115|FG000|STARTED|Overall Study||26
10358352|NCT00483561|11498115|FG000|COMPLETED|Overall Study||15
10358353|NCT00483561|11498115|FG000|NOT COMPLETED|Overall Study||11
10358354|NCT00483574|11498121|FG000|STARTED|Overall Study||1053
10358355|NCT00483574|11498122|FG001|STARTED|Overall Study||321
10716210|NCT02688387|11880063|FG020|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
10716211|NCT02688387|11880064|FG021|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
10716212|NCT02688387|11880043|FG000|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10358356|NCT00483574|11498121|FG000|COMPLETED|Overall Study||951
10358357|NCT00483574|11498122|FG001|COMPLETED|Overall Study||308
10358358|NCT00483574|11498121|FG000|NOT COMPLETED|Overall Study||102
10358359|NCT00483574|11498122|FG001|NOT COMPLETED|Overall Study||13
10358360|NCT00483652|11498132|FG000|STARTED|Double-blind Treatment Period||120
10358361|NCT00483652|11498133|FG001|STARTED|Double-blind Treatment Period||119
10358362|NCT00483652|11498132|FG000|COMPLETED|Double-blind Treatment Period||113
10358363|NCT00483652|11498133|FG001|COMPLETED|Double-blind Treatment Period||114
10358364|NCT00483652|11498132|FG000|NOT COMPLETED|Double-blind Treatment Period||7
10358365|NCT00483652|11498133|FG001|NOT COMPLETED|Double-blind Treatment Period||5
10358366|NCT00483652|11498132|FG000|STARTED|Post-study Follow-up||113
10358367|NCT00483652|11498133|FG001|STARTED|Post-study Follow-up||114
10358368|NCT00483652|11498132|FG000|COMPLETED|Post-study Follow-up||113
10358369|NCT00483652|11498133|FG001|COMPLETED|Post-study Follow-up||114
10358370|NCT00483652|11498132|FG000|NOT COMPLETED|Post-study Follow-up||0
10358371|NCT00483652|11498133|FG001|NOT COMPLETED|Post-study Follow-up||0
10358372|NCT00483704|11498142|FG000|STARTED|Randomization||644
10358373|NCT00483704|11498143|FG001|STARTED|Randomization||645
10358374|NCT00483704|11498144|FG002|STARTED|Randomization||646
10358375|NCT00483704|11498142|FG000|COMPLETED|Randomization||573
10358376|NCT00483704|11498143|FG001|COMPLETED|Randomization||549
10358377|NCT00483704|11498144|FG002|COMPLETED|Randomization||555
10358378|NCT00483704|11498142|FG000|NOT COMPLETED|Randomization||71
10358379|NCT00483704|11498143|FG001|NOT COMPLETED|Randomization||96
10358380|NCT00483704|11498144|FG002|NOT COMPLETED|Randomization||91
10358381|NCT00483704|11498142|FG000|STARTED|Treatment||573
10358382|NCT00483704|11498143|FG001|STARTED|Treatment||549
10358383|NCT00483704|11498144|FG002|STARTED|Treatment||555
10358384|NCT00483704|11498142|FG000|COMPLETED|Treatment||444
10358385|NCT00483704|11498143|FG001|COMPLETED|Treatment||420
10358386|NCT00483704|11498144|FG002|COMPLETED|Treatment||399
10358387|NCT00483704|11498142|FG000|NOT COMPLETED|Treatment||129
10358388|NCT00483704|11498143|FG001|NOT COMPLETED|Treatment||129
10358389|NCT00483704|11498144|FG002|NOT COMPLETED|Treatment||156
10358390|NCT00483717|11498157|FG000|STARTED|Overall Study||87
10358391|NCT00483717|11498158|FG001|STARTED|Overall Study||86
10358392|NCT00483717|11498157|FG000|COMPLETED|Overall Study||63
10358393|NCT00483717|11498158|FG001|COMPLETED|Overall Study||65
10358394|NCT00483717|11498157|FG000|NOT COMPLETED|Overall Study||24
10358395|NCT00483717|11498158|FG001|NOT COMPLETED|Overall Study||21
10358396|NCT00483756|11498167|FG000|STARTED|Overall Study||110
10358397|NCT00483756|11498168|FG001|STARTED|Overall Study||110
10358398|NCT00483756|11498169|FG002|STARTED|Overall Study||111
10358399|NCT00483756|11498167|FG000|Treated|Overall Study||109
10358400|NCT00483756|11498168|FG001|Treated|Overall Study||106
10358401|NCT00483756|11498169|FG002|Treated|Overall Study||107
10358402|NCT00483756|11498167|FG000|COMPLETED|Overall Study||77
10358403|NCT00483756|11498168|FG001|COMPLETED|Overall Study||60
10358404|NCT00483756|11498169|FG002|COMPLETED|Overall Study||59
10534341|NCT01430169|11686481|FG000|NOT COMPLETED|Overall Study||0
10534342|NCT01430182|11686487|FG000|STARTED|Overall Study||9
10534343|NCT01430182|11686488|FG001|STARTED|Overall Study||8
10534344|NCT01430182|11686487|FG000|COMPLETED|Overall Study||9
10534345|NCT01430182|11686488|FG001|COMPLETED|Overall Study||8
10534346|NCT01430182|11686487|FG000|NOT COMPLETED|Overall Study||0
10534347|NCT01430182|11686488|FG001|NOT COMPLETED|Overall Study||0
10534348|NCT01430299|11686496|FG000|STARTED|Overall Study||20
10534349|NCT01430299|11686497|FG001|STARTED|Overall Study||23
10534350|NCT01430299|11686496|FG000|COMPLETED|Overall Study||16
10534351|NCT01430299|11686497|FG001|COMPLETED|Overall Study||21
10534352|NCT01430299|11686496|FG000|NOT COMPLETED|Overall Study||4
10534353|NCT01430299|11686497|FG001|NOT COMPLETED|Overall Study||2
10534354|NCT01430325|11686507|FG000|STARTED|Overall Study||10
10534355|NCT01430325|11686508|FG001|STARTED|Overall Study||12
10534356|NCT01430325|11686509|FG002|STARTED|Overall Study||8
10534357|NCT01430325|11686510|FG003|STARTED|Overall Study||12
10534358|NCT01430325|11686507|FG000|COMPLETED|Overall Study||10
10534359|NCT01430325|11686508|FG001|COMPLETED|Overall Study||12
10534360|NCT01430325|11686509|FG002|COMPLETED|Overall Study||8
10534361|NCT01430325|11686510|FG003|COMPLETED|Overall Study||12
10534362|NCT01430325|11686507|FG000|NOT COMPLETED|Overall Study||0
10534363|NCT01430325|11686508|FG001|NOT COMPLETED|Overall Study||0
10534364|NCT01430325|11686509|FG002|NOT COMPLETED|Overall Study||0
10534365|NCT01430325|11686510|FG003|NOT COMPLETED|Overall Study||0
10534366|NCT01430403|11686523|FG000|STARTED|Overall Study|Intent-to-treat|259
10534367|NCT01430403|11686524|FG001|STARTED|Overall Study|Intent-to-treat|130
10534368|NCT01430403|11686525|FG002|STARTED|Overall Study|Intent-to-treat|89
10534369|NCT01430403|11686523|FG000|COMPLETED|Overall Study||242
10534370|NCT01430403|11686524|FG001|COMPLETED|Overall Study||121
10534371|NCT01430403|11686525|FG002|COMPLETED|Overall Study||81
10534372|NCT01430403|11686523|FG000|NOT COMPLETED|Overall Study||17
10534373|NCT01430403|11686524|FG001|NOT COMPLETED|Overall Study||9
10534374|NCT01430403|11686525|FG002|NOT COMPLETED|Overall Study||8
10534375|NCT01430442|11686546|FG000|STARTED|Overall Study||85
10534376|NCT01430442|11686547|FG001|STARTED|Overall Study||68
10534377|NCT01430442|11686548|FG002|STARTED|Overall Study||91
10534378|NCT01430442|11686549|FG003|STARTED|Overall Study||90
10534379|NCT01430442|11686550|FG004|STARTED|Overall Study||121
10534380|NCT01430442|11686551|FG005|STARTED|Overall Study||92
10534381|NCT01430442|11686552|FG006|STARTED|Overall Study||229
10656363|NCT02217436|11817334|FG001|NOT COMPLETED|Overall Study||2
10656364|NCT02217475|11817343|FG000|STARTED|Treatment Period 1 (Year 1)||72
10656365|NCT02217475|11817344|FG001|STARTED|Treatment Period 1 (Year 1)||72
10656366|NCT02217475|11817345|FG002|STARTED|Treatment Period 1 (Year 1)||145
10656367|NCT02217475|11817343|FG000|Safety Analysis Set|Treatment Period 1 (Year 1)||72
10656368|NCT02217475|11817344|FG001|Safety Analysis Set|Treatment Period 1 (Year 1)||72
10656369|NCT02217475|11817345|FG002|Safety Analysis Set|Treatment Period 1 (Year 1)||144
10656370|NCT02217475|11817343|FG000|COMPLETED|Treatment Period 1 (Year 1)||62
10656371|NCT02217475|11817344|FG001|COMPLETED|Treatment Period 1 (Year 1)||64
10656372|NCT02217475|11817345|FG002|COMPLETED|Treatment Period 1 (Year 1)||124
10656373|NCT02217475|11817343|FG000|NOT COMPLETED|Treatment Period 1 (Year 1)||10
10656374|NCT02217475|11817344|FG001|NOT COMPLETED|Treatment Period 1 (Year 1)||8
10656375|NCT02217475|11817345|FG002|NOT COMPLETED|Treatment Period 1 (Year 1)||21
10656376|NCT02217475|11817343|FG000|STARTED|Discontinued After Period 1||62
10656377|NCT02217475|11817344|FG001|STARTED|Discontinued After Period 1||64
10656378|NCT02217475|11817345|FG002|STARTED|Discontinued After Period 1||124
10656379|NCT02217475|11817343|FG000|COMPLETED|Discontinued After Period 1||60
10656380|NCT02217475|11817344|FG001|COMPLETED|Discontinued After Period 1||61
10656381|NCT02217475|11817345|FG002|COMPLETED|Discontinued After Period 1||121
10656382|NCT02217475|11817343|FG000|NOT COMPLETED|Discontinued After Period 1||2
10656383|NCT02217475|11817344|FG001|NOT COMPLETED|Discontinued After Period 1||3
10656384|NCT02217475|11817345|FG002|NOT COMPLETED|Discontinued After Period 1||3
10656385|NCT02217475|11817343|FG000|STARTED|Treatment Period 2 (Year 2)||60
10656386|NCT02217475|11817344|FG001|STARTED|Treatment Period 2 (Year 2)||61
10656387|NCT02217475|11817345|FG002|STARTED|Treatment Period 2 (Year 2)||121
10656388|NCT02217475|11817343|FG000|COMPLETED|Treatment Period 2 (Year 2)||58
10656389|NCT02217475|11817344|FG001|COMPLETED|Treatment Period 2 (Year 2)||59
10656390|NCT02217475|11817345|FG002|COMPLETED|Treatment Period 2 (Year 2)||109
10656391|NCT02217475|11817343|FG000|NOT COMPLETED|Treatment Period 2 (Year 2)||2
10656392|NCT02217475|11817344|FG001|NOT COMPLETED|Treatment Period 2 (Year 2)||2
10656393|NCT02217475|11817345|FG002|NOT COMPLETED|Treatment Period 2 (Year 2)||12
10656394|NCT02217501|11817364|FG000|STARTED|Overall Study||77
10656395|NCT02217501|11817365|FG001|STARTED|Overall Study||82
10656396|NCT02217501|11817364|FG000|COMPLETED|Overall Study||74
10656397|NCT02217501|11817365|FG001|COMPLETED|Overall Study||78
10656398|NCT02217501|11817364|FG000|NOT COMPLETED|Overall Study||3
10656399|NCT02217501|11817365|FG001|NOT COMPLETED|Overall Study||4
10656400|NCT02217527|11817373|FG000|STARTED|Drug Condition 1: First Study Phase||18
10656401|NCT02217527|11817374|FG001|STARTED|Drug Condition 1: First Study Phase||18
10358405|NCT00483756|11498167|FG000|NOT COMPLETED|Overall Study||33
10358406|NCT00483756|11498168|FG001|NOT COMPLETED|Overall Study||50
10534382|NCT01430442|11686553|FG007|STARTED|Overall Study||109
10534383|NCT01430442|11686546|FG000|COMPLETED|Overall Study||72
10358407|NCT00483756|11498169|FG002|NOT COMPLETED|Overall Study||52
10358408|NCT00483938|11498184|FG000|STARTED|Overall Study||41
10358409|NCT00483938|11498185|FG001|STARTED|Overall Study||43
10358410|NCT00483938|11498186|FG002|STARTED|Overall Study||30
10358411|NCT00483938|11498187|FG003|STARTED|Overall Study||31
10358412|NCT00483938|11498188|FG004|STARTED|Overall Study||25
10358413|NCT00483938|11498189|FG005|STARTED|Overall Study||26
10716213|NCT02688387|11880044|FG001|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10358414|NCT00483938|11498190|FG006|STARTED|Overall Study||40
10358415|NCT00483938|11498184|FG000|COMPLETED|Overall Study||36
10358416|NCT00483938|11498185|FG001|COMPLETED|Overall Study||24
10358417|NCT00483938|11498186|FG002|COMPLETED|Overall Study||30
10358418|NCT00483938|11498187|FG003|COMPLETED|Overall Study||25
10358419|NCT00483938|11498188|FG004|COMPLETED|Overall Study||23
10358420|NCT00483938|11498189|FG005|COMPLETED|Overall Study||18
10358421|NCT00483938|11498190|FG006|COMPLETED|Overall Study||0
10358422|NCT00483938|11498184|FG000|NOT COMPLETED|Overall Study||5
10358423|NCT00483938|11498185|FG001|NOT COMPLETED|Overall Study||19
10358424|NCT00483938|11498186|FG002|NOT COMPLETED|Overall Study||0
10358425|NCT00483938|11498187|FG003|NOT COMPLETED|Overall Study||6
10358426|NCT00483938|11498188|FG004|NOT COMPLETED|Overall Study||2
10358427|NCT00483938|11498189|FG005|NOT COMPLETED|Overall Study||8
10358428|NCT00483938|11498190|FG006|NOT COMPLETED|Overall Study||40
10358429|NCT00484094|11498209|FG000|STARTED|Overall Study||209
10358430|NCT00484094|11498209|FG000|COMPLETED|Overall Study||167
10358431|NCT00484094|11498209|FG000|NOT COMPLETED|Overall Study||42
10358432|NCT00484159|11498216|FG000|STARTED|Overall Study||50
10358433|NCT00484159|11498217|FG001|STARTED|Overall Study||50
10358434|NCT00484159|11498218|FG002|STARTED|Overall Study||51
10358435|NCT00484159|11498216|FG000|COMPLETED|Overall Study||49
10358436|NCT00484159|11498217|FG001|COMPLETED|Overall Study||49
10358437|NCT00484159|11498218|FG002|COMPLETED|Overall Study||51
10358438|NCT00484159|11498216|FG000|NOT COMPLETED|Overall Study||1
10358439|NCT00484159|11498217|FG001|NOT COMPLETED|Overall Study||1
10358440|NCT00484159|11498218|FG002|NOT COMPLETED|Overall Study||0
10358441|NCT00484185|11498226|FG000|STARTED|Overall Study||183
10358442|NCT00484185|11498226|FG000|Treated|Overall Study||178
10358443|NCT00484185|11498226|FG000|COMPLETED|Overall Study||112
10358444|NCT00484185|11498226|FG000|NOT COMPLETED|Overall Study||71
10358445|NCT00484198|11498234|FG000|STARTED|Overall Study||137
10358446|NCT00484198|11498235|FG001|STARTED|Overall Study||274
10358447|NCT00484198|11498236|FG002|STARTED|Overall Study||750
10358448|NCT00484198|11498237|FG003|STARTED|Overall Study||751
10358449|NCT00484198|11498234|FG000|COMPLETED|Overall Study||96
10358450|NCT00484198|11498235|FG001|COMPLETED|Overall Study||208
10358451|NCT00484198|11498236|FG002|COMPLETED|Overall Study||599
10358452|NCT00484198|11498237|FG003|COMPLETED|Overall Study||579
10358453|NCT00484198|11498234|FG000|NOT COMPLETED|Overall Study||41
10358454|NCT00484198|11498235|FG001|NOT COMPLETED|Overall Study||66
10358455|NCT00484198|11498236|FG002|NOT COMPLETED|Overall Study||151
10358456|NCT00484198|11498237|FG003|NOT COMPLETED|Overall Study||172
10358457|NCT00484289|11498255|FG000|STARTED|Long Term Phase||13
10358458|NCT00484289|11498256|FG001|STARTED|Long Term Phase||178
10358459|NCT00484289|11498257|FG002|STARTED|Long Term Phase||26
10358460|NCT00484289|11498255|FG000|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|10
10358461|NCT00484289|11498256|FG001|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|142
10358462|NCT00484289|11498257|FG002|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|10
10358463|NCT00484289|11498255|FG000|NOT COMPLETED|Long Term Phase||3
10358464|NCT00484289|11498256|FG001|NOT COMPLETED|Long Term Phase||36
10358465|NCT00484289|11498257|FG002|NOT COMPLETED|Long Term Phase||16
10358466|NCT00484289|11498255|FG000|STARTED|Post Marketing Phase||10
10358467|NCT00484289|11498256|FG001|STARTED|Post Marketing Phase||142
10358468|NCT00484289|11498257|FG002|STARTED|Post Marketing Phase||10
10358469|NCT00484289|11498255|FG000|COMPLETED|Post Marketing Phase||10
10358470|NCT00484289|11498256|FG001|COMPLETED|Post Marketing Phase||141
10358471|NCT00484289|11498257|FG002|COMPLETED|Post Marketing Phase||10
10716214|NCT02688387|11880045|FG002|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10716215|NCT02688387|11880046|FG003|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10305954|NCT00096018|11438904|FG001|NOT COMPLETED|Overall Study||14
10315292|NCT00176865|11449114|FG002|COMPLETED|Overall Study||6
10315293|NCT00176865|11449112|FG000|NOT COMPLETED|Overall Study||0
10315294|NCT00176865|11449113|FG001|NOT COMPLETED|Overall Study||0
10315295|NCT00176865|11449114|FG002|NOT COMPLETED|Overall Study||0
10315296|NCT00176878|11449122|FG000|STARTED|Overall Study||10
10315297|NCT00176878|11449122|FG000|COMPLETED|Overall Study||10
10315298|NCT00176878|11449122|FG000|NOT COMPLETED|Overall Study||0
10315299|NCT00176891|11449126|FG000|STARTED|Overall Study||25
10315300|NCT00176891|11449126|FG000|COMPLETED|Overall Study||22
10315301|NCT00176891|11449126|FG000|NOT COMPLETED|Overall Study||3
10315302|NCT00176904|11449130|FG000|STARTED|Overall Study||135
10315303|NCT00176904|11449130|FG000|COMPLETED|Overall Study||135
10315304|NCT00176904|11449130|FG000|NOT COMPLETED|Overall Study||0
10358472|NCT00484289|11498255|FG000|NOT COMPLETED|Post Marketing Phase||0
10358473|NCT00484289|11498256|FG001|NOT COMPLETED|Post Marketing Phase||1
10358474|NCT00484289|11498257|FG002|NOT COMPLETED|Post Marketing Phase||0
10358475|NCT00484315|11498268|FG000|STARTED|12-Month Clinical Follow-up||942
10358476|NCT00484315|11498269|FG001|STARTED|12-Month Clinical Follow-up||320
10358477|NCT00484315|11498268|FG000|COMPLETED|12-Month Clinical Follow-up||914
10358478|NCT00484315|11498269|FG001|COMPLETED|12-Month Clinical Follow-up||311
10358479|NCT00484315|11498268|FG000|NOT COMPLETED|12-Month Clinical Follow-up||28
10358480|NCT00484315|11498269|FG001|NOT COMPLETED|12-Month Clinical Follow-up||9
10358481|NCT00484315|11498268|FG000|STARTED|9-Month Angiographic Follow-up||256
10358482|NCT00484315|11498269|FG001|STARTED|9-Month Angiographic Follow-up||74
10358483|NCT00484315|11498268|FG000|COMPLETED|9-Month Angiographic Follow-up||228
10358484|NCT00484315|11498269|FG001|COMPLETED|9-Month Angiographic Follow-up||61
10358485|NCT00484315|11498268|FG000|NOT COMPLETED|9-Month Angiographic Follow-up||28
10358486|NCT00484315|11498269|FG001|NOT COMPLETED|9-Month Angiographic Follow-up||13
10358487|NCT00484354|11498277|FG000|STARTED|Overall Study||64
10358488|NCT00484354|11498278|FG001|STARTED|Overall Study||59
10358489|NCT00484354|11498277|FG000|COMPLETED|Overall Study||63
10358490|NCT00484354|11498278|FG001|COMPLETED|Overall Study||57
10358491|NCT00484354|11498277|FG000|NOT COMPLETED|Overall Study||1
10358492|NCT00484354|11498278|FG001|NOT COMPLETED|Overall Study||2
10358493|NCT00484393|11498286|FG000|STARTED|Overall Study||4
10358494|NCT00484393|11498287|FG001|STARTED|Overall Study||3
10358495|NCT00484393|11498286|FG000|COMPLETED|Overall Study||4
10358496|NCT00484393|11498287|FG001|COMPLETED|Overall Study||3
10358497|NCT00484393|11498286|FG000|NOT COMPLETED|Overall Study||0
10358498|NCT00484393|11498287|FG001|NOT COMPLETED|Overall Study||0
10358499|NCT00484679|11498293|FG000|STARTED|Overall Study||18
10358500|NCT00484679|11498293|FG000|COMPLETED|Overall Study||15
10358501|NCT00484679|11498293|FG000|NOT COMPLETED|Overall Study||3
10358502|NCT00484874|11498297|FG000|STARTED|Overall Study||12
10358503|NCT00484874|11498297|FG000|COMPLETED|Overall Study||12
10358504|NCT00484874|11498297|FG000|NOT COMPLETED|Overall Study||0
10358505|NCT00484939|11498306|FG000|STARTED|Overall Study||140
10358506|NCT00484939|11498307|FG001|STARTED|Overall Study||140
10358507|NCT00484939|11498306|FG000|COMPLETED|Overall Study||0
10358508|NCT00484939|11498307|FG001|COMPLETED|Overall Study||0
10358509|NCT00484939|11498306|FG000|NOT COMPLETED|Overall Study||140
10358510|NCT00484939|11498307|FG001|NOT COMPLETED|Overall Study||140
10358511|NCT00485069|11498315|FG000|STARTED|Overall Study||65
10358512|NCT00485069|11498316|FG001|STARTED|Overall Study||58
10358513|NCT00485069|11498315|FG000|COMPLETED|Overall Study||47
10358514|NCT00485069|11498316|FG001|COMPLETED|Overall Study||46
10358515|NCT00485069|11498315|FG000|NOT COMPLETED|Overall Study||18
10358516|NCT00485069|11498316|FG001|NOT COMPLETED|Overall Study||12
10358517|NCT00485134|11498337|FG000|STARTED|Overall Study||12
10358518|NCT00485134|11498338|FG001|STARTED|Overall Study||12
10358519|NCT00485134|11498339|FG002|STARTED|Overall Study||12
10358520|NCT00485134|11498340|FG003|STARTED|Overall Study||8
10358521|NCT00485134|11498341|FG004|STARTED|Overall Study||10
10358522|NCT00485134|11498342|FG005|STARTED|Overall Study||7
10358523|NCT00485134|11498343|FG006|STARTED|Overall Study||31
10358524|NCT00485134|11498344|FG007|STARTED|Overall Study||21
10358525|NCT00485134|11498337|FG000|COMPLETED|Overall Study||11
10358526|NCT00485134|11498338|FG001|COMPLETED|Overall Study||10
10358527|NCT00485134|11498339|FG002|COMPLETED|Overall Study||9
10358528|NCT00485134|11498340|FG003|COMPLETED|Overall Study||7
10358529|NCT00485134|11498341|FG004|COMPLETED|Overall Study||7
10358530|NCT00485134|11498342|FG005|COMPLETED|Overall Study||3
10358531|NCT00485134|11498343|FG006|COMPLETED|Overall Study||28
10358532|NCT00485134|11498344|FG007|COMPLETED|Overall Study||20
10358533|NCT00485134|11498337|FG000|NOT COMPLETED|Overall Study||1
10358534|NCT00485134|11498338|FG001|NOT COMPLETED|Overall Study||2
10358535|NCT00485134|11498339|FG002|NOT COMPLETED|Overall Study||3
10358536|NCT00485134|11498340|FG003|NOT COMPLETED|Overall Study||1
10358537|NCT00485134|11498341|FG004|NOT COMPLETED|Overall Study||3
10358538|NCT00485134|11498342|FG005|NOT COMPLETED|Overall Study||4
10358539|NCT00485134|11498343|FG006|NOT COMPLETED|Overall Study||3
10358540|NCT00485134|11498344|FG007|NOT COMPLETED|Overall Study||1
10358541|NCT00485173|11498358|FG000|STARTED|Overall Study||224
10358542|NCT00485173|11498359|FG001|STARTED|Overall Study||486
10358543|NCT00485173|11498358|FG000|COMPLETED|Overall Study|The number of completed participants is reported the number of subjects who had any 24-month data.|188
10358544|NCT00485173|11498359|FG001|COMPLETED|Overall Study|The number of completed participants is reported the number of subjects who had any 24-month data.|422
10358545|NCT00485173|11498358|FG000|NOT COMPLETED|Overall Study||36
10358546|NCT00485173|11498359|FG001|NOT COMPLETED|Overall Study||64
10358547|NCT00485264|11498371|FG000|STARTED|Overall Study||71
10358548|NCT00485264|11498372|FG001|STARTED|Overall Study||16
10358549|NCT00485264|11498373|FG002|STARTED|Overall Study||18
10358550|NCT00485264|11498374|FG003|STARTED|Overall Study||21
10358551|NCT00485264|11498375|FG004|STARTED|Overall Study||15
10358552|NCT00485264|11498376|FG005|STARTED|Overall Study||12
10358553|NCT00485264|11498371|FG000|Completed Week 24|Overall Study||67
10358554|NCT00485264|11498372|FG001|Completed Week 24|Overall Study||16
10358555|NCT00485264|11498373|FG002|Completed Week 24|Overall Study||18
10358556|NCT00485264|11498374|FG003|Completed Week 24|Overall Study||21
10358557|NCT00485264|11498375|FG004|Completed Week 24|Overall Study||14
10358558|NCT00485264|11498376|FG005|Completed Week 24|Overall Study||11
10358559|NCT00485264|11498371|FG000|COMPLETED|Overall Study||35
10358560|NCT00485264|11498372|FG001|COMPLETED|Overall Study||9
10358561|NCT00485264|11498373|FG002|COMPLETED|Overall Study||12
10358562|NCT00485264|11498374|FG003|COMPLETED|Overall Study||17
10358563|NCT00485264|11498375|FG004|COMPLETED|Overall Study||9
10358564|NCT00485264|11498376|FG005|COMPLETED|Overall Study||5
10358565|NCT00485264|11498371|FG000|NOT COMPLETED|Overall Study||36
10358566|NCT00485264|11498372|FG001|NOT COMPLETED|Overall Study||7
10358567|NCT00485264|11498373|FG002|NOT COMPLETED|Overall Study||6
10358568|NCT00485264|11498374|FG003|NOT COMPLETED|Overall Study||4
10358569|NCT00485264|11498375|FG004|NOT COMPLETED|Overall Study||6
10358570|NCT00485264|11498376|FG005|NOT COMPLETED|Overall Study||7
10358571|NCT00485303|11498395|FG000|STARTED|Overall Study||58
10358572|NCT00485303|11498395|FG000|COMPLETED|Overall Study||2
10358573|NCT00485303|11498395|FG000|NOT COMPLETED|Overall Study||56
10358574|NCT00485433|11498403|FG000|STARTED|Overall Study||24
10358575|NCT00485433|11498404|FG001|STARTED|Overall Study||25
10358576|NCT00485433|11498405|FG002|STARTED|Overall Study||24
10358577|NCT00485433|11498406|FG003|STARTED|Overall Study||25
10358578|NCT00485433|11498403|FG000|COMPLETED|Overall Study||24
10358579|NCT00485433|11498404|FG001|COMPLETED|Overall Study||25
10358580|NCT00485433|11498405|FG002|COMPLETED|Overall Study||24
10358581|NCT00485433|11498406|FG003|COMPLETED|Overall Study||25
10358582|NCT00485433|11498403|FG000|NOT COMPLETED|Overall Study||0
10358583|NCT00485433|11498404|FG001|NOT COMPLETED|Overall Study||0
10358584|NCT00485433|11498405|FG002|NOT COMPLETED|Overall Study||0
10358585|NCT00485433|11498406|FG003|NOT COMPLETED|Overall Study||0
10358586|NCT00485472|11498416|FG000|STARTED|Overall Study||73
10358587|NCT00485472|11498417|FG001|STARTED|Overall Study||76
10358588|NCT00485472|11498416|FG000|Entered Maintenance Phase|Overall Study||65
10358589|NCT00485472|11498417|FG001|Entered Maintenance Phase|Overall Study||67
10358590|NCT00485472|11498416|FG000|COMPLETED|Overall Study||57
10358591|NCT00485472|11498417|FG001|COMPLETED|Overall Study||64
10358592|NCT00485472|11498416|FG000|NOT COMPLETED|Overall Study||16
10358593|NCT00485472|11498417|FG001|NOT COMPLETED|Overall Study||12
10358594|NCT00485485|11498423|FG000|STARTED|Overall Study||7
10358595|NCT00485485|11498423|FG000|COMPLETED|Overall Study||7
10358596|NCT00485485|11498423|FG000|NOT COMPLETED|Overall Study||0
10358597|NCT00485589|11498430|FG000|STARTED|Overall Study||210
10358598|NCT00485589|11498431|FG001|STARTED|Overall Study||200
10358599|NCT00485589|11498432|FG002|STARTED|Overall Study||203
10358600|NCT00485589|11498430|FG000|COMPLETED|Overall Study||183
10358601|NCT00485589|11498431|FG001|COMPLETED|Overall Study||180
10358602|NCT00485589|11498432|FG002|COMPLETED|Overall Study||185
10358603|NCT00485589|11498430|FG000|NOT COMPLETED|Overall Study||27
10358604|NCT00485589|11498431|FG001|NOT COMPLETED|Overall Study||20
10534384|NCT01430442|11686547|FG001|COMPLETED|Overall Study||62
10534385|NCT01430442|11686548|FG002|COMPLETED|Overall Study||86
10534386|NCT01430442|11686549|FG003|COMPLETED|Overall Study||86
10534387|NCT01430442|11686550|FG004|COMPLETED|Overall Study||112
10534388|NCT01430442|11686551|FG005|COMPLETED|Overall Study||84
10534389|NCT01430442|11686552|FG006|COMPLETED|Overall Study||210
10534390|NCT01430442|11686553|FG007|COMPLETED|Overall Study||100
10534391|NCT01430442|11686546|FG000|NOT COMPLETED|Overall Study||13
10534392|NCT01430442|11686547|FG001|NOT COMPLETED|Overall Study||6
10534393|NCT01430442|11686548|FG002|NOT COMPLETED|Overall Study||5
10534394|NCT01430442|11686549|FG003|NOT COMPLETED|Overall Study||4
10534395|NCT01430442|11686550|FG004|NOT COMPLETED|Overall Study||9
10534396|NCT01430442|11686551|FG005|NOT COMPLETED|Overall Study||8
10534397|NCT01430442|11686552|FG006|NOT COMPLETED|Overall Study||19
10534398|NCT01430442|11686553|FG007|NOT COMPLETED|Overall Study||9
10534399|NCT01430455|11686571|FG000|STARTED|Overall Study||7
10534400|NCT01430455|11686571|FG000|COMPLETED|Overall Study||5
10534401|NCT01430455|11686571|FG000|NOT COMPLETED|Overall Study||2
10534402|NCT01430468|11686577|FG000|STARTED|Overall Study||22
10534403|NCT01430468|11686578|FG001|STARTED|Overall Study||22
10534404|NCT01430468|11686577|FG000|COMPLETED|Overall Study||15
10534405|NCT01430468|11686578|FG001|COMPLETED|Overall Study||16
10534406|NCT01430468|11686577|FG000|NOT COMPLETED|Overall Study||7
10534407|NCT01430468|11686578|FG001|NOT COMPLETED|Overall Study||6
10716216|NCT02688387|11880047|FG004|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10716217|NCT02688387|11880048|FG005|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10534408|NCT01430559|11686586|FG000|STARTED|Overall Study||146
10534409|NCT01430559|11686587|FG001|STARTED|Overall Study||147
10534410|NCT01430559|11686586|FG000|Treated|Overall Study||143
10534411|NCT01430559|11686587|FG001|Treated|Overall Study||144
10534412|NCT01430559|11686586|FG000|COMPLETED|Overall Study||126
10534413|NCT01430559|11686587|FG001|COMPLETED|Overall Study||135
10716218|NCT02688387|11880049|FG006|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10534414|NCT01430559|11686586|FG000|NOT COMPLETED|Overall Study||20
10534415|NCT01430559|11686587|FG001|NOT COMPLETED|Overall Study||12
10534416|NCT01430585|11686598|FG000|STARTED|Overall Study||14
10534417|NCT01430585|11686598|FG000|COMPLETED|Overall Study||0
10534418|NCT01430585|11686598|FG000|NOT COMPLETED|Overall Study||14
10534419|NCT01430611|11686610|FG000|STARTED|Overall Study||332
10534420|NCT01430611|11686611|FG001|STARTED|Overall Study||333
10534421|NCT01430611|11686610|FG000|COMPLETED|Overall Study||315
10534422|NCT01430611|11686611|FG001|COMPLETED|Overall Study||318
10534423|NCT01430611|11686610|FG000|NOT COMPLETED|Overall Study||17
10534424|NCT01430611|11686611|FG001|NOT COMPLETED|Overall Study||15
10534425|NCT01430624|11686620|FG000|STARTED|Overall Study|Initial potential eligible screened enrolled|82
10534426|NCT01430624|11686621|FG001|STARTED|Overall Study||82
10534427|NCT01430624|11686622|FG002|STARTED|Overall Study||81
10358605|NCT00485589|11498432|FG002|NOT COMPLETED|Overall Study||18
10358606|NCT00485732|11498451|FG000|STARTED|Overall Study||149
10358607|NCT00485732|11498452|FG001|STARTED|Overall Study||76
10358608|NCT00485732|11498451|FG000|COMPLETED|Overall Study||141
10358609|NCT00485732|11498452|FG001|COMPLETED|Overall Study||67
10358610|NCT00485732|11498451|FG000|NOT COMPLETED|Overall Study||8
10358611|NCT00485732|11498452|FG001|NOT COMPLETED|Overall Study||9
10358612|NCT00485758|11498460|FG000|STARTED|Overall Study||454
10358613|NCT00485758|11498461|FG001|STARTED|Overall Study||342
10358614|NCT00485758|11498460|FG000|COMPLETED|Overall Study||298
10358615|NCT00485758|11498461|FG001|COMPLETED|Overall Study||277
10358616|NCT00485758|11498460|FG000|NOT COMPLETED|Overall Study||156
10358617|NCT00485758|11498461|FG001|NOT COMPLETED|Overall Study||65
10358618|NCT00485836|11498470|FG000|STARTED|Overall Study||130
10358619|NCT00485836|11498471|FG001|STARTED|Overall Study||132
10358620|NCT00485836|11498472|FG002|STARTED|Overall Study||130
10358621|NCT00485836|11498470|FG000|Received Study Drug (Safety Population)|Overall Study||129
10358622|NCT00485836|11498471|FG001|Received Study Drug (Safety Population)|Overall Study||132
10358623|NCT00485836|11498472|FG002|Received Study Drug (Safety Population)|Overall Study||129
10358624|NCT00485836|11498470|FG000|COMPLETED|Overall Study||115
10358625|NCT00485836|11498471|FG001|COMPLETED|Overall Study||129
10358626|NCT00485836|11498472|FG002|COMPLETED|Overall Study||119
10358627|NCT00485836|11498470|FG000|NOT COMPLETED|Overall Study||15
10358628|NCT00485836|11498471|FG001|NOT COMPLETED|Overall Study||3
10358629|NCT00485836|11498472|FG002|NOT COMPLETED|Overall Study||11
10358630|NCT00485953|11498482|FG000|STARTED|Overall Study||55
10358631|NCT00485953|11498483|FG001|STARTED|Overall Study||54
10358632|NCT00485953|11498482|FG000|COMPLETED|Overall Study||48
10358633|NCT00485953|11498483|FG001|COMPLETED|Overall Study||47
10358634|NCT00485953|11498482|FG000|NOT COMPLETED|Overall Study||7
10358635|NCT00485953|11498483|FG001|NOT COMPLETED|Overall Study||7
10358636|NCT00486018|11498494|FG000|STARTED|Overall Study||132
10358637|NCT00486018|11498495|FG001|STARTED|Overall Study||134
10358638|NCT00486018|11498496|FG002|STARTED|Overall Study||131
10358639|NCT00486018|11498494|FG000|Received Drug (Safety Population)|Overall Study||131
10358640|NCT00486018|11498495|FG001|Received Drug (Safety Population)|Overall Study||134
10358641|NCT00486018|11498496|FG002|Received Drug (Safety Population)|Overall Study||130
10358642|NCT00486018|11498494|FG000|COMPLETED|Overall Study||123
10358643|NCT00486018|11498495|FG001|COMPLETED|Overall Study||128
10358644|NCT00486018|11498496|FG002|COMPLETED|Overall Study||125
10358645|NCT00486018|11498494|FG000|NOT COMPLETED|Overall Study||9
10358646|NCT00486018|11498495|FG001|NOT COMPLETED|Overall Study||6
10358647|NCT00486018|11498496|FG002|NOT COMPLETED|Overall Study||6
10358648|NCT00486031|11498504|FG000|STARTED|Overall Study||443
10358649|NCT00486031|11498504|FG000|COMPLETED|Overall Study||440
10358650|NCT00486031|11498504|FG000|NOT COMPLETED|Overall Study||3
10358651|NCT00486044|11498511|FG000|STARTED|Overall Study|50 received assigned intervention (1 withdrew during baseline) 27 in MRI sub-study|51
10358652|NCT00486044|11498512|FG001|STARTED|Overall Study|23 in MRI sub-study|49
10358653|NCT00486044|11498511|FG000|COMPLETED|Overall Study|27 completed MRI sub-study|49
10358654|NCT00486044|11498512|FG001|COMPLETED|Overall Study|21 completed MRI sub-study|46
10358655|NCT00486044|11498511|FG000|NOT COMPLETED|Overall Study||2
10358656|NCT00486044|11498512|FG001|NOT COMPLETED|Overall Study||3
10358657|NCT00486226|11498518|FG000|STARTED|Overall Study||105
10358658|NCT00486226|11498518|FG000|COMPLETED|Overall Study||92
10358659|NCT00486226|11498518|FG000|NOT COMPLETED|Overall Study||13
10358660|NCT00486252|11498525|FG000|STARTED|Overall Study||996
10358661|NCT00486252|11498525|FG000|COMPLETED|Overall Study||938
10534428|NCT01430624|11686620|FG000|Eligible Baseline Completes|Overall Study||77
10534429|NCT01430624|11686621|FG001|Eligible Baseline Completes|Overall Study||77
10534430|NCT01430624|11686622|FG002|Eligible Baseline Completes|Overall Study||79
10534431|NCT01430624|11686620|FG000|COMPLETED|Overall Study|Completed one or more follow-ups|54
10534432|NCT01430624|11686621|FG001|COMPLETED|Overall Study|Completed one or more follow-ups|48
10358662|NCT00486252|11498525|FG000|NOT COMPLETED|Overall Study||58
10358663|NCT00486265|11498531|FG000|STARTED|Overall Study|Partipants dosed on day 1.|9
10358664|NCT00486265|11498531|FG000|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until a discontinuation criterion is met|0
10358665|NCT00486265|11498531|FG000|NOT COMPLETED|Overall Study||9
10358666|NCT00486278|11498535|FG000|STARTED|Overall Study|96 bleeds by 51 subjects, 77 were treated with vatreptacog alfa and 19 with rFVIIa|51
10534433|NCT01430624|11686622|FG002|COMPLETED|Overall Study|Completed one or more follow-ups|52
10534434|NCT01430624|11686620|FG000|NOT COMPLETED|Overall Study||28
10534435|NCT01430624|11686621|FG001|NOT COMPLETED|Overall Study||34
10534436|NCT01430624|11686622|FG002|NOT COMPLETED|Overall Study||29
10358667|NCT00486278|11498535|FG000|COMPLETED|Overall Study||42
10358668|NCT00486278|11498535|FG000|NOT COMPLETED|Overall Study||9
10358669|NCT00486291|11498551|FG000|STARTED|Overall Study|3 subjects discontinued prior to first dose|105
10358670|NCT00486291|11498552|FG001|STARTED|Overall Study|1 subject discontinued prior to first dose|105
10358671|NCT00486291|11498551|FG000|COMPLETED|Overall Study||89
10358672|NCT00486291|11498552|FG001|COMPLETED|Overall Study||76
10358673|NCT00486291|11498551|FG000|NOT COMPLETED|Overall Study||16
10358674|NCT00486291|11498552|FG001|NOT COMPLETED|Overall Study||29
10358675|NCT00486330|11498558|FG000|STARTED|Overall Study|Twelve subjects met inclusion/exclusion criteria|12
10358676|NCT00486330|11498558|FG000|COMPLETED|Overall Study|Of the 12 subjects treated, two developed adverse events leading to study drug discontinuation.|10
10358677|NCT00486330|11498558|FG000|NOT COMPLETED|Overall Study||2
10358678|NCT00486434|11498564|FG000|STARTED|Overall Study||588
10358679|NCT00486434|11498565|FG001|STARTED|Overall Study||588
10358680|NCT00486434|11498564|FG000|COMPLETED|Overall Study||394
10358681|NCT00486434|11498565|FG001|COMPLETED|Overall Study||454
10358682|NCT00486434|11498564|FG000|NOT COMPLETED|Overall Study||194
10358683|NCT00486434|11498565|FG001|NOT COMPLETED|Overall Study||134
10358684|NCT00486447|11498572|FG000|STARTED|Overall Study||249
10358685|NCT00486447|11498572|FG000|COMPLETED|Overall Study||249
10358686|NCT00486447|11498572|FG000|NOT COMPLETED|Overall Study||0
10358687|NCT00486525|11498579|FG000|STARTED|Overall Study||100
10358688|NCT00486525|11498580|FG001|STARTED|Overall Study||100
10358689|NCT00486525|11498579|FG000|COMPLETED|Overall Study||94
10358690|NCT00486525|11498580|FG001|COMPLETED|Overall Study||87
10358691|NCT00486525|11498579|FG000|NOT COMPLETED|Overall Study||6
10358692|NCT00486525|11498580|FG001|NOT COMPLETED|Overall Study||13
10358693|NCT00486603|11498588|FG000|STARTED|Overall Study||3
10358694|NCT00486603|11498589|FG001|STARTED|Overall Study||7
10358695|NCT00486603|11498590|FG002|STARTED|Overall Study||3
10358696|NCT00486603|11498591|FG003|STARTED|Overall Study||3
10358697|NCT00486603|11498592|FG004|STARTED|Overall Study||76
10358698|NCT00486603|11498588|FG000|COMPLETED|Overall Study||2
10358699|NCT00486603|11498589|FG001|COMPLETED|Overall Study||6
10358700|NCT00486603|11498590|FG002|COMPLETED|Overall Study||3
10358701|NCT00486603|11498591|FG003|COMPLETED|Overall Study||3
10358702|NCT00486603|11498592|FG004|COMPLETED|Overall Study||76
10358703|NCT00486603|11498588|FG000|NOT COMPLETED|Overall Study||1
10358704|NCT00486603|11498589|FG001|NOT COMPLETED|Overall Study||1
10358705|NCT00486603|11498590|FG002|NOT COMPLETED|Overall Study||0
10358706|NCT00486603|11498591|FG003|NOT COMPLETED|Overall Study||0
10358707|NCT00486603|11498592|FG004|NOT COMPLETED|Overall Study||0
10358708|NCT00486642|11498609|FG000|STARTED|Overall Study||10
10358709|NCT00486642|11498610|FG001|STARTED|Overall Study||13
10358710|NCT00486642|11498609|FG000|COMPLETED|Overall Study||10
10358711|NCT00486642|11498610|FG001|COMPLETED|Overall Study||13
10358712|NCT00486642|11498609|FG000|NOT COMPLETED|Overall Study||0
10358713|NCT00486642|11498610|FG001|NOT COMPLETED|Overall Study||0
10358714|NCT00486720|11498620|FG000|STARTED|Overall Study|1 randomized patient was discontinued before receiving treatment due to a protocol violation|10
10358715|NCT00486720|11498621|FG001|STARTED|Overall Study||12
10358716|NCT00486720|11498620|FG000|COMPLETED|Overall Study||0
10358717|NCT00486720|11498621|FG001|COMPLETED|Overall Study||0
10358718|NCT00486720|11498620|FG000|NOT COMPLETED|Overall Study||10
10358719|NCT00486720|11498621|FG001|NOT COMPLETED|Overall Study||12
10358720|NCT00486759|11498629|FG000|STARTED|Treatment||390
10358721|NCT00486759|11498630|FG001|STARTED|Treatment||397
10358722|NCT00486759|11498629|FG000|COMPLETED|Treatment||203
10358723|NCT00486759|11498630|FG001|COMPLETED|Treatment||260
10358724|NCT00486759|11498629|FG000|NOT COMPLETED|Treatment||187
10358725|NCT00486759|11498630|FG001|NOT COMPLETED|Treatment||137
10358726|NCT00486759|11498629|FG000|STARTED|Safety Follow-up||203
10358727|NCT00486759|11498630|FG001|STARTED|Safety Follow-up||260
10358728|NCT00486759|11498629|FG000|COMPLETED|Safety Follow-up||64
10358729|NCT00486759|11498630|FG001|COMPLETED|Safety Follow-up||142
10358730|NCT00486759|11498629|FG000|NOT COMPLETED|Safety Follow-up||139
10358731|NCT00486759|11498630|FG001|NOT COMPLETED|Safety Follow-up||118
10358732|NCT00486811|11498639|FG000|STARTED|Overall Study||337
10358733|NCT00486811|11498640|FG001|STARTED|Overall Study|One participant was not eligible to be dosed.|320
10358734|NCT00486811|11498641|FG002|STARTED|Overall Study|Two participants were not eligible to be dosed.|333
10358735|NCT00486811|11498639|FG000|COMPLETED|Overall Study||215
10358736|NCT00486811|11498640|FG001|COMPLETED|Overall Study||179
10358737|NCT00486811|11498641|FG002|COMPLETED|Overall Study||119
10358738|NCT00486811|11498639|FG000|NOT COMPLETED|Overall Study||122
10358739|NCT00486811|11498640|FG001|NOT COMPLETED|Overall Study||141
10358740|NCT00486811|11498641|FG002|NOT COMPLETED|Overall Study||214
10358741|NCT00486824|11498651|FG000|STARTED|Overall Study||5
10358742|NCT00486824|11498652|FG001|STARTED|Overall Study||5
10358743|NCT00486824|11498651|FG000|COMPLETED|Overall Study||3
10358744|NCT00486824|11498652|FG001|COMPLETED|Overall Study||3
10358745|NCT00486824|11498651|FG000|NOT COMPLETED|Overall Study||2
10358746|NCT00486824|11498652|FG001|NOT COMPLETED|Overall Study||2
10427032|NCT00850759|11572812|FG000|STARTED|Overall Study||59
10427033|NCT00850759|11572813|FG001|STARTED|Overall Study||57
10427034|NCT00850759|11572814|FG002|STARTED|Overall Study||57
10427035|NCT00850759|11572815|FG003|STARTED|Overall Study||58
10358747|NCT00486837|11498660|FG000|STARTED|Overall Study||37
10358748|NCT00486837|11498661|FG001|STARTED|Overall Study||35
10358749|NCT00486837|11498660|FG000|COMPLETED|Overall Study||28
10358750|NCT00486837|11498661|FG001|COMPLETED|Overall Study||28
10358751|NCT00486837|11498660|FG000|NOT COMPLETED|Overall Study||9
10358752|NCT00486837|11498661|FG001|NOT COMPLETED|Overall Study||7
10358753|NCT00486863|11498671|FG000|STARTED|Overall Study||184
10358754|NCT00486863|11498672|FG001|STARTED|Overall Study||186
10358755|NCT00486863|11498671|FG000|COMPLETED|Overall Study||183
10358756|NCT00486863|11498672|FG001|COMPLETED|Overall Study||183
10358757|NCT00486863|11498671|FG000|NOT COMPLETED|Overall Study||1
10358758|NCT00486863|11498672|FG001|NOT COMPLETED|Overall Study||3
10358759|NCT00486902|11498681|FG000|STARTED|Overall Study||94
10358760|NCT00486902|11498682|FG001|STARTED|Overall Study||94
10358761|NCT00486902|11498681|FG000|COMPLETED|Overall Study||85
10358762|NCT00486902|11498682|FG001|COMPLETED|Overall Study||89
10358763|NCT00486902|11498681|FG000|NOT COMPLETED|Overall Study||9
10358764|NCT00486902|11498682|FG001|NOT COMPLETED|Overall Study||5
10358765|NCT00486954|11498692|FG000|STARTED|Pilot Part||6
10358766|NCT00486954|11498693|FG001|STARTED|Pilot Part||0
10358767|NCT00486954|11498694|FG002|STARTED|Pilot Part||6
10358768|NCT00486954|11498695|FG003|STARTED|Pilot Part||0
10358769|NCT00486954|11498696|FG004|STARTED|Pilot Part||0
10358770|NCT00486954|11498692|FG000|COMPLETED|Pilot Part||0
10358771|NCT00486954|11498693|FG001|COMPLETED|Pilot Part||0
10358772|NCT00486954|11498694|FG002|COMPLETED|Pilot Part||0
10358773|NCT00486954|11498695|FG003|COMPLETED|Pilot Part||0
10358774|NCT00486954|11498696|FG004|COMPLETED|Pilot Part||0
10358775|NCT00486954|11498692|FG000|NOT COMPLETED|Pilot Part||6
10358776|NCT00486954|11498693|FG001|NOT COMPLETED|Pilot Part||0
10358777|NCT00486954|11498694|FG002|NOT COMPLETED|Pilot Part||6
10358778|NCT00486954|11498695|FG003|NOT COMPLETED|Pilot Part||0
10358779|NCT00486954|11498696|FG004|NOT COMPLETED|Pilot Part||0
10358780|NCT00486954|11498692|FG000|STARTED|Randomized Part||0
10358781|NCT00486954|11498693|FG001|STARTED|Randomized Part||0
10358782|NCT00486954|11498694|FG002|STARTED|Randomized Part||0
10358783|NCT00486954|11498695|FG003|STARTED|Randomized Part||132
10358784|NCT00486954|11498696|FG004|STARTED|Randomized Part||129
10358785|NCT00486954|11498692|FG000|COMPLETED|Randomized Part||0
10358786|NCT00486954|11498693|FG001|COMPLETED|Randomized Part||0
10358787|NCT00486954|11498694|FG002|COMPLETED|Randomized Part||0
10358788|NCT00486954|11498695|FG003|COMPLETED|Randomized Part||112
10358789|NCT00486954|11498696|FG004|COMPLETED|Randomized Part||115
10358790|NCT00486954|11498692|FG000|NOT COMPLETED|Randomized Part||0
10358791|NCT00486954|11498693|FG001|NOT COMPLETED|Randomized Part||0
10358792|NCT00486954|11498694|FG002|NOT COMPLETED|Randomized Part||0
10358793|NCT00486954|11498695|FG003|NOT COMPLETED|Randomized Part||20
10358794|NCT00486954|11498696|FG004|NOT COMPLETED|Randomized Part||14
10358795|NCT00487084|11498709|FG000|STARTED|Overall Study||33
10358796|NCT00487084|11498710|FG001|STARTED|Overall Study||33
10358797|NCT00487084|11498711|FG002|STARTED|Overall Study||33
10358798|NCT00487084|11498709|FG000|COMPLETED|Overall Study||29
10358799|NCT00487084|11498710|FG001|COMPLETED|Overall Study||30
10358800|NCT00487084|11498711|FG002|COMPLETED|Overall Study||28
10358801|NCT00487084|11498709|FG000|NOT COMPLETED|Overall Study||4
10358802|NCT00487084|11498710|FG001|NOT COMPLETED|Overall Study||3
10358803|NCT00487084|11498711|FG002|NOT COMPLETED|Overall Study||5
10358804|NCT00487188|11498721|FG000|STARTED|Induction Phase||31
10358805|NCT00487188|11498722|FG001|STARTED|Induction Phase||16
10358806|NCT00487188|11498723|FG002|STARTED|Induction Phase|Participants were only randomized to this treatment arm in the Maintenance Phase|0
10358807|NCT00487188|11498721|FG000|Safety Population|Induction Phase||29
10358808|NCT00487188|11498722|FG001|Safety Population|Induction Phase|2 patients randomized to ENF + HARRT only received treatment with HAART|18
10358809|NCT00487188|11498723|FG002|Safety Population|Induction Phase||0
10358810|NCT00487188|11498721|FG000|COMPLETED|Induction Phase||22
10358811|NCT00487188|11498722|FG001|COMPLETED|Induction Phase||9
10358812|NCT00487188|11498723|FG002|COMPLETED|Induction Phase||0
10358813|NCT00487188|11498721|FG000|NOT COMPLETED|Induction Phase||9
10358814|NCT00487188|11498722|FG001|NOT COMPLETED|Induction Phase||7
10358815|NCT00487188|11498723|FG002|NOT COMPLETED|Induction Phase||0
10358816|NCT00487188|11498721|FG000|STARTED|Maintenance Phase||10
10358817|NCT00487188|11498722|FG001|STARTED|Maintenance Phase||8
10358818|NCT00487188|11498723|FG002|STARTED|Maintenance Phase||9
10358819|NCT00487188|11498721|FG000|COMPLETED|Maintenance Phase||7
10358820|NCT00487188|11498722|FG001|COMPLETED|Maintenance Phase||8
10358821|NCT00487188|11498723|FG002|COMPLETED|Maintenance Phase||8
10358822|NCT00487188|11498721|FG000|NOT COMPLETED|Maintenance Phase||3
10358823|NCT00487188|11498722|FG001|NOT COMPLETED|Maintenance Phase||0
10358824|NCT00487188|11498723|FG002|NOT COMPLETED|Maintenance Phase||1
10358825|NCT00487240|11498741|FG000|STARTED|Overall Study||195
10358826|NCT00487240|11498742|FG001|STARTED|Overall Study||192
10358827|NCT00487240|11498741|FG000|Full Analysis Set (ITT Population)|Overall Study||192
10358828|NCT00487240|11498742|FG001|Full Analysis Set (ITT Population)|Overall Study||189
10358829|NCT00487240|11498741|FG000|COMPLETED|Overall Study||164
10358830|NCT00487240|11498742|FG001|COMPLETED|Overall Study||166
10358831|NCT00487240|11498741|FG000|NOT COMPLETED|Overall Study||31
10358832|NCT00487240|11498742|FG001|NOT COMPLETED|Overall Study||26
10358833|NCT00487279|11498750|FG000|STARTED|Overall Study||44
10358834|NCT00487279|11498751|FG001|STARTED|Overall Study||37
10358835|NCT00487279|11498750|FG000|COMPLETED|Overall Study||43
10358836|NCT00487279|11498751|FG001|COMPLETED|Overall Study||35
10358837|NCT00487279|11498750|FG000|NOT COMPLETED|Overall Study||1
10358838|NCT00487279|11498751|FG001|NOT COMPLETED|Overall Study||2
10358839|NCT00487396|11498757|FG000|STARTED|Overall Study||98
10534437|NCT01430741|11686638|FG000|STARTED|Overall Study||22
10534438|NCT01430741|11686639|FG001|STARTED|Overall Study||87
10534439|NCT01430741|11686640|FG002|STARTED|Overall Study||47
10534440|NCT01430741|11686641|FG003|STARTED|Overall Study||81
10534441|NCT01430741|11686638|FG000|COMPLETED|Overall Study||22
10534442|NCT01430741|11686639|FG001|COMPLETED|Overall Study||87
10534443|NCT01430741|11686640|FG002|COMPLETED|Overall Study||37
10534444|NCT01430741|11686641|FG003|COMPLETED|Overall Study||81
10534445|NCT01430741|11686638|FG000|NOT COMPLETED|Overall Study||0
10534446|NCT01430741|11686639|FG001|NOT COMPLETED|Overall Study||0
10534447|NCT01430741|11686640|FG002|NOT COMPLETED|Overall Study||10
10534448|NCT01430741|11686641|FG003|NOT COMPLETED|Overall Study||0
10534449|NCT01430754|11686654|FG000|STARTED|Run-In Phase||57
10534450|NCT01430754|11686655|FG001|STARTED|Run-In Phase|During the run-in phase, participants were treated with tasimelteon only.|0
10534451|NCT01430754|11686654|FG000|Entrained - After Run-In Phase|Run-In Phase||24
10534452|NCT01430754|11686655|FG001|Entrained - After Run-In Phase|Run-In Phase||0
10534453|NCT01430754|11686654|FG000|COMPLETED|Run-In Phase|Defined as the number of patients who entered the randomized-withdrawal phase|20
10534454|NCT01430754|11686655|FG001|COMPLETED|Run-In Phase||0
10534455|NCT01430754|11686654|FG000|NOT COMPLETED|Run-In Phase||37
10534456|NCT01430754|11686655|FG001|NOT COMPLETED|Run-In Phase||0
10534457|NCT01430754|11686654|FG000|STARTED|Randomized Phase||10
10534458|NCT01430754|11686655|FG001|STARTED|Randomized Phase||10
10534459|NCT01430754|11686654|FG000|COMPLETED|Randomized Phase||10
10534460|NCT01430754|11686655|FG001|COMPLETED|Randomized Phase||10
10534461|NCT01430754|11686654|FG000|NOT COMPLETED|Randomized Phase||0
10534462|NCT01430754|11686655|FG001|NOT COMPLETED|Randomized Phase||0
10534463|NCT01430819|11686665|FG000|STARTED|Overall Study||150
10534464|NCT01430819|11686666|FG001|STARTED|Overall Study||150
10534465|NCT01430819|11686665|FG000|COMPLETED|Overall Study||150
10534466|NCT01430819|11686666|FG001|COMPLETED|Overall Study||150
10534467|NCT01430819|11686665|FG000|NOT COMPLETED|Overall Study||0
10534468|NCT01430819|11686666|FG001|NOT COMPLETED|Overall Study||0
10534469|NCT01431014|11686674|FG000|STARTED|Overall Study||34
10534470|NCT01431014|11686675|FG001|STARTED|Overall Study||34
10534471|NCT01431014|11686674|FG000|COMPLETED|Overall Study||31
10534472|NCT01431014|11686675|FG001|COMPLETED|Overall Study||25
10534473|NCT01431014|11686674|FG000|NOT COMPLETED|Overall Study||3
10534474|NCT01431014|11686675|FG001|NOT COMPLETED|Overall Study||9
10534475|NCT01431079|11686683|FG000|STARTED|Overall Study||45
10534476|NCT01431079|11686684|FG001|STARTED|Overall Study||45
10534477|NCT01431079|11686683|FG000|Post-test|Overall Study||45
10534478|NCT01431079|11686684|FG001|Post-test|Overall Study||45
10534479|NCT01431079|11686683|FG000|COMPLETED|Overall Study||10
10534480|NCT01431079|11686684|FG001|COMPLETED|Overall Study||6
10534481|NCT01431079|11686683|FG000|NOT COMPLETED|Overall Study||35
10534482|NCT01431079|11686684|FG001|NOT COMPLETED|Overall Study||39
10534483|NCT01431105|11686714|FG000|STARTED|Overall Study||34
10534484|NCT01431105|11686714|FG000|COMPLETED|Overall Study||34
10534485|NCT01431105|11686714|FG000|NOT COMPLETED|Overall Study||0
10534486|NCT01431131|11686720|FG000|STARTED|Overall Study||12
10534487|NCT01431131|11686721|FG001|STARTED|Overall Study||12
10534488|NCT01431131|11686720|FG000|COMPLETED|Overall Study||12
10534489|NCT01431131|11686721|FG001|COMPLETED|Overall Study||12
10534490|NCT01431131|11686720|FG000|NOT COMPLETED|Overall Study||0
10534491|NCT01431131|11686721|FG001|NOT COMPLETED|Overall Study||0
10534492|NCT01431144|11686729|FG000|STARTED|Overall Study||13
10534493|NCT01431144|11686730|FG001|STARTED|Overall Study||14
10534494|NCT01431144|11686729|FG000|COMPLETED|Overall Study||11
10534495|NCT01431144|11686730|FG001|COMPLETED|Overall Study||14
10534496|NCT01431144|11686729|FG000|NOT COMPLETED|Overall Study||2
10534497|NCT01431144|11686730|FG001|NOT COMPLETED|Overall Study||0
10534498|NCT01431170|11686738|FG000|STARTED|Overall Study||12
10534499|NCT01431170|11686739|FG001|STARTED|Overall Study||12
10534500|NCT01431170|11686738|FG000|COMPLETED|Overall Study||9
10534501|NCT01431170|11686739|FG001|COMPLETED|Overall Study||11
10534502|NCT01431170|11686738|FG000|NOT COMPLETED|Overall Study||3
10534503|NCT01431170|11686739|FG001|NOT COMPLETED|Overall Study||1
10534504|NCT01431209|11686757|FG000|STARTED|Overall Study||47
10534505|NCT01431209|11686758|FG001|STARTED|Overall Study||13
10534506|NCT01431209|11686757|FG000|COMPLETED|Overall Study||43
10534507|NCT01431209|11686758|FG001|COMPLETED|Overall Study||12
10656402|NCT02217527|11817373|FG000|COMPLETED|Drug Condition 1: First Study Phase||17
10656403|NCT02217527|11817374|FG001|COMPLETED|Drug Condition 1: First Study Phase||15
10656404|NCT02217527|11817373|FG000|NOT COMPLETED|Drug Condition 1: First Study Phase||1
10656405|NCT02217527|11817374|FG001|NOT COMPLETED|Drug Condition 1: First Study Phase||3
10656406|NCT02217527|11817373|FG000|STARTED|Drug Condition 2: Second Study Phase||17
10656407|NCT02217527|11817374|FG001|STARTED|Drug Condition 2: Second Study Phase||15
10534508|NCT01431209|11686757|FG000|NOT COMPLETED|Overall Study||4
10534509|NCT01431209|11686758|FG001|NOT COMPLETED|Overall Study||1
10534510|NCT01431274|11686769|FG000|STARTED|Overall Study||528
10534511|NCT01431274|11686770|FG001|STARTED|Overall Study||525
10534512|NCT01431274|11686771|FG002|STARTED|Overall Study||527
10534513|NCT01431274|11686772|FG003|STARTED|Overall Study||522
10534514|NCT01431274|11686773|FG004|STARTED|Overall Study||522
10534515|NCT01431274|11686769|FG000|COMPLETED|Overall Study||431
10534516|NCT01431274|11686770|FG001|COMPLETED|Overall Study||448
10534517|NCT01431274|11686771|FG002|COMPLETED|Overall Study||455
10534518|NCT01431274|11686772|FG003|COMPLETED|Overall Study||462
10358840|NCT00487396|11498757|FG000|COMPLETED|Overall Study||95
10358841|NCT00487396|11498757|FG000|NOT COMPLETED|Overall Study||3
10358842|NCT00487435|11498766|FG000|STARTED|Overall Study|Patients who received at least one dose of Tapentadol (CG5503) Extended Release (ER)|1154
10358843|NCT00487435|11498766|FG000|COMPLETED|Overall Study||669
10358844|NCT00487435|11498766|FG000|NOT COMPLETED|Overall Study||485
10358845|NCT00487539|11498774|FG000|STARTED|Overall Study||331
10358846|NCT00487539|11498775|FG001|STARTED|Overall Study||72
10358847|NCT00487539|11498776|FG002|STARTED|Overall Study||331
10358848|NCT00487539|11498777|FG003|STARTED|Overall Study||331
10358849|NCT00487539|11498774|FG000|COMPLETED|Overall Study||324
10358850|NCT00487539|11498775|FG001|COMPLETED|Overall Study||69
10358851|NCT00487539|11498776|FG002|COMPLETED|Overall Study||328
10358852|NCT00487539|11498777|FG003|COMPLETED|Overall Study||327
10358853|NCT00487539|11498774|FG000|NOT COMPLETED|Overall Study||7
10358854|NCT00487539|11498775|FG001|NOT COMPLETED|Overall Study||3
10358855|NCT00487539|11498776|FG002|NOT COMPLETED|Overall Study||3
10358856|NCT00487539|11498777|FG003|NOT COMPLETED|Overall Study||4
10358857|NCT00487552|11498786|FG000|STARTED|Overall Study||18
10358858|NCT00487552|11498786|FG000|COMPLETED|Overall Study||12
10358859|NCT00487552|11498786|FG000|NOT COMPLETED|Overall Study||6
10358860|NCT00487565|11498791|FG000|STARTED|Overall Study||210
10358861|NCT00487565|11498791|FG000|COMPLETED|Overall Study||182
10358862|NCT00487565|11498791|FG000|NOT COMPLETED|Overall Study||28
10358863|NCT00487669|11498795|FG000|STARTED|Overall Study||12
10358864|NCT00487669|11498795|FG000|COMPLETED|Overall Study||12
10358865|NCT00487669|11498795|FG000|NOT COMPLETED|Overall Study||0
10812539|NCT03544242|11974622|FG000|COMPLETED|Overall Study||1
10358866|NCT00487695|11498801|FG000|STARTED|First Procedure||23
10534519|NCT01431274|11686773|FG004|COMPLETED|Overall Study||466
10534520|NCT01431274|11686769|FG000|NOT COMPLETED|Overall Study||97
10534521|NCT01431274|11686770|FG001|NOT COMPLETED|Overall Study||77
10534522|NCT01431274|11686771|FG002|NOT COMPLETED|Overall Study||72
10534523|NCT01431274|11686772|FG003|NOT COMPLETED|Overall Study||60
10534524|NCT01431274|11686773|FG004|NOT COMPLETED|Overall Study||56
10534525|NCT01431287|11686790|FG000|STARTED|Overall Study|started are actually the randomized|510
10534526|NCT01431287|11686791|FG001|STARTED|Overall Study||507
10534527|NCT01431287|11686792|FG002|STARTED|Overall Study||507
10534528|NCT01431287|11686793|FG003|STARTED|Overall Study||508
10534529|NCT01431287|11686794|FG004|STARTED|Overall Study||507
10534530|NCT01431287|11686790|FG000|COMPLETED|Overall Study||412
10534531|NCT01431287|11686791|FG001|COMPLETED|Overall Study||409
10534532|NCT01431287|11686792|FG002|COMPLETED|Overall Study||410
10534533|NCT01431287|11686793|FG003|COMPLETED|Overall Study||445
10534534|NCT01431287|11686794|FG004|COMPLETED|Overall Study||430
10534535|NCT01431287|11686790|FG000|NOT COMPLETED|Overall Study||98
10534536|NCT01431287|11686791|FG001|NOT COMPLETED|Overall Study||98
10534537|NCT01431287|11686792|FG002|NOT COMPLETED|Overall Study||97
10534538|NCT01431287|11686793|FG003|NOT COMPLETED|Overall Study||63
10534539|NCT01431287|11686794|FG004|NOT COMPLETED|Overall Study||77
10534540|NCT01431300|11686809|FG000|STARTED|Overall Study|One subject with indeterminate pregnancy test, subject declined to proceed|11
10534541|NCT01431300|11686810|FG001|STARTED|Overall Study||10
10534542|NCT01431300|11686811|FG002|STARTED|Overall Study||10
10534543|NCT01431300|11686809|FG000|COMPLETED|Overall Study||10
10534544|NCT01431300|11686810|FG001|COMPLETED|Overall Study||10
10534545|NCT01431300|11686811|FG002|COMPLETED|Overall Study||10
10534546|NCT01431300|11686809|FG000|NOT COMPLETED|Overall Study||1
10534547|NCT01431300|11686810|FG001|NOT COMPLETED|Overall Study||0
10534548|NCT01431300|11686811|FG002|NOT COMPLETED|Overall Study||0
10534549|NCT01431313|11686822|FG000|STARTED|Overall Study||20
10534550|NCT01431313|11686823|FG001|STARTED|Overall Study||20
10534551|NCT01431313|11686824|FG002|STARTED|Overall Study||8
10534552|NCT01431313|11686822|FG000|COMPLETED|Overall Study||20
10534553|NCT01431313|11686823|FG001|COMPLETED|Overall Study||20
10534554|NCT01431313|11686824|FG002|COMPLETED|Overall Study||8
10534555|NCT01431313|11686822|FG000|NOT COMPLETED|Overall Study||0
10534556|NCT01431313|11686823|FG001|NOT COMPLETED|Overall Study||0
10812540|NCT03544242|11974623|FG001|COMPLETED|Overall Study||1
10812541|NCT03544242|11974624|FG002|COMPLETED|Overall Study||2
10812542|NCT03544242|11974622|FG000|NOT COMPLETED|Overall Study||0
10812543|NCT03544242|11974623|FG001|NOT COMPLETED|Overall Study||0
10812544|NCT03544242|11974624|FG002|NOT COMPLETED|Overall Study||0
10812545|NCT03543358|11974632|FG000|STARTED|Overall Study||3
10358867|NCT00487695|11498802|FG001|STARTED|First Procedure||23
10358868|NCT00487695|11498801|FG000|COMPLETED|First Procedure||20
10358869|NCT00487695|11498802|FG001|COMPLETED|First Procedure||23
10358870|NCT00487695|11498801|FG000|NOT COMPLETED|First Procedure||3
10358871|NCT00487695|11498802|FG001|NOT COMPLETED|First Procedure||0
10358872|NCT00487695|11498801|FG000|STARTED|Second Procedure||20
10358873|NCT00487695|11498802|FG001|STARTED|Second Procedure||23
10358874|NCT00487695|11498801|FG000|COMPLETED|Second Procedure||19
10358875|NCT00487695|11498802|FG001|COMPLETED|Second Procedure||20
10358876|NCT00487695|11498801|FG000|NOT COMPLETED|Second Procedure||1
10358877|NCT00487695|11498802|FG001|NOT COMPLETED|Second Procedure||3
10358878|NCT00487721|11498810|FG000|STARTED|Overall Study||6
10358879|NCT00487721|11498811|FG001|STARTED|Overall Study||6
10358880|NCT00487721|11498810|FG000|COMPLETED|Overall Study||6
10358881|NCT00487721|11498811|FG001|COMPLETED|Overall Study||6
10358882|NCT00487721|11498810|FG000|NOT COMPLETED|Overall Study||0
10358883|NCT00487721|11498811|FG001|NOT COMPLETED|Overall Study||0
10358884|NCT00487747|11498816|FG000|STARTED|Overall Study||18
10358885|NCT00487747|11498816|FG000|COMPLETED|Overall Study||7
10358886|NCT00487747|11498816|FG000|NOT COMPLETED|Overall Study||11
10358887|NCT00487825|11498822|FG000|STARTED|Overall Study|"Started indicates Intent-to-treat population (ITT)"|52
10358888|NCT00487825|11498823|FG001|STARTED|Overall Study||26
10358889|NCT00487825|11498822|FG000|COMPLETED|Overall Study||46
10358890|NCT00487825|11498823|FG001|COMPLETED|Overall Study||21
10358891|NCT00487825|11498822|FG000|NOT COMPLETED|Overall Study||6
10358892|NCT00487825|11498823|FG001|NOT COMPLETED|Overall Study||5
10358893|NCT00487942|11498833|FG000|STARTED|Overall Study||15
10358894|NCT00487942|11498834|FG001|STARTED|Overall Study||15
10358895|NCT00487942|11498835|FG002|STARTED|Overall Study||15
10358896|NCT00487942|11498836|FG003|STARTED|Overall Study|One subject randomized to placebo discontinued prior to receiving any study drug, leaving 14.|15
10358897|NCT00487942|11498833|FG000|COMPLETED|Overall Study||12
10534557|NCT01431313|11686824|FG002|NOT COMPLETED|Overall Study||0
10534558|NCT01431339|11686835|FG000|STARTED|Overall Study||371
10534559|NCT01431339|11686836|FG001|STARTED|Overall Study||368
10534560|NCT01431339|11686835|FG000|Safety Population|Overall Study||368
10534561|NCT01431339|11686836|FG001|Safety Population|Overall Study||367
10534562|NCT01431339|11686835|FG000|COMPLETED|Overall Study||332
10534563|NCT01431339|11686836|FG001|COMPLETED|Overall Study||333
10534564|NCT01431339|11686835|FG000|NOT COMPLETED|Overall Study||39
10534565|NCT01431339|11686836|FG001|NOT COMPLETED|Overall Study||35
10534566|NCT01431391|11686844|FG000|STARTED|Overall Study||34
10534567|NCT01431391|11686845|FG001|STARTED|Overall Study||34
10534568|NCT01431391|11686844|FG000|Received ≥1 Leaukapheresis|Overall Study||34
10358898|NCT00487942|11498834|FG001|COMPLETED|Overall Study||12
10358899|NCT00487942|11498835|FG002|COMPLETED|Overall Study||12
10358900|NCT00487942|11498836|FG003|COMPLETED|Overall Study||13
10358901|NCT00487942|11498833|FG000|NOT COMPLETED|Overall Study||3
10358902|NCT00487942|11498834|FG001|NOT COMPLETED|Overall Study||3
10358903|NCT00487942|11498835|FG002|NOT COMPLETED|Overall Study||3
10534569|NCT01431391|11686845|FG001|Received ≥1 Leaukapheresis|Overall Study||34
10358904|NCT00487942|11498836|FG003|NOT COMPLETED|Overall Study||2
10358905|NCT00488033|11498848|FG000|STARTED|Overall Study||448
10358906|NCT00488033|11498849|FG001|STARTED|Overall Study||452
10358907|NCT00488033|11498848|FG000|COMPLETED|Overall Study||447
10358908|NCT00488033|11498849|FG001|COMPLETED|Overall Study||452
10534570|NCT01431391|11686844|FG000|COMPLETED|Overall Study||26
10534571|NCT01431391|11686845|FG001|COMPLETED|Overall Study||30
10534572|NCT01431391|11686844|FG000|NOT COMPLETED|Overall Study||8
10358909|NCT00488033|11498848|FG000|NOT COMPLETED|Overall Study||1
10358910|NCT00488033|11498849|FG001|NOT COMPLETED|Overall Study||0
10358911|NCT00488059|11498855|FG000|STARTED|Phase I: ENF 90mg SC BID||29
10358912|NCT00488059|11498856|FG001|STARTED|Phase I: ENF 90mg SC BID||0
10358913|NCT00488059|11498857|FG002|STARTED|Phase I: ENF 90mg SC BID||0
10358914|NCT00488059|11498855|FG000|COMPLETED|Phase I: ENF 90mg SC BID||14
10358915|NCT00488059|11498856|FG001|COMPLETED|Phase I: ENF 90mg SC BID||0
10358916|NCT00488059|11498857|FG002|COMPLETED|Phase I: ENF 90mg SC BID||0
10358917|NCT00488059|11498855|FG000|NOT COMPLETED|Phase I: ENF 90mg SC BID||15
10358918|NCT00488059|11498856|FG001|NOT COMPLETED|Phase I: ENF 90mg SC BID||0
10358919|NCT00488059|11498857|FG002|NOT COMPLETED|Phase I: ENF 90mg SC BID||0
10358920|NCT00488059|11498855|FG000|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||0
10358921|NCT00488059|11498856|FG001|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||9
10656408|NCT02217527|11817373|FG000|COMPLETED|Drug Condition 2: Second Study Phase||17
10656409|NCT02217527|11817374|FG001|COMPLETED|Drug Condition 2: Second Study Phase||14
10358922|NCT00488059|11498857|FG002|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||0
10358923|NCT00488059|11498855|FG000|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
10358924|NCT00488059|11498856|FG001|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||7
10358925|NCT00488059|11498857|FG002|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
10358926|NCT00488059|11498855|FG000|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
10358927|NCT00488059|11498856|FG001|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||2
10358928|NCT00488059|11498857|FG002|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
10358929|NCT00488059|11498855|FG000|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||0
10358930|NCT00488059|11498856|FG001|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||0
10358931|NCT00488059|11498857|FG002|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||5
10358932|NCT00488059|11498855|FG000|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
10358933|NCT00488059|11498856|FG001|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
10358934|NCT00488059|11498857|FG002|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||1
10358935|NCT00488059|11498855|FG000|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
10358936|NCT00488059|11498856|FG001|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
10358937|NCT00488059|11498857|FG002|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||4
10358938|NCT00488293|11498872|FG000|STARTED|Overall Study||196
10358939|NCT00488293|11498873|FG001|STARTED|Overall Study||196
10358940|NCT00488293|11498872|FG000|COMPLETED|Overall Study||160
10358941|NCT00488293|11498873|FG001|COMPLETED|Overall Study||166
10358942|NCT00488293|11498872|FG000|NOT COMPLETED|Overall Study||36
10358943|NCT00488293|11498873|FG001|NOT COMPLETED|Overall Study||30
10358944|NCT00488319|11498882|FG000|STARTED|Overall Study||39
10358945|NCT00488319|11498883|FG001|STARTED|Overall Study||118
10358946|NCT00488319|11498884|FG002|STARTED|Overall Study||243
10358947|NCT00488319|11498882|FG000|COMPLETED|Overall Study||24
10358948|NCT00488319|11498883|FG001|COMPLETED|Overall Study||75
10358949|NCT00488319|11498884|FG002|COMPLETED|Overall Study||121
10358950|NCT00488319|11498882|FG000|NOT COMPLETED|Overall Study||15
10358951|NCT00488319|11498883|FG001|NOT COMPLETED|Overall Study||43
10358952|NCT00488319|11498884|FG002|NOT COMPLETED|Overall Study||122
10358953|NCT00488345|11498896|FG000|STARTED|Overall Study||17
10358954|NCT00488345|11498897|FG001|STARTED|Overall Study||21
10358955|NCT00488345|11498898|FG002|STARTED|Overall Study||20
10358956|NCT00488345|11498896|FG000|COMPLETED|Overall Study||17
10358957|NCT00488345|11498897|FG001|COMPLETED|Overall Study||17
10358958|NCT00488345|11498898|FG002|COMPLETED|Overall Study||17
10358959|NCT00488345|11498896|FG000|NOT COMPLETED|Overall Study||0
10358960|NCT00488345|11498897|FG001|NOT COMPLETED|Overall Study||4
10358961|NCT00488345|11498898|FG002|NOT COMPLETED|Overall Study||3
10358962|NCT00488475|11498907|FG000|STARTED|Overall Study||4945
10358963|NCT00488475|11498907|FG000|COMPLETED|Overall Study||3191
10358964|NCT00488475|11498907|FG000|NOT COMPLETED|Overall Study||1754
10358965|NCT00488488|11498911|FG000|STARTED|Overall Study||1028
10358966|NCT00488488|11498911|FG000|Analyzed|Overall Study|3 participants were not analyzed due to retrospective documentation.|1025
10358967|NCT00488488|11498911|FG000|COMPLETED|Overall Study|Excludes 4 participants with missing information.|760
10358968|NCT00488488|11498911|FG000|NOT COMPLETED|Overall Study||268
10358969|NCT00488514|11498915|FG000|STARTED|Overall Study||656
10358970|NCT00488514|11498915|FG000|COMPLETED|Overall Study||363
10358971|NCT00488514|11498915|FG000|NOT COMPLETED|Overall Study||293
10358972|NCT00488592|11498936|FG000|STARTED|Overall Study|10 subjects were accrued|10
10358973|NCT00488592|11498936|FG000|COMPLETED|Overall Study|7 completed the initial series of 6 vaccinations|7
10358974|NCT00488592|11498936|FG000|NOT COMPLETED|Overall Study||3
10358975|NCT00488618|11498942|FG000|STARTED|Overall Study||120
10358976|NCT00488618|11498943|FG001|STARTED|Overall Study||118
10358977|NCT00488618|11498942|FG000|Safety Population: Received Study Drug|Overall Study||118
10358978|NCT00488618|11498943|FG001|Safety Population: Received Study Drug|Overall Study||118
10358979|NCT00488618|11498942|FG000|COMPLETED|Overall Study||73
10358980|NCT00488618|11498943|FG001|COMPLETED|Overall Study||75
10358981|NCT00488618|11498942|FG000|NOT COMPLETED|Overall Study||47
10358982|NCT00488618|11498943|FG001|NOT COMPLETED|Overall Study||43
10358983|NCT00488631|11498955|FG000|STARTED|Double Blind Period (Week 0-54)||156
10358984|NCT00488631|11498956|FG001|STARTED|Double Blind Period (Week 0-54)||154
10358985|NCT00488631|11498957|FG002|STARTED|Double Blind Period (Week 0-54)||154
10358986|NCT00488631|11498958|FG003|STARTED|Double Blind Period (Week 0-54)||129
10358987|NCT00488631|11498959|FG004|STARTED|Double Blind Period (Week 0-54)||230
10358988|NCT00488631|11498960|FG005|STARTED|Double Blind Period (Week 0-54)||405
10358989|NCT00488631|11498961|FG006|STARTED|Double Blind Period (Week 0-54)||0
10358990|NCT00488631|11498962|FG007|STARTED|Double Blind Period (Week 0-54)||0
10358991|NCT00488631|11498963|FG008|STARTED|Double Blind Period (Week 0-54)||0
10358992|NCT00488631|11498964|FG009|STARTED|Double Blind Period (Week 0-54)||0
10358993|NCT00488631|11498955|FG000|COMPLETED|Double Blind Period (Week 0-54)||113
10358994|NCT00488631|11498956|FG001|COMPLETED|Double Blind Period (Week 0-54)||111
10358995|NCT00488631|11498957|FG002|COMPLETED|Double Blind Period (Week 0-54)||109
10358996|NCT00488631|11498958|FG003|COMPLETED|Double Blind Period (Week 0-54)||88
10358997|NCT00488631|11498959|FG004|COMPLETED|Double Blind Period (Week 0-54)||127
10358998|NCT00488631|11498960|FG005|COMPLETED|Double Blind Period (Week 0-54)||189
10358999|NCT00488631|11498961|FG006|COMPLETED|Double Blind Period (Week 0-54)||0
10359000|NCT00488631|11498962|FG007|COMPLETED|Double Blind Period (Week 0-54)||0
10359001|NCT00488631|11498963|FG008|COMPLETED|Double Blind Period (Week 0-54)||0
10359002|NCT00488631|11498964|FG009|COMPLETED|Double Blind Period (Week 0-54)||0
10359003|NCT00488631|11498955|FG000|NOT COMPLETED|Double Blind Period (Week 0-54)||43
10359004|NCT00488631|11498956|FG001|NOT COMPLETED|Double Blind Period (Week 0-54)||43
10359005|NCT00488631|11498957|FG002|NOT COMPLETED|Double Blind Period (Week 0-54)||45
10359006|NCT00488631|11498958|FG003|NOT COMPLETED|Double Blind Period (Week 0-54)||41
10716219|NCT02688387|11880050|FG007|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10716220|NCT02688387|11880051|FG008|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10716221|NCT02688387|11880052|FG009|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10359007|NCT00488631|11498959|FG004|NOT COMPLETED|Double Blind Period (Week 0-54)||103
10359008|NCT00488631|11498960|FG005|NOT COMPLETED|Double Blind Period (Week 0-54)||216
10359009|NCT00488631|11498961|FG006|NOT COMPLETED|Double Blind Period (Week 0-54)||0
10359010|NCT00488631|11498962|FG007|NOT COMPLETED|Double Blind Period (Week 0-54)||0
10359011|NCT00488631|11498963|FG008|NOT COMPLETED|Double Blind Period (Week 0-54)||0
10359012|NCT00488631|11498964|FG009|NOT COMPLETED|Double Blind Period (Week 0-54)||0
10359013|NCT00488631|11498955|FG000|STARTED|Open Label Study Extension (Week 54-228)||0
10359014|NCT00488631|11498956|FG001|STARTED|Open Label Study Extension (Week 54-228)||0
10359015|NCT00488631|11498957|FG002|STARTED|Open Label Study Extension (Week 54-228)||0
10359016|NCT00488631|11498958|FG003|STARTED|Open Label Study Extension (Week 54-228)||0
10359017|NCT00488631|11498959|FG004|STARTED|Open Label Study Extension (Week 54-228)||0
10359018|NCT00488631|11498960|FG005|STARTED|Open Label Study Extension (Week 54-228)||0
10359019|NCT00488631|11498961|FG006|STARTED|Open Label Study Extension (Week 54-228)||96
10359020|NCT00488631|11498962|FG007|STARTED|Open Label Study Extension (Week 54-228)||93
10359021|NCT00488631|11498963|FG008|STARTED|Open Label Study Extension (Week 54-228)||470
10359022|NCT00488631|11498964|FG009|STARTED|Open Label Study Extension (Week 54-228)||7
10359023|NCT00488631|11498955|FG000|COMPLETED|Open Label Study Extension (Week 54-228)||0
10359024|NCT00488631|11498956|FG001|COMPLETED|Open Label Study Extension (Week 54-228)||0
10359025|NCT00488631|11498957|FG002|COMPLETED|Open Label Study Extension (Week 54-228)||0
10359026|NCT00488631|11498958|FG003|COMPLETED|Open Label Study Extension (Week 54-228)||0
10359027|NCT00488631|11498959|FG004|COMPLETED|Open Label Study Extension (Week 54-228)||0
10359028|NCT00488631|11498960|FG005|COMPLETED|Open Label Study Extension (Week 54-228)||0
10359029|NCT00488631|11498961|FG006|COMPLETED|Open Label Study Extension (Week 54-228)||16
10359030|NCT00488631|11498962|FG007|COMPLETED|Open Label Study Extension (Week 54-228)||66
10359031|NCT00488631|11498963|FG008|COMPLETED|Open Label Study Extension (Week 54-228)||288
10359032|NCT00488631|11498964|FG009|COMPLETED|Open Label Study Extension (Week 54-228)||4
10359033|NCT00488631|11498955|FG000|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
10359034|NCT00488631|11498956|FG001|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
10359035|NCT00488631|11498957|FG002|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
10359036|NCT00488631|11498958|FG003|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
10359037|NCT00488631|11498959|FG004|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
10359038|NCT00488631|11498960|FG005|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
10359039|NCT00488631|11498961|FG006|NOT COMPLETED|Open Label Study Extension (Week 54-228)||80
10359040|NCT00488631|11498962|FG007|NOT COMPLETED|Open Label Study Extension (Week 54-228)||27
10359041|NCT00488631|11498963|FG008|NOT COMPLETED|Open Label Study Extension (Week 54-228)||182
10359042|NCT00488631|11498964|FG009|NOT COMPLETED|Open Label Study Extension (Week 54-228)||3
10359043|NCT00488644|11498987|FG000|STARTED|Overall Study||12
10359044|NCT00488644|11498987|FG000|COMPLETED|Overall Study||10
10359045|NCT00488644|11498987|FG000|NOT COMPLETED|Overall Study||2
10359046|NCT00488683|11498994|FG000|STARTED|Overall Study||108
10359047|NCT00488683|11498995|FG001|STARTED|Overall Study||54
10359048|NCT00488683|11498996|FG002|STARTED|Overall Study||54
10359049|NCT00488683|11498994|FG000|COMPLETED|Overall Study||96
10359050|NCT00488683|11498995|FG001|COMPLETED|Overall Study||48
10359051|NCT00488683|11498996|FG002|COMPLETED|Overall Study||52
10359052|NCT00488683|11498994|FG000|NOT COMPLETED|Overall Study||12
10359053|NCT00488683|11498995|FG001|NOT COMPLETED|Overall Study||6
10359054|NCT00488683|11498996|FG002|NOT COMPLETED|Overall Study||2
10359055|NCT00488774|11499012|FG000|STARTED|Overall Study||77
10359056|NCT00488774|11499013|FG001|STARTED|Overall Study||62
10359057|NCT00488774|11499014|FG002|STARTED|Overall Study||75
10359058|NCT00488774|11499015|FG003|STARTED|Overall Study||77
10359059|NCT00488774|11499012|FG000|COMPLETED|Overall Study||69
10359060|NCT00488774|11499013|FG001|COMPLETED|Overall Study||57
10359061|NCT00488774|11499014|FG002|COMPLETED|Overall Study||70
10716222|NCT02688387|11880053|FG010|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10716223|NCT02688387|11880054|FG011|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10359062|NCT00488774|11499015|FG003|COMPLETED|Overall Study||74
10359063|NCT00488774|11499012|FG000|NOT COMPLETED|Overall Study||8
10359064|NCT00488774|11499013|FG001|NOT COMPLETED|Overall Study||5
10359065|NCT00488774|11499014|FG002|NOT COMPLETED|Overall Study||5
10359066|NCT00488774|11499015|FG003|NOT COMPLETED|Overall Study||3
10359067|NCT00488826|11499029|FG000|STARTED|Overall Study||300
10359068|NCT00488826|11499030|FG001|STARTED|Overall Study||296
10359069|NCT00488826|11499031|FG002|STARTED|Overall Study||204
10359070|NCT00488826|11499029|FG000|COMPLETED|Overall Study||244
10359071|NCT00488826|11499030|FG001|COMPLETED|Overall Study||244
10359072|NCT00488826|11499031|FG002|COMPLETED|Overall Study||178
10359073|NCT00488826|11499029|FG000|NOT COMPLETED|Overall Study||56
10359074|NCT00488826|11499030|FG001|NOT COMPLETED|Overall Study||52
10359075|NCT00488826|11499031|FG002|NOT COMPLETED|Overall Study||26
10359076|NCT00488865|11499039|FG000|STARTED|Overall Study||100
10359077|NCT00488865|11499039|FG000|COMPLETED|Overall Study||100
10359078|NCT00488865|11499039|FG000|NOT COMPLETED|Overall Study||0
10359079|NCT00488982|11499043|FG000|STARTED|Induction Chemotherapy||125
10359080|NCT00488982|11499044|FG001|STARTED|Induction Chemotherapy||0
10359081|NCT00488982|11499045|FG002|STARTED|Induction Chemotherapy||0
10359082|NCT00488982|11499043|FG000|6 Cycles Completed|Induction Chemotherapy||94
10359083|NCT00488982|11499044|FG001|6 Cycles Completed|Induction Chemotherapy||0
10359084|NCT00488982|11499045|FG002|6 Cycles Completed|Induction Chemotherapy||0
10359085|NCT00488982|11499043|FG000|≥ 50% Prostate-specific Antigen Decline|Induction Chemotherapy||52
10359086|NCT00488982|11499044|FG001|≥ 50% Prostate-specific Antigen Decline|Induction Chemotherapy||0
10359087|NCT00488982|11499045|FG002|≥ 50% Prostate-specific Antigen Decline|Induction Chemotherapy||0
10359088|NCT00488982|11499043|FG000|COMPLETED|Induction Chemotherapy||52
10359089|NCT00488982|11499044|FG001|COMPLETED|Induction Chemotherapy||0
10359090|NCT00488982|11499045|FG002|COMPLETED|Induction Chemotherapy||0
10359091|NCT00488982|11499043|FG000|NOT COMPLETED|Induction Chemotherapy||73
10359092|NCT00488982|11499044|FG001|NOT COMPLETED|Induction Chemotherapy||0
10359093|NCT00488982|11499045|FG002|NOT COMPLETED|Induction Chemotherapy||0
10359094|NCT00488982|11499043|FG000|STARTED|Course 1||0
10359095|NCT00488982|11499044|FG001|STARTED|Course 1||25
10359096|NCT00488982|11499045|FG002|STARTED|Course 1||27
10359097|NCT00488982|11499043|FG000|COMPLETED|Course 1||0
10359098|NCT00488982|11499044|FG001|COMPLETED|Course 1||13
10359099|NCT00488982|11499045|FG002|COMPLETED|Course 1||13
10777243|NCT03338062|11939179|FG001|NOT COMPLETED|Overall Study||0
10359100|NCT00488982|11499043|FG000|NOT COMPLETED|Course 1||0
10359101|NCT00488982|11499044|FG001|NOT COMPLETED|Course 1||12
10359102|NCT00488982|11499045|FG002|NOT COMPLETED|Course 1||14
10359103|NCT00488982|11499043|FG000|STARTED|Course 2||0
10359104|NCT00488982|11499044|FG001|STARTED|Course 2||13
10359105|NCT00488982|11499045|FG002|STARTED|Course 2||13
10359106|NCT00488982|11499043|FG000|COMPLETED|Course 2||0
10359107|NCT00488982|11499044|FG001|COMPLETED|Course 2||4
10359108|NCT00488982|11499045|FG002|COMPLETED|Course 2||8
10359109|NCT00488982|11499043|FG000|NOT COMPLETED|Course 2||0
10359110|NCT00488982|11499044|FG001|NOT COMPLETED|Course 2||9
10359111|NCT00488982|11499045|FG002|NOT COMPLETED|Course 2||5
10359112|NCT00488982|11499043|FG000|STARTED|Course 3||0
10359113|NCT00488982|11499044|FG001|STARTED|Course 3||4
10359114|NCT00488982|11499045|FG002|STARTED|Course 3||8
10359115|NCT00488982|11499043|FG000|COMPLETED|Course 3||0
10359116|NCT00488982|11499044|FG001|COMPLETED|Course 3||2
10359117|NCT00488982|11499045|FG002|COMPLETED|Course 3||3
10359118|NCT00488982|11499043|FG000|NOT COMPLETED|Course 3||0
10359119|NCT00488982|11499044|FG001|NOT COMPLETED|Course 3||2
10359120|NCT00488982|11499045|FG002|NOT COMPLETED|Course 3||5
10359121|NCT00488982|11499043|FG000|STARTED|Response to Course 3||0
10359122|NCT00488982|11499044|FG001|STARTED|Response to Course 3||2
10359123|NCT00488982|11499045|FG002|STARTED|Response to Course 3||3
10359124|NCT00488982|11499043|FG000|COMPLETED|Response to Course 3||0
10359125|NCT00488982|11499044|FG001|COMPLETED|Response to Course 3||1
10359126|NCT00488982|11499045|FG002|COMPLETED|Response to Course 3||0
10359127|NCT00488982|11499043|FG000|NOT COMPLETED|Response to Course 3||0
10359128|NCT00488982|11499044|FG001|NOT COMPLETED|Response to Course 3||1
10359129|NCT00488982|11499045|FG002|NOT COMPLETED|Response to Course 3||3
10359130|NCT00489086|11499059|FG000|STARTED|Overall Study||36
10359131|NCT00489086|11499059|FG000|Completed 18 Months|Overall Study||23
10359132|NCT00489086|11499059|FG000|COMPLETED|Overall Study||13
10359133|NCT00489086|11499059|FG000|NOT COMPLETED|Overall Study||23
10359134|NCT00489216|11499063|FG000|STARTED|Overall Study||2
10359135|NCT00489216|11499063|FG000|COMPLETED|Overall Study||1
10359136|NCT00489216|11499063|FG000|NOT COMPLETED|Overall Study||1
10359137|NCT00489255|11499069|FG000|STARTED|Screening and Initial Randomization|Total randomized subjects to receive Tigan|145
10359138|NCT00489255|11499070|FG001|STARTED|Screening and Initial Randomization|Total randomized subjects to receive placebo|49
10359139|NCT00489255|11499069|FG000|COMPLETED|Screening and Initial Randomization||136
10359140|NCT00489255|11499070|FG001|COMPLETED|Screening and Initial Randomization||46
10359141|NCT00489255|11499069|FG000|NOT COMPLETED|Screening and Initial Randomization||9
10359142|NCT00489255|11499070|FG001|NOT COMPLETED|Screening and Initial Randomization||3
10359143|NCT00489255|11499069|FG000|STARTED|Period 1: Days 1 to 28||136
10359144|NCT00489255|11499070|FG001|STARTED|Period 1: Days 1 to 28||46
10359145|NCT00489255|11499069|FG000|Completed and Follow Period 2|Period 1: Days 1 to 28||94
10359146|NCT00489255|11499070|FG001|Completed and Follow Period 2|Period 1: Days 1 to 28||29
10359147|NCT00489255|11499069|FG000|Completed But Discontinued Study|Period 1: Days 1 to 28||13
10427036|NCT00850759|11572812|FG000|COMPLETED|Overall Study||52
10359148|NCT00489255|11499070|FG001|Completed But Discontinued Study|Period 1: Days 1 to 28||5
10359149|NCT00489255|11499069|FG000|COMPLETED|Period 1: Days 1 to 28||107
10359150|NCT00489255|11499070|FG001|COMPLETED|Period 1: Days 1 to 28||34
10359151|NCT00489255|11499069|FG000|NOT COMPLETED|Period 1: Days 1 to 28||29
10359152|NCT00489255|11499070|FG001|NOT COMPLETED|Period 1: Days 1 to 28||12
10359153|NCT00489255|11499069|FG000|STARTED|Period 2: Days 29 to 56||64
10359154|NCT00489255|11499070|FG001|STARTED|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|59
10359155|NCT00489255|11499069|FG000|Completed and Follow Period 3|Period 2: Days 29 to 56||58
10359156|NCT00489255|11499070|FG001|Completed and Follow Period 3|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|52
10359157|NCT00489255|11499069|FG000|Completed But Discontinued Study|Period 2: Days 29 to 56||3
10359158|NCT00489255|11499070|FG001|Completed But Discontinued Study|Period 2: Days 29 to 56|Re-randomized participants is 2.Sample sizes differed due to withdrawal&re-randomization design.|3
10359159|NCT00489255|11499069|FG000|COMPLETED|Period 2: Days 29 to 56||61
10359160|NCT00489255|11499070|FG001|COMPLETED|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|55
10359161|NCT00489255|11499069|FG000|NOT COMPLETED|Period 2: Days 29 to 56||3
10359162|NCT00489255|11499070|FG001|NOT COMPLETED|Period 2: Days 29 to 56||4
10359163|NCT00489255|11499069|FG000|STARTED|Period 3: Days 57 to 84||28
10359164|NCT00489255|11499070|FG001|STARTED|Period 3: Days 57 to 84|Re-randomized participants is 30.Sample sizes differed due to withdrawal&re-randomization design.|82
10359165|NCT00489255|11499069|FG000|COMPLETED|Period 3: Days 57 to 84||24
10359166|NCT00489255|11499070|FG001|COMPLETED|Period 3: Days 57 to 84|Re-randomized participants is 27.Sample sizes differed due to withdrawal&re-randomization design.|78
10359167|NCT00489255|11499069|FG000|NOT COMPLETED|Period 3: Days 57 to 84||4
10359168|NCT00489255|11499070|FG001|NOT COMPLETED|Period 3: Days 57 to 84||4
10359169|NCT00489268|11499081|FG000|STARTED|Overall Study||1
10359170|NCT00489268|11499082|FG001|STARTED|Overall Study||10
10359171|NCT00489268|11499083|FG002|STARTED|Overall Study||10
10359172|NCT00489268|11499084|FG003|STARTED|Overall Study||11
10359173|NCT00489268|11499085|FG004|STARTED|Overall Study||70
10359174|NCT00489268|11499081|FG000|COMPLETED|Overall Study||1
10359175|NCT00489268|11499082|FG001|COMPLETED|Overall Study||10
10359176|NCT00489268|11499083|FG002|COMPLETED|Overall Study||9
10359177|NCT00489268|11499084|FG003|COMPLETED|Overall Study||11
10359178|NCT00489268|11499085|FG004|COMPLETED|Overall Study||50
10359179|NCT00489268|11499081|FG000|NOT COMPLETED|Overall Study||0
10359180|NCT00489268|11499082|FG001|NOT COMPLETED|Overall Study||0
10359181|NCT00489268|11499083|FG002|NOT COMPLETED|Overall Study||1
10359182|NCT00489268|11499084|FG003|NOT COMPLETED|Overall Study||0
10359183|NCT00489268|11499085|FG004|NOT COMPLETED|Overall Study||20
10359184|NCT00489281|11499099|FG000|STARTED|Overall Study||29
10359185|NCT00489281|11499100|FG001|STARTED|Overall Study||13
10359186|NCT00489281|11499099|FG000|COMPLETED|Overall Study||29
10359187|NCT00489281|11499100|FG001|COMPLETED|Overall Study||13
10359188|NCT00489281|11499099|FG000|NOT COMPLETED|Overall Study||0
10359189|NCT00489281|11499100|FG001|NOT COMPLETED|Overall Study||0
10359190|NCT00489359|11499108|FG000|STARTED|Overall Study||20
10359191|NCT00489359|11499109|FG001|STARTED|Overall Study||66
10427037|NCT00850759|11572813|FG001|COMPLETED|Overall Study||52
10534573|NCT01431391|11686845|FG001|NOT COMPLETED|Overall Study||4
10534574|NCT01431521|11686856|FG000|STARTED|Overall Study||10
10534575|NCT01431521|11686857|FG001|STARTED|Overall Study||5
10534576|NCT01431521|11686858|FG002|STARTED|Overall Study||11
10534577|NCT01431521|11686859|FG003|STARTED|Overall Study||5
10534578|NCT01431521|11686856|FG000|Treated|Overall Study||10
10534579|NCT01431521|11686857|FG001|Treated|Overall Study||5
10534580|NCT01431521|11686858|FG002|Treated|Overall Study||10
10534581|NCT01431521|11686859|FG003|Treated|Overall Study||5
10534582|NCT01431521|11686856|FG000|COMPLETED|Overall Study||10
10534583|NCT01431521|11686857|FG001|COMPLETED|Overall Study||5
10534584|NCT01431521|11686858|FG002|COMPLETED|Overall Study||10
10534585|NCT01431521|11686859|FG003|COMPLETED|Overall Study||5
10534586|NCT01431521|11686856|FG000|NOT COMPLETED|Overall Study||0
10534587|NCT01431521|11686857|FG001|NOT COMPLETED|Overall Study||0
10534588|NCT01431521|11686858|FG002|NOT COMPLETED|Overall Study||1
10534589|NCT01431521|11686859|FG003|NOT COMPLETED|Overall Study||0
10534590|NCT01431534|11686871|FG000|STARTED|Treatment Phase||4
10534591|NCT01431534|11686872|FG001|STARTED|Treatment Phase||3
10534592|NCT01431534|11686873|FG002|STARTED|Treatment Phase||13
10534593|NCT01431534|11686871|FG000|COMPLETED|Treatment Phase||0
10534594|NCT01431534|11686872|FG001|COMPLETED|Treatment Phase||0
10534595|NCT01431534|11686873|FG002|COMPLETED|Treatment Phase|Participants completing Treatment Phase could continue in Extension Phase.|2
10534596|NCT01431534|11686871|FG000|NOT COMPLETED|Treatment Phase||4
10534597|NCT01431534|11686872|FG001|NOT COMPLETED|Treatment Phase||3
10534598|NCT01431534|11686873|FG002|NOT COMPLETED|Treatment Phase||11
10534599|NCT01431534|11686871|FG000|STARTED|Extension Phase|No participants continued in Extension Phase.|0
10534600|NCT01431534|11686872|FG001|STARTED|Extension Phase|No participants continued in Extension Phase.|0
10534601|NCT01431534|11686873|FG002|STARTED|Extension Phase|Participants from Treatment Phase who continued in Extension Phase.|2
10534602|NCT01431534|11686871|FG000|COMPLETED|Extension Phase||0
10534603|NCT01431534|11686872|FG001|COMPLETED|Extension Phase||0
10534604|NCT01431534|11686873|FG002|COMPLETED|Extension Phase||2
10656410|NCT02217527|11817373|FG000|NOT COMPLETED|Drug Condition 2: Second Study Phase||0
10534605|NCT01431534|11686871|FG000|NOT COMPLETED|Extension Phase||0
10534606|NCT01431534|11686872|FG001|NOT COMPLETED|Extension Phase||0
10359192|NCT00489359|11499108|FG000|COMPLETED|Overall Study|Received at least 6 cycles of therapy. Not completed implies participant received <6 cycles.|13
10359193|NCT00489359|11499109|FG001|COMPLETED|Overall Study|Received at least 6 cycles of therapy. Not completed implies participant received <6 cycles.|37
10359194|NCT00489359|11499108|FG000|NOT COMPLETED|Overall Study||7
10359195|NCT00489359|11499109|FG001|NOT COMPLETED|Overall Study||29
10359196|NCT00489411|11499122|FG000|STARTED|Initial Treatment Period (Weeks 1-5)||115
10534607|NCT01431534|11686873|FG002|NOT COMPLETED|Extension Phase||0
10534608|NCT01431573|11686881|FG000|STARTED|Overall Study||8
10534609|NCT01431573|11686881|FG000|COMPLETED|Overall Study||8
10534610|NCT01431573|11686881|FG000|NOT COMPLETED|Overall Study||0
10534611|NCT01431638|11686888|FG000|STARTED|Overall Study||133
10534612|NCT01431638|11686889|FG001|STARTED|Overall Study||132
10534613|NCT01431638|11686890|FG002|STARTED|Overall Study||132
10534614|NCT01431638|11686888|FG000|Completed Core Study|Overall Study||124
10534615|NCT01431638|11686889|FG001|Completed Core Study|Overall Study||117
10534616|NCT01431638|11686890|FG002|Completed Core Study|Overall Study||108
10534617|NCT01431638|11686888|FG000|Entered Extension 1 Study|Overall Study||85
10534618|NCT01431638|11686889|FG001|Entered Extension 1 Study|Overall Study||71
10534619|NCT01431638|11686890|FG002|Entered Extension 1 Study|Overall Study||76
10534620|NCT01431638|11686888|FG000|COMPLETED|Overall Study||67
10534621|NCT01431638|11686889|FG001|COMPLETED|Overall Study||61
10534622|NCT01431638|11686890|FG002|COMPLETED|Overall Study||70
10534623|NCT01431638|11686888|FG000|NOT COMPLETED|Overall Study||66
10534624|NCT01431638|11686889|FG001|NOT COMPLETED|Overall Study||71
10534625|NCT01431638|11686890|FG002|NOT COMPLETED|Overall Study||62
10534626|NCT01431703|11686898|FG000|STARTED|Overall Study||326
10534627|NCT01431703|11686898|FG000|COMPLETED|Overall Study||326
10534628|NCT01431703|11686898|FG000|NOT COMPLETED|Overall Study||0
10534629|NCT01431716|11686902|FG000|STARTED|Overall Study||42
10534630|NCT01431716|11686902|FG000|COMPLETED|Overall Study||41
10534631|NCT01431716|11686902|FG000|NOT COMPLETED|Overall Study||1
10534635|NCT01431794|11686917|FG000|STARTED|Overall Study||13
10534636|NCT01431794|11686918|FG001|STARTED|Overall Study|not started due to early study's termination|0
10534637|NCT01431794|11686919|FG002|STARTED|Overall Study|not started due to early study's termination|0
10359234|NCT00489476|11499149|FG003|NOT COMPLETED|Overall Study||0
10534638|NCT01431794|11686920|FG003|STARTED|Overall Study|not started due to early study's termination|0
10534639|NCT01431794|11686921|FG004|STARTED|Overall Study|not started due to early study's termination|0
10534640|NCT01431794|11686917|FG000|COMPLETED|Overall Study||13
10534641|NCT01431794|11686918|FG001|COMPLETED|Overall Study|not started due to early study's termination|0
10534642|NCT01431794|11686919|FG002|COMPLETED|Overall Study|not started due to early study's termination|0
10534643|NCT01431794|11686920|FG003|COMPLETED|Overall Study|not started due to early study's termination|0
10534644|NCT01431794|11686921|FG004|COMPLETED|Overall Study|not started due to early study's termination|0
10534645|NCT01431794|11686917|FG000|NOT COMPLETED|Overall Study||0
10534646|NCT01431794|11686918|FG001|NOT COMPLETED|Overall Study||0
10534647|NCT01431794|11686919|FG002|NOT COMPLETED|Overall Study||0
10534648|NCT01431794|11686920|FG003|NOT COMPLETED|Overall Study||0
10534649|NCT01431794|11686921|FG004|NOT COMPLETED|Overall Study||0
10534650|NCT01431846|11686936|FG000|STARTED|Overall Study||8
10534651|NCT01431846|11686937|FG001|STARTED|Overall Study||3
10534652|NCT01431846|11686938|FG002|STARTED|Overall Study||8
10534653|NCT01431846|11686936|FG000|COMPLETED|Overall Study||8
10534654|NCT01431846|11686937|FG001|COMPLETED|Overall Study||3
10534655|NCT01431846|11686938|FG002|COMPLETED|Overall Study||8
10534656|NCT01431846|11686936|FG000|NOT COMPLETED|Overall Study||0
10534657|NCT01431846|11686937|FG001|NOT COMPLETED|Overall Study||0
10656411|NCT02217527|11817374|FG001|NOT COMPLETED|Drug Condition 2: Second Study Phase||1
10656412|NCT02217566|11817380|FG000|STARTED|Overall Study||46
10656413|NCT02217566|11817380|FG000|COMPLETED|Overall Study||35
10656414|NCT02217566|11817380|FG000|NOT COMPLETED|Overall Study||11
10656415|NCT02217618|11817384|FG000|STARTED|Overall Study||16
10656416|NCT02217618|11817384|FG000|Received Study Drug|Overall Study||16
10656417|NCT02217618|11817384|FG000|COMPLETED|Overall Study||16
10656418|NCT02217618|11817384|FG000|NOT COMPLETED|Overall Study||0
10656419|NCT02217800|11817388|FG000|STARTED|Overall Study||8
10656420|NCT02217800|11817388|FG000|COMPLETED|Overall Study||8
10656421|NCT02217800|11817388|FG000|NOT COMPLETED|Overall Study||0
10656422|NCT02217878|11817402|FG000|STARTED|Overall Study||37
10656423|NCT02217878|11817403|FG001|STARTED|Overall Study||37
10656424|NCT02217878|11817402|FG000|COMPLETED|Overall Study||35
10656425|NCT02217878|11817403|FG001|COMPLETED|Overall Study||35
10656426|NCT02217878|11817402|FG000|NOT COMPLETED|Overall Study||2
10656427|NCT02217878|11817403|FG001|NOT COMPLETED|Overall Study||2
10656428|NCT02217904|11817414|FG000|STARTED|Overall Study||6
10656429|NCT02217904|11817415|FG001|STARTED|Overall Study||6
10656430|NCT02217904|11817416|FG002|STARTED|Overall Study||6
10656431|NCT02217904|11817417|FG003|STARTED|Overall Study||6
10656432|NCT02217904|11817418|FG004|STARTED|Overall Study||6
10656433|NCT02217904|11817419|FG005|STARTED|Overall Study||0
10656434|NCT02217904|11817420|FG006|STARTED|Overall Study||0
10656435|NCT02217904|11817414|FG000|COMPLETED|Overall Study||6
10656436|NCT02217904|11817415|FG001|COMPLETED|Overall Study||6
10656437|NCT02217904|11817416|FG002|COMPLETED|Overall Study||6
10534658|NCT01431846|11686938|FG002|NOT COMPLETED|Overall Study||0
10656438|NCT02217904|11817417|FG003|COMPLETED|Overall Study||6
10359197|NCT00489411|11499123|FG001|STARTED|Initial Treatment Period (Weeks 1-5)||116
10359198|NCT00489411|11499122|FG000|COMPLETED|Initial Treatment Period (Weeks 1-5)||87
10359199|NCT00489411|11499123|FG001|COMPLETED|Initial Treatment Period (Weeks 1-5)||94
10359200|NCT00489411|11499122|FG000|NOT COMPLETED|Initial Treatment Period (Weeks 1-5)||28
10359201|NCT00489411|11499123|FG001|NOT COMPLETED|Initial Treatment Period (Weeks 1-5)||22
10359202|NCT00489411|11499122|FG000|STARTED|Washout Period (Weeks 6-7)||87
10359203|NCT00489411|11499123|FG001|STARTED|Washout Period (Weeks 6-7)||94
10359204|NCT00489411|11499122|FG000|COMPLETED|Washout Period (Weeks 6-7)||85
10359205|NCT00489411|11499123|FG001|COMPLETED|Washout Period (Weeks 6-7)||93
10359206|NCT00489411|11499122|FG000|NOT COMPLETED|Washout Period (Weeks 6-7)||2
10359207|NCT00489411|11499123|FG001|NOT COMPLETED|Washout Period (Weeks 6-7)||1
10359208|NCT00489411|11499122|FG000|STARTED|Crossover Treatment Period (Weeks 8-12)||85
10359209|NCT00489411|11499123|FG001|STARTED|Crossover Treatment Period (Weeks 8-12)||93
10359210|NCT00489411|11499122|FG000|COMPLETED|Crossover Treatment Period (Weeks 8-12)||67
10359211|NCT00489411|11499123|FG001|COMPLETED|Crossover Treatment Period (Weeks 8-12)||74
10359212|NCT00489411|11499122|FG000|NOT COMPLETED|Crossover Treatment Period (Weeks 8-12)||18
10359213|NCT00489411|11499123|FG001|NOT COMPLETED|Crossover Treatment Period (Weeks 8-12)||19
10359214|NCT00489424|11499132|FG000|STARTED|Overall Study||267
10359215|NCT00489424|11499133|FG001|STARTED|Overall Study||264
10359216|NCT00489424|11499134|FG002|STARTED|Overall Study||262
10359217|NCT00489424|11499132|FG000|COMPLETED|Overall Study||263
10359218|NCT00489424|11499133|FG001|COMPLETED|Overall Study||259
10359219|NCT00489424|11499134|FG002|COMPLETED|Overall Study||257
10359220|NCT00489424|11499132|FG000|NOT COMPLETED|Overall Study||4
10359221|NCT00489424|11499133|FG001|NOT COMPLETED|Overall Study||5
10359222|NCT00489424|11499134|FG002|NOT COMPLETED|Overall Study||5
10359223|NCT00489476|11499146|FG000|STARTED|Overall Study||39
10359224|NCT00489476|11499147|FG001|STARTED|Overall Study||43
10359225|NCT00489476|11499148|FG002|STARTED|Overall Study||43
10359226|NCT00489476|11499149|FG003|STARTED|Overall Study||43
10359227|NCT00489476|11499146|FG000|COMPLETED|Overall Study||39
10359228|NCT00489476|11499147|FG001|COMPLETED|Overall Study||42
10359229|NCT00489476|11499148|FG002|COMPLETED|Overall Study||43
10359230|NCT00489476|11499149|FG003|COMPLETED|Overall Study||43
10359231|NCT00489476|11499146|FG000|NOT COMPLETED|Overall Study||0
10359232|NCT00489476|11499147|FG001|NOT COMPLETED|Overall Study||1
10359233|NCT00489476|11499148|FG002|NOT COMPLETED|Overall Study||0
10359235|NCT00489489|11499162|FG000|STARTED|Overall Study|randomized|41
10359236|NCT00489489|11499163|FG001|STARTED|Overall Study|randomized|37
10359237|NCT00489489|11499164|FG002|STARTED|Overall Study|randomized|40
10359238|NCT00489489|11499162|FG000|Treated|Overall Study||41
10359239|NCT00489489|11499163|FG001|Treated|Overall Study||36
10359240|NCT00489489|11499164|FG002|Treated|Overall Study|One participant received teriflunomide 7 mg instead of teriflunomide 14 mg|39
10359241|NCT00489489|11499162|FG000|COMPLETED|Overall Study|completed treatment period|38
10359242|NCT00489489|11499163|FG001|COMPLETED|Overall Study|completed treatment period|32
10359243|NCT00489489|11499164|FG002|COMPLETED|Overall Study|completed treatment period|37
10359244|NCT00489489|11499162|FG000|NOT COMPLETED|Overall Study||3
10359245|NCT00489489|11499163|FG001|NOT COMPLETED|Overall Study||5
10359246|NCT00489489|11499164|FG002|NOT COMPLETED|Overall Study||3
10359247|NCT00489541|11499176|FG000|STARTED|12-Month Clinical Follow-up||224
10359248|NCT00489541|11499177|FG001|STARTED|12-Month Clinical Follow-up||125
10359249|NCT00489541|11499176|FG000|COMPLETED|12-Month Clinical Follow-up||215
10359250|NCT00489541|11499177|FG001|COMPLETED|12-Month Clinical Follow-up||120
10359251|NCT00489541|11499176|FG000|NOT COMPLETED|12-Month Clinical Follow-up||9
10359252|NCT00489541|11499177|FG001|NOT COMPLETED|12-Month Clinical Follow-up||5
10359253|NCT00489541|11499176|FG000|STARTED|9-Month Angiographic Follow-up||224
10359254|NCT00489541|11499177|FG001|STARTED|9-Month Angiographic Follow-up||125
10359255|NCT00489541|11499176|FG000|COMPLETED|9-Month Angiographic Follow-up||197
10359256|NCT00489541|11499177|FG001|COMPLETED|9-Month Angiographic Follow-up||108
10359257|NCT00489541|11499176|FG000|NOT COMPLETED|9-Month Angiographic Follow-up||27
10359258|NCT00489541|11499177|FG001|NOT COMPLETED|9-Month Angiographic Follow-up||17
10359259|NCT00489554|11499183|FG000|STARTED|Overall Study||230
10359260|NCT00489554|11499183|FG000|COMPLETED|Overall Study||226
10359261|NCT00489554|11499183|FG000|NOT COMPLETED|Overall Study||4
10359262|NCT00489736|11499189|FG000|STARTED|Overall Study|Randomized and treated patients|249
10359263|NCT00489736|11499190|FG001|STARTED|Overall Study|Randomized and treated patients|255
10359264|NCT00489736|11499189|FG000|COMPLETED|Overall Study|completed study drug period|153
10359265|NCT00489736|11499190|FG001|COMPLETED|Overall Study|completed study drug period|186
10359266|NCT00489736|11499189|FG000|NOT COMPLETED|Overall Study||96
10656439|NCT02217904|11817418|FG004|COMPLETED|Overall Study||6
10656440|NCT02217904|11817419|FG005|COMPLETED|Overall Study||0
10656441|NCT02217904|11817420|FG006|COMPLETED|Overall Study||0
10656442|NCT02217904|11817414|FG000|NOT COMPLETED|Overall Study||0
10359267|NCT00489736|11499190|FG001|NOT COMPLETED|Overall Study||69
10359268|NCT00489853|11499196|FG000|STARTED|Treatment Period 1||36
10359269|NCT00489853|11499197|FG001|STARTED|Treatment Period 1||37
10359270|NCT00489853|11499198|FG002|STARTED|Treatment Period 1||38
10359271|NCT00489853|11499196|FG000|COMPLETED|Treatment Period 1||36
10359272|NCT00489853|11499197|FG001|COMPLETED|Treatment Period 1||37
10359273|NCT00489853|11499198|FG002|COMPLETED|Treatment Period 1||38
10359274|NCT00489853|11499196|FG000|NOT COMPLETED|Treatment Period 1||0
10359275|NCT00489853|11499197|FG001|NOT COMPLETED|Treatment Period 1||0
10359276|NCT00489853|11499198|FG002|NOT COMPLETED|Treatment Period 1||0
10359277|NCT00489853|11499196|FG000|STARTED|Wash-out Period 1||36
10359278|NCT00489853|11499197|FG001|STARTED|Wash-out Period 1||37
10359279|NCT00489853|11499198|FG002|STARTED|Wash-out Period 1||38
10359280|NCT00489853|11499196|FG000|COMPLETED|Wash-out Period 1||35
10359281|NCT00489853|11499197|FG001|COMPLETED|Wash-out Period 1||34
10359282|NCT00489853|11499198|FG002|COMPLETED|Wash-out Period 1||32
10359283|NCT00489853|11499196|FG000|NOT COMPLETED|Wash-out Period 1||1
10359284|NCT00489853|11499197|FG001|NOT COMPLETED|Wash-out Period 1||3
10359285|NCT00489853|11499198|FG002|NOT COMPLETED|Wash-out Period 1||6
10359286|NCT00489853|11499196|FG000|STARTED|Treatment Period 2||33
10359287|NCT00489853|11499197|FG001|STARTED|Treatment Period 2||35
10359288|NCT00489853|11499198|FG002|STARTED|Treatment Period 2||33
10359289|NCT00489853|11499196|FG000|COMPLETED|Treatment Period 2||33
10359290|NCT00489853|11499197|FG001|COMPLETED|Treatment Period 2||35
10359291|NCT00489853|11499198|FG002|COMPLETED|Treatment Period 2||33
10359292|NCT00489853|11499196|FG000|NOT COMPLETED|Treatment Period 2||0
10359293|NCT00489853|11499197|FG001|NOT COMPLETED|Treatment Period 2||0
10359294|NCT00489853|11499198|FG002|NOT COMPLETED|Treatment Period 2||0
10359295|NCT00489853|11499196|FG000|STARTED|Wash-out Period 2||33
10359296|NCT00489853|11499197|FG001|STARTED|Wash-out Period 2||35
10359297|NCT00489853|11499198|FG002|STARTED|Wash-out Period 2||33
10359298|NCT00489853|11499196|FG000|COMPLETED|Wash-out Period 2||29
10359299|NCT00489853|11499197|FG001|COMPLETED|Wash-out Period 2||32
10359300|NCT00489853|11499198|FG002|COMPLETED|Wash-out Period 2||31
10359301|NCT00489853|11499196|FG000|NOT COMPLETED|Wash-out Period 2||4
10359302|NCT00489853|11499197|FG001|NOT COMPLETED|Wash-out Period 2||3
10359303|NCT00489853|11499198|FG002|NOT COMPLETED|Wash-out Period 2||2
10359304|NCT00489853|11499196|FG000|STARTED|Treatment Period 3||29
10359305|NCT00489853|11499197|FG001|STARTED|Treatment Period 3||30
10359306|NCT00489853|11499198|FG002|STARTED|Treatment Period 3||33
10359307|NCT00489853|11499196|FG000|COMPLETED|Treatment Period 3||29
10359308|NCT00489853|11499197|FG001|COMPLETED|Treatment Period 3||29
10359309|NCT00489853|11499198|FG002|COMPLETED|Treatment Period 3||33
10359310|NCT00489853|11499196|FG000|NOT COMPLETED|Treatment Period 3||0
10359311|NCT00489853|11499197|FG001|NOT COMPLETED|Treatment Period 3||1
10359312|NCT00489853|11499198|FG002|NOT COMPLETED|Treatment Period 3||0
10359313|NCT00489853|11499196|FG000|STARTED|Follow-up Period||29
10359314|NCT00489853|11499197|FG001|STARTED|Follow-up Period||29
10359315|NCT00489853|11499198|FG002|STARTED|Follow-up Period||33
10359316|NCT00489853|11499196|FG000|COMPLETED|Follow-up Period||29
10359317|NCT00489853|11499197|FG001|COMPLETED|Follow-up Period||29
10359318|NCT00489853|11499198|FG002|COMPLETED|Follow-up Period||33
10359319|NCT00489853|11499196|FG000|NOT COMPLETED|Follow-up Period||0
10359320|NCT00489853|11499197|FG001|NOT COMPLETED|Follow-up Period||0
10359321|NCT00489853|11499198|FG002|NOT COMPLETED|Follow-up Period||0
10359322|NCT00489866|11499208|FG000|STARTED|Overall Study||7
10359323|NCT00489866|11499209|FG001|STARTED|Overall Study||7
10359324|NCT00489866|11499208|FG000|COMPLETED|Overall Study||5
10359325|NCT00489866|11499209|FG001|COMPLETED|Overall Study||7
10716224|NCT02688387|11880055|FG012|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10716225|NCT02688387|11880056|FG013|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10716226|NCT02688387|11880057|FG014|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10716227|NCT02688387|11880058|FG015|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10716228|NCT02688387|11880059|FG016|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10359326|NCT00489866|11499208|FG000|NOT COMPLETED|Overall Study||2
10359327|NCT00489866|11499209|FG001|NOT COMPLETED|Overall Study||0
10359328|NCT00489918|11499228|FG000|STARTED|Overall Study||33
10359329|NCT00489918|11499229|FG001|STARTED|Overall Study||34
10359330|NCT00489918|11499230|FG002|STARTED|Overall Study||32
10359331|NCT00489918|11499231|FG003|STARTED|Overall Study||33
10359332|NCT00489918|11499232|FG004|STARTED|Overall Study||33
10359333|NCT00489918|11499228|FG000|COMPLETED|Overall Study||31
10359334|NCT00489918|11499229|FG001|COMPLETED|Overall Study||32
10359335|NCT00489918|11499230|FG002|COMPLETED|Overall Study||28
10359336|NCT00489918|11499231|FG003|COMPLETED|Overall Study||32
10359337|NCT00489918|11499232|FG004|COMPLETED|Overall Study||32
10359338|NCT00489918|11499228|FG000|NOT COMPLETED|Overall Study||2
10359339|NCT00489918|11499229|FG001|NOT COMPLETED|Overall Study||2
10359340|NCT00489918|11499230|FG002|NOT COMPLETED|Overall Study||4
10359341|NCT00489918|11499231|FG003|NOT COMPLETED|Overall Study||1
10359342|NCT00489918|11499232|FG004|NOT COMPLETED|Overall Study||1
10359343|NCT00489970|11499247|FG000|STARTED|Persistence Year 1||1069
10359344|NCT00489970|11499248|FG001|STARTED|Persistence Year 1||523
10359345|NCT00489970|11499249|FG002|STARTED|Persistence Year 1||0
10359346|NCT00489970|11499247|FG000|COMPLETED|Persistence Year 1||1069
10359347|NCT00489970|11499248|FG001|COMPLETED|Persistence Year 1||523
10359348|NCT00489970|11499249|FG002|COMPLETED|Persistence Year 1||0
10359349|NCT00489970|11499247|FG000|NOT COMPLETED|Persistence Year 1||0
10359350|NCT00489970|11499248|FG001|NOT COMPLETED|Persistence Year 1||0
10359351|NCT00489970|11499249|FG002|NOT COMPLETED|Persistence Year 1||0
10359352|NCT00489970|11499247|FG000|STARTED|Persistence Year 3|Number of subjects who returned at Year 3|1019
10359353|NCT00489970|11499248|FG001|STARTED|Persistence Year 3|Number of subjects who returned at Year 3|486
10359354|NCT00489970|11499249|FG002|STARTED|Persistence Year 3||0
10359355|NCT00489970|11499247|FG000|COMPLETED|Persistence Year 3||1019
10359356|NCT00489970|11499248|FG001|COMPLETED|Persistence Year 3||486
10359357|NCT00489970|11499249|FG002|COMPLETED|Persistence Year 3||0
10716229|NCT02688387|11880060|FG017|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10359358|NCT00489970|11499247|FG000|NOT COMPLETED|Persistence Year 3||0
10359359|NCT00489970|11499248|FG001|NOT COMPLETED|Persistence Year 3||0
10359360|NCT00489970|11499249|FG002|NOT COMPLETED|Persistence Year 3||0
10359361|NCT00489970|11499247|FG000|STARTED|Persistence Year 5|Number of subjects who returned at Year 5|856
10359362|NCT00489970|11499248|FG001|STARTED|Persistence Year 5|Number of subjects who returned at Year 5|401
10359363|NCT00489970|11499249|FG002|STARTED|Persistence Year 5||0
10359364|NCT00489970|11499247|FG000|COMPLETED|Persistence Year 5||856
10359365|NCT00489970|11499248|FG001|COMPLETED|Persistence Year 5||401
10359366|NCT00489970|11499249|FG002|COMPLETED|Persistence Year 5||0
10359367|NCT00489970|11499247|FG000|NOT COMPLETED|Persistence Year 5||0
10359368|NCT00489970|11499248|FG001|NOT COMPLETED|Persistence Year 5||0
10359369|NCT00489970|11499249|FG002|NOT COMPLETED|Persistence Year 5||0
10359370|NCT00489970|11499247|FG000|STARTED|Persistence Year 9|Number of subjects who returned at Year 9.|309
10359371|NCT00489970|11499248|FG001|STARTED|Persistence Year 9|Number of subjects who returned at Year 9.|138
10359372|NCT00489970|11499249|FG002|STARTED|Persistence Year 9|Number of subjects who received the first dose at Year 9.|362
10359373|NCT00489970|11499247|FG000|COMPLETED|Persistence Year 9||306
10359374|NCT00489970|11499248|FG001|COMPLETED|Persistence Year 9||136
10359375|NCT00489970|11499249|FG002|COMPLETED|Persistence Year 9||357
10359376|NCT00489970|11499247|FG000|NOT COMPLETED|Persistence Year 9||3
10359377|NCT00489970|11499248|FG001|NOT COMPLETED|Persistence Year 9||2
10359378|NCT00489970|11499249|FG002|NOT COMPLETED|Persistence Year 9||5
10359379|NCT00490009|11499260|FG000|STARTED|Overall Study||9
10359380|NCT00490009|11499260|FG000|COMPLETED|Overall Study||9
10359381|NCT00490009|11499260|FG000|NOT COMPLETED|Overall Study||0
10359382|NCT00490022|11499267|FG000|STARTED|Overall Study||16
10359383|NCT00490022|11499268|FG001|STARTED|Overall Study||15
10359384|NCT00490022|11499267|FG000|COMPLETED|Overall Study||15
10359385|NCT00490022|11499268|FG001|COMPLETED|Overall Study||12
10359386|NCT00490022|11499267|FG000|NOT COMPLETED|Overall Study||1
10359387|NCT00490022|11499268|FG001|NOT COMPLETED|Overall Study||3
10534659|NCT01431950|11686948|FG000|STARTED|Overall Study||119
10534660|NCT01431950|11686949|FG001|STARTED|Overall Study||119
10534661|NCT01431950|11686948|FG000|COMPLETED|Overall Study||100
10534662|NCT01431950|11686949|FG001|COMPLETED|Overall Study||104
10534663|NCT01431950|11686948|FG000|NOT COMPLETED|Overall Study||19
10534664|NCT01431950|11686949|FG001|NOT COMPLETED|Overall Study||15
10359400|NCT00490061|11499291|FG000|STARTED|Overall Study||17
10359401|NCT00490061|11499291|FG000|COMPLETED|Overall Study||16
10534665|NCT01431963|11686955|FG000|STARTED|Overall Study||67
10534666|NCT01431963|11686955|FG000|Begin Escalation Phase (EP; 6 Weeks)|Overall Study||67
10534667|NCT01431963|11686955|FG000|Received Treatment|Overall Study||65
10534668|NCT01431963|11686955|FG000|Complete EP (6 Weeks)|Overall Study||52
10534669|NCT01431963|11686955|FG000|Begin Maintenance Phase (MP; 24 Weeks)|Overall Study||52
10534670|NCT01431963|11686955|FG000|Complete MP (24 Weeks)|Overall Study||42
10534671|NCT01431963|11686955|FG000|Begin Extension Phase (ExP; gt= 24weeks)|Overall Study|Only Japanese participants in ExP,lamotrigine monotherapy was available in Korea. (>=24weeks)|19
10534672|NCT01431963|11686955|FG000|Complete ExP (gt= 24 Weeks)|Overall Study|(>=24 weeks); gt= abbreviation for greater than or equal to|19
10534673|NCT01431963|11686955|FG000|COMPLETED|Overall Study||32
10534674|NCT01431963|11686955|FG000|NOT COMPLETED|Overall Study||35
10534675|NCT01431976|11686959|FG000|STARTED|Overall Study||20
10534676|NCT01431976|11686959|FG000|COMPLETED|Overall Study||6
10534677|NCT01431976|11686959|FG000|NOT COMPLETED|Overall Study||14
10534678|NCT01431989|11686963|FG000|STARTED|Period 1||14
10534679|NCT01431989|11686964|FG001|STARTED|Period 1||14
10534680|NCT01431989|11686963|FG000|COMPLETED|Period 1||14
10656443|NCT02217904|11817415|FG001|NOT COMPLETED|Overall Study||0
10656444|NCT02217904|11817416|FG002|NOT COMPLETED|Overall Study||0
10656445|NCT02217904|11817417|FG003|NOT COMPLETED|Overall Study||0
10656446|NCT02217904|11817418|FG004|NOT COMPLETED|Overall Study||0
10656447|NCT02217904|11817419|FG005|NOT COMPLETED|Overall Study||0
10656448|NCT02217904|11817420|FG006|NOT COMPLETED|Overall Study||0
10656449|NCT02217982|11817434|FG000|STARTED|Overall Study||1
10656450|NCT02217982|11817435|FG001|STARTED|Overall Study||4
10656451|NCT02217982|11817434|FG000|COMPLETED|Overall Study|Trial closed before patient finished|0
10656452|NCT02217982|11817435|FG001|COMPLETED|Overall Study||3
10656453|NCT02217982|11817434|FG000|NOT COMPLETED|Overall Study||1
10359402|NCT00490061|11499291|FG000|NOT COMPLETED|Overall Study||1
10359403|NCT00490100|11499295|FG000|STARTED|Overall Study||6
10359404|NCT00490100|11499295|FG000|COMPLETED|Overall Study||3
10359405|NCT00490100|11499295|FG000|NOT COMPLETED|Overall Study||3
10359406|NCT00490139|11499304|FG000|STARTED|Overall Study||2093
10359407|NCT00490139|11499305|FG001|STARTED|Overall Study||2091
10359408|NCT00490139|11499306|FG002|STARTED|Overall Study||2100
10359409|NCT00490139|11499307|FG003|STARTED|Overall Study||2097
10359410|NCT00490139|11499304|FG000|COMPLETED|Overall Study||1785
10359411|NCT00490139|11499305|FG001|COMPLETED|Overall Study||1816
10359412|NCT00490139|11499306|FG002|COMPLETED|Overall Study||1666
10359413|NCT00490139|11499307|FG003|COMPLETED|Overall Study||1790
10359414|NCT00490139|11499304|FG000|NOT COMPLETED|Overall Study||308
10359415|NCT00490139|11499305|FG001|NOT COMPLETED|Overall Study||275
10359416|NCT00490139|11499306|FG002|NOT COMPLETED|Overall Study||434
10359417|NCT00490139|11499307|FG003|NOT COMPLETED|Overall Study||307
10359418|NCT00490256|11499321|FG000|STARTED|Overall Study||7
10359419|NCT00490256|11499322|FG001|STARTED|Overall Study||7
10359420|NCT00490256|11499321|FG000|Intraoperative Portion of the Study|Overall Study|Intraoperative management|7
10359421|NCT00490256|11499322|FG001|Intraoperative Portion of the Study|Overall Study|Intraoperative management|7
10359422|NCT00490256|11499321|FG000|COMPLETED|Overall Study||7
10359423|NCT00490256|11499322|FG001|COMPLETED|Overall Study||7
10359424|NCT00490256|11499321|FG000|NOT COMPLETED|Overall Study||0
10359425|NCT00490256|11499322|FG001|NOT COMPLETED|Overall Study||0
10359426|NCT00490269|11499330|FG000|STARTED|Dronabinol Then Placebo||6
10359427|NCT00490269|11499331|FG001|STARTED|Dronabinol Then Placebo||6
10359428|NCT00490269|11499330|FG000|COMPLETED|Dronabinol Then Placebo||6
10359429|NCT00490269|11499331|FG001|COMPLETED|Dronabinol Then Placebo||6
10359430|NCT00490269|11499330|FG000|NOT COMPLETED|Dronabinol Then Placebo||0
10359431|NCT00490269|11499331|FG001|NOT COMPLETED|Dronabinol Then Placebo||0
10359432|NCT00490269|11499330|FG000|STARTED|Placebo Then Dronabinol||6
10359433|NCT00490269|11499331|FG001|STARTED|Placebo Then Dronabinol||6
10359434|NCT00490269|11499330|FG000|COMPLETED|Placebo Then Dronabinol||6
10359435|NCT00490269|11499331|FG001|COMPLETED|Placebo Then Dronabinol||6
10359436|NCT00490269|11499330|FG000|NOT COMPLETED|Placebo Then Dronabinol||0
10359437|NCT00490269|11499331|FG001|NOT COMPLETED|Placebo Then Dronabinol||0
10359438|NCT00490282|11499337|FG000|STARTED|Overall Study||25
10359439|NCT00490282|11499337|FG000|COMPLETED|Overall Study||22
10359440|NCT00490282|11499337|FG000|NOT COMPLETED|Overall Study||3
10359441|NCT00490451|11499344|FG000|STARTED|Overall Study||63
10359442|NCT00490451|11499345|FG001|STARTED|Overall Study||38
10359443|NCT00490451|11499344|FG000|COMPLETED|Overall Study||0
10359444|NCT00490451|11499345|FG001|COMPLETED|Overall Study||0
10716230|NCT02688387|11880061|FG018|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10716231|NCT02688387|11880062|FG019|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10716232|NCT02688387|11880063|FG020|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10716233|NCT02688387|11880064|FG021|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
10716234|NCT02688387|11880043|FG000|STARTED|Part 3B, Period 3 (up to 6 Days)||0
10716235|NCT02688387|11880044|FG001|STARTED|Part 3B, Period 3 (up to 6 Days)||0
10716236|NCT02688387|11880045|FG002|STARTED|Part 3B, Period 3 (up to 6 Days)||0
10716237|NCT02688387|11880046|FG003|STARTED|Part 3B, Period 3 (up to 6 Days)||0
10359445|NCT00490451|11499344|FG000|NOT COMPLETED|Overall Study||63
10359446|NCT00490451|11499345|FG001|NOT COMPLETED|Overall Study||38
10359447|NCT00490477|11499353|FG000|STARTED|Overall Study||8
10359448|NCT00490477|11499354|FG001|STARTED|Overall Study||8
10359449|NCT00490477|11499353|FG000|COMPLETED|Overall Study||8
10359450|NCT00490477|11499354|FG001|COMPLETED|Overall Study||8
10359451|NCT00490477|11499353|FG000|NOT COMPLETED|Overall Study||0
10359452|NCT00490477|11499354|FG001|NOT COMPLETED|Overall Study||0
10359453|NCT00490490|11499360|FG000|STARTED|Completed Assessment for CR||8
10359454|NCT00490490|11499360|FG000|COMPLETED|Completed Assessment for CR||8
10359455|NCT00490490|11499360|FG000|NOT COMPLETED|Completed Assessment for CR||0
10359456|NCT00490490|11499360|FG000|STARTED|Completed Assessment for TTP||8
10359457|NCT00490490|11499360|FG000|COMPLETED|Completed Assessment for TTP||5
10359458|NCT00490490|11499360|FG000|NOT COMPLETED|Completed Assessment for TTP||3
10359459|NCT00490529|11499364|FG000|STARTED|Completed Pre-CpG-MCL Vaccine Procedures||59
10359460|NCT00490529|11499364|FG000|COMPLETED|Completed Pre-CpG-MCL Vaccine Procedures||48
10359461|NCT00490529|11499364|FG000|NOT COMPLETED|Completed Pre-CpG-MCL Vaccine Procedures||11
10359462|NCT00490529|11499364|FG000|STARTED|Treatment With CpG-MCL Vaccine||48
10359463|NCT00490529|11499364|FG000|COMPLETED|Treatment With CpG-MCL Vaccine||47
10359464|NCT00490529|11499364|FG000|NOT COMPLETED|Treatment With CpG-MCL Vaccine||1
10359465|NCT00490542|11499370|FG000|STARTED|Overall Study||38
10359466|NCT00490542|11499371|FG001|STARTED|Overall Study||35
10359467|NCT00490542|11499370|FG000|COMPLETED|Overall Study||31
10359468|NCT00490542|11499371|FG001|COMPLETED|Overall Study||31
10359469|NCT00490542|11499370|FG000|NOT COMPLETED|Overall Study||7
10359470|NCT00490542|11499371|FG001|NOT COMPLETED|Overall Study||4
10359471|NCT00490555|11499381|FG000|STARTED|Overall Study||8
10359472|NCT00490555|11499382|FG001|STARTED|Overall Study||8
10359473|NCT00490555|11499383|FG002|STARTED|Overall Study||9
10359474|NCT00490555|11499384|FG003|STARTED|Overall Study||7
10359475|NCT00490555|11499381|FG000|COMPLETED|Overall Study||8
10359476|NCT00490555|11499382|FG001|COMPLETED|Overall Study||8
10359477|NCT00490555|11499383|FG002|COMPLETED|Overall Study||7
10359478|NCT00490555|11499384|FG003|COMPLETED|Overall Study||7
10359479|NCT00490555|11499381|FG000|NOT COMPLETED|Overall Study||0
10359480|NCT00490555|11499382|FG001|NOT COMPLETED|Overall Study||0
10359481|NCT00490555|11499383|FG002|NOT COMPLETED|Overall Study||2
10359482|NCT00490555|11499384|FG003|NOT COMPLETED|Overall Study||0
10359483|NCT00490568|11499394|FG000|STARTED|Overall Study||1461
10359484|NCT00490568|11499394|FG000|COMPLETED|Overall Study||97
10359485|NCT00490568|11499394|FG000|NOT COMPLETED|Overall Study||1364
10359486|NCT00490646|11499401|FG000|STARTED|Overall Study||25
10359487|NCT00490646|11499402|FG001|STARTED|Overall Study||25
10359488|NCT00490646|11499401|FG000|Treated|Overall Study||24
10359489|NCT00490646|11499402|FG001|Treated|Overall Study||24
10359490|NCT00490646|11499401|FG000|COMPLETED|Overall Study|Completed=Off-treatment (Major reasons: Disease progression=14; study drug toxicity=4)|23
10359491|NCT00490646|11499402|FG001|COMPLETED|Overall Study|Completed=Off-treatment (Major reasons: Disease progression=13; study drug toxicity=1)|23
10359492|NCT00490646|11499401|FG000|NOT COMPLETED|Overall Study||2
10359493|NCT00490646|11499402|FG001|NOT COMPLETED|Overall Study||2
10359494|NCT00490698|11499408|FG000|STARTED|Overall Study||11
10359495|NCT00490698|11499408|FG000|COMPLETED|Overall Study||1
10359496|NCT00490698|11499408|FG000|NOT COMPLETED|Overall Study||10
10359497|NCT00490724|11499415|FG000|STARTED|Period I||21
10359498|NCT00490724|11499416|FG001|STARTED|Period I||20
10359499|NCT00490724|11499417|FG002|STARTED|Period I||20
10359500|NCT00490724|11499415|FG000|COMPLETED|Period I||21
10359501|NCT00490724|11499416|FG001|COMPLETED|Period I||20
10359502|NCT00490724|11499417|FG002|COMPLETED|Period I||19
10359503|NCT00490724|11499415|FG000|NOT COMPLETED|Period I||0
10359504|NCT00490724|11499416|FG001|NOT COMPLETED|Period I||0
10359505|NCT00490724|11499417|FG002|NOT COMPLETED|Period I||1
10359506|NCT00490724|11499415|FG000|STARTED|Period II||21
10359507|NCT00490724|11499416|FG001|STARTED|Period II||20
10359508|NCT00490724|11499417|FG002|STARTED|Period II||19
10359509|NCT00490724|11499415|FG000|COMPLETED|Period II||18
10359510|NCT00490724|11499416|FG001|COMPLETED|Period II||19
10359511|NCT00490724|11499417|FG002|COMPLETED|Period II||16
10359512|NCT00490724|11499415|FG000|NOT COMPLETED|Period II||3
10359513|NCT00490724|11499416|FG001|NOT COMPLETED|Period II||1
10359514|NCT00490724|11499417|FG002|NOT COMPLETED|Period II||3
10359515|NCT00490802|11499427|FG000|STARTED|Overall Study||10
10359516|NCT00490802|11499428|FG001|STARTED|Overall Study||9
10359517|NCT00490802|11499427|FG000|COMPLETED|Overall Study||9
10359518|NCT00490802|11499428|FG001|COMPLETED|Overall Study||7
10359519|NCT00490802|11499427|FG000|NOT COMPLETED|Overall Study||1
10359520|NCT00490802|11499428|FG001|NOT COMPLETED|Overall Study||2
10359521|NCT00490815|11499437|FG000|STARTED|Overall Study||20
10359522|NCT00490815|11499438|FG001|STARTED|Overall Study||17
10359523|NCT00490815|11499437|FG000|COMPLETED|Overall Study||12
10359524|NCT00490815|11499438|FG001|COMPLETED|Overall Study||8
10359525|NCT00490815|11499437|FG000|NOT COMPLETED|Overall Study||8
10359526|NCT00490815|11499438|FG001|NOT COMPLETED|Overall Study||9
10359527|NCT00490841|11499444|FG000|STARTED|Overall Study||202
10359528|NCT00490841|11499444|FG000|COMPLETED|Overall Study||189
10359529|NCT00490841|11499444|FG000|NOT COMPLETED|Overall Study||13
10359530|NCT00490919|11499451|FG000|STARTED|Open-label Run-in Period||1024
10359531|NCT00490919|11499452|FG001|STARTED|Open-label Run-in Period||0
10359532|NCT00490919|11499453|FG002|STARTED|Open-label Run-in Period||0
10359533|NCT00490919|11499451|FG000|COMPLETED|Open-label Run-in Period|Completed run-in and randomized; however 2 had no safety data after randomization visit (N = 539)|541
10359534|NCT00490919|11499452|FG001|COMPLETED|Open-label Run-in Period||0
10359535|NCT00490919|11499453|FG002|COMPLETED|Open-label Run-in Period||0
10359536|NCT00490919|11499451|FG000|NOT COMPLETED|Open-label Run-in Period||483
10359537|NCT00490919|11499452|FG001|NOT COMPLETED|Open-label Run-in Period||0
10359538|NCT00490919|11499453|FG002|NOT COMPLETED|Open-label Run-in Period||0
10359539|NCT00490919|11499451|FG000|STARTED|Double-blind Phase||0
10359540|NCT00490919|11499452|FG001|STARTED|Double-blind Phase|1 subject had no safety data in DB phase; therefore is excluded from randomized safety population.|256
10359541|NCT00490919|11499453|FG002|STARTED|Double-blind Phase|1 subject had no safety data in DB phase; therefore is excluded from randomized safety population.|283
10359542|NCT00490919|11499451|FG000|COMPLETED|Double-blind Phase||0
10359543|NCT00490919|11499452|FG001|COMPLETED|Double-blind Phase||170
10359544|NCT00490919|11499453|FG002|COMPLETED|Double-blind Phase||199
10359545|NCT00490919|11499451|FG000|NOT COMPLETED|Double-blind Phase||0
10359546|NCT00490919|11499452|FG001|NOT COMPLETED|Double-blind Phase||86
10359547|NCT00490919|11499453|FG002|NOT COMPLETED|Double-blind Phase||84
10359548|NCT00490945|11499465|FG000|STARTED|Overall Study||8
10359549|NCT00490945|11499466|FG001|STARTED|Overall Study||9
10359550|NCT00490945|11499467|FG002|STARTED|Overall Study||8
10359551|NCT00490945|11499468|FG003|STARTED|Overall Study||7
10359552|NCT00490945|11499469|FG004|STARTED|Overall Study||7
10359553|NCT00490945|11499465|FG000|COMPLETED|Overall Study||8
10359554|NCT00490945|11499466|FG001|COMPLETED|Overall Study||8
10359555|NCT00490945|11499467|FG002|COMPLETED|Overall Study||8
10359556|NCT00490945|11499468|FG003|COMPLETED|Overall Study||7
10359557|NCT00490945|11499469|FG004|COMPLETED|Overall Study||7
10359558|NCT00490945|11499465|FG000|NOT COMPLETED|Overall Study||0
10359559|NCT00490945|11499466|FG001|NOT COMPLETED|Overall Study||1
10359560|NCT00490945|11499467|FG002|NOT COMPLETED|Overall Study||0
10359561|NCT00490945|11499468|FG003|NOT COMPLETED|Overall Study||0
10359562|NCT00490945|11499469|FG004|NOT COMPLETED|Overall Study||0
10359563|NCT00490971|11499489|FG000|STARTED|Acute/Continuation|617 participants were assigned to paliperidone, out of which 614 took the study medication.|614
10359564|NCT00490971|11499490|FG001|STARTED|Acute/Continuation|149 participants were assigned to paliperidone, out of which 148 took the study medication.|148
10359565|NCT00490971|11499491|FG002|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
10359566|NCT00490971|11499492|FG003|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
10359567|NCT00490971|11499493|FG004|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
10359568|NCT00490971|11499489|FG000|COMPLETED|Acute/Continuation||308
10359569|NCT00490971|11499490|FG001|COMPLETED|Acute/Continuation||86
10427038|NCT00850759|11572814|FG002|COMPLETED|Overall Study||52
10359570|NCT00490971|11499491|FG002|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
10359571|NCT00490971|11499492|FG003|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
10359572|NCT00490971|11499493|FG004|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
10359573|NCT00490971|11499489|FG000|NOT COMPLETED|Acute/Continuation||306
10359574|NCT00490971|11499490|FG001|NOT COMPLETED|Acute/Continuation||62
10359575|NCT00490971|11499491|FG002|NOT COMPLETED|Acute/Continuation||0
10359576|NCT00490971|11499492|FG003|NOT COMPLETED|Acute/Continuation||0
10359577|NCT00490971|11499493|FG004|NOT COMPLETED|Acute/Continuation||0
10359578|NCT00490971|11499489|FG000|STARTED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
10359579|NCT00490971|11499490|FG001|STARTED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
10359580|NCT00490971|11499491|FG002|STARTED|Maintenance|148 participants were assigned to pali/placebo, out of which 147 took the study medication.|147
10359581|NCT00490971|11499492|FG003|STARTED|Maintenance|152 participants were assigned to pali/pali, out of which 149 took the study medication.|149
10359582|NCT00490971|11499493|FG004|STARTED|Maintenance||83
10359583|NCT00490971|11499489|FG000|COMPLETED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
10359584|NCT00490971|11499490|FG001|COMPLETED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
10359585|NCT00490971|11499491|FG002|COMPLETED|Maintenance||96
10359586|NCT00490971|11499492|FG003|COMPLETED|Maintenance||96
10359587|NCT00490971|11499493|FG004|COMPLETED|Maintenance||44
10359588|NCT00490971|11499489|FG000|NOT COMPLETED|Maintenance||0
10359589|NCT00490971|11499490|FG001|NOT COMPLETED|Maintenance||0
10359590|NCT00490971|11499491|FG002|NOT COMPLETED|Maintenance||51
10359591|NCT00490971|11499492|FG003|NOT COMPLETED|Maintenance||53
10359592|NCT00490971|11499493|FG004|NOT COMPLETED|Maintenance||39
10359593|NCT00491075|11499505|FG000|STARTED|Overall Study||16
10359594|NCT00491075|11499505|FG000|COMPLETED|Overall Study||14
10359595|NCT00491075|11499505|FG000|NOT COMPLETED|Overall Study||2
10359596|NCT00491179|11499511|FG000|STARTED|Overall Study||25
10359597|NCT00491179|11499512|FG001|STARTED|Overall Study||10
10359598|NCT00491179|11499511|FG000|COMPLETED|Overall Study||18
10359599|NCT00491179|11499512|FG001|COMPLETED|Overall Study||8
10359600|NCT00491179|11499511|FG000|NOT COMPLETED|Overall Study||7
10359601|NCT00491179|11499512|FG001|NOT COMPLETED|Overall Study||2
10359602|NCT00491244|11499520|FG000|STARTED|Overall Study||189
10359603|NCT00491244|11499521|FG001|STARTED|Overall Study||188
10359604|NCT00491244|11499520|FG000|COMPLETED|Overall Study||162
10359605|NCT00491244|11499521|FG001|COMPLETED|Overall Study||168
10359606|NCT00491244|11499520|FG000|NOT COMPLETED|Overall Study||27
10359607|NCT00491244|11499521|FG001|NOT COMPLETED|Overall Study||20
10359608|NCT00491322|11499529|FG000|STARTED|Overall Study||41
10359609|NCT00491322|11499530|FG001|STARTED|Overall Study||51
10359610|NCT00491322|11499529|FG000|COMPLETED|Overall Study||40
10359611|NCT00491322|11499530|FG001|COMPLETED|Overall Study||50
10359612|NCT00491322|11499529|FG000|NOT COMPLETED|Overall Study||1
10359613|NCT00491322|11499530|FG001|NOT COMPLETED|Overall Study||1
10359614|NCT00491374|11499538|FG000|STARTED|Overall Study||0
10359615|NCT00491374|11499539|FG001|STARTED|Overall Study||0
10359616|NCT00491374|11499538|FG000|COMPLETED|Overall Study||0
10359617|NCT00491374|11499539|FG001|COMPLETED|Overall Study||0
10359618|NCT00491374|11499538|FG000|NOT COMPLETED|Overall Study||0
10359619|NCT00491374|11499539|FG001|NOT COMPLETED|Overall Study||0
10359620|NCT00491491|11499547|FG000|STARTED|Overall Study||22
10359621|NCT00491491|11499548|FG001|STARTED|Overall Study||21
10359622|NCT00491491|11499547|FG000|COMPLETED|Overall Study||22
10359623|NCT00491491|11499548|FG001|COMPLETED|Overall Study||21
10359624|NCT00491491|11499547|FG000|NOT COMPLETED|Overall Study||0
10359625|NCT00491491|11499548|FG001|NOT COMPLETED|Overall Study||0
10359626|NCT00491530|11499557|FG000|STARTED|Overall Study||174
10359627|NCT00491530|11499558|FG001|STARTED|Overall Study||50
10359628|NCT00491530|11499559|FG002|STARTED|Overall Study||86
10359629|NCT00491530|11499557|FG000|COMPLETED|Overall Study||162
10359630|NCT00491530|11499558|FG001|COMPLETED|Overall Study||44
10359631|NCT00491530|11499559|FG002|COMPLETED|Overall Study||81
10359632|NCT00491530|11499557|FG000|NOT COMPLETED|Overall Study||12
10359633|NCT00491530|11499558|FG001|NOT COMPLETED|Overall Study||6
10359634|NCT00491530|11499559|FG002|NOT COMPLETED|Overall Study||5
10359635|NCT00491556|11499569|FG000|STARTED|Entry-Week (WK) 48: EXP/Standard Care||75
10359636|NCT00491556|11499570|FG001|STARTED|Entry-Week (WK) 48: EXP/Standard Care||27
10359637|NCT00491556|11499569|FG000|Wk 24 VL Suppressed (EXP)/WK 24 (STAND)|Entry-Week (WK) 48: EXP/Standard Care||53
10359638|NCT00491556|11499570|FG001|Wk 24 VL Suppressed (EXP)/WK 24 (STAND)|Entry-Week (WK) 48: EXP/Standard Care||27
10359639|NCT00491556|11499569|FG000|COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||49
10359640|NCT00491556|11499570|FG001|COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||27
10359641|NCT00491556|11499569|FG000|NOT COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||26
10359642|NCT00491556|11499570|FG001|NOT COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||0
10359643|NCT00491556|11499569|FG000|STARTED|Wk 48-152: EXP (On De-Int)/Standard Care||49
10359644|NCT00491556|11499570|FG001|STARTED|Wk 48-152: EXP (On De-Int)/Standard Care||27
10359645|NCT00491556|11499569|FG000|COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||25
10359646|NCT00491556|11499570|FG001|COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||22
10359647|NCT00491556|11499569|FG000|NOT COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||24
10359648|NCT00491556|11499570|FG001|NOT COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||5
10359649|NCT00491608|11499576|FG000|STARTED|Overall Study|Participants who received treatment|209
10359650|NCT00491608|11499576|FG000|COMPLETED|Overall Study||206
10359651|NCT00491608|11499576|FG000|NOT COMPLETED|Overall Study||3
10534681|NCT01431989|11686964|FG001|COMPLETED|Period 1||14
10534682|NCT01431989|11686963|FG000|NOT COMPLETED|Period 1||0
10534683|NCT01431989|11686964|FG001|NOT COMPLETED|Period 1||0
10534684|NCT01431989|11686963|FG000|STARTED|14-Day Washout Period||14
10534685|NCT01431989|11686964|FG001|STARTED|14-Day Washout Period||14
10534686|NCT01431989|11686963|FG000|COMPLETED|14-Day Washout Period||14
10534687|NCT01431989|11686964|FG001|COMPLETED|14-Day Washout Period||14
10534688|NCT01431989|11686963|FG000|NOT COMPLETED|14-Day Washout Period||0
10534689|NCT01431989|11686964|FG001|NOT COMPLETED|14-Day Washout Period||0
10534690|NCT01431989|11686963|FG000|STARTED|Period 2||14
10534691|NCT01431989|11686964|FG001|STARTED|Period 2||14
10534692|NCT01431989|11686963|FG000|COMPLETED|Period 2||14
10534693|NCT01431989|11686964|FG001|COMPLETED|Period 2||14
10534694|NCT01431989|11686963|FG000|NOT COMPLETED|Period 2||0
10534695|NCT01431989|11686964|FG001|NOT COMPLETED|Period 2||0
10534696|NCT01432015|11686972|FG000|STARTED|Overall Study||10
10534697|NCT01432015|11686973|FG001|STARTED|Overall Study||10
10534698|NCT01432015|11686972|FG000|COMPLETED|Overall Study||10
10534699|NCT01432015|11686973|FG001|COMPLETED|Overall Study||10
10534700|NCT01432015|11686972|FG000|NOT COMPLETED|Overall Study||0
10534701|NCT01432015|11686973|FG001|NOT COMPLETED|Overall Study||0
10534702|NCT01432145|11686979|FG000|STARTED|Overall Study|Corrected from 75. 75 was entered in error|74
10534703|NCT01432145|11686979|FG000|COMPLETED|Overall Study||67
10534704|NCT01432145|11686979|FG000|NOT COMPLETED|Overall Study||7
10534705|NCT01432171|11686985|FG000|STARTED|Overall Study||18
10534706|NCT01432171|11686986|FG001|STARTED|Overall Study||19
10534707|NCT01432171|11686985|FG000|COMPLETED|Overall Study||4
10534708|NCT01432171|11686986|FG001|COMPLETED|Overall Study||8
10534709|NCT01432171|11686985|FG000|NOT COMPLETED|Overall Study||14
10534710|NCT01432171|11686986|FG001|NOT COMPLETED|Overall Study||11
10534711|NCT01432236|11686994|FG000|STARTED|Overall Study||96
10534712|NCT01432236|11686995|FG001|STARTED|Overall Study||97
10534713|NCT01432236|11686994|FG000|COMPLETED|Overall Study||70
10534714|NCT01432236|11686995|FG001|COMPLETED|Overall Study||79
10534715|NCT01432236|11686994|FG000|NOT COMPLETED|Overall Study||26
10534716|NCT01432236|11686995|FG001|NOT COMPLETED|Overall Study||18
10534717|NCT01432262|11687010|FG000|STARTED|Overall Study||162
10534718|NCT01432262|11687011|FG001|STARTED|Overall Study||162
10534719|NCT01432262|11687010|FG000|Vaccinated|Overall Study||162
10534720|NCT01432262|11687011|FG001|Vaccinated|Overall Study||161
10534721|NCT01432262|11687010|FG000|COMPLETED|Overall Study||160
10534722|NCT01432262|11687011|FG001|COMPLETED|Overall Study||161
10534723|NCT01432262|11687010|FG000|NOT COMPLETED|Overall Study||2
10534724|NCT01432262|11687011|FG001|NOT COMPLETED|Overall Study||1
10534725|NCT01432275|11687017|FG000|STARTED|First BG Meter System (7 Days)||90
10534726|NCT01432275|11687018|FG001|STARTED|First BG Meter System (7 Days)||87
10534727|NCT01432275|11687017|FG000|COMPLETED|First BG Meter System (7 Days)||90
10534728|NCT01432275|11687018|FG001|COMPLETED|First BG Meter System (7 Days)||84
10534729|NCT01432275|11687017|FG000|NOT COMPLETED|First BG Meter System (7 Days)||0
10534730|NCT01432275|11687018|FG001|NOT COMPLETED|First BG Meter System (7 Days)||3
10534731|NCT01432275|11687017|FG000|STARTED|Second BG Meter System (7 Days)||90
10534732|NCT01432275|11687018|FG001|STARTED|Second BG Meter System (7 Days)||84
10534733|NCT01432275|11687017|FG000|COMPLETED|Second BG Meter System (7 Days)||88
10534734|NCT01432275|11687018|FG001|COMPLETED|Second BG Meter System (7 Days)||81
10534735|NCT01432275|11687017|FG000|NOT COMPLETED|Second BG Meter System (7 Days)||2
10534736|NCT01432275|11687018|FG001|NOT COMPLETED|Second BG Meter System (7 Days)||3
10534737|NCT01432275|11687017|FG000|STARTED|ADC With Calculator (10 Days)||88
10534738|NCT01432275|11687018|FG001|STARTED|ADC With Calculator (10 Days)||81
10534739|NCT01432275|11687017|FG000|COMPLETED|ADC With Calculator (10 Days)||85
10534740|NCT01432275|11687018|FG001|COMPLETED|ADC With Calculator (10 Days)||79
10534741|NCT01432275|11687017|FG000|NOT COMPLETED|ADC With Calculator (10 Days)||3
10534742|NCT01432275|11687018|FG001|NOT COMPLETED|ADC With Calculator (10 Days)||2
10534743|NCT01432327|11687028|FG000|STARTED|Baseline||56
10534744|NCT01432327|11687029|FG001|STARTED|Baseline||57
10534745|NCT01432327|11687030|FG002|STARTED|Baseline||57
10534746|NCT01432327|11687031|FG003|STARTED|Baseline||57
10534747|NCT01432327|11687028|FG000|COMPLETED|Baseline||56
10534748|NCT01432327|11687029|FG001|COMPLETED|Baseline||57
10534749|NCT01432327|11687030|FG002|COMPLETED|Baseline||57
10534750|NCT01432327|11687031|FG003|COMPLETED|Baseline||57
10534751|NCT01432327|11687028|FG000|NOT COMPLETED|Baseline||0
10534752|NCT01432327|11687029|FG001|NOT COMPLETED|Baseline||0
10534753|NCT01432327|11687030|FG002|NOT COMPLETED|Baseline||0
10534754|NCT01432327|11687031|FG003|NOT COMPLETED|Baseline||0
10716238|NCT02688387|11880047|FG004|STARTED|Part 3B, Period 3 (up to 6 Days)||0
10716239|NCT02688387|11880048|FG005|STARTED|Part 3B, Period 3 (up to 6 Days)||0
10359652|NCT00491751|11499583|FG000|STARTED|Overall Study||22
10359653|NCT00491751|11499584|FG001|STARTED|Overall Study||44
10359654|NCT00491751|11499585|FG002|STARTED|Overall Study||42
10359655|NCT00491751|11499583|FG000|COMPLETED|Overall Study||22
10359656|NCT00491751|11499584|FG001|COMPLETED|Overall Study||44
10359657|NCT00491751|11499585|FG002|COMPLETED|Overall Study||42
10359658|NCT00491751|11499583|FG000|NOT COMPLETED|Overall Study||0
10359659|NCT00491751|11499584|FG001|NOT COMPLETED|Overall Study||0
10359660|NCT00491751|11499585|FG002|NOT COMPLETED|Overall Study||0
10359661|NCT00491764|11499601|FG000|STARTED|Overall Study||37
10359662|NCT00491764|11499602|FG001|STARTED|Overall Study||37
10359663|NCT00491764|11499603|FG002|STARTED|Overall Study||36
10359664|NCT00491764|11499604|FG003|STARTED|Overall Study||36
10359665|NCT00491764|11499605|FG004|STARTED|Overall Study||36
10359666|NCT00491764|11499606|FG005|STARTED|Overall Study||36
10359667|NCT00491764|11499601|FG000|COMPLETED|Overall Study||32
10359668|NCT00491764|11499602|FG001|COMPLETED|Overall Study||30
10359669|NCT00491764|11499603|FG002|COMPLETED|Overall Study||28
10359670|NCT00491764|11499604|FG003|COMPLETED|Overall Study||28
10359671|NCT00491764|11499605|FG004|COMPLETED|Overall Study||33
10359672|NCT00491764|11499606|FG005|COMPLETED|Overall Study||27
10359673|NCT00491764|11499601|FG000|NOT COMPLETED|Overall Study||5
10359674|NCT00491764|11499602|FG001|NOT COMPLETED|Overall Study||7
10359675|NCT00491764|11499603|FG002|NOT COMPLETED|Overall Study||8
10534755|NCT01432327|11687028|FG000|STARTED|Posttest 3 Months||56
10534756|NCT01432327|11687029|FG001|STARTED|Posttest 3 Months||57
10534757|NCT01432327|11687030|FG002|STARTED|Posttest 3 Months||57
10534758|NCT01432327|11687031|FG003|STARTED|Posttest 3 Months||57
10534759|NCT01432327|11687028|FG000|COMPLETED|Posttest 3 Months||52
10534760|NCT01432327|11687029|FG001|COMPLETED|Posttest 3 Months||55
10534761|NCT01432327|11687030|FG002|COMPLETED|Posttest 3 Months||55
10656454|NCT02217982|11817435|FG001|NOT COMPLETED|Overall Study||1
10656455|NCT02218008|11817444|FG000|STARTED|Stage 1 (S1)||280
10656456|NCT02218008|11817445|FG001|STARTED|Stage 1 (S1)||63
10656457|NCT02218008|11817446|FG002|STARTED|Stage 1 (S1)||63
10656458|NCT02218008|11817447|FG003|STARTED|Stage 1 (S1)||0
10656459|NCT02218008|11817448|FG004|STARTED|Stage 1 (S1)||0
10656460|NCT02218008|11817449|FG005|STARTED|Stage 1 (S1)||0
10656461|NCT02218008|11817444|FG000|COMPLETED|Stage 1 (S1)||258
10656462|NCT02218008|11817445|FG001|COMPLETED|Stage 1 (S1)||56
10656463|NCT02218008|11817446|FG002|COMPLETED|Stage 1 (S1)||48
10656464|NCT02218008|11817447|FG003|COMPLETED|Stage 1 (S1)||0
10656465|NCT02218008|11817448|FG004|COMPLETED|Stage 1 (S1)||0
10656466|NCT02218008|11817449|FG005|COMPLETED|Stage 1 (S1)||0
10656467|NCT02218008|11817444|FG000|NOT COMPLETED|Stage 1 (S1)||22
10656468|NCT02218008|11817445|FG001|NOT COMPLETED|Stage 1 (S1)||7
10656469|NCT02218008|11817446|FG002|NOT COMPLETED|Stage 1 (S1)||15
10656470|NCT02218008|11817447|FG003|NOT COMPLETED|Stage 1 (S1)||0
10656471|NCT02218008|11817448|FG004|NOT COMPLETED|Stage 1 (S1)||0
10656472|NCT02218008|11817449|FG005|NOT COMPLETED|Stage 1 (S1)||0
10656473|NCT02218008|11817444|FG000|STARTED|Stage 2 (S2)||0
10656474|NCT02218008|11817445|FG001|STARTED|Stage 2 (S2)||0
10656475|NCT02218008|11817446|FG002|STARTED|Stage 2 (S2)||0
10656476|NCT02218008|11817447|FG003|STARTED|Stage 2 (S2)||62
10656477|NCT02218008|11817448|FG004|STARTED|Stage 2 (S2)||62
10656478|NCT02218008|11817449|FG005|STARTED|Stage 2 (S2)||63
10656479|NCT02218008|11817444|FG000|COMPLETED|Stage 2 (S2)||0
10656480|NCT02218008|11817445|FG001|COMPLETED|Stage 2 (S2)||0
10656481|NCT02218008|11817446|FG002|COMPLETED|Stage 2 (S2)||0
10656482|NCT02218008|11817447|FG003|COMPLETED|Stage 2 (S2)||58
10656483|NCT02218008|11817448|FG004|COMPLETED|Stage 2 (S2)||58
10656484|NCT02218008|11817449|FG005|COMPLETED|Stage 2 (S2)||57
10656485|NCT02218008|11817444|FG000|NOT COMPLETED|Stage 2 (S2)||0
10656486|NCT02218008|11817445|FG001|NOT COMPLETED|Stage 2 (S2)||0
10656487|NCT02218008|11817446|FG002|NOT COMPLETED|Stage 2 (S2)||0
10656488|NCT02218008|11817447|FG003|NOT COMPLETED|Stage 2 (S2)||4
10656489|NCT02218008|11817448|FG004|NOT COMPLETED|Stage 2 (S2)||4
10656490|NCT02218008|11817449|FG005|NOT COMPLETED|Stage 2 (S2)||6
10656491|NCT02218190|11817465|FG000|STARTED|Overall Study||13
10656492|NCT02218190|11817466|FG001|STARTED|Overall Study||13
10656493|NCT02218190|11817465|FG000|COMPLETED|Overall Study||13
10656494|NCT02218190|11817466|FG001|COMPLETED|Overall Study||13
10656495|NCT02218190|11817465|FG000|NOT COMPLETED|Overall Study||0
10656496|NCT02218190|11817466|FG001|NOT COMPLETED|Overall Study||0
10656497|NCT02218203|11817472|FG000|STARTED|Overall Study||26
10656498|NCT02218203|11817472|FG000|Placebo Dex v. 0mg/km LBM Lidocaine|Overall Study||24
10656499|NCT02218203|11817472|FG000|Placebo Dex v. 1mg/km LBM Lidocaine|Overall Study||24
10656500|NCT02218203|11817472|FG000|Placebo Dex v. 2mg/km LBM Lidocaine|Overall Study||24
10656501|NCT02218203|11817472|FG000|Placebo Dex v. 4mg/km LBM Lidocaine|Overall Study||24
10656502|NCT02218203|11817472|FG000|Low Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||26
10656503|NCT02218203|11817472|FG000|Low Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||26
10656504|NCT02218203|11817472|FG000|Low Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||26
10656505|NCT02218203|11817472|FG000|Low Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||26
10656506|NCT02218203|11817472|FG000|Medium Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||24
10656507|NCT02218203|11817472|FG000|Medium Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||24
10656508|NCT02218203|11817472|FG000|Medium Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||24
10359676|NCT00491764|11499604|FG003|NOT COMPLETED|Overall Study||8
10359677|NCT00491764|11499605|FG004|NOT COMPLETED|Overall Study||3
10359678|NCT00491764|11499606|FG005|NOT COMPLETED|Overall Study||9
10534762|NCT01432327|11687031|FG003|COMPLETED|Posttest 3 Months||56
10534763|NCT01432327|11687028|FG000|NOT COMPLETED|Posttest 3 Months||4
10656509|NCT02218203|11817472|FG000|Medium Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||24
10656510|NCT02218203|11817472|FG000|High Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||24
10656511|NCT02218203|11817472|FG000|High Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||24
10656512|NCT02218203|11817472|FG000|High Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||24
10656513|NCT02218203|11817472|FG000|High Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||24
10656514|NCT02218203|11817472|FG000|COMPLETED|Overall Study|2 subjects did not complete the placebo, medium dose, and high dose dex/lido combination arms.|26
10656515|NCT02218203|11817472|FG000|NOT COMPLETED|Overall Study||0
10656516|NCT02218216|11817496|FG000|STARTED|Overall Study||14
10656517|NCT02218216|11817497|FG001|STARTED|Overall Study||2
10359679|NCT00491829|11499623|FG000|STARTED|Overall Study||311
10359680|NCT00491829|11499624|FG001|STARTED|Overall Study||316
10359681|NCT00491829|11499625|FG002|STARTED|Overall Study||318
10359682|NCT00491829|11499623|FG000|COMPLETED|Overall Study||216
10359683|NCT00491829|11499624|FG001|COMPLETED|Overall Study||202
10359684|NCT00491829|11499625|FG002|COMPLETED|Overall Study||243
10359685|NCT00491829|11499623|FG000|NOT COMPLETED|Overall Study||95
10359686|NCT00491829|11499624|FG001|NOT COMPLETED|Overall Study||114
10359687|NCT00491829|11499625|FG002|NOT COMPLETED|Overall Study||75
10359688|NCT00491894|11499633|FG000|STARTED|Overall Study||137
10359689|NCT00491894|11499633|FG000|COMPLETED|Overall Study||103
10359690|NCT00491894|11499633|FG000|NOT COMPLETED|Overall Study||34
10359691|NCT00492024|11499639|FG000|STARTED|Treatment||251
10359692|NCT00492024|11499640|FG001|STARTED|Treatment||123
10359693|NCT00492024|11499639|FG000|COMPLETED|Treatment||222
10359694|NCT00492024|11499640|FG001|COMPLETED|Treatment||101
10359695|NCT00492024|11499639|FG000|NOT COMPLETED|Treatment||29
10359696|NCT00492024|11499640|FG001|NOT COMPLETED|Treatment||22
10359697|NCT00492024|11499639|FG000|STARTED|Follow up||222
10359698|NCT00492024|11499640|FG001|STARTED|Follow up||101
10359699|NCT00492024|11499639|FG000|COMPLETED|Follow up||221
10359700|NCT00492024|11499640|FG001|COMPLETED|Follow up||99
10359701|NCT00492024|11499639|FG000|NOT COMPLETED|Follow up||1
10359702|NCT00492024|11499640|FG001|NOT COMPLETED|Follow up||2
10359703|NCT00492063|11499650|FG000|STARTED|Overall Study||652
10359704|NCT00492063|11499651|FG001|STARTED|Overall Study||648
10359705|NCT00492063|11499652|FG002|STARTED|Overall Study||678
10359706|NCT00492063|11499653|FG003|STARTED|Overall Study||676
10359707|NCT00492063|11499650|FG000|COMPLETED|Overall Study||642
10359708|NCT00492063|11499651|FG001|COMPLETED|Overall Study||634
10359709|NCT00492063|11499652|FG002|COMPLETED|Overall Study||667
10359710|NCT00492063|11499653|FG003|COMPLETED|Overall Study||666
10359711|NCT00492063|11499650|FG000|NOT COMPLETED|Overall Study||10
10359712|NCT00492063|11499651|FG001|NOT COMPLETED|Overall Study||14
10359713|NCT00492063|11499652|FG002|NOT COMPLETED|Overall Study||11
10359714|NCT00492063|11499653|FG003|NOT COMPLETED|Overall Study||10
10359715|NCT00492089|11499665|FG000|STARTED|First Intervention (6 Weeks)||5
10359716|NCT00492089|11499666|FG001|STARTED|First Intervention (6 Weeks)||6
10359717|NCT00492089|11499665|FG000|COMPLETED|First Intervention (6 Weeks)||5
10359718|NCT00492089|11499666|FG001|COMPLETED|First Intervention (6 Weeks)||6
10359719|NCT00492089|11499665|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
10359720|NCT00492089|11499666|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
10359721|NCT00492089|11499665|FG000|STARTED|Second Intervention (6 Weeks)||5
10359722|NCT00492089|11499666|FG001|STARTED|Second Intervention (6 Weeks)||6
10359723|NCT00492089|11499665|FG000|COMPLETED|Second Intervention (6 Weeks)||5
10359724|NCT00492089|11499666|FG001|COMPLETED|Second Intervention (6 Weeks)||6
10359725|NCT00492089|11499665|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
10359726|NCT00492089|11499666|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
10359727|NCT00492115|11499674|FG000|STARTED|Overall Study||19
10359728|NCT00492115|11499675|FG001|STARTED|Overall Study||19
10359729|NCT00492115|11499674|FG000|COMPLETED|Overall Study|3 dropped due to anxiety or not being able to tolerate CPAP|16
10359730|NCT00492115|11499675|FG001|COMPLETED|Overall Study|4 dropped due to not being able to tolerate CPAP|15
10359731|NCT00492115|11499674|FG000|NOT COMPLETED|Overall Study||3
10359732|NCT00492115|11499675|FG001|NOT COMPLETED|Overall Study||4
10359733|NCT00492206|11499681|FG000|STARTED|Overall Study||40
10359734|NCT00492206|11499681|FG000|COMPLETED|Overall Study||40
10359735|NCT00492206|11499681|FG000|NOT COMPLETED|Overall Study||0
10359736|NCT00492232|11499689|FG000|STARTED|Placebo Run-in||0
10359737|NCT00492232|11499690|FG001|STARTED|Placebo Run-in|All subjects received placebo in the placebo run-in period.|205
10359738|NCT00492232|11499689|FG000|COMPLETED|Placebo Run-in||0
10359739|NCT00492232|11499690|FG001|COMPLETED|Placebo Run-in|These subjects successfully completed the placebo run-in period and were randomized to the DBTP.|135
10359740|NCT00492232|11499689|FG000|NOT COMPLETED|Placebo Run-in||0
10359741|NCT00492232|11499690|FG001|NOT COMPLETED|Placebo Run-in||70
10359742|NCT00492232|11499689|FG000|STARTED|Double-Blind Treatment||65
10359743|NCT00492232|11499690|FG001|STARTED|Double-Blind Treatment||70
10359744|NCT00492232|11499689|FG000|COMPLETED|Double-Blind Treatment||47
10359745|NCT00492232|11499690|FG001|COMPLETED|Double-Blind Treatment||45
10359746|NCT00492232|11499689|FG000|NOT COMPLETED|Double-Blind Treatment||18
10359747|NCT00492232|11499690|FG001|NOT COMPLETED|Double-Blind Treatment||25
10359748|NCT00492232|11499689|FG000|STARTED|Open-Label Treatment|In the previous DBTP, 45 and 44 subjects were randomized to ramelteon and placebo, respectively.|89
10359749|NCT00492232|11499690|FG001|STARTED|Open-Label Treatment|All subjects received ramelteon in the OLTP.|0
10359750|NCT00492232|11499689|FG000|COMPLETED|Open-Label Treatment||88
10359751|NCT00492232|11499690|FG001|COMPLETED|Open-Label Treatment||0
10359752|NCT00492232|11499689|FG000|NOT COMPLETED|Open-Label Treatment||1
10359753|NCT00492232|11499690|FG001|NOT COMPLETED|Open-Label Treatment||0
10359754|NCT00492284|11499700|FG000|STARTED|Overall Study||39
10359755|NCT00492284|11499701|FG001|STARTED|Overall Study||39
10359756|NCT00492284|11499702|FG002|STARTED|Overall Study||43
10359757|NCT00492284|11499703|FG003|STARTED|Overall Study||41
10359758|NCT00492284|11499700|FG000|COMPLETED|Overall Study||38
10359759|NCT00492284|11499701|FG001|COMPLETED|Overall Study||35
10359760|NCT00492284|11499702|FG002|COMPLETED|Overall Study||37
10359761|NCT00492284|11499703|FG003|COMPLETED|Overall Study||31
10359762|NCT00492284|11499700|FG000|NOT COMPLETED|Overall Study||1
10359763|NCT00492284|11499701|FG001|NOT COMPLETED|Overall Study||4
10359764|NCT00492284|11499702|FG002|NOT COMPLETED|Overall Study||6
10359765|NCT00492284|11499703|FG003|NOT COMPLETED|Overall Study||10
10359766|NCT00492297|11499713|FG000|STARTED|Treatment||83
10359767|NCT00492297|11499713|FG000|First Stage of Simon Optimal Design|Treatment|32 subjects of 83 subjects enrolled were treated in first stage.|32
10359768|NCT00492297|11499713|FG000|Second Stage of Simon Optimal Design|Treatment|Recruitment continued into the second stage. 51 of 83 subjects were treated in the second stage.|51
10359769|NCT00492297|11499713|FG000|COMPLETED|Treatment||78
10359770|NCT00492297|11499713|FG000|NOT COMPLETED|Treatment||5
10359771|NCT00492297|11499713|FG000|STARTED|Active Follow-up 30(+4) Days Duration|AFU is 30(+4) days duration for subjects withdrawn from sorafenib due to PD.|78
10359772|NCT00492297|11499713|FG000|COMPLETED|Active Follow-up 30(+4) Days Duration||59
10359773|NCT00492297|11499713|FG000|NOT COMPLETED|Active Follow-up 30(+4) Days Duration||19
10359774|NCT00492297|11499713|FG000|STARTED|Survival Only Follow-up||59
10359775|NCT00492297|11499713|FG000|COMPLETED|Survival Only Follow-up||0
10359776|NCT00492297|11499713|FG000|NOT COMPLETED|Survival Only Follow-up||59
10359777|NCT00492336|11499719|FG000|STARTED|Overall Study||28
10359778|NCT00492336|11499720|FG001|STARTED|Overall Study||29
10359779|NCT00492336|11499719|FG000|COMPLETED|Overall Study||26
10359780|NCT00492336|11499720|FG001|COMPLETED|Overall Study||23
10359781|NCT00492336|11499719|FG000|NOT COMPLETED|Overall Study||2
10359782|NCT00492336|11499720|FG001|NOT COMPLETED|Overall Study||6
10427039|NCT00850759|11572815|FG003|COMPLETED|Overall Study||55
10427040|NCT00850759|11572812|FG000|NOT COMPLETED|Overall Study||7
10427041|NCT00850759|11572813|FG001|NOT COMPLETED|Overall Study||5
10427042|NCT00850759|11572814|FG002|NOT COMPLETED|Overall Study||5
10427043|NCT00850759|11572815|FG003|NOT COMPLETED|Overall Study||3
10427044|NCT00850889|11572825|FG000|STARTED|Overall Study||32
10427045|NCT00850889|11572825|FG000|COMPLETED|Overall Study||32
10427046|NCT00850889|11572825|FG000|NOT COMPLETED|Overall Study||0
10427047|NCT00850993|11572836|FG000|STARTED|Overall Study||17
10427048|NCT00850993|11572837|FG001|STARTED|Overall Study||18
10427049|NCT00850993|11572838|FG002|STARTED|Overall Study||8
10427050|NCT00850993|11572839|FG003|STARTED|Overall Study||15
10534764|NCT01432327|11687029|FG001|NOT COMPLETED|Posttest 3 Months||2
10534765|NCT01432327|11687030|FG002|NOT COMPLETED|Posttest 3 Months||2
10534766|NCT01432327|11687031|FG003|NOT COMPLETED|Posttest 3 Months||1
10534767|NCT01432327|11687028|FG000|STARTED|Posttest 6 Months||52
10534768|NCT01432327|11687029|FG001|STARTED|Posttest 6 Months||55
10534769|NCT01432327|11687030|FG002|STARTED|Posttest 6 Months||55
10534770|NCT01432327|11687031|FG003|STARTED|Posttest 6 Months||56
10534771|NCT01432327|11687028|FG000|COMPLETED|Posttest 6 Months||52
10534772|NCT01432327|11687029|FG001|COMPLETED|Posttest 6 Months||55
10534773|NCT01432327|11687030|FG002|COMPLETED|Posttest 6 Months||50
10534774|NCT01432327|11687031|FG003|COMPLETED|Posttest 6 Months||54
10534775|NCT01432327|11687028|FG000|NOT COMPLETED|Posttest 6 Months||0
10534776|NCT01432327|11687029|FG001|NOT COMPLETED|Posttest 6 Months||0
10534777|NCT01432327|11687030|FG002|NOT COMPLETED|Posttest 6 Months||5
10534778|NCT01432327|11687031|FG003|NOT COMPLETED|Posttest 6 Months||2
10534779|NCT01432327|11687028|FG000|STARTED|Posttest 1 Year||52
10534780|NCT01432327|11687029|FG001|STARTED|Posttest 1 Year||55
10534781|NCT01432327|11687030|FG002|STARTED|Posttest 1 Year||50
10534782|NCT01432327|11687031|FG003|STARTED|Posttest 1 Year||54
10534783|NCT01432327|11687028|FG000|COMPLETED|Posttest 1 Year||28
10534784|NCT01432327|11687029|FG001|COMPLETED|Posttest 1 Year||27
10534785|NCT01432327|11687030|FG002|COMPLETED|Posttest 1 Year||30
10534786|NCT01432327|11687031|FG003|COMPLETED|Posttest 1 Year||31
10534787|NCT01432327|11687028|FG000|NOT COMPLETED|Posttest 1 Year||24
10534788|NCT01432327|11687029|FG001|NOT COMPLETED|Posttest 1 Year||28
10534789|NCT01432327|11687030|FG002|NOT COMPLETED|Posttest 1 Year||20
10534790|NCT01432327|11687031|FG003|NOT COMPLETED|Posttest 1 Year||23
10716240|NCT02688387|11880049|FG006|STARTED|Part 3B, Period 3 (up to 6 Days)||0
10716241|NCT02688387|11880050|FG007|STARTED|Part 3B, Period 3 (up to 6 Days)||0
10716242|NCT02688387|11880051|FG008|STARTED|Part 3B, Period 3 (up to 6 Days)||0
10716243|NCT02688387|11880052|FG009|STARTED|Part 3B, Period 3 (up to 6 Days)||0
10716244|NCT02688387|11880053|FG010|STARTED|Part 3B, Period 3 (up to 6 Days)||0
10716245|NCT02688387|11880054|FG011|STARTED|Part 3B, Period 3 (up to 6 Days)||0
10427051|NCT00850993|11572836|FG000|Safety|Overall Study||17
10427052|NCT00850993|11572837|FG001|Safety|Overall Study||18
10427053|NCT00850993|11572838|FG002|Safety|Overall Study||8
10427054|NCT00850993|11572839|FG003|Safety|Overall Study||15
10427055|NCT00850993|11572836|FG000|Intent-to-treat|Overall Study||17
10534791|NCT01432366|11687041|FG000|STARTED|Overall Study||460
10534792|NCT01432366|11687041|FG000|COMPLETED|Overall Study||392
10534793|NCT01432366|11687041|FG000|NOT COMPLETED|Overall Study||68
10534794|NCT01432379|11687045|FG000|STARTED|Overall Study||1168
10534795|NCT01432379|11687045|FG000|COMPLETED|Overall Study||783
10534796|NCT01432379|11687045|FG000|NOT COMPLETED|Overall Study||385
10359783|NCT00492401|11499726|FG000|STARTED|Overall Study||55
10359784|NCT00492401|11499726|FG000|COMPLETED|Overall Study||55
10359785|NCT00492401|11499726|FG000|NOT COMPLETED|Overall Study||0
10359786|NCT00492531|11499734|FG000|STARTED|Overall Study||37
10359787|NCT00492531|11499735|FG001|STARTED|Overall Study||37
10359788|NCT00492531|11499734|FG000|COMPLETED|Overall Study|Of 15 subjects who completed study, 13 were enrolled in Open label.|15
10359789|NCT00492531|11499735|FG001|COMPLETED|Overall Study|Of 14 subjects who completed study, 13 were enrolled in Open label.|14
10359790|NCT00492531|11499734|FG000|NOT COMPLETED|Overall Study||22
10359791|NCT00492531|11499735|FG001|NOT COMPLETED|Overall Study||23
10359792|NCT00492544|11499741|FG000|STARTED|Overall Study||100
10359793|NCT00492544|11499741|FG000|COMPLETED|Overall Study||100
10359794|NCT00492544|11499741|FG000|NOT COMPLETED|Overall Study||0
10359795|NCT00492557|11499747|FG000|STARTED|Overall Study||580
10359796|NCT00492557|11499748|FG001|STARTED|Overall Study||580
10359797|NCT00492557|11499747|FG000|Vaccinated Dose 1|Overall Study||577
10359798|NCT00492557|11499748|FG001|Vaccinated Dose 1|Overall Study||575
10359799|NCT00492557|11499747|FG000|Vaccinated Dose 2|Overall Study||560
10359800|NCT00492557|11499748|FG001|Vaccinated Dose 2|Overall Study||558
10359801|NCT00492557|11499747|FG000|COMPLETED|Overall Study||556
10359802|NCT00492557|11499748|FG001|COMPLETED|Overall Study||557
10359803|NCT00492557|11499747|FG000|NOT COMPLETED|Overall Study||24
10359804|NCT00492557|11499748|FG001|NOT COMPLETED|Overall Study||23
10359805|NCT00492583|11499759|FG000|STARTED|Overall Study||95
10359806|NCT00492583|11499760|FG001|STARTED|Overall Study||87
10359807|NCT00492583|11499759|FG000|COMPLETED|Overall Study||95
10359808|NCT00492583|11499760|FG001|COMPLETED|Overall Study||87
10359809|NCT00492583|11499759|FG000|NOT COMPLETED|Overall Study||0
10359810|NCT00492583|11499760|FG001|NOT COMPLETED|Overall Study||0
10359811|NCT00492622|11499766|FG000|STARTED|Overall Study|all subjects received the immediate release formulation|12
10359812|NCT00492622|11499766|FG000|COMPLETED|Overall Study||12
10359813|NCT00492622|11499766|FG000|NOT COMPLETED|Overall Study||0
10359814|NCT00492648|11499776|FG000|STARTED|Month 30 (109671 Study)||4
10359815|NCT00492648|11499777|FG001|STARTED|Month 30 (109671 Study)||30
10359816|NCT00492648|11499776|FG000|COMPLETED|Month 30 (109671 Study)||4
10359817|NCT00492648|11499777|FG001|COMPLETED|Month 30 (109671 Study)||29
10359818|NCT00492648|11499776|FG000|NOT COMPLETED|Month 30 (109671 Study)||0
10359819|NCT00492648|11499777|FG001|NOT COMPLETED|Month 30 (109671 Study)||1
10359820|NCT00492648|11499776|FG000|STARTED|Month 42 (109674 Study)||3
10359821|NCT00492648|11499777|FG001|STARTED|Month 42 (109674 Study)||20
10534797|NCT01432405|11687051|FG000|STARTED|Overall Study||12
10534798|NCT01432405|11687052|FG001|STARTED|Overall Study||12
10534799|NCT01432405|11687051|FG000|COMPLETED|Overall Study||11
10534800|NCT01432405|11687052|FG001|COMPLETED|Overall Study||10
10534801|NCT01432405|11687051|FG000|NOT COMPLETED|Overall Study||1
10534802|NCT01432405|11687052|FG001|NOT COMPLETED|Overall Study||2
10534803|NCT01432444|11687058|FG000|STARTED|Tolerability/Cross-titration Phase||325
10534804|NCT01432444|11687059|FG001|STARTED|Tolerability/Cross-titration Phase||0
10534805|NCT01432444|11687060|FG002|STARTED|Tolerability/Cross-titration Phase||0
10534806|NCT01432444|11687058|FG000|COMPLETED|Tolerability/Cross-titration Phase||265
10534807|NCT01432444|11687059|FG001|COMPLETED|Tolerability/Cross-titration Phase||0
10534808|NCT01432444|11687060|FG002|COMPLETED|Tolerability/Cross-titration Phase||0
10534809|NCT01432444|11687058|FG000|NOT COMPLETED|Tolerability/Cross-titration Phase||60
10534810|NCT01432444|11687059|FG001|NOT COMPLETED|Tolerability/Cross-titration Phase||0
10534811|NCT01432444|11687060|FG002|NOT COMPLETED|Tolerability/Cross-titration Phase||0
10534812|NCT01432444|11687058|FG000|STARTED|Treatment Phase||0
10534813|NCT01432444|11687059|FG001|STARTED|Treatment Phase||433
10534814|NCT01432444|11687060|FG002|STARTED|Treatment Phase||0
10534815|NCT01432444|11687058|FG000|COMPLETED|Treatment Phase||0
10534816|NCT01432444|11687059|FG001|COMPLETED|Treatment Phase||293
10534817|NCT01432444|11687060|FG002|COMPLETED|Treatment Phase||0
10656518|NCT02218216|11817498|FG002|STARTED|Overall Study||3
10656519|NCT02218216|11817496|FG000|COMPLETED|Overall Study||8
10656520|NCT02218216|11817497|FG001|COMPLETED|Overall Study||2
10656521|NCT02218216|11817498|FG002|COMPLETED|Overall Study||3
10656522|NCT02218216|11817496|FG000|NOT COMPLETED|Overall Study||6
10656523|NCT02218216|11817497|FG001|NOT COMPLETED|Overall Study||0
10656524|NCT02218216|11817498|FG002|NOT COMPLETED|Overall Study||0
10656525|NCT02218242|11817506|FG000|STARTED|Overall Study||9
10656526|NCT02218242|11817506|FG000|COMPLETED|Overall Study||9
10656527|NCT02218242|11817506|FG000|NOT COMPLETED|Overall Study||0
10656528|NCT02218268|11817510|FG000|STARTED|First Phase (2 Hours)||30
10656529|NCT02218268|11817511|FG001|STARTED|First Phase (2 Hours)||30
10656530|NCT02218268|11817510|FG000|COMPLETED|First Phase (2 Hours)||30
10656531|NCT02218268|11817511|FG001|COMPLETED|First Phase (2 Hours)||30
10656532|NCT02218268|11817510|FG000|NOT COMPLETED|First Phase (2 Hours)||0
10656533|NCT02218268|11817511|FG001|NOT COMPLETED|First Phase (2 Hours)||0
10359822|NCT00492648|11499776|FG000|COMPLETED|Month 42 (109674 Study)||3
10359823|NCT00492648|11499777|FG001|COMPLETED|Month 42 (109674 Study)||20
10534818|NCT01432444|11687058|FG000|NOT COMPLETED|Treatment Phase||0
10534819|NCT01432444|11687059|FG001|NOT COMPLETED|Treatment Phase||140
10534820|NCT01432444|11687060|FG002|NOT COMPLETED|Treatment Phase||0
10534821|NCT01432444|11687058|FG000|STARTED|Extension Phase||0
10534822|NCT01432444|11687059|FG001|STARTED|Extension Phase||0
10359824|NCT00492648|11499776|FG000|NOT COMPLETED|Month 42 (109674 Study)||0
10359825|NCT00492648|11499777|FG001|NOT COMPLETED|Month 42 (109674 Study)||0
10656534|NCT02218268|11817510|FG000|STARTED|24 Hour Washout||30
10656535|NCT02218268|11817511|FG001|STARTED|24 Hour Washout||30
10359826|NCT00492726|11499785|FG000|STARTED|Overall Study||410
10359827|NCT00492726|11499786|FG001|STARTED|Overall Study||394
10359828|NCT00492726|11499785|FG000|End of Treatment (EOT, Day 5 to 14)|Overall Study||387
10359829|NCT00492726|11499786|FG001|End of Treatment (EOT, Day 5 to 14)|Overall Study||377
10359830|NCT00492726|11499785|FG000|End of Study|Overall Study||360
10359831|NCT00492726|11499786|FG001|End of Study|Overall Study||358
10359832|NCT00492726|11499785|FG000|COMPLETED|Overall Study||360
10359833|NCT00492726|11499786|FG001|COMPLETED|Overall Study||358
10359834|NCT00492726|11499785|FG000|NOT COMPLETED|Overall Study||50
10359835|NCT00492726|11499786|FG001|NOT COMPLETED|Overall Study||36
10359836|NCT00492752|11499794|FG000|STARTED|Double Blind Treatment||134
10359837|NCT00492752|11499795|FG001|STARTED|Double Blind Treatment||16
10359838|NCT00492752|11499796|FG002|STARTED|Double Blind Treatment||70
10359839|NCT00492752|11499797|FG003|STARTED|Double Blind Treatment||6
10359840|NCT00492752|11499794|FG000|Received Treatment|Double Blind Treatment|Safety Population. 1 participant never received treatment due to an Adverse Event.|133
10359841|NCT00492752|11499795|FG001|Received Treatment|Double Blind Treatment|Safety Population|16
10359842|NCT00492752|11499796|FG002|Received Treatment|Double Blind Treatment|Safety Population. 1 participant never received treatment due to protocol violation.|69
10359843|NCT00492752|11499797|FG003|Received Treatment|Double Blind Treatment|Safety Population|6
10359844|NCT00492752|11499794|FG000|COMPLETED|Double Blind Treatment||120
10359845|NCT00492752|11499795|FG001|COMPLETED|Double Blind Treatment||16
10359846|NCT00492752|11499796|FG002|COMPLETED|Double Blind Treatment||67
10359847|NCT00492752|11499797|FG003|COMPLETED|Double Blind Treatment||6
10359848|NCT00492752|11499794|FG000|NOT COMPLETED|Double Blind Treatment||14
10359849|NCT00492752|11499795|FG001|NOT COMPLETED|Double Blind Treatment||0
10359850|NCT00492752|11499796|FG002|NOT COMPLETED|Double Blind Treatment||3
10359851|NCT00492752|11499797|FG003|NOT COMPLETED|Double Blind Treatment||0
10359852|NCT00492752|11499794|FG000|STARTED|Follow-up and/or Open Label Sorafenib||120
10359853|NCT00492752|11499795|FG001|STARTED|Follow-up and/or Open Label Sorafenib||16
10359854|NCT00492752|11499796|FG002|STARTED|Follow-up and/or Open Label Sorafenib||67
10359855|NCT00492752|11499797|FG003|STARTED|Follow-up and/or Open Label Sorafenib||6
10359856|NCT00492752|11499794|FG000|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||120
10359857|NCT00492752|11499795|FG001|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||0
10359858|NCT00492752|11499796|FG002|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||67
10359859|NCT00492752|11499797|FG003|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||0
10359860|NCT00492752|11499794|FG000|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||0
10359861|NCT00492752|11499795|FG001|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||16
10359862|NCT00492752|11499796|FG002|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||0
10359863|NCT00492752|11499797|FG003|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||6
10359864|NCT00492752|11499794|FG000|COMPLETED|Follow-up and/or Open Label Sorafenib|1 participant completed all assessments, 33 were followed up until the end of this trial|34
10359865|NCT00492752|11499795|FG001|COMPLETED|Follow-up and/or Open Label Sorafenib||0
10359866|NCT00492752|11499796|FG002|COMPLETED|Follow-up and/or Open Label Sorafenib|20 participants were followed up until the end of this trial|20
10359867|NCT00492752|11499797|FG003|COMPLETED|Follow-up and/or Open Label Sorafenib||0
10359868|NCT00492752|11499794|FG000|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||86
10359869|NCT00492752|11499795|FG001|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||16
10359870|NCT00492752|11499796|FG002|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||47
10359871|NCT00492752|11499797|FG003|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||6
10359872|NCT00492856|11499804|FG000|STARTED|Induction||105
10359873|NCT00492856|11499805|FG001|STARTED|Induction||0
10359874|NCT00492856|11499806|FG002|STARTED|Induction||0
10359875|NCT00492856|11499807|FG003|STARTED|Induction||0
10359876|NCT00492856|11499804|FG000|COMPLETED|Induction||99
10359877|NCT00492856|11499805|FG001|COMPLETED|Induction||0
10359878|NCT00492856|11499806|FG002|COMPLETED|Induction||0
10359879|NCT00492856|11499807|FG003|COMPLETED|Induction||0
10359880|NCT00492856|11499804|FG000|NOT COMPLETED|Induction||6
10359881|NCT00492856|11499805|FG001|NOT COMPLETED|Induction||0
10359882|NCT00492856|11499806|FG002|NOT COMPLETED|Induction||0
10359883|NCT00492856|11499807|FG003|NOT COMPLETED|Induction||0
10534880|NCT01432756|11687133|FG002|STARTED|Overall Study||32
10359884|NCT00492856|11499804|FG000|STARTED|Consolidation|Patients in CR (CRm), CRi, or PR after induction, register for consolidation and are eligible.|92
10359885|NCT00492856|11499805|FG001|STARTED|Consolidation||0
10359886|NCT00492856|11499806|FG002|STARTED|Consolidation||0
10359887|NCT00492856|11499807|FG003|STARTED|Consolidation||0
10359888|NCT00492856|11499804|FG000|COMPLETED|Consolidation||83
10359889|NCT00492856|11499805|FG001|COMPLETED|Consolidation||0
10359890|NCT00492856|11499806|FG002|COMPLETED|Consolidation||0
10359891|NCT00492856|11499807|FG003|COMPLETED|Consolidation||0
10359892|NCT00492856|11499804|FG000|NOT COMPLETED|Consolidation||9
10359893|NCT00492856|11499805|FG001|NOT COMPLETED|Consolidation||0
10716246|NCT02688387|11880055|FG012|STARTED|Part 3B, Period 3 (up to 6 Days)||0
10716247|NCT02688387|11880056|FG013|STARTED|Part 3B, Period 3 (up to 6 Days)||0
10716248|NCT02688387|11880057|FG014|STARTED|Part 3B, Period 3 (up to 6 Days)||0
10359894|NCT00492856|11499806|FG002|NOT COMPLETED|Consolidation||0
10359895|NCT00492856|11499807|FG003|NOT COMPLETED|Consolidation||0
10716249|NCT02688387|11880058|FG015|STARTED|Part 3B, Period 3 (up to 6 Days)||0
10359896|NCT00492856|11499804|FG000|STARTED|Post-consolidation|Patients who achieve CRm, are randomized to the treatment arm, and are eligible.|0
10359897|NCT00492856|11499805|FG001|STARTED|Post-consolidation||41
10359898|NCT00492856|11499806|FG002|STARTED|Post-consolidation||27
10359899|NCT00492856|11499807|FG003|STARTED|Post-consolidation||1
10359900|NCT00492856|11499804|FG000|COMPLETED|Post-consolidation||0
10359901|NCT00492856|11499805|FG001|COMPLETED|Post-consolidation||29
10359902|NCT00492856|11499806|FG002|COMPLETED|Post-consolidation||0
10359903|NCT00492856|11499807|FG003|COMPLETED|Post-consolidation||0
10359904|NCT00492856|11499804|FG000|NOT COMPLETED|Post-consolidation||0
10359905|NCT00492856|11499805|FG001|NOT COMPLETED|Post-consolidation||12
10359906|NCT00492856|11499806|FG002|NOT COMPLETED|Post-consolidation||27
10359907|NCT00492856|11499807|FG003|NOT COMPLETED|Post-consolidation||1
10359908|NCT00492921|11499819|FG000|STARTED|Overall Study||5
10359909|NCT00492921|11499820|FG001|STARTED|Overall Study||4
10359910|NCT00492921|11499821|FG002|STARTED|Overall Study||3
10534823|NCT01432444|11687060|FG002|STARTED|Extension Phase||192
10534824|NCT01432444|11687058|FG000|COMPLETED|Extension Phase||0
10534825|NCT01432444|11687059|FG001|COMPLETED|Extension Phase||0
10534826|NCT01432444|11687060|FG002|COMPLETED|Extension Phase||0
10534827|NCT01432444|11687058|FG000|NOT COMPLETED|Extension Phase||0
10534828|NCT01432444|11687059|FG001|NOT COMPLETED|Extension Phase||0
10534829|NCT01432444|11687060|FG002|NOT COMPLETED|Extension Phase||192
10534830|NCT01432457|11687068|FG000|STARTED|Overall Study||306
10534831|NCT01432457|11687069|FG001|STARTED|Overall Study||306
10534832|NCT01432457|11687070|FG002|STARTED|Overall Study||312
10534833|NCT01432457|11687068|FG000|COMPLETED|Overall Study||269
10534834|NCT01432457|11687069|FG001|COMPLETED|Overall Study||258
10534835|NCT01432457|11687070|FG002|COMPLETED|Overall Study||253
10534836|NCT01432457|11687068|FG000|NOT COMPLETED|Overall Study||37
10534837|NCT01432457|11687069|FG001|NOT COMPLETED|Overall Study||48
10534838|NCT01432457|11687070|FG002|NOT COMPLETED|Overall Study||59
10534839|NCT01432535|11687081|FG000|STARTED|Overall Study||12
10534840|NCT01432535|11687082|FG001|STARTED|Overall Study|One participant later determined ineligible is not included in baseline/efficacy analyses.|7
10534841|NCT01432535|11687083|FG002|STARTED|Overall Study||6
10534842|NCT01432535|11687081|FG000|COMPLETED|Overall Study||12
10534843|NCT01432535|11687082|FG001|COMPLETED|Overall Study||7
10534844|NCT01432535|11687083|FG002|COMPLETED|Overall Study||6
10534845|NCT01432535|11687081|FG000|NOT COMPLETED|Overall Study||0
10534846|NCT01432535|11687082|FG001|NOT COMPLETED|Overall Study||0
10534847|NCT01432535|11687083|FG002|NOT COMPLETED|Overall Study||0
10534848|NCT01432561|11687091|FG000|STARTED|Overall Study||8
10534849|NCT01432561|11687091|FG000|COMPLETED|Overall Study||8
10534850|NCT01432561|11687091|FG000|NOT COMPLETED|Overall Study||0
10534851|NCT01432574|11687095|FG000|STARTED|Overall Study||150
10534852|NCT01432574|11687095|FG000|COMPLETED|Overall Study||147
10534853|NCT01432574|11687095|FG000|NOT COMPLETED|Overall Study||3
10534854|NCT01432600|11687104|FG000|STARTED|Overall Study||10
10534855|NCT01432600|11687105|FG001|STARTED|Overall Study||36
10534856|NCT01432600|11687106|FG002|STARTED|Overall Study||34
10534857|NCT01432600|11687104|FG000|COMPLETED|Overall Study||10
10534858|NCT01432600|11687105|FG001|COMPLETED|Overall Study||35
10534859|NCT01432600|11687106|FG002|COMPLETED|Overall Study||33
10534860|NCT01432600|11687104|FG000|NOT COMPLETED|Overall Study||0
10534861|NCT01432600|11687105|FG001|NOT COMPLETED|Overall Study||1
10534862|NCT01432600|11687106|FG002|NOT COMPLETED|Overall Study||1
10534863|NCT01432626|11687116|FG000|STARTED|Overall Study||10
10534864|NCT01432626|11687116|FG000|COMPLETED|Overall Study|Completed both images|3
10534865|NCT01432626|11687116|FG000|NOT COMPLETED|Overall Study||7
10534866|NCT01432730|11687120|FG000|STARTED|Period 1||12
10534867|NCT01432730|11687121|FG001|STARTED|Period 1||12
10534868|NCT01432730|11687120|FG000|COMPLETED|Period 1||10
10534869|NCT01432730|11687121|FG001|COMPLETED|Period 1||12
10534870|NCT01432730|11687120|FG000|NOT COMPLETED|Period 1||2
10534871|NCT01432730|11687121|FG001|NOT COMPLETED|Period 1||0
10534872|NCT01432730|11687120|FG000|STARTED|Period 2||10
10534873|NCT01432730|11687121|FG001|STARTED|Period 2||12
10534874|NCT01432730|11687120|FG000|COMPLETED|Period 2||10
10534875|NCT01432730|11687121|FG001|COMPLETED|Period 2||8
10534876|NCT01432730|11687120|FG000|NOT COMPLETED|Period 2||0
10359911|NCT00492921|11499819|FG000|COMPLETED|Overall Study||4
10534877|NCT01432730|11687121|FG001|NOT COMPLETED|Period 2||4
10534878|NCT01432756|11687131|FG000|STARTED|Overall Study||32
10359912|NCT00492921|11499820|FG001|COMPLETED|Overall Study||4
10534879|NCT01432756|11687132|FG001|STARTED|Overall Study||34
10534881|NCT01432756|11687134|FG003|STARTED|Overall Study||34
10534882|NCT01432756|11687131|FG000|COMPLETED|Overall Study||31
10534883|NCT01432756|11687132|FG001|COMPLETED|Overall Study||34
10534884|NCT01432756|11687133|FG002|COMPLETED|Overall Study||30
10534885|NCT01432756|11687134|FG003|COMPLETED|Overall Study||33
10534886|NCT01432756|11687131|FG000|NOT COMPLETED|Overall Study||1
10534887|NCT01432756|11687132|FG001|NOT COMPLETED|Overall Study||0
10359913|NCT00492921|11499821|FG002|COMPLETED|Overall Study||2
10359914|NCT00492921|11499819|FG000|NOT COMPLETED|Overall Study||1
10359915|NCT00492921|11499820|FG001|NOT COMPLETED|Overall Study||0
10359916|NCT00492921|11499821|FG002|NOT COMPLETED|Overall Study||1
10359917|NCT00492973|11499831|FG000|STARTED|Overall Study||37
10359918|NCT00492973|11499832|FG001|STARTED|Overall Study||39
10359919|NCT00492973|11499831|FG000|COMPLETED|Overall Study||37
10359920|NCT00492973|11499832|FG001|COMPLETED|Overall Study|One patient died of complications related to deep joint sepsis in the early postoperative period.|38
10359921|NCT00492973|11499831|FG000|NOT COMPLETED|Overall Study||0
10359922|NCT00492973|11499832|FG001|NOT COMPLETED|Overall Study||1
10359923|NCT00493012|11499840|FG000|STARTED|Overall Study||100
10359924|NCT00493012|11499841|FG001|STARTED|Overall Study||100
10359925|NCT00493012|11499840|FG000|COMPLETED|Overall Study||82
10359926|NCT00493012|11499841|FG001|COMPLETED|Overall Study||83
10359927|NCT00493012|11499840|FG000|NOT COMPLETED|Overall Study||18
10359928|NCT00493012|11499841|FG001|NOT COMPLETED|Overall Study||17
10359929|NCT00493038|11499849|FG000|STARTED|Treatment||147
10359930|NCT00493038|11499850|FG001|STARTED|Treatment||146
10359931|NCT00493038|11499849|FG000|Randomization|Treatment||147
10359932|NCT00493038|11499850|FG001|Randomization|Treatment||146
10359933|NCT00493038|11499849|FG000|Treated With Study Medication|Treatment||145
10359934|NCT00493038|11499850|FG001|Treated With Study Medication|Treatment||142
10359935|NCT00493038|11499849|FG000|Test-of-Cure Visit|Treatment||123
10359936|NCT00493038|11499850|FG001|Test-of-Cure Visit|Treatment||126
10359937|NCT00493038|11499849|FG000|COMPLETED|Treatment||123
10359938|NCT00493038|11499850|FG001|COMPLETED|Treatment||126
10359939|NCT00493038|11499849|FG000|NOT COMPLETED|Treatment||24
10359940|NCT00493038|11499850|FG001|NOT COMPLETED|Treatment||20
10359941|NCT00493038|11499849|FG000|STARTED|Follow-up||123
10359942|NCT00493038|11499850|FG001|STARTED|Follow-up||126
10359943|NCT00493038|11499849|FG000|COMPLETED|Follow-up||122
10359944|NCT00493038|11499850|FG001|COMPLETED|Follow-up||126
10359945|NCT00493038|11499849|FG000|NOT COMPLETED|Follow-up||1
10359946|NCT00493038|11499850|FG001|NOT COMPLETED|Follow-up||0
10359947|NCT00493064|11499856|FG000|STARTED|Overall Study||63
10359948|NCT00493064|11499856|FG000|COMPLETED|Overall Study||52
10359949|NCT00493064|11499856|FG000|NOT COMPLETED|Overall Study||11
10359950|NCT00493181|11499860|FG000|STARTED|Overall Study||8
10359951|NCT00493181|11499860|FG000|COMPLETED|Overall Study||8
10359952|NCT00493181|11499860|FG000|NOT COMPLETED|Overall Study||0
10359953|NCT00493220|11499870|FG000|STARTED|First Intervention||5
10359954|NCT00493220|11499871|FG001|STARTED|First Intervention||5
10359955|NCT00493220|11499872|FG002|STARTED|First Intervention||5
10359956|NCT00493220|11499873|FG003|STARTED|First Intervention||5
10359957|NCT00493220|11499874|FG004|STARTED|First Intervention||5
10359958|NCT00493220|11499875|FG005|STARTED|First Intervention||5
10359959|NCT00493220|11499870|FG000|COMPLETED|First Intervention||5
10359960|NCT00493220|11499871|FG001|COMPLETED|First Intervention||5
10359961|NCT00493220|11499872|FG002|COMPLETED|First Intervention||5
10359962|NCT00493220|11499873|FG003|COMPLETED|First Intervention||5
10359963|NCT00493220|11499874|FG004|COMPLETED|First Intervention||5
10359964|NCT00493220|11499875|FG005|COMPLETED|First Intervention||5
10359965|NCT00493220|11499870|FG000|NOT COMPLETED|First Intervention||0
10359966|NCT00493220|11499871|FG001|NOT COMPLETED|First Intervention||0
10359967|NCT00493220|11499872|FG002|NOT COMPLETED|First Intervention||0
10359968|NCT00493220|11499873|FG003|NOT COMPLETED|First Intervention||0
10359969|NCT00493220|11499874|FG004|NOT COMPLETED|First Intervention||0
10359970|NCT00493220|11499875|FG005|NOT COMPLETED|First Intervention||0
10359971|NCT00493220|11499870|FG000|STARTED|First 7-Day Washout & Safety Follow-up||5
10359972|NCT00493220|11499871|FG001|STARTED|First 7-Day Washout & Safety Follow-up||5
10359973|NCT00493220|11499872|FG002|STARTED|First 7-Day Washout & Safety Follow-up||5
10359974|NCT00493220|11499873|FG003|STARTED|First 7-Day Washout & Safety Follow-up||5
10359975|NCT00493220|11499874|FG004|STARTED|First 7-Day Washout & Safety Follow-up||5
10359976|NCT00493220|11499875|FG005|STARTED|First 7-Day Washout & Safety Follow-up||5
10359977|NCT00493220|11499870|FG000|COMPLETED|First 7-Day Washout & Safety Follow-up||5
10359978|NCT00493220|11499871|FG001|COMPLETED|First 7-Day Washout & Safety Follow-up||5
10359979|NCT00493220|11499872|FG002|COMPLETED|First 7-Day Washout & Safety Follow-up||5
10359980|NCT00493220|11499873|FG003|COMPLETED|First 7-Day Washout & Safety Follow-up||5
10359981|NCT00493220|11499874|FG004|COMPLETED|First 7-Day Washout & Safety Follow-up||5
10359982|NCT00493220|11499875|FG005|COMPLETED|First 7-Day Washout & Safety Follow-up||5
10359983|NCT00493220|11499870|FG000|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
10359984|NCT00493220|11499871|FG001|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
10359985|NCT00493220|11499872|FG002|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
10359986|NCT00493220|11499873|FG003|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
10359987|NCT00493220|11499874|FG004|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
10359988|NCT00493220|11499875|FG005|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
10359989|NCT00493220|11499870|FG000|STARTED|Second Intervention||5
10359990|NCT00493220|11499871|FG001|STARTED|Second Intervention||5
10359991|NCT00493220|11499872|FG002|STARTED|Second Intervention||5
10359992|NCT00493220|11499873|FG003|STARTED|Second Intervention||5
10359993|NCT00493220|11499874|FG004|STARTED|Second Intervention||5
10359994|NCT00493220|11499875|FG005|STARTED|Second Intervention||5
10359995|NCT00493220|11499870|FG000|COMPLETED|Second Intervention||5
10359996|NCT00493220|11499871|FG001|COMPLETED|Second Intervention||5
10359997|NCT00493220|11499872|FG002|COMPLETED|Second Intervention||5
10359998|NCT00493220|11499873|FG003|COMPLETED|Second Intervention||5
10359999|NCT00493220|11499874|FG004|COMPLETED|Second Intervention||5
10360000|NCT00493220|11499875|FG005|COMPLETED|Second Intervention||5
10360001|NCT00493220|11499870|FG000|NOT COMPLETED|Second Intervention||0
10360002|NCT00493220|11499871|FG001|NOT COMPLETED|Second Intervention||0
10360003|NCT00493220|11499872|FG002|NOT COMPLETED|Second Intervention||0
10360004|NCT00493220|11499873|FG003|NOT COMPLETED|Second Intervention||0
10360005|NCT00493220|11499874|FG004|NOT COMPLETED|Second Intervention||0
10360006|NCT00493220|11499875|FG005|NOT COMPLETED|Second Intervention||0
10360007|NCT00493220|11499870|FG000|STARTED|Second 7-Day Washout & Safety Follow-up||5
10360008|NCT00493220|11499871|FG001|STARTED|Second 7-Day Washout & Safety Follow-up||5
10360009|NCT00493220|11499872|FG002|STARTED|Second 7-Day Washout & Safety Follow-up||5
10360010|NCT00493220|11499873|FG003|STARTED|Second 7-Day Washout & Safety Follow-up||5
10360011|NCT00493220|11499874|FG004|STARTED|Second 7-Day Washout & Safety Follow-up||5
10360012|NCT00493220|11499875|FG005|STARTED|Second 7-Day Washout & Safety Follow-up||5
10360013|NCT00493220|11499870|FG000|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
10360014|NCT00493220|11499871|FG001|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
10360015|NCT00493220|11499872|FG002|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
10360016|NCT00493220|11499873|FG003|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
10360017|NCT00493220|11499874|FG004|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
10360018|NCT00493220|11499875|FG005|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
10360019|NCT00493220|11499870|FG000|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
10360020|NCT00493220|11499871|FG001|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
10360021|NCT00493220|11499872|FG002|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
10360022|NCT00493220|11499873|FG003|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
10360023|NCT00493220|11499874|FG004|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
10360024|NCT00493220|11499875|FG005|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
10360025|NCT00493220|11499870|FG000|STARTED|Third Intervention||5
10360026|NCT00493220|11499871|FG001|STARTED|Third Intervention||5
10360027|NCT00493220|11499872|FG002|STARTED|Third Intervention||5
10360028|NCT00493220|11499873|FG003|STARTED|Third Intervention||5
10360029|NCT00493220|11499874|FG004|STARTED|Third Intervention||5
10360030|NCT00493220|11499875|FG005|STARTED|Third Intervention||5
10360031|NCT00493220|11499870|FG000|COMPLETED|Third Intervention||4
10360032|NCT00493220|11499871|FG001|COMPLETED|Third Intervention||5
10360033|NCT00493220|11499872|FG002|COMPLETED|Third Intervention||5
10360034|NCT00493220|11499873|FG003|COMPLETED|Third Intervention||5
10360035|NCT00493220|11499874|FG004|COMPLETED|Third Intervention||5
10360036|NCT00493220|11499875|FG005|COMPLETED|Third Intervention||5
10360037|NCT00493220|11499870|FG000|NOT COMPLETED|Third Intervention||1
10360038|NCT00493220|11499871|FG001|NOT COMPLETED|Third Intervention||0
10360039|NCT00493220|11499872|FG002|NOT COMPLETED|Third Intervention||0
10360040|NCT00493220|11499873|FG003|NOT COMPLETED|Third Intervention||0
10360041|NCT00493220|11499874|FG004|NOT COMPLETED|Third Intervention||0
10360042|NCT00493220|11499875|FG005|NOT COMPLETED|Third Intervention||0
10360043|NCT00493220|11499870|FG000|STARTED|Final 7-Day Safety Follow-up||4
10360044|NCT00493220|11499871|FG001|STARTED|Final 7-Day Safety Follow-up||5
10360045|NCT00493220|11499872|FG002|STARTED|Final 7-Day Safety Follow-up||5
10360046|NCT00493220|11499873|FG003|STARTED|Final 7-Day Safety Follow-up||5
10360047|NCT00493220|11499874|FG004|STARTED|Final 7-Day Safety Follow-up||5
10360048|NCT00493220|11499875|FG005|STARTED|Final 7-Day Safety Follow-up||5
10360049|NCT00493220|11499870|FG000|COMPLETED|Final 7-Day Safety Follow-up||4
10360050|NCT00493220|11499871|FG001|COMPLETED|Final 7-Day Safety Follow-up||5
10360051|NCT00493220|11499872|FG002|COMPLETED|Final 7-Day Safety Follow-up||5
10360052|NCT00493220|11499873|FG003|COMPLETED|Final 7-Day Safety Follow-up||5
10360053|NCT00493220|11499874|FG004|COMPLETED|Final 7-Day Safety Follow-up||5
10360054|NCT00493220|11499875|FG005|COMPLETED|Final 7-Day Safety Follow-up||5
10360055|NCT00493220|11499870|FG000|NOT COMPLETED|Final 7-Day Safety Follow-up||0
10360056|NCT00493220|11499871|FG001|NOT COMPLETED|Final 7-Day Safety Follow-up||0
10360057|NCT00493220|11499872|FG002|NOT COMPLETED|Final 7-Day Safety Follow-up||0
10360058|NCT00493220|11499873|FG003|NOT COMPLETED|Final 7-Day Safety Follow-up||0
10360059|NCT00493220|11499874|FG004|NOT COMPLETED|Final 7-Day Safety Follow-up||0
10360060|NCT00493220|11499875|FG005|NOT COMPLETED|Final 7-Day Safety Follow-up||0
10360061|NCT00493246|11499893|FG000|STARTED|Overall Study||2
10360062|NCT00493246|11499894|FG001|STARTED|Overall Study||1
10360063|NCT00493246|11499895|FG002|STARTED|Overall Study||12
10716250|NCT02688387|11880059|FG016|STARTED|Part 3B, Period 3 (up to 6 Days)||0
10716251|NCT02688387|11880060|FG017|STARTED|Part 3B, Period 3 (up to 6 Days)||0
10716252|NCT02688387|11880061|FG018|STARTED|Part 3B, Period 3 (up to 6 Days)||8
10716253|NCT02688387|11880062|FG019|STARTED|Part 3B, Period 3 (up to 6 Days)||8
10716254|NCT02688387|11880063|FG020|STARTED|Part 3B, Period 3 (up to 6 Days)||8
10716255|NCT02688387|11880064|FG021|STARTED|Part 3B, Period 3 (up to 6 Days)||8
10716256|NCT02688387|11880043|FG000|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10716257|NCT02688387|11880044|FG001|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10716258|NCT02688387|11880045|FG002|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10716259|NCT02688387|11880046|FG003|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10656539|NCT02218268|11817511|FG001|NOT COMPLETED|24 Hour Washout||9
10716260|NCT02688387|11880047|FG004|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10716261|NCT02688387|11880048|FG005|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10360064|NCT00493246|11499896|FG003|STARTED|Overall Study||13
10360065|NCT00493246|11499897|FG004|STARTED|Overall Study|All subjects who were randomized.Excludes 1 subject who was randomized in error.|9
10360066|NCT00493246|11499898|FG005|STARTED|Overall Study|All subjects who were randomized.|16
10360067|NCT00493246|11499899|FG006|STARTED|Overall Study|All subjects who were randomized.|12
10360068|NCT00493246|11499900|FG007|STARTED|Overall Study|All subjects who were randomized.|10
10360069|NCT00493246|11499893|FG000|COMPLETED|Overall Study|Completed study 30 days after the last dose|2
10360070|NCT00493246|11499894|FG001|COMPLETED|Overall Study|Completed study 30 days after the last dose|1
10360071|NCT00493246|11499895|FG002|COMPLETED|Overall Study|Completed study 30 days after the last dose|12
10360072|NCT00493246|11499896|FG003|COMPLETED|Overall Study|Completed study 30 days after the last dose|13
10360073|NCT00493246|11499897|FG004|COMPLETED|Overall Study|Completed study 30 days after the last dose|8
10360074|NCT00493246|11499898|FG005|COMPLETED|Overall Study|Completed study 30 days after the last dose|15
10360075|NCT00493246|11499899|FG006|COMPLETED|Overall Study|Completed study 30 days after the last dose|11
10360076|NCT00493246|11499900|FG007|COMPLETED|Overall Study|Completed study 30 days after the last dose|10
10360077|NCT00493246|11499893|FG000|NOT COMPLETED|Overall Study||0
10360078|NCT00493246|11499894|FG001|NOT COMPLETED|Overall Study||0
10360079|NCT00493246|11499895|FG002|NOT COMPLETED|Overall Study||0
10360080|NCT00493246|11499896|FG003|NOT COMPLETED|Overall Study||0
10360081|NCT00493246|11499897|FG004|NOT COMPLETED|Overall Study||1
10360082|NCT00493246|11499898|FG005|NOT COMPLETED|Overall Study||1
10360083|NCT00493246|11499899|FG006|NOT COMPLETED|Overall Study||1
10360084|NCT00493246|11499900|FG007|NOT COMPLETED|Overall Study||0
10360085|NCT00493285|11499924|FG000|STARTED|Overall Study||13
10360086|NCT00493285|11499925|FG001|STARTED|Overall Study||6
10360087|NCT00493285|11499926|FG002|STARTED|Overall Study||9
10360088|NCT00493285|11499927|FG003|STARTED|Overall Study||6
10360089|NCT00493285|11499928|FG004|STARTED|Overall Study||10
10360090|NCT00493285|11499929|FG005|STARTED|Overall Study||5
10360091|NCT00493285|11499924|FG000|COMPLETED|Overall Study||13
10360092|NCT00493285|11499925|FG001|COMPLETED|Overall Study||6
10360093|NCT00493285|11499926|FG002|COMPLETED|Overall Study||9
10360094|NCT00493285|11499927|FG003|COMPLETED|Overall Study||6
10360095|NCT00493285|11499928|FG004|COMPLETED|Overall Study||9
10360096|NCT00493285|11499929|FG005|COMPLETED|Overall Study||5
10360097|NCT00493285|11499924|FG000|NOT COMPLETED|Overall Study||0
10360098|NCT00493285|11499925|FG001|NOT COMPLETED|Overall Study||0
10716262|NCT02688387|11880049|FG006|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10716263|NCT02688387|11880050|FG007|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10716264|NCT02688387|11880051|FG008|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10360099|NCT00493285|11499926|FG002|NOT COMPLETED|Overall Study||0
10360100|NCT00493285|11499927|FG003|NOT COMPLETED|Overall Study||0
10360101|NCT00493285|11499928|FG004|NOT COMPLETED|Overall Study||1
10360102|NCT00493285|11499929|FG005|NOT COMPLETED|Overall Study||0
10360103|NCT00493311|11499945|FG000|STARTED|Overall Study||29
10360104|NCT00493311|11499946|FG001|STARTED|Overall Study||31
10360105|NCT00493311|11499945|FG000|COMPLETED|Overall Study||27
10360106|NCT00493311|11499946|FG001|COMPLETED|Overall Study||29
10360107|NCT00493311|11499945|FG000|NOT COMPLETED|Overall Study||2
10360108|NCT00493311|11499946|FG001|NOT COMPLETED|Overall Study||2
10360109|NCT00493454|11499952|FG000|STARTED|Overall Study||6
10360110|NCT00493454|11499952|FG000|COMPLETED|Overall Study||5
10360111|NCT00493454|11499952|FG000|NOT COMPLETED|Overall Study||1
10360115|NCT00493636|11499962|FG000|STARTED|Overall Study||81
10360116|NCT00493636|11499963|FG001|STARTED|Overall Study||79
10360117|NCT00493636|11499962|FG000|COMPLETED|Overall Study||79
10360118|NCT00493636|11499963|FG001|COMPLETED|Overall Study||77
10360119|NCT00493636|11499962|FG000|NOT COMPLETED|Overall Study||2
10360120|NCT00493636|11499963|FG001|NOT COMPLETED|Overall Study||2
10360121|NCT00493649|11499969|FG000|STARTED|Overall Study||493
10360122|NCT00493649|11499969|FG000|COMPLETED|Overall Study||411
10360123|NCT00493649|11499969|FG000|NOT COMPLETED|Overall Study||82
10360124|NCT00493779|11499976|FG000|STARTED|Overall Study|Number of subjects who had discontinued clopidogrel treatment and entered follow-up phase|98
10360125|NCT00493779|11499976|FG000|COMPLETED|Overall Study|Completed follow-up phase|97
10360126|NCT00493779|11499976|FG000|NOT COMPLETED|Overall Study||1
10360127|NCT00493805|11499981|FG000|STARTED|Overall Study||17
10360128|NCT00493805|11499982|FG001|STARTED|Overall Study||42
10360129|NCT00493805|11499981|FG000|COMPLETED|Overall Study||17
10360130|NCT00493805|11499982|FG001|COMPLETED|Overall Study||42
10360131|NCT00493805|11499981|FG000|NOT COMPLETED|Overall Study||0
10360132|NCT00493805|11499982|FG001|NOT COMPLETED|Overall Study||0
10360133|NCT00493974|11499990|FG000|STARTED|Overall Study||60
10360134|NCT00493974|11499991|FG001|STARTED|Overall Study||59
10716265|NCT02688387|11880052|FG009|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10360135|NCT00493974|11499990|FG000|COMPLETED|Overall Study||47
10360136|NCT00493974|11499991|FG001|COMPLETED|Overall Study||45
10360137|NCT00493974|11499990|FG000|NOT COMPLETED|Overall Study||13
10360138|NCT00493974|11499991|FG001|NOT COMPLETED|Overall Study||14
10360139|NCT00494013|11499999|FG000|STARTED|Overall Study||223
10360140|NCT00494013|11500000|FG001|STARTED|Overall Study||219
10360141|NCT00494013|11499999|FG000|Full Analysis Set (Intent to Treat)|Overall Study||219
10360142|NCT00494013|11500000|FG001|Full Analysis Set (Intent to Treat)|Overall Study||210
10360143|NCT00494013|11499999|FG000|COMPLETED|Overall Study||193
10360144|NCT00494013|11500000|FG001|COMPLETED|Overall Study||183
10360145|NCT00494013|11499999|FG000|NOT COMPLETED|Overall Study||30
10360146|NCT00494013|11500000|FG001|NOT COMPLETED|Overall Study||36
10360147|NCT00494026|11500006|FG000|STARTED|Overall Study||4
10360148|NCT00494026|11500006|FG000|COMPLETED|Overall Study|2 patients did receive the full study treatment prior to the study being terminated.|0
10360149|NCT00494026|11500006|FG000|NOT COMPLETED|Overall Study||4
10360150|NCT00494091|11500012|FG000|STARTED|Overall Study||6
10360151|NCT00494091|11500013|FG001|STARTED|Overall Study||76
10360152|NCT00494091|11500012|FG000|COMPLETED|Overall Study||0
10360153|NCT00494091|11500013|FG001|COMPLETED|Overall Study||0
10360154|NCT00494091|11500012|FG000|NOT COMPLETED|Overall Study||6
10360155|NCT00494091|11500013|FG001|NOT COMPLETED|Overall Study||76
10360156|NCT00494143|11500020|FG000|STARTED|Overall Study||1
10360157|NCT00494143|11500021|FG001|STARTED|Overall Study||2
10360158|NCT00494143|11500022|FG002|STARTED|Overall Study||3
10360159|NCT00494143|11500023|FG003|STARTED|Overall Study||0
10360160|NCT00494143|11500024|FG004|STARTED|Overall Study||1
10360161|NCT00494143|11500025|FG005|STARTED|Overall Study||0
10360162|NCT00494143|11500020|FG000|COMPLETED|Overall Study||1
10360163|NCT00494143|11500021|FG001|COMPLETED|Overall Study||2
10360164|NCT00494143|11500022|FG002|COMPLETED|Overall Study||3
10360165|NCT00494143|11500023|FG003|COMPLETED|Overall Study||0
10360166|NCT00494143|11500024|FG004|COMPLETED|Overall Study||1
10360167|NCT00494143|11500025|FG005|COMPLETED|Overall Study||0
10360168|NCT00494143|11500020|FG000|NOT COMPLETED|Overall Study||0
10360169|NCT00494143|11500021|FG001|NOT COMPLETED|Overall Study||0
10360170|NCT00494143|11500022|FG002|NOT COMPLETED|Overall Study||0
10360171|NCT00494143|11500023|FG003|NOT COMPLETED|Overall Study||0
10360172|NCT00494143|11500024|FG004|NOT COMPLETED|Overall Study||0
10360173|NCT00494143|11500025|FG005|NOT COMPLETED|Overall Study||0
10360174|NCT00494221|11500040|FG000|STARTED|Overall Study||58
10360175|NCT00494221|11500041|FG001|STARTED|Overall Study||56
10360176|NCT00494221|11500042|FG002|STARTED|Overall Study||58
10360177|NCT00494221|11500040|FG000|COMPLETED|Overall Study||42
10360178|NCT00494221|11500041|FG001|COMPLETED|Overall Study||45
10360179|NCT00494221|11500042|FG002|COMPLETED|Overall Study||44
10360180|NCT00494221|11500040|FG000|NOT COMPLETED|Overall Study||16
10360181|NCT00494221|11500041|FG001|NOT COMPLETED|Overall Study||11
10360182|NCT00494221|11500042|FG002|NOT COMPLETED|Overall Study||14
10360183|NCT00494299|11500052|FG000|STARTED|Overall Study||229
10360184|NCT00494299|11500053|FG001|STARTED|Overall Study||229
10360185|NCT00494299|11500052|FG000|Received Treatment|Overall Study||229
10360186|NCT00494299|11500053|FG001|Received Treatment|Overall Study||227
10360187|NCT00494299|11500052|FG000|COMPLETED|Overall Study||0
10360188|NCT00494299|11500053|FG001|COMPLETED|Overall Study||0
10534888|NCT01432756|11687133|FG002|NOT COMPLETED|Overall Study||2
10534889|NCT01432756|11687134|FG003|NOT COMPLETED|Overall Study||1
10534890|NCT01432886|11687144|FG000|STARTED|Overall Study||6
10534891|NCT01432886|11687145|FG001|STARTED|Overall Study||6
10534892|NCT01432886|11687144|FG000|COMPLETED|Overall Study|Discontinuation met per discontinuation criteria|6
10534893|NCT01432886|11687145|FG001|COMPLETED|Overall Study|Discontinuation met per discontinuation criteria|6
10534894|NCT01432886|11687144|FG000|NOT COMPLETED|Overall Study||0
10534895|NCT01432886|11687145|FG001|NOT COMPLETED|Overall Study||0
10534896|NCT01432938|11687152|FG000|STARTED|First Intervention||14
10534897|NCT01432938|11687153|FG001|STARTED|First Intervention||14
10534898|NCT01432938|11687152|FG000|Received at Least 1 Dose of Study Drug|First Intervention||14
10534899|NCT01432938|11687153|FG001|Received at Least 1 Dose of Study Drug|First Intervention||14
10534900|NCT01432938|11687152|FG000|COMPLETED|First Intervention||12
10534901|NCT01432938|11687153|FG001|COMPLETED|First Intervention||14
10534902|NCT01432938|11687152|FG000|NOT COMPLETED|First Intervention||2
10534903|NCT01432938|11687153|FG001|NOT COMPLETED|First Intervention||0
10534904|NCT01432938|11687152|FG000|STARTED|Washout Period of at Least 24 Days||12
10534905|NCT01432938|11687153|FG001|STARTED|Washout Period of at Least 24 Days||14
10534906|NCT01432938|11687152|FG000|COMPLETED|Washout Period of at Least 24 Days||12
10534907|NCT01432938|11687153|FG001|COMPLETED|Washout Period of at Least 24 Days||14
10534908|NCT01432938|11687152|FG000|NOT COMPLETED|Washout Period of at Least 24 Days||0
10534909|NCT01432938|11687153|FG001|NOT COMPLETED|Washout Period of at Least 24 Days||0
10534910|NCT01432938|11687152|FG000|STARTED|Second Intervention||12
10534911|NCT01432938|11687153|FG001|STARTED|Second Intervention||14
10534912|NCT01432938|11687152|FG000|COMPLETED|Second Intervention||11
10534913|NCT01432938|11687153|FG001|COMPLETED|Second Intervention||14
10534914|NCT01432938|11687152|FG000|NOT COMPLETED|Second Intervention||1
10534915|NCT01432938|11687153|FG001|NOT COMPLETED|Second Intervention||0
10534916|NCT01432951|11687160|FG000|STARTED|Treatment Phase (Day 1 to 30)||26
10534917|NCT01432951|11687160|FG000|Received at Least One Dose of Study Drug|Treatment Phase (Day 1 to 30)||25
10534918|NCT01432951|11687160|FG000|PK Sampling (no Dosing) Days 15-17|Treatment Phase (Day 1 to 30)||23
10534919|NCT01432951|11687160|FG000|Progressive Disease|Treatment Phase (Day 1 to 30)||10
10534920|NCT01432951|11687160|FG000|COMPLETED|Treatment Phase (Day 1 to 30)||25
10534921|NCT01432951|11687160|FG000|NOT COMPLETED|Treatment Phase (Day 1 to 30)||1
10534922|NCT01432951|11687160|FG000|STARTED|Safety Extension Day 30 to End of Study|Participants had the option to continue on to safety extension period.|15
10656536|NCT02218268|11817510|FG000|COMPLETED|24 Hour Washout||19
10656537|NCT02218268|11817511|FG001|COMPLETED|24 Hour Washout||21
10656538|NCT02218268|11817510|FG000|NOT COMPLETED|24 Hour Washout||11
10360189|NCT00494299|11500052|FG000|NOT COMPLETED|Overall Study||229
10360190|NCT00494299|11500053|FG001|NOT COMPLETED|Overall Study||229
10360191|NCT00494442|11500061|FG000|STARTED|Overall Study|Patients received treatment|24
10360192|NCT00494442|11500062|FG001|STARTED|Overall Study|Patients received treatment|33
10360193|NCT00494442|11500061|FG000|COMPLETED|Overall Study|Patients completed the full study schedule (168 days treatment)|7
10427056|NCT00850993|11572837|FG001|Intent-to-treat|Overall Study||18
10360194|NCT00494442|11500062|FG001|COMPLETED|Overall Study|Patients completed the full study schedule (168 days treatment)|17
10360195|NCT00494442|11500061|FG000|NOT COMPLETED|Overall Study||17
10360196|NCT00494442|11500062|FG001|NOT COMPLETED|Overall Study||16
10360197|NCT00494481|11500070|FG000|STARTED|Overall Study|randomised patients|35
10360198|NCT00494481|11500071|FG001|STARTED|Overall Study|randomised patients|29
10360199|NCT00494481|11500070|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|6
10360200|NCT00494481|11500071|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|5
10360201|NCT00494481|11500070|FG000|NOT COMPLETED|Overall Study||29
10360202|NCT00494481|11500071|FG001|NOT COMPLETED|Overall Study||24
10360203|NCT00494494|11500079|FG000|STARTED|Overall Study||40
10360204|NCT00494494|11500080|FG001|STARTED|Overall Study||39
10360205|NCT00494494|11500079|FG000|COMPLETED|Overall Study||40
10360206|NCT00494494|11500080|FG001|COMPLETED|Overall Study||39
10360207|NCT00494494|11500079|FG000|NOT COMPLETED|Overall Study||0
10360208|NCT00494494|11500080|FG001|NOT COMPLETED|Overall Study||0
10360209|NCT00494507|11500090|FG000|STARTED|Double-Blind Phase||12
10360210|NCT00494507|11500091|FG001|STARTED|Double-Blind Phase||9
10360211|NCT00494507|11500092|FG002|STARTED|Double-Blind Phase||24
10360212|NCT00494507|11500093|FG003|STARTED|Double-Blind Phase||20
10360213|NCT00494507|11500090|FG000|Reached Endpoint of Acute Worsening|Double-Blind Phase||0
10360214|NCT00494507|11500091|FG001|Reached Endpoint of Acute Worsening|Double-Blind Phase||2
10360215|NCT00494507|11500092|FG002|Reached Endpoint of Acute Worsening|Double-Blind Phase||0
10360216|NCT00494507|11500093|FG003|Reached Endpoint of Acute Worsening|Double-Blind Phase||5
10360217|NCT00494507|11500090|FG000|COMPLETED|Double-Blind Phase||9
10360218|NCT00494507|11500091|FG001|COMPLETED|Double-Blind Phase||9
10360219|NCT00494507|11500092|FG002|COMPLETED|Double-Blind Phase||22
10360220|NCT00494507|11500093|FG003|COMPLETED|Double-Blind Phase||19
10360221|NCT00494507|11500090|FG000|NOT COMPLETED|Double-Blind Phase||3
10360222|NCT00494507|11500091|FG001|NOT COMPLETED|Double-Blind Phase||0
10360223|NCT00494507|11500092|FG002|NOT COMPLETED|Double-Blind Phase||2
10360224|NCT00494507|11500093|FG003|NOT COMPLETED|Double-Blind Phase||1
10360225|NCT00494507|11500090|FG000|STARTED|Open-Label Phase||9
10360226|NCT00494507|11500091|FG001|STARTED|Open-Label Phase|1 subject randomized to Acetazolamide in this phase is not included-drug arm was removed from trial.|8
10360227|NCT00494507|11500092|FG002|STARTED|Open-Label Phase||22
10360228|NCT00494507|11500093|FG003|STARTED|Open-Label Phase||19
10360229|NCT00494507|11500090|FG000|COMPLETED|Open-Label Phase||9
10360230|NCT00494507|11500091|FG001|COMPLETED|Open-Label Phase||7
10360231|NCT00494507|11500092|FG002|COMPLETED|Open-Label Phase||17
10360232|NCT00494507|11500093|FG003|COMPLETED|Open-Label Phase||14
10360233|NCT00494507|11500090|FG000|NOT COMPLETED|Open-Label Phase||0
10360234|NCT00494507|11500091|FG001|NOT COMPLETED|Open-Label Phase||1
10360235|NCT00494507|11500092|FG002|NOT COMPLETED|Open-Label Phase||5
10360236|NCT00494507|11500093|FG003|NOT COMPLETED|Open-Label Phase||5
10360237|NCT00494585|11500113|FG000|STARTED|Overall Study||22
10360238|NCT00494585|11500113|FG000|COMPLETED|Overall Study||22
10360239|NCT00494585|11500113|FG000|NOT COMPLETED|Overall Study||0
10360240|NCT00494676|11500117|FG000|STARTED|Allocation||37
10360241|NCT00494676|11500118|FG001|STARTED|Allocation||36
10360242|NCT00494676|11500117|FG000|COMPLETED|Allocation||35
10360243|NCT00494676|11500118|FG001|COMPLETED|Allocation||32
10360244|NCT00494676|11500117|FG000|NOT COMPLETED|Allocation||2
10360245|NCT00494676|11500118|FG001|NOT COMPLETED|Allocation||4
10360246|NCT00494676|11500117|FG000|STARTED|First Intervention||35
10360247|NCT00494676|11500118|FG001|STARTED|First Intervention||32
10360248|NCT00494676|11500117|FG000|COMPLETED|First Intervention||34
10360249|NCT00494676|11500118|FG001|COMPLETED|First Intervention||29
10360250|NCT00494676|11500117|FG000|NOT COMPLETED|First Intervention||1
10360251|NCT00494676|11500118|FG001|NOT COMPLETED|First Intervention||3
10360252|NCT00494676|11500117|FG000|STARTED|Second Intervention||34
10360253|NCT00494676|11500118|FG001|STARTED|Second Intervention||29
10360254|NCT00494676|11500117|FG000|COMPLETED|Second Intervention||33
10360255|NCT00494676|11500118|FG001|COMPLETED|Second Intervention||28
10360256|NCT00494676|11500117|FG000|NOT COMPLETED|Second Intervention||1
10360257|NCT00494676|11500118|FG001|NOT COMPLETED|Second Intervention||1
10360258|NCT00494780|11500126|FG000|STARTED|Overall Study||29
10360259|NCT00494780|11500127|FG001|STARTED|Overall Study||30
10360260|NCT00494780|11500126|FG000|COMPLETED|Overall Study||18
10360261|NCT00494780|11500127|FG001|COMPLETED|Overall Study||17
10360262|NCT00494780|11500126|FG000|NOT COMPLETED|Overall Study||11
10360263|NCT00494780|11500127|FG001|NOT COMPLETED|Overall Study||13
10360264|NCT00494806|11500137|FG000|STARTED|Overall Study||34
10360265|NCT00494806|11500138|FG001|STARTED|Overall Study||32
10360266|NCT00494806|11500137|FG000|COMPLETED|Overall Study||34
10360267|NCT00494806|11500138|FG001|COMPLETED|Overall Study||32
10360268|NCT00494806|11500137|FG000|NOT COMPLETED|Overall Study||0
10360269|NCT00494806|11500138|FG001|NOT COMPLETED|Overall Study||0
10360270|NCT00494871|11500146|FG000|STARTED|Double-blind (DB) Treatment Period||640
10360271|NCT00494871|11500147|FG001|STARTED|Double-blind (DB) Treatment Period||640
10360272|NCT00494871|11500146|FG000|Started Treatment|Double-blind (DB) Treatment Period|Safety population|639
10360273|NCT00494871|11500147|FG001|Started Treatment|Double-blind (DB) Treatment Period|Safety population|639
10360274|NCT00494871|11500146|FG000|COMPLETED|Double-blind (DB) Treatment Period||480
10360275|NCT00494871|11500147|FG001|COMPLETED|Double-blind (DB) Treatment Period||468
10360276|NCT00494871|11500146|FG000|NOT COMPLETED|Double-blind (DB) Treatment Period||160
10360277|NCT00494871|11500147|FG001|NOT COMPLETED|Double-blind (DB) Treatment Period||172
10360278|NCT00494871|11500146|FG000|STARTED|Follow-up (FU) Period|All treated participants were to enter FU period, whether or not they completed the DB period|639
10360279|NCT00494871|11500147|FG001|STARTED|Follow-up (FU) Period|All treated participants were to enter FU period, whether or not they completed the DB period|639
10360280|NCT00494871|11500146|FG000|Entered FU and Valid for Safety|Follow-up (FU) Period|Safety population|628
10360281|NCT00494871|11500147|FG001|Entered FU and Valid for Safety|Follow-up (FU) Period|Safety population|630
10360282|NCT00494871|11500146|FG000|COMPLETED|Follow-up (FU) Period||610
10360283|NCT00494871|11500147|FG001|COMPLETED|Follow-up (FU) Period||616
10360284|NCT00494871|11500146|FG000|NOT COMPLETED|Follow-up (FU) Period||29
10360285|NCT00494871|11500147|FG001|NOT COMPLETED|Follow-up (FU) Period||23
10360286|NCT00494975|11500157|FG000|STARTED|Overall Study||10
10360287|NCT00494975|11500158|FG001|STARTED|Overall Study||11
10360288|NCT00494975|11500157|FG000|COMPLETED|Overall Study||8
10360289|NCT00494975|11500158|FG001|COMPLETED|Overall Study||10
10360290|NCT00494975|11500157|FG000|NOT COMPLETED|Overall Study||2
10360291|NCT00494975|11500158|FG001|NOT COMPLETED|Overall Study||1
10360292|NCT00495040|11500164|FG000|STARTED|Overall Study||38
10360293|NCT00495040|11500164|FG000|COMPLETED|Overall Study||35
10360294|NCT00495040|11500164|FG000|NOT COMPLETED|Overall Study||3
10360295|NCT00495079|11500168|FG000|STARTED|Overall Study||65
10360296|NCT00495079|11500168|FG000|COMPLETED|Overall Study||65
10360297|NCT00495079|11500168|FG000|NOT COMPLETED|Overall Study||0
10360298|NCT00495157|11500178|FG000|STARTED|Overall Study||113
10360299|NCT00495157|11500179|FG001|STARTED|Overall Study||115
10360300|NCT00495157|11500180|FG002|STARTED|Overall Study||114
10360301|NCT00495157|11500178|FG000|COMPLETED|Overall Study||97
10360302|NCT00495157|11500179|FG001|COMPLETED|Overall Study||92
10360303|NCT00495157|11500180|FG002|COMPLETED|Overall Study||101
10360304|NCT00495157|11500178|FG000|NOT COMPLETED|Overall Study||16
10360305|NCT00495157|11500179|FG001|NOT COMPLETED|Overall Study||23
10360306|NCT00495157|11500180|FG002|NOT COMPLETED|Overall Study||13
10360307|NCT00495170|11500188|FG000|STARTED|Overall Study||84
10360308|NCT00495170|11500188|FG000|COMPLETED|Overall Study||64
10360309|NCT00495170|11500188|FG000|NOT COMPLETED|Overall Study||20
10360310|NCT00495391|11500194|FG000|STARTED|Overall Study||42
10360311|NCT00495391|11500195|FG001|STARTED|Overall Study||22
10360312|NCT00495391|11500194|FG000|From Baseline to Week 8|Overall Study||31
10360313|NCT00495391|11500195|FG001|From Baseline to Week 8|Overall Study||20
10360314|NCT00495391|11500194|FG000|From Baseline to Week 16|Overall Study||24
10360315|NCT00495391|11500195|FG001|From Baseline to Week 16|Overall Study||11
10360316|NCT00495391|11500194|FG000|From Baseline to End of Treatment|Overall Study||6
10360317|NCT00495391|11500195|FG001|From Baseline to End of Treatment|Overall Study||1
10360318|NCT00495391|11500194|FG000|From Baseline to End of Follow up|Overall Study||6
10534923|NCT01432951|11687160|FG000|COMPLETED|Safety Extension Day 30 to End of Study||15
10534924|NCT01432951|11687160|FG000|NOT COMPLETED|Safety Extension Day 30 to End of Study||0
10534925|NCT01433016|11687165|FG000|STARTED|Overall Study||20
10534926|NCT01433016|11687165|FG000|COMPLETED|Overall Study||20
10534927|NCT01433016|11687165|FG000|NOT COMPLETED|Overall Study||0
10534928|NCT01433042|11687169|FG000|STARTED|Overall Study||225
10534929|NCT01433042|11687169|FG000|COMPLETED|Overall Study||224
10534930|NCT01433042|11687169|FG000|NOT COMPLETED|Overall Study||1
10534931|NCT01433055|11687175|FG000|STARTED|Overall Study||29
10534932|NCT01433055|11687176|FG001|STARTED|Overall Study||23
10534933|NCT01433055|11687175|FG000|COMPLETED|Overall Study||27
10534934|NCT01433055|11687176|FG001|COMPLETED|Overall Study||23
10534935|NCT01433055|11687175|FG000|NOT COMPLETED|Overall Study||2
10534936|NCT01433055|11687176|FG001|NOT COMPLETED|Overall Study||0
10534937|NCT01433081|11687184|FG000|STARTED|Overall Study||25
10534938|NCT01433081|11687185|FG001|STARTED|Overall Study||25
10534939|NCT01433081|11687184|FG000|COMPLETED|Overall Study||23
10534940|NCT01433081|11687185|FG001|COMPLETED|Overall Study||23
10534941|NCT01433081|11687184|FG000|NOT COMPLETED|Overall Study||2
10534942|NCT01433081|11687185|FG001|NOT COMPLETED|Overall Study||2
10534943|NCT01433107|11687194|FG000|STARTED|Overall Study||145
10534944|NCT01433107|11687195|FG001|STARTED|Overall Study||145
10534945|NCT01433107|11687194|FG000|COMPLETED|Overall Study||118
10534946|NCT01433107|11687195|FG001|COMPLETED|Overall Study||128
10534947|NCT01433107|11687194|FG000|NOT COMPLETED|Overall Study||27
10534948|NCT01433107|11687195|FG001|NOT COMPLETED|Overall Study||17
10534949|NCT01433159|11687203|FG000|STARTED|Overall Study||9
10534950|NCT01433159|11687204|FG001|STARTED|Overall Study||10
10534951|NCT01433159|11687203|FG000|COMPLETED|Overall Study||7
10534952|NCT01433159|11687204|FG001|COMPLETED|Overall Study||9
10534953|NCT01433159|11687203|FG000|NOT COMPLETED|Overall Study||2
10534954|NCT01433159|11687204|FG001|NOT COMPLETED|Overall Study||1
10534955|NCT01433172|11687213|FG000|STARTED|Overall Study||3
10534956|NCT01433172|11687214|FG001|STARTED|Overall Study||37
10534957|NCT01433172|11687215|FG002|STARTED|Overall Study||33
10534958|NCT01433172|11687213|FG000|COMPLETED|Overall Study||3
10534959|NCT01433172|11687214|FG001|COMPLETED|Overall Study||34
10534960|NCT01433172|11687215|FG002|COMPLETED|Overall Study||32
10534961|NCT01433172|11687213|FG000|NOT COMPLETED|Overall Study||0
10534962|NCT01433172|11687214|FG001|NOT COMPLETED|Overall Study||3
10534963|NCT01433172|11687215|FG002|NOT COMPLETED|Overall Study||1
10534964|NCT01433250|11687225|FG000|STARTED|Overall Study||22
10534965|NCT01433250|11687226|FG001|STARTED|Overall Study||17
10534966|NCT01433250|11687225|FG000|COMPLETED|Overall Study||19
10534967|NCT01433250|11687226|FG001|COMPLETED|Overall Study||14
10534968|NCT01433250|11687225|FG000|NOT COMPLETED|Overall Study||3
10656540|NCT02218268|11817510|FG000|STARTED|Final Phase (2 Hours)||19
10360319|NCT00495391|11500195|FG001|From Baseline to End of Follow up|Overall Study||1
10360320|NCT00495391|11500194|FG000|COMPLETED|Overall Study||6
10360321|NCT00495391|11500195|FG001|COMPLETED|Overall Study||1
10360322|NCT00495391|11500194|FG000|NOT COMPLETED|Overall Study||36
10360323|NCT00495391|11500195|FG001|NOT COMPLETED|Overall Study||21
10360324|NCT00495469|11500208|FG000|STARTED|Overall Study||36
10360325|NCT00495469|11500209|FG001|STARTED|Overall Study||37
10360326|NCT00495469|11500210|FG002|STARTED|Overall Study||34
10360327|NCT00495469|11500211|FG003|STARTED|Overall Study||36
10360328|NCT00495469|11500212|FG004|STARTED|Overall Study||36
10360329|NCT00495469|11500213|FG005|STARTED|Overall Study||36
10360330|NCT00495469|11500214|FG006|STARTED|Overall Study||35
10360331|NCT00495469|11500208|FG000|COMPLETED|Overall Study||30
10360332|NCT00495469|11500209|FG001|COMPLETED|Overall Study||30
10360333|NCT00495469|11500210|FG002|COMPLETED|Overall Study||27
10360334|NCT00495469|11500211|FG003|COMPLETED|Overall Study||32
10360335|NCT00495469|11500212|FG004|COMPLETED|Overall Study||31
10360336|NCT00495469|11500213|FG005|COMPLETED|Overall Study||31
10360337|NCT00495469|11500214|FG006|COMPLETED|Overall Study||30
10360338|NCT00495469|11500208|FG000|NOT COMPLETED|Overall Study||6
10360339|NCT00495469|11500209|FG001|NOT COMPLETED|Overall Study||7
10360340|NCT00495469|11500210|FG002|NOT COMPLETED|Overall Study||7
10360341|NCT00495469|11500211|FG003|NOT COMPLETED|Overall Study||4
10360342|NCT00495469|11500212|FG004|NOT COMPLETED|Overall Study||5
10360343|NCT00495469|11500213|FG005|NOT COMPLETED|Overall Study||5
10360344|NCT00495469|11500214|FG006|NOT COMPLETED|Overall Study||5
10360345|NCT00495495|11500237|FG000|STARTED|Overall Study||394
10360346|NCT00495495|11500237|FG000|COMPLETED|Overall Study||295
10360347|NCT00495495|11500237|FG000|NOT COMPLETED|Overall Study||99
10360348|NCT00495521|11500244|FG000|STARTED|Overall Study||1
10360349|NCT00495521|11500245|FG001|STARTED|Overall Study||1
10360350|NCT00495521|11500244|FG000|COMPLETED|Overall Study||1
10360351|NCT00495521|11500245|FG001|COMPLETED|Overall Study||0
10360352|NCT00495521|11500244|FG000|NOT COMPLETED|Overall Study||0
10360353|NCT00495521|11500245|FG001|NOT COMPLETED|Overall Study||1
10360354|NCT00495586|11500253|FG000|STARTED|Overall Study||156
10360355|NCT00495586|11500254|FG001|STARTED|Overall Study||162
10360356|NCT00495586|11500253|FG000|COMPLETED|Overall Study||152
10360357|NCT00495586|11500254|FG001|COMPLETED|Overall Study||158
10360358|NCT00495586|11500253|FG000|NOT COMPLETED|Overall Study||4
10360359|NCT00495586|11500254|FG001|NOT COMPLETED|Overall Study||4
10360360|NCT00495612|11500264|FG000|STARTED|Overall Study||36
10360361|NCT00495612|11500265|FG001|STARTED|Overall Study||33
10360362|NCT00495612|11500264|FG000|COMPLETED|Overall Study||32
10360363|NCT00495612|11500265|FG001|COMPLETED|Overall Study||33
10360364|NCT00495612|11500264|FG000|NOT COMPLETED|Overall Study||4
10360365|NCT00495612|11500265|FG001|NOT COMPLETED|Overall Study||0
10360366|NCT00495625|11500271|FG000|STARTED|Overall Study||33
10360367|NCT00495625|11500271|FG000|COMPLETED|Overall Study||23
10360368|NCT00495625|11500271|FG000|NOT COMPLETED|Overall Study||10
10360369|NCT00495677|11500282|FG000|STARTED|Stage 1 (25 Days)||2
10360370|NCT00495677|11500283|FG001|STARTED|Stage 1 (25 Days)||6
10360371|NCT00495677|11500284|FG002|STARTED|Stage 1 (25 Days)||6
10360372|NCT00495677|11500285|FG003|STARTED|Stage 1 (25 Days)||6
10360373|NCT00495677|11500286|FG004|STARTED|Stage 1 (25 Days)||0
10360374|NCT00495677|11500287|FG005|STARTED|Stage 1 (25 Days)||0
10360375|NCT00495677|11500288|FG006|STARTED|Stage 1 (25 Days)||0
10360376|NCT00495677|11500282|FG000|COMPLETED|Stage 1 (25 Days)||2
10360377|NCT00495677|11500283|FG001|COMPLETED|Stage 1 (25 Days)||6
10360378|NCT00495677|11500284|FG002|COMPLETED|Stage 1 (25 Days)||5
10360379|NCT00495677|11500285|FG003|COMPLETED|Stage 1 (25 Days)||6
10360380|NCT00495677|11500286|FG004|COMPLETED|Stage 1 (25 Days)||0
10360381|NCT00495677|11500287|FG005|COMPLETED|Stage 1 (25 Days)||0
10360382|NCT00495677|11500288|FG006|COMPLETED|Stage 1 (25 Days)||0
10360383|NCT00495677|11500282|FG000|NOT COMPLETED|Stage 1 (25 Days)||0
10360384|NCT00495677|11500283|FG001|NOT COMPLETED|Stage 1 (25 Days)||0
10360385|NCT00495677|11500284|FG002|NOT COMPLETED|Stage 1 (25 Days)||1
10360386|NCT00495677|11500285|FG003|NOT COMPLETED|Stage 1 (25 Days)||0
10360387|NCT00495677|11500286|FG004|NOT COMPLETED|Stage 1 (25 Days)||0
10360388|NCT00495677|11500287|FG005|NOT COMPLETED|Stage 1 (25 Days)||0
10360389|NCT00495677|11500288|FG006|NOT COMPLETED|Stage 1 (25 Days)||0
10360390|NCT00495677|11500282|FG000|STARTED|Stage 2 (25 Days)||0
10360391|NCT00495677|11500283|FG001|STARTED|Stage 2 (25 Days)||0
10360392|NCT00495677|11500284|FG002|STARTED|Stage 2 (25 Days)||0
10360393|NCT00495677|11500285|FG003|STARTED|Stage 2 (25 Days)||0
10360394|NCT00495677|11500286|FG004|STARTED|Stage 2 (25 Days)||8
10360395|NCT00495677|11500287|FG005|STARTED|Stage 2 (25 Days)||8
10360396|NCT00495677|11500288|FG006|STARTED|Stage 2 (25 Days)||7
10360397|NCT00495677|11500282|FG000|COMPLETED|Stage 2 (25 Days)||0
10360398|NCT00495677|11500283|FG001|COMPLETED|Stage 2 (25 Days)||0
10360399|NCT00495677|11500284|FG002|COMPLETED|Stage 2 (25 Days)||0
10360400|NCT00495677|11500285|FG003|COMPLETED|Stage 2 (25 Days)||0
10360401|NCT00495677|11500286|FG004|COMPLETED|Stage 2 (25 Days)||8
10360402|NCT00495677|11500287|FG005|COMPLETED|Stage 2 (25 Days)||8
10360403|NCT00495677|11500288|FG006|COMPLETED|Stage 2 (25 Days)||7
10360404|NCT00495677|11500282|FG000|NOT COMPLETED|Stage 2 (25 Days)||0
10360405|NCT00495677|11500283|FG001|NOT COMPLETED|Stage 2 (25 Days)||0
10360406|NCT00495677|11500284|FG002|NOT COMPLETED|Stage 2 (25 Days)||0
10360407|NCT00495677|11500285|FG003|NOT COMPLETED|Stage 2 (25 Days)||0
10360408|NCT00495677|11500286|FG004|NOT COMPLETED|Stage 2 (25 Days)||0
10360409|NCT00495677|11500287|FG005|NOT COMPLETED|Stage 2 (25 Days)||0
10360410|NCT00495677|11500288|FG006|NOT COMPLETED|Stage 2 (25 Days)||0
10360411|NCT00495755|11500304|FG000|STARTED|Overall Study||13
10360412|NCT00495755|11500304|FG000|COMPLETED|Overall Study||10
10360413|NCT00495755|11500304|FG000|NOT COMPLETED|Overall Study||3
10360414|NCT00495794|11500311|FG000|STARTED|Overall Study||2319
10360415|NCT00495794|11500312|FG001|STARTED|Overall Study||2303
10360416|NCT00495794|11500311|FG000|COMPLETED|Overall Study||1797
10360417|NCT00495794|11500312|FG001|COMPLETED|Overall Study||2303
10360418|NCT00495794|11500311|FG000|NOT COMPLETED|Overall Study||522
10360419|NCT00495794|11500312|FG001|NOT COMPLETED|Overall Study||0
10360420|NCT00495820|11500320|FG000|STARTED|Overall Study||30
10360421|NCT00495820|11500321|FG001|STARTED|Overall Study||30
10360422|NCT00495820|11500320|FG000|COMPLETED|Overall Study||29
10360423|NCT00495820|11500321|FG001|COMPLETED|Overall Study||29
10360424|NCT00495820|11500320|FG000|NOT COMPLETED|Overall Study||1
10360425|NCT00495820|11500321|FG001|NOT COMPLETED|Overall Study||1
10360426|NCT00496015|11500332|FG000|STARTED|Overall Study||178
10360427|NCT00496015|11500333|FG001|STARTED|Overall Study||27
10360428|NCT00496015|11500334|FG002|STARTED|Overall Study||172
10360429|NCT00496015|11500335|FG003|STARTED|Overall Study||37
10360430|NCT00496015|11500336|FG004|STARTED|Overall Study||336
10360431|NCT00496015|11500332|FG000|COMPLETED|Overall Study||177
10360432|NCT00496015|11500333|FG001|COMPLETED|Overall Study||27
10360433|NCT00496015|11500334|FG002|COMPLETED|Overall Study||172
10360434|NCT00496015|11500335|FG003|COMPLETED|Overall Study||36
10360435|NCT00496015|11500336|FG004|COMPLETED|Overall Study||336
10360436|NCT00496015|11500332|FG000|NOT COMPLETED|Overall Study||1
10360437|NCT00496015|11500333|FG001|NOT COMPLETED|Overall Study||0
10360438|NCT00496015|11500334|FG002|NOT COMPLETED|Overall Study||0
10360439|NCT00496015|11500335|FG003|NOT COMPLETED|Overall Study||1
10360440|NCT00496015|11500336|FG004|NOT COMPLETED|Overall Study||0
10360441|NCT00496054|11500356|FG000|STARTED|Overall Study||110
10360442|NCT00496054|11500356|FG000|COMPLETED|Overall Study||102
10360443|NCT00496054|11500356|FG000|NOT COMPLETED|Overall Study||8
10360444|NCT00496080|11500360|FG000|STARTED|Overall Study||87
10360445|NCT00496080|11500360|FG000|COMPLETED|Overall Study||60
10360446|NCT00496080|11500360|FG000|NOT COMPLETED|Overall Study||27
10360447|NCT00496197|11500365|FG000|STARTED|Overall Study||282
10360448|NCT00496197|11500365|FG000|COMPLETED|Overall Study||160
10360449|NCT00496197|11500365|FG000|NOT COMPLETED|Overall Study||122
10360450|NCT00496262|11500369|FG000|STARTED|Overall Study||15
10360451|NCT00496262|11500369|FG000|COMPLETED|Overall Study||15
10360452|NCT00496262|11500369|FG000|NOT COMPLETED|Overall Study||0
10360453|NCT00496340|11500375|FG000|STARTED|Overall Study||42
10360454|NCT00496340|11500375|FG000|COMPLETED|Overall Study||42
10360455|NCT00496340|11500375|FG000|NOT COMPLETED|Overall Study||0
10360456|NCT00496366|11500379|FG000|STARTED|Overall Study||11
10360457|NCT00496366|11500379|FG000|COMPLETED|Overall Study||10
10360458|NCT00496366|11500379|FG000|NOT COMPLETED|Overall Study||1
10360459|NCT00496379|11500383|FG000|STARTED|Overall Study||15
10360460|NCT00496379|11500383|FG000|COMPLETED|Overall Study||15
10360461|NCT00496379|11500383|FG000|NOT COMPLETED|Overall Study||0
10360462|NCT00496470|11500389|FG000|STARTED|Overall Study||329
10360463|NCT00496470|11500390|FG001|STARTED|Overall Study||331
10360464|NCT00496470|11500389|FG000|Received Study Medication|Overall Study||329
10360465|NCT00496470|11500390|FG001|Received Study Medication|Overall Study||330
10360466|NCT00496470|11500389|FG000|COMPLETED|Overall Study||303
10360467|NCT00496470|11500390|FG001|COMPLETED|Overall Study||302
10360468|NCT00496470|11500389|FG000|NOT COMPLETED|Overall Study||26
10360469|NCT00496470|11500390|FG001|NOT COMPLETED|Overall Study||29
10360470|NCT00496483|11500396|FG000|STARTED|Overall Study||60
10360471|NCT00496483|11500396|FG000|Dosed|Overall Study||51
10360472|NCT00496483|11500396|FG000|COMPLETED|Overall Study||48
10360473|NCT00496483|11500396|FG000|NOT COMPLETED|Overall Study||12
10360474|NCT00496587|11500403|FG000|STARTED|Overall Study||34
10360475|NCT00496587|11500403|FG000|COMPLETED|Overall Study||3
10360476|NCT00496587|11500403|FG000|NOT COMPLETED|Overall Study||31
10360477|NCT00496626|11500409|FG000|STARTED|Overall Study||302
10360478|NCT00496626|11500410|FG001|STARTED|Overall Study||298
10360479|NCT00496626|11500409|FG000|COMPLETED|Overall Study||296
10360480|NCT00496626|11500410|FG001|COMPLETED|Overall Study||292
10360481|NCT00496626|11500409|FG000|NOT COMPLETED|Overall Study||6
10360482|NCT00496626|11500410|FG001|NOT COMPLETED|Overall Study||6
10360483|NCT00496769|11500422|FG000|STARTED|Double Blind|Randomized|2807
10360484|NCT00496769|11500423|FG001|STARTED|Double Blind|Randomized|2791
10360485|NCT00496769|11500424|FG002|STARTED|Double Blind||0
10360486|NCT00496769|11500422|FG000|Received Treatment|Double Blind||2798
10360487|NCT00496769|11500423|FG001|Received Treatment|Double Blind||2708
10360488|NCT00496769|11500424|FG002|Received Treatment|Double Blind||0
10360489|NCT00496769|11500422|FG000|COMPLETED|Double Blind||2249
10360490|NCT00496769|11500423|FG001|COMPLETED|Double Blind||2142
10360491|NCT00496769|11500424|FG002|COMPLETED|Double Blind||0
10360492|NCT00496769|11500422|FG000|NOT COMPLETED|Double Blind||558
10360493|NCT00496769|11500423|FG001|NOT COMPLETED|Double Blind||649
10360494|NCT00496769|11500424|FG002|NOT COMPLETED|Double Blind||0
10360495|NCT00496769|11500422|FG000|STARTED|Open Label||0
10360496|NCT00496769|11500423|FG001|STARTED|Open Label||0
10360497|NCT00496769|11500424|FG002|STARTED|Open Label||3275
10360498|NCT00496769|11500422|FG000|COMPLETED|Open Label||0
10360499|NCT00496769|11500423|FG001|COMPLETED|Open Label||0
10360500|NCT00496769|11500424|FG002|COMPLETED|Open Label||2264
10360501|NCT00496769|11500422|FG000|NOT COMPLETED|Open Label||0
10360502|NCT00496769|11500423|FG001|NOT COMPLETED|Open Label||0
10360503|NCT00496769|11500424|FG002|NOT COMPLETED|Open Label||1011
10360504|NCT00496808|11500433|FG000|STARTED|Overall Study||69
10360505|NCT00496808|11500433|FG000|COMPLETED|Overall Study||69
10360506|NCT00496808|11500433|FG000|NOT COMPLETED|Overall Study||0
10360507|NCT00496860|11500440|FG000|STARTED|Overall Study||4
10360508|NCT00496860|11500441|FG001|STARTED|Overall Study||16
10360509|NCT00496860|11500442|FG002|STARTED|Overall Study||6
10360510|NCT00496860|11500440|FG000|COMPLETED|Overall Study||3
10360511|NCT00496860|11500441|FG001|COMPLETED|Overall Study||15
10360512|NCT00496860|11500442|FG002|COMPLETED|Overall Study||6
10360513|NCT00496860|11500440|FG000|NOT COMPLETED|Overall Study||1
10360514|NCT00496860|11500441|FG001|NOT COMPLETED|Overall Study||1
10360515|NCT00496860|11500442|FG002|NOT COMPLETED|Overall Study||0
10360516|NCT00496873|11500450|FG000|STARTED|Overall Study||85
10360517|NCT00496873|11500450|FG000|COMPLETED|Overall Study||78
10360518|NCT00496873|11500450|FG000|NOT COMPLETED|Overall Study||7
10360519|NCT00496964|11500456|FG000|STARTED|Overall Study||1
10360520|NCT00496964|11500457|FG001|STARTED|Overall Study||4
10360521|NCT00496964|11500456|FG000|COMPLETED|Overall Study||1
10360522|NCT00496964|11500457|FG001|COMPLETED|Overall Study||3
10360523|NCT00496964|11500456|FG000|NOT COMPLETED|Overall Study||0
10360524|NCT00496964|11500457|FG001|NOT COMPLETED|Overall Study||1
10360525|NCT00497055|11500467|FG000|STARTED|Overall Study||45
10360526|NCT00497055|11500468|FG001|STARTED|Overall Study||45
10360527|NCT00497055|11500467|FG000|COMPLETED|Overall Study||35
10360528|NCT00497055|11500468|FG001|COMPLETED|Overall Study||40
10360529|NCT00497055|11500467|FG000|NOT COMPLETED|Overall Study||10
10360530|NCT00497055|11500468|FG001|NOT COMPLETED|Overall Study||5
10360531|NCT00497081|11500476|FG000|STARTED|Overall Study||30
10360532|NCT00497081|11500477|FG001|STARTED|Overall Study||30
10360533|NCT00497081|11500476|FG000|COMPLETED|Overall Study||28
10360534|NCT00497081|11500477|FG001|COMPLETED|Overall Study||28
10360535|NCT00497081|11500476|FG000|NOT COMPLETED|Overall Study||2
10360536|NCT00497081|11500477|FG001|NOT COMPLETED|Overall Study||2
10360537|NCT00497146|11500485|FG000|STARTED|Treatment Period||115
10360538|NCT00497146|11500486|FG001|STARTED|Treatment Period||112
10360539|NCT00497146|11500485|FG000|COMPLETED|Treatment Period||88
10360540|NCT00497146|11500486|FG001|COMPLETED|Treatment Period||91
10360541|NCT00497146|11500485|FG000|NOT COMPLETED|Treatment Period||27
10360542|NCT00497146|11500486|FG001|NOT COMPLETED|Treatment Period||21
10360543|NCT00497146|11500485|FG000|STARTED|Long-term Follow-up Period||65
10360544|NCT00497146|11500486|FG001|STARTED|Long-term Follow-up Period||72
10360545|NCT00497146|11500485|FG000|COMPLETED|Long-term Follow-up Period||50
10360546|NCT00497146|11500486|FG001|COMPLETED|Long-term Follow-up Period||66
10360547|NCT00497146|11500485|FG000|NOT COMPLETED|Long-term Follow-up Period||15
10360548|NCT00497146|11500486|FG001|NOT COMPLETED|Long-term Follow-up Period||6
10360549|NCT00497198|11500496|FG000|STARTED|Overall Study||92
10360550|NCT00497198|11500497|FG001|STARTED|Overall Study||91
10360551|NCT00497198|11500496|FG000|COMPLETED|Overall Study||87
10360552|NCT00497198|11500497|FG001|COMPLETED|Overall Study||86
10360553|NCT00497198|11500496|FG000|NOT COMPLETED|Overall Study||5
10534969|NCT01433250|11687226|FG001|NOT COMPLETED|Overall Study||3
10656541|NCT02218268|11817511|FG001|STARTED|Final Phase (2 Hours)||21
10656542|NCT02218268|11817510|FG000|COMPLETED|Final Phase (2 Hours)||19
10656543|NCT02218268|11817511|FG001|COMPLETED|Final Phase (2 Hours)||21
10360554|NCT00497198|11500497|FG001|NOT COMPLETED|Overall Study||5
10360555|NCT00497289|11500505|FG000|STARTED|Overall Study||24
10360556|NCT00497289|11500506|FG001|STARTED|Overall Study||24
10360557|NCT00497289|11500505|FG000|COMPLETED|Overall Study||19
10360558|NCT00497289|11500506|FG001|COMPLETED|Overall Study||18
10360559|NCT00497289|11500505|FG000|NOT COMPLETED|Overall Study||5
10360560|NCT00497289|11500506|FG001|NOT COMPLETED|Overall Study||6
10360561|NCT00497770|11500518|FG000|STARTED|Overall Study||304
10360562|NCT00497770|11500519|FG001|STARTED|Overall Study||65
10360563|NCT00497770|11500520|FG002|STARTED|Overall Study||37
10360564|NCT00497770|11500521|FG003|STARTED|Overall Study||28
10360565|NCT00497770|11500518|FG000|COMPLETED|Overall Study||304
10360566|NCT00497770|11500519|FG001|COMPLETED|Overall Study||65
10360567|NCT00497770|11500520|FG002|COMPLETED|Overall Study||37
10360568|NCT00497770|11500521|FG003|COMPLETED|Overall Study||28
10360569|NCT00497770|11500518|FG000|NOT COMPLETED|Overall Study||0
10360570|NCT00497770|11500519|FG001|NOT COMPLETED|Overall Study||0
10360571|NCT00497770|11500520|FG002|NOT COMPLETED|Overall Study||0
10360572|NCT00497770|11500521|FG003|NOT COMPLETED|Overall Study||0
10534970|NCT01433263|11687234|FG000|STARTED|Overall Study||29
10534971|NCT01433263|11687235|FG001|STARTED|Overall Study||28
10360573|NCT00497796|11500534|FG000|STARTED|Overall Study||147
10360574|NCT00497796|11500535|FG001|STARTED|Overall Study||160
10360575|NCT00497796|11500534|FG000|COMPLETED|Overall Study||62
10360576|NCT00497796|11500535|FG001|COMPLETED|Overall Study||101
10360577|NCT00497796|11500534|FG000|NOT COMPLETED|Overall Study||85
10360578|NCT00497796|11500535|FG001|NOT COMPLETED|Overall Study||59
10360579|NCT00497874|11500543|FG000|STARTED|Overall Study||443
10360580|NCT00497874|11500544|FG001|STARTED|Overall Study||459
10360581|NCT00497874|11500543|FG000|COMPLETED|Overall Study||296
10360582|NCT00497874|11500544|FG001|COMPLETED|Overall Study||343
10360583|NCT00497874|11500543|FG000|NOT COMPLETED|Overall Study||147
10360584|NCT00497874|11500544|FG001|NOT COMPLETED|Overall Study||116
10360585|NCT00498173|11500554|FG000|STARTED|Phase 1-Blinded Randomization (8 Weeks)||29
10360586|NCT00498173|11500555|FG001|STARTED|Phase 1-Blinded Randomization (8 Weeks)||31
10360587|NCT00498173|11500556|FG002|STARTED|Phase 1-Blinded Randomization (8 Weeks)||0
10360588|NCT00498173|11500554|FG000|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||27
10360589|NCT00498173|11500555|FG001|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||30
10360590|NCT00498173|11500556|FG002|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||0
10360591|NCT00498173|11500554|FG000|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||2
10360592|NCT00498173|11500555|FG001|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||1
10360593|NCT00498173|11500556|FG002|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||0
10360594|NCT00498173|11500554|FG000|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
10360595|NCT00498173|11500555|FG001|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
10360596|NCT00498173|11500556|FG002|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||26
10360597|NCT00498173|11500554|FG000|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
10360598|NCT00498173|11500555|FG001|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
10360599|NCT00498173|11500556|FG002|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||26
10360600|NCT00498173|11500554|FG000|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
10360601|NCT00498173|11500555|FG001|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
10360602|NCT00498173|11500556|FG002|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
10360603|NCT00498186|11500564|FG000|STARTED|Overall Study||295
10360604|NCT00498186|11500564|FG000|COMPLETED|Overall Study||122
10360605|NCT00498186|11500564|FG000|NOT COMPLETED|Overall Study||173
10360606|NCT00498355|11500568|FG000|STARTED|Overall Study||7
10360607|NCT00498355|11500568|FG000|COMPLETED|Overall Study||6
10360608|NCT00498355|11500568|FG000|NOT COMPLETED|Overall Study||1
10360609|NCT00498368|11500575|FG000|STARTED|Overall Study||17
10360610|NCT00498368|11500576|FG001|STARTED|Overall Study||17
10360611|NCT00498368|11500575|FG000|COMPLETED|Overall Study||14
10360612|NCT00498368|11500576|FG001|COMPLETED|Overall Study||15
10360613|NCT00498368|11500575|FG000|NOT COMPLETED|Overall Study||3
10360614|NCT00498368|11500576|FG001|NOT COMPLETED|Overall Study||2
10360615|NCT00498433|11500585|FG000|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||10
10360616|NCT00498433|11500586|FG001|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
10360617|NCT00498433|11500587|FG002|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
10360618|NCT00498433|11500585|FG000|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||10
10360619|NCT00498433|11500586|FG001|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
10360620|NCT00498433|11500587|FG002|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
10360621|NCT00498433|11500585|FG000|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
10360622|NCT00498433|11500586|FG001|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
10360623|NCT00498433|11500587|FG002|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
10360624|NCT00498433|11500585|FG000|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||0
10360625|NCT00498433|11500586|FG001|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||10
10360626|NCT00498433|11500587|FG002|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||0
10360627|NCT00498433|11500585|FG000|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
10534972|NCT01433263|11687234|FG000|COMPLETED|Overall Study||10
10534973|NCT01433263|11687235|FG001|COMPLETED|Overall Study||16
10534974|NCT01433263|11687234|FG000|NOT COMPLETED|Overall Study||19
10534975|NCT01433263|11687235|FG001|NOT COMPLETED|Overall Study||12
10534976|NCT01433354|11687244|FG000|STARTED|Overall Study|120 enrolled of which 119 were administered drug|119
10534977|NCT01433354|11687244|FG000|COMPLETED|Overall Study||0
10534978|NCT01433354|11687244|FG000|NOT COMPLETED|Overall Study||119
10534979|NCT01433549|11687258|FG000|STARTED|Phase 1: First Study Product||12
10534980|NCT01433549|11687259|FG001|STARTED|Phase 1: First Study Product||13
10534981|NCT01433549|11687258|FG000|COMPLETED|Phase 1: First Study Product||12
10534982|NCT01433549|11687259|FG001|COMPLETED|Phase 1: First Study Product||13
10534983|NCT01433549|11687258|FG000|NOT COMPLETED|Phase 1: First Study Product||0
10534984|NCT01433549|11687259|FG001|NOT COMPLETED|Phase 1: First Study Product||0
10534985|NCT01433549|11687258|FG000|STARTED|Phase 2: Second Study Product||12
10534986|NCT01433549|11687259|FG001|STARTED|Phase 2: Second Study Product||13
10534987|NCT01433549|11687258|FG000|COMPLETED|Phase 2: Second Study Product||12
10534988|NCT01433549|11687259|FG001|COMPLETED|Phase 2: Second Study Product||12
10534989|NCT01433549|11687258|FG000|NOT COMPLETED|Phase 2: Second Study Product||0
10534990|NCT01433549|11687259|FG001|NOT COMPLETED|Phase 2: Second Study Product||1
10534991|NCT01433731|11687269|FG000|STARTED|Overall Study||3
10534992|NCT01433731|11687270|FG001|STARTED|Overall Study||5
10534993|NCT01433731|11687271|FG002|STARTED|Overall Study||5
10534994|NCT01433731|11687272|FG003|STARTED|Overall Study||5
10656544|NCT02218268|11817510|FG000|NOT COMPLETED|Final Phase (2 Hours)||0
10656545|NCT02218268|11817511|FG001|NOT COMPLETED|Final Phase (2 Hours)||0
10656546|NCT02218307|11817519|FG000|STARTED|Overall Study||34
10656547|NCT02218307|11817520|FG001|STARTED|Overall Study||34
10656548|NCT02218307|11817519|FG000|COMPLETED|Overall Study||25
10360628|NCT00498433|11500586|FG001|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||10
10360629|NCT00498433|11500587|FG002|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
10360630|NCT00498433|11500585|FG000|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
10360631|NCT00498433|11500586|FG001|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
10360632|NCT00498433|11500587|FG002|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
10360633|NCT00498433|11500585|FG000|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
10360634|NCT00498433|11500586|FG001|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
10360635|NCT00498433|11500587|FG002|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||10
10360636|NCT00498433|11500585|FG000|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
10360637|NCT00498433|11500586|FG001|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
10360638|NCT00498433|11500587|FG002|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||10
10360639|NCT00498433|11500585|FG000|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
10360640|NCT00498433|11500586|FG001|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
10360641|NCT00498433|11500587|FG002|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
10360642|NCT00498433|11500585|FG000|STARTED|Part 2: Placebo Run-in (2 Weeks)||36
10360643|NCT00498433|11500586|FG001|STARTED|Part 2: Placebo Run-in (2 Weeks)|For part 2, this arm belongs to randomized, double blind period.|0
10360644|NCT00498433|11500587|FG002|STARTED|Part 2: Placebo Run-in (2 Weeks)|For part 2, this arm belongs to randomized, double blind period.|0
10360645|NCT00498433|11500585|FG000|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||16
10360646|NCT00498433|11500586|FG001|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
10360647|NCT00498433|11500587|FG002|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
10360648|NCT00498433|11500585|FG000|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||20
10360649|NCT00498433|11500586|FG001|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
10360650|NCT00498433|11500587|FG002|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
10360651|NCT00498433|11500585|FG000|STARTED|Part 2: Double Blind (12 Weeks)||0
10360652|NCT00498433|11500586|FG001|STARTED|Part 2: Double Blind (12 Weeks)||8
10360653|NCT00498433|11500587|FG002|STARTED|Part 2: Double Blind (12 Weeks)||8
10360654|NCT00498433|11500585|FG000|COMPLETED|Part 2: Double Blind (12 Weeks)||0
10360655|NCT00498433|11500586|FG001|COMPLETED|Part 2: Double Blind (12 Weeks)||8
10360656|NCT00498433|11500587|FG002|COMPLETED|Part 2: Double Blind (12 Weeks)||8
10360657|NCT00498433|11500585|FG000|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
10360658|NCT00498433|11500586|FG001|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
10360659|NCT00498433|11500587|FG002|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
10360660|NCT00498485|11500606|FG000|STARTED|Overall Study||7
10360661|NCT00498485|11500607|FG001|STARTED|Overall Study||10
10360662|NCT00498485|11500606|FG000|COMPLETED|Overall Study||6
10360663|NCT00498485|11500607|FG001|COMPLETED|Overall Study||5
10360664|NCT00498485|11500606|FG000|NOT COMPLETED|Overall Study||1
10360665|NCT00498485|11500607|FG001|NOT COMPLETED|Overall Study||5
10360666|NCT00498550|11500617|FG000|STARTED|Overall Study||15
10360667|NCT00498550|11500618|FG001|STARTED|Overall Study||16
10360668|NCT00498550|11500617|FG000|COMPLETED|Overall Study|13 of 15 received clozapine all 12 visits, two discontinued clozapine early but remained in study.|15
10360669|NCT00498550|11500618|FG001|COMPLETED|Overall Study||15
10360670|NCT00498550|11500617|FG000|NOT COMPLETED|Overall Study||0
10360671|NCT00498550|11500618|FG001|NOT COMPLETED|Overall Study||1
10360672|NCT00498602|11500631|FG000|STARTED|Overall Study||36
10360673|NCT00498602|11500632|FG001|STARTED|Overall Study||61
10360674|NCT00498602|11500633|FG002|STARTED|Overall Study||40
10360675|NCT00498602|11500634|FG003|STARTED|Overall Study||35
10360676|NCT00498602|11500635|FG004|STARTED|Overall Study||12
10360677|NCT00498602|11500636|FG005|STARTED|Overall Study||44
10360678|NCT00498602|11500637|FG006|STARTED|Overall Study||17
10360679|NCT00498602|11500631|FG000|Treated|Overall Study||36
10360680|NCT00498602|11500632|FG001|Treated|Overall Study|One participant discontinued due to an AE, with an outcome of death.|60
10360681|NCT00498602|11500633|FG002|Treated|Overall Study||40
10360682|NCT00498602|11500634|FG003|Treated|Overall Study||35
10360683|NCT00498602|11500635|FG004|Treated|Overall Study||12
10360684|NCT00498602|11500636|FG005|Treated|Overall Study||44
10812546|NCT03543358|11974633|FG001|STARTED|Overall Study||0
10812547|NCT03543358|11974632|FG000|Received Treatment or Retreatment|Overall Study||0
10812548|NCT03543358|11974633|FG001|Received Treatment or Retreatment|Overall Study||0
10812549|NCT03543358|11974632|FG000|COMPLETED|Overall Study||0
10360685|NCT00498602|11500637|FG006|Treated|Overall Study||17
10360686|NCT00498602|11500631|FG000|COMPLETED|Overall Study||26
10360687|NCT00498602|11500632|FG001|COMPLETED|Overall Study||51
10360688|NCT00498602|11500633|FG002|COMPLETED|Overall Study||32
10360689|NCT00498602|11500634|FG003|COMPLETED|Overall Study||30
10360690|NCT00498602|11500635|FG004|COMPLETED|Overall Study||8
10360691|NCT00498602|11500636|FG005|COMPLETED|Overall Study||31
10360692|NCT00498602|11500637|FG006|COMPLETED|Overall Study||15
10360693|NCT00498602|11500631|FG000|NOT COMPLETED|Overall Study||10
10360694|NCT00498602|11500632|FG001|NOT COMPLETED|Overall Study||10
10360695|NCT00498602|11500633|FG002|NOT COMPLETED|Overall Study||8
10360696|NCT00498602|11500634|FG003|NOT COMPLETED|Overall Study||5
10360697|NCT00498602|11500635|FG004|NOT COMPLETED|Overall Study||4
10360698|NCT00498602|11500636|FG005|NOT COMPLETED|Overall Study||13
10360699|NCT00498602|11500637|FG006|NOT COMPLETED|Overall Study||2
10360700|NCT00498615|11500653|FG000|STARTED|Fasudil 80mg||2
10360701|NCT00498615|11500654|FG001|STARTED|Fasudil 80mg||4
10360702|NCT00498615|11500655|FG002|STARTED|Fasudil 80mg||3
10360703|NCT00498615|11500656|FG003|STARTED|Fasudil 80mg||2
10812550|NCT03543358|11974633|FG001|COMPLETED|Overall Study||0
10812551|NCT03543358|11974632|FG000|NOT COMPLETED|Overall Study||3
10360704|NCT00498615|11500657|FG004|STARTED|Fasudil 80mg||3
10360705|NCT00498615|11500658|FG005|STARTED|Fasudil 80mg||3
10360706|NCT00498615|11500653|FG000|COMPLETED|Fasudil 80mg||2
10360707|NCT00498615|11500654|FG001|COMPLETED|Fasudil 80mg||4
10360708|NCT00498615|11500655|FG002|COMPLETED|Fasudil 80mg||3
10360709|NCT00498615|11500656|FG003|COMPLETED|Fasudil 80mg||2
10360710|NCT00498615|11500657|FG004|COMPLETED|Fasudil 80mg||3
10360711|NCT00498615|11500658|FG005|COMPLETED|Fasudil 80mg||3
10360712|NCT00498615|11500653|FG000|NOT COMPLETED|Fasudil 80mg||0
10360713|NCT00498615|11500654|FG001|NOT COMPLETED|Fasudil 80mg||0
10360714|NCT00498615|11500655|FG002|NOT COMPLETED|Fasudil 80mg||0
10360715|NCT00498615|11500656|FG003|NOT COMPLETED|Fasudil 80mg||0
10360716|NCT00498615|11500657|FG004|NOT COMPLETED|Fasudil 80mg||0
10360717|NCT00498615|11500658|FG005|NOT COMPLETED|Fasudil 80mg||0
10360718|NCT00498615|11500653|FG000|STARTED|Fasudil 40mg||2
10360719|NCT00498615|11500654|FG001|STARTED|Fasudil 40mg||4
10360720|NCT00498615|11500655|FG002|STARTED|Fasudil 40mg||3
10360721|NCT00498615|11500656|FG003|STARTED|Fasudil 40mg||2
10360722|NCT00498615|11500657|FG004|STARTED|Fasudil 40mg||3
10360723|NCT00498615|11500658|FG005|STARTED|Fasudil 40mg||3
10360724|NCT00498615|11500653|FG000|COMPLETED|Fasudil 40mg||2
10360725|NCT00498615|11500654|FG001|COMPLETED|Fasudil 40mg||4
10360726|NCT00498615|11500655|FG002|COMPLETED|Fasudil 40mg||3
10360727|NCT00498615|11500656|FG003|COMPLETED|Fasudil 40mg||2
10360728|NCT00498615|11500657|FG004|COMPLETED|Fasudil 40mg||3
10360729|NCT00498615|11500658|FG005|COMPLETED|Fasudil 40mg||3
10360730|NCT00498615|11500653|FG000|NOT COMPLETED|Fasudil 40mg||0
10360731|NCT00498615|11500654|FG001|NOT COMPLETED|Fasudil 40mg||0
10360732|NCT00498615|11500655|FG002|NOT COMPLETED|Fasudil 40mg||0
10360733|NCT00498615|11500656|FG003|NOT COMPLETED|Fasudil 40mg||0
10360734|NCT00498615|11500657|FG004|NOT COMPLETED|Fasudil 40mg||0
10360735|NCT00498615|11500658|FG005|NOT COMPLETED|Fasudil 40mg||0
10360736|NCT00498615|11500653|FG000|STARTED|Placebo||2
10360737|NCT00498615|11500654|FG001|STARTED|Placebo||4
10360738|NCT00498615|11500655|FG002|STARTED|Placebo||3
10360739|NCT00498615|11500656|FG003|STARTED|Placebo||2
10360740|NCT00498615|11500657|FG004|STARTED|Placebo||3
10360741|NCT00498615|11500658|FG005|STARTED|Placebo||3
10360742|NCT00498615|11500653|FG000|COMPLETED|Placebo||2
10360743|NCT00498615|11500654|FG001|COMPLETED|Placebo||4
10360744|NCT00498615|11500655|FG002|COMPLETED|Placebo||3
10360745|NCT00498615|11500656|FG003|COMPLETED|Placebo||2
10360746|NCT00498615|11500657|FG004|COMPLETED|Placebo||3
10360747|NCT00498615|11500658|FG005|COMPLETED|Placebo||3
10360748|NCT00498615|11500653|FG000|NOT COMPLETED|Placebo||0
10360749|NCT00498615|11500654|FG001|NOT COMPLETED|Placebo||0
10360750|NCT00498615|11500655|FG002|NOT COMPLETED|Placebo||0
10360751|NCT00498615|11500656|FG003|NOT COMPLETED|Placebo||0
10360752|NCT00498615|11500657|FG004|NOT COMPLETED|Placebo||0
10360753|NCT00498615|11500658|FG005|NOT COMPLETED|Placebo||0
10360754|NCT00498628|11500674|FG000|STARTED|Overall Study||105
10360755|NCT00498628|11500675|FG001|STARTED|Overall Study||113
10360756|NCT00498628|11500674|FG000|COMPLETED|Overall Study||90
10534995|NCT01433731|11687269|FG000|COMPLETED|Overall Study||3
10534996|NCT01433731|11687270|FG001|COMPLETED|Overall Study||5
10534997|NCT01433731|11687271|FG002|COMPLETED|Overall Study||5
10534998|NCT01433731|11687272|FG003|COMPLETED|Overall Study||5
10534999|NCT01433731|11687269|FG000|NOT COMPLETED|Overall Study||0
10535000|NCT01433731|11687270|FG001|NOT COMPLETED|Overall Study||0
10535001|NCT01433731|11687271|FG002|NOT COMPLETED|Overall Study||0
10535002|NCT01433731|11687272|FG003|NOT COMPLETED|Overall Study||0
10535003|NCT01433913|11687282|FG000|STARTED|Overall Study||10
10535004|NCT01433913|11687283|FG001|STARTED|Overall Study||10
10535005|NCT01433913|11687282|FG000|COMPLETED|Overall Study||9
10535006|NCT01433913|11687283|FG001|COMPLETED|Overall Study||10
10535007|NCT01433913|11687282|FG000|NOT COMPLETED|Overall Study||1
10535008|NCT01433913|11687283|FG001|NOT COMPLETED|Overall Study||0
10535009|NCT01433978|11687292|FG000|STARTED|Core Study||11
10535010|NCT01433978|11687293|FG001|STARTED|Core Study||12
10535011|NCT01433978|11687294|FG002|STARTED|Core Study||0
10535012|NCT01433978|11687292|FG000|COMPLETED|Core Study||0
10535013|NCT01433978|11687293|FG001|COMPLETED|Core Study||1
10535014|NCT01433978|11687294|FG002|COMPLETED|Core Study||0
10535015|NCT01433978|11687292|FG000|NOT COMPLETED|Core Study||11
10535016|NCT01433978|11687293|FG001|NOT COMPLETED|Core Study||11
10535017|NCT01433978|11687294|FG002|NOT COMPLETED|Core Study||0
10535018|NCT01433978|11687292|FG000|STARTED|Extension Phase||0
10656549|NCT02218307|11817520|FG001|COMPLETED|Overall Study||33
10656550|NCT02218307|11817519|FG000|NOT COMPLETED|Overall Study||9
10656551|NCT02218307|11817520|FG001|NOT COMPLETED|Overall Study||1
10656552|NCT02218320|11817528|FG000|STARTED|Overall Study|First participant visit on this arm Dec 2014|10
10360757|NCT00498628|11500675|FG001|COMPLETED|Overall Study||92
10360758|NCT00498628|11500674|FG000|NOT COMPLETED|Overall Study||15
10360759|NCT00498628|11500675|FG001|NOT COMPLETED|Overall Study||21
10360760|NCT00498706|11500685|FG000|STARTED|Overall Study||163
10360761|NCT00498706|11500686|FG001|STARTED|Overall Study||162
10656553|NCT02218320|11817529|FG001|STARTED|Overall Study|First participant contact on this arm was December 2014|10
10656554|NCT02218320|11817528|FG000|COMPLETED|Overall Study|Last participant contact on this arm was June 2015|10
10360762|NCT00498706|11500685|FG000|Post Treatment Week 18|Overall Study||163
10360763|NCT00498706|11500686|FG001|Post Treatment Week 18|Overall Study||162
10535019|NCT01433978|11687293|FG001|STARTED|Extension Phase||0
10535020|NCT01433978|11687294|FG002|STARTED|Extension Phase||6
10535021|NCT01433978|11687292|FG000|COMPLETED|Extension Phase||0
10360764|NCT00498706|11500685|FG000|COMPLETED|Overall Study||163
10360765|NCT00498706|11500686|FG001|COMPLETED|Overall Study||162
10360766|NCT00498706|11500685|FG000|NOT COMPLETED|Overall Study||0
10360767|NCT00498706|11500686|FG001|NOT COMPLETED|Overall Study||0
10535022|NCT01433978|11687293|FG001|COMPLETED|Extension Phase||0
10535023|NCT01433978|11687294|FG002|COMPLETED|Extension Phase||0
10535024|NCT01433978|11687292|FG000|NOT COMPLETED|Extension Phase||0
10535025|NCT01433978|11687293|FG001|NOT COMPLETED|Extension Phase||0
10535026|NCT01433978|11687294|FG002|NOT COMPLETED|Extension Phase||6
10547946|NCT01515865|11701717|FG000|STARTED|Part B (Open-label)|Twenty-four subjects from Part A did not meet the criteria required to be enrolled into Part B.|71
10547947|NCT01515865|11701718|FG001|STARTED|Part B (Open-label)||0
10547948|NCT01515865|11701719|FG002|STARTED|Part B (Open-label)||0
10547949|NCT01515865|11701717|FG000|COMPLETED|Part B (Open-label)||69
10547950|NCT01515865|11701718|FG001|COMPLETED|Part B (Open-label)||0
10547951|NCT01515865|11701719|FG002|COMPLETED|Part B (Open-label)||0
10547952|NCT01515865|11701717|FG000|NOT COMPLETED|Part B (Open-label)||2
10547953|NCT01515865|11701718|FG001|NOT COMPLETED|Part B (Open-label)||0
10547954|NCT01515865|11701719|FG002|NOT COMPLETED|Part B (Open-label)||0
10547955|NCT01515865|11701717|FG000|STARTED|Part C (Randomized)||0
10547956|NCT01515865|11701718|FG001|STARTED|Part C (Randomized)|A total of two subjects from Part B did not meet the criteria required to be enrolled into Part C.|33
10547957|NCT01515865|11701719|FG002|STARTED|Part C (Randomized)||34
10547958|NCT01515865|11701717|FG000|COMPLETED|Part C (Randomized)||0
10547959|NCT01515865|11701718|FG001|COMPLETED|Part C (Randomized)||33
10547960|NCT01515865|11701719|FG002|COMPLETED|Part C (Randomized)||34
10547961|NCT01515865|11701717|FG000|NOT COMPLETED|Part C (Randomized)||0
10547962|NCT01515865|11701718|FG001|NOT COMPLETED|Part C (Randomized)||0
10547963|NCT01515865|11701719|FG002|NOT COMPLETED|Part C (Randomized)||0
10547964|NCT01515891|11701727|FG000|STARTED|Overall Study||4
10547965|NCT01515891|11701727|FG000|COMPLETED|Overall Study||4
10547966|NCT01515891|11701727|FG000|NOT COMPLETED|Overall Study||0
10547967|NCT01515943|11701734|FG000|STARTED|Overall Study||75
10547968|NCT01515943|11701735|FG001|STARTED|Overall Study||85
10547969|NCT01515943|11701736|FG002|STARTED|Overall Study||44
10547970|NCT01515943|11701734|FG000|COMPLETED|Overall Study||69
10547971|NCT01515943|11701735|FG001|COMPLETED|Overall Study||69
10656555|NCT02218320|11817529|FG001|COMPLETED|Overall Study|Last participant contact on this arm was October 2015|10
10656556|NCT02218320|11817528|FG000|NOT COMPLETED|Overall Study||0
10656557|NCT02218320|11817529|FG001|NOT COMPLETED|Overall Study||0
10656558|NCT02218372|11817537|FG000|STARTED|Overall Study||100
10656559|NCT02218372|11817538|FG001|STARTED|Overall Study||48
10656560|NCT02218372|11817537|FG000|Treated|Overall Study||98
10656561|NCT02218372|11817538|FG001|Treated|Overall Study||44
10656562|NCT02218372|11817537|FG000|COMPLETED|Overall Study||95
10656563|NCT02218372|11817538|FG001|COMPLETED|Overall Study||42
10656564|NCT02218372|11817537|FG000|NOT COMPLETED|Overall Study||5
10656565|NCT02218372|11817538|FG001|NOT COMPLETED|Overall Study||6
10656566|NCT02218424|11817551|FG000|STARTED|Overall Study||30
10656567|NCT02218424|11817552|FG001|STARTED|Overall Study||30
10656568|NCT02218424|11817551|FG000|COMPLETED|Overall Study||30
10656569|NCT02218424|11817552|FG001|COMPLETED|Overall Study||30
10656570|NCT02218424|11817551|FG000|NOT COMPLETED|Overall Study||0
10656571|NCT02218424|11817552|FG001|NOT COMPLETED|Overall Study||0
10656572|NCT02218463|11817560|FG000|STARTED|Overall Study||21
10656573|NCT02218463|11817561|FG001|STARTED|Overall Study||22
10656574|NCT02218463|11817560|FG000|COMPLETED|Overall Study||18
10656575|NCT02218463|11817561|FG001|COMPLETED|Overall Study||19
10656576|NCT02218463|11817560|FG000|NOT COMPLETED|Overall Study||3
10656577|NCT02218463|11817561|FG001|NOT COMPLETED|Overall Study||3
10656578|NCT02218489|11817569|FG000|STARTED|Overall Study||101
10656579|NCT02218489|11817570|FG001|STARTED|Overall Study||104
10656580|NCT02218489|11817569|FG000|COMPLETED|Overall Study||96
10656581|NCT02218489|11817570|FG001|COMPLETED|Overall Study||101
10656582|NCT02218489|11817569|FG000|NOT COMPLETED|Overall Study||5
10656583|NCT02218489|11817570|FG001|NOT COMPLETED|Overall Study||3
10656584|NCT02218541|11817579|FG000|STARTED|Overall Study||11
10656585|NCT02218541|11817580|FG001|STARTED|Overall Study||11
10656586|NCT02218541|11817579|FG000|COMPLETED|Overall Study||5
10656587|NCT02218541|11817580|FG001|COMPLETED|Overall Study||9
10656588|NCT02218541|11817579|FG000|NOT COMPLETED|Overall Study||6
10656589|NCT02218541|11817580|FG001|NOT COMPLETED|Overall Study||2
10656590|NCT02218736|11817589|FG000|STARTED|Overall Study||45
10656591|NCT02218736|11817590|FG001|STARTED|Overall Study||44
10656592|NCT02218736|11817589|FG000|COMPLETED|Overall Study||33
10656593|NCT02218736|11817590|FG001|COMPLETED|Overall Study||35
10360768|NCT00498797|11500696|FG000|STARTED|Overall Study|randomised patients|43
10360769|NCT00498797|11500697|FG001|STARTED|Overall Study|randomised patients|43
10427057|NCT00850993|11572838|FG002|Intent-to-treat|Overall Study||8
10547972|NCT01515943|11701736|FG002|COMPLETED|Overall Study||31
10547973|NCT01515943|11701734|FG000|NOT COMPLETED|Overall Study||6
10547974|NCT01515943|11701735|FG001|NOT COMPLETED|Overall Study||16
10656594|NCT02218736|11817589|FG000|NOT COMPLETED|Overall Study||12
10656595|NCT02218736|11817590|FG001|NOT COMPLETED|Overall Study||9
10656596|NCT02219009|11817598|FG000|STARTED|Overall Study||37
10656597|NCT02219009|11817599|FG001|STARTED|Overall Study||30
10656598|NCT02219009|11817598|FG000|COMPLETED|Overall Study||27
10656599|NCT02219009|11817599|FG001|COMPLETED|Overall Study||22
10656600|NCT02219009|11817598|FG000|NOT COMPLETED|Overall Study||10
10656601|NCT02219009|11817599|FG001|NOT COMPLETED|Overall Study||8
10656602|NCT02219048|11817607|FG000|STARTED|Overall Study||26
10812552|NCT03543358|11974633|FG001|NOT COMPLETED|Overall Study||0
10812553|NCT03538015|11974640|FG000|STARTED|Overall Study||0
10812554|NCT03538015|11974641|FG001|STARTED|Overall Study||0
10812555|NCT03538015|11974642|FG002|STARTED|Overall Study||1
10812556|NCT03538015|11974640|FG000|COMPLETED|Overall Study||0
10812557|NCT03538015|11974641|FG001|COMPLETED|Overall Study||0
10812558|NCT03538015|11974642|FG002|COMPLETED|Overall Study||0
10812559|NCT03538015|11974640|FG000|NOT COMPLETED|Overall Study||0
10812560|NCT03538015|11974641|FG001|NOT COMPLETED|Overall Study||0
10812561|NCT03538015|11974642|FG002|NOT COMPLETED|Overall Study||1
10812562|NCT03534362|11974652|FG000|STARTED|Overall Study||0
10812563|NCT03534362|11974653|FG001|STARTED|Overall Study||1
10535027|NCT01433991|11687305|FG000|STARTED|Pretreatment Phase (Single Agent Run-in)||5
10716266|NCT02688387|11880053|FG010|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10716267|NCT02688387|11880054|FG011|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10716268|NCT02688387|11880055|FG012|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10716269|NCT02688387|11880056|FG013|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10716270|NCT02688387|11880057|FG014|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10716271|NCT02688387|11880058|FG015|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10716272|NCT02688387|11880059|FG016|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10716273|NCT02688387|11880060|FG017|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10716274|NCT02688387|11880061|FG018|COMPLETED|Part 3B, Period 3 (up to 6 Days)||8
10716275|NCT02688387|11880062|FG019|COMPLETED|Part 3B, Period 3 (up to 6 Days)||8
10716276|NCT02688387|11880063|FG020|COMPLETED|Part 3B, Period 3 (up to 6 Days)||7
10716277|NCT02688387|11880064|FG021|COMPLETED|Part 3B, Period 3 (up to 6 Days)||8
10716278|NCT02688387|11880043|FG000|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10360770|NCT00498797|11500696|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|5
10360771|NCT00498797|11500697|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|14
10360772|NCT00498797|11500696|FG000|NOT COMPLETED|Overall Study||38
10360773|NCT00498797|11500697|FG001|NOT COMPLETED|Overall Study||29
10360774|NCT00498927|11500703|FG000|STARTED|Overall Study||47
10360775|NCT00498927|11500703|FG000|COMPLETED|Overall Study||47
10360776|NCT00498927|11500703|FG000|NOT COMPLETED|Overall Study||0
10360777|NCT00498940|11500709|FG000|STARTED|Overall Study||30
10360778|NCT00498940|11500710|FG001|STARTED|Overall Study||31
10360779|NCT00498940|11500709|FG000|COMPLETED|Overall Study||30
10360780|NCT00498940|11500710|FG001|COMPLETED|Overall Study||31
10360781|NCT00498940|11500709|FG000|NOT COMPLETED|Overall Study||0
10360782|NCT00498940|11500710|FG001|NOT COMPLETED|Overall Study||0
10360783|NCT00499031|11500716|FG000|STARTED|Overall Study|Total number participants enrolled on study|38
10427058|NCT00850993|11572839|FG003|Intent-to-treat|Overall Study||15
10360784|NCT00499031|11500716|FG000|COMPLETED|Overall Study|Total number participants that are eligible and evaluable.|35
10360785|NCT00499031|11500716|FG000|NOT COMPLETED|Overall Study||3
10360786|NCT00499083|11500720|FG000|STARTED|Overall Study||17
10360787|NCT00499083|11500720|FG000|Participants at UNMC|Overall Study||3
10360788|NCT00499083|11500720|FG000|Participants at Moffitt Cancer Center|Overall Study||14
10360789|NCT00499083|11500720|FG000|COMPLETED|Overall Study||14
10360790|NCT00499083|11500720|FG000|NOT COMPLETED|Overall Study||3
10360791|NCT00499096|11500726|FG000|STARTED|Overall Study||58
10360792|NCT00499096|11500727|FG001|STARTED|Overall Study||60
10360793|NCT00499096|11500726|FG000|COMPLETED|Overall Study||35
10360794|NCT00499096|11500727|FG001|COMPLETED|Overall Study||40
10360795|NCT00499096|11500726|FG000|NOT COMPLETED|Overall Study||23
10360796|NCT00499096|11500727|FG001|NOT COMPLETED|Overall Study||20
10427059|NCT00850993|11572836|FG000|Received Phototherapy|Overall Study||3
10427060|NCT00850993|11572837|FG001|Received Phototherapy|Overall Study||6
10427061|NCT00850993|11572838|FG002|Received Phototherapy|Overall Study||2
10427062|NCT00850993|11572839|FG003|Received Phototherapy|Overall Study||8
10427063|NCT00850993|11572836|FG000|Per Protocol|Overall Study||10
10427064|NCT00850993|11572837|FG001|Per Protocol|Overall Study||13
10427065|NCT00850993|11572838|FG002|Per Protocol|Overall Study||5
10427066|NCT00850993|11572839|FG003|Per Protocol|Overall Study||13
10427067|NCT00850993|11572836|FG000|COMPLETED|Overall Study||16
10427068|NCT00850993|11572837|FG001|COMPLETED|Overall Study||18
10427069|NCT00850993|11572838|FG002|COMPLETED|Overall Study||8
10427070|NCT00850993|11572839|FG003|COMPLETED|Overall Study||14
10427071|NCT00850993|11572836|FG000|NOT COMPLETED|Overall Study||1
10427072|NCT00850993|11572837|FG001|NOT COMPLETED|Overall Study||0
10427073|NCT00850993|11572838|FG002|NOT COMPLETED|Overall Study||0
10427074|NCT00850993|11572839|FG003|NOT COMPLETED|Overall Study||1
10427075|NCT00851006|11572849|FG000|STARTED|Overall Study||7
10427076|NCT00851006|11572850|FG001|STARTED|Overall Study||6
10427077|NCT00851006|11572849|FG000|COMPLETED|Overall Study||7
10427078|NCT00851006|11572850|FG001|COMPLETED|Overall Study||6
10427079|NCT00851006|11572849|FG000|NOT COMPLETED|Overall Study||0
10427080|NCT00851006|11572850|FG001|NOT COMPLETED|Overall Study||0
10427081|NCT00851084|11572859|FG000|STARTED|Overall Study||117
10427082|NCT00851084|11572860|FG001|STARTED|Overall Study||119
10427083|NCT00851084|11572859|FG000|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria.|0
10427084|NCT00851084|11572860|FG001|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria.|0
10427085|NCT00851084|11572859|FG000|NOT COMPLETED|Overall Study||117
10427086|NCT00851084|11572860|FG001|NOT COMPLETED|Overall Study||119
10427087|NCT00851253|11572870|FG000|STARTED|Overall Study||2
10427088|NCT00851253|11572871|FG001|STARTED|Overall Study||10
10427089|NCT00851253|11572870|FG000|COMPLETED|Overall Study||1
10427090|NCT00851253|11572871|FG001|COMPLETED|Overall Study||10
10427091|NCT00851253|11572870|FG000|NOT COMPLETED|Overall Study||1
10427092|NCT00851253|11572871|FG001|NOT COMPLETED|Overall Study||0
10427093|NCT00851279|11572877|FG000|STARTED|Overall Study||53
10427094|NCT00851279|11572877|FG000|COMPLETED|Overall Study||53
10427095|NCT00851279|11572877|FG000|NOT COMPLETED|Overall Study||0
10427096|NCT00851318|11572885|FG000|STARTED|Overall Study||81
10427097|NCT00851318|11572886|FG001|STARTED|Overall Study||19
10427098|NCT00851318|11572887|FG002|STARTED|Overall Study||93
10427099|NCT00851318|11572888|FG003|STARTED|Overall Study||92
10427100|NCT00851318|11572885|FG000|Completed Week 24|Overall Study||69
10427101|NCT00851318|11572886|FG001|Completed Week 24|Overall Study||17
10427102|NCT00851318|11572887|FG002|Completed Week 24|Overall Study||90
10427103|NCT00851318|11572888|FG003|Completed Week 24|Overall Study||87
10427104|NCT00851318|11572885|FG000|Completed Week 52|Overall Study||64
10535028|NCT01433991|11687306|FG001|STARTED|Pretreatment Phase (Single Agent Run-in)||3
10535029|NCT01433991|11687307|FG002|STARTED|Pretreatment Phase (Single Agent Run-in)||14
10535030|NCT01433991|11687308|FG003|STARTED|Pretreatment Phase (Single Agent Run-in)||8
10535031|NCT01433991|11687305|FG000|COMPLETED|Pretreatment Phase (Single Agent Run-in)||3
10535032|NCT01433991|11687306|FG001|COMPLETED|Pretreatment Phase (Single Agent Run-in)||3
10535033|NCT01433991|11687307|FG002|COMPLETED|Pretreatment Phase (Single Agent Run-in)||14
10656603|NCT02219048|11817608|FG001|STARTED|Overall Study||25
10656604|NCT02219048|11817607|FG000|COMPLETED|Overall Study||5
10656605|NCT02219048|11817608|FG001|COMPLETED|Overall Study||4
10656606|NCT02219048|11817607|FG000|NOT COMPLETED|Overall Study||21
10656607|NCT02219048|11817608|FG001|NOT COMPLETED|Overall Study||21
10656608|NCT02219087|11817616|FG000|STARTED|Overall Study||30
10656609|NCT02219087|11817617|FG001|STARTED|Overall Study||30
10656610|NCT02219087|11817616|FG000|COMPLETED|Overall Study||30
10656611|NCT02219087|11817617|FG001|COMPLETED|Overall Study|Randomization envelope pulled out of sequence for consented patient. Excluded by request of IRB|29
10656612|NCT02219087|11817616|FG000|NOT COMPLETED|Overall Study||0
10656613|NCT02219087|11817617|FG001|NOT COMPLETED|Overall Study||1
10656614|NCT02219256|11817635|FG000|STARTED|Overall Study||12
10656615|NCT02219256|11817636|FG001|STARTED|Overall Study||4
10656616|NCT02219256|11817637|FG002|STARTED|Overall Study||4
10656617|NCT02219256|11817638|FG003|STARTED|Overall Study||4
10427105|NCT00851318|11572886|FG001|Completed Week 52|Overall Study||16
10427106|NCT00851318|11572887|FG002|Completed Week 52|Overall Study||87
10427107|NCT00851318|11572888|FG003|Completed Week 52|Overall Study||85
10427108|NCT00851318|11572885|FG000|COMPLETED|Overall Study||51
10656618|NCT02219256|11817639|FG004|STARTED|Overall Study||6
10656619|NCT02219256|11817640|FG005|STARTED|Overall Study||6
10360797|NCT00499109|11500737|FG000|STARTED|Overall Study||183
10360798|NCT00499109|11500738|FG001|STARTED|Overall Study||92
10360799|NCT00499109|11500737|FG000|COMPLETED|Overall Study||165
10360800|NCT00499109|11500738|FG001|COMPLETED|Overall Study||85
10360801|NCT00499109|11500737|FG000|NOT COMPLETED|Overall Study||18
10360802|NCT00499109|11500738|FG001|NOT COMPLETED|Overall Study||7
10360803|NCT00499122|11500747|FG000|STARTED|Overall Study||41
10360804|NCT00499122|11500747|FG000|COMPLETED|Overall Study||39
10360805|NCT00499122|11500747|FG000|NOT COMPLETED|Overall Study||2
10360806|NCT00499174|11500754|FG000|STARTED|Overall Study||78
10360807|NCT00499174|11500755|FG001|STARTED|Overall Study||102
10360808|NCT00499174|11500754|FG000|COMPLETED|Overall Study||0
10360809|NCT00499174|11500755|FG001|COMPLETED|Overall Study||93
10360810|NCT00499174|11500754|FG000|NOT COMPLETED|Overall Study||78
10360811|NCT00499174|11500755|FG001|NOT COMPLETED|Overall Study||9
10360812|NCT00499252|11500763|FG000|STARTED|Overall Study||51
10360813|NCT00499252|11500763|FG000|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|39
10360814|NCT00499252|11500763|FG000|NOT COMPLETED|Overall Study||12
10360815|NCT00499343|11500773|FG000|STARTED|Overall Study||41
10360816|NCT00499343|11500774|FG001|STARTED|Overall Study||43
10360817|NCT00499343|11500773|FG000|COMPLETED|Overall Study||41
10360818|NCT00499343|11500774|FG001|COMPLETED|Overall Study||43
10360819|NCT00499343|11500773|FG000|NOT COMPLETED|Overall Study||0
10360820|NCT00499343|11500774|FG001|NOT COMPLETED|Overall Study||0
10360821|NCT00499369|11500785|FG000|STARTED|Overall Study||16
10360822|NCT00499369|11500786|FG001|STARTED|Overall Study||18
10360823|NCT00499369|11500787|FG002|STARTED|Overall Study||17
10360824|NCT00499369|11500788|FG003|STARTED|Overall Study||9
10360825|NCT00499369|11500789|FG004|STARTED|Overall Study||12
10360826|NCT00499369|11500785|FG000|Eligible|Overall Study||14
10360827|NCT00499369|11500786|FG001|Eligible|Overall Study||16
10360828|NCT00499369|11500787|FG002|Eligible|Overall Study||16
10360829|NCT00499369|11500788|FG003|Eligible|Overall Study||8
10360830|NCT00499369|11500789|FG004|Eligible|Overall Study||12
10360831|NCT00499369|11500785|FG000|COMPLETED|Overall Study||0
10360832|NCT00499369|11500786|FG001|COMPLETED|Overall Study||0
10360833|NCT00499369|11500787|FG002|COMPLETED|Overall Study||0
10360834|NCT00499369|11500788|FG003|COMPLETED|Overall Study||0
10360835|NCT00499369|11500789|FG004|COMPLETED|Overall Study||0
10360836|NCT00499369|11500785|FG000|NOT COMPLETED|Overall Study||16
10360837|NCT00499369|11500786|FG001|NOT COMPLETED|Overall Study||18
10360838|NCT00499369|11500787|FG002|NOT COMPLETED|Overall Study||17
10360839|NCT00499369|11500788|FG003|NOT COMPLETED|Overall Study||9
10360840|NCT00499369|11500789|FG004|NOT COMPLETED|Overall Study||12
10360841|NCT00499408|11500801|FG000|STARTED|Overall Study||26
10360842|NCT00499408|11500801|FG000|COMPLETED|Overall Study|Three patients did not have adequate testing to be evaluable for a response.|26
10360843|NCT00499408|11500801|FG000|NOT COMPLETED|Overall Study||0
10360844|NCT00499447|11500805|FG000|STARTED|Overall Study||13
10360845|NCT00499447|11500805|FG000|COMPLETED|Overall Study||13
10360846|NCT00499447|11500805|FG000|NOT COMPLETED|Overall Study||0
10360847|NCT00499460|11500811|FG000|STARTED|Intervention 1 (30 Days)||8
10360848|NCT00499460|11500812|FG001|STARTED|Intervention 1 (30 Days)||7
10360849|NCT00499460|11500811|FG000|COMPLETED|Intervention 1 (30 Days)||6
10360850|NCT00499460|11500812|FG001|COMPLETED|Intervention 1 (30 Days)||7
10360851|NCT00499460|11500811|FG000|NOT COMPLETED|Intervention 1 (30 Days)||2
10360852|NCT00499460|11500812|FG001|NOT COMPLETED|Intervention 1 (30 Days)||0
10360853|NCT00499460|11500811|FG000|STARTED|Intervention 2 (30 Days)||6
10360854|NCT00499460|11500812|FG001|STARTED|Intervention 2 (30 Days)||7
10360855|NCT00499460|11500811|FG000|COMPLETED|Intervention 2 (30 Days)||6
10360856|NCT00499460|11500812|FG001|COMPLETED|Intervention 2 (30 Days)||6
10360857|NCT00499460|11500811|FG000|NOT COMPLETED|Intervention 2 (30 Days)||0
10360858|NCT00499460|11500812|FG001|NOT COMPLETED|Intervention 2 (30 Days)||1
10360859|NCT00499473|11500830|FG000|STARTED|Overall Study||27
10360860|NCT00499473|11500831|FG001|STARTED|Overall Study||4
10360861|NCT00499473|11500830|FG000|COMPLETED|Overall Study|Patients evaluable|21
10360862|NCT00499473|11500831|FG001|COMPLETED|Overall Study||4
10360863|NCT00499473|11500830|FG000|NOT COMPLETED|Overall Study||6
10360864|NCT00499473|11500831|FG001|NOT COMPLETED|Overall Study||0
10360865|NCT00499486|11500837|FG000|STARTED|Overall Study||47
10360866|NCT00499486|11500837|FG000|COMPLETED|Overall Study||31
10360867|NCT00499486|11500837|FG000|NOT COMPLETED|Overall Study||16
10360868|NCT00499603|11500843|FG000|STARTED|Overall Study||27
10360869|NCT00499603|11500844|FG001|STARTED|Overall Study||23
10360870|NCT00499603|11500843|FG000|COMPLETED|Overall Study||27
10360871|NCT00499603|11500844|FG001|COMPLETED|Overall Study||22
10360872|NCT00499603|11500843|FG000|NOT COMPLETED|Overall Study||0
10360873|NCT00499603|11500844|FG001|NOT COMPLETED|Overall Study||1
10360874|NCT00499616|11500856|FG000|STARTED|Overall Study||176
10360875|NCT00499616|11500857|FG001|STARTED|Overall Study||142
10360876|NCT00499616|11500858|FG002|STARTED|Overall Study||89
10360877|NCT00499616|11500859|FG003|STARTED|Overall Study||57
10360878|NCT00499616|11500856|FG000|COMPLETED|Overall Study||161
10360879|NCT00499616|11500857|FG001|COMPLETED|Overall Study||114
10360880|NCT00499616|11500858|FG002|COMPLETED|Overall Study||53
10360881|NCT00499616|11500859|FG003|COMPLETED|Overall Study||0
10360882|NCT00499616|11500856|FG000|NOT COMPLETED|Overall Study||15
10360883|NCT00499616|11500857|FG001|NOT COMPLETED|Overall Study||28
10360884|NCT00499616|11500858|FG002|NOT COMPLETED|Overall Study||36
10360885|NCT00499616|11500859|FG003|NOT COMPLETED|Overall Study||57
10360886|NCT00499655|11500874|FG000|STARTED|Overall Study||53
10360887|NCT00499655|11500875|FG001|STARTED|Overall Study||54
10360888|NCT00499655|11500874|FG000|COMPLETED|Overall Study||53
10360889|NCT00499655|11500875|FG001|COMPLETED|Overall Study||54
10360890|NCT00499655|11500874|FG000|NOT COMPLETED|Overall Study||0
10360891|NCT00499655|11500875|FG001|NOT COMPLETED|Overall Study||0
10360892|NCT00499681|11500884|FG000|STARTED|Overall Study||4
10360893|NCT00499681|11500885|FG001|STARTED|Overall Study||2
10360894|NCT00499681|11500884|FG000|COMPLETED|Overall Study||4
10360895|NCT00499681|11500885|FG001|COMPLETED|Overall Study||0
10360896|NCT00499681|11500884|FG000|NOT COMPLETED|Overall Study||0
10360897|NCT00499681|11500885|FG001|NOT COMPLETED|Overall Study||2
10360898|NCT00499694|11500891|FG000|STARTED|Overall Study||31
10360899|NCT00499694|11500891|FG000|COMPLETED|Overall Study||30
10360900|NCT00499694|11500891|FG000|NOT COMPLETED|Overall Study||1
10360901|NCT00499746|11500896|FG000|STARTED|Phase 1(6-9 One Day Sessions)||20
10360902|NCT00499746|11500896|FG000|COMPLETED|Phase 1(6-9 One Day Sessions)||8
10360903|NCT00499746|11500896|FG000|NOT COMPLETED|Phase 1(6-9 One Day Sessions)||12
10360904|NCT00499746|11500896|FG000|STARTED|Phase 2 (6-9 One Day Sessions)||8
10360905|NCT00499746|11500896|FG000|COMPLETED|Phase 2 (6-9 One Day Sessions)||8
10360906|NCT00499746|11500896|FG000|NOT COMPLETED|Phase 2 (6-9 One Day Sessions)||0
10360907|NCT00499746|11500896|FG000|STARTED|Phase 3 (9-14 One Day Sessions)||8
10360908|NCT00499746|11500896|FG000|COMPLETED|Phase 3 (9-14 One Day Sessions)||8
10360909|NCT00499746|11500896|FG000|NOT COMPLETED|Phase 3 (9-14 One Day Sessions)||0
10360910|NCT00499863|11500912|FG000|STARTED|Overall Study||145
10360911|NCT00499863|11500913|FG001|STARTED|Overall Study||72
10360912|NCT00499863|11500912|FG000|COMPLETED|Overall Study||95
10360913|NCT00499863|11500913|FG001|COMPLETED|Overall Study||29
10360914|NCT00499863|11500912|FG000|NOT COMPLETED|Overall Study||50
10360915|NCT00499863|11500913|FG001|NOT COMPLETED|Overall Study||43
10360916|NCT00499889|11500919|FG000|STARTED|Overall Study||42
10360917|NCT00499889|11500919|FG000|COMPLETED|Overall Study||41
10360918|NCT00499889|11500919|FG000|NOT COMPLETED|Overall Study||1
10360919|NCT00499915|11500925|FG000|STARTED|Overall Study||83
10360920|NCT00499915|11500926|FG001|STARTED|Overall Study||82
10360921|NCT00499915|11500925|FG000|COMPLETED|Overall Study||68
10360922|NCT00499915|11500926|FG001|COMPLETED|Overall Study||76
10360923|NCT00499915|11500925|FG000|NOT COMPLETED|Overall Study||15
10360924|NCT00499915|11500926|FG001|NOT COMPLETED|Overall Study||6
10360925|NCT00500110|11500932|FG000|STARTED|Overall Study||39
10360926|NCT00500110|11500932|FG000|COMPLETED|Overall Study||36
10360927|NCT00500110|11500932|FG000|NOT COMPLETED|Overall Study||3
10360928|NCT00500149|11500936|FG000|STARTED|Enrolled (Dose-optimization Phase)||129
10360929|NCT00500149|11500937|FG001|STARTED|Enrolled (Dose-optimization Phase)||0
10360930|NCT00500149|11500936|FG000|COMPLETED|Enrolled (Dose-optimization Phase)||117
10360931|NCT00500149|11500937|FG001|COMPLETED|Enrolled (Dose-optimization Phase)||0
10360932|NCT00500149|11500936|FG000|NOT COMPLETED|Enrolled (Dose-optimization Phase)||12
10360933|NCT00500149|11500937|FG001|NOT COMPLETED|Enrolled (Dose-optimization Phase)||0
10360934|NCT00500149|11500936|FG000|STARTED|First Intervention (Cross-over Phase)||58
10360935|NCT00500149|11500937|FG001|STARTED|First Intervention (Cross-over Phase)||59
10360936|NCT00500149|11500936|FG000|COMPLETED|First Intervention (Cross-over Phase)||56
10360937|NCT00500149|11500937|FG001|COMPLETED|First Intervention (Cross-over Phase)||57
10716279|NCT02688387|11880044|FG001|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10716280|NCT02688387|11880045|FG002|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10716281|NCT02688387|11880046|FG003|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10716282|NCT02688387|11880047|FG004|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10716283|NCT02688387|11880048|FG005|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10716284|NCT02688387|11880049|FG006|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10716285|NCT02688387|11880050|FG007|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10716286|NCT02688387|11880051|FG008|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10716287|NCT02688387|11880052|FG009|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10716288|NCT02688387|11880053|FG010|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10716289|NCT02688387|11880054|FG011|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10716290|NCT02688387|11880055|FG012|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10716291|NCT02688387|11880056|FG013|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10716292|NCT02688387|11880057|FG014|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10360938|NCT00500149|11500936|FG000|NOT COMPLETED|First Intervention (Cross-over Phase)||2
10360939|NCT00500149|11500937|FG001|NOT COMPLETED|First Intervention (Cross-over Phase)||2
10360940|NCT00500149|11500936|FG000|STARTED|Second Intervention (Cross-over Phase)||56
10360941|NCT00500149|11500937|FG001|STARTED|Second Intervention (Cross-over Phase)||57
10360942|NCT00500149|11500936|FG000|COMPLETED|Second Intervention (Cross-over Phase)||54
10360943|NCT00500149|11500937|FG001|COMPLETED|Second Intervention (Cross-over Phase)||57
10360944|NCT00500149|11500936|FG000|NOT COMPLETED|Second Intervention (Cross-over Phase)||2
10360945|NCT00500149|11500937|FG001|NOT COMPLETED|Second Intervention (Cross-over Phase)||0
10360946|NCT00500240|11500945|FG000|STARTED|Overall Study||25
10360947|NCT00500240|11500946|FG001|STARTED|Overall Study||26
10360948|NCT00500240|11500945|FG000|COMPLETED|Overall Study||25
10360949|NCT00500240|11500946|FG001|COMPLETED|Overall Study||26
10360950|NCT00500240|11500945|FG000|NOT COMPLETED|Overall Study||0
10360951|NCT00500240|11500946|FG001|NOT COMPLETED|Overall Study||0
10360952|NCT00500266|11500954|FG000|STARTED|Overall Study||1053
10360953|NCT00500266|11500954|FG000|Treated|Overall Study||1049
10360954|NCT00500266|11500954|FG000|COMPLETED|Overall Study||1040
10360955|NCT00500266|11500954|FG000|NOT COMPLETED|Overall Study||13
10360956|NCT00500292|11500962|FG000|STARTED|Overall Study|randomised patients|32
10360957|NCT00500292|11500963|FG001|STARTED|Overall Study|randomised patients|35
10360958|NCT00500292|11500964|FG002|STARTED|Overall Study|randomised patients|37
10360959|NCT00500292|11500962|FG000|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|7
10360960|NCT00500292|11500963|FG001|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|4
10360961|NCT00500292|11500964|FG002|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|10
10360962|NCT00500292|11500962|FG000|NOT COMPLETED|Overall Study||25
10360963|NCT00500292|11500963|FG001|NOT COMPLETED|Overall Study||31
10360964|NCT00500292|11500964|FG002|NOT COMPLETED|Overall Study||27
10360965|NCT00500318|11500974|FG000|STARTED|Overall Study||86
10360966|NCT00500318|11500975|FG001|STARTED|Overall Study||95
10360967|NCT00500318|11500974|FG000|COMPLETED|Overall Study||81
10360968|NCT00500318|11500975|FG001|COMPLETED|Overall Study||78
10360969|NCT00500318|11500974|FG000|NOT COMPLETED|Overall Study||5
10360970|NCT00500318|11500975|FG001|NOT COMPLETED|Overall Study||17
10360971|NCT00500331|11500988|FG000|STARTED|Overall Study||48
10360972|NCT00500331|11500989|FG001|STARTED|Overall Study||47
10360973|NCT00500331|11500990|FG002|STARTED|Overall Study||48
10360974|NCT00500331|11500991|FG003|STARTED|Overall Study||48
10360975|NCT00500331|11500992|FG004|STARTED|Overall Study||48
10360976|NCT00500331|11500993|FG005|STARTED|Overall Study||47
10360977|NCT00500331|11500994|FG006|STARTED|Overall Study||48
10360978|NCT00500331|11500988|FG000|COMPLETED|Overall Study||33
10360979|NCT00500331|11500989|FG001|COMPLETED|Overall Study||42
10360980|NCT00500331|11500990|FG002|COMPLETED|Overall Study||43
10360981|NCT00500331|11500991|FG003|COMPLETED|Overall Study||38
10360982|NCT00500331|11500992|FG004|COMPLETED|Overall Study||44
10360983|NCT00500331|11500993|FG005|COMPLETED|Overall Study||42
10360984|NCT00500331|11500994|FG006|COMPLETED|Overall Study||46
10360985|NCT00500331|11500988|FG000|NOT COMPLETED|Overall Study||15
10360986|NCT00500331|11500989|FG001|NOT COMPLETED|Overall Study||5
10360987|NCT00500331|11500990|FG002|NOT COMPLETED|Overall Study||5
10360988|NCT00500331|11500991|FG003|NOT COMPLETED|Overall Study||10
10360989|NCT00500331|11500992|FG004|NOT COMPLETED|Overall Study||4
10360990|NCT00500331|11500993|FG005|NOT COMPLETED|Overall Study||5
10360991|NCT00500331|11500994|FG006|NOT COMPLETED|Overall Study||2
10360992|NCT00500357|11501011|FG000|STARTED|Overall Study||105
10360993|NCT00500357|11501011|FG000|Received 13vPnC (Vax 3)|Overall Study||105
10360994|NCT00500357|11501011|FG000|Evaluable Immunogenicity Population|Overall Study|Administered Vax 1 and Vax 2 in study 6115A1-500; Vax 3 and at least 1 assay result in 6115A1-3009.|98
10360995|NCT00500357|11501011|FG000|COMPLETED|Overall Study||104
10360996|NCT00500357|11501011|FG000|NOT COMPLETED|Overall Study||1
10360997|NCT00500370|11501028|FG000|STARTED|Overall Study||80
10360998|NCT00500370|11501029|FG001|STARTED|Overall Study||83
10360999|NCT00500370|11501028|FG000|Treatment Start-Baseline (Week 0)|Overall Study||73
10361000|NCT00500370|11501029|FG001|Treatment Start-Baseline (Week 0)|Overall Study||79
10361001|NCT00500370|11501028|FG000|Treatment Complete (Week 24)|Overall Study||48
10361002|NCT00500370|11501029|FG001|Treatment Complete (Week 24)|Overall Study||54
10361003|NCT00500370|11501028|FG000|COMPLETED|Overall Study|COMPLETED = completion of treatment period (Week 24) plus follow-up visit 4 weeks later|47
10361004|NCT00500370|11501029|FG001|COMPLETED|Overall Study|COMPLETED = completion of treatment period (Week 24) plus follow-up visit 4 weeks later|49
10361005|NCT00500370|11501028|FG000|NOT COMPLETED|Overall Study||33
10361006|NCT00500370|11501029|FG001|NOT COMPLETED|Overall Study||34
10361007|NCT00500448|11501037|FG000|STARTED|Overall Study||14
10361008|NCT00500448|11501038|FG001|STARTED|Overall Study||16
10361009|NCT00500448|11501037|FG000|COMPLETED|Overall Study||14
10361010|NCT00500448|11501038|FG001|COMPLETED|Overall Study||16
10361011|NCT00500448|11501037|FG000|NOT COMPLETED|Overall Study||0
10361012|NCT00500448|11501038|FG001|NOT COMPLETED|Overall Study||0
10361013|NCT00500539|11501044|FG000|STARTED|Treatment Period (24 Weeks)||155
10361014|NCT00500539|11501044|FG000|COMPLETED|Treatment Period (24 Weeks)||140
10361015|NCT00500539|11501044|FG000|NOT COMPLETED|Treatment Period (24 Weeks)||15
10361016|NCT00500539|11501044|FG000|STARTED|Follow-up Period (16 Weeks)|Participants could discontinue study drug and still enter the follow-up period.|148
10361017|NCT00500539|11501044|FG000|COMPLETED|Follow-up Period (16 Weeks)||136
10361018|NCT00500539|11501044|FG000|NOT COMPLETED|Follow-up Period (16 Weeks)||12
10361019|NCT00500578|11501053|FG000|STARTED|Overall Study||18
10361020|NCT00500578|11501054|FG001|STARTED|Overall Study||32
10361021|NCT00500578|11501053|FG000|COMPLETED|Overall Study|All completed|18
10361022|NCT00500578|11501054|FG001|COMPLETED|Overall Study|All completed|32
10361023|NCT00500578|11501053|FG000|NOT COMPLETED|Overall Study||0
10361024|NCT00500578|11501054|FG001|NOT COMPLETED|Overall Study||0
10361025|NCT00500656|11501064|FG000|STARTED|Controlled Phase||36
10361026|NCT00500656|11501065|FG001|STARTED|Controlled Phase||38
10361027|NCT00500656|11501066|FG002|STARTED|Controlled Phase||3
10361028|NCT00500656|11501067|FG003|STARTED|Controlled Phase||8
10361029|NCT00500656|11501064|FG000|COMPLETED|Controlled Phase||26
10361030|NCT00500656|11501065|FG001|COMPLETED|Controlled Phase||28
10361031|NCT00500656|11501066|FG002|COMPLETED|Controlled Phase||2
10361032|NCT00500656|11501067|FG003|COMPLETED|Controlled Phase||0
10361033|NCT00500656|11501064|FG000|NOT COMPLETED|Controlled Phase||10
10361034|NCT00500656|11501065|FG001|NOT COMPLETED|Controlled Phase||10
10361035|NCT00500656|11501066|FG002|NOT COMPLETED|Controlled Phase||1
10361036|NCT00500656|11501067|FG003|NOT COMPLETED|Controlled Phase||8
10361037|NCT00500656|11501064|FG000|STARTED|Open Label Extension (OLE) Phase|3 Subjects did not experience an angioedema attack after their first attack in the controlled phase|23
10361038|NCT00500656|11501065|FG001|STARTED|Open Label Extension (OLE) Phase|7 Subjects did not experience an angioedema attack after their first attack in the controlled phase|21
10361039|NCT00500656|11501066|FG002|STARTED|Open Label Extension (OLE) Phase||2
10361040|NCT00500656|11501067|FG003|STARTED|Open Label Extension (OLE) Phase|Subjects did not experience an angioedema attack during the controlled phase|8
10361041|NCT00500656|11501064|FG000|COMPLETED|Open Label Extension (OLE) Phase||16
10361042|NCT00500656|11501065|FG001|COMPLETED|Open Label Extension (OLE) Phase||9
10361043|NCT00500656|11501066|FG002|COMPLETED|Open Label Extension (OLE) Phase||1
10361044|NCT00500656|11501067|FG003|COMPLETED|Open Label Extension (OLE) Phase||6
10361045|NCT00500656|11501064|FG000|NOT COMPLETED|Open Label Extension (OLE) Phase||7
10361046|NCT00500656|11501065|FG001|NOT COMPLETED|Open Label Extension (OLE) Phase||12
10361047|NCT00500656|11501066|FG002|NOT COMPLETED|Open Label Extension (OLE) Phase||1
10361048|NCT00500656|11501067|FG003|NOT COMPLETED|Open Label Extension (OLE) Phase||2
10361049|NCT00500760|11501079|FG000|STARTED|Overall Study||89
10361050|NCT00500760|11501080|FG001|STARTED|Overall Study||64
10361051|NCT00500760|11501079|FG000|Received Treatment|Overall Study||87
10361052|NCT00500760|11501080|FG001|Received Treatment|Overall Study||63
10361053|NCT00500760|11501079|FG000|COMPLETED|Overall Study||46
10361054|NCT00500760|11501080|FG001|COMPLETED|Overall Study||40
10361055|NCT00500760|11501079|FG000|NOT COMPLETED|Overall Study||43
10361056|NCT00500760|11501080|FG001|NOT COMPLETED|Overall Study||24
10361057|NCT00500903|11501089|FG000|STARTED|Overall Study||65
10361058|NCT00500903|11501090|FG001|STARTED|Overall Study||2
10361059|NCT00500903|11501091|FG002|STARTED|Overall Study||20
10361060|NCT00500903|11501089|FG000|COMPLETED|Overall Study||0
10361061|NCT00500903|11501090|FG001|COMPLETED|Overall Study||0
10361062|NCT00500903|11501091|FG002|COMPLETED|Overall Study||0
10361063|NCT00500903|11501089|FG000|NOT COMPLETED|Overall Study||65
10361064|NCT00500903|11501090|FG001|NOT COMPLETED|Overall Study||2
10361065|NCT00500903|11501091|FG002|NOT COMPLETED|Overall Study||20
10361066|NCT00501007|11501129|FG000|STARTED|Overall Study||100
10361067|NCT00501007|11501130|FG001|STARTED|Overall Study||103
10361068|NCT00501007|11501129|FG000|COMPLETED|Overall Study||71
10361069|NCT00501007|11501130|FG001|COMPLETED|Overall Study||78
10361070|NCT00501007|11501129|FG000|NOT COMPLETED|Overall Study||29
10361071|NCT00501007|11501130|FG001|NOT COMPLETED|Overall Study||25
10361072|NCT00501059|11501138|FG000|STARTED|Overall Study||6270
10361073|NCT00501059|11501139|FG001|STARTED|Overall Study||6276
10361074|NCT00501059|11501138|FG000|COMPLETED|Overall Study||4402
10361075|NCT00501059|11501139|FG001|COMPLETED|Overall Study||4384
10361076|NCT00501059|11501138|FG000|NOT COMPLETED|Overall Study||1868
10361077|NCT00501059|11501139|FG001|NOT COMPLETED|Overall Study||1892
10361078|NCT00501085|11501147|FG000|STARTED|Overall Study|Number of participants who were treated with the LAP-BAND System.|515
10361079|NCT00501085|11501147|FG000|COMPLETED|Overall Study|Number of participants completing 5 year follow-up visit.|83
10361080|NCT00501085|11501147|FG000|NOT COMPLETED|Overall Study||432
10361081|NCT00501293|11501153|FG000|STARTED|Optimization Period||110
10361082|NCT00501293|11501154|FG001|STARTED|Optimization Period||53
10361083|NCT00501293|11501153|FG000|COMPLETED|Optimization Period||109
10361084|NCT00501293|11501154|FG001|COMPLETED|Optimization Period||53
10361085|NCT00501293|11501153|FG000|NOT COMPLETED|Optimization Period||1
10361086|NCT00501293|11501154|FG001|NOT COMPLETED|Optimization Period||0
10361087|NCT00501293|11501153|FG000|STARTED|Maintenance Period||109
10361088|NCT00501293|11501154|FG001|STARTED|Maintenance Period||53
10361089|NCT00501293|11501153|FG000|COMPLETED|Maintenance Period||63
10361090|NCT00501293|11501154|FG001|COMPLETED|Maintenance Period||25
10361091|NCT00501293|11501153|FG000|NOT COMPLETED|Maintenance Period||46
10361092|NCT00501293|11501154|FG001|NOT COMPLETED|Maintenance Period||28
10361093|NCT00501540|11501161|FG000|STARTED|Overall Study||15
10361094|NCT00501540|11501161|FG000|COMPLETED|Overall Study||10
10361095|NCT00501540|11501161|FG000|NOT COMPLETED|Overall Study||5
10361096|NCT00501592|11501168|FG000|STARTED|Overall Study||20
10361097|NCT00501592|11501169|FG001|STARTED|Overall Study||21
10361098|NCT00501592|11501170|FG002|STARTED|Overall Study||23
10361099|NCT00501592|11501168|FG000|COMPLETED|Overall Study||20
10361100|NCT00501592|11501169|FG001|COMPLETED|Overall Study||16
10361101|NCT00501592|11501170|FG002|COMPLETED|Overall Study||20
10361102|NCT00501592|11501168|FG000|NOT COMPLETED|Overall Study||0
10361103|NCT00501592|11501169|FG001|NOT COMPLETED|Overall Study||5
10361104|NCT00501592|11501170|FG002|NOT COMPLETED|Overall Study||3
10361105|NCT00501631|11501180|FG000|STARTED|Part A (Double-blind Period)||152
10361106|NCT00501631|11501181|FG001|STARTED|Part A (Double-blind Period)||148
10361107|NCT00501631|11501180|FG000|COMPLETED|Part A (Double-blind Period)||90
10361108|NCT00501631|11501181|FG001|COMPLETED|Part A (Double-blind Period)||99
10361109|NCT00501631|11501180|FG000|NOT COMPLETED|Part A (Double-blind Period)||62
10361110|NCT00501631|11501181|FG001|NOT COMPLETED|Part A (Double-blind Period)||49
10361111|NCT00501631|11501180|FG000|STARTED|Part B (Open-label Period)||90
10361112|NCT00501631|11501181|FG001|STARTED|Part B (Open-label Period)||99
10361113|NCT00501631|11501180|FG000|COMPLETED|Part B (Open-label Period)||37
10361114|NCT00501631|11501181|FG001|COMPLETED|Part B (Open-label Period)||48
10361115|NCT00501631|11501180|FG000|NOT COMPLETED|Part B (Open-label Period)||53
10361116|NCT00501631|11501181|FG001|NOT COMPLETED|Part B (Open-label Period)||51
10361117|NCT00501644|11501187|FG000|STARTED|Overall Study||59
10361118|NCT00501644|11501187|FG000|COMPLETED|Overall Study||54
10361119|NCT00501644|11501187|FG000|NOT COMPLETED|Overall Study||5
10361120|NCT00501852|11501191|FG000|STARTED|Overall Study||83
10361121|NCT00501852|11501191|FG000|NVA237 12.5µg|Overall Study||55
10361122|NCT00501852|11501191|FG000|NVA237 25µg|Overall Study||51
10361123|NCT00501852|11501191|FG000|NVA237 50µg|Overall Study||53
10361124|NCT00501852|11501191|FG000|NVA237 100µg|Overall Study||54
10361125|NCT00501852|11501191|FG000|Placebo|Overall Study||55
10361126|NCT00501852|11501191|FG000|Tiotropium|Overall Study||55
10361127|NCT00501852|11501191|FG000|COMPLETED|Overall Study||78
10361128|NCT00501852|11501191|FG000|NOT COMPLETED|Overall Study||5
10361129|NCT00501891|11501205|FG000|STARTED|Overall Study||32
10361130|NCT00501891|11501205|FG000|COMPLETED|Overall Study||32
10361131|NCT00501891|11501205|FG000|NOT COMPLETED|Overall Study||0
10361132|NCT00501943|11501212|FG000|STARTED|Overall Study||22
10361133|NCT00501943|11501213|FG001|STARTED|Overall Study||21
10361134|NCT00501943|11501212|FG000|COMPLETED|Overall Study||20
10361135|NCT00501943|11501213|FG001|COMPLETED|Overall Study||18
10361136|NCT00501943|11501212|FG000|NOT COMPLETED|Overall Study||2
10361137|NCT00501943|11501213|FG001|NOT COMPLETED|Overall Study||3
10361138|NCT00501969|11501221|FG000|STARTED|Overall Study||395
10361139|NCT00501969|11501221|FG000|COMPLETED|Overall Study||189
10361140|NCT00501969|11501221|FG000|NOT COMPLETED|Overall Study||206
10361141|NCT00501995|11501225|FG000|STARTED|Overall Study||6
10361142|NCT00501995|11501225|FG000|COMPLETED|Overall Study||5
10361143|NCT00501995|11501225|FG000|NOT COMPLETED|Overall Study||1
10361144|NCT00502203|11501229|FG000|STARTED|Overall Study||23
10361145|NCT00502203|11501229|FG000|COMPLETED|Overall Study||22
10361146|NCT00502203|11501229|FG000|NOT COMPLETED|Overall Study||1
10361147|NCT00502216|11501235|FG000|STARTED|Overall Study||21
10361148|NCT00502216|11501236|FG001|STARTED|Overall Study||19
10361149|NCT00502216|11501235|FG000|COMPLETED|Overall Study||21
10361150|NCT00502216|11501236|FG001|COMPLETED|Overall Study||19
10361151|NCT00502216|11501235|FG000|NOT COMPLETED|Overall Study||0
10361152|NCT00502216|11501236|FG001|NOT COMPLETED|Overall Study||0
10361153|NCT00502242|11501244|FG000|STARTED|Overall Study||155
10361154|NCT00502242|11501245|FG001|STARTED|Overall Study||140
10361155|NCT00502242|11501244|FG000|COMPLETED|Overall Study||104
10361156|NCT00502242|11501245|FG001|COMPLETED|Overall Study||84
10361157|NCT00502242|11501244|FG000|NOT COMPLETED|Overall Study||51
10361158|NCT00502242|11501245|FG001|NOT COMPLETED|Overall Study||56
10361159|NCT00502307|11501251|FG000|STARTED|Open Label Period (16 Weeks)||272
10361160|NCT00502307|11501252|FG001|STARTED|Open Label Period (16 Weeks)||0
10361161|NCT00502307|11501253|FG002|STARTED|Open Label Period (16 Weeks)||0
10361162|NCT00502307|11501251|FG000|COMPLETED|Open Label Period (16 Weeks)||196
10361163|NCT00502307|11501252|FG001|COMPLETED|Open Label Period (16 Weeks)||0
10361164|NCT00502307|11501253|FG002|COMPLETED|Open Label Period (16 Weeks)||0
10361165|NCT00502307|11501251|FG000|NOT COMPLETED|Open Label Period (16 Weeks)||76
10361166|NCT00502307|11501252|FG001|NOT COMPLETED|Open Label Period (16 Weeks)||0
10361167|NCT00502307|11501253|FG002|NOT COMPLETED|Open Label Period (16 Weeks)||0
10361168|NCT00502307|11501251|FG000|STARTED|Double-Blind Period (12 Weeks)||0
10361169|NCT00502307|11501252|FG001|STARTED|Double-Blind Period (12 Weeks)||61
10361170|NCT00502307|11501253|FG002|STARTED|Double-Blind Period (12 Weeks)||57
10361171|NCT00502307|11501251|FG000|COMPLETED|Double-Blind Period (12 Weeks)||0
10361172|NCT00502307|11501252|FG001|COMPLETED|Double-Blind Period (12 Weeks)||35
10361173|NCT00502307|11501253|FG002|COMPLETED|Double-Blind Period (12 Weeks)||48
10361174|NCT00502307|11501251|FG000|NOT COMPLETED|Double-Blind Period (12 Weeks)||0
10361175|NCT00502307|11501252|FG001|NOT COMPLETED|Double-Blind Period (12 Weeks)||26
10361176|NCT00502307|11501253|FG002|NOT COMPLETED|Double-Blind Period (12 Weeks)||9
10361177|NCT00502307|11501251|FG000|STARTED|Maintenance Period||148
10361178|NCT00502307|11501252|FG001|STARTED|Maintenance Period||0
10361179|NCT00502307|11501253|FG002|STARTED|Maintenance Period||0
10361180|NCT00502307|11501251|FG000|COMPLETED|Maintenance Period||0
10361181|NCT00502307|11501252|FG001|COMPLETED|Maintenance Period||0
10361182|NCT00502307|11501253|FG002|COMPLETED|Maintenance Period||0
10361183|NCT00502307|11501251|FG000|NOT COMPLETED|Maintenance Period||148
10361184|NCT00502307|11501252|FG001|NOT COMPLETED|Maintenance Period||0
10361185|NCT00502307|11501253|FG002|NOT COMPLETED|Maintenance Period||0
10361186|NCT00502320|11501272|FG000|STARTED|Overall Study||25
10361187|NCT00502320|11501273|FG001|STARTED|Overall Study||25
10716293|NCT02688387|11880058|FG015|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10716294|NCT02688387|11880059|FG016|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10716295|NCT02688387|11880060|FG017|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10361188|NCT00502320|11501272|FG000|Screening Visit|Overall Study||25
10361189|NCT00502320|11501273|FG001|Screening Visit|Overall Study|Participant signed informed consent but was a screen failure because she was nursing at the time.|24
10361190|NCT00502320|11501272|FG000|COMPLETED|Overall Study||19
10361191|NCT00502320|11501273|FG001|COMPLETED|Overall Study||18
10361192|NCT00502320|11501272|FG000|NOT COMPLETED|Overall Study||6
10361193|NCT00502320|11501273|FG001|NOT COMPLETED|Overall Study||7
10361194|NCT00502593|11501291|FG000|STARTED|Overall Study||51
10361195|NCT00502593|11501292|FG001|STARTED|Overall Study||18
10361196|NCT00502593|11501293|FG002|STARTED|Overall Study||51
10361197|NCT00502593|11501294|FG003|STARTED|Overall Study||18
10361198|NCT00502593|11501295|FG004|STARTED|Overall Study||51
10361199|NCT00502593|11501296|FG005|STARTED|Overall Study||17
10361200|NCT00502593|11501297|FG006|STARTED|Overall Study||49
10716296|NCT02688387|11880061|FG018|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10361201|NCT00502593|11501298|FG007|STARTED|Overall Study||17
10361202|NCT00502593|11501299|FG008|STARTED|Overall Study||49
10361203|NCT00502593|11501300|FG009|STARTED|Overall Study||17
10361204|NCT00502593|11501301|FG010|STARTED|Overall Study||49
10361205|NCT00502593|11501302|FG011|STARTED|Overall Study||18
10361206|NCT00502593|11501291|FG000|COMPLETED|Overall Study||48
10361207|NCT00502593|11501292|FG001|COMPLETED|Overall Study||16
10361208|NCT00502593|11501293|FG002|COMPLETED|Overall Study||41
10361209|NCT00502593|11501294|FG003|COMPLETED|Overall Study||14
10361210|NCT00502593|11501295|FG004|COMPLETED|Overall Study||47
10361211|NCT00502593|11501296|FG005|COMPLETED|Overall Study||17
10361212|NCT00502593|11501297|FG006|COMPLETED|Overall Study||44
10361213|NCT00502593|11501298|FG007|COMPLETED|Overall Study||17
10361214|NCT00502593|11501299|FG008|COMPLETED|Overall Study||43
10361215|NCT00502593|11501300|FG009|COMPLETED|Overall Study||17
10361216|NCT00502593|11501301|FG010|COMPLETED|Overall Study||47
10361217|NCT00502593|11501302|FG011|COMPLETED|Overall Study||18
10361218|NCT00502593|11501291|FG000|NOT COMPLETED|Overall Study||3
10361219|NCT00502593|11501292|FG001|NOT COMPLETED|Overall Study||2
10361220|NCT00502593|11501293|FG002|NOT COMPLETED|Overall Study||10
10361221|NCT00502593|11501294|FG003|NOT COMPLETED|Overall Study||4
10361222|NCT00502593|11501295|FG004|NOT COMPLETED|Overall Study||4
10361223|NCT00502593|11501296|FG005|NOT COMPLETED|Overall Study||0
10361224|NCT00502593|11501297|FG006|NOT COMPLETED|Overall Study||5
10361225|NCT00502593|11501298|FG007|NOT COMPLETED|Overall Study||0
10361226|NCT00502593|11501299|FG008|NOT COMPLETED|Overall Study||6
10361227|NCT00502593|11501300|FG009|NOT COMPLETED|Overall Study||0
10361228|NCT00502593|11501301|FG010|NOT COMPLETED|Overall Study||2
10361229|NCT00502593|11501302|FG011|NOT COMPLETED|Overall Study||0
10361230|NCT00502671|11501351|FG000|STARTED|Overall Study||228
10361231|NCT00502671|11501351|FG000|COMPLETED|Overall Study||151
10361232|NCT00502671|11501351|FG000|NOT COMPLETED|Overall Study||77
10361233|NCT00502697|11501357|FG000|STARTED|Overall Study||122
10361234|NCT00502697|11501358|FG001|STARTED|Overall Study||114
10361235|NCT00502697|11501357|FG000|COMPLETED|Overall Study||109
10361236|NCT00502697|11501358|FG001|COMPLETED|Overall Study||102
10361237|NCT00502697|11501357|FG000|NOT COMPLETED|Overall Study||13
10361238|NCT00502697|11501358|FG001|NOT COMPLETED|Overall Study||12
10361239|NCT00502775|11501367|FG000|STARTED|Overall Study||229
10361240|NCT00502775|11501368|FG001|STARTED|Overall Study||224
10361241|NCT00502775|11501369|FG002|STARTED|Overall Study||227
10361242|NCT00502775|11501367|FG000|COMPLETED|Overall Study||219
10361243|NCT00502775|11501368|FG001|COMPLETED|Overall Study||209
10361244|NCT00502775|11501369|FG002|COMPLETED|Overall Study||214
10361245|NCT00502775|11501367|FG000|NOT COMPLETED|Overall Study||10
10361246|NCT00502775|11501368|FG001|NOT COMPLETED|Overall Study||15
10361247|NCT00502775|11501369|FG002|NOT COMPLETED|Overall Study||13
10361248|NCT00502801|11501377|FG000|STARTED|Treatment Period||183
10361249|NCT00502801|11501377|FG000|COMPLETED|Treatment Period||129
10361250|NCT00502801|11501377|FG000|NOT COMPLETED|Treatment Period||54
10361251|NCT00502801|11501377|FG000|STARTED|End of Therapy to Test of Cure||129
10361252|NCT00502801|11501377|FG000|COMPLETED|End of Therapy to Test of Cure||121
10361253|NCT00502801|11501377|FG000|NOT COMPLETED|End of Therapy to Test of Cure||8
10361254|NCT00502840|11501381|FG000|STARTED|Overall Study||193
10361255|NCT00502840|11501381|FG000|COMPLETED|Overall Study||93
10361256|NCT00502840|11501381|FG000|NOT COMPLETED|Overall Study||100
10361257|NCT00502853|11501386|FG000|STARTED|Overall Study||10
10361258|NCT00502853|11501386|FG000|COMPLETED|Overall Study||10
10361259|NCT00502853|11501386|FG000|NOT COMPLETED|Overall Study||0
10361260|NCT00502905|11501391|FG000|STARTED|Overall Study||196
10361261|NCT00502905|11501391|FG000|COMPLETED|Overall Study||196
10361262|NCT00502905|11501391|FG000|NOT COMPLETED|Overall Study||0
10361263|NCT00502944|11501397|FG000|STARTED|Overall Study||2446
10716297|NCT02688387|11880062|FG019|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10716298|NCT02688387|11880063|FG020|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||1
10361264|NCT00502944|11501398|FG001|STARTED|Overall Study||2409
10361265|NCT00502944|11501397|FG000|COMPLETED|Overall Study||1382
10361266|NCT00502944|11501398|FG001|COMPLETED|Overall Study||643
10361267|NCT00502944|11501397|FG000|NOT COMPLETED|Overall Study||1064
10361268|NCT00502944|11501398|FG001|NOT COMPLETED|Overall Study||1766
10361269|NCT00502996|11501404|FG000|STARTED|Overall Study||232
10361270|NCT00502996|11501404|FG000|COMPLETED|Overall Study||188
10361271|NCT00502996|11501404|FG000|NOT COMPLETED|Overall Study||44
10361272|NCT00503113|11501411|FG000|STARTED|Overall Study||268
10361273|NCT00503113|11501412|FG001|STARTED|Overall Study||264
10361274|NCT00503113|11501413|FG002|STARTED|Overall Study||269
10361275|NCT00503113|11501411|FG000|Intent to Treat Population (ITT)|Overall Study||262
10361276|NCT00503113|11501412|FG001|Intent to Treat Population (ITT)|Overall Study||261
10361277|NCT00503113|11501413|FG002|Intent to Treat Population (ITT)|Overall Study||268
10361278|NCT00503113|11501411|FG000|Per Protocol Population (PP)|Overall Study||246
10361279|NCT00503113|11501412|FG001|Per Protocol Population (PP)|Overall Study||243
10361280|NCT00503113|11501413|FG002|Per Protocol Population (PP)|Overall Study||241
10361281|NCT00503113|11501411|FG000|Safety Population|Overall Study||263
10361282|NCT00503113|11501412|FG001|Safety Population|Overall Study||263
10361283|NCT00503113|11501413|FG002|Safety Population|Overall Study||267
10361284|NCT00503113|11501411|FG000|COMPLETED|Overall Study||235
10361285|NCT00503113|11501412|FG001|COMPLETED|Overall Study||236
10361286|NCT00503113|11501413|FG002|COMPLETED|Overall Study||241
10361287|NCT00503113|11501411|FG000|NOT COMPLETED|Overall Study||33
10361288|NCT00503113|11501412|FG001|NOT COMPLETED|Overall Study||28
10361289|NCT00503113|11501413|FG002|NOT COMPLETED|Overall Study||28
10361290|NCT00503139|11501421|FG000|STARTED|Overall Study||684
10361291|NCT00503139|11501421|FG000|COMPLETED|Overall Study||676
10361292|NCT00503139|11501421|FG000|NOT COMPLETED|Overall Study||8
10361293|NCT00503308|11501427|FG000|STARTED|Overall Study||146
10361294|NCT00503308|11501428|FG001|STARTED|Overall Study||135
10361295|NCT00503308|11501427|FG000|COMPLETED|Overall Study||144
10361296|NCT00503308|11501428|FG001|COMPLETED|Overall Study||134
10361297|NCT00503308|11501427|FG000|NOT COMPLETED|Overall Study||2
10361298|NCT00503308|11501428|FG001|NOT COMPLETED|Overall Study||1
10361299|NCT00503399|11501436|FG000|STARTED|Overall Study||45
10361300|NCT00503399|11501437|FG001|STARTED|Overall Study||47
10361301|NCT00503399|11501436|FG000|COMPLETED|Overall Study||38
10361302|NCT00503399|11501437|FG001|COMPLETED|Overall Study||39
10361303|NCT00503399|11501436|FG000|NOT COMPLETED|Overall Study||7
10361304|NCT00503399|11501437|FG001|NOT COMPLETED|Overall Study||8
10361305|NCT00503425|11501443|FG000|STARTED|Overall Study||215
10361306|NCT00503425|11501443|FG000|COMPLETED|Overall Study||161
10361307|NCT00503425|11501443|FG000|NOT COMPLETED|Overall Study||54
10361308|NCT00503685|11501451|FG000|STARTED|Overall Study||23
10361309|NCT00503685|11501452|FG001|STARTED|Overall Study||22
10361310|NCT00503685|11501453|FG002|STARTED|Overall Study||20
10361311|NCT00503685|11501451|FG000|Received at Least 1 Dose of Study Drug|Overall Study||23
10361312|NCT00503685|11501452|FG001|Received at Least 1 Dose of Study Drug|Overall Study||21
10361313|NCT00503685|11501453|FG002|Received at Least 1 Dose of Study Drug|Overall Study||20
10361314|NCT00503685|11501451|FG000|COMPLETED|Overall Study||23
10361315|NCT00503685|11501452|FG001|COMPLETED|Overall Study||19
10361316|NCT00503685|11501453|FG002|COMPLETED|Overall Study||18
10361317|NCT00503685|11501451|FG000|NOT COMPLETED|Overall Study||0
10361318|NCT00503685|11501452|FG001|NOT COMPLETED|Overall Study||3
10361319|NCT00503685|11501453|FG002|NOT COMPLETED|Overall Study||2
10361320|NCT00503698|11501464|FG000|STARTED|Overall Study|Randomised|357
10361321|NCT00503698|11501465|FG001|STARTED|Overall Study|Randomised|355
10361322|NCT00503698|11501464|FG000|Exposed to Trial Drug|Overall Study|11 subjects randomised but not exposed to trial drug. Subjects not included in full analysis set.|346
10361323|NCT00503698|11501465|FG001|Exposed to Trial Drug|Overall Study|6 subjects randomised but not exposed to trial drug. Subjects not included in full analysis set.|349
10361324|NCT00503698|11501464|FG000|COMPLETED|Overall Study|Trial prematurely terminated|0
10361325|NCT00503698|11501465|FG001|COMPLETED|Overall Study|Trial prematurely terminated|0
10361326|NCT00503698|11501464|FG000|NOT COMPLETED|Overall Study||357
10361327|NCT00503698|11501465|FG001|NOT COMPLETED|Overall Study||355
10361328|NCT00503750|11501471|FG000|STARTED|Overall Study||27
10361329|NCT00503750|11501471|FG000|COMPLETED|Overall Study||27
10361330|NCT00503750|11501471|FG000|NOT COMPLETED|Overall Study||0
10361331|NCT00503776|11501479|FG000|STARTED|Overall Study||8
10361332|NCT00503776|11501480|FG001|STARTED|Overall Study||12
10361333|NCT00503776|11501481|FG002|STARTED|Overall Study|one patient withdrew before receiving protocol therapy|12
10361334|NCT00503776|11501482|FG003|STARTED|Overall Study|one patient withdrew before receiving protocol therapy|10
10361335|NCT00503776|11501479|FG000|COMPLETED|Overall Study||7
10361336|NCT00503776|11501480|FG001|COMPLETED|Overall Study||12
10361337|NCT00503776|11501481|FG002|COMPLETED|Overall Study||10
10656620|NCT02219256|11817641|FG006|STARTED|Overall Study||6
10656621|NCT02219256|11817642|FG007|STARTED|Overall Study||8
10656622|NCT02219256|11817643|FG008|STARTED|Overall Study||6
10656623|NCT02219256|11817644|FG009|STARTED|Overall Study||6
10656624|NCT02219256|11817645|FG010|STARTED|Overall Study||6
10656625|NCT02219256|11817646|FG011|STARTED|Overall Study||6
10656626|NCT02219256|11817635|FG000|COMPLETED|Overall Study||12
10656627|NCT02219256|11817636|FG001|COMPLETED|Overall Study||4
10656628|NCT02219256|11817637|FG002|COMPLETED|Overall Study||4
10656629|NCT02219256|11817638|FG003|COMPLETED|Overall Study||4
10656630|NCT02219256|11817639|FG004|COMPLETED|Overall Study||6
10656631|NCT02219256|11817640|FG005|COMPLETED|Overall Study||6
10656632|NCT02219256|11817641|FG006|COMPLETED|Overall Study||6
10656633|NCT02219256|11817642|FG007|COMPLETED|Overall Study||8
10656634|NCT02219256|11817643|FG008|COMPLETED|Overall Study||6
10716299|NCT02688387|11880064|FG021|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
10716300|NCT02688387|11880043|FG000|STARTED|Part 3B, Washout Period 3 (10 Days)||0
10716301|NCT02688387|11880044|FG001|STARTED|Part 3B, Washout Period 3 (10 Days)||0
10716302|NCT02688387|11880045|FG002|STARTED|Part 3B, Washout Period 3 (10 Days)||0
10716303|NCT02688387|11880046|FG003|STARTED|Part 3B, Washout Period 3 (10 Days)||0
10716304|NCT02688387|11880047|FG004|STARTED|Part 3B, Washout Period 3 (10 Days)||0
10716305|NCT02688387|11880048|FG005|STARTED|Part 3B, Washout Period 3 (10 Days)||0
10716306|NCT02688387|11880049|FG006|STARTED|Part 3B, Washout Period 3 (10 Days)||0
10656635|NCT02219256|11817644|FG009|COMPLETED|Overall Study||6
10656636|NCT02219256|11817645|FG010|COMPLETED|Overall Study||6
10656637|NCT02219256|11817646|FG011|COMPLETED|Overall Study||6
10656638|NCT02219256|11817635|FG000|NOT COMPLETED|Overall Study||0
10777244|NCT03338296|11939188|FG000|STARTED|Overall Study||139
10361338|NCT00503776|11501482|FG003|COMPLETED|Overall Study||8
10361339|NCT00503776|11501479|FG000|NOT COMPLETED|Overall Study||1
10656639|NCT02219256|11817636|FG001|NOT COMPLETED|Overall Study||0
10656640|NCT02219256|11817637|FG002|NOT COMPLETED|Overall Study||0
10656641|NCT02219256|11817638|FG003|NOT COMPLETED|Overall Study||0
10656642|NCT02219256|11817639|FG004|NOT COMPLETED|Overall Study||0
10656643|NCT02219256|11817640|FG005|NOT COMPLETED|Overall Study||0
10656644|NCT02219256|11817641|FG006|NOT COMPLETED|Overall Study||0
10656645|NCT02219256|11817642|FG007|NOT COMPLETED|Overall Study||0
10656646|NCT02219256|11817643|FG008|NOT COMPLETED|Overall Study||0
10656647|NCT02219256|11817644|FG009|NOT COMPLETED|Overall Study||0
10656648|NCT02219256|11817645|FG010|NOT COMPLETED|Overall Study||0
10656649|NCT02219256|11817646|FG011|NOT COMPLETED|Overall Study||0
10656650|NCT02219282|11817674|FG000|STARTED|Overall Study||33
10361340|NCT00503776|11501480|FG001|NOT COMPLETED|Overall Study||0
10361341|NCT00503776|11501481|FG002|NOT COMPLETED|Overall Study||2
10361342|NCT00503776|11501482|FG003|NOT COMPLETED|Overall Study||2
10361343|NCT00503867|11501497|FG000|STARTED|Overall Study||10
10361344|NCT00503867|11501497|FG000|COMPLETED|Overall Study||8
10361345|NCT00503867|11501497|FG000|NOT COMPLETED|Overall Study||2
10361346|NCT00503906|11501501|FG000|STARTED|Overall Study||30
10361347|NCT00503906|11501501|FG000|COMPLETED|Overall Study||29
10361348|NCT00503906|11501501|FG000|NOT COMPLETED|Overall Study||1
10361349|NCT00503984|11501508|FG000|STARTED|Overall Study||3
10361350|NCT00503984|11501509|FG001|STARTED|Overall Study||3
10361351|NCT00503984|11501510|FG002|STARTED|Overall Study||3
10361352|NCT00503984|11501511|FG003|STARTED|Overall Study||6
10361353|NCT00503984|11501512|FG004|STARTED|Overall Study||6
10361354|NCT00503984|11501513|FG005|STARTED|Overall Study||1
10361355|NCT00503984|11501508|FG000|COMPLETED|Overall Study||3
10361356|NCT00503984|11501509|FG001|COMPLETED|Overall Study||1
10361357|NCT00503984|11501510|FG002|COMPLETED|Overall Study||3
10361358|NCT00503984|11501511|FG003|COMPLETED|Overall Study||6
10361359|NCT00503984|11501512|FG004|COMPLETED|Overall Study||5
10361360|NCT00503984|11501513|FG005|COMPLETED|Overall Study||1
10361361|NCT00503984|11501508|FG000|NOT COMPLETED|Overall Study||0
10361362|NCT00503984|11501509|FG001|NOT COMPLETED|Overall Study||2
10361363|NCT00503984|11501510|FG002|NOT COMPLETED|Overall Study||0
10535034|NCT01433991|11687308|FG003|COMPLETED|Pretreatment Phase (Single Agent Run-in)||8
10535035|NCT01433991|11687305|FG000|NOT COMPLETED|Pretreatment Phase (Single Agent Run-in)||2
10535036|NCT01433991|11687306|FG001|NOT COMPLETED|Pretreatment Phase (Single Agent Run-in)||0
10535037|NCT01433991|11687307|FG002|NOT COMPLETED|Pretreatment Phase (Single Agent Run-in)||0
10535038|NCT01433991|11687308|FG003|NOT COMPLETED|Pretreatment Phase (Single Agent Run-in)||0
10535039|NCT01433991|11687305|FG000|STARTED|Treatment Phase (Combination Agent)||3
10535040|NCT01433991|11687306|FG001|STARTED|Treatment Phase (Combination Agent)||3
10535041|NCT01433991|11687307|FG002|STARTED|Treatment Phase (Combination Agent)||14
10535042|NCT01433991|11687308|FG003|STARTED|Treatment Phase (Combination Agent)||8
10535043|NCT01433991|11687305|FG000|COMPLETED|Treatment Phase (Combination Agent)||1
10535044|NCT01433991|11687306|FG001|COMPLETED|Treatment Phase (Combination Agent)||2
10535045|NCT01433991|11687307|FG002|COMPLETED|Treatment Phase (Combination Agent)||8
10535046|NCT01433991|11687308|FG003|COMPLETED|Treatment Phase (Combination Agent)||2
10535047|NCT01433991|11687305|FG000|NOT COMPLETED|Treatment Phase (Combination Agent)||2
10535048|NCT01433991|11687306|FG001|NOT COMPLETED|Treatment Phase (Combination Agent)||1
10535049|NCT01433991|11687307|FG002|NOT COMPLETED|Treatment Phase (Combination Agent)||6
10656651|NCT02219282|11817675|FG001|STARTED|Overall Study||33
10656652|NCT02219282|11817674|FG000|COMPLETED|Overall Study||32
10656653|NCT02219282|11817675|FG001|COMPLETED|Overall Study||32
10656654|NCT02219282|11817674|FG000|NOT COMPLETED|Overall Study||1
10656655|NCT02219282|11817675|FG001|NOT COMPLETED|Overall Study||1
10656656|NCT02219308|11817687|FG000|STARTED|Overall Study||32
10656657|NCT02219308|11817688|FG001|STARTED|Overall Study||35
10656658|NCT02219308|11817687|FG000|COMPLETED|Overall Study||31
10656659|NCT02219308|11817688|FG001|COMPLETED|Overall Study||33
10656660|NCT02219308|11817687|FG000|NOT COMPLETED|Overall Study||1
10656661|NCT02219308|11817688|FG001|NOT COMPLETED|Overall Study||2
10656662|NCT02219321|11817696|FG000|STARTED|Overall Study||1
10656663|NCT02219321|11817697|FG001|STARTED|Overall Study||2
10656664|NCT02219321|11817696|FG000|COMPLETED|Overall Study||1
10656665|NCT02219321|11817697|FG001|COMPLETED|Overall Study||2
10656666|NCT02219321|11817696|FG000|NOT COMPLETED|Overall Study||0
10656667|NCT02219321|11817697|FG001|NOT COMPLETED|Overall Study||0
10656668|NCT02219334|11817705|FG000|STARTED|Overall Study||32
10656669|NCT02219334|11817706|FG001|STARTED|Overall Study||23
10656670|NCT02219334|11817705|FG000|COMPLETED|Overall Study||24
10656671|NCT02219334|11817706|FG001|COMPLETED|Overall Study||20
10656672|NCT02219334|11817705|FG000|NOT COMPLETED|Overall Study||8
10656673|NCT02219334|11817706|FG001|NOT COMPLETED|Overall Study||3
10656674|NCT02219438|11817714|FG000|STARTED|Overall Study||13
10656675|NCT02219438|11817715|FG001|STARTED|Overall Study||11
10656676|NCT02219438|11817714|FG000|COMPLETED|Overall Study||13
10656677|NCT02219438|11817715|FG001|COMPLETED|Overall Study||11
10656678|NCT02219438|11817714|FG000|NOT COMPLETED|Overall Study||0
10656679|NCT02219438|11817715|FG001|NOT COMPLETED|Overall Study||0
10656680|NCT02219464|11817725|FG000|STARTED|Overall Study||30
10656681|NCT02219464|11817726|FG001|STARTED|Overall Study||30
10656682|NCT02219464|11817725|FG000|COMPLETED|Overall Study||27
10656683|NCT02219464|11817726|FG001|COMPLETED|Overall Study||30
10656684|NCT02219464|11817725|FG000|NOT COMPLETED|Overall Study||3
10656685|NCT02219464|11817726|FG001|NOT COMPLETED|Overall Study||0
10656686|NCT02219477|11817735|FG000|STARTED|Overall Study||9
10656687|NCT02219477|11817736|FG001|STARTED|Overall Study||24
10656688|NCT02219477|11817737|FG002|STARTED|Overall Study||3
10656689|NCT02219477|11817735|FG000|COMPLETED|Overall Study||9
10656690|NCT02219477|11817736|FG001|COMPLETED|Overall Study||22
10656691|NCT02219477|11817737|FG002|COMPLETED|Overall Study||2
10361364|NCT00503984|11501511|FG003|NOT COMPLETED|Overall Study||0
10361365|NCT00503984|11501512|FG004|NOT COMPLETED|Overall Study||1
10361366|NCT00503984|11501513|FG005|NOT COMPLETED|Overall Study||0
10361367|NCT00503997|11501537|FG000|STARTED|Overall Study||42
10535050|NCT01433991|11687308|FG003|NOT COMPLETED|Treatment Phase (Combination Agent)||6
10656692|NCT02219477|11817735|FG000|NOT COMPLETED|Overall Study||0
10656693|NCT02219477|11817736|FG001|NOT COMPLETED|Overall Study||2
10361368|NCT00503997|11501537|FG000|COMPLETED|Overall Study||34
10361369|NCT00503997|11501537|FG000|NOT COMPLETED|Overall Study||8
10361370|NCT00504023|11501541|FG000|STARTED|Overall Study||8
10361371|NCT00504023|11501541|FG000|COMPLETED|Overall Study||8
10361372|NCT00504023|11501541|FG000|NOT COMPLETED|Overall Study||0
10361373|NCT00504075|11501545|FG000|STARTED|Overall Study||35
10361374|NCT00504075|11501545|FG000|COMPLETED|Overall Study||27
10361375|NCT00504075|11501545|FG000|NOT COMPLETED|Overall Study||8
10361376|NCT00504153|11501550|FG000|STARTED|Overall Study||19
10361377|NCT00504153|11501550|FG000|COMPLETED|Overall Study||13
10361378|NCT00504153|11501550|FG000|NOT COMPLETED|Overall Study||6
10361379|NCT00504166|11501556|FG000|STARTED|Overall Study||26
10361380|NCT00504166|11501557|FG001|STARTED|Overall Study||27
10361381|NCT00504166|11501556|FG000|COMPLETED|Overall Study||20
10361382|NCT00504166|11501557|FG001|COMPLETED|Overall Study||13
10361383|NCT00504166|11501556|FG000|NOT COMPLETED|Overall Study||6
10361384|NCT00504166|11501557|FG001|NOT COMPLETED|Overall Study||14
10361385|NCT00504231|11501567|FG000|STARTED|Overall Study||65
10361386|NCT00504231|11501568|FG001|STARTED|Overall Study||64
10361387|NCT00504231|11501569|FG002|STARTED|Overall Study||64
10361388|NCT00504231|11501570|FG003|STARTED|Overall Study||65
10361389|NCT00504231|11501567|FG000|COMPLETED|Overall Study||65
10361390|NCT00504231|11501568|FG001|COMPLETED|Overall Study||64
10361391|NCT00504231|11501569|FG002|COMPLETED|Overall Study||63
10361392|NCT00504231|11501570|FG003|COMPLETED|Overall Study||65
10361393|NCT00504231|11501567|FG000|NOT COMPLETED|Overall Study||0
10361394|NCT00504231|11501568|FG001|NOT COMPLETED|Overall Study||0
10361395|NCT00504231|11501569|FG002|NOT COMPLETED|Overall Study||1
10361396|NCT00504231|11501570|FG003|NOT COMPLETED|Overall Study||0
10361397|NCT00504257|11501584|FG000|STARTED|Overall Study||45
10361398|NCT00504257|11501584|FG000|COMPLETED|Overall Study||41
10361399|NCT00504257|11501584|FG000|NOT COMPLETED|Overall Study||4
10361400|NCT00504309|11501594|FG000|STARTED|Overall Study||7
10361401|NCT00504309|11501595|FG001|STARTED|Overall Study||5
10361402|NCT00504309|11501596|FG002|STARTED|Overall Study||2
10361403|NCT00504309|11501597|FG003|STARTED|Overall Study||3
10361404|NCT00504309|11501598|FG004|STARTED|Overall Study||8
10361405|NCT00504309|11501599|FG005|STARTED|Overall Study||3
10361406|NCT00504309|11501594|FG000|COMPLETED|Overall Study||7
10361407|NCT00504309|11501595|FG001|COMPLETED|Overall Study||5
10361408|NCT00504309|11501596|FG002|COMPLETED|Overall Study|Participant dropped out during second period|1
10361409|NCT00504309|11501597|FG003|COMPLETED|Overall Study||3
10361410|NCT00504309|11501598|FG004|COMPLETED|Overall Study|Participant died during washout after 2nd period|7
10361411|NCT00504309|11501599|FG005|COMPLETED|Overall Study||3
10361412|NCT00504309|11501594|FG000|NOT COMPLETED|Overall Study||0
10361413|NCT00504309|11501595|FG001|NOT COMPLETED|Overall Study||0
10361414|NCT00504309|11501596|FG002|NOT COMPLETED|Overall Study||1
10361415|NCT00504309|11501597|FG003|NOT COMPLETED|Overall Study||0
10361416|NCT00504309|11501598|FG004|NOT COMPLETED|Overall Study||1
10361417|NCT00504309|11501599|FG005|NOT COMPLETED|Overall Study||0
10361418|NCT00504348|11501611|FG000|STARTED|Overall Study||25
10361419|NCT00504348|11501611|FG000|COMPLETED|Overall Study||17
10361420|NCT00504348|11501611|FG000|NOT COMPLETED|Overall Study||8
10361421|NCT00504426|11501619|FG000|STARTED|Overall Study||32
10361422|NCT00504426|11501620|FG001|STARTED|Overall Study||23
10361423|NCT00504426|11501621|FG002|STARTED|Overall Study||22
10361424|NCT00504426|11501622|FG003|STARTED|Overall Study||24
10361425|NCT00504426|11501619|FG000|COMPLETED|Overall Study||29
10361426|NCT00504426|11501620|FG001|COMPLETED|Overall Study||22
10361427|NCT00504426|11501621|FG002|COMPLETED|Overall Study||18
10361428|NCT00504426|11501622|FG003|COMPLETED|Overall Study||24
10361429|NCT00504426|11501619|FG000|NOT COMPLETED|Overall Study||3
10361430|NCT00504426|11501620|FG001|NOT COMPLETED|Overall Study||1
10361431|NCT00504426|11501621|FG002|NOT COMPLETED|Overall Study||4
10361432|NCT00504426|11501622|FG003|NOT COMPLETED|Overall Study||0
10361433|NCT00504504|11501635|FG000|STARTED|Overall Study||82
10361434|NCT00504504|11501635|FG000|COMPLETED|Overall Study||82
10361435|NCT00504504|11501635|FG000|NOT COMPLETED|Overall Study||0
10361436|NCT00504556|11501644|FG000|STARTED|Overall Study||235
10361437|NCT00504556|11501645|FG001|STARTED|Overall Study||245
10361438|NCT00504556|11501646|FG002|STARTED|Overall Study||235
10361439|NCT00504556|11501647|FG003|STARTED|Overall Study||180
10361440|NCT00504556|11501648|FG004|STARTED|Overall Study||251
10361441|NCT00504556|11501644|FG000|Safety Analysis Set|Overall Study||235
10361442|NCT00504556|11501645|FG001|Safety Analysis Set|Overall Study||244
10361443|NCT00504556|11501646|FG002|Safety Analysis Set|Overall Study||234
10361444|NCT00504556|11501647|FG003|Safety Analysis Set|Overall Study||180
10361445|NCT00504556|11501648|FG004|Safety Analysis Set|Overall Study||250
10361446|NCT00504556|11501644|FG000|Per Protocol Analysis Set|Overall Study||235
10361447|NCT00504556|11501645|FG001|Per Protocol Analysis Set|Overall Study||243
10361448|NCT00504556|11501646|FG002|Per Protocol Analysis Set|Overall Study||234
10361449|NCT00504556|11501647|FG003|Per Protocol Analysis Set|Overall Study||180
10361450|NCT00504556|11501648|FG004|Per Protocol Analysis Set|Overall Study||250
10361451|NCT00504556|11501644|FG000|Pharmacodynamic Analysis Set|Overall Study||230
10361452|NCT00504556|11501645|FG001|Pharmacodynamic Analysis Set|Overall Study||236
10361453|NCT00504556|11501646|FG002|Pharmacodynamic Analysis Set|Overall Study||228
10361454|NCT00504556|11501647|FG003|Pharmacodynamic Analysis Set|Overall Study||170
10361455|NCT00504556|11501648|FG004|Pharmacodynamic Analysis Set|Overall Study||244
10361456|NCT00504556|11501644|FG000|COMPLETED|Overall Study||200
10361457|NCT00504556|11501645|FG001|COMPLETED|Overall Study||207
10361458|NCT00504556|11501646|FG002|COMPLETED|Overall Study||204
10361459|NCT00504556|11501647|FG003|COMPLETED|Overall Study||52
10361460|NCT00504556|11501648|FG004|COMPLETED|Overall Study||226
10361461|NCT00504556|11501644|FG000|NOT COMPLETED|Overall Study||35
10361462|NCT00504556|11501645|FG001|NOT COMPLETED|Overall Study||38
10361463|NCT00504556|11501646|FG002|NOT COMPLETED|Overall Study||31
10361464|NCT00504556|11501647|FG003|NOT COMPLETED|Overall Study||128
10361465|NCT00504556|11501648|FG004|NOT COMPLETED|Overall Study||25
10361466|NCT00504595|11501664|FG000|STARTED|Overall Study||50
10361467|NCT00504595|11501665|FG001|STARTED|Overall Study||10
10361468|NCT00504595|11501666|FG002|STARTED|Overall Study||10
10361469|NCT00504595|11501667|FG003|STARTED|Overall Study||10
10361470|NCT00504595|11501664|FG000|COMPLETED|Overall Study||49
10361471|NCT00504595|11501665|FG001|COMPLETED|Overall Study||10
10361472|NCT00504595|11501666|FG002|COMPLETED|Overall Study||8
10361473|NCT00504595|11501667|FG003|COMPLETED|Overall Study||10
10361474|NCT00504595|11501664|FG000|NOT COMPLETED|Overall Study||1
10361475|NCT00504595|11501665|FG001|NOT COMPLETED|Overall Study||0
10361476|NCT00504595|11501666|FG002|NOT COMPLETED|Overall Study||2
10535051|NCT01434030|11687324|FG000|STARTED|Overall Study||57
10535052|NCT01434030|11687324|FG000|COMPLETED|Overall Study||56
10535053|NCT01434030|11687324|FG000|NOT COMPLETED|Overall Study||1
10535054|NCT01434121|11687332|FG000|STARTED|Overall Study||8
10535055|NCT01434121|11687333|FG001|STARTED|Overall Study||8
10535056|NCT01434121|11687334|FG002|STARTED|Overall Study||8
10535057|NCT01434121|11687332|FG000|COMPLETED|Overall Study||8
10535058|NCT01434121|11687333|FG001|COMPLETED|Overall Study||8
10535059|NCT01434121|11687334|FG002|COMPLETED|Overall Study||8
10535060|NCT01434121|11687332|FG000|NOT COMPLETED|Overall Study||0
10535061|NCT01434121|11687333|FG001|NOT COMPLETED|Overall Study||0
10535062|NCT01434121|11687334|FG002|NOT COMPLETED|Overall Study||0
10535063|NCT01434186|11687347|FG000|STARTED|Overall Study||2
10716307|NCT02688387|11880050|FG007|STARTED|Part 3B, Washout Period 3 (10 Days)||0
10716308|NCT02688387|11880051|FG008|STARTED|Part 3B, Washout Period 3 (10 Days)||0
10716309|NCT02688387|11880052|FG009|STARTED|Part 3B, Washout Period 3 (10 Days)||0
10716310|NCT02688387|11880053|FG010|STARTED|Part 3B, Washout Period 3 (10 Days)||0
10716311|NCT02688387|11880054|FG011|STARTED|Part 3B, Washout Period 3 (10 Days)||0
10716312|NCT02688387|11880055|FG012|STARTED|Part 3B, Washout Period 3 (10 Days)||0
10716313|NCT02688387|11880056|FG013|STARTED|Part 3B, Washout Period 3 (10 Days)||0
10716314|NCT02688387|11880057|FG014|STARTED|Part 3B, Washout Period 3 (10 Days)||0
10361477|NCT00504595|11501667|FG003|NOT COMPLETED|Overall Study||0
10361478|NCT00504660|11501679|FG000|STARTED|Overall Study||31
10535064|NCT01434186|11687348|FG001|STARTED|Overall Study||4
10535065|NCT01434186|11687347|FG000|COMPLETED|Overall Study||2
10656694|NCT02219477|11817737|FG002|NOT COMPLETED|Overall Study||1
10656695|NCT02219503|11817746|FG000|STARTED|Overall Study||60
10656696|NCT02219503|11817746|FG000|COMPLETED|Overall Study||60
10656697|NCT02219503|11817746|FG000|NOT COMPLETED|Overall Study||0
10656698|NCT02219516|11817754|FG000|STARTED|Overall Study||8
10656699|NCT02219516|11817755|FG001|STARTED|Overall Study||8
10656700|NCT02219516|11817756|FG002|STARTED|Overall Study||7
10656701|NCT02219516|11817757|FG003|STARTED|Overall Study||8
10656702|NCT02219516|11817754|FG000|COMPLETED|Overall Study||8
10656703|NCT02219516|11817755|FG001|COMPLETED|Overall Study||8
10656704|NCT02219516|11817756|FG002|COMPLETED|Overall Study||7
10656705|NCT02219516|11817757|FG003|COMPLETED|Overall Study||8
10656706|NCT02219516|11817754|FG000|NOT COMPLETED|Overall Study||0
10656707|NCT02219516|11817755|FG001|NOT COMPLETED|Overall Study||0
10656708|NCT02219516|11817756|FG002|NOT COMPLETED|Overall Study||0
10716315|NCT02688387|11880058|FG015|STARTED|Part 3B, Washout Period 3 (10 Days)||0
10716316|NCT02688387|11880059|FG016|STARTED|Part 3B, Washout Period 3 (10 Days)||0
10361479|NCT00504660|11501680|FG001|STARTED|Overall Study||43
10361480|NCT00504660|11501679|FG000|COMPLETED|Overall Study||31
10361481|NCT00504660|11501680|FG001|COMPLETED|Overall Study||43
10361482|NCT00504660|11501679|FG000|NOT COMPLETED|Overall Study||0
10361483|NCT00504660|11501680|FG001|NOT COMPLETED|Overall Study||0
10535066|NCT01434186|11687348|FG001|COMPLETED|Overall Study||4
10535067|NCT01434186|11687347|FG000|NOT COMPLETED|Overall Study||0
10656709|NCT02219516|11817757|FG003|NOT COMPLETED|Overall Study||0
10361484|NCT00504725|11501688|FG000|STARTED|Overall Study||21
10361485|NCT00504725|11501689|FG001|STARTED|Overall Study||20
10361486|NCT00504725|11501688|FG000|COMPLETED|Overall Study|Prior to unblinding, one subject was discontinued due to elevated CRP levels at baseline.|20
10361487|NCT00504725|11501689|FG001|COMPLETED|Overall Study||20
10361488|NCT00504725|11501688|FG000|NOT COMPLETED|Overall Study||1
10361489|NCT00504725|11501689|FG001|NOT COMPLETED|Overall Study||0
10361490|NCT00504751|11501695|FG000|STARTED|Overall Study||15
10361491|NCT00504751|11501695|FG000|COMPLETED|Overall Study||15
10361492|NCT00504751|11501695|FG000|NOT COMPLETED|Overall Study||0
10361493|NCT00504777|11501699|FG000|STARTED|Overall Study||36
10361494|NCT00504777|11501699|FG000|COMPLETED|Overall Study||35
10361495|NCT00504777|11501699|FG000|NOT COMPLETED|Overall Study||1
10361496|NCT00504829|11501706|FG000|STARTED|Overall Study||73
10361497|NCT00504829|11501707|FG001|STARTED|Overall Study||74
10361498|NCT00504829|11501708|FG002|STARTED|Overall Study||73
10361499|NCT00504829|11501706|FG000|COMPLETED|Overall Study||67
10361500|NCT00504829|11501707|FG001|COMPLETED|Overall Study||70
10361501|NCT00504829|11501708|FG002|COMPLETED|Overall Study||63
10361502|NCT00504829|11501706|FG000|NOT COMPLETED|Overall Study||6
10361503|NCT00504829|11501707|FG001|NOT COMPLETED|Overall Study||4
10361504|NCT00504829|11501708|FG002|NOT COMPLETED|Overall Study||10
10361505|NCT00504881|11501718|FG000|STARTED|Overall Study||121
10361506|NCT00504881|11501719|FG001|STARTED|Overall Study||359
10361507|NCT00504881|11501718|FG000|COMPLETED|Overall Study||111
10361508|NCT00504881|11501719|FG001|COMPLETED|Overall Study||323
10361509|NCT00504881|11501718|FG000|NOT COMPLETED|Overall Study||10
10361510|NCT00504881|11501719|FG001|NOT COMPLETED|Overall Study||36
10361511|NCT00504894|11501730|FG000|STARTED|Overall Study||20
10361512|NCT00504894|11501731|FG001|STARTED|Overall Study||21
10361513|NCT00504894|11501732|FG002|STARTED|Overall Study||19
10361514|NCT00504894|11501730|FG000|COMPLETED|Overall Study||17
10361515|NCT00504894|11501731|FG001|COMPLETED|Overall Study||18
10361516|NCT00504894|11501732|FG002|COMPLETED|Overall Study||19
10361517|NCT00504894|11501730|FG000|NOT COMPLETED|Overall Study||3
10361518|NCT00504894|11501731|FG001|NOT COMPLETED|Overall Study||3
10535068|NCT01434186|11687348|FG001|NOT COMPLETED|Overall Study||0
10535069|NCT01434342|11687356|FG000|STARTED|Overall Study||98
10535070|NCT01434342|11687357|FG001|STARTED|Overall Study||48
10535071|NCT01434342|11687356|FG000|COMPLETED|Overall Study||50
10535072|NCT01434342|11687357|FG001|COMPLETED|Overall Study||31
10535073|NCT01434342|11687356|FG000|NOT COMPLETED|Overall Study||48
10535074|NCT01434342|11687357|FG001|NOT COMPLETED|Overall Study||17
10535075|NCT01434472|11687363|FG000|STARTED|Overall Study||20
10535076|NCT01434472|11687363|FG000|COMPLETED|Overall Study||20
10535077|NCT01434472|11687363|FG000|NOT COMPLETED|Overall Study||0
10535078|NCT01434641|11687367|FG000|STARTED|Overall Study||102
10535079|NCT01434641|11687367|FG000|COMPLETED|Overall Study||102
10535080|NCT01434641|11687367|FG000|NOT COMPLETED|Overall Study||0
10535081|NCT01434654|11687373|FG000|STARTED|Overall Study||7
10535082|NCT01434654|11687374|FG001|STARTED|Overall Study||12
10535083|NCT01434654|11687373|FG000|COMPLETED|Overall Study||5
10535084|NCT01434654|11687374|FG001|COMPLETED|Overall Study||12
10716317|NCT02688387|11880060|FG017|STARTED|Part 3B, Washout Period 3 (10 Days)||0
10716318|NCT02688387|11880061|FG018|STARTED|Part 3B, Washout Period 3 (10 Days)||8
10716319|NCT02688387|11880062|FG019|STARTED|Part 3B, Washout Period 3 (10 Days)||8
10716320|NCT02688387|11880063|FG020|STARTED|Part 3B, Washout Period 3 (10 Days)||7
10716321|NCT02688387|11880064|FG021|STARTED|Part 3B, Washout Period 3 (10 Days)||8
10361519|NCT00504894|11501732|FG002|NOT COMPLETED|Overall Study||0
10535085|NCT01434654|11687373|FG000|NOT COMPLETED|Overall Study||2
10535086|NCT01434654|11687374|FG001|NOT COMPLETED|Overall Study||0
10535087|NCT01434667|11687384|FG000|STARTED|Overall Study||39
10535088|NCT01434667|11687385|FG001|STARTED|Overall Study||75
10535089|NCT01434667|11687384|FG000|COMPLETED|Overall Study||34
10535090|NCT01434667|11687385|FG001|COMPLETED|Overall Study||65
10535091|NCT01434667|11687384|FG000|NOT COMPLETED|Overall Study||5
10535092|NCT01434667|11687385|FG001|NOT COMPLETED|Overall Study||10
10535093|NCT01434680|11687395|FG000|STARTED|Overall Study||299
10535094|NCT01434680|11687396|FG001|STARTED|Overall Study||268
10535095|NCT01434680|11687397|FG002|STARTED|Overall Study||306
10535096|NCT01434680|11687398|FG003|STARTED|Overall Study||119
10535097|NCT01434680|11687395|FG000|COMPLETED|Overall Study||296
10535098|NCT01434680|11687396|FG001|COMPLETED|Overall Study||266
10535099|NCT01434680|11687397|FG002|COMPLETED|Overall Study||304
10535100|NCT01434680|11687398|FG003|COMPLETED|Overall Study||119
10361520|NCT00505076|11501743|FG000|STARTED|Overall Study||22
10361521|NCT00505076|11501744|FG001|STARTED|Overall Study||19
10361522|NCT00505076|11501745|FG002|STARTED|Overall Study||22
10361523|NCT00505076|11501743|FG000|COMPLETED|Overall Study||19
10361524|NCT00505076|11501744|FG001|COMPLETED|Overall Study||17
10361525|NCT00505076|11501745|FG002|COMPLETED|Overall Study||17
10361526|NCT00505076|11501743|FG000|NOT COMPLETED|Overall Study||3
10361527|NCT00505076|11501744|FG001|NOT COMPLETED|Overall Study||2
10361528|NCT00505076|11501745|FG002|NOT COMPLETED|Overall Study||5
10361529|NCT00505284|11501758|FG000|STARTED|Overall Study||73
10361530|NCT00505284|11501759|FG001|STARTED|Overall Study||72
10361531|NCT00505284|11501760|FG002|STARTED|Overall Study||69
10361532|NCT00505284|11501761|FG003|STARTED|Overall Study||68
10361533|NCT00505284|11501762|FG004|STARTED|Overall Study||70
10361534|NCT00505284|11501758|FG000|COMPLETED|Overall Study||63
10361535|NCT00505284|11501759|FG001|COMPLETED|Overall Study||56
10361536|NCT00505284|11501760|FG002|COMPLETED|Overall Study||57
10361537|NCT00505284|11501761|FG003|COMPLETED|Overall Study||49
10361538|NCT00505284|11501762|FG004|COMPLETED|Overall Study||37
10361539|NCT00505284|11501758|FG000|NOT COMPLETED|Overall Study||10
10361540|NCT00505284|11501759|FG001|NOT COMPLETED|Overall Study||16
10361541|NCT00505284|11501760|FG002|NOT COMPLETED|Overall Study||12
10361542|NCT00505284|11501761|FG003|NOT COMPLETED|Overall Study||19
10361543|NCT00505284|11501762|FG004|NOT COMPLETED|Overall Study||33
10361544|NCT00505362|11501776|FG000|STARTED|Overall Study||35
10361545|NCT00505362|11501777|FG001|STARTED|Overall Study||28
10361546|NCT00505362|11501776|FG000|COMPLETED|Overall Study||35
10361547|NCT00505362|11501777|FG001|COMPLETED|Overall Study||28
10361548|NCT00505362|11501776|FG000|NOT COMPLETED|Overall Study||0
10361549|NCT00505362|11501777|FG001|NOT COMPLETED|Overall Study||0
10361550|NCT00505375|11501785|FG000|STARTED|Overall Study||77
10361551|NCT00505375|11501786|FG001|STARTED|Overall Study||35
10361552|NCT00505375|11501785|FG000|COMPLETED|Overall Study||73
10361553|NCT00505375|11501786|FG001|COMPLETED|Overall Study||30
10535101|NCT01434680|11687395|FG000|NOT COMPLETED|Overall Study||3
10535102|NCT01434680|11687396|FG001|NOT COMPLETED|Overall Study||2
10535103|NCT01434680|11687397|FG002|NOT COMPLETED|Overall Study||2
10535104|NCT01434680|11687398|FG003|NOT COMPLETED|Overall Study||0
10535105|NCT01434693|11687412|FG000|STARTED|Overall Study||9
10535106|NCT01434693|11687413|FG001|STARTED|Overall Study||9
10535107|NCT01434693|11687414|FG002|STARTED|Overall Study||9
10535108|NCT01434693|11687415|FG003|STARTED|Overall Study||9
10535109|NCT01434693|11687412|FG000|COMPLETED|Overall Study||6
10535110|NCT01434693|11687413|FG001|COMPLETED|Overall Study||9
10535111|NCT01434693|11687414|FG002|COMPLETED|Overall Study||8
10535112|NCT01434693|11687415|FG003|COMPLETED|Overall Study||8
10535113|NCT01434693|11687412|FG000|NOT COMPLETED|Overall Study||3
10535114|NCT01434693|11687413|FG001|NOT COMPLETED|Overall Study||0
10716322|NCT02688387|11880043|FG000|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10716323|NCT02688387|11880044|FG001|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10716324|NCT02688387|11880045|FG002|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10716325|NCT02688387|11880046|FG003|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10535115|NCT01434693|11687414|FG002|NOT COMPLETED|Overall Study||1
10361554|NCT00505375|11501785|FG000|NOT COMPLETED|Overall Study||4
10361555|NCT00505375|11501786|FG001|NOT COMPLETED|Overall Study||5
10361556|NCT00505414|11501794|FG000|STARTED|Titration Phase||0
10361557|NCT00505414|11501795|FG001|STARTED|Titration Phase||0
10535116|NCT01434693|11687415|FG003|NOT COMPLETED|Overall Study||1
10361558|NCT00505414|11501796|FG002|STARTED|Titration Phase||0
10535117|NCT01434810|11687427|FG000|STARTED|Overall Study||224
10535118|NCT01434810|11687428|FG001|STARTED|Overall Study||223
10361559|NCT00505414|11501797|FG003|STARTED|Titration Phase||62
10361560|NCT00505414|11501798|FG004|STARTED|Titration Phase||31
10361561|NCT00505414|11501794|FG000|COMPLETED|Titration Phase||0
10361562|NCT00505414|11501795|FG001|COMPLETED|Titration Phase||0
10361563|NCT00505414|11501796|FG002|COMPLETED|Titration Phase||0
10361564|NCT00505414|11501797|FG003|COMPLETED|Titration Phase||32
10361565|NCT00505414|11501798|FG004|COMPLETED|Titration Phase||19
10361566|NCT00505414|11501794|FG000|NOT COMPLETED|Titration Phase||0
10361567|NCT00505414|11501795|FG001|NOT COMPLETED|Titration Phase||0
10361568|NCT00505414|11501796|FG002|NOT COMPLETED|Titration Phase||0
10361569|NCT00505414|11501797|FG003|NOT COMPLETED|Titration Phase||30
10361570|NCT00505414|11501798|FG004|NOT COMPLETED|Titration Phase||12
10361571|NCT00505414|11501794|FG000|STARTED|Maintenance Phase|18 of the 19 morphine participants continued with morphine in the maintenance phase.|18
10361572|NCT00505414|11501795|FG001|STARTED|Maintenance Phase|15 of 32 tapentadol titration participants continued with tapentadol in the maintenance phase|15
10361573|NCT00505414|11501796|FG002|STARTED|Maintenance Phase|14 of 32 tapentadol titration participants were treated with placebo in the maintenance phase.|14
10361574|NCT00505414|11501797|FG003|STARTED|Maintenance Phase|29 of 32 participants were treated in the maintenance phase either with placebo or tapentadol|0
10361575|NCT00505414|11501798|FG004|STARTED|Maintenance Phase|18 of 19 participants completing the morphine titration phase were continued on morphine.|0
10361576|NCT00505414|11501794|FG000|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
10361577|NCT00505414|11501795|FG001|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
10361578|NCT00505414|11501796|FG002|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
10361579|NCT00505414|11501797|FG003|Did Not Qualify for Maintenance Phase|Maintenance Phase||3
10361580|NCT00505414|11501798|FG004|Did Not Qualify for Maintenance Phase|Maintenance Phase||1
10361581|NCT00505414|11501794|FG000|COMPLETED|Maintenance Phase||12
10361582|NCT00505414|11501795|FG001|COMPLETED|Maintenance Phase||10
10361583|NCT00505414|11501796|FG002|COMPLETED|Maintenance Phase||6
10361584|NCT00505414|11501797|FG003|COMPLETED|Maintenance Phase||0
10361585|NCT00505414|11501798|FG004|COMPLETED|Maintenance Phase||0
10361586|NCT00505414|11501794|FG000|NOT COMPLETED|Maintenance Phase||6
10361587|NCT00505414|11501795|FG001|NOT COMPLETED|Maintenance Phase||5
10361588|NCT00505414|11501796|FG002|NOT COMPLETED|Maintenance Phase||8
10361589|NCT00505414|11501797|FG003|NOT COMPLETED|Maintenance Phase||0
10361590|NCT00505414|11501798|FG004|NOT COMPLETED|Maintenance Phase||0
10427109|NCT00851318|11572886|FG001|COMPLETED|Overall Study||14
10427110|NCT00851318|11572887|FG002|COMPLETED|Overall Study||72
10427111|NCT00851318|11572888|FG003|COMPLETED|Overall Study||73
10427112|NCT00851318|11572885|FG000|NOT COMPLETED|Overall Study||30
10427113|NCT00851318|11572886|FG001|NOT COMPLETED|Overall Study||5
10427114|NCT00851318|11572887|FG002|NOT COMPLETED|Overall Study||21
10427115|NCT00851318|11572888|FG003|NOT COMPLETED|Overall Study||19
10427116|NCT00851357|11572901|FG000|STARTED|Overall Study||1200
10427117|NCT00851357|11572902|FG001|STARTED|Overall Study||1201
10427118|NCT00851357|11572903|FG002|STARTED|Overall Study||1799
10427119|NCT00851357|11572901|FG000|COMPLETED|Overall Study||1200
10427120|NCT00851357|11572902|FG001|COMPLETED|Overall Study||1201
10427121|NCT00851357|11572903|FG002|COMPLETED|Overall Study||1799
10427122|NCT00851357|11572901|FG000|NOT COMPLETED|Overall Study||0
10427123|NCT00851357|11572902|FG001|NOT COMPLETED|Overall Study||0
10427124|NCT00851357|11572903|FG002|NOT COMPLETED|Overall Study||0
10427125|NCT00851409|11572911|FG000|STARTED|Overall Study||25
10427126|NCT00851409|11572911|FG000|COMPLETED|Overall Study||25
10427127|NCT00851409|11572911|FG000|NOT COMPLETED|Overall Study||0
10427128|NCT00851630|11572918|FG000|STARTED|Overall Study||35
10427129|NCT00851630|11572919|FG001|STARTED|Overall Study||35
10427130|NCT00851630|11572918|FG000|COMPLETED|Overall Study||33
10427131|NCT00851630|11572919|FG001|COMPLETED|Overall Study||33
10427132|NCT00851630|11572918|FG000|NOT COMPLETED|Overall Study||2
10427133|NCT00851630|11572919|FG001|NOT COMPLETED|Overall Study||2
10427134|NCT00851643|11572931|FG000|STARTED|Base Study (Up to 12 Months)||15
10427135|NCT00851643|11572932|FG001|STARTED|Base Study (Up to 12 Months)||30
10427136|NCT00851643|11572933|FG002|STARTED|Base Study (Up to 12 Months)||30
10427137|NCT00851643|11572934|FG003|STARTED|Base Study (Up to 12 Months)||15
10427138|NCT00851643|11572935|FG004|STARTED|Base Study (Up to 12 Months)||30
10427139|NCT00851643|11572936|FG005|STARTED|Base Study (Up to 12 Months)||30
10427140|NCT00851643|11572931|FG000|COMPLETED|Base Study (Up to 12 Months)||14
10427141|NCT00851643|11572932|FG001|COMPLETED|Base Study (Up to 12 Months)||30
10427142|NCT00851643|11572933|FG002|COMPLETED|Base Study (Up to 12 Months)||30
10427143|NCT00851643|11572934|FG003|COMPLETED|Base Study (Up to 12 Months)||15
10427144|NCT00851643|11572935|FG004|COMPLETED|Base Study (Up to 12 Months)||30
10427145|NCT00851643|11572936|FG005|COMPLETED|Base Study (Up to 12 Months)||29
10427146|NCT00851643|11572931|FG000|NOT COMPLETED|Base Study (Up to 12 Months)||1
10427147|NCT00851643|11572932|FG001|NOT COMPLETED|Base Study (Up to 12 Months)||0
10427148|NCT00851643|11572933|FG002|NOT COMPLETED|Base Study (Up to 12 Months)||0
10427149|NCT00851643|11572934|FG003|NOT COMPLETED|Base Study (Up to 12 Months)||0
10427150|NCT00851643|11572935|FG004|NOT COMPLETED|Base Study (Up to 12 Months)||0
10427151|NCT00851643|11572936|FG005|NOT COMPLETED|Base Study (Up to 12 Months)||1
10427152|NCT00851643|11572931|FG000|STARTED|Extension Study (Up to 36 Months)||10
10427153|NCT00851643|11572932|FG001|STARTED|Extension Study (Up to 36 Months)||19
10427154|NCT00851643|11572933|FG002|STARTED|Extension Study (Up to 36 Months)||19
10427155|NCT00851643|11572934|FG003|STARTED|Extension Study (Up to 36 Months)||7
10427156|NCT00851643|11572935|FG004|STARTED|Extension Study (Up to 36 Months)||21
10427157|NCT00851643|11572936|FG005|STARTED|Extension Study (Up to 36 Months)||15
10361591|NCT00505518|11501810|FG000|STARTED|Overall Study||9
10361592|NCT00505518|11501810|FG000|COMPLETED|Overall Study||9
10361593|NCT00505518|11501810|FG000|NOT COMPLETED|Overall Study||0
10361594|NCT00505622|11501817|FG000|STARTED|Overall Study||121
10361595|NCT00505622|11501818|FG001|STARTED|Overall Study||108
10361596|NCT00505622|11501819|FG002|STARTED|Overall Study||96
10361597|NCT00505622|11501817|FG000|COMPLETED|Overall Study||0
10361598|NCT00505622|11501818|FG001|COMPLETED|Overall Study||0
10361599|NCT00505622|11501819|FG002|COMPLETED|Overall Study||0
10361600|NCT00505622|11501817|FG000|NOT COMPLETED|Overall Study||121
10361601|NCT00505622|11501818|FG001|NOT COMPLETED|Overall Study||108
10361602|NCT00505622|11501819|FG002|NOT COMPLETED|Overall Study||96
10361603|NCT00505635|11501827|FG000|STARTED|Overall Study||5
10361604|NCT00505635|11501827|FG000|COMPLETED|Overall Study||5
10361605|NCT00505635|11501827|FG000|NOT COMPLETED|Overall Study||0
10361606|NCT00505661|11501831|FG000|STARTED|Overall Study||16
10361607|NCT00505661|11501831|FG000|COMPLETED|Overall Study||12
10361608|NCT00505661|11501831|FG000|NOT COMPLETED|Overall Study||4
10361609|NCT00505687|11501835|FG000|STARTED|Overall Study||186
10361610|NCT00505687|11501835|FG000|COMPLETED|Overall Study||91
10361611|NCT00505687|11501835|FG000|NOT COMPLETED|Overall Study||95
10361612|NCT00505752|11501843|FG000|STARTED|Overall Study||132
10361613|NCT00505752|11501844|FG001|STARTED|Overall Study||128
10361614|NCT00505752|11501845|FG002|STARTED|Overall Study||128
10361615|NCT00505752|11501846|FG003|STARTED|Overall Study||132
10361616|NCT00505752|11501843|FG000|COMPLETED|Overall Study||126
10361617|NCT00505752|11501844|FG001|COMPLETED|Overall Study||119
10361618|NCT00505752|11501845|FG002|COMPLETED|Overall Study||120
10361619|NCT00505752|11501846|FG003|COMPLETED|Overall Study||126
10361620|NCT00505752|11501843|FG000|NOT COMPLETED|Overall Study||6
10361621|NCT00505752|11501844|FG001|NOT COMPLETED|Overall Study||9
10361622|NCT00505752|11501845|FG002|NOT COMPLETED|Overall Study||8
10361623|NCT00505752|11501846|FG003|NOT COMPLETED|Overall Study||6
10361624|NCT00505765|11501859|FG000|STARTED|Overall Study||21
10361625|NCT00505765|11501860|FG001|STARTED|Overall Study||20
10361626|NCT00505765|11501861|FG002|STARTED|Overall Study||22
10361627|NCT00505765|11501859|FG000|Mid-Point Assessment|Overall Study||20
10361628|NCT00505765|11501860|FG001|Mid-Point Assessment|Overall Study||19
10361629|NCT00505765|11501861|FG002|Mid-Point Assessment|Overall Study||21
10361630|NCT00505765|11501859|FG000|COMPLETED|Overall Study||19
10361631|NCT00505765|11501860|FG001|COMPLETED|Overall Study||17
10361632|NCT00505765|11501861|FG002|COMPLETED|Overall Study||19
10361633|NCT00505765|11501859|FG000|NOT COMPLETED|Overall Study||2
10361634|NCT00505765|11501860|FG001|NOT COMPLETED|Overall Study||3
10361635|NCT00505765|11501861|FG002|NOT COMPLETED|Overall Study||3
10361636|NCT00505778|11501871|FG000|STARTED|Overall Study||514
10361637|NCT00505778|11501872|FG001|STARTED|Overall Study||513
10361638|NCT00505778|11501871|FG000|Intent to Treat (ITT) Population|Overall Study||512
10361639|NCT00505778|11501872|FG001|Intent to Treat (ITT) Population|Overall Study||511
10361640|NCT00505778|11501871|FG000|COMPLETED|Overall Study||380
10361641|NCT00505778|11501872|FG001|COMPLETED|Overall Study||378
10361642|NCT00505778|11501871|FG000|NOT COMPLETED|Overall Study||134
10361643|NCT00505778|11501872|FG001|NOT COMPLETED|Overall Study||135
10361644|NCT00505895|11501880|FG000|STARTED|Overall Study||27
10361645|NCT00505895|11501881|FG001|STARTED|Overall Study||23
10361646|NCT00505895|11501880|FG000|COMPLETED|Overall Study||27
10361647|NCT00505895|11501881|FG001|COMPLETED|Overall Study||23
10361648|NCT00505895|11501880|FG000|NOT COMPLETED|Overall Study||0
10361649|NCT00505895|11501881|FG001|NOT COMPLETED|Overall Study||0
10361650|NCT00505921|11501887|FG000|STARTED|Overall Study||27
10361651|NCT00505921|11501887|FG000|COMPLETED|Overall Study||18
10361652|NCT00505921|11501887|FG000|NOT COMPLETED|Overall Study||9
10361653|NCT00505934|11501891|FG000|STARTED|Overall Study|Of the 23 subjects screened, 19 were enrolled into the study and received levetiracetam IV (LEV IV).|19
10361654|NCT00505934|11501891|FG000|COMPLETED|Overall Study||16
10361655|NCT00505934|11501891|FG000|NOT COMPLETED|Overall Study||3
10361656|NCT00506025|11501898|FG000|STARTED|Overall Study||10
10361657|NCT00506025|11501899|FG001|STARTED|Overall Study||9
10361658|NCT00506025|11501900|FG002|STARTED|Overall Study||8
10361659|NCT00506025|11501898|FG000|COMPLETED|Overall Study||10
10361660|NCT00506025|11501899|FG001|COMPLETED|Overall Study||9
10361661|NCT00506025|11501900|FG002|COMPLETED|Overall Study||8
10361662|NCT00506025|11501898|FG000|NOT COMPLETED|Overall Study||0
10535119|NCT01434810|11687427|FG000|COMPLETED|Overall Study||201
10535120|NCT01434810|11687428|FG001|COMPLETED|Overall Study||213
10535121|NCT01434810|11687427|FG000|NOT COMPLETED|Overall Study||23
10535122|NCT01434810|11687428|FG001|NOT COMPLETED|Overall Study||10
10535123|NCT01434823|11687436|FG000|STARTED|Overall Study||824
10535124|NCT01434823|11687437|FG001|STARTED|Overall Study||785
10535125|NCT01434823|11687436|FG000|COMPLETED|Overall Study||820
10535126|NCT01434823|11687437|FG001|COMPLETED|Overall Study||778
10535127|NCT01434823|11687436|FG000|NOT COMPLETED|Overall Study||4
10535128|NCT01434823|11687437|FG001|NOT COMPLETED|Overall Study||7
10812564|NCT03534362|11974652|FG000|COMPLETED|Overall Study||0
10535129|NCT01435018|11687447|FG000|STARTED|Overall Study||135
10535130|NCT01435018|11687448|FG001|STARTED|Overall Study||60
10535131|NCT01435018|11687449|FG002|STARTED|Overall Study||139
10535132|NCT01435018|11687447|FG000|COMPLETED|Overall Study||88
10535133|NCT01435018|11687448|FG001|COMPLETED|Overall Study||26
10535134|NCT01435018|11687449|FG002|COMPLETED|Overall Study||98
10812565|NCT03534362|11974653|FG001|COMPLETED|Overall Study||1
10361663|NCT00506025|11501899|FG001|NOT COMPLETED|Overall Study||0
10361664|NCT00506025|11501900|FG002|NOT COMPLETED|Overall Study||0
10361665|NCT00506077|11501910|FG000|STARTED|Treatment Period 1||28
10361666|NCT00506077|11501911|FG001|STARTED|Treatment Period 1||27
10361667|NCT00506077|11501910|FG000|COMPLETED|Treatment Period 1||24
10361668|NCT00506077|11501911|FG001|COMPLETED|Treatment Period 1||24
10361669|NCT00506077|11501910|FG000|NOT COMPLETED|Treatment Period 1||4
10361670|NCT00506077|11501911|FG001|NOT COMPLETED|Treatment Period 1||3
10361671|NCT00506077|11501910|FG000|STARTED|Washout||24
10361672|NCT00506077|11501911|FG001|STARTED|Washout||24
10361673|NCT00506077|11501910|FG000|COMPLETED|Washout||24
10361674|NCT00506077|11501911|FG001|COMPLETED|Washout||24
10361675|NCT00506077|11501910|FG000|NOT COMPLETED|Washout||0
10361676|NCT00506077|11501911|FG001|NOT COMPLETED|Washout||0
10361677|NCT00506077|11501910|FG000|STARTED|Treatment Period 2||24
10361678|NCT00506077|11501911|FG001|STARTED|Treatment Period 2||24
10361679|NCT00506077|11501910|FG000|COMPLETED|Treatment Period 2||23
10361680|NCT00506077|11501911|FG001|COMPLETED|Treatment Period 2||23
10361681|NCT00506077|11501910|FG000|NOT COMPLETED|Treatment Period 2||1
10361682|NCT00506077|11501911|FG001|NOT COMPLETED|Treatment Period 2||1
10361683|NCT00506129|11501917|FG000|STARTED|Overall Study||33
10361684|NCT00506129|11501917|FG000|COMPLETED|Overall Study||11
10361685|NCT00506129|11501917|FG000|NOT COMPLETED|Overall Study||22
10361686|NCT00506142|11501923|FG000|STARTED|Overall Study||35
10361687|NCT00506142|11501924|FG001|STARTED|Overall Study||19
10361688|NCT00506142|11501923|FG000|COMPLETED|Overall Study||0
10361689|NCT00506142|11501924|FG001|COMPLETED|Overall Study||0
10361690|NCT00506142|11501923|FG000|NOT COMPLETED|Overall Study||35
10361691|NCT00506142|11501924|FG001|NOT COMPLETED|Overall Study||19
10535135|NCT01435018|11687447|FG000|NOT COMPLETED|Overall Study||47
10535136|NCT01435018|11687448|FG001|NOT COMPLETED|Overall Study||34
10535137|NCT01435018|11687449|FG002|NOT COMPLETED|Overall Study||41
10535138|NCT01435031|11687459|FG000|STARTED|ITT at 1 Month|ITT population|222
10535139|NCT01435031|11687459|FG000|COMPLETED|ITT at 1 Month||216
10535140|NCT01435031|11687459|FG000|NOT COMPLETED|ITT at 1 Month||6
10535141|NCT01435031|11687459|FG000|STARTED|ITT at 6 Months||216
10535142|NCT01435031|11687459|FG000|COMPLETED|ITT at 6 Months||211
10535143|NCT01435031|11687459|FG000|NOT COMPLETED|ITT at 6 Months||5
10535144|NCT01435031|11687459|FG000|STARTED|ITT at 1 Year||211
10535145|NCT01435031|11687459|FG000|COMPLETED|ITT at 1 Year||202
10535146|NCT01435031|11687459|FG000|NOT COMPLETED|ITT at 1 Year||9
10535147|NCT01435031|11687459|FG000|STARTED|ITT at 2 Years||202
10535148|NCT01435031|11687459|FG000|COMPLETED|ITT at 2 Years||189
10535149|NCT01435031|11687459|FG000|NOT COMPLETED|ITT at 2 Years||13
10535150|NCT01435031|11687459|FG000|STARTED|ITT at 3 Years||189
10535151|NCT01435031|11687459|FG000|COMPLETED|ITT at 3 Years||178
10535152|NCT01435031|11687459|FG000|NOT COMPLETED|ITT at 3 Years||11
10535153|NCT01435031|11687459|FG000|STARTED|ITT at 4 Years||178
10535154|NCT01435031|11687459|FG000|COMPLETED|ITT at 4 Years||171
10535155|NCT01435031|11687459|FG000|NOT COMPLETED|ITT at 4 Years||7
10535156|NCT01435122|11687463|FG000|STARTED|Overall Study||30
10535157|NCT01435122|11687463|FG000|COMPLETED|Overall Study||22
10535158|NCT01435122|11687463|FG000|NOT COMPLETED|Overall Study||8
10535159|NCT01435174|11687467|FG000|STARTED|Overall Study||17
10535160|NCT01435174|11687467|FG000|COMPLETED|Overall Study||8
10535161|NCT01435174|11687467|FG000|NOT COMPLETED|Overall Study||9
10535162|NCT01435265|11687473|FG000|STARTED|Overall Study||3
10535163|NCT01435265|11687474|FG001|STARTED|Overall Study||4
10535164|NCT01435265|11687473|FG000|COMPLETED|Overall Study||3
10535165|NCT01435265|11687474|FG001|COMPLETED|Overall Study||3
10535166|NCT01435265|11687473|FG000|NOT COMPLETED|Overall Study||0
10535167|NCT01435265|11687474|FG001|NOT COMPLETED|Overall Study||1
10535168|NCT01435304|11687482|FG000|STARTED|Overall Study||50
10535169|NCT01435304|11687483|FG001|STARTED|Overall Study||50
10535170|NCT01435304|11687482|FG000|COMPLETED|Overall Study||50
10535171|NCT01435304|11687483|FG001|COMPLETED|Overall Study||50
10535172|NCT01435304|11687482|FG000|NOT COMPLETED|Overall Study||0
10535173|NCT01435304|11687483|FG001|NOT COMPLETED|Overall Study||0
10535174|NCT01435356|11687491|FG000|STARTED|Overall Study||48
10535175|NCT01435356|11687492|FG001|STARTED|Overall Study||29
10535176|NCT01435356|11687491|FG000|COMPLETED|Overall Study||16
10535177|NCT01435356|11687492|FG001|COMPLETED|Overall Study||5
10535178|NCT01435356|11687491|FG000|NOT COMPLETED|Overall Study||32
10535179|NCT01435356|11687492|FG001|NOT COMPLETED|Overall Study||24
10535180|NCT01435382|11687502|FG000|STARTED|Overall Study||12
10535181|NCT01435382|11687503|FG001|STARTED|Overall Study||13
10535182|NCT01435382|11687504|FG002|STARTED|Overall Study||13
10535183|NCT01435382|11687505|FG003|STARTED|Overall Study||11
10535184|NCT01435382|11687502|FG000|COMPLETED|Overall Study||11
10361692|NCT00506155|11501930|FG000|STARTED|Overall Study||60
10361693|NCT00506155|11501930|FG000|COMPLETED|Overall Study||60
10361694|NCT00506155|11501930|FG000|NOT COMPLETED|Overall Study||0
10361695|NCT00506285|11501936|FG000|STARTED|3 Week Screening Phase||46
10361696|NCT00506285|11501937|FG001|STARTED|3 Week Screening Phase||46
10535185|NCT01435382|11687503|FG001|COMPLETED|Overall Study||11
10535186|NCT01435382|11687504|FG002|COMPLETED|Overall Study||12
10535187|NCT01435382|11687505|FG003|COMPLETED|Overall Study||10
10535188|NCT01435382|11687502|FG000|NOT COMPLETED|Overall Study||1
10535189|NCT01435382|11687503|FG001|NOT COMPLETED|Overall Study||2
10535190|NCT01435382|11687504|FG002|NOT COMPLETED|Overall Study||1
10535191|NCT01435382|11687505|FG003|NOT COMPLETED|Overall Study||1
10535192|NCT01435460|11687523|FG000|STARTED|Overall Study||151
10535193|NCT01435460|11687524|FG001|STARTED|Overall Study||149
10535194|NCT01435460|11687523|FG000|COMPLETED|Overall Study||140
10535195|NCT01435460|11687524|FG001|COMPLETED|Overall Study||143
10361697|NCT00506285|11501936|FG000|COMPLETED|3 Week Screening Phase||29
10361698|NCT00506285|11501937|FG001|COMPLETED|3 Week Screening Phase||36
10361699|NCT00506285|11501936|FG000|NOT COMPLETED|3 Week Screening Phase||17
10361700|NCT00506285|11501937|FG001|NOT COMPLETED|3 Week Screening Phase||10
10361701|NCT00506285|11501936|FG000|STARTED|Double Blind Cross-Over Phase||29
10361702|NCT00506285|11501937|FG001|STARTED|Double Blind Cross-Over Phase||36
10361703|NCT00506285|11501936|FG000|Received at Least 1 Dose MTS|Double Blind Cross-Over Phase||29
10361704|NCT00506285|11501937|FG001|Received at Least 1 Dose MTS|Double Blind Cross-Over Phase||31
10361705|NCT00506285|11501936|FG000|COMPLETED|Double Blind Cross-Over Phase||20
10361706|NCT00506285|11501937|FG001|COMPLETED|Double Blind Cross-Over Phase||31
10361707|NCT00506285|11501936|FG000|NOT COMPLETED|Double Blind Cross-Over Phase||9
10361708|NCT00506285|11501937|FG001|NOT COMPLETED|Double Blind Cross-Over Phase||5
10361709|NCT00506285|11501936|FG000|STARTED|6-month Open Label Phase||20
10361710|NCT00506285|11501937|FG001|STARTED|6-month Open Label Phase||31
10361711|NCT00506285|11501936|FG000|COMPLETED|6-month Open Label Phase||10
10361712|NCT00506285|11501937|FG001|COMPLETED|6-month Open Label Phase||19
10361713|NCT00506285|11501936|FG000|NOT COMPLETED|6-month Open Label Phase||10
10361714|NCT00506285|11501937|FG001|NOT COMPLETED|6-month Open Label Phase||12
10361715|NCT00506350|11501954|FG000|STARTED|Overall Study||36
10361716|NCT00506350|11501955|FG001|STARTED|Overall Study||40
10361717|NCT00506350|11501956|FG002|STARTED|Overall Study||37
10361718|NCT00506350|11501957|FG003|STARTED|Overall Study||36
10361719|NCT00506350|11501958|FG004|STARTED|Overall Study||50
10361720|NCT00506350|11501959|FG005|STARTED|Overall Study||40
10361721|NCT00506350|11501960|FG006|STARTED|Overall Study||35
10361722|NCT00506350|11501961|FG007|STARTED|Overall Study||41
10361723|NCT00506350|11501962|FG008|STARTED|Overall Study||35
10361724|NCT00506350|11501954|FG000|COMPLETED|Overall Study||33
10361725|NCT00506350|11501955|FG001|COMPLETED|Overall Study||37
10361726|NCT00506350|11501956|FG002|COMPLETED|Overall Study||31
10361727|NCT00506350|11501957|FG003|COMPLETED|Overall Study||34
10361728|NCT00506350|11501958|FG004|COMPLETED|Overall Study||40
10361729|NCT00506350|11501959|FG005|COMPLETED|Overall Study||38
10361730|NCT00506350|11501960|FG006|COMPLETED|Overall Study||33
10361731|NCT00506350|11501961|FG007|COMPLETED|Overall Study||36
10361732|NCT00506350|11501962|FG008|COMPLETED|Overall Study||30
10361733|NCT00506350|11501954|FG000|NOT COMPLETED|Overall Study||3
10361734|NCT00506350|11501955|FG001|NOT COMPLETED|Overall Study||3
10361735|NCT00506350|11501956|FG002|NOT COMPLETED|Overall Study||6
10361736|NCT00506350|11501957|FG003|NOT COMPLETED|Overall Study||2
10361737|NCT00506350|11501958|FG004|NOT COMPLETED|Overall Study||10
10361738|NCT00506350|11501959|FG005|NOT COMPLETED|Overall Study||2
10361739|NCT00506350|11501960|FG006|NOT COMPLETED|Overall Study||2
10361740|NCT00506350|11501961|FG007|NOT COMPLETED|Overall Study||5
10361741|NCT00506350|11501962|FG008|NOT COMPLETED|Overall Study||5
10361742|NCT00506389|11501992|FG000|STARTED|In-treatment Period||143
10361743|NCT00506389|11501993|FG001|STARTED|In-treatment Period||139
10361744|NCT00506389|11501994|FG002|STARTED|In-treatment Period||137
10361745|NCT00506389|11501992|FG000|All Participants Treated|In-treatment Period||139
10361746|NCT00506389|11501993|FG001|All Participants Treated|In-treatment Period||138
10361747|NCT00506389|11501994|FG002|All Participants Treated|In-treatment Period||136
10361748|NCT00506389|11501992|FG000|COMPLETED|In-treatment Period||117
10361749|NCT00506389|11501993|FG001|COMPLETED|In-treatment Period||124
10361750|NCT00506389|11501994|FG002|COMPLETED|In-treatment Period||125
10361751|NCT00506389|11501992|FG000|NOT COMPLETED|In-treatment Period||26
10361752|NCT00506389|11501993|FG001|NOT COMPLETED|In-treatment Period||15
10361753|NCT00506389|11501994|FG002|NOT COMPLETED|In-treatment Period||12
10361754|NCT00506389|11501992|FG000|STARTED|Follow-up Period|22 participants who discontinued treatment entered the Follow-up Period.|139
10361755|NCT00506389|11501993|FG001|STARTED|Follow-up Period|14 participants who discontinued treatment entered the Follow-up Period.|138
10361756|NCT00506389|11501994|FG002|STARTED|Follow-up Period|11 participants who discontinued treatment entered the Follow-up Period.|136
10361757|NCT00506389|11501992|FG000|COMPLETED|Follow-up Period||139
10361758|NCT00506389|11501993|FG001|COMPLETED|Follow-up Period||138
10361759|NCT00506389|11501994|FG002|COMPLETED|Follow-up Period||136
10361760|NCT00506389|11501992|FG000|NOT COMPLETED|Follow-up Period||0
10361761|NCT00506389|11501993|FG001|NOT COMPLETED|Follow-up Period||0
10361762|NCT00506389|11501994|FG002|NOT COMPLETED|Follow-up Period||0
10361763|NCT00506415|11502005|FG000|STARTED|Initial Open Label (Maximum 48 Weeks)|Enrolled patients.|1584
10361764|NCT00506415|11502006|FG001|STARTED|Initial Open Label (Maximum 48 Weeks)||0
10361765|NCT00506415|11502007|FG002|STARTED|Initial Open Label (Maximum 48 Weeks)||0
10361766|NCT00506415|11502008|FG003|STARTED|Initial Open Label (Maximum 48 Weeks)||0
10361767|NCT00506415|11502005|FG000|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||1582
10361768|NCT00506415|11502006|FG001|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
10361769|NCT00506415|11502007|FG002|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
10361770|NCT00506415|11502008|FG003|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
10361771|NCT00506415|11502005|FG000|COMPLETED|Initial Open Label (Maximum 48 Weeks)||1085
10361772|NCT00506415|11502006|FG001|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
10361773|NCT00506415|11502007|FG002|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
10361774|NCT00506415|11502008|FG003|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
10361775|NCT00506415|11502005|FG000|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||499
10361776|NCT00506415|11502006|FG001|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
10361777|NCT00506415|11502007|FG002|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
10361778|NCT00506415|11502008|FG003|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
10361779|NCT00506415|11502005|FG000|STARTED|Double Blind (Maximum 48 Weeks )||0
10361780|NCT00506415|11502006|FG001|STARTED|Double Blind (Maximum 48 Weeks )|1 patient was randomized in error and did not receive study drug, hence excluded from this arm.|286
10361781|NCT00506415|11502007|FG002|STARTED|Double Blind (Maximum 48 Weeks )||280
10361782|NCT00506415|11502008|FG003|STARTED|Double Blind (Maximum 48 Weeks )||0
10361783|NCT00506415|11502005|FG000|COMPLETED|Double Blind (Maximum 48 Weeks )||0
10361784|NCT00506415|11502006|FG001|COMPLETED|Double Blind (Maximum 48 Weeks )||203
10361785|NCT00506415|11502007|FG002|COMPLETED|Double Blind (Maximum 48 Weeks )||207
10361786|NCT00506415|11502008|FG003|COMPLETED|Double Blind (Maximum 48 Weeks )||0
10361787|NCT00506415|11502005|FG000|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||0
10361788|NCT00506415|11502006|FG001|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||83
10361789|NCT00506415|11502007|FG002|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||73
10361790|NCT00506415|11502008|FG003|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||0
10361791|NCT00506415|11502005|FG000|STARTED|Extended Open Label (Maximum 48 Weeks)||0
10361792|NCT00506415|11502006|FG001|STARTED|Extended Open Label (Maximum 48 Weeks)||0
10361793|NCT00506415|11502007|FG002|STARTED|Extended Open Label (Maximum 48 Weeks)||0
10361794|NCT00506415|11502008|FG003|STARTED|Extended Open Label (Maximum 48 Weeks)|Two participants did not receive study drug, hence excluded from this arm.|457
10361795|NCT00506415|11502005|FG000|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
10361796|NCT00506415|11502006|FG001|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
10361797|NCT00506415|11502007|FG002|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
10361798|NCT00506415|11502008|FG003|COMPLETED|Extended Open Label (Maximum 48 Weeks)||395
10361799|NCT00506415|11502005|FG000|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
10361800|NCT00506415|11502006|FG001|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
10361801|NCT00506415|11502007|FG002|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
10361802|NCT00506415|11502008|FG003|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||62
10361803|NCT00506441|11502021|FG000|STARTED|Period 1; Open-label Period||245
10361804|NCT00506441|11502022|FG001|STARTED|Period 1; Open-label Period||0
10361805|NCT00506441|11502021|FG000|COMPLETED|Period 1; Open-label Period||169
10361806|NCT00506441|11502022|FG001|COMPLETED|Period 1; Open-label Period||0
10361807|NCT00506441|11502021|FG000|NOT COMPLETED|Period 1; Open-label Period||76
10361808|NCT00506441|11502022|FG001|NOT COMPLETED|Period 1; Open-label Period||0
10361809|NCT00506441|11502021|FG000|STARTED|Period 2; Double-blind Period||85
10361810|NCT00506441|11502022|FG001|STARTED|Period 2; Double-blind Period||84
10361811|NCT00506441|11502021|FG000|COMPLETED|Period 2; Double-blind Period||82
10361812|NCT00506441|11502022|FG001|COMPLETED|Period 2; Double-blind Period||79
10361813|NCT00506441|11502021|FG000|NOT COMPLETED|Period 2; Double-blind Period||3
10361814|NCT00506441|11502022|FG001|NOT COMPLETED|Period 2; Double-blind Period||5
10361815|NCT00506454|11502032|FG000|STARTED|Overall Study||11
10361816|NCT00506454|11502033|FG001|STARTED|Overall Study||11
10361817|NCT00506454|11502032|FG000|COMPLETED|Overall Study||10
10361818|NCT00506454|11502033|FG001|COMPLETED|Overall Study||10
10361819|NCT00506454|11502032|FG000|NOT COMPLETED|Overall Study||1
10361820|NCT00506454|11502033|FG001|NOT COMPLETED|Overall Study||1
10361821|NCT00506493|11502039|FG000|STARTED|Overall Study||75
10361822|NCT00506493|11502039|FG000|COMPLETED|Overall Study||64
10361823|NCT00506493|11502039|FG000|NOT COMPLETED|Overall Study||11
10361824|NCT00506519|11502048|FG000|STARTED|Overall Study||10
10361825|NCT00506519|11502049|FG001|STARTED|Overall Study||10
10361826|NCT00506519|11502050|FG002|STARTED|Overall Study||5
10361827|NCT00506519|11502048|FG000|Completed Treatment (Day 5)|Overall Study||8
10361828|NCT00506519|11502049|FG001|Completed Treatment (Day 5)|Overall Study||7
10361829|NCT00506519|11502050|FG002|Completed Treatment (Day 5)|Overall Study||5
10361830|NCT00506519|11502048|FG000|Day 28 Follow up|Overall Study||8
10361831|NCT00506519|11502049|FG001|Day 28 Follow up|Overall Study||6
10361832|NCT00506519|11502050|FG002|Day 28 Follow up|Overall Study||5
10361833|NCT00506519|11502048|FG000|COMPLETED|Overall Study||5
10361834|NCT00506519|11502049|FG001|COMPLETED|Overall Study||4
10361835|NCT00506519|11502050|FG002|COMPLETED|Overall Study||5
10361836|NCT00506519|11502048|FG000|NOT COMPLETED|Overall Study||5
10361837|NCT00506519|11502049|FG001|NOT COMPLETED|Overall Study||6
10361838|NCT00506519|11502050|FG002|NOT COMPLETED|Overall Study||0
10361839|NCT00506597|11502061|FG000|STARTED|Overall Study||33
10361840|NCT00506597|11502061|FG000|COMPLETED|Overall Study||33
10361841|NCT00506597|11502061|FG000|NOT COMPLETED|Overall Study||0
10361842|NCT00506662|11502067|FG000|STARTED|Overall Study||38
10361843|NCT00506662|11502068|FG001|STARTED|Overall Study||48
10361844|NCT00506662|11502067|FG000|COMPLETED|Overall Study||21
10361845|NCT00506662|11502068|FG001|COMPLETED|Overall Study||20
10361846|NCT00506662|11502067|FG000|NOT COMPLETED|Overall Study||17
10361847|NCT00506662|11502068|FG001|NOT COMPLETED|Overall Study||28
10361848|NCT00506675|11502076|FG000|STARTED|Overall Study||27
10361849|NCT00506675|11502077|FG001|STARTED|Overall Study||28
10361850|NCT00506675|11502076|FG000|COMPLETED|Overall Study||27
10361851|NCT00506675|11502077|FG001|COMPLETED|Overall Study||28
10361852|NCT00506675|11502076|FG000|NOT COMPLETED|Overall Study||0
10361853|NCT00506675|11502077|FG001|NOT COMPLETED|Overall Study||0
10361854|NCT00506714|11502085|FG000|STARTED|Overall Study||13
10361855|NCT00506714|11502086|FG001|STARTED|Overall Study||13
10361856|NCT00506714|11502085|FG000|COMPLETED|Overall Study||13
10361857|NCT00506714|11502086|FG001|COMPLETED|Overall Study||13
10361858|NCT00506714|11502085|FG000|NOT COMPLETED|Overall Study||0
10361859|NCT00506714|11502086|FG001|NOT COMPLETED|Overall Study||0
10716326|NCT02688387|11880047|FG004|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10716327|NCT02688387|11880048|FG005|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10716328|NCT02688387|11880049|FG006|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10716329|NCT02688387|11880050|FG007|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10361860|NCT00506753|11502096|FG000|STARTED|Overall Study||100
10361861|NCT00506753|11502097|FG001|STARTED|Overall Study||99
10361862|NCT00506753|11502096|FG000|COMPLETED|Overall Study||79
10361863|NCT00506753|11502097|FG001|COMPLETED|Overall Study||84
10361864|NCT00506753|11502096|FG000|NOT COMPLETED|Overall Study||21
10361865|NCT00506753|11502097|FG001|NOT COMPLETED|Overall Study||15
10361866|NCT00506779|11502105|FG000|STARTED|Overall Study||4
10361867|NCT00506779|11502106|FG001|STARTED|Overall Study||6
10361868|NCT00506779|11502107|FG002|STARTED|Overall Study||2
10361869|NCT00506779|11502108|FG003|STARTED|Overall Study||5
10361870|NCT00506779|11502105|FG000|COMPLETED|Overall Study||3
10361871|NCT00506779|11502106|FG001|COMPLETED|Overall Study||5
10361872|NCT00506779|11502107|FG002|COMPLETED|Overall Study||0
10361873|NCT00506779|11502108|FG003|COMPLETED|Overall Study||4
10361874|NCT00506779|11502105|FG000|NOT COMPLETED|Overall Study||1
10361875|NCT00506779|11502106|FG001|NOT COMPLETED|Overall Study||1
10361876|NCT00506779|11502107|FG002|NOT COMPLETED|Overall Study||2
10361877|NCT00506779|11502108|FG003|NOT COMPLETED|Overall Study||1
10361878|NCT00506831|11502119|FG000|STARTED|Overall Study||9
10361879|NCT00506831|11502119|FG000|COMPLETED|Overall Study||7
10361880|NCT00506831|11502119|FG000|NOT COMPLETED|Overall Study||2
10361881|NCT00506857|11502123|FG000|STARTED|Overall Study||80
10361882|NCT00506857|11502123|FG000|COMPLETED|Overall Study||80
10361883|NCT00506857|11502123|FG000|NOT COMPLETED|Overall Study||0
10361884|NCT00506883|11502131|FG000|STARTED|Overall Study||52
10361885|NCT00506883|11502132|FG001|STARTED|Overall Study||74
10361886|NCT00506883|11502133|FG002|STARTED|Overall Study||59
10361887|NCT00506883|11502131|FG000|COMPLETED|Overall Study||45
10361888|NCT00506883|11502132|FG001|COMPLETED|Overall Study||71
10361889|NCT00506883|11502133|FG002|COMPLETED|Overall Study||55
10361890|NCT00506883|11502131|FG000|NOT COMPLETED|Overall Study||7
10361891|NCT00506883|11502132|FG001|NOT COMPLETED|Overall Study||3
10361892|NCT00506883|11502133|FG002|NOT COMPLETED|Overall Study||4
10361893|NCT00506922|11502146|FG000|STARTED|Overall Study||37
10361894|NCT00506922|11502147|FG001|STARTED|Overall Study||10
10361895|NCT00506922|11502148|FG002|STARTED|Overall Study||29
10361896|NCT00506922|11502149|FG003|STARTED|Overall Study||63
10361897|NCT00506922|11502150|FG004|STARTED|Overall Study||11
10361898|NCT00506922|11502146|FG000|COMPLETED|Overall Study||37
10361899|NCT00506922|11502147|FG001|COMPLETED|Overall Study||10
10361900|NCT00506922|11502148|FG002|COMPLETED|Overall Study||29
10361901|NCT00506922|11502149|FG003|COMPLETED|Overall Study||61
10361902|NCT00506922|11502150|FG004|COMPLETED|Overall Study||10
10361903|NCT00506922|11502146|FG000|NOT COMPLETED|Overall Study||0
10361904|NCT00506922|11502147|FG001|NOT COMPLETED|Overall Study||0
10361905|NCT00506922|11502148|FG002|NOT COMPLETED|Overall Study||0
10361906|NCT00506922|11502149|FG003|NOT COMPLETED|Overall Study||2
10361907|NCT00506922|11502150|FG004|NOT COMPLETED|Overall Study||1
10361908|NCT00506948|11502158|FG000|STARTED|Overall Study||10
10361909|NCT00506948|11502158|FG000|COMPLETED|Overall Study||0
10361910|NCT00506948|11502158|FG000|NOT COMPLETED|Overall Study||10
10361911|NCT00507026|11502165|FG000|STARTED|Overall Study||145
10361912|NCT00507026|11502166|FG001|STARTED|Overall Study||60
10361913|NCT00507026|11502167|FG002|STARTED|Overall Study||72
10361914|NCT00507026|11502165|FG000|COMPLETED|Overall Study||132
10361915|NCT00507026|11502166|FG001|COMPLETED|Overall Study||56
10361916|NCT00507026|11502167|FG002|COMPLETED|Overall Study||51
10361917|NCT00507026|11502165|FG000|NOT COMPLETED|Overall Study||13
10361918|NCT00507026|11502166|FG001|NOT COMPLETED|Overall Study||4
10361919|NCT00507026|11502167|FG002|NOT COMPLETED|Overall Study||21
10361920|NCT00507130|11502179|FG000|STARTED|Overall Study||9
10361921|NCT00507130|11502180|FG001|STARTED|Overall Study||9
10361922|NCT00507130|11502181|FG002|STARTED|Overall Study||9
10361923|NCT00507130|11502182|FG003|STARTED|Overall Study||9
10361924|NCT00507130|11502179|FG000|COMPLETED|Overall Study||8
10361925|NCT00507130|11502180|FG001|COMPLETED|Overall Study||9
10361926|NCT00507130|11502181|FG002|COMPLETED|Overall Study||8
10361927|NCT00507130|11502182|FG003|COMPLETED|Overall Study||8
10361928|NCT00507130|11502179|FG000|NOT COMPLETED|Overall Study||1
10361929|NCT00507130|11502180|FG001|NOT COMPLETED|Overall Study||0
10361930|NCT00507130|11502181|FG002|NOT COMPLETED|Overall Study||1
10361931|NCT00507130|11502182|FG003|NOT COMPLETED|Overall Study||1
10361932|NCT00507208|11502194|FG000|STARTED|Overall Study||27
10361933|NCT00507208|11502195|FG001|STARTED|Overall Study||26
10361934|NCT00507208|11502194|FG000|Received Dynasplint in Crossover|Overall Study||0
10361935|NCT00507208|11502195|FG001|Received Dynasplint in Crossover|Overall Study||3
10361936|NCT00507208|11502194|FG000|COMPLETED|Overall Study||27
10361937|NCT00507208|11502195|FG001|COMPLETED|Overall Study||26
10361938|NCT00507208|11502194|FG000|NOT COMPLETED|Overall Study||0
10361939|NCT00507208|11502195|FG001|NOT COMPLETED|Overall Study||0
10361940|NCT00507416|11502204|FG000|STARTED|Overall Study||168
10361941|NCT00507416|11502205|FG001|STARTED|Overall Study||167
10361942|NCT00507416|11502206|FG002|STARTED|Overall Study||167
10361943|NCT00507416|11502204|FG000|Treated (Safety Population)|Overall Study||165
10361944|NCT00507416|11502205|FG001|Treated (Safety Population)|Overall Study||158
10361945|NCT00507416|11502206|FG002|Treated (Safety Population)|Overall Study||163
10361946|NCT00507416|11502204|FG000|Completed 8 Treatment Cycles|Overall Study||82
10361947|NCT00507416|11502205|FG001|Completed 8 Treatment Cycles|Overall Study||60
10361948|NCT00507416|11502206|FG002|Completed 8 Treatment Cycles|Overall Study||69
10361949|NCT00507416|11502204|FG000|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|50
10361950|NCT00507416|11502205|FG001|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|42
10361951|NCT00507416|11502206|FG002|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|53
10361952|NCT00507416|11502204|FG000|NOT COMPLETED|Overall Study||118
10361953|NCT00507416|11502205|FG001|NOT COMPLETED|Overall Study||125
10361954|NCT00507416|11502206|FG002|NOT COMPLETED|Overall Study||114
10361955|NCT00507429|11502216|FG000|STARTED|Treatment Phase|Randomized|55
10361956|NCT00507429|11502217|FG001|STARTED|Treatment Phase|Randomized|25
10361957|NCT00507429|11502216|FG000|COMPLETED|Treatment Phase||18
10361958|NCT00507429|11502217|FG001|COMPLETED|Treatment Phase||7
10361959|NCT00507429|11502216|FG000|NOT COMPLETED|Treatment Phase||37
10361960|NCT00507429|11502217|FG001|NOT COMPLETED|Treatment Phase||18
10361961|NCT00507429|11502216|FG000|STARTED|Maintenance Phase|2 subjects did not enter maintenance: 1/18 progressive disease; 1/18 lost to follow-up.|16
10361962|NCT00507429|11502217|FG001|STARTED|Maintenance Phase|Control arm subjects followed for survival only; not enrolled in Maintenance period|0
10361963|NCT00507429|11502216|FG000|COMPLETED|Maintenance Phase|14 subjects were withdrawn due to progressive disease, 2 subjects continued beyond data cut-off|2
10361964|NCT00507429|11502217|FG001|COMPLETED|Maintenance Phase||0
10361965|NCT00507429|11502216|FG000|NOT COMPLETED|Maintenance Phase||14
10361966|NCT00507429|11502217|FG001|NOT COMPLETED|Maintenance Phase||0
10361967|NCT00507442|11502229|FG000|STARTED|Overall Study||42
10361968|NCT00507442|11502230|FG001|STARTED|Overall Study||66
10361969|NCT00507442|11502231|FG002|STARTED|Overall Study||33
10361970|NCT00507442|11502232|FG003|STARTED|Overall Study||17
10361971|NCT00507442|11502229|FG000|COMPLETED|Overall Study||26
10361972|NCT00507442|11502230|FG001|COMPLETED|Overall Study||39
10361973|NCT00507442|11502231|FG002|COMPLETED|Overall Study||18
10361974|NCT00507442|11502232|FG003|COMPLETED|Overall Study||12
10361975|NCT00507442|11502229|FG000|NOT COMPLETED|Overall Study||16
10361976|NCT00507442|11502230|FG001|NOT COMPLETED|Overall Study||27
10361977|NCT00507442|11502231|FG002|NOT COMPLETED|Overall Study||15
10361978|NCT00507442|11502232|FG003|NOT COMPLETED|Overall Study||5
10361979|NCT00507455|11502249|FG000|STARTED|Overall Study||74
10361980|NCT00507455|11502250|FG001|STARTED|Overall Study||74
10361981|NCT00507455|11502251|FG002|STARTED|Overall Study||74
10361982|NCT00507455|11502249|FG000|COMPLETED|Overall Study||62
10361983|NCT00507455|11502250|FG001|COMPLETED|Overall Study||68
10361984|NCT00507455|11502251|FG002|COMPLETED|Overall Study||62
10361985|NCT00507455|11502249|FG000|NOT COMPLETED|Overall Study||12
10361986|NCT00507455|11502250|FG001|NOT COMPLETED|Overall Study||6
10361987|NCT00507455|11502251|FG002|NOT COMPLETED|Overall Study||12
10361988|NCT00507507|11502261|FG000|STARTED|Treatment Period||64
10361989|NCT00507507|11502262|FG001|STARTED|Treatment Period||62
10361990|NCT00507507|11502261|FG000|Completed 192 Weeks of Treatment|Treatment Period||52
10361991|NCT00507507|11502262|FG001|Completed 192 Weeks of Treatment|Treatment Period||52
10361992|NCT00507507|11502261|FG000|COMPLETED|Treatment Period||12
10361993|NCT00507507|11502262|FG001|COMPLETED|Treatment Period||9
10361994|NCT00507507|11502261|FG000|NOT COMPLETED|Treatment Period||52
10361995|NCT00507507|11502262|FG001|NOT COMPLETED|Treatment Period||53
10361996|NCT00507507|11502261|FG000|STARTED|24-week Treatment-free Follow-up Period|Participants who discontinued treatment early may have entered the treatment-free follow-up period.|26
10361997|NCT00507507|11502262|FG001|STARTED|24-week Treatment-free Follow-up Period|Participants who discontinued treatment early may have entered the treatment-free follow-up period.|29
10361998|NCT00507507|11502261|FG000|COMPLETED|24-week Treatment-free Follow-up Period||16
10361999|NCT00507507|11502262|FG001|COMPLETED|24-week Treatment-free Follow-up Period||12
10362000|NCT00507507|11502261|FG000|NOT COMPLETED|24-week Treatment-free Follow-up Period||10
10362001|NCT00507507|11502262|FG001|NOT COMPLETED|24-week Treatment-free Follow-up Period||17
10362002|NCT00507546|11502272|FG000|STARTED|Overall Study||4
10362003|NCT00507546|11502273|FG001|STARTED|Overall Study||4
10362004|NCT00507546|11502272|FG000|COMPLETED|Overall Study||2
10362005|NCT00507546|11502273|FG001|COMPLETED|Overall Study||3
10362006|NCT00507546|11502272|FG000|NOT COMPLETED|Overall Study||2
10362007|NCT00507546|11502273|FG001|NOT COMPLETED|Overall Study||1
10362008|NCT00507559|11502281|FG000|STARTED|Overall Study||155
10362009|NCT00507559|11502281|FG000|COMPLETED|Overall Study||84
10362010|NCT00507559|11502281|FG000|NOT COMPLETED|Overall Study||71
10362011|NCT00507689|11502288|FG000|STARTED|Pre-Randomization Period||40
10362012|NCT00507689|11502289|FG001|STARTED|Pre-Randomization Period||0
10716330|NCT02688387|11880051|FG008|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10716331|NCT02688387|11880052|FG009|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10716332|NCT02688387|11880053|FG010|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10716333|NCT02688387|11880054|FG011|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10716334|NCT02688387|11880055|FG012|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10716335|NCT02688387|11880056|FG013|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10716336|NCT02688387|11880057|FG014|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10716337|NCT02688387|11880058|FG015|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10716338|NCT02688387|11880059|FG016|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10716339|NCT02688387|11880060|FG017|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10716340|NCT02688387|11880061|FG018|COMPLETED|Part 3B, Washout Period 3 (10 Days)||7
10716341|NCT02688387|11880062|FG019|COMPLETED|Part 3B, Washout Period 3 (10 Days)||7
10362013|NCT00507689|11502288|FG000|COMPLETED|Pre-Randomization Period||37
10362014|NCT00507689|11502289|FG001|COMPLETED|Pre-Randomization Period||0
10362015|NCT00507689|11502288|FG000|NOT COMPLETED|Pre-Randomization Period||3
10362016|NCT00507689|11502289|FG001|NOT COMPLETED|Pre-Randomization Period||0
10362017|NCT00507689|11502288|FG000|STARTED|Randomized Period|19 of 37 participants who completed the pre-randomization period were randomized to FTC/TDF+HBIg.|19
10362018|NCT00507689|11502289|FG001|STARTED|Randomized Period|18 of 37 participants who completed the pre-randomization period were randomized to FTC/TDF.|18
10362019|NCT00507689|11502288|FG000|COMPLETED|Randomized Period||18
10362020|NCT00507689|11502289|FG001|COMPLETED|Randomized Period||16
10362021|NCT00507689|11502288|FG000|NOT COMPLETED|Randomized Period||1
10362022|NCT00507689|11502289|FG001|NOT COMPLETED|Randomized Period||2
10362023|NCT00507728|11502299|FG000|STARTED|Randomization to Month 3||75
10362024|NCT00507728|11502300|FG001|STARTED|Randomization to Month 3||89
10362025|NCT00507728|11502301|FG002|STARTED|Randomization to Month 3||90
10362026|NCT00507728|11502299|FG000|COMPLETED|Randomization to Month 3||60
10362027|NCT00507728|11502300|FG001|COMPLETED|Randomization to Month 3||75
10362028|NCT00507728|11502301|FG002|COMPLETED|Randomization to Month 3||70
10362029|NCT00507728|11502299|FG000|NOT COMPLETED|Randomization to Month 3||15
10362030|NCT00507728|11502300|FG001|NOT COMPLETED|Randomization to Month 3||14
10362031|NCT00507728|11502301|FG002|NOT COMPLETED|Randomization to Month 3||20
10362032|NCT00507728|11502299|FG000|STARTED|From 3 Months to 6 Months||60
10362033|NCT00507728|11502300|FG001|STARTED|From 3 Months to 6 Months||75
10362034|NCT00507728|11502301|FG002|STARTED|From 3 Months to 6 Months||70
10362035|NCT00507728|11502299|FG000|COMPLETED|From 3 Months to 6 Months||54
10362036|NCT00507728|11502300|FG001|COMPLETED|From 3 Months to 6 Months||65
10362037|NCT00507728|11502301|FG002|COMPLETED|From 3 Months to 6 Months||61
10362038|NCT00507728|11502299|FG000|NOT COMPLETED|From 3 Months to 6 Months||6
10362039|NCT00507728|11502300|FG001|NOT COMPLETED|From 3 Months to 6 Months||10
10362040|NCT00507728|11502301|FG002|NOT COMPLETED|From 3 Months to 6 Months||9
10362041|NCT00507767|11502315|FG000|STARTED|Overall Study||15
10362042|NCT00507767|11502315|FG000|COMPLETED|Overall Study||15
10362043|NCT00507767|11502315|FG000|NOT COMPLETED|Overall Study||0
10362044|NCT00507819|11502319|FG000|STARTED|First Intervention (6 Weeks)||14
10362045|NCT00507819|11502320|FG001|STARTED|First Intervention (6 Weeks)||14
10362046|NCT00507819|11502319|FG000|COMPLETED|First Intervention (6 Weeks)||14
10362047|NCT00507819|11502320|FG001|COMPLETED|First Intervention (6 Weeks)||14
10362048|NCT00507819|11502319|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
10362049|NCT00507819|11502320|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
10362050|NCT00507819|11502319|FG000|STARTED|Washout (6 Weeks)||14
10362051|NCT00507819|11502320|FG001|STARTED|Washout (6 Weeks)||14
10362052|NCT00507819|11502319|FG000|COMPLETED|Washout (6 Weeks)||13
10362053|NCT00507819|11502320|FG001|COMPLETED|Washout (6 Weeks)||14
10362054|NCT00507819|11502319|FG000|NOT COMPLETED|Washout (6 Weeks)||1
10362055|NCT00507819|11502320|FG001|NOT COMPLETED|Washout (6 Weeks)||0
10362056|NCT00507819|11502319|FG000|STARTED|Second Intervention (6 Weeks)||13
10362057|NCT00507819|11502320|FG001|STARTED|Second Intervention (6 Weeks)||14
10362058|NCT00507819|11502319|FG000|COMPLETED|Second Intervention (6 Weeks)||13
10362059|NCT00507819|11502320|FG001|COMPLETED|Second Intervention (6 Weeks)||14
10362060|NCT00507819|11502319|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
10362061|NCT00507819|11502320|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
10362062|NCT00508001|11502329|FG000|STARTED|Overall Study||19
10362063|NCT00508001|11502330|FG001|STARTED|Overall Study||25
10362064|NCT00508001|11502331|FG002|STARTED|Overall Study||23
10362065|NCT00508001|11502329|FG000|Secondary Treatment Phase|Overall Study||0
10362066|NCT00508001|11502330|FG001|Secondary Treatment Phase|Overall Study||13
10535196|NCT01435460|11687523|FG000|NOT COMPLETED|Overall Study||11
10535197|NCT01435460|11687524|FG001|NOT COMPLETED|Overall Study||6
10535198|NCT01435512|11687532|FG000|STARTED|Overall Study||67
10535199|NCT01435512|11687533|FG001|STARTED|Overall Study||68
10716342|NCT02688387|11880063|FG020|COMPLETED|Part 3B, Washout Period 3 (10 Days)||6
10716343|NCT02688387|11880064|FG021|COMPLETED|Part 3B, Washout Period 3 (10 Days)||8
10716344|NCT02688387|11880043|FG000|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10812566|NCT03534362|11974652|FG000|NOT COMPLETED|Overall Study||0
10812567|NCT03534362|11974653|FG001|NOT COMPLETED|Overall Study||0
10362067|NCT00508001|11502331|FG002|Secondary Treatment Phase|Overall Study||16
10362068|NCT00508001|11502329|FG000|COMPLETED|Overall Study||0
10362069|NCT00508001|11502330|FG001|COMPLETED|Overall Study||13
10535200|NCT01435512|11687532|FG000|COMPLETED|Overall Study||67
10812568|NCT03509207|11974661|FG000|STARTED|Overall Study||3
10362070|NCT00508001|11502331|FG002|COMPLETED|Overall Study||16
10362071|NCT00508001|11502329|FG000|NOT COMPLETED|Overall Study||19
10362072|NCT00508001|11502330|FG001|NOT COMPLETED|Overall Study||12
10362073|NCT00508001|11502331|FG002|NOT COMPLETED|Overall Study||7
10362074|NCT00508027|11502339|FG000|STARTED|Dose Level 1|The participants starting each dose period is a new cohort of subjects. 20 subjects started dose 1|20
10362075|NCT00508027|11502339|FG000|COMPLETED|Dose Level 1||12
10362076|NCT00508027|11502339|FG000|NOT COMPLETED|Dose Level 1||8
10362077|NCT00508027|11502339|FG000|STARTED|Dose Level 2|The participants starting each dose period is a new cohort of subjects. 20 new subjects in dose 2|20
10362078|NCT00508027|11502339|FG000|COMPLETED|Dose Level 2||16
10362079|NCT00508027|11502339|FG000|NOT COMPLETED|Dose Level 2||4
10362080|NCT00508027|11502339|FG000|STARTED|Dose Level 3|enrollment discontinued due to FDA recommendations regarding high dose (80mg/day) simvastatin|2
10362081|NCT00508027|11502339|FG000|COMPLETED|Dose Level 3||2
10362082|NCT00508027|11502339|FG000|NOT COMPLETED|Dose Level 3||0
10362083|NCT00508105|11502354|FG000|STARTED|Overall Study||44
10362084|NCT00508105|11502355|FG001|STARTED|Overall Study||43
10362085|NCT00508105|11502354|FG000|COMPLETED|Overall Study||40
10362086|NCT00508105|11502355|FG001|COMPLETED|Overall Study||37
10362087|NCT00508105|11502354|FG000|NOT COMPLETED|Overall Study||4
10362088|NCT00508105|11502355|FG001|NOT COMPLETED|Overall Study||6
10362089|NCT00508118|11502364|FG000|STARTED|Overall Study||3
10362090|NCT00508118|11502365|FG001|STARTED|Overall Study|Documentation is not available for the 7th subject and treatment arm.|4
10362091|NCT00508118|11502364|FG000|COMPLETED|Overall Study||3
10362092|NCT00508118|11502365|FG001|COMPLETED|Overall Study||4
10362093|NCT00508118|11502364|FG000|NOT COMPLETED|Overall Study||0
10362094|NCT00508118|11502365|FG001|NOT COMPLETED|Overall Study||0
10362095|NCT00508144|11502372|FG000|STARTED|Overall Study||64
10362096|NCT00508144|11502372|FG000|COMPLETED|Overall Study||53
10362097|NCT00508144|11502372|FG000|NOT COMPLETED|Overall Study||11
10362098|NCT00508157|11502378|FG000|STARTED|Overall Study||26
10362099|NCT00508157|11502379|FG001|STARTED|Overall Study||26
10812569|NCT03509207|11974661|FG000|COMPLETED|Overall Study||1
10362100|NCT00508157|11502378|FG000|Randomized Sample|Overall Study||26
10362101|NCT00508157|11502379|FG001|Randomized Sample|Overall Study||26
10362102|NCT00508157|11502378|FG000|Safety Sample|Overall Study||26
10362103|NCT00508157|11502379|FG001|Safety Sample|Overall Study|1 participant was withdrawn from study prior to receiving study drug & excluded from safety sample.|25
10362104|NCT00508157|11502378|FG000|COMPLETED|Overall Study||24
10362105|NCT00508157|11502379|FG001|COMPLETED|Overall Study||23
10362106|NCT00508157|11502378|FG000|NOT COMPLETED|Overall Study||2
10362107|NCT00508157|11502379|FG001|NOT COMPLETED|Overall Study||3
10362108|NCT00508183|11502387|FG000|STARTED|Overall Study||48
10362109|NCT00508183|11502388|FG001|STARTED|Overall Study||42
10362110|NCT00508183|11502387|FG000|COMPLETED|Overall Study||39
10362111|NCT00508183|11502388|FG001|COMPLETED|Overall Study||34
10656710|NCT02219685|11817769|FG000|STARTED|Blinded Treatment Phase||26
10656711|NCT02219685|11817770|FG001|STARTED|Blinded Treatment Phase||14
10656712|NCT02219685|11817769|FG000|COMPLETED|Blinded Treatment Phase||24
10362112|NCT00508183|11502387|FG000|NOT COMPLETED|Overall Study||9
10362113|NCT00508183|11502388|FG001|NOT COMPLETED|Overall Study||8
10362114|NCT00508196|11502394|FG000|STARTED|Overall Study||11
10362115|NCT00508196|11502395|FG001|STARTED|Overall Study||11
10362116|NCT00508196|11502394|FG000|COMPLETED|Overall Study||11
10362117|NCT00508196|11502395|FG001|COMPLETED|Overall Study||11
10362118|NCT00508196|11502394|FG000|NOT COMPLETED|Overall Study||0
10362119|NCT00508196|11502395|FG001|NOT COMPLETED|Overall Study||0
10362120|NCT00508261|11502405|FG000|STARTED|Overall Study||222
10362121|NCT00508261|11502406|FG001|STARTED|Overall Study||220
10362122|NCT00508261|11502407|FG002|STARTED|Overall Study||224
10362123|NCT00508261|11502408|FG003|STARTED|Overall Study||127
10362124|NCT00508261|11502405|FG000|COMPLETED|Overall Study||219
10362125|NCT00508261|11502406|FG001|COMPLETED|Overall Study||212
10362126|NCT00508261|11502407|FG002|COMPLETED|Overall Study||218
10362127|NCT00508261|11502408|FG003|COMPLETED|Overall Study||126
10362128|NCT00508261|11502405|FG000|NOT COMPLETED|Overall Study||3
10362129|NCT00508261|11502406|FG001|NOT COMPLETED|Overall Study||8
10362130|NCT00508261|11502407|FG002|NOT COMPLETED|Overall Study||6
10362131|NCT00508261|11502408|FG003|NOT COMPLETED|Overall Study||1
10362132|NCT00508274|11502422|FG000|STARTED|Overall Study||52
10362133|NCT00508274|11502422|FG000|COMPLETED|Overall Study||2
10362134|NCT00508274|11502422|FG000|NOT COMPLETED|Overall Study||50
10362135|NCT00508300|11502428|FG000|STARTED|Overall Study||67
10362136|NCT00508300|11502429|FG001|STARTED|Overall Study||61
10362137|NCT00508300|11502428|FG000|COMPLETED|Overall Study||65
10362138|NCT00508300|11502429|FG001|COMPLETED|Overall Study||57
10362139|NCT00508300|11502428|FG000|NOT COMPLETED|Overall Study||2
10362140|NCT00508300|11502429|FG001|NOT COMPLETED|Overall Study||4
10362141|NCT00508391|11502437|FG000|STARTED|First Treatment||60
10362142|NCT00508391|11502438|FG001|STARTED|First Treatment||62
10362143|NCT00508391|11502437|FG000|COMPLETED|First Treatment||54
10362144|NCT00508391|11502438|FG001|COMPLETED|First Treatment||59
10362145|NCT00508391|11502437|FG000|NOT COMPLETED|First Treatment||6
10362146|NCT00508391|11502438|FG001|NOT COMPLETED|First Treatment||3
10362147|NCT00508391|11502437|FG000|STARTED|Second Treatment||54
10362148|NCT00508391|11502438|FG001|STARTED|Second Treatment||59
10362149|NCT00508391|11502437|FG000|COMPLETED|Second Treatment||52
10362150|NCT00508391|11502438|FG001|COMPLETED|Second Treatment||59
10362151|NCT00508391|11502437|FG000|NOT COMPLETED|Second Treatment||2
10362152|NCT00508391|11502438|FG001|NOT COMPLETED|Second Treatment||0
10362153|NCT00508404|11502446|FG000|STARTED|Overall Study||154
10362154|NCT00508404|11502446|FG000|COMPLETED|Overall Study|Completion of safety follow-up visit conducted 8 weeks after last dose|112
10362155|NCT00508404|11502446|FG000|NOT COMPLETED|Overall Study||42
10362156|NCT00508469|11502453|FG000|STARTED|Overall Study||52
10362157|NCT00508469|11502454|FG001|STARTED|Overall Study||50
10362158|NCT00508469|11502453|FG000|COMPLETED|Overall Study||35
10362159|NCT00508469|11502454|FG001|COMPLETED|Overall Study||40
10362160|NCT00508469|11502453|FG000|NOT COMPLETED|Overall Study||17
10362161|NCT00508469|11502454|FG001|NOT COMPLETED|Overall Study||10
10362162|NCT00508482|11502463|FG000|STARTED|Over 4 Weeks of Treatment||237
10362163|NCT00508482|11502464|FG001|STARTED|Over 4 Weeks of Treatment||119
10362164|NCT00508482|11502465|FG002|STARTED|Over 4 Weeks of Treatment||119
10362165|NCT00508482|11502463|FG000|COMPLETED|Over 4 Weeks of Treatment||216
10362166|NCT00508482|11502464|FG001|COMPLETED|Over 4 Weeks of Treatment||102
10362167|NCT00508482|11502465|FG002|COMPLETED|Over 4 Weeks of Treatment||99
10362168|NCT00508482|11502463|FG000|NOT COMPLETED|Over 4 Weeks of Treatment||21
10362169|NCT00508482|11502464|FG001|NOT COMPLETED|Over 4 Weeks of Treatment||17
10362170|NCT00508482|11502465|FG002|NOT COMPLETED|Over 4 Weeks of Treatment||20
10362171|NCT00508482|11502463|FG000|STARTED|at the 4th Week of Follow-up||216
10362172|NCT00508482|11502464|FG001|STARTED|at the 4th Week of Follow-up||102
10362173|NCT00508482|11502465|FG002|STARTED|at the 4th Week of Follow-up||99
10362174|NCT00508482|11502463|FG000|COMPLETED|at the 4th Week of Follow-up||196
10362175|NCT00508482|11502464|FG001|COMPLETED|at the 4th Week of Follow-up||96
10362176|NCT00508482|11502465|FG002|COMPLETED|at the 4th Week of Follow-up||98
10362177|NCT00508482|11502463|FG000|NOT COMPLETED|at the 4th Week of Follow-up||20
10535201|NCT01435512|11687533|FG001|COMPLETED|Overall Study||68
10535202|NCT01435512|11687532|FG000|NOT COMPLETED|Overall Study||0
10535203|NCT01435512|11687533|FG001|NOT COMPLETED|Overall Study||0
10362178|NCT00508482|11502464|FG001|NOT COMPLETED|at the 4th Week of Follow-up||6
10362179|NCT00508482|11502465|FG002|NOT COMPLETED|at the 4th Week of Follow-up||1
10362180|NCT00508482|11502463|FG000|STARTED|at the 12th Week of Follow-up||196
10362181|NCT00508482|11502464|FG001|STARTED|at the 12th Week of Follow-up||96
10362182|NCT00508482|11502465|FG002|STARTED|at the 12th Week of Follow-up||98
10362183|NCT00508482|11502463|FG000|COMPLETED|at the 12th Week of Follow-up||196
10362184|NCT00508482|11502464|FG001|COMPLETED|at the 12th Week of Follow-up||96
10362185|NCT00508482|11502465|FG002|COMPLETED|at the 12th Week of Follow-up||98
10362186|NCT00508482|11502463|FG000|NOT COMPLETED|at the 12th Week of Follow-up||0
10362187|NCT00508482|11502464|FG001|NOT COMPLETED|at the 12th Week of Follow-up||0
10362188|NCT00508482|11502465|FG002|NOT COMPLETED|at the 12th Week of Follow-up||0
10362189|NCT00508521|11502474|FG000|STARTED|Overall Study||4
10362190|NCT00508521|11502474|FG000|COMPLETED|Overall Study||4
10362191|NCT00508521|11502474|FG000|NOT COMPLETED|Overall Study||0
10362192|NCT00508651|11502480|FG000|STARTED|Overall Study||20
10362193|NCT00508651|11502481|FG001|STARTED|Overall Study||10
10362194|NCT00508651|11502480|FG000|COMPLETED|Overall Study||16
10362195|NCT00508651|11502481|FG001|COMPLETED|Overall Study||8
10362196|NCT00508651|11502480|FG000|NOT COMPLETED|Overall Study||4
10535204|NCT01435577|11687541|FG000|STARTED|Overall Study||64
10362197|NCT00508651|11502481|FG001|NOT COMPLETED|Overall Study||2
10362198|NCT00508716|11502489|FG000|STARTED|Overall Study||61
10362199|NCT00508716|11502490|FG001|STARTED|Overall Study||63
10362200|NCT00508716|11502489|FG000|COMPLETED|Overall Study||61
10362201|NCT00508716|11502490|FG001|COMPLETED|Overall Study||63
10362202|NCT00508716|11502489|FG000|NOT COMPLETED|Overall Study||0
10362203|NCT00508716|11502490|FG001|NOT COMPLETED|Overall Study||0
10362204|NCT00508742|11502498|FG000|STARTED|Period 1: Infant Series||932
10362205|NCT00508742|11502499|FG001|STARTED|Period 1: Infant Series||934
10362206|NCT00508742|11502498|FG000|Vaccinated Dose 1 (at 2 Months of Age)|Period 1: Infant Series||930
10362207|NCT00508742|11502499|FG001|Vaccinated Dose 1 (at 2 Months of Age)|Period 1: Infant Series||933
10362208|NCT00508742|11502498|FG000|Vaccinated Dose 2 (at 4 Months of Age)|Period 1: Infant Series||904
10362209|NCT00508742|11502499|FG001|Vaccinated Dose 2 (at 4 Months of Age)|Period 1: Infant Series||902
10362210|NCT00508742|11502498|FG000|Vaccinated Dose 3 (at 6 Months of Age)|Period 1: Infant Series||898
10362211|NCT00508742|11502499|FG001|Vaccinated Dose 3 (at 6 Months of Age)|Period 1: Infant Series||892
10362212|NCT00508742|11502498|FG000|COMPLETED|Period 1: Infant Series||890
10362213|NCT00508742|11502499|FG001|COMPLETED|Period 1: Infant Series||889
10362214|NCT00508742|11502498|FG000|NOT COMPLETED|Period 1: Infant Series||42
10362215|NCT00508742|11502499|FG001|NOT COMPLETED|Period 1: Infant Series||45
10362216|NCT00508742|11502498|FG000|STARTED|Period 2: After Infant Series||890
10362217|NCT00508742|11502499|FG001|STARTED|Period 2: After Infant Series||889
10362218|NCT00508742|11502498|FG000|COMPLETED|Period 2: After Infant Series||883
10362219|NCT00508742|11502499|FG001|COMPLETED|Period 2: After Infant Series||878
10362220|NCT00508742|11502498|FG000|NOT COMPLETED|Period 2: After Infant Series||7
10362221|NCT00508742|11502499|FG001|NOT COMPLETED|Period 2: After Infant Series||11
10362222|NCT00508742|11502498|FG000|STARTED|Period 3: Toddler Dose||883
10362223|NCT00508742|11502499|FG001|STARTED|Period 3: Toddler Dose||878
10362224|NCT00508742|11502498|FG000|COMPLETED|Period 3: Toddler Dose||858
10362225|NCT00508742|11502499|FG001|COMPLETED|Period 3: Toddler Dose||863
10362226|NCT00508742|11502498|FG000|NOT COMPLETED|Period 3: Toddler Dose||25
10362227|NCT00508742|11502499|FG001|NOT COMPLETED|Period 3: Toddler Dose||15
10362228|NCT00508755|11502511|FG000|STARTED|Overall Study||6
10362229|NCT00508755|11502511|FG000|COMPLETED|Overall Study||5
10362230|NCT00508755|11502511|FG000|NOT COMPLETED|Overall Study||1
10362237|NCT00508924|11502530|FG000|STARTED|Overall Study||36
10362238|NCT00508924|11502531|FG001|STARTED|Overall Study||38
10362239|NCT00508924|11502532|FG002|STARTED|Overall Study||32
10362240|NCT00508924|11502533|FG003|STARTED|Overall Study||34
10362241|NCT00508924|11502530|FG000|COMPLETED|Overall Study||36
10362242|NCT00508924|11502531|FG001|COMPLETED|Overall Study||38
10362243|NCT00508924|11502532|FG002|COMPLETED|Overall Study||31
10362244|NCT00508924|11502533|FG003|COMPLETED|Overall Study||33
10716345|NCT02688387|11880044|FG001|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10362245|NCT00508924|11502530|FG000|NOT COMPLETED|Overall Study||0
10362246|NCT00508924|11502531|FG001|NOT COMPLETED|Overall Study||0
10362247|NCT00508924|11502532|FG002|NOT COMPLETED|Overall Study||1
10362248|NCT00508924|11502533|FG003|NOT COMPLETED|Overall Study||1
10362249|NCT00509002|11502543|FG000|STARTED|Overall Study||37
10535205|NCT01435577|11687542|FG001|STARTED|Overall Study||65
10535206|NCT01435577|11687541|FG000|COMPLETED|Overall Study||47
10535207|NCT01435577|11687542|FG001|COMPLETED|Overall Study||13
10535208|NCT01435577|11687541|FG000|NOT COMPLETED|Overall Study||17
10535209|NCT01435577|11687542|FG001|NOT COMPLETED|Overall Study||52
10535210|NCT01435603|11687554|FG000|STARTED|Overall Study||167
10535211|NCT01435603|11687555|FG001|STARTED|Overall Study||164
10535212|NCT01435603|11687554|FG000|COMPLETED|Overall Study||128
10535213|NCT01435603|11687555|FG001|COMPLETED|Overall Study||129
10716346|NCT02688387|11880045|FG002|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10362250|NCT00509002|11502543|FG000|COMPLETED|Overall Study||37
10362251|NCT00509002|11502543|FG000|NOT COMPLETED|Overall Study||0
10362252|NCT00509028|11502549|FG000|STARTED|Overall Study||121
10535214|NCT01435603|11687554|FG000|NOT COMPLETED|Overall Study||39
10716347|NCT02688387|11880046|FG003|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10362253|NCT00509028|11502550|FG001|STARTED|Overall Study||120
10362254|NCT00509028|11502549|FG000|COMPLETED|Overall Study||109
10362255|NCT00509028|11502550|FG001|COMPLETED|Overall Study||113
10362256|NCT00509028|11502549|FG000|NOT COMPLETED|Overall Study||12
10362257|NCT00509028|11502550|FG001|NOT COMPLETED|Overall Study||7
10362258|NCT00509041|11502556|FG000|STARTED|Overall Study||43
10362259|NCT00509041|11502556|FG000|COMPLETED|Overall Study||43
10362260|NCT00509041|11502556|FG000|NOT COMPLETED|Overall Study||0
10362261|NCT00509067|11502562|FG000|STARTED|Overall Study||19
10362262|NCT00509067|11502563|FG001|STARTED|Overall Study||24
10362263|NCT00509067|11502562|FG000|COMPLETED|Overall Study||15
10362264|NCT00509067|11502563|FG001|COMPLETED|Overall Study||19
10362265|NCT00509067|11502562|FG000|NOT COMPLETED|Overall Study||4
10362266|NCT00509067|11502563|FG001|NOT COMPLETED|Overall Study||5
10362267|NCT00509093|11502573|FG000|STARTED|Overall Study||32
10362268|NCT00509093|11502573|FG000|COMPLETED|Overall Study||8
10362269|NCT00509093|11502573|FG000|NOT COMPLETED|Overall Study||24
10362270|NCT00509106|11502579|FG000|STARTED|Overall Study||315
10716348|NCT02688387|11880047|FG004|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10716349|NCT02688387|11880048|FG005|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10716350|NCT02688387|11880049|FG006|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10716351|NCT02688387|11880050|FG007|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10716352|NCT02688387|11880051|FG008|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10362271|NCT00509106|11502580|FG001|STARTED|Overall Study||307
10362272|NCT00509106|11502579|FG000|COMPLETED|Overall Study||284
10362273|NCT00509106|11502580|FG001|COMPLETED|Overall Study||278
10362274|NCT00509106|11502579|FG000|NOT COMPLETED|Overall Study||31
10362275|NCT00509106|11502580|FG001|NOT COMPLETED|Overall Study||29
10362276|NCT00509145|11502588|FG000|STARTED|Overall Study||550
10362277|NCT00509145|11502589|FG001|STARTED|Overall Study||556
10362278|NCT00509145|11502588|FG000|COMPLETED|Overall Study||437
10362279|NCT00509145|11502589|FG001|COMPLETED|Overall Study||427
10362280|NCT00509145|11502588|FG000|NOT COMPLETED|Overall Study||113
10362281|NCT00509145|11502589|FG001|NOT COMPLETED|Overall Study||129
10362282|NCT00509171|11502597|FG000|STARTED|Overall Study||11
10362283|NCT00509171|11502598|FG001|STARTED|Overall Study||11
10362284|NCT00509171|11502597|FG000|COMPLETED|Overall Study||11
10362285|NCT00509171|11502598|FG001|COMPLETED|Overall Study||11
10362286|NCT00509171|11502597|FG000|NOT COMPLETED|Overall Study||0
10362287|NCT00509171|11502598|FG001|NOT COMPLETED|Overall Study||0
10362288|NCT00509197|11502606|FG000|STARTED|Overall Study||6
10362289|NCT00509197|11502607|FG001|STARTED|Overall Study||6
10535215|NCT01435603|11687555|FG001|NOT COMPLETED|Overall Study||35
10535216|NCT01435616|11687563|FG000|STARTED|Overall Study||1003
10535217|NCT01435616|11687564|FG001|STARTED|Overall Study||535
10535218|NCT01435616|11687563|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1003
10535219|NCT01435616|11687564|FG001|Received at Least 1 Dose of Study Drug|Overall Study||535
10535220|NCT01435616|11687563|FG000|COMPLETED|Overall Study||832
10535221|NCT01435616|11687564|FG001|COMPLETED|Overall Study||455
10535222|NCT01435616|11687563|FG000|NOT COMPLETED|Overall Study||171
10535223|NCT01435616|11687564|FG001|NOT COMPLETED|Overall Study||80
10535224|NCT01435655|11687572|FG000|STARTED|Overall Study||10
10535225|NCT01435655|11687572|FG000|COMPLETED|Overall Study||7
10535226|NCT01435655|11687572|FG000|NOT COMPLETED|Overall Study||3
10535227|NCT01435759|11687581|FG000|STARTED|Antidepressant Lead-in Phase|Of these 1197 subjects, 19 subjects were not dosed.|1197
10535228|NCT01435759|11687582|FG001|STARTED|Antidepressant Lead-in Phase||0
10535229|NCT01435759|11687583|FG002|STARTED|Antidepressant Lead-in Phase||0
10535230|NCT01435759|11687584|FG003|STARTED|Antidepressant Lead-in Phase||0
10535231|NCT01435759|11687585|FG004|STARTED|Antidepressant Lead-in Phase||0
10535232|NCT01435759|11687586|FG005|STARTED|Antidepressant Lead-in Phase||0
10535233|NCT01435759|11687581|FG000|COMPLETED|Antidepressant Lead-in Phase||855
10535234|NCT01435759|11687582|FG001|COMPLETED|Antidepressant Lead-in Phase||0
10535235|NCT01435759|11687583|FG002|COMPLETED|Antidepressant Lead-in Phase||0
10535236|NCT01435759|11687584|FG003|COMPLETED|Antidepressant Lead-in Phase||0
10535237|NCT01435759|11687585|FG004|COMPLETED|Antidepressant Lead-in Phase||0
10535238|NCT01435759|11687586|FG005|COMPLETED|Antidepressant Lead-in Phase||0
10535239|NCT01435759|11687581|FG000|NOT COMPLETED|Antidepressant Lead-in Phase||342
10362290|NCT00509197|11502606|FG000|COMPLETED|Overall Study||6
10362291|NCT00509197|11502607|FG001|COMPLETED|Overall Study||6
10362292|NCT00509197|11502606|FG000|NOT COMPLETED|Overall Study||0
10362293|NCT00509197|11502607|FG001|NOT COMPLETED|Overall Study||0
10535240|NCT01435759|11687582|FG001|NOT COMPLETED|Antidepressant Lead-in Phase||0
10535241|NCT01435759|11687583|FG002|NOT COMPLETED|Antidepressant Lead-in Phase||0
10535242|NCT01435759|11687584|FG003|NOT COMPLETED|Antidepressant Lead-in Phase||0
10535243|NCT01435759|11687585|FG004|NOT COMPLETED|Antidepressant Lead-in Phase||0
10362294|NCT00509223|11502617|FG000|STARTED|Overall Study||207
10362295|NCT00509223|11502618|FG001|STARTED|Overall Study||209
10362296|NCT00509223|11502617|FG000|COMPLETED|Overall Study||119
10362297|NCT00509223|11502618|FG001|COMPLETED|Overall Study||137
10362298|NCT00509223|11502617|FG000|NOT COMPLETED|Overall Study||88
10362299|NCT00509223|11502618|FG001|NOT COMPLETED|Overall Study||72
10362300|NCT00509236|11502626|FG000|STARTED|Overall Study||64
10362301|NCT00509236|11502627|FG001|STARTED|Overall Study||65
10362302|NCT00509236|11502626|FG000|COMPLETED|Overall Study||47
10362303|NCT00509236|11502627|FG001|COMPLETED|Overall Study||45
10362304|NCT00509236|11502626|FG000|NOT COMPLETED|Overall Study||17
10362305|NCT00509236|11502627|FG001|NOT COMPLETED|Overall Study||20
10362306|NCT00509249|11502633|FG000|STARTED|Overall Study||18
10362307|NCT00509249|11502633|FG000|COMPLETED|Overall Study||18
10362308|NCT00509249|11502633|FG000|NOT COMPLETED|Overall Study||0
10362309|NCT00509262|11502639|FG000|STARTED|Overall Study||211
10362310|NCT00509262|11502640|FG001|STARTED|Overall Study||212
10362311|NCT00509262|11502639|FG000|COMPLETED|Overall Study||164
10362312|NCT00509262|11502640|FG001|COMPLETED|Overall Study||170
10362313|NCT00509262|11502639|FG000|NOT COMPLETED|Overall Study||47
10362314|NCT00509262|11502640|FG001|NOT COMPLETED|Overall Study||42
10362315|NCT00509288|11502648|FG000|STARTED|Overall Study||21
10362316|NCT00509288|11502649|FG001|STARTED|Overall Study||3
10362317|NCT00509288|11502648|FG000|COMPLETED|Overall Study||21
10362318|NCT00509288|11502649|FG001|COMPLETED|Overall Study||3
10362319|NCT00509288|11502648|FG000|NOT COMPLETED|Overall Study||0
10362320|NCT00509288|11502649|FG001|NOT COMPLETED|Overall Study||0
10362321|NCT00509366|11502660|FG000|STARTED|Overall Study|Registered patients who were assigned cisplatin/gemcitabine treatment.|18
10362322|NCT00509366|11502661|FG001|STARTED|Overall Study|Registered patients who were assigned cisplatin/pemetrexed treatment.|8
10362323|NCT00509366|11502662|FG002|STARTED|Overall Study|Registered patients who were assigned pemetrexed/gemcitabine treatment.|22
10362324|NCT00509366|11502663|FG003|STARTED|Overall Study|Registered patients who were assigned docetaxel/gemcitabine treatment.|2
10362325|NCT00509366|11502664|FG004|STARTED|Overall Study|Registered patients who were neither assigned nor treated with protocol-based therapy.|51
10362326|NCT00509366|11502660|FG000|Assigned Treatment|Overall Study|Patients who were assigned to cisplatin/gemcitabine treatment arm.|18
10362327|NCT00509366|11502661|FG001|Assigned Treatment|Overall Study|Patients who were assigned to cisplatin/pemetrexed treatment arm.|8
10362328|NCT00509366|11502662|FG002|Assigned Treatment|Overall Study|Patients who were assigned to pemetrexed/gemcitabine treatment arm.|22
10362329|NCT00509366|11502663|FG003|Assigned Treatment|Overall Study|Patients who were assigned to docetaxel/gemcitabine treatment arm.|2
10362330|NCT00509366|11502664|FG004|Assigned Treatment|Overall Study||0
10362399|NCT00509821|11502725|FG000|COMPLETED|Study Period 2 (Radiation)||3
10362331|NCT00509366|11502660|FG000|COMPLETED|Overall Study|Patients assigned to treatment and treated with cisplatin/gemcitabine treatment combination.|17
10362332|NCT00509366|11502661|FG001|COMPLETED|Overall Study|Patients assigned to treatment and treated with cisplatin/pemetrexed treatment combination.|7
10362333|NCT00509366|11502662|FG002|COMPLETED|Overall Study|Patients assigned to treatment and treated with pemetrexed/gemcitabine treatment combination.|21
10362334|NCT00509366|11502663|FG003|COMPLETED|Overall Study|Patients assigned to treatment and treated with docetaxel/gemcitabine treatment combination.|2
10362335|NCT00509366|11502664|FG004|COMPLETED|Overall Study|Patients who were neither assigned nor treated with protocol-based therapy.|51
10362336|NCT00509366|11502660|FG000|NOT COMPLETED|Overall Study||1
10362337|NCT00509366|11502661|FG001|NOT COMPLETED|Overall Study||1
10362338|NCT00509366|11502662|FG002|NOT COMPLETED|Overall Study||1
10362339|NCT00509366|11502663|FG003|NOT COMPLETED|Overall Study||0
10362340|NCT00509366|11502664|FG004|NOT COMPLETED|Overall Study||0
10362341|NCT00509392|11502676|FG000|STARTED|Overall Study||32
10362342|NCT00509392|11502677|FG001|STARTED|Overall Study||33
10362343|NCT00509392|11502678|FG002|STARTED|Overall Study||4
10362344|NCT00509392|11502676|FG000|COMPLETED|Overall Study||32
10362345|NCT00509392|11502677|FG001|COMPLETED|Overall Study||33
10716353|NCT02688387|11880052|FG009|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10716354|NCT02688387|11880053|FG010|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10716355|NCT02688387|11880054|FG011|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10716356|NCT02688387|11880055|FG012|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10716357|NCT02688387|11880056|FG013|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10716358|NCT02688387|11880057|FG014|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10362346|NCT00509392|11502678|FG002|COMPLETED|Overall Study||4
10362347|NCT00509392|11502676|FG000|NOT COMPLETED|Overall Study||0
10362348|NCT00509392|11502677|FG001|NOT COMPLETED|Overall Study||0
10362349|NCT00509392|11502678|FG002|NOT COMPLETED|Overall Study||0
10362350|NCT00509496|11502686|FG000|STARTED|Overall Study||19
10362351|NCT00509496|11502687|FG001|STARTED|Overall Study||2
10362352|NCT00509496|11502686|FG000|COMPLETED|Overall Study||19
10362353|NCT00509496|11502687|FG001|COMPLETED|Overall Study||2
10362354|NCT00509496|11502686|FG000|NOT COMPLETED|Overall Study||0
10362355|NCT00509496|11502687|FG001|NOT COMPLETED|Overall Study||0
10716359|NCT02688387|11880058|FG015|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10716360|NCT02688387|11880059|FG016|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10716361|NCT02688387|11880060|FG017|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10716362|NCT02688387|11880061|FG018|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||1
10716363|NCT02688387|11880062|FG019|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||1
10716364|NCT02688387|11880063|FG020|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||1
10362356|NCT00509587|11502693|FG000|STARTED|Overall Study||21
10362357|NCT00509587|11502693|FG000|COMPLETED|Overall Study||21
10362358|NCT00509587|11502693|FG000|NOT COMPLETED|Overall Study||0
10362359|NCT00509665|11502697|FG000|STARTED|Overall Study||18
10362360|NCT00509665|11502697|FG000|COMPLETED|Overall Study||18
10362361|NCT00509665|11502697|FG000|NOT COMPLETED|Overall Study||0
10362362|NCT00509769|11502701|FG000|STARTED|Overall Study||112
10362363|NCT00509769|11502701|FG000|COMPLETED|Overall Study||21
10362364|NCT00509769|11502701|FG000|NOT COMPLETED|Overall Study||91
10362365|NCT00509795|11502709|FG000|STARTED|Overall Study||306
10362366|NCT00509795|11502710|FG001|STARTED|Overall Study||304
10362367|NCT00509795|11502711|FG002|STARTED|Overall Study||304
10362368|NCT00509795|11502712|FG003|STARTED|Overall Study||303
10362369|NCT00509795|11502709|FG000|Patients Received Treatment (SAF)|Overall Study||304
10362370|NCT00509795|11502710|FG001|Patients Received Treatment (SAF)|Overall Study||304
10362371|NCT00509795|11502711|FG002|Patients Received Treatment (SAF)|Overall Study||304
10362372|NCT00509795|11502712|FG003|Patients Received Treatment (SAF)|Overall Study||303
10362373|NCT00509795|11502709|FG000|Full Analysis Set (FAS) Population|Overall Study||304
10362374|NCT00509795|11502710|FG001|Full Analysis Set (FAS) Population|Overall Study||304
10362375|NCT00509795|11502711|FG002|Full Analysis Set (FAS) Population|Overall Study||301
10362376|NCT00509795|11502712|FG003|Full Analysis Set (FAS) Population|Overall Study||301
10362377|NCT00509795|11502709|FG000|Per Protocol Set (PPS) Population|Overall Study||269
10362378|NCT00509795|11502710|FG001|Per Protocol Set (PPS) Population|Overall Study||285
10362379|NCT00509795|11502711|FG002|Per Protocol Set (PPS) Population|Overall Study||270
10362380|NCT00509795|11502712|FG003|Per Protocol Set (PPS) Population|Overall Study||265
10362381|NCT00509795|11502709|FG000|COMPLETED|Overall Study||284
10362382|NCT00509795|11502710|FG001|COMPLETED|Overall Study||293
10362383|NCT00509795|11502711|FG002|COMPLETED|Overall Study||277
10362384|NCT00509795|11502712|FG003|COMPLETED|Overall Study||276
10362385|NCT00509795|11502709|FG000|NOT COMPLETED|Overall Study||22
10362386|NCT00509795|11502710|FG001|NOT COMPLETED|Overall Study||11
10362387|NCT00509795|11502711|FG002|NOT COMPLETED|Overall Study||27
10362388|NCT00509795|11502712|FG003|NOT COMPLETED|Overall Study||27
10362389|NCT00509821|11502725|FG000|STARTED|Study Period 1 (Induction)||3
10362390|NCT00509821|11502726|FG001|STARTED|Study Period 1 (Induction)||57
10362391|NCT00509821|11502725|FG000|Received at Least 1 Dose of Study Drug|Study Period 1 (Induction)||3
10362392|NCT00509821|11502726|FG001|Received at Least 1 Dose of Study Drug|Study Period 1 (Induction)||57
10362393|NCT00509821|11502725|FG000|COMPLETED|Study Period 1 (Induction)||3
10362394|NCT00509821|11502726|FG001|COMPLETED|Study Period 1 (Induction)||53
10362395|NCT00509821|11502725|FG000|NOT COMPLETED|Study Period 1 (Induction)||0
10362396|NCT00509821|11502726|FG001|NOT COMPLETED|Study Period 1 (Induction)||4
10362397|NCT00509821|11502725|FG000|STARTED|Study Period 2 (Radiation)|Participants moved to Radiation Phase.|3
10362398|NCT00509821|11502726|FG001|STARTED|Study Period 2 (Radiation)|Participants moved to Radiation Phase.|53
10362400|NCT00509821|11502726|FG001|COMPLETED|Study Period 2 (Radiation)||0
10535244|NCT01435759|11687586|FG005|NOT COMPLETED|Antidepressant Lead-in Phase||0
10535245|NCT01435759|11687581|FG000|STARTED|Double-blind Phase|These subjects were not included in the Safety Dose Response Evaluable Set or Safety Analysis Set.|463
10535246|NCT01435759|11687582|FG001|STARTED|Double-blind Phase||78
10535247|NCT01435759|11687583|FG002|STARTED|Double-blind Phase|One subject was not dosed.|78
10535248|NCT01435759|11687584|FG003|STARTED|Double-blind Phase|Two subjects were not dosed.|78
10535249|NCT01435759|11687585|FG004|STARTED|Double-blind Phase||78
10535250|NCT01435759|11687586|FG005|STARTED|Double-blind Phase||80
10535251|NCT01435759|11687581|FG000|COMPLETED|Double-blind Phase||397
10535252|NCT01435759|11687582|FG001|COMPLETED|Double-blind Phase||71
10535253|NCT01435759|11687583|FG002|COMPLETED|Double-blind Phase||71
10535254|NCT01435759|11687584|FG003|COMPLETED|Double-blind Phase||69
10535255|NCT01435759|11687585|FG004|COMPLETED|Double-blind Phase||69
10535256|NCT01435759|11687586|FG005|COMPLETED|Double-blind Phase||71
10535257|NCT01435759|11687581|FG000|NOT COMPLETED|Double-blind Phase||66
10535258|NCT01435759|11687582|FG001|NOT COMPLETED|Double-blind Phase||7
10535259|NCT01435759|11687583|FG002|NOT COMPLETED|Double-blind Phase||7
10535260|NCT01435759|11687584|FG003|NOT COMPLETED|Double-blind Phase||9
10535261|NCT01435759|11687585|FG004|NOT COMPLETED|Double-blind Phase||9
10535262|NCT01435759|11687586|FG005|NOT COMPLETED|Double-blind Phase||9
10535263|NCT01435772|11687601|FG000|STARTED|Overall Study||3
10535264|NCT01435772|11687602|FG001|STARTED|Overall Study||3
10535265|NCT01435772|11687603|FG002|STARTED|Overall Study||15
10535266|NCT01435772|11687601|FG000|COMPLETED|Overall Study||0
10535267|NCT01435772|11687602|FG001|COMPLETED|Overall Study||0
10535268|NCT01435772|11687603|FG002|COMPLETED|Overall Study||0
10535269|NCT01435772|11687601|FG000|NOT COMPLETED|Overall Study||3
10535270|NCT01435772|11687602|FG001|NOT COMPLETED|Overall Study||3
10535271|NCT01435772|11687603|FG002|NOT COMPLETED|Overall Study||15
10535272|NCT01435798|11687612|FG000|STARTED|Overall Study|Crossover design|26
10535273|NCT01435798|11687612|FG000|0% MTD|Overall Study||25
10535274|NCT01435798|11687612|FG000|25% MTD|Overall Study||26
10535275|NCT01435798|11687612|FG000|50% MTD|Overall Study||25
10535276|NCT01435798|11687612|FG000|100% MTD|Overall Study||25
10535277|NCT01435798|11687612|FG000|COMPLETED|Overall Study|Crossover design|25
10535278|NCT01435798|11687612|FG000|NOT COMPLETED|Overall Study||1
10535279|NCT01435824|11687622|FG000|STARTED|First Intervention||8
10535280|NCT01435824|11687623|FG001|STARTED|First Intervention||8
10362401|NCT00509821|11502725|FG000|NOT COMPLETED|Study Period 2 (Radiation)||0
10535281|NCT01435824|11687622|FG000|COMPLETED|First Intervention||8
10656713|NCT02219685|11817770|FG001|COMPLETED|Blinded Treatment Phase||14
10362402|NCT00509821|11502726|FG001|NOT COMPLETED|Study Period 2 (Radiation)||53
10362403|NCT00509821|11502725|FG000|STARTED|Study Period 3 (Maintenance)||3
10362404|NCT00509821|11502726|FG001|STARTED|Study Period 3 (Maintenance)|4 participants completed Radiation Phase but did not enter Maintenance Phase.|49
10362405|NCT00509821|11502725|FG000|COMPLETED|Study Period 3 (Maintenance)||3
10362406|NCT00509821|11502726|FG001|COMPLETED|Study Period 3 (Maintenance)||0
10362407|NCT00509821|11502725|FG000|NOT COMPLETED|Study Period 3 (Maintenance)||0
10362408|NCT00509821|11502726|FG001|NOT COMPLETED|Study Period 3 (Maintenance)||49
10362409|NCT00509821|11502725|FG000|STARTED|Study Period 4 (Follow Up)|1 Participant completed Maintenance Phase but did not enter Follow-Up.|2
10427158|NCT00851643|11572931|FG000|COMPLETED|Extension Study (Up to 36 Months)||6
10535282|NCT01435824|11687623|FG001|COMPLETED|First Intervention||8
10535283|NCT01435824|11687622|FG000|NOT COMPLETED|First Intervention||0
10535284|NCT01435824|11687623|FG001|NOT COMPLETED|First Intervention||0
10535285|NCT01435824|11687622|FG000|STARTED|Washout of 1-2 Weeks||8
10535286|NCT01435824|11687623|FG001|STARTED|Washout of 1-2 Weeks||8
10535287|NCT01435824|11687622|FG000|COMPLETED|Washout of 1-2 Weeks||8
10535288|NCT01435824|11687623|FG001|COMPLETED|Washout of 1-2 Weeks||8
10535289|NCT01435824|11687622|FG000|NOT COMPLETED|Washout of 1-2 Weeks||0
10535290|NCT01435824|11687623|FG001|NOT COMPLETED|Washout of 1-2 Weeks||0
10535291|NCT01435824|11687622|FG000|STARTED|Second Intervention||8
10535292|NCT01435824|11687623|FG001|STARTED|Second Intervention||8
10535293|NCT01435824|11687622|FG000|COMPLETED|Second Intervention||8
10535294|NCT01435824|11687623|FG001|COMPLETED|Second Intervention||8
10535295|NCT01435824|11687622|FG000|NOT COMPLETED|Second Intervention||0
10535296|NCT01435824|11687623|FG001|NOT COMPLETED|Second Intervention||0
10535297|NCT01435928|11687631|FG000|STARTED|Open Label Phase - up to 24 Weeks||676
10535298|NCT01435928|11687632|FG001|STARTED|Open Label Phase - up to 24 Weeks||0
10535299|NCT01435928|11687633|FG002|STARTED|Open Label Phase - up to 24 Weeks||0
10535300|NCT01435928|11687631|FG000|COMPLETED|Open Label Phase - up to 24 Weeks||287
10535301|NCT01435928|11687632|FG001|COMPLETED|Open Label Phase - up to 24 Weeks||0
10535302|NCT01435928|11687633|FG002|COMPLETED|Open Label Phase - up to 24 Weeks||0
10535303|NCT01435928|11687631|FG000|NOT COMPLETED|Open Label Phase - up to 24 Weeks||389
10535304|NCT01435928|11687632|FG001|NOT COMPLETED|Open Label Phase - up to 24 Weeks||0
10535305|NCT01435928|11687633|FG002|NOT COMPLETED|Open Label Phase - up to 24 Weeks||0
10535306|NCT01435928|11687631|FG000|STARTED|Double Blind Phase - 28 Weeks||0
10535307|NCT01435928|11687632|FG001|STARTED|Double Blind Phase - 28 Weeks||144
10535308|NCT01435928|11687633|FG002|STARTED|Double Blind Phase - 28 Weeks||141
10535309|NCT01435928|11687631|FG000|COMPLETED|Double Blind Phase - 28 Weeks||0
10535310|NCT01435928|11687632|FG001|COMPLETED|Double Blind Phase - 28 Weeks||28
10535311|NCT01435928|11687633|FG002|COMPLETED|Double Blind Phase - 28 Weeks||20
10535312|NCT01435928|11687631|FG000|NOT COMPLETED|Double Blind Phase - 28 Weeks||0
10535313|NCT01435928|11687632|FG001|NOT COMPLETED|Double Blind Phase - 28 Weeks||116
10535314|NCT01435928|11687633|FG002|NOT COMPLETED|Double Blind Phase - 28 Weeks||121
10535315|NCT01436006|11687640|FG000|STARTED|Overall Study||6700
10535316|NCT01436006|11687640|FG000|COMPLETED|Overall Study||6663
10535317|NCT01436006|11687640|FG000|NOT COMPLETED|Overall Study||37
10535318|NCT01436045|11687652|FG000|STARTED|Overall Study||6
10535319|NCT01436045|11687653|FG001|STARTED|Overall Study||6
10535320|NCT01436045|11687652|FG000|COMPLETED|Overall Study||6
10535321|NCT01436045|11687653|FG001|COMPLETED|Overall Study||6
10535322|NCT01436045|11687652|FG000|NOT COMPLETED|Overall Study||0
10535323|NCT01436045|11687653|FG001|NOT COMPLETED|Overall Study||0
10535324|NCT01436071|11687661|FG000|STARTED|Overall Study|These participants were randomized to trial medication.|124
10535325|NCT01436071|11687662|FG001|STARTED|Overall Study|These participants were randomized to trial medication.|124
10535326|NCT01436071|11687661|FG000|Safety Population|Overall Study|These randomized participants received at least a single dose of trial medication.|121
10535327|NCT01436071|11687662|FG001|Safety Population|Overall Study|These randomized participants received at least a single dose of trial medication.|121
10535328|NCT01436071|11687661|FG000|COMPLETED|Overall Study||98
10535329|NCT01436071|11687662|FG001|COMPLETED|Overall Study||110
10656714|NCT02219685|11817769|FG000|NOT COMPLETED|Blinded Treatment Phase||2
10656715|NCT02219685|11817770|FG001|NOT COMPLETED|Blinded Treatment Phase||0
10656716|NCT02219685|11817769|FG000|STARTED|Open-Label (After Posttreatment Week 4)|Only participants from the Placebo arm were eligible to enroll in the Open-Label Phase.|0
10656717|NCT02219685|11817770|FG001|STARTED|Open-Label (After Posttreatment Week 4)||14
10656718|NCT02219685|11817769|FG000|COMPLETED|Open-Label (After Posttreatment Week 4)||0
10656719|NCT02219685|11817770|FG001|COMPLETED|Open-Label (After Posttreatment Week 4)||14
10656720|NCT02219685|11817769|FG000|NOT COMPLETED|Open-Label (After Posttreatment Week 4)||0
10656721|NCT02219685|11817770|FG001|NOT COMPLETED|Open-Label (After Posttreatment Week 4)||0
10656722|NCT02219815|11817780|FG000|STARTED|Overall Study||44
10656723|NCT02219815|11817781|FG001|STARTED|Overall Study||45
10656724|NCT02219815|11817780|FG000|Post Hospital Discharge Analysis|Overall Study||42
10656725|NCT02219815|11817781|FG001|Post Hospital Discharge Analysis|Overall Study||39
10656726|NCT02219815|11817780|FG000|3 Month Post Surgery|Overall Study||34
10656727|NCT02219815|11817781|FG001|3 Month Post Surgery|Overall Study||31
10656728|NCT02219815|11817780|FG000|COMPLETED|Overall Study||22
10656729|NCT02219815|11817781|FG001|COMPLETED|Overall Study||21
10656730|NCT02219815|11817780|FG000|NOT COMPLETED|Overall Study||22
10656731|NCT02219815|11817781|FG001|NOT COMPLETED|Overall Study||24
10656732|NCT02219932|11817789|FG000|STARTED|Overall Study||319
10656733|NCT02219932|11817790|FG001|STARTED|Overall Study||317
10656734|NCT02219932|11817789|FG000|Randomized, Not Treated|Overall Study||0
10362410|NCT00509821|11502726|FG001|STARTED|Study Period 4 (Follow Up)|1 Participant completed Radiation Phase, did not enter Maintenance Phase but entered Follow Up.|50
10362411|NCT00509821|11502725|FG000|COMPLETED|Study Period 4 (Follow Up)||2
10362412|NCT00509821|11502726|FG001|COMPLETED|Study Period 4 (Follow Up)||50
10362413|NCT00509821|11502725|FG000|NOT COMPLETED|Study Period 4 (Follow Up)||0
10362414|NCT00509821|11502726|FG001|NOT COMPLETED|Study Period 4 (Follow Up)||0
10362415|NCT00509873|11502739|FG000|STARTED|Overall Study||287
10362416|NCT00509873|11502740|FG001|STARTED|Overall Study||291
10362417|NCT00509873|11502739|FG000|COMPLETED|Overall Study||276
10362418|NCT00509873|11502740|FG001|COMPLETED|Overall Study||276
10362419|NCT00509873|11502739|FG000|NOT COMPLETED|Overall Study||11
10362420|NCT00509873|11502740|FG001|NOT COMPLETED|Overall Study||15
10362421|NCT00509899|11502754|FG000|STARTED|Overall Study||30
10362422|NCT00509899|11502755|FG001|STARTED|Overall Study||35
10362423|NCT00509899|11502756|FG002|STARTED|Overall Study||47
10362424|NCT00509899|11502757|FG003|STARTED|Overall Study||5
10362425|NCT00509899|11502758|FG004|STARTED|Overall Study||6
10362426|NCT00509899|11502759|FG005|STARTED|Overall Study||22
10362427|NCT00509899|11502760|FG006|STARTED|Overall Study||6
10362428|NCT00509899|11502761|FG007|STARTED|Overall Study||3
10362429|NCT00509899|11502754|FG000|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|14
10362430|NCT00509899|11502755|FG001|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|26
10362431|NCT00509899|11502756|FG002|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|27
10362432|NCT00509899|11502757|FG003|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|1
10362433|NCT00509899|11502758|FG004|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|1
10362434|NCT00509899|11502759|FG005|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|12
10362435|NCT00509899|11502760|FG006|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|5
10362436|NCT00509899|11502761|FG007|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|2
10362437|NCT00509899|11502754|FG000|NOT COMPLETED|Overall Study||16
10362438|NCT00509899|11502755|FG001|NOT COMPLETED|Overall Study||9
10362439|NCT00509899|11502756|FG002|NOT COMPLETED|Overall Study||20
10362440|NCT00509899|11502757|FG003|NOT COMPLETED|Overall Study||4
10362441|NCT00509899|11502758|FG004|NOT COMPLETED|Overall Study||5
10362442|NCT00509899|11502759|FG005|NOT COMPLETED|Overall Study||10
10362443|NCT00509899|11502760|FG006|NOT COMPLETED|Overall Study||1
10362444|NCT00509899|11502761|FG007|NOT COMPLETED|Overall Study||1
10362445|NCT00509925|11502775|FG000|STARTED|Overall Study||12
10362446|NCT00509925|11502776|FG001|STARTED|Overall Study||11
10362447|NCT00509925|11502775|FG000|COMPLETED|Overall Study||12
10362448|NCT00509925|11502776|FG001|COMPLETED|Overall Study||10
10362449|NCT00509925|11502775|FG000|NOT COMPLETED|Overall Study||0
10362450|NCT00509925|11502776|FG001|NOT COMPLETED|Overall Study||1
10362451|NCT00510068|11502786|FG000|STARTED|Double-blind Period||207
10362452|NCT00510068|11502787|FG001|STARTED|Double-blind Period||203
10362453|NCT00510068|11502786|FG000|Safety Population|Double-blind Period||204
10362454|NCT00510068|11502787|FG001|Safety Population|Double-blind Period||203
10362455|NCT00510068|11502786|FG000|COMPLETED|Double-blind Period||0
10362456|NCT00510068|11502787|FG001|COMPLETED|Double-blind Period||0
10362457|NCT00510068|11502786|FG000|NOT COMPLETED|Double-blind Period||207
10362458|NCT00510068|11502787|FG001|NOT COMPLETED|Double-blind Period||203
10362459|NCT00510068|11502786|FG000|STARTED|Open-label Period|172 patients switched over from placebo & 53 who were initially randomized to Everolimus arm.|225
10362460|NCT00510068|11502787|FG001|STARTED|Open-label Period||0
10362461|NCT00510068|11502786|FG000|COMPLETED|Open-label Period||0
10362462|NCT00510068|11502787|FG001|COMPLETED|Open-label Period||0
10362463|NCT00510068|11502786|FG000|NOT COMPLETED|Open-label Period||225
10362464|NCT00510068|11502787|FG001|NOT COMPLETED|Open-label Period||0
10362465|NCT00510146|11502797|FG000|STARTED|Double-Blind Treatment||343
10362466|NCT00510146|11502798|FG001|STARTED|Double-Blind Treatment||171
10362467|NCT00510146|11502797|FG000|COMPLETED|Double-Blind Treatment||267
10362468|NCT00510146|11502798|FG001|COMPLETED|Double-Blind Treatment||122
10362469|NCT00510146|11502797|FG000|NOT COMPLETED|Double-Blind Treatment||76
10362470|NCT00510146|11502798|FG001|NOT COMPLETED|Double-Blind Treatment||49
10362471|NCT00510146|11502797|FG000|STARTED|Open-Label Treatment||267
10362472|NCT00510146|11502798|FG001|STARTED|Open-Label Treatment||122
10362473|NCT00510146|11502797|FG000|COMPLETED|Open-Label Treatment||196
10362474|NCT00510146|11502798|FG001|COMPLETED|Open-Label Treatment||96
10362475|NCT00510146|11502797|FG000|NOT COMPLETED|Open-Label Treatment||71
10362476|NCT00510146|11502798|FG001|NOT COMPLETED|Open-Label Treatment||26
10362477|NCT00510198|11502808|FG000|STARTED|Overall Study||59
10362478|NCT00510198|11502809|FG001|STARTED|Overall Study||58
10362479|NCT00510198|11502808|FG000|COMPLETED|Overall Study||54
10362480|NCT00510198|11502809|FG001|COMPLETED|Overall Study||54
10362481|NCT00510198|11502808|FG000|NOT COMPLETED|Overall Study||5
10362482|NCT00510198|11502809|FG001|NOT COMPLETED|Overall Study||4
10362483|NCT00510224|11502817|FG000|STARTED|Overall Study||13
10362484|NCT00510224|11502817|FG000|COMPLETED|Overall Study||10
10362485|NCT00510224|11502817|FG000|NOT COMPLETED|Overall Study||3
10427159|NCT00851643|11572932|FG001|COMPLETED|Extension Study (Up to 36 Months)||15
10427160|NCT00851643|11572933|FG002|COMPLETED|Extension Study (Up to 36 Months)||14
10362486|NCT00510276|11502823|FG000|STARTED|Acute Double-Blind Phase||220
10362487|NCT00510276|11502824|FG001|STARTED|Acute Double-Blind Phase||225
10362488|NCT00510276|11502823|FG000|COMPLETED|Acute Double-Blind Phase||115
10362489|NCT00510276|11502824|FG001|COMPLETED|Acute Double-Blind Phase||130
10362490|NCT00510276|11502823|FG000|NOT COMPLETED|Acute Double-Blind Phase||105
10362491|NCT00510276|11502824|FG001|NOT COMPLETED|Acute Double-Blind Phase||95
10362492|NCT00510276|11502823|FG000|STARTED|Extension Open-Label Phase|4 patients who completed acute phase did not participate in the optional atomoxetine extension phase|111
10362493|NCT00510276|11502824|FG001|STARTED|Extension Open-Label Phase|1 patient who completed acute phase did not participate in the optional atometine extension phase|129
10362494|NCT00510276|11502823|FG000|COMPLETED|Extension Open-Label Phase||78
10362495|NCT00510276|11502824|FG001|COMPLETED|Extension Open-Label Phase||81
10362496|NCT00510276|11502823|FG000|NOT COMPLETED|Extension Open-Label Phase||33
10362497|NCT00510276|11502824|FG001|NOT COMPLETED|Extension Open-Label Phase||48
10362498|NCT00510289|11502837|FG000|STARTED|Overall Study|All patients who consented|19
10362499|NCT00510289|11502837|FG000|Started Study Drug|Overall Study|3 patients progressed prior to starting study drug|16
10362500|NCT00510289|11502837|FG000|COMPLETED|Overall Study|Completed at least one cycle of study drug and had disease assessments|7
10362501|NCT00510289|11502837|FG000|NOT COMPLETED|Overall Study||12
10362502|NCT00510458|11502842|FG000|STARTED|Overall Study||74
10362503|NCT00510458|11502842|FG000|COMPLETED|Overall Study||27
10362504|NCT00510458|11502842|FG000|NOT COMPLETED|Overall Study||47
10362505|NCT00510484|11502849|FG000|STARTED|Period 1||16
10362506|NCT00510484|11502850|FG001|STARTED|Period 1||16
10362507|NCT00510484|11502849|FG000|COMPLETED|Period 1||16
10362508|NCT00510484|11502850|FG001|COMPLETED|Period 1||16
10362509|NCT00510484|11502849|FG000|NOT COMPLETED|Period 1||0
10362510|NCT00510484|11502850|FG001|NOT COMPLETED|Period 1||0
10362511|NCT00510484|11502849|FG000|STARTED|Wash-out Period||16
10362512|NCT00510484|11502850|FG001|STARTED|Wash-out Period||16
10362513|NCT00510484|11502849|FG000|COMPLETED|Wash-out Period||16
10362514|NCT00510484|11502850|FG001|COMPLETED|Wash-out Period||15
10362515|NCT00510484|11502849|FG000|NOT COMPLETED|Wash-out Period||0
10362516|NCT00510484|11502850|FG001|NOT COMPLETED|Wash-out Period||1
10362517|NCT00510484|11502849|FG000|STARTED|Period 2||16
10362518|NCT00510484|11502850|FG001|STARTED|Period 2||15
10362519|NCT00510484|11502849|FG000|COMPLETED|Period 2||16
10362520|NCT00510484|11502850|FG001|COMPLETED|Period 2||15
10362521|NCT00510484|11502849|FG000|NOT COMPLETED|Period 2||0
10362522|NCT00510484|11502850|FG001|NOT COMPLETED|Period 2||0
10362523|NCT00510497|11502856|FG000|STARTED|Overall Study||11
10362524|NCT00510497|11502856|FG000|COMPLETED|Overall Study||8
10362525|NCT00510497|11502856|FG000|NOT COMPLETED|Overall Study||3
10362526|NCT00510510|11502863|FG000|STARTED|Overall Study||92
10362527|NCT00510510|11502864|FG001|STARTED|Overall Study||98
10362528|NCT00510510|11502865|FG002|STARTED|Overall Study||91
10362529|NCT00510510|11502863|FG000|COMPLETED|Overall Study||87
10362530|NCT00510510|11502864|FG001|COMPLETED|Overall Study||89
10362531|NCT00510510|11502865|FG002|COMPLETED|Overall Study||74
10362532|NCT00510510|11502863|FG000|NOT COMPLETED|Overall Study||5
10362533|NCT00510510|11502864|FG001|NOT COMPLETED|Overall Study||9
10362534|NCT00510510|11502865|FG002|NOT COMPLETED|Overall Study||17
10362535|NCT00510653|11502873|FG000|STARTED|Overall Study||24
10362536|NCT00510653|11502873|FG000|COMPLETED|Overall Study||13
10362537|NCT00510653|11502873|FG000|NOT COMPLETED|Overall Study||11
10362538|NCT00510692|11502879|FG000|STARTED|Overall Study||29
10362539|NCT00510692|11502880|FG001|STARTED|Overall Study||29
10362540|NCT00510692|11502879|FG000|COMPLETED|Overall Study||27
10362541|NCT00510692|11502880|FG001|COMPLETED|Overall Study||26
10362542|NCT00510692|11502879|FG000|NOT COMPLETED|Overall Study||2
10362543|NCT00510692|11502880|FG001|NOT COMPLETED|Overall Study||3
10362544|NCT00510718|11502895|FG000|STARTED|Single Dose Period: 1 Week||15
10362545|NCT00510718|11502896|FG001|STARTED|Single Dose Period: 1 Week||12
10362546|NCT00510718|11502895|FG000|30 mg/Day|Single Dose Period: 1 Week||3
10535330|NCT01436071|11687661|FG000|NOT COMPLETED|Overall Study||26
10535331|NCT01436071|11687662|FG001|NOT COMPLETED|Overall Study||14
10535332|NCT01436110|11687671|FG000|STARTED|Overall Study|These participants were randomized to trial medication.|116
10535333|NCT01436110|11687672|FG001|STARTED|Overall Study|These participants were randomized to trial medication.|117
10535334|NCT01436110|11687673|FG002|STARTED|Overall Study|These participants were randomized to trial medication.|118
10535335|NCT01436110|11687671|FG000|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|115
10535336|NCT01436110|11687672|FG001|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|117
10535337|NCT01436110|11687673|FG002|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|115
10535338|NCT01436110|11687671|FG000|COMPLETED|Overall Study||77
10535339|NCT01436110|11687672|FG001|COMPLETED|Overall Study||91
10535340|NCT01436110|11687673|FG002|COMPLETED|Overall Study||95
10535341|NCT01436110|11687671|FG000|NOT COMPLETED|Overall Study||39
10535342|NCT01436110|11687672|FG001|NOT COMPLETED|Overall Study||26
10535343|NCT01436110|11687673|FG002|NOT COMPLETED|Overall Study||23
10535344|NCT01436149|11687683|FG000|STARTED|Antidepressant Lead-in Phase|Twenty-three subjects were enrolled but not dosed.|1262
10535345|NCT01436149|11687684|FG001|STARTED|Antidepressant Lead-in Phase||0
10535346|NCT01436149|11687685|FG002|STARTED|Antidepressant Lead-in Phase||0
10362547|NCT00510718|11502896|FG001|30 mg/Day|Single Dose Period: 1 Week||0
10362548|NCT00510718|11502895|FG000|60 mg/Day|Single Dose Period: 1 Week||3
10362549|NCT00510718|11502896|FG001|60 mg/Day|Single Dose Period: 1 Week||0
10535347|NCT01436149|11687683|FG000|COMPLETED|Antidepressant Lead-in Phase||896
10535348|NCT01436149|11687684|FG001|COMPLETED|Antidepressant Lead-in Phase||0
10535349|NCT01436149|11687685|FG002|COMPLETED|Antidepressant Lead-in Phase||0
10535350|NCT01436149|11687683|FG000|NOT COMPLETED|Antidepressant Lead-in Phase||366
10535351|NCT01436149|11687684|FG001|NOT COMPLETED|Antidepressant Lead-in Phase||0
10535352|NCT01436149|11687685|FG002|NOT COMPLETED|Antidepressant Lead-in Phase||0
10535353|NCT01436149|11687683|FG000|STARTED|Randomized Phase|These subjects were not included in the Safety Analysis Set or Full Analysis Set.|492
10535354|NCT01436149|11687684|FG001|STARTED|Randomized Phase|One subject did not receive at least 1 dose of double-blind treatment.|202
10535355|NCT01436149|11687685|FG002|STARTED|Randomized Phase|One subject did not receive at least 1 dose of double-blind treatment.|202
10535356|NCT01436149|11687683|FG000|COMPLETED|Randomized Phase||415
10535357|NCT01436149|11687684|FG001|COMPLETED|Randomized Phase||164
10716365|NCT02688387|11880064|FG021|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
10716366|NCT02688387|11880043|FG000|STARTED|Part 3B, Period 4 (up to 6 Days)||0
10716367|NCT02688387|11880044|FG001|STARTED|Part 3B, Period 4 (up to 6 Days)||0
10716368|NCT02688387|11880045|FG002|STARTED|Part 3B, Period 4 (up to 6 Days)||0
10716369|NCT02688387|11880046|FG003|STARTED|Part 3B, Period 4 (up to 6 Days)||0
10716370|NCT02688387|11880047|FG004|STARTED|Part 3B, Period 4 (up to 6 Days)||0
10716371|NCT02688387|11880048|FG005|STARTED|Part 3B, Period 4 (up to 6 Days)||0
10716372|NCT02688387|11880049|FG006|STARTED|Part 3B, Period 4 (up to 6 Days)||0
10716373|NCT02688387|11880050|FG007|STARTED|Part 3B, Period 4 (up to 6 Days)||0
10716374|NCT02688387|11880051|FG008|STARTED|Part 3B, Period 4 (up to 6 Days)||0
10716375|NCT02688387|11880052|FG009|STARTED|Part 3B, Period 4 (up to 6 Days)||0
10716376|NCT02688387|11880053|FG010|STARTED|Part 3B, Period 4 (up to 6 Days)||0
10716377|NCT02688387|11880054|FG011|STARTED|Part 3B, Period 4 (up to 6 Days)||0
10716378|NCT02688387|11880055|FG012|STARTED|Part 3B, Period 4 (up to 6 Days)||0
10716379|NCT02688387|11880056|FG013|STARTED|Part 3B, Period 4 (up to 6 Days)||0
10716380|NCT02688387|11880057|FG014|STARTED|Part 3B, Period 4 (up to 6 Days)||0
10716381|NCT02688387|11880058|FG015|STARTED|Part 3B, Period 4 (up to 6 Days)||0
10716382|NCT02688387|11880059|FG016|STARTED|Part 3B, Period 4 (up to 6 Days)||0
10305955|NCT00096031|11438910|FG000|STARTED|Overall Study||63
10305956|NCT00096031|11438910|FG000|Eligible|Overall Study||57
10305957|NCT00096031|11438910|FG000|Eligible and Began Protocol Therapy|Overall Study||55
10305958|NCT00096031|11438910|FG000|COMPLETED|Overall Study||0
10305959|NCT00096031|11438910|FG000|NOT COMPLETED|Overall Study||63
10305960|NCT00096044|11438914|FG000|STARTED|Overall Study||45
10305961|NCT00096044|11438914|FG000|COMPLETED|Overall Study||11
10305962|NCT00096044|11438914|FG000|NOT COMPLETED|Overall Study||34
10305963|NCT00096109|11438918|FG000|STARTED|Overall Study||11
10305964|NCT00096109|11438918|FG000|COMPLETED|Overall Study||11
10305965|NCT00096109|11438918|FG000|NOT COMPLETED|Overall Study||0
10305966|NCT00096122|11438922|FG000|STARTED|Overall Study||95
10305967|NCT00096122|11438922|FG000|COMPLETED|Overall Study||95
10305968|NCT00096122|11438922|FG000|NOT COMPLETED|Overall Study||0
10305969|NCT00096135|11438928|FG000|STARTED|Overall Study||126
10305970|NCT00096135|11438929|FG001|STARTED|Overall Study||42
10305971|NCT00096135|11438928|FG000|COMPLETED|Overall Study||63
10305972|NCT00096135|11438929|FG001|COMPLETED|Overall Study||27
10305973|NCT00096135|11438928|FG000|NOT COMPLETED|Overall Study||63
10305974|NCT00096135|11438929|FG001|NOT COMPLETED|Overall Study||15
10305975|NCT00096161|11438939|FG000|STARTED|Overall Study||20
10305976|NCT00096161|11438940|FG001|STARTED|Overall Study||10
10305977|NCT00096161|11438941|FG002|STARTED|Overall Study||6
10305978|NCT00096161|11438942|FG003|STARTED|Overall Study||0
10305979|NCT00096161|11438939|FG000|COMPLETED|Overall Study||20
10305980|NCT00096161|11438940|FG001|COMPLETED|Overall Study||10
10305981|NCT00096161|11438941|FG002|COMPLETED|Overall Study||6
10305982|NCT00096161|11438942|FG003|COMPLETED|Overall Study||0
10305983|NCT00096161|11438939|FG000|NOT COMPLETED|Overall Study||0
10305984|NCT00096161|11438940|FG001|NOT COMPLETED|Overall Study||0
10305985|NCT00096161|11438941|FG002|NOT COMPLETED|Overall Study||0
10305986|NCT00096161|11438942|FG003|NOT COMPLETED|Overall Study||0
10305987|NCT00096174|11438952|FG000|STARTED|Overall Study||69
10305988|NCT00096174|11438952|FG000|Began Protocol Therapy|Overall Study|3 patients never started treatment|66
10305989|NCT00096174|11438952|FG000|Eligible and Treated|Overall Study|6 treated patients were ineligible|60
10305990|NCT00096174|11438952|FG000|COMPLETED|Overall Study||7
10305991|NCT00096174|11438952|FG000|NOT COMPLETED|Overall Study||62
10305992|NCT00096226|11438956|FG000|STARTED|Overall Study||60
10305993|NCT00096226|11438956|FG000|Eligible|Overall Study||57
10305994|NCT00096226|11438956|FG000|Eligible and Underwent Surgery|Overall Study||37
10305995|NCT00096226|11438956|FG000|COMPLETED|Overall Study|Subjects contributing any data to analysis are considered to have completed the study|57
10305996|NCT00096226|11438956|FG000|NOT COMPLETED|Overall Study||3
10305997|NCT00096265|11438963|FG000|STARTED|Overall Study||45
10305998|NCT00096265|11438964|FG001|STARTED|Overall Study||40
10305999|NCT00096265|11438965|FG002|STARTED|Overall Study||41
10306000|NCT00096265|11438963|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
10306001|NCT00096265|11438964|FG001|COMPLETED|Overall Study||40
10306002|NCT00096265|11438965|FG002|COMPLETED|Overall Study||41
10306003|NCT00096265|11438963|FG000|NOT COMPLETED|Overall Study||1
10306004|NCT00096265|11438964|FG001|NOT COMPLETED|Overall Study||0
10306005|NCT00096265|11438965|FG002|NOT COMPLETED|Overall Study||0
10306006|NCT00096278|11438976|FG000|STARTED|Overall Study||1356
10812570|NCT03509207|11974661|FG000|NOT COMPLETED|Overall Study||2
10812571|NCT03505372|11974665|FG000|STARTED|Overall Study||5
10716383|NCT02688387|11880060|FG017|STARTED|Part 3B, Period 4 (up to 6 Days)||0
10716384|NCT02688387|11880061|FG018|STARTED|Part 3B, Period 4 (up to 6 Days)||7
10716385|NCT02688387|11880062|FG019|STARTED|Part 3B, Period 4 (up to 6 Days)||7
10716386|NCT02688387|11880063|FG020|STARTED|Part 3B, Period 4 (up to 6 Days)||6
10716387|NCT02688387|11880064|FG021|STARTED|Part 3B, Period 4 (up to 6 Days)||8
10716388|NCT02688387|11880043|FG000|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10812572|NCT03505372|11974665|FG000|COMPLETED|Overall Study||5
10812573|NCT03505372|11974665|FG000|NOT COMPLETED|Overall Study||0
10362550|NCT00510718|11502895|FG000|150/160 mg/Day|Single Dose Period: 1 Week||2
10362551|NCT00510718|11502896|FG001|150/160 mg/Day|Single Dose Period: 1 Week||1
10362552|NCT00510718|11502895|FG000|240 mg/Day|Single Dose Period: 1 Week||3
10362553|NCT00510718|11502896|FG001|240 mg/Day|Single Dose Period: 1 Week||0
10362554|NCT00510718|11502895|FG000|360 mg/Day|Single Dose Period: 1 Week||4
10362555|NCT00510718|11502896|FG001|360 mg/Day|Single Dose Period: 1 Week||2
10362556|NCT00510718|11502895|FG000|480 mg/Day|Single Dose Period: 1 Week||0
10362557|NCT00510718|11502896|FG001|480 mg/Day|Single Dose Period: 1 Week||6
10362558|NCT00510718|11502895|FG000|600 mg/Day|Single Dose Period: 1 Week||0
10362559|NCT00510718|11502896|FG001|600 mg/Day|Single Dose Period: 1 Week||3
10362560|NCT00510718|11502895|FG000|COMPLETED|Single Dose Period: 1 Week||15
10362561|NCT00510718|11502896|FG001|COMPLETED|Single Dose Period: 1 Week||12
10362562|NCT00510718|11502895|FG000|NOT COMPLETED|Single Dose Period: 1 Week||0
10362563|NCT00510718|11502896|FG001|NOT COMPLETED|Single Dose Period: 1 Week||0
10362564|NCT00510718|11502895|FG000|STARTED|Multiple Dose Period: 12 Weeks|Participants who completed single dose period + new participants enrolled in multiple dose period.|65
10362565|NCT00510718|11502896|FG001|STARTED|Multiple Dose Period: 12 Weeks|Participants who completed single dose period + new participants enrolled in multiple dose period.|75
10362566|NCT00510718|11502895|FG000|30 mg/Day|Multiple Dose Period: 12 Weeks||3
10362567|NCT00510718|11502896|FG001|30 mg/Day|Multiple Dose Period: 12 Weeks||0
10362568|NCT00510718|11502895|FG000|60 mg/Day|Multiple Dose Period: 12 Weeks||15
10362569|NCT00510718|11502896|FG001|60 mg/Day|Multiple Dose Period: 12 Weeks||12
10362570|NCT00510718|11502895|FG000|150/160 mg/Day|Multiple Dose Period: 12 Weeks||15
10362571|NCT00510718|11502896|FG001|150/160 mg/Day|Multiple Dose Period: 12 Weeks||13
10362572|NCT00510718|11502895|FG000|240 mg/Day|Multiple Dose Period: 12 Weeks||17
10362573|NCT00510718|11502896|FG001|240 mg/Day|Multiple Dose Period: 12 Weeks||12
10362574|NCT00510718|11502895|FG000|360 mg/Day|Multiple Dose Period: 12 Weeks||15
10362575|NCT00510718|11502896|FG001|360 mg/Day|Multiple Dose Period: 12 Weeks||13
10362576|NCT00510718|11502895|FG000|480 mg/Day|Multiple Dose Period: 12 Weeks||0
10362577|NCT00510718|11502896|FG001|480 mg/Day|Multiple Dose Period: 12 Weeks||22
10362578|NCT00510718|11502895|FG000|600 mg/Day|Multiple Dose Period: 12 Weeks||0
10362579|NCT00510718|11502896|FG001|600 mg/Day|Multiple Dose Period: 12 Weeks||3
10362580|NCT00510718|11502895|FG000|COMPLETED|Multiple Dose Period: 12 Weeks||50
10362581|NCT00510718|11502896|FG001|COMPLETED|Multiple Dose Period: 12 Weeks||43
10362582|NCT00510718|11502895|FG000|NOT COMPLETED|Multiple Dose Period: 12 Weeks||15
10362583|NCT00510718|11502896|FG001|NOT COMPLETED|Multiple Dose Period: 12 Weeks||32
10362584|NCT00510744|11502915|FG000|STARTED|Overall Study||5
10362585|NCT00510744|11502915|FG000|COMPLETED|Overall Study||5
10362586|NCT00510744|11502915|FG000|NOT COMPLETED|Overall Study||0
10362587|NCT00510783|11502921|FG000|STARTED|Overall Study||82
10362588|NCT00510783|11502922|FG001|STARTED|Overall Study||76
10362589|NCT00510783|11502921|FG000|COMPLETED|Overall Study||51
10362590|NCT00510783|11502922|FG001|COMPLETED|Overall Study||47
10362591|NCT00510783|11502921|FG000|NOT COMPLETED|Overall Study||31
10362592|NCT00510783|11502922|FG001|NOT COMPLETED|Overall Study||29
10362593|NCT00510809|11502931|FG000|STARTED|Overall Study||18
10362594|NCT00510809|11502932|FG001|STARTED|Overall Study||18
10362595|NCT00510809|11502933|FG002|STARTED|Overall Study||18
10362596|NCT00510809|11502931|FG000|COMPLETED|Overall Study||18
10362597|NCT00510809|11502932|FG001|COMPLETED|Overall Study||18
10362598|NCT00510809|11502933|FG002|COMPLETED|Overall Study||18
10362599|NCT00510809|11502931|FG000|NOT COMPLETED|Overall Study||0
10362600|NCT00510809|11502932|FG001|NOT COMPLETED|Overall Study||0
10362601|NCT00510809|11502933|FG002|NOT COMPLETED|Overall Study||0
10362602|NCT00510835|11502944|FG000|STARTED|Overall Study||445
10362603|NCT00510835|11502945|FG001|STARTED|Overall Study||448
10362604|NCT00510835|11502946|FG002|STARTED|Overall Study||458
10362605|NCT00510835|11502944|FG000|COMPLETED|Overall Study||439
10362606|NCT00510835|11502945|FG001|COMPLETED|Overall Study||446
10362607|NCT00510835|11502946|FG002|COMPLETED|Overall Study||456
10362608|NCT00510835|11502944|FG000|NOT COMPLETED|Overall Study||6
10716389|NCT02688387|11880044|FG001|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10716390|NCT02688387|11880045|FG002|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10716391|NCT02688387|11880046|FG003|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10716392|NCT02688387|11880047|FG004|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10362609|NCT00510835|11502945|FG001|NOT COMPLETED|Overall Study||2
10362610|NCT00510835|11502946|FG002|NOT COMPLETED|Overall Study||2
10362611|NCT00510874|11502961|FG000|STARTED|Overall Study||78
10362612|NCT00510874|11502962|FG001|STARTED|Overall Study||152
10362613|NCT00510874|11502963|FG002|STARTED|Overall Study||151
10362614|NCT00510874|11502964|FG003|STARTED|Overall Study||151
10812574|NCT03500406|11974671|FG000|STARTED|Overall Study||4
10812575|NCT03500406|11974672|FG001|STARTED|Overall Study||20
10362615|NCT00510874|11502965|FG004|STARTED|Overall Study||148
10362616|NCT00510874|11502966|FG005|STARTED|Overall Study||50
10812576|NCT03500406|11974671|FG000|COMPLETED|Overall Study||4
10362617|NCT00510874|11502967|FG006|STARTED|Overall Study||50
10362618|NCT00510874|11502961|FG000|COMPLETED|Overall Study|Upto Day 182|75
10362619|NCT00510874|11502962|FG001|COMPLETED|Overall Study|Upto Day 182|148
10362620|NCT00510874|11502963|FG002|COMPLETED|Overall Study|Upto Day 182|150
10362621|NCT00510874|11502964|FG003|COMPLETED|Overall Study|Upto Day 182|148
10362622|NCT00510874|11502965|FG004|COMPLETED|Overall Study|Upto Day 182|141
10362623|NCT00510874|11502966|FG005|COMPLETED|Overall Study|Upto Day 182|50
10362624|NCT00510874|11502967|FG006|COMPLETED|Overall Study|Upto Day 182|49
10362625|NCT00510874|11502961|FG000|NOT COMPLETED|Overall Study||3
10362626|NCT00510874|11502962|FG001|NOT COMPLETED|Overall Study||4
10362627|NCT00510874|11502963|FG002|NOT COMPLETED|Overall Study||1
10362628|NCT00510874|11502964|FG003|NOT COMPLETED|Overall Study||3
10362629|NCT00510874|11502965|FG004|NOT COMPLETED|Overall Study||7
10362630|NCT00510874|11502966|FG005|NOT COMPLETED|Overall Study||0
10362631|NCT00510874|11502967|FG006|NOT COMPLETED|Overall Study||1
10362632|NCT00510887|11502984|FG000|STARTED|Overall Study||12
10362633|NCT00510887|11502984|FG000|COMPLETED|Overall Study||11
10362634|NCT00510887|11502984|FG000|NOT COMPLETED|Overall Study||1
10362635|NCT00510952|11502990|FG000|STARTED|Overall Study||235
10362636|NCT00510952|11502991|FG001|STARTED|Overall Study||236
10362637|NCT00510952|11502990|FG000|Full Analysis Set (Intent to Treat)|Overall Study||229
10362638|NCT00510952|11502991|FG001|Full Analysis Set (Intent to Treat)|Overall Study||229
10362639|NCT00510952|11502990|FG000|COMPLETED|Overall Study||209
10362640|NCT00510952|11502991|FG001|COMPLETED|Overall Study||220
10362641|NCT00510952|11502990|FG000|NOT COMPLETED|Overall Study||26
10362642|NCT00510952|11502991|FG001|NOT COMPLETED|Overall Study||16
10362643|NCT00511004|11503000|FG000|STARTED|Overall Study||13
10362644|NCT00511004|11503001|FG001|STARTED|Overall Study||13
10362645|NCT00511004|11503002|FG002|STARTED|Overall Study||14
10362646|NCT00511004|11503000|FG000|COMPLETED|Overall Study||13
10362647|NCT00511004|11503001|FG001|COMPLETED|Overall Study||13
10362648|NCT00511004|11503002|FG002|COMPLETED|Overall Study||10
10362649|NCT00511004|11503000|FG000|NOT COMPLETED|Overall Study||0
10362650|NCT00511004|11503001|FG001|NOT COMPLETED|Overall Study||0
10362651|NCT00511004|11503002|FG002|NOT COMPLETED|Overall Study||4
10362652|NCT00511095|11503013|FG000|STARTED|Overall Study||207
10362653|NCT00511095|11503013|FG000|COMPLETED|Overall Study||196
10362654|NCT00511095|11503013|FG000|NOT COMPLETED|Overall Study||11
10362655|NCT00511108|11503027|FG000|STARTED|Overall Study||52
10362656|NCT00511108|11503028|FG001|STARTED|Overall Study||54
10362657|NCT00511108|11503029|FG002|STARTED|Overall Study||52
10362658|NCT00511108|11503030|FG003|STARTED|Overall Study||53
10362659|NCT00511108|11503027|FG000|COMPLETED|Overall Study||46
10362660|NCT00511108|11503028|FG001|COMPLETED|Overall Study||52
10362661|NCT00511108|11503029|FG002|COMPLETED|Overall Study||47
10362662|NCT00511108|11503030|FG003|COMPLETED|Overall Study||48
10362663|NCT00511108|11503027|FG000|NOT COMPLETED|Overall Study||6
10362664|NCT00511108|11503028|FG001|NOT COMPLETED|Overall Study||2
10812577|NCT03500406|11974672|FG001|COMPLETED|Overall Study||20
10812578|NCT03500406|11974671|FG000|NOT COMPLETED|Overall Study||0
10362665|NCT00511108|11503029|FG002|NOT COMPLETED|Overall Study||5
10362666|NCT00511108|11503030|FG003|NOT COMPLETED|Overall Study||5
10362667|NCT00511147|11503040|FG000|STARTED|Overall Study||64
10362668|NCT00511147|11503040|FG000|COMPLETED|Overall Study||57
10362669|NCT00511147|11503040|FG000|NOT COMPLETED|Overall Study||7
10362670|NCT00511173|11503044|FG000|STARTED|Overall Study||102
10362671|NCT00511173|11503044|FG000|COMPLETED|Overall Study||102
10535358|NCT01436149|11687685|FG002|COMPLETED|Randomized Phase|1 subject completed the study without a Visit 14 MADRS and was not included in the completers set.|160
10535359|NCT01436149|11687683|FG000|NOT COMPLETED|Randomized Phase||77
10535360|NCT01436149|11687684|FG001|NOT COMPLETED|Randomized Phase||38
10535361|NCT01436149|11687685|FG002|NOT COMPLETED|Randomized Phase||42
10535362|NCT01436162|11687693|FG000|STARTED|Single-blind Lead-in Phase|Ten subjects were enrolled but not dosed.|1105
10535363|NCT01436162|11687694|FG001|STARTED|Single-blind Lead-in Phase||0
10535364|NCT01436162|11687695|FG002|STARTED|Single-blind Lead-in Phase||0
10535365|NCT01436162|11687693|FG000|COMPLETED|Single-blind Lead-in Phase||823
10535366|NCT01436162|11687694|FG001|COMPLETED|Single-blind Lead-in Phase||0
10535367|NCT01436162|11687695|FG002|COMPLETED|Single-blind Lead-in Phase||0
10535368|NCT01436162|11687693|FG000|NOT COMPLETED|Single-blind Lead-in Phase||282
10535369|NCT01436162|11687694|FG001|NOT COMPLETED|Single-blind Lead-in Phase||0
10535370|NCT01436162|11687695|FG002|NOT COMPLETED|Single-blind Lead-in Phase||0
10535371|NCT01436162|11687693|FG000|STARTED|Randomized Phase|These subjects were not included in the Safety Analysis Set or Full Analysis Set.|397
10362672|NCT00511173|11503044|FG000|NOT COMPLETED|Overall Study||0
10362673|NCT00511238|11503051|FG000|STARTED|Overall Study||46
10362674|NCT00511238|11503052|FG001|STARTED|Overall Study||266
10362675|NCT00511238|11503051|FG000|COMPLETED|Overall Study|Number of patients who completed 12 cycles of treatment|4
10362676|NCT00511238|11503052|FG001|COMPLETED|Overall Study|Number of patients who completed 12 cycles of treatment|40
10362677|NCT00511238|11503051|FG000|NOT COMPLETED|Overall Study||42
10362678|NCT00511238|11503052|FG001|NOT COMPLETED|Overall Study||226
10362679|NCT00511472|11503070|FG000|STARTED|Overall Study||47
10362680|NCT00511472|11503071|FG001|STARTED|Overall Study||23
10535372|NCT01436162|11687694|FG001|STARTED|Randomized Phase|One subject was randomized to this arm but did not receive at least 1 dose of double-blind treatment|212
10812579|NCT03500406|11974672|FG001|NOT COMPLETED|Overall Study||0
10362681|NCT00511472|11503070|FG000|COMPLETED|Overall Study||44
10362682|NCT00511472|11503071|FG001|COMPLETED|Overall Study||17
10362683|NCT00511472|11503070|FG000|NOT COMPLETED|Overall Study||3
10362684|NCT00511472|11503071|FG001|NOT COMPLETED|Overall Study||6
10362685|NCT00511667|11503088|FG000|STARTED|Overall Study||52
10362686|NCT00511667|11503089|FG001|STARTED|Overall Study||18
10362687|NCT00511667|11503088|FG000|COMPLETED|Overall Study||40
10362688|NCT00511667|11503089|FG001|COMPLETED|Overall Study||15
10362689|NCT00511667|11503088|FG000|NOT COMPLETED|Overall Study||12
10362690|NCT00511667|11503089|FG001|NOT COMPLETED|Overall Study||3
10362691|NCT00511706|11503103|FG000|STARTED|Overall Study||123
10362692|NCT00511706|11503104|FG001|STARTED|Overall Study||120
10362693|NCT00511706|11503103|FG000|COMPLETED|Overall Study||115
10362694|NCT00511706|11503104|FG001|COMPLETED|Overall Study||115
10362695|NCT00511706|11503103|FG000|NOT COMPLETED|Overall Study||8
10362696|NCT00511706|11503104|FG001|NOT COMPLETED|Overall Study||5
10362697|NCT00511797|11503114|FG000|STARTED|Overall Study||62
10362698|NCT00511797|11503115|FG001|STARTED|Overall Study||63
10362699|NCT00511797|11503116|FG002|STARTED|Overall Study||62
10362700|NCT00511797|11503117|FG003|STARTED|Overall Study||62
10362701|NCT00511797|11503114|FG000|Subjects Dispensed Drugs|Overall Study||61
10362702|NCT00511797|11503115|FG001|Subjects Dispensed Drugs|Overall Study||63
10362703|NCT00511797|11503116|FG002|Subjects Dispensed Drugs|Overall Study||61
10362704|NCT00511797|11503117|FG003|Subjects Dispensed Drugs|Overall Study||59
10362705|NCT00511797|11503114|FG000|Subjects Received Treatment|Overall Study|FAS|61
10362706|NCT00511797|11503115|FG001|Subjects Received Treatment|Overall Study|FAS|62
10362707|NCT00511797|11503116|FG002|Subjects Received Treatment|Overall Study|FAS|61
10362708|NCT00511797|11503117|FG003|Subjects Received Treatment|Overall Study|FAS|58
10362709|NCT00511797|11503114|FG000|COMPLETED|Overall Study||55
10362710|NCT00511797|11503115|FG001|COMPLETED|Overall Study||55
10362711|NCT00511797|11503116|FG002|COMPLETED|Overall Study||51
10362712|NCT00511797|11503117|FG003|COMPLETED|Overall Study||47
10362713|NCT00511797|11503114|FG000|NOT COMPLETED|Overall Study||7
10362714|NCT00511797|11503115|FG001|NOT COMPLETED|Overall Study||8
10362715|NCT00511797|11503116|FG002|NOT COMPLETED|Overall Study||11
10362716|NCT00511797|11503117|FG003|NOT COMPLETED|Overall Study||15
10362717|NCT00511810|11503129|FG000|STARTED|Overall Study||8
10362718|NCT00511810|11503130|FG001|STARTED|Overall Study||12
10362719|NCT00511810|11503129|FG000|COMPLETED|Overall Study||7
10362720|NCT00511810|11503130|FG001|COMPLETED|Overall Study|2 terminated for worsening symptoms;1 refused a scan;2 lost to follow up (could not be contacted)|7
10362721|NCT00511810|11503129|FG000|NOT COMPLETED|Overall Study||1
10362722|NCT00511810|11503130|FG001|NOT COMPLETED|Overall Study||5
10362723|NCT00511836|11503138|FG000|STARTED|Double-blind Period||16
10362724|NCT00511836|11503139|FG001|STARTED|Double-blind Period||15
10362725|NCT00511836|11503138|FG000|COMPLETED|Double-blind Period||15
10362726|NCT00511836|11503139|FG001|COMPLETED|Double-blind Period||15
10362727|NCT00511836|11503138|FG000|NOT COMPLETED|Double-blind Period||1
10362728|NCT00511836|11503139|FG001|NOT COMPLETED|Double-blind Period||0
10362729|NCT00511836|11503138|FG000|STARTED|Optional Open-label VIVITROL (2 Months)|Subjects who received placebo during Month 1 switched to VIVITROL for the optional extension phase.|22
10362730|NCT00511836|11503139|FG001|STARTED|Optional Open-label VIVITROL (2 Months)|Not all subjects from the double-blind phase entered the optional open-label extension.|0
10362731|NCT00511836|11503138|FG000|COMPLETED|Optional Open-label VIVITROL (2 Months)||6
10362732|NCT00511836|11503139|FG001|COMPLETED|Optional Open-label VIVITROL (2 Months)||0
10362733|NCT00511836|11503138|FG000|NOT COMPLETED|Optional Open-label VIVITROL (2 Months)||16
10362734|NCT00511836|11503139|FG001|NOT COMPLETED|Optional Open-label VIVITROL (2 Months)||0
10362735|NCT00511862|11503149|FG000|STARTED|Overall Study||61
10362736|NCT00511862|11503150|FG001|STARTED|Overall Study||43
10362737|NCT00511862|11503151|FG002|STARTED|Overall Study||47
10362738|NCT00511862|11503149|FG000|COMPLETED|Overall Study||61
10362739|NCT00511862|11503150|FG001|COMPLETED|Overall Study||43
10362740|NCT00511862|11503151|FG002|COMPLETED|Overall Study||47
10362741|NCT00511862|11503149|FG000|NOT COMPLETED|Overall Study||0
10362742|NCT00511862|11503150|FG001|NOT COMPLETED|Overall Study||0
10362743|NCT00511862|11503151|FG002|NOT COMPLETED|Overall Study||0
10362744|NCT00511875|11503163|FG000|STARTED|Overall Study||15
10362745|NCT00511875|11503164|FG001|STARTED|Overall Study||15
10362746|NCT00511875|11503163|FG000|COMPLETED|Overall Study||10
10362747|NCT00511875|11503164|FG001|COMPLETED|Overall Study||15
10362748|NCT00511875|11503163|FG000|NOT COMPLETED|Overall Study||5
10362749|NCT00511875|11503164|FG001|NOT COMPLETED|Overall Study||0
10362750|NCT00511901|11503172|FG000|STARTED|Overall Study||11
10362751|NCT00511901|11503173|FG001|STARTED|Overall Study||11
10362752|NCT00511901|11503172|FG000|COMPLETED|Overall Study||10
10362753|NCT00511901|11503173|FG001|COMPLETED|Overall Study||8
10362754|NCT00511901|11503172|FG000|NOT COMPLETED|Overall Study||1
10362755|NCT00511901|11503173|FG001|NOT COMPLETED|Overall Study||3
10362756|NCT00511914|11503181|FG000|STARTED|Overall Study||68
10362757|NCT00511914|11503182|FG001|STARTED|Overall Study||67
10362758|NCT00511914|11503181|FG000|COMPLETED|Overall Study||68
10362759|NCT00511914|11503182|FG001|COMPLETED|Overall Study||67
10362760|NCT00511914|11503181|FG000|NOT COMPLETED|Overall Study||0
10362761|NCT00511914|11503182|FG001|NOT COMPLETED|Overall Study||0
10362762|NCT00511992|11503188|FG000|STARTED|Overall Study||20
10362763|NCT00511992|11503188|FG000|COMPLETED|Overall Study||13
10362764|NCT00511992|11503188|FG000|NOT COMPLETED|Overall Study||7
10362765|NCT00512096|11503192|FG000|STARTED|Overall Study||30
10362766|NCT00512096|11503192|FG000|COMPLETED|Overall Study||23
10362767|NCT00512096|11503192|FG000|NOT COMPLETED|Overall Study||7
10362768|NCT00512135|11503196|FG000|STARTED|Overall Study||801
10362769|NCT00512135|11503196|FG000|Treated|Overall Study||796
10362770|NCT00512135|11503196|FG000|COMPLETED|Overall Study||717
10362771|NCT00512135|11503196|FG000|NOT COMPLETED|Overall Study||84
10362772|NCT00512148|11503201|FG000|STARTED|Primay Study Period||7
10362773|NCT00512148|11503201|FG000|COMPLETED|Primay Study Period||6
10362774|NCT00512148|11503201|FG000|NOT COMPLETED|Primay Study Period||1
10362775|NCT00512148|11503201|FG000|STARTED|Long Term Follow Up Period||6
10362776|NCT00512148|11503201|FG000|COMPLETED|Long Term Follow Up Period|6 patients are being followed in long term follow up|0
10362777|NCT00512148|11503201|FG000|NOT COMPLETED|Long Term Follow Up Period||6
10362778|NCT00512252|11503210|FG000|STARTED|Overall Study||3
10362779|NCT00512252|11503211|FG001|STARTED|Overall Study||3
10362780|NCT00512252|11503212|FG002|STARTED|Overall Study||46
10362781|NCT00512252|11503210|FG000|COMPLETED|Overall Study||3
10362782|NCT00512252|11503211|FG001|COMPLETED|Overall Study||3
10362783|NCT00512252|11503212|FG002|COMPLETED|Overall Study||43
10362784|NCT00512252|11503210|FG000|NOT COMPLETED|Overall Study||0
10362785|NCT00512252|11503211|FG001|NOT COMPLETED|Overall Study||0
10362786|NCT00512252|11503212|FG002|NOT COMPLETED|Overall Study||3
10362787|NCT00512278|11503229|FG000|STARTED|Overall Study||73
10362788|NCT00512278|11503230|FG001|STARTED|Overall Study||73
10362789|NCT00512278|11503229|FG000|COMPLETED|Overall Study||45
10362790|NCT00512278|11503230|FG001|COMPLETED|Overall Study||56
10362791|NCT00512278|11503229|FG000|NOT COMPLETED|Overall Study||28
10362792|NCT00512278|11503230|FG001|NOT COMPLETED|Overall Study||17
10362793|NCT00512707|11503240|FG000|STARTED|Overall Study||70
10362794|NCT00512707|11503241|FG001|STARTED|Overall Study||70
10362795|NCT00512707|11503240|FG000|COMPLETED|Overall Study||60
10362796|NCT00512707|11503241|FG001|COMPLETED|Overall Study||58
10362797|NCT00512707|11503240|FG000|NOT COMPLETED|Overall Study||10
10362798|NCT00512707|11503241|FG001|NOT COMPLETED|Overall Study||12
10362799|NCT00512798|11503249|FG000|STARTED|Overall Study||19
10362800|NCT00512798|11503250|FG001|STARTED|Overall Study||28
10362801|NCT00512798|11503249|FG000|COMPLETED|Overall Study||0
10362802|NCT00512798|11503250|FG001|COMPLETED|Overall Study||1
10362803|NCT00512798|11503249|FG000|NOT COMPLETED|Overall Study||19
10362804|NCT00512798|11503250|FG001|NOT COMPLETED|Overall Study||27
10362805|NCT00512876|11503257|FG000|STARTED|Overall Study||24
10362806|NCT00512876|11503257|FG000|COMPLETED|Overall Study||20
10362807|NCT00512876|11503257|FG000|NOT COMPLETED|Overall Study||4
10362808|NCT00512902|11503261|FG000|STARTED|Overall Study||20
10362809|NCT00512902|11503261|FG000|COMPLETED|Overall Study||12
10362810|NCT00512902|11503261|FG000|NOT COMPLETED|Overall Study||8
10362811|NCT00513019|11503267|FG000|STARTED|Overall Study||17
10362812|NCT00513019|11503268|FG001|STARTED|Overall Study||18
10362813|NCT00513019|11503267|FG000|COMPLETED|Overall Study||12
10362814|NCT00513019|11503268|FG001|COMPLETED|Overall Study||13
10362815|NCT00513019|11503267|FG000|NOT COMPLETED|Overall Study||5
10362816|NCT00513019|11503268|FG001|NOT COMPLETED|Overall Study||5
10362817|NCT00513071|11503274|FG000|STARTED|Overall Study||28
10362818|NCT00513071|11503274|FG000|COMPLETED|Overall Study||23
10362819|NCT00513071|11503274|FG000|NOT COMPLETED|Overall Study||5
10362820|NCT00513240|11503280|FG000|STARTED|Overall Study|3 did not have intended surgery; 28 had all 3 doses; 4 had 1 dose but no more due to delayed surgery|35
10362821|NCT00513240|11503281|FG001|STARTED|Overall Study|25 had 3 doses; 1 had 1 dose due to rash; 1 had 2 doses and 1 dose of EPO due to pharmacy error|27
10362822|NCT00513240|11503280|FG000|Clinical Data Collection &Pre/Postop MRI|Overall Study|3 not having intended surgery are subtracted from original 35 subjects, leaving 32|32
10362823|NCT00513240|11503281|FG001|Clinical Data Collection &Pre/Postop MRI|Overall Study||27
10362824|NCT00513240|11503280|FG000|COMPLETED|Overall Study|Competed 12 month neurodevelopmental exam, which are the only results published at this time.|22
10362825|NCT00513240|11503281|FG001|COMPLETED|Overall Study|Competed 12 month neurodevelopmental exam, which are the only results published at this time.|20
10362826|NCT00513240|11503280|FG000|NOT COMPLETED|Overall Study||13
10362827|NCT00513240|11503281|FG001|NOT COMPLETED|Overall Study||7
10362828|NCT00513292|11503292|FG000|STARTED|Overall Study||138
10362829|NCT00513292|11503293|FG001|STARTED|Overall Study||142
10362830|NCT00513292|11503292|FG000|COMPLETED|Overall Study||138
10362831|NCT00513292|11503293|FG001|COMPLETED|Overall Study||142
10362832|NCT00513292|11503292|FG000|NOT COMPLETED|Overall Study||0
10362833|NCT00513292|11503293|FG001|NOT COMPLETED|Overall Study||0
10362834|NCT00513305|11503301|FG000|STARTED|Overall Study||33
10362835|NCT00513305|11503302|FG001|STARTED|Overall Study|One subject withdrew prior to receiving study medication|34
10362836|NCT00513305|11503301|FG000|COMPLETED|Overall Study||5
10716393|NCT02688387|11880048|FG005|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10777245|NCT03338296|11939189|FG001|STARTED|Overall Study||139
10362837|NCT00513305|11503302|FG001|COMPLETED|Overall Study||7
10362838|NCT00513305|11503301|FG000|NOT COMPLETED|Overall Study||28
10362839|NCT00513305|11503302|FG001|NOT COMPLETED|Overall Study||27
10362840|NCT00513344|11503308|FG000|STARTED|Diet Restriction (3 Days)||5
10362841|NCT00513344|11503308|FG000|COMPLETED|Diet Restriction (3 Days)||5
10362842|NCT00513344|11503308|FG000|NOT COMPLETED|Diet Restriction (3 Days)||0
10362843|NCT00513344|11503308|FG000|STARTED|1st Intervention 1 Day||5
10362844|NCT00513344|11503308|FG000|COMPLETED|1st Intervention 1 Day||5
10362845|NCT00513344|11503308|FG000|NOT COMPLETED|1st Intervention 1 Day||0
10362846|NCT00513344|11503308|FG000|STARTED|Washout Period 3 Days||5
10362847|NCT00513344|11503308|FG000|COMPLETED|Washout Period 3 Days||5
10362848|NCT00513344|11503308|FG000|NOT COMPLETED|Washout Period 3 Days||0
10362849|NCT00513344|11503308|FG000|STARTED|2nd Intervention 1 Day||5
10362850|NCT00513344|11503308|FG000|COMPLETED|2nd Intervention 1 Day||5
10362851|NCT00513344|11503308|FG000|NOT COMPLETED|2nd Intervention 1 Day||0
10716394|NCT02688387|11880049|FG006|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10716395|NCT02688387|11880050|FG007|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10716396|NCT02688387|11880051|FG008|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10716397|NCT02688387|11880052|FG009|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10716398|NCT02688387|11880053|FG010|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10716399|NCT02688387|11880054|FG011|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10362852|NCT00513344|11503308|FG000|STARTED|Washout Period 3 Days||5
10362853|NCT00513344|11503308|FG000|COMPLETED|Washout Period 3 Days||5
10362854|NCT00513344|11503308|FG000|NOT COMPLETED|Washout Period 3 Days||0
10362855|NCT00513344|11503308|FG000|STARTED|3rd Intervention 1 Day||5
10362856|NCT00513344|11503308|FG000|COMPLETED|3rd Intervention 1 Day||5
10362857|NCT00513344|11503308|FG000|NOT COMPLETED|3rd Intervention 1 Day||0
10362858|NCT00513357|11503318|FG000|STARTED|Overall Study||38
10362859|NCT00513357|11503319|FG001|STARTED|Overall Study||35
10716400|NCT02688387|11880055|FG012|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10716401|NCT02688387|11880056|FG013|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10716402|NCT02688387|11880057|FG014|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10716403|NCT02688387|11880058|FG015|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10362860|NCT00513357|11503318|FG000|COMPLETED|Overall Study||23
10362861|NCT00513357|11503319|FG001|COMPLETED|Overall Study||25
10362862|NCT00513357|11503318|FG000|NOT COMPLETED|Overall Study||15
10362863|NCT00513357|11503319|FG001|NOT COMPLETED|Overall Study||10
10362864|NCT00513370|11503325|FG000|STARTED|Overall Study||203
10362865|NCT00513370|11503325|FG000|COMPLETED|Overall Study||179
10362866|NCT00513370|11503325|FG000|NOT COMPLETED|Overall Study||24
10362867|NCT00513409|11503333|FG000|STARTED|Overall Study||84
10362868|NCT00513409|11503334|FG001|STARTED|Overall Study||79
10362869|NCT00513409|11503333|FG000|COMPLETED|Overall Study||82
10362870|NCT00513409|11503334|FG001|COMPLETED|Overall Study||73
10362871|NCT00513409|11503333|FG000|NOT COMPLETED|Overall Study||2
10362872|NCT00513409|11503334|FG001|NOT COMPLETED|Overall Study||6
10362873|NCT00513435|11503340|FG000|STARTED|Overall Study||9
10362874|NCT00513435|11503340|FG000|COMPLETED|Overall Study||9
10362875|NCT00513435|11503340|FG000|NOT COMPLETED|Overall Study||0
10362876|NCT00513461|11503346|FG000|STARTED|Overall Study||57
10362877|NCT00513461|11503347|FG001|STARTED|Overall Study||53
10362878|NCT00513461|11503346|FG000|COMPLETED|Overall Study||44
10362879|NCT00513461|11503347|FG001|COMPLETED|Overall Study||43
10362880|NCT00513461|11503346|FG000|NOT COMPLETED|Overall Study||13
10362881|NCT00513461|11503347|FG001|NOT COMPLETED|Overall Study||10
10362882|NCT00513474|11503355|FG000|STARTED|Overall Study||25
10362883|NCT00513474|11503356|FG001|STARTED|Overall Study||21
10362884|NCT00513474|11503355|FG000|Received Rasburicase Per Protocol|Overall Study||24
10362885|NCT00513474|11503356|FG001|Received Rasburicase Per Protocol|Overall Study||0
10362886|NCT00513474|11503355|FG000|COMPLETED|Overall Study||18
10362887|NCT00513474|11503356|FG001|COMPLETED|Overall Study||12
10362888|NCT00513474|11503355|FG000|NOT COMPLETED|Overall Study||7
10362889|NCT00513474|11503356|FG001|NOT COMPLETED|Overall Study||9
10362890|NCT00513500|11503364|FG000|STARTED|Overall Study||1017
10362891|NCT00513500|11503365|FG001|STARTED|Overall Study||2108
10362892|NCT00513500|11503364|FG000|COMPLETED|Overall Study||976
10362893|NCT00513500|11503365|FG001|COMPLETED|Overall Study||2054
10362894|NCT00513500|11503364|FG000|NOT COMPLETED|Overall Study||41
10362895|NCT00513500|11503365|FG001|NOT COMPLETED|Overall Study||54
10362896|NCT00513526|11503371|FG000|STARTED|Overall Study||109
10362897|NCT00513526|11503371|FG000|COMPLETED|Overall Study||92
10362898|NCT00513526|11503371|FG000|NOT COMPLETED|Overall Study||17
10362899|NCT00513604|11503382|FG000|STARTED|Overall Study|Cohort 1 = unselected TIL|26
10362900|NCT00513604|11503383|FG001|STARTED|Overall Study|Cohort 2 = CD4+ depleted (selected) TIL|39
10362901|NCT00513604|11503384|FG002|STARTED|Overall Study|Cohort 3 = CD4+ depleted (selected) TIL + 600Gy radiation|24
10362902|NCT00513604|11503385|FG003|STARTED|Overall Study|Cohort 4 = unselected TIL - it is the SAME as cohort 1|34
10362903|NCT00513604|11503386|FG004|STARTED|Overall Study|Cohort 5 = CD4+ depleted TIL-it is the SAME as cohort 2|35
10362904|NCT00513604|11503382|FG000|COMPLETED|Overall Study||24
10362905|NCT00513604|11503383|FG001|COMPLETED|Overall Study||36
10362906|NCT00513604|11503384|FG002|COMPLETED|Overall Study||21
10362907|NCT00513604|11503385|FG003|COMPLETED|Overall Study||34
10362908|NCT00513604|11503386|FG004|COMPLETED|Overall Study||35
10362909|NCT00513604|11503382|FG000|NOT COMPLETED|Overall Study||2
10362910|NCT00513604|11503383|FG001|NOT COMPLETED|Overall Study||3
10362911|NCT00513604|11503384|FG002|NOT COMPLETED|Overall Study||3
10362912|NCT00513604|11503385|FG003|NOT COMPLETED|Overall Study||0
10362913|NCT00513604|11503386|FG004|NOT COMPLETED|Overall Study||0
10362914|NCT00513682|11503398|FG000|STARTED|Screening Phase||9
10362915|NCT00513682|11503398|FG000|COMPLETED|Screening Phase||9
10362916|NCT00513682|11503398|FG000|NOT COMPLETED|Screening Phase||0
10362917|NCT00513682|11503398|FG000|STARTED|Washout Phase||9
10362918|NCT00513682|11503398|FG000|COMPLETED|Washout Phase||7
10362919|NCT00513682|11503398|FG000|NOT COMPLETED|Washout Phase||2
10362920|NCT00513682|11503398|FG000|STARTED|Treatment Phase||7
10362921|NCT00513682|11503398|FG000|COMPLETED|Treatment Phase||7
10362922|NCT00513682|11503398|FG000|NOT COMPLETED|Treatment Phase||0
10362923|NCT00513695|11503405|FG000|STARTED|Overall Study||68
10362924|NCT00513695|11503405|FG000|COMPLETED|Overall Study||63
10362925|NCT00513695|11503405|FG000|NOT COMPLETED|Overall Study||5
10362926|NCT00513708|11503412|FG000|STARTED|Overall Study||50
10362927|NCT00513708|11503413|FG001|STARTED|Overall Study||50
10362928|NCT00513708|11503414|FG002|STARTED|Overall Study||50
10362929|NCT00513708|11503412|FG000|COMPLETED|Overall Study||46
10362930|NCT00513708|11503413|FG001|COMPLETED|Overall Study||46
10362931|NCT00513708|11503414|FG002|COMPLETED|Overall Study||46
10362932|NCT00513708|11503412|FG000|NOT COMPLETED|Overall Study||4
10362933|NCT00513708|11503413|FG001|NOT COMPLETED|Overall Study||4
10362934|NCT00513708|11503414|FG002|NOT COMPLETED|Overall Study||4
10362935|NCT00513747|11503425|FG000|STARTED|Overall Study||17
10362936|NCT00513747|11503426|FG001|STARTED|Overall Study||11
10362937|NCT00513747|11503427|FG002|STARTED|Overall Study||55
10362938|NCT00513747|11503425|FG000|Received at Least One Dose of Treatment|Overall Study||9
10362939|NCT00513747|11503426|FG001|Received at Least One Dose of Treatment|Overall Study||11
10362940|NCT00513747|11503427|FG002|Received at Least One Dose of Treatment|Overall Study||40
10362941|NCT00513747|11503425|FG000|COMPLETED|Overall Study||17
10362942|NCT00513747|11503426|FG001|COMPLETED|Overall Study||11
10362943|NCT00513747|11503427|FG002|COMPLETED|Overall Study||55
10362944|NCT00513747|11503425|FG000|NOT COMPLETED|Overall Study||0
10362945|NCT00513747|11503426|FG001|NOT COMPLETED|Overall Study||0
10362946|NCT00513747|11503427|FG002|NOT COMPLETED|Overall Study||0
10362947|NCT00513799|11503441|FG000|STARTED|One-Month Follow-Up||75
10362948|NCT00513799|11503442|FG001|STARTED|One-Month Follow-Up||75
10362949|NCT00513799|11503443|FG002|STARTED|One-Month Follow-Up||75
10362950|NCT00513799|11503444|FG003|STARTED|One-Month Follow-Up||75
10362951|NCT00513799|11503441|FG000|COMPLETED|One-Month Follow-Up||64
10362952|NCT00513799|11503442|FG001|COMPLETED|One-Month Follow-Up||62
10362953|NCT00513799|11503443|FG002|COMPLETED|One-Month Follow-Up||64
10362954|NCT00513799|11503444|FG003|COMPLETED|One-Month Follow-Up||54
10362955|NCT00513799|11503441|FG000|NOT COMPLETED|One-Month Follow-Up||11
10362956|NCT00513799|11503442|FG001|NOT COMPLETED|One-Month Follow-Up||13
10362957|NCT00513799|11503443|FG002|NOT COMPLETED|One-Month Follow-Up||11
10362958|NCT00513799|11503444|FG003|NOT COMPLETED|One-Month Follow-Up||21
10362959|NCT00513799|11503441|FG000|STARTED|Four-Month Follow-Up||64
10362960|NCT00513799|11503442|FG001|STARTED|Four-Month Follow-Up||62
10362961|NCT00513799|11503443|FG002|STARTED|Four-Month Follow-Up||64
10362962|NCT00513799|11503444|FG003|STARTED|Four-Month Follow-Up||54
10362963|NCT00513799|11503441|FG000|COMPLETED|Four-Month Follow-Up||64
10362964|NCT00513799|11503442|FG001|COMPLETED|Four-Month Follow-Up||57
10362965|NCT00513799|11503443|FG002|COMPLETED|Four-Month Follow-Up||57
10362966|NCT00513799|11503444|FG003|COMPLETED|Four-Month Follow-Up||51
10362967|NCT00513799|11503441|FG000|NOT COMPLETED|Four-Month Follow-Up||0
10362968|NCT00513799|11503442|FG001|NOT COMPLETED|Four-Month Follow-Up||5
10362969|NCT00513799|11503443|FG002|NOT COMPLETED|Four-Month Follow-Up||7
10362970|NCT00513799|11503444|FG003|NOT COMPLETED|Four-Month Follow-Up||3
10362971|NCT00514020|11503458|FG000|STARTED|Overall Study|two patients withdrew before treatment; one withdrew after treatment|33
10362972|NCT00514020|11503458|FG000|COMPLETED|Overall Study||5
10362973|NCT00514020|11503458|FG000|NOT COMPLETED|Overall Study||28
10362974|NCT00514046|11503471|FG000|STARTED|Overall Study||5
10362975|NCT00514046|11503472|FG001|STARTED|Overall Study||1
10362976|NCT00514046|11503473|FG002|STARTED|Overall Study||5
10362977|NCT00514046|11503474|FG003|STARTED|Overall Study||1
10362978|NCT00514046|11503475|FG004|STARTED|Overall Study||1
10362979|NCT00514046|11503476|FG005|STARTED|Overall Study||1
10362980|NCT00514046|11503477|FG006|STARTED|Overall Study||1
10362981|NCT00514046|11503478|FG007|STARTED|Overall Study||1
10362982|NCT00514046|11503479|FG008|STARTED|Overall Study||1
10362983|NCT00514046|11503471|FG000|COMPLETED|Overall Study||2
10362984|NCT00514046|11503472|FG001|COMPLETED|Overall Study||0
10362985|NCT00514046|11503473|FG002|COMPLETED|Overall Study||0
10362986|NCT00514046|11503474|FG003|COMPLETED|Overall Study||1
10362987|NCT00514046|11503475|FG004|COMPLETED|Overall Study||0
10362988|NCT00514046|11503476|FG005|COMPLETED|Overall Study||0
10362989|NCT00514046|11503477|FG006|COMPLETED|Overall Study||1
10362990|NCT00514046|11503478|FG007|COMPLETED|Overall Study||0
10362991|NCT00514046|11503479|FG008|COMPLETED|Overall Study||0
10362992|NCT00514046|11503471|FG000|NOT COMPLETED|Overall Study||3
10362993|NCT00514046|11503472|FG001|NOT COMPLETED|Overall Study||1
10362994|NCT00514046|11503473|FG002|NOT COMPLETED|Overall Study||5
10362995|NCT00514046|11503474|FG003|NOT COMPLETED|Overall Study||0
10362996|NCT00514046|11503475|FG004|NOT COMPLETED|Overall Study||1
10362997|NCT00514046|11503476|FG005|NOT COMPLETED|Overall Study||1
10362998|NCT00514046|11503477|FG006|NOT COMPLETED|Overall Study||0
10362999|NCT00514046|11503478|FG007|NOT COMPLETED|Overall Study||1
10363000|NCT00514046|11503479|FG008|NOT COMPLETED|Overall Study||1
10363001|NCT00514137|11503501|FG000|STARTED|Overall Study||13
10363002|NCT00514137|11503501|FG000|COMPLETED|Overall Study||13
10363003|NCT00514137|11503501|FG000|NOT COMPLETED|Overall Study||0
10363004|NCT00514215|11503505|FG000|STARTED|Overall Study||8
10363005|NCT00514215|11503505|FG000|COMPLETED|Overall Study||8
10363006|NCT00514215|11503505|FG000|NOT COMPLETED|Overall Study||0
10363007|NCT00514449|11503511|FG000|STARTED|Overall Study||12
10363008|NCT00514449|11503512|FG001|STARTED|Overall Study||12
10363009|NCT00514449|11503511|FG000|COMPLETED|Overall Study||9
10363010|NCT00514449|11503512|FG001|COMPLETED|Overall Study||8
10363011|NCT00514449|11503511|FG000|NOT COMPLETED|Overall Study||3
10363012|NCT00514449|11503512|FG001|NOT COMPLETED|Overall Study||4
10363013|NCT00514501|11503521|FG000|STARTED|Overall Study||510
10363014|NCT00514501|11503521|FG000|COMPLETED|Overall Study||507
10363015|NCT00514501|11503521|FG000|NOT COMPLETED|Overall Study||3
10363016|NCT00514514|11503528|FG000|STARTED|Pre-phase|All enrolled patients received standard regimen for 3 months|802
10363017|NCT00514514|11503529|FG001|STARTED|Pre-phase||0
10363018|NCT00514514|11503530|FG002|STARTED|Pre-phase||0
10363019|NCT00514514|11503528|FG000|COMPLETED|Pre-phase||499
10363020|NCT00514514|11503529|FG001|COMPLETED|Pre-phase||0
10363021|NCT00514514|11503530|FG002|COMPLETED|Pre-phase||0
10363022|NCT00514514|11503528|FG000|NOT COMPLETED|Pre-phase||303
10363023|NCT00514514|11503529|FG001|NOT COMPLETED|Pre-phase||0
10363024|NCT00514514|11503530|FG002|NOT COMPLETED|Pre-phase||0
10363025|NCT00514514|11503528|FG000|STARTED|Randomized - 9 Month||166
10363026|NCT00514514|11503529|FG001|STARTED|Randomized - 9 Month||171
10363027|NCT00514514|11503530|FG002|STARTED|Randomized - 9 Month||162
10363028|NCT00514514|11503528|FG000|Randomized - Received Treatment|Randomized - 9 Month||165
10363029|NCT00514514|11503529|FG001|Randomized - Received Treatment|Randomized - 9 Month||171
10363030|NCT00514514|11503530|FG002|Randomized - Received Treatment|Randomized - 9 Month||161
10363031|NCT00514514|11503528|FG000|COMPLETED|Randomized - 9 Month||127
10363032|NCT00514514|11503529|FG001|COMPLETED|Randomized - 9 Month||110
10363033|NCT00514514|11503530|FG002|COMPLETED|Randomized - 9 Month||124
10363034|NCT00514514|11503528|FG000|NOT COMPLETED|Randomized - 9 Month||39
10363035|NCT00514514|11503529|FG001|NOT COMPLETED|Randomized - 9 Month||61
10363036|NCT00514514|11503530|FG002|NOT COMPLETED|Randomized - 9 Month||38
10363037|NCT00514514|11503528|FG000|STARTED|Extension - 4 Years||145
10363038|NCT00514514|11503529|FG001|STARTED|Extension - 4 Years||139
10363039|NCT00514514|11503530|FG002|STARTED|Extension - 4 Years||134
10363040|NCT00514514|11503528|FG000|Non-randomized (Followed)|Extension - 4 Years|Patients were not randomized but continued on standard regimen and entered follow up.|95
10363041|NCT00514514|11503529|FG001|Non-randomized (Followed)|Extension - 4 Years||0
10363042|NCT00514514|11503530|FG002|Non-randomized (Followed)|Extension - 4 Years||0
10363043|NCT00514514|11503528|FG000|COMPLETED|Extension - 4 Years||108
10363044|NCT00514514|11503529|FG001|COMPLETED|Extension - 4 Years||117
10363045|NCT00514514|11503530|FG002|COMPLETED|Extension - 4 Years||113
10363046|NCT00514514|11503528|FG000|NOT COMPLETED|Extension - 4 Years||37
10363047|NCT00514514|11503529|FG001|NOT COMPLETED|Extension - 4 Years||22
10363048|NCT00514514|11503530|FG002|NOT COMPLETED|Extension - 4 Years||21
10363049|NCT00514540|11503538|FG000|STARTED|First-Line Chemo||113
10363050|NCT00514540|11503538|FG000|COMPLETED|First-Line Chemo||105
10363051|NCT00514540|11503538|FG000|NOT COMPLETED|First-Line Chemo||8
10363052|NCT00514540|11503538|FG000|STARTED|Second-Line||105
10363053|NCT00514540|11503538|FG000|COMPLETED|Second-Line||74
10363054|NCT00514540|11503538|FG000|NOT COMPLETED|Second-Line||31
10363055|NCT00514592|11503546|FG000|STARTED|Overall Study||230
10363056|NCT00514592|11503546|FG000|COMPLETED|Overall Study||230
10363057|NCT00514592|11503546|FG000|NOT COMPLETED|Overall Study||0
10363058|NCT00514683|11503555|FG000|STARTED|Overall Study|Randomised|87
10363059|NCT00514683|11503556|FG001|STARTED|Overall Study|Randomised|87
10363060|NCT00514683|11503557|FG002|STARTED|Overall Study|Randomised|86
10363061|NCT00514683|11503558|FG003|STARTED|Overall Study|Randomised|86
10363062|NCT00514683|11503559|FG004|STARTED|Overall Study|Randomised|86
10363063|NCT00514683|11503555|FG000|COMPLETED|Overall Study||61
10363064|NCT00514683|11503556|FG001|COMPLETED|Overall Study||62
10363065|NCT00514683|11503557|FG002|COMPLETED|Overall Study||68
10363066|NCT00514683|11503558|FG003|COMPLETED|Overall Study||72
10363067|NCT00514683|11503559|FG004|COMPLETED|Overall Study||53
10363068|NCT00514683|11503555|FG000|NOT COMPLETED|Overall Study||26
10363069|NCT00514683|11503556|FG001|NOT COMPLETED|Overall Study||25
10363070|NCT00514683|11503557|FG002|NOT COMPLETED|Overall Study||18
10363071|NCT00514683|11503558|FG003|NOT COMPLETED|Overall Study||14
10363072|NCT00514683|11503559|FG004|NOT COMPLETED|Overall Study||33
10363073|NCT00514709|11503577|FG000|STARTED|Overall Study||1230
10363074|NCT00514709|11503578|FG001|STARTED|Overall Study||613
10363075|NCT00514709|11503577|FG000|COMPLETED|Overall Study||1230
10363076|NCT00514709|11503578|FG001|COMPLETED|Overall Study||613
10363077|NCT00514709|11503577|FG000|NOT COMPLETED|Overall Study||0
10363078|NCT00514709|11503578|FG001|NOT COMPLETED|Overall Study||0
10363079|NCT00514735|11503588|FG000|STARTED|Overall Study||138
10363080|NCT00514735|11503589|FG001|STARTED|Overall Study||72
10363081|NCT00514735|11503588|FG000|COMPLETED|Overall Study||124
10363082|NCT00514735|11503589|FG001|COMPLETED|Overall Study||66
10363083|NCT00514735|11503588|FG000|NOT COMPLETED|Overall Study||14
10363084|NCT00514735|11503589|FG001|NOT COMPLETED|Overall Study||6
10363085|NCT00514852|11503599|FG000|STARTED|Overall Study||157
10363086|NCT00514852|11503600|FG001|STARTED|Overall Study||159
10363087|NCT00514852|11503599|FG000|COMPLETED|Overall Study||152
10363088|NCT00514852|11503600|FG001|COMPLETED|Overall Study||154
10363089|NCT00514852|11503599|FG000|NOT COMPLETED|Overall Study||5
10363090|NCT00514852|11503600|FG001|NOT COMPLETED|Overall Study||5
10363091|NCT00514904|11503608|FG000|STARTED|Overall Study||1125
10363092|NCT00514904|11503609|FG001|STARTED|Overall Study||376
10363093|NCT00514904|11503608|FG000|COMPLETED|Overall Study||1101
10363094|NCT00514904|11503609|FG001|COMPLETED|Overall Study||371
10363095|NCT00514904|11503608|FG000|NOT COMPLETED|Overall Study||24
10363096|NCT00514904|11503609|FG001|NOT COMPLETED|Overall Study||5
10363097|NCT00514917|11503617|FG000|STARTED|Overall Study||207
10363098|NCT00514917|11503618|FG001|STARTED|Overall Study||206
10363099|NCT00514917|11503617|FG000|Treated|Overall Study||196
10363100|NCT00514917|11503618|FG001|Treated|Overall Study||204
10363101|NCT00514917|11503617|FG000|Completed Study Treatment|Overall Study||170
10363102|NCT00514917|11503618|FG001|Completed Study Treatment|Overall Study||182
10363103|NCT00514917|11503617|FG000|Testosterone-Specific Evaluable|Overall Study||122
10363104|NCT00514917|11503618|FG001|Testosterone-Specific Evaluable|Overall Study||124
10363105|NCT00514917|11503617|FG000|COMPLETED|Overall Study||81
10363106|NCT00514917|11503618|FG001|COMPLETED|Overall Study||91
10363107|NCT00514917|11503617|FG000|NOT COMPLETED|Overall Study||126
10363108|NCT00514917|11503618|FG001|NOT COMPLETED|Overall Study||115
10363109|NCT00514943|11503628|FG000|STARTED|Stage 1|1 randomized patient was not treated|62
10363110|NCT00514943|11503629|FG001|STARTED|Stage 1|2 randomized patients were not treated|62
10363111|NCT00514943|11503628|FG000|COMPLETED|Stage 1||32
10363112|NCT00514943|11503629|FG001|COMPLETED|Stage 1||36
10363113|NCT00514943|11503628|FG000|NOT COMPLETED|Stage 1||30
10363114|NCT00514943|11503629|FG001|NOT COMPLETED|Stage 1||26
10363115|NCT00514943|11503628|FG000|STARTED|Stage 2||32
10363116|NCT00514943|11503629|FG001|STARTED|Stage 2||36
10363117|NCT00514943|11503628|FG000|COMPLETED|Stage 2||0
10363118|NCT00514943|11503629|FG001|COMPLETED|Stage 2||0
10363119|NCT00514943|11503628|FG000|NOT COMPLETED|Stage 2||32
10363120|NCT00514943|11503629|FG001|NOT COMPLETED|Stage 2||36
10363121|NCT00515008|11503652|FG000|STARTED|Overall Study||33
10363122|NCT00515008|11503653|FG001|STARTED|Overall Study||33
10363123|NCT00515008|11503652|FG000|Completed 12 Week Evaluation|Overall Study||32
10363124|NCT00515008|11503653|FG001|Completed 12 Week Evaluation|Overall Study||29
10363125|NCT00515008|11503652|FG000|COMPLETED|Overall Study||30
10363126|NCT00515008|11503653|FG001|COMPLETED|Overall Study||29
10363127|NCT00515008|11503652|FG000|NOT COMPLETED|Overall Study||3
10363128|NCT00515008|11503653|FG001|NOT COMPLETED|Overall Study||4
10363129|NCT00515021|11503664|FG000|STARTED|Overall Study||9
10363130|NCT00515021|11503665|FG001|STARTED|Overall Study||11
10363131|NCT00515021|11503664|FG000|COMPLETED|Overall Study||9
10363132|NCT00515021|11503665|FG001|COMPLETED|Overall Study||11
10363133|NCT00515021|11503664|FG000|NOT COMPLETED|Overall Study||0
10363134|NCT00515021|11503665|FG001|NOT COMPLETED|Overall Study||0
10363135|NCT00515034|11503677|FG000|STARTED|Overall Study||49
10363136|NCT00515034|11503678|FG001|STARTED|Overall Study||15
10363137|NCT00515034|11503679|FG002|STARTED|Overall Study||62
10363138|NCT00515034|11503680|FG003|STARTED|Overall Study||20
10363139|NCT00515034|11503677|FG000|TREATED|Overall Study||48
10363140|NCT00515034|11503678|FG001|TREATED|Overall Study||15
10363141|NCT00515034|11503679|FG002|TREATED|Overall Study||61
10363142|NCT00515034|11503680|FG003|TREATED|Overall Study||19
10363143|NCT00515034|11503677|FG000|COMPLETED|Overall Study||41
10535373|NCT01436162|11687695|FG002|STARTED|Randomized Phase|One subject was randomized to this arm but did not receive at least 1 dose of double-blind treatment|214
10535374|NCT01436162|11687693|FG000|COMPLETED|Randomized Phase||353
10535375|NCT01436162|11687694|FG001|COMPLETED|Randomized Phase||181
10535376|NCT01436162|11687695|FG002|COMPLETED|Randomized Phase||189
10535377|NCT01436162|11687693|FG000|NOT COMPLETED|Randomized Phase||44
10535378|NCT01436162|11687694|FG001|NOT COMPLETED|Randomized Phase||31
10535379|NCT01436162|11687695|FG002|NOT COMPLETED|Randomized Phase||25
10535380|NCT01436175|11687703|FG000|STARTED|Overall Study||1570
10535381|NCT01436175|11687703|FG000|COMPLETED|Overall Study||300
10535382|NCT01436175|11687703|FG000|NOT COMPLETED|Overall Study||1270
10535383|NCT01436201|11687708|FG000|STARTED|Overall Study||24
10535384|NCT01436201|11687708|FG000|Received at Least 1 Dose of Study Drug|Overall Study||24
10535385|NCT01436201|11687708|FG000|COMPLETED|Overall Study||20
10535386|NCT01436201|11687708|FG000|NOT COMPLETED|Overall Study||4
10535387|NCT01436266|11687716|FG000|STARTED|Overall Study||1
10535388|NCT01436266|11687717|FG001|STARTED|Overall Study||1
10535389|NCT01436266|11687716|FG000|COMPLETED|Overall Study||1
10535390|NCT01436266|11687717|FG001|COMPLETED|Overall Study||1
10363144|NCT00515034|11503678|FG001|COMPLETED|Overall Study||13
10363145|NCT00515034|11503679|FG002|COMPLETED|Overall Study||54
10363146|NCT00515034|11503680|FG003|COMPLETED|Overall Study||15
10363147|NCT00515034|11503677|FG000|NOT COMPLETED|Overall Study||8
10363148|NCT00515034|11503678|FG001|NOT COMPLETED|Overall Study||2
10363149|NCT00515034|11503679|FG002|NOT COMPLETED|Overall Study||8
10363150|NCT00515034|11503680|FG003|NOT COMPLETED|Overall Study||5
10363151|NCT00515073|11503690|FG000|STARTED|Overall Study||30
10363152|NCT00515073|11503690|FG000|COMPLETED|Overall Study||28
10363153|NCT00515073|11503690|FG000|NOT COMPLETED|Overall Study||2
10363154|NCT00515086|11503698|FG000|STARTED|Overall Study||24
10535391|NCT01436266|11687716|FG000|NOT COMPLETED|Overall Study||0
10535392|NCT01436266|11687717|FG001|NOT COMPLETED|Overall Study||0
10535393|NCT01436279|11687725|FG000|STARTED|Overall Study||30
10535394|NCT01436279|11687726|FG001|STARTED|Overall Study||20
10535395|NCT01436279|11687725|FG000|COMPLETED|Overall Study||30
10535396|NCT01436279|11687726|FG001|COMPLETED|Overall Study||20
10363155|NCT00515086|11503699|FG001|STARTED|Overall Study||6
10363156|NCT00515086|11503700|FG002|STARTED|Overall Study||5
10363157|NCT00515086|11503701|FG003|STARTED|Overall Study||6
10363158|NCT00515086|11503698|FG000|COMPLETED|Overall Study||0
10363159|NCT00515086|11503699|FG001|COMPLETED|Overall Study||0
10363160|NCT00515086|11503700|FG002|COMPLETED|Overall Study||0
10363161|NCT00515086|11503701|FG003|COMPLETED|Overall Study||0
10363162|NCT00515086|11503698|FG000|NOT COMPLETED|Overall Study||24
10363163|NCT00515086|11503699|FG001|NOT COMPLETED|Overall Study||6
10363164|NCT00515086|11503700|FG002|NOT COMPLETED|Overall Study||5
10363165|NCT00515086|11503701|FG003|NOT COMPLETED|Overall Study||6
10363166|NCT00515099|11503719|FG000|STARTED|Overall Study||38
10363167|NCT00515099|11503720|FG001|STARTED|Overall Study||20
10363168|NCT00515099|11503719|FG000|COMPLETED|Overall Study||35
10363169|NCT00515099|11503720|FG001|COMPLETED|Overall Study||16
10363170|NCT00515099|11503719|FG000|NOT COMPLETED|Overall Study||3
10363171|NCT00515099|11503720|FG001|NOT COMPLETED|Overall Study||4
10363172|NCT00515177|11503728|FG000|STARTED|Overall Study||20
10363173|NCT00515177|11503729|FG001|STARTED|Overall Study||10
10363174|NCT00515177|11503728|FG000|COMPLETED|Overall Study||18
10363175|NCT00515177|11503729|FG001|COMPLETED|Overall Study||9
10363176|NCT00515177|11503728|FG000|NOT COMPLETED|Overall Study||2
10363177|NCT00515177|11503729|FG001|NOT COMPLETED|Overall Study||1
10363178|NCT00515203|11503738|FG000|STARTED|Overall Study||17
10363179|NCT00515203|11503739|FG001|STARTED|Overall Study||5
10363180|NCT00515203|11503738|FG000|COMPLETED|Overall Study||17
10363181|NCT00515203|11503739|FG001|COMPLETED|Overall Study||5
10363182|NCT00515203|11503738|FG000|NOT COMPLETED|Overall Study||0
10363183|NCT00515203|11503739|FG001|NOT COMPLETED|Overall Study||0
10363184|NCT00515216|11503745|FG000|STARTED|Overall Study||26
10363185|NCT00515216|11503745|FG000|COMPLETED|Overall Study||25
10363186|NCT00515216|11503745|FG000|NOT COMPLETED|Overall Study||1
10363187|NCT00515294|11503754|FG000|STARTED|Overall Study||38
10363188|NCT00515294|11503755|FG001|STARTED|Overall Study||39
10363189|NCT00515294|11503756|FG002|STARTED|Overall Study||38
10363190|NCT00515294|11503757|FG003|STARTED|Overall Study||39
10363191|NCT00515294|11503754|FG000|COMPLETED|Overall Study||29
10363192|NCT00515294|11503755|FG001|COMPLETED|Overall Study||36
10363193|NCT00515294|11503756|FG002|COMPLETED|Overall Study||27
10363194|NCT00515294|11503757|FG003|COMPLETED|Overall Study||35
10363195|NCT00515294|11503754|FG000|NOT COMPLETED|Overall Study||9
10363196|NCT00515294|11503755|FG001|NOT COMPLETED|Overall Study||3
10363197|NCT00515294|11503756|FG002|NOT COMPLETED|Overall Study||11
10363198|NCT00515294|11503757|FG003|NOT COMPLETED|Overall Study||4
10363199|NCT00515411|11503770|FG000|STARTED|Overall Study||54
10363200|NCT00515411|11503771|FG001|STARTED|Overall Study||31
10363201|NCT00515411|11503772|FG002|STARTED|Overall Study||26
10363202|NCT00515411|11503770|FG000|COMPLETED|Overall Study||54
10363203|NCT00515411|11503771|FG001|COMPLETED|Overall Study||31
10363204|NCT00515411|11503772|FG002|COMPLETED|Overall Study||26
10363205|NCT00515411|11503770|FG000|NOT COMPLETED|Overall Study||0
10363206|NCT00515411|11503771|FG001|NOT COMPLETED|Overall Study||0
10363207|NCT00515411|11503772|FG002|NOT COMPLETED|Overall Study||0
10363208|NCT00515437|11503784|FG000|STARTED|Overall Study||14
10363209|NCT00515437|11503785|FG001|STARTED|Overall Study||12
10363210|NCT00515437|11503786|FG002|STARTED|Overall Study||13
10363211|NCT00515437|11503787|FG003|STARTED|Overall Study||15
10363212|NCT00515437|11503784|FG000|COMPLETED|Overall Study||14
10363213|NCT00515437|11503785|FG001|COMPLETED|Overall Study||12
10363214|NCT00515437|11503786|FG002|COMPLETED|Overall Study||13
10363215|NCT00515437|11503787|FG003|COMPLETED|Overall Study||14
10363216|NCT00515437|11503784|FG000|NOT COMPLETED|Overall Study||0
10363217|NCT00515437|11503785|FG001|NOT COMPLETED|Overall Study||0
10363218|NCT00515437|11503786|FG002|NOT COMPLETED|Overall Study||0
10363219|NCT00515437|11503787|FG003|NOT COMPLETED|Overall Study||1
10363220|NCT00515463|11503799|FG000|STARTED|Overall Study||155
10363221|NCT00515463|11503800|FG001|STARTED|Overall Study||156
10363222|NCT00515463|11503799|FG000|Received Study Medication|Overall Study||154
10716404|NCT02688387|11880059|FG016|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10716405|NCT02688387|11880060|FG017|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10716406|NCT02688387|11880061|FG018|COMPLETED|Part 3B, Period 4 (up to 6 Days)||7
10716407|NCT02688387|11880062|FG019|COMPLETED|Part 3B, Period 4 (up to 6 Days)||7
10363223|NCT00515463|11503800|FG001|Received Study Medication|Overall Study||156
10363224|NCT00515463|11503799|FG000|COMPLETED|Overall Study||141
10363225|NCT00515463|11503800|FG001|COMPLETED|Overall Study||142
10363226|NCT00515463|11503799|FG000|NOT COMPLETED|Overall Study||14
10363227|NCT00515463|11503800|FG001|NOT COMPLETED|Overall Study||14
10363228|NCT00515502|11503807|FG000|STARTED|Treatment Period 1||1
10363229|NCT00515502|11503808|FG001|STARTED|Treatment Period 1||4
10363230|NCT00515502|11503809|FG002|STARTED|Treatment Period 1||4
10363231|NCT00515502|11503810|FG003|STARTED|Treatment Period 1||3
10363232|NCT00515502|11503811|FG004|STARTED|Treatment Period 1||3
10363233|NCT00515502|11503812|FG005|STARTED|Treatment Period 1||1
10363234|NCT00515502|11503813|FG006|STARTED|Treatment Period 1||2
10363235|NCT00515502|11503814|FG007|STARTED|Treatment Period 1||1
10363236|NCT00515502|11503815|FG008|STARTED|Treatment Period 1||1
10363237|NCT00515502|11503816|FG009|STARTED|Treatment Period 1||2
10363238|NCT00515502|11503817|FG010|STARTED|Treatment Period 1||1
10363239|NCT00515502|11503818|FG011|STARTED|Treatment Period 1||1
10363240|NCT00515502|11503807|FG000|COMPLETED|Treatment Period 1||1
10363241|NCT00515502|11503808|FG001|COMPLETED|Treatment Period 1||4
10363242|NCT00515502|11503809|FG002|COMPLETED|Treatment Period 1||4
10363243|NCT00515502|11503810|FG003|COMPLETED|Treatment Period 1||3
10363244|NCT00515502|11503811|FG004|COMPLETED|Treatment Period 1||3
10363245|NCT00515502|11503812|FG005|COMPLETED|Treatment Period 1||1
10363246|NCT00515502|11503813|FG006|COMPLETED|Treatment Period 1||1
10363247|NCT00515502|11503814|FG007|COMPLETED|Treatment Period 1||1
10363248|NCT00515502|11503815|FG008|COMPLETED|Treatment Period 1||0
10363249|NCT00515502|11503816|FG009|COMPLETED|Treatment Period 1||2
10363250|NCT00515502|11503817|FG010|COMPLETED|Treatment Period 1||1
10363251|NCT00515502|11503818|FG011|COMPLETED|Treatment Period 1||0
10363252|NCT00515502|11503807|FG000|NOT COMPLETED|Treatment Period 1||0
10363253|NCT00515502|11503808|FG001|NOT COMPLETED|Treatment Period 1||0
10363254|NCT00515502|11503809|FG002|NOT COMPLETED|Treatment Period 1||0
10363255|NCT00515502|11503810|FG003|NOT COMPLETED|Treatment Period 1||0
10363256|NCT00515502|11503811|FG004|NOT COMPLETED|Treatment Period 1||0
10363257|NCT00515502|11503812|FG005|NOT COMPLETED|Treatment Period 1||0
10363258|NCT00515502|11503813|FG006|NOT COMPLETED|Treatment Period 1||1
10363259|NCT00515502|11503814|FG007|NOT COMPLETED|Treatment Period 1||0
10363260|NCT00515502|11503815|FG008|NOT COMPLETED|Treatment Period 1||1
10363261|NCT00515502|11503816|FG009|NOT COMPLETED|Treatment Period 1||0
10363262|NCT00515502|11503817|FG010|NOT COMPLETED|Treatment Period 1||0
10363263|NCT00515502|11503818|FG011|NOT COMPLETED|Treatment Period 1||1
10363264|NCT00515502|11503807|FG000|STARTED|Washout Period 1||1
10363265|NCT00515502|11503808|FG001|STARTED|Washout Period 1||4
10363266|NCT00515502|11503809|FG002|STARTED|Washout Period 1||4
10363267|NCT00515502|11503810|FG003|STARTED|Washout Period 1||3
10363268|NCT00515502|11503811|FG004|STARTED|Washout Period 1||3
10363269|NCT00515502|11503812|FG005|STARTED|Washout Period 1||1
10363270|NCT00515502|11503813|FG006|STARTED|Washout Period 1||1
10716408|NCT02688387|11880063|FG020|COMPLETED|Part 3B, Period 4 (up to 6 Days)||6
10363271|NCT00515502|11503814|FG007|STARTED|Washout Period 1||1
10363272|NCT00515502|11503815|FG008|STARTED|Washout Period 1||0
10363273|NCT00515502|11503816|FG009|STARTED|Washout Period 1||2
10363274|NCT00515502|11503817|FG010|STARTED|Washout Period 1||1
10363275|NCT00515502|11503818|FG011|STARTED|Washout Period 1||0
10363276|NCT00515502|11503807|FG000|COMPLETED|Washout Period 1||1
10363277|NCT00515502|11503808|FG001|COMPLETED|Washout Period 1||4
10363278|NCT00515502|11503809|FG002|COMPLETED|Washout Period 1||4
10363279|NCT00515502|11503810|FG003|COMPLETED|Washout Period 1||3
10363280|NCT00515502|11503811|FG004|COMPLETED|Washout Period 1||3
10363281|NCT00515502|11503812|FG005|COMPLETED|Washout Period 1||1
10363282|NCT00515502|11503813|FG006|COMPLETED|Washout Period 1||1
10363283|NCT00515502|11503814|FG007|COMPLETED|Washout Period 1||1
10363284|NCT00515502|11503815|FG008|COMPLETED|Washout Period 1||0
10363285|NCT00515502|11503816|FG009|COMPLETED|Washout Period 1||2
10363286|NCT00515502|11503817|FG010|COMPLETED|Washout Period 1||1
10363287|NCT00515502|11503818|FG011|COMPLETED|Washout Period 1||0
10363288|NCT00515502|11503807|FG000|NOT COMPLETED|Washout Period 1||0
10363289|NCT00515502|11503808|FG001|NOT COMPLETED|Washout Period 1||0
10363290|NCT00515502|11503809|FG002|NOT COMPLETED|Washout Period 1||0
10535397|NCT01436279|11687725|FG000|NOT COMPLETED|Overall Study||0
10535398|NCT01436279|11687726|FG001|NOT COMPLETED|Overall Study||0
10535399|NCT01436305|11687737|FG000|STARTED|Overall Study||6
10535400|NCT01436305|11687738|FG001|STARTED|Overall Study||6
10535401|NCT01436305|11687739|FG002|STARTED|Overall Study||7
10535402|NCT01436305|11687737|FG000|COMPLETED|Overall Study||4
10535403|NCT01436305|11687738|FG001|COMPLETED|Overall Study||2
10535404|NCT01436305|11687739|FG002|COMPLETED|Overall Study||7
10535405|NCT01436305|11687737|FG000|NOT COMPLETED|Overall Study||2
10535406|NCT01436305|11687738|FG001|NOT COMPLETED|Overall Study||4
10535407|NCT01436305|11687739|FG002|NOT COMPLETED|Overall Study||0
10535408|NCT01436357|11687749|FG000|STARTED|Overall Study||274
10535409|NCT01436357|11687750|FG001|STARTED|Overall Study||274
10535410|NCT01436357|11687749|FG000|Stage 1|Overall Study||49
10535411|NCT01436357|11687750|FG001|Stage 1|Overall Study||48
10535412|NCT01436357|11687749|FG000|Stage 2|Overall Study||225
10656735|NCT02219932|11817790|FG001|Randomized, Not Treated|Overall Study||1
10363291|NCT00515502|11503810|FG003|NOT COMPLETED|Washout Period 1||0
10535413|NCT01436357|11687750|FG001|Stage 2|Overall Study||226
10535414|NCT01436357|11687749|FG000|COMPLETED|Overall Study||152
10535415|NCT01436357|11687750|FG001|COMPLETED|Overall Study||146
10535416|NCT01436357|11687749|FG000|NOT COMPLETED|Overall Study||122
10535417|NCT01436357|11687750|FG001|NOT COMPLETED|Overall Study||128
10535418|NCT01436370|11687764|FG000|STARTED|Overall Study||6
10535419|NCT01436370|11687765|FG001|STARTED|Overall Study||6
10535420|NCT01436370|11687766|FG002|STARTED|Overall Study||10
10535421|NCT01436370|11687767|FG003|STARTED|Overall Study||10
10535422|NCT01436370|11687768|FG004|STARTED|Overall Study||19
10535423|NCT01436370|11687769|FG005|STARTED|Overall Study||19
10535424|NCT01436370|11687770|FG006|STARTED|Overall Study||16
10656736|NCT02219932|11817789|FG000|COMPLETED|Overall Study||254
10656737|NCT02219932|11817790|FG001|COMPLETED|Overall Study||266
10656738|NCT02219932|11817789|FG000|NOT COMPLETED|Overall Study||65
10656739|NCT02219932|11817790|FG001|NOT COMPLETED|Overall Study||51
10656740|NCT02219997|11817798|FG000|STARTED|First Filter||33
10656741|NCT02219997|11817799|FG001|STARTED|First Filter||17
10656742|NCT02219997|11817800|FG002|STARTED|First Filter||18
10656743|NCT02219997|11817798|FG000|COMPLETED|First Filter||33
10656744|NCT02219997|11817799|FG001|COMPLETED|First Filter||17
10656745|NCT02219997|11817800|FG002|COMPLETED|First Filter||18
10656746|NCT02219997|11817798|FG000|NOT COMPLETED|First Filter||0
10363292|NCT00515502|11503811|FG004|NOT COMPLETED|Washout Period 1||0
10363293|NCT00515502|11503812|FG005|NOT COMPLETED|Washout Period 1||0
10363294|NCT00515502|11503813|FG006|NOT COMPLETED|Washout Period 1||0
10363295|NCT00515502|11503814|FG007|NOT COMPLETED|Washout Period 1||0
10363296|NCT00515502|11503815|FG008|NOT COMPLETED|Washout Period 1||0
10363297|NCT00515502|11503816|FG009|NOT COMPLETED|Washout Period 1||0
10363298|NCT00515502|11503817|FG010|NOT COMPLETED|Washout Period 1||0
10363299|NCT00515502|11503818|FG011|NOT COMPLETED|Washout Period 1||0
10363300|NCT00515502|11503807|FG000|STARTED|Treatment Period 2||1
10363301|NCT00515502|11503808|FG001|STARTED|Treatment Period 2||4
10363302|NCT00515502|11503809|FG002|STARTED|Treatment Period 2||4
10363303|NCT00515502|11503810|FG003|STARTED|Treatment Period 2||3
10363304|NCT00515502|11503811|FG004|STARTED|Treatment Period 2||3
10363305|NCT00515502|11503812|FG005|STARTED|Treatment Period 2||1
10363306|NCT00515502|11503813|FG006|STARTED|Treatment Period 2||1
10363307|NCT00515502|11503814|FG007|STARTED|Treatment Period 2||1
10363308|NCT00515502|11503815|FG008|STARTED|Treatment Period 2||0
10363309|NCT00515502|11503816|FG009|STARTED|Treatment Period 2||2
10363310|NCT00515502|11503817|FG010|STARTED|Treatment Period 2||1
10363311|NCT00515502|11503818|FG011|STARTED|Treatment Period 2||0
10363312|NCT00515502|11503807|FG000|COMPLETED|Treatment Period 2||1
10363313|NCT00515502|11503808|FG001|COMPLETED|Treatment Period 2||3
10363314|NCT00515502|11503809|FG002|COMPLETED|Treatment Period 2||4
10363315|NCT00515502|11503810|FG003|COMPLETED|Treatment Period 2||3
10363316|NCT00515502|11503811|FG004|COMPLETED|Treatment Period 2||3
10363317|NCT00515502|11503812|FG005|COMPLETED|Treatment Period 2||1
10363318|NCT00515502|11503813|FG006|COMPLETED|Treatment Period 2||1
10363319|NCT00515502|11503814|FG007|COMPLETED|Treatment Period 2||1
10363320|NCT00515502|11503815|FG008|COMPLETED|Treatment Period 2||0
10535425|NCT01436370|11687771|FG007|STARTED|Overall Study||16
10535426|NCT01436370|11687764|FG000|COMPLETED|Overall Study||6
10535427|NCT01436370|11687765|FG001|COMPLETED|Overall Study||6
10535428|NCT01436370|11687766|FG002|COMPLETED|Overall Study||10
10535429|NCT01436370|11687767|FG003|COMPLETED|Overall Study||10
10535430|NCT01436370|11687768|FG004|COMPLETED|Overall Study||18
10535431|NCT01436370|11687769|FG005|COMPLETED|Overall Study||19
10535432|NCT01436370|11687770|FG006|COMPLETED|Overall Study||16
10535433|NCT01436370|11687771|FG007|COMPLETED|Overall Study||16
10535434|NCT01436370|11687764|FG000|NOT COMPLETED|Overall Study||0
10535435|NCT01436370|11687765|FG001|NOT COMPLETED|Overall Study||0
10535436|NCT01436370|11687766|FG002|NOT COMPLETED|Overall Study||0
10535437|NCT01436370|11687767|FG003|NOT COMPLETED|Overall Study||0
10656747|NCT02219997|11817799|FG001|NOT COMPLETED|First Filter||0
10363321|NCT00515502|11503816|FG009|COMPLETED|Treatment Period 2||2
10363322|NCT00515502|11503817|FG010|COMPLETED|Treatment Period 2||1
10363323|NCT00515502|11503818|FG011|COMPLETED|Treatment Period 2||0
10363324|NCT00515502|11503807|FG000|NOT COMPLETED|Treatment Period 2||0
10363325|NCT00515502|11503808|FG001|NOT COMPLETED|Treatment Period 2||1
10363326|NCT00515502|11503809|FG002|NOT COMPLETED|Treatment Period 2||0
10363327|NCT00515502|11503810|FG003|NOT COMPLETED|Treatment Period 2||0
10363328|NCT00515502|11503811|FG004|NOT COMPLETED|Treatment Period 2||0
10363329|NCT00515502|11503812|FG005|NOT COMPLETED|Treatment Period 2||0
10363330|NCT00515502|11503813|FG006|NOT COMPLETED|Treatment Period 2||0
10363331|NCT00515502|11503814|FG007|NOT COMPLETED|Treatment Period 2||0
10363332|NCT00515502|11503815|FG008|NOT COMPLETED|Treatment Period 2||0
10363333|NCT00515502|11503816|FG009|NOT COMPLETED|Treatment Period 2||0
10363334|NCT00515502|11503817|FG010|NOT COMPLETED|Treatment Period 2||0
10363335|NCT00515502|11503818|FG011|NOT COMPLETED|Treatment Period 2||0
10363336|NCT00515502|11503807|FG000|STARTED|Washout Period 2||1
10363337|NCT00515502|11503808|FG001|STARTED|Washout Period 2||3
10363338|NCT00515502|11503809|FG002|STARTED|Washout Period 2||4
10363339|NCT00515502|11503810|FG003|STARTED|Washout Period 2||3
10363340|NCT00515502|11503811|FG004|STARTED|Washout Period 2||3
10363341|NCT00515502|11503812|FG005|STARTED|Washout Period 2||1
10363342|NCT00515502|11503813|FG006|STARTED|Washout Period 2||1
10363343|NCT00515502|11503814|FG007|STARTED|Washout Period 2||1
10363344|NCT00515502|11503815|FG008|STARTED|Washout Period 2||0
10363345|NCT00515502|11503816|FG009|STARTED|Washout Period 2||2
10363346|NCT00515502|11503817|FG010|STARTED|Washout Period 2||1
10363347|NCT00515502|11503818|FG011|STARTED|Washout Period 2||0
10363348|NCT00515502|11503807|FG000|COMPLETED|Washout Period 2||1
10535438|NCT01436370|11687768|FG004|NOT COMPLETED|Overall Study||1
10535439|NCT01436370|11687769|FG005|NOT COMPLETED|Overall Study||0
10535440|NCT01436370|11687770|FG006|NOT COMPLETED|Overall Study||0
10535441|NCT01436370|11687771|FG007|NOT COMPLETED|Overall Study||0
10535442|NCT01436435|11687797|FG000|STARTED|Overall Study||241
10535443|NCT01436435|11687797|FG000|COMPLETED|Overall Study||177
10535444|NCT01436435|11687797|FG000|NOT COMPLETED|Overall Study||64
10535445|NCT01436500|11687803|FG000|STARTED|Overall Study||12
10535446|NCT01436500|11687804|FG001|STARTED|Overall Study||12
10363349|NCT00515502|11503808|FG001|COMPLETED|Washout Period 2||3
10363350|NCT00515502|11503809|FG002|COMPLETED|Washout Period 2||4
10363351|NCT00515502|11503810|FG003|COMPLETED|Washout Period 2||3
10363352|NCT00515502|11503811|FG004|COMPLETED|Washout Period 2||3
10363353|NCT00515502|11503812|FG005|COMPLETED|Washout Period 2||1
10363354|NCT00515502|11503813|FG006|COMPLETED|Washout Period 2||1
10363355|NCT00515502|11503814|FG007|COMPLETED|Washout Period 2||1
10363356|NCT00515502|11503815|FG008|COMPLETED|Washout Period 2||0
10363357|NCT00515502|11503816|FG009|COMPLETED|Washout Period 2||2
10363358|NCT00515502|11503817|FG010|COMPLETED|Washout Period 2||1
10363359|NCT00515502|11503818|FG011|COMPLETED|Washout Period 2||0
10363360|NCT00515502|11503807|FG000|NOT COMPLETED|Washout Period 2||0
10363361|NCT00515502|11503808|FG001|NOT COMPLETED|Washout Period 2||0
10363362|NCT00515502|11503809|FG002|NOT COMPLETED|Washout Period 2||0
10363363|NCT00515502|11503810|FG003|NOT COMPLETED|Washout Period 2||0
10363364|NCT00515502|11503811|FG004|NOT COMPLETED|Washout Period 2||0
10363365|NCT00515502|11503812|FG005|NOT COMPLETED|Washout Period 2||0
10363366|NCT00515502|11503813|FG006|NOT COMPLETED|Washout Period 2||0
10363367|NCT00515502|11503814|FG007|NOT COMPLETED|Washout Period 2||0
10363368|NCT00515502|11503815|FG008|NOT COMPLETED|Washout Period 2||0
10363369|NCT00515502|11503816|FG009|NOT COMPLETED|Washout Period 2||0
10363370|NCT00515502|11503817|FG010|NOT COMPLETED|Washout Period 2||0
10363371|NCT00515502|11503818|FG011|NOT COMPLETED|Washout Period 2||0
10363372|NCT00515502|11503807|FG000|STARTED|Treatment Period 3||1
10363373|NCT00515502|11503808|FG001|STARTED|Treatment Period 3||3
10363374|NCT00515502|11503809|FG002|STARTED|Treatment Period 3||4
10363375|NCT00515502|11503810|FG003|STARTED|Treatment Period 3||3
10363376|NCT00515502|11503811|FG004|STARTED|Treatment Period 3||3
10363377|NCT00515502|11503812|FG005|STARTED|Treatment Period 3||1
10363378|NCT00515502|11503813|FG006|STARTED|Treatment Period 3||1
10363379|NCT00515502|11503814|FG007|STARTED|Treatment Period 3||1
10363380|NCT00515502|11503815|FG008|STARTED|Treatment Period 3||0
10363381|NCT00515502|11503816|FG009|STARTED|Treatment Period 3||2
10363382|NCT00515502|11503817|FG010|STARTED|Treatment Period 3||1
10363383|NCT00515502|11503818|FG011|STARTED|Treatment Period 3||0
10363384|NCT00515502|11503807|FG000|COMPLETED|Treatment Period 3||1
10363385|NCT00515502|11503808|FG001|COMPLETED|Treatment Period 3||3
10363386|NCT00515502|11503809|FG002|COMPLETED|Treatment Period 3||4
10363387|NCT00515502|11503810|FG003|COMPLETED|Treatment Period 3||3
10363388|NCT00515502|11503811|FG004|COMPLETED|Treatment Period 3||3
10363389|NCT00515502|11503812|FG005|COMPLETED|Treatment Period 3||1
10363390|NCT00515502|11503813|FG006|COMPLETED|Treatment Period 3||1
10363391|NCT00515502|11503814|FG007|COMPLETED|Treatment Period 3||1
10363392|NCT00515502|11503815|FG008|COMPLETED|Treatment Period 3||0
10363393|NCT00515502|11503816|FG009|COMPLETED|Treatment Period 3||2
10363394|NCT00515502|11503817|FG010|COMPLETED|Treatment Period 3||1
10363395|NCT00515502|11503818|FG011|COMPLETED|Treatment Period 3||0
10363396|NCT00515502|11503807|FG000|NOT COMPLETED|Treatment Period 3||0
10363397|NCT00515502|11503808|FG001|NOT COMPLETED|Treatment Period 3||0
10363398|NCT00515502|11503809|FG002|NOT COMPLETED|Treatment Period 3||0
10363399|NCT00515502|11503810|FG003|NOT COMPLETED|Treatment Period 3||0
10363400|NCT00515502|11503811|FG004|NOT COMPLETED|Treatment Period 3||0
10363401|NCT00515502|11503812|FG005|NOT COMPLETED|Treatment Period 3||0
10363402|NCT00515502|11503813|FG006|NOT COMPLETED|Treatment Period 3||0
10363403|NCT00515502|11503814|FG007|NOT COMPLETED|Treatment Period 3||0
10363404|NCT00515502|11503815|FG008|NOT COMPLETED|Treatment Period 3||0
10363405|NCT00515502|11503816|FG009|NOT COMPLETED|Treatment Period 3||0
10363406|NCT00515502|11503817|FG010|NOT COMPLETED|Treatment Period 3||0
10363407|NCT00515502|11503818|FG011|NOT COMPLETED|Treatment Period 3||0
10363408|NCT00515502|11503807|FG000|STARTED|Washout Period 3||1
10363409|NCT00515502|11503808|FG001|STARTED|Washout Period 3||3
10363410|NCT00515502|11503809|FG002|STARTED|Washout Period 3||4
10363411|NCT00515502|11503810|FG003|STARTED|Washout Period 3||3
10363412|NCT00515502|11503811|FG004|STARTED|Washout Period 3||3
10363413|NCT00515502|11503812|FG005|STARTED|Washout Period 3||1
10363414|NCT00515502|11503813|FG006|STARTED|Washout Period 3||1
10363415|NCT00515502|11503814|FG007|STARTED|Washout Period 3||1
10363416|NCT00515502|11503815|FG008|STARTED|Washout Period 3||0
10363417|NCT00515502|11503816|FG009|STARTED|Washout Period 3||2
10535447|NCT01436500|11687805|FG002|STARTED|Overall Study||12
10535448|NCT01436500|11687806|FG003|STARTED|Overall Study||6
10535449|NCT01436500|11687807|FG004|STARTED|Overall Study||13
10656748|NCT02219997|11817800|FG002|NOT COMPLETED|First Filter||0
10656749|NCT02219997|11817798|FG000|STARTED|Second Filter||0
10363418|NCT00515502|11503817|FG010|STARTED|Washout Period 3||1
10363419|NCT00515502|11503818|FG011|STARTED|Washout Period 3||0
10363420|NCT00515502|11503807|FG000|COMPLETED|Washout Period 3||1
10363421|NCT00515502|11503808|FG001|COMPLETED|Washout Period 3||3
10363422|NCT00515502|11503809|FG002|COMPLETED|Washout Period 3||4
10363423|NCT00515502|11503810|FG003|COMPLETED|Washout Period 3||3
10363424|NCT00515502|11503811|FG004|COMPLETED|Washout Period 3||3
10363425|NCT00515502|11503812|FG005|COMPLETED|Washout Period 3||1
10535450|NCT01436500|11687803|FG000|COMPLETED|Overall Study||9
10535451|NCT01436500|11687804|FG001|COMPLETED|Overall Study||9
10535452|NCT01436500|11687805|FG002|COMPLETED|Overall Study||7
10535453|NCT01436500|11687806|FG003|COMPLETED|Overall Study||5
10363426|NCT00515502|11503813|FG006|COMPLETED|Washout Period 3||1
10363427|NCT00515502|11503814|FG007|COMPLETED|Washout Period 3||1
10363428|NCT00515502|11503815|FG008|COMPLETED|Washout Period 3||0
10363429|NCT00515502|11503816|FG009|COMPLETED|Washout Period 3||2
10363430|NCT00515502|11503817|FG010|COMPLETED|Washout Period 3||1
10363431|NCT00515502|11503818|FG011|COMPLETED|Washout Period 3||0
10363432|NCT00515502|11503807|FG000|NOT COMPLETED|Washout Period 3||0
10363433|NCT00515502|11503808|FG001|NOT COMPLETED|Washout Period 3||0
10363434|NCT00515502|11503809|FG002|NOT COMPLETED|Washout Period 3||0
10363435|NCT00515502|11503810|FG003|NOT COMPLETED|Washout Period 3||0
10363436|NCT00515502|11503811|FG004|NOT COMPLETED|Washout Period 3||0
10363437|NCT00515502|11503812|FG005|NOT COMPLETED|Washout Period 3||0
10363438|NCT00515502|11503813|FG006|NOT COMPLETED|Washout Period 3||0
10363439|NCT00515502|11503814|FG007|NOT COMPLETED|Washout Period 3||0
10363440|NCT00515502|11503815|FG008|NOT COMPLETED|Washout Period 3||0
10363441|NCT00515502|11503816|FG009|NOT COMPLETED|Washout Period 3||0
10363442|NCT00515502|11503817|FG010|NOT COMPLETED|Washout Period 3||0
10363443|NCT00515502|11503818|FG011|NOT COMPLETED|Washout Period 3||0
10363444|NCT00515502|11503807|FG000|STARTED|Treatment Period 4||1
10363445|NCT00515502|11503808|FG001|STARTED|Treatment Period 4||3
10363446|NCT00515502|11503809|FG002|STARTED|Treatment Period 4||4
10363447|NCT00515502|11503810|FG003|STARTED|Treatment Period 4||3
10363448|NCT00515502|11503811|FG004|STARTED|Treatment Period 4||3
10363449|NCT00515502|11503812|FG005|STARTED|Treatment Period 4||1
10363450|NCT00515502|11503813|FG006|STARTED|Treatment Period 4||1
10363451|NCT00515502|11503814|FG007|STARTED|Treatment Period 4||1
10363452|NCT00515502|11503815|FG008|STARTED|Treatment Period 4||0
10363453|NCT00515502|11503816|FG009|STARTED|Treatment Period 4||2
10363454|NCT00515502|11503817|FG010|STARTED|Treatment Period 4||1
10363455|NCT00515502|11503818|FG011|STARTED|Treatment Period 4||0
10363456|NCT00515502|11503807|FG000|COMPLETED|Treatment Period 4||1
10363457|NCT00515502|11503808|FG001|COMPLETED|Treatment Period 4||3
10363458|NCT00515502|11503809|FG002|COMPLETED|Treatment Period 4||4
10363459|NCT00515502|11503810|FG003|COMPLETED|Treatment Period 4||3
10363460|NCT00515502|11503811|FG004|COMPLETED|Treatment Period 4||3
10363461|NCT00515502|11503812|FG005|COMPLETED|Treatment Period 4||1
10363462|NCT00515502|11503813|FG006|COMPLETED|Treatment Period 4||1
10363463|NCT00515502|11503814|FG007|COMPLETED|Treatment Period 4||1
10363464|NCT00515502|11503815|FG008|COMPLETED|Treatment Period 4||0
10363465|NCT00515502|11503816|FG009|COMPLETED|Treatment Period 4||2
10363466|NCT00515502|11503817|FG010|COMPLETED|Treatment Period 4||1
10363467|NCT00515502|11503818|FG011|COMPLETED|Treatment Period 4||0
10363468|NCT00515502|11503807|FG000|NOT COMPLETED|Treatment Period 4||0
10363469|NCT00515502|11503808|FG001|NOT COMPLETED|Treatment Period 4||0
10363470|NCT00515502|11503809|FG002|NOT COMPLETED|Treatment Period 4||0
10363471|NCT00515502|11503810|FG003|NOT COMPLETED|Treatment Period 4||0
10363472|NCT00515502|11503811|FG004|NOT COMPLETED|Treatment Period 4||0
10363473|NCT00515502|11503812|FG005|NOT COMPLETED|Treatment Period 4||0
10716409|NCT02688387|11880064|FG021|COMPLETED|Part 3B, Period 4 (up to 6 Days)||8
10716410|NCT02688387|11880043|FG000|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10716411|NCT02688387|11880044|FG001|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10716412|NCT02688387|11880045|FG002|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10716413|NCT02688387|11880046|FG003|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10716414|NCT02688387|11880047|FG004|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10716415|NCT02688387|11880048|FG005|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10363474|NCT00515502|11503813|FG006|NOT COMPLETED|Treatment Period 4||0
10363475|NCT00515502|11503814|FG007|NOT COMPLETED|Treatment Period 4||0
10363476|NCT00515502|11503815|FG008|NOT COMPLETED|Treatment Period 4||0
10363477|NCT00515502|11503816|FG009|NOT COMPLETED|Treatment Period 4||0
10363478|NCT00515502|11503817|FG010|NOT COMPLETED|Treatment Period 4||0
10363479|NCT00515502|11503818|FG011|NOT COMPLETED|Treatment Period 4||0
10363480|NCT00515528|11503837|FG000|STARTED|Overall Study||10
10363481|NCT00515528|11503838|FG001|STARTED|Overall Study||7
10363482|NCT00515528|11503837|FG000|COMPLETED|Overall Study||10
10363483|NCT00515528|11503838|FG001|COMPLETED|Overall Study||7
10363484|NCT00515528|11503837|FG000|NOT COMPLETED|Overall Study||0
10363485|NCT00515528|11503838|FG001|NOT COMPLETED|Overall Study||0
10363486|NCT00515541|11503848|FG000|STARTED|Overall Study||10
10363487|NCT00515541|11503849|FG001|STARTED|Overall Study||12
10363488|NCT00515541|11503850|FG002|STARTED|Overall Study||10
10363489|NCT00515541|11503851|FG003|STARTED|Overall Study||11
10363490|NCT00515541|11503848|FG000|6 Weeks (1 gm Lovaza)|Overall Study||10
10363491|NCT00515541|11503849|FG001|6 Weeks (1 gm Lovaza)|Overall Study|One subject pulled after baseline. One subject pulled due to no show for appt.after baseline|10
10363492|NCT00515541|11503850|FG002|6 Weeks (1 gm Lovaza)|Overall Study||10
10363493|NCT00515541|11503851|FG003|6 Weeks (1 gm Lovaza)|Overall Study|One subject pulled due to no show for appt. after baseline.|10
10363494|NCT00515541|11503848|FG000|12 Weeks (2 gm Lovaza)|Overall Study||10
10363495|NCT00515541|11503849|FG001|12 Weeks (2 gm Lovaza)|Overall Study||10
10363496|NCT00515541|11503850|FG002|12 Weeks (2 gm Lovaza)|Overall Study||10
10716416|NCT02688387|11880049|FG006|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10716417|NCT02688387|11880050|FG007|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10363497|NCT00515541|11503851|FG003|12 Weeks (2 gm Lovaza)|Overall Study||10
10363498|NCT00515541|11503848|FG000|18 Weeks (4 gm Lovaza)|Overall Study||10
10363499|NCT00515541|11503849|FG001|18 Weeks (4 gm Lovaza)|Overall Study|One subject withdrew at 12 weeks due to acquired bleeding disorder present before enrolling.|9
10363500|NCT00515541|11503850|FG002|18 Weeks (4 gm Lovaza)|Overall Study||10
10363501|NCT00515541|11503851|FG003|18 Weeks (4 gm Lovaza)|Overall Study|One subject withdrew at 14 weeks with GI problems.|9
10363502|NCT00515541|11503848|FG000|24 Weeks (8 gm Lovaza)|Overall Study||10
10427161|NCT00851643|11572934|FG003|COMPLETED|Extension Study (Up to 36 Months)||5
10306007|NCT00096278|11438977|FG001|STARTED|Overall Study||1354
10306008|NCT00096278|11438976|FG000|COMPLETED|Overall Study||1338
10306009|NCT00096278|11438977|FG001|COMPLETED|Overall Study||1334
10306010|NCT00096278|11438976|FG000|NOT COMPLETED|Overall Study||18
10306011|NCT00096278|11438977|FG001|NOT COMPLETED|Overall Study||20
10306012|NCT00096356|11438987|FG000|STARTED|Overall Study||122
10306013|NCT00096356|11438988|FG001|STARTED|Overall Study||114
10306014|NCT00096356|11438987|FG000|COMPLETED|Overall Study||78
10306015|NCT00096356|11438988|FG001|COMPLETED|Overall Study||61
10306016|NCT00096356|11438987|FG000|NOT COMPLETED|Overall Study||44
10306017|NCT00096356|11438988|FG001|NOT COMPLETED|Overall Study||53
10306018|NCT00096382|11438997|FG000|STARTED|Overall Study||23
10306019|NCT00096382|11438998|FG001|STARTED|Overall Study||3
10306020|NCT00096382|11438997|FG000|COMPLETED|Overall Study||21
10306021|NCT00096382|11438998|FG001|COMPLETED|Overall Study||3
10306022|NCT00096382|11438997|FG000|NOT COMPLETED|Overall Study||2
10306023|NCT00096382|11438998|FG001|NOT COMPLETED|Overall Study||0
10306024|NCT00096447|11439004|FG000|STARTED|Overall Study||31
10306025|NCT00096447|11439004|FG000|COMPLETED|Overall Study|Eligible and treated patients.|30
10306026|NCT00096447|11439004|FG000|NOT COMPLETED|Overall Study||1
10306027|NCT00096460|11439015|FG000|STARTED|Overall Study||22
10306028|NCT00096460|11439016|FG001|STARTED|Overall Study||8
10306029|NCT00096460|11439015|FG000|COMPLETED|Overall Study||15
10306030|NCT00096460|11439016|FG001|COMPLETED|Overall Study||7
10306031|NCT00096460|11439015|FG000|NOT COMPLETED|Overall Study||7
10306032|NCT00096460|11439016|FG001|NOT COMPLETED|Overall Study||1
10306033|NCT00096486|11439026|FG000|STARTED|Overall Study||4
10306034|NCT00096486|11439027|FG001|STARTED|Overall Study||6
10306035|NCT00096486|11439028|FG002|STARTED|Overall Study||26
10306036|NCT00096486|11439029|FG003|STARTED|Overall Study||38
10306037|NCT00096486|11439026|FG000|COMPLETED|Overall Study||4
10363503|NCT00515541|11503849|FG001|24 Weeks (8 gm Lovaza)|Overall Study|Two subjects withdrew at 20 and 21 weeks due to nausea. Subjects were closed out early.|7
10363504|NCT00515541|11503850|FG002|24 Weeks (8 gm Lovaza)|Overall Study||10
10363505|NCT00515541|11503851|FG003|24 Weeks (8 gm Lovaza)|Overall Study|Three subjects withdrew after 18 weeks (1 GI problem, 1 undefined medical problem, 1 no show)|6
10363506|NCT00515541|11503848|FG000|COMPLETED|Overall Study|All subjects completed 24 weeks.|10
10363507|NCT00515541|11503849|FG001|COMPLETED|Overall Study||7
10363508|NCT00515541|11503850|FG002|COMPLETED|Overall Study|All subjects completed 24 weeks.|10
10363509|NCT00515541|11503851|FG003|COMPLETED|Overall Study||6
10363510|NCT00515541|11503848|FG000|NOT COMPLETED|Overall Study||0
10363511|NCT00515541|11503849|FG001|NOT COMPLETED|Overall Study||5
10363512|NCT00515541|11503850|FG002|NOT COMPLETED|Overall Study||0
10363513|NCT00515541|11503851|FG003|NOT COMPLETED|Overall Study||5
10363514|NCT00515619|11503861|FG000|STARTED|Overall Study||376
10363515|NCT00515619|11503861|FG000|Safety Set|Overall Study||376
10363516|NCT00515619|11503861|FG000|COMPLETED|Overall Study||160
10363517|NCT00515619|11503861|FG000|NOT COMPLETED|Overall Study||216
10363518|NCT00515697|11503865|FG000|STARTED|Overall Study||39
10363519|NCT00515697|11503865|FG000|Received at Least 1 Dose of Study Drug|Overall Study||39
10535454|NCT01436500|11687807|FG004|COMPLETED|Overall Study||9
10535455|NCT01436500|11687803|FG000|NOT COMPLETED|Overall Study||3
10535456|NCT01436500|11687804|FG001|NOT COMPLETED|Overall Study||3
10535457|NCT01436500|11687805|FG002|NOT COMPLETED|Overall Study||5
10535458|NCT01436500|11687806|FG003|NOT COMPLETED|Overall Study||1
10535459|NCT01436500|11687807|FG004|NOT COMPLETED|Overall Study||4
10535460|NCT01436526|11687822|FG000|STARTED|Period 1||14
10535461|NCT01436526|11687823|FG001|STARTED|Period 1||14
10535462|NCT01436526|11687822|FG000|Participants Received Treatment|Period 1||14
10535463|NCT01436526|11687823|FG001|Participants Received Treatment|Period 1||14
10535464|NCT01436526|11687822|FG000|COMPLETED|Period 1||14
10535465|NCT01436526|11687823|FG001|COMPLETED|Period 1||14
10535466|NCT01436526|11687822|FG000|NOT COMPLETED|Period 1||0
10535467|NCT01436526|11687823|FG001|NOT COMPLETED|Period 1||0
10535468|NCT01436526|11687822|FG000|STARTED|Period 2|1 participant withdrew his consent after completing the first period.|13
10535469|NCT01436526|11687823|FG001|STARTED|Period 2|1 participant withdrew his consent after completing the first period.|13
10535470|NCT01436526|11687822|FG000|Participants Received Treatment|Period 2||13
10535471|NCT01436526|11687823|FG001|Participants Received Treatment|Period 2||13
10535472|NCT01436526|11687822|FG000|COMPLETED|Period 2||13
10656750|NCT02219997|11817799|FG001|STARTED|Second Filter||17
10656751|NCT02219997|11817800|FG002|STARTED|Second Filter||18
10656752|NCT02219997|11817798|FG000|COMPLETED|Second Filter||0
10716418|NCT02688387|11880051|FG008|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10716419|NCT02688387|11880052|FG009|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10716420|NCT02688387|11880053|FG010|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10716421|NCT02688387|11880054|FG011|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10363520|NCT00515697|11503865|FG000|COMPLETED|Overall Study||39
10363521|NCT00515697|11503865|FG000|NOT COMPLETED|Overall Study||0
10363522|NCT00515723|11503873|FG000|STARTED|Overall Study||25
10363523|NCT00515723|11503874|FG001|STARTED|Overall Study||22
10363524|NCT00515723|11503875|FG002|STARTED|Overall Study||22
10363525|NCT00515723|11503876|FG003|STARTED|Overall Study||27
10363526|NCT00515723|11503873|FG000|COMPLETED|Overall Study||20
10363527|NCT00515723|11503874|FG001|COMPLETED|Overall Study||21
10656753|NCT02219997|11817799|FG001|COMPLETED|Second Filter||17
10656754|NCT02219997|11817800|FG002|COMPLETED|Second Filter||18
10656755|NCT02219997|11817798|FG000|NOT COMPLETED|Second Filter||0
10656756|NCT02219997|11817799|FG001|NOT COMPLETED|Second Filter||0
10656757|NCT02219997|11817800|FG002|NOT COMPLETED|Second Filter||0
10656758|NCT02220205|11817813|FG000|STARTED|Overall Study||30
10656759|NCT02220205|11817814|FG001|STARTED|Overall Study||30
10656760|NCT02220205|11817813|FG000|COMPLETED|Overall Study||29
10656761|NCT02220205|11817814|FG001|COMPLETED|Overall Study||30
10656762|NCT02220205|11817813|FG000|NOT COMPLETED|Overall Study||1
10656763|NCT02220205|11817814|FG001|NOT COMPLETED|Overall Study||0
10656764|NCT02220712|11817820|FG000|STARTED|Overall Study||17
10656765|NCT02220712|11817820|FG000|COMPLETED|Overall Study||13
10656766|NCT02220712|11817820|FG000|NOT COMPLETED|Overall Study||4
10656767|NCT02220725|11817832|FG000|STARTED|Overall Study||14
10656768|NCT02220725|11817833|FG001|STARTED|Overall Study||27
10656769|NCT02220725|11817834|FG002|STARTED|Overall Study||13
10656770|NCT02220725|11817835|FG003|STARTED|Overall Study||26
10656771|NCT02220725|11817832|FG000|COMPLETED|Overall Study||14
10656772|NCT02220725|11817833|FG001|COMPLETED|Overall Study||27
10656773|NCT02220725|11817834|FG002|COMPLETED|Overall Study||13
10656774|NCT02220725|11817835|FG003|COMPLETED|Overall Study||24
10656775|NCT02220725|11817832|FG000|NOT COMPLETED|Overall Study||0
10656776|NCT02220725|11817833|FG001|NOT COMPLETED|Overall Study||0
10656777|NCT02220725|11817834|FG002|NOT COMPLETED|Overall Study||0
10656778|NCT02220725|11817835|FG003|NOT COMPLETED|Overall Study||2
10656779|NCT02220764|11817850|FG000|STARTED|Overall Study||24
10656780|NCT02220764|11817851|FG001|STARTED|Overall Study||8
10656781|NCT02220764|11817850|FG000|COMPLETED|Overall Study||20
10656782|NCT02220764|11817851|FG001|COMPLETED|Overall Study||7
10656783|NCT02220764|11817850|FG000|NOT COMPLETED|Overall Study||4
10656784|NCT02220764|11817851|FG001|NOT COMPLETED|Overall Study||1
10656785|NCT02220907|11817857|FG000|STARTED|Overall Study||153
10656786|NCT02220907|11817857|FG000|COMPLETED|Overall Study||142
10656787|NCT02220907|11817857|FG000|NOT COMPLETED|Overall Study||11
10656788|NCT02220920|11817863|FG000|STARTED|Overall Study||76
10363528|NCT00515723|11503875|FG002|COMPLETED|Overall Study||21
10363529|NCT00515723|11503876|FG003|COMPLETED|Overall Study||21
10363530|NCT00515723|11503873|FG000|NOT COMPLETED|Overall Study||5
10363531|NCT00515723|11503874|FG001|NOT COMPLETED|Overall Study||1
10363532|NCT00515723|11503875|FG002|NOT COMPLETED|Overall Study||1
10363533|NCT00515723|11503876|FG003|NOT COMPLETED|Overall Study||6
10363534|NCT00515827|11503889|FG000|STARTED|First Intervention (12 Weeks)||27
10363535|NCT00515827|11503890|FG001|STARTED|First Intervention (12 Weeks)||26
10363536|NCT00515827|11503889|FG000|COMPLETED|First Intervention (12 Weeks)||26
10363537|NCT00515827|11503890|FG001|COMPLETED|First Intervention (12 Weeks)||25
10363538|NCT00515827|11503889|FG000|NOT COMPLETED|First Intervention (12 Weeks)||1
10363539|NCT00515827|11503890|FG001|NOT COMPLETED|First Intervention (12 Weeks)||1
10363540|NCT00515827|11503889|FG000|STARTED|Second Intervention (12 Weeks)||26
10363541|NCT00515827|11503890|FG001|STARTED|Second Intervention (12 Weeks)||25
10363542|NCT00515827|11503889|FG000|COMPLETED|Second Intervention (12 Weeks)||25
10535473|NCT01436526|11687823|FG001|COMPLETED|Period 2||13
10535474|NCT01436526|11687822|FG000|NOT COMPLETED|Period 2||0
10535475|NCT01436526|11687823|FG001|NOT COMPLETED|Period 2||0
10535476|NCT01436643|11687832|FG000|STARTED|2-week Pre-treatment||0
10535477|NCT01436643|11687833|FG001|STARTED|2-week Pre-treatment||0
10535478|NCT01436643|11687834|FG002|STARTED|2-week Pre-treatment||0
10535479|NCT01436643|11687835|FG003|STARTED|2-week Pre-treatment||54
10535480|NCT01436643|11687832|FG000|COMPLETED|2-week Pre-treatment||0
10535481|NCT01436643|11687833|FG001|COMPLETED|2-week Pre-treatment||0
10535482|NCT01436643|11687834|FG002|COMPLETED|2-week Pre-treatment||0
10535483|NCT01436643|11687835|FG003|COMPLETED|2-week Pre-treatment||44
10535484|NCT01436643|11687832|FG000|NOT COMPLETED|2-week Pre-treatment||0
10535485|NCT01436643|11687833|FG001|NOT COMPLETED|2-week Pre-treatment||0
10535486|NCT01436643|11687834|FG002|NOT COMPLETED|2-week Pre-treatment||0
10535487|NCT01436643|11687835|FG003|NOT COMPLETED|2-week Pre-treatment||10
10535488|NCT01436643|11687832|FG000|STARTED|Core Phase (16 Weeks)||17
10535489|NCT01436643|11687833|FG001|STARTED|Core Phase (16 Weeks)||15
10535490|NCT01436643|11687834|FG002|STARTED|Core Phase (16 Weeks)||20
10535491|NCT01436643|11687835|FG003|STARTED|Core Phase (16 Weeks)||0
10535492|NCT01436643|11687832|FG000|COMPLETED|Core Phase (16 Weeks)||16
10535493|NCT01436643|11687833|FG001|COMPLETED|Core Phase (16 Weeks)||11
10535494|NCT01436643|11687834|FG002|COMPLETED|Core Phase (16 Weeks)||17
10535495|NCT01436643|11687835|FG003|COMPLETED|Core Phase (16 Weeks)||0
10535496|NCT01436643|11687832|FG000|NOT COMPLETED|Core Phase (16 Weeks)||1
10535497|NCT01436643|11687833|FG001|NOT COMPLETED|Core Phase (16 Weeks)||4
10535498|NCT01436643|11687834|FG002|NOT COMPLETED|Core Phase (16 Weeks)||3
10535499|NCT01436643|11687835|FG003|NOT COMPLETED|Core Phase (16 Weeks)||0
10535500|NCT01436799|11687847|FG000|STARTED|Overall Study||20
10535501|NCT01436799|11687848|FG001|STARTED|Overall Study||20
10535502|NCT01436799|11687847|FG000|COMPLETED|Overall Study||20
10535503|NCT01436799|11687848|FG001|COMPLETED|Overall Study||20
10535504|NCT01436799|11687847|FG000|NOT COMPLETED|Overall Study||0
10535505|NCT01436799|11687848|FG001|NOT COMPLETED|Overall Study||0
10535506|NCT01437098|11687854|FG000|STARTED|Overall Study||55
10535507|NCT01437098|11687854|FG000|30 Days|Overall Study||51
10535508|NCT01437098|11687854|FG000|6 Months|Overall Study||47
10535509|NCT01437098|11687854|FG000|12 Months|Overall Study||45
10535510|NCT01437098|11687854|FG000|24 Months|Overall Study||42
10535511|NCT01437098|11687854|FG000|36 Months|Overall Study||36
10535512|NCT01437098|11687854|FG000|COMPLETED|Overall Study||42
10535513|NCT01437098|11687854|FG000|NOT COMPLETED|Overall Study||13
10535514|NCT01437124|11687866|FG000|STARTED|Overall Study||83
10535515|NCT01437124|11687866|FG000|COMPLETED|Overall Study||83
10535516|NCT01437124|11687866|FG000|NOT COMPLETED|Overall Study||0
10535517|NCT01437267|11687876|FG000|STARTED|Overall Study||20
10535518|NCT01437267|11687877|FG001|STARTED|Overall Study||20
10535519|NCT01437267|11687878|FG002|STARTED|Overall Study||20
10535520|NCT01437267|11687879|FG003|STARTED|Overall Study||20
10535521|NCT01437267|11687880|FG004|STARTED|Overall Study||20
10535522|NCT01437267|11687881|FG005|STARTED|Overall Study||20
10535523|NCT01437267|11687876|FG000|COMPLETED|Overall Study||20
10535524|NCT01437267|11687877|FG001|COMPLETED|Overall Study||19
10535525|NCT01437267|11687878|FG002|COMPLETED|Overall Study||20
10535526|NCT01437267|11687879|FG003|COMPLETED|Overall Study||19
10656789|NCT02220920|11817864|FG001|STARTED|Overall Study||70
10656790|NCT02220920|11817863|FG000|COMPLETED|Overall Study||73
10656791|NCT02220920|11817864|FG001|COMPLETED|Overall Study||67
10656792|NCT02220920|11817863|FG000|NOT COMPLETED|Overall Study||3
10656793|NCT02220920|11817864|FG001|NOT COMPLETED|Overall Study||3
10656794|NCT02220998|11817872|FG000|STARTED|Overall Study||135
10656795|NCT02220998|11817873|FG001|STARTED|Overall Study||134
10656796|NCT02220998|11817872|FG000|COMPLETED|Overall Study||128
10535527|NCT01437267|11687880|FG004|COMPLETED|Overall Study||20
10535528|NCT01437267|11687881|FG005|COMPLETED|Overall Study||20
10535529|NCT01437267|11687876|FG000|NOT COMPLETED|Overall Study||0
10535530|NCT01437267|11687877|FG001|NOT COMPLETED|Overall Study||1
10535531|NCT01437267|11687878|FG002|NOT COMPLETED|Overall Study||0
10535532|NCT01437267|11687879|FG003|NOT COMPLETED|Overall Study||1
10535533|NCT01437267|11687880|FG004|NOT COMPLETED|Overall Study||0
10535534|NCT01437267|11687881|FG005|NOT COMPLETED|Overall Study||0
10535535|NCT01437319|11687895|FG000|STARTED|Phase I||282
10535536|NCT01437319|11687896|FG001|STARTED|Phase I||0
10535537|NCT01437319|11687897|FG002|STARTED|Phase I||0
10535538|NCT01437319|11687895|FG000|COMPLETED|Phase I||227
10656797|NCT02220998|11817873|FG001|COMPLETED|Overall Study||123
10363543|NCT00515827|11503890|FG001|COMPLETED|Second Intervention (12 Weeks)||25
10363544|NCT00515827|11503889|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||1
10363545|NCT00515827|11503890|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||0
10363546|NCT00515879|11503900|FG000|STARTED|Overall Study||87
10363547|NCT00515879|11503901|FG001|STARTED|Overall Study||82
10363548|NCT00515879|11503900|FG000|COMPLETED|Overall Study||62
10363549|NCT00515879|11503901|FG001|COMPLETED|Overall Study||62
10363550|NCT00515879|11503900|FG000|NOT COMPLETED|Overall Study||25
10363551|NCT00515879|11503901|FG001|NOT COMPLETED|Overall Study||20
10363552|NCT00516048|11503911|FG000|STARTED|Overall Study||15
10363553|NCT00516048|11503912|FG001|STARTED|Overall Study||42
10363554|NCT00516048|11503913|FG002|STARTED|Overall Study||1
10363555|NCT00516048|11503911|FG000|COMPLETED|Overall Study||15
10363556|NCT00516048|11503912|FG001|COMPLETED|Overall Study||40
10363557|NCT00516048|11503913|FG002|COMPLETED|Overall Study||0
10363558|NCT00516048|11503911|FG000|NOT COMPLETED|Overall Study||0
10363559|NCT00516048|11503912|FG001|NOT COMPLETED|Overall Study||2
10363560|NCT00516048|11503913|FG002|NOT COMPLETED|Overall Study||1
10427162|NCT00851643|11572935|FG004|COMPLETED|Extension Study (Up to 36 Months)||19
10427163|NCT00851643|11572936|FG005|COMPLETED|Extension Study (Up to 36 Months)||14
10427164|NCT00851643|11572931|FG000|NOT COMPLETED|Extension Study (Up to 36 Months)||4
10427165|NCT00851643|11572932|FG001|NOT COMPLETED|Extension Study (Up to 36 Months)||4
10427166|NCT00851643|11572933|FG002|NOT COMPLETED|Extension Study (Up to 36 Months)||5
10427167|NCT00851643|11572934|FG003|NOT COMPLETED|Extension Study (Up to 36 Months)||2
10427168|NCT00851643|11572935|FG004|NOT COMPLETED|Extension Study (Up to 36 Months)||2
10427169|NCT00851643|11572936|FG005|NOT COMPLETED|Extension Study (Up to 36 Months)||1
10427170|NCT00851721|11572951|FG000|STARTED|Overall Study||19
10427171|NCT00851721|11572952|FG001|STARTED|Overall Study||17
10427172|NCT00851721|11572951|FG000|COMPLETED|Overall Study||17
10427173|NCT00851721|11572952|FG001|COMPLETED|Overall Study||16
10427174|NCT00851721|11572951|FG000|NOT COMPLETED|Overall Study||2
10427175|NCT00851721|11572952|FG001|NOT COMPLETED|Overall Study||1
10427176|NCT00851786|11572966|FG000|STARTED|Overall Study|One subject cannot adhere to protocol requirement and was off study with no vaccine.|296
10427177|NCT00851786|11572967|FG001|STARTED|Overall Study|Two subjects (one found ineligible and one withdrew consent) were off study with no vaccine.|99
10427178|NCT00851786|11572966|FG000|COMPLETED|Overall Study||291
10427179|NCT00851786|11572967|FG001|COMPLETED|Overall Study||97
10427180|NCT00851786|11572966|FG000|NOT COMPLETED|Overall Study||5
10427181|NCT00851786|11572967|FG001|NOT COMPLETED|Overall Study||2
10427182|NCT00851799|11572976|FG000|STARTED|Overall Study||109
10427183|NCT00851799|11572977|FG001|STARTED|Overall Study||106
10427184|NCT00851799|11572978|FG002|STARTED|Overall Study||113
10427185|NCT00851799|11572976|FG000|COMPLETED|Overall Study||93
10427186|NCT00851799|11572977|FG001|COMPLETED|Overall Study||93
10427187|NCT00851799|11572978|FG002|COMPLETED|Overall Study||89
10427188|NCT00851799|11572976|FG000|NOT COMPLETED|Overall Study||16
10427189|NCT00851799|11572977|FG001|NOT COMPLETED|Overall Study||13
10427190|NCT00851799|11572978|FG002|NOT COMPLETED|Overall Study||24
10427191|NCT00851877|11572986|FG000|STARTED|Phase I-1||7
10656798|NCT02220998|11817872|FG000|NOT COMPLETED|Overall Study||7
10656799|NCT02220998|11817873|FG001|NOT COMPLETED|Overall Study||11
10656800|NCT02221219|11817883|FG000|STARTED|Overall Study||36
10427192|NCT00851877|11572987|FG001|STARTED|Phase I-1||0
10427193|NCT00851877|11572988|FG002|STARTED|Phase I-1||0
10427194|NCT00851877|11572986|FG000|COMPLETED|Phase I-1||6
10427195|NCT00851877|11572987|FG001|COMPLETED|Phase I-1||0
10427196|NCT00851877|11572988|FG002|COMPLETED|Phase I-1||0
10427197|NCT00851877|11572986|FG000|NOT COMPLETED|Phase I-1||1
10427198|NCT00851877|11572987|FG001|NOT COMPLETED|Phase I-1||0
10427199|NCT00851877|11572988|FG002|NOT COMPLETED|Phase I-1||0
10427200|NCT00851877|11572986|FG000|STARTED|Phase I-2||0
10427201|NCT00851877|11572987|FG001|STARTED|Phase I-2||5
10427202|NCT00851877|11572988|FG002|STARTED|Phase I-2||0
10535539|NCT01437319|11687896|FG001|COMPLETED|Phase I||0
10535540|NCT01437319|11687897|FG002|COMPLETED|Phase I||0
10535541|NCT01437319|11687895|FG000|NOT COMPLETED|Phase I||55
10535542|NCT01437319|11687896|FG001|NOT COMPLETED|Phase I||0
10535543|NCT01437319|11687897|FG002|NOT COMPLETED|Phase I||0
10535544|NCT01437319|11687895|FG000|STARTED|Phase II||0
10535545|NCT01437319|11687896|FG001|STARTED|Phase II||115
10535546|NCT01437319|11687897|FG002|STARTED|Phase II||112
10535547|NCT01437319|11687895|FG000|COMPLETED|Phase II||0
10535548|NCT01437319|11687896|FG001|COMPLETED|Phase II||71
10535549|NCT01437319|11687897|FG002|COMPLETED|Phase II||75
10535550|NCT01437319|11687895|FG000|NOT COMPLETED|Phase II||0
10535551|NCT01437319|11687896|FG001|NOT COMPLETED|Phase II||44
10656801|NCT02221219|11817884|FG001|STARTED|Overall Study||87
10656802|NCT02221219|11817885|FG002|STARTED|Overall Study||41
10427203|NCT00851877|11572986|FG000|COMPLETED|Phase I-2||0
10427204|NCT00851877|11572987|FG001|COMPLETED|Phase I-2||5
10427205|NCT00851877|11572988|FG002|COMPLETED|Phase I-2||0
10427206|NCT00851877|11572986|FG000|NOT COMPLETED|Phase I-2||0
10427207|NCT00851877|11572987|FG001|NOT COMPLETED|Phase I-2||0
10427208|NCT00851877|11572988|FG002|NOT COMPLETED|Phase I-2||0
10427209|NCT00851877|11572986|FG000|STARTED|Phase II||0
10427210|NCT00851877|11572987|FG001|STARTED|Phase II||0
10427211|NCT00851877|11572988|FG002|STARTED|Phase II||25
10427212|NCT00851877|11572986|FG000|COMPLETED|Phase II||0
10427213|NCT00851877|11572987|FG001|COMPLETED|Phase II||0
10535552|NCT01437319|11687897|FG002|NOT COMPLETED|Phase II||37
10535553|NCT01437397|11687911|FG000|STARTED|Overall Study||338
10656803|NCT02221219|11817886|FG003|STARTED|Overall Study||92
10363561|NCT00516074|11503923|FG000|STARTED|Overall Study||28
10363562|NCT00516074|11503924|FG001|STARTED|Overall Study||26
10363563|NCT00516074|11503923|FG000|COMPLETED|Overall Study||22
10363564|NCT00516074|11503924|FG001|COMPLETED|Overall Study||23
10363565|NCT00516074|11503923|FG000|NOT COMPLETED|Overall Study||6
10363566|NCT00516074|11503924|FG001|NOT COMPLETED|Overall Study||3
10363567|NCT00516139|11503930|FG000|STARTED|Overall Study||122
10363568|NCT00516139|11503930|FG000|COMPLETED|Overall Study|Study completers completed Escalation, AM, and either AO or both Conversion and Monotherapy Phases.|84
10363569|NCT00516139|11503930|FG000|NOT COMPLETED|Overall Study||38
10363570|NCT00516165|11503938|FG000|STARTED|Overall Study||28
10363571|NCT00516165|11503938|FG000|COMPLETED|Overall Study||28
10363572|NCT00516165|11503938|FG000|NOT COMPLETED|Overall Study||0
10363573|NCT00516217|11503942|FG000|STARTED|Overall Study||29
10363574|NCT00516217|11503942|FG000|COMPLETED|Overall Study||29
10716422|NCT02688387|11880055|FG012|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10716423|NCT02688387|11880056|FG013|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10716424|NCT02688387|11880057|FG014|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10716425|NCT02688387|11880058|FG015|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10716426|NCT02688387|11880059|FG016|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10716427|NCT02688387|11880060|FG017|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10716428|NCT02688387|11880061|FG018|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10716429|NCT02688387|11880062|FG019|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10716430|NCT02688387|11880063|FG020|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10716431|NCT02688387|11880064|FG021|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
10716438|NCT02688621|11880121|FG000|STARTED|Overall Study||212
10716439|NCT02688621|11880122|FG001|STARTED|Overall Study||206
10716440|NCT02688621|11880121|FG000|COMPLETED|Overall Study||172
10716441|NCT02688621|11880122|FG001|COMPLETED|Overall Study||188
10716442|NCT02688621|11880121|FG000|NOT COMPLETED|Overall Study||40
10716443|NCT02688621|11880122|FG001|NOT COMPLETED|Overall Study||18
10716444|NCT02688764|11880133|FG000|STARTED|Overall Study||66
10716445|NCT02688764|11880134|FG001|STARTED|Overall Study||19
10363575|NCT00516217|11503942|FG000|NOT COMPLETED|Overall Study||0
10363576|NCT00516269|11503948|FG000|STARTED|Overall Study||19
10363577|NCT00516269|11503949|FG001|STARTED|Overall Study||19
10363578|NCT00516269|11503948|FG000|COMPLETED|Overall Study|2 patients had an early termination|17
10363579|NCT00516269|11503949|FG001|COMPLETED|Overall Study|2 patients did not complete the study and 1 randomized to placebo twice.|16
10363580|NCT00516269|11503948|FG000|NOT COMPLETED|Overall Study||2
10363581|NCT00516269|11503949|FG001|NOT COMPLETED|Overall Study||3
10363582|NCT00516295|11503958|FG000|STARTED|Overall Study||7
10363583|NCT00516295|11503959|FG001|STARTED|Overall Study||0
10363584|NCT00516295|11503960|FG002|STARTED|Overall Study||0
10363585|NCT00516295|11503958|FG000|COMPLETED|Overall Study||4
10363586|NCT00516295|11503959|FG001|COMPLETED|Overall Study||0
10363587|NCT00516295|11503960|FG002|COMPLETED|Overall Study||0
10363588|NCT00516295|11503958|FG000|NOT COMPLETED|Overall Study||3
10363589|NCT00516295|11503959|FG001|NOT COMPLETED|Overall Study||0
10363590|NCT00516295|11503960|FG002|NOT COMPLETED|Overall Study||0
10363591|NCT00516321|11503970|FG000|STARTED|Open-label (OL) Pre-Antiviral Treatment||715
10363592|NCT00516321|11503971|FG001|STARTED|Open-label (OL) Pre-Antiviral Treatment||0
10363593|NCT00516321|11503972|FG002|STARTED|Open-label (OL) Pre-Antiviral Treatment||0
10363594|NCT00516321|11503970|FG000|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||682
10363595|NCT00516321|11503971|FG001|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
10363596|NCT00516321|11503972|FG002|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
10363597|NCT00516321|11503970|FG000|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||33
10363598|NCT00516321|11503971|FG001|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
10363599|NCT00516321|11503972|FG002|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
10363600|NCT00516321|11503970|FG000|STARTED|Double-blind (DB) Antiviral Treatment||0
10363601|NCT00516321|11503971|FG001|STARTED|Double-blind (DB) Antiviral Treatment||232
10363602|NCT00516321|11503972|FG002|STARTED|Double-blind (DB) Antiviral Treatment||450
10716446|NCT02688764|11880133|FG000|Treated in Stage 1|Overall Study||66
10812580|NCT03500341|11974678|FG000|STARTED|Overall Study||16
10363603|NCT00516321|11503970|FG000|COMPLETED|Double-blind (DB) Antiviral Treatment||0
10363604|NCT00516321|11503971|FG001|COMPLETED|Double-blind (DB) Antiviral Treatment||197
10363605|NCT00516321|11503972|FG002|COMPLETED|Double-blind (DB) Antiviral Treatment||396
10363606|NCT00516321|11503970|FG000|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||0
10363607|NCT00516321|11503971|FG001|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||35
10363608|NCT00516321|11503972|FG002|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||54
10363609|NCT00516386|11503980|FG000|STARTED|Overall Study||16
10363610|NCT00516386|11503980|FG000|COMPLETED|Overall Study||10
10363611|NCT00516386|11503980|FG000|NOT COMPLETED|Overall Study||6
10363612|NCT00516503|11503986|FG000|STARTED|Overall Study||101
10363613|NCT00516503|11503987|FG001|STARTED|Overall Study||102
10716447|NCT02688764|11880134|FG001|Treated in Stage 1|Overall Study||19
10716448|NCT02688764|11880133|FG000|Treated in Stage 2|Overall Study||43
10716449|NCT02688764|11880134|FG001|Treated in Stage 2|Overall Study||8
10716450|NCT02688764|11880133|FG000|COMPLETED|Overall Study||26
10363614|NCT00516503|11503986|FG000|COMPLETED|Overall Study||101
10363615|NCT00516503|11503987|FG001|COMPLETED|Overall Study||102
10363616|NCT00516503|11503986|FG000|NOT COMPLETED|Overall Study||0
10363617|NCT00516503|11503987|FG001|NOT COMPLETED|Overall Study||0
10363618|NCT00516893|11503993|FG000|STARTED|Overall Study||113
10363619|NCT00516893|11503993|FG000|Received Study Treatment|Overall Study||112
10363620|NCT00516893|11503993|FG000|COMPLETED|Overall Study||92
10363621|NCT00516893|11503993|FG000|NOT COMPLETED|Overall Study||21
10363622|NCT00516906|11503999|FG000|STARTED|Overall Study||36
10363623|NCT00516906|11504000|FG001|STARTED|Overall Study|33 patients were randomized but one patient was discharged prior to treatment.|32
10363624|NCT00516906|11503999|FG000|COMPLETED|Overall Study|Thirty patients were required to complete. Patients not completing were replaced.|30
10363625|NCT00516906|11504000|FG001|COMPLETED|Overall Study|Thirty patients were required to complete. Patients not completing were replaced.|30
10363626|NCT00516906|11503999|FG000|NOT COMPLETED|Overall Study||6
10363627|NCT00516906|11504000|FG001|NOT COMPLETED|Overall Study||2
10363628|NCT00516919|11504006|FG000|STARTED|Overall Study||40
10363629|NCT00516919|11504007|FG001|STARTED|Overall Study||39
10363630|NCT00516919|11504006|FG000|COMPLETED|Overall Study||30
10363631|NCT00516919|11504007|FG001|COMPLETED|Overall Study||32
10363632|NCT00516919|11504006|FG000|NOT COMPLETED|Overall Study||10
10363633|NCT00516919|11504007|FG001|NOT COMPLETED|Overall Study||7
10363634|NCT00517010|11504013|FG000|STARTED|Overall Study||6
10363635|NCT00517010|11504013|FG000|COMPLETED|Overall Study||5
10363636|NCT00517010|11504013|FG000|NOT COMPLETED|Overall Study||1
10363637|NCT00517296|11504019|FG000|STARTED|Overall Study||10
10363638|NCT00517296|11504020|FG001|STARTED|Overall Study||11
10363639|NCT00517296|11504019|FG000|COMPLETED|Overall Study||9
10363640|NCT00517296|11504020|FG001|COMPLETED|Overall Study||11
10363641|NCT00517296|11504019|FG000|NOT COMPLETED|Overall Study||1
10363642|NCT00517296|11504020|FG001|NOT COMPLETED|Overall Study||0
10363643|NCT00517413|11504026|FG000|STARTED|Overall Study||163
10363644|NCT00517413|11504026|FG000|COMPLETED|Overall Study||102
10363645|NCT00517413|11504026|FG000|NOT COMPLETED|Overall Study||61
10363646|NCT00517530|11504037|FG000|STARTED|Overall Study||21
10363647|NCT00517530|11504038|FG001|STARTED|Overall Study||13
10363648|NCT00517530|11504039|FG002|STARTED|Overall Study||18
10363649|NCT00517530|11504040|FG003|STARTED|Overall Study||22
10363650|NCT00517530|11504041|FG004|STARTED|Overall Study||21
10363651|NCT00517530|11504042|FG005|STARTED|Overall Study||19
10363652|NCT00517530|11504043|FG006|STARTED|Overall Study||20
10363653|NCT00517530|11504037|FG000|Completed Treatment|Overall Study||11
10363654|NCT00517530|11504038|FG001|Completed Treatment|Overall Study||13
10363655|NCT00517530|11504039|FG002|Completed Treatment|Overall Study||13
10363656|NCT00517530|11504040|FG003|Completed Treatment|Overall Study||18
10363657|NCT00517530|11504041|FG004|Completed Treatment|Overall Study||9
10363658|NCT00517530|11504042|FG005|Completed Treatment|Overall Study||9
10363659|NCT00517530|11504043|FG006|Completed Treatment|Overall Study||13
10363660|NCT00517530|11504037|FG000|Started Follow-up|Overall Study||20
10363661|NCT00517530|11504038|FG001|Started Follow-up|Overall Study||13
10363662|NCT00517530|11504039|FG002|Started Follow-up|Overall Study||17
10363663|NCT00517530|11504040|FG003|Started Follow-up|Overall Study||21
10363664|NCT00517530|11504041|FG004|Started Follow-up|Overall Study||17
10363665|NCT00517530|11504042|FG005|Started Follow-up|Overall Study||16
10363666|NCT00517530|11504043|FG006|Started Follow-up|Overall Study||19
10363667|NCT00517530|11504037|FG000|Completed Follow-up|Overall Study||2
10363668|NCT00517530|11504038|FG001|Completed Follow-up|Overall Study||0
10363669|NCT00517530|11504039|FG002|Completed Follow-up|Overall Study||0
10363670|NCT00517530|11504040|FG003|Completed Follow-up|Overall Study||1
10363671|NCT00517530|11504041|FG004|Completed Follow-up|Overall Study||0
10363672|NCT00517530|11504042|FG005|Completed Follow-up|Overall Study||0
10363673|NCT00517530|11504043|FG006|Completed Follow-up|Overall Study||1
10363674|NCT00517530|11504037|FG000|Retreated Population|Overall Study||2
10363675|NCT00517530|11504038|FG001|Retreated Population|Overall Study||2
10363676|NCT00517530|11504039|FG002|Retreated Population|Overall Study||1
10363677|NCT00517530|11504040|FG003|Retreated Population|Overall Study||4
10363678|NCT00517530|11504041|FG004|Retreated Population|Overall Study||2
10363679|NCT00517530|11504042|FG005|Retreated Population|Overall Study||2
10363680|NCT00517530|11504043|FG006|Retreated Population|Overall Study||0
10363681|NCT00517530|11504037|FG000|COMPLETED|Overall Study||2
10363682|NCT00517530|11504038|FG001|COMPLETED|Overall Study||0
10363683|NCT00517530|11504039|FG002|COMPLETED|Overall Study||0
10363684|NCT00517530|11504040|FG003|COMPLETED|Overall Study||1
10363685|NCT00517530|11504041|FG004|COMPLETED|Overall Study||1
10363686|NCT00517530|11504042|FG005|COMPLETED|Overall Study||0
10363687|NCT00517530|11504043|FG006|COMPLETED|Overall Study||1
10363688|NCT00517530|11504037|FG000|NOT COMPLETED|Overall Study||19
10363689|NCT00517530|11504038|FG001|NOT COMPLETED|Overall Study||13
10363690|NCT00517530|11504039|FG002|NOT COMPLETED|Overall Study||18
10363691|NCT00517530|11504040|FG003|NOT COMPLETED|Overall Study||21
10363692|NCT00517530|11504041|FG004|NOT COMPLETED|Overall Study||20
10363693|NCT00517530|11504042|FG005|NOT COMPLETED|Overall Study||19
10363694|NCT00517530|11504043|FG006|NOT COMPLETED|Overall Study||19
10363695|NCT00517556|11504076|FG000|STARTED|Overall Study||19
10363696|NCT00517556|11504077|FG001|STARTED|Overall Study||19
10363697|NCT00517556|11504076|FG000|COMPLETED|Overall Study||15
10363698|NCT00517556|11504077|FG001|COMPLETED|Overall Study||14
10363699|NCT00517556|11504076|FG000|NOT COMPLETED|Overall Study||4
10363700|NCT00517556|11504077|FG001|NOT COMPLETED|Overall Study||5
10363701|NCT00517595|11504083|FG000|STARTED|Overall Study||48
10363702|NCT00517595|11504083|FG000|COMPLETED|Overall Study||48
10363703|NCT00517595|11504083|FG000|NOT COMPLETED|Overall Study||0
10363704|NCT00517634|11504087|FG000|STARTED|First Treatment Period||4
10363705|NCT00517634|11504088|FG001|STARTED|First Treatment Period||4
10363706|NCT00517634|11504089|FG002|STARTED|First Treatment Period||4
10363707|NCT00517634|11504090|FG003|STARTED|First Treatment Period||3
10363708|NCT00517634|11504091|FG004|STARTED|First Treatment Period||4
10363709|NCT00517634|11504092|FG005|STARTED|First Treatment Period||4
10363710|NCT00517634|11504087|FG000|COMPLETED|First Treatment Period||4
10363711|NCT00517634|11504088|FG001|COMPLETED|First Treatment Period||4
10363712|NCT00517634|11504089|FG002|COMPLETED|First Treatment Period||4
10363713|NCT00517634|11504090|FG003|COMPLETED|First Treatment Period||3
10363714|NCT00517634|11504091|FG004|COMPLETED|First Treatment Period||4
10363715|NCT00517634|11504092|FG005|COMPLETED|First Treatment Period||4
10363716|NCT00517634|11504087|FG000|NOT COMPLETED|First Treatment Period||0
10363717|NCT00517634|11504088|FG001|NOT COMPLETED|First Treatment Period||0
10363718|NCT00517634|11504089|FG002|NOT COMPLETED|First Treatment Period||0
10363719|NCT00517634|11504090|FG003|NOT COMPLETED|First Treatment Period||0
10363720|NCT00517634|11504091|FG004|NOT COMPLETED|First Treatment Period||0
10363721|NCT00517634|11504092|FG005|NOT COMPLETED|First Treatment Period||0
10363722|NCT00517634|11504087|FG000|STARTED|Second Treatment Period||4
10363723|NCT00517634|11504088|FG001|STARTED|Second Treatment Period||4
10363724|NCT00517634|11504089|FG002|STARTED|Second Treatment Period||4
10363725|NCT00517634|11504090|FG003|STARTED|Second Treatment Period||3
10363726|NCT00517634|11504091|FG004|STARTED|Second Treatment Period||4
10363727|NCT00517634|11504092|FG005|STARTED|Second Treatment Period||4
10363728|NCT00517634|11504087|FG000|COMPLETED|Second Treatment Period||4
10363729|NCT00517634|11504088|FG001|COMPLETED|Second Treatment Period||4
10363730|NCT00517634|11504089|FG002|COMPLETED|Second Treatment Period||4
10363731|NCT00517634|11504090|FG003|COMPLETED|Second Treatment Period||3
10363732|NCT00517634|11504091|FG004|COMPLETED|Second Treatment Period||3
10363733|NCT00517634|11504092|FG005|COMPLETED|Second Treatment Period||4
10363734|NCT00517634|11504087|FG000|NOT COMPLETED|Second Treatment Period||0
10363735|NCT00517634|11504088|FG001|NOT COMPLETED|Second Treatment Period||0
10363736|NCT00517634|11504089|FG002|NOT COMPLETED|Second Treatment Period||0
10363737|NCT00517634|11504090|FG003|NOT COMPLETED|Second Treatment Period||0
10363738|NCT00517634|11504091|FG004|NOT COMPLETED|Second Treatment Period||1
10363739|NCT00517634|11504092|FG005|NOT COMPLETED|Second Treatment Period||0
10363740|NCT00517634|11504087|FG000|STARTED|Third Treatment Period||4
10363741|NCT00517634|11504088|FG001|STARTED|Third Treatment Period||4
10363742|NCT00517634|11504089|FG002|STARTED|Third Treatment Period||4
10363743|NCT00517634|11504090|FG003|STARTED|Third Treatment Period||3
10363744|NCT00517634|11504091|FG004|STARTED|Third Treatment Period||3
10363745|NCT00517634|11504092|FG005|STARTED|Third Treatment Period||4
10363746|NCT00517634|11504087|FG000|COMPLETED|Third Treatment Period||4
10363747|NCT00517634|11504088|FG001|COMPLETED|Third Treatment Period||4
10363748|NCT00517634|11504089|FG002|COMPLETED|Third Treatment Period||4
10363749|NCT00517634|11504090|FG003|COMPLETED|Third Treatment Period||3
10363750|NCT00517634|11504091|FG004|COMPLETED|Third Treatment Period||3
10363751|NCT00517634|11504092|FG005|COMPLETED|Third Treatment Period||4
10363752|NCT00517634|11504087|FG000|NOT COMPLETED|Third Treatment Period||0
10363753|NCT00517634|11504088|FG001|NOT COMPLETED|Third Treatment Period||0
10363754|NCT00517634|11504089|FG002|NOT COMPLETED|Third Treatment Period||0
10363755|NCT00517634|11504090|FG003|NOT COMPLETED|Third Treatment Period||0
10363756|NCT00517634|11504091|FG004|NOT COMPLETED|Third Treatment Period||0
10363757|NCT00517634|11504092|FG005|NOT COMPLETED|Third Treatment Period||0
10363758|NCT00517751|11504100|FG000|STARTED|Overall Study||162
10363759|NCT00517751|11504100|FG000|COMPLETED|Overall Study||33
10363760|NCT00517751|11504100|FG000|NOT COMPLETED|Overall Study||129
10363761|NCT00517829|11504106|FG000|STARTED|Overall Study||75
10363762|NCT00517829|11504107|FG001|STARTED|Overall Study||75
10363763|NCT00517829|11504106|FG000|COMPLETED|Overall Study||0
10363764|NCT00517829|11504107|FG001|COMPLETED|Overall Study||0
10363765|NCT00517829|11504106|FG000|NOT COMPLETED|Overall Study||75
10363766|NCT00517829|11504107|FG001|NOT COMPLETED|Overall Study||75
10363767|NCT00517881|11504113|FG000|STARTED|Overall Study||29
10363768|NCT00517881|11504113|FG000|COMPLETED|Overall Study||24
10363769|NCT00517881|11504113|FG000|NOT COMPLETED|Overall Study||5
10363770|NCT00517933|11504119|FG000|STARTED|Period 1|Patients decreased due to death, adverse event, lost to follow up and other (see below)|89
10363771|NCT00517933|11504120|FG001|STARTED|Period 1|Patients decreased due to death, adverse event and other (see below)|91
10363772|NCT00517933|11504119|FG000|COMPLETED|Period 1||81
10363773|NCT00517933|11504120|FG001|COMPLETED|Period 1||85
10363774|NCT00517933|11504119|FG000|NOT COMPLETED|Period 1||8
10363775|NCT00517933|11504120|FG001|NOT COMPLETED|Period 1||6
10363776|NCT00517933|11504119|FG000|STARTED|Period 2|2 patients terminated after completion of period one, but before starting period 2|79
10363777|NCT00517933|11504120|FG001|STARTED|Period 2|2 patients terminated after completion of period one, but before starting period 2|83
10363778|NCT00517933|11504119|FG000|COMPLETED|Period 2||73
10363779|NCT00517933|11504120|FG001|COMPLETED|Period 2||70
10363780|NCT00517933|11504119|FG000|NOT COMPLETED|Period 2||6
10363781|NCT00517933|11504120|FG001|NOT COMPLETED|Period 2||13
10363782|NCT00518011|11504131|FG000|STARTED|Overall Study||9
10363783|NCT00518011|11504132|FG001|STARTED|Overall Study||8
10363784|NCT00518011|11504131|FG000|COMPLETED|Overall Study||0
10363785|NCT00518011|11504132|FG001|COMPLETED|Overall Study||0
10363786|NCT00518011|11504131|FG000|NOT COMPLETED|Overall Study||9
10363787|NCT00518011|11504132|FG001|NOT COMPLETED|Overall Study||8
10363788|NCT00518089|11504141|FG000|STARTED|Overall Study||430
10363789|NCT00518089|11504142|FG001|STARTED|Overall Study||429
10363790|NCT00518089|11504141|FG000|COMPLETED|Overall Study||402
10363791|NCT00518089|11504142|FG001|COMPLETED|Overall Study||398
10363792|NCT00518089|11504141|FG000|NOT COMPLETED|Overall Study||28
10363793|NCT00518089|11504142|FG001|NOT COMPLETED|Overall Study||31
10363794|NCT00518115|11504158|FG000|STARTED|Overall Study||52
10363795|NCT00518115|11504159|FG001|STARTED|Overall Study||35
10363796|NCT00518115|11504160|FG002|STARTED|Overall Study||36
10363797|NCT00518115|11504161|FG003|STARTED|Overall Study||35
10363798|NCT00518115|11504162|FG004|STARTED|Overall Study||31
10363799|NCT00518115|11504163|FG005|STARTED|Overall Study||34
10363800|NCT00518115|11504164|FG006|STARTED|Overall Study||33
10363801|NCT00518115|11504165|FG007|STARTED|Overall Study||35
10363802|NCT00518115|11504166|FG008|STARTED|Overall Study||35
10363803|NCT00518115|11504167|FG009|STARTED|Overall Study||35
10363804|NCT00518115|11504158|FG000|Safety Population|Overall Study|These participants received at least one dose of study drug.|51
10363805|NCT00518115|11504159|FG001|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
10363806|NCT00518115|11504160|FG002|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
10363807|NCT00518115|11504161|FG003|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
10363808|NCT00518115|11504162|FG004|Safety Population|Overall Study|These participants received at least one dose of study drug.|31
10363809|NCT00518115|11504163|FG005|Safety Population|Overall Study|These participants received at least one dose of study drug.|33
10363810|NCT00518115|11504164|FG006|Safety Population|Overall Study|These participants received at least one dose of study drug.|32
10363811|NCT00518115|11504165|FG007|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
10535554|NCT01437397|11687912|FG001|STARTED|Overall Study||338
10535555|NCT01437397|11687913|FG002|STARTED|Overall Study||340
10535556|NCT01437397|11687914|FG003|STARTED|Overall Study||339
10535557|NCT01437397|11687915|FG004|STARTED|Overall Study||337
10535558|NCT01437397|11687911|FG000|COMPLETED|Overall Study||272
10535559|NCT01437397|11687912|FG001|COMPLETED|Overall Study||276
10535560|NCT01437397|11687913|FG002|COMPLETED|Overall Study||268
10535561|NCT01437397|11687914|FG003|COMPLETED|Overall Study||270
10535562|NCT01437397|11687915|FG004|COMPLETED|Overall Study||236
10535563|NCT01437397|11687911|FG000|NOT COMPLETED|Overall Study||66
10363812|NCT00518115|11504166|FG008|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
10363813|NCT00518115|11504167|FG009|Safety Population|Overall Study|These participants received at least one dose of study drug.|34
10363814|NCT00518115|11504158|FG000|COMPLETED|Overall Study||40
10363815|NCT00518115|11504159|FG001|COMPLETED|Overall Study||29
10363816|NCT00518115|11504160|FG002|COMPLETED|Overall Study||19
10363817|NCT00518115|11504161|FG003|COMPLETED|Overall Study||24
10363818|NCT00518115|11504162|FG004|COMPLETED|Overall Study||21
10363819|NCT00518115|11504163|FG005|COMPLETED|Overall Study||19
10363820|NCT00518115|11504164|FG006|COMPLETED|Overall Study||25
10363821|NCT00518115|11504165|FG007|COMPLETED|Overall Study||20
10363822|NCT00518115|11504166|FG008|COMPLETED|Overall Study||30
10363823|NCT00518115|11504167|FG009|COMPLETED|Overall Study||20
10363824|NCT00518115|11504158|FG000|NOT COMPLETED|Overall Study||12
10363825|NCT00518115|11504159|FG001|NOT COMPLETED|Overall Study||6
10363826|NCT00518115|11504160|FG002|NOT COMPLETED|Overall Study||17
10363827|NCT00518115|11504161|FG003|NOT COMPLETED|Overall Study||11
10363828|NCT00518115|11504162|FG004|NOT COMPLETED|Overall Study||10
10535564|NCT01437397|11687912|FG001|NOT COMPLETED|Overall Study||62
10535565|NCT01437397|11687913|FG002|NOT COMPLETED|Overall Study||72
10306038|NCT00096486|11439027|FG001|COMPLETED|Overall Study||6
10306039|NCT00096486|11439028|FG002|COMPLETED|Overall Study||24
10306040|NCT00096486|11439029|FG003|COMPLETED|Overall Study||36
10306041|NCT00096486|11439026|FG000|NOT COMPLETED|Overall Study||0
10306042|NCT00096486|11439027|FG001|NOT COMPLETED|Overall Study||0
10306043|NCT00096486|11439028|FG002|NOT COMPLETED|Overall Study||2
10306044|NCT00096486|11439029|FG003|NOT COMPLETED|Overall Study||2
10306045|NCT00096538|11439039|FG000|STARTED|Overall Study||6
10306046|NCT00096538|11439039|FG000|COMPLETED|Overall Study||5
10306047|NCT00096538|11439039|FG000|NOT COMPLETED|Overall Study||1
10306048|NCT00096681|11439043|FG000|STARTED|Overall Study||762
10306049|NCT00096681|11439043|FG000|COMPLETED|Overall Study||762
10306050|NCT00096681|11439043|FG000|NOT COMPLETED|Overall Study||0
10306051|NCT00096785|11439049|FG000|STARTED|Overall Study|1 participant randomized to ADV, treated with ETV. (As randomized= 35; as treated=36)|35
10306052|NCT00096785|11439050|FG001|STARTED|Overall Study|1 participant randomized to ADV, treated with ETV. (As randomized= 34; as treated=33)|34
10306053|NCT00096785|11439049|FG000|As-Randomized Population|Overall Study||35
10716451|NCT02688764|11880134|FG001|COMPLETED|Overall Study||2
10716452|NCT02688764|11880133|FG000|NOT COMPLETED|Overall Study||40
10716453|NCT02688764|11880134|FG001|NOT COMPLETED|Overall Study||17
10716454|NCT02688829|11880143|FG000|STARTED|Overall Study||21
10363829|NCT00518115|11504163|FG005|NOT COMPLETED|Overall Study||15
10363830|NCT00518115|11504164|FG006|NOT COMPLETED|Overall Study||8
10363831|NCT00518115|11504165|FG007|NOT COMPLETED|Overall Study||15
10363832|NCT00518115|11504166|FG008|NOT COMPLETED|Overall Study||5
10363833|NCT00518115|11504167|FG009|NOT COMPLETED|Overall Study||15
10363834|NCT00518154|11504190|FG000|STARTED|Overall Study||7
10363835|NCT00518154|11504190|FG000|COMPLETED|Overall Study||7
10363836|NCT00518154|11504190|FG000|NOT COMPLETED|Overall Study||0
10363837|NCT00518180|11504197|FG000|STARTED|Overall Study||540
10363838|NCT00518180|11504198|FG001|STARTED|Overall Study||541
10363839|NCT00518180|11504199|FG002|STARTED|Overall Study||539
10363840|NCT00518180|11504197|FG000|COMPLETED|Overall Study||475
10363841|NCT00518180|11504198|FG001|COMPLETED|Overall Study||472
10363842|NCT00518180|11504199|FG002|COMPLETED|Overall Study||457
10363843|NCT00518180|11504197|FG000|NOT COMPLETED|Overall Study||65
10363844|NCT00518180|11504198|FG001|NOT COMPLETED|Overall Study||69
10363845|NCT00518180|11504199|FG002|NOT COMPLETED|Overall Study||82
10363846|NCT00518206|11504218|FG000|STARTED|Overall Study||27
10363847|NCT00518206|11504219|FG001|STARTED|Overall Study||19
10363848|NCT00518206|11504218|FG000|COMPLETED|Overall Study||16
10363849|NCT00518206|11504219|FG001|COMPLETED|Overall Study||13
10363850|NCT00518206|11504218|FG000|NOT COMPLETED|Overall Study||11
10363851|NCT00518206|11504219|FG001|NOT COMPLETED|Overall Study||6
10363852|NCT00518284|11504229|FG000|STARTED|Overall Study||0
10363853|NCT00518284|11504230|FG001|STARTED|Overall Study||3
10363854|NCT00518284|11504231|FG002|STARTED|Overall Study||1
10363855|NCT00518284|11504232|FG003|STARTED|Overall Study||2
10363856|NCT00518284|11504229|FG000|COMPLETED|Overall Study||0
10363857|NCT00518284|11504230|FG001|COMPLETED|Overall Study||0
10363858|NCT00518284|11504231|FG002|COMPLETED|Overall Study||0
10363859|NCT00518284|11504232|FG003|COMPLETED|Overall Study||0
10363860|NCT00518284|11504229|FG000|NOT COMPLETED|Overall Study||0
10363861|NCT00518284|11504230|FG001|NOT COMPLETED|Overall Study||3
10363862|NCT00518284|11504231|FG002|NOT COMPLETED|Overall Study||1
10363863|NCT00518284|11504232|FG003|NOT COMPLETED|Overall Study||2
10363864|NCT00518323|11504246|FG000|STARTED|Overall Study||54
10363865|NCT00518323|11504247|FG001|STARTED|Overall Study||48
10363866|NCT00518323|11504248|FG002|STARTED|Overall Study||48
10363867|NCT00518323|11504249|FG003|STARTED|Overall Study||51
10363868|NCT00518323|11504246|FG000|COMPLETED|Overall Study||35
10363869|NCT00518323|11504247|FG001|COMPLETED|Overall Study||40
10363870|NCT00518323|11504248|FG002|COMPLETED|Overall Study||37
10363871|NCT00518323|11504249|FG003|COMPLETED|Overall Study||26
10363872|NCT00518323|11504246|FG000|NOT COMPLETED|Overall Study||19
10363873|NCT00518323|11504247|FG001|NOT COMPLETED|Overall Study||8
10363874|NCT00518323|11504248|FG002|NOT COMPLETED|Overall Study||11
10363875|NCT00518323|11504249|FG003|NOT COMPLETED|Overall Study||25
10363876|NCT00518336|11504261|FG000|STARTED|Year 7||222
10363877|NCT00518336|11504262|FG001|STARTED|Year 7||211
10363878|NCT00518336|11504261|FG000|COMPLETED|Year 7||220
10363879|NCT00518336|11504262|FG001|COMPLETED|Year 7||208
10363880|NCT00518336|11504261|FG000|NOT COMPLETED|Year 7||2
10363881|NCT00518336|11504262|FG001|NOT COMPLETED|Year 7||3
10363882|NCT00518336|11504261|FG000|STARTED|Year 8|1 subject withdrawn at Year 7 came back and was therefore no longer considered as withdrawn.|223
10363883|NCT00518336|11504262|FG001|STARTED|Year 8|2 subjects withdrawn at Year 7 came back and were therefore no longer considered as withdrawn.|213
10363884|NCT00518336|11504261|FG000|COMPLETED|Year 8||222
10363885|NCT00518336|11504262|FG001|COMPLETED|Year 8||211
10363886|NCT00518336|11504261|FG000|NOT COMPLETED|Year 8||1
10363887|NCT00518336|11504262|FG001|NOT COMPLETED|Year 8||2
10363888|NCT00518336|11504261|FG000|STARTED|Year 9|1 subject did not particpate at the previous timepoint, came back and was added in the Total cohort|224
10363889|NCT00518336|11504262|FG001|STARTED|Year 9||213
10363890|NCT00518336|11504261|FG000|COMPLETED|Year 9||219
10363891|NCT00518336|11504262|FG001|COMPLETED|Year 9||212
10363892|NCT00518336|11504261|FG000|NOT COMPLETED|Year 9||5
10363893|NCT00518336|11504262|FG001|NOT COMPLETED|Year 9||1
10363894|NCT00518349|11504270|FG000|STARTED|Overall Study||60
10363895|NCT00518349|11504271|FG001|STARTED|Overall Study||60
10363896|NCT00518349|11504270|FG000|COMPLETED|Overall Study||60
10363897|NCT00518349|11504271|FG001|COMPLETED|Overall Study||60
10363898|NCT00518349|11504270|FG000|NOT COMPLETED|Overall Study||0
10363899|NCT00518349|11504271|FG001|NOT COMPLETED|Overall Study||0
10716455|NCT02688829|11880143|FG000|COMPLETED|Overall Study||19
10363900|NCT00518531|11504279|FG000|STARTED|Treatment Period 1||124
10363901|NCT00518531|11504280|FG001|STARTED|Treatment Period 1||126
10363902|NCT00518531|11504279|FG000|Received Treatment|Treatment Period 1||119
10363903|NCT00518531|11504280|FG001|Received Treatment|Treatment Period 1||124
10363904|NCT00518531|11504279|FG000|COMPLETED|Treatment Period 1||106
10363905|NCT00518531|11504280|FG001|COMPLETED|Treatment Period 1|Participants who completed Treatment Period 1 may choose not to start Treatment Period 2|114
10363906|NCT00518531|11504279|FG000|NOT COMPLETED|Treatment Period 1||18
10363907|NCT00518531|11504280|FG001|NOT COMPLETED|Treatment Period 1||12
10363908|NCT00518531|11504279|FG000|STARTED|Treatment Period 2||106
10363909|NCT00518531|11504280|FG001|STARTED|Treatment Period 2|Participants can start Treatment Period 2 without completing Treatment Period 1.|115
10716456|NCT02688829|11880143|FG000|NOT COMPLETED|Overall Study||2
10363910|NCT00518531|11504279|FG000|Received Treatment|Treatment Period 2||106
10716457|NCT02688842|11880147|FG000|STARTED|Overall Study||38
10363911|NCT00518531|11504280|FG001|Received Treatment|Treatment Period 2||110
10363912|NCT00518531|11504279|FG000|COMPLETED|Treatment Period 2||103
10363913|NCT00518531|11504280|FG001|COMPLETED|Treatment Period 2||95
10363914|NCT00518531|11504279|FG000|NOT COMPLETED|Treatment Period 2||3
10363915|NCT00518531|11504280|FG001|NOT COMPLETED|Treatment Period 2||20
10427214|NCT00851877|11572988|FG002|COMPLETED|Phase II||22
10427215|NCT00851877|11572986|FG000|NOT COMPLETED|Phase II||0
10427216|NCT00851877|11572987|FG001|NOT COMPLETED|Phase II||0
10427217|NCT00851877|11572988|FG002|NOT COMPLETED|Phase II||3
10427218|NCT00851890|11572998|FG000|STARTED|Overall Study||8
10427219|NCT00851890|11572999|FG001|STARTED|Overall Study||8
10427220|NCT00851890|11573000|FG002|STARTED|Overall Study||8
10427221|NCT00851890|11573001|FG003|STARTED|Overall Study||6
10427222|NCT00851890|11572998|FG000|COMPLETED|Overall Study||8
10427223|NCT00851890|11572999|FG001|COMPLETED|Overall Study||7
10427224|NCT00851890|11573000|FG002|COMPLETED|Overall Study||8
10427225|NCT00851890|11573001|FG003|COMPLETED|Overall Study||5
10427226|NCT00851890|11572998|FG000|NOT COMPLETED|Overall Study||0
10427227|NCT00851890|11572999|FG001|NOT COMPLETED|Overall Study||1
10427228|NCT00851890|11573000|FG002|NOT COMPLETED|Overall Study||0
10427229|NCT00851890|11573001|FG003|NOT COMPLETED|Overall Study||1
10427230|NCT00851903|11573011|FG000|STARTED|Overall Study||112
10427231|NCT00851903|11573011|FG000|Safety Population|Overall Study|patients treated with at least one dose of insulin glargine OR one dose of sitagliptin|112
10427232|NCT00851903|11573011|FG000|Treated by Combination|Overall Study|patients treated with at least one dose of insulin glargine AND one dose of sitagliptin|111
10427233|NCT00851903|11573011|FG000|Modified Intent-To-Treat Population|Overall Study|mITT population: patients treated by combination with at least 1 on-treatment efficacy measure|111
10427234|NCT00851903|11573011|FG000|COMPLETED|Overall Study||110
10427235|NCT00851903|11573011|FG000|NOT COMPLETED|Overall Study||2
10427236|NCT00852137|11573017|FG000|STARTED|Overall Study||13
10427237|NCT00852137|11573018|FG001|STARTED|Overall Study||3
10427238|NCT00852137|11573017|FG000|COMPLETED|Overall Study||13
10427239|NCT00852137|11573018|FG001|COMPLETED|Overall Study||3
10427240|NCT00852137|11573017|FG000|NOT COMPLETED|Overall Study||0
10427241|NCT00852137|11573018|FG001|NOT COMPLETED|Overall Study||0
10427242|NCT00852202|11573027|FG000|STARTED|Overall Study||77
10427243|NCT00852202|11573028|FG001|STARTED|Overall Study||75
10427244|NCT00852202|11573029|FG002|STARTED|Overall Study||75
10427245|NCT00852202|11573027|FG000|COMPLETED|Overall Study||60
10427246|NCT00852202|11573028|FG001|COMPLETED|Overall Study||63
10427247|NCT00852202|11573029|FG002|COMPLETED|Overall Study||49
10427248|NCT00852202|11573027|FG000|NOT COMPLETED|Overall Study||17
10427249|NCT00852202|11573028|FG001|NOT COMPLETED|Overall Study||12
10427250|NCT00852202|11573029|FG002|NOT COMPLETED|Overall Study||26
10427251|NCT00852397|11573041|FG000|STARTED|Overall Study||52
10427252|NCT00852397|11573042|FG001|STARTED|Overall Study||49
10427253|NCT00852397|11573043|FG002|STARTED|Overall Study||50
10427254|NCT00852397|11573041|FG000|Treated Participants|Overall Study||51
10427255|NCT00852397|11573042|FG001|Treated Participants|Overall Study||49
10427256|NCT00852397|11573043|FG002|Treated Participants|Overall Study||49
10427257|NCT00852397|11573041|FG000|COMPLETED|Overall Study||41
10427258|NCT00852397|11573042|FG001|COMPLETED|Overall Study||41
10427259|NCT00852397|11573043|FG002|COMPLETED|Overall Study||36
10427260|NCT00852397|11573041|FG000|NOT COMPLETED|Overall Study||11
10427261|NCT00852397|11573042|FG001|NOT COMPLETED|Overall Study||8
10427262|NCT00852397|11573043|FG002|NOT COMPLETED|Overall Study||14
10427263|NCT00852475|11573053|FG000|STARTED|Overall Study||26
10427264|NCT00852475|11573054|FG001|STARTED|Overall Study||20
10427265|NCT00852475|11573053|FG000|COMPLETED|Overall Study||23
10427266|NCT00852475|11573054|FG001|COMPLETED|Overall Study||16
10427267|NCT00852475|11573053|FG000|NOT COMPLETED|Overall Study||3
10427268|NCT00852475|11573054|FG001|NOT COMPLETED|Overall Study||4
10427269|NCT00852527|11573062|FG000|STARTED|Overall Study||196
10427270|NCT00852527|11573063|FG001|STARTED|Overall Study||242
10427271|NCT00852527|11573062|FG000|COMPLETED|Overall Study||196
10427272|NCT00852527|11573063|FG001|COMPLETED|Overall Study||242
10427273|NCT00852527|11573062|FG000|NOT COMPLETED|Overall Study||0
10427274|NCT00852527|11573063|FG001|NOT COMPLETED|Overall Study||0
10427275|NCT00852540|11573070|FG000|STARTED|Overall Study||270
10427276|NCT00852540|11573071|FG001|STARTED|Overall Study||140
10427277|NCT00852540|11573070|FG000|COMPLETED|Overall Study||234
10427278|NCT00852540|11573071|FG001|COMPLETED|Overall Study||122
10427279|NCT00852540|11573070|FG000|NOT COMPLETED|Overall Study||36
10427280|NCT00852540|11573071|FG001|NOT COMPLETED|Overall Study||18
10427281|NCT00852592|11573080|FG000|STARTED|Overall Study||23
10427282|NCT00852592|11573081|FG001|STARTED|Overall Study||23
10427283|NCT00852592|11573080|FG000|COMPLETED|Overall Study||20
10427284|NCT00852592|11573081|FG001|COMPLETED|Overall Study||19
10427285|NCT00852592|11573080|FG000|NOT COMPLETED|Overall Study||3
10427286|NCT00852592|11573081|FG001|NOT COMPLETED|Overall Study||4
10427287|NCT00852631|11573087|FG000|STARTED|Overall Study||28
10427288|NCT00852631|11573087|FG000|COMPLETED|Overall Study||17
10427289|NCT00852631|11573087|FG000|NOT COMPLETED|Overall Study||11
10427290|NCT00852644|11573091|FG000|STARTED|Overall Study||3
10427291|NCT00852644|11573092|FG001|STARTED|Overall Study||3
10427292|NCT00852644|11573093|FG002|STARTED|Overall Study||0
10427293|NCT00852644|11573094|FG003|STARTED|Overall Study||3
10427294|NCT00852644|11573095|FG004|STARTED|Overall Study||0
10427295|NCT00852644|11573096|FG005|STARTED|Overall Study||0
10427296|NCT00852644|11573091|FG000|COMPLETED|Overall Study||3
10427297|NCT00852644|11573092|FG001|COMPLETED|Overall Study||3
10363916|NCT00518622|11504296|FG000|STARTED|Overall Study||3
10363917|NCT00518622|11504297|FG001|STARTED|Overall Study||6
10363918|NCT00518622|11504298|FG002|STARTED|Overall Study||6
10363919|NCT00518622|11504299|FG003|STARTED|Overall Study||5
10363920|NCT00518622|11504300|FG004|STARTED|Overall Study||6
10363921|NCT00518622|11504301|FG005|STARTED|Overall Study||5
10363922|NCT00518622|11504302|FG006|STARTED|Overall Study||4
10363923|NCT00518622|11504303|FG007|STARTED|Overall Study||5
10363924|NCT00518622|11504296|FG000|Completed Therapy|Overall Study|Completed therapy defined if participant has taken 8 days of study medication per the protocol.|3
10363925|NCT00518622|11504297|FG001|Completed Therapy|Overall Study||5
10363926|NCT00518622|11504298|FG002|Completed Therapy|Overall Study||6
10363927|NCT00518622|11504299|FG003|Completed Therapy|Overall Study||5
10363928|NCT00518622|11504300|FG004|Completed Therapy|Overall Study||6
10363929|NCT00518622|11504301|FG005|Completed Therapy|Overall Study||5
10363930|NCT00518622|11504302|FG006|Completed Therapy|Overall Study||4
10363931|NCT00518622|11504303|FG007|Completed Therapy|Overall Study||5
10363932|NCT00518622|11504296|FG000|Discontinued Therapy|Overall Study|Discontinued therapy defined if participant has not taken 8 days of medication per the protocol.|0
10363933|NCT00518622|11504297|FG001|Discontinued Therapy|Overall Study||1
10363934|NCT00518622|11504298|FG002|Discontinued Therapy|Overall Study||0
10363935|NCT00518622|11504299|FG003|Discontinued Therapy|Overall Study||0
10363936|NCT00518622|11504300|FG004|Discontinued Therapy|Overall Study||0
10363937|NCT00518622|11504301|FG005|Discontinued Therapy|Overall Study||0
10363938|NCT00518622|11504302|FG006|Discontinued Therapy|Overall Study||0
10363939|NCT00518622|11504303|FG007|Discontinued Therapy|Overall Study||0
10363940|NCT00518622|11504296|FG000|COMPLETED|Overall Study||3
10363941|NCT00518622|11504297|FG001|COMPLETED|Overall Study||5
10363942|NCT00518622|11504298|FG002|COMPLETED|Overall Study||5
10363943|NCT00518622|11504299|FG003|COMPLETED|Overall Study||5
10363944|NCT00518622|11504300|FG004|COMPLETED|Overall Study||6
10363945|NCT00518622|11504301|FG005|COMPLETED|Overall Study||5
10363946|NCT00518622|11504302|FG006|COMPLETED|Overall Study||4
10363947|NCT00518622|11504303|FG007|COMPLETED|Overall Study||5
10363948|NCT00518622|11504296|FG000|NOT COMPLETED|Overall Study||0
10363949|NCT00518622|11504297|FG001|NOT COMPLETED|Overall Study||1
10363950|NCT00518622|11504298|FG002|NOT COMPLETED|Overall Study||1
10363951|NCT00518622|11504299|FG003|NOT COMPLETED|Overall Study||0
10363952|NCT00518622|11504300|FG004|NOT COMPLETED|Overall Study||0
10363953|NCT00518622|11504301|FG005|NOT COMPLETED|Overall Study||0
10363954|NCT00518622|11504302|FG006|NOT COMPLETED|Overall Study||0
10363955|NCT00518622|11504303|FG007|NOT COMPLETED|Overall Study||0
10363956|NCT00518687|11504323|FG000|STARTED|Overall Study|An additional 10 participants were not analyzed because of questionable clinical practices at 1 site|4005
10363957|NCT00518687|11504324|FG001|STARTED|Overall Study|An additional 11 participants were not analyzed because of questionable clinical practices at 1 site|4005
10363958|NCT00518687|11504323|FG000|Vaccinated|Overall Study||3981
10363959|NCT00518687|11504324|FG001|Vaccinated|Overall Study||3982
10363960|NCT00518687|11504323|FG000|COMPLETED|Overall Study||2568
10363961|NCT00518687|11504324|FG001|COMPLETED|Overall Study||2585
10363962|NCT00518687|11504323|FG000|NOT COMPLETED|Overall Study||1437
10363963|NCT00518687|11504324|FG001|NOT COMPLETED|Overall Study||1420
10363964|NCT00518713|11504334|FG000|STARTED|Overall Study||58
10363965|NCT00518713|11504335|FG001|STARTED|Overall Study||62
10363966|NCT00518713|11504336|FG002|STARTED|Overall Study||59
10363967|NCT00518713|11504337|FG003|STARTED|Overall Study||59
10363968|NCT00518713|11504334|FG000|Modified Intent-to-Treat Population|Overall Study||53
10363969|NCT00518713|11504335|FG001|Modified Intent-to-Treat Population|Overall Study||58
10363970|NCT00518713|11504336|FG002|Modified Intent-to-Treat Population|Overall Study||49
10363971|NCT00518713|11504337|FG003|Modified Intent-to-Treat Population|Overall Study||57
10363972|NCT00518713|11504334|FG000|COMPLETED|Overall Study||50
10363973|NCT00518713|11504335|FG001|COMPLETED|Overall Study||45
10363974|NCT00518713|11504336|FG002|COMPLETED|Overall Study||41
10363975|NCT00518713|11504337|FG003|COMPLETED|Overall Study||41
10363976|NCT00518713|11504334|FG000|NOT COMPLETED|Overall Study||8
10363977|NCT00518713|11504335|FG001|NOT COMPLETED|Overall Study||17
10363978|NCT00518713|11504336|FG002|NOT COMPLETED|Overall Study||18
10363979|NCT00518713|11504337|FG003|NOT COMPLETED|Overall Study||18
10364055|NCT00519376|11504392|FG001|NOT COMPLETED|Treatment Period 1||0
10364056|NCT00519376|11504393|FG002|NOT COMPLETED|Treatment Period 1||0
10363980|NCT00518882|11504349|FG000|STARTED|Double-Blind, Week 0-26|2 subjects exposed to study drug before randomisation. Subjects only included in safety analysis set|235
10363981|NCT00518882|11504350|FG001|STARTED|Double-Blind, Week 0-26|1 subject exposed to study drug before randomisation. Subject only included in safety analysis set|232
10363982|NCT00518882|11504349|FG000|Randomised|Double-Blind, Week 0-26||233
10716458|NCT02688842|11880147|FG000|COMPLETED|Overall Study||38
10716459|NCT02688842|11880147|FG000|NOT COMPLETED|Overall Study||0
10716460|NCT02688868|11880151|FG000|STARTED|Overall Study||38
10716461|NCT02688868|11880151|FG000|COMPLETED|Overall Study||34
10716462|NCT02688868|11880151|FG000|NOT COMPLETED|Overall Study||4
10363983|NCT00518882|11504350|FG001|Randomised|Double-Blind, Week 0-26||231
10363984|NCT00518882|11504349|FG000|COMPLETED|Double-Blind, Week 0-26||202
10363985|NCT00518882|11504350|FG001|COMPLETED|Double-Blind, Week 0-26||187
10363986|NCT00518882|11504349|FG000|NOT COMPLETED|Double-Blind, Week 0-26||33
10363987|NCT00518882|11504350|FG001|NOT COMPLETED|Double-Blind, Week 0-26||45
10363988|NCT00518882|11504349|FG000|STARTED|Open-Label Extension, Week 26-78||202
10363989|NCT00518882|11504350|FG001|STARTED|Open-Label Extension, Week 26-78||187
10363990|NCT00518882|11504349|FG000|COMPLETED|Open-Label Extension, Week 26-78||161
10716463|NCT02689063|11880159|FG000|STARTED|Overall Study||75
10716464|NCT02689063|11880160|FG001|STARTED|Overall Study||75
10363991|NCT00518882|11504350|FG001|COMPLETED|Open-Label Extension, Week 26-78||138
10363992|NCT00518882|11504349|FG000|NOT COMPLETED|Open-Label Extension, Week 26-78||41
10363993|NCT00518882|11504350|FG001|NOT COMPLETED|Open-Label Extension, Week 26-78||49
10363994|NCT00518973|11504358|FG000|STARTED|Overall Study||9
10363995|NCT00518973|11504359|FG001|STARTED|Overall Study||6
10363996|NCT00518973|11504358|FG000|COMPLETED|Overall Study||6
10363997|NCT00518973|11504359|FG001|COMPLETED|Overall Study||4
10363998|NCT00518973|11504358|FG000|NOT COMPLETED|Overall Study||3
10363999|NCT00518973|11504359|FG001|NOT COMPLETED|Overall Study||2
10364000|NCT00518986|11504367|FG000|STARTED|Overall Study|One subject discontinued before treatment, only 124 subjects in each treatment group were dosed.|125
10364001|NCT00518986|11504368|FG001|STARTED|Overall Study||124
10364002|NCT00518986|11504367|FG000|COMPLETED|Overall Study||99
10364003|NCT00518986|11504368|FG001|COMPLETED|Overall Study||98
10364004|NCT00518986|11504367|FG000|NOT COMPLETED|Overall Study||26
10364005|NCT00518986|11504368|FG001|NOT COMPLETED|Overall Study||26
10364006|NCT00519077|11504374|FG000|STARTED|Overall Study||44
10364007|NCT00519077|11504374|FG000|COMPLETED|Overall Study||36
10364008|NCT00519077|11504374|FG000|NOT COMPLETED|Overall Study||8
10364009|NCT00519194|11504378|FG000|STARTED|Overall Study||112
10364010|NCT00519194|11504378|FG000|COMPLETED|Overall Study||91
10364011|NCT00519194|11504378|FG000|NOT COMPLETED|Overall Study||21
10364012|NCT00519285|11504384|FG000|STARTED|Overall Study|Randomized|612
10364013|NCT00519285|11504385|FG001|STARTED|Overall Study|Randomized|612
10364014|NCT00519285|11504384|FG000|TREATED|Overall Study|Received at least part of one dose of placebo|604
10364015|NCT00519285|11504385|FG001|TREATED|Overall Study|Received at least part of one dose of aflibercept|605
10364016|NCT00519285|11504384|FG000|Still Treated at Cut-off Date|Overall Study|The cut-off date for analysis was defined as 07 February 2012, date at which 873 deaths has occurred|1
10364017|NCT00519285|11504385|FG001|Still Treated at Cut-off Date|Overall Study||2
10364018|NCT00519285|11504384|FG000|COMPLETED|Overall Study|Participants were treated until progressive disease, unacceptable toxicity, or refusal of treatment|0
10364019|NCT00519285|11504385|FG001|COMPLETED|Overall Study||0
10364020|NCT00519285|11504384|FG000|NOT COMPLETED|Overall Study||612
10364021|NCT00519285|11504385|FG001|NOT COMPLETED|Overall Study||612
10364022|NCT00519376|11504391|FG000|STARTED|Treatment Period 1||2
10364023|NCT00519376|11504392|FG001|STARTED|Treatment Period 1||2
10364024|NCT00519376|11504393|FG002|STARTED|Treatment Period 1||2
10364025|NCT00519376|11504394|FG003|STARTED|Treatment Period 1||2
10364026|NCT00519376|11504395|FG004|STARTED|Treatment Period 1||1
10364027|NCT00519376|11504396|FG005|STARTED|Treatment Period 1||1
10364028|NCT00519376|11504397|FG006|STARTED|Treatment Period 1||1
10364029|NCT00519376|11504398|FG007|STARTED|Treatment Period 1||1
10364030|NCT00519376|11504399|FG008|STARTED|Treatment Period 1||1
10364031|NCT00519376|11504400|FG009|STARTED|Treatment Period 1||1
10364032|NCT00519376|11504401|FG010|STARTED|Treatment Period 1||1
10364033|NCT00519376|11504402|FG011|STARTED|Treatment Period 1||1
10364034|NCT00519376|11504403|FG012|STARTED|Treatment Period 1||1
10364035|NCT00519376|11504404|FG013|STARTED|Treatment Period 1||1
10364036|NCT00519376|11504405|FG014|STARTED|Treatment Period 1||1
10364037|NCT00519376|11504406|FG015|STARTED|Treatment Period 1||1
10364038|NCT00519376|11504391|FG000|COMPLETED|Treatment Period 1||2
10364039|NCT00519376|11504392|FG001|COMPLETED|Treatment Period 1||2
10364040|NCT00519376|11504393|FG002|COMPLETED|Treatment Period 1||2
10364041|NCT00519376|11504394|FG003|COMPLETED|Treatment Period 1||2
10364042|NCT00519376|11504395|FG004|COMPLETED|Treatment Period 1||1
10364043|NCT00519376|11504396|FG005|COMPLETED|Treatment Period 1||1
10364044|NCT00519376|11504397|FG006|COMPLETED|Treatment Period 1||1
10364045|NCT00519376|11504398|FG007|COMPLETED|Treatment Period 1||1
10364046|NCT00519376|11504399|FG008|COMPLETED|Treatment Period 1||1
10364047|NCT00519376|11504400|FG009|COMPLETED|Treatment Period 1||1
10364048|NCT00519376|11504401|FG010|COMPLETED|Treatment Period 1||1
10364049|NCT00519376|11504402|FG011|COMPLETED|Treatment Period 1||1
10364050|NCT00519376|11504403|FG012|COMPLETED|Treatment Period 1||1
10364051|NCT00519376|11504404|FG013|COMPLETED|Treatment Period 1||1
10364052|NCT00519376|11504405|FG014|COMPLETED|Treatment Period 1||1
10364053|NCT00519376|11504406|FG015|COMPLETED|Treatment Period 1||1
10364054|NCT00519376|11504391|FG000|NOT COMPLETED|Treatment Period 1||0
10364057|NCT00519376|11504394|FG003|NOT COMPLETED|Treatment Period 1||0
10364058|NCT00519376|11504395|FG004|NOT COMPLETED|Treatment Period 1||0
10364059|NCT00519376|11504396|FG005|NOT COMPLETED|Treatment Period 1||0
10364060|NCT00519376|11504397|FG006|NOT COMPLETED|Treatment Period 1||0
10364061|NCT00519376|11504398|FG007|NOT COMPLETED|Treatment Period 1||0
10364062|NCT00519376|11504399|FG008|NOT COMPLETED|Treatment Period 1||0
10364063|NCT00519376|11504400|FG009|NOT COMPLETED|Treatment Period 1||0
10364064|NCT00519376|11504401|FG010|NOT COMPLETED|Treatment Period 1||0
10364065|NCT00519376|11504402|FG011|NOT COMPLETED|Treatment Period 1||0
10364066|NCT00519376|11504403|FG012|NOT COMPLETED|Treatment Period 1||0
10364067|NCT00519376|11504404|FG013|NOT COMPLETED|Treatment Period 1||0
10364068|NCT00519376|11504405|FG014|NOT COMPLETED|Treatment Period 1||0
10364069|NCT00519376|11504406|FG015|NOT COMPLETED|Treatment Period 1||0
10364070|NCT00519376|11504391|FG000|STARTED|Washout Period 1||2
10364071|NCT00519376|11504392|FG001|STARTED|Washout Period 1||2
10364072|NCT00519376|11504393|FG002|STARTED|Washout Period 1||2
10364073|NCT00519376|11504394|FG003|STARTED|Washout Period 1||2
10364074|NCT00519376|11504395|FG004|STARTED|Washout Period 1||1
10364075|NCT00519376|11504396|FG005|STARTED|Washout Period 1||1
10364076|NCT00519376|11504397|FG006|STARTED|Washout Period 1||1
10364077|NCT00519376|11504398|FG007|STARTED|Washout Period 1||1
10364078|NCT00519376|11504399|FG008|STARTED|Washout Period 1||1
10364079|NCT00519376|11504400|FG009|STARTED|Washout Period 1||1
10364080|NCT00519376|11504401|FG010|STARTED|Washout Period 1||1
10364081|NCT00519376|11504402|FG011|STARTED|Washout Period 1||1
10364082|NCT00519376|11504403|FG012|STARTED|Washout Period 1||1
10716465|NCT02689063|11880161|FG002|STARTED|Overall Study||76
10364083|NCT00519376|11504404|FG013|STARTED|Washout Period 1||1
10364084|NCT00519376|11504405|FG014|STARTED|Washout Period 1||1
10364085|NCT00519376|11504406|FG015|STARTED|Washout Period 1||1
10364086|NCT00519376|11504391|FG000|COMPLETED|Washout Period 1||2
10364087|NCT00519376|11504392|FG001|COMPLETED|Washout Period 1||2
10364088|NCT00519376|11504393|FG002|COMPLETED|Washout Period 1||2
10364089|NCT00519376|11504394|FG003|COMPLETED|Washout Period 1||2
10364090|NCT00519376|11504395|FG004|COMPLETED|Washout Period 1||1
10364091|NCT00519376|11504396|FG005|COMPLETED|Washout Period 1||1
10364092|NCT00519376|11504397|FG006|COMPLETED|Washout Period 1||1
10364093|NCT00519376|11504398|FG007|COMPLETED|Washout Period 1||1
10364094|NCT00519376|11504399|FG008|COMPLETED|Washout Period 1||1
10364095|NCT00519376|11504400|FG009|COMPLETED|Washout Period 1||1
10364096|NCT00519376|11504401|FG010|COMPLETED|Washout Period 1||1
10364097|NCT00519376|11504402|FG011|COMPLETED|Washout Period 1||1
10364098|NCT00519376|11504403|FG012|COMPLETED|Washout Period 1||1
10364099|NCT00519376|11504404|FG013|COMPLETED|Washout Period 1||1
10364100|NCT00519376|11504405|FG014|COMPLETED|Washout Period 1||1
10364101|NCT00519376|11504406|FG015|COMPLETED|Washout Period 1||1
10364102|NCT00519376|11504391|FG000|NOT COMPLETED|Washout Period 1||0
10364103|NCT00519376|11504392|FG001|NOT COMPLETED|Washout Period 1||0
10364104|NCT00519376|11504393|FG002|NOT COMPLETED|Washout Period 1||0
10364105|NCT00519376|11504394|FG003|NOT COMPLETED|Washout Period 1||0
10364106|NCT00519376|11504395|FG004|NOT COMPLETED|Washout Period 1||0
10364107|NCT00519376|11504396|FG005|NOT COMPLETED|Washout Period 1||0
10364108|NCT00519376|11504397|FG006|NOT COMPLETED|Washout Period 1||0
10535566|NCT01437397|11687914|FG003|NOT COMPLETED|Overall Study||69
10535567|NCT01437397|11687915|FG004|NOT COMPLETED|Overall Study||101
10535568|NCT01437449|11687927|FG000|STARTED|Overall Study||27
10535569|NCT01437449|11687927|FG000|COMPLETED|Overall Study||27
10535570|NCT01437449|11687927|FG000|NOT COMPLETED|Overall Study||0
10535571|NCT01437488|11687931|FG000|STARTED|Overall Study||14
10535572|NCT01437488|11687931|FG000|COMPLETED|Overall Study||14
10535573|NCT01437488|11687931|FG000|NOT COMPLETED|Overall Study||0
10535574|NCT01437501|11687940|FG000|STARTED|Overall Study||148
10535575|NCT01437501|11687941|FG001|STARTED|Overall Study||143
10535576|NCT01437501|11687940|FG000|COMPLETED|Overall Study||135
10535577|NCT01437501|11687941|FG001|COMPLETED|Overall Study||132
10535578|NCT01437501|11687940|FG000|NOT COMPLETED|Overall Study||13
10535579|NCT01437501|11687941|FG001|NOT COMPLETED|Overall Study||11
10535580|NCT01437540|11687951|FG000|STARTED|Overall Study||392
10535581|NCT01437540|11687952|FG001|STARTED|Overall Study||198
10535582|NCT01437540|11687951|FG000|COMPLETED|Overall Study||265
10535583|NCT01437540|11687952|FG001|COMPLETED|Overall Study||133
10535584|NCT01437540|11687951|FG000|NOT COMPLETED|Overall Study||127
10535585|NCT01437540|11687952|FG001|NOT COMPLETED|Overall Study||65
10535586|NCT01437605|11687960|FG000|STARTED|Overall Study||9
10535587|NCT01437605|11687961|FG001|STARTED|Overall Study||5
10535588|NCT01437605|11687960|FG000|COMPLETED|Overall Study||9
10535589|NCT01437605|11687961|FG001|COMPLETED|Overall Study||5
10535590|NCT01437605|11687960|FG000|NOT COMPLETED|Overall Study||0
10535591|NCT01437605|11687961|FG001|NOT COMPLETED|Overall Study||0
10535592|NCT01437852|11687967|FG000|STARTED|Overall Study||30
10535593|NCT01437852|11687967|FG000|Received StrataGraft Skin Tissue|Overall Study||30
10364109|NCT00519376|11504398|FG007|NOT COMPLETED|Washout Period 1||0
10364110|NCT00519376|11504399|FG008|NOT COMPLETED|Washout Period 1||0
10364111|NCT00519376|11504400|FG009|NOT COMPLETED|Washout Period 1||0
10364112|NCT00519376|11504401|FG010|NOT COMPLETED|Washout Period 1||0
10364113|NCT00519376|11504402|FG011|NOT COMPLETED|Washout Period 1||0
10535594|NCT01437852|11687967|FG000|Received Autograft|Overall Study||30
10535595|NCT01437852|11687967|FG000|COMPLETED|Overall Study||30
10535596|NCT01437852|11687967|FG000|NOT COMPLETED|Overall Study||0
10535597|NCT01437878|11687974|FG000|STARTED|Overall Study|Patient discontinued the study prior to initiation of study treatment|1
10364114|NCT00519376|11504403|FG012|NOT COMPLETED|Washout Period 1||0
10364115|NCT00519376|11504404|FG013|NOT COMPLETED|Washout Period 1||0
10364116|NCT00519376|11504405|FG014|NOT COMPLETED|Washout Period 1||0
10535598|NCT01437878|11687975|FG001|STARTED|Overall Study||1
10535599|NCT01437878|11687974|FG000|COMPLETED|Overall Study||0
10535600|NCT01437878|11687975|FG001|COMPLETED|Overall Study||1
10535601|NCT01437878|11687974|FG000|NOT COMPLETED|Overall Study||1
10535602|NCT01437878|11687975|FG001|NOT COMPLETED|Overall Study||0
10535603|NCT01437943|11687983|FG000|STARTED|Overall Study||7
10364117|NCT00519376|11504406|FG015|NOT COMPLETED|Washout Period 1||0
10364118|NCT00519376|11504391|FG000|STARTED|Treatment Period 2||2
10364119|NCT00519376|11504392|FG001|STARTED|Treatment Period 2||2
10364120|NCT00519376|11504393|FG002|STARTED|Treatment Period 2||2
10364121|NCT00519376|11504394|FG003|STARTED|Treatment Period 2||2
10364122|NCT00519376|11504395|FG004|STARTED|Treatment Period 2||1
10364123|NCT00519376|11504396|FG005|STARTED|Treatment Period 2||1
10364124|NCT00519376|11504397|FG006|STARTED|Treatment Period 2||1
10364125|NCT00519376|11504398|FG007|STARTED|Treatment Period 2||1
10364126|NCT00519376|11504399|FG008|STARTED|Treatment Period 2||1
10364127|NCT00519376|11504400|FG009|STARTED|Treatment Period 2||1
10364128|NCT00519376|11504401|FG010|STARTED|Treatment Period 2||1
10364129|NCT00519376|11504402|FG011|STARTED|Treatment Period 2||1
10364130|NCT00519376|11504403|FG012|STARTED|Treatment Period 2||1
10364131|NCT00519376|11504404|FG013|STARTED|Treatment Period 2||1
10364132|NCT00519376|11504405|FG014|STARTED|Treatment Period 2||1
10364133|NCT00519376|11504406|FG015|STARTED|Treatment Period 2||1
10364134|NCT00519376|11504391|FG000|COMPLETED|Treatment Period 2||2
10364135|NCT00519376|11504392|FG001|COMPLETED|Treatment Period 2||2
10364136|NCT00519376|11504393|FG002|COMPLETED|Treatment Period 2||2
10364137|NCT00519376|11504394|FG003|COMPLETED|Treatment Period 2||2
10364138|NCT00519376|11504395|FG004|COMPLETED|Treatment Period 2||1
10364139|NCT00519376|11504396|FG005|COMPLETED|Treatment Period 2||1
10364140|NCT00519376|11504397|FG006|COMPLETED|Treatment Period 2||1
10364141|NCT00519376|11504398|FG007|COMPLETED|Treatment Period 2||1
10364142|NCT00519376|11504399|FG008|COMPLETED|Treatment Period 2||1
10364143|NCT00519376|11504400|FG009|COMPLETED|Treatment Period 2||1
10364144|NCT00519376|11504401|FG010|COMPLETED|Treatment Period 2||1
10364145|NCT00519376|11504402|FG011|COMPLETED|Treatment Period 2||1
10364146|NCT00519376|11504403|FG012|COMPLETED|Treatment Period 2||0
10364147|NCT00519376|11504404|FG013|COMPLETED|Treatment Period 2||1
10364148|NCT00519376|11504405|FG014|COMPLETED|Treatment Period 2||1
10364149|NCT00519376|11504406|FG015|COMPLETED|Treatment Period 2||1
10364150|NCT00519376|11504391|FG000|NOT COMPLETED|Treatment Period 2||0
10364151|NCT00519376|11504392|FG001|NOT COMPLETED|Treatment Period 2||0
10364152|NCT00519376|11504393|FG002|NOT COMPLETED|Treatment Period 2||0
10364153|NCT00519376|11504394|FG003|NOT COMPLETED|Treatment Period 2||0
10364154|NCT00519376|11504395|FG004|NOT COMPLETED|Treatment Period 2||0
10364155|NCT00519376|11504396|FG005|NOT COMPLETED|Treatment Period 2||0
10364156|NCT00519376|11504397|FG006|NOT COMPLETED|Treatment Period 2||0
10364157|NCT00519376|11504398|FG007|NOT COMPLETED|Treatment Period 2||0
10364158|NCT00519376|11504399|FG008|NOT COMPLETED|Treatment Period 2||0
10364159|NCT00519376|11504400|FG009|NOT COMPLETED|Treatment Period 2||0
10364160|NCT00519376|11504401|FG010|NOT COMPLETED|Treatment Period 2||0
10364161|NCT00519376|11504402|FG011|NOT COMPLETED|Treatment Period 2||0
10364162|NCT00519376|11504403|FG012|NOT COMPLETED|Treatment Period 2||1
10535604|NCT01437943|11687984|FG001|STARTED|Overall Study||3
10535605|NCT01437943|11687983|FG000|COMPLETED|Overall Study||0
10535606|NCT01437943|11687984|FG001|COMPLETED|Overall Study||1
10535607|NCT01437943|11687983|FG000|NOT COMPLETED|Overall Study||7
10535608|NCT01437943|11687984|FG001|NOT COMPLETED|Overall Study||2
10535609|NCT01437995|11687993|FG000|STARTED|Overall Study||151
10535610|NCT01437995|11687994|FG001|STARTED|Overall Study||149
10535611|NCT01437995|11687995|FG002|STARTED|Overall Study||155
10535612|NCT01437995|11687993|FG000|Included in Treatment Failure Analysis|Overall Study||150
10535613|NCT01437995|11687994|FG001|Included in Treatment Failure Analysis|Overall Study||146
10656804|NCT02221219|11817883|FG000|COMPLETED|Overall Study||36
10656805|NCT02221219|11817884|FG001|COMPLETED|Overall Study||87
10656806|NCT02221219|11817885|FG002|COMPLETED|Overall Study||41
10656807|NCT02221219|11817886|FG003|COMPLETED|Overall Study||92
10656808|NCT02221219|11817883|FG000|NOT COMPLETED|Overall Study||0
10656809|NCT02221219|11817884|FG001|NOT COMPLETED|Overall Study||0
10535614|NCT01437995|11687995|FG002|Included in Treatment Failure Analysis|Overall Study||151
10535615|NCT01437995|11687993|FG000|COMPLETED|Overall Study||140
10535616|NCT01437995|11687994|FG001|COMPLETED|Overall Study||131
10535617|NCT01437995|11687995|FG002|COMPLETED|Overall Study||135
10535618|NCT01437995|11687993|FG000|NOT COMPLETED|Overall Study||11
10535619|NCT01437995|11687994|FG001|NOT COMPLETED|Overall Study||18
10535620|NCT01437995|11687995|FG002|NOT COMPLETED|Overall Study||20
10535621|NCT01438008|11688005|FG000|STARTED|Overall Study||4
10535622|NCT01438008|11688006|FG001|STARTED|Overall Study||5
10535623|NCT01438008|11688005|FG000|COMPLETED|Overall Study||4
10535624|NCT01438008|11688006|FG001|COMPLETED|Overall Study||5
10535625|NCT01438008|11688005|FG000|NOT COMPLETED|Overall Study||0
10535626|NCT01438008|11688006|FG001|NOT COMPLETED|Overall Study||0
10535627|NCT01438060|11688014|FG000|STARTED|Acute Phase: Double-blind, 10 Weeks||102
10656810|NCT02221219|11817885|FG002|NOT COMPLETED|Overall Study||0
10364163|NCT00519376|11504404|FG013|NOT COMPLETED|Treatment Period 2||0
10364164|NCT00519376|11504405|FG014|NOT COMPLETED|Treatment Period 2||0
10364165|NCT00519376|11504406|FG015|NOT COMPLETED|Treatment Period 2||0
10364166|NCT00519376|11504391|FG000|STARTED|Washout Period 2||2
10364167|NCT00519376|11504392|FG001|STARTED|Washout Period 2||2
10364168|NCT00519376|11504393|FG002|STARTED|Washout Period 2||2
10364169|NCT00519376|11504394|FG003|STARTED|Washout Period 2||2
10364170|NCT00519376|11504395|FG004|STARTED|Washout Period 2||1
10364171|NCT00519376|11504396|FG005|STARTED|Washout Period 2||1
10364172|NCT00519376|11504397|FG006|STARTED|Washout Period 2||1
10535628|NCT01438060|11688015|FG001|STARTED|Acute Phase: Double-blind, 10 Weeks||106
10656811|NCT02221219|11817886|FG003|NOT COMPLETED|Overall Study||0
10364173|NCT00519376|11504398|FG007|STARTED|Washout Period 2||1
10364174|NCT00519376|11504399|FG008|STARTED|Washout Period 2||1
10364175|NCT00519376|11504400|FG009|STARTED|Washout Period 2||1
10364176|NCT00519376|11504401|FG010|STARTED|Washout Period 2||1
10364177|NCT00519376|11504402|FG011|STARTED|Washout Period 2||1
10364178|NCT00519376|11504403|FG012|STARTED|Washout Period 2||0
10364179|NCT00519376|11504404|FG013|STARTED|Washout Period 2||1
10364180|NCT00519376|11504405|FG014|STARTED|Washout Period 2||1
10364181|NCT00519376|11504406|FG015|STARTED|Washout Period 2||1
10364182|NCT00519376|11504391|FG000|COMPLETED|Washout Period 2||2
10364183|NCT00519376|11504392|FG001|COMPLETED|Washout Period 2||2
10364184|NCT00519376|11504393|FG002|COMPLETED|Washout Period 2||2
10364185|NCT00519376|11504394|FG003|COMPLETED|Washout Period 2||2
10364186|NCT00519376|11504395|FG004|COMPLETED|Washout Period 2||1
10364187|NCT00519376|11504396|FG005|COMPLETED|Washout Period 2||1
10364188|NCT00519376|11504397|FG006|COMPLETED|Washout Period 2||1
10364189|NCT00519376|11504398|FG007|COMPLETED|Washout Period 2||1
10364190|NCT00519376|11504399|FG008|COMPLETED|Washout Period 2||1
10364191|NCT00519376|11504400|FG009|COMPLETED|Washout Period 2||1
10364192|NCT00519376|11504401|FG010|COMPLETED|Washout Period 2||1
10364193|NCT00519376|11504402|FG011|COMPLETED|Washout Period 2||1
10364194|NCT00519376|11504403|FG012|COMPLETED|Washout Period 2||0
10364195|NCT00519376|11504404|FG013|COMPLETED|Washout Period 2||1
10364196|NCT00519376|11504405|FG014|COMPLETED|Washout Period 2||1
10364197|NCT00519376|11504406|FG015|COMPLETED|Washout Period 2||1
10364198|NCT00519376|11504391|FG000|NOT COMPLETED|Washout Period 2||0
10364199|NCT00519376|11504392|FG001|NOT COMPLETED|Washout Period 2||0
10716466|NCT02689063|11880162|FG003|STARTED|Overall Study||50
10716467|NCT02689063|11880159|FG000|COMPLETED|Overall Study||75
10716468|NCT02689063|11880160|FG001|COMPLETED|Overall Study||73
10364200|NCT00519376|11504393|FG002|NOT COMPLETED|Washout Period 2||0
10364201|NCT00519376|11504394|FG003|NOT COMPLETED|Washout Period 2||0
10364202|NCT00519376|11504395|FG004|NOT COMPLETED|Washout Period 2||0
10364203|NCT00519376|11504396|FG005|NOT COMPLETED|Washout Period 2||0
10364204|NCT00519376|11504397|FG006|NOT COMPLETED|Washout Period 2||0
10364205|NCT00519376|11504398|FG007|NOT COMPLETED|Washout Period 2||0
10364206|NCT00519376|11504399|FG008|NOT COMPLETED|Washout Period 2||0
10364207|NCT00519376|11504400|FG009|NOT COMPLETED|Washout Period 2||0
10364208|NCT00519376|11504401|FG010|NOT COMPLETED|Washout Period 2||0
10364209|NCT00519376|11504402|FG011|NOT COMPLETED|Washout Period 2||0
10364210|NCT00519376|11504403|FG012|NOT COMPLETED|Washout Period 2||0
10364211|NCT00519376|11504404|FG013|NOT COMPLETED|Washout Period 2||0
10364212|NCT00519376|11504405|FG014|NOT COMPLETED|Washout Period 2||0
10364213|NCT00519376|11504406|FG015|NOT COMPLETED|Washout Period 2||0
10364214|NCT00519376|11504391|FG000|STARTED|Treatment Period 3||2
10364215|NCT00519376|11504392|FG001|STARTED|Treatment Period 3||2
10364216|NCT00519376|11504393|FG002|STARTED|Treatment Period 3||2
10364217|NCT00519376|11504394|FG003|STARTED|Treatment Period 3||2
10364218|NCT00519376|11504395|FG004|STARTED|Treatment Period 3||1
10364219|NCT00519376|11504396|FG005|STARTED|Treatment Period 3||1
10364220|NCT00519376|11504397|FG006|STARTED|Treatment Period 3||1
10716469|NCT02689063|11880161|FG002|COMPLETED|Overall Study||73
10716470|NCT02689063|11880162|FG003|COMPLETED|Overall Study||50
10716471|NCT02689063|11880159|FG000|NOT COMPLETED|Overall Study||0
10716472|NCT02689063|11880160|FG001|NOT COMPLETED|Overall Study||2
10716473|NCT02689063|11880161|FG002|NOT COMPLETED|Overall Study||3
10716474|NCT02689063|11880162|FG003|NOT COMPLETED|Overall Study||0
10716475|NCT02689076|11880175|FG000|STARTED|Overall Study||268
10716476|NCT02689076|11880176|FG001|STARTED|Overall Study||337
10716477|NCT02689076|11880177|FG002|STARTED|Overall Study||191
10364221|NCT00519376|11504398|FG007|STARTED|Treatment Period 3||1
10364222|NCT00519376|11504399|FG008|STARTED|Treatment Period 3||1
10364223|NCT00519376|11504400|FG009|STARTED|Treatment Period 3||1
10364224|NCT00519376|11504401|FG010|STARTED|Treatment Period 3||1
10364225|NCT00519376|11504402|FG011|STARTED|Treatment Period 3||1
10364226|NCT00519376|11504403|FG012|STARTED|Treatment Period 3||0
10364227|NCT00519376|11504404|FG013|STARTED|Treatment Period 3||1
10364228|NCT00519376|11504405|FG014|STARTED|Treatment Period 3||1
10364229|NCT00519376|11504406|FG015|STARTED|Treatment Period 3||1
10364230|NCT00519376|11504391|FG000|COMPLETED|Treatment Period 3||2
10364231|NCT00519376|11504392|FG001|COMPLETED|Treatment Period 3||2
10364232|NCT00519376|11504393|FG002|COMPLETED|Treatment Period 3||2
10364233|NCT00519376|11504394|FG003|COMPLETED|Treatment Period 3||2
10364234|NCT00519376|11504395|FG004|COMPLETED|Treatment Period 3||1
10364235|NCT00519376|11504396|FG005|COMPLETED|Treatment Period 3||1
10364236|NCT00519376|11504397|FG006|COMPLETED|Treatment Period 3||1
10364237|NCT00519376|11504398|FG007|COMPLETED|Treatment Period 3||1
10364238|NCT00519376|11504399|FG008|COMPLETED|Treatment Period 3||1
10364239|NCT00519376|11504400|FG009|COMPLETED|Treatment Period 3||1
10364240|NCT00519376|11504401|FG010|COMPLETED|Treatment Period 3||1
10364241|NCT00519376|11504402|FG011|COMPLETED|Treatment Period 3||1
10364242|NCT00519376|11504403|FG012|COMPLETED|Treatment Period 3||0
10716478|NCT02689076|11880175|FG000|COMPLETED|Overall Study||87
10716479|NCT02689076|11880176|FG001|COMPLETED|Overall Study||115
10716480|NCT02689076|11880177|FG002|COMPLETED|Overall Study||191
10716481|NCT02689076|11880175|FG000|NOT COMPLETED|Overall Study||181
10716482|NCT02689076|11880176|FG001|NOT COMPLETED|Overall Study||222
10364243|NCT00519376|11504404|FG013|COMPLETED|Treatment Period 3||1
10364244|NCT00519376|11504405|FG014|COMPLETED|Treatment Period 3||1
10716483|NCT02689076|11880177|FG002|NOT COMPLETED|Overall Study||0
10364245|NCT00519376|11504406|FG015|COMPLETED|Treatment Period 3||1
10364246|NCT00519376|11504391|FG000|NOT COMPLETED|Treatment Period 3||0
10364247|NCT00519376|11504392|FG001|NOT COMPLETED|Treatment Period 3||0
10364248|NCT00519376|11504393|FG002|NOT COMPLETED|Treatment Period 3||0
10364249|NCT00519376|11504394|FG003|NOT COMPLETED|Treatment Period 3||0
10364250|NCT00519376|11504395|FG004|NOT COMPLETED|Treatment Period 3||0
10364251|NCT00519376|11504396|FG005|NOT COMPLETED|Treatment Period 3||0
10364252|NCT00519376|11504397|FG006|NOT COMPLETED|Treatment Period 3||0
10364253|NCT00519376|11504398|FG007|NOT COMPLETED|Treatment Period 3||0
10364254|NCT00519376|11504399|FG008|NOT COMPLETED|Treatment Period 3||0
10364255|NCT00519376|11504400|FG009|NOT COMPLETED|Treatment Period 3||0
10364256|NCT00519376|11504401|FG010|NOT COMPLETED|Treatment Period 3||0
10364257|NCT00519376|11504402|FG011|NOT COMPLETED|Treatment Period 3||0
10364258|NCT00519376|11504403|FG012|NOT COMPLETED|Treatment Period 3||0
10364259|NCT00519376|11504404|FG013|NOT COMPLETED|Treatment Period 3||0
10364260|NCT00519376|11504405|FG014|NOT COMPLETED|Treatment Period 3||0
10364261|NCT00519376|11504406|FG015|NOT COMPLETED|Treatment Period 3||0
10364262|NCT00519376|11504391|FG000|STARTED|Washout Period 3||2
10364263|NCT00519376|11504392|FG001|STARTED|Washout Period 3||2
10364264|NCT00519376|11504393|FG002|STARTED|Washout Period 3||2
10364265|NCT00519376|11504394|FG003|STARTED|Washout Period 3||2
10364266|NCT00519376|11504395|FG004|STARTED|Washout Period 3||1
10364267|NCT00519376|11504396|FG005|STARTED|Washout Period 3||1
10364268|NCT00519376|11504397|FG006|STARTED|Washout Period 3||1
10364269|NCT00519376|11504398|FG007|STARTED|Washout Period 3||1
10364270|NCT00519376|11504399|FG008|STARTED|Washout Period 3||1
10364271|NCT00519376|11504400|FG009|STARTED|Washout Period 3||1
10364272|NCT00519376|11504401|FG010|STARTED|Washout Period 3||1
10364273|NCT00519376|11504402|FG011|STARTED|Washout Period 3||1
10364274|NCT00519376|11504403|FG012|STARTED|Washout Period 3||0
10364275|NCT00519376|11504404|FG013|STARTED|Washout Period 3||1
10364276|NCT00519376|11504405|FG014|STARTED|Washout Period 3||1
10364277|NCT00519376|11504406|FG015|STARTED|Washout Period 3||1
10364278|NCT00519376|11504391|FG000|COMPLETED|Washout Period 3||2
10364279|NCT00519376|11504392|FG001|COMPLETED|Washout Period 3||2
10364280|NCT00519376|11504393|FG002|COMPLETED|Washout Period 3||2
10364281|NCT00519376|11504394|FG003|COMPLETED|Washout Period 3||2
10364282|NCT00519376|11504395|FG004|COMPLETED|Washout Period 3||1
10364283|NCT00519376|11504396|FG005|COMPLETED|Washout Period 3||1
10364284|NCT00519376|11504397|FG006|COMPLETED|Washout Period 3||1
10364285|NCT00519376|11504398|FG007|COMPLETED|Washout Period 3||1
10364286|NCT00519376|11504399|FG008|COMPLETED|Washout Period 3||1
10364287|NCT00519376|11504400|FG009|COMPLETED|Washout Period 3||1
10364288|NCT00519376|11504401|FG010|COMPLETED|Washout Period 3||1
10364289|NCT00519376|11504402|FG011|COMPLETED|Washout Period 3||1
10364290|NCT00519376|11504403|FG012|COMPLETED|Washout Period 3||0
10364291|NCT00519376|11504404|FG013|COMPLETED|Washout Period 3||1
10364292|NCT00519376|11504405|FG014|COMPLETED|Washout Period 3||1
10364293|NCT00519376|11504406|FG015|COMPLETED|Washout Period 3||1
10364294|NCT00519376|11504391|FG000|NOT COMPLETED|Washout Period 3||0
10364295|NCT00519376|11504392|FG001|NOT COMPLETED|Washout Period 3||0
10364296|NCT00519376|11504393|FG002|NOT COMPLETED|Washout Period 3||0
10535629|NCT01438060|11688014|FG000|COMPLETED|Acute Phase: Double-blind, 10 Weeks||84
10535630|NCT01438060|11688015|FG001|COMPLETED|Acute Phase: Double-blind, 10 Weeks||88
10535631|NCT01438060|11688014|FG000|NOT COMPLETED|Acute Phase: Double-blind, 10 Weeks||18
10535632|NCT01438060|11688015|FG001|NOT COMPLETED|Acute Phase: Double-blind, 10 Weeks||18
10535633|NCT01438060|11688014|FG000|STARTED|Extension Phase: Week 10 to Week 130|80 out of the 84 participants entered extension phase. All were treated with open-label aripiprazole|80
10535634|NCT01438060|11688015|FG001|STARTED|Extension Phase: Week 10 to Week 130|Of the 88 participants, who completed Acute Phase, 81 opted to enter 130-week extension phase|81
10535635|NCT01438060|11688014|FG000|COMPLETED|Extension Phase: Week 10 to Week 130||22
10716484|NCT02689154|11880185|FG000|STARTED|Overall Study||18
10716485|NCT02689154|11880185|FG000|COMPLETED|Overall Study||18
10716486|NCT02689154|11880185|FG000|NOT COMPLETED|Overall Study||0
10716487|NCT02689206|11880194|FG000|STARTED|Overall Study||20
10716488|NCT02689206|11880195|FG001|STARTED|Overall Study||20
10716489|NCT02689206|11880196|FG002|STARTED|Overall Study||20
10716490|NCT02689206|11880197|FG003|STARTED|Overall Study||21
10716491|NCT02689206|11880198|FG004|STARTED|Overall Study||22
10716492|NCT02689206|11880194|FG000|COMPLETED|Overall Study||17
10364297|NCT00519376|11504394|FG003|NOT COMPLETED|Washout Period 3||0
10364298|NCT00519376|11504395|FG004|NOT COMPLETED|Washout Period 3||0
10364299|NCT00519376|11504396|FG005|NOT COMPLETED|Washout Period 3||0
10364300|NCT00519376|11504397|FG006|NOT COMPLETED|Washout Period 3||0
10364301|NCT00519376|11504398|FG007|NOT COMPLETED|Washout Period 3||0
10364302|NCT00519376|11504399|FG008|NOT COMPLETED|Washout Period 3||0
10364303|NCT00519376|11504400|FG009|NOT COMPLETED|Washout Period 3||0
10364304|NCT00519376|11504401|FG010|NOT COMPLETED|Washout Period 3||0
10364305|NCT00519376|11504402|FG011|NOT COMPLETED|Washout Period 3||0
10364306|NCT00519376|11504403|FG012|NOT COMPLETED|Washout Period 3||0
10364307|NCT00519376|11504404|FG013|NOT COMPLETED|Washout Period 3||0
10716493|NCT02689206|11880195|FG001|COMPLETED|Overall Study||19
10716494|NCT02689206|11880196|FG002|COMPLETED|Overall Study||16
10716495|NCT02689206|11880197|FG003|COMPLETED|Overall Study||17
10716496|NCT02689206|11880198|FG004|COMPLETED|Overall Study||14
10716497|NCT02689206|11880194|FG000|NOT COMPLETED|Overall Study||3
10716498|NCT02689206|11880195|FG001|NOT COMPLETED|Overall Study||1
10716499|NCT02689206|11880196|FG002|NOT COMPLETED|Overall Study||4
10364308|NCT00519376|11504405|FG014|NOT COMPLETED|Washout Period 3||0
10364309|NCT00519376|11504406|FG015|NOT COMPLETED|Washout Period 3||0
10364310|NCT00519376|11504391|FG000|STARTED|Treatment Period 4||2
10364311|NCT00519376|11504392|FG001|STARTED|Treatment Period 4||2
10364312|NCT00519376|11504393|FG002|STARTED|Treatment Period 4||2
10364313|NCT00519376|11504394|FG003|STARTED|Treatment Period 4||2
10364314|NCT00519376|11504395|FG004|STARTED|Treatment Period 4||1
10364315|NCT00519376|11504396|FG005|STARTED|Treatment Period 4||1
10364316|NCT00519376|11504397|FG006|STARTED|Treatment Period 4||1
10364317|NCT00519376|11504398|FG007|STARTED|Treatment Period 4||1
10364318|NCT00519376|11504399|FG008|STARTED|Treatment Period 4||1
10364319|NCT00519376|11504400|FG009|STARTED|Treatment Period 4||1
10364320|NCT00519376|11504401|FG010|STARTED|Treatment Period 4||1
10364321|NCT00519376|11504402|FG011|STARTED|Treatment Period 4||1
10364322|NCT00519376|11504403|FG012|STARTED|Treatment Period 4||0
10364323|NCT00519376|11504404|FG013|STARTED|Treatment Period 4||1
10364324|NCT00519376|11504405|FG014|STARTED|Treatment Period 4||1
10364325|NCT00519376|11504406|FG015|STARTED|Treatment Period 4||1
10535636|NCT01438060|11688015|FG001|COMPLETED|Extension Phase: Week 10 to Week 130||25
10535637|NCT01438060|11688014|FG000|NOT COMPLETED|Extension Phase: Week 10 to Week 130||58
10535638|NCT01438060|11688015|FG001|NOT COMPLETED|Extension Phase: Week 10 to Week 130||56
10535639|NCT01438060|11688014|FG000|STARTED|On Study Beyond Week 140||0
10535640|NCT01438060|11688015|FG001|STARTED|On Study Beyond Week 140|9 participants in France who showed improvement at Week 140 continued treatment beyond 140 weeks|9
10535641|NCT01438060|11688014|FG000|COMPLETED|On Study Beyond Week 140||0
10535642|NCT01438060|11688015|FG001|COMPLETED|On Study Beyond Week 140||1
10535643|NCT01438060|11688014|FG000|NOT COMPLETED|On Study Beyond Week 140||0
10535644|NCT01438060|11688015|FG001|NOT COMPLETED|On Study Beyond Week 140||8
10535645|NCT01438151|11688026|FG000|STARTED|Overall Study||11
10535646|NCT01438151|11688026|FG000|COMPLETED|Overall Study||3
10535647|NCT01438151|11688026|FG000|NOT COMPLETED|Overall Study||8
10535648|NCT01438177|11688030|FG000|STARTED|Overall Study||11
10535649|NCT01438177|11688030|FG000|COMPLETED|Overall Study|Patients who were off due to disease progression|9
10535650|NCT01438177|11688030|FG000|NOT COMPLETED|Overall Study||2
10535651|NCT01438229|11688034|FG000|STARTED|Overall Study||47
10535652|NCT01438229|11688034|FG000|Excluded Due to Renal Artery Anatomy|Overall Study||1
10535653|NCT01438229|11688034|FG000|Underwent Procedure|Overall Study||46
10535654|NCT01438229|11688034|FG000|COMPLETED|Overall Study||44
10535655|NCT01438229|11688034|FG000|NOT COMPLETED|Overall Study||3
10535656|NCT01438294|11688040|FG000|STARTED|Overall Study||16
10535657|NCT01438294|11688041|FG001|STARTED|Overall Study||20
10535658|NCT01438294|11688040|FG000|COMPLETED|Overall Study||13
10535659|NCT01438294|11688041|FG001|COMPLETED|Overall Study||13
10535660|NCT01438294|11688040|FG000|NOT COMPLETED|Overall Study||3
10535661|NCT01438294|11688041|FG001|NOT COMPLETED|Overall Study||7
10535662|NCT01438307|11688049|FG000|STARTED|Overall Study||14
10535663|NCT01438307|11688050|FG001|STARTED|Overall Study||14
10535664|NCT01438307|11688049|FG000|COMPLETED|Overall Study||13
10535665|NCT01438307|11688050|FG001|COMPLETED|Overall Study||13
10535666|NCT01438307|11688049|FG000|NOT COMPLETED|Overall Study||1
10535667|NCT01438307|11688050|FG001|NOT COMPLETED|Overall Study||1
10535668|NCT01438411|11688056|FG000|STARTED|Overall Study||53
10535669|NCT01438411|11688056|FG000|COMPLETED|Overall Study||40
10535670|NCT01438411|11688056|FG000|NOT COMPLETED|Overall Study||13
10535671|NCT01438424|11688060|FG000|STARTED|Overall Study|Received treatment|1051
10535672|NCT01438424|11688060|FG000|COMPLETED|Overall Study|Completed treatment|634
10535673|NCT01438424|11688060|FG000|NOT COMPLETED|Overall Study||417
10535674|NCT01438476|11688076|FG000|STARTED|Overall Study||116
10535675|NCT01438476|11688077|FG001|STARTED|Overall Study||45
10535676|NCT01438476|11688076|FG000|COMPLETED|Overall Study||106
10535677|NCT01438476|11688077|FG001|COMPLETED|Overall Study||34
10535678|NCT01438476|11688076|FG000|NOT COMPLETED|Overall Study||10
10535679|NCT01438476|11688077|FG001|NOT COMPLETED|Overall Study||11
10535680|NCT01438489|11688086|FG000|STARTED|Overall Study||103
10535681|NCT01438489|11688087|FG001|STARTED|Overall Study||100
10535682|NCT01438489|11688088|FG002|STARTED|Overall Study||104
10656812|NCT02221284|11817900|FG000|STARTED|Overall Study||964
10656813|NCT02221284|11817900|FG000|COMPLETED|Overall Study||903
10535683|NCT01438489|11688086|FG000|COMPLETED|Overall Study||77
10535684|NCT01438489|11688087|FG001|COMPLETED|Overall Study||84
10535685|NCT01438489|11688088|FG002|COMPLETED|Overall Study||85
10535686|NCT01438489|11688086|FG000|NOT COMPLETED|Overall Study||26
10535687|NCT01438489|11688087|FG001|NOT COMPLETED|Overall Study||16
10535688|NCT01438489|11688088|FG002|NOT COMPLETED|Overall Study||19
10535689|NCT01438541|11688098|FG000|STARTED|Overall Study||29
10535690|NCT01438541|11688098|FG000|COMPLETED|Overall Study||22
10535691|NCT01438541|11688098|FG000|NOT COMPLETED|Overall Study||7
10535692|NCT01438710|11688102|FG000|STARTED|First Week of Treatment|Patients are only treated with Prograf/generic Tacrolimus during the first week.|0
10535693|NCT01438710|11688103|FG001|STARTED|First Week of Treatment||44
10364332|NCT00519376|11504397|FG006|COMPLETED|Treatment Period 4||1
10535694|NCT01438710|11688102|FG000|COMPLETED|First Week of Treatment|Patients are only treated with Prograf/generic Tacrolimus during the first week.|0
10535695|NCT01438710|11688103|FG001|COMPLETED|First Week of Treatment||41
10535696|NCT01438710|11688102|FG000|NOT COMPLETED|First Week of Treatment||0
10656814|NCT02221284|11817900|FG000|NOT COMPLETED|Overall Study||61
10364326|NCT00519376|11504391|FG000|COMPLETED|Treatment Period 4||2
10364327|NCT00519376|11504392|FG001|COMPLETED|Treatment Period 4||2
10364328|NCT00519376|11504393|FG002|COMPLETED|Treatment Period 4||1
10364329|NCT00519376|11504394|FG003|COMPLETED|Treatment Period 4||2
10535697|NCT01438710|11688103|FG001|NOT COMPLETED|First Week of Treatment||3
10535698|NCT01438710|11688102|FG000|STARTED|Second Week of Treatment|Patients completing the first week will continue on LCP-Tacro treatment during the second week.|41
10535699|NCT01438710|11688103|FG001|STARTED|Second Week of Treatment|Patients are only treated with LCP-Tacro during the second week.|0
10535700|NCT01438710|11688102|FG000|COMPLETED|Second Week of Treatment||40
10535701|NCT01438710|11688103|FG001|COMPLETED|Second Week of Treatment|Patients are only treated with LCP-Tacro during the second week.|0
10535702|NCT01438710|11688102|FG000|NOT COMPLETED|Second Week of Treatment||1
10535703|NCT01438710|11688103|FG001|NOT COMPLETED|Second Week of Treatment||0
10535704|NCT01438814|11688110|FG000|STARTED|Overall Study||344
10535705|NCT01438814|11688111|FG001|STARTED|Overall Study||345
10535706|NCT01438814|11688110|FG000|COMPLETED|Overall Study||330
10535707|NCT01438814|11688111|FG001|COMPLETED|Overall Study||331
10535708|NCT01438814|11688110|FG000|NOT COMPLETED|Overall Study||14
10535709|NCT01438814|11688111|FG001|NOT COMPLETED|Overall Study||14
10535710|NCT01438840|11688119|FG000|STARTED|Core Study||17
10535711|NCT01438840|11688120|FG001|STARTED|Core Study||32
10535712|NCT01438840|11688121|FG002|STARTED|Core Study||0
10535713|NCT01438840|11688119|FG000|COMPLETED|Core Study||1
10535714|NCT01438840|11688120|FG001|COMPLETED|Core Study||22
10535715|NCT01438840|11688121|FG002|COMPLETED|Core Study||0
10535716|NCT01438840|11688119|FG000|NOT COMPLETED|Core Study||16
10535717|NCT01438840|11688120|FG001|NOT COMPLETED|Core Study||10
10535718|NCT01438840|11688121|FG002|NOT COMPLETED|Core Study||0
10535719|NCT01438840|11688119|FG000|STARTED|Extension Phase||0
10535720|NCT01438840|11688120|FG001|STARTED|Extension Phase||0
10535721|NCT01438840|11688121|FG002|STARTED|Extension Phase|39 participants met eligibility criteria for the Extension Phase.|39
10535722|NCT01438840|11688119|FG000|COMPLETED|Extension Phase||0
10535723|NCT01438840|11688120|FG001|COMPLETED|Extension Phase||0
10535724|NCT01438840|11688121|FG002|COMPLETED|Extension Phase||29
10535725|NCT01438840|11688119|FG000|NOT COMPLETED|Extension Phase||0
10535726|NCT01438840|11688120|FG001|NOT COMPLETED|Extension Phase||0
10535727|NCT01438840|11688121|FG002|NOT COMPLETED|Extension Phase||10
10535728|NCT01438957|11688133|FG000|STARTED|Overall Study||22
10535729|NCT01438957|11688134|FG001|STARTED|Overall Study||23
10535730|NCT01438957|11688135|FG002|STARTED|Overall Study||24
10535731|NCT01438957|11688136|FG003|STARTED|Overall Study||25
10535732|NCT01438957|11688137|FG004|STARTED|Overall Study||25
10535733|NCT01438957|11688133|FG000|COMPLETED|Overall Study||21
10535734|NCT01438957|11688134|FG001|COMPLETED|Overall Study||22
10535735|NCT01438957|11688135|FG002|COMPLETED|Overall Study||24
10535736|NCT01438957|11688136|FG003|COMPLETED|Overall Study||24
10535737|NCT01438957|11688137|FG004|COMPLETED|Overall Study||25
10535738|NCT01438957|11688133|FG000|NOT COMPLETED|Overall Study||1
10535739|NCT01438957|11688134|FG001|NOT COMPLETED|Overall Study||1
10535740|NCT01438957|11688135|FG002|NOT COMPLETED|Overall Study||0
10535741|NCT01438957|11688136|FG003|NOT COMPLETED|Overall Study||1
10535742|NCT01438957|11688137|FG004|NOT COMPLETED|Overall Study||0
10535743|NCT01438996|11688152|FG000|STARTED|Overall Study||18
10535744|NCT01438996|11688153|FG001|STARTED|Overall Study||13
10535745|NCT01438996|11688154|FG002|STARTED|Overall Study||20
10535746|NCT01438996|11688152|FG000|COMPLETED|Overall Study||14
10535747|NCT01438996|11688153|FG001|COMPLETED|Overall Study||12
10535748|NCT01438996|11688154|FG002|COMPLETED|Overall Study||20
10535749|NCT01438996|11688152|FG000|NOT COMPLETED|Overall Study||4
10535750|NCT01438996|11688153|FG001|NOT COMPLETED|Overall Study||1
10535751|NCT01438996|11688154|FG002|NOT COMPLETED|Overall Study||0
10535752|NCT01439009|11688164|FG000|STARTED|Overall Study||50
10535753|NCT01439009|11688165|FG001|STARTED|Overall Study||50
10535754|NCT01439009|11688164|FG000|COMPLETED|Overall Study||42
10535755|NCT01439009|11688165|FG001|COMPLETED|Overall Study||47
10535756|NCT01439009|11688164|FG000|NOT COMPLETED|Overall Study||8
10535757|NCT01439009|11688165|FG001|NOT COMPLETED|Overall Study||3
10535758|NCT01439035|11688171|FG000|STARTED|Overall Study||6
10535759|NCT01439035|11688171|FG000|COMPLETED|Overall Study||6
10535760|NCT01439035|11688171|FG000|NOT COMPLETED|Overall Study||0
10535761|NCT01439074|11688177|FG000|STARTED|Overall Study||75
10535762|NCT01439074|11688178|FG001|STARTED|Overall Study||87
10535763|NCT01439074|11688177|FG000|COMPLETED|Overall Study||66
10535764|NCT01439074|11688178|FG001|COMPLETED|Overall Study||74
10535765|NCT01439074|11688177|FG000|NOT COMPLETED|Overall Study||9
10535766|NCT01439074|11688178|FG001|NOT COMPLETED|Overall Study||13
10535767|NCT01439087|11688184|FG000|STARTED|Overall Study||2
10535768|NCT01439087|11688184|FG000|COMPLETED|Overall Study||2
10535769|NCT01439087|11688184|FG000|NOT COMPLETED|Overall Study||0
10306054|NCT00096785|11439050|FG001|As-Randomized Population|Overall Study||34
10306055|NCT00096785|11439049|FG000|As-Treated Population|Overall Study||36
10306056|NCT00096785|11439050|FG001|As-Treated Population|Overall Study||33
10306057|NCT00096785|11439049|FG000|COMPLETED|Overall Study|As randomized cohort|33
10364330|NCT00519376|11504395|FG004|COMPLETED|Treatment Period 4||1
10364331|NCT00519376|11504396|FG005|COMPLETED|Treatment Period 4||1
10364333|NCT00519376|11504398|FG007|COMPLETED|Treatment Period 4||1
10364334|NCT00519376|11504399|FG008|COMPLETED|Treatment Period 4||1
10364335|NCT00519376|11504400|FG009|COMPLETED|Treatment Period 4||1
10364336|NCT00519376|11504401|FG010|COMPLETED|Treatment Period 4||1
10364337|NCT00519376|11504402|FG011|COMPLETED|Treatment Period 4||1
10364338|NCT00519376|11504403|FG012|COMPLETED|Treatment Period 4||0
10364339|NCT00519376|11504404|FG013|COMPLETED|Treatment Period 4||1
10364340|NCT00519376|11504405|FG014|COMPLETED|Treatment Period 4||1
10364341|NCT00519376|11504406|FG015|COMPLETED|Treatment Period 4||1
10364342|NCT00519376|11504391|FG000|NOT COMPLETED|Treatment Period 4||0
10364343|NCT00519376|11504392|FG001|NOT COMPLETED|Treatment Period 4||0
10364344|NCT00519376|11504393|FG002|NOT COMPLETED|Treatment Period 4||1
10364345|NCT00519376|11504394|FG003|NOT COMPLETED|Treatment Period 4||0
10364346|NCT00519376|11504395|FG004|NOT COMPLETED|Treatment Period 4||0
10364347|NCT00519376|11504396|FG005|NOT COMPLETED|Treatment Period 4||0
10364348|NCT00519376|11504397|FG006|NOT COMPLETED|Treatment Period 4||0
10364349|NCT00519376|11504398|FG007|NOT COMPLETED|Treatment Period 4||0
10364350|NCT00519376|11504399|FG008|NOT COMPLETED|Treatment Period 4||0
10364351|NCT00519376|11504400|FG009|NOT COMPLETED|Treatment Period 4||0
10364352|NCT00519376|11504401|FG010|NOT COMPLETED|Treatment Period 4||0
10364353|NCT00519376|11504402|FG011|NOT COMPLETED|Treatment Period 4||0
10364354|NCT00519376|11504403|FG012|NOT COMPLETED|Treatment Period 4||0
10364355|NCT00519376|11504404|FG013|NOT COMPLETED|Treatment Period 4||0
10364356|NCT00519376|11504405|FG014|NOT COMPLETED|Treatment Period 4||0
10364357|NCT00519376|11504406|FG015|NOT COMPLETED|Treatment Period 4||0
10364358|NCT00519428|11504421|FG000|STARTED|Overall Study||78
10364359|NCT00519428|11504422|FG001|STARTED|Overall Study||84
10364360|NCT00519428|11504423|FG002|STARTED|Overall Study||83
10364361|NCT00519428|11504421|FG000|COMPLETED|Overall Study||57
10364362|NCT00519428|11504422|FG001|COMPLETED|Overall Study||69
10364363|NCT00519428|11504423|FG002|COMPLETED|Overall Study||58
10364364|NCT00519428|11504421|FG000|NOT COMPLETED|Overall Study||21
10364365|NCT00519428|11504422|FG001|NOT COMPLETED|Overall Study||15
10364366|NCT00519428|11504423|FG002|NOT COMPLETED|Overall Study||25
10364367|NCT00519532|11504434|FG000|STARTED|Overall Study||84
10364368|NCT00519532|11504434|FG000|COMPLETED|Overall Study||66
10364369|NCT00519532|11504434|FG000|NOT COMPLETED|Overall Study||18
10364370|NCT00519584|11504442|FG000|STARTED|Overall Study||54
10364371|NCT00519584|11504443|FG001|STARTED|Overall Study||54
10364372|NCT00519584|11504444|FG002|STARTED|Overall Study||54
10364373|NCT00519584|11504445|FG003|STARTED|Overall Study||56
10364374|NCT00519584|11504442|FG000|COMPLETED|Overall Study||54
10364375|NCT00519584|11504443|FG001|COMPLETED|Overall Study||54
10364376|NCT00519584|11504444|FG002|COMPLETED|Overall Study||54
10364377|NCT00519584|11504445|FG003|COMPLETED|Overall Study||56
10364378|NCT00519584|11504442|FG000|NOT COMPLETED|Overall Study||0
10364379|NCT00519584|11504443|FG001|NOT COMPLETED|Overall Study||0
10364380|NCT00519584|11504444|FG002|NOT COMPLETED|Overall Study||0
10364381|NCT00519584|11504445|FG003|NOT COMPLETED|Overall Study||0
10364382|NCT00519623|11504455|FG000|STARTED|Overall Study||9
10364383|NCT00519623|11504455|FG000|COMPLETED|Overall Study||8
10364384|NCT00519623|11504455|FG000|NOT COMPLETED|Overall Study||1
10364385|NCT00519636|11504463|FG000|STARTED|Treatment Period 1||91
10364386|NCT00519636|11504464|FG001|STARTED|Treatment Period 1||86
10364387|NCT00519636|11504465|FG002|STARTED|Treatment Period 1||90
10364388|NCT00519636|11504466|FG003|STARTED|Treatment Period 1||93
10364389|NCT00519636|11504463|FG000|COMPLETED|Treatment Period 1||89
10364390|NCT00519636|11504464|FG001|COMPLETED|Treatment Period 1||86
10364391|NCT00519636|11504465|FG002|COMPLETED|Treatment Period 1||89
10364392|NCT00519636|11504466|FG003|COMPLETED|Treatment Period 1||93
10364393|NCT00519636|11504463|FG000|NOT COMPLETED|Treatment Period 1||2
10364394|NCT00519636|11504464|FG001|NOT COMPLETED|Treatment Period 1||0
10364395|NCT00519636|11504465|FG002|NOT COMPLETED|Treatment Period 1||1
10364396|NCT00519636|11504466|FG003|NOT COMPLETED|Treatment Period 1||0
10364397|NCT00519636|11504463|FG000|STARTED|Washout Period||89
10364398|NCT00519636|11504464|FG001|STARTED|Washout Period||86
10364399|NCT00519636|11504465|FG002|STARTED|Washout Period||89
10364400|NCT00519636|11504466|FG003|STARTED|Washout Period||93
10364401|NCT00519636|11504463|FG000|COMPLETED|Washout Period||69
10364402|NCT00519636|11504464|FG001|COMPLETED|Washout Period||72
10364403|NCT00519636|11504465|FG002|COMPLETED|Washout Period||75
10364404|NCT00519636|11504466|FG003|COMPLETED|Washout Period||88
10364405|NCT00519636|11504463|FG000|NOT COMPLETED|Washout Period||20
10364406|NCT00519636|11504464|FG001|NOT COMPLETED|Washout Period||14
10716500|NCT02689206|11880197|FG003|NOT COMPLETED|Overall Study||4
10364407|NCT00519636|11504465|FG002|NOT COMPLETED|Washout Period||14
10364408|NCT00519636|11504466|FG003|NOT COMPLETED|Washout Period||5
10364409|NCT00519636|11504463|FG000|STARTED|Treatment Period 2||69
10364410|NCT00519636|11504464|FG001|STARTED|Treatment Period 2||72
10364411|NCT00519636|11504465|FG002|STARTED|Treatment Period 2||75
10364412|NCT00519636|11504466|FG003|STARTED|Treatment Period 2||88
10364413|NCT00519636|11504463|FG000|COMPLETED|Treatment Period 2||69
10364414|NCT00519636|11504464|FG001|COMPLETED|Treatment Period 2||71
10364415|NCT00519636|11504465|FG002|COMPLETED|Treatment Period 2||74
10364416|NCT00519636|11504466|FG003|COMPLETED|Treatment Period 2||86
10364417|NCT00519636|11504463|FG000|NOT COMPLETED|Treatment Period 2||0
10364418|NCT00519636|11504464|FG001|NOT COMPLETED|Treatment Period 2||1
10364419|NCT00519636|11504465|FG002|NOT COMPLETED|Treatment Period 2||1
10364420|NCT00519636|11504466|FG003|NOT COMPLETED|Treatment Period 2||2
10364421|NCT00519636|11504463|FG000|STARTED|Post Study Period||69
10364422|NCT00519636|11504464|FG001|STARTED|Post Study Period||71
10364423|NCT00519636|11504465|FG002|STARTED|Post Study Period||74
10364424|NCT00519636|11504466|FG003|STARTED|Post Study Period||86
10364425|NCT00519636|11504463|FG000|COMPLETED|Post Study Period||69
10364426|NCT00519636|11504464|FG001|COMPLETED|Post Study Period||71
10364427|NCT00519636|11504465|FG002|COMPLETED|Post Study Period||74
10364428|NCT00519636|11504466|FG003|COMPLETED|Post Study Period||85
10364429|NCT00519636|11504463|FG000|NOT COMPLETED|Post Study Period||0
10364430|NCT00519636|11504464|FG001|NOT COMPLETED|Post Study Period||0
10364431|NCT00519636|11504465|FG002|NOT COMPLETED|Post Study Period||0
10364432|NCT00519636|11504466|FG003|NOT COMPLETED|Post Study Period||1
10364433|NCT00519649|11504480|FG000|STARTED|Overall Study||300
10364434|NCT00519649|11504480|FG000|COMPLETED|Overall Study||299
10364435|NCT00519649|11504480|FG000|NOT COMPLETED|Overall Study||1
10364436|NCT00519779|11504486|FG000|STARTED|Overall Study||34
10364437|NCT00519779|11504487|FG001|STARTED|Overall Study||34
10364438|NCT00519779|11504486|FG000|COMPLETED|Overall Study||34
10364439|NCT00519779|11504487|FG001|COMPLETED|Overall Study||33
10364440|NCT00519779|11504486|FG000|NOT COMPLETED|Overall Study||0
10364441|NCT00519779|11504487|FG001|NOT COMPLETED|Overall Study||1
10364442|NCT00519831|11504493|FG000|STARTED|Overall Study||16
10364443|NCT00519831|11504493|FG000|COMPLETED|Overall Study||13
10364444|NCT00519831|11504493|FG000|NOT COMPLETED|Overall Study||3
10364445|NCT00519896|11504497|FG000|STARTED|Overall Study||35
10364446|NCT00519896|11504497|FG000|COMPLETED|Overall Study||33
10364447|NCT00519896|11504497|FG000|NOT COMPLETED|Overall Study||2
10364448|NCT00520013|11504504|FG000|STARTED|Overall Study||23
10364449|NCT00520013|11504505|FG001|STARTED|Overall Study||25
10364450|NCT00520013|11504506|FG002|STARTED|Overall Study|Excludes a pt who went off-study (on reg day) due to consent that may not have been informed (ESL).|11
10364451|NCT00520013|11504504|FG000|Treated|Overall Study||23
10364452|NCT00520013|11504505|FG001|Treated|Overall Study||25
10364453|NCT00520013|11504506|FG002|Treated|Overall Study||11
10364454|NCT00520013|11504504|FG000|COMPLETED|Overall Study||11
10364455|NCT00520013|11504505|FG001|COMPLETED|Overall Study||10
10364456|NCT00520013|11504506|FG002|COMPLETED|Overall Study||0
10364457|NCT00520013|11504504|FG000|NOT COMPLETED|Overall Study||12
10364458|NCT00520013|11504505|FG001|NOT COMPLETED|Overall Study||15
10364459|NCT00520013|11504506|FG002|NOT COMPLETED|Overall Study||11
10364460|NCT00520039|11504514|FG000|STARTED|Overall Study||28
10364461|NCT00520039|11504515|FG001|STARTED|Overall Study||24
10364462|NCT00520039|11504514|FG000|COMPLETED|Overall Study||21
10364463|NCT00520039|11504515|FG001|COMPLETED|Overall Study||19
10364464|NCT00520039|11504514|FG000|NOT COMPLETED|Overall Study||7
10364465|NCT00520039|11504515|FG001|NOT COMPLETED|Overall Study||5
10364466|NCT00520130|11504525|FG000|STARTED|Overall Study||44
10364467|NCT00520130|11504526|FG001|STARTED|Overall Study||45
10364468|NCT00520130|11504525|FG000|COMPLETED|Overall Study||39
10364469|NCT00520130|11504526|FG001|COMPLETED|Overall Study||44
10364470|NCT00520130|11504525|FG000|NOT COMPLETED|Overall Study||5
10364471|NCT00520130|11504526|FG001|NOT COMPLETED|Overall Study||1
10364472|NCT00520234|11504538|FG000|STARTED|Overall Study||118
10364473|NCT00520234|11504539|FG001|STARTED|Overall Study||104
10364474|NCT00520234|11504538|FG000|COMPLETED|Overall Study||117
10364475|NCT00520234|11504539|FG001|COMPLETED|Overall Study||102
10364476|NCT00520234|11504538|FG000|NOT COMPLETED|Overall Study||1
10364477|NCT00520234|11504539|FG001|NOT COMPLETED|Overall Study||2
10364478|NCT00520286|11504548|FG000|STARTED|Overall Study||142
10364479|NCT00520286|11504549|FG001|STARTED|Overall Study||68
10364480|NCT00520286|11504548|FG000|COMPLETED|Overall Study||76
10364481|NCT00520286|11504549|FG001|COMPLETED|Overall Study||36
10364482|NCT00520286|11504548|FG000|NOT COMPLETED|Overall Study||66
10364483|NCT00520286|11504549|FG001|NOT COMPLETED|Overall Study||32
10364484|NCT00520299|11504558|FG000|STARTED|Overall Study||6
10364485|NCT00520299|11504559|FG001|STARTED|Overall Study||6
10364486|NCT00520299|11504560|FG002|STARTED|Overall Study||19
10364487|NCT00520299|11504558|FG000|COMPLETED|Overall Study|Defined as completion of 1 treatment cycle|6
10364488|NCT00520299|11504559|FG001|COMPLETED|Overall Study||3
10364489|NCT00520299|11504560|FG002|COMPLETED|Overall Study||13
10364490|NCT00520299|11504558|FG000|NOT COMPLETED|Overall Study||0
10364491|NCT00520299|11504559|FG001|NOT COMPLETED|Overall Study||3
10364492|NCT00520299|11504560|FG002|NOT COMPLETED|Overall Study||6
10364493|NCT00520351|11504570|FG000|STARTED|First Intervention|Start date is Sep.06, 2007|15
10364494|NCT00520351|11504571|FG001|STARTED|First Intervention|Start date is Sep.06, 2007|15
10364495|NCT00520351|11504570|FG000|COMPLETED|First Intervention|End date is Feb.25, 2008|14
10364496|NCT00520351|11504571|FG001|COMPLETED|First Intervention|End date is Feb.25, 2008|14
10364497|NCT00520351|11504570|FG000|NOT COMPLETED|First Intervention||1
10364498|NCT00520351|11504571|FG001|NOT COMPLETED|First Intervention||1
10364499|NCT00520351|11504570|FG000|STARTED|Second Intervention||14
10364500|NCT00520351|11504571|FG001|STARTED|Second Intervention||14
10364501|NCT00520351|11504570|FG000|COMPLETED|Second Intervention||14
10364502|NCT00520351|11504571|FG001|COMPLETED|Second Intervention||14
10364503|NCT00520351|11504570|FG000|NOT COMPLETED|Second Intervention||0
10364504|NCT00520351|11504571|FG001|NOT COMPLETED|Second Intervention||0
10364505|NCT00520403|11504577|FG000|STARTED|Bevacizumab + IFN/Vinblastine||25
10364506|NCT00520403|11504577|FG000|COMPLETED|Bevacizumab + IFN/Vinblastine||7
10364507|NCT00520403|11504577|FG000|NOT COMPLETED|Bevacizumab + IFN/Vinblastine||18
10364508|NCT00520403|11504577|FG000|STARTED|Bevacizumab Monotherapy|2 of 7 participants completing Bevacizumab+IFN/vinblastine cycles initiated bevacizumab monotherapy|2
10364509|NCT00520403|11504577|FG000|COMPLETED|Bevacizumab Monotherapy||0
10364510|NCT00520403|11504577|FG000|NOT COMPLETED|Bevacizumab Monotherapy||2
10364511|NCT00520468|11504581|FG000|STARTED|Overall Study||14
10364512|NCT00520468|11504581|FG000|COMPLETED|Overall Study||14
10364513|NCT00520468|11504581|FG000|NOT COMPLETED|Overall Study||0
10364514|NCT00520481|11504587|FG000|STARTED|Overall Study||31
10364515|NCT00520481|11504588|FG001|STARTED|Overall Study||10
10364516|NCT00520481|11504587|FG000|Received at Least 1 Dose of Study Drug|Overall Study||31
10535770|NCT01439126|11688190|FG000|STARTED|Overall Study||68
10535771|NCT01439126|11688191|FG001|STARTED|Overall Study||67
10535772|NCT01439126|11688190|FG000|COMPLETED|Overall Study||37
10535773|NCT01439126|11688191|FG001|COMPLETED|Overall Study||25
10535774|NCT01439126|11688190|FG000|NOT COMPLETED|Overall Study||31
10535775|NCT01439126|11688191|FG001|NOT COMPLETED|Overall Study||42
10535776|NCT01439204|11688199|FG000|STARTED|Overall Study||36
10535777|NCT01439204|11688200|FG001|STARTED|Overall Study||36
10535778|NCT01439204|11688199|FG000|COMPLETED|Overall Study||32
10535779|NCT01439204|11688200|FG001|COMPLETED|Overall Study||33
10535780|NCT01439204|11688199|FG000|NOT COMPLETED|Overall Study||4
10535781|NCT01439204|11688200|FG001|NOT COMPLETED|Overall Study||3
10535782|NCT01439282|11688208|FG000|STARTED|Overall Study||67
10535783|NCT01439282|11688209|FG001|STARTED|Overall Study||10
10535784|NCT01439282|11688208|FG000|COMPLETED|Overall Study||59
10535785|NCT01439282|11688209|FG001|COMPLETED|Overall Study||9
10535786|NCT01439282|11688208|FG000|NOT COMPLETED|Overall Study||8
10535787|NCT01439282|11688209|FG001|NOT COMPLETED|Overall Study||1
10535788|NCT01439360|11688218|FG000|STARTED|Overall Study||6006
10535789|NCT01439360|11688219|FG001|STARTED|Overall Study||6012
10535790|NCT01439360|11688218|FG000|COMPLETED|Overall Study||5808
10535791|NCT01439360|11688219|FG001|COMPLETED|Overall Study||5804
10535792|NCT01439360|11688218|FG000|NOT COMPLETED|Overall Study||198
10535793|NCT01439360|11688219|FG001|NOT COMPLETED|Overall Study||208
10535794|NCT01439373|11688227|FG000|STARTED|Monotherapy (Day 1)||11
10535795|NCT01439373|11688228|FG001|STARTED|Monotherapy (Day 1)||5
10535796|NCT01439373|11688227|FG000|COMPLETED|Monotherapy (Day 1)||11
10535797|NCT01439373|11688228|FG001|COMPLETED|Monotherapy (Day 1)||4
10535798|NCT01439373|11688227|FG000|NOT COMPLETED|Monotherapy (Day 1)||0
10535799|NCT01439373|11688228|FG001|NOT COMPLETED|Monotherapy (Day 1)||1
10535800|NCT01439373|11688227|FG000|STARTED|Combined With PEG and RIBA (Day 2 to 28)||11
10535801|NCT01439373|11688228|FG001|STARTED|Combined With PEG and RIBA (Day 2 to 28)||4
10535802|NCT01439373|11688227|FG000|COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||9
10535803|NCT01439373|11688228|FG001|COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||4
10535804|NCT01439373|11688227|FG000|NOT COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||2
10535805|NCT01439373|11688228|FG001|NOT COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||0
10535806|NCT01439555|11688238|FG000|STARTED|Overall Study||11
10535807|NCT01439555|11688238|FG000|COMPLETED|Overall Study||10
10535808|NCT01439555|11688238|FG000|NOT COMPLETED|Overall Study||1
10535809|NCT01439568|11688244|FG000|STARTED|Overall Study||47
10535810|NCT01439568|11688245|FG001|STARTED|Overall Study||43
10535811|NCT01439568|11688244|FG000|Received at Least One Dose of Study Drug|Overall Study||47
10535812|NCT01439568|11688245|FG001|Received at Least One Dose of Study Drug|Overall Study||43
10535813|NCT01439568|11688244|FG000|COMPLETED|Overall Study||44
10535814|NCT01439568|11688245|FG001|COMPLETED|Overall Study||41
10535815|NCT01439568|11688244|FG000|NOT COMPLETED|Overall Study||3
10535816|NCT01439568|11688245|FG001|NOT COMPLETED|Overall Study||2
10535817|NCT01439581|11688253|FG000|STARTED|Overall Study||216
10535818|NCT01439581|11688254|FG001|STARTED|Overall Study||212
10535819|NCT01439581|11688253|FG000|COMPLETED|Overall Study||216
10535820|NCT01439581|11688254|FG001|COMPLETED|Overall Study||212
10535821|NCT01439581|11688253|FG000|NOT COMPLETED|Overall Study||0
10535822|NCT01439581|11688254|FG001|NOT COMPLETED|Overall Study||0
10535823|NCT01439594|11688260|FG000|STARTED|Overall Study||17
10535824|NCT01439594|11688260|FG000|COMPLETED|Overall Study||17
10535825|NCT01439594|11688260|FG000|NOT COMPLETED|Overall Study||0
10535826|NCT01439620|11688264|FG000|STARTED|Overall Study||7
10535827|NCT01439620|11688264|FG000|COMPLETED|Overall Study||7
10535828|NCT01439620|11688264|FG000|NOT COMPLETED|Overall Study||0
10535829|NCT01439633|11688268|FG000|STARTED|Overall Study||22
10535830|NCT01439633|11688268|FG000|COMPLETED|Overall Study||22
10535831|NCT01439633|11688268|FG000|NOT COMPLETED|Overall Study||0
10535832|NCT01439672|11688272|FG000|STARTED|Overall Study||35
10535833|NCT01439672|11688272|FG000|COMPLETED|Overall Study||11
10535834|NCT01439672|11688272|FG000|NOT COMPLETED|Overall Study||24
10535835|NCT01439711|11688276|FG000|STARTED|Overall Study||108
10535836|NCT01439711|11688276|FG000|COMPLETED|Overall Study||68
10535837|NCT01439711|11688276|FG000|NOT COMPLETED|Overall Study||40
10535838|NCT01439724|11688282|FG000|STARTED|Overall Study||47
10656815|NCT02221349|11817912|FG000|STARTED|Overall Study||15
10535839|NCT01439724|11688283|FG001|STARTED|Overall Study||47
10535840|NCT01439724|11688282|FG000|COMPLETED|Overall Study||38
10535841|NCT01439724|11688283|FG001|COMPLETED|Overall Study||39
10535842|NCT01439724|11688282|FG000|NOT COMPLETED|Overall Study||9
10535843|NCT01439724|11688283|FG001|NOT COMPLETED|Overall Study||8
10535844|NCT01439815|11688291|FG000|STARTED|Overall Study||11
10535845|NCT01439815|11688292|FG001|STARTED|Overall Study||11
10535846|NCT01439815|11688291|FG000|All Randomized Participant Population|Overall Study||11
10535847|NCT01439815|11688292|FG001|All Randomized Participant Population|Overall Study||11
10364517|NCT00520481|11504588|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
10364518|NCT00520481|11504587|FG000|COMPLETED|Overall Study||24
10364519|NCT00520481|11504588|FG001|COMPLETED|Overall Study||9
10364520|NCT00520481|11504587|FG000|NOT COMPLETED|Overall Study||7
10364521|NCT00520481|11504588|FG001|NOT COMPLETED|Overall Study||1
10364522|NCT00520494|11504596|FG000|STARTED|Overall Study||18
10364523|NCT00520494|11504596|FG000|COMPLETED|Overall Study||17
10364524|NCT00520494|11504596|FG000|NOT COMPLETED|Overall Study||1
10364525|NCT00520533|11504600|FG000|STARTED|Overall Study||8
10364526|NCT00520533|11504600|FG000|COMPLETED|Overall Study||4
10364527|NCT00520533|11504600|FG000|NOT COMPLETED|Overall Study||4
10364528|NCT00520546|11504605|FG000|STARTED|Overall Study||44
10364529|NCT00520546|11504605|FG000|COMPLETED|Overall Study||38
10364530|NCT00520546|11504605|FG000|NOT COMPLETED|Overall Study||6
10364531|NCT00520572|11504620|FG000|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|64
10364532|NCT00520572|11504621|FG001|STARTED|Overall Study|Participants randomised.|64
10364533|NCT00520572|11504622|FG002|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|64
10364534|NCT00520572|11504623|FG003|STARTED|Overall Study|Participants randomised.|64
10364535|NCT00520572|11504624|FG004|STARTED|Overall Study|Participants randomised.|65
10364536|NCT00520572|11504625|FG005|STARTED|Overall Study|Participants randomised.|64
10364537|NCT00520572|11504620|FG000|COMPLETED|Overall Study|Participants completed the study.|52
10364538|NCT00520572|11504621|FG001|COMPLETED|Overall Study|Participants completed the study.|50
10364539|NCT00520572|11504622|FG002|COMPLETED|Overall Study|Participants completed the study.|49
10364540|NCT00520572|11504623|FG003|COMPLETED|Overall Study|Participants completed the study.|50
10364541|NCT00520572|11504624|FG004|COMPLETED|Overall Study|Participants completed the study.|53
10364542|NCT00520572|11504625|FG005|COMPLETED|Overall Study|Participants completed the study.|62
10364543|NCT00520572|11504620|FG000|NOT COMPLETED|Overall Study||12
10364544|NCT00520572|11504621|FG001|NOT COMPLETED|Overall Study||14
10364545|NCT00520572|11504622|FG002|NOT COMPLETED|Overall Study||15
10364546|NCT00520572|11504623|FG003|NOT COMPLETED|Overall Study||14
10364547|NCT00520572|11504624|FG004|NOT COMPLETED|Overall Study||12
10364548|NCT00520572|11504625|FG005|NOT COMPLETED|Overall Study||2
10364549|NCT00520676|11504641|FG000|STARTED|Overall Study||128
10364550|NCT00520676|11504642|FG001|STARTED|Overall Study||132
10364551|NCT00520676|11504641|FG000|Received at Least 1 Dose of Study Drug|Overall Study||118
10364552|NCT00520676|11504642|FG001|Received at Least 1 Dose of Study Drug|Overall Study||127
10364553|NCT00520676|11504641|FG000|Qualified Intent-to-treat (Q-ITT)|Overall Study||106
10364554|NCT00520676|11504642|FG001|Qualified Intent-to-treat (Q-ITT)|Overall Study||105
10364555|NCT00520676|11504641|FG000|COMPLETED|Overall Study||27
10364556|NCT00520676|11504642|FG001|COMPLETED|Overall Study||29
10364557|NCT00520676|11504641|FG000|NOT COMPLETED|Overall Study||101
10364558|NCT00520676|11504642|FG001|NOT COMPLETED|Overall Study||103
10364559|NCT00520741|11504650|FG000|STARTED|Overall Study||106
10364560|NCT00520741|11504651|FG001|STARTED|Overall Study|One subject was randomized at 2 sites and excluded from the Safety Set.|319
10364561|NCT00520741|11504650|FG000|COMPLETED|Overall Study||69
10364562|NCT00520741|11504651|FG001|COMPLETED|Overall Study||194
10364563|NCT00520741|11504650|FG000|NOT COMPLETED|Overall Study||37
10364564|NCT00520741|11504651|FG001|NOT COMPLETED|Overall Study||125
10364565|NCT00520845|11504659|FG000|STARTED|Overall Study||23
10364566|NCT00520845|11504659|FG000|COMPLETED|Overall Study||1
10364567|NCT00520845|11504659|FG000|NOT COMPLETED|Overall Study||22
10364568|NCT00520884|11504665|FG000|STARTED|Overall Study||3
10364569|NCT00520884|11504666|FG001|STARTED|Overall Study||2
10364570|NCT00520884|11504667|FG002|STARTED|Overall Study||2
10364571|NCT00520884|11504668|FG003|STARTED|Overall Study||3
10364572|NCT00520884|11504665|FG000|COMPLETED|Overall Study||3
10364573|NCT00520884|11504666|FG001|COMPLETED|Overall Study||2
10364574|NCT00520884|11504667|FG002|COMPLETED|Overall Study||2
10364575|NCT00520884|11504668|FG003|COMPLETED|Overall Study||3
10364576|NCT00520884|11504665|FG000|NOT COMPLETED|Overall Study||0
10364577|NCT00520884|11504666|FG001|NOT COMPLETED|Overall Study||0
10364578|NCT00520884|11504667|FG002|NOT COMPLETED|Overall Study||0
10364579|NCT00520884|11504668|FG003|NOT COMPLETED|Overall Study||0
10364580|NCT00520910|11504677|FG000|STARTED|Overall Study||5
10364581|NCT00520910|11504678|FG001|STARTED|Overall Study||5
10716501|NCT02689206|11880198|FG004|NOT COMPLETED|Overall Study||8
10716502|NCT02689219|11880216|FG000|STARTED|Overall Study||11
10716503|NCT02689219|11880217|FG001|STARTED|Overall Study||7
10716504|NCT02689219|11880216|FG000|COMPLETED|Overall Study||0
10364582|NCT00520910|11504677|FG000|COMPLETED|Overall Study||5
10364583|NCT00520910|11504678|FG001|COMPLETED|Overall Study||5
10364584|NCT00520910|11504677|FG000|NOT COMPLETED|Overall Study||0
10364585|NCT00520910|11504678|FG001|NOT COMPLETED|Overall Study||0
10364586|NCT00520936|11504692|FG000|STARTED|Overall Study|75 participants entered the study and 72 were enrolled and received study drug.|10
10364587|NCT00520936|11504693|FG001|STARTED|Overall Study||11
10364588|NCT00520936|11504694|FG002|STARTED|Overall Study||9
10364589|NCT00520936|11504695|FG003|STARTED|Overall Study||5
10364590|NCT00520936|11504696|FG004|STARTED|Overall Study||6
10364591|NCT00520936|11504697|FG005|STARTED|Overall Study||10
10364592|NCT00520936|11504698|FG006|STARTED|Overall Study||11
10364593|NCT00520936|11504699|FG007|STARTED|Overall Study||10
10364594|NCT00520936|11504692|FG000|COMPLETED|Overall Study|Study completion defined as treated until disease progression. Completed=progressive disease.|10
10364595|NCT00520936|11504693|FG001|COMPLETED|Overall Study||7
10716505|NCT02689219|11880217|FG001|COMPLETED|Overall Study||0
10364596|NCT00520936|11504694|FG002|COMPLETED|Overall Study||7
10364597|NCT00520936|11504695|FG003|COMPLETED|Overall Study||5
10364598|NCT00520936|11504696|FG004|COMPLETED|Overall Study||5
10364599|NCT00520936|11504697|FG005|COMPLETED|Overall Study||10
10364600|NCT00520936|11504698|FG006|COMPLETED|Overall Study||7
10364601|NCT00520936|11504699|FG007|COMPLETED|Overall Study||9
10364602|NCT00520936|11504692|FG000|NOT COMPLETED|Overall Study||0
10364603|NCT00520936|11504693|FG001|NOT COMPLETED|Overall Study||4
10364604|NCT00520936|11504694|FG002|NOT COMPLETED|Overall Study||2
10535848|NCT01439815|11688291|FG000|COMPLETED|Overall Study||11
10535849|NCT01439815|11688292|FG001|COMPLETED|Overall Study||9
10535850|NCT01439815|11688291|FG000|NOT COMPLETED|Overall Study||0
10535851|NCT01439815|11688292|FG001|NOT COMPLETED|Overall Study||2
10547975|NCT01515943|11701736|FG002|NOT COMPLETED|Overall Study||13
10547976|NCT01515956|11701746|FG000|STARTED|Overall Study||15
10547977|NCT01515956|11701746|FG000|COMPLETED|Overall Study||15
10547978|NCT01515956|11701746|FG000|NOT COMPLETED|Overall Study||0
10547979|NCT01515995|11701753|FG000|STARTED|Overall Study||25
10547980|NCT01515995|11701754|FG001|STARTED|Overall Study||25
10547981|NCT01515995|11701753|FG000|COMPLETED|Overall Study||22
10547982|NCT01515995|11701754|FG001|COMPLETED|Overall Study||21
10547983|NCT01515995|11701753|FG000|NOT COMPLETED|Overall Study||3
10547984|NCT01515995|11701754|FG001|NOT COMPLETED|Overall Study||4
10547985|NCT01516008|11701763|FG000|STARTED|Overall Study||114
10547986|NCT01516008|11701764|FG001|STARTED|Overall Study||121
10547987|NCT01516008|11701765|FG002|STARTED|Overall Study||117
10547988|NCT01516008|11701763|FG000|COMPLETED|Overall Study||69
10547989|NCT01516008|11701764|FG001|COMPLETED|Overall Study||105
10547990|NCT01516008|11701765|FG002|COMPLETED|Overall Study||99
10547991|NCT01516008|11701763|FG000|NOT COMPLETED|Overall Study||45
10547992|NCT01516008|11701764|FG001|NOT COMPLETED|Overall Study||16
10547993|NCT01516008|11701765|FG002|NOT COMPLETED|Overall Study||18
10547994|NCT01516268|11701775|FG000|STARTED|Overall Study||25
10547995|NCT01516268|11701776|FG001|STARTED|Overall Study||25
10547996|NCT01516268|11701775|FG000|COMPLETED|Overall Study||25
10547997|NCT01516268|11701776|FG001|COMPLETED|Overall Study||25
10547998|NCT01516268|11701775|FG000|NOT COMPLETED|Overall Study||0
10547999|NCT01516268|11701776|FG001|NOT COMPLETED|Overall Study||0
10548000|NCT01516424|11701784|FG000|STARTED|Overall Study|the patient number of randomization for Blonanserin Group|131
10548001|NCT01516424|11701785|FG001|STARTED|Overall Study|the patient number of randomization for Risperidone Group|136
10548002|NCT01516424|11701784|FG000|COMPLETED|Overall Study||96
10548003|NCT01516424|11701785|FG001|COMPLETED|Overall Study||114
10548004|NCT01516424|11701784|FG000|NOT COMPLETED|Overall Study||35
10548005|NCT01516424|11701785|FG001|NOT COMPLETED|Overall Study||22
10548006|NCT01516437|11701795|FG000|STARTED|Overall Study||24
10548007|NCT01516437|11701796|FG001|STARTED|Overall Study||24
10548008|NCT01516437|11701797|FG002|STARTED|Overall Study||15
10548009|NCT01516437|11701798|FG003|STARTED|Overall Study||7
10548010|NCT01516437|11701795|FG000|COMPLETED|Overall Study||24
10548011|NCT01516437|11701796|FG001|COMPLETED|Overall Study||24
10548012|NCT01516437|11701797|FG002|COMPLETED|Overall Study||14
10548013|NCT01516437|11701798|FG003|COMPLETED|Overall Study||6
10548014|NCT01516437|11701795|FG000|NOT COMPLETED|Overall Study||0
10548015|NCT01516437|11701796|FG001|NOT COMPLETED|Overall Study||0
10548016|NCT01516437|11701797|FG002|NOT COMPLETED|Overall Study||1
10548017|NCT01516437|11701798|FG003|NOT COMPLETED|Overall Study||1
10548018|NCT01516632|11701812|FG000|STARTED|Overall Study||101
10548019|NCT01516632|11701813|FG001|STARTED|Overall Study||63
10548020|NCT01516632|11701812|FG000|COMPLETED|Overall Study||77
10548021|NCT01516632|11701813|FG001|COMPLETED|Overall Study||48
10548022|NCT01516632|11701812|FG000|NOT COMPLETED|Overall Study||24
10548023|NCT01516632|11701813|FG001|NOT COMPLETED|Overall Study||15
10548024|NCT01516684|11701823|FG000|STARTED|Overall Study|"Overall number of units (trials) was used for measuring results with 170 trials.~Trials were randomized for each arm, not participants"|
10548025|NCT01516684|11701824|FG001|STARTED|Overall Study|"Overall number of units (trials) was used for measuring results with 170 trials.~Trials were randomized for each arm, not participants"|
10548026|NCT01516684|11701823|FG000|COMPLETED|Overall Study|Trials were randomized for each arm, not participants|
10548027|NCT01516684|11701824|FG001|COMPLETED|Overall Study|"Overall number of units (trials) completed was 152~Trials were randomized for each arm, not participants"|
10548028|NCT01516684|11701823|FG000|NOT COMPLETED|Overall Study||
10548029|NCT01516684|11701824|FG001|NOT COMPLETED|Overall Study||
10548030|NCT01516736|11701834|FG000|STARTED|Overall Study||155
10548031|NCT01516736|11701835|FG001|STARTED|Overall Study||153
10548032|NCT01516736|11701834|FG000|COMPLETED|Overall Study||135
10548033|NCT01516736|11701835|FG001|COMPLETED|Overall Study||140
10548034|NCT01516736|11701834|FG000|NOT COMPLETED|Overall Study||20
10548035|NCT01516736|11701835|FG001|NOT COMPLETED|Overall Study||13
10364605|NCT00520936|11504695|FG003|NOT COMPLETED|Overall Study||0
10364606|NCT00520936|11504696|FG004|NOT COMPLETED|Overall Study||1
10548036|NCT01516749|11701841|FG000|STARTED|Active Therapy||6
10548037|NCT01516749|11701841|FG000|COMPLETED|Active Therapy||5
10548038|NCT01516749|11701841|FG000|NOT COMPLETED|Active Therapy||1
10548039|NCT01516749|11701841|FG000|STARTED|Follow-up Off Therapy||5
10548040|NCT01516749|11701841|FG000|COMPLETED|Follow-up Off Therapy||4
10548041|NCT01516749|11701841|FG000|NOT COMPLETED|Follow-up Off Therapy||1
10364607|NCT00520936|11504697|FG005|NOT COMPLETED|Overall Study||0
10364608|NCT00520936|11504698|FG006|NOT COMPLETED|Overall Study||4
10364609|NCT00520936|11504699|FG007|NOT COMPLETED|Overall Study||1
10364610|NCT00520975|11504712|FG000|STARTED|Overall Study||48
10364611|NCT00520975|11504713|FG001|STARTED|Overall Study||48
10364612|NCT00520975|11504712|FG000|Treated and Reported Adverse Events Data|Overall Study||47
10364613|NCT00520975|11504713|FG001|Treated and Reported Adverse Events Data|Overall Study||45
10364614|NCT00520975|11504712|FG000|COMPLETED|Overall Study|Treatment continued until progression or intolerable toxicity.|0
10364615|NCT00520975|11504713|FG001|COMPLETED|Overall Study|Treatment continued until progression or intolerable toxicity.|0
10364616|NCT00520975|11504712|FG000|NOT COMPLETED|Overall Study||48
10364617|NCT00520975|11504713|FG001|NOT COMPLETED|Overall Study||48
10364618|NCT00521001|11504719|FG000|STARTED|Overall Study||49
10364619|NCT00521001|11504719|FG000|COMPLETED|Overall Study||48
10364620|NCT00521001|11504719|FG000|NOT COMPLETED|Overall Study||1
10364621|NCT00521014|11504723|FG000|STARTED|Overall Study||14
10364622|NCT00521014|11504723|FG000|COMPLETED|Overall Study||13
10364623|NCT00521014|11504723|FG000|NOT COMPLETED|Overall Study||1
10364624|NCT00521053|11504727|FG000|STARTED|Treatment Phase||80
10364625|NCT00521053|11504727|FG000|Received 1 Cycle of PV-10|Treatment Phase||35
10364626|NCT00521053|11504727|FG000|Received 2 Cycles of PV-10|Treatment Phase||26
10364627|NCT00521053|11504727|FG000|Received 3 Cycles of PV-10|Treatment Phase||16
10364628|NCT00521053|11504727|FG000|Received 4 Cycles of PV-10|Treatment Phase||3
10364629|NCT00521053|11504727|FG000|COMPLETED|Treatment Phase||80
10364630|NCT00521053|11504727|FG000|NOT COMPLETED|Treatment Phase||0
10364631|NCT00521053|11504727|FG000|STARTED|Observation Phase||80
10364632|NCT00521053|11504727|FG000|COMPLETED|Observation Phase||12
10364633|NCT00521053|11504727|FG000|NOT COMPLETED|Observation Phase||68
10364634|NCT00521079|11504736|FG000|STARTED|Overall Study||192
10364635|NCT00521079|11504737|FG001|STARTED|Overall Study||102
10364636|NCT00521079|11504736|FG000|Surgical Roll-In|Overall Study||9
10364637|NCT00521079|11504737|FG001|Surgical Roll-In|Overall Study||5
10364638|NCT00521079|11504736|FG000|COMPLETED|Overall Study||178
10364639|NCT00521079|11504737|FG001|COMPLETED|Overall Study||97
10364640|NCT00521079|11504736|FG000|NOT COMPLETED|Overall Study||14
10364641|NCT00521079|11504737|FG001|NOT COMPLETED|Overall Study||5
10364642|NCT00521144|11504748|FG000|STARTED|Overall Study||6
10364643|NCT00521144|11504749|FG001|STARTED|Overall Study||5
10364644|NCT00521144|11504750|FG002|STARTED|Overall Study||3
10364645|NCT00521144|11504751|FG003|STARTED|Overall Study||1
10364646|NCT00521144|11504752|FG004|STARTED|Overall Study||7
10364647|NCT00521144|11504748|FG000|COMPLETED|Overall Study||2
10364648|NCT00521144|11504749|FG001|COMPLETED|Overall Study||2
10364649|NCT00521144|11504750|FG002|COMPLETED|Overall Study||1
10364650|NCT00521144|11504751|FG003|COMPLETED|Overall Study||0
10364651|NCT00521144|11504752|FG004|COMPLETED|Overall Study||0
10364652|NCT00521144|11504748|FG000|NOT COMPLETED|Overall Study||4
10364653|NCT00521144|11504749|FG001|NOT COMPLETED|Overall Study||3
10364654|NCT00521144|11504750|FG002|NOT COMPLETED|Overall Study||2
10364655|NCT00521144|11504751|FG003|NOT COMPLETED|Overall Study||1
10364656|NCT00521144|11504752|FG004|NOT COMPLETED|Overall Study||7
10364657|NCT00521339|11504764|FG000|STARTED|Treatment Phase||31
10364658|NCT00521339|11504765|FG001|STARTED|Treatment Phase||0
10364659|NCT00521339|11504766|FG002|STARTED|Treatment Phase||0
10364660|NCT00521339|11504764|FG000|Received Apremilast|Treatment Phase|1 participant withdrew consent prior to first visit and was excluded from safety population|30
10364661|NCT00521339|11504765|FG001|Received Apremilast|Treatment Phase||0
10364662|NCT00521339|11504766|FG002|Received Apremilast|Treatment Phase||0
10364663|NCT00521339|11504764|FG000|COMPLETED|Treatment Phase||19
10364664|NCT00521339|11504765|FG001|COMPLETED|Treatment Phase||0
10364665|NCT00521339|11504766|FG002|COMPLETED|Treatment Phase||0
10364666|NCT00521339|11504764|FG000|NOT COMPLETED|Treatment Phase||12
10364667|NCT00521339|11504765|FG001|NOT COMPLETED|Treatment Phase||0
10364668|NCT00521339|11504766|FG002|NOT COMPLETED|Treatment Phase||0
10364669|NCT00521339|11504764|FG000|STARTED|Treatment Extension Phase||0
10364670|NCT00521339|11504765|FG001|STARTED|Treatment Extension Phase|Some participants had completed the treatment phase prior to inception of extension phase|4
10364671|NCT00521339|11504766|FG002|STARTED|Treatment Extension Phase|Some participants had completed the treatment phase prior to inception of extension phase|7
10364672|NCT00521339|11504764|FG000|COMPLETED|Treatment Extension Phase||0
10364673|NCT00521339|11504765|FG001|COMPLETED|Treatment Extension Phase||4
10364674|NCT00521339|11504766|FG002|COMPLETED|Treatment Extension Phase||4
10364675|NCT00521339|11504764|FG000|NOT COMPLETED|Treatment Extension Phase||0
10364676|NCT00521339|11504765|FG001|NOT COMPLETED|Treatment Extension Phase||0
10364677|NCT00521339|11504766|FG002|NOT COMPLETED|Treatment Extension Phase||3
10364678|NCT00521339|11504764|FG000|STARTED|Observational Follow Up Phase||14
10364679|NCT00521339|11504765|FG001|STARTED|Observational Follow Up Phase||4
10364680|NCT00521339|11504766|FG002|STARTED|Observational Follow Up Phase||4
10364681|NCT00521339|11504764|FG000|COMPLETED|Observational Follow Up Phase||14
10364682|NCT00521339|11504765|FG001|COMPLETED|Observational Follow Up Phase||4
10364683|NCT00521339|11504766|FG002|COMPLETED|Observational Follow Up Phase||4
10364684|NCT00521339|11504764|FG000|NOT COMPLETED|Observational Follow Up Phase||0
10364685|NCT00521339|11504765|FG001|NOT COMPLETED|Observational Follow Up Phase||0
10364686|NCT00521339|11504766|FG002|NOT COMPLETED|Observational Follow Up Phase||0
10364687|NCT00521352|11504789|FG000|STARTED|Overall Study||12
10364688|NCT00521352|11504790|FG001|STARTED|Overall Study||13
10364689|NCT00521352|11504789|FG000|COMPLETED|Overall Study||11
10364690|NCT00521352|11504790|FG001|COMPLETED|Overall Study||10
10364691|NCT00521352|11504789|FG000|NOT COMPLETED|Overall Study||1
10364692|NCT00521352|11504790|FG001|NOT COMPLETED|Overall Study||3
10364693|NCT00521365|11504796|FG000|STARTED|Overall Study|98 participants were screened and obtain 88 patients who receive study treatment|88
10364694|NCT00521365|11504796|FG000|Modified Intention to Treat (mITT)|Overall Study|Participants who have an YMRS assessment at inclusion, and at least one assessment after inclusion|88
10364695|NCT00521365|11504796|FG000|Per Protocol (PP) Population|Overall Study|All participants without protocol deviations|68
10364696|NCT00521365|11504796|FG000|Safety Analysis Set|Overall Study|All participants who received study treatment|88
10364697|NCT00521365|11504796|FG000|COMPLETED|Overall Study|68 participants completed the study and 68 completed without protocol deviations|68
10364698|NCT00521365|11504796|FG000|NOT COMPLETED|Overall Study||20
10364699|NCT00521404|11504800|FG000|STARTED|Overall Study||62
10364700|NCT00521404|11504800|FG000|COMPLETED|Overall Study||0
10364701|NCT00521404|11504800|FG000|NOT COMPLETED|Overall Study||62
10364702|NCT00521456|11504806|FG000|STARTED|Overall Study||176
10364703|NCT00521456|11504807|FG001|STARTED|Overall Study||87
10364704|NCT00521456|11504806|FG000|COMPLETED|Overall Study||163
10716506|NCT02689219|11880216|FG000|NOT COMPLETED|Overall Study||11
10716507|NCT02689219|11880217|FG001|NOT COMPLETED|Overall Study||7
10716508|NCT02689492|11880223|FG000|STARTED|Overall Study||401
10716509|NCT02689492|11880223|FG000|COMPLETED|Overall Study||315
10716510|NCT02689492|11880223|FG000|NOT COMPLETED|Overall Study||86
10716511|NCT02689804|11880232|FG000|STARTED|Overall Study||18
10716512|NCT02689804|11880233|FG001|STARTED|Overall Study||16
10716513|NCT02689804|11880232|FG000|COMPLETED|Overall Study||16
10716514|NCT02689804|11880233|FG001|COMPLETED|Overall Study||16
10364705|NCT00521456|11504807|FG001|COMPLETED|Overall Study||59
10364706|NCT00521456|11504806|FG000|NOT COMPLETED|Overall Study||13
10364707|NCT00521456|11504807|FG001|NOT COMPLETED|Overall Study||28
10364708|NCT00521586|11504815|FG000|STARTED|Initial Vaccination (Year 0)||554
10364709|NCT00521586|11504816|FG001|STARTED|Initial Vaccination (Year 0)||562
10364710|NCT00521586|11504815|FG000|Vaccinated Dose 1|Initial Vaccination (Year 0)||551
10364711|NCT00521586|11504816|FG001|Vaccinated Dose 1|Initial Vaccination (Year 0)||560
10364712|NCT00521586|11504815|FG000|Vaccinated Dose 2|Initial Vaccination (Year 0)||538
10364713|NCT00521586|11504816|FG001|Vaccinated Dose 2|Initial Vaccination (Year 0)||543
10364714|NCT00521586|11504815|FG000|Initially Reported to Complete Year 0|Initial Vaccination (Year 0)|Initially 1060 participants were reported to complete follow-up(Year 0),but 1066 actually completed.|531
10364715|NCT00521586|11504816|FG001|Initially Reported to Complete Year 0|Initial Vaccination (Year 0)|Initially 1060 participants were reported to complete follow-up(Year 0),but 1066 actually completed.|529
10364716|NCT00521586|11504815|FG000|COMPLETED|Initial Vaccination (Year 0)|6 additional participants initially reported to have withdrawn, actually completed follow-up(Year 0)|533
10364717|NCT00521586|11504816|FG001|COMPLETED|Initial Vaccination (Year 0)|6 additional participants initially reported to have withdrawn, actually completed follow-up(Year 0)|533
10364718|NCT00521586|11504815|FG000|NOT COMPLETED|Initial Vaccination (Year 0)||21
10364719|NCT00521586|11504816|FG001|NOT COMPLETED|Initial Vaccination (Year 0)||29
10364720|NCT00521586|11504815|FG000|STARTED|Follow-up (From 6-month[Year 0]-Year 5)||533
10364721|NCT00521586|11504816|FG001|STARTED|Follow-up (From 6-month[Year 0]-Year 5)||533
10364722|NCT00521586|11504815|FG000|COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||364
10364723|NCT00521586|11504816|FG001|COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||363
10364724|NCT00521586|11504815|FG000|NOT COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||169
10364725|NCT00521586|11504816|FG001|NOT COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||170
10364726|NCT00521586|11504815|FG000|STARTED|Revaccination With 13vPnC (Year 5)||364
10364727|NCT00521586|11504816|FG001|STARTED|Revaccination With 13vPnC (Year 5)||363
10364728|NCT00521586|11504815|FG000|Vaccinated 13vPnC (Year 5)|Revaccination With 13vPnC (Year 5)||364
10364729|NCT00521586|11504816|FG001|Vaccinated 13vPnC (Year 5)|Revaccination With 13vPnC (Year 5)||363
10364730|NCT00521586|11504815|FG000|Completed 1 Month Follow-up|Revaccination With 13vPnC (Year 5)||363
10364731|NCT00521586|11504816|FG001|Completed 1 Month Follow-up|Revaccination With 13vPnC (Year 5)||359
10364732|NCT00521586|11504815|FG000|Completed 6 Month Follow-up|Revaccination With 13vPnC (Year 5)||361
10364733|NCT00521586|11504816|FG001|Completed 6 Month Follow-up|Revaccination With 13vPnC (Year 5)||351
10364734|NCT00521586|11504815|FG000|COMPLETED|Revaccination With 13vPnC (Year 5)||361
10364735|NCT00521586|11504816|FG001|COMPLETED|Revaccination With 13vPnC (Year 5)||351
10364736|NCT00521586|11504815|FG000|NOT COMPLETED|Revaccination With 13vPnC (Year 5)||3
10364737|NCT00521586|11504816|FG001|NOT COMPLETED|Revaccination With 13vPnC (Year 5)||12
10364738|NCT00521976|11504834|FG000|STARTED|Overall Study||871
10364739|NCT00521976|11504834|FG000|COMPLETED|Overall Study||871
10364740|NCT00521976|11504834|FG000|NOT COMPLETED|Overall Study||0
10364741|NCT00521989|11504843|FG000|STARTED|Overall Study||56
10364742|NCT00521989|11504844|FG001|STARTED|Overall Study||54
10364743|NCT00521989|11504845|FG002|STARTED|Overall Study||57
10364744|NCT00521989|11504846|FG003|STARTED|Overall Study||54
10364745|NCT00521989|11504847|FG004|STARTED|Overall Study||58
10364746|NCT00521989|11504843|FG000|COMPLETED|Overall Study||36
10364747|NCT00521989|11504844|FG001|COMPLETED|Overall Study||37
10364748|NCT00521989|11504845|FG002|COMPLETED|Overall Study||41
10364749|NCT00521989|11504846|FG003|COMPLETED|Overall Study||42
10364750|NCT00521989|11504847|FG004|COMPLETED|Overall Study||35
10535852|NCT01439854|11688300|FG000|STARTED|Overall Study||8
10535853|NCT01439854|11688301|FG001|STARTED|Overall Study||10
10716515|NCT02689804|11880232|FG000|NOT COMPLETED|Overall Study||2
10716516|NCT02689804|11880233|FG001|NOT COMPLETED|Overall Study||0
10716517|NCT02689973|11880246|FG000|STARTED|Overall Study||311
10364751|NCT00521989|11504843|FG000|NOT COMPLETED|Overall Study||20
10364752|NCT00521989|11504844|FG001|NOT COMPLETED|Overall Study||17
10364753|NCT00521989|11504845|FG002|NOT COMPLETED|Overall Study||16
10364754|NCT00521989|11504846|FG003|NOT COMPLETED|Overall Study||12
10364755|NCT00521989|11504847|FG004|NOT COMPLETED|Overall Study||23
10364756|NCT00522041|11504861|FG000|STARTED|Overall Study||123
10364757|NCT00522041|11504862|FG001|STARTED|Overall Study||125
10364758|NCT00522041|11504861|FG000|Received Treatment|Overall Study||123
10364759|NCT00522041|11504862|FG001|Received Treatment|Overall Study||124
10364760|NCT00522041|11504861|FG000|COMPLETED|Overall Study||106
10364761|NCT00522041|11504862|FG001|COMPLETED|Overall Study||113
10364762|NCT00522041|11504861|FG000|NOT COMPLETED|Overall Study||17
10364763|NCT00522041|11504862|FG001|NOT COMPLETED|Overall Study||12
10364764|NCT00522171|11504871|FG000|STARTED|Overall Study||15
10364765|NCT00522171|11504872|FG001|STARTED|Overall Study||15
10364766|NCT00522171|11504871|FG000|COMPLETED|Overall Study||15
10364767|NCT00522171|11504872|FG001|COMPLETED|Overall Study||15
10364768|NCT00522171|11504871|FG000|NOT COMPLETED|Overall Study||0
10364769|NCT00522171|11504872|FG001|NOT COMPLETED|Overall Study||0
10364770|NCT00522275|11504878|FG000|STARTED|Overall Study||308
10364771|NCT00522275|11504878|FG000|COMPLETED|Overall Study||138
10364772|NCT00522275|11504878|FG000|NOT COMPLETED|Overall Study||170
10364773|NCT00522379|11504887|FG000|STARTED|Overall Study||101
10364774|NCT00522379|11504888|FG001|STARTED|Overall Study||107
10364775|NCT00522379|11504889|FG002|STARTED|Overall Study||104
10364776|NCT00522379|11504890|FG003|STARTED|Overall Study||94
10364777|NCT00522379|11504891|FG004|STARTED|Overall Study||108
10364778|NCT00522379|11504887|FG000|COMPLETED|Overall Study||79
10364779|NCT00522379|11504888|FG001|COMPLETED|Overall Study||84
10364780|NCT00522379|11504889|FG002|COMPLETED|Overall Study||82
10364781|NCT00522379|11504890|FG003|COMPLETED|Overall Study||80
10364782|NCT00522379|11504891|FG004|COMPLETED|Overall Study||81
10364783|NCT00522379|11504887|FG000|NOT COMPLETED|Overall Study||22
10364784|NCT00522379|11504888|FG001|NOT COMPLETED|Overall Study||23
10364785|NCT00522379|11504889|FG002|NOT COMPLETED|Overall Study||22
10364786|NCT00522379|11504890|FG003|NOT COMPLETED|Overall Study||14
10364787|NCT00522379|11504891|FG004|NOT COMPLETED|Overall Study||27
10364788|NCT00522392|11504905|FG000|STARTED|Overall Study||23
10364789|NCT00522392|11504906|FG001|STARTED|Overall Study||25
10364790|NCT00522392|11504905|FG000|Pts w/ Measurable Disease at Baseline|Overall Study||16
10364791|NCT00522392|11504906|FG001|Pts w/ Measurable Disease at Baseline|Overall Study||16
10364792|NCT00522392|11504905|FG000|Pts w/ QOL Assessments Complete|Overall Study||12
10364793|NCT00522392|11504906|FG001|Pts w/ QOL Assessments Complete|Overall Study||8
10364794|NCT00522392|11504905|FG000|COMPLETED|Overall Study||15
10364795|NCT00522392|11504906|FG001|COMPLETED|Overall Study||12
10364796|NCT00522392|11504905|FG000|NOT COMPLETED|Overall Study||8
10364797|NCT00522392|11504906|FG001|NOT COMPLETED|Overall Study||13
10364798|NCT00522418|11504914|FG000|STARTED|Overall Study||59
10364799|NCT00522418|11504915|FG001|STARTED|Overall Study||63
10364800|NCT00522418|11504914|FG000|Safety Set|Overall Study|Data of 5 randomized patients removed due to lack of ICF approval by site's local ethics committee.|54
10364801|NCT00522418|11504915|FG001|Safety Set|Overall Study|Data of 5 randomized patients removed due to lack of ICF approval by site's local ethics committee.|58
10364802|NCT00522418|11504914|FG000|Efficacy Set|Overall Study|6 pts. data excluded: exited prior to collection of baseline data & one postbaseline followup QOLIE|48
10364803|NCT00522418|11504915|FG001|Efficacy Set|Overall Study|10 pts. data excluded: exited prior to collection of baseline data & one postbaseline followup QOLIE|48
10364804|NCT00522418|11504914|FG000|Baseline and Month 3|Overall Study|Completed Baseline and Month 3|47
10364805|NCT00522418|11504915|FG001|Baseline and Month 3|Overall Study|Completed Baseline and Month 3|47
10364806|NCT00522418|11504914|FG000|Baseline and Month 6|Overall Study|Completed Baseline and Month 6|38
10364807|NCT00522418|11504915|FG001|Baseline and Month 6|Overall Study|Completed Baseline and Month 6|45
10364808|NCT00522418|11504914|FG000|Baseline and Month 9|Overall Study|Completed Baseline and Month 9|33
10364809|NCT00522418|11504915|FG001|Baseline and Month 9|Overall Study|Completed Baseline and Month 9|35
10364810|NCT00522418|11504914|FG000|Baseline and Month 12|Overall Study|Completed Baseline and Month 12|31
10364811|NCT00522418|11504915|FG001|Baseline and Month 12|Overall Study|Completed Baseline and Month 12|29
10364812|NCT00522418|11504914|FG000|COMPLETED|Overall Study|Completed 2-year follow-up|2
10364813|NCT00522418|11504915|FG001|COMPLETED|Overall Study|Completed 2-year follow-up|5
10364814|NCT00522418|11504914|FG000|NOT COMPLETED|Overall Study||57
10364815|NCT00522418|11504915|FG001|NOT COMPLETED|Overall Study||58
10364816|NCT00522431|11504923|FG000|STARTED|Overall Study||149
10364817|NCT00522431|11504923|FG000|COMPLETED|Overall Study||138
10364818|NCT00522431|11504923|FG000|NOT COMPLETED|Overall Study||11
10364819|NCT00522548|11504929|FG000|STARTED|Overall Study||18
10364820|NCT00522548|11504930|FG001|STARTED|Overall Study||19
10364821|NCT00522548|11504929|FG000|Consented to Pharmacokinetic Study|Overall Study||11
10364822|NCT00522548|11504930|FG001|Consented to Pharmacokinetic Study|Overall Study||10
10364823|NCT00522548|11504929|FG000|Completed 0/2 PK Visits|Overall Study||3
10364824|NCT00522548|11504930|FG001|Completed 0/2 PK Visits|Overall Study||4
10364825|NCT00522548|11504929|FG000|Completed 1/2 PK Visits|Overall Study||1
10364826|NCT00522548|11504930|FG001|Completed 1/2 PK Visits|Overall Study||1
10364827|NCT00522548|11504929|FG000|Completed 2/2 PK Visits|Overall Study||7
10364828|NCT00522548|11504930|FG001|Completed 2/2 PK Visits|Overall Study||5
10364829|NCT00522548|11504929|FG000|COMPLETED|Overall Study||16
10364830|NCT00522548|11504930|FG001|COMPLETED|Overall Study||15
10364831|NCT00522548|11504929|FG000|NOT COMPLETED|Overall Study||2
10364832|NCT00522548|11504930|FG001|NOT COMPLETED|Overall Study||4
10364833|NCT00522626|11504936|FG000|STARTED|Overall Study||19
10364834|NCT00522626|11504936|FG000|COMPLETED|Overall Study||12
10364835|NCT00522626|11504936|FG000|NOT COMPLETED|Overall Study||7
10364836|NCT00522795|11504940|FG000|STARTED|Overall Study||40
10364837|NCT00522795|11504940|FG000|COMPLETED|Overall Study||40
10364838|NCT00522795|11504940|FG000|NOT COMPLETED|Overall Study||0
10364839|NCT00522873|11504946|FG000|STARTED|Overall Study||490
10364840|NCT00522873|11504947|FG001|STARTED|Overall Study||172
10364841|NCT00522873|11504946|FG000|Received Treatment|Overall Study||489
10364842|NCT00522873|11504947|FG001|Received Treatment|Overall Study||172
10364843|NCT00522873|11504946|FG000|COMPLETED|Overall Study|394 women completed study medication. 398 women completed the study.|394
10535928|NCT01440049|11688376|FG000|NOT COMPLETED|Overall Study||5
10364844|NCT00522873|11504947|FG001|COMPLETED|Overall Study|128 women completed study medication. 129 women completed the study.|128
10364845|NCT00522873|11504946|FG000|NOT COMPLETED|Overall Study||96
10364846|NCT00522873|11504947|FG001|NOT COMPLETED|Overall Study||44
10364847|NCT00522925|11504956|FG000|STARTED|Overall Study||36
10535854|NCT01439854|11688300|FG000|COMPLETED|Overall Study||8
10535855|NCT01439854|11688301|FG001|COMPLETED|Overall Study||10
10535856|NCT01439854|11688300|FG000|NOT COMPLETED|Overall Study||0
10535857|NCT01439854|11688301|FG001|NOT COMPLETED|Overall Study||0
10535858|NCT01439867|11688309|FG000|STARTED|Overall Study||8
10535859|NCT01439867|11688310|FG001|STARTED|Overall Study||10
10535860|NCT01439867|11688309|FG000|Received Treatment|Overall Study||7
10535861|NCT01439867|11688310|FG001|Received Treatment|Overall Study||10
10535862|NCT01439867|11688309|FG000|COMPLETED|Overall Study||2
10535863|NCT01439867|11688310|FG001|COMPLETED|Overall Study||2
10535864|NCT01439867|11688309|FG000|NOT COMPLETED|Overall Study||6
10535865|NCT01439867|11688310|FG001|NOT COMPLETED|Overall Study||8
10535882|NCT01439945|11688341|FG000|STARTED|Double-Blind Treatment Phase||97
10535883|NCT01439945|11688342|FG001|STARTED|Double-Blind Treatment Phase||96
10535884|NCT01439945|11688343|FG002|STARTED|Double-Blind Treatment Phase||48
10535885|NCT01439945|11688344|FG003|STARTED|Double-Blind Treatment Phase||48
10535886|NCT01439945|11688341|FG000|COMPLETED|Double-Blind Treatment Phase||93
10535887|NCT01439945|11688342|FG001|COMPLETED|Double-Blind Treatment Phase||91
10535888|NCT01439945|11688343|FG002|COMPLETED|Double-Blind Treatment Phase||45
10535889|NCT01439945|11688344|FG003|COMPLETED|Double-Blind Treatment Phase||46
10535890|NCT01439945|11688341|FG000|NOT COMPLETED|Double-Blind Treatment Phase||4
10535891|NCT01439945|11688342|FG001|NOT COMPLETED|Double-Blind Treatment Phase||5
10535892|NCT01439945|11688343|FG002|NOT COMPLETED|Double-Blind Treatment Phase||3
10535893|NCT01439945|11688344|FG003|NOT COMPLETED|Double-Blind Treatment Phase||2
10535894|NCT01439945|11688341|FG000|STARTED|Optional Continuation Phase||72
10535895|NCT01439945|11688342|FG001|STARTED|Optional Continuation Phase||44
10364848|NCT00522925|11504957|FG001|STARTED|Overall Study||39
10364849|NCT00522925|11504958|FG002|STARTED|Overall Study||38
10535896|NCT01439945|11688343|FG002|STARTED|Optional Continuation Phase||0
10535897|NCT01439945|11688344|FG003|STARTED|Optional Continuation Phase||0
10535898|NCT01439945|11688341|FG000|COMPLETED|Optional Continuation Phase||72
10535899|NCT01439945|11688342|FG001|COMPLETED|Optional Continuation Phase||44
10535900|NCT01439945|11688343|FG002|COMPLETED|Optional Continuation Phase||0
10535901|NCT01439945|11688344|FG003|COMPLETED|Optional Continuation Phase||0
10535902|NCT01439945|11688341|FG000|NOT COMPLETED|Optional Continuation Phase||0
10535903|NCT01439945|11688342|FG001|NOT COMPLETED|Optional Continuation Phase||0
10535904|NCT01439945|11688343|FG002|NOT COMPLETED|Optional Continuation Phase||0
10535905|NCT01439945|11688344|FG003|NOT COMPLETED|Optional Continuation Phase||0
10535906|NCT01439971|11688360|FG000|STARTED|Overall Study||1
10535907|NCT01439971|11688361|FG001|STARTED|Overall Study||7
10535908|NCT01439971|11688362|FG002|STARTED|Overall Study||8
10535909|NCT01439971|11688363|FG003|STARTED|Overall Study||6
10535910|NCT01439971|11688364|FG004|STARTED|Overall Study||7
10535911|NCT01439971|11688360|FG000|Received Treatment|Overall Study||1
10535912|NCT01439971|11688361|FG001|Received Treatment|Overall Study||6
10656816|NCT02221349|11817913|FG001|STARTED|Overall Study||15
10535913|NCT01439971|11688362|FG002|Received Treatment|Overall Study||6
10535914|NCT01439971|11688363|FG003|Received Treatment|Overall Study||6
10656817|NCT02221349|11817912|FG000|COMPLETED|Overall Study||14
10656818|NCT02221349|11817913|FG001|COMPLETED|Overall Study||15
10656819|NCT02221349|11817912|FG000|NOT COMPLETED|Overall Study||1
10656820|NCT02221349|11817913|FG001|NOT COMPLETED|Overall Study||0
10535915|NCT01439971|11688364|FG004|Received Treatment|Overall Study||6
10535916|NCT01439971|11688360|FG000|COMPLETED|Overall Study||1
10535917|NCT01439971|11688361|FG001|COMPLETED|Overall Study||6
10535918|NCT01439971|11688362|FG002|COMPLETED|Overall Study||6
10535919|NCT01439971|11688363|FG003|COMPLETED|Overall Study||6
10535920|NCT01439971|11688364|FG004|COMPLETED|Overall Study||6
10535921|NCT01439971|11688360|FG000|NOT COMPLETED|Overall Study||0
10535922|NCT01439971|11688361|FG001|NOT COMPLETED|Overall Study||1
10535923|NCT01439971|11688362|FG002|NOT COMPLETED|Overall Study||2
10535924|NCT01439971|11688363|FG003|NOT COMPLETED|Overall Study||0
10535925|NCT01439971|11688364|FG004|NOT COMPLETED|Overall Study||1
10535926|NCT01440049|11688376|FG000|STARTED|Overall Study||160
10535927|NCT01440049|11688376|FG000|COMPLETED|Overall Study||155
10535929|NCT01440101|11688383|FG000|STARTED|Overall Study||12
10535930|NCT01440101|11688384|FG001|STARTED|Overall Study||47
10535931|NCT01440101|11688385|FG002|STARTED|Overall Study||47
10535932|NCT01440101|11688383|FG000|COMPLETED|Overall Study||10
10656821|NCT02221557|11817919|FG000|STARTED|Overall Study||8
10656822|NCT02221557|11817919|FG000|COMPLETED|Overall Study||5
10656823|NCT02221557|11817919|FG000|NOT COMPLETED|Overall Study||3
10656824|NCT02221648|11817925|FG000|STARTED|Overall Study||22
10656825|NCT02221648|11817926|FG001|STARTED|Overall Study||21
10656826|NCT02221648|11817925|FG000|COMPLETED|Overall Study||19
10656827|NCT02221648|11817926|FG001|COMPLETED|Overall Study||18
10656828|NCT02221648|11817925|FG000|NOT COMPLETED|Overall Study||3
10535933|NCT01440101|11688384|FG001|COMPLETED|Overall Study||43
10535934|NCT01440101|11688385|FG002|COMPLETED|Overall Study||46
10535935|NCT01440101|11688383|FG000|NOT COMPLETED|Overall Study||2
10656829|NCT02221648|11817926|FG001|NOT COMPLETED|Overall Study||3
10656830|NCT02221674|11817939|FG000|STARTED|Overall Study||8
10364850|NCT00522925|11504956|FG000|COMPLETED|Overall Study||28
10364851|NCT00522925|11504957|FG001|COMPLETED|Overall Study||38
10364852|NCT00522925|11504958|FG002|COMPLETED|Overall Study||36
10364853|NCT00522925|11504956|FG000|NOT COMPLETED|Overall Study||8
10364854|NCT00522925|11504957|FG001|NOT COMPLETED|Overall Study||1
10364855|NCT00522925|11504958|FG002|NOT COMPLETED|Overall Study||2
10364856|NCT00522951|11504966|FG000|STARTED|Period 1||86
10364857|NCT00522951|11504967|FG001|STARTED|Period 1||79
10364858|NCT00522951|11504966|FG000|Received Treatment|Period 1||86
10364859|NCT00522951|11504967|FG001|Received Treatment|Period 1||78
10364860|NCT00522951|11504966|FG000|COMPLETED|Period 1||86
10364861|NCT00522951|11504967|FG001|COMPLETED|Period 1||78
10364862|NCT00522951|11504966|FG000|NOT COMPLETED|Period 1||0
10364863|NCT00522951|11504967|FG001|NOT COMPLETED|Period 1||1
10364864|NCT00522951|11504966|FG000|STARTED|Washout Period||86
10364865|NCT00522951|11504967|FG001|STARTED|Washout Period||78
10364866|NCT00522951|11504966|FG000|COMPLETED|Washout Period||86
10364867|NCT00522951|11504967|FG001|COMPLETED|Washout Period||76
10364868|NCT00522951|11504966|FG000|NOT COMPLETED|Washout Period||0
10364869|NCT00522951|11504967|FG001|NOT COMPLETED|Washout Period||2
10364870|NCT00522951|11504966|FG000|STARTED|Period 2||86
10364871|NCT00522951|11504967|FG001|STARTED|Period 2||76
10364872|NCT00522951|11504966|FG000|Subjects Received Treatment|Period 2||84
10364873|NCT00522951|11504967|FG001|Subjects Received Treatment|Period 2||75
10364874|NCT00522951|11504966|FG000|COMPLETED|Period 2||84
10364875|NCT00522951|11504967|FG001|COMPLETED|Period 2||75
10364876|NCT00522951|11504966|FG000|NOT COMPLETED|Period 2||2
10364877|NCT00522951|11504967|FG001|NOT COMPLETED|Period 2||1
10427298|NCT00852644|11573093|FG002|COMPLETED|Overall Study||0
10427299|NCT00852644|11573094|FG003|COMPLETED|Overall Study||3
10427300|NCT00852644|11573095|FG004|COMPLETED|Overall Study||0
10427301|NCT00852644|11573096|FG005|COMPLETED|Overall Study||0
10427302|NCT00852644|11573091|FG000|NOT COMPLETED|Overall Study||0
10427303|NCT00852644|11573092|FG001|NOT COMPLETED|Overall Study||0
10427304|NCT00852644|11573093|FG002|NOT COMPLETED|Overall Study||0
10427305|NCT00852644|11573094|FG003|NOT COMPLETED|Overall Study||0
10427306|NCT00852644|11573095|FG004|NOT COMPLETED|Overall Study||0
10427307|NCT00852644|11573096|FG005|NOT COMPLETED|Overall Study||0
10427308|NCT00852761|11573113|FG000|STARTED|Overall Study||17
10427309|NCT00852761|11573114|FG001|STARTED|Overall Study||17
10427310|NCT00852761|11573113|FG000|COMPLETED|Overall Study||17
10427311|NCT00852761|11573114|FG001|COMPLETED|Overall Study||17
10427312|NCT00852761|11573113|FG000|NOT COMPLETED|Overall Study||0
10427313|NCT00852761|11573114|FG001|NOT COMPLETED|Overall Study||0
10427314|NCT00852917|11573124|FG000|STARTED|Overall Study||106
10427315|NCT00852917|11573125|FG001|STARTED|Overall Study||111
10427316|NCT00852917|11573126|FG002|STARTED|Overall Study||108
10427317|NCT00852917|11573127|FG003|STARTED|Overall Study||227
10427318|NCT00852917|11573124|FG000|COMPLETED|Overall Study||62
10427319|NCT00852917|11573125|FG001|COMPLETED|Overall Study||65
10427320|NCT00852917|11573126|FG002|COMPLETED|Overall Study||50
10427321|NCT00852917|11573127|FG003|COMPLETED|Overall Study||134
10427322|NCT00852917|11573124|FG000|NOT COMPLETED|Overall Study||44
10427323|NCT00852917|11573125|FG001|NOT COMPLETED|Overall Study||46
10427324|NCT00852917|11573126|FG002|NOT COMPLETED|Overall Study||58
10427325|NCT00852917|11573127|FG003|NOT COMPLETED|Overall Study||93
10427326|NCT00852930|11573140|FG000|STARTED|Overall Study||16
10427327|NCT00852930|11573141|FG001|STARTED|Overall Study||17
10427328|NCT00852930|11573142|FG002|STARTED|Overall Study||17
10427329|NCT00852930|11573140|FG000|COMPLETED|Overall Study||15
10427330|NCT00852930|11573141|FG001|COMPLETED|Overall Study||16
10427331|NCT00852930|11573142|FG002|COMPLETED|Overall Study||15
10427332|NCT00852930|11573140|FG000|NOT COMPLETED|Overall Study||1
10427333|NCT00852930|11573141|FG001|NOT COMPLETED|Overall Study||1
10427334|NCT00852930|11573142|FG002|NOT COMPLETED|Overall Study||2
10427335|NCT00852969|11573153|FG000|STARTED|Overall Study||15
10427336|NCT00852969|11573154|FG001|STARTED|Overall Study||15
10427337|NCT00852969|11573153|FG000|COMPLETED|Overall Study||15
10427338|NCT00852969|11573154|FG001|COMPLETED|Overall Study||13
10427339|NCT00852969|11573153|FG000|NOT COMPLETED|Overall Study||0
10427340|NCT00852969|11573154|FG001|NOT COMPLETED|Overall Study||2
10427341|NCT00852995|11573165|FG000|STARTED|Overall Study||46
10427342|NCT00852995|11573166|FG001|STARTED|Overall Study||43
10427343|NCT00852995|11573167|FG002|STARTED|Overall Study||44
10427344|NCT00852995|11573168|FG003|STARTED|Overall Study||45
10427345|NCT00852995|11573169|FG004|STARTED|Overall Study||50
10427346|NCT00852995|11573165|FG000|COMPLETED|Overall Study||38
10427347|NCT00852995|11573166|FG001|COMPLETED|Overall Study||42
10427348|NCT00852995|11573167|FG002|COMPLETED|Overall Study||39
10427349|NCT00852995|11573168|FG003|COMPLETED|Overall Study||40
10427350|NCT00852995|11573169|FG004|COMPLETED|Overall Study||46
10535936|NCT01440101|11688384|FG001|NOT COMPLETED|Overall Study||4
10535937|NCT01440101|11688385|FG002|NOT COMPLETED|Overall Study||1
10427351|NCT00852995|11573165|FG000|NOT COMPLETED|Overall Study||8
10427352|NCT00852995|11573166|FG001|NOT COMPLETED|Overall Study||1
10427353|NCT00852995|11573167|FG002|NOT COMPLETED|Overall Study||5
10427354|NCT00852995|11573168|FG003|NOT COMPLETED|Overall Study||5
10427355|NCT00852995|11573169|FG004|NOT COMPLETED|Overall Study||4
10427356|NCT00853021|11573186|FG000|STARTED|Overall Study||26
10427357|NCT00853021|11573186|FG000|COMPLETED|Overall Study||21
10427358|NCT00853021|11573186|FG000|NOT COMPLETED|Overall Study||5
10427359|NCT00853047|11573195|FG000|STARTED|Core Phase||5
10427360|NCT00853047|11573196|FG001|STARTED|Core Phase||3
10427361|NCT00853047|11573197|FG002|STARTED|Core Phase||3
10364878|NCT00523237|11504977|FG000|STARTED|Overall Study||14
10364879|NCT00523237|11504977|FG000|COMPLETED|Overall Study||14
10364880|NCT00523237|11504977|FG000|NOT COMPLETED|Overall Study||0
10364881|NCT00523302|11504983|FG000|STARTED|Overall Study||10
10364882|NCT00523302|11504984|FG001|STARTED|Overall Study||10
10364883|NCT00523302|11504983|FG000|COMPLETED|Overall Study||10
10364884|NCT00523302|11504984|FG001|COMPLETED|Overall Study||10
10364885|NCT00523302|11504983|FG000|NOT COMPLETED|Overall Study||0
10364886|NCT00523302|11504984|FG001|NOT COMPLETED|Overall Study||0
10364895|NCT00523367|11504999|FG000|STARTED|Overall Study||25
10364896|NCT00523367|11504999|FG000|COMPLETED|Overall Study||2
10364897|NCT00523367|11504999|FG000|NOT COMPLETED|Overall Study||23
10364898|NCT00523419|11505003|FG000|STARTED|Overall Study||32
10364899|NCT00523419|11505003|FG000|COMPLETED|Overall Study||0
10364900|NCT00523419|11505003|FG000|NOT COMPLETED|Overall Study||32
10364901|NCT00523549|11505009|FG000|STARTED|Overall Study||114
10364902|NCT00523549|11505010|FG001|STARTED|Overall Study||115
10364903|NCT00523549|11505009|FG000|COMPLETED|Overall Study||95
10364904|NCT00523549|11505010|FG001|COMPLETED|Overall Study||99
10364905|NCT00523549|11505009|FG000|NOT COMPLETED|Overall Study||19
10364906|NCT00523549|11505010|FG001|NOT COMPLETED|Overall Study||16
10364907|NCT00523614|11505018|FG000|STARTED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|680
10364908|NCT00523614|11505019|FG001|STARTED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|2720
10364909|NCT00523614|11505018|FG000|COMPLETED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|680
10364910|NCT00523614|11505019|FG001|COMPLETED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|2720
10364911|NCT00523614|11505018|FG000|NOT COMPLETED|Overall Study||0
10364912|NCT00523614|11505019|FG001|NOT COMPLETED|Overall Study||0
10364913|NCT00523640|11505025|FG000|STARTED|Overall Study||30
10364914|NCT00523640|11505025|FG000|COMPLETED|Overall Study|1 patient died before starting treatment|29
10364915|NCT00523640|11505025|FG000|NOT COMPLETED|Overall Study||1
10364916|NCT00523705|11505031|FG000|STARTED|Overall Study||7
10364917|NCT00523705|11505032|FG001|STARTED|Overall Study||4
10364918|NCT00523705|11505031|FG000|COMPLETED|Overall Study||7
10364919|NCT00523705|11505032|FG001|COMPLETED|Overall Study|1 withdrew due to no time|3
10364920|NCT00523705|11505031|FG000|NOT COMPLETED|Overall Study||0
10364921|NCT00523705|11505032|FG001|NOT COMPLETED|Overall Study||1
10364922|NCT00523718|11505040|FG000|STARTED|Overall Study||20
10364923|NCT00523718|11505041|FG001|STARTED|Overall Study||18
10364924|NCT00523718|11505040|FG000|COMPLETED|Overall Study||17
10364925|NCT00523718|11505041|FG001|COMPLETED|Overall Study||18
10364926|NCT00523718|11505040|FG000|NOT COMPLETED|Overall Study||3
10364927|NCT00523718|11505041|FG001|NOT COMPLETED|Overall Study||0
10364928|NCT00523744|11505047|FG000|STARTED|Phase 1 - Amlodipine+Olmesartan||257
10364929|NCT00523744|11505047|FG000|COMPLETED|Phase 1 - Amlodipine+Olmesartan||251
10364930|NCT00523744|11505047|FG000|NOT COMPLETED|Phase 1 - Amlodipine+Olmesartan||6
10364931|NCT00523744|11505047|FG000|STARTED|Phase 2 - Amlodipine+Valsartan|Only patients with mean sitting diastolic BP ≥ 90 mmHg at the end of Phase 1 entered this phase.|176
10364932|NCT00523744|11505047|FG000|COMPLETED|Phase 2 - Amlodipine+Valsartan||173
10364933|NCT00523744|11505047|FG000|NOT COMPLETED|Phase 2 - Amlodipine+Valsartan||3
10364934|NCT00523744|11505047|FG000|STARTED|Phase 3 - Amlodipine+Valsartan+HCTZ|Only patients with systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg at the end of Phase 2.|91
10364935|NCT00523744|11505047|FG000|COMPLETED|Phase 3 - Amlodipine+Valsartan+HCTZ||91
10716518|NCT02689973|11880247|FG001|STARTED|Overall Study||270
10716519|NCT02689973|11880248|FG002|STARTED|Overall Study||351
10716520|NCT02689973|11880249|FG003|STARTED|Overall Study||285
10716521|NCT02689973|11880246|FG000|COMPLETED|Overall Study||257
10716522|NCT02689973|11880247|FG001|COMPLETED|Overall Study||221
10716523|NCT02689973|11880248|FG002|COMPLETED|Overall Study||279
10364936|NCT00523744|11505047|FG000|NOT COMPLETED|Phase 3 - Amlodipine+Valsartan+HCTZ||0
10364937|NCT00523848|11505054|FG000|STARTED|Overall Study||46
10364938|NCT00523848|11505054|FG000|Treated With Study Therapy|Overall Study||44
10364939|NCT00523848|11505054|FG000|COMPLETED|Overall Study||22
10364940|NCT00523848|11505054|FG000|NOT COMPLETED|Overall Study||24
10364941|NCT00523978|11505060|FG000|STARTED|Overall Study||171
10364942|NCT00523978|11505061|FG001|STARTED|Overall Study||87
10364943|NCT00523978|11505060|FG000|COMPLETED|Overall Study||162
10364944|NCT00523978|11505061|FG001|COMPLETED|Overall Study||79
10364945|NCT00523978|11505060|FG000|NOT COMPLETED|Overall Study||9
10364946|NCT00523978|11505061|FG001|NOT COMPLETED|Overall Study||8
10364947|NCT00523991|11505070|FG000|STARTED|Overall Study||219
10364948|NCT00523991|11505071|FG001|STARTED|Overall Study||238
10364949|NCT00523991|11505070|FG000|COMPLETED|Overall Study||198
10364950|NCT00523991|11505071|FG001|COMPLETED|Overall Study||211
10364951|NCT00523991|11505070|FG000|NOT COMPLETED|Overall Study||21
10364952|NCT00523991|11505071|FG001|NOT COMPLETED|Overall Study||27
10364953|NCT00524017|11505079|FG000|STARTED|Overall Study||13
10716524|NCT02689973|11880249|FG003|COMPLETED|Overall Study||232
10716525|NCT02689973|11880246|FG000|NOT COMPLETED|Overall Study||54
10364954|NCT00524017|11505080|FG001|STARTED|Overall Study||6
10364955|NCT00524017|11505079|FG000|COMPLETED|Overall Study||13
10364956|NCT00524017|11505080|FG001|COMPLETED|Overall Study||5
10364957|NCT00524017|11505079|FG000|NOT COMPLETED|Overall Study||0
10364958|NCT00524017|11505080|FG001|NOT COMPLETED|Overall Study||1
10364959|NCT00524030|11505088|FG000|STARTED|Overall Study||32
10364960|NCT00524030|11505089|FG001|STARTED|Overall Study||129
10364961|NCT00524030|11505088|FG000|Completed Double-Blind Treatment Phase|Overall Study||15
10364962|NCT00524030|11505089|FG001|Completed Double-Blind Treatment Phase|Overall Study||70
10364963|NCT00524030|11505088|FG000|Completed Taper/Titration Phase|Overall Study||15
10364964|NCT00524030|11505089|FG001|Completed Taper/Titration Phase|Overall Study||70
10364965|NCT00524030|11505088|FG000|COMPLETED|Overall Study||15
10364966|NCT00524030|11505089|FG001|COMPLETED|Overall Study||70
10364967|NCT00524030|11505088|FG000|NOT COMPLETED|Overall Study||17
10364968|NCT00524030|11505089|FG001|NOT COMPLETED|Overall Study||59
10364969|NCT00524043|11505099|FG000|STARTED|Overall Study|One patient was randomly assigned to treatment but did not receive placebo.|64
10364970|NCT00524043|11505100|FG001|STARTED|Overall Study||70
10364971|NCT00524043|11505101|FG002|STARTED|Overall Study||66
10364972|NCT00524043|11505099|FG000|COMPLETED|Overall Study||34
10364973|NCT00524043|11505100|FG001|COMPLETED|Overall Study||42
10364974|NCT00524043|11505101|FG002|COMPLETED|Overall Study||35
10364975|NCT00524043|11505099|FG000|NOT COMPLETED|Overall Study||30
10364976|NCT00524043|11505100|FG001|NOT COMPLETED|Overall Study||28
10364977|NCT00524043|11505101|FG002|NOT COMPLETED|Overall Study||31
10364978|NCT00524121|11505109|FG000|STARTED|Overall Study||22
10364979|NCT00524121|11505109|FG000|COMPLETED|Overall Study||3
10364980|NCT00524121|11505109|FG000|NOT COMPLETED|Overall Study||19
10364981|NCT00524173|11505126|FG000|STARTED|Overall Study||17
10364982|NCT00524173|11505127|FG001|STARTED|Overall Study||15
10364983|NCT00524173|11505126|FG000|COMPLETED|Overall Study||12
10364984|NCT00524173|11505127|FG001|COMPLETED|Overall Study||13
10364985|NCT00524173|11505126|FG000|NOT COMPLETED|Overall Study||5
10364986|NCT00524173|11505127|FG001|NOT COMPLETED|Overall Study||2
10364987|NCT00524225|11505133|FG000|STARTED|Overall Study||3
10364988|NCT00524225|11505133|FG000|COMPLETED|Overall Study||3
10364989|NCT00524225|11505133|FG000|NOT COMPLETED|Overall Study||0
10364990|NCT00524264|11505140|FG000|STARTED|Overall Study||164
10364991|NCT00524264|11505141|FG001|STARTED|Overall Study||84
10364992|NCT00524264|11505140|FG000|COMPLETED|Overall Study||144
10364993|NCT00524264|11505141|FG001|COMPLETED|Overall Study||57
10364994|NCT00524264|11505140|FG000|NOT COMPLETED|Overall Study||20
10364995|NCT00524264|11505141|FG001|NOT COMPLETED|Overall Study||27
10364996|NCT00524303|11505150|FG000|STARTED|Overall Study||33
10364997|NCT00524303|11505151|FG001|STARTED|Overall Study||34
10364998|NCT00524303|11505152|FG002|STARTED|Overall Study||33
10364999|NCT00524303|11505150|FG000|COMPLETED|Overall Study||21
10365000|NCT00524303|11505151|FG001|COMPLETED|Overall Study||24
10365001|NCT00524303|11505152|FG002|COMPLETED|Overall Study||15
10365002|NCT00524303|11505150|FG000|NOT COMPLETED|Overall Study||12
10365003|NCT00524303|11505151|FG001|NOT COMPLETED|Overall Study||10
10365004|NCT00524303|11505152|FG002|NOT COMPLETED|Overall Study||18
10365005|NCT00524316|11505163|FG000|STARTED|Overall Study||16
10365006|NCT00524316|11505163|FG000|COMPLETED|Overall Study||0
10365007|NCT00524316|11505163|FG000|NOT COMPLETED|Overall Study||16
10365008|NCT00524342|11505167|FG000|STARTED|Overall Study||7
10365009|NCT00524342|11505167|FG000|COMPLETED|Overall Study||7
10365010|NCT00524342|11505167|FG000|NOT COMPLETED|Overall Study||0
10365011|NCT00524368|11505173|FG000|STARTED|Overall Study||294
10365012|NCT00524368|11505174|FG001|STARTED|Overall Study||296
10365013|NCT00524368|11505173|FG000|COMPLETED|Overall Study||253
10365014|NCT00524368|11505174|FG001|COMPLETED|Overall Study||248
10365015|NCT00524368|11505173|FG000|NOT COMPLETED|Overall Study||41
10365016|NCT00524368|11505174|FG001|NOT COMPLETED|Overall Study||48
10365017|NCT00524420|11505182|FG000|STARTED|Overall Study|One was incorrectly randomized;she did not have a BIRS of >7. Was excluded from efficacy analysis.|8
10365018|NCT00524420|11505183|FG001|STARTED|Overall Study||11
10365019|NCT00524420|11505182|FG000|COMPLETED|Overall Study|1 dropped out after treatment 10 because of poor response and was included in the efficacy analyses.|7
10365020|NCT00524420|11505183|FG001|COMPLETED|Overall Study||11
10365021|NCT00524420|11505182|FG000|NOT COMPLETED|Overall Study||1
10365022|NCT00524420|11505183|FG001|NOT COMPLETED|Overall Study||0
10365023|NCT00524472|11505193|FG000|STARTED|Overall Study||709
10365024|NCT00524472|11505194|FG001|STARTED|Overall Study||730
10365025|NCT00524472|11505193|FG000|COMPLETED|Overall Study||709
10365026|NCT00524472|11505194|FG001|COMPLETED|Overall Study||730
10365027|NCT00524472|11505193|FG000|NOT COMPLETED|Overall Study||0
10365028|NCT00524472|11505194|FG001|NOT COMPLETED|Overall Study||0
10365029|NCT00524537|11505200|FG000|STARTED|Overall Study|All Treated Population: All participants who received at least 1 injection of Humira in the registry|5025
10365030|NCT00524537|11505200|FG000|Discontinued|Overall Study|Discontinued from study|2811
10365031|NCT00524537|11505200|FG000|Re-enrolled|Overall Study|Discontinued from study and later re-enrolled in study|339
10365032|NCT00524537|11505200|FG000|Discontinued After Re-enrollment|Overall Study|Discontinued from study after re-enrollment|102
10365033|NCT00524537|11505200|FG000|COMPLETED|Overall Study|Still enrolled in study at the end of study|2451
10365034|NCT00524537|11505200|FG000|NOT COMPLETED|Overall Study||2574
10365035|NCT00524576|11505206|FG000|STARTED|Overall Study||97
10365036|NCT00524576|11505207|FG001|STARTED|Overall Study||47
10365037|NCT00524576|11505206|FG000|COMPLETED|Overall Study||97
10365038|NCT00524576|11505207|FG001|COMPLETED|Overall Study||47
10365039|NCT00524576|11505206|FG000|NOT COMPLETED|Overall Study||0
10365040|NCT00524576|11505207|FG001|NOT COMPLETED|Overall Study||0
10365041|NCT00524589|11505213|FG000|STARTED|Overall Study||18
10365042|NCT00524589|11505213|FG000|COMPLETED|Overall Study||0
10365043|NCT00524589|11505213|FG000|NOT COMPLETED|Overall Study||18
10365044|NCT00524680|11505221|FG000|STARTED|Overall Study||37
10365045|NCT00524680|11505222|FG001|STARTED|Overall Study||35
10365046|NCT00524680|11505223|FG002|STARTED|Overall Study||36
10365047|NCT00524680|11505224|FG003|STARTED|Overall Study||40
10365048|NCT00524680|11505221|FG000|COMPLETED|Overall Study||34
10365049|NCT00524680|11505222|FG001|COMPLETED|Overall Study||34
10365050|NCT00524680|11505223|FG002|COMPLETED|Overall Study||33
10365051|NCT00524680|11505224|FG003|COMPLETED|Overall Study||34
10365052|NCT00524680|11505221|FG000|NOT COMPLETED|Overall Study||3
10365053|NCT00524680|11505222|FG001|NOT COMPLETED|Overall Study||1
10365054|NCT00524680|11505223|FG002|NOT COMPLETED|Overall Study||3
10365055|NCT00524680|11505224|FG003|NOT COMPLETED|Overall Study||6
10365056|NCT00524745|11505238|FG000|STARTED|Overall Study||229
10365057|NCT00524745|11505239|FG001|STARTED|Overall Study||206
10365058|NCT00524745|11505240|FG002|STARTED|Overall Study||241
10365059|NCT00524745|11505241|FG003|STARTED|Overall Study||227
10365060|NCT00524745|11505238|FG000|COMPLETED|Overall Study||195
10365061|NCT00524745|11505239|FG001|COMPLETED|Overall Study||193
10365062|NCT00524745|11505240|FG002|COMPLETED|Overall Study||212
10365063|NCT00524745|11505241|FG003|COMPLETED|Overall Study||205
10365064|NCT00524745|11505238|FG000|NOT COMPLETED|Overall Study||34
10365065|NCT00524745|11505239|FG001|NOT COMPLETED|Overall Study||13
10365066|NCT00524745|11505240|FG002|NOT COMPLETED|Overall Study||29
10365067|NCT00524745|11505241|FG003|NOT COMPLETED|Overall Study||22
10365068|NCT00524771|11505253|FG000|STARTED|Overall Study||17084
10365069|NCT00524771|11505254|FG001|STARTED|Overall Study||17016
10365070|NCT00524771|11505253|FG000|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 4.0 years.|16864
10365071|NCT00524771|11505254|FG001|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 4.0 years.|16431
10365072|NCT00524771|11505253|FG000|NOT COMPLETED|Overall Study||220
10365073|NCT00524771|11505254|FG001|NOT COMPLETED|Overall Study||585
10535938|NCT01440283|11688394|FG000|STARTED|Overall Study||14
10535939|NCT01440283|11688394|FG000|COMPLETED|Overall Study||4
10535940|NCT01440283|11688394|FG000|NOT COMPLETED|Overall Study||10
10535941|NCT01440322|11688406|FG000|STARTED|Overall Study||97
10535942|NCT01440322|11688407|FG001|STARTED|Overall Study||50
10535943|NCT01440322|11688406|FG000|COMPLETED|Overall Study||90
10535944|NCT01440322|11688407|FG001|COMPLETED|Overall Study||49
10535945|NCT01440322|11688406|FG000|NOT COMPLETED|Overall Study||7
10535946|NCT01440322|11688407|FG001|NOT COMPLETED|Overall Study||1
10535947|NCT01440374|11688416|FG000|STARTED|Part 1: Open-label Phase||17
10535948|NCT01440374|11688417|FG001|STARTED|Part 1: Open-label Phase||0
10535949|NCT01440374|11688418|FG002|STARTED|Part 1: Open-label Phase||0
10535950|NCT01440374|11688419|FG003|STARTED|Part 1: Open-label Phase||0
10535951|NCT01440374|11688416|FG000|COMPLETED|Part 1: Open-label Phase||11
10535952|NCT01440374|11688417|FG001|COMPLETED|Part 1: Open-label Phase||0
10535953|NCT01440374|11688418|FG002|COMPLETED|Part 1: Open-label Phase||0
10535954|NCT01440374|11688419|FG003|COMPLETED|Part 1: Open-label Phase||0
10535955|NCT01440374|11688416|FG000|NOT COMPLETED|Part 1: Open-label Phase||6
10535956|NCT01440374|11688417|FG001|NOT COMPLETED|Part 1: Open-label Phase||0
10535957|NCT01440374|11688418|FG002|NOT COMPLETED|Part 1: Open-label Phase||0
10535958|NCT01440374|11688419|FG003|NOT COMPLETED|Part 1: Open-label Phase||0
10535959|NCT01440374|11688416|FG000|STARTED|Part 2; Double-blind Phase||0
10535960|NCT01440374|11688417|FG001|STARTED|Part 2; Double-blind Phase||47
10535961|NCT01440374|11688418|FG002|STARTED|Part 2; Double-blind Phase||98
10535962|NCT01440374|11688419|FG003|STARTED|Part 2; Double-blind Phase||0
10535963|NCT01440374|11688416|FG000|COMPLETED|Part 2; Double-blind Phase||0
10535964|NCT01440374|11688417|FG001|COMPLETED|Part 2; Double-blind Phase||27
10535965|NCT01440374|11688418|FG002|COMPLETED|Part 2; Double-blind Phase||43
10656831|NCT02221674|11817940|FG001|STARTED|Overall Study||6
10656832|NCT02221674|11817941|FG002|STARTED|Overall Study||5
10656833|NCT02221674|11817939|FG000|COMPLETED|Overall Study||7
10656834|NCT02221674|11817940|FG001|COMPLETED|Overall Study||6
10656835|NCT02221674|11817941|FG002|COMPLETED|Overall Study||5
10656836|NCT02221674|11817939|FG000|NOT COMPLETED|Overall Study||1
10656837|NCT02221674|11817940|FG001|NOT COMPLETED|Overall Study||0
10656838|NCT02221674|11817941|FG002|NOT COMPLETED|Overall Study||0
10656839|NCT02221739|11817952|FG000|STARTED|Overall Study||39
10656840|NCT02221739|11817952|FG000|COMPLETED|Overall Study||21
10656841|NCT02221739|11817952|FG000|NOT COMPLETED|Overall Study||18
10656842|NCT02221869|11817959|FG000|STARTED|Overall Study||31
10656843|NCT02221869|11817960|FG001|STARTED|Overall Study||32
10656844|NCT02221869|11817961|FG002|STARTED|Overall Study||43
10656845|NCT02221869|11817959|FG000|COMPLETED|Overall Study||30
10656846|NCT02221869|11817960|FG001|COMPLETED|Overall Study||32
10656847|NCT02221869|11817961|FG002|COMPLETED|Overall Study||33
10656848|NCT02221869|11817959|FG000|NOT COMPLETED|Overall Study||1
10656849|NCT02221869|11817960|FG001|NOT COMPLETED|Overall Study||0
10656850|NCT02221869|11817961|FG002|NOT COMPLETED|Overall Study||10
10656851|NCT02221882|11817973|FG000|STARTED|Overall Study||3
10656852|NCT02221882|11817974|FG001|STARTED|Overall Study||3
10656853|NCT02221882|11817975|FG002|STARTED|Overall Study||11
10656854|NCT02221882|11817976|FG003|STARTED|Overall Study||3
10656855|NCT02221882|11817977|FG004|STARTED|Overall Study||5
10365074|NCT00524940|11505261|FG000|STARTED|Overall Study||124
10365075|NCT00524940|11505261|FG000|COMPLETED|Overall Study||124
10365076|NCT00524940|11505261|FG000|NOT COMPLETED|Overall Study||0
10365077|NCT00525031|11505267|FG000|STARTED|Overall Study||27
10365078|NCT00525031|11505268|FG001|STARTED|Overall Study||25
10365079|NCT00525031|11505267|FG000|COMPLETED|Overall Study||26
10365080|NCT00525031|11505268|FG001|COMPLETED|Overall Study||24
10365081|NCT00525031|11505267|FG000|NOT COMPLETED|Overall Study||1
10365082|NCT00525031|11505268|FG001|NOT COMPLETED|Overall Study||1
10365083|NCT00525044|11505277|FG000|STARTED|Overall Study||124
10365084|NCT00525044|11505278|FG001|STARTED|Overall Study||125
10365085|NCT00525044|11505277|FG000|COMPLETED|Overall Study||124
10365086|NCT00525044|11505278|FG001|COMPLETED|Overall Study||124
10365087|NCT00525044|11505277|FG000|NOT COMPLETED|Overall Study||0
10365088|NCT00525044|11505278|FG001|NOT COMPLETED|Overall Study||1
10365089|NCT00525057|11505286|FG000|STARTED|Overall Study||25
10365090|NCT00525057|11505287|FG001|STARTED|Overall Study||25
10365091|NCT00525057|11505286|FG000|COMPLETED|Overall Study||25
10365092|NCT00525057|11505287|FG001|COMPLETED|Overall Study||25
10365093|NCT00525057|11505286|FG000|NOT COMPLETED|Overall Study||0
10365094|NCT00525057|11505287|FG001|NOT COMPLETED|Overall Study||0
10365095|NCT00525135|11505293|FG000|STARTED|Overall Study||5
10365096|NCT00525135|11505293|FG000|COMPLETED|Overall Study||5
10365097|NCT00525135|11505293|FG000|NOT COMPLETED|Overall Study||0
10365098|NCT00525148|11505301|FG000|STARTED|Overall Study|entered and treated|23
10365099|NCT00525148|11505302|FG001|STARTED|Overall Study|entered and treated|38
10365100|NCT00525148|11505303|FG002|STARTED|Overall Study|entered and treated|7
10365101|NCT00525148|11505304|FG003|STARTED|Overall Study|entered and treated|61
10365102|NCT00525148|11505301|FG000|COMPLETED|Overall Study||0
10365103|NCT00525148|11505302|FG001|COMPLETED|Overall Study||0
10365104|NCT00525148|11505303|FG002|COMPLETED|Overall Study||0
10365105|NCT00525148|11505304|FG003|COMPLETED|Overall Study||0
10365106|NCT00525148|11505301|FG000|NOT COMPLETED|Overall Study||23
10365107|NCT00525148|11505302|FG001|NOT COMPLETED|Overall Study||38
10365108|NCT00525148|11505303|FG002|NOT COMPLETED|Overall Study||7
10365109|NCT00525148|11505304|FG003|NOT COMPLETED|Overall Study||61
10365110|NCT00525161|11505314|FG000|STARTED|Overall Study||11
10535966|NCT01440374|11688419|FG003|COMPLETED|Part 2; Double-blind Phase||0
10535967|NCT01440374|11688416|FG000|NOT COMPLETED|Part 2; Double-blind Phase||0
10535968|NCT01440374|11688417|FG001|NOT COMPLETED|Part 2; Double-blind Phase||20
10535969|NCT01440374|11688418|FG002|NOT COMPLETED|Part 2; Double-blind Phase||55
10535970|NCT01440374|11688419|FG003|NOT COMPLETED|Part 2; Double-blind Phase||0
10535971|NCT01440374|11688416|FG000|STARTED|Part 3: Extension||0
10535972|NCT01440374|11688417|FG001|STARTED|Part 3: Extension||0
10535973|NCT01440374|11688418|FG002|STARTED|Part 3: Extension||0
10535974|NCT01440374|11688419|FG003|STARTED|Part 3: Extension||59
10535975|NCT01440374|11688416|FG000|COMPLETED|Part 3: Extension||0
10535976|NCT01440374|11688417|FG001|COMPLETED|Part 3: Extension||0
10535977|NCT01440374|11688418|FG002|COMPLETED|Part 3: Extension||0
10535978|NCT01440374|11688419|FG003|COMPLETED|Part 3: Extension||27
10535979|NCT01440374|11688416|FG000|NOT COMPLETED|Part 3: Extension||0
10535980|NCT01440374|11688417|FG001|NOT COMPLETED|Part 3: Extension||0
10535981|NCT01440374|11688418|FG002|NOT COMPLETED|Part 3: Extension||0
10535982|NCT01440374|11688419|FG003|NOT COMPLETED|Part 3: Extension||32
10535983|NCT01440387|11688433|FG000|STARTED|Overall Study||56
10535984|NCT01440387|11688434|FG001|STARTED|Overall Study||56
10535985|NCT01440387|11688433|FG000|COMPLETED|Overall Study||56
10535986|NCT01440387|11688434|FG001|COMPLETED|Overall Study||56
10535987|NCT01440387|11688433|FG000|NOT COMPLETED|Overall Study||0
10535988|NCT01440387|11688434|FG001|NOT COMPLETED|Overall Study||0
10535989|NCT01440543|11688444|FG000|STARTED|Overall Study||106
10535990|NCT01440543|11688445|FG001|STARTED|Overall Study||105
10535991|NCT01440543|11688446|FG002|STARTED|Overall Study||102
10535992|NCT01440543|11688447|FG003|STARTED|Overall Study||107
10535993|NCT01440543|11688444|FG000|COMPLETED|Overall Study||102
10535994|NCT01440543|11688445|FG001|COMPLETED|Overall Study||101
10535995|NCT01440543|11688446|FG002|COMPLETED|Overall Study||100
10535996|NCT01440543|11688447|FG003|COMPLETED|Overall Study||101
10535997|NCT01440543|11688444|FG000|NOT COMPLETED|Overall Study||4
10535998|NCT01440543|11688445|FG001|NOT COMPLETED|Overall Study||4
10535999|NCT01440543|11688446|FG002|NOT COMPLETED|Overall Study||2
10536000|NCT01440543|11688447|FG003|NOT COMPLETED|Overall Study||6
10536001|NCT01440569|11688459|FG000|STARTED|Main Study||296
10536002|NCT01440569|11688460|FG001|STARTED|Main Study||18
10536003|NCT01440569|11688459|FG000|Enrolled and Treated|Main Study||295
10536004|NCT01440569|11688460|FG001|Enrolled and Treated|Main Study||18
10536005|NCT01440569|11688459|FG000|COMPLETED|Main Study||260
10536006|NCT01440569|11688460|FG001|COMPLETED|Main Study||14
10365111|NCT00525161|11505314|FG000|COMPLETED|Overall Study||10
10365112|NCT00525161|11505314|FG000|NOT COMPLETED|Overall Study||1
10365113|NCT00525174|11505320|FG000|STARTED|Overall Study||97
10365114|NCT00525174|11505321|FG001|STARTED|Overall Study||89
10365115|NCT00525174|11505320|FG000|COMPLETED|Overall Study||88
10536007|NCT01440569|11688459|FG000|NOT COMPLETED|Main Study||36
10536008|NCT01440569|11688460|FG001|NOT COMPLETED|Main Study||4
10536009|NCT01440569|11688459|FG000|STARTED|Open-Label Rollover Phase|9 participants who completed the Main Study did not enroll into the Rollover Phase.|251
10536010|NCT01440569|11688460|FG001|STARTED|Open-Label Rollover Phase|1 participant who completed the Main Study did not enroll into the Rollover Phase.|13
10536011|NCT01440569|11688459|FG000|COMPLETED|Open-Label Rollover Phase||204
10365116|NCT00525174|11505321|FG001|COMPLETED|Overall Study||81
10365117|NCT00525174|11505320|FG000|NOT COMPLETED|Overall Study||9
10365118|NCT00525174|11505321|FG001|NOT COMPLETED|Overall Study||8
10365119|NCT00525265|11505329|FG000|STARTED|Overall Study||10
10365120|NCT00525265|11505330|FG001|STARTED|Overall Study||10
10365121|NCT00525265|11505329|FG000|COMPLETED|Overall Study||9
10365122|NCT00525265|11505330|FG001|COMPLETED|Overall Study||10
10365123|NCT00525265|11505329|FG000|NOT COMPLETED|Overall Study||1
10365124|NCT00525265|11505330|FG001|NOT COMPLETED|Overall Study||0
10365125|NCT00525421|11505338|FG000|STARTED|Overall Study|Enrollment started october 2007|10
10365126|NCT00525421|11505339|FG001|STARTED|Overall Study||10
10365127|NCT00525421|11505338|FG000|COMPLETED|Overall Study||10
10365128|NCT00525421|11505339|FG001|COMPLETED|Overall Study||10
10365129|NCT00525421|11505338|FG000|NOT COMPLETED|Overall Study||0
10365130|NCT00525421|11505339|FG001|NOT COMPLETED|Overall Study||0
10365131|NCT00525499|11505349|FG000|STARTED|Overall Study||47
10365132|NCT00525499|11505350|FG001|STARTED|Overall Study||46
10365133|NCT00525499|11505351|FG002|STARTED|Overall Study||47
10365134|NCT00525499|11505352|FG003|STARTED|Overall Study||46
10365135|NCT00525499|11505349|FG000|COMPLETED|Overall Study||40
10365136|NCT00525499|11505350|FG001|COMPLETED|Overall Study||39
10365137|NCT00525499|11505351|FG002|COMPLETED|Overall Study||40
10365138|NCT00525499|11505352|FG003|COMPLETED|Overall Study||39
10365139|NCT00525499|11505349|FG000|NOT COMPLETED|Overall Study||7
10365140|NCT00525499|11505350|FG001|NOT COMPLETED|Overall Study||7
10365141|NCT00525499|11505351|FG002|NOT COMPLETED|Overall Study||7
10365142|NCT00525499|11505352|FG003|NOT COMPLETED|Overall Study||7
10365143|NCT00525512|11505364|FG000|STARTED|Double-Blind Phase||259
10365144|NCT00525512|11505365|FG001|STARTED|Double-Blind Phase||260
10365145|NCT00525512|11505366|FG002|STARTED|Double-Blind Phase||0
10365146|NCT00525512|11505367|FG003|STARTED|Double-Blind Phase||0
10365147|NCT00525512|11505364|FG000|COMPLETED|Double-Blind Phase||163
10365148|NCT00525512|11505365|FG001|COMPLETED|Double-Blind Phase||194
10365149|NCT00525512|11505366|FG002|COMPLETED|Double-Blind Phase||0
10365150|NCT00525512|11505367|FG003|COMPLETED|Double-Blind Phase||0
10365151|NCT00525512|11505364|FG000|NOT COMPLETED|Double-Blind Phase||96
10365152|NCT00525512|11505365|FG001|NOT COMPLETED|Double-Blind Phase||66
10365153|NCT00525512|11505366|FG002|NOT COMPLETED|Double-Blind Phase||0
10365154|NCT00525512|11505367|FG003|NOT COMPLETED|Double-Blind Phase||0
10365155|NCT00525512|11505364|FG000|STARTED|Open-Label Phase||0
10365156|NCT00525512|11505365|FG001|STARTED|Open-Label Phase||0
10365157|NCT00525512|11505366|FG002|STARTED|Open-Label Phase||164
10365158|NCT00525512|11505367|FG003|STARTED|Open-Label Phase||194
10365159|NCT00525512|11505364|FG000|COMPLETED|Open-Label Phase||0
10365160|NCT00525512|11505365|FG001|COMPLETED|Open-Label Phase||0
10365161|NCT00525512|11505366|FG002|COMPLETED|Open-Label Phase||158
10365162|NCT00525512|11505367|FG003|COMPLETED|Open-Label Phase||189
10365163|NCT00525512|11505364|FG000|NOT COMPLETED|Open-Label Phase||0
10536012|NCT01440569|11688460|FG001|COMPLETED|Open-Label Rollover Phase||7
10536013|NCT01440569|11688459|FG000|NOT COMPLETED|Open-Label Rollover Phase||47
10536014|NCT01440569|11688460|FG001|NOT COMPLETED|Open-Label Rollover Phase||6
10536015|NCT01440634|11688468|FG000|STARTED|Cross Sectional Phase||0
10536016|NCT01440634|11688469|FG001|STARTED|Cross Sectional Phase||347
10536017|NCT01440634|11688468|FG000|COMPLETED|Cross Sectional Phase||0
10536018|NCT01440634|11688469|FG001|COMPLETED|Cross Sectional Phase||347
10536019|NCT01440634|11688468|FG000|NOT COMPLETED|Cross Sectional Phase||0
10536020|NCT01440634|11688469|FG001|NOT COMPLETED|Cross Sectional Phase||0
10536021|NCT01440634|11688468|FG000|STARTED|Randomization Phase||30
10536022|NCT01440634|11688469|FG001|STARTED|Randomization Phase||24
10536023|NCT01440634|11688468|FG000|COMPLETED|Randomization Phase||24
10536024|NCT01440634|11688469|FG001|COMPLETED|Randomization Phase||14
10536025|NCT01440634|11688468|FG000|NOT COMPLETED|Randomization Phase||6
10536026|NCT01440634|11688469|FG001|NOT COMPLETED|Randomization Phase||10
10536027|NCT01440647|11688477|FG000|STARTED|Overall Study||16
10716526|NCT02689973|11880247|FG001|NOT COMPLETED|Overall Study||49
10716527|NCT02689973|11880248|FG002|NOT COMPLETED|Overall Study||72
10716528|NCT02689973|11880249|FG003|NOT COMPLETED|Overall Study||53
10365164|NCT00525512|11505365|FG001|NOT COMPLETED|Open-Label Phase||0
10365165|NCT00525512|11505366|FG002|NOT COMPLETED|Open-Label Phase||6
10365166|NCT00525512|11505367|FG003|NOT COMPLETED|Open-Label Phase||5
10365167|NCT00525525|11505381|FG000|STARTED|Overall Study||59
10365168|NCT00525525|11505382|FG001|STARTED|Overall Study||15
10536028|NCT01440647|11688478|FG001|STARTED|Overall Study||18
10536029|NCT01440647|11688477|FG000|COMPLETED|Overall Study||14
10536030|NCT01440647|11688478|FG001|COMPLETED|Overall Study||15
10536031|NCT01440647|11688477|FG000|NOT COMPLETED|Overall Study||2
10536032|NCT01440647|11688478|FG001|NOT COMPLETED|Overall Study||3
10536033|NCT01440764|11688486|FG000|STARTED|Test Day 1||4
10716529|NCT02690168|11880260|FG000|STARTED|Overall Study||6
10365169|NCT00525525|11505381|FG000|COMPLETED|Overall Study||59
10365170|NCT00525525|11505382|FG001|COMPLETED|Overall Study||15
10365171|NCT00525525|11505381|FG000|NOT COMPLETED|Overall Study||0
10365172|NCT00525525|11505382|FG001|NOT COMPLETED|Overall Study||0
10365173|NCT00525590|11505388|FG000|STARTED|Overall Study||59
10365174|NCT00525590|11505388|FG000|COMPLETED|Overall Study||14
10365175|NCT00525590|11505388|FG000|NOT COMPLETED|Overall Study||45
10365176|NCT00525603|11505392|FG000|STARTED|Overall Study||60
10365177|NCT00525603|11505392|FG000|COMPLETED|Overall Study||60
10365178|NCT00525603|11505392|FG000|NOT COMPLETED|Overall Study||0
10365179|NCT00525629|11505396|FG000|STARTED|First Intervention||20
10365180|NCT00525629|11505397|FG001|STARTED|First Intervention||20
10365181|NCT00525629|11505396|FG000|COMPLETED|First Intervention||15
10365182|NCT00525629|11505397|FG001|COMPLETED|First Intervention||15
10365183|NCT00525629|11505396|FG000|NOT COMPLETED|First Intervention||5
10365184|NCT00525629|11505397|FG001|NOT COMPLETED|First Intervention||5
10365185|NCT00525629|11505396|FG000|STARTED|Washout||15
10365186|NCT00525629|11505397|FG001|STARTED|Washout||15
10365187|NCT00525629|11505396|FG000|COMPLETED|Washout||15
10365188|NCT00525629|11505397|FG001|COMPLETED|Washout||15
10365189|NCT00525629|11505396|FG000|NOT COMPLETED|Washout||0
10365190|NCT00525629|11505397|FG001|NOT COMPLETED|Washout||0
10365191|NCT00525629|11505396|FG000|STARTED|Second Intervention||15
10365192|NCT00525629|11505397|FG001|STARTED|Second Intervention||15
10365193|NCT00525629|11505396|FG000|COMPLETED|Second Intervention||0
10365194|NCT00525629|11505397|FG001|COMPLETED|Second Intervention||0
10365195|NCT00525629|11505396|FG000|NOT COMPLETED|Second Intervention||15
10365196|NCT00525629|11505397|FG001|NOT COMPLETED|Second Intervention||15
10365197|NCT00525733|11505405|FG000|STARTED|Overall Study||14
10365198|NCT00525733|11505406|FG001|STARTED|Overall Study||26
10365199|NCT00525733|11505405|FG000|COMPLETED|Overall Study||11
10365200|NCT00525733|11505406|FG001|COMPLETED|Overall Study||23
10365201|NCT00525733|11505405|FG000|NOT COMPLETED|Overall Study||3
10365202|NCT00525733|11505406|FG001|NOT COMPLETED|Overall Study||3
10365203|NCT00525785|11505412|FG000|STARTED|Overall Study||58
10365204|NCT00525785|11505412|FG000|COMPLETED|Overall Study||55
10365205|NCT00525785|11505412|FG000|NOT COMPLETED|Overall Study||3
10365206|NCT00525798|11505418|FG000|STARTED|Overall Study||2334
10365207|NCT00525798|11505419|FG001|STARTED|Overall Study||2331
10365208|NCT00525798|11505418|FG000|COMPLETED|Overall Study||1578
10365209|NCT00525798|11505419|FG001|COMPLETED|Overall Study||1732
10365210|NCT00525798|11505418|FG000|NOT COMPLETED|Overall Study||756
10365211|NCT00525798|11505419|FG001|NOT COMPLETED|Overall Study||599
10365212|NCT00525824|11505429|FG000|STARTED|Overall Study|Randomized population|214
10365213|NCT00525824|11505430|FG001|STARTED|Overall Study|Randomized population|214
10365214|NCT00525824|11505431|FG002|STARTED|Overall Study|Randomized population|202
10365215|NCT00525824|11505432|FG003|STARTED|Overall Study|Randomized population|203
10365216|NCT00525824|11505429|FG000|COMPLETED|Overall Study||195
10365217|NCT00525824|11505430|FG001|COMPLETED|Overall Study||186
10365218|NCT00525824|11505431|FG002|COMPLETED|Overall Study||183
10365219|NCT00525824|11505432|FG003|COMPLETED|Overall Study||188
10365220|NCT00525824|11505429|FG000|NOT COMPLETED|Overall Study||19
10365221|NCT00525824|11505430|FG001|NOT COMPLETED|Overall Study||28
10365222|NCT00525824|11505431|FG002|NOT COMPLETED|Overall Study||19
10365223|NCT00525824|11505432|FG003|NOT COMPLETED|Overall Study||15
10365224|NCT00525837|11505446|FG000|STARTED|Overall Study||18
10365225|NCT00525837|11505446|FG000|COMPLETED|Overall Study||14
10365226|NCT00525837|11505446|FG000|NOT COMPLETED|Overall Study||4
10365227|NCT00525876|11505453|FG000|STARTED|Overall Study||16
10365228|NCT00525876|11505454|FG001|STARTED|Overall Study||20
10365229|NCT00525876|11505453|FG000|COMPLETED|Overall Study||16
10365230|NCT00525876|11505454|FG001|COMPLETED|Overall Study||20
10365231|NCT00525876|11505453|FG000|NOT COMPLETED|Overall Study||0
10365232|NCT00525876|11505454|FG001|NOT COMPLETED|Overall Study||0
10365233|NCT00525902|11505460|FG000|STARTED|Overall Study||31
10365234|NCT00525902|11505460|FG000|10 Weeks|Overall Study||30
10365235|NCT00525902|11505460|FG000|50 Weeks|Overall Study||12
10365236|NCT00525902|11505460|FG000|COMPLETED|Overall Study||30
10365237|NCT00525902|11505460|FG000|NOT COMPLETED|Overall Study||1
10365238|NCT00525915|11505466|FG000|STARTED|Overall Study||63
10365239|NCT00525915|11505467|FG001|STARTED|Overall Study||63
10365240|NCT00525915|11505466|FG000|COMPLETED|Overall Study|Participants who underwent surgery.|55
10365241|NCT00525915|11505467|FG001|COMPLETED|Overall Study||54
10365242|NCT00525915|11505466|FG000|NOT COMPLETED|Overall Study||8
10365243|NCT00525915|11505467|FG001|NOT COMPLETED|Overall Study||9
10365244|NCT00526058|11505475|FG000|STARTED|Period: First Intervention||9
10365245|NCT00526058|11505476|FG001|STARTED|Period: First Intervention||9
10365246|NCT00526058|11505475|FG000|COMPLETED|Period: First Intervention||9
10365247|NCT00526058|11505476|FG001|COMPLETED|Period: First Intervention||9
10365248|NCT00526058|11505475|FG000|NOT COMPLETED|Period: First Intervention||0
10365249|NCT00526058|11505476|FG001|NOT COMPLETED|Period: First Intervention||0
10365250|NCT00526058|11505475|FG000|STARTED|Period: Second Intervention||9
10365251|NCT00526058|11505476|FG001|STARTED|Period: Second Intervention||9
10365252|NCT00526058|11505475|FG000|COMPLETED|Period: Second Intervention||9
10365253|NCT00526058|11505476|FG001|COMPLETED|Period: Second Intervention||9
10365254|NCT00526058|11505475|FG000|NOT COMPLETED|Period: Second Intervention||0
10365255|NCT00526058|11505476|FG001|NOT COMPLETED|Period: Second Intervention||0
10365256|NCT00526071|11505482|FG000|STARTED|Overall Study||23
10365257|NCT00526071|11505482|FG000|Safety Population|Overall Study||23
10365258|NCT00526071|11505482|FG000|Pharmacodynamic (PD) Population|Overall Study||23
10365259|NCT00526071|11505482|FG000|Amenable Population; Men|Overall Study||11
10365260|NCT00526071|11505482|FG000|Amenable Population; Women|Overall Study||5
10365261|NCT00526071|11505482|FG000|Non-amenable Population; Men|Overall Study||3
10365262|NCT00526071|11505482|FG000|Non-amenable Population; Women|Overall Study||4
10365263|NCT00526071|11505482|FG000|COMPLETED|Overall Study||17
10365264|NCT00526071|11505482|FG000|NOT COMPLETED|Overall Study||6
10365265|NCT00526097|11505492|FG000|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|121
10365266|NCT00526097|11505493|FG001|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|247
10365267|NCT00526097|11505492|FG000|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|106
10365268|NCT00526097|11505493|FG001|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|191
10365269|NCT00526097|11505492|FG000|NOT COMPLETED|Overall Study||15
10365270|NCT00526097|11505493|FG001|NOT COMPLETED|Overall Study||56
10365271|NCT00526110|11505501|FG000|STARTED|Overall Study||53
10365272|NCT00526110|11505502|FG001|STARTED|Overall Study||45
10365273|NCT00526110|11505501|FG000|COMPLETED|Overall Study||51
10365274|NCT00526110|11505502|FG001|COMPLETED|Overall Study||4
10365275|NCT00526110|11505501|FG000|NOT COMPLETED|Overall Study||2
10365276|NCT00526110|11505502|FG001|NOT COMPLETED|Overall Study||41
10365277|NCT00526123|11505510|FG000|STARTED|Overall Study|Intent-to-Treat population|303
10365278|NCT00526123|11505511|FG001|STARTED|Overall Study|Intent-to-Treat population|296
10365279|NCT00526123|11505510|FG000|COMPLETED|Overall Study||39
10365280|NCT00526123|11505511|FG001|COMPLETED|Overall Study||50
10365281|NCT00526123|11505510|FG000|NOT COMPLETED|Overall Study||264
10365282|NCT00526123|11505511|FG001|NOT COMPLETED|Overall Study||246
10365283|NCT00526162|11505517|FG000|STARTED|Overall Study||83
10365284|NCT00526162|11505517|FG000|COMPLETED|Overall Study||80
10365285|NCT00526162|11505517|FG000|NOT COMPLETED|Overall Study||3
10365286|NCT00526188|11505525|FG000|STARTED|Overall Study||234
10365287|NCT00526188|11505525|FG000|COMPLETED|Overall Study||234
10365288|NCT00526188|11505525|FG000|NOT COMPLETED|Overall Study||0
10365289|NCT00526292|11505529|FG000|STARTED|Overall Study||6
10365290|NCT00526292|11505529|FG000|COMPLETED|Overall Study||6
10365291|NCT00526292|11505529|FG000|NOT COMPLETED|Overall Study||0
10365292|NCT00526474|11505535|FG000|STARTED|Overall Study||13224
10365293|NCT00526474|11505536|FG001|STARTED|Overall Study||13225
10365294|NCT00526474|11505535|FG000|Received Study Drug|Overall Study||13166
10365295|NCT00526474|11505536|FG001|Received Study Drug|Overall Study||13186
10365296|NCT00526474|11505535|FG000|COMPLETED|Overall Study||12932
10365297|NCT00526474|11505536|FG001|COMPLETED|Overall Study||12953
10365298|NCT00526474|11505535|FG000|NOT COMPLETED|Overall Study||292
10365299|NCT00526474|11505536|FG001|NOT COMPLETED|Overall Study||272
10365300|NCT00526591|11505544|FG000|STARTED|Overall Study||8
10365301|NCT00526591|11505545|FG001|STARTED|Overall Study||9
10365302|NCT00526591|11505544|FG000|COMPLETED|Overall Study||8
10365303|NCT00526591|11505545|FG001|COMPLETED|Overall Study||9
10365304|NCT00526591|11505544|FG000|NOT COMPLETED|Overall Study||0
10365305|NCT00526591|11505545|FG001|NOT COMPLETED|Overall Study||0
10365306|NCT00526630|11505553|FG000|STARTED|First Intervention Period - 12 Weeks||12
10365307|NCT00526630|11505554|FG001|STARTED|First Intervention Period - 12 Weeks||11
10365308|NCT00526630|11505553|FG000|COMPLETED|First Intervention Period - 12 Weeks||12
10365309|NCT00526630|11505554|FG001|COMPLETED|First Intervention Period - 12 Weeks||8
10365310|NCT00526630|11505553|FG000|NOT COMPLETED|First Intervention Period - 12 Weeks||0
10365311|NCT00526630|11505554|FG001|NOT COMPLETED|First Intervention Period - 12 Weeks||3
10365312|NCT00526630|11505553|FG000|STARTED|Second Intervention Period - 12 Weeks||12
10365313|NCT00526630|11505554|FG001|STARTED|Second Intervention Period - 12 Weeks||8
10365314|NCT00526630|11505553|FG000|COMPLETED|Second Intervention Period - 12 Weeks||10
10365315|NCT00526630|11505554|FG001|COMPLETED|Second Intervention Period - 12 Weeks||7
10365316|NCT00526630|11505553|FG000|NOT COMPLETED|Second Intervention Period - 12 Weeks||2
10365317|NCT00526630|11505554|FG001|NOT COMPLETED|Second Intervention Period - 12 Weeks||1
10365318|NCT00526656|11505562|FG000|STARTED|Overall Study||9
10365319|NCT00526656|11505562|FG000|COMPLETED|Overall Study||7
10365320|NCT00526656|11505562|FG000|NOT COMPLETED|Overall Study||2
10365321|NCT00526669|11505567|FG000|STARTED|7-Day Run-in Monotherapy Treatment Phase||67
10365322|NCT00526669|11505568|FG001|STARTED|7-Day Run-in Monotherapy Treatment Phase||0
10365323|NCT00526669|11505567|FG000|COMPLETED|7-Day Run-in Monotherapy Treatment Phase||67
10365324|NCT00526669|11505568|FG001|COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
10365325|NCT00526669|11505567|FG000|NOT COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
10365326|NCT00526669|11505568|FG001|NOT COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
10365327|NCT00526669|11505567|FG000|STARTED|Combined Treatment Phase||0
10365328|NCT00526669|11505568|FG001|STARTED|Combined Treatment Phase||67
10716530|NCT02690168|11880260|FG000|COMPLETED|Overall Study||6
10716531|NCT02690168|11880260|FG000|NOT COMPLETED|Overall Study||0
10716532|NCT02690181|11880271|FG000|STARTED|Overall Study||14
10716533|NCT02690181|11880272|FG001|STARTED|Overall Study||14
10716534|NCT02690181|11880273|FG002|STARTED|Overall Study||15
10716535|NCT02690181|11880274|FG003|STARTED|Overall Study||10
10716536|NCT02690181|11880275|FG004|STARTED|Overall Study||6
10716537|NCT02690181|11880276|FG005|STARTED|Overall Study||21
10716538|NCT02690181|11880271|FG000|COMPLETED|Overall Study||14
10716539|NCT02690181|11880272|FG001|COMPLETED|Overall Study||14
10716540|NCT02690181|11880273|FG002|COMPLETED|Overall Study||15
10716541|NCT02690181|11880274|FG003|COMPLETED|Overall Study||10
10716542|NCT02690181|11880275|FG004|COMPLETED|Overall Study||6
10812581|NCT03500341|11974678|FG000|COMPLETED|Overall Study||14
10716543|NCT02690181|11880276|FG005|COMPLETED|Overall Study||21
10365329|NCT00526669|11505567|FG000|COMPLETED|Combined Treatment Phase||0
10365330|NCT00526669|11505568|FG001|COMPLETED|Combined Treatment Phase||59
10365331|NCT00526669|11505567|FG000|NOT COMPLETED|Combined Treatment Phase||0
10365332|NCT00526669|11505568|FG001|NOT COMPLETED|Combined Treatment Phase||8
10365333|NCT00526799|11505576|FG000|STARTED|Overall Study||16
10365334|NCT00526799|11505577|FG001|STARTED|Overall Study||14
10365335|NCT00526799|11505576|FG000|COMPLETED|Overall Study||15
10365336|NCT00526799|11505577|FG001|COMPLETED|Overall Study||13
10365337|NCT00526799|11505576|FG000|NOT COMPLETED|Overall Study||1
10365338|NCT00526799|11505577|FG001|NOT COMPLETED|Overall Study||1
10365339|NCT00526890|11505583|FG000|STARTED|Overall Study||16
10365340|NCT00526890|11505583|FG000|COMPLETED|Overall Study||14
10365341|NCT00526890|11505583|FG000|NOT COMPLETED|Overall Study||2
10365342|NCT00526994|11505590|FG000|STARTED|Overall Study||909
10365343|NCT00526994|11505591|FG001|STARTED|Overall Study||893
10536034|NCT01440764|11688487|FG001|STARTED|Test Day 1||2
10536035|NCT01440764|11688488|FG002|STARTED|Test Day 1||6
10536036|NCT01440764|11688489|FG003|STARTED|Test Day 1||1
10536037|NCT01440764|11688490|FG004|STARTED|Test Day 1||3
10536038|NCT01440764|11688491|FG005|STARTED|Test Day 1||5
10536039|NCT01440764|11688492|FG006|STARTED|Test Day 1||3
10536040|NCT01440764|11688486|FG000|COMPLETED|Test Day 1||4
10536041|NCT01440764|11688487|FG001|COMPLETED|Test Day 1||2
10536042|NCT01440764|11688488|FG002|COMPLETED|Test Day 1||6
10536043|NCT01440764|11688489|FG003|COMPLETED|Test Day 1||1
10536044|NCT01440764|11688490|FG004|COMPLETED|Test Day 1||3
10536045|NCT01440764|11688491|FG005|COMPLETED|Test Day 1||5
10536046|NCT01440764|11688492|FG006|COMPLETED|Test Day 1||3
10536047|NCT01440764|11688486|FG000|NOT COMPLETED|Test Day 1||0
10536048|NCT01440764|11688487|FG001|NOT COMPLETED|Test Day 1||0
10536049|NCT01440764|11688488|FG002|NOT COMPLETED|Test Day 1||0
10536050|NCT01440764|11688489|FG003|NOT COMPLETED|Test Day 1||0
10656856|NCT02221882|11817978|FG005|STARTED|Overall Study||4
10716544|NCT02690181|11880271|FG000|NOT COMPLETED|Overall Study||0
10716545|NCT02690181|11880272|FG001|NOT COMPLETED|Overall Study||0
10716546|NCT02690181|11880273|FG002|NOT COMPLETED|Overall Study||0
10716547|NCT02690181|11880274|FG003|NOT COMPLETED|Overall Study||0
10716548|NCT02690181|11880275|FG004|NOT COMPLETED|Overall Study||0
10716549|NCT02690181|11880276|FG005|NOT COMPLETED|Overall Study||0
10716550|NCT02690194|11880293|FG000|STARTED|Overall Study||17
10365344|NCT00526994|11505592|FG002|STARTED|Overall Study||898
10716551|NCT02690194|11880294|FG001|STARTED|Overall Study||18
10716552|NCT02690194|11880295|FG002|STARTED|Overall Study||19
10716553|NCT02690194|11880293|FG000|COMPLETED|Overall Study||16
10365345|NCT00526994|11505590|FG000|COMPLETED|Overall Study||801
10365346|NCT00526994|11505591|FG001|COMPLETED|Overall Study||772
10365347|NCT00526994|11505592|FG002|COMPLETED|Overall Study||791
10365348|NCT00526994|11505590|FG000|NOT COMPLETED|Overall Study||108
10365349|NCT00526994|11505591|FG001|NOT COMPLETED|Overall Study||121
10365350|NCT00526994|11505592|FG002|NOT COMPLETED|Overall Study||107
10365351|NCT00527072|11505600|FG000|STARTED|Overall Study||215
10365352|NCT00527072|11505600|FG000|COMPLETED|Overall Study||179
10365353|NCT00527072|11505600|FG000|NOT COMPLETED|Overall Study||36
10365354|NCT00527098|11505607|FG000|STARTED|Overall Study||36
10365355|NCT00527098|11505608|FG001|STARTED|Overall Study||83
10365356|NCT00527098|11505607|FG000|COMPLETED|Overall Study||36
10365357|NCT00527098|11505608|FG001|COMPLETED|Overall Study||83
10365358|NCT00527098|11505607|FG000|NOT COMPLETED|Overall Study||0
10365359|NCT00527098|11505608|FG001|NOT COMPLETED|Overall Study||0
10365360|NCT00527111|11505615|FG000|STARTED|Overall Study||70
10365361|NCT00527111|11505616|FG001|STARTED|Overall Study||69
10365362|NCT00527111|11505615|FG000|COMPLETED|Overall Study||50
10365363|NCT00527111|11505616|FG001|COMPLETED|Overall Study||47
10365364|NCT00527111|11505615|FG000|NOT COMPLETED|Overall Study||20
10365365|NCT00527111|11505616|FG001|NOT COMPLETED|Overall Study||22
10365366|NCT00527124|11505624|FG000|STARTED|Overall Study||29
10365367|NCT00527124|11505625|FG001|STARTED|Overall Study||28
10365368|NCT00527124|11505624|FG000|COMPLETED|Overall Study||29
10365369|NCT00527124|11505625|FG001|COMPLETED|Overall Study||28
10365370|NCT00527124|11505624|FG000|NOT COMPLETED|Overall Study||0
10365371|NCT00527124|11505625|FG001|NOT COMPLETED|Overall Study||0
10365372|NCT00527319|11505634|FG000|STARTED|Overall Study||12
10365373|NCT00527319|11505635|FG001|STARTED|Overall Study||12
10365374|NCT00527319|11505636|FG002|STARTED|Overall Study||13
10365375|NCT00527319|11505634|FG000|COMPLETED|Overall Study||6
10365376|NCT00527319|11505635|FG001|COMPLETED|Overall Study||8
10365377|NCT00527319|11505636|FG002|COMPLETED|Overall Study||7
10365378|NCT00527319|11505634|FG000|NOT COMPLETED|Overall Study||6
10365379|NCT00527319|11505635|FG001|NOT COMPLETED|Overall Study||4
10365380|NCT00527319|11505636|FG002|NOT COMPLETED|Overall Study||6
10365381|NCT00527332|11505646|FG000|STARTED|Overall Study||91
10365382|NCT00527332|11505647|FG001|STARTED|Overall Study||89
10365383|NCT00527332|11505646|FG000|COMPLETED|Overall Study||82
10365384|NCT00527332|11505647|FG001|COMPLETED|Overall Study||80
10365385|NCT00527332|11505646|FG000|NOT COMPLETED|Overall Study||9
10365386|NCT00527332|11505647|FG001|NOT COMPLETED|Overall Study||9
10365387|NCT00527397|11505653|FG000|STARTED|Overall Study||24
10365388|NCT00527397|11505653|FG000|COMPLETED|Overall Study||0
10365389|NCT00527397|11505653|FG000|NOT COMPLETED|Overall Study||24
10365390|NCT00527423|11505660|FG000|STARTED|Overall Study||157
10365391|NCT00527423|11505660|FG000|COMPLETED|Overall Study||120
10365392|NCT00527423|11505660|FG000|NOT COMPLETED|Overall Study||37
10365393|NCT00527475|11505668|FG000|STARTED|Overall Study||30
10365394|NCT00527475|11505669|FG001|STARTED|Overall Study||30
10365395|NCT00527475|11505668|FG000|COMPLETED|Overall Study||27
10365396|NCT00527475|11505669|FG001|COMPLETED|Overall Study||29
10365397|NCT00527475|11505668|FG000|NOT COMPLETED|Overall Study||3
10365398|NCT00527475|11505669|FG001|NOT COMPLETED|Overall Study||1
10365399|NCT00527488|11505679|FG000|STARTED|Overall Study||13
10365400|NCT00527488|11505680|FG001|STARTED|Overall Study||13
10365401|NCT00527488|11505681|FG002|STARTED|Overall Study||13
10365402|NCT00527488|11505682|FG003|STARTED|Overall Study||13
10365403|NCT00527488|11505679|FG000|COMPLETED|Overall Study||13
10365404|NCT00527488|11505680|FG001|COMPLETED|Overall Study||12
10365405|NCT00527488|11505681|FG002|COMPLETED|Overall Study||12
10365406|NCT00527488|11505682|FG003|COMPLETED|Overall Study||13
10365407|NCT00527488|11505679|FG000|NOT COMPLETED|Overall Study||0
10365408|NCT00527488|11505680|FG001|NOT COMPLETED|Overall Study||1
10365409|NCT00527488|11505681|FG002|NOT COMPLETED|Overall Study||1
10365410|NCT00527488|11505682|FG003|NOT COMPLETED|Overall Study||0
10365411|NCT00527514|11505692|FG000|STARTED|Weeks 1-3: Amlodipine (Aml) 5mg||185
10365412|NCT00527514|11505692|FG000|COMPLETED|Weeks 1-3: Amlodipine (Aml) 5mg|1 participant dropped out. 2 participants were subsequently mis-titrated to the third regimen.|184
10365413|NCT00527514|11505692|FG000|NOT COMPLETED|Weeks 1-3: Amlodipine (Aml) 5mg||1
10365414|NCT00527514|11505692|FG000|STARTED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|184 -2 who were mis-titrated -2 who met blood pressure goal = 180|180
10365415|NCT00527514|11505692|FG000|COMPLETED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg||178
10365416|NCT00527514|11505692|FG000|NOT COMPLETED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg||2
10365417|NCT00527514|11505692|FG000|STARTED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|178 -19 who met blood pressure goal + 2 who were mis-titrated = 161|161
10656857|NCT02221882|11817973|FG000|Received at Least One Dose of Study Drug|Overall Study||3
10365418|NCT00527514|11505692|FG000|COMPLETED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg||158
10365419|NCT00527514|11505692|FG000|NOT COMPLETED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg||3
10365420|NCT00527514|11505692|FG000|STARTED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|158 -24 who met blood pressure goal = 134|134
10365421|NCT00527514|11505692|FG000|COMPLETED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg||132
10365422|NCT00527514|11505692|FG000|NOT COMPLETED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg||2
10365423|NCT00527566|11505703|FG000|STARTED|Overall Study||10
10365424|NCT00527566|11505703|FG000|COMPLETED|Overall Study||10
10365425|NCT00527566|11505703|FG000|NOT COMPLETED|Overall Study||0
10716554|NCT02690194|11880294|FG001|COMPLETED|Overall Study||14
10716555|NCT02690194|11880295|FG002|COMPLETED|Overall Study||19
10716556|NCT02690194|11880293|FG000|NOT COMPLETED|Overall Study||1
10716557|NCT02690194|11880294|FG001|NOT COMPLETED|Overall Study||4
10716558|NCT02690194|11880295|FG002|NOT COMPLETED|Overall Study||0
10365426|NCT00527592|11505709|FG000|STARTED|Overall Study||54
10365427|NCT00527592|11505709|FG000|COMPLETED|Overall Study||54
10365428|NCT00527592|11505709|FG000|NOT COMPLETED|Overall Study||0
10365429|NCT00527605|11505717|FG000|STARTED|Overall Study||126
10365430|NCT00527605|11505718|FG001|STARTED|Overall Study||127
10365431|NCT00527605|11505717|FG000|COMPLETED|Overall Study||113
10365432|NCT00527605|11505718|FG001|COMPLETED|Overall Study||116
10365433|NCT00527605|11505717|FG000|NOT COMPLETED|Overall Study||13
10365434|NCT00527605|11505718|FG001|NOT COMPLETED|Overall Study||11
10365435|NCT00527618|11505724|FG000|STARTED|Week 1-12 (First Intervention)|Acyclovir|16
10365436|NCT00527618|11505725|FG001|STARTED|Week 1-12 (First Intervention)|Valacyclovir; one participant was removed from the study due to urticaria after 2.5 weeks|18
10365437|NCT00527618|11505724|FG000|COMPLETED|Week 1-12 (First Intervention)|Acyclovir|13
10365438|NCT00527618|11505725|FG001|COMPLETED|Week 1-12 (First Intervention)|Valacyclovir|16
10365439|NCT00527618|11505724|FG000|NOT COMPLETED|Week 1-12 (First Intervention)||3
10365440|NCT00527618|11505725|FG001|NOT COMPLETED|Week 1-12 (First Intervention)||2
10365441|NCT00527618|11505724|FG000|STARTED|Week 13-14 (Washout)||13
10365442|NCT00527618|11505725|FG001|STARTED|Week 13-14 (Washout)||16
10365443|NCT00527618|11505724|FG000|COMPLETED|Week 13-14 (Washout)||12
10365444|NCT00527618|11505725|FG001|COMPLETED|Week 13-14 (Washout)||16
10365445|NCT00527618|11505724|FG000|NOT COMPLETED|Week 13-14 (Washout)||1
10365446|NCT00527618|11505725|FG001|NOT COMPLETED|Week 13-14 (Washout)||0
10365447|NCT00527618|11505724|FG000|STARTED|Week 15-18 (Second Intervention)|Valacyclovir|12
10365448|NCT00527618|11505725|FG001|STARTED|Week 15-18 (Second Intervention)|Acyclovir|16
10365449|NCT00527618|11505724|FG000|COMPLETED|Week 15-18 (Second Intervention)|Valacyclovir|12
10365450|NCT00527618|11505725|FG001|COMPLETED|Week 15-18 (Second Intervention)|Acyclovir|13
10365451|NCT00527618|11505724|FG000|NOT COMPLETED|Week 15-18 (Second Intervention)||0
10365452|NCT00527618|11505725|FG001|NOT COMPLETED|Week 15-18 (Second Intervention)||3
10365453|NCT00527644|11505732|FG000|STARTED|Overall Study||14
10365454|NCT00527644|11505732|FG000|COMPLETED|Overall Study||14
10365455|NCT00527644|11505732|FG000|NOT COMPLETED|Overall Study||0
10365456|NCT00527722|11505738|FG000|STARTED|Overall Study||22
10365457|NCT00527722|11505739|FG001|STARTED|Overall Study||25
10365458|NCT00527722|11505738|FG000|COMPLETED|Overall Study||22
10365459|NCT00527722|11505739|FG001|COMPLETED|Overall Study||25
10365460|NCT00527722|11505738|FG000|NOT COMPLETED|Overall Study||0
10365461|NCT00527722|11505739|FG001|NOT COMPLETED|Overall Study||0
10365462|NCT00527735|11505748|FG000|STARTED|Overall Study|Treated|113
10365463|NCT00527735|11505749|FG001|STARTED|Overall Study|Treated|109
10365464|NCT00527735|11505750|FG002|STARTED|Overall Study|Treated|109
10365465|NCT00527735|11505748|FG000|COMPLETED|Overall Study|Still on treatment|5
10365466|NCT00527735|11505749|FG001|COMPLETED|Overall Study|Still on treatment|2
10365467|NCT00527735|11505750|FG002|COMPLETED|Overall Study|Still on treatment|2
10365468|NCT00527735|11505748|FG000|NOT COMPLETED|Overall Study||108
10365469|NCT00527735|11505749|FG001|NOT COMPLETED|Overall Study||107
10365470|NCT00527735|11505750|FG002|NOT COMPLETED|Overall Study||107
10365471|NCT00527787|11505772|FG000|STARTED|Overall Study||218
10365472|NCT00527787|11505773|FG001|STARTED|Overall Study|Safety and Intent-to-treat population (>=1 dose drug + no baseline ulcer) N=216|216
10365473|NCT00527787|11505772|FG000|COMPLETED|Overall Study||180
10365474|NCT00527787|11505773|FG001|COMPLETED|Overall Study||153
10365475|NCT00527787|11505772|FG000|NOT COMPLETED|Overall Study||38
10365476|NCT00527787|11505773|FG001|NOT COMPLETED|Overall Study||63
10365477|NCT00527826|11505781|FG000|STARTED|Overall Study|All Patients Population was used for Participant Flow section.|108
10365478|NCT00527826|11505782|FG001|STARTED|Overall Study||106
10365479|NCT00527826|11505781|FG000|COMPLETED|Overall Study||87
10365480|NCT00527826|11505782|FG001|COMPLETED|Overall Study||80
10365481|NCT00527826|11505781|FG000|NOT COMPLETED|Overall Study||21
10365482|NCT00527826|11505782|FG001|NOT COMPLETED|Overall Study||26
10365483|NCT00527878|11505791|FG000|STARTED|Intervention 1||7
10365484|NCT00527878|11505792|FG001|STARTED|Intervention 1||7
10365485|NCT00527878|11505791|FG000|COMPLETED|Intervention 1||5
10365486|NCT00527878|11505792|FG001|COMPLETED|Intervention 1||4
10365487|NCT00527878|11505791|FG000|NOT COMPLETED|Intervention 1||2
10365488|NCT00527878|11505792|FG001|NOT COMPLETED|Intervention 1||3
10365489|NCT00527878|11505791|FG000|STARTED|Intervention 2||5
10365490|NCT00527878|11505792|FG001|STARTED|Intervention 2||4
10365491|NCT00527878|11505791|FG000|COMPLETED|Intervention 2||5
10365492|NCT00527878|11505792|FG001|COMPLETED|Intervention 2||4
10365493|NCT00527878|11505791|FG000|NOT COMPLETED|Intervention 2||0
10365494|NCT00527878|11505792|FG001|NOT COMPLETED|Intervention 2||0
10365495|NCT00527904|11505798|FG000|STARTED|Overall Study||239
10365496|NCT00527904|11505798|FG000|COMPLETED|Overall Study||143
10365497|NCT00527904|11505798|FG000|NOT COMPLETED|Overall Study||96
10365498|NCT00527943|11505804|FG000|STARTED|Overall Study||6471
10365499|NCT00527943|11505805|FG001|STARTED|Overall Study||6473
10365500|NCT00527943|11505804|FG000|Received Treatment|Overall Study||6441
10365501|NCT00527943|11505805|FG001|Received Treatment|Overall Study||6446
10365502|NCT00527943|11505804|FG000|COMPLETED|Overall Study||6311
10365503|NCT00527943|11505805|FG001|COMPLETED|Overall Study||6327
10365504|NCT00527943|11505804|FG000|NOT COMPLETED|Overall Study||160
10365505|NCT00527943|11505805|FG001|NOT COMPLETED|Overall Study||146
10716559|NCT02690207|11880303|FG000|STARTED|Overall Study||8687
10365506|NCT00528112|11505813|FG000|STARTED|Treatment up to 3 Years||1432
10365507|NCT00528112|11505814|FG001|STARTED|Treatment up to 3 Years||1453
10365508|NCT00528112|11505813|FG000|Participants Received Treatment|Treatment up to 3 Years|Full analysis set/Safety population|1432
10365509|NCT00528112|11505814|FG001|Participants Received Treatment|Treatment up to 3 Years|Full analysis set/Safety population|1452
10365510|NCT00528112|11505813|FG000|COMPLETED|Treatment up to 3 Years||819
10365511|NCT00528112|11505814|FG001|COMPLETED|Treatment up to 3 Years||870
10365512|NCT00528112|11505813|FG000|NOT COMPLETED|Treatment up to 3 Years||613
10365513|NCT00528112|11505814|FG001|NOT COMPLETED|Treatment up to 3 Years||583
10365514|NCT00528112|11505813|FG000|STARTED|Extension Phase|Only subjects in the LCS16 groups could participate in the extension phase|0
10365515|NCT00528112|11505814|FG001|STARTED|Extension Phase||707
10365516|NCT00528112|11505813|FG000|COMPLETED|Extension Phase||0
10365517|NCT00528112|11505814|FG001|COMPLETED|Extension Phase||550
10365518|NCT00528112|11505813|FG000|NOT COMPLETED|Extension Phase||0
10365519|NCT00528112|11505814|FG001|NOT COMPLETED|Extension Phase||157
10365520|NCT00528190|11505824|FG000|STARTED|Overall Study||18
10365521|NCT00528190|11505825|FG001|STARTED|Overall Study||17
10365522|NCT00528190|11505824|FG000|COMPLETED|Overall Study||18
10365523|NCT00528190|11505825|FG001|COMPLETED|Overall Study||16
10365524|NCT00528190|11505824|FG000|NOT COMPLETED|Overall Study||0
10365525|NCT00528190|11505825|FG001|NOT COMPLETED|Overall Study||1
10365526|NCT00528268|11505833|FG000|STARTED|Overall Study||6
10365527|NCT00528268|11505834|FG001|STARTED|Overall Study||8
10365528|NCT00528268|11505833|FG000|COMPLETED|Overall Study||5
10365529|NCT00528268|11505834|FG001|COMPLETED|Overall Study||7
10365530|NCT00528268|11505833|FG000|NOT COMPLETED|Overall Study||1
10365531|NCT00528268|11505834|FG001|NOT COMPLETED|Overall Study||1
10365532|NCT00528372|11505849|FG000|STARTED|Short-term (ST) Period (Day 1-Week 24)||75
10365533|NCT00528372|11505850|FG001|STARTED|Short-term (ST) Period (Day 1-Week 24)||65
10365534|NCT00528372|11505851|FG002|STARTED|Short-term (ST) Period (Day 1-Week 24)||64
10365535|NCT00528372|11505852|FG003|STARTED|Short-term (ST) Period (Day 1-Week 24)||70
10365536|NCT00528372|11505853|FG004|STARTED|Short-term (ST) Period (Day 1-Week 24)||67
10365537|NCT00528372|11505854|FG005|STARTED|Short-term (ST) Period (Day 1-Week 24)||68
10365538|NCT00528372|11505855|FG006|STARTED|Short-term (ST) Period (Day 1-Week 24)||76
10365539|NCT00528372|11505856|FG007|STARTED|Short-term (ST) Period (Day 1-Week 24)||34
10365540|NCT00528372|11505857|FG008|STARTED|Short-term (ST) Period (Day 1-Week 24)||39
10365541|NCT00528372|11505849|FG000|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||63
10365542|NCT00528372|11505850|FG001|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||60
10365543|NCT00528372|11505851|FG002|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||52
10365544|NCT00528372|11505852|FG003|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||57
10365545|NCT00528372|11505853|FG004|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||58
10365546|NCT00528372|11505854|FG005|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||57
10365547|NCT00528372|11505855|FG006|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||65
10365548|NCT00528372|11505856|FG007|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||28
10365549|NCT00528372|11505857|FG008|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||34
10365550|NCT00528372|11505849|FG000|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||12
10365551|NCT00528372|11505850|FG001|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||5
10365552|NCT00528372|11505851|FG002|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||12
10365553|NCT00528372|11505852|FG003|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||13
10365554|NCT00528372|11505853|FG004|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||9
10536051|NCT01440764|11688490|FG004|NOT COMPLETED|Test Day 1||0
10536052|NCT01440764|11688491|FG005|NOT COMPLETED|Test Day 1||0
10536053|NCT01440764|11688492|FG006|NOT COMPLETED|Test Day 1||0
10536054|NCT01440764|11688486|FG000|STARTED|Test Day 2|Following Test Day 1, 1 subject withdrew from the study before beginning Test Day 2.|3
10536055|NCT01440764|11688487|FG001|STARTED|Test Day 2||2
10536056|NCT01440764|11688488|FG002|STARTED|Test Day 2||6
10536057|NCT01440764|11688489|FG003|STARTED|Test Day 2||1
10536058|NCT01440764|11688490|FG004|STARTED|Test Day 2||3
10536059|NCT01440764|11688491|FG005|STARTED|Test Day 2||5
10536060|NCT01440764|11688492|FG006|STARTED|Test Day 2||3
10536061|NCT01440764|11688486|FG000|COMPLETED|Test Day 2||3
10536062|NCT01440764|11688487|FG001|COMPLETED|Test Day 2||2
10536063|NCT01440764|11688488|FG002|COMPLETED|Test Day 2||6
10427362|NCT00853047|11573198|FG003|STARTED|Core Phase||3
10536064|NCT01440764|11688489|FG003|COMPLETED|Test Day 2||1
10536065|NCT01440764|11688490|FG004|COMPLETED|Test Day 2||3
10536066|NCT01440764|11688491|FG005|COMPLETED|Test Day 2||5
10536067|NCT01440764|11688492|FG006|COMPLETED|Test Day 2||3
10536068|NCT01440764|11688486|FG000|NOT COMPLETED|Test Day 2||0
10365555|NCT00528372|11505854|FG005|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||11
10365556|NCT00528372|11505855|FG006|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||11
10365557|NCT00528372|11505856|FG007|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||6
10365558|NCT00528372|11505857|FG008|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||5
10365559|NCT00528372|11505849|FG000|STARTED|Long-term (LT) Period (Weeks 24-102)||62
10365560|NCT00528372|11505850|FG001|STARTED|Long-term (LT) Period (Weeks 24-102)||59
10365561|NCT00528372|11505851|FG002|STARTED|Long-term (LT) Period (Weeks 24-102)||51
10365562|NCT00528372|11505852|FG003|STARTED|Long-term (LT) Period (Weeks 24-102)||56
10716560|NCT02690207|11880303|FG000|COMPLETED|Overall Study||8434
10716561|NCT02690207|11880303|FG000|NOT COMPLETED|Overall Study||253
10716562|NCT02690558|11880307|FG000|STARTED|Overall Study||39
10716563|NCT02690558|11880307|FG000|COMPLETED|Overall Study||39
10716564|NCT02690558|11880307|FG000|NOT COMPLETED|Overall Study||0
10716565|NCT02690649|11880313|FG000|STARTED|Overall Study||80
10716566|NCT02690649|11880314|FG001|STARTED|Overall Study||80
10716567|NCT02690649|11880313|FG000|COMPLETED|Overall Study||79
10365563|NCT00528372|11505853|FG004|STARTED|Long-term (LT) Period (Weeks 24-102)||58
10365564|NCT00528372|11505854|FG005|STARTED|Long-term (LT) Period (Weeks 24-102)||57
10365565|NCT00528372|11505855|FG006|STARTED|Long-term (LT) Period (Weeks 24-102)||65
10365566|NCT00528372|11505856|FG007|STARTED|Long-term (LT) Period (Weeks 24-102)||28
10365567|NCT00528372|11505857|FG008|STARTED|Long-term (LT) Period (Weeks 24-102)|1 patient completed ST phase but withdrew for sponsor administrative reason before start of LT phase|33
10365568|NCT00528372|11505849|FG000|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
10365569|NCT00528372|11505850|FG001|COMPLETED|Long-term (LT) Period (Weeks 24-102)||40
10365570|NCT00528372|11505851|FG002|COMPLETED|Long-term (LT) Period (Weeks 24-102)||43
10365571|NCT00528372|11505852|FG003|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
10365572|NCT00528372|11505853|FG004|COMPLETED|Long-term (LT) Period (Weeks 24-102)||37
10365573|NCT00528372|11505854|FG005|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
10365574|NCT00528372|11505855|FG006|COMPLETED|Long-term (LT) Period (Weeks 24-102)||48
10365575|NCT00528372|11505856|FG007|COMPLETED|Long-term (LT) Period (Weeks 24-102)||22
10365576|NCT00528372|11505857|FG008|COMPLETED|Long-term (LT) Period (Weeks 24-102)||27
10365577|NCT00528372|11505849|FG000|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||20
10365578|NCT00528372|11505850|FG001|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||19
10365579|NCT00528372|11505851|FG002|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||8
10365580|NCT00528372|11505852|FG003|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||14
10365581|NCT00528372|11505853|FG004|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||21
10365582|NCT00528372|11505854|FG005|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||15
10365583|NCT00528372|11505855|FG006|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||17
10365584|NCT00528372|11505856|FG007|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||6
10365585|NCT00528372|11505857|FG008|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||6
10427363|NCT00853047|11573199|FG004|STARTED|Core Phase||9
10427364|NCT00853047|11573200|FG005|STARTED|Core Phase||0
10427365|NCT00853047|11573195|FG000|COMPLETED|Core Phase||5
10427366|NCT00853047|11573196|FG001|COMPLETED|Core Phase||3
10427367|NCT00853047|11573197|FG002|COMPLETED|Core Phase||3
10427368|NCT00853047|11573198|FG003|COMPLETED|Core Phase||2
10427369|NCT00853047|11573199|FG004|COMPLETED|Core Phase||9
10427370|NCT00853047|11573200|FG005|COMPLETED|Core Phase||0
10427371|NCT00853047|11573195|FG000|NOT COMPLETED|Core Phase||0
10427372|NCT00853047|11573196|FG001|NOT COMPLETED|Core Phase||0
10427373|NCT00853047|11573197|FG002|NOT COMPLETED|Core Phase||0
10427374|NCT00853047|11573198|FG003|NOT COMPLETED|Core Phase||1
10427375|NCT00853047|11573199|FG004|NOT COMPLETED|Core Phase||0
10427376|NCT00853047|11573200|FG005|NOT COMPLETED|Core Phase||0
10427377|NCT00853047|11573195|FG000|STARTED|Open-Label Extension Phase||0
10427378|NCT00853047|11573196|FG001|STARTED|Open-Label Extension Phase||0
10427379|NCT00853047|11573197|FG002|STARTED|Open-Label Extension Phase||0
10427380|NCT00853047|11573198|FG003|STARTED|Open-Label Extension Phase||0
10427381|NCT00853047|11573199|FG004|STARTED|Open-Label Extension Phase||0
10427382|NCT00853047|11573200|FG005|STARTED|Open-Label Extension Phase|19 of the 22 participants who completed the Core Phase entered the optional Open-Label Extension.|19
10427383|NCT00853047|11573195|FG000|Completed 8-week Extension Period|Open-Label Extension Phase||0
10427384|NCT00853047|11573196|FG001|Completed 8-week Extension Period|Open-Label Extension Phase||0
10427385|NCT00853047|11573197|FG002|Completed 8-week Extension Period|Open-Label Extension Phase||0
10427386|NCT00853047|11573198|FG003|Completed 8-week Extension Period|Open-Label Extension Phase||0
10427387|NCT00853047|11573199|FG004|Completed 8-week Extension Period|Open-Label Extension Phase||0
10427388|NCT00853047|11573200|FG005|Completed 8-week Extension Period|Open-Label Extension Phase||16
10427389|NCT00853047|11573195|FG000|COMPLETED|Open-Label Extension Phase||0
10427390|NCT00853047|11573196|FG001|COMPLETED|Open-Label Extension Phase||0
10427391|NCT00853047|11573197|FG002|COMPLETED|Open-Label Extension Phase||0
10427392|NCT00853047|11573198|FG003|COMPLETED|Open-Label Extension Phase||0
10427393|NCT00853047|11573199|FG004|COMPLETED|Open-Label Extension Phase||0
10427394|NCT00853047|11573200|FG005|COMPLETED|Open-Label Extension Phase||2
10427395|NCT00853047|11573195|FG000|NOT COMPLETED|Open-Label Extension Phase||0
10427396|NCT00853047|11573196|FG001|NOT COMPLETED|Open-Label Extension Phase||0
10427397|NCT00853047|11573197|FG002|NOT COMPLETED|Open-Label Extension Phase||0
10427398|NCT00853047|11573198|FG003|NOT COMPLETED|Open-Label Extension Phase||0
10716568|NCT02690649|11880314|FG001|COMPLETED|Overall Study||76
10716569|NCT02690649|11880313|FG000|NOT COMPLETED|Overall Study||1
10365586|NCT00528398|11505903|FG000|STARTED|Overall Study||111
10365587|NCT00528398|11505903|FG000|COMPLETED|Overall Study||111
10365588|NCT00528398|11505903|FG000|NOT COMPLETED|Overall Study||0
10365589|NCT00528411|11505910|FG000|STARTED|Overall Study||57
10365590|NCT00528411|11505911|FG001|STARTED|Overall Study||54
10365591|NCT00528411|11505912|FG002|STARTED|Overall Study||12
10365592|NCT00528411|11505910|FG000|COMPLETED|Overall Study||52
10365593|NCT00528411|11505911|FG001|COMPLETED|Overall Study||51
10365594|NCT00528411|11505912|FG002|COMPLETED|Overall Study||11
10365595|NCT00528411|11505910|FG000|NOT COMPLETED|Overall Study||5
10365596|NCT00528411|11505911|FG001|NOT COMPLETED|Overall Study||3
10365597|NCT00528411|11505912|FG002|NOT COMPLETED|Overall Study||1
10365598|NCT00528424|11505920|FG000|STARTED|Overall Study||286
10365599|NCT00528424|11505920|FG000|COMPLETED|Overall Study||257
10365600|NCT00528424|11505920|FG000|NOT COMPLETED|Overall Study||29
10365601|NCT00528450|11505924|FG000|STARTED|Overall Study||1
10365602|NCT00528450|11505924|FG000|COMPLETED|Overall Study||1
10365603|NCT00528450|11505924|FG000|NOT COMPLETED|Overall Study||0
10365604|NCT00528528|11505932|FG000|STARTED|Overall Study||40
10365605|NCT00528528|11505933|FG001|STARTED|Overall Study||42
10365606|NCT00528528|11505934|FG002|STARTED|Overall Study||40
10365607|NCT00528528|11505935|FG003|STARTED|Overall Study||39
10365608|NCT00528528|11505932|FG000|Ongoing at Time of Cut-off|Overall Study||0
10365609|NCT00528528|11505933|FG001|Ongoing at Time of Cut-off|Overall Study||0
10365610|NCT00528528|11505934|FG002|Ongoing at Time of Cut-off|Overall Study||1
10365611|NCT00528528|11505935|FG003|Ongoing at Time of Cut-off|Overall Study||0
10365612|NCT00528528|11505932|FG000|COMPLETED|Overall Study||37
10365613|NCT00528528|11505933|FG001|COMPLETED|Overall Study||39
10365614|NCT00528528|11505934|FG002|COMPLETED|Overall Study||37
10365615|NCT00528528|11505935|FG003|COMPLETED|Overall Study||36
10365616|NCT00528528|11505932|FG000|NOT COMPLETED|Overall Study||3
10365617|NCT00528528|11505933|FG001|NOT COMPLETED|Overall Study||3
10365618|NCT00528528|11505934|FG002|NOT COMPLETED|Overall Study||3
10365619|NCT00528528|11505935|FG003|NOT COMPLETED|Overall Study||3
10365620|NCT00528541|11505949|FG000|STARTED|Overall Study||75
10365621|NCT00528541|11505950|FG001|STARTED|Overall Study||70
10365622|NCT00528541|11505949|FG000|COMPLETED|Overall Study||73
10365623|NCT00528541|11505950|FG001|COMPLETED|Overall Study||69
10365624|NCT00528541|11505949|FG000|NOT COMPLETED|Overall Study||2
10365625|NCT00528541|11505950|FG001|NOT COMPLETED|Overall Study||1
10365626|NCT00528567|11505958|FG000|STARTED|Overall Study||1301
10365627|NCT00528567|11505959|FG001|STARTED|Overall Study||1290
10365628|NCT00528567|11505958|FG000|Intention to Treat|Overall Study||1301
10365629|NCT00528567|11505959|FG001|Intention to Treat|Overall Study||1290
10365630|NCT00528567|11505958|FG000|Safety Population|Overall Study||1288
10365631|NCT00528567|11505959|FG001|Safety Population|Overall Study||1271
10365632|NCT00528567|11505958|FG000|COMPLETED|Overall Study||870
10365633|NCT00528567|11505959|FG001|COMPLETED|Overall Study||982
10365634|NCT00528567|11505958|FG000|NOT COMPLETED|Overall Study||431
10365635|NCT00528567|11505959|FG001|NOT COMPLETED|Overall Study||308
10365636|NCT00528580|11505974|FG000|STARTED|Overall Study||34
10365637|NCT00528580|11505975|FG001|STARTED|Overall Study||34
10365638|NCT00528580|11505974|FG000|COMPLETED|Overall Study||34
10365639|NCT00528580|11505975|FG001|COMPLETED|Overall Study||34
10365640|NCT00528580|11505974|FG000|NOT COMPLETED|Overall Study||0
10365641|NCT00528580|11505975|FG001|NOT COMPLETED|Overall Study||0
10365642|NCT00528606|11505983|FG000|STARTED|Overall Study||204
10365643|NCT00528606|11505984|FG001|STARTED|Overall Study||104
10365644|NCT00528606|11505983|FG000|COMPLETED|Overall Study||191
10365645|NCT00528606|11505984|FG001|COMPLETED|Overall Study||100
10365646|NCT00528606|11505983|FG000|NOT COMPLETED|Overall Study||13
10365647|NCT00528606|11505984|FG001|NOT COMPLETED|Overall Study||4
10536069|NCT01440764|11688487|FG001|NOT COMPLETED|Test Day 2||0
10536070|NCT01440764|11688488|FG002|NOT COMPLETED|Test Day 2||0
10536071|NCT01440764|11688489|FG003|NOT COMPLETED|Test Day 2||0
10536072|NCT01440764|11688490|FG004|NOT COMPLETED|Test Day 2||0
10536073|NCT01440764|11688491|FG005|NOT COMPLETED|Test Day 2||0
10536074|NCT01440764|11688492|FG006|NOT COMPLETED|Test Day 2||0
10536075|NCT01440764|11688486|FG000|STARTED|Test Day 3||3
10536076|NCT01440764|11688487|FG001|STARTED|Test Day 3||2
10536077|NCT01440764|11688488|FG002|STARTED|Test Day 3||6
10536078|NCT01440764|11688489|FG003|STARTED|Test Day 3||1
10536079|NCT01440764|11688490|FG004|STARTED|Test Day 3||3
10536080|NCT01440764|11688491|FG005|STARTED|Test Day 3||5
10536081|NCT01440764|11688492|FG006|STARTED|Test Day 3||3
10536082|NCT01440764|11688486|FG000|COMPLETED|Test Day 3||3
10536083|NCT01440764|11688487|FG001|COMPLETED|Test Day 3||2
10365648|NCT00528645|11505990|FG000|STARTED|Overall Study||23
10365649|NCT00528645|11505990|FG000|COMPLETED|Overall Study||20
10365650|NCT00528645|11505990|FG000|NOT COMPLETED|Overall Study||3
10365651|NCT00528788|11505995|FG000|STARTED|Overall Study||24
10365652|NCT00528788|11505995|FG000|COMPLETED|Overall Study||20
10365653|NCT00528788|11505995|FG000|NOT COMPLETED|Overall Study||4
10365654|NCT00528801|11506001|FG000|STARTED|Overall Study||160
10365655|NCT00528801|11506002|FG001|STARTED|Overall Study||52
10365656|NCT00528801|11506001|FG000|COMPLETED|Overall Study||133
10536084|NCT01440764|11688488|FG002|COMPLETED|Test Day 3||6
10365657|NCT00528801|11506002|FG001|COMPLETED|Overall Study||41
10365658|NCT00528801|11506001|FG000|NOT COMPLETED|Overall Study||27
10365659|NCT00528801|11506002|FG001|NOT COMPLETED|Overall Study||11
10365660|NCT00528840|11506008|FG000|STARTED|Overall Study||201
10365661|NCT00528840|11506008|FG000|COMPLETED|Overall Study||168
10536085|NCT01440764|11688489|FG003|COMPLETED|Test Day 3||1
10365662|NCT00528840|11506008|FG000|NOT COMPLETED|Overall Study||33
10365663|NCT00528866|11506012|FG000|STARTED|Overall Study||80
10365664|NCT00528866|11506012|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|74
10365665|NCT00528866|11506012|FG000|NOT COMPLETED|Overall Study||6
10365666|NCT00528879|11506021|FG000|STARTED|Short-term Period (Day 1 to Week 24)||137
10716570|NCT02690649|11880314|FG001|NOT COMPLETED|Overall Study||4
10716571|NCT02690701|11880324|FG000|STARTED|Treatment Period 1||46
10716572|NCT02690701|11880325|FG001|STARTED|Treatment Period 1||45
10716573|NCT02690701|11880324|FG000|COMPLETED|Treatment Period 1||44
10716574|NCT02690701|11880325|FG001|COMPLETED|Treatment Period 1||42
10716575|NCT02690701|11880324|FG000|NOT COMPLETED|Treatment Period 1||2
10716576|NCT02690701|11880325|FG001|NOT COMPLETED|Treatment Period 1||3
10716577|NCT02690701|11880324|FG000|STARTED|Treatment Period 2|Completed Treatment Period 1 and continued to Treatment Period 2|44
10365667|NCT00528879|11506022|FG001|STARTED|Short-term Period (Day 1 to Week 24)||137
10365668|NCT00528879|11506023|FG002|STARTED|Short-term Period (Day 1 to Week 24)||137
10365669|NCT00528879|11506024|FG003|STARTED|Short-term Period (Day 1 to Week 24)||135
10365670|NCT00528879|11506021|FG000|Completed the Period|Short-term Period (Day 1 to Week 24)||119
10365671|NCT00528879|11506022|FG001|Completed the Period|Short-term Period (Day 1 to Week 24)||121
10365672|NCT00528879|11506023|FG002|Completed the Period|Short-term Period (Day 1 to Week 24)||122
10365673|NCT00528879|11506024|FG003|Completed the Period|Short-term Period (Day 1 to Week 24)||121
10365674|NCT00528879|11506021|FG000|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|115
10365675|NCT00528879|11506022|FG001|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|120
10365676|NCT00528879|11506023|FG002|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|122
10365677|NCT00528879|11506024|FG003|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|119
10365678|NCT00528879|11506021|FG000|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||22
10365679|NCT00528879|11506022|FG001|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||17
10365680|NCT00528879|11506023|FG002|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||15
10365681|NCT00528879|11506024|FG003|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||16
10365682|NCT00528879|11506021|FG000|STARTED|Long-term Period (Weeks 24 to 102)||115
10365683|NCT00528879|11506022|FG001|STARTED|Long-term Period (Weeks 24 to 102)||120
10365684|NCT00528879|11506023|FG002|STARTED|Long-term Period (Weeks 24 to 102)||122
10365685|NCT00528879|11506024|FG003|STARTED|Long-term Period (Weeks 24 to 102)||119
10365686|NCT00528879|11506021|FG000|COMPLETED|Long-term Period (Weeks 24 to 102)||73
10365687|NCT00528879|11506022|FG001|COMPLETED|Long-term Period (Weeks 24 to 102)||82
10365688|NCT00528879|11506023|FG002|COMPLETED|Long-term Period (Weeks 24 to 102)||89
10365689|NCT00528879|11506024|FG003|COMPLETED|Long-term Period (Weeks 24 to 102)||95
10365690|NCT00528879|11506021|FG000|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||42
10365691|NCT00528879|11506022|FG001|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||38
10365692|NCT00528879|11506023|FG002|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||33
10365693|NCT00528879|11506024|FG003|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||24
10365694|NCT00528931|11506034|FG000|STARTED|Overall Study||16
10365695|NCT00528931|11506034|FG000|COMPLETED|Overall Study||15
10365696|NCT00528931|11506034|FG000|NOT COMPLETED|Overall Study||1
10365697|NCT00528957|11506041|FG000|STARTED|Randomized Phase (Baseline to Week 48)||48
10365698|NCT00528957|11506042|FG001|STARTED|Randomized Phase (Baseline to Week 48)||49
10365699|NCT00528957|11506041|FG000|COMPLETED|Randomized Phase (Baseline to Week 48)||44
10365700|NCT00528957|11506042|FG001|COMPLETED|Randomized Phase (Baseline to Week 48)||48
10365701|NCT00528957|11506041|FG000|NOT COMPLETED|Randomized Phase (Baseline to Week 48)||4
10365702|NCT00528957|11506042|FG001|NOT COMPLETED|Randomized Phase (Baseline to Week 48)||1
10365703|NCT00528957|11506041|FG000|STARTED|First Extension (Week 48 to Week 144)|Six participants completed the 48-week randomized phase and did not enroll in the first extension.|38
10365704|NCT00528957|11506042|FG001|STARTED|First Extension (Week 48 to Week 144)|Seven participants completed the 48-week randomized phase and did not enroll in the first extension.|41
10365705|NCT00528957|11506041|FG000|COMPLETED|First Extension (Week 48 to Week 144)||35
10365706|NCT00528957|11506042|FG001|COMPLETED|First Extension (Week 48 to Week 144)||40
10536109|NCT01440816|11688523|FG001|STARTED|Overall Study||12
10365707|NCT00528957|11506041|FG000|NOT COMPLETED|First Extension (Week 48 to Week 144)||3
10365708|NCT00528957|11506042|FG001|NOT COMPLETED|First Extension (Week 48 to Week 144)||1
10365709|NCT00528957|11506041|FG000|STARTED|Second Extension (Week 144 to Week 240)|One participant completed the first extension and did not enroll in the second extension.|34
10365710|NCT00528957|11506042|FG001|STARTED|Second Extension (Week 144 to Week 240)||40
10365711|NCT00528957|11506041|FG000|COMPLETED|Second Extension (Week 144 to Week 240)||27
10365712|NCT00528957|11506042|FG001|COMPLETED|Second Extension (Week 144 to Week 240)||37
10365713|NCT00528957|11506041|FG000|NOT COMPLETED|Second Extension (Week 144 to Week 240)||7
10365714|NCT00528957|11506042|FG001|NOT COMPLETED|Second Extension (Week 144 to Week 240)||3
10365715|NCT00528957|11506041|FG000|STARTED|Third Extension (Week 240 to Week 336)||27
10365716|NCT00528957|11506042|FG001|STARTED|Third Extension (Week 240 to Week 336)||37
10365717|NCT00528957|11506041|FG000|COMPLETED|Third Extension (Week 240 to Week 336)||21
10365718|NCT00528957|11506042|FG001|COMPLETED|Third Extension (Week 240 to Week 336)||27
10365719|NCT00528957|11506041|FG000|NOT COMPLETED|Third Extension (Week 240 to Week 336)||6
10365720|NCT00528957|11506042|FG001|NOT COMPLETED|Third Extension (Week 240 to Week 336)||10
10427399|NCT00853047|11573199|FG004|NOT COMPLETED|Open-Label Extension Phase||0
10716578|NCT02690701|11880325|FG001|STARTED|Treatment Period 2||42
10716579|NCT02690701|11880324|FG000|COMPLETED|Treatment Period 2|Completed Treatment Period 2|41
10365721|NCT00528957|11506041|FG000|STARTED|Long-Term Extension (Week 336 and On)|Two participants completed the third extension and did not enroll in the long-term extension.|19
10365722|NCT00528957|11506042|FG001|STARTED|Long-Term Extension (Week 336 and On)|Two participants completed the third extension and did not enroll in the long-term extension.|25
10365723|NCT00528957|11506041|FG000|COMPLETED|Long-Term Extension (Week 336 and On)||9
10365724|NCT00528957|11506042|FG001|COMPLETED|Long-Term Extension (Week 336 and On)||8
10365725|NCT00528957|11506041|FG000|NOT COMPLETED|Long-Term Extension (Week 336 and On)||10
10365726|NCT00528957|11506042|FG001|NOT COMPLETED|Long-Term Extension (Week 336 and On)||17
10365727|NCT00528970|11506061|FG000|STARTED|Overall Study||124
10365728|NCT00528970|11506062|FG001|STARTED|Overall Study||125
10365729|NCT00528970|11506063|FG002|STARTED|Overall Study||125
10365730|NCT00528970|11506061|FG000|Received at Least 1 Dose of Study Drug|Overall Study||124
10365731|NCT00528970|11506062|FG001|Received at Least 1 Dose of Study Drug|Overall Study||125
10365732|NCT00528970|11506063|FG002|Received at Least 1 Dose of Study Drug|Overall Study||124
10365733|NCT00528970|11506061|FG000|COMPLETED|Overall Study||110
10365734|NCT00528970|11506062|FG001|COMPLETED|Overall Study||110
10365735|NCT00528970|11506063|FG002|COMPLETED|Overall Study||105
10365736|NCT00528970|11506061|FG000|NOT COMPLETED|Overall Study||14
10365737|NCT00528970|11506062|FG001|NOT COMPLETED|Overall Study||15
10365738|NCT00528970|11506063|FG002|NOT COMPLETED|Overall Study||20
10365739|NCT00528996|11506076|FG000|STARTED|Overall Study||429
10365740|NCT00528996|11506077|FG001|STARTED|Overall Study||419
10365741|NCT00528996|11506078|FG002|STARTED|Overall Study||415
10365742|NCT00528996|11506079|FG003|STARTED|Overall Study||390
10365743|NCT00528996|11506080|FG004|STARTED|Overall Study||427
10365744|NCT00528996|11506076|FG000|COMPLETED|Overall Study||365
10365745|NCT00528996|11506077|FG001|COMPLETED|Overall Study||395
10365746|NCT00528996|11506078|FG002|COMPLETED|Overall Study||372
10365747|NCT00528996|11506079|FG003|COMPLETED|Overall Study||340
10365748|NCT00528996|11506080|FG004|COMPLETED|Overall Study||390
10536086|NCT01440764|11688490|FG004|COMPLETED|Test Day 3||3
10536087|NCT01440764|11688491|FG005|COMPLETED|Test Day 3||5
10536088|NCT01440764|11688492|FG006|COMPLETED|Test Day 3||3
10536089|NCT01440764|11688486|FG000|NOT COMPLETED|Test Day 3||0
10536090|NCT01440764|11688487|FG001|NOT COMPLETED|Test Day 3||0
10536091|NCT01440764|11688488|FG002|NOT COMPLETED|Test Day 3||0
10536092|NCT01440764|11688489|FG003|NOT COMPLETED|Test Day 3||0
10536093|NCT01440764|11688490|FG004|NOT COMPLETED|Test Day 3||0
10656858|NCT02221882|11817974|FG001|Received at Least One Dose of Study Drug|Overall Study||3
10656859|NCT02221882|11817975|FG002|Received at Least One Dose of Study Drug|Overall Study||11
10656860|NCT02221882|11817976|FG003|Received at Least One Dose of Study Drug|Overall Study||3
10656861|NCT02221882|11817977|FG004|Received at Least One Dose of Study Drug|Overall Study||5
10656862|NCT02221882|11817978|FG005|Received at Least One Dose of Study Drug|Overall Study||4
10656863|NCT02221882|11817973|FG000|COMPLETED|Overall Study||3
10656864|NCT02221882|11817974|FG001|COMPLETED|Overall Study||2
10656865|NCT02221882|11817975|FG002|COMPLETED|Overall Study||7
10656866|NCT02221882|11817976|FG003|COMPLETED|Overall Study||1
10656867|NCT02221882|11817977|FG004|COMPLETED|Overall Study||3
10656868|NCT02221882|11817978|FG005|COMPLETED|Overall Study||2
10656869|NCT02221882|11817973|FG000|NOT COMPLETED|Overall Study||0
10656870|NCT02221882|11817974|FG001|NOT COMPLETED|Overall Study||1
10536094|NCT01440764|11688491|FG005|NOT COMPLETED|Test Day 3||0
10536095|NCT01440764|11688492|FG006|NOT COMPLETED|Test Day 3||0
10536096|NCT01440803|11688512|FG000|STARTED|Overall Study||13
10536097|NCT01440803|11688513|FG001|STARTED|Overall Study||28
10536098|NCT01440803|11688512|FG000|Period 1 - Forteo/Placebo|Overall Study||13
10536099|NCT01440803|11688513|FG001|Period 1 - Forteo/Placebo|Overall Study||28
10536100|NCT01440803|11688512|FG000|Period 2 - Forteo/Forteo|Overall Study||13
10536101|NCT01440803|11688513|FG001|Period 2 - Forteo/Forteo|Overall Study||28
10536102|NCT01440803|11688512|FG000|Period 3 - Forteo Open Label|Overall Study||13
10536103|NCT01440803|11688513|FG001|Period 3 - Forteo Open Label|Overall Study||27
10536104|NCT01440803|11688512|FG000|COMPLETED|Overall Study||11
10536105|NCT01440803|11688513|FG001|COMPLETED|Overall Study||24
10536106|NCT01440803|11688512|FG000|NOT COMPLETED|Overall Study||2
10536107|NCT01440803|11688513|FG001|NOT COMPLETED|Overall Study||4
10536108|NCT01440816|11688522|FG000|STARTED|Overall Study||3
10536110|NCT01440816|11688522|FG000|COMPLETED|Overall Study||2
10536111|NCT01440816|11688523|FG001|COMPLETED|Overall Study||1
10536112|NCT01440816|11688522|FG000|NOT COMPLETED|Overall Study||1
10536113|NCT01440816|11688523|FG001|NOT COMPLETED|Overall Study||11
10536114|NCT01440881|11688533|FG000|STARTED|Overall Study||14
10536115|NCT01440881|11688534|FG001|STARTED|Overall Study||15
10536116|NCT01440881|11688533|FG000|COMPLETED|Overall Study||14
10536117|NCT01440881|11688534|FG001|COMPLETED|Overall Study||14
10536118|NCT01440881|11688533|FG000|NOT COMPLETED|Overall Study||0
10536119|NCT01440881|11688534|FG001|NOT COMPLETED|Overall Study||1
10536120|NCT01440920|11688544|FG000|STARTED|Overall Study||3
10536121|NCT01440920|11688545|FG001|STARTED|Overall Study||3
10536122|NCT01440920|11688546|FG002|STARTED|Overall Study||3
10536123|NCT01440920|11688544|FG000|COMPLETED|Overall Study||3
10536124|NCT01440920|11688545|FG001|COMPLETED|Overall Study||3
10536125|NCT01440920|11688546|FG002|COMPLETED|Overall Study||3
10536126|NCT01440920|11688544|FG000|NOT COMPLETED|Overall Study||0
10536127|NCT01440920|11688545|FG001|NOT COMPLETED|Overall Study||0
10536128|NCT01440920|11688546|FG002|NOT COMPLETED|Overall Study||0
10536129|NCT01440946|11688556|FG000|STARTED|Overall Study||15
10365749|NCT00528996|11506076|FG000|NOT COMPLETED|Overall Study||64
10365750|NCT00528996|11506077|FG001|NOT COMPLETED|Overall Study||24
10365751|NCT00528996|11506078|FG002|NOT COMPLETED|Overall Study||43
10365752|NCT00528996|11506079|FG003|NOT COMPLETED|Overall Study||50
10365753|NCT00528996|11506080|FG004|NOT COMPLETED|Overall Study||37
10365754|NCT00529035|11506095|FG000|STARTED|Overall Study|29 enrolled|29
10365755|NCT00529035|11506095|FG000|COMPLETED|Overall Study|28 evaluable, 1 patient withdrew participation and was not evaluable|28
10365756|NCT00529035|11506095|FG000|NOT COMPLETED|Overall Study||1
10365757|NCT00529087|11506109|FG000|STARTED|Overall Study||150
10365758|NCT00529087|11506110|FG001|STARTED|Overall Study||148
10365759|NCT00529087|11506111|FG002|STARTED|Overall Study||162
10365760|NCT00529087|11506109|FG000|COMPLETED|Overall Study||122
10365761|NCT00529087|11506110|FG001|COMPLETED|Overall Study||120
10365762|NCT00529087|11506111|FG002|COMPLETED|Overall Study||146
10365763|NCT00529087|11506109|FG000|NOT COMPLETED|Overall Study||28
10365764|NCT00529087|11506110|FG001|NOT COMPLETED|Overall Study||28
10365765|NCT00529087|11506111|FG002|NOT COMPLETED|Overall Study||16
10365766|NCT00529100|11506132|FG000|STARTED|Overall Study||16
10365767|NCT00529100|11506133|FG001|STARTED|Overall Study||33
10365768|NCT00529100|11506132|FG000|Received at Least 1 Dose of Study Drug|Overall Study||16
10365769|NCT00529100|11506133|FG001|Received at Least 1 Dose of Study Drug|Overall Study||33
10365770|NCT00529100|11506132|FG000|COMPLETED|Overall Study||16
10365771|NCT00529100|11506133|FG001|COMPLETED|Overall Study||24
10365772|NCT00529100|11506132|FG000|NOT COMPLETED|Overall Study||0
10365773|NCT00529100|11506133|FG001|NOT COMPLETED|Overall Study||9
10365774|NCT00529126|11506147|FG000|STARTED|Overall Study||25
10365775|NCT00529126|11506148|FG001|STARTED|Overall Study||25
10365776|NCT00529126|11506149|FG002|STARTED|Overall Study||24
10365777|NCT00529126|11506150|FG003|STARTED|Overall Study||26
10365778|NCT00529126|11506147|FG000|COMPLETED|Overall Study||25
10365779|NCT00529126|11506148|FG001|COMPLETED|Overall Study||25
10365780|NCT00529126|11506149|FG002|COMPLETED|Overall Study||24
10365781|NCT00529126|11506150|FG003|COMPLETED|Overall Study||26
10365782|NCT00529126|11506147|FG000|NOT COMPLETED|Overall Study||0
10365783|NCT00529126|11506148|FG001|NOT COMPLETED|Overall Study||0
10365784|NCT00529126|11506149|FG002|NOT COMPLETED|Overall Study||0
10365785|NCT00529126|11506150|FG003|NOT COMPLETED|Overall Study||0
10365786|NCT00529191|11506162|FG000|STARTED|Overall Study||27
10365787|NCT00529191|11506163|FG001|STARTED|Overall Study||13
10365788|NCT00529191|11506162|FG000|COMPLETED|Overall Study||24
10365789|NCT00529191|11506163|FG001|COMPLETED|Overall Study||13
10365790|NCT00529191|11506162|FG000|NOT COMPLETED|Overall Study||3
10365791|NCT00529191|11506163|FG001|NOT COMPLETED|Overall Study||0
10365792|NCT00529204|11506178|FG000|STARTED|Overall Study||1
10365793|NCT00529204|11506178|FG000|COMPLETED|Overall Study||1
10365794|NCT00529204|11506178|FG000|NOT COMPLETED|Overall Study||0
10365795|NCT00529217|11506182|FG000|STARTED|Overall Study||12
10365796|NCT00529217|11506182|FG000|COMPLETED|Overall Study||8
10365797|NCT00529217|11506182|FG000|NOT COMPLETED|Overall Study||4
10365798|NCT00529243|11506187|FG000|STARTED|Overall Study||52
10365799|NCT00529243|11506187|FG000|COMPLETED|Overall Study||49
10365800|NCT00529243|11506187|FG000|NOT COMPLETED|Overall Study||3
10365801|NCT00529308|11506193|FG000|STARTED|Overall Study||9
10365802|NCT00529308|11506194|FG001|STARTED|Overall Study||11
10365803|NCT00529308|11506193|FG000|COMPLETED|Overall Study||8
10365804|NCT00529308|11506194|FG001|COMPLETED|Overall Study||10
10365805|NCT00529308|11506193|FG000|NOT COMPLETED|Overall Study||1
10365806|NCT00529308|11506194|FG001|NOT COMPLETED|Overall Study||1
10365807|NCT00529373|11506202|FG000|STARTED|Base Study||8043
10365808|NCT00529373|11506203|FG001|STARTED|Base Study||8028
10365809|NCT00529373|11506202|FG000|COMPLETED|Base Study||4297
10365810|NCT00529373|11506203|FG001|COMPLETED|Base Study||3960
10365811|NCT00529373|11506202|FG000|NOT COMPLETED|Base Study||3746
10365812|NCT00529373|11506203|FG001|NOT COMPLETED|Base Study||4068
10365813|NCT00529373|11506202|FG000|STARTED|First Extension Study||4297
10365814|NCT00529373|11506203|FG001|STARTED|First Extension Study||3960
10365815|NCT00529373|11506202|FG000|COMPLETED|First Extension Study||3144
10365816|NCT00529373|11506203|FG001|COMPLETED|First Extension Study||2309
10365817|NCT00529373|11506202|FG000|NOT COMPLETED|First Extension Study||1153
10365818|NCT00529373|11506203|FG001|NOT COMPLETED|First Extension Study||1651
10365819|NCT00529373|11506202|FG000|STARTED|Second Extension Study||3144
10365820|NCT00529373|11506203|FG001|STARTED|Second Extension Study||2309
10365821|NCT00529373|11506202|FG000|COMPLETED|Second Extension Study||2844
10365822|NCT00529373|11506203|FG001|COMPLETED|Second Extension Study||2112
10365823|NCT00529373|11506202|FG000|NOT COMPLETED|Second Extension Study||300
10365824|NCT00529373|11506203|FG001|NOT COMPLETED|Second Extension Study||197
10365825|NCT00529386|11506217|FG000|STARTED|Overall Study|Study has been discontinued|7
10365826|NCT00529386|11506217|FG000|COMPLETED|Overall Study|Study discontinued after 7 patients enrolled and analyzed|6
10365827|NCT00529386|11506217|FG000|NOT COMPLETED|Overall Study||1
10365828|NCT00529399|11506224|FG000|STARTED|Overall Study||48
10365829|NCT00529399|11506225|FG001|STARTED|Overall Study||49
10365830|NCT00529399|11506226|FG002|STARTED|Overall Study||48
10365831|NCT00529399|11506224|FG000|COMPLETED|Overall Study||46
10365832|NCT00529399|11506225|FG001|COMPLETED|Overall Study||48
10365833|NCT00529399|11506226|FG002|COMPLETED|Overall Study||46
10365834|NCT00529399|11506224|FG000|NOT COMPLETED|Overall Study||2
10365835|NCT00529399|11506225|FG001|NOT COMPLETED|Overall Study||1
10365836|NCT00529399|11506226|FG002|NOT COMPLETED|Overall Study||2
10365837|NCT00529451|11506238|FG000|STARTED|Overall Study||331
10365838|NCT00529451|11506239|FG001|STARTED|Overall Study||323
10365839|NCT00529451|11506240|FG002|STARTED|Overall Study||332
10365840|NCT00529451|11506241|FG003|STARTED|Overall Study||330
10365841|NCT00529451|11506238|FG000|COMPLETED|Overall Study||294
10365842|NCT00529451|11506239|FG001|COMPLETED|Overall Study||275
10365843|NCT00529451|11506240|FG002|COMPLETED|Overall Study||292
10365844|NCT00529451|11506241|FG003|COMPLETED|Overall Study||299
10365845|NCT00529451|11506238|FG000|NOT COMPLETED|Overall Study||37
10365846|NCT00529451|11506239|FG001|NOT COMPLETED|Overall Study||48
10365847|NCT00529451|11506240|FG002|NOT COMPLETED|Overall Study||40
10365848|NCT00529451|11506241|FG003|NOT COMPLETED|Overall Study||31
10365849|NCT00529516|11506257|FG000|STARTED|Overall Study||475
10365850|NCT00529516|11506258|FG001|STARTED|Overall Study||488
10365851|NCT00529516|11506259|FG002|STARTED|Overall Study||289
10365852|NCT00529516|11506257|FG000|COMPLETED|Overall Study||472
10365853|NCT00529516|11506258|FG001|COMPLETED|Overall Study||486
10365854|NCT00529516|11506259|FG002|COMPLETED|Overall Study||288
10365855|NCT00529516|11506257|FG000|NOT COMPLETED|Overall Study||3
10365856|NCT00529516|11506258|FG001|NOT COMPLETED|Overall Study||2
10365857|NCT00529516|11506259|FG002|NOT COMPLETED|Overall Study||1
10365858|NCT00529529|11506270|FG000|STARTED|Overall Study||268
10365859|NCT00529529|11506271|FG001|STARTED|Overall Study||268
10365860|NCT00529529|11506272|FG002|STARTED|Overall Study||269
10365861|NCT00529529|11506270|FG000|COMPLETED|Overall Study||225
10365862|NCT00529529|11506271|FG001|COMPLETED|Overall Study||225
10365863|NCT00529529|11506272|FG002|COMPLETED|Overall Study||238
10365864|NCT00529529|11506270|FG000|NOT COMPLETED|Overall Study||43
10365865|NCT00529529|11506271|FG001|NOT COMPLETED|Overall Study||43
10365866|NCT00529529|11506272|FG002|NOT COMPLETED|Overall Study||31
10365867|NCT00529542|11506282|FG000|STARTED|Overall Study||9
10365868|NCT00529542|11506283|FG001|STARTED|Overall Study||11
10365869|NCT00529542|11506282|FG000|COMPLETED|Overall Study||8
10365870|NCT00529542|11506283|FG001|COMPLETED|Overall Study||10
10365871|NCT00529542|11506282|FG000|NOT COMPLETED|Overall Study||1
10365872|NCT00529542|11506283|FG001|NOT COMPLETED|Overall Study||1
10365873|NCT00529555|11506292|FG000|STARTED|Overall Study||200
10365874|NCT00529555|11506293|FG001|STARTED|Overall Study||202
10365875|NCT00529555|11506294|FG002|STARTED|Overall Study||200
10365876|NCT00529555|11506292|FG000|COMPLETED|Overall Study||171
10365877|NCT00529555|11506293|FG001|COMPLETED|Overall Study||172
10365878|NCT00529555|11506294|FG002|COMPLETED|Overall Study||174
10365879|NCT00529555|11506292|FG000|NOT COMPLETED|Overall Study||29
10365880|NCT00529555|11506293|FG001|NOT COMPLETED|Overall Study||30
10365881|NCT00529555|11506294|FG002|NOT COMPLETED|Overall Study||26
10365882|NCT00529568|11506304|FG000|STARTED|Open-label Pre-Antiviral Treatment Phase||805
10365883|NCT00529568|11506305|FG001|STARTED|Open-label Pre-Antiviral Treatment Phase||0
10365884|NCT00529568|11506306|FG002|STARTED|Open-label Pre-Antiviral Treatment Phase||0
10365885|NCT00529568|11506304|FG000|COMPLETED|Open-label Pre-Antiviral Treatment Phase||759
10365886|NCT00529568|11506305|FG001|COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
10365887|NCT00529568|11506306|FG002|COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
10365888|NCT00529568|11506304|FG000|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||46
10365889|NCT00529568|11506305|FG001|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
10365890|NCT00529568|11506306|FG002|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
10365891|NCT00529568|11506304|FG000|STARTED|Double-bilnd Antiviral Treatment Phase||0
10365892|NCT00529568|11506305|FG001|STARTED|Double-bilnd Antiviral Treatment Phase||253
10365893|NCT00529568|11506306|FG002|STARTED|Double-bilnd Antiviral Treatment Phase||506
10365894|NCT00529568|11506304|FG000|COMPLETED|Double-bilnd Antiviral Treatment Phase||0
10365895|NCT00529568|11506305|FG001|COMPLETED|Double-bilnd Antiviral Treatment Phase||205
10365896|NCT00529568|11506306|FG002|COMPLETED|Double-bilnd Antiviral Treatment Phase||404
10365897|NCT00529568|11506304|FG000|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||0
10365898|NCT00529568|11506305|FG001|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||48
10365899|NCT00529568|11506306|FG002|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||102
10365900|NCT00529633|11506317|FG000|STARTED|Overall Study||2
10365901|NCT00529633|11506318|FG001|STARTED|Overall Study||2
10365902|NCT00529633|11506317|FG000|COMPLETED|Overall Study||1
10365903|NCT00529633|11506318|FG001|COMPLETED|Overall Study||1
10716580|NCT02690701|11880325|FG001|COMPLETED|Treatment Period 2||37
10716581|NCT02690701|11880324|FG000|NOT COMPLETED|Treatment Period 2||3
10365904|NCT00529633|11506317|FG000|NOT COMPLETED|Overall Study||1
10365905|NCT00529633|11506318|FG001|NOT COMPLETED|Overall Study||1
10365906|NCT00529659|11506326|FG000|STARTED|Overall Study||81
10365907|NCT00529659|11506327|FG001|STARTED|Overall Study||89
10365908|NCT00529659|11506326|FG000|COMPLETED|Overall Study||70
10365909|NCT00529659|11506327|FG001|COMPLETED|Overall Study||66
10365910|NCT00529659|11506326|FG000|NOT COMPLETED|Overall Study||11
10365911|NCT00529659|11506327|FG001|NOT COMPLETED|Overall Study||23
10365912|NCT00529789|11506333|FG000|STARTED|Study Period II/III||72
10365913|NCT00529789|11506333|FG000|COMPLETED|Study Period II/III||48
10365914|NCT00529789|11506333|FG000|NOT COMPLETED|Study Period II/III||24
10365915|NCT00529789|11506333|FG000|STARTED|Study Period IV||48
10365916|NCT00529789|11506333|FG000|COMPLETED|Study Period IV|Includes 1 patient who withdrew at last visit; didn't enter Taper; however received 30 weeks of drug|42
10365917|NCT00529789|11506333|FG000|NOT COMPLETED|Study Period IV||6
10365918|NCT00529802|11506343|FG000|STARTED|Evaluable for Primary Endpoint|60 patients started trial|60
10365919|NCT00529802|11506343|FG000|COMPLETED|Evaluable for Primary Endpoint|Evaluable for primary endpoint|50
10365920|NCT00529802|11506343|FG000|NOT COMPLETED|Evaluable for Primary Endpoint||10
10365921|NCT00529802|11506343|FG000|STARTED|Evaluable for Secondary Endpoint||50
10365922|NCT00529802|11506343|FG000|COMPLETED|Evaluable for Secondary Endpoint||48
10365923|NCT00529802|11506343|FG000|NOT COMPLETED|Evaluable for Secondary Endpoint||2
10365924|NCT00529958|11506352|FG000|STARTED|2-Year Follow-up||110
10365925|NCT00529958|11506353|FG001|STARTED|2-Year Follow-up|110 randomized to HT, but there was (n=1) cross-over from the DB group|110
10365926|NCT00529958|11506354|FG002|STARTED|2-Year Follow-up|110 randomized to DB, but there was (n=1) cross-over to the HT group|110
10365927|NCT00529958|11506352|FG000|COMPLETED|2-Year Follow-up||106
10365928|NCT00529958|11506353|FG001|COMPLETED|2-Year Follow-up|108 HT patients analyzed excludes n=1 cross-over patient (analyzed on intention-to-treat basis).|108
10365929|NCT00529958|11506354|FG002|COMPLETED|2-Year Follow-up|108 DB patients analyzed include 1 cross-over with HT graft (analyzed on intention-to-treat basis).|108
10365930|NCT00529958|11506352|FG000|NOT COMPLETED|2-Year Follow-up||4
10365931|NCT00529958|11506353|FG001|NOT COMPLETED|2-Year Follow-up||2
10365932|NCT00529958|11506354|FG002|NOT COMPLETED|2-Year Follow-up||2
10365933|NCT00529958|11506352|FG000|STARTED|5-Year Follow-up||106
10365934|NCT00529958|11506353|FG001|STARTED|5-Year Follow-up|108 HT patients available for 5-year follow-up excludes n=1 cross-over patient from the DB group|108
10365935|NCT00529958|11506354|FG002|STARTED|5-Year Follow-up|108 DB patients available for 5-year follow-up includes n=1 cross-over with a single-bundle HT graft|108
10365936|NCT00529958|11506352|FG000|COMPLETED|5-Year Follow-up||103
10365937|NCT00529958|11506353|FG001|COMPLETED|5-Year Follow-up||105
10365938|NCT00529958|11506354|FG002|COMPLETED|5-Year Follow-up||107
10365939|NCT00529958|11506352|FG000|NOT COMPLETED|5-Year Follow-up||3
10365940|NCT00529958|11506353|FG001|NOT COMPLETED|5-Year Follow-up||3
10365941|NCT00529958|11506354|FG002|NOT COMPLETED|5-Year Follow-up||1
10365942|NCT00530023|11506364|FG000|STARTED|Overall Study||14
10365943|NCT00530023|11506365|FG001|STARTED|Overall Study||15
10365944|NCT00530023|11506364|FG000|COMPLETED|Overall Study||14
10365945|NCT00530023|11506365|FG001|COMPLETED|Overall Study||14
10365946|NCT00530023|11506364|FG000|NOT COMPLETED|Overall Study||0
10365947|NCT00530023|11506365|FG001|NOT COMPLETED|Overall Study||1
10365948|NCT00530075|11506371|FG000|STARTED|Overall Study||45
10365949|NCT00530075|11506371|FG000|COMPLETED|Overall Study||38
10365950|NCT00530075|11506371|FG000|NOT COMPLETED|Overall Study||7
10365951|NCT00530088|11506375|FG000|STARTED|Overall Study||30
10365952|NCT00530088|11506375|FG000|COMPLETED|Overall Study||20
10365953|NCT00530088|11506375|FG000|NOT COMPLETED|Overall Study||10
10365954|NCT00530218|11506379|FG000|STARTED|Overall Study||61
10365955|NCT00530218|11506379|FG000|COMPLETED|Overall Study|CMV Reactivation Was Detected|36
10365956|NCT00530218|11506379|FG000|NOT COMPLETED|Overall Study||25
10365957|NCT00530257|11506386|FG000|STARTED|Overall Study||31
10365958|NCT00530257|11506386|FG000|COMPLETED|Overall Study||30
10365959|NCT00530257|11506386|FG000|NOT COMPLETED|Overall Study||1
10365960|NCT00530270|11506395|FG000|STARTED|Overall Study||6
10365961|NCT00530270|11506396|FG001|STARTED|Overall Study||6
10365962|NCT00530270|11506395|FG000|COMPLETED|Overall Study||5
10365963|NCT00530270|11506396|FG001|COMPLETED|Overall Study||6
10365964|NCT00530270|11506395|FG000|NOT COMPLETED|Overall Study||1
10365965|NCT00530270|11506396|FG001|NOT COMPLETED|Overall Study||0
10365966|NCT00530335|11506402|FG000|STARTED|Overall Study||45
10365967|NCT00530335|11506402|FG000|COMPLETED|Overall Study||39
10365968|NCT00530335|11506402|FG000|NOT COMPLETED|Overall Study||6
10365969|NCT00530348|11506408|FG000|STARTED|Overall Study|Randomized.|195
10365970|NCT00530348|11506409|FG001|STARTED|Overall Study|Randomized.|386
10365971|NCT00530348|11506408|FG000|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug.|187
10365972|NCT00530348|11506409|FG001|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug.|376
10365973|NCT00530348|11506408|FG000|COMPLETED|Overall Study||173
10365974|NCT00530348|11506409|FG001|COMPLETED|Overall Study||367
10365975|NCT00530348|11506408|FG000|NOT COMPLETED|Overall Study||22
10365976|NCT00530348|11506409|FG001|NOT COMPLETED|Overall Study||19
10365977|NCT00530439|11506417|FG000|STARTED|Overall Study||180
10365978|NCT00530439|11506418|FG001|STARTED|Overall Study||180
10365979|NCT00530439|11506417|FG000|COMPLETED|Overall Study||150
10536130|NCT01440946|11688557|FG001|STARTED|Overall Study||15
10536131|NCT01440946|11688556|FG000|COMPLETED|Overall Study||13
10536132|NCT01440946|11688557|FG001|COMPLETED|Overall Study||14
10536133|NCT01440946|11688556|FG000|NOT COMPLETED|Overall Study||2
10536134|NCT01440946|11688557|FG001|NOT COMPLETED|Overall Study||1
10536135|NCT01440959|11688564|FG000|STARTED|Overall Study||30
10536136|NCT01440959|11688564|FG000|COMPLETED|Overall Study||30
10536137|NCT01440959|11688564|FG000|NOT COMPLETED|Overall Study||0
10536138|NCT01440972|11688570|FG000|STARTED|Overall Study||24
10536139|NCT01440972|11688571|FG001|STARTED|Overall Study||21
10536140|NCT01440972|11688570|FG000|COMPLETED|Overall Study||21
10656871|NCT02221882|11817975|FG002|NOT COMPLETED|Overall Study||4
10656872|NCT02221882|11817976|FG003|NOT COMPLETED|Overall Study||2
10656873|NCT02221882|11817977|FG004|NOT COMPLETED|Overall Study||2
10656874|NCT02221882|11817978|FG005|NOT COMPLETED|Overall Study||2
10656875|NCT02221947|11817999|FG000|STARTED|Overall Study||6
10656876|NCT02221947|11818000|FG001|STARTED|Overall Study||3
10656877|NCT02221947|11817999|FG000|COMPLETED|Overall Study||6
10656878|NCT02221947|11818000|FG001|COMPLETED|Overall Study||3
10656879|NCT02221947|11817999|FG000|NOT COMPLETED|Overall Study||0
10656880|NCT02221947|11818000|FG001|NOT COMPLETED|Overall Study||0
10656881|NCT02222129|11818011|FG000|STARTED|Overall Study||100
10656882|NCT02222129|11818012|FG001|STARTED|Overall Study||106
10656883|NCT02222129|11818011|FG000|COMPLETED|Overall Study||100
10656884|NCT02222129|11818012|FG001|COMPLETED|Overall Study||106
10656885|NCT02222129|11818011|FG000|NOT COMPLETED|Overall Study||0
10365980|NCT00530439|11506418|FG001|COMPLETED|Overall Study||154
10365981|NCT00530439|11506417|FG000|NOT COMPLETED|Overall Study||30
10365982|NCT00530439|11506418|FG001|NOT COMPLETED|Overall Study||26
10365983|NCT00530504|11506424|FG000|STARTED|Overall Study||1500
10365984|NCT00530504|11506424|FG000|COMPLETED|Overall Study||1348
10365985|NCT00530504|11506424|FG000|NOT COMPLETED|Overall Study||152
10365986|NCT00530621|11506430|FG000|STARTED|Overall Study||80
10365987|NCT00530621|11506431|FG001|STARTED|Overall Study||80
10365988|NCT00530621|11506430|FG000|Received at Least 1 Dose of Study Drug|Overall Study||79
10365989|NCT00530621|11506431|FG001|Received at Least 1 Dose of Study Drug|Overall Study||80
10365990|NCT00530621|11506430|FG000|COMPLETED|Overall Study||0
10365991|NCT00530621|11506431|FG001|COMPLETED|Overall Study||0
10365992|NCT00530621|11506430|FG000|NOT COMPLETED|Overall Study||80
10365993|NCT00530621|11506431|FG001|NOT COMPLETED|Overall Study||80
10365994|NCT00530634|11506441|FG000|STARTED|Overall Study||3
10365995|NCT00530634|11506441|FG000|COMPLETED|Overall Study||3
10365996|NCT00530634|11506441|FG000|NOT COMPLETED|Overall Study||0
10365997|NCT00530712|11506445|FG000|STARTED|Enrollment|Total Enrolled Subjects|287
10365998|NCT00530712|11506445|FG000|COMPLETED|Enrollment|Subjects Available at Discharge|287
10365999|NCT00530712|11506445|FG000|NOT COMPLETED|Enrollment||0
10366000|NCT00530712|11506445|FG000|STARTED|30 Day Follow-up Visit|Subjects Expected for 30-Day Visit|287
10366001|NCT00530712|11506445|FG000|COMPLETED|30 Day Follow-up Visit|Subjects that Completed 30-Day Follow-up Visit|280
10366002|NCT00530712|11506445|FG000|NOT COMPLETED|30 Day Follow-up Visit||7
10366003|NCT00530712|11506445|FG000|STARTED|6 Month Follow-up Visit|Subjects Expected for 6-Month Visit|287
10366004|NCT00530712|11506445|FG000|COMPLETED|6 Month Follow-up Visit|Subjects that Completed 6-Month Follow-up Visit|275
10366005|NCT00530712|11506445|FG000|NOT COMPLETED|6 Month Follow-up Visit||12
10366006|NCT00530712|11506445|FG000|STARTED|12 Month Follow-up Visit|Subjects Expected for 12 Month Visit|287
10366007|NCT00530712|11506445|FG000|COMPLETED|12 Month Follow-up Visit|Subjects that Completed 12-Month Follow-up Visit|263
10366008|NCT00530712|11506445|FG000|NOT COMPLETED|12 Month Follow-up Visit||24
10366009|NCT00530764|11506454|FG000|STARTED|Overall Study||90
10366010|NCT00530764|11506455|FG001|STARTED|Overall Study||88
10366011|NCT00530764|11506456|FG002|STARTED|Overall Study||91
10366012|NCT00530764|11506457|FG003|STARTED|Overall Study||91
10366013|NCT00530764|11506454|FG000|COMPLETED|Overall Study||59
10366014|NCT00530764|11506455|FG001|COMPLETED|Overall Study||67
10366015|NCT00530764|11506456|FG002|COMPLETED|Overall Study||71
10366016|NCT00530764|11506457|FG003|COMPLETED|Overall Study||66
10366017|NCT00530764|11506454|FG000|NOT COMPLETED|Overall Study||31
10366018|NCT00530764|11506455|FG001|NOT COMPLETED|Overall Study||21
10366019|NCT00530764|11506456|FG002|NOT COMPLETED|Overall Study||20
10366020|NCT00530764|11506457|FG003|NOT COMPLETED|Overall Study||25
10366021|NCT00530777|11506472|FG000|STARTED|Overall Study||74
10366022|NCT00530777|11506473|FG001|STARTED|Overall Study||74
10366023|NCT00530777|11506472|FG000|COMPLETED|Overall Study||67
10366024|NCT00530777|11506473|FG001|COMPLETED|Overall Study||69
10366025|NCT00530777|11506472|FG000|NOT COMPLETED|Overall Study||7
10366026|NCT00530777|11506473|FG001|NOT COMPLETED|Overall Study||5
10366027|NCT00530790|11506479|FG000|STARTED|Overall Study||35
10366028|NCT00530790|11506479|FG000|COMPLETED|Overall Study||30
10366029|NCT00530790|11506479|FG000|NOT COMPLETED|Overall Study||5
10366030|NCT00530803|11506485|FG000|STARTED|Overall Study||50
10366031|NCT00530803|11506486|FG001|STARTED|Overall Study||50
10366032|NCT00530803|11506485|FG000|COMPLETED|Overall Study||50
10366033|NCT00530803|11506486|FG001|COMPLETED|Overall Study||50
10366034|NCT00530803|11506485|FG000|NOT COMPLETED|Overall Study||0
10366035|NCT00530803|11506486|FG001|NOT COMPLETED|Overall Study||0
10366036|NCT00530816|11506495|FG000|STARTED|Overall Study||35
10366037|NCT00530816|11506496|FG001|STARTED|Overall Study||59
10366038|NCT00530816|11506497|FG002|STARTED|Overall Study||70
10366039|NCT00530816|11506495|FG000|COMPLETED|Overall Study||9
10366040|NCT00530816|11506496|FG001|COMPLETED|Overall Study||17
10366041|NCT00530816|11506497|FG002|COMPLETED|Overall Study||29
10366042|NCT00530816|11506495|FG000|NOT COMPLETED|Overall Study||26
10366043|NCT00530816|11506496|FG001|NOT COMPLETED|Overall Study||42
10366044|NCT00530816|11506497|FG002|NOT COMPLETED|Overall Study||41
10366045|NCT00530842|11506507|FG000|STARTED|Overall Study||172
10366046|NCT00530842|11506508|FG001|STARTED|Overall Study||172
10366047|NCT00530842|11506507|FG000|COMPLETED|Overall Study||149
10366048|NCT00530842|11506508|FG001|COMPLETED|Overall Study||151
10716582|NCT02690701|11880325|FG001|NOT COMPLETED|Treatment Period 2||5
10716583|NCT02690714|11880332|FG000|STARTED|Segment 1: Single-dose Day -4 to Day 0||9
10716584|NCT02690714|11880332|FG000|COMPLETED|Segment 1: Single-dose Day -4 to Day 0|Six participants skipped Segment 1 as they had PK data from Phase 1 study 2002C005G.|9
10366049|NCT00530842|11506507|FG000|NOT COMPLETED|Overall Study||23
10366050|NCT00530842|11506508|FG001|NOT COMPLETED|Overall Study||21
10366051|NCT00530842|11506507|FG000|STARTED|Period 1||172
10366052|NCT00530842|11506508|FG001|STARTED|Period 1||172
10366053|NCT00530842|11506507|FG000|COMPLETED|Period 1||158
10366054|NCT00530842|11506508|FG001|COMPLETED|Period 1||161
10366055|NCT00530842|11506507|FG000|NOT COMPLETED|Period 1||14
10366056|NCT00530842|11506508|FG001|NOT COMPLETED|Period 1||11
10366057|NCT00530842|11506507|FG000|STARTED|Period 2||157
10366058|NCT00530842|11506508|FG001|STARTED|Period 2||160
10366059|NCT00530842|11506507|FG000|COMPLETED|Period 2||149
10366060|NCT00530842|11506508|FG001|COMPLETED|Period 2||151
10366061|NCT00530842|11506507|FG000|NOT COMPLETED|Period 2||8
10366062|NCT00530842|11506508|FG001|NOT COMPLETED|Period 2||9
10366063|NCT00530855|11506516|FG000|STARTED|Overall Study||322
10366064|NCT00530855|11506516|FG000|COMPLETED|Overall Study||210
10366065|NCT00530855|11506516|FG000|NOT COMPLETED|Overall Study||112
10366066|NCT00530894|11506524|FG000|STARTED|Overall Study||348
10366067|NCT00530894|11506525|FG001|STARTED|Overall Study||351
10366068|NCT00530894|11506526|FG002|STARTED|Overall Study||179
10366069|NCT00530894|11506527|FG003|STARTED|Overall Study||179
10366070|NCT00530894|11506524|FG000|COMPLETED|Overall Study||260
10366071|NCT00530894|11506525|FG001|COMPLETED|Overall Study||236
10366072|NCT00530894|11506526|FG002|COMPLETED|Overall Study||124
10366073|NCT00530894|11506527|FG003|COMPLETED|Overall Study||85
10366074|NCT00530894|11506524|FG000|NOT COMPLETED|Overall Study||88
10366075|NCT00530894|11506525|FG001|NOT COMPLETED|Overall Study||115
10366076|NCT00530894|11506526|FG002|NOT COMPLETED|Overall Study||55
10366077|NCT00530894|11506527|FG003|NOT COMPLETED|Overall Study||94
10366078|NCT00530920|11506542|FG000|STARTED|Overall Study||30
10366079|NCT00530920|11506543|FG001|STARTED|Overall Study||27
10366080|NCT00530920|11506544|FG002|STARTED|Overall Study||28
10366081|NCT00530920|11506542|FG000|COMPLETED|Overall Study||30
10366082|NCT00530920|11506543|FG001|COMPLETED|Overall Study||25
10366083|NCT00530920|11506544|FG002|COMPLETED|Overall Study||24
10536141|NCT01440972|11688571|FG001|COMPLETED|Overall Study||19
10536142|NCT01440972|11688570|FG000|NOT COMPLETED|Overall Study||3
10536143|NCT01440972|11688571|FG001|NOT COMPLETED|Overall Study||2
10536144|NCT01441037|11688577|FG000|STARTED|Overall Study||27
10536145|NCT01441037|11688577|FG000|COMPLETED|Overall Study||27
10536146|NCT01441037|11688577|FG000|NOT COMPLETED|Overall Study||0
10536147|NCT01441063|11688581|FG000|STARTED|Tocilizumab Alone||8
10536148|NCT01441063|11688581|FG000|COMPLETED|Tocilizumab Alone||5
10536149|NCT01441063|11688581|FG000|NOT COMPLETED|Tocilizumab Alone||3
10536150|NCT01441063|11688581|FG000|STARTED|Tocilizumab + Zidovudine /Valganciclovir||3
10536151|NCT01441063|11688581|FG000|COMPLETED|Tocilizumab + Zidovudine /Valganciclovir||2
10536152|NCT01441063|11688581|FG000|NOT COMPLETED|Tocilizumab + Zidovudine /Valganciclovir||1
10536153|NCT01441076|11688588|FG000|STARTED|Overall Study||6
10536154|NCT01441076|11688588|FG000|COMPLETED|Overall Study||4
10536155|NCT01441076|11688588|FG000|NOT COMPLETED|Overall Study||2
10536156|NCT01441102|11688592|FG000|STARTED|Overall Study|Two participants withdrew prior to Month 6; therefore, two additional participants were enrolled.|7
10536157|NCT01441102|11688592|FG000|COMPLETED|Overall Study||4
10536158|NCT01441102|11688592|FG000|NOT COMPLETED|Overall Study||3
10536159|NCT01441180|11688599|FG000|STARTED|Overall Study||10
10536160|NCT01441180|11688600|FG001|STARTED|Overall Study||25
10536161|NCT01441180|11688601|FG002|STARTED|Overall Study||25
10536162|NCT01441180|11688599|FG000|COMPLETED|Overall Study||9
10536163|NCT01441180|11688600|FG001|COMPLETED|Overall Study||24
10536164|NCT01441180|11688601|FG002|COMPLETED|Overall Study||22
10536165|NCT01441180|11688599|FG000|NOT COMPLETED|Overall Study||1
10536166|NCT01441180|11688600|FG001|NOT COMPLETED|Overall Study||1
10536167|NCT01441180|11688601|FG002|NOT COMPLETED|Overall Study||3
10536168|NCT01441245|11688614|FG000|STARTED|Overall Study||30
10536169|NCT01441245|11688615|FG001|STARTED|Overall Study||27
10536170|NCT01441245|11688614|FG000|COMPLETED|Overall Study||30
10536171|NCT01441245|11688615|FG001|COMPLETED|Overall Study||27
10536172|NCT01441245|11688614|FG000|NOT COMPLETED|Overall Study||0
10366084|NCT00530920|11506542|FG000|NOT COMPLETED|Overall Study||0
10366085|NCT00530920|11506543|FG001|NOT COMPLETED|Overall Study||2
10366086|NCT00530920|11506544|FG002|NOT COMPLETED|Overall Study||4
10366087|NCT00530946|11506557|FG000|STARTED|Overall Study||43
10366088|NCT00530946|11506558|FG001|STARTED|Overall Study||41
10366089|NCT00530946|11506559|FG002|STARTED|Overall Study||41
10366090|NCT00530946|11506560|FG003|STARTED|Overall Study||40
10366091|NCT00530946|11506557|FG000|COMPLETED|Overall Study||41
10366092|NCT00530946|11506558|FG001|COMPLETED|Overall Study||39
10366093|NCT00530946|11506559|FG002|COMPLETED|Overall Study||40
10366094|NCT00530946|11506560|FG003|COMPLETED|Overall Study||38
10366095|NCT00530946|11506557|FG000|NOT COMPLETED|Overall Study||2
10366096|NCT00530946|11506558|FG001|NOT COMPLETED|Overall Study||2
10366097|NCT00530946|11506559|FG002|NOT COMPLETED|Overall Study||1
10366098|NCT00530946|11506560|FG003|NOT COMPLETED|Overall Study||2
10366099|NCT00531011|11506572|FG000|STARTED|Overall Study||103
10366100|NCT00531011|11506573|FG001|STARTED|Overall Study||97
10366101|NCT00531011|11506572|FG000|COMPLETED|Overall Study||99
10366102|NCT00531011|11506573|FG001|COMPLETED|Overall Study||90
10366103|NCT00531011|11506572|FG000|NOT COMPLETED|Overall Study||4
10366104|NCT00531011|11506573|FG001|NOT COMPLETED|Overall Study||7
10366105|NCT00531050|11506585|FG000|STARTED|Part 1: Period 1||4
10366106|NCT00531050|11506586|FG001|STARTED|Part 1: Period 1||5
10366107|NCT00531050|11506587|FG002|STARTED|Part 1: Period 1||4
10366108|NCT00531050|11506588|FG003|STARTED|Part 1: Period 1||5
10366109|NCT00531050|11506589|FG004|STARTED|Part 1: Period 1||4
10366110|NCT00531050|11506590|FG005|STARTED|Part 1: Period 1||5
10366111|NCT00531050|11506585|FG000|COMPLETED|Part 1: Period 1||4
10366112|NCT00531050|11506586|FG001|COMPLETED|Part 1: Period 1||4
10366113|NCT00531050|11506587|FG002|COMPLETED|Part 1: Period 1||4
10366114|NCT00531050|11506588|FG003|COMPLETED|Part 1: Period 1||4
10366115|NCT00531050|11506589|FG004|COMPLETED|Part 1: Period 1||4
10366116|NCT00531050|11506590|FG005|COMPLETED|Part 1: Period 1||5
10536173|NCT01441245|11688615|FG001|NOT COMPLETED|Overall Study||0
10366117|NCT00531050|11506585|FG000|NOT COMPLETED|Part 1: Period 1||0
10366118|NCT00531050|11506586|FG001|NOT COMPLETED|Part 1: Period 1||1
10366119|NCT00531050|11506587|FG002|NOT COMPLETED|Part 1: Period 1||0
10366120|NCT00531050|11506588|FG003|NOT COMPLETED|Part 1: Period 1||1
10366121|NCT00531050|11506589|FG004|NOT COMPLETED|Part 1: Period 1||0
10366122|NCT00531050|11506590|FG005|NOT COMPLETED|Part 1: Period 1||0
10366123|NCT00531050|11506585|FG000|STARTED|Part 1: Period 2||4
10366124|NCT00531050|11506586|FG001|STARTED|Part 1: Period 2||4
10366125|NCT00531050|11506587|FG002|STARTED|Part 1: Period 2||4
10366126|NCT00531050|11506588|FG003|STARTED|Part 1: Period 2||4
10366127|NCT00531050|11506589|FG004|STARTED|Part 1: Period 2||4
10366128|NCT00531050|11506590|FG005|STARTED|Part 1: Period 2||5
10366129|NCT00531050|11506585|FG000|COMPLETED|Part 1: Period 2||4
10366130|NCT00531050|11506586|FG001|COMPLETED|Part 1: Period 2||4
10366131|NCT00531050|11506587|FG002|COMPLETED|Part 1: Period 2||4
10366132|NCT00531050|11506588|FG003|COMPLETED|Part 1: Period 2||4
10366133|NCT00531050|11506589|FG004|COMPLETED|Part 1: Period 2||4
10366134|NCT00531050|11506590|FG005|COMPLETED|Part 1: Period 2||5
10366135|NCT00531050|11506585|FG000|NOT COMPLETED|Part 1: Period 2||0
10366136|NCT00531050|11506586|FG001|NOT COMPLETED|Part 1: Period 2||0
10366137|NCT00531050|11506587|FG002|NOT COMPLETED|Part 1: Period 2||0
10366138|NCT00531050|11506588|FG003|NOT COMPLETED|Part 1: Period 2||0
10366139|NCT00531050|11506589|FG004|NOT COMPLETED|Part 1: Period 2||0
10366140|NCT00531050|11506590|FG005|NOT COMPLETED|Part 1: Period 2||0
10366141|NCT00531050|11506585|FG000|STARTED|Part 1: Period 3||4
10366142|NCT00531050|11506586|FG001|STARTED|Part 1: Period 3||4
10366143|NCT00531050|11506587|FG002|STARTED|Part 1: Period 3||4
10366144|NCT00531050|11506588|FG003|STARTED|Part 1: Period 3||4
10366145|NCT00531050|11506589|FG004|STARTED|Part 1: Period 3||4
10366146|NCT00531050|11506590|FG005|STARTED|Part 1: Period 3||5
10366147|NCT00531050|11506585|FG000|COMPLETED|Part 1: Period 3||3
10366148|NCT00531050|11506586|FG001|COMPLETED|Part 1: Period 3||4
10366149|NCT00531050|11506587|FG002|COMPLETED|Part 1: Period 3||4
10366150|NCT00531050|11506588|FG003|COMPLETED|Part 1: Period 3||4
10366151|NCT00531050|11506589|FG004|COMPLETED|Part 1: Period 3||4
10366152|NCT00531050|11506590|FG005|COMPLETED|Part 1: Period 3||5
10366153|NCT00531050|11506585|FG000|NOT COMPLETED|Part 1: Period 3||1
10366154|NCT00531050|11506586|FG001|NOT COMPLETED|Part 1: Period 3||0
10366155|NCT00531050|11506587|FG002|NOT COMPLETED|Part 1: Period 3||0
10366156|NCT00531050|11506588|FG003|NOT COMPLETED|Part 1: Period 3||0
10366157|NCT00531050|11506589|FG004|NOT COMPLETED|Part 1: Period 3||0
10366158|NCT00531050|11506590|FG005|NOT COMPLETED|Part 1: Period 3||0
10366159|NCT00531050|11506585|FG000|STARTED|Part 2: Period 1||3
10366160|NCT00531050|11506586|FG001|STARTED|Part 2: Period 1||4
10366161|NCT00531050|11506587|FG002|STARTED|Part 2: Period 1||4
10366162|NCT00531050|11506588|FG003|STARTED|Part 2: Period 1||4
10366163|NCT00531050|11506589|FG004|STARTED|Part 2: Period 1||4
10366164|NCT00531050|11506590|FG005|STARTED|Part 2: Period 1||5
10366165|NCT00531050|11506585|FG000|COMPLETED|Part 2: Period 1||3
10366166|NCT00531050|11506586|FG001|COMPLETED|Part 2: Period 1||4
10366167|NCT00531050|11506587|FG002|COMPLETED|Part 2: Period 1||4
10366168|NCT00531050|11506588|FG003|COMPLETED|Part 2: Period 1||4
10366169|NCT00531050|11506589|FG004|COMPLETED|Part 2: Period 1||4
10366170|NCT00531050|11506590|FG005|COMPLETED|Part 2: Period 1||4
10366171|NCT00531050|11506585|FG000|NOT COMPLETED|Part 2: Period 1||0
10366172|NCT00531050|11506586|FG001|NOT COMPLETED|Part 2: Period 1||0
10366173|NCT00531050|11506587|FG002|NOT COMPLETED|Part 2: Period 1||0
10366174|NCT00531050|11506588|FG003|NOT COMPLETED|Part 2: Period 1||0
10366175|NCT00531050|11506589|FG004|NOT COMPLETED|Part 2: Period 1||0
10366176|NCT00531050|11506590|FG005|NOT COMPLETED|Part 2: Period 1||1
10366177|NCT00531050|11506585|FG000|STARTED|Part 2: Period 2||3
10366178|NCT00531050|11506586|FG001|STARTED|Part 2: Period 2||4
10366179|NCT00531050|11506587|FG002|STARTED|Part 2: Period 2||4
10366180|NCT00531050|11506588|FG003|STARTED|Part 2: Period 2||4
10366181|NCT00531050|11506589|FG004|STARTED|Part 2: Period 2||4
10366182|NCT00531050|11506590|FG005|STARTED|Part 2: Period 2||4
10366183|NCT00531050|11506585|FG000|COMPLETED|Part 2: Period 2||3
10366184|NCT00531050|11506586|FG001|COMPLETED|Part 2: Period 2||4
10366185|NCT00531050|11506587|FG002|COMPLETED|Part 2: Period 2||4
10366186|NCT00531050|11506588|FG003|COMPLETED|Part 2: Period 2||4
10366187|NCT00531050|11506589|FG004|COMPLETED|Part 2: Period 2||4
10366188|NCT00531050|11506590|FG005|COMPLETED|Part 2: Period 2||4
10366189|NCT00531050|11506585|FG000|NOT COMPLETED|Part 2: Period 2||0
10366190|NCT00531050|11506586|FG001|NOT COMPLETED|Part 2: Period 2||0
10366191|NCT00531050|11506587|FG002|NOT COMPLETED|Part 2: Period 2||0
10366192|NCT00531050|11506588|FG003|NOT COMPLETED|Part 2: Period 2||0
10366193|NCT00531050|11506589|FG004|NOT COMPLETED|Part 2: Period 2||0
10366194|NCT00531050|11506590|FG005|NOT COMPLETED|Part 2: Period 2||0
10366195|NCT00531050|11506585|FG000|STARTED|Part 2: Period 3||3
10366196|NCT00531050|11506586|FG001|STARTED|Part 2: Period 3||4
10366197|NCT00531050|11506587|FG002|STARTED|Part 2: Period 3||4
10366198|NCT00531050|11506588|FG003|STARTED|Part 2: Period 3||4
10366199|NCT00531050|11506589|FG004|STARTED|Part 2: Period 3||4
10366200|NCT00531050|11506590|FG005|STARTED|Part 2: Period 3||4
10366201|NCT00531050|11506585|FG000|COMPLETED|Part 2: Period 3||2
10366202|NCT00531050|11506586|FG001|COMPLETED|Part 2: Period 3||4
10366203|NCT00531050|11506587|FG002|COMPLETED|Part 2: Period 3||4
10366204|NCT00531050|11506588|FG003|COMPLETED|Part 2: Period 3||4
10366205|NCT00531050|11506589|FG004|COMPLETED|Part 2: Period 3||4
10366206|NCT00531050|11506590|FG005|COMPLETED|Part 2: Period 3||3
10366207|NCT00531050|11506585|FG000|NOT COMPLETED|Part 2: Period 3||1
10366208|NCT00531050|11506586|FG001|NOT COMPLETED|Part 2: Period 3||0
10366209|NCT00531050|11506587|FG002|NOT COMPLETED|Part 2: Period 3||0
10366210|NCT00531050|11506588|FG003|NOT COMPLETED|Part 2: Period 3||0
10366211|NCT00531050|11506589|FG004|NOT COMPLETED|Part 2: Period 3||0
10366212|NCT00531050|11506590|FG005|NOT COMPLETED|Part 2: Period 3||1
10366213|NCT00531206|11506607|FG000|STARTED|Overall Study||65
10366214|NCT00531206|11506607|FG000|COMPLETED|Overall Study||45
10366215|NCT00531206|11506607|FG000|NOT COMPLETED|Overall Study||20
10366216|NCT00531284|11506628|FG000|STARTED|Overall Study||3
10366217|NCT00531284|11506629|FG001|STARTED|Overall Study||4
10366218|NCT00531284|11506630|FG002|STARTED|Overall Study||7
10366219|NCT00531284|11506631|FG003|STARTED|Overall Study||65
10366220|NCT00531284|11506632|FG004|STARTED|Overall Study||6
10366221|NCT00531284|11506633|FG005|STARTED|Overall Study||7
10366222|NCT00531284|11506634|FG006|STARTED|Overall Study||6
10536174|NCT01441401|11688637|FG000|STARTED|Overall Study||82
10536175|NCT01441401|11688637|FG000|COMPLETED|Overall Study|Number of participants whose survey form was collected was presented.|82
10536176|NCT01441401|11688637|FG000|NOT COMPLETED|Overall Study||0
10536177|NCT01441414|11688655|FG000|STARTED|Overall Study||18
10536178|NCT01441414|11688655|FG000|COMPLETED|Overall Study||3
10536179|NCT01441414|11688655|FG000|NOT COMPLETED|Overall Study||15
10536180|NCT01441440|11688674|FG000|STARTED|Overall Study|Safety analysis set|183
10536181|NCT01441440|11688675|FG001|STARTED|Overall Study|Safety analysis set|174
10536182|NCT01441440|11688676|FG002|STARTED|Overall Study|Safety analysis set|180
10536183|NCT01441440|11688674|FG000|COMPLETED|Overall Study||166
10536184|NCT01441440|11688675|FG001|COMPLETED|Overall Study||151
10536185|NCT01441440|11688676|FG002|COMPLETED|Overall Study||158
10536186|NCT01441440|11688674|FG000|NOT COMPLETED|Overall Study||17
10536187|NCT01441440|11688675|FG001|NOT COMPLETED|Overall Study||23
10536188|NCT01441440|11688676|FG002|NOT COMPLETED|Overall Study||22
10536189|NCT01441466|11688686|FG000|STARTED|Overall Study||37
10536190|NCT01441466|11688687|FG001|STARTED|Overall Study||11
10536191|NCT01441466|11688686|FG000|COMPLETED|Overall Study||37
10536192|NCT01441466|11688687|FG001|COMPLETED|Overall Study||11
10536193|NCT01441466|11688686|FG000|NOT COMPLETED|Overall Study||0
10536194|NCT01441466|11688687|FG001|NOT COMPLETED|Overall Study||0
10536195|NCT01441492|11688696|FG000|STARTED|Overall Study||197
10536196|NCT01441492|11688697|FG001|STARTED|Overall Study||202
10536197|NCT01441492|11688696|FG000|COMPLETED|Overall Study||170
10536198|NCT01441492|11688697|FG001|COMPLETED|Overall Study||174
10536199|NCT01441492|11688696|FG000|NOT COMPLETED|Overall Study||27
10536200|NCT01441492|11688697|FG001|NOT COMPLETED|Overall Study||28
10536201|NCT01441570|11688707|FG000|STARTED|Overall Study||6
10536202|NCT01441570|11688708|FG001|STARTED|Overall Study||5
10536203|NCT01441570|11688707|FG000|COMPLETED|Overall Study||6
10536204|NCT01441570|11688708|FG001|COMPLETED|Overall Study||5
10536205|NCT01441570|11688707|FG000|NOT COMPLETED|Overall Study||0
10536206|NCT01441570|11688708|FG001|NOT COMPLETED|Overall Study||0
10536207|NCT01441596|11688717|FG000|STARTED|Overall Study||40
10536208|NCT01441596|11688718|FG001|STARTED|Overall Study||38
10536209|NCT01441596|11688719|FG002|STARTED|Overall Study||43
10536210|NCT01441596|11688717|FG000|COMPLETED|Overall Study||36
10656886|NCT02222129|11818012|FG001|NOT COMPLETED|Overall Study||0
10656887|NCT02222181|11818018|FG000|STARTED|Overall Study||163
10656888|NCT02222181|11818018|FG000|COMPLETED|Overall Study||55
10656889|NCT02222181|11818018|FG000|NOT COMPLETED|Overall Study||108
10656890|NCT02222207|11818022|FG000|STARTED|Overall Study||52
10656891|NCT02222207|11818022|FG000|Treated and Valid for Full Analysis Set|Overall Study||51
10656892|NCT02222207|11818022|FG000|COMPLETED|Overall Study||48
10656893|NCT02222207|11818022|FG000|NOT COMPLETED|Overall Study||4
10656894|NCT02222246|11818028|FG000|STARTED|Overall Study||53
10716585|NCT02690714|11880332|FG000|NOT COMPLETED|Segment 1: Single-dose Day -4 to Day 0||0
10716586|NCT02690714|11880332|FG000|STARTED|Segment 2: Multi-dose Day 0 to Week 12||15
10716587|NCT02690714|11880332|FG000|COMPLETED|Segment 2: Multi-dose Day 0 to Week 12||15
10716588|NCT02690714|11880332|FG000|NOT COMPLETED|Segment 2: Multi-dose Day 0 to Week 12||0
10656895|NCT02222246|11818029|FG001|STARTED|Overall Study||53
10656896|NCT02222246|11818028|FG000|COMPLETED|Overall Study||26
10656897|NCT02222246|11818029|FG001|COMPLETED|Overall Study||26
10656898|NCT02222246|11818028|FG000|NOT COMPLETED|Overall Study||27
10716589|NCT02690714|11880332|FG000|STARTED|Segment 3: Extended Treatment Wks 12-48||15
10716590|NCT02690714|11880332|FG000|COMPLETED|Segment 3: Extended Treatment Wks 12-48||15
10366223|NCT00531284|11506635|FG007|STARTED|Overall Study||10
10366224|NCT00531284|11506636|FG008|STARTED|Overall Study||11
10366225|NCT00531284|11506637|FG009|STARTED|Overall Study||4
10366226|NCT00531284|11506638|FG010|STARTED|Overall Study||3
10366227|NCT00531284|11506639|FG011|STARTED|Overall Study||24
10366228|NCT00531284|11506640|FG012|STARTED|Overall Study||2
10366229|NCT00531284|11506641|FG013|STARTED|Overall Study||3
10366230|NCT00531284|11506642|FG014|STARTED|Overall Study||7
10366231|NCT00531284|11506643|FG015|STARTED|Overall Study||14
10366232|NCT00531284|11506644|FG016|STARTED|Overall Study||8
10366233|NCT00531284|11506628|FG000|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|0
10366234|NCT00531284|11506629|FG001|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|0
10536211|NCT01441596|11688718|FG001|COMPLETED|Overall Study||35
10536212|NCT01441596|11688719|FG002|COMPLETED|Overall Study||39
10536213|NCT01441596|11688717|FG000|NOT COMPLETED|Overall Study||4
10536214|NCT01441596|11688718|FG001|NOT COMPLETED|Overall Study||3
10366235|NCT00531284|11506630|FG002|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|1
10427400|NCT00853047|11573200|FG005|NOT COMPLETED|Open-Label Extension Phase||17
10536215|NCT01441596|11688719|FG002|NOT COMPLETED|Overall Study||4
10536216|NCT01441635|11688737|FG000|STARTED|Overall Study||32
10536217|NCT01441635|11688738|FG001|STARTED|Overall Study||33
10812582|NCT03500341|11974678|FG000|NOT COMPLETED|Overall Study||2
10366236|NCT00531284|11506631|FG003|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|2
10366237|NCT00531284|11506632|FG004|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
10366238|NCT00531284|11506633|FG005|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
10366239|NCT00531284|11506634|FG006|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
10366240|NCT00531284|11506635|FG007|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
10366241|NCT00531284|11506636|FG008|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
10366242|NCT00531284|11506637|FG009|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
10366243|NCT00531284|11506638|FG010|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
10366244|NCT00531284|11506639|FG011|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
10366245|NCT00531284|11506640|FG012|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
10366246|NCT00531284|11506641|FG013|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
10366247|NCT00531284|11506642|FG014|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|3
10366248|NCT00531284|11506643|FG015|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|2
10366249|NCT00531284|11506644|FG016|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
10366250|NCT00531284|11506628|FG000|NOT COMPLETED|Overall Study||3
10366251|NCT00531284|11506629|FG001|NOT COMPLETED|Overall Study||4
10366252|NCT00531284|11506630|FG002|NOT COMPLETED|Overall Study||6
10366253|NCT00531284|11506631|FG003|NOT COMPLETED|Overall Study||63
10366254|NCT00531284|11506632|FG004|NOT COMPLETED|Overall Study||6
10366255|NCT00531284|11506633|FG005|NOT COMPLETED|Overall Study||7
10366256|NCT00531284|11506634|FG006|NOT COMPLETED|Overall Study||6
10366257|NCT00531284|11506635|FG007|NOT COMPLETED|Overall Study||10
10366258|NCT00531284|11506636|FG008|NOT COMPLETED|Overall Study||11
10366259|NCT00531284|11506637|FG009|NOT COMPLETED|Overall Study||4
10366260|NCT00531284|11506638|FG010|NOT COMPLETED|Overall Study||3
10366261|NCT00531284|11506639|FG011|NOT COMPLETED|Overall Study||24
10366262|NCT00531284|11506640|FG012|NOT COMPLETED|Overall Study||2
10366263|NCT00531284|11506641|FG013|NOT COMPLETED|Overall Study||3
10366264|NCT00531284|11506642|FG014|NOT COMPLETED|Overall Study||4
10366265|NCT00531284|11506643|FG015|NOT COMPLETED|Overall Study||12
10366266|NCT00531284|11506644|FG016|NOT COMPLETED|Overall Study||8
10366267|NCT00531427|11506702|FG000|STARTED|Overall Study||282
10366268|NCT00531427|11506703|FG001|STARTED|Overall Study||285
10366269|NCT00531427|11506702|FG000|COMPLETED|Overall Study||209
10366270|NCT00531427|11506703|FG001|COMPLETED|Overall Study||191
10366271|NCT00531427|11506702|FG000|NOT COMPLETED|Overall Study||73
10366272|NCT00531427|11506703|FG001|NOT COMPLETED|Overall Study||94
10366273|NCT00531453|11506712|FG000|STARTED|Overall Study|02 October 2007|49
10366274|NCT00531453|11506713|FG001|STARTED|Overall Study|02 October 2007|49
10366275|NCT00531453|11506712|FG000|COMPLETED|Overall Study|10 April 2009|49
10366276|NCT00531453|11506713|FG001|COMPLETED|Overall Study|10 April 2009|49
10366277|NCT00531453|11506712|FG000|NOT COMPLETED|Overall Study||0
10366278|NCT00531453|11506713|FG001|NOT COMPLETED|Overall Study||0
10366279|NCT00531479|11506721|FG000|STARTED|Overall Study||230
10366280|NCT00531479|11506722|FG001|STARTED|Overall Study||229
10366281|NCT00531479|11506721|FG000|Treated|Overall Study||228
10366282|NCT00531479|11506722|FG001|Treated|Overall Study||226
10366283|NCT00531479|11506721|FG000|COMPLETED|Overall Study||154
10366284|NCT00531479|11506722|FG001|COMPLETED|Overall Study||146
10366285|NCT00531479|11506721|FG000|NOT COMPLETED|Overall Study||76
10366286|NCT00531479|11506722|FG001|NOT COMPLETED|Overall Study||83
10366287|NCT00531518|11506730|FG000|STARTED|Overall Study||87
10366288|NCT00531518|11506731|FG001|STARTED|Overall Study||205
10366289|NCT00531518|11506730|FG000|COMPLETED|Overall Study||55
10366290|NCT00531518|11506731|FG001|COMPLETED|Overall Study||134
10366291|NCT00531518|11506730|FG000|NOT COMPLETED|Overall Study||32
10366292|NCT00531518|11506731|FG001|NOT COMPLETED|Overall Study||71
10366293|NCT00531661|11506739|FG000|STARTED|6 Months||270
10366294|NCT00531661|11506740|FG001|STARTED|6 Months||280
10366295|NCT00531661|11506739|FG000|COMPLETED|6 Months||244
10366296|NCT00531661|11506740|FG001|COMPLETED|6 Months||254
10366297|NCT00531661|11506739|FG000|NOT COMPLETED|6 Months||26
10366298|NCT00531661|11506740|FG001|NOT COMPLETED|6 Months||26
10366299|NCT00531661|11506739|FG000|STARTED|Study Duration: 15 Months Avg. Follow-up||244
10366300|NCT00531661|11506740|FG001|STARTED|Study Duration: 15 Months Avg. Follow-up||254
10366301|NCT00531661|11506739|FG000|COMPLETED|Study Duration: 15 Months Avg. Follow-up||186
10366302|NCT00531661|11506740|FG001|COMPLETED|Study Duration: 15 Months Avg. Follow-up||197
10366303|NCT00531661|11506739|FG000|NOT COMPLETED|Study Duration: 15 Months Avg. Follow-up||58
10366304|NCT00531661|11506740|FG001|NOT COMPLETED|Study Duration: 15 Months Avg. Follow-up||57
10366305|NCT00531752|11506753|FG000|STARTED|First Double-blind Intervention Period||17
10366306|NCT00531752|11506754|FG001|STARTED|First Double-blind Intervention Period||17
10366307|NCT00531752|11506755|FG002|STARTED|First Double-blind Intervention Period||16
10366308|NCT00531752|11506756|FG003|STARTED|First Double-blind Intervention Period||16
10366309|NCT00531752|11506753|FG000|Treated|First Double-blind Intervention Period||16
10366310|NCT00531752|11506754|FG001|Treated|First Double-blind Intervention Period||17
10366311|NCT00531752|11506755|FG002|Treated|First Double-blind Intervention Period||16
10366312|NCT00531752|11506756|FG003|Treated|First Double-blind Intervention Period||16
10366313|NCT00531752|11506753|FG000|COMPLETED|First Double-blind Intervention Period||11
10366314|NCT00531752|11506754|FG001|COMPLETED|First Double-blind Intervention Period||13
10366315|NCT00531752|11506755|FG002|COMPLETED|First Double-blind Intervention Period||9
10366316|NCT00531752|11506756|FG003|COMPLETED|First Double-blind Intervention Period||13
10366317|NCT00531752|11506753|FG000|NOT COMPLETED|First Double-blind Intervention Period||6
10366318|NCT00531752|11506754|FG001|NOT COMPLETED|First Double-blind Intervention Period||4
10366319|NCT00531752|11506755|FG002|NOT COMPLETED|First Double-blind Intervention Period||7
10366320|NCT00531752|11506756|FG003|NOT COMPLETED|First Double-blind Intervention Period||3
10366321|NCT00531752|11506753|FG000|STARTED|Wash-out Period (at Least 7 Days)||11
10366322|NCT00531752|11506754|FG001|STARTED|Wash-out Period (at Least 7 Days)||13
10366323|NCT00531752|11506755|FG002|STARTED|Wash-out Period (at Least 7 Days)||9
10366324|NCT00531752|11506756|FG003|STARTED|Wash-out Period (at Least 7 Days)||13
10366325|NCT00531752|11506753|FG000|COMPLETED|Wash-out Period (at Least 7 Days)||11
10366326|NCT00531752|11506754|FG001|COMPLETED|Wash-out Period (at Least 7 Days)||13
10366327|NCT00531752|11506755|FG002|COMPLETED|Wash-out Period (at Least 7 Days)||9
10366328|NCT00531752|11506756|FG003|COMPLETED|Wash-out Period (at Least 7 Days)||13
10366329|NCT00531752|11506753|FG000|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
10366330|NCT00531752|11506754|FG001|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
10366331|NCT00531752|11506755|FG002|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
10716591|NCT02690714|11880332|FG000|NOT COMPLETED|Segment 3: Extended Treatment Wks 12-48||0
10716592|NCT02690714|11880332|FG000|STARTED|Post-Wk 48: Safety Week 48 to EoS Visit|3 subjects from Norway did not go past 48 weeks|12
10366332|NCT00531752|11506756|FG003|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
10366333|NCT00531752|11506753|FG000|STARTED|Second Double-blind Intervention Period||11
10366334|NCT00531752|11506754|FG001|STARTED|Second Double-blind Intervention Period||13
10366335|NCT00531752|11506755|FG002|STARTED|Second Double-blind Intervention Period||9
10366336|NCT00531752|11506756|FG003|STARTED|Second Double-blind Intervention Period||13
10366337|NCT00531752|11506753|FG000|COMPLETED|Second Double-blind Intervention Period||9
10366338|NCT00531752|11506754|FG001|COMPLETED|Second Double-blind Intervention Period||11
10366339|NCT00531752|11506755|FG002|COMPLETED|Second Double-blind Intervention Period||9
10366340|NCT00531752|11506756|FG003|COMPLETED|Second Double-blind Intervention Period||11
10366341|NCT00531752|11506753|FG000|NOT COMPLETED|Second Double-blind Intervention Period||2
10366342|NCT00531752|11506754|FG001|NOT COMPLETED|Second Double-blind Intervention Period||2
10366343|NCT00531752|11506755|FG002|NOT COMPLETED|Second Double-blind Intervention Period||0
10366344|NCT00531752|11506756|FG003|NOT COMPLETED|Second Double-blind Intervention Period||2
10366345|NCT00531817|11506766|FG000|STARTED|Randomized||412
10366346|NCT00531817|11506767|FG001|STARTED|Randomized||207
10366347|NCT00531817|11506766|FG000|Received Study Drug in Core Study|Randomized|3 patients did not receive any study medication. Intent-to-treat population = 409.|409
10366348|NCT00531817|11506767|FG001|Received Study Drug in Core Study|Randomized|2 patients did not receive any study medication. Intent-to-treat population = 205.|205
10366349|NCT00531817|11506766|FG000|COMPLETED|Randomized||353
10366350|NCT00531817|11506767|FG001|COMPLETED|Randomized||173
10366351|NCT00531817|11506766|FG000|NOT COMPLETED|Randomized||59
10366352|NCT00531817|11506767|FG001|NOT COMPLETED|Randomized||34
10366353|NCT00531817|11506766|FG000|STARTED|Entered Extended Treatment Period|Eligible patients completing core study could participate in extension at investigator's discretion.|343
10366354|NCT00531817|11506767|FG001|STARTED|Entered Extended Treatment Period|Eligible patients completing core study could participate in extension at investigator's discretion.|170
10366355|NCT00531817|11506766|FG000|COMPLETED|Entered Extended Treatment Period||206
10366356|NCT00531817|11506767|FG001|COMPLETED|Entered Extended Treatment Period||113
10366357|NCT00531817|11506766|FG000|NOT COMPLETED|Entered Extended Treatment Period||137
10366358|NCT00531817|11506767|FG001|NOT COMPLETED|Entered Extended Treatment Period||57
10366359|NCT00531843|11506776|FG000|STARTED|Overall Study||81
10366360|NCT00531843|11506777|FG001|STARTED|Overall Study||6
10366361|NCT00531843|11506776|FG000|COMPLETED|Overall Study||81
10366362|NCT00531843|11506777|FG001|COMPLETED|Overall Study||6
10366363|NCT00531843|11506776|FG000|NOT COMPLETED|Overall Study||0
10366364|NCT00531843|11506777|FG001|NOT COMPLETED|Overall Study||0
10366365|NCT00531882|11506786|FG000|STARTED|Overall Study||10
10366366|NCT00531882|11506787|FG001|STARTED|Overall Study||10
10366367|NCT00531882|11506788|FG002|STARTED|Overall Study||5
10366368|NCT00531882|11506786|FG000|COMPLETED|Overall Study||10
10366369|NCT00531882|11506787|FG001|COMPLETED|Overall Study||10
10366370|NCT00531882|11506788|FG002|COMPLETED|Overall Study||5
10366371|NCT00531882|11506786|FG000|NOT COMPLETED|Overall Study||0
10366372|NCT00531882|11506787|FG001|NOT COMPLETED|Overall Study||0
10366373|NCT00531882|11506788|FG002|NOT COMPLETED|Overall Study||0
10366374|NCT00531934|11506798|FG000|STARTED|Overall Study||73
10366375|NCT00531934|11506799|FG001|STARTED|Overall Study||74
10366376|NCT00531934|11506798|FG000|COMPLETED|Overall Study||7
10366377|NCT00531934|11506799|FG001|COMPLETED|Overall Study||11
10366378|NCT00531934|11506798|FG000|NOT COMPLETED|Overall Study||66
10366379|NCT00531934|11506799|FG001|NOT COMPLETED|Overall Study||63
10366380|NCT00531947|11506807|FG000|STARTED|Overall Study|all randomized subjects who received at least one dose of placebo study medication|156
10366381|NCT00531947|11506808|FG001|STARTED|Overall Study|all randomized subjects who received at least one dose of EMSAM study medication|152
10777246|NCT03338296|11939188|FG000|Safety Analysis Set|Overall Study||139
10366382|NCT00531947|11506807|FG000|COMPLETED|Overall Study||114
10366383|NCT00531947|11506808|FG001|COMPLETED|Overall Study||101
10366384|NCT00531947|11506807|FG000|NOT COMPLETED|Overall Study||42
10366385|NCT00531947|11506808|FG001|NOT COMPLETED|Overall Study||51
10366386|NCT00531960|11506816|FG000|STARTED|Overall Study||61
10366387|NCT00531960|11506817|FG001|STARTED|Overall Study||63
10366388|NCT00531960|11506816|FG000|COMPLETED|Overall Study||0
10366389|NCT00531960|11506817|FG001|COMPLETED|Overall Study||0
10366390|NCT00531960|11506816|FG000|NOT COMPLETED|Overall Study||61
10536218|NCT01441635|11688739|FG002|STARTED|Overall Study||16
10536219|NCT01441635|11688740|FG003|STARTED|Overall Study||35
10536220|NCT01441635|11688741|FG004|STARTED|Overall Study||18
10536221|NCT01441635|11688742|FG005|STARTED|Overall Study||34
10536222|NCT01441635|11688743|FG006|STARTED|Overall Study||30
10536223|NCT01441635|11688744|FG007|STARTED|Overall Study||30
10536224|NCT01441635|11688745|FG008|STARTED|Overall Study||16
10536225|NCT01441635|11688746|FG009|STARTED|Overall Study||27
10536226|NCT01441635|11688737|FG000|COMPLETED|Overall Study||26
10536227|NCT01441635|11688738|FG001|COMPLETED|Overall Study||27
10536228|NCT01441635|11688739|FG002|COMPLETED|Overall Study||13
10536229|NCT01441635|11688740|FG003|COMPLETED|Overall Study||28
10536230|NCT01441635|11688741|FG004|COMPLETED|Overall Study||16
10536231|NCT01441635|11688742|FG005|COMPLETED|Overall Study||29
10536232|NCT01441635|11688743|FG006|COMPLETED|Overall Study||24
10536233|NCT01441635|11688744|FG007|COMPLETED|Overall Study||26
10536234|NCT01441635|11688745|FG008|COMPLETED|Overall Study||14
10536235|NCT01441635|11688746|FG009|COMPLETED|Overall Study||25
10536236|NCT01441635|11688737|FG000|NOT COMPLETED|Overall Study||6
10536237|NCT01441635|11688738|FG001|NOT COMPLETED|Overall Study||6
10536238|NCT01441635|11688739|FG002|NOT COMPLETED|Overall Study||3
10536239|NCT01441635|11688740|FG003|NOT COMPLETED|Overall Study||7
10536240|NCT01441635|11688741|FG004|NOT COMPLETED|Overall Study||2
10536241|NCT01441635|11688742|FG005|NOT COMPLETED|Overall Study||5
10536242|NCT01441635|11688743|FG006|NOT COMPLETED|Overall Study||6
10536243|NCT01441635|11688744|FG007|NOT COMPLETED|Overall Study||4
10536244|NCT01441635|11688745|FG008|NOT COMPLETED|Overall Study||2
10536245|NCT01441635|11688746|FG009|NOT COMPLETED|Overall Study||2
10536246|NCT01441765|11688770|FG000|STARTED|Overall Study||11
10536247|NCT01441765|11688771|FG001|STARTED|Overall Study|not opened|0
10536248|NCT01441765|11688770|FG000|COMPLETED|Overall Study||10
10536249|NCT01441765|11688771|FG001|COMPLETED|Overall Study|not opened|0
10536250|NCT01441765|11688770|FG000|NOT COMPLETED|Overall Study||1
10536251|NCT01441765|11688771|FG001|NOT COMPLETED|Overall Study||0
10536252|NCT01441843|11688779|FG000|STARTED|Overall Study||200
10716593|NCT02690714|11880332|FG000|COMPLETED|Post-Wk 48: Safety Week 48 to EoS Visit||10
10716594|NCT02690714|11880332|FG000|NOT COMPLETED|Post-Wk 48: Safety Week 48 to EoS Visit||2
10716595|NCT02690727|11880340|FG000|STARTED|Overall Study||9
10716596|NCT02690727|11880341|FG001|STARTED|Overall Study||9
10716597|NCT02690727|11880340|FG000|COMPLETED|Overall Study||7
10716598|NCT02690727|11880341|FG001|COMPLETED|Overall Study||7
10716599|NCT02690727|11880340|FG000|NOT COMPLETED|Overall Study||2
10716600|NCT02690727|11880341|FG001|NOT COMPLETED|Overall Study||2
10777247|NCT03338296|11939189|FG001|Safety Analysis Set|Overall Study||136
10777248|NCT03338296|11939188|FG000|COMPLETED|Overall Study||36
10777249|NCT03338296|11939189|FG001|COMPLETED|Overall Study||31
10777250|NCT03338296|11939188|FG000|NOT COMPLETED|Overall Study||103
10777251|NCT03338296|11939189|FG001|NOT COMPLETED|Overall Study||108
10777252|NCT03338400|11939197|FG000|STARTED|Overall Study||25
10777253|NCT03338400|11939198|FG001|STARTED|Overall Study||26
10777254|NCT03338400|11939197|FG000|COMPLETED|Overall Study||24
10777255|NCT03338400|11939198|FG001|COMPLETED|Overall Study||24
10777256|NCT03338400|11939197|FG000|NOT COMPLETED|Overall Study||1
10777257|NCT03338400|11939198|FG001|NOT COMPLETED|Overall Study||2
10777258|NCT03338556|11939216|FG000|STARTED|Overall Study||25
10777259|NCT03338556|11939217|FG001|STARTED|Overall Study||27
10366391|NCT00531960|11506817|FG001|NOT COMPLETED|Overall Study||63
10366392|NCT00532129|11506823|FG000|STARTED|Treatment Period||100
10366393|NCT00532129|11506823|FG000|COMPLETED|Treatment Period||51
10366394|NCT00532129|11506823|FG000|NOT COMPLETED|Treatment Period||49
10366395|NCT00532129|11506823|FG000|STARTED|Follow-up Period||98
10366396|NCT00532129|11506823|FG000|COMPLETED|Follow-up Period||33
10366397|NCT00532129|11506823|FG000|NOT COMPLETED|Follow-up Period||65
10366398|NCT00532155|11506829|FG000|STARTED|Overall Study||457
10366399|NCT00532155|11506830|FG001|STARTED|Overall Study||456
10366400|NCT00532155|11506829|FG000|SAFETY POPULATION|Overall Study||455
10366401|NCT00532155|11506830|FG001|SAFETY POPULATION|Overall Study||450
10366402|NCT00532155|11506829|FG000|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria|0
10366403|NCT00532155|11506830|FG001|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria|0
10366404|NCT00532155|11506829|FG000|NOT COMPLETED|Overall Study||457
10536253|NCT01441843|11688780|FG001|STARTED|Overall Study||200
10536254|NCT01441843|11688779|FG000|COMPLETED|Overall Study||188
10536255|NCT01441843|11688780|FG001|COMPLETED|Overall Study||195
10536256|NCT01441843|11688779|FG000|NOT COMPLETED|Overall Study||12
10536257|NCT01441843|11688780|FG001|NOT COMPLETED|Overall Study||5
10536258|NCT01441882|11688786|FG000|STARTED|Overall Study||19
10536259|NCT01441882|11688786|FG000|COMPLETED|Overall Study||13
10536260|NCT01441882|11688786|FG000|NOT COMPLETED|Overall Study||6
10536261|NCT01441960|11688790|FG000|STARTED|First Neuromuscular Blocking Agent:||26
10536262|NCT01441960|11688791|FG001|STARTED|First Neuromuscular Blocking Agent:||19
10366405|NCT00532155|11506830|FG001|NOT COMPLETED|Overall Study||456
10366406|NCT00532259|11506836|FG000|STARTED|Overall Study||72
10366407|NCT00532259|11506836|FG000|COMPLETED|Overall Study||40
10366408|NCT00532259|11506836|FG000|NOT COMPLETED|Overall Study||32
10366409|NCT00532298|11506847|FG000|STARTED|Overall Study||269
10366410|NCT00532298|11506848|FG001|STARTED|Overall Study||266
10366411|NCT00532298|11506849|FG002|STARTED|Overall Study||264
10366412|NCT00532298|11506850|FG003|STARTED|Overall Study||264
10366413|NCT00532298|11506851|FG004|STARTED|Overall Study||268
10366414|NCT00532298|11506852|FG005|STARTED|Overall Study||263
10366415|NCT00532298|11506847|FG000|COMPLETED|Overall Study||267
10366416|NCT00532298|11506848|FG001|COMPLETED|Overall Study||265
10366417|NCT00532298|11506849|FG002|COMPLETED|Overall Study||263
10366418|NCT00532298|11506850|FG003|COMPLETED|Overall Study||264
10366419|NCT00532298|11506851|FG004|COMPLETED|Overall Study||267
10366420|NCT00532298|11506852|FG005|COMPLETED|Overall Study||261
10366421|NCT00532298|11506847|FG000|NOT COMPLETED|Overall Study||2
10366422|NCT00532298|11506848|FG001|NOT COMPLETED|Overall Study||1
10366423|NCT00532298|11506849|FG002|NOT COMPLETED|Overall Study||1
10366424|NCT00532298|11506850|FG003|NOT COMPLETED|Overall Study||0
10366425|NCT00532298|11506851|FG004|NOT COMPLETED|Overall Study||1
10366426|NCT00532298|11506852|FG005|NOT COMPLETED|Overall Study||2
10366427|NCT00532441|11506866|FG000|STARTED|Overall Study||14
10366428|NCT00532441|11506867|FG001|STARTED|Overall Study||11
10366429|NCT00532441|11506866|FG000|COMPLETED|Overall Study||13
10366430|NCT00532441|11506867|FG001|COMPLETED|Overall Study||11
10366431|NCT00532441|11506866|FG000|NOT COMPLETED|Overall Study||1
10366432|NCT00532441|11506867|FG001|NOT COMPLETED|Overall Study||0
10366433|NCT00532480|11506876|FG000|STARTED|Overall Study||10
10366434|NCT00532480|11506876|FG000|COMPLETED|Overall Study||7
10366435|NCT00532480|11506876|FG000|NOT COMPLETED|Overall Study||3
10366436|NCT00532493|11506882|FG000|STARTED|Overall Study||152
10366437|NCT00532493|11506883|FG001|STARTED|Overall Study||152
10366438|NCT00532493|11506882|FG000|COMPLETED|Overall Study||122
10366439|NCT00532493|11506883|FG001|COMPLETED|Overall Study||123
10366440|NCT00532493|11506882|FG000|NOT COMPLETED|Overall Study||30
10366441|NCT00532493|11506883|FG001|NOT COMPLETED|Overall Study||29
10366442|NCT00532779|11506894|FG000|STARTED|Overall Study||578
10366443|NCT00532779|11506895|FG001|STARTED|Overall Study||583
10366444|NCT00532779|11506896|FG002|STARTED|Overall Study||581
10366445|NCT00532779|11506894|FG000|COMPLETED|Overall Study||284
10366446|NCT00532779|11506895|FG001|COMPLETED|Overall Study||296
10366447|NCT00532779|11506896|FG002|COMPLETED|Overall Study||290
10366448|NCT00532779|11506894|FG000|NOT COMPLETED|Overall Study||294
10366449|NCT00532779|11506895|FG001|NOT COMPLETED|Overall Study||287
10366450|NCT00532779|11506896|FG002|NOT COMPLETED|Overall Study||291
10366451|NCT00532844|11506906|FG000|STARTED|Treatment Period - Day 1 to Day 14|Only the 48 subjects enrolled in the final protocol are included in the participant flow.|24
10366452|NCT00532844|11506907|FG001|STARTED|Treatment Period - Day 1 to Day 14|Only the 48 subjects enrolled in the final protocol are included in the participant flow.|24
10366453|NCT00532844|11506906|FG000|COMPLETED|Treatment Period - Day 1 to Day 14||24
10366454|NCT00532844|11506907|FG001|COMPLETED|Treatment Period - Day 1 to Day 14||23
10366455|NCT00532844|11506906|FG000|NOT COMPLETED|Treatment Period - Day 1 to Day 14||0
10366456|NCT00532844|11506907|FG001|NOT COMPLETED|Treatment Period - Day 1 to Day 14||1
10366457|NCT00532844|11506906|FG000|STARTED|Washout (1 Day)||24
10366458|NCT00532844|11506907|FG001|STARTED|Washout (1 Day)||23
10366459|NCT00532844|11506906|FG000|COMPLETED|Washout (1 Day)||24
10366460|NCT00532844|11506907|FG001|COMPLETED|Washout (1 Day)||23
10366461|NCT00532844|11506906|FG000|NOT COMPLETED|Washout (1 Day)||0
10366462|NCT00532844|11506907|FG001|NOT COMPLETED|Washout (1 Day)||0
10366463|NCT00532844|11506906|FG000|STARTED|Treatment Period - Day 15 to Day 28||24
10366464|NCT00532844|11506907|FG001|STARTED|Treatment Period - Day 15 to Day 28||23
10366465|NCT00532844|11506906|FG000|COMPLETED|Treatment Period - Day 15 to Day 28||20
10366466|NCT00532844|11506907|FG001|COMPLETED|Treatment Period - Day 15 to Day 28||23
10366467|NCT00532844|11506906|FG000|NOT COMPLETED|Treatment Period - Day 15 to Day 28||4
10366468|NCT00532844|11506907|FG001|NOT COMPLETED|Treatment Period - Day 15 to Day 28||0
10366469|NCT00532883|11506930|FG000|STARTED|Overall Study||11
10366470|NCT00532883|11506931|FG001|STARTED|Overall Study||12
10366471|NCT00532883|11506932|FG002|STARTED|Overall Study||10
10366472|NCT00532883|11506933|FG003|STARTED|Overall Study||11
10366473|NCT00532883|11506930|FG000|COMPLETED|Overall Study|Study terminated early.|5
10366474|NCT00532883|11506931|FG001|COMPLETED|Overall Study|Study terminated early.|5
10366475|NCT00532883|11506932|FG002|COMPLETED|Overall Study|Study terminated early.|6
10366476|NCT00532883|11506933|FG003|COMPLETED|Overall Study|Study terminated early.|6
10366477|NCT00532883|11506930|FG000|NOT COMPLETED|Overall Study||6
10366478|NCT00532883|11506931|FG001|NOT COMPLETED|Overall Study||7
10366479|NCT00532883|11506932|FG002|NOT COMPLETED|Overall Study||4
10366480|NCT00532883|11506933|FG003|NOT COMPLETED|Overall Study||5
10366481|NCT00532935|11506945|FG000|STARTED|Overall Study|Excludes 1 patient who was randomized twice at different sites.|261
10366482|NCT00532935|11506946|FG001|STARTED|Overall Study|Excludes 1 patient who was randomized twice at different sites.|256
10366483|NCT00532935|11506945|FG000|COMPLETED|Overall Study||210
10366484|NCT00532935|11506946|FG001|COMPLETED|Overall Study||204
10366485|NCT00532935|11506945|FG000|NOT COMPLETED|Overall Study||51
10366486|NCT00532935|11506946|FG001|NOT COMPLETED|Overall Study||52
10366487|NCT00532948|11506955|FG000|STARTED|Overall Study||4
10366488|NCT00532948|11506956|FG001|STARTED|Overall Study||14
10366489|NCT00532948|11506957|FG002|STARTED|Overall Study||6
10366490|NCT00532948|11506955|FG000|COMPLETED|Overall Study||0
10366491|NCT00532948|11506956|FG001|COMPLETED|Overall Study||9
10366492|NCT00532948|11506957|FG002|COMPLETED|Overall Study||2
10366493|NCT00532948|11506955|FG000|NOT COMPLETED|Overall Study||4
10366494|NCT00532948|11506956|FG001|NOT COMPLETED|Overall Study||5
10366495|NCT00532948|11506957|FG002|NOT COMPLETED|Overall Study||4
10366496|NCT00533117|11506973|FG000|STARTED|Overall Study||18
10366497|NCT00533117|11506974|FG001|STARTED|Overall Study||19
10366498|NCT00533117|11506975|FG002|STARTED|Overall Study||20
10366499|NCT00533117|11506976|FG003|STARTED|Overall Study||18
10366500|NCT00533117|11506973|FG000|COMPLETED|Overall Study||14
10366501|NCT00533117|11506974|FG001|COMPLETED|Overall Study||14
10366502|NCT00533117|11506975|FG002|COMPLETED|Overall Study||14
10366503|NCT00533117|11506976|FG003|COMPLETED|Overall Study||13
10366504|NCT00533117|11506973|FG000|NOT COMPLETED|Overall Study||4
10366505|NCT00533117|11506974|FG001|NOT COMPLETED|Overall Study||5
10366506|NCT00533117|11506975|FG002|NOT COMPLETED|Overall Study||6
10366507|NCT00533117|11506976|FG003|NOT COMPLETED|Overall Study||5
10366508|NCT00533273|11506988|FG000|STARTED|Double-blind||45
10366509|NCT00533273|11506989|FG001|STARTED|Double-blind||21
10366510|NCT00533273|11506988|FG000|COMPLETED|Double-blind||45
10366511|NCT00533273|11506989|FG001|COMPLETED|Double-blind||19
10366512|NCT00533273|11506988|FG000|NOT COMPLETED|Double-blind||0
10366513|NCT00533273|11506989|FG001|NOT COMPLETED|Double-blind||2
10366514|NCT00533273|11506988|FG000|STARTED|Open-label|open-label was extension of double-blind; 64 of 66 patients continued into open-label|64
10366515|NCT00533273|11506989|FG001|STARTED|Open-label|no placebo - this phase was open label|0
10366516|NCT00533273|11506988|FG000|COMPLETED|Open-label||58
10366517|NCT00533273|11506989|FG001|COMPLETED|Open-label||0
10366518|NCT00533273|11506988|FG000|NOT COMPLETED|Open-label||6
10366519|NCT00533273|11506989|FG001|NOT COMPLETED|Open-label||0
10366520|NCT00533429|11506997|FG000|STARTED|Overall Study||20
10366521|NCT00533429|11506998|FG001|STARTED|Overall Study||20
10366522|NCT00533429|11506997|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20
10366523|NCT00533429|11506998|FG001|Received at Least 1 Dose of Study Drug|Overall Study||20
10366524|NCT00533429|11506997|FG000|Entered Maintenance|Overall Study||8
10366525|NCT00533429|11506998|FG001|Entered Maintenance|Overall Study||10
10366526|NCT00533429|11506997|FG000|COMPLETED|Overall Study||1
10366527|NCT00533429|11506998|FG001|COMPLETED|Overall Study||4
10366528|NCT00533429|11506997|FG000|NOT COMPLETED|Overall Study||19
10366529|NCT00533429|11506998|FG001|NOT COMPLETED|Overall Study||16
10366530|NCT00533442|11507008|FG000|STARTED|Allocation and Intent to Treat Analysis||86
10366531|NCT00533442|11507009|FG001|STARTED|Allocation and Intent to Treat Analysis||84
10366532|NCT00533442|11507008|FG000|COMPLETED|Allocation and Intent to Treat Analysis||86
10366533|NCT00533442|11507009|FG001|COMPLETED|Allocation and Intent to Treat Analysis||84
10366534|NCT00533442|11507008|FG000|NOT COMPLETED|Allocation and Intent to Treat Analysis||0
10366535|NCT00533442|11507009|FG001|NOT COMPLETED|Allocation and Intent to Treat Analysis||0
10366536|NCT00533442|11507008|FG000|STARTED|Follow-up|Ongoing Follow-up at 13-123 months (N=77); Lost to Follow-up (N=9, at 5-100 months).|86
10366537|NCT00533442|11507009|FG001|STARTED|Follow-up|Ongoing Follow-up at 17-124 months (N=74); Lost to Follow-up (N=10, at 5-67 months).|84
10366538|NCT00533442|11507008|FG000|COMPLETED|Follow-up||77
10366539|NCT00533442|11507009|FG001|COMPLETED|Follow-up||74
10366540|NCT00533442|11507008|FG000|NOT COMPLETED|Follow-up||9
10366541|NCT00533442|11507009|FG001|NOT COMPLETED|Follow-up||10
10366542|NCT00533507|11507017|FG000|STARTED|Overall Study||230
10366543|NCT00533507|11507017|FG000|COMPLETED|Overall Study||229
10366544|NCT00533507|11507017|FG000|NOT COMPLETED|Overall Study||1
10366545|NCT00533546|11507021|FG000|STARTED|Overall Study||12
10366546|NCT00533546|11507021|FG000|COMPLETED|Overall Study||12
10366547|NCT00533546|11507021|FG000|NOT COMPLETED|Overall Study||0
10366548|NCT00533702|11507028|FG000|STARTED|Overall Study||54
10366549|NCT00533702|11507029|FG001|STARTED|Overall Study||52
10366550|NCT00533702|11507028|FG000|Received Any Quantity of Study Drug|Overall Study||52
10366551|NCT00533702|11507029|FG001|Received Any Quantity of Study Drug|Overall Study||50
10366552|NCT00533702|11507028|FG000|COMPLETED|Overall Study||49
10366553|NCT00533702|11507029|FG001|COMPLETED|Overall Study||50
10366554|NCT00533702|11507028|FG000|NOT COMPLETED|Overall Study||5
10366555|NCT00533702|11507029|FG001|NOT COMPLETED|Overall Study||2
10427401|NCT00853073|11573217|FG000|STARTED|Overall Study||32
10427402|NCT00853073|11573218|FG001|STARTED|Overall Study||31
10427403|NCT00853073|11573217|FG000|COMPLETED|Overall Study||29
10427404|NCT00853073|11573218|FG001|COMPLETED|Overall Study||29
10427405|NCT00853073|11573217|FG000|NOT COMPLETED|Overall Study||3
10427406|NCT00853073|11573218|FG001|NOT COMPLETED|Overall Study||2
10427407|NCT00853099|11573227|FG000|STARTED|Double-blind Period||96
10427408|NCT00853099|11573228|FG001|STARTED|Double-blind Period||87
10427409|NCT00853099|11573229|FG002|STARTED|Double-blind Period||91
10427410|NCT00853099|11573230|FG003|STARTED|Double-blind Period||0
10427411|NCT00853099|11573227|FG000|Treated|Double-blind Period||96
10427412|NCT00853099|11573228|FG001|Treated|Double-blind Period||87
10427413|NCT00853099|11573229|FG002|Treated|Double-blind Period|1 participant, incorrectly treated with open-label (rescue) study drug at Week 0, was excluded.|90
10427414|NCT00853099|11573230|FG003|Treated|Double-blind Period||0
10427415|NCT00853099|11573227|FG000|Completed Week 8|Double-blind Period||92
10427416|NCT00853099|11573228|FG001|Completed Week 8|Double-blind Period||85
10427417|NCT00853099|11573229|FG002|Completed Week 8|Double-blind Period||86
10427418|NCT00853099|11573230|FG003|Completed Week 8|Double-blind Period||0
10427419|NCT00853099|11573227|FG000|COMPLETED|Double-blind Period|Participants who completed Week 52.|73
10429830|NCT00866697|11575956|FG001|COMPLETED|Overall Study||244
10366556|NCT00533845|11507037|FG000|STARTED|Overall Study||15
10366557|NCT00533845|11507038|FG001|STARTED|Overall Study||15
10366558|NCT00533845|11507037|FG000|COMPLETED|Overall Study||14
10366559|NCT00533845|11507038|FG001|COMPLETED|Overall Study||15
10366560|NCT00533845|11507037|FG000|NOT COMPLETED|Overall Study||1
10366561|NCT00533845|11507038|FG001|NOT COMPLETED|Overall Study||0
10366562|NCT00533897|11507047|FG000|STARTED|Lead-in (LI) Period 1||167
10366563|NCT00533897|11507048|FG001|STARTED|Lead-in (LI) Period 1||0
10366564|NCT00533897|11507049|FG002|STARTED|Lead-in (LI) Period 1||0
10366565|NCT00533897|11507050|FG003|STARTED|Lead-in (LI) Period 1||0
10366566|NCT00533897|11507051|FG004|STARTED|Lead-in (LI) Period 1||0
10366567|NCT00533897|11507052|FG005|STARTED|Lead-in (LI) Period 1||0
10366568|NCT00533897|11507053|FG006|STARTED|Lead-in (LI) Period 1||0
10366569|NCT00533897|11507054|FG007|STARTED|Lead-in (LI) Period 1||0
10366570|NCT00533897|11507047|FG000|COMPLETED|Lead-in (LI) Period 1|37 participants entered the LTE directly and did not enter the DBW Period nor receive DBW treatment.|157
10366571|NCT00533897|11507048|FG001|COMPLETED|Lead-in (LI) Period 1||0
10366572|NCT00533897|11507049|FG002|COMPLETED|Lead-in (LI) Period 1||0
10366573|NCT00533897|11507050|FG003|COMPLETED|Lead-in (LI) Period 1||0
10366574|NCT00533897|11507051|FG004|COMPLETED|Lead-in (LI) Period 1||0
10366575|NCT00533897|11507052|FG005|COMPLETED|Lead-in (LI) Period 1||0
10366576|NCT00533897|11507053|FG006|COMPLETED|Lead-in (LI) Period 1||0
10366577|NCT00533897|11507054|FG007|COMPLETED|Lead-in (LI) Period 1||0
10366578|NCT00533897|11507047|FG000|NOT COMPLETED|Lead-in (LI) Period 1||10
10536263|NCT01441960|11688790|FG000|COMPLETED|First Neuromuscular Blocking Agent:||18
10536264|NCT01441960|11688791|FG001|COMPLETED|First Neuromuscular Blocking Agent:||13
10536265|NCT01441960|11688790|FG000|NOT COMPLETED|First Neuromuscular Blocking Agent:||8
10536266|NCT01441960|11688791|FG001|NOT COMPLETED|First Neuromuscular Blocking Agent:||6
10536267|NCT01441960|11688790|FG000|STARTED|Second Neuromuscular Blocking Agent||18
10536268|NCT01441960|11688791|FG001|STARTED|Second Neuromuscular Blocking Agent||13
10536269|NCT01441960|11688790|FG000|COMPLETED|Second Neuromuscular Blocking Agent||18
10536270|NCT01441960|11688791|FG001|COMPLETED|Second Neuromuscular Blocking Agent||13
10536271|NCT01441960|11688790|FG000|NOT COMPLETED|Second Neuromuscular Blocking Agent||0
10536272|NCT01441960|11688791|FG001|NOT COMPLETED|Second Neuromuscular Blocking Agent||0
10536273|NCT01441973|11688803|FG000|STARTED|Overall Study||15
10536274|NCT01441973|11688804|FG001|STARTED|Overall Study||16
10536275|NCT01441973|11688803|FG000|COMPLETED|Overall Study|Still receiving treatment|0
10536276|NCT01441973|11688804|FG001|COMPLETED|Overall Study|Still receiving treatment|0
10536277|NCT01441973|11688803|FG000|NOT COMPLETED|Overall Study||15
10536278|NCT01441973|11688804|FG001|NOT COMPLETED|Overall Study||16
10536279|NCT01442038|11688813|FG000|STARTED|Overall Study||1332
10536280|NCT01442038|11688814|FG001|STARTED|Overall Study||1319
10536281|NCT01442038|11688813|FG000|COMPLETED|Overall Study||1029
10536282|NCT01442038|11688814|FG001|COMPLETED|Overall Study||1040
10536283|NCT01442038|11688813|FG000|NOT COMPLETED|Overall Study||303
10536284|NCT01442038|11688814|FG001|NOT COMPLETED|Overall Study||279
10536285|NCT01442064|11688826|FG000|STARTED|Overall Study||97
10536286|NCT01442064|11688827|FG001|STARTED|Overall Study||103
10536287|NCT01442064|11688828|FG002|STARTED|Overall Study||104
10536288|NCT01442064|11688829|FG003|STARTED|Overall Study||98
10536289|NCT01442064|11688830|FG004|STARTED|Overall Study||107
10536290|NCT01442064|11688831|FG005|STARTED|Overall Study||99
10536291|NCT01442064|11688826|FG000|Ranibizumab-Treated Subjects|Overall Study|Includes participants who received Ranibizumab in either the initial studies or the extension study.|93
10536292|NCT01442064|11688827|FG001|Ranibizumab-Treated Subjects|Overall Study||103
10536293|NCT01442064|11688828|FG002|Ranibizumab-Treated Subjects|Overall Study||104
10536294|NCT01442064|11688829|FG003|Ranibizumab-Treated Subjects|Overall Study||96
10536295|NCT01442064|11688830|FG004|Ranibizumab-Treated Subjects|Overall Study||107
10536296|NCT01442064|11688831|FG005|Ranibizumab-Treated Subjects|Overall Study||99
10536297|NCT01442064|11688826|FG000|Received Study Drug in Extension Study|Overall Study||61
10536298|NCT01442064|11688827|FG001|Received Study Drug in Extension Study|Overall Study||70
10536299|NCT01442064|11688828|FG002|Received Study Drug in Extension Study|Overall Study||60
10536300|NCT01442064|11688829|FG003|Received Study Drug in Extension Study|Overall Study||70
10536301|NCT01442064|11688830|FG004|Received Study Drug in Extension Study|Overall Study||89
10536302|NCT01442064|11688831|FG005|Received Study Drug in Extension Study|Overall Study||81
10536303|NCT01442064|11688826|FG000|COMPLETED|Overall Study||0
10536304|NCT01442064|11688827|FG001|COMPLETED|Overall Study||2
10536305|NCT01442064|11688828|FG002|COMPLETED|Overall Study||0
10536306|NCT01442064|11688829|FG003|COMPLETED|Overall Study||0
10536307|NCT01442064|11688830|FG004|COMPLETED|Overall Study||1
10536308|NCT01442064|11688831|FG005|COMPLETED|Overall Study||0
10536309|NCT01442064|11688826|FG000|NOT COMPLETED|Overall Study||97
10536310|NCT01442064|11688827|FG001|NOT COMPLETED|Overall Study||101
10656899|NCT02222246|11818029|FG001|NOT COMPLETED|Overall Study||27
10656900|NCT02222337|11818039|FG000|STARTED|Overall Study||140
10656901|NCT02222337|11818040|FG001|STARTED|Overall Study|132 participants were enrolled but 2 withdrew and never provided any data.|132
10656902|NCT02222337|11818039|FG000|COMPLETED|Overall Study||114
10656903|NCT02222337|11818040|FG001|COMPLETED|Overall Study||108
10366579|NCT00533897|11507048|FG001|NOT COMPLETED|Lead-in (LI) Period 1||0
10656904|NCT02222337|11818039|FG000|NOT COMPLETED|Overall Study||26
10656905|NCT02222337|11818040|FG001|NOT COMPLETED|Overall Study||24
10366580|NCT00533897|11507049|FG002|NOT COMPLETED|Lead-in (LI) Period 1||0
10366581|NCT00533897|11507050|FG003|NOT COMPLETED|Lead-in (LI) Period 1||0
10366582|NCT00533897|11507051|FG004|NOT COMPLETED|Lead-in (LI) Period 1||0
10366583|NCT00533897|11507052|FG005|NOT COMPLETED|Lead-in (LI) Period 1||0
10366584|NCT00533897|11507053|FG006|NOT COMPLETED|Lead-in (LI) Period 1||0
10366585|NCT00533897|11507054|FG007|NOT COMPLETED|Lead-in (LI) Period 1||0
10366586|NCT00533897|11507047|FG000|STARTED|Double-blind Withdrawal (DBW) Period 2||0
10366587|NCT00533897|11507048|FG001|STARTED|Double-blind Withdrawal (DBW) Period 2||40
10366588|NCT00533897|11507049|FG002|STARTED|Double-blind Withdrawal (DBW) Period 2||80
10366589|NCT00533897|11507050|FG003|STARTED|Double-blind Withdrawal (DBW) Period 2||0
10366590|NCT00533897|11507051|FG004|STARTED|Double-blind Withdrawal (DBW) Period 2||0
10366591|NCT00533897|11507052|FG005|STARTED|Double-blind Withdrawal (DBW) Period 2||0
10366592|NCT00533897|11507053|FG006|STARTED|Double-blind Withdrawal (DBW) Period 2||0
10366593|NCT00533897|11507054|FG007|STARTED|Double-blind Withdrawal (DBW) Period 2||0
10366594|NCT00533897|11507047|FG000|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
10366595|NCT00533897|11507048|FG001|COMPLETED|Double-blind Withdrawal (DBW) Period 2|One participant discontinued the DBW Period due to Lack of Efficacy to enter the RI Period early|39
10366596|NCT00533897|11507049|FG002|COMPLETED|Double-blind Withdrawal (DBW) Period 2|Two participants discontinued the DBW Period due to Lack of Efficacy to enter the RI Period early|77
10366597|NCT00533897|11507050|FG003|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
10366598|NCT00533897|11507051|FG004|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
10366599|NCT00533897|11507052|FG005|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
10366600|NCT00533897|11507053|FG006|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
10366601|NCT00533897|11507054|FG007|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
10366602|NCT00533897|11507047|FG000|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
10366603|NCT00533897|11507048|FG001|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||1
10366604|NCT00533897|11507049|FG002|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||3
10366605|NCT00533897|11507050|FG003|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
10366606|NCT00533897|11507051|FG004|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
10366607|NCT00533897|11507052|FG005|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
10366608|NCT00533897|11507053|FG006|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
10366609|NCT00533897|11507054|FG007|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
10366610|NCT00533897|11507047|FG000|STARTED|Re-introduction (RI) Period 3||0
10366611|NCT00533897|11507048|FG001|STARTED|Re-introduction (RI) Period 3||0
10716601|NCT02690935|11880351|FG000|STARTED|Overall Study|Count of participants|51
10716602|NCT02690935|11880352|FG001|STARTED|Overall Study|Count of participants|51
10716603|NCT02690935|11880351|FG000|COMPLETED|Overall Study|Count of participants|51
10366612|NCT00533897|11507049|FG002|STARTED|Re-introduction (RI) Period 3||0
10366613|NCT00533897|11507050|FG003|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|40
10366614|NCT00533897|11507051|FG004|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|35
10366615|NCT00533897|11507052|FG005|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|44
10366616|NCT00533897|11507053|FG006|STARTED|Re-introduction (RI) Period 3||0
10366617|NCT00533897|11507054|FG007|STARTED|Re-introduction (RI) Period 3||0
10366618|NCT00533897|11507047|FG000|COMPLETED|Re-introduction (RI) Period 3||0
10366619|NCT00533897|11507048|FG001|COMPLETED|Re-introduction (RI) Period 3||0
10366620|NCT00533897|11507049|FG002|COMPLETED|Re-introduction (RI) Period 3||0
10366621|NCT00533897|11507050|FG003|COMPLETED|Re-introduction (RI) Period 3||40
10366622|NCT00533897|11507051|FG004|COMPLETED|Re-introduction (RI) Period 3||35
10366623|NCT00533897|11507052|FG005|COMPLETED|Re-introduction (RI) Period 3||42
10366624|NCT00533897|11507053|FG006|COMPLETED|Re-introduction (RI) Period 3||0
10366625|NCT00533897|11507054|FG007|COMPLETED|Re-introduction (RI) Period 3||0
10366626|NCT00533897|11507047|FG000|NOT COMPLETED|Re-introduction (RI) Period 3||0
10366627|NCT00533897|11507048|FG001|NOT COMPLETED|Re-introduction (RI) Period 3||0
10366628|NCT00533897|11507049|FG002|NOT COMPLETED|Re-introduction (RI) Period 3||0
10366629|NCT00533897|11507050|FG003|NOT COMPLETED|Re-introduction (RI) Period 3||0
10366630|NCT00533897|11507051|FG004|NOT COMPLETED|Re-introduction (RI) Period 3||0
10366631|NCT00533897|11507052|FG005|NOT COMPLETED|Re-introduction (RI) Period 3||2
10366632|NCT00533897|11507053|FG006|NOT COMPLETED|Re-introduction (RI) Period 3||0
10366633|NCT00533897|11507054|FG007|NOT COMPLETED|Re-introduction (RI) Period 3||0
10366634|NCT00533897|11507047|FG000|STARTED|Long Term Extension (LTE)||0
10366635|NCT00533897|11507048|FG001|STARTED|Long Term Extension (LTE)||0
10366636|NCT00533897|11507049|FG002|STARTED|Long Term Extension (LTE)||0
10366637|NCT00533897|11507050|FG003|STARTED|Long Term Extension (LTE)||0
10366638|NCT00533897|11507051|FG004|STARTED|Long Term Extension (LTE)||0
10366639|NCT00533897|11507052|FG005|STARTED|Long Term Extension (LTE)||0
10366640|NCT00533897|11507053|FG006|STARTED|Long Term Extension (LTE)|37 non-responders in Lead-In entered the LTE directly and didn't participate in DBW or RI Periods.|37
10427420|NCT00853099|11573228|FG001|COMPLETED|Double-blind Period|Participants who completed Week 52.|58
10536311|NCT01442064|11688828|FG002|NOT COMPLETED|Overall Study||104
10536312|NCT01442064|11688829|FG003|NOT COMPLETED|Overall Study||98
10536313|NCT01442064|11688830|FG004|NOT COMPLETED|Overall Study||106
10536314|NCT01442064|11688831|FG005|NOT COMPLETED|Overall Study||99
10536315|NCT01442103|11688848|FG000|STARTED|Overall Study||10
10536316|NCT01442103|11688848|FG000|COMPLETED|Overall Study||8
10536317|NCT01442103|11688848|FG000|NOT COMPLETED|Overall Study||2
10716604|NCT02690935|11880352|FG001|COMPLETED|Overall Study|Count of participants|51
10716605|NCT02690935|11880351|FG000|NOT COMPLETED|Overall Study||0
10716606|NCT02690935|11880352|FG001|NOT COMPLETED|Overall Study||0
10366641|NCT00533897|11507054|FG007|STARTED|Long Term Extension (LTE)|117 completed RI but 4 did not enter LTE: 1 lack of efficacy and 3 had their site closed.|113
10366642|NCT00533897|11507047|FG000|COMPLETED|Long Term Extension (LTE)||0
10366643|NCT00533897|11507048|FG001|COMPLETED|Long Term Extension (LTE)||0
10366644|NCT00533897|11507049|FG002|COMPLETED|Long Term Extension (LTE)||0
10366645|NCT00533897|11507050|FG003|COMPLETED|Long Term Extension (LTE)||0
10366646|NCT00533897|11507051|FG004|COMPLETED|Long Term Extension (LTE)||0
10366647|NCT00533897|11507052|FG005|COMPLETED|Long Term Extension (LTE)||0
10366648|NCT00533897|11507053|FG006|COMPLETED|Long Term Extension (LTE)|Participant continued until SC ABA was available in respective country or Sponsor ended study.|24
10366649|NCT00533897|11507054|FG007|COMPLETED|Long Term Extension (LTE)|Participant continued until SC ABA was available in respective country or Sponsor ended study.|88
10366650|NCT00533897|11507047|FG000|NOT COMPLETED|Long Term Extension (LTE)||0
10366651|NCT00533897|11507048|FG001|NOT COMPLETED|Long Term Extension (LTE)||0
10366652|NCT00533897|11507049|FG002|NOT COMPLETED|Long Term Extension (LTE)||0
10366653|NCT00533897|11507050|FG003|NOT COMPLETED|Long Term Extension (LTE)||0
10366654|NCT00533897|11507051|FG004|NOT COMPLETED|Long Term Extension (LTE)||0
10366655|NCT00533897|11507052|FG005|NOT COMPLETED|Long Term Extension (LTE)||0
10366656|NCT00533897|11507053|FG006|NOT COMPLETED|Long Term Extension (LTE)||13
10366657|NCT00533897|11507054|FG007|NOT COMPLETED|Long Term Extension (LTE)||25
10366658|NCT00533910|11507087|FG000|STARTED|Overall Study||21
10366659|NCT00533910|11507088|FG001|STARTED|Overall Study||21
10366660|NCT00533910|11507087|FG000|COMPLETED|Overall Study||21
10366661|NCT00533910|11507088|FG001|COMPLETED|Overall Study||21
10366662|NCT00533910|11507087|FG000|NOT COMPLETED|Overall Study||0
10366663|NCT00533910|11507088|FG001|NOT COMPLETED|Overall Study||0
10366664|NCT00534001|11507096|FG000|STARTED|Overall Study||48
10366665|NCT00534001|11507097|FG001|STARTED|Overall Study||47
10366666|NCT00534001|11507096|FG000|COMPLETED|Overall Study||43
10366667|NCT00534001|11507097|FG001|COMPLETED|Overall Study||43
10366668|NCT00534001|11507096|FG000|NOT COMPLETED|Overall Study||5
10366669|NCT00534001|11507097|FG001|NOT COMPLETED|Overall Study||4
10366670|NCT00534092|11507105|FG000|STARTED|Overall Study||55
10366671|NCT00534092|11507106|FG001|STARTED|Overall Study||14
10366672|NCT00534092|11507105|FG000|COMPLETED|Overall Study||53
10366673|NCT00534092|11507106|FG001|COMPLETED|Overall Study||14
10366674|NCT00534092|11507105|FG000|NOT COMPLETED|Overall Study||2
10366675|NCT00534092|11507106|FG001|NOT COMPLETED|Overall Study||0
10366676|NCT00534105|11507116|FG000|STARTED|Overall Study||47
10366677|NCT00534105|11507117|FG001|STARTED|Overall Study||59
10366678|NCT00534105|11507116|FG000|COMPLETED|Overall Study||24
10366679|NCT00534105|11507117|FG001|COMPLETED|Overall Study||20
10366680|NCT00534105|11507116|FG000|NOT COMPLETED|Overall Study||23
10366681|NCT00534105|11507117|FG001|NOT COMPLETED|Overall Study||39
10366682|NCT00534118|11507125|FG000|STARTED|Overall Study||17
10366683|NCT00534118|11507126|FG001|STARTED|Overall Study||22
10366684|NCT00534118|11507125|FG000|COMPLETED|Overall Study||17
10366685|NCT00534118|11507126|FG001|COMPLETED|Overall Study||22
10366686|NCT00534118|11507125|FG000|NOT COMPLETED|Overall Study||0
10366687|NCT00534118|11507126|FG001|NOT COMPLETED|Overall Study||0
10366688|NCT00534209|11507134|FG000|STARTED|Overall Study||1
10366689|NCT00534209|11507134|FG000|COMPLETED|Overall Study||1
10366690|NCT00534209|11507134|FG000|NOT COMPLETED|Overall Study||0
10366691|NCT00534235|11507142|FG000|STARTED|Overall Study||107
10366692|NCT00534235|11507143|FG001|STARTED|Overall Study||215
10366693|NCT00534235|11507142|FG000|COMPLETED|Overall Study||91
10366694|NCT00534235|11507143|FG001|COMPLETED|Overall Study||192
10366695|NCT00534235|11507142|FG000|NOT COMPLETED|Overall Study||16
10366696|NCT00534235|11507143|FG001|NOT COMPLETED|Overall Study||23
10366697|NCT00534248|11507152|FG000|STARTED|Overall Study||11211
10366698|NCT00534248|11507153|FG001|STARTED|Overall Study||11228
10366699|NCT00534248|11507152|FG000|VACCINATED|Overall Study||11186
10366700|NCT00534248|11507153|FG001|VACCINATED|Overall Study||11210
10366701|NCT00534248|11507152|FG000|COMPLETED|Overall Study||10550
10366702|NCT00534248|11507153|FG001|COMPLETED|Overall Study||10555
10366703|NCT00534248|11507152|FG000|NOT COMPLETED|Overall Study||661
10366704|NCT00534248|11507153|FG001|NOT COMPLETED|Overall Study||673
10366705|NCT00534313|11507163|FG000|STARTED|Short-term Period||43
10366706|NCT00534313|11507164|FG001|STARTED|Short-term Period||40
10366707|NCT00534313|11507165|FG002|STARTED|Short-term Period||45
10366708|NCT00534313|11507166|FG003|STARTED|Short-term Period||42
10366709|NCT00534313|11507163|FG000|COMPLETED|Short-term Period|Completed the short-term study|37
10366710|NCT00534313|11507164|FG001|COMPLETED|Short-term Period|Completed the short-term study|34
10366711|NCT00534313|11507165|FG002|COMPLETED|Short-term Period|Completed the short-term study|43
10366712|NCT00534313|11507166|FG003|COMPLETED|Short-term Period|Completed the short-term study|33
10366713|NCT00534313|11507163|FG000|NOT COMPLETED|Short-term Period||6
10366714|NCT00534313|11507164|FG001|NOT COMPLETED|Short-term Period||6
10366715|NCT00534313|11507165|FG002|NOT COMPLETED|Short-term Period||2
10366716|NCT00534313|11507166|FG003|NOT COMPLETED|Short-term Period||9
10366717|NCT00534313|11507163|FG000|STARTED|Long-term Period||37
10366718|NCT00534313|11507164|FG001|STARTED|Long-term Period||34
10366719|NCT00534313|11507165|FG002|STARTED|Long-term Period||43
10366720|NCT00534313|11507166|FG003|STARTED|Long-term Period||33
10366721|NCT00534313|11507163|FG000|COMPLETED|Long-term Period||0
10366722|NCT00534313|11507164|FG001|COMPLETED|Long-term Period||0
10366723|NCT00534313|11507165|FG002|COMPLETED|Long-term Period||0
10366724|NCT00534313|11507166|FG003|COMPLETED|Long-term Period||0
10366725|NCT00534313|11507163|FG000|NOT COMPLETED|Long-term Period||37
10366726|NCT00534313|11507164|FG001|NOT COMPLETED|Long-term Period||34
10366727|NCT00534313|11507165|FG002|NOT COMPLETED|Long-term Period||43
10366728|NCT00534313|11507166|FG003|NOT COMPLETED|Long-term Period||33
10366729|NCT00534352|11507211|FG000|STARTED|Treatment A: TMC125 + TDF/FTC||23
10366730|NCT00534352|11507211|FG000|COMPLETED|Treatment A: TMC125 + TDF/FTC||21
10366731|NCT00534352|11507211|FG000|NOT COMPLETED|Treatment A: TMC125 + TDF/FTC||2
10366732|NCT00534352|11507211|FG000|STARTED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||21
10366733|NCT00534352|11507211|FG000|COMPLETED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||21
10366734|NCT00534352|11507211|FG000|NOT COMPLETED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||0
10366735|NCT00534352|11507211|FG000|STARTED|Treatment C: DRV/Rtv + TDF/FTC||21
10366736|NCT00534352|11507211|FG000|COMPLETED|Treatment C: DRV/Rtv + TDF/FTC||20
10366737|NCT00534352|11507211|FG000|NOT COMPLETED|Treatment C: DRV/Rtv + TDF/FTC||1
10366738|NCT00534352|11507211|FG000|STARTED|Optional Extension: DRV/Rtv + TDF/FTC||18
10366739|NCT00534352|11507211|FG000|COMPLETED|Optional Extension: DRV/Rtv + TDF/FTC||14
10366740|NCT00534352|11507211|FG000|NOT COMPLETED|Optional Extension: DRV/Rtv + TDF/FTC||4
10366741|NCT00534365|11507226|FG000|STARTED|Overall Study||127
10366742|NCT00534365|11507227|FG001|STARTED|Overall Study||136
10366743|NCT00534365|11507226|FG000|Received Procedure|Overall Study||127
10366744|NCT00534365|11507227|FG001|Received Procedure|Overall Study|7 patients excluded due to receipt of sling other than mini-sling|129
10366745|NCT00534365|11507226|FG000|Any Follow up|Overall Study||126
10366746|NCT00534365|11507227|FG001|Any Follow up|Overall Study||135
10366747|NCT00534365|11507226|FG000|Follow up at 12 Months or More|Overall Study||119
10366748|NCT00534365|11507227|FG001|Follow up at 12 Months or More|Overall Study||128
10366749|NCT00534365|11507226|FG000|Included in Intent to Treat Analysis|Overall Study||127
10366750|NCT00534365|11507227|FG001|Included in Intent to Treat Analysis|Overall Study||136
10366751|NCT00534365|11507226|FG000|COMPLETED|Overall Study||127
10366752|NCT00534365|11507227|FG001|COMPLETED|Overall Study||129
10366753|NCT00534365|11507226|FG000|NOT COMPLETED|Overall Study||0
10366754|NCT00534365|11507227|FG001|NOT COMPLETED|Overall Study||7
10366755|NCT00534404|11507238|FG000|STARTED|Overall Study||827
10366756|NCT00534404|11507239|FG001|STARTED|Overall Study||830
10366757|NCT00534404|11507240|FG002|STARTED|Overall Study||828
10366758|NCT00534404|11507238|FG000|Completed at Least 1 Online Session|Overall Study||781
10366759|NCT00534404|11507239|FG001|Completed at Least 1 Online Session|Overall Study||813
10366760|NCT00534404|11507240|FG002|Completed at Least 1 Online Session|Overall Study||658
10366761|NCT00534404|11507238|FG000|Completed First NRT Order|Overall Study||765
10366762|NCT00534404|11507239|FG001|Completed First NRT Order|Overall Study|Participants could order NRT without completing a web session|821
10366763|NCT00534404|11507240|FG002|Completed First NRT Order|Overall Study|NRT was not available for this arm|0
10366764|NCT00534404|11507238|FG000|Completed Second NRT Order|Overall Study||640
10366765|NCT00534404|11507239|FG001|Completed Second NRT Order|Overall Study||789
10366766|NCT00534404|11507240|FG002|Completed Second NRT Order|Overall Study|NRT not available for this arm.|0
10366767|NCT00534404|11507238|FG000|Completed at Least 1 Counseling Call|Overall Study||813
10366768|NCT00534404|11507239|FG001|Completed at Least 1 Counseling Call|Overall Study|There was no counseling offered in this arm|0
10366769|NCT00534404|11507240|FG002|Completed at Least 1 Counseling Call|Overall Study|There was no counseling offered in this arm|0
10366770|NCT00534404|11507238|FG000|1-month Follow up Completed|Overall Study||742
10366771|NCT00534404|11507239|FG001|1-month Follow up Completed|Overall Study||781
10366772|NCT00534404|11507240|FG002|1-month Follow up Completed|Overall Study||626
10366773|NCT00534404|11507238|FG000|3-month Follow up Completed|Overall Study||682
10366774|NCT00534404|11507239|FG001|3-month Follow up Completed|Overall Study||731
10366775|NCT00534404|11507240|FG002|3-month Follow up Completed|Overall Study||593
10366776|NCT00534404|11507238|FG000|COMPLETED|Overall Study||647
10366777|NCT00534404|11507239|FG001|COMPLETED|Overall Study||687
10366778|NCT00534404|11507240|FG002|COMPLETED|Overall Study||586
10366779|NCT00534404|11507238|FG000|NOT COMPLETED|Overall Study||180
10366780|NCT00534404|11507239|FG001|NOT COMPLETED|Overall Study||143
10366781|NCT00534404|11507240|FG002|NOT COMPLETED|Overall Study||242
10366782|NCT00534417|11507248|FG000|STARTED|Overall Study||41
10366783|NCT00534417|11507248|FG000|COMPLETED|Overall Study||41
10366784|NCT00534417|11507248|FG000|NOT COMPLETED|Overall Study||0
10366785|NCT00534495|11507254|FG000|STARTED|Double Blind Placebo Phase Week 0-4||36
10366786|NCT00534495|11507255|FG001|STARTED|Double Blind Placebo Phase Week 0-4||35
10366787|NCT00534495|11507256|FG002|STARTED|Double Blind Placebo Phase Week 0-4||0
10366788|NCT00534495|11507254|FG000|COMPLETED|Double Blind Placebo Phase Week 0-4||36
10366789|NCT00534495|11507255|FG001|COMPLETED|Double Blind Placebo Phase Week 0-4||34
10366790|NCT00534495|11507256|FG002|COMPLETED|Double Blind Placebo Phase Week 0-4||0
10366791|NCT00534495|11507254|FG000|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||0
10366792|NCT00534495|11507255|FG001|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||1
10366793|NCT00534495|11507256|FG002|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||0
10366794|NCT00534495|11507254|FG000|STARTED|All Active Treatment Phase Week 4-24||36
10366795|NCT00534495|11507255|FG001|STARTED|All Active Treatment Phase Week 4-24||34
10366796|NCT00534495|11507256|FG002|STARTED|All Active Treatment Phase Week 4-24||0
10366797|NCT00534495|11507254|FG000|COMPLETED|All Active Treatment Phase Week 4-24||32
10366798|NCT00534495|11507255|FG001|COMPLETED|All Active Treatment Phase Week 4-24||25
10366799|NCT00534495|11507256|FG002|COMPLETED|All Active Treatment Phase Week 4-24||0
10366800|NCT00534495|11507254|FG000|NOT COMPLETED|All Active Treatment Phase Week 4-24||4
10366801|NCT00534495|11507255|FG001|NOT COMPLETED|All Active Treatment Phase Week 4-24||9
10366802|NCT00534495|11507256|FG002|NOT COMPLETED|All Active Treatment Phase Week 4-24||0
10366803|NCT00534495|11507254|FG000|STARTED|Long Term Ext. Phase Week 24-month 21||0
10366804|NCT00534495|11507255|FG001|STARTED|Long Term Ext. Phase Week 24-month 21||0
10366805|NCT00534495|11507256|FG002|STARTED|Long Term Ext. Phase Week 24-month 21||40
10366806|NCT00534495|11507254|FG000|COMPLETED|Long Term Ext. Phase Week 24-month 21||0
10366807|NCT00534495|11507255|FG001|COMPLETED|Long Term Ext. Phase Week 24-month 21||0
10366808|NCT00534495|11507256|FG002|COMPLETED|Long Term Ext. Phase Week 24-month 21||29
10366809|NCT00534495|11507254|FG000|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||0
10366810|NCT00534495|11507255|FG001|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||0
10366811|NCT00534495|11507256|FG002|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||11
10366812|NCT00534599|11507269|FG000|STARTED|Overall Study|Randomized|209
10366813|NCT00534599|11507270|FG001|STARTED|Overall Study|Randomized|200
10366814|NCT00534599|11507269|FG000|COMPLETED|Overall Study||152
10366815|NCT00534599|11507270|FG001|COMPLETED|Overall Study||168
10366816|NCT00534599|11507269|FG000|NOT COMPLETED|Overall Study||57
10366817|NCT00534599|11507270|FG001|NOT COMPLETED|Overall Study||32
10366818|NCT00534638|11507278|FG000|STARTED|Overall Study||14837
10366819|NCT00534638|11507279|FG001|STARTED|Overall Study||17338
10366820|NCT00534638|11507278|FG000|COMPLETED|Overall Study||8346
10366821|NCT00534638|11507279|FG001|COMPLETED|Overall Study||5547
10366822|NCT00534638|11507278|FG000|NOT COMPLETED|Overall Study||6491
10366823|NCT00534638|11507279|FG001|NOT COMPLETED|Overall Study||11791
10366824|NCT00534703|11507292|FG000|STARTED|Overall Study||4
10366825|NCT00534703|11507293|FG001|STARTED|Overall Study||1
10366826|NCT00534703|11507292|FG000|COMPLETED|Overall Study||4
10366827|NCT00534703|11507293|FG001|COMPLETED|Overall Study||1
10366828|NCT00534703|11507292|FG000|NOT COMPLETED|Overall Study||0
10366829|NCT00534703|11507293|FG001|NOT COMPLETED|Overall Study||0
10366830|NCT00534794|11507303|FG000|STARTED|Overall Study||40
10366831|NCT00534794|11507304|FG001|STARTED|Overall Study||39
10366832|NCT00534794|11507303|FG000|COMPLETED|Overall Study||40
10366833|NCT00534794|11507304|FG001|COMPLETED|Overall Study||39
10366834|NCT00534794|11507303|FG000|NOT COMPLETED|Overall Study||0
10366835|NCT00534794|11507304|FG001|NOT COMPLETED|Overall Study||0
10366836|NCT00534833|11507312|FG000|STARTED|Overall Study||182
10366837|NCT00534833|11507313|FG001|STARTED|Overall Study||180
10366838|NCT00534833|11507312|FG000|COMPLETED|Overall Study||182
10366839|NCT00534833|11507313|FG001|COMPLETED|Overall Study||180
10366840|NCT00534833|11507312|FG000|NOT COMPLETED|Overall Study||0
10366841|NCT00534833|11507313|FG001|NOT COMPLETED|Overall Study||0
10366842|NCT00534937|11507323|FG000|STARTED|Overall Study||42
10366843|NCT00534937|11507324|FG001|STARTED|Overall Study||47
10366844|NCT00534937|11507323|FG000|COMPLETED|Overall Study||34
10366845|NCT00534937|11507324|FG001|COMPLETED|Overall Study||35
10366846|NCT00534937|11507323|FG000|NOT COMPLETED|Overall Study||8
10366847|NCT00534937|11507324|FG001|NOT COMPLETED|Overall Study||12
10366848|NCT00535002|11507340|FG000|STARTED|Overall Study||19
10366849|NCT00535002|11507341|FG001|STARTED|Overall Study||12
10366850|NCT00535002|11507342|FG002|STARTED|Overall Study||13
10366851|NCT00535002|11507343|FG003|STARTED|Overall Study||14
10366852|NCT00535002|11507344|FG004|STARTED|Overall Study||9
10366853|NCT00535002|11507345|FG005|STARTED|Overall Study||17
10366854|NCT00535002|11507346|FG006|STARTED|Overall Study||12
10366855|NCT00535002|11507347|FG007|STARTED|Overall Study||16
10366856|NCT00535002|11507340|FG000|COMPLETED|Overall Study||19
10366857|NCT00535002|11507341|FG001|COMPLETED|Overall Study||12
10366858|NCT00535002|11507342|FG002|COMPLETED|Overall Study||13
10366859|NCT00535002|11507343|FG003|COMPLETED|Overall Study||14
10366860|NCT00535002|11507344|FG004|COMPLETED|Overall Study||9
10366861|NCT00535002|11507345|FG005|COMPLETED|Overall Study||17
10366862|NCT00535002|11507346|FG006|COMPLETED|Overall Study||12
10366863|NCT00535002|11507347|FG007|COMPLETED|Overall Study||16
10366864|NCT00535002|11507340|FG000|NOT COMPLETED|Overall Study||0
10366865|NCT00535002|11507341|FG001|NOT COMPLETED|Overall Study||0
10366866|NCT00535002|11507342|FG002|NOT COMPLETED|Overall Study||0
10366867|NCT00535002|11507343|FG003|NOT COMPLETED|Overall Study||0
10366868|NCT00535002|11507344|FG004|NOT COMPLETED|Overall Study||0
10366869|NCT00535002|11507345|FG005|NOT COMPLETED|Overall Study||0
10366870|NCT00535002|11507346|FG006|NOT COMPLETED|Overall Study||0
10366871|NCT00535002|11507347|FG007|NOT COMPLETED|Overall Study||0
10366872|NCT00535132|11507363|FG000|STARTED|Randomized Population|Number of Subjects Randomized|100
10366873|NCT00535132|11507364|FG001|STARTED|Randomized Population|Number of Subjects Randomized|101
10366874|NCT00535132|11507363|FG000|COMPLETED|Randomized Population||100
10366875|NCT00535132|11507364|FG001|COMPLETED|Randomized Population||101
10366876|NCT00535132|11507363|FG000|NOT COMPLETED|Randomized Population||0
10366877|NCT00535132|11507364|FG001|NOT COMPLETED|Randomized Population||0
10366878|NCT00535132|11507363|FG000|STARTED|Safety Analysis Set||100
10366879|NCT00535132|11507364|FG001|STARTED|Safety Analysis Set||101
10366880|NCT00535132|11507363|FG000|COMPLETED|Safety Analysis Set|Two patients were randomized but not treated.|98
10366881|NCT00535132|11507364|FG001|COMPLETED|Safety Analysis Set|Two patients were randomized but not treated.|99
10366882|NCT00535132|11507363|FG000|NOT COMPLETED|Safety Analysis Set||2
10366883|NCT00535132|11507364|FG001|NOT COMPLETED|Safety Analysis Set||2
10366884|NCT00535132|11507363|FG000|STARTED|Intent-to-Treat (ITT) Analysis Set||98
10366885|NCT00535132|11507364|FG001|STARTED|Intent-to-Treat (ITT) Analysis Set||99
10366886|NCT00535132|11507363|FG000|COMPLETED|Intent-to-Treat (ITT) Analysis Set|Patients who received at least one dose of study drug and have some follow-up efficacy data.|95
10366887|NCT00535132|11507364|FG001|COMPLETED|Intent-to-Treat (ITT) Analysis Set|Patients who received at least one dose of study drug and have some follow-up efficacy data.|96
10366888|NCT00535132|11507363|FG000|NOT COMPLETED|Intent-to-Treat (ITT) Analysis Set||3
10366889|NCT00535132|11507364|FG001|NOT COMPLETED|Intent-to-Treat (ITT) Analysis Set||3
10366890|NCT00535145|11507372|FG000|STARTED|Phase I||114
10366891|NCT00535145|11507372|FG000|COMPLETED|Phase I||85
10366892|NCT00535145|11507372|FG000|NOT COMPLETED|Phase I||29
10366893|NCT00535145|11507372|FG000|STARTED|Phase II|Of the 85 participants who completed Phase 1, 84 met the criteria to enroll into Phase 2|84
10366894|NCT00535145|11507372|FG000|COMPLETED|Phase II||69
10366895|NCT00535145|11507372|FG000|NOT COMPLETED|Phase II||15
10366896|NCT00535223|11507382|FG000|STARTED|Overall Study|Patients were randomized in cohorts of ten.|41
10366897|NCT00535223|11507383|FG001|STARTED|Overall Study|Patients were randomized in cohorts of ten.|40
10366898|NCT00535223|11507382|FG000|COMPLETED|Overall Study||37
10366899|NCT00535223|11507383|FG001|COMPLETED|Overall Study||39
10366900|NCT00535223|11507382|FG000|NOT COMPLETED|Overall Study||4
10366901|NCT00535223|11507383|FG001|NOT COMPLETED|Overall Study||1
10366902|NCT00535236|11507399|FG000|STARTED|Overall Study||40
10366903|NCT00535236|11507400|FG001|STARTED|Overall Study||10
10366904|NCT00535236|11507401|FG002|STARTED|Overall Study||41
10366905|NCT00535236|11507402|FG003|STARTED|Overall Study||10
10366906|NCT00535236|11507403|FG004|STARTED|Overall Study||59
10366907|NCT00535236|11507404|FG005|STARTED|Overall Study||20
10366908|NCT00535236|11507405|FG006|STARTED|Overall Study||62
10366909|NCT00535236|11507406|FG007|STARTED|Overall Study||19
10366910|NCT00535236|11507407|FG008|STARTED|Overall Study||60
10366911|NCT00535236|11507408|FG009|STARTED|Overall Study||20
10366912|NCT00535236|11507399|FG000|Vaccination 1|Overall Study||40
10366913|NCT00535236|11507400|FG001|Vaccination 1|Overall Study||10
10366914|NCT00535236|11507401|FG002|Vaccination 1|Overall Study||40
10366915|NCT00535236|11507402|FG003|Vaccination 1|Overall Study||10
10366916|NCT00535236|11507403|FG004|Vaccination 1|Overall Study||58
10366917|NCT00535236|11507404|FG005|Vaccination 1|Overall Study||19
10366918|NCT00535236|11507405|FG006|Vaccination 1|Overall Study||61
10366919|NCT00535236|11507406|FG007|Vaccination 1|Overall Study||19
10366920|NCT00535236|11507407|FG008|Vaccination 1|Overall Study||60
10366921|NCT00535236|11507408|FG009|Vaccination 1|Overall Study||20
10366922|NCT00535236|11507399|FG000|Vaccination 2|Overall Study||35
10366923|NCT00535236|11507400|FG001|Vaccination 2|Overall Study||10
10366924|NCT00535236|11507401|FG002|Vaccination 2|Overall Study||37
10366925|NCT00535236|11507402|FG003|Vaccination 2|Overall Study||8
10366926|NCT00535236|11507403|FG004|Vaccination 2|Overall Study||52
10366927|NCT00535236|11507404|FG005|Vaccination 2|Overall Study||19
10366928|NCT00535236|11507405|FG006|Vaccination 2|Overall Study||58
10366929|NCT00535236|11507406|FG007|Vaccination 2|Overall Study||19
10366930|NCT00535236|11507407|FG008|Vaccination 2|Overall Study||57
10366931|NCT00535236|11507408|FG009|Vaccination 2|Overall Study||19
10366932|NCT00535236|11507399|FG000|Vaccination 3|Overall Study||34
10366933|NCT00535236|11507400|FG001|Vaccination 3|Overall Study||10
10366934|NCT00535236|11507401|FG002|Vaccination 3|Overall Study||35
10366935|NCT00535236|11507402|FG003|Vaccination 3|Overall Study||8
10366936|NCT00535236|11507403|FG004|Vaccination 3|Overall Study||48
10366937|NCT00535236|11507404|FG005|Vaccination 3|Overall Study||19
10366938|NCT00535236|11507405|FG006|Vaccination 3|Overall Study||51
10366939|NCT00535236|11507406|FG007|Vaccination 3|Overall Study||18
10366940|NCT00535236|11507407|FG008|Vaccination 3|Overall Study||53
10366941|NCT00535236|11507408|FG009|Vaccination 3|Overall Study||18
10366942|NCT00535236|11507399|FG000|Vaccination 4|Overall Study||34
10366943|NCT00535236|11507400|FG001|Vaccination 4|Overall Study||10
10366944|NCT00535236|11507401|FG002|Vaccination 4|Overall Study||32
10366945|NCT00535236|11507402|FG003|Vaccination 4|Overall Study||6
10366946|NCT00535236|11507403|FG004|Vaccination 4|Overall Study||47
10366947|NCT00535236|11507404|FG005|Vaccination 4|Overall Study||19
10366948|NCT00535236|11507405|FG006|Vaccination 4|Overall Study||51
10366949|NCT00535236|11507406|FG007|Vaccination 4|Overall Study||18
10366950|NCT00535236|11507407|FG008|Vaccination 4|Overall Study||50
10366951|NCT00535236|11507408|FG009|Vaccination 4|Overall Study||17
10656906|NCT02222493|11818052|FG000|STARTED|Period 1: First Dose-Week 30 (Pre-dose)||324
10366952|NCT00535236|11507399|FG000|COMPLETED|Overall Study||33
10366953|NCT00535236|11507400|FG001|COMPLETED|Overall Study||8
10366954|NCT00535236|11507401|FG002|COMPLETED|Overall Study||29
10366955|NCT00535236|11507402|FG003|COMPLETED|Overall Study||6
10366956|NCT00535236|11507403|FG004|COMPLETED|Overall Study||47
10366957|NCT00535236|11507404|FG005|COMPLETED|Overall Study||19
10366958|NCT00535236|11507405|FG006|COMPLETED|Overall Study||51
10366959|NCT00535236|11507406|FG007|COMPLETED|Overall Study||18
10366960|NCT00535236|11507407|FG008|COMPLETED|Overall Study||47
10366961|NCT00535236|11507408|FG009|COMPLETED|Overall Study||16
10366962|NCT00535236|11507399|FG000|NOT COMPLETED|Overall Study||7
10536318|NCT01442129|11688854|FG000|STARTED|Overall Study||20
10536319|NCT01442129|11688855|FG001|STARTED|Overall Study||10
10536320|NCT01442129|11688854|FG000|COMPLETED|Overall Study|Treatment withheld from 1 patient randomized before results of screening PRA known|20
10536321|NCT01442129|11688855|FG001|COMPLETED|Overall Study||10
10536322|NCT01442129|11688854|FG000|NOT COMPLETED|Overall Study||0
10536323|NCT01442129|11688855|FG001|NOT COMPLETED|Overall Study||0
10366963|NCT00535236|11507400|FG001|NOT COMPLETED|Overall Study||2
10366964|NCT00535236|11507401|FG002|NOT COMPLETED|Overall Study||12
10366965|NCT00535236|11507402|FG003|NOT COMPLETED|Overall Study||4
10366966|NCT00535236|11507403|FG004|NOT COMPLETED|Overall Study||12
10366967|NCT00535236|11507404|FG005|NOT COMPLETED|Overall Study||1
10366968|NCT00535236|11507405|FG006|NOT COMPLETED|Overall Study||11
10366969|NCT00535236|11507406|FG007|NOT COMPLETED|Overall Study||1
10366970|NCT00535236|11507407|FG008|NOT COMPLETED|Overall Study||13
10366971|NCT00535236|11507408|FG009|NOT COMPLETED|Overall Study||4
10366972|NCT00535288|11507438|FG000|STARTED|Overall Study|2 participants randomized to receive placebo did not receive placebo|314
10366973|NCT00535288|11507439|FG001|STARTED|Overall Study||162
10366974|NCT00535288|11507440|FG002|STARTED|Overall Study||160
10366975|NCT00535288|11507441|FG003|STARTED|Overall Study||151
10366976|NCT00535288|11507442|FG004|STARTED|Overall Study|One participant randomized to receive placebo received esmirtazapine 18 mg.|158
10366977|NCT00535288|11507438|FG000|COMPLETED|Overall Study||260
10366978|NCT00535288|11507439|FG001|COMPLETED|Overall Study||130
10366979|NCT00535288|11507440|FG002|COMPLETED|Overall Study||127
10366980|NCT00535288|11507441|FG003|COMPLETED|Overall Study||122
10366981|NCT00535288|11507442|FG004|COMPLETED|Overall Study||116
10366982|NCT00535288|11507438|FG000|NOT COMPLETED|Overall Study||54
10366983|NCT00535288|11507439|FG001|NOT COMPLETED|Overall Study||32
10366984|NCT00535288|11507440|FG002|NOT COMPLETED|Overall Study||33
10366985|NCT00535288|11507441|FG003|NOT COMPLETED|Overall Study||29
10366986|NCT00535288|11507442|FG004|NOT COMPLETED|Overall Study||42
10366987|NCT00535301|11507461|FG000|STARTED|Overall Study||38
10366988|NCT00535301|11507462|FG001|STARTED|Overall Study||38
10366989|NCT00535301|11507461|FG000|COMPLETED|Overall Study||33
10366990|NCT00535301|11507462|FG001|COMPLETED|Overall Study||33
10366991|NCT00535301|11507461|FG000|NOT COMPLETED|Overall Study||5
10366992|NCT00535301|11507462|FG001|NOT COMPLETED|Overall Study||5
10366993|NCT00535392|11507470|FG000|STARTED|Overall Study||33
10366994|NCT00535392|11507470|FG000|COMPLETED|Overall Study||33
10536324|NCT01442155|11688861|FG000|STARTED|Overall Study||74
10536325|NCT01442155|11688861|FG000|COMPLETED|Overall Study||9
10536326|NCT01442155|11688861|FG000|NOT COMPLETED|Overall Study||65
10536327|NCT01442181|11688867|FG000|STARTED|Overall Study||14
10536328|NCT01442181|11688868|FG001|STARTED|Overall Study||11
10536329|NCT01442181|11688867|FG000|COMPLETED|Overall Study||10
10536330|NCT01442181|11688868|FG001|COMPLETED|Overall Study||8
10536331|NCT01442181|11688867|FG000|NOT COMPLETED|Overall Study||4
10536332|NCT01442181|11688868|FG001|NOT COMPLETED|Overall Study||3
10536333|NCT01442376|11688878|FG000|STARTED|Overall Study|Randomized patients|169
10536334|NCT01442376|11688879|FG001|STARTED|Overall Study|Randomized patients|169
10536335|NCT01442376|11688880|FG002|STARTED|Overall Study|Randomized patients|164
10536336|NCT01442376|11688878|FG000|COMPLETED|Overall Study||166
10536337|NCT01442376|11688879|FG001|COMPLETED|Overall Study||160
10536338|NCT01442376|11688880|FG002|COMPLETED|Overall Study||159
10536339|NCT01442376|11688878|FG000|NOT COMPLETED|Overall Study||3
10536340|NCT01442376|11688879|FG001|NOT COMPLETED|Overall Study||9
10536341|NCT01442376|11688880|FG002|NOT COMPLETED|Overall Study||5
10536342|NCT01442493|11688890|FG000|STARTED|Overall Study||149
10536343|NCT01442493|11688891|FG001|STARTED|Overall Study||151
10536344|NCT01442493|11688890|FG000|COMPLETED|Overall Study||146
10536345|NCT01442493|11688891|FG001|COMPLETED|Overall Study||149
10536346|NCT01442493|11688890|FG000|NOT COMPLETED|Overall Study||3
10536347|NCT01442493|11688891|FG001|NOT COMPLETED|Overall Study||2
10536348|NCT01442675|11688897|FG000|STARTED|Overall Study||834
10536349|NCT01442675|11688897|FG000|Safety Analysis Set|Overall Study|Safety Analysis Set are subjects who received study vaccine and for whom safety data were available.|831
10536350|NCT01442675|11688897|FG000|Per-Protocol Analysis Set|Overall Study|The Per-Protocol Analysis Set are subjects with no pre-defined protocol deviations.|781
10536351|NCT01442675|11688897|FG000|COMPLETED|Overall Study||822
10536352|NCT01442675|11688897|FG000|NOT COMPLETED|Overall Study||12
10536353|NCT01442688|11688904|FG000|STARTED|First Intervention||31
10536354|NCT01442688|11688905|FG001|STARTED|First Intervention||31
10536355|NCT01442688|11688904|FG000|COMPLETED|First Intervention||29
10536356|NCT01442688|11688905|FG001|COMPLETED|First Intervention||31
10536357|NCT01442688|11688904|FG000|NOT COMPLETED|First Intervention||2
10536358|NCT01442688|11688905|FG001|NOT COMPLETED|First Intervention||0
10536359|NCT01442688|11688904|FG000|STARTED|Second Intervention||29
10536360|NCT01442688|11688905|FG001|STARTED|Second Intervention||31
10716607|NCT02690948|11880360|FG000|STARTED|Overall Study||9
10366995|NCT00535392|11507470|FG000|NOT COMPLETED|Overall Study||0
10366996|NCT00535496|11507476|FG000|STARTED|Overall Study||15
10366997|NCT00535496|11507477|FG001|STARTED|Overall Study||15
10366998|NCT00535496|11507478|FG002|STARTED|Overall Study||30
10366999|NCT00535496|11507479|FG003|STARTED|Overall Study||31
10367000|NCT00535496|11507476|FG000|All-Subjects-Treated (AST) Group|Overall Study||15
10716608|NCT02690948|11880361|FG001|STARTED|Overall Study||7
10367001|NCT00535496|11507477|FG001|All-Subjects-Treated (AST) Group|Overall Study||14
10367002|NCT00535496|11507478|FG002|All-Subjects-Treated (AST) Group|Overall Study||30
10367003|NCT00535496|11507479|FG003|All-Subjects-Treated (AST) Group|Overall Study||31
10367004|NCT00535496|11507476|FG000|COMPLETED|Overall Study||15
10367005|NCT00535496|11507477|FG001|COMPLETED|Overall Study||13
10367006|NCT00535496|11507478|FG002|COMPLETED|Overall Study||30
10367007|NCT00535496|11507479|FG003|COMPLETED|Overall Study||31
10367008|NCT00535496|11507476|FG000|NOT COMPLETED|Overall Study||0
10367009|NCT00535496|11507477|FG001|NOT COMPLETED|Overall Study||2
10367010|NCT00535496|11507478|FG002|NOT COMPLETED|Overall Study||0
10367011|NCT00535496|11507479|FG003|NOT COMPLETED|Overall Study||0
10367012|NCT00535587|11507490|FG000|STARTED|Overall Study||53
10367013|NCT00535587|11507491|FG001|STARTED|Overall Study||53
10367014|NCT00535587|11507492|FG002|STARTED|Overall Study||47
10367015|NCT00535587|11507493|FG003|STARTED|Overall Study||54
10367016|NCT00535587|11507490|FG000|COMPLETED|Overall Study||43
10367017|NCT00535587|11507491|FG001|COMPLETED|Overall Study||42
10367018|NCT00535587|11507492|FG002|COMPLETED|Overall Study||39
10367019|NCT00535587|11507493|FG003|COMPLETED|Overall Study||41
10367020|NCT00535587|11507490|FG000|NOT COMPLETED|Overall Study||10
10367021|NCT00535587|11507491|FG001|NOT COMPLETED|Overall Study||11
10367022|NCT00535587|11507492|FG002|NOT COMPLETED|Overall Study||8
10536361|NCT01442688|11688904|FG000|COMPLETED|Second Intervention||28
10536362|NCT01442688|11688905|FG001|COMPLETED|Second Intervention||31
10536363|NCT01442688|11688904|FG000|NOT COMPLETED|Second Intervention||1
10536364|NCT01442688|11688905|FG001|NOT COMPLETED|Second Intervention||0
10536365|NCT01442714|11688911|FG000|STARTED|Overall Study||33
10536366|NCT01442714|11688911|FG000|COMPLETED|Overall Study||21
10536367|NCT01442714|11688911|FG000|NOT COMPLETED|Overall Study||12
10536368|NCT01442779|11688917|FG000|STARTED|Overall Study||18
10536369|NCT01442779|11688917|FG000|COMPLETED|Overall Study||11
10536370|NCT01442779|11688917|FG000|NOT COMPLETED|Overall Study||7
10536371|NCT01442844|11688923|FG000|STARTED|Overall Study||1
10536372|NCT01442844|11688924|FG001|STARTED|Overall Study||2
10536373|NCT01442844|11688923|FG000|COMPLETED|Overall Study||1
10536374|NCT01442844|11688924|FG001|COMPLETED|Overall Study||2
10536375|NCT01442844|11688923|FG000|NOT COMPLETED|Overall Study||0
10536376|NCT01442844|11688924|FG001|NOT COMPLETED|Overall Study||0
10536377|NCT01443026|11688932|FG000|STARTED|Overall Study||29
10536378|NCT01443026|11688933|FG001|STARTED|Overall Study||37
10536379|NCT01443026|11688932|FG000|COMPLETED|Overall Study||26
10536380|NCT01443026|11688933|FG001|COMPLETED|Overall Study||32
10536381|NCT01443026|11688932|FG000|NOT COMPLETED|Overall Study||3
10536382|NCT01443026|11688933|FG001|NOT COMPLETED|Overall Study||5
10536383|NCT01443078|11688939|FG000|STARTED|Overall Study||42
10536384|NCT01443078|11688939|FG000|COMPLETED|Overall Study||13
10536385|NCT01443078|11688939|FG000|NOT COMPLETED|Overall Study||29
10536386|NCT01443130|11688949|FG000|STARTED|Overall Study||300
10536387|NCT01443130|11688950|FG001|STARTED|Overall Study||300
10536388|NCT01443130|11688951|FG002|STARTED|Overall Study||300
10536389|NCT01443130|11688952|FG003|STARTED|Overall Study||270
10536390|NCT01443130|11688953|FG004|STARTED|Overall Study||274
10536391|NCT01443130|11688954|FG005|STARTED|Overall Study||259
10536392|NCT01443130|11688949|FG000|COMPLETED|Overall Study||232
10536393|NCT01443130|11688950|FG001|COMPLETED|Overall Study||231
10536394|NCT01443130|11688951|FG002|COMPLETED|Overall Study||223
10536395|NCT01443130|11688952|FG003|COMPLETED|Overall Study||231
10536396|NCT01443130|11688953|FG004|COMPLETED|Overall Study||230
10536397|NCT01443130|11688954|FG005|COMPLETED|Overall Study||225
10536398|NCT01443130|11688949|FG000|NOT COMPLETED|Overall Study||68
10536399|NCT01443130|11688950|FG001|NOT COMPLETED|Overall Study||69
10536400|NCT01443130|11688951|FG002|NOT COMPLETED|Overall Study||77
10536401|NCT01443130|11688952|FG003|NOT COMPLETED|Overall Study||39
10536402|NCT01443130|11688953|FG004|NOT COMPLETED|Overall Study||44
10536403|NCT01443130|11688954|FG005|NOT COMPLETED|Overall Study||34
10536404|NCT01443364|11688968|FG000|STARTED|Overall Study||132
10536405|NCT01443364|11688968|FG000|COMPLETED|Overall Study||91
10536406|NCT01443364|11688968|FG000|NOT COMPLETED|Overall Study||41
10536407|NCT01443403|11688976|FG000|STARTED|Overall Study||61
10536408|NCT01443403|11688977|FG001|STARTED|Overall Study||61
10536409|NCT01443403|11688978|FG002|STARTED|Overall Study||61
10536410|NCT01443403|11688979|FG003|STARTED|Overall Study||61
10536411|NCT01443403|11688976|FG000|Received Treatment|Overall Study||61
10536412|NCT01443403|11688977|FG001|Received Treatment|Overall Study||61
10536413|NCT01443403|11688978|FG002|Received Treatment|Overall Study||60
10536414|NCT01443403|11688979|FG003|Received Treatment|Overall Study||61
10536415|NCT01443403|11688976|FG000|COMPLETED|Overall Study||55
10536416|NCT01443403|11688977|FG001|COMPLETED|Overall Study||55
10536417|NCT01443403|11688978|FG002|COMPLETED|Overall Study||54
10536418|NCT01443403|11688979|FG003|COMPLETED|Overall Study||52
10536419|NCT01443403|11688976|FG000|NOT COMPLETED|Overall Study||6
10367023|NCT00535587|11507493|FG003|NOT COMPLETED|Overall Study||13
10367024|NCT00535613|11507503|FG000|STARTED|Overall Study||49
10367025|NCT00535613|11507504|FG001|STARTED|Overall Study||50
10536420|NCT01443403|11688977|FG001|NOT COMPLETED|Overall Study||6
10536421|NCT01443403|11688978|FG002|NOT COMPLETED|Overall Study||7
10536422|NCT01443403|11688979|FG003|NOT COMPLETED|Overall Study||9
10536423|NCT01443442|11688994|FG000|STARTED|Overall Study||12
10536424|NCT01443442|11688995|FG001|STARTED|Overall Study||11
10536425|NCT01443442|11688994|FG000|COMPLETED|Overall Study||12
10536426|NCT01443442|11688995|FG001|COMPLETED|Overall Study||11
10536427|NCT01443442|11688994|FG000|NOT COMPLETED|Overall Study||0
10367026|NCT00535613|11507503|FG000|COMPLETED|Overall Study||49
10367027|NCT00535613|11507504|FG001|COMPLETED|Overall Study||50
10367028|NCT00535613|11507503|FG000|NOT COMPLETED|Overall Study||0
10367029|NCT00535613|11507504|FG001|NOT COMPLETED|Overall Study||0
10367030|NCT00535626|11507510|FG000|STARTED|Overall Study||190
10367031|NCT00535626|11507510|FG000|COMPLETED|Overall Study||85
10367032|NCT00535626|11507510|FG000|NOT COMPLETED|Overall Study||105
10367033|NCT00535652|11507515|FG000|STARTED|Overall Study||23
10367034|NCT00535652|11507515|FG000|COMPLETED|Overall Study||20
10367035|NCT00535652|11507515|FG000|NOT COMPLETED|Overall Study||3
10367036|NCT00535730|11507521|FG000|STARTED|Overall Study||236
10367037|NCT00535730|11507522|FG001|STARTED|Overall Study|Two subjects were allocated but not vaccinated making the number of subjects vaccinated 235|237
10367038|NCT00535730|11507521|FG000|COMPLETED|Overall Study||234
10367039|NCT00535730|11507522|FG001|COMPLETED|Overall Study||230
10367040|NCT00535730|11507521|FG000|NOT COMPLETED|Overall Study||2
10367041|NCT00535730|11507522|FG001|NOT COMPLETED|Overall Study||7
10367042|NCT00535743|11507553|FG000|STARTED|Overall Study||5
10367043|NCT00535743|11507554|FG001|STARTED|Overall Study||11
10367044|NCT00535743|11507555|FG002|STARTED|Overall Study||11
10367045|NCT00535743|11507556|FG003|STARTED|Overall Study||11
10367046|NCT00535743|11507557|FG004|STARTED|Overall Study||11
10367047|NCT00535743|11507558|FG005|STARTED|Overall Study||10
10367048|NCT00535743|11507559|FG006|STARTED|Overall Study||3
10367049|NCT00535743|11507560|FG007|STARTED|Overall Study||5
10367050|NCT00535743|11507561|FG008|STARTED|Overall Study||5
10367051|NCT00535743|11507562|FG009|STARTED|Overall Study||5
10367052|NCT00535743|11507563|FG010|STARTED|Overall Study||5
10367053|NCT00535743|11507564|FG011|STARTED|Overall Study||5
10367054|NCT00535743|11507565|FG012|STARTED|Overall Study||5
10367055|NCT00535743|11507566|FG013|STARTED|Overall Study||10
10367056|NCT00535743|11507567|FG014|STARTED|Overall Study||9
10367057|NCT00535743|11507568|FG015|STARTED|Overall Study|N=11 randomized to Arm P. An additional N=2 (randomized to Arm O) are counted as Started in Arm P|13
10367058|NCT00535743|11507569|FG016|STARTED|Overall Study||10
10367059|NCT00535743|11507570|FG017|STARTED|Overall Study||11
10367060|NCT00535743|11507571|FG018|STARTED|Overall Study||3
10367061|NCT00535743|11507572|FG019|STARTED|Overall Study||5
10367062|NCT00535743|11507573|FG020|STARTED|Overall Study||5
10367063|NCT00535743|11507574|FG021|STARTED|Overall Study||5
10367064|NCT00535743|11507575|FG022|STARTED|Overall Study|N=5 randomized to Arm W. An additional N=1 (randomized to Arm Q) is counted as Started in Arm W|6
10367065|NCT00535743|11507576|FG023|STARTED|Overall Study||5
10367066|NCT00535743|11507553|FG000|Treated|Overall Study||5
10367067|NCT00535743|11507554|FG001|Treated|Overall Study||11
10367068|NCT00535743|11507555|FG002|Treated|Overall Study||11
10367069|NCT00535743|11507556|FG003|Treated|Overall Study||11
10367070|NCT00535743|11507557|FG004|Treated|Overall Study||11
10367071|NCT00535743|11507558|FG005|Treated|Overall Study||10
10367072|NCT00535743|11507559|FG006|Treated|Overall Study||3
10367073|NCT00535743|11507560|FG007|Treated|Overall Study||5
10367074|NCT00535743|11507561|FG008|Treated|Overall Study||4
10367075|NCT00535743|11507562|FG009|Treated|Overall Study||5
10367076|NCT00535743|11507563|FG010|Treated|Overall Study||5
10367077|NCT00535743|11507564|FG011|Treated|Overall Study||5
10367078|NCT00535743|11507565|FG012|Treated|Overall Study||5
10367079|NCT00535743|11507566|FG013|Treated|Overall Study||10
10367080|NCT00535743|11507567|FG014|Treated|Overall Study||9
10367081|NCT00535743|11507568|FG015|Treated|Overall Study|N=2 (randomized to Arm O) rec'd 8 mg/kg Sugammadex, 3 min after 1.2 mg/kg Esmeron®|13
10367082|NCT00535743|11507569|FG016|Treated|Overall Study||10
10367083|NCT00535743|11507570|FG017|Treated|Overall Study||11
10367084|NCT00535743|11507571|FG018|Treated|Overall Study||3
10367085|NCT00535743|11507572|FG019|Treated|Overall Study||5
10367086|NCT00535743|11507573|FG020|Treated|Overall Study||5
10367087|NCT00535743|11507574|FG021|Treated|Overall Study||5
10367088|NCT00535743|11507575|FG022|Treated|Overall Study|N=1 (randomized to Arm Q) rec'd 12 mg/kg Sugammadex, 29 min after 1.2 mg/kg Esmeron®|6
10367089|NCT00535743|11507576|FG023|Treated|Overall Study||5
10367090|NCT00535743|11507553|FG000|COMPLETED|Overall Study||5
10367091|NCT00535743|11507554|FG001|COMPLETED|Overall Study||11
10367092|NCT00535743|11507555|FG002|COMPLETED|Overall Study||11
10367093|NCT00535743|11507556|FG003|COMPLETED|Overall Study||11
10367094|NCT00535743|11507557|FG004|COMPLETED|Overall Study||11
10367095|NCT00535743|11507558|FG005|COMPLETED|Overall Study||10
10367096|NCT00535743|11507559|FG006|COMPLETED|Overall Study||3
10367097|NCT00535743|11507560|FG007|COMPLETED|Overall Study||5
10367098|NCT00535743|11507561|FG008|COMPLETED|Overall Study||4
10367099|NCT00535743|11507562|FG009|COMPLETED|Overall Study||4
10367100|NCT00535743|11507563|FG010|COMPLETED|Overall Study||5
10367101|NCT00535743|11507564|FG011|COMPLETED|Overall Study||5
10367102|NCT00535743|11507565|FG012|COMPLETED|Overall Study||5
10367103|NCT00535743|11507566|FG013|COMPLETED|Overall Study||10
10367104|NCT00535743|11507567|FG014|COMPLETED|Overall Study||9
10367105|NCT00535743|11507568|FG015|COMPLETED|Overall Study||13
10367106|NCT00535743|11507569|FG016|COMPLETED|Overall Study||10
10367107|NCT00535743|11507570|FG017|COMPLETED|Overall Study||11
10367108|NCT00535743|11507571|FG018|COMPLETED|Overall Study||3
10367109|NCT00535743|11507572|FG019|COMPLETED|Overall Study||5
10367110|NCT00535743|11507573|FG020|COMPLETED|Overall Study||5
10367111|NCT00535743|11507574|FG021|COMPLETED|Overall Study||4
10367112|NCT00535743|11507575|FG022|COMPLETED|Overall Study||6
10367113|NCT00535743|11507576|FG023|COMPLETED|Overall Study||5
10367114|NCT00535743|11507553|FG000|NOT COMPLETED|Overall Study||0
10367115|NCT00535743|11507554|FG001|NOT COMPLETED|Overall Study||0
10367116|NCT00535743|11507555|FG002|NOT COMPLETED|Overall Study||0
10367117|NCT00535743|11507556|FG003|NOT COMPLETED|Overall Study||0
10367118|NCT00535743|11507557|FG004|NOT COMPLETED|Overall Study||0
10367119|NCT00535743|11507558|FG005|NOT COMPLETED|Overall Study||0
10367120|NCT00535743|11507559|FG006|NOT COMPLETED|Overall Study||0
10367121|NCT00535743|11507560|FG007|NOT COMPLETED|Overall Study||0
10367122|NCT00535743|11507561|FG008|NOT COMPLETED|Overall Study||1
10367123|NCT00535743|11507562|FG009|NOT COMPLETED|Overall Study||1
10367124|NCT00535743|11507563|FG010|NOT COMPLETED|Overall Study||0
10367125|NCT00535743|11507564|FG011|NOT COMPLETED|Overall Study||0
10367126|NCT00535743|11507565|FG012|NOT COMPLETED|Overall Study||0
10367127|NCT00535743|11507566|FG013|NOT COMPLETED|Overall Study||0
10367128|NCT00535743|11507567|FG014|NOT COMPLETED|Overall Study||0
10367129|NCT00535743|11507568|FG015|NOT COMPLETED|Overall Study||0
10367130|NCT00535743|11507569|FG016|NOT COMPLETED|Overall Study||0
10367131|NCT00535743|11507570|FG017|NOT COMPLETED|Overall Study||0
10367132|NCT00535743|11507571|FG018|NOT COMPLETED|Overall Study||0
10367133|NCT00535743|11507572|FG019|NOT COMPLETED|Overall Study||0
10367134|NCT00535743|11507573|FG020|NOT COMPLETED|Overall Study||0
10367135|NCT00535743|11507574|FG021|NOT COMPLETED|Overall Study||1
10367136|NCT00535743|11507575|FG022|NOT COMPLETED|Overall Study||0
10367137|NCT00535743|11507576|FG023|NOT COMPLETED|Overall Study||0
10367138|NCT00535769|11507628|FG000|STARTED|Overall Study||35
10367139|NCT00535769|11507629|FG001|STARTED|Overall Study||35
10367140|NCT00535769|11507628|FG000|COMPLETED|Overall Study||35
10367141|NCT00535769|11507629|FG001|COMPLETED|Overall Study||35
10367142|NCT00535769|11507628|FG000|NOT COMPLETED|Overall Study||0
10367143|NCT00535769|11507629|FG001|NOT COMPLETED|Overall Study||0
10367144|NCT00535782|11507638|FG000|STARTED|Part 1: 24-Week Double-blind Period||69
10367145|NCT00535782|11507639|FG001|STARTED|Part 1: 24-Week Double-blind Period||63
10367146|NCT00535782|11507640|FG002|STARTED|Part 1: 24-Week Double-blind Period||0
10367147|NCT00535782|11507638|FG000|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period||69
10367148|NCT00535782|11507639|FG001|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period|1 misrandomized patient received the TCZ in error, and 1 patient received TCZ as rescue therapy.|2
10367149|NCT00535782|11507640|FG002|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period||0
10367150|NCT00535782|11507638|FG000|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||0
10367151|NCT00535782|11507639|FG001|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||62
10367152|NCT00535782|11507640|FG002|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||0
10367153|NCT00535782|11507638|FG000|COMPLETED|Part 1: 24-Week Double-blind Period||65
10367154|NCT00535782|11507639|FG001|COMPLETED|Part 1: 24-Week Double-blind Period||59
10367155|NCT00535782|11507640|FG002|COMPLETED|Part 1: 24-Week Double-blind Period||0
10367156|NCT00535782|11507638|FG000|NOT COMPLETED|Part 1: 24-Week Double-blind Period||4
10367157|NCT00535782|11507639|FG001|NOT COMPLETED|Part 1: 24-Week Double-blind Period||4
10367158|NCT00535782|11507640|FG002|NOT COMPLETED|Part 1: 24-Week Double-blind Period||0
10367159|NCT00535782|11507638|FG000|STARTED|Part 2: 80-Week Open-label Period||0
10367160|NCT00535782|11507639|FG001|STARTED|Part 2: 80-Week Open-label Period||0
10367161|NCT00535782|11507640|FG002|STARTED|Part 2: 80-Week Open-label Period||124
10367162|NCT00535782|11507638|FG000|COMPLETED|Part 2: 80-Week Open-label Period||0
10367163|NCT00535782|11507639|FG001|COMPLETED|Part 2: 80-Week Open-label Period||0
10367164|NCT00535782|11507640|FG002|COMPLETED|Part 2: 80-Week Open-label Period||98
10367165|NCT00535782|11507638|FG000|NOT COMPLETED|Part 2: 80-Week Open-label Period||0
10367166|NCT00535782|11507639|FG001|NOT COMPLETED|Part 2: 80-Week Open-label Period||0
10367167|NCT00535782|11507640|FG002|NOT COMPLETED|Part 2: 80-Week Open-label Period||26
10367168|NCT00535821|11507649|FG000|STARTED|Overall Study||2
10367169|NCT00535821|11507650|FG001|STARTED|Overall Study||3
10367170|NCT00535821|11507649|FG000|COMPLETED|Overall Study||2
10367171|NCT00535821|11507650|FG001|COMPLETED|Overall Study||3
10367172|NCT00535821|11507649|FG000|NOT COMPLETED|Overall Study||0
10367173|NCT00535821|11507650|FG001|NOT COMPLETED|Overall Study||0
10367174|NCT00535847|11507659|FG000|STARTED|Overall Study||81
10367175|NCT00535847|11507660|FG001|STARTED|Overall Study||34
10367176|NCT00535847|11507661|FG002|STARTED|Overall Study||2
10367177|NCT00535847|11507659|FG000|COMPLETED|Overall Study||59
10367178|NCT00535847|11507660|FG001|COMPLETED|Overall Study||20
10367179|NCT00535847|11507661|FG002|COMPLETED|Overall Study||0
10367180|NCT00535847|11507659|FG000|NOT COMPLETED|Overall Study||22
10367181|NCT00535847|11507660|FG001|NOT COMPLETED|Overall Study||14
10367182|NCT00535847|11507661|FG002|NOT COMPLETED|Overall Study||2
10367183|NCT00535873|11507673|FG000|STARTED|Overall Study||60
10367184|NCT00535873|11507673|FG000|COMPLETED|Overall Study||60
10367185|NCT00535873|11507673|FG000|NOT COMPLETED|Overall Study||0
10367186|NCT00535925|11507679|FG000|STARTED|Overall Study||188
10367187|NCT00535925|11507680|FG001|STARTED|Overall Study||207
10367188|NCT00535925|11507679|FG000|COMPLETED|Overall Study||169
10367189|NCT00535925|11507680|FG001|COMPLETED|Overall Study||199
10367190|NCT00535925|11507679|FG000|NOT COMPLETED|Overall Study||19
10367191|NCT00535925|11507680|FG001|NOT COMPLETED|Overall Study||8
10367192|NCT00535938|11507690|FG000|STARTED|Overall Study||506
10367193|NCT00535938|11507691|FG001|STARTED|Overall Study||866
10367194|NCT00535938|11507690|FG000|COMPLETED|Overall Study||115
10367195|NCT00535938|11507691|FG001|COMPLETED|Overall Study||404
10367196|NCT00535938|11507690|FG000|NOT COMPLETED|Overall Study||391
10367197|NCT00535938|11507691|FG001|NOT COMPLETED|Overall Study||462
10367198|NCT00536107|11507699|FG000|STARTED|Overall Study||8
10367199|NCT00536107|11507700|FG001|STARTED|Overall Study||6
10367200|NCT00536107|11507699|FG000|COMPLETED|Overall Study||0
10367201|NCT00536107|11507700|FG001|COMPLETED|Overall Study||0
10367202|NCT00536107|11507699|FG000|NOT COMPLETED|Overall Study||8
10367203|NCT00536107|11507700|FG001|NOT COMPLETED|Overall Study||6
10367204|NCT00536120|11507708|FG000|STARTED|Overall Study||30
10367205|NCT00536120|11507709|FG001|STARTED|Overall Study||30
10367206|NCT00536120|11507708|FG000|COMPLETED|Overall Study||24
10367207|NCT00536120|11507709|FG001|COMPLETED|Overall Study||27
10367208|NCT00536120|11507708|FG000|NOT COMPLETED|Overall Study||6
10367209|NCT00536120|11507709|FG001|NOT COMPLETED|Overall Study||3
10367210|NCT00536172|11507717|FG000|STARTED|Overall Study||74
10367211|NCT00536172|11507718|FG001|STARTED|Overall Study||74
10367212|NCT00536172|11507717|FG000|COMPLETED|Overall Study||60
10367213|NCT00536172|11507718|FG001|COMPLETED|Overall Study||65
10367214|NCT00536172|11507717|FG000|NOT COMPLETED|Overall Study||14
10367215|NCT00536172|11507718|FG001|NOT COMPLETED|Overall Study||9
10367216|NCT00536198|11507726|FG000|STARTED|Overall Study||125
10367217|NCT00536198|11507727|FG001|STARTED|Overall Study||127
10367218|NCT00536198|11507726|FG000|Cycle 1|Overall Study||110
10367219|NCT00536198|11507727|FG001|Cycle 1|Overall Study||123
10367220|NCT00536198|11507726|FG000|Cycle 2|Overall Study||104
10367221|NCT00536198|11507727|FG001|Cycle 2|Overall Study||112
10367222|NCT00536198|11507726|FG000|Cycle 3|Overall Study||100
10367223|NCT00536198|11507727|FG001|Cycle 3|Overall Study||101
10367224|NCT00536198|11507726|FG000|Cycle 4|Overall Study||95
10367225|NCT00536198|11507727|FG001|Cycle 4|Overall Study||98
10367226|NCT00536198|11507726|FG000|Cycle 5|Overall Study||88
10367227|NCT00536198|11507727|FG001|Cycle 5|Overall Study||85
10367228|NCT00536198|11507726|FG000|Cycle 6|Overall Study||88
10367229|NCT00536198|11507727|FG001|Cycle 6|Overall Study||88
10367230|NCT00536198|11507726|FG000|COMPLETED|Overall Study||88
10367231|NCT00536198|11507727|FG001|COMPLETED|Overall Study||88
10367232|NCT00536198|11507726|FG000|NOT COMPLETED|Overall Study||37
10367233|NCT00536198|11507727|FG001|NOT COMPLETED|Overall Study||39
10367234|NCT00536263|11507738|FG000|STARTED|Overall Study||225
10367235|NCT00536263|11507739|FG001|STARTED|Overall Study||221
10367236|NCT00536263|11507740|FG002|STARTED|Overall Study|One (1) participant withdrawn from study for non-compliance.|225
10367237|NCT00536263|11507738|FG000|COMPLETED|Overall Study||214
10367238|NCT00536263|11507739|FG001|COMPLETED|Overall Study||207
10367239|NCT00536263|11507740|FG002|COMPLETED|Overall Study||204
10367240|NCT00536263|11507738|FG000|NOT COMPLETED|Overall Study||11
10367241|NCT00536263|11507739|FG001|NOT COMPLETED|Overall Study||14
10367242|NCT00536263|11507740|FG002|NOT COMPLETED|Overall Study||21
10367243|NCT00536341|11507750|FG000|STARTED|Overall Study||10
10367244|NCT00536341|11507751|FG001|STARTED|Overall Study||54
10367245|NCT00536341|11507750|FG000|COMPLETED|Overall Study||5
10367246|NCT00536341|11507751|FG001|COMPLETED|Overall Study||43
10536428|NCT01443442|11688995|FG001|NOT COMPLETED|Overall Study||0
10536429|NCT01443494|11689001|FG000|STARTED|Overall Study||19
10536430|NCT01443494|11689001|FG000|COMPLETED|Overall Study||19
10536431|NCT01443494|11689001|FG000|NOT COMPLETED|Overall Study||0
10536432|NCT01443546|11689008|FG000|STARTED|Overall Study||9
10536433|NCT01443546|11689009|FG001|STARTED|Overall Study||9
10536434|NCT01443546|11689010|FG002|STARTED|Overall Study||8
10536435|NCT01443546|11689008|FG000|COMPLETED|Overall Study||9
10536436|NCT01443546|11689009|FG001|COMPLETED|Overall Study||9
10716609|NCT02690948|11880360|FG000|COMPLETED|Overall Study||9
10367247|NCT00536341|11507750|FG000|NOT COMPLETED|Overall Study||5
10367248|NCT00536341|11507751|FG001|NOT COMPLETED|Overall Study||11
10367249|NCT00536471|11507762|FG000|STARTED|Overall Study||257
10367250|NCT00536471|11507763|FG001|STARTED|Overall Study||127
10367251|NCT00536471|11507764|FG002|STARTED|Overall Study||261
10367252|NCT00536471|11507765|FG003|STARTED|Overall Study||131
10367253|NCT00536471|11507762|FG000|COMPLETED|Overall Study||101
10367254|NCT00536471|11507763|FG001|COMPLETED|Overall Study||43
10367255|NCT00536471|11507764|FG002|COMPLETED|Overall Study||122
10367256|NCT00536471|11507765|FG003|COMPLETED|Overall Study||57
10536437|NCT01443546|11689010|FG002|COMPLETED|Overall Study||8
10536438|NCT01443546|11689008|FG000|NOT COMPLETED|Overall Study||0
10536439|NCT01443546|11689009|FG001|NOT COMPLETED|Overall Study||0
10536440|NCT01443546|11689010|FG002|NOT COMPLETED|Overall Study||0
10536441|NCT01443845|11689022|FG000|STARTED|Overall Study||1176
10536442|NCT01443845|11689023|FG001|STARTED|Overall Study||1178
10367257|NCT00536471|11507762|FG000|NOT COMPLETED|Overall Study||156
10367258|NCT00536471|11507763|FG001|NOT COMPLETED|Overall Study||84
10367259|NCT00536471|11507764|FG002|NOT COMPLETED|Overall Study||139
10367260|NCT00536471|11507765|FG003|NOT COMPLETED|Overall Study||74
10367261|NCT00536484|11507784|FG000|STARTED|Overall Study|448 participants randomised; 3 not treated|445
10536443|NCT01443845|11689022|FG000|COMPLETED|Overall Study||922
10367262|NCT00536484|11507785|FG001|STARTED|Overall Study|448 participants randomised; 10 not treated|438
10367263|NCT00536484|11507784|FG000|COMPLETED|Overall Study|88 completed on matched 4mg dose and 297 on matched 8mg dose|385
10367264|NCT00536484|11507785|FG001|COMPLETED|Overall Study|134 completed on 4mg dose and 248 on 8mg dose|382
10367265|NCT00536484|11507784|FG000|NOT COMPLETED|Overall Study||60
10367266|NCT00536484|11507785|FG001|NOT COMPLETED|Overall Study||56
10367267|NCT00536510|11507793|FG000|STARTED|Overall Study||322
10367268|NCT00536510|11507794|FG001|STARTED|Overall Study||324
10367269|NCT00536510|11507793|FG000|COMPLETED|Overall Study||240
10536444|NCT01443845|11689023|FG001|COMPLETED|Overall Study||841
10536445|NCT01443845|11689022|FG000|NOT COMPLETED|Overall Study||254
10536446|NCT01443845|11689023|FG001|NOT COMPLETED|Overall Study||337
10536447|NCT01443858|11689032|FG000|STARTED|Overall Study||25
10536448|NCT01443858|11689033|FG001|STARTED|Overall Study||25
10536449|NCT01443858|11689034|FG002|STARTED|Overall Study||25
10536450|NCT01443858|11689032|FG000|COMPLETED|Overall Study||10
10536451|NCT01443858|11689033|FG001|COMPLETED|Overall Study||12
10536452|NCT01443858|11689034|FG002|COMPLETED|Overall Study||18
10536453|NCT01443858|11689032|FG000|NOT COMPLETED|Overall Study||15
10536454|NCT01443858|11689033|FG001|NOT COMPLETED|Overall Study||13
10536455|NCT01443858|11689034|FG002|NOT COMPLETED|Overall Study||7
10536456|NCT01444027|11689045|FG000|STARTED|Overall Study||172
10536457|NCT01444027|11689046|FG001|STARTED|Overall Study||171
10536458|NCT01444027|11689047|FG002|STARTED|Overall Study||171
10536459|NCT01444027|11689045|FG000|Received Intervention as Assigned|Overall Study||168
10536460|NCT01444027|11689046|FG001|Received Intervention as Assigned|Overall Study||161
10656907|NCT02222493|11818053|FG001|STARTED|Period 1: First Dose-Week 30 (Pre-dose)||326
10656908|NCT02222493|11818052|FG000|Received Treatment|Period 1: First Dose-Week 30 (Pre-dose)||323
10656909|NCT02222493|11818053|FG001|Received Treatment|Period 1: First Dose-Week 30 (Pre-dose)||326
10656910|NCT02222493|11818052|FG000|COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||280
10656911|NCT02222493|11818053|FG001|COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||286
10656912|NCT02222493|11818052|FG000|NOT COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||44
10656913|NCT02222493|11818053|FG001|NOT COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||40
10656914|NCT02222493|11818052|FG000|STARTED|Period 2: Week30 Dosing-Week54(Pre-dose)||423
10656915|NCT02222493|11818053|FG001|STARTED|Period 2: Week30 Dosing-Week54(Pre-dose)||143
10656916|NCT02222493|11818052|FG000|COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||380
10656917|NCT02222493|11818053|FG001|COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||126
10656918|NCT02222493|11818052|FG000|NOT COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||43
10656919|NCT02222493|11818053|FG001|NOT COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||17
10656920|NCT02222493|11818052|FG000|STARTED|Period 3: Week 54 Dosing-Week 78 Visit||505
10656921|NCT02222493|11818053|FG001|STARTED|Period 3: Week 54 Dosing-Week 78 Visit||0
10656922|NCT02222493|11818052|FG000|COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||474
10656923|NCT02222493|11818053|FG001|COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||0
10656924|NCT02222493|11818052|FG000|NOT COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||31
10656925|NCT02222493|11818053|FG001|NOT COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||0
10656926|NCT02222558|11818072|FG000|STARTED|Period 1: Single Dose||25
10656927|NCT02222558|11818073|FG001|STARTED|Period 1: Single Dose||0
10656928|NCT02222558|11818074|FG002|STARTED|Period 1: Single Dose||0
10656929|NCT02222558|11818075|FG003|STARTED|Period 1: Single Dose||0
10656930|NCT02222558|11818076|FG004|STARTED|Period 1: Single Dose||0
10656931|NCT02222558|11818077|FG005|STARTED|Period 1: Single Dose||0
10656932|NCT02222558|11818072|FG000|COMPLETED|Period 1: Single Dose||21
10656933|NCT02222558|11818073|FG001|COMPLETED|Period 1: Single Dose||0
10656934|NCT02222558|11818074|FG002|COMPLETED|Period 1: Single Dose||0
10656935|NCT02222558|11818075|FG003|COMPLETED|Period 1: Single Dose||0
10656936|NCT02222558|11818076|FG004|COMPLETED|Period 1: Single Dose||0
10656937|NCT02222558|11818077|FG005|COMPLETED|Period 1: Single Dose||0
10656938|NCT02222558|11818072|FG000|NOT COMPLETED|Period 1: Single Dose||4
10656939|NCT02222558|11818073|FG001|NOT COMPLETED|Period 1: Single Dose||0
10656940|NCT02222558|11818074|FG002|NOT COMPLETED|Period 1: Single Dose||0
10656941|NCT02222558|11818075|FG003|NOT COMPLETED|Period 1: Single Dose||0
10656942|NCT02222558|11818076|FG004|NOT COMPLETED|Period 1: Single Dose||0
10656943|NCT02222558|11818077|FG005|NOT COMPLETED|Period 1: Single Dose||0
10656944|NCT02222558|11818072|FG000|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
10656945|NCT02222558|11818073|FG001|STARTED|Period 2: Two Times Daily Dosing 90 mg||21
10656946|NCT02222558|11818074|FG002|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
10656947|NCT02222558|11818075|FG003|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
10656948|NCT02222558|11818076|FG004|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
10656949|NCT02222558|11818077|FG005|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
10656950|NCT02222558|11818072|FG000|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
10656951|NCT02222558|11818073|FG001|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||21
10656952|NCT02222558|11818074|FG002|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
10656953|NCT02222558|11818075|FG003|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
10367270|NCT00536510|11507794|FG001|COMPLETED|Overall Study||295
10536461|NCT01444027|11689047|FG002|Received Intervention as Assigned|Overall Study||147
10536462|NCT01444027|11689045|FG000|1 Month Follow-up|Overall Study||160
10536463|NCT01444027|11689046|FG001|1 Month Follow-up|Overall Study||159
10536464|NCT01444027|11689047|FG002|1 Month Follow-up|Overall Study||141
10536465|NCT01444027|11689045|FG000|3 Month Follow-up|Overall Study||142
10536466|NCT01444027|11689046|FG001|3 Month Follow-up|Overall Study||141
10536467|NCT01444027|11689047|FG002|3 Month Follow-up|Overall Study||133
10367271|NCT00536510|11507793|FG000|NOT COMPLETED|Overall Study||82
10367272|NCT00536510|11507794|FG001|NOT COMPLETED|Overall Study||29
10367273|NCT00536575|11507800|FG000|STARTED|Overall Study||13
10367274|NCT00536575|11507800|FG000|COMPLETED|Overall Study||11
10367275|NCT00536575|11507800|FG000|NOT COMPLETED|Overall Study||2
10367276|NCT00536601|11507809|FG000|STARTED|Overall Study||6
10367277|NCT00536601|11507810|FG001|STARTED|Overall Study||21
10367278|NCT00536601|11507811|FG002|STARTED|Overall Study||71
10367279|NCT00536601|11507812|FG003|STARTED|Overall Study||65
10367280|NCT00536601|11507813|FG004|STARTED|Overall Study||11
10367281|NCT00536601|11507809|FG000|COMPLETED|Overall Study||6
10367282|NCT00536601|11507810|FG001|COMPLETED|Overall Study||21
10367283|NCT00536601|11507811|FG002|COMPLETED|Overall Study||71
10367284|NCT00536601|11507812|FG003|COMPLETED|Overall Study||65
10367285|NCT00536601|11507813|FG004|COMPLETED|Overall Study||11
10367286|NCT00536601|11507809|FG000|NOT COMPLETED|Overall Study||0
10367287|NCT00536601|11507810|FG001|NOT COMPLETED|Overall Study||0
10367288|NCT00536601|11507811|FG002|NOT COMPLETED|Overall Study||0
10367289|NCT00536601|11507812|FG003|NOT COMPLETED|Overall Study||0
10367290|NCT00536601|11507813|FG004|NOT COMPLETED|Overall Study||0
10367291|NCT00536731|11507828|FG000|STARTED|Overall Study||253
10367292|NCT00536731|11507829|FG001|STARTED|Overall Study||246
10367293|NCT00536731|11507830|FG002|STARTED|Overall Study||243
10367294|NCT00536731|11507828|FG000|COMPLETED|Overall Study||249
10367295|NCT00536731|11507829|FG001|COMPLETED|Overall Study||241
10367296|NCT00536731|11507830|FG002|COMPLETED|Overall Study||238
10367297|NCT00536731|11507828|FG000|NOT COMPLETED|Overall Study||4
10367298|NCT00536731|11507829|FG001|NOT COMPLETED|Overall Study||5
10367299|NCT00536731|11507830|FG002|NOT COMPLETED|Overall Study||5
10367300|NCT00536744|11507840|FG000|STARTED|Overall Study||107
10367301|NCT00536744|11507841|FG001|STARTED|Overall Study||99
10367302|NCT00536744|11507840|FG000|COMPLETED|Overall Study||78
10367303|NCT00536744|11507841|FG001|COMPLETED|Overall Study||71
10367304|NCT00536744|11507840|FG000|NOT COMPLETED|Overall Study||29
10367305|NCT00536744|11507841|FG001|NOT COMPLETED|Overall Study||28
10367306|NCT00536809|11507847|FG000|STARTED|Phase I (Dose-finding Phase)||10
10367307|NCT00536809|11507847|FG000|COMPLETED|Phase I (Dose-finding Phase)||10
10367308|NCT00536809|11507847|FG000|NOT COMPLETED|Phase I (Dose-finding Phase)||0
10367309|NCT00536809|11507847|FG000|STARTED|Phase II||2
10367310|NCT00536809|11507847|FG000|COMPLETED|Phase II||0
10367311|NCT00536809|11507847|FG000|NOT COMPLETED|Phase II||2
10367312|NCT00536874|11507851|FG000|STARTED|Overall Study||39
10367313|NCT00536874|11507851|FG000|COMPLETED|Overall Study||35
10367314|NCT00536874|11507851|FG000|NOT COMPLETED|Overall Study||4
10367315|NCT00536913|11507857|FG000|STARTED|Overall Study||55
10367316|NCT00536913|11507858|FG001|STARTED|Overall Study||52
10367317|NCT00536913|11507857|FG000|COMPLETED|Overall Study||55
10367318|NCT00536913|11507858|FG001|COMPLETED|Overall Study||52
10367319|NCT00536913|11507857|FG000|NOT COMPLETED|Overall Study||0
10367320|NCT00536913|11507858|FG001|NOT COMPLETED|Overall Study||0
10367321|NCT00536939|11507864|FG000|STARTED|Overall Study||2
10367322|NCT00536939|11507865|FG001|STARTED|Overall Study||0
10367323|NCT00536939|11507864|FG000|Entered Safety lead-in|Overall Study||2
10367324|NCT00536939|11507865|FG001|Entered Safety lead-in|Overall Study||0
10367325|NCT00536939|11507864|FG000|Randomized|Overall Study||0
10367326|NCT00536939|11507865|FG001|Randomized|Overall Study||0
10367327|NCT00536939|11507864|FG000|COMPLETED|Overall Study||0
10367328|NCT00536939|11507865|FG001|COMPLETED|Overall Study||0
10367329|NCT00536939|11507864|FG000|NOT COMPLETED|Overall Study||2
10367330|NCT00536939|11507865|FG001|NOT COMPLETED|Overall Study||0
10367331|NCT00536991|11507870|FG000|STARTED|Overall Study||51
10367332|NCT00536991|11507870|FG000|COMPLETED|Overall Study||38
10367333|NCT00536991|11507870|FG000|NOT COMPLETED|Overall Study||13
10367334|NCT00537017|11507875|FG000|STARTED|Treatment Phase||140
10367335|NCT00537017|11507875|FG000|COMPLETED|Treatment Phase||106
10367336|NCT00537017|11507875|FG000|NOT COMPLETED|Treatment Phase||34
10367337|NCT00537017|11507875|FG000|STARTED|Follow-up Phase|All TP participants were eligible for FUP entry. 5 participants completing TP did not enter FUP.|135
10367338|NCT00537017|11507875|FG000|COMPLETED|Follow-up Phase||126
10367339|NCT00537017|11507875|FG000|NOT COMPLETED|Follow-up Phase||9
10367340|NCT00537030|11507879|FG000|STARTED|Overall Study||59
10367341|NCT00537030|11507879|FG000|COMPLETED|Overall Study||43
10367342|NCT00537030|11507879|FG000|NOT COMPLETED|Overall Study||16
10812583|NCT03500159|11974684|FG000|STARTED|Overall Study||2
10812584|NCT03500159|11974685|FG001|STARTED|Overall Study||1
10367343|NCT00537056|11507883|FG000|STARTED|Baseline PET/CT||17
10367344|NCT00537056|11507883|FG000|COMPLETED|Baseline PET/CT||17
10367345|NCT00537056|11507883|FG000|NOT COMPLETED|Baseline PET/CT||0
10367346|NCT00537056|11507883|FG000|STARTED|Interim PET/CT||17
10367347|NCT00537056|11507883|FG000|COMPLETED|Interim PET/CT||12
10367348|NCT00537056|11507883|FG000|NOT COMPLETED|Interim PET/CT||5
10367349|NCT00537056|11507883|FG000|STARTED|12-month Follow-up||17
10367350|NCT00537056|11507883|FG000|COMPLETED|12-month Follow-up||17
10367351|NCT00537056|11507883|FG000|NOT COMPLETED|12-month Follow-up||0
10367352|NCT00537082|11507892|FG000|STARTED|Overall Study||57
10367353|NCT00537082|11507893|FG001|STARTED|Overall Study||57
10367354|NCT00537082|11507894|FG002|STARTED|Overall Study||57
10367355|NCT00537082|11507892|FG000|COMPLETED|Overall Study||48
10367356|NCT00537082|11507893|FG001|COMPLETED|Overall Study||48
10367357|NCT00537082|11507894|FG002|COMPLETED|Overall Study||51
10367358|NCT00537082|11507892|FG000|NOT COMPLETED|Overall Study||9
10367359|NCT00537082|11507893|FG001|NOT COMPLETED|Overall Study||9
10812585|NCT03500159|11974684|FG000|COMPLETED|Overall Study||0
10367360|NCT00537082|11507894|FG002|NOT COMPLETED|Overall Study||6
10367361|NCT00537095|11507904|FG000|STARTED|Overall Study||72
10367362|NCT00537095|11507905|FG001|STARTED|Overall Study||73
10367363|NCT00537095|11507904|FG000|COMPLETED|Overall Study||21
10367364|NCT00537095|11507905|FG001|COMPLETED|Overall Study||16
10367365|NCT00537095|11507904|FG000|NOT COMPLETED|Overall Study||51
10367366|NCT00537095|11507905|FG001|NOT COMPLETED|Overall Study||57
10367367|NCT00537238|11507913|FG000|STARTED|Overall Study||254
10367368|NCT00537238|11507914|FG001|STARTED|Overall Study||255
10367369|NCT00537238|11507913|FG000|Completed Titration Phase|Overall Study||226
10367370|NCT00537238|11507914|FG001|Completed Titration Phase|Overall Study||236
10367371|NCT00537238|11507913|FG000|Completed Maintenance Phase|Overall Study|Primary analysis drawn from the population in the maintenance phase.|208
10367372|NCT00537238|11507914|FG001|Completed Maintenance Phase|Overall Study|Primary analysis drawn from the population in the maintenance phase.|210
10367373|NCT00537238|11507913|FG000|Entered Opt Blinded Continuation Phase|Overall Study|Participants who had clinical benefit were eligible to progress into opt blinded continuation phase.|185
10367374|NCT00537238|11507914|FG001|Entered Opt Blinded Continuation Phase|Overall Study|Participants who had clinical benefit were eligible to progress into opt blinded continuation phase.|195
10367375|NCT00537238|11507913|FG000|COMPLETED|Overall Study|Completed designates participants who completed the opt blinded continuation phase.|80
10367376|NCT00537238|11507914|FG001|COMPLETED|Overall Study|Completed designates participants who completed the opt blinded continuation phase.|82
10367377|NCT00537238|11507913|FG000|NOT COMPLETED|Overall Study||174
10367378|NCT00537238|11507914|FG001|NOT COMPLETED|Overall Study||173
10367379|NCT00537277|11507920|FG000|STARTED|Overall Study||161
10367380|NCT00537277|11507920|FG000|Exposed to Trial Drug|Overall Study|One subject not exposed to trial drug, and thus not included in full analysis set (FAS)|160
10367381|NCT00537277|11507920|FG000|COMPLETED|Overall Study||112
10367382|NCT00537277|11507920|FG000|NOT COMPLETED|Overall Study||49
10367383|NCT00537290|11507924|FG000|STARTED|Overall Study||19
10367384|NCT00537290|11507924|FG000|COMPLETED|Overall Study||19
10367385|NCT00537290|11507924|FG000|NOT COMPLETED|Overall Study||0
10367386|NCT00537303|11507930|FG000|STARTED|Overall Study||146
10367387|NCT00537303|11507931|FG001|STARTED|Overall Study||150
10367388|NCT00537303|11507930|FG000|COMPLETED|Overall Study||120
10367389|NCT00537303|11507931|FG001|COMPLETED|Overall Study||125
10367390|NCT00537303|11507930|FG000|NOT COMPLETED|Overall Study||26
10367391|NCT00537303|11507931|FG001|NOT COMPLETED|Overall Study||25
10367392|NCT00537316|11507943|FG000|STARTED|Part 1||79
10367393|NCT00537316|11507944|FG001|STARTED|Part 1||80
10367394|NCT00537316|11507945|FG002|STARTED|Part 1||80
10367395|NCT00537316|11507946|FG003|STARTED|Part 1||0
10367396|NCT00537316|11507947|FG004|STARTED|Part 1||0
10367397|NCT00537316|11507948|FG005|STARTED|Part 1||0
10367398|NCT00537316|11507949|FG006|STARTED|Part 1||0
10367399|NCT00537316|11507943|FG000|COMPLETED|Part 1||65
10367400|NCT00537316|11507944|FG001|COMPLETED|Part 1||53
10367401|NCT00537316|11507945|FG002|COMPLETED|Part 1||63
10367402|NCT00537316|11507946|FG003|COMPLETED|Part 1||0
10367403|NCT00537316|11507947|FG004|COMPLETED|Part 1||0
10367404|NCT00537316|11507948|FG005|COMPLETED|Part 1||0
10367405|NCT00537316|11507949|FG006|COMPLETED|Part 1||0
10367406|NCT00537316|11507943|FG000|NOT COMPLETED|Part 1||14
10367407|NCT00537316|11507944|FG001|NOT COMPLETED|Part 1||27
10367408|NCT00537316|11507945|FG002|NOT COMPLETED|Part 1||17
10367409|NCT00537316|11507946|FG003|NOT COMPLETED|Part 1||0
10367410|NCT00537316|11507947|FG004|NOT COMPLETED|Part 1||0
10367411|NCT00537316|11507948|FG005|NOT COMPLETED|Part 1||0
10367412|NCT00537316|11507949|FG006|NOT COMPLETED|Part 1||0
10367413|NCT00537316|11507943|FG000|STARTED|Part 2||37
10367414|NCT00537316|11507944|FG001|STARTED|Part 2||10
10367415|NCT00537316|11507945|FG002|STARTED|Part 2||48
10367416|NCT00537316|11507946|FG003|STARTED|Part 2||5
10367417|NCT00537316|11507947|FG004|STARTED|Part 2||2
10367418|NCT00537316|11507948|FG005|STARTED|Part 2||4
10367419|NCT00537316|11507949|FG006|STARTED|Part 2||2
10367420|NCT00537316|11507943|FG000|COMPLETED|Part 2||11
10367421|NCT00537316|11507944|FG001|COMPLETED|Part 2||1
10367422|NCT00537316|11507945|FG002|COMPLETED|Part 2||16
10367423|NCT00537316|11507946|FG003|COMPLETED|Part 2||2
10367424|NCT00537316|11507947|FG004|COMPLETED|Part 2||1
10367425|NCT00537316|11507948|FG005|COMPLETED|Part 2||0
10367426|NCT00537316|11507949|FG006|COMPLETED|Part 2||0
10367427|NCT00537316|11507943|FG000|NOT COMPLETED|Part 2||26
10367428|NCT00537316|11507944|FG001|NOT COMPLETED|Part 2||9
10367429|NCT00537316|11507945|FG002|NOT COMPLETED|Part 2||32
10367430|NCT00537316|11507946|FG003|NOT COMPLETED|Part 2||3
10367431|NCT00537316|11507947|FG004|NOT COMPLETED|Part 2||1
10367432|NCT00537316|11507948|FG005|NOT COMPLETED|Part 2||4
10367433|NCT00537316|11507949|FG006|NOT COMPLETED|Part 2||2
10367434|NCT00537329|11507968|FG000|STARTED|Overall Study||43
10367435|NCT00537329|11507968|FG000|COMPLETED|Overall Study||17
10367436|NCT00537329|11507968|FG000|NOT COMPLETED|Overall Study||26
10367437|NCT00537381|11507974|FG000|STARTED|Overall Study|11 Participants after disease progression switched to intetumumab alone (2) or D+P+ Intetumumab (9).|65
10367438|NCT00537381|11507975|FG001|STARTED|Overall Study||66
10367439|NCT00537381|11507974|FG000|COMPLETED|Overall Study||9
10367440|NCT00537381|11507975|FG001|COMPLETED|Overall Study||4
10367441|NCT00537381|11507974|FG000|NOT COMPLETED|Overall Study||56
10367442|NCT00537381|11507975|FG001|NOT COMPLETED|Overall Study||62
10367443|NCT00537394|11507986|FG000|STARTED|First Year of Follow-up||181
10367444|NCT00537394|11507987|FG001|STARTED|First Year of Follow-up||179
10367445|NCT00537394|11507988|FG002|STARTED|First Year of Follow-up||53
10367446|NCT00537394|11507986|FG000|COMPLETED|First Year of Follow-up|Completed refers to completing first 48 weeks of follow-up.|169
10367447|NCT00537394|11507987|FG001|COMPLETED|First Year of Follow-up|Completed refers to completing first 48 weeks of follow-up.|168
10367448|NCT00537394|11507988|FG002|COMPLETED|First Year of Follow-up||50
10367449|NCT00537394|11507986|FG000|NOT COMPLETED|First Year of Follow-up||12
10367450|NCT00537394|11507987|FG001|NOT COMPLETED|First Year of Follow-up||11
10367451|NCT00537394|11507988|FG002|NOT COMPLETED|First Year of Follow-up||3
10367452|NCT00537394|11507986|FG000|STARTED|2nd Year of Follow-up||169
10367453|NCT00537394|11507987|FG001|STARTED|2nd Year of Follow-up||168
10367454|NCT00537394|11507988|FG002|STARTED|2nd Year of Follow-up||50
10367455|NCT00537394|11507986|FG000|COMPLETED|2nd Year of Follow-up||158
10367456|NCT00537394|11507987|FG001|COMPLETED|2nd Year of Follow-up||159
10367457|NCT00537394|11507988|FG002|COMPLETED|2nd Year of Follow-up||44
10367458|NCT00537394|11507986|FG000|NOT COMPLETED|2nd Year of Follow-up||11
10367459|NCT00537394|11507987|FG001|NOT COMPLETED|2nd Year of Follow-up||9
10367460|NCT00537394|11507988|FG002|NOT COMPLETED|2nd Year of Follow-up||6
10367461|NCT00537407|11507999|FG000|STARTED|Part 1 Weeks 1-4||10
10367462|NCT00537407|11508000|FG001|STARTED|Part 1 Weeks 1-4||9
10367463|NCT00537407|11508001|FG002|STARTED|Part 1 Weeks 1-4||11
10536468|NCT01444027|11689045|FG000|COMPLETED|Overall Study||142
10536469|NCT01444027|11689046|FG001|COMPLETED|Overall Study||141
10536470|NCT01444027|11689047|FG002|COMPLETED|Overall Study||133
10536471|NCT01444027|11689045|FG000|NOT COMPLETED|Overall Study||30
10536472|NCT01444027|11689046|FG001|NOT COMPLETED|Overall Study||30
10536473|NCT01444027|11689047|FG002|NOT COMPLETED|Overall Study||38
10536474|NCT01444287|11689055|FG000|STARTED|Period 1||22
10536475|NCT01444287|11689055|FG000|COMPLETED|Period 1||22
10536476|NCT01444287|11689055|FG000|NOT COMPLETED|Period 1||0
10536477|NCT01444287|11689055|FG000|STARTED|Period 2||22
10536478|NCT01444287|11689055|FG000|COMPLETED|Period 2||22
10536479|NCT01444287|11689055|FG000|NOT COMPLETED|Period 2||0
10536480|NCT01444287|11689055|FG000|STARTED|Period 3||22
10536481|NCT01444287|11689055|FG000|COMPLETED|Period 3||22
10536482|NCT01444287|11689055|FG000|NOT COMPLETED|Period 3||0
10536483|NCT01444287|11689055|FG000|STARTED|Period 4||22
10536484|NCT01444287|11689055|FG000|COMPLETED|Period 4||22
10536485|NCT01444287|11689055|FG000|NOT COMPLETED|Period 4||0
10536486|NCT01444300|11689071|FG000|STARTED|Overall Study||12
10536487|NCT01444300|11689072|FG001|STARTED|Overall Study||12
10536488|NCT01444300|11689071|FG000|COMPLETED|Overall Study||8
10536489|NCT01444300|11689072|FG001|COMPLETED|Overall Study||12
10536490|NCT01444300|11689071|FG000|NOT COMPLETED|Overall Study||4
10536491|NCT01444300|11689072|FG001|NOT COMPLETED|Overall Study||0
10536492|NCT01444378|11689079|FG000|STARTED|Overall Study|A total of 141 patients were enrolled into MOMENTUM|141
10536493|NCT01444378|11689079|FG000|COMPLETED|Overall Study||124
10536494|NCT01444378|11689079|FG000|NOT COMPLETED|Overall Study||17
10536495|NCT01444391|11689086|FG000|STARTED|Overall Study||42
10536496|NCT01444391|11689086|FG000|COMPLETED|Overall Study||41
10536497|NCT01444391|11689086|FG000|NOT COMPLETED|Overall Study||1
10536498|NCT01444417|11689092|FG000|STARTED|Overall Study||20
10536499|NCT01444417|11689093|FG001|STARTED|Overall Study||42
10536500|NCT01444417|11689092|FG000|Received Treatment|Overall Study||19
10536501|NCT01444417|11689093|FG001|Received Treatment|Overall Study||42
10536502|NCT01444417|11689092|FG000|COMPLETED|Overall Study||18
10536503|NCT01444417|11689093|FG001|COMPLETED|Overall Study||41
10536504|NCT01444417|11689092|FG000|NOT COMPLETED|Overall Study||2
10536505|NCT01444417|11689093|FG001|NOT COMPLETED|Overall Study||1
10536506|NCT01444430|11689101|FG000|STARTED|Overall Study||5846
10536507|NCT01444430|11689102|FG001|STARTED|Overall Study||5847
10536508|NCT01444430|11689101|FG000|COMPLETED|Overall Study||5785
10536509|NCT01444430|11689102|FG001|COMPLETED|Overall Study||5766
10536510|NCT01444430|11689101|FG000|NOT COMPLETED|Overall Study||61
10536511|NCT01444430|11689102|FG001|NOT COMPLETED|Overall Study||81
10536512|NCT01444456|11689108|FG000|STARTED|Overall Study||1262
10536513|NCT01444456|11689108|FG000|Received Darbepoetin Alfa or Other ESA|Overall Study||1158
10536514|NCT01444456|11689108|FG000|Received Darbepoetin Alfa|Overall Study||1134
10536515|NCT01444456|11689108|FG000|COMPLETED|Overall Study|Defined as 4 weeks after last dose of ESA or chemotherapy or 13 weeks after enrolment|977
10536516|NCT01444456|11689108|FG000|NOT COMPLETED|Overall Study||285
10536517|NCT01444651|11689114|FG000|STARTED|Overall Study||36
10716610|NCT02690948|11880361|FG001|COMPLETED|Overall Study||7
10367464|NCT00537407|11508002|FG003|STARTED|Part 1 Weeks 1-4||10
10367465|NCT00537407|11508003|FG004|STARTED|Part 1 Weeks 1-4||10
10367466|NCT00537407|11507999|FG000|COMPLETED|Part 1 Weeks 1-4||10
10367467|NCT00537407|11508000|FG001|COMPLETED|Part 1 Weeks 1-4||9
10367468|NCT00537407|11508001|FG002|COMPLETED|Part 1 Weeks 1-4||11
10367469|NCT00537407|11508002|FG003|COMPLETED|Part 1 Weeks 1-4||10
10367470|NCT00537407|11508003|FG004|COMPLETED|Part 1 Weeks 1-4||10
10367471|NCT00537407|11507999|FG000|NOT COMPLETED|Part 1 Weeks 1-4||0
10367472|NCT00537407|11508000|FG001|NOT COMPLETED|Part 1 Weeks 1-4||0
10367473|NCT00537407|11508001|FG002|NOT COMPLETED|Part 1 Weeks 1-4||0
10367474|NCT00537407|11508002|FG003|NOT COMPLETED|Part 1 Weeks 1-4||0
10367475|NCT00537407|11508003|FG004|NOT COMPLETED|Part 1 Weeks 1-4||0
10367476|NCT00537407|11507999|FG000|STARTED|Part 2 Weeks 5-48 or 72||10
10367477|NCT00537407|11508000|FG001|STARTED|Part 2 Weeks 5-48 or 72||9
10367478|NCT00537407|11508001|FG002|STARTED|Part 2 Weeks 5-48 or 72||11
10367479|NCT00537407|11508002|FG003|STARTED|Part 2 Weeks 5-48 or 72||10
10536518|NCT01444651|11689115|FG001|STARTED|Overall Study||37
10536519|NCT01444651|11689114|FG000|COMPLETED|Overall Study||25
10536520|NCT01444651|11689115|FG001|COMPLETED|Overall Study||28
10536521|NCT01444651|11689114|FG000|NOT COMPLETED|Overall Study||11
10536522|NCT01444651|11689115|FG001|NOT COMPLETED|Overall Study||9
10367480|NCT00537407|11508003|FG004|STARTED|Part 2 Weeks 5-48 or 72||10
10367481|NCT00537407|11507999|FG000|COMPLETED|Part 2 Weeks 5-48 or 72||2
10367482|NCT00537407|11508000|FG001|COMPLETED|Part 2 Weeks 5-48 or 72||1
10367483|NCT00537407|11508001|FG002|COMPLETED|Part 2 Weeks 5-48 or 72||2
10367484|NCT00537407|11508002|FG003|COMPLETED|Part 2 Weeks 5-48 or 72||4
10367485|NCT00537407|11508003|FG004|COMPLETED|Part 2 Weeks 5-48 or 72||3
10367486|NCT00537407|11507999|FG000|NOT COMPLETED|Part 2 Weeks 5-48 or 72||8
10367487|NCT00537407|11508000|FG001|NOT COMPLETED|Part 2 Weeks 5-48 or 72||8
10367488|NCT00537407|11508001|FG002|NOT COMPLETED|Part 2 Weeks 5-48 or 72||9
10367489|NCT00537407|11508002|FG003|NOT COMPLETED|Part 2 Weeks 5-48 or 72||6
10367490|NCT00537407|11508003|FG004|NOT COMPLETED|Part 2 Weeks 5-48 or 72||7
10367491|NCT00537485|11508021|FG000|STARTED|Overall Study||90
10367492|NCT00537485|11508022|FG001|STARTED|Overall Study||90
10367493|NCT00537485|11508021|FG000|COMPLETED|Overall Study||75
10367494|NCT00537485|11508022|FG001|COMPLETED|Overall Study||80
10367495|NCT00537485|11508021|FG000|NOT COMPLETED|Overall Study||15
10367496|NCT00537485|11508022|FG001|NOT COMPLETED|Overall Study||10
10367497|NCT00537511|11508028|FG000|STARTED|Treatment Period (Combination)||22
10367498|NCT00537511|11508028|FG000|Intent-to-Treat (ITT) Populaton|Treatment Period (Combination)|ITT = all participants enrolled in the study.|22
10367499|NCT00537511|11508028|FG000|Safety Population|Treatment Period (Combination)|Safety = All participants who took ≥1 dose of study treatment.|22
10367500|NCT00537511|11508028|FG000|COMPLETED|Treatment Period (Combination)||17
10367501|NCT00537511|11508028|FG000|NOT COMPLETED|Treatment Period (Combination)||5
10367502|NCT00537511|11508028|FG000|STARTED|Extension Period (Combination)||17
10367503|NCT00537511|11508028|FG000|COMPLETED|Extension Period (Combination)||11
10367504|NCT00537511|11508028|FG000|NOT COMPLETED|Extension Period (Combination)||6
10367505|NCT00537511|11508028|FG000|STARTED|Recovery Period (Monotherapy)||11
10367506|NCT00537511|11508028|FG000|COMPLETED|Recovery Period (Monotherapy)||3
10367507|NCT00537511|11508028|FG000|NOT COMPLETED|Recovery Period (Monotherapy)||8
10367508|NCT00537511|11508028|FG000|STARTED|Maintenance Phase (Monotherapy)||8
10367509|NCT00537511|11508028|FG000|COMPLETED|Maintenance Phase (Monotherapy)||0
10367510|NCT00537511|11508028|FG000|NOT COMPLETED|Maintenance Phase (Monotherapy)||8
10367511|NCT00537576|11508051|FG000|STARTED|Overall Study||3
10367512|NCT00537576|11508052|FG001|STARTED|Overall Study||3
10367513|NCT00537576|11508053|FG002|STARTED|Overall Study||3
10367514|NCT00537576|11508054|FG003|STARTED|Overall Study||1
10367515|NCT00537576|11508055|FG004|STARTED|Overall Study||1
10367516|NCT00537576|11508056|FG005|STARTED|Overall Study||1
10367517|NCT00537576|11508051|FG000|COMPLETED|Overall Study||3
10367518|NCT00537576|11508052|FG001|COMPLETED|Overall Study||3
10367519|NCT00537576|11508053|FG002|COMPLETED|Overall Study||3
10367520|NCT00537576|11508054|FG003|COMPLETED|Overall Study||1
10367521|NCT00537576|11508055|FG004|COMPLETED|Overall Study||1
10367522|NCT00537576|11508056|FG005|COMPLETED|Overall Study||1
10367523|NCT00537576|11508051|FG000|NOT COMPLETED|Overall Study||0
10367524|NCT00537576|11508052|FG001|NOT COMPLETED|Overall Study||0
10367525|NCT00537576|11508053|FG002|NOT COMPLETED|Overall Study||0
10367526|NCT00537576|11508054|FG003|NOT COMPLETED|Overall Study||0
10367527|NCT00537576|11508055|FG004|NOT COMPLETED|Overall Study||0
10367528|NCT00537576|11508056|FG005|NOT COMPLETED|Overall Study||0
10367529|NCT00537680|11508073|FG000|STARTED|Overall Study||22
10367530|NCT00537680|11508074|FG001|STARTED|Overall Study||24
10367531|NCT00537680|11508075|FG002|STARTED|Overall Study||24
10367532|NCT00537680|11508073|FG000|COMPLETED|Overall Study||22
10367533|NCT00537680|11508074|FG001|COMPLETED|Overall Study||22
10367534|NCT00537680|11508075|FG002|COMPLETED|Overall Study||24
10367535|NCT00537680|11508073|FG000|NOT COMPLETED|Overall Study||0
10367536|NCT00537680|11508074|FG001|NOT COMPLETED|Overall Study||2
10367537|NCT00537680|11508075|FG002|NOT COMPLETED|Overall Study||0
10367538|NCT00537745|11508083|FG000|STARTED|Overall Study|There were three screen fails and two early terminations.|14
10367539|NCT00537745|11508083|FG000|Began Intervention|Overall Study||11
10367540|NCT00537745|11508083|FG000|COMPLETED|Overall Study||9
10656954|NCT02222558|11818076|FG004|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
10656955|NCT02222558|11818077|FG005|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
10656956|NCT02222558|11818072|FG000|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
10656957|NCT02222558|11818073|FG001|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
10656958|NCT02222558|11818074|FG002|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
10367541|NCT00537745|11508083|FG000|NOT COMPLETED|Overall Study||5
10367542|NCT00537771|11508090|FG000|STARTED|Overall Study||178
10367543|NCT00537771|11508091|FG001|STARTED|Overall Study||175
10367544|NCT00537771|11508090|FG000|COMPLETED|Overall Study||149
10367545|NCT00537771|11508091|FG001|COMPLETED|Overall Study||114
10367546|NCT00537771|11508090|FG000|NOT COMPLETED|Overall Study||29
10367547|NCT00537771|11508091|FG001|NOT COMPLETED|Overall Study||61
10367548|NCT00537810|11508101|FG000|STARTED|Overall Study||26
10367549|NCT00537810|11508102|FG001|STARTED|Overall Study||27
10367550|NCT00537810|11508103|FG002|STARTED|Overall Study||25
10367551|NCT00537810|11508104|FG003|STARTED|Overall Study||26
10367552|NCT00537810|11508101|FG000|COMPLETED|Overall Study||20
10367553|NCT00537810|11508102|FG001|COMPLETED|Overall Study||14
10367554|NCT00537810|11508103|FG002|COMPLETED|Overall Study||21
10367555|NCT00537810|11508104|FG003|COMPLETED|Overall Study||22
10367556|NCT00537810|11508101|FG000|NOT COMPLETED|Overall Study||6
10367557|NCT00537810|11508102|FG001|NOT COMPLETED|Overall Study||13
10367558|NCT00537810|11508103|FG002|NOT COMPLETED|Overall Study||4
10367559|NCT00537810|11508104|FG003|NOT COMPLETED|Overall Study||4
10367560|NCT00537823|11508116|FG000|STARTED|Overall Study||7
10367561|NCT00537823|11508117|FG001|STARTED|Overall Study||2
10367562|NCT00537823|11508116|FG000|COMPLETED|Overall Study||5
10367563|NCT00537823|11508117|FG001|COMPLETED|Overall Study||2
10367564|NCT00537823|11508116|FG000|NOT COMPLETED|Overall Study||2
10367565|NCT00537823|11508117|FG001|NOT COMPLETED|Overall Study||0
10367566|NCT00537940|11508126|FG000|STARTED|Overall Study||241
10367567|NCT00537940|11508127|FG001|STARTED|Overall Study||241
10367568|NCT00537940|11508126|FG000|Completed Titration Phase|Overall Study||213
10367569|NCT00537940|11508127|FG001|Completed Titration Phase|Overall Study||210
10367570|NCT00537940|11508126|FG000|Completed Maintenance Phase|Overall Study||187
10367571|NCT00537940|11508127|FG001|Completed Maintenance Phase|Overall Study||172
10367572|NCT00537940|11508126|FG000|Entered Opt Blinded Continuation Phase|Overall Study||140
10367573|NCT00537940|11508127|FG001|Entered Opt Blinded Continuation Phase|Overall Study||139
10367574|NCT00537940|11508126|FG000|COMPLETED|Overall Study|2 participants had both treatment related and non-treatment related AE leading to discontinuation.|58
10367575|NCT00537940|11508127|FG001|COMPLETED|Overall Study||62
10367576|NCT00537940|11508126|FG000|NOT COMPLETED|Overall Study||183
10367577|NCT00537940|11508127|FG001|NOT COMPLETED|Overall Study||179
10367578|NCT00537979|11508135|FG000|STARTED|Overall Study||38
10367579|NCT00537979|11508136|FG001|STARTED|Overall Study||109
10367580|NCT00537979|11508135|FG000|COMPLETED|Overall Study||32
10367581|NCT00537979|11508136|FG001|COMPLETED|Overall Study||89
10367582|NCT00537979|11508135|FG000|NOT COMPLETED|Overall Study||6
10716611|NCT02690948|11880360|FG000|NOT COMPLETED|Overall Study||0
10716612|NCT02690948|11880361|FG001|NOT COMPLETED|Overall Study||0
10716613|NCT02690974|11880367|FG000|STARTED|Overall Study||302
10716614|NCT02690974|11880367|FG000|COMPLETED|Overall Study||262
10716615|NCT02690974|11880367|FG000|NOT COMPLETED|Overall Study||40
10716616|NCT02691143|11880373|FG000|STARTED|Overall Study||27
10716617|NCT02691143|11880374|FG001|STARTED|Overall Study||23
10716618|NCT02691143|11880373|FG000|COMPLETED|Overall Study||27
10716619|NCT02691143|11880374|FG001|COMPLETED|Overall Study||23
10716620|NCT02691143|11880373|FG000|NOT COMPLETED|Overall Study||0
10716621|NCT02691143|11880374|FG001|NOT COMPLETED|Overall Study||0
10367583|NCT00537979|11508136|FG001|NOT COMPLETED|Overall Study||20
10367584|NCT00538213|11508146|FG000|STARTED|Overall Study||55
10367585|NCT00538213|11508147|FG001|STARTED|Overall Study||40
10716622|NCT02691247|11880383|FG000|STARTED|Overall Study||40
10367586|NCT00538213|11508148|FG002|STARTED|Overall Study||38
10367587|NCT00538213|11508146|FG000|COMPLETED|Overall Study||55
10367588|NCT00538213|11508147|FG001|COMPLETED|Overall Study||40
10367589|NCT00538213|11508148|FG002|COMPLETED|Overall Study||38
10367590|NCT00538213|11508146|FG000|NOT COMPLETED|Overall Study||0
10367591|NCT00538213|11508147|FG001|NOT COMPLETED|Overall Study||0
10367592|NCT00538213|11508148|FG002|NOT COMPLETED|Overall Study||0
10367593|NCT00538291|11508157|FG000|STARTED|Overall Study||13
10367594|NCT00538291|11508157|FG000|COMPLETED|Overall Study||10
10367595|NCT00538291|11508157|FG000|NOT COMPLETED|Overall Study||3
10536523|NCT01444716|11689121|FG000|STARTED|Overall Study||34
10536524|NCT01444716|11689121|FG000|COMPLETED|Overall Study||34
10536525|NCT01444716|11689121|FG000|NOT COMPLETED|Overall Study||0
10536526|NCT01444742|11689125|FG000|STARTED|Overall Study||81
10536527|NCT01444742|11689125|FG000|COMPLETED|Overall Study||80
10536528|NCT01444742|11689125|FG000|NOT COMPLETED|Overall Study||1
10536529|NCT01444781|11689132|FG000|STARTED|Overall Study||416
10536530|NCT01444781|11689133|FG001|STARTED|Overall Study||415
10536531|NCT01444781|11689134|FG002|STARTED|Overall Study||275
10536532|NCT01444781|11689132|FG000|COMPLETED|Overall Study||413
10536533|NCT01444781|11689133|FG001|COMPLETED|Overall Study||411
10536534|NCT01444781|11689134|FG002|COMPLETED|Overall Study||272
10367596|NCT00538304|11508163|FG000|STARTED|Overall Study||151
10367597|NCT00538304|11508164|FG001|STARTED|Overall Study||71
10367598|NCT00538304|11508163|FG000|COMPLETED|Overall Study||144
10367599|NCT00538304|11508164|FG001|COMPLETED|Overall Study||66
10367600|NCT00538304|11508163|FG000|NOT COMPLETED|Overall Study||7
10367601|NCT00538304|11508164|FG001|NOT COMPLETED|Overall Study||5
10367602|NCT00538434|11508174|FG000|STARTED|Overall Study||56
10367603|NCT00538434|11508175|FG001|STARTED|Overall Study||57
10367604|NCT00538434|11508176|FG002|STARTED|Overall Study||57
10367605|NCT00538434|11508177|FG003|STARTED|Overall Study||57
10367606|NCT00538434|11508174|FG000|Intent-to-treat (ITT) Population|Overall Study|1 participant was randomized but not treated|55
10367607|NCT00538434|11508175|FG001|Intent-to-treat (ITT) Population|Overall Study||57
10367608|NCT00538434|11508176|FG002|Intent-to-treat (ITT) Population|Overall Study||57
10367609|NCT00538434|11508177|FG003|Intent-to-treat (ITT) Population|Overall Study||57
10536535|NCT01444781|11689132|FG000|NOT COMPLETED|Overall Study||3
10536536|NCT01444781|11689133|FG001|NOT COMPLETED|Overall Study||4
10536537|NCT01444781|11689134|FG002|NOT COMPLETED|Overall Study||3
10536538|NCT01444898|11689149|FG000|STARTED|Overall Study||10
10536539|NCT01444898|11689149|FG000|COMPLETED|Overall Study||9
10536540|NCT01444898|11689149|FG000|NOT COMPLETED|Overall Study||1
10536541|NCT01444911|11689155|FG000|STARTED|Overall Study||16
10536542|NCT01444911|11689156|FG001|STARTED|Overall Study||13
10536543|NCT01444911|11689155|FG000|COMPLETED|Overall Study||8
10536544|NCT01444911|11689156|FG001|COMPLETED|Overall Study||13
10536545|NCT01444911|11689155|FG000|NOT COMPLETED|Overall Study||8
10536546|NCT01444911|11689156|FG001|NOT COMPLETED|Overall Study||0
10716623|NCT02691247|11880384|FG001|STARTED|Overall Study||24
10716624|NCT02691247|11880385|FG002|STARTED|Overall Study||46
10716625|NCT02691247|11880383|FG000|COMPLETED|Overall Study||37
10716626|NCT02691247|11880384|FG001|COMPLETED|Overall Study||22
10716627|NCT02691247|11880385|FG002|COMPLETED|Overall Study||43
10716628|NCT02691247|11880383|FG000|NOT COMPLETED|Overall Study||3
10716629|NCT02691247|11880384|FG001|NOT COMPLETED|Overall Study||2
10716630|NCT02691247|11880385|FG002|NOT COMPLETED|Overall Study||3
10716631|NCT02691260|11880397|FG000|STARTED|Overall Study||26
10536547|NCT01444924|11689164|FG000|STARTED|Overall Study||31
10536548|NCT01444924|11689165|FG001|STARTED|Overall Study||33
10536549|NCT01444924|11689164|FG000|COMPLETED|Overall Study||31
10536550|NCT01444924|11689165|FG001|COMPLETED|Overall Study||33
10536551|NCT01444924|11689164|FG000|NOT COMPLETED|Overall Study||0
10536552|NCT01444924|11689165|FG001|NOT COMPLETED|Overall Study||0
10536553|NCT01445028|11689173|FG000|STARTED|Overall Study||58
10536554|NCT01445028|11689174|FG001|STARTED|Overall Study||54
10536555|NCT01445028|11689173|FG000|COMPLETED|Overall Study||58
10536556|NCT01445028|11689174|FG001|COMPLETED|Overall Study||51
10536557|NCT01445028|11689173|FG000|NOT COMPLETED|Overall Study||0
10536558|NCT01445028|11689174|FG001|NOT COMPLETED|Overall Study||3
10536559|NCT01445080|11689189|FG000|STARTED|Overall Study||7
10536560|NCT01445080|11689190|FG001|STARTED|Overall Study||5
10536561|NCT01445080|11689191|FG002|STARTED|Overall Study||12
10536562|NCT01445080|11689192|FG003|STARTED|Overall Study||8
10536563|NCT01445080|11689193|FG004|STARTED|Overall Study||4
10536564|NCT01445080|11689194|FG005|STARTED|Overall Study||9
10536565|NCT01445080|11689195|FG006|STARTED|Overall Study||2
10536566|NCT01445080|11689196|FG007|STARTED|Overall Study||5
10536567|NCT01445080|11689197|FG008|STARTED|Overall Study||18
10536568|NCT01445080|11689189|FG000|COMPLETED|Overall Study||0
10536569|NCT01445080|11689190|FG001|COMPLETED|Overall Study||0
10716632|NCT02691260|11880398|FG001|STARTED|Overall Study||26
10536570|NCT01445080|11689191|FG002|COMPLETED|Overall Study||0
10536571|NCT01445080|11689192|FG003|COMPLETED|Overall Study||0
10716633|NCT02691260|11880399|FG002|STARTED|Overall Study||27
10716634|NCT02691260|11880400|FG003|STARTED|Overall Study||26
10536572|NCT01445080|11689193|FG004|COMPLETED|Overall Study||0
10536573|NCT01445080|11689194|FG005|COMPLETED|Overall Study||0
10536574|NCT01445080|11689195|FG006|COMPLETED|Overall Study||0
10536575|NCT01445080|11689196|FG007|COMPLETED|Overall Study||0
10536576|NCT01445080|11689197|FG008|COMPLETED|Overall Study||0
10536577|NCT01445080|11689189|FG000|NOT COMPLETED|Overall Study||7
10536578|NCT01445080|11689190|FG001|NOT COMPLETED|Overall Study||5
10536579|NCT01445080|11689191|FG002|NOT COMPLETED|Overall Study||12
10536580|NCT01445080|11689192|FG003|NOT COMPLETED|Overall Study||8
10536581|NCT01445080|11689193|FG004|NOT COMPLETED|Overall Study||4
10536582|NCT01445080|11689194|FG005|NOT COMPLETED|Overall Study||9
10536583|NCT01445080|11689195|FG006|NOT COMPLETED|Overall Study||2
10716635|NCT02691260|11880397|FG000|COMPLETED|Overall Study||24
10536584|NCT01445080|11689196|FG007|NOT COMPLETED|Overall Study||5
10536585|NCT01445080|11689197|FG008|NOT COMPLETED|Overall Study||18
10536586|NCT01445171|11689232|FG000|STARTED|Overall Study||295
10536587|NCT01445171|11689232|FG000|Implanted With Study Device|Overall Study||287
10536588|NCT01445171|11689232|FG000|COMPLETED|Overall Study||200
10536589|NCT01445171|11689232|FG000|NOT COMPLETED|Overall Study||95
10536590|NCT01445301|11689241|FG000|STARTED|Overall Study||204
10536591|NCT01445301|11689242|FG001|STARTED|Overall Study||297
10536592|NCT01445301|11689243|FG002|STARTED|Overall Study||299
10536593|NCT01445301|11689241|FG000|COMPLETED|Overall Study||183
10536594|NCT01445301|11689242|FG001|COMPLETED|Overall Study||262
10536595|NCT01445301|11689243|FG002|COMPLETED|Overall Study||290
10536596|NCT01445301|11689241|FG000|NOT COMPLETED|Overall Study||21
10536597|NCT01445301|11689242|FG001|NOT COMPLETED|Overall Study||35
10536598|NCT01445301|11689243|FG002|NOT COMPLETED|Overall Study||9
10536599|NCT01445535|11689255|FG000|STARTED|Overall Study||3
10536600|NCT01445535|11689256|FG001|STARTED|Overall Study||3
10536601|NCT01445535|11689257|FG002|STARTED|Overall Study||3
10536602|NCT01445535|11689258|FG003|STARTED|Overall Study||6
10536603|NCT01445535|11689255|FG000|COMPLETED|Overall Study||2
10536604|NCT01445535|11689256|FG001|COMPLETED|Overall Study||3
10536605|NCT01445535|11689257|FG002|COMPLETED|Overall Study||2
10536606|NCT01445535|11689258|FG003|COMPLETED|Overall Study||4
10536607|NCT01445535|11689255|FG000|NOT COMPLETED|Overall Study||1
10536608|NCT01445535|11689256|FG001|NOT COMPLETED|Overall Study||0
10536609|NCT01445535|11689257|FG002|NOT COMPLETED|Overall Study||1
10536610|NCT01445535|11689258|FG003|NOT COMPLETED|Overall Study||2
10536611|NCT01445548|11689269|FG000|STARTED|Overall Study||6
10367610|NCT00538434|11508174|FG000|COMPLETED|Overall Study|Completed all scheduled study visits|47
10367611|NCT00538434|11508175|FG001|COMPLETED|Overall Study|Completed all scheduled study visits|46
10367612|NCT00538434|11508176|FG002|COMPLETED|Overall Study|Completed all scheduled study visits|50
10367613|NCT00538434|11508177|FG003|COMPLETED|Overall Study|Completed all scheduled study visits|51
10367614|NCT00538434|11508174|FG000|NOT COMPLETED|Overall Study||9
10367615|NCT00538434|11508175|FG001|NOT COMPLETED|Overall Study||11
10367616|NCT00538434|11508176|FG002|NOT COMPLETED|Overall Study||7
10367617|NCT00538434|11508177|FG003|NOT COMPLETED|Overall Study||6
10367618|NCT00538473|11508190|FG000|STARTED|Overall Study||33
10367619|NCT00538473|11508191|FG001|STARTED|Overall Study||35
10367620|NCT00538473|11508190|FG000|COMPLETED|Overall Study||32
10367621|NCT00538473|11508191|FG001|COMPLETED|Overall Study||35
10367622|NCT00538473|11508190|FG000|NOT COMPLETED|Overall Study||1
10367623|NCT00538473|11508191|FG001|NOT COMPLETED|Overall Study||0
10367624|NCT00538512|11508200|FG000|STARTED|Overall Study||814
10367625|NCT00538512|11508201|FG001|STARTED|Overall Study||813
10367626|NCT00538512|11508202|FG002|STARTED|Overall Study||325
10367627|NCT00538512|11508200|FG000|COMPLETED|Overall Study||787
10367628|NCT00538512|11508201|FG001|COMPLETED|Overall Study||783
10367629|NCT00538512|11508202|FG002|COMPLETED|Overall Study||312
10367630|NCT00538512|11508200|FG000|NOT COMPLETED|Overall Study||27
10367631|NCT00538512|11508201|FG001|NOT COMPLETED|Overall Study||30
10367632|NCT00538512|11508202|FG002|NOT COMPLETED|Overall Study||13
10367633|NCT00538590|11508212|FG000|STARTED|Overall Study||10
10367634|NCT00538590|11508213|FG001|STARTED|Overall Study||10
10367635|NCT00538590|11508212|FG000|COMPLETED|Overall Study|Deceased 8 months after surgery due to known cardiovascular co-morbidity.|9
10367636|NCT00538590|11508213|FG001|COMPLETED|Overall Study||10
10367637|NCT00538590|11508212|FG000|NOT COMPLETED|Overall Study||1
10367638|NCT00538590|11508213|FG001|NOT COMPLETED|Overall Study||0
10367639|NCT00538616|11508221|FG000|STARTED|Overall Study||5
10367640|NCT00538616|11508222|FG001|STARTED|Overall Study||3
10367641|NCT00538616|11508221|FG000|COMPLETED|Overall Study||5
10367642|NCT00538616|11508222|FG001|COMPLETED|Overall Study||3
10367643|NCT00538616|11508221|FG000|NOT COMPLETED|Overall Study||0
10367644|NCT00538616|11508222|FG001|NOT COMPLETED|Overall Study||0
10367645|NCT00538629|11508228|FG000|STARTED|Overall Study||471
10716636|NCT02691260|11880398|FG001|COMPLETED|Overall Study||24
10716637|NCT02691260|11880399|FG002|COMPLETED|Overall Study||25
10716638|NCT02691260|11880400|FG003|COMPLETED|Overall Study||23
10716639|NCT02691260|11880397|FG000|NOT COMPLETED|Overall Study||2
10367646|NCT00538629|11508228|FG000|COMPLETED|Overall Study||449
10367647|NCT00538629|11508228|FG000|NOT COMPLETED|Overall Study||22
10716640|NCT02691260|11880398|FG001|NOT COMPLETED|Overall Study||2
10367648|NCT00538642|11508234|FG000|STARTED|Overall Study||10
10367649|NCT00538642|11508235|FG001|STARTED|Overall Study||14
10367650|NCT00538642|11508234|FG000|COMPLETED|Overall Study||9
10367651|NCT00538642|11508235|FG001|COMPLETED|Overall Study||9
10367652|NCT00538642|11508234|FG000|NOT COMPLETED|Overall Study||1
10367653|NCT00538642|11508235|FG001|NOT COMPLETED|Overall Study||5
10367654|NCT00538681|11508246|FG000|STARTED|Overall Study||9
10367655|NCT00538681|11508247|FG001|STARTED|Overall Study||4
10367656|NCT00538681|11508248|FG002|STARTED|Overall Study||11
10536612|NCT01445548|11689269|FG000|COMPLETED|Overall Study||5
10536613|NCT01445548|11689269|FG000|NOT COMPLETED|Overall Study||1
10367657|NCT00538681|11508249|FG003|STARTED|Overall Study|One (1) participant received pemetrexed and cisplatin only before the study was closed.|11
10367658|NCT00538681|11508246|FG000|Received ≥1 Dose of Any Study Drug|Overall Study||9
10367659|NCT00538681|11508247|FG001|Received ≥1 Dose of Any Study Drug|Overall Study||4
10367660|NCT00538681|11508248|FG002|Received ≥1 Dose of Any Study Drug|Overall Study||11
10367661|NCT00538681|11508249|FG003|Received ≥1 Dose of Any Study Drug|Overall Study||11
10716641|NCT02691260|11880399|FG002|NOT COMPLETED|Overall Study||2
10367662|NCT00538681|11508246|FG000|COMPLETED|Overall Study||0
10367663|NCT00538681|11508247|FG001|COMPLETED|Overall Study||0
10367664|NCT00538681|11508248|FG002|COMPLETED|Overall Study||0
10367665|NCT00538681|11508249|FG003|COMPLETED|Overall Study||0
10367666|NCT00538681|11508246|FG000|NOT COMPLETED|Overall Study||9
10367667|NCT00538681|11508247|FG001|NOT COMPLETED|Overall Study||4
10367668|NCT00538681|11508248|FG002|NOT COMPLETED|Overall Study||11
10367669|NCT00538681|11508249|FG003|NOT COMPLETED|Overall Study||11
10367670|NCT00538733|11508260|FG000|STARTED|Overall Study||26
10367671|NCT00538733|11508260|FG000|Removed Due to Progression of Disease|Overall Study||1
10367672|NCT00538733|11508260|FG000|Removed to Pursue a Stem Cell Transplant|Overall Study||11
10367673|NCT00538733|11508260|FG000|Removed to Pursue Alternative Theray|Overall Study||2
10367674|NCT00538733|11508260|FG000|COMPLETED|Overall Study||14
10367675|NCT00538733|11508260|FG000|NOT COMPLETED|Overall Study||12
10367676|NCT00538759|11508269|FG000|STARTED|Overall Study||13
10367677|NCT00538759|11508270|FG001|STARTED|Overall Study||8
10367678|NCT00538759|11508269|FG000|COMPLETED|Overall Study||13
10367679|NCT00538759|11508270|FG001|COMPLETED|Overall Study||8
10367680|NCT00538759|11508269|FG000|NOT COMPLETED|Overall Study||0
10367681|NCT00538759|11508270|FG001|NOT COMPLETED|Overall Study||0
10367682|NCT00538785|11508278|FG000|STARTED|Overall Study|A subject was randomized without appropriate consent in France and is not included in the results.|623
10367683|NCT00538785|11508279|FG001|STARTED|Overall Study||612
10367684|NCT00538785|11508278|FG000|COMPLETED|Overall Study||604
10367685|NCT00538785|11508279|FG001|COMPLETED|Overall Study||595
10367686|NCT00538785|11508278|FG000|NOT COMPLETED|Overall Study||19
10367687|NCT00538785|11508279|FG001|NOT COMPLETED|Overall Study||17
10427421|NCT00853099|11573229|FG002|COMPLETED|Double-blind Period|Participants who completed Week 52.|60
10427422|NCT00853099|11573230|FG003|COMPLETED|Double-blind Period||0
10427423|NCT00853099|11573227|FG000|NOT COMPLETED|Double-blind Period||23
10427424|NCT00853099|11573228|FG001|NOT COMPLETED|Double-blind Period||29
10427425|NCT00853099|11573229|FG002|NOT COMPLETED|Double-blind Period||31
10427426|NCT00853099|11573230|FG003|NOT COMPLETED|Double-blind Period||0
10427427|NCT00853099|11573227|FG000|STARTED|Double-blind + Open-label Periods||0
10427428|NCT00853099|11573228|FG001|STARTED|Double-blind + Open-label Periods||0
10427429|NCT00853099|11573229|FG002|STARTED|Double-blind + Open-label Periods||0
10427430|NCT00853099|11573230|FG003|STARTED|Double-blind + Open-label Periods|7 participants randomized to placebo did not receive any adalimumab; 1 participant was excluded.|266
10427431|NCT00853099|11573227|FG000|COMPLETED|Double-blind + Open-label Periods||0
10427432|NCT00853099|11573228|FG001|COMPLETED|Double-blind + Open-label Periods||0
10427433|NCT00853099|11573229|FG002|COMPLETED|Double-blind + Open-label Periods||0
10427434|NCT00853099|11573230|FG003|COMPLETED|Double-blind + Open-label Periods||119
10427435|NCT00853099|11573227|FG000|NOT COMPLETED|Double-blind + Open-label Periods||0
10427436|NCT00853099|11573228|FG001|NOT COMPLETED|Double-blind + Open-label Periods||0
10427437|NCT00853099|11573229|FG002|NOT COMPLETED|Double-blind + Open-label Periods||0
10427438|NCT00853099|11573230|FG003|NOT COMPLETED|Double-blind + Open-label Periods||147
10427439|NCT00853112|11573247|FG000|STARTED|Overall Study||6
10427440|NCT00853112|11573248|FG001|STARTED|Overall Study||7
10427441|NCT00853112|11573249|FG002|STARTED|Overall Study||7
10427442|NCT00853112|11573250|FG003|STARTED|Overall Study||8
10427443|NCT00853112|11573251|FG004|STARTED|Overall Study||6
10427444|NCT00853112|11573252|FG005|STARTED|Overall Study||7
10427445|NCT00853112|11573253|FG006|STARTED|Overall Study||7
10427446|NCT00853112|11573247|FG000|Treated|Overall Study||6
10427447|NCT00853112|11573248|FG001|Treated|Overall Study||6
10536614|NCT01445613|11689273|FG000|STARTED|30-day Follow-up||1200
10536615|NCT01445613|11689273|FG000|COMPLETED|30-day Follow-up||1165
10536616|NCT01445613|11689273|FG000|NOT COMPLETED|30-day Follow-up||35
10536617|NCT01445613|11689273|FG000|STARTED|1-year Follow-up||1165
10536618|NCT01445613|11689273|FG000|COMPLETED|1-year Follow-up||1088
10536619|NCT01445613|11689273|FG000|NOT COMPLETED|1-year Follow-up||77
10536620|NCT01445626|11689283|FG000|STARTED|Overall Study||87
10536621|NCT01445626|11689283|FG000|COMPLETED|Overall Study||87
10536622|NCT01445626|11689283|FG000|NOT COMPLETED|Overall Study||0
10536623|NCT01445652|11689289|FG000|STARTED|Overall Study||57
10536624|NCT01445652|11689290|FG001|STARTED|Overall Study||53
10536625|NCT01445652|11689289|FG000|COMPLETED|Overall Study||47
10536626|NCT01445652|11689290|FG001|COMPLETED|Overall Study||50
10536627|NCT01445652|11689289|FG000|NOT COMPLETED|Overall Study||10
10536628|NCT01445652|11689290|FG001|NOT COMPLETED|Overall Study||3
10536629|NCT01445678|11689298|FG000|STARTED|Overall Study||482
10536630|NCT01445678|11689299|FG001|STARTED|Overall Study||497
10536631|NCT01445678|11689298|FG000|COMPLETED|Overall Study||452
10536632|NCT01445678|11689299|FG001|COMPLETED|Overall Study||476
10536633|NCT01445678|11689298|FG000|NOT COMPLETED|Overall Study||30
10536634|NCT01445678|11689299|FG001|NOT COMPLETED|Overall Study||21
10536635|NCT01445730|11689305|FG000|STARTED|Overall Study||82
10536636|NCT01445730|11689305|FG000|COMPLETED|Overall Study||71
10536637|NCT01445730|11689305|FG000|NOT COMPLETED|Overall Study||11
10536638|NCT01445769|11689309|FG000|STARTED|Overall Study||45
10536639|NCT01445769|11689309|FG000|COMPLETED|Overall Study||37
10536640|NCT01445769|11689309|FG000|NOT COMPLETED|Overall Study||8
10427448|NCT00853112|11573249|FG002|Treated|Overall Study||7
10427449|NCT00853112|11573250|FG003|Treated|Overall Study||6
10427450|NCT00853112|11573251|FG004|Treated|Overall Study||6
10427451|NCT00853112|11573252|FG005|Treated|Overall Study||7
10536641|NCT01445821|11689317|FG000|STARTED|Overall Study||22
10536642|NCT01445821|11689318|FG001|STARTED|Overall Study||22
10536643|NCT01445821|11689317|FG000|COMPLETED|Overall Study||22
10367688|NCT00538824|11508285|FG000|STARTED|Overall Study||5
10367689|NCT00538824|11508285|FG000|Progression of Disease|Overall Study||2
10367690|NCT00538824|11508285|FG000|COMPLETED|Overall Study||5
10367691|NCT00538824|11508285|FG000|NOT COMPLETED|Overall Study||0
10367692|NCT00538850|11508289|FG000|STARTED|Titration Period||130
10367693|NCT00538850|11508290|FG001|STARTED|Titration Period|There were no participants in this reporting group in the titration period.|0
10367694|NCT00538850|11508291|FG002|STARTED|Titration Period|There were no participants in this reporting group in the titration period.|0
10367695|NCT00538850|11508289|FG000|COMPLETED|Titration Period||98
10367696|NCT00538850|11508290|FG001|COMPLETED|Titration Period||0
10367697|NCT00538850|11508291|FG002|COMPLETED|Titration Period||0
10367698|NCT00538850|11508289|FG000|NOT COMPLETED|Titration Period||32
10367699|NCT00538850|11508290|FG001|NOT COMPLETED|Titration Period||0
10367700|NCT00538850|11508291|FG002|NOT COMPLETED|Titration Period||0
10367701|NCT00538850|11508289|FG000|STARTED|Fentanyl Sublingual Spray - Double-blind|There were no participants in this reporting group in the double-blind period.|0
10367702|NCT00538850|11508290|FG001|STARTED|Fentanyl Sublingual Spray - Double-blind||98
10367703|NCT00538850|11508291|FG002|STARTED|Fentanyl Sublingual Spray - Double-blind|There were no participants in this reporting group in the double-blind period.|0
10367704|NCT00538850|11508289|FG000|COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
10367705|NCT00538850|11508290|FG001|COMPLETED|Fentanyl Sublingual Spray - Double-blind||95
10367706|NCT00538850|11508291|FG002|COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
10536644|NCT01445821|11689318|FG001|COMPLETED|Overall Study||22
10536645|NCT01445821|11689317|FG000|NOT COMPLETED|Overall Study||0
10536646|NCT01445821|11689318|FG001|NOT COMPLETED|Overall Study||0
10536647|NCT01445847|11689326|FG000|STARTED|Overall Study||50
10536648|NCT01445847|11689327|FG001|STARTED|Overall Study||50
10536649|NCT01445847|11689326|FG000|COMPLETED|Overall Study||36
10536650|NCT01445847|11689327|FG001|COMPLETED|Overall Study||36
10536651|NCT01445847|11689326|FG000|NOT COMPLETED|Overall Study||14
10536652|NCT01445847|11689327|FG001|NOT COMPLETED|Overall Study||14
10536653|NCT01445873|11689333|FG000|STARTED|Overall Study||36
10536654|NCT01445873|11689333|FG000|COMPLETED|Overall Study||36
10536655|NCT01445873|11689333|FG000|NOT COMPLETED|Overall Study||0
10536656|NCT01445886|11689337|FG000|STARTED|Overall Study||33
10536657|NCT01445886|11689337|FG000|COMPLETED|Overall Study||28
10536658|NCT01445886|11689337|FG000|NOT COMPLETED|Overall Study||5
10536659|NCT01445951|11689346|FG000|STARTED|Overall Study||174
10536660|NCT01445951|11689347|FG001|STARTED|Overall Study||174
10536661|NCT01445951|11689348|FG002|STARTED|Overall Study||170
10536662|NCT01445951|11689346|FG000|COMPLETED|Overall Study||130
10536663|NCT01445951|11689347|FG001|COMPLETED|Overall Study||138
10536664|NCT01445951|11689348|FG002|COMPLETED|Overall Study||151
10536665|NCT01445951|11689346|FG000|NOT COMPLETED|Overall Study||44
10536666|NCT01445951|11689347|FG001|NOT COMPLETED|Overall Study||36
10536667|NCT01445951|11689348|FG002|NOT COMPLETED|Overall Study||19
10536668|NCT01446003|11689356|FG000|STARTED|Period 1||16
10536669|NCT01446003|11689357|FG001|STARTED|Period 1||15
10536670|NCT01446003|11689356|FG000|COMPLETED|Period 1||14
10536671|NCT01446003|11689357|FG001|COMPLETED|Period 1||15
10536672|NCT01446003|11689356|FG000|NOT COMPLETED|Period 1||2
10536673|NCT01446003|11689357|FG001|NOT COMPLETED|Period 1||0
10536674|NCT01446003|11689356|FG000|STARTED|Period 2||14
10536675|NCT01446003|11689357|FG001|STARTED|Period 2||15
10536676|NCT01446003|11689356|FG000|COMPLETED|Period 2||13
10536677|NCT01446003|11689357|FG001|COMPLETED|Period 2||15
10536678|NCT01446003|11689356|FG000|NOT COMPLETED|Period 2||1
10536679|NCT01446003|11689357|FG001|NOT COMPLETED|Period 2||0
10536680|NCT01446042|11689366|FG000|STARTED|Overall Study||142
10536681|NCT01446042|11689367|FG001|STARTED|Overall Study||86
10536682|NCT01446042|11689368|FG002|STARTED|Overall Study||78
10536683|NCT01446042|11689366|FG000|COMPLETED|Overall Study||122
10536684|NCT01446042|11689367|FG001|COMPLETED|Overall Study||83
10536685|NCT01446042|11689368|FG002|COMPLETED|Overall Study||69
10536686|NCT01446042|11689366|FG000|NOT COMPLETED|Overall Study||20
10536687|NCT01446042|11689367|FG001|NOT COMPLETED|Overall Study||3
10536688|NCT01446042|11689368|FG002|NOT COMPLETED|Overall Study||9
10536689|NCT01446159|11689380|FG000|STARTED|Overall Study||3
10536690|NCT01446159|11689381|FG001|STARTED|Overall Study||3
10536691|NCT01446159|11689382|FG002|STARTED|Overall Study||92
10536692|NCT01446159|11689383|FG003|STARTED|Overall Study||85
10536693|NCT01446159|11689380|FG000|COMPLETED|Overall Study||0
10536694|NCT01446159|11689381|FG001|COMPLETED|Overall Study||0
10536695|NCT01446159|11689382|FG002|COMPLETED|Overall Study||21
10536696|NCT01446159|11689383|FG003|COMPLETED|Overall Study||23
10536697|NCT01446159|11689380|FG000|NOT COMPLETED|Overall Study||3
10536698|NCT01446159|11689381|FG001|NOT COMPLETED|Overall Study||3
10536699|NCT01446159|11689382|FG002|NOT COMPLETED|Overall Study||71
10536700|NCT01446159|11689383|FG003|NOT COMPLETED|Overall Study||62
10548050|NCT01516892|11701854|FG000|STARTED|Overall Study||716
10548051|NCT01516892|11701854|FG000|COMPLETED|Overall Study||373
10548052|NCT01516892|11701854|FG000|NOT COMPLETED|Overall Study||343
10548053|NCT01516957|11701861|FG000|STARTED|Placebo-controlled Phase||55
10548054|NCT01516957|11701862|FG001|STARTED|Placebo-controlled Phase||57
10548055|NCT01516957|11701863|FG002|STARTED|Placebo-controlled Phase||56
10548056|NCT01516957|11701864|FG003|STARTED|Placebo-controlled Phase||0
10548057|NCT01516957|11701861|FG000|COMPLETED|Placebo-controlled Phase||52
10367707|NCT00538850|11508289|FG000|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
10367708|NCT00538850|11508290|FG001|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||3
10367709|NCT00538850|11508291|FG002|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
10367710|NCT00538850|11508289|FG000|STARTED|Placebo - Double-blind|There were no participants in this reporting group in the double-blind period.|0
10367711|NCT00538850|11508290|FG001|STARTED|Placebo - Double-blind|There were no participants in this reporting group in the double-blind period.|0
10367712|NCT00538850|11508291|FG002|STARTED|Placebo - Double-blind||98
10812586|NCT03500159|11974685|FG001|COMPLETED|Overall Study||0
10812587|NCT03500159|11974684|FG000|NOT COMPLETED|Overall Study||2
10812588|NCT03500159|11974685|FG001|NOT COMPLETED|Overall Study||1
10812589|NCT03490916|11974693|FG000|STARTED|Overall Study||0
10812590|NCT03490916|11974694|FG001|STARTED|Overall Study||0
10367713|NCT00538850|11508289|FG000|COMPLETED|Placebo - Double-blind||0
10367714|NCT00538850|11508290|FG001|COMPLETED|Placebo - Double-blind||0
10367715|NCT00538850|11508291|FG002|COMPLETED|Placebo - Double-blind||95
10367716|NCT00538850|11508289|FG000|NOT COMPLETED|Placebo - Double-blind||0
10367717|NCT00538850|11508290|FG001|NOT COMPLETED|Placebo - Double-blind||0
10367718|NCT00538850|11508291|FG002|NOT COMPLETED|Placebo - Double-blind||3
10367719|NCT00538863|11508297|FG000|STARTED|Open-label Titration||229
10367720|NCT00538863|11508297|FG000|COMPLETED|Open-label Titration||184
10367721|NCT00538863|11508297|FG000|NOT COMPLETED|Open-label Titration||45
10367722|NCT00538863|11508297|FG000|STARTED|Open-label Maintenance|Five participants who completed the titration period did not start the maintenance period.|269
10367723|NCT00538863|11508297|FG000|COMPLETED|Open-label Maintenance||163
10367724|NCT00538863|11508297|FG000|NOT COMPLETED|Open-label Maintenance||106
10367725|NCT00538902|11508306|FG000|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||60
10367726|NCT00538902|11508307|FG001|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||121
10367727|NCT00538902|11508308|FG002|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||121
10536701|NCT01446237|11689395|FG000|STARTED|Overall Study||125
10536702|NCT01446237|11689395|FG000|COMPLETED|Overall Study||115
10536703|NCT01446237|11689395|FG000|NOT COMPLETED|Overall Study||10
10536704|NCT01446289|11689403|FG000|STARTED|Overall Study||51
10536705|NCT01446289|11689404|FG001|STARTED|Overall Study||35
10536706|NCT01446289|11689405|FG002|STARTED|Overall Study||51
10536707|NCT01446289|11689406|FG003|STARTED|Overall Study||35
10536708|NCT01446289|11689403|FG000|COMPLETED|Overall Study||50
10536709|NCT01446289|11689404|FG001|COMPLETED|Overall Study||35
10536710|NCT01446289|11689405|FG002|COMPLETED|Overall Study||50
10536711|NCT01446289|11689406|FG003|COMPLETED|Overall Study||35
10536712|NCT01446289|11689403|FG000|NOT COMPLETED|Overall Study||1
10536713|NCT01446289|11689404|FG001|NOT COMPLETED|Overall Study||0
10536714|NCT01446289|11689405|FG002|NOT COMPLETED|Overall Study||1
10536715|NCT01446289|11689406|FG003|NOT COMPLETED|Overall Study||0
10536716|NCT01446419|11689420|FG000|STARTED|Overall Study||147
10536717|NCT01446419|11689421|FG001|STARTED|Overall Study||78
10536718|NCT01446419|11689420|FG000|3 Month Follow-up|Overall Study||146
10536719|NCT01446419|11689421|FG001|3 Month Follow-up|Overall Study||77
10536720|NCT01446419|11689420|FG000|6 Month Follow-up|Overall Study||144
10536721|NCT01446419|11689421|FG001|6 Month Follow-up|Overall Study||77
10536722|NCT01446419|11689420|FG000|12 Month Follow-up|Overall Study||142
10536723|NCT01446419|11689421|FG001|12 Month Follow-up|Overall Study||77
10536724|NCT01446419|11689420|FG000|COMPLETED|Overall Study||142
10536725|NCT01446419|11689421|FG001|COMPLETED|Overall Study||77
10536726|NCT01446419|11689420|FG000|NOT COMPLETED|Overall Study||5
10536727|NCT01446419|11689421|FG001|NOT COMPLETED|Overall Study||1
10536728|NCT01446666|11689427|FG000|STARTED|Overall Study|Among the 423 participants who consented, 15 withdrew the consent and one died.|407
10536729|NCT01446666|11689427|FG000|COMPLETED|Overall Study||326
10536730|NCT01446666|11689427|FG000|NOT COMPLETED|Overall Study||81
10536731|NCT01446705|11689434|FG000|STARTED|Overall Study||50446
10536732|NCT01446705|11689435|FG001|STARTED|Overall Study||6627
10536733|NCT01446705|11689434|FG000|COMPLETED|Overall Study||50446
10536734|NCT01446705|11689435|FG001|COMPLETED|Overall Study||6627
10536735|NCT01446705|11689434|FG000|NOT COMPLETED|Overall Study||0
10536736|NCT01446705|11689435|FG001|NOT COMPLETED|Overall Study||0
10536737|NCT01446809|11689453|FG000|STARTED|Overall Study||14
10536738|NCT01446809|11689454|FG001|STARTED|Overall Study||7
10536739|NCT01446809|11689455|FG002|STARTED|Overall Study||2
10536740|NCT01446809|11689453|FG000|COMPLETED|Overall Study||14
10536741|NCT01446809|11689454|FG001|COMPLETED|Overall Study||7
10536742|NCT01446809|11689455|FG002|COMPLETED|Overall Study||0
10536743|NCT01446809|11689453|FG000|NOT COMPLETED|Overall Study||0
10536744|NCT01446809|11689454|FG001|NOT COMPLETED|Overall Study||0
10536745|NCT01446809|11689455|FG002|NOT COMPLETED|Overall Study||2
10536746|NCT01446874|11689467|FG000|STARTED|Overall Study||20
10536747|NCT01446874|11689468|FG001|STARTED|Overall Study||50
10536748|NCT01446874|11689469|FG002|STARTED|Overall Study||80
10536749|NCT01446874|11689467|FG000|COMPLETED|Overall Study||18
10536750|NCT01446874|11689468|FG001|COMPLETED|Overall Study||46
10536751|NCT01446874|11689469|FG002|COMPLETED|Overall Study||62
10536752|NCT01446874|11689467|FG000|NOT COMPLETED|Overall Study||2
10536753|NCT01446874|11689468|FG001|NOT COMPLETED|Overall Study||4
10536754|NCT01446874|11689469|FG002|NOT COMPLETED|Overall Study||18
10536755|NCT01446913|11689480|FG000|STARTED|Overall Study||86
10536756|NCT01446913|11689481|FG001|STARTED|Overall Study||82
10536757|NCT01446913|11689482|FG002|STARTED|Overall Study||84
10536758|NCT01446913|11689480|FG000|Patients With Sleep Study|Overall Study||53
10812591|NCT03490916|11974693|FG000|COMPLETED|Overall Study||0
10812592|NCT03490916|11974694|FG001|COMPLETED|Overall Study||0
10367728|NCT00538902|11508306|FG000|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||59
10367729|NCT00538902|11508307|FG001|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||119
10367730|NCT00538902|11508308|FG002|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||116
10367731|NCT00538902|11508306|FG000|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||1
10367732|NCT00538902|11508307|FG001|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||2
10367733|NCT00538902|11508308|FG002|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||5
10367734|NCT00538902|11508306|FG000|STARTED|OL Wk 24 to End (Primary D/C Reasons)||59
10367735|NCT00538902|11508307|FG001|STARTED|OL Wk 24 to End (Primary D/C Reasons)||119
10367736|NCT00538902|11508308|FG002|STARTED|OL Wk 24 to End (Primary D/C Reasons)||116
10367737|NCT00538902|11508306|FG000|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||23
10367738|NCT00538902|11508307|FG001|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||55
10367739|NCT00538902|11508308|FG002|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||52
10367740|NCT00538902|11508306|FG000|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||36
10367741|NCT00538902|11508307|FG001|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||64
10367742|NCT00538902|11508308|FG002|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||64
10367743|NCT00538915|11508318|FG000|STARTED|Overall Study||63
10367744|NCT00538915|11508318|FG000|COMPLETED|Overall Study||52
10367745|NCT00538915|11508318|FG000|NOT COMPLETED|Overall Study||11
10367746|NCT00539006|11508326|FG000|STARTED|Pre-treatment||96
10367747|NCT00539006|11508327|FG001|STARTED|Pre-treatment||95
10367748|NCT00539006|11508328|FG002|STARTED|Pre-treatment||95
10367749|NCT00539006|11508329|FG003|STARTED|Pre-treatment||91
10367750|NCT00539006|11508326|FG000|COMPLETED|Pre-treatment||96
10367751|NCT00539006|11508327|FG001|COMPLETED|Pre-treatment||94
10367752|NCT00539006|11508328|FG002|COMPLETED|Pre-treatment||95
10367753|NCT00539006|11508329|FG003|COMPLETED|Pre-treatment||91
10367754|NCT00539006|11508326|FG000|NOT COMPLETED|Pre-treatment||0
10367755|NCT00539006|11508327|FG001|NOT COMPLETED|Pre-treatment||1
10367756|NCT00539006|11508328|FG002|NOT COMPLETED|Pre-treatment||0
10367757|NCT00539006|11508329|FG003|NOT COMPLETED|Pre-treatment||0
10367758|NCT00539006|11508326|FG000|STARTED|Treatment Period 1||96
10367759|NCT00539006|11508327|FG001|STARTED|Treatment Period 1||94
10367760|NCT00539006|11508328|FG002|STARTED|Treatment Period 1||95
10367761|NCT00539006|11508329|FG003|STARTED|Treatment Period 1||91
10367762|NCT00539006|11508326|FG000|COMPLETED|Treatment Period 1||96
10367763|NCT00539006|11508327|FG001|COMPLETED|Treatment Period 1||94
10367764|NCT00539006|11508328|FG002|COMPLETED|Treatment Period 1||93
10367765|NCT00539006|11508329|FG003|COMPLETED|Treatment Period 1||90
10367766|NCT00539006|11508326|FG000|NOT COMPLETED|Treatment Period 1||0
10367767|NCT00539006|11508327|FG001|NOT COMPLETED|Treatment Period 1||0
10367768|NCT00539006|11508328|FG002|NOT COMPLETED|Treatment Period 1||2
10367769|NCT00539006|11508329|FG003|NOT COMPLETED|Treatment Period 1||1
10367770|NCT00539006|11508326|FG000|STARTED|Washout||96
10367771|NCT00539006|11508327|FG001|STARTED|Washout||94
10367772|NCT00539006|11508328|FG002|STARTED|Washout||93
10367773|NCT00539006|11508329|FG003|STARTED|Washout||90
10367774|NCT00539006|11508326|FG000|COMPLETED|Washout||76
10367775|NCT00539006|11508327|FG001|COMPLETED|Washout||84
10367776|NCT00539006|11508328|FG002|COMPLETED|Washout||77
10367777|NCT00539006|11508329|FG003|COMPLETED|Washout||81
10367778|NCT00539006|11508326|FG000|NOT COMPLETED|Washout||20
10367779|NCT00539006|11508327|FG001|NOT COMPLETED|Washout||10
10367780|NCT00539006|11508328|FG002|NOT COMPLETED|Washout||16
10367781|NCT00539006|11508329|FG003|NOT COMPLETED|Washout||9
10367782|NCT00539006|11508326|FG000|STARTED|Treatment Period 2||76
10367783|NCT00539006|11508327|FG001|STARTED|Treatment Period 2||84
10367784|NCT00539006|11508328|FG002|STARTED|Treatment Period 2||77
10367785|NCT00539006|11508329|FG003|STARTED|Treatment Period 2||81
10367786|NCT00539006|11508326|FG000|COMPLETED|Treatment Period 2||75
10367787|NCT00539006|11508327|FG001|COMPLETED|Treatment Period 2||83
10367788|NCT00539006|11508328|FG002|COMPLETED|Treatment Period 2||77
10367789|NCT00539006|11508329|FG003|COMPLETED|Treatment Period 2||81
10367790|NCT00539006|11508326|FG000|NOT COMPLETED|Treatment Period 2||1
10367791|NCT00539006|11508327|FG001|NOT COMPLETED|Treatment Period 2||1
10367792|NCT00539006|11508328|FG002|NOT COMPLETED|Treatment Period 2||0
10367793|NCT00539006|11508329|FG003|NOT COMPLETED|Treatment Period 2||0
10367794|NCT00539006|11508326|FG000|STARTED|Post-Study||75
10367795|NCT00539006|11508327|FG001|STARTED|Post-Study||83
10367796|NCT00539006|11508328|FG002|STARTED|Post-Study||77
10367797|NCT00539006|11508329|FG003|STARTED|Post-Study||81
10367798|NCT00539006|11508326|FG000|COMPLETED|Post-Study||75
10367799|NCT00539006|11508327|FG001|COMPLETED|Post-Study||83
10367800|NCT00539006|11508328|FG002|COMPLETED|Post-Study||77
10367801|NCT00539006|11508329|FG003|COMPLETED|Post-Study||81
10367802|NCT00539006|11508326|FG000|NOT COMPLETED|Post-Study||0
10367803|NCT00539006|11508327|FG001|NOT COMPLETED|Post-Study||0
10367804|NCT00539006|11508328|FG002|NOT COMPLETED|Post-Study||0
10367805|NCT00539006|11508329|FG003|NOT COMPLETED|Post-Study||0
10367806|NCT00539032|11508347|FG000|STARTED|Overall Study||153
10367807|NCT00539032|11508348|FG001|STARTED|Overall Study||85
10367808|NCT00539032|11508347|FG000|COMPLETED|Overall Study||151
10367809|NCT00539032|11508348|FG001|COMPLETED|Overall Study||84
10716642|NCT02691260|11880400|FG003|NOT COMPLETED|Overall Study||3
10716643|NCT02691416|11880412|FG000|STARTED|Overall Study||30
10716644|NCT02691416|11880413|FG001|STARTED|Overall Study||30
10716645|NCT02691416|11880412|FG000|COMPLETED|Overall Study||30
10716646|NCT02691416|11880413|FG001|COMPLETED|Overall Study||30
10716647|NCT02691416|11880412|FG000|NOT COMPLETED|Overall Study||0
10367810|NCT00539032|11508347|FG000|NOT COMPLETED|Overall Study||2
10367811|NCT00539032|11508348|FG001|NOT COMPLETED|Overall Study||1
10367812|NCT00539110|11508356|FG000|STARTED|Overall Study||5
10367813|NCT00539110|11508357|FG001|STARTED|Overall Study||5
10367814|NCT00539110|11508356|FG000|COMPLETED|Overall Study||5
10367815|NCT00539110|11508357|FG001|COMPLETED|Overall Study||5
10367816|NCT00539110|11508356|FG000|NOT COMPLETED|Overall Study||0
10367817|NCT00539110|11508357|FG001|NOT COMPLETED|Overall Study||0
10367818|NCT00539188|11508365|FG000|STARTED|Overall Study||4
10367819|NCT00539188|11508366|FG001|STARTED|Overall Study||2
10367820|NCT00539188|11508365|FG000|Received Allocated Intervention|Overall Study||3
10367821|NCT00539188|11508366|FG001|Received Allocated Intervention|Overall Study||2
10367822|NCT00539188|11508365|FG000|COMPLETED|Overall Study||1
10367823|NCT00539188|11508366|FG001|COMPLETED|Overall Study||1
10367824|NCT00539188|11508365|FG000|NOT COMPLETED|Overall Study||3
10367825|NCT00539188|11508366|FG001|NOT COMPLETED|Overall Study||1
10367826|NCT00539240|11508375|FG000|STARTED|Overall Study||59
10367827|NCT00539240|11508376|FG001|STARTED|Overall Study||55
10367828|NCT00539240|11508377|FG002|STARTED|Overall Study||54
10367829|NCT00539240|11508375|FG000|COMPLETED|Overall Study||53
10367830|NCT00539240|11508376|FG001|COMPLETED|Overall Study||48
10367831|NCT00539240|11508377|FG002|COMPLETED|Overall Study||39
10367832|NCT00539240|11508375|FG000|NOT COMPLETED|Overall Study||6
10367833|NCT00539240|11508376|FG001|NOT COMPLETED|Overall Study||7
10367834|NCT00539240|11508377|FG002|NOT COMPLETED|Overall Study||15
10367835|NCT00539253|11508385|FG000|STARTED|Overall Study||45
10367836|NCT00539253|11508385|FG000|COMPLETED|Overall Study||19
10367837|NCT00539253|11508385|FG000|NOT COMPLETED|Overall Study||26
10716648|NCT02691416|11880413|FG001|NOT COMPLETED|Overall Study||0
10716649|NCT02691455|11880425|FG000|STARTED|Overall Study||23
10716650|NCT02691455|11880426|FG001|STARTED|Overall Study||22
10716651|NCT02691455|11880425|FG000|Randomized|Overall Study||23
10716652|NCT02691455|11880426|FG001|Randomized|Overall Study||22
10716653|NCT02691455|11880425|FG000|Received Assigned Intervention|Overall Study||22
10716654|NCT02691455|11880426|FG001|Received Assigned Intervention|Overall Study||20
10716655|NCT02691455|11880425|FG000|Week 1 Follow up|Overall Study||22
10716656|NCT02691455|11880426|FG001|Week 1 Follow up|Overall Study||19
10716657|NCT02691455|11880425|FG000|Month 1 Follow up|Overall Study||22
10716658|NCT02691455|11880426|FG001|Month 1 Follow up|Overall Study||18
10367838|NCT00539279|11508391|FG000|STARTED|Treatment||41
10367839|NCT00539279|11508392|FG001|STARTED|Treatment||46
10367840|NCT00539279|11508391|FG000|COMPLETED|Treatment||30
10367841|NCT00539279|11508392|FG001|COMPLETED|Treatment||38
10367842|NCT00539279|11508391|FG000|NOT COMPLETED|Treatment||11
10367843|NCT00539279|11508392|FG001|NOT COMPLETED|Treatment||8
10367844|NCT00539279|11508391|FG000|STARTED|Post-Treatment Assessment|Individuals eligible for post-treatment assessment (includes all individuals randomized to PE)|30
10367845|NCT00539279|11508392|FG001|STARTED|Post-Treatment Assessment|Individuals eligible for post-treatment assessment (includes all individuals randomized to RT)|38
10367846|NCT00539279|11508391|FG000|COMPLETED|Post-Treatment Assessment||18
10367847|NCT00539279|11508392|FG001|COMPLETED|Post-Treatment Assessment||29
10367848|NCT00539279|11508391|FG000|NOT COMPLETED|Post-Treatment Assessment||12
10367849|NCT00539279|11508392|FG001|NOT COMPLETED|Post-Treatment Assessment||9
10427452|NCT00853112|11573253|FG006|Treated|Overall Study||6
10427453|NCT00853112|11573247|FG000|COMPLETED|Overall Study||6
10716659|NCT02691455|11880425|FG000|Month 3 Follow up|Overall Study||21
10367850|NCT00539279|11508391|FG000|STARTED|6-Month Follow-Up Assessment|Individuals eligible for 6-month assessment (includes all individuals randomized to PE)|18
10367851|NCT00539279|11508392|FG001|STARTED|6-Month Follow-Up Assessment|Individuals eligible for 6-month assessment (includes all individuals randomized to RT)|29
10367852|NCT00539279|11508391|FG000|COMPLETED|6-Month Follow-Up Assessment||17
10367853|NCT00539279|11508392|FG001|COMPLETED|6-Month Follow-Up Assessment||22
10367854|NCT00539279|11508391|FG000|NOT COMPLETED|6-Month Follow-Up Assessment||1
10536759|NCT01446913|11689481|FG001|Patients With Sleep Study|Overall Study||56
10536760|NCT01446913|11689482|FG002|Patients With Sleep Study|Overall Study||29
10536761|NCT01446913|11689480|FG000|Patients With Sleep Apnea|Overall Study||39
10536762|NCT01446913|11689481|FG001|Patients With Sleep Apnea|Overall Study||45
10536763|NCT01446913|11689482|FG002|Patients With Sleep Apnea|Overall Study||21
10536764|NCT01446913|11689480|FG000|COMPLETED|Overall Study||77
10536765|NCT01446913|11689481|FG001|COMPLETED|Overall Study||73
10536766|NCT01446913|11689482|FG002|COMPLETED|Overall Study||73
10536767|NCT01446913|11689480|FG000|NOT COMPLETED|Overall Study||9
10536768|NCT01446913|11689481|FG001|NOT COMPLETED|Overall Study||9
10536769|NCT01446913|11689482|FG002|NOT COMPLETED|Overall Study||11
10536770|NCT01446965|11689498|FG000|STARTED|Randominization||1554
10536771|NCT01446965|11689499|FG001|STARTED|Randominization||794
10536772|NCT01446965|11689498|FG000|COMPLETED|Randominization||1524
10536773|NCT01446965|11689499|FG001|COMPLETED|Randominization||778
10536774|NCT01446965|11689498|FG000|NOT COMPLETED|Randominization||30
10536775|NCT01446965|11689499|FG001|NOT COMPLETED|Randominization||16
10536776|NCT01446965|11689498|FG000|STARTED|Participants Followed and Analyzed||1524
10536777|NCT01446965|11689499|FG001|STARTED|Participants Followed and Analyzed||778
10536778|NCT01446965|11689498|FG000|Received WCD|Participants Followed and Analyzed||1481
10536779|NCT01446965|11689499|FG001|Received WCD|Participants Followed and Analyzed||0
10536780|NCT01446965|11689498|FG000|Never Wore WCD|Participants Followed and Analyzed||43
10536781|NCT01446965|11689499|FG001|Never Wore WCD|Participants Followed and Analyzed||0
10656959|NCT02222558|11818075|FG003|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
10656960|NCT02222558|11818076|FG004|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
10656961|NCT02222558|11818077|FG005|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
10656962|NCT02222558|11818072|FG000|STARTED|Period 3||0
10656963|NCT02222558|11818073|FG001|STARTED|Period 3||0
10656964|NCT02222558|11818074|FG002|STARTED|Period 3||4
10656965|NCT02222558|11818075|FG003|STARTED|Period 3||1
10656966|NCT02222558|11818076|FG004|STARTED|Period 3||8
10656967|NCT02222558|11818077|FG005|STARTED|Period 3||8
10656968|NCT02222558|11818072|FG000|COMPLETED|Period 3||0
10656969|NCT02222558|11818073|FG001|COMPLETED|Period 3||0
10656970|NCT02222558|11818074|FG002|COMPLETED|Period 3||4
10656971|NCT02222558|11818075|FG003|COMPLETED|Period 3||1
10656972|NCT02222558|11818076|FG004|COMPLETED|Period 3||8
10656973|NCT02222558|11818077|FG005|COMPLETED|Period 3||7
10656974|NCT02222558|11818072|FG000|NOT COMPLETED|Period 3||0
10656975|NCT02222558|11818073|FG001|NOT COMPLETED|Period 3||0
10656976|NCT02222558|11818074|FG002|NOT COMPLETED|Period 3||0
10656977|NCT02222558|11818075|FG003|NOT COMPLETED|Period 3||0
10656978|NCT02222558|11818076|FG004|NOT COMPLETED|Period 3||0
10656979|NCT02222558|11818077|FG005|NOT COMPLETED|Period 3||1
10656980|NCT02222610|11818094|FG000|STARTED|Baseline to W48||8
10656981|NCT02222610|11818095|FG001|STARTED|Baseline to W48||16
10656982|NCT02222610|11818096|FG002|STARTED|Baseline to W48||16
10656983|NCT02222610|11818094|FG000|COMPLETED|Baseline to W48||8
10656984|NCT02222610|11818095|FG001|COMPLETED|Baseline to W48||14
10656985|NCT02222610|11818096|FG002|COMPLETED|Baseline to W48||15
10656986|NCT02222610|11818094|FG000|NOT COMPLETED|Baseline to W48||0
10656987|NCT02222610|11818095|FG001|NOT COMPLETED|Baseline to W48||2
10656988|NCT02222610|11818096|FG002|NOT COMPLETED|Baseline to W48||1
10656989|NCT02222610|11818094|FG000|STARTED|Baseline to W104||8
10656990|NCT02222610|11818095|FG001|STARTED|Baseline to W104||16
10656991|NCT02222610|11818096|FG002|STARTED|Baseline to W104||16
10656992|NCT02222610|11818094|FG000|COMPLETED|Baseline to W104||8
10656993|NCT02222610|11818095|FG001|COMPLETED|Baseline to W104||11
10656994|NCT02222610|11818096|FG002|COMPLETED|Baseline to W104||10
10656995|NCT02222610|11818094|FG000|NOT COMPLETED|Baseline to W104||0
10656996|NCT02222610|11818095|FG001|NOT COMPLETED|Baseline to W104||5
10656997|NCT02222610|11818096|FG002|NOT COMPLETED|Baseline to W104||6
10656998|NCT02222688|11818111|FG000|STARTED|Overall Study||4
10656999|NCT02222688|11818112|FG001|STARTED|Overall Study||3
10657000|NCT02222688|11818113|FG002|STARTED|Overall Study||3
10657001|NCT02222688|11818114|FG003|STARTED|Overall Study||5
10657002|NCT02222688|11818115|FG004|STARTED|Overall Study||3
10657003|NCT02222688|11818116|FG005|STARTED|Overall Study||3
10657004|NCT02222688|11818117|FG006|STARTED|Overall Study||6
10657005|NCT02222688|11818111|FG000|COMPLETED|Overall Study||3
10657006|NCT02222688|11818112|FG001|COMPLETED|Overall Study||3
10657007|NCT02222688|11818113|FG002|COMPLETED|Overall Study||3
10657008|NCT02222688|11818114|FG003|COMPLETED|Overall Study||3
10657009|NCT02222688|11818115|FG004|COMPLETED|Overall Study||2
10657010|NCT02222688|11818116|FG005|COMPLETED|Overall Study||3
10657011|NCT02222688|11818117|FG006|COMPLETED|Overall Study||5
10657012|NCT02222688|11818111|FG000|NOT COMPLETED|Overall Study||1
10657013|NCT02222688|11818112|FG001|NOT COMPLETED|Overall Study||0
10657014|NCT02222688|11818113|FG002|NOT COMPLETED|Overall Study||0
10657015|NCT02222688|11818114|FG003|NOT COMPLETED|Overall Study||2
10657016|NCT02222688|11818115|FG004|NOT COMPLETED|Overall Study||1
10657017|NCT02222688|11818116|FG005|NOT COMPLETED|Overall Study||0
10657018|NCT02222688|11818117|FG006|NOT COMPLETED|Overall Study||1
10367855|NCT00539279|11508392|FG001|NOT COMPLETED|6-Month Follow-Up Assessment||7
10367856|NCT00539305|11508400|FG000|STARTED|Overall Study||10
10367857|NCT00539305|11508401|FG001|STARTED|Overall Study||12
10367858|NCT00539305|11508400|FG000|COMPLETED|Overall Study||9
10367859|NCT00539305|11508401|FG001|COMPLETED|Overall Study||10
10367860|NCT00539305|11508400|FG000|NOT COMPLETED|Overall Study||1
10367861|NCT00539305|11508401|FG001|NOT COMPLETED|Overall Study||2
10367862|NCT00539500|11508407|FG000|STARTED|Overall Study||3
10367863|NCT00539500|11508407|FG000|COMPLETED|Overall Study||0
10367864|NCT00539500|11508407|FG000|NOT COMPLETED|Overall Study||3
10367865|NCT00539513|11508413|FG000|STARTED|Overall Study||5
10367866|NCT00539513|11508414|FG001|STARTED|Overall Study||5
10367867|NCT00539513|11508413|FG000|Received Allocated Intervention|Overall Study||3
10367868|NCT00539513|11508414|FG001|Received Allocated Intervention|Overall Study||4
10367869|NCT00539513|11508413|FG000|COMPLETED|Overall Study||3
10367870|NCT00539513|11508414|FG001|COMPLETED|Overall Study||3
10367871|NCT00539513|11508413|FG000|NOT COMPLETED|Overall Study||2
10367872|NCT00539513|11508414|FG001|NOT COMPLETED|Overall Study||2
10367873|NCT00539526|11508423|FG000|STARTED|Overall Study||35
10367874|NCT00539526|11508424|FG001|STARTED|Overall Study||33
10367875|NCT00539526|11508425|FG002|STARTED|Overall Study||38
10367876|NCT00539526|11508423|FG000|COMPLETED|Overall Study||32
10367877|NCT00539526|11508424|FG001|COMPLETED|Overall Study||31
10367878|NCT00539526|11508425|FG002|COMPLETED|Overall Study||36
10367879|NCT00539526|11508423|FG000|NOT COMPLETED|Overall Study||3
10367880|NCT00539526|11508424|FG001|NOT COMPLETED|Overall Study||2
10367881|NCT00539526|11508425|FG002|NOT COMPLETED|Overall Study||2
10367882|NCT00539539|11508435|FG000|STARTED|Overall Study||815
10367883|NCT00539539|11508436|FG001|STARTED|Overall Study||771
10367884|NCT00539539|11508435|FG000|COMPLETED|Overall Study||815
10367885|NCT00539539|11508436|FG001|COMPLETED|Overall Study||771
10367886|NCT00539539|11508435|FG000|NOT COMPLETED|Overall Study||0
10367887|NCT00539539|11508436|FG001|NOT COMPLETED|Overall Study||0
10367888|NCT00539656|11508442|FG000|STARTED|Overall Study||3
10367889|NCT00539656|11508442|FG000|COMPLETED|Overall Study||3
10367890|NCT00539656|11508442|FG000|NOT COMPLETED|Overall Study||0
10367891|NCT00539695|11508446|FG000|STARTED|Overall Study||25
10367892|NCT00539695|11508446|FG000|Evaluable Patients|Overall Study|Patients who received IL-2.|22
10367893|NCT00539695|11508446|FG000|COMPLETED|Overall Study||12
10367894|NCT00539695|11508446|FG000|NOT COMPLETED|Overall Study||13
10367895|NCT00539734|11508450|FG000|STARTED|Overall Study||26
10367896|NCT00539734|11508450|FG000|COMPLETED|Overall Study||25
10367897|NCT00539734|11508450|FG000|NOT COMPLETED|Overall Study||1
10367898|NCT00539864|11508456|FG000|STARTED|Overall Study||300
10367899|NCT00539864|11508457|FG001|STARTED|Overall Study||302
10367900|NCT00539864|11508456|FG000|COMPLETED|Overall Study||299
10367901|NCT00539864|11508457|FG001|COMPLETED|Overall Study||300
10367902|NCT00539864|11508456|FG000|NOT COMPLETED|Overall Study||1
10367903|NCT00539864|11508457|FG001|NOT COMPLETED|Overall Study||2
10367904|NCT00539942|11508465|FG000|STARTED|Overall Study||4
10367905|NCT00539942|11508466|FG001|STARTED|Overall Study||3
10367906|NCT00539942|11508465|FG000|COMPLETED|Overall Study||4
10367907|NCT00539942|11508466|FG001|COMPLETED|Overall Study||3
10367908|NCT00539942|11508465|FG000|NOT COMPLETED|Overall Study||0
10657019|NCT02222714|11818140|FG000|STARTED|Overall Study||15
10657020|NCT02222714|11818141|FG001|STARTED|Overall Study||24
10657021|NCT02222714|11818142|FG002|STARTED|Overall Study||12
10657022|NCT02222714|11818143|FG003|STARTED|Overall Study||15
10657023|NCT02222714|11818144|FG004|STARTED|Overall Study||44
10657024|NCT02222714|11818140|FG000|COMPLETED|Overall Study||15
10657025|NCT02222714|11818141|FG001|COMPLETED|Overall Study||22
10657026|NCT02222714|11818142|FG002|COMPLETED|Overall Study||8
10657027|NCT02222714|11818143|FG003|COMPLETED|Overall Study||11
10657028|NCT02222714|11818144|FG004|COMPLETED|Overall Study||37
10657029|NCT02222714|11818140|FG000|NOT COMPLETED|Overall Study||0
10716660|NCT02691455|11880426|FG001|Month 3 Follow up|Overall Study||18
10716661|NCT02691455|11880425|FG000|Month 6 Follow up|Overall Study||19
10716662|NCT02691455|11880426|FG001|Month 6 Follow up|Overall Study||19
10657030|NCT02222714|11818141|FG001|NOT COMPLETED|Overall Study||2
10657031|NCT02222714|11818142|FG002|NOT COMPLETED|Overall Study||4
10657032|NCT02222714|11818143|FG003|NOT COMPLETED|Overall Study||4
10657033|NCT02222714|11818144|FG004|NOT COMPLETED|Overall Study||7
10657034|NCT02222818|11818161|FG000|STARTED|Period 1|Start of CAFR evaluation period|33
10657035|NCT02222818|11818162|FG001|STARTED|Period 1|Start of CAFRPlus evaluation period|33
10657036|NCT02222818|11818161|FG000|COMPLETED|Period 1|End of CAFR evaluation period|33
10367909|NCT00539942|11508466|FG001|NOT COMPLETED|Overall Study||0
10367910|NCT00539994|11508475|FG000|STARTED|Overall Study||23
10367911|NCT00539994|11508476|FG001|STARTED|Overall Study||19
10367912|NCT00539994|11508477|FG002|STARTED|Overall Study||15
10367913|NCT00539994|11508475|FG000|COMPLETED|Overall Study||20
10367914|NCT00539994|11508476|FG001|COMPLETED|Overall Study||18
10367915|NCT00539994|11508477|FG002|COMPLETED|Overall Study||13
10367916|NCT00539994|11508475|FG000|NOT COMPLETED|Overall Study||3
10367917|NCT00539994|11508476|FG001|NOT COMPLETED|Overall Study||1
10367918|NCT00539994|11508477|FG002|NOT COMPLETED|Overall Study||2
10367919|NCT00540007|11508494|FG000|STARTED|Overall Study||38
10367920|NCT00540007|11508495|FG001|STARTED|Overall Study||42
10367921|NCT00540007|11508494|FG000|COMPLETED|Overall Study||38
10367922|NCT00540007|11508495|FG001|COMPLETED|Overall Study||42
10367923|NCT00540007|11508494|FG000|NOT COMPLETED|Overall Study||0
10367924|NCT00540007|11508495|FG001|NOT COMPLETED|Overall Study||0
10367925|NCT00540046|11508504|FG000|STARTED|Overall Study||104
10367926|NCT00540046|11508505|FG001|STARTED|Overall Study||111
10367927|NCT00540046|11508504|FG000|COMPLETED|Overall Study||71
10367928|NCT00540046|11508505|FG001|COMPLETED|Overall Study||88
10367929|NCT00540046|11508504|FG000|NOT COMPLETED|Overall Study||33
10367930|NCT00540046|11508505|FG001|NOT COMPLETED|Overall Study||23
10367931|NCT00540124|11508516|FG000|STARTED|Overall Study||51
10367932|NCT00540124|11508517|FG001|STARTED|Overall Study||51
10367933|NCT00540124|11508518|FG002|STARTED|Overall Study||49
10367934|NCT00540124|11508516|FG000|COMPLETED|Overall Study||47
10367935|NCT00540124|11508517|FG001|COMPLETED|Overall Study||48
10367936|NCT00540124|11508518|FG002|COMPLETED|Overall Study||48
10367937|NCT00540124|11508516|FG000|NOT COMPLETED|Overall Study||4
10716663|NCT02691455|11880425|FG000|Month 12 Follow up|Overall Study||16
10367938|NCT00540124|11508517|FG001|NOT COMPLETED|Overall Study||3
10367939|NCT00540124|11508518|FG002|NOT COMPLETED|Overall Study||1
10367940|NCT00540228|11508531|FG000|STARTED|Overall Study||200
10367941|NCT00540228|11508532|FG001|STARTED|Overall Study||198
10367942|NCT00540228|11508533|FG002|STARTED|Overall Study||204
10367943|NCT00540228|11508534|FG003|STARTED|Overall Study||202
10367944|NCT00540228|11508535|FG004|STARTED|Overall Study||202
10367945|NCT00540228|11508531|FG000|COMPLETED|Overall Study||197
10367946|NCT00540228|11508532|FG001|COMPLETED|Overall Study||197
10367947|NCT00540228|11508533|FG002|COMPLETED|Overall Study||204
10367948|NCT00540228|11508534|FG003|COMPLETED|Overall Study||202
10367949|NCT00540228|11508535|FG004|COMPLETED|Overall Study||202
10367950|NCT00540228|11508531|FG000|NOT COMPLETED|Overall Study||3
10367951|NCT00540228|11508532|FG001|NOT COMPLETED|Overall Study||1
10367952|NCT00540228|11508533|FG002|NOT COMPLETED|Overall Study||0
10367953|NCT00540228|11508534|FG003|NOT COMPLETED|Overall Study||0
10367954|NCT00540228|11508535|FG004|NOT COMPLETED|Overall Study||0
10367955|NCT00540293|11508547|FG000|STARTED|Overall Study||425
10367956|NCT00540293|11508547|FG000|COMPLETED|Overall Study||390
10367957|NCT00540293|11508547|FG000|NOT COMPLETED|Overall Study||35
10367958|NCT00540423|11508559|FG000|STARTED|Double-Blind Treatment Period||8
10367959|NCT00540423|11508560|FG001|STARTED|Double-Blind Treatment Period||15
10367960|NCT00540423|11508561|FG002|STARTED|Double-Blind Treatment Period||0
10367961|NCT00540423|11508559|FG000|COMPLETED|Double-Blind Treatment Period||8
10367962|NCT00540423|11508560|FG001|COMPLETED|Double-Blind Treatment Period||14
10367963|NCT00540423|11508561|FG002|COMPLETED|Double-Blind Treatment Period||0
10367964|NCT00540423|11508559|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
10367965|NCT00540423|11508560|FG001|NOT COMPLETED|Double-Blind Treatment Period||1
10367966|NCT00540423|11508561|FG002|NOT COMPLETED|Double-Blind Treatment Period||0
10367967|NCT00540423|11508559|FG000|STARTED|Open-Label Treatment Period||0
10367968|NCT00540423|11508560|FG001|STARTED|Open-Label Treatment Period||0
10367969|NCT00540423|11508561|FG002|STARTED|Open-Label Treatment Period||22
10367970|NCT00540423|11508559|FG000|COMPLETED|Open-Label Treatment Period||0
10367971|NCT00540423|11508560|FG001|COMPLETED|Open-Label Treatment Period||0
10367972|NCT00540423|11508561|FG002|COMPLETED|Open-Label Treatment Period||20
10367973|NCT00540423|11508559|FG000|NOT COMPLETED|Open-Label Treatment Period||0
10367974|NCT00540423|11508560|FG001|NOT COMPLETED|Open-Label Treatment Period||0
10367975|NCT00540423|11508561|FG002|NOT COMPLETED|Open-Label Treatment Period||2
10367976|NCT00540436|11508579|FG000|STARTED|First 12-Week Treatment Period||25
10367977|NCT00540436|11508579|FG000|COMPLETED|First 12-Week Treatment Period||22
10367978|NCT00540436|11508579|FG000|NOT COMPLETED|First 12-Week Treatment Period||3
10367979|NCT00540436|11508579|FG000|STARTED|Second 12-Week Treatment Period||22
10367980|NCT00540436|11508579|FG000|COMPLETED|Second 12-Week Treatment Period||21
10367981|NCT00540436|11508579|FG000|NOT COMPLETED|Second 12-Week Treatment Period||1
10367982|NCT00540449|11508585|FG000|STARTED|Overall Study||346
10367983|NCT00540449|11508586|FG001|STARTED|Overall Study||344
10367984|NCT00540449|11508585|FG000|COMPLETED|Overall Study||262
10367985|NCT00540449|11508586|FG001|COMPLETED|Overall Study||266
10367986|NCT00540449|11508585|FG000|NOT COMPLETED|Overall Study||84
10367987|NCT00540449|11508586|FG001|NOT COMPLETED|Overall Study||78
10367988|NCT00540514|11508594|FG000|STARTED|Overall Study|Intent-to-treat Population: all randomized patients regardless of treatment received.|521
10367989|NCT00540514|11508595|FG001|STARTED|Overall Study|Intent-to-treat Population: all randomized patients regardless of treatment received.|531
10367990|NCT00540514|11508594|FG000|Treated|Overall Study||514
10367991|NCT00540514|11508595|FG001|Treated|Overall Study||524
10367992|NCT00540514|11508594|FG000|Biomarker Population|Overall Study||35
10367993|NCT00540514|11508595|FG001|Biomarker Population|Overall Study||36
10367994|NCT00540514|11508594|FG000|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease|275
10367995|NCT00540514|11508595|FG001|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease|265
10367996|NCT00540514|11508594|FG000|NOT COMPLETED|Overall Study||246
10367997|NCT00540514|11508595|FG001|NOT COMPLETED|Overall Study||266
10367998|NCT00540579|11508602|FG000|STARTED|Overall Study||23
10367999|NCT00540579|11508602|FG000|COMPLETED|Overall Study||23
10368000|NCT00540579|11508602|FG000|NOT COMPLETED|Overall Study||0
10368001|NCT00540592|11508616|FG000|STARTED|Overall Study||204
10368002|NCT00540592|11508617|FG001|STARTED|Overall Study||202
10368003|NCT00540592|11508618|FG002|STARTED|Overall Study||202
10368004|NCT00540592|11508619|FG003|STARTED|Overall Study||202
10368005|NCT00540592|11508620|FG004|STARTED|Overall Study||199
10368006|NCT00540592|11508621|FG005|STARTED|Overall Study||198
10368007|NCT00540592|11508622|FG006|STARTED|Overall Study||198
10368008|NCT00540592|11508623|FG007|STARTED|Overall Study||199
10368009|NCT00540592|11508624|FG008|STARTED|Overall Study||200
10368010|NCT00540592|11508625|FG009|STARTED|Overall Study||203
10368011|NCT00540592|11508616|FG000|Completed at Day 180|Overall Study||200
10368012|NCT00540592|11508617|FG001|Completed at Day 180|Overall Study||201
10368013|NCT00540592|11508618|FG002|Completed at Day 180|Overall Study||197
10368014|NCT00540592|11508619|FG003|Completed at Day 180|Overall Study||197
10368015|NCT00540592|11508620|FG004|Completed at Day 180|Overall Study||195
10368016|NCT00540592|11508621|FG005|Completed at Day 180|Overall Study||198
10368017|NCT00540592|11508622|FG006|Completed at Day 180|Overall Study||196
10368018|NCT00540592|11508623|FG007|Completed at Day 180|Overall Study||193
10368019|NCT00540592|11508624|FG008|Completed at Day 180|Overall Study||198
10368020|NCT00540592|11508625|FG009|Completed at Day 180|Overall Study||189
10368021|NCT00540592|11508616|FG000|COMPLETED|Overall Study||202
10368022|NCT00540592|11508617|FG001|COMPLETED|Overall Study||201
10368023|NCT00540592|11508618|FG002|COMPLETED|Overall Study||201
10368024|NCT00540592|11508619|FG003|COMPLETED|Overall Study||201
10368025|NCT00540592|11508620|FG004|COMPLETED|Overall Study||198
10368026|NCT00540592|11508621|FG005|COMPLETED|Overall Study||198
10368027|NCT00540592|11508622|FG006|COMPLETED|Overall Study||198
10368028|NCT00540592|11508623|FG007|COMPLETED|Overall Study||198
10368029|NCT00540592|11508624|FG008|COMPLETED|Overall Study||199
10368030|NCT00540592|11508625|FG009|COMPLETED|Overall Study||201
10368031|NCT00540592|11508616|FG000|NOT COMPLETED|Overall Study||2
10368032|NCT00540592|11508617|FG001|NOT COMPLETED|Overall Study||1
10368033|NCT00540592|11508618|FG002|NOT COMPLETED|Overall Study||1
10368034|NCT00540592|11508619|FG003|NOT COMPLETED|Overall Study||1
10368035|NCT00540592|11508620|FG004|NOT COMPLETED|Overall Study||1
10368036|NCT00540592|11508621|FG005|NOT COMPLETED|Overall Study||0
10368037|NCT00540592|11508622|FG006|NOT COMPLETED|Overall Study||0
10368038|NCT00540592|11508623|FG007|NOT COMPLETED|Overall Study||1
10368039|NCT00540592|11508624|FG008|NOT COMPLETED|Overall Study||1
10368040|NCT00540592|11508625|FG009|NOT COMPLETED|Overall Study||2
10368041|NCT00540644|11508649|FG000|STARTED|Overall Study||48
10368042|NCT00540644|11508650|FG001|STARTED|Overall Study||22
10368043|NCT00540644|11508649|FG000|COMPLETED|Overall Study||39
10368044|NCT00540644|11508650|FG001|COMPLETED|Overall Study||13
10368045|NCT00540644|11508649|FG000|NOT COMPLETED|Overall Study||9
10368046|NCT00540644|11508650|FG001|NOT COMPLETED|Overall Study||9
10368047|NCT00540722|11508656|FG000|STARTED|Overall Study||56
10368048|NCT00540722|11508656|FG000|COMPLETED|Overall Study||56
10368049|NCT00540722|11508656|FG000|NOT COMPLETED|Overall Study||0
10368050|NCT00540982|11508661|FG000|STARTED|Overall Study||47
10368051|NCT00540982|11508661|FG000|Normal Liver Function|Overall Study||11
10368052|NCT00540982|11508661|FG000|Mild Liver Dysfunction|Overall Study||6
10368053|NCT00540982|11508661|FG000|Moderate Liver Dysfunction|Overall Study||18
10368054|NCT00540982|11508661|FG000|Severe Liver Dysfunction|Overall Study||12
10368055|NCT00540982|11508661|FG000|COMPLETED|Overall Study||47
10368056|NCT00540982|11508661|FG000|NOT COMPLETED|Overall Study||0
10368057|NCT00541034|11508683|FG000|STARTED|Overall Study||49
10368058|NCT00541034|11508683|FG000|COMPLETED|Overall Study||46
10368059|NCT00541034|11508683|FG000|NOT COMPLETED|Overall Study||3
10368060|NCT00541099|11508687|FG000|STARTED|Overall Study||11
10368061|NCT00541099|11508687|FG000|COMPLETED|Overall Study||8
10368062|NCT00541099|11508687|FG000|NOT COMPLETED|Overall Study||3
10368063|NCT00541190|11508693|FG000|STARTED|Overall Study||10
10368064|NCT00541190|11508694|FG001|STARTED|Overall Study||11
10368065|NCT00541190|11508693|FG000|COMPLETED|Overall Study||10
10368066|NCT00541190|11508694|FG001|COMPLETED|Overall Study||11
10368067|NCT00541190|11508693|FG000|NOT COMPLETED|Overall Study||0
10368068|NCT00541190|11508694|FG001|NOT COMPLETED|Overall Study||0
10368069|NCT00541229|11508708|FG000|STARTED|Treatment Period I (Week 1)||17
10368070|NCT00541229|11508709|FG001|STARTED|Treatment Period I (Week 1)||16
10368071|NCT00541229|11508710|FG002|STARTED|Treatment Period I (Week 1)||20
10368072|NCT00541229|11508711|FG003|STARTED|Treatment Period I (Week 1)||18
10368073|NCT00541229|11508712|FG004|STARTED|Treatment Period I (Week 1)||14
10368074|NCT00541229|11508713|FG005|STARTED|Treatment Period I (Week 1)||18
10368075|NCT00541229|11508708|FG000|COMPLETED|Treatment Period I (Week 1)||17
10368076|NCT00541229|11508709|FG001|COMPLETED|Treatment Period I (Week 1)||15
10368077|NCT00541229|11508710|FG002|COMPLETED|Treatment Period I (Week 1)||17
10368078|NCT00541229|11508711|FG003|COMPLETED|Treatment Period I (Week 1)||17
10368079|NCT00541229|11508712|FG004|COMPLETED|Treatment Period I (Week 1)||14
10368080|NCT00541229|11508713|FG005|COMPLETED|Treatment Period I (Week 1)||16
10368081|NCT00541229|11508708|FG000|NOT COMPLETED|Treatment Period I (Week 1)||0
10368082|NCT00541229|11508709|FG001|NOT COMPLETED|Treatment Period I (Week 1)||1
10368083|NCT00541229|11508710|FG002|NOT COMPLETED|Treatment Period I (Week 1)||3
10368084|NCT00541229|11508711|FG003|NOT COMPLETED|Treatment Period I (Week 1)||1
10368085|NCT00541229|11508712|FG004|NOT COMPLETED|Treatment Period I (Week 1)||0
10368086|NCT00541229|11508713|FG005|NOT COMPLETED|Treatment Period I (Week 1)||2
10368087|NCT00541229|11508708|FG000|STARTED|Washout Period I (Week 2-5)||17
10368088|NCT00541229|11508709|FG001|STARTED|Washout Period I (Week 2-5)||15
10368089|NCT00541229|11508710|FG002|STARTED|Washout Period I (Week 2-5)||17
10368090|NCT00541229|11508711|FG003|STARTED|Washout Period I (Week 2-5)||17
10368091|NCT00541229|11508712|FG004|STARTED|Washout Period I (Week 2-5)||14
10368092|NCT00541229|11508713|FG005|STARTED|Washout Period I (Week 2-5)||16
10368093|NCT00541229|11508708|FG000|COMPLETED|Washout Period I (Week 2-5)||13
10368094|NCT00541229|11508709|FG001|COMPLETED|Washout Period I (Week 2-5)||13
10368095|NCT00541229|11508710|FG002|COMPLETED|Washout Period I (Week 2-5)||13
10368096|NCT00541229|11508711|FG003|COMPLETED|Washout Period I (Week 2-5)||13
10368097|NCT00541229|11508712|FG004|COMPLETED|Washout Period I (Week 2-5)||13
10368098|NCT00541229|11508713|FG005|COMPLETED|Washout Period I (Week 2-5)||11
10368099|NCT00541229|11508708|FG000|NOT COMPLETED|Washout Period I (Week 2-5)||4
10368100|NCT00541229|11508709|FG001|NOT COMPLETED|Washout Period I (Week 2-5)||2
10368101|NCT00541229|11508710|FG002|NOT COMPLETED|Washout Period I (Week 2-5)||4
10368102|NCT00541229|11508711|FG003|NOT COMPLETED|Washout Period I (Week 2-5)||4
10368103|NCT00541229|11508712|FG004|NOT COMPLETED|Washout Period I (Week 2-5)||1
10368104|NCT00541229|11508713|FG005|NOT COMPLETED|Washout Period I (Week 2-5)||5
10368105|NCT00541229|11508708|FG000|STARTED|Treatment Period II (Week 6)||13
10368106|NCT00541229|11508709|FG001|STARTED|Treatment Period II (Week 6)||13
10368107|NCT00541229|11508710|FG002|STARTED|Treatment Period II (Week 6)||13
10368108|NCT00541229|11508711|FG003|STARTED|Treatment Period II (Week 6)||13
10368109|NCT00541229|11508712|FG004|STARTED|Treatment Period II (Week 6)||13
10368110|NCT00541229|11508713|FG005|STARTED|Treatment Period II (Week 6)||11
10368111|NCT00541229|11508708|FG000|COMPLETED|Treatment Period II (Week 6)||11
10368112|NCT00541229|11508709|FG001|COMPLETED|Treatment Period II (Week 6)||12
10368113|NCT00541229|11508710|FG002|COMPLETED|Treatment Period II (Week 6)||12
10368114|NCT00541229|11508711|FG003|COMPLETED|Treatment Period II (Week 6)||12
10368115|NCT00541229|11508712|FG004|COMPLETED|Treatment Period II (Week 6)||11
10368116|NCT00541229|11508713|FG005|COMPLETED|Treatment Period II (Week 6)||8
10368117|NCT00541229|11508708|FG000|NOT COMPLETED|Treatment Period II (Week 6)||2
10368118|NCT00541229|11508709|FG001|NOT COMPLETED|Treatment Period II (Week 6)||1
10716664|NCT02691455|11880426|FG001|Month 12 Follow up|Overall Study||16
10716665|NCT02691455|11880425|FG000|Year 2 Follow up|Overall Study||6
10716666|NCT02691455|11880426|FG001|Year 2 Follow up|Overall Study||9
10716667|NCT02691455|11880425|FG000|Year 3 Follow up|Overall Study||7
10368119|NCT00541229|11508710|FG002|NOT COMPLETED|Treatment Period II (Week 6)||1
10368120|NCT00541229|11508711|FG003|NOT COMPLETED|Treatment Period II (Week 6)||1
10368121|NCT00541229|11508712|FG004|NOT COMPLETED|Treatment Period II (Week 6)||2
10368122|NCT00541229|11508713|FG005|NOT COMPLETED|Treatment Period II (Week 6)||3
10368123|NCT00541229|11508708|FG000|STARTED|Washout Period II (Week 7-10)||11
10368124|NCT00541229|11508709|FG001|STARTED|Washout Period II (Week 7-10)||12
10368125|NCT00541229|11508710|FG002|STARTED|Washout Period II (Week 7-10)||12
10368126|NCT00541229|11508711|FG003|STARTED|Washout Period II (Week 7-10)||12
10368127|NCT00541229|11508712|FG004|STARTED|Washout Period II (Week 7-10)||11
10368128|NCT00541229|11508713|FG005|STARTED|Washout Period II (Week 7-10)||8
10368129|NCT00541229|11508708|FG000|COMPLETED|Washout Period II (Week 7-10)||7
10368130|NCT00541229|11508709|FG001|COMPLETED|Washout Period II (Week 7-10)||8
10368131|NCT00541229|11508710|FG002|COMPLETED|Washout Period II (Week 7-10)||10
10368132|NCT00541229|11508711|FG003|COMPLETED|Washout Period II (Week 7-10)||8
10368133|NCT00541229|11508712|FG004|COMPLETED|Washout Period II (Week 7-10)||7
10368134|NCT00541229|11508713|FG005|COMPLETED|Washout Period II (Week 7-10)||5
10368135|NCT00541229|11508708|FG000|NOT COMPLETED|Washout Period II (Week 7-10)||4
10368136|NCT00541229|11508709|FG001|NOT COMPLETED|Washout Period II (Week 7-10)||4
10368137|NCT00541229|11508710|FG002|NOT COMPLETED|Washout Period II (Week 7-10)||2
10368138|NCT00541229|11508711|FG003|NOT COMPLETED|Washout Period II (Week 7-10)||4
10368139|NCT00541229|11508712|FG004|NOT COMPLETED|Washout Period II (Week 7-10)||4
10368140|NCT00541229|11508713|FG005|NOT COMPLETED|Washout Period II (Week 7-10)||3
10368141|NCT00541229|11508708|FG000|STARTED|Treatment Period III (Week 11)||7
10368142|NCT00541229|11508709|FG001|STARTED|Treatment Period III (Week 11)||8
10368143|NCT00541229|11508710|FG002|STARTED|Treatment Period III (Week 11)||10
10368144|NCT00541229|11508711|FG003|STARTED|Treatment Period III (Week 11)||8
10368145|NCT00541229|11508712|FG004|STARTED|Treatment Period III (Week 11)||7
10368146|NCT00541229|11508713|FG005|STARTED|Treatment Period III (Week 11)||5
10368147|NCT00541229|11508708|FG000|COMPLETED|Treatment Period III (Week 11)||7
10368148|NCT00541229|11508709|FG001|COMPLETED|Treatment Period III (Week 11)||8
10368149|NCT00541229|11508710|FG002|COMPLETED|Treatment Period III (Week 11)||9
10368150|NCT00541229|11508711|FG003|COMPLETED|Treatment Period III (Week 11)||8
10368151|NCT00541229|11508712|FG004|COMPLETED|Treatment Period III (Week 11)||6
10368152|NCT00541229|11508713|FG005|COMPLETED|Treatment Period III (Week 11)||4
10368153|NCT00541229|11508708|FG000|NOT COMPLETED|Treatment Period III (Week 11)||0
10368154|NCT00541229|11508709|FG001|NOT COMPLETED|Treatment Period III (Week 11)||0
10368155|NCT00541229|11508710|FG002|NOT COMPLETED|Treatment Period III (Week 11)||1
10368156|NCT00541229|11508711|FG003|NOT COMPLETED|Treatment Period III (Week 11)||0
10368157|NCT00541229|11508712|FG004|NOT COMPLETED|Treatment Period III (Week 11)||1
10368158|NCT00541229|11508713|FG005|NOT COMPLETED|Treatment Period III (Week 11)||1
10368159|NCT00541242|11508723|FG000|STARTED|Treatment Period 1||0
10368160|NCT00541242|11508724|FG001|STARTED|Treatment Period 1|586 patients were enrolled and received open-label latanoprost for 6 weeks|586
10368161|NCT00541242|11508723|FG000|COMPLETED|Treatment Period 1||0
10368162|NCT00541242|11508724|FG001|COMPLETED|Treatment Period 1|43 of the 586 patients did not enter Treatment Period 2 (Randomized at Week 6)|586
10368163|NCT00541242|11508723|FG000|NOT COMPLETED|Treatment Period 1||0
10368164|NCT00541242|11508724|FG001|NOT COMPLETED|Treatment Period 1||0
10368165|NCT00541242|11508723|FG000|STARTED|Treatment Period 2||270
10368166|NCT00541242|11508724|FG001|STARTED|Treatment Period 2||273
10368167|NCT00541242|11508723|FG000|COMPLETED|Treatment Period 2||261
10368168|NCT00541242|11508724|FG001|COMPLETED|Treatment Period 2||266
10368169|NCT00541242|11508723|FG000|NOT COMPLETED|Treatment Period 2||9
10368170|NCT00541242|11508724|FG001|NOT COMPLETED|Treatment Period 2||7
10368171|NCT00541307|11508730|FG000|STARTED|Overall Study||119
10368172|NCT00541307|11508730|FG000|COMPLETED|Overall Study||95
10368173|NCT00541307|11508730|FG000|NOT COMPLETED|Overall Study||24
10368174|NCT00541346|11508734|FG000|STARTED|Baseline||16
10368175|NCT00541346|11508734|FG000|COMPLETED|Baseline||16
10368176|NCT00541346|11508734|FG000|NOT COMPLETED|Baseline||0
10368177|NCT00541346|11508734|FG000|STARTED|Follow-up||16
10368178|NCT00541346|11508734|FG000|COMPLETED|Follow-up||15
10368179|NCT00541346|11508734|FG000|NOT COMPLETED|Follow-up||1
10368180|NCT00541385|11508740|FG000|STARTED|Overall Study||355
10368181|NCT00541385|11508741|FG001|STARTED|Overall Study||180
10368182|NCT00541385|11508740|FG000|COMPLETED|Overall Study||274
10368183|NCT00541385|11508741|FG001|COMPLETED|Overall Study||142
10368184|NCT00541385|11508740|FG000|NOT COMPLETED|Overall Study||81
10368185|NCT00541385|11508741|FG001|NOT COMPLETED|Overall Study||38
10368186|NCT00541450|11508749|FG000|STARTED|Phase A||244
10536782|NCT01446965|11689498|FG000|Never Given WCD|Participants Followed and Analyzed||0
10536783|NCT01446965|11689499|FG001|Never Given WCD|Participants Followed and Analyzed||758
10536784|NCT01446965|11689498|FG000|Given WCD Out of Protocol|Participants Followed and Analyzed||0
10716668|NCT02691455|11880426|FG001|Year 3 Follow up|Overall Study||5
10368187|NCT00541450|11508750|FG001|STARTED|Phase A||248
10368188|NCT00541450|11508749|FG000|COMPLETED|Phase A||224
10368189|NCT00541450|11508750|FG001|COMPLETED|Phase A||231
10368190|NCT00541450|11508749|FG000|NOT COMPLETED|Phase A||20
10368191|NCT00541450|11508750|FG001|NOT COMPLETED|Phase A||17
10368192|NCT00541450|11508749|FG000|STARTED|Phase B||224
10368193|NCT00541450|11508750|FG001|STARTED|Phase B||231
10368194|NCT00541450|11508749|FG000|COMPLETED|Phase B||187
10368195|NCT00541450|11508750|FG001|COMPLETED|Phase B||200
10368196|NCT00541450|11508749|FG000|NOT COMPLETED|Phase B||37
10368197|NCT00541450|11508750|FG001|NOT COMPLETED|Phase B||31
10368198|NCT00541593|11508760|FG000|STARTED|Overall Study||5
10368199|NCT00541593|11508760|FG000|COMPLETED|Overall Study||5
10368200|NCT00541593|11508760|FG000|NOT COMPLETED|Overall Study||0
10368201|NCT00541658|11508767|FG000|STARTED|Overall Study||308
10368202|NCT00541658|11508768|FG001|STARTED|Overall Study||307
10368203|NCT00541658|11508769|FG002|STARTED|Overall Study||308
10368204|NCT00541658|11508767|FG000|ITT Population|Overall Study||307
10368205|NCT00541658|11508768|FG001|ITT Population|Overall Study||307
10716669|NCT02691455|11880425|FG000|COMPLETED|Overall Study||7
10716670|NCT02691455|11880426|FG001|COMPLETED|Overall Study||5
10716671|NCT02691455|11880425|FG000|NOT COMPLETED|Overall Study||16
10716672|NCT02691455|11880426|FG001|NOT COMPLETED|Overall Study||17
10716673|NCT02691468|11880434|FG000|STARTED|Overall Study||54
10368206|NCT00541658|11508769|FG002|ITT Population|Overall Study||308
10368207|NCT00541658|11508767|FG000|COMPLETED|Overall Study||248
10368208|NCT00541658|11508768|FG001|COMPLETED|Overall Study||234
10368209|NCT00541658|11508769|FG002|COMPLETED|Overall Study||240
10368210|NCT00541658|11508767|FG000|NOT COMPLETED|Overall Study||60
10368211|NCT00541658|11508768|FG001|NOT COMPLETED|Overall Study||73
10368212|NCT00541658|11508769|FG002|NOT COMPLETED|Overall Study||68
10368213|NCT00541671|11508781|FG000|STARTED|Overall Study||13
10368214|NCT00541671|11508782|FG001|STARTED|Overall Study||12
10368215|NCT00541671|11508781|FG000|COMPLETED|Overall Study||13
10716674|NCT02691468|11880435|FG001|STARTED|Overall Study||54
10716675|NCT02691468|11880434|FG000|COMPLETED|Overall Study||48
10716676|NCT02691468|11880435|FG001|COMPLETED|Overall Study||52
10716677|NCT02691468|11880434|FG000|NOT COMPLETED|Overall Study||6
10368216|NCT00541671|11508782|FG001|COMPLETED|Overall Study||12
10368217|NCT00541671|11508781|FG000|NOT COMPLETED|Overall Study||0
10536785|NCT01446965|11689499|FG001|Given WCD Out of Protocol|Participants Followed and Analyzed||20
10536786|NCT01446965|11689498|FG000|COMPLETED|Participants Followed and Analyzed||1514
10536787|NCT01446965|11689499|FG001|COMPLETED|Participants Followed and Analyzed||766
10536788|NCT01446965|11689498|FG000|NOT COMPLETED|Participants Followed and Analyzed||10
10536789|NCT01446965|11689499|FG001|NOT COMPLETED|Participants Followed and Analyzed||12
10536790|NCT01447017|11689507|FG000|STARTED|Overall Study||45
10536791|NCT01447017|11689508|FG001|STARTED|Overall Study||24
10536792|NCT01447017|11689507|FG000|Performed Visit 2|Overall Study||43
10536793|NCT01447017|11689508|FG001|Performed Visit 2|Overall Study||24
10536794|NCT01447017|11689507|FG000|COMPLETED|Overall Study|In safety analysis: 42. In efficacy analyses: 40 in full analysis set, and 39 in per-protocol set.|35
10536795|NCT01447017|11689508|FG001|COMPLETED|Overall Study|In safety analysis: 24. In efficacy analyses: 24 in full analysis set, and 22 in per-protocol set.|14
10536796|NCT01447017|11689507|FG000|NOT COMPLETED|Overall Study||10
10536797|NCT01447017|11689508|FG001|NOT COMPLETED|Overall Study||10
10536798|NCT01447121|11689514|FG000|STARTED|Overall Study||118
10536799|NCT01447121|11689514|FG000|COMPLETED|Overall Study||118
10716678|NCT02691468|11880435|FG001|NOT COMPLETED|Overall Study||2
10716679|NCT02691494|11880444|FG000|STARTED|Treatment Period||94
10368218|NCT00541671|11508782|FG001|NOT COMPLETED|Overall Study||0
10368219|NCT00541775|11508791|FG000|STARTED|Overall Study||94
10368220|NCT00541775|11508792|FG001|STARTED|Overall Study||87
10368221|NCT00541775|11508793|FG002|STARTED|Overall Study||92
10368222|NCT00541775|11508791|FG000|COMPLETED|Overall Study||85
10368223|NCT00541775|11508792|FG001|COMPLETED|Overall Study||85
10368224|NCT00541775|11508793|FG002|COMPLETED|Overall Study||84
10368225|NCT00541775|11508791|FG000|NOT COMPLETED|Overall Study||9
10368226|NCT00541775|11508792|FG001|NOT COMPLETED|Overall Study||2
10368227|NCT00541775|11508793|FG002|NOT COMPLETED|Overall Study||8
10368228|NCT00541866|11508806|FG000|STARTED|Overall Study|41 started, but only 39 treated|41
10368229|NCT00541866|11508807|FG001|STARTED|Overall Study||18
10368230|NCT00541866|11508808|FG002|STARTED|Overall Study||17
10368231|NCT00541866|11508809|FG003|STARTED|Overall Study||16
10368232|NCT00541866|11508810|FG004|STARTED|Overall Study||18
10368233|NCT00541866|11508806|FG000|COMPLETED|Overall Study||7
10368234|NCT00541866|11508807|FG001|COMPLETED|Overall Study||0
10368235|NCT00541866|11508808|FG002|COMPLETED|Overall Study||2
10368236|NCT00541866|11508809|FG003|COMPLETED|Overall Study||0
10368237|NCT00541866|11508810|FG004|COMPLETED|Overall Study||3
10368238|NCT00541866|11508806|FG000|NOT COMPLETED|Overall Study||34
10368239|NCT00541866|11508807|FG001|NOT COMPLETED|Overall Study||18
10368240|NCT00541866|11508808|FG002|NOT COMPLETED|Overall Study||15
10368241|NCT00541866|11508809|FG003|NOT COMPLETED|Overall Study||16
10368242|NCT00541866|11508810|FG004|NOT COMPLETED|Overall Study||15
10368243|NCT00541931|11508840|FG000|STARTED|Overall Study||22
10368244|NCT00541931|11508841|FG001|STARTED|Overall Study||15
10368245|NCT00541931|11508840|FG000|COMPLETED|Overall Study||17
10368246|NCT00541931|11508841|FG001|COMPLETED|Overall Study||11
10368247|NCT00541931|11508840|FG000|NOT COMPLETED|Overall Study||5
10368248|NCT00541931|11508841|FG001|NOT COMPLETED|Overall Study||4
10368249|NCT00541970|11508853|FG000|STARTED|Month 7||240
10368250|NCT00541970|11508854|FG001|STARTED|Month 7||241
10368251|NCT00541970|11508855|FG002|STARTED|Month 7||240
10368252|NCT00541970|11508856|FG003|STARTED|Month 7||239
10368253|NCT00541970|11508853|FG000|COMPLETED|Month 7||231
10368254|NCT00541970|11508854|FG001|COMPLETED|Month 7||228
10368255|NCT00541970|11508855|FG002|COMPLETED|Month 7||229
10368256|NCT00541970|11508856|FG003|COMPLETED|Month 7||234
10368257|NCT00541970|11508853|FG000|NOT COMPLETED|Month 7||9
10368258|NCT00541970|11508854|FG001|NOT COMPLETED|Month 7||13
10368259|NCT00541970|11508855|FG002|NOT COMPLETED|Month 7||11
10368260|NCT00541970|11508856|FG003|NOT COMPLETED|Month 7||5
10368261|NCT00541970|11508853|FG000|STARTED|Month 12||240
10368262|NCT00541970|11508854|FG001|STARTED|Month 12||241
10368263|NCT00541970|11508855|FG002|STARTED|Month 12||240
10368264|NCT00541970|11508856|FG003|STARTED|Month 12||239
10368265|NCT00541970|11508853|FG000|COMPLETED|Month 12||228
10368266|NCT00541970|11508854|FG001|COMPLETED|Month 12||219
10368267|NCT00541970|11508855|FG002|COMPLETED|Month 12||219
10368268|NCT00541970|11508856|FG003|COMPLETED|Month 12||223
10368269|NCT00541970|11508853|FG000|NOT COMPLETED|Month 12||12
10368270|NCT00541970|11508854|FG001|NOT COMPLETED|Month 12||22
10368271|NCT00541970|11508855|FG002|NOT COMPLETED|Month 12||21
10368272|NCT00541970|11508856|FG003|NOT COMPLETED|Month 12||16
10368273|NCT00541970|11508853|FG000|STARTED|Month 18||240
10368274|NCT00541970|11508854|FG001|STARTED|Month 18||241
10368275|NCT00541970|11508855|FG002|STARTED|Month 18||240
10368276|NCT00541970|11508856|FG003|STARTED|Month 18||239
10368277|NCT00541970|11508853|FG000|COMPLETED|Month 18||226
10368278|NCT00541970|11508854|FG001|COMPLETED|Month 18||217
10368279|NCT00541970|11508855|FG002|COMPLETED|Month 18||215
10368280|NCT00541970|11508856|FG003|COMPLETED|Month 18||222
10368281|NCT00541970|11508853|FG000|NOT COMPLETED|Month 18||14
10368282|NCT00541970|11508854|FG001|NOT COMPLETED|Month 18||24
10368283|NCT00541970|11508855|FG002|NOT COMPLETED|Month 18||25
10368284|NCT00541970|11508856|FG003|NOT COMPLETED|Month 18||17
10368285|NCT00541970|11508853|FG000|STARTED|Month 24||240
10368286|NCT00541970|11508854|FG001|STARTED|Month 24||241
10368287|NCT00541970|11508855|FG002|STARTED|Month 24||240
10368288|NCT00541970|11508856|FG003|STARTED|Month 24||239
10368289|NCT00541970|11508853|FG000|COMPLETED|Month 24||211
10368290|NCT00541970|11508854|FG001|COMPLETED|Month 24||209
10368291|NCT00541970|11508855|FG002|COMPLETED|Month 24||208
10368292|NCT00541970|11508856|FG003|COMPLETED|Month 24||217
10368293|NCT00541970|11508853|FG000|NOT COMPLETED|Month 24||29
10368294|NCT00541970|11508854|FG001|NOT COMPLETED|Month 24||32
10368295|NCT00541970|11508855|FG002|NOT COMPLETED|Month 24||32
10368296|NCT00541970|11508856|FG003|NOT COMPLETED|Month 24||22
10368297|NCT00541970|11508853|FG000|STARTED|Month 36||240
10368298|NCT00541970|11508854|FG001|STARTED|Month 36||241
10368299|NCT00541970|11508855|FG002|STARTED|Month 36||240
10368300|NCT00541970|11508856|FG003|STARTED|Month 36||239
10368301|NCT00541970|11508853|FG000|COMPLETED|Month 36||179
10368302|NCT00541970|11508854|FG001|COMPLETED|Month 36||175
10368303|NCT00541970|11508855|FG002|COMPLETED|Month 36||174
10368304|NCT00541970|11508856|FG003|COMPLETED|Month 36||179
10368305|NCT00541970|11508853|FG000|NOT COMPLETED|Month 36||61
10368306|NCT00541970|11508854|FG001|NOT COMPLETED|Month 36||66
10368307|NCT00541970|11508855|FG002|NOT COMPLETED|Month 36||66
10368308|NCT00541970|11508856|FG003|NOT COMPLETED|Month 36||60
10368309|NCT00541970|11508853|FG000|STARTED|Month 48||240
10368310|NCT00541970|11508854|FG001|STARTED|Month 48||241
10368311|NCT00541970|11508855|FG002|STARTED|Month 48||240
10368312|NCT00541970|11508856|FG003|STARTED|Month 48||239
10368313|NCT00541970|11508853|FG000|COMPLETED|Month 48||169
10368314|NCT00541970|11508854|FG001|COMPLETED|Month 48||168
10368315|NCT00541970|11508855|FG002|COMPLETED|Month 48||167
10368316|NCT00541970|11508856|FG003|COMPLETED|Month 48||164
10368317|NCT00541970|11508853|FG000|NOT COMPLETED|Month 48||71
10368318|NCT00541970|11508854|FG001|NOT COMPLETED|Month 48||73
10368319|NCT00541970|11508855|FG002|NOT COMPLETED|Month 48||73
10368320|NCT00541970|11508856|FG003|NOT COMPLETED|Month 48||75
10368321|NCT00541970|11508853|FG000|STARTED|Month 60||240
10368322|NCT00541970|11508854|FG001|STARTED|Month 60||241
10368323|NCT00541970|11508855|FG002|STARTED|Month 60||240
10368324|NCT00541970|11508856|FG003|STARTED|Month 60||239
10368325|NCT00541970|11508853|FG000|COMPLETED|Month 60||162
10368326|NCT00541970|11508854|FG001|COMPLETED|Month 60||164
10368327|NCT00541970|11508855|FG002|COMPLETED|Month 60||158
10368328|NCT00541970|11508856|FG003|COMPLETED|Month 60||167
10368329|NCT00541970|11508853|FG000|NOT COMPLETED|Month 60||78
10368330|NCT00541970|11508854|FG001|NOT COMPLETED|Month 60||77
10368331|NCT00541970|11508855|FG002|NOT COMPLETED|Month 60||82
10368332|NCT00541970|11508856|FG003|NOT COMPLETED|Month 60||72
10368333|NCT00542178|11508872|FG000|STARTED|Overall Study||390
10368334|NCT00542178|11508873|FG001|STARTED|Overall Study||412
10368335|NCT00542178|11508874|FG002|STARTED|Overall Study||382
10368336|NCT00542178|11508875|FG003|STARTED|Overall Study||370
10368337|NCT00542178|11508876|FG004|STARTED|Overall Study||464
10368338|NCT00542178|11508877|FG005|STARTED|Overall Study||495
10368339|NCT00542178|11508878|FG006|STARTED|Overall Study||493
10368340|NCT00542178|11508879|FG007|STARTED|Overall Study||466
10368341|NCT00542178|11508872|FG000|COMPLETED|Overall Study||315
10368342|NCT00542178|11508873|FG001|COMPLETED|Overall Study||332
10368343|NCT00542178|11508874|FG002|COMPLETED|Overall Study||308
10368344|NCT00542178|11508875|FG003|COMPLETED|Overall Study||308
10368345|NCT00542178|11508876|FG004|COMPLETED|Overall Study||400
10368346|NCT00542178|11508877|FG005|COMPLETED|Overall Study||406
10368347|NCT00542178|11508878|FG006|COMPLETED|Overall Study||406
10368348|NCT00542178|11508879|FG007|COMPLETED|Overall Study||381
10368349|NCT00542178|11508872|FG000|NOT COMPLETED|Overall Study||75
10368350|NCT00542178|11508873|FG001|NOT COMPLETED|Overall Study||80
10368351|NCT00542178|11508874|FG002|NOT COMPLETED|Overall Study||74
10368352|NCT00542178|11508875|FG003|NOT COMPLETED|Overall Study||62
10368353|NCT00542178|11508876|FG004|NOT COMPLETED|Overall Study||64
10368354|NCT00542178|11508877|FG005|NOT COMPLETED|Overall Study||89
10368355|NCT00542178|11508878|FG006|NOT COMPLETED|Overall Study||87
10368356|NCT00542178|11508879|FG007|NOT COMPLETED|Overall Study||85
10368357|NCT00542191|11508893|FG000|STARTED|Overall Study||21
10368358|NCT00542191|11508893|FG000|COMPLETED|Overall Study||18
10368359|NCT00542191|11508893|FG000|NOT COMPLETED|Overall Study||3
10368360|NCT00542269|11508900|FG000|STARTED|Overall Study||61
10368361|NCT00542269|11508901|FG001|STARTED|Overall Study||60
10368362|NCT00542269|11508902|FG002|STARTED|Overall Study||57
10368363|NCT00542269|11508900|FG000|COMPLETED|Overall Study||48
10368364|NCT00542269|11508901|FG001|COMPLETED|Overall Study||54
10368365|NCT00542269|11508902|FG002|COMPLETED|Overall Study||51
10368366|NCT00542269|11508900|FG000|NOT COMPLETED|Overall Study||13
10368367|NCT00542269|11508901|FG001|NOT COMPLETED|Overall Study||6
10368368|NCT00542269|11508902|FG002|NOT COMPLETED|Overall Study||6
10368369|NCT00542308|11508912|FG000|STARTED|Overall Study||90
10368370|NCT00542308|11508912|FG000|COMPLETED|Overall Study||90
10368371|NCT00542308|11508912|FG000|NOT COMPLETED|Overall Study||0
10368372|NCT00542321|11508918|FG000|STARTED|Overall Study||8
10368373|NCT00542321|11508919|FG001|STARTED|Overall Study||8
10368374|NCT00542321|11508918|FG000|COMPLETED|Overall Study||8
10368375|NCT00542321|11508919|FG001|COMPLETED|Overall Study||7
10368376|NCT00542321|11508918|FG000|NOT COMPLETED|Overall Study||0
10368377|NCT00542321|11508919|FG001|NOT COMPLETED|Overall Study||1
10368378|NCT00542386|11508931|FG000|STARTED|Overall Study||104
10368379|NCT00542386|11508932|FG001|STARTED|Overall Study||102
10368380|NCT00542386|11508933|FG002|STARTED|Overall Study||99
10368381|NCT00542386|11508934|FG003|STARTED|Overall Study||103
10368382|NCT00542386|11508935|FG004|STARTED|Overall Study||102
10536800|NCT01447121|11689514|FG000|NOT COMPLETED|Overall Study||0
10536801|NCT01447225|11689523|FG000|STARTED|Overall Study||3
10536802|NCT01447225|11689524|FG001|STARTED|Overall Study||8
10368383|NCT00542386|11508936|FG005|STARTED|Overall Study||132
10368384|NCT00542386|11508931|FG000|COMPLETED|Overall Study||61
10368385|NCT00542386|11508932|FG001|COMPLETED|Overall Study||74
10368386|NCT00542386|11508933|FG002|COMPLETED|Overall Study||66
10368387|NCT00542386|11508934|FG003|COMPLETED|Overall Study||65
10368388|NCT00542386|11508935|FG004|COMPLETED|Overall Study||62
10368389|NCT00542386|11508936|FG005|COMPLETED|Overall Study||82
10368390|NCT00542386|11508931|FG000|NOT COMPLETED|Overall Study||43
10368391|NCT00542386|11508932|FG001|NOT COMPLETED|Overall Study||28
10368392|NCT00542386|11508933|FG002|NOT COMPLETED|Overall Study||33
10368393|NCT00542386|11508934|FG003|NOT COMPLETED|Overall Study||38
10368394|NCT00542386|11508935|FG004|NOT COMPLETED|Overall Study||40
10368395|NCT00542386|11508936|FG005|NOT COMPLETED|Overall Study||50
10368396|NCT00542425|11508955|FG000|STARTED|Initial 24 Weeks||46
10368397|NCT00542425|11508956|FG001|STARTED|Initial 24 Weeks||43
10368398|NCT00542425|11508957|FG002|STARTED|Initial 24 Weeks||43
10368399|NCT00542425|11508958|FG003|STARTED|Initial 24 Weeks||45
10368400|NCT00542425|11508959|FG004|STARTED|Initial 24 Weeks||45
10368401|NCT00542425|11508955|FG000|COMPLETED|Initial 24 Weeks||42
10368402|NCT00542425|11508956|FG001|COMPLETED|Initial 24 Weeks||33
10368403|NCT00542425|11508957|FG002|COMPLETED|Initial 24 Weeks||36
10368404|NCT00542425|11508958|FG003|COMPLETED|Initial 24 Weeks||34
10368405|NCT00542425|11508959|FG004|COMPLETED|Initial 24 Weeks||39
10368406|NCT00542425|11508955|FG000|NOT COMPLETED|Initial 24 Weeks||4
10368407|NCT00542425|11508956|FG001|NOT COMPLETED|Initial 24 Weeks||10
10368408|NCT00542425|11508957|FG002|NOT COMPLETED|Initial 24 Weeks||7
10368409|NCT00542425|11508958|FG003|NOT COMPLETED|Initial 24 Weeks||11
10368410|NCT00542425|11508959|FG004|NOT COMPLETED|Initial 24 Weeks||6
10368411|NCT00542425|11508955|FG000|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|11
10368412|NCT00542425|11508956|FG001|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|13
10368413|NCT00542425|11508957|FG002|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|10
10368414|NCT00542425|11508958|FG003|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|7
10368415|NCT00542425|11508959|FG004|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|14
10368416|NCT00542425|11508955|FG000|COMPLETED|Extended 24 Weeks of Treatment||10
10368417|NCT00542425|11508956|FG001|COMPLETED|Extended 24 Weeks of Treatment||11
10368418|NCT00542425|11508957|FG002|COMPLETED|Extended 24 Weeks of Treatment||8
10368419|NCT00542425|11508958|FG003|COMPLETED|Extended 24 Weeks of Treatment||6
10368420|NCT00542425|11508959|FG004|COMPLETED|Extended 24 Weeks of Treatment||13
10368421|NCT00542425|11508955|FG000|NOT COMPLETED|Extended 24 Weeks of Treatment||1
10368422|NCT00542425|11508956|FG001|NOT COMPLETED|Extended 24 Weeks of Treatment||2
10368423|NCT00542425|11508957|FG002|NOT COMPLETED|Extended 24 Weeks of Treatment||2
10368424|NCT00542425|11508958|FG003|NOT COMPLETED|Extended 24 Weeks of Treatment||1
10368425|NCT00542425|11508959|FG004|NOT COMPLETED|Extended 24 Weeks of Treatment||1
10368426|NCT00542490|11508971|FG000|STARTED|Overall Study||23
10368427|NCT00542490|11508971|FG000|COMPLETED|Overall Study||21
10368428|NCT00542490|11508971|FG000|NOT COMPLETED|Overall Study||2
10368429|NCT00542620|11508977|FG000|STARTED|Overall Study||13
10368430|NCT00542620|11508978|FG001|STARTED|Overall Study||12
10368431|NCT00542620|11508977|FG000|Exposed to Drug|Overall Study|One subject randomly assigned to receive mixed injections, but received a separate injection mode|12
10368432|NCT00542620|11508978|FG001|Exposed to Drug|Overall Study|One subject randomly assigned to receive mixed injections, but received a separate injection mode|13
10368433|NCT00542620|11508977|FG000|COMPLETED|Overall Study||13
10368434|NCT00542620|11508978|FG001|COMPLETED|Overall Study||12
10368435|NCT00542620|11508977|FG000|NOT COMPLETED|Overall Study||0
10368436|NCT00542620|11508978|FG001|NOT COMPLETED|Overall Study||0
10368437|NCT00542750|11508984|FG000|STARTED|Overall Study||24
10368438|NCT00542750|11508984|FG000|COMPLETED|Overall Study||24
10368439|NCT00542750|11508984|FG000|NOT COMPLETED|Overall Study||0
10368440|NCT00542789|11508990|FG000|STARTED|Overall Study|Randomised|175
10368441|NCT00542789|11508991|FG001|STARTED|Overall Study|Randomised|168
10368442|NCT00542789|11508990|FG000|COMPLETED|Overall Study||134
10368443|NCT00542789|11508991|FG001|COMPLETED|Overall Study||90
10368444|NCT00542789|11508990|FG000|NOT COMPLETED|Overall Study||41
10368445|NCT00542789|11508991|FG001|NOT COMPLETED|Overall Study||78
10368446|NCT00542815|11509000|FG000|STARTED|Overall Study||432
10368447|NCT00542815|11509001|FG001|STARTED|Overall Study||76
10368448|NCT00542815|11509002|FG002|STARTED|Overall Study||124
10368449|NCT00542815|11509000|FG000|COMPLETED|Overall Study||326
10368450|NCT00542815|11509001|FG001|COMPLETED|Overall Study||44
10368451|NCT00542815|11509002|FG002|COMPLETED|Overall Study||92
10368452|NCT00542815|11509000|FG000|NOT COMPLETED|Overall Study||106
10368453|NCT00542815|11509001|FG001|NOT COMPLETED|Overall Study||32
10368454|NCT00542815|11509002|FG002|NOT COMPLETED|Overall Study||32
10368455|NCT00542828|11509010|FG000|STARTED|Overall Study|Number of participants enrolled in the study; of the 16 enrolled, 14 received study treatment.|16
10368456|NCT00542828|11509010|FG000|COMPLETED|Overall Study|Number of participants who completed the 12-month study period.|3
10536803|NCT01447225|11689525|FG002|STARTED|Overall Study||5
10536804|NCT01447225|11689526|FG003|STARTED|Overall Study||3
10536805|NCT01447225|11689527|FG004|STARTED|Overall Study||3
10368457|NCT00542828|11509010|FG000|NOT COMPLETED|Overall Study||13
10368458|NCT00542880|11509016|FG000|STARTED|Period 1|This was a cross-over study|217
10368459|NCT00542880|11509017|FG001|STARTED|Period 1||225
10368460|NCT00542880|11509016|FG000|COMPLETED|Period 1||211
10368461|NCT00542880|11509017|FG001|COMPLETED|Period 1||213
10368462|NCT00542880|11509016|FG000|NOT COMPLETED|Period 1||6
10368463|NCT00542880|11509017|FG001|NOT COMPLETED|Period 1||12
10368464|NCT00542880|11509016|FG000|STARTED|Period 2||211
10368465|NCT00542880|11509017|FG001|STARTED|Period 2||213
10368466|NCT00542880|11509016|FG000|COMPLETED|Period 2||204
10368467|NCT00542880|11509017|FG001|COMPLETED|Period 2||203
10536806|NCT01447225|11689528|FG005|STARTED|Overall Study||3
10536807|NCT01447225|11689529|FG006|STARTED|Overall Study||7
10536808|NCT01447225|11689530|FG007|STARTED|Overall Study||4
10536809|NCT01447225|11689531|FG008|STARTED|Overall Study||3
10536810|NCT01447225|11689532|FG009|STARTED|Overall Study||4
10536811|NCT01447225|11689523|FG000|COMPLETED|Overall Study||3
10536812|NCT01447225|11689524|FG001|COMPLETED|Overall Study||8
10536813|NCT01447225|11689525|FG002|COMPLETED|Overall Study||5
10536814|NCT01447225|11689526|FG003|COMPLETED|Overall Study||3
10536815|NCT01447225|11689527|FG004|COMPLETED|Overall Study||3
10536816|NCT01447225|11689528|FG005|COMPLETED|Overall Study||3
10536817|NCT01447225|11689529|FG006|COMPLETED|Overall Study||7
10536818|NCT01447225|11689530|FG007|COMPLETED|Overall Study||4
10536819|NCT01447225|11689531|FG008|COMPLETED|Overall Study||3
10536820|NCT01447225|11689532|FG009|COMPLETED|Overall Study||4
10536821|NCT01447225|11689523|FG000|NOT COMPLETED|Overall Study||0
10536822|NCT01447225|11689524|FG001|NOT COMPLETED|Overall Study||0
10536823|NCT01447225|11689525|FG002|NOT COMPLETED|Overall Study||0
10536824|NCT01447225|11689526|FG003|NOT COMPLETED|Overall Study||0
10536825|NCT01447225|11689527|FG004|NOT COMPLETED|Overall Study||0
10536826|NCT01447225|11689528|FG005|NOT COMPLETED|Overall Study||0
10536827|NCT01447225|11689529|FG006|NOT COMPLETED|Overall Study||0
10536828|NCT01447225|11689530|FG007|NOT COMPLETED|Overall Study||0
10536829|NCT01447225|11689531|FG008|NOT COMPLETED|Overall Study||0
10536830|NCT01447225|11689532|FG009|NOT COMPLETED|Overall Study||0
10536831|NCT01447407|11689568|FG000|STARTED|Overall Study||41
10536832|NCT01447407|11689569|FG001|STARTED|Overall Study||40
10536833|NCT01447407|11689570|FG002|STARTED|Overall Study||41
10536834|NCT01447407|11689571|FG003|STARTED|Overall Study||42
10536835|NCT01447407|11689568|FG000|COMPLETED|Overall Study||39
10536836|NCT01447407|11689569|FG001|COMPLETED|Overall Study||40
10536837|NCT01447407|11689570|FG002|COMPLETED|Overall Study||40
10536838|NCT01447407|11689571|FG003|COMPLETED|Overall Study||40
10536839|NCT01447407|11689568|FG000|NOT COMPLETED|Overall Study||2
10536840|NCT01447407|11689569|FG001|NOT COMPLETED|Overall Study||0
10536841|NCT01447407|11689570|FG002|NOT COMPLETED|Overall Study||1
10536842|NCT01447407|11689571|FG003|NOT COMPLETED|Overall Study||2
10536843|NCT01447420|11689584|FG000|STARTED|Overall Study||39
10536844|NCT01447420|11689585|FG001|STARTED|Overall Study||72
10536845|NCT01447420|11689586|FG002|STARTED|Overall Study||18
10536846|NCT01447420|11689584|FG000|COMPLETED|Overall Study||29
10536847|NCT01447420|11689585|FG001|COMPLETED|Overall Study||45
10536848|NCT01447420|11689586|FG002|COMPLETED|Overall Study||8
10716680|NCT02691494|11880445|FG001|STARTED|Treatment Period||95
10716681|NCT02691494|11880446|FG002|STARTED|Treatment Period||189
10536849|NCT01447420|11689584|FG000|NOT COMPLETED|Overall Study||10
10536850|NCT01447420|11689585|FG001|NOT COMPLETED|Overall Study||27
10536851|NCT01447420|11689586|FG002|NOT COMPLETED|Overall Study||10
10536852|NCT01447433|11689595|FG000|STARTED|Overall Study||26
10536853|NCT01447433|11689596|FG001|STARTED|Overall Study||27
10536854|NCT01447433|11689595|FG000|COMPLETED|Overall Study||22
10536855|NCT01447433|11689596|FG001|COMPLETED|Overall Study||21
10536856|NCT01447433|11689595|FG000|NOT COMPLETED|Overall Study||4
10536857|NCT01447433|11689596|FG001|NOT COMPLETED|Overall Study||6
10536858|NCT01447446|11689608|FG000|STARTED|Overall Study|Started means participants who started treatment and included in core population.|2312
10536859|NCT01447446|11689609|FG001|STARTED|Overall Study||496
10536860|NCT01447446|11689610|FG002|STARTED|Overall Study||292
10536861|NCT01447446|11689611|FG003|STARTED|Overall Study||93
10536862|NCT01447446|11689612|FG004|STARTED|Overall Study||821
10536863|NCT01447446|11689613|FG005|STARTED|Overall Study||86
10536864|NCT01447446|11689608|FG000|COMPLETED|Overall Study|Completed means the participants who completed the 24- weeks of follow-up period.|1590
10536865|NCT01447446|11689609|FG001|COMPLETED|Overall Study|Insuff.=Insufficient VR= Virological response TRT.=Treatment SVR= Sustained Virological Response|331
10536866|NCT01447446|11689610|FG002|COMPLETED|Overall Study||192
10536867|NCT01447446|11689611|FG003|COMPLETED|Overall Study||60
10536868|NCT01447446|11689612|FG004|COMPLETED|Overall Study||610
10536869|NCT01447446|11689613|FG005|COMPLETED|Overall Study||54
10536870|NCT01447446|11689608|FG000|NOT COMPLETED|Overall Study||722
10536871|NCT01447446|11689609|FG001|NOT COMPLETED|Overall Study||165
10536872|NCT01447446|11689610|FG002|NOT COMPLETED|Overall Study||100
10536873|NCT01447446|11689611|FG003|NOT COMPLETED|Overall Study||33
10536874|NCT01447446|11689612|FG004|NOT COMPLETED|Overall Study||211
10536875|NCT01447446|11689613|FG005|NOT COMPLETED|Overall Study||32
10536876|NCT01447511|11689638|FG000|STARTED|Control Period||8
10536877|NCT01447511|11689639|FG001|STARTED|Control Period||5
10536878|NCT01447511|11689640|FG002|STARTED|Control Period||9
10536879|NCT01447511|11689641|FG003|STARTED|Control Period||3
10536880|NCT01447511|11689642|FG004|STARTED|Control Period||4
10536881|NCT01447511|11689638|FG000|COMPLETED|Control Period||8
10536882|NCT01447511|11689639|FG001|COMPLETED|Control Period||5
10536883|NCT01447511|11689640|FG002|COMPLETED|Control Period||9
10536884|NCT01447511|11689641|FG003|COMPLETED|Control Period||3
10536885|NCT01447511|11689642|FG004|COMPLETED|Control Period||4
10536886|NCT01447511|11689638|FG000|NOT COMPLETED|Control Period||0
10536887|NCT01447511|11689639|FG001|NOT COMPLETED|Control Period||0
10536888|NCT01447511|11689640|FG002|NOT COMPLETED|Control Period||0
10536889|NCT01447511|11689641|FG003|NOT COMPLETED|Control Period||0
10536890|NCT01447511|11689642|FG004|NOT COMPLETED|Control Period||0
10536891|NCT01447511|11689638|FG000|STARTED|Fluconazole Period||8
10536892|NCT01447511|11689639|FG001|STARTED|Fluconazole Period||0
10536893|NCT01447511|11689640|FG002|STARTED|Fluconazole Period||9
10536894|NCT01447511|11689641|FG003|STARTED|Fluconazole Period||3
10536895|NCT01447511|11689642|FG004|STARTED|Fluconazole Period||4
10536896|NCT01447511|11689638|FG000|COMPLETED|Fluconazole Period||8
10536897|NCT01447511|11689639|FG001|COMPLETED|Fluconazole Period||0
10536898|NCT01447511|11689640|FG002|COMPLETED|Fluconazole Period||8
10536899|NCT01447511|11689641|FG003|COMPLETED|Fluconazole Period||3
10536900|NCT01447511|11689642|FG004|COMPLETED|Fluconazole Period||4
10716682|NCT02691494|11880444|FG000|COMPLETED|Treatment Period|completed treatment period|72
10716683|NCT02691494|11880445|FG001|COMPLETED|Treatment Period|completed treatment period|69
10716684|NCT02691494|11880446|FG002|COMPLETED|Treatment Period|completed treatment period|148
10716685|NCT02691494|11880444|FG000|NOT COMPLETED|Treatment Period||22
10716686|NCT02691494|11880445|FG001|NOT COMPLETED|Treatment Period||26
10536901|NCT01447511|11689638|FG000|NOT COMPLETED|Fluconazole Period||0
10536902|NCT01447511|11689639|FG001|NOT COMPLETED|Fluconazole Period||0
10536903|NCT01447511|11689640|FG002|NOT COMPLETED|Fluconazole Period||1
10536904|NCT01447511|11689641|FG003|NOT COMPLETED|Fluconazole Period||0
10536905|NCT01447511|11689642|FG004|NOT COMPLETED|Fluconazole Period||0
10536906|NCT01447511|11689638|FG000|STARTED|Rifampin Period||8
10536907|NCT01447511|11689639|FG001|STARTED|Rifampin Period||5
10536908|NCT01447511|11689640|FG002|STARTED|Rifampin Period||8
10536909|NCT01447511|11689641|FG003|STARTED|Rifampin Period||3
10536910|NCT01447511|11689642|FG004|STARTED|Rifampin Period||4
10536911|NCT01447511|11689638|FG000|COMPLETED|Rifampin Period||8
10536912|NCT01447511|11689639|FG001|COMPLETED|Rifampin Period||5
10536913|NCT01447511|11689640|FG002|COMPLETED|Rifampin Period||8
10536914|NCT01447511|11689641|FG003|COMPLETED|Rifampin Period||2
10536915|NCT01447511|11689642|FG004|COMPLETED|Rifampin Period||4
10536916|NCT01447511|11689638|FG000|NOT COMPLETED|Rifampin Period||0
10536917|NCT01447511|11689639|FG001|NOT COMPLETED|Rifampin Period||0
10657037|NCT02222818|11818162|FG001|COMPLETED|Period 1|End of CAFRPlus evaluation period|30
10657038|NCT02222818|11818161|FG000|NOT COMPLETED|Period 1||0
10657039|NCT02222818|11818162|FG001|NOT COMPLETED|Period 1||3
10657040|NCT02222818|11818161|FG000|STARTED|Period 2|Start of CAFRPlus evaluation period|33
10657041|NCT02222818|11818162|FG001|STARTED|Period 2|Start of CAFR evaluation period|30
10657042|NCT02222818|11818161|FG000|COMPLETED|Period 2|End of CAFRPlus evaluation period|33
10657043|NCT02222818|11818162|FG001|COMPLETED|Period 2|End of CAFR evaluation period|30
10657044|NCT02222818|11818161|FG000|NOT COMPLETED|Period 2||0
10657045|NCT02222818|11818162|FG001|NOT COMPLETED|Period 2||0
10657046|NCT02222870|11818169|FG000|STARTED|Overall Study||30
10657047|NCT02222870|11818170|FG001|STARTED|Overall Study||30
10657048|NCT02222870|11818169|FG000|COMPLETED|Overall Study||30
10657049|NCT02222870|11818170|FG001|COMPLETED|Overall Study||30
10657050|NCT02222870|11818169|FG000|NOT COMPLETED|Overall Study||0
10657051|NCT02222870|11818170|FG001|NOT COMPLETED|Overall Study||0
10657052|NCT02222896|11818176|FG000|STARTED|Abdomen||253
10657053|NCT02222896|11818177|FG001|STARTED|Abdomen||48
10657054|NCT02222896|11818178|FG002|STARTED|Abdomen||253
10657055|NCT02222896|11818176|FG000|COMPLETED|Abdomen||219
10657056|NCT02222896|11818177|FG001|COMPLETED|Abdomen||38
10657057|NCT02222896|11818178|FG002|COMPLETED|Abdomen||221
10657058|NCT02222896|11818176|FG000|NOT COMPLETED|Abdomen||34
10657059|NCT02222896|11818177|FG001|NOT COMPLETED|Abdomen||10
10657060|NCT02222896|11818178|FG002|NOT COMPLETED|Abdomen||32
10657061|NCT02222896|11818176|FG000|STARTED|Groin||254
10657062|NCT02222896|11818177|FG001|STARTED|Groin||48
10657063|NCT02222896|11818178|FG002|STARTED|Groin||250
10657064|NCT02222896|11818176|FG000|COMPLETED|Groin||211
10657065|NCT02222896|11818177|FG001|COMPLETED|Groin||39
10657066|NCT02222896|11818178|FG002|COMPLETED|Groin||210
10657067|NCT02222896|11818176|FG000|NOT COMPLETED|Groin||43
10657068|NCT02222896|11818177|FG001|NOT COMPLETED|Groin||9
10657069|NCT02222896|11818178|FG002|NOT COMPLETED|Groin||40
10368468|NCT00542880|11509016|FG000|NOT COMPLETED|Period 2||7
10657070|NCT02222922|11818198|FG000|STARTED|Overall Study||2
10716687|NCT02691494|11880446|FG002|NOT COMPLETED|Treatment Period||41
10716688|NCT02691494|11880444|FG000|STARTED|Post-Treatment Follow-Up Period||14
10368469|NCT00542880|11509017|FG001|NOT COMPLETED|Period 2||10
10657071|NCT02222922|11818199|FG001|STARTED|Overall Study||2
10657072|NCT02222922|11818200|FG002|STARTED|Overall Study||2
10657073|NCT02222922|11818201|FG003|STARTED|Overall Study||5
10657074|NCT02222922|11818202|FG004|STARTED|Overall Study||96
10657075|NCT02222922|11818203|FG005|STARTED|Overall Study||6
10368470|NCT00542880|11509016|FG000|STARTED|Period 3||204
10368471|NCT00542880|11509017|FG001|STARTED|Period 3||203
10368472|NCT00542880|11509016|FG000|COMPLETED|Period 3||204
10368473|NCT00542880|11509017|FG001|COMPLETED|Period 3||201
10368474|NCT00542880|11509016|FG000|NOT COMPLETED|Period 3||0
10368475|NCT00542880|11509017|FG001|NOT COMPLETED|Period 3||2
10368476|NCT00542919|11509027|FG000|STARTED|Overall Study||23
10368477|NCT00542919|11509028|FG001|STARTED|Overall Study||19
10368478|NCT00542919|11509029|FG002|STARTED|Overall Study||15
10368479|NCT00542919|11509027|FG000|Received At Least One Dose of Study Drug|Overall Study||23
10368480|NCT00542919|11509028|FG001|Received At Least One Dose of Study Drug|Overall Study||19
10368481|NCT00542919|11509029|FG002|Received At Least One Dose of Study Drug|Overall Study||15
10368482|NCT00542919|11509027|FG000|Progressive Disease|Overall Study||15
10368483|NCT00542919|11509028|FG001|Progressive Disease|Overall Study||11
10368484|NCT00542919|11509029|FG002|Progressive Disease|Overall Study||7
10368485|NCT00542919|11509027|FG000|Death|Overall Study||1
10368486|NCT00542919|11509028|FG001|Death|Overall Study||1
10368487|NCT00542919|11509029|FG002|Death|Overall Study||2
10368488|NCT00542919|11509027|FG000|COMPLETED|Overall Study||16
10368489|NCT00542919|11509028|FG001|COMPLETED|Overall Study||12
10368490|NCT00542919|11509029|FG002|COMPLETED|Overall Study||9
10368491|NCT00542919|11509027|FG000|NOT COMPLETED|Overall Study||7
10368492|NCT00542919|11509028|FG001|NOT COMPLETED|Overall Study||7
10368493|NCT00542919|11509029|FG002|NOT COMPLETED|Overall Study||6
10368494|NCT00542971|11509052|FG000|STARTED|Overall Study||75
10368495|NCT00542971|11509052|FG000|COMPLETED|Overall Study||75
10368496|NCT00542971|11509052|FG000|NOT COMPLETED|Overall Study||0
10368497|NCT00542997|11509056|FG000|STARTED|Wash in / Wash Out Period||51
10368498|NCT00542997|11509056|FG000|COMPLETED|Wash in / Wash Out Period||46
10368499|NCT00542997|11509056|FG000|NOT COMPLETED|Wash in / Wash Out Period||5
10368500|NCT00542997|11509056|FG000|STARTED|Efficacy Period||46
10368501|NCT00542997|11509056|FG000|COMPLETED|Efficacy Period||43
10368502|NCT00542997|11509056|FG000|NOT COMPLETED|Efficacy Period||3
10368503|NCT00543062|11509063|FG000|STARTED|Overall Study||12
10368504|NCT00543062|11509064|FG001|STARTED|Overall Study||12
10368505|NCT00543062|11509065|FG002|STARTED|Overall Study||12
10368506|NCT00543062|11509066|FG003|STARTED|Overall Study||12
10368507|NCT00543062|11509063|FG000|COMPLETED|Overall Study||10
10368508|NCT00543062|11509064|FG001|COMPLETED|Overall Study||11
10368509|NCT00543062|11509065|FG002|COMPLETED|Overall Study||9
10368510|NCT00543062|11509066|FG003|COMPLETED|Overall Study||11
10368511|NCT00543062|11509063|FG000|NOT COMPLETED|Overall Study||2
10368512|NCT00543062|11509064|FG001|NOT COMPLETED|Overall Study||1
10368513|NCT00543062|11509065|FG002|NOT COMPLETED|Overall Study||3
10368514|NCT00543062|11509066|FG003|NOT COMPLETED|Overall Study||1
10368515|NCT00543101|11509086|FG000|STARTED|Overall Study||12
10368516|NCT00543101|11509087|FG001|STARTED|Overall Study||12
10368517|NCT00543101|11509086|FG000|COMPLETED|Overall Study||12
10368518|NCT00543101|11509087|FG001|COMPLETED|Overall Study||12
10368519|NCT00543101|11509086|FG000|NOT COMPLETED|Overall Study||0
10368520|NCT00543101|11509087|FG001|NOT COMPLETED|Overall Study||0
10368521|NCT00543127|11509096|FG000|STARTED|Overall Study||433
10368522|NCT00543127|11509097|FG001|STARTED|Overall Study||437
10368523|NCT00543127|11509096|FG000|COMPLETED|Overall Study||303
10368524|NCT00543127|11509097|FG001|COMPLETED|Overall Study||350
10368525|NCT00543127|11509096|FG000|NOT COMPLETED|Overall Study||130
10368526|NCT00543127|11509097|FG001|NOT COMPLETED|Overall Study||87
10368527|NCT00543140|11509103|FG000|STARTED|Overall Study||303
10368528|NCT00543140|11509103|FG000|COMPLETED|Overall Study||231
10368529|NCT00543140|11509103|FG000|NOT COMPLETED|Overall Study||72
10368530|NCT00543296|11509107|FG000|STARTED|Overall Study||21
10368531|NCT00543296|11509107|FG000|COMPLETED|Overall Study||14
10368532|NCT00543296|11509107|FG000|NOT COMPLETED|Overall Study||7
10368533|NCT00543309|11509114|FG000|STARTED|Overall Study||35
10368534|NCT00543309|11509115|FG001|STARTED|Overall Study||36
10368535|NCT00543309|11509116|FG002|STARTED|Overall Study||35
10368536|NCT00543309|11509114|FG000|COMPLETED|Overall Study||35
10368537|NCT00543309|11509115|FG001|COMPLETED|Overall Study||35
10368538|NCT00543309|11509116|FG002|COMPLETED|Overall Study||35
10368539|NCT00543309|11509114|FG000|NOT COMPLETED|Overall Study||0
10368540|NCT00543309|11509115|FG001|NOT COMPLETED|Overall Study||1
10368541|NCT00543309|11509116|FG002|NOT COMPLETED|Overall Study||0
10368542|NCT00543387|11509134|FG000|STARTED|Panel 1 + Panel 2||3
10368543|NCT00543387|11509135|FG001|STARTED|Panel 1 + Panel 2||3
10368544|NCT00543387|11509136|FG002|STARTED|Panel 1 + Panel 2||3
10368545|NCT00543387|11509137|FG003|STARTED|Panel 1 + Panel 2||3
10536918|NCT01447511|11689640|FG002|NOT COMPLETED|Rifampin Period||0
10368546|NCT00543387|11509138|FG004|STARTED|Panel 1 + Panel 2||3
10368547|NCT00543387|11509139|FG005|STARTED|Panel 1 + Panel 2||3
10368548|NCT00543387|11509140|FG006|STARTED|Panel 1 + Panel 2||6
10368549|NCT00543387|11509141|FG007|STARTED|Panel 1 + Panel 2||6
10368550|NCT00543387|11509142|FG008|STARTED|Panel 1 + Panel 2||5
10368551|NCT00543387|11509143|FG009|STARTED|Panel 1 + Panel 2||0
10368552|NCT00543387|11509144|FG010|STARTED|Panel 1 + Panel 2||0
10368553|NCT00543387|11509134|FG000|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
10368554|NCT00543387|11509135|FG001|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||1
10368555|NCT00543387|11509136|FG002|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
10368556|NCT00543387|11509137|FG003|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
10368557|NCT00543387|11509138|FG004|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||2
10368558|NCT00543387|11509139|FG005|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||1
10368559|NCT00543387|11509140|FG006|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
10368560|NCT00543387|11509141|FG007|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
10536919|NCT01447511|11689641|FG003|NOT COMPLETED|Rifampin Period||1
10536920|NCT01447511|11689642|FG004|NOT COMPLETED|Rifampin Period||0
10536921|NCT01447576|11689654|FG000|STARTED|Overall Study||1036
10536922|NCT01447576|11689654|FG000|COMPLETED|Overall Study||560
10536923|NCT01447576|11689654|FG000|NOT COMPLETED|Overall Study||476
10536924|NCT01447706|11689660|FG000|STARTED|Overall Study||140
10536925|NCT01447706|11689661|FG001|STARTED|Overall Study|3 patients enrolled but not dosed|83
10536926|NCT01447706|11689660|FG000|COMPLETED|Overall Study||140
10536927|NCT01447706|11689661|FG001|COMPLETED|Overall Study||80
10536928|NCT01447706|11689660|FG000|NOT COMPLETED|Overall Study||0
10536929|NCT01447706|11689661|FG001|NOT COMPLETED|Overall Study||3
10536930|NCT01447719|11689671|FG000|STARTED|Overall Study||152
10536931|NCT01447719|11689671|FG000|Valid AV-45 Scan Acquired|Overall Study||147
10536932|NCT01447719|11689671|FG000|Deceased <2 Years After AV-45 Scan|Overall Study||66
10536933|NCT01447719|11689671|FG000|COMPLETED|Overall Study||59
10536934|NCT01447719|11689671|FG000|NOT COMPLETED|Overall Study||93
10536935|NCT01447849|11689684|FG000|STARTED|First Intervention||10
10536936|NCT01447849|11689685|FG001|STARTED|First Intervention||10
10536937|NCT01447849|11689686|FG002|STARTED|First Intervention||10
10536938|NCT01447849|11689687|FG003|STARTED|First Intervention||10
10536939|NCT01447849|11689684|FG000|COMPLETED|First Intervention||10
10536940|NCT01447849|11689685|FG001|COMPLETED|First Intervention||10
10536941|NCT01447849|11689686|FG002|COMPLETED|First Intervention||10
10536942|NCT01447849|11689687|FG003|COMPLETED|First Intervention||10
10536943|NCT01447849|11689684|FG000|NOT COMPLETED|First Intervention||0
10536944|NCT01447849|11689685|FG001|NOT COMPLETED|First Intervention||0
10536945|NCT01447849|11689686|FG002|NOT COMPLETED|First Intervention||0
10536946|NCT01447849|11689687|FG003|NOT COMPLETED|First Intervention||0
10536947|NCT01447849|11689684|FG000|STARTED|Washout Period for 1 Week||10
10536948|NCT01447849|11689685|FG001|STARTED|Washout Period for 1 Week||10
10536949|NCT01447849|11689686|FG002|STARTED|Washout Period for 1 Week||10
10536950|NCT01447849|11689687|FG003|STARTED|Washout Period for 1 Week||10
10536951|NCT01447849|11689684|FG000|COMPLETED|Washout Period for 1 Week||10
10536952|NCT01447849|11689685|FG001|COMPLETED|Washout Period for 1 Week||10
10536953|NCT01447849|11689686|FG002|COMPLETED|Washout Period for 1 Week||10
10536954|NCT01447849|11689687|FG003|COMPLETED|Washout Period for 1 Week||10
10536955|NCT01447849|11689684|FG000|NOT COMPLETED|Washout Period for 1 Week||0
10536956|NCT01447849|11689685|FG001|NOT COMPLETED|Washout Period for 1 Week||0
10536957|NCT01447849|11689686|FG002|NOT COMPLETED|Washout Period for 1 Week||0
10536958|NCT01447849|11689687|FG003|NOT COMPLETED|Washout Period for 1 Week||0
10716689|NCT02691494|11880445|FG001|STARTED|Post-Treatment Follow-Up Period||25
10536959|NCT01447849|11689684|FG000|STARTED|Second Intervention||10
10536960|NCT01447849|11689685|FG001|STARTED|Second Intervention||10
10536961|NCT01447849|11689686|FG002|STARTED|Second Intervention||10
10536962|NCT01447849|11689687|FG003|STARTED|Second Intervention||10
10536963|NCT01447849|11689684|FG000|COMPLETED|Second Intervention||10
10536964|NCT01447849|11689685|FG001|COMPLETED|Second Intervention||10
10536965|NCT01447849|11689686|FG002|COMPLETED|Second Intervention||10
10536966|NCT01447849|11689687|FG003|COMPLETED|Second Intervention||10
10536967|NCT01447849|11689684|FG000|NOT COMPLETED|Second Intervention||0
10536968|NCT01447849|11689685|FG001|NOT COMPLETED|Second Intervention||0
10536969|NCT01447849|11689686|FG002|NOT COMPLETED|Second Intervention||0
10536970|NCT01447849|11689687|FG003|NOT COMPLETED|Second Intervention||0
10536971|NCT01447888|11689699|FG000|STARTED|Overall Study||45
10536972|NCT01447888|11689700|FG001|STARTED|Overall Study||55
10536973|NCT01447888|11689699|FG000|COMPLETED|Overall Study||45
10536974|NCT01447888|11689700|FG001|COMPLETED|Overall Study||55
10536975|NCT01447888|11689699|FG000|NOT COMPLETED|Overall Study||0
10536976|NCT01447888|11689700|FG001|NOT COMPLETED|Overall Study||0
10536977|NCT01447914|11689706|FG000|STARTED|Overall Study||16
10536978|NCT01447914|11689706|FG000|COMPLETED|Overall Study||16
10368561|NCT00543387|11509142|FG008|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
10536979|NCT01447914|11689706|FG000|NOT COMPLETED|Overall Study||0
10536980|NCT01447927|11689712|FG000|STARTED|Overall Study||38
10536981|NCT01447927|11689713|FG001|STARTED|Overall Study||36
10536982|NCT01447927|11689712|FG000|COMPLETED|Overall Study||33
10536983|NCT01447927|11689713|FG001|COMPLETED|Overall Study||33
10536984|NCT01447927|11689712|FG000|NOT COMPLETED|Overall Study||5
10536985|NCT01447927|11689713|FG001|NOT COMPLETED|Overall Study||3
10536986|NCT01448044|11689721|FG000|STARTED|Treatment Period||82
10536987|NCT01448044|11689722|FG001|STARTED|Treatment Period||42
10536988|NCT01448044|11689721|FG000|COMPLETED|Treatment Period||59
10536989|NCT01448044|11689722|FG001|COMPLETED|Treatment Period||26
10536990|NCT01448044|11689721|FG000|NOT COMPLETED|Treatment Period||23
10536991|NCT01448044|11689722|FG001|NOT COMPLETED|Treatment Period||16
10548058|NCT01516957|11701862|FG001|COMPLETED|Placebo-controlled Phase||53
10536992|NCT01448044|11689721|FG000|STARTED|Follow Up Period|Out of 82 participants who entered the treatment period, 77 continued in the follow-up period.|77
10536993|NCT01448044|11689722|FG001|STARTED|Follow Up Period|Out of 42 participants who entered the treatment period, 40 continued in the follow-up period.|40
10536994|NCT01448044|11689721|FG000|COMPLETED|Follow Up Period||65
10536995|NCT01448044|11689722|FG001|COMPLETED|Follow Up Period||26
10657076|NCT02222922|11818204|FG006|STARTED|Overall Study||3
10657077|NCT02222922|11818205|FG007|STARTED|Overall Study||10
10657078|NCT02222922|11818206|FG008|STARTED|Overall Study||12
10657079|NCT02222922|11818198|FG000|Received Treatment|Overall Study||2
10716690|NCT02691494|11880446|FG002|STARTED|Post-Treatment Follow-Up Period||59
10716691|NCT02691494|11880444|FG000|COMPLETED|Post-Treatment Follow-Up Period||9
10657080|NCT02222922|11818199|FG001|Received Treatment|Overall Study||2
10657081|NCT02222922|11818200|FG002|Received Treatment|Overall Study||2
10657082|NCT02222922|11818201|FG003|Received Treatment|Overall Study||4
10657083|NCT02222922|11818202|FG004|Received Treatment|Overall Study||96
10657084|NCT02222922|11818203|FG005|Received Treatment|Overall Study||6
10657085|NCT02222922|11818204|FG006|Received Treatment|Overall Study||3
10657086|NCT02222922|11818205|FG007|Received Treatment|Overall Study||10
10657087|NCT02222922|11818206|FG008|Received Treatment|Overall Study||12
10716692|NCT02691494|11880445|FG001|COMPLETED|Post-Treatment Follow-Up Period||18
10716693|NCT02691494|11880446|FG002|COMPLETED|Post-Treatment Follow-Up Period||42
10716694|NCT02691494|11880444|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||5
10306058|NCT00096785|11439050|FG001|COMPLETED|Overall Study|As randomized cohort|33
10306059|NCT00096785|11439049|FG000|NOT COMPLETED|Overall Study||2
10306060|NCT00096785|11439050|FG001|NOT COMPLETED|Overall Study||1
10306061|NCT00096941|11439056|FG000|STARTED|Overall Study||3
10306062|NCT00096941|11439056|FG000|COMPLETED|Overall Study||0
10306063|NCT00096941|11439056|FG000|NOT COMPLETED|Overall Study||3
10306064|NCT00096954|11439062|FG000|STARTED|Overall Study||159
10306065|NCT00096954|11439063|FG001|STARTED|Overall Study||174
10306066|NCT00096954|11439062|FG000|Received Study Drug|Overall Study||157
10306067|NCT00096954|11439063|FG001|Received Study Drug|Overall Study||171
10306068|NCT00096954|11439062|FG000|COMPLETED|Overall Study||135
10306069|NCT00096954|11439063|FG001|COMPLETED|Overall Study||154
10306070|NCT00096954|11439062|FG000|NOT COMPLETED|Overall Study||24
10306071|NCT00096954|11439063|FG001|NOT COMPLETED|Overall Study||20
10306072|NCT00096993|11439071|FG000|STARTED|Overall Study||66
10306073|NCT00096993|11439072|FG001|STARTED|Overall Study||65
10306074|NCT00096993|11439071|FG000|COMPLETED|Overall Study||1
10306075|NCT00096993|11439072|FG001|COMPLETED|Overall Study||0
10306076|NCT00096993|11439071|FG000|NOT COMPLETED|Overall Study||65
10306077|NCT00096993|11439072|FG001|NOT COMPLETED|Overall Study||65
10306078|NCT00097253|11439078|FG000|STARTED|Lavender||56
10306079|NCT00097253|11439078|FG000|COMPLETED|Lavender||56
10306080|NCT00097253|11439078|FG000|NOT COMPLETED|Lavender||0
10306081|NCT00097253|11439078|FG000|STARTED|Lemon||56
10306082|NCT00097253|11439078|FG000|COMPLETED|Lemon||56
10306083|NCT00097253|11439078|FG000|NOT COMPLETED|Lemon||0
10306084|NCT00097253|11439078|FG000|STARTED|Water (Control)||56
10306085|NCT00097253|11439078|FG000|COMPLETED|Water (Control)||56
10306086|NCT00097253|11439078|FG000|NOT COMPLETED|Water (Control)||0
10306087|NCT00097370|11439086|FG000|STARTED|Stage 1|Participants entered from study MHE100185.|37
10306088|NCT00097370|11439086|FG000|COMPLETED|Stage 1||31
10306089|NCT00097370|11439086|FG000|NOT COMPLETED|Stage 1||6
10306090|NCT00097370|11439086|FG000|STARTED|Stage 2|41 participants entered from study MHE100185 and 31 participants continued from Stage 1.|72
10306091|NCT00097370|11439086|FG000|COMPLETED|Stage 2||59
10306092|NCT00097370|11439086|FG000|NOT COMPLETED|Stage 2||13
10306093|NCT00097370|11439086|FG000|STARTED|Stage 3|Participants continued from Stage 2.|59
10306094|NCT00097370|11439086|FG000|COMPLETED|Stage 3||0
10306095|NCT00097370|11439086|FG000|NOT COMPLETED|Stage 3||59
10306096|NCT00097448|11439092|FG000|STARTED|Overall Study||125
10306097|NCT00097448|11439093|FG001|STARTED|Overall Study||130
10306098|NCT00097448|11439092|FG000|COMPLETED|Overall Study||121
10306099|NCT00097448|11439093|FG001|COMPLETED|Overall Study||129
10306100|NCT00097448|11439092|FG000|NOT COMPLETED|Overall Study||4
10306101|NCT00097448|11439093|FG001|NOT COMPLETED|Overall Study||1
10306102|NCT00097500|11439101|FG000|STARTED|On-drug Period (Week 0 to Week 52)||36
10306103|NCT00097500|11439102|FG001|STARTED|On-drug Period (Week 0 to Week 52)||33
10306104|NCT00097500|11439101|FG000|COMPLETED|On-drug Period (Week 0 to Week 52)|Subjects experiencing loss of glucose control after Week 52 are considered to have completed study.|30
10306105|NCT00097500|11439102|FG001|COMPLETED|On-drug Period (Week 0 to Week 52)|Subjects experiencing loss of glucose control after Week 52 are considered to have completed study.|30
10306106|NCT00097500|11439101|FG000|NOT COMPLETED|On-drug Period (Week 0 to Week 52)||6
10306107|NCT00097500|11439102|FG001|NOT COMPLETED|On-drug Period (Week 0 to Week 52)||3
10306108|NCT00097500|11439101|FG000|STARTED|Off-drug Period (Week 52 to Week 64)|Exenatide is discontinued, metformin is continued|30
10306109|NCT00097500|11439102|FG001|STARTED|Off-drug Period (Week 52 to Week 64)|Insulin Glargine is discontinued, metformin is continued|30
10306110|NCT00097500|11439101|FG000|COMPLETED|Off-drug Period (Week 52 to Week 64)||25
10306111|NCT00097500|11439102|FG001|COMPLETED|Off-drug Period (Week 52 to Week 64)||26
10657088|NCT02222922|11818198|FG000|COMPLETED|Overall Study||1
10657089|NCT02222922|11818199|FG001|COMPLETED|Overall Study||2
10657090|NCT02222922|11818200|FG002|COMPLETED|Overall Study||1
10368592|NCT00543387|11509140|FG006|STARTED|Crossover Participants||0
10368562|NCT00543387|11509143|FG009|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
10368563|NCT00543387|11509144|FG010|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
10368564|NCT00543387|11509134|FG000|COMPLETED|Panel 1 + Panel 2||0
10368565|NCT00543387|11509135|FG001|COMPLETED|Panel 1 + Panel 2||0
10368566|NCT00543387|11509136|FG002|COMPLETED|Panel 1 + Panel 2||0
10368567|NCT00543387|11509137|FG003|COMPLETED|Panel 1 + Panel 2||0
10368568|NCT00543387|11509138|FG004|COMPLETED|Panel 1 + Panel 2||0
10368569|NCT00543387|11509139|FG005|COMPLETED|Panel 1 + Panel 2||0
10368570|NCT00543387|11509140|FG006|COMPLETED|Panel 1 + Panel 2||0
10368571|NCT00543387|11509141|FG007|COMPLETED|Panel 1 + Panel 2||0
10368572|NCT00543387|11509142|FG008|COMPLETED|Panel 1 + Panel 2||0
10368573|NCT00543387|11509143|FG009|COMPLETED|Panel 1 + Panel 2||0
10368574|NCT00543387|11509144|FG010|COMPLETED|Panel 1 + Panel 2||0
10368575|NCT00543387|11509134|FG000|NOT COMPLETED|Panel 1 + Panel 2||3
10368576|NCT00543387|11509135|FG001|NOT COMPLETED|Panel 1 + Panel 2||3
10368577|NCT00543387|11509136|FG002|NOT COMPLETED|Panel 1 + Panel 2||3
10368578|NCT00543387|11509137|FG003|NOT COMPLETED|Panel 1 + Panel 2||3
10368579|NCT00543387|11509138|FG004|NOT COMPLETED|Panel 1 + Panel 2||3
10368580|NCT00543387|11509139|FG005|NOT COMPLETED|Panel 1 + Panel 2||3
10368581|NCT00543387|11509140|FG006|NOT COMPLETED|Panel 1 + Panel 2||6
10368582|NCT00543387|11509141|FG007|NOT COMPLETED|Panel 1 + Panel 2||6
10368583|NCT00543387|11509142|FG008|NOT COMPLETED|Panel 1 + Panel 2||5
10368584|NCT00543387|11509143|FG009|NOT COMPLETED|Panel 1 + Panel 2||0
10368585|NCT00543387|11509144|FG010|NOT COMPLETED|Panel 1 + Panel 2||0
10368586|NCT00543387|11509134|FG000|STARTED|Crossover Participants||0
10536996|NCT01448044|11689721|FG000|NOT COMPLETED|Follow Up Period||12
10536997|NCT01448044|11689722|FG001|NOT COMPLETED|Follow Up Period||14
10536998|NCT01448057|11689730|FG000|STARTED|Overall Study||170
10536999|NCT01448057|11689731|FG001|STARTED|Overall Study||171
10537000|NCT01448057|11689730|FG000|COMPLETED|Overall Study||162
10537001|NCT01448057|11689731|FG001|COMPLETED|Overall Study||167
10537002|NCT01448057|11689730|FG000|NOT COMPLETED|Overall Study||8
10537003|NCT01448057|11689731|FG001|NOT COMPLETED|Overall Study||4
10537004|NCT01448213|11689739|FG000|STARTED|Overall Study||130
10537005|NCT01448213|11689740|FG001|STARTED|Overall Study||134
10537006|NCT01448213|11689739|FG000|COMPLETED|Overall Study||113
10537007|NCT01448213|11689740|FG001|COMPLETED|Overall Study||112
10537008|NCT01448213|11689739|FG000|NOT COMPLETED|Overall Study||17
10537009|NCT01448213|11689740|FG001|NOT COMPLETED|Overall Study||22
10537010|NCT01448356|11689746|FG000|STARTED|Overall Study||10
10537011|NCT01448356|11689746|FG000|COMPLETED|Overall Study|cross-over|10
10537012|NCT01448356|11689746|FG000|NOT COMPLETED|Overall Study||0
10537013|NCT01448421|11689751|FG000|STARTED|Overall Study||37
10537014|NCT01448421|11689751|FG000|COMPLETED|Overall Study||37
10537015|NCT01448421|11689751|FG000|NOT COMPLETED|Overall Study||0
10537016|NCT01448447|11689757|FG000|STARTED|Overall Study||20
10537017|NCT01448447|11689758|FG001|STARTED|Overall Study||0
10537018|NCT01448447|11689757|FG000|COMPLETED|Overall Study||20
10537019|NCT01448447|11689758|FG001|COMPLETED|Overall Study||0
10537020|NCT01448447|11689757|FG000|NOT COMPLETED|Overall Study||0
10537021|NCT01448447|11689758|FG001|NOT COMPLETED|Overall Study||0
10537022|NCT01448486|11689766|FG000|STARTED|Overall Study||3
10537023|NCT01448486|11689767|FG001|STARTED|Overall Study||3
10537024|NCT01448486|11689766|FG000|COMPLETED|Overall Study||3
10537025|NCT01448486|11689767|FG001|COMPLETED|Overall Study||3
10537026|NCT01448486|11689766|FG000|NOT COMPLETED|Overall Study||0
10537027|NCT01448486|11689767|FG001|NOT COMPLETED|Overall Study||0
10537028|NCT01448525|11689775|FG000|STARTED|Overall Study||44
10537029|NCT01448525|11689776|FG001|STARTED|Overall Study||44
10537030|NCT01448525|11689775|FG000|COMPLETED|Overall Study||43
10537031|NCT01448525|11689776|FG001|COMPLETED|Overall Study||42
10537032|NCT01448525|11689775|FG000|NOT COMPLETED|Overall Study||1
10537033|NCT01448525|11689776|FG001|NOT COMPLETED|Overall Study||2
10537034|NCT01448616|11689785|FG000|STARTED|Lead-In (Observational Phase)||73
10537035|NCT01448616|11689786|FG001|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
10537036|NCT01448616|11689787|FG002|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
10537037|NCT01448616|11689788|FG003|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
10657091|NCT02222922|11818201|FG003|COMPLETED|Overall Study||2
10657092|NCT02222922|11818202|FG004|COMPLETED|Overall Study||58
10657093|NCT02222922|11818203|FG005|COMPLETED|Overall Study||3
10657094|NCT02222922|11818204|FG006|COMPLETED|Overall Study||1
10657095|NCT02222922|11818205|FG007|COMPLETED|Overall Study||6
10657096|NCT02222922|11818206|FG008|COMPLETED|Overall Study||6
10657097|NCT02222922|11818198|FG000|NOT COMPLETED|Overall Study||1
10657098|NCT02222922|11818199|FG001|NOT COMPLETED|Overall Study||0
10657099|NCT02222922|11818200|FG002|NOT COMPLETED|Overall Study||1
10657100|NCT02222922|11818201|FG003|NOT COMPLETED|Overall Study||3
10657101|NCT02222922|11818202|FG004|NOT COMPLETED|Overall Study||38
10657102|NCT02222922|11818203|FG005|NOT COMPLETED|Overall Study||3
10657103|NCT02222922|11818204|FG006|NOT COMPLETED|Overall Study||2
10657104|NCT02222922|11818205|FG007|NOT COMPLETED|Overall Study||4
10657105|NCT02222922|11818206|FG008|NOT COMPLETED|Overall Study||6
10657106|NCT02223065|11818242|FG000|STARTED|Overall Study||18
10368587|NCT00543387|11509135|FG001|STARTED|Crossover Participants||0
10368588|NCT00543387|11509136|FG002|STARTED|Crossover Participants||0
10368589|NCT00543387|11509137|FG003|STARTED|Crossover Participants||0
10368590|NCT00543387|11509138|FG004|STARTED|Crossover Participants||0
10368591|NCT00543387|11509139|FG005|STARTED|Crossover Participants||0
10368593|NCT00543387|11509141|FG007|STARTED|Crossover Participants||0
10368594|NCT00543387|11509142|FG008|STARTED|Crossover Participants||0
10368595|NCT00543387|11509143|FG009|STARTED|Crossover Participants|Participant originally treated in MK-5108 400 mg BID (Panel 1) in Period 1|1
10368596|NCT00543387|11509144|FG010|STARTED|Crossover Participants|3 participants originally treated with 1500 (2) and 1800 mg (1) MK-5108 in Panel 1 Period 1|3
10368597|NCT00543387|11509134|FG000|COMPLETED|Crossover Participants||0
10368598|NCT00543387|11509135|FG001|COMPLETED|Crossover Participants||0
10368599|NCT00543387|11509136|FG002|COMPLETED|Crossover Participants||0
10368600|NCT00543387|11509137|FG003|COMPLETED|Crossover Participants||0
10368601|NCT00543387|11509138|FG004|COMPLETED|Crossover Participants||0
10368602|NCT00543387|11509139|FG005|COMPLETED|Crossover Participants||0
10368603|NCT00543387|11509140|FG006|COMPLETED|Crossover Participants||0
10368604|NCT00543387|11509141|FG007|COMPLETED|Crossover Participants||0
10368605|NCT00543387|11509142|FG008|COMPLETED|Crossover Participants||0
10368606|NCT00543387|11509143|FG009|COMPLETED|Crossover Participants||0
10368607|NCT00543387|11509144|FG010|COMPLETED|Crossover Participants||0
10368608|NCT00543387|11509134|FG000|NOT COMPLETED|Crossover Participants||0
10368609|NCT00543387|11509135|FG001|NOT COMPLETED|Crossover Participants||0
10368610|NCT00543387|11509136|FG002|NOT COMPLETED|Crossover Participants||0
10368611|NCT00543387|11509137|FG003|NOT COMPLETED|Crossover Participants||0
10368612|NCT00543387|11509138|FG004|NOT COMPLETED|Crossover Participants||0
10368613|NCT00543387|11509139|FG005|NOT COMPLETED|Crossover Participants||0
10368614|NCT00543387|11509140|FG006|NOT COMPLETED|Crossover Participants||0
10368615|NCT00543387|11509141|FG007|NOT COMPLETED|Crossover Participants||0
10368616|NCT00543387|11509142|FG008|NOT COMPLETED|Crossover Participants||0
10368617|NCT00543387|11509143|FG009|NOT COMPLETED|Crossover Participants||1
10368618|NCT00543387|11509144|FG010|NOT COMPLETED|Crossover Participants||3
10368619|NCT00543400|11509172|FG000|STARTED|Overall Study||151
10368620|NCT00543400|11509173|FG001|STARTED|Overall Study||44
10368621|NCT00543400|11509174|FG002|STARTED|Overall Study||152
10368622|NCT00543400|11509175|FG003|STARTED|Overall Study||156
10368623|NCT00543400|11509172|FG000|COMPLETED|Overall Study||146
10368624|NCT00543400|11509173|FG001|COMPLETED|Overall Study||43
10368625|NCT00543400|11509174|FG002|COMPLETED|Overall Study||148
10368626|NCT00543400|11509175|FG003|COMPLETED|Overall Study||151
10368627|NCT00543400|11509172|FG000|NOT COMPLETED|Overall Study||5
10368628|NCT00543400|11509173|FG001|NOT COMPLETED|Overall Study||1
10368629|NCT00543400|11509174|FG002|NOT COMPLETED|Overall Study||4
10368630|NCT00543400|11509175|FG003|NOT COMPLETED|Overall Study||5
10368631|NCT00543439|11509188|FG000|STARTED|Period 1||10
10368632|NCT00543439|11509189|FG001|STARTED|Period 1||29
10368633|NCT00543439|11509190|FG002|STARTED|Period 1||27
10368634|NCT00543439|11509188|FG000|Treated|Period 1||9
10368635|NCT00543439|11509189|FG001|Treated|Period 1||29
10368636|NCT00543439|11509190|FG002|Treated|Period 1||27
10368637|NCT00543439|11509188|FG000|COMPLETED|Period 1||9
10368638|NCT00543439|11509189|FG001|COMPLETED|Period 1||26
10368639|NCT00543439|11509190|FG002|COMPLETED|Period 1||25
10368640|NCT00543439|11509188|FG000|NOT COMPLETED|Period 1||1
10368641|NCT00543439|11509189|FG001|NOT COMPLETED|Period 1||3
10368642|NCT00543439|11509190|FG002|NOT COMPLETED|Period 1||2
10368643|NCT00543439|11509188|FG000|STARTED|Period 2||9
10368644|NCT00543439|11509189|FG001|STARTED|Period 2||26
10368645|NCT00543439|11509190|FG002|STARTED|Period 2||25
10368646|NCT00543439|11509188|FG000|COMPLETED|Period 2||8
10368647|NCT00543439|11509189|FG001|COMPLETED|Period 2||25
10368648|NCT00543439|11509190|FG002|COMPLETED|Period 2||23
10368649|NCT00543439|11509188|FG000|NOT COMPLETED|Period 2||1
10368650|NCT00543439|11509189|FG001|NOT COMPLETED|Period 2||1
10368651|NCT00543439|11509190|FG002|NOT COMPLETED|Period 2||2
10368652|NCT00543543|11509211|FG000|STARTED|Base Study||315
10368653|NCT00543543|11509212|FG001|STARTED|Base Study||7106
10368654|NCT00543543|11509213|FG002|STARTED|Base Study||310
10368655|NCT00543543|11509214|FG003|STARTED|Base Study||7109
10368656|NCT00543543|11509211|FG000|Completed 3 Vaccinations|Base Study||300
10368657|NCT00543543|11509212|FG001|Completed 3 Vaccinations|Base Study||6928
10368658|NCT00543543|11509213|FG002|Completed 3 Vaccinations|Base Study||297
10368659|NCT00543543|11509214|FG003|Completed 3 Vaccinations|Base Study||6934
10368660|NCT00543543|11509211|FG000|COMPLETED|Base Study|Follow-up was up to 7 months|295
10368661|NCT00543543|11509212|FG001|COMPLETED|Base Study|Follow-up was up to 54 months|5854
10368662|NCT00543543|11509213|FG002|COMPLETED|Base Study|Follow-up was up to 7 months|296
10368663|NCT00543543|11509214|FG003|COMPLETED|Base Study|Follow-up was up to 54 months|5887
10368664|NCT00543543|11509211|FG000|NOT COMPLETED|Base Study||20
10368665|NCT00543543|11509212|FG001|NOT COMPLETED|Base Study||1252
10368666|NCT00543543|11509213|FG002|NOT COMPLETED|Base Study||14
10368667|NCT00543543|11509214|FG003|NOT COMPLETED|Base Study||1222
10368668|NCT00543543|11509211|FG000|STARTED|Extension Study|This group did not participate in the Extension Study|0
10368669|NCT00543543|11509212|FG001|STARTED|Extension Study|Cohort 1|150
10368670|NCT00543543|11509213|FG002|STARTED|Extension Study|This group did not participate in the Extension Study|0
10368671|NCT00543543|11509214|FG003|STARTED|Extension Study|Cohort 2|3050
10368672|NCT00543543|11509211|FG000|COMPLETED|Extension Study||0
10368673|NCT00543543|11509212|FG001|COMPLETED|Extension Study||150
10368674|NCT00543543|11509213|FG002|COMPLETED|Extension Study||0
10368675|NCT00543543|11509214|FG003|COMPLETED|Extension Study||2824
10368676|NCT00543543|11509211|FG000|NOT COMPLETED|Extension Study||0
10368677|NCT00543543|11509212|FG001|NOT COMPLETED|Extension Study||0
10368678|NCT00543543|11509213|FG002|NOT COMPLETED|Extension Study||0
10368679|NCT00543543|11509214|FG003|NOT COMPLETED|Extension Study||226
10368680|NCT00543569|11509233|FG000|STARTED|Overall Study||82
10368681|NCT00543569|11509234|FG001|STARTED|Overall Study||80
10368682|NCT00543569|11509235|FG002|STARTED|Overall Study||80
10368683|NCT00543569|11509236|FG003|STARTED|Overall Study||81
10368684|NCT00543569|11509233|FG000|Received Treatment|Overall Study||79
10368685|NCT00543569|11509234|FG001|Received Treatment|Overall Study||77
10368686|NCT00543569|11509235|FG002|Received Treatment|Overall Study||75
10368687|NCT00543569|11509236|FG003|Received Treatment|Overall Study||78
10368688|NCT00543569|11509233|FG000|COMPLETED|Overall Study||70
10368689|NCT00543569|11509234|FG001|COMPLETED|Overall Study||72
10368690|NCT00543569|11509235|FG002|COMPLETED|Overall Study||60
10368691|NCT00543569|11509236|FG003|COMPLETED|Overall Study||72
10368692|NCT00543569|11509233|FG000|NOT COMPLETED|Overall Study||12
10368693|NCT00543569|11509234|FG001|NOT COMPLETED|Overall Study||8
10368694|NCT00543569|11509235|FG002|NOT COMPLETED|Overall Study||20
10368695|NCT00543569|11509236|FG003|NOT COMPLETED|Overall Study||9
10368696|NCT00543725|11509248|FG000|STARTED|Overall Study||340
10368697|NCT00543725|11509249|FG001|STARTED|Overall Study||338
10368698|NCT00543725|11509248|FG000|COMPLETED|Overall Study||272
10368699|NCT00543725|11509249|FG001|COMPLETED|Overall Study||264
10368700|NCT00543725|11509248|FG000|NOT COMPLETED|Overall Study||68
10368701|NCT00543725|11509249|FG001|NOT COMPLETED|Overall Study||74
10368702|NCT00543764|11509257|FG000|STARTED|Overall Study||100
10368703|NCT00543764|11509258|FG001|STARTED|Overall Study||50
10368704|NCT00543764|11509257|FG000|COMPLETED|Overall Study||100
10368705|NCT00543764|11509258|FG001|COMPLETED|Overall Study||50
10368706|NCT00543764|11509257|FG000|NOT COMPLETED|Overall Study||0
10368707|NCT00543764|11509258|FG001|NOT COMPLETED|Overall Study||0
10368708|NCT00543777|11509264|FG000|STARTED|Overall Study||44
10368709|NCT00543777|11509264|FG000|COMPLETED|Overall Study||44
10368710|NCT00543777|11509264|FG000|NOT COMPLETED|Overall Study||0
10368711|NCT00543803|11509268|FG000|STARTED|Overall Study||334
10368712|NCT00543803|11509268|FG000|COMPLETED|Overall Study||192
10368713|NCT00543803|11509268|FG000|NOT COMPLETED|Overall Study||142
10368714|NCT00543855|11509278|FG000|STARTED|Overall Study||35
10368715|NCT00543855|11509279|FG001|STARTED|Overall Study||33
10368716|NCT00543855|11509280|FG002|STARTED|Overall Study||37
10368717|NCT00543855|11509281|FG003|STARTED|Overall Study||34
10368718|NCT00543855|11509278|FG000|COMPLETED|Overall Study||31
10368719|NCT00543855|11509279|FG001|COMPLETED|Overall Study||31
10368720|NCT00543855|11509280|FG002|COMPLETED|Overall Study||31
10368721|NCT00543855|11509281|FG003|COMPLETED|Overall Study||30
10368722|NCT00543855|11509278|FG000|NOT COMPLETED|Overall Study||4
10368723|NCT00543855|11509279|FG001|NOT COMPLETED|Overall Study||2
10368724|NCT00543855|11509280|FG002|NOT COMPLETED|Overall Study||6
10368725|NCT00543855|11509281|FG003|NOT COMPLETED|Overall Study||4
10368726|NCT00543985|11509291|FG000|STARTED|Overall Study||36
10368727|NCT00543985|11509291|FG000|COMPLETED|Overall Study||32
10368728|NCT00543985|11509291|FG000|NOT COMPLETED|Overall Study||4
10368729|NCT00544076|11509301|FG000|STARTED|Overall Study||34
10368730|NCT00544076|11509302|FG001|STARTED|Overall Study||35
10368731|NCT00544076|11509303|FG002|STARTED|Overall Study||31
10368732|NCT00544076|11509301|FG000|COMPLETED|Overall Study||17
10368733|NCT00544076|11509302|FG001|COMPLETED|Overall Study||19
10368734|NCT00544076|11509303|FG002|COMPLETED|Overall Study||20
10368735|NCT00544076|11509301|FG000|NOT COMPLETED|Overall Study||17
10368736|NCT00544076|11509302|FG001|NOT COMPLETED|Overall Study||16
10368737|NCT00544076|11509303|FG002|NOT COMPLETED|Overall Study||11
10368738|NCT00544167|11509312|FG000|STARTED|Overall Study||45
10368739|NCT00544167|11509312|FG000|COMPLETED|Overall Study||16
10368740|NCT00544167|11509312|FG000|NOT COMPLETED|Overall Study||29
10368741|NCT00544440|11509316|FG000|STARTED|Overall Study||57
10657107|NCT02223065|11818243|FG001|STARTED|Overall Study||18
10657108|NCT02223065|11818242|FG000|COMPLETED|Overall Study||18
10657109|NCT02223065|11818243|FG001|COMPLETED|Overall Study||18
10716695|NCT02691494|11880445|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||7
10716696|NCT02691494|11880446|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||17
10368742|NCT00544440|11509316|FG000|COMPLETED|Overall Study||0
10368743|NCT00544440|11509316|FG000|NOT COMPLETED|Overall Study||57
10368744|NCT00544544|11509320|FG000|STARTED|Overall Study||14
10368745|NCT00544544|11509320|FG000|COMPLETED|Overall Study||11
10657110|NCT02223065|11818242|FG000|NOT COMPLETED|Overall Study||0
10716697|NCT02691507|11880456|FG000|STARTED|Overall Study||40
10368746|NCT00544544|11509320|FG000|NOT COMPLETED|Overall Study||3
10368747|NCT00544557|11509324|FG000|STARTED|Overall Study||1685
10368748|NCT00544557|11509324|FG000|COMPLETED|Overall Study||1251
10368749|NCT00544557|11509324|FG000|NOT COMPLETED|Overall Study||434
10368750|NCT00544648|11509330|FG000|STARTED|Overall Study||11
10368751|NCT00544648|11509331|FG001|STARTED|Overall Study||2
10368752|NCT00544648|11509330|FG000|COMPLETED|Overall Study||8
10368753|NCT00544648|11509331|FG001|COMPLETED|Overall Study||1
10368754|NCT00544648|11509330|FG000|NOT COMPLETED|Overall Study||3
10368755|NCT00544648|11509331|FG001|NOT COMPLETED|Overall Study||1
10368756|NCT00544674|11509339|FG000|STARTED|Overall Study|1 subject registered and expired prior to dosing|5
10368757|NCT00544674|11509339|FG000|COMPLETED|Overall Study||4
10368758|NCT00544674|11509339|FG000|NOT COMPLETED|Overall Study||1
10368759|NCT00544713|11509345|FG000|STARTED|Overall Study||114
10368760|NCT00544713|11509346|FG001|STARTED|Overall Study||114
10368761|NCT00544713|11509345|FG000|COMPLETED|Overall Study||111
10368762|NCT00544713|11509346|FG001|COMPLETED|Overall Study||109
10368763|NCT00544713|11509345|FG000|NOT COMPLETED|Overall Study||3
10368764|NCT00544713|11509346|FG001|NOT COMPLETED|Overall Study||5
10368765|NCT00544778|11509352|FG000|STARTED|Overall Study||7
10368766|NCT00544778|11509352|FG000|COMPLETED|Overall Study||7
10368767|NCT00544778|11509352|FG000|NOT COMPLETED|Overall Study||0
10368768|NCT00544817|11509356|FG000|STARTED|Combined Modality||47
10368769|NCT00544817|11509356|FG000|COMPLETED|Combined Modality||40
10368770|NCT00544817|11509356|FG000|NOT COMPLETED|Combined Modality||7
10368771|NCT00544817|11509356|FG000|STARTED|No Treatment Interval||40
10368772|NCT00544817|11509356|FG000|COMPLETED|No Treatment Interval||28
10368773|NCT00544817|11509356|FG000|NOT COMPLETED|No Treatment Interval||12
10368774|NCT00544817|11509356|FG000|STARTED|Follow-up Systemic Therapy||28
10368775|NCT00544817|11509356|FG000|COMPLETED|Follow-up Systemic Therapy||9
10368776|NCT00544817|11509356|FG000|NOT COMPLETED|Follow-up Systemic Therapy||19
10368777|NCT00544869|11509363|FG000|STARTED|Overall Study||36
10368778|NCT00544869|11509364|FG001|STARTED|Overall Study||14
10368779|NCT00544869|11509365|FG002|STARTED|Overall Study||2
10368780|NCT00544869|11509363|FG000|COMPLETED|Overall Study||24
10368781|NCT00544869|11509364|FG001|COMPLETED|Overall Study||12
10368782|NCT00544869|11509365|FG002|COMPLETED|Overall Study||2
10368783|NCT00544869|11509363|FG000|NOT COMPLETED|Overall Study||12
10368784|NCT00544869|11509364|FG001|NOT COMPLETED|Overall Study||2
10368785|NCT00544869|11509365|FG002|NOT COMPLETED|Overall Study||0
10368786|NCT00544882|11509375|FG000|STARTED|Cycle 1: Run-in Cycle||61
10368787|NCT00544882|11509376|FG001|STARTED|Cycle 1: Run-in Cycle||0
10368788|NCT00544882|11509377|FG002|STARTED|Cycle 1: Run-in Cycle||0
10368789|NCT00544882|11509375|FG000|COMPLETED|Cycle 1: Run-in Cycle||58
10368790|NCT00544882|11509376|FG001|COMPLETED|Cycle 1: Run-in Cycle||0
10368791|NCT00544882|11509377|FG002|COMPLETED|Cycle 1: Run-in Cycle||0
10368792|NCT00544882|11509375|FG000|NOT COMPLETED|Cycle 1: Run-in Cycle||3
10368793|NCT00544882|11509376|FG001|NOT COMPLETED|Cycle 1: Run-in Cycle||0
10368794|NCT00544882|11509377|FG002|NOT COMPLETED|Cycle 1: Run-in Cycle||0
10368795|NCT00544882|11509375|FG000|STARTED|Cycle 2: Randomized Treatment Cycle||0
10368796|NCT00544882|11509376|FG001|STARTED|Cycle 2: Randomized Treatment Cycle||29
10368797|NCT00544882|11509377|FG002|STARTED|Cycle 2: Randomized Treatment Cycle||29
10368798|NCT00544882|11509375|FG000|Treated|Cycle 2: Randomized Treatment Cycle||0
10537038|NCT01448616|11689785|FG000|COMPLETED|Lead-In (Observational Phase)|Participants who swabbed >90% completed this phase and were randomized to treatment 2:2:1.|64
10537039|NCT01448616|11689786|FG001|COMPLETED|Lead-In (Observational Phase)|completed >90% of sample collection to qualify for randomization for next phase|0
10537040|NCT01448616|11689787|FG002|COMPLETED|Lead-In (Observational Phase)||0
10537041|NCT01448616|11689788|FG003|COMPLETED|Lead-In (Observational Phase)||0
10537042|NCT01448616|11689785|FG000|NOT COMPLETED|Lead-In (Observational Phase)||9
10537043|NCT01448616|11689786|FG001|NOT COMPLETED|Lead-In (Observational Phase)||0
10537044|NCT01448616|11689787|FG002|NOT COMPLETED|Lead-In (Observational Phase)||0
10657111|NCT02223065|11818243|FG001|NOT COMPLETED|Overall Study||0
10657112|NCT02223260|11818249|FG000|STARTED|Overall Study||8
10657113|NCT02223260|11818249|FG000|COMPLETED|Overall Study||8
10657114|NCT02223260|11818249|FG000|NOT COMPLETED|Overall Study||0
10657115|NCT02223338|11818255|FG000|STARTED|Overall Study||60
10657116|NCT02223338|11818256|FG001|STARTED|Overall Study||60
10657117|NCT02223338|11818255|FG000|COMPLETED|Overall Study||60
10657118|NCT02223338|11818256|FG001|COMPLETED|Overall Study||60
10657119|NCT02223338|11818255|FG000|NOT COMPLETED|Overall Study||0
10657120|NCT02223338|11818256|FG001|NOT COMPLETED|Overall Study||0
10657121|NCT02223351|11818264|FG000|STARTED|Overall Study||24
10657122|NCT02223351|11818265|FG001|STARTED|Overall Study||24
10657123|NCT02223351|11818264|FG000|First Intervention (8 Days)|Overall Study||24
10716698|NCT02691507|11880457|FG001|STARTED|Overall Study||13
10716699|NCT02691507|11880456|FG000|COMPLETED|Overall Study||40
10716700|NCT02691507|11880457|FG001|COMPLETED|Overall Study||12
10716701|NCT02691507|11880456|FG000|NOT COMPLETED|Overall Study||0
10716702|NCT02691507|11880457|FG001|NOT COMPLETED|Overall Study||1
10716703|NCT02691572|11880465|FG000|STARTED|Overall Study||40
10716704|NCT02691572|11880466|FG001|STARTED|Overall Study||40
10716705|NCT02691572|11880465|FG000|COMPLETED|Overall Study||39
10716706|NCT02691572|11880466|FG001|COMPLETED|Overall Study||39
10716707|NCT02691572|11880465|FG000|NOT COMPLETED|Overall Study||1
10716708|NCT02691572|11880466|FG001|NOT COMPLETED|Overall Study||1
10716709|NCT02691702|11880483|FG000|STARTED|Overall Study||10
10716710|NCT02691702|11880484|FG001|STARTED|Overall Study||11
10716711|NCT02691702|11880485|FG002|STARTED|Overall Study||8
10716712|NCT02691702|11880486|FG003|STARTED|Overall Study||8
10716713|NCT02691702|11880487|FG004|STARTED|Overall Study||8
10716714|NCT02691702|11880488|FG005|STARTED|Overall Study||8
10716715|NCT02691702|11880489|FG006|STARTED|Overall Study||8
10716716|NCT02691702|11880490|FG007|STARTED|Overall Study||12
10716717|NCT02691702|11880491|FG008|STARTED|Overall Study||8
10368799|NCT00544882|11509376|FG001|Treated|Cycle 2: Randomized Treatment Cycle|One participant withdrew prior to treatment|28
10368800|NCT00544882|11509377|FG002|Treated|Cycle 2: Randomized Treatment Cycle|One participant was dropped from the study due to noncompliance prior to treatment.|28
10368801|NCT00544882|11509375|FG000|COMPLETED|Cycle 2: Randomized Treatment Cycle||0
10368802|NCT00544882|11509376|FG001|COMPLETED|Cycle 2: Randomized Treatment Cycle||28
10716718|NCT02691702|11880492|FG009|STARTED|Overall Study||8
10716719|NCT02691702|11880493|FG010|STARTED|Overall Study||8
10716720|NCT02691702|11880483|FG000|COMPLETED|Overall Study||8
10368803|NCT00544882|11509377|FG002|COMPLETED|Cycle 2: Randomized Treatment Cycle||28
10368804|NCT00544882|11509375|FG000|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||0
10368805|NCT00544882|11509376|FG001|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||1
10368806|NCT00544882|11509377|FG002|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||1
10368807|NCT00544882|11509375|FG000|STARTED|Cycle 3: Follow-up||0
10368808|NCT00544882|11509376|FG001|STARTED|Cycle 3: Follow-up||28
10537045|NCT01448616|11689788|FG003|NOT COMPLETED|Lead-In (Observational Phase)||0
10537046|NCT01448616|11689785|FG000|STARTED|Study Drug (Treatment Phase)|All qualifying participants from this group moved to treatment group.|0
10537047|NCT01448616|11689786|FG001|STARTED|Study Drug (Treatment Phase)||24
10537048|NCT01448616|11689787|FG002|STARTED|Study Drug (Treatment Phase)||27
10657124|NCT02223351|11818265|FG001|First Intervention (8 Days)|Overall Study||24
10657125|NCT02223351|11818264|FG000|Wasout (2weeks)|Overall Study||24
10657126|NCT02223351|11818265|FG001|Wasout (2weeks)|Overall Study||24
10657127|NCT02223351|11818264|FG000|Second Intervention (8 Days)|Overall Study||24
10657128|NCT02223351|11818265|FG001|Second Intervention (8 Days)|Overall Study||24
10657129|NCT02223351|11818264|FG000|COMPLETED|Overall Study||24
10657130|NCT02223351|11818265|FG001|COMPLETED|Overall Study||24
10657131|NCT02223351|11818264|FG000|NOT COMPLETED|Overall Study||0
10657132|NCT02223351|11818265|FG001|NOT COMPLETED|Overall Study||0
10657133|NCT02223364|11818282|FG000|STARTED|Overall Study||55
10657134|NCT02223364|11818283|FG001|STARTED|Overall Study||55
10657135|NCT02223364|11818284|FG002|STARTED|Overall Study||55
10657136|NCT02223364|11818282|FG000|COMPLETED|Overall Study||50
10716721|NCT02691702|11880484|FG001|COMPLETED|Overall Study||10
10716722|NCT02691702|11880485|FG002|COMPLETED|Overall Study||7
10716723|NCT02691702|11880486|FG003|COMPLETED|Overall Study||8
10716724|NCT02691702|11880487|FG004|COMPLETED|Overall Study||8
10716725|NCT02691702|11880488|FG005|COMPLETED|Overall Study||5
10716726|NCT02691702|11880489|FG006|COMPLETED|Overall Study||5
10716727|NCT02691702|11880490|FG007|COMPLETED|Overall Study||12
10716728|NCT02691702|11880491|FG008|COMPLETED|Overall Study||6
10716729|NCT02691702|11880492|FG009|COMPLETED|Overall Study||6
10716730|NCT02691702|11880493|FG010|COMPLETED|Overall Study||6
10716731|NCT02691702|11880483|FG000|NOT COMPLETED|Overall Study||2
10716732|NCT02691702|11880484|FG001|NOT COMPLETED|Overall Study||1
10716733|NCT02691702|11880485|FG002|NOT COMPLETED|Overall Study||1
10716734|NCT02691702|11880486|FG003|NOT COMPLETED|Overall Study||0
10716735|NCT02691702|11880487|FG004|NOT COMPLETED|Overall Study||0
10716736|NCT02691702|11880488|FG005|NOT COMPLETED|Overall Study||3
10716737|NCT02691702|11880489|FG006|NOT COMPLETED|Overall Study||3
10716738|NCT02691702|11880490|FG007|NOT COMPLETED|Overall Study||0
10716739|NCT02691702|11880491|FG008|NOT COMPLETED|Overall Study||2
10716740|NCT02691702|11880492|FG009|NOT COMPLETED|Overall Study||2
10716741|NCT02691702|11880493|FG010|NOT COMPLETED|Overall Study||2
10716742|NCT02691741|11880527|FG000|STARTED|Overall Study||94
10716743|NCT02691741|11880528|FG001|STARTED|Overall Study||94
10716744|NCT02691741|11880527|FG000|All-Implanted Analysis Set|Overall Study||93
10716745|NCT02691741|11880528|FG001|All-Implanted Analysis Set|Overall Study||89
10716746|NCT02691741|11880527|FG000|Best-Case Analysis Set|Overall Study||86
10716747|NCT02691741|11880528|FG001|Best-Case Analysis Set|Overall Study||85
10716748|NCT02691741|11880527|FG000|Safety Analysis Set|Overall Study||93
10716749|NCT02691741|11880528|FG001|Safety Analysis Set|Overall Study||89
10716750|NCT02691741|11880527|FG000|COMPLETED|Overall Study||93
10716751|NCT02691741|11880528|FG001|COMPLETED|Overall Study||87
10716752|NCT02691741|11880527|FG000|NOT COMPLETED|Overall Study||1
10716753|NCT02691741|11880528|FG001|NOT COMPLETED|Overall Study||7
10716754|NCT02691936|11880541|FG000|STARTED|Overall Study||35
10812593|NCT03490916|11974693|FG000|NOT COMPLETED|Overall Study||0
10812594|NCT03490916|11974694|FG001|NOT COMPLETED|Overall Study||0
10812595|NCT03483051|11974702|FG000|STARTED|First Treatment, Pre Crossover||2
10812596|NCT03483051|11974703|FG001|STARTED|First Treatment, Pre Crossover||1
10368809|NCT00544882|11509377|FG002|STARTED|Cycle 3: Follow-up||28
10537049|NCT01448616|11689788|FG003|STARTED|Study Drug (Treatment Phase)||13
10716755|NCT02691936|11880542|FG001|STARTED|Overall Study||34
10716756|NCT02691936|11880541|FG000|COMPLETED|Overall Study||33
10716757|NCT02691936|11880542|FG001|COMPLETED|Overall Study||29
10716758|NCT02691936|11880541|FG000|NOT COMPLETED|Overall Study||2
10716759|NCT02691936|11880542|FG001|NOT COMPLETED|Overall Study||5
10812597|NCT03483051|11974702|FG000|COMPLETED|First Treatment, Pre Crossover||2
10368810|NCT00544882|11509375|FG000|COMPLETED|Cycle 3: Follow-up||0
10537050|NCT01448616|11689785|FG000|COMPLETED|Study Drug (Treatment Phase)||0
10537051|NCT01448616|11689786|FG001|COMPLETED|Study Drug (Treatment Phase)||22
10537052|NCT01448616|11689787|FG002|COMPLETED|Study Drug (Treatment Phase)||23
10657137|NCT02223364|11818283|FG001|COMPLETED|Overall Study||55
10657138|NCT02223364|11818284|FG002|COMPLETED|Overall Study||52
10657139|NCT02223364|11818282|FG000|NOT COMPLETED|Overall Study||5
10657140|NCT02223364|11818283|FG001|NOT COMPLETED|Overall Study||0
10657141|NCT02223364|11818284|FG002|NOT COMPLETED|Overall Study||3
10716760|NCT02691962|11880548|FG000|STARTED|Overall Study||75
10716761|NCT02691962|11880548|FG000|COMPLETED|Overall Study||59
10716762|NCT02691962|11880548|FG000|NOT COMPLETED|Overall Study||16
10716763|NCT02692040|11880570|FG000|STARTED|Overall Study||10
10716764|NCT02692040|11880571|FG001|STARTED|Overall Study||4
10716765|NCT02692040|11880572|FG002|STARTED|Overall Study||5
10716766|NCT02692040|11880573|FG003|STARTED|Overall Study||5
10716767|NCT02692040|11880574|FG004|STARTED|Overall Study||4
10716768|NCT02692040|11880575|FG005|STARTED|Overall Study||5
10368811|NCT00544882|11509376|FG001|COMPLETED|Cycle 3: Follow-up|Completed 21 days of Cycle 3|26
10368812|NCT00544882|11509377|FG002|COMPLETED|Cycle 3: Follow-up|Completed 21 days of Cycle 3|28
10368813|NCT00544882|11509375|FG000|NOT COMPLETED|Cycle 3: Follow-up||0
10368814|NCT00544882|11509376|FG001|NOT COMPLETED|Cycle 3: Follow-up||2
10368815|NCT00544882|11509377|FG002|NOT COMPLETED|Cycle 3: Follow-up||0
10368816|NCT00544908|11509383|FG000|STARTED|Overall Study||7
10368817|NCT00544908|11509383|FG000|COMPLETED|Overall Study||7
10368818|NCT00544908|11509383|FG000|NOT COMPLETED|Overall Study||0
10427454|NCT00853112|11573248|FG001|COMPLETED|Overall Study||6
10427455|NCT00853112|11573249|FG002|COMPLETED|Overall Study||7
10427456|NCT00853112|11573250|FG003|COMPLETED|Overall Study||6
10427457|NCT00853112|11573251|FG004|COMPLETED|Overall Study||6
10427458|NCT00853112|11573252|FG005|COMPLETED|Overall Study||7
10427459|NCT00853112|11573253|FG006|COMPLETED|Overall Study||6
10427460|NCT00853112|11573247|FG000|NOT COMPLETED|Overall Study||0
10427461|NCT00853112|11573248|FG001|NOT COMPLETED|Overall Study||1
10427462|NCT00853112|11573249|FG002|NOT COMPLETED|Overall Study||0
10427463|NCT00853112|11573250|FG003|NOT COMPLETED|Overall Study||2
10427464|NCT00853112|11573251|FG004|NOT COMPLETED|Overall Study||0
10427465|NCT00853112|11573252|FG005|NOT COMPLETED|Overall Study||0
10427466|NCT00853112|11573253|FG006|NOT COMPLETED|Overall Study||1
10427467|NCT00853125|11573269|FG000|STARTED|Overall Study||10
10427468|NCT00853125|11573269|FG000|COMPLETED|Overall Study||9
10427469|NCT00853125|11573269|FG000|NOT COMPLETED|Overall Study||1
10427470|NCT00853151|11573278|FG000|STARTED|Overall Study||38
10427471|NCT00853151|11573279|FG001|STARTED|Overall Study||37
10427472|NCT00853151|11573280|FG002|STARTED|Overall Study||38
10427473|NCT00853151|11573281|FG003|STARTED|Overall Study||18
10427474|NCT00853151|11573278|FG000|COMPLETED|Overall Study||28
10427475|NCT00853151|11573279|FG001|COMPLETED|Overall Study||24
10427476|NCT00853151|11573280|FG002|COMPLETED|Overall Study||30
10427477|NCT00853151|11573281|FG003|COMPLETED|Overall Study||15
10427478|NCT00853151|11573278|FG000|NOT COMPLETED|Overall Study||10
10427479|NCT00853151|11573279|FG001|NOT COMPLETED|Overall Study||13
10427480|NCT00853151|11573280|FG002|NOT COMPLETED|Overall Study||8
10427481|NCT00853151|11573281|FG003|NOT COMPLETED|Overall Study||3
10427482|NCT00853242|11573301|FG000|STARTED|Overall Study||50
10427483|NCT00853242|11573302|FG001|STARTED|Overall Study||50
10427484|NCT00853242|11573303|FG002|STARTED|Overall Study||49
10427485|NCT00853242|11573304|FG003|STARTED|Overall Study||50
10427486|NCT00853242|11573305|FG004|STARTED|Overall Study||50
10427487|NCT00853242|11573306|FG005|STARTED|Overall Study||51
10427488|NCT00853242|11573307|FG006|STARTED|Overall Study||49
10427489|NCT00853242|11573301|FG000|Treated|Overall Study||50
10427490|NCT00853242|11573302|FG001|Treated|Overall Study||49
10427491|NCT00853242|11573303|FG002|Treated|Overall Study||48
10427492|NCT00853242|11573304|FG003|Treated|Overall Study||50
10427493|NCT00853242|11573305|FG004|Treated|Overall Study||50
10427494|NCT00853242|11573306|FG005|Treated|Overall Study||51
10427495|NCT00853242|11573307|FG006|Treated|Overall Study||48
10427496|NCT00853242|11573301|FG000|COMPLETED|Overall Study||47
10427497|NCT00853242|11573302|FG001|COMPLETED|Overall Study||47
10427498|NCT00853242|11573303|FG002|COMPLETED|Overall Study||46
10427499|NCT00853242|11573304|FG003|COMPLETED|Overall Study||46
10427500|NCT00853242|11573305|FG004|COMPLETED|Overall Study||46
10427501|NCT00853242|11573306|FG005|COMPLETED|Overall Study||49
10427502|NCT00853242|11573307|FG006|COMPLETED|Overall Study||44
10427503|NCT00853242|11573301|FG000|NOT COMPLETED|Overall Study||3
10427504|NCT00853242|11573302|FG001|NOT COMPLETED|Overall Study||3
10427505|NCT00853242|11573303|FG002|NOT COMPLETED|Overall Study||3
10427506|NCT00853242|11573304|FG003|NOT COMPLETED|Overall Study||4
10427507|NCT00853242|11573305|FG004|NOT COMPLETED|Overall Study||4
10427508|NCT00853242|11573306|FG005|NOT COMPLETED|Overall Study||2
10427509|NCT00853242|11573307|FG006|NOT COMPLETED|Overall Study||5
10427510|NCT00853333|11573332|FG000|STARTED|Overall Study||28
10427511|NCT00853333|11573333|FG001|STARTED|Overall Study||27
10427512|NCT00853333|11573334|FG002|STARTED|Overall Study||31
10427513|NCT00853333|11573332|FG000|COMPLETED|Overall Study||28
10427514|NCT00853333|11573333|FG001|COMPLETED|Overall Study||27
10427515|NCT00853333|11573334|FG002|COMPLETED|Overall Study||31
10427516|NCT00853333|11573332|FG000|NOT COMPLETED|Overall Study||0
10427517|NCT00853333|11573333|FG001|NOT COMPLETED|Overall Study||0
10427518|NCT00853333|11573334|FG002|NOT COMPLETED|Overall Study||0
10427519|NCT00853372|11573344|FG000|STARTED|Overall Study||43
10427520|NCT00853372|11573345|FG001|STARTED|Overall Study||42
10427521|NCT00853372|11573344|FG000|COMPLETED|Overall Study||11
10427522|NCT00853372|11573345|FG001|COMPLETED|Overall Study||13
10716769|NCT02692040|11880576|FG006|STARTED|Overall Study||5
10427523|NCT00853372|11573344|FG000|NOT COMPLETED|Overall Study||32
10427524|NCT00853372|11573345|FG001|NOT COMPLETED|Overall Study||29
10427525|NCT00853385|11573356|FG000|STARTED|Overall Study||204
10427526|NCT00853385|11573357|FG001|STARTED|Overall Study||201
10427527|NCT00853385|11573358|FG002|STARTED|Overall Study||56
10427528|NCT00853385|11573359|FG003|STARTED|Overall Study||52
10427529|NCT00853385|11573360|FG004|STARTED|Overall Study||204
10427530|NCT00853385|11573356|FG000|COMPLETED|Overall Study||150
10427531|NCT00853385|11573357|FG001|COMPLETED|Overall Study||158
10427532|NCT00853385|11573358|FG002|COMPLETED|Overall Study||47
10427533|NCT00853385|11573359|FG003|COMPLETED|Overall Study||39
10427534|NCT00853385|11573360|FG004|COMPLETED|Overall Study||162
10427535|NCT00853385|11573356|FG000|NOT COMPLETED|Overall Study||54
10427536|NCT00853385|11573357|FG001|NOT COMPLETED|Overall Study||43
10427537|NCT00853385|11573358|FG002|NOT COMPLETED|Overall Study||9
10368819|NCT00545025|11509389|FG000|STARTED|Overall Study||160
10368820|NCT00545025|11509390|FG001|STARTED|Overall Study||83
10368821|NCT00545025|11509389|FG000|COMPLETED|Overall Study||160
10368822|NCT00545025|11509390|FG001|COMPLETED|Overall Study||83
10368823|NCT00545025|11509389|FG000|NOT COMPLETED|Overall Study||0
10368824|NCT00545025|11509390|FG001|NOT COMPLETED|Overall Study||0
10368825|NCT00545051|11509398|FG000|STARTED|Overall Study||68
10368826|NCT00545051|11509399|FG001|STARTED|Overall Study||72
10368827|NCT00545051|11509398|FG000|COMPLETED|Overall Study||59
10368828|NCT00545051|11509399|FG001|COMPLETED|Overall Study||65
10368829|NCT00545051|11509398|FG000|NOT COMPLETED|Overall Study||9
10368830|NCT00545051|11509399|FG001|NOT COMPLETED|Overall Study||7
10368831|NCT00545064|11509405|FG000|STARTED|Overall Study||178
10368832|NCT00545064|11509405|FG000|Visit 1 (Baseline)|Overall Study||178
10368833|NCT00545064|11509405|FG000|Visit 2 (Week 4)|Overall Study||169
10368834|NCT00545064|11509405|FG000|Visit 3 (Week 8)|Overall Study|8 patients didn't complete the 8-week period. 6 were retrieved and considered as Visit 3 (Week 8)|176
10368835|NCT00545064|11509405|FG000|COMPLETED|Overall Study||170
10368836|NCT00545064|11509405|FG000|NOT COMPLETED|Overall Study||8
10368837|NCT00545077|11509413|FG000|STARTED|Overall Study||189
10368838|NCT00545077|11509414|FG001|STARTED|Overall Study||191
10368839|NCT00545077|11509413|FG000|COMPLETED|Overall Study||41
10368840|NCT00545077|11509414|FG001|COMPLETED|Overall Study||36
10368841|NCT00545077|11509413|FG000|NOT COMPLETED|Overall Study||148
10368842|NCT00545077|11509414|FG001|NOT COMPLETED|Overall Study||155
10368843|NCT00545103|11509424|FG000|STARTED|Overall Study||148
10368844|NCT00545103|11509425|FG001|STARTED|Overall Study||148
10368845|NCT00545103|11509426|FG002|STARTED|Overall Study||150
10716770|NCT02692040|11880577|FG007|STARTED|Overall Study||5
10716771|NCT02692040|11880578|FG008|STARTED|Overall Study||5
10716772|NCT02692040|11880579|FG009|STARTED|Overall Study||4
10368846|NCT00545103|11509427|FG003|STARTED|Overall Study||146
10368847|NCT00545103|11509424|FG000|COMPLETED|Overall Study||73
10368848|NCT00545103|11509425|FG001|COMPLETED|Overall Study||70
10368849|NCT00545103|11509426|FG002|COMPLETED|Overall Study||74
10368850|NCT00545103|11509427|FG003|COMPLETED|Overall Study||76
10368851|NCT00545103|11509424|FG000|NOT COMPLETED|Overall Study||75
10368852|NCT00545103|11509425|FG001|NOT COMPLETED|Overall Study||78
10368853|NCT00545103|11509426|FG002|NOT COMPLETED|Overall Study||76
10368854|NCT00545103|11509427|FG003|NOT COMPLETED|Overall Study||70
10368855|NCT00545155|11509437|FG000|STARTED|Overall Study||187
10368856|NCT00545155|11509437|FG000|COMPLETED|Overall Study||187
10368857|NCT00545155|11509437|FG000|NOT COMPLETED|Overall Study||0
10368858|NCT00545168|11509444|FG000|STARTED|Overall Study||203
10368859|NCT00545168|11509445|FG001|STARTED|Overall Study||63
10368860|NCT00545168|11509446|FG002|STARTED|Overall Study||214
10368861|NCT00545168|11509444|FG000|COMPLETED|Overall Study||187
10368862|NCT00545168|11509445|FG001|COMPLETED|Overall Study||58
10368863|NCT00545168|11509446|FG002|COMPLETED|Overall Study||193
10368864|NCT00545168|11509444|FG000|NOT COMPLETED|Overall Study||16
10368865|NCT00545168|11509445|FG001|NOT COMPLETED|Overall Study||5
10368866|NCT00545168|11509446|FG002|NOT COMPLETED|Overall Study||21
10368867|NCT00545181|11509457|FG000|STARTED|Overall Study||29
10368868|NCT00545181|11509458|FG001|STARTED|Overall Study||25
10368869|NCT00545181|11509457|FG000|COMPLETED|Overall Study||29
10368870|NCT00545181|11509458|FG001|COMPLETED|Overall Study||25
10368871|NCT00545181|11509457|FG000|NOT COMPLETED|Overall Study||0
10368872|NCT00545181|11509458|FG001|NOT COMPLETED|Overall Study||0
10368873|NCT00545233|11509466|FG000|STARTED|Overall Study||79
10368874|NCT00545233|11509467|FG001|STARTED|Overall Study||76
10368875|NCT00545233|11509466|FG000|Safety Set|Overall Study||77
10368876|NCT00545233|11509467|FG001|Safety Set|Overall Study||75
10368877|NCT00545233|11509466|FG000|Intent-to-Treat (ITT)|Overall Study||77
10368878|NCT00545233|11509467|FG001|Intent-to-Treat (ITT)|Overall Study||73
10368879|NCT00545233|11509466|FG000|COMPLETED|Overall Study||33
10368880|NCT00545233|11509467|FG001|COMPLETED|Overall Study||41
10368881|NCT00545233|11509466|FG000|NOT COMPLETED|Overall Study||46
10368882|NCT00545233|11509467|FG001|NOT COMPLETED|Overall Study||35
10368883|NCT00545272|11509480|FG000|STARTED|Overall Study||61
10368884|NCT00545272|11509481|FG001|STARTED|Overall Study||68
10368885|NCT00545272|11509482|FG002|STARTED|Overall Study||65
10368886|NCT00545272|11509483|FG003|STARTED|Overall Study||72
10368887|NCT00545272|11509484|FG004|STARTED|Overall Study||64
10368888|NCT00545272|11509485|FG005|STARTED|Overall Study||62
10368889|NCT00545272|11509480|FG000|COMPLETED|Overall Study||61
10368890|NCT00545272|11509481|FG001|COMPLETED|Overall Study||67
10716773|NCT02692040|11880580|FG010|STARTED|Overall Study||5
10716774|NCT02692040|11880581|FG011|STARTED|Overall Study||5
10368891|NCT00545272|11509482|FG002|COMPLETED|Overall Study||64
10368892|NCT00545272|11509483|FG003|COMPLETED|Overall Study||71
10368893|NCT00545272|11509484|FG004|COMPLETED|Overall Study||62
10368894|NCT00545272|11509485|FG005|COMPLETED|Overall Study||59
10368895|NCT00545272|11509480|FG000|NOT COMPLETED|Overall Study||0
10368896|NCT00545272|11509481|FG001|NOT COMPLETED|Overall Study||1
10368897|NCT00545272|11509482|FG002|NOT COMPLETED|Overall Study||1
10368898|NCT00545272|11509483|FG003|NOT COMPLETED|Overall Study||1
10368899|NCT00545272|11509484|FG004|NOT COMPLETED|Overall Study||2
10368900|NCT00545272|11509485|FG005|NOT COMPLETED|Overall Study||3
10368901|NCT00545298|11509502|FG000|STARTED|Overall Study||2
10368902|NCT00545298|11509503|FG001|STARTED|Overall Study||1
10368903|NCT00545298|11509504|FG002|STARTED|Overall Study||1
10368904|NCT00545298|11509502|FG000|COMPLETED|Overall Study||0
10368905|NCT00545298|11509503|FG001|COMPLETED|Overall Study||1
10368906|NCT00545298|11509504|FG002|COMPLETED|Overall Study||0
10368907|NCT00545298|11509502|FG000|NOT COMPLETED|Overall Study||2
10368908|NCT00545298|11509503|FG001|NOT COMPLETED|Overall Study||0
10368909|NCT00545298|11509504|FG002|NOT COMPLETED|Overall Study||1
10368910|NCT00545363|11509517|FG000|STARTED|Overall Study||358
10368911|NCT00545363|11509518|FG001|STARTED|Overall Study||358
10368912|NCT00545363|11509517|FG000|Treated|Overall Study||354
10368913|NCT00545363|11509518|FG001|Treated|Overall Study||357
10368914|NCT00545363|11509517|FG000|COMPLETED|Overall Study||339
10368915|NCT00545363|11509518|FG001|COMPLETED|Overall Study||343
10368916|NCT00545363|11509517|FG000|NOT COMPLETED|Overall Study||19
10368917|NCT00545363|11509518|FG001|NOT COMPLETED|Overall Study||15
10368918|NCT00545402|11509526|FG000|STARTED|Overall Study||90
10368919|NCT00545402|11509527|FG001|STARTED|Overall Study||90
10368920|NCT00545402|11509526|FG000|COMPLETED|Overall Study||56
10368921|NCT00545402|11509527|FG001|COMPLETED|Overall Study||61
10368922|NCT00545402|11509526|FG000|NOT COMPLETED|Overall Study||34
10368923|NCT00545402|11509527|FG001|NOT COMPLETED|Overall Study||29
10368924|NCT00545441|11509535|FG000|STARTED|Overall Study||44
10368925|NCT00545441|11509536|FG001|STARTED|Overall Study||42
10368926|NCT00545441|11509535|FG000|COMPLETED|Overall Study||26
10368927|NCT00545441|11509536|FG001|COMPLETED|Overall Study||26
10368928|NCT00545441|11509535|FG000|NOT COMPLETED|Overall Study||18
10368929|NCT00545441|11509536|FG001|NOT COMPLETED|Overall Study||16
10368930|NCT00545532|11509544|FG000|STARTED|Overall Study||105
10368931|NCT00545532|11509545|FG001|STARTED|Overall Study||110
10368932|NCT00545532|11509544|FG000|COMPLETED|Overall Study||99
10368933|NCT00545532|11509545|FG001|COMPLETED|Overall Study||100
10368934|NCT00545532|11509544|FG000|NOT COMPLETED|Overall Study||6
10368935|NCT00545532|11509545|FG001|NOT COMPLETED|Overall Study||10
10368936|NCT00545571|11509553|FG000|STARTED|Overall Study||120
10368937|NCT00545571|11509553|FG000|COMPLETED|Overall Study||53
10368938|NCT00545571|11509553|FG000|NOT COMPLETED|Overall Study||67
10368939|NCT00545584|11509560|FG000|STARTED|Overall Study||412
10368940|NCT00545584|11509561|FG001|STARTED|Overall Study||414
10368941|NCT00545584|11509562|FG002|STARTED|Overall Study|306 subjects were randomized but only 305 were treated.|306
10368942|NCT00545584|11509560|FG000|COMPLETED|Overall Study||333
10368943|NCT00545584|11509561|FG001|COMPLETED|Overall Study||334
10368944|NCT00545584|11509562|FG002|COMPLETED|Overall Study||250
10368945|NCT00545584|11509560|FG000|NOT COMPLETED|Overall Study||79
10537053|NCT01448616|11689788|FG003|COMPLETED|Study Drug (Treatment Phase)||9
10537054|NCT01448616|11689785|FG000|NOT COMPLETED|Study Drug (Treatment Phase)||0
10537055|NCT01448616|11689786|FG001|NOT COMPLETED|Study Drug (Treatment Phase)||2
10537056|NCT01448616|11689787|FG002|NOT COMPLETED|Study Drug (Treatment Phase)||4
10537057|NCT01448616|11689788|FG003|NOT COMPLETED|Study Drug (Treatment Phase)||4
10537058|NCT01448707|11689803|FG000|STARTED|Overall Study||137
10537059|NCT01448707|11689804|FG001|STARTED|Overall Study||136
10537060|NCT01448707|11689803|FG000|COMPLETED|Overall Study||119
10537061|NCT01448707|11689804|FG001|COMPLETED|Overall Study||118
10537062|NCT01448707|11689803|FG000|NOT COMPLETED|Overall Study||18
10537063|NCT01448707|11689804|FG001|NOT COMPLETED|Overall Study||18
10657142|NCT02223390|11818294|FG000|STARTED|Overall Study||32
10812598|NCT03483051|11974703|FG001|COMPLETED|First Treatment, Pre Crossover||1
10812599|NCT03483051|11974702|FG000|NOT COMPLETED|First Treatment, Pre Crossover||0
10537064|NCT01448824|11689818|FG000|STARTED|Part 1 Period 1: Multiple Ascending Dose||12
10537065|NCT01448824|11689819|FG001|STARTED|Part 1 Period 1: Multiple Ascending Dose||4
10537066|NCT01448824|11689820|FG002|STARTED|Part 1 Period 1: Multiple Ascending Dose||4
10368946|NCT00545584|11509561|FG001|NOT COMPLETED|Overall Study||80
10368947|NCT00545584|11509562|FG002|NOT COMPLETED|Overall Study||56
10368948|NCT00545623|11509574|FG000|STARTED|Overall Study||32
10657143|NCT02223390|11818295|FG001|STARTED|Overall Study||32
10368949|NCT00545623|11509575|FG001|STARTED|Overall Study||31
10368950|NCT00545623|11509576|FG002|STARTED|Overall Study||33
10368951|NCT00545623|11509577|FG003|STARTED|Overall Study||34
10368952|NCT00545623|11509574|FG000|COMPLETED|Overall Study||25
10368953|NCT00545623|11509575|FG001|COMPLETED|Overall Study||21
10368954|NCT00545623|11509576|FG002|COMPLETED|Overall Study||20
10716775|NCT02692040|11880582|FG012|STARTED|Overall Study||6
10716776|NCT02692040|11880583|FG013|STARTED|Overall Study||6
10716777|NCT02692040|11880584|FG014|STARTED|Overall Study||6
10716778|NCT02692040|11880585|FG015|STARTED|Overall Study||6
10716779|NCT02692040|11880586|FG016|STARTED|Overall Study||4
10716780|NCT02692040|11880570|FG000|COMPLETED|Overall Study||10
10716781|NCT02692040|11880571|FG001|COMPLETED|Overall Study||4
10716782|NCT02692040|11880572|FG002|COMPLETED|Overall Study||5
10306112|NCT00097500|11439101|FG000|NOT COMPLETED|Off-drug Period (Week 52 to Week 64)||5
10306113|NCT00097500|11439102|FG001|NOT COMPLETED|Off-drug Period (Week 52 to Week 64)||4
10306114|NCT00097539|11439115|FG000|STARTED|Overall Study||27286
10306115|NCT00097539|11439116|FG001|STARTED|Overall Study||9356
10306116|NCT00097539|11439117|FG002|STARTED|Overall Study||12519
10306117|NCT00097539|11439118|FG003|STARTED|Overall Study||5651
10306118|NCT00097539|11439119|FG004|STARTED|Overall Study||2144
10306119|NCT00097539|11439120|FG005|STARTED|Overall Study||8010
10306120|NCT00097539|11439121|FG006|STARTED|Overall Study||239
10306121|NCT00097539|11439115|FG000|COMPLETED|Overall Study||8220
10306122|NCT00097539|11439116|FG001|COMPLETED|Overall Study||2825
10306123|NCT00097539|11439117|FG002|COMPLETED|Overall Study||3411
10306124|NCT00097539|11439118|FG003|COMPLETED|Overall Study||2066
10306125|NCT00097539|11439119|FG004|COMPLETED|Overall Study||386
10306126|NCT00097539|11439120|FG005|COMPLETED|Overall Study||2118
10306127|NCT00097539|11439121|FG006|COMPLETED|Overall Study||68
10306128|NCT00097539|11439115|FG000|NOT COMPLETED|Overall Study||19066
10306129|NCT00097539|11439116|FG001|NOT COMPLETED|Overall Study||6531
10306130|NCT00097539|11439117|FG002|NOT COMPLETED|Overall Study||9108
10306131|NCT00097539|11439118|FG003|NOT COMPLETED|Overall Study||3585
10306132|NCT00097539|11439119|FG004|NOT COMPLETED|Overall Study||1758
10306133|NCT00097539|11439120|FG005|NOT COMPLETED|Overall Study||5892
10306134|NCT00097539|11439121|FG006|NOT COMPLETED|Overall Study||171
10306135|NCT00097591|11439139|FG000|STARTED|Overall Study|7 subjects randomized but not analyzed due to an incomplete informed consent document|6813
10306136|NCT00097591|11439140|FG001|STARTED|Overall Study|4 subjects randomized but not analyzed due to an incomplete informed consent document|6795
10306137|NCT00097591|11439139|FG000|COMPLETED|Overall Study||6403
10306138|NCT00097591|11439140|FG001|COMPLETED|Overall Study||6401
10306139|NCT00097591|11439139|FG000|NOT COMPLETED|Overall Study||410
10306140|NCT00097591|11439140|FG001|NOT COMPLETED|Overall Study||394
10306141|NCT00097669|11439148|FG000|STARTED|Overall Study||4089
10306142|NCT00097669|11439149|FG001|STARTED|Overall Study||4075
10306143|NCT00097669|11439148|FG000|COMPLETED|Overall Study||4089
10306144|NCT00097669|11439149|FG001|COMPLETED|Overall Study||4075
10306145|NCT00097669|11439148|FG000|NOT COMPLETED|Overall Study||0
10306146|NCT00097669|11439149|FG001|NOT COMPLETED|Overall Study||0
10306147|NCT00097695|11439159|FG000|STARTED|The Controlled Phase||27
10306148|NCT00097695|11439160|FG001|STARTED|The Controlled Phase||29
10306149|NCT00097695|11439161|FG002|STARTED|The Controlled Phase||8
10306150|NCT00097695|11439162|FG003|STARTED|The Controlled Phase||20
10306151|NCT00097695|11439159|FG000|COMPLETED|The Controlled Phase||23
10306152|NCT00097695|11439160|FG001|COMPLETED|The Controlled Phase||26
10306153|NCT00097695|11439161|FG002|COMPLETED|The Controlled Phase||3
10306154|NCT00097695|11439162|FG003|COMPLETED|The Controlled Phase|Patients screened and found eligible but did not have HAE attack or attack was not severe enough|0
10306155|NCT00097695|11439159|FG000|NOT COMPLETED|The Controlled Phase||4
10306156|NCT00097695|11439160|FG001|NOT COMPLETED|The Controlled Phase||3
10306157|NCT00097695|11439161|FG002|NOT COMPLETED|The Controlled Phase||5
10306158|NCT00097695|11439162|FG003|NOT COMPLETED|The Controlled Phase||20
10306159|NCT00097695|11439159|FG000|STARTED|The Open Label Extension (OLE) Phase||23
10306160|NCT00097695|11439160|FG001|STARTED|The Open Label Extension (OLE) Phase||26
10306161|NCT00097695|11439161|FG002|STARTED|The Open Label Extension (OLE) Phase||3
10306162|NCT00097695|11439162|FG003|STARTED|The Open Label Extension (OLE) Phase||20
10306163|NCT00097695|11439159|FG000|COMPLETED|The Open Label Extension (OLE) Phase||10
10306164|NCT00097695|11439160|FG001|COMPLETED|The Open Label Extension (OLE) Phase||11
10306165|NCT00097695|11439161|FG002|COMPLETED|The Open Label Extension (OLE) Phase||1
10306166|NCT00097695|11439162|FG003|COMPLETED|The Open Label Extension (OLE) Phase||15
10306167|NCT00097695|11439159|FG000|NOT COMPLETED|The Open Label Extension (OLE) Phase||13
10368955|NCT00545623|11509577|FG003|COMPLETED|Overall Study||23
10368956|NCT00545623|11509574|FG000|NOT COMPLETED|Overall Study||7
10716783|NCT02692040|11880573|FG003|COMPLETED|Overall Study||5
10716784|NCT02692040|11880574|FG004|COMPLETED|Overall Study||4
10716785|NCT02692040|11880575|FG005|COMPLETED|Overall Study||5
10368957|NCT00545623|11509575|FG001|NOT COMPLETED|Overall Study||10
10368958|NCT00545623|11509576|FG002|NOT COMPLETED|Overall Study||13
10368959|NCT00545623|11509577|FG003|NOT COMPLETED|Overall Study||11
10368960|NCT00545662|11509589|FG000|STARTED|Overall Study||606
10368961|NCT00545662|11509590|FG001|STARTED|Overall Study||607
10368962|NCT00545662|11509589|FG000|COMPLETED|Overall Study||521
10368963|NCT00545662|11509590|FG001|COMPLETED|Overall Study||528
10368964|NCT00545662|11509589|FG000|NOT COMPLETED|Overall Study||85
10368965|NCT00545662|11509590|FG001|NOT COMPLETED|Overall Study||79
10368966|NCT00545688|11509600|FG000|STARTED|Neo-Adjuvant Treatment Period||107
10368967|NCT00545688|11509601|FG001|STARTED|Neo-Adjuvant Treatment Period||107
10368968|NCT00545688|11509602|FG002|STARTED|Neo-Adjuvant Treatment Period||108
10368969|NCT00545688|11509603|FG003|STARTED|Neo-Adjuvant Treatment Period||94
10368970|NCT00545688|11509600|FG000|COMPLETED|Neo-Adjuvant Treatment Period||103
10368971|NCT00545688|11509601|FG001|COMPLETED|Neo-Adjuvant Treatment Period||102
10368972|NCT00545688|11509602|FG002|COMPLETED|Neo-Adjuvant Treatment Period||94
10368973|NCT00545688|11509603|FG003|COMPLETED|Neo-Adjuvant Treatment Period||88
10368974|NCT00545688|11509600|FG000|NOT COMPLETED|Neo-Adjuvant Treatment Period||4
10368975|NCT00545688|11509601|FG001|NOT COMPLETED|Neo-Adjuvant Treatment Period||5
10368976|NCT00545688|11509602|FG002|NOT COMPLETED|Neo-Adjuvant Treatment Period||14
10368977|NCT00545688|11509603|FG003|NOT COMPLETED|Neo-Adjuvant Treatment Period||6
10368978|NCT00545688|11509600|FG000|STARTED|Adjuvant Treatment Period||103
10368979|NCT00545688|11509601|FG001|STARTED|Adjuvant Treatment Period||102
10368980|NCT00545688|11509602|FG002|STARTED|Adjuvant Treatment Period||94
10368981|NCT00545688|11509603|FG003|STARTED|Adjuvant Treatment Period||88
10368982|NCT00545688|11509600|FG000|COMPLETED|Adjuvant Treatment Period||98
10368983|NCT00545688|11509601|FG001|COMPLETED|Adjuvant Treatment Period||94
10368984|NCT00545688|11509602|FG002|COMPLETED|Adjuvant Treatment Period||90
10368985|NCT00545688|11509603|FG003|COMPLETED|Adjuvant Treatment Period||74
10368986|NCT00545688|11509600|FG000|NOT COMPLETED|Adjuvant Treatment Period||5
10368987|NCT00545688|11509601|FG001|NOT COMPLETED|Adjuvant Treatment Period||8
10368988|NCT00545688|11509602|FG002|NOT COMPLETED|Adjuvant Treatment Period||4
10368989|NCT00545688|11509603|FG003|NOT COMPLETED|Adjuvant Treatment Period||14
10368990|NCT00545688|11509600|FG000|STARTED|Follow-Up Period||98
10368991|NCT00545688|11509601|FG001|STARTED|Follow-Up Period||102
10368992|NCT00545688|11509602|FG002|STARTED|Follow-Up Period||98
10368993|NCT00545688|11509603|FG003|STARTED|Follow-Up Period||87
10368994|NCT00545688|11509600|FG000|COMPLETED|Follow-Up Period||77
10368995|NCT00545688|11509601|FG001|COMPLETED|Follow-Up Period||83
10368996|NCT00545688|11509602|FG002|COMPLETED|Follow-Up Period||78
10368997|NCT00545688|11509603|FG003|COMPLETED|Follow-Up Period||60
10368998|NCT00545688|11509600|FG000|NOT COMPLETED|Follow-Up Period||21
10368999|NCT00545688|11509601|FG001|NOT COMPLETED|Follow-Up Period||19
10369000|NCT00545688|11509602|FG002|NOT COMPLETED|Follow-Up Period||20
10369001|NCT00545688|11509603|FG003|NOT COMPLETED|Follow-Up Period||27
10369002|NCT00545714|11509616|FG000|STARTED|Induction Phase (6 Months)||86
10369003|NCT00545714|11509616|FG000|Safety Population|Induction Phase (6 Months)||86
10369004|NCT00545714|11509616|FG000|Intent-to-Treat (ITT) Population|Induction Phase (6 Months)||84
10369005|NCT00545714|11509616|FG000|COMPLETED|Induction Phase (6 Months)||74
10369006|NCT00545714|11509616|FG000|NOT COMPLETED|Induction Phase (6 Months)||12
10369007|NCT00545714|11509616|FG000|STARTED|Maintenance Phase (36 Months)||74
10369008|NCT00545714|11509616|FG000|COMPLETED|Maintenance Phase (36 Months)||42
10369009|NCT00545714|11509616|FG000|NOT COMPLETED|Maintenance Phase (36 Months)||32
10369010|NCT00545740|11509624|FG000|STARTED|Overall Study||145
10369011|NCT00545740|11509625|FG001|STARTED|Overall Study||145
10369012|NCT00545740|11509626|FG002|STARTED|Overall Study||151
10369013|NCT00545740|11509627|FG003|STARTED|Overall Study||149
10369014|NCT00545740|11509624|FG000|COMPLETED|Overall Study||70
10369015|NCT00545740|11509625|FG001|COMPLETED|Overall Study||62
10369016|NCT00545740|11509626|FG002|COMPLETED|Overall Study||55
10369017|NCT00545740|11509627|FG003|COMPLETED|Overall Study||78
10369018|NCT00545740|11509624|FG000|NOT COMPLETED|Overall Study||75
10369019|NCT00545740|11509625|FG001|NOT COMPLETED|Overall Study||83
10369020|NCT00545740|11509626|FG002|NOT COMPLETED|Overall Study||96
10369021|NCT00545740|11509627|FG003|NOT COMPLETED|Overall Study||71
10369022|NCT00545753|11509640|FG000|STARTED|Overall Study||243
10369023|NCT00545753|11509641|FG001|STARTED|Overall Study||59
10369024|NCT00545753|11509642|FG002|STARTED|Overall Study||256
10369025|NCT00545753|11509640|FG000|COMPLETED|Overall Study||227
10369026|NCT00545753|11509641|FG001|COMPLETED|Overall Study||54
10369027|NCT00545753|11509642|FG002|COMPLETED|Overall Study||230
10369028|NCT00545753|11509640|FG000|NOT COMPLETED|Overall Study||16
10369029|NCT00545753|11509641|FG001|NOT COMPLETED|Overall Study||5
10369030|NCT00545753|11509642|FG002|NOT COMPLETED|Overall Study||26
10369031|NCT00545779|11509651|FG000|STARTED|Overall Study||677
10369032|NCT00545779|11509651|FG000|COMPLETED|Overall Study||633
10369033|NCT00545779|11509651|FG000|NOT COMPLETED|Overall Study||44
10369034|NCT00545792|11509655|FG000|STARTED|Overall Study||21
10369035|NCT00545792|11509655|FG000|COMPLETED|Overall Study||20
10369036|NCT00545792|11509655|FG000|NOT COMPLETED|Overall Study||1
10369037|NCT00545818|11509661|FG000|STARTED|Overall Study||49
10369038|NCT00545818|11509662|FG001|STARTED|Overall Study||46
10369039|NCT00545818|11509661|FG000|COMPLETED|Overall Study||46
10369040|NCT00545818|11509662|FG001|COMPLETED|Overall Study||39
10369041|NCT00545818|11509661|FG000|NOT COMPLETED|Overall Study||3
10369042|NCT00545818|11509662|FG001|NOT COMPLETED|Overall Study||7
10427538|NCT00853385|11573359|FG003|NOT COMPLETED|Overall Study||13
10369043|NCT00545948|11509671|FG000|STARTED|Overall Study|Registered patients assigned to receive vinorelbine + cisplatin protocol therapy.|9
10369044|NCT00545948|11509672|FG001|STARTED|Overall Study|Registered patients assigned to receive pemetrexed + cisplatin protocol therapy.|15
10369045|NCT00545948|11509673|FG002|STARTED|Overall Study|Registered patients who were not assigned to receive protocol therapy.|7
10369046|NCT00545948|11509671|FG000|Assigned Treatment|Overall Study||9
10716786|NCT02692040|11880576|FG006|COMPLETED|Overall Study||5
10716787|NCT02692040|11880577|FG007|COMPLETED|Overall Study||5
10716788|NCT02692040|11880578|FG008|COMPLETED|Overall Study||5
10716789|NCT02692040|11880579|FG009|COMPLETED|Overall Study||4
10716790|NCT02692040|11880580|FG010|COMPLETED|Overall Study||5
10716791|NCT02692040|11880581|FG011|COMPLETED|Overall Study||5
10716792|NCT02692040|11880582|FG012|COMPLETED|Overall Study||5
10716793|NCT02692040|11880583|FG013|COMPLETED|Overall Study||3
10369047|NCT00545948|11509672|FG001|Assigned Treatment|Overall Study||15
10369048|NCT00545948|11509673|FG002|Assigned Treatment|Overall Study||0
10369049|NCT00545948|11509671|FG000|COMPLETED|Overall Study|Patients who received vinorelbine + cisplatin protocol therapy.|8
10369050|NCT00545948|11509672|FG001|COMPLETED|Overall Study|Patients who received pemetrexed + cisplatin protocol therapy.|14
10369051|NCT00545948|11509673|FG002|COMPLETED|Overall Study||0
10369052|NCT00545948|11509671|FG000|NOT COMPLETED|Overall Study||1
10369053|NCT00545948|11509672|FG001|NOT COMPLETED|Overall Study||1
10369054|NCT00545948|11509673|FG002|NOT COMPLETED|Overall Study||7
10369055|NCT00545974|11509684|FG000|STARTED|Overall Study|subjects randomized to memantine cohort|39
10369056|NCT00545974|11509685|FG001|STARTED|Overall Study|subjects randomized to placebo cohort|42
10369057|NCT00545974|11509684|FG000|COMPLETED|Overall Study|subjects completed 26 weeks treatment in memantine cohort|37
10369058|NCT00545974|11509685|FG001|COMPLETED|Overall Study|subjects completed 26 weeks treatment in placebo cohort|39
10369059|NCT00545974|11509684|FG000|NOT COMPLETED|Overall Study||2
10369060|NCT00545974|11509685|FG001|NOT COMPLETED|Overall Study||3
10369061|NCT00546000|11509691|FG000|STARTED|Overall Study||56
10369062|NCT00546000|11509691|FG000|COMPLETED|Overall Study||52
10369063|NCT00546000|11509691|FG000|NOT COMPLETED|Overall Study||4
10369064|NCT00546078|11509697|FG000|STARTED|Overall Study||65
10369065|NCT00546078|11509698|FG001|STARTED|Overall Study||50
10369066|NCT00546078|11509697|FG000|Month 18|Overall Study||61
10369067|NCT00546078|11509698|FG001|Month 18|Overall Study||45
10369068|NCT00546078|11509697|FG000|COMPLETED|Overall Study||61
10369069|NCT00546078|11509698|FG001|COMPLETED|Overall Study||43
10369070|NCT00546078|11509697|FG000|NOT COMPLETED|Overall Study||4
10369071|NCT00546078|11509698|FG001|NOT COMPLETED|Overall Study||7
10369072|NCT00546104|11509704|FG000|STARTED|Overall Study||31
10369073|NCT00546104|11509704|FG000|COMPLETED|Overall Study||31
10369074|NCT00546104|11509704|FG000|NOT COMPLETED|Overall Study||0
10369075|NCT00546117|11509710|FG000|STARTED|Overall Study||9
10369076|NCT00546117|11509711|FG001|STARTED|Overall Study||7
10369077|NCT00546117|11509710|FG000|COMPLETED|Overall Study||5
10369078|NCT00546117|11509711|FG001|COMPLETED|Overall Study||7
10369079|NCT00546117|11509710|FG000|NOT COMPLETED|Overall Study||4
10369080|NCT00546117|11509711|FG001|NOT COMPLETED|Overall Study||0
10369081|NCT00546156|11509721|FG000|STARTED|Overall Study||84
10369082|NCT00546156|11509722|FG001|STARTED|Overall Study||20
10369083|NCT00546156|11509721|FG000|COMPLETED|Overall Study||70
10369084|NCT00546156|11509722|FG001|COMPLETED|Overall Study||19
10369085|NCT00546156|11509721|FG000|NOT COMPLETED|Overall Study||14
10369086|NCT00546156|11509722|FG001|NOT COMPLETED|Overall Study||1
10369087|NCT00546260|11509729|FG000|STARTED|Overall Study||36
10369088|NCT00546260|11509730|FG001|STARTED|Overall Study||34
10369089|NCT00546260|11509729|FG000|COMPLETED|Overall Study||28
10369090|NCT00546260|11509730|FG001|COMPLETED|Overall Study||32
10369091|NCT00546260|11509729|FG000|NOT COMPLETED|Overall Study||8
10369092|NCT00546260|11509730|FG001|NOT COMPLETED|Overall Study||2
10369093|NCT00546351|11509736|FG000|STARTED|Overall Study||621
10369094|NCT00546351|11509736|FG000|COMPLETED|Overall Study||385
10369095|NCT00546351|11509736|FG000|NOT COMPLETED|Overall Study||236
10369096|NCT00546364|11509743|FG000|STARTED|Overall Study||20
10369097|NCT00546364|11509744|FG001|STARTED|Overall Study||22
10369098|NCT00546364|11509745|FG002|STARTED|Overall Study||20
10369099|NCT00546364|11509743|FG000|Never Treated|Overall Study||0
10369100|NCT00546364|11509744|FG001|Never Treated|Overall Study||0
10369101|NCT00546364|11509745|FG002|Never Treated|Overall Study||0
10369102|NCT00546364|11509743|FG000|COMPLETED|Overall Study|Still on treatment|3
10369103|NCT00546364|11509744|FG001|COMPLETED|Overall Study|Still on treatment|4
10369104|NCT00546364|11509745|FG002|COMPLETED|Overall Study|Still on treatment|3
10369105|NCT00546364|11509743|FG000|NOT COMPLETED|Overall Study||17
10369106|NCT00546364|11509744|FG001|NOT COMPLETED|Overall Study||18
10369107|NCT00546364|11509745|FG002|NOT COMPLETED|Overall Study||17
10369108|NCT00546377|11509753|FG000|STARTED|Overall Study||50
10369109|NCT00546377|11509753|FG000|COMPLETED|Overall Study||43
10369110|NCT00546377|11509753|FG000|NOT COMPLETED|Overall Study||7
10369111|NCT00546390|11509759|FG000|STARTED|Overall Study||27
10369112|NCT00546390|11509760|FG001|STARTED|Overall Study||28
10716794|NCT02692040|11880584|FG014|COMPLETED|Overall Study||5
10369113|NCT00546390|11509759|FG000|COMPLETED|Overall Study||27
10369114|NCT00546390|11509760|FG001|COMPLETED|Overall Study||28
10369115|NCT00546390|11509759|FG000|NOT COMPLETED|Overall Study||0
10369116|NCT00546390|11509760|FG001|NOT COMPLETED|Overall Study||0
10427539|NCT00853385|11573360|FG004|NOT COMPLETED|Overall Study||42
10716795|NCT02692040|11880585|FG015|COMPLETED|Overall Study||5
10716796|NCT02692040|11880586|FG016|COMPLETED|Overall Study||4
10306168|NCT00097695|11439160|FG001|NOT COMPLETED|The Open Label Extension (OLE) Phase||15
10306169|NCT00097695|11439161|FG002|NOT COMPLETED|The Open Label Extension (OLE) Phase||2
10306170|NCT00097695|11439162|FG003|NOT COMPLETED|The Open Label Extension (OLE) Phase||5
10306171|NCT00097708|11439177|FG000|STARTED|Overall Study||173
10306172|NCT00097708|11439178|FG001|STARTED|Overall Study||176
10306173|NCT00097708|11439179|FG002|STARTED|Overall Study||162
10306174|NCT00097708|11439177|FG000|Intent-to-Treat (ITT)|Overall Study||165
10306175|NCT00097708|11439178|FG001|Intent-to-Treat (ITT)|Overall Study||169
10306176|NCT00097708|11439179|FG002|Intent-to-Treat (ITT)|Overall Study||149
10306177|NCT00097708|11439177|FG000|Treated|Overall Study||171
10306178|NCT00097708|11439178|FG001|Treated|Overall Study||176
10306179|NCT00097708|11439179|FG002|Treated|Overall Study||160
10306180|NCT00097708|11439177|FG000|COMPLETED|Overall Study||109
10306181|NCT00097708|11439178|FG001|COMPLETED|Overall Study||120
10306182|NCT00097708|11439179|FG002|COMPLETED|Overall Study||97
10306183|NCT00097708|11439177|FG000|NOT COMPLETED|Overall Study||64
10306184|NCT00097708|11439178|FG001|NOT COMPLETED|Overall Study||56
10306185|NCT00097708|11439179|FG002|NOT COMPLETED|Overall Study||65
10306186|NCT00097721|11439189|FG000|STARTED|Overall Study|The number started is all enrolled subjects.BL Characteristics consists of Safety Population.|71
10306187|NCT00097721|11439190|FG001|STARTED|Overall Study||33
10306188|NCT00097721|11439189|FG000|COMPLETED|Overall Study||0
10306189|NCT00097721|11439190|FG001|COMPLETED|Overall Study||0
10306190|NCT00097721|11439189|FG000|NOT COMPLETED|Overall Study||71
10306191|NCT00097721|11439190|FG001|NOT COMPLETED|Overall Study||33
10306192|NCT00097773|11439200|FG000|STARTED|Overall Study||76
10306193|NCT00097773|11439201|FG001|STARTED|Overall Study||76
10306194|NCT00097773|11439202|FG002|STARTED|Overall Study||76
10306195|NCT00097773|11439203|FG003|STARTED|Overall Study||76
10306196|NCT00097773|11439200|FG000|COMPLETED|Overall Study||68
10306197|NCT00097773|11439201|FG001|COMPLETED|Overall Study||68
10306198|NCT00097773|11439202|FG002|COMPLETED|Overall Study||68
10306199|NCT00097773|11439203|FG003|COMPLETED|Overall Study||73
10306200|NCT00097773|11439200|FG000|NOT COMPLETED|Overall Study||8
10306201|NCT00097773|11439201|FG001|NOT COMPLETED|Overall Study||8
10306202|NCT00097773|11439202|FG002|NOT COMPLETED|Overall Study||8
10306203|NCT00097773|11439203|FG003|NOT COMPLETED|Overall Study||3
10306204|NCT00097786|11439222|FG000|STARTED|Overall Study|"Started indicates Full Analysis Set (FAS) population. Initially enrolled 9518, 212 excluded."|2316
10306205|NCT00097786|11439223|FG001|STARTED|Overall Study||2315
10306206|NCT00097786|11439224|FG002|STARTED|Overall Study||2329
10306207|NCT00097786|11439225|FG003|STARTED|Overall Study||2346
10306208|NCT00097786|11439222|FG000|Complete FU for Progression to Diabetes|Overall Study||1709
10306209|NCT00097786|11439223|FG001|Complete FU for Progression to Diabetes|Overall Study||1712
10306210|NCT00097786|11439224|FG002|Complete FU for Progression to Diabetes|Overall Study||1734
10306211|NCT00097786|11439225|FG003|Complete FU for Progression to Diabetes|Overall Study||1762
10306212|NCT00097786|11439222|FG000|Complete Follow-up for Extended CV EPs|Overall Study||1969
10306213|NCT00097786|11439223|FG001|Complete Follow-up for Extended CV EPs|Overall Study||1985
10306214|NCT00097786|11439224|FG002|Complete Follow-up for Extended CV EPs|Overall Study||1987
10306215|NCT00097786|11439225|FG003|Complete Follow-up for Extended CV EPs|Overall Study||2015
10306216|NCT00097786|11439222|FG000|Complete Follow-up for Core CV EPs|Overall Study||1948
10306217|NCT00097786|11439223|FG001|Complete Follow-up for Core CV EPs|Overall Study||1963
10306218|NCT00097786|11439224|FG002|Complete Follow-up for Core CV EPs|Overall Study||1966
10306219|NCT00097786|11439225|FG003|Complete Follow-up for Core CV EPs|Overall Study||1988
10306220|NCT00097786|11439222|FG000|COMPLETED|Overall Study|"Completed means completed follow up for all cause death."|2020
10306221|NCT00097786|11439223|FG001|COMPLETED|Overall Study||2023
10306222|NCT00097786|11439224|FG002|COMPLETED|Overall Study||2016
10306223|NCT00097786|11439225|FG003|COMPLETED|Overall Study||2036
10306224|NCT00097786|11439222|FG000|NOT COMPLETED|Overall Study||296
10306225|NCT00097786|11439223|FG001|NOT COMPLETED|Overall Study||292
10306226|NCT00097786|11439224|FG002|NOT COMPLETED|Overall Study||313
10306227|NCT00097786|11439225|FG003|NOT COMPLETED|Overall Study||310
10306228|NCT00097981|11439237|FG000|STARTED|Overall Study|Enrollment at randomization|113
10306229|NCT00097981|11439238|FG001|STARTED|Overall Study|Enrollment at randomization|112
10306230|NCT00097981|11439237|FG000|Received Study Medication|Overall Study||110
10306231|NCT00097981|11439238|FG001|Received Study Medication|Overall Study||106
10306232|NCT00097981|11439237|FG000|COMPLETED|Overall Study|Completion of 2 or more cycles after CR or nCR, or completion of 12 cycles.|7
10306233|NCT00097981|11439238|FG001|COMPLETED|Overall Study|Completion of 2 or more cycles after CR or nCR, or completion of 12 cycles.|12
10306234|NCT00097981|11439237|FG000|NOT COMPLETED|Overall Study||106
10306235|NCT00097981|11439238|FG001|NOT COMPLETED|Overall Study||100
10306236|NCT00098020|11439244|FG000|STARTED|Overall Study||12
10306237|NCT00098020|11439244|FG000|Started Isotretinoin|Overall Study||8
10306238|NCT00098020|11439244|FG000|COMPLETED|Overall Study||6
10306239|NCT00098020|11439244|FG000|NOT COMPLETED|Overall Study||6
10306240|NCT00098059|11439250|FG000|STARTED|Overall Study||27
10306241|NCT00098059|11439251|FG001|STARTED|Overall Study||47
10369117|NCT00546429|11509767|FG000|STARTED|Overall Study|2 subjects did not have a preoperative Merle D'Aubigne score.|62
10369118|NCT00546429|11509767|FG000|COMPLETED|Overall Study||32
10369119|NCT00546429|11509767|FG000|NOT COMPLETED|Overall Study||30
10369120|NCT00546481|11509773|FG000|STARTED|Correction Phase (CERA or Epoetin Beta)||39
10369121|NCT00546481|11509774|FG001|STARTED|Correction Phase (CERA or Epoetin Beta)||41
10369122|NCT00546481|11509775|FG002|STARTED|Correction Phase (CERA or Epoetin Beta)||0
10369123|NCT00546481|11509773|FG000|COMPLETED|Correction Phase (CERA or Epoetin Beta)||33
10369124|NCT00546481|11509774|FG001|COMPLETED|Correction Phase (CERA or Epoetin Beta)||36
10369125|NCT00546481|11509775|FG002|COMPLETED|Correction Phase (CERA or Epoetin Beta)||0
10369126|NCT00546481|11509773|FG000|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||6
10369127|NCT00546481|11509774|FG001|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||5
10369128|NCT00546481|11509775|FG002|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||0
10369129|NCT00546481|11509773|FG000|STARTED|Maintenance Phase (CERA)||0
10369130|NCT00546481|11509774|FG001|STARTED|Maintenance Phase (CERA)||0
10369131|NCT00546481|11509775|FG002|STARTED|Maintenance Phase (CERA)||54
10369132|NCT00546481|11509773|FG000|COMPLETED|Maintenance Phase (CERA)||0
10369133|NCT00546481|11509774|FG001|COMPLETED|Maintenance Phase (CERA)||0
10369134|NCT00546481|11509775|FG002|COMPLETED|Maintenance Phase (CERA)||50
10369135|NCT00546481|11509773|FG000|NOT COMPLETED|Maintenance Phase (CERA)||0
10369136|NCT00546481|11509774|FG001|NOT COMPLETED|Maintenance Phase (CERA)||0
10369137|NCT00546481|11509775|FG002|NOT COMPLETED|Maintenance Phase (CERA)||4
10369138|NCT00546572|11509785|FG000|STARTED|Vax 1 / Year 0||464
10369139|NCT00546572|11509786|FG001|STARTED|Vax 1 / Year 0||474
10369140|NCT00546572|11509785|FG000|Received Vax 1|Vax 1 / Year 0||463
10369141|NCT00546572|11509786|FG001|Received Vax 1|Vax 1 / Year 0||473
10369142|NCT00546572|11509785|FG000|COMPLETED|Vax 1 / Year 0||391
10369143|NCT00546572|11509786|FG001|COMPLETED|Vax 1 / Year 0||404
10369144|NCT00546572|11509785|FG000|NOT COMPLETED|Vax 1 / Year 0||73
10369145|NCT00546572|11509786|FG001|NOT COMPLETED|Vax 1 / Year 0||70
10369146|NCT00546572|11509785|FG000|STARTED|Vax 2 / Year 1||391
10369147|NCT00546572|11509786|FG001|STARTED|Vax 2 / Year 1||404
10369148|NCT00546572|11509785|FG000|Received Vax 2|Vax 2 / Year 1||391
10369149|NCT00546572|11509786|FG001|Received Vax 2|Vax 2 / Year 1||404
10369150|NCT00546572|11509785|FG000|COMPLETED|Vax 2 / Year 1||387
10369151|NCT00546572|11509786|FG001|COMPLETED|Vax 2 / Year 1||402
10369152|NCT00546572|11509785|FG000|NOT COMPLETED|Vax 2 / Year 1||4
10369153|NCT00546572|11509786|FG001|NOT COMPLETED|Vax 2 / Year 1||2
10369154|NCT00546637|11509805|FG000|STARTED|Overall Study||474
10369155|NCT00546637|11509806|FG001|STARTED|Overall Study||473
10369156|NCT00546637|11509805|FG000|Received Treatment|Overall Study||471
10369157|NCT00546637|11509806|FG001|Received Treatment|Overall Study||472
10369158|NCT00546637|11509805|FG000|COMPLETED|Overall Study||401
10369159|NCT00546637|11509806|FG001|COMPLETED|Overall Study||424
10369160|NCT00546637|11509805|FG000|NOT COMPLETED|Overall Study||73
10369161|NCT00546637|11509806|FG001|NOT COMPLETED|Overall Study||49
10369162|NCT00546715|11509816|FG000|STARTED|Overall Study||6
10369163|NCT00546715|11509817|FG001|STARTED|Overall Study||5
10369164|NCT00546715|11509818|FG002|STARTED|Overall Study||5
10369165|NCT00546715|11509819|FG003|STARTED|Overall Study||2
10369166|NCT00546715|11509816|FG000|COMPLETED|Overall Study||6
10369167|NCT00546715|11509817|FG001|COMPLETED|Overall Study||4
10369168|NCT00546715|11509818|FG002|COMPLETED|Overall Study||5
10369169|NCT00546715|11509819|FG003|COMPLETED|Overall Study||2
10369170|NCT00546715|11509816|FG000|NOT COMPLETED|Overall Study||0
10369171|NCT00546715|11509817|FG001|NOT COMPLETED|Overall Study||1
10369172|NCT00546715|11509818|FG002|NOT COMPLETED|Overall Study||0
10369173|NCT00546715|11509819|FG003|NOT COMPLETED|Overall Study||0
10369174|NCT00546728|11509831|FG000|STARTED|Overall Study||25
10369175|NCT00546728|11509832|FG001|STARTED|Overall Study||25
10369176|NCT00546728|11509831|FG000|COMPLETED|Overall Study||25
10369177|NCT00546728|11509832|FG001|COMPLETED|Overall Study||25
10369178|NCT00546728|11509831|FG000|NOT COMPLETED|Overall Study||0
10369179|NCT00546728|11509832|FG001|NOT COMPLETED|Overall Study||0
10537067|NCT01448824|11689821|FG003|STARTED|Part 1 Period 1: Multiple Ascending Dose||10
10537068|NCT01448824|11689822|FG004|STARTED|Part 1 Period 1: Multiple Ascending Dose||16
10537069|NCT01448824|11689823|FG005|STARTED|Part 1 Period 1: Multiple Ascending Dose||12
10537070|NCT01448824|11689824|FG006|STARTED|Part 1 Period 1: Multiple Ascending Dose||12
10537071|NCT01448824|11689825|FG007|STARTED|Part 1 Period 1: Multiple Ascending Dose||0
10537072|NCT01448824|11689818|FG000|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||12
10537073|NCT01448824|11689819|FG001|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||4
10537074|NCT01448824|11689820|FG002|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||4
10537075|NCT01448824|11689821|FG003|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||10
10537076|NCT01448824|11689822|FG004|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||16
10537077|NCT01448824|11689823|FG005|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||12
10537078|NCT01448824|11689824|FG006|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||12
10537079|NCT01448824|11689825|FG007|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||0
10537080|NCT01448824|11689818|FG000|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||12
10537081|NCT01448824|11689819|FG001|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||4
10537082|NCT01448824|11689820|FG002|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||4
10537083|NCT01448824|11689821|FG003|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||9
10537084|NCT01448824|11689822|FG004|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||14
10369180|NCT00546819|11509840|FG000|STARTED|Overall Study||207
10369181|NCT00546819|11509841|FG001|STARTED|Overall Study||102
10369182|NCT00546819|11509840|FG000|VACCINATED|Overall Study||206
10369183|NCT00546819|11509841|FG001|VACCINATED|Overall Study||100
10369184|NCT00546819|11509840|FG000|COMPLETED|Overall Study||199
10369185|NCT00546819|11509841|FG001|COMPLETED|Overall Study||96
10369186|NCT00546819|11509840|FG000|NOT COMPLETED|Overall Study||8
10369187|NCT00546819|11509841|FG001|NOT COMPLETED|Overall Study||6
10369188|NCT00546871|11509847|FG000|STARTED|Part 1 - IV Infusions of IGIV, PK||14
10369189|NCT00546871|11509848|FG001|STARTED|Part 1 - IV Infusions of IGIV, PK||35
10369190|NCT00546871|11509847|FG000|COMPLETED|Part 1 - IV Infusions of IGIV, PK||13
10369191|NCT00546871|11509848|FG001|COMPLETED|Part 1 - IV Infusions of IGIV, PK||35
10369192|NCT00546871|11509847|FG000|NOT COMPLETED|Part 1 - IV Infusions of IGIV, PK||1
10369193|NCT00546871|11509848|FG001|NOT COMPLETED|Part 1 - IV Infusions of IGIV, PK||0
10369194|NCT00546871|11509847|FG000|STARTED|Part 2 - Subcutaneous (SC) IGIV, PK||13
10369195|NCT00546871|11509848|FG001|STARTED|Part 2 - Subcutaneous (SC) IGIV, PK||35
10369196|NCT00546871|11509847|FG000|COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||12
10369197|NCT00546871|11509848|FG001|COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||32
10369198|NCT00546871|11509847|FG000|NOT COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||1
10369199|NCT00546871|11509848|FG001|NOT COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||3
10369200|NCT00546871|11509847|FG000|STARTED|Part 3a- SC IGIV Adjusted Dose, PK Based||12
10369201|NCT00546871|11509848|FG001|STARTED|Part 3a- SC IGIV Adjusted Dose, PK Based||32
10369202|NCT00546871|11509847|FG000|COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||12
10369203|NCT00546871|11509848|FG001|COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||32
10369204|NCT00546871|11509847|FG000|NOT COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||0
10369205|NCT00546871|11509848|FG001|NOT COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||0
10369206|NCT00546871|11509847|FG000|STARTED|Part 3b - SC IGIV 12 Weeks||12
10369207|NCT00546871|11509848|FG001|STARTED|Part 3b - SC IGIV 12 Weeks||32
10369208|NCT00546871|11509847|FG000|COMPLETED|Part 3b - SC IGIV 12 Weeks||12
10369209|NCT00546871|11509848|FG001|COMPLETED|Part 3b - SC IGIV 12 Weeks||32
10369210|NCT00546871|11509847|FG000|NOT COMPLETED|Part 3b - SC IGIV 12 Weeks||0
10369211|NCT00546871|11509848|FG001|NOT COMPLETED|Part 3b - SC IGIV 12 Weeks||0
10369212|NCT00546871|11509847|FG000|STARTED|Study Extension Period|2 withdrawn after Part 3b|10
10369213|NCT00546871|11509848|FG001|STARTED|Study Extension Period|6 withdrawn after Part 3b|26
10369214|NCT00546871|11509847|FG000|COMPLETED|Study Extension Period||9
10369215|NCT00546871|11509848|FG001|COMPLETED|Study Extension Period||25
10369216|NCT00546871|11509847|FG000|NOT COMPLETED|Study Extension Period||1
10369217|NCT00546871|11509848|FG001|NOT COMPLETED|Study Extension Period||1
10369218|NCT00546884|11509879|FG000|STARTED|Overall Study||145
10369219|NCT00546884|11509880|FG001|STARTED|Overall Study||117
10369220|NCT00546884|11509879|FG000|COMPLETED|Overall Study||145
10537085|NCT01448824|11689823|FG005|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||10
10537086|NCT01448824|11689824|FG006|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||11
10537087|NCT01448824|11689825|FG007|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
10537088|NCT01448824|11689818|FG000|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
10537089|NCT01448824|11689819|FG001|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
10537090|NCT01448824|11689820|FG002|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
10537091|NCT01448824|11689821|FG003|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||1
10537092|NCT01448824|11689822|FG004|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||2
10537093|NCT01448824|11689823|FG005|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||2
10537094|NCT01448824|11689824|FG006|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||1
10537095|NCT01448824|11689825|FG007|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
10537096|NCT01448824|11689818|FG000|STARTED|Part 1: Washout Period||12
10537097|NCT01448824|11689819|FG001|STARTED|Part 1: Washout Period||4
10537098|NCT01448824|11689820|FG002|STARTED|Part 1: Washout Period||4
10537099|NCT01448824|11689821|FG003|STARTED|Part 1: Washout Period|Participants in Part 1 Cohorts B through D participated in Period 1 only.|0
10537100|NCT01448824|11689822|FG004|STARTED|Part 1: Washout Period|Participants in Part 1 Cohort B participated in Period 1 only.|0
10537101|NCT01448824|11689823|FG005|STARTED|Part 1: Washout Period|Participants in Part 1 Cohort C participated in Period 1 only.|0
10537102|NCT01448824|11689824|FG006|STARTED|Part 1: Washout Period|Participants in Part 1 Cohort D participated in Period 1 only.|0
10537103|NCT01448824|11689825|FG007|STARTED|Part 1: Washout Period||0
10537104|NCT01448824|11689818|FG000|COMPLETED|Part 1: Washout Period||11
10537105|NCT01448824|11689819|FG001|COMPLETED|Part 1: Washout Period||4
10537106|NCT01448824|11689820|FG002|COMPLETED|Part 1: Washout Period||4
10537107|NCT01448824|11689821|FG003|COMPLETED|Part 1: Washout Period||0
10537108|NCT01448824|11689822|FG004|COMPLETED|Part 1: Washout Period||0
10537109|NCT01448824|11689823|FG005|COMPLETED|Part 1: Washout Period||0
10537110|NCT01448824|11689824|FG006|COMPLETED|Part 1: Washout Period||0
10537111|NCT01448824|11689825|FG007|COMPLETED|Part 1: Washout Period||0
10537112|NCT01448824|11689818|FG000|NOT COMPLETED|Part 1: Washout Period||1
10537113|NCT01448824|11689819|FG001|NOT COMPLETED|Part 1: Washout Period||0
10537114|NCT01448824|11689820|FG002|NOT COMPLETED|Part 1: Washout Period||0
10537115|NCT01448824|11689821|FG003|NOT COMPLETED|Part 1: Washout Period||0
10537116|NCT01448824|11689822|FG004|NOT COMPLETED|Part 1: Washout Period||0
10537117|NCT01448824|11689823|FG005|NOT COMPLETED|Part 1: Washout Period||0
10537118|NCT01448824|11689824|FG006|NOT COMPLETED|Part 1: Washout Period||0
10537119|NCT01448824|11689825|FG007|NOT COMPLETED|Part 1: Washout Period||0
10537120|NCT01448824|11689818|FG000|STARTED|Part 1 Period 2: Multiple Ascending Dose||11
10537121|NCT01448824|11689819|FG001|STARTED|Part 1 Period 2: Multiple Ascending Dose||4
10537122|NCT01448824|11689820|FG002|STARTED|Part 1 Period 2: Multiple Ascending Dose||4
10657144|NCT02223390|11818294|FG000|COMPLETED|Overall Study||23
10657145|NCT02223390|11818295|FG001|COMPLETED|Overall Study||28
10657146|NCT02223390|11818294|FG000|NOT COMPLETED|Overall Study||9
10657147|NCT02223390|11818295|FG001|NOT COMPLETED|Overall Study||4
10657148|NCT02223429|11818305|FG000|STARTED|Overall Study||8
10657149|NCT02223429|11818306|FG001|STARTED|Overall Study||8
10657150|NCT02223429|11818307|FG002|STARTED|Overall Study||8
10657151|NCT02223429|11818308|FG003|STARTED|Overall Study||8
10657152|NCT02223429|11818305|FG000|COMPLETED|Overall Study||7
10657153|NCT02223429|11818306|FG001|COMPLETED|Overall Study||8
10657154|NCT02223429|11818307|FG002|COMPLETED|Overall Study||8
10369221|NCT00546884|11509880|FG001|COMPLETED|Overall Study||117
10369222|NCT00546884|11509879|FG000|NOT COMPLETED|Overall Study||0
10369223|NCT00546884|11509880|FG001|NOT COMPLETED|Overall Study||0
10369224|NCT00546897|11509888|FG000|STARTED|Overall Study||15
10369225|NCT00546897|11509889|FG001|STARTED|Overall Study||33
10369226|NCT00546897|11509888|FG000|COMPLETED|Overall Study||15
10369227|NCT00546897|11509889|FG001|COMPLETED|Overall Study||33
10369228|NCT00546897|11509888|FG000|NOT COMPLETED|Overall Study||0
10369229|NCT00546897|11509889|FG001|NOT COMPLETED|Overall Study||0
10369230|NCT00546910|11509897|FG000|STARTED|Overall Study||63
10369231|NCT00546910|11509898|FG001|STARTED|Overall Study||62
10369232|NCT00546910|11509897|FG000|COMPLETED|Overall Study||54
10369233|NCT00546910|11509898|FG001|COMPLETED|Overall Study||51
10369234|NCT00546910|11509897|FG000|NOT COMPLETED|Overall Study||9
10369235|NCT00546910|11509898|FG001|NOT COMPLETED|Overall Study||11
10369236|NCT00547105|11509904|FG000|STARTED|Overall Study||24
10369237|NCT00547105|11509904|FG000|COMPLETED|Overall Study||24
10369238|NCT00547105|11509904|FG000|NOT COMPLETED|Overall Study||0
10369239|NCT00547118|11509910|FG000|STARTED|Overall Study||8
10369240|NCT00547118|11509911|FG001|STARTED|Overall Study||9
10369241|NCT00547118|11509910|FG000|COMPLETED|Overall Study||0
10369242|NCT00547118|11509911|FG001|COMPLETED|Overall Study||0
10369243|NCT00547118|11509910|FG000|NOT COMPLETED|Overall Study||8
10369244|NCT00547118|11509911|FG001|NOT COMPLETED|Overall Study||9
10369245|NCT00547157|11509921|FG000|STARTED|Overall Study||90
10369246|NCT00547157|11509922|FG001|STARTED|Overall Study||62
10369247|NCT00547157|11509921|FG000|COMPLETED|Overall Study||41
10369248|NCT00547157|11509922|FG001|COMPLETED|Overall Study||39
10369249|NCT00547157|11509921|FG000|NOT COMPLETED|Overall Study||49
10369250|NCT00547157|11509922|FG001|NOT COMPLETED|Overall Study||23
10369251|NCT00547248|11509932|FG000|STARTED|Overall Study||280
10369252|NCT00547248|11509933|FG001|STARTED|Overall Study||93
10369253|NCT00547248|11509934|FG002|STARTED|Overall Study||285
10369254|NCT00547248|11509935|FG003|STARTED|Overall Study||98
10369255|NCT00547248|11509932|FG000|COMPLETED|Overall Study||280
10369256|NCT00547248|11509933|FG001|COMPLETED|Overall Study||93
10369257|NCT00547248|11509934|FG002|COMPLETED|Overall Study||275
10369258|NCT00547248|11509935|FG003|COMPLETED|Overall Study||96
10369259|NCT00547248|11509932|FG000|NOT COMPLETED|Overall Study||0
10369260|NCT00547248|11509933|FG001|NOT COMPLETED|Overall Study||0
10369261|NCT00547248|11509934|FG002|NOT COMPLETED|Overall Study||10
10369262|NCT00547248|11509935|FG003|NOT COMPLETED|Overall Study||2
10369263|NCT00547365|11509948|FG000|STARTED|Overall Study||10
10369264|NCT00547365|11509948|FG000|COMPLETED|Overall Study||2
10369265|NCT00547365|11509948|FG000|NOT COMPLETED|Overall Study||8
10369266|NCT00547378|11509956|FG000|STARTED|Randomized Cohort||70
10369267|NCT00547378|11509957|FG001|STARTED|Randomized Cohort||77
10369268|NCT00547378|11509958|FG002|STARTED|Randomized Cohort||0
10369269|NCT00547378|11509956|FG000|Month 3|Randomized Cohort|This includes IST subjects reached Month 3 visit, regardless of implant or not.|62
10369270|NCT00547378|11509957|FG001|Month 3|Randomized Cohort|This included SMT subjects who reached SMT Month 3 visit.|72
10369271|NCT00547378|11509958|FG002|Month 3|Randomized Cohort||0
10369272|NCT00547378|11509956|FG000|Month 6|Randomized Cohort|This includes IST subjects reached Month 6 visit, regardless of implant or not.|59
10369273|NCT00547378|11509957|FG001|Month 6|Randomized Cohort|This included SMT subjects who reached SMT Month 6 visit.|71
10369274|NCT00547378|11509958|FG002|Month 6|Randomized Cohort||0
10369275|NCT00547378|11509956|FG000|COMPLETED|Randomized Cohort||59
10369276|NCT00547378|11509957|FG001|COMPLETED|Randomized Cohort||71
10369277|NCT00547378|11509958|FG002|COMPLETED|Randomized Cohort||0
10369278|NCT00547378|11509956|FG000|NOT COMPLETED|Randomized Cohort||11
10369279|NCT00547378|11509957|FG001|NOT COMPLETED|Randomized Cohort||6
10369280|NCT00547378|11509958|FG002|NOT COMPLETED|Randomized Cohort||0
10369281|NCT00547378|11509956|FG000|STARTED|All Implanted Cohort|This included subjects who received full system implant after randomized to IST.|51
10369282|NCT00547378|11509957|FG001|STARTED|All Implanted Cohort|This included SMT subjects who received full system implant after completing randomization period.|40
10369283|NCT00547378|11509958|FG002|STARTED|All Implanted Cohort|This included subjects who received full system implant from non-randomized subjects.|181
10369284|NCT00547378|11509956|FG000|Month 3|All Implanted Cohort||51
10369285|NCT00547378|11509957|FG001|Month 3|All Implanted Cohort||39
10369286|NCT00547378|11509958|FG002|Month 3|All Implanted Cohort||178
10369287|NCT00547378|11509956|FG000|Month 6|All Implanted Cohort||50
10369288|NCT00547378|11509957|FG001|Month 6|All Implanted Cohort||36
10369289|NCT00547378|11509958|FG002|Month 6|All Implanted Cohort||178
10369290|NCT00547378|11509956|FG000|Month 12|All Implanted Cohort||48
10369291|NCT00547378|11509957|FG001|Month 12|All Implanted Cohort||32
10369292|NCT00547378|11509958|FG002|Month 12|All Implanted Cohort||175
10657155|NCT02223429|11818308|FG003|COMPLETED|Overall Study||8
10369293|NCT00547378|11509956|FG000|Month 24|All Implanted Cohort||42
10369294|NCT00547378|11509957|FG001|Month 24|All Implanted Cohort||30
10369295|NCT00547378|11509958|FG002|Month 24|All Implanted Cohort||161
10369296|NCT00547378|11509956|FG000|Month 36|All Implanted Cohort||42
10369297|NCT00547378|11509957|FG001|Month 36|All Implanted Cohort||29
10369298|NCT00547378|11509958|FG002|Month 36|All Implanted Cohort||146
10369299|NCT00547378|11509956|FG000|Month 48|All Implanted Cohort||38
10369300|NCT00547378|11509957|FG001|Month 48|All Implanted Cohort||27
10369301|NCT00547378|11509958|FG002|Month 48|All Implanted Cohort||136
10369302|NCT00547378|11509956|FG000|Month 60|All Implanted Cohort||36
10369303|NCT00547378|11509957|FG001|Month 60|All Implanted Cohort||23
10369304|NCT00547378|11509958|FG002|Month 60|All Implanted Cohort||114
10369305|NCT00547378|11509956|FG000|COMPLETED|All Implanted Cohort||36
10369306|NCT00547378|11509957|FG001|COMPLETED|All Implanted Cohort||22
10369307|NCT00547378|11509958|FG002|COMPLETED|All Implanted Cohort||111
10369308|NCT00547378|11509956|FG000|NOT COMPLETED|All Implanted Cohort||15
10369309|NCT00547378|11509957|FG001|NOT COMPLETED|All Implanted Cohort||18
10369310|NCT00547378|11509958|FG002|NOT COMPLETED|All Implanted Cohort||70
10369311|NCT00547521|11509968|FG000|STARTED|Short Term Study (4 Months)|Number of participants treated.|51
10369312|NCT00547521|11509969|FG001|STARTED|Short Term Study (4 Months)|Number of participants treated.|49
10369313|NCT00547521|11509968|FG000|COMPLETED|Short Term Study (4 Months)||50
10369314|NCT00547521|11509969|FG001|COMPLETED|Short Term Study (4 Months)||45
10369315|NCT00547521|11509968|FG000|NOT COMPLETED|Short Term Study (4 Months)||1
10369316|NCT00547521|11509969|FG001|NOT COMPLETED|Short Term Study (4 Months)||4
10369317|NCT00547521|11509968|FG000|STARTED|Long Term Extension (LTE) Study|ST Study had 2 arms, LTE Study pooled all participants who had abatacept injection.|0
10369318|NCT00547521|11509969|FG001|STARTED|Long Term Extension (LTE) Study|ST Study had 2 arms, LTE Study pooled all participants who had abatacept injection.|90
10369319|NCT00547521|11509968|FG000|COMPLETED|Long Term Extension (LTE) Study||0
10369320|NCT00547521|11509969|FG001|COMPLETED|Long Term Extension (LTE) Study||59
10369321|NCT00547521|11509968|FG000|NOT COMPLETED|Long Term Extension (LTE) Study||0
10369322|NCT00547521|11509969|FG001|NOT COMPLETED|Long Term Extension (LTE) Study||31
10369323|NCT00547534|11509982|FG000|STARTED|Overall Study|31 patients enrolled; one patient was determined to be ineligible, and did not receive any therapy.|30
10369324|NCT00547534|11509982|FG000|COMPLETED|Overall Study|25 patients received at least 4 cycles. 29 patients were evaluable for response.|19
10369325|NCT00547534|11509982|FG000|NOT COMPLETED|Overall Study||11
10369326|NCT00547586|11509992|FG000|STARTED|Overall Study||33
10369327|NCT00547586|11509993|FG001|STARTED|Overall Study||7
10369328|NCT00547586|11509994|FG002|STARTED|Overall Study||14
10369329|NCT00547586|11509995|FG003|STARTED|Overall Study||33
10369330|NCT00547586|11509996|FG004|STARTED|Overall Study||35
10369331|NCT00547586|11509992|FG000|COMPLETED|Overall Study||28
10369332|NCT00547586|11509993|FG001|COMPLETED|Overall Study||6
10369333|NCT00547586|11509994|FG002|COMPLETED|Overall Study||13
10369334|NCT00547586|11509995|FG003|COMPLETED|Overall Study||27
10537123|NCT01448824|11689821|FG003|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohorts B through D participated in Period 1 only.|0
10537124|NCT01448824|11689822|FG004|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohort B participated in Period 1 only.|0
10537125|NCT01448824|11689823|FG005|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohort C participated in Period 1 only.|0
10537126|NCT01448824|11689824|FG006|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohort D participated in Period 1 only.|0
10537127|NCT01448824|11689825|FG007|STARTED|Part 1 Period 2: Multiple Ascending Dose||0
10537128|NCT01448824|11689818|FG000|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||11
10537129|NCT01448824|11689819|FG001|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||4
10537130|NCT01448824|11689820|FG002|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||4
10537131|NCT01448824|11689821|FG003|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
10537132|NCT01448824|11689822|FG004|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
10537133|NCT01448824|11689823|FG005|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
10537134|NCT01448824|11689824|FG006|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
10537135|NCT01448824|11689825|FG007|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
10537136|NCT01448824|11689818|FG000|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||11
10537137|NCT01448824|11689819|FG001|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||4
10537138|NCT01448824|11689820|FG002|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||4
10537139|NCT01448824|11689821|FG003|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
10537140|NCT01448824|11689822|FG004|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
10369335|NCT00547586|11509996|FG004|COMPLETED|Overall Study||32
10369336|NCT00547586|11509992|FG000|NOT COMPLETED|Overall Study||5
10369337|NCT00547586|11509993|FG001|NOT COMPLETED|Overall Study||1
10369338|NCT00547586|11509994|FG002|NOT COMPLETED|Overall Study||1
10369339|NCT00547586|11509995|FG003|NOT COMPLETED|Overall Study||6
10369340|NCT00547586|11509996|FG004|NOT COMPLETED|Overall Study||3
10537141|NCT01448824|11689823|FG005|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
10537142|NCT01448824|11689824|FG006|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
10369341|NCT00547638|11510010|FG000|STARTED|Overall Study||143
10369342|NCT00547638|11510011|FG001|STARTED|Overall Study||73
10369343|NCT00547638|11510010|FG000|COMPLETED|Overall Study||119
10369344|NCT00547638|11510011|FG001|COMPLETED|Overall Study||59
10369345|NCT00547638|11510010|FG000|NOT COMPLETED|Overall Study||24
10369346|NCT00547638|11510011|FG001|NOT COMPLETED|Overall Study||14
10369347|NCT00547703|11510019|FG000|STARTED|Overall Study||4
10369348|NCT00547703|11510020|FG001|STARTED|Overall Study||1
10369349|NCT00547703|11510019|FG000|COMPLETED|Overall Study||3
10369350|NCT00547703|11510020|FG001|COMPLETED|Overall Study||1
10369351|NCT00547703|11510019|FG000|NOT COMPLETED|Overall Study||1
10369352|NCT00547703|11510020|FG001|NOT COMPLETED|Overall Study||0
10369353|NCT00547729|11510026|FG000|STARTED|Overall Study||71
10369354|NCT00547729|11510026|FG000|COMPLETED|Overall Study||71
10369355|NCT00547729|11510026|FG000|NOT COMPLETED|Overall Study||0
10369356|NCT00547898|11510034|FG000|STARTED|Overall Study||138
10369357|NCT00547898|11510035|FG001|STARTED|Overall Study||136
10369358|NCT00547898|11510036|FG002|STARTED|Overall Study||54
10369359|NCT00547898|11510037|FG003|STARTED|Overall Study||46
10369360|NCT00547898|11510034|FG000|COMPLETED|Overall Study||129
10369361|NCT00547898|11510035|FG001|COMPLETED|Overall Study||126
10369362|NCT00547898|11510036|FG002|COMPLETED|Overall Study||54
10369363|NCT00547898|11510037|FG003|COMPLETED|Overall Study||40
10369364|NCT00547898|11510034|FG000|NOT COMPLETED|Overall Study||9
10369365|NCT00547898|11510035|FG001|NOT COMPLETED|Overall Study||10
10369366|NCT00547898|11510036|FG002|NOT COMPLETED|Overall Study||0
10369367|NCT00547898|11510037|FG003|NOT COMPLETED|Overall Study||6
10369368|NCT00547911|11510053|FG000|STARTED|Overall Study||2
10369369|NCT00547911|11510054|FG001|STARTED|Overall Study||2
10369370|NCT00547911|11510055|FG002|STARTED|Overall Study||2
10369371|NCT00547911|11510056|FG003|STARTED|Overall Study||2
10369372|NCT00547911|11510057|FG004|STARTED|Overall Study||3
10369373|NCT00547911|11510058|FG005|STARTED|Overall Study||3
10369374|NCT00547911|11510053|FG000|COMPLETED|Overall Study||2
10369375|NCT00547911|11510054|FG001|COMPLETED|Overall Study||2
10369376|NCT00547911|11510055|FG002|COMPLETED|Overall Study||2
10369377|NCT00547911|11510056|FG003|COMPLETED|Overall Study||1
10369378|NCT00547911|11510057|FG004|COMPLETED|Overall Study||3
10369379|NCT00547911|11510058|FG005|COMPLETED|Overall Study||3
10369380|NCT00547911|11510053|FG000|NOT COMPLETED|Overall Study||0
10369381|NCT00547911|11510054|FG001|NOT COMPLETED|Overall Study||0
10369382|NCT00547911|11510055|FG002|NOT COMPLETED|Overall Study||0
10369383|NCT00547911|11510056|FG003|NOT COMPLETED|Overall Study||1
10369384|NCT00547911|11510057|FG004|NOT COMPLETED|Overall Study||0
10369385|NCT00547911|11510058|FG005|NOT COMPLETED|Overall Study||0
10369386|NCT00548041|11510071|FG000|STARTED|Overall Study||100
10369387|NCT00548041|11510071|FG000|COMPLETED|Overall Study||100
10369388|NCT00548041|11510071|FG000|NOT COMPLETED|Overall Study||0
10369389|NCT00548132|11510077|FG000|STARTED|Overall Study||534
10369390|NCT00548132|11510078|FG001|STARTED|Overall Study||554
10369391|NCT00548132|11510077|FG000|Consented to Study|Overall Study||534
10369392|NCT00548132|11510078|FG001|Consented to Study|Overall Study||554
10369393|NCT00548132|11510077|FG000|COMPLETED|Overall Study||534
10369394|NCT00548132|11510078|FG001|COMPLETED|Overall Study||554
10369395|NCT00548132|11510077|FG000|NOT COMPLETED|Overall Study||0
10369396|NCT00548132|11510078|FG001|NOT COMPLETED|Overall Study||0
10537143|NCT01448824|11689825|FG007|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
10537144|NCT01448824|11689818|FG000|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
10537145|NCT01448824|11689819|FG001|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
10537146|NCT01448824|11689820|FG002|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
10537147|NCT01448824|11689821|FG003|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
10537148|NCT01448824|11689822|FG004|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
10537149|NCT01448824|11689823|FG005|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
10537150|NCT01448824|11689824|FG006|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
10537151|NCT01448824|11689825|FG007|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
10537152|NCT01448824|11689818|FG000|STARTED|Part 2 Period 1: Drug-drug Interaction||0
10537153|NCT01448824|11689819|FG001|STARTED|Part 2 Period 1: Drug-drug Interaction||0
10537154|NCT01448824|11689820|FG002|STARTED|Part 2 Period 1: Drug-drug Interaction||0
10537155|NCT01448824|11689821|FG003|STARTED|Part 2 Period 1: Drug-drug Interaction||0
10537156|NCT01448824|11689822|FG004|STARTED|Part 2 Period 1: Drug-drug Interaction||0
10537157|NCT01448824|11689823|FG005|STARTED|Part 2 Period 1: Drug-drug Interaction||0
10537158|NCT01448824|11689824|FG006|STARTED|Part 2 Period 1: Drug-drug Interaction||0
10537159|NCT01448824|11689825|FG007|STARTED|Part 2 Period 1: Drug-drug Interaction||12
10537160|NCT01448824|11689818|FG000|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
10537161|NCT01448824|11689819|FG001|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
10537162|NCT01448824|11689820|FG002|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
10537163|NCT01448824|11689821|FG003|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
10369397|NCT00548145|11510088|FG000|STARTED|Overall Study||18
10369398|NCT00548145|11510089|FG001|STARTED|Overall Study||20
10369399|NCT00548145|11510088|FG000|COMPLETED|Overall Study||17
10369400|NCT00548145|11510089|FG001|COMPLETED|Overall Study||16
10369401|NCT00548145|11510088|FG000|NOT COMPLETED|Overall Study||1
10369402|NCT00548145|11510089|FG001|NOT COMPLETED|Overall Study||4
10369403|NCT00548171|11510097|FG000|STARTED|Overall Study||164
10369404|NCT00548171|11510098|FG001|STARTED|Overall Study||39
10537164|NCT01448824|11689822|FG004|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
10369405|NCT00548171|11510097|FG000|COMPLETED|Overall Study||164
10369406|NCT00548171|11510098|FG001|COMPLETED|Overall Study||39
10369407|NCT00548171|11510097|FG000|NOT COMPLETED|Overall Study||0
10369408|NCT00548171|11510098|FG001|NOT COMPLETED|Overall Study||0
10369409|NCT00548184|11510104|FG000|STARTED|Overall Study||65
10369410|NCT00548184|11510104|FG000|COMPLETED|Overall Study|65 patients were on treatment. 5 did not complete due to adverse events or other reasons.|60
10369411|NCT00548184|11510104|FG000|NOT COMPLETED|Overall Study||5
10369412|NCT00548197|11510110|FG000|STARTED|Overall Study||18
10369413|NCT00548197|11510111|FG001|STARTED|Overall Study||22
10369414|NCT00548197|11510110|FG000|COMPLETED|Overall Study||18
10369415|NCT00548197|11510111|FG001|COMPLETED|Overall Study||22
10369416|NCT00548197|11510110|FG000|NOT COMPLETED|Overall Study||0
10369417|NCT00548197|11510111|FG001|NOT COMPLETED|Overall Study||0
10369418|NCT00548249|11510124|FG000|STARTED|Overall Study||26
10369419|NCT00548249|11510125|FG001|STARTED|Overall Study||26
10369420|NCT00548249|11510126|FG002|STARTED|Overall Study||29
10369421|NCT00548249|11510127|FG003|STARTED|Overall Study||22
10369422|NCT00548249|11510128|FG004|STARTED|Overall Study||28
10369423|NCT00548249|11510124|FG000|COMPLETED|Overall Study||10
10369424|NCT00548249|11510125|FG001|COMPLETED|Overall Study||13
10369425|NCT00548249|11510126|FG002|COMPLETED|Overall Study||9
10369426|NCT00548249|11510127|FG003|COMPLETED|Overall Study||9
10369427|NCT00548249|11510128|FG004|COMPLETED|Overall Study||7
10369428|NCT00548249|11510124|FG000|NOT COMPLETED|Overall Study||16
10369429|NCT00548249|11510125|FG001|NOT COMPLETED|Overall Study||13
10369430|NCT00548249|11510126|FG002|NOT COMPLETED|Overall Study||20
10369431|NCT00548249|11510127|FG003|NOT COMPLETED|Overall Study||13
10369432|NCT00548249|11510128|FG004|NOT COMPLETED|Overall Study||21
10369433|NCT00548262|11510140|FG000|STARTED|Overall Study|1 participant (N) had death recorded twice; reported as 1 death in reason for discontinuation (D/C)|54
10369434|NCT00548262|11510140|FG000|COMPLETED|Overall Study|1 N had D/C recorded as died and as lack of efficacy; reported as lack of efficacy in reason for D/C|22
10369435|NCT00548262|11510140|FG000|NOT COMPLETED|Overall Study||32
10369436|NCT00548340|11510147|FG000|STARTED|Overall Study||109
10369437|NCT00548340|11510148|FG001|STARTED|Overall Study||109
10369438|NCT00548340|11510149|FG002|STARTED|Overall Study||104
10369439|NCT00548340|11510147|FG000|COMPLETED|Overall Study||101
10369440|NCT00548340|11510148|FG001|COMPLETED|Overall Study||98
10369441|NCT00548340|11510149|FG002|COMPLETED|Overall Study||95
10369442|NCT00548340|11510147|FG000|NOT COMPLETED|Overall Study||8
10369443|NCT00548340|11510148|FG001|NOT COMPLETED|Overall Study||11
10369444|NCT00548340|11510149|FG002|NOT COMPLETED|Overall Study||9
10369445|NCT00548405|11510160|FG000|STARTED|Overall Study|Randomized.|231
10369446|NCT00548405|11510161|FG001|STARTED|Overall Study|Randomized.|436
10369447|NCT00548405|11510162|FG002|STARTED|Overall Study|Randomized.|173
10369448|NCT00548405|11510160|FG000|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|202
10369449|NCT00548405|11510161|FG001|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|426
10369450|NCT00548405|11510162|FG002|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|170
10369451|NCT00548405|11510160|FG000|COMPLETED|Overall Study||175
10369452|NCT00548405|11510161|FG001|COMPLETED|Overall Study||416
10369453|NCT00548405|11510162|FG002|COMPLETED|Overall Study||164
10369454|NCT00548405|11510160|FG000|NOT COMPLETED|Overall Study||56
10369455|NCT00548405|11510161|FG001|NOT COMPLETED|Overall Study||20
10369456|NCT00548405|11510162|FG002|NOT COMPLETED|Overall Study||9
10369457|NCT00548418|11510171|FG000|STARTED|Overall Study||27
10369458|NCT00548418|11510171|FG000|COMPLETED|Overall Study||27
10369459|NCT00548418|11510171|FG000|NOT COMPLETED|Overall Study||0
10369460|NCT00548431|11510175|FG000|STARTED|Overall Study||38
10369461|NCT00548431|11510175|FG000|COMPLETED|Overall Study||38
10369462|NCT00548431|11510175|FG000|NOT COMPLETED|Overall Study||0
10369463|NCT00548470|11510179|FG000|STARTED|Overall Study||14
10369464|NCT00548470|11510179|FG000|COMPLETED|Overall Study||12
10369465|NCT00548470|11510179|FG000|NOT COMPLETED|Overall Study||2
10369466|NCT00548548|11510185|FG000|STARTED|Overall Study||387
10369467|NCT00548548|11510186|FG001|STARTED|Overall Study||387
10369468|NCT00548548|11510185|FG000|Treated|Overall Study||383
10369469|NCT00548548|11510186|FG001|Treated|Overall Study||384
10369470|NCT00548548|11510185|FG000|Safety Population|Overall Study|Four patients randomized to placebo received single doses of bevacizumab in error.|386
10369471|NCT00548548|11510186|FG001|Safety Population|Overall Study||381
10537165|NCT01448824|11689823|FG005|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
10537166|NCT01448824|11689824|FG006|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
10537167|NCT01448824|11689825|FG007|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||12
10537168|NCT01448824|11689818|FG000|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
10537169|NCT01448824|11689819|FG001|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
10537170|NCT01448824|11689820|FG002|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
10537171|NCT01448824|11689821|FG003|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
10537172|NCT01448824|11689822|FG004|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
10537173|NCT01448824|11689823|FG005|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
10537174|NCT01448824|11689824|FG006|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
10537175|NCT01448824|11689825|FG007|COMPLETED|Part 2 Period 1: Drug-drug Interaction||11
10537176|NCT01448824|11689818|FG000|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
10537177|NCT01448824|11689819|FG001|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
10537178|NCT01448824|11689820|FG002|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
10369472|NCT00548548|11510185|FG000|COMPLETED|Overall Study|Completed treatment discontinuation form was not completed; patient was counted alive on treatment.|25
10369473|NCT00548548|11510186|FG001|COMPLETED|Overall Study||21
10369474|NCT00548548|11510185|FG000|NOT COMPLETED|Overall Study||362
10369475|NCT00548548|11510186|FG001|NOT COMPLETED|Overall Study||366
10369476|NCT00548652|11510195|FG000|STARTED|Overall Study||18
10369477|NCT00548652|11510196|FG001|STARTED|Overall Study||38
10369478|NCT00548652|11510197|FG002|STARTED|Overall Study||45
10369479|NCT00548652|11510195|FG000|COMPLETED|Overall Study||16
10369480|NCT00548652|11510196|FG001|COMPLETED|Overall Study||29
10369481|NCT00548652|11510197|FG002|COMPLETED|Overall Study||34
10369482|NCT00548652|11510195|FG000|NOT COMPLETED|Overall Study||2
10369483|NCT00548652|11510196|FG001|NOT COMPLETED|Overall Study||9
10369484|NCT00548652|11510197|FG002|NOT COMPLETED|Overall Study||11
10369485|NCT00548691|11510207|FG000|STARTED|Overall Study||258
10369486|NCT00548691|11510208|FG001|STARTED|Overall Study||259
10369487|NCT00548691|11510207|FG000|COMPLETED|Overall Study||251
10369488|NCT00548691|11510208|FG001|COMPLETED|Overall Study||250
10369489|NCT00548691|11510207|FG000|NOT COMPLETED|Overall Study||7
10369490|NCT00548691|11510208|FG001|NOT COMPLETED|Overall Study||9
10369491|NCT00548717|11510216|FG000|STARTED|Overall Study||13
10369492|NCT00548717|11510217|FG001|STARTED|Overall Study||2
10369493|NCT00548717|11510216|FG000|COMPLETED|Overall Study||4
10369494|NCT00548717|11510217|FG001|COMPLETED|Overall Study||0
10369495|NCT00548717|11510216|FG000|NOT COMPLETED|Overall Study||9
10369496|NCT00548717|11510217|FG001|NOT COMPLETED|Overall Study||2
10369497|NCT00548808|11510228|FG000|STARTED|Overall Study||214
10369498|NCT00548808|11510229|FG001|STARTED|Overall Study||212
10369499|NCT00548808|11510228|FG000|Full Analysis Set|Overall Study||211
10369500|NCT00548808|11510229|FG001|Full Analysis Set|Overall Study||212
10369501|NCT00548808|11510228|FG000|Per-Protocol Set|Overall Study||177
10369502|NCT00548808|11510229|FG001|Per-Protocol Set|Overall Study||184
10369503|NCT00548808|11510228|FG000|COMPLETED|Overall Study||172
10369504|NCT00548808|11510229|FG001|COMPLETED|Overall Study||186
10369505|NCT00548808|11510228|FG000|NOT COMPLETED|Overall Study||42
10369506|NCT00548808|11510229|FG001|NOT COMPLETED|Overall Study||26
10369507|NCT00548847|11510235|FG000|STARTED|Overall Study||15
10369508|NCT00548847|11510235|FG000|COMPLETED|Overall Study||8
10369509|NCT00548847|11510235|FG000|NOT COMPLETED|Overall Study||7
10369510|NCT00548860|11510241|FG000|STARTED|Overall Study||996
10369511|NCT00548860|11510242|FG001|STARTED|Overall Study||1022
10369512|NCT00548860|11510241|FG000|COMPLETED|Overall Study||860
10369513|NCT00548860|11510242|FG001|COMPLETED|Overall Study||847
10369514|NCT00548860|11510241|FG000|NOT COMPLETED|Overall Study||136
10369515|NCT00548860|11510242|FG001|NOT COMPLETED|Overall Study||175
10369516|NCT00549042|11510250|FG000|STARTED|Conversion and Titration Phase||459
10369517|NCT00549042|11510251|FG001|STARTED|Conversion and Titration Phase|Per the study design, no patients received placebo during this phase.|0
10369518|NCT00549042|11510250|FG000|COMPLETED|Conversion and Titration Phase||268
10369519|NCT00549042|11510251|FG001|COMPLETED|Conversion and Titration Phase|Per the study design, no patients received placebo during this phase.|0
10369520|NCT00549042|11510250|FG000|NOT COMPLETED|Conversion and Titration Phase||191
10369521|NCT00549042|11510251|FG001|NOT COMPLETED|Conversion and Titration Phase||0
10369522|NCT00549042|11510250|FG000|STARTED|Double-blind Phase||134
10369523|NCT00549042|11510251|FG001|STARTED|Double-blind Phase||134
10369524|NCT00549042|11510250|FG000|COMPLETED|Double-blind Phase||66
10369525|NCT00549042|11510251|FG001|COMPLETED|Double-blind Phase||44
10369526|NCT00549042|11510250|FG000|NOT COMPLETED|Double-blind Phase||68
10369527|NCT00549042|11510251|FG001|NOT COMPLETED|Double-blind Phase||90
10369528|NCT00549055|11510258|FG000|STARTED|Overall Study||38
10369529|NCT00549055|11510258|FG000|COMPLETED|Overall Study||3
10369530|NCT00549055|11510258|FG000|NOT COMPLETED|Overall Study||35
10369531|NCT00549172|11510264|FG000|STARTED|Overall Study||70
10369532|NCT00549172|11510265|FG001|STARTED|Overall Study||76
10369533|NCT00549172|11510264|FG000|COMPLETED|Overall Study||70
10369534|NCT00549172|11510265|FG001|COMPLETED|Overall Study||76
10369535|NCT00549172|11510264|FG000|NOT COMPLETED|Overall Study||0
10369536|NCT00549172|11510265|FG001|NOT COMPLETED|Overall Study||0
10369537|NCT00549198|11510273|FG000|STARTED|Overall Study|Three participants were randomized but were not exposed to study drug (ABC/3TC).|195
10369538|NCT00549198|11510274|FG001|STARTED|Overall Study|Four participants were randomized but were not exposed to study drug (TDF/FTC).|197
10369539|NCT00549198|11510273|FG000|COMPLETED|Overall Study||115
10369540|NCT00549198|11510274|FG001|COMPLETED|Overall Study||134
10369541|NCT00549198|11510273|FG000|NOT COMPLETED|Overall Study||80
10369542|NCT00549198|11510274|FG001|NOT COMPLETED|Overall Study||63
10369543|NCT00549302|11510282|FG000|STARTED|Double-Blind||63
10369544|NCT00549302|11510283|FG001|STARTED|Double-Blind||294
10369545|NCT00549302|11510284|FG002|STARTED|Double-Blind||0
10369546|NCT00549302|11510282|FG000|Received at Least One Dose of Study Drug|Double-Blind||63
10369547|NCT00549302|11510283|FG001|Received at Least One Dose of Study Drug|Double-Blind||294
10369548|NCT00549302|11510284|FG002|Received at Least One Dose of Study Drug|Double-Blind||0
10369549|NCT00549302|11510282|FG000|COMPLETED|Double-Blind|Participants who completed the Double-Blind Period were eligible to enter the Open-Label Period.|52
10369550|NCT00549302|11510283|FG001|COMPLETED|Double-Blind|Participants who completed the Double-Blind Period were eligible to enter the Open-Label Period.|241
10369551|NCT00549302|11510284|FG002|COMPLETED|Double-Blind||0
10369552|NCT00549302|11510282|FG000|NOT COMPLETED|Double-Blind||11
10369553|NCT00549302|11510283|FG001|NOT COMPLETED|Double-Blind||53
10369554|NCT00549302|11510284|FG002|NOT COMPLETED|Double-Blind||0
10369555|NCT00549302|11510282|FG000|STARTED|Open-Label||0
10369556|NCT00549302|11510283|FG001|STARTED|Open-Label||0
10369557|NCT00549302|11510284|FG002|STARTED|Open-Label|7 participants who completed the Double-Blind Period did not enter the Open-Label Period.|286
10369558|NCT00549302|11510282|FG000|COMPLETED|Open-Label||0
10369559|NCT00549302|11510283|FG001|COMPLETED|Open-Label||0
10369560|NCT00549302|11510284|FG002|COMPLETED|Open-Label|Another death occurred during the 30-day follow-up period after study drug discontinuation|217
10369561|NCT00549302|11510282|FG000|NOT COMPLETED|Open-Label||0
10369562|NCT00549302|11510283|FG001|NOT COMPLETED|Open-Label||0
10369563|NCT00549302|11510284|FG002|NOT COMPLETED|Open-Label||69
10369564|NCT00549393|11510294|FG000|STARTED|Period 1 (6 Months)|intention to treat (ITT)|1319
10369565|NCT00549393|11510295|FG001|STARTED|Period 1 (6 Months)|ITT|1199
10369566|NCT00549393|11510294|FG000|Per Protocol|Period 1 (6 Months)||880
10369567|NCT00549393|11510295|FG001|Per Protocol|Period 1 (6 Months)||1199
10369568|NCT00549393|11510294|FG000|COMPLETED|Period 1 (6 Months)||1319
10369569|NCT00549393|11510295|FG001|COMPLETED|Period 1 (6 Months)||1199
10369570|NCT00549393|11510294|FG000|NOT COMPLETED|Period 1 (6 Months)||0
10369571|NCT00549393|11510295|FG001|NOT COMPLETED|Period 1 (6 Months)||0
10369572|NCT00549393|11510294|FG000|STARTED|Period 2 Washout (2 Weeks)||0
10369573|NCT00549393|11510295|FG001|STARTED|Period 2 Washout (2 Weeks)||0
10369574|NCT00549393|11510294|FG000|COMPLETED|Period 2 Washout (2 Weeks)||0
10369575|NCT00549393|11510295|FG001|COMPLETED|Period 2 Washout (2 Weeks)||0
10369576|NCT00549393|11510294|FG000|NOT COMPLETED|Period 2 Washout (2 Weeks)||0
10369577|NCT00549393|11510295|FG001|NOT COMPLETED|Period 2 Washout (2 Weeks)||0
10369578|NCT00549393|11510294|FG000|STARTED|Period 3 (6 Months)|number not equal to period 1 due to unit cross over design|1103
10369579|NCT00549393|11510295|FG001|STARTED|Period 3 (6 Months)|number not equal to period 1 due to unit cross over design|1326
10369580|NCT00549393|11510294|FG000|Per Protocol|Period 3 (6 Months)||667
10369581|NCT00549393|11510295|FG001|Per Protocol|Period 3 (6 Months)||1326
10369582|NCT00549393|11510294|FG000|COMPLETED|Period 3 (6 Months)||1103
10369583|NCT00549393|11510295|FG001|COMPLETED|Period 3 (6 Months)||1326
10369584|NCT00549393|11510294|FG000|NOT COMPLETED|Period 3 (6 Months)||0
10369585|NCT00549393|11510295|FG001|NOT COMPLETED|Period 3 (6 Months)||0
10369586|NCT00549445|11510305|FG000|STARTED|Overall Study||23
10369587|NCT00549445|11510306|FG001|STARTED|Overall Study||30
10369588|NCT00549445|11510305|FG000|COMPLETED|Overall Study||8
10369589|NCT00549445|11510306|FG001|COMPLETED|Overall Study||13
10369590|NCT00549445|11510305|FG000|NOT COMPLETED|Overall Study||15
10369591|NCT00549445|11510306|FG001|NOT COMPLETED|Overall Study||17
10369592|NCT00549549|11510316|FG000|STARTED|Overall Study||101
10369593|NCT00549549|11510317|FG001|STARTED|Overall Study||99
10369594|NCT00549549|11510318|FG002|STARTED|Overall Study||99
10369595|NCT00549549|11510319|FG003|STARTED|Overall Study||103
10369596|NCT00549549|11510316|FG000|Treated|Overall Study||101
10369597|NCT00549549|11510317|FG001|Treated|Overall Study||99
10369598|NCT00549549|11510318|FG002|Treated|Overall Study||98
10369599|NCT00549549|11510319|FG003|Treated|Overall Study||102
10369600|NCT00549549|11510316|FG000|COMPLETED|Overall Study||77
10369601|NCT00549549|11510317|FG001|COMPLETED|Overall Study||77
10369602|NCT00549549|11510318|FG002|COMPLETED|Overall Study||82
10369603|NCT00549549|11510319|FG003|COMPLETED|Overall Study||78
10369604|NCT00549549|11510316|FG000|NOT COMPLETED|Overall Study||24
10369605|NCT00549549|11510317|FG001|NOT COMPLETED|Overall Study||22
10369606|NCT00549549|11510318|FG002|NOT COMPLETED|Overall Study||17
10369607|NCT00549549|11510319|FG003|NOT COMPLETED|Overall Study||25
10369608|NCT00549562|11510329|FG000|STARTED|Overall Study||25
10369609|NCT00549562|11510329|FG000|COMPLETED|Overall Study||23
10369610|NCT00549562|11510329|FG000|NOT COMPLETED|Overall Study||2
10369611|NCT00549601|11510336|FG000|STARTED|Randomized||43
10369612|NCT00549601|11510337|FG001|STARTED|Randomized||48
10369613|NCT00549601|11510338|FG002|STARTED|Randomized||51
10369614|NCT00549601|11510336|FG000|COMPLETED|Randomized||43
10369615|NCT00549601|11510337|FG001|COMPLETED|Randomized||47
10369616|NCT00549601|11510338|FG002|COMPLETED|Randomized||49
10369617|NCT00549601|11510336|FG000|NOT COMPLETED|Randomized||0
10369618|NCT00549601|11510337|FG001|NOT COMPLETED|Randomized||1
10369619|NCT00549601|11510338|FG002|NOT COMPLETED|Randomized||2
10369620|NCT00549601|11510336|FG000|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|43
10369621|NCT00549601|11510337|FG001|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|47
10369622|NCT00549601|11510338|FG002|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|49
10369623|NCT00549601|11510336|FG000|COMPLETED|Received Study Drug||36
10369624|NCT00549601|11510337|FG001|COMPLETED|Received Study Drug||36
10369625|NCT00549601|11510338|FG002|COMPLETED|Received Study Drug||45
10369626|NCT00549601|11510336|FG000|NOT COMPLETED|Received Study Drug||7
10369627|NCT00549601|11510337|FG001|NOT COMPLETED|Received Study Drug||11
10369628|NCT00549601|11510338|FG002|NOT COMPLETED|Received Study Drug||4
10369629|NCT00549640|11510350|FG000|STARTED|Overall Study||40
10369630|NCT00549640|11510351|FG001|STARTED|Overall Study||40
10369631|NCT00549640|11510350|FG000|COMPLETED|Overall Study|For the primary endpoint, subjects who discontinued participation were assumed to be smoking.|22
10369632|NCT00549640|11510351|FG001|COMPLETED|Overall Study||24
10369633|NCT00549640|11510350|FG000|NOT COMPLETED|Overall Study||18
10369634|NCT00549640|11510351|FG001|NOT COMPLETED|Overall Study||16
10369635|NCT00549718|11510361|FG000|STARTED|Overall Study||125
10369636|NCT00549718|11510362|FG001|STARTED|Overall Study||123
10369637|NCT00549718|11510363|FG002|STARTED|Overall Study||124
10369638|NCT00549718|11510364|FG003|STARTED|Overall Study||128
10369639|NCT00549718|11510361|FG000|COMPLETED|Overall Study||84
10369640|NCT00549718|11510362|FG001|COMPLETED|Overall Study||86
10369641|NCT00549718|11510363|FG002|COMPLETED|Overall Study||85
10369642|NCT00549718|11510364|FG003|COMPLETED|Overall Study||73
10369643|NCT00549718|11510361|FG000|NOT COMPLETED|Overall Study||41
10369644|NCT00549718|11510362|FG001|NOT COMPLETED|Overall Study||37
10369645|NCT00549718|11510363|FG002|NOT COMPLETED|Overall Study||39
10369646|NCT00549718|11510364|FG003|NOT COMPLETED|Overall Study||55
10369647|NCT00549757|11510376|FG000|STARTED|Active Treatment Phase: Max. 50 Months|"Started indicates randomized patients."|4296
10369648|NCT00549757|11510377|FG001|STARTED|Active Treatment Phase: Max. 50 Months||4310
10369649|NCT00549757|11510376|FG000|Full Analysis Set|Active Treatment Phase: Max. 50 Months||4274
10369650|NCT00549757|11510377|FG001|Full Analysis Set|Active Treatment Phase: Max. 50 Months||4287
10369651|NCT00549757|11510376|FG000|Safety Set|Active Treatment Phase: Max. 50 Months||4272
10369652|NCT00549757|11510377|FG001|Safety Set|Active Treatment Phase: Max. 50 Months||4285
10369653|NCT00549757|11510376|FG000|COMPLETED|Active Treatment Phase: Max. 50 Months||0
10369654|NCT00549757|11510377|FG001|COMPLETED|Active Treatment Phase: Max. 50 Months||0
10369655|NCT00549757|11510376|FG000|NOT COMPLETED|Active Treatment Phase: Max. 50 Months||4296
10369656|NCT00549757|11510377|FG001|NOT COMPLETED|Active Treatment Phase: Max. 50 Months||4310
10369657|NCT00549757|11510376|FG000|STARTED|Extension Period (in Average 9 Months)|"As explained in pre-assignment detail, follow up was made after drug discontinuation"|3773
10369658|NCT00549757|11510377|FG001|STARTED|Extension Period (in Average 9 Months)|"As explained in pre-assignment detail, follow up was made after drug discontinuation"|3817
10369659|NCT00549757|11510376|FG000|COMPLETED|Extension Period (in Average 9 Months)||3148
10369660|NCT00549757|11510377|FG001|COMPLETED|Extension Period (in Average 9 Months)||3182
10369661|NCT00549757|11510376|FG000|NOT COMPLETED|Extension Period (in Average 9 Months)||625
10369662|NCT00549757|11510377|FG001|NOT COMPLETED|Extension Period (in Average 9 Months)||635
10369663|NCT00549770|11510397|FG000|STARTED|Overall Study||156
10369664|NCT00549770|11510398|FG001|STARTED|Overall Study||169
10369665|NCT00549770|11510399|FG002|STARTED|Overall Study||172
10369666|NCT00549770|11510400|FG003|STARTED|Overall Study||163
10369667|NCT00549770|11510401|FG004|STARTED|Overall Study||166
10369668|NCT00549770|11510402|FG005|STARTED|Overall Study||164
10369669|NCT00549770|11510403|FG006|STARTED|Overall Study||165
10369670|NCT00549770|11510404|FG007|STARTED|Overall Study||173
10369671|NCT00549770|11510397|FG000|Intent-to-treat Population|Overall Study||154
10369672|NCT00549770|11510398|FG001|Intent-to-treat Population|Overall Study||168
10369673|NCT00549770|11510399|FG002|Intent-to-treat Population|Overall Study||170
10369674|NCT00549770|11510400|FG003|Intent-to-treat Population|Overall Study||163
10369675|NCT00549770|11510401|FG004|Intent-to-treat Population|Overall Study||163
10369676|NCT00549770|11510402|FG005|Intent-to-treat Population|Overall Study||163
10369677|NCT00549770|11510403|FG006|Intent-to-treat Population|Overall Study||164
10369678|NCT00549770|11510404|FG007|Intent-to-treat Population|Overall Study||172
10369679|NCT00549770|11510397|FG000|Ambulatory Blood Pressure Monitoring|Overall Study||48
10369680|NCT00549770|11510398|FG001|Ambulatory Blood Pressure Monitoring|Overall Study||61
10369681|NCT00549770|11510399|FG002|Ambulatory Blood Pressure Monitoring|Overall Study||53
10369682|NCT00549770|11510400|FG003|Ambulatory Blood Pressure Monitoring|Overall Study||55
10369683|NCT00549770|11510401|FG004|Ambulatory Blood Pressure Monitoring|Overall Study||49
10369684|NCT00549770|11510402|FG005|Ambulatory Blood Pressure Monitoring|Overall Study||54
10369685|NCT00549770|11510403|FG006|Ambulatory Blood Pressure Monitoring|Overall Study||50
10369686|NCT00549770|11510404|FG007|Ambulatory Blood Pressure Monitoring|Overall Study||57
10369687|NCT00549770|11510397|FG000|COMPLETED|Overall Study||149
10369688|NCT00549770|11510398|FG001|COMPLETED|Overall Study||158
10369689|NCT00549770|11510399|FG002|COMPLETED|Overall Study||162
10369690|NCT00549770|11510400|FG003|COMPLETED|Overall Study||147
10369691|NCT00549770|11510401|FG004|COMPLETED|Overall Study||149
10369692|NCT00549770|11510402|FG005|COMPLETED|Overall Study||151
10369693|NCT00549770|11510403|FG006|COMPLETED|Overall Study||151
10369694|NCT00549770|11510404|FG007|COMPLETED|Overall Study||148
10369695|NCT00549770|11510397|FG000|NOT COMPLETED|Overall Study||7
10369696|NCT00549770|11510398|FG001|NOT COMPLETED|Overall Study||11
10369697|NCT00549770|11510399|FG002|NOT COMPLETED|Overall Study||10
10369698|NCT00549770|11510400|FG003|NOT COMPLETED|Overall Study||16
10369699|NCT00549770|11510401|FG004|NOT COMPLETED|Overall Study||17
10369700|NCT00549770|11510402|FG005|NOT COMPLETED|Overall Study||13
10369701|NCT00549770|11510403|FG006|NOT COMPLETED|Overall Study||14
10369702|NCT00549770|11510404|FG007|NOT COMPLETED|Overall Study||25
10369703|NCT00549783|11510424|FG000|STARTED|Overall Study||139
10369704|NCT00549783|11510425|FG001|STARTED|Overall Study||135
10369705|NCT00549783|11510424|FG000|COMPLETED|Overall Study||131
10369706|NCT00549783|11510425|FG001|COMPLETED|Overall Study||122
10369707|NCT00549783|11510424|FG000|NOT COMPLETED|Overall Study||8
10369708|NCT00549783|11510425|FG001|NOT COMPLETED|Overall Study||13
10369709|NCT00549822|11510431|FG000|STARTED|Overall Study||3
10369710|NCT00549822|11510431|FG000|COMPLETED|Overall Study||3
10369711|NCT00549822|11510431|FG000|NOT COMPLETED|Overall Study||0
10369712|NCT00549900|11510435|FG000|STARTED|Overall Study||30
10369713|NCT00549900|11510435|FG000|COMPLETED|Overall Study||29
10369714|NCT00549900|11510435|FG000|NOT COMPLETED|Overall Study||1
10537179|NCT01448824|11689821|FG003|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
10657156|NCT02223429|11818305|FG000|NOT COMPLETED|Overall Study||1
10427540|NCT00853489|11573384|FG000|STARTED|Overall Study||16
10427541|NCT00853489|11573385|FG001|STARTED|Overall Study||14
10427542|NCT00853489|11573384|FG000|COMPLETED|Overall Study||11
10427543|NCT00853489|11573385|FG001|COMPLETED|Overall Study||12
10427544|NCT00853489|11573384|FG000|NOT COMPLETED|Overall Study||5
10427545|NCT00853489|11573385|FG001|NOT COMPLETED|Overall Study||2
10427546|NCT00853580|11573393|FG000|STARTED|Overall Study||74
10427547|NCT00853580|11573394|FG001|STARTED|Overall Study||72
10657157|NCT02223429|11818306|FG001|NOT COMPLETED|Overall Study||0
10369715|NCT00549939|11510442|FG000|STARTED|12-week Double Blind Treatment Period|29 (Alfuzosin 0.1 mg/kg/day matching placebo) + 28 (Alfuzosin 0.2 mg/kg/day matching placebo)|57
10369716|NCT00549939|11510443|FG001|STARTED|12-week Double Blind Treatment Period||57
10369717|NCT00549939|11510444|FG002|STARTED|12-week Double Blind Treatment Period||58
10369718|NCT00549939|11510442|FG000|COMPLETED|12-week Double Blind Treatment Period||56
10369719|NCT00549939|11510443|FG001|COMPLETED|12-week Double Blind Treatment Period||55
10369720|NCT00549939|11510444|FG002|COMPLETED|12-week Double Blind Treatment Period||56
10369721|NCT00549939|11510442|FG000|NOT COMPLETED|12-week Double Blind Treatment Period||1
10369722|NCT00549939|11510443|FG001|NOT COMPLETED|12-week Double Blind Treatment Period||2
10369723|NCT00549939|11510444|FG002|NOT COMPLETED|12-week Double Blind Treatment Period||2
10369724|NCT00549939|11510442|FG000|STARTED|40-week Open Label Treatment Period|54 patients continued and switched to Alfuzosin: 26 to 0.1 mg/kg/day and 28 to 0.2 mg/kg/day.|0
10369725|NCT00549939|11510443|FG001|STARTED|40-week Open Label Treatment Period|54 patients continued Alfuzosin 0.1 mg/kg/day and 26 patients started Alfuzosin 0.1 mg/kg/day.|80
10369726|NCT00549939|11510444|FG002|STARTED|40-week Open Label Treatment Period|55 patients continued Alfuzosin 0.2 mg/kg/day and 28 patients started Alfuzosin 0.2 mg/kg/day.|83
10369727|NCT00549939|11510442|FG000|COMPLETED|40-week Open Label Treatment Period||0
10537180|NCT01448824|11689822|FG004|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
10537181|NCT01448824|11689823|FG005|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
10537182|NCT01448824|11689824|FG006|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
10537183|NCT01448824|11689825|FG007|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||1
10537184|NCT01448824|11689818|FG000|STARTED|Part 2: Washout Period||0
10537185|NCT01448824|11689819|FG001|STARTED|Part 2: Washout Period||0
10537186|NCT01448824|11689820|FG002|STARTED|Part 2: Washout Period||0
10537187|NCT01448824|11689821|FG003|STARTED|Part 2: Washout Period||0
10537188|NCT01448824|11689822|FG004|STARTED|Part 2: Washout Period||0
10537189|NCT01448824|11689823|FG005|STARTED|Part 2: Washout Period||0
10537190|NCT01448824|11689824|FG006|STARTED|Part 2: Washout Period||0
10537191|NCT01448824|11689825|FG007|STARTED|Part 2: Washout Period||11
10537192|NCT01448824|11689818|FG000|COMPLETED|Part 2: Washout Period||0
10537193|NCT01448824|11689819|FG001|COMPLETED|Part 2: Washout Period||0
10537194|NCT01448824|11689820|FG002|COMPLETED|Part 2: Washout Period||0
10537195|NCT01448824|11689821|FG003|COMPLETED|Part 2: Washout Period||0
10537196|NCT01448824|11689822|FG004|COMPLETED|Part 2: Washout Period||0
10537197|NCT01448824|11689823|FG005|COMPLETED|Part 2: Washout Period||0
10537198|NCT01448824|11689824|FG006|COMPLETED|Part 2: Washout Period||0
10537199|NCT01448824|11689825|FG007|COMPLETED|Part 2: Washout Period||11
10537200|NCT01448824|11689818|FG000|NOT COMPLETED|Part 2: Washout Period||0
10537201|NCT01448824|11689819|FG001|NOT COMPLETED|Part 2: Washout Period||0
10537202|NCT01448824|11689820|FG002|NOT COMPLETED|Part 2: Washout Period||0
10537203|NCT01448824|11689821|FG003|NOT COMPLETED|Part 2: Washout Period||0
10537204|NCT01448824|11689822|FG004|NOT COMPLETED|Part 2: Washout Period||0
10537205|NCT01448824|11689823|FG005|NOT COMPLETED|Part 2: Washout Period||0
10537206|NCT01448824|11689824|FG006|NOT COMPLETED|Part 2: Washout Period||0
10537207|NCT01448824|11689825|FG007|NOT COMPLETED|Part 2: Washout Period||0
10537208|NCT01448824|11689818|FG000|STARTED|Part 2 Period 2: Drug-drug Interaction||0
10537209|NCT01448824|11689819|FG001|STARTED|Part 2 Period 2: Drug-drug Interaction||0
10537210|NCT01448824|11689820|FG002|STARTED|Part 2 Period 2: Drug-drug Interaction||0
10537211|NCT01448824|11689821|FG003|STARTED|Part 2 Period 2: Drug-drug Interaction||0
10537212|NCT01448824|11689822|FG004|STARTED|Part 2 Period 2: Drug-drug Interaction||0
10537213|NCT01448824|11689823|FG005|STARTED|Part 2 Period 2: Drug-drug Interaction||0
10537214|NCT01448824|11689824|FG006|STARTED|Part 2 Period 2: Drug-drug Interaction||0
10537215|NCT01448824|11689825|FG007|STARTED|Part 2 Period 2: Drug-drug Interaction||11
10537216|NCT01448824|11689818|FG000|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
10537217|NCT01448824|11689819|FG001|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
10537218|NCT01448824|11689820|FG002|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
10537219|NCT01448824|11689821|FG003|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
10537220|NCT01448824|11689822|FG004|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
10537221|NCT01448824|11689823|FG005|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
10537222|NCT01448824|11689824|FG006|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
10537223|NCT01448824|11689825|FG007|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||11
10537224|NCT01448824|11689818|FG000|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
10537225|NCT01448824|11689819|FG001|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
10537226|NCT01448824|11689820|FG002|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
10537227|NCT01448824|11689821|FG003|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
10537228|NCT01448824|11689822|FG004|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
10537229|NCT01448824|11689823|FG005|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
10537230|NCT01448824|11689824|FG006|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
10537231|NCT01448824|11689825|FG007|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||10
10537232|NCT01448824|11689818|FG000|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
10537233|NCT01448824|11689819|FG001|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
10537234|NCT01448824|11689820|FG002|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
10537235|NCT01448824|11689821|FG003|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
10548059|NCT01516957|11701863|FG002|COMPLETED|Placebo-controlled Phase||51
10369728|NCT00549939|11510443|FG001|COMPLETED|40-week Open Label Treatment Period||75
10369729|NCT00549939|11510444|FG002|COMPLETED|40-week Open Label Treatment Period||78
10369730|NCT00549939|11510442|FG000|NOT COMPLETED|40-week Open Label Treatment Period||0
10369731|NCT00549939|11510443|FG001|NOT COMPLETED|40-week Open Label Treatment Period||5
10369732|NCT00549939|11510444|FG002|NOT COMPLETED|40-week Open Label Treatment Period||5
10369733|NCT00550043|11510459|FG000|STARTED|Overall Study||9
10369734|NCT00550043|11510460|FG001|STARTED|Overall Study||12
10369735|NCT00550043|11510461|FG002|STARTED|Overall Study||9
10369736|NCT00550043|11510462|FG003|STARTED|Overall Study||10
10369737|NCT00550043|11510463|FG004|STARTED|Overall Study||10
10369738|NCT00550043|11510459|FG000|COMPLETED|Overall Study||9
10369739|NCT00550043|11510460|FG001|COMPLETED|Overall Study||9
10369740|NCT00550043|11510461|FG002|COMPLETED|Overall Study||8
10369741|NCT00550043|11510462|FG003|COMPLETED|Overall Study||8
10369742|NCT00550043|11510463|FG004|COMPLETED|Overall Study||9
10369743|NCT00550043|11510459|FG000|NOT COMPLETED|Overall Study||0
10369744|NCT00550043|11510460|FG001|NOT COMPLETED|Overall Study||3
10369745|NCT00550043|11510461|FG002|NOT COMPLETED|Overall Study||1
10369746|NCT00550043|11510462|FG003|NOT COMPLETED|Overall Study||2
10369747|NCT00550043|11510463|FG004|NOT COMPLETED|Overall Study||1
10369748|NCT00550147|11510475|FG000|STARTED|OROS Methylphenidate Monotherapy||30
10369749|NCT00550147|11510475|FG000|COMPLETED|OROS Methylphenidate Monotherapy||24
10369750|NCT00550147|11510475|FG000|NOT COMPLETED|OROS Methylphenidate Monotherapy||6
10369751|NCT00550147|11510475|FG000|STARTED|Quetiapine Addition Treatment Period||24
10369752|NCT00550147|11510475|FG000|COMPLETED|Quetiapine Addition Treatment Period||18
10369753|NCT00550147|11510475|FG000|NOT COMPLETED|Quetiapine Addition Treatment Period||6
10369754|NCT00550173|11510491|FG000|STARTED|Overall Study||81
10369755|NCT00550173|11510492|FG001|STARTED|Overall Study||82
10369756|NCT00550173|11510493|FG002|STARTED|Overall Study||84
10369757|NCT00550173|11510491|FG000|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|78
10716797|NCT02692040|11880570|FG000|NOT COMPLETED|Overall Study||0
10716798|NCT02692040|11880571|FG001|NOT COMPLETED|Overall Study||0
10716799|NCT02692040|11880572|FG002|NOT COMPLETED|Overall Study||0
10716800|NCT02692040|11880573|FG003|NOT COMPLETED|Overall Study||0
10716801|NCT02692040|11880574|FG004|NOT COMPLETED|Overall Study||0
10369758|NCT00550173|11510492|FG001|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|82
10369759|NCT00550173|11510493|FG002|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|80
10369760|NCT00550173|11510491|FG000|Not Discontinued at 18 Months|Overall Study||9
10369761|NCT00550173|11510492|FG001|Not Discontinued at 18 Months|Overall Study||19
10369762|NCT00550173|11510493|FG002|Not Discontinued at 18 Months|Overall Study||11
10369763|NCT00550173|11510491|FG000|COMPLETED|Overall Study||9
10369764|NCT00550173|11510492|FG001|COMPLETED|Overall Study||19
10537236|NCT01448824|11689822|FG004|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
10537237|NCT01448824|11689823|FG005|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
10537238|NCT01448824|11689824|FG006|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
10537239|NCT01448824|11689825|FG007|COMPLETED|Part 2 Period 2: Drug-drug Interaction||8
10537240|NCT01448824|11689818|FG000|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
10537241|NCT01448824|11689819|FG001|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
10537242|NCT01448824|11689820|FG002|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
10537243|NCT01448824|11689821|FG003|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
10716802|NCT02692040|11880575|FG005|NOT COMPLETED|Overall Study||0
10716803|NCT02692040|11880576|FG006|NOT COMPLETED|Overall Study||0
10369765|NCT00550173|11510493|FG002|COMPLETED|Overall Study||11
10369766|NCT00550173|11510491|FG000|NOT COMPLETED|Overall Study||72
10369767|NCT00550173|11510492|FG001|NOT COMPLETED|Overall Study||63
10369768|NCT00550173|11510493|FG002|NOT COMPLETED|Overall Study||73
10369769|NCT00550238|11510502|FG000|STARTED|Overall Study||459
10369770|NCT00550238|11510502|FG000|COMPLETED|Overall Study||0
10369771|NCT00550238|11510502|FG000|NOT COMPLETED|Overall Study||459
10369772|NCT00550277|11510506|FG000|STARTED|Overall Study||20
10369773|NCT00550277|11510506|FG000|COMPLETED|Overall Study||11
10369774|NCT00550277|11510506|FG000|NOT COMPLETED|Overall Study||9
10369775|NCT00550290|11510512|FG000|STARTED|Overall Study||10
10369776|NCT00550290|11510513|FG001|STARTED|Overall Study||8
10369777|NCT00550290|11510512|FG000|COMPLETED|Overall Study||10
10369778|NCT00550290|11510513|FG001|COMPLETED|Overall Study||8
10369779|NCT00550290|11510512|FG000|NOT COMPLETED|Overall Study||0
10369780|NCT00550290|11510513|FG001|NOT COMPLETED|Overall Study||0
10369781|NCT00550368|11510521|FG000|STARTED|Overall Study||26
10369782|NCT00550368|11510522|FG001|STARTED|Overall Study||19
10369783|NCT00550368|11510521|FG000|COMPLETED|Overall Study||26
10369784|NCT00550368|11510522|FG001|COMPLETED|Overall Study||19
10369785|NCT00550368|11510521|FG000|NOT COMPLETED|Overall Study||0
10369786|NCT00550368|11510522|FG001|NOT COMPLETED|Overall Study||0
10369787|NCT00550394|11510530|FG000|STARTED|Overall Study||21
10369788|NCT00550394|11510531|FG001|STARTED|Overall Study||18
10369789|NCT00550394|11510530|FG000|COMPLETED|Overall Study||9
10369790|NCT00550394|11510531|FG001|COMPLETED|Overall Study||5
10369791|NCT00550394|11510530|FG000|NOT COMPLETED|Overall Study||12
10369792|NCT00550394|11510531|FG001|NOT COMPLETED|Overall Study||13
10369793|NCT00550407|11510541|FG000|STARTED|8-16 Week Preliminary (Open-Label) Phase||215
10369794|NCT00550407|11510542|FG001|STARTED|8-16 Week Preliminary (Open-Label) Phase||0
10369795|NCT00550407|11510543|FG002|STARTED|8-16 Week Preliminary (Open-Label) Phase||0
10369796|NCT00550407|11510541|FG000|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||103
10369797|NCT00550407|11510542|FG001|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
10369798|NCT00550407|11510543|FG002|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
10369799|NCT00550407|11510541|FG000|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||112
10369800|NCT00550407|11510542|FG001|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
10369801|NCT00550407|11510543|FG002|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
10369802|NCT00550407|11510541|FG000|STARTED|26-Week Randomized Phase||0
10369803|NCT00550407|11510542|FG001|STARTED|26-Week Randomized Phase||58
10369804|NCT00550407|11510543|FG002|STARTED|26-Week Randomized Phase||45
10369805|NCT00550407|11510541|FG000|COMPLETED|26-Week Randomized Phase||0
10369806|NCT00550407|11510542|FG001|COMPLETED|26-Week Randomized Phase||15
10369807|NCT00550407|11510543|FG002|COMPLETED|26-Week Randomized Phase||21
10369808|NCT00550407|11510541|FG000|NOT COMPLETED|26-Week Randomized Phase||0
10369809|NCT00550407|11510542|FG001|NOT COMPLETED|26-Week Randomized Phase||43
10369810|NCT00550407|11510543|FG002|NOT COMPLETED|26-Week Randomized Phase||24
10369811|NCT00550420|11510551|FG000|STARTED|Overall Study||331
10369812|NCT00550420|11510551|FG000|COMPLETED|Overall Study||26
10369813|NCT00550420|11510551|FG000|NOT COMPLETED|Overall Study||305
10369814|NCT00550446|11510564|FG000|STARTED|Up To Week 12||54
10369815|NCT00550446|11510565|FG001|STARTED|Up To Week 12||52
10369816|NCT00550446|11510566|FG002|STARTED|Up To Week 12||50
10369817|NCT00550446|11510567|FG003|STARTED|Up To Week 12||61
10369818|NCT00550446|11510568|FG004|STARTED|Up To Week 12||57
10369819|NCT00550446|11510569|FG005|STARTED|Up To Week 12||53
10369820|NCT00550446|11510570|FG006|STARTED|Up To Week 12||59
10369821|NCT00550446|11510571|FG007|STARTED|Up To Week 12||0
10369822|NCT00550446|11510572|FG008|STARTED|Up To Week 12||0
10369823|NCT00550446|11510573|FG009|STARTED|Up To Week 12||0
10369824|NCT00550446|11510574|FG010|STARTED|Up To Week 12||0
10369825|NCT00550446|11510564|FG000|Treated|Up To Week 12||54
10369826|NCT00550446|11510565|FG001|Treated|Up To Week 12||51
10369827|NCT00550446|11510566|FG002|Treated|Up To Week 12||49
10369828|NCT00550446|11510567|FG003|Treated|Up To Week 12||61
10369829|NCT00550446|11510568|FG004|Treated|Up To Week 12||57
10369830|NCT00550446|11510569|FG005|Treated|Up To Week 12||53
10369831|NCT00550446|11510570|FG006|Treated|Up To Week 12||59
10369832|NCT00550446|11510571|FG007|Treated|Up To Week 12||0
10369833|NCT00550446|11510572|FG008|Treated|Up To Week 12||0
10369834|NCT00550446|11510573|FG009|Treated|Up To Week 12||0
10369835|NCT00550446|11510574|FG010|Treated|Up To Week 12||0
10369836|NCT00550446|11510564|FG000|COMPLETED|Up To Week 12||44
10369837|NCT00550446|11510565|FG001|COMPLETED|Up To Week 12||47
10369838|NCT00550446|11510566|FG002|COMPLETED|Up To Week 12||46
10369839|NCT00550446|11510567|FG003|COMPLETED|Up To Week 12||58
10369840|NCT00550446|11510568|FG004|COMPLETED|Up To Week 12||54
10369841|NCT00550446|11510569|FG005|COMPLETED|Up To Week 12||45
10369842|NCT00550446|11510570|FG006|COMPLETED|Up To Week 12||46
10369843|NCT00550446|11510571|FG007|COMPLETED|Up To Week 12||0
10369844|NCT00550446|11510572|FG008|COMPLETED|Up To Week 12||0
10369845|NCT00550446|11510573|FG009|COMPLETED|Up To Week 12||0
10716804|NCT02692040|11880577|FG007|NOT COMPLETED|Overall Study||0
10716805|NCT02692040|11880578|FG008|NOT COMPLETED|Overall Study||0
10716806|NCT02692040|11880579|FG009|NOT COMPLETED|Overall Study||0
10716807|NCT02692040|11880580|FG010|NOT COMPLETED|Overall Study||0
10716808|NCT02692040|11880581|FG011|NOT COMPLETED|Overall Study||0
10716809|NCT02692040|11880582|FG012|NOT COMPLETED|Overall Study||1
10716810|NCT02692040|11880583|FG013|NOT COMPLETED|Overall Study||3
10716811|NCT02692040|11880584|FG014|NOT COMPLETED|Overall Study||1
10716812|NCT02692040|11880585|FG015|NOT COMPLETED|Overall Study||1
10716813|NCT02692040|11880586|FG016|NOT COMPLETED|Overall Study||0
10716814|NCT02692209|11880663|FG000|STARTED|Overall Study||298
10716815|NCT02692209|11880663|FG000|COMPLETED|Overall Study||298
10812600|NCT03483051|11974703|FG001|NOT COMPLETED|First Treatment, Pre Crossover||0
10812601|NCT03483051|11974702|FG000|STARTED|Second Treatment, After Crossover||2
10812602|NCT03483051|11974703|FG001|STARTED|Second Treatment, After Crossover||1
10812603|NCT03483051|11974702|FG000|COMPLETED|Second Treatment, After Crossover||2
10812604|NCT03483051|11974703|FG001|COMPLETED|Second Treatment, After Crossover||1
10369846|NCT00550446|11510574|FG010|COMPLETED|Up To Week 12||0
10369847|NCT00550446|11510564|FG000|NOT COMPLETED|Up To Week 12||10
10369848|NCT00550446|11510565|FG001|NOT COMPLETED|Up To Week 12||5
10369849|NCT00550446|11510566|FG002|NOT COMPLETED|Up To Week 12||4
10369850|NCT00550446|11510567|FG003|NOT COMPLETED|Up To Week 12||3
10369851|NCT00550446|11510568|FG004|NOT COMPLETED|Up To Week 12||3
10369852|NCT00550446|11510569|FG005|NOT COMPLETED|Up To Week 12||8
10369853|NCT00550446|11510570|FG006|NOT COMPLETED|Up To Week 12||13
10716816|NCT02692209|11880663|FG000|NOT COMPLETED|Overall Study||0
10716817|NCT02692235|11880671|FG000|STARTED|Overall Study||14
10369854|NCT00550446|11510571|FG007|NOT COMPLETED|Up To Week 12||0
10369855|NCT00550446|11510572|FG008|NOT COMPLETED|Up To Week 12||0
10369856|NCT00550446|11510573|FG009|NOT COMPLETED|Up To Week 12||0
10369857|NCT00550446|11510574|FG010|NOT COMPLETED|Up To Week 12||0
10369858|NCT00550446|11510564|FG000|STARTED|Post Week 12||27
10369859|NCT00550446|11510565|FG001|STARTED|Post Week 12||30
10369860|NCT00550446|11510566|FG002|STARTED|Post Week 12||46
10369861|NCT00550446|11510567|FG003|STARTED|Post Week 12||58
10369862|NCT00550446|11510568|FG004|STARTED|Post Week 12||54
10369863|NCT00550446|11510569|FG005|STARTED|Post Week 12||1
10369864|NCT00550446|11510570|FG006|STARTED|Post Week 12||21
10369865|NCT00550446|11510571|FG007|STARTED|Post Week 12||17
10369866|NCT00550446|11510572|FG008|STARTED|Post Week 12||17
10369867|NCT00550446|11510573|FG009|STARTED|Post Week 12||44
10369868|NCT00550446|11510574|FG010|STARTED|Post Week 12||25
10369869|NCT00550446|11510564|FG000|COMPLETED|Post Week 12||24
10369870|NCT00550446|11510565|FG001|COMPLETED|Post Week 12||28
10369871|NCT00550446|11510566|FG002|COMPLETED|Post Week 12||43
10369872|NCT00550446|11510567|FG003|COMPLETED|Post Week 12||55
10369873|NCT00550446|11510568|FG004|COMPLETED|Post Week 12||52
10369874|NCT00550446|11510569|FG005|COMPLETED|Post Week 12||0
10369875|NCT00550446|11510570|FG006|COMPLETED|Post Week 12||19
10369876|NCT00550446|11510571|FG007|COMPLETED|Post Week 12||16
10369877|NCT00550446|11510572|FG008|COMPLETED|Post Week 12||15
10369878|NCT00550446|11510573|FG009|COMPLETED|Post Week 12||37
10369879|NCT00550446|11510574|FG010|COMPLETED|Post Week 12||24
10369880|NCT00550446|11510564|FG000|NOT COMPLETED|Post Week 12||3
10369881|NCT00550446|11510565|FG001|NOT COMPLETED|Post Week 12||2
10369882|NCT00550446|11510566|FG002|NOT COMPLETED|Post Week 12||3
10369883|NCT00550446|11510567|FG003|NOT COMPLETED|Post Week 12||3
10369884|NCT00550446|11510568|FG004|NOT COMPLETED|Post Week 12||2
10369885|NCT00550446|11510569|FG005|NOT COMPLETED|Post Week 12||1
10369886|NCT00550446|11510570|FG006|NOT COMPLETED|Post Week 12||2
10369887|NCT00550446|11510571|FG007|NOT COMPLETED|Post Week 12||1
10369888|NCT00550446|11510572|FG008|NOT COMPLETED|Post Week 12||2
10369889|NCT00550446|11510573|FG009|NOT COMPLETED|Post Week 12||7
10369890|NCT00550446|11510574|FG010|NOT COMPLETED|Post Week 12||1
10369891|NCT00550459|11510614|FG000|STARTED|Overall Study||28
10369892|NCT00550459|11510615|FG001|STARTED|Overall Study||29
10369893|NCT00550459|11510614|FG000|COMPLETED|Overall Study||27
10369894|NCT00550459|11510615|FG001|COMPLETED|Overall Study||26
10369895|NCT00550459|11510614|FG000|NOT COMPLETED|Overall Study||1
10369896|NCT00550459|11510615|FG001|NOT COMPLETED|Overall Study||3
10369897|NCT00550537|11510621|FG000|STARTED|Overall Study||116
10369898|NCT00550537|11510621|FG000|COMPLETED|Overall Study||12
10369899|NCT00550537|11510621|FG000|NOT COMPLETED|Overall Study||104
10369900|NCT00550550|11510632|FG000|STARTED|Overall Study||176
10369901|NCT00550550|11510633|FG001|STARTED|Overall Study||169
10369902|NCT00550550|11510632|FG000|Number Treated|Overall Study||175
10369903|NCT00550550|11510633|FG001|Number Treated|Overall Study||169
10369904|NCT00550550|11510632|FG000|COMPLETED|Overall Study||142
10369905|NCT00550550|11510633|FG001|COMPLETED|Overall Study||140
10369906|NCT00550550|11510632|FG000|NOT COMPLETED|Overall Study||34
10537244|NCT01448824|11689822|FG004|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
10537245|NCT01448824|11689823|FG005|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
10537246|NCT01448824|11689824|FG006|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
10537247|NCT01448824|11689825|FG007|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||3
10537248|NCT01448850|11689855|FG000|STARTED|Overall Study||164
10537249|NCT01448850|11689856|FG001|STARTED|Overall Study||160
10537250|NCT01448850|11689855|FG000|COMPLETED|Overall Study||130
10537251|NCT01448850|11689856|FG001|COMPLETED|Overall Study||120
10537252|NCT01448850|11689855|FG000|NOT COMPLETED|Overall Study||34
10537253|NCT01448850|11689856|FG001|NOT COMPLETED|Overall Study||40
10537254|NCT01449006|11689865|FG000|STARTED|Overall Study||8
10537255|NCT01449006|11689866|FG001|STARTED|Overall Study||9
10537256|NCT01449006|11689865|FG000|COMPLETED|Overall Study||5
10537257|NCT01449006|11689866|FG001|COMPLETED|Overall Study||9
10537258|NCT01449006|11689865|FG000|NOT COMPLETED|Overall Study||3
10537259|NCT01449006|11689866|FG001|NOT COMPLETED|Overall Study||0
10537260|NCT01449240|11689872|FG000|STARTED|Overall Study||10
10537261|NCT01449240|11689872|FG000|COMPLETED|Overall Study||10
10537262|NCT01449240|11689872|FG000|NOT COMPLETED|Overall Study||0
10537263|NCT01449266|11689876|FG000|STARTED|Overall Study||10
10537264|NCT01449266|11689876|FG000|COMPLETED|Overall Study||10
10537265|NCT01449266|11689876|FG000|NOT COMPLETED|Overall Study||0
10537266|NCT01449279|11689880|FG000|STARTED|Overall Study||22
10537267|NCT01449279|11689880|FG000|COMPLETED|Overall Study||15
10537268|NCT01449279|11689880|FG000|NOT COMPLETED|Overall Study||7
10537269|NCT01449305|11689884|FG000|STARTED|Overall Study||44
10369907|NCT00550550|11510633|FG001|NOT COMPLETED|Overall Study||29
10369908|NCT00550589|11510639|FG000|STARTED|Overall Study||33
10369909|NCT00550589|11510639|FG000|COMPLETED|Overall Study||33
10369910|NCT00550589|11510639|FG000|NOT COMPLETED|Overall Study||0
10369911|NCT00550615|11510647|FG000|STARTED|Overall Study||3
10369912|NCT00550615|11510648|FG001|STARTED|Overall Study||3
10369913|NCT00550615|11510649|FG002|STARTED|Overall Study||10
10369914|NCT00550615|11510650|FG003|STARTED|Overall Study||22
10369915|NCT00550615|11510647|FG000|COMPLETED|Overall Study||3
10369916|NCT00550615|11510648|FG001|COMPLETED|Overall Study||3
10657158|NCT02223429|11818307|FG002|NOT COMPLETED|Overall Study||0
10369917|NCT00550615|11510649|FG002|COMPLETED|Overall Study||6
10369918|NCT00550615|11510650|FG003|COMPLETED|Overall Study||12
10369919|NCT00550615|11510647|FG000|NOT COMPLETED|Overall Study||0
10369920|NCT00550615|11510648|FG001|NOT COMPLETED|Overall Study||0
10369921|NCT00550615|11510649|FG002|NOT COMPLETED|Overall Study||4
10369922|NCT00550615|11510650|FG003|NOT COMPLETED|Overall Study||10
10369923|NCT00550654|11510656|FG000|STARTED|Overall Study||1
10369924|NCT00550654|11510656|FG000|COMPLETED|Overall Study||1
10369925|NCT00550654|11510656|FG000|NOT COMPLETED|Overall Study||0
10369926|NCT00550680|11510660|FG000|STARTED|Overall Study||208
10369927|NCT00550680|11510660|FG000|COMPLETED|Overall Study||152
10369928|NCT00550680|11510660|FG000|NOT COMPLETED|Overall Study||56
10369929|NCT00550732|11510664|FG000|STARTED|Overall Study||40
10369930|NCT00550732|11510664|FG000|COMPLETED|Overall Study||29
10369931|NCT00550732|11510664|FG000|NOT COMPLETED|Overall Study||11
10369932|NCT00550745|11510671|FG000|STARTED|Overall Study||6000
10369933|NCT00550745|11510672|FG001|STARTED|Overall Study||5999
10369934|NCT00550745|11510671|FG000|COMPLETED|Overall Study||5913
10369935|NCT00550745|11510672|FG001|COMPLETED|Overall Study||5939
10369936|NCT00550745|11510671|FG000|NOT COMPLETED|Overall Study||87
10369937|NCT00550745|11510672|FG001|NOT COMPLETED|Overall Study||60
10369938|NCT00550771|11510680|FG000|STARTED|Overall Study||121
10369939|NCT00550771|11510681|FG001|STARTED|Overall Study||60
10369940|NCT00550771|11510680|FG000|COMPLETED|Overall Study||104
10369941|NCT00550771|11510681|FG001|COMPLETED|Overall Study||50
10369942|NCT00550771|11510680|FG000|NOT COMPLETED|Overall Study||17
10369943|NCT00550771|11510681|FG001|NOT COMPLETED|Overall Study||10
10369944|NCT00550836|11510689|FG000|STARTED|Overall Study||49
10369945|NCT00550836|11510690|FG001|STARTED|Overall Study||55
10369946|NCT00550836|11510689|FG000|COMPLETED|Overall Study||46
10369947|NCT00550836|11510690|FG001|COMPLETED|Overall Study||46
10369948|NCT00550836|11510689|FG000|NOT COMPLETED|Overall Study||3
10369949|NCT00550836|11510690|FG001|NOT COMPLETED|Overall Study||9
10369950|NCT00550862|11510700|FG000|STARTED|Overall Study||38
10369951|NCT00550862|11510701|FG001|STARTED|Overall Study||48
10369952|NCT00550862|11510702|FG002|STARTED|Overall Study||41
10369953|NCT00550862|11510703|FG003|STARTED|Overall Study||38
10369954|NCT00550862|11510700|FG000|COMPLETED|Overall Study||32
10369955|NCT00550862|11510701|FG001|COMPLETED|Overall Study||42
10369956|NCT00550862|11510702|FG002|COMPLETED|Overall Study||25
10369957|NCT00550862|11510703|FG003|COMPLETED|Overall Study||37
10369958|NCT00550862|11510700|FG000|NOT COMPLETED|Overall Study||6
10369959|NCT00550862|11510701|FG001|NOT COMPLETED|Overall Study||6
10369960|NCT00550862|11510702|FG002|NOT COMPLETED|Overall Study||16
10369961|NCT00550862|11510703|FG003|NOT COMPLETED|Overall Study||1
10369962|NCT00550953|11510715|FG000|STARTED|Overall Study||156
10369963|NCT00550953|11510716|FG001|STARTED|Overall Study||158
10369964|NCT00550953|11510715|FG000|COMPLETED|Overall Study||150
10369965|NCT00550953|11510716|FG001|COMPLETED|Overall Study||152
10369966|NCT00550953|11510715|FG000|NOT COMPLETED|Overall Study||6
10369967|NCT00550953|11510716|FG001|NOT COMPLETED|Overall Study||6
10369968|NCT00551031|11510727|FG000|STARTED|Overall Study||637
10369969|NCT00551031|11510728|FG001|STARTED|Overall Study||636
10369970|NCT00551031|11510729|FG002|STARTED|Overall Study||319
10369971|NCT00551031|11510730|FG003|STARTED|Overall Study||320
10369972|NCT00551031|11510731|FG004|STARTED|Overall Study||186
10369973|NCT00551031|11510727|FG000|COMPLETED|Overall Study||635
10369974|NCT00551031|11510728|FG001|COMPLETED|Overall Study||625
10369975|NCT00551031|11510729|FG002|COMPLETED|Overall Study||317
10369976|NCT00551031|11510730|FG003|COMPLETED|Overall Study||317
10369977|NCT00551031|11510731|FG004|COMPLETED|Overall Study||185
10369978|NCT00551031|11510727|FG000|NOT COMPLETED|Overall Study||2
10369979|NCT00551031|11510728|FG001|NOT COMPLETED|Overall Study||11
10369980|NCT00551031|11510729|FG002|NOT COMPLETED|Overall Study||2
10369981|NCT00551031|11510730|FG003|NOT COMPLETED|Overall Study||3
10369982|NCT00551031|11510731|FG004|NOT COMPLETED|Overall Study||1
10369983|NCT00551070|11510743|FG000|STARTED|Overall Study||52
10369984|NCT00551070|11510743|FG000|COMPLETED|Overall Study||52
10369985|NCT00551070|11510743|FG000|NOT COMPLETED|Overall Study||0
10369986|NCT00551135|11510751|FG000|STARTED|Overall Study||108
10369987|NCT00551135|11510752|FG001|STARTED|Overall Study||106
10369988|NCT00551135|11510753|FG002|STARTED|Overall Study||103
10369989|NCT00551135|11510754|FG003|STARTED|Overall Study||108
10369990|NCT00551135|11510751|FG000|COMPLETED|Overall Study||103
10369991|NCT00551135|11510752|FG001|COMPLETED|Overall Study||104
10369992|NCT00551135|11510753|FG002|COMPLETED|Overall Study||98
10537270|NCT01449305|11689884|FG000|COMPLETED|Overall Study||42
10537271|NCT01449305|11689884|FG000|NOT COMPLETED|Overall Study||2
10537272|NCT01449370|11689913|FG000|STARTED|Overall Study||6
10369993|NCT00551135|11510754|FG003|COMPLETED|Overall Study||103
10369994|NCT00551135|11510751|FG000|NOT COMPLETED|Overall Study||5
10369995|NCT00551135|11510752|FG001|NOT COMPLETED|Overall Study||2
10369996|NCT00551135|11510753|FG002|NOT COMPLETED|Overall Study||5
10369997|NCT00551135|11510754|FG003|NOT COMPLETED|Overall Study||5
10369998|NCT00551161|11510764|FG000|STARTED|Overall Study||12
10369999|NCT00551161|11510764|FG000|COMPLETED|Overall Study||11
10370000|NCT00551161|11510764|FG000|NOT COMPLETED|Overall Study||1
10370001|NCT00551174|11510770|FG000|STARTED|Overall Study||381
10370002|NCT00551174|11510771|FG001|STARTED|Overall Study||400
10370003|NCT00551174|11510770|FG000|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|362
10370004|NCT00551174|11510771|FG001|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|394
10370005|NCT00551174|11510770|FG000|NOT COMPLETED|Overall Study||19
10370006|NCT00551174|11510771|FG001|NOT COMPLETED|Overall Study||6
10370007|NCT00551200|11510777|FG000|STARTED|Overall Study||14
10537273|NCT01449370|11689914|FG001|STARTED|Overall Study||6
10537274|NCT01449370|11689915|FG002|STARTED|Overall Study||8
10537275|NCT01449370|11689916|FG003|STARTED|Overall Study||4
10370008|NCT00551200|11510777|FG000|COMPLETED|Overall Study||10
10370009|NCT00551200|11510777|FG000|NOT COMPLETED|Overall Study||4
10370010|NCT00551213|11510789|FG000|STARTED|Overall Study||50
10370011|NCT00551213|11510790|FG001|STARTED|Overall Study||17
10370012|NCT00551213|11510789|FG000|Treated|Overall Study||49
10370013|NCT00551213|11510790|FG001|Treated|Overall Study||15
10370014|NCT00551213|11510789|FG000|COMPLETED|Overall Study||0
10370015|NCT00551213|11510790|FG001|COMPLETED|Overall Study||0
10370016|NCT00551213|11510789|FG000|NOT COMPLETED|Overall Study||50
10370017|NCT00551213|11510790|FG001|NOT COMPLETED|Overall Study||17
10370018|NCT00551291|11510796|FG000|STARTED|Overall Study||10
10370019|NCT00551291|11510796|FG000|COMPLETED|Overall Study||9
10370020|NCT00551291|11510796|FG000|NOT COMPLETED|Overall Study||1
10370021|NCT00551369|11510800|FG000|STARTED|Overall Study||33
10370022|NCT00551369|11510800|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study|26
10370023|NCT00551369|11510800|FG000|NOT COMPLETED|Overall Study||7
10370024|NCT00551421|11510804|FG000|STARTED|Original Protocol, Dose Level 1||3
10370025|NCT00551421|11510804|FG000|COMPLETED|Original Protocol, Dose Level 1|1 subject developed Grade 3 diarrhea, all 3 subjects experienced significant skin toxicity.|3
10370026|NCT00551421|11510804|FG000|NOT COMPLETED|Original Protocol, Dose Level 1||0
10370027|NCT00551421|11510804|FG000|STARTED|Amended Protocol (Cetuximab-refr. mCRC)||14
10370028|NCT00551421|11510804|FG000|COMPLETED|Amended Protocol (Cetuximab-refr. mCRC)||13
10370029|NCT00551421|11510804|FG000|NOT COMPLETED|Amended Protocol (Cetuximab-refr. mCRC)||1
10370030|NCT00551460|11510809|FG000|STARTED|Overall Study||78
10370031|NCT00551460|11510809|FG000|COMPLETED|Overall Study||60
10370032|NCT00551460|11510809|FG000|NOT COMPLETED|Overall Study||18
10370033|NCT00551525|11510813|FG000|STARTED|Overall Study||67
10370034|NCT00551525|11510813|FG000|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study|62
10370035|NCT00551525|11510813|FG000|NOT COMPLETED|Overall Study||5
10370036|NCT00551642|11510819|FG000|STARTED|Treatment Period||399
10370037|NCT00551642|11510820|FG001|STARTED|Treatment Period||401
10370038|NCT00551642|11510819|FG000|Safety Population|Treatment Period||395
10370039|NCT00551642|11510820|FG001|Safety Population|Treatment Period||397
10370040|NCT00551642|11510819|FG000|COMPLETED|Treatment Period||338
10370041|NCT00551642|11510820|FG001|COMPLETED|Treatment Period||338
10370042|NCT00551642|11510819|FG000|NOT COMPLETED|Treatment Period||61
10370043|NCT00551642|11510820|FG001|NOT COMPLETED|Treatment Period||63
10370044|NCT00551642|11510819|FG000|STARTED|7-Year Follow-up||152
10370045|NCT00551642|11510820|FG001|STARTED|7-Year Follow-up||153
10370046|NCT00551642|11510819|FG000|COMPLETED|7-Year Follow-up||152
10370047|NCT00551642|11510820|FG001|COMPLETED|7-Year Follow-up||153
10370048|NCT00551642|11510819|FG000|NOT COMPLETED|7-Year Follow-up||0
10370049|NCT00551642|11510820|FG001|NOT COMPLETED|7-Year Follow-up||0
10370050|NCT00551707|11510831|FG000|STARTED|Overall Study||4
10370051|NCT00551707|11510832|FG001|STARTED|Overall Study||22
10370052|NCT00551707|11510833|FG002|STARTED|Overall Study||13
10370053|NCT00551707|11510834|FG003|STARTED|Overall Study||8
10370054|NCT00551707|11510835|FG004|STARTED|Overall Study||4
10370055|NCT00551707|11510831|FG000|COMPLETED|Overall Study||4
10370056|NCT00551707|11510832|FG001|COMPLETED|Overall Study||16
10370057|NCT00551707|11510833|FG002|COMPLETED|Overall Study||10
10370058|NCT00551707|11510834|FG003|COMPLETED|Overall Study||4
10370059|NCT00551707|11510835|FG004|COMPLETED|Overall Study||3
10370060|NCT00551707|11510831|FG000|NOT COMPLETED|Overall Study||0
10370061|NCT00551707|11510832|FG001|NOT COMPLETED|Overall Study||6
10370062|NCT00551707|11510833|FG002|NOT COMPLETED|Overall Study||3
10370063|NCT00551707|11510834|FG003|NOT COMPLETED|Overall Study||4
10370064|NCT00551707|11510835|FG004|NOT COMPLETED|Overall Study||1
10370065|NCT00551746|11510851|FG000|STARTED|Overall Study||36
10370066|NCT00551746|11510852|FG001|STARTED|Overall Study||34
10370067|NCT00551746|11510851|FG000|COMPLETED|Overall Study||25
10370068|NCT00551746|11510852|FG001|COMPLETED|Overall Study||26
10370069|NCT00551746|11510851|FG000|NOT COMPLETED|Overall Study||11
10370070|NCT00551746|11510852|FG001|NOT COMPLETED|Overall Study||8
10370071|NCT00551759|11510858|FG000|STARTED|Overall Study||22
10370072|NCT00551759|11510858|FG000|Eligible and Began Treatment|Overall Study||21
10370073|NCT00551759|11510858|FG000|Underwent Surgery|Overall Study||17
10370074|NCT00551759|11510858|FG000|Received Adjuvant Therapy|Overall Study||12
10370075|NCT00551759|11510858|FG000|COMPLETED|Overall Study||9
10370076|NCT00551759|11510858|FG000|NOT COMPLETED|Overall Study||13
10370077|NCT00552058|11510864|FG000|STARTED|Overall Study||223
10370078|NCT00552058|11510865|FG001|STARTED|Overall Study||216
10370079|NCT00552058|11510864|FG000|COMPLETED|Overall Study||207
10370080|NCT00552058|11510865|FG001|COMPLETED|Overall Study||192
10370081|NCT00552058|11510864|FG000|NOT COMPLETED|Overall Study||16
10370082|NCT00552058|11510865|FG001|NOT COMPLETED|Overall Study||24
10370083|NCT00552071|11510873|FG000|STARTED|Overall Study||10
10370084|NCT00552071|11510874|FG001|STARTED|Overall Study||11
10370085|NCT00552071|11510873|FG000|COMPLETED|Overall Study||6
10370086|NCT00552071|11510874|FG001|COMPLETED|Overall Study||9
10370087|NCT00552071|11510873|FG000|NOT COMPLETED|Overall Study||4
10370088|NCT00552071|11510874|FG001|NOT COMPLETED|Overall Study||2
10370089|NCT00552084|11510884|FG000|STARTED|Overall Study||126
10370090|NCT00552084|11510885|FG001|STARTED|Overall Study||64
10370091|NCT00552084|11510884|FG000|COMPLETED|Overall Study||118
10370092|NCT00552084|11510885|FG001|COMPLETED|Overall Study||55
10370093|NCT00552084|11510884|FG000|NOT COMPLETED|Overall Study||8
10370094|NCT00552084|11510885|FG001|NOT COMPLETED|Overall Study||9
10427548|NCT00853580|11573393|FG000|COMPLETED|Overall Study||67
10370095|NCT00552110|11510896|FG000|STARTED|Overall Study|One subject was excluded from the intent to treat population because there was no record of dosing.|146
10370096|NCT00552110|11510897|FG001|STARTED|Overall Study||139
10370097|NCT00552110|11510898|FG002|STARTED|Overall Study||139
10370098|NCT00552110|11510899|FG003|STARTED|Overall Study|One subject was excluded from the intent to treat population because there was no record of dosing.|141
10370099|NCT00552110|11510900|FG004|STARTED|Overall Study||142
10370100|NCT00552110|11510896|FG000|COMPLETED|Overall Study||142
10370101|NCT00552110|11510897|FG001|COMPLETED|Overall Study||134
10370102|NCT00552110|11510898|FG002|COMPLETED|Overall Study||137
10370103|NCT00552110|11510899|FG003|COMPLETED|Overall Study||133
10370104|NCT00552110|11510900|FG004|COMPLETED|Overall Study||133
10370105|NCT00552110|11510896|FG000|NOT COMPLETED|Overall Study||4
10370106|NCT00552110|11510897|FG001|NOT COMPLETED|Overall Study||5
10370107|NCT00552110|11510898|FG002|NOT COMPLETED|Overall Study||2
10370108|NCT00552110|11510899|FG003|NOT COMPLETED|Overall Study||8
10370109|NCT00552110|11510900|FG004|NOT COMPLETED|Overall Study||9
10370110|NCT00552175|11510915|FG000|STARTED|Overall Study||167
10370111|NCT00552175|11510916|FG001|STARTED|Overall Study||86
10370112|NCT00552175|11510917|FG002|STARTED|Overall Study||86
10370113|NCT00552175|11510915|FG000|Full Analysis Set Population|Overall Study||167
10370114|NCT00552175|11510916|FG001|Full Analysis Set Population|Overall Study||85
10370115|NCT00552175|11510917|FG002|Full Analysis Set Population|Overall Study||86
10370116|NCT00552175|11510915|FG000|COMPLETED|Overall Study||150
10370117|NCT00552175|11510916|FG001|COMPLETED|Overall Study||73
10370118|NCT00552175|11510917|FG002|COMPLETED|Overall Study||72
10370119|NCT00552175|11510915|FG000|NOT COMPLETED|Overall Study||17
10370120|NCT00552175|11510916|FG001|NOT COMPLETED|Overall Study||13
10370121|NCT00552175|11510917|FG002|NOT COMPLETED|Overall Study||14
10370122|NCT00552188|11510928|FG000|STARTED|Overall Study||26
10370123|NCT00552188|11510929|FG001|STARTED|Overall Study||26
10370124|NCT00552188|11510928|FG000|COMPLETED|Overall Study||24
10370125|NCT00552188|11510929|FG001|COMPLETED|Overall Study||21
10370126|NCT00552188|11510928|FG000|NOT COMPLETED|Overall Study||2
10370127|NCT00552188|11510929|FG001|NOT COMPLETED|Overall Study||5
10370128|NCT00552240|11510937|FG000|STARTED|Overall Study|Number in Full Analysis Set (FAS)|75
10370129|NCT00552240|11510938|FG001|STARTED|Overall Study|Number in Full Analysis Set (FAS)|77
10370130|NCT00552240|11510937|FG000|COMPLETED|Overall Study||51
10370131|NCT00552240|11510938|FG001|COMPLETED|Overall Study||59
10370132|NCT00552240|11510937|FG000|NOT COMPLETED|Overall Study||24
10370133|NCT00552240|11510938|FG001|NOT COMPLETED|Overall Study||18
10370134|NCT00552279|11510946|FG000|STARTED|Overall Study||403
10370135|NCT00552279|11510947|FG001|STARTED|Overall Study||401
10370136|NCT00552279|11510946|FG000|COMPLETED|Overall Study||389
10370137|NCT00552279|11510947|FG001|COMPLETED|Overall Study||398
10370138|NCT00552279|11510946|FG000|NOT COMPLETED|Overall Study||14
10370139|NCT00552279|11510947|FG001|NOT COMPLETED|Overall Study||3
10370140|NCT00552305|11510953|FG000|STARTED|Overall Study||370
10370141|NCT00552305|11510953|FG000|COMPLETED|Overall Study||120
10370142|NCT00552305|11510953|FG000|NOT COMPLETED|Overall Study||250
10370143|NCT00552344|11510957|FG000|STARTED|Overall Study||402
10370144|NCT00552344|11510957|FG000|COMPLETED|Overall Study||87
10370145|NCT00552344|11510957|FG000|NOT COMPLETED|Overall Study||315
10370146|NCT00552396|11510969|FG000|STARTED|Overall Study||4
10370147|NCT00552396|11510970|FG001|STARTED|Overall Study||3
10370148|NCT00552396|11510971|FG002|STARTED|Overall Study||3
10370149|NCT00552396|11510972|FG003|STARTED|Overall Study||6
10370150|NCT00552396|11510973|FG004|STARTED|Overall Study||3
10370151|NCT00552396|11510974|FG005|STARTED|Overall Study||3
10370152|NCT00552396|11510975|FG006|STARTED|Overall Study||10
10370153|NCT00552396|11510969|FG000|COMPLETED|Overall Study||1
10370154|NCT00552396|11510970|FG001|COMPLETED|Overall Study||0
10370155|NCT00552396|11510971|FG002|COMPLETED|Overall Study||0
10370156|NCT00552396|11510972|FG003|COMPLETED|Overall Study||0
10370157|NCT00552396|11510973|FG004|COMPLETED|Overall Study||0
10370158|NCT00552396|11510974|FG005|COMPLETED|Overall Study||0
10370159|NCT00552396|11510975|FG006|COMPLETED|Overall Study||1
10370160|NCT00552396|11510969|FG000|NOT COMPLETED|Overall Study||3
10370161|NCT00552396|11510970|FG001|NOT COMPLETED|Overall Study||3
10370162|NCT00552396|11510971|FG002|NOT COMPLETED|Overall Study||3
10370163|NCT00552396|11510972|FG003|NOT COMPLETED|Overall Study||6
10370164|NCT00552396|11510973|FG004|NOT COMPLETED|Overall Study||3
10370165|NCT00552396|11510974|FG005|NOT COMPLETED|Overall Study||3
10370166|NCT00552396|11510975|FG006|NOT COMPLETED|Overall Study||9
10370167|NCT00552409|11511011|FG000|STARTED|Overall Study||11
10370168|NCT00552409|11511012|FG001|STARTED|Overall Study||11
10370169|NCT00552409|11511011|FG000|COMPLETED|Overall Study||10
10370170|NCT00552409|11511012|FG001|COMPLETED|Overall Study||9
10370171|NCT00552409|11511011|FG000|NOT COMPLETED|Overall Study||1
10370172|NCT00552409|11511012|FG001|NOT COMPLETED|Overall Study||2
10370173|NCT00552422|11511018|FG000|STARTED|Overall Study||6
10370174|NCT00552422|11511018|FG000|COMPLETED|Overall Study||6
10370175|NCT00552422|11511018|FG000|NOT COMPLETED|Overall Study||0
10370176|NCT00552448|11511024|FG000|STARTED|Overall Study||20
10370177|NCT00552448|11511025|FG001|STARTED|Overall Study||16
10370178|NCT00552448|11511024|FG000|COMPLETED|Overall Study||19
10370179|NCT00552448|11511025|FG001|COMPLETED|Overall Study||16
10370180|NCT00552448|11511024|FG000|NOT COMPLETED|Overall Study||1
10370181|NCT00552448|11511025|FG001|NOT COMPLETED|Overall Study||0
10370182|NCT00552578|11511033|FG000|STARTED|Overall Study||6
10370183|NCT00552578|11511034|FG001|STARTED|Overall Study||6
10370184|NCT00552578|11511033|FG000|COMPLETED|Overall Study||5
10370185|NCT00552578|11511034|FG001|COMPLETED|Overall Study||5
10370186|NCT00552578|11511033|FG000|NOT COMPLETED|Overall Study||1
10370187|NCT00552578|11511034|FG001|NOT COMPLETED|Overall Study||1
10370188|NCT00552617|11511050|FG000|STARTED|Overall Study||10
10370189|NCT00552617|11511051|FG001|STARTED|Overall Study||10
10370190|NCT00552617|11511052|FG002|STARTED|Overall Study||10
10370191|NCT00552617|11511053|FG003|STARTED|Overall Study||10
10370192|NCT00552617|11511054|FG004|STARTED|Overall Study||10
10370193|NCT00552617|11511055|FG005|STARTED|Overall Study||10
10370194|NCT00552617|11511056|FG006|STARTED|Overall Study||10
10370195|NCT00552617|11511057|FG007|STARTED|Overall Study||10
10370196|NCT00552617|11511058|FG008|STARTED|Overall Study||10
10370197|NCT00552617|11511059|FG009|STARTED|Overall Study||10
10370198|NCT00552617|11511050|FG000|Treated|Overall Study||10
10370199|NCT00552617|11511051|FG001|Treated|Overall Study||10
10370200|NCT00552617|11511052|FG002|Treated|Overall Study||9
10370201|NCT00552617|11511053|FG003|Treated|Overall Study||10
10370202|NCT00552617|11511054|FG004|Treated|Overall Study||10
10370203|NCT00552617|11511055|FG005|Treated|Overall Study||10
10370204|NCT00552617|11511056|FG006|Treated|Overall Study||10
10370205|NCT00552617|11511057|FG007|Treated|Overall Study||10
10370206|NCT00552617|11511058|FG008|Treated|Overall Study||10
10370207|NCT00552617|11511059|FG009|Treated|Overall Study||9
10370208|NCT00552617|11511050|FG000|COMPLETED|Overall Study||10
10370209|NCT00552617|11511051|FG001|COMPLETED|Overall Study||10
10370210|NCT00552617|11511052|FG002|COMPLETED|Overall Study||9
10370211|NCT00552617|11511053|FG003|COMPLETED|Overall Study||9
10370212|NCT00552617|11511054|FG004|COMPLETED|Overall Study||10
10370213|NCT00552617|11511055|FG005|COMPLETED|Overall Study||8
10370214|NCT00552617|11511056|FG006|COMPLETED|Overall Study||10
10370215|NCT00552617|11511057|FG007|COMPLETED|Overall Study||10
10370216|NCT00552617|11511058|FG008|COMPLETED|Overall Study||8
10370217|NCT00552617|11511059|FG009|COMPLETED|Overall Study||9
10370218|NCT00552617|11511050|FG000|NOT COMPLETED|Overall Study||0
10370219|NCT00552617|11511051|FG001|NOT COMPLETED|Overall Study||0
10370220|NCT00552617|11511052|FG002|NOT COMPLETED|Overall Study||1
10370221|NCT00552617|11511053|FG003|NOT COMPLETED|Overall Study||1
10537276|NCT01449370|11689917|FG004|STARTED|Overall Study||3
10537277|NCT01449370|11689918|FG005|STARTED|Overall Study||3
10537278|NCT01449370|11689919|FG006|STARTED|Overall Study||3
10537279|NCT01449370|11689920|FG007|STARTED|Overall Study||3
10537280|NCT01449370|11689921|FG008|STARTED|Overall Study||12
10537281|NCT01449370|11689922|FG009|STARTED|Overall Study||3
10537282|NCT01449370|11689923|FG010|STARTED|Overall Study||3
10370222|NCT00552617|11511054|FG004|NOT COMPLETED|Overall Study||0
10370223|NCT00552617|11511055|FG005|NOT COMPLETED|Overall Study||2
10370224|NCT00552617|11511056|FG006|NOT COMPLETED|Overall Study||0
10370225|NCT00552617|11511057|FG007|NOT COMPLETED|Overall Study||0
10537283|NCT01449370|11689924|FG011|STARTED|Overall Study||3
10537284|NCT01449370|11689925|FG012|STARTED|Overall Study||3
10537285|NCT01449370|11689926|FG013|STARTED|Overall Study||11
10537286|NCT01449370|11689927|FG014|STARTED|Overall Study||3
10537287|NCT01449370|11689928|FG015|STARTED|Overall Study||3
10537288|NCT01449370|11689929|FG016|STARTED|Overall Study||7
10537289|NCT01449370|11689930|FG017|STARTED|Overall Study||3
10537290|NCT01449370|11689931|FG018|STARTED|Overall Study||3
10657159|NCT02223429|11818308|FG003|NOT COMPLETED|Overall Study||0
10657160|NCT02223455|11818326|FG000|STARTED|Overall Study|Participant level data not collected.|
10657161|NCT02223455|11818327|FG001|STARTED|Overall Study|Participant level data not collected.|
10657162|NCT02223455|11818328|FG002|STARTED|Overall Study|Participant level data not collected.|
10657163|NCT02223455|11818326|FG000|COMPLETED|Overall Study|Participant level data not collected.|
10657164|NCT02223455|11818327|FG001|COMPLETED|Overall Study|Participant level data not collected.|
10657165|NCT02223455|11818328|FG002|COMPLETED|Overall Study|Participant level data not collected.|
10657166|NCT02223455|11818326|FG000|NOT COMPLETED|Overall Study||
10657167|NCT02223455|11818327|FG001|NOT COMPLETED|Overall Study||
10657168|NCT02223455|11818328|FG002|NOT COMPLETED|Overall Study||
10657169|NCT02223546|11818336|FG000|STARTED|Overall Study||15
10657170|NCT02223546|11818336|FG000|COMPLETED|Overall Study||15
10370226|NCT00552617|11511058|FG008|NOT COMPLETED|Overall Study||2
10370227|NCT00552617|11511059|FG009|NOT COMPLETED|Overall Study||1
10370228|NCT00552669|11511083|FG000|STARTED|Overall Study|patients|100
10370229|NCT00552669|11511084|FG001|STARTED|Overall Study|patients|100
10370230|NCT00552669|11511083|FG000|COMPLETED|Overall Study|All patients were followed for 18.3 +/- 7 months.|97
10370231|NCT00552669|11511084|FG001|COMPLETED|Overall Study|All patients were followed for 18.3 +/- 7 months.|93
10537291|NCT01449370|11689932|FG019|STARTED|Overall Study||3
10537292|NCT01449370|11689933|FG020|STARTED|Overall Study||6
10537293|NCT01449370|11689934|FG021|STARTED|Overall Study||4
10657171|NCT02223546|11818336|FG000|NOT COMPLETED|Overall Study||0
10370232|NCT00552669|11511083|FG000|NOT COMPLETED|Overall Study||3
10370233|NCT00552669|11511084|FG001|NOT COMPLETED|Overall Study||7
10370234|NCT00552695|11511092|FG000|STARTED|Overall Study|August 2007|22
10370235|NCT00552695|11511093|FG001|STARTED|Overall Study|August 2007|23
10370236|NCT00552695|11511092|FG000|COMPLETED|Overall Study|September 2007|22
10370237|NCT00552695|11511093|FG001|COMPLETED|Overall Study|September 2007|23
10370238|NCT00552695|11511092|FG000|NOT COMPLETED|Overall Study||0
10370239|NCT00552695|11511093|FG001|NOT COMPLETED|Overall Study||0
10370240|NCT00552760|11511101|FG000|STARTED|Overall Study||42
10370241|NCT00552760|11511102|FG001|STARTED|Overall Study||41
10370242|NCT00552760|11511101|FG000|COMPLETED|Overall Study||16
10537294|NCT01449370|11689935|FG022|STARTED|Overall Study||4
10537295|NCT01449370|11689936|FG023|STARTED|Overall Study||10
10370243|NCT00552760|11511102|FG001|COMPLETED|Overall Study||8
10370244|NCT00552760|11511101|FG000|NOT COMPLETED|Overall Study||26
10370245|NCT00552760|11511102|FG001|NOT COMPLETED|Overall Study||33
10370246|NCT00552786|11511110|FG000|STARTED|First Intervention||25
10370247|NCT00552786|11511111|FG001|STARTED|First Intervention||28
10370248|NCT00552786|11511110|FG000|Medication and Hearing Evaluation|First Intervention||25
10370249|NCT00552786|11511111|FG001|Medication and Hearing Evaluation|First Intervention||28
10370250|NCT00552786|11511110|FG000|COMPLETED|First Intervention||25
10370251|NCT00552786|11511111|FG001|COMPLETED|First Intervention||28
10370252|NCT00552786|11511110|FG000|NOT COMPLETED|First Intervention||0
10370253|NCT00552786|11511111|FG001|NOT COMPLETED|First Intervention||0
10370254|NCT00552786|11511110|FG000|STARTED|Washout Period of 2 Weeks||25
10370255|NCT00552786|11511111|FG001|STARTED|Washout Period of 2 Weeks||28
10370256|NCT00552786|11511110|FG000|COMPLETED|Washout Period of 2 Weeks||25
10370257|NCT00552786|11511111|FG001|COMPLETED|Washout Period of 2 Weeks||28
10370258|NCT00552786|11511110|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
10370259|NCT00552786|11511111|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
10370260|NCT00552786|11511110|FG000|STARTED|Second Intervention||25
10370261|NCT00552786|11511111|FG001|STARTED|Second Intervention||28
10370262|NCT00552786|11511110|FG000|COMPLETED|Second Intervention||25
10370263|NCT00552786|11511111|FG001|COMPLETED|Second Intervention||28
10370264|NCT00552786|11511110|FG000|NOT COMPLETED|Second Intervention||0
10370265|NCT00552786|11511111|FG001|NOT COMPLETED|Second Intervention||0
10370266|NCT00552812|11511117|FG000|STARTED|Overall Study|168 consents, 57 failed cath criteria, 5 met criteria but received covered stent, 1 withdrew consent|105
10370267|NCT00552812|11511117|FG000|COMPLETED|Overall Study|Some still remain inside the 2 year follow up window. 2 year follow up data is not yet complete.|85
10370268|NCT00552812|11511117|FG000|NOT COMPLETED|Overall Study||20
10370269|NCT00552929|11511131|FG000|STARTED|Overall Study||9
10370270|NCT00552929|11511132|FG001|STARTED|Overall Study||10
10370271|NCT00552929|11511133|FG002|STARTED|Overall Study||10
10370272|NCT00552929|11511134|FG003|STARTED|Overall Study||11
10370273|NCT00552929|11511135|FG004|STARTED|Overall Study||10
10370274|NCT00552929|11511136|FG005|STARTED|Overall Study||10
10370275|NCT00552929|11511137|FG006|STARTED|Overall Study||10
10370276|NCT00552929|11511138|FG007|STARTED|Overall Study||11
10370277|NCT00552929|11511139|FG008|STARTED|Overall Study||10
10370278|NCT00552929|11511140|FG009|STARTED|Overall Study||11
10370279|NCT00552929|11511131|FG000|Participants as Treated|Overall Study|One participant randomized to sugammadex 0.5 mg/kg received sugammadex 3.7 mg/kg (4.0 mg\kg group)|9
10370280|NCT00552929|11511132|FG001|Participants as Treated|Overall Study||10
10370281|NCT00552929|11511133|FG002|Participants as Treated|Overall Study||10
10370282|NCT00552929|11511134|FG003|Participants as Treated|Overall Study|One participant randomized to sugammadex 0.5 mg/kg received sugammadex 3.7 mg/kg (4.0 mg\kg group)|11
10370283|NCT00552929|11511135|FG004|Participants as Treated|Overall Study||10
10370284|NCT00552929|11511136|FG005|Participants as Treated|Overall Study||9
10370285|NCT00552929|11511137|FG006|Participants as Treated|Overall Study||10
10370286|NCT00552929|11511138|FG007|Participants as Treated|Overall Study||11
10370287|NCT00552929|11511139|FG008|Participants as Treated|Overall Study||10
10370288|NCT00552929|11511140|FG009|Participants as Treated|Overall Study||11
10370289|NCT00552929|11511131|FG000|COMPLETED|Overall Study||9
10370290|NCT00552929|11511132|FG001|COMPLETED|Overall Study||10
10370291|NCT00552929|11511133|FG002|COMPLETED|Overall Study||10
10370292|NCT00552929|11511134|FG003|COMPLETED|Overall Study||11
10370293|NCT00552929|11511135|FG004|COMPLETED|Overall Study||10
10370294|NCT00552929|11511136|FG005|COMPLETED|Overall Study||9
10370295|NCT00552929|11511137|FG006|COMPLETED|Overall Study||10
10370296|NCT00552929|11511138|FG007|COMPLETED|Overall Study||11
10370297|NCT00552929|11511139|FG008|COMPLETED|Overall Study||9
10370298|NCT00552929|11511140|FG009|COMPLETED|Overall Study||11
10370299|NCT00552929|11511131|FG000|NOT COMPLETED|Overall Study||0
10370300|NCT00552929|11511132|FG001|NOT COMPLETED|Overall Study||0
10370301|NCT00552929|11511133|FG002|NOT COMPLETED|Overall Study||0
10370302|NCT00552929|11511134|FG003|NOT COMPLETED|Overall Study||0
10370303|NCT00552929|11511135|FG004|NOT COMPLETED|Overall Study||0
10370304|NCT00552929|11511136|FG005|NOT COMPLETED|Overall Study||1
10370305|NCT00552929|11511137|FG006|NOT COMPLETED|Overall Study||0
10370306|NCT00552929|11511138|FG007|NOT COMPLETED|Overall Study||0
10370307|NCT00552929|11511139|FG008|NOT COMPLETED|Overall Study||1
10370308|NCT00552929|11511140|FG009|NOT COMPLETED|Overall Study||0
10370309|NCT00553059|11511164|FG000|STARTED|Overall Study||31
10370310|NCT00553059|11511165|FG001|STARTED|Overall Study||31
10370311|NCT00553059|11511164|FG000|COMPLETED|Overall Study||30
10370312|NCT00553059|11511165|FG001|COMPLETED|Overall Study||29
10370313|NCT00553059|11511164|FG000|NOT COMPLETED|Overall Study||1
10370314|NCT00553059|11511165|FG001|NOT COMPLETED|Overall Study||2
10370315|NCT00553098|11511171|FG000|STARTED|Overall Study||29
10370316|NCT00553098|11511171|FG000|COMPLETED|Overall Study||28
10370317|NCT00553098|11511171|FG000|NOT COMPLETED|Overall Study||1
10370318|NCT00553150|11511181|FG000|STARTED|Overall Study||6
10370319|NCT00553150|11511182|FG001|STARTED|Overall Study||6
10370320|NCT00553150|11511183|FG002|STARTED|Overall Study||6
10370321|NCT00553150|11511184|FG003|STARTED|Overall Study||104
10370322|NCT00553150|11511181|FG000|COMPLETED|Overall Study||6
10370323|NCT00553150|11511182|FG001|COMPLETED|Overall Study||6
10370324|NCT00553150|11511183|FG002|COMPLETED|Overall Study||6
10370325|NCT00553150|11511184|FG003|COMPLETED|Overall Study||100
10370326|NCT00553150|11511181|FG000|NOT COMPLETED|Overall Study||0
10370327|NCT00553150|11511182|FG001|NOT COMPLETED|Overall Study||0
10370328|NCT00553150|11511183|FG002|NOT COMPLETED|Overall Study||0
10370329|NCT00553150|11511184|FG003|NOT COMPLETED|Overall Study||4
10370330|NCT00553163|11511194|FG000|STARTED|Overall Study||16
10370331|NCT00553163|11511195|FG001|STARTED|Overall Study||10
10370332|NCT00553163|11511194|FG000|COMPLETED|Overall Study||16
10370333|NCT00553163|11511195|FG001|COMPLETED|Overall Study||10
10370334|NCT00553163|11511194|FG000|NOT COMPLETED|Overall Study||0
10370335|NCT00553163|11511195|FG001|NOT COMPLETED|Overall Study||0
10370336|NCT00553202|11511206|FG000|STARTED|Overall Study||158
10370337|NCT00553202|11511206|FG000|COMPLETED|Overall Study||90
10370338|NCT00553202|11511206|FG000|NOT COMPLETED|Overall Study||68
10370339|NCT00553254|11511213|FG000|STARTED|Overall Study||6
10370340|NCT00553254|11511214|FG001|STARTED|Overall Study||6
10370341|NCT00553254|11511215|FG002|STARTED|Overall Study||43
10370342|NCT00553254|11511213|FG000|COMPLETED|Overall Study||0
10370343|NCT00553254|11511214|FG001|COMPLETED|Overall Study||0
10370344|NCT00553254|11511215|FG002|COMPLETED|Overall Study||0
10370345|NCT00553254|11511213|FG000|NOT COMPLETED|Overall Study||6
10370346|NCT00553254|11511214|FG001|NOT COMPLETED|Overall Study||6
10370347|NCT00553254|11511215|FG002|NOT COMPLETED|Overall Study||43
10370348|NCT00553267|11511230|FG000|STARTED|Overall Study||315
10370349|NCT00553267|11511231|FG001|STARTED|Overall Study||315
10370350|NCT00553267|11511232|FG002|STARTED|Overall Study||317
10370351|NCT00553267|11511230|FG000|COMPLETED|Overall Study||301
10370352|NCT00553267|11511231|FG001|COMPLETED|Overall Study||297
10370353|NCT00553267|11511232|FG002|COMPLETED|Overall Study||307
10370354|NCT00553267|11511230|FG000|NOT COMPLETED|Overall Study||14
10370355|NCT00553267|11511231|FG001|NOT COMPLETED|Overall Study||18
10370356|NCT00553267|11511232|FG002|NOT COMPLETED|Overall Study||10
10370357|NCT00553280|11511240|FG000|STARTED|Overall Study||123
10370358|NCT00553280|11511240|FG000|COMPLETED|Overall Study||97
10370359|NCT00553280|11511240|FG000|NOT COMPLETED|Overall Study||26
10370360|NCT00553319|11511247|FG000|STARTED|Overall Study||43
10370361|NCT00553319|11511248|FG001|STARTED|Overall Study||40
10370362|NCT00553319|11511249|FG002|STARTED|Overall Study||43
10370363|NCT00553319|11511247|FG000|COMPLETED|Overall Study||29
10370364|NCT00553319|11511248|FG001|COMPLETED|Overall Study||30
10537296|NCT01449370|11689937|FG024|STARTED|Overall Study||8
10537297|NCT01449370|11689913|FG000|COMPLETED|Overall Study||0
10537298|NCT01449370|11689914|FG001|COMPLETED|Overall Study||0
10537299|NCT01449370|11689915|FG002|COMPLETED|Overall Study||0
10537300|NCT01449370|11689916|FG003|COMPLETED|Overall Study||0
10537301|NCT01449370|11689917|FG004|COMPLETED|Overall Study||0
10537302|NCT01449370|11689918|FG005|COMPLETED|Overall Study||0
10537303|NCT01449370|11689919|FG006|COMPLETED|Overall Study||0
10537304|NCT01449370|11689920|FG007|COMPLETED|Overall Study||0
10537305|NCT01449370|11689921|FG008|COMPLETED|Overall Study||0
10537306|NCT01449370|11689922|FG009|COMPLETED|Overall Study||0
10537307|NCT01449370|11689923|FG010|COMPLETED|Overall Study||0
10537308|NCT01449370|11689924|FG011|COMPLETED|Overall Study||0
10537309|NCT01449370|11689925|FG012|COMPLETED|Overall Study||0
10537310|NCT01449370|11689926|FG013|COMPLETED|Overall Study||0
10537311|NCT01449370|11689927|FG014|COMPLETED|Overall Study||0
10537312|NCT01449370|11689928|FG015|COMPLETED|Overall Study||0
10537313|NCT01449370|11689929|FG016|COMPLETED|Overall Study||0
10537314|NCT01449370|11689930|FG017|COMPLETED|Overall Study||0
10537315|NCT01449370|11689931|FG018|COMPLETED|Overall Study||0
10537316|NCT01449370|11689932|FG019|COMPLETED|Overall Study||0
10537317|NCT01449370|11689933|FG020|COMPLETED|Overall Study||0
10537318|NCT01449370|11689934|FG021|COMPLETED|Overall Study||0
10537319|NCT01449370|11689935|FG022|COMPLETED|Overall Study||0
10537320|NCT01449370|11689936|FG023|COMPLETED|Overall Study||0
10537321|NCT01449370|11689937|FG024|COMPLETED|Overall Study||0
10537322|NCT01449370|11689913|FG000|NOT COMPLETED|Overall Study||6
10537323|NCT01449370|11689914|FG001|NOT COMPLETED|Overall Study||6
10537324|NCT01449370|11689915|FG002|NOT COMPLETED|Overall Study||8
10537325|NCT01449370|11689916|FG003|NOT COMPLETED|Overall Study||4
10537326|NCT01449370|11689917|FG004|NOT COMPLETED|Overall Study||3
10537327|NCT01449370|11689918|FG005|NOT COMPLETED|Overall Study||3
10537328|NCT01449370|11689919|FG006|NOT COMPLETED|Overall Study||3
10537329|NCT01449370|11689920|FG007|NOT COMPLETED|Overall Study||3
10537330|NCT01449370|11689921|FG008|NOT COMPLETED|Overall Study||12
10537331|NCT01449370|11689922|FG009|NOT COMPLETED|Overall Study||3
10537332|NCT01449370|11689923|FG010|NOT COMPLETED|Overall Study||3
10537333|NCT01449370|11689924|FG011|NOT COMPLETED|Overall Study||3
10537334|NCT01449370|11689925|FG012|NOT COMPLETED|Overall Study||3
10537335|NCT01449370|11689926|FG013|NOT COMPLETED|Overall Study||11
10370365|NCT00553319|11511249|FG002|COMPLETED|Overall Study||34
10370366|NCT00553319|11511247|FG000|NOT COMPLETED|Overall Study||14
10370367|NCT00553319|11511248|FG001|NOT COMPLETED|Overall Study||10
10370368|NCT00553319|11511249|FG002|NOT COMPLETED|Overall Study||9
10370369|NCT00553332|11511257|FG000|STARTED|Overall Study||29
10370370|NCT00553332|11511257|FG000|COMPLETED|Overall Study|evaluable for response|28
10370371|NCT00553332|11511257|FG000|NOT COMPLETED|Overall Study||1
10370372|NCT00553358|11511264|FG000|STARTED|Overall Study||152
10370373|NCT00553358|11511265|FG001|STARTED|Overall Study||154
10370374|NCT00553358|11511266|FG002|STARTED|Overall Study||149
10537336|NCT01449370|11689927|FG014|NOT COMPLETED|Overall Study||3
10537337|NCT01449370|11689928|FG015|NOT COMPLETED|Overall Study||3
10537338|NCT01449370|11689929|FG016|NOT COMPLETED|Overall Study||7
10537339|NCT01449370|11689930|FG017|NOT COMPLETED|Overall Study||3
10537340|NCT01449370|11689931|FG018|NOT COMPLETED|Overall Study||3
10537341|NCT01449370|11689932|FG019|NOT COMPLETED|Overall Study||3
10370375|NCT00553358|11511264|FG000|COMPLETED|Overall Study||73
10370376|NCT00553358|11511265|FG001|COMPLETED|Overall Study||58
10370377|NCT00553358|11511266|FG002|COMPLETED|Overall Study||61
10370378|NCT00553358|11511264|FG000|NOT COMPLETED|Overall Study||79
10370379|NCT00553358|11511265|FG001|NOT COMPLETED|Overall Study||96
10370380|NCT00553358|11511266|FG002|NOT COMPLETED|Overall Study||88
10370381|NCT00553410|11511282|FG000|STARTED|Overall Study||2441
10370382|NCT00553410|11511283|FG001|STARTED|Overall Study||2443
10370383|NCT00553410|11511282|FG000|COMPLETED|Overall Study||2426
10370384|NCT00553410|11511283|FG001|COMPLETED|Overall Study||2425
10370385|NCT00553410|11511282|FG000|NOT COMPLETED|Overall Study||15
10370386|NCT00553410|11511283|FG001|NOT COMPLETED|Overall Study||18
10370387|NCT00553436|11511289|FG000|STARTED|Overall Study|20 August 2007|7
10370388|NCT00553436|11511289|FG000|COMPLETED|Overall Study|09 April 2009|6
10370389|NCT00553436|11511289|FG000|NOT COMPLETED|Overall Study||1
10370390|NCT00553462|11511293|FG000|STARTED|Overall Study||75
10370391|NCT00553462|11511293|FG000|COMPLETED|Overall Study||61
10370392|NCT00553462|11511293|FG000|NOT COMPLETED|Overall Study||14
10370393|NCT00553475|11511300|FG000|STARTED|Overall Study||135
10370394|NCT00553475|11511301|FG001|STARTED|Overall Study||134
10370395|NCT00553475|11511302|FG002|STARTED|Overall Study||45
10370396|NCT00553475|11511300|FG000|COMPLETED|Overall Study||119
10370397|NCT00553475|11511301|FG001|COMPLETED|Overall Study||114
10370398|NCT00553475|11511302|FG002|COMPLETED|Overall Study||32
10370399|NCT00553475|11511300|FG000|NOT COMPLETED|Overall Study||16
10370400|NCT00553475|11511301|FG001|NOT COMPLETED|Overall Study||20
10370401|NCT00553475|11511302|FG002|NOT COMPLETED|Overall Study||13
10370402|NCT00553501|11511312|FG000|STARTED|Overall Study||59
10370403|NCT00553501|11511312|FG000|COMPLETED|Overall Study||55
10370404|NCT00553501|11511312|FG000|NOT COMPLETED|Overall Study||4
10370405|NCT00553514|11511321|FG000|STARTED|Overall Study||14
10370406|NCT00553514|11511322|FG001|STARTED|Overall Study||14
10370407|NCT00553514|11511323|FG002|STARTED|Overall Study||15
10370408|NCT00553514|11511324|FG003|STARTED|Overall Study||13
10370409|NCT00553514|11511325|FG004|STARTED|Overall Study||15
10370410|NCT00553514|11511321|FG000|COMPLETED|Overall Study||6
10370411|NCT00553514|11511322|FG001|COMPLETED|Overall Study||6
10370412|NCT00553514|11511323|FG002|COMPLETED|Overall Study||9
10370413|NCT00553514|11511324|FG003|COMPLETED|Overall Study||6
10370414|NCT00553514|11511325|FG004|COMPLETED|Overall Study||8
10370415|NCT00553514|11511321|FG000|NOT COMPLETED|Overall Study||8
10370416|NCT00553514|11511322|FG001|NOT COMPLETED|Overall Study||8
10370417|NCT00553514|11511323|FG002|NOT COMPLETED|Overall Study||6
10370418|NCT00553514|11511324|FG003|NOT COMPLETED|Overall Study||7
10370419|NCT00553514|11511325|FG004|NOT COMPLETED|Overall Study||7
10370420|NCT00553540|11511339|FG000|STARTED|Overall Study||25
10370421|NCT00553540|11511340|FG001|STARTED|Overall Study||25
10370422|NCT00553540|11511339|FG000|COMPLETED|Overall Study||23
10370423|NCT00553540|11511340|FG001|COMPLETED|Overall Study||20
10370424|NCT00553540|11511339|FG000|NOT COMPLETED|Overall Study||2
10370425|NCT00553540|11511340|FG001|NOT COMPLETED|Overall Study||5
10370426|NCT00553605|11511348|FG000|STARTED|Overall Study||176
10370427|NCT00553605|11511349|FG001|STARTED|Overall Study||164
10370428|NCT00553605|11511348|FG000|Treated|Overall Study||174
10370429|NCT00553605|11511349|FG001|Treated|Overall Study||164
10370430|NCT00553605|11511348|FG000|COMPLETED|Overall Study||172
10370431|NCT00553605|11511349|FG001|COMPLETED|Overall Study||161
10370432|NCT00553605|11511348|FG000|NOT COMPLETED|Overall Study||4
10370433|NCT00553605|11511349|FG001|NOT COMPLETED|Overall Study||3
10370434|NCT00553631|11511357|FG000|STARTED|Overall Study|Intent-to-treat (ITT) population|17
10370435|NCT00553631|11511358|FG001|STARTED|Overall Study|Intent-to-treat (ITT) population|17
10370436|NCT00553631|11511357|FG000|COMPLETED|Overall Study||16
10370437|NCT00553631|11511358|FG001|COMPLETED|Overall Study||16
10370438|NCT00553631|11511357|FG000|NOT COMPLETED|Overall Study||1
10370439|NCT00553631|11511358|FG001|NOT COMPLETED|Overall Study||1
10370440|NCT00553644|11511364|FG000|STARTED|Overall Study||53
10370441|NCT00553644|11511364|FG000|COMPLETED|Overall Study||25
10370442|NCT00553644|11511364|FG000|NOT COMPLETED|Overall Study||28
10370443|NCT00553696|11511372|FG000|STARTED|Overall Study||4
10370444|NCT00553696|11511373|FG001|STARTED|Overall Study||16
10370445|NCT00553696|11511374|FG002|STARTED|Overall Study||6
10370446|NCT00553696|11511375|FG003|STARTED|Overall Study||1
10370447|NCT00553696|11511372|FG000|COMPLETED|Overall Study||0
10370448|NCT00553696|11511373|FG001|COMPLETED|Overall Study||0
10370449|NCT00553696|11511374|FG002|COMPLETED|Overall Study||0
10370450|NCT00553696|11511375|FG003|COMPLETED|Overall Study||0
10370451|NCT00553696|11511372|FG000|NOT COMPLETED|Overall Study||4
10370452|NCT00553696|11511373|FG001|NOT COMPLETED|Overall Study||16
10370453|NCT00553696|11511374|FG002|NOT COMPLETED|Overall Study||6
10370454|NCT00553696|11511375|FG003|NOT COMPLETED|Overall Study||1
10370455|NCT00553735|11511388|FG000|STARTED|Overall Study||8
10370456|NCT00553735|11511388|FG000|COMPLETED|Overall Study||1
10370457|NCT00553735|11511388|FG000|NOT COMPLETED|Overall Study||7
10370458|NCT00553787|11511398|FG000|STARTED|Overall Study||994
10370459|NCT00553787|11511399|FG001|STARTED|Overall Study||498
10370460|NCT00553787|11511400|FG002|STARTED|Overall Study||995
10370461|NCT00553787|11511398|FG000|COMPLETED|Overall Study||616
10370462|NCT00553787|11511399|FG001|COMPLETED|Overall Study||374
10370463|NCT00553787|11511400|FG002|COMPLETED|Overall Study||733
10370464|NCT00553787|11511398|FG000|NOT COMPLETED|Overall Study||378
10370465|NCT00553787|11511399|FG001|NOT COMPLETED|Overall Study||124
10370466|NCT00553787|11511400|FG002|NOT COMPLETED|Overall Study||262
10370467|NCT00553839|11511408|FG000|STARTED|Overall Study||21
10370468|NCT00553839|11511408|FG000|COMPLETED|Overall Study||21
10370469|NCT00553839|11511408|FG000|NOT COMPLETED|Overall Study||0
10370470|NCT00553969|11511416|FG000|STARTED|Overall Study||31
10370471|NCT00553969|11511417|FG001|STARTED|Overall Study||24
10370472|NCT00553969|11511418|FG002|STARTED|Overall Study||22
10370473|NCT00553969|11511419|FG003|STARTED|Overall Study||24
10370474|NCT00553969|11511416|FG000|COMPLETED|Overall Study||23
10370475|NCT00553969|11511417|FG001|COMPLETED|Overall Study||24
10370476|NCT00553969|11511418|FG002|COMPLETED|Overall Study||21
10370477|NCT00553969|11511419|FG003|COMPLETED|Overall Study||23
10370478|NCT00553969|11511416|FG000|NOT COMPLETED|Overall Study||8
10370479|NCT00553969|11511417|FG001|NOT COMPLETED|Overall Study||0
10370480|NCT00553969|11511418|FG002|NOT COMPLETED|Overall Study||1
10370481|NCT00553969|11511419|FG003|NOT COMPLETED|Overall Study||1
10370482|NCT00554099|11511432|FG000|STARTED|Treatment Period (12 Weeks)||41
10370483|NCT00554099|11511433|FG001|STARTED|Treatment Period (12 Weeks)||40
10370484|NCT00554099|11511434|FG002|STARTED|Treatment Period (12 Weeks)||36
10370485|NCT00554099|11511432|FG000|COMPLETED|Treatment Period (12 Weeks)||29
10370486|NCT00554099|11511433|FG001|COMPLETED|Treatment Period (12 Weeks)||32
10370487|NCT00554099|11511434|FG002|COMPLETED|Treatment Period (12 Weeks)||27
10370488|NCT00554099|11511432|FG000|NOT COMPLETED|Treatment Period (12 Weeks)||12
10370489|NCT00554099|11511433|FG001|NOT COMPLETED|Treatment Period (12 Weeks)||8
10370490|NCT00554099|11511434|FG002|NOT COMPLETED|Treatment Period (12 Weeks)||9
10370491|NCT00554099|11511432|FG000|STARTED|Non-Treatment Phase (9 Months)||29
10370492|NCT00554099|11511433|FG001|STARTED|Non-Treatment Phase (9 Months)||32
10370493|NCT00554099|11511434|FG002|STARTED|Non-Treatment Phase (9 Months)||27
10370494|NCT00554099|11511432|FG000|COMPLETED|Non-Treatment Phase (9 Months)||22
10370495|NCT00554099|11511433|FG001|COMPLETED|Non-Treatment Phase (9 Months)||27
10370496|NCT00554099|11511434|FG002|COMPLETED|Non-Treatment Phase (9 Months)||24
10716818|NCT02692235|11880672|FG001|STARTED|Overall Study||14
10716819|NCT02692235|11880671|FG000|COMPLETED|Overall Study||11
10716820|NCT02692235|11880672|FG001|COMPLETED|Overall Study||11
10716821|NCT02692235|11880671|FG000|NOT COMPLETED|Overall Study||3
10716822|NCT02692235|11880672|FG001|NOT COMPLETED|Overall Study||3
10716823|NCT02692391|11880680|FG000|STARTED|Overall Study||24
10716824|NCT02692391|11880681|FG001|STARTED|Overall Study||18
10716825|NCT02692391|11880680|FG000|COMPLETED|Overall Study||24
10716826|NCT02692391|11880681|FG001|COMPLETED|Overall Study||18
10716827|NCT02692391|11880680|FG000|NOT COMPLETED|Overall Study||0
10370497|NCT00554099|11511432|FG000|NOT COMPLETED|Non-Treatment Phase (9 Months)||7
10370498|NCT00554099|11511433|FG001|NOT COMPLETED|Non-Treatment Phase (9 Months)||5
10370499|NCT00554099|11511434|FG002|NOT COMPLETED|Non-Treatment Phase (9 Months)||3
10370500|NCT00554216|11511445|FG000|STARTED|Overall Study||514
10370501|NCT00554216|11511446|FG001|STARTED|Overall Study||241
10370502|NCT00554216|11511447|FG002|STARTED|Overall Study||512
10370503|NCT00554216|11511445|FG000|COMPLETED|Overall Study||272
10370504|NCT00554216|11511446|FG001|COMPLETED|Overall Study||147
10370505|NCT00554216|11511447|FG002|COMPLETED|Overall Study||340
10370506|NCT00554216|11511445|FG000|NOT COMPLETED|Overall Study||242
10370507|NCT00554216|11511446|FG001|NOT COMPLETED|Overall Study||94
10370508|NCT00554216|11511447|FG002|NOT COMPLETED|Overall Study||172
10370509|NCT00554229|11511457|FG000|STARTED|Overall Study||299
10370510|NCT00554229|11511458|FG001|STARTED|Overall Study||295
10370511|NCT00554229|11511457|FG000|Patients Who Received Treatment|Overall Study||298
10370512|NCT00554229|11511458|FG001|Patients Who Received Treatment|Overall Study||295
10370513|NCT00554229|11511457|FG000|COMPLETED|Overall Study||73
10370514|NCT00554229|11511458|FG001|COMPLETED|Overall Study||70
10370515|NCT00554229|11511457|FG000|NOT COMPLETED|Overall Study||226
10370516|NCT00554229|11511458|FG001|NOT COMPLETED|Overall Study||225
10370517|NCT00554372|11511466|FG000|STARTED|Overall Study||14
10370518|NCT00554372|11511467|FG001|STARTED|Overall Study||16
10370519|NCT00554372|11511466|FG000|COMPLETED|Overall Study||14
10370520|NCT00554372|11511467|FG001|COMPLETED|Overall Study||16
10370521|NCT00554372|11511466|FG000|NOT COMPLETED|Overall Study||0
10370522|NCT00554372|11511467|FG001|NOT COMPLETED|Overall Study||0
10370523|NCT00554463|11511475|FG000|STARTED|Overall Study||5
10370524|NCT00554463|11511475|FG000|COMPLETED|Overall Study||5
10370525|NCT00554463|11511475|FG000|NOT COMPLETED|Overall Study||0
10716828|NCT02692391|11880681|FG001|NOT COMPLETED|Overall Study||0
10716829|NCT02692417|11880689|FG000|STARTED|Overall Study||9
10370530|NCT00554619|11511504|FG000|STARTED|Overall Study||21
10370531|NCT00554619|11511504|FG000|COMPLETED|Overall Study||18
10370532|NCT00554619|11511504|FG000|NOT COMPLETED|Overall Study||3
10370533|NCT00554671|11511510|FG000|STARTED|Overall Study||117
10370534|NCT00554671|11511511|FG001|STARTED|Overall Study||133
10370535|NCT00554671|11511510|FG000|COMPLETED|Overall Study||97
10370536|NCT00554671|11511511|FG001|COMPLETED|Overall Study||117
10370537|NCT00554671|11511510|FG000|NOT COMPLETED|Overall Study||20
10370538|NCT00554671|11511511|FG001|NOT COMPLETED|Overall Study||16
10370539|NCT00554749|11511518|FG000|STARTED|Overall Study||7
10370540|NCT00554749|11511518|FG000|COMPLETED|Overall Study||7
10370541|NCT00554749|11511518|FG000|NOT COMPLETED|Overall Study||0
10812605|NCT03483051|11974702|FG000|NOT COMPLETED|Second Treatment, After Crossover||0
10812606|NCT03483051|11974703|FG001|NOT COMPLETED|Second Treatment, After Crossover||0
10812607|NCT03477903|11974711|FG000|STARTED|Overall Study||1
10812608|NCT03477903|11974711|FG000|COMPLETED|Overall Study||0
10812609|NCT03477903|11974711|FG000|NOT COMPLETED|Overall Study||1
10812610|NCT03469258|11974715|FG000|STARTED|Overall Study||4
10812611|NCT03469258|11974715|FG000|COMPLETED|Overall Study||0
10812612|NCT03469258|11974715|FG000|NOT COMPLETED|Overall Study||4
10370551|NCT00554801|11511538|FG000|STARTED|Overall Study||55
10370552|NCT00554801|11511539|FG001|STARTED|Overall Study||29
10370553|NCT00554801|11511538|FG000|COMPLETED|Overall Study||36
10370554|NCT00554801|11511539|FG001|COMPLETED|Overall Study||29
10370555|NCT00554801|11511538|FG000|NOT COMPLETED|Overall Study||19
10370556|NCT00554801|11511539|FG001|NOT COMPLETED|Overall Study||0
10427549|NCT00853580|11573394|FG001|COMPLETED|Overall Study||56
10427550|NCT00853580|11573393|FG000|NOT COMPLETED|Overall Study||7
10427551|NCT00853580|11573394|FG001|NOT COMPLETED|Overall Study||16
10427552|NCT00853593|11573400|FG000|STARTED|Overall Study||197
10427553|NCT00853593|11573400|FG000|Implant Attempted|Overall Study||193
10427554|NCT00853593|11573400|FG000|Model 4396 Lead Attempted|Overall Study||164
10427555|NCT00853593|11573400|FG000|COMPLETED|Overall Study||152
10427556|NCT00853593|11573400|FG000|NOT COMPLETED|Overall Study||45
10427557|NCT00853606|11573421|FG000|STARTED|Overall Study||712
10427558|NCT00853606|11573421|FG000|COMPLETED|Overall Study||492
10427559|NCT00853606|11573421|FG000|NOT COMPLETED|Overall Study||220
10427560|NCT00853645|11573425|FG000|STARTED|Overall Study||6
10427561|NCT00853645|11573425|FG000|COMPLETED|Overall Study||6
10427562|NCT00853645|11573425|FG000|NOT COMPLETED|Overall Study||0
10427563|NCT00853658|11573432|FG000|STARTED|Overall Study||2354
10427564|NCT00853658|11573433|FG001|STARTED|Overall Study||2356
10427565|NCT00853658|11573434|FG002|STARTED|Overall Study||2354
10427566|NCT00853658|11573432|FG000|Full Analysis Set (FAS)|Overall Study||2340
10427567|NCT00853658|11573433|FG001|Full Analysis Set (FAS)|Overall Study||2340
10427568|NCT00853658|11573434|FG002|Full Analysis Set (FAS)|Overall Study||2336
10427569|NCT00853658|11573432|FG000|Safety Set|Overall Study||2347
10427570|NCT00853658|11573433|FG001|Safety Set|Overall Study||2348
10427571|NCT00853658|11573434|FG002|Safety Set|Overall Study||2345
10427572|NCT00853658|11573432|FG000|COMPLETED|Overall Study||1567
10427573|NCT00853658|11573433|FG001|COMPLETED|Overall Study||1524
10427574|NCT00853658|11573434|FG002|COMPLETED|Overall Study||1539
10427575|NCT00853658|11573432|FG000|NOT COMPLETED|Overall Study||787
10427576|NCT00853658|11573433|FG001|NOT COMPLETED|Overall Study||832
10427577|NCT00853658|11573434|FG002|NOT COMPLETED|Overall Study||815
10427578|NCT00853671|11573442|FG000|STARTED|Overall Study||50
10427579|NCT00853671|11573442|FG000|COMPLETED|Overall Study||50
10427580|NCT00853671|11573442|FG000|NOT COMPLETED|Overall Study||0
10427581|NCT00853723|11573449|FG000|STARTED|Overall Study||35
10427582|NCT00853723|11573450|FG001|STARTED|Overall Study||35
10427583|NCT00853723|11573451|FG002|STARTED|Overall Study||35
10427584|NCT00853723|11573449|FG000|COMPLETED|Overall Study||29
10427585|NCT00853723|11573450|FG001|COMPLETED|Overall Study||28
10427586|NCT00853723|11573451|FG002|COMPLETED|Overall Study||33
10427587|NCT00853723|11573449|FG000|NOT COMPLETED|Overall Study||6
10537342|NCT01449370|11689933|FG020|NOT COMPLETED|Overall Study||6
10537343|NCT01449370|11689934|FG021|NOT COMPLETED|Overall Study||4
10537344|NCT01449370|11689935|FG022|NOT COMPLETED|Overall Study||4
10537345|NCT01449370|11689936|FG023|NOT COMPLETED|Overall Study||10
10537346|NCT01449370|11689937|FG024|NOT COMPLETED|Overall Study||8
10537347|NCT01449461|11690016|FG000|STARTED|Overall Study||6
10537348|NCT01449461|11690017|FG001|STARTED|Overall Study||18
10537349|NCT01449461|11690018|FG002|STARTED|Overall Study||18
10537350|NCT01449461|11690019|FG003|STARTED|Overall Study||32
10537351|NCT01449461|11690020|FG004|STARTED|Overall Study||48
10537352|NCT01449461|11690021|FG005|STARTED|Overall Study||15
10537353|NCT01449461|11690016|FG000|COMPLETED|Overall Study||0
10537354|NCT01449461|11690017|FG001|COMPLETED|Overall Study||0
10537355|NCT01449461|11690018|FG002|COMPLETED|Overall Study||0
10537356|NCT01449461|11690019|FG003|COMPLETED|Overall Study||0
10537357|NCT01449461|11690020|FG004|COMPLETED|Overall Study||0
10537358|NCT01449461|11690021|FG005|COMPLETED|Overall Study||0
10537359|NCT01449461|11690016|FG000|NOT COMPLETED|Overall Study||6
10537360|NCT01449461|11690017|FG001|NOT COMPLETED|Overall Study||18
10716830|NCT02692417|11880690|FG001|STARTED|Overall Study||7
10716831|NCT02692417|11880689|FG000|COMPLETED|Overall Study||3
10716832|NCT02692417|11880690|FG001|COMPLETED|Overall Study||6
10427588|NCT00853723|11573450|FG001|NOT COMPLETED|Overall Study||7
10427589|NCT00853723|11573451|FG002|NOT COMPLETED|Overall Study||2
10427590|NCT00853749|11573464|FG000|STARTED|Overall Study||50
10427591|NCT00853749|11573465|FG001|STARTED|Overall Study||39
10427592|NCT00853749|11573464|FG000|Vaccinated|Overall Study||50
10427593|NCT00853749|11573465|FG001|Vaccinated|Overall Study||39
10427594|NCT00853749|11573464|FG000|COMPLETED|Overall Study||50
10427595|NCT00853749|11573465|FG001|COMPLETED|Overall Study||38
10427596|NCT00853749|11573464|FG000|NOT COMPLETED|Overall Study||0
10427597|NCT00853749|11573465|FG001|NOT COMPLETED|Overall Study||1
10427598|NCT00853762|11573475|FG000|STARTED|Overall Study||16
10427599|NCT00853762|11573476|FG001|STARTED|Overall Study||19
10427600|NCT00853762|11573477|FG002|STARTED|Overall Study||17
10427601|NCT00853762|11573478|FG003|STARTED|Overall Study||22
10427602|NCT00853762|11573475|FG000|COMPLETED|Overall Study||0
10537361|NCT01449461|11690018|FG002|NOT COMPLETED|Overall Study||18
10537362|NCT01449461|11690019|FG003|NOT COMPLETED|Overall Study||32
10537363|NCT01449461|11690020|FG004|NOT COMPLETED|Overall Study||48
10537364|NCT01449461|11690021|FG005|NOT COMPLETED|Overall Study||15
10537365|NCT01449513|11690046|FG000|STARTED|Overall Study||16
10370557|NCT00554853|11511549|FG000|STARTED|First Arm of Study||72
10370558|NCT00554853|11511550|FG001|STARTED|First Arm of Study||71
10370559|NCT00554853|11511549|FG000|COMPLETED|First Arm of Study||56
10370560|NCT00554853|11511550|FG001|COMPLETED|First Arm of Study||64
10370561|NCT00554853|11511549|FG000|NOT COMPLETED|First Arm of Study||16
10370562|NCT00554853|11511550|FG001|NOT COMPLETED|First Arm of Study||7
10370563|NCT00554853|11511549|FG000|STARTED|Washout Period (2 Weeks)||56
10370564|NCT00554853|11511550|FG001|STARTED|Washout Period (2 Weeks)||64
10370565|NCT00554853|11511549|FG000|COMPLETED|Washout Period (2 Weeks)||56
10370566|NCT00554853|11511550|FG001|COMPLETED|Washout Period (2 Weeks)||57
10370567|NCT00554853|11511549|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
10370568|NCT00554853|11511550|FG001|NOT COMPLETED|Washout Period (2 Weeks)||7
10370569|NCT00554853|11511549|FG000|STARTED|Crossover Arm (3 Months)||56
10370570|NCT00554853|11511550|FG001|STARTED|Crossover Arm (3 Months)||57
10370571|NCT00554853|11511549|FG000|COMPLETED|Crossover Arm (3 Months)||53
10370572|NCT00554853|11511550|FG001|COMPLETED|Crossover Arm (3 Months)||55
10370573|NCT00554853|11511549|FG000|NOT COMPLETED|Crossover Arm (3 Months)||3
10537366|NCT01449513|11690047|FG001|STARTED|Overall Study||8
10537367|NCT01449513|11690046|FG000|COMPLETED|Overall Study||16
10537368|NCT01449513|11690047|FG001|COMPLETED|Overall Study||8
10537369|NCT01449513|11690046|FG000|NOT COMPLETED|Overall Study||0
10537370|NCT01449513|11690047|FG001|NOT COMPLETED|Overall Study||0
10537371|NCT01449526|11690055|FG000|STARTED|Overall Study||83
10537372|NCT01449526|11690056|FG001|STARTED|Overall Study||83
10537373|NCT01449526|11690055|FG000|COMPLETED|Overall Study||81
10537374|NCT01449526|11690056|FG001|COMPLETED|Overall Study||77
10537375|NCT01449526|11690055|FG000|NOT COMPLETED|Overall Study||2
10537376|NCT01449526|11690056|FG001|NOT COMPLETED|Overall Study||6
10537377|NCT01449539|11690062|FG000|STARTED|Overall Study||8
10537378|NCT01449539|11690062|FG000|COMPLETED|Overall Study||4
10537379|NCT01449539|11690062|FG000|NOT COMPLETED|Overall Study||4
10537380|NCT01449630|11690075|FG000|STARTED|Period 1||2
10537381|NCT01449630|11690076|FG001|STARTED|Period 1||6
10537382|NCT01449630|11690077|FG002|STARTED|Period 1||2
10537383|NCT01449630|11690078|FG003|STARTED|Period 1||2
10537384|NCT01449630|11690079|FG004|STARTED|Period 1||5
10657172|NCT02223637|11818340|FG000|STARTED|Overall Study||82
10657173|NCT02223637|11818340|FG000|COMPLETED|Overall Study||82
10657174|NCT02223637|11818340|FG000|NOT COMPLETED|Overall Study||0
10657175|NCT02223650|11818347|FG000|STARTED|Overall Study||27
10657176|NCT02223650|11818348|FG001|STARTED|Overall Study||31
10657177|NCT02223650|11818347|FG000|COMPLETED|Overall Study||27
10657178|NCT02223650|11818348|FG001|COMPLETED|Overall Study||31
10657179|NCT02223650|11818347|FG000|NOT COMPLETED|Overall Study||0
10657180|NCT02223650|11818348|FG001|NOT COMPLETED|Overall Study||0
10657181|NCT02223689|11818356|FG000|STARTED|Overall Study||35
10716833|NCT02692417|11880689|FG000|NOT COMPLETED|Overall Study||6
10370574|NCT00554853|11511550|FG001|NOT COMPLETED|Crossover Arm (3 Months)||2
10657182|NCT02223689|11818356|FG000|COMPLETED|Overall Study||35
10657183|NCT02223689|11818356|FG000|NOT COMPLETED|Overall Study||0
10657184|NCT02223702|11818363|FG000|STARTED|Overall Study||20
10657185|NCT02223702|11818364|FG001|STARTED|Overall Study||19
10657186|NCT02223702|11818363|FG000|COMPLETED|Overall Study||19
10657187|NCT02223702|11818364|FG001|COMPLETED|Overall Study||15
10657188|NCT02223702|11818363|FG000|NOT COMPLETED|Overall Study||1
10657189|NCT02223702|11818364|FG001|NOT COMPLETED|Overall Study||4
10657190|NCT02223715|11818370|FG000|STARTED|Overall Study||600
10657191|NCT02223715|11818370|FG000|COMPLETED|Overall Study||496
10657192|NCT02223715|11818370|FG000|NOT COMPLETED|Overall Study||104
10657193|NCT02223754|11818379|FG000|STARTED|Period 1||163
10657194|NCT02223754|11818380|FG001|STARTED|Period 1||159
10657195|NCT02223754|11818379|FG000|COMPLETED|Period 1||159
10657196|NCT02223754|11818380|FG001|COMPLETED|Period 1||144
10657197|NCT02223754|11818379|FG000|NOT COMPLETED|Period 1||4
10657198|NCT02223754|11818380|FG001|NOT COMPLETED|Period 1||15
10657199|NCT02223754|11818379|FG000|STARTED|Period 2||159
10657200|NCT02223754|11818380|FG001|STARTED|Period 2||144
10657201|NCT02223754|11818379|FG000|COMPLETED|Period 2||156
10657202|NCT02223754|11818380|FG001|COMPLETED|Period 2||141
10657203|NCT02223754|11818379|FG000|NOT COMPLETED|Period 2||3
10657204|NCT02223754|11818380|FG001|NOT COMPLETED|Period 2||3
10657205|NCT02223793|11818390|FG000|STARTED|Overall Study||185
10657206|NCT02223793|11818391|FG001|STARTED|Overall Study||199
10657207|NCT02223793|11818392|FG002|STARTED|Overall Study||198
10657208|NCT02223793|11818390|FG000|COMPLETED|Overall Study||168
10657209|NCT02223793|11818391|FG001|COMPLETED|Overall Study||190
10716834|NCT02692417|11880690|FG001|NOT COMPLETED|Overall Study||1
10370575|NCT00554970|11511566|FG000|STARTED|Period 1||8
10370576|NCT00554970|11511567|FG001|STARTED|Period 1||8
10537385|NCT01449630|11690080|FG005|STARTED|Period 1||2
10537386|NCT01449630|11690081|FG006|STARTED|Period 1||2
10537387|NCT01449630|11690082|FG007|STARTED|Period 1||6
10537388|NCT01449630|11690083|FG008|STARTED|Period 1||2
10537389|NCT01449630|11690075|FG000|Received at Least 1 Dose|Period 1||2
10537390|NCT01449630|11690076|FG001|Received at Least 1 Dose|Period 1||6
10537391|NCT01449630|11690077|FG002|Received at Least 1 Dose|Period 1||2
10657210|NCT02223793|11818392|FG002|COMPLETED|Overall Study||185
10657211|NCT02223793|11818390|FG000|NOT COMPLETED|Overall Study||17
10657212|NCT02223793|11818391|FG001|NOT COMPLETED|Overall Study||9
10657213|NCT02223793|11818392|FG002|NOT COMPLETED|Overall Study||13
10716835|NCT02692482|11880698|FG000|STARTED|Overall Study||177
10716836|NCT02692482|11880699|FG001|STARTED|Overall Study||182
10716837|NCT02692482|11880698|FG000|COMPLETED|Overall Study||174
10716838|NCT02692482|11880699|FG001|COMPLETED|Overall Study||178
10370577|NCT00554970|11511568|FG002|STARTED|Period 1||8
10370578|NCT00554970|11511569|FG003|STARTED|Period 1||8
10370579|NCT00554970|11511566|FG000|COMPLETED|Period 1||7
10370580|NCT00554970|11511567|FG001|COMPLETED|Period 1||8
10370581|NCT00554970|11511568|FG002|COMPLETED|Period 1||8
10370582|NCT00554970|11511569|FG003|COMPLETED|Period 1||8
10370583|NCT00554970|11511566|FG000|NOT COMPLETED|Period 1||1
10370584|NCT00554970|11511567|FG001|NOT COMPLETED|Period 1||0
10370585|NCT00554970|11511568|FG002|NOT COMPLETED|Period 1||0
10370586|NCT00554970|11511569|FG003|NOT COMPLETED|Period 1||0
10370587|NCT00554970|11511566|FG000|STARTED|Period 2||7
10370588|NCT00554970|11511567|FG001|STARTED|Period 2||8
10370589|NCT00554970|11511568|FG002|STARTED|Period 2||8
10370590|NCT00554970|11511569|FG003|STARTED|Period 2||8
10537392|NCT01449630|11690078|FG003|Received at Least 1 Dose|Period 1||2
10537393|NCT01449630|11690079|FG004|Received at Least 1 Dose|Period 1||5
10537394|NCT01449630|11690080|FG005|Received at Least 1 Dose|Period 1||1
10537395|NCT01449630|11690081|FG006|Received at Least 1 Dose|Period 1||2
10537396|NCT01449630|11690082|FG007|Received at Least 1 Dose|Period 1||6
10537397|NCT01449630|11690083|FG008|Received at Least 1 Dose|Period 1||2
10537398|NCT01449630|11690075|FG000|COMPLETED|Period 1||1
10537399|NCT01449630|11690076|FG001|COMPLETED|Period 1||6
10537400|NCT01449630|11690077|FG002|COMPLETED|Period 1||2
10537401|NCT01449630|11690078|FG003|COMPLETED|Period 1||1
10537402|NCT01449630|11690079|FG004|COMPLETED|Period 1||5
10537403|NCT01449630|11690080|FG005|COMPLETED|Period 1||1
10537404|NCT01449630|11690081|FG006|COMPLETED|Period 1||2
10537405|NCT01449630|11690082|FG007|COMPLETED|Period 1||6
10537406|NCT01449630|11690083|FG008|COMPLETED|Period 1||2
10537407|NCT01449630|11690075|FG000|NOT COMPLETED|Period 1||1
10537408|NCT01449630|11690076|FG001|NOT COMPLETED|Period 1||0
10537409|NCT01449630|11690077|FG002|NOT COMPLETED|Period 1||0
10537410|NCT01449630|11690078|FG003|NOT COMPLETED|Period 1||1
10537411|NCT01449630|11690079|FG004|NOT COMPLETED|Period 1||0
10537412|NCT01449630|11690080|FG005|NOT COMPLETED|Period 1||1
10537413|NCT01449630|11690081|FG006|NOT COMPLETED|Period 1||0
10537414|NCT01449630|11690082|FG007|NOT COMPLETED|Period 1||0
10537415|NCT01449630|11690083|FG008|NOT COMPLETED|Period 1||0
10537416|NCT01449630|11690075|FG000|STARTED|Period 2||1
10537417|NCT01449630|11690076|FG001|STARTED|Period 2||6
10537418|NCT01449630|11690077|FG002|STARTED|Period 2||2
10537419|NCT01449630|11690078|FG003|STARTED|Period 2||1
10537420|NCT01449630|11690079|FG004|STARTED|Period 2||5
10537421|NCT01449630|11690080|FG005|STARTED|Period 2||1
10537422|NCT01449630|11690081|FG006|STARTED|Period 2||2
10537423|NCT01449630|11690082|FG007|STARTED|Period 2||6
10537424|NCT01449630|11690083|FG008|STARTED|Period 2||2
10537425|NCT01449630|11690075|FG000|COMPLETED|Period 2||1
10537426|NCT01449630|11690076|FG001|COMPLETED|Period 2||6
10537427|NCT01449630|11690077|FG002|COMPLETED|Period 2||2
10537428|NCT01449630|11690078|FG003|COMPLETED|Period 2||1
10537429|NCT01449630|11690079|FG004|COMPLETED|Period 2||5
10537430|NCT01449630|11690080|FG005|COMPLETED|Period 2||1
10537431|NCT01449630|11690081|FG006|COMPLETED|Period 2||1
10537432|NCT01449630|11690082|FG007|COMPLETED|Period 2||6
10537433|NCT01449630|11690083|FG008|COMPLETED|Period 2||2
10537434|NCT01449630|11690075|FG000|NOT COMPLETED|Period 2||0
10537435|NCT01449630|11690076|FG001|NOT COMPLETED|Period 2||0
10537436|NCT01449630|11690077|FG002|NOT COMPLETED|Period 2||0
10537437|NCT01449630|11690078|FG003|NOT COMPLETED|Period 2||0
10537438|NCT01449630|11690079|FG004|NOT COMPLETED|Period 2||0
10537439|NCT01449630|11690080|FG005|NOT COMPLETED|Period 2||0
10537440|NCT01449630|11690081|FG006|NOT COMPLETED|Period 2||1
10537441|NCT01449630|11690082|FG007|NOT COMPLETED|Period 2||0
10537442|NCT01449630|11690083|FG008|NOT COMPLETED|Period 2||0
10537443|NCT01449630|11690075|FG000|STARTED|Period 3||1
10537444|NCT01449630|11690076|FG001|STARTED|Period 3||6
10537445|NCT01449630|11690077|FG002|STARTED|Period 3||2
10370591|NCT00554970|11511566|FG000|COMPLETED|Period 2||7
10370592|NCT00554970|11511567|FG001|COMPLETED|Period 2||8
10370593|NCT00554970|11511568|FG002|COMPLETED|Period 2||7
10370594|NCT00554970|11511569|FG003|COMPLETED|Period 2||8
10370595|NCT00554970|11511566|FG000|NOT COMPLETED|Period 2||0
10370596|NCT00554970|11511567|FG001|NOT COMPLETED|Period 2||0
10370597|NCT00554970|11511568|FG002|NOT COMPLETED|Period 2||1
10370598|NCT00554970|11511569|FG003|NOT COMPLETED|Period 2||0
10370599|NCT00554996|11511579|FG000|STARTED|Overall Study||10
10370600|NCT00554996|11511579|FG000|COMPLETED|Overall Study||10
10657214|NCT02223858|11818402|FG000|STARTED|Overall Study||180
10657215|NCT02223858|11818403|FG001|STARTED|Overall Study||180
10657216|NCT02223858|11818402|FG000|1-month Follow-up|Overall Study||156
10657217|NCT02223858|11818403|FG001|1-month Follow-up|Overall Study||150
10657218|NCT02223858|11818402|FG000|3-month Follow-up|Overall Study||155
10370601|NCT00554996|11511579|FG000|NOT COMPLETED|Overall Study||0
10370602|NCT00555048|11511583|FG000|STARTED|Overall Study||1
10370603|NCT00555048|11511583|FG000|COMPLETED|Overall Study||1
10370604|NCT00555048|11511583|FG000|NOT COMPLETED|Overall Study||0
10427603|NCT00853762|11573476|FG001|COMPLETED|Overall Study||0
10537446|NCT01449630|11690078|FG003|STARTED|Period 3||1
10537447|NCT01449630|11690079|FG004|STARTED|Period 3||5
10537448|NCT01449630|11690080|FG005|STARTED|Period 3||1
10537449|NCT01449630|11690081|FG006|STARTED|Period 3||1
10537450|NCT01449630|11690082|FG007|STARTED|Period 3||6
10537451|NCT01449630|11690083|FG008|STARTED|Period 3||2
10537452|NCT01449630|11690075|FG000|COMPLETED|Period 3||1
10537453|NCT01449630|11690076|FG001|COMPLETED|Period 3||6
10537454|NCT01449630|11690077|FG002|COMPLETED|Period 3||2
10537455|NCT01449630|11690078|FG003|COMPLETED|Period 3||1
10370605|NCT00555061|11511587|FG000|STARTED|Overall Study|One participant did not receive study medication and was not included in the analysis population.|87
10370606|NCT00555061|11511587|FG000|COMPLETED|Overall Study||78
10370607|NCT00555061|11511587|FG000|NOT COMPLETED|Overall Study||9
10370608|NCT00555152|11511595|FG000|STARTED|Period Open at BCM: 1/17/08-3/8/10||2
10370609|NCT00555152|11511596|FG001|STARTED|Period Open at BCM: 1/17/08-3/8/10|Participants in initial and second study registration periods reported separately.|0
10370610|NCT00555152|11511597|FG002|STARTED|Period Open at BCM: 1/17/08-3/8/10||0
10370611|NCT00555152|11511598|FG003|STARTED|Period Open at BCM: 1/17/08-3/8/10||1
10370612|NCT00555152|11511595|FG000|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||2
10370613|NCT00555152|11511596|FG001|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
10370614|NCT00555152|11511597|FG002|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
10370615|NCT00555152|11511598|FG003|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||1
10370616|NCT00555152|11511595|FG000|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
10370617|NCT00555152|11511596|FG001|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
10370618|NCT00555152|11511597|FG002|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
10370619|NCT00555152|11511598|FG003|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
10370620|NCT00555152|11511595|FG000|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14|Participants in initial and second study registration periods reported separately.|0
10370621|NCT00555152|11511596|FG001|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||10
10370622|NCT00555152|11511597|FG002|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||0
10370623|NCT00555152|11511598|FG003|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||9
10370624|NCT00555152|11511595|FG000|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
10370625|NCT00555152|11511596|FG001|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||10
10370626|NCT00555152|11511597|FG002|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
10370627|NCT00555152|11511598|FG003|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||9
10370628|NCT00555152|11511595|FG000|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
10370629|NCT00555152|11511596|FG001|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
10370630|NCT00555152|11511597|FG002|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
10370631|NCT00555152|11511598|FG003|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
10370632|NCT00555217|11511610|FG000|STARTED|Overall Study||724
10370633|NCT00555217|11511611|FG001|STARTED|Overall Study||724
10370634|NCT00555217|11511610|FG000|COMPLETED|Overall Study||649
10370635|NCT00555217|11511611|FG001|COMPLETED|Overall Study||656
10370636|NCT00555217|11511610|FG000|NOT COMPLETED|Overall Study||75
10370637|NCT00555217|11511611|FG001|NOT COMPLETED|Overall Study||68
10370638|NCT00555321|11511622|FG000|STARTED|Treatment Phase up to 12-months||52
10370639|NCT00555321|11511623|FG001|STARTED|Treatment Phase up to 12-months||51
10370640|NCT00555321|11511624|FG002|STARTED|Treatment Phase up to 12-months||50
10370641|NCT00555321|11511625|FG003|STARTED|Treatment Phase up to 12-months||53
10370642|NCT00555321|11511626|FG004|STARTED|Treatment Phase up to 12-months||54
10370643|NCT00555321|11511622|FG000|Received Transplant and Treated|Treatment Phase up to 12-months||50
10370644|NCT00555321|11511623|FG001|Received Transplant and Treated|Treatment Phase up to 12-months||48
10370645|NCT00555321|11511624|FG002|Received Transplant and Treated|Treatment Phase up to 12-months||49
10370646|NCT00555321|11511625|FG003|Received Transplant and Treated|Treatment Phase up to 12-months||53
10370647|NCT00555321|11511626|FG004|Received Transplant and Treated|Treatment Phase up to 12-months||50
10370648|NCT00555321|11511622|FG000|COMPLETED|Treatment Phase up to 12-months||31
10370649|NCT00555321|11511623|FG001|COMPLETED|Treatment Phase up to 12-months||29
10370650|NCT00555321|11511624|FG002|COMPLETED|Treatment Phase up to 12-months||26
10370651|NCT00555321|11511625|FG003|COMPLETED|Treatment Phase up to 12-months||46
10370652|NCT00555321|11511626|FG004|COMPLETED|Treatment Phase up to 12-months||32
10370653|NCT00555321|11511622|FG000|NOT COMPLETED|Treatment Phase up to 12-months||21
10370654|NCT00555321|11511623|FG001|NOT COMPLETED|Treatment Phase up to 12-months||22
10370655|NCT00555321|11511624|FG002|NOT COMPLETED|Treatment Phase up to 12-months||24
10370656|NCT00555321|11511625|FG003|NOT COMPLETED|Treatment Phase up to 12-months||7
10370657|NCT00555321|11511626|FG004|NOT COMPLETED|Treatment Phase up to 12-months||22
10370658|NCT00555321|11511622|FG000|STARTED|Long-term Extension Phase|1 participant did not enter LTE|30
10370659|NCT00555321|11511623|FG001|STARTED|Long-term Extension Phase|2 participants did not enter LTE|27
10370660|NCT00555321|11511624|FG002|STARTED|Long-term Extension Phase|2 participants did not enter LTE|24
10370661|NCT00555321|11511625|FG003|STARTED|Long-term Extension Phase|8 participants did not enter LTE|38
10370662|NCT00555321|11511626|FG004|STARTED|Long-term Extension Phase|6 participants did not enter LTE|26
10370663|NCT00555321|11511622|FG000|COMPLETED|Long-term Extension Phase||0
10370664|NCT00555321|11511623|FG001|COMPLETED|Long-term Extension Phase||0
10370665|NCT00555321|11511624|FG002|COMPLETED|Long-term Extension Phase||0
10370666|NCT00555321|11511625|FG003|COMPLETED|Long-term Extension Phase||0
10370667|NCT00555321|11511626|FG004|COMPLETED|Long-term Extension Phase||0
10370668|NCT00555321|11511622|FG000|NOT COMPLETED|Long-term Extension Phase||30
10370669|NCT00555321|11511623|FG001|NOT COMPLETED|Long-term Extension Phase||27
10370670|NCT00555321|11511624|FG002|NOT COMPLETED|Long-term Extension Phase||24
10370671|NCT00555321|11511625|FG003|NOT COMPLETED|Long-term Extension Phase||38
10370672|NCT00555321|11511626|FG004|NOT COMPLETED|Long-term Extension Phase||26
10370673|NCT00555360|11511645|FG000|STARTED|Overall Study||183
10370674|NCT00555360|11511646|FG001|STARTED|Overall Study||189
10370675|NCT00555360|11511645|FG000|COMPLETED|Overall Study||156
10370676|NCT00555360|11511646|FG001|COMPLETED|Overall Study||153
10370677|NCT00555360|11511645|FG000|NOT COMPLETED|Overall Study||27
10370678|NCT00555360|11511646|FG001|NOT COMPLETED|Overall Study||36
10716839|NCT02692482|11880698|FG000|NOT COMPLETED|Overall Study||3
10716840|NCT02692482|11880699|FG001|NOT COMPLETED|Overall Study||4
10716841|NCT02692495|11880708|FG000|STARTED|Overall Study||12
10716842|NCT02692495|11880709|FG001|STARTED|Overall Study||4
10716843|NCT02692495|11880708|FG000|COMPLETED|Overall Study||12
10716844|NCT02692495|11880709|FG001|COMPLETED|Overall Study||4
10716845|NCT02692495|11880708|FG000|NOT COMPLETED|Overall Study||0
10716846|NCT02692495|11880709|FG001|NOT COMPLETED|Overall Study||0
10716847|NCT02692560|11880721|FG000|STARTED|Overall Study||29
10716848|NCT02692560|11880722|FG001|STARTED|Overall Study||31
10716849|NCT02692560|11880721|FG000|COMPLETED|Overall Study||29
10716850|NCT02692560|11880722|FG001|COMPLETED|Overall Study||25
10370679|NCT00555425|11511655|FG000|STARTED|Overall Study||57
10370680|NCT00555425|11511656|FG001|STARTED|Overall Study||56
10370681|NCT00555425|11511655|FG000|COMPLETED|Overall Study||6
10370682|NCT00555425|11511656|FG001|COMPLETED|Overall Study||37
10370683|NCT00555425|11511655|FG000|NOT COMPLETED|Overall Study||51
10370684|NCT00555425|11511656|FG001|NOT COMPLETED|Overall Study||19
10370685|NCT00555438|11511662|FG000|STARTED|10 Days Post-operative||442
10370686|NCT00555438|11511662|FG000|COMPLETED|10 Days Post-operative|438 patients attended the day 10 visit (four patients died during hospitalization)|438
10370687|NCT00555438|11511662|FG000|NOT COMPLETED|10 Days Post-operative||4
10370688|NCT00555438|11511662|FG000|STARTED|Between 10 Days and 30 Days Postoperativ||438
10370689|NCT00555438|11511662|FG000|COMPLETED|Between 10 Days and 30 Days Postoperativ||433
10370690|NCT00555438|11511662|FG000|NOT COMPLETED|Between 10 Days and 30 Days Postoperativ||5
10370691|NCT00555464|11511668|FG000|STARTED|Overall Study||4
10370692|NCT00555464|11511669|FG001|STARTED|Overall Study||4
10370693|NCT00555464|11511668|FG000|COMPLETED|Overall Study||4
10370694|NCT00555464|11511669|FG001|COMPLETED|Overall Study||1
10370695|NCT00555464|11511668|FG000|NOT COMPLETED|Overall Study||0
10370696|NCT00555464|11511669|FG001|NOT COMPLETED|Overall Study||3
10370697|NCT00555477|11511677|FG000|STARTED|Overall Study||14
10370698|NCT00555477|11511678|FG001|STARTED|Overall Study||45
10370699|NCT00555477|11511677|FG000|COMPLETED|Overall Study||12
10370700|NCT00555477|11511678|FG001|COMPLETED|Overall Study||32
10370701|NCT00555477|11511677|FG000|NOT COMPLETED|Overall Study||2
10370702|NCT00555477|11511678|FG001|NOT COMPLETED|Overall Study||13
10370703|NCT00555568|11511686|FG000|STARTED|Overall Study||100
10370704|NCT00555568|11511687|FG001|STARTED|Overall Study||98
10370705|NCT00555568|11511688|FG002|STARTED|Overall Study||100
10370706|NCT00555568|11511686|FG000|COMPLETED|Overall Study||74
10370707|NCT00555568|11511687|FG001|COMPLETED|Overall Study||82
10370708|NCT00555568|11511688|FG002|COMPLETED|Overall Study||84
10370709|NCT00555568|11511686|FG000|NOT COMPLETED|Overall Study||26
10370710|NCT00555568|11511687|FG001|NOT COMPLETED|Overall Study||16
10370711|NCT00555568|11511688|FG002|NOT COMPLETED|Overall Study||16
10370712|NCT00555581|11511696|FG000|STARTED|Overall Study||30
10370713|NCT00555581|11511696|FG000|COMPLETED|Overall Study||24
10370714|NCT00555581|11511696|FG000|NOT COMPLETED|Overall Study||6
10370715|NCT00555620|11511706|FG000|STARTED|Overall Study||6
10370716|NCT00555620|11511707|FG001|STARTED|Overall Study||7
10370717|NCT00555620|11511708|FG002|STARTED|Overall Study||15
10370718|NCT00555620|11511709|FG003|STARTED|Overall Study||23
10370719|NCT00555620|11511710|FG004|STARTED|Overall Study||3
10370720|NCT00555620|11511711|FG005|STARTED|Overall Study||22
10370721|NCT00555620|11511706|FG000|COMPLETED|Overall Study||0
10370722|NCT00555620|11511707|FG001|COMPLETED|Overall Study||0
10370723|NCT00555620|11511708|FG002|COMPLETED|Overall Study||0
10370724|NCT00555620|11511709|FG003|COMPLETED|Overall Study||0
10370725|NCT00555620|11511710|FG004|COMPLETED|Overall Study||0
10370726|NCT00555620|11511711|FG005|COMPLETED|Overall Study||0
10370727|NCT00555620|11511706|FG000|NOT COMPLETED|Overall Study||6
10370728|NCT00555620|11511707|FG001|NOT COMPLETED|Overall Study||7
10370729|NCT00555620|11511708|FG002|NOT COMPLETED|Overall Study||15
10370730|NCT00555620|11511709|FG003|NOT COMPLETED|Overall Study||23
10370731|NCT00555620|11511710|FG004|NOT COMPLETED|Overall Study||3
10370732|NCT00555620|11511711|FG005|NOT COMPLETED|Overall Study||22
10370733|NCT00555672|11511731|FG000|STARTED|Overall Study||24
10370734|NCT00555672|11511732|FG001|STARTED|Overall Study||10
10370735|NCT00555672|11511731|FG000|COMPLETED|Overall Study||0
10370736|NCT00555672|11511732|FG001|COMPLETED|Overall Study||0
10370737|NCT00555672|11511731|FG000|NOT COMPLETED|Overall Study||24
10370738|NCT00555672|11511732|FG001|NOT COMPLETED|Overall Study||10
10370739|NCT00555750|11511740|FG000|STARTED|Overall Study||10
10370740|NCT00555750|11511741|FG001|STARTED|Overall Study||10
10537456|NCT01449630|11690079|FG004|COMPLETED|Period 3||5
10716851|NCT02692560|11880721|FG000|NOT COMPLETED|Overall Study||0
10716852|NCT02692560|11880722|FG001|NOT COMPLETED|Overall Study||6
10370741|NCT00555750|11511740|FG000|COMPLETED|Overall Study||10
10370742|NCT00555750|11511741|FG001|COMPLETED|Overall Study||10
10370743|NCT00555750|11511740|FG000|NOT COMPLETED|Overall Study||0
10370744|NCT00555750|11511741|FG001|NOT COMPLETED|Overall Study||0
10370745|NCT00555880|11511749|FG000|STARTED|Treatment Period 1 (1 Day)||13
10370746|NCT00555880|11511750|FG001|STARTED|Treatment Period 1 (1 Day)||11
10370747|NCT00555880|11511749|FG000|COMPLETED|Treatment Period 1 (1 Day)||13
10370748|NCT00555880|11511750|FG001|COMPLETED|Treatment Period 1 (1 Day)||11
10370749|NCT00555880|11511749|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0
10370750|NCT00555880|11511750|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0
10370751|NCT00555880|11511749|FG000|STARTED|Washout (1 Day)||13
10537457|NCT01449630|11690080|FG005|COMPLETED|Period 3||1
10716853|NCT02692586|11880728|FG000|STARTED|Overall Study||106
10812613|NCT03466658|11974719|FG000|STARTED|Overall Study||17
10370752|NCT00555880|11511750|FG001|STARTED|Washout (1 Day)||11
10370753|NCT00555880|11511749|FG000|COMPLETED|Washout (1 Day)||13
10370754|NCT00555880|11511750|FG001|COMPLETED|Washout (1 Day)||11
10370755|NCT00555880|11511749|FG000|NOT COMPLETED|Washout (1 Day)||0
10370756|NCT00555880|11511750|FG001|NOT COMPLETED|Washout (1 Day)||0
10370757|NCT00555880|11511749|FG000|STARTED|Treatment Period 2 (1 Day)||13
10370758|NCT00555880|11511750|FG001|STARTED|Treatment Period 2 (1 Day)||11
10370759|NCT00555880|11511749|FG000|COMPLETED|Treatment Period 2 (1 Day)||13
10370760|NCT00555880|11511750|FG001|COMPLETED|Treatment Period 2 (1 Day)||11
10370761|NCT00555880|11511749|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0
10370762|NCT00555880|11511750|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0
10370763|NCT00555893|11511759|FG000|STARTED|Overall Study||130
10370764|NCT00555893|11511760|FG001|STARTED|Overall Study||63
10370765|NCT00555893|11511759|FG000|Final Analysis|Overall Study|n=16 excluded from number started because >119 hrs|114
10370766|NCT00555893|11511760|FG001|Final Analysis|Overall Study|n=12 excluded from number started because >119 hrs|51
10370767|NCT00555893|11511759|FG000|COMPLETED|Overall Study||130
10370768|NCT00555893|11511760|FG001|COMPLETED|Overall Study||63
10370769|NCT00555893|11511759|FG000|NOT COMPLETED|Overall Study||0
10370770|NCT00555893|11511760|FG001|NOT COMPLETED|Overall Study||0
10370771|NCT00555906|11511769|FG000|STARTED|Phase 1||3
10370772|NCT00555906|11511770|FG001|STARTED|Phase 1||6
10370773|NCT00555906|11511771|FG002|STARTED|Phase 1||7
10370774|NCT00555906|11511772|FG003|STARTED|Phase 1||5
10370775|NCT00555906|11511773|FG004|STARTED|Phase 1||0
10370776|NCT00555906|11511769|FG000|COMPLETED|Phase 1||0
10370777|NCT00555906|11511770|FG001|COMPLETED|Phase 1||0
10370778|NCT00555906|11511771|FG002|COMPLETED|Phase 1||0
10370779|NCT00555906|11511772|FG003|COMPLETED|Phase 1||0
10370780|NCT00555906|11511773|FG004|COMPLETED|Phase 1||0
10370781|NCT00555906|11511769|FG000|NOT COMPLETED|Phase 1||3
10370782|NCT00555906|11511770|FG001|NOT COMPLETED|Phase 1||6
10370783|NCT00555906|11511771|FG002|NOT COMPLETED|Phase 1||7
10370784|NCT00555906|11511772|FG003|NOT COMPLETED|Phase 1||5
10370785|NCT00555906|11511773|FG004|NOT COMPLETED|Phase 1||0
10370786|NCT00555906|11511769|FG000|STARTED|Phase 2||0
10370787|NCT00555906|11511770|FG001|STARTED|Phase 2||0
10370788|NCT00555906|11511771|FG002|STARTED|Phase 2||0
10370789|NCT00555906|11511772|FG003|STARTED|Phase 2||0
10370790|NCT00555906|11511773|FG004|STARTED|Phase 2||32
10370791|NCT00555906|11511769|FG000|Treated|Phase 2||0
10370792|NCT00555906|11511770|FG001|Treated|Phase 2||0
10370793|NCT00555906|11511771|FG002|Treated|Phase 2||0
10370794|NCT00555906|11511772|FG003|Treated|Phase 2||0
10370795|NCT00555906|11511773|FG004|Treated|Phase 2||30
10370796|NCT00555906|11511769|FG000|COMPLETED|Phase 2||0
10370797|NCT00555906|11511770|FG001|COMPLETED|Phase 2||0
10370798|NCT00555906|11511771|FG002|COMPLETED|Phase 2||0
10370799|NCT00555906|11511772|FG003|COMPLETED|Phase 2||0
10370800|NCT00555906|11511773|FG004|COMPLETED|Phase 2||0
10370801|NCT00555906|11511769|FG000|NOT COMPLETED|Phase 2||0
10370802|NCT00555906|11511770|FG001|NOT COMPLETED|Phase 2||0
10370803|NCT00555906|11511771|FG002|NOT COMPLETED|Phase 2||0
10370804|NCT00555906|11511772|FG003|NOT COMPLETED|Phase 2||0
10370805|NCT00555906|11511773|FG004|NOT COMPLETED|Phase 2||32
10370806|NCT00555971|11511790|FG000|STARTED|Overall Study||5
10370807|NCT00555971|11511791|FG001|STARTED|Overall Study||8
10370808|NCT00555971|11511790|FG000|COMPLETED|Overall Study||4
10370809|NCT00555971|11511791|FG001|COMPLETED|Overall Study||7
10370810|NCT00555971|11511790|FG000|NOT COMPLETED|Overall Study||1
10370811|NCT00555971|11511791|FG001|NOT COMPLETED|Overall Study||1
10370812|NCT00555997|11511800|FG000|STARTED|Phase 1 SPCD||29
10370813|NCT00555997|11511801|FG001|STARTED|Phase 1 SPCD||91
10370814|NCT00555997|11511802|FG002|STARTED|Phase 1 SPCD||0
10370815|NCT00555997|11511803|FG003|STARTED|Phase 1 SPCD||0
10370816|NCT00555997|11511800|FG000|COMPLETED|Phase 1 SPCD||17
10370817|NCT00555997|11511801|FG001|COMPLETED|Phase 1 SPCD||76
10370818|NCT00555997|11511802|FG002|COMPLETED|Phase 1 SPCD||0
10370819|NCT00555997|11511803|FG003|COMPLETED|Phase 1 SPCD||0
10370820|NCT00555997|11511800|FG000|NOT COMPLETED|Phase 1 SPCD||12
10370821|NCT00555997|11511801|FG001|NOT COMPLETED|Phase 1 SPCD||15
10370822|NCT00555997|11511802|FG002|NOT COMPLETED|Phase 1 SPCD||0
10370823|NCT00555997|11511803|FG003|NOT COMPLETED|Phase 1 SPCD||0
10370824|NCT00555997|11511800|FG000|STARTED|Phase 2 SPCD||0
10370825|NCT00555997|11511801|FG001|STARTED|Phase 2 SPCD||0
10370826|NCT00555997|11511802|FG002|STARTED|Phase 2 SPCD||38
10370827|NCT00555997|11511803|FG003|STARTED|Phase 2 SPCD||25
10657219|NCT02223858|11818403|FG001|3-month Follow-up|Overall Study||154
10370828|NCT00555997|11511800|FG000|COMPLETED|Phase 2 SPCD||0
10370829|NCT00555997|11511801|FG001|COMPLETED|Phase 2 SPCD||0
10370830|NCT00555997|11511802|FG002|COMPLETED|Phase 2 SPCD||31
10657220|NCT02223858|11818402|FG000|6-month Follow-up|Overall Study||156
10657221|NCT02223858|11818403|FG001|6-month Follow-up|Overall Study||154
10812614|NCT03466658|11974719|FG000|COMPLETED|Overall Study||14
10370831|NCT00555997|11511803|FG003|COMPLETED|Phase 2 SPCD||22
10370832|NCT00555997|11511800|FG000|NOT COMPLETED|Phase 2 SPCD||0
10370833|NCT00555997|11511801|FG001|NOT COMPLETED|Phase 2 SPCD||0
10370834|NCT00555997|11511802|FG002|NOT COMPLETED|Phase 2 SPCD||7
10370835|NCT00555997|11511803|FG003|NOT COMPLETED|Phase 2 SPCD||3
10370836|NCT00556049|11511815|FG000|STARTED|Overall Study||72
10370837|NCT00556049|11511815|FG000|COMPLETED|Overall Study||72
10370838|NCT00556049|11511815|FG000|NOT COMPLETED|Overall Study||0
10370839|NCT00556140|11511819|FG000|STARTED|Overall Study||16
10370840|NCT00556140|11511819|FG000|COMPLETED|Overall Study||13
10370841|NCT00556140|11511819|FG000|NOT COMPLETED|Overall Study||3
10370842|NCT00556322|11511825|FG000|STARTED|Overall Study||221
10370843|NCT00556322|11511826|FG001|STARTED|Overall Study||203
10370844|NCT00556322|11511825|FG000|COMPLETED|Overall Study|Data cutoff was 01 August 2010|0
10370845|NCT00556322|11511826|FG001|COMPLETED|Overall Study|Data cutoff was 01 August 2010|0
10370846|NCT00556322|11511825|FG000|NOT COMPLETED|Overall Study||221
10370847|NCT00556322|11511826|FG001|NOT COMPLETED|Overall Study||203
10370856|NCT00556426|11511844|FG000|STARTED|Overall Study||100
10370857|NCT00556426|11511844|FG000|COMPLETED|Overall Study||91
10370858|NCT00556426|11511844|FG000|NOT COMPLETED|Overall Study||9
10370859|NCT00556439|11511853|FG000|STARTED|Study Entry to Week 12|58 signed informed consent with 9 not being eligible. The remaining 49 received study drug.|49
10370860|NCT00556439|11511854|FG001|STARTED|Study Entry to Week 12|No participants received placebo until the Week 12 Randomization|0
10370861|NCT00556439|11511855|FG002|STARTED|Study Entry to Week 12|39 signed informed consent with 5 not being eligible. The remaining 34 received study drug.|34
10370862|NCT00556439|11511856|FG003|STARTED|Study Entry to Week 12|No participants received placebo until the Week 12 Randomization|0
10370863|NCT00556439|11511853|FG000|COMPLETED|Study Entry to Week 12||41
10370864|NCT00556439|11511854|FG001|COMPLETED|Study Entry to Week 12||0
10370865|NCT00556439|11511855|FG002|COMPLETED|Study Entry to Week 12||26
10370866|NCT00556439|11511856|FG003|COMPLETED|Study Entry to Week 12||0
10370867|NCT00556439|11511853|FG000|NOT COMPLETED|Study Entry to Week 12||8
10370868|NCT00556439|11511854|FG001|NOT COMPLETED|Study Entry to Week 12||0
10370869|NCT00556439|11511855|FG002|NOT COMPLETED|Study Entry to Week 12||8
10370870|NCT00556439|11511856|FG003|NOT COMPLETED|Study Entry to Week 12||0
10370871|NCT00556439|11511853|FG000|STARTED|After Week 12 (Randomized Study Period)||20
10370872|NCT00556439|11511854|FG001|STARTED|After Week 12 (Randomized Study Period)||21
10370873|NCT00556439|11511855|FG002|STARTED|After Week 12 (Randomized Study Period)||11
10370874|NCT00556439|11511856|FG003|STARTED|After Week 12 (Randomized Study Period)||15
10370875|NCT00556439|11511853|FG000|COMPLETED|After Week 12 (Randomized Study Period)||17
10370876|NCT00556439|11511854|FG001|COMPLETED|After Week 12 (Randomized Study Period)||17
10370877|NCT00556439|11511855|FG002|COMPLETED|After Week 12 (Randomized Study Period)||11
10370878|NCT00556439|11511856|FG003|COMPLETED|After Week 12 (Randomized Study Period)||14
10370879|NCT00556439|11511853|FG000|NOT COMPLETED|After Week 12 (Randomized Study Period)||3
10370880|NCT00556439|11511854|FG001|NOT COMPLETED|After Week 12 (Randomized Study Period)||4
10370881|NCT00556439|11511855|FG002|NOT COMPLETED|After Week 12 (Randomized Study Period)||0
10370882|NCT00556439|11511856|FG003|NOT COMPLETED|After Week 12 (Randomized Study Period)||1
10370883|NCT00556452|11511869|FG000|STARTED|Overall Study||6
10370884|NCT00556452|11511870|FG001|STARTED|Overall Study||21
10370885|NCT00556452|11511871|FG002|STARTED|Overall Study||19
10370886|NCT00556452|11511869|FG000|COMPLETED|Overall Study||6
10370887|NCT00556452|11511870|FG001|COMPLETED|Overall Study||21
10370888|NCT00556452|11511871|FG002|COMPLETED|Overall Study||19
10370889|NCT00556452|11511869|FG000|NOT COMPLETED|Overall Study||0
10370890|NCT00556452|11511870|FG001|NOT COMPLETED|Overall Study||0
10370891|NCT00556452|11511871|FG002|NOT COMPLETED|Overall Study||0
10370892|NCT00556478|11511878|FG000|STARTED|Double-blind Phase||171
10370893|NCT00556478|11511879|FG001|STARTED|Double-blind Phase||85
10370894|NCT00556478|11511878|FG000|ITT|Double-blind Phase||167
10370895|NCT00556478|11511879|FG001|ITT|Double-blind Phase||82
10370896|NCT00556478|11511878|FG000|COMPLETED|Double-blind Phase||150
10370897|NCT00556478|11511879|FG001|COMPLETED|Double-blind Phase||77
10370898|NCT00556478|11511878|FG000|NOT COMPLETED|Double-blind Phase||21
10370899|NCT00556478|11511879|FG001|NOT COMPLETED|Double-blind Phase||8
10370900|NCT00556478|11511878|FG000|STARTED|Open-Label Phase||146
10370901|NCT00556478|11511879|FG001|STARTED|Open-Label Phase||77
10370902|NCT00556478|11511878|FG000|Treated in Open-label|Open-Label Phase||142
10370903|NCT00556478|11511879|FG001|Treated in Open-label|Open-Label Phase||71
10370904|NCT00556478|11511878|FG000|COMPLETED|Open-Label Phase||132
10370905|NCT00556478|11511879|FG001|COMPLETED|Open-Label Phase||67
10370906|NCT00556478|11511878|FG000|NOT COMPLETED|Open-Label Phase||14
10370907|NCT00556478|11511879|FG001|NOT COMPLETED|Open-Label Phase||10
10370908|NCT00556491|11511890|FG000|STARTED|Overall Study|January 2008|20
10370909|NCT00556491|11511891|FG001|STARTED|Overall Study||20
10370910|NCT00556491|11511890|FG000|COMPLETED|Overall Study||19
10370911|NCT00556491|11511891|FG001|COMPLETED|Overall Study||19
10370912|NCT00556491|11511890|FG000|NOT COMPLETED|Overall Study||1
10370913|NCT00556491|11511891|FG001|NOT COMPLETED|Overall Study||1
10370914|NCT00556504|11511909|FG000|STARTED|Overall Study||42
10370915|NCT00556504|11511910|FG001|STARTED|Overall Study||42
10370916|NCT00556504|11511909|FG000|Intend-to Treat Population|Overall Study||42
10370917|NCT00556504|11511910|FG001|Intend-to Treat Population|Overall Study||42
10370918|NCT00556504|11511909|FG000|Safety Population|Overall Study||41
10370919|NCT00556504|11511910|FG001|Safety Population|Overall Study||42
10370920|NCT00556504|11511909|FG000|COMPLETED|Overall Study||34
10370921|NCT00556504|11511910|FG001|COMPLETED|Overall Study||33
10370922|NCT00556504|11511909|FG000|NOT COMPLETED|Overall Study||8
10370923|NCT00556504|11511910|FG001|NOT COMPLETED|Overall Study||9
10370924|NCT00556543|11511916|FG000|STARTED|Overall Study||10
10370925|NCT00556543|11511916|FG000|COMPLETED|Overall Study|Subjects completed 180 days of study enrollment|10
10370926|NCT00556543|11511916|FG000|NOT COMPLETED|Overall Study||0
10370927|NCT00556673|11511925|FG000|STARTED|Overall Study||16
10370928|NCT00556673|11511926|FG001|STARTED|Overall Study||15
10370929|NCT00556673|11511925|FG000|Pharmacodynamic (PD) Population|Overall Study|4 patients inadvertently unblinded were not included in PD analysis population.|12
10370930|NCT00556673|11511926|FG001|Pharmacodynamic (PD) Population|Overall Study|3 patients inadvertently unblinded were not included in PD analysis population.|12
10370931|NCT00556673|11511925|FG000|COMPLETED|Overall Study||13
10370932|NCT00556673|11511926|FG001|COMPLETED|Overall Study||13
10370933|NCT00556673|11511925|FG000|NOT COMPLETED|Overall Study||3
10370934|NCT00556673|11511926|FG001|NOT COMPLETED|Overall Study||2
10370935|NCT00556712|11511936|FG000|STARTED|Overall Study||451
10370936|NCT00556712|11511937|FG001|STARTED|Overall Study||438
10370937|NCT00556712|11511936|FG000|COMPLETED|Overall Study|Data cutoff date: 17 May 2008|0
10370938|NCT00556712|11511937|FG001|COMPLETED|Overall Study|Data cutoff date: 17 May 2008|0
10370939|NCT00556712|11511936|FG000|NOT COMPLETED|Overall Study||451
10370940|NCT00556712|11511937|FG001|NOT COMPLETED|Overall Study||438
10370941|NCT00556842|11511945|FG000|STARTED|Overall Study||749
10370942|NCT00556842|11511946|FG001|STARTED|Overall Study||746
10370943|NCT00556842|11511945|FG000|COMPLETED|Overall Study||718
10370944|NCT00556842|11511946|FG001|COMPLETED|Overall Study||723
10370945|NCT00556842|11511945|FG000|NOT COMPLETED|Overall Study||31
10370946|NCT00556842|11511946|FG001|NOT COMPLETED|Overall Study||23
10370947|NCT00556894|11511963|FG000|STARTED|Overall Study||82
10370948|NCT00556894|11511964|FG001|STARTED|Overall Study||87
10370949|NCT00556894|11511965|FG002|STARTED|Overall Study||84
10370950|NCT00556894|11511963|FG000|COMPLETED|Overall Study||66
10370951|NCT00556894|11511964|FG001|COMPLETED|Overall Study||68
10370952|NCT00556894|11511965|FG002|COMPLETED|Overall Study||65
10370953|NCT00556894|11511963|FG000|NOT COMPLETED|Overall Study||16
10370954|NCT00556894|11511964|FG001|NOT COMPLETED|Overall Study||19
10370955|NCT00556894|11511965|FG002|NOT COMPLETED|Overall Study||19
10370956|NCT00556933|11511977|FG000|STARTED|Single vs. Divided-dose rATG Induction||45
10370957|NCT00556933|11511978|FG001|STARTED|Single vs. Divided-dose rATG Induction||45
10370958|NCT00556933|11511979|FG002|STARTED|Single vs. Divided-dose rATG Induction||45
10370959|NCT00556933|11511980|FG003|STARTED|Single vs. Divided-dose rATG Induction||45
10370960|NCT00556933|11511977|FG000|COMPLETED|Single vs. Divided-dose rATG Induction||43
10370961|NCT00556933|11511978|FG001|COMPLETED|Single vs. Divided-dose rATG Induction||37
10370962|NCT00556933|11511979|FG002|COMPLETED|Single vs. Divided-dose rATG Induction||39
10370963|NCT00556933|11511980|FG003|COMPLETED|Single vs. Divided-dose rATG Induction||43
10370964|NCT00556933|11511977|FG000|NOT COMPLETED|Single vs. Divided-dose rATG Induction||2
10370965|NCT00556933|11511978|FG001|NOT COMPLETED|Single vs. Divided-dose rATG Induction||8
10370966|NCT00556933|11511979|FG002|NOT COMPLETED|Single vs. Divided-dose rATG Induction||6
10370967|NCT00556933|11511980|FG003|NOT COMPLETED|Single vs. Divided-dose rATG Induction||2
10370968|NCT00556933|11511977|FG000|STARTED|CNI Withdrawal vs. Minimization||43
10370969|NCT00556933|11511978|FG001|STARTED|CNI Withdrawal vs. Minimization||37
10370970|NCT00556933|11511979|FG002|STARTED|CNI Withdrawal vs. Minimization||39
10370971|NCT00556933|11511980|FG003|STARTED|CNI Withdrawal vs. Minimization||43
10370972|NCT00556933|11511977|FG000|COMPLETED|CNI Withdrawal vs. Minimization||42
10370973|NCT00556933|11511978|FG001|COMPLETED|CNI Withdrawal vs. Minimization||33
10370974|NCT00556933|11511979|FG002|COMPLETED|CNI Withdrawal vs. Minimization||36
10370975|NCT00556933|11511980|FG003|COMPLETED|CNI Withdrawal vs. Minimization||41
10370976|NCT00556933|11511977|FG000|NOT COMPLETED|CNI Withdrawal vs. Minimization||1
10370977|NCT00556933|11511978|FG001|NOT COMPLETED|CNI Withdrawal vs. Minimization||4
10370978|NCT00556933|11511979|FG002|NOT COMPLETED|CNI Withdrawal vs. Minimization||3
10370979|NCT00556933|11511980|FG003|NOT COMPLETED|CNI Withdrawal vs. Minimization||2
10370980|NCT00556946|11511999|FG000|STARTED|Overall Study||17
10370981|NCT00556946|11511999|FG000|COMPLETED|Overall Study||16
10370982|NCT00556946|11511999|FG000|NOT COMPLETED|Overall Study||1
10370983|NCT00556972|11512003|FG000|STARTED|Overall Study||4
10370984|NCT00556972|11512003|FG000|COMPLETED|Overall Study||4
10370985|NCT00556972|11512003|FG000|NOT COMPLETED|Overall Study||0
10370986|NCT00556998|11512007|FG000|STARTED|Voriconazole Intravenous (IV)||26
10370987|NCT00556998|11512007|FG000|Treated|Voriconazole Intravenous (IV)||26
10370988|NCT00556998|11512007|FG000|COMPLETED|Voriconazole Intravenous (IV)|One participant received 2 days of oral; then received IV again before discontinuing from study.|21
10370989|NCT00556998|11512007|FG000|NOT COMPLETED|Voriconazole Intravenous (IV)||5
10370990|NCT00556998|11512007|FG000|STARTED|Voriconazole Oral|One participant received voriconazole 150 mg every 12 hours during oral phase.|22
10370991|NCT00556998|11512007|FG000|COMPLETED|Voriconazole Oral||20
10370992|NCT00556998|11512007|FG000|NOT COMPLETED|Voriconazole Oral||2
10370993|NCT00557076|11512017|FG000|STARTED|Overall Study||8
10370994|NCT00557076|11512018|FG001|STARTED|Overall Study||8
10370995|NCT00557076|11512017|FG000|COMPLETED|Overall Study||8
10370996|NCT00557076|11512018|FG001|COMPLETED|Overall Study|One participant was withdrawn due to unblinding|7
10370997|NCT00557076|11512017|FG000|NOT COMPLETED|Overall Study||0
10370998|NCT00557076|11512018|FG001|NOT COMPLETED|Overall Study||1
10370999|NCT00557245|11512027|FG000|STARTED|Overall Study||1589
10371000|NCT00557245|11512028|FG001|STARTED|Overall Study||1583
10371001|NCT00557245|11512029|FG002|STARTED|Overall Study||1586
10371002|NCT00557245|11512027|FG000|COMPLETED|Overall Study||1577
10371003|NCT00557245|11512028|FG001|COMPLETED|Overall Study||1571
10371004|NCT00557245|11512029|FG002|COMPLETED|Overall Study||1574
10371005|NCT00557245|11512027|FG000|NOT COMPLETED|Overall Study||12
10371006|NCT00557245|11512028|FG001|NOT COMPLETED|Overall Study||12
10371007|NCT00557245|11512029|FG002|NOT COMPLETED|Overall Study||12
10371008|NCT00557284|11512042|FG000|STARTED|Overall Study||9
10371009|NCT00557284|11512043|FG001|STARTED|Overall Study||11
10371010|NCT00557284|11512042|FG000|COMPLETED|Overall Study||9
10371011|NCT00557284|11512043|FG001|COMPLETED|Overall Study||11
10371012|NCT00557284|11512042|FG000|NOT COMPLETED|Overall Study||0
10371013|NCT00557284|11512043|FG001|NOT COMPLETED|Overall Study||0
10371014|NCT00557310|11512049|FG000|STARTED|Main Study (0 - 18 Months)||35
10371015|NCT00557310|11512049|FG000|COMPLETED|Main Study (0 - 18 Months)|One had a metal hip implant, a protocol violation, and was excluded from efficacy analyses.|30
10371016|NCT00557310|11512049|FG000|NOT COMPLETED|Main Study (0 - 18 Months)||5
10371017|NCT00557310|11512049|FG000|STARTED|Extension Phase (18 - 24 Months)||30
10371018|NCT00557310|11512049|FG000|COMPLETED|Extension Phase (18 - 24 Months)|One had a metal hip implant, a protocol violation, and was excluded from efficacy analyses.|25
10371019|NCT00557310|11512049|FG000|NOT COMPLETED|Extension Phase (18 - 24 Months)||5
10371020|NCT00557323|11512053|FG000|STARTED|Overall Study||34
10371021|NCT00557323|11512053|FG000|COMPLETED|Overall Study||27
10371022|NCT00557323|11512053|FG000|NOT COMPLETED|Overall Study||7
10371023|NCT00557349|11512059|FG000|STARTED|Overall Study|omeprazole/bicarb|22
10371024|NCT00557349|11512060|FG001|STARTED|Overall Study||18
10371025|NCT00557349|11512059|FG000|COMPLETED|Overall Study||17
10371026|NCT00557349|11512060|FG001|COMPLETED|Overall Study||13
10371027|NCT00557349|11512059|FG000|NOT COMPLETED|Overall Study||5
10371028|NCT00557349|11512060|FG001|NOT COMPLETED|Overall Study||5
10371029|NCT00557362|11512070|FG000|STARTED|Overall Study||30
10371030|NCT00557362|11512071|FG001|STARTED|Overall Study||30
10371031|NCT00557362|11512072|FG002|STARTED|Overall Study||30
10371032|NCT00557362|11512073|FG003|STARTED|Overall Study||30
10371033|NCT00557362|11512070|FG000|COMPLETED|Overall Study||28
10371034|NCT00557362|11512071|FG001|COMPLETED|Overall Study||28
10371035|NCT00557362|11512072|FG002|COMPLETED|Overall Study||26
10371036|NCT00557362|11512073|FG003|COMPLETED|Overall Study||27
10371037|NCT00557362|11512070|FG000|NOT COMPLETED|Overall Study||2
10371038|NCT00557362|11512071|FG001|NOT COMPLETED|Overall Study||2
10371039|NCT00557362|11512072|FG002|NOT COMPLETED|Overall Study||4
10371040|NCT00557362|11512073|FG003|NOT COMPLETED|Overall Study||3
10371041|NCT00557440|11512089|FG000|STARTED|Treatment Period 1||12
10371042|NCT00557440|11512090|FG001|STARTED|Treatment Period 1||12
10371043|NCT00557440|11512091|FG002|STARTED|Treatment Period 1||13
10371044|NCT00557440|11512089|FG000|COMPLETED|Treatment Period 1||12
10371045|NCT00557440|11512090|FG001|COMPLETED|Treatment Period 1||12
10371046|NCT00557440|11512091|FG002|COMPLETED|Treatment Period 1||12
10371047|NCT00557440|11512089|FG000|NOT COMPLETED|Treatment Period 1||0
10371048|NCT00557440|11512090|FG001|NOT COMPLETED|Treatment Period 1||0
10371049|NCT00557440|11512091|FG002|NOT COMPLETED|Treatment Period 1||1
10371050|NCT00557440|11512089|FG000|STARTED|Treatment Period 2||12
10371051|NCT00557440|11512090|FG001|STARTED|Treatment Period 2||12
10371052|NCT00557440|11512091|FG002|STARTED|Treatment Period 2||12
10371053|NCT00557440|11512089|FG000|COMPLETED|Treatment Period 2||12
10371054|NCT00557440|11512090|FG001|COMPLETED|Treatment Period 2||12
10371055|NCT00557440|11512091|FG002|COMPLETED|Treatment Period 2||12
10371056|NCT00557440|11512089|FG000|NOT COMPLETED|Treatment Period 2||0
10371057|NCT00557440|11512090|FG001|NOT COMPLETED|Treatment Period 2||0
10371058|NCT00557440|11512091|FG002|NOT COMPLETED|Treatment Period 2||0
10371059|NCT00557440|11512089|FG000|STARTED|Treatment Period 3||12
10371060|NCT00557440|11512090|FG001|STARTED|Treatment Period 3||12
10371061|NCT00557440|11512091|FG002|STARTED|Treatment Period 3||12
10371062|NCT00557440|11512089|FG000|COMPLETED|Treatment Period 3||12
10371063|NCT00557440|11512090|FG001|COMPLETED|Treatment Period 3||12
10371064|NCT00557440|11512091|FG002|COMPLETED|Treatment Period 3||12
10371065|NCT00557440|11512089|FG000|NOT COMPLETED|Treatment Period 3||0
10371066|NCT00557440|11512090|FG001|NOT COMPLETED|Treatment Period 3||0
10371067|NCT00557440|11512091|FG002|NOT COMPLETED|Treatment Period 3||0
10537458|NCT01449630|11690081|FG006|COMPLETED|Period 3||1
10537459|NCT01449630|11690082|FG007|COMPLETED|Period 3||6
10537460|NCT01449630|11690083|FG008|COMPLETED|Period 3||2
10537461|NCT01449630|11690075|FG000|NOT COMPLETED|Period 3||0
10537462|NCT01449630|11690076|FG001|NOT COMPLETED|Period 3||0
10537463|NCT01449630|11690077|FG002|NOT COMPLETED|Period 3||0
10537464|NCT01449630|11690078|FG003|NOT COMPLETED|Period 3||0
10537465|NCT01449630|11690079|FG004|NOT COMPLETED|Period 3||0
10537466|NCT01449630|11690080|FG005|NOT COMPLETED|Period 3||0
10537467|NCT01449630|11690081|FG006|NOT COMPLETED|Period 3||0
10537468|NCT01449630|11690082|FG007|NOT COMPLETED|Period 3||0
10537469|NCT01449630|11690083|FG008|NOT COMPLETED|Period 3||0
10537470|NCT01449682|11690107|FG000|STARTED|Overall Study||5
10537471|NCT01449682|11690108|FG001|STARTED|Overall Study||5
10537472|NCT01449682|11690107|FG000|COMPLETED|Overall Study||4
10537473|NCT01449682|11690108|FG001|COMPLETED|Overall Study||4
10537474|NCT01449682|11690107|FG000|NOT COMPLETED|Overall Study||1
10537475|NCT01449682|11690108|FG001|NOT COMPLETED|Overall Study||1
10537476|NCT01449708|11690116|FG000|STARTED|Overall Study||61
10537477|NCT01449708|11690117|FG001|STARTED|Overall Study||63
10537478|NCT01449708|11690116|FG000|COMPLETED|Overall Study||59
10537479|NCT01449708|11690117|FG001|COMPLETED|Overall Study||60
10537480|NCT01449708|11690116|FG000|NOT COMPLETED|Overall Study||2
10371068|NCT00557466|11512105|FG000|STARTED|Overall Study||98
10371069|NCT00557466|11512106|FG001|STARTED|Overall Study||92
10537481|NCT01449708|11690117|FG001|NOT COMPLETED|Overall Study||3
10371070|NCT00557466|11512107|FG002|STARTED|Overall Study||101
10371071|NCT00557466|11512108|FG003|STARTED|Overall Study||96
10371072|NCT00557466|11512109|FG004|STARTED|Overall Study||90
10371073|NCT00557466|11512110|FG005|STARTED|Overall Study||91
10371074|NCT00557466|11512105|FG000|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|98
10371075|NCT00557466|11512106|FG001|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|92
10371076|NCT00557466|11512107|FG002|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|101
10371077|NCT00557466|11512108|FG003|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|96
10371078|NCT00557466|11512109|FG004|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|90
10371079|NCT00557466|11512110|FG005|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|91
10371080|NCT00557466|11512105|FG000|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|98
10371081|NCT00557466|11512106|FG001|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|91
10371082|NCT00557466|11512107|FG002|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|98
10371083|NCT00557466|11512108|FG003|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|93
10371084|NCT00557466|11512109|FG004|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|87
10371085|NCT00557466|11512110|FG005|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|89
10371086|NCT00557466|11512105|FG000|COMPLETED|Overall Study||94
10371087|NCT00557466|11512106|FG001|COMPLETED|Overall Study||87
10371088|NCT00557466|11512107|FG002|COMPLETED|Overall Study||95
10371089|NCT00557466|11512108|FG003|COMPLETED|Overall Study||92
10371090|NCT00557466|11512109|FG004|COMPLETED|Overall Study||87
10371091|NCT00557466|11512110|FG005|COMPLETED|Overall Study||85
10371092|NCT00557466|11512105|FG000|NOT COMPLETED|Overall Study||4
10371093|NCT00557466|11512106|FG001|NOT COMPLETED|Overall Study||5
10371094|NCT00557466|11512107|FG002|NOT COMPLETED|Overall Study||6
10371095|NCT00557466|11512108|FG003|NOT COMPLETED|Overall Study||4
10371096|NCT00557466|11512109|FG004|NOT COMPLETED|Overall Study||3
10371097|NCT00557466|11512110|FG005|NOT COMPLETED|Overall Study||6
10371098|NCT00557492|11512124|FG000|STARTED|Overall Study||59
10371099|NCT00557492|11512124|FG000|COMPLETED|Overall Study|Evaluable for outcomes|58
10371100|NCT00557492|11512124|FG000|NOT COMPLETED|Overall Study||1
10371101|NCT00557505|11512137|FG000|STARTED|Overall Study||3
10371102|NCT00557505|11512138|FG001|STARTED|Overall Study||3
10371103|NCT00557505|11512139|FG002|STARTED|Overall Study||4
10371104|NCT00557505|11512140|FG003|STARTED|Overall Study||3
10371105|NCT00557505|11512141|FG004|STARTED|Overall Study||2
10371106|NCT00557505|11512142|FG005|STARTED|Overall Study||3
10371107|NCT00557505|11512143|FG006|STARTED|Overall Study||3
10371108|NCT00557505|11512144|FG007|STARTED|Overall Study||5
10371109|NCT00557505|11512145|FG008|STARTED|Overall Study||17
10371110|NCT00557505|11512137|FG000|COMPLETED|Overall Study||0
10371111|NCT00557505|11512138|FG001|COMPLETED|Overall Study||0
10371112|NCT00557505|11512139|FG002|COMPLETED|Overall Study||0
10371113|NCT00557505|11512140|FG003|COMPLETED|Overall Study||0
10371114|NCT00557505|11512141|FG004|COMPLETED|Overall Study||0
10371115|NCT00557505|11512142|FG005|COMPLETED|Overall Study||0
10371116|NCT00557505|11512143|FG006|COMPLETED|Overall Study||0
10371117|NCT00557505|11512144|FG007|COMPLETED|Overall Study||0
10371118|NCT00557505|11512145|FG008|COMPLETED|Overall Study||0
10371119|NCT00557505|11512137|FG000|NOT COMPLETED|Overall Study||3
10371120|NCT00557505|11512138|FG001|NOT COMPLETED|Overall Study||3
10371121|NCT00557505|11512139|FG002|NOT COMPLETED|Overall Study||4
10371122|NCT00557505|11512140|FG003|NOT COMPLETED|Overall Study||3
10537482|NCT01449721|11690128|FG000|STARTED|Overall Study||112
10537483|NCT01449721|11690129|FG001|STARTED|Overall Study||30
10537484|NCT01449721|11690128|FG000|COMPLETED|Overall Study||112
10537485|NCT01449721|11690129|FG001|COMPLETED|Overall Study||28
10537486|NCT01449721|11690128|FG000|NOT COMPLETED|Overall Study||0
10537487|NCT01449721|11690129|FG001|NOT COMPLETED|Overall Study||2
10537488|NCT01449734|11690135|FG000|STARTED|Overall Study||215
10371123|NCT00557505|11512141|FG004|NOT COMPLETED|Overall Study||2
10371124|NCT00557505|11512142|FG005|NOT COMPLETED|Overall Study||3
10371125|NCT00557505|11512143|FG006|NOT COMPLETED|Overall Study||3
10537489|NCT01449734|11690135|FG000|COMPLETED|Overall Study||215
10537490|NCT01449734|11690135|FG000|NOT COMPLETED|Overall Study||0
10537491|NCT01449747|11690141|FG000|STARTED|Overall Study||12
10537492|NCT01449747|11690142|FG001|STARTED|Overall Study||12
10537493|NCT01449747|11690141|FG000|COMPLETED|Overall Study||12
10537494|NCT01449747|11690142|FG001|COMPLETED|Overall Study||12
10657222|NCT02223858|11818402|FG000|COMPLETED|Overall Study||156
10657223|NCT02223858|11818403|FG001|COMPLETED|Overall Study||154
10657224|NCT02223858|11818402|FG000|NOT COMPLETED|Overall Study||24
10657225|NCT02223858|11818403|FG001|NOT COMPLETED|Overall Study||26
10371126|NCT00557505|11512144|FG007|NOT COMPLETED|Overall Study||5
10371127|NCT00557505|11512145|FG008|NOT COMPLETED|Overall Study||17
10371128|NCT00557622|11512170|FG000|STARTED|4-Week Run-in Phase||5
10537495|NCT01449747|11690141|FG000|NOT COMPLETED|Overall Study||0
10537496|NCT01449747|11690142|FG001|NOT COMPLETED|Overall Study||0
10537497|NCT01449812|11690151|FG000|STARTED|Overall Study||272
10537498|NCT01449812|11690152|FG001|STARTED|Overall Study||273
10371129|NCT00557622|11512171|FG001|STARTED|4-Week Run-in Phase||0
10371130|NCT00557622|11512170|FG000|COMPLETED|4-Week Run-in Phase||3
10371131|NCT00557622|11512171|FG001|COMPLETED|4-Week Run-in Phase||0
10371132|NCT00557622|11512170|FG000|NOT COMPLETED|4-Week Run-in Phase||2
10371133|NCT00557622|11512171|FG001|NOT COMPLETED|4-Week Run-in Phase||0
10537499|NCT01449812|11690153|FG002|STARTED|Overall Study||280
10537500|NCT01449812|11690151|FG000|COMPLETED|Overall Study||270
10537501|NCT01449812|11690152|FG001|COMPLETED|Overall Study||273
10537502|NCT01449812|11690153|FG002|COMPLETED|Overall Study||279
10537503|NCT01449812|11690151|FG000|NOT COMPLETED|Overall Study||2
10537504|NCT01449812|11690152|FG001|NOT COMPLETED|Overall Study||0
10537505|NCT01449812|11690153|FG002|NOT COMPLETED|Overall Study||1
10537506|NCT01449864|11690161|FG000|STARTED|Overall Study||22
10537507|NCT01449864|11690161|FG000|COMPLETED|Overall Study||17
10537508|NCT01449864|11690161|FG000|NOT COMPLETED|Overall Study||5
10537509|NCT01449929|11690167|FG000|STARTED|Randomization Phase 96 Week||242
10537510|NCT01449929|11690168|FG001|STARTED|Randomization Phase 96 Week||242
10537511|NCT01449929|11690169|FG002|STARTED|Randomization Phase 96 Week||0
10537512|NCT01449929|11690167|FG000|COMPLETED|Randomization Phase 96 Week||209
10537513|NCT01449929|11690168|FG001|COMPLETED|Randomization Phase 96 Week||189
10537514|NCT01449929|11690169|FG002|COMPLETED|Randomization Phase 96 Week||0
10537515|NCT01449929|11690167|FG000|NOT COMPLETED|Randomization Phase 96 Week||33
10537516|NCT01449929|11690168|FG001|NOT COMPLETED|Randomization Phase 96 Week||53
10537517|NCT01449929|11690169|FG002|NOT COMPLETED|Randomization Phase 96 Week||0
10537518|NCT01449929|11690167|FG000|STARTED|Extension Phase Approximately 3 Years||0
10537519|NCT01449929|11690168|FG001|STARTED|Extension Phase Approximately 3 Years||0
10537520|NCT01449929|11690169|FG002|STARTED|Extension Phase Approximately 3 Years||123
10537521|NCT01449929|11690167|FG000|COMPLETED|Extension Phase Approximately 3 Years||0
10537522|NCT01449929|11690168|FG001|COMPLETED|Extension Phase Approximately 3 Years||0
10537523|NCT01449929|11690169|FG002|COMPLETED|Extension Phase Approximately 3 Years||115
10537524|NCT01449929|11690167|FG000|NOT COMPLETED|Extension Phase Approximately 3 Years||0
10537525|NCT01449929|11690168|FG001|NOT COMPLETED|Extension Phase Approximately 3 Years||0
10537526|NCT01449929|11690169|FG002|NOT COMPLETED|Extension Phase Approximately 3 Years||8
10537527|NCT01449955|11690181|FG000|STARTED|Overall Study||28
10537528|NCT01449955|11690182|FG001|STARTED|Overall Study||26
10537529|NCT01449955|11690181|FG000|COMPLETED|Overall Study||27
10537530|NCT01449955|11690182|FG001|COMPLETED|Overall Study||24
10537531|NCT01449955|11690181|FG000|NOT COMPLETED|Overall Study||1
10537532|NCT01449955|11690182|FG001|NOT COMPLETED|Overall Study||2
10537533|NCT01450007|11690198|FG000|STARTED|Overall Study||44
10537534|NCT01450007|11690199|FG001|STARTED|Overall Study||42
10537535|NCT01450007|11690200|FG002|STARTED|Overall Study||44
10537536|NCT01450007|11690198|FG000|COMPLETED|Overall Study||42
10537537|NCT01450007|11690199|FG001|COMPLETED|Overall Study||37
10537538|NCT01450007|11690200|FG002|COMPLETED|Overall Study||41
10537539|NCT01450007|11690198|FG000|NOT COMPLETED|Overall Study||2
10537540|NCT01450007|11690199|FG001|NOT COMPLETED|Overall Study||5
10537541|NCT01450007|11690200|FG002|NOT COMPLETED|Overall Study||3
10537542|NCT01450098|11690210|FG000|STARTED|Period 1||8
10537543|NCT01450098|11690211|FG001|STARTED|Period 1||31
10537544|NCT01450098|11690210|FG000|Received at Least 1 Dose of Study Drug|Period 1||8
10537545|NCT01450098|11690211|FG001|Received at Least 1 Dose of Study Drug|Period 1||31
10537546|NCT01450098|11690210|FG000|COMPLETED|Period 1||8
10537547|NCT01450098|11690211|FG001|COMPLETED|Period 1||31
10537548|NCT01450098|11690210|FG000|NOT COMPLETED|Period 1||0
10537549|NCT01450098|11690211|FG001|NOT COMPLETED|Period 1||0
10537550|NCT01450098|11690210|FG000|STARTED|Washout Period of at Least 14 Days||8
10537551|NCT01450098|11690211|FG001|STARTED|Washout Period of at Least 14 Days||31
10537552|NCT01450098|11690210|FG000|COMPLETED|Washout Period of at Least 14 Days||8
10537553|NCT01450098|11690211|FG001|COMPLETED|Washout Period of at Least 14 Days||31
10537554|NCT01450098|11690210|FG000|NOT COMPLETED|Washout Period of at Least 14 Days||0
10537555|NCT01450098|11690211|FG001|NOT COMPLETED|Washout Period of at Least 14 Days||0
10537556|NCT01450098|11690210|FG000|STARTED|Period 2||8
10537557|NCT01450098|11690211|FG001|STARTED|Period 2||31
10537558|NCT01450098|11690210|FG000|Received at Least 1 Dose of Study Drug|Period 2||8
10537559|NCT01450098|11690211|FG001|Received at Least 1 Dose of Study Drug|Period 2||31
10537560|NCT01450098|11690210|FG000|COMPLETED|Period 2||8
10537561|NCT01450098|11690211|FG001|COMPLETED|Period 2||31
10537562|NCT01450098|11690210|FG000|NOT COMPLETED|Period 2||0
10812615|NCT03466658|11974719|FG000|NOT COMPLETED|Overall Study||3
10537563|NCT01450098|11690211|FG001|NOT COMPLETED|Period 2||0
10537564|NCT01450098|11690210|FG000|STARTED|Washout of at Least 14 Days||8
10537565|NCT01450098|11690211|FG001|STARTED|Washout of at Least 14 Days||31
10537566|NCT01450098|11690210|FG000|COMPLETED|Washout of at Least 14 Days||8
10537567|NCT01450098|11690211|FG001|COMPLETED|Washout of at Least 14 Days||31
10537568|NCT01450098|11690210|FG000|NOT COMPLETED|Washout of at Least 14 Days||0
10537569|NCT01450098|11690211|FG001|NOT COMPLETED|Washout of at Least 14 Days||0
10537570|NCT01450098|11690210|FG000|STARTED|Period 3||8
10537571|NCT01450098|11690211|FG001|STARTED|Period 3||31
10537572|NCT01450098|11690210|FG000|Received at Least 1 Dose of Study Drug|Period 3||8
10537573|NCT01450098|11690211|FG001|Received at Least 1 Dose of Study Drug|Period 3||30
10657226|NCT02223871|11818409|FG000|STARTED|Overall Study||8
10371134|NCT00557622|11512170|FG000|STARTED|12-Week Treatment Phase||1
10537574|NCT01450098|11690210|FG000|COMPLETED|Period 3||8
10537575|NCT01450098|11690211|FG001|COMPLETED|Period 3||28
10812616|NCT03465891|11974727|FG000|STARTED|Overall Study||1
10371135|NCT00557622|11512171|FG001|STARTED|12-Week Treatment Phase||2
10371136|NCT00557622|11512170|FG000|COMPLETED|12-Week Treatment Phase||1
10371137|NCT00557622|11512171|FG001|COMPLETED|12-Week Treatment Phase||1
10371138|NCT00557622|11512170|FG000|NOT COMPLETED|12-Week Treatment Phase||0
10371139|NCT00557622|11512171|FG001|NOT COMPLETED|12-Week Treatment Phase||1
10371140|NCT00557830|11512180|FG000|STARTED|Screening Treatment Phase||12
10371141|NCT00557830|11512181|FG001|STARTED|Screening Treatment Phase||0
10371142|NCT00557830|11512182|FG002|STARTED|Screening Treatment Phase||0
10371143|NCT00557830|11512180|FG000|COMPLETED|Screening Treatment Phase||6
10371144|NCT00557830|11512181|FG001|COMPLETED|Screening Treatment Phase||0
10371145|NCT00557830|11512182|FG002|COMPLETED|Screening Treatment Phase||0
10371146|NCT00557830|11512180|FG000|NOT COMPLETED|Screening Treatment Phase||6
10371147|NCT00557830|11512181|FG001|NOT COMPLETED|Screening Treatment Phase||0
10371148|NCT00557830|11512182|FG002|NOT COMPLETED|Screening Treatment Phase||0
10371149|NCT00557830|11512180|FG000|STARTED|Treatment Phase||0
10371150|NCT00557830|11512181|FG001|STARTED|Treatment Phase||4
10371151|NCT00557830|11512182|FG002|STARTED|Treatment Phase||2
10371152|NCT00557830|11512180|FG000|COMPLETED|Treatment Phase||0
10371153|NCT00557830|11512181|FG001|COMPLETED|Treatment Phase||4
10371154|NCT00557830|11512182|FG002|COMPLETED|Treatment Phase||2
10371155|NCT00557830|11512180|FG000|NOT COMPLETED|Treatment Phase||0
10371156|NCT00557830|11512181|FG001|NOT COMPLETED|Treatment Phase||0
10371157|NCT00557830|11512182|FG002|NOT COMPLETED|Treatment Phase||0
10371158|NCT00557856|11512190|FG000|STARTED|Part 1: Dose Escalation Phase||7
10371159|NCT00557856|11512191|FG001|STARTED|Part 1: Dose Escalation Phase||5
10371160|NCT00557856|11512192|FG002|STARTED|Part 1: Dose Escalation Phase||6
10371161|NCT00557856|11512193|FG003|STARTED|Part 1: Dose Escalation Phase||3
10371162|NCT00557856|11512194|FG004|STARTED|Part 1: Dose Escalation Phase||4
10371163|NCT00557856|11512195|FG005|STARTED|Part 1: Dose Escalation Phase||8
10371164|NCT00557856|11512196|FG006|STARTED|Part 1: Dose Escalation Phase||7
10371165|NCT00557856|11512197|FG007|STARTED|Part 1: Dose Escalation Phase||6
10371166|NCT00557856|11512198|FG008|STARTED|Part 1: Dose Escalation Phase||0
10371167|NCT00557856|11512190|FG000|Treated|Part 1: Dose Escalation Phase||5
10371168|NCT00557856|11512191|FG001|Treated|Part 1: Dose Escalation Phase||5
10371169|NCT00557856|11512192|FG002|Treated|Part 1: Dose Escalation Phase||6
10371170|NCT00557856|11512193|FG003|Treated|Part 1: Dose Escalation Phase||3
10371171|NCT00557856|11512194|FG004|Treated|Part 1: Dose Escalation Phase||4
10371172|NCT00557856|11512195|FG005|Treated|Part 1: Dose Escalation Phase||8
10371173|NCT00557856|11512196|FG006|Treated|Part 1: Dose Escalation Phase||7
10371174|NCT00557856|11512197|FG007|Treated|Part 1: Dose Escalation Phase||6
10371175|NCT00557856|11512198|FG008|Treated|Part 1: Dose Escalation Phase||0
10371176|NCT00557856|11512190|FG000|COMPLETED|Part 1: Dose Escalation Phase||0
10371177|NCT00557856|11512191|FG001|COMPLETED|Part 1: Dose Escalation Phase||0
10371178|NCT00557856|11512192|FG002|COMPLETED|Part 1: Dose Escalation Phase||0
10371179|NCT00557856|11512193|FG003|COMPLETED|Part 1: Dose Escalation Phase||0
10371180|NCT00557856|11512194|FG004|COMPLETED|Part 1: Dose Escalation Phase||0
10371181|NCT00557856|11512195|FG005|COMPLETED|Part 1: Dose Escalation Phase||0
10371182|NCT00557856|11512196|FG006|COMPLETED|Part 1: Dose Escalation Phase||0
10371183|NCT00557856|11512197|FG007|COMPLETED|Part 1: Dose Escalation Phase||0
10371184|NCT00557856|11512198|FG008|COMPLETED|Part 1: Dose Escalation Phase||0
10371185|NCT00557856|11512190|FG000|NOT COMPLETED|Part 1: Dose Escalation Phase||7
10371186|NCT00557856|11512191|FG001|NOT COMPLETED|Part 1: Dose Escalation Phase||5
10371187|NCT00557856|11512192|FG002|NOT COMPLETED|Part 1: Dose Escalation Phase||6
10371188|NCT00557856|11512193|FG003|NOT COMPLETED|Part 1: Dose Escalation Phase||3
10371189|NCT00557856|11512194|FG004|NOT COMPLETED|Part 1: Dose Escalation Phase||4
10371190|NCT00557856|11512195|FG005|NOT COMPLETED|Part 1: Dose Escalation Phase||8
10371191|NCT00557856|11512196|FG006|NOT COMPLETED|Part 1: Dose Escalation Phase||7
10371192|NCT00557856|11512197|FG007|NOT COMPLETED|Part 1: Dose Escalation Phase||6
10371193|NCT00557856|11512198|FG008|NOT COMPLETED|Part 1: Dose Escalation Phase||0
10371194|NCT00557856|11512190|FG000|STARTED|Part 2: Exploratory Phase||0
10371195|NCT00557856|11512191|FG001|STARTED|Part 2: Exploratory Phase||0
10371196|NCT00557856|11512192|FG002|STARTED|Part 2: Exploratory Phase||0
10371197|NCT00557856|11512193|FG003|STARTED|Part 2: Exploratory Phase||0
10371198|NCT00557856|11512194|FG004|STARTED|Part 2: Exploratory Phase||0
10371199|NCT00557856|11512195|FG005|STARTED|Part 2: Exploratory Phase||0
10371200|NCT00557856|11512196|FG006|STARTED|Part 2: Exploratory Phase||0
10371201|NCT00557856|11512197|FG007|STARTED|Part 2: Exploratory Phase||0
10371202|NCT00557856|11512198|FG008|STARTED|Part 2: Exploratory Phase||24
10371203|NCT00557856|11512190|FG000|COMPLETED|Part 2: Exploratory Phase||0
10371204|NCT00557856|11512191|FG001|COMPLETED|Part 2: Exploratory Phase||0
10371205|NCT00557856|11512192|FG002|COMPLETED|Part 2: Exploratory Phase||0
10371206|NCT00557856|11512193|FG003|COMPLETED|Part 2: Exploratory Phase||0
10371207|NCT00557856|11512194|FG004|COMPLETED|Part 2: Exploratory Phase||0
10371208|NCT00557856|11512195|FG005|COMPLETED|Part 2: Exploratory Phase||0
10371209|NCT00557856|11512196|FG006|COMPLETED|Part 2: Exploratory Phase||0
10371210|NCT00557856|11512197|FG007|COMPLETED|Part 2: Exploratory Phase||0
10657227|NCT02223871|11818409|FG000|COMPLETED|Overall Study||8
10371211|NCT00557856|11512198|FG008|COMPLETED|Part 2: Exploratory Phase||0
10371212|NCT00557856|11512190|FG000|NOT COMPLETED|Part 2: Exploratory Phase||0
10371213|NCT00557856|11512191|FG001|NOT COMPLETED|Part 2: Exploratory Phase||0
10371214|NCT00557856|11512192|FG002|NOT COMPLETED|Part 2: Exploratory Phase||0
10371215|NCT00557856|11512193|FG003|NOT COMPLETED|Part 2: Exploratory Phase||0
10657228|NCT02223871|11818409|FG000|NOT COMPLETED|Overall Study||0
10371216|NCT00557856|11512194|FG004|NOT COMPLETED|Part 2: Exploratory Phase||0
10371217|NCT00557856|11512195|FG005|NOT COMPLETED|Part 2: Exploratory Phase||0
10371218|NCT00557856|11512196|FG006|NOT COMPLETED|Part 2: Exploratory Phase||0
10371219|NCT00557856|11512197|FG007|NOT COMPLETED|Part 2: Exploratory Phase||0
10371220|NCT00557856|11512198|FG008|NOT COMPLETED|Part 2: Exploratory Phase||24
10371221|NCT00557882|11512215|FG000|STARTED|Overall Study||32
10371222|NCT00557882|11512216|FG001|STARTED|Overall Study||33
10371223|NCT00557882|11512215|FG000|COMPLETED|Overall Study||27
10371224|NCT00557882|11512216|FG001|COMPLETED|Overall Study||33
10371225|NCT00557882|11512215|FG000|NOT COMPLETED|Overall Study||5
10371226|NCT00557882|11512216|FG001|NOT COMPLETED|Overall Study||0
10371227|NCT00557947|11512222|FG000|STARTED|Overall Study||83
10371228|NCT00557947|11512222|FG000|COMPLETED|Overall Study||83
10371229|NCT00557947|11512222|FG000|NOT COMPLETED|Overall Study||0
10371230|NCT00558012|11512232|FG000|STARTED|Overall Study||89
10371231|NCT00558012|11512233|FG001|STARTED|Overall Study||92
10371232|NCT00558012|11512232|FG000|COMPLETED|Overall Study||64
10371233|NCT00558012|11512233|FG001|COMPLETED|Overall Study||74
10371234|NCT00558012|11512232|FG000|NOT COMPLETED|Overall Study||25
10371235|NCT00558012|11512233|FG001|NOT COMPLETED|Overall Study||18
10371236|NCT00558025|11512241|FG000|STARTED|Overall Study||104
10371237|NCT00558025|11512242|FG001|STARTED|Overall Study||52
10371238|NCT00558025|11512241|FG000|COMPLETED|Overall Study||100
10371239|NCT00558025|11512242|FG001|COMPLETED|Overall Study||49
10371240|NCT00558025|11512241|FG000|NOT COMPLETED|Overall Study||4
10371241|NCT00558025|11512242|FG001|NOT COMPLETED|Overall Study||3
10371242|NCT00558064|11512250|FG000|STARTED|Overall Study||269
10371243|NCT00558064|11512251|FG001|STARTED|Overall Study||262
10371244|NCT00558064|11512250|FG000|COMPLETED|Overall Study||264
10371245|NCT00558064|11512251|FG001|COMPLETED|Overall Study||257
10371246|NCT00558064|11512250|FG000|NOT COMPLETED|Overall Study||5
10371247|NCT00558064|11512251|FG001|NOT COMPLETED|Overall Study||5
10371248|NCT00558103|11512262|FG000|STARTED|Randomized Treatment Phase||38
10371249|NCT00558103|11512263|FG001|STARTED|Randomized Treatment Phase||38
10371250|NCT00558103|11512264|FG002|STARTED|Randomized Treatment Phase||36
10371251|NCT00558103|11512265|FG003|STARTED|Randomized Treatment Phase||13
10371252|NCT00558103|11512266|FG004|STARTED|Randomized Treatment Phase||38
10371253|NCT00558103|11512267|FG005|STARTED|Randomized Treatment Phase||0
10371254|NCT00558103|11512262|FG000|COMPLETED|Randomized Treatment Phase||33
10371255|NCT00558103|11512263|FG001|COMPLETED|Randomized Treatment Phase||34
10371256|NCT00558103|11512264|FG002|COMPLETED|Randomized Treatment Phase||33
10371257|NCT00558103|11512265|FG003|COMPLETED|Randomized Treatment Phase||11
10371258|NCT00558103|11512266|FG004|COMPLETED|Randomized Treatment Phase||33
10371259|NCT00558103|11512267|FG005|COMPLETED|Randomized Treatment Phase||0
10371260|NCT00558103|11512262|FG000|NOT COMPLETED|Randomized Treatment Phase||5
10371261|NCT00558103|11512263|FG001|NOT COMPLETED|Randomized Treatment Phase||4
10371262|NCT00558103|11512264|FG002|NOT COMPLETED|Randomized Treatment Phase||3
10371263|NCT00558103|11512265|FG003|NOT COMPLETED|Randomized Treatment Phase||2
10371264|NCT00558103|11512266|FG004|NOT COMPLETED|Randomized Treatment Phase||5
10371265|NCT00558103|11512267|FG005|NOT COMPLETED|Randomized Treatment Phase||0
10371266|NCT00558103|11512262|FG000|STARTED|Monotherapy Extension Phase||0
10371267|NCT00558103|11512263|FG001|STARTED|Monotherapy Extension Phase||0
10371268|NCT00558103|11512264|FG002|STARTED|Monotherapy Extension Phase||0
10371269|NCT00558103|11512265|FG003|STARTED|Monotherapy Extension Phase||0
10371270|NCT00558103|11512266|FG004|STARTED|Monotherapy Extension Phase||0
10371271|NCT00558103|11512267|FG005|STARTED|Monotherapy Extension Phase|9/11 participants completing pazopanib monotherapy elected to receive lapatinib monotherapy.|9
10371272|NCT00558103|11512262|FG000|COMPLETED|Monotherapy Extension Phase||0
10371273|NCT00558103|11512263|FG001|COMPLETED|Monotherapy Extension Phase||0
10371274|NCT00558103|11512264|FG002|COMPLETED|Monotherapy Extension Phase||0
10371275|NCT00558103|11512265|FG003|COMPLETED|Monotherapy Extension Phase||0
10371276|NCT00558103|11512266|FG004|COMPLETED|Monotherapy Extension Phase||0
10371277|NCT00558103|11512267|FG005|COMPLETED|Monotherapy Extension Phase||0
10371278|NCT00558103|11512262|FG000|NOT COMPLETED|Monotherapy Extension Phase||0
10371279|NCT00558103|11512263|FG001|NOT COMPLETED|Monotherapy Extension Phase||0
10371280|NCT00558103|11512264|FG002|NOT COMPLETED|Monotherapy Extension Phase||0
10371281|NCT00558103|11512265|FG003|NOT COMPLETED|Monotherapy Extension Phase||0
10371282|NCT00558103|11512266|FG004|NOT COMPLETED|Monotherapy Extension Phase||0
10371283|NCT00558103|11512267|FG005|NOT COMPLETED|Monotherapy Extension Phase||9
10371284|NCT00558246|11512280|FG000|STARTED|Overall Study||79
10371285|NCT00558246|11512280|FG000|COMPLETED|Overall Study||79
10371286|NCT00558246|11512280|FG000|NOT COMPLETED|Overall Study||0
10371287|NCT00558259|11512289|FG000|STARTED|Overall Study|Number who started treatment. There were 4 patients randomised to Dabigatran and not treated.|681
10371288|NCT00558259|11512290|FG001|STARTED|Overall Study|Number who started treatment. There were 6 patients randomised to placebo and not treated.|662
10371289|NCT00558259|11512289|FG000|COMPLETED|Overall Study|Completed treatment.|610
10371290|NCT00558259|11512290|FG001|COMPLETED|Overall Study|Completed treatment.|563
10371291|NCT00558259|11512289|FG000|NOT COMPLETED|Overall Study||71
10371292|NCT00558259|11512290|FG001|NOT COMPLETED|Overall Study||99
10371293|NCT00558272|11512298|FG000|STARTED|Overall Study|Randomised|69
10371294|NCT00558272|11512299|FG001|STARTED|Overall Study|Randomised|70
10371295|NCT00558272|11512298|FG000|30 Days Follow-up|Overall Study|30 days after last dose|41
10371296|NCT00558272|11512299|FG001|30 Days Follow-up|Overall Study|30 days after last dose|67
10371297|NCT00558272|11512298|FG000|COMPLETED|Overall Study|4-week treatment period|56
10716854|NCT02692586|11880728|FG000|COMPLETED|Overall Study||103
10716855|NCT02692586|11880728|FG000|NOT COMPLETED|Overall Study||3
10716856|NCT02692703|11880732|FG000|STARTED|Overall Study||100
10716857|NCT02692703|11880732|FG000|COMPLETED|Overall Study||98
10716858|NCT02692703|11880732|FG000|NOT COMPLETED|Overall Study||2
10716869|NCT02692755|11880745|FG000|STARTED|Overall Study||35
10716870|NCT02692755|11880745|FG000|COMPLETED|Overall Study||35
10716871|NCT02692755|11880745|FG000|NOT COMPLETED|Overall Study||0
10716872|NCT02692859|11880752|FG000|STARTED|Overall Study||996
10716873|NCT02692859|11880753|FG001|STARTED|Overall Study||996
10716874|NCT02692859|11880752|FG000|COMPLETED|Overall Study||912
10371298|NCT00558272|11512299|FG001|COMPLETED|Overall Study|4-week treatment period|68
10371299|NCT00558272|11512298|FG000|NOT COMPLETED|Overall Study||13
10371300|NCT00558272|11512299|FG001|NOT COMPLETED|Overall Study||2
10371301|NCT00558285|11512310|FG000|STARTED|Overall Study||50
10371302|NCT00558285|11512311|FG001|STARTED|Overall Study||51
10371303|NCT00558285|11512312|FG002|STARTED|Overall Study||51
10371304|NCT00558285|11512313|FG003|STARTED|Overall Study||52
10371305|NCT00558285|11512314|FG004|STARTED|Overall Study||53
10371306|NCT00558285|11512310|FG000|Safety: Received Study Drug|Overall Study||49
10371307|NCT00558285|11512311|FG001|Safety: Received Study Drug|Overall Study||51
10371308|NCT00558285|11512312|FG002|Safety: Received Study Drug|Overall Study||51
10371309|NCT00558285|11512313|FG003|Safety: Received Study Drug|Overall Study||51
10371310|NCT00558285|11512314|FG004|Safety: Received Study Drug|Overall Study||53
10371311|NCT00558285|11512310|FG000|COMPLETED|Overall Study||44
10371312|NCT00558285|11512311|FG001|COMPLETED|Overall Study||48
10371313|NCT00558285|11512312|FG002|COMPLETED|Overall Study||46
10371314|NCT00558285|11512313|FG003|COMPLETED|Overall Study||48
10537576|NCT01450098|11690210|FG000|NOT COMPLETED|Period 3||0
10537577|NCT01450098|11690211|FG001|NOT COMPLETED|Period 3||3
10537578|NCT01450137|11690226|FG000|STARTED|Up to Week 12||20
10537579|NCT01450137|11690227|FG001|STARTED|Up to Week 12||10
10537580|NCT01450137|11690226|FG000|COMPLETED|Up to Week 12||18
10537581|NCT01450137|11690227|FG001|COMPLETED|Up to Week 12||7
10537582|NCT01450137|11690226|FG000|NOT COMPLETED|Up to Week 12||2
10537583|NCT01450137|11690227|FG001|NOT COMPLETED|Up to Week 12||3
10537584|NCT01450137|11690226|FG000|STARTED|Week 12 to Study End||18
10537585|NCT01450137|11690227|FG001|STARTED|Week 12 to Study End||7
10537586|NCT01450137|11690226|FG000|COMPLETED|Week 12 to Study End||18
10537587|NCT01450137|11690227|FG001|COMPLETED|Week 12 to Study End||5
10537588|NCT01450137|11690226|FG000|NOT COMPLETED|Week 12 to Study End||0
10537589|NCT01450137|11690227|FG001|NOT COMPLETED|Week 12 to Study End||2
10537590|NCT01450189|11690236|FG000|STARTED|Overall Study||9
10537591|NCT01450189|11690237|FG001|STARTED|Overall Study||18
10537592|NCT01450189|11690238|FG002|STARTED|Overall Study||19
10537593|NCT01450189|11690236|FG000|COMPLETED|Overall Study||9
10537594|NCT01450189|11690237|FG001|COMPLETED|Overall Study||18
10537595|NCT01450189|11690238|FG002|COMPLETED|Overall Study||19
10537596|NCT01450189|11690236|FG000|NOT COMPLETED|Overall Study||0
10537597|NCT01450189|11690237|FG001|NOT COMPLETED|Overall Study||0
10537598|NCT01450189|11690238|FG002|NOT COMPLETED|Overall Study||0
10537599|NCT01450306|11690255|FG000|STARTED|Overall Study||10
10537600|NCT01450306|11690256|FG001|STARTED|Overall Study||10
10537601|NCT01450306|11690255|FG000|COMPLETED|Overall Study||10
10537602|NCT01450306|11690256|FG001|COMPLETED|Overall Study||10
10537603|NCT01450306|11690255|FG000|NOT COMPLETED|Overall Study||0
10537604|NCT01450306|11690256|FG001|NOT COMPLETED|Overall Study||0
10537605|NCT01450319|11690262|FG000|STARTED|Overall Study||70
10537606|NCT01450319|11690262|FG000|COMPLETED|Overall Study||70
10537607|NCT01450319|11690262|FG000|NOT COMPLETED|Overall Study||0
10537608|NCT01450397|11690266|FG000|STARTED|Overall Study||5
10537609|NCT01450397|11690266|FG000|COMPLETED|Overall Study||5
10537610|NCT01450397|11690266|FG000|NOT COMPLETED|Overall Study||0
10537611|NCT01450540|11690272|FG000|STARTED|Overall Study||123
10371315|NCT00558285|11512314|FG004|COMPLETED|Overall Study||49
10537612|NCT01450540|11690273|FG001|STARTED|Overall Study||118
10537613|NCT01450540|11690272|FG000|COMPLETED|Overall Study||101
10537614|NCT01450540|11690273|FG001|COMPLETED|Overall Study||82
10537615|NCT01450540|11690272|FG000|NOT COMPLETED|Overall Study||22
10716875|NCT02692859|11880753|FG001|COMPLETED|Overall Study||901
10716876|NCT02692859|11880752|FG000|NOT COMPLETED|Overall Study||84
10716877|NCT02692859|11880753|FG001|NOT COMPLETED|Overall Study||95
10716878|NCT02693106|11880759|FG000|STARTED|Overall Study||13
10371316|NCT00558285|11512310|FG000|NOT COMPLETED|Overall Study||6
10371317|NCT00558285|11512311|FG001|NOT COMPLETED|Overall Study||3
10371318|NCT00558285|11512312|FG002|NOT COMPLETED|Overall Study||5
10537616|NCT01450540|11690273|FG001|NOT COMPLETED|Overall Study||36
10716879|NCT02693106|11880759|FG000|COMPLETED|Overall Study||10
10716880|NCT02693106|11880759|FG000|NOT COMPLETED|Overall Study||3
10716881|NCT02693119|11880771|FG000|STARTED|Double-Blind Period||8
10371319|NCT00558285|11512313|FG003|NOT COMPLETED|Overall Study||4
10371320|NCT00558285|11512314|FG004|NOT COMPLETED|Overall Study||4
10371321|NCT00558363|11512328|FG000|STARTED|Overall Study||147
10371322|NCT00558363|11512329|FG001|STARTED|Overall Study||147
10371323|NCT00558363|11512328|FG000|COMPLETED|Overall Study||76
10371324|NCT00558363|11512329|FG001|COMPLETED|Overall Study||111
10371325|NCT00558363|11512328|FG000|NOT COMPLETED|Overall Study||71
10371326|NCT00558363|11512329|FG001|NOT COMPLETED|Overall Study||36
10371327|NCT00558428|11512339|FG000|STARTED|Overall Study||267
10371328|NCT00558428|11512340|FG001|STARTED|Overall Study||276
10371329|NCT00558428|11512341|FG002|STARTED|Overall Study||277
10371330|NCT00558428|11512342|FG003|STARTED|Overall Study||277
10371331|NCT00558428|11512339|FG000|COMPLETED|Overall Study||255
10371332|NCT00558428|11512340|FG001|COMPLETED|Overall Study||252
10371333|NCT00558428|11512341|FG002|COMPLETED|Overall Study||273
10371334|NCT00558428|11512342|FG003|COMPLETED|Overall Study||266
10371335|NCT00558428|11512339|FG000|NOT COMPLETED|Overall Study||12
10371336|NCT00558428|11512340|FG001|NOT COMPLETED|Overall Study||24
10371337|NCT00558428|11512341|FG002|NOT COMPLETED|Overall Study||4
10371338|NCT00558428|11512342|FG003|NOT COMPLETED|Overall Study||11
10371339|NCT00558467|11512354|FG000|STARTED|Overall Study||20
10371340|NCT00558467|11512355|FG001|STARTED|Overall Study||43
10371341|NCT00558467|11512354|FG000|COMPLETED|Overall Study||19
10371342|NCT00558467|11512355|FG001|COMPLETED|Overall Study||39
10371343|NCT00558467|11512354|FG000|NOT COMPLETED|Overall Study||1
10371344|NCT00558467|11512355|FG001|NOT COMPLETED|Overall Study||4
10371345|NCT00558519|11512361|FG000|STARTED|Overall Study||318
10371346|NCT00558519|11512361|FG000|COMPLETED|Overall Study||295
10371347|NCT00558519|11512361|FG000|NOT COMPLETED|Overall Study||23
10371348|NCT00558571|11512369|FG000|STARTED|Overall Study||16
10371349|NCT00558571|11512370|FG001|STARTED|Overall Study||16
10371350|NCT00558571|11512371|FG002|STARTED|Overall Study||16
10371351|NCT00558571|11512372|FG003|STARTED|Overall Study||30
10371352|NCT00558571|11512369|FG000|COMPLETED|Overall Study||16
10371353|NCT00558571|11512370|FG001|COMPLETED|Overall Study||16
10537623|NCT01450683|11690290|FG000|STARTED|Overall Study||4
10537624|NCT01450683|11690290|FG000|COMPLETED|Overall Study||2
10537625|NCT01450683|11690290|FG000|NOT COMPLETED|Overall Study||2
10537626|NCT01450696|11690296|FG000|STARTED|Overall Study||148
10537627|NCT01450696|11690297|FG001|STARTED|Overall Study||148
10537628|NCT01450696|11690296|FG000|Treated (Safety Population)|Overall Study||147
10537629|NCT01450696|11690297|FG001|Treated (Safety Population)|Overall Study||147
10537630|NCT01450696|11690296|FG000|COMPLETED|Overall Study||0
10537631|NCT01450696|11690297|FG001|COMPLETED|Overall Study||0
10537632|NCT01450696|11690296|FG000|NOT COMPLETED|Overall Study||148
10537633|NCT01450696|11690297|FG001|NOT COMPLETED|Overall Study||148
10537634|NCT01450761|11690305|FG000|STARTED|Randomization||566
10537635|NCT01450761|11690306|FG001|STARTED|Randomization||566
10537636|NCT01450761|11690305|FG000|COMPLETED|Randomization||562
10537637|NCT01450761|11690306|FG001|COMPLETED|Randomization||561
10537638|NCT01450761|11690305|FG000|NOT COMPLETED|Randomization||4
10537639|NCT01450761|11690306|FG001|NOT COMPLETED|Randomization||5
10537640|NCT01450761|11690305|FG000|STARTED|Lead-in Chemotherapy||562
10537641|NCT01450761|11690306|FG001|STARTED|Lead-in Chemotherapy||561
10537642|NCT01450761|11690305|FG000|COMPLETED|Lead-in Chemotherapy||478
10537643|NCT01450761|11690306|FG001|COMPLETED|Lead-in Chemotherapy||476
10537644|NCT01450761|11690305|FG000|NOT COMPLETED|Lead-in Chemotherapy||84
10537645|NCT01450761|11690306|FG001|NOT COMPLETED|Lead-in Chemotherapy||85
10537646|NCT01450761|11690305|FG000|STARTED|Treatment With Blinded Study Therapy||478
10537647|NCT01450761|11690306|FG001|STARTED|Treatment With Blinded Study Therapy||476
10537648|NCT01450761|11690305|FG000|COMPLETED|Treatment With Blinded Study Therapy||0
10537649|NCT01450761|11690306|FG001|COMPLETED|Treatment With Blinded Study Therapy||0
10537650|NCT01450761|11690305|FG000|NOT COMPLETED|Treatment With Blinded Study Therapy||478
10537651|NCT01450761|11690306|FG001|NOT COMPLETED|Treatment With Blinded Study Therapy||476
10537652|NCT01450787|11690314|FG000|STARTED|Overall Study||38
10537653|NCT01450787|11690315|FG001|STARTED|Overall Study||25
10657229|NCT02224053|11818413|FG000|STARTED|AZD9291 and Omeprazole Co-administration||68
10657230|NCT02224053|11818413|FG000|COMPLETED|AZD9291 and Omeprazole Co-administration||47
10657231|NCT02224053|11818413|FG000|NOT COMPLETED|AZD9291 and Omeprazole Co-administration||21
10657232|NCT02224053|11818413|FG000|STARTED|AZD9291 Alone||47
10371354|NCT00558571|11512371|FG002|COMPLETED|Overall Study||16
10371355|NCT00558571|11512372|FG003|COMPLETED|Overall Study||30
10371356|NCT00558571|11512369|FG000|NOT COMPLETED|Overall Study||0
10371357|NCT00558571|11512370|FG001|NOT COMPLETED|Overall Study||0
10371358|NCT00558571|11512371|FG002|NOT COMPLETED|Overall Study||0
10537654|NCT01450787|11690314|FG000|COMPLETED|Overall Study||38
10537655|NCT01450787|11690315|FG001|COMPLETED|Overall Study||25
10371359|NCT00558571|11512372|FG003|NOT COMPLETED|Overall Study||0
10371360|NCT00558636|11512395|FG000|STARTED|Treatment|up to 6 cycles of combination therapy|47
10371361|NCT00558636|11512396|FG001|STARTED|Treatment||44
10371362|NCT00558636|11512395|FG000|Start of Maintenance Monotherapy|Treatment|Sorafenib taken as the single agent in the Maintenance Phase|2
10537656|NCT01450787|11690314|FG000|NOT COMPLETED|Overall Study||0
10537657|NCT01450787|11690315|FG001|NOT COMPLETED|Overall Study||0
10537658|NCT01450800|11690323|FG000|STARTED|Overall Study|82 participants were randomized to nitrofurantoin|82
10371363|NCT00558636|11512396|FG001|Start of Maintenance Monotherapy|Treatment|Placebo taken as the single agent in the Maintenance Phase|2
10371364|NCT00558636|11512395|FG000|COMPLETED|Treatment|Patients still on treatment did not enter follow-up because the study was prematurely terminated|0
10371365|NCT00558636|11512396|FG001|COMPLETED|Treatment|Patients still on treatment did not enter follow-up because the study was prematurely terminated|0
10371366|NCT00558636|11512395|FG000|NOT COMPLETED|Treatment||47
10371367|NCT00558636|11512396|FG001|NOT COMPLETED|Treatment||44
10371368|NCT00558636|11512395|FG000|STARTED|Follow-up|12 subjects entered Follow-up phase before they completed the treatment phase|12
10371369|NCT00558636|11512396|FG001|STARTED|Follow-up|7 subjects entered Follow-up phase before they completed the treatment phase|7
10371370|NCT00558636|11512395|FG000|COMPLETED|Follow-up|Study was prematurely terminated|0
10371371|NCT00558636|11512396|FG001|COMPLETED|Follow-up|Study was prematurely terminated|0
10371372|NCT00558636|11512395|FG000|NOT COMPLETED|Follow-up||12
10371373|NCT00558636|11512396|FG001|NOT COMPLETED|Follow-up||7
10371374|NCT00558701|11512404|FG000|STARTED|Overall Study||15
10371375|NCT00558701|11512405|FG001|STARTED|Overall Study||15
10371376|NCT00558701|11512404|FG000|COMPLETED|Overall Study||14
10371377|NCT00558701|11512405|FG001|COMPLETED|Overall Study||11
10371378|NCT00558701|11512404|FG000|NOT COMPLETED|Overall Study||1
10371379|NCT00558701|11512405|FG001|NOT COMPLETED|Overall Study||4
10371380|NCT00558753|11512413|FG000|STARTED|Overall Study||120
10371381|NCT00558753|11512414|FG001|STARTED|Overall Study||120
10371382|NCT00558753|11512413|FG000|COMPLETED|Overall Study||115
10371383|NCT00558753|11512414|FG001|COMPLETED|Overall Study||113
10371384|NCT00558753|11512413|FG000|NOT COMPLETED|Overall Study||5
10371385|NCT00558753|11512414|FG001|NOT COMPLETED|Overall Study||7
10371386|NCT00558792|11512423|FG000|STARTED|Overall Study||68
10371387|NCT00558792|11512424|FG001|STARTED|Overall Study||63
10371388|NCT00558792|11512425|FG002|STARTED|Overall Study||60
10371389|NCT00558792|11512423|FG000|COMPLETED|Overall Study||68
10371390|NCT00558792|11512424|FG001|COMPLETED|Overall Study||63
10371391|NCT00558792|11512425|FG002|COMPLETED|Overall Study||60
10371392|NCT00558792|11512423|FG000|NOT COMPLETED|Overall Study||0
10371393|NCT00558792|11512424|FG001|NOT COMPLETED|Overall Study||0
10371394|NCT00558792|11512425|FG002|NOT COMPLETED|Overall Study||0
10371395|NCT00558831|11512436|FG000|STARTED|Overall Study||11
10371396|NCT00558831|11512436|FG000|COMPLETED|Overall Study||10
10371397|NCT00558831|11512436|FG000|NOT COMPLETED|Overall Study||1
10371398|NCT00558844|11512447|FG000|STARTED|Overall Study||15
10371399|NCT00558844|11512448|FG001|STARTED|Overall Study||7
10371400|NCT00558844|11512449|FG002|STARTED|Overall Study||7
10371401|NCT00558844|11512450|FG003|STARTED|Overall Study||5
10371402|NCT00558844|11512451|FG004|STARTED|Overall Study||7
10371403|NCT00558844|11512447|FG000|COMPLETED|Overall Study||12
10371404|NCT00558844|11512448|FG001|COMPLETED|Overall Study||7
10371405|NCT00558844|11512449|FG002|COMPLETED|Overall Study||6
10371406|NCT00558844|11512450|FG003|COMPLETED|Overall Study||5
10371407|NCT00558844|11512451|FG004|COMPLETED|Overall Study||6
10371408|NCT00558844|11512447|FG000|NOT COMPLETED|Overall Study||3
10371409|NCT00558844|11512448|FG001|NOT COMPLETED|Overall Study||0
10371410|NCT00558844|11512449|FG002|NOT COMPLETED|Overall Study||1
10371411|NCT00558844|11512450|FG003|NOT COMPLETED|Overall Study||0
10371412|NCT00558844|11512451|FG004|NOT COMPLETED|Overall Study||1
10371413|NCT00558896|11512471|FG000|STARTED|Overall Study||60
10371414|NCT00558896|11512472|FG001|STARTED|Overall Study||34
10371415|NCT00558896|11512473|FG002|STARTED|Overall Study||35
10371416|NCT00558896|11512474|FG003|STARTED|Overall Study||35
10371417|NCT00558896|11512475|FG004|STARTED|Overall Study||60
10371418|NCT00558896|11512476|FG005|STARTED|Overall Study||120
10371419|NCT00558896|11512477|FG006|STARTED|Overall Study||33
10371420|NCT00558896|11512471|FG000|COMPLETED|Overall Study||39
10371421|NCT00558896|11512472|FG001|COMPLETED|Overall Study||27
10371422|NCT00558896|11512473|FG002|COMPLETED|Overall Study||30
10371423|NCT00558896|11512474|FG003|COMPLETED|Overall Study||23
10371424|NCT00558896|11512475|FG004|COMPLETED|Overall Study||37
10371425|NCT00558896|11512476|FG005|COMPLETED|Overall Study||68
10371426|NCT00558896|11512477|FG006|COMPLETED|Overall Study||9
10371427|NCT00558896|11512471|FG000|NOT COMPLETED|Overall Study||21
10371428|NCT00558896|11512472|FG001|NOT COMPLETED|Overall Study||7
10371429|NCT00558896|11512473|FG002|NOT COMPLETED|Overall Study||5
10371430|NCT00558896|11512474|FG003|NOT COMPLETED|Overall Study||12
10371431|NCT00558896|11512475|FG004|NOT COMPLETED|Overall Study||23
10371432|NCT00558896|11512476|FG005|NOT COMPLETED|Overall Study||52
10371433|NCT00558896|11512477|FG006|NOT COMPLETED|Overall Study||24
10371434|NCT00559013|11512493|FG000|STARTED|Overall Study||38
10371435|NCT00559013|11512493|FG000|COMPLETED|Overall Study||38
10371436|NCT00559013|11512493|FG000|NOT COMPLETED|Overall Study||0
10371437|NCT00559104|11512499|FG000|STARTED|Overall Study||55
10371438|NCT00559104|11512500|FG001|STARTED|Overall Study||5
10371439|NCT00559104|11512499|FG000|COMPLETED|Overall Study|Progression was the reason for off-treatment for 9 of 9 patients who went off of treatment.|46
10371440|NCT00559104|11512500|FG001|COMPLETED|Overall Study||5
10371441|NCT00559104|11512499|FG000|NOT COMPLETED|Overall Study||9
10371442|NCT00559104|11512500|FG001|NOT COMPLETED|Overall Study||0
10371443|NCT00559273|11512508|FG000|STARTED|Correction Period (20 Weeks)||153
10371444|NCT00559273|11512509|FG001|STARTED|Correction Period (20 Weeks)||154
10371445|NCT00559273|11512508|FG000|Treated|Correction Period (20 Weeks)||151
10371446|NCT00559273|11512509|FG001|Treated|Correction Period (20 Weeks)||154
10371447|NCT00559273|11512508|FG000|COMPLETED|Correction Period (20 Weeks)||144
10371448|NCT00559273|11512509|FG001|COMPLETED|Correction Period (20 Weeks)||142
10371449|NCT00559273|11512508|FG000|NOT COMPLETED|Correction Period (20 Weeks)||9
10371450|NCT00559273|11512509|FG001|NOT COMPLETED|Correction Period (20 Weeks)||12
10371451|NCT00559273|11512508|FG000|STARTED|Evaluation Period (8 Weeks)||144
10371452|NCT00559273|11512509|FG001|STARTED|Evaluation Period (8 Weeks)||142
10371453|NCT00559273|11512508|FG000|COMPLETED|Evaluation Period (8 Weeks)||141
10371454|NCT00559273|11512509|FG001|COMPLETED|Evaluation Period (8 Weeks)||137
10371455|NCT00559273|11512508|FG000|NOT COMPLETED|Evaluation Period (8 Weeks)||3
10371456|NCT00559273|11512509|FG001|NOT COMPLETED|Evaluation Period (8 Weeks)||5
10371457|NCT00559364|11512517|FG000|STARTED|Overall Study||30
10371458|NCT00559364|11512518|FG001|STARTED|Overall Study||20
10371459|NCT00559364|11512517|FG000|COMPLETED|Overall Study||29
10371460|NCT00559364|11512518|FG001|COMPLETED|Overall Study||20
10371461|NCT00559364|11512517|FG000|NOT COMPLETED|Overall Study||1
10371462|NCT00559364|11512518|FG001|NOT COMPLETED|Overall Study||0
10371463|NCT00559377|11512524|FG000|STARTED|Overall Study||16
10371464|NCT00559377|11512524|FG000|COMPLETED|Overall Study||7
10371465|NCT00559377|11512524|FG000|NOT COMPLETED|Overall Study||9
10371466|NCT00559468|11512533|FG000|STARTED|Overall Study||26
10371467|NCT00559468|11512534|FG001|STARTED|Overall Study||26
10371468|NCT00559468|11512533|FG000|Treated|Overall Study||26
10371469|NCT00559468|11512534|FG001|Treated|Overall Study||25
10371470|NCT00559468|11512533|FG000|COMPLETED|Overall Study||26
10371471|NCT00559468|11512534|FG001|COMPLETED|Overall Study||25
10371472|NCT00559468|11512533|FG000|NOT COMPLETED|Overall Study||0
10371473|NCT00559468|11512534|FG001|NOT COMPLETED|Overall Study||1
10371474|NCT00559507|11512540|FG000|STARTED|Overall Study||12
10371475|NCT00559507|11512540|FG000|COMPLETED|Overall Study||9
10371476|NCT00559507|11512540|FG000|NOT COMPLETED|Overall Study||3
10371477|NCT00559585|11512546|FG000|STARTED|Double Blind ST Period Main Study|Randomized and treated|736
10371478|NCT00559585|11512547|FG001|STARTED|Double Blind ST Period Main Study|Randomized and treated|721
10371479|NCT00559585|11512546|FG000|COMPLETED|Double Blind ST Period Main Study||693
10371480|NCT00559585|11512547|FG001|COMPLETED|Double Blind ST Period Main Study||676
10371481|NCT00559585|11512546|FG000|NOT COMPLETED|Double Blind ST Period Main Study||43
10371482|NCT00559585|11512547|FG001|NOT COMPLETED|Double Blind ST Period Main Study||45
10371483|NCT00559585|11512546|FG000|STARTED|Anti-TNF Sub-Study in ST Period|7 completed Sub-Study ST period and 6 chose to roll over into LT Period.|8
10371484|NCT00559585|11512547|FG001|STARTED|Anti-TNF Sub-Study in ST Period|9 completed Sub-Study ST Period and 9 chose to over into the LT Period.|10
10371485|NCT00559585|11512546|FG000|COMPLETED|Anti-TNF Sub-Study in ST Period||7
10371486|NCT00559585|11512547|FG001|COMPLETED|Anti-TNF Sub-Study in ST Period||9
10371487|NCT00559585|11512546|FG000|NOT COMPLETED|Anti-TNF Sub-Study in ST Period||1
10371488|NCT00559585|11512547|FG001|NOT COMPLETED|Anti-TNF Sub-Study in ST Period||1
10371489|NCT00559585|11512546|FG000|STARTED|Open Label LT Period Main + Sub-Study|1373 includes 15 participants from ST Period Sub-Study who rolled over into LT Period (6 SC + 9 IV).|1373
10371490|NCT00559585|11512547|FG001|STARTED|Open Label LT Period Main + Sub-Study|IV administration was discontinued and abatacept was only administered SC during LT Period.|0
10371491|NCT00559585|11512546|FG000|COMPLETED|Open Label LT Period Main + Sub-Study||945
10371492|NCT00559585|11512547|FG001|COMPLETED|Open Label LT Period Main + Sub-Study||0
10371493|NCT00559585|11512546|FG000|NOT COMPLETED|Open Label LT Period Main + Sub-Study||428
10371494|NCT00559585|11512547|FG001|NOT COMPLETED|Open Label LT Period Main + Sub-Study||0
10371495|NCT00559637|11512564|FG000|STARTED|Overall Study||184
10371496|NCT00559637|11512564|FG000|COMPLETED|Overall Study||130
10371497|NCT00559637|11512564|FG000|NOT COMPLETED|Overall Study||54
10371498|NCT00559754|11512568|FG000|STARTED|Overall Study||72
10371499|NCT00559754|11512568|FG000|COMPLETED|Overall Study||61
10371500|NCT00559754|11512568|FG000|NOT COMPLETED|Overall Study||11
10371501|NCT00559845|11512572|FG000|STARTED|Overall Study||56
10371502|NCT00559845|11512572|FG000|COMPLETED|Overall Study||49
10371503|NCT00559845|11512572|FG000|NOT COMPLETED|Overall Study||7
10371504|NCT00559949|11512576|FG000|STARTED|Overall Study||39
10371505|NCT00559949|11512576|FG000|COMPLETED|Overall Study||32
10371506|NCT00559949|11512576|FG000|NOT COMPLETED|Overall Study||7
10371507|NCT00559962|11512588|FG000|STARTED|Overall Study||33
10371508|NCT00559962|11512589|FG001|STARTED|Overall Study||34
10371509|NCT00559962|11512590|FG002|STARTED|Overall Study||34
10371510|NCT00559962|11512591|FG003|STARTED|Overall Study||34
10371511|NCT00559962|11512592|FG004|STARTED|Overall Study||35
10371512|NCT00559962|11512593|FG005|STARTED|Overall Study||28
10371513|NCT00559962|11512594|FG006|STARTED|Overall Study||33
10371514|NCT00559962|11512595|FG007|STARTED|Overall Study||29
10371515|NCT00559962|11512588|FG000|COMPLETED|Overall Study||31
10371516|NCT00559962|11512589|FG001|COMPLETED|Overall Study||25
10371517|NCT00559962|11512590|FG002|COMPLETED|Overall Study||24
10371518|NCT00559962|11512591|FG003|COMPLETED|Overall Study||29
10371519|NCT00559962|11512592|FG004|COMPLETED|Overall Study||21
10371520|NCT00559962|11512593|FG005|COMPLETED|Overall Study||23
10371521|NCT00559962|11512594|FG006|COMPLETED|Overall Study||28
10371522|NCT00559962|11512595|FG007|COMPLETED|Overall Study||25
10371523|NCT00559962|11512588|FG000|NOT COMPLETED|Overall Study||2
10371524|NCT00559962|11512589|FG001|NOT COMPLETED|Overall Study||9
10371525|NCT00559962|11512590|FG002|NOT COMPLETED|Overall Study||10
10371526|NCT00559962|11512591|FG003|NOT COMPLETED|Overall Study||5
10371527|NCT00559962|11512592|FG004|NOT COMPLETED|Overall Study||14
10371528|NCT00559962|11512593|FG005|NOT COMPLETED|Overall Study||5
10371529|NCT00559962|11512594|FG006|NOT COMPLETED|Overall Study||5
10371530|NCT00559962|11512595|FG007|NOT COMPLETED|Overall Study||4
10371531|NCT00559988|11512616|FG000|STARTED|Overall Study||1357
10371532|NCT00559988|11512617|FG001|STARTED|Overall Study||1361
10371533|NCT00559988|11512616|FG000|COMPLETED|Overall Study||1006
10371534|NCT00559988|11512617|FG001|COMPLETED|Overall Study||1009
10371535|NCT00559988|11512616|FG000|NOT COMPLETED|Overall Study||351
10371536|NCT00559988|11512617|FG001|NOT COMPLETED|Overall Study||352
10371537|NCT00560066|11512625|FG000|STARTED|Overall Study||396
10371538|NCT00560066|11512626|FG001|STARTED|Overall Study||1002
10371539|NCT00560066|11512625|FG000|COMPLETED|Overall Study||390
10371540|NCT00560066|11512626|FG001|COMPLETED|Overall Study||980
10371541|NCT00560066|11512625|FG000|NOT COMPLETED|Overall Study||6
10371542|NCT00560066|11512626|FG001|NOT COMPLETED|Overall Study||22
10371543|NCT00560105|11512639|FG000|STARTED|Overall Study||20
10371544|NCT00560105|11512640|FG001|STARTED|Overall Study||20
10371545|NCT00560105|11512639|FG000|COMPLETED|Overall Study||19
10371546|NCT00560105|11512640|FG001|COMPLETED|Overall Study||18
10371547|NCT00560105|11512639|FG000|NOT COMPLETED|Overall Study||1
10371548|NCT00560105|11512640|FG001|NOT COMPLETED|Overall Study||2
10371549|NCT00560235|11512649|FG000|STARTED|Phase 1||10
10371550|NCT00560235|11512650|FG001|STARTED|Phase 1||0
10371551|NCT00560235|11512651|FG002|STARTED|Phase 1||0
10371552|NCT00560235|11512649|FG000|COMPLETED|Phase 1||2
10371553|NCT00560235|11512650|FG001|COMPLETED|Phase 1||0
10371554|NCT00560235|11512651|FG002|COMPLETED|Phase 1||0
10537659|NCT01450800|11690324|FG001|STARTED|Overall Study|81 participants were randomized to placebo|81
10537660|NCT01450800|11690323|FG000|COMPLETED|Overall Study||81
10537661|NCT01450800|11690324|FG001|COMPLETED|Overall Study||78
10537662|NCT01450800|11690323|FG000|NOT COMPLETED|Overall Study||1
10537663|NCT01450800|11690324|FG001|NOT COMPLETED|Overall Study||3
10537664|NCT01450813|11690336|FG000|STARTED|Overall Study||20
10537665|NCT01450813|11690337|FG001|STARTED|Overall Study||20
10537666|NCT01450813|11690338|FG002|STARTED|Overall Study||20
10537667|NCT01450813|11690339|FG003|STARTED|Overall Study||20
10537668|NCT01450813|11690336|FG000|COMPLETED|Overall Study||19
10537669|NCT01450813|11690337|FG001|COMPLETED|Overall Study||19
10537670|NCT01450813|11690338|FG002|COMPLETED|Overall Study||20
10537671|NCT01450813|11690339|FG003|COMPLETED|Overall Study||17
10537672|NCT01450813|11690336|FG000|NOT COMPLETED|Overall Study||1
10537673|NCT01450813|11690337|FG001|NOT COMPLETED|Overall Study||1
10537674|NCT01450813|11690338|FG002|NOT COMPLETED|Overall Study||0
10537675|NCT01450813|11690339|FG003|NOT COMPLETED|Overall Study||3
10537676|NCT01450826|11690353|FG000|STARTED|Overall Study||70
10537677|NCT01450826|11690354|FG001|STARTED|Overall Study||66
10657233|NCT02224053|11818413|FG000|COMPLETED|AZD9291 Alone||47
10657234|NCT02224053|11818413|FG000|NOT COMPLETED|AZD9291 Alone||0
10657235|NCT02224157|11818421|FG000|STARTED|Overall Study||2095
10657236|NCT02224157|11818422|FG001|STARTED|Overall Study||2094
10657237|NCT02224157|11818421|FG000|Patients Who Completed Treatment|Overall Study||1924
10657238|NCT02224157|11818422|FG001|Patients Who Completed Treatment|Overall Study||1903
10657239|NCT02224157|11818421|FG000|COMPLETED|Overall Study||1985
10716882|NCT02693119|11880772|FG001|STARTED|Double-Blind Period||4
10657240|NCT02224157|11818422|FG001|COMPLETED|Overall Study||1983
10716883|NCT02693119|11880771|FG000|COMPLETED|Double-Blind Period||8
10716884|NCT02693119|11880772|FG001|COMPLETED|Double-Blind Period||4
10812617|NCT03465891|11974728|FG001|STARTED|Overall Study||1
10812618|NCT03465891|11974727|FG000|COMPLETED|Overall Study||0
10371555|NCT00560235|11512649|FG000|NOT COMPLETED|Phase 1||8
10371556|NCT00560235|11512650|FG001|NOT COMPLETED|Phase 1||0
10371557|NCT00560235|11512651|FG002|NOT COMPLETED|Phase 1||0
10371558|NCT00560235|11512649|FG000|STARTED|Phase 1B||0
10371559|NCT00560235|11512650|FG001|STARTED|Phase 1B||21
10371560|NCT00560235|11512651|FG002|STARTED|Phase 1B||0
10371561|NCT00560235|11512649|FG000|COMPLETED|Phase 1B||0
10371562|NCT00560235|11512650|FG001|COMPLETED|Phase 1B||2
10537678|NCT01450826|11690353|FG000|COMPLETED|Overall Study||70
10537679|NCT01450826|11690354|FG001|COMPLETED|Overall Study||66
10537680|NCT01450826|11690353|FG000|NOT COMPLETED|Overall Study||0
10537681|NCT01450826|11690354|FG001|NOT COMPLETED|Overall Study||0
10537682|NCT01450943|11690363|FG000|STARTED|Overall Study||28
10537683|NCT01450943|11690364|FG001|STARTED|Overall Study||42
10537684|NCT01450943|11690365|FG002|STARTED|Overall Study||48
10657241|NCT02224157|11818421|FG000|NOT COMPLETED|Overall Study||110
10657242|NCT02224157|11818422|FG001|NOT COMPLETED|Overall Study||111
10657243|NCT02224274|11818430|FG000|STARTED|Overall Study||17
10657244|NCT02224274|11818431|FG001|STARTED|Overall Study||20
10657245|NCT02224274|11818430|FG000|COMPLETED|Overall Study||16
10657246|NCT02224274|11818431|FG001|COMPLETED|Overall Study||20
10657247|NCT02224274|11818430|FG000|NOT COMPLETED|Overall Study||1
10657248|NCT02224274|11818431|FG001|NOT COMPLETED|Overall Study||0
10657249|NCT02224313|11818439|FG000|STARTED|Overall Study||10
10657250|NCT02224313|11818440|FG001|STARTED|Overall Study||10
10657251|NCT02224313|11818439|FG000|COMPLETED|Overall Study||7
10657252|NCT02224313|11818440|FG001|COMPLETED|Overall Study||9
10657253|NCT02224313|11818439|FG000|NOT COMPLETED|Overall Study||3
10657254|NCT02224313|11818440|FG001|NOT COMPLETED|Overall Study||1
10657255|NCT02224404|11818446|FG000|STARTED|Overall Study||21
10657256|NCT02224404|11818446|FG000|COMPLETED|Overall Study||21
10657257|NCT02224404|11818446|FG000|NOT COMPLETED|Overall Study||0
10657258|NCT02224482|11818452|FG000|STARTED|Overall Study||214
10657259|NCT02224482|11818453|FG001|STARTED|Overall Study||217
10657260|NCT02224482|11818452|FG000|COMPLETED|Overall Study||63
10657261|NCT02224482|11818453|FG001|COMPLETED|Overall Study||57
10657262|NCT02224482|11818452|FG000|NOT COMPLETED|Overall Study||151
10657263|NCT02224482|11818453|FG001|NOT COMPLETED|Overall Study||160
10371563|NCT00560235|11512651|FG002|COMPLETED|Phase 1B||0
10371564|NCT00560235|11512649|FG000|NOT COMPLETED|Phase 1B||0
10371565|NCT00560235|11512650|FG001|NOT COMPLETED|Phase 1B||19
10371566|NCT00560235|11512651|FG002|NOT COMPLETED|Phase 1B||0
10371567|NCT00560235|11512649|FG000|STARTED|Phase 2||0
10371568|NCT00560235|11512650|FG001|STARTED|Phase 2||0
10371569|NCT00560235|11512651|FG002|STARTED|Phase 2||107
10371570|NCT00560235|11512649|FG000|COMPLETED|Phase 2||0
10371571|NCT00560235|11512650|FG001|COMPLETED|Phase 2||0
10371572|NCT00560235|11512651|FG002|COMPLETED|Phase 2||10
10371573|NCT00560235|11512649|FG000|NOT COMPLETED|Phase 2||0
10371574|NCT00560235|11512650|FG001|NOT COMPLETED|Phase 2||0
10371575|NCT00560235|11512651|FG002|NOT COMPLETED|Phase 2||97
10371576|NCT00560313|11512669|FG000|STARTED|Overall Study||54
10371577|NCT00560313|11512669|FG000|COMPLETED|Overall Study||48
10371578|NCT00560313|11512669|FG000|NOT COMPLETED|Overall Study||6
10371579|NCT00560352|11512691|FG000|STARTED|Overall Study||7
10371580|NCT00560352|11512692|FG001|STARTED|Overall Study||3
10371581|NCT00560352|11512693|FG002|STARTED|Overall Study||4
10371582|NCT00560352|11512691|FG000|COMPLETED|Overall Study||0
10371583|NCT00560352|11512692|FG001|COMPLETED|Overall Study||0
10371584|NCT00560352|11512693|FG002|COMPLETED|Overall Study||0
10371585|NCT00560352|11512691|FG000|NOT COMPLETED|Overall Study||7
10371586|NCT00560352|11512692|FG001|NOT COMPLETED|Overall Study||3
10371587|NCT00560352|11512693|FG002|NOT COMPLETED|Overall Study||4
10371588|NCT00560391|11512710|FG000|STARTED|Overall Study|Participants who received treatment|6
10371589|NCT00560391|11512711|FG001|STARTED|Overall Study|Participants who received treatment|3
10371590|NCT00560391|11512712|FG002|STARTED|Overall Study|Participants who received treatment|3
10371591|NCT00560391|11512713|FG003|STARTED|Overall Study|Participants who received treatment|6
10371592|NCT00560391|11512714|FG004|STARTED|Overall Study|Participants who received treatment|17
10716885|NCT02693119|11880771|FG000|NOT COMPLETED|Double-Blind Period||0
10716886|NCT02693119|11880772|FG001|NOT COMPLETED|Double-Blind Period||0
10371593|NCT00560391|11512710|FG000|COMPLETED|Overall Study|Completed=off treatment;Disease progression-1;Death-1;Max. clinical benefit-2;Study drug toxicity-2|6
10371594|NCT00560391|11512711|FG001|COMPLETED|Overall Study|Completed=off treatment; Disease progression-1;Death-1; Unrelated AE-1|3
10371595|NCT00560391|11512712|FG002|COMPLETED|Overall Study|Completed=off treatment; Disease progression-1;Maximum clinical benefit-1; Unrelated AE-1|3
10371596|NCT00560391|11512713|FG003|COMPLETED|Overall Study|Completed=off treatment; Disease progression-2; Unrelated AE 1 and Subject request 2|5
10371597|NCT00560391|11512714|FG004|COMPLETED|Overall Study|Completed=offtreatment;Disease progression-6;Study drug toxicity-7; Unrelated AE-1,Subject request-1|15
10371598|NCT00560391|11512710|FG000|NOT COMPLETED|Overall Study||0
10371599|NCT00560391|11512711|FG001|NOT COMPLETED|Overall Study||0
10371600|NCT00560391|11512712|FG002|NOT COMPLETED|Overall Study||0
10371601|NCT00560391|11512713|FG003|NOT COMPLETED|Overall Study||1
10371602|NCT00560391|11512714|FG004|NOT COMPLETED|Overall Study||2
10371603|NCT00560404|11512729|FG000|STARTED|Overall Study||112
10371604|NCT00560404|11512730|FG001|STARTED|Overall Study||121
10371605|NCT00560404|11512729|FG000|COMPLETED|Overall Study||76
10371606|NCT00560404|11512730|FG001|COMPLETED|Overall Study||100
10371607|NCT00560404|11512729|FG000|NOT COMPLETED|Overall Study||36
10371608|NCT00560404|11512730|FG001|NOT COMPLETED|Overall Study||21
10371609|NCT00560417|11512738|FG000|STARTED|Overall Study||171
10371610|NCT00560417|11512739|FG001|STARTED|Overall Study||168
10371611|NCT00560417|11512738|FG000|Intention to Treat (ITT) Population|Overall Study||170
10371612|NCT00560417|11512739|FG001|Intention to Treat (ITT) Population|Overall Study||167
10371613|NCT00560417|11512738|FG000|COMPLETED|Overall Study||154
10371614|NCT00560417|11512739|FG001|COMPLETED|Overall Study||151
10371615|NCT00560417|11512738|FG000|NOT COMPLETED|Overall Study||17
10371616|NCT00560417|11512739|FG001|NOT COMPLETED|Overall Study||17
10427604|NCT00853762|11573477|FG002|COMPLETED|Overall Study||0
10427605|NCT00853762|11573478|FG003|COMPLETED|Overall Study||0
10427606|NCT00853762|11573475|FG000|NOT COMPLETED|Overall Study||16
10427607|NCT00853762|11573476|FG001|NOT COMPLETED|Overall Study||19
10427608|NCT00853762|11573477|FG002|NOT COMPLETED|Overall Study||17
10427609|NCT00853762|11573478|FG003|NOT COMPLETED|Overall Study||22
10427610|NCT00853827|11573490|FG000|STARTED|Single Blind Period (1 Week)|Enrolled patients in single blind|652
10427611|NCT00853827|11573491|FG001|STARTED|Single Blind Period (1 Week)|This arm was only used in double blind period|0
10427612|NCT00853827|11573490|FG000|COMPLETED|Single Blind Period (1 Week)|Completed patients in single blind period|613
10427613|NCT00853827|11573491|FG001|COMPLETED|Single Blind Period (1 Week)||0
10427614|NCT00853827|11573490|FG000|NOT COMPLETED|Single Blind Period (1 Week)||39
10427615|NCT00853827|11573491|FG001|NOT COMPLETED|Single Blind Period (1 Week)||0
10427616|NCT00853827|11573490|FG000|STARTED|Double Blind Period (103 Weeks)|"Started indicates number of patients in randomized set, full analysis set (FAS) and safety set."|305
10427617|NCT00853827|11573491|FG001|STARTED|Double Blind Period (103 Weeks)||308
10427618|NCT00853827|11573490|FG000|Modified Full Analysis Set (mFAS)|Double Blind Period (103 Weeks)||225
10427619|NCT00853827|11573491|FG001|Modified Full Analysis Set (mFAS)|Double Blind Period (103 Weeks)||233
10427620|NCT00853827|11573490|FG000|COMPLETED|Double Blind Period (103 Weeks)||201
10427621|NCT00853827|11573491|FG001|COMPLETED|Double Blind Period (103 Weeks)||199
10427622|NCT00853827|11573490|FG000|NOT COMPLETED|Double Blind Period (103 Weeks)||104
10716887|NCT02693119|11880771|FG000|STARTED|Open-Label Period||8
10716888|NCT02693119|11880772|FG001|STARTED|Open-Label Period||4
10427623|NCT00853827|11573491|FG001|NOT COMPLETED|Double Blind Period (103 Weeks)||109
10427624|NCT00853840|11573497|FG000|STARTED|Period 1||9
10427625|NCT00853840|11573498|FG001|STARTED|Period 1||9
10427626|NCT00853840|11573497|FG000|Maraviroc (Days 1 - 4)|Period 1||9
10371617|NCT00560508|11512747|FG000|STARTED|12 Week Double-blind Period||56
10537685|NCT01450943|11690363|FG000|COMPLETED|Overall Study||26
10537686|NCT01450943|11690364|FG001|COMPLETED|Overall Study||35
10537687|NCT01450943|11690365|FG002|COMPLETED|Overall Study||42
10537688|NCT01450943|11690363|FG000|NOT COMPLETED|Overall Study||2
10537689|NCT01450943|11690364|FG001|NOT COMPLETED|Overall Study||7
10537690|NCT01450943|11690365|FG002|NOT COMPLETED|Overall Study||6
10537691|NCT01451164|11690381|FG000|STARTED|Overall Study||115
10537692|NCT01451164|11690382|FG001|STARTED|Overall Study||115
10537693|NCT01451164|11690383|FG002|STARTED|Overall Study||113
10371618|NCT00560508|11512748|FG001|STARTED|12 Week Double-blind Period||56
10371619|NCT00560508|11512747|FG000|COMPLETED|12 Week Double-blind Period||51
10371620|NCT00560508|11512748|FG001|COMPLETED|12 Week Double-blind Period||53
10371621|NCT00560508|11512747|FG000|NOT COMPLETED|12 Week Double-blind Period||5
10371622|NCT00560508|11512748|FG001|NOT COMPLETED|12 Week Double-blind Period||3
10371623|NCT00560508|11512747|FG000|STARTED|52-week Open-label Period Pramipexole ER|all patients received Pramipexole ER for the 52-week open-label period|51
10371624|NCT00560508|11512748|FG001|STARTED|52-week Open-label Period Pramipexole ER|all patients received Pramipexole ER for the 52-week open-label period|53
10371625|NCT00560508|11512747|FG000|COMPLETED|52-week Open-label Period Pramipexole ER||43
10371626|NCT00560508|11512748|FG001|COMPLETED|52-week Open-label Period Pramipexole ER||42
10371627|NCT00560508|11512747|FG000|NOT COMPLETED|52-week Open-label Period Pramipexole ER||8
10371628|NCT00560508|11512748|FG001|NOT COMPLETED|52-week Open-label Period Pramipexole ER||11
10371629|NCT00560560|11512761|FG000|STARTED|Overall Study||85
10371630|NCT00560560|11512762|FG001|STARTED|Overall Study||83
10371631|NCT00560560|11512761|FG000|COMPLETED|Overall Study||0
10371632|NCT00560560|11512762|FG001|COMPLETED|Overall Study||0
10371633|NCT00560560|11512761|FG000|NOT COMPLETED|Overall Study||85
10371634|NCT00560560|11512762|FG001|NOT COMPLETED|Overall Study||83
10371635|NCT00560573|11512768|FG000|STARTED|Overall Study||6
10537694|NCT01451164|11690384|FG003|STARTED|Overall Study||116
10537695|NCT01451164|11690381|FG000|COMPLETED|Overall Study||72
10537696|NCT01451164|11690382|FG001|COMPLETED|Overall Study||81
10537697|NCT01451164|11690383|FG002|COMPLETED|Overall Study||68
10537698|NCT01451164|11690384|FG003|COMPLETED|Overall Study||70
10537699|NCT01451164|11690381|FG000|NOT COMPLETED|Overall Study||43
10537700|NCT01451164|11690382|FG001|NOT COMPLETED|Overall Study||34
10537701|NCT01451164|11690383|FG002|NOT COMPLETED|Overall Study||45
10537702|NCT01451164|11690384|FG003|NOT COMPLETED|Overall Study||46
10537703|NCT01451203|11690396|FG000|STARTED|Double-blind Treatment Period||158
10537704|NCT01451203|11690397|FG001|STARTED|Double-blind Treatment Period||161
10371636|NCT00560573|11512769|FG001|STARTED|Overall Study||3
10371637|NCT00560573|11512770|FG002|STARTED|Overall Study||6
10371638|NCT00560573|11512771|FG003|STARTED|Overall Study||10
10371639|NCT00560573|11512772|FG004|STARTED|Overall Study||8
10371640|NCT00560573|11512773|FG005|STARTED|Overall Study||13
10371641|NCT00560573|11512768|FG000|Treated|Overall Study||6
10371642|NCT00560573|11512769|FG001|Treated|Overall Study||3
10371643|NCT00560573|11512770|FG002|Treated|Overall Study||6
10371644|NCT00560573|11512771|FG003|Treated|Overall Study||10
10371645|NCT00560573|11512772|FG004|Treated|Overall Study||7
10371646|NCT00560573|11512773|FG005|Treated|Overall Study||13
10371647|NCT00560573|11512768|FG000|COMPLETED|Overall Study||0
10371648|NCT00560573|11512769|FG001|COMPLETED|Overall Study||0
10371649|NCT00560573|11512770|FG002|COMPLETED|Overall Study||0
10371650|NCT00560573|11512771|FG003|COMPLETED|Overall Study||0
10371651|NCT00560573|11512772|FG004|COMPLETED|Overall Study||1
10371652|NCT00560573|11512773|FG005|COMPLETED|Overall Study||0
10371653|NCT00560573|11512768|FG000|NOT COMPLETED|Overall Study||6
10371654|NCT00560573|11512769|FG001|NOT COMPLETED|Overall Study||3
10371655|NCT00560573|11512770|FG002|NOT COMPLETED|Overall Study||6
10371656|NCT00560573|11512771|FG003|NOT COMPLETED|Overall Study||10
10371657|NCT00560573|11512772|FG004|NOT COMPLETED|Overall Study||7
10371658|NCT00560573|11512773|FG005|NOT COMPLETED|Overall Study||13
10371659|NCT00560612|11512805|FG000|STARTED|Overall Study||5
10371660|NCT00560612|11512806|FG001|STARTED|Overall Study||7
10371661|NCT00560612|11512805|FG000|COMPLETED|Overall Study||5
10371662|NCT00560612|11512806|FG001|COMPLETED|Overall Study||7
10371663|NCT00560612|11512805|FG000|NOT COMPLETED|Overall Study||0
10371664|NCT00560612|11512806|FG001|NOT COMPLETED|Overall Study||0
10371665|NCT00560703|11512814|FG000|STARTED|Overall Study||46
10371666|NCT00560703|11512815|FG001|STARTED|Overall Study||24
10371667|NCT00560703|11512814|FG000|COMPLETED|Overall Study||46
10371668|NCT00560703|11512815|FG001|COMPLETED|Overall Study||18
10371669|NCT00560703|11512814|FG000|NOT COMPLETED|Overall Study||0
10371670|NCT00560703|11512815|FG001|NOT COMPLETED|Overall Study||6
10371671|NCT00560755|11512821|FG000|STARTED|Overall Study|Vaccinated (at least one ProQuad® dose)|3388
10371672|NCT00560755|11512821|FG000|ProQuad® Dose 1 and Dose 2|Overall Study||3346
10371673|NCT00560755|11512821|FG000|COMPLETED|Overall Study||3328
10371674|NCT00560755|11512821|FG000|NOT COMPLETED|Overall Study||60
10371675|NCT00560794|11512826|FG000|STARTED|Overall Study||21
10371676|NCT00560794|11512826|FG000|Completed 1 Treatment Cycle|Overall Study||20
10371677|NCT00560794|11512826|FG000|COMPLETED|Overall Study||10
10371678|NCT00560794|11512826|FG000|NOT COMPLETED|Overall Study||11
10371679|NCT00560833|11512837|FG000|STARTED|Overall Study||317
10371680|NCT00560833|11512838|FG001|STARTED|Overall Study||155
10371681|NCT00560833|11512839|FG002|STARTED|Overall Study||160
10371682|NCT00560833|11512840|FG003|STARTED|Overall Study||155
10371683|NCT00560833|11512841|FG004|STARTED|Overall Study||156
10427627|NCT00853840|11573498|FG001|Maraviroc (Days 1 - 4)|Period 1||9
10306242|NCT00098059|11439250|FG000|COMPLETED|Overall Study||27
10306243|NCT00098059|11439251|FG001|COMPLETED|Overall Study||46
10306244|NCT00098059|11439250|FG000|NOT COMPLETED|Overall Study||0
10306245|NCT00098059|11439251|FG001|NOT COMPLETED|Overall Study||1
10306246|NCT00098254|11439262|FG000|STARTED|Overall Study||37
10306247|NCT00098254|11439262|FG000|COMPLETED|Overall Study||34
10306248|NCT00098254|11439262|FG000|NOT COMPLETED|Overall Study||3
10306249|NCT00098293|11439269|FG000|STARTED|Double-blind (DB) Phase||177
10306250|NCT00098293|11439270|FG001|STARTED|Double-blind (DB) Phase||368
10306251|NCT00098293|11439271|FG002|STARTED|Double-blind (DB) Phase||372
10306252|NCT00098293|11439272|FG003|STARTED|Double-blind (DB) Phase||0
10306253|NCT00098293|11439273|FG004|STARTED|Double-blind (DB) Phase||0
10306254|NCT00098293|11439269|FG000|Treated|Double-blind (DB) Phase||174
10306255|NCT00098293|11439270|FG001|Treated|Double-blind (DB) Phase||360
10306256|NCT00098293|11439271|FG002|Treated|Double-blind (DB) Phase||361
10306257|NCT00098293|11439272|FG003|Treated|Double-blind (DB) Phase||0
10306258|NCT00098293|11439273|FG004|Treated|Double-blind (DB) Phase||0
10306259|NCT00098293|11439269|FG000|COMPLETED|Double-blind (DB) Phase||0
10306260|NCT00098293|11439270|FG001|COMPLETED|Double-blind (DB) Phase||202
10306261|NCT00098293|11439271|FG002|COMPLETED|Double-blind (DB) Phase||202
10306262|NCT00098293|11439272|FG003|COMPLETED|Double-blind (DB) Phase||0
10306263|NCT00098293|11439273|FG004|COMPLETED|Double-blind (DB) Phase||0
10306264|NCT00098293|11439269|FG000|NOT COMPLETED|Double-blind (DB) Phase||177
10306265|NCT00098293|11439270|FG001|NOT COMPLETED|Double-blind (DB) Phase||166
10306266|NCT00098293|11439271|FG002|NOT COMPLETED|Double-blind (DB) Phase||170
10306267|NCT00098293|11439272|FG003|NOT COMPLETED|Double-blind (DB) Phase||0
10306268|NCT00098293|11439273|FG004|NOT COMPLETED|Double-blind (DB) Phase||0
10306269|NCT00098293|11439269|FG000|STARTED|Between DB and OL Phase||0
10306270|NCT00098293|11439270|FG001|STARTED|Between DB and OL Phase||202
10306271|NCT00098293|11439271|FG002|STARTED|Between DB and OL Phase||202
10306272|NCT00098293|11439272|FG003|STARTED|Between DB and OL Phase||0
10306273|NCT00098293|11439273|FG004|STARTED|Between DB and OL Phase||0
10306274|NCT00098293|11439269|FG000|COMPLETED|Between DB and OL Phase||0
10306275|NCT00098293|11439270|FG001|COMPLETED|Between DB and OL Phase||202
10306276|NCT00098293|11439271|FG002|COMPLETED|Between DB and OL Phase||199
10306277|NCT00098293|11439272|FG003|COMPLETED|Between DB and OL Phase||0
10306278|NCT00098293|11439273|FG004|COMPLETED|Between DB and OL Phase||0
10306279|NCT00098293|11439269|FG000|NOT COMPLETED|Between DB and OL Phase||0
10306280|NCT00098293|11439270|FG001|NOT COMPLETED|Between DB and OL Phase||0
10306281|NCT00098293|11439271|FG002|NOT COMPLETED|Between DB and OL Phase||3
10306282|NCT00098293|11439272|FG003|NOT COMPLETED|Between DB and OL Phase||0
10306283|NCT00098293|11439273|FG004|NOT COMPLETED|Between DB and OL Phase||0
10306284|NCT00098293|11439269|FG000|STARTED|Open-label (OL) Phase||0
10306285|NCT00098293|11439270|FG001|STARTED|Open-label (OL) Phase||202
10306286|NCT00098293|11439271|FG002|STARTED|Open-label (OL) Phase||199
10306287|NCT00098293|11439272|FG003|STARTED|Open-label (OL) Phase||130
10306288|NCT00098293|11439273|FG004|STARTED|Open-label (OL) Phase||0
10306289|NCT00098293|11439269|FG000|COMPLETED|Open-label (OL) Phase||0
10306290|NCT00098293|11439270|FG001|COMPLETED|Open-label (OL) Phase||177
10306291|NCT00098293|11439271|FG002|COMPLETED|Open-label (OL) Phase||158
10306292|NCT00098293|11439272|FG003|COMPLETED|Open-label (OL) Phase||65
10306293|NCT00098293|11439273|FG004|COMPLETED|Open-label (OL) Phase||0
10306294|NCT00098293|11439269|FG000|NOT COMPLETED|Open-label (OL) Phase||0
10306295|NCT00098293|11439270|FG001|NOT COMPLETED|Open-label (OL) Phase||25
10306296|NCT00098293|11439271|FG002|NOT COMPLETED|Open-label (OL) Phase||41
10306297|NCT00098293|11439272|FG003|NOT COMPLETED|Open-label (OL) Phase||65
10306298|NCT00098293|11439273|FG004|NOT COMPLETED|Open-label (OL) Phase||0
10306299|NCT00098293|11439269|FG000|STARTED|Supplemental Phase (SP)||0
10306300|NCT00098293|11439270|FG001|STARTED|Supplemental Phase (SP)||0
10306301|NCT00098293|11439271|FG002|STARTED|Supplemental Phase (SP)||0
10306302|NCT00098293|11439272|FG003|STARTED|Supplemental Phase (SP)||0
10306303|NCT00098293|11439273|FG004|STARTED|Supplemental Phase (SP)||127
10306304|NCT00098293|11439269|FG000|COMPLETED|Supplemental Phase (SP)||0
10306305|NCT00098293|11439270|FG001|COMPLETED|Supplemental Phase (SP)||0
10306306|NCT00098293|11439271|FG002|COMPLETED|Supplemental Phase (SP)||0
10306307|NCT00098293|11439272|FG003|COMPLETED|Supplemental Phase (SP)||0
10306308|NCT00098293|11439273|FG004|COMPLETED|Supplemental Phase (SP)||94
10306309|NCT00098293|11439269|FG000|NOT COMPLETED|Supplemental Phase (SP)||0
10306310|NCT00098293|11439270|FG001|NOT COMPLETED|Supplemental Phase (SP)||0
10306311|NCT00098293|11439271|FG002|NOT COMPLETED|Supplemental Phase (SP)||0
10306312|NCT00098293|11439272|FG003|NOT COMPLETED|Supplemental Phase (SP)||0
10306313|NCT00098293|11439273|FG004|NOT COMPLETED|Supplemental Phase (SP)||33
10306314|NCT00098306|11439287|FG000|STARTED|Double Blind||241
10306315|NCT00098306|11439288|FG001|STARTED|Double Blind||240
10371684|NCT00560833|11512837|FG000|Treated|Overall Study|One participant was not randomized but was treated with placebo|317
10371685|NCT00560833|11512838|FG001|Treated|Overall Study|One participant was randomized but not treated|154
10371686|NCT00560833|11512839|FG002|Treated|Overall Study||160
10371687|NCT00560833|11512840|FG003|Treated|Overall Study||155
10371688|NCT00560833|11512841|FG004|Treated|Overall Study|One participant was randomized but not treated|155
10371689|NCT00560833|11512837|FG000|COMPLETED|Overall Study||273
10371690|NCT00560833|11512838|FG001|COMPLETED|Overall Study||129
10371691|NCT00560833|11512839|FG002|COMPLETED|Overall Study||121
10371692|NCT00560833|11512840|FG003|COMPLETED|Overall Study||124
10371693|NCT00560833|11512841|FG004|COMPLETED|Overall Study||114
10371694|NCT00560833|11512837|FG000|NOT COMPLETED|Overall Study||44
10371695|NCT00560833|11512838|FG001|NOT COMPLETED|Overall Study||26
10371696|NCT00560833|11512839|FG002|NOT COMPLETED|Overall Study||39
10371697|NCT00560833|11512840|FG003|NOT COMPLETED|Overall Study||31
10371698|NCT00560833|11512841|FG004|NOT COMPLETED|Overall Study||42
10371699|NCT00560859|11512855|FG000|STARTED|Overall Study||226
10371700|NCT00560859|11512856|FG001|STARTED|Overall Study||227
10371701|NCT00560859|11512855|FG000|COMPLETED|Overall Study||194
10716889|NCT02693119|11880771|FG000|COMPLETED|Open-Label Period||8
10716890|NCT02693119|11880772|FG001|COMPLETED|Open-Label Period||3
10716891|NCT02693119|11880771|FG000|NOT COMPLETED|Open-Label Period||0
10716892|NCT02693119|11880772|FG001|NOT COMPLETED|Open-Label Period||1
10716893|NCT02693132|11880811|FG000|STARTED|Overall Study||17
10371702|NCT00560859|11512856|FG001|COMPLETED|Overall Study||203
10371703|NCT00560859|11512855|FG000|NOT COMPLETED|Overall Study||32
10371704|NCT00560859|11512856|FG001|NOT COMPLETED|Overall Study||24
10371705|NCT00560885|11512863|FG000|STARTED|Overall Study||55
10371706|NCT00560885|11512863|FG000|30 Day Follow-up|Overall Study|53 pts available for 30 day follow-up, 52 pts assessed|53
10371707|NCT00560885|11512863|FG000|3 Month Follow-up|Overall Study|51 pts available for 3 month follow-up, 48 pts assessed.|51
10371708|NCT00560885|11512863|FG000|6 Month Follow-up|Overall Study|50 pts available for 6 month follow-up, 50 pts assessed|50
10371709|NCT00560885|11512863|FG000|12 Month Follow-up|Overall Study|48 pts available for 12 month follow-up, 46 pts assessed|48
10371710|NCT00560885|11512863|FG000|2 Year Follow-up|Overall Study||47
10371711|NCT00560885|11512863|FG000|COMPLETED|Overall Study||47
10371712|NCT00560885|11512863|FG000|NOT COMPLETED|Overall Study||8
10371713|NCT00560937|11512869|FG000|STARTED|Overall Study||10
10371714|NCT00560937|11512870|FG001|STARTED|Overall Study||11
10371715|NCT00560937|11512869|FG000|COMPLETED|Overall Study|One participant was withdrawn after 6 weeks and data were carried forward|9
10371716|NCT00560937|11512870|FG001|COMPLETED|Overall Study||9
10371717|NCT00560937|11512869|FG000|NOT COMPLETED|Overall Study||1
10371718|NCT00560937|11512870|FG001|NOT COMPLETED|Overall Study||2
10371719|NCT00560950|11512878|FG000|STARTED|Overall Study||72
10371720|NCT00560950|11512879|FG001|STARTED|Overall Study||71
10371721|NCT00560950|11512878|FG000|COMPLETED|Overall Study||71
10371722|NCT00560950|11512879|FG001|COMPLETED|Overall Study||71
10371723|NCT00560950|11512878|FG000|NOT COMPLETED|Overall Study||1
10371724|NCT00560950|11512879|FG001|NOT COMPLETED|Overall Study||0
10371725|NCT00561002|11512889|FG000|STARTED|Overall Study||23
10371726|NCT00561002|11512890|FG001|STARTED|Overall Study||9
10371727|NCT00561002|11512889|FG000|COMPLETED|Overall Study||23
10371728|NCT00561002|11512890|FG001|COMPLETED|Overall Study||9
10371729|NCT00561002|11512889|FG000|NOT COMPLETED|Overall Study||0
10371730|NCT00561002|11512890|FG001|NOT COMPLETED|Overall Study||0
10371731|NCT00561015|11512902|FG000|STARTED|Overall Study||9
10371732|NCT00561015|11512903|FG001|STARTED|Overall Study||5
10371733|NCT00561015|11512904|FG002|STARTED|Overall Study||9
10371734|NCT00561015|11512905|FG003|STARTED|Overall Study||8
10371735|NCT00561015|11512906|FG004|STARTED|Overall Study||9
10371736|NCT00561015|11512907|FG005|STARTED|Overall Study||9
10371737|NCT00561015|11512902|FG000|COMPLETED|Overall Study||5
10371738|NCT00561015|11512903|FG001|COMPLETED|Overall Study||5
10371739|NCT00561015|11512904|FG002|COMPLETED|Overall Study||9
10371740|NCT00561015|11512905|FG003|COMPLETED|Overall Study||7
10371741|NCT00561015|11512906|FG004|COMPLETED|Overall Study||8
10371742|NCT00561015|11512907|FG005|COMPLETED|Overall Study||6
10371743|NCT00561015|11512902|FG000|NOT COMPLETED|Overall Study||4
10371744|NCT00561015|11512903|FG001|NOT COMPLETED|Overall Study||0
10371745|NCT00561015|11512904|FG002|NOT COMPLETED|Overall Study||0
10371746|NCT00561015|11512905|FG003|NOT COMPLETED|Overall Study||1
10371747|NCT00561015|11512906|FG004|NOT COMPLETED|Overall Study||1
10371748|NCT00561015|11512907|FG005|NOT COMPLETED|Overall Study||3
10371749|NCT00561080|11512928|FG000|STARTED|Vaccination Period (up to Month 4)||253
10371750|NCT00561080|11512929|FG001|STARTED|Vaccination Period (up to Month 4)||255
10371751|NCT00561080|11512930|FG002|STARTED|Vaccination Period (up to Month 4)||251
10371752|NCT00561080|11512928|FG000|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||253
10371753|NCT00561080|11512929|FG001|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||254
10371754|NCT00561080|11512930|FG002|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||250
10371755|NCT00561080|11512928|FG000|COMPLETED|Vaccination Period (up to Month 4)||250
10371756|NCT00561080|11512929|FG001|COMPLETED|Vaccination Period (up to Month 4)||229
10371757|NCT00561080|11512930|FG002|COMPLETED|Vaccination Period (up to Month 4)||225
10371758|NCT00561080|11512928|FG000|NOT COMPLETED|Vaccination Period (up to Month 4)||3
10371759|NCT00561080|11512929|FG001|NOT COMPLETED|Vaccination Period (up to Month 4)||26
10371760|NCT00561080|11512930|FG002|NOT COMPLETED|Vaccination Period (up to Month 4)||26
10716894|NCT02693132|11880812|FG001|STARTED|Overall Study||17
10716895|NCT02693132|11880813|FG002|STARTED|Overall Study||18
10371761|NCT00561080|11512928|FG000|STARTED|12-month Post Last Dose Follow-up||250
10371762|NCT00561080|11512929|FG001|STARTED|12-month Post Last Dose Follow-up||229
10371763|NCT00561080|11512930|FG002|STARTED|12-month Post Last Dose Follow-up||225
10371764|NCT00561080|11512928|FG000|COMPLETED|12-month Post Last Dose Follow-up||243
10371765|NCT00561080|11512929|FG001|COMPLETED|12-month Post Last Dose Follow-up||220
10371766|NCT00561080|11512930|FG002|COMPLETED|12-month Post Last Dose Follow-up||215
10371767|NCT00561080|11512928|FG000|NOT COMPLETED|12-month Post Last Dose Follow-up||7
10371768|NCT00561080|11512929|FG001|NOT COMPLETED|12-month Post Last Dose Follow-up||9
10371769|NCT00561080|11512930|FG002|NOT COMPLETED|12-month Post Last Dose Follow-up||10
10371770|NCT00561080|11512928|FG000|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
10371771|NCT00561080|11512929|FG001|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
10371772|NCT00561080|11512930|FG002|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
10371773|NCT00561080|11512928|FG000|COMPLETED|24-month Post Last Dose Follow-up||0
10371774|NCT00561080|11512929|FG001|COMPLETED|24-month Post Last Dose Follow-up||0
10371775|NCT00561080|11512930|FG002|COMPLETED|24-month Post Last Dose Follow-up||0
10371776|NCT00561080|11512928|FG000|NOT COMPLETED|24-month Post Last Dose Follow-up||0
10371777|NCT00561080|11512929|FG001|NOT COMPLETED|24-month Post Last Dose Follow-up||0
10371778|NCT00561080|11512930|FG002|NOT COMPLETED|24-month Post Last Dose Follow-up||0
10371779|NCT00561080|11512928|FG000|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
10371780|NCT00561080|11512929|FG001|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
10371781|NCT00561080|11512930|FG002|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
10371782|NCT00561080|11512928|FG000|COMPLETED|36 Month Post Last Dose Follow-up||0
10371783|NCT00561080|11512929|FG001|COMPLETED|36 Month Post Last Dose Follow-up||0
10371784|NCT00561080|11512930|FG002|COMPLETED|36 Month Post Last Dose Follow-up||0
10371785|NCT00561080|11512928|FG000|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
10371786|NCT00561080|11512929|FG001|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
10371787|NCT00561080|11512930|FG002|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
10371788|NCT00561145|11512942|FG000|STARTED|Overall Study||15
10371789|NCT00561145|11512943|FG001|STARTED|Overall Study||17
10371790|NCT00561145|11512942|FG000|COMPLETED|Overall Study||15
10371791|NCT00561145|11512943|FG001|COMPLETED|Overall Study||17
10371792|NCT00561145|11512942|FG000|NOT COMPLETED|Overall Study||0
10371793|NCT00561145|11512943|FG001|NOT COMPLETED|Overall Study||0
10371794|NCT00561340|11512951|FG000|STARTED|Overall Study||13
10371795|NCT00561340|11512952|FG001|STARTED|Overall Study||16
10371796|NCT00561340|11512951|FG000|COMPLETED|Overall Study||7
10716896|NCT02693132|11880811|FG000|COMPLETED|Overall Study||16
10716897|NCT02693132|11880812|FG001|COMPLETED|Overall Study||16
10716898|NCT02693132|11880813|FG002|COMPLETED|Overall Study||17
10716899|NCT02693132|11880811|FG000|NOT COMPLETED|Overall Study||1
10716900|NCT02693132|11880812|FG001|NOT COMPLETED|Overall Study||1
10716901|NCT02693132|11880813|FG002|NOT COMPLETED|Overall Study||1
10371797|NCT00561340|11512952|FG001|COMPLETED|Overall Study||16
10371798|NCT00561340|11512951|FG000|NOT COMPLETED|Overall Study||6
10371799|NCT00561340|11512952|FG001|NOT COMPLETED|Overall Study||0
10371800|NCT00561353|11512968|FG000|STARTED|Overall Study||18
10371801|NCT00561353|11512969|FG001|STARTED|Overall Study||19
10371802|NCT00561353|11512970|FG002|STARTED|Overall Study||13
10371803|NCT00561353|11512971|FG003|STARTED|Overall Study||18
10716902|NCT02693262|11880821|FG000|STARTED|Overall Study||4
10716903|NCT02693262|11880822|FG001|STARTED|Overall Study||5
10716904|NCT02693262|11880821|FG000|COMPLETED|Overall Study||4
10716905|NCT02693262|11880822|FG001|COMPLETED|Overall Study||5
10716906|NCT02693262|11880821|FG000|NOT COMPLETED|Overall Study||0
10716907|NCT02693262|11880822|FG001|NOT COMPLETED|Overall Study||0
10716908|NCT02693418|11880833|FG000|STARTED|Overall Study||22
10716909|NCT02693418|11880834|FG001|STARTED|Overall Study||21
10716910|NCT02693418|11880835|FG002|STARTED|Overall Study||21
10716911|NCT02693418|11880836|FG003|STARTED|Overall Study||20
10716912|NCT02693418|11880837|FG004|STARTED|Overall Study||21
10716913|NCT02693418|11880833|FG000|COMPLETED|Overall Study||21
10716914|NCT02693418|11880834|FG001|COMPLETED|Overall Study||19
10371804|NCT00561353|11512972|FG004|STARTED|Overall Study||6
10371805|NCT00561353|11512973|FG005|STARTED|Overall Study||9
10371806|NCT00561353|11512974|FG006|STARTED|Overall Study||9
10371807|NCT00561353|11512975|FG007|STARTED|Overall Study||10
10716915|NCT02693418|11880835|FG002|COMPLETED|Overall Study||19
10716916|NCT02693418|11880836|FG003|COMPLETED|Overall Study||20
10716917|NCT02693418|11880837|FG004|COMPLETED|Overall Study||21
10716918|NCT02693418|11880833|FG000|NOT COMPLETED|Overall Study||1
10716919|NCT02693418|11880834|FG001|NOT COMPLETED|Overall Study||2
10371808|NCT00561353|11512976|FG008|STARTED|Overall Study||9
10371809|NCT00561353|11512977|FG009|STARTED|Overall Study||5
10371810|NCT00561353|11512968|FG000|COMPLETED|Overall Study||13
10371811|NCT00561353|11512969|FG001|COMPLETED|Overall Study||16
10371812|NCT00561353|11512970|FG002|COMPLETED|Overall Study||10
10371813|NCT00561353|11512971|FG003|COMPLETED|Overall Study||12
10371814|NCT00561353|11512972|FG004|COMPLETED|Overall Study||5
10371815|NCT00561353|11512973|FG005|COMPLETED|Overall Study||3
10371816|NCT00561353|11512974|FG006|COMPLETED|Overall Study||3
10371817|NCT00561353|11512975|FG007|COMPLETED|Overall Study||6
10371818|NCT00561353|11512976|FG008|COMPLETED|Overall Study||2
10371819|NCT00561353|11512977|FG009|COMPLETED|Overall Study||3
10716920|NCT02693418|11880835|FG002|NOT COMPLETED|Overall Study||2
10716921|NCT02693418|11880836|FG003|NOT COMPLETED|Overall Study||0
10371820|NCT00561353|11512968|FG000|NOT COMPLETED|Overall Study||5
10371821|NCT00561353|11512969|FG001|NOT COMPLETED|Overall Study||3
10371822|NCT00561353|11512970|FG002|NOT COMPLETED|Overall Study||3
10371823|NCT00561353|11512971|FG003|NOT COMPLETED|Overall Study||6
10371824|NCT00561353|11512972|FG004|NOT COMPLETED|Overall Study||1
10371825|NCT00561353|11512973|FG005|NOT COMPLETED|Overall Study||6
10371826|NCT00561353|11512974|FG006|NOT COMPLETED|Overall Study||6
10371827|NCT00561353|11512975|FG007|NOT COMPLETED|Overall Study||4
10371828|NCT00561353|11512976|FG008|NOT COMPLETED|Overall Study||7
10371829|NCT00561353|11512977|FG009|NOT COMPLETED|Overall Study||2
10371830|NCT00561392|11513039|FG000|STARTED|Overall Study||208
10371831|NCT00561392|11513039|FG000|COMPLETED|Overall Study||155
10371832|NCT00561392|11513039|FG000|NOT COMPLETED|Overall Study||53
10371833|NCT00561418|11513043|FG000|STARTED|Overall Study||23
10371834|NCT00561418|11513043|FG000|COMPLETED|Overall Study||23
10371835|NCT00561418|11513043|FG000|NOT COMPLETED|Overall Study||0
10371836|NCT00561431|11513049|FG000|STARTED|Overall Study||100
10371837|NCT00561431|11513050|FG001|STARTED|Overall Study||100
10371838|NCT00561431|11513049|FG000|COMPLETED|Overall Study||100
10371839|NCT00561431|11513050|FG001|COMPLETED|Overall Study||100
10371840|NCT00561431|11513049|FG000|NOT COMPLETED|Overall Study||0
10371841|NCT00561431|11513050|FG001|NOT COMPLETED|Overall Study||0
10371842|NCT00561457|11513056|FG000|STARTED|Overall Study||134
10371843|NCT00561457|11513056|FG000|COMPLETED|Overall Study||110
10371844|NCT00561457|11513056|FG000|NOT COMPLETED|Overall Study||24
10371845|NCT00561470|11513062|FG000|STARTED|Overall Study||614
10371846|NCT00561470|11513063|FG001|STARTED|Overall Study||612
10371847|NCT00561470|11513062|FG000|TREATED|Overall Study||609
10371848|NCT00561470|11513063|FG001|TREATED|Overall Study||607
10371849|NCT00561470|11513062|FG000|SAFETY POPULATION|Overall Study|Treated participants excluding 4 who received at least 1 dose of Aflibercept|605
10371850|NCT00561470|11513063|FG001|SAFETY POPULATION|Overall Study|Treated participants including 4 from Placebo/FOLFIRI who received at least 1 dose of Aflibercept|611
10371851|NCT00561470|11513062|FG000|ONGOING TREATMENT|Overall Study|Participants continuing treatment on the cutoff date of the final analysis|11
10371852|NCT00561470|11513063|FG001|ONGOING TREATMENT|Overall Study|Participants continuing treatment on the cutoff date of the final analysis|14
10371853|NCT00561470|11513062|FG000|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were ongoing treatment on the cutoff date|0
10371854|NCT00561470|11513063|FG001|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were ongoing treatment on the cutoff date|0
10371855|NCT00561470|11513062|FG000|NOT COMPLETED|Overall Study||614
10371856|NCT00561470|11513063|FG001|NOT COMPLETED|Overall Study||612
10371857|NCT00561574|11513073|FG000|STARTED|Overall Study||128
10371858|NCT00561574|11513074|FG001|STARTED|Overall Study||131
10371859|NCT00561574|11513073|FG000|COMPLETED|Overall Study||80
10371860|NCT00561574|11513074|FG001|COMPLETED|Overall Study||73
10371861|NCT00561574|11513073|FG000|NOT COMPLETED|Overall Study||48
10371862|NCT00561574|11513074|FG001|NOT COMPLETED|Overall Study||58
10371863|NCT00561600|11513082|FG000|STARTED|Overall Study||130
10371864|NCT00561600|11513083|FG001|STARTED|Overall Study||135
10371865|NCT00561600|11513082|FG000|COMPLETED|Overall Study||112
10371866|NCT00561600|11513083|FG001|COMPLETED|Overall Study||119
10371867|NCT00561600|11513082|FG000|NOT COMPLETED|Overall Study||18
10371868|NCT00561600|11513083|FG001|NOT COMPLETED|Overall Study||16
10371869|NCT00561652|11513093|FG000|STARTED|Overall Study||10
10371870|NCT00561652|11513094|FG001|STARTED|Overall Study||20
10371871|NCT00561652|11513093|FG000|COMPLETED|Overall Study||10
10371872|NCT00561652|11513094|FG001|COMPLETED|Overall Study||19
10371873|NCT00561652|11513093|FG000|NOT COMPLETED|Overall Study||0
10371874|NCT00561652|11513094|FG001|NOT COMPLETED|Overall Study||1
10371875|NCT00561678|11513102|FG000|STARTED|Overall Study||197
10371876|NCT00561678|11513103|FG001|STARTED|Overall Study||207
10371877|NCT00561678|11513102|FG000|COMPLETED|Overall Study||189
10371878|NCT00561678|11513103|FG001|COMPLETED|Overall Study||201
10371879|NCT00561678|11513102|FG000|NOT COMPLETED|Overall Study||8
10371880|NCT00561678|11513103|FG001|NOT COMPLETED|Overall Study||6
10371881|NCT00561730|11513109|FG000|STARTED|Overall Study||1995
10371882|NCT00561730|11513109|FG000|COMPLETED|Overall Study||1986
10371883|NCT00561730|11513109|FG000|NOT COMPLETED|Overall Study||9
10371884|NCT00561821|11513119|FG000|STARTED|Overall Study||132
10371885|NCT00561821|11513120|FG001|STARTED|Overall Study||136
10371886|NCT00561821|11513121|FG002|STARTED|Overall Study||134
10371887|NCT00561821|11513122|FG003|STARTED|Overall Study||136
10371888|NCT00561821|11513119|FG000|Treated|Overall Study||132
10371889|NCT00561821|11513120|FG001|Treated|Overall Study||136
10371890|NCT00561821|11513121|FG002|Treated|Overall Study||133
10371891|NCT00561821|11513122|FG003|Treated|Overall Study||136
10371892|NCT00561821|11513119|FG000|COMPLETED|Overall Study||127
10371893|NCT00561821|11513120|FG001|COMPLETED|Overall Study||130
10371894|NCT00561821|11513121|FG002|COMPLETED|Overall Study||132
10371895|NCT00561821|11513122|FG003|COMPLETED|Overall Study||133
10371896|NCT00561821|11513119|FG000|NOT COMPLETED|Overall Study||5
10371897|NCT00561821|11513120|FG001|NOT COMPLETED|Overall Study||6
10371898|NCT00561821|11513121|FG002|NOT COMPLETED|Overall Study||2
10371899|NCT00561821|11513122|FG003|NOT COMPLETED|Overall Study||3
10371900|NCT00561834|11513132|FG000|STARTED|Overall Study||2
10371901|NCT00561834|11513132|FG000|COMPLETED|Overall Study||2
10371902|NCT00561834|11513132|FG000|NOT COMPLETED|Overall Study||0
10371903|NCT00561925|11513139|FG000|STARTED|14 Day Lead-In Period||1068
10371904|NCT00561925|11513140|FG001|STARTED|14 Day Lead-In Period||0
10371905|NCT00561925|11513141|FG002|STARTED|14 Day Lead-In Period||0
10371906|NCT00561925|11513142|FG003|STARTED|14 Day Lead-In Period||0
10371907|NCT00561925|11513143|FG004|STARTED|14 Day Lead-In Period||0
10371908|NCT00561925|11513139|FG000|COMPLETED|14 Day Lead-In Period||1013
10371909|NCT00561925|11513140|FG001|COMPLETED|14 Day Lead-In Period||0
10371910|NCT00561925|11513141|FG002|COMPLETED|14 Day Lead-In Period||0
10371911|NCT00561925|11513142|FG003|COMPLETED|14 Day Lead-In Period||0
10371912|NCT00561925|11513143|FG004|COMPLETED|14 Day Lead-In Period||0
10371913|NCT00561925|11513139|FG000|NOT COMPLETED|14 Day Lead-In Period||55
10371914|NCT00561925|11513140|FG001|NOT COMPLETED|14 Day Lead-In Period||0
10371915|NCT00561925|11513141|FG002|NOT COMPLETED|14 Day Lead-In Period||0
10371916|NCT00561925|11513142|FG003|NOT COMPLETED|14 Day Lead-In Period||0
10537705|NCT01451203|11690396|FG000|Received Treatment|Double-blind Treatment Period||157
10537706|NCT01451203|11690397|FG001|Received Treatment|Double-blind Treatment Period||159
10716922|NCT02693418|11880837|FG004|NOT COMPLETED|Overall Study||0
10716923|NCT02693704|11880853|FG000|STARTED|Overall Study||10
10716924|NCT02693704|11880854|FG001|STARTED|Overall Study||10
10716925|NCT02693704|11880855|FG002|STARTED|Overall Study||10
10716926|NCT02693704|11880856|FG003|STARTED|Overall Study||10
10716927|NCT02693704|11880853|FG000|COMPLETED|Overall Study||10
10537707|NCT01451203|11690396|FG000|Received Rescue Treatment|Double-blind Treatment Period|Participants who did not achieve improvement at & after Week 24 were dropped out of study schedule.|70
10537724|NCT01451385|11690407|FG000|STARTED|Overall Study||376
10537708|NCT01451203|11690397|FG001|Received Rescue Treatment|Double-blind Treatment Period|Participants who did not achieve improvement at & after Week 24 were dropped out of study schedule.|36
10657264|NCT02224508|11818461|FG000|STARTED|Overall Study|Number of patients surveyed in intervention segment of the health plan (group practice).|935
10657265|NCT02224508|11818462|FG001|STARTED|Overall Study|Number of patients surveyed in the control segment of the health plan (contracted care).|653
10657266|NCT02224508|11818461|FG000|COMPLETED|Overall Study||935
10657267|NCT02224508|11818462|FG001|COMPLETED|Overall Study||653
10657268|NCT02224508|11818461|FG000|NOT COMPLETED|Overall Study||0
10657269|NCT02224508|11818462|FG001|NOT COMPLETED|Overall Study||0
10657285|NCT02224612|11818482|FG000|STARTED|Overall Study||48
10657286|NCT02224612|11818483|FG001|STARTED|Overall Study||48
10657287|NCT02224612|11818482|FG000|COMPLETED|Overall Study||48
10657288|NCT02224612|11818483|FG001|COMPLETED|Overall Study||48
10657289|NCT02224612|11818482|FG000|NOT COMPLETED|Overall Study||0
10657290|NCT02224612|11818483|FG001|NOT COMPLETED|Overall Study||0
10657291|NCT02224625|11818491|FG000|STARTED|Irritation||39
10657292|NCT02224625|11818491|FG000|COMPLETED|Irritation||33
10657293|NCT02224625|11818491|FG000|NOT COMPLETED|Irritation||6
10657294|NCT02224625|11818491|FG000|STARTED|Sensitization|Subjects from Irritation study also participated in Sensitization Study|249
10657295|NCT02224625|11818491|FG000|COMPLETED|Sensitization||194
10657296|NCT02224625|11818491|FG000|NOT COMPLETED|Sensitization||55
10657297|NCT02224638|11818505|FG000|STARTED|Overall Study||11
10657298|NCT02224638|11818506|FG001|STARTED|Overall Study||10
10657299|NCT02224638|11818505|FG000|COMPLETED|Overall Study||10
10657300|NCT02224638|11818506|FG001|COMPLETED|Overall Study||9
10657301|NCT02224638|11818505|FG000|NOT COMPLETED|Overall Study||1
10657302|NCT02224638|11818506|FG001|NOT COMPLETED|Overall Study||1
10657303|NCT02224664|11818514|FG000|STARTED|Lead-in Period (3 Days)||50
10716928|NCT02693704|11880854|FG001|COMPLETED|Overall Study||10
10716929|NCT02693704|11880855|FG002|COMPLETED|Overall Study||10
10716930|NCT02693704|11880856|FG003|COMPLETED|Overall Study||10
10537709|NCT01451203|11690396|FG000|COMPLETED|Double-blind Treatment Period||73
10537710|NCT01451203|11690397|FG001|COMPLETED|Double-blind Treatment Period||111
10537711|NCT01451203|11690396|FG000|NOT COMPLETED|Double-blind Treatment Period||85
10537712|NCT01451203|11690397|FG001|NOT COMPLETED|Double-blind Treatment Period||50
10537713|NCT01451203|11690396|FG000|STARTED|Post-treatment Period|Two participants received rescue treatment and did not enter this period.|71
10537714|NCT01451203|11690397|FG001|STARTED|Post-treatment Period|Three participants received rescue treatment and did not enter this period.|108
10537715|NCT01451203|11690396|FG000|Received Rescue Treatment|Post-treatment Period|Participants who presented with flares at any time were dropped out of study schedule.|12
10537716|NCT01451203|11690397|FG001|Received Rescue Treatment|Post-treatment Period|Participants who presented with flares at any time were dropped out of study schedule.|28
10371917|NCT00561925|11513143|FG004|NOT COMPLETED|14 Day Lead-In Period||0
10371918|NCT00561925|11513139|FG000|STARTED|144-week Double-blind, Double-dummy||0
10371919|NCT00561925|11513140|FG001|STARTED|144-week Double-blind, Double-dummy||508
10371920|NCT00561925|11513141|FG002|STARTED|144-week Double-blind, Double-dummy||505
10371921|NCT00561925|11513142|FG003|STARTED|144-week Double-blind, Double-dummy||0
10371922|NCT00561925|11513143|FG004|STARTED|144-week Double-blind, Double-dummy||0
10371923|NCT00561925|11513139|FG000|COMPLETED|144-week Double-blind, Double-dummy||0
10371924|NCT00561925|11513140|FG001|COMPLETED|144-week Double-blind, Double-dummy||358
10371925|NCT00561925|11513141|FG002|COMPLETED|144-week Double-blind, Double-dummy||378
10371926|NCT00561925|11513142|FG003|COMPLETED|144-week Double-blind, Double-dummy||0
10371927|NCT00561925|11513143|FG004|COMPLETED|144-week Double-blind, Double-dummy||0
10371928|NCT00561925|11513139|FG000|NOT COMPLETED|144-week Double-blind, Double-dummy||0
10371929|NCT00561925|11513140|FG001|NOT COMPLETED|144-week Double-blind, Double-dummy||150
10371930|NCT00561925|11513141|FG002|NOT COMPLETED|144-week Double-blind, Double-dummy||127
10371931|NCT00561925|11513142|FG003|NOT COMPLETED|144-week Double-blind, Double-dummy||0
10371932|NCT00561925|11513143|FG004|NOT COMPLETED|144-week Double-blind, Double-dummy||0
10371933|NCT00561925|11513139|FG000|STARTED|Open-Label Extension Period||0
10371934|NCT00561925|11513140|FG001|STARTED|Open-Label Extension Period||1
10537717|NCT01451203|11690396|FG000|COMPLETED|Post-treatment Period||57
10537718|NCT01451203|11690397|FG001|COMPLETED|Post-treatment Period||74
10537719|NCT01451203|11690396|FG000|NOT COMPLETED|Post-treatment Period||14
10537720|NCT01451203|11690397|FG001|NOT COMPLETED|Post-treatment Period||34
10537721|NCT01451372|11690403|FG000|STARTED|Overall Study||69
10537722|NCT01451372|11690403|FG000|COMPLETED|Overall Study||69
10537723|NCT01451372|11690403|FG000|NOT COMPLETED|Overall Study||0
10537725|NCT01451385|11690407|FG000|COMPLETED|Overall Study||285
10537726|NCT01451385|11690407|FG000|NOT COMPLETED|Overall Study||91
10371935|NCT00561925|11513141|FG002|STARTED|Open-Label Extension Period||0
10371936|NCT00561925|11513142|FG003|STARTED|Open-Label Extension Period||358
10537727|NCT01451398|11690413|FG000|STARTED|Overall Study||177
10537728|NCT01451398|11690414|FG001|STARTED|Overall Study||176
10537729|NCT01451398|11690413|FG000|COMPLETED|Overall Study||150
10537730|NCT01451398|11690414|FG001|COMPLETED|Overall Study||139
10537731|NCT01451398|11690413|FG000|NOT COMPLETED|Overall Study||27
10537732|NCT01451398|11690414|FG001|NOT COMPLETED|Overall Study||37
10537733|NCT01451411|11690422|FG000|STARTED|Overall Study||3
10537734|NCT01451411|11690423|FG001|STARTED|Overall Study||1
10537735|NCT01451411|11690422|FG000|COMPLETED|Overall Study||3
10537736|NCT01451411|11690423|FG001|COMPLETED|Overall Study||1
10537737|NCT01451411|11690422|FG000|NOT COMPLETED|Overall Study||0
10537738|NCT01451411|11690423|FG001|NOT COMPLETED|Overall Study||0
10537739|NCT01451424|11690433|FG000|STARTED|Overall Study||9
10537740|NCT01451424|11690434|FG001|STARTED|Overall Study||9
10537741|NCT01451424|11690435|FG002|STARTED|Overall Study||12
10537742|NCT01451424|11690436|FG003|STARTED|Overall Study||10
10537743|NCT01451424|11690433|FG000|COMPLETED|Overall Study||8
10537744|NCT01451424|11690434|FG001|COMPLETED|Overall Study||7
10537745|NCT01451424|11690435|FG002|COMPLETED|Overall Study||11
10537746|NCT01451424|11690436|FG003|COMPLETED|Overall Study||5
10537747|NCT01451424|11690433|FG000|NOT COMPLETED|Overall Study||1
10537748|NCT01451424|11690434|FG001|NOT COMPLETED|Overall Study||2
10537749|NCT01451424|11690435|FG002|NOT COMPLETED|Overall Study||1
10537750|NCT01451424|11690436|FG003|NOT COMPLETED|Overall Study||5
10537751|NCT01451437|11690460|FG000|STARTED|Overall Study||1
10537752|NCT01451437|11690461|FG001|STARTED|Overall Study||1
10537753|NCT01451437|11690462|FG002|STARTED|Overall Study||3
10537754|NCT01451437|11690463|FG003|STARTED|Overall Study||1
10537755|NCT01451437|11690464|FG004|STARTED|Overall Study||4
10537756|NCT01451437|11690465|FG005|STARTED|Overall Study||3
10537757|NCT01451437|11690466|FG006|STARTED|Overall Study||6
10537758|NCT01451437|11690467|FG007|STARTED|Overall Study||3
10537759|NCT01451437|11690468|FG008|STARTED|Overall Study||4
10537760|NCT01451437|11690460|FG000|COMPLETED|Overall Study||0
10537761|NCT01451437|11690461|FG001|COMPLETED|Overall Study||0
10537762|NCT01451437|11690462|FG002|COMPLETED|Overall Study||0
10537763|NCT01451437|11690463|FG003|COMPLETED|Overall Study||0
10537764|NCT01451437|11690464|FG004|COMPLETED|Overall Study||0
10537765|NCT01451437|11690465|FG005|COMPLETED|Overall Study||0
10537766|NCT01451437|11690466|FG006|COMPLETED|Overall Study||0
10537767|NCT01451437|11690467|FG007|COMPLETED|Overall Study||0
10537768|NCT01451437|11690468|FG008|COMPLETED|Overall Study||0
10537769|NCT01451437|11690460|FG000|NOT COMPLETED|Overall Study||1
10537770|NCT01451437|11690461|FG001|NOT COMPLETED|Overall Study||1
10537771|NCT01451437|11690462|FG002|NOT COMPLETED|Overall Study||3
10537772|NCT01451437|11690463|FG003|NOT COMPLETED|Overall Study||1
10537773|NCT01451437|11690464|FG004|NOT COMPLETED|Overall Study||4
10537774|NCT01451437|11690465|FG005|NOT COMPLETED|Overall Study||3
10537775|NCT01451437|11690466|FG006|NOT COMPLETED|Overall Study||6
10537776|NCT01451437|11690467|FG007|NOT COMPLETED|Overall Study||3
10537777|NCT01451437|11690468|FG008|NOT COMPLETED|Overall Study||4
10537778|NCT01451463|11690497|FG000|STARTED|Overall Study||11
10537779|NCT01451463|11690497|FG000|COMPLETED|Overall Study||11
10537780|NCT01451463|11690497|FG000|NOT COMPLETED|Overall Study||0
10537781|NCT01451541|11690509|FG000|STARTED|Overall Study||283
10537782|NCT01451541|11690510|FG001|STARTED|Overall Study||282
10537783|NCT01451541|11690511|FG002|STARTED|Overall Study|283 randomized. ITT = 281 (2 subjects discontinued prior to study medication).|281
10537784|NCT01451541|11690509|FG000|COMPLETED|Overall Study||247
10537785|NCT01451541|11690510|FG001|COMPLETED|Overall Study||257
10537786|NCT01451541|11690511|FG002|COMPLETED|Overall Study||254
10537787|NCT01451541|11690509|FG000|NOT COMPLETED|Overall Study||36
10537788|NCT01451541|11690510|FG001|NOT COMPLETED|Overall Study||25
10537789|NCT01451541|11690511|FG002|NOT COMPLETED|Overall Study||27
10371937|NCT00561925|11513143|FG004|STARTED|Open-Label Extension Period||378
10371938|NCT00561925|11513139|FG000|COMPLETED|Open-Label Extension Period||0
10371939|NCT00561925|11513140|FG001|COMPLETED|Open-Label Extension Period||1
10371940|NCT00561925|11513141|FG002|COMPLETED|Open-Label Extension Period||0
10371941|NCT00561925|11513142|FG003|COMPLETED|Open-Label Extension Period||315
10371942|NCT00561925|11513143|FG004|COMPLETED|Open-Label Extension Period||328
10371943|NCT00561925|11513139|FG000|NOT COMPLETED|Open-Label Extension Period||0
10371944|NCT00561925|11513140|FG001|NOT COMPLETED|Open-Label Extension Period||0
10371945|NCT00561925|11513141|FG002|NOT COMPLETED|Open-Label Extension Period||0
10371946|NCT00561925|11513142|FG003|NOT COMPLETED|Open-Label Extension Period||43
10371947|NCT00561925|11513143|FG004|NOT COMPLETED|Open-Label Extension Period||50
10371948|NCT00561951|11513164|FG000|STARTED|Overall Study||318
10371949|NCT00561951|11513165|FG001|STARTED|Overall Study||320
10371950|NCT00561951|11513166|FG002|STARTED|Overall Study||313
10371951|NCT00561951|11513164|FG000|COMPLETED|Overall Study||285
10371952|NCT00561951|11513165|FG001|COMPLETED|Overall Study||286
10371953|NCT00561951|11513166|FG002|COMPLETED|Overall Study||281
10371954|NCT00561951|11513164|FG000|NOT COMPLETED|Overall Study||33
10371955|NCT00561951|11513165|FG001|NOT COMPLETED|Overall Study||34
10371956|NCT00561951|11513166|FG002|NOT COMPLETED|Overall Study||32
10371957|NCT00561977|11513177|FG000|STARTED|Overall Study||12
10371958|NCT00561977|11513178|FG001|STARTED|Overall Study||12
10371959|NCT00561977|11513179|FG002|STARTED|Overall Study||12
10371960|NCT00561977|11513177|FG000|COMPLETED|Overall Study||12
10371961|NCT00561977|11513178|FG001|COMPLETED|Overall Study||9
10371962|NCT00561977|11513179|FG002|COMPLETED|Overall Study||10
10371963|NCT00561977|11513177|FG000|NOT COMPLETED|Overall Study||0
10371964|NCT00561977|11513178|FG001|NOT COMPLETED|Overall Study||3
10371965|NCT00561977|11513179|FG002|NOT COMPLETED|Overall Study||2
10371966|NCT00562094|11513187|FG000|STARTED|Overall Study||8616
10371967|NCT00562094|11513187|FG000|COMPLETED|Overall Study||8554
10371968|NCT00562094|11513187|FG000|NOT COMPLETED|Overall Study||62
10371969|NCT00562120|11513195|FG000|STARTED|First Intervention Period||6
10371970|NCT00562120|11513196|FG001|STARTED|First Intervention Period||5
10371971|NCT00562120|11513197|FG002|STARTED|First Intervention Period||5
10371972|NCT00562120|11513198|FG003|STARTED|First Intervention Period||5
10371973|NCT00562120|11513195|FG000|Treated|First Intervention Period||5
10371974|NCT00562120|11513196|FG001|Treated|First Intervention Period||5
10371975|NCT00562120|11513197|FG002|Treated|First Intervention Period||5
10371976|NCT00562120|11513198|FG003|Treated|First Intervention Period||5
10371977|NCT00562120|11513195|FG000|COMPLETED|First Intervention Period||4
10371978|NCT00562120|11513196|FG001|COMPLETED|First Intervention Period||5
10371979|NCT00562120|11513197|FG002|COMPLETED|First Intervention Period||5
10371980|NCT00562120|11513198|FG003|COMPLETED|First Intervention Period||5
10371981|NCT00562120|11513195|FG000|NOT COMPLETED|First Intervention Period||2
10371982|NCT00562120|11513196|FG001|NOT COMPLETED|First Intervention Period||0
10371983|NCT00562120|11513197|FG002|NOT COMPLETED|First Intervention Period||0
10371984|NCT00562120|11513198|FG003|NOT COMPLETED|First Intervention Period||0
10371985|NCT00562120|11513195|FG000|STARTED|Washout Period 1 (At Least 14 Days)||4
10371986|NCT00562120|11513196|FG001|STARTED|Washout Period 1 (At Least 14 Days)||5
10371987|NCT00562120|11513197|FG002|STARTED|Washout Period 1 (At Least 14 Days)||5
10371988|NCT00562120|11513198|FG003|STARTED|Washout Period 1 (At Least 14 Days)||5
10371989|NCT00562120|11513195|FG000|COMPLETED|Washout Period 1 (At Least 14 Days)||4
10537790|NCT01451554|11690523|FG000|STARTED|Overall Study||33
10537791|NCT01451554|11690524|FG001|STARTED|Overall Study||32
10537792|NCT01451554|11690523|FG000|COMPLETED|Overall Study||19
10537793|NCT01451554|11690524|FG001|COMPLETED|Overall Study||23
10537794|NCT01451554|11690523|FG000|NOT COMPLETED|Overall Study||14
10537795|NCT01451554|11690524|FG001|NOT COMPLETED|Overall Study||9
10537796|NCT01451606|11690532|FG000|STARTED|Overall Study||16
10537797|NCT01451606|11690533|FG001|STARTED|Overall Study||18
10537798|NCT01451606|11690532|FG000|COMPLETED|Overall Study||12
10537799|NCT01451606|11690533|FG001|COMPLETED|Overall Study||15
10537800|NCT01451606|11690532|FG000|NOT COMPLETED|Overall Study||4
10537801|NCT01451606|11690533|FG001|NOT COMPLETED|Overall Study||3
10537802|NCT01451632|11690541|FG000|STARTED|Overall Study||8
10537803|NCT01451632|11690542|FG001|STARTED|Overall Study||4
10537804|NCT01451632|11690543|FG002|STARTED|Overall Study||3
10537805|NCT01451632|11690544|FG003|STARTED|Overall Study||3
10537806|NCT01451632|11690545|FG004|STARTED|Overall Study||4
10537807|NCT01451632|11690546|FG005|STARTED|Overall Study||4
10537808|NCT01451632|11690547|FG006|STARTED|Overall Study||8
10537809|NCT01451632|11690548|FG007|STARTED|Overall Study||6
10537810|NCT01451632|11690549|FG008|STARTED|Overall Study||4
10537811|NCT01451632|11690550|FG009|STARTED|Overall Study||4
10537812|NCT01451632|11690541|FG000|COMPLETED|Overall Study||8
10537813|NCT01451632|11690542|FG001|COMPLETED|Overall Study||4
10537814|NCT01451632|11690543|FG002|COMPLETED|Overall Study||3
10537815|NCT01451632|11690544|FG003|COMPLETED|Overall Study||3
10537816|NCT01451632|11690545|FG004|COMPLETED|Overall Study||4
10537817|NCT01451632|11690546|FG005|COMPLETED|Overall Study||4
10537818|NCT01451632|11690547|FG006|COMPLETED|Overall Study||8
10537819|NCT01451632|11690548|FG007|COMPLETED|Overall Study||6
10371990|NCT00562120|11513196|FG001|COMPLETED|Washout Period 1 (At Least 14 Days)||5
10537820|NCT01451632|11690549|FG008|COMPLETED|Overall Study||4
10537821|NCT01451632|11690550|FG009|COMPLETED|Overall Study||4
10537822|NCT01451632|11690541|FG000|NOT COMPLETED|Overall Study||0
10537823|NCT01451632|11690542|FG001|NOT COMPLETED|Overall Study||0
10537824|NCT01451632|11690543|FG002|NOT COMPLETED|Overall Study||0
10371991|NCT00562120|11513197|FG002|COMPLETED|Washout Period 1 (At Least 14 Days)||5
10371992|NCT00562120|11513198|FG003|COMPLETED|Washout Period 1 (At Least 14 Days)||5
10371993|NCT00562120|11513195|FG000|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
10371994|NCT00562120|11513196|FG001|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
10371995|NCT00562120|11513197|FG002|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
10371996|NCT00562120|11513198|FG003|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
10371997|NCT00562120|11513195|FG000|STARTED|Second Intervention Period||4
10371998|NCT00562120|11513196|FG001|STARTED|Second Intervention Period||5
10371999|NCT00562120|11513197|FG002|STARTED|Second Intervention Period||5
10372000|NCT00562120|11513198|FG003|STARTED|Second Intervention Period||5
10372001|NCT00562120|11513195|FG000|COMPLETED|Second Intervention Period||4
10372002|NCT00562120|11513196|FG001|COMPLETED|Second Intervention Period||5
10372003|NCT00562120|11513197|FG002|COMPLETED|Second Intervention Period||5
10372004|NCT00562120|11513198|FG003|COMPLETED|Second Intervention Period||5
10372005|NCT00562120|11513195|FG000|NOT COMPLETED|Second Intervention Period||0
10372006|NCT00562120|11513196|FG001|NOT COMPLETED|Second Intervention Period||0
10372007|NCT00562120|11513197|FG002|NOT COMPLETED|Second Intervention Period||0
10372008|NCT00562120|11513198|FG003|NOT COMPLETED|Second Intervention Period||0
10372009|NCT00562120|11513195|FG000|STARTED|Washout Period 2 (At Least 14 Days)||4
10372010|NCT00562120|11513196|FG001|STARTED|Washout Period 2 (At Least 14 Days)||5
10372011|NCT00562120|11513197|FG002|STARTED|Washout Period 2 (At Least 14 Days)||5
10372012|NCT00562120|11513198|FG003|STARTED|Washout Period 2 (At Least 14 Days)||5
10372013|NCT00562120|11513195|FG000|COMPLETED|Washout Period 2 (At Least 14 Days)||4
10372014|NCT00562120|11513196|FG001|COMPLETED|Washout Period 2 (At Least 14 Days)||5
10372015|NCT00562120|11513197|FG002|COMPLETED|Washout Period 2 (At Least 14 Days)||5
10372016|NCT00562120|11513198|FG003|COMPLETED|Washout Period 2 (At Least 14 Days)||5
10372017|NCT00562120|11513195|FG000|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
10372018|NCT00562120|11513196|FG001|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
10372019|NCT00562120|11513197|FG002|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
10372020|NCT00562120|11513198|FG003|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
10372021|NCT00562120|11513195|FG000|STARTED|Third Intervention Period||4
10372022|NCT00562120|11513196|FG001|STARTED|Third Intervention Period||5
10372023|NCT00562120|11513197|FG002|STARTED|Third Intervention Period||5
10372024|NCT00562120|11513198|FG003|STARTED|Third Intervention Period||5
10372025|NCT00562120|11513195|FG000|COMPLETED|Third Intervention Period||4
10372026|NCT00562120|11513196|FG001|COMPLETED|Third Intervention Period||5
10372027|NCT00562120|11513197|FG002|COMPLETED|Third Intervention Period||5
10372028|NCT00562120|11513198|FG003|COMPLETED|Third Intervention Period||5
10372029|NCT00562120|11513195|FG000|NOT COMPLETED|Third Intervention Period||0
10372030|NCT00562120|11513196|FG001|NOT COMPLETED|Third Intervention Period||0
10372031|NCT00562120|11513197|FG002|NOT COMPLETED|Third Intervention Period||0
10372032|NCT00562120|11513198|FG003|NOT COMPLETED|Third Intervention Period||0
10372033|NCT00562120|11513195|FG000|STARTED|Washout Period 3 (At Least 14 Days)||4
10372034|NCT00562120|11513196|FG001|STARTED|Washout Period 3 (At Least 14 Days)||5
10372035|NCT00562120|11513197|FG002|STARTED|Washout Period 3 (At Least 14 Days)||5
10716931|NCT02693704|11880853|FG000|NOT COMPLETED|Overall Study||0
10716932|NCT02693704|11880854|FG001|NOT COMPLETED|Overall Study||0
10372036|NCT00562120|11513198|FG003|STARTED|Washout Period 3 (At Least 14 Days)||5
10372037|NCT00562120|11513195|FG000|COMPLETED|Washout Period 3 (At Least 14 Days)||4
10372038|NCT00562120|11513196|FG001|COMPLETED|Washout Period 3 (At Least 14 Days)||5
10372039|NCT00562120|11513197|FG002|COMPLETED|Washout Period 3 (At Least 14 Days)||5
10372040|NCT00562120|11513198|FG003|COMPLETED|Washout Period 3 (At Least 14 Days)||5
10372041|NCT00562120|11513195|FG000|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
10372042|NCT00562120|11513196|FG001|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
10372043|NCT00562120|11513197|FG002|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
10372044|NCT00562120|11513198|FG003|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
10372045|NCT00562120|11513195|FG000|STARTED|Fourth Intervention Period||4
10372046|NCT00562120|11513196|FG001|STARTED|Fourth Intervention Period||5
10372047|NCT00562120|11513197|FG002|STARTED|Fourth Intervention Period||5
10372048|NCT00562120|11513198|FG003|STARTED|Fourth Intervention Period||5
10372049|NCT00562120|11513195|FG000|COMPLETED|Fourth Intervention Period||4
10372050|NCT00562120|11513196|FG001|COMPLETED|Fourth Intervention Period||5
10372051|NCT00562120|11513197|FG002|COMPLETED|Fourth Intervention Period||5
10372052|NCT00562120|11513198|FG003|COMPLETED|Fourth Intervention Period||5
10372053|NCT00562120|11513195|FG000|NOT COMPLETED|Fourth Intervention Period||0
10372054|NCT00562120|11513196|FG001|NOT COMPLETED|Fourth Intervention Period||0
10372055|NCT00562120|11513197|FG002|NOT COMPLETED|Fourth Intervention Period||0
10372056|NCT00562120|11513198|FG003|NOT COMPLETED|Fourth Intervention Period||0
10372057|NCT00562159|11513210|FG000|STARTED|Overall Study||213
10716933|NCT02693704|11880855|FG002|NOT COMPLETED|Overall Study||0
10372058|NCT00562159|11513211|FG001|STARTED|Overall Study||225
10372059|NCT00562159|11513210|FG000|COMPLETED|Overall Study||175
10372060|NCT00562159|11513211|FG001|COMPLETED|Overall Study||192
10372061|NCT00562159|11513210|FG000|NOT COMPLETED|Overall Study||38
10372062|NCT00562159|11513211|FG001|NOT COMPLETED|Overall Study||33
10372063|NCT00562302|11513220|FG000|STARTED|Overall Study||170
10372064|NCT00562302|11513221|FG001|STARTED|Overall Study||169
10372065|NCT00562302|11513220|FG000|COMPLETED|Overall Study||150
10372066|NCT00562302|11513221|FG001|COMPLETED|Overall Study||137
10372067|NCT00562302|11513220|FG000|NOT COMPLETED|Overall Study||20
10372068|NCT00562302|11513221|FG001|NOT COMPLETED|Overall Study||32
10372069|NCT00562315|11513227|FG000|STARTED|Overall Study||93
10372070|NCT00562315|11513227|FG000|COMPLETED|Overall Study||93
10372071|NCT00562315|11513227|FG000|NOT COMPLETED|Overall Study||0
10372072|NCT00562328|11513233|FG000|STARTED|Overall Study||33
10372073|NCT00562328|11513233|FG000|COMPLETED|Overall Study||33
10372074|NCT00562328|11513233|FG000|NOT COMPLETED|Overall Study||0
10372075|NCT00562354|11513239|FG000|STARTED|Overall Study||134
10372076|NCT00562354|11513240|FG001|STARTED|Overall Study||137
10372077|NCT00562354|11513239|FG000|Received Study Treatment|Overall Study||134
10372078|NCT00562354|11513240|FG001|Received Study Treatment|Overall Study||136
10372079|NCT00562354|11513239|FG000|Evaluable Immunogenicity Population|Overall Study||134
10372080|NCT00562354|11513240|FG001|Evaluable Immunogenicity Population|Overall Study||134
10372081|NCT00562354|11513239|FG000|COMPLETED|Overall Study||134
10372082|NCT00562354|11513240|FG001|COMPLETED|Overall Study||135
10372083|NCT00562354|11513239|FG000|NOT COMPLETED|Overall Study||0
10372084|NCT00562354|11513240|FG001|NOT COMPLETED|Overall Study||2
10372085|NCT00562484|11513250|FG000|STARTED|Overall Study||10033
10372086|NCT00562484|11513251|FG001|STARTED|Overall Study||5011
10372087|NCT00562484|11513250|FG000|COMPLETED|Overall Study||9827
10372088|NCT00562484|11513251|FG001|COMPLETED|Overall Study||4907
10372089|NCT00562484|11513250|FG000|NOT COMPLETED|Overall Study||206
10372090|NCT00562484|11513251|FG001|NOT COMPLETED|Overall Study||104
10372091|NCT00562588|11513259|FG000|STARTED|Overall Study||260
10372092|NCT00562588|11513260|FG001|STARTED|Overall Study||283
10372093|NCT00562588|11513259|FG000|COMPLETED|Overall Study||168
10372094|NCT00562588|11513260|FG001|COMPLETED|Overall Study||184
10372095|NCT00562588|11513259|FG000|NOT COMPLETED|Overall Study||92
10372096|NCT00562588|11513260|FG001|NOT COMPLETED|Overall Study||99
10372097|NCT00562627|11513269|FG000|STARTED|Overall Study||34
10372098|NCT00562627|11513270|FG001|STARTED|Overall Study||34
10372099|NCT00562627|11513271|FG002|STARTED|Overall Study||34
10372100|NCT00562627|11513269|FG000|COMPLETED|Overall Study||33
10372101|NCT00562627|11513270|FG001|COMPLETED|Overall Study||33
10372102|NCT00562627|11513271|FG002|COMPLETED|Overall Study||33
10372103|NCT00562627|11513269|FG000|NOT COMPLETED|Overall Study||1
10372104|NCT00562627|11513270|FG001|NOT COMPLETED|Overall Study||1
10372105|NCT00562627|11513271|FG002|NOT COMPLETED|Overall Study||1
10372106|NCT00562718|11513279|FG000|STARTED|Overall Study||50
10372107|NCT00562718|11513279|FG000|COMPLETED|Overall Study||39
10372108|NCT00562718|11513279|FG000|NOT COMPLETED|Overall Study||11
10372109|NCT00562861|11513285|FG000|STARTED|Overall Study||60
10372110|NCT00562861|11513286|FG001|STARTED|Overall Study||59
10372111|NCT00562861|11513285|FG000|COMPLETED|Overall Study||40
10372112|NCT00562861|11513286|FG001|COMPLETED|Overall Study||48
10537825|NCT01451632|11690544|FG003|NOT COMPLETED|Overall Study||0
10537826|NCT01451632|11690545|FG004|NOT COMPLETED|Overall Study||0
10537827|NCT01451632|11690546|FG005|NOT COMPLETED|Overall Study||0
10537828|NCT01451632|11690547|FG006|NOT COMPLETED|Overall Study||0
10537829|NCT01451632|11690548|FG007|NOT COMPLETED|Overall Study||0
10537830|NCT01451632|11690549|FG008|NOT COMPLETED|Overall Study||0
10537831|NCT01451632|11690550|FG009|NOT COMPLETED|Overall Study||0
10537832|NCT01451645|11690577|FG000|STARTED|Overall Study||41
10537833|NCT01451645|11690578|FG001|STARTED|Overall Study||41
10537834|NCT01451645|11690577|FG000|COMPLETED|Overall Study||32
10537835|NCT01451645|11690578|FG001|COMPLETED|Overall Study||33
10537836|NCT01451645|11690577|FG000|NOT COMPLETED|Overall Study||9
10537837|NCT01451645|11690578|FG001|NOT COMPLETED|Overall Study||8
10537838|NCT01451749|11690586|FG000|STARTED|Overall Study||216
10537839|NCT01451749|11690587|FG001|STARTED|Overall Study||108
10537840|NCT01451749|11690586|FG000|COMPLETED|Overall Study||184
10537841|NCT01451749|11690587|FG001|COMPLETED|Overall Study||94
10537842|NCT01451749|11690586|FG000|NOT COMPLETED|Overall Study||32
10537843|NCT01451749|11690587|FG001|NOT COMPLETED|Overall Study||14
10537844|NCT01451762|11690598|FG000|STARTED|Overall Study||30
10537845|NCT01451762|11690599|FG001|STARTED|Overall Study||30
10537846|NCT01451762|11690600|FG002|STARTED|Overall Study||30
10372113|NCT00562861|11513285|FG000|NOT COMPLETED|Overall Study||20
10372114|NCT00562861|11513286|FG001|NOT COMPLETED|Overall Study||11
10372115|NCT00562965|11513294|FG000|STARTED|Overall Study||15
10372116|NCT00562965|11513295|FG001|STARTED|Overall Study||14
10537847|NCT01451762|11690598|FG000|COMPLETED|Overall Study||27
10372117|NCT00562965|11513294|FG000|Treated|Overall Study||15
10372118|NCT00562965|11513295|FG001|Treated|Overall Study||13
10372119|NCT00562965|11513294|FG000|COMPLETED|Overall Study||12
10372120|NCT00562965|11513295|FG001|COMPLETED|Overall Study||8
10372121|NCT00562965|11513294|FG000|NOT COMPLETED|Overall Study||3
10372122|NCT00562965|11513295|FG001|NOT COMPLETED|Overall Study||6
10372123|NCT00562978|11513303|FG000|STARTED|Overall Study||6
10372124|NCT00562978|11513304|FG001|STARTED|Overall Study||48
10537848|NCT01451762|11690599|FG001|COMPLETED|Overall Study||24
10537849|NCT01451762|11690600|FG002|COMPLETED|Overall Study||24
10537850|NCT01451762|11690598|FG000|NOT COMPLETED|Overall Study||3
10372125|NCT00562978|11513303|FG000|COMPLETED|Overall Study||5
10372126|NCT00562978|11513304|FG001|COMPLETED|Overall Study||37
10372127|NCT00562978|11513303|FG000|NOT COMPLETED|Overall Study||1
10372128|NCT00562978|11513304|FG001|NOT COMPLETED|Overall Study||11
10372129|NCT00563186|11513312|FG000|STARTED|Overall Study|Patients allocated to the Novel Hospital Ward|1008
10372130|NCT00563186|11513313|FG001|STARTED|Overall Study|Patients allocated to the Traditional Hospital Ward|679
10372131|NCT00563186|11513312|FG000|COMPLETED|Overall Study||910
10372132|NCT00563186|11513313|FG001|COMPLETED|Overall Study||604
10372133|NCT00563186|11513312|FG000|NOT COMPLETED|Overall Study||98
10372134|NCT00563186|11513313|FG001|NOT COMPLETED|Overall Study||75
10372135|NCT00563290|11513324|FG000|STARTED|Overall Study||3
10372136|NCT00563290|11513325|FG001|STARTED|Overall Study||4
10372137|NCT00563290|11513324|FG000|COMPLETED|Overall Study||3
10372138|NCT00563290|11513325|FG001|COMPLETED|Overall Study||4
10372139|NCT00563290|11513324|FG000|NOT COMPLETED|Overall Study||0
10372140|NCT00563290|11513325|FG001|NOT COMPLETED|Overall Study||0
10372141|NCT00563316|11513333|FG000|STARTED|Overall Study||28
10372142|NCT00563316|11513333|FG000|Received Investigational Product|Overall Study||27
10372143|NCT00563316|11513333|FG000|COMPLETED|Overall Study||16
10372144|NCT00563316|11513333|FG000|NOT COMPLETED|Overall Study||12
10372145|NCT00563368|11513348|FG000|STARTED|Overall Study||109
10372146|NCT00563368|11513349|FG001|STARTED|Overall Study||109
10372147|NCT00563368|11513350|FG002|STARTED|Overall Study||108
10372148|NCT00563368|11513351|FG003|STARTED|Overall Study||107
10372149|NCT00563368|11513352|FG004|STARTED|Overall Study||108
10372150|NCT00563368|11513353|FG005|STARTED|Overall Study||107
10372151|NCT00563368|11513354|FG006|STARTED|Overall Study||108
10372152|NCT00563368|11513348|FG000|COMPLETED|Overall Study||74
10372153|NCT00563368|11513349|FG001|COMPLETED|Overall Study||79
10372154|NCT00563368|11513350|FG002|COMPLETED|Overall Study||78
10372155|NCT00563368|11513351|FG003|COMPLETED|Overall Study||78
10372156|NCT00563368|11513352|FG004|COMPLETED|Overall Study||80
10372157|NCT00563368|11513353|FG005|COMPLETED|Overall Study||77
10372158|NCT00563368|11513354|FG006|COMPLETED|Overall Study||75
10372159|NCT00563368|11513348|FG000|NOT COMPLETED|Overall Study||35
10372160|NCT00563368|11513349|FG001|NOT COMPLETED|Overall Study||30
10372161|NCT00563368|11513350|FG002|NOT COMPLETED|Overall Study||30
10372162|NCT00563368|11513351|FG003|NOT COMPLETED|Overall Study||29
10372163|NCT00563368|11513352|FG004|NOT COMPLETED|Overall Study||28
10372164|NCT00563368|11513353|FG005|NOT COMPLETED|Overall Study||30
10372165|NCT00563368|11513354|FG006|NOT COMPLETED|Overall Study||33
10372166|NCT00563381|11513372|FG000|STARTED|Overall Study|Started treatment|3707
10372167|NCT00563381|11513373|FG001|STARTED|Overall Study|Started treatment|3669
10372168|NCT00563381|11513372|FG000|COMPLETED|Overall Study|Completed treatment|3122
10372169|NCT00563381|11513373|FG001|COMPLETED|Overall Study|Completed treatment|3021
10372170|NCT00563381|11513372|FG000|NOT COMPLETED|Overall Study||585
10372171|NCT00563381|11513373|FG001|NOT COMPLETED|Overall Study||648
10372172|NCT00563706|11513388|FG000|STARTED|DB Treatment Period (Day 1 up to Day 28)||37
10372173|NCT00563706|11513389|FG001|STARTED|DB Treatment Period (Day 1 up to Day 28)||18
10372174|NCT00563706|11513390|FG002|STARTED|DB Treatment Period (Day 1 up to Day 28)||8
10372175|NCT00563706|11513391|FG003|STARTED|DB Treatment Period (Day 1 up to Day 28)||19
10372176|NCT00563706|11513392|FG004|STARTED|DB Treatment Period (Day 1 up to Day 28)||16
10372177|NCT00563706|11513393|FG005|STARTED|DB Treatment Period (Day 1 up to Day 28)||19
10372178|NCT00563706|11513394|FG006|STARTED|DB Treatment Period (Day 1 up to Day 28)||12
10372179|NCT00563706|11513395|FG007|STARTED|DB Treatment Period (Day 1 up to Day 28)||30
10372180|NCT00563706|11513396|FG008|STARTED|DB Treatment Period (Day 1 up to Day 28)||43
10372181|NCT00563706|11513388|FG000|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||20
10372182|NCT00563706|11513389|FG001|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||13
10372183|NCT00563706|11513390|FG002|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||3
10372184|NCT00563706|11513391|FG003|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||9
10372185|NCT00563706|11513392|FG004|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||11
10372186|NCT00563706|11513393|FG005|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||14
10372187|NCT00563706|11513394|FG006|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||9
10372188|NCT00563706|11513395|FG007|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||16
10372189|NCT00563706|11513396|FG008|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||32
10372190|NCT00563706|11513388|FG000|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||17
10537851|NCT01451762|11690599|FG001|NOT COMPLETED|Overall Study||6
10537852|NCT01451762|11690600|FG002|NOT COMPLETED|Overall Study||6
10537853|NCT01451775|11690608|FG000|STARTED|Overall Study||3
10537854|NCT01451775|11690609|FG001|STARTED|Overall Study||3
10537855|NCT01451775|11690610|FG002|STARTED|Overall Study||3
10537856|NCT01451775|11690611|FG003|STARTED|Overall Study||3
10537857|NCT01451775|11690612|FG004|STARTED|Overall Study||3
10537858|NCT01451775|11690613|FG005|STARTED|Overall Study||3
10537859|NCT01451775|11690608|FG000|COMPLETED|Overall Study||3
10537860|NCT01451775|11690609|FG001|COMPLETED|Overall Study||3
10537861|NCT01451775|11690610|FG002|COMPLETED|Overall Study||3
10537862|NCT01451775|11690611|FG003|COMPLETED|Overall Study||3
10372191|NCT00563706|11513389|FG001|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
10372192|NCT00563706|11513390|FG002|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
10537863|NCT01451775|11690612|FG004|COMPLETED|Overall Study||3
10372193|NCT00563706|11513391|FG003|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||10
10537864|NCT01451775|11690613|FG005|COMPLETED|Overall Study||3
10537865|NCT01451775|11690608|FG000|NOT COMPLETED|Overall Study||0
10537866|NCT01451775|11690609|FG001|NOT COMPLETED|Overall Study||0
10372194|NCT00563706|11513392|FG004|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
10372195|NCT00563706|11513393|FG005|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
10372196|NCT00563706|11513394|FG006|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||3
10372197|NCT00563706|11513395|FG007|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||14
10372198|NCT00563706|11513396|FG008|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||11
10372199|NCT00563706|11513388|FG000|STARTED|Taper Phase (Day 29 up to Day 35)||20
10372200|NCT00563706|11513389|FG001|STARTED|Taper Phase (Day 29 up to Day 35)||13
10372201|NCT00563706|11513390|FG002|STARTED|Taper Phase (Day 29 up to Day 35)||3
10372202|NCT00563706|11513391|FG003|STARTED|Taper Phase (Day 29 up to Day 35)||9
10372203|NCT00563706|11513392|FG004|STARTED|Taper Phase (Day 29 up to Day 35)||11
10372204|NCT00563706|11513393|FG005|STARTED|Taper Phase (Day 29 up to Day 35)||14
10372205|NCT00563706|11513394|FG006|STARTED|Taper Phase (Day 29 up to Day 35)||9
10372206|NCT00563706|11513395|FG007|STARTED|Taper Phase (Day 29 up to Day 35)||16
10372207|NCT00563706|11513396|FG008|STARTED|Taper Phase (Day 29 up to Day 35)||32
10372208|NCT00563706|11513388|FG000|COMPLETED|Taper Phase (Day 29 up to Day 35)||20
10372209|NCT00563706|11513389|FG001|COMPLETED|Taper Phase (Day 29 up to Day 35)||13
10372210|NCT00563706|11513390|FG002|COMPLETED|Taper Phase (Day 29 up to Day 35)||3
10372211|NCT00563706|11513391|FG003|COMPLETED|Taper Phase (Day 29 up to Day 35)||9
10372212|NCT00563706|11513392|FG004|COMPLETED|Taper Phase (Day 29 up to Day 35)||11
10372213|NCT00563706|11513393|FG005|COMPLETED|Taper Phase (Day 29 up to Day 35)||14
10372214|NCT00563706|11513394|FG006|COMPLETED|Taper Phase (Day 29 up to Day 35)||9
10372215|NCT00563706|11513395|FG007|COMPLETED|Taper Phase (Day 29 up to Day 35)||16
10372216|NCT00563706|11513396|FG008|COMPLETED|Taper Phase (Day 29 up to Day 35)||32
10372217|NCT00563706|11513388|FG000|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
10372218|NCT00563706|11513389|FG001|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
10372219|NCT00563706|11513390|FG002|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
10372220|NCT00563706|11513391|FG003|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
10372221|NCT00563706|11513392|FG004|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
10372222|NCT00563706|11513393|FG005|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
10372223|NCT00563706|11513394|FG006|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
10372224|NCT00563706|11513395|FG007|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
10372225|NCT00563706|11513396|FG008|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
10372226|NCT00563784|11513416|FG000|STARTED|Overall Study||68
10372227|NCT00563784|11513416|FG000|COMPLETED|Overall Study||46
10372228|NCT00563784|11513416|FG000|NOT COMPLETED|Overall Study||22
10372229|NCT00563797|11513422|FG000|STARTED|Overall Study||11
10372230|NCT00563797|11513423|FG001|STARTED|Overall Study||10
10372231|NCT00563797|11513422|FG000|Received Allocated Intervention|Overall Study||11
10372232|NCT00563797|11513423|FG001|Received Allocated Intervention|Overall Study||10
10372233|NCT00563797|11513422|FG000|Follow-Up|Overall Study||11
10372234|NCT00563797|11513423|FG001|Follow-Up|Overall Study||10
10372235|NCT00563797|11513422|FG000|COMPLETED|Overall Study||4
10372236|NCT00563797|11513423|FG001|COMPLETED|Overall Study||8
10372237|NCT00563797|11513422|FG000|NOT COMPLETED|Overall Study||7
10372238|NCT00563797|11513423|FG001|NOT COMPLETED|Overall Study||2
10372239|NCT00564018|11513434|FG000|STARTED|Overall Study||11
10372240|NCT00564018|11513435|FG001|STARTED|Overall Study||10
10372241|NCT00564018|11513436|FG002|STARTED|Overall Study||12
10372242|NCT00564018|11513434|FG000|COMPLETED|Overall Study||9
10372243|NCT00564018|11513435|FG001|COMPLETED|Overall Study||7
10372244|NCT00564018|11513436|FG002|COMPLETED|Overall Study||11
10372245|NCT00564018|11513434|FG000|NOT COMPLETED|Overall Study||2
10372246|NCT00564018|11513435|FG001|NOT COMPLETED|Overall Study||3
10372247|NCT00564018|11513436|FG002|NOT COMPLETED|Overall Study||1
10372248|NCT00564070|11513446|FG000|STARTED|Overall Study||42
10372249|NCT00564070|11513447|FG001|STARTED|Overall Study||45
10372250|NCT00564070|11513446|FG000|COMPLETED|Overall Study||30
10372251|NCT00564070|11513447|FG001|COMPLETED|Overall Study||38
10372252|NCT00564070|11513446|FG000|NOT COMPLETED|Overall Study||12
10372253|NCT00564070|11513447|FG001|NOT COMPLETED|Overall Study||7
10372254|NCT00564265|11513453|FG000|STARTED|Overall Study||24
10372255|NCT00564265|11513453|FG000|COMPLETED|Overall Study||24
10372256|NCT00564265|11513453|FG000|NOT COMPLETED|Overall Study||0
10372257|NCT00564278|11513459|FG000|STARTED|Overall Study||97
10372258|NCT00564278|11513460|FG001|STARTED|Overall Study||98
10372259|NCT00564278|11513459|FG000|COMPLETED|Overall Study||50
10372260|NCT00564278|11513460|FG001|COMPLETED|Overall Study||56
10372261|NCT00564278|11513459|FG000|NOT COMPLETED|Overall Study||47
10372262|NCT00564278|11513460|FG001|NOT COMPLETED|Overall Study||42
10372263|NCT00564395|11513466|FG000|STARTED|First Intervention (10 Days)||9
10372264|NCT00564395|11513467|FG001|STARTED|First Intervention (10 Days)||9
10372265|NCT00564395|11513466|FG000|Received Intervention|First Intervention (10 Days)||7
10372266|NCT00564395|11513467|FG001|Received Intervention|First Intervention (10 Days)||7
10372267|NCT00564395|11513466|FG000|COMPLETED|First Intervention (10 Days)||7
10372268|NCT00564395|11513467|FG001|COMPLETED|First Intervention (10 Days)||7
10372269|NCT00564395|11513466|FG000|NOT COMPLETED|First Intervention (10 Days)||2
10372270|NCT00564395|11513467|FG001|NOT COMPLETED|First Intervention (10 Days)||2
10372271|NCT00564395|11513466|FG000|STARTED|Second Intervention (10 Days)||7
10372272|NCT00564395|11513467|FG001|STARTED|Second Intervention (10 Days)||7
10372273|NCT00564395|11513466|FG000|COMPLETED|Second Intervention (10 Days)||7
10372274|NCT00564395|11513467|FG001|COMPLETED|Second Intervention (10 Days)||7
10372275|NCT00564395|11513466|FG000|NOT COMPLETED|Second Intervention (10 Days)||0
10372276|NCT00564395|11513467|FG001|NOT COMPLETED|Second Intervention (10 Days)||0
10372277|NCT00564447|11513481|FG000|STARTED|Overall Study||6
10372278|NCT00564447|11513482|FG001|STARTED|Overall Study||6
10372279|NCT00564447|11513483|FG002|STARTED|Overall Study||6
10372280|NCT00564447|11513484|FG003|STARTED|Overall Study||6
10372281|NCT00564447|11513485|FG004|STARTED|Overall Study||6
10372282|NCT00564447|11513486|FG005|STARTED|Overall Study||6
10372283|NCT00564447|11513487|FG006|STARTED|Overall Study||6
10372284|NCT00564447|11513488|FG007|STARTED|Overall Study||6
10372285|NCT00564447|11513481|FG000|COMPLETED|Overall Study||6
10372286|NCT00564447|11513482|FG001|COMPLETED|Overall Study||6
10372287|NCT00564447|11513483|FG002|COMPLETED|Overall Study||6
10372288|NCT00564447|11513484|FG003|COMPLETED|Overall Study||6
10372289|NCT00564447|11513485|FG004|COMPLETED|Overall Study||6
10372290|NCT00564447|11513486|FG005|COMPLETED|Overall Study||6
10372291|NCT00564447|11513487|FG006|COMPLETED|Overall Study||6
10372292|NCT00564447|11513488|FG007|COMPLETED|Overall Study||6
10372293|NCT00564447|11513481|FG000|NOT COMPLETED|Overall Study||0
10372294|NCT00564447|11513482|FG001|NOT COMPLETED|Overall Study||0
10372295|NCT00564447|11513483|FG002|NOT COMPLETED|Overall Study||0
10372296|NCT00564447|11513484|FG003|NOT COMPLETED|Overall Study||0
10372297|NCT00564447|11513485|FG004|NOT COMPLETED|Overall Study||0
10372298|NCT00564447|11513486|FG005|NOT COMPLETED|Overall Study||0
10372299|NCT00564447|11513487|FG006|NOT COMPLETED|Overall Study||0
10372300|NCT00564447|11513488|FG007|NOT COMPLETED|Overall Study||0
10372301|NCT00564486|11513509|FG000|STARTED|Overall Study||43
10372302|NCT00564486|11513510|FG001|STARTED|Overall Study|One subject was randomized to receive 1 g IVAPAP but was administered 650 mg IV in error|92
10372303|NCT00564486|11513511|FG002|STARTED|Overall Study|One subject randomized to receive 1 g IVAPAP but was administered 650 mg IV in error|42
10372304|NCT00564486|11513512|FG003|STARTED|Overall Study||67
10372305|NCT00564486|11513509|FG000|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|36
10372306|NCT00564486|11513510|FG001|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|91
10372307|NCT00564486|11513511|FG002|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|39
10372308|NCT00564486|11513512|FG003|COMPLETED|Overall Study||60
10372309|NCT00564486|11513509|FG000|NOT COMPLETED|Overall Study||7
10372310|NCT00564486|11513510|FG001|NOT COMPLETED|Overall Study||1
10372311|NCT00564486|11513511|FG002|NOT COMPLETED|Overall Study||3
10372312|NCT00564486|11513512|FG003|NOT COMPLETED|Overall Study||7
10372313|NCT00564629|11513528|FG000|STARTED|Overall Study||51
10372314|NCT00564629|11513529|FG001|STARTED|Overall Study||54
10372315|NCT00564629|11513528|FG000|COMPLETED|Overall Study||36
10372316|NCT00564629|11513529|FG001|COMPLETED|Overall Study||45
10372317|NCT00564629|11513528|FG000|NOT COMPLETED|Overall Study||15
10372318|NCT00564629|11513529|FG001|NOT COMPLETED|Overall Study||9
10372319|NCT00564681|11513539|FG000|STARTED|Overall Study||117
10372320|NCT00564681|11513540|FG001|STARTED|Overall Study||61
10372321|NCT00564681|11513541|FG002|STARTED|Overall Study||43
10372322|NCT00564681|11513542|FG003|STARTED|Overall Study||21
10372323|NCT00564681|11513539|FG000|COMPLETED|Overall Study||106
10372324|NCT00564681|11513540|FG001|COMPLETED|Overall Study||58
10372325|NCT00564681|11513541|FG002|COMPLETED|Overall Study||40
10372326|NCT00564681|11513542|FG003|COMPLETED|Overall Study||19
10372327|NCT00564681|11513539|FG000|NOT COMPLETED|Overall Study||11
10372328|NCT00564681|11513540|FG001|NOT COMPLETED|Overall Study||3
10372329|NCT00564681|11513541|FG002|NOT COMPLETED|Overall Study||3
10372330|NCT00564681|11513542|FG003|NOT COMPLETED|Overall Study||2
10372331|NCT00564733|11513551|FG000|STARTED|Overall Study||55
10372332|NCT00564733|11513551|FG000|COMPLETED|Overall Study||46
10372333|NCT00564733|11513551|FG000|NOT COMPLETED|Overall Study||9
10372334|NCT00564850|11513555|FG000|STARTED|Overall Study||37
10372335|NCT00564850|11513555|FG000|COMPLETED|Overall Study||35
10372336|NCT00564850|11513555|FG000|NOT COMPLETED|Overall Study||2
10372337|NCT00564889|11513559|FG000|STARTED|Overall Study||35
10372338|NCT00564889|11513559|FG000|COMPLETED|Overall Study||6
10372339|NCT00564889|11513559|FG000|NOT COMPLETED|Overall Study||29
10372340|NCT00564902|11513566|FG000|STARTED|Overall Study||10
10372341|NCT00564902|11513567|FG001|STARTED|Overall Study||25
10372342|NCT00564902|11513568|FG002|STARTED|Overall Study||25
10372343|NCT00564902|11513566|FG000|4 Months|Overall Study||9
10372344|NCT00564902|11513567|FG001|4 Months|Overall Study||24
10372345|NCT00564902|11513568|FG002|4 Months|Overall Study||23
10537867|NCT01451775|11690610|FG002|NOT COMPLETED|Overall Study||0
10372346|NCT00564902|11513566|FG000|8 Months|Overall Study||9
10372347|NCT00564902|11513567|FG001|8 Months|Overall Study||22
10372348|NCT00564902|11513568|FG002|8 Months|Overall Study||21
10372349|NCT00564902|11513566|FG000|12 Months|Overall Study||9
10372350|NCT00564902|11513567|FG001|12 Months|Overall Study||21
10372351|NCT00564902|11513568|FG002|12 Months|Overall Study||21
10372352|NCT00564902|11513566|FG000|COMPLETED|Overall Study||9
10372353|NCT00564902|11513567|FG001|COMPLETED|Overall Study||21
10372354|NCT00564902|11513568|FG002|COMPLETED|Overall Study||21
10372355|NCT00564902|11513566|FG000|NOT COMPLETED|Overall Study||1
10372356|NCT00564902|11513567|FG001|NOT COMPLETED|Overall Study||4
10372357|NCT00564902|11513568|FG002|NOT COMPLETED|Overall Study||4
10372358|NCT00564954|11513578|FG000|STARTED|Period 1- 1 Week||44
10372359|NCT00564954|11513579|FG001|STARTED|Period 1- 1 Week||42
10372360|NCT00564954|11513578|FG000|COMPLETED|Period 1- 1 Week||44
10372361|NCT00564954|11513579|FG001|COMPLETED|Period 1- 1 Week||42
10372362|NCT00564954|11513578|FG000|NOT COMPLETED|Period 1- 1 Week||0
10372363|NCT00564954|11513579|FG001|NOT COMPLETED|Period 1- 1 Week||0
10372364|NCT00564954|11513578|FG000|STARTED|Period 2- 1 Week||44
10372365|NCT00564954|11513579|FG001|STARTED|Period 2- 1 Week||42
10372366|NCT00564954|11513578|FG000|COMPLETED|Period 2- 1 Week||44
10372367|NCT00564954|11513579|FG001|COMPLETED|Period 2- 1 Week||42
10372368|NCT00564954|11513578|FG000|NOT COMPLETED|Period 2- 1 Week||0
10372369|NCT00564954|11513579|FG001|NOT COMPLETED|Period 2- 1 Week||0
10372370|NCT00565045|11513587|FG000|STARTED|Overall Study||10
10372371|NCT00565045|11513588|FG001|STARTED|Overall Study||11
10372372|NCT00565045|11513587|FG000|COMPLETED|Overall Study||9
10372373|NCT00565045|11513588|FG001|COMPLETED|Overall Study||8
10372374|NCT00565045|11513587|FG000|NOT COMPLETED|Overall Study||1
10372375|NCT00565045|11513588|FG001|NOT COMPLETED|Overall Study||3
10372376|NCT00565058|11513596|FG000|STARTED|Overall Study||10
10372377|NCT00565058|11513597|FG001|STARTED|Overall Study||15
10372378|NCT00565058|11513596|FG000|COMPLETED|Overall Study||9
10372379|NCT00565058|11513597|FG001|COMPLETED|Overall Study||15
10372380|NCT00565058|11513596|FG000|NOT COMPLETED|Overall Study||1
10372381|NCT00565058|11513597|FG001|NOT COMPLETED|Overall Study||0
10372382|NCT00565084|11513603|FG000|STARTED|First Treatment Period||11
10372383|NCT00565084|11513604|FG001|STARTED|First Treatment Period||11
10372384|NCT00565084|11513605|FG002|STARTED|First Treatment Period||11
10372385|NCT00565084|11513603|FG000|COMPLETED|First Treatment Period||11
10372386|NCT00565084|11513604|FG001|COMPLETED|First Treatment Period||11
10372387|NCT00565084|11513605|FG002|COMPLETED|First Treatment Period||11
10372388|NCT00565084|11513603|FG000|NOT COMPLETED|First Treatment Period||0
10372389|NCT00565084|11513604|FG001|NOT COMPLETED|First Treatment Period||0
10372390|NCT00565084|11513605|FG002|NOT COMPLETED|First Treatment Period||0
10372391|NCT00565084|11513603|FG000|STARTED|Second Treatment Period||11
10372392|NCT00565084|11513604|FG001|STARTED|Second Treatment Period||11
10372393|NCT00565084|11513605|FG002|STARTED|Second Treatment Period||11
10372394|NCT00565084|11513603|FG000|COMPLETED|Second Treatment Period||11
10372395|NCT00565084|11513604|FG001|COMPLETED|Second Treatment Period||11
10372396|NCT00565084|11513605|FG002|COMPLETED|Second Treatment Period||11
10372397|NCT00565084|11513603|FG000|NOT COMPLETED|Second Treatment Period||0
10372398|NCT00565084|11513604|FG001|NOT COMPLETED|Second Treatment Period||0
10372399|NCT00565084|11513605|FG002|NOT COMPLETED|Second Treatment Period||0
10372400|NCT00565084|11513603|FG000|STARTED|Third Treatment Period||11
10372401|NCT00565084|11513604|FG001|STARTED|Third Treatment Period||11
10372402|NCT00565084|11513605|FG002|STARTED|Third Treatment Period||11
10372403|NCT00565084|11513603|FG000|COMPLETED|Third Treatment Period||11
10372404|NCT00565084|11513604|FG001|COMPLETED|Third Treatment Period||11
10372405|NCT00565084|11513605|FG002|COMPLETED|Third Treatment Period||11
10372406|NCT00565084|11513603|FG000|NOT COMPLETED|Third Treatment Period||0
10372407|NCT00565084|11513604|FG001|NOT COMPLETED|Third Treatment Period||0
10372408|NCT00565084|11513605|FG002|NOT COMPLETED|Third Treatment Period||0
10372409|NCT00565110|11513615|FG000|STARTED|Overall Study||230
10372410|NCT00565110|11513616|FG001|STARTED|Overall Study||242
10372411|NCT00565110|11513615|FG000|12-Month|Overall Study||114
10372412|NCT00565110|11513616|FG001|12-Month|Overall Study||144
10372413|NCT00565110|11513615|FG000|COMPLETED|Overall Study||99
10372414|NCT00565110|11513616|FG001|COMPLETED|Overall Study||111
10372415|NCT00565110|11513615|FG000|NOT COMPLETED|Overall Study||131
10372416|NCT00565110|11513616|FG001|NOT COMPLETED|Overall Study||131
10372417|NCT00565136|11513622|FG000|STARTED|Overall Study||29
10372418|NCT00565136|11513622|FG000|COMPLETED|Overall Study||26
10372419|NCT00565136|11513622|FG000|NOT COMPLETED|Overall Study||3
10372420|NCT00565266|11513626|FG000|STARTED|Overall Study||210
10372421|NCT00565266|11513626|FG000|COMPLETED|Overall Study||174
10372422|NCT00565266|11513626|FG000|NOT COMPLETED|Overall Study||36
10372423|NCT00565370|11513634|FG000|STARTED|Overall Study||21
10372424|NCT00565370|11513634|FG000|COMPLETED|Overall Study||21
10372425|NCT00565370|11513634|FG000|NOT COMPLETED|Overall Study||0
10372426|NCT00565409|11513638|FG000|STARTED|Period 1 Open Label||834
10372427|NCT00565409|11513639|FG001|STARTED|Period 1 Open Label||0
10372428|NCT00565409|11513640|FG002|STARTED|Period 1 Open Label||0
10372429|NCT00565409|11513641|FG003|STARTED|Period 1 Open Label||0
10372430|NCT00565409|11513638|FG000|COMPLETED|Period 1 Open Label||756
10372431|NCT00565409|11513639|FG001|COMPLETED|Period 1 Open Label||0
10372432|NCT00565409|11513640|FG002|COMPLETED|Period 1 Open Label||0
10372433|NCT00565409|11513641|FG003|COMPLETED|Period 1 Open Label||0
10372434|NCT00565409|11513638|FG000|NOT COMPLETED|Period 1 Open Label||78
10372435|NCT00565409|11513639|FG001|NOT COMPLETED|Period 1 Open Label||0
10372436|NCT00565409|11513640|FG002|NOT COMPLETED|Period 1 Open Label||0
10372437|NCT00565409|11513641|FG003|NOT COMPLETED|Period 1 Open Label||0
10372438|NCT00565409|11513638|FG000|STARTED|After Period 1, Prior to Period 2||756
10372439|NCT00565409|11513639|FG001|STARTED|After Period 1, Prior to Period 2||0
10372440|NCT00565409|11513640|FG002|STARTED|After Period 1, Prior to Period 2||0
10372441|NCT00565409|11513641|FG003|STARTED|After Period 1, Prior to Period 2||0
10372442|NCT00565409|11513638|FG000|COMPLETED|After Period 1, Prior to Period 2||604
10372443|NCT00565409|11513639|FG001|COMPLETED|After Period 1, Prior to Period 2||0
10372444|NCT00565409|11513640|FG002|COMPLETED|After Period 1, Prior to Period 2||0
10372445|NCT00565409|11513641|FG003|COMPLETED|After Period 1, Prior to Period 2||0
10372446|NCT00565409|11513638|FG000|NOT COMPLETED|After Period 1, Prior to Period 2||152
10372447|NCT00565409|11513639|FG001|NOT COMPLETED|After Period 1, Prior to Period 2||0
10372448|NCT00565409|11513640|FG002|NOT COMPLETED|After Period 1, Prior to Period 2||0
10372449|NCT00565409|11513641|FG003|NOT COMPLETED|After Period 1, Prior to Period 2||0
10372450|NCT00565409|11513638|FG000|STARTED|Period 2 Double-Blind||0
10372451|NCT00565409|11513639|FG001|STARTED|Period 2 Double-Blind||202
10372452|NCT00565409|11513640|FG002|STARTED|Period 2 Double-Blind||202
10372453|NCT00565409|11513641|FG003|STARTED|Period 2 Double-Blind||200
10372454|NCT00565409|11513638|FG000|COMPLETED|Period 2 Double-Blind||0
10372455|NCT00565409|11513639|FG001|COMPLETED|Period 2 Double-Blind||181
10372456|NCT00565409|11513640|FG002|COMPLETED|Period 2 Double-Blind||175
10372457|NCT00565409|11513641|FG003|COMPLETED|Period 2 Double-Blind||141
10372458|NCT00565409|11513638|FG000|NOT COMPLETED|Period 2 Double-Blind||0
10372459|NCT00565409|11513639|FG001|NOT COMPLETED|Period 2 Double-Blind||21
10372460|NCT00565409|11513640|FG002|NOT COMPLETED|Period 2 Double-Blind||27
10372461|NCT00565409|11513641|FG003|NOT COMPLETED|Period 2 Double-Blind||59
10372462|NCT00565448|11513653|FG000|STARTED|Overall Study|Intent to treat (ITT) population: all randomized participants. All were treated.|50
10372463|NCT00565448|11513654|FG001|STARTED|Overall Study|ITT population: all randomized participants. All were treated.|25
10372464|NCT00565448|11513653|FG000|COMPLETED|Overall Study|Completed induction period as per protocol.|47
10372465|NCT00565448|11513654|FG001|COMPLETED|Overall Study|Completed induction period as per protocol.|23
10372466|NCT00565448|11513653|FG000|NOT COMPLETED|Overall Study||3
10372467|NCT00565448|11513654|FG001|NOT COMPLETED|Overall Study||2
10372468|NCT00565604|11513663|FG000|STARTED|Overall Study||43
10372469|NCT00565604|11513663|FG000|7 Day|Overall Study||41
10372470|NCT00565604|11513663|FG000|2 Week|Overall Study||41
10372471|NCT00565604|11513663|FG000|6 Week|Overall Study||39
10372472|NCT00565604|11513663|FG000|6 Month|Overall Study||39
10372473|NCT00565604|11513663|FG000|COMPLETED|Overall Study||39
10537868|NCT01451775|11690611|FG003|NOT COMPLETED|Overall Study||0
10537869|NCT01451775|11690612|FG004|NOT COMPLETED|Overall Study||0
10537870|NCT01451775|11690613|FG005|NOT COMPLETED|Overall Study||0
10537871|NCT01451814|11690623|FG000|STARTED|Overall Study||35
10537872|NCT01451814|11690624|FG001|STARTED|Overall Study||31
10537873|NCT01451814|11690623|FG000|Attended a Session|Overall Study||35
10372474|NCT00565604|11513663|FG000|NOT COMPLETED|Overall Study||4
10372475|NCT00565643|11513669|FG000|STARTED|Overall Study||380
10372476|NCT00565643|11513670|FG001|STARTED|Overall Study||373
10372477|NCT00565643|11513669|FG000|Safety Data|Overall Study||380
10372478|NCT00565643|11513670|FG001|Safety Data|Overall Study||373
10372479|NCT00565643|11513669|FG000|Primary Outcome (Subsequent Cesarean)|Overall Study||80
10372480|NCT00565643|11513670|FG001|Primary Outcome (Subsequent Cesarean)|Overall Study||92
10372481|NCT00565643|11513669|FG000|COMPLETED|Overall Study||380
10372482|NCT00565643|11513670|FG001|COMPLETED|Overall Study||373
10372483|NCT00565643|11513669|FG000|NOT COMPLETED|Overall Study||0
10372484|NCT00565643|11513670|FG001|NOT COMPLETED|Overall Study||0
10372485|NCT00565669|11513679|FG000|STARTED|Overall Study||11
10372486|NCT00565669|11513680|FG001|STARTED|Overall Study||9
10372487|NCT00565669|11513679|FG000|COMPLETED|Overall Study||11
10372488|NCT00565669|11513680|FG001|COMPLETED|Overall Study||9
10537874|NCT01451814|11690624|FG001|Attended a Session|Overall Study||31
10537875|NCT01451814|11690623|FG000|COMPLETED|Overall Study||29
10537876|NCT01451814|11690624|FG001|COMPLETED|Overall Study||26
10537877|NCT01451814|11690623|FG000|NOT COMPLETED|Overall Study||6
10537878|NCT01451814|11690624|FG001|NOT COMPLETED|Overall Study||5
10537879|NCT01451827|11690634|FG000|STARTED|Overall Study||45
10537880|NCT01451827|11690635|FG001|STARTED|Overall Study||45
10537881|NCT01451827|11690636|FG002|STARTED|Overall Study||44
10537882|NCT01451827|11690637|FG003|STARTED|Overall Study||43
10372489|NCT00565669|11513679|FG000|NOT COMPLETED|Overall Study||0
10372490|NCT00565669|11513680|FG001|NOT COMPLETED|Overall Study||0
10537883|NCT01451827|11690634|FG000|COMPLETED|Overall Study||42
10537884|NCT01451827|11690635|FG001|COMPLETED|Overall Study||40
10537885|NCT01451827|11690636|FG002|COMPLETED|Overall Study||42
10537886|NCT01451827|11690637|FG003|COMPLETED|Overall Study||39
10537887|NCT01451827|11690634|FG000|NOT COMPLETED|Overall Study||3
10537888|NCT01451827|11690635|FG001|NOT COMPLETED|Overall Study||5
10537889|NCT01451827|11690636|FG002|NOT COMPLETED|Overall Study||2
10537890|NCT01451827|11690637|FG003|NOT COMPLETED|Overall Study||4
10537891|NCT01451931|11690650|FG000|STARTED|Overall Study||909
10537892|NCT01451931|11690651|FG001|STARTED|Overall Study||901
10537893|NCT01451931|11690652|FG002|STARTED|Overall Study||966
10657304|NCT02224664|11818515|FG001|STARTED|Lead-in Period (3 Days)||0
10657305|NCT02224664|11818516|FG002|STARTED|Lead-in Period (3 Days)||0
10657306|NCT02224664|11818517|FG003|STARTED|Lead-in Period (3 Days)||0
10657307|NCT02224664|11818518|FG004|STARTED|Lead-in Period (3 Days)||0
10657308|NCT02224664|11818514|FG000|COMPLETED|Lead-in Period (3 Days)||45
10657309|NCT02224664|11818515|FG001|COMPLETED|Lead-in Period (3 Days)||0
10372491|NCT00565721|11513686|FG000|STARTED|Overall Study||33
10372492|NCT00565721|11513686|FG000|COMPLETED|Overall Study||16
10372493|NCT00565721|11513686|FG000|NOT COMPLETED|Overall Study||17
10372494|NCT00565747|11513707|FG000|STARTED|Overall Study||654
10372495|NCT00565747|11513708|FG001|STARTED|Overall Study||678
10372496|NCT00565747|11513707|FG000|COMPLETED|Overall Study|Completed with an embryo transfer|587
10372497|NCT00565747|11513708|FG001|COMPLETED|Overall Study|Completed with an embryo transfer|605
10537894|NCT01451931|11690650|FG000|Baseline Data Collection|Overall Study||908
10537895|NCT01451931|11690651|FG001|Baseline Data Collection|Overall Study||893
10657310|NCT02224664|11818516|FG002|COMPLETED|Lead-in Period (3 Days)||0
10657311|NCT02224664|11818517|FG003|COMPLETED|Lead-in Period (3 Days)||0
10657312|NCT02224664|11818518|FG004|COMPLETED|Lead-in Period (3 Days)||0
10537896|NCT01451931|11690652|FG002|Baseline Data Collection|Overall Study||958
10657313|NCT02224664|11818514|FG000|NOT COMPLETED|Lead-in Period (3 Days)||5
10372498|NCT00565747|11513707|FG000|NOT COMPLETED|Overall Study||67
10372499|NCT00565747|11513708|FG001|NOT COMPLETED|Overall Study||73
10372500|NCT00565773|11513714|FG000|STARTED|Overall Study||40
10372501|NCT00565773|11513714|FG000|COMPLETED|Overall Study||38
10372502|NCT00565773|11513714|FG000|NOT COMPLETED|Overall Study||2
10372503|NCT00565812|11513721|FG000|STARTED|Overall Study||485
10372504|NCT00565812|11513722|FG001|STARTED|Overall Study||486
10372505|NCT00565812|11513723|FG002|STARTED|Overall Study||486
10372506|NCT00565812|11513721|FG000|COMPLETED|Overall Study||341
10372507|NCT00565812|11513722|FG001|COMPLETED|Overall Study||351
10372508|NCT00565812|11513723|FG002|COMPLETED|Overall Study||356
10372509|NCT00565812|11513721|FG000|NOT COMPLETED|Overall Study||144
10372510|NCT00565812|11513722|FG001|NOT COMPLETED|Overall Study||135
10372511|NCT00565812|11513723|FG002|NOT COMPLETED|Overall Study||130
10372512|NCT00565864|11513734|FG000|STARTED|Overall Study||58
10372513|NCT00565864|11513735|FG001|STARTED|Overall Study||59
10372514|NCT00565864|11513736|FG002|STARTED|Overall Study||56
10372515|NCT00565864|11513734|FG000|COMPLETED|Overall Study||46
10372516|NCT00565864|11513735|FG001|COMPLETED|Overall Study||47
10372517|NCT00565864|11513736|FG002|COMPLETED|Overall Study||45
10372518|NCT00565864|11513734|FG000|NOT COMPLETED|Overall Study||12
10372519|NCT00565864|11513735|FG001|NOT COMPLETED|Overall Study||12
10372520|NCT00565864|11513736|FG002|NOT COMPLETED|Overall Study||11
10372521|NCT00565916|11513748|FG000|STARTED|Overall Study||11
10372522|NCT00565916|11513749|FG001|STARTED|Overall Study||11
10372523|NCT00565916|11513748|FG000|COMPLETED|Overall Study||11
10372524|NCT00565916|11513749|FG001|COMPLETED|Overall Study||11
10372525|NCT00565916|11513748|FG000|NOT COMPLETED|Overall Study||0
10372526|NCT00565916|11513749|FG001|NOT COMPLETED|Overall Study||0
10372527|NCT00566020|11513755|FG000|STARTED|6-week Dosage Adjustment Phase||92
10372528|NCT00566020|11513756|FG001|STARTED|6-week Dosage Adjustment Phase||0
10372529|NCT00566020|11513755|FG000|COMPLETED|6-week Dosage Adjustment Phase||85
10372530|NCT00566020|11513756|FG001|COMPLETED|6-week Dosage Adjustment Phase||0
10372531|NCT00566020|11513755|FG000|NOT COMPLETED|6-week Dosage Adjustment Phase||7
10372532|NCT00566020|11513756|FG001|NOT COMPLETED|6-week Dosage Adjustment Phase||0
10372533|NCT00566020|11513755|FG000|STARTED|46-week Long-term Administration Phase||0
10372534|NCT00566020|11513756|FG001|STARTED|46-week Long-term Administration Phase||85
10372535|NCT00566020|11513755|FG000|COMPLETED|46-week Long-term Administration Phase||0
10372536|NCT00566020|11513756|FG001|COMPLETED|46-week Long-term Administration Phase||68
10372537|NCT00566020|11513755|FG000|NOT COMPLETED|46-week Long-term Administration Phase||0
10372538|NCT00566020|11513756|FG001|NOT COMPLETED|46-week Long-term Administration Phase||17
10372539|NCT00566098|11513761|FG000|STARTED|Collection of MILs||25
10372540|NCT00566098|11513761|FG000|COMPLETED|Collection of MILs||23
10372541|NCT00566098|11513761|FG000|NOT COMPLETED|Collection of MILs||2
10372542|NCT00566098|11513761|FG000|STARTED|Generation of MILs Product||23
10372543|NCT00566098|11513761|FG000|COMPLETED|Generation of MILs Product||22
10372544|NCT00566098|11513761|FG000|NOT COMPLETED|Generation of MILs Product||1
10372545|NCT00566098|11513761|FG000|STARTED|Administration of ASCT+MILs||22
10372546|NCT00566098|11513761|FG000|COMPLETED|Administration of ASCT+MILs||4
10372547|NCT00566098|11513761|FG000|NOT COMPLETED|Administration of ASCT+MILs||18
10372548|NCT00566111|11513768|FG000|STARTED|Overall Study||2
10372549|NCT00566111|11513769|FG001|STARTED|Overall Study||3
10372550|NCT00566111|11513768|FG000|COMPLETED|Overall Study||2
10372551|NCT00566111|11513769|FG001|COMPLETED|Overall Study||1
10372552|NCT00566111|11513768|FG000|NOT COMPLETED|Overall Study||0
10372553|NCT00566111|11513769|FG001|NOT COMPLETED|Overall Study||2
10372554|NCT00566150|11513777|FG000|STARTED|Overall Study||19
10372555|NCT00566150|11513778|FG001|STARTED|Overall Study||16
10372556|NCT00566150|11513777|FG000|COMPLETED|Overall Study||10
10372557|NCT00566150|11513778|FG001|COMPLETED|Overall Study||11
10372558|NCT00566150|11513777|FG000|NOT COMPLETED|Overall Study||9
10372559|NCT00566150|11513778|FG001|NOT COMPLETED|Overall Study||5
10372560|NCT00566228|11513786|FG000|STARTED|Overall Study||62
10372561|NCT00566228|11513787|FG001|STARTED|Overall Study||60
10372562|NCT00566228|11513786|FG000|COMPLETED|Overall Study||56
10372563|NCT00566228|11513787|FG001|COMPLETED|Overall Study||55
10372564|NCT00566228|11513786|FG000|NOT COMPLETED|Overall Study||6
10372565|NCT00566228|11513787|FG001|NOT COMPLETED|Overall Study||5
10372566|NCT00566254|11513795|FG000|STARTED|Overall Study||100
10372567|NCT00566254|11513796|FG001|STARTED|Overall Study||107
10372568|NCT00566254|11513795|FG000|COMPLETED|Overall Study||90
10372569|NCT00566254|11513796|FG001|COMPLETED|Overall Study||93
10372570|NCT00566254|11513795|FG000|NOT COMPLETED|Overall Study||10
10372571|NCT00566254|11513796|FG001|NOT COMPLETED|Overall Study||14
10372572|NCT00566501|11513804|FG000|STARTED|Overall Study||570
10372573|NCT00566501|11513805|FG001|STARTED|Overall Study||332
10372574|NCT00566501|11513804|FG000|COMPLETED|Overall Study||423
10372575|NCT00566501|11513805|FG001|COMPLETED|Overall Study||210
10372576|NCT00566501|11513804|FG000|NOT COMPLETED|Overall Study||147
10372577|NCT00566501|11513805|FG001|NOT COMPLETED|Overall Study||122
10372578|NCT00566527|11513814|FG000|STARTED|Overall Study|Number randomized.|541
10372579|NCT00566527|11513815|FG001|STARTED|Overall Study|Number randomized.|540
10372580|NCT00566527|11513816|FG002|STARTED|Overall Study|Number randomized.|539
10372581|NCT00566527|11513814|FG000|Received ProQuad® Dose 1|Overall Study||529
10372582|NCT00566527|11513815|FG001|Received ProQuad® Dose 1|Overall Study||484
10372583|NCT00566527|11513816|FG002|Received ProQuad® Dose 1|Overall Study||470
10372584|NCT00566527|11513814|FG000|Received ProQuad® Dose 2|Overall Study||525
10372585|NCT00566527|11513815|FG001|Received ProQuad® Dose 2|Overall Study||478
10372586|NCT00566527|11513816|FG002|Received ProQuad® Dose 2|Overall Study||462
10372587|NCT00566527|11513814|FG000|COMPLETED|Overall Study||524
10372588|NCT00566527|11513815|FG001|COMPLETED|Overall Study||474
10372589|NCT00566527|11513816|FG002|COMPLETED|Overall Study||461
10372590|NCT00566527|11513814|FG000|NOT COMPLETED|Overall Study||17
10372591|NCT00566527|11513815|FG001|NOT COMPLETED|Overall Study||66
10537897|NCT01451931|11690650|FG000|6-month Follow up|Overall Study||876
10537898|NCT01451931|11690651|FG001|6-month Follow up|Overall Study||843
10537899|NCT01451931|11690652|FG002|6-month Follow up|Overall Study||923
10537900|NCT01451931|11690650|FG000|COMPLETED|Overall Study||876
10537901|NCT01451931|11690651|FG001|COMPLETED|Overall Study||843
10537902|NCT01451931|11690652|FG002|COMPLETED|Overall Study||923
10537903|NCT01451931|11690650|FG000|NOT COMPLETED|Overall Study||33
10537904|NCT01451931|11690651|FG001|NOT COMPLETED|Overall Study||58
10537905|NCT01451931|11690652|FG002|NOT COMPLETED|Overall Study||43
10537906|NCT01451983|11690665|FG000|STARTED|Overall Study||26
10537907|NCT01451983|11690666|FG001|STARTED|Overall Study||27
10537908|NCT01451983|11690667|FG002|STARTED|Overall Study||61
10657314|NCT02224664|11818515|FG001|NOT COMPLETED|Lead-in Period (3 Days)||0
10657315|NCT02224664|11818516|FG002|NOT COMPLETED|Lead-in Period (3 Days)||0
10657316|NCT02224664|11818517|FG003|NOT COMPLETED|Lead-in Period (3 Days)||0
10657317|NCT02224664|11818518|FG004|NOT COMPLETED|Lead-in Period (3 Days)||0
10657318|NCT02224664|11818514|FG000|STARTED|Dose Escalation Period (21 Days)||0
10657319|NCT02224664|11818515|FG001|STARTED|Dose Escalation Period (21 Days)||9
10657320|NCT02224664|11818516|FG002|STARTED|Dose Escalation Period (21 Days)||11
10657321|NCT02224664|11818517|FG003|STARTED|Dose Escalation Period (21 Days)||6
10657322|NCT02224664|11818518|FG004|STARTED|Dose Escalation Period (21 Days)||19
10657323|NCT02224664|11818514|FG000|COMPLETED|Dose Escalation Period (21 Days)||0
10657324|NCT02224664|11818515|FG001|COMPLETED|Dose Escalation Period (21 Days)||9
10657325|NCT02224664|11818516|FG002|COMPLETED|Dose Escalation Period (21 Days)||9
10657326|NCT02224664|11818517|FG003|COMPLETED|Dose Escalation Period (21 Days)||3
10716934|NCT02693704|11880856|FG003|NOT COMPLETED|Overall Study||0
10716935|NCT02693834|11880866|FG000|STARTED|Baseline Measurement|10 were randomized to PLS AFO first week group (2 dropped out at baseline)|12
10716936|NCT02693834|11880867|FG001|STARTED|Baseline Measurement|11 participants were assigned to DA AFO first group|11
10716937|NCT02693834|11880866|FG000|COMPLETED|Baseline Measurement|10 particiapnts completed wearing PLS AFO during the first week and 10 during the second week|10
10716938|NCT02693834|11880867|FG001|COMPLETED|Baseline Measurement|10 particiapnts completed wearing DA AFO during the first week and 10 the second week (1 was lost)|11
10716939|NCT02693834|11880866|FG000|NOT COMPLETED|Baseline Measurement||2
10716940|NCT02693834|11880867|FG001|NOT COMPLETED|Baseline Measurement||0
10716941|NCT02693834|11880866|FG000|STARTED|Week 1 Practice|During the first week of practice, 10 participants were assigned to PLS AFO group|10
10716942|NCT02693834|11880867|FG001|STARTED|Week 1 Practice|During the first week of practice, 11 participants were assigned to DAAFO group|11
10716943|NCT02693834|11880866|FG000|COMPLETED|Week 1 Practice||10
10716944|NCT02693834|11880867|FG001|COMPLETED|Week 1 Practice||11
10716945|NCT02693834|11880866|FG000|NOT COMPLETED|Week 1 Practice||0
10716946|NCT02693834|11880867|FG001|NOT COMPLETED|Week 1 Practice||0
10716947|NCT02693834|11880866|FG000|STARTED|Week 2 Practice||10
10716948|NCT02693834|11880867|FG001|STARTED|Week 2 Practice||11
10716949|NCT02693834|11880866|FG000|COMPLETED|Week 2 Practice||10
10716950|NCT02693834|11880867|FG001|COMPLETED|Week 2 Practice||10
10716951|NCT02693834|11880866|FG000|NOT COMPLETED|Week 2 Practice||0
10716952|NCT02693834|11880867|FG001|NOT COMPLETED|Week 2 Practice||1
10716953|NCT02694029|11880875|FG000|STARTED|Overall Study||5
10716954|NCT02694029|11880876|FG001|STARTED|Overall Study||5
10716955|NCT02694029|11880875|FG000|First Intervention|Overall Study||5
10716956|NCT02694029|11880876|FG001|First Intervention|Overall Study||5
10716957|NCT02694029|11880875|FG000|Second Intervention|Overall Study||5
10716958|NCT02694029|11880876|FG001|Second Intervention|Overall Study||5
10716959|NCT02694029|11880875|FG000|COMPLETED|Overall Study||5
10716960|NCT02694029|11880876|FG001|COMPLETED|Overall Study||5
10716961|NCT02694029|11880875|FG000|NOT COMPLETED|Overall Study||0
10716962|NCT02694029|11880876|FG001|NOT COMPLETED|Overall Study||0
10716963|NCT02694198|11880886|FG000|STARTED|Overall Study||135
10716964|NCT02694198|11880886|FG000|COMPLETED|Overall Study||135
10716965|NCT02694198|11880886|FG000|NOT COMPLETED|Overall Study||0
10716966|NCT02694315|11880890|FG000|STARTED|Overall Study||200
10716967|NCT02694315|11880890|FG000|COMPLETED|Overall Study||200
10716968|NCT02694315|11880890|FG000|NOT COMPLETED|Overall Study||0
10716969|NCT02694328|11880896|FG000|STARTED|Overall Study||276
10716970|NCT02694328|11880897|FG001|STARTED|Overall Study||274
10716971|NCT02694328|11880896|FG000|COMPLETED|Overall Study||176
10716972|NCT02694328|11880897|FG001|COMPLETED|Overall Study||176
10716973|NCT02694328|11880896|FG000|NOT COMPLETED|Overall Study||100
10716974|NCT02694328|11880897|FG001|NOT COMPLETED|Overall Study||98
10716975|NCT02694445|11880903|FG000|STARTED|Overall Study||3098
10716976|NCT02694445|11880903|FG000|COMPLETED|Overall Study||3046
10716977|NCT02694445|11880903|FG000|NOT COMPLETED|Overall Study||52
10716978|NCT02694523|11880909|FG000|STARTED|Part A||304
10537909|NCT01451983|11690668|FG003|STARTED|Overall Study||24
10716979|NCT02694523|11880910|FG001|STARTED|Part A||301
10372592|NCT00566527|11513816|FG002|NOT COMPLETED|Overall Study||78
10716980|NCT02694523|11880911|FG002|STARTED|Part A||0
10716981|NCT02694523|11880912|FG003|STARTED|Part A||0
10716982|NCT02694523|11880913|FG004|STARTED|Part A||0
10372593|NCT00566540|11513826|FG000|STARTED|Overall Study||11
10537910|NCT01451983|11690665|FG000|COMPLETED|Overall Study||26
10537911|NCT01451983|11690666|FG001|COMPLETED|Overall Study||27
10537912|NCT01451983|11690667|FG002|COMPLETED|Overall Study||61
10716983|NCT02694523|11880914|FG005|STARTED|Part A||0
10716984|NCT02694523|11880915|FG006|STARTED|Part A||0
10716985|NCT02694523|11880909|FG000|COMPLETED|Part A||291
10716986|NCT02694523|11880910|FG001|COMPLETED|Part A||294
10716987|NCT02694523|11880911|FG002|COMPLETED|Part A||0
10716988|NCT02694523|11880912|FG003|COMPLETED|Part A||0
10716989|NCT02694523|11880913|FG004|COMPLETED|Part A||0
10306316|NCT00098306|11439289|FG002|STARTED|Double Blind||120
10306317|NCT00098306|11439290|FG003|STARTED|Double Blind||0
10306318|NCT00098306|11439291|FG004|STARTED|Double Blind||0
10306319|NCT00098306|11439292|FG005|STARTED|Double Blind||0
10306320|NCT00098306|11439293|FG006|STARTED|Double Blind||0
10306321|NCT00098306|11439287|FG000|Treated|Double Blind||232
10306322|NCT00098306|11439288|FG001|Treated|Double Blind||235
10306323|NCT00098306|11439289|FG002|Treated|Double Blind||118
10306324|NCT00098306|11439290|FG003|Treated|Double Blind||0
10306325|NCT00098306|11439291|FG004|Treated|Double Blind||0
10306326|NCT00098306|11439292|FG005|Treated|Double Blind||0
10306327|NCT00098306|11439293|FG006|Treated|Double Blind||0
10306328|NCT00098306|11439287|FG000|COMPLETED|Double Blind||0
10306329|NCT00098306|11439288|FG001|COMPLETED|Double Blind||0
10306330|NCT00098306|11439289|FG002|COMPLETED|Double Blind||0
10306331|NCT00098306|11439290|FG003|COMPLETED|Double Blind||0
10306332|NCT00098306|11439291|FG004|COMPLETED|Double Blind||0
10306333|NCT00098306|11439292|FG005|COMPLETED|Double Blind||0
10306334|NCT00098306|11439293|FG006|COMPLETED|Double Blind||0
10306335|NCT00098306|11439287|FG000|NOT COMPLETED|Double Blind||241
10306336|NCT00098306|11439288|FG001|NOT COMPLETED|Double Blind||240
10306337|NCT00098306|11439289|FG002|NOT COMPLETED|Double Blind||120
10306338|NCT00098306|11439290|FG003|NOT COMPLETED|Double Blind||0
10306339|NCT00098306|11439291|FG004|NOT COMPLETED|Double Blind||0
10306340|NCT00098306|11439292|FG005|NOT COMPLETED|Double Blind||0
10306341|NCT00098306|11439293|FG006|NOT COMPLETED|Double Blind||0
10306342|NCT00098306|11439287|FG000|STARTED|Open Label||0
10306343|NCT00098306|11439288|FG001|STARTED|Open Label||0
10306344|NCT00098306|11439289|FG002|STARTED|Open Label||0
10306345|NCT00098306|11439290|FG003|STARTED|Open Label||327
10306346|NCT00098306|11439291|FG004|STARTED|Open Label||62
10306347|NCT00098306|11439292|FG005|STARTED|Open Label||0
10306348|NCT00098306|11439293|FG006|STARTED|Open Label||0
10306349|NCT00098306|11439287|FG000|COMPLETED|Open Label||0
10306350|NCT00098306|11439288|FG001|COMPLETED|Open Label||0
10306351|NCT00098306|11439289|FG002|COMPLETED|Open Label||0
10306352|NCT00098306|11439290|FG003|COMPLETED|Open Label||0
10306353|NCT00098306|11439291|FG004|COMPLETED|Open Label||0
10306354|NCT00098306|11439292|FG005|COMPLETED|Open Label||0
10306355|NCT00098306|11439293|FG006|COMPLETED|Open Label||0
10306356|NCT00098306|11439287|FG000|NOT COMPLETED|Open Label||0
10306357|NCT00098306|11439288|FG001|NOT COMPLETED|Open Label||0
10306358|NCT00098306|11439289|FG002|NOT COMPLETED|Open Label||0
10306359|NCT00098306|11439290|FG003|NOT COMPLETED|Open Label||327
10306360|NCT00098306|11439291|FG004|NOT COMPLETED|Open Label||62
10306361|NCT00098306|11439292|FG005|NOT COMPLETED|Open Label||0
10306362|NCT00098306|11439293|FG006|NOT COMPLETED|Open Label||0
10306363|NCT00098306|11439287|FG000|STARTED|Observational Phase||0
10306364|NCT00098306|11439288|FG001|STARTED|Observational Phase||0
10306365|NCT00098306|11439289|FG002|STARTED|Observational Phase||0
10306366|NCT00098306|11439290|FG003|STARTED|Observational Phase||0
10306367|NCT00098306|11439291|FG004|STARTED|Observational Phase||0
10306368|NCT00098306|11439292|FG005|STARTED|Observational Phase||250
10306369|NCT00098306|11439293|FG006|STARTED|Observational Phase||81
10306370|NCT00098306|11439287|FG000|COMPLETED|Observational Phase||0
10306371|NCT00098306|11439288|FG001|COMPLETED|Observational Phase||0
10306372|NCT00098306|11439289|FG002|COMPLETED|Observational Phase||0
10306373|NCT00098306|11439290|FG003|COMPLETED|Observational Phase||0
10306374|NCT00098306|11439291|FG004|COMPLETED|Observational Phase||0
10306375|NCT00098306|11439292|FG005|COMPLETED|Observational Phase||204
10306376|NCT00098306|11439293|FG006|COMPLETED|Observational Phase||55
10306377|NCT00098306|11439287|FG000|NOT COMPLETED|Observational Phase||0
10306378|NCT00098306|11439288|FG001|NOT COMPLETED|Observational Phase||0
10306379|NCT00098306|11439289|FG002|NOT COMPLETED|Observational Phase||0
10306380|NCT00098306|11439290|FG003|NOT COMPLETED|Observational Phase||0
10306381|NCT00098306|11439291|FG004|NOT COMPLETED|Observational Phase||0
10306382|NCT00098306|11439292|FG005|NOT COMPLETED|Observational Phase||46
10306383|NCT00098306|11439293|FG006|NOT COMPLETED|Observational Phase||26
10306384|NCT00098345|11439306|FG000|STARTED|Overall Study||30
10716990|NCT02694523|11880914|FG005|COMPLETED|Part A||0
10306385|NCT00098345|11439306|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|17
10306386|NCT00098345|11439306|FG000|NOT COMPLETED|Overall Study||13
10306387|NCT00098371|11439310|FG000|STARTED|Overall Study||64
10306388|NCT00098371|11439310|FG000|COMPLETED|Overall Study||64
10716991|NCT02694523|11880915|FG006|COMPLETED|Part A||0
10306389|NCT00098371|11439310|FG000|NOT COMPLETED|Overall Study||0
10306390|NCT00098670|11439325|FG000|STARTED|Overall Study||102
10716992|NCT02694523|11880909|FG000|NOT COMPLETED|Part A||13
10372594|NCT00566540|11513826|FG000|COMPLETED|Overall Study||11
10372595|NCT00566540|11513826|FG000|NOT COMPLETED|Overall Study||0
10372596|NCT00566579|11513832|FG000|STARTED|Overall Study||29
10372597|NCT00566579|11513833|FG001|STARTED|Overall Study||31
10372598|NCT00566579|11513832|FG000|COMPLETED|Overall Study||29
10372599|NCT00566579|11513833|FG001|COMPLETED|Overall Study||31
10372600|NCT00566579|11513832|FG000|NOT COMPLETED|Overall Study||0
10372601|NCT00566579|11513833|FG001|NOT COMPLETED|Overall Study||0
10372602|NCT00566631|11513839|FG000|STARTED|Part 1: Core Treatment Phase||294
10372603|NCT00566631|11513839|FG000|COMPLETED|Part 1: Core Treatment Phase||234
10372604|NCT00566631|11513839|FG000|NOT COMPLETED|Part 1: Core Treatment Phase||60
10372605|NCT00566631|11513839|FG000|STARTED|Between Treatment and Extension Phase||234
10372606|NCT00566631|11513839|FG000|COMPLETED|Between Treatment and Extension Phase||139
10372607|NCT00566631|11513839|FG000|NOT COMPLETED|Between Treatment and Extension Phase||95
10372608|NCT00566631|11513839|FG000|STARTED|Part 2: Extension Phase||139
10372609|NCT00566631|11513839|FG000|COMPLETED|Part 2: Extension Phase||57
10372610|NCT00566631|11513839|FG000|NOT COMPLETED|Part 2: Extension Phase||82
10372611|NCT00566696|11513843|FG000|STARTED|Overall Study||73
10372612|NCT00566696|11513843|FG000|COMPLETED|Overall Study||31
10372613|NCT00566696|11513843|FG000|NOT COMPLETED|Overall Study||42
10372614|NCT00566709|11513849|FG000|STARTED|Overall Study||51
10372615|NCT00566709|11513850|FG001|STARTED|Overall Study||51
10372616|NCT00566709|11513849|FG000|COMPLETED|Overall Study||46
10372617|NCT00566709|11513850|FG001|COMPLETED|Overall Study||51
10372618|NCT00566709|11513849|FG000|NOT COMPLETED|Overall Study||5
10372619|NCT00566709|11513850|FG001|NOT COMPLETED|Overall Study||0
10427628|NCT00853840|11573497|FG000|Vardenafil or Placebo (Day 4)|Period 1|Administered 1 hour post Maraviroc dosing|9
10427629|NCT00853840|11573498|FG001|Vardenafil or Placebo (Day 4)|Period 1|Administered 1 hour post Maraviroc dosing|9
10427630|NCT00853840|11573497|FG000|COMPLETED|Period 1||9
10427631|NCT00853840|11573498|FG001|COMPLETED|Period 1||9
10427632|NCT00853840|11573497|FG000|NOT COMPLETED|Period 1||0
10427633|NCT00853840|11573498|FG001|NOT COMPLETED|Period 1||0
10427634|NCT00853840|11573497|FG000|STARTED|Period 2||9
10427635|NCT00853840|11573498|FG001|STARTED|Period 2||9
10427636|NCT00853840|11573497|FG000|Maraviroc (Days 1 - 3)|Period 2||9
10427637|NCT00853840|11573498|FG001|Maraviroc (Days 1 - 3)|Period 2||9
10427638|NCT00853840|11573497|FG000|Vardenafil or Placebo (Day 3)|Period 2|Administered 1 hour post Maraviroc dosing|9
10427639|NCT00853840|11573498|FG001|Vardenafil or Placebo (Day 3)|Period 2|Administered 1 hour post Maraviroc dosing|9
10427640|NCT00853840|11573497|FG000|COMPLETED|Period 2||9
10427641|NCT00853840|11573498|FG001|COMPLETED|Period 2||9
10427642|NCT00853840|11573497|FG000|NOT COMPLETED|Period 2||0
10427643|NCT00853840|11573498|FG001|NOT COMPLETED|Period 2||0
10427644|NCT00853905|11573507|FG000|STARTED|Overall Study||37
10427645|NCT00853905|11573508|FG001|STARTED|Overall Study||40
10427646|NCT00853905|11573507|FG000|COMPLETED|Overall Study||35
10427647|NCT00853905|11573508|FG001|COMPLETED|Overall Study||36
10427648|NCT00853905|11573507|FG000|NOT COMPLETED|Overall Study||2
10427649|NCT00853905|11573508|FG001|NOT COMPLETED|Overall Study||4
10427650|NCT00853957|11573519|FG000|STARTED|Overall Study||220
10427651|NCT00853957|11573520|FG001|STARTED|Overall Study||223
10427652|NCT00853957|11573519|FG000|COMPLETED|Overall Study||206
10427653|NCT00853957|11573520|FG001|COMPLETED|Overall Study||204
10427654|NCT00853957|11573519|FG000|NOT COMPLETED|Overall Study||14
10427655|NCT00853957|11573520|FG001|NOT COMPLETED|Overall Study||19
10427656|NCT00853970|11573528|FG000|STARTED|Overall Study||152
10427657|NCT00853970|11573529|FG001|STARTED|Overall Study||147
10427658|NCT00853970|11573528|FG000|COMPLETED|Overall Study||146
10427659|NCT00853970|11573529|FG001|COMPLETED|Overall Study||144
10427660|NCT00853970|11573528|FG000|NOT COMPLETED|Overall Study||6
10427661|NCT00853970|11573529|FG001|NOT COMPLETED|Overall Study||3
10427662|NCT00853996|11573535|FG000|STARTED|Overall Study||25
10427663|NCT00853996|11573535|FG000|COMPLETED|Overall Study||25
10427664|NCT00853996|11573535|FG000|NOT COMPLETED|Overall Study||0
10427665|NCT00854061|11573539|FG000|STARTED|Overall Study||172
10427666|NCT00854061|11573539|FG000|Completed 1st Surgery (T-PRED in One Eye and Pred Forte in the Other Eye)|Overall Study||162
10427667|NCT00854061|11573539|FG000|Completed 2nd Surgery (T-PRED and Pred Forte in Opposite Eyes Compared to 1st Surgery)|Overall Study||149
10427668|NCT00854061|11573539|FG000|COMPLETED|Overall Study||149
10427669|NCT00854061|11573539|FG000|NOT COMPLETED|Overall Study||23
10427670|NCT00854087|11573547|FG000|STARTED|Overall Study||59
10427671|NCT00854087|11573548|FG001|STARTED|Overall Study||59
10427672|NCT00854087|11573547|FG000|COMPLETED|Overall Study||40
10427673|NCT00854087|11573548|FG001|COMPLETED|Overall Study||40
10427674|NCT00854087|11573547|FG000|NOT COMPLETED|Overall Study||19
10427675|NCT00854087|11573548|FG001|NOT COMPLETED|Overall Study||19
10427676|NCT00854100|11573557|FG000|STARTED|Overall Study||81
10427677|NCT00854100|11573558|FG001|STARTED|Overall Study||76
10427678|NCT00854100|11573559|FG002|STARTED|Overall Study||74
10427679|NCT00854100|11573557|FG000|COMPLETED|Overall Study||72
10427680|NCT00854100|11573558|FG001|COMPLETED|Overall Study||70
10427681|NCT00854100|11573559|FG002|COMPLETED|Overall Study||63
10427682|NCT00854100|11573557|FG000|NOT COMPLETED|Overall Study||9
10427683|NCT00854100|11573558|FG001|NOT COMPLETED|Overall Study||6
10427684|NCT00854100|11573559|FG002|NOT COMPLETED|Overall Study||11
10427685|NCT00854113|11573579|FG000|STARTED|Overall Study||6
10427686|NCT00854113|11573580|FG001|STARTED|Overall Study||6
10427687|NCT00854113|11573581|FG002|STARTED|Overall Study||6
10427688|NCT00854113|11573582|FG003|STARTED|Overall Study||6
10427689|NCT00854113|11573583|FG004|STARTED|Overall Study||6
10372620|NCT00566722|11513859|FG000|STARTED|Overall Study||41
10372621|NCT00566722|11513860|FG001|STARTED|Overall Study||29
10372622|NCT00566722|11513861|FG002|STARTED|Overall Study||82
10372623|NCT00566722|11513859|FG000|COMPLETED|Overall Study||39
10372624|NCT00566722|11513860|FG001|COMPLETED|Overall Study||24
10372625|NCT00566722|11513861|FG002|COMPLETED|Overall Study||73
10372626|NCT00566722|11513859|FG000|NOT COMPLETED|Overall Study||2
10372627|NCT00566722|11513860|FG001|NOT COMPLETED|Overall Study||5
10372628|NCT00566722|11513861|FG002|NOT COMPLETED|Overall Study||9
10372629|NCT00566735|11513874|FG000|STARTED|Overall Study||20
10372630|NCT00566735|11513875|FG001|STARTED|Overall Study||19
10372631|NCT00566735|11513874|FG000|Withdrew Before Baseline Measures|Overall Study||2
10372632|NCT00566735|11513875|FG001|Withdrew Before Baseline Measures|Overall Study||7
10372633|NCT00566735|11513874|FG000|COMPLETED|Overall Study|2 participants withdrew before baselines. Therefore, 18 participants will be included in baselines.|18
10372634|NCT00566735|11513875|FG001|COMPLETED|Overall Study|7 participants withdrew before baselines. Therefore, 12 participants will be included in baselines.|12
10372635|NCT00566735|11513874|FG000|NOT COMPLETED|Overall Study||2
10372636|NCT00566735|11513875|FG001|NOT COMPLETED|Overall Study||7
10372637|NCT00566813|11513883|FG000|STARTED|Overall Study||4
10372638|NCT00566813|11513884|FG001|STARTED|Overall Study||6
10372639|NCT00566813|11513883|FG000|COMPLETED|Overall Study||4
10372640|NCT00566813|11513884|FG001|COMPLETED|Overall Study||6
10372641|NCT00566813|11513883|FG000|NOT COMPLETED|Overall Study||0
10372642|NCT00566813|11513884|FG001|NOT COMPLETED|Overall Study||0
10372643|NCT00566852|11513892|FG000|STARTED|Overall Study||278
10372644|NCT00566852|11513893|FG001|STARTED|Overall Study||276
10372645|NCT00566852|11513892|FG000|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|71
10372646|NCT00566852|11513893|FG001|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|78
10372647|NCT00566852|11513892|FG000|NOT COMPLETED|Overall Study||207
10372648|NCT00566852|11513893|FG001|NOT COMPLETED|Overall Study||198
10372649|NCT00566930|11513902|FG000|STARTED|Overall Study||29
10372650|NCT00566930|11513903|FG001|STARTED|Overall Study||36
10372651|NCT00566930|11513904|FG002|STARTED|Overall Study||33
10372652|NCT00566930|11513902|FG000|COMPLETED|Overall Study||27
10372653|NCT00566930|11513903|FG001|COMPLETED|Overall Study||32
10372654|NCT00566930|11513904|FG002|COMPLETED|Overall Study||32
10372655|NCT00566930|11513902|FG000|NOT COMPLETED|Overall Study||2
10372656|NCT00566930|11513903|FG001|NOT COMPLETED|Overall Study||4
10372657|NCT00566930|11513904|FG002|NOT COMPLETED|Overall Study||1
10372658|NCT00566943|11513914|FG000|STARTED|Overall Study||52
10372659|NCT00566943|11513915|FG001|STARTED|Overall Study||49
10372660|NCT00566943|11513914|FG000|COMPLETED|Overall Study||52
10372661|NCT00566943|11513915|FG001|COMPLETED|Overall Study||49
10372662|NCT00566943|11513914|FG000|NOT COMPLETED|Overall Study||0
10372663|NCT00566943|11513915|FG001|NOT COMPLETED|Overall Study||0
10372664|NCT00566969|11513930|FG000|STARTED|Overall Study||34
10372665|NCT00566969|11513931|FG001|STARTED|Overall Study||37
10372666|NCT00566969|11513932|FG002|STARTED|Overall Study||35
10372667|NCT00566969|11513930|FG000|COMPLETED|Overall Study||19
10372668|NCT00566969|11513931|FG001|COMPLETED|Overall Study||28
10372669|NCT00566969|11513932|FG002|COMPLETED|Overall Study||23
10372670|NCT00566969|11513930|FG000|NOT COMPLETED|Overall Study||15
10372671|NCT00566969|11513931|FG001|NOT COMPLETED|Overall Study||9
10372672|NCT00566969|11513932|FG002|NOT COMPLETED|Overall Study||12
10372673|NCT00566982|11513942|FG000|STARTED|Overall Study||63
10372674|NCT00566982|11513943|FG001|STARTED|Overall Study||363
10372675|NCT00566982|11513942|FG000|COMPLETED|Overall Study||55
10372676|NCT00566982|11513943|FG001|COMPLETED|Overall Study||294
10372677|NCT00566982|11513942|FG000|NOT COMPLETED|Overall Study||8
10372678|NCT00566982|11513943|FG001|NOT COMPLETED|Overall Study||69
10372679|NCT00567008|11513954|FG000|STARTED|Overall Study||18
10372680|NCT00567008|11513955|FG001|STARTED|Overall Study||19
10372681|NCT00567008|11513954|FG000|COMPLETED|Overall Study||17
10372682|NCT00567008|11513955|FG001|COMPLETED|Overall Study||18
10372683|NCT00567008|11513954|FG000|NOT COMPLETED|Overall Study||1
10716993|NCT02694523|11880910|FG001|NOT COMPLETED|Part A||7
10716994|NCT02694523|11880911|FG002|NOT COMPLETED|Part A||0
10716995|NCT02694523|11880912|FG003|NOT COMPLETED|Part A||0
10716996|NCT02694523|11880913|FG004|NOT COMPLETED|Part A||0
10716997|NCT02694523|11880914|FG005|NOT COMPLETED|Part A||0
10372684|NCT00567008|11513955|FG001|NOT COMPLETED|Overall Study||1
10372685|NCT00567112|11513961|FG000|STARTED|Treatment Period 1 (3 Days)||7
10372686|NCT00567112|11513962|FG001|STARTED|Treatment Period 1 (3 Days)||8
10372687|NCT00567112|11513963|FG002|STARTED|Treatment Period 1 (3 Days)||0
10372688|NCT00567112|11513961|FG000|COMPLETED|Treatment Period 1 (3 Days)||7
10372689|NCT00567112|11513962|FG001|COMPLETED|Treatment Period 1 (3 Days)||8
10372690|NCT00567112|11513963|FG002|COMPLETED|Treatment Period 1 (3 Days)||0
10372691|NCT00567112|11513961|FG000|NOT COMPLETED|Treatment Period 1 (3 Days)||0
10372692|NCT00567112|11513962|FG001|NOT COMPLETED|Treatment Period 1 (3 Days)||0
10372693|NCT00567112|11513963|FG002|NOT COMPLETED|Treatment Period 1 (3 Days)||0
10372694|NCT00567112|11513961|FG000|STARTED|Washout Period 1 (3 Days)||7
10716998|NCT02694523|11880915|FG006|NOT COMPLETED|Part A||0
10372695|NCT00567112|11513962|FG001|STARTED|Washout Period 1 (3 Days)||8
10372696|NCT00567112|11513963|FG002|STARTED|Washout Period 1 (3 Days)||0
10372697|NCT00567112|11513961|FG000|COMPLETED|Washout Period 1 (3 Days)||7
10372698|NCT00567112|11513962|FG001|COMPLETED|Washout Period 1 (3 Days)||8
10372699|NCT00567112|11513963|FG002|COMPLETED|Washout Period 1 (3 Days)||0
10716999|NCT02694523|11880909|FG000|STARTED|Part B||0
10372700|NCT00567112|11513961|FG000|NOT COMPLETED|Washout Period 1 (3 Days)||0
10372701|NCT00567112|11513962|FG001|NOT COMPLETED|Washout Period 1 (3 Days)||0
10372702|NCT00567112|11513963|FG002|NOT COMPLETED|Washout Period 1 (3 Days)||0
10372703|NCT00567112|11513961|FG000|STARTED|Treatment Period 2 (3 Days)||7
10372704|NCT00567112|11513962|FG001|STARTED|Treatment Period 2 (3 Days)||8
10372705|NCT00567112|11513963|FG002|STARTED|Treatment Period 2 (3 Days)|3 new participants added to Treatment Group ABCD & received treatment sequence BCD for Periods 2-4|3
10372706|NCT00567112|11513961|FG000|COMPLETED|Treatment Period 2 (3 Days)||7
10372707|NCT00567112|11513962|FG001|COMPLETED|Treatment Period 2 (3 Days)||7
10372708|NCT00567112|11513963|FG002|COMPLETED|Treatment Period 2 (3 Days)||3
10372709|NCT00567112|11513961|FG000|NOT COMPLETED|Treatment Period 2 (3 Days)||0
10372710|NCT00567112|11513962|FG001|NOT COMPLETED|Treatment Period 2 (3 Days)||1
10372711|NCT00567112|11513963|FG002|NOT COMPLETED|Treatment Period 2 (3 Days)||0
10372712|NCT00567112|11513961|FG000|STARTED|Washout Period 2 (3 Days)||7
10372713|NCT00567112|11513962|FG001|STARTED|Washout Period 2 (3 Days)||7
10372714|NCT00567112|11513963|FG002|STARTED|Washout Period 2 (3 Days)||3
10372715|NCT00567112|11513961|FG000|COMPLETED|Washout Period 2 (3 Days)||7
10372716|NCT00567112|11513962|FG001|COMPLETED|Washout Period 2 (3 Days)||7
10372717|NCT00567112|11513963|FG002|COMPLETED|Washout Period 2 (3 Days)||3
10372718|NCT00567112|11513961|FG000|NOT COMPLETED|Washout Period 2 (3 Days)||0
10372719|NCT00567112|11513962|FG001|NOT COMPLETED|Washout Period 2 (3 Days)||0
10372720|NCT00567112|11513963|FG002|NOT COMPLETED|Washout Period 2 (3 Days)||0
10372721|NCT00567112|11513961|FG000|STARTED|Treatment Period 3 (3 Days)||7
10372722|NCT00567112|11513962|FG001|STARTED|Treatment Period 3 (3 Days)||7
10372723|NCT00567112|11513963|FG002|STARTED|Treatment Period 3 (3 Days)||3
10372724|NCT00567112|11513961|FG000|COMPLETED|Treatment Period 3 (3 Days)||7
10372725|NCT00567112|11513962|FG001|COMPLETED|Treatment Period 3 (3 Days)||7
10372726|NCT00567112|11513963|FG002|COMPLETED|Treatment Period 3 (3 Days)||3
10372727|NCT00567112|11513961|FG000|NOT COMPLETED|Treatment Period 3 (3 Days)||0
10372728|NCT00567112|11513962|FG001|NOT COMPLETED|Treatment Period 3 (3 Days)||0
10372729|NCT00567112|11513963|FG002|NOT COMPLETED|Treatment Period 3 (3 Days)||0
10372730|NCT00567112|11513961|FG000|STARTED|Washout Period 3 (3 Days)||7
10372731|NCT00567112|11513962|FG001|STARTED|Washout Period 3 (3 Days)||7
10372732|NCT00567112|11513963|FG002|STARTED|Washout Period 3 (3 Days)||3
10372733|NCT00567112|11513961|FG000|COMPLETED|Washout Period 3 (3 Days)||4
10372734|NCT00567112|11513962|FG001|COMPLETED|Washout Period 3 (3 Days)||7
10372735|NCT00567112|11513963|FG002|COMPLETED|Washout Period 3 (3 Days)||3
10372736|NCT00567112|11513961|FG000|NOT COMPLETED|Washout Period 3 (3 Days)||3
10372737|NCT00567112|11513962|FG001|NOT COMPLETED|Washout Period 3 (3 Days)||0
10372738|NCT00567112|11513963|FG002|NOT COMPLETED|Washout Period 3 (3 Days)||0
10372739|NCT00567112|11513961|FG000|STARTED|Treatment Period 4 (3 Days)||4
10372740|NCT00567112|11513962|FG001|STARTED|Treatment Period 4 (3 Days)||7
10372741|NCT00567112|11513963|FG002|STARTED|Treatment Period 4 (3 Days)||3
10372742|NCT00567112|11513961|FG000|COMPLETED|Treatment Period 4 (3 Days)||4
10372743|NCT00567112|11513962|FG001|COMPLETED|Treatment Period 4 (3 Days)||7
10372744|NCT00567112|11513963|FG002|COMPLETED|Treatment Period 4 (3 Days)||3
10372745|NCT00567112|11513961|FG000|NOT COMPLETED|Treatment Period 4 (3 Days)||0
10372746|NCT00567112|11513962|FG001|NOT COMPLETED|Treatment Period 4 (3 Days)||0
10372747|NCT00567112|11513963|FG002|NOT COMPLETED|Treatment Period 4 (3 Days)||0
10372748|NCT00567164|11513975|FG000|STARTED|Overall Study||1421
10372749|NCT00567164|11513976|FG001|STARTED|Overall Study||234
10372750|NCT00567164|11513977|FG002|STARTED|Overall Study||232
10372751|NCT00567164|11513975|FG000|Subjects Received Treatment|Overall Study|Full Analysis Set|1406
10372752|NCT00567164|11513976|FG001|Subjects Received Treatment|Overall Study|Full Analysis Set|232
10372753|NCT00567164|11513977|FG002|Subjects Received Treatment|Overall Study|Full Analysis Set|226
10372754|NCT00567164|11513975|FG000|COMPLETED|Overall Study||875
10372755|NCT00567164|11513976|FG001|COMPLETED|Overall Study||161
10372756|NCT00567164|11513977|FG002|COMPLETED|Overall Study||160
10372757|NCT00567164|11513975|FG000|NOT COMPLETED|Overall Study||546
10372758|NCT00567164|11513976|FG001|NOT COMPLETED|Overall Study||73
10372759|NCT00567164|11513977|FG002|NOT COMPLETED|Overall Study||72
10372760|NCT00567190|11513991|FG000|STARTED|Overall Study||402
10372761|NCT00567190|11513992|FG001|STARTED|Overall Study||406
10372762|NCT00567190|11513991|FG000|Did Not Receive Any Study Treatment|Overall Study||2
10372763|NCT00567190|11513992|FG001|Did Not Receive Any Study Treatment|Overall Study||2
10372764|NCT00567190|11513991|FG000|Received at Least One Dose of Pertuzumab|Overall Study||399
10372765|NCT00567190|11513992|FG001|Received at Least One Dose of Pertuzumab|Overall Study|9 participants randomized to the Placebo arm actually received at least one dose of pertuzumab.|9
10372766|NCT00567190|11513991|FG000|Received at Least One Dose of Placebo|Overall Study|1 participant randomized to the Pertuzumab arm actually received placebo at every treatment cycle.|1
10372767|NCT00567190|11513992|FG001|Received at Least One Dose of Placebo|Overall Study||395
10372768|NCT00567190|11513991|FG000|Crossover From Placebo to Pertuzumab|Overall Study||0
10372769|NCT00567190|11513992|FG001|Crossover From Placebo to Pertuzumab|Overall Study|From July 2012, 50 participants randomized to Placebo arm crossed over to open-label pertuzumab.|50
10372770|NCT00567190|11513991|FG000|COMPLETED|Overall Study||119
10372771|NCT00567190|11513992|FG001|COMPLETED|Overall Study||73
10372772|NCT00567190|11513991|FG000|NOT COMPLETED|Overall Study||283
10372773|NCT00567190|11513992|FG001|NOT COMPLETED|Overall Study||333
10372774|NCT00567229|11514003|FG000|STARTED|Overall Study||3
10372775|NCT00567229|11514003|FG000|COMPLETED|Overall Study||3
10372776|NCT00567229|11514003|FG000|NOT COMPLETED|Overall Study||0
10372777|NCT00567242|11514009|FG000|STARTED|Overall Study||7
10372778|NCT00567242|11514010|FG001|STARTED|Overall Study||7
10372779|NCT00567242|11514009|FG000|COMPLETED|Overall Study||7
10372780|NCT00567242|11514010|FG001|COMPLETED|Overall Study||7
10372781|NCT00567242|11514009|FG000|NOT COMPLETED|Overall Study||0
10372782|NCT00567242|11514010|FG001|NOT COMPLETED|Overall Study||0
10372783|NCT00567255|11514018|FG000|STARTED|Overall Study||1001
10372784|NCT00567255|11514019|FG001|STARTED|Overall Study||495
10537913|NCT01451983|11690668|FG003|COMPLETED|Overall Study||24
10537914|NCT01451983|11690665|FG000|NOT COMPLETED|Overall Study||0
10537915|NCT01451983|11690666|FG001|NOT COMPLETED|Overall Study||0
10537916|NCT01451983|11690667|FG002|NOT COMPLETED|Overall Study||0
10537917|NCT01451983|11690668|FG003|NOT COMPLETED|Overall Study||0
10537918|NCT01451996|11690682|FG000|STARTED|Overall Study||83
10537919|NCT01451996|11690683|FG001|STARTED|Overall Study||87
10537920|NCT01451996|11690684|FG002|STARTED|Overall Study||85
10537921|NCT01451996|11690685|FG003|STARTED|Overall Study||85
10537922|NCT01451996|11690682|FG000|COMPLETED|Overall Study||83
10537923|NCT01451996|11690683|FG001|COMPLETED|Overall Study||87
10537924|NCT01451996|11690684|FG002|COMPLETED|Overall Study||85
10537925|NCT01451996|11690685|FG003|COMPLETED|Overall Study||85
10537926|NCT01451996|11690682|FG000|NOT COMPLETED|Overall Study||0
10537927|NCT01451996|11690683|FG001|NOT COMPLETED|Overall Study||0
10537928|NCT01451996|11690684|FG002|NOT COMPLETED|Overall Study||0
10537929|NCT01451996|11690685|FG003|NOT COMPLETED|Overall Study||0
10537930|NCT01452126|11690695|FG000|STARTED|Overall Study||49
10537931|NCT01452126|11690695|FG000|COMPLETED|Overall Study||49
10537932|NCT01452126|11690695|FG000|NOT COMPLETED|Overall Study||0
10657327|NCT02224664|11818518|FG004|COMPLETED|Dose Escalation Period (21 Days)||8
10657328|NCT02224664|11818514|FG000|NOT COMPLETED|Dose Escalation Period (21 Days)||0
10657329|NCT02224664|11818515|FG001|NOT COMPLETED|Dose Escalation Period (21 Days)||0
10657330|NCT02224664|11818516|FG002|NOT COMPLETED|Dose Escalation Period (21 Days)||2
10657331|NCT02224664|11818517|FG003|NOT COMPLETED|Dose Escalation Period (21 Days)||3
10657332|NCT02224664|11818518|FG004|NOT COMPLETED|Dose Escalation Period (21 Days)||11
10657361|NCT02224729|11818557|FG000|STARTED|Overall Study||24
10657362|NCT02224729|11818557|FG000|COMPLETED|Overall Study||24
10657363|NCT02224729|11818557|FG000|NOT COMPLETED|Overall Study||0
10657364|NCT02224820|11818561|FG000|STARTED|Overall Study||8
10657365|NCT02224820|11818561|FG000|COMPLETED|Overall Study|One patient did not receive full dose|8
10657366|NCT02224820|11818561|FG000|NOT COMPLETED|Overall Study||0
10372785|NCT00567255|11514018|FG000|COMPLETED|Overall Study||538
10372786|NCT00567255|11514019|FG001|COMPLETED|Overall Study||267
10372787|NCT00567255|11514018|FG000|NOT COMPLETED|Overall Study||463
10372788|NCT00567255|11514019|FG001|NOT COMPLETED|Overall Study||228
10372789|NCT00567268|11514025|FG000|STARTED|Overall Study||1194
10372790|NCT00567268|11514025|FG000|COMPLETED|Overall Study||1144
10372791|NCT00567268|11514025|FG000|NOT COMPLETED|Overall Study||50
10372792|NCT00567307|11514066|FG000|STARTED|Overall Study||111
10372793|NCT00567307|11514067|FG001|STARTED|Overall Study||105
10372794|NCT00567307|11514066|FG000|COMPLETED|Overall Study||99
10372795|NCT00567307|11514067|FG001|COMPLETED|Overall Study||104
10372796|NCT00567307|11514066|FG000|NOT COMPLETED|Overall Study||12
10372797|NCT00567307|11514067|FG001|NOT COMPLETED|Overall Study||1
10372798|NCT00567320|11514075|FG000|STARTED|Overall Study||13
10372799|NCT00567320|11514076|FG001|STARTED|Overall Study||18
10372800|NCT00567320|11514075|FG000|COMPLETED|Overall Study||13
10372801|NCT00567320|11514076|FG001|COMPLETED|Overall Study||18
10372802|NCT00567320|11514075|FG000|NOT COMPLETED|Overall Study||0
10372803|NCT00567320|11514076|FG001|NOT COMPLETED|Overall Study||0
10372804|NCT00567359|11514082|FG000|STARTED|Overall Study||100
10372805|NCT00567359|11514082|FG000|COMPLETED|Overall Study||99
10372806|NCT00567359|11514082|FG000|NOT COMPLETED|Overall Study||1
10372807|NCT00567398|11514088|FG000|STARTED|Overall Study||127
10372808|NCT00567398|11514089|FG001|STARTED|Overall Study||124
10372809|NCT00567398|11514088|FG000|COMPLETED|Overall Study||120
10372810|NCT00567398|11514089|FG001|COMPLETED|Overall Study||101
10372811|NCT00567398|11514088|FG000|NOT COMPLETED|Overall Study||7
10372812|NCT00567398|11514089|FG001|NOT COMPLETED|Overall Study||23
10372813|NCT00567476|11514097|FG000|STARTED|Overall Study||78
10372814|NCT00567476|11514098|FG001|STARTED|Overall Study||38
10372815|NCT00567476|11514097|FG000|COMPLETED|Overall Study||70
10372816|NCT00567476|11514098|FG001|COMPLETED|Overall Study||34
10372817|NCT00567476|11514097|FG000|NOT COMPLETED|Overall Study||8
10537933|NCT01452191|11690706|FG000|STARTED|Overall Study||373
10537934|NCT01452191|11690707|FG001|STARTED|Overall Study||369
10537935|NCT01452191|11690708|FG002|STARTED|Overall Study||370
10537936|NCT01452191|11690706|FG000|COMPLETED|Overall Study||241
10537937|NCT01452191|11690707|FG001|COMPLETED|Overall Study||252
10537938|NCT01452191|11690708|FG002|COMPLETED|Overall Study||258
10537939|NCT01452191|11690706|FG000|NOT COMPLETED|Overall Study||132
10537940|NCT01452191|11690707|FG001|NOT COMPLETED|Overall Study||117
10537941|NCT01452191|11690708|FG002|NOT COMPLETED|Overall Study||112
10537942|NCT01452269|11690718|FG000|STARTED|Overall Study||48
10537943|NCT01452269|11690719|FG001|STARTED|Overall Study||56
10537944|NCT01452269|11690718|FG000|COMPLETED|Overall Study||47
10537945|NCT01452269|11690719|FG001|COMPLETED|Overall Study||51
10537946|NCT01452269|11690718|FG000|NOT COMPLETED|Overall Study||1
10657367|NCT02224846|11818567|FG000|STARTED|Period 1 (Month 3)||211
10657368|NCT02224846|11818568|FG001|STARTED|Period 1 (Month 3)||424
10657369|NCT02224846|11818567|FG000|Received at Least One Dose of Study Drug|Period 1 (Month 3)||210
10657370|NCT02224846|11818568|FG001|Received at Least One Dose of Study Drug|Period 1 (Month 3)||421
10657371|NCT02224846|11818567|FG000|COMPLETED|Period 1 (Month 3)||192
10657372|NCT02224846|11818568|FG001|COMPLETED|Period 1 (Month 3)||388
10657373|NCT02224846|11818567|FG000|NOT COMPLETED|Period 1 (Month 3)||19
10657374|NCT02224846|11818568|FG001|NOT COMPLETED|Period 1 (Month 3)||36
10657375|NCT02224846|11818567|FG000|STARTED|Period 2 (Month 3 to Month 12)||192
10657376|NCT02224846|11818568|FG001|STARTED|Period 2 (Month 3 to Month 12)||388
10657377|NCT02224846|11818567|FG000|COMPLETED|Period 2 (Month 3 to Month 12)||173
10372818|NCT00567476|11514098|FG001|NOT COMPLETED|Overall Study||4
10372819|NCT00567489|11514106|FG000|STARTED|Overall Study||127
10372820|NCT00567489|11514107|FG001|STARTED|Overall Study||124
10537947|NCT01452269|11690719|FG001|NOT COMPLETED|Overall Study||5
10537948|NCT01452347|11690727|FG000|STARTED|Overall Study||168
10537949|NCT01452347|11690728|FG001|STARTED|Overall Study||84
10537950|NCT01452347|11690727|FG000|COMPLETED|Overall Study||151
10537951|NCT01452347|11690728|FG001|COMPLETED|Overall Study||77
10537952|NCT01452347|11690727|FG000|NOT COMPLETED|Overall Study||17
10372821|NCT00567489|11514106|FG000|COMPLETED|Overall Study||120
10372822|NCT00567489|11514107|FG001|COMPLETED|Overall Study||101
10372823|NCT00567489|11514106|FG000|NOT COMPLETED|Overall Study||7
10372824|NCT00567489|11514107|FG001|NOT COMPLETED|Overall Study||23
10372825|NCT00567502|11514117|FG000|STARTED|Overall Study||804
10372826|NCT00567502|11514118|FG001|STARTED|Overall Study||141
10372827|NCT00567502|11514119|FG002|STARTED|Overall Study||2666
10372828|NCT00567502|11514120|FG003|STARTED|Overall Study||110
10372829|NCT00567502|11514117|FG000|Initiated Treatment|Overall Study||804
10372830|NCT00567502|11514118|FG001|Initiated Treatment|Overall Study||141
10372831|NCT00567502|11514119|FG002|Initiated Treatment|Overall Study||2666
10372832|NCT00567502|11514120|FG003|Initiated Treatment|Overall Study||38
10372833|NCT00567502|11514117|FG000|COMPLETED|Overall Study||563
10372834|NCT00567502|11514118|FG001|COMPLETED|Overall Study||108
10537953|NCT01452347|11690728|FG001|NOT COMPLETED|Overall Study||7
10537954|NCT01452412|11690738|FG000|STARTED|Overall Study||74
10537955|NCT01452412|11690739|FG001|STARTED|Overall Study||75
10537956|NCT01452412|11690738|FG000|COMPLETED|Overall Study||46
10537957|NCT01452412|11690739|FG001|COMPLETED|Overall Study||58
10537958|NCT01452412|11690738|FG000|NOT COMPLETED|Overall Study||28
10372835|NCT00567502|11514119|FG002|COMPLETED|Overall Study||1758
10372836|NCT00567502|11514120|FG003|COMPLETED|Overall Study||23
10372837|NCT00567502|11514117|FG000|NOT COMPLETED|Overall Study||241
10372838|NCT00567502|11514118|FG001|NOT COMPLETED|Overall Study||33
10372839|NCT00567502|11514119|FG002|NOT COMPLETED|Overall Study||908
10372840|NCT00567502|11514120|FG003|NOT COMPLETED|Overall Study||87
10372841|NCT00567541|11514143|FG000|STARTED|Overall Study||7
10372842|NCT00567541|11514144|FG001|STARTED|Overall Study||9
10372843|NCT00567541|11514143|FG000|COMPLETED|Overall Study||7
10372844|NCT00567541|11514144|FG001|COMPLETED|Overall Study||8
10372845|NCT00567541|11514143|FG000|NOT COMPLETED|Overall Study||0
10372846|NCT00567541|11514144|FG001|NOT COMPLETED|Overall Study||1
10372847|NCT00567593|11514150|FG000|STARTED|Overall Study||12
10372848|NCT00567593|11514150|FG000|COMPLETED|Overall Study||10
10372849|NCT00567593|11514150|FG000|NOT COMPLETED|Overall Study||2
10372850|NCT00567840|11514159|FG000|STARTED|Overall Study||15
10372851|NCT00567840|11514160|FG001|STARTED|Overall Study||15
10372852|NCT00567840|11514161|FG002|STARTED|Overall Study||16
10372853|NCT00567840|11514162|FG003|STARTED|Overall Study||15
10372854|NCT00567840|11514163|FG004|STARTED|Overall Study||8
10372855|NCT00567840|11514159|FG000|COMPLETED|Overall Study||13
10372856|NCT00567840|11514160|FG001|COMPLETED|Overall Study||15
10372857|NCT00567840|11514161|FG002|COMPLETED|Overall Study||15
10372858|NCT00567840|11514162|FG003|COMPLETED|Overall Study||14
10372859|NCT00567840|11514163|FG004|COMPLETED|Overall Study||8
10372860|NCT00567840|11514159|FG000|NOT COMPLETED|Overall Study||2
10372861|NCT00567840|11514160|FG001|NOT COMPLETED|Overall Study||0
10372862|NCT00567840|11514161|FG002|NOT COMPLETED|Overall Study||1
10372863|NCT00567840|11514162|FG003|NOT COMPLETED|Overall Study||1
10372864|NCT00567840|11514163|FG004|NOT COMPLETED|Overall Study||0
10372865|NCT00567879|11514181|FG000|STARTED|Overall Study||7
10372866|NCT00567879|11514182|FG001|STARTED|Overall Study||7
10372867|NCT00567879|11514183|FG002|STARTED|Overall Study|7 participants belonged to the dose expansion group at 20mg/m2 i.v.|21
10372868|NCT00567879|11514184|FG003|STARTED|Overall Study||6
10372869|NCT00567879|11514185|FG004|STARTED|Overall Study||12
10372870|NCT00567879|11514186|FG005|STARTED|Overall Study||3
10372871|NCT00567879|11514181|FG000|Maximum Tolerated Dose Determining Set|Overall Study||5
10372872|NCT00567879|11514182|FG001|Maximum Tolerated Dose Determining Set|Overall Study||7
10372873|NCT00567879|11514183|FG002|Maximum Tolerated Dose Determining Set|Overall Study|6 participants belonged to the dose expansion group at 20mg/m2 i.v.|18
10372874|NCT00567879|11514184|FG003|Maximum Tolerated Dose Determining Set|Overall Study||6
10372875|NCT00567879|11514185|FG004|Maximum Tolerated Dose Determining Set|Overall Study||12
10372876|NCT00567879|11514186|FG005|Maximum Tolerated Dose Determining Set|Overall Study||3
10372877|NCT00567879|11514181|FG000|COMPLETED|Overall Study||0
10372878|NCT00567879|11514182|FG001|COMPLETED|Overall Study||0
10372879|NCT00567879|11514183|FG002|COMPLETED|Overall Study||0
10372880|NCT00567879|11514184|FG003|COMPLETED|Overall Study||0
10372881|NCT00567879|11514185|FG004|COMPLETED|Overall Study||0
10372882|NCT00567879|11514186|FG005|COMPLETED|Overall Study||0
10372883|NCT00567879|11514181|FG000|NOT COMPLETED|Overall Study||7
10372884|NCT00567879|11514182|FG001|NOT COMPLETED|Overall Study||7
10372885|NCT00567879|11514183|FG002|NOT COMPLETED|Overall Study||21
10372886|NCT00567879|11514184|FG003|NOT COMPLETED|Overall Study||6
10372887|NCT00567879|11514185|FG004|NOT COMPLETED|Overall Study||12
10372888|NCT00567879|11514186|FG005|NOT COMPLETED|Overall Study||3
10372889|NCT00567892|11514206|FG000|STARTED|First Treatment (2 or 4 Weeks)||7
10372890|NCT00567892|11514207|FG001|STARTED|First Treatment (2 or 4 Weeks)||7
10372891|NCT00567892|11514208|FG002|STARTED|First Treatment (2 or 4 Weeks)||10
10372892|NCT00567892|11514209|FG003|STARTED|First Treatment (2 or 4 Weeks)||10
10372893|NCT00567892|11514206|FG000|COMPLETED|First Treatment (2 or 4 Weeks)||7
10372894|NCT00567892|11514207|FG001|COMPLETED|First Treatment (2 or 4 Weeks)||7
10372895|NCT00567892|11514208|FG002|COMPLETED|First Treatment (2 or 4 Weeks)||9
10372896|NCT00567892|11514209|FG003|COMPLETED|First Treatment (2 or 4 Weeks)||6
10372897|NCT00567892|11514206|FG000|NOT COMPLETED|First Treatment (2 or 4 Weeks)||0
10372898|NCT00567892|11514207|FG001|NOT COMPLETED|First Treatment (2 or 4 Weeks)||0
10372899|NCT00567892|11514208|FG002|NOT COMPLETED|First Treatment (2 or 4 Weeks)||1
10372900|NCT00567892|11514209|FG003|NOT COMPLETED|First Treatment (2 or 4 Weeks)||4
10372901|NCT00567892|11514206|FG000|STARTED|Washout (2 Weeks)||7
10372902|NCT00567892|11514207|FG001|STARTED|Washout (2 Weeks)||7
10372903|NCT00567892|11514208|FG002|STARTED|Washout (2 Weeks)||9
10372904|NCT00567892|11514209|FG003|STARTED|Washout (2 Weeks)||6
10372905|NCT00567892|11514206|FG000|COMPLETED|Washout (2 Weeks)||7
10372906|NCT00567892|11514207|FG001|COMPLETED|Washout (2 Weeks)||7
10372907|NCT00567892|11514208|FG002|COMPLETED|Washout (2 Weeks)||9
10372908|NCT00567892|11514209|FG003|COMPLETED|Washout (2 Weeks)||6
10372909|NCT00567892|11514206|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10372910|NCT00567892|11514207|FG001|NOT COMPLETED|Washout (2 Weeks)||0
10372911|NCT00567892|11514208|FG002|NOT COMPLETED|Washout (2 Weeks)||0
10372912|NCT00567892|11514209|FG003|NOT COMPLETED|Washout (2 Weeks)||0
10372913|NCT00567892|11514206|FG000|STARTED|Second Treatment (2 or 4 Weeks)||7
10372914|NCT00567892|11514207|FG001|STARTED|Second Treatment (2 or 4 Weeks)||7
10372915|NCT00567892|11514208|FG002|STARTED|Second Treatment (2 or 4 Weeks)||9
10372916|NCT00567892|11514209|FG003|STARTED|Second Treatment (2 or 4 Weeks)||6
10372917|NCT00567892|11514206|FG000|COMPLETED|Second Treatment (2 or 4 Weeks)||7
10372918|NCT00567892|11514207|FG001|COMPLETED|Second Treatment (2 or 4 Weeks)||7
10372919|NCT00567892|11514208|FG002|COMPLETED|Second Treatment (2 or 4 Weeks)||9
10372920|NCT00567892|11514209|FG003|COMPLETED|Second Treatment (2 or 4 Weeks)||5
10372921|NCT00567892|11514206|FG000|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
10372922|NCT00567892|11514207|FG001|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
10372923|NCT00567892|11514208|FG002|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
10372924|NCT00567892|11514209|FG003|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||1
10372925|NCT00567996|11514224|FG000|STARTED|Overall Study|Randomized participants|333
10372926|NCT00567996|11514225|FG001|STARTED|Overall Study||334
10372927|NCT00567996|11514226|FG002|STARTED|Overall Study||335
10372928|NCT00567996|11514224|FG000|Intent-to-treat: Received Study Drug|Overall Study||330
10372929|NCT00567996|11514225|FG001|Intent-to-treat: Received Study Drug|Overall Study||333
10372930|NCT00567996|11514226|FG002|Intent-to-treat: Received Study Drug|Overall Study||335
10372931|NCT00567996|11514224|FG000|COMPLETED|Overall Study||289
10372932|NCT00567996|11514225|FG001|COMPLETED|Overall Study||284
10372933|NCT00567996|11514226|FG002|COMPLETED|Overall Study||265
10372934|NCT00567996|11514224|FG000|NOT COMPLETED|Overall Study||44
10372935|NCT00567996|11514225|FG001|NOT COMPLETED|Overall Study||50
10372936|NCT00567996|11514226|FG002|NOT COMPLETED|Overall Study||70
10372937|NCT00568022|11514237|FG000|STARTED|Overall Study||3
10372938|NCT00568022|11514238|FG001|STARTED|Overall Study||3
10372939|NCT00568022|11514239|FG002|STARTED|Overall Study||3
10372940|NCT00568022|11514237|FG000|COMPLETED|Overall Study||3
10372941|NCT00568022|11514238|FG001|COMPLETED|Overall Study||3
10372942|NCT00568022|11514239|FG002|COMPLETED|Overall Study||3
10372943|NCT00568022|11514237|FG000|NOT COMPLETED|Overall Study||0
10372944|NCT00568022|11514238|FG001|NOT COMPLETED|Overall Study||0
10372945|NCT00568022|11514239|FG002|NOT COMPLETED|Overall Study||0
10372946|NCT00568061|11514250|FG000|STARTED|Overall Study||13
10372947|NCT00568061|11514251|FG001|STARTED|Overall Study||16
10372948|NCT00568061|11514250|FG000|COMPLETED|Overall Study||8
10372949|NCT00568061|11514251|FG001|COMPLETED|Overall Study||14
10372950|NCT00568061|11514250|FG000|NOT COMPLETED|Overall Study||5
10372951|NCT00568061|11514251|FG001|NOT COMPLETED|Overall Study||2
10372952|NCT00568087|11514260|FG000|STARTED|Overall Study||22
10372953|NCT00568087|11514261|FG001|STARTED|Overall Study||24
10372954|NCT00568087|11514260|FG000|Received Intervention|Overall Study||21
10372955|NCT00568087|11514261|FG001|Received Intervention|Overall Study||23
10372956|NCT00568087|11514260|FG000|COMPLETED|Overall Study||15
10372957|NCT00568087|11514261|FG001|COMPLETED|Overall Study||17
10372958|NCT00568087|11514260|FG000|NOT COMPLETED|Overall Study||7
10372959|NCT00568087|11514261|FG001|NOT COMPLETED|Overall Study||7
10372960|NCT00568126|11514269|FG000|STARTED|Overall Study||24
10372961|NCT00568126|11514270|FG001|STARTED|Overall Study||21
10372962|NCT00568126|11514269|FG000|COMPLETED|Overall Study||13
10537959|NCT01452412|11690739|FG001|NOT COMPLETED|Overall Study||17
10548060|NCT01516957|11701864|FG003|COMPLETED|Placebo-controlled Phase||0
10548061|NCT01516957|11701861|FG000|NOT COMPLETED|Placebo-controlled Phase||3
10548062|NCT01516957|11701862|FG001|NOT COMPLETED|Placebo-controlled Phase||4
10548063|NCT01516957|11701863|FG002|NOT COMPLETED|Placebo-controlled Phase||5
10548064|NCT01516957|11701864|FG003|NOT COMPLETED|Placebo-controlled Phase||0
10548065|NCT01516957|11701861|FG000|STARTED|Open-label Phase||0
10548066|NCT01516957|11701862|FG001|STARTED|Open-label Phase||0
10548067|NCT01516957|11701863|FG002|STARTED|Open-label Phase||0
10548068|NCT01516957|11701864|FG003|STARTED|Open-label Phase||156
10548069|NCT01516957|11701861|FG000|COMPLETED|Open-label Phase||0
10548070|NCT01516957|11701862|FG001|COMPLETED|Open-label Phase||0
10372963|NCT00568126|11514270|FG001|COMPLETED|Overall Study||12
10372964|NCT00568126|11514269|FG000|NOT COMPLETED|Overall Study||11
10372965|NCT00568126|11514270|FG001|NOT COMPLETED|Overall Study||9
10372966|NCT00568321|11514279|FG000|STARTED|Overall Study||33
10372967|NCT00568321|11514280|FG001|STARTED|Overall Study||33
10372968|NCT00568321|11514281|FG002|STARTED|Overall Study||33
10372969|NCT00568321|11514279|FG000|Treated|Overall Study||31
10372970|NCT00568321|11514280|FG001|Treated|Overall Study||33
10372971|NCT00568321|11514281|FG002|Treated|Overall Study||32
10372972|NCT00568321|11514279|FG000|COMPLETED|Overall Study||20
10372973|NCT00568321|11514280|FG001|COMPLETED|Overall Study||28
10548071|NCT01516957|11701863|FG002|COMPLETED|Open-label Phase||0
10548072|NCT01516957|11701864|FG003|COMPLETED|Open-label Phase||0
10548073|NCT01516957|11701861|FG000|NOT COMPLETED|Open-label Phase||0
10548074|NCT01516957|11701862|FG001|NOT COMPLETED|Open-label Phase||0
10548075|NCT01516957|11701863|FG002|NOT COMPLETED|Open-label Phase||0
10548076|NCT01516957|11701864|FG003|NOT COMPLETED|Open-label Phase||156
10372974|NCT00568321|11514281|FG002|COMPLETED|Overall Study||24
10372975|NCT00568321|11514279|FG000|NOT COMPLETED|Overall Study||13
10372976|NCT00568321|11514280|FG001|NOT COMPLETED|Overall Study||5
10372977|NCT00568321|11514281|FG002|NOT COMPLETED|Overall Study||9
10372978|NCT00568334|11514293|FG000|STARTED|Overall Study||122
10372979|NCT00568334|11514294|FG001|STARTED|Overall Study||122
10372980|NCT00568334|11514293|FG000|COMPLETED|Overall Study||121
10372981|NCT00568334|11514294|FG001|COMPLETED|Overall Study||121
10372982|NCT00568334|11514293|FG000|NOT COMPLETED|Overall Study||1
10372983|NCT00568334|11514294|FG001|NOT COMPLETED|Overall Study||1
10372984|NCT00568386|11514302|FG000|STARTED|Overall Study||20
10372985|NCT00568386|11514303|FG001|STARTED|Overall Study||20
10372986|NCT00568386|11514302|FG000|COMPLETED|Overall Study||20
10372987|NCT00568386|11514303|FG001|COMPLETED|Overall Study||20
10372988|NCT00568386|11514302|FG000|NOT COMPLETED|Overall Study||0
10372989|NCT00568386|11514303|FG001|NOT COMPLETED|Overall Study||0
10372990|NCT00568399|11514309|FG000|STARTED|Overall Study||37
10372991|NCT00568399|11514309|FG000|COMPLETED|Overall Study|Of 48 subject enrolled, 37 initiated sodium thiosulfate treatment. 22 completed the entire protocol|22
10372992|NCT00568399|11514309|FG000|NOT COMPLETED|Overall Study||15
10372993|NCT00568451|11514317|FG000|STARTED|Overall Study||0
10372994|NCT00568451|11514318|FG001|STARTED|Overall Study||0
10372995|NCT00568451|11514319|FG002|STARTED|Overall Study||2
10372996|NCT00568451|11514320|FG003|STARTED|Overall Study||9
10372997|NCT00568451|11514317|FG000|COMPLETED|Overall Study||0
10372998|NCT00568451|11514318|FG001|COMPLETED|Overall Study||0
10372999|NCT00568451|11514319|FG002|COMPLETED|Overall Study||0
10373000|NCT00568451|11514320|FG003|COMPLETED|Overall Study||2
10373001|NCT00568451|11514317|FG000|NOT COMPLETED|Overall Study||0
10373002|NCT00568451|11514318|FG001|NOT COMPLETED|Overall Study||0
10373003|NCT00568451|11514319|FG002|NOT COMPLETED|Overall Study||2
10373004|NCT00568451|11514320|FG003|NOT COMPLETED|Overall Study||7
10373005|NCT00568555|11514333|FG000|STARTED|Overall Study||16
10373006|NCT00568555|11514334|FG001|STARTED|Overall Study||15
10373007|NCT00568555|11514333|FG000|COMPLETED|Overall Study||15
10373008|NCT00568555|11514334|FG001|COMPLETED|Overall Study||14
10373009|NCT00568555|11514333|FG000|NOT COMPLETED|Overall Study||1
10373010|NCT00568555|11514334|FG001|NOT COMPLETED|Overall Study||1
10373011|NCT00568633|11514344|FG000|STARTED|Overall Study||25
10373012|NCT00568633|11514345|FG001|STARTED|Overall Study||33
10373013|NCT00568633|11514344|FG000|COMPLETED|Overall Study||25
10373014|NCT00568633|11514345|FG001|COMPLETED|Overall Study||33
10373015|NCT00568633|11514344|FG000|NOT COMPLETED|Overall Study||0
10373016|NCT00568633|11514345|FG001|NOT COMPLETED|Overall Study||0
10373017|NCT00568685|11514354|FG000|STARTED|Overall Study||51
10373018|NCT00568685|11514355|FG001|STARTED|Overall Study||51
10373019|NCT00568685|11514356|FG002|STARTED|Overall Study||51
10373020|NCT00568685|11514354|FG000|COMPLETED|Overall Study||41
10373021|NCT00568685|11514355|FG001|COMPLETED|Overall Study||46
10373022|NCT00568685|11514356|FG002|COMPLETED|Overall Study||46
10373023|NCT00568685|11514354|FG000|NOT COMPLETED|Overall Study||10
10373024|NCT00568685|11514355|FG001|NOT COMPLETED|Overall Study||5
10373025|NCT00568685|11514356|FG002|NOT COMPLETED|Overall Study||5
10373026|NCT00568776|11514372|FG000|STARTED|Overall Study|One randomized patient withdrew consent and did not receive placebo|83
10373027|NCT00568776|11514373|FG001|STARTED|Overall Study|One randomized patient withdrew consent and did not receive ELND005 250 mg BID|88
10373028|NCT00568776|11514374|FG002|STARTED|Overall Study|41 patients withdrawn per interim safety review (sponsors decision); excluded in efficacy analysis.|89
10373029|NCT00568776|11514375|FG003|STARTED|Overall Study|42 patients withdrawn per interim safety review (sponsors decision); excluded in efficacy analysis.|91
10373030|NCT00568776|11514372|FG000|COMPLETED|Overall Study||53
10373031|NCT00568776|11514373|FG001|COMPLETED|Overall Study||52
10373032|NCT00568776|11514374|FG002|COMPLETED|Overall Study||15
10373033|NCT00568776|11514375|FG003|COMPLETED|Overall Study||19
10373034|NCT00568776|11514372|FG000|NOT COMPLETED|Overall Study||30
10373035|NCT00568776|11514373|FG001|NOT COMPLETED|Overall Study||36
10373036|NCT00568776|11514374|FG002|NOT COMPLETED|Overall Study||74
10373037|NCT00568776|11514375|FG003|NOT COMPLETED|Overall Study||72
10657378|NCT02224846|11818568|FG001|COMPLETED|Period 2 (Month 3 to Month 12)||357
10657379|NCT02224846|11818567|FG000|NOT COMPLETED|Period 2 (Month 3 to Month 12)||19
10657380|NCT02224846|11818568|FG001|NOT COMPLETED|Period 2 (Month 3 to Month 12)||31
10657381|NCT02224846|11818567|FG000|STARTED|Period 2 (Month 12 to Month 24)||173
10657382|NCT02224846|11818568|FG001|STARTED|Period 2 (Month 12 to Month 24)||357
10657383|NCT02224846|11818567|FG000|COMPLETED|Period 2 (Month 12 to Month 24)||131
10427690|NCT00854113|11573584|FG005|STARTED|Overall Study||6
10427691|NCT00854113|11573585|FG006|STARTED|Overall Study||12
10427692|NCT00854113|11573586|FG007|STARTED|Overall Study||8
10427693|NCT00854113|11573587|FG008|STARTED|Overall Study||8
10427694|NCT00854113|11573588|FG009|STARTED|Overall Study||8
10427695|NCT00854113|11573589|FG010|STARTED|Overall Study||6
10427696|NCT00854113|11573579|FG000|COMPLETED|Overall Study||6
10427697|NCT00854113|11573580|FG001|COMPLETED|Overall Study||6
10427698|NCT00854113|11573581|FG002|COMPLETED|Overall Study||6
10427699|NCT00854113|11573582|FG003|COMPLETED|Overall Study||6
10427700|NCT00854113|11573583|FG004|COMPLETED|Overall Study||6
10427701|NCT00854113|11573584|FG005|COMPLETED|Overall Study||6
10427702|NCT00854113|11573585|FG006|COMPLETED|Overall Study||12
10427703|NCT00854113|11573586|FG007|COMPLETED|Overall Study||5
10427704|NCT00854113|11573587|FG008|COMPLETED|Overall Study||7
10427705|NCT00854113|11573588|FG009|COMPLETED|Overall Study||8
10427706|NCT00854113|11573589|FG010|COMPLETED|Overall Study||6
10373038|NCT04274192|11514387|FG000|STARTED|Overall Study||1
10373039|NCT04274192|11514388|FG001|STARTED|Overall Study||0
10373040|NCT04274192|11514387|FG000|COMPLETED|Overall Study||0
10373041|NCT04274192|11514388|FG001|COMPLETED|Overall Study||0
10373042|NCT04274192|11514387|FG000|NOT COMPLETED|Overall Study||1
10373043|NCT04274192|11514388|FG001|NOT COMPLETED|Overall Study||0
10373044|NCT04200833|11514396|FG000|STARTED|Overall Study||10
10373045|NCT04200833|11514396|FG000|COMPLETED|Overall Study||10
10373046|NCT04200833|11514396|FG000|NOT COMPLETED|Overall Study||0
10373047|NCT04110314|11514406|FG000|STARTED|Overall Study||71781
10373048|NCT04110314|11514407|FG001|STARTED|Overall Study||71492
10373049|NCT04110314|11514408|FG002|STARTED|Overall Study||72177
10373050|NCT04110314|11514409|FG003|STARTED|Overall Study||71512
10373051|NCT04110314|11514410|FG004|STARTED|Overall Study||71536
10373052|NCT04110314|11514411|FG005|STARTED|Overall Study||72138
10373053|NCT04110314|11514406|FG000|Patients Who Met Inclusion|Overall Study||36526
10373054|NCT04110314|11514407|FG001|Patients Who Met Inclusion|Overall Study||36388
10373055|NCT04110314|11514408|FG002|Patients Who Met Inclusion|Overall Study||36541
10373056|NCT04110314|11514409|FG003|Patients Who Met Inclusion|Overall Study||36377
10373057|NCT04110314|11514410|FG004|Patients Who Met Inclusion|Overall Study||36289
10373058|NCT04110314|11514411|FG005|Patients Who Met Inclusion|Overall Study||36411
10373059|NCT04110314|11514406|FG000|COMPLETED|Overall Study||36526
10373060|NCT04110314|11514407|FG001|COMPLETED|Overall Study||36388
10373061|NCT04110314|11514408|FG002|COMPLETED|Overall Study||36541
10373062|NCT04110314|11514409|FG003|COMPLETED|Overall Study||36377
10373063|NCT04110314|11514410|FG004|COMPLETED|Overall Study||36289
10373064|NCT04110314|11514411|FG005|COMPLETED|Overall Study||36411
10373065|NCT04110314|11514406|FG000|NOT COMPLETED|Overall Study||35255
10373066|NCT04110314|11514407|FG001|NOT COMPLETED|Overall Study||35104
10373067|NCT04110314|11514408|FG002|NOT COMPLETED|Overall Study||35636
10373068|NCT04110314|11514409|FG003|NOT COMPLETED|Overall Study||35135
10373069|NCT04110314|11514410|FG004|NOT COMPLETED|Overall Study||35247
10373070|NCT04110314|11514411|FG005|NOT COMPLETED|Overall Study||35727
10373101|NCT04084288|11514444|FG000|STARTED|Overall Study||41
10373102|NCT04084288|11514444|FG000|COMPLETED|Overall Study||41
10373103|NCT04084288|11514444|FG000|NOT COMPLETED|Overall Study||0
10373104|NCT03961204|11514453|FG000|STARTED|Overall Study||662
10373105|NCT03961204|11514453|FG000|COMPLETED|Overall Study||655
10373106|NCT03961204|11514453|FG000|NOT COMPLETED|Overall Study||7
10373107|NCT03895840|11514457|FG000|STARTED|Overall Study||70
10537960|NCT01452425|11690745|FG000|STARTED|Overall Study||10
10717000|NCT02694523|11880910|FG001|STARTED|Part B||0
10373108|NCT03895840|11514457|FG000|6-Week Follow-Up|Overall Study||70
10373109|NCT03895840|11514457|FG000|12-Week Follow-Up|Overall Study||65
10373110|NCT03895840|11514457|FG000|24-Week Follow-Up|Overall Study||49
10373111|NCT03895840|11514457|FG000|COMPLETED|Overall Study||49
10373112|NCT03895840|11514457|FG000|NOT COMPLETED|Overall Study||21
10373113|NCT03818399|11514461|FG000|STARTED|Overall Study||19
10373114|NCT03818399|11514461|FG000|COMPLETED|Overall Study||5
10537961|NCT01452425|11690745|FG000|COMPLETED|Overall Study||10
10777260|NCT03338556|11939218|FG002|STARTED|Overall Study||24
10373115|NCT03818399|11514461|FG000|NOT COMPLETED|Overall Study||14
10373116|NCT03603496|11514467|FG000|STARTED|Overall Study||706
10373117|NCT03603496|11514468|FG001|STARTED|Overall Study||703
10373118|NCT03603496|11514467|FG000|COMPLETED|Overall Study||520
10373119|NCT03603496|11514468|FG001|COMPLETED|Overall Study||518
10373120|NCT03603496|11514467|FG000|NOT COMPLETED|Overall Study||186
10373121|NCT03603496|11514468|FG001|NOT COMPLETED|Overall Study||185
10373122|NCT03480802|11514476|FG000|STARTED|Overall Study||152
10373123|NCT03480802|11514477|FG001|STARTED|Overall Study||150
10373124|NCT03480802|11514476|FG000|Week 8|Overall Study||150
10373125|NCT03480802|11514477|FG001|Week 8|Overall Study||148
10373126|NCT03480802|11514476|FG000|COMPLETED|Overall Study||145
10373127|NCT03480802|11514477|FG001|COMPLETED|Overall Study||147
10373128|NCT03480802|11514476|FG000|NOT COMPLETED|Overall Study||7
10373129|NCT03480802|11514477|FG001|NOT COMPLETED|Overall Study||3
10373130|NCT03472521|11514487|FG000|STARTED|Overall Study||41
10373131|NCT03472521|11514488|FG001|STARTED|Overall Study||37
10373132|NCT03472521|11514487|FG000|Received Allocated Intervention|Overall Study||41
10373133|NCT03472521|11514488|FG001|Received Allocated Intervention|Overall Study||37
10373134|NCT03472521|11514487|FG000|COMPLETED|Overall Study||35
10373135|NCT03472521|11514488|FG001|COMPLETED|Overall Study||34
10373136|NCT03472521|11514487|FG000|NOT COMPLETED|Overall Study||6
10373137|NCT03472521|11514488|FG001|NOT COMPLETED|Overall Study||3
10373138|NCT03303950|11514494|FG000|STARTED|Overall Study||6
10373139|NCT03303950|11514494|FG000|COMPLETED|Overall Study||6
10373140|NCT03303950|11514494|FG000|NOT COMPLETED|Overall Study||0
10427707|NCT00854113|11573579|FG000|NOT COMPLETED|Overall Study||0
10427708|NCT00854113|11573580|FG001|NOT COMPLETED|Overall Study||0
10427709|NCT00854113|11573581|FG002|NOT COMPLETED|Overall Study||0
10427710|NCT00854113|11573582|FG003|NOT COMPLETED|Overall Study||0
10427711|NCT00854113|11573583|FG004|NOT COMPLETED|Overall Study||0
10427712|NCT00854113|11573584|FG005|NOT COMPLETED|Overall Study||0
10427713|NCT00854113|11573585|FG006|NOT COMPLETED|Overall Study||0
10427714|NCT00854113|11573586|FG007|NOT COMPLETED|Overall Study||3
10427715|NCT00854113|11573587|FG008|NOT COMPLETED|Overall Study||1
10427716|NCT00854113|11573588|FG009|NOT COMPLETED|Overall Study||0
10427717|NCT00854113|11573589|FG010|NOT COMPLETED|Overall Study||0
10427718|NCT00854308|11573615|FG000|STARTED|Overall Study||69
10427719|NCT00854308|11573616|FG001|STARTED|Overall Study||68
10427720|NCT00854308|11573615|FG000|Received Study Drug|Overall Study||69
10427721|NCT00854308|11573616|FG001|Received Study Drug|Overall Study||67
10427722|NCT00854308|11573615|FG000|COMPLETED|Overall Study|Completed participants in both arms were still receiving study drug when analyses were performed.|7
10427723|NCT00854308|11573616|FG001|COMPLETED|Overall Study||1
10427724|NCT00854308|11573615|FG000|NOT COMPLETED|Overall Study||62
10427725|NCT00854308|11573616|FG001|NOT COMPLETED|Overall Study||67
10427726|NCT00854360|11573626|FG000|STARTED|Overall Study||118
10427727|NCT00854360|11573627|FG001|STARTED|Overall Study||123
10427728|NCT00854360|11573628|FG002|STARTED|Overall Study||122
10427729|NCT00854360|11573629|FG003|STARTED|Overall Study||124
10537962|NCT01452425|11690745|FG000|NOT COMPLETED|Overall Study||0
10537963|NCT01452529|11690752|FG000|STARTED|Run-in Period||905
10537964|NCT01452529|11690753|FG001|STARTED|Run-in Period||0
10537965|NCT01452529|11690754|FG002|STARTED|Run-in Period||0
10537966|NCT01452529|11690752|FG000|COMPLETED|Run-in Period||592
10537967|NCT01452529|11690753|FG001|COMPLETED|Run-in Period||0
10537968|NCT01452529|11690754|FG002|COMPLETED|Run-in Period||0
10537969|NCT01452529|11690752|FG000|NOT COMPLETED|Run-in Period||313
10537970|NCT01452529|11690753|FG001|NOT COMPLETED|Run-in Period||0
10537971|NCT01452529|11690754|FG002|NOT COMPLETED|Run-in Period||0
10537972|NCT01452529|11690752|FG000|STARTED|Double-blind (DB) Period||0
10537973|NCT01452529|11690753|FG001|STARTED|Double-blind (DB) Period|Four subjects were randomized but did not receive DB medication|296
10537974|NCT01452529|11690754|FG002|STARTED|Double-blind (DB) Period||292
10537975|NCT01452529|11690752|FG000|COMPLETED|Double-blind (DB) Period||0
10537976|NCT01452529|11690753|FG001|COMPLETED|Double-blind (DB) Period|4 subjects who did not receive DB medication were still counted as discontinued in the DB period|229
10537977|NCT01452529|11690754|FG002|COMPLETED|Double-blind (DB) Period||210
10537978|NCT01452529|11690752|FG000|NOT COMPLETED|Double-blind (DB) Period||0
10537979|NCT01452529|11690753|FG001|NOT COMPLETED|Double-blind (DB) Period||67
10537980|NCT01452529|11690754|FG002|NOT COMPLETED|Double-blind (DB) Period||82
10537981|NCT01452789|11690763|FG000|STARTED|Overall Study||33
10537982|NCT01452789|11690764|FG001|STARTED|Overall Study||30
10537983|NCT01452789|11690763|FG000|COMPLETED|Overall Study||30
10537984|NCT01452789|11690764|FG001|COMPLETED|Overall Study||28
10537985|NCT01452789|11690763|FG000|NOT COMPLETED|Overall Study||3
10537986|NCT01452789|11690764|FG001|NOT COMPLETED|Overall Study||2
10657384|NCT02224846|11818568|FG001|COMPLETED|Period 2 (Month 12 to Month 24)||283
10427730|NCT00854360|11573626|FG000|Intent to Treat / Safety Population|Overall Study||118
10427731|NCT00854360|11573627|FG001|Intent to Treat / Safety Population|Overall Study||123
10427732|NCT00854360|11573628|FG002|Intent to Treat / Safety Population|Overall Study||122
10427733|NCT00854360|11573629|FG003|Intent to Treat / Safety Population|Overall Study|One patient did not receive any double-blind study medication.|123
10427734|NCT00854360|11573626|FG000|COMPLETED|Overall Study||116
10427735|NCT00854360|11573627|FG001|COMPLETED|Overall Study|One patient discontinued due to both an AE and study medication discontinuation.|120
10427736|NCT00854360|11573628|FG002|COMPLETED|Overall Study||120
10427737|NCT00854360|11573629|FG003|COMPLETED|Overall Study||114
10427738|NCT00854360|11573626|FG000|NOT COMPLETED|Overall Study||2
10427739|NCT00854360|11573627|FG001|NOT COMPLETED|Overall Study||3
10427740|NCT00854360|11573628|FG002|NOT COMPLETED|Overall Study||2
10373141|NCT02673203|11514501|FG000|STARTED|Overall Study||16
10373142|NCT02673203|11514502|FG001|STARTED|Overall Study||15
10373143|NCT02673203|11514501|FG000|COMPLETED|Overall Study||16
10373144|NCT02673203|11514502|FG001|COMPLETED|Overall Study||15
10373145|NCT02673203|11514501|FG000|NOT COMPLETED|Overall Study||0
10373146|NCT02673203|11514502|FG001|NOT COMPLETED|Overall Study||0
10373147|NCT02664441|11514510|FG000|STARTED|Randomization||23
10373148|NCT02664441|11514511|FG001|STARTED|Randomization||19
10373149|NCT02664441|11514510|FG000|COMPLETED|Randomization||23
10373150|NCT02664441|11514511|FG001|COMPLETED|Randomization||18
10373151|NCT02664441|11514510|FG000|NOT COMPLETED|Randomization||0
10373152|NCT02664441|11514511|FG001|NOT COMPLETED|Randomization||1
10373153|NCT02664441|11514510|FG000|STARTED|36-week Randomized Trial||23
10373154|NCT02664441|11514511|FG001|STARTED|36-week Randomized Trial||18
10373155|NCT02664441|11514510|FG000|COMPLETED|36-week Randomized Trial||20
10373156|NCT02664441|11514511|FG001|COMPLETED|36-week Randomized Trial||15
10373157|NCT02664441|11514510|FG000|NOT COMPLETED|36-week Randomized Trial||3
10373158|NCT02664441|11514511|FG001|NOT COMPLETED|36-week Randomized Trial||3
10373159|NCT02664441|11514510|FG000|STARTED|18-week Open Label Extension||20
10373160|NCT02664441|11514511|FG001|STARTED|18-week Open Label Extension||15
10373161|NCT02664441|11514510|FG000|COMPLETED|18-week Open Label Extension||17
10373162|NCT02664441|11514511|FG001|COMPLETED|18-week Open Label Extension||14
10373163|NCT02664441|11514510|FG000|NOT COMPLETED|18-week Open Label Extension||3
10373164|NCT02664441|11514511|FG001|NOT COMPLETED|18-week Open Label Extension||1
10373165|NCT02527187|11514520|FG000|STARTED|Overall Study||75
10373166|NCT02527187|11514521|FG001|STARTED|Overall Study||126
10373167|NCT02527187|11514520|FG000|COMPLETED|Overall Study||75
10373168|NCT02527187|11514521|FG001|COMPLETED|Overall Study||126
10373169|NCT02527187|11514520|FG000|NOT COMPLETED|Overall Study||0
10373170|NCT02527187|11514521|FG001|NOT COMPLETED|Overall Study||0
10373171|NCT02513472|11514531|FG000|STARTED|Overall Study||66
10373172|NCT02513472|11514532|FG001|STARTED|Overall Study||101
10373173|NCT02513472|11514531|FG000|Phase 1b Safety run-in|Overall Study||3
10373174|NCT02513472|11514532|FG001|Phase 1b Safety run-in|Overall Study||4
10373175|NCT02513472|11514531|FG000|Phase 2|Overall Study||63
10373176|NCT02513472|11514532|FG001|Phase 2|Overall Study||97
10373177|NCT02513472|11514531|FG000|COMPLETED|Overall Study||0
10373178|NCT02513472|11514532|FG001|COMPLETED|Overall Study||0
10373179|NCT02513472|11514531|FG000|NOT COMPLETED|Overall Study||66
10373180|NCT02513472|11514532|FG001|NOT COMPLETED|Overall Study||101
10373181|NCT02476409|11514542|FG000|STARTED|Overall Study||19
10373182|NCT02476409|11514543|FG001|STARTED|Overall Study||21
10373183|NCT02476409|11514542|FG000|COMPLETED|Overall Study||19
10373184|NCT02476409|11514543|FG001|COMPLETED|Overall Study||21
10373185|NCT02476409|11514542|FG000|NOT COMPLETED|Overall Study||0
10373186|NCT02476409|11514543|FG001|NOT COMPLETED|Overall Study||0
10373187|NCT02132650|11514555|FG000|STARTED|Overall Study||20
10373188|NCT02132650|11514556|FG001|STARTED|Overall Study||18
10373189|NCT02132650|11514555|FG000|Post-Intervention Assessment|Overall Study||19
10373190|NCT02132650|11514556|FG001|Post-Intervention Assessment|Overall Study||17
10373191|NCT02132650|11514555|FG000|COMPLETED|Overall Study||17
10373192|NCT02132650|11514556|FG001|COMPLETED|Overall Study||14
10373193|NCT02132650|11514555|FG000|NOT COMPLETED|Overall Study||3
10373194|NCT02132650|11514556|FG001|NOT COMPLETED|Overall Study||4
10373195|NCT01980355|11514564|FG000|STARTED|Overall Study||39
10373196|NCT01980355|11514565|FG001|STARTED|Overall Study||37
10373197|NCT01980355|11514564|FG000|COMPLETED|Overall Study||39
10373198|NCT01980355|11514565|FG001|COMPLETED|Overall Study||37
10373199|NCT01980355|11514564|FG000|NOT COMPLETED|Overall Study||0
10373200|NCT01980355|11514565|FG001|NOT COMPLETED|Overall Study||0
10373201|NCT01559935|11514571|FG000|STARTED|Car Phase||72
10373202|NCT01559935|11514571|FG000|COMPLETED|Car Phase||58
10373203|NCT01559935|11514571|FG000|NOT COMPLETED|Car Phase||14
10373204|NCT01559935|11514571|FG000|STARTED|BiRD Phase||58
10373205|NCT01559935|11514571|FG000|COMPLETED|BiRD Phase||54
10373206|NCT01559935|11514571|FG000|NOT COMPLETED|BiRD Phase||4
10373207|NCT01559935|11514571|FG000|STARTED|Maintenance Phase||54
10373208|NCT01559935|11514571|FG000|COMPLETED|Maintenance Phase||0
10373209|NCT01559935|11514571|FG000|NOT COMPLETED|Maintenance Phase||54
10373210|NCT01285362|11514577|FG000|STARTED|Overall Study||4
10373211|NCT01285362|11514578|FG001|STARTED|Overall Study||4
10373212|NCT01285362|11514577|FG000|COMPLETED|Overall Study||4
10373213|NCT01285362|11514578|FG001|COMPLETED|Overall Study||4
10373214|NCT01285362|11514577|FG000|NOT COMPLETED|Overall Study||0
10373215|NCT01285362|11514578|FG001|NOT COMPLETED|Overall Study||0
10373216|NCT01067144|11514586|FG000|STARTED|Treatment||207
10373217|NCT01067144|11514587|FG001|STARTED|Treatment||215
10373218|NCT01067144|11514586|FG000|COMPLETED|Treatment||203
10373219|NCT01067144|11514587|FG001|COMPLETED|Treatment||208
10373220|NCT01067144|11514586|FG000|NOT COMPLETED|Treatment||4
10373221|NCT01067144|11514587|FG001|NOT COMPLETED|Treatment||7
10373222|NCT01067144|11514586|FG000|STARTED|Follow-up||203
10373223|NCT01067144|11514587|FG001|STARTED|Follow-up||208
10373224|NCT01067144|11514586|FG000|Intention-to-Treat Analysis Set|Follow-up||202
10373225|NCT01067144|11514587|FG001|Intention-to-Treat Analysis Set|Follow-up||208
10373226|NCT01067144|11514586|FG000|COMPLETED|Follow-up||144
10373227|NCT01067144|11514587|FG001|COMPLETED|Follow-up||152
10373228|NCT01067144|11514586|FG000|NOT COMPLETED|Follow-up||59
10373229|NCT01067144|11514587|FG001|NOT COMPLETED|Follow-up||56
10373230|NCT00600483|11514595|FG000|STARTED|Overall Study||753
10373231|NCT00600483|11514596|FG001|STARTED|Overall Study||749
10373232|NCT00600483|11514595|FG000|COMPLETED|Overall Study||717
10373233|NCT00600483|11514596|FG001|COMPLETED|Overall Study||702
10373234|NCT00600483|11514595|FG000|NOT COMPLETED|Overall Study||36
10373235|NCT00600483|11514596|FG001|NOT COMPLETED|Overall Study||47
10373236|NCT00568854|11514604|FG000|STARTED|Overall Study||6
10373237|NCT00568854|11514605|FG001|STARTED|Overall Study||4
10373238|NCT00568854|11514604|FG000|COMPLETED|Overall Study||6
10373239|NCT00568854|11514605|FG001|COMPLETED|Overall Study||4
10373240|NCT00568854|11514604|FG000|NOT COMPLETED|Overall Study||0
10373241|NCT00568854|11514605|FG001|NOT COMPLETED|Overall Study||0
10373242|NCT00568958|11514613|FG000|STARTED|Allocation||70
10373243|NCT00568958|11514614|FG001|STARTED|Allocation||70
10373244|NCT00568958|11514613|FG000|COMPLETED|Allocation||61
10373245|NCT00568958|11514614|FG001|COMPLETED|Allocation||67
10373246|NCT00568958|11514613|FG000|NOT COMPLETED|Allocation||9
10373247|NCT00568958|11514614|FG001|NOT COMPLETED|Allocation||3
10373248|NCT00568958|11514613|FG000|STARTED|Follow-Up||61
10373249|NCT00568958|11514614|FG001|STARTED|Follow-Up||67
10373250|NCT00568958|11514613|FG000|COMPLETED|Follow-Up||52
10373251|NCT00568958|11514614|FG001|COMPLETED|Follow-Up||60
10373252|NCT00568958|11514613|FG000|NOT COMPLETED|Follow-Up||9
10373253|NCT00568958|11514614|FG001|NOT COMPLETED|Follow-Up||7
10373254|NCT00569010|11514624|FG000|STARTED|Overall Study||6
10373255|NCT00569010|11514625|FG001|STARTED|Overall Study||6
10373256|NCT00569010|11514626|FG002|STARTED|Overall Study||11
10373257|NCT00569010|11514627|FG003|STARTED|Overall Study||11
10373258|NCT00569010|11514624|FG000|COMPLETED|Overall Study||6
10373259|NCT00569010|11514625|FG001|COMPLETED|Overall Study||6
10373260|NCT00569010|11514626|FG002|COMPLETED|Overall Study||11
10373261|NCT00569010|11514627|FG003|COMPLETED|Overall Study||11
10373262|NCT00569010|11514624|FG000|NOT COMPLETED|Overall Study||0
10373263|NCT00569010|11514625|FG001|NOT COMPLETED|Overall Study||0
10373264|NCT00569010|11514626|FG002|NOT COMPLETED|Overall Study||0
10373265|NCT00569010|11514627|FG003|NOT COMPLETED|Overall Study||0
10373266|NCT00569166|11514640|FG000|STARTED|Overall Study||30
10373267|NCT00569166|11514641|FG001|STARTED|Overall Study||31
10373268|NCT00569166|11514642|FG002|STARTED|Overall Study||31
10373269|NCT00569166|11514640|FG000|COMPLETED|Overall Study||21
10373270|NCT00569166|11514641|FG001|COMPLETED|Overall Study||25
10373271|NCT00569166|11514642|FG002|COMPLETED|Overall Study||27
10373272|NCT00569166|11514640|FG000|NOT COMPLETED|Overall Study||9
10373273|NCT00569166|11514641|FG001|NOT COMPLETED|Overall Study||6
10373274|NCT00569166|11514642|FG002|NOT COMPLETED|Overall Study||4
10373275|NCT00569192|11514653|FG000|STARTED|Overall Study||111
10373276|NCT00569192|11514654|FG001|STARTED|Overall Study||125
10373277|NCT00569192|11514655|FG002|STARTED|Overall Study||124
10373278|NCT00569192|11514653|FG000|COMPLETED|Overall Study||88
10373279|NCT00569192|11514654|FG001|COMPLETED|Overall Study||105
10373280|NCT00569192|11514655|FG002|COMPLETED|Overall Study||99
10373281|NCT00569192|11514653|FG000|NOT COMPLETED|Overall Study||23
10373282|NCT00569192|11514654|FG001|NOT COMPLETED|Overall Study||20
10373283|NCT00569192|11514655|FG002|NOT COMPLETED|Overall Study||25
10373284|NCT00569231|11514663|FG000|STARTED|Overall Study||18
10373285|NCT00569231|11514663|FG000|COMPLETED|Overall Study||11
10373286|NCT00569231|11514663|FG000|NOT COMPLETED|Overall Study||7
10373287|NCT00569270|11514667|FG000|STARTED|Period: First Intervention|randomized cross over study|15
10373288|NCT00569270|11514668|FG001|STARTED|Period: First Intervention||15
10373289|NCT00569270|11514667|FG000|COMPLETED|Period: First Intervention||15
10373290|NCT00569270|11514668|FG001|COMPLETED|Period: First Intervention||14
10373291|NCT00569270|11514667|FG000|NOT COMPLETED|Period: First Intervention||0
10373292|NCT00569270|11514668|FG001|NOT COMPLETED|Period: First Intervention||1
10373293|NCT00569270|11514667|FG000|STARTED|Period: Second Intervention||15
10373294|NCT00569270|11514668|FG001|STARTED|Period: Second Intervention||14
10373295|NCT00569270|11514667|FG000|29 Days|Period: Second Intervention||15
10373296|NCT00569270|11514668|FG001|29 Days|Period: Second Intervention||14
10373297|NCT00569270|11514667|FG000|COMPLETED|Period: Second Intervention||15
10373298|NCT00569270|11514668|FG001|COMPLETED|Period: Second Intervention||14
10373299|NCT00569270|11514667|FG000|NOT COMPLETED|Period: Second Intervention||0
10373300|NCT00569270|11514668|FG001|NOT COMPLETED|Period: Second Intervention||0
10373301|NCT00569309|11514683|FG000|STARTED|Overall Study||30
10373302|NCT00569309|11514683|FG000|COMPLETED|Overall Study||30
10373303|NCT00569309|11514683|FG000|NOT COMPLETED|Overall Study||0
10373304|NCT00569374|11514687|FG000|STARTED|Overall Study||8
10373305|NCT00569374|11514687|FG000|COMPLETED|Overall Study||4
10373306|NCT00569374|11514687|FG000|NOT COMPLETED|Overall Study||4
10373307|NCT00569530|11514693|FG000|STARTED|Overall Study||43
10373308|NCT00569530|11514694|FG001|STARTED|Overall Study||42
10373309|NCT00569530|11514693|FG000|COMPLETED|Overall Study||43
10373310|NCT00569530|11514694|FG001|COMPLETED|Overall Study||42
10373311|NCT00569530|11514693|FG000|NOT COMPLETED|Overall Study||0
10373312|NCT00569530|11514694|FG001|NOT COMPLETED|Overall Study||0
10373313|NCT00569582|11514700|FG000|STARTED|Overall Study||50
10373314|NCT00569582|11514700|FG000|COMPLETED|Overall Study||34
10373315|NCT00569582|11514700|FG000|NOT COMPLETED|Overall Study||16
10373316|NCT00569660|11514704|FG000|STARTED|Overall Study||34
10373317|NCT00569660|11514704|FG000|COMPLETED|Overall Study||34
10373318|NCT00569660|11514704|FG000|NOT COMPLETED|Overall Study||0
10373319|NCT00569673|11514708|FG000|STARTED|Overall Study|Total number participants enrolled on study|71
10373320|NCT00569673|11514708|FG000|COMPLETED|Overall Study|Total number participants that are eligible and evaluable.|71
10373321|NCT00569673|11514708|FG000|NOT COMPLETED|Overall Study||0
10373322|NCT00569777|11514714|FG000|STARTED|Overall Study||206
10373323|NCT00569777|11514715|FG001|STARTED|Overall Study||104
10373324|NCT00569777|11514714|FG000|COMPLETED|Overall Study||196
10373325|NCT00569777|11514715|FG001|COMPLETED|Overall Study||101
10373326|NCT00569777|11514714|FG000|NOT COMPLETED|Overall Study||10
10373327|NCT00569777|11514715|FG001|NOT COMPLETED|Overall Study||3
10373328|NCT00569803|11514729|FG000|STARTED|Overall Study||5
10373329|NCT00569803|11514730|FG001|STARTED|Overall Study||5
10373330|NCT00569803|11514731|FG002|STARTED|Overall Study||5
10373331|NCT00569803|11514732|FG003|STARTED|Overall Study||6
10373332|NCT00569803|11514733|FG004|STARTED|Overall Study||5
10373333|NCT00569803|11514734|FG005|STARTED|Overall Study||5
10373334|NCT00569803|11514735|FG006|STARTED|Overall Study||10
10373335|NCT00569803|11514736|FG007|STARTED|Overall Study||6
10373336|NCT00569803|11514729|FG000|COMPLETED|Overall Study||4
10373337|NCT00569803|11514730|FG001|COMPLETED|Overall Study||5
10373338|NCT00569803|11514731|FG002|COMPLETED|Overall Study||5
10373339|NCT00569803|11514732|FG003|COMPLETED|Overall Study||5
10373340|NCT00569803|11514733|FG004|COMPLETED|Overall Study||5
10373341|NCT00569803|11514734|FG005|COMPLETED|Overall Study||5
10373342|NCT00569803|11514735|FG006|COMPLETED|Overall Study||10
10373343|NCT00569803|11514736|FG007|COMPLETED|Overall Study||5
10373344|NCT00569803|11514729|FG000|NOT COMPLETED|Overall Study||1
10373345|NCT00569803|11514730|FG001|NOT COMPLETED|Overall Study||0
10373346|NCT00569803|11514731|FG002|NOT COMPLETED|Overall Study||0
10373347|NCT00569803|11514732|FG003|NOT COMPLETED|Overall Study||1
10373348|NCT00569803|11514733|FG004|NOT COMPLETED|Overall Study||0
10373349|NCT00569803|11514734|FG005|NOT COMPLETED|Overall Study||0
10373350|NCT00569803|11514735|FG006|NOT COMPLETED|Overall Study||0
10373351|NCT00569803|11514736|FG007|NOT COMPLETED|Overall Study||1
10373352|NCT00569855|11514758|FG000|STARTED|Overall Study|832 subjects enrolled; however, study records only available for analysis from 2004 =446 subjects|785
10373353|NCT00569855|11514758|FG000|COMPLETED|Overall Study|785 subjects treated with study drug|785
10373354|NCT00569855|11514758|FG000|NOT COMPLETED|Overall Study||0
10373355|NCT00569946|11514762|FG000|STARTED|Overall Study||64
10373356|NCT00569946|11514762|FG000|COMPLETED|Overall Study||5
10373357|NCT00569946|11514762|FG000|NOT COMPLETED|Overall Study||59
10373358|NCT00570037|11514768|FG000|STARTED|Overall Study||238
10373359|NCT00570037|11514769|FG001|STARTED|Overall Study||306
10373360|NCT00570037|11514768|FG000|COMPLETED|Overall Study||194
10373361|NCT00570037|11514769|FG001|COMPLETED|Overall Study||237
10373362|NCT00570037|11514768|FG000|NOT COMPLETED|Overall Study||44
10373363|NCT00570037|11514769|FG001|NOT COMPLETED|Overall Study||69
10373364|NCT00570063|11514777|FG000|STARTED|Overall Study||24
10373365|NCT00570063|11514778|FG001|STARTED|Overall Study||11
10373366|NCT00570063|11514777|FG000|COMPLETED|Overall Study||9
10373367|NCT00570063|11514778|FG001|COMPLETED|Overall Study||3
10373368|NCT00570063|11514777|FG000|NOT COMPLETED|Overall Study||15
10373369|NCT00570063|11514778|FG001|NOT COMPLETED|Overall Study||8
10373370|NCT00570089|11514784|FG000|STARTED|Period 1||10
10373371|NCT00570089|11514785|FG001|STARTED|Period 1||10
10373372|NCT00570089|11514784|FG000|COMPLETED|Period 1||10
10538011|NCT01453023|11690782|FG000|STARTED|Treatment Period (TP) 1||13
10373373|NCT00570089|11514785|FG001|COMPLETED|Period 1||10
10373374|NCT00570089|11514784|FG000|NOT COMPLETED|Period 1||0
10373375|NCT00570089|11514785|FG001|NOT COMPLETED|Period 1||0
10373376|NCT00570089|11514784|FG000|STARTED|Perod 2||10
10373377|NCT00570089|11514785|FG001|STARTED|Perod 2||10
10373378|NCT00570089|11514784|FG000|COMPLETED|Perod 2||10
10373379|NCT00570089|11514785|FG001|COMPLETED|Perod 2||10
10373380|NCT00570089|11514784|FG000|NOT COMPLETED|Perod 2||0
10373381|NCT00570089|11514785|FG001|NOT COMPLETED|Perod 2||0
10373382|NCT00570128|11514795|FG000|STARTED|Overall Study||64
10373383|NCT00570128|11514796|FG001|STARTED|Overall Study||65
10373384|NCT00570128|11514795|FG000|Intent to Treat (ITT) Population|Overall Study||62
10538012|NCT01453023|11690783|FG001|STARTED|Treatment Period (TP) 1||13
10538013|NCT01453023|11690782|FG000|COMPLETED|Treatment Period (TP) 1||12
10373385|NCT00570128|11514796|FG001|Intent to Treat (ITT) Population|Overall Study||65
10373386|NCT00570128|11514795|FG000|COMPLETED|Overall Study||60
10373387|NCT00570128|11514796|FG001|COMPLETED|Overall Study||65
10373388|NCT00570128|11514795|FG000|NOT COMPLETED|Overall Study||4
10373389|NCT00570128|11514796|FG001|NOT COMPLETED|Overall Study||0
10373390|NCT00570141|11514802|FG000|STARTED|Overall Study||13
10373391|NCT00570141|11514802|FG000|COMPLETED|Overall Study||10
10373392|NCT00570141|11514802|FG000|NOT COMPLETED|Overall Study||3
10373393|NCT00570232|11514806|FG000|STARTED|Overall Study||31
10373394|NCT00570232|11514806|FG000|COMPLETED|Overall Study||8
10373395|NCT00570232|11514806|FG000|NOT COMPLETED|Overall Study||23
10373396|NCT00570310|11514812|FG000|STARTED|Overall Study||53
10373397|NCT00570310|11514813|FG001|STARTED|Overall Study||51
10373398|NCT00570310|11514812|FG000|COMPLETED|Overall Study||51
10373399|NCT00570310|11514813|FG001|COMPLETED|Overall Study||45
10373400|NCT00570310|11514812|FG000|NOT COMPLETED|Overall Study||2
10373401|NCT00570310|11514813|FG001|NOT COMPLETED|Overall Study||6
10373402|NCT00570323|11514821|FG000|STARTED|Started Treatment After Randomization||36
10373403|NCT00570323|11514822|FG001|STARTED|Started Treatment After Randomization||36
10373404|NCT00570323|11514821|FG000|COMPLETED|Started Treatment After Randomization||34
10373405|NCT00570323|11514822|FG001|COMPLETED|Started Treatment After Randomization||35
10373406|NCT00570323|11514821|FG000|NOT COMPLETED|Started Treatment After Randomization||2
10373407|NCT00570323|11514822|FG001|NOT COMPLETED|Started Treatment After Randomization||1
10373408|NCT00570323|11514821|FG000|STARTED|Complete Study After Start||34
10373409|NCT00570323|11514822|FG001|STARTED|Complete Study After Start||35
10373410|NCT00570323|11514821|FG000|COMPLETED|Complete Study After Start||31
10373411|NCT00570323|11514822|FG001|COMPLETED|Complete Study After Start||34
10373412|NCT00570323|11514821|FG000|NOT COMPLETED|Complete Study After Start||3
10373413|NCT00570323|11514822|FG001|NOT COMPLETED|Complete Study After Start||1
10373414|NCT00570349|11514833|FG000|STARTED|Overall Study||6
10373415|NCT00570349|11514834|FG001|STARTED|Overall Study||6
10373416|NCT00570349|11514835|FG002|STARTED|Overall Study||6
10373417|NCT00570349|11514833|FG000|COMPLETED|Overall Study||6
10373418|NCT00570349|11514834|FG001|COMPLETED|Overall Study||6
10373419|NCT00570349|11514835|FG002|COMPLETED|Overall Study||6
10373420|NCT00570349|11514833|FG000|NOT COMPLETED|Overall Study||0
10373421|NCT00570349|11514834|FG001|NOT COMPLETED|Overall Study||0
10373422|NCT00570349|11514835|FG002|NOT COMPLETED|Overall Study||0
10373423|NCT00570362|11514845|FG000|STARTED|Overall Study||19
10373424|NCT00570362|11514846|FG001|STARTED|Overall Study||30
10373425|NCT00570362|11514845|FG000|COMPLETED|Overall Study||19
10373426|NCT00570362|11514846|FG001|COMPLETED|Overall Study||30
10373427|NCT00570362|11514845|FG000|NOT COMPLETED|Overall Study||0
10373428|NCT00570362|11514846|FG001|NOT COMPLETED|Overall Study||0
10427741|NCT00854360|11573629|FG003|NOT COMPLETED|Overall Study||10
10717001|NCT02694523|11880911|FG002|STARTED|Part B|Participants who received risankizumab in Part A continued to received risankizumab in Part B|294
10717002|NCT02694523|11880912|FG003|STARTED|Part B|Adalimumab responders in Part A continued to received adalimumab in Part B|144
10717003|NCT02694523|11880913|FG004|STARTED|Part B|Adalimumab nonresponders in Part A switched to risankizumab in Part B|38
10717004|NCT02694523|11880914|FG005|STARTED|Part B|Adalimumab inadequate responders in Part A, rerandomized to adalimumab in Part B|56
10717005|NCT02694523|11880915|FG006|STARTED|Part B|Adalimumab inadequate responders in Part A, rerandomized to risankizumab in Part B|53
10717006|NCT02694523|11880909|FG000|COMPLETED|Part B||0
10717007|NCT02694523|11880910|FG001|COMPLETED|Part B||0
10427742|NCT00854373|11573641|FG000|STARTED|Overall Study||95
10427743|NCT00854373|11573642|FG001|STARTED|Overall Study||93
10427744|NCT00854373|11573641|FG000|COMPLETED|Overall Study||93
10427745|NCT00854373|11573642|FG001|COMPLETED|Overall Study||89
10427746|NCT00854373|11573641|FG000|NOT COMPLETED|Overall Study||2
10427747|NCT00854373|11573642|FG001|NOT COMPLETED|Overall Study||4
10427748|NCT00854581|11573648|FG000|STARTED|Induction (Up to Day 21)||13
10427749|NCT00854581|11573648|FG000|COMPLETED|Induction (Up to Day 21)||7
10427750|NCT00854581|11573648|FG000|NOT COMPLETED|Induction (Up to Day 21)||6
10427751|NCT00854581|11573648|FG000|STARTED|Part 1 Maintenance (Up to Day 60)||7
10427752|NCT00854581|11573648|FG000|COMPLETED|Part 1 Maintenance (Up to Day 60)||5
10427753|NCT00854581|11573648|FG000|NOT COMPLETED|Part 1 Maintenance (Up to Day 60)||2
10427754|NCT00854581|11573648|FG000|STARTED|Part 2 Maintenance (Up to 12 Months)||5
10427755|NCT00854581|11573648|FG000|COMPLETED|Part 2 Maintenance (Up to 12 Months)||2
10427756|NCT00854581|11573648|FG000|NOT COMPLETED|Part 2 Maintenance (Up to 12 Months)||3
10427757|NCT00854594|11573659|FG000|STARTED|Overall Study|9 sites randomized to control arm, providers completed surveys before and/or after study period|48
10427758|NCT00854594|11573660|FG001|STARTED|Overall Study|9 sites randomized to intervention, providers completed surveys before and/or after study period|69
10427759|NCT00854594|11573659|FG000|COMPLETED|Overall Study||48
10427760|NCT00854594|11573660|FG001|COMPLETED|Overall Study||69
10427761|NCT00854594|11573659|FG000|NOT COMPLETED|Overall Study||0
10427762|NCT00854594|11573660|FG001|NOT COMPLETED|Overall Study||0
10427763|NCT00854607|11573666|FG000|STARTED|Enrollment||116
10427764|NCT00854607|11573666|FG000|COMPLETED|Enrollment||116
10427765|NCT00854607|11573666|FG000|NOT COMPLETED|Enrollment||0
10427766|NCT00854607|11573666|FG000|STARTED|2 Weeks After Start Anti-fungal Therapy||116
10427767|NCT00854607|11573666|FG000|COMPLETED|2 Weeks After Start Anti-fungal Therapy||51
10427768|NCT00854607|11573666|FG000|NOT COMPLETED|2 Weeks After Start Anti-fungal Therapy||65
10427769|NCT00854620|11573677|FG000|STARTED|Overall Study||9
10427770|NCT00854620|11573677|FG000|COMPLETED|Overall Study||8
10427771|NCT00854620|11573677|FG000|NOT COMPLETED|Overall Study||1
10427772|NCT00854724|11573683|FG000|STARTED|First Intervention||8
10427773|NCT00854724|11573684|FG001|STARTED|First Intervention||8
10427774|NCT00854724|11573683|FG000|COMPLETED|First Intervention||7
10427775|NCT00854724|11573684|FG001|COMPLETED|First Intervention||7
10427776|NCT00854724|11573683|FG000|NOT COMPLETED|First Intervention||1
10538014|NCT01453023|11690783|FG001|COMPLETED|Treatment Period (TP) 1||12
10538015|NCT01453023|11690782|FG000|NOT COMPLETED|Treatment Period (TP) 1||1
10538016|NCT01453023|11690783|FG001|NOT COMPLETED|Treatment Period (TP) 1||1
10538017|NCT01453023|11690782|FG000|STARTED|Washout Period||12
10538018|NCT01453023|11690783|FG001|STARTED|Washout Period||12
10538019|NCT01453023|11690782|FG000|COMPLETED|Washout Period||12
10538020|NCT01453023|11690783|FG001|COMPLETED|Washout Period||12
10538021|NCT01453023|11690782|FG000|NOT COMPLETED|Washout Period||0
10538022|NCT01453023|11690783|FG001|NOT COMPLETED|Washout Period||0
10538023|NCT01453023|11690782|FG000|STARTED|Treatment Period 2||12
10657385|NCT02224846|11818567|FG000|NOT COMPLETED|Period 2 (Month 12 to Month 24)||42
10657386|NCT02224846|11818568|FG001|NOT COMPLETED|Period 2 (Month 12 to Month 24)||74
10657387|NCT02225080|11818574|FG000|STARTED|Overall Study||100
10657388|NCT02225080|11818574|FG000|COMPLETED|Overall Study||100
10657389|NCT02225080|11818574|FG000|NOT COMPLETED|Overall Study||0
10657390|NCT02225106|11818578|FG000|STARTED|Overall Study||11
10657391|NCT02225106|11818578|FG000|COMPLETED|Overall Study||11
10657392|NCT02225106|11818578|FG000|NOT COMPLETED|Overall Study||0
10657393|NCT02225132|11818582|FG000|STARTED|Overall Study||10
10657394|NCT02225132|11818582|FG000|COMPLETED|Overall Study||10
10657395|NCT02225132|11818582|FG000|NOT COMPLETED|Overall Study||0
10657396|NCT02225223|11818588|FG000|STARTED|Overall Study||27
10657397|NCT02225223|11818589|FG001|STARTED|Overall Study||8
10657398|NCT02225223|11818588|FG000|COMPLETED|Overall Study||8
10657399|NCT02225223|11818589|FG001|COMPLETED|Overall Study||3
10657400|NCT02225223|11818588|FG000|NOT COMPLETED|Overall Study||19
10657401|NCT02225223|11818589|FG001|NOT COMPLETED|Overall Study||5
10657402|NCT02225353|11818598|FG000|STARTED|Overall Study||91
10657403|NCT02225353|11818599|FG001|STARTED|Overall Study||90
10657404|NCT02225353|11818600|FG002|STARTED|Overall Study||90
10657405|NCT02225353|11818598|FG000|COMPLETED|Overall Study||87
10657406|NCT02225353|11818599|FG001|COMPLETED|Overall Study||84
10657407|NCT02225353|11818600|FG002|COMPLETED|Overall Study||75
10657408|NCT02225353|11818598|FG000|NOT COMPLETED|Overall Study||4
10657409|NCT02225353|11818599|FG001|NOT COMPLETED|Overall Study||6
10657410|NCT02225353|11818600|FG002|NOT COMPLETED|Overall Study||15
10657411|NCT02225587|11818613|FG000|STARTED|Overall Study||200
10657412|NCT02225587|11818614|FG001|STARTED|Overall Study||200
10657413|NCT02225587|11818613|FG000|Vaccination 2|Overall Study||188
10657414|NCT02225587|11818614|FG001|Vaccination 2|Overall Study||185
10657415|NCT02225587|11818613|FG000|Vaccination 3|Overall Study||172
10812619|NCT03465891|11974728|FG001|COMPLETED|Overall Study||0
10812620|NCT03465891|11974727|FG000|NOT COMPLETED|Overall Study||1
10812621|NCT03465891|11974728|FG001|NOT COMPLETED|Overall Study||1
10812622|NCT03465735|11974736|FG000|STARTED|Overall Study||8
10812623|NCT03465735|11974737|FG001|STARTED|Overall Study||7
10812624|NCT03465735|11974736|FG000|COMPLETED|Overall Study||7
10812625|NCT03465735|11974737|FG001|COMPLETED|Overall Study||5
10812626|NCT03465735|11974736|FG000|NOT COMPLETED|Overall Study||1
10812627|NCT03465735|11974737|FG001|NOT COMPLETED|Overall Study||2
10373429|NCT00570401|11514852|FG000|STARTED|Overall Study||21
10373430|NCT00570401|11514852|FG000|COMPLETED|Overall Study||19
10373431|NCT00570401|11514852|FG000|NOT COMPLETED|Overall Study||2
10812628|NCT03461705|11974743|FG000|STARTED|Overall Study||5
10812629|NCT03461705|11974743|FG000|COMPLETED|Overall Study||5
10812630|NCT03461705|11974743|FG000|NOT COMPLETED|Overall Study||0
10373432|NCT00570492|11514858|FG000|STARTED|16-week Single-blind Baseline Period||910
10427777|NCT00854724|11573684|FG001|NOT COMPLETED|First Intervention||1
10538024|NCT01453023|11690783|FG001|STARTED|Treatment Period 2||12
10657416|NCT02225587|11818614|FG001|Vaccination 3|Overall Study||164
10657417|NCT02225587|11818613|FG000|COMPLETED|Overall Study||172
10657418|NCT02225587|11818614|FG001|COMPLETED|Overall Study||162
10657419|NCT02225587|11818613|FG000|NOT COMPLETED|Overall Study||28
10427778|NCT00854724|11573683|FG000|STARTED|Washout||7
10427779|NCT00854724|11573684|FG001|STARTED|Washout||7
10427780|NCT00854724|11573683|FG000|COMPLETED|Washout||6
10427781|NCT00854724|11573684|FG001|COMPLETED|Washout||6
10427782|NCT00854724|11573683|FG000|NOT COMPLETED|Washout||1
10427783|NCT00854724|11573684|FG001|NOT COMPLETED|Washout||1
10427784|NCT00854724|11573683|FG000|STARTED|Second Intervention||6
10373433|NCT00570492|11514859|FG001|STARTED|16-week Single-blind Baseline Period||0
10373434|NCT00570492|11514860|FG002|STARTED|16-week Single-blind Baseline Period||0
10373435|NCT00570492|11514858|FG000|COMPLETED|16-week Single-blind Baseline Period||474
10373436|NCT00570492|11514859|FG001|COMPLETED|16-week Single-blind Baseline Period||0
10373437|NCT00570492|11514860|FG002|COMPLETED|16-week Single-blind Baseline Period||0
10373438|NCT00570492|11514858|FG000|NOT COMPLETED|16-week Single-blind Baseline Period||436
10373439|NCT00570492|11514859|FG001|NOT COMPLETED|16-week Single-blind Baseline Period||0
10373440|NCT00570492|11514860|FG002|NOT COMPLETED|16-week Single-blind Baseline Period||0
10373441|NCT00570492|11514858|FG000|STARTED|52-week Double-blind Treatment Period||0
10373442|NCT00570492|11514859|FG001|STARTED|52-week Double-blind Treatment Period||237
10373443|NCT00570492|11514860|FG002|STARTED|52-week Double-blind Treatment Period||237
10373444|NCT00570492|11514858|FG000|COMPLETED|52-week Double-blind Treatment Period||0
10373445|NCT00570492|11514859|FG001|COMPLETED|52-week Double-blind Treatment Period||187
10373446|NCT00570492|11514860|FG002|COMPLETED|52-week Double-blind Treatment Period||186
10373447|NCT00570492|11514858|FG000|NOT COMPLETED|52-week Double-blind Treatment Period||0
10373448|NCT00570492|11514859|FG001|NOT COMPLETED|52-week Double-blind Treatment Period||50
10373449|NCT00570492|11514860|FG002|NOT COMPLETED|52-week Double-blind Treatment Period||51
10373450|NCT00570505|11514866|FG000|STARTED|Overall Study||149
10373451|NCT00570505|11514866|FG000|COMPLETED|Overall Study|The number of subjects completing the 60-month study|108
10373452|NCT00570505|11514866|FG000|NOT COMPLETED|Overall Study||41
10373453|NCT00570661|11514870|FG000|STARTED|Overall Study||17
10373454|NCT00570661|11514870|FG000|COMPLETED|Overall Study||10
10373455|NCT00570661|11514870|FG000|NOT COMPLETED|Overall Study||7
10373456|NCT00570674|11514875|FG000|STARTED|Overall Study||6
10373457|NCT00570674|11514876|FG001|STARTED|Overall Study||3
10373458|NCT00570674|11514877|FG002|STARTED|Overall Study||4
10373459|NCT00570674|11514878|FG003|STARTED|Overall Study||3
10373460|NCT00570674|11514879|FG004|STARTED|Overall Study||3
10373461|NCT00570674|11514880|FG005|STARTED|Overall Study||10
10373462|NCT00570674|11514881|FG006|STARTED|Overall Study|The study did not continue beyond phase I.|0
10373463|NCT00570674|11514875|FG000|Treated|Overall Study||6
10373464|NCT00570674|11514876|FG001|Treated|Overall Study||3
10373465|NCT00570674|11514877|FG002|Treated|Overall Study||3
10373466|NCT00570674|11514878|FG003|Treated|Overall Study||3
10373467|NCT00570674|11514879|FG004|Treated|Overall Study||3
10373468|NCT00570674|11514880|FG005|Treated|Overall Study||10
10373469|NCT00570674|11514881|FG006|Treated|Overall Study||0
10373470|NCT00570674|11514875|FG000|PEG Evaluable|Overall Study||6
10373471|NCT00570674|11514876|FG001|PEG Evaluable|Overall Study||3
10373472|NCT00570674|11514877|FG002|PEG Evaluable|Overall Study||3
10373473|NCT00570674|11514878|FG003|PEG Evaluable|Overall Study||3
10373474|NCT00570674|11514879|FG004|PEG Evaluable|Overall Study||2
10373475|NCT00570674|11514880|FG005|PEG Evaluable|Overall Study||10
10373476|NCT00570674|11514881|FG006|PEG Evaluable|Overall Study||0
10373477|NCT00570674|11514875|FG000|COMPLETED|Overall Study||6
10373478|NCT00570674|11514876|FG001|COMPLETED|Overall Study||3
10373479|NCT00570674|11514877|FG002|COMPLETED|Overall Study||3
10373480|NCT00570674|11514878|FG003|COMPLETED|Overall Study||3
10373481|NCT00570674|11514879|FG004|COMPLETED|Overall Study||3
10373482|NCT00570674|11514880|FG005|COMPLETED|Overall Study||10
10373483|NCT00570674|11514881|FG006|COMPLETED|Overall Study||0
10373484|NCT00570674|11514875|FG000|NOT COMPLETED|Overall Study||0
10373485|NCT00570674|11514876|FG001|NOT COMPLETED|Overall Study||0
10373486|NCT00570674|11514877|FG002|NOT COMPLETED|Overall Study||1
10373487|NCT00570674|11514878|FG003|NOT COMPLETED|Overall Study||0
10373488|NCT00570674|11514879|FG004|NOT COMPLETED|Overall Study||0
10373489|NCT00570674|11514880|FG005|NOT COMPLETED|Overall Study||0
10373490|NCT00570674|11514881|FG006|NOT COMPLETED|Overall Study||0
10373491|NCT00570687|11514894|FG000|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
10373492|NCT00570687|11514895|FG001|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
10373493|NCT00570687|11514896|FG002|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
10373494|NCT00570687|11514897|FG003|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
10373495|NCT00570687|11514898|FG004|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
10373496|NCT00570687|11514899|FG005|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
10373497|NCT00570687|11514900|FG006|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
10373498|NCT00570687|11514901|FG007|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
10373499|NCT00570687|11514902|FG008|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
10373500|NCT00570687|11514903|FG009|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
10373501|NCT00570687|11514894|FG000|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
10373502|NCT00570687|11514895|FG001|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
10373503|NCT00570687|11514896|FG002|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
10373504|NCT00570687|11514897|FG003|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
10373505|NCT00570687|11514898|FG004|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
10373506|NCT00570687|11514899|FG005|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
10373507|NCT00570687|11514900|FG006|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
10373508|NCT00570687|11514901|FG007|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
10373509|NCT00570687|11514902|FG008|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
10373510|NCT00570687|11514903|FG009|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
10373511|NCT00570687|11514894|FG000|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
10373512|NCT00570687|11514895|FG001|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
10373513|NCT00570687|11514896|FG002|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
10373514|NCT00570687|11514897|FG003|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
10538025|NCT01453023|11690782|FG000|COMPLETED|Treatment Period 2||12
10538026|NCT01453023|11690783|FG001|COMPLETED|Treatment Period 2||11
10538027|NCT01453023|11690782|FG000|NOT COMPLETED|Treatment Period 2||0
10538028|NCT01453023|11690783|FG001|NOT COMPLETED|Treatment Period 2||1
10657420|NCT02225587|11818614|FG001|NOT COMPLETED|Overall Study||38
10657421|NCT02225665|11818622|FG000|STARTED|Overall Study||3
10657422|NCT02225665|11818623|FG001|STARTED|Overall Study||5
10657423|NCT02225665|11818622|FG000|COMPLETED|Overall Study||2
10657424|NCT02225665|11818623|FG001|COMPLETED|Overall Study||4
10657425|NCT02225665|11818622|FG000|NOT COMPLETED|Overall Study||1
10657426|NCT02225665|11818623|FG001|NOT COMPLETED|Overall Study||1
10657427|NCT02225743|11818629|FG000|STARTED|Overall Study||120
10657428|NCT02225743|11818629|FG000|COMPLETED|Overall Study|18 patients chose not to participate on the day of surgery.|102
10657429|NCT02225743|11818629|FG000|NOT COMPLETED|Overall Study||18
10657430|NCT02225860|11818635|FG000|STARTED|Overall Study||17
10657431|NCT02225860|11818636|FG001|STARTED|Overall Study||17
10657432|NCT02225860|11818635|FG000|COMPLETED|Overall Study||16
10657433|NCT02225860|11818636|FG001|COMPLETED|Overall Study||17
10717008|NCT02694523|11880911|FG002|COMPLETED|Part B||274
10717009|NCT02694523|11880912|FG003|COMPLETED|Part B||140
10717010|NCT02694523|11880913|FG004|COMPLETED|Part B||34
10717011|NCT02694523|11880914|FG005|COMPLETED|Part B||51
10717012|NCT02694523|11880915|FG006|COMPLETED|Part B||51
10717013|NCT02694523|11880909|FG000|NOT COMPLETED|Part B||0
10717014|NCT02694523|11880910|FG001|NOT COMPLETED|Part B||0
10717015|NCT02694523|11880911|FG002|NOT COMPLETED|Part B||20
10717016|NCT02694523|11880912|FG003|NOT COMPLETED|Part B||4
10717017|NCT02694523|11880913|FG004|NOT COMPLETED|Part B||4
10717018|NCT02694523|11880914|FG005|NOT COMPLETED|Part B||5
10717019|NCT02694523|11880915|FG006|NOT COMPLETED|Part B||2
10717020|NCT02694536|11880927|FG000|STARTED|Overall Study||80
10717021|NCT02694536|11880927|FG000|COMPLETED|Overall Study||0
10717022|NCT02694536|11880927|FG000|NOT COMPLETED|Overall Study||80
10717023|NCT02694549|11880931|FG000|STARTED|Overall Study||12
10717024|NCT02694549|11880931|FG000|COMPLETED|Overall Study||10
10717025|NCT02694549|11880931|FG000|NOT COMPLETED|Overall Study||2
10717026|NCT02694562|11880935|FG000|STARTED|Overall Study||20
10717027|NCT02694562|11880935|FG000|COMPLETED|Overall Study||2
10717028|NCT02694562|11880935|FG000|NOT COMPLETED|Overall Study||18
10717029|NCT02694601|11880939|FG000|STARTED|Overall Study||10
10717030|NCT02694601|11880939|FG000|COMPLETED|Overall Study||10
10717031|NCT02694601|11880939|FG000|NOT COMPLETED|Overall Study||0
10717032|NCT02694718|11880943|FG000|STARTED|Overall Study||60
10717033|NCT02694718|11880943|FG000|COMPLETED|Overall Study||58
10717034|NCT02694718|11880943|FG000|NOT COMPLETED|Overall Study||2
10717035|NCT02694744|11880949|FG000|STARTED|Overall Study||57
10717036|NCT02694744|11880950|FG001|STARTED|Overall Study||57
10717037|NCT02694744|11880949|FG000|Safety Population|Overall Study||57
10717038|NCT02694744|11880950|FG001|Safety Population|Overall Study||56
10717039|NCT02694744|11880949|FG000|ITT|Overall Study||57
10717040|NCT02694744|11880950|FG001|ITT|Overall Study||55
10717041|NCT02694744|11880949|FG000|COMPLETED|Overall Study||51
10717042|NCT02694744|11880950|FG001|COMPLETED|Overall Study||52
10717043|NCT02694744|11880949|FG000|NOT COMPLETED|Overall Study||6
10717044|NCT02694744|11880950|FG001|NOT COMPLETED|Overall Study||5
10717045|NCT02694835|11880960|FG000|STARTED|Overall Study||41
10717046|NCT02694835|11880961|FG001|STARTED|Overall Study||39
10717047|NCT02694835|11880960|FG000|COMPLETED|Overall Study||41
10717048|NCT02694835|11880961|FG001|COMPLETED|Overall Study||39
10717049|NCT02694835|11880960|FG000|NOT COMPLETED|Overall Study||0
10717050|NCT02694835|11880961|FG001|NOT COMPLETED|Overall Study||0
10717051|NCT02694978|11880969|FG000|STARTED|Overall Study||1006
10717052|NCT02694978|11880970|FG001|STARTED|Overall Study||1008
10717053|NCT02694978|11880969|FG000|Received at Least 1 Dose of Study Drug|Overall Study||997
10538029|NCT01453036|11690792|FG000|STARTED|Overall Study||308
10538030|NCT01453036|11690793|FG001|STARTED|Overall Study||308
10538031|NCT01453036|11690794|FG002|STARTED|Overall Study||308
10538032|NCT01453036|11690792|FG000|COMPLETED|Overall Study||282
10538033|NCT01453036|11690793|FG001|COMPLETED|Overall Study||193
10538034|NCT01453036|11690794|FG002|COMPLETED|Overall Study||277
10538035|NCT01453036|11690792|FG000|NOT COMPLETED|Overall Study||26
10538036|NCT01453036|11690793|FG001|NOT COMPLETED|Overall Study||115
10657434|NCT02225860|11818635|FG000|NOT COMPLETED|Overall Study||1
10657435|NCT02225860|11818636|FG001|NOT COMPLETED|Overall Study||0
10717054|NCT02694978|11880970|FG001|Received at Least 1 Dose of Study Drug|Overall Study||1000
10717055|NCT02694978|11880969|FG000|COMPLETED|Overall Study||935
10717056|NCT02694978|11880970|FG001|COMPLETED|Overall Study||948
10538037|NCT01453036|11690794|FG002|NOT COMPLETED|Overall Study||31
10538038|NCT01453049|11690804|FG000|STARTED|Overall Study||42
10538039|NCT01453049|11690805|FG001|STARTED|Overall Study||44
10538040|NCT01453049|11690804|FG000|COMPLETED|Overall Study||1
10538041|NCT01453049|11690805|FG001|COMPLETED|Overall Study||2
10538042|NCT01453049|11690804|FG000|NOT COMPLETED|Overall Study||41
10538043|NCT01453049|11690805|FG001|NOT COMPLETED|Overall Study||42
10538044|NCT01453075|11690813|FG000|STARTED|Overall Study||16
10717057|NCT02694978|11880969|FG000|NOT COMPLETED|Overall Study||71
10717058|NCT02694978|11880970|FG001|NOT COMPLETED|Overall Study||60
10717059|NCT02695290|11880976|FG000|STARTED|Overall Study||1
10717060|NCT02695290|11880976|FG000|COMPLETED|Overall Study||1
10717061|NCT02695290|11880976|FG000|NOT COMPLETED|Overall Study||0
10373515|NCT00570687|11514898|FG004|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
10373516|NCT00570687|11514899|FG005|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
10373517|NCT00570687|11514900|FG006|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
10373518|NCT00570687|11514901|FG007|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
10373519|NCT00570687|11514902|FG008|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
10373520|NCT00570687|11514903|FG009|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
10373521|NCT00570687|11514894|FG000|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
10373522|NCT00570687|11514895|FG001|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
10373523|NCT00570687|11514896|FG002|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
10373524|NCT00570687|11514897|FG003|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
10373525|NCT00570687|11514898|FG004|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
10373526|NCT00570687|11514899|FG005|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
10373527|NCT00570687|11514900|FG006|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
10373528|NCT00570687|11514901|FG007|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
10373529|NCT00570687|11514902|FG008|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
10373530|NCT00570687|11514903|FG009|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
10373531|NCT00570687|11514894|FG000|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
10373532|NCT00570687|11514895|FG001|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
10373533|NCT00570687|11514896|FG002|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
10373534|NCT00570687|11514897|FG003|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
10373535|NCT00570687|11514898|FG004|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
10373536|NCT00570687|11514899|FG005|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
10373537|NCT00570687|11514900|FG006|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
10373538|NCT00570687|11514901|FG007|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
10373539|NCT00570687|11514902|FG008|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
10373540|NCT00570687|11514903|FG009|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
10373541|NCT00570687|11514894|FG000|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
10373542|NCT00570687|11514895|FG001|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
10373543|NCT00570687|11514896|FG002|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
10373544|NCT00570687|11514897|FG003|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
10373545|NCT00570687|11514898|FG004|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
10373546|NCT00570687|11514899|FG005|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
10373547|NCT00570687|11514900|FG006|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
10373548|NCT00570687|11514901|FG007|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
10373549|NCT00570687|11514902|FG008|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
10373550|NCT00570687|11514903|FG009|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
10373551|NCT00570687|11514894|FG000|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
10373552|NCT00570687|11514895|FG001|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
10373553|NCT00570687|11514896|FG002|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
10373554|NCT00570687|11514897|FG003|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
10373555|NCT00570687|11514898|FG004|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
10373556|NCT00570687|11514899|FG005|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
10373557|NCT00570687|11514900|FG006|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
10373558|NCT00570687|11514901|FG007|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
10373559|NCT00570687|11514902|FG008|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
10373560|NCT00570687|11514903|FG009|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
10373561|NCT00570687|11514894|FG000|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
10373562|NCT00570687|11514895|FG001|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
10373563|NCT00570687|11514896|FG002|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
10373564|NCT00570687|11514897|FG003|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
10373565|NCT00570687|11514898|FG004|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
10373566|NCT00570687|11514899|FG005|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
10373567|NCT00570687|11514900|FG006|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
10373568|NCT00570687|11514901|FG007|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
10373569|NCT00570687|11514902|FG008|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
10373570|NCT00570687|11514903|FG009|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
10373571|NCT00570687|11514894|FG000|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
10373572|NCT00570687|11514895|FG001|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
10373573|NCT00570687|11514896|FG002|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
10373574|NCT00570687|11514897|FG003|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
10373575|NCT00570687|11514898|FG004|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
10373576|NCT00570687|11514899|FG005|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
10373577|NCT00570687|11514900|FG006|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
10373578|NCT00570687|11514901|FG007|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
10373579|NCT00570687|11514902|FG008|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
10373580|NCT00570687|11514903|FG009|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
10373581|NCT00570687|11514894|FG000|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
10373582|NCT00570687|11514895|FG001|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
10373583|NCT00570687|11514896|FG002|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
10373584|NCT00570687|11514897|FG003|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
10373585|NCT00570687|11514898|FG004|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
10373586|NCT00570687|11514899|FG005|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
10373587|NCT00570687|11514900|FG006|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
10373588|NCT00570687|11514901|FG007|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
10373589|NCT00570687|11514902|FG008|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
10373590|NCT00570687|11514903|FG009|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
10373591|NCT00570687|11514894|FG000|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
10373592|NCT00570687|11514895|FG001|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
10373593|NCT00570687|11514896|FG002|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
10373594|NCT00570687|11514897|FG003|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
10373595|NCT00570687|11514898|FG004|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
10373596|NCT00570687|11514899|FG005|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
10373597|NCT00570687|11514900|FG006|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
10373598|NCT00570687|11514901|FG007|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
10373599|NCT00570687|11514902|FG008|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
10373600|NCT00570687|11514903|FG009|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
10373601|NCT00570687|11514894|FG000|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
10373602|NCT00570687|11514895|FG001|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
10373603|NCT00570687|11514896|FG002|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
10373604|NCT00570687|11514897|FG003|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
10373605|NCT00570687|11514898|FG004|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
10373606|NCT00570687|11514899|FG005|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
10373607|NCT00570687|11514900|FG006|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
10373608|NCT00570687|11514901|FG007|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
10373609|NCT00570687|11514902|FG008|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
10373610|NCT00570687|11514903|FG009|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
10373611|NCT00570687|11514894|FG000|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
10373612|NCT00570687|11514895|FG001|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
10373613|NCT00570687|11514896|FG002|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
10373614|NCT00570687|11514897|FG003|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
10373615|NCT00570687|11514898|FG004|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
10373616|NCT00570687|11514899|FG005|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
10373617|NCT00570687|11514900|FG006|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
10373618|NCT00570687|11514901|FG007|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
10373619|NCT00570687|11514902|FG008|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
10373620|NCT00570687|11514903|FG009|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
10373621|NCT00570687|11514894|FG000|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
10373622|NCT00570687|11514895|FG001|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
10373623|NCT00570687|11514896|FG002|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
10373624|NCT00570687|11514897|FG003|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
10373625|NCT00570687|11514898|FG004|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
10373626|NCT00570687|11514899|FG005|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
10373627|NCT00570687|11514900|FG006|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
10373628|NCT00570687|11514901|FG007|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
10373629|NCT00570687|11514902|FG008|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
10373630|NCT00570687|11514903|FG009|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
10373631|NCT00570687|11514894|FG000|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
10373632|NCT00570687|11514895|FG001|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
10373633|NCT00570687|11514896|FG002|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
10373634|NCT00570687|11514897|FG003|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
10373635|NCT00570687|11514898|FG004|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
10373636|NCT00570687|11514899|FG005|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
10373637|NCT00570687|11514900|FG006|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
10373638|NCT00570687|11514901|FG007|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
10373639|NCT00570687|11514902|FG008|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
10373640|NCT00570687|11514903|FG009|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
10373641|NCT00570687|11514894|FG000|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
10373642|NCT00570687|11514895|FG001|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
10373643|NCT00570687|11514896|FG002|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
10373644|NCT00570687|11514897|FG003|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
10373645|NCT00570687|11514898|FG004|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
10373646|NCT00570687|11514899|FG005|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
10373647|NCT00570687|11514900|FG006|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
10373648|NCT00570687|11514901|FG007|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
10373649|NCT00570687|11514902|FG008|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
10373650|NCT00570687|11514903|FG009|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
10373651|NCT00570687|11514894|FG000|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
10373652|NCT00570687|11514895|FG001|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
10373653|NCT00570687|11514896|FG002|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
10373654|NCT00570687|11514897|FG003|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
10373655|NCT00570687|11514898|FG004|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
10373656|NCT00570687|11514899|FG005|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
10373657|NCT00570687|11514900|FG006|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||1
10373658|NCT00570687|11514901|FG007|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
10373659|NCT00570687|11514902|FG008|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||1
10373660|NCT00570687|11514903|FG009|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
10373661|NCT00570687|11514894|FG000|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
10373662|NCT00570687|11514895|FG001|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
10373663|NCT00570687|11514896|FG002|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
10373664|NCT00570687|11514897|FG003|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
10373665|NCT00570687|11514898|FG004|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
10373666|NCT00570687|11514899|FG005|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
10373667|NCT00570687|11514900|FG006|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||2
10373668|NCT00570687|11514901|FG007|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
10427785|NCT00854724|11573684|FG001|STARTED|Second Intervention||6
10538045|NCT01453075|11690814|FG001|STARTED|Overall Study||15
10538046|NCT01453075|11690813|FG000|COMPLETED|Overall Study||11
10538047|NCT01453075|11690814|FG001|COMPLETED|Overall Study||14
10657436|NCT02225925|11818643|FG000|STARTED|Overall Study||45
10657437|NCT02225925|11818643|FG000|COMPLETED|Overall Study||45
10657438|NCT02225925|11818643|FG000|NOT COMPLETED|Overall Study||0
10657439|NCT02226003|11818650|FG000|STARTED|Overall Study||98
10657440|NCT02226003|11818651|FG001|STARTED|Overall Study||96
10657441|NCT02226003|11818652|FG002|STARTED|Overall Study||97
10657442|NCT02226003|11818650|FG000|COMPLETED|Overall Study||96
10657443|NCT02226003|11818651|FG001|COMPLETED|Overall Study||95
10657444|NCT02226003|11818652|FG002|COMPLETED|Overall Study||91
10657445|NCT02226003|11818650|FG000|NOT COMPLETED|Overall Study||2
10657446|NCT02226003|11818651|FG001|NOT COMPLETED|Overall Study||1
10657447|NCT02226003|11818652|FG002|NOT COMPLETED|Overall Study||6
10657448|NCT02226120|11818660|FG000|STARTED|Overall Study||1980
10657449|NCT02226120|11818660|FG000|COMPLETED|Overall Study||1660
10657450|NCT02226120|11818660|FG000|NOT COMPLETED|Overall Study||320
10657457|NCT02226172|11818673|FG000|STARTED|Overall Study||21
10657458|NCT02226172|11818673|FG000|COMPLETED|Overall Study||4
10657459|NCT02226172|11818673|FG000|NOT COMPLETED|Overall Study||17
10657460|NCT02226198|11818677|FG000|STARTED|Lead-in Phase||11
10657461|NCT02226198|11818678|FG001|STARTED|Lead-in Phase||0
10657462|NCT02226198|11818679|FG002|STARTED|Lead-in Phase||0
10657463|NCT02226198|11818677|FG000|COMPLETED|Lead-in Phase||10
10657464|NCT02226198|11818678|FG001|COMPLETED|Lead-in Phase||0
10657465|NCT02226198|11818679|FG002|COMPLETED|Lead-in Phase||0
10657466|NCT02226198|11818677|FG000|NOT COMPLETED|Lead-in Phase||1
10657467|NCT02226198|11818678|FG001|NOT COMPLETED|Lead-in Phase||0
10657468|NCT02226198|11818679|FG002|NOT COMPLETED|Lead-in Phase||0
10657469|NCT02226198|11818677|FG000|STARTED|Cross-Over: First Intervention (6 Weeks)||0
10657470|NCT02226198|11818678|FG001|STARTED|Cross-Over: First Intervention (6 Weeks)||7
10657471|NCT02226198|11818679|FG002|STARTED|Cross-Over: First Intervention (6 Weeks)||7
10657472|NCT02226198|11818677|FG000|COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
10657473|NCT02226198|11818678|FG001|COMPLETED|Cross-Over: First Intervention (6 Weeks)||6
10657474|NCT02226198|11818679|FG002|COMPLETED|Cross-Over: First Intervention (6 Weeks)||7
10657475|NCT02226198|11818677|FG000|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
10657476|NCT02226198|11818678|FG001|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||1
10657477|NCT02226198|11818679|FG002|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
10657478|NCT02226198|11818677|FG000|STARTED|Cross-Over: Second Interv. (6 Weeks)||0
10657479|NCT02226198|11818678|FG001|STARTED|Cross-Over: Second Interv. (6 Weeks)||6
10657480|NCT02226198|11818679|FG002|STARTED|Cross-Over: Second Interv. (6 Weeks)||7
10657481|NCT02226198|11818677|FG000|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
10657482|NCT02226198|11818678|FG001|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||6
10657483|NCT02226198|11818679|FG002|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||7
10657484|NCT02226198|11818677|FG000|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
10657485|NCT02226198|11818678|FG001|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
10657486|NCT02226198|11818679|FG002|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
10657487|NCT02226198|11818677|FG000|STARTED|Maintenance Phase (12 Weeks)||13
10657488|NCT02226198|11818678|FG001|STARTED|Maintenance Phase (12 Weeks)||0
10657489|NCT02226198|11818679|FG002|STARTED|Maintenance Phase (12 Weeks)||0
10657490|NCT02226198|11818677|FG000|COMPLETED|Maintenance Phase (12 Weeks)||13
10657491|NCT02226198|11818678|FG001|COMPLETED|Maintenance Phase (12 Weeks)||0
10427786|NCT00854724|11573683|FG000|COMPLETED|Second Intervention||5
10427787|NCT00854724|11573684|FG001|COMPLETED|Second Intervention||5
10427788|NCT00854724|11573683|FG000|NOT COMPLETED|Second Intervention||1
10427789|NCT00854724|11573684|FG001|NOT COMPLETED|Second Intervention||1
10427790|NCT00854828|11573694|FG000|STARTED|Overall Study|6 patients crossed over to non-operative intervention.|30
10657492|NCT02226198|11818679|FG002|COMPLETED|Maintenance Phase (12 Weeks)||0
10657493|NCT02226198|11818677|FG000|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
10373669|NCT00570687|11514902|FG008|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||2
10373670|NCT00570687|11514903|FG009|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
10373671|NCT00570687|11514894|FG000|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
10373672|NCT00570687|11514895|FG001|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
10373673|NCT00570687|11514896|FG002|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
10373674|NCT00570687|11514897|FG003|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
10373675|NCT00570687|11514898|FG004|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
10373676|NCT00570687|11514899|FG005|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
10373677|NCT00570687|11514900|FG006|STARTED|Clamp 1 (1 Day) - Orig Protocol||1
10373678|NCT00570687|11514901|FG007|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
10373679|NCT00570687|11514902|FG008|STARTED|Clamp 1 (1 Day) - Orig Protocol||1
10373680|NCT00570687|11514903|FG009|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
10373681|NCT00570687|11514894|FG000|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
10373682|NCT00570687|11514895|FG001|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
10373683|NCT00570687|11514896|FG002|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
10373684|NCT00570687|11514897|FG003|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
10373685|NCT00570687|11514898|FG004|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
10373686|NCT00570687|11514899|FG005|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
10373687|NCT00570687|11514900|FG006|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||1
10538048|NCT01453075|11690813|FG000|NOT COMPLETED|Overall Study||5
10538049|NCT01453075|11690814|FG001|NOT COMPLETED|Overall Study||1
10538050|NCT01453153|11690823|FG000|STARTED|Overall Study||4
10538051|NCT01453153|11690824|FG001|STARTED|Overall Study||4
10538052|NCT01453153|11690825|FG002|STARTED|Overall Study||20
10538053|NCT01453153|11690823|FG000|COMPLETED|Overall Study||0
10538054|NCT01453153|11690824|FG001|COMPLETED|Overall Study||0
10538055|NCT01453153|11690825|FG002|COMPLETED|Overall Study||0
10538056|NCT01453153|11690823|FG000|NOT COMPLETED|Overall Study||4
10538057|NCT01453153|11690824|FG001|NOT COMPLETED|Overall Study||4
10538058|NCT01453153|11690825|FG002|NOT COMPLETED|Overall Study||20
10538059|NCT01453166|11690840|FG000|STARTED|Overall Study||42
10538060|NCT01453166|11690841|FG001|STARTED|Overall Study||41
10538061|NCT01453166|11690842|FG002|STARTED|Overall Study||39
10538062|NCT01453166|11690840|FG000|COMPLETED|Overall Study||40
10538063|NCT01453166|11690841|FG001|COMPLETED|Overall Study||39
10538064|NCT01453166|11690842|FG002|COMPLETED|Overall Study||38
10538065|NCT01453166|11690840|FG000|NOT COMPLETED|Overall Study||2
10538066|NCT01453166|11690841|FG001|NOT COMPLETED|Overall Study||2
10538067|NCT01453166|11690842|FG002|NOT COMPLETED|Overall Study||1
10538068|NCT01453205|11690853|FG000|STARTED|Overall Study||80
10538069|NCT01453205|11690854|FG001|STARTED|Overall Study||52
10538070|NCT01453205|11690855|FG002|STARTED|Overall Study||55
10538071|NCT01453205|11690853|FG000|COMPLETED|Overall Study||0
10538072|NCT01453205|11690854|FG001|COMPLETED|Overall Study||0
10538073|NCT01453205|11690855|FG002|COMPLETED|Overall Study||1
10538074|NCT01453205|11690853|FG000|NOT COMPLETED|Overall Study||80
10538075|NCT01453205|11690854|FG001|NOT COMPLETED|Overall Study||52
10373688|NCT00570687|11514901|FG007|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
10373689|NCT00570687|11514902|FG008|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||1
10373690|NCT00570687|11514903|FG009|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
10538076|NCT01453205|11690855|FG002|NOT COMPLETED|Overall Study||54
10538077|NCT01453296|11690866|FG000|STARTED|Treatment Period 1||14
10538078|NCT01453296|11690867|FG001|STARTED|Treatment Period 1||14
10538079|NCT01453296|11690866|FG000|COMPLETED|Treatment Period 1||13
10538080|NCT01453296|11690867|FG001|COMPLETED|Treatment Period 1||13
10538081|NCT01453296|11690866|FG000|NOT COMPLETED|Treatment Period 1||1
10538082|NCT01453296|11690867|FG001|NOT COMPLETED|Treatment Period 1||1
10538083|NCT01453296|11690866|FG000|STARTED|Washout Period||13
10538084|NCT01453296|11690867|FG001|STARTED|Washout Period||13
10538085|NCT01453296|11690866|FG000|COMPLETED|Washout Period||13
10538086|NCT01453296|11690867|FG001|COMPLETED|Washout Period||13
10538087|NCT01453296|11690866|FG000|NOT COMPLETED|Washout Period||0
10538088|NCT01453296|11690867|FG001|NOT COMPLETED|Washout Period||0
10538089|NCT01453296|11690866|FG000|STARTED|Treatment Period 2||13
10538090|NCT01453296|11690867|FG001|STARTED|Treatment Period 2||13
10538091|NCT01453296|11690866|FG000|COMPLETED|Treatment Period 2||11
10538092|NCT01453296|11690867|FG001|COMPLETED|Treatment Period 2||13
10538093|NCT01453296|11690866|FG000|NOT COMPLETED|Treatment Period 2||2
10538094|NCT01453296|11690867|FG001|NOT COMPLETED|Treatment Period 2||0
10538095|NCT01453348|11690876|FG000|STARTED|Overall Study||84
10538096|NCT01453348|11690877|FG001|STARTED|Overall Study||84
10538097|NCT01453348|11690878|FG002|STARTED|Overall Study||84
10538098|NCT01453348|11690876|FG000|COMPLETED|Overall Study||83
10538099|NCT01453348|11690877|FG001|COMPLETED|Overall Study||83
10538100|NCT01453348|11690878|FG002|COMPLETED|Overall Study||83
10538101|NCT01453348|11690876|FG000|NOT COMPLETED|Overall Study||1
10373691|NCT00570687|11514894|FG000|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
10373692|NCT00570687|11514895|FG001|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
10538102|NCT01453348|11690877|FG001|NOT COMPLETED|Overall Study||1
10538103|NCT01453348|11690878|FG002|NOT COMPLETED|Overall Study||1
10538104|NCT01453361|11690889|FG000|STARTED|Overall Study||18
10538105|NCT01453361|11690889|FG000|COMPLETED|Overall Study||2
10538106|NCT01453361|11690889|FG000|NOT COMPLETED|Overall Study||16
10538107|NCT01453374|11690893|FG000|STARTED|Overall Study||27
10538108|NCT01453374|11690893|FG000|COMPLETED|Overall Study|Defined as receiving 7 injections and 2 follow-up visits.|9
10538109|NCT01453374|11690893|FG000|NOT COMPLETED|Overall Study||18
10538110|NCT01453387|11690901|FG000|STARTED|Overall Study||21
10538111|NCT01453387|11690902|FG001|STARTED|Overall Study||7
10373693|NCT00570687|11514896|FG002|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
10373694|NCT00570687|11514897|FG003|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
10373695|NCT00570687|11514898|FG004|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
10373696|NCT00570687|11514899|FG005|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
10373697|NCT00570687|11514900|FG006|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
10373698|NCT00570687|11514901|FG007|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
10373699|NCT00570687|11514902|FG008|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
10373700|NCT00570687|11514903|FG009|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
10373701|NCT00570687|11514894|FG000|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
10373702|NCT00570687|11514895|FG001|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
10373703|NCT00570687|11514896|FG002|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
10373704|NCT00570687|11514897|FG003|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
10373705|NCT00570687|11514898|FG004|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
10373706|NCT00570687|11514899|FG005|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
10373707|NCT00570687|11514900|FG006|STARTED|Washout 4 (7-21 Days) - Orig Protocol||1
10373708|NCT00570687|11514901|FG007|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
10373709|NCT00570687|11514902|FG008|STARTED|Washout 4 (7-21 Days) - Orig Protocol||1
10373710|NCT00570687|11514903|FG009|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
10373711|NCT00570687|11514894|FG000|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
10373712|NCT00570687|11514895|FG001|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
10373713|NCT00570687|11514896|FG002|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
10373714|NCT00570687|11514897|FG003|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
10373715|NCT00570687|11514898|FG004|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
10373716|NCT00570687|11514899|FG005|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
10373717|NCT00570687|11514900|FG006|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||1
10373718|NCT00570687|11514901|FG007|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
10373719|NCT00570687|11514902|FG008|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
10373720|NCT00570687|11514903|FG009|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
10373721|NCT00570687|11514894|FG000|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
10373722|NCT00570687|11514895|FG001|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
10373723|NCT00570687|11514896|FG002|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
10373724|NCT00570687|11514897|FG003|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
10373725|NCT00570687|11514898|FG004|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
10373726|NCT00570687|11514899|FG005|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
10373727|NCT00570687|11514900|FG006|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
10373728|NCT00570687|11514901|FG007|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
10373729|NCT00570687|11514902|FG008|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||1
10373730|NCT00570687|11514903|FG009|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
10538112|NCT01453387|11690901|FG000|COMPLETED|Overall Study||21
10538113|NCT01453387|11690902|FG001|COMPLETED|Overall Study||7
10538114|NCT01453387|11690901|FG000|NOT COMPLETED|Overall Study||0
10538115|NCT01453387|11690902|FG001|NOT COMPLETED|Overall Study||0
10538116|NCT01453413|11690925|FG000|STARTED|Overall Study||297
10538117|NCT01453413|11690925|FG000|COMPLETED|Overall Study||297
10538118|NCT01453413|11690925|FG000|NOT COMPLETED|Overall Study||0
10538119|NCT01453439|11690931|FG000|STARTED|Treatment Phase||61
10538120|NCT01453439|11690932|FG001|STARTED|Treatment Phase||59
10538121|NCT01453439|11690931|FG000|COMPLETED|Treatment Phase||44
10538122|NCT01453439|11690932|FG001|COMPLETED|Treatment Phase||48
10538123|NCT01453439|11690931|FG000|NOT COMPLETED|Treatment Phase||17
10538124|NCT01453439|11690932|FG001|NOT COMPLETED|Treatment Phase||11
10538125|NCT01453439|11690931|FG000|STARTED|Follow-up||44
10538126|NCT01453439|11690932|FG001|STARTED|Follow-up||48
10538127|NCT01453439|11690931|FG000|COMPLETED|Follow-up||39
10538128|NCT01453439|11690932|FG001|COMPLETED|Follow-up||37
10538129|NCT01453439|11690931|FG000|NOT COMPLETED|Follow-up||5
10538130|NCT01453439|11690932|FG001|NOT COMPLETED|Follow-up||11
10538131|NCT01453569|11690941|FG000|STARTED|Overall Study||86
10538132|NCT01453569|11690942|FG001|STARTED|Overall Study||84
10538133|NCT01453569|11690943|FG002|STARTED|Overall Study||85
10538134|NCT01453569|11690941|FG000|COMPLETED|Overall Study||75
10538135|NCT01453569|11690942|FG001|COMPLETED|Overall Study||70
10538136|NCT01453569|11690943|FG002|COMPLETED|Overall Study||78
10538137|NCT01453569|11690941|FG000|NOT COMPLETED|Overall Study||11
10538138|NCT01453569|11690942|FG001|NOT COMPLETED|Overall Study||14
10538139|NCT01453569|11690943|FG002|NOT COMPLETED|Overall Study||7
10657494|NCT02226198|11818678|FG001|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
10657495|NCT02226198|11818679|FG002|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
10657496|NCT02226549|11818707|FG000|STARTED|Overall Study||23
10657497|NCT02226549|11818708|FG001|STARTED|Overall Study||24
10657498|NCT02226549|11818707|FG000|COMPLETED|Overall Study||22
10538140|NCT01453595|11690954|FG000|STARTED|Overall Study||2
10538141|NCT01453595|11690955|FG001|STARTED|Overall Study||6
10538142|NCT01453595|11690956|FG002|STARTED|Overall Study||2
10538143|NCT01453595|11690954|FG000|COMPLETED|Overall Study||0
10538144|NCT01453595|11690955|FG001|COMPLETED|Overall Study||5
10538145|NCT01453595|11690956|FG002|COMPLETED|Overall Study||0
10538146|NCT01453595|11690954|FG000|NOT COMPLETED|Overall Study||2
10538147|NCT01453595|11690955|FG001|NOT COMPLETED|Overall Study||1
10538148|NCT01453595|11690956|FG002|NOT COMPLETED|Overall Study||2
10538149|NCT01453725|11690964|FG000|STARTED|Overall Study||98
10538150|NCT01453725|11690965|FG001|STARTED|Overall Study||100
10657499|NCT02226549|11818708|FG001|COMPLETED|Overall Study||23
10373731|NCT00570687|11514894|FG000|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
10373732|NCT00570687|11514895|FG001|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
10373733|NCT00570687|11514896|FG002|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
10373734|NCT00570687|11514897|FG003|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
10373735|NCT00570687|11514898|FG004|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
10373736|NCT00570687|11514899|FG005|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
10373737|NCT00570687|11514900|FG006|STARTED|Clamp 2 (1 Day) - Orig Protocol||1
10373738|NCT00570687|11514901|FG007|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
10373739|NCT00570687|11514902|FG008|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
10373740|NCT00570687|11514903|FG009|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
10373741|NCT00570687|11514894|FG000|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
10373742|NCT00570687|11514895|FG001|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
10373743|NCT00570687|11514896|FG002|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
10373744|NCT00570687|11514897|FG003|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
10373745|NCT00570687|11514898|FG004|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
10373746|NCT00570687|11514899|FG005|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
10373747|NCT00570687|11514900|FG006|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||1
10373748|NCT00570687|11514901|FG007|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
10373749|NCT00570687|11514902|FG008|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
10373750|NCT00570687|11514903|FG009|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
10373751|NCT00570687|11514894|FG000|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
10373752|NCT00570687|11514895|FG001|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
10373753|NCT00570687|11514896|FG002|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
10373754|NCT00570687|11514897|FG003|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
10373755|NCT00570687|11514898|FG004|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
10373756|NCT00570687|11514899|FG005|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
10373757|NCT00570687|11514900|FG006|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
10373758|NCT00570687|11514901|FG007|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
10373759|NCT00570687|11514902|FG008|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
10373760|NCT00570687|11514903|FG009|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
10373761|NCT00570687|11514894|FG000|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
10373762|NCT00570687|11514895|FG001|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
10373763|NCT00570687|11514896|FG002|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
10373764|NCT00570687|11514897|FG003|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
10373765|NCT00570687|11514898|FG004|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
10373766|NCT00570687|11514899|FG005|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
10373767|NCT00570687|11514900|FG006|STARTED|Washout 5 (7-21 Days) - Orig Protocol||1
10373768|NCT00570687|11514901|FG007|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
10373769|NCT00570687|11514902|FG008|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
10373770|NCT00570687|11514903|FG009|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
10373771|NCT00570687|11514894|FG000|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
10373772|NCT00570687|11514895|FG001|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
10373773|NCT00570687|11514896|FG002|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
10373774|NCT00570687|11514897|FG003|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
10373775|NCT00570687|11514898|FG004|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
10373776|NCT00570687|11514899|FG005|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
10373777|NCT00570687|11514900|FG006|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
10373778|NCT00570687|11514901|FG007|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
10373779|NCT00570687|11514902|FG008|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
10373780|NCT00570687|11514903|FG009|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
10373781|NCT00570687|11514894|FG000|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
10373782|NCT00570687|11514895|FG001|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
10373783|NCT00570687|11514896|FG002|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
10373784|NCT00570687|11514897|FG003|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
10373785|NCT00570687|11514898|FG004|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
10373786|NCT00570687|11514899|FG005|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
10373787|NCT00570687|11514900|FG006|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||1
10373788|NCT00570687|11514901|FG007|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
10373789|NCT00570687|11514902|FG008|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
10373790|NCT00570687|11514903|FG009|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
10373791|NCT00570687|11514894|FG000|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||4
10373792|NCT00570687|11514895|FG001|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||2
10373793|NCT00570687|11514896|FG002|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||2
10373794|NCT00570687|11514897|FG003|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||4
10373795|NCT00570687|11514898|FG004|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
10373796|NCT00570687|11514899|FG005|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
10373797|NCT00570687|11514900|FG006|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
10373798|NCT00570687|11514901|FG007|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
10373799|NCT00570687|11514902|FG008|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
10373800|NCT00570687|11514903|FG009|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
10373801|NCT00570687|11514894|FG000|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||4
10373802|NCT00570687|11514895|FG001|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||2
10373803|NCT00570687|11514896|FG002|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||2
10373804|NCT00570687|11514897|FG003|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||4
10373805|NCT00570687|11514898|FG004|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
10373806|NCT00570687|11514899|FG005|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
10373807|NCT00570687|11514900|FG006|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
10373808|NCT00570687|11514901|FG007|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
10373809|NCT00570687|11514902|FG008|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
10373810|NCT00570687|11514903|FG009|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
10373811|NCT00570687|11514894|FG000|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
10373812|NCT00570687|11514895|FG001|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
10373813|NCT00570687|11514896|FG002|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
10373814|NCT00570687|11514897|FG003|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
10373815|NCT00570687|11514898|FG004|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
10373816|NCT00570687|11514899|FG005|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
10373817|NCT00570687|11514900|FG006|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
10373818|NCT00570687|11514901|FG007|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
10373819|NCT00570687|11514902|FG008|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
10373820|NCT00570687|11514903|FG009|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
10373821|NCT00570687|11514894|FG000|STARTED|Washout 1 (7-21 Days) - Amendment 1||4
10373822|NCT00570687|11514895|FG001|STARTED|Washout 1 (7-21 Days) - Amendment 1||2
10373823|NCT00570687|11514896|FG002|STARTED|Washout 1 (7-21 Days) - Amendment 1||2
10373824|NCT00570687|11514897|FG003|STARTED|Washout 1 (7-21 Days) - Amendment 1||4
10373825|NCT00570687|11514898|FG004|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
10373826|NCT00570687|11514899|FG005|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
10373827|NCT00570687|11514900|FG006|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
10373828|NCT00570687|11514901|FG007|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
10373829|NCT00570687|11514902|FG008|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
10373830|NCT00570687|11514903|FG009|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
10373831|NCT00570687|11514894|FG000|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||4
10373832|NCT00570687|11514895|FG001|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||2
10373833|NCT00570687|11514896|FG002|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||2
10373834|NCT00570687|11514897|FG003|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||4
10373835|NCT00570687|11514898|FG004|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
10373836|NCT00570687|11514899|FG005|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
10373837|NCT00570687|11514900|FG006|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
10373838|NCT00570687|11514901|FG007|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
10373839|NCT00570687|11514902|FG008|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
10373840|NCT00570687|11514903|FG009|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
10373841|NCT00570687|11514894|FG000|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
10373842|NCT00570687|11514895|FG001|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
10373843|NCT00570687|11514896|FG002|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
10373844|NCT00570687|11514897|FG003|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
10373845|NCT00570687|11514898|FG004|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
10373846|NCT00570687|11514899|FG005|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
10373847|NCT00570687|11514900|FG006|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
10373848|NCT00570687|11514901|FG007|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
10373849|NCT00570687|11514902|FG008|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
10373850|NCT00570687|11514903|FG009|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
10373851|NCT00570687|11514894|FG000|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||4
10373852|NCT00570687|11514895|FG001|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||2
10373853|NCT00570687|11514896|FG002|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||2
10373854|NCT00570687|11514897|FG003|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||4
10373855|NCT00570687|11514898|FG004|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
10373856|NCT00570687|11514899|FG005|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
10373857|NCT00570687|11514900|FG006|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
10373858|NCT00570687|11514901|FG007|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
10373859|NCT00570687|11514902|FG008|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
10373860|NCT00570687|11514903|FG009|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
10373861|NCT00570687|11514894|FG000|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||4
10373862|NCT00570687|11514895|FG001|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||2
10373863|NCT00570687|11514896|FG002|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||2
10373864|NCT00570687|11514897|FG003|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||4
10373865|NCT00570687|11514898|FG004|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
10373866|NCT00570687|11514899|FG005|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
10373867|NCT00570687|11514900|FG006|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
10373868|NCT00570687|11514901|FG007|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
10373869|NCT00570687|11514902|FG008|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
10373870|NCT00570687|11514903|FG009|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
10373871|NCT00570687|11514894|FG000|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
10373872|NCT00570687|11514895|FG001|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
10373873|NCT00570687|11514896|FG002|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
10373874|NCT00570687|11514897|FG003|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
10373875|NCT00570687|11514898|FG004|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
10373876|NCT00570687|11514899|FG005|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
10373877|NCT00570687|11514900|FG006|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
10373878|NCT00570687|11514901|FG007|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
10373879|NCT00570687|11514902|FG008|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
10373880|NCT00570687|11514903|FG009|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
10373881|NCT00570687|11514894|FG000|STARTED|Washout 2 (8 Weeks) - Amendment 1||4
10373882|NCT00570687|11514895|FG001|STARTED|Washout 2 (8 Weeks) - Amendment 1||2
10373883|NCT00570687|11514896|FG002|STARTED|Washout 2 (8 Weeks) - Amendment 1||2
10373884|NCT00570687|11514897|FG003|STARTED|Washout 2 (8 Weeks) - Amendment 1||4
10373885|NCT00570687|11514898|FG004|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
10373886|NCT00570687|11514899|FG005|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
10373887|NCT00570687|11514900|FG006|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
10373888|NCT00570687|11514901|FG007|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
10373889|NCT00570687|11514902|FG008|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
10373890|NCT00570687|11514903|FG009|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
10373891|NCT00570687|11514894|FG000|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||4
10373892|NCT00570687|11514895|FG001|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||2
10373893|NCT00570687|11514896|FG002|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||2
10373894|NCT00570687|11514897|FG003|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||4
10373895|NCT00570687|11514898|FG004|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
10373896|NCT00570687|11514899|FG005|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
10373897|NCT00570687|11514900|FG006|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
10373898|NCT00570687|11514901|FG007|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
10373899|NCT00570687|11514902|FG008|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
10373900|NCT00570687|11514903|FG009|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
10373901|NCT00570687|11514894|FG000|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
10373902|NCT00570687|11514895|FG001|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
10373903|NCT00570687|11514896|FG002|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
10373904|NCT00570687|11514897|FG003|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
10373905|NCT00570687|11514898|FG004|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
10373906|NCT00570687|11514899|FG005|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
10373907|NCT00570687|11514900|FG006|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
10373908|NCT00570687|11514901|FG007|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
10373909|NCT00570687|11514902|FG008|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
10373910|NCT00570687|11514903|FG009|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
10373911|NCT00570687|11514894|FG000|STARTED|Clamp 1 (1 Day) - Amendment 1||4
10373912|NCT00570687|11514895|FG001|STARTED|Clamp 1 (1 Day) - Amendment 1||2
10373913|NCT00570687|11514896|FG002|STARTED|Clamp 1 (1 Day) - Amendment 1||2
10373914|NCT00570687|11514897|FG003|STARTED|Clamp 1 (1 Day) - Amendment 1||4
10373915|NCT00570687|11514898|FG004|STARTED|Clamp 1 (1 Day) - Amendment 1||0
10373916|NCT00570687|11514899|FG005|STARTED|Clamp 1 (1 Day) - Amendment 1||0
10373917|NCT00570687|11514900|FG006|STARTED|Clamp 1 (1 Day) - Amendment 1||0
10373918|NCT00570687|11514901|FG007|STARTED|Clamp 1 (1 Day) - Amendment 1||0
10373919|NCT00570687|11514902|FG008|STARTED|Clamp 1 (1 Day) - Amendment 1||0
10373920|NCT00570687|11514903|FG009|STARTED|Clamp 1 (1 Day) - Amendment 1||0
10373921|NCT00570687|11514894|FG000|COMPLETED|Clamp 1 (1 Day) - Amendment 1||4
10373922|NCT00570687|11514895|FG001|COMPLETED|Clamp 1 (1 Day) - Amendment 1||2
10373923|NCT00570687|11514896|FG002|COMPLETED|Clamp 1 (1 Day) - Amendment 1||2
10373924|NCT00570687|11514897|FG003|COMPLETED|Clamp 1 (1 Day) - Amendment 1||4
10373925|NCT00570687|11514898|FG004|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
10373926|NCT00570687|11514899|FG005|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
10373927|NCT00570687|11514900|FG006|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
10373928|NCT00570687|11514901|FG007|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
10373929|NCT00570687|11514902|FG008|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
10373930|NCT00570687|11514903|FG009|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
10373931|NCT00570687|11514894|FG000|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
10373932|NCT00570687|11514895|FG001|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
10373933|NCT00570687|11514896|FG002|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
10373934|NCT00570687|11514897|FG003|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
10373935|NCT00570687|11514898|FG004|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
10373936|NCT00570687|11514899|FG005|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
10373937|NCT00570687|11514900|FG006|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
10373938|NCT00570687|11514901|FG007|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
10373939|NCT00570687|11514902|FG008|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
10373940|NCT00570687|11514903|FG009|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
10373941|NCT00570687|11514894|FG000|STARTED|Washout 3 (7-21 Days) - Amendment 1||4
10373942|NCT00570687|11514895|FG001|STARTED|Washout 3 (7-21 Days) - Amendment 1||2
10373943|NCT00570687|11514896|FG002|STARTED|Washout 3 (7-21 Days) - Amendment 1||2
10373944|NCT00570687|11514897|FG003|STARTED|Washout 3 (7-21 Days) - Amendment 1||4
10373945|NCT00570687|11514898|FG004|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
10373946|NCT00570687|11514899|FG005|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
10373947|NCT00570687|11514900|FG006|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
10373948|NCT00570687|11514901|FG007|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
10373949|NCT00570687|11514902|FG008|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
10373950|NCT00570687|11514903|FG009|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
10373951|NCT00570687|11514894|FG000|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||4
10373952|NCT00570687|11514895|FG001|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||2
10373953|NCT00570687|11514896|FG002|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||2
10373954|NCT00570687|11514897|FG003|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||4
10373955|NCT00570687|11514898|FG004|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
10373956|NCT00570687|11514899|FG005|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
10373957|NCT00570687|11514900|FG006|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
10373958|NCT00570687|11514901|FG007|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
10373959|NCT00570687|11514902|FG008|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
10373960|NCT00570687|11514903|FG009|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
10373961|NCT00570687|11514894|FG000|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
10373962|NCT00570687|11514895|FG001|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
10373963|NCT00570687|11514896|FG002|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
10373964|NCT00570687|11514897|FG003|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
10373965|NCT00570687|11514898|FG004|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
10373966|NCT00570687|11514899|FG005|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
10373967|NCT00570687|11514900|FG006|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
10373968|NCT00570687|11514901|FG007|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
10373969|NCT00570687|11514902|FG008|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
10373970|NCT00570687|11514903|FG009|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
10373971|NCT00570687|11514894|FG000|STARTED|Clamp 2 (1 Day) - Amendment 1||4
10373972|NCT00570687|11514895|FG001|STARTED|Clamp 2 (1 Day) - Amendment 1||2
10717062|NCT02695329|11880982|FG000|STARTED|Overall Study||50
10717063|NCT02695329|11880983|FG001|STARTED|Overall Study||50
10717064|NCT02695329|11880982|FG000|COMPLETED|Overall Study||45
10717065|NCT02695329|11880983|FG001|COMPLETED|Overall Study||45
10717066|NCT02695329|11880982|FG000|NOT COMPLETED|Overall Study||5
10717067|NCT02695329|11880983|FG001|NOT COMPLETED|Overall Study||5
10717068|NCT02695420|11880993|FG000|STARTED|Overall Study||21
10373973|NCT00570687|11514896|FG002|STARTED|Clamp 2 (1 Day) - Amendment 1||2
10373974|NCT00570687|11514897|FG003|STARTED|Clamp 2 (1 Day) - Amendment 1||4
10373975|NCT00570687|11514898|FG004|STARTED|Clamp 2 (1 Day) - Amendment 1||0
10373976|NCT00570687|11514899|FG005|STARTED|Clamp 2 (1 Day) - Amendment 1||0
10373977|NCT00570687|11514900|FG006|STARTED|Clamp 2 (1 Day) - Amendment 1||0
10373978|NCT00570687|11514901|FG007|STARTED|Clamp 2 (1 Day) - Amendment 1||0
10373979|NCT00570687|11514902|FG008|STARTED|Clamp 2 (1 Day) - Amendment 1||0
10373980|NCT00570687|11514903|FG009|STARTED|Clamp 2 (1 Day) - Amendment 1||0
10373981|NCT00570687|11514894|FG000|COMPLETED|Clamp 2 (1 Day) - Amendment 1||4
10373982|NCT00570687|11514895|FG001|COMPLETED|Clamp 2 (1 Day) - Amendment 1||2
10373983|NCT00570687|11514896|FG002|COMPLETED|Clamp 2 (1 Day) - Amendment 1||2
10373984|NCT00570687|11514897|FG003|COMPLETED|Clamp 2 (1 Day) - Amendment 1||4
10373985|NCT00570687|11514898|FG004|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
10373986|NCT00570687|11514899|FG005|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
10373987|NCT00570687|11514900|FG006|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
10373988|NCT00570687|11514901|FG007|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
10373989|NCT00570687|11514902|FG008|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
10373990|NCT00570687|11514903|FG009|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
10373991|NCT00570687|11514894|FG000|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
10373992|NCT00570687|11514895|FG001|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
10373993|NCT00570687|11514896|FG002|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
10373994|NCT00570687|11514897|FG003|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
10373995|NCT00570687|11514898|FG004|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
10373996|NCT00570687|11514899|FG005|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
10373997|NCT00570687|11514900|FG006|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
10373998|NCT00570687|11514901|FG007|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
10373999|NCT00570687|11514902|FG008|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
10374000|NCT00570687|11514903|FG009|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
10374001|NCT00570700|11514917|FG000|STARTED|Overall Study||38
10374002|NCT00570700|11514917|FG000|COMPLETED|Overall Study||27
10374003|NCT00570700|11514917|FG000|NOT COMPLETED|Overall Study||11
10374004|NCT00570713|11514923|FG000|STARTED|Overall Study||78
10374005|NCT00570713|11514924|FG001|STARTED|Overall Study||77
10374006|NCT00570713|11514923|FG000|COMPLETED|Overall Study||0
10374007|NCT00570713|11514924|FG001|COMPLETED|Overall Study||0
10374008|NCT00570713|11514923|FG000|NOT COMPLETED|Overall Study||78
10374009|NCT00570713|11514924|FG001|NOT COMPLETED|Overall Study||77
10717069|NCT02695420|11880994|FG001|STARTED|Overall Study||21
10717070|NCT02695420|11880995|FG002|STARTED|Overall Study||19
10717071|NCT02695420|11880996|FG003|STARTED|Overall Study||20
10717072|NCT02695420|11880993|FG000|COMPLETED|Overall Study||21
10717073|NCT02695420|11880994|FG001|COMPLETED|Overall Study||20
10717074|NCT02695420|11880995|FG002|COMPLETED|Overall Study||19
10374010|NCT00570739|11514934|FG000|STARTED|Overall Study||141
10374011|NCT00570739|11514935|FG001|STARTED|Overall Study||145
10374012|NCT00570739|11514936|FG002|STARTED|Overall Study||108
10374013|NCT00570739|11514937|FG003|STARTED|Overall Study||108
10374014|NCT00570739|11514934|FG000|COMPLETED|Overall Study||120
10374015|NCT00570739|11514935|FG001|COMPLETED|Overall Study||124
10374016|NCT00570739|11514936|FG002|COMPLETED|Overall Study||92
10374017|NCT00570739|11514937|FG003|COMPLETED|Overall Study||96
10374018|NCT00570739|11514934|FG000|NOT COMPLETED|Overall Study||21
10374019|NCT00570739|11514935|FG001|NOT COMPLETED|Overall Study||21
10374020|NCT00570739|11514936|FG002|NOT COMPLETED|Overall Study||16
10374021|NCT00570739|11514937|FG003|NOT COMPLETED|Overall Study||12
10374022|NCT00570765|11514970|FG000|STARTED|DB Phase||20
10374023|NCT00570765|11514971|FG001|STARTED|DB Phase||16
10374024|NCT00570765|11514972|FG002|STARTED|DB Phase||24
10374025|NCT00570765|11514973|FG003|STARTED|DB Phase||0
10374026|NCT00570765|11514970|FG000|Received at Least 1 Dose of Study Drug|DB Phase||20
10374027|NCT00570765|11514971|FG001|Received at Least 1 Dose of Study Drug|DB Phase||16
10374028|NCT00570765|11514972|FG002|Received at Least 1 Dose of Study Drug|DB Phase||23
10374029|NCT00570765|11514973|FG003|Received at Least 1 Dose of Study Drug|DB Phase||0
10374030|NCT00570765|11514970|FG000|Safety Population|DB Phase||20
10374031|NCT00570765|11514971|FG001|Safety Population|DB Phase||16
10374032|NCT00570765|11514972|FG002|Safety Population|DB Phase||23
10374033|NCT00570765|11514973|FG003|Safety Population|DB Phase||0
10374034|NCT00570765|11514970|FG000|COMPLETED|DB Phase||16
10374035|NCT00570765|11514971|FG001|COMPLETED|DB Phase||9
10374036|NCT00570765|11514972|FG002|COMPLETED|DB Phase||23
10374037|NCT00570765|11514973|FG003|COMPLETED|DB Phase||0
10374038|NCT00570765|11514970|FG000|NOT COMPLETED|DB Phase||4
10374039|NCT00570765|11514971|FG001|NOT COMPLETED|DB Phase||7
10374040|NCT00570765|11514972|FG002|NOT COMPLETED|DB Phase||1
10374041|NCT00570765|11514973|FG003|NOT COMPLETED|DB Phase||0
10374042|NCT00570765|11514970|FG000|STARTED|LTSE Phase|Eligible participants who completed the DB phase enrolled in the LTSE phase.|0
10374043|NCT00570765|11514971|FG001|STARTED|LTSE Phase|Eligible participants who completed the DB phase enrolled in the LTSE phase.|0
10538151|NCT01453725|11690964|FG000|COMPLETED|Overall Study||85
10538152|NCT01453725|11690965|FG001|COMPLETED|Overall Study||89
10538153|NCT01453725|11690964|FG000|NOT COMPLETED|Overall Study||13
10538154|NCT01453725|11690965|FG001|NOT COMPLETED|Overall Study||11
10538155|NCT01453855|11690975|FG000|STARTED|Overall Study||442
10538156|NCT01453855|11690976|FG001|STARTED|Overall Study||422
10538157|NCT01453855|11690975|FG000|COMPLETED|Overall Study||432
10538158|NCT01453855|11690976|FG001|COMPLETED|Overall Study||408
10538159|NCT01453855|11690975|FG000|NOT COMPLETED|Overall Study||10
10538160|NCT01453855|11690976|FG001|NOT COMPLETED|Overall Study||14
10374044|NCT00570765|11514972|FG002|STARTED|LTSE Phase|Eligible participants who completed the DB phase enrolled in the LTSE phase.|0
10374045|NCT00570765|11514973|FG003|STARTED|LTSE Phase|Eligible participants who completed the DB phase enrolled in the LTSE phase.|28
10374046|NCT00570765|11514970|FG000|Received at Least 1 Dose of Study Drug|LTSE Phase||0
10374047|NCT00570765|11514971|FG001|Received at Least 1 Dose of Study Drug|LTSE Phase||0
10374048|NCT00570765|11514972|FG002|Received at Least 1 Dose of Study Drug|LTSE Phase||0
10374049|NCT00570765|11514973|FG003|Received at Least 1 Dose of Study Drug|LTSE Phase||28
10374050|NCT00570765|11514970|FG000|Safety Population|LTSE Phase||0
10374051|NCT00570765|11514971|FG001|Safety Population|LTSE Phase||0
10374052|NCT00570765|11514972|FG002|Safety Population|LTSE Phase||0
10374053|NCT00570765|11514973|FG003|Safety Population|LTSE Phase||28
10374054|NCT00570765|11514970|FG000|COMPLETED|LTSE Phase||0
10374055|NCT00570765|11514971|FG001|COMPLETED|LTSE Phase||0
10374056|NCT00570765|11514972|FG002|COMPLETED|LTSE Phase||0
10374057|NCT00570765|11514973|FG003|COMPLETED|LTSE Phase||16
10374058|NCT00570765|11514970|FG000|NOT COMPLETED|LTSE Phase||0
10374059|NCT00570765|11514971|FG001|NOT COMPLETED|LTSE Phase||0
10374060|NCT00570765|11514972|FG002|NOT COMPLETED|LTSE Phase||0
10374061|NCT00570765|11514973|FG003|NOT COMPLETED|LTSE Phase||12
10374062|NCT00570778|11514984|FG000|STARTED|Overall Study||41
10374063|NCT00570778|11514985|FG001|STARTED|Overall Study||38
10374064|NCT00570778|11514986|FG002|STARTED|Overall Study||37
10374065|NCT00570778|11514987|FG003|STARTED|Overall Study||38
10374066|NCT00570778|11514984|FG000|Safety Population: Received Study Drug|Overall Study|Safety Population included all participants who received at least 1 dose of any study drug.|41
10374067|NCT00570778|11514985|FG001|Safety Population: Received Study Drug|Overall Study||38
10374068|NCT00570778|11514986|FG002|Safety Population: Received Study Drug|Overall Study||36
10374069|NCT00570778|11514987|FG003|Safety Population: Received Study Drug|Overall Study||38
10374070|NCT00570778|11514984|FG000|Modified Intent-to-treat Population|Overall Study||40
10374071|NCT00570778|11514985|FG001|Modified Intent-to-treat Population|Overall Study||37
10538161|NCT01453894|11690984|FG000|STARTED|Overall Study||225
10538162|NCT01453894|11690985|FG001|STARTED|Overall Study||225
10538163|NCT01453894|11690984|FG000|COMPLETED|Overall Study||225
10538164|NCT01453894|11690985|FG001|COMPLETED|Overall Study||225
10374072|NCT00570778|11514986|FG002|Modified Intent-to-treat Population|Overall Study||35
10374073|NCT00570778|11514987|FG003|Modified Intent-to-treat Population|Overall Study||37
10374074|NCT00570778|11514984|FG000|COMPLETED|Overall Study||37
10374075|NCT00570778|11514985|FG001|COMPLETED|Overall Study||34
10374076|NCT00570778|11514986|FG002|COMPLETED|Overall Study||30
10374077|NCT00570778|11514987|FG003|COMPLETED|Overall Study||34
10374078|NCT00570778|11514984|FG000|NOT COMPLETED|Overall Study||4
10374079|NCT00570778|11514985|FG001|NOT COMPLETED|Overall Study||4
10374080|NCT00570778|11514986|FG002|NOT COMPLETED|Overall Study||7
10374081|NCT00570778|11514987|FG003|NOT COMPLETED|Overall Study||4
10374082|NCT00570908|11514997|FG000|STARTED|Overall Study||12
10374083|NCT00570908|11514997|FG000|COMPLETED|Overall Study|5 patients progressed during the study treatment|5
10374084|NCT00570908|11514997|FG000|NOT COMPLETED|Overall Study||7
10374085|NCT00570921|11515001|FG000|STARTED|Overall Study||33
10374086|NCT00570921|11515001|FG000|COMPLETED|Overall Study||31
10374087|NCT00570921|11515001|FG000|NOT COMPLETED|Overall Study||2
10374088|NCT00570960|11515007|FG000|STARTED|Overall Study||4
10374089|NCT00570960|11515008|FG001|STARTED|Overall Study||4
10374090|NCT00570960|11515007|FG000|COMPLETED|Overall Study||4
10374091|NCT00570960|11515008|FG001|COMPLETED|Overall Study||4
10374092|NCT00570960|11515007|FG000|NOT COMPLETED|Overall Study||0
10374093|NCT00570960|11515008|FG001|NOT COMPLETED|Overall Study||0
10374094|NCT00571038|11515016|FG000|STARTED|Overall Study||219
10374095|NCT00571038|11515017|FG001|STARTED|Overall Study||185
10374096|NCT00571038|11515016|FG000|6 Month Follow up|Overall Study||208
10374097|NCT00571038|11515017|FG001|6 Month Follow up|Overall Study||176
10374098|NCT00571038|11515016|FG000|18 Month Survey Only|Overall Study||199
10374099|NCT00571038|11515017|FG001|18 Month Survey Only|Overall Study||163
10374100|NCT00571038|11515016|FG000|COMPLETED|Overall Study|"7 died 2 moved~1 asked to be withdrawn~1 unable to reach"|208
10374101|NCT00571038|11515017|FG001|COMPLETED|Overall Study|5 died 2 moved 3 asked to be withdrawn 4 unable to reach|171
10374102|NCT00571038|11515016|FG000|NOT COMPLETED|Overall Study||11
10374103|NCT00571038|11515017|FG001|NOT COMPLETED|Overall Study||14
10374104|NCT00571064|11515023|FG000|STARTED|Overall Study||97
10374105|NCT00571064|11515023|FG000|COMPLETED|Overall Study||76
10374106|NCT00571064|11515023|FG000|NOT COMPLETED|Overall Study||21
10374107|NCT00571103|11515028|FG000|STARTED|Overall Study||28
10374108|NCT00571103|11515028|FG000|COMPLETED|Overall Study|Of the 28 participants, 1 subject withdrew and 1 was lost to follow-up after their baseline visit.|26
10374109|NCT00571103|11515028|FG000|NOT COMPLETED|Overall Study||2
10374110|NCT00571259|11515034|FG000|STARTED|Overall Study||148
10374111|NCT00571259|11515035|FG001|STARTED|Overall Study||155
10374112|NCT00571259|11515034|FG000|COMPLETED|Overall Study||4
10374113|NCT00571259|11515035|FG001|COMPLETED|Overall Study||14
10374114|NCT00571259|11515034|FG000|NOT COMPLETED|Overall Study||144
10374115|NCT00571259|11515035|FG001|NOT COMPLETED|Overall Study||141
10374116|NCT00571324|11515043|FG000|STARTED|Intervention 1 (7 Hours)||5
10374117|NCT00571324|11515044|FG001|STARTED|Intervention 1 (7 Hours)||4
10374118|NCT00571324|11515043|FG000|COMPLETED|Intervention 1 (7 Hours)||5
10374119|NCT00571324|11515044|FG001|COMPLETED|Intervention 1 (7 Hours)||4
10374120|NCT00571324|11515043|FG000|NOT COMPLETED|Intervention 1 (7 Hours)||0
10374121|NCT00571324|11515044|FG001|NOT COMPLETED|Intervention 1 (7 Hours)||0
10374122|NCT00571324|11515043|FG000|STARTED|Intervention 2 (7 Hours)||5
10374123|NCT00571324|11515044|FG001|STARTED|Intervention 2 (7 Hours)||4
10374124|NCT00571324|11515043|FG000|COMPLETED|Intervention 2 (7 Hours)||5
10374125|NCT00571324|11515044|FG001|COMPLETED|Intervention 2 (7 Hours)||4
10374126|NCT00571324|11515043|FG000|NOT COMPLETED|Intervention 2 (7 Hours)||0
10374127|NCT00571324|11515044|FG001|NOT COMPLETED|Intervention 2 (7 Hours)||0
10374128|NCT00571428|11515052|FG000|STARTED|Overall Study||15
10374129|NCT00571428|11515053|FG001|STARTED|Overall Study||18
10374130|NCT00571428|11515052|FG000|COMPLETED|Overall Study||15
10374131|NCT00571428|11515053|FG001|COMPLETED|Overall Study||18
10374132|NCT00571428|11515052|FG000|NOT COMPLETED|Overall Study||0
10374133|NCT00571428|11515053|FG001|NOT COMPLETED|Overall Study||0
10374134|NCT00571493|11515059|FG000|STARTED|Overall Study||3
10374135|NCT00571493|11515060|FG001|STARTED|Overall Study||4
10374136|NCT00571493|11515061|FG002|STARTED|Overall Study||3
10374137|NCT00571493|11515062|FG003|STARTED|Overall Study||3
10374138|NCT00571493|11515063|FG004|STARTED|Overall Study||11
10374139|NCT00571493|11515064|FG005|STARTED|Overall Study||12
10374140|NCT00571493|11515065|FG006|STARTED|Overall Study||6
10374141|NCT00571493|11515059|FG000|COMPLETED|Overall Study||3
10374142|NCT00571493|11515060|FG001|COMPLETED|Overall Study||4
10374143|NCT00571493|11515061|FG002|COMPLETED|Overall Study||3
10374144|NCT00571493|11515062|FG003|COMPLETED|Overall Study||3
10374145|NCT00571493|11515063|FG004|COMPLETED|Overall Study||11
10374146|NCT00571493|11515064|FG005|COMPLETED|Overall Study||12
10374147|NCT00571493|11515065|FG006|COMPLETED|Overall Study||6
10374148|NCT00571493|11515059|FG000|NOT COMPLETED|Overall Study||0
10374149|NCT00571493|11515060|FG001|NOT COMPLETED|Overall Study||0
10374150|NCT00571493|11515061|FG002|NOT COMPLETED|Overall Study||0
10374151|NCT00571493|11515062|FG003|NOT COMPLETED|Overall Study||0
10374152|NCT00571493|11515063|FG004|NOT COMPLETED|Overall Study||0
10657500|NCT02226549|11818707|FG000|NOT COMPLETED|Overall Study||1
10374153|NCT00571493|11515064|FG005|NOT COMPLETED|Overall Study||0
10374154|NCT00571493|11515065|FG006|NOT COMPLETED|Overall Study||0
10374155|NCT00571519|11515080|FG000|STARTED|Overall Study||3
10374156|NCT00571519|11515081|FG001|STARTED|Overall Study||9
10374157|NCT00571519|11515082|FG002|STARTED|Overall Study||12
10374158|NCT00571519|11515083|FG003|STARTED|Overall Study||27
10374159|NCT00571519|11515084|FG004|STARTED|Overall Study||9
10374160|NCT00571519|11515085|FG005|STARTED|Overall Study||10
10374161|NCT00571519|11515086|FG006|STARTED|Overall Study||24
10374162|NCT00571519|11515080|FG000|COMPLETED|Overall Study||0
10374163|NCT00571519|11515081|FG001|COMPLETED|Overall Study||0
10374164|NCT00571519|11515082|FG002|COMPLETED|Overall Study||0
10374165|NCT00571519|11515083|FG003|COMPLETED|Overall Study||0
10374166|NCT00571519|11515084|FG004|COMPLETED|Overall Study||0
10374167|NCT00571519|11515085|FG005|COMPLETED|Overall Study||0
10374168|NCT00571519|11515086|FG006|COMPLETED|Overall Study||0
10374169|NCT00571519|11515080|FG000|NOT COMPLETED|Overall Study||3
10374170|NCT00571519|11515081|FG001|NOT COMPLETED|Overall Study||9
10374171|NCT00571519|11515082|FG002|NOT COMPLETED|Overall Study||12
10374172|NCT00571519|11515083|FG003|NOT COMPLETED|Overall Study||27
10374173|NCT00571519|11515084|FG004|NOT COMPLETED|Overall Study||9
10717075|NCT02695420|11880996|FG003|COMPLETED|Overall Study||20
10374174|NCT00571519|11515085|FG005|NOT COMPLETED|Overall Study||10
10374175|NCT00571519|11515086|FG006|NOT COMPLETED|Overall Study||24
10374176|NCT00571649|11515104|FG000|STARTED|Treatment Period||4050
10374177|NCT00571649|11515105|FG001|STARTED|Treatment Period||4051
10374178|NCT00571649|11515104|FG000|Participants Received Treatment|Treatment Period||3997
10374179|NCT00571649|11515105|FG001|Participants Received Treatment|Treatment Period||4001
10374180|NCT00571649|11515104|FG000|Day 10|Treatment Period||3454
10538165|NCT01453894|11690984|FG000|NOT COMPLETED|Overall Study||0
10538166|NCT01453894|11690985|FG001|NOT COMPLETED|Overall Study||0
10538167|NCT01453998|11690994|FG000|STARTED|Before Protocol Amendment 2||85
10538168|NCT01453998|11690995|FG001|STARTED|Before Protocol Amendment 2||88
10538169|NCT01453998|11690996|FG002|STARTED|Before Protocol Amendment 2||99
10538170|NCT01453998|11690994|FG000|COMPLETED|Before Protocol Amendment 2||85
10538171|NCT01453998|11690995|FG001|COMPLETED|Before Protocol Amendment 2||88
10538172|NCT01453998|11690996|FG002|COMPLETED|Before Protocol Amendment 2||99
10538173|NCT01453998|11690994|FG000|NOT COMPLETED|Before Protocol Amendment 2||0
10538174|NCT01453998|11690995|FG001|NOT COMPLETED|Before Protocol Amendment 2||0
10657501|NCT02226549|11818708|FG001|NOT COMPLETED|Overall Study||1
10657502|NCT02226562|11818716|FG000|STARTED|Overall Study||95
10657503|NCT02226562|11818717|FG001|STARTED|Overall Study||96
10657504|NCT02226562|11818716|FG000|COMPLETED|Overall Study||95
10657505|NCT02226562|11818717|FG001|COMPLETED|Overall Study|Lost to follow up|95
10657506|NCT02226562|11818716|FG000|NOT COMPLETED|Overall Study||0
10657507|NCT02226562|11818717|FG001|NOT COMPLETED|Overall Study||1
10657508|NCT02226653|11818725|FG000|STARTED|Treatment Period 1 Fasted State||24
10657509|NCT02226653|11818726|FG001|STARTED|Treatment Period 1 Fasted State||24
10657510|NCT02226653|11818725|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1 Fasted State||24
10657511|NCT02226653|11818726|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1 Fasted State||24
10657512|NCT02226653|11818725|FG000|COMPLETED|Treatment Period 1 Fasted State||24
10657513|NCT02226653|11818726|FG001|COMPLETED|Treatment Period 1 Fasted State||24
10717076|NCT02695420|11880993|FG000|NOT COMPLETED|Overall Study||0
10717077|NCT02695420|11880994|FG001|NOT COMPLETED|Overall Study||1
10717078|NCT02695420|11880995|FG002|NOT COMPLETED|Overall Study||0
10717079|NCT02695420|11880996|FG003|NOT COMPLETED|Overall Study||0
10717080|NCT02695446|11881009|FG000|STARTED|Overall Study||12
10717081|NCT02695446|11881009|FG000|COMPLETED|Overall Study||12
10717082|NCT02695446|11881009|FG000|NOT COMPLETED|Overall Study||0
10717083|NCT02695524|11881015|FG000|STARTED|Overall Study||30
10717084|NCT02695524|11881016|FG001|STARTED|Overall Study||30
10717085|NCT02695524|11881015|FG000|COMPLETED|Overall Study||27
10717086|NCT02695524|11881016|FG001|COMPLETED|Overall Study||27
10717087|NCT02695524|11881015|FG000|NOT COMPLETED|Overall Study||3
10717088|NCT02695524|11881016|FG001|NOT COMPLETED|Overall Study||3
10717089|NCT02695537|11881022|FG000|STARTED|Overall Study||89
10717090|NCT02695537|11881022|FG000|COMPLETED|Overall Study||51
10717091|NCT02695537|11881022|FG000|NOT COMPLETED|Overall Study||38
10717092|NCT02695628|11881026|FG000|STARTED|Overall Study||5
10717093|NCT02695628|11881026|FG000|COMPLETED|Overall Study||4
10538175|NCT01453998|11690996|FG002|NOT COMPLETED|Before Protocol Amendment 2||0
10374181|NCT00571649|11515105|FG001|Day 10|Treatment Period||3499
10374182|NCT00571649|11515104|FG000|Day 35|Treatment Period||3033
10538176|NCT01453998|11690994|FG000|STARTED|After Protocol Amendment 2.||131
10657514|NCT02226653|11818725|FG000|NOT COMPLETED|Treatment Period 1 Fasted State||0
10717094|NCT02695628|11881026|FG000|NOT COMPLETED|Overall Study||1
10717095|NCT02695719|11881032|FG000|STARTED|Overall Study||74
10717096|NCT02695719|11881033|FG001|STARTED|Overall Study||82
10717097|NCT02695719|11881032|FG000|COMPLETED|Overall Study||71
10717098|NCT02695719|11881033|FG001|COMPLETED|Overall Study||72
10374183|NCT00571649|11515105|FG001|Day 35|Treatment Period||3115
10374184|NCT00571649|11515104|FG000|COMPLETED|Treatment Period||2958
10374185|NCT00571649|11515105|FG001|COMPLETED|Treatment Period||3047
10374186|NCT00571649|11515104|FG000|NOT COMPLETED|Treatment Period||1092
10374187|NCT00571649|11515105|FG001|NOT COMPLETED|Treatment Period||1004
10374188|NCT00571649|11515104|FG000|STARTED|Follow-up Period|Participants were required to enter follow-up even if treatment period not completed.|3583
10374189|NCT00571649|11515105|FG001|STARTED|Follow-up Period|Participants were required to enter follow-up even if treatment period not completed.|3635
10374190|NCT00571649|11515104|FG000|COMPLETED|Follow-up Period|Began day after last dose study drug; ended on Day 90 (+/- 7 days) .|3038
10374191|NCT00571649|11515105|FG001|COMPLETED|Follow-up Period|Began day after last dose study drug; ended on Day 90 (+/- 7 days) .|3107
10374192|NCT00571649|11515104|FG000|NOT COMPLETED|Follow-up Period||545
10374193|NCT00571649|11515105|FG001|NOT COMPLETED|Follow-up Period||528
10374194|NCT00571662|11515111|FG000|STARTED|Overall Study||76
10374195|NCT00571662|11515111|FG000|COMPLETED|Overall Study||68
10374196|NCT00571662|11515111|FG000|NOT COMPLETED|Overall Study||8
10374197|NCT00571688|11515119|FG000|STARTED|Overall Study||25
10374198|NCT00571688|11515120|FG001|STARTED|Overall Study||25
10374199|NCT00571688|11515119|FG000|COMPLETED|Overall Study||20
10374200|NCT00571688|11515120|FG001|COMPLETED|Overall Study||19
10374201|NCT00571688|11515119|FG000|NOT COMPLETED|Overall Study||5
10374202|NCT00571688|11515120|FG001|NOT COMPLETED|Overall Study||6
10374203|NCT00571701|11515128|FG000|STARTED|First Intervention 12 Months||19
10374204|NCT00571701|11515129|FG001|STARTED|First Intervention 12 Months||22
10374205|NCT00571701|11515128|FG000|COMPLETED|First Intervention 12 Months||16
10374206|NCT00571701|11515129|FG001|COMPLETED|First Intervention 12 Months||21
10374207|NCT00571701|11515128|FG000|NOT COMPLETED|First Intervention 12 Months||3
10374208|NCT00571701|11515129|FG001|NOT COMPLETED|First Intervention 12 Months||1
10374209|NCT00571701|11515128|FG000|STARTED|Second Intervention 12 Months||16
10374210|NCT00571701|11515129|FG001|STARTED|Second Intervention 12 Months||21
10374211|NCT00571701|11515128|FG000|COMPLETED|Second Intervention 12 Months||13
10374212|NCT00571701|11515129|FG001|COMPLETED|Second Intervention 12 Months||20
10374213|NCT00571701|11515128|FG000|NOT COMPLETED|Second Intervention 12 Months||3
10374214|NCT00571701|11515129|FG001|NOT COMPLETED|Second Intervention 12 Months||1
10374215|NCT00571948|11515155|FG000|STARTED|Overall Study||66
10374216|NCT00571948|11515156|FG001|STARTED|Overall Study||66
10374217|NCT00571948|11515155|FG000|COMPLETED|Overall Study|Excluded from analysis (n = 2) Reason: diet record for less than 75 % of days (n = 2)|55
10374218|NCT00571948|11515156|FG001|COMPLETED|Overall Study|Excluded n = 3) Reasons: diet record < 75 % of days (n = 2); blood analysis failed (n= 1)|52
10374219|NCT00571948|11515155|FG000|NOT COMPLETED|Overall Study||11
10374220|NCT00571948|11515156|FG001|NOT COMPLETED|Overall Study||14
10374221|NCT00571961|11515162|FG000|STARTED|Overall Study||12
10374222|NCT00571961|11515162|FG000|COMPLETED|Overall Study||12
10374223|NCT00571961|11515162|FG000|NOT COMPLETED|Overall Study||0
10374224|NCT00571974|11515168|FG000|STARTED|Phase I||9
10374225|NCT00571974|11515169|FG001|STARTED|Phase I||0
10374226|NCT00571974|11515168|FG000|COMPLETED|Phase I||9
10374227|NCT00571974|11515169|FG001|COMPLETED|Phase I||0
10374228|NCT00571974|11515168|FG000|NOT COMPLETED|Phase I||0
10374229|NCT00571974|11515169|FG001|NOT COMPLETED|Phase I||0
10374230|NCT00571974|11515168|FG000|STARTED|Phase II||0
10374231|NCT00571974|11515169|FG001|STARTED|Phase II|3 participants are from phase I|21
10374232|NCT00571974|11515168|FG000|COMPLETED|Phase II||0
10374233|NCT00571974|11515169|FG001|COMPLETED|Phase II||17
10374234|NCT00571974|11515168|FG000|NOT COMPLETED|Phase II||0
10374235|NCT00571974|11515169|FG001|NOT COMPLETED|Phase II||4
10374236|NCT00571987|11515175|FG000|STARTED|Overall Study||107
10374237|NCT00571987|11515175|FG000|COMPLETED|Overall Study||100
10374238|NCT00571987|11515175|FG000|NOT COMPLETED|Overall Study||7
10374239|NCT00572039|11515182|FG000|STARTED|Overall Study||121
10374240|NCT00572039|11515183|FG001|STARTED|Overall Study||120
10374241|NCT00572039|11515182|FG000|COMPLETED|Overall Study||105
10374242|NCT00572039|11515183|FG001|COMPLETED|Overall Study||110
10374243|NCT00572039|11515182|FG000|NOT COMPLETED|Overall Study||16
10374244|NCT00572039|11515183|FG001|NOT COMPLETED|Overall Study||10
10374245|NCT00572117|11515193|FG000|STARTED|Overall Study||5
10374246|NCT00572117|11515194|FG001|STARTED|Overall Study||7
10374247|NCT00572117|11515193|FG000|COMPLETED|Overall Study||3
10374248|NCT00572117|11515194|FG001|COMPLETED|Overall Study||5
10374249|NCT00572117|11515193|FG000|NOT COMPLETED|Overall Study||2
10374250|NCT00572117|11515194|FG001|NOT COMPLETED|Overall Study||2
10374251|NCT00572156|11515206|FG000|STARTED|Overall Study||26
10717099|NCT02695719|11881032|FG000|NOT COMPLETED|Overall Study||3
10374252|NCT00572156|11515207|FG001|STARTED|Overall Study||27
10374253|NCT00572156|11515208|FG002|STARTED|Overall Study||27
10717100|NCT02695719|11881033|FG001|NOT COMPLETED|Overall Study||10
10374254|NCT00572156|11515209|FG003|STARTED|Overall Study||26
10374255|NCT00572156|11515206|FG000|COMPLETED|Overall Study||0
10374256|NCT00572156|11515207|FG001|COMPLETED|Overall Study||1
10374257|NCT00572156|11515208|FG002|COMPLETED|Overall Study||0
10374258|NCT00572156|11515209|FG003|COMPLETED|Overall Study||1
10374259|NCT00572156|11515206|FG000|NOT COMPLETED|Overall Study||26
10374260|NCT00572156|11515207|FG001|NOT COMPLETED|Overall Study||26
10374261|NCT00572156|11515208|FG002|NOT COMPLETED|Overall Study||27
10374262|NCT00572156|11515209|FG003|NOT COMPLETED|Overall Study||25
10374263|NCT00572195|11515219|FG000|STARTED|Overall Study||230
10374264|NCT00572195|11515219|FG000|COMPLETED|Overall Study||162
10374265|NCT00572195|11515219|FG000|NOT COMPLETED|Overall Study||68
10374266|NCT00572234|11515225|FG000|STARTED|Overall Study||19
10374267|NCT00572234|11515226|FG001|STARTED|Overall Study||21
10374268|NCT00572234|11515225|FG000|COMPLETED|Overall Study||18
10374269|NCT00572234|11515226|FG001|COMPLETED|Overall Study||16
10374270|NCT00572234|11515225|FG000|NOT COMPLETED|Overall Study||1
10374271|NCT00572234|11515226|FG001|NOT COMPLETED|Overall Study||5
10374272|NCT00572455|11515246|FG000|STARTED|Stage I (14 Days)||9
10374273|NCT00572455|11515247|FG001|STARTED|Stage I (14 Days)||9
10374274|NCT00572455|11515248|FG002|STARTED|Stage I (14 Days)||9
10374275|NCT00572455|11515249|FG003|STARTED|Stage I (14 Days)||10
10374276|NCT00572455|11515250|FG004|STARTED|Stage I (14 Days)||9
10374277|NCT00572455|11515251|FG005|STARTED|Stage I (14 Days)||9
10374278|NCT00572455|11515252|FG006|STARTED|Stage I (14 Days)||12
10374279|NCT00572455|11515253|FG007|STARTED|Stage I (14 Days)||0
10374280|NCT00572455|11515254|FG008|STARTED|Stage I (14 Days)||0
10374281|NCT00572455|11515255|FG009|STARTED|Stage I (14 Days)||0
10374282|NCT00572455|11515256|FG010|STARTED|Stage I (14 Days)||0
10374283|NCT00572455|11515257|FG011|STARTED|Stage I (14 Days)||0
10374284|NCT00572455|11515258|FG012|STARTED|Stage I (14 Days)||0
10374285|NCT00572455|11515259|FG013|STARTED|Stage I (14 Days)||0
10374286|NCT00572455|11515246|FG000|COMPLETED|Stage I (14 Days)||9
10374287|NCT00572455|11515247|FG001|COMPLETED|Stage I (14 Days)||9
10374288|NCT00572455|11515248|FG002|COMPLETED|Stage I (14 Days)||9
10374289|NCT00572455|11515249|FG003|COMPLETED|Stage I (14 Days)||10
10374290|NCT00572455|11515250|FG004|COMPLETED|Stage I (14 Days)||8
10374291|NCT00572455|11515251|FG005|COMPLETED|Stage I (14 Days)||6
10374292|NCT00572455|11515252|FG006|COMPLETED|Stage I (14 Days)||12
10374293|NCT00572455|11515253|FG007|COMPLETED|Stage I (14 Days)||0
10374294|NCT00572455|11515254|FG008|COMPLETED|Stage I (14 Days)||0
10374295|NCT00572455|11515255|FG009|COMPLETED|Stage I (14 Days)||0
10374296|NCT00572455|11515256|FG010|COMPLETED|Stage I (14 Days)||0
10374297|NCT00572455|11515257|FG011|COMPLETED|Stage I (14 Days)||0
10374298|NCT00572455|11515258|FG012|COMPLETED|Stage I (14 Days)||0
10374299|NCT00572455|11515259|FG013|COMPLETED|Stage I (14 Days)||0
10374300|NCT00572455|11515246|FG000|NOT COMPLETED|Stage I (14 Days)||0
10374301|NCT00572455|11515247|FG001|NOT COMPLETED|Stage I (14 Days)||0
10374302|NCT00572455|11515248|FG002|NOT COMPLETED|Stage I (14 Days)||0
10374303|NCT00572455|11515249|FG003|NOT COMPLETED|Stage I (14 Days)||0
10374304|NCT00572455|11515250|FG004|NOT COMPLETED|Stage I (14 Days)||1
10374305|NCT00572455|11515251|FG005|NOT COMPLETED|Stage I (14 Days)||3
10374306|NCT00572455|11515252|FG006|NOT COMPLETED|Stage I (14 Days)||0
10374307|NCT00572455|11515253|FG007|NOT COMPLETED|Stage I (14 Days)||0
10374308|NCT00572455|11515254|FG008|NOT COMPLETED|Stage I (14 Days)||0
10374309|NCT00572455|11515255|FG009|NOT COMPLETED|Stage I (14 Days)||0
10374310|NCT00572455|11515256|FG010|NOT COMPLETED|Stage I (14 Days)||0
10374311|NCT00572455|11515257|FG011|NOT COMPLETED|Stage I (14 Days)||0
10374312|NCT00572455|11515258|FG012|NOT COMPLETED|Stage I (14 Days)||0
10374313|NCT00572455|11515259|FG013|NOT COMPLETED|Stage I (14 Days)||0
10374314|NCT00572455|11515246|FG000|STARTED|Stage II (28 Days)||0
10374315|NCT00572455|11515247|FG001|STARTED|Stage II (28 Days)||0
10374316|NCT00572455|11515248|FG002|STARTED|Stage II (28 Days)||0
10374317|NCT00572455|11515249|FG003|STARTED|Stage II (28 Days)||0
10374318|NCT00572455|11515250|FG004|STARTED|Stage II (28 Days)||0
10374319|NCT00572455|11515251|FG005|STARTED|Stage II (28 Days)||0
10374320|NCT00572455|11515252|FG006|STARTED|Stage II (28 Days)||0
10374321|NCT00572455|11515253|FG007|STARTED|Stage II (28 Days)||35
10374322|NCT00572455|11515254|FG008|STARTED|Stage II (28 Days)||36
10374323|NCT00572455|11515255|FG009|STARTED|Stage II (28 Days)||36
10374324|NCT00572455|11515256|FG010|STARTED|Stage II (28 Days)||36
10374325|NCT00572455|11515257|FG011|STARTED|Stage II (28 Days)||36
10374326|NCT00572455|11515258|FG012|STARTED|Stage II (28 Days)||36
10374327|NCT00572455|11515259|FG013|STARTED|Stage II (28 Days)||36
10374328|NCT00572455|11515246|FG000|Treated|Stage II (28 Days)||0
10374329|NCT00572455|11515247|FG001|Treated|Stage II (28 Days)||0
10717101|NCT02696070|11881041|FG000|STARTED|Overall Study||8
10717102|NCT02696070|11881042|FG001|STARTED|Overall Study||14
10717103|NCT02696070|11881041|FG000|COMPLETED|Overall Study||7
10717104|NCT02696070|11881042|FG001|COMPLETED|Overall Study||12
10717105|NCT02696070|11881041|FG000|NOT COMPLETED|Overall Study||1
10374330|NCT00572455|11515248|FG002|Treated|Stage II (28 Days)||0
10374331|NCT00572455|11515249|FG003|Treated|Stage II (28 Days)||0
10374332|NCT00572455|11515250|FG004|Treated|Stage II (28 Days)||0
10717106|NCT02696070|11881042|FG001|NOT COMPLETED|Overall Study||2
10717107|NCT02696083|11881048|FG000|STARTED|Overall Study||19
10374333|NCT00572455|11515251|FG005|Treated|Stage II (28 Days)||0
10374334|NCT00572455|11515252|FG006|Treated|Stage II (28 Days)||0
10374335|NCT00572455|11515253|FG007|Treated|Stage II (28 Days)||35
10374336|NCT00572455|11515254|FG008|Treated|Stage II (28 Days)||36
10717108|NCT02696083|11881048|FG000|COMPLETED|Overall Study||13
10374337|NCT00572455|11515255|FG009|Treated|Stage II (28 Days)||36
10374338|NCT00572455|11515256|FG010|Treated|Stage II (28 Days)||36
10374339|NCT00572455|11515257|FG011|Treated|Stage II (28 Days)||36
10374340|NCT00572455|11515258|FG012|Treated|Stage II (28 Days)||36
10374341|NCT00572455|11515259|FG013|Treated|Stage II (28 Days)||35
10374342|NCT00572455|11515246|FG000|COMPLETED|Stage II (28 Days)||0
10374343|NCT00572455|11515247|FG001|COMPLETED|Stage II (28 Days)||0
10374344|NCT00572455|11515248|FG002|COMPLETED|Stage II (28 Days)||0
10374345|NCT00572455|11515249|FG003|COMPLETED|Stage II (28 Days)||0
10374346|NCT00572455|11515250|FG004|COMPLETED|Stage II (28 Days)||0
10374347|NCT00572455|11515251|FG005|COMPLETED|Stage II (28 Days)||0
10374348|NCT00572455|11515252|FG006|COMPLETED|Stage II (28 Days)||0
10374349|NCT00572455|11515253|FG007|COMPLETED|Stage II (28 Days)||34
10374350|NCT00572455|11515254|FG008|COMPLETED|Stage II (28 Days)||33
10374351|NCT00572455|11515255|FG009|COMPLETED|Stage II (28 Days)||33
10374352|NCT00572455|11515256|FG010|COMPLETED|Stage II (28 Days)||31
10374353|NCT00572455|11515257|FG011|COMPLETED|Stage II (28 Days)||32
10374354|NCT00572455|11515258|FG012|COMPLETED|Stage II (28 Days)||31
10374355|NCT00572455|11515259|FG013|COMPLETED|Stage II (28 Days)||34
10374356|NCT00572455|11515246|FG000|NOT COMPLETED|Stage II (28 Days)||0
10374357|NCT00572455|11515247|FG001|NOT COMPLETED|Stage II (28 Days)||0
10374358|NCT00572455|11515248|FG002|NOT COMPLETED|Stage II (28 Days)||0
10374359|NCT00572455|11515249|FG003|NOT COMPLETED|Stage II (28 Days)||0
10717109|NCT02696083|11881048|FG000|NOT COMPLETED|Overall Study||6
10374360|NCT00572455|11515250|FG004|NOT COMPLETED|Stage II (28 Days)||0
10374361|NCT00572455|11515251|FG005|NOT COMPLETED|Stage II (28 Days)||0
10374362|NCT00572455|11515252|FG006|NOT COMPLETED|Stage II (28 Days)||0
10374363|NCT00572455|11515253|FG007|NOT COMPLETED|Stage II (28 Days)||1
10374364|NCT00572455|11515254|FG008|NOT COMPLETED|Stage II (28 Days)||3
10374365|NCT00572455|11515255|FG009|NOT COMPLETED|Stage II (28 Days)||3
10374366|NCT00572455|11515256|FG010|NOT COMPLETED|Stage II (28 Days)||5
10374367|NCT00572455|11515257|FG011|NOT COMPLETED|Stage II (28 Days)||4
10374368|NCT00572455|11515258|FG012|NOT COMPLETED|Stage II (28 Days)||5
10374369|NCT00572455|11515259|FG013|NOT COMPLETED|Stage II (28 Days)||2
10374370|NCT00572468|11515291|FG000|STARTED|Overall Study||22
10374371|NCT00572468|11515292|FG001|STARTED|Overall Study||20
10374372|NCT00572468|11515291|FG000|COMPLETED|Overall Study||20
10374373|NCT00572468|11515292|FG001|COMPLETED|Overall Study||16
10374374|NCT00572468|11515291|FG000|NOT COMPLETED|Overall Study||2
10374375|NCT00572468|11515292|FG001|NOT COMPLETED|Overall Study||4
10374376|NCT00572533|11515300|FG000|STARTED|Overall Study||31
10538177|NCT01453998|11690995|FG001|STARTED|After Protocol Amendment 2.||130
10538178|NCT01453998|11690996|FG002|STARTED|After Protocol Amendment 2.||124
10538179|NCT01453998|11690994|FG000|COMPLETED|After Protocol Amendment 2.||130
10538180|NCT01453998|11690995|FG001|COMPLETED|After Protocol Amendment 2.||130
10538181|NCT01453998|11690996|FG002|COMPLETED|After Protocol Amendment 2.||124
10538182|NCT01453998|11690994|FG000|NOT COMPLETED|After Protocol Amendment 2.||1
10538183|NCT01453998|11690995|FG001|NOT COMPLETED|After Protocol Amendment 2.||0
10538184|NCT01453998|11690996|FG002|NOT COMPLETED|After Protocol Amendment 2.||0
10538185|NCT01454063|11691009|FG000|STARTED|Randomized||202
10538186|NCT01454063|11691010|FG001|STARTED|Randomized||203
10538187|NCT01454063|11691009|FG000|COMPLETED|Randomized||201
10538188|NCT01454063|11691010|FG001|COMPLETED|Randomized||201
10538189|NCT01454063|11691009|FG000|NOT COMPLETED|Randomized||1
10538190|NCT01454063|11691010|FG001|NOT COMPLETED|Randomized||2
10538191|NCT01454063|11691009|FG000|STARTED|Treated||201
10538192|NCT01454063|11691010|FG001|STARTED|Treated||201
10538193|NCT01454063|11691009|FG000|COMPLETED|Treated||199
10538194|NCT01454063|11691010|FG001|COMPLETED|Treated||201
10538195|NCT01454063|11691009|FG000|NOT COMPLETED|Treated||2
10538196|NCT01454063|11691010|FG001|NOT COMPLETED|Treated||0
10538197|NCT01454076|11691021|FG000|STARTED|Overall Study||29
10538198|NCT01454076|11691022|FG001|STARTED|Overall Study||20
10538199|NCT01454076|11691023|FG002|STARTED|Overall Study||24
10538200|NCT01454076|11691024|FG003|STARTED|Overall Study||18
10538201|NCT01454076|11691025|FG004|STARTED|Overall Study||21
10538202|NCT01454076|11691021|FG000|COMPLETED|Overall Study||16
10538203|NCT01454076|11691022|FG001|COMPLETED|Overall Study||14
10538204|NCT01454076|11691023|FG002|COMPLETED|Overall Study||15
10538205|NCT01454076|11691024|FG003|COMPLETED|Overall Study||16
10538206|NCT01454076|11691025|FG004|COMPLETED|Overall Study||15
10538207|NCT01454076|11691021|FG000|NOT COMPLETED|Overall Study||13
10657515|NCT02226653|11818726|FG001|NOT COMPLETED|Treatment Period 1 Fasted State||0
10717110|NCT02696200|11881059|FG000|STARTED|Overall Study||32
10717111|NCT02696200|11881060|FG001|STARTED|Overall Study||30
10374377|NCT00572533|11515301|FG001|STARTED|Overall Study||31
10374378|NCT00572533|11515300|FG000|COMPLETED|Overall Study||24
10374379|NCT00572533|11515301|FG001|COMPLETED|Overall Study||28
10374380|NCT00572533|11515300|FG000|NOT COMPLETED|Overall Study||7
10374381|NCT00572533|11515301|FG001|NOT COMPLETED|Overall Study||3
10374382|NCT00572572|11515309|FG000|STARTED|Overall Study||35
10374383|NCT00572572|11515310|FG001|STARTED|Overall Study||34
10374384|NCT00572572|11515309|FG000|COMPLETED|Overall Study||32
10538208|NCT01454076|11691022|FG001|NOT COMPLETED|Overall Study||6
10538209|NCT01454076|11691023|FG002|NOT COMPLETED|Overall Study||9
10538210|NCT01454076|11691024|FG003|NOT COMPLETED|Overall Study||2
10538211|NCT01454076|11691025|FG004|NOT COMPLETED|Overall Study||6
10538212|NCT01454102|11691062|FG000|STARTED|Overall Study||12
10657516|NCT02226653|11818725|FG000|STARTED|Washout Period 1 (at Least 21 Days)||24
10657517|NCT02226653|11818726|FG001|STARTED|Washout Period 1 (at Least 21 Days)||24
10374385|NCT00572572|11515310|FG001|COMPLETED|Overall Study||28
10374386|NCT00572572|11515309|FG000|NOT COMPLETED|Overall Study||3
10374387|NCT00572572|11515310|FG001|NOT COMPLETED|Overall Study||6
10374388|NCT00572624|11515318|FG000|STARTED|Overall Study||37
10374389|NCT00572624|11515319|FG001|STARTED|Overall Study||14
10374390|NCT00572624|11515318|FG000|COMPLETED|Overall Study||20
10374391|NCT00572624|11515319|FG001|COMPLETED|Overall Study||10
10374392|NCT00572624|11515318|FG000|NOT COMPLETED|Overall Study||17
10374393|NCT00572624|11515319|FG001|NOT COMPLETED|Overall Study||4
10374394|NCT00572728|11515325|FG000|STARTED|Overall Study|Registered|90
10374395|NCT00572728|11515325|FG000|Eligible|Overall Study||87
10374396|NCT00572728|11515325|FG000|Enrolled Under Amendment 5 or Later|Overall Study||82
10374397|NCT00572728|11515325|FG000|Did Not Withdraw|Overall Study||72
10374398|NCT00572728|11515325|FG000|On Study|Overall Study||71
10374399|NCT00572728|11515325|FG000|Completed FLT1 Scan|Overall Study||67
10374400|NCT00572728|11515325|FG000|First Therapy Initiated|Overall Study||65
10374401|NCT00572728|11515325|FG000|Completed FLT2 Scan|Overall Study||60
10374402|NCT00572728|11515325|FG000|Second Chemotherapy Initiated|Overall Study||59
10374403|NCT00572728|11515325|FG000|Second Chemotherapy Initiated After FLT2|Overall Study||52
10374404|NCT00572728|11515325|FG000|Pathology Complete|Overall Study||51
10374405|NCT00572728|11515325|FG000|Completed FLT3 Scan|Overall Study|Secondary analysis milestone: 43 pts had FLT-3 performed.|43
10374406|NCT00572728|11515325|FG000|LN Evaluation After NAC|Overall Study|Secondary:38 patients were available for histopathological LN evaluation after NAC|38
10374407|NCT00572728|11515325|FG000|RCB Evaluation|Overall Study|Secondary: histopathology was available in 35 patients for RCB evaluation|35
10374408|NCT00572728|11515325|FG000|COMPLETED|Overall Study|51 patients eligible for primary objective analysis|51
10374409|NCT00572728|11515325|FG000|NOT COMPLETED|Overall Study||39
10374410|NCT00572832|11515333|FG000|STARTED|Overall Study||100
10374411|NCT00572832|11515334|FG001|STARTED|Overall Study||100
10374412|NCT00572832|11515333|FG000|COMPLETED|Overall Study||100
10374413|NCT00572832|11515334|FG001|COMPLETED|Overall Study||88
10374414|NCT00572832|11515333|FG000|NOT COMPLETED|Overall Study||0
10374415|NCT00572832|11515334|FG001|NOT COMPLETED|Overall Study||12
10374416|NCT00572897|11515342|FG000|STARTED|Overall Study||32
10374417|NCT00572897|11515343|FG001|STARTED|Overall Study||34
10374418|NCT00572897|11515342|FG000|COMPLETED|Overall Study||32
10374419|NCT00572897|11515343|FG001|COMPLETED|Overall Study||34
10374420|NCT00572897|11515342|FG000|NOT COMPLETED|Overall Study||0
10374421|NCT00572897|11515343|FG001|NOT COMPLETED|Overall Study||0
10374422|NCT00572910|11515355|FG000|STARTED|Overall Study||19
10374423|NCT00572910|11515356|FG001|STARTED|Overall Study||18
10374424|NCT00572910|11515357|FG002|STARTED|Overall Study||19
10717112|NCT02696200|11881059|FG000|COMPLETED|Overall Study||32
10717113|NCT02696200|11881060|FG001|COMPLETED|Overall Study||30
10717114|NCT02696200|11881059|FG000|NOT COMPLETED|Overall Study||0
10374425|NCT00572910|11515358|FG003|STARTED|Overall Study||18
10374426|NCT00572910|11515359|FG004|STARTED|Overall Study||19
10374427|NCT00572910|11515360|FG005|STARTED|Overall Study||19
10374428|NCT00572910|11515361|FG006|STARTED|Overall Study||19
10374429|NCT00572910|11515362|FG007|STARTED|Overall Study||19
10374430|NCT00572910|11515363|FG008|STARTED|Overall Study||19
10374431|NCT00572910|11515364|FG009|STARTED|Overall Study||19
10374432|NCT00572910|11515365|FG010|STARTED|Overall Study||18
10374433|NCT00572910|11515355|FG000|COMPLETED|Overall Study||15
10374434|NCT00572910|11515356|FG001|COMPLETED|Overall Study||15
10374435|NCT00572910|11515357|FG002|COMPLETED|Overall Study||17
10374436|NCT00572910|11515358|FG003|COMPLETED|Overall Study||14
10374437|NCT00572910|11515359|FG004|COMPLETED|Overall Study||17
10374438|NCT00572910|11515360|FG005|COMPLETED|Overall Study||16
10374439|NCT00572910|11515361|FG006|COMPLETED|Overall Study||15
10374440|NCT00572910|11515362|FG007|COMPLETED|Overall Study||15
10374441|NCT00572910|11515363|FG008|COMPLETED|Overall Study||16
10374442|NCT00572910|11515364|FG009|COMPLETED|Overall Study||13
10374443|NCT00572910|11515365|FG010|COMPLETED|Overall Study||15
10374444|NCT00572910|11515355|FG000|NOT COMPLETED|Overall Study||4
10374445|NCT00572910|11515356|FG001|NOT COMPLETED|Overall Study||3
10717115|NCT02696200|11881060|FG001|NOT COMPLETED|Overall Study||0
10717116|NCT02696291|11881068|FG000|STARTED|Overall Study||5
10374446|NCT00572910|11515357|FG002|NOT COMPLETED|Overall Study||2
10374447|NCT00572910|11515358|FG003|NOT COMPLETED|Overall Study||4
10374448|NCT00572910|11515359|FG004|NOT COMPLETED|Overall Study||2
10374449|NCT00572910|11515360|FG005|NOT COMPLETED|Overall Study||3
10374450|NCT00572910|11515361|FG006|NOT COMPLETED|Overall Study||4
10374451|NCT00572910|11515362|FG007|NOT COMPLETED|Overall Study||4
10374452|NCT00572910|11515363|FG008|NOT COMPLETED|Overall Study||3
10374453|NCT00572910|11515364|FG009|NOT COMPLETED|Overall Study||6
10374454|NCT00572910|11515365|FG010|NOT COMPLETED|Overall Study||3
10374455|NCT00572936|11515400|FG000|STARTED|First Intervention||4
10374456|NCT00572936|11515401|FG001|STARTED|First Intervention||4
10374457|NCT00572936|11515402|FG002|STARTED|First Intervention||5
10374458|NCT00572936|11515403|FG003|STARTED|First Intervention||5
10374459|NCT00572936|11515404|FG004|STARTED|First Intervention||5
10374460|NCT00572936|11515405|FG005|STARTED|First Intervention||5
10374461|NCT00572936|11515400|FG000|COMPLETED|First Intervention||4
10374462|NCT00572936|11515401|FG001|COMPLETED|First Intervention||4
10374463|NCT00572936|11515402|FG002|COMPLETED|First Intervention||5
10374464|NCT00572936|11515403|FG003|COMPLETED|First Intervention||5
10374465|NCT00572936|11515404|FG004|COMPLETED|First Intervention||5
10374466|NCT00572936|11515405|FG005|COMPLETED|First Intervention||5
10374467|NCT00572936|11515400|FG000|NOT COMPLETED|First Intervention||0
10374468|NCT00572936|11515401|FG001|NOT COMPLETED|First Intervention||0
10374469|NCT00572936|11515402|FG002|NOT COMPLETED|First Intervention||0
10374470|NCT00572936|11515403|FG003|NOT COMPLETED|First Intervention||0
10374471|NCT00572936|11515404|FG004|NOT COMPLETED|First Intervention||0
10374472|NCT00572936|11515405|FG005|NOT COMPLETED|First Intervention||0
10374473|NCT00572936|11515400|FG000|STARTED|Second Intervention||4
10374474|NCT00572936|11515401|FG001|STARTED|Second Intervention|1 participant dropped out between the first and second intervention due to car accident|3
10374475|NCT00572936|11515402|FG002|STARTED|Second Intervention|1 participant dropped out between first intervention and second intervention due to increased IOP|4
10374476|NCT00572936|11515403|FG003|STARTED|Second Intervention||5
10374477|NCT00572936|11515404|FG004|STARTED|Second Intervention|1 participant dropped out between first intervention and second intervention due to increased IOP|4
10374478|NCT00572936|11515405|FG005|STARTED|Second Intervention||5
10374479|NCT00572936|11515400|FG000|COMPLETED|Second Intervention||4
10374480|NCT00572936|11515401|FG001|COMPLETED|Second Intervention||3
10374481|NCT00572936|11515402|FG002|COMPLETED|Second Intervention||4
10374482|NCT00572936|11515403|FG003|COMPLETED|Second Intervention||5
10374483|NCT00572936|11515404|FG004|COMPLETED|Second Intervention||4
10374484|NCT00572936|11515405|FG005|COMPLETED|Second Intervention||5
10374485|NCT00572936|11515400|FG000|NOT COMPLETED|Second Intervention||0
10374486|NCT00572936|11515401|FG001|NOT COMPLETED|Second Intervention||0
10374487|NCT00572936|11515402|FG002|NOT COMPLETED|Second Intervention||0
10374488|NCT00572936|11515403|FG003|NOT COMPLETED|Second Intervention||0
10374489|NCT00572936|11515404|FG004|NOT COMPLETED|Second Intervention||0
10374490|NCT00572936|11515405|FG005|NOT COMPLETED|Second Intervention||0
10374491|NCT00572936|11515400|FG000|STARTED|Third Intervention||4
10374492|NCT00572936|11515401|FG001|STARTED|Third Intervention||3
10374493|NCT00572936|11515402|FG002|STARTED|Third Intervention||4
10374494|NCT00572936|11515403|FG003|STARTED|Third Intervention||5
10374495|NCT00572936|11515404|FG004|STARTED|Third Intervention|1 participant dropped out between second intervention and third intervention due to increased IOP|3
10374496|NCT00572936|11515405|FG005|STARTED|Third Intervention||5
10374497|NCT00572936|11515400|FG000|COMPLETED|Third Intervention||4
10374498|NCT00572936|11515401|FG001|COMPLETED|Third Intervention||3
10374499|NCT00572936|11515402|FG002|COMPLETED|Third Intervention||4
10374500|NCT00572936|11515403|FG003|COMPLETED|Third Intervention||5
10374501|NCT00572936|11515404|FG004|COMPLETED|Third Intervention||3
10374502|NCT00572936|11515405|FG005|COMPLETED|Third Intervention||5
10374503|NCT00572936|11515400|FG000|NOT COMPLETED|Third Intervention||0
10374504|NCT00572936|11515401|FG001|NOT COMPLETED|Third Intervention||0
10374505|NCT00572936|11515402|FG002|NOT COMPLETED|Third Intervention||0
10374506|NCT00572936|11515403|FG003|NOT COMPLETED|Third Intervention||0
10374507|NCT00572936|11515404|FG004|NOT COMPLETED|Third Intervention||0
10374508|NCT00572936|11515405|FG005|NOT COMPLETED|Third Intervention||0
10374509|NCT00573066|11515413|FG000|STARTED|Overall Study||56
10374510|NCT00573066|11515413|FG000|COMPLETED|Overall Study||36
10374511|NCT00573066|11515413|FG000|NOT COMPLETED|Overall Study||20
10374512|NCT00573144|11515419|FG000|STARTED|Overall Study||30
10374513|NCT00573144|11515420|FG001|STARTED|Overall Study||28
10374514|NCT00573144|11515419|FG000|COMPLETED|Overall Study||28
10374515|NCT00573144|11515420|FG001|COMPLETED|Overall Study||25
10374516|NCT00573144|11515419|FG000|NOT COMPLETED|Overall Study||2
10374517|NCT00573144|11515420|FG001|NOT COMPLETED|Overall Study||3
10374518|NCT00573170|11515426|FG000|STARTED|First Treatment Period||64
10374519|NCT00573170|11515427|FG001|STARTED|First Treatment Period||60
10374520|NCT00573170|11515428|FG002|STARTED|First Treatment Period||60
10374521|NCT00573170|11515429|FG003|STARTED|First Treatment Period||66
10374522|NCT00573170|11515430|FG004|STARTED|First Treatment Period||63
10374523|NCT00573170|11515431|FG005|STARTED|First Treatment Period||62
10538213|NCT01454102|11691063|FG001|STARTED|Overall Study||15
10538214|NCT01454102|11691064|FG002|STARTED|Overall Study||15
10538215|NCT01454102|11691065|FG003|STARTED|Overall Study||12
10538216|NCT01454102|11691066|FG004|STARTED|Overall Study||21
10538217|NCT01454102|11691067|FG005|STARTED|Overall Study||52
10538218|NCT01454102|11691068|FG006|STARTED|Overall Study||24
10374524|NCT00573170|11515426|FG000|COMPLETED|First Treatment Period||64
10374525|NCT00573170|11515427|FG001|COMPLETED|First Treatment Period||60
10374526|NCT00573170|11515428|FG002|COMPLETED|First Treatment Period||60
10374527|NCT00573170|11515429|FG003|COMPLETED|First Treatment Period||66
10374528|NCT00573170|11515430|FG004|COMPLETED|First Treatment Period||62
10374529|NCT00573170|11515431|FG005|COMPLETED|First Treatment Period||62
10538219|NCT01454102|11691069|FG007|STARTED|Overall Study||25
10538220|NCT01454102|11691070|FG008|STARTED|Overall Study||13
10538221|NCT01454102|11691071|FG009|STARTED|Overall Study||13
10538222|NCT01454102|11691072|FG010|STARTED|Overall Study||12
10538223|NCT01454102|11691073|FG011|STARTED|Overall Study||31
10374530|NCT00573170|11515426|FG000|NOT COMPLETED|First Treatment Period||0
10374531|NCT00573170|11515427|FG001|NOT COMPLETED|First Treatment Period||0
10374532|NCT00573170|11515428|FG002|NOT COMPLETED|First Treatment Period||0
10374533|NCT00573170|11515429|FG003|NOT COMPLETED|First Treatment Period||0
10374534|NCT00573170|11515430|FG004|NOT COMPLETED|First Treatment Period||1
10374535|NCT00573170|11515431|FG005|NOT COMPLETED|First Treatment Period||0
10374536|NCT00573170|11515426|FG000|STARTED|First Washout Period||64
10374537|NCT00573170|11515427|FG001|STARTED|First Washout Period||60
10374538|NCT00573170|11515428|FG002|STARTED|First Washout Period||60
10374539|NCT00573170|11515429|FG003|STARTED|First Washout Period||66
10374540|NCT00573170|11515430|FG004|STARTED|First Washout Period||62
10374541|NCT00573170|11515431|FG005|STARTED|First Washout Period||62
10374542|NCT00573170|11515426|FG000|COMPLETED|First Washout Period||56
10374543|NCT00573170|11515427|FG001|COMPLETED|First Washout Period||58
10374544|NCT00573170|11515428|FG002|COMPLETED|First Washout Period||59
10374545|NCT00573170|11515429|FG003|COMPLETED|First Washout Period||61
10374546|NCT00573170|11515430|FG004|COMPLETED|First Washout Period|Source data list 4 noncompleters; per number starting next period, there were only 3 noncompleters.|59
10374547|NCT00573170|11515431|FG005|COMPLETED|First Washout Period||55
10374548|NCT00573170|11515426|FG000|NOT COMPLETED|First Washout Period||8
10374549|NCT00573170|11515427|FG001|NOT COMPLETED|First Washout Period||2
10374550|NCT00573170|11515428|FG002|NOT COMPLETED|First Washout Period||1
10374551|NCT00573170|11515429|FG003|NOT COMPLETED|First Washout Period||5
10374552|NCT00573170|11515430|FG004|NOT COMPLETED|First Washout Period||3
10374553|NCT00573170|11515431|FG005|NOT COMPLETED|First Washout Period||7
10374554|NCT00573170|11515426|FG000|STARTED|Second Treatment Period||56
10374555|NCT00573170|11515427|FG001|STARTED|Second Treatment Period||58
10374556|NCT00573170|11515428|FG002|STARTED|Second Treatment Period||59
10374557|NCT00573170|11515429|FG003|STARTED|Second Treatment Period||61
10374558|NCT00573170|11515430|FG004|STARTED|Second Treatment Period||59
10374559|NCT00573170|11515431|FG005|STARTED|Second Treatment Period||55
10374560|NCT00573170|11515426|FG000|COMPLETED|Second Treatment Period||56
10374561|NCT00573170|11515427|FG001|COMPLETED|Second Treatment Period||58
10374562|NCT00573170|11515428|FG002|COMPLETED|Second Treatment Period||59
10374563|NCT00573170|11515429|FG003|COMPLETED|Second Treatment Period||61
10374564|NCT00573170|11515430|FG004|COMPLETED|Second Treatment Period||59
10374565|NCT00573170|11515431|FG005|COMPLETED|Second Treatment Period||55
10374566|NCT00573170|11515426|FG000|NOT COMPLETED|Second Treatment Period||0
10374567|NCT00573170|11515427|FG001|NOT COMPLETED|Second Treatment Period||0
10374568|NCT00573170|11515428|FG002|NOT COMPLETED|Second Treatment Period||0
10374569|NCT00573170|11515429|FG003|NOT COMPLETED|Second Treatment Period||0
10374570|NCT00573170|11515430|FG004|NOT COMPLETED|Second Treatment Period||0
10374571|NCT00573170|11515431|FG005|NOT COMPLETED|Second Treatment Period||0
10374572|NCT00573170|11515426|FG000|STARTED|Second Washout Period||56
10374573|NCT00573170|11515427|FG001|STARTED|Second Washout Period||58
10374574|NCT00573170|11515428|FG002|STARTED|Second Washout Period||59
10374575|NCT00573170|11515429|FG003|STARTED|Second Washout Period||61
10374576|NCT00573170|11515430|FG004|STARTED|Second Washout Period||59
10374577|NCT00573170|11515431|FG005|STARTED|Second Washout Period||55
10374578|NCT00573170|11515426|FG000|COMPLETED|Second Washout Period||51
10374579|NCT00573170|11515427|FG001|COMPLETED|Second Washout Period||54
10374580|NCT00573170|11515428|FG002|COMPLETED|Second Washout Period||55
10374581|NCT00573170|11515429|FG003|COMPLETED|Second Washout Period||56
10374582|NCT00573170|11515430|FG004|COMPLETED|Second Washout Period||51
10374583|NCT00573170|11515431|FG005|COMPLETED|Second Washout Period||53
10374584|NCT00573170|11515426|FG000|NOT COMPLETED|Second Washout Period||5
10374585|NCT00573170|11515427|FG001|NOT COMPLETED|Second Washout Period||4
10374586|NCT00573170|11515428|FG002|NOT COMPLETED|Second Washout Period||4
10374587|NCT00573170|11515429|FG003|NOT COMPLETED|Second Washout Period||5
10374588|NCT00573170|11515430|FG004|NOT COMPLETED|Second Washout Period||8
10374589|NCT00573170|11515431|FG005|NOT COMPLETED|Second Washout Period||2
10374590|NCT00573170|11515426|FG000|STARTED|Third Treatment Period||51
10374591|NCT00573170|11515427|FG001|STARTED|Third Treatment Period||54
10374592|NCT00573170|11515428|FG002|STARTED|Third Treatment Period||55
10374593|NCT00573170|11515429|FG003|STARTED|Third Treatment Period||56
10374594|NCT00573170|11515430|FG004|STARTED|Third Treatment Period||51
10374595|NCT00573170|11515431|FG005|STARTED|Third Treatment Period||53
10374596|NCT00573170|11515426|FG000|COMPLETED|Third Treatment Period||50
10374597|NCT00573170|11515427|FG001|COMPLETED|Third Treatment Period||54
10374598|NCT00573170|11515428|FG002|COMPLETED|Third Treatment Period||55
10374599|NCT00573170|11515429|FG003|COMPLETED|Third Treatment Period||56
10374600|NCT00573170|11515430|FG004|COMPLETED|Third Treatment Period||51
10374601|NCT00573170|11515431|FG005|COMPLETED|Third Treatment Period||51
10374602|NCT00573170|11515426|FG000|NOT COMPLETED|Third Treatment Period||1
10374603|NCT00573170|11515427|FG001|NOT COMPLETED|Third Treatment Period||0
10374604|NCT00573170|11515428|FG002|NOT COMPLETED|Third Treatment Period||0
10374605|NCT00573170|11515429|FG003|NOT COMPLETED|Third Treatment Period||0
10374606|NCT00573170|11515430|FG004|NOT COMPLETED|Third Treatment Period||0
10374607|NCT00573170|11515431|FG005|NOT COMPLETED|Third Treatment Period||2
10374608|NCT00573183|11515450|FG000|STARTED|Overall Study||234
10374609|NCT00573183|11515451|FG001|STARTED|Overall Study||237
10374610|NCT00573183|11515450|FG000|COMPLETED|Overall Study||162
10374611|NCT00573183|11515451|FG001|COMPLETED|Overall Study||174
10374612|NCT00573183|11515450|FG000|NOT COMPLETED|Overall Study||72
10374613|NCT00573183|11515451|FG001|NOT COMPLETED|Overall Study||63
10374614|NCT00573248|11515461|FG000|STARTED|Overall Study||40
10374615|NCT00573248|11515462|FG001|STARTED|Overall Study||38
10374616|NCT00573248|11515461|FG000|Nicotine Patches and Placebo Patches|Overall Study||25
10374617|NCT00573248|11515462|FG001|Nicotine Patches and Placebo Patches|Overall Study||27
10374618|NCT00573248|11515461|FG000|COMPLETED|Overall Study||25
10374619|NCT00573248|11515462|FG001|COMPLETED|Overall Study||27
10374620|NCT00573248|11515461|FG000|NOT COMPLETED|Overall Study||15
10374621|NCT00573248|11515462|FG001|NOT COMPLETED|Overall Study||11
10374622|NCT00573261|11515470|FG000|STARTED|Overall Study||20
10374623|NCT00573261|11515471|FG001|STARTED|Overall Study||20
10374624|NCT00573261|11515470|FG000|COMPLETED|Overall Study||14
10374625|NCT00573261|11515471|FG001|COMPLETED|Overall Study||15
10374626|NCT00573261|11515470|FG000|NOT COMPLETED|Overall Study||6
10374627|NCT00573261|11515471|FG001|NOT COMPLETED|Overall Study||5
10374628|NCT00573287|11515481|FG000|STARTED|Overall Study||7
10374629|NCT00573287|11515482|FG001|STARTED|Overall Study||7
10374630|NCT00573287|11515481|FG000|COMPLETED|Overall Study||3
10374631|NCT00573287|11515482|FG001|COMPLETED|Overall Study||4
10374632|NCT00573287|11515481|FG000|NOT COMPLETED|Overall Study||4
10374633|NCT00573287|11515482|FG001|NOT COMPLETED|Overall Study||3
10374634|NCT00573313|11515492|FG000|STARTED|Overall Study|Eighteen participants recruited to start.|18
10374635|NCT00573313|11515493|FG001|STARTED|Overall Study||28
10374636|NCT00573313|11515494|FG002|STARTED|Overall Study|Nineteen recruited to start.|19
10374637|NCT00573313|11515495|FG003|STARTED|Overall Study||26
10374638|NCT00573313|11515492|FG000|COMPLETED|Overall Study||13
10374639|NCT00573313|11515493|FG001|COMPLETED|Overall Study||28
10374640|NCT00573313|11515494|FG002|COMPLETED|Overall Study||13
10374641|NCT00573313|11515495|FG003|COMPLETED|Overall Study||26
10374642|NCT00573313|11515492|FG000|NOT COMPLETED|Overall Study||5
10374643|NCT00573313|11515493|FG001|NOT COMPLETED|Overall Study||0
10374644|NCT00573313|11515494|FG002|NOT COMPLETED|Overall Study||6
10374645|NCT00573313|11515495|FG003|NOT COMPLETED|Overall Study||0
10374646|NCT00573430|11515505|FG000|STARTED|Overall Study|randomized|40
10374647|NCT00573430|11515506|FG001|STARTED|Overall Study|randomized|45
10374648|NCT00573430|11515507|FG002|STARTED|Overall Study|randomized|43
10374649|NCT00573430|11515505|FG000|COMPLETED|Overall Study||39
10374650|NCT00573430|11515506|FG001|COMPLETED|Overall Study||40
10374651|NCT00573430|11515507|FG002|COMPLETED|Overall Study||33
10374652|NCT00573430|11515505|FG000|NOT COMPLETED|Overall Study||1
10374653|NCT00573430|11515506|FG001|NOT COMPLETED|Overall Study||5
10374654|NCT00573430|11515507|FG002|NOT COMPLETED|Overall Study||10
10374655|NCT00573443|11515518|FG000|STARTED|Double-Blind Phase||110
10374656|NCT00573443|11515519|FG001|STARTED|Double-Blind Phase||107
10374657|NCT00573443|11515520|FG002|STARTED|Double-Blind Phase||109
10374658|NCT00573443|11515518|FG000|Subjects With PBA Secondary to ALS|Double-Blind Phase||65
10374659|NCT00573443|11515519|FG001|Subjects With PBA Secondary to ALS|Double-Blind Phase||68
10374660|NCT00573443|11515520|FG002|Subjects With PBA Secondary to ALS|Double-Blind Phase||64
10374661|NCT00573443|11515518|FG000|Subjects With PBA Secondary to MS|Double-Blind Phase||45
10374662|NCT00573443|11515519|FG001|Subjects With PBA Secondary to MS|Double-Blind Phase||39
10374663|NCT00573443|11515520|FG002|Subjects With PBA Secondary to MS|Double-Blind Phase||45
10374664|NCT00573443|11515518|FG000|COMPLETED|Double-Blind Phase||101
10374665|NCT00573443|11515519|FG001|COMPLETED|Double-Blind Phase||88
10374666|NCT00573443|11515520|FG002|COMPLETED|Double-Blind Phase||94
10374667|NCT00573443|11515518|FG000|NOT COMPLETED|Double-Blind Phase||9
10374668|NCT00573443|11515519|FG001|NOT COMPLETED|Double-Blind Phase||19
10374669|NCT00573443|11515520|FG002|NOT COMPLETED|Double-Blind Phase||15
10812637|NCT03455556|11974756|FG000|STARTED|Overall Study||1
10374670|NCT00573443|11515518|FG000|STARTED|Open-Label Extension Phase|Subjects who completed any of the arms in the DB phase had the option to enroll in this OLE phase|253
10374671|NCT00573443|11515519|FG001|STARTED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
10374672|NCT00573443|11515520|FG002|STARTED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
10374673|NCT00573443|11515518|FG000|Subjects With PBA Secondary to ALS|Open-Label Extension Phase||146
10374674|NCT00573443|11515519|FG001|Subjects With PBA Secondary to ALS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
10812638|NCT03455556|11974756|FG000|COMPLETED|Overall Study||1
10812639|NCT03455556|11974756|FG000|NOT COMPLETED|Overall Study||0
10374675|NCT00573443|11515520|FG002|Subjects With PBA Secondary to ALS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
10374676|NCT00573443|11515518|FG000|Subjects With PBA Secondary to MS|Open-Label Extension Phase||107
10374677|NCT00573443|11515519|FG001|Subjects With PBA Secondary to MS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
10717117|NCT02696291|11881069|FG001|STARTED|Overall Study||2
10717118|NCT02696291|11881068|FG000|COMPLETED|Overall Study||5
10717119|NCT02696291|11881069|FG001|COMPLETED|Overall Study||2
10717120|NCT02696291|11881068|FG000|NOT COMPLETED|Overall Study||0
10717121|NCT02696291|11881069|FG001|NOT COMPLETED|Overall Study||0
10717122|NCT02696317|11881075|FG000|STARTED|Habitual, 10 Days of Wear||42
10717123|NCT02696317|11881076|FG001|STARTED|Habitual, 10 Days of Wear||40
10717124|NCT02696317|11881075|FG000|COMPLETED|Habitual, 10 Days of Wear||40
10717125|NCT02696317|11881076|FG001|COMPLETED|Habitual, 10 Days of Wear||36
10374678|NCT00573443|11515520|FG002|Subjects With PBA Secondary to MS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
10374679|NCT00573443|11515518|FG000|COMPLETED|Open-Label Extension Phase||235
10374680|NCT00573443|11515519|FG001|COMPLETED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
10374681|NCT00573443|11515520|FG002|COMPLETED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
10374682|NCT00573443|11515518|FG000|NOT COMPLETED|Open-Label Extension Phase||18
10374683|NCT00573443|11515519|FG001|NOT COMPLETED|Open-Label Extension Phase||0
10374684|NCT00573443|11515520|FG002|NOT COMPLETED|Open-Label Extension Phase||0
10374685|NCT00573469|11515532|FG000|STARTED|Overall Study||26
10374686|NCT00573469|11515533|FG001|STARTED|Overall Study||25
10538224|NCT01454102|11691074|FG012|STARTED|Overall Study||40
10538225|NCT01454102|11691075|FG013|STARTED|Overall Study||38
10538226|NCT01454102|11691076|FG014|STARTED|Overall Study||39
10538227|NCT01454102|11691077|FG015|STARTED|Overall Study||14
10538228|NCT01454102|11691062|FG000|COMPLETED|Overall Study||12
10538229|NCT01454102|11691063|FG001|COMPLETED|Overall Study||15
10538230|NCT01454102|11691064|FG002|COMPLETED|Overall Study||15
10538231|NCT01454102|11691065|FG003|COMPLETED|Overall Study||12
10538232|NCT01454102|11691066|FG004|COMPLETED|Overall Study||18
10538233|NCT01454102|11691067|FG005|COMPLETED|Overall Study||49
10538234|NCT01454102|11691068|FG006|COMPLETED|Overall Study||22
10538235|NCT01454102|11691069|FG007|COMPLETED|Overall Study||25
10538236|NCT01454102|11691070|FG008|COMPLETED|Overall Study||12
10538237|NCT01454102|11691071|FG009|COMPLETED|Overall Study||13
10538238|NCT01454102|11691072|FG010|COMPLETED|Overall Study||12
10538239|NCT01454102|11691073|FG011|COMPLETED|Overall Study||27
10538240|NCT01454102|11691074|FG012|COMPLETED|Overall Study||33
10538241|NCT01454102|11691075|FG013|COMPLETED|Overall Study||34
10538242|NCT01454102|11691076|FG014|COMPLETED|Overall Study||36
10538243|NCT01454102|11691077|FG015|COMPLETED|Overall Study||13
10538244|NCT01454102|11691062|FG000|NOT COMPLETED|Overall Study||0
10538245|NCT01454102|11691063|FG001|NOT COMPLETED|Overall Study||0
10538246|NCT01454102|11691064|FG002|NOT COMPLETED|Overall Study||0
10538247|NCT01454102|11691065|FG003|NOT COMPLETED|Overall Study||0
10538248|NCT01454102|11691066|FG004|NOT COMPLETED|Overall Study||3
10538249|NCT01454102|11691067|FG005|NOT COMPLETED|Overall Study||3
10538250|NCT01454102|11691068|FG006|NOT COMPLETED|Overall Study||2
10538251|NCT01454102|11691069|FG007|NOT COMPLETED|Overall Study||0
10538252|NCT01454102|11691070|FG008|NOT COMPLETED|Overall Study||1
10538253|NCT01454102|11691071|FG009|NOT COMPLETED|Overall Study||0
10538254|NCT01454102|11691072|FG010|NOT COMPLETED|Overall Study||0
10538255|NCT01454102|11691073|FG011|NOT COMPLETED|Overall Study||4
10538256|NCT01454102|11691074|FG012|NOT COMPLETED|Overall Study||7
10538257|NCT01454102|11691075|FG013|NOT COMPLETED|Overall Study||4
10657518|NCT02226653|11818725|FG000|COMPLETED|Washout Period 1 (at Least 21 Days)||24
10657519|NCT02226653|11818726|FG001|COMPLETED|Washout Period 1 (at Least 21 Days)||24
10657520|NCT02226653|11818725|FG000|NOT COMPLETED|Washout Period 1 (at Least 21 Days)||0
10657521|NCT02226653|11818726|FG001|NOT COMPLETED|Washout Period 1 (at Least 21 Days)||0
10657522|NCT02226653|11818725|FG000|STARTED|Treatment Period 2 Fasted State||24
10657523|NCT02226653|11818726|FG001|STARTED|Treatment Period 2 Fasted State||24
10657524|NCT02226653|11818725|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 2 Fasted State||24
10657525|NCT02226653|11818726|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 2 Fasted State||24
10657526|NCT02226653|11818725|FG000|COMPLETED|Treatment Period 2 Fasted State||23
10657527|NCT02226653|11818726|FG001|COMPLETED|Treatment Period 2 Fasted State||24
10657528|NCT02226653|11818725|FG000|NOT COMPLETED|Treatment Period 2 Fasted State||1
10657529|NCT02226653|11818726|FG001|NOT COMPLETED|Treatment Period 2 Fasted State||0
10657530|NCT02226653|11818725|FG000|STARTED|Washout Period 2 (at Least 21 Days)||23
10657531|NCT02226653|11818726|FG001|STARTED|Washout Period 2 (at Least 21 Days)||24
10657532|NCT02226653|11818725|FG000|COMPLETED|Washout Period 2 (at Least 21 Days)||23
10657533|NCT02226653|11818726|FG001|COMPLETED|Washout Period 2 (at Least 21 Days)||24
10657534|NCT02226653|11818725|FG000|NOT COMPLETED|Washout Period 2 (at Least 21 Days)||0
10657535|NCT02226653|11818726|FG001|NOT COMPLETED|Washout Period 2 (at Least 21 Days)||0
10717126|NCT02696317|11881075|FG000|NOT COMPLETED|Habitual, 10 Days of Wear||2
10717127|NCT02696317|11881076|FG001|NOT COMPLETED|Habitual, 10 Days of Wear||4
10717128|NCT02696317|11881075|FG000|STARTED|Period 1, 10 Days of Wear||40
10717129|NCT02696317|11881076|FG001|STARTED|Period 1, 10 Days of Wear||36
10717130|NCT02696317|11881075|FG000|COMPLETED|Period 1, 10 Days of Wear||40
10717131|NCT02696317|11881076|FG001|COMPLETED|Period 1, 10 Days of Wear||36
10717132|NCT02696317|11881075|FG000|NOT COMPLETED|Period 1, 10 Days of Wear||0
10374687|NCT00573469|11515534|FG002|STARTED|Overall Study||26
10374688|NCT00573469|11515532|FG000|COMPLETED|Overall Study||20
10374689|NCT00573469|11515533|FG001|COMPLETED|Overall Study||21
10374690|NCT00573469|11515534|FG002|COMPLETED|Overall Study||22
10374691|NCT00573469|11515532|FG000|NOT COMPLETED|Overall Study||6
10374692|NCT00573469|11515533|FG001|NOT COMPLETED|Overall Study||4
10374693|NCT00573469|11515534|FG002|NOT COMPLETED|Overall Study||4
10374694|NCT00573508|11515544|FG000|STARTED|Overall Study||382
10374695|NCT00573508|11515545|FG001|STARTED|Overall Study||386
10374696|NCT00573508|11515544|FG000|Full Analysis Set (FAS)|Overall Study|Patients who took >= 1 dose of double-blind study drug, had a baseline OAB-q & >= 1 subsequent visit|374
10374697|NCT00573508|11515545|FG001|Full Analysis Set (FAS)|Overall Study|Patients who took >= 1 dose of double-blind study drug, had a baseline OAB-q & >= 1 subsequent visit|377
10374698|NCT00573508|11515544|FG000|COMPLETED|Overall Study||318
10374699|NCT00573508|11515545|FG001|COMPLETED|Overall Study||345
10374700|NCT00573508|11515544|FG000|NOT COMPLETED|Overall Study||64
10374701|NCT00573508|11515545|FG001|NOT COMPLETED|Overall Study||41
10374702|NCT00573534|11515551|FG000|STARTED|Overall Study||8
10374703|NCT00573534|11515551|FG000|COMPLETED|Overall Study||5
10374704|NCT00573534|11515551|FG000|NOT COMPLETED|Overall Study||3
10374705|NCT00573755|11515558|FG000|STARTED|Overall Study||2
10374706|NCT00573755|11515559|FG001|STARTED|Overall Study||2
10374707|NCT00573755|11515558|FG000|COMPLETED|Overall Study||1
10374708|NCT00573755|11515559|FG001|COMPLETED|Overall Study||2
10374709|NCT00573755|11515558|FG000|NOT COMPLETED|Overall Study||1
10374710|NCT00573755|11515559|FG001|NOT COMPLETED|Overall Study||0
10374711|NCT00573768|11515568|FG000|STARTED|Overall Study||89
10374712|NCT00573768|11515569|FG001|STARTED|Overall Study||91
10374713|NCT00573768|11515570|FG002|STARTED|Overall Study||91
10374714|NCT00573768|11515568|FG000|COMPLETED|Overall Study||87
10374715|NCT00573768|11515569|FG001|COMPLETED|Overall Study||89
10374716|NCT00573768|11515570|FG002|COMPLETED|Overall Study||87
10374717|NCT00573768|11515568|FG000|NOT COMPLETED|Overall Study||2
10374718|NCT00573768|11515569|FG001|NOT COMPLETED|Overall Study||2
10374719|NCT00573768|11515570|FG002|NOT COMPLETED|Overall Study||4
10374720|NCT00573794|11515578|FG000|STARTED|Overall Study||585
10374721|NCT00573794|11515578|FG000|COMPLETED|Overall Study||255
10374722|NCT00573794|11515578|FG000|NOT COMPLETED|Overall Study||330
10374723|NCT00573833|11515582|FG000|STARTED|Overall Study||23
10374724|NCT00573833|11515582|FG000|COMPLETED|Overall Study||21
10374725|NCT00573833|11515582|FG000|NOT COMPLETED|Overall Study||2
10374726|NCT00573859|11515586|FG000|STARTED|Medication Versus Placebo||27
10374727|NCT00573859|11515586|FG000|COMPLETED|Medication Versus Placebo||15
10374728|NCT00573859|11515586|FG000|NOT COMPLETED|Medication Versus Placebo||12
10374729|NCT00573859|11515586|FG000|STARTED|Smoking Versus Abstinence||27
10374730|NCT00573859|11515586|FG000|COMPLETED|Smoking Versus Abstinence||15
10374731|NCT00573859|11515586|FG000|NOT COMPLETED|Smoking Versus Abstinence||12
10374732|NCT00573872|11515590|FG000|STARTED|Overall Study|# of patients that signed consent|43
10374733|NCT00573872|11515590|FG000|COMPLETED|Overall Study|# of patients that completed treatment|32
10374734|NCT00573872|11515590|FG000|NOT COMPLETED|Overall Study||11
10374735|NCT00573989|11515594|FG000|STARTED|Erlotinib Phase I||4
10374736|NCT00573989|11515595|FG001|STARTED|Erlotinib Phase I||6
10374737|NCT00573989|11515596|FG002|STARTED|Erlotinib Phase I||5
10374738|NCT00573989|11515597|FG003|STARTED|Erlotinib Phase I||0
10374739|NCT00573989|11515594|FG000|COMPLETED|Erlotinib Phase I||4
10374740|NCT00573989|11515595|FG001|COMPLETED|Erlotinib Phase I||6
10374741|NCT00573989|11515596|FG002|COMPLETED|Erlotinib Phase I||5
10374742|NCT00573989|11515597|FG003|COMPLETED|Erlotinib Phase I||0
10374743|NCT00573989|11515594|FG000|NOT COMPLETED|Erlotinib Phase I||0
10374744|NCT00573989|11515595|FG001|NOT COMPLETED|Erlotinib Phase I||0
10374745|NCT00573989|11515596|FG002|NOT COMPLETED|Erlotinib Phase I||0
10374746|NCT00573989|11515597|FG003|NOT COMPLETED|Erlotinib Phase I||0
10374747|NCT00573989|11515594|FG000|STARTED|Erlotinib 125mg- Phase II||0
10374748|NCT00573989|11515595|FG001|STARTED|Erlotinib 125mg- Phase II||0
10374749|NCT00573989|11515596|FG002|STARTED|Erlotinib 125mg- Phase II||0
10374750|NCT00573989|11515597|FG003|STARTED|Erlotinib 125mg- Phase II||12
10374751|NCT00573989|11515594|FG000|COMPLETED|Erlotinib 125mg- Phase II||0
10538258|NCT01454102|11691076|FG014|NOT COMPLETED|Overall Study||3
10374752|NCT00573989|11515595|FG001|COMPLETED|Erlotinib 125mg- Phase II||0
10374753|NCT00573989|11515596|FG002|COMPLETED|Erlotinib 125mg- Phase II||0
10374754|NCT00573989|11515597|FG003|COMPLETED|Erlotinib 125mg- Phase II||12
10374755|NCT00573989|11515594|FG000|NOT COMPLETED|Erlotinib 125mg- Phase II||0
10374756|NCT00573989|11515595|FG001|NOT COMPLETED|Erlotinib 125mg- Phase II||0
10374757|NCT00573989|11515596|FG002|NOT COMPLETED|Erlotinib 125mg- Phase II||0
10374758|NCT00573989|11515597|FG003|NOT COMPLETED|Erlotinib 125mg- Phase II||0
10374759|NCT00574067|11515608|FG000|STARTED|Overall Study||53
10374760|NCT00574067|11515609|FG001|STARTED|Overall Study||53
10374761|NCT00574067|11515610|FG002|STARTED|Overall Study||54
10374762|NCT00574067|11515611|FG003|STARTED|Overall Study||53
10374763|NCT00574067|11515608|FG000|COMPLETED|Overall Study||52
10374764|NCT00574067|11515609|FG001|COMPLETED|Overall Study||52
10374765|NCT00574067|11515610|FG002|COMPLETED|Overall Study||54
10374766|NCT00574067|11515611|FG003|COMPLETED|Overall Study||53
10374767|NCT00574067|11515608|FG000|NOT COMPLETED|Overall Study||1
10374768|NCT00574067|11515609|FG001|NOT COMPLETED|Overall Study||1
10374769|NCT00574067|11515610|FG002|NOT COMPLETED|Overall Study||0
10374770|NCT00574067|11515611|FG003|NOT COMPLETED|Overall Study||0
10374771|NCT00574119|11515625|FG000|STARTED|Overall Study||16
10374772|NCT00574119|11515625|FG000|COMPLETED|Overall Study||12
10717133|NCT02696317|11881076|FG001|NOT COMPLETED|Period 1, 10 Days of Wear||0
10717134|NCT02696317|11881075|FG000|STARTED|Period 2, 10 Days of Wear||40
10717135|NCT02696317|11881076|FG001|STARTED|Period 2, 10 Days of Wear||36
10717136|NCT02696317|11881075|FG000|COMPLETED|Period 2, 10 Days of Wear||39
10306391|NCT00098670|11439325|FG000|COMPLETED|Overall Study||102
10306392|NCT00098670|11439325|FG000|NOT COMPLETED|Overall Study||0
10306393|NCT00098722|11439333|FG000|STARTED|Double Blind Phase||186
10306394|NCT00098722|11439334|FG001|STARTED|Double Blind Phase||194
10306395|NCT00098722|11439335|FG002|STARTED|Double Blind Phase||94
10306396|NCT00098722|11439336|FG003|STARTED|Double Blind Phase||0
10306397|NCT00098722|11439337|FG004|STARTED|Double Blind Phase||0
10306398|NCT00098722|11439338|FG005|STARTED|Double Blind Phase||0
10306399|NCT00098722|11439339|FG006|STARTED|Double Blind Phase||0
10306400|NCT00098722|11439333|FG000|Treated|Double Blind Phase||182
10306401|NCT00098722|11439334|FG001|Treated|Double Blind Phase||191
10306402|NCT00098722|11439335|FG002|Treated|Double Blind Phase||91
10306403|NCT00098722|11439336|FG003|Treated|Double Blind Phase||0
10306404|NCT00098722|11439337|FG004|Treated|Double Blind Phase||0
10306405|NCT00098722|11439338|FG005|Treated|Double Blind Phase||0
10306406|NCT00098722|11439339|FG006|Treated|Double Blind Phase||0
10306407|NCT00098722|11439333|FG000|COMPLETED|Double Blind Phase||0
10306408|NCT00098722|11439334|FG001|COMPLETED|Double Blind Phase||0
10306409|NCT00098722|11439335|FG002|COMPLETED|Double Blind Phase||0
10306410|NCT00098722|11439336|FG003|COMPLETED|Double Blind Phase||0
10306411|NCT00098722|11439337|FG004|COMPLETED|Double Blind Phase||0
10306412|NCT00098722|11439338|FG005|COMPLETED|Double Blind Phase||0
10306413|NCT00098722|11439339|FG006|COMPLETED|Double Blind Phase||0
10306414|NCT00098722|11439333|FG000|NOT COMPLETED|Double Blind Phase||186
10306415|NCT00098722|11439334|FG001|NOT COMPLETED|Double Blind Phase||194
10306416|NCT00098722|11439335|FG002|NOT COMPLETED|Double Blind Phase||94
10306417|NCT00098722|11439336|FG003|NOT COMPLETED|Double Blind Phase||0
10306418|NCT00098722|11439337|FG004|NOT COMPLETED|Double Blind Phase||0
10306419|NCT00098722|11439338|FG005|NOT COMPLETED|Double Blind Phase||0
10306420|NCT00098722|11439339|FG006|NOT COMPLETED|Double Blind Phase||0
10306421|NCT00098722|11439333|FG000|STARTED|Open Label Phase||0
10306422|NCT00098722|11439334|FG001|STARTED|Open Label Phase||0
10306423|NCT00098722|11439335|FG002|STARTED|Open Label Phase||0
10306424|NCT00098722|11439336|FG003|STARTED|Open Label Phase||272
10306425|NCT00098722|11439337|FG004|STARTED|Open Label Phase||50
10306426|NCT00098722|11439338|FG005|STARTED|Open Label Phase||0
10306427|NCT00098722|11439339|FG006|STARTED|Open Label Phase||0
10306428|NCT00098722|11439333|FG000|COMPLETED|Open Label Phase||0
10306429|NCT00098722|11439334|FG001|COMPLETED|Open Label Phase||0
10306430|NCT00098722|11439335|FG002|COMPLETED|Open Label Phase||0
10306431|NCT00098722|11439336|FG003|COMPLETED|Open Label Phase||0
10306432|NCT00098722|11439337|FG004|COMPLETED|Open Label Phase||0
10306433|NCT00098722|11439338|FG005|COMPLETED|Open Label Phase||0
10306434|NCT00098722|11439339|FG006|COMPLETED|Open Label Phase||0
10306435|NCT00098722|11439333|FG000|NOT COMPLETED|Open Label Phase||0
10306436|NCT00098722|11439334|FG001|NOT COMPLETED|Open Label Phase||0
10306437|NCT00098722|11439335|FG002|NOT COMPLETED|Open Label Phase||0
10306438|NCT00098722|11439336|FG003|NOT COMPLETED|Open Label Phase||272
10306439|NCT00098722|11439337|FG004|NOT COMPLETED|Open Label Phase||50
10306440|NCT00098722|11439338|FG005|NOT COMPLETED|Open Label Phase||0
10306441|NCT00098722|11439339|FG006|NOT COMPLETED|Open Label Phase||0
10306442|NCT00098722|11439333|FG000|STARTED|Observation Phase||0
10306443|NCT00098722|11439334|FG001|STARTED|Observation Phase||0
10306444|NCT00098722|11439335|FG002|STARTED|Observation Phase||0
10306445|NCT00098722|11439336|FG003|STARTED|Observation Phase||0
10306446|NCT00098722|11439337|FG004|STARTED|Observation Phase||0
10306447|NCT00098722|11439338|FG005|STARTED|Observation Phase||205
10306448|NCT00098722|11439339|FG006|STARTED|Observation Phase||65
10306449|NCT00098722|11439333|FG000|COMPLETED|Observation Phase||0
10306450|NCT00098722|11439334|FG001|COMPLETED|Observation Phase||0
10717137|NCT02696317|11881076|FG001|COMPLETED|Period 2, 10 Days of Wear||36
10717138|NCT02696317|11881075|FG000|NOT COMPLETED|Period 2, 10 Days of Wear||1
10374773|NCT00574119|11515625|FG000|NOT COMPLETED|Overall Study||4
10374774|NCT00574145|11515631|FG000|STARTED|Overall Study||22
10374775|NCT00574145|11515632|FG001|STARTED|Overall Study||22
10374776|NCT00574145|11515631|FG000|COMPLETED|Overall Study||20
10374777|NCT00574145|11515632|FG001|COMPLETED|Overall Study||21
10374778|NCT00574145|11515631|FG000|NOT COMPLETED|Overall Study||2
10374779|NCT00574145|11515632|FG001|NOT COMPLETED|Overall Study||1
10374780|NCT00574171|11515638|FG000|STARTED|Overall Study||29
10374781|NCT00574171|11515638|FG000|COMPLETED|Overall Study||29
10374782|NCT00574171|11515638|FG000|NOT COMPLETED|Overall Study||0
10374783|NCT00574197|11515642|FG000|STARTED|Overall Study||11
10374784|NCT00574197|11515642|FG000|COMPLETED|Overall Study||6
10374785|NCT00574197|11515642|FG000|NOT COMPLETED|Overall Study||5
10374786|NCT00574236|11515646|FG000|STARTED|Overall Study||4
10374787|NCT00574236|11515646|FG000|COMPLETED|Overall Study||4
10374788|NCT00574236|11515646|FG000|NOT COMPLETED|Overall Study||0
10374789|NCT00574249|11515652|FG000|STARTED|Overall Study||364
10374790|NCT00574249|11515653|FG001|STARTED|Overall Study||366
10374791|NCT00574249|11515652|FG000|COMPLETED|Overall Study||338
10374792|NCT00574249|11515653|FG001|COMPLETED|Overall Study||338
10374793|NCT00574249|11515652|FG000|NOT COMPLETED|Overall Study||26
10374794|NCT00574249|11515653|FG001|NOT COMPLETED|Overall Study||28
10374795|NCT00574275|11515661|FG000|STARTED|Overall Study||275
10374796|NCT00574275|11515662|FG001|STARTED|Overall Study||271
10374797|NCT00574275|11515661|FG000|TREATED|Overall Study||273
10374798|NCT00574275|11515662|FG001|TREATED|Overall Study||268
10374799|NCT00574275|11515661|FG000|SAFETY POPULATION|Overall Study|Excludes 2 participants who received 1 dose of Aflibercept|271
10374800|NCT00574275|11515662|FG001|SAFETY POPULATION|Overall Study|Includes 2 participants from the Placebo and Gemcitabine arm who received 1 dose of Aflibercept|270
10374801|NCT00574275|11515661|FG000|COMPLETED|Overall Study|All participants stopped when they met treatment discontinuation criteria or by DMC recommendation|0
10374802|NCT00574275|11515662|FG001|COMPLETED|Overall Study|All participants stopped when they met treatment discontinuation criteria or by DMC recommendation|0
10374803|NCT00574275|11515661|FG000|NOT COMPLETED|Overall Study||275
10374804|NCT00574275|11515662|FG001|NOT COMPLETED|Overall Study||271
10374805|NCT00574288|11515675|FG000|STARTED|Overall Study||20
10374806|NCT00574288|11515676|FG001|STARTED|Overall Study||3
10374807|NCT00574288|11515677|FG002|STARTED|Overall Study||3
10374808|NCT00574288|11515678|FG003|STARTED|Overall Study||3
10374809|NCT00574288|11515679|FG004|STARTED|Overall Study||3
10374810|NCT00574288|11515680|FG005|STARTED|Overall Study||30
10374811|NCT00574288|11515681|FG006|STARTED|Overall Study||42
10374812|NCT00574288|11515675|FG000|COMPLETED|Overall Study||0
10374813|NCT00574288|11515676|FG001|COMPLETED|Overall Study||0
10374814|NCT00574288|11515677|FG002|COMPLETED|Overall Study||0
10374815|NCT00574288|11515678|FG003|COMPLETED|Overall Study||1
10374816|NCT00574288|11515679|FG004|COMPLETED|Overall Study||1
10374817|NCT00574288|11515680|FG005|COMPLETED|Overall Study||4
10374818|NCT00574288|11515681|FG006|COMPLETED|Overall Study||14
10374819|NCT00574288|11515675|FG000|NOT COMPLETED|Overall Study||20
10374820|NCT00574288|11515676|FG001|NOT COMPLETED|Overall Study||3
10374821|NCT00574288|11515677|FG002|NOT COMPLETED|Overall Study||3
10374822|NCT00574288|11515678|FG003|NOT COMPLETED|Overall Study||2
10374823|NCT00574288|11515679|FG004|NOT COMPLETED|Overall Study||2
10374824|NCT00574288|11515680|FG005|NOT COMPLETED|Overall Study||26
10374825|NCT00574288|11515681|FG006|NOT COMPLETED|Overall Study||28
10374826|NCT00574340|11515707|FG000|STARTED|Study 1 (2 Days)||10
10538259|NCT01454102|11691077|FG015|NOT COMPLETED|Overall Study||1
10538260|NCT01454258|11691112|FG000|STARTED|Overall Study||10100
10538261|NCT01454258|11691112|FG000|COMPLETED|Overall Study||9103
10538262|NCT01454258|11691112|FG000|NOT COMPLETED|Overall Study||997
10538263|NCT01454284|11691120|FG000|STARTED|Overall Study||664
10538264|NCT01454284|11691121|FG001|STARTED|Overall Study||450
10538265|NCT01454284|11691120|FG000|Received at Least 1 Dose of Study Drug|Overall Study||663
10538266|NCT01454284|11691121|FG001|Received at Least 1 Dose of Study Drug|Overall Study||449
10538267|NCT01454284|11691120|FG000|COMPLETED|Overall Study||548
10538268|NCT01454284|11691121|FG001|COMPLETED|Overall Study||377
10538269|NCT01454284|11691120|FG000|NOT COMPLETED|Overall Study||116
10538270|NCT01454284|11691121|FG001|NOT COMPLETED|Overall Study||73
10538271|NCT01454362|11691129|FG000|STARTED|Overall Study||28
10538272|NCT01454362|11691130|FG001|STARTED|Overall Study||23
10538273|NCT01454362|11691129|FG000|COMPLETED|Overall Study||28
10538274|NCT01454362|11691130|FG001|COMPLETED|Overall Study||23
10538275|NCT01454362|11691129|FG000|NOT COMPLETED|Overall Study||0
10374827|NCT00574340|11515708|FG001|STARTED|Study 1 (2 Days)||10
10374828|NCT00574340|11515707|FG000|COMPLETED|Study 1 (2 Days)||10
10374829|NCT00574340|11515708|FG001|COMPLETED|Study 1 (2 Days)||10
10374830|NCT00574340|11515707|FG000|NOT COMPLETED|Study 1 (2 Days)||0
10374831|NCT00574340|11515708|FG001|NOT COMPLETED|Study 1 (2 Days)||0
10374832|NCT00574340|11515707|FG000|STARTED|Study 2 (2 Days)||6
10538276|NCT01454362|11691130|FG001|NOT COMPLETED|Overall Study||0
10538277|NCT01454401|11691138|FG000|STARTED|Overall Study|ITT|44
10657536|NCT02226653|11818725|FG000|STARTED|Treatment Period 3 Fasted State||23
10374833|NCT00574340|11515708|FG001|STARTED|Study 2 (2 Days)||6
10374834|NCT00574340|11515707|FG000|COMPLETED|Study 2 (2 Days)||6
10374835|NCT00574340|11515708|FG001|COMPLETED|Study 2 (2 Days)||6
10374836|NCT00574340|11515707|FG000|NOT COMPLETED|Study 2 (2 Days)||0
10374837|NCT00574340|11515708|FG001|NOT COMPLETED|Study 2 (2 Days)||0
10374838|NCT00574405|11515716|FG000|STARTED|Overall Study||12
10374839|NCT00574405|11515717|FG001|STARTED|Overall Study||12
10538278|NCT01454401|11691138|FG000|COMPLETED|Overall Study|Per Protocol (PP)|39
10374840|NCT00574405|11515716|FG000|COMPLETED|Overall Study||9
10374841|NCT00574405|11515717|FG001|COMPLETED|Overall Study||10
10374842|NCT00574405|11515716|FG000|NOT COMPLETED|Overall Study||3
10374843|NCT00574405|11515717|FG001|NOT COMPLETED|Overall Study||2
10374844|NCT00574548|11515725|FG000|STARTED|Overall Study||482
10374845|NCT00574548|11515726|FG001|STARTED|Overall Study||238
10374846|NCT00574548|11515725|FG000|Received Vaccination 1 (Vax 1)|Overall Study||478
10374847|NCT00574548|11515726|FG001|Received Vaccination 1 (Vax 1)|Overall Study||237
10374848|NCT00574548|11515725|FG000|Completed Vax 1 (6 Month Contact)|Overall Study||468
10374849|NCT00574548|11515726|FG001|Completed Vax 1 (6 Month Contact)|Overall Study||234
10374850|NCT00574548|11515725|FG000|Withdrawn After Vax 1 (6 Month Contact)|Overall Study||7
10374851|NCT00574548|11515726|FG001|Withdrawn After Vax 1 (6 Month Contact)|Overall Study||3
10538279|NCT01454401|11691138|FG000|NOT COMPLETED|Overall Study||5
10538280|NCT01454414|11691144|FG000|STARTED|Overall Study||79
10538281|NCT01454414|11691145|FG001|STARTED|Overall Study||80
10538282|NCT01454414|11691144|FG000|Baseline: Subjects That Sent Uniforms|Overall Study||67
10538283|NCT01454414|11691145|FG001|Baseline: Subjects That Sent Uniforms|Overall Study||66
10538284|NCT01454414|11691144|FG000|COMPLETED|Overall Study||66
10538285|NCT01454414|11691145|FG001|COMPLETED|Overall Study||64
10538286|NCT01454414|11691144|FG000|NOT COMPLETED|Overall Study||13
10538287|NCT01454414|11691145|FG001|NOT COMPLETED|Overall Study||16
10538288|NCT01454505|11691154|FG000|STARTED|Overall Study||35
10538289|NCT01454505|11691155|FG001|STARTED|Overall Study||15
10538290|NCT01454505|11691156|FG002|STARTED|Overall Study||40
10538291|NCT01454505|11691157|FG003|STARTED|Overall Study||20
10538292|NCT01454505|11691154|FG000|COMPLETED|Overall Study||35
10538293|NCT01454505|11691155|FG001|COMPLETED|Overall Study||15
10538294|NCT01454505|11691156|FG002|COMPLETED|Overall Study||40
10717139|NCT02696317|11881076|FG001|NOT COMPLETED|Period 2, 10 Days of Wear||0
10717140|NCT02696434|11881086|FG000|STARTED|Overall Study||50
10717141|NCT02696434|11881087|FG001|STARTED|Overall Study||51
10538295|NCT01454505|11691157|FG003|COMPLETED|Overall Study||20
10538296|NCT01454505|11691154|FG000|NOT COMPLETED|Overall Study||0
10538297|NCT01454505|11691155|FG001|NOT COMPLETED|Overall Study||0
10538298|NCT01454505|11691156|FG002|NOT COMPLETED|Overall Study||0
10538299|NCT01454505|11691157|FG003|NOT COMPLETED|Overall Study||0
10538300|NCT01454531|11691167|FG000|STARTED|Overall Study||196
10538301|NCT01454531|11691167|FG000|Subjects Treated|Overall Study||192
10538302|NCT01454531|11691167|FG000|COMPLETED|Overall Study||173
10538303|NCT01454531|11691167|FG000|NOT COMPLETED|Overall Study||23
10538304|NCT01454570|11691171|FG000|STARTED|Overall Study||19
10538305|NCT01454570|11691171|FG000|COMPLETED|Overall Study||10
10538306|NCT01454570|11691171|FG000|NOT COMPLETED|Overall Study||9
10538307|NCT01454583|11691178|FG000|STARTED|1st Year|From initially 15337 pat. 351 withdrawed from the registry, 14986 pat. were assigned to the groups.|10177
10657537|NCT02226653|11818726|FG001|STARTED|Treatment Period 3 Fasted State||24
10657538|NCT02226653|11818725|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 3 Fasted State||23
10657539|NCT02226653|11818726|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 3 Fasted State||24
10657540|NCT02226653|11818725|FG000|COMPLETED|Treatment Period 3 Fasted State||23
10717142|NCT02696434|11881086|FG000|COMPLETED|Overall Study||28
10657541|NCT02226653|11818726|FG001|COMPLETED|Treatment Period 3 Fasted State||24
10657542|NCT02226653|11818725|FG000|NOT COMPLETED|Treatment Period 3 Fasted State||0
10657543|NCT02226653|11818726|FG001|NOT COMPLETED|Treatment Period 3 Fasted State||0
10657544|NCT02226653|11818725|FG000|STARTED|Washout Period 3 (at Least 21 Days)||23
10657545|NCT02226653|11818726|FG001|STARTED|Washout Period 3 (at Least 21 Days)||24
10657546|NCT02226653|11818725|FG000|COMPLETED|Washout Period 3 (at Least 21 Days)||23
10717143|NCT02696434|11881087|FG001|COMPLETED|Overall Study||33
10717144|NCT02696434|11881086|FG000|NOT COMPLETED|Overall Study||22
10374852|NCT00574548|11515725|FG000|Withdrawn Before Vax 2|Overall Study||41
10374853|NCT00574548|11515726|FG001|Withdrawn Before Vax 2|Overall Study||11
10374854|NCT00574548|11515725|FG000|Received Vax 2|Overall Study||427
10374855|NCT00574548|11515726|FG001|Received Vax 2|Overall Study||223
10538308|NCT01454583|11691179|FG001|STARTED|1st Year||2696
10538309|NCT01454583|11691180|FG002|STARTED|1st Year||2113
10538310|NCT01454583|11691178|FG000|COMPLETED|1st Year||9120
10538311|NCT01454583|11691179|FG001|COMPLETED|1st Year||2378
10657547|NCT02226653|11818726|FG001|COMPLETED|Washout Period 3 (at Least 21 Days)||24
10374856|NCT00574548|11515725|FG000|Completed Vax 2 (6 Month Contact)|Overall Study||421
10374857|NCT00574548|11515726|FG001|Completed Vax 2 (6 Month Contact)|Overall Study||222
10374858|NCT00574548|11515725|FG000|COMPLETED|Overall Study||421
10374859|NCT00574548|11515726|FG001|COMPLETED|Overall Study||222
10374860|NCT00574548|11515725|FG000|NOT COMPLETED|Overall Study||61
10374861|NCT00574548|11515726|FG001|NOT COMPLETED|Overall Study||16
10374862|NCT00574587|11515754|FG000|STARTED|Overall Study||3
10374863|NCT00574587|11515755|FG001|STARTED|Overall Study||23
10374864|NCT00574587|11515756|FG002|STARTED|Overall Study||16
10374865|NCT00574587|11515757|FG003|STARTED|Overall Study||13
10374866|NCT00574587|11515754|FG000|COMPLETED|Overall Study||3
10374867|NCT00574587|11515755|FG001|COMPLETED|Overall Study||23
10374868|NCT00574587|11515756|FG002|COMPLETED|Overall Study||16
10374869|NCT00574587|11515757|FG003|COMPLETED|Overall Study||13
10374870|NCT00574587|11515754|FG000|NOT COMPLETED|Overall Study||0
10374871|NCT00574587|11515755|FG001|NOT COMPLETED|Overall Study||0
10374872|NCT00574587|11515756|FG002|NOT COMPLETED|Overall Study||0
10374873|NCT00574587|11515757|FG003|NOT COMPLETED|Overall Study||0
10374874|NCT00574704|11515772|FG000|STARTED|Overall Study||10
10374875|NCT00574704|11515773|FG001|STARTED|Overall Study||10
10374876|NCT00574704|11515774|FG002|STARTED|Overall Study||10
10374877|NCT00574704|11515775|FG003|STARTED|Overall Study||10
10374878|NCT00574704|11515772|FG000|COMPLETED|Overall Study||10
10374879|NCT00574704|11515773|FG001|COMPLETED|Overall Study||10
10374880|NCT00574704|11515774|FG002|COMPLETED|Overall Study||9
10374881|NCT00574704|11515775|FG003|COMPLETED|Overall Study||10
10374882|NCT00574704|11515772|FG000|NOT COMPLETED|Overall Study||0
10374883|NCT00574704|11515773|FG001|NOT COMPLETED|Overall Study||0
10374884|NCT00574704|11515774|FG002|NOT COMPLETED|Overall Study||1
10374885|NCT00574704|11515775|FG003|NOT COMPLETED|Overall Study||0
10374886|NCT00574795|11515785|FG000|STARTED|Infant Series||193
10374887|NCT00574795|11515785|FG000|Vaccinated Dose 1|Infant Series||193
10374888|NCT00574795|11515785|FG000|Vaccinated Dose 2|Infant Series||190
10374889|NCT00574795|11515785|FG000|Vaccinated Dose 3|Infant Series||190
10374890|NCT00574795|11515785|FG000|COMPLETED|Infant Series||188
10374891|NCT00574795|11515785|FG000|NOT COMPLETED|Infant Series||5
10374892|NCT00574795|11515785|FG000|STARTED|After Infant Series||188
10374893|NCT00574795|11515785|FG000|COMPLETED|After Infant Series||185
10374894|NCT00574795|11515785|FG000|NOT COMPLETED|After Infant Series||3
10374895|NCT00574795|11515785|FG000|STARTED|Toddler Dose||185
10374896|NCT00574795|11515785|FG000|COMPLETED|Toddler Dose||184
10374897|NCT00574795|11515785|FG000|NOT COMPLETED|Toddler Dose||1
10374898|NCT00574834|11515803|FG000|STARTED|Overall Study||9
10374899|NCT00574834|11515804|FG001|STARTED|Overall Study||4
10374900|NCT00574834|11515805|FG002|STARTED|Overall Study||4
10374901|NCT00574834|11515803|FG000|COMPLETED|Overall Study||9
10374902|NCT00574834|11515804|FG001|COMPLETED|Overall Study||4
10374903|NCT00574834|11515805|FG002|COMPLETED|Overall Study||4
10717145|NCT02696434|11881087|FG001|NOT COMPLETED|Overall Study||18
10657548|NCT02226653|11818725|FG000|NOT COMPLETED|Washout Period 3 (at Least 21 Days)||0
10657549|NCT02226653|11818726|FG001|NOT COMPLETED|Washout Period 3 (at Least 21 Days)||0
10657550|NCT02226653|11818725|FG000|STARTED|Treatment Period 4 Fasted State||23
10657551|NCT02226653|11818726|FG001|STARTED|Treatment Period 4 Fasted State||24
10657552|NCT02226653|11818725|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 4 Fasted State||23
10657553|NCT02226653|11818726|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 4 Fasted State||24
10657554|NCT02226653|11818725|FG000|COMPLETED|Treatment Period 4 Fasted State||23
10657555|NCT02226653|11818726|FG001|COMPLETED|Treatment Period 4 Fasted State||24
10657556|NCT02226653|11818725|FG000|NOT COMPLETED|Treatment Period 4 Fasted State||0
10657557|NCT02226653|11818726|FG001|NOT COMPLETED|Treatment Period 4 Fasted State||0
10657558|NCT02226653|11818725|FG000|STARTED|Washout Period 4 (at Least 21 Days)||23
10657559|NCT02226653|11818726|FG001|STARTED|Washout Period 4 (at Least 21 Days)||24
10374904|NCT00574834|11515803|FG000|NOT COMPLETED|Overall Study||0
10374905|NCT00574834|11515804|FG001|NOT COMPLETED|Overall Study||0
10374906|NCT00574834|11515805|FG002|NOT COMPLETED|Overall Study||0
10374907|NCT00574847|11515815|FG000|STARTED|Overall Study||64
10374908|NCT00574847|11515816|FG001|STARTED|Overall Study||63
10374909|NCT00574847|11515815|FG000|COMPLETED|Overall Study||56
10374910|NCT00574847|11515816|FG001|COMPLETED|Overall Study||56
10374911|NCT00574847|11515815|FG000|NOT COMPLETED|Overall Study||8
10374912|NCT00574847|11515816|FG001|NOT COMPLETED|Overall Study||7
10374913|NCT00574873|11515824|FG000|STARTED|Overall Study||250
10374914|NCT00574873|11515825|FG001|STARTED|Overall Study||252
10657560|NCT02226653|11818725|FG000|COMPLETED|Washout Period 4 (at Least 21 Days)||23
10717146|NCT02696785|11881097|FG000|STARTED|Blinded Treatment Period||87
10717147|NCT02696785|11881098|FG001|STARTED|Blinded Treatment Period||90
10717148|NCT02696785|11881099|FG002|STARTED|Blinded Treatment Period||83
10717149|NCT02696785|11881100|FG003|STARTED|Blinded Treatment Period||81
10374985|NCT00575185|11515916|FG001|NOT COMPLETED|Overall Study||0
10717150|NCT02696785|11881097|FG000|Received at Least One Dose of Study Drug|Blinded Treatment Period||86
10717151|NCT02696785|11881098|FG001|Received at Least One Dose of Study Drug|Blinded Treatment Period||90
10717152|NCT02696785|11881099|FG002|Received at Least One Dose of Study Drug|Blinded Treatment Period||83
10717153|NCT02696785|11881100|FG003|Received at Least One Dose of Study Drug|Blinded Treatment Period||81
10717154|NCT02696785|11881097|FG000|COMPLETED|Blinded Treatment Period||86
10717155|NCT02696785|11881098|FG001|COMPLETED|Blinded Treatment Period||88
10717156|NCT02696785|11881099|FG002|COMPLETED|Blinded Treatment Period||79
10717157|NCT02696785|11881100|FG003|COMPLETED|Blinded Treatment Period||78
10717158|NCT02696785|11881097|FG000|NOT COMPLETED|Blinded Treatment Period||1
10374915|NCT00574873|11515824|FG000|Treated|Overall Study||248
10374916|NCT00574873|11515825|FG001|Treated|Overall Study||251
10374917|NCT00574873|11515824|FG000|COMPLETED|Overall Study||12
10374918|NCT00574873|11515825|FG001|COMPLETED|Overall Study||1
10374919|NCT00574873|11515824|FG000|NOT COMPLETED|Overall Study||238
10374920|NCT00574873|11515825|FG001|NOT COMPLETED|Overall Study||251
10374921|NCT00574912|11515831|FG000|STARTED|Overall Study||20
10374922|NCT00574912|11515831|FG000|Completed Placebo|Overall Study|12 original participants started the trial.|12
10374923|NCT00574912|11515831|FG000|Completed 0.5|Overall Study||12
10374924|NCT00574912|11515831|FG000|Completed 1.0|Overall Study||12
10374925|NCT00574912|11515831|FG000|Completed 1.5|Overall Study||12
10374926|NCT00574912|11515831|FG000|Completed 2.0|Overall Study||12
10374927|NCT00574912|11515831|FG000|COMPLETED|Overall Study||12
10374928|NCT00574912|11515831|FG000|NOT COMPLETED|Overall Study||8
10374929|NCT00574951|11515843|FG000|STARTED|Overall Study||23
10374930|NCT00574951|11515843|FG000|COMPLETED|Overall Study||22
10374931|NCT00574951|11515843|FG000|NOT COMPLETED|Overall Study||1
10374932|NCT00574990|11515850|FG000|STARTED|Overall Study||12
10374933|NCT00574990|11515851|FG001|STARTED|Overall Study||19
10374934|NCT00574990|11515852|FG002|STARTED|Overall Study||8
10374935|NCT00574990|11515850|FG000|COMPLETED|Overall Study||12
10374936|NCT00574990|11515851|FG001|COMPLETED|Overall Study||19
10374937|NCT00574990|11515852|FG002|COMPLETED|Overall Study||8
10374938|NCT00574990|11515850|FG000|NOT COMPLETED|Overall Study||0
10374939|NCT00574990|11515851|FG001|NOT COMPLETED|Overall Study||0
10374940|NCT00574990|11515852|FG002|NOT COMPLETED|Overall Study||0
10374941|NCT00575016|11515867|FG000|STARTED|Treatment Cycle 1||17
10374942|NCT00575016|11515868|FG001|STARTED|Treatment Cycle 1||21
10374943|NCT00575016|11515869|FG002|STARTED|Treatment Cycle 1||19
10374944|NCT00575016|11515870|FG003|STARTED|Treatment Cycle 1|1 pt randomized to Placebo never received treatment|17
10374945|NCT00575016|11515867|FG000|COMPLETED|Treatment Cycle 1|3 pts from 200U group entered Cycle 2|8
10374946|NCT00575016|11515868|FG001|COMPLETED|Treatment Cycle 1|11 pts from 100U group entered Cycle 2|16
10374947|NCT00575016|11515869|FG002|COMPLETED|Treatment Cycle 1|8 pts from 50U group entered Cycle 2|15
10374948|NCT00575016|11515870|FG003|COMPLETED|Treatment Cycle 1|9 pts from Placebo group entered Cycle 2|12
10374949|NCT00575016|11515867|FG000|NOT COMPLETED|Treatment Cycle 1||9
10374950|NCT00575016|11515868|FG001|NOT COMPLETED|Treatment Cycle 1||5
10374951|NCT00575016|11515869|FG002|NOT COMPLETED|Treatment Cycle 1||4
10374952|NCT00575016|11515870|FG003|NOT COMPLETED|Treatment Cycle 1||5
10374953|NCT00575016|11515867|FG000|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|31
10374954|NCT00575016|11515868|FG001|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
10374955|NCT00575016|11515869|FG002|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
10374956|NCT00575016|11515870|FG003|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
10374957|NCT00575016|11515867|FG000|COMPLETED|Treatment Cycle 2||30
10374958|NCT00575016|11515868|FG001|COMPLETED|Treatment Cycle 2||0
10374959|NCT00575016|11515869|FG002|COMPLETED|Treatment Cycle 2||0
10374960|NCT00575016|11515870|FG003|COMPLETED|Treatment Cycle 2||0
10374961|NCT00575016|11515867|FG000|NOT COMPLETED|Treatment Cycle 2||1
10374962|NCT00575016|11515868|FG001|NOT COMPLETED|Treatment Cycle 2||0
10374963|NCT00575016|11515869|FG002|NOT COMPLETED|Treatment Cycle 2||0
10374964|NCT00575016|11515870|FG003|NOT COMPLETED|Treatment Cycle 2||0
10374965|NCT00575029|11515880|FG000|STARTED|Overall Study||7
10374966|NCT00575029|11515880|FG000|COMPLETED|Overall Study||7
10374967|NCT00575029|11515880|FG000|NOT COMPLETED|Overall Study||0
10374968|NCT00575042|11515884|FG000|STARTED|Overall Study||20
10374969|NCT00575042|11515884|FG000|COMPLETED|Overall Study|2 with side effects and 1 lost to follow-up|17
10374970|NCT00575042|11515884|FG000|NOT COMPLETED|Overall Study||3
10374971|NCT00575094|11515889|FG000|STARTED|Overall Study||9
10374972|NCT00575094|11515889|FG000|COMPLETED|Overall Study||6
10374973|NCT00575094|11515889|FG000|NOT COMPLETED|Overall Study||3
10374974|NCT00575146|11515893|FG000|STARTED|Overall Study||20
10374975|NCT00575146|11515893|FG000|COMPLETED|Overall Study||17
10374976|NCT00575146|11515893|FG000|NOT COMPLETED|Overall Study||3
10374977|NCT00575159|11515897|FG000|STARTED|Overall Study||10
10374978|NCT00575159|11515897|FG000|COMPLETED|Overall Study||10
10374979|NCT00575159|11515897|FG000|NOT COMPLETED|Overall Study||0
10374980|NCT00575185|11515915|FG000|STARTED|Overall Study||12
10374981|NCT00575185|11515916|FG001|STARTED|Overall Study||11
10717159|NCT02696785|11881098|FG001|NOT COMPLETED|Blinded Treatment Period||2
10717160|NCT02696785|11881099|FG002|NOT COMPLETED|Blinded Treatment Period||4
10717161|NCT02696785|11881100|FG003|NOT COMPLETED|Blinded Treatment Period||3
10717162|NCT02696785|11881097|FG000|STARTED|Washout Period|Washout period occurred only for Adalimumab group.|0
10374982|NCT00575185|11515915|FG000|COMPLETED|Overall Study||12
10374983|NCT00575185|11515916|FG001|COMPLETED|Overall Study||11
10374984|NCT00575185|11515915|FG000|NOT COMPLETED|Overall Study||0
10374986|NCT00575328|11515926|FG000|STARTED|Overall Study||4
10374987|NCT00575328|11515927|FG001|STARTED|Overall Study||4
10374988|NCT00575328|11515926|FG000|COMPLETED|Overall Study||1
10374989|NCT00575328|11515927|FG001|COMPLETED|Overall Study||2
10374990|NCT00575328|11515926|FG000|NOT COMPLETED|Overall Study||3
10374991|NCT00575328|11515927|FG001|NOT COMPLETED|Overall Study||2
10374992|NCT00575367|11515935|FG000|STARTED|Overall Study||19
10374993|NCT00575367|11515936|FG001|STARTED|Overall Study||18
10374994|NCT00575367|11515935|FG000|COMPLETED|Overall Study||19
10374995|NCT00575367|11515936|FG001|COMPLETED|Overall Study||18
10374996|NCT00575367|11515935|FG000|NOT COMPLETED|Overall Study||0
10374997|NCT00575367|11515936|FG001|NOT COMPLETED|Overall Study||0
10374998|NCT00575380|11515944|FG000|STARTED|Overall Study||58
10374999|NCT00575380|11515945|FG001|STARTED|Overall Study||58
10375000|NCT00575380|11515944|FG000|COMPLETED|Overall Study||57
10375001|NCT00575380|11515945|FG001|COMPLETED|Overall Study||55
10375002|NCT00575380|11515944|FG000|NOT COMPLETED|Overall Study||1
10375003|NCT00575380|11515945|FG001|NOT COMPLETED|Overall Study||3
10375004|NCT00575510|11515954|FG000|STARTED|Overall Study||114
10375005|NCT00575510|11515955|FG001|STARTED|Overall Study||114
10375006|NCT00575510|11515956|FG002|STARTED|Overall Study||113
10375007|NCT00575510|11515954|FG000|COMPLETED|Overall Study||102
10375008|NCT00575510|11515955|FG001|COMPLETED|Overall Study||101
10375009|NCT00575510|11515956|FG002|COMPLETED|Overall Study||96
10538312|NCT01454583|11691180|FG002|COMPLETED|1st Year||1933
10538313|NCT01454583|11691178|FG000|NOT COMPLETED|1st Year||1057
10538314|NCT01454583|11691179|FG001|NOT COMPLETED|1st Year||318
10538315|NCT01454583|11691180|FG002|NOT COMPLETED|1st Year||180
10538316|NCT01454583|11691178|FG000|STARTED|2nd Year||10177
10538317|NCT01454583|11691179|FG001|STARTED|2nd Year||2696
10538318|NCT01454583|11691180|FG002|STARTED|2nd Year||2113
10538319|NCT01454583|11691178|FG000|COMPLETED|2nd Year||6212
10538320|NCT01454583|11691179|FG001|COMPLETED|2nd Year||1647
10538321|NCT01454583|11691180|FG002|COMPLETED|2nd Year||1376
10538322|NCT01454583|11691178|FG000|NOT COMPLETED|2nd Year||3965
10538323|NCT01454583|11691179|FG001|NOT COMPLETED|2nd Year||1049
10538324|NCT01454583|11691180|FG002|NOT COMPLETED|2nd Year||737
10538325|NCT01454583|11691178|FG000|STARTED|3rd Year||3791
10538326|NCT01454583|11691179|FG001|STARTED|3rd Year||982
10538327|NCT01454583|11691180|FG002|STARTED|3rd Year||582
10538328|NCT01454583|11691178|FG000|COMPLETED|3rd Year||1832
10538329|NCT01454583|11691179|FG001|COMPLETED|3rd Year||470
10538330|NCT01454583|11691180|FG002|COMPLETED|3rd Year||285
10538331|NCT01454583|11691178|FG000|NOT COMPLETED|3rd Year||1959
10538332|NCT01454583|11691179|FG001|NOT COMPLETED|3rd Year||512
10538333|NCT01454583|11691180|FG002|NOT COMPLETED|3rd Year||297
10538334|NCT01454596|11691200|FG000|STARTED|Overall Study||1
10538335|NCT01454596|11691201|FG001|STARTED|Overall Study||1
10538336|NCT01454596|11691202|FG002|STARTED|Overall Study||1
10538337|NCT01454596|11691203|FG003|STARTED|Overall Study||1
10538338|NCT01454596|11691204|FG004|STARTED|Overall Study||1
10538339|NCT01454596|11691205|FG005|STARTED|Overall Study||1
10538340|NCT01454596|11691206|FG006|STARTED|Overall Study||1
10538341|NCT01454596|11691207|FG007|STARTED|Overall Study||3
10538342|NCT01454596|11691208|FG008|STARTED|Overall Study||3
10538343|NCT01454596|11691209|FG009|STARTED|Overall Study||3
10538344|NCT01454596|11691210|FG010|STARTED|Overall Study||1
10538345|NCT01454596|11691211|FG011|STARTED|Overall Study||1
10538346|NCT01454596|11691200|FG000|COMPLETED|Overall Study||1
10657561|NCT02226653|11818726|FG001|COMPLETED|Washout Period 4 (at Least 21 Days)||24
10657562|NCT02226653|11818725|FG000|NOT COMPLETED|Washout Period 4 (at Least 21 Days)||0
10657563|NCT02226653|11818726|FG001|NOT COMPLETED|Washout Period 4 (at Least 21 Days)||0
10657564|NCT02226653|11818725|FG000|STARTED|Treatment Period 5 Fed State||23
10657565|NCT02226653|11818726|FG001|STARTED|Treatment Period 5 Fed State||24
10657566|NCT02226653|11818725|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 5 Fed State||23
10657567|NCT02226653|11818726|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 5 Fed State||24
10657568|NCT02226653|11818725|FG000|COMPLETED|Treatment Period 5 Fed State||23
10657569|NCT02226653|11818726|FG001|COMPLETED|Treatment Period 5 Fed State||23
10657570|NCT02226653|11818725|FG000|NOT COMPLETED|Treatment Period 5 Fed State||0
10657571|NCT02226653|11818726|FG001|NOT COMPLETED|Treatment Period 5 Fed State||1
10657572|NCT02226653|11818725|FG000|STARTED|Washout Period 5 (at Least 21 Days)||23
10375010|NCT00575510|11515954|FG000|NOT COMPLETED|Overall Study||12
10375011|NCT00575510|11515955|FG001|NOT COMPLETED|Overall Study||13
10375012|NCT00575510|11515956|FG002|NOT COMPLETED|Overall Study||17
10375013|NCT00575588|11515967|FG000|STARTED|Overall Study|Randomized and treated|428
10375014|NCT00575588|11515968|FG001|STARTED|Overall Study|Randomized and treated|430
10375015|NCT00575588|11515967|FG000|COMPLETED|Overall Study|Completed 104 weeks of treatment|165
10375016|NCT00575588|11515968|FG001|COMPLETED|Overall Study|Completed 104 weeks of treatment|147
10375017|NCT00575588|11515967|FG000|NOT COMPLETED|Overall Study||263
10538347|NCT01454596|11691201|FG001|COMPLETED|Overall Study||1
10538348|NCT01454596|11691202|FG002|COMPLETED|Overall Study||1
10375018|NCT00575588|11515968|FG001|NOT COMPLETED|Overall Study||283
10538349|NCT01454596|11691203|FG003|COMPLETED|Overall Study||1
10538350|NCT01454596|11691204|FG004|COMPLETED|Overall Study||1
10538351|NCT01454596|11691205|FG005|COMPLETED|Overall Study||1
10538352|NCT01454596|11691206|FG006|COMPLETED|Overall Study||1
10538353|NCT01454596|11691207|FG007|COMPLETED|Overall Study||3
10375019|NCT00575666|11515976|FG000|STARTED|Overall Study||21
10375020|NCT00575666|11515977|FG001|STARTED|Overall Study||24
10375021|NCT00575666|11515976|FG000|COMPLETED|Overall Study||17
10375022|NCT00575666|11515977|FG001|COMPLETED|Overall Study||21
10375023|NCT00575666|11515976|FG000|NOT COMPLETED|Overall Study||4
10375024|NCT00575666|11515977|FG001|NOT COMPLETED|Overall Study||3
10375025|NCT00575887|11515983|FG000|STARTED|Overall Study||25
10375026|NCT00575887|11515983|FG000|COMPLETED|Overall Study||25
10375027|NCT00575887|11515983|FG000|NOT COMPLETED|Overall Study||0
10427791|NCT00854828|11573695|FG001|STARTED|Overall Study||33
10427792|NCT00854828|11573696|FG002|STARTED|Overall Study||112
10427793|NCT00854828|11573697|FG003|STARTED|Overall Study||111
10427794|NCT00854828|11573694|FG000|3 Months Post Intervention|Overall Study|6 missed visits|24
10427795|NCT00854828|11573695|FG001|3 Months Post Intervention|Overall Study|1 missed visit|32
10427796|NCT00854828|11573696|FG002|3 Months Post Intervention|Overall Study|112 (100%) of patients underwent operative treatment.|112
10427797|NCT00854828|11573697|FG003|3 Months Post Intervention|Overall Study|2 missed visits. 3 withdrew.|106
10427798|NCT00854828|11573694|FG000|12 Months Post Intervention|Overall Study|"2 missed visits.~1 withdrew.~1 deceased."|26
10427799|NCT00854828|11573695|FG001|12 Months Post Intervention|Overall Study|1 withdrew. 15 (45%) crossed over to operative treatment.|32
10427800|NCT00854828|11573696|FG002|12 Months Post Intervention|Overall Study||112
10427801|NCT00854828|11573697|FG003|12 Months Post Intervention|Overall Study|4 missed visits. 6 withdrew. 6 (5%) crossed over to operative treatment.|101
10427802|NCT00854828|11573694|FG000|24 Months Post Intervention|Overall Study|"1 missed visit.~1 withdrew.~1 deceased. 24 patients (80%) underwent surgery."|27
10427803|NCT00854828|11573695|FG001|24 Months Post Intervention|Overall Study|"1 missed visit.~1 withdrew. 21 (64%) crossed over to operative treatment."|31
10427804|NCT00854828|11573696|FG002|24 Months Post Intervention|Overall Study|8 missed visits.|104
10427805|NCT00854828|11573697|FG003|24 Months Post Intervention|Overall Study|8 missed visits. 9 withdrew. 14 (13%) crossed over to operative treatment.|94
10427806|NCT00854828|11573694|FG000|COMPLETED|Overall Study||27
10427807|NCT00854828|11573695|FG001|COMPLETED|Overall Study||31
10427808|NCT00854828|11573696|FG002|COMPLETED|Overall Study||104
10427809|NCT00854828|11573697|FG003|COMPLETED|Overall Study||94
10427810|NCT00854828|11573694|FG000|NOT COMPLETED|Overall Study||3
10427811|NCT00854828|11573695|FG001|NOT COMPLETED|Overall Study||2
10427812|NCT00854828|11573696|FG002|NOT COMPLETED|Overall Study||8
10427813|NCT00854828|11573697|FG003|NOT COMPLETED|Overall Study||17
10427814|NCT00854906|11573707|FG000|STARTED|Overall Study|There were 26 participants whose eyes were measured in the KTBUT group.|26
10427815|NCT00854906|11573707|FG000|COMPLETED|Overall Study|There were 26 participants in this group. One person was excluded be causes of no ocular history.|25
10427816|NCT00854906|11573707|FG000|NOT COMPLETED|Overall Study||1
10427817|NCT00855010|11573716|FG000|STARTED|Overall Study||23
10427818|NCT00855010|11573717|FG001|STARTED|Overall Study||19
10427819|NCT00855010|11573716|FG000|COMPLETED|Overall Study||19
10427820|NCT00855010|11573717|FG001|COMPLETED|Overall Study||18
10427821|NCT00855010|11573716|FG000|NOT COMPLETED|Overall Study||4
10427822|NCT00855010|11573717|FG001|NOT COMPLETED|Overall Study||1
10427823|NCT00855062|11573729|FG000|STARTED|Step1||36
10427824|NCT00855062|11573730|FG001|STARTED|Step1||37
10427825|NCT00855062|11573729|FG000|COMPLETED|Step1||26
10427826|NCT00855062|11573730|FG001|COMPLETED|Step1||26
10427827|NCT00855062|11573729|FG000|NOT COMPLETED|Step1||10
10427828|NCT00855062|11573730|FG001|NOT COMPLETED|Step1||11
10427829|NCT00855062|11573729|FG000|STARTED|Step2|26 participants completed STEP1; however, only 19 out of the 26 decided to enroll in STEP2.|19
10427830|NCT00855062|11573730|FG001|STARTED|Step2|26 participants completed STEP1; however, only 21 out of the 26 decided to enroll in STEP2.|21
10427831|NCT00855062|11573729|FG000|COMPLETED|Step2||13
10427832|NCT00855062|11573730|FG001|COMPLETED|Step2||15
10427833|NCT00855062|11573729|FG000|NOT COMPLETED|Step2||6
10427834|NCT00855062|11573730|FG001|NOT COMPLETED|Step2||6
10427835|NCT00855166|11573738|FG000|STARTED|Overall Study||91
10427836|NCT00855166|11573739|FG001|STARTED|Overall Study|Of the 91 randomized participants only 89 were included in the full analysis set.|91
10427837|NCT00855166|11573738|FG000|COMPLETED|Overall Study||86
10427838|NCT00855166|11573739|FG001|COMPLETED|Overall Study||83
10427839|NCT00855166|11573738|FG000|NOT COMPLETED|Overall Study||5
10427840|NCT00855166|11573739|FG001|NOT COMPLETED|Overall Study||8
10427841|NCT00855218|11573749|FG000|STARTED|Overall Study||154
10427842|NCT00855218|11573750|FG001|STARTED|Overall Study||153
10427843|NCT00855218|11573749|FG000|Participants Received Treatment|Overall Study||153
10427844|NCT00855218|11573750|FG001|Participants Received Treatment|Overall Study||151
10427845|NCT00855218|11573749|FG000|COMPLETED|Overall Study||0
10427846|NCT00855218|11573750|FG001|COMPLETED|Overall Study||0
10427847|NCT00855218|11573749|FG000|NOT COMPLETED|Overall Study||154
10427848|NCT00855218|11573750|FG001|NOT COMPLETED|Overall Study||153
10427849|NCT00855309|11573758|FG000|STARTED|Overall Study||57
10427850|NCT00855309|11573759|FG001|STARTED|Overall Study||55
10427851|NCT00855309|11573758|FG000|COMPLETED|Overall Study||56
10427852|NCT00855309|11573759|FG001|COMPLETED|Overall Study||55
10427853|NCT00855309|11573758|FG000|NOT COMPLETED|Overall Study||1
10427854|NCT00855309|11573759|FG001|NOT COMPLETED|Overall Study||0
10427855|NCT00855335|11573770|FG000|STARTED|Overall Study||18
10427856|NCT00855335|11573771|FG001|STARTED|Overall Study||18
10427857|NCT00855335|11573772|FG002|STARTED|Overall Study||15
10427858|NCT00855335|11573773|FG003|STARTED|Overall Study||19
10427859|NCT00855335|11573774|FG004|STARTED|Overall Study||7
10427860|NCT00855335|11573770|FG000|COMPLETED|Overall Study||13
10427861|NCT00855335|11573771|FG001|COMPLETED|Overall Study||16
10427862|NCT00855335|11573772|FG002|COMPLETED|Overall Study||10
10375028|NCT00575965|11515987|FG000|STARTED|Overall Study||18
10375029|NCT00575965|11515987|FG000|COMPLETED|Overall Study||18
10375030|NCT00575965|11515987|FG000|NOT COMPLETED|Overall Study||0
10375031|NCT00576056|11515991|FG000|STARTED|Overall Study||19
10375032|NCT00576056|11515991|FG000|COMPLETED|Overall Study||5
10375033|NCT00576056|11515991|FG000|NOT COMPLETED|Overall Study||14
10375034|NCT00576147|11515995|FG000|STARTED|Overall Study||431
10375035|NCT00576147|11515995|FG000|COMPLETED|Overall Study||431
10375036|NCT00576147|11515995|FG000|NOT COMPLETED|Overall Study||0
10375037|NCT00576199|11515999|FG000|STARTED|Overall Study||30
10375038|NCT00576199|11515999|FG000|COMPLETED|Overall Study||0
10375039|NCT00576199|11515999|FG000|NOT COMPLETED|Overall Study||30
10375040|NCT00576251|11516005|FG000|STARTED|Overall Study||109
10375041|NCT00576251|11516006|FG001|STARTED|Overall Study||112
10375042|NCT00576251|11516005|FG000|COMPLETED|Overall Study||108
10375043|NCT00576251|11516006|FG001|COMPLETED|Overall Study||111
10375044|NCT00576251|11516005|FG000|NOT COMPLETED|Overall Study||1
10375045|NCT00576251|11516006|FG001|NOT COMPLETED|Overall Study||1
10375046|NCT00576303|11516012|FG000|STARTED|Dose Titration Period||200
10375047|NCT00576303|11516012|FG000|COMPLETED|Dose Titration Period||183
10375048|NCT00576303|11516012|FG000|NOT COMPLETED|Dose Titration Period||17
10375049|NCT00576303|11516012|FG000|STARTED|Efficacy Evaluation Period||183
10375050|NCT00576303|11516012|FG000|COMPLETED|Efficacy Evaluation Period||178
10375051|NCT00576303|11516012|FG000|NOT COMPLETED|Efficacy Evaluation Period||5
10375052|NCT00576303|11516012|FG000|STARTED|Long Term Safety Period||178
10375053|NCT00576303|11516012|FG000|COMPLETED|Long Term Safety Period||162
10375054|NCT00576303|11516012|FG000|NOT COMPLETED|Long Term Safety Period||16
10375055|NCT00576316|11516016|FG000|STARTED|Overall Study|Number of patients recruited|201
10375056|NCT00576316|11516016|FG000|COMPLETED|Overall Study|Number of patients who completed study|181
10375057|NCT00576316|11516016|FG000|NOT COMPLETED|Overall Study||20
10375058|NCT00576381|11516020|FG000|STARTED|Overall Study||30
10375059|NCT00576381|11516020|FG000|COMPLETED|Overall Study||23
10375060|NCT00576381|11516020|FG000|NOT COMPLETED|Overall Study||7
10375061|NCT00576420|11516027|FG000|STARTED|Overall Study||26
10375062|NCT00576420|11516028|FG001|STARTED|Overall Study||24
10375063|NCT00576420|11516029|FG002|STARTED|Overall Study||23
10375064|NCT00576420|11516027|FG000|COMPLETED|Overall Study||26
10375065|NCT00576420|11516028|FG001|COMPLETED|Overall Study||24
10375066|NCT00576420|11516029|FG002|COMPLETED|Overall Study||22
10375067|NCT00576420|11516027|FG000|NOT COMPLETED|Overall Study||0
10375068|NCT00576420|11516028|FG001|NOT COMPLETED|Overall Study||0
10375069|NCT00576420|11516029|FG002|NOT COMPLETED|Overall Study||1
10375070|NCT00576472|11516093|FG000|STARTED|Initial Screening||230
10375071|NCT00576472|11516094|FG001|STARTED|Initial Screening||40
10375072|NCT00576472|11516095|FG002|STARTED|Initial Screening||199
10375073|NCT00576472|11516096|FG003|STARTED|Initial Screening||0
10375074|NCT00576472|11516097|FG004|STARTED|Initial Screening||0
10375075|NCT00576472|11516098|FG005|STARTED|Initial Screening||0
10375076|NCT00576472|11516099|FG006|STARTED|Initial Screening||0
10375077|NCT00576472|11516100|FG007|STARTED|Initial Screening||0
10375078|NCT00576472|11516101|FG008|STARTED|Initial Screening||0
10375079|NCT00576472|11516102|FG009|STARTED|Initial Screening||0
10375080|NCT00576472|11516103|FG010|STARTED|Initial Screening||0
10375081|NCT00576472|11516104|FG011|STARTED|Initial Screening||0
10375082|NCT00576472|11516105|FG012|STARTED|Initial Screening||0
10375083|NCT00576472|11516106|FG013|STARTED|Initial Screening||0
10375084|NCT00576472|11516107|FG014|STARTED|Initial Screening||0
10375085|NCT00576472|11516093|FG000|COMPLETED|Initial Screening||230
10375086|NCT00576472|11516094|FG001|COMPLETED|Initial Screening||40
10375087|NCT00576472|11516095|FG002|COMPLETED|Initial Screening||199
10375088|NCT00576472|11516096|FG003|COMPLETED|Initial Screening||0
10375089|NCT00576472|11516097|FG004|COMPLETED|Initial Screening||0
10375090|NCT00576472|11516098|FG005|COMPLETED|Initial Screening||0
10375091|NCT00576472|11516099|FG006|COMPLETED|Initial Screening||0
10375092|NCT00576472|11516100|FG007|COMPLETED|Initial Screening||0
10375093|NCT00576472|11516101|FG008|COMPLETED|Initial Screening||0
10375094|NCT00576472|11516102|FG009|COMPLETED|Initial Screening||0
10375095|NCT00576472|11516103|FG010|COMPLETED|Initial Screening||0
10375096|NCT00576472|11516104|FG011|COMPLETED|Initial Screening||0
10375097|NCT00576472|11516105|FG012|COMPLETED|Initial Screening||0
10375098|NCT00576472|11516106|FG013|COMPLETED|Initial Screening||0
10375099|NCT00576472|11516107|FG014|COMPLETED|Initial Screening||0
10375100|NCT00576472|11516093|FG000|NOT COMPLETED|Initial Screening||0
10375101|NCT00576472|11516094|FG001|NOT COMPLETED|Initial Screening||0
10375102|NCT00576472|11516095|FG002|NOT COMPLETED|Initial Screening||0
10375103|NCT00576472|11516096|FG003|NOT COMPLETED|Initial Screening||0
10375104|NCT00576472|11516097|FG004|NOT COMPLETED|Initial Screening||0
10375105|NCT00576472|11516098|FG005|NOT COMPLETED|Initial Screening||0
10375106|NCT00576472|11516099|FG006|NOT COMPLETED|Initial Screening||0
10375107|NCT00576472|11516100|FG007|NOT COMPLETED|Initial Screening||0
10375108|NCT00576472|11516101|FG008|NOT COMPLETED|Initial Screening||0
10375109|NCT00576472|11516102|FG009|NOT COMPLETED|Initial Screening||0
10375110|NCT00576472|11516103|FG010|NOT COMPLETED|Initial Screening||0
10375111|NCT00576472|11516104|FG011|NOT COMPLETED|Initial Screening||0
10375112|NCT00576472|11516105|FG012|NOT COMPLETED|Initial Screening||0
10375113|NCT00576472|11516106|FG013|NOT COMPLETED|Initial Screening||0
10375114|NCT00576472|11516107|FG014|NOT COMPLETED|Initial Screening||0
10375115|NCT00576472|11516093|FG000|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
10375116|NCT00576472|11516094|FG001|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
10375117|NCT00576472|11516095|FG002|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
10375118|NCT00576472|11516096|FG003|STARTED|MPH In-Lab Phase||335
10375119|NCT00576472|11516097|FG004|STARTED|MPH In-Lab Phase||67
10375120|NCT00576472|11516098|FG005|STARTED|MPH In-Lab Phase||67
10375121|NCT00576472|11516099|FG006|STARTED|MPH In-Lab Phase||0
10375122|NCT00576472|11516100|FG007|STARTED|MPH In-Lab Phase||0
10375123|NCT00576472|11516101|FG008|STARTED|MPH In-Lab Phase||0
10375124|NCT00576472|11516102|FG009|STARTED|MPH In-Lab Phase||0
10375125|NCT00576472|11516103|FG010|STARTED|MPH In-Lab Phase||0
10375126|NCT00576472|11516104|FG011|STARTED|MPH In-Lab Phase||0
10375127|NCT00576472|11516105|FG012|STARTED|MPH In-Lab Phase||0
10375128|NCT00576472|11516106|FG013|STARTED|MPH In-Lab Phase||0
10375129|NCT00576472|11516107|FG014|STARTED|MPH In-Lab Phase||0
10375130|NCT00576472|11516093|FG000|COMPLETED|MPH In-Lab Phase||0
10375131|NCT00576472|11516094|FG001|COMPLETED|MPH In-Lab Phase||0
10375132|NCT00576472|11516095|FG002|COMPLETED|MPH In-Lab Phase||0
10717163|NCT02696785|11881098|FG001|STARTED|Washout Period||88
10717164|NCT02696785|11881099|FG002|STARTED|Washout Period|Washout period occurred only for Adalimumab group.|0
10375133|NCT00576472|11516096|FG003|COMPLETED|MPH In-Lab Phase||0
10375134|NCT00576472|11516097|FG004|COMPLETED|MPH In-Lab Phase||67
10375135|NCT00576472|11516098|FG005|COMPLETED|MPH In-Lab Phase||67
10375136|NCT00576472|11516099|FG006|COMPLETED|MPH In-Lab Phase||0
10375137|NCT00576472|11516100|FG007|COMPLETED|MPH In-Lab Phase||0
10375138|NCT00576472|11516101|FG008|COMPLETED|MPH In-Lab Phase||0
10375139|NCT00576472|11516102|FG009|COMPLETED|MPH In-Lab Phase||0
10375140|NCT00576472|11516103|FG010|COMPLETED|MPH In-Lab Phase||0
10375141|NCT00576472|11516104|FG011|COMPLETED|MPH In-Lab Phase||0
10375142|NCT00576472|11516105|FG012|COMPLETED|MPH In-Lab Phase||0
10375143|NCT00576472|11516106|FG013|COMPLETED|MPH In-Lab Phase||0
10375144|NCT00576472|11516107|FG014|COMPLETED|MPH In-Lab Phase||0
10375145|NCT00576472|11516093|FG000|NOT COMPLETED|MPH In-Lab Phase||0
10375146|NCT00576472|11516094|FG001|NOT COMPLETED|MPH In-Lab Phase||0
10375147|NCT00576472|11516095|FG002|NOT COMPLETED|MPH In-Lab Phase||0
10375148|NCT00576472|11516096|FG003|NOT COMPLETED|MPH In-Lab Phase||335
10375149|NCT00576472|11516097|FG004|NOT COMPLETED|MPH In-Lab Phase||0
10375150|NCT00576472|11516098|FG005|NOT COMPLETED|MPH In-Lab Phase||0
10375151|NCT00576472|11516099|FG006|NOT COMPLETED|MPH In-Lab Phase||0
10375152|NCT00576472|11516100|FG007|NOT COMPLETED|MPH In-Lab Phase||0
10375153|NCT00576472|11516101|FG008|NOT COMPLETED|MPH In-Lab Phase||0
10375154|NCT00576472|11516102|FG009|NOT COMPLETED|MPH In-Lab Phase||0
10375155|NCT00576472|11516103|FG010|NOT COMPLETED|MPH In-Lab Phase||0
10375156|NCT00576472|11516104|FG011|NOT COMPLETED|MPH In-Lab Phase||0
10375157|NCT00576472|11516105|FG012|NOT COMPLETED|MPH In-Lab Phase||0
10375158|NCT00576472|11516106|FG013|NOT COMPLETED|MPH In-Lab Phase||0
10375159|NCT00576472|11516107|FG014|NOT COMPLETED|MPH In-Lab Phase||0
10375160|NCT00576472|11516093|FG000|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
10375161|NCT00576472|11516094|FG001|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
10375162|NCT00576472|11516095|FG002|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
10375163|NCT00576472|11516096|FG003|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
10375164|NCT00576472|11516097|FG004|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
10375165|NCT00576472|11516098|FG005|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
10375166|NCT00576472|11516099|FG006|STARTED|MPH Cross Over Phase||12
10375167|NCT00576472|11516100|FG007|STARTED|MPH Cross Over Phase||20
10375168|NCT00576472|11516101|FG008|STARTED|MPH Cross Over Phase||18
10375169|NCT00576472|11516102|FG009|STARTED|MPH Cross Over Phase||22
10375170|NCT00576472|11516103|FG010|STARTED|MPH Cross Over Phase||23
10375171|NCT00576472|11516104|FG011|STARTED|MPH Cross Over Phase||18
10375172|NCT00576472|11516105|FG012|STARTED|MPH Cross Over Phase||21
10375173|NCT00576472|11516106|FG013|STARTED|MPH Cross Over Phase||0
10375174|NCT00576472|11516107|FG014|STARTED|MPH Cross Over Phase||0
10375175|NCT00576472|11516093|FG000|COMPLETED|MPH Cross Over Phase||0
10375176|NCT00576472|11516094|FG001|COMPLETED|MPH Cross Over Phase||0
10375177|NCT00576472|11516095|FG002|COMPLETED|MPH Cross Over Phase||0
10375178|NCT00576472|11516096|FG003|COMPLETED|MPH Cross Over Phase||0
10375179|NCT00576472|11516097|FG004|COMPLETED|MPH Cross Over Phase||0
10375180|NCT00576472|11516098|FG005|COMPLETED|MPH Cross Over Phase||0
10375181|NCT00576472|11516099|FG006|COMPLETED|MPH Cross Over Phase||0
10375182|NCT00576472|11516100|FG007|COMPLETED|MPH Cross Over Phase||20
10375183|NCT00576472|11516101|FG008|COMPLETED|MPH Cross Over Phase||16
10375184|NCT00576472|11516102|FG009|COMPLETED|MPH Cross Over Phase||22
10375185|NCT00576472|11516103|FG010|COMPLETED|MPH Cross Over Phase||22
10375186|NCT00576472|11516104|FG011|COMPLETED|MPH Cross Over Phase||17
10375187|NCT00576472|11516105|FG012|COMPLETED|MPH Cross Over Phase||21
10375188|NCT00576472|11516106|FG013|COMPLETED|MPH Cross Over Phase||0
10375189|NCT00576472|11516107|FG014|COMPLETED|MPH Cross Over Phase||0
10375190|NCT00576472|11516093|FG000|NOT COMPLETED|MPH Cross Over Phase||0
10375191|NCT00576472|11516094|FG001|NOT COMPLETED|MPH Cross Over Phase||0
10375192|NCT00576472|11516095|FG002|NOT COMPLETED|MPH Cross Over Phase||0
10375193|NCT00576472|11516096|FG003|NOT COMPLETED|MPH Cross Over Phase||0
10375194|NCT00576472|11516097|FG004|NOT COMPLETED|MPH Cross Over Phase||0
10717165|NCT02696785|11881100|FG003|STARTED|Washout Period|Washout period occurred only for Adalimumab group.|0
10717166|NCT02696785|11881097|FG000|COMPLETED|Washout Period||0
10375195|NCT00576472|11516098|FG005|NOT COMPLETED|MPH Cross Over Phase||0
10375196|NCT00576472|11516099|FG006|NOT COMPLETED|MPH Cross Over Phase||12
10717167|NCT02696785|11881098|FG001|COMPLETED|Washout Period||86
10717168|NCT02696785|11881099|FG002|COMPLETED|Washout Period||0
10717169|NCT02696785|11881100|FG003|COMPLETED|Washout Period||0
10717170|NCT02696785|11881097|FG000|NOT COMPLETED|Washout Period||0
10717171|NCT02696785|11881098|FG001|NOT COMPLETED|Washout Period||2
10717172|NCT02696785|11881099|FG002|NOT COMPLETED|Washout Period||0
10717173|NCT02696785|11881100|FG003|NOT COMPLETED|Washout Period||0
10717174|NCT02696785|11881097|FG000|STARTED|Extended Treatment Period||86
10717175|NCT02696785|11881098|FG001|STARTED|Extended Treatment Period||86
10717176|NCT02696785|11881099|FG002|STARTED|Extended Treatment Period||79
10717177|NCT02696785|11881100|FG003|STARTED|Extended Treatment Period||78
10717178|NCT02696785|11881097|FG000|COMPLETED|Extended Treatment Period||83
10375197|NCT00576472|11516100|FG007|NOT COMPLETED|MPH Cross Over Phase||0
10375198|NCT00576472|11516101|FG008|NOT COMPLETED|MPH Cross Over Phase||2
10375199|NCT00576472|11516102|FG009|NOT COMPLETED|MPH Cross Over Phase||0
10375200|NCT00576472|11516103|FG010|NOT COMPLETED|MPH Cross Over Phase||1
10375201|NCT00576472|11516104|FG011|NOT COMPLETED|MPH Cross Over Phase||1
10375202|NCT00576472|11516105|FG012|NOT COMPLETED|MPH Cross Over Phase||0
10375203|NCT00576472|11516106|FG013|NOT COMPLETED|MPH Cross Over Phase||0
10375204|NCT00576472|11516107|FG014|NOT COMPLETED|MPH Cross Over Phase||0
10375205|NCT00576472|11516093|FG000|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
10375206|NCT00576472|11516094|FG001|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
10812640|NCT03447639|11974762|FG000|STARTED|Overall Study|No patients were randomized to the Povidone-Iodine irrigation arm|0
10812641|NCT03447639|11974763|FG001|STARTED|Overall Study|3 patients were randomized to the Standard of Care arm.|3
10812642|NCT03447639|11974762|FG000|COMPLETED|Overall Study|No patients were randomized to the Povidone-Iodine irrigation arm|0
10375207|NCT00576472|11516095|FG002|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
10375208|NCT00576472|11516096|FG003|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
10375209|NCT00576472|11516097|FG004|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
10375210|NCT00576472|11516098|FG005|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
10375211|NCT00576472|11516099|FG006|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
10375212|NCT00576472|11516100|FG007|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
10375213|NCT00576472|11516101|FG008|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
10375214|NCT00576472|11516102|FG009|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
10375215|NCT00576472|11516103|FG010|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
10375216|NCT00576472|11516104|FG011|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
10375217|NCT00576472|11516105|FG012|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
10375218|NCT00576472|11516106|FG013|STARTED|MPH Home Maintenance Phase||27
10375219|NCT00576472|11516107|FG014|STARTED|MPH Home Maintenance Phase||91
10375220|NCT00576472|11516093|FG000|COMPLETED|MPH Home Maintenance Phase||0
10375221|NCT00576472|11516094|FG001|COMPLETED|MPH Home Maintenance Phase||0
10375222|NCT00576472|11516095|FG002|COMPLETED|MPH Home Maintenance Phase||0
10375223|NCT00576472|11516096|FG003|COMPLETED|MPH Home Maintenance Phase||0
10375224|NCT00576472|11516097|FG004|COMPLETED|MPH Home Maintenance Phase||0
10375225|NCT00576472|11516098|FG005|COMPLETED|MPH Home Maintenance Phase||0
10375226|NCT00576472|11516099|FG006|COMPLETED|MPH Home Maintenance Phase||0
10375227|NCT00576472|11516100|FG007|COMPLETED|MPH Home Maintenance Phase||0
10375228|NCT00576472|11516101|FG008|COMPLETED|MPH Home Maintenance Phase||0
10375229|NCT00576472|11516102|FG009|COMPLETED|MPH Home Maintenance Phase||0
10375230|NCT00576472|11516103|FG010|COMPLETED|MPH Home Maintenance Phase||0
10375231|NCT00576472|11516104|FG011|COMPLETED|MPH Home Maintenance Phase||0
10538354|NCT01454596|11691208|FG008|COMPLETED|Overall Study||3
10538355|NCT01454596|11691209|FG009|COMPLETED|Overall Study||2
10538356|NCT01454596|11691210|FG010|COMPLETED|Overall Study||0
10538357|NCT01454596|11691211|FG011|COMPLETED|Overall Study||1
10538358|NCT01454596|11691200|FG000|NOT COMPLETED|Overall Study||0
10538359|NCT01454596|11691201|FG001|NOT COMPLETED|Overall Study||0
10538360|NCT01454596|11691202|FG002|NOT COMPLETED|Overall Study||0
10538361|NCT01454596|11691203|FG003|NOT COMPLETED|Overall Study||0
10538362|NCT01454596|11691204|FG004|NOT COMPLETED|Overall Study||0
10538363|NCT01454596|11691205|FG005|NOT COMPLETED|Overall Study||0
10538364|NCT01454596|11691206|FG006|NOT COMPLETED|Overall Study||0
10538365|NCT01454596|11691207|FG007|NOT COMPLETED|Overall Study||0
10538366|NCT01454596|11691208|FG008|NOT COMPLETED|Overall Study||0
10538367|NCT01454596|11691209|FG009|NOT COMPLETED|Overall Study||1
10538368|NCT01454596|11691210|FG010|NOT COMPLETED|Overall Study||1
10538369|NCT01454596|11691211|FG011|NOT COMPLETED|Overall Study||0
10538370|NCT01454726|11691239|FG000|STARTED|Overall Study||16
10538371|NCT01454726|11691240|FG001|STARTED|Overall Study||11
10538372|NCT01454726|11691239|FG000|COMPLETED|Overall Study||16
10538373|NCT01454726|11691240|FG001|COMPLETED|Overall Study||10
10538374|NCT01454726|11691239|FG000|NOT COMPLETED|Overall Study||0
10538375|NCT01454726|11691240|FG001|NOT COMPLETED|Overall Study||1
10538376|NCT01454739|11691248|FG000|STARTED|Overall Study|30 participants in <6 Years Old Age Cohort and 31 participants in 6 to <12 Years Old Age Cohort.|61
10717179|NCT02696785|11881098|FG001|COMPLETED|Extended Treatment Period||80
10717180|NCT02696785|11881099|FG002|COMPLETED|Extended Treatment Period||74
10657573|NCT02226653|11818726|FG001|STARTED|Washout Period 5 (at Least 21 Days)||23
10657574|NCT02226653|11818725|FG000|COMPLETED|Washout Period 5 (at Least 21 Days)||23
10657575|NCT02226653|11818726|FG001|COMPLETED|Washout Period 5 (at Least 21 Days)||23
10657576|NCT02226653|11818725|FG000|NOT COMPLETED|Washout Period 5 (at Least 21 Days)||0
10657577|NCT02226653|11818726|FG001|NOT COMPLETED|Washout Period 5 (at Least 21 Days)||0
10657578|NCT02226796|11818739|FG000|STARTED|First Intervention Phase (Week 1)||2
10657579|NCT02226796|11818740|FG001|STARTED|First Intervention Phase (Week 1)||1
10657580|NCT02226796|11818739|FG000|Baseline Assessment|First Intervention Phase (Week 1)||2
10657581|NCT02226796|11818740|FG001|Baseline Assessment|First Intervention Phase (Week 1)||1
10812643|NCT03447639|11974763|FG001|COMPLETED|Overall Study|2 patients were withdrawn because their catheters had to be re-inserted.|1
10812644|NCT03447639|11974762|FG000|NOT COMPLETED|Overall Study||0
10812645|NCT03447639|11974763|FG001|NOT COMPLETED|Overall Study||2
10812646|NCT03429712|11974769|FG000|STARTED|Overall Study||19
10812647|NCT03429712|11974769|FG000|COMPLETED|Overall Study||10
10812648|NCT03429712|11974769|FG000|NOT COMPLETED|Overall Study||9
10306451|NCT00098722|11439335|FG002|COMPLETED|Observation Phase||0
10306452|NCT00098722|11439336|FG003|COMPLETED|Observation Phase||0
10375232|NCT00576472|11516105|FG012|COMPLETED|MPH Home Maintenance Phase||0
10375233|NCT00576472|11516106|FG013|COMPLETED|MPH Home Maintenance Phase||0
10375234|NCT00576472|11516107|FG014|COMPLETED|MPH Home Maintenance Phase||68
10375235|NCT00576472|11516093|FG000|NOT COMPLETED|MPH Home Maintenance Phase||0
10375236|NCT00576472|11516094|FG001|NOT COMPLETED|MPH Home Maintenance Phase||0
10375237|NCT00576472|11516095|FG002|NOT COMPLETED|MPH Home Maintenance Phase||0
10375238|NCT00576472|11516096|FG003|NOT COMPLETED|MPH Home Maintenance Phase||0
10375239|NCT00576472|11516097|FG004|NOT COMPLETED|MPH Home Maintenance Phase||0
10375240|NCT00576472|11516098|FG005|NOT COMPLETED|MPH Home Maintenance Phase||0
10375241|NCT00576472|11516099|FG006|NOT COMPLETED|MPH Home Maintenance Phase||0
10375242|NCT00576472|11516100|FG007|NOT COMPLETED|MPH Home Maintenance Phase||0
10375243|NCT00576472|11516101|FG008|NOT COMPLETED|MPH Home Maintenance Phase||0
10375244|NCT00576472|11516102|FG009|NOT COMPLETED|MPH Home Maintenance Phase||0
10375245|NCT00576472|11516103|FG010|NOT COMPLETED|MPH Home Maintenance Phase||0
10375246|NCT00576472|11516104|FG011|NOT COMPLETED|MPH Home Maintenance Phase||0
10375247|NCT00576472|11516105|FG012|NOT COMPLETED|MPH Home Maintenance Phase||0
10375248|NCT00576472|11516106|FG013|NOT COMPLETED|MPH Home Maintenance Phase||27
10375249|NCT00576472|11516107|FG014|NOT COMPLETED|MPH Home Maintenance Phase||23
10375250|NCT00576576|11516138|FG000|STARTED|Overall Study||27
10375251|NCT00576576|11516138|FG000|COMPLETED|Overall Study||20
10375252|NCT00576576|11516138|FG000|NOT COMPLETED|Overall Study||7
10375253|NCT00576628|11516142|FG000|STARTED|Overall Study||125
10375254|NCT00576628|11516142|FG000|COMPLETED|Overall Study||82
10375255|NCT00576628|11516142|FG000|NOT COMPLETED|Overall Study||43
10375256|NCT00576680|11516147|FG000|STARTED|Overall Study||43
10375257|NCT00576680|11516147|FG000|COMPLETED|Overall Study||43
10375258|NCT00576680|11516147|FG000|NOT COMPLETED|Overall Study||0
10375259|NCT00576693|11516153|FG000|STARTED|Overall Study||224
10375260|NCT00576693|11516154|FG001|STARTED|Overall Study||227
10375261|NCT00576693|11516153|FG000|COMPLETED|Overall Study||214
10375262|NCT00576693|11516154|FG001|COMPLETED|Overall Study||203
10375263|NCT00576693|11516153|FG000|NOT COMPLETED|Overall Study||10
10375264|NCT00576693|11516154|FG001|NOT COMPLETED|Overall Study||24
10375265|NCT00576732|11516163|FG000|STARTED|DOUBLE BLIND||35
10375266|NCT00576732|11516164|FG001|STARTED|DOUBLE BLIND||30
10375267|NCT00576732|11516165|FG002|STARTED|DOUBLE BLIND||31
10375268|NCT00576732|11516166|FG003|STARTED|DOUBLE BLIND||0
10375269|NCT00576732|11516167|FG004|STARTED|DOUBLE BLIND||0
10375270|NCT00576732|11516168|FG005|STARTED|DOUBLE BLIND||0
10375271|NCT00576732|11516163|FG000|COMPLETED|DOUBLE BLIND||27
10375272|NCT00576732|11516164|FG001|COMPLETED|DOUBLE BLIND||25
10375273|NCT00576732|11516165|FG002|COMPLETED|DOUBLE BLIND||25
10375274|NCT00576732|11516166|FG003|COMPLETED|DOUBLE BLIND||0
10375275|NCT00576732|11516167|FG004|COMPLETED|DOUBLE BLIND||0
10375276|NCT00576732|11516168|FG005|COMPLETED|DOUBLE BLIND||0
10375277|NCT00576732|11516163|FG000|NOT COMPLETED|DOUBLE BLIND||8
10375278|NCT00576732|11516164|FG001|NOT COMPLETED|DOUBLE BLIND||5
10375279|NCT00576732|11516165|FG002|NOT COMPLETED|DOUBLE BLIND||6
10375280|NCT00576732|11516166|FG003|NOT COMPLETED|DOUBLE BLIND||0
10375281|NCT00576732|11516167|FG004|NOT COMPLETED|DOUBLE BLIND||0
10375282|NCT00576732|11516168|FG005|NOT COMPLETED|DOUBLE BLIND||0
10375283|NCT00576732|11516163|FG000|STARTED|OPEN LABEL||0
10375284|NCT00576732|11516164|FG001|STARTED|OPEN LABEL||0
10375285|NCT00576732|11516165|FG002|STARTED|OPEN LABEL||0
10375286|NCT00576732|11516166|FG003|STARTED|OPEN LABEL|26 of 27 double-blind placebo completers and 4 of 8 placebo non-completers entered open-label.|30
10375287|NCT00576732|11516167|FG004|STARTED|OPEN LABEL|24 of 25 double-blind RIS low dose completers and 0 RIS low dose non-completers entered open-label.|24
10375288|NCT00576732|11516168|FG005|STARTED|OPEN LABEL|All 25 double-blind RIS high dose completers and 0 RIS high dose non-completers entered open-label.|25
10375289|NCT00576732|11516163|FG000|COMPLETED|OPEN LABEL||0
10375290|NCT00576732|11516164|FG001|COMPLETED|OPEN LABEL||0
10375291|NCT00576732|11516165|FG002|COMPLETED|OPEN LABEL||0
10375292|NCT00576732|11516166|FG003|COMPLETED|OPEN LABEL||19
10375293|NCT00576732|11516167|FG004|COMPLETED|OPEN LABEL||20
10375294|NCT00576732|11516168|FG005|COMPLETED|OPEN LABEL||17
10375295|NCT00576732|11516163|FG000|NOT COMPLETED|OPEN LABEL||0
10375296|NCT00576732|11516164|FG001|NOT COMPLETED|OPEN LABEL||0
10375297|NCT00576732|11516165|FG002|NOT COMPLETED|OPEN LABEL||0
10375298|NCT00576732|11516166|FG003|NOT COMPLETED|OPEN LABEL||11
10538377|NCT01454739|11691249|FG001|STARTED|Overall Study||179
10538378|NCT01454739|11691248|FG000|Tailored Prophylaxis|Overall Study||59
10717181|NCT02696785|11881100|FG003|COMPLETED|Extended Treatment Period||72
10717182|NCT02696785|11881097|FG000|NOT COMPLETED|Extended Treatment Period||3
10717183|NCT02696785|11881098|FG001|NOT COMPLETED|Extended Treatment Period||6
10717184|NCT02696785|11881099|FG002|NOT COMPLETED|Extended Treatment Period||5
10538379|NCT01454739|11691249|FG001|Tailored Prophylaxis|Overall Study||131
10538380|NCT01454739|11691248|FG000|Weekly Prophylaxis|Overall Study||0
10538381|NCT01454739|11691249|FG001|Weekly Prophylaxis|Overall Study||34
10538382|NCT01454739|11691248|FG000|Personalized Prophylaxis|Overall Study||3
10717185|NCT02696785|11881100|FG003|NOT COMPLETED|Extended Treatment Period||6
10538383|NCT01454739|11691249|FG001|Personalized Prophylaxis|Overall Study||23
10538384|NCT01454739|11691248|FG000|Episodic|Overall Study||0
10538385|NCT01454739|11691249|FG001|Episodic|Overall Study||13
10538386|NCT01454739|11691248|FG000|Surgery Subgroup|Overall Study||2
10538387|NCT01454739|11691249|FG001|Surgery Subgroup|Overall Study||26
10538388|NCT01454739|11691248|FG000|COMPLETED|Overall Study||54
10538389|NCT01454739|11691249|FG001|COMPLETED|Overall Study||158
10777261|NCT03338556|11939219|FG003|STARTED|Overall Study||26
10375299|NCT00576732|11516167|FG004|NOT COMPLETED|OPEN LABEL||4
10306453|NCT00098722|11439337|FG004|COMPLETED|Observation Phase||0
10306454|NCT00098722|11439338|FG005|COMPLETED|Observation Phase||160
10306455|NCT00098722|11439339|FG006|COMPLETED|Observation Phase||48
10306456|NCT00098722|11439333|FG000|NOT COMPLETED|Observation Phase||0
10306457|NCT00098722|11439334|FG001|NOT COMPLETED|Observation Phase||0
10306458|NCT00098722|11439335|FG002|NOT COMPLETED|Observation Phase||0
10306459|NCT00098722|11439336|FG003|NOT COMPLETED|Observation Phase||0
10306460|NCT00098722|11439337|FG004|NOT COMPLETED|Observation Phase||0
10306461|NCT00098722|11439338|FG005|NOT COMPLETED|Observation Phase||45
10306462|NCT00098722|11439339|FG006|NOT COMPLETED|Observation Phase||17
10306463|NCT00098748|11439354|FG000|STARTED|Assigned to Study Treatment||63
10306464|NCT00098748|11439355|FG001|STARTED|Assigned to Study Treatment||63
10306465|NCT00098748|11439356|FG002|STARTED|Assigned to Study Treatment||64
10306466|NCT00098748|11439354|FG000|COMPLETED|Assigned to Study Treatment||63
10306467|NCT00098748|11439355|FG001|COMPLETED|Assigned to Study Treatment||61
10306468|NCT00098748|11439356|FG002|COMPLETED|Assigned to Study Treatment||62
10306469|NCT00098748|11439354|FG000|NOT COMPLETED|Assigned to Study Treatment||0
10306470|NCT00098748|11439355|FG001|NOT COMPLETED|Assigned to Study Treatment||2
10306471|NCT00098748|11439356|FG002|NOT COMPLETED|Assigned to Study Treatment||2
10306472|NCT00098748|11439354|FG000|STARTED|Received Study Treatment||63
10306473|NCT00098748|11439355|FG001|STARTED|Received Study Treatment|Due to 1 placebo subject switched to maraviroc BID, BID = 62 subjects in Adverse event tables.|61
10306474|NCT00098748|11439356|FG002|STARTED|Received Study Treatment|Due to 1 placebo subject switched to maraviroc BID, Placebo = 61 subjects in Adverse event tables.|62
10306475|NCT00098748|11439354|FG000|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment|Dual-tropic: Virus capable of using both CCR5 and CXCR4 coreceptors for cell entry.|57
10306476|NCT00098748|11439355|FG001|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment||52
10306477|NCT00098748|11439356|FG002|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment||58
10306478|NCT00098748|11439354|FG000|COMPLETED|Received Study Treatment||15
10306479|NCT00098748|11439355|FG001|COMPLETED|Received Study Treatment||25
10306480|NCT00098748|11439356|FG002|COMPLETED|Received Study Treatment||18
10306481|NCT00098748|11439354|FG000|NOT COMPLETED|Received Study Treatment||48
10306482|NCT00098748|11439355|FG001|NOT COMPLETED|Received Study Treatment||36
10306483|NCT00098748|11439356|FG002|NOT COMPLETED|Received Study Treatment||44
10306484|NCT00098748|11439354|FG000|STARTED|Continued on Open-Label Treatment||15
10306485|NCT00098748|11439355|FG001|STARTED|Continued on Open-Label Treatment||25
10306486|NCT00098748|11439356|FG002|STARTED|Continued on Open-Label Treatment|Placebo group not offered open-label maraviroc due to study not reaching primary endpoint at Week 24|0
10306487|NCT00098748|11439354|FG000|COMPLETED|Continued on Open-Label Treatment||7
10306488|NCT00098748|11439355|FG001|COMPLETED|Continued on Open-Label Treatment||10
10306489|NCT00098748|11439356|FG002|COMPLETED|Continued on Open-Label Treatment||0
10306490|NCT00098748|11439354|FG000|NOT COMPLETED|Continued on Open-Label Treatment||8
10306491|NCT00098748|11439355|FG001|NOT COMPLETED|Continued on Open-Label Treatment||15
10306492|NCT00098748|11439356|FG002|NOT COMPLETED|Continued on Open-Label Treatment||0
10306493|NCT00098774|11439364|FG000|STARTED|Overall Study||44
10306494|NCT00098774|11439364|FG000|COMPLETED|Overall Study||26
10306495|NCT00098774|11439364|FG000|NOT COMPLETED|Overall Study||18
10306496|NCT00098787|11439371|FG000|STARTED|Overall Study||73
10306497|NCT00098787|11439372|FG001|STARTED|Overall Study||75
10306498|NCT00098787|11439373|FG002|STARTED|Overall Study||63
10306499|NCT00098787|11439371|FG000|Treated|Overall Study||70
10306500|NCT00098787|11439372|FG001|Treated|Overall Study||73
10306501|NCT00098787|11439373|FG002|Treated|Overall Study||62
10306502|NCT00098787|11439371|FG000|Eligible and Treated|Overall Study||61
10306503|NCT00098787|11439372|FG001|Eligible and Treated|Overall Study||66
10306504|NCT00098787|11439373|FG002|Eligible and Treated|Overall Study||59
10306505|NCT00098787|11439371|FG000|COMPLETED|Overall Study||0
10306506|NCT00098787|11439372|FG001|COMPLETED|Overall Study||0
10306507|NCT00098787|11439373|FG002|COMPLETED|Overall Study||0
10306508|NCT00098787|11439371|FG000|NOT COMPLETED|Overall Study||73
10306509|NCT00098787|11439372|FG001|NOT COMPLETED|Overall Study||75
10306510|NCT00098787|11439373|FG002|NOT COMPLETED|Overall Study||63
10306511|NCT00098813|11439381|FG000|STARTED|Overall Study||20
10306512|NCT00098813|11439381|FG000|COMPLETED|Overall Study||1
10306513|NCT00098813|11439381|FG000|NOT COMPLETED|Overall Study||19
10306514|NCT00098839|11439387|FG000|STARTED|Overall Study||56
10306515|NCT00098839|11439388|FG001|STARTED|Overall Study||60
10306516|NCT00098839|11439387|FG000|COMPLETED|Overall Study||24
10306517|NCT00098839|11439388|FG001|COMPLETED|Overall Study||27
10306518|NCT00098839|11439387|FG000|NOT COMPLETED|Overall Study||32
10375300|NCT00576732|11516168|FG005|NOT COMPLETED|OPEN LABEL||8
10375301|NCT00576758|11516182|FG000|STARTED|Induction Treatment Period||87
10375302|NCT00576758|11516183|FG001|STARTED|Induction Treatment Period||88
10375303|NCT00576758|11516182|FG000|Received Treatment|Induction Treatment Period||86
10375304|NCT00576758|11516183|FG001|Received Treatment|Induction Treatment Period||87
10375305|NCT00576758|11516182|FG000|COMPLETED|Induction Treatment Period||79
10375306|NCT00576758|11516183|FG001|COMPLETED|Induction Treatment Period||83
10375307|NCT00576758|11516182|FG000|NOT COMPLETED|Induction Treatment Period||8
10375308|NCT00576758|11516183|FG001|NOT COMPLETED|Induction Treatment Period||5
10375309|NCT00576758|11516182|FG000|STARTED|Extension Treatment Period|6 patients did not enter extended treatment phase/follow-up + 1 patient entered follow-up.|72
10375310|NCT00576758|11516183|FG001|STARTED|Extension Treatment Period|8 patients did not enter extended treatment phase/follow-up phase + 2 patients entered follow-up.|73
10375311|NCT00576758|11516182|FG000|COMPLETED|Extension Treatment Period|+ 2 patients (pts) who withdrew prior to receiving study drug.|30
10375312|NCT00576758|11516183|FG001|COMPLETED|Extension Treatment Period||30
10375313|NCT00576758|11516182|FG000|NOT COMPLETED|Extension Treatment Period||42
10375314|NCT00576758|11516183|FG001|NOT COMPLETED|Extension Treatment Period||43
10375315|NCT00576758|11516182|FG000|STARTED|Follow-up Period|Includes 23 pts who entered follow-up after induction and didn't enter the extended treatment phase.|55
10375316|NCT00576758|11516183|FG001|STARTED|Follow-up Period|Includes 21 pts who entered follow-up after induction and didn't enter the extended treatment phase.|51
10375317|NCT00576758|11516182|FG000|COMPLETED|Follow-up Period||28
10375318|NCT00576758|11516183|FG001|COMPLETED|Follow-up Period||34
10375319|NCT00576758|11516182|FG000|NOT COMPLETED|Follow-up Period||27
10375320|NCT00576758|11516183|FG001|NOT COMPLETED|Follow-up Period||17
10375321|NCT00576823|11516193|FG000|STARTED|12-week Efficacy Phase||12
10375322|NCT00576823|11516194|FG001|STARTED|12-week Efficacy Phase||6
10375323|NCT00576823|11516195|FG002|STARTED|12-week Efficacy Phase||7
10375324|NCT00576823|11516193|FG000|COMPLETED|12-week Efficacy Phase||11
10375325|NCT00576823|11516194|FG001|COMPLETED|12-week Efficacy Phase||6
10375326|NCT00576823|11516195|FG002|COMPLETED|12-week Efficacy Phase||7
10375327|NCT00576823|11516193|FG000|NOT COMPLETED|12-week Efficacy Phase||1
10375328|NCT00576823|11516194|FG001|NOT COMPLETED|12-week Efficacy Phase||0
10375329|NCT00576823|11516195|FG002|NOT COMPLETED|12-week Efficacy Phase||0
10375330|NCT00576823|11516193|FG000|STARTED|40-week Safety Extension Phase||11
10375331|NCT00576823|11516194|FG001|STARTED|40-week Safety Extension Phase||6
10375332|NCT00576823|11516195|FG002|STARTED|40-week Safety Extension Phase|One patient refused to continue in the extension phase.|6
10375333|NCT00576823|11516193|FG000|COMPLETED|40-week Safety Extension Phase||10
10375334|NCT00576823|11516194|FG001|COMPLETED|40-week Safety Extension Phase||6
10375335|NCT00576823|11516195|FG002|COMPLETED|40-week Safety Extension Phase||6
10375336|NCT00576823|11516193|FG000|NOT COMPLETED|40-week Safety Extension Phase||1
10375337|NCT00576823|11516194|FG001|NOT COMPLETED|40-week Safety Extension Phase||0
10375338|NCT00576823|11516195|FG002|NOT COMPLETED|40-week Safety Extension Phase||0
10375339|NCT00576901|11516206|FG000|STARTED|Overall Study||23
10375340|NCT00576901|11516206|FG000|COMPLETED|Overall Study||20
10375341|NCT00576901|11516206|FG000|NOT COMPLETED|Overall Study||3
10375342|NCT00576927|11516212|FG000|STARTED|Clinical Assessment||79
10375343|NCT00576927|11516212|FG000|COMPLETED|Clinical Assessment||43
10375344|NCT00576927|11516212|FG000|NOT COMPLETED|Clinical Assessment||36
10375345|NCT00576927|11516212|FG000|STARTED|Baseline||43
10375346|NCT00576927|11516212|FG000|COMPLETED|Baseline||30
10375347|NCT00576927|11516212|FG000|NOT COMPLETED|Baseline||13
10375348|NCT00576927|11516212|FG000|STARTED|Sleep Hygiene Behavioral Intervention||30
10375349|NCT00576927|11516212|FG000|COMPLETED|Sleep Hygiene Behavioral Intervention||23
10375350|NCT00576927|11516212|FG000|NOT COMPLETED|Sleep Hygiene Behavioral Intervention||7
10375351|NCT00576927|11516212|FG000|STARTED|Sleep Hygiene With the Placebo||23
10375352|NCT00576927|11516212|FG000|COMPLETED|Sleep Hygiene With the Placebo||22
10375353|NCT00576927|11516212|FG000|NOT COMPLETED|Sleep Hygiene With the Placebo||1
10375354|NCT00576927|11516212|FG000|STARTED|Sleep Hygiene With Study Drug||22
10375355|NCT00576927|11516212|FG000|COMPLETED|Sleep Hygiene With Study Drug||22
10375356|NCT00576927|11516212|FG000|NOT COMPLETED|Sleep Hygiene With Study Drug||0
10538390|NCT01454739|11691248|FG000|NOT COMPLETED|Overall Study||7
10538391|NCT01454739|11691249|FG001|NOT COMPLETED|Overall Study||21
10538392|NCT01454778|11691262|FG000|STARTED|Overall Study||50
10538393|NCT01454778|11691262|FG000|COMPLETED|Overall Study||47
10538394|NCT01454778|11691262|FG000|NOT COMPLETED|Overall Study||3
10538395|NCT01454791|11691268|FG000|STARTED|Overall Study||20
10538396|NCT01454791|11691269|FG001|STARTED|Overall Study||20
10538397|NCT01454791|11691268|FG000|COMPLETED|Overall Study|20 subjects started with Diclofenac, then switched to placebo|20
10538398|NCT01454791|11691269|FG001|COMPLETED|Overall Study|20 subjects started with placebo, then switched to Diclofenac|20
10538399|NCT01454791|11691268|FG000|NOT COMPLETED|Overall Study||0
10538400|NCT01454791|11691269|FG001|NOT COMPLETED|Overall Study||0
10538401|NCT01454830|11691279|FG000|STARTED|Overall Study||61
10538402|NCT01454830|11691280|FG001|STARTED|Overall Study||57
10538403|NCT01454830|11691279|FG000|COMPLETED|Overall Study||30
10538404|NCT01454830|11691280|FG001|COMPLETED|Overall Study||30
10538405|NCT01454830|11691279|FG000|NOT COMPLETED|Overall Study||31
10538406|NCT01454830|11691280|FG001|NOT COMPLETED|Overall Study||27
10538407|NCT01454934|11691288|FG000|STARTED|Overall Study||270
10538408|NCT01454934|11691289|FG001|STARTED|Overall Study||270
10538409|NCT01454934|11691288|FG000|COMPLETED|Overall Study||0
10538410|NCT01454934|11691289|FG001|COMPLETED|Overall Study||0
10375357|NCT00576927|11516212|FG000|STARTED|Randomization 1:1 Placebo or Active Drug||22
10375358|NCT00576927|11516212|FG000|COMPLETED|Randomization 1:1 Placebo or Active Drug||22
10375359|NCT00576927|11516212|FG000|NOT COMPLETED|Randomization 1:1 Placebo or Active Drug||0
10375360|NCT00577005|11516220|FG000|STARTED|Overall Study||16
10375361|NCT00577005|11516221|FG001|STARTED|Overall Study||12
10375362|NCT00577005|11516220|FG000|COMPLETED|Overall Study||11
10375363|NCT00577005|11516221|FG001|COMPLETED|Overall Study||9
10375364|NCT00577005|11516220|FG000|NOT COMPLETED|Overall Study||5
10375365|NCT00577005|11516221|FG001|NOT COMPLETED|Overall Study||3
10375366|NCT00577031|11516230|FG000|STARTED|Overall Study||205
10375367|NCT00577031|11516230|FG000|COMPLETED|Overall Study||0
10375368|NCT00577031|11516230|FG000|NOT COMPLETED|Overall Study||205
10375369|NCT00577083|11516239|FG000|STARTED|First Intervention (14 Days)||48
10375370|NCT00577083|11516240|FG001|STARTED|First Intervention (14 Days)||52
10375371|NCT00577083|11516239|FG000|COMPLETED|First Intervention (14 Days)||48
10375372|NCT00577083|11516240|FG001|COMPLETED|First Intervention (14 Days)||52
10375373|NCT00577083|11516239|FG000|NOT COMPLETED|First Intervention (14 Days)||0
10375374|NCT00577083|11516240|FG001|NOT COMPLETED|First Intervention (14 Days)||0
10375375|NCT00577083|11516239|FG000|STARTED|Washout (14 Days)||48
10538411|NCT01454934|11691288|FG000|NOT COMPLETED|Overall Study||270
10538412|NCT01454934|11691289|FG001|NOT COMPLETED|Overall Study||270
10538413|NCT01454947|11691303|FG000|STARTED|Overall Study||27
10538414|NCT01454947|11691304|FG001|STARTED|Overall Study||42
10538415|NCT01454947|11691305|FG002|STARTED|Overall Study||35
10538416|NCT01454947|11691306|FG003|STARTED|Overall Study||20
10538417|NCT01454947|11691307|FG004|STARTED|Overall Study||34
10538418|NCT01454947|11691308|FG005|STARTED|Overall Study||35
10538419|NCT01454947|11691309|FG006|STARTED|Overall Study||27
10538420|NCT01454947|11691310|FG007|STARTED|Overall Study||28
10375376|NCT00577083|11516240|FG001|STARTED|Washout (14 Days)||52
10375377|NCT00577083|11516239|FG000|COMPLETED|Washout (14 Days)||48
10375378|NCT00577083|11516240|FG001|COMPLETED|Washout (14 Days)||52
10375379|NCT00577083|11516239|FG000|NOT COMPLETED|Washout (14 Days)||0
10375380|NCT00577083|11516240|FG001|NOT COMPLETED|Washout (14 Days)||0
10375381|NCT00577083|11516239|FG000|STARTED|Second Intervention (14days)||48
10375382|NCT00577083|11516240|FG001|STARTED|Second Intervention (14days)||52
10375383|NCT00577083|11516239|FG000|COMPLETED|Second Intervention (14days)||48
10375384|NCT00577083|11516240|FG001|COMPLETED|Second Intervention (14days)||52
10375385|NCT00577083|11516239|FG000|NOT COMPLETED|Second Intervention (14days)||0
10375386|NCT00577083|11516240|FG001|NOT COMPLETED|Second Intervention (14days)||0
10375387|NCT00577096|11516254|FG000|STARTED|Short Term Participation||69
10375388|NCT00577096|11516255|FG001|STARTED|Short Term Participation||66
10375389|NCT00577096|11516254|FG000|COMPLETED|Short Term Participation||62
10375390|NCT00577096|11516255|FG001|COMPLETED|Short Term Participation||58
10375391|NCT00577096|11516254|FG000|NOT COMPLETED|Short Term Participation||7
10375392|NCT00577096|11516255|FG001|NOT COMPLETED|Short Term Participation||8
10375393|NCT00577096|11516254|FG000|STARTED|Long Term Participation|Only the first 34 patients who met long-term eligibility (response to EPO) were enrolled.|34
10375394|NCT00577096|11516255|FG001|STARTED|Long Term Participation|Only 35 patients who met long-term eligibility (response to EPO) were enrolled.|35
10375395|NCT00577096|11516254|FG000|COMPLETED|Long Term Participation||34
10375396|NCT00577096|11516255|FG001|COMPLETED|Long Term Participation|Sub-set of patients (n=69) who completed short term (n=120) continued in long term participation.|35
10538421|NCT01454947|11691303|FG000|COMPLETED|Overall Study||24
10538422|NCT01454947|11691304|FG001|COMPLETED|Overall Study||38
10538423|NCT01454947|11691305|FG002|COMPLETED|Overall Study||32
10538424|NCT01454947|11691306|FG003|COMPLETED|Overall Study||19
10538425|NCT01454947|11691307|FG004|COMPLETED|Overall Study||33
10538426|NCT01454947|11691308|FG005|COMPLETED|Overall Study||32
10538427|NCT01454947|11691309|FG006|COMPLETED|Overall Study||26
10538428|NCT01454947|11691310|FG007|COMPLETED|Overall Study||23
10538429|NCT01454947|11691303|FG000|NOT COMPLETED|Overall Study||3
10538430|NCT01454947|11691304|FG001|NOT COMPLETED|Overall Study||4
10538431|NCT01454947|11691305|FG002|NOT COMPLETED|Overall Study||3
10538432|NCT01454947|11691306|FG003|NOT COMPLETED|Overall Study||1
10538433|NCT01454947|11691307|FG004|NOT COMPLETED|Overall Study||1
10538434|NCT01454947|11691308|FG005|NOT COMPLETED|Overall Study||3
10538435|NCT01454947|11691309|FG006|NOT COMPLETED|Overall Study||1
10538436|NCT01454947|11691310|FG007|NOT COMPLETED|Overall Study||5
10538437|NCT01455012|11691330|FG000|STARTED|Overall Study||41
10538438|NCT01455012|11691331|FG001|STARTED|Overall Study||40
10538439|NCT01455012|11691330|FG000|COMPLETED|Overall Study||30
10538440|NCT01455012|11691331|FG001|COMPLETED|Overall Study||36
10375397|NCT00577096|11516254|FG000|NOT COMPLETED|Long Term Participation||0
10375398|NCT00577096|11516255|FG001|NOT COMPLETED|Long Term Participation||0
10375399|NCT00577122|11516263|FG000|STARTED|Overall Study||14
10375400|NCT00577122|11516264|FG001|STARTED|Overall Study||16
10375401|NCT00577122|11516263|FG000|COMPLETED|Overall Study||0
10375402|NCT00577122|11516264|FG001|COMPLETED|Overall Study||0
10375403|NCT00577122|11516263|FG000|NOT COMPLETED|Overall Study||14
10375404|NCT00577122|11516264|FG001|NOT COMPLETED|Overall Study||16
10538441|NCT01455012|11691330|FG000|NOT COMPLETED|Overall Study||11
10538442|NCT01455012|11691331|FG001|NOT COMPLETED|Overall Study||4
10538443|NCT01455064|11691337|FG000|STARTED|Overall Study||31
10538444|NCT01455064|11691337|FG000|COMPLETED|Overall Study||30
10538445|NCT01455064|11691337|FG000|NOT COMPLETED|Overall Study||1
10538446|NCT01455181|11691341|FG000|STARTED|Overall Study||24
10538447|NCT01455181|11691341|FG000|COMPLETED|Overall Study||24
10375405|NCT00577135|11516275|FG000|STARTED|Overall Study||74
10375406|NCT00577135|11516276|FG001|STARTED|Overall Study||82
10717186|NCT02696785|11881097|FG000|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|1
10717228|NCT02696850|11881158|FG001|COMPLETED|Overall Study||32
10717187|NCT02696785|11881098|FG001|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|0
10717188|NCT02696785|11881099|FG002|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|24
10717189|NCT02696785|11881100|FG003|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|16
10717190|NCT02696785|11881097|FG000|COMPLETED|Follow-up Period||0
10717191|NCT02696785|11881098|FG001|COMPLETED|Follow-up Period||0
10717192|NCT02696785|11881099|FG002|COMPLETED|Follow-up Period||11
10717193|NCT02696785|11881100|FG003|COMPLETED|Follow-up Period||8
10717194|NCT02696785|11881097|FG000|NOT COMPLETED|Follow-up Period||1
10717195|NCT02696785|11881098|FG001|NOT COMPLETED|Follow-up Period||0
10717196|NCT02696785|11881099|FG002|NOT COMPLETED|Follow-up Period||13
10717197|NCT02696785|11881100|FG003|NOT COMPLETED|Follow-up Period||8
10375407|NCT00577135|11516277|FG002|STARTED|Overall Study||77
10717198|NCT02696798|11881131|FG000|STARTED|Blinded Treatment Dosing Period||104
10717199|NCT02696798|11881132|FG001|STARTED|Blinded Treatment Dosing Period||114
10717200|NCT02696798|11881133|FG002|STARTED|Blinded Treatment Dosing Period||98
10717201|NCT02696798|11881131|FG000|COMPLETED|Blinded Treatment Dosing Period||93
10717202|NCT02696798|11881132|FG001|COMPLETED|Blinded Treatment Dosing Period||99
10717203|NCT02696798|11881133|FG002|COMPLETED|Blinded Treatment Dosing Period||90
10717204|NCT02696798|11881131|FG000|NOT COMPLETED|Blinded Treatment Dosing Period||11
10717205|NCT02696798|11881132|FG001|NOT COMPLETED|Blinded Treatment Dosing Period||15
10717206|NCT02696798|11881133|FG002|NOT COMPLETED|Blinded Treatment Dosing Period||8
10717207|NCT02696798|11881131|FG000|STARTED|Extended Treatment Period||93
10717208|NCT02696798|11881132|FG001|STARTED|Extended Treatment Period|1 participant completed blinded treatment period and entered post-treatment followup period directly|98
10717209|NCT02696798|11881133|FG002|STARTED|Extended Treatment Period||90
10717210|NCT02696798|11881131|FG000|COMPLETED|Extended Treatment Period||81
10717211|NCT02696798|11881132|FG001|COMPLETED|Extended Treatment Period||89
10717212|NCT02696798|11881133|FG002|COMPLETED|Extended Treatment Period||80
10717213|NCT02696798|11881131|FG000|NOT COMPLETED|Extended Treatment Period||12
10717214|NCT02696798|11881132|FG001|NOT COMPLETED|Extended Treatment Period||9
10717215|NCT02696798|11881133|FG002|NOT COMPLETED|Extended Treatment Period||10
10717216|NCT02696798|11881131|FG000|STARTED|Post-treatment Follow-up Period|Participants who terminate RHBW early or who didn't enroll into RHBY entered Follow-Up Period.|5
10717217|NCT02696798|11881132|FG001|STARTED|Post-treatment Follow-up Period|Participants who terminate RHBW early or who didn't enroll into RHBY entered Follow-Up Period.|34
10717218|NCT02696798|11881133|FG002|STARTED|Post-treatment Follow-up Period|Participants who terminate RHBW early or who didn't enroll into RHBY entered Follow-Up Period.|22
10717219|NCT02696798|11881131|FG000|COMPLETED|Post-treatment Follow-up Period||0
10717220|NCT02696798|11881132|FG001|COMPLETED|Post-treatment Follow-up Period||8
10717221|NCT02696798|11881133|FG002|COMPLETED|Post-treatment Follow-up Period||3
10375408|NCT00577135|11516278|FG003|STARTED|Overall Study||75
10375409|NCT00577135|11516275|FG000|COMPLETED|Overall Study||74
10375410|NCT00577135|11516276|FG001|COMPLETED|Overall Study||82
10375411|NCT00577135|11516277|FG002|COMPLETED|Overall Study||77
10375412|NCT00577135|11516278|FG003|COMPLETED|Overall Study||75
10375413|NCT00577135|11516275|FG000|NOT COMPLETED|Overall Study||0
10375414|NCT00577135|11516276|FG001|NOT COMPLETED|Overall Study||0
10375415|NCT00577135|11516277|FG002|NOT COMPLETED|Overall Study||0
10375416|NCT00577135|11516278|FG003|NOT COMPLETED|Overall Study||0
10375417|NCT00577382|11516290|FG000|STARTED|Overall Study||21
10375418|NCT00577382|11516291|FG001|STARTED|Overall Study||31
10375419|NCT00577382|11516290|FG000|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
10375420|NCT00577382|11516291|FG001|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
10375421|NCT00577382|11516290|FG000|NOT COMPLETED|Overall Study||21
10375422|NCT00577382|11516291|FG001|NOT COMPLETED|Overall Study||31
10375423|NCT00577408|11516299|FG000|STARTED|Overall Study||28
10375424|NCT00577408|11516300|FG001|STARTED|Overall Study||32
10375425|NCT00577408|11516299|FG000|COMPLETED|Overall Study||16
10375426|NCT00577408|11516300|FG001|COMPLETED|Overall Study||9
10375427|NCT00577408|11516299|FG000|NOT COMPLETED|Overall Study||12
10375428|NCT00577408|11516300|FG001|NOT COMPLETED|Overall Study||23
10375429|NCT00577460|11516309|FG000|STARTED|Overall Study||129
10375430|NCT00577460|11516310|FG001|STARTED|Overall Study||123
10375431|NCT00577460|11516311|FG002|STARTED|Overall Study||139
10375432|NCT00577460|11516309|FG000|COMPLETED|Overall Study||113
10375433|NCT00577460|11516310|FG001|COMPLETED|Overall Study||104
10375434|NCT00577460|11516311|FG002|COMPLETED|Overall Study||112
10375435|NCT00577460|11516309|FG000|NOT COMPLETED|Overall Study||16
10306519|NCT00098839|11439388|FG001|NOT COMPLETED|Overall Study||33
10306520|NCT00098865|11439395|FG000|STARTED|Overall Study||15
10306521|NCT00098865|11439395|FG000|COMPLETED|Overall Study||6
10306522|NCT00098865|11439395|FG000|NOT COMPLETED|Overall Study||9
10306523|NCT00098956|11439399|FG000|STARTED|Overall Study||19
10306524|NCT00098956|11439399|FG000|COMPLETED|Overall Study||19
10538448|NCT01455181|11691341|FG000|NOT COMPLETED|Overall Study||0
10538449|NCT01455194|11691348|FG000|STARTED|Overall Study||153
10538450|NCT01455194|11691349|FG001|STARTED|Overall Study||120
10717222|NCT02696798|11881131|FG000|NOT COMPLETED|Post-treatment Follow-up Period||5
10717223|NCT02696798|11881132|FG001|NOT COMPLETED|Post-treatment Follow-up Period||26
10717224|NCT02696798|11881133|FG002|NOT COMPLETED|Post-treatment Follow-up Period||19
10717225|NCT02696850|11881157|FG000|STARTED|Overall Study||40
10717226|NCT02696850|11881158|FG001|STARTED|Overall Study||40
10717227|NCT02696850|11881157|FG000|COMPLETED|Overall Study||29
10717229|NCT02696850|11881157|FG000|NOT COMPLETED|Overall Study||11
10717230|NCT02696850|11881158|FG001|NOT COMPLETED|Overall Study||8
10717231|NCT02696902|11881167|FG000|STARTED|Overall Study||85
10717232|NCT02696902|11881168|FG001|STARTED|Overall Study||16
10717233|NCT02696902|11881169|FG002|STARTED|Overall Study||87
10717234|NCT02696902|11881167|FG000|Treated|Overall Study||83
10717235|NCT02696902|11881168|FG001|Treated|Overall Study||16
10306525|NCT00098956|11439399|FG000|NOT COMPLETED|Overall Study||0
10306526|NCT00099021|11439403|FG000|STARTED|Overall Study||21
10375436|NCT00577460|11516310|FG001|NOT COMPLETED|Overall Study||19
10375437|NCT00577460|11516311|FG002|NOT COMPLETED|Overall Study||27
10375438|NCT00577473|11516328|FG000|STARTED|Overall Study||154
10375439|NCT00577473|11516329|FG001|STARTED|Overall Study||147
10375440|NCT00577473|11516328|FG000|ITT Population|Overall Study||150
10375441|NCT00577473|11516329|FG001|ITT Population|Overall Study||136
10375442|NCT00577473|11516328|FG000|COMPLETED|Overall Study||133
10375443|NCT00577473|11516329|FG001|COMPLETED|Overall Study||123
10375444|NCT00577473|11516328|FG000|NOT COMPLETED|Overall Study||21
10375445|NCT00577473|11516329|FG001|NOT COMPLETED|Overall Study||24
10375446|NCT00577512|11516335|FG000|STARTED|Overall Study||4
10375447|NCT00577512|11516335|FG000|COMPLETED|Overall Study||0
10375448|NCT00577512|11516335|FG000|NOT COMPLETED|Overall Study||4
10375449|NCT00577590|11516342|FG000|STARTED|Overall Study||28
10375450|NCT00577590|11516343|FG001|STARTED|Overall Study||27
10375451|NCT00577590|11516344|FG002|STARTED|Overall Study||23
10375452|NCT00577590|11516342|FG000|COMPLETED|Overall Study||28
10375453|NCT00577590|11516343|FG001|COMPLETED|Overall Study||27
10375454|NCT00577590|11516344|FG002|COMPLETED|Overall Study||23
10375455|NCT00577590|11516342|FG000|NOT COMPLETED|Overall Study||0
10375456|NCT00577590|11516343|FG001|NOT COMPLETED|Overall Study||0
10375457|NCT00577590|11516344|FG002|NOT COMPLETED|Overall Study||0
10375458|NCT00577629|11516352|FG000|STARTED|Treatment Period||39
10375459|NCT00577629|11516352|FG000|COMPLETED|Treatment Period||38
10375460|NCT00577629|11516352|FG000|NOT COMPLETED|Treatment Period||1
10375461|NCT00577629|11516352|FG000|STARTED|Long Term Follow-Up||38
10375462|NCT00577629|11516352|FG000|COMPLETED|Long Term Follow-Up||13
10375463|NCT00577629|11516352|FG000|NOT COMPLETED|Long Term Follow-Up||25
10375464|NCT00577642|11516358|FG000|STARTED|Overall Study||29
10375465|NCT00577642|11516358|FG000|COMPLETED|Overall Study||28
10375466|NCT00577642|11516358|FG000|NOT COMPLETED|Overall Study||1
10375467|NCT00577655|11516364|FG000|STARTED|Overall Study|This number represents the number of participants randomized.|52
10375468|NCT00577655|11516365|FG001|STARTED|Overall Study|This number represents the number of participants randomized.|51
10375469|NCT00577655|11516364|FG000|COMPLETED|Overall Study||51
10375470|NCT00577655|11516365|FG001|COMPLETED|Overall Study||47
10375471|NCT00577655|11516364|FG000|NOT COMPLETED|Overall Study||1
10375472|NCT00577655|11516365|FG001|NOT COMPLETED|Overall Study||4
10375473|NCT00577707|11516372|FG000|STARTED|Overall Study||9
10375474|NCT00577707|11516372|FG000|COMPLETED|Overall Study||6
10375475|NCT00577707|11516372|FG000|NOT COMPLETED|Overall Study||3
10375476|NCT00577720|11516380|FG000|STARTED|Overall Study||37
10375477|NCT00577720|11516381|FG001|STARTED|Overall Study||36
10375478|NCT00577720|11516382|FG002|STARTED|Overall Study||36
10306527|NCT00099021|11439403|FG000|COMPLETED|Overall Study||21
10306528|NCT00099021|11439403|FG000|NOT COMPLETED|Overall Study||0
10306529|NCT00099047|11439409|FG000|STARTED|Overall Study||11
10306530|NCT00099047|11439410|FG001|STARTED|Overall Study||12
10375479|NCT00577720|11516383|FG003|STARTED|Overall Study||72
10375480|NCT00577720|11516380|FG000|ITT (Intent to Treat) Population|Overall Study||34
10375481|NCT00577720|11516381|FG001|ITT (Intent to Treat) Population|Overall Study||35
10375482|NCT00577720|11516382|FG002|ITT (Intent to Treat) Population|Overall Study||35
10717236|NCT02696902|11881169|FG002|Treated|Overall Study||85
10306531|NCT00099047|11439409|FG000|COMPLETED|Overall Study||11
10306532|NCT00099047|11439410|FG001|COMPLETED|Overall Study||12
10306533|NCT00099047|11439409|FG000|NOT COMPLETED|Overall Study||0
10306534|NCT00099047|11439410|FG001|NOT COMPLETED|Overall Study||0
10375483|NCT00577720|11516383|FG003|ITT (Intent to Treat) Population|Overall Study||65
10375484|NCT00577720|11516380|FG000|COMPLETED|Overall Study||33
10538451|NCT01455194|11691350|FG002|STARTED|Overall Study||122
10717237|NCT02696902|11881167|FG000|Intent-to-treat (ITT) Population|Overall Study||85
10717238|NCT02696902|11881168|FG001|Intent-to-treat (ITT) Population|Overall Study||16
10717239|NCT02696902|11881169|FG002|Intent-to-treat (ITT) Population|Overall Study||87
10375485|NCT00577720|11516381|FG001|COMPLETED|Overall Study||35
10375486|NCT00577720|11516382|FG002|COMPLETED|Overall Study||35
10375487|NCT00577720|11516383|FG003|COMPLETED|Overall Study||65
10375488|NCT00577720|11516380|FG000|NOT COMPLETED|Overall Study||4
10375489|NCT00577720|11516381|FG001|NOT COMPLETED|Overall Study||1
10375490|NCT00577720|11516382|FG002|NOT COMPLETED|Overall Study||1
10375491|NCT00577720|11516383|FG003|NOT COMPLETED|Overall Study||7
10375492|NCT00577824|11516396|FG000|STARTED|Overall Study|Started=Randomized|72
10375493|NCT00577824|11516397|FG001|STARTED|Overall Study||73
10375494|NCT00577824|11516398|FG002|STARTED|Overall Study||36
10375495|NCT00577824|11516396|FG000|Full Analysis Set|Overall Study|Full Analysis Set=subject received at least one dose of study medication (active or placebo)|72
10375496|NCT00577824|11516397|FG001|Full Analysis Set|Overall Study||72
10375497|NCT00577824|11516398|FG002|Full Analysis Set|Overall Study||35
10375498|NCT00577824|11516396|FG000|COMPLETED|Overall Study||65
10375499|NCT00577824|11516397|FG001|COMPLETED|Overall Study||53
10375500|NCT00577824|11516398|FG002|COMPLETED|Overall Study||34
10717240|NCT02696902|11881167|FG000|As-treated Population|Overall Study||83
10717241|NCT02696902|11881168|FG001|As-treated Population|Overall Study||16
10375501|NCT00577824|11516396|FG000|NOT COMPLETED|Overall Study||7
10538452|NCT01455194|11691351|FG003|STARTED|Overall Study||125
10538453|NCT01455194|11691348|FG000|COMPLETED|Overall Study||0
10538454|NCT01455194|11691349|FG001|COMPLETED|Overall Study||89
10538455|NCT01455194|11691350|FG002|COMPLETED|Overall Study||92
10538456|NCT01455194|11691351|FG003|COMPLETED|Overall Study||97
10538457|NCT01455194|11691348|FG000|NOT COMPLETED|Overall Study||153
10538458|NCT01455194|11691349|FG001|NOT COMPLETED|Overall Study||31
10538459|NCT01455194|11691350|FG002|NOT COMPLETED|Overall Study||30
10538460|NCT01455194|11691351|FG003|NOT COMPLETED|Overall Study||28
10538461|NCT01455220|11691364|FG000|STARTED|Overall Study||45
10538462|NCT01455220|11691364|FG000|COMPLETED|Overall Study||15
10538463|NCT01455220|11691364|FG000|NOT COMPLETED|Overall Study||30
10538464|NCT01455415|11691373|FG000|STARTED|Period 1|Started=Treated|154
10538465|NCT01455415|11691374|FG001|STARTED|Period 1|Started=Treated|147
10538466|NCT01455415|11691373|FG000|COMPLETED|Period 1||135
10538467|NCT01455415|11691374|FG001|COMPLETED|Period 1||123
10538468|NCT01455415|11691373|FG000|NOT COMPLETED|Period 1||19
10538469|NCT01455415|11691374|FG001|NOT COMPLETED|Period 1||24
10538470|NCT01455415|11691373|FG000|STARTED|Washout||135
10538471|NCT01455415|11691374|FG001|STARTED|Washout||123
10538472|NCT01455415|11691373|FG000|COMPLETED|Washout||127
10538473|NCT01455415|11691374|FG001|COMPLETED|Washout||116
10538474|NCT01455415|11691373|FG000|NOT COMPLETED|Washout||8
10538475|NCT01455415|11691374|FG001|NOT COMPLETED|Washout||7
10538476|NCT01455415|11691373|FG000|STARTED|Period 2||127
10538477|NCT01455415|11691374|FG001|STARTED|Period 2||116
10538478|NCT01455415|11691373|FG000|COMPLETED|Period 2||114
10538479|NCT01455415|11691374|FG001|COMPLETED|Period 2||106
10538480|NCT01455415|11691373|FG000|NOT COMPLETED|Period 2||13
10538481|NCT01455415|11691374|FG001|NOT COMPLETED|Period 2||10
10538482|NCT01455415|11691373|FG000|STARTED|Follow-up||114
10538483|NCT01455415|11691374|FG001|STARTED|Follow-up||106
10538484|NCT01455415|11691373|FG000|COMPLETED|Follow-up||111
10538485|NCT01455415|11691374|FG001|COMPLETED|Follow-up||104
10538486|NCT01455415|11691373|FG000|NOT COMPLETED|Follow-up||3
10538487|NCT01455415|11691374|FG001|NOT COMPLETED|Follow-up||2
10538488|NCT01455428|11691382|FG000|STARTED|Overall Study||112
10657582|NCT02226796|11818739|FG000|Follow Up Assessment|First Intervention Phase (Week 1)||2
10657583|NCT02226796|11818740|FG001|Follow Up Assessment|First Intervention Phase (Week 1)||1
10657584|NCT02226796|11818739|FG000|COMPLETED|First Intervention Phase (Week 1)||2
10657585|NCT02226796|11818740|FG001|COMPLETED|First Intervention Phase (Week 1)||1
10657586|NCT02226796|11818739|FG000|NOT COMPLETED|First Intervention Phase (Week 1)||0
10657587|NCT02226796|11818740|FG001|NOT COMPLETED|First Intervention Phase (Week 1)||0
10657588|NCT02226796|11818739|FG000|STARTED|Washout (Weeks 2-5)||2
10657589|NCT02226796|11818740|FG001|STARTED|Washout (Weeks 2-5)||1
10657590|NCT02226796|11818739|FG000|COMPLETED|Washout (Weeks 2-5)||2
10657591|NCT02226796|11818740|FG001|COMPLETED|Washout (Weeks 2-5)||1
10657592|NCT02226796|11818739|FG000|NOT COMPLETED|Washout (Weeks 2-5)||0
10657593|NCT02226796|11818740|FG001|NOT COMPLETED|Washout (Weeks 2-5)||0
10657594|NCT02226796|11818739|FG000|STARTED|Second Intervention Phase (Week 6)||2
10657595|NCT02226796|11818740|FG001|STARTED|Second Intervention Phase (Week 6)||1
10657596|NCT02226796|11818739|FG000|Baseline Assessment|Second Intervention Phase (Week 6)||2
10657597|NCT02226796|11818740|FG001|Baseline Assessment|Second Intervention Phase (Week 6)||1
10657598|NCT02226796|11818739|FG000|Follow Up Assessment|Second Intervention Phase (Week 6)||2
10657599|NCT02226796|11818740|FG001|Follow Up Assessment|Second Intervention Phase (Week 6)||1
10717242|NCT02696902|11881169|FG002|As-treated Population|Overall Study||85
10375502|NCT00577824|11516397|FG001|NOT COMPLETED|Overall Study||20
10375503|NCT00577824|11516398|FG002|NOT COMPLETED|Overall Study||2
10538489|NCT01455428|11691383|FG001|STARTED|Overall Study||110
10538490|NCT01455428|11691382|FG000|Treated|Overall Study||111
10538491|NCT01455428|11691383|FG001|Treated|Overall Study||109
10538492|NCT01455428|11691382|FG000|COMPLETED|Overall Study||98
10538493|NCT01455428|11691383|FG001|COMPLETED|Overall Study||92
10538494|NCT01455428|11691382|FG000|NOT COMPLETED|Overall Study||14
10375504|NCT00577863|11516408|FG000|STARTED|Overall Study||92
10375505|NCT00577863|11516409|FG001|STARTED|Overall Study||108
10538495|NCT01455428|11691383|FG001|NOT COMPLETED|Overall Study||18
10538496|NCT01455519|11691391|FG000|STARTED|Overall Study||12
10538497|NCT01455519|11691392|FG001|STARTED|Overall Study||23
10538498|NCT01455519|11691391|FG000|COMPLETED|Overall Study||8
10375506|NCT00577863|11516408|FG000|Received at Least One Injection|Overall Study||92
10375507|NCT00577863|11516409|FG001|Received at Least One Injection|Overall Study||107
10375508|NCT00577863|11516408|FG000|COMPLETED|Overall Study||82
10375509|NCT00577863|11516409|FG001|COMPLETED|Overall Study||94
10375510|NCT00577863|11516408|FG000|NOT COMPLETED|Overall Study||10
10375511|NCT00577863|11516409|FG001|NOT COMPLETED|Overall Study||14
10375512|NCT00577889|11516418|FG000|STARTED|Overall Study||9
10375513|NCT00577889|11516419|FG001|STARTED|Overall Study||6
10375514|NCT00577889|11516420|FG002|STARTED|Overall Study||6
10375515|NCT00577889|11516418|FG000|COMPLETED|Overall Study||8
10375516|NCT00577889|11516419|FG001|COMPLETED|Overall Study||6
10538499|NCT01455519|11691392|FG001|COMPLETED|Overall Study||18
10538500|NCT01455519|11691391|FG000|NOT COMPLETED|Overall Study||4
10657600|NCT02226796|11818739|FG000|COMPLETED|Second Intervention Phase (Week 6)||2
10657601|NCT02226796|11818740|FG001|COMPLETED|Second Intervention Phase (Week 6)||1
10657602|NCT02226796|11818739|FG000|NOT COMPLETED|Second Intervention Phase (Week 6)||0
10657603|NCT02226796|11818740|FG001|NOT COMPLETED|Second Intervention Phase (Week 6)||0
10657604|NCT02226965|11818746|FG000|STARTED|Overall Study||45
10657605|NCT02226965|11818746|FG000|COMPLETED|Overall Study||4
10657606|NCT02226965|11818746|FG000|NOT COMPLETED|Overall Study||41
10657607|NCT02227108|11818750|FG000|STARTED|Overall Study||32
10657608|NCT02227108|11818750|FG000|Treated|Overall Study||30
10657609|NCT02227108|11818750|FG000|COMPLETED|Overall Study||1
10657610|NCT02227108|11818750|FG000|NOT COMPLETED|Overall Study||31
10657611|NCT02227121|11818754|FG000|STARTED|Overall Study||16
10657612|NCT02227121|11818754|FG000|COMPLETED|Overall Study||16
10657613|NCT02227121|11818754|FG000|NOT COMPLETED|Overall Study||0
10657614|NCT02227316|11818762|FG000|STARTED|Overall Study||4
10657615|NCT02227316|11818763|FG001|STARTED|Overall Study||4
10657616|NCT02227316|11818764|FG002|STARTED|Overall Study||16
10657617|NCT02227316|11818765|FG003|STARTED|Overall Study||16
10657618|NCT02227316|11818762|FG000|COMPLETED|Overall Study||4
10657619|NCT02227316|11818763|FG001|COMPLETED|Overall Study||4
10657620|NCT02227316|11818764|FG002|COMPLETED|Overall Study||16
10657621|NCT02227316|11818765|FG003|COMPLETED|Overall Study||16
10657622|NCT02227316|11818762|FG000|NOT COMPLETED|Overall Study||0
10657623|NCT02227316|11818763|FG001|NOT COMPLETED|Overall Study||0
10657624|NCT02227316|11818764|FG002|NOT COMPLETED|Overall Study||0
10657625|NCT02227316|11818765|FG003|NOT COMPLETED|Overall Study||0
10657626|NCT02227329|11818777|FG000|STARTED|Overall Study||18
10657627|NCT02227329|11818778|FG001|STARTED|Overall Study||20
10657628|NCT02227329|11818777|FG000|COMPLETED|Overall Study||18
10657629|NCT02227329|11818778|FG001|COMPLETED|Overall Study||20
10657630|NCT02227329|11818777|FG000|NOT COMPLETED|Overall Study||0
10657631|NCT02227329|11818778|FG001|NOT COMPLETED|Overall Study||0
10657632|NCT02227368|11818786|FG000|STARTED|Overall Study||16
10657633|NCT02227368|11818787|FG001|STARTED|Overall Study||24
10657634|NCT02227368|11818786|FG000|Sujects Who Received Treatment|Overall Study||16
10657635|NCT02227368|11818787|FG001|Sujects Who Received Treatment|Overall Study||24
10657636|NCT02227368|11818786|FG000|Sujects Who Completed Treatment|Overall Study||10
10657637|NCT02227368|11818787|FG001|Sujects Who Completed Treatment|Overall Study||17
10657638|NCT02227368|11818786|FG000|COMPLETED|Overall Study|Subjects who discontinued treatment were encouraged to remain in the study.|14
10657639|NCT02227368|11818787|FG001|COMPLETED|Overall Study|Subjects who discontinued treatment were encouraged to remain in the study.|20
10657640|NCT02227368|11818786|FG000|NOT COMPLETED|Overall Study||2
10657641|NCT02227368|11818787|FG001|NOT COMPLETED|Overall Study||4
10657642|NCT02227446|11818795|FG000|STARTED|Overall Study||521
10657643|NCT02227446|11818796|FG001|STARTED|Overall Study||515
10657644|NCT02227446|11818795|FG000|COMPLETED|Overall Study||499
10657645|NCT02227446|11818796|FG001|COMPLETED|Overall Study||481
10657646|NCT02227446|11818795|FG000|NOT COMPLETED|Overall Study||22
10657647|NCT02227446|11818796|FG001|NOT COMPLETED|Overall Study||34
10657648|NCT02227485|11818804|FG000|STARTED|First Follow-up||40
10657649|NCT02227485|11818805|FG001|STARTED|First Follow-up||40
10657650|NCT02227485|11818804|FG000|COMPLETED|First Follow-up|At the first follow-up we lost 4 patients.|36
10657651|NCT02227485|11818805|FG001|COMPLETED|First Follow-up|After 2 weeks, 2 patients had withdrew the study.|38
10657652|NCT02227485|11818804|FG000|NOT COMPLETED|First Follow-up||4
10657653|NCT02227485|11818805|FG001|NOT COMPLETED|First Follow-up||2
10657654|NCT02227485|11818804|FG000|STARTED|Second Follow-up||36
10657655|NCT02227485|11818805|FG001|STARTED|Second Follow-up||38
10657656|NCT02227485|11818804|FG000|COMPLETED|Second Follow-up|At the second follow-up we lost 2 patients.|34
10657657|NCT02227485|11818805|FG001|COMPLETED|Second Follow-up|At the second follow-up we lost 2 patients.|36
10657658|NCT02227485|11818804|FG000|NOT COMPLETED|Second Follow-up||2
10657659|NCT02227485|11818805|FG001|NOT COMPLETED|Second Follow-up||2
10657660|NCT02227667|11818812|FG000|STARTED|Overall Study||16
10657661|NCT02227667|11818812|FG000|COMPLETED|Overall Study||16
10657662|NCT02227667|11818812|FG000|NOT COMPLETED|Overall Study||0
10657663|NCT02227693|11818820|FG000|STARTED|Overall Study||11
10657664|NCT02227693|11818821|FG001|STARTED|Overall Study||7
10657665|NCT02227693|11818822|FG002|STARTED|Overall Study||11
10657666|NCT02227693|11818823|FG003|STARTED|Overall Study||10
10657667|NCT02227693|11818820|FG000|COMPLETED|Overall Study||11
10657668|NCT02227693|11818821|FG001|COMPLETED|Overall Study||7
10657669|NCT02227693|11818822|FG002|COMPLETED|Overall Study||11
10657670|NCT02227693|11818823|FG003|COMPLETED|Overall Study||10
10375517|NCT00577889|11516420|FG002|COMPLETED|Overall Study||6
10375518|NCT00577889|11516418|FG000|NOT COMPLETED|Overall Study||1
10375519|NCT00577889|11516419|FG001|NOT COMPLETED|Overall Study||0
10375520|NCT00577889|11516420|FG002|NOT COMPLETED|Overall Study||0
10375521|NCT00577993|11516431|FG000|STARTED|Overall Study||85
10375522|NCT00577993|11516432|FG001|STARTED|Overall Study||90
10375523|NCT00577993|11516433|FG002|STARTED|Overall Study||35
10375524|NCT00577993|11516431|FG000|COMPLETED|Overall Study||78
10375525|NCT00577993|11516432|FG001|COMPLETED|Overall Study||80
10375526|NCT00577993|11516433|FG002|COMPLETED|Overall Study||32
10375527|NCT00577993|11516431|FG000|NOT COMPLETED|Overall Study||7
10375528|NCT00577993|11516432|FG001|NOT COMPLETED|Overall Study||10
10375529|NCT00577993|11516433|FG002|NOT COMPLETED|Overall Study||3
10375530|NCT00578071|11516439|FG000|STARTED|Overall Study||29
10375531|NCT00578071|11516439|FG000|COMPLETED|Overall Study||29
10375532|NCT00578071|11516439|FG000|NOT COMPLETED|Overall Study||0
10375533|NCT00578136|11516446|FG000|STARTED|Overall Study||27
10375534|NCT00578136|11516447|FG001|STARTED|Overall Study||27
10375535|NCT00578136|11516446|FG000|COMPLETED|Overall Study||26
10375536|NCT00578136|11516447|FG001|COMPLETED|Overall Study||26
10375537|NCT00578136|11516446|FG000|NOT COMPLETED|Overall Study||1
10375538|NCT00578136|11516447|FG001|NOT COMPLETED|Overall Study||1
10375539|NCT00578175|11516456|FG000|STARTED|Overall Study||705
10375540|NCT00578175|11516457|FG001|STARTED|Overall Study||689
10375541|NCT00578175|11516458|FG002|STARTED|Overall Study||389
10375542|NCT00578175|11516456|FG000|COMPLETED|Overall Study||635
10375543|NCT00578175|11516457|FG001|COMPLETED|Overall Study||646
10375544|NCT00578175|11516458|FG002|COMPLETED|Overall Study||365
10375545|NCT00578175|11516456|FG000|NOT COMPLETED|Overall Study||70
10375546|NCT00578175|11516457|FG001|NOT COMPLETED|Overall Study||43
10375547|NCT00578175|11516458|FG002|NOT COMPLETED|Overall Study||24
10375548|NCT00578214|11516471|FG000|STARTED|Overall Study||22
10375549|NCT00578214|11516472|FG001|STARTED|Overall Study||22
10375550|NCT00578214|11516473|FG002|STARTED|Overall Study||31
10375551|NCT00578214|11516471|FG000|COMPLETED|Overall Study||22
10375552|NCT00578214|11516472|FG001|COMPLETED|Overall Study||22
10375553|NCT00578214|11516473|FG002|COMPLETED|Overall Study||31
10375554|NCT00578214|11516471|FG000|NOT COMPLETED|Overall Study||0
10538501|NCT01455519|11691392|FG001|NOT COMPLETED|Overall Study||5
10538502|NCT01455545|11691398|FG000|STARTED|Overall Study||55
10375555|NCT00578214|11516472|FG001|NOT COMPLETED|Overall Study||0
10375556|NCT00578214|11516473|FG002|NOT COMPLETED|Overall Study||0
10375557|NCT00578227|11516484|FG000|STARTED|Overall Study||272
10375558|NCT00578227|11516485|FG001|STARTED|Overall Study||270
10375559|NCT00578227|11516486|FG002|STARTED|Overall Study||271
10375560|NCT00578227|11516484|FG000|COMPLETED|Overall Study||267
10375561|NCT00578227|11516485|FG001|COMPLETED|Overall Study||268
10375562|NCT00578227|11516486|FG002|COMPLETED|Overall Study||267
10375563|NCT00578227|11516484|FG000|NOT COMPLETED|Overall Study||5
10375564|NCT00578227|11516485|FG001|NOT COMPLETED|Overall Study||2
10375565|NCT00578227|11516486|FG002|NOT COMPLETED|Overall Study||4
10375566|NCT00578279|11516498|FG000|STARTED|Overall Study||10
10375567|NCT00578279|11516499|FG001|STARTED|Overall Study||10
10375568|NCT00578279|11516498|FG000|COMPLETED|Overall Study||10
10375569|NCT00578279|11516499|FG001|COMPLETED|Overall Study||10
10375570|NCT00578279|11516498|FG000|NOT COMPLETED|Overall Study||0
10375571|NCT00578279|11516499|FG001|NOT COMPLETED|Overall Study||0
10375572|NCT00578292|11516505|FG000|STARTED|Overall Study||10
10375573|NCT00578292|11516505|FG000|COMPLETED|Overall Study||7
10375574|NCT00578292|11516505|FG000|NOT COMPLETED|Overall Study||3
10375575|NCT00578305|11516512|FG000|STARTED|Double-blind Treatment Phase||62
10538503|NCT01455545|11691399|FG001|STARTED|Overall Study||45
10538504|NCT01455545|11691398|FG000|COMPLETED|Overall Study||55
10538505|NCT01455545|11691399|FG001|COMPLETED|Overall Study||45
10538506|NCT01455545|11691398|FG000|NOT COMPLETED|Overall Study||0
10538507|NCT01455545|11691399|FG001|NOT COMPLETED|Overall Study||0
10375576|NCT00578305|11516513|FG001|STARTED|Double-blind Treatment Phase||60
10375577|NCT00578305|11516514|FG002|STARTED|Double-blind Treatment Phase||63
10375578|NCT00578305|11516512|FG000|Treated|Double-blind Treatment Phase||62
10375579|NCT00578305|11516513|FG001|Treated|Double-blind Treatment Phase||60
10375580|NCT00578305|11516514|FG002|Treated|Double-blind Treatment Phase||63
10375581|NCT00578305|11516512|FG000|COMPLETED|Double-blind Treatment Phase||59
10375582|NCT00578305|11516513|FG001|COMPLETED|Double-blind Treatment Phase||56
10375583|NCT00578305|11516514|FG002|COMPLETED|Double-blind Treatment Phase||49
10375584|NCT00578305|11516512|FG000|NOT COMPLETED|Double-blind Treatment Phase||3
10375585|NCT00578305|11516513|FG001|NOT COMPLETED|Double-blind Treatment Phase||4
10375586|NCT00578305|11516514|FG002|NOT COMPLETED|Double-blind Treatment Phase||14
10375587|NCT00578305|11516512|FG000|STARTED|Extension Phase||53
10375588|NCT00578305|11516513|FG001|STARTED|Extension Phase||50
10375589|NCT00578305|11516514|FG002|STARTED|Extension Phase||43
10375590|NCT00578305|11516512|FG000|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|49
10375591|NCT00578305|11516513|FG001|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|49
10375592|NCT00578305|11516514|FG002|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|40
10375593|NCT00578305|11516512|FG000|NOT COMPLETED|Extension Phase||4
10375594|NCT00578305|11516513|FG001|NOT COMPLETED|Extension Phase||1
10375595|NCT00578305|11516514|FG002|NOT COMPLETED|Extension Phase||3
10375596|NCT00578305|11516512|FG000|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|57
10375597|NCT00578305|11516513|FG001|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|54
10375598|NCT00578305|11516514|FG002|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|54
10375599|NCT00578305|11516512|FG000|COMPLETED|Safety Follow-up Phase||11
10375600|NCT00578305|11516513|FG001|COMPLETED|Safety Follow-up Phase||9
10375601|NCT00578305|11516514|FG002|COMPLETED|Safety Follow-up Phase||8
10375602|NCT00578305|11516512|FG000|NOT COMPLETED|Safety Follow-up Phase||46
10375603|NCT00578305|11516513|FG001|NOT COMPLETED|Safety Follow-up Phase||45
10375604|NCT00578305|11516514|FG002|NOT COMPLETED|Safety Follow-up Phase||46
10375605|NCT00578318|11516530|FG000|STARTED|Overall Study||8
10375606|NCT00578318|11516531|FG001|STARTED|Overall Study||8
10375607|NCT00578318|11516530|FG000|COMPLETED|Overall Study||5
10375608|NCT00578318|11516531|FG001|COMPLETED|Overall Study||8
10375609|NCT00578318|11516530|FG000|NOT COMPLETED|Overall Study||3
10375610|NCT00578318|11516531|FG001|NOT COMPLETED|Overall Study||0
10375611|NCT00578331|11516539|FG000|STARTED|Overall Study||445
10375612|NCT00578331|11516540|FG001|STARTED|Overall Study||445
10375613|NCT00578331|11516539|FG000|COMPLETED|Overall Study||329
10375614|NCT00578331|11516540|FG001|COMPLETED|Overall Study||320
10375615|NCT00578331|11516539|FG000|NOT COMPLETED|Overall Study||116
10375616|NCT00578331|11516540|FG001|NOT COMPLETED|Overall Study||125
10375617|NCT00578344|11516546|FG000|STARTED|Overall Study||8
10375618|NCT00578344|11516546|FG000|COMPLETED|Overall Study||6
10375619|NCT00578344|11516546|FG000|NOT COMPLETED|Overall Study||2
10375620|NCT00578383|11516554|FG000|STARTED|Overall Study||37
10375621|NCT00578383|11516555|FG001|STARTED|Overall Study||36
10375622|NCT00578383|11516556|FG002|STARTED|Overall Study||19
10375623|NCT00578383|11516557|FG003|STARTED|Overall Study||15
10375624|NCT00578383|11516554|FG000|COMPLETED|Overall Study||21
10375625|NCT00578383|11516555|FG001|COMPLETED|Overall Study||20
10375626|NCT00578383|11516556|FG002|COMPLETED|Overall Study||13
10375627|NCT00578383|11516557|FG003|COMPLETED|Overall Study||9
10375628|NCT00578383|11516554|FG000|NOT COMPLETED|Overall Study||16
10375629|NCT00578383|11516555|FG001|NOT COMPLETED|Overall Study||16
10375630|NCT00578383|11516556|FG002|NOT COMPLETED|Overall Study||6
10375631|NCT00578383|11516557|FG003|NOT COMPLETED|Overall Study||6
10375632|NCT00578448|11516571|FG000|STARTED|Day 1 up to 3 Years of Planned Study||12
10375633|NCT00578448|11516571|FG000|COMPLETED|Day 1 up to 3 Years of Planned Study||9
10375634|NCT00578448|11516571|FG000|NOT COMPLETED|Day 1 up to 3 Years of Planned Study||3
10375635|NCT00578448|11516571|FG000|STARTED|1 Year Long Term Extension (LTE)||9
10375636|NCT00578448|11516571|FG000|COMPLETED|1 Year Long Term Extension (LTE)||8
10375637|NCT00578448|11516571|FG000|NOT COMPLETED|1 Year Long Term Extension (LTE)||1
10375638|NCT00578461|11516577|FG000|STARTED|Overall Study||26
10375639|NCT00578461|11516577|FG000|COMPLETED|Overall Study||26
10375640|NCT00578461|11516577|FG000|NOT COMPLETED|Overall Study||0
10375641|NCT00578539|11516581|FG000|STARTED|Overall Study||24
10375642|NCT00578539|11516581|FG000|COMPLETED|Overall Study||24
10375643|NCT00578539|11516581|FG000|NOT COMPLETED|Overall Study||0
10375644|NCT00578552|11516588|FG000|STARTED|Overall Study||27
10375645|NCT00578552|11516589|FG001|STARTED|Overall Study||27
10375646|NCT00578552|11516590|FG002|STARTED|Overall Study||26
10375647|NCT00578552|11516588|FG000|COMPLETED|Overall Study||12
10375648|NCT00578552|11516589|FG001|COMPLETED|Overall Study||13
10375649|NCT00578552|11516590|FG002|COMPLETED|Overall Study||11
10375650|NCT00578552|11516588|FG000|NOT COMPLETED|Overall Study||15
10375651|NCT00578552|11516589|FG001|NOT COMPLETED|Overall Study||14
10375652|NCT00578552|11516590|FG002|NOT COMPLETED|Overall Study||15
10375653|NCT00578565|11516598|FG000|STARTED|Overall Study||10
10375654|NCT00578565|11516598|FG000|COMPLETED|Overall Study||7
10375655|NCT00578565|11516598|FG000|NOT COMPLETED|Overall Study||3
10375656|NCT00578617|11516605|FG000|STARTED|Overall Study||31
10375657|NCT00578617|11516606|FG001|STARTED|Overall Study||29
10375658|NCT00578617|11516605|FG000|COMPLETED|Overall Study||31
10375659|NCT00578617|11516606|FG001|COMPLETED|Overall Study||29
10375660|NCT00578617|11516605|FG000|NOT COMPLETED|Overall Study||0
10375661|NCT00578617|11516606|FG001|NOT COMPLETED|Overall Study||0
10375662|NCT00578643|11516612|FG000|STARTED|Overall Study||15
10375663|NCT00578643|11516612|FG000|COMPLETED|Overall Study||13
10375664|NCT00578643|11516612|FG000|NOT COMPLETED|Overall Study||2
10375665|NCT00578669|11516618|FG000|STARTED|Overall Study||107
10375666|NCT00578669|11516619|FG001|STARTED|Overall Study||99
10375667|NCT00578669|11516618|FG000|COMPLETED|Overall Study||107
10375668|NCT00578669|11516619|FG001|COMPLETED|Overall Study||99
10375669|NCT00578669|11516618|FG000|NOT COMPLETED|Overall Study||0
10375670|NCT00578669|11516619|FG001|NOT COMPLETED|Overall Study||0
10375671|NCT00578734|11516627|FG000|STARTED|Overall Study||84
10375672|NCT00578734|11516628|FG001|STARTED|Overall Study||81
10375673|NCT00578734|11516627|FG000|COMPLETED|Overall Study||84
10375674|NCT00578734|11516628|FG001|COMPLETED|Overall Study||81
10375675|NCT00578734|11516627|FG000|NOT COMPLETED|Overall Study||0
10375676|NCT00578734|11516628|FG001|NOT COMPLETED|Overall Study||0
10375677|NCT00578786|11516637|FG000|STARTED|Overall Study||96
10375678|NCT00578786|11516638|FG001|STARTED|Overall Study||190
10375679|NCT00578786|11516639|FG002|STARTED|Overall Study||97
10375680|NCT00578786|11516637|FG000|COMPLETED|Overall Study||57
10375681|NCT00578786|11516638|FG001|COMPLETED|Overall Study||124
10375682|NCT00578786|11516639|FG002|COMPLETED|Overall Study||67
10375683|NCT00578786|11516637|FG000|NOT COMPLETED|Overall Study||39
10375684|NCT00578786|11516638|FG001|NOT COMPLETED|Overall Study||66
10375685|NCT00578786|11516639|FG002|NOT COMPLETED|Overall Study||30
10375686|NCT00578812|11516659|FG000|STARTED|Overall Study|Does not include investigational training patients (78 STARTED, 76 COMPLETED, 2 Not Treated).|224
10375687|NCT00578812|11516660|FG001|STARTED|Overall Study||192
10375688|NCT00578812|11516659|FG000|COMPLETED|Overall Study|Modified Intent-to-Treat (treated patients; analyzed as randomized).|218
10375689|NCT00578812|11516660|FG001|COMPLETED|Overall Study||185
10375690|NCT00578812|11516659|FG000|NOT COMPLETED|Overall Study||6
10375691|NCT00578812|11516660|FG001|NOT COMPLETED|Overall Study||7
10375692|NCT00578864|11516669|FG000|STARTED|Overall Study||7
10375693|NCT00578864|11516670|FG001|STARTED|Overall Study||6
10375694|NCT00578864|11516669|FG000|COMPLETED|Overall Study|died of complications of surgery after 2 cycles|6
10306535|NCT00099268|11439418|FG000|STARTED|Overall Study||374
10306536|NCT00099268|11439419|FG001|STARTED|Overall Study||373
10306537|NCT00099268|11439418|FG000|Intent-to-Treat|Overall Study|One patient from each group discontinued without receiving a single dose of study drug.|373
10306538|NCT00099268|11439419|FG001|Intent-to-Treat|Overall Study||372
10306539|NCT00099268|11439418|FG000|COMPLETED|Overall Study|Plus 1 death in the carbidopa/levodopa/entacapone group within 30 days of treatment discontinuation|282
10306540|NCT00099268|11439419|FG001|COMPLETED|Overall Study|Plus 1 death in the carbidopa/levodopa group within 30 days of treatment discontinuation|291
10306541|NCT00099268|11439418|FG000|NOT COMPLETED|Overall Study||92
10375695|NCT00578864|11516670|FG001|COMPLETED|Overall Study||6
10375696|NCT00578864|11516669|FG000|NOT COMPLETED|Overall Study||1
10375697|NCT00578864|11516670|FG001|NOT COMPLETED|Overall Study||0
10375698|NCT00578877|11516678|FG000|STARTED|Overall Study||150
10375699|NCT00578877|11516679|FG001|STARTED|Overall Study||300
10375700|NCT00578877|11516678|FG000|COMPLETED|Overall Study||69
10375701|NCT00578877|11516679|FG001|COMPLETED|Overall Study||172
10375702|NCT00578877|11516678|FG000|NOT COMPLETED|Overall Study||81
10375703|NCT00578877|11516679|FG001|NOT COMPLETED|Overall Study||128
10375704|NCT00578903|11516685|FG000|STARTED|Overall Study||22
10375705|NCT00578903|11516685|FG000|COMPLETED|Overall Study||22
10375706|NCT00578903|11516685|FG000|NOT COMPLETED|Overall Study||0
10375707|NCT00578929|11516693|FG000|STARTED|Vehicle Run-In Period||0
10375708|NCT00578929|11516694|FG001|STARTED|Vehicle Run-In Period||2388
10375709|NCT00578929|11516695|FG002|STARTED|Vehicle Run-In Period||0
10375710|NCT00578929|11516696|FG003|STARTED|Vehicle Run-In Period||0
10375711|NCT00578929|11516693|FG000|COMPLETED|Vehicle Run-In Period||0
10375712|NCT00578929|11516694|FG001|COMPLETED|Vehicle Run-In Period||2388
10375713|NCT00578929|11516695|FG002|COMPLETED|Vehicle Run-In Period||0
10375714|NCT00578929|11516696|FG003|COMPLETED|Vehicle Run-In Period||0
10375715|NCT00578929|11516693|FG000|NOT COMPLETED|Vehicle Run-In Period||0
10375716|NCT00578929|11516694|FG001|NOT COMPLETED|Vehicle Run-In Period||0
10375717|NCT00578929|11516695|FG002|NOT COMPLETED|Vehicle Run-In Period||0
10375718|NCT00578929|11516696|FG003|NOT COMPLETED|Vehicle Run-In Period||0
10375719|NCT00578929|11516693|FG000|STARTED|Randomized Period||298
10375720|NCT00578929|11516694|FG001|STARTED|Randomized Period||297
10375721|NCT00578929|11516695|FG002|STARTED|Randomized Period||296
10375722|NCT00578929|11516696|FG003|STARTED|Randomized Period||297
10375723|NCT00578929|11516693|FG000|COMPLETED|Randomized Period||281
10306542|NCT00099268|11439419|FG001|NOT COMPLETED|Overall Study||82
10306543|NCT00099359|11439428|FG000|STARTED|Overall Study||581
10306544|NCT00099359|11439429|FG001|STARTED|Overall Study||580
10306545|NCT00099359|11439430|FG002|STARTED|Overall Study||574
10375724|NCT00578929|11516694|FG001|COMPLETED|Randomized Period||283
10375725|NCT00578929|11516695|FG002|COMPLETED|Randomized Period||288
10375726|NCT00578929|11516696|FG003|COMPLETED|Randomized Period||283
10375727|NCT00578929|11516693|FG000|NOT COMPLETED|Randomized Period||17
10375728|NCT00578929|11516694|FG001|NOT COMPLETED|Randomized Period||14
10375729|NCT00578929|11516695|FG002|NOT COMPLETED|Randomized Period||8
10375730|NCT00578929|11516696|FG003|NOT COMPLETED|Randomized Period||14
10375731|NCT00578942|11516707|FG000|STARTED|Overall Study||48
10375732|NCT00578942|11516707|FG000|COMPLETED|Overall Study||47
10375733|NCT00578942|11516707|FG000|NOT COMPLETED|Overall Study||1
10375734|NCT00578968|11516714|FG000|STARTED|Baseline (Prior to Intervention)||12
10375735|NCT00578968|11516715|FG001|STARTED|Baseline (Prior to Intervention)||12
10375736|NCT00578968|11516716|FG002|STARTED|Baseline (Prior to Intervention)||12
10375737|NCT00578968|11516714|FG000|COMPLETED|Baseline (Prior to Intervention)||12
10375738|NCT00578968|11516715|FG001|COMPLETED|Baseline (Prior to Intervention)||12
10375739|NCT00578968|11516716|FG002|COMPLETED|Baseline (Prior to Intervention)||12
10375740|NCT00578968|11516714|FG000|NOT COMPLETED|Baseline (Prior to Intervention)||0
10375741|NCT00578968|11516715|FG001|NOT COMPLETED|Baseline (Prior to Intervention)||0
10375742|NCT00578968|11516716|FG002|NOT COMPLETED|Baseline (Prior to Intervention)||0
10375743|NCT00578968|11516714|FG000|STARTED|Intervention||12
10375744|NCT00578968|11516715|FG001|STARTED|Intervention||12
10375745|NCT00578968|11516716|FG002|STARTED|Intervention||0
10375746|NCT00578968|11516714|FG000|COMPLETED|Intervention||12
10375747|NCT00578968|11516715|FG001|COMPLETED|Intervention||12
10375748|NCT00578968|11516716|FG002|COMPLETED|Intervention||0
10375749|NCT00578968|11516714|FG000|NOT COMPLETED|Intervention||0
10375750|NCT00578968|11516715|FG001|NOT COMPLETED|Intervention||0
10375751|NCT00578968|11516716|FG002|NOT COMPLETED|Intervention||0
10375752|NCT00579059|11516727|FG000|STARTED|Overall Study|Enrollment was incomplete due to study cancellation.|21
10375753|NCT00579059|11516728|FG001|STARTED|Overall Study|Enrollment was incomplete due to study cancellation.|10
10375754|NCT00579059|11516727|FG000|Immediate Post-Op|Overall Study|1 Patient didn't return for follow-up.|20
10375755|NCT00579059|11516728|FG001|Immediate Post-Op|Overall Study|1 Patient didn't return for follow-up.|9
10375756|NCT00579059|11516727|FG000|6 Months|Overall Study|10 Patients didn't return for follow-up.|11
10375757|NCT00579059|11516728|FG001|6 Months|Overall Study|6 patients didn't return for follow-up.|4
10375758|NCT00579059|11516727|FG000|1 Year|Overall Study|13 patients didn't return for follow-up.|8
10375759|NCT00579059|11516728|FG001|1 Year|Overall Study|7 patients didn't return for follow-up.|3
10375760|NCT00579059|11516727|FG000|3 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
10375761|NCT00579059|11516728|FG001|3 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
10375762|NCT00579059|11516727|FG000|5 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
10375763|NCT00579059|11516728|FG001|5 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
10375764|NCT00579059|11516727|FG000|COMPLETED|Overall Study|No Patients completed through 5 years due to study closure at 1-year of follow-up.|0
10375765|NCT00579059|11516728|FG001|COMPLETED|Overall Study|No Patients completed through 5 years due to study closure at 1-year of follow-up.|0
10375766|NCT00579059|11516727|FG000|NOT COMPLETED|Overall Study||21
10375767|NCT00579059|11516728|FG001|NOT COMPLETED|Overall Study||10
10375768|NCT00579098|11516736|FG000|STARTED|Overall Study||62
10375769|NCT00579098|11516737|FG001|STARTED|Overall Study||63
10375770|NCT00579098|11516736|FG000|COMPLETED|Overall Study||53
10375771|NCT00579098|11516737|FG001|COMPLETED|Overall Study||55
10375772|NCT00579098|11516736|FG000|NOT COMPLETED|Overall Study||9
10375773|NCT00579098|11516737|FG001|NOT COMPLETED|Overall Study||8
10375774|NCT00579111|11516745|FG000|STARTED|Overall Study||3
10375775|NCT00579111|11516746|FG001|STARTED|Overall Study||1
10375776|NCT00579111|11516745|FG000|COMPLETED|Overall Study||1
10375777|NCT00579111|11516746|FG001|COMPLETED|Overall Study||0
10375778|NCT00579111|11516745|FG000|NOT COMPLETED|Overall Study||2
10375779|NCT00579111|11516746|FG001|NOT COMPLETED|Overall Study||1
10375780|NCT00579137|11516752|FG000|STARTED|Overall Study||3
10375781|NCT00579137|11516752|FG000|COMPLETED|Overall Study||3
10375782|NCT00579137|11516752|FG000|NOT COMPLETED|Overall Study||0
10375783|NCT00579280|11516759|FG000|STARTED|Overall Study||49
10375784|NCT00579280|11516760|FG001|STARTED|Overall Study||49
10375785|NCT00579280|11516761|FG002|STARTED|Overall Study||51
10717243|NCT02696902|11881167|FG000|Modified Intent-to-treat (mITT) Population|Overall Study||83
10717244|NCT02696902|11881168|FG001|Modified Intent-to-treat (mITT) Population|Overall Study||16
10717245|NCT02696902|11881169|FG002|Modified Intent-to-treat (mITT) Population|Overall Study||85
10717246|NCT02696902|11881167|FG000|COMPLETED|Overall Study||63
10717247|NCT02696902|11881168|FG001|COMPLETED|Overall Study||12
10717248|NCT02696902|11881169|FG002|COMPLETED|Overall Study||59
10375786|NCT00579280|11516759|FG000|COMPLETED|Overall Study|LOCF evaluable sample|47
10375787|NCT00579280|11516760|FG001|COMPLETED|Overall Study|LOCF evaluable sample|46
10375788|NCT00579280|11516761|FG002|COMPLETED|Overall Study|LOCF evaluable sample|51
10375789|NCT00579280|11516759|FG000|NOT COMPLETED|Overall Study||2
10375790|NCT00579280|11516760|FG001|NOT COMPLETED|Overall Study||3
10375791|NCT00579280|11516761|FG002|NOT COMPLETED|Overall Study||0
10375792|NCT00579345|11516777|FG000|STARTED|Overall Study||549
10375793|NCT00579345|11516778|FG001|STARTED|Overall Study||169
10375794|NCT00579345|11516779|FG002|STARTED|Overall Study||391
10375795|NCT00579345|11516780|FG003|STARTED|Overall Study||144
10375796|NCT00579345|11516781|FG004|STARTED|Overall Study||90
10375797|NCT00579345|11516782|FG005|STARTED|Overall Study||78
10375798|NCT00579345|11516783|FG006|STARTED|Overall Study||57
10375799|NCT00579345|11516784|FG007|STARTED|Overall Study||44
10375800|NCT00579345|11516777|FG000|COMPLETED|Overall Study||544
10375801|NCT00579345|11516778|FG001|COMPLETED|Overall Study||168
10375802|NCT00579345|11516779|FG002|COMPLETED|Overall Study||389
10375803|NCT00579345|11516780|FG003|COMPLETED|Overall Study||143
10375804|NCT00579345|11516781|FG004|COMPLETED|Overall Study||90
10375805|NCT00579345|11516782|FG005|COMPLETED|Overall Study||78
10375806|NCT00579345|11516783|FG006|COMPLETED|Overall Study||57
10375807|NCT00579345|11516784|FG007|COMPLETED|Overall Study||42
10375808|NCT00579345|11516777|FG000|NOT COMPLETED|Overall Study||5
10375809|NCT00579345|11516778|FG001|NOT COMPLETED|Overall Study||1
10375810|NCT00579345|11516779|FG002|NOT COMPLETED|Overall Study||2
10375811|NCT00579345|11516780|FG003|NOT COMPLETED|Overall Study||1
10375812|NCT00579345|11516781|FG004|NOT COMPLETED|Overall Study||0
10375813|NCT00579345|11516782|FG005|NOT COMPLETED|Overall Study||0
10717249|NCT02696902|11881167|FG000|NOT COMPLETED|Overall Study||22
10375814|NCT00579345|11516783|FG006|NOT COMPLETED|Overall Study||0
10375815|NCT00579345|11516784|FG007|NOT COMPLETED|Overall Study||2
10375816|NCT00579436|11516814|FG000|STARTED|Overall Study||19
10375817|NCT00579436|11516815|FG001|STARTED|Overall Study||14
10375818|NCT00579436|11516814|FG000|COMPLETED|Overall Study||19
10375819|NCT00579436|11516815|FG001|COMPLETED|Overall Study||14
10375820|NCT00579436|11516814|FG000|NOT COMPLETED|Overall Study||0
10375821|NCT00579436|11516815|FG001|NOT COMPLETED|Overall Study||0
10375822|NCT00579501|11516821|FG000|STARTED|Overall Study||29
10375823|NCT00579501|11516821|FG000|COMPLETED|Overall Study||0
10375824|NCT00579501|11516821|FG000|NOT COMPLETED|Overall Study||29
10375825|NCT00579553|11516827|FG000|STARTED|Overall Study||82
10375826|NCT00579553|11516828|FG001|STARTED|Overall Study||92
10375827|NCT00579553|11516827|FG000|COMPLETED|Overall Study||66
10375828|NCT00579553|11516828|FG001|COMPLETED|Overall Study||79
10375829|NCT00579553|11516827|FG000|NOT COMPLETED|Overall Study||16
10375830|NCT00579553|11516828|FG001|NOT COMPLETED|Overall Study||13
10375831|NCT00579670|11516839|FG000|STARTED|Overall Study|Full Analysis Set (FAS): at least 1 dose study medication and at least 1 efficacy measurement|15
10375832|NCT00579670|11516840|FG001|STARTED|Overall Study||57
10375833|NCT00579670|11516841|FG002|STARTED|Overall Study||88
10375834|NCT00579670|11516842|FG003|STARTED|Overall Study||285
10375835|NCT00579670|11516843|FG004|STARTED|Overall Study||5
10375836|NCT00579670|11516839|FG000|Population: Within SmPC (Started)|Overall Study|"Within summary of product characteristics (SmPC): FAS subjects who received all doses Within SmPC"|15
10375837|NCT00579670|11516840|FG001|Population: Within SmPC (Started)|Overall Study||56
10375838|NCT00579670|11516841|FG002|Population: Within SmPC (Started)|Overall Study||83
10375839|NCT00579670|11516842|FG003|Population: Within SmPC (Started)|Overall Study||159
10375840|NCT00579670|11516843|FG004|Population: Within SmPC (Started)|Overall Study|"Ziprasidone Unknown reporting group is not applicable to the Within SmPC population"|0
10375841|NCT00579670|11516839|FG000|Population: Within SmPC (Completed)|Overall Study|Not Completed (DC): Subject died N=1; Adverse Event (AE) N=1|13
10375842|NCT00579670|11516840|FG001|Population: Within SmPC (Completed)|Overall Study|DC: Lost to follow-up (LTFU) N=1|55
10375843|NCT00579670|11516841|FG002|Population: Within SmPC (Completed)|Overall Study|DC: AE N=1; Lack of efficacy N=1; Other unspecified N=1; Withdrawal by subject N=1|79
10375844|NCT00579670|11516842|FG003|Population: Within SmPC (Completed)|Overall Study|DC: AE N=2; Lack of efficacy N=5; LTFU N=3; Other unspecified N=2|147
10375845|NCT00579670|11516843|FG004|Population: Within SmPC (Completed)|Overall Study||0
10375846|NCT00579670|11516839|FG000|COMPLETED|Overall Study||13
10375847|NCT00579670|11516840|FG001|COMPLETED|Overall Study||56
10375848|NCT00579670|11516841|FG002|COMPLETED|Overall Study||84
10375849|NCT00579670|11516842|FG003|COMPLETED|Overall Study||263
10375850|NCT00579670|11516843|FG004|COMPLETED|Overall Study||5
10375851|NCT00579670|11516839|FG000|NOT COMPLETED|Overall Study||2
10375852|NCT00579670|11516840|FG001|NOT COMPLETED|Overall Study||1
10375853|NCT00579670|11516841|FG002|NOT COMPLETED|Overall Study||4
10375854|NCT00579670|11516842|FG003|NOT COMPLETED|Overall Study||22
10375855|NCT00579670|11516843|FG004|NOT COMPLETED|Overall Study||0
10375856|NCT00579813|11516869|FG000|STARTED|Overall Study||60
10375857|NCT00579813|11516870|FG001|STARTED|Overall Study||10
10375858|NCT00579813|11516869|FG000|COMPLETED|Overall Study||60
10375859|NCT00579813|11516870|FG001|COMPLETED|Overall Study||10
10375860|NCT00579813|11516869|FG000|NOT COMPLETED|Overall Study||0
10375861|NCT00579813|11516870|FG001|NOT COMPLETED|Overall Study||0
10375862|NCT00579878|11516880|FG000|STARTED|Overall Study||22
10375863|NCT00579878|11516881|FG001|STARTED|Overall Study||23
10375864|NCT00579878|11516882|FG002|STARTED|Overall Study||24
10375865|NCT00579878|11516880|FG000|COMPLETED|Overall Study||15
10375866|NCT00579878|11516881|FG001|COMPLETED|Overall Study||20
10375867|NCT00579878|11516882|FG002|COMPLETED|Overall Study||14
10375868|NCT00579878|11516880|FG000|NOT COMPLETED|Overall Study||7
10375869|NCT00579878|11516881|FG001|NOT COMPLETED|Overall Study||3
10375870|NCT00579878|11516882|FG002|NOT COMPLETED|Overall Study||10
10375871|NCT00579982|11516890|FG000|STARTED|Overall Study||97
10375872|NCT00579982|11516890|FG000|COMPLETED|Overall Study||89
10375873|NCT00579982|11516890|FG000|NOT COMPLETED|Overall Study||8
10375874|NCT00580034|11516894|FG000|STARTED|Overall Study||88
10375875|NCT00580034|11516895|FG001|STARTED|Overall Study||88
10375876|NCT00580034|11516894|FG000|COMPLETED|Overall Study||78
10375877|NCT00580034|11516895|FG001|COMPLETED|Overall Study||88
10375878|NCT00580034|11516894|FG000|NOT COMPLETED|Overall Study||10
10375879|NCT00580034|11516895|FG001|NOT COMPLETED|Overall Study||0
10375880|NCT00580047|11516902|FG000|STARTED|Overall Study||24
10375881|NCT00580047|11516903|FG001|STARTED|Overall Study||23
10375882|NCT00580047|11516904|FG002|STARTED|Overall Study||12
10375883|NCT00580047|11516902|FG000|COMPLETED|Overall Study||21
10375884|NCT00580047|11516903|FG001|COMPLETED|Overall Study||21
10375885|NCT00580047|11516904|FG002|COMPLETED|Overall Study||10
10375886|NCT00580047|11516902|FG000|NOT COMPLETED|Overall Study||3
10375887|NCT00580047|11516903|FG001|NOT COMPLETED|Overall Study||2
10375888|NCT00580047|11516904|FG002|NOT COMPLETED|Overall Study||2
10375889|NCT00580073|11516915|FG000|STARTED|Overall Study||6
10375890|NCT00580073|11516915|FG000|COMPLETED|Overall Study||6
10538508|NCT01456000|11691416|FG000|STARTED|Overall Study||178
10538509|NCT01456000|11691417|FG001|STARTED|Overall Study||175
10375891|NCT00580073|11516915|FG000|NOT COMPLETED|Overall Study||0
10375892|NCT00580138|11516919|FG000|STARTED|Overall Study||30
10375893|NCT00580138|11516919|FG000|COMPLETED|Overall Study||30
10375894|NCT00580138|11516919|FG000|NOT COMPLETED|Overall Study||0
10375895|NCT00580151|11516925|FG000|STARTED|Overall Study||9
10538510|NCT01456000|11691416|FG000|COMPLETED|Overall Study||170
10375896|NCT00580151|11516926|FG001|STARTED|Overall Study||0
10375897|NCT00580151|11516925|FG000|COMPLETED|Overall Study||9
10375898|NCT00580151|11516926|FG001|COMPLETED|Overall Study||0
10375899|NCT00580151|11516925|FG000|NOT COMPLETED|Overall Study||0
10375900|NCT00580151|11516926|FG001|NOT COMPLETED|Overall Study||0
10375901|NCT00580229|11516932|FG000|STARTED|Overall Study||50
10375902|NCT00580229|11516932|FG000|COMPLETED|Overall Study||50
10375903|NCT00580229|11516932|FG000|NOT COMPLETED|Overall Study||0
10375904|NCT00580294|11516936|FG000|STARTED|Overall Study||12
10375905|NCT00580294|11516936|FG000|COMPLETED|Overall Study||12
10375906|NCT00580294|11516936|FG000|NOT COMPLETED|Overall Study||0
10375907|NCT00580333|11516940|FG000|STARTED|Overall Study||51
10375908|NCT00580333|11516940|FG000|COMPLETED|Overall Study||51
10375909|NCT00580333|11516940|FG000|NOT COMPLETED|Overall Study||0
10375910|NCT00580372|11516945|FG000|STARTED|Overall Study||231
10375911|NCT00580372|11516945|FG000|COMPLETED|Overall Study||231
10375912|NCT00580372|11516945|FG000|NOT COMPLETED|Overall Study||0
10375913|NCT00580398|11516951|FG000|STARTED|Overall Study||17
10375914|NCT00580398|11516952|FG001|STARTED|Overall Study||32
10375915|NCT00580398|11516951|FG000|COMPLETED|Overall Study||17
10375916|NCT00580398|11516952|FG001|COMPLETED|Overall Study||32
10375917|NCT00580398|11516951|FG000|NOT COMPLETED|Overall Study||0
10375918|NCT00580398|11516952|FG001|NOT COMPLETED|Overall Study||0
10375919|NCT00580502|11516958|FG000|STARTED|Overall Study||50
10375920|NCT00580502|11516958|FG000|COMPLETED|Overall Study||50
10375921|NCT00580502|11516958|FG000|NOT COMPLETED|Overall Study||0
10538511|NCT01456000|11691417|FG001|COMPLETED|Overall Study||172
10538512|NCT01456000|11691416|FG000|NOT COMPLETED|Overall Study||8
10538513|NCT01456000|11691417|FG001|NOT COMPLETED|Overall Study||3
10538514|NCT01456039|11691426|FG000|STARTED|Phase 1 (First Step)||3
10538515|NCT01456039|11691427|FG001|STARTED|Phase 1 (First Step)||8
10538516|NCT01456039|11691428|FG002|STARTED|Phase 1 (First Step)||0
10538517|NCT01456039|11691426|FG000|COMPLETED|Phase 1 (First Step)|Completed = on treatment|1
10538518|NCT01456039|11691427|FG001|COMPLETED|Phase 1 (First Step)|Completed = on treatment|1
10538519|NCT01456039|11691428|FG002|COMPLETED|Phase 1 (First Step)||0
10538520|NCT01456039|11691426|FG000|NOT COMPLETED|Phase 1 (First Step)||2
10538521|NCT01456039|11691427|FG001|NOT COMPLETED|Phase 1 (First Step)||7
10538522|NCT01456039|11691428|FG002|NOT COMPLETED|Phase 1 (First Step)||0
10538523|NCT01456039|11691426|FG000|STARTED|Phase 2 (Second Step)||0
10538524|NCT01456039|11691427|FG001|STARTED|Phase 2 (Second Step)||0
10538525|NCT01456039|11691428|FG002|STARTED|Phase 2 (Second Step)||40
10538526|NCT01456039|11691426|FG000|COMPLETED|Phase 2 (Second Step)||0
10538527|NCT01456039|11691427|FG001|COMPLETED|Phase 2 (Second Step)||0
10538528|NCT01456039|11691428|FG002|COMPLETED|Phase 2 (Second Step)||7
10538529|NCT01456039|11691426|FG000|NOT COMPLETED|Phase 2 (Second Step)||0
10538530|NCT01456039|11691427|FG001|NOT COMPLETED|Phase 2 (Second Step)||0
10538531|NCT01456039|11691428|FG002|NOT COMPLETED|Phase 2 (Second Step)||33
10538532|NCT01456052|11691447|FG000|STARTED|Overall Study||10
10538533|NCT01456052|11691448|FG001|STARTED|Overall Study|One subject did not receive any study drug. That subject is not included in the safety population.|25
10538534|NCT01456052|11691449|FG002|STARTED|Overall Study||24
10538535|NCT01456052|11691447|FG000|COMPLETED|Overall Study||8
10538536|NCT01456052|11691448|FG001|COMPLETED|Overall Study||20
10538537|NCT01456052|11691449|FG002|COMPLETED|Overall Study||19
10538538|NCT01456052|11691447|FG000|NOT COMPLETED|Overall Study||2
10538539|NCT01456052|11691448|FG001|NOT COMPLETED|Overall Study||5
10538540|NCT01456052|11691449|FG002|NOT COMPLETED|Overall Study||5
10538541|NCT01456130|11691458|FG000|STARTED|Overall Study||67
10538542|NCT01456130|11691458|FG000|COMPLETED|Overall Study||57
10538543|NCT01456130|11691458|FG000|NOT COMPLETED|Overall Study||10
10538544|NCT01456143|11691462|FG000|STARTED|Overall Study||33
10538545|NCT01456143|11691462|FG000|COMPLETED|Overall Study||33
10538546|NCT01456143|11691462|FG000|NOT COMPLETED|Overall Study||0
10538547|NCT01456169|11691469|FG000|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|133
10538548|NCT01456169|11691470|FG001|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|127
10538549|NCT01456169|11691471|FG002|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|135
10538550|NCT01456169|11691469|FG000|COMPLETED|Overall Study||123
10538551|NCT01456169|11691470|FG001|COMPLETED|Overall Study||122
10375922|NCT00580606|11516964|FG000|STARTED|Double Blind (DB)||20
10538552|NCT01456169|11691471|FG002|COMPLETED|Overall Study||123
10538553|NCT01456169|11691469|FG000|NOT COMPLETED|Overall Study||10
10375923|NCT00580606|11516965|FG001|STARTED|Double Blind (DB)||20
10375924|NCT00580606|11516964|FG000|Had Week 44 Oral Food Challenge|Double Blind (DB)||18
10375925|NCT00580606|11516965|FG001|Had Week 44 Oral Food Challenge|Double Blind (DB)||19
10538554|NCT01456169|11691470|FG001|NOT COMPLETED|Overall Study||5
10538555|NCT01456169|11691471|FG002|NOT COMPLETED|Overall Study||12
10538556|NCT01456195|11691483|FG000|STARTED|Overall Study||143
10375926|NCT00580606|11516964|FG000|COMPLETED|Double Blind (DB)|Completed: Participants who were assessed for the primary outcome measure.|20
10375927|NCT00580606|11516965|FG001|COMPLETED|Double Blind (DB)|Completed: Participants who were assessed for the primary outcome measure.|20
10375928|NCT00580606|11516964|FG000|NOT COMPLETED|Double Blind (DB)||0
10375929|NCT00580606|11516965|FG001|NOT COMPLETED|Double Blind (DB)||0
10375930|NCT00580606|11516964|FG000|STARTED|Open Label (OL)|2 participants discontinued dosing before Open Label (OL) period.|18
10375931|NCT00580606|11516965|FG001|STARTED|Open Label (OL)|1 participant discontinued dosing before OL period; 2 passed Week 44 OFC & ineligible to crossover.|17
10375932|NCT00580606|11516964|FG000|Had Week 44 Oral Food Challenge|Open Label (OL)|The Week 44 OFC for Low Dose Peanut SLIT was done at the end of the DB Period, not the OL period.|0
10375933|NCT00580606|11516965|FG001|Had Week 44 Oral Food Challenge|Open Label (OL)|After 44 weeks of OL high dose SLIT; 1 additional participant declined Week 44 OFC in OL period.|12
10375934|NCT00580606|11516964|FG000|Had Week 68 Oral Food Challenge|Open Label (OL)||15
10375935|NCT00580606|11516965|FG001|Had Week 68 Oral Food Challenge|Open Label (OL)||12
10375936|NCT00580606|11516964|FG000|Had Week 116 Oral Food Challenge|Open Label (OL)||13
10375937|NCT00580606|11516965|FG001|Had Week 116 Oral Food Challenge|Open Label (OL)||6
10375938|NCT00580606|11516964|FG000|Had Week 164 Oral Food Challenge|Open Label (OL)||9
10375939|NCT00580606|11516965|FG001|Had Week 164 Oral Food Challenge|Open Label (OL)||5
10375940|NCT00580606|11516964|FG000|Had Week 172 Oral Food Challenge|Open Label (OL)||2
10375941|NCT00580606|11516965|FG001|Had Week 172 Oral Food Challenge|Open Label (OL)||2
10375942|NCT00580606|11516964|FG000|COMPLETED|Open Label (OL)|Completed dosing & final Wk 164 desensitization OFC & Wk 172 tolerance OFC (if passed Wk 164 OFC).|9
10375943|NCT00580606|11516965|FG001|COMPLETED|Open Label (OL)|Completed dosing & final Wk 164 desensitization OFC & Wk 172 tolerance OFC (if passed Wk 164 OFC).|5
10375944|NCT00580606|11516964|FG000|NOT COMPLETED|Open Label (OL)||9
10375945|NCT00580606|11516965|FG001|NOT COMPLETED|Open Label (OL)||12
10375946|NCT00580645|11516982|FG000|STARTED|Overall Study||20
10375947|NCT00580645|11516983|FG001|STARTED|Overall Study||20
10375948|NCT00580645|11516984|FG002|STARTED|Overall Study||20
10375949|NCT00580645|11516982|FG000|COMPLETED|Overall Study||20
10375950|NCT00580645|11516983|FG001|COMPLETED|Overall Study||20
10375951|NCT00580645|11516984|FG002|COMPLETED|Overall Study||20
10375952|NCT00580645|11516982|FG000|NOT COMPLETED|Overall Study||0
10375953|NCT00580645|11516983|FG001|NOT COMPLETED|Overall Study||0
10375954|NCT00580645|11516984|FG002|NOT COMPLETED|Overall Study||0
10375955|NCT00580671|11516995|FG000|STARTED|Overall Study||51
10375956|NCT00580671|11516996|FG001|STARTED|Overall Study||51
10375957|NCT00580671|11516997|FG002|STARTED|Overall Study||51
10375958|NCT00580671|11516995|FG000|COMPLETED|Overall Study||35
10375959|NCT00580671|11516996|FG001|COMPLETED|Overall Study||35
10717250|NCT02696902|11881168|FG001|NOT COMPLETED|Overall Study||4
10717251|NCT02696902|11881169|FG002|NOT COMPLETED|Overall Study||28
10717252|NCT02696967|11881183|FG000|STARTED|Overall Study||4
10375960|NCT00580671|11516997|FG002|COMPLETED|Overall Study||34
10375961|NCT00580671|11516995|FG000|NOT COMPLETED|Overall Study||16
10375962|NCT00580671|11516996|FG001|NOT COMPLETED|Overall Study||16
10375963|NCT00580671|11516997|FG002|NOT COMPLETED|Overall Study||17
10375964|NCT00580723|11517005|FG000|STARTED|Overall Study||24
10375965|NCT00580723|11517005|FG000|COMPLETED|Overall Study||16
10375966|NCT00580723|11517005|FG000|NOT COMPLETED|Overall Study||8
10375967|NCT00580788|11517013|FG000|STARTED|Overall Study||3
10375968|NCT00580788|11517014|FG001|STARTED|Overall Study||6
10375969|NCT00580788|11517015|FG002|STARTED|Overall Study||3
10375970|NCT00580788|11517016|FG003|STARTED|Overall Study||2
10375971|NCT00580788|11517013|FG000|COMPLETED|Overall Study||3
10375972|NCT00580788|11517014|FG001|COMPLETED|Overall Study||6
10375973|NCT00580788|11517015|FG002|COMPLETED|Overall Study||3
10375974|NCT00580788|11517016|FG003|COMPLETED|Overall Study|One subject was stopped early for hypertension. One subject completed but was not analyzed.|1
10375975|NCT00580788|11517013|FG000|NOT COMPLETED|Overall Study||0
10375976|NCT00580788|11517014|FG001|NOT COMPLETED|Overall Study||0
10375977|NCT00580788|11517015|FG002|NOT COMPLETED|Overall Study||0
10375978|NCT00580788|11517016|FG003|NOT COMPLETED|Overall Study||1
10375979|NCT00580801|11517036|FG000|STARTED|Overall Study||8
10375980|NCT00580801|11517037|FG001|STARTED|Overall Study||8
10375981|NCT00580801|11517038|FG002|STARTED|Overall Study||8
10375982|NCT00580801|11517036|FG000|COMPLETED|Overall Study||2
10375983|NCT00580801|11517037|FG001|COMPLETED|Overall Study||7
10375984|NCT00580801|11517038|FG002|COMPLETED|Overall Study||5
10375985|NCT00580801|11517036|FG000|NOT COMPLETED|Overall Study||6
10375986|NCT00580801|11517037|FG001|NOT COMPLETED|Overall Study||1
10375987|NCT00580801|11517038|FG002|NOT COMPLETED|Overall Study||3
10375988|NCT00580840|11517046|FG000|STARTED|Run-in|620 subjects were screened for the study with 333 being enrolled.|333
10375989|NCT00580840|11517047|FG001|STARTED|Run-in||0
10375990|NCT00580840|11517048|FG002|STARTED|Run-in||0
10375991|NCT00580840|11517049|FG003|STARTED|Run-in||0
10375992|NCT00580840|11517046|FG000|COMPLETED|Run-in|Of the 209 randomized participants, 208 are in the Full Analysis Set (FAS).|209
10375993|NCT00580840|11517047|FG001|COMPLETED|Run-in||0
10375994|NCT00580840|11517048|FG002|COMPLETED|Run-in||0
10375995|NCT00580840|11517049|FG003|COMPLETED|Run-in||0
10375996|NCT00580840|11517046|FG000|NOT COMPLETED|Run-in||124
10375997|NCT00580840|11517047|FG001|NOT COMPLETED|Run-in||0
10375998|NCT00580840|11517048|FG002|NOT COMPLETED|Run-in||0
10375999|NCT00580840|11517049|FG003|NOT COMPLETED|Run-in||0
10657671|NCT02227693|11818820|FG000|NOT COMPLETED|Overall Study||0
10717253|NCT02696967|11881184|FG001|STARTED|Overall Study||6
10717254|NCT02696967|11881185|FG002|STARTED|Overall Study||6
10717255|NCT02696967|11881186|FG003|STARTED|Overall Study||10
10376000|NCT00580840|11517046|FG000|STARTED|Double-Blind||0
10376001|NCT00580840|11517047|FG001|STARTED|Double-Blind||70
10376002|NCT00580840|11517048|FG002|STARTED|Double-Blind||70
10376003|NCT00580840|11517049|FG003|STARTED|Double-Blind||69
10376004|NCT00580840|11517046|FG000|COMPLETED|Double-Blind||0
10376005|NCT00580840|11517047|FG001|COMPLETED|Double-Blind||63
10376006|NCT00580840|11517048|FG002|COMPLETED|Double-Blind||61
10376007|NCT00580840|11517049|FG003|COMPLETED|Double-Blind||54
10376008|NCT00580840|11517046|FG000|NOT COMPLETED|Double-Blind||0
10376009|NCT00580840|11517047|FG001|NOT COMPLETED|Double-Blind||7
10376010|NCT00580840|11517048|FG002|NOT COMPLETED|Double-Blind||9
10376011|NCT00580840|11517049|FG003|NOT COMPLETED|Double-Blind||15
10427863|NCT00855335|11573773|FG003|COMPLETED|Overall Study||12
10427864|NCT00855335|11573774|FG004|COMPLETED|Overall Study||6
10427865|NCT00855335|11573770|FG000|NOT COMPLETED|Overall Study||5
10427866|NCT00855335|11573771|FG001|NOT COMPLETED|Overall Study||2
10427867|NCT00855335|11573772|FG002|NOT COMPLETED|Overall Study||5
10427868|NCT00855335|11573773|FG003|NOT COMPLETED|Overall Study||7
10427869|NCT00855335|11573774|FG004|NOT COMPLETED|Overall Study||1
10427870|NCT00855413|11573799|FG000|STARTED|Overall Study||15
10427871|NCT00855413|11573799|FG000|COMPLETED|Overall Study||15
10427872|NCT00855413|11573799|FG000|NOT COMPLETED|Overall Study||0
10427873|NCT00855439|11573805|FG000|STARTED|Overall Study||22
10427874|NCT00855439|11573806|FG001|STARTED|Overall Study||24
10427875|NCT00855439|11573805|FG000|COMPLETED|Overall Study||19
10427876|NCT00855439|11573806|FG001|COMPLETED|Overall Study||24
10427877|NCT00855439|11573805|FG000|NOT COMPLETED|Overall Study||3
10427878|NCT00855439|11573806|FG001|NOT COMPLETED|Overall Study||0
10427879|NCT00855465|11573814|FG000|STARTED|Treatment Period||174
10427880|NCT00855465|11573815|FG001|STARTED|Treatment Period||88
10427881|NCT00855465|11573814|FG000|Participants Received Treatment|Treatment Period|1 subject randomized but not treated|173
10427882|NCT00855465|11573815|FG001|Participants Received Treatment|Treatment Period||88
10427883|NCT00855465|11573814|FG000|COMPLETED|Treatment Period||160
10427884|NCT00855465|11573815|FG001|COMPLETED|Treatment Period||83
10427885|NCT00855465|11573814|FG000|NOT COMPLETED|Treatment Period||14
10427886|NCT00855465|11573815|FG001|NOT COMPLETED|Treatment Period||5
10427887|NCT00855465|11573814|FG000|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|17
10427888|NCT00855465|11573815|FG001|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|4
10427889|NCT00855465|11573814|FG000|COMPLETED|Follow-up Period (FUP)||9
10427890|NCT00855465|11573815|FG001|COMPLETED|Follow-up Period (FUP)||2
10427891|NCT00855465|11573814|FG000|NOT COMPLETED|Follow-up Period (FUP)||8
10427892|NCT00855465|11573815|FG001|NOT COMPLETED|Follow-up Period (FUP)||2
10427893|NCT00855582|11573824|FG000|STARTED|Overall Study||198
10427894|NCT00855582|11573825|FG001|STARTED|Overall Study||208
10427895|NCT00855582|11573826|FG002|STARTED|Overall Study||200
10427896|NCT00855582|11573824|FG000|COMPLETED|Overall Study||172
10427897|NCT00855582|11573825|FG001|COMPLETED|Overall Study||184
10427898|NCT00855582|11573826|FG002|COMPLETED|Overall Study||170
10427899|NCT00855582|11573824|FG000|NOT COMPLETED|Overall Study||26
10427900|NCT00855582|11573825|FG001|NOT COMPLETED|Overall Study||24
10427901|NCT00855582|11573826|FG002|NOT COMPLETED|Overall Study||30
10427902|NCT00855595|11573839|FG000|STARTED|Overall Study||106
10427903|NCT00855595|11573840|FG001|STARTED|Overall Study||101
10427904|NCT00855595|11573839|FG000|COMPLETED|Overall Study||100
10427905|NCT00855595|11573840|FG001|COMPLETED|Overall Study||94
10427906|NCT00855595|11573839|FG000|NOT COMPLETED|Overall Study||6
10427907|NCT00855595|11573840|FG001|NOT COMPLETED|Overall Study||7
10427908|NCT00855738|11573846|FG000|STARTED|Overall Study||111
10427909|NCT00855738|11573846|FG000|At Least 1 Dose and 1 Endpoint|Overall Study|Received at least 1 dose of study drug and had data for at least 1 efficacy endpoint.|108
10427910|NCT00855738|11573846|FG000|COMPLETED|Overall Study||106
10427911|NCT00855738|11573846|FG000|NOT COMPLETED|Overall Study||5
10427912|NCT00855816|11573854|FG000|STARTED|Overall Study||47
10427913|NCT00855816|11573855|FG001|STARTED|Overall Study||33
10427914|NCT00855816|11573854|FG000|COMPLETED|Overall Study||21
10427915|NCT00855816|11573855|FG001|COMPLETED|Overall Study||12
10427916|NCT00855816|11573854|FG000|NOT COMPLETED|Overall Study||26
10427917|NCT00855816|11573855|FG001|NOT COMPLETED|Overall Study||21
10427918|NCT00855842|11573861|FG000|STARTED|Overall Study||4
10427919|NCT00855842|11573861|FG000|COMPLETED|Overall Study||4
10427920|NCT00855842|11573861|FG000|NOT COMPLETED|Overall Study||0
10427921|NCT00855868|11573867|FG000|STARTED|Overall Study||13
10427922|NCT00855868|11573868|FG001|STARTED|Overall Study||15
10427923|NCT00855868|11573867|FG000|COMPLETED|Overall Study||12
10427924|NCT00855868|11573868|FG001|COMPLETED|Overall Study||14
10427925|NCT00855868|11573867|FG000|NOT COMPLETED|Overall Study||1
10427926|NCT00855868|11573868|FG001|NOT COMPLETED|Overall Study||1
10427927|NCT00855894|11573874|FG000|STARTED|Overall Study||41
10427928|NCT00855894|11573874|FG000|COMPLETED|Overall Study||8
10427929|NCT00855894|11573874|FG000|NOT COMPLETED|Overall Study||33
10427930|NCT00855920|11573881|FG000|STARTED|Overall Study||76
10427931|NCT00855920|11573882|FG001|STARTED|Overall Study||74
10427932|NCT00855920|11573883|FG002|STARTED|Overall Study||75
10427933|NCT00855920|11573881|FG000|Safety Population|Overall Study|1 participant from Rilonacept+Indomethacin arm received Placebo (for Rilonacept)+Indomethacin|77
10427934|NCT00855920|11573882|FG001|Safety Population|Overall Study|1 participant from Rilonacept+Indomethacin arm received Placebo (for Rilonacept)+Indomethacin|73
10427935|NCT00855920|11573883|FG002|Safety Population|Overall Study||75
10427936|NCT00855920|11573881|FG000|COMPLETED|Overall Study||68
10376012|NCT00580853|11517062|FG000|STARTED|Overall Study||20
10376013|NCT00580853|11517063|FG001|STARTED|Overall Study||21
10376014|NCT00580853|11517064|FG002|STARTED|Overall Study||21
10376015|NCT00580853|11517062|FG000|COMPLETED|Overall Study||20
10376016|NCT00580853|11517063|FG001|COMPLETED|Overall Study||21
10376017|NCT00580853|11517064|FG002|COMPLETED|Overall Study||21
10376018|NCT00580853|11517062|FG000|NOT COMPLETED|Overall Study||0
10376019|NCT00580853|11517063|FG001|NOT COMPLETED|Overall Study||0
10376020|NCT00580853|11517064|FG002|NOT COMPLETED|Overall Study||0
10376021|NCT00580866|11517074|FG000|STARTED|Overall Study||10
10376022|NCT00580866|11517075|FG001|STARTED|Overall Study||7
10376023|NCT00580866|11517074|FG000|COMPLETED|Overall Study||8
10376024|NCT00580866|11517075|FG001|COMPLETED|Overall Study||5
10376025|NCT00580866|11517074|FG000|NOT COMPLETED|Overall Study||2
10376026|NCT00580866|11517075|FG001|NOT COMPLETED|Overall Study||2
10376027|NCT00580957|11517083|FG000|STARTED|Overall Study||28
10376028|NCT00580957|11517084|FG001|STARTED|Overall Study||28
10376029|NCT00580957|11517083|FG000|COMPLETED|Overall Study||21
10376030|NCT00580957|11517084|FG001|COMPLETED|Overall Study||21
10376031|NCT00580957|11517083|FG000|NOT COMPLETED|Overall Study||7
10376032|NCT00580957|11517084|FG001|NOT COMPLETED|Overall Study||7
10376033|NCT00580970|11517092|FG000|STARTED|Pre-treatment||73
10376034|NCT00580970|11517092|FG000|COMPLETED|Pre-treatment||72
10376035|NCT00580970|11517092|FG000|NOT COMPLETED|Pre-treatment||1
10376036|NCT00580970|11517092|FG000|STARTED|Treatment (Lovastatin)||72
10376037|NCT00580970|11517092|FG000|6 Months of Treatment|Treatment (Lovastatin)|Subjects evaluable for analysis|53
10376038|NCT00580970|11517092|FG000|COMPLETED|Treatment (Lovastatin)||53
10376039|NCT00580970|11517092|FG000|NOT COMPLETED|Treatment (Lovastatin)||19
10376040|NCT00580983|11517096|FG000|STARTED|Overall Study||80
10376041|NCT00580983|11517096|FG000|COMPLETED|Overall Study||73
10376042|NCT00580983|11517096|FG000|NOT COMPLETED|Overall Study||7
10376043|NCT00581048|11517100|FG000|STARTED|Overall Study||33
10376044|NCT00581048|11517100|FG000|COMPLETED|Overall Study||33
10376045|NCT00581048|11517100|FG000|NOT COMPLETED|Overall Study||0
10376046|NCT00581061|11517105|FG000|STARTED|Overall Study||13
10376047|NCT00581061|11517105|FG000|COMPLETED|Overall Study||13
10376048|NCT00581061|11517105|FG000|NOT COMPLETED|Overall Study||0
10376049|NCT00581100|11517113|FG000|STARTED|Overall Study||38
10376050|NCT00581100|11517114|FG001|STARTED|Overall Study||34
10376051|NCT00581100|11517113|FG000|Modified Intent-To-Treat Population|Overall Study|At least one dose of study medication, and had baseline and post-baseline data.|36
10376052|NCT00581100|11517114|FG001|Modified Intent-To-Treat Population|Overall Study|At least one dose of study medication, and had baseline and post-baseline data.|33
10376053|NCT00581100|11517113|FG000|COMPLETED|Overall Study||31
10376054|NCT00581100|11517114|FG001|COMPLETED|Overall Study||29
10376055|NCT00581100|11517113|FG000|NOT COMPLETED|Overall Study||7
10376056|NCT00581100|11517114|FG001|NOT COMPLETED|Overall Study||5
10376057|NCT00581230|11517120|FG000|STARTED|Overall Study||51
10376058|NCT00581230|11517120|FG000|Laryngoscopy Without RAMP|Overall Study||51
10376059|NCT00581230|11517120|FG000|Laryngoscopy With RAMP|Overall Study||51
10376060|NCT00581230|11517120|FG000|COMPLETED|Overall Study||51
10376061|NCT00581230|11517120|FG000|NOT COMPLETED|Overall Study||0
10376062|NCT00581256|11517129|FG000|STARTED|Overall Study||28
10376063|NCT00581256|11517130|FG001|STARTED|Overall Study||26
10376064|NCT00581256|11517129|FG000|COMPLETED|Overall Study||28
10376065|NCT00581256|11517130|FG001|COMPLETED|Overall Study||26
10717256|NCT02696967|11881183|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||4
10376066|NCT00581256|11517129|FG000|NOT COMPLETED|Overall Study||0
10376067|NCT00581256|11517130|FG001|NOT COMPLETED|Overall Study||0
10376068|NCT00581308|11517136|FG000|STARTED|Pre Discharge||215
10376069|NCT00581308|11517136|FG000|COMPLETED|Pre Discharge||213
10376070|NCT00581308|11517136|FG000|NOT COMPLETED|Pre Discharge||2
10376071|NCT00581308|11517136|FG000|STARTED|Month 1||213
10538557|NCT01456195|11691484|FG001|STARTED|Overall Study||137
10538558|NCT01456195|11691485|FG002|STARTED|Overall Study||141
10538559|NCT01456195|11691483|FG000|COMPLETED|Overall Study||132
10538560|NCT01456195|11691484|FG001|COMPLETED|Overall Study||127
10538561|NCT01456195|11691485|FG002|COMPLETED|Overall Study||127
10538562|NCT01456195|11691483|FG000|NOT COMPLETED|Overall Study||11
10538563|NCT01456195|11691484|FG001|NOT COMPLETED|Overall Study||10
10376072|NCT00581308|11517136|FG000|COMPLETED|Month 1||205
10376073|NCT00581308|11517136|FG000|NOT COMPLETED|Month 1||8
10376074|NCT00581308|11517136|FG000|STARTED|Month 6||205
10376075|NCT00581308|11517136|FG000|COMPLETED|Month 6||202
10376076|NCT00581308|11517136|FG000|NOT COMPLETED|Month 6||3
10376077|NCT00581308|11517136|FG000|STARTED|Month 12||202
10376078|NCT00581308|11517136|FG000|COMPLETED|Month 12||182
10376079|NCT00581308|11517136|FG000|NOT COMPLETED|Month 12||20
10376080|NCT00581308|11517136|FG000|STARTED|24 Months||182
10376081|NCT00581308|11517136|FG000|COMPLETED|24 Months||176
10376082|NCT00581308|11517136|FG000|NOT COMPLETED|24 Months||6
10538564|NCT01456195|11691485|FG002|NOT COMPLETED|Overall Study||14
10538565|NCT01456221|11691495|FG000|STARTED|Overall Study||183
10376083|NCT00581308|11517136|FG000|STARTED|36 Months||176
10376084|NCT00581308|11517136|FG000|COMPLETED|36 Months||170
10376085|NCT00581308|11517136|FG000|NOT COMPLETED|36 Months||6
10376086|NCT00581308|11517136|FG000|STARTED|48 Months||170
10376087|NCT00581308|11517136|FG000|COMPLETED|48 Months||161
10376088|NCT00581308|11517136|FG000|NOT COMPLETED|48 Months||9
10376089|NCT00581308|11517136|FG000|STARTED|60 Months||161
10376090|NCT00581308|11517136|FG000|COMPLETED|60 Months||158
10376091|NCT00581308|11517136|FG000|NOT COMPLETED|60 Months||3
10376092|NCT00581347|11517145|FG000|STARTED|Overall Study||3839
10376093|NCT00581347|11517146|FG001|STARTED|Overall Study||3707
10376094|NCT00581347|11517145|FG000|COMPLETED|Overall Study||3839
10376095|NCT00581347|11517146|FG001|COMPLETED|Overall Study||3707
10376096|NCT00581347|11517145|FG000|NOT COMPLETED|Overall Study||0
10376097|NCT00581347|11517146|FG001|NOT COMPLETED|Overall Study||0
10376098|NCT00581360|11517152|FG000|STARTED|Overall Study||10
10376099|NCT00581360|11517152|FG000|COMPLETED|Overall Study||9
10376100|NCT00581360|11517152|FG000|NOT COMPLETED|Overall Study||1
10376101|NCT00581386|11517159|FG000|STARTED|Overall Study|05/30/2007|73
10376102|NCT00581386|11517160|FG001|STARTED|Overall Study|05/30/2007|73
10376103|NCT00581386|11517161|FG002|STARTED|Overall Study|05/30/2007|72
10376104|NCT00581386|11517159|FG000|COMPLETED|Overall Study|04/15/2009|73
10376105|NCT00581386|11517160|FG001|COMPLETED|Overall Study|04/15/2009|73
10376106|NCT00581386|11517161|FG002|COMPLETED|Overall Study|04/15/2009|72
10376107|NCT00581386|11517159|FG000|NOT COMPLETED|Overall Study||0
10376108|NCT00581386|11517160|FG001|NOT COMPLETED|Overall Study||0
10376109|NCT00581386|11517161|FG002|NOT COMPLETED|Overall Study||0
10376110|NCT00581399|11517171|FG000|STARTED|Overall Study||46
10376111|NCT00581399|11517172|FG001|STARTED|Overall Study||48
10376112|NCT00581399|11517171|FG000|COMPLETED|Overall Study||46
10538566|NCT01456221|11691496|FG001|STARTED|Overall Study||183
10538567|NCT01456221|11691495|FG000|COMPLETED|Overall Study||119
10538568|NCT01456221|11691496|FG001|COMPLETED|Overall Study||126
10538569|NCT01456221|11691495|FG000|NOT COMPLETED|Overall Study||64
10538570|NCT01456221|11691496|FG001|NOT COMPLETED|Overall Study||57
10538571|NCT01456299|11691505|FG000|STARTED|Overall Study||34
10538572|NCT01456299|11691506|FG001|STARTED|Overall Study||34
10538573|NCT01456299|11691507|FG002|STARTED|Overall Study||34
10538574|NCT01456299|11691505|FG000|COMPLETED|Overall Study||34
10538575|NCT01456299|11691506|FG001|COMPLETED|Overall Study||33
10538576|NCT01456299|11691507|FG002|COMPLETED|Overall Study||33
10538577|NCT01456299|11691505|FG000|NOT COMPLETED|Overall Study||0
10538578|NCT01456299|11691506|FG001|NOT COMPLETED|Overall Study||1
10538579|NCT01456299|11691507|FG002|NOT COMPLETED|Overall Study||1
10657672|NCT02227693|11818821|FG001|NOT COMPLETED|Overall Study||0
10657673|NCT02227693|11818822|FG002|NOT COMPLETED|Overall Study||0
10657674|NCT02227693|11818823|FG003|NOT COMPLETED|Overall Study||0
10657675|NCT02227706|11818839|FG000|STARTED|Overall Study||20
10657676|NCT02227706|11818840|FG001|STARTED|Overall Study||20
10657677|NCT02227706|11818839|FG000|COMPLETED|Overall Study||20
10657678|NCT02227706|11818840|FG001|COMPLETED|Overall Study||20
10657679|NCT02227706|11818839|FG000|NOT COMPLETED|Overall Study||0
10657680|NCT02227706|11818840|FG001|NOT COMPLETED|Overall Study||0
10657681|NCT02227758|11818846|FG000|STARTED|Overall Study||112
10657682|NCT02227758|11818846|FG000|COMPLETED|Overall Study||45
10657683|NCT02227758|11818846|FG000|NOT COMPLETED|Overall Study||67
10657684|NCT02227784|11818856|FG000|STARTED|Double-Blind Phase||123
10657685|NCT02227784|11818857|FG001|STARTED|Double-Blind Phase||54
10657686|NCT02227784|11818858|FG002|STARTED|Double-Blind Phase||62
10657687|NCT02227784|11818859|FG003|STARTED|Double-Blind Phase||127
10657688|NCT02227784|11818860|FG004|STARTED|Double-Blind Phase||0
10657689|NCT02227784|11818856|FG000|COMPLETED|Double-Blind Phase||83
10657690|NCT02227784|11818857|FG001|COMPLETED|Double-Blind Phase||36
10376113|NCT00581399|11517172|FG001|COMPLETED|Overall Study||48
10376114|NCT00581399|11517171|FG000|NOT COMPLETED|Overall Study||0
10376115|NCT00581399|11517172|FG001|NOT COMPLETED|Overall Study||0
10376116|NCT00581529|11517178|FG000|STARTED|Overall Study||34
10376117|NCT00581529|11517178|FG000|COMPLETED|Overall Study||34
10376118|NCT00581529|11517178|FG000|NOT COMPLETED|Overall Study||0
10376119|NCT00581542|11517184|FG000|STARTED|Overall Study||62
10376120|NCT00581542|11517185|FG001|STARTED|Overall Study||62
10538580|NCT01456494|11691517|FG000|STARTED|Initial Inpatient Visit||24
10538581|NCT01456494|11691518|FG001|STARTED|Initial Inpatient Visit||26
10538582|NCT01456494|11691517|FG000|COMPLETED|Initial Inpatient Visit||24
10538583|NCT01456494|11691518|FG001|COMPLETED|Initial Inpatient Visit||26
10657691|NCT02227784|11818858|FG002|COMPLETED|Double-Blind Phase||41
10657692|NCT02227784|11818859|FG003|COMPLETED|Double-Blind Phase||88
10657693|NCT02227784|11818860|FG004|COMPLETED|Double-Blind Phase||0
10657694|NCT02227784|11818856|FG000|NOT COMPLETED|Double-Blind Phase||40
10376121|NCT00581542|11517184|FG000|COMPLETED|Overall Study||51
10376122|NCT00581542|11517185|FG001|COMPLETED|Overall Study||39
10376123|NCT00581542|11517184|FG000|NOT COMPLETED|Overall Study||11
10376124|NCT00581542|11517185|FG001|NOT COMPLETED|Overall Study||23
10376125|NCT00581555|11517195|FG000|STARTED|Overall Study||62
10376126|NCT00581555|11517196|FG001|STARTED|Overall Study||58
10376127|NCT00581555|11517195|FG000|COMPLETED|Overall Study||19
10376128|NCT00581555|11517196|FG001|COMPLETED|Overall Study||38
10376129|NCT00581555|11517195|FG000|NOT COMPLETED|Overall Study||43
10376130|NCT00581555|11517196|FG001|NOT COMPLETED|Overall Study||20
10376131|NCT00581581|11517204|FG000|STARTED|Overall Study||32
10376132|NCT00581581|11517205|FG001|STARTED|Overall Study||30
10376133|NCT00581581|11517204|FG000|COMPLETED|Overall Study||32
10376134|NCT00581581|11517205|FG001|COMPLETED|Overall Study||30
10376135|NCT00581581|11517204|FG000|NOT COMPLETED|Overall Study||0
10376136|NCT00581581|11517205|FG001|NOT COMPLETED|Overall Study||0
10376137|NCT00581776|11517211|FG000|STARTED|Overall Study||30
10376138|NCT00581776|11517211|FG000|COMPLETED|Overall Study|3 subjects did not complete the planned induction chemotherapy.|27
10376139|NCT00581776|11517211|FG000|NOT COMPLETED|Overall Study||3
10376140|NCT00581828|11517215|FG000|STARTED|Overall Study||19
10376141|NCT00581828|11517215|FG000|COMPLETED|Overall Study||18
10376142|NCT00581828|11517215|FG000|NOT COMPLETED|Overall Study||1
10376143|NCT00581854|11517219|FG000|STARTED|Overall Study||22
10376144|NCT00581854|11517219|FG000|COMPLETED|Overall Study||22
10376145|NCT00581854|11517219|FG000|NOT COMPLETED|Overall Study||0
10376146|NCT00581867|11517223|FG000|STARTED|First Intervention||16
10376147|NCT00581867|11517224|FG001|STARTED|First Intervention||15
10376148|NCT00581867|11517223|FG000|COMPLETED|First Intervention||16
10376149|NCT00581867|11517224|FG001|COMPLETED|First Intervention||15
10376150|NCT00581867|11517223|FG000|NOT COMPLETED|First Intervention||0
10376151|NCT00581867|11517224|FG001|NOT COMPLETED|First Intervention||0
10376152|NCT00581867|11517223|FG000|STARTED|Second Intervention|n=1 completed period 1 (placebo) but not period 2 (insulin). This individuals died between periods.|15
10376153|NCT00581867|11517224|FG001|STARTED|Second Intervention|1 individual completed period 1 (Intranasal Insulin) but did not complete period 2 (Placebo).|14
10376154|NCT00581867|11517223|FG000|COMPLETED|Second Intervention||15
10376155|NCT00581867|11517224|FG001|COMPLETED|Second Intervention||14
10376156|NCT00581867|11517223|FG000|NOT COMPLETED|Second Intervention||0
10376157|NCT00581867|11517224|FG001|NOT COMPLETED|Second Intervention||0
10376158|NCT00581893|11517230|FG000|STARTED|First Intervention (1 Month)||10
10376159|NCT00581893|11517231|FG001|STARTED|First Intervention (1 Month)||10
10376160|NCT00581893|11517230|FG000|COMPLETED|First Intervention (1 Month)||10
10376161|NCT00581893|11517231|FG001|COMPLETED|First Intervention (1 Month)||10
10376162|NCT00581893|11517230|FG000|NOT COMPLETED|First Intervention (1 Month)||0
10376163|NCT00581893|11517231|FG001|NOT COMPLETED|First Intervention (1 Month)||0
10376164|NCT00581893|11517230|FG000|STARTED|Washout (14 Days)||10
10376165|NCT00581893|11517231|FG001|STARTED|Washout (14 Days)||10
10376166|NCT00581893|11517230|FG000|COMPLETED|Washout (14 Days)||10
10376167|NCT00581893|11517231|FG001|COMPLETED|Washout (14 Days)||10
10376168|NCT00581893|11517230|FG000|NOT COMPLETED|Washout (14 Days)||0
10376169|NCT00581893|11517231|FG001|NOT COMPLETED|Washout (14 Days)||0
10376170|NCT00581893|11517230|FG000|STARTED|Second Intervention (1 Month)||10
10376171|NCT00581893|11517231|FG001|STARTED|Second Intervention (1 Month)||10
10376172|NCT00581893|11517230|FG000|COMPLETED|Second Intervention (1 Month)||7
10376173|NCT00581893|11517231|FG001|COMPLETED|Second Intervention (1 Month)||8
10376174|NCT00581893|11517230|FG000|NOT COMPLETED|Second Intervention (1 Month)||3
10376175|NCT00581893|11517231|FG001|NOT COMPLETED|Second Intervention (1 Month)||2
10376176|NCT00581919|11517237|FG000|STARTED|Overall Study||32
10376177|NCT00581919|11517237|FG000|COMPLETED|Overall Study||8
10376178|NCT00581919|11517237|FG000|NOT COMPLETED|Overall Study||24
10376179|NCT00581945|11517244|FG000|STARTED|Overall Study||74
10376180|NCT00581945|11517245|FG001|STARTED|Overall Study||73
10376181|NCT00581945|11517244|FG000|COMPLETED|Overall Study||65
10376182|NCT00581945|11517245|FG001|COMPLETED|Overall Study||63
10376183|NCT00581945|11517244|FG000|NOT COMPLETED|Overall Study||9
10376184|NCT00581945|11517245|FG001|NOT COMPLETED|Overall Study||10
10376185|NCT00581971|11517251|FG000|STARTED|Overall Study||30
10376186|NCT00581971|11517251|FG000|COMPLETED|Overall Study||30
10376187|NCT00581971|11517251|FG000|NOT COMPLETED|Overall Study||0
10376188|NCT00582010|11517258|FG000|STARTED|Overall Study||40
10376189|NCT00582010|11517259|FG001|STARTED|Overall Study||40
10376190|NCT00582010|11517258|FG000|COMPLETED|Overall Study||40
10376191|NCT00582010|11517259|FG001|COMPLETED|Overall Study||39
10376192|NCT00582010|11517258|FG000|NOT COMPLETED|Overall Study||0
10376193|NCT00582010|11517259|FG001|NOT COMPLETED|Overall Study||1
10376194|NCT00582075|11517265|FG000|STARTED|Overall Study||25
10376195|NCT00582075|11517265|FG000|COMPLETED|Overall Study||25
10376196|NCT00582075|11517265|FG000|NOT COMPLETED|Overall Study||0
10376197|NCT00582114|11517271|FG000|STARTED|Overall Study||100
10376198|NCT00582114|11517272|FG001|STARTED|Overall Study||100
10376199|NCT00582114|11517271|FG000|COMPLETED|Overall Study||58
10376200|NCT00582114|11517272|FG001|COMPLETED|Overall Study||46
10376201|NCT00582114|11517271|FG000|NOT COMPLETED|Overall Study||42
10376202|NCT00582114|11517272|FG001|NOT COMPLETED|Overall Study||54
10376203|NCT00582166|11517278|FG000|STARTED|Overall Study||18
10376204|NCT00582166|11517278|FG000|COMPLETED|Overall Study||16
10376205|NCT00582166|11517278|FG000|NOT COMPLETED|Overall Study||2
10376206|NCT00582205|11517282|FG000|STARTED|Overall Study||21
10376207|NCT00582205|11517282|FG000|COMPLETED|Overall Study||11
10657695|NCT02227784|11818857|FG001|NOT COMPLETED|Double-Blind Phase||18
10657696|NCT02227784|11818858|FG002|NOT COMPLETED|Double-Blind Phase||21
10657697|NCT02227784|11818859|FG003|NOT COMPLETED|Double-Blind Phase||39
10657698|NCT02227784|11818860|FG004|NOT COMPLETED|Double-Blind Phase||0
10657699|NCT02227784|11818856|FG000|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
10657700|NCT02227784|11818857|FG001|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
10657701|NCT02227784|11818858|FG002|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
10657702|NCT02227784|11818859|FG003|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
10376208|NCT00582205|11517282|FG000|NOT COMPLETED|Overall Study||10
10376209|NCT00582309|11517289|FG000|STARTED|Overall Study||56
10376210|NCT00582309|11517290|FG001|STARTED|Overall Study||49
10376211|NCT00582309|11517291|FG002|STARTED|Overall Study||46
10376212|NCT00582309|11517289|FG000|COMPLETED|Overall Study||56
10376213|NCT00582309|11517290|FG001|COMPLETED|Overall Study||49
10376214|NCT00582309|11517291|FG002|COMPLETED|Overall Study|2 did not have enough data collected to be used|44
10376215|NCT00582309|11517289|FG000|NOT COMPLETED|Overall Study||0
10376216|NCT00582309|11517290|FG001|NOT COMPLETED|Overall Study||0
10376217|NCT00582309|11517291|FG002|NOT COMPLETED|Overall Study||2
10376218|NCT00582361|11517301|FG000|STARTED|Overall Study||25
10376219|NCT00582361|11517302|FG001|STARTED|Overall Study||38
10376220|NCT00582361|11517301|FG000|COMPLETED|Overall Study||25
10376221|NCT00582361|11517302|FG001|COMPLETED|Overall Study||38
10376222|NCT00582361|11517301|FG000|NOT COMPLETED|Overall Study||0
10376223|NCT00582361|11517302|FG001|NOT COMPLETED|Overall Study||0
10376224|NCT00582400|11517308|FG000|STARTED|Overall Study||9
10376225|NCT00582400|11517308|FG000|COMPLETED|Overall Study||6
10376226|NCT00582400|11517308|FG000|NOT COMPLETED|Overall Study||3
10376227|NCT00582426|11517314|FG000|STARTED|Overall Study|"Patient in both arms belongs to started indicates safety and intent to treat (ITT) populations."|68
10376228|NCT00582426|11517315|FG001|STARTED|Overall Study||71
10376229|NCT00582426|11517314|FG000|COMPLETED|Overall Study||48
10376230|NCT00582426|11517315|FG001|COMPLETED|Overall Study||58
10306546|NCT00099359|11439428|FG000|COMPLETED|Overall Study||527
10306547|NCT00099359|11439429|FG001|COMPLETED|Overall Study||515
10306548|NCT00099359|11439430|FG002|COMPLETED|Overall Study||506
10306549|NCT00099359|11439428|FG000|NOT COMPLETED|Overall Study||54
10306550|NCT00099359|11439429|FG001|NOT COMPLETED|Overall Study||65
10306551|NCT00099359|11439430|FG002|NOT COMPLETED|Overall Study||68
10306552|NCT00099372|11439450|FG000|STARTED|Enrolled in Extended CARE Trial||104
10306553|NCT00099372|11439451|FG001|STARTED|Enrolled in Extended CARE Trial||111
10306554|NCT00099372|11439450|FG000|COMPLETED|Enrolled in Extended CARE Trial||104
10306555|NCT00099372|11439451|FG001|COMPLETED|Enrolled in Extended CARE Trial||111
10306556|NCT00099372|11439450|FG000|NOT COMPLETED|Enrolled in Extended CARE Trial||0
10306557|NCT00099372|11439451|FG001|NOT COMPLETED|Enrolled in Extended CARE Trial||0
10306558|NCT00099372|11439450|FG000|STARTED|Followed up 5 Years After Index Surgery||104
10306559|NCT00099372|11439451|FG001|STARTED|Followed up 5 Years After Index Surgery||111
10376231|NCT00582426|11517314|FG000|NOT COMPLETED|Overall Study||20
10376232|NCT00582426|11517315|FG001|NOT COMPLETED|Overall Study||13
10376233|NCT00582491|11517323|FG000|STARTED|Overall Study||11
10376234|NCT00582491|11517324|FG001|STARTED|Overall Study||10
10376235|NCT00582491|11517323|FG000|COMPLETED|Overall Study||10
10376236|NCT00582491|11517324|FG001|COMPLETED|Overall Study||10
10376237|NCT00582491|11517323|FG000|NOT COMPLETED|Overall Study||1
10376238|NCT00582491|11517324|FG001|NOT COMPLETED|Overall Study||0
10376239|NCT00582517|11517332|FG000|STARTED|Overall Study||45
10376240|NCT00582517|11517333|FG001|STARTED|Overall Study||55
10376241|NCT00582517|11517332|FG000|COMPLETED|Overall Study||45
10376242|NCT00582517|11517333|FG001|COMPLETED|Overall Study||55
10717257|NCT02696967|11881184|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||6
10717258|NCT02696967|11881185|FG002|Pharmacokinetic (PK) Analysis Set|Overall Study||4
10376243|NCT00582517|11517332|FG000|NOT COMPLETED|Overall Study||0
10376244|NCT00582517|11517333|FG001|NOT COMPLETED|Overall Study||0
10376245|NCT00582556|11517342|FG000|STARTED|Overall Study||14
10376246|NCT00582556|11517343|FG001|STARTED|Overall Study||15
10376247|NCT00582556|11517344|FG002|STARTED|Overall Study||14
10376248|NCT00582556|11517342|FG000|COMPLETED|Overall Study||14
10376249|NCT00582556|11517343|FG001|COMPLETED|Overall Study||14
10376250|NCT00582556|11517344|FG002|COMPLETED|Overall Study||12
10376251|NCT00582556|11517342|FG000|NOT COMPLETED|Overall Study||0
10376252|NCT00582556|11517343|FG001|NOT COMPLETED|Overall Study||1
10376253|NCT00582556|11517344|FG002|NOT COMPLETED|Overall Study||2
10376254|NCT00582608|11517353|FG000|STARTED|Overall Study||12
10376255|NCT00582608|11517353|FG000|COMPLETED|Overall Study||0
10376256|NCT00582608|11517353|FG000|NOT COMPLETED|Overall Study||12
10376257|NCT00582660|11517359|FG000|STARTED|Overall Study||20
10376258|NCT00582660|11517360|FG001|STARTED|Overall Study||20
10376259|NCT00582660|11517359|FG000|COMPLETED|Overall Study||20
10376260|NCT00582660|11517360|FG001|COMPLETED|Overall Study||20
10376261|NCT00582660|11517359|FG000|NOT COMPLETED|Overall Study||0
10376262|NCT00582660|11517360|FG001|NOT COMPLETED|Overall Study||0
10376263|NCT00582738|11517368|FG000|STARTED|Overall Study||21
10376264|NCT00582738|11517369|FG001|STARTED|Overall Study||22
10376265|NCT00582738|11517368|FG000|COMPLETED|Overall Study||12
10376266|NCT00582738|11517369|FG001|COMPLETED|Overall Study||4
10376267|NCT00582738|11517368|FG000|NOT COMPLETED|Overall Study||9
10376268|NCT00582738|11517369|FG001|NOT COMPLETED|Overall Study||18
10376269|NCT00582790|11517381|FG000|STARTED|Overall Study|only 11 of the 12 patients received study treatment.|12
10376270|NCT00582790|11517381|FG000|COMPLETED|Overall Study||11
10376271|NCT00582790|11517381|FG000|NOT COMPLETED|Overall Study||1
10376272|NCT00582816|11517386|FG000|STARTED|Overall Study||9
10376273|NCT00582816|11517386|FG000|COMPLETED|Overall Study|"Completed here means patients stably engrafted with donor cells."|6
10376274|NCT00582816|11517386|FG000|NOT COMPLETED|Overall Study||3
10376275|NCT00582894|11517390|FG000|STARTED|Overall Study||17
10376276|NCT00582894|11517390|FG000|Day 100 Post Transplant|Overall Study||17
10376277|NCT00582894|11517390|FG000|COMPLETED|Overall Study||17
10376278|NCT00582894|11517390|FG000|NOT COMPLETED|Overall Study||0
10376279|NCT00582907|11517394|FG000|STARTED|1st Course||4
10376280|NCT00582907|11517395|FG001|STARTED|1st Course||3
10376281|NCT00582907|11517396|FG002|STARTED|1st Course||3
10376282|NCT00582907|11517397|FG003|STARTED|1st Course||4
10376283|NCT00582907|11517394|FG000|COMPLETED|1st Course|1 left after 1st course (transportation issues)|3
10376284|NCT00582907|11517395|FG001|COMPLETED|1st Course||3
10376285|NCT00582907|11517396|FG002|COMPLETED|1st Course||3
10376286|NCT00582907|11517397|FG003|COMPLETED|1st Course|Patient lost to follow-up towards end of 1st course|3
10376287|NCT00582907|11517394|FG000|NOT COMPLETED|1st Course||1
10376288|NCT00582907|11517395|FG001|NOT COMPLETED|1st Course||0
10376289|NCT00582907|11517396|FG002|NOT COMPLETED|1st Course||0
10376290|NCT00582907|11517397|FG003|NOT COMPLETED|1st Course||1
10376291|NCT00582907|11517394|FG000|STARTED|2nd Course||3
10376292|NCT00582907|11517395|FG001|STARTED|2nd Course||3
10376293|NCT00582907|11517396|FG002|STARTED|2nd Course||3
10376294|NCT00582907|11517397|FG003|STARTED|2nd Course||3
10376295|NCT00582907|11517394|FG000|COMPLETED|2nd Course||2
10376296|NCT00582907|11517395|FG001|COMPLETED|2nd Course||3
10376297|NCT00582907|11517396|FG002|COMPLETED|2nd Course||3
10376298|NCT00582907|11517397|FG003|COMPLETED|2nd Course||3
10376299|NCT00582907|11517394|FG000|NOT COMPLETED|2nd Course||1
10376300|NCT00582907|11517395|FG001|NOT COMPLETED|2nd Course||0
10376301|NCT00582907|11517396|FG002|NOT COMPLETED|2nd Course||0
10376302|NCT00582907|11517397|FG003|NOT COMPLETED|2nd Course||0
10376303|NCT00582907|11517394|FG000|STARTED|3rd Course||2
10376304|NCT00582907|11517395|FG001|STARTED|3rd Course||3
10376305|NCT00582907|11517396|FG002|STARTED|3rd Course||3
10376306|NCT00582907|11517397|FG003|STARTED|3rd Course||3
10376307|NCT00582907|11517394|FG000|COMPLETED|3rd Course||2
10376308|NCT00582907|11517395|FG001|COMPLETED|3rd Course||3
10376309|NCT00582907|11517396|FG002|COMPLETED|3rd Course||3
10376310|NCT00582907|11517397|FG003|COMPLETED|3rd Course||3
10376311|NCT00582907|11517394|FG000|NOT COMPLETED|3rd Course||0
10376312|NCT00582907|11517395|FG001|NOT COMPLETED|3rd Course||0
10717259|NCT02696967|11881186|FG003|Pharmacokinetic (PK) Analysis Set|Overall Study||0
10717260|NCT02696967|11881183|FG000|COMPLETED|Overall Study||4
10376313|NCT00582907|11517396|FG002|NOT COMPLETED|3rd Course||0
10376314|NCT00582907|11517397|FG003|NOT COMPLETED|3rd Course||0
10376315|NCT00582907|11517394|FG000|STARTED|4th Course||2
10376316|NCT00582907|11517395|FG001|STARTED|4th Course||3
10376317|NCT00582907|11517396|FG002|STARTED|4th Course||3
10376318|NCT00582907|11517397|FG003|STARTED|4th Course||3
10376319|NCT00582907|11517394|FG000|COMPLETED|4th Course||2
10376320|NCT00582907|11517395|FG001|COMPLETED|4th Course||3
10376321|NCT00582907|11517396|FG002|COMPLETED|4th Course||3
10376322|NCT00582907|11517397|FG003|COMPLETED|4th Course||3
10376323|NCT00582907|11517394|FG000|NOT COMPLETED|4th Course||0
10376324|NCT00582907|11517395|FG001|NOT COMPLETED|4th Course||0
10376325|NCT00582907|11517396|FG002|NOT COMPLETED|4th Course||0
10376326|NCT00582907|11517397|FG003|NOT COMPLETED|4th Course||0
10376327|NCT00582933|11517403|FG000|STARTED|Overall Study||95
10376328|NCT00582933|11517403|FG000|COMPLETED|Overall Study||92
10376329|NCT00582933|11517403|FG000|NOT COMPLETED|Overall Study||3
10717261|NCT02696967|11881184|FG001|COMPLETED|Overall Study||6
10376330|NCT00582946|11517407|FG000|STARTED|Overall Study||16
10376331|NCT00582946|11517407|FG000|COMPLETED|Overall Study||16
10376332|NCT00582946|11517407|FG000|NOT COMPLETED|Overall Study||0
10376333|NCT00582972|11517411|FG000|STARTED|Overall Study||23
10376334|NCT00582972|11517411|FG000|COMPLETED|Overall Study||21
10376335|NCT00582972|11517411|FG000|NOT COMPLETED|Overall Study||2
10376336|NCT00582998|11517418|FG000|STARTED|Overall Study||119
10376337|NCT00582998|11517419|FG001|STARTED|Overall Study||130
10376338|NCT00582998|11517418|FG000|COMPLETED|Overall Study||119
10376339|NCT00582998|11517419|FG001|COMPLETED|Overall Study||130
10376340|NCT00582998|11517418|FG000|NOT COMPLETED|Overall Study||0
10376341|NCT00582998|11517419|FG001|NOT COMPLETED|Overall Study||0
10376342|NCT00583011|11517427|FG000|STARTED|Overall Study||36
10376343|NCT00583011|11517428|FG001|STARTED|Overall Study||40
10376344|NCT00583011|11517427|FG000|COMPLETED|Overall Study||36
10376345|NCT00583011|11517428|FG001|COMPLETED|Overall Study||40
10376346|NCT00583011|11517427|FG000|NOT COMPLETED|Overall Study||0
10376347|NCT00583011|11517428|FG001|NOT COMPLETED|Overall Study||0
10376348|NCT00583050|11517435|FG000|STARTED|Overall Study||1366
10376349|NCT00583050|11517435|FG000|COMPLETED|Overall Study||1366
10376350|NCT00583050|11517435|FG000|NOT COMPLETED|Overall Study||0
10376351|NCT00583102|11517439|FG000|STARTED|Overall Study||23
10376352|NCT00583102|11517439|FG000|COMPLETED|Overall Study||20
10376353|NCT00583102|11517439|FG000|NOT COMPLETED|Overall Study||3
10376354|NCT00583219|11517443|FG000|STARTED|Phase 1|First 3 subjects in Phase 1 received 200 units Botox. The remaining subjects got 300 units Botox.|9
10376355|NCT00583219|11517443|FG000|COMPLETED|Phase 1||9
10376356|NCT00583219|11517443|FG000|NOT COMPLETED|Phase 1||0
10376357|NCT00583219|11517443|FG000|STARTED|Phase 2|6 subjects from P1 continued in P2; plus 16 new subjects. All subjects in P2 got 300 units Botox.|22
10376358|NCT00583219|11517443|FG000|COMPLETED|Phase 2||21
10376359|NCT00583219|11517443|FG000|NOT COMPLETED|Phase 2||1
10376360|NCT00583362|11517447|FG000|STARTED|Overall Study||298
10376361|NCT00583362|11517447|FG000|COMPLETED|Overall Study||96
10376362|NCT00583362|11517447|FG000|NOT COMPLETED|Overall Study||202
10376363|NCT00583375|11517453|FG000|STARTED|Overall Study||142
10376364|NCT00583375|11517454|FG001|STARTED|Overall Study||272
10376365|NCT00583375|11517453|FG000|COMPLETED|Overall Study||142
10376366|NCT00583375|11517454|FG001|COMPLETED|Overall Study||272
10376367|NCT00583375|11517453|FG000|NOT COMPLETED|Overall Study||0
10376368|NCT00583375|11517454|FG001|NOT COMPLETED|Overall Study||0
10376369|NCT00583414|11517460|FG000|STARTED|Overall Study||401
10376370|NCT00583414|11517460|FG000|COMPLETED|Overall Study||401
10376371|NCT00583414|11517460|FG000|NOT COMPLETED|Overall Study||0
10376372|NCT00583453|11517466|FG000|STARTED|Overall Study||9
10376373|NCT00583453|11517467|FG001|STARTED|Overall Study||8
10376374|NCT00583453|11517466|FG000|COMPLETED|Overall Study||9
10376375|NCT00583453|11517467|FG001|COMPLETED|Overall Study||6
10376376|NCT00583453|11517466|FG000|NOT COMPLETED|Overall Study||0
10376377|NCT00583453|11517467|FG001|NOT COMPLETED|Overall Study||2
10376378|NCT00583492|11517477|FG000|STARTED|Overall Study||21
10376379|NCT00583492|11517478|FG001|STARTED|Overall Study||23
10376380|NCT00583492|11517477|FG000|COMPLETED|Overall Study||21
10376381|NCT00583492|11517478|FG001|COMPLETED|Overall Study||23
10376382|NCT00583492|11517477|FG000|NOT COMPLETED|Overall Study||0
10376383|NCT00583492|11517478|FG001|NOT COMPLETED|Overall Study||0
10376384|NCT00583557|11517484|FG000|STARTED|Overall Study||155
10376385|NCT00583557|11517484|FG000|Received at Least 1 Dose Belimumab|Overall Study||153
10376386|NCT00583557|11517484|FG000|COMPLETED|Overall Study|Completer defined as subjects whose reason for discontinuation was sponsor discontinuation of study|85
10376387|NCT00583557|11517484|FG000|NOT COMPLETED|Overall Study||70
10376388|NCT00583596|11517488|FG000|STARTED|Overall Study|Subjects in Phase 2 clinical trial who received the AMPLATZER Duct Occluder.|436
10376389|NCT00583596|11517488|FG000|COMPLETED|Overall Study||152
10376390|NCT00583596|11517488|FG000|NOT COMPLETED|Overall Study||284
10376391|NCT00583622|11517493|FG000|STARTED|Overall Study||12
10376392|NCT00583622|11517493|FG000|COMPLETED|Overall Study||12
10376393|NCT00583622|11517493|FG000|NOT COMPLETED|Overall Study||0
10376394|NCT00583661|11517497|FG000|STARTED|Overall Study||48
10376395|NCT00583661|11517497|FG000|COMPLETED|Overall Study||48
10376396|NCT00583661|11517497|FG000|NOT COMPLETED|Overall Study||0
10376397|NCT00583700|11517504|FG000|STARTED|Overall Study||27
10376398|NCT00583700|11517505|FG001|STARTED|Overall Study||27
10376399|NCT00583700|11517504|FG000|COMPLETED|Overall Study||24
10376400|NCT00583700|11517505|FG001|COMPLETED|Overall Study||23
10538584|NCT01456494|11691517|FG000|NOT COMPLETED|Initial Inpatient Visit||0
10538585|NCT01456494|11691518|FG001|NOT COMPLETED|Initial Inpatient Visit||0
10538586|NCT01456494|11691517|FG000|STARTED|Follow-Up Visit (Post 30-day Discharge)||24
10538587|NCT01456494|11691518|FG001|STARTED|Follow-Up Visit (Post 30-day Discharge)||26
10538588|NCT01456494|11691517|FG000|COMPLETED|Follow-Up Visit (Post 30-day Discharge)||19
10657703|NCT02227784|11818860|FG004|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|248
10657704|NCT02227784|11818856|FG000|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
10657705|NCT02227784|11818857|FG001|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
10657706|NCT02227784|11818858|FG002|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
10657707|NCT02227784|11818859|FG003|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
10657708|NCT02227784|11818860|FG004|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||247
10376401|NCT00583700|11517504|FG000|NOT COMPLETED|Overall Study||3
10376402|NCT00583700|11517505|FG001|NOT COMPLETED|Overall Study||4
10376403|NCT00583713|11517514|FG000|STARTED|Overall Study||6
10376404|NCT00583713|11517515|FG001|STARTED|Overall Study||6
10376405|NCT00583713|11517516|FG002|STARTED|Overall Study||6
10376406|NCT00583713|11517514|FG000|COMPLETED|Overall Study||6
10376407|NCT00583713|11517515|FG001|COMPLETED|Overall Study||6
10376408|NCT00583713|11517516|FG002|COMPLETED|Overall Study||6
10376409|NCT00583713|11517514|FG000|NOT COMPLETED|Overall Study||0
10376410|NCT00583713|11517515|FG001|NOT COMPLETED|Overall Study||0
10376411|NCT00583713|11517516|FG002|NOT COMPLETED|Overall Study||0
10376412|NCT00583791|11517524|FG000|STARTED|Overall Study||91
10376413|NCT00583791|11517524|FG000|COMPLETED|Overall Study||18
10376414|NCT00583791|11517524|FG000|NOT COMPLETED|Overall Study||73
10376415|NCT00583908|11517528|FG000|STARTED|Period 1 - First Intervention||1
10376416|NCT00583908|11517529|FG001|STARTED|Period 1 - First Intervention||2
10376417|NCT00583908|11517530|FG002|STARTED|Period 1 - First Intervention||1
10376418|NCT00583908|11517531|FG003|STARTED|Period 1 - First Intervention||1
10376419|NCT00583908|11517532|FG004|STARTED|Period 1 - First Intervention||2
10376420|NCT00583908|11517533|FG005|STARTED|Period 1 - First Intervention||1
10376421|NCT00583908|11517534|FG006|STARTED|Period 1 - First Intervention||1
10376422|NCT00583908|11517535|FG007|STARTED|Period 1 - First Intervention||1
10376423|NCT00583908|11517536|FG008|STARTED|Period 1 - First Intervention||1
10376424|NCT00583908|11517537|FG009|STARTED|Period 1 - First Intervention||1
10376425|NCT00583908|11517538|FG010|STARTED|Period 1 - First Intervention||1
10376426|NCT00583908|11517539|FG011|STARTED|Period 1 - First Intervention||1
10376427|NCT00583908|11517528|FG000|COMPLETED|Period 1 - First Intervention||1
10376428|NCT00583908|11517529|FG001|COMPLETED|Period 1 - First Intervention||2
10376429|NCT00583908|11517530|FG002|COMPLETED|Period 1 - First Intervention||1
10376430|NCT00583908|11517531|FG003|COMPLETED|Period 1 - First Intervention||1
10376431|NCT00583908|11517532|FG004|COMPLETED|Period 1 - First Intervention||2
10376432|NCT00583908|11517533|FG005|COMPLETED|Period 1 - First Intervention||1
10376433|NCT00583908|11517534|FG006|COMPLETED|Period 1 - First Intervention||1
10376434|NCT00583908|11517535|FG007|COMPLETED|Period 1 - First Intervention||1
10376435|NCT00583908|11517536|FG008|COMPLETED|Period 1 - First Intervention||1
10376436|NCT00583908|11517537|FG009|COMPLETED|Period 1 - First Intervention||1
10376437|NCT00583908|11517538|FG010|COMPLETED|Period 1 - First Intervention||1
10376438|NCT00583908|11517539|FG011|COMPLETED|Period 1 - First Intervention||1
10376439|NCT00583908|11517528|FG000|NOT COMPLETED|Period 1 - First Intervention||0
10376440|NCT00583908|11517529|FG001|NOT COMPLETED|Period 1 - First Intervention||0
10376441|NCT00583908|11517530|FG002|NOT COMPLETED|Period 1 - First Intervention||0
10376442|NCT00583908|11517531|FG003|NOT COMPLETED|Period 1 - First Intervention||0
10376443|NCT00583908|11517532|FG004|NOT COMPLETED|Period 1 - First Intervention||0
10376444|NCT00583908|11517533|FG005|NOT COMPLETED|Period 1 - First Intervention||0
10376445|NCT00583908|11517534|FG006|NOT COMPLETED|Period 1 - First Intervention||0
10376446|NCT00583908|11517535|FG007|NOT COMPLETED|Period 1 - First Intervention||0
10376447|NCT00583908|11517536|FG008|NOT COMPLETED|Period 1 - First Intervention||0
10376448|NCT00583908|11517537|FG009|NOT COMPLETED|Period 1 - First Intervention||0
10376449|NCT00583908|11517538|FG010|NOT COMPLETED|Period 1 - First Intervention||0
10376450|NCT00583908|11517539|FG011|NOT COMPLETED|Period 1 - First Intervention||0
10376451|NCT00583908|11517528|FG000|STARTED|Period 2 - Second Intervention||1
10376452|NCT00583908|11517529|FG001|STARTED|Period 2 - Second Intervention||2
10376453|NCT00583908|11517530|FG002|STARTED|Period 2 - Second Intervention||1
10376454|NCT00583908|11517531|FG003|STARTED|Period 2 - Second Intervention||1
10376455|NCT00583908|11517532|FG004|STARTED|Period 2 - Second Intervention||2
10376456|NCT00583908|11517533|FG005|STARTED|Period 2 - Second Intervention||1
10376457|NCT00583908|11517534|FG006|STARTED|Period 2 - Second Intervention||1
10376458|NCT00583908|11517535|FG007|STARTED|Period 2 - Second Intervention||1
10538589|NCT01456494|11691518|FG001|COMPLETED|Follow-Up Visit (Post 30-day Discharge)||20
10538590|NCT01456494|11691517|FG000|NOT COMPLETED|Follow-Up Visit (Post 30-day Discharge)||5
10538591|NCT01456494|11691518|FG001|NOT COMPLETED|Follow-Up Visit (Post 30-day Discharge)||6
10538592|NCT01456780|11691527|FG000|STARTED|Overall Study||20
10538593|NCT01456780|11691528|FG001|STARTED|Overall Study||20
10538594|NCT01456780|11691529|FG002|STARTED|Overall Study||20
10538595|NCT01456780|11691527|FG000|COMPLETED|Overall Study||17
10538596|NCT01456780|11691528|FG001|COMPLETED|Overall Study||17
10538597|NCT01456780|11691529|FG002|COMPLETED|Overall Study||20
10538598|NCT01456780|11691527|FG000|NOT COMPLETED|Overall Study||3
10538599|NCT01456780|11691528|FG001|NOT COMPLETED|Overall Study||3
10538600|NCT01456780|11691529|FG002|NOT COMPLETED|Overall Study||0
10538601|NCT01456897|11691539|FG000|STARTED|Overall Study||184
10538602|NCT01456897|11691540|FG001|STARTED|Overall Study||98
10538603|NCT01456897|11691539|FG000|COMPLETED|Overall Study||109
10538604|NCT01456897|11691540|FG001|COMPLETED|Overall Study||41
10538605|NCT01456897|11691539|FG000|NOT COMPLETED|Overall Study||75
10538606|NCT01456897|11691540|FG001|NOT COMPLETED|Overall Study||57
10538607|NCT01456936|11691550|FG000|STARTED|Overall Study||2037
10538608|NCT01456936|11691551|FG001|STARTED|Overall Study||2034
10538609|NCT01456936|11691552|FG002|STARTED|Overall Study||2038
10657709|NCT02227784|11818856|FG000|COMPLETED|Open-Label Extension Phase (OLE)||0
10657710|NCT02227784|11818857|FG001|COMPLETED|Open-Label Extension Phase (OLE)||0
10376459|NCT00583908|11517536|FG008|STARTED|Period 2 - Second Intervention||1
10538610|NCT01456936|11691553|FG003|STARTED|Overall Study||2035
10538611|NCT01456936|11691550|FG000|Randomized and Treated|Overall Study||2016
10538612|NCT01456936|11691551|FG001|Randomized and Treated|Overall Study||2006
10717262|NCT02696967|11881185|FG002|COMPLETED|Overall Study||6
10376460|NCT00583908|11517537|FG009|STARTED|Period 2 - Second Intervention||1
10376461|NCT00583908|11517538|FG010|STARTED|Period 2 - Second Intervention||1
10376462|NCT00583908|11517539|FG011|STARTED|Period 2 - Second Intervention||1
10376463|NCT00583908|11517528|FG000|COMPLETED|Period 2 - Second Intervention||1
10376464|NCT00583908|11517529|FG001|COMPLETED|Period 2 - Second Intervention||2
10376465|NCT00583908|11517530|FG002|COMPLETED|Period 2 - Second Intervention||1
10376466|NCT00583908|11517531|FG003|COMPLETED|Period 2 - Second Intervention||1
10376467|NCT00583908|11517532|FG004|COMPLETED|Period 2 - Second Intervention||2
10376468|NCT00583908|11517533|FG005|COMPLETED|Period 2 - Second Intervention||1
10376469|NCT00583908|11517534|FG006|COMPLETED|Period 2 - Second Intervention||1
10376470|NCT00583908|11517535|FG007|COMPLETED|Period 2 - Second Intervention||1
10376471|NCT00583908|11517536|FG008|COMPLETED|Period 2 - Second Intervention||1
10376472|NCT00583908|11517537|FG009|COMPLETED|Period 2 - Second Intervention||1
10376473|NCT00583908|11517538|FG010|COMPLETED|Period 2 - Second Intervention||1
10376474|NCT00583908|11517539|FG011|COMPLETED|Period 2 - Second Intervention||1
10376475|NCT00583908|11517528|FG000|NOT COMPLETED|Period 2 - Second Intervention||0
10376476|NCT00583908|11517529|FG001|NOT COMPLETED|Period 2 - Second Intervention||0
10376477|NCT00583908|11517530|FG002|NOT COMPLETED|Period 2 - Second Intervention||0
10376478|NCT00583908|11517531|FG003|NOT COMPLETED|Period 2 - Second Intervention||0
10376479|NCT00583908|11517532|FG004|NOT COMPLETED|Period 2 - Second Intervention||0
10376480|NCT00583908|11517533|FG005|NOT COMPLETED|Period 2 - Second Intervention||0
10376481|NCT00583908|11517534|FG006|NOT COMPLETED|Period 2 - Second Intervention||0
10376482|NCT00583908|11517535|FG007|NOT COMPLETED|Period 2 - Second Intervention||0
10376483|NCT00583908|11517536|FG008|NOT COMPLETED|Period 2 - Second Intervention||0
10376484|NCT00583908|11517537|FG009|NOT COMPLETED|Period 2 - Second Intervention||0
10427937|NCT00855920|11573882|FG001|COMPLETED|Overall Study||65
10427938|NCT00855920|11573883|FG002|COMPLETED|Overall Study||64
10427939|NCT00855920|11573881|FG000|NOT COMPLETED|Overall Study||8
10538613|NCT01456936|11691552|FG002|Randomized and Treated|Overall Study||2022
10538614|NCT01456936|11691553|FG003|Randomized and Treated|Overall Study||2014
10538615|NCT01456936|11691550|FG000|COMPLETED|Overall Study||1598
10538616|NCT01456936|11691551|FG001|COMPLETED|Overall Study||1586
10538617|NCT01456936|11691552|FG002|COMPLETED|Overall Study||1557
10538618|NCT01456936|11691553|FG003|COMPLETED|Overall Study||1552
10538619|NCT01456936|11691550|FG000|NOT COMPLETED|Overall Study||439
10538620|NCT01456936|11691551|FG001|NOT COMPLETED|Overall Study||448
10538621|NCT01456936|11691552|FG002|NOT COMPLETED|Overall Study||481
10538622|NCT01456936|11691553|FG003|NOT COMPLETED|Overall Study||483
10538623|NCT01456949|11691563|FG000|STARTED|Enrollment||402
10538624|NCT01456949|11691563|FG000|Treated|Enrollment||359
10538625|NCT01456949|11691563|FG000|Modified Intent to Treat Group (mITT)|Enrollment||354
10538626|NCT01456949|11691563|FG000|COMPLETED|Enrollment|6 rollover subjects not included in final analysis. 359 treated; 354 treated & met all I/E criteria.|365
10538627|NCT01456949|11691563|FG000|NOT COMPLETED|Enrollment||37
10538628|NCT01456949|11691563|FG000|STARTED|Study Cryoablation Procedure & Follow-up||365
10538629|NCT01456949|11691563|FG000|3-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of 354 subjects who were treated and met all I/E criteria (mITT group).|344
10538630|NCT01456949|11691563|FG000|6-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|342
10538631|NCT01456949|11691563|FG000|12-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|325
10538632|NCT01456949|11691563|FG000|24-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|309
10538633|NCT01456949|11691563|FG000|36-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|298
10538634|NCT01456949|11691563|FG000|COMPLETED|Study Cryoablation Procedure & Follow-up|5 subjects completed at least 36 months of follow-up but did not complete a 36 month follow-up visit|303
10538635|NCT01456949|11691563|FG000|NOT COMPLETED|Study Cryoablation Procedure & Follow-up||62
10538636|NCT01456962|11691569|FG000|STARTED|Overall Study||16
10538637|NCT01456962|11691570|FG001|STARTED|Overall Study||20
10538638|NCT01456962|11691569|FG000|COMPLETED|Overall Study||14
10538639|NCT01456962|11691570|FG001|COMPLETED|Overall Study||19
10538640|NCT01456962|11691569|FG000|NOT COMPLETED|Overall Study||2
10538641|NCT01456962|11691570|FG001|NOT COMPLETED|Overall Study||1
10538642|NCT01457014|11691576|FG000|STARTED|First Night||74
10538643|NCT01457014|11691577|FG001|STARTED|First Night||0
10538644|NCT01457014|11691578|FG002|STARTED|First Night||0
10538645|NCT01457014|11691579|FG003|STARTED|First Night||0
10538646|NCT01457014|11691576|FG000|COMPLETED|First Night||34
10538647|NCT01457014|11691577|FG001|COMPLETED|First Night||0
10538648|NCT01457014|11691578|FG002|COMPLETED|First Night||0
10538649|NCT01457014|11691579|FG003|COMPLETED|First Night||0
10538650|NCT01457014|11691576|FG000|NOT COMPLETED|First Night||40
10538651|NCT01457014|11691577|FG001|NOT COMPLETED|First Night||0
10538652|NCT01457014|11691578|FG002|NOT COMPLETED|First Night||0
10538653|NCT01457014|11691579|FG003|NOT COMPLETED|First Night||0
10538654|NCT01457014|11691576|FG000|STARTED|Second Night|The Diagnostic PSG was only completed on the First night|0
10538655|NCT01457014|11691577|FG001|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
10427940|NCT00855920|11573882|FG001|NOT COMPLETED|Overall Study||9
10427941|NCT00855920|11573883|FG002|NOT COMPLETED|Overall Study||11
10427942|NCT00855933|11573893|FG000|STARTED|Overall Study||30
10427943|NCT00855933|11573894|FG001|STARTED|Overall Study||30
10427944|NCT00855933|11573893|FG000|COMPLETED|Overall Study||30
10427945|NCT00855933|11573894|FG001|COMPLETED|Overall Study||29
10427946|NCT00855933|11573893|FG000|NOT COMPLETED|Overall Study||0
10717263|NCT02696967|11881186|FG003|COMPLETED|Overall Study||10
10376485|NCT00583908|11517538|FG010|NOT COMPLETED|Period 2 - Second Intervention||0
10376486|NCT00583908|11517539|FG011|NOT COMPLETED|Period 2 - Second Intervention||0
10376487|NCT00583908|11517528|FG000|STARTED|Period 3 - Third Intervention||1
10376488|NCT00583908|11517529|FG001|STARTED|Period 3 - Third Intervention||2
10376489|NCT00583908|11517530|FG002|STARTED|Period 3 - Third Intervention||1
10376490|NCT00583908|11517531|FG003|STARTED|Period 3 - Third Intervention||1
10376491|NCT00583908|11517532|FG004|STARTED|Period 3 - Third Intervention||2
10376492|NCT00583908|11517533|FG005|STARTED|Period 3 - Third Intervention||1
10376493|NCT00583908|11517534|FG006|STARTED|Period 3 - Third Intervention||1
10376494|NCT00583908|11517535|FG007|STARTED|Period 3 - Third Intervention||1
10376495|NCT00583908|11517536|FG008|STARTED|Period 3 - Third Intervention||1
10376496|NCT00583908|11517537|FG009|STARTED|Period 3 - Third Intervention||1
10376497|NCT00583908|11517538|FG010|STARTED|Period 3 - Third Intervention||1
10376498|NCT00583908|11517539|FG011|STARTED|Period 3 - Third Intervention||1
10376499|NCT00583908|11517528|FG000|COMPLETED|Period 3 - Third Intervention||1
10376500|NCT00583908|11517529|FG001|COMPLETED|Period 3 - Third Intervention||2
10376501|NCT00583908|11517530|FG002|COMPLETED|Period 3 - Third Intervention||1
10376502|NCT00583908|11517531|FG003|COMPLETED|Period 3 - Third Intervention||1
10376503|NCT00583908|11517532|FG004|COMPLETED|Period 3 - Third Intervention||2
10376504|NCT00583908|11517533|FG005|COMPLETED|Period 3 - Third Intervention||1
10376505|NCT00583908|11517534|FG006|COMPLETED|Period 3 - Third Intervention||1
10657711|NCT02227784|11818858|FG002|COMPLETED|Open-Label Extension Phase (OLE)||0
10657712|NCT02227784|11818859|FG003|COMPLETED|Open-Label Extension Phase (OLE)||0
10657713|NCT02227784|11818860|FG004|COMPLETED|Open-Label Extension Phase (OLE)||0
10306560|NCT00099372|11439450|FG000|COMPLETED|Followed up 5 Years After Index Surgery||89
10306561|NCT00099372|11439451|FG001|COMPLETED|Followed up 5 Years After Index Surgery||92
10657714|NCT02227784|11818856|FG000|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
10657715|NCT02227784|11818857|FG001|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
10657716|NCT02227784|11818858|FG002|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
10376506|NCT00583908|11517535|FG007|COMPLETED|Period 3 - Third Intervention||1
10376507|NCT00583908|11517536|FG008|COMPLETED|Period 3 - Third Intervention||1
10376508|NCT00583908|11517537|FG009|COMPLETED|Period 3 - Third Intervention||1
10376509|NCT00583908|11517538|FG010|COMPLETED|Period 3 - Third Intervention||1
10376510|NCT00583908|11517539|FG011|COMPLETED|Period 3 - Third Intervention||1
10376511|NCT00583908|11517528|FG000|NOT COMPLETED|Period 3 - Third Intervention||0
10376512|NCT00583908|11517529|FG001|NOT COMPLETED|Period 3 - Third Intervention||0
10538656|NCT01457014|11691578|FG002|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
10538657|NCT01457014|11691579|FG003|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
10538658|NCT01457014|11691576|FG000|COMPLETED|Second Night|The Diagnostic PSG was only completed on the First night|0
10538659|NCT01457014|11691577|FG001|COMPLETED|Second Night||12
10538660|NCT01457014|11691578|FG002|COMPLETED|Second Night||11
10538661|NCT01457014|11691579|FG003|COMPLETED|Second Night||11
10538662|NCT01457014|11691576|FG000|NOT COMPLETED|Second Night||0
10538663|NCT01457014|11691577|FG001|NOT COMPLETED|Second Night||0
10538664|NCT01457014|11691578|FG002|NOT COMPLETED|Second Night||0
10538665|NCT01457014|11691579|FG003|NOT COMPLETED|Second Night||0
10538666|NCT01457014|11691576|FG000|STARTED|Third Night|The Diagnostic PSG was only completed on the First night|0
10657717|NCT02227784|11818859|FG003|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
10306562|NCT00099372|11439450|FG000|NOT COMPLETED|Followed up 5 Years After Index Surgery||15
10306563|NCT00099372|11439451|FG001|NOT COMPLETED|Followed up 5 Years After Index Surgery||19
10306564|NCT00099372|11439450|FG000|STARTED|Followed up 7 Years After Index Surgery||89
10306565|NCT00099372|11439451|FG001|STARTED|Followed up 7 Years After Index Surgery||92
10306566|NCT00099372|11439450|FG000|COMPLETED|Followed up 7 Years After Index Surgery||66
10306567|NCT00099372|11439451|FG001|COMPLETED|Followed up 7 Years After Index Surgery||60
10306568|NCT00099372|11439450|FG000|NOT COMPLETED|Followed up 7 Years After Index Surgery||23
10306569|NCT00099372|11439451|FG001|NOT COMPLETED|Followed up 7 Years After Index Surgery||32
10306570|NCT00099632|11439465|FG000|STARTED|Overall Study||73
10376513|NCT00583908|11517530|FG002|NOT COMPLETED|Period 3 - Third Intervention||0
10657718|NCT02227784|11818860|FG004|NOT COMPLETED|Open-Label Extension Phase (OLE)||248
10657719|NCT02227810|11818875|FG000|STARTED|Overall Study||19
10657720|NCT02227810|11818876|FG001|STARTED|Overall Study||34
10657721|NCT02227810|11818875|FG000|COMPLETED|Overall Study||17
10657722|NCT02227810|11818876|FG001|COMPLETED|Overall Study||29
10657723|NCT02227810|11818875|FG000|NOT COMPLETED|Overall Study||2
10376514|NCT00583908|11517531|FG003|NOT COMPLETED|Period 3 - Third Intervention||0
10376515|NCT00583908|11517532|FG004|NOT COMPLETED|Period 3 - Third Intervention||0
10376516|NCT00583908|11517533|FG005|NOT COMPLETED|Period 3 - Third Intervention||0
10376517|NCT00583908|11517534|FG006|NOT COMPLETED|Period 3 - Third Intervention||0
10376518|NCT00583908|11517535|FG007|NOT COMPLETED|Period 3 - Third Intervention||0
10376519|NCT00583908|11517536|FG008|NOT COMPLETED|Period 3 - Third Intervention||0
10376520|NCT00583908|11517537|FG009|NOT COMPLETED|Period 3 - Third Intervention||0
10376521|NCT00583908|11517538|FG010|NOT COMPLETED|Period 3 - Third Intervention||0
10376522|NCT00583908|11517539|FG011|NOT COMPLETED|Period 3 - Third Intervention||0
10376523|NCT00583908|11517528|FG000|STARTED|Period 4 - Fourth Intervention||1
10376524|NCT00583908|11517529|FG001|STARTED|Period 4 - Fourth Intervention||2
10376525|NCT00583908|11517530|FG002|STARTED|Period 4 - Fourth Intervention||1
10376526|NCT00583908|11517531|FG003|STARTED|Period 4 - Fourth Intervention||1
10376527|NCT00583908|11517532|FG004|STARTED|Period 4 - Fourth Intervention||2
10376528|NCT00583908|11517533|FG005|STARTED|Period 4 - Fourth Intervention||1
10376529|NCT00583908|11517534|FG006|STARTED|Period 4 - Fourth Intervention||1
10376530|NCT00583908|11517535|FG007|STARTED|Period 4 - Fourth Intervention||1
10376531|NCT00583908|11517536|FG008|STARTED|Period 4 - Fourth Intervention||1
10376532|NCT00583908|11517537|FG009|STARTED|Period 4 - Fourth Intervention||1
10376533|NCT00583908|11517538|FG010|STARTED|Period 4 - Fourth Intervention||1
10376534|NCT00583908|11517539|FG011|STARTED|Period 4 - Fourth Intervention||1
10376535|NCT00583908|11517528|FG000|COMPLETED|Period 4 - Fourth Intervention||1
10376536|NCT00583908|11517529|FG001|COMPLETED|Period 4 - Fourth Intervention||2
10376537|NCT00583908|11517530|FG002|COMPLETED|Period 4 - Fourth Intervention||1
10376538|NCT00583908|11517531|FG003|COMPLETED|Period 4 - Fourth Intervention||1
10376539|NCT00583908|11517532|FG004|COMPLETED|Period 4 - Fourth Intervention||2
10376540|NCT00583908|11517533|FG005|COMPLETED|Period 4 - Fourth Intervention||1
10376541|NCT00583908|11517534|FG006|COMPLETED|Period 4 - Fourth Intervention||1
10376542|NCT00583908|11517535|FG007|COMPLETED|Period 4 - Fourth Intervention||1
10717264|NCT02696967|11881183|FG000|NOT COMPLETED|Overall Study||0
10717265|NCT02696967|11881184|FG001|NOT COMPLETED|Overall Study||0
10717266|NCT02696967|11881185|FG002|NOT COMPLETED|Overall Study||0
10376543|NCT00583908|11517536|FG008|COMPLETED|Period 4 - Fourth Intervention||1
10376544|NCT00583908|11517537|FG009|COMPLETED|Period 4 - Fourth Intervention||1
10376545|NCT00583908|11517538|FG010|COMPLETED|Period 4 - Fourth Intervention||1
10376546|NCT00583908|11517539|FG011|COMPLETED|Period 4 - Fourth Intervention||1
10376547|NCT00583908|11517528|FG000|NOT COMPLETED|Period 4 - Fourth Intervention||0
10376548|NCT00583908|11517529|FG001|NOT COMPLETED|Period 4 - Fourth Intervention||0
10376549|NCT00583908|11517530|FG002|NOT COMPLETED|Period 4 - Fourth Intervention||0
10376550|NCT00583908|11517531|FG003|NOT COMPLETED|Period 4 - Fourth Intervention||0
10376551|NCT00583908|11517532|FG004|NOT COMPLETED|Period 4 - Fourth Intervention||0
10376552|NCT00583908|11517533|FG005|NOT COMPLETED|Period 4 - Fourth Intervention||0
10376553|NCT00583908|11517534|FG006|NOT COMPLETED|Period 4 - Fourth Intervention||0
10376554|NCT00583908|11517535|FG007|NOT COMPLETED|Period 4 - Fourth Intervention||0
10376555|NCT00583908|11517536|FG008|NOT COMPLETED|Period 4 - Fourth Intervention||0
10376556|NCT00583908|11517537|FG009|NOT COMPLETED|Period 4 - Fourth Intervention||0
10717267|NCT02696967|11881186|FG003|NOT COMPLETED|Overall Study||0
10717268|NCT02697071|11881198|FG000|STARTED|Overall Study||18
10717269|NCT02697071|11881199|FG001|STARTED|Overall Study||16
10717270|NCT02697071|11881198|FG000|COMPLETED|Overall Study||18
10376557|NCT00583908|11517538|FG010|NOT COMPLETED|Period 4 - Fourth Intervention||0
10717271|NCT02697071|11881199|FG001|COMPLETED|Overall Study||16
10717272|NCT02697071|11881198|FG000|NOT COMPLETED|Overall Study||0
10717273|NCT02697071|11881199|FG001|NOT COMPLETED|Overall Study||0
10717274|NCT02697188|11881205|FG000|STARTED|TE Period 1 - 400 mg QD||12
10717275|NCT02697188|11881205|FG000|COMPLETED|TE Period 1 - 400 mg QD||12
10717276|NCT02697188|11881205|FG000|NOT COMPLETED|TE Period 1 - 400 mg QD||0
10717277|NCT02697188|11881205|FG000|STARTED|TU Period 2 - 200 mg QD||12
10717278|NCT02697188|11881205|FG000|COMPLETED|TU Period 2 - 200 mg QD||12
10717279|NCT02697188|11881205|FG000|NOT COMPLETED|TU Period 2 - 200 mg QD||0
10717280|NCT02697188|11881205|FG000|STARTED|TU Period 3 - 200 mg BID||12
10717281|NCT02697188|11881205|FG000|COMPLETED|TU Period 3 - 200 mg BID||12
10717282|NCT02697188|11881205|FG000|NOT COMPLETED|TU Period 3 - 200 mg BID||0
10376558|NCT00583908|11517539|FG011|NOT COMPLETED|Period 4 - Fourth Intervention||0
10376559|NCT00583947|11517559|FG000|STARTED|Cross-over Period|Participants were stratified by age group at randomization: ages 2-5 yrs and 6-11 years|27
10376560|NCT00583947|11517560|FG001|STARTED|Cross-over Period|Participants were stratified by age group at randomization: ages 2-5 yrs and 6-11 years|26
10376561|NCT00583947|11517559|FG000|COMPLETED|Cross-over Period||22
10376562|NCT00583947|11517560|FG001|COMPLETED|Cross-over Period||24
10376563|NCT00583947|11517559|FG000|NOT COMPLETED|Cross-over Period||5
10376564|NCT00583947|11517560|FG001|NOT COMPLETED|Cross-over Period||2
10376565|NCT00583947|11517559|FG000|STARTED|Washout||22
10717283|NCT02697188|11881205|FG000|STARTED|TU Period 4 - 400 BID||12
10376566|NCT00583947|11517560|FG001|STARTED|Washout||24
10376567|NCT00583947|11517559|FG000|COMPLETED|Washout||22
10376568|NCT00583947|11517560|FG001|COMPLETED|Washout||24
10376569|NCT00583947|11517559|FG000|NOT COMPLETED|Washout||0
10376570|NCT00583947|11517560|FG001|NOT COMPLETED|Washout||0
10717284|NCT02697188|11881205|FG000|COMPLETED|TU Period 4 - 400 BID||12
10717285|NCT02697188|11881205|FG000|NOT COMPLETED|TU Period 4 - 400 BID||0
10717286|NCT02697188|11881205|FG000|STARTED|TE Period 5 - 800 mg BID||12
10717287|NCT02697188|11881205|FG000|COMPLETED|TE Period 5 - 800 mg BID||12
10376571|NCT00583947|11517559|FG000|STARTED|Open Label Period|3 subjects were dosed with arformoterol 7.5 microgram in error|22
10376572|NCT00583947|11517560|FG001|STARTED|Open Label Period|3 subjects were dosed with arformoterol 7.5 microgram in error|24
10376573|NCT00583947|11517559|FG000|COMPLETED|Open Label Period||22
10376574|NCT00583947|11517560|FG001|COMPLETED|Open Label Period||24
10376575|NCT00583947|11517559|FG000|NOT COMPLETED|Open Label Period||0
10376576|NCT00583947|11517560|FG001|NOT COMPLETED|Open Label Period||0
10376577|NCT00584077|11517568|FG000|STARTED|Overall Study||15
10376578|NCT00584077|11517568|FG000|COMPLETED|Overall Study||15
10376579|NCT00584077|11517568|FG000|NOT COMPLETED|Overall Study||0
10376580|NCT00584194|11517573|FG000|STARTED|Overall Study||278
10376581|NCT00584194|11517573|FG000|COMPLETED|Overall Study||143
10376582|NCT00584194|11517573|FG000|NOT COMPLETED|Overall Study||135
10376583|NCT00584220|11517577|FG000|STARTED|First Period||48
10376584|NCT00584220|11517578|FG001|STARTED|First Period||39
10376585|NCT00584220|11517577|FG000|COMPLETED|First Period||48
10376586|NCT00584220|11517578|FG001|COMPLETED|First Period||39
10376587|NCT00584220|11517577|FG000|NOT COMPLETED|First Period||0
10376588|NCT00584220|11517578|FG001|NOT COMPLETED|First Period||0
10376589|NCT00584220|11517577|FG000|STARTED|Second Period||48
10376590|NCT00584220|11517578|FG001|STARTED|Second Period||39
10376591|NCT00584220|11517577|FG000|COMPLETED|Second Period||48
10376592|NCT00584220|11517578|FG001|COMPLETED|Second Period||39
10376593|NCT00584220|11517577|FG000|NOT COMPLETED|Second Period||0
10376594|NCT00584220|11517578|FG001|NOT COMPLETED|Second Period||0
10376595|NCT00584285|11517584|FG000|STARTED|Overall Study||18
10376596|NCT00584285|11517584|FG000|COMPLETED|Overall Study||18
10376597|NCT00584285|11517584|FG000|NOT COMPLETED|Overall Study||0
10376598|NCT00584402|11517588|FG000|STARTED|Overall Study||8
10376599|NCT00584402|11517588|FG000|COMPLETED|Overall Study||8
10376600|NCT00584402|11517588|FG000|NOT COMPLETED|Overall Study||0
10376601|NCT00584415|11517592|FG000|STARTED|Overall Study|A total of 119 enrolled and 112 underwent the ablation procedure;|119
10376602|NCT00584415|11517592|FG000|COMPLETED|Overall Study||112
10376603|NCT00584415|11517592|FG000|NOT COMPLETED|Overall Study||7
10376604|NCT00584454|11517597|FG000|STARTED|Overall Study||10
10376605|NCT00584454|11517597|FG000|COMPLETED|Overall Study||6
10376606|NCT00584454|11517597|FG000|NOT COMPLETED|Overall Study||4
10376607|NCT00584480|11517601|FG000|STARTED|First 8 Weeks (40 Treatments)||10
10376608|NCT00584480|11517601|FG000|COMPLETED|First 8 Weeks (40 Treatments)||10
10376609|NCT00584480|11517601|FG000|NOT COMPLETED|First 8 Weeks (40 Treatments)||0
10376610|NCT00584480|11517601|FG000|STARTED|4-Week Break From Treatment||10
10376611|NCT00584480|11517601|FG000|COMPLETED|4-Week Break From Treatment||10
10376612|NCT00584480|11517601|FG000|NOT COMPLETED|4-Week Break From Treatment||0
10376613|NCT00584480|11517601|FG000|STARTED|Second 8 Weeks (40 Treatments)||10
10376614|NCT00584480|11517601|FG000|COMPLETED|Second 8 Weeks (40 Treatments)||10
10376615|NCT00584480|11517601|FG000|NOT COMPLETED|Second 8 Weeks (40 Treatments)||0
10376616|NCT00584558|11517605|FG000|STARTED|Overall Study||2420
10376617|NCT00584558|11517605|FG000|COMPLETED|Overall Study||2420
10376618|NCT00584558|11517605|FG000|NOT COMPLETED|Overall Study||0
10376619|NCT00584701|11517610|FG000|STARTED|Active Risperidone||49
10376620|NCT00584701|11517610|FG000|COMPLETED|Active Risperidone||46
10376621|NCT00584701|11517610|FG000|NOT COMPLETED|Active Risperidone||3
10376622|NCT00584701|11517610|FG000|STARTED|Follow-up||46
10376623|NCT00584701|11517610|FG000|COMPLETED|Follow-up||34
10376624|NCT00584701|11517610|FG000|NOT COMPLETED|Follow-up||12
10376625|NCT00584727|11517615|FG000|STARTED|First Intervention||17
10376626|NCT00584727|11517616|FG001|STARTED|First Intervention||17
10376627|NCT00584727|11517617|FG002|STARTED|First Intervention||16
10376628|NCT00584727|11517618|FG003|STARTED|First Intervention||14
10376629|NCT00584727|11517619|FG004|STARTED|First Intervention||16
10376630|NCT00584727|11517620|FG005|STARTED|First Intervention||16
10376631|NCT00584727|11517615|FG000|COMPLETED|First Intervention||17
10376632|NCT00584727|11517616|FG001|COMPLETED|First Intervention||17
10376633|NCT00584727|11517617|FG002|COMPLETED|First Intervention||15
10376634|NCT00584727|11517618|FG003|COMPLETED|First Intervention||14
10376635|NCT00584727|11517619|FG004|COMPLETED|First Intervention||16
10376636|NCT00584727|11517620|FG005|COMPLETED|First Intervention||16
10376637|NCT00584727|11517615|FG000|NOT COMPLETED|First Intervention||0
10376638|NCT00584727|11517616|FG001|NOT COMPLETED|First Intervention||0
10376639|NCT00584727|11517617|FG002|NOT COMPLETED|First Intervention||1
10376640|NCT00584727|11517618|FG003|NOT COMPLETED|First Intervention||0
10376641|NCT00584727|11517619|FG004|NOT COMPLETED|First Intervention||0
10376642|NCT00584727|11517620|FG005|NOT COMPLETED|First Intervention||0
10376643|NCT00584727|11517615|FG000|STARTED|Second Intervention||17
10376644|NCT00584727|11517616|FG001|STARTED|Second Intervention||17
10376645|NCT00584727|11517617|FG002|STARTED|Second Intervention||15
10376646|NCT00584727|11517618|FG003|STARTED|Second Intervention||14
10376647|NCT00584727|11517619|FG004|STARTED|Second Intervention||16
10376648|NCT00584727|11517620|FG005|STARTED|Second Intervention||16
10376649|NCT00584727|11517615|FG000|COMPLETED|Second Intervention||17
10376650|NCT00584727|11517616|FG001|COMPLETED|Second Intervention||17
10376651|NCT00584727|11517617|FG002|COMPLETED|Second Intervention||15
10376652|NCT00584727|11517618|FG003|COMPLETED|Second Intervention||14
10376653|NCT00584727|11517619|FG004|COMPLETED|Second Intervention||16
10376654|NCT00584727|11517620|FG005|COMPLETED|Second Intervention||16
10376655|NCT00584727|11517615|FG000|NOT COMPLETED|Second Intervention||0
10376656|NCT00584727|11517616|FG001|NOT COMPLETED|Second Intervention||0
10376657|NCT00584727|11517617|FG002|NOT COMPLETED|Second Intervention||0
10376658|NCT00584727|11517618|FG003|NOT COMPLETED|Second Intervention||0
10376659|NCT00584727|11517619|FG004|NOT COMPLETED|Second Intervention||0
10376660|NCT00584727|11517620|FG005|NOT COMPLETED|Second Intervention||0
10376661|NCT00584727|11517615|FG000|STARTED|Third Intervention||17
10376662|NCT00584727|11517616|FG001|STARTED|Third Intervention||17
10376663|NCT00584727|11517617|FG002|STARTED|Third Intervention||15
10376664|NCT00584727|11517618|FG003|STARTED|Third Intervention||14
10376665|NCT00584727|11517619|FG004|STARTED|Third Intervention||16
10376666|NCT00584727|11517620|FG005|STARTED|Third Intervention||16
10376667|NCT00584727|11517615|FG000|COMPLETED|Third Intervention||17
10376668|NCT00584727|11517616|FG001|COMPLETED|Third Intervention||17
10376669|NCT00584727|11517617|FG002|COMPLETED|Third Intervention||14
10376670|NCT00584727|11517618|FG003|COMPLETED|Third Intervention||14
10376671|NCT00584727|11517619|FG004|COMPLETED|Third Intervention||12
10376672|NCT00584727|11517620|FG005|COMPLETED|Third Intervention||14
10376673|NCT00584727|11517615|FG000|NOT COMPLETED|Third Intervention||0
10376674|NCT00584727|11517616|FG001|NOT COMPLETED|Third Intervention||0
10376675|NCT00584727|11517617|FG002|NOT COMPLETED|Third Intervention||1
10376676|NCT00584727|11517618|FG003|NOT COMPLETED|Third Intervention||0
10376677|NCT00584727|11517619|FG004|NOT COMPLETED|Third Intervention||4
10376678|NCT00584727|11517620|FG005|NOT COMPLETED|Third Intervention||2
10376679|NCT00584740|11517633|FG000|STARTED|Overall Study||39
10376680|NCT00584740|11517634|FG001|STARTED|Overall Study||20
10376681|NCT00584740|11517633|FG000|COMPLETED|Overall Study||27
10376682|NCT00584740|11517634|FG001|COMPLETED|Overall Study||14
10376683|NCT00584740|11517633|FG000|NOT COMPLETED|Overall Study||12
10376684|NCT00584740|11517634|FG001|NOT COMPLETED|Overall Study||6
10376685|NCT00584805|11517640|FG000|STARTED|Overall Study||138
10376686|NCT00584805|11517640|FG000|COMPLETED|Overall Study||39
10376687|NCT00584805|11517640|FG000|NOT COMPLETED|Overall Study||99
10376688|NCT00584831|11517646|FG000|STARTED|Intervention 1||1
10376689|NCT00584831|11517647|FG001|STARTED|Intervention 1||3
10376690|NCT00584831|11517648|FG002|STARTED|Intervention 1||2
10376691|NCT00584831|11517649|FG003|STARTED|Intervention 1||1
10376692|NCT00584831|11517650|FG004|STARTED|Intervention 1||2
10376693|NCT00584831|11517651|FG005|STARTED|Intervention 1||1
10376694|NCT00584831|11517652|FG006|STARTED|Intervention 1||6
10376695|NCT00584831|11517653|FG007|STARTED|Intervention 1||2
10376696|NCT00584831|11517654|FG008|STARTED|Intervention 1||4
10376697|NCT00584831|11517655|FG009|STARTED|Intervention 1||2
10376698|NCT00584831|11517656|FG010|STARTED|Intervention 1||2
10376699|NCT00584831|11517657|FG011|STARTED|Intervention 1||1
10376700|NCT00584831|11517658|FG012|STARTED|Intervention 1||2
10376701|NCT00584831|11517659|FG013|STARTED|Intervention 1||1
10376702|NCT00584831|11517660|FG014|STARTED|Intervention 1||3
10376703|NCT00584831|11517661|FG015|STARTED|Intervention 1||1
10376704|NCT00584831|11517662|FG016|STARTED|Intervention 1||4
10376705|NCT00584831|11517663|FG017|STARTED|Intervention 1||1
10376706|NCT00584831|11517664|FG018|STARTED|Intervention 1||1
10376707|NCT00584831|11517646|FG000|COMPLETED|Intervention 1||1
10376708|NCT00584831|11517647|FG001|COMPLETED|Intervention 1||3
10376709|NCT00584831|11517648|FG002|COMPLETED|Intervention 1||2
10376710|NCT00584831|11517649|FG003|COMPLETED|Intervention 1||1
10376711|NCT00584831|11517650|FG004|COMPLETED|Intervention 1||2
10376712|NCT00584831|11517651|FG005|COMPLETED|Intervention 1||1
10376713|NCT00584831|11517652|FG006|COMPLETED|Intervention 1||6
10376714|NCT00584831|11517653|FG007|COMPLETED|Intervention 1||2
10812649|NCT03426137|11974776|FG000|STARTED|Overall Study||0
10812650|NCT03426137|11974777|FG001|STARTED|Overall Study||0
10812651|NCT03426137|11974778|FG002|STARTED|Overall Study||0
10812652|NCT03426137|11974776|FG000|COMPLETED|Overall Study||0
10812653|NCT03426137|11974777|FG001|COMPLETED|Overall Study||0
10812654|NCT03426137|11974778|FG002|COMPLETED|Overall Study||0
10812655|NCT03426137|11974776|FG000|NOT COMPLETED|Overall Study||0
10376715|NCT00584831|11517654|FG008|COMPLETED|Intervention 1||4
10376716|NCT00584831|11517655|FG009|COMPLETED|Intervention 1||2
10538667|NCT01457014|11691577|FG001|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
10538668|NCT01457014|11691578|FG002|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
10538669|NCT01457014|11691579|FG003|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
10538670|NCT01457014|11691576|FG000|COMPLETED|Third Night|The Diagnostic PSG was only completed on the First night|0
10538671|NCT01457014|11691577|FG001|COMPLETED|Third Night||11
10538672|NCT01457014|11691578|FG002|COMPLETED|Third Night||11
10538673|NCT01457014|11691579|FG003|COMPLETED|Third Night||12
10538674|NCT01457014|11691576|FG000|NOT COMPLETED|Third Night||0
10538675|NCT01457014|11691577|FG001|NOT COMPLETED|Third Night||0
10538676|NCT01457014|11691578|FG002|NOT COMPLETED|Third Night||0
10538677|NCT01457014|11691579|FG003|NOT COMPLETED|Third Night||0
10548077|NCT01516970|11701875|FG000|STARTED|Overall Study||159
10812656|NCT03426137|11974777|FG001|NOT COMPLETED|Overall Study||0
10812657|NCT03426137|11974778|FG002|NOT COMPLETED|Overall Study||0
10812658|NCT03425799|11974788|FG000|STARTED|Overall Study|Study terminated due to low recruitment|0
10812659|NCT03425799|11974789|FG001|STARTED|Overall Study|Study terminated due to low recruitment|0
10376717|NCT00584831|11517656|FG010|COMPLETED|Intervention 1||2
10376718|NCT00584831|11517657|FG011|COMPLETED|Intervention 1||1
10376719|NCT00584831|11517658|FG012|COMPLETED|Intervention 1||2
10376720|NCT00584831|11517659|FG013|COMPLETED|Intervention 1||1
10376721|NCT00584831|11517660|FG014|COMPLETED|Intervention 1||3
10376722|NCT00584831|11517661|FG015|COMPLETED|Intervention 1||1
10376723|NCT00584831|11517662|FG016|COMPLETED|Intervention 1||4
10376724|NCT00584831|11517663|FG017|COMPLETED|Intervention 1||1
10376725|NCT00584831|11517664|FG018|COMPLETED|Intervention 1||1
10376726|NCT00584831|11517646|FG000|NOT COMPLETED|Intervention 1||0
10376727|NCT00584831|11517647|FG001|NOT COMPLETED|Intervention 1||0
10376728|NCT00584831|11517648|FG002|NOT COMPLETED|Intervention 1||0
10376729|NCT00584831|11517649|FG003|NOT COMPLETED|Intervention 1||0
10376730|NCT00584831|11517650|FG004|NOT COMPLETED|Intervention 1||0
10376731|NCT00584831|11517651|FG005|NOT COMPLETED|Intervention 1||0
10376732|NCT00584831|11517652|FG006|NOT COMPLETED|Intervention 1||0
10376733|NCT00584831|11517653|FG007|NOT COMPLETED|Intervention 1||0
10376734|NCT00584831|11517654|FG008|NOT COMPLETED|Intervention 1||0
10376735|NCT00584831|11517655|FG009|NOT COMPLETED|Intervention 1||0
10376736|NCT00584831|11517656|FG010|NOT COMPLETED|Intervention 1||0
10376737|NCT00584831|11517657|FG011|NOT COMPLETED|Intervention 1||0
10376738|NCT00584831|11517658|FG012|NOT COMPLETED|Intervention 1||0
10376739|NCT00584831|11517659|FG013|NOT COMPLETED|Intervention 1||0
10376740|NCT00584831|11517660|FG014|NOT COMPLETED|Intervention 1||0
10376741|NCT00584831|11517661|FG015|NOT COMPLETED|Intervention 1||0
10376742|NCT00584831|11517662|FG016|NOT COMPLETED|Intervention 1||0
10376743|NCT00584831|11517663|FG017|NOT COMPLETED|Intervention 1||0
10376744|NCT00584831|11517664|FG018|NOT COMPLETED|Intervention 1||0
10376745|NCT00584831|11517646|FG000|STARTED|Intervention 2||1
10376746|NCT00584831|11517647|FG001|STARTED|Intervention 2||3
10376747|NCT00584831|11517648|FG002|STARTED|Intervention 2||2
10376748|NCT00584831|11517649|FG003|STARTED|Intervention 2||1
10376749|NCT00584831|11517650|FG004|STARTED|Intervention 2||2
10376750|NCT00584831|11517651|FG005|STARTED|Intervention 2||1
10376751|NCT00584831|11517652|FG006|STARTED|Intervention 2||6
10376752|NCT00584831|11517653|FG007|STARTED|Intervention 2||2
10376753|NCT00584831|11517654|FG008|STARTED|Intervention 2||4
10376754|NCT00584831|11517655|FG009|STARTED|Intervention 2||2
10376755|NCT00584831|11517656|FG010|STARTED|Intervention 2||2
10376756|NCT00584831|11517657|FG011|STARTED|Intervention 2||1
10376757|NCT00584831|11517658|FG012|STARTED|Intervention 2||2
10376758|NCT00584831|11517659|FG013|STARTED|Intervention 2||1
10376759|NCT00584831|11517660|FG014|STARTED|Intervention 2||3
10376760|NCT00584831|11517661|FG015|STARTED|Intervention 2||1
10376761|NCT00584831|11517662|FG016|STARTED|Intervention 2||4
10376762|NCT00584831|11517663|FG017|STARTED|Intervention 2||1
10376763|NCT00584831|11517664|FG018|STARTED|Intervention 2||1
10376764|NCT00584831|11517646|FG000|COMPLETED|Intervention 2||1
10376765|NCT00584831|11517647|FG001|COMPLETED|Intervention 2||3
10376766|NCT00584831|11517648|FG002|COMPLETED|Intervention 2||2
10376767|NCT00584831|11517649|FG003|COMPLETED|Intervention 2||1
10376768|NCT00584831|11517650|FG004|COMPLETED|Intervention 2||2
10376769|NCT00584831|11517651|FG005|COMPLETED|Intervention 2||1
10376770|NCT00584831|11517652|FG006|COMPLETED|Intervention 2||6
10376771|NCT00584831|11517653|FG007|COMPLETED|Intervention 2||2
10376772|NCT00584831|11517654|FG008|COMPLETED|Intervention 2||4
10376773|NCT00584831|11517655|FG009|COMPLETED|Intervention 2||2
10376774|NCT00584831|11517656|FG010|COMPLETED|Intervention 2||2
10376775|NCT00584831|11517657|FG011|COMPLETED|Intervention 2||1
10376776|NCT00584831|11517658|FG012|COMPLETED|Intervention 2||2
10376777|NCT00584831|11517659|FG013|COMPLETED|Intervention 2||1
10376778|NCT00584831|11517660|FG014|COMPLETED|Intervention 2||3
10376779|NCT00584831|11517661|FG015|COMPLETED|Intervention 2||1
10376780|NCT00584831|11517662|FG016|COMPLETED|Intervention 2||4
10376781|NCT00584831|11517663|FG017|COMPLETED|Intervention 2||1
10376782|NCT00584831|11517664|FG018|COMPLETED|Intervention 2||1
10376783|NCT00584831|11517646|FG000|NOT COMPLETED|Intervention 2||0
10376784|NCT00584831|11517647|FG001|NOT COMPLETED|Intervention 2||0
10306571|NCT00099632|11439466|FG001|STARTED|Overall Study||68
10306572|NCT00099632|11439467|FG002|STARTED|Overall Study||75
10306573|NCT00099632|11439468|FG003|STARTED|Overall Study||67
10306574|NCT00099632|11439469|FG004|STARTED|Overall Study||71
10306575|NCT00099632|11439470|FG005|STARTED|Overall Study||68
10306576|NCT00099632|11439465|FG000|COMPLETED|Overall Study||72
10306577|NCT00099632|11439466|FG001|COMPLETED|Overall Study||67
10306578|NCT00099632|11439467|FG002|COMPLETED|Overall Study||72
10306579|NCT00099632|11439468|FG003|COMPLETED|Overall Study||66
10306580|NCT00099632|11439469|FG004|COMPLETED|Overall Study||70
10306581|NCT00099632|11439470|FG005|COMPLETED|Overall Study||66
10306582|NCT00099632|11439465|FG000|NOT COMPLETED|Overall Study||1
10376785|NCT00584831|11517648|FG002|NOT COMPLETED|Intervention 2||0
10376786|NCT00584831|11517649|FG003|NOT COMPLETED|Intervention 2||0
10376787|NCT00584831|11517650|FG004|NOT COMPLETED|Intervention 2||0
10376788|NCT00584831|11517651|FG005|NOT COMPLETED|Intervention 2||0
10376789|NCT00584831|11517652|FG006|NOT COMPLETED|Intervention 2||0
10376790|NCT00584831|11517653|FG007|NOT COMPLETED|Intervention 2||0
10376791|NCT00584831|11517654|FG008|NOT COMPLETED|Intervention 2||0
10376792|NCT00584831|11517655|FG009|NOT COMPLETED|Intervention 2||0
10376793|NCT00584831|11517656|FG010|NOT COMPLETED|Intervention 2||0
10306583|NCT00099632|11439466|FG001|NOT COMPLETED|Overall Study||1
10306584|NCT00099632|11439467|FG002|NOT COMPLETED|Overall Study||3
10306585|NCT00099632|11439468|FG003|NOT COMPLETED|Overall Study||1
10306586|NCT00099632|11439469|FG004|NOT COMPLETED|Overall Study||1
10376794|NCT00584831|11517657|FG011|NOT COMPLETED|Intervention 2||0
10376795|NCT00584831|11517658|FG012|NOT COMPLETED|Intervention 2||0
10376796|NCT00584831|11517659|FG013|NOT COMPLETED|Intervention 2||0
10376797|NCT00584831|11517660|FG014|NOT COMPLETED|Intervention 2||0
10376798|NCT00584831|11517661|FG015|NOT COMPLETED|Intervention 2||0
10376799|NCT00584831|11517662|FG016|NOT COMPLETED|Intervention 2||0
10376800|NCT00584831|11517663|FG017|NOT COMPLETED|Intervention 2||0
10376801|NCT00584831|11517664|FG018|NOT COMPLETED|Intervention 2||0
10376802|NCT00584831|11517646|FG000|STARTED|Intervention 3||1
10376803|NCT00584831|11517647|FG001|STARTED|Intervention 3||3
10376804|NCT00584831|11517648|FG002|STARTED|Intervention 3||2
10376805|NCT00584831|11517649|FG003|STARTED|Intervention 3||1
10376806|NCT00584831|11517650|FG004|STARTED|Intervention 3||2
10376807|NCT00584831|11517651|FG005|STARTED|Intervention 3||1
10376808|NCT00584831|11517652|FG006|STARTED|Intervention 3||6
10376809|NCT00584831|11517653|FG007|STARTED|Intervention 3||2
10376810|NCT00584831|11517654|FG008|STARTED|Intervention 3||4
10376811|NCT00584831|11517655|FG009|STARTED|Intervention 3||2
10376812|NCT00584831|11517656|FG010|STARTED|Intervention 3||2
10376813|NCT00584831|11517657|FG011|STARTED|Intervention 3||1
10376814|NCT00584831|11517658|FG012|STARTED|Intervention 3||2
10376815|NCT00584831|11517659|FG013|STARTED|Intervention 3||1
10376816|NCT00584831|11517660|FG014|STARTED|Intervention 3||3
10376817|NCT00584831|11517661|FG015|STARTED|Intervention 3||1
10376818|NCT00584831|11517662|FG016|STARTED|Intervention 3||4
10376819|NCT00584831|11517663|FG017|STARTED|Intervention 3||1
10376820|NCT00584831|11517664|FG018|STARTED|Intervention 3||1
10717288|NCT02697188|11881205|FG000|NOT COMPLETED|TE Period 5 - 800 mg BID||0
10717289|NCT02697214|11881217|FG000|STARTED|Overall Study||26
10717290|NCT02697214|11881218|FG001|STARTED|Overall Study||25
10376821|NCT00584831|11517646|FG000|COMPLETED|Intervention 3||1
10376822|NCT00584831|11517647|FG001|COMPLETED|Intervention 3||3
10538678|NCT01457014|11691576|FG000|STARTED|Fourth Night|The Diagnostic PSG was only completed on the First night|0
10376823|NCT00584831|11517648|FG002|COMPLETED|Intervention 3||2
10376824|NCT00584831|11517649|FG003|COMPLETED|Intervention 3||1
10376825|NCT00584831|11517650|FG004|COMPLETED|Intervention 3||2
10376826|NCT00584831|11517651|FG005|COMPLETED|Intervention 3||1
10376827|NCT00584831|11517652|FG006|COMPLETED|Intervention 3||6
10376828|NCT00584831|11517653|FG007|COMPLETED|Intervention 3||2
10548078|NCT01516970|11701876|FG001|STARTED|Overall Study||153
10376829|NCT00584831|11517654|FG008|COMPLETED|Intervention 3||4
10376830|NCT00584831|11517655|FG009|COMPLETED|Intervention 3||2
10376831|NCT00584831|11517656|FG010|COMPLETED|Intervention 3||2
10717291|NCT02697214|11881219|FG002|STARTED|Overall Study||25
10376832|NCT00584831|11517657|FG011|COMPLETED|Intervention 3||1
10376833|NCT00584831|11517658|FG012|COMPLETED|Intervention 3||2
10376834|NCT00584831|11517659|FG013|COMPLETED|Intervention 3||1
10376835|NCT00584831|11517660|FG014|COMPLETED|Intervention 3||3
10376836|NCT00584831|11517661|FG015|COMPLETED|Intervention 3||1
10376837|NCT00584831|11517662|FG016|COMPLETED|Intervention 3||4
10376838|NCT00584831|11517663|FG017|COMPLETED|Intervention 3||1
10376839|NCT00584831|11517664|FG018|COMPLETED|Intervention 3||1
10376840|NCT00584831|11517646|FG000|NOT COMPLETED|Intervention 3||0
10376841|NCT00584831|11517647|FG001|NOT COMPLETED|Intervention 3||0
10376842|NCT00584831|11517648|FG002|NOT COMPLETED|Intervention 3||0
10376843|NCT00584831|11517649|FG003|NOT COMPLETED|Intervention 3||0
10538679|NCT01457014|11691577|FG001|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
10538680|NCT01457014|11691578|FG002|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
10538681|NCT01457014|11691579|FG003|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
10538682|NCT01457014|11691576|FG000|COMPLETED|Fourth Night|The Diagnostic PSG was only completed on the First night|0
10538683|NCT01457014|11691577|FG001|COMPLETED|Fourth Night||11
10538684|NCT01457014|11691578|FG002|COMPLETED|Fourth Night||12
10538685|NCT01457014|11691579|FG003|COMPLETED|Fourth Night||11
10538686|NCT01457014|11691576|FG000|NOT COMPLETED|Fourth Night||0
10538687|NCT01457014|11691577|FG001|NOT COMPLETED|Fourth Night||0
10538688|NCT01457014|11691578|FG002|NOT COMPLETED|Fourth Night||0
10538689|NCT01457014|11691579|FG003|NOT COMPLETED|Fourth Night||0
10538690|NCT01457118|11691591|FG000|STARTED|Overall Study||20
10538691|NCT01457118|11691592|FG001|STARTED|Overall Study||4
10538692|NCT01457118|11691593|FG002|STARTED|Overall Study||1
10538693|NCT01457118|11691594|FG003|STARTED|Overall Study||2
10538694|NCT01457118|11691591|FG000|COMPLETED|Overall Study||0
10538695|NCT01457118|11691592|FG001|COMPLETED|Overall Study||0
10538696|NCT01457118|11691593|FG002|COMPLETED|Overall Study||0
10538697|NCT01457118|11691594|FG003|COMPLETED|Overall Study||0
10538698|NCT01457118|11691591|FG000|NOT COMPLETED|Overall Study||20
10538699|NCT01457118|11691592|FG001|NOT COMPLETED|Overall Study||4
10538700|NCT01457118|11691593|FG002|NOT COMPLETED|Overall Study||1
10538701|NCT01457118|11691594|FG003|NOT COMPLETED|Overall Study||2
10538702|NCT01457196|11691604|FG000|STARTED|Overall Study||2074
10538703|NCT01457196|11691604|FG000|COMPLETED|Overall Study||2074
10538704|NCT01457196|11691604|FG000|NOT COMPLETED|Overall Study||0
10538705|NCT01457339|11691612|FG000|STARTED|Period 1 (50 mg)||7
10538706|NCT01457339|11691613|FG001|STARTED|Period 1 (50 mg)||24
10538707|NCT01457339|11691612|FG000|COMPLETED|Period 1 (50 mg)||7
10538708|NCT01457339|11691613|FG001|COMPLETED|Period 1 (50 mg)||24
10538709|NCT01457339|11691612|FG000|NOT COMPLETED|Period 1 (50 mg)||0
10538710|NCT01457339|11691613|FG001|NOT COMPLETED|Period 1 (50 mg)||0
10538711|NCT01457339|11691612|FG000|STARTED|Period 2 (70 mg)||7
10538712|NCT01457339|11691613|FG001|STARTED|Period 2 (70 mg)||24
10538713|NCT01457339|11691612|FG000|COMPLETED|Period 2 (70 mg)||7
10657724|NCT02227810|11818876|FG001|NOT COMPLETED|Overall Study||5
10657725|NCT02227836|11818884|FG000|STARTED|Overall Study||8
10657726|NCT02227836|11818884|FG000|COMPLETED|Overall Study||8
10657727|NCT02227836|11818884|FG000|NOT COMPLETED|Overall Study||0
10657728|NCT02227849|11818888|FG000|STARTED|Overall Study||71
10657729|NCT02227849|11818888|FG000|COMPLETED|Overall Study||63
10657730|NCT02227849|11818888|FG000|NOT COMPLETED|Overall Study||8
10657731|NCT02228096|11818894|FG000|STARTED|Overall Study||75
10657732|NCT02228096|11818894|FG000|Enrolled Into Long-term f/u Protocol|Overall Study||31
10657733|NCT02228096|11818894|FG000|Enrolled But Not Infused|Overall Study||11
10657734|NCT02228096|11818894|FG000|Enrolled and Infused|Overall Study||64
10657735|NCT02228096|11818894|FG000|COMPLETED|Overall Study|Completed = study follow-up completed|4
10657736|NCT02228096|11818894|FG000|NOT COMPLETED|Overall Study||71
10657737|NCT02228174|11818912|FG000|STARTED|Overall Study||147
10657738|NCT02228174|11818912|FG000|Full Analysis Population|Overall Study|Subjects who didn't become pregnant or diagnosed with an interfering medical condition at 12-months|143
10657739|NCT02228174|11818912|FG000|COMPLETED|Overall Study||142
10657740|NCT02228174|11818912|FG000|NOT COMPLETED|Overall Study||5
10657741|NCT02228395|11818916|FG000|STARTED|First Intervention Period||3
10717292|NCT02697214|11881220|FG003|STARTED|Overall Study||24
10717293|NCT02697214|11881221|FG004|STARTED|Overall Study||50
10717294|NCT02697214|11881222|FG005|STARTED|Overall Study||50
10376844|NCT00584831|11517650|FG004|NOT COMPLETED|Intervention 3||0
10376845|NCT00584831|11517651|FG005|NOT COMPLETED|Intervention 3||0
10376846|NCT00584831|11517652|FG006|NOT COMPLETED|Intervention 3||0
10376847|NCT00584831|11517653|FG007|NOT COMPLETED|Intervention 3||0
10376848|NCT00584831|11517654|FG008|NOT COMPLETED|Intervention 3||0
10376849|NCT00584831|11517655|FG009|NOT COMPLETED|Intervention 3||0
10376850|NCT00584831|11517656|FG010|NOT COMPLETED|Intervention 3||0
10376851|NCT00584831|11517657|FG011|NOT COMPLETED|Intervention 3||0
10376852|NCT00584831|11517658|FG012|NOT COMPLETED|Intervention 3||0
10376853|NCT00584831|11517659|FG013|NOT COMPLETED|Intervention 3||0
10376854|NCT00584831|11517660|FG014|NOT COMPLETED|Intervention 3||0
10376855|NCT00584831|11517661|FG015|NOT COMPLETED|Intervention 3||0
10376856|NCT00584831|11517662|FG016|NOT COMPLETED|Intervention 3||0
10376857|NCT00584831|11517663|FG017|NOT COMPLETED|Intervention 3||0
10376858|NCT00584831|11517664|FG018|NOT COMPLETED|Intervention 3||0
10376859|NCT00584831|11517646|FG000|STARTED|Intervention 4||1
10376860|NCT00584831|11517647|FG001|STARTED|Intervention 4||3
10376861|NCT00584831|11517648|FG002|STARTED|Intervention 4||2
10376862|NCT00584831|11517649|FG003|STARTED|Intervention 4||1
10376863|NCT00584831|11517650|FG004|STARTED|Intervention 4||2
10376864|NCT00584831|11517651|FG005|STARTED|Intervention 4||1
10376865|NCT00584831|11517652|FG006|STARTED|Intervention 4||6
10376866|NCT00584831|11517653|FG007|STARTED|Intervention 4||2
10376867|NCT00584831|11517654|FG008|STARTED|Intervention 4||3
10376868|NCT00584831|11517655|FG009|STARTED|Intervention 4||2
10376869|NCT00584831|11517656|FG010|STARTED|Intervention 4||2
10376870|NCT00584831|11517657|FG011|STARTED|Intervention 4||1
10376871|NCT00584831|11517658|FG012|STARTED|Intervention 4||2
10376872|NCT00584831|11517659|FG013|STARTED|Intervention 4||1
10376873|NCT00584831|11517660|FG014|STARTED|Intervention 4||2
10376874|NCT00584831|11517661|FG015|STARTED|Intervention 4||1
10376875|NCT00584831|11517662|FG016|STARTED|Intervention 4||4
10376876|NCT00584831|11517663|FG017|STARTED|Intervention 4||1
10376877|NCT00584831|11517664|FG018|STARTED|Intervention 4||1
10376878|NCT00584831|11517646|FG000|COMPLETED|Intervention 4||1
10376879|NCT00584831|11517647|FG001|COMPLETED|Intervention 4||3
10376880|NCT00584831|11517648|FG002|COMPLETED|Intervention 4||2
10376881|NCT00584831|11517649|FG003|COMPLETED|Intervention 4||1
10376882|NCT00584831|11517650|FG004|COMPLETED|Intervention 4||2
10376883|NCT00584831|11517651|FG005|COMPLETED|Intervention 4||1
10376884|NCT00584831|11517652|FG006|COMPLETED|Intervention 4||6
10376885|NCT00584831|11517653|FG007|COMPLETED|Intervention 4||2
10376886|NCT00584831|11517654|FG008|COMPLETED|Intervention 4||3
10376887|NCT00584831|11517655|FG009|COMPLETED|Intervention 4||2
10376888|NCT00584831|11517656|FG010|COMPLETED|Intervention 4||2
10376889|NCT00584831|11517657|FG011|COMPLETED|Intervention 4||1
10376890|NCT00584831|11517658|FG012|COMPLETED|Intervention 4||2
10376891|NCT00584831|11517659|FG013|COMPLETED|Intervention 4||1
10376892|NCT00584831|11517660|FG014|COMPLETED|Intervention 4||2
10376893|NCT00584831|11517661|FG015|COMPLETED|Intervention 4||1
10376894|NCT00584831|11517662|FG016|COMPLETED|Intervention 4||4
10376895|NCT00584831|11517663|FG017|COMPLETED|Intervention 4||1
10376896|NCT00584831|11517664|FG018|COMPLETED|Intervention 4||1
10376897|NCT00584831|11517646|FG000|NOT COMPLETED|Intervention 4||0
10376898|NCT00584831|11517647|FG001|NOT COMPLETED|Intervention 4||0
10376899|NCT00584831|11517648|FG002|NOT COMPLETED|Intervention 4||0
10376900|NCT00584831|11517649|FG003|NOT COMPLETED|Intervention 4||0
10376901|NCT00584831|11517650|FG004|NOT COMPLETED|Intervention 4||0
10376902|NCT00584831|11517651|FG005|NOT COMPLETED|Intervention 4||0
10376903|NCT00584831|11517652|FG006|NOT COMPLETED|Intervention 4||0
10376904|NCT00584831|11517653|FG007|NOT COMPLETED|Intervention 4||0
10376905|NCT00584831|11517654|FG008|NOT COMPLETED|Intervention 4||0
10376906|NCT00584831|11517655|FG009|NOT COMPLETED|Intervention 4||0
10376907|NCT00584831|11517656|FG010|NOT COMPLETED|Intervention 4||0
10376908|NCT00584831|11517657|FG011|NOT COMPLETED|Intervention 4||0
10376909|NCT00584831|11517658|FG012|NOT COMPLETED|Intervention 4||0
10376910|NCT00584831|11517659|FG013|NOT COMPLETED|Intervention 4||0
10376911|NCT00584831|11517660|FG014|NOT COMPLETED|Intervention 4||0
10376912|NCT00584831|11517661|FG015|NOT COMPLETED|Intervention 4||0
10376913|NCT00584831|11517662|FG016|NOT COMPLETED|Intervention 4||0
10376914|NCT00584831|11517663|FG017|NOT COMPLETED|Intervention 4||0
10376915|NCT00584831|11517664|FG018|NOT COMPLETED|Intervention 4||0
10376916|NCT00584844|11517674|FG000|STARTED|Overall Study||484
10376917|NCT00584844|11517674|FG000|COMPLETED|Overall Study||405
10376918|NCT00584844|11517674|FG000|NOT COMPLETED|Overall Study||79
10376919|NCT00584857|11517682|FG000|STARTED|Overall Study||30
10376920|NCT00584857|11517682|FG000|COMPLETED|Overall Study||30
10376921|NCT00584857|11517682|FG000|NOT COMPLETED|Overall Study||0
10376922|NCT00584870|11517689|FG000|STARTED|Overall Study||88
10376923|NCT00584870|11517690|FG001|STARTED|Overall Study||89
10376924|NCT00584870|11517691|FG002|STARTED|Overall Study||43
10376925|NCT00584870|11517689|FG000|Treated|Overall Study||88
10376926|NCT00584870|11517690|FG001|Treated|Overall Study||88
10376927|NCT00584870|11517691|FG002|Treated|Overall Study||41
10376928|NCT00584870|11517689|FG000|COMPLETED|Overall Study||59
10376929|NCT00584870|11517690|FG001|COMPLETED|Overall Study||64
10376930|NCT00584870|11517691|FG002|COMPLETED|Overall Study||25
10376931|NCT00584870|11517689|FG000|NOT COMPLETED|Overall Study||29
10376932|NCT00584870|11517690|FG001|NOT COMPLETED|Overall Study||25
10376933|NCT00584870|11517691|FG002|NOT COMPLETED|Overall Study||18
10376934|NCT00584909|11517699|FG000|STARTED|Overall Study||13
10376935|NCT00584909|11517699|FG000|COMPLETED|Overall Study||9
10376936|NCT00584909|11517699|FG000|NOT COMPLETED|Overall Study||4
10376937|NCT00584922|11517703|FG000|STARTED|Overall Study||175
10376938|NCT00584922|11517703|FG000|COMPLETED|Overall Study||175
10376939|NCT00584922|11517703|FG000|NOT COMPLETED|Overall Study||0
10376940|NCT00584948|11517709|FG000|STARTED|Overall Study||47
10376941|NCT00584948|11517710|FG001|STARTED|Overall Study||47
10376942|NCT00584948|11517709|FG000|COMPLETED|Overall Study||34
10376943|NCT00584948|11517710|FG001|COMPLETED|Overall Study||36
10376944|NCT00584948|11517709|FG000|NOT COMPLETED|Overall Study||13
10376945|NCT00584948|11517710|FG001|NOT COMPLETED|Overall Study||11
10376946|NCT00584987|11517720|FG000|STARTED|Overall Study||15
10376947|NCT00584987|11517721|FG001|STARTED|Overall Study||16
10376948|NCT00584987|11517722|FG002|STARTED|Overall Study||17
10376949|NCT00584987|11517723|FG003|STARTED|Overall Study||16
10376950|NCT00584987|11517720|FG000|COMPLETED|Overall Study||14
10376951|NCT00584987|11517721|FG001|COMPLETED|Overall Study||15
10376952|NCT00584987|11517722|FG002|COMPLETED|Overall Study||16
10376953|NCT00584987|11517723|FG003|COMPLETED|Overall Study||15
10376954|NCT00584987|11517720|FG000|NOT COMPLETED|Overall Study||1
10376955|NCT00584987|11517721|FG001|NOT COMPLETED|Overall Study||1
10376956|NCT00584987|11517722|FG002|NOT COMPLETED|Overall Study||1
10376957|NCT00584987|11517723|FG003|NOT COMPLETED|Overall Study||1
10376958|NCT00585013|11517735|FG000|STARTED|Overall Study||8
10376959|NCT00585013|11517736|FG001|STARTED|Overall Study||8
10376960|NCT00585013|11517735|FG000|COMPLETED|Overall Study||8
10376961|NCT00585013|11517736|FG001|COMPLETED|Overall Study||8
10376962|NCT00585013|11517735|FG000|NOT COMPLETED|Overall Study||0
10376963|NCT00585013|11517736|FG001|NOT COMPLETED|Overall Study||0
10376964|NCT00585039|11517746|FG000|STARTED|Overall Study||57
10376965|NCT00585039|11517747|FG001|STARTED|Overall Study||44
10376966|NCT00585039|11517746|FG000|COMPLETED|Overall Study||55
10376967|NCT00585039|11517747|FG001|COMPLETED|Overall Study||44
10376968|NCT00585039|11517746|FG000|NOT COMPLETED|Overall Study||2
10376969|NCT00585039|11517747|FG001|NOT COMPLETED|Overall Study||0
10376970|NCT00585052|11517755|FG000|STARTED|Overall Study||11
10376971|NCT00585052|11517755|FG000|COMPLETED|Overall Study||10
10376972|NCT00585052|11517755|FG000|NOT COMPLETED|Overall Study||1
10376973|NCT00585078|11517759|FG000|STARTED|Overall Study||40
10376974|NCT00585078|11517759|FG000|Treated|Overall Study||37
10376975|NCT00585078|11517759|FG000|Toxicity Evaluable|Overall Study||36
10376976|NCT00585078|11517759|FG000|Response Evaluable|Overall Study||24
10376977|NCT00585078|11517759|FG000|COMPLETED|Overall Study||0
10376978|NCT00585078|11517759|FG000|NOT COMPLETED|Overall Study||40
10376979|NCT00585104|11517763|FG000|STARTED|Overall Study||10
10376980|NCT00585104|11517763|FG000|COMPLETED|Overall Study||6
10376981|NCT00585104|11517763|FG000|NOT COMPLETED|Overall Study||4
10376982|NCT00585169|11517767|FG000|STARTED|Overall Study||29
10376983|NCT00585169|11517767|FG000|COMPLETED|Overall Study||28
10376984|NCT00585169|11517767|FG000|NOT COMPLETED|Overall Study||1
10376985|NCT00585182|11517773|FG000|STARTED|Overall Study||28
10376986|NCT00585182|11517773|FG000|COMPLETED|Overall Study||28
10376987|NCT00585182|11517773|FG000|NOT COMPLETED|Overall Study||0
10376988|NCT00585247|11517779|FG000|STARTED|Overall Study||14
10376989|NCT00585247|11517780|FG001|STARTED|Overall Study||13
10376990|NCT00585247|11517779|FG000|COMPLETED|Overall Study||14
10376991|NCT00585247|11517780|FG001|COMPLETED|Overall Study||13
10376992|NCT00585247|11517779|FG000|NOT COMPLETED|Overall Study||0
10376993|NCT00585247|11517780|FG001|NOT COMPLETED|Overall Study||0
10376994|NCT00585286|11517786|FG000|STARTED|Overall Study||15
10376995|NCT00585286|11517786|FG000|COMPLETED|Overall Study||14
10376996|NCT00585286|11517786|FG000|NOT COMPLETED|Overall Study||1
10376997|NCT00585312|11517792|FG000|STARTED|Overall Study|STARTED=Randomized|55
10376998|NCT00585312|11517793|FG001|STARTED|Overall Study|STARTED=Randomized|51
10376999|NCT00585312|11517792|FG000|Treated|Overall Study||53
10377000|NCT00585312|11517793|FG001|Treated|Overall Study||48
10377001|NCT00585312|11517792|FG000|COMPLETED|Overall Study||4
10377002|NCT00585312|11517793|FG001|COMPLETED|Overall Study||7
10377003|NCT00585312|11517792|FG000|NOT COMPLETED|Overall Study||51
10377004|NCT00585312|11517793|FG001|NOT COMPLETED|Overall Study||44
10377005|NCT00585325|11517801|FG000|STARTED|Overall Study||10
10377006|NCT00585325|11517802|FG001|STARTED|Overall Study||13
10377007|NCT00585325|11517801|FG000|COMPLETED|Overall Study||9
10377008|NCT00585325|11517802|FG001|COMPLETED|Overall Study||12
10377009|NCT00585325|11517801|FG000|NOT COMPLETED|Overall Study||1
10377010|NCT00585325|11517802|FG001|NOT COMPLETED|Overall Study||1
10427947|NCT00855933|11573894|FG001|NOT COMPLETED|Overall Study||1
10429831|NCT00866697|11575955|FG000|NOT COMPLETED|Overall Study||214
10429832|NCT00866697|11575956|FG001|NOT COMPLETED|Overall Study||228
10429833|NCT00866723|11575962|FG000|STARTED|Overall Study||5
10429834|NCT00866723|11575962|FG000|COMPLETED|Overall Study||0
10812660|NCT03425799|11974788|FG000|COMPLETED|Overall Study|Study terminated due to low recruitment|0
10812661|NCT03425799|11974789|FG001|COMPLETED|Overall Study|Study terminated due to low recruitment|0
10812662|NCT03425799|11974788|FG000|NOT COMPLETED|Overall Study||0
10812663|NCT03425799|11974789|FG001|NOT COMPLETED|Overall Study||0
10812664|NCT03423654|11974797|FG000|STARTED|Overall Study||3
10429835|NCT00866723|11575962|FG000|NOT COMPLETED|Overall Study||5
10429836|NCT00866749|11575966|FG000|STARTED|Overall Study||120
10429837|NCT00866749|11575966|FG000|COMPLETED|Overall Study||120
10429838|NCT00866749|11575966|FG000|NOT COMPLETED|Overall Study||0
10429839|NCT00866775|11575972|FG000|STARTED|Overall Study||65
10429840|NCT00866775|11575973|FG001|STARTED|Overall Study||128
10429841|NCT00866775|11575972|FG000|COMPLETED|Overall Study||29
10429842|NCT00866775|11575973|FG001|COMPLETED|Overall Study||76
10429843|NCT00866775|11575972|FG000|NOT COMPLETED|Overall Study||36
10429844|NCT00866775|11575973|FG001|NOT COMPLETED|Overall Study||52
10429845|NCT00866788|11575985|FG000|STARTED|Overall Study||21
10429846|NCT00866788|11575986|FG001|STARTED|Overall Study||23
10429847|NCT00866788|11575987|FG002|STARTED|Overall Study||25
10429848|NCT00866788|11575988|FG003|STARTED|Overall Study||21
10429849|NCT00866788|11575985|FG000|COMPLETED|Overall Study||15
10812665|NCT03423654|11974798|FG001|STARTED|Overall Study||3
10429850|NCT00866788|11575986|FG001|COMPLETED|Overall Study||17
10429851|NCT00866788|11575987|FG002|COMPLETED|Overall Study||23
10429852|NCT00866788|11575988|FG003|COMPLETED|Overall Study||16
10429853|NCT00866788|11575985|FG000|NOT COMPLETED|Overall Study||6
10429854|NCT00866788|11575986|FG001|NOT COMPLETED|Overall Study||6
10429855|NCT00866788|11575987|FG002|NOT COMPLETED|Overall Study||2
10429856|NCT00866788|11575988|FG003|NOT COMPLETED|Overall Study||5
10429857|NCT00866814|11576001|FG000|STARTED|Overall Study||119
10429858|NCT00866814|11576001|FG000|COMPLETED|Overall Study||99
10429859|NCT00866814|11576001|FG000|NOT COMPLETED|Overall Study||20
10429860|NCT00866879|11576007|FG000|STARTED|Overall Study||90
10377011|NCT00585351|11517814|FG000|STARTED|Notification Period (Informed Consent)||50
10377012|NCT00585351|11517815|FG001|STARTED|Notification Period (Informed Consent)||50
10377013|NCT00585351|11517816|FG002|STARTED|Notification Period (Informed Consent)||0
10377014|NCT00585351|11517817|FG003|STARTED|Notification Period (Informed Consent)||0
10377015|NCT00585351|11517818|FG004|STARTED|Notification Period (Informed Consent)||0
10377016|NCT00585351|11517819|FG005|STARTED|Notification Period (Informed Consent)||0
10377017|NCT00585351|11517820|FG006|STARTED|Notification Period (Informed Consent)||0
10377018|NCT00585351|11517821|FG007|STARTED|Notification Period (Informed Consent)||0
10377019|NCT00585351|11517814|FG000|COMPLETED|Notification Period (Informed Consent)||27
10377020|NCT00585351|11517815|FG001|COMPLETED|Notification Period (Informed Consent)||25
10377021|NCT00585351|11517816|FG002|COMPLETED|Notification Period (Informed Consent)||0
10377022|NCT00585351|11517817|FG003|COMPLETED|Notification Period (Informed Consent)||0
10377023|NCT00585351|11517818|FG004|COMPLETED|Notification Period (Informed Consent)||0
10377024|NCT00585351|11517819|FG005|COMPLETED|Notification Period (Informed Consent)||0
10377025|NCT00585351|11517820|FG006|COMPLETED|Notification Period (Informed Consent)||0
10377026|NCT00585351|11517821|FG007|COMPLETED|Notification Period (Informed Consent)||0
10377027|NCT00585351|11517814|FG000|NOT COMPLETED|Notification Period (Informed Consent)||23
10377028|NCT00585351|11517815|FG001|NOT COMPLETED|Notification Period (Informed Consent)||25
10377029|NCT00585351|11517816|FG002|NOT COMPLETED|Notification Period (Informed Consent)||0
10377030|NCT00585351|11517817|FG003|NOT COMPLETED|Notification Period (Informed Consent)||0
10377031|NCT00585351|11517818|FG004|NOT COMPLETED|Notification Period (Informed Consent)||0
10377032|NCT00585351|11517819|FG005|NOT COMPLETED|Notification Period (Informed Consent)||0
10377033|NCT00585351|11517820|FG006|NOT COMPLETED|Notification Period (Informed Consent)||0
10377034|NCT00585351|11517821|FG007|NOT COMPLETED|Notification Period (Informed Consent)||0
10377035|NCT00585351|11517814|FG000|STARTED|Enrollment Period (Intervention)|"Please refer to additional columns for subjects in Advanced Notification group for this period."|0
10377036|NCT00585351|11517815|FG001|STARTED|Enrollment Period (Intervention)|"Please refer to additional columns for subjects in No Advanced Notification group for this period."|0
10538714|NCT01457339|11691613|FG001|COMPLETED|Period 2 (70 mg)||24
10538715|NCT01457339|11691612|FG000|NOT COMPLETED|Period 2 (70 mg)||0
10377037|NCT00585351|11517816|FG002|STARTED|Enrollment Period (Intervention)||15
10377038|NCT00585351|11517817|FG003|STARTED|Enrollment Period (Intervention)||15
10377039|NCT00585351|11517818|FG004|STARTED|Enrollment Period (Intervention)||5
10377040|NCT00585351|11517819|FG005|STARTED|Enrollment Period (Intervention)||7
10377041|NCT00585351|11517820|FG006|STARTED|Enrollment Period (Intervention)||7
10377042|NCT00585351|11517821|FG007|STARTED|Enrollment Period (Intervention)||3
10377043|NCT00585351|11517814|FG000|COMPLETED|Enrollment Period (Intervention)||0
10377044|NCT00585351|11517815|FG001|COMPLETED|Enrollment Period (Intervention)||0
10377045|NCT00585351|11517816|FG002|COMPLETED|Enrollment Period (Intervention)||15
10377046|NCT00585351|11517817|FG003|COMPLETED|Enrollment Period (Intervention)||15
10377047|NCT00585351|11517818|FG004|COMPLETED|Enrollment Period (Intervention)||3
10377048|NCT00585351|11517819|FG005|COMPLETED|Enrollment Period (Intervention)||5
10377049|NCT00585351|11517820|FG006|COMPLETED|Enrollment Period (Intervention)||5
10377050|NCT00585351|11517821|FG007|COMPLETED|Enrollment Period (Intervention)||2
10377051|NCT00585351|11517814|FG000|NOT COMPLETED|Enrollment Period (Intervention)||0
10377052|NCT00585351|11517815|FG001|NOT COMPLETED|Enrollment Period (Intervention)||0
10377053|NCT00585351|11517816|FG002|NOT COMPLETED|Enrollment Period (Intervention)||0
10377054|NCT00585351|11517817|FG003|NOT COMPLETED|Enrollment Period (Intervention)||0
10377055|NCT00585351|11517818|FG004|NOT COMPLETED|Enrollment Period (Intervention)||2
10377056|NCT00585351|11517819|FG005|NOT COMPLETED|Enrollment Period (Intervention)||2
10377057|NCT00585351|11517820|FG006|NOT COMPLETED|Enrollment Period (Intervention)||2
10377058|NCT00585351|11517821|FG007|NOT COMPLETED|Enrollment Period (Intervention)||1
10377059|NCT00585377|11517835|FG000|STARTED|Overall Study||50
10377060|NCT00585377|11517835|FG000|COMPLETED|Overall Study||50
10377061|NCT00585377|11517835|FG000|NOT COMPLETED|Overall Study||0
10377062|NCT00585468|11517839|FG000|STARTED|First Intervention||10
10377063|NCT00585468|11517840|FG001|STARTED|First Intervention||11
10377064|NCT00585468|11517839|FG000|COMPLETED|First Intervention||9
10377065|NCT00585468|11517840|FG001|COMPLETED|First Intervention||10
10377066|NCT00585468|11517839|FG000|NOT COMPLETED|First Intervention||1
10377067|NCT00585468|11517840|FG001|NOT COMPLETED|First Intervention||1
10377068|NCT00585468|11517839|FG000|STARTED|Second Intervention||9
10377069|NCT00585468|11517840|FG001|STARTED|Second Intervention||10
10377070|NCT00585468|11517839|FG000|COMPLETED|Second Intervention||9
10377071|NCT00585468|11517840|FG001|COMPLETED|Second Intervention||10
10377072|NCT00585468|11517839|FG000|NOT COMPLETED|Second Intervention||0
10377073|NCT00585468|11517840|FG001|NOT COMPLETED|Second Intervention||0
10377074|NCT00585494|11517848|FG000|STARTED|Overall Study||300
10377075|NCT00585494|11517848|FG000|COMPLETED|Overall Study||244
10377076|NCT00585494|11517848|FG000|NOT COMPLETED|Overall Study||56
10377077|NCT00585533|11517852|FG000|STARTED|Overall Study||40
10377078|NCT00585533|11517852|FG000|COMPLETED|Overall Study||31
10377079|NCT00585533|11517852|FG000|NOT COMPLETED|Overall Study||9
10377080|NCT00585546|11517856|FG000|STARTED|LVAD Implantation Required for 4 Months||18
10377081|NCT00585546|11517856|FG000|COMPLETED|LVAD Implantation Required for 4 Months||13
10377082|NCT00585546|11517856|FG000|NOT COMPLETED|LVAD Implantation Required for 4 Months||5
10377083|NCT00585546|11517856|FG000|STARTED|Clenbuterol Treatment - up to 12 Months||13
10377084|NCT00585546|11517856|FG000|COMPLETED|Clenbuterol Treatment - up to 12 Months||9
10377085|NCT00585546|11517856|FG000|NOT COMPLETED|Clenbuterol Treatment - up to 12 Months||4
10377086|NCT00585637|11517864|FG000|STARTED|Baseline||81
10377087|NCT00585637|11517865|FG001|STARTED|Baseline||81
10377088|NCT00585637|11517866|FG002|STARTED|Baseline||83
10377089|NCT00585637|11517867|FG003|STARTED|Baseline||83
10377090|NCT00585637|11517864|FG000|COMPLETED|Baseline||81
10377091|NCT00585637|11517865|FG001|COMPLETED|Baseline||81
10377092|NCT00585637|11517866|FG002|COMPLETED|Baseline||83
10377093|NCT00585637|11517867|FG003|COMPLETED|Baseline||83
10377094|NCT00585637|11517864|FG000|NOT COMPLETED|Baseline||0
10377095|NCT00585637|11517865|FG001|NOT COMPLETED|Baseline||0
10377096|NCT00585637|11517866|FG002|NOT COMPLETED|Baseline||0
10377097|NCT00585637|11517867|FG003|NOT COMPLETED|Baseline||0
10377098|NCT00585637|11517864|FG000|STARTED|3-month Time Point||81
10377099|NCT00585637|11517865|FG001|STARTED|3-month Time Point||81
10377100|NCT00585637|11517866|FG002|STARTED|3-month Time Point||83
10377101|NCT00585637|11517867|FG003|STARTED|3-month Time Point||83
10377102|NCT00585637|11517864|FG000|COMPLETED|3-month Time Point||71
10377103|NCT00585637|11517865|FG001|COMPLETED|3-month Time Point||67
10377104|NCT00585637|11517866|FG002|COMPLETED|3-month Time Point||76
10377105|NCT00585637|11517867|FG003|COMPLETED|3-month Time Point||78
10377106|NCT00585637|11517864|FG000|NOT COMPLETED|3-month Time Point||10
10377107|NCT00585637|11517865|FG001|NOT COMPLETED|3-month Time Point||14
10377108|NCT00585637|11517866|FG002|NOT COMPLETED|3-month Time Point||7
10377109|NCT00585637|11517867|FG003|NOT COMPLETED|3-month Time Point||5
10377110|NCT00585637|11517864|FG000|STARTED|6-month Time Point||81
10377111|NCT00585637|11517865|FG001|STARTED|6-month Time Point||81
10377112|NCT00585637|11517866|FG002|STARTED|6-month Time Point||83
10377113|NCT00585637|11517867|FG003|STARTED|6-month Time Point||83
10538716|NCT01457339|11691613|FG001|NOT COMPLETED|Period 2 (70 mg)||0
10538717|NCT01457339|11691612|FG000|STARTED|Period 3 (100 mg)||7
10538718|NCT01457339|11691613|FG001|STARTED|Period 3 (100 mg)||24
10538719|NCT01457339|11691612|FG000|COMPLETED|Period 3 (100 mg)||7
10538720|NCT01457339|11691613|FG001|COMPLETED|Period 3 (100 mg)||23
10538721|NCT01457339|11691612|FG000|NOT COMPLETED|Period 3 (100 mg)||0
10538722|NCT01457339|11691613|FG001|NOT COMPLETED|Period 3 (100 mg)||1
10538723|NCT01457339|11691612|FG000|STARTED|Period 4 (150 mg)||7
10538724|NCT01457339|11691613|FG001|STARTED|Period 4 (150 mg)||23
10538725|NCT01457339|11691612|FG000|COMPLETED|Period 4 (150 mg)||7
10538726|NCT01457339|11691613|FG001|COMPLETED|Period 4 (150 mg)||23
10538727|NCT01457339|11691612|FG000|NOT COMPLETED|Period 4 (150 mg)||0
10538728|NCT01457339|11691613|FG001|NOT COMPLETED|Period 4 (150 mg)||0
10538729|NCT01457339|11691612|FG000|STARTED|Period 5 (200 mg)||7
10538730|NCT01457339|11691613|FG001|STARTED|Period 5 (200 mg)||23
10538731|NCT01457339|11691612|FG000|COMPLETED|Period 5 (200 mg)||7
10538732|NCT01457339|11691613|FG001|COMPLETED|Period 5 (200 mg)||22
10538733|NCT01457339|11691612|FG000|NOT COMPLETED|Period 5 (200 mg)||0
10538734|NCT01457339|11691613|FG001|NOT COMPLETED|Period 5 (200 mg)||1
10538735|NCT01457339|11691612|FG000|STARTED|Period 6 (250 mg)||7
10538736|NCT01457339|11691613|FG001|STARTED|Period 6 (250 mg)||22
10538737|NCT01457339|11691612|FG000|COMPLETED|Period 6 (250 mg)||6
10538738|NCT01457339|11691613|FG001|COMPLETED|Period 6 (250 mg)||21
10538739|NCT01457339|11691612|FG000|NOT COMPLETED|Period 6 (250 mg)||1
10538740|NCT01457339|11691613|FG001|NOT COMPLETED|Period 6 (250 mg)||1
10538741|NCT01457352|11691638|FG000|STARTED|Period 1||392
10538742|NCT01457352|11691639|FG001|STARTED|Period 1||0
10538743|NCT01457352|11691638|FG000|COMPLETED|Period 1||376
10538744|NCT01457352|11691639|FG001|COMPLETED|Period 1||0
10538745|NCT01457352|11691638|FG000|NOT COMPLETED|Period 1||16
10377114|NCT00585637|11517864|FG000|COMPLETED|6-month Time Point||75
10377115|NCT00585637|11517865|FG001|COMPLETED|6-month Time Point||68
10377116|NCT00585637|11517866|FG002|COMPLETED|6-month Time Point||72
10377117|NCT00585637|11517867|FG003|COMPLETED|6-month Time Point||77
10538746|NCT01457352|11691639|FG001|NOT COMPLETED|Period 1||0
10538747|NCT01457352|11691638|FG000|STARTED|Period 2||376
10538748|NCT01457352|11691639|FG001|STARTED|Period 2||0
10538749|NCT01457352|11691638|FG000|COMPLETED|Period 2||296
10538750|NCT01457352|11691639|FG001|COMPLETED|Period 2||0
10377118|NCT00585637|11517864|FG000|NOT COMPLETED|6-month Time Point||6
10377119|NCT00585637|11517865|FG001|NOT COMPLETED|6-month Time Point||13
10377120|NCT00585637|11517866|FG002|NOT COMPLETED|6-month Time Point||11
10377121|NCT00585637|11517867|FG003|NOT COMPLETED|6-month Time Point||6
10377122|NCT00585650|11517879|FG000|STARTED|Overall Study||8
10377123|NCT00585650|11517880|FG001|STARTED|Overall Study||12
10377124|NCT00585650|11517879|FG000|COMPLETED|Overall Study||8
10377125|NCT00585650|11517880|FG001|COMPLETED|Overall Study||12
10377126|NCT00585650|11517879|FG000|NOT COMPLETED|Overall Study||0
10377127|NCT00585650|11517880|FG001|NOT COMPLETED|Overall Study||0
10377128|NCT00585689|11517886|FG000|STARTED|Overall Study||29
10377129|NCT00585689|11517886|FG000|COMPLETED|Overall Study||22
10377130|NCT00585689|11517886|FG000|NOT COMPLETED|Overall Study||7
10377131|NCT00585715|11517892|FG000|STARTED|Overall Study||11
10377132|NCT00585715|11517893|FG001|STARTED|Overall Study||11
10377133|NCT00585715|11517892|FG000|COMPLETED|Overall Study||8
10377134|NCT00585715|11517893|FG001|COMPLETED|Overall Study||11
10377135|NCT00585715|11517892|FG000|NOT COMPLETED|Overall Study||3
10377136|NCT00585715|11517893|FG001|NOT COMPLETED|Overall Study||0
10377137|NCT00585780|11517903|FG000|STARTED|Overall Study||21
10377138|NCT00585780|11517904|FG001|STARTED|Overall Study||23
10377139|NCT00585780|11517905|FG002|STARTED|Overall Study||34
10377140|NCT00585780|11517906|FG003|STARTED|Overall Study||22
10377141|NCT00585780|11517903|FG000|COMPLETED|Overall Study||13
10377142|NCT00585780|11517904|FG001|COMPLETED|Overall Study||14
10377143|NCT00585780|11517905|FG002|COMPLETED|Overall Study||21
10377144|NCT00585780|11517906|FG003|COMPLETED|Overall Study||14
10377145|NCT00585780|11517903|FG000|NOT COMPLETED|Overall Study||8
10377146|NCT00585780|11517904|FG001|NOT COMPLETED|Overall Study||9
10377147|NCT00585780|11517905|FG002|NOT COMPLETED|Overall Study||13
10377148|NCT00585780|11517906|FG003|NOT COMPLETED|Overall Study||8
10377149|NCT00585910|11517920|FG000|STARTED|Atomoxetine (ATMX) Alone|This is the number of subjects who were exposed to ATMX in Phase I of the study.|72
10377150|NCT00585910|11517920|FG000|COMPLETED|Atomoxetine (ATMX) Alone|Number of subjects who completed Phase I. 15 completed only Phase I. 40 proceeded onto Phase II.|55
10377151|NCT00585910|11517920|FG000|NOT COMPLETED|Atomoxetine (ATMX) Alone||17
10377152|NCT00585910|11517920|FG000|STARTED|ATMX + Osmotic-Release Methylphenidate|Number of participants to add OROS MPH to their ATMX regimen|50
10377153|NCT00585910|11517920|FG000|COMPLETED|ATMX + Osmotic-Release Methylphenidate||41
10377154|NCT00585910|11517920|FG000|NOT COMPLETED|ATMX + Osmotic-Release Methylphenidate||9
10377155|NCT00585923|11517927|FG000|STARTED|Overall Study||56
10377156|NCT00585923|11517928|FG001|STARTED|Overall Study||59
10377157|NCT00585923|11517927|FG000|COMPLETED|Overall Study||25
10377158|NCT00585923|11517928|FG001|COMPLETED|Overall Study||26
10377159|NCT00585923|11517927|FG000|NOT COMPLETED|Overall Study||31
10377160|NCT00585923|11517928|FG001|NOT COMPLETED|Overall Study||33
10377161|NCT00585975|11517936|FG000|STARTED|Overall Study||277
10377162|NCT00585975|11517937|FG001|STARTED|Overall Study||291
10377163|NCT00585975|11517936|FG000|COMPLETED|Overall Study||262
10377164|NCT00585975|11517937|FG001|COMPLETED|Overall Study||278
10377165|NCT00585975|11517936|FG000|NOT COMPLETED|Overall Study||15
10377166|NCT00585975|11517937|FG001|NOT COMPLETED|Overall Study||13
10377167|NCT00586001|11517945|FG000|STARTED|Overall Study||26
10377168|NCT00586001|11517946|FG001|STARTED|Overall Study||11
10377169|NCT00586001|11517945|FG000|COMPLETED|Overall Study||22
10377170|NCT00586001|11517946|FG001|COMPLETED|Overall Study||10
10377171|NCT00586001|11517945|FG000|NOT COMPLETED|Overall Study||4
10377172|NCT00586001|11517946|FG001|NOT COMPLETED|Overall Study||1
10377173|NCT00586066|11517955|FG000|STARTED|Overall Study||48
10377174|NCT00586066|11517956|FG001|STARTED|Overall Study||24
10377175|NCT00586066|11517955|FG000|COMPLETED|Overall Study||30
10377176|NCT00586066|11517956|FG001|COMPLETED|Overall Study||14
10377177|NCT00586066|11517955|FG000|NOT COMPLETED|Overall Study||18
10377178|NCT00586066|11517956|FG001|NOT COMPLETED|Overall Study||10
10377179|NCT00586105|11517962|FG000|STARTED|Overall Study||39
10377180|NCT00586105|11517962|FG000|COMPLETED|Overall Study||0
10538751|NCT01457352|11691638|FG000|NOT COMPLETED|Period 2||80
10377181|NCT00586105|11517962|FG000|NOT COMPLETED|Overall Study||39
10538752|NCT01457352|11691639|FG001|NOT COMPLETED|Period 2||0
10377182|NCT00586157|11517966|FG000|STARTED|First Intervention||15
10377183|NCT00586157|11517967|FG001|STARTED|First Intervention||15
10377184|NCT00586157|11517966|FG000|COMPLETED|First Intervention||14
10377185|NCT00586157|11517967|FG001|COMPLETED|First Intervention||15
10377186|NCT00586157|11517966|FG000|NOT COMPLETED|First Intervention||1
10377187|NCT00586157|11517967|FG001|NOT COMPLETED|First Intervention||0
10377188|NCT00586157|11517966|FG000|STARTED|Second Intervention||14
10377189|NCT00586157|11517967|FG001|STARTED|Second Intervention||15
10377190|NCT00586157|11517966|FG000|COMPLETED|Second Intervention||12
10377191|NCT00586157|11517967|FG001|COMPLETED|Second Intervention||14
10377192|NCT00586157|11517966|FG000|NOT COMPLETED|Second Intervention||2
10377193|NCT00586157|11517967|FG001|NOT COMPLETED|Second Intervention||1
10377194|NCT00586170|11517975|FG000|STARTED|Overall Study||5
10377195|NCT00586170|11517976|FG001|STARTED|Overall Study|Initially enrollment was listed as 9. 1 placebo patient withdrew prior to surgery, so enrollment=8.|3
10377196|NCT00586170|11517975|FG000|COMPLETED|Overall Study||5
10377197|NCT00586170|11517976|FG001|COMPLETED|Overall Study||3
10377198|NCT00586170|11517975|FG000|NOT COMPLETED|Overall Study||0
10377199|NCT00586170|11517976|FG001|NOT COMPLETED|Overall Study||0
10377200|NCT00586196|11517984|FG000|STARTED|Overall Study||7
10377201|NCT00586196|11517985|FG001|STARTED|Overall Study||9
10717295|NCT02697214|11881217|FG000|Heart Rate at 2mph|Overall Study||26
10717296|NCT02697214|11881218|FG001|Heart Rate at 2mph|Overall Study||25
10717297|NCT02697214|11881219|FG002|Heart Rate at 2mph|Overall Study||25
10717298|NCT02697214|11881220|FG003|Heart Rate at 2mph|Overall Study||24
10717299|NCT02697214|11881221|FG004|Heart Rate at 2mph|Overall Study||50
10717300|NCT02697214|11881222|FG005|Heart Rate at 2mph|Overall Study||50
10306587|NCT00099632|11439470|FG005|NOT COMPLETED|Overall Study||2
10306588|NCT00099983|11439486|FG000|STARTED|Overall Study||147
10306589|NCT00099983|11439487|FG001|STARTED|Overall Study||149
10306590|NCT00099983|11439486|FG000|COMPLETED|Overall Study||123
10306591|NCT00099983|11439487|FG001|COMPLETED|Overall Study||124
10306592|NCT00099983|11439486|FG000|NOT COMPLETED|Overall Study||24
10306593|NCT00099983|11439487|FG001|NOT COMPLETED|Overall Study||25
10306594|NCT00100048|11439498|FG000|STARTED|Cohort I-Monotherapy Phase 10 Days||7
10306595|NCT00100048|11439499|FG001|STARTED|Cohort I-Monotherapy Phase 10 Days||7
10306596|NCT00100048|11439500|FG002|STARTED|Cohort I-Monotherapy Phase 10 Days||6
10306597|NCT00100048|11439501|FG003|STARTED|Cohort I-Monotherapy Phase 10 Days||8
10306598|NCT00100048|11439502|FG004|STARTED|Cohort I-Monotherapy Phase 10 Days||7
10306599|NCT00100048|11439503|FG005|STARTED|Cohort I-Monotherapy Phase 10 Days|participants only assigned Efavirenz 600 mg q.h.s in Cohort II Combined-Combination Therapy Phase|0
10306600|NCT00100048|11439498|FG000|Treated|Cohort I-Monotherapy Phase 10 Days||7
10717323|NCT02697214|11881221|FG004|COMPLETED|Overall Study||50
10306601|NCT00100048|11439499|FG001|Treated|Cohort I-Monotherapy Phase 10 Days||7
10306602|NCT00100048|11439500|FG002|Treated|Cohort I-Monotherapy Phase 10 Days||6
10306603|NCT00100048|11439501|FG003|Treated|Cohort I-Monotherapy Phase 10 Days||8
10306604|NCT00100048|11439502|FG004|Treated|Cohort I-Monotherapy Phase 10 Days||7
10306605|NCT00100048|11439503|FG005|Treated|Cohort I-Monotherapy Phase 10 Days||0
10306606|NCT00100048|11439498|FG000|COMPLETED|Cohort I-Monotherapy Phase 10 Days|7 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|7
10306607|NCT00100048|11439499|FG001|COMPLETED|Cohort I-Monotherapy Phase 10 Days|7 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|7
10306608|NCT00100048|11439500|FG002|COMPLETED|Cohort I-Monotherapy Phase 10 Days|6 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|6
10306609|NCT00100048|11439501|FG003|COMPLETED|Cohort I-Monotherapy Phase 10 Days|6 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|8
10306610|NCT00100048|11439502|FG004|COMPLETED|Cohort I-Monotherapy Phase 10 Days|4 Subjects Continued to Cohort II, as part of the Efavirenz 600 mg q.d. arm|7
10306611|NCT00100048|11439503|FG005|COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
10306612|NCT00100048|11439498|FG000|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
10306613|NCT00100048|11439499|FG001|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
10306614|NCT00100048|11439500|FG002|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
10306615|NCT00100048|11439501|FG003|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
10306616|NCT00100048|11439502|FG004|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
10306617|NCT00100048|11439503|FG005|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
10306618|NCT00100048|11439498|FG000|STARTED|Cohort I & II-Combination Therapy Phase|7 subjects from the Monotherapy Phase and 34 new subjects|41
10306619|NCT00100048|11439499|FG001|STARTED|Cohort I & II-Combination Therapy Phase|7 subjects from the Monotherapy Phase and 33 new subjects|40
10306620|NCT00100048|11439500|FG002|STARTED|Cohort I & II-Combination Therapy Phase|6 subjects from the Monotherapy Phase and 35 new subjects|41
10306621|NCT00100048|11439501|FG003|STARTED|Cohort I & II-Combination Therapy Phase|8 subjects from the Monotherapy Phase and 32 new subjects|40
10306622|NCT00100048|11439502|FG004|STARTED|Cohort I & II-Combination Therapy Phase|participants only assigned Placebo in Cohort I-Monotherapy Phase.|0
10717301|NCT02697214|11881217|FG000|Heart Rate at 3mph|Overall Study||26
10717302|NCT02697214|11881218|FG001|Heart Rate at 3mph|Overall Study||25
10717303|NCT02697214|11881219|FG002|Heart Rate at 3mph|Overall Study||25
10717304|NCT02697214|11881220|FG003|Heart Rate at 3mph|Overall Study||24
10717305|NCT02697214|11881221|FG004|Heart Rate at 3mph|Overall Study||50
10377202|NCT00586196|11517984|FG000|COMPLETED|Overall Study||7
10377203|NCT00586196|11517985|FG001|COMPLETED|Overall Study||9
10377204|NCT00586196|11517984|FG000|NOT COMPLETED|Overall Study||0
10377205|NCT00586196|11517985|FG001|NOT COMPLETED|Overall Study||0
10377206|NCT00586261|11517993|FG000|STARTED|Overall Study||17
10377207|NCT00586261|11517994|FG001|STARTED|Overall Study||19
10377208|NCT00586261|11517993|FG000|COMPLETED|Overall Study||17
10377209|NCT00586261|11517994|FG001|COMPLETED|Overall Study||19
10377210|NCT00586261|11517993|FG000|NOT COMPLETED|Overall Study||0
10377211|NCT00586261|11517994|FG001|NOT COMPLETED|Overall Study||0
10377212|NCT00586313|11518000|FG000|STARTED|Overall Study||21
10377213|NCT00586313|11518000|FG000|COMPLETED|Overall Study||19
10377214|NCT00586313|11518000|FG000|NOT COMPLETED|Overall Study||2
10377215|NCT00586326|11518004|FG000|STARTED|Enrollment to Device Placement-Enrolled||133
10377216|NCT00586326|11518004|FG000|COMPLETED|Enrollment to Device Placement-Enrolled||118
10377217|NCT00586326|11518004|FG000|NOT COMPLETED|Enrollment to Device Placement-Enrolled||15
10377218|NCT00586326|11518004|FG000|STARTED|Device Placed toTreatment-ITT||118
10377219|NCT00586326|11518004|FG000|COMPLETED|Device Placed toTreatment-ITT||100
10377220|NCT00586326|11518004|FG000|NOT COMPLETED|Device Placed toTreatment-ITT||18
10377221|NCT00586326|11518004|FG000|STARTED|Treated Through 5-yr Follow Up-Treated||100
10377222|NCT00586326|11518004|FG000|COMPLETED|Treated Through 5-yr Follow Up-Treated||74
10377223|NCT00586326|11518004|FG000|NOT COMPLETED|Treated Through 5-yr Follow Up-Treated||26
10377224|NCT00586339|11518015|FG000|STARTED|Overall Study||61
10377225|NCT00586339|11518016|FG001|STARTED|Overall Study||59
10377226|NCT00586339|11518017|FG002|STARTED|Overall Study||30
10377227|NCT00586339|11518015|FG000|COMPLETED|Overall Study||54
10377228|NCT00586339|11518016|FG001|COMPLETED|Overall Study||52
10377229|NCT00586339|11518017|FG002|COMPLETED|Overall Study||24
10377230|NCT00586339|11518015|FG000|NOT COMPLETED|Overall Study||7
10377231|NCT00586339|11518016|FG001|NOT COMPLETED|Overall Study||7
10377232|NCT00586339|11518017|FG002|NOT COMPLETED|Overall Study||6
10377233|NCT00586469|11518027|FG000|STARTED|Overall Study||500
10377234|NCT00586469|11518028|FG001|STARTED|Overall Study||500
10717306|NCT02697214|11881222|FG005|Heart Rate at 3mph|Overall Study||50
10717307|NCT02697214|11881217|FG000|Heart Rate at 4mph|Overall Study||26
10717308|NCT02697214|11881218|FG001|Heart Rate at 4mph|Overall Study||25
10717309|NCT02697214|11881219|FG002|Heart Rate at 4mph|Overall Study||25
10717310|NCT02697214|11881220|FG003|Heart Rate at 4mph|Overall Study||24
10717311|NCT02697214|11881221|FG004|Heart Rate at 4mph|Overall Study||50
10717312|NCT02697214|11881222|FG005|Heart Rate at 4mph|Overall Study||50
10717313|NCT02697214|11881217|FG000|Heart Rate at 6mph|Overall Study||26
10717314|NCT02697214|11881218|FG001|Heart Rate at 6mph|Overall Study||25
10717315|NCT02697214|11881219|FG002|Heart Rate at 6mph|Overall Study||25
10717316|NCT02697214|11881220|FG003|Heart Rate at 6mph|Overall Study||24
10717317|NCT02697214|11881221|FG004|Heart Rate at 6mph|Overall Study||50
10717318|NCT02697214|11881222|FG005|Heart Rate at 6mph|Overall Study||50
10717319|NCT02697214|11881217|FG000|COMPLETED|Overall Study||26
10717320|NCT02697214|11881218|FG001|COMPLETED|Overall Study||25
10717321|NCT02697214|11881219|FG002|COMPLETED|Overall Study||25
10717322|NCT02697214|11881220|FG003|COMPLETED|Overall Study||24
10717324|NCT02697214|11881222|FG005|COMPLETED|Overall Study||50
10717325|NCT02697214|11881217|FG000|NOT COMPLETED|Overall Study||0
10717326|NCT02697214|11881218|FG001|NOT COMPLETED|Overall Study||0
10377235|NCT00586469|11518027|FG000|COMPLETED|Overall Study||500
10377236|NCT00586469|11518028|FG001|COMPLETED|Overall Study||499
10377237|NCT00586469|11518027|FG000|NOT COMPLETED|Overall Study||0
10377238|NCT00586469|11518028|FG001|NOT COMPLETED|Overall Study||1
10377239|NCT00586482|11518036|FG000|STARTED|Overall Study||22
10377240|NCT00586482|11518037|FG001|STARTED|Overall Study||24
10377241|NCT00586482|11518036|FG000|COMPLETED|Overall Study||22
10377242|NCT00586482|11518037|FG001|COMPLETED|Overall Study||24
10717327|NCT02697214|11881219|FG002|NOT COMPLETED|Overall Study||0
10717328|NCT02697214|11881220|FG003|NOT COMPLETED|Overall Study||0
10717329|NCT02697214|11881221|FG004|NOT COMPLETED|Overall Study||0
10717330|NCT02697214|11881222|FG005|NOT COMPLETED|Overall Study||0
10717331|NCT02697240|11881232|FG000|STARTED|Overall Study||4
10717332|NCT02697240|11881232|FG000|COMPLETED|Overall Study||4
10717333|NCT02697240|11881232|FG000|NOT COMPLETED|Overall Study||0
10717334|NCT02697292|11881238|FG000|STARTED|Overall Study||9
10717335|NCT02697292|11881239|FG001|STARTED|Overall Study||8
10717336|NCT02697292|11881238|FG000|COMPLETED|Overall Study||9
10717337|NCT02697292|11881239|FG001|COMPLETED|Overall Study||8
10717338|NCT02697292|11881238|FG000|NOT COMPLETED|Overall Study||0
10717339|NCT02697292|11881239|FG001|NOT COMPLETED|Overall Study||0
10717340|NCT02697435|11881248|FG000|STARTED|Overall Study||25
10717341|NCT02697435|11881249|FG001|STARTED|Overall Study||30
10717342|NCT02697435|11881248|FG000|COMPLETED|Overall Study||24
10717343|NCT02697435|11881249|FG001|COMPLETED|Overall Study||26
10717344|NCT02697435|11881248|FG000|NOT COMPLETED|Overall Study||1
10717345|NCT02697435|11881249|FG001|NOT COMPLETED|Overall Study||4
10717346|NCT02697591|11881266|FG000|STARTED|Overall Study||4
10717347|NCT02697591|11881267|FG001|STARTED|Overall Study||4
10717348|NCT02697591|11881268|FG002|STARTED|Overall Study||4
10717349|NCT02697591|11881269|FG003|STARTED|Overall Study||3
10717350|NCT02697591|11881270|FG004|STARTED|Overall Study||15
10717351|NCT02697591|11881271|FG005|STARTED|Overall Study||18
10717352|NCT02697591|11881272|FG006|STARTED|Overall Study||16
10717353|NCT02697591|11881273|FG007|STARTED|Overall Study||4
10717354|NCT02697591|11881274|FG008|STARTED|Overall Study||10
10717355|NCT02697591|11881275|FG009|STARTED|Overall Study||22
10717356|NCT02697591|11881266|FG000|COMPLETED|Overall Study||0
10717357|NCT02697591|11881267|FG001|COMPLETED|Overall Study||0
10717358|NCT02697591|11881268|FG002|COMPLETED|Overall Study||1
10717359|NCT02697591|11881269|FG003|COMPLETED|Overall Study||0
10717360|NCT02697591|11881270|FG004|COMPLETED|Overall Study||2
10717361|NCT02697591|11881271|FG005|COMPLETED|Overall Study||2
10717362|NCT02697591|11881272|FG006|COMPLETED|Overall Study||0
10717363|NCT02697591|11881273|FG007|COMPLETED|Overall Study||1
10717364|NCT02697591|11881274|FG008|COMPLETED|Overall Study||1
10717365|NCT02697591|11881275|FG009|COMPLETED|Overall Study||2
10717366|NCT02697591|11881266|FG000|NOT COMPLETED|Overall Study||4
10717367|NCT02697591|11881267|FG001|NOT COMPLETED|Overall Study||4
10717368|NCT02697591|11881268|FG002|NOT COMPLETED|Overall Study||3
10717369|NCT02697591|11881269|FG003|NOT COMPLETED|Overall Study||3
10717370|NCT02697591|11881270|FG004|NOT COMPLETED|Overall Study||13
10717371|NCT02697591|11881271|FG005|NOT COMPLETED|Overall Study||16
10717372|NCT02697591|11881272|FG006|NOT COMPLETED|Overall Study||16
10717373|NCT02697591|11881273|FG007|NOT COMPLETED|Overall Study||3
10717374|NCT02697591|11881274|FG008|NOT COMPLETED|Overall Study||9
10717375|NCT02697591|11881275|FG009|NOT COMPLETED|Overall Study||20
10717376|NCT02697617|11881298|FG000|STARTED|Overall Study||9
10717377|NCT02697617|11881299|FG001|STARTED|Overall Study||9
10717378|NCT02697617|11881298|FG000|COMPLETED|Overall Study|15 completed both arms|8
10717379|NCT02697617|11881299|FG001|COMPLETED|Overall Study||7
10717380|NCT02697617|11881298|FG000|NOT COMPLETED|Overall Study||1
10717381|NCT02697617|11881299|FG001|NOT COMPLETED|Overall Study||2
10717382|NCT02697734|11881311|FG000|STARTED|Core Phase - up to Week 48||48
10717383|NCT02697734|11881312|FG001|STARTED|Core Phase - up to Week 48||25
10717384|NCT02697734|11881311|FG000|COMPLETED|Core Phase - up to Week 48||42
10717385|NCT02697734|11881312|FG001|COMPLETED|Core Phase - up to Week 48||23
10717386|NCT02697734|11881311|FG000|NOT COMPLETED|Core Phase - up to Week 48||6
10717387|NCT02697734|11881312|FG001|NOT COMPLETED|Core Phase - up to Week 48||2
10717388|NCT02697734|11881311|FG000|STARTED|Optional Extension Phase||38
10717389|NCT02697734|11881312|FG001|STARTED|Optional Extension Phase||22
10717390|NCT02697734|11881311|FG000|COMPLETED|Optional Extension Phase||33
10717391|NCT02697734|11881312|FG001|COMPLETED|Optional Extension Phase||20
10717392|NCT02697734|11881311|FG000|NOT COMPLETED|Optional Extension Phase||5
10717393|NCT02697734|11881312|FG001|NOT COMPLETED|Optional Extension Phase||2
10717394|NCT02697773|11881329|FG000|STARTED|Overall Study||233
10717395|NCT02697773|11881330|FG001|STARTED|Overall Study||232
10717396|NCT02697773|11881331|FG002|STARTED|Overall Study||233
10717397|NCT02697773|11881329|FG000|Treated|Overall Study||232
10717398|NCT02697773|11881330|FG001|Treated|Overall Study||231
10717399|NCT02697773|11881331|FG002|Treated|Overall Study||233
10717400|NCT02697773|11881329|FG000|COMPLETED|Overall Study||195
10717401|NCT02697773|11881330|FG001|COMPLETED|Overall Study||194
10717402|NCT02697773|11881331|FG002|COMPLETED|Overall Study||193
10717403|NCT02697773|11881329|FG000|NOT COMPLETED|Overall Study||38
10717404|NCT02697773|11881330|FG001|NOT COMPLETED|Overall Study||38
10717405|NCT02697773|11881331|FG002|NOT COMPLETED|Overall Study||40
10812666|NCT03423654|11974797|FG000|COMPLETED|Overall Study||3
10717406|NCT02697890|11881341|FG000|STARTED|Overall Study||14
10717407|NCT02697890|11881342|FG001|STARTED|Overall Study||14
10717408|NCT02697890|11881341|FG000|COMPLETED|Overall Study||14
10717409|NCT02697890|11881342|FG001|COMPLETED|Overall Study||14
10717410|NCT02697890|11881341|FG000|NOT COMPLETED|Overall Study||0
10717411|NCT02697890|11881342|FG001|NOT COMPLETED|Overall Study||0
10717412|NCT02697916|11881350|FG000|STARTED|Overall Study||7540
10717413|NCT02697916|11881351|FG001|STARTED|Overall Study||7536
10717414|NCT02697916|11881350|FG000|COMPLETED|Overall Study||6962
10717415|NCT02697916|11881351|FG001|COMPLETED|Overall Study||6828
10717416|NCT02697916|11881350|FG000|NOT COMPLETED|Overall Study||578
10717417|NCT02697916|11881351|FG001|NOT COMPLETED|Overall Study||708
10717418|NCT02698033|11881357|FG000|STARTED|Overall Study||7
10717419|NCT02698033|11881357|FG000|COMPLETED|Overall Study||6
10717420|NCT02698033|11881357|FG000|NOT COMPLETED|Overall Study||1
10717421|NCT02698176|11881364|FG000|STARTED|Overall Study||9
10717422|NCT02698176|11881365|FG001|STARTED|Overall Study||3
10377243|NCT00586482|11518036|FG000|NOT COMPLETED|Overall Study||0
10377244|NCT00586482|11518037|FG001|NOT COMPLETED|Overall Study||0
10377245|NCT00586495|11518043|FG000|STARTED|Treatment Period||95
10377246|NCT00586495|11518043|FG000|COMPLETED|Treatment Period||0
10377247|NCT00586495|11518043|FG000|NOT COMPLETED|Treatment Period||95
10377248|NCT00586495|11518043|FG000|STARTED|Follow-up||92
10377249|NCT00586495|11518043|FG000|COMPLETED|Follow-up||0
10377250|NCT00586495|11518043|FG000|NOT COMPLETED|Follow-up||92
10377251|NCT00586508|11518049|FG000|STARTED|Overall Study||68
10377252|NCT00586508|11518050|FG001|STARTED|Overall Study||13
10717423|NCT02698176|11881366|FG002|STARTED|Overall Study||1
10717424|NCT02698176|11881367|FG003|STARTED|Overall Study|No participants were enrolled in Part B.|0
10717425|NCT02698176|11881364|FG000|COMPLETED|Overall Study||0
10717426|NCT02698176|11881365|FG001|COMPLETED|Overall Study||0
10717427|NCT02698176|11881366|FG002|COMPLETED|Overall Study||0
10717428|NCT02698176|11881367|FG003|COMPLETED|Overall Study||0
10717429|NCT02698176|11881364|FG000|NOT COMPLETED|Overall Study||9
10717430|NCT02698176|11881365|FG001|NOT COMPLETED|Overall Study||3
10717431|NCT02698176|11881366|FG002|NOT COMPLETED|Overall Study||1
10717432|NCT02698176|11881367|FG003|NOT COMPLETED|Overall Study||0
10717439|NCT02698215|11881391|FG000|STARTED|Overall Study||83
10717440|NCT02698215|11881392|FG001|STARTED|Overall Study||82
10717441|NCT02698215|11881391|FG000|COMPLETED|Overall Study||55
10717442|NCT02698215|11881392|FG001|COMPLETED|Overall Study||64
10717443|NCT02698215|11881391|FG000|NOT COMPLETED|Overall Study||28
10717444|NCT02698215|11881392|FG001|NOT COMPLETED|Overall Study||18
10717445|NCT02698241|11881398|FG000|STARTED|Overall Study|Number of subjects enrolled the study|79
10717446|NCT02698241|11881398|FG000|Baseline & Programming|Overall Study|Number of subjects that passed screening and completed baseline and programming visit|66
10717447|NCT02698241|11881398|FG000|COMPLETED|Overall Study|Number of subjects completed the study (no early exit or death)|45
10717448|NCT02698241|11881398|FG000|NOT COMPLETED|Overall Study||34
10717449|NCT02698371|11881402|FG000|STARTED|All Participants Flow||38
10717450|NCT02698371|11881402|FG000|COMPLETED|All Participants Flow||35
10717451|NCT02698371|11881402|FG000|NOT COMPLETED|All Participants Flow||3
10717452|NCT02698371|11881402|FG000|STARTED|FBDC-SE (G1; Control) Arm/Group Flow|Each participant received one NCCLs restoration with FBDC-SE (G1control Arm/Group).|35
10717453|NCT02698371|11881402|FG000|COMPLETED|FBDC-SE (G1; Control) Arm/Group Flow||32
10717454|NCT02698371|11881402|FG000|NOT COMPLETED|FBDC-SE (G1; Control) Arm/Group Flow||3
10717455|NCT02698371|11881402|FG000|STARTED|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Each participant received one NCCLs restoration with FBDC-SE-EE (G2 control Arm/group)|35
10717456|NCT02698371|11881402|FG000|COMPLETED|FBDC-SE-EE (G2; Control ) Arm/Group Flow||32
10717457|NCT02698371|11881402|FG000|NOT COMPLETED|FBDC-SE-EE (G2; Control ) Arm/Group Flow||3
10717458|NCT02698371|11881402|FG000|STARTED|FBU-ER (G3) Arm/Group Flow|Each participant received one NCCLs restoration with FBU-ER (G3 Arm/group)|35
10717459|NCT02698371|11881402|FG000|COMPLETED|FBU-ER (G3) Arm/Group Flow||32
10717460|NCT02698371|11881402|FG000|NOT COMPLETED|FBU-ER (G3) Arm/Group Flow||3
10717461|NCT02698371|11881402|FG000|STARTED|FBU-SE (G4) Arm/Group Flow|Each participant received one NCCLs restoration with FBU-SE (G4 Arm/group)|35
10717462|NCT02698371|11881402|FG000|COMPLETED|FBU-SE (G4) Arm/Group Flow||32
10717463|NCT02698371|11881402|FG000|NOT COMPLETED|FBU-SE (G4) Arm/Group Flow||3
10717464|NCT02698371|11881402|FG000|STARTED|ADU-ER (G5) Arm/Group Flow|Each participant received one NCCLs restoration with ADU-ER (G5 Arm/group)|35
10717465|NCT02698371|11881402|FG000|COMPLETED|ADU-ER (G5) Arm/Group Flow||32
10717466|NCT02698371|11881402|FG000|NOT COMPLETED|ADU-ER (G5) Arm/Group Flow||3
10717467|NCT02698371|11881402|FG000|STARTED|ADU-SE (G6) Arm/Group Flow|Each participant received one NCCLs restoration with ADU-SE (G6 Arm/group)|35
10717468|NCT02698371|11881402|FG000|COMPLETED|ADU-SE (G6) Arm/Group Flow||33
10717469|NCT02698371|11881402|FG000|NOT COMPLETED|ADU-SE (G6) Arm/Group Flow||2
10717470|NCT02698410|11881418|FG000|STARTED|Overall Study||40
10717471|NCT02698410|11881418|FG000|COMPLETED|Overall Study||36
10717472|NCT02698410|11881418|FG000|NOT COMPLETED|Overall Study||4
10717473|NCT02698423|11881424|FG000|STARTED|Overall Study||336
10717474|NCT02698423|11881425|FG001|STARTED|Overall Study||331
10717475|NCT02698423|11881424|FG000|COMPLETED|Overall Study||317
10717476|NCT02698423|11881425|FG001|COMPLETED|Overall Study||307
10377253|NCT00586508|11518049|FG000|Received at Least 1 Dose of Study Drug|Overall Study||68
10377254|NCT00586508|11518050|FG001|Received at Least 1 Dose of Study Drug|Overall Study||13
10377255|NCT00586508|11518049|FG000|COMPLETED|Overall Study||0
10377256|NCT00586508|11518050|FG001|COMPLETED|Overall Study||0
10717477|NCT02698423|11881424|FG000|NOT COMPLETED|Overall Study||19
10377257|NCT00586508|11518049|FG000|NOT COMPLETED|Overall Study||68
10377258|NCT00586508|11518050|FG001|NOT COMPLETED|Overall Study||13
10377259|NCT00586521|11518056|FG000|STARTED|On Demand Treatment (Months 1-6)||20
10377260|NCT00586521|11518056|FG000|COMPLETED|On Demand Treatment (Months 1-6)||19
10377261|NCT00586521|11518056|FG000|NOT COMPLETED|On Demand Treatment (Months 1-6)||1
10377262|NCT00586521|11518056|FG000|STARTED|Prophylactic Treatment (Months 8-13)||19
10377263|NCT00586521|11518056|FG000|COMPLETED|Prophylactic Treatment (Months 8-13)||19
10377264|NCT00586521|11518056|FG000|NOT COMPLETED|Prophylactic Treatment (Months 8-13)||0
10377265|NCT00586573|11518060|FG000|STARTED|Overall Study||34
10377266|NCT00586573|11518060|FG000|COMPLETED|Overall Study||28
10377267|NCT00586573|11518060|FG000|NOT COMPLETED|Overall Study||6
10377268|NCT00586612|11518066|FG000|STARTED|Primary Phase||163
10377269|NCT00586612|11518067|FG001|STARTED|Primary Phase||150
10377270|NCT00586612|11518066|FG000|COMPLETED|Primary Phase||162
10377271|NCT00586612|11518067|FG001|COMPLETED|Primary Phase||147
10377272|NCT00586612|11518066|FG000|NOT COMPLETED|Primary Phase||1
10377273|NCT00586612|11518067|FG001|NOT COMPLETED|Primary Phase||3
10377274|NCT00586612|11518066|FG000|STARTED|Booster Phase||154
10377275|NCT00586612|11518067|FG001|STARTED|Booster Phase||144
10377276|NCT00586612|11518066|FG000|COMPLETED|Booster Phase||151
10717478|NCT02698423|11881425|FG001|NOT COMPLETED|Overall Study||24
10717479|NCT02698436|11881435|FG000|STARTED|Overall Study||59
10717480|NCT02698436|11881436|FG001|STARTED|Overall Study||58
10717481|NCT02698436|11881435|FG000|COMPLETED|Overall Study||52
10717482|NCT02698436|11881436|FG001|COMPLETED|Overall Study||51
10717483|NCT02698436|11881435|FG000|NOT COMPLETED|Overall Study||7
10717484|NCT02698436|11881436|FG001|NOT COMPLETED|Overall Study||7
10717485|NCT02698475|11881442|FG000|STARTED|Main Study Period||44
10717486|NCT02698475|11881442|FG000|COMPLETED|Main Study Period||41
10717487|NCT02698475|11881442|FG000|NOT COMPLETED|Main Study Period||3
10717488|NCT02698475|11881442|FG000|STARTED|Long-Term Extension Period|13 participants did not enter the long-term extension period.|28
10717489|NCT02698475|11881442|FG000|COMPLETED|Long-Term Extension Period||0
10717490|NCT02698475|11881442|FG000|NOT COMPLETED|Long-Term Extension Period||28
10717491|NCT02698566|11881449|FG000|STARTED|Overall Study||35
10717492|NCT02698566|11881450|FG001|STARTED|Overall Study||3
10717493|NCT02698566|11881449|FG000|COMPLETED|Overall Study||35
10717494|NCT02698566|11881450|FG001|COMPLETED|Overall Study||3
10717495|NCT02698566|11881449|FG000|NOT COMPLETED|Overall Study||0
10717496|NCT02698566|11881450|FG001|NOT COMPLETED|Overall Study||0
10717497|NCT02698735|11881454|FG000|STARTED|Overall Study||5
10717498|NCT02698735|11881454|FG000|COMPLETED|Overall Study|There are only 18 out of 20 samples because one patient declined intradermal injection intervention.|5
10717499|NCT02698735|11881454|FG000|NOT COMPLETED|Overall Study||0
10717500|NCT02698787|11881466|FG000|STARTED|First Intervention (3 Months)||6
10717501|NCT02698787|11881467|FG001|STARTED|First Intervention (3 Months)||5
10717502|NCT02698787|11881466|FG000|COMPLETED|First Intervention (3 Months)||6
10717503|NCT02698787|11881467|FG001|COMPLETED|First Intervention (3 Months)||5
10717504|NCT02698787|11881466|FG000|NOT COMPLETED|First Intervention (3 Months)||0
10717505|NCT02698787|11881467|FG001|NOT COMPLETED|First Intervention (3 Months)||0
10717506|NCT02698787|11881466|FG000|STARTED|Second Intervention (3 Months)||6
10717507|NCT02698787|11881467|FG001|STARTED|Second Intervention (3 Months)||5
10717508|NCT02698787|11881466|FG000|COMPLETED|Second Intervention (3 Months)||6
10717509|NCT02698787|11881467|FG001|COMPLETED|Second Intervention (3 Months)||4
10717510|NCT02698787|11881466|FG000|NOT COMPLETED|Second Intervention (3 Months)||0
10717511|NCT02698787|11881467|FG001|NOT COMPLETED|Second Intervention (3 Months)||1
10717512|NCT02698800|11881474|FG000|STARTED|Overall Study||7
10717513|NCT02698800|11881475|FG001|STARTED|Overall Study||8
10717514|NCT02698800|11881474|FG000|COMPLETED|Overall Study||6
10717515|NCT02698800|11881475|FG001|COMPLETED|Overall Study||8
10717516|NCT02698800|11881474|FG000|NOT COMPLETED|Overall Study||1
10717517|NCT02698800|11881475|FG001|NOT COMPLETED|Overall Study||0
10717518|NCT02699099|11881484|FG000|STARTED|Overall Study||231
10717519|NCT02699099|11881485|FG001|STARTED|Overall Study||236
10717520|NCT02699099|11881486|FG002|STARTED|Overall Study||232
10717521|NCT02699099|11881484|FG000|COMPLETED|Overall Study||223
10717522|NCT02699099|11881485|FG001|COMPLETED|Overall Study||233
10717523|NCT02699099|11881486|FG002|COMPLETED|Overall Study||226
10717524|NCT02699099|11881484|FG000|NOT COMPLETED|Overall Study||8
10717525|NCT02699099|11881485|FG001|NOT COMPLETED|Overall Study||3
10717526|NCT02699099|11881486|FG002|NOT COMPLETED|Overall Study||6
10717527|NCT02699125|11881496|FG000|STARTED|Placebo||21
10717528|NCT02699125|11881497|FG001|STARTED|Placebo||20
10717529|NCT02699125|11881496|FG000|COMPLETED|Placebo||18
10717530|NCT02699125|11881497|FG001|COMPLETED|Placebo||16
10717531|NCT02699125|11881496|FG000|NOT COMPLETED|Placebo||3
10717532|NCT02699125|11881497|FG001|NOT COMPLETED|Placebo||4
10717533|NCT02699125|11881496|FG000|STARTED|First Intervention (6 Weeks).||18
10717534|NCT02699125|11881497|FG001|STARTED|First Intervention (6 Weeks).||16
10717535|NCT02699125|11881496|FG000|COMPLETED|First Intervention (6 Weeks).||18
10717536|NCT02699125|11881497|FG001|COMPLETED|First Intervention (6 Weeks).||16
10717537|NCT02699125|11881496|FG000|NOT COMPLETED|First Intervention (6 Weeks).||0
10717538|NCT02699125|11881497|FG001|NOT COMPLETED|First Intervention (6 Weeks).||0
10377277|NCT00586612|11518067|FG001|COMPLETED|Booster Phase||143
10377278|NCT00586612|11518066|FG000|NOT COMPLETED|Booster Phase||3
10377279|NCT00586612|11518067|FG001|NOT COMPLETED|Booster Phase||1
10377280|NCT00586625|11518075|FG000|STARTED|Overall Study||575
10377281|NCT00586625|11518076|FG001|STARTED|Overall Study||286
10377282|NCT00586625|11518075|FG000|COMPLETED|Overall Study||532
10377283|NCT00586625|11518076|FG001|COMPLETED|Overall Study||269
10717539|NCT02699125|11881496|FG000|STARTED|Second Intervention (6 Weeks).||18
10377284|NCT00586625|11518075|FG000|NOT COMPLETED|Overall Study||43
10377285|NCT00586625|11518076|FG001|NOT COMPLETED|Overall Study||17
10377286|NCT00586664|11518085|FG000|STARTED|Overall Study||43
10377287|NCT00586664|11518086|FG001|STARTED|Overall Study||43
10377288|NCT00586664|11518087|FG002|STARTED|Overall Study||44
10377289|NCT00586664|11518085|FG000|COMPLETED|Overall Study||38
10377290|NCT00586664|11518086|FG001|COMPLETED|Overall Study||36
10377291|NCT00586664|11518087|FG002|COMPLETED|Overall Study||43
10377292|NCT00586664|11518085|FG000|NOT COMPLETED|Overall Study||5
10377293|NCT00586664|11518086|FG001|NOT COMPLETED|Overall Study||7
10377294|NCT00586664|11518087|FG002|NOT COMPLETED|Overall Study||1
10377295|NCT00586690|11518097|FG000|STARTED|Overall Study|Four consented subjects were screen failures.|21
10377296|NCT00586690|11518098|FG001|STARTED|Overall Study||22
10377297|NCT00586690|11518097|FG000|COMPLETED|Overall Study||5
10538753|NCT01457352|11691638|FG000|STARTED|Period 3||147
10538754|NCT01457352|11691639|FG001|STARTED|Period 3||149
10538755|NCT01457352|11691638|FG000|Randomization|Period 3||147
10538756|NCT01457352|11691639|FG001|Randomization|Period 3||149
10538757|NCT01457352|11691638|FG000|COMPLETED|Period 3||146
10538758|NCT01457352|11691639|FG001|COMPLETED|Period 3||144
10538759|NCT01457352|11691638|FG000|NOT COMPLETED|Period 3||1
10538760|NCT01457352|11691639|FG001|NOT COMPLETED|Period 3||5
10377298|NCT00586690|11518098|FG001|COMPLETED|Overall Study||22
10377299|NCT00586690|11518097|FG000|NOT COMPLETED|Overall Study||16
10377300|NCT00586690|11518098|FG001|NOT COMPLETED|Overall Study||0
10377301|NCT00586703|11518103|FG000|STARTED|Overall Study||16
10377302|NCT00586703|11518103|FG000|COMPLETED|Overall Study||4
10377303|NCT00586703|11518103|FG000|NOT COMPLETED|Overall Study||12
10377304|NCT00586729|11518109|FG000|STARTED|Overall Study||14
10377305|NCT00586729|11518110|FG001|STARTED|Overall Study||9
10377306|NCT00586729|11518109|FG000|COMPLETED|Overall Study||11
10377307|NCT00586729|11518110|FG001|COMPLETED|Overall Study||8
10377308|NCT00586729|11518109|FG000|NOT COMPLETED|Overall Study||3
10377309|NCT00586729|11518110|FG001|NOT COMPLETED|Overall Study||1
10377310|NCT00586820|11518118|FG000|STARTED|Overall Study||12
10538761|NCT01457417|11691654|FG000|STARTED|Overall Study||3
10717540|NCT02699125|11881497|FG001|STARTED|Second Intervention (6 Weeks).||16
10717541|NCT02699125|11881496|FG000|COMPLETED|Second Intervention (6 Weeks).||11
10717542|NCT02699125|11881497|FG001|COMPLETED|Second Intervention (6 Weeks).||14
10717543|NCT02699125|11881496|FG000|NOT COMPLETED|Second Intervention (6 Weeks).||7
10717544|NCT02699125|11881497|FG001|NOT COMPLETED|Second Intervention (6 Weeks).||2
10717545|NCT02699450|11881510|FG000|STARTED|Overall Study||90
10717546|NCT02699450|11881511|FG001|STARTED|Overall Study||55
10717547|NCT02699450|11881512|FG002|STARTED|Overall Study||82
10717548|NCT02699450|11881510|FG000|Received at Least One Dose of Study Drug|Overall Study||89
10717549|NCT02699450|11881511|FG001|Received at Least One Dose of Study Drug|Overall Study||55
10717550|NCT02699450|11881512|FG002|Received at Least One Dose of Study Drug|Overall Study||80
10717551|NCT02699450|11881510|FG000|Completed up to Week 24|Overall Study||81
10717552|NCT02699450|11881511|FG001|Completed up to Week 24|Overall Study||53
10717553|NCT02699450|11881512|FG002|Completed up to Week 24|Overall Study||73
10717554|NCT02699450|11881510|FG000|COMPLETED|Overall Study||75
10717555|NCT02699450|11881511|FG001|COMPLETED|Overall Study||50
10717556|NCT02699450|11881512|FG002|COMPLETED|Overall Study||67
10717557|NCT02699450|11881510|FG000|NOT COMPLETED|Overall Study||15
10717558|NCT02699450|11881511|FG001|NOT COMPLETED|Overall Study||5
10717559|NCT02699450|11881512|FG002|NOT COMPLETED|Overall Study||15
10717560|NCT02699463|11881523|FG000|STARTED|Overall Study||115
10717561|NCT02699463|11881524|FG001|STARTED|Overall Study||118
10812667|NCT03423654|11974798|FG001|COMPLETED|Overall Study||3
10812668|NCT03423654|11974797|FG000|NOT COMPLETED|Overall Study||0
10812669|NCT03423654|11974798|FG001|NOT COMPLETED|Overall Study||0
10812670|NCT03387059|11974806|FG000|STARTED|Overall Study||5
10812671|NCT03387059|11974807|FG001|STARTED|Overall Study||4
10812672|NCT03387059|11974806|FG000|COMPLETED|Overall Study||0
10812673|NCT03387059|11974807|FG001|COMPLETED|Overall Study||0
10812674|NCT03387059|11974806|FG000|NOT COMPLETED|Overall Study||5
10377311|NCT00586820|11518119|FG001|STARTED|Overall Study||11
10377312|NCT00586820|11518118|FG000|COMPLETED|Overall Study||11
10717562|NCT02699463|11881523|FG000|COMPLETED|Overall Study||100
10717563|NCT02699463|11881524|FG001|COMPLETED|Overall Study||109
10717564|NCT02699463|11881523|FG000|NOT COMPLETED|Overall Study||15
10717565|NCT02699463|11881524|FG001|NOT COMPLETED|Overall Study||9
10717566|NCT02699593|11881530|FG000|STARTED|Period 1||72
10377313|NCT00586820|11518119|FG001|COMPLETED|Overall Study||11
10377314|NCT00586820|11518118|FG000|NOT COMPLETED|Overall Study||1
10377315|NCT00586820|11518119|FG001|NOT COMPLETED|Overall Study||0
10377316|NCT00586846|11518125|FG000|STARTED|Overall Study||40
10377317|NCT00586846|11518125|FG000|COMPLETED|Overall Study||34
10377318|NCT00586846|11518125|FG000|NOT COMPLETED|Overall Study||6
10377319|NCT00586898|11518129|FG000|STARTED|Overall Study||36
10717567|NCT02699593|11881531|FG001|STARTED|Period 1||69
10717568|NCT02699593|11881530|FG000|COMPLETED|Period 1||67
10717569|NCT02699593|11881531|FG001|COMPLETED|Period 1||62
10717570|NCT02699593|11881530|FG000|NOT COMPLETED|Period 1||5
10812675|NCT03387059|11974807|FG001|NOT COMPLETED|Overall Study||4
10377320|NCT00586898|11518129|FG000|COMPLETED|Overall Study||29
10377321|NCT00586898|11518129|FG000|NOT COMPLETED|Overall Study||7
10538762|NCT01457417|11691655|FG001|STARTED|Overall Study||3
10538763|NCT01457417|11691656|FG002|STARTED|Overall Study||4
10538764|NCT01457417|11691657|FG003|STARTED|Overall Study||3
10812676|NCT03382925|11974815|FG000|STARTED|Overall Study||10
10377322|NCT00587041|11518136|FG000|STARTED|Overall Study||12
10377323|NCT00587041|11518137|FG001|STARTED|Overall Study||14
10377324|NCT00587041|11518138|FG002|STARTED|Overall Study||14
10377325|NCT00587041|11518136|FG000|COMPLETED|Overall Study||12
10377326|NCT00587041|11518137|FG001|COMPLETED|Overall Study||14
10377327|NCT00587041|11518138|FG002|COMPLETED|Overall Study||14
10377328|NCT00587041|11518136|FG000|NOT COMPLETED|Overall Study||0
10377329|NCT00587041|11518137|FG001|NOT COMPLETED|Overall Study||0
10377330|NCT00587041|11518138|FG002|NOT COMPLETED|Overall Study||0
10377331|NCT00587054|11518146|FG000|STARTED|Overall Study||129
10377332|NCT00587054|11518146|FG000|COMPLETED|Overall Study||120
10377333|NCT00587054|11518146|FG000|NOT COMPLETED|Overall Study||9
10377334|NCT00587067|11518150|FG000|STARTED|Overall Study||34
10377335|NCT00587067|11518150|FG000|COMPLETED|Overall Study||34
10377336|NCT00587067|11518150|FG000|NOT COMPLETED|Overall Study||0
10377337|NCT00587132|11518158|FG000|STARTED|Overall Study||4
10377338|NCT00587132|11518159|FG001|STARTED|Overall Study||0
10377339|NCT00587132|11518160|FG002|STARTED|Overall Study||0
10377340|NCT00587132|11518161|FG003|STARTED|Overall Study||0
10377341|NCT00587132|11518158|FG000|COMPLETED|Overall Study||4
10377342|NCT00587132|11518159|FG001|COMPLETED|Overall Study||0
10377343|NCT00587132|11518160|FG002|COMPLETED|Overall Study||0
10377344|NCT00587132|11518161|FG003|COMPLETED|Overall Study||0
10377345|NCT00587132|11518158|FG000|NOT COMPLETED|Overall Study||0
10377346|NCT00587132|11518159|FG001|NOT COMPLETED|Overall Study||0
10377347|NCT00587132|11518160|FG002|NOT COMPLETED|Overall Study||0
10377348|NCT00587132|11518161|FG003|NOT COMPLETED|Overall Study||0
10377349|NCT00587158|11518173|FG000|STARTED|Overall Study||49
10538765|NCT01457417|11691658|FG004|STARTED|Overall Study||19
10717571|NCT02699593|11881531|FG001|NOT COMPLETED|Period 1||7
10717572|NCT02699593|11881530|FG000|STARTED|Period 2||67
10717573|NCT02699593|11881531|FG001|STARTED|Period 2||62
10717574|NCT02699593|11881530|FG000|COMPLETED|Period 2||65
10717575|NCT02699593|11881531|FG001|COMPLETED|Period 2||60
10717576|NCT02699593|11881530|FG000|NOT COMPLETED|Period 2||2
10717577|NCT02699593|11881531|FG001|NOT COMPLETED|Period 2||2
10777262|NCT03338556|11939216|FG000|COMPLETED|Overall Study||23
10777263|NCT03338556|11939217|FG001|COMPLETED|Overall Study||23
10777264|NCT03338556|11939218|FG002|COMPLETED|Overall Study||22
10777265|NCT03338556|11939219|FG003|COMPLETED|Overall Study||24
10777266|NCT03338556|11939216|FG000|NOT COMPLETED|Overall Study||2
10777267|NCT03338556|11939217|FG001|NOT COMPLETED|Overall Study||4
10777268|NCT03338556|11939218|FG002|NOT COMPLETED|Overall Study||2
10777269|NCT03338556|11939219|FG003|NOT COMPLETED|Overall Study||2
10777270|NCT03338569|11939231|FG000|STARTED|Overall Study||64
10777271|NCT03338569|11939232|FG001|STARTED|Overall Study||61
10777272|NCT03338569|11939231|FG000|COMPLETED|Overall Study||56
10777273|NCT03338569|11939232|FG001|COMPLETED|Overall Study||56
10777274|NCT03338569|11939231|FG000|NOT COMPLETED|Overall Study||8
10777275|NCT03338569|11939232|FG001|NOT COMPLETED|Overall Study||5
10777276|NCT03338673|11939240|FG000|STARTED|Overall Study||6
10777277|NCT03338673|11939241|FG001|STARTED|Overall Study||6
10777278|NCT03338673|11939240|FG000|COMPLETED|Overall Study||5
10777279|NCT03338673|11939241|FG001|COMPLETED|Overall Study||5
10777280|NCT03338673|11939240|FG000|NOT COMPLETED|Overall Study||1
10777281|NCT03338673|11939241|FG001|NOT COMPLETED|Overall Study||1
10777282|NCT03338686|11939250|FG000|STARTED|Overall Study||2
10777283|NCT03338686|11939251|FG001|STARTED|Overall Study||5
10777284|NCT03338686|11939252|FG002|STARTED|Overall Study|12 FGG implant sites and 7 CTG implant sites for this Arm/Group|7
10777285|NCT03338686|11939250|FG000|COMPLETED|Overall Study||2
10777286|NCT03338686|11939251|FG001|COMPLETED|Overall Study||5
10777287|NCT03338686|11939252|FG002|COMPLETED|Overall Study||7
10777288|NCT03338686|11939250|FG000|NOT COMPLETED|Overall Study||0
10777289|NCT03338686|11939251|FG001|NOT COMPLETED|Overall Study||0
10777290|NCT03338686|11939252|FG002|NOT COMPLETED|Overall Study||0
10777291|NCT03338803|11939259|FG000|STARTED|Overall Study||11001
10777292|NCT03338803|11939259|FG000|COMPLETED|Overall Study||11001
10777293|NCT03338803|11939259|FG000|NOT COMPLETED|Overall Study||0
10777294|NCT03338855|11939265|FG000|STARTED|Overall Study||12
10777295|NCT03338855|11939266|FG001|STARTED|Overall Study||14
10777296|NCT03338855|11939265|FG000|Received Treatment in Period 1|Overall Study||12
10777297|NCT03338855|11939266|FG001|Received Treatment in Period 1|Overall Study||14
10777298|NCT03338855|11939265|FG000|Received Treatment in Period 2|Overall Study||11
10777299|NCT03338855|11939266|FG001|Received Treatment in Period 2|Overall Study||14
10377350|NCT00587158|11518174|FG001|STARTED|Overall Study||51
10377351|NCT00587158|11518173|FG000|Continued in Study|Overall Study||45
10377352|NCT00587158|11518174|FG001|Continued in Study|Overall Study||46
10377353|NCT00587158|11518173|FG000|COMPLETED|Overall Study||44
10377354|NCT00587158|11518174|FG001|COMPLETED|Overall Study||43
10377355|NCT00587158|11518173|FG000|NOT COMPLETED|Overall Study||5
10377356|NCT00587158|11518174|FG001|NOT COMPLETED|Overall Study||8
10538766|NCT01457417|11691654|FG000|COMPLETED|Overall Study||3
10538767|NCT01457417|11691655|FG001|COMPLETED|Overall Study||3
10777300|NCT03338855|11939265|FG000|COMPLETED|Overall Study||11
10777301|NCT03338855|11939266|FG001|COMPLETED|Overall Study||14
10777302|NCT03338855|11939265|FG000|NOT COMPLETED|Overall Study||1
10777303|NCT03338855|11939266|FG001|NOT COMPLETED|Overall Study||0
10377357|NCT00587171|11518182|FG000|STARTED|Overall Study||9
10377358|NCT00587171|11518183|FG001|STARTED|Overall Study||10
10377359|NCT00587171|11518182|FG000|COMPLETED|Overall Study||8
10377360|NCT00587171|11518183|FG001|COMPLETED|Overall Study||9
10377361|NCT00587171|11518182|FG000|NOT COMPLETED|Overall Study||1
10377362|NCT00587171|11518183|FG001|NOT COMPLETED|Overall Study||1
10377363|NCT00587288|11518191|FG000|STARTED|Overall Study||53
10377364|NCT00587288|11518192|FG001|STARTED|Overall Study||53
10377365|NCT00587288|11518191|FG000|COMPLETED|Overall Study||50
10377366|NCT00587288|11518192|FG001|COMPLETED|Overall Study||44
10377367|NCT00587288|11518191|FG000|NOT COMPLETED|Overall Study||3
10538768|NCT01457417|11691656|FG002|COMPLETED|Overall Study||4
10538769|NCT01457417|11691657|FG003|COMPLETED|Overall Study||3
10538770|NCT01457417|11691658|FG004|COMPLETED|Overall Study||19
10538771|NCT01457417|11691654|FG000|NOT COMPLETED|Overall Study||0
10538772|NCT01457417|11691655|FG001|NOT COMPLETED|Overall Study||0
10717578|NCT02699632|11881537|FG000|STARTED|Overall Study||360
10717579|NCT02699632|11881537|FG000|COMPLETED|Overall Study||358
10717580|NCT02699632|11881537|FG000|NOT COMPLETED|Overall Study||2
10717581|NCT02699684|11881544|FG000|STARTED|Period 1, First 30 Days of Wear||37
10717582|NCT02699684|11881545|FG001|STARTED|Period 1, First 30 Days of Wear||38
10717583|NCT02699684|11881544|FG000|COMPLETED|Period 1, First 30 Days of Wear||37
10717584|NCT02699684|11881545|FG001|COMPLETED|Period 1, First 30 Days of Wear||38
10717585|NCT02699684|11881544|FG000|NOT COMPLETED|Period 1, First 30 Days of Wear||0
10717586|NCT02699684|11881545|FG001|NOT COMPLETED|Period 1, First 30 Days of Wear||0
10717587|NCT02699684|11881544|FG000|STARTED|Period 2, Second 30 Days of Wear||37
10717588|NCT02699684|11881545|FG001|STARTED|Period 2, Second 30 Days of Wear||38
10717589|NCT02699684|11881544|FG000|COMPLETED|Period 2, Second 30 Days of Wear||36
10717590|NCT02699684|11881545|FG001|COMPLETED|Period 2, Second 30 Days of Wear||38
10717591|NCT02699684|11881544|FG000|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
10717592|NCT02699684|11881545|FG001|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
10717593|NCT02699749|11881566|FG000|STARTED|Overall Study||3
10717594|NCT02699749|11881567|FG001|STARTED|Overall Study||3
10717595|NCT02699749|11881568|FG002|STARTED|Overall Study||16
10717596|NCT02699749|11881569|FG003|STARTED|Overall Study||3
10717597|NCT02699749|11881570|FG004|STARTED|Overall Study||3
10717598|NCT02699749|11881571|FG005|STARTED|Overall Study||9
10717599|NCT02699749|11881572|FG006|STARTED|Overall Study||6
10717600|NCT02699749|11881573|FG007|STARTED|Overall Study||6
10717601|NCT02699749|11881574|FG008|STARTED|Overall Study||6
10717602|NCT02699749|11881575|FG009|STARTED|Overall Study||6
10717603|NCT02699749|11881576|FG010|STARTED|Overall Study||6
10717604|NCT02699749|11881577|FG011|STARTED|Overall Study||4
10377368|NCT00587288|11518192|FG001|NOT COMPLETED|Overall Study||9
10377369|NCT00587431|11518202|FG000|STARTED|Overall Study||63
10538773|NCT01457417|11691656|FG002|NOT COMPLETED|Overall Study||0
10538774|NCT01457417|11691657|FG003|NOT COMPLETED|Overall Study||0
10717605|NCT02699749|11881578|FG012|STARTED|Overall Study||3
10717606|NCT02699749|11881579|FG013|STARTED|Overall Study||6
10717607|NCT02699749|11881566|FG000|COMPLETED|Overall Study||0
10717608|NCT02699749|11881567|FG001|COMPLETED|Overall Study||0
10717609|NCT02699749|11881568|FG002|COMPLETED|Overall Study||0
10377370|NCT00587431|11518203|FG001|STARTED|Overall Study||39
10377371|NCT00587431|11518202|FG000|COMPLETED|Overall Study||62
10377372|NCT00587431|11518203|FG001|COMPLETED|Overall Study||38
10377373|NCT00587431|11518202|FG000|NOT COMPLETED|Overall Study||1
10377374|NCT00587431|11518203|FG001|NOT COMPLETED|Overall Study||1
10377375|NCT00587457|11518215|FG000|STARTED|Overall Study||3
10377376|NCT00587457|11518216|FG001|STARTED|Overall Study||3
10377377|NCT00587457|11518217|FG002|STARTED|Overall Study||5
10377378|NCT00587457|11518215|FG000|COMPLETED|Overall Study||0
10377379|NCT00587457|11518216|FG001|COMPLETED|Overall Study||0
10377380|NCT00587457|11518217|FG002|COMPLETED|Overall Study||0
10377381|NCT00587457|11518215|FG000|NOT COMPLETED|Overall Study||3
10377382|NCT00587457|11518216|FG001|NOT COMPLETED|Overall Study||3
10377383|NCT00587457|11518217|FG002|NOT COMPLETED|Overall Study||5
10377384|NCT00587483|11518228|FG000|STARTED|Overall Study||115
10377385|NCT00587483|11518229|FG001|STARTED|Overall Study||115
10377386|NCT00587483|11518230|FG002|STARTED|Overall Study||112
10377387|NCT00587483|11518228|FG000|COMPLETED|Overall Study||115
10377388|NCT00587483|11518229|FG001|COMPLETED|Overall Study||115
10377389|NCT00587483|11518230|FG002|COMPLETED|Overall Study||112
10377390|NCT00587483|11518228|FG000|NOT COMPLETED|Overall Study||0
10377391|NCT00587483|11518229|FG001|NOT COMPLETED|Overall Study||0
10377392|NCT00587483|11518230|FG002|NOT COMPLETED|Overall Study||0
10377393|NCT00587587|11518240|FG000|STARTED|Overall Study||17
10377394|NCT00587587|11518241|FG001|STARTED|Overall Study||13
10538775|NCT01457417|11691658|FG004|NOT COMPLETED|Overall Study||0
10538776|NCT01457430|11691672|FG000|STARTED|Overall Study||19
10538777|NCT01457430|11691672|FG000|COMPLETED|Overall Study||19
10538778|NCT01457430|11691672|FG000|NOT COMPLETED|Overall Study||0
10538779|NCT01457521|11691679|FG000|STARTED|Overall Study||123
10538780|NCT01457521|11691680|FG001|STARTED|Overall Study||127
10538781|NCT01457521|11691679|FG000|COMPLETED|Overall Study||111
10538782|NCT01457521|11691680|FG001|COMPLETED|Overall Study||117
10538783|NCT01457521|11691679|FG000|NOT COMPLETED|Overall Study||12
10657742|NCT02228395|11818917|FG001|STARTED|First Intervention Period||3
10657743|NCT02228395|11818918|FG002|STARTED|First Intervention Period||3
10657744|NCT02228395|11818916|FG000|COMPLETED|First Intervention Period||2
10538784|NCT01457521|11691680|FG001|NOT COMPLETED|Overall Study||10
10538785|NCT01457573|11691686|FG000|STARTED|Overall Study||10
10538786|NCT01457573|11691686|FG000|COMPLETED|Overall Study||10
10538787|NCT01457573|11691686|FG000|NOT COMPLETED|Overall Study||0
10538788|NCT01457703|11691693|FG000|STARTED|Overall Study||29
10538789|NCT01457703|11691694|FG001|STARTED|Overall Study||33
10538790|NCT01457703|11691693|FG000|COMPLETED|Overall Study||23
10538791|NCT01457703|11691694|FG001|COMPLETED|Overall Study||22
10538792|NCT01457703|11691693|FG000|NOT COMPLETED|Overall Study||6
10538793|NCT01457703|11691694|FG001|NOT COMPLETED|Overall Study||11
10538794|NCT01457846|11691704|FG000|STARTED|Overall Study||41
10538795|NCT01457846|11691705|FG001|STARTED|Overall Study||30
10657745|NCT02228395|11818917|FG001|COMPLETED|First Intervention Period||2
10657746|NCT02228395|11818918|FG002|COMPLETED|First Intervention Period||2
10657747|NCT02228395|11818916|FG000|NOT COMPLETED|First Intervention Period||1
10657748|NCT02228395|11818917|FG001|NOT COMPLETED|First Intervention Period||1
10538796|NCT01457846|11691704|FG000|Received Treatment|Overall Study||40
10538797|NCT01457846|11691705|FG001|Received Treatment|Overall Study||27
10538798|NCT01457846|11691704|FG000|Did Not Receive Treatment|Overall Study||1
10538799|NCT01457846|11691705|FG001|Did Not Receive Treatment|Overall Study||3
10377395|NCT00587587|11518240|FG000|COMPLETED|Overall Study||11
10377396|NCT00587587|11518241|FG001|COMPLETED|Overall Study||12
10377397|NCT00587587|11518240|FG000|NOT COMPLETED|Overall Study||6
10377398|NCT00587587|11518241|FG001|NOT COMPLETED|Overall Study||1
10377399|NCT00587639|11518249|FG000|STARTED|Overall Study||8
10377400|NCT00587639|11518249|FG000|COMPLETED|Overall Study||7
10377401|NCT00587639|11518249|FG000|NOT COMPLETED|Overall Study||1
10377402|NCT00587678|11518256|FG000|STARTED|Overall Study||22
10377403|NCT00587678|11518257|FG001|STARTED|Overall Study||22
10377404|NCT00587678|11518258|FG002|STARTED|Overall Study||41
10377405|NCT00587678|11518256|FG000|COMPLETED|Overall Study||16
10377406|NCT00587678|11518257|FG001|COMPLETED|Overall Study||18
10377407|NCT00587678|11518258|FG002|COMPLETED|Overall Study||33
10377408|NCT00587678|11518256|FG000|NOT COMPLETED|Overall Study||6
10377409|NCT00587678|11518257|FG001|NOT COMPLETED|Overall Study||4
10377410|NCT00587678|11518258|FG002|NOT COMPLETED|Overall Study||8
10377411|NCT00587769|11518266|FG000|STARTED|Overall Study||38
10377412|NCT00587769|11518266|FG000|COMPLETED|Overall Study||38
10377413|NCT00587769|11518266|FG000|NOT COMPLETED|Overall Study||0
10377414|NCT00587834|11518270|FG000|STARTED|Overall Study||96
10377415|NCT00587834|11518270|FG000|COMPLETED|Overall Study||96
10377416|NCT00587834|11518270|FG000|NOT COMPLETED|Overall Study||0
10377417|NCT00587847|11518285|FG000|STARTED|Overall Study||12
10377418|NCT00587847|11518285|FG000|COMPLETED|Overall Study||5
10377419|NCT00587847|11518285|FG000|NOT COMPLETED|Overall Study||7
10427948|NCT00855959|11573900|FG000|STARTED|Overall Study||108
10427949|NCT00855959|11573900|FG000|Patients Who Received Pulmicort Respules|Overall Study||105
10427950|NCT00855959|11573900|FG000|COMPLETED|Overall Study||99
10427951|NCT00855959|11573900|FG000|NOT COMPLETED|Overall Study||9
10427952|NCT00856024|11573904|FG000|STARTED|Overall Study||902
10427953|NCT00856024|11573904|FG000|COMPLETED|Overall Study||902
10306623|NCT00100048|11439503|FG005|STARTED|Cohort I & II-Combination Therapy Phase|4 subjects from the Monotherapy Phase (Placebo)and 35 new subjects|39
10306624|NCT00100048|11439498|FG000|Treated|Cohort I & II-Combination Therapy Phase||39
10306625|NCT00100048|11439499|FG001|Treated|Cohort I & II-Combination Therapy Phase||40
10306626|NCT00100048|11439500|FG002|Treated|Cohort I & II-Combination Therapy Phase||41
10306627|NCT00100048|11439501|FG003|Treated|Cohort I & II-Combination Therapy Phase||40
10306628|NCT00100048|11439502|FG004|Treated|Cohort I & II-Combination Therapy Phase||0
10306629|NCT00100048|11439503|FG005|Treated|Cohort I & II-Combination Therapy Phase||38
10306630|NCT00100048|11439498|FG000|Never Treated|Cohort I & II-Combination Therapy Phase|Randomised in Cohort II did not start Period|2
10306631|NCT00100048|11439499|FG001|Never Treated|Cohort I & II-Combination Therapy Phase||0
10306632|NCT00100048|11439500|FG002|Never Treated|Cohort I & II-Combination Therapy Phase||0
10306633|NCT00100048|11439501|FG003|Never Treated|Cohort I & II-Combination Therapy Phase||0
10306634|NCT00100048|11439502|FG004|Never Treated|Cohort I & II-Combination Therapy Phase||0
10306635|NCT00100048|11439503|FG005|Never Treated|Cohort I & II-Combination Therapy Phase|Randomised in Cohort II did not start Period|1
10306636|NCT00100048|11439498|FG000|COMPLETED|Cohort I & II-Combination Therapy Phase||27
10306637|NCT00100048|11439499|FG001|COMPLETED|Cohort I & II-Combination Therapy Phase||31
10306638|NCT00100048|11439500|FG002|COMPLETED|Cohort I & II-Combination Therapy Phase||28
10306639|NCT00100048|11439501|FG003|COMPLETED|Cohort I & II-Combination Therapy Phase||30
10306640|NCT00100048|11439502|FG004|COMPLETED|Cohort I & II-Combination Therapy Phase||0
10306641|NCT00100048|11439503|FG005|COMPLETED|Cohort I & II-Combination Therapy Phase||26
10306642|NCT00100048|11439498|FG000|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||14
10306643|NCT00100048|11439499|FG001|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||9
10306644|NCT00100048|11439500|FG002|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||13
10306645|NCT00100048|11439501|FG003|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||10
10306646|NCT00100048|11439502|FG004|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||0
10306647|NCT00100048|11439503|FG005|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||13
10306648|NCT00100165|11439531|FG000|STARTED|Baseline||10
10306649|NCT00100165|11439532|FG001|STARTED|Baseline||10
10306650|NCT00100165|11439533|FG002|STARTED|Baseline||9
10306651|NCT00100165|11439531|FG000|COMPLETED|Baseline||10
10306652|NCT00100165|11439532|FG001|COMPLETED|Baseline||10
10306653|NCT00100165|11439533|FG002|COMPLETED|Baseline||9
10306654|NCT00100165|11439531|FG000|NOT COMPLETED|Baseline||0
10306655|NCT00100165|11439532|FG001|NOT COMPLETED|Baseline||0
10306656|NCT00100165|11439533|FG002|NOT COMPLETED|Baseline||0
10306657|NCT00100165|11439531|FG000|STARTED|First Intervention (4 Weeks)||10
10306658|NCT00100165|11439532|FG001|STARTED|First Intervention (4 Weeks)||10
10306659|NCT00100165|11439533|FG002|STARTED|First Intervention (4 Weeks)||9
10306660|NCT00100165|11439531|FG000|COMPLETED|First Intervention (4 Weeks)||10
10427954|NCT00856024|11573904|FG000|NOT COMPLETED|Overall Study||0
10427955|NCT00856050|11573910|FG000|STARTED|Overall Study||26
10427956|NCT00856050|11573910|FG000|COMPLETED|Overall Study||26
10427957|NCT00856050|11573910|FG000|NOT COMPLETED|Overall Study||0
10427958|NCT00856180|11573914|FG000|STARTED|Overall Study||20
10427959|NCT00856180|11573914|FG000|COMPLETED|Overall Study||0
10427960|NCT00856180|11573914|FG000|NOT COMPLETED|Overall Study||20
10427961|NCT00856193|11573920|FG000|STARTED|Period 1||16
10427962|NCT00856193|11573921|FG001|STARTED|Period 1||17
10377420|NCT04545008|11518290|FG000|STARTED|Overall Study||2
10377421|NCT04545008|11518290|FG000|COMPLETED|Overall Study||2
10377422|NCT04545008|11518290|FG000|NOT COMPLETED|Overall Study||0
10377423|NCT04411680|11518296|FG000|STARTED|Treatment Period||78
10377424|NCT04411680|11518297|FG001|STARTED|Treatment Period||44
10377425|NCT04411680|11518296|FG000|COMPLETED|Treatment Period||49
10377426|NCT04411680|11518297|FG001|COMPLETED|Treatment Period||36
10377427|NCT04411680|11518296|FG000|NOT COMPLETED|Treatment Period||29
10377428|NCT04411680|11518297|FG001|NOT COMPLETED|Treatment Period||8
10377429|NCT04411680|11518296|FG000|STARTED|Follow up Period||78
10377430|NCT04411680|11518297|FG001|STARTED|Follow up Period||44
10377431|NCT04411680|11518296|FG000|COMPLETED|Follow up Period||60
10377432|NCT04411680|11518297|FG001|COMPLETED|Follow up Period||30
10377433|NCT04411680|11518296|FG000|NOT COMPLETED|Follow up Period||18
10377434|NCT04411680|11518297|FG001|NOT COMPLETED|Follow up Period||14
10377435|NCT04364984|11518306|FG000|STARTED|Overall Study||37
10377436|NCT04364984|11518307|FG001|STARTED|Overall Study||44
10377437|NCT04364984|11518308|FG002|STARTED|Overall Study||31
10377438|NCT04364984|11518306|FG000|COMPLETED|Overall Study||35
10377439|NCT04364984|11518307|FG001|COMPLETED|Overall Study||42
10377440|NCT04364984|11518308|FG002|COMPLETED|Overall Study||31
10377441|NCT04364984|11518306|FG000|NOT COMPLETED|Overall Study||2
10377442|NCT04364984|11518307|FG001|NOT COMPLETED|Overall Study||2
10377443|NCT04364984|11518308|FG002|NOT COMPLETED|Overall Study||0
10377444|NCT04363437|11518318|FG000|STARTED|Overall Study||10
10377445|NCT04363437|11518319|FG001|STARTED|Overall Study||11
10377446|NCT04363437|11518318|FG000|COMPLETED|Overall Study||10
10377447|NCT04363437|11518319|FG001|COMPLETED|Overall Study||11
10377448|NCT04363437|11518318|FG000|NOT COMPLETED|Overall Study||0
10377449|NCT04363437|11518319|FG001|NOT COMPLETED|Overall Study||0
10427963|NCT00856193|11573920|FG000|COMPLETED|Period 1||16
10427964|NCT00856193|11573921|FG001|COMPLETED|Period 1||17
10427965|NCT00856193|11573920|FG000|NOT COMPLETED|Period 1||0
10427966|NCT00856193|11573921|FG001|NOT COMPLETED|Period 1||0
10657749|NCT02228395|11818918|FG002|NOT COMPLETED|First Intervention Period||1
10812677|NCT03382925|11974816|FG001|STARTED|Overall Study||6
10812678|NCT03382925|11974815|FG000|COMPLETED|Overall Study||10
10812679|NCT03382925|11974816|FG001|COMPLETED|Overall Study||6
10812680|NCT03382925|11974815|FG000|NOT COMPLETED|Overall Study||0
10812681|NCT03382925|11974816|FG001|NOT COMPLETED|Overall Study||0
10812682|NCT03379233|11974824|FG000|STARTED|Overall Study||1
10427967|NCT00856193|11573920|FG000|STARTED|Period 2||16
10427968|NCT00856193|11573921|FG001|STARTED|Period 2||17
10427969|NCT00856193|11573920|FG000|COMPLETED|Period 2||16
10427970|NCT00856193|11573921|FG001|COMPLETED|Period 2||15
10427971|NCT00856193|11573920|FG000|NOT COMPLETED|Period 2||0
10427972|NCT00856193|11573921|FG001|NOT COMPLETED|Period 2||2
10427973|NCT00856206|11573929|FG000|STARTED|Overall Study||330
10427974|NCT00856206|11573930|FG001|STARTED|Overall Study||985
10717610|NCT02699749|11881569|FG003|COMPLETED|Overall Study||0
10538800|NCT01457846|11691704|FG000|Ongoing Treatment at Data Cut-off|Overall Study||1
10538801|NCT01457846|11691705|FG001|Ongoing Treatment at Data Cut-off|Overall Study||1
10538802|NCT01457846|11691704|FG000|COMPLETED|Overall Study||0
10538803|NCT01457846|11691705|FG001|COMPLETED|Overall Study||0
10538804|NCT01457846|11691704|FG000|NOT COMPLETED|Overall Study||41
10538805|NCT01457846|11691705|FG001|NOT COMPLETED|Overall Study||30
10538806|NCT01457885|11691711|FG000|STARTED|Overall Study||74
10538807|NCT01457885|11691711|FG000|COMPLETED|Overall Study||74
10538808|NCT01457885|11691711|FG000|NOT COMPLETED|Overall Study||0
10538809|NCT01457924|11691720|FG000|STARTED|Treatment Phase (Weeks 0-24)||67
10538810|NCT01457924|11691721|FG001|STARTED|Treatment Phase (Weeks 0-24)||34
10538811|NCT01457924|11691722|FG002|STARTED|Treatment Phase (Weeks 0-24)||32
10538812|NCT01457924|11691723|FG003|STARTED|Treatment Phase (Weeks 0-24)||34
10538813|NCT01457924|11691724|FG004|STARTED|Treatment Phase (Weeks 0-24)||64
10538814|NCT01457924|11691720|FG000|Completed to Week 12|Treatment Phase (Weeks 0-24)||65
10377454|NCT04033991|11518329|FG000|STARTED|Overall Study||684
10538815|NCT01457924|11691721|FG001|Completed to Week 12|Treatment Phase (Weeks 0-24)||31
10538816|NCT01457924|11691722|FG002|Completed to Week 12|Treatment Phase (Weeks 0-24)||30
10538817|NCT01457924|11691723|FG003|Completed to Week 12|Treatment Phase (Weeks 0-24)||33
10548079|NCT01516970|11701875|FG000|COMPLETED|Overall Study||141
10377455|NCT04033991|11518329|FG000|Participants Who Took First-line Sunitinib Therapy|Overall Study||622
10377456|NCT04033991|11518329|FG000|Participants Who Took Second-line Axitinib Therapy|Overall Study||121
10377457|NCT04033991|11518329|FG000|Participants Who Took First-line Sunitinib Therapy and Then Second-line Axitinib Therapy|Overall Study||59
10306662|NCT00100165|11439533|FG002|COMPLETED|First Intervention (4 Weeks)||9
10377458|NCT04033991|11518329|FG000|Participants Who Took Drugs Other Than Sunitinib as First-line and Then Second-line Axitinib Therapy|Overall Study||62
10377459|NCT04033991|11518329|FG000|COMPLETED|Overall Study||684
10377460|NCT04033991|11518329|FG000|NOT COMPLETED|Overall Study||0
10377461|NCT03930849|11518338|FG000|STARTED|Overall Study||17
10377462|NCT03930849|11518339|FG001|STARTED|Overall Study||18
10377463|NCT03930849|11518340|FG002|STARTED|Overall Study||18
10538818|NCT01457924|11691724|FG004|Completed to Week 12|Treatment Phase (Weeks 0-24)||60
10538819|NCT01457924|11691720|FG000|COMPLETED|Treatment Phase (Weeks 0-24)||64
10717611|NCT02699749|11881570|FG004|COMPLETED|Overall Study||0
10717612|NCT02699749|11881571|FG005|COMPLETED|Overall Study||0
10717613|NCT02699749|11881572|FG006|COMPLETED|Overall Study||0
10717614|NCT02699749|11881573|FG007|COMPLETED|Overall Study||0
10717615|NCT02699749|11881574|FG008|COMPLETED|Overall Study||0
10717616|NCT02699749|11881575|FG009|COMPLETED|Overall Study||0
10717617|NCT02699749|11881576|FG010|COMPLETED|Overall Study||0
10717618|NCT02699749|11881577|FG011|COMPLETED|Overall Study||0
10538820|NCT01457924|11691721|FG001|COMPLETED|Treatment Phase (Weeks 0-24)||29
10538821|NCT01457924|11691722|FG002|COMPLETED|Treatment Phase (Weeks 0-24)||30
10717619|NCT02699749|11881578|FG012|COMPLETED|Overall Study||0
10717620|NCT02699749|11881579|FG013|COMPLETED|Overall Study||0
10717621|NCT02699749|11881566|FG000|NOT COMPLETED|Overall Study||3
10717622|NCT02699749|11881567|FG001|NOT COMPLETED|Overall Study||3
10538822|NCT01457924|11691723|FG003|COMPLETED|Treatment Phase (Weeks 0-24)||33
10538823|NCT01457924|11691724|FG004|COMPLETED|Treatment Phase (Weeks 0-24)||58
10538824|NCT01457924|11691720|FG000|NOT COMPLETED|Treatment Phase (Weeks 0-24)||3
10538825|NCT01457924|11691721|FG001|NOT COMPLETED|Treatment Phase (Weeks 0-24)||5
10538826|NCT01457924|11691722|FG002|NOT COMPLETED|Treatment Phase (Weeks 0-24)||2
10538827|NCT01457924|11691723|FG003|NOT COMPLETED|Treatment Phase (Weeks 0-24)||1
10717623|NCT02699749|11881568|FG002|NOT COMPLETED|Overall Study||16
10717624|NCT02699749|11881569|FG003|NOT COMPLETED|Overall Study||3
10377464|NCT03930849|11518338|FG000|COMPLETED|Overall Study||13
10377465|NCT03930849|11518339|FG001|COMPLETED|Overall Study||18
10377466|NCT03930849|11518340|FG002|COMPLETED|Overall Study||14
10377467|NCT03930849|11518338|FG000|NOT COMPLETED|Overall Study||4
10377468|NCT03930849|11518339|FG001|NOT COMPLETED|Overall Study||0
10377469|NCT03930849|11518340|FG002|NOT COMPLETED|Overall Study||4
10377470|NCT03793439|11518348|FG000|STARTED|Overall Study||5
10377471|NCT03793439|11518348|FG000|COMPLETED|Overall Study||3
10377472|NCT03793439|11518348|FG000|NOT COMPLETED|Overall Study||2
10377473|NCT03711266|11518352|FG000|STARTED|Overall Study||30
10377474|NCT03711266|11518352|FG000|COMPLETED|Overall Study||20
10377475|NCT03711266|11518352|FG000|NOT COMPLETED|Overall Study||10
10377476|NCT03630393|11518358|FG000|STARTED|Overall Study||68
10377477|NCT03630393|11518359|FG001|STARTED|Overall Study||71
10377478|NCT03630393|11518358|FG000|COMPLETED|Overall Study||67
10377479|NCT03630393|11518359|FG001|COMPLETED|Overall Study||71
10377480|NCT03630393|11518358|FG000|NOT COMPLETED|Overall Study||1
10377481|NCT03630393|11518359|FG001|NOT COMPLETED|Overall Study||0
10377482|NCT03531788|11518367|FG000|STARTED|Overall Study||12
10377483|NCT03531788|11518368|FG001|STARTED|Overall Study||6
10377484|NCT03531788|11518367|FG000|COMPLETED|Overall Study||11
10377485|NCT03531788|11518368|FG001|COMPLETED|Overall Study||6
10377486|NCT03531788|11518367|FG000|NOT COMPLETED|Overall Study||1
10377487|NCT03531788|11518368|FG001|NOT COMPLETED|Overall Study||0
10377488|NCT03359811|11518376|FG000|STARTED|Overall Study||35
10377489|NCT03359811|11518377|FG001|STARTED|Overall Study||35
10377490|NCT03359811|11518376|FG000|COMPLETED|Overall Study||33
10377491|NCT03359811|11518377|FG001|COMPLETED|Overall Study||35
10377492|NCT03359811|11518376|FG000|NOT COMPLETED|Overall Study||2
10377493|NCT03359811|11518377|FG001|NOT COMPLETED|Overall Study||0
10427975|NCT00856206|11573929|FG000|COMPLETED|Overall Study||276
10427976|NCT00856206|11573930|FG001|COMPLETED|Overall Study||824
10427977|NCT00856206|11573929|FG000|NOT COMPLETED|Overall Study||54
10427978|NCT00856206|11573930|FG001|NOT COMPLETED|Overall Study||161
10427979|NCT00856232|11573939|FG000|STARTED|Overall Study||26
10427980|NCT00856232|11573940|FG001|STARTED|Overall Study||29
10427981|NCT00856232|11573941|FG002|STARTED|Overall Study||36
10427982|NCT00856232|11573939|FG000|COMPLETED|Overall Study||26
10427983|NCT00856232|11573940|FG001|COMPLETED|Overall Study||29
10427984|NCT00856232|11573941|FG002|COMPLETED|Overall Study||36
10427985|NCT00856232|11573939|FG000|NOT COMPLETED|Overall Study||0
10427986|NCT00856232|11573940|FG001|NOT COMPLETED|Overall Study||0
10427987|NCT00856232|11573941|FG002|NOT COMPLETED|Overall Study||0
10538828|NCT01457924|11691724|FG004|NOT COMPLETED|Treatment Phase (Weeks 0-24)||6
10538829|NCT01457924|11691720|FG000|STARTED|FUP (Weeks 24-48)||66
10717625|NCT02699749|11881570|FG004|NOT COMPLETED|Overall Study||3
10717626|NCT02699749|11881571|FG005|NOT COMPLETED|Overall Study||9
10717627|NCT02699749|11881572|FG006|NOT COMPLETED|Overall Study||6
10717628|NCT02699749|11881573|FG007|NOT COMPLETED|Overall Study||6
10717629|NCT02699749|11881574|FG008|NOT COMPLETED|Overall Study||6
10717630|NCT02699749|11881575|FG009|NOT COMPLETED|Overall Study||6
10717631|NCT02699749|11881576|FG010|NOT COMPLETED|Overall Study||6
10717632|NCT02699749|11881577|FG011|NOT COMPLETED|Overall Study||4
10717633|NCT02699749|11881578|FG012|NOT COMPLETED|Overall Study||3
10717634|NCT02699749|11881579|FG013|NOT COMPLETED|Overall Study||6
10717635|NCT02699866|11881609|FG000|STARTED|Overall Study|First study centre initiation.|46
10717636|NCT02699866|11881609|FG000|Included|Overall Study||41
10717637|NCT02699866|11881609|FG000|COMPLETED|Overall Study|Last study centre close-out.|38
10306661|NCT00100165|11439532|FG001|COMPLETED|First Intervention (4 Weeks)||10
10306663|NCT00100165|11439531|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
10306664|NCT00100165|11439532|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
10306665|NCT00100165|11439533|FG002|NOT COMPLETED|First Intervention (4 Weeks)||0
10306666|NCT00100165|11439531|FG000|STARTED|Washout (1 Week)||10
10306667|NCT00100165|11439532|FG001|STARTED|Washout (1 Week)||10
10306668|NCT00100165|11439533|FG002|STARTED|Washout (1 Week)||9
10306669|NCT00100165|11439531|FG000|COMPLETED|Washout (1 Week)||10
10306670|NCT00100165|11439532|FG001|COMPLETED|Washout (1 Week)||10
10306671|NCT00100165|11439533|FG002|COMPLETED|Washout (1 Week)||9
10306672|NCT00100165|11439531|FG000|NOT COMPLETED|Washout (1 Week)||0
10306673|NCT00100165|11439532|FG001|NOT COMPLETED|Washout (1 Week)||0
10306674|NCT00100165|11439533|FG002|NOT COMPLETED|Washout (1 Week)||0
10306675|NCT00100165|11439531|FG000|STARTED|Second Intervention (4 Weeks)||10
10306676|NCT00100165|11439532|FG001|STARTED|Second Intervention (4 Weeks)||10
10306677|NCT00100165|11439533|FG002|STARTED|Second Intervention (4 Weeks)||9
10306678|NCT00100165|11439531|FG000|COMPLETED|Second Intervention (4 Weeks)||10
10306679|NCT00100165|11439532|FG001|COMPLETED|Second Intervention (4 Weeks)||10
10306680|NCT00100165|11439533|FG002|COMPLETED|Second Intervention (4 Weeks)||9
10306681|NCT00100165|11439531|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
10306682|NCT00100165|11439532|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
10306683|NCT00100165|11439533|FG002|NOT COMPLETED|Second Intervention (4 Weeks)||0
10306684|NCT00100165|11439531|FG000|STARTED|Washout (1 Week)||10
10306685|NCT00100165|11439532|FG001|STARTED|Washout (1 Week)||10
10306686|NCT00100165|11439533|FG002|STARTED|Washout (1 Week)||9
10306687|NCT00100165|11439531|FG000|COMPLETED|Washout (1 Week)||10
10306688|NCT00100165|11439532|FG001|COMPLETED|Washout (1 Week)||10
10306689|NCT00100165|11439533|FG002|COMPLETED|Washout (1 Week)||9
10306690|NCT00100165|11439531|FG000|NOT COMPLETED|Washout (1 Week)||0
10306691|NCT00100165|11439532|FG001|NOT COMPLETED|Washout (1 Week)||0
10306692|NCT00100165|11439533|FG002|NOT COMPLETED|Washout (1 Week)||0
10306693|NCT00100165|11439531|FG000|STARTED|Third Intervention (4 Weeks)||10
10306694|NCT00100165|11439532|FG001|STARTED|Third Intervention (4 Weeks)||10
10306695|NCT00100165|11439533|FG002|STARTED|Third Intervention (4 Weeks)||9
10306696|NCT00100165|11439531|FG000|COMPLETED|Third Intervention (4 Weeks)||10
10306697|NCT00100165|11439532|FG001|COMPLETED|Third Intervention (4 Weeks)||10
10306698|NCT00100165|11439533|FG002|COMPLETED|Third Intervention (4 Weeks)||9
10306699|NCT00100165|11439531|FG000|NOT COMPLETED|Third Intervention (4 Weeks)||0
10306700|NCT00100165|11439532|FG001|NOT COMPLETED|Third Intervention (4 Weeks)||0
10306701|NCT00100165|11439533|FG002|NOT COMPLETED|Third Intervention (4 Weeks)||0
10306702|NCT00100178|11439547|FG000|STARTED|Overall Study||41
10306703|NCT00100178|11439548|FG001|STARTED|Overall Study|12 subjects randomized to the MMF alone group were excluded from analysis due to randomization error|31
10306704|NCT00100178|11439549|FG002|STARTED|Overall Study||42
10306705|NCT00100178|11439547|FG000|COMPLETED|Overall Study||32
10377494|NCT03241589|11518386|FG000|STARTED|Overall Study||109
10377495|NCT03241589|11518387|FG001|STARTED|Overall Study||357
10377496|NCT03241589|11518386|FG000|COMPLETED|Overall Study||109
10377497|NCT03241589|11518387|FG001|COMPLETED|Overall Study||357
10717638|NCT02699866|11881609|FG000|NOT COMPLETED|Overall Study||8
10306706|NCT00100178|11439548|FG001|COMPLETED|Overall Study||21
10306707|NCT00100178|11439549|FG002|COMPLETED|Overall Study||32
10306708|NCT00100178|11439547|FG000|NOT COMPLETED|Overall Study||9
10306709|NCT00100178|11439548|FG001|NOT COMPLETED|Overall Study||10
10306710|NCT00100178|11439549|FG002|NOT COMPLETED|Overall Study||10
10306711|NCT00100230|11439559|FG000|STARTED|Overall Study||41
10306712|NCT00100230|11439560|FG001|STARTED|Overall Study||37
10306713|NCT00100230|11439559|FG000|COMPLETED|Overall Study||29
10306714|NCT00100230|11439560|FG001|COMPLETED|Overall Study||22
10306715|NCT00100230|11439559|FG000|NOT COMPLETED|Overall Study||12
10306716|NCT00100230|11439560|FG001|NOT COMPLETED|Overall Study||15
10306717|NCT00100659|11439570|FG000|STARTED|Overall Study||55
10306718|NCT00100659|11439571|FG001|STARTED|Overall Study||59
10306719|NCT00100659|11439570|FG000|COMPLETED|Overall Study||52
10306720|NCT00100659|11439571|FG001|COMPLETED|Overall Study||57
10306721|NCT00100659|11439570|FG000|NOT COMPLETED|Overall Study||3
10306722|NCT00100659|11439571|FG001|NOT COMPLETED|Overall Study||2
10306723|NCT00100698|11439581|FG000|STARTED|Overall Study||27
10306724|NCT00100698|11439582|FG001|STARTED|Overall Study||29
10306725|NCT00100698|11439581|FG000|COMPLETED|Overall Study||21
10306726|NCT00100698|11439582|FG001|COMPLETED|Overall Study||27
10306727|NCT00100698|11439581|FG000|NOT COMPLETED|Overall Study||6
10306728|NCT00100698|11439582|FG001|NOT COMPLETED|Overall Study||2
10306729|NCT00100789|11439588|FG000|STARTED|Overall Study||67
10306730|NCT00100789|11439588|FG000|Eligible|Overall Study||64
10306731|NCT00100789|11439588|FG000|Eligible and Began Protocol Therapy|Overall Study||63
10306732|NCT00100789|11439588|FG000|COMPLETED|Overall Study||3
10306733|NCT00100789|11439588|FG000|NOT COMPLETED|Overall Study||64
10306734|NCT00100802|11439593|FG000|STARTED|Overall Study||118
10306735|NCT00100802|11439593|FG000|COMPLETED|Overall Study||38
10306736|NCT00100802|11439593|FG000|NOT COMPLETED|Overall Study||80
10306737|NCT00100815|11439597|FG000|STARTED|Overall Study||50
10306738|NCT00100815|11439597|FG000|COMPLETED|Overall Study||1
10306739|NCT00100815|11439597|FG000|NOT COMPLETED|Overall Study||49
10306740|NCT00100841|11439601|FG000|STARTED|Overall Study||66
10306741|NCT00100841|11439601|FG000|COMPLETED|Overall Study||66
10306742|NCT00100841|11439601|FG000|NOT COMPLETED|Overall Study||0
10306743|NCT00100932|11439607|FG000|STARTED|Overall Study|Represents all enrolled pts; counts in demographic section represents ITT/Safety Population.|78
10377525|NCT02954406|11518424|FG005|COMPLETED|Overall Study||0
10306744|NCT00100932|11439608|FG001|STARTED|Overall Study|Represents all enrolled pts; counts in demographic section represents ITT/Safety Population.|28
10306745|NCT00100932|11439607|FG000|COMPLETED|Overall Study||5
10306746|NCT00100932|11439608|FG001|COMPLETED|Overall Study||1
10306747|NCT00100932|11439607|FG000|NOT COMPLETED|Overall Study||73
10377498|NCT03241589|11518386|FG000|NOT COMPLETED|Overall Study||0
10377499|NCT03241589|11518387|FG001|NOT COMPLETED|Overall Study||0
10377500|NCT02959775|11518398|FG000|STARTED|Overall Study||160
10377501|NCT02959775|11518399|FG001|STARTED|Overall Study||160
10377502|NCT02959775|11518400|FG002|STARTED|Overall Study||160
10377503|NCT02959775|11518398|FG000|COMPLETED|Overall Study||133
10377504|NCT02959775|11518399|FG001|COMPLETED|Overall Study||133
10377505|NCT02959775|11518400|FG002|COMPLETED|Overall Study||124
10377506|NCT02959775|11518398|FG000|NOT COMPLETED|Overall Study||27
10377507|NCT02959775|11518399|FG001|NOT COMPLETED|Overall Study||27
10377508|NCT02959775|11518400|FG002|NOT COMPLETED|Overall Study||36
10377509|NCT02954406|11518419|FG000|STARTED|Overall Study||3
10377510|NCT02954406|11518420|FG001|STARTED|Overall Study||6
10377511|NCT02954406|11518421|FG002|STARTED|Overall Study||6
10377512|NCT02954406|11518422|FG003|STARTED|Overall Study||6
10377513|NCT02954406|11518423|FG004|STARTED|Overall Study||7
10377514|NCT02954406|11518424|FG005|STARTED|Overall Study||3
10377515|NCT02954406|11518425|FG006|STARTED|Overall Study||3
10377516|NCT02954406|11518426|FG007|STARTED|Overall Study||2
10377517|NCT02954406|11518427|FG008|STARTED|Overall Study||4
10717639|NCT02699892|11881613|FG000|STARTED|Overall Study||130
10377518|NCT02954406|11518428|FG009|STARTED|Overall Study||3
10717640|NCT02699892|11881613|FG000|COMPLETED|Overall Study||94
10377519|NCT02954406|11518429|FG010|STARTED|Overall Study||0
10377520|NCT02954406|11518419|FG000|COMPLETED|Overall Study||0
10377521|NCT02954406|11518420|FG001|COMPLETED|Overall Study||0
10306748|NCT00100932|11439608|FG001|NOT COMPLETED|Overall Study||27
10306749|NCT00101010|11439614|FG000|STARTED|Overall Study||80
10306750|NCT00101010|11439614|FG000|COMPLETED|Overall Study||79
10306751|NCT00101010|11439614|FG000|NOT COMPLETED|Overall Study||1
10306752|NCT00101036|11439620|FG000|STARTED|Overall Study||17
10306753|NCT00101036|11439621|FG001|STARTED|Overall Study||40
10377522|NCT02954406|11518421|FG002|COMPLETED|Overall Study||0
10377523|NCT02954406|11518422|FG003|COMPLETED|Overall Study||0
10377524|NCT02954406|11518423|FG004|COMPLETED|Overall Study||0
10306754|NCT00101036|11439620|FG000|COMPLETED|Overall Study||17
10306755|NCT00101036|11439621|FG001|COMPLETED|Overall Study||40
10306756|NCT00101036|11439620|FG000|NOT COMPLETED|Overall Study||0
10306757|NCT00101036|11439621|FG001|NOT COMPLETED|Overall Study||0
10306761|NCT00101166|11439631|FG000|STARTED|Overall Study||28
10306762|NCT00101166|11439631|FG000|COMPLETED|Overall Study||18
10306763|NCT00101166|11439631|FG000|NOT COMPLETED|Overall Study||10
10306764|NCT00101192|11439635|FG000|STARTED|Overall Study||76
10306765|NCT00101192|11439635|FG000|COMPLETED|Overall Study||69
10306766|NCT00101192|11439635|FG000|NOT COMPLETED|Overall Study||7
10306767|NCT00101283|11439641|FG000|STARTED|Overall Study||16
10306768|NCT00101283|11439642|FG001|STARTED|Overall Study||16
10306769|NCT00101283|11439641|FG000|Began Treatment|Overall Study||16
10306770|NCT00101283|11439642|FG001|Began Treatment|Overall Study||13
10306771|NCT00101283|11439641|FG000|COMPLETED|Overall Study||16
10306772|NCT00101283|11439642|FG001|COMPLETED|Overall Study||13
10306773|NCT00101283|11439641|FG000|NOT COMPLETED|Overall Study||0
10306774|NCT00101283|11439642|FG001|NOT COMPLETED|Overall Study||3
10306775|NCT00101361|11439650|FG000|STARTED|Overall Study||108
10306776|NCT00101361|11439651|FG001|STARTED|Overall Study||104
10306777|NCT00101361|11439650|FG000|COMPLETED|Overall Study||108
10306778|NCT00101361|11439651|FG001|COMPLETED|Overall Study||104
10306779|NCT00101361|11439650|FG000|NOT COMPLETED|Overall Study||0
10306780|NCT00101361|11439651|FG001|NOT COMPLETED|Overall Study||0
10306781|NCT00101400|11439657|FG000|STARTED|Treatment|Treated until disease progression, unacceptable sorafenib-related toxicity or withdrawal of consent.|54
10306782|NCT00101400|11439657|FG000|COMPLETED|Treatment|Reasons for treatment termination: 4 Adverse Events, 3 Deaths, 46 Progression, 1 Withdrawal.|54
10306783|NCT00101400|11439657|FG000|NOT COMPLETED|Treatment||0
10306784|NCT00101400|11439657|FG000|STARTED|Survival Follow-Up|3 subjects died during previous period (completion as defined in protocol)|51
10306785|NCT00101400|11439657|FG000|COMPLETED|Survival Follow-Up|44 subjects reached endpoint (death); 7 subjects were still alive|44
10306786|NCT00101400|11439657|FG000|NOT COMPLETED|Survival Follow-Up||7
10306787|NCT00101413|11439661|FG000|STARTED|Overall Study||52
10306788|NCT00101413|11439661|FG000|COMPLETED|Overall Study|Safety data collected for 4 subjects after 30 Jun 2005 until 11 Apr 2008.|52
10306789|NCT00101413|11439661|FG000|NOT COMPLETED|Overall Study||0
10306790|NCT00101452|11439668|FG000|STARTED|Overall Study||65
10306791|NCT00101452|11439669|FG001|STARTED|Overall Study||69
10306792|NCT00101452|11439670|FG002|STARTED|Overall Study||65
10306793|NCT00101452|11439668|FG000|COMPLETED|Overall Study||21
10306794|NCT00101452|11439669|FG001|COMPLETED|Overall Study||26
10306795|NCT00101452|11439670|FG002|COMPLETED|Overall Study||22
10306796|NCT00101452|11439668|FG000|NOT COMPLETED|Overall Study||44
10306797|NCT00101452|11439669|FG001|NOT COMPLETED|Overall Study||43
10306798|NCT00101452|11439670|FG002|NOT COMPLETED|Overall Study||43
10306799|NCT00101582|11439684|FG000|STARTED|Overall Study||94
10306800|NCT00101582|11439685|FG001|STARTED|Overall Study||94
10306801|NCT00101582|11439684|FG000|Received Study Drug|Overall Study||91
10306802|NCT00101582|11439685|FG001|Received Study Drug|Overall Study||94
10377526|NCT02954406|11518425|FG006|COMPLETED|Overall Study||0
10377527|NCT02954406|11518426|FG007|COMPLETED|Overall Study||0
10377528|NCT02954406|11518427|FG008|COMPLETED|Overall Study||0
10377529|NCT02954406|11518428|FG009|COMPLETED|Overall Study||0
10377530|NCT02954406|11518429|FG010|COMPLETED|Overall Study||0
10377531|NCT02954406|11518419|FG000|NOT COMPLETED|Overall Study||3
10377532|NCT02954406|11518420|FG001|NOT COMPLETED|Overall Study||6
10377533|NCT02954406|11518421|FG002|NOT COMPLETED|Overall Study||6
10377534|NCT02954406|11518422|FG003|NOT COMPLETED|Overall Study||6
10377535|NCT02954406|11518423|FG004|NOT COMPLETED|Overall Study||7
10377536|NCT02954406|11518424|FG005|NOT COMPLETED|Overall Study||3
10377537|NCT02954406|11518425|FG006|NOT COMPLETED|Overall Study||3
10377538|NCT02954406|11518426|FG007|NOT COMPLETED|Overall Study||2
10377539|NCT02954406|11518427|FG008|NOT COMPLETED|Overall Study||4
10377540|NCT02954406|11518428|FG009|NOT COMPLETED|Overall Study||3
10377541|NCT02954406|11518429|FG010|NOT COMPLETED|Overall Study||0
10377542|NCT02927145|11518464|FG000|STARTED|Initial Recruitment||12
10377543|NCT02927145|11518465|FG001|STARTED|Initial Recruitment||12
10377544|NCT02927145|11518466|FG002|STARTED|Initial Recruitment||12
10377545|NCT02927145|11518467|FG003|STARTED|Initial Recruitment||14
10377546|NCT02927145|11518468|FG004|STARTED|Initial Recruitment||17
10377547|NCT02927145|11518469|FG005|STARTED|Initial Recruitment||15
10377548|NCT02927145|11518470|FG006|STARTED|Initial Recruitment||0
10377549|NCT02927145|11518471|FG007|STARTED|Initial Recruitment||0
10377550|NCT02927145|11518472|FG008|STARTED|Initial Recruitment||6
10377551|NCT02927145|11518464|FG000|COMPLETED|Initial Recruitment||12
10377552|NCT02927145|11518465|FG001|COMPLETED|Initial Recruitment||11
10377553|NCT02927145|11518466|FG002|COMPLETED|Initial Recruitment||11
10377554|NCT02927145|11518467|FG003|COMPLETED|Initial Recruitment||10
10377555|NCT02927145|11518468|FG004|COMPLETED|Initial Recruitment||14
10377556|NCT02927145|11518469|FG005|COMPLETED|Initial Recruitment||14
10377557|NCT02927145|11518470|FG006|COMPLETED|Initial Recruitment||0
10377558|NCT02927145|11518471|FG007|COMPLETED|Initial Recruitment||0
10377559|NCT02927145|11518472|FG008|COMPLETED|Initial Recruitment||4
10377560|NCT02927145|11518464|FG000|NOT COMPLETED|Initial Recruitment||0
10377561|NCT02927145|11518465|FG001|NOT COMPLETED|Initial Recruitment||1
10377562|NCT02927145|11518466|FG002|NOT COMPLETED|Initial Recruitment||1
10377563|NCT02927145|11518467|FG003|NOT COMPLETED|Initial Recruitment||4
10377564|NCT02927145|11518468|FG004|NOT COMPLETED|Initial Recruitment||3
10377565|NCT02927145|11518469|FG005|NOT COMPLETED|Initial Recruitment||1
10377566|NCT02927145|11518470|FG006|NOT COMPLETED|Initial Recruitment||0
10377567|NCT02927145|11518471|FG007|NOT COMPLETED|Initial Recruitment||0
10377568|NCT02927145|11518472|FG008|NOT COMPLETED|Initial Recruitment||2
10377569|NCT02927145|11518464|FG000|STARTED|Invitation for Additional Challenge||0
10377570|NCT02927145|11518465|FG001|STARTED|Invitation for Additional Challenge||0
10377571|NCT02927145|11518466|FG002|STARTED|Invitation for Additional Challenge||0
10377572|NCT02927145|11518467|FG003|STARTED|Invitation for Additional Challenge||0
10377573|NCT02927145|11518468|FG004|STARTED|Invitation for Additional Challenge||0
10377574|NCT02927145|11518469|FG005|STARTED|Invitation for Additional Challenge||0
10377575|NCT02927145|11518470|FG006|STARTED|Invitation for Additional Challenge||9
10657750|NCT02228395|11818916|FG000|STARTED|Washout Period (at Least 10 Days)|One participant discontinued in the First Intervention Period and was replaced.|3
10377576|NCT02927145|11518471|FG007|STARTED|Invitation for Additional Challenge||8
10377577|NCT02927145|11518472|FG008|STARTED|Invitation for Additional Challenge||0
10377578|NCT02927145|11518464|FG000|COMPLETED|Invitation for Additional Challenge||0
10377579|NCT02927145|11518465|FG001|COMPLETED|Invitation for Additional Challenge||0
10377580|NCT02927145|11518466|FG002|COMPLETED|Invitation for Additional Challenge||0
10377581|NCT02927145|11518467|FG003|COMPLETED|Invitation for Additional Challenge||0
10377582|NCT02927145|11518468|FG004|COMPLETED|Invitation for Additional Challenge||0
10377583|NCT02927145|11518469|FG005|COMPLETED|Invitation for Additional Challenge||0
10377584|NCT02927145|11518470|FG006|COMPLETED|Invitation for Additional Challenge||8
10377585|NCT02927145|11518471|FG007|COMPLETED|Invitation for Additional Challenge||8
10377586|NCT02927145|11518472|FG008|COMPLETED|Invitation for Additional Challenge||0
10377587|NCT02927145|11518464|FG000|NOT COMPLETED|Invitation for Additional Challenge||0
10377588|NCT02927145|11518465|FG001|NOT COMPLETED|Invitation for Additional Challenge||0
10377589|NCT02927145|11518466|FG002|NOT COMPLETED|Invitation for Additional Challenge||0
10377590|NCT02927145|11518467|FG003|NOT COMPLETED|Invitation for Additional Challenge||0
10377591|NCT02927145|11518468|FG004|NOT COMPLETED|Invitation for Additional Challenge||0
10377592|NCT02927145|11518469|FG005|NOT COMPLETED|Invitation for Additional Challenge||0
10377593|NCT02927145|11518470|FG006|NOT COMPLETED|Invitation for Additional Challenge||1
10377594|NCT02927145|11518471|FG007|NOT COMPLETED|Invitation for Additional Challenge||0
10377595|NCT02927145|11518472|FG008|NOT COMPLETED|Invitation for Additional Challenge||0
10377596|NCT02910583|11518495|FG000|STARTED|Overall Study||159
10377597|NCT02910583|11518496|FG001|STARTED|Overall Study||164
10377598|NCT02910583|11518495|FG000|MRD Cohort/ Not Randomized|Overall Study|Not applicable to this cohort.|0
10377599|NCT02910583|11518496|FG001|MRD Cohort/ Not Randomized|Overall Study||15
10377600|NCT02910583|11518495|FG000|MRD Cohort/ Confirmed uMRD: Randomized to Ibrutinib (Blinded)|Overall Study|Not applicable to this cohort.|0
10377601|NCT02910583|11518496|FG001|MRD Cohort/ Confirmed uMRD: Randomized to Ibrutinib (Blinded)|Overall Study||43
10377602|NCT02910583|11518495|FG000|MRD Cohort/ Confirmed uMRD: Randomized Placebo (Blinded)|Overall Study|Not applicable to this cohort.|0
10377603|NCT02910583|11518496|FG001|MRD Cohort/ Confirmed uMRD: Randomized Placebo (Blinded)|Overall Study||43
10377689|NCT00588159|11518649|FG000|NOT COMPLETED|Overall Study||15
10377604|NCT02910583|11518495|FG000|MRD Cohort/uMRD Not Confirmed: Randomized to Ibrutinib (Open-Label)|Overall Study|Not applicable to this cohort.|0
10377605|NCT02910583|11518496|FG001|MRD Cohort/uMRD Not Confirmed: Randomized to Ibrutinib (Open-Label)|Overall Study||31
10377606|NCT02910583|11518495|FG000|MRD Cohort/uMRD Not Confirmed: Randomized Ibrutinib + Venetoclax (Open-Label)|Overall Study|Not applicable to this cohort.|0
10377607|NCT02910583|11518496|FG001|MRD Cohort/uMRD Not Confirmed: Randomized Ibrutinib + Venetoclax (Open-Label)|Overall Study||32
10377608|NCT02910583|11518495|FG000|COMPLETED|Overall Study||152
10377609|NCT02910583|11518496|FG001|COMPLETED|Overall Study||157
10377610|NCT02910583|11518495|FG000|NOT COMPLETED|Overall Study||7
10377611|NCT02910583|11518496|FG001|NOT COMPLETED|Overall Study||7
10377612|NCT02699060|11518533|FG000|STARTED|Overall Study||68
10377613|NCT02699060|11518533|FG000|COMPLETED|Overall Study||68
10377614|NCT02699060|11518533|FG000|NOT COMPLETED|Overall Study||0
10377615|NCT02598388|11518553|FG000|STARTED|Overall Study||40
10377616|NCT02598388|11518554|FG001|STARTED|Overall Study||10
10377617|NCT02598388|11518555|FG002|STARTED|Overall Study||20
10377618|NCT02598388|11518556|FG003|STARTED|Overall Study||5
10377619|NCT02598388|11518557|FG004|STARTED|Overall Study||161
10377620|NCT02598388|11518558|FG005|STARTED|Overall Study||39
10377621|NCT02598388|11518559|FG006|STARTED|Overall Study||161
10377622|NCT02598388|11518560|FG007|STARTED|Overall Study||39
10377623|NCT02598388|11518561|FG008|STARTED|Overall Study||39
10377624|NCT02598388|11518562|FG009|STARTED|Overall Study||10
10377625|NCT02598388|11518563|FG010|STARTED|Overall Study||40
10377626|NCT02598388|11518564|FG011|STARTED|Overall Study||10
10377627|NCT02598388|11518553|FG000|COMPLETED|Overall Study||39
10377628|NCT02598388|11518554|FG001|COMPLETED|Overall Study||10
10377629|NCT02598388|11518555|FG002|COMPLETED|Overall Study||18
10377630|NCT02598388|11518556|FG003|COMPLETED|Overall Study||5
10377631|NCT02598388|11518557|FG004|COMPLETED|Overall Study||151
10377632|NCT02598388|11518558|FG005|COMPLETED|Overall Study||38
10377633|NCT02598388|11518559|FG006|COMPLETED|Overall Study||156
10377634|NCT02598388|11518560|FG007|COMPLETED|Overall Study||38
10377635|NCT02598388|11518561|FG008|COMPLETED|Overall Study||39
10377636|NCT02598388|11518562|FG009|COMPLETED|Overall Study||9
10377637|NCT02598388|11518563|FG010|COMPLETED|Overall Study||39
10377638|NCT02598388|11518564|FG011|COMPLETED|Overall Study||10
10377639|NCT02598388|11518553|FG000|NOT COMPLETED|Overall Study||1
10377640|NCT02598388|11518554|FG001|NOT COMPLETED|Overall Study||0
10377641|NCT02598388|11518555|FG002|NOT COMPLETED|Overall Study||2
10377642|NCT02598388|11518556|FG003|NOT COMPLETED|Overall Study||0
10377643|NCT02598388|11518557|FG004|NOT COMPLETED|Overall Study||10
10377644|NCT02598388|11518558|FG005|NOT COMPLETED|Overall Study||1
10377645|NCT02598388|11518559|FG006|NOT COMPLETED|Overall Study||5
10377646|NCT02598388|11518560|FG007|NOT COMPLETED|Overall Study||1
10377647|NCT02598388|11518561|FG008|NOT COMPLETED|Overall Study||0
10377648|NCT02598388|11518562|FG009|NOT COMPLETED|Overall Study||1
10377649|NCT02598388|11518563|FG010|NOT COMPLETED|Overall Study||1
10377650|NCT02598388|11518564|FG011|NOT COMPLETED|Overall Study||0
10377651|NCT02493751|11518597|FG000|STARTED|Overall Study||16
10377652|NCT02493751|11518598|FG001|STARTED|Overall Study||39
10377653|NCT02493751|11518597|FG000|COMPLETED|Overall Study||0
10377654|NCT02493751|11518598|FG001|COMPLETED|Overall Study||0
10377655|NCT02493751|11518597|FG000|NOT COMPLETED|Overall Study||16
10377656|NCT02493751|11518598|FG001|NOT COMPLETED|Overall Study||39
10377657|NCT02285166|11518605|FG000|STARTED|Overall Study||15330
10377658|NCT02285166|11518605|FG000|COMPLETED|Overall Study||14364
10377659|NCT02285166|11518605|FG000|NOT COMPLETED|Overall Study||966
10377660|NCT02075593|11518611|FG000|STARTED|Overall Study||4
10377661|NCT02075593|11518611|FG000|Infants Born to Pregnant Women Who Received at Least One Dose of Study Treatment|Overall Study||4
10377662|NCT02075593|11518611|FG000|COMPLETED|Overall Study||1
10377663|NCT02075593|11518611|FG000|NOT COMPLETED|Overall Study||3
10377664|NCT00587860|11518619|FG000|STARTED|Overall Study||35
10377665|NCT00587860|11518620|FG001|STARTED|Overall Study||35
10377666|NCT00587860|11518619|FG000|COMPLETED|Overall Study||30
10377667|NCT00587860|11518620|FG001|COMPLETED|Overall Study||30
10377668|NCT00587860|11518619|FG000|NOT COMPLETED|Overall Study||5
10377669|NCT00587860|11518620|FG001|NOT COMPLETED|Overall Study||5
10427988|NCT00856245|11573951|FG000|STARTED|Overall Study||19
10427989|NCT00856245|11573951|FG000|COMPLETED|Overall Study||14
10427990|NCT00856245|11573951|FG000|NOT COMPLETED|Overall Study||5
10427991|NCT00856284|11573958|FG000|STARTED|Overall Study||880
10427992|NCT00856284|11573959|FG001|STARTED|Overall Study||885
10377670|NCT00587964|11518626|FG000|STARTED|Overall Study||51
10377671|NCT00587964|11518626|FG000|COMPLETED|Overall Study||39
10377672|NCT00587964|11518626|FG000|NOT COMPLETED|Overall Study||12
10377673|NCT00587990|11518633|FG000|STARTED|Overall Study||2
10377674|NCT00587990|11518634|FG001|STARTED|Overall Study||4
10377675|NCT00587990|11518635|FG002|STARTED|Overall Study||3
10377676|NCT00587990|11518633|FG000|COMPLETED|Overall Study||2
10377677|NCT00587990|11518634|FG001|COMPLETED|Overall Study||4
10377678|NCT00587990|11518635|FG002|COMPLETED|Overall Study||2
10377679|NCT00587990|11518633|FG000|NOT COMPLETED|Overall Study||0
10377680|NCT00587990|11518634|FG001|NOT COMPLETED|Overall Study||0
10377681|NCT00587990|11518635|FG002|NOT COMPLETED|Overall Study||1
10377682|NCT00588094|11518643|FG000|STARTED|Overall Study||20
10377683|NCT00588094|11518643|FG000|COMPLETED|Overall Study||15
10377684|NCT00588094|11518643|FG000|NOT COMPLETED|Overall Study||5
10377685|NCT00588159|11518649|FG000|STARTED|Overall Study||72
10377686|NCT00588159|11518650|FG001|STARTED|Overall Study||74
10377687|NCT00588159|11518649|FG000|COMPLETED|Overall Study||57
10377688|NCT00588159|11518650|FG001|COMPLETED|Overall Study||63
10377690|NCT00588159|11518650|FG001|NOT COMPLETED|Overall Study||11
10377691|NCT00588237|11518656|FG000|STARTED|Overall Study||42
10377692|NCT00588237|11518656|FG000|COMPLETED|Overall Study||38
10377693|NCT00588237|11518656|FG000|NOT COMPLETED|Overall Study||4
10377694|NCT00588341|11518660|FG000|STARTED|Overall Study||24
10377695|NCT00588341|11518660|FG000|COMPLETED|Overall Study||19
10377696|NCT00588341|11518660|FG000|NOT COMPLETED|Overall Study||5
10377697|NCT00588354|11518666|FG000|STARTED|Baseline to 2 Weeks||11
10377698|NCT00588354|11518667|FG001|STARTED|Baseline to 2 Weeks||15
10377699|NCT00588354|11518666|FG000|COMPLETED|Baseline to 2 Weeks||9
10377700|NCT00588354|11518667|FG001|COMPLETED|Baseline to 2 Weeks||15
10377701|NCT00588354|11518666|FG000|NOT COMPLETED|Baseline to 2 Weeks||2
10377702|NCT00588354|11518667|FG001|NOT COMPLETED|Baseline to 2 Weeks||0
10377703|NCT00588354|11518666|FG000|STARTED|Baseline to 4 Weeks||9
10377704|NCT00588354|11518667|FG001|STARTED|Baseline to 4 Weeks||15
10377705|NCT00588354|11518666|FG000|COMPLETED|Baseline to 4 Weeks||9
10538830|NCT01457924|11691721|FG001|STARTED|FUP (Weeks 24-48)||31
10538831|NCT01457924|11691722|FG002|STARTED|FUP (Weeks 24-48)||32
10538832|NCT01457924|11691723|FG003|STARTED|FUP (Weeks 24-48)||33
10377706|NCT00588354|11518667|FG001|COMPLETED|Baseline to 4 Weeks||14
10377707|NCT00588354|11518666|FG000|NOT COMPLETED|Baseline to 4 Weeks||0
10377708|NCT00588354|11518667|FG001|NOT COMPLETED|Baseline to 4 Weeks||1
10377709|NCT00588380|11518674|FG000|STARTED|Overall Study||88
10377710|NCT00588380|11518674|FG000|COMPLETED|Overall Study||88
10377711|NCT00588380|11518674|FG000|NOT COMPLETED|Overall Study||0
10377712|NCT00588406|11518681|FG000|STARTED|Overall Study||46
10377713|NCT00588406|11518682|FG001|STARTED|Overall Study||49
10377714|NCT00588406|11518681|FG000|COMPLETED|Overall Study||46
10377715|NCT00588406|11518682|FG001|COMPLETED|Overall Study||49
10377716|NCT00588406|11518681|FG000|NOT COMPLETED|Overall Study||0
10377717|NCT00588406|11518682|FG001|NOT COMPLETED|Overall Study||0
10377718|NCT00588445|11518688|FG000|STARTED|Overall Study||65
10377719|NCT00588445|11518688|FG000|COMPLETED|Overall Study||50
10377720|NCT00588445|11518688|FG000|NOT COMPLETED|Overall Study||15
10377721|NCT00588536|11518694|FG000|STARTED|Overall Study||5
10377722|NCT00588536|11518694|FG000|COMPLETED|Overall Study||5
10377723|NCT00588536|11518694|FG000|NOT COMPLETED|Overall Study||0
10377724|NCT00588640|11518698|FG000|STARTED|Overall Study||10
10377725|NCT00588640|11518698|FG000|COMPLETED|Overall Study||8
10377726|NCT00588640|11518698|FG000|NOT COMPLETED|Overall Study||2
10377727|NCT00588666|11518702|FG000|STARTED|Overall Study||51
10377728|NCT00588666|11518702|FG000|COMPLETED|Overall Study||47
10377729|NCT00588666|11518702|FG000|NOT COMPLETED|Overall Study||4
10377730|NCT00588692|11518708|FG000|STARTED|Overall Study||30
10377731|NCT00588692|11518709|FG001|STARTED|Overall Study||30
10377732|NCT00588692|11518708|FG000|COMPLETED|Overall Study||23
10377733|NCT00588692|11518709|FG001|COMPLETED|Overall Study||27
10377734|NCT00588692|11518708|FG000|NOT COMPLETED|Overall Study||7
10377735|NCT00588692|11518709|FG001|NOT COMPLETED|Overall Study||3
10377736|NCT00588731|11518719|FG000|STARTED|Overall Study||21
10377737|NCT00588731|11518720|FG001|STARTED|Overall Study||20
10377738|NCT00588731|11518719|FG000|COMPLETED|Overall Study||18
10377739|NCT00588731|11518720|FG001|COMPLETED|Overall Study||18
10377740|NCT00588731|11518719|FG000|NOT COMPLETED|Overall Study||3
10377741|NCT00588731|11518720|FG001|NOT COMPLETED|Overall Study||2
10377742|NCT00588809|11518726|FG000|STARTED|Overall Study||47
10377743|NCT00588809|11518726|FG000|COMPLETED|Overall Study||47
10377744|NCT00588809|11518726|FG000|NOT COMPLETED|Overall Study||0
10377745|NCT00588822|11518730|FG000|STARTED|Overall Study||21
10377746|NCT00588822|11518730|FG000|COMPLETED|Overall Study||13
10377747|NCT00588822|11518730|FG000|NOT COMPLETED|Overall Study||8
10377748|NCT00588848|11518736|FG000|STARTED|Overall Study||3
10377749|NCT00588848|11518737|FG001|STARTED|Overall Study||8
10377750|NCT00588848|11518736|FG000|COMPLETED|Overall Study||3
10377751|NCT00588848|11518737|FG001|COMPLETED|Overall Study||5
10377752|NCT00588848|11518736|FG000|NOT COMPLETED|Overall Study||0
10377753|NCT00588848|11518737|FG001|NOT COMPLETED|Overall Study||3
10377754|NCT00588900|11518745|FG000|STARTED|Overall Study||5
10377755|NCT00588900|11518745|FG000|COMPLETED|Overall Study||5
10377756|NCT00588900|11518745|FG000|NOT COMPLETED|Overall Study||0
10377757|NCT00588952|11518751|FG000|STARTED|Overall Study||29
10377758|NCT00588952|11518752|FG001|STARTED|Overall Study||70
10377759|NCT00588952|11518751|FG000|COMPLETED|Overall Study||26
10377760|NCT00588952|11518752|FG001|COMPLETED|Overall Study||63
10377761|NCT00588952|11518751|FG000|NOT COMPLETED|Overall Study||3
10377762|NCT00588952|11518752|FG001|NOT COMPLETED|Overall Study||7
10377763|NCT00588965|11518758|FG000|STARTED|Overall Study||35
10377764|NCT00588965|11518758|FG000|COMPLETED|Overall Study||35
10377765|NCT00588965|11518758|FG000|NOT COMPLETED|Overall Study||0
10377766|NCT00589056|11518764|FG000|STARTED|Overall Study||55
10377767|NCT00589056|11518764|FG000|COMPLETED|Overall Study||52
10377768|NCT00589056|11518764|FG000|NOT COMPLETED|Overall Study||3
10377769|NCT00589108|11518771|FG000|STARTED|Overall Study||80
10377770|NCT00589108|11518772|FG001|STARTED|Overall Study||80
10377771|NCT00589108|11518773|FG002|STARTED|Overall Study||80
10377772|NCT00589108|11518771|FG000|COMPLETED|Overall Study||76
10377773|NCT00589108|11518772|FG001|COMPLETED|Overall Study||76
10377774|NCT00589108|11518773|FG002|COMPLETED|Overall Study||75
10538833|NCT01457924|11691724|FG004|STARTED|FUP (Weeks 24-48)||59
10538834|NCT01457924|11691720|FG000|COMPLETED|FUP (Weeks 24-48)||63
10538835|NCT01457924|11691721|FG001|COMPLETED|FUP (Weeks 24-48)||30
10538836|NCT01457924|11691722|FG002|COMPLETED|FUP (Weeks 24-48)||30
10538837|NCT01457924|11691723|FG003|COMPLETED|FUP (Weeks 24-48)||32
10538838|NCT01457924|11691724|FG004|COMPLETED|FUP (Weeks 24-48)||57
10538839|NCT01457924|11691720|FG000|NOT COMPLETED|FUP (Weeks 24-48)||3
10538840|NCT01457924|11691721|FG001|NOT COMPLETED|FUP (Weeks 24-48)||1
10538841|NCT01457924|11691722|FG002|NOT COMPLETED|FUP (Weeks 24-48)||2
10538842|NCT01457924|11691723|FG003|NOT COMPLETED|FUP (Weeks 24-48)||1
10538843|NCT01457924|11691724|FG004|NOT COMPLETED|FUP (Weeks 24-48)||2
10538844|NCT01457924|11691720|FG000|STARTED|Individualized FUP (Weeks 48+)||16
10538845|NCT01457924|11691721|FG001|STARTED|Individualized FUP (Weeks 48+)||18
10538846|NCT01457924|11691722|FG002|STARTED|Individualized FUP (Weeks 48+)||16
10538847|NCT01457924|11691723|FG003|STARTED|Individualized FUP (Weeks 48+)||20
10538848|NCT01457924|11691724|FG004|STARTED|Individualized FUP (Weeks 48+)||42
10538849|NCT01457924|11691720|FG000|COMPLETED|Individualized FUP (Weeks 48+)||11
10538850|NCT01457924|11691721|FG001|COMPLETED|Individualized FUP (Weeks 48+)||14
10538851|NCT01457924|11691722|FG002|COMPLETED|Individualized FUP (Weeks 48+)||12
10538852|NCT01457924|11691723|FG003|COMPLETED|Individualized FUP (Weeks 48+)||15
10538853|NCT01457924|11691724|FG004|COMPLETED|Individualized FUP (Weeks 48+)||36
10538854|NCT01457924|11691720|FG000|NOT COMPLETED|Individualized FUP (Weeks 48+)||5
10538855|NCT01457924|11691721|FG001|NOT COMPLETED|Individualized FUP (Weeks 48+)||4
10538856|NCT01457924|11691722|FG002|NOT COMPLETED|Individualized FUP (Weeks 48+)||4
10538857|NCT01457924|11691723|FG003|NOT COMPLETED|Individualized FUP (Weeks 48+)||5
10538858|NCT01457924|11691724|FG004|NOT COMPLETED|Individualized FUP (Weeks 48+)||6
10538859|NCT01457950|11691738|FG000|STARTED|Double-Blind Phase||69
10538860|NCT01457950|11691739|FG001|STARTED|Double-Blind Phase||66
10538861|NCT01457950|11691740|FG002|STARTED|Double-Blind Phase||0
10538862|NCT01457950|11691741|FG003|STARTED|Double-Blind Phase||0
10538863|NCT01457950|11691738|FG000|Completed the 6 Month Assessment|Double-Blind Phase|"Completed 6 month assessment refers to par. that completed at least one 6 month assessment."|62
10538864|NCT01457950|11691739|FG001|Completed the 6 Month Assessment|Double-Blind Phase|"Completed 6 month assessment refers to par. that completed at least one 6 month assessment."|64
10538865|NCT01457950|11691740|FG002|Completed the 6 Month Assessment|Double-Blind Phase||0
10538866|NCT01457950|11691741|FG003|Completed the 6 Month Assessment|Double-Blind Phase||0
10538867|NCT01457950|11691738|FG000|COMPLETED|Double-Blind Phase|"Completed refers to par. that did not have a withdraw reason at the 6 month visit."|60
10538868|NCT01457950|11691739|FG001|COMPLETED|Double-Blind Phase|"Completed refers to par. that did not have a withdraw reason at the 6 month visit."|63
10538869|NCT01457950|11691740|FG002|COMPLETED|Double-Blind Phase||0
10538870|NCT01457950|11691741|FG003|COMPLETED|Double-Blind Phase||0
10538871|NCT01457950|11691738|FG000|NOT COMPLETED|Double-Blind Phase||9
10538872|NCT01457950|11691739|FG001|NOT COMPLETED|Double-Blind Phase||3
10538873|NCT01457950|11691740|FG002|NOT COMPLETED|Double-Blind Phase||0
10538874|NCT01457950|11691741|FG003|NOT COMPLETED|Double-Blind Phase||0
10538875|NCT01457950|11691738|FG000|STARTED|Open-Label Phase||0
10538876|NCT01457950|11691739|FG001|STARTED|Open-Label Phase||0
10538877|NCT01457950|11691740|FG002|STARTED|Open-Label Phase||60
10538878|NCT01457950|11691741|FG003|STARTED|Open-Label Phase||63
10538879|NCT01457950|11691738|FG000|COMPLETED|Open-Label Phase||0
10538880|NCT01457950|11691739|FG001|COMPLETED|Open-Label Phase||0
10538881|NCT01457950|11691740|FG002|COMPLETED|Open-Label Phase||58
10538882|NCT01457950|11691741|FG003|COMPLETED|Open-Label Phase||61
10538883|NCT01457950|11691738|FG000|NOT COMPLETED|Open-Label Phase||0
10538884|NCT01457950|11691739|FG001|NOT COMPLETED|Open-Label Phase||0
10538885|NCT01457950|11691740|FG002|NOT COMPLETED|Open-Label Phase||2
10538886|NCT01457950|11691741|FG003|NOT COMPLETED|Open-Label Phase||2
10538887|NCT01458106|11691754|FG000|STARTED|Overall Study||36
10538888|NCT01458106|11691755|FG001|STARTED|Overall Study||35
10538889|NCT01458106|11691754|FG000|PK Subgroup|Overall Study||25
10538890|NCT01458106|11691755|FG001|PK Subgroup|Overall Study||35
10538891|NCT01458106|11691754|FG000|Non-PK Subgroup|Overall Study||11
10538892|NCT01458106|11691755|FG001|Non-PK Subgroup|Overall Study||0
10538893|NCT01458106|11691754|FG000|COMPLETED|Overall Study||33
10377775|NCT00589108|11518771|FG000|NOT COMPLETED|Overall Study||4
10377776|NCT00589108|11518772|FG001|NOT COMPLETED|Overall Study||4
10377777|NCT00589108|11518773|FG002|NOT COMPLETED|Overall Study||5
10377778|NCT00589121|11518783|FG000|STARTED|Overall Study||12
10377779|NCT00589121|11518784|FG001|STARTED|Overall Study||86
10377780|NCT00589121|11518783|FG000|COMPLETED|Overall Study|Subjects with data available for the analysis are considered to have completed the study.|10
10377781|NCT00589121|11518784|FG001|COMPLETED|Overall Study|Subjects with data available for the analysis are considered to have completed the study.|79
10377782|NCT00589121|11518783|FG000|NOT COMPLETED|Overall Study||2
10377783|NCT00589121|11518784|FG001|NOT COMPLETED|Overall Study||7
10377784|NCT00589277|11518795|FG000|STARTED|Overall Study||1222
10377785|NCT00589277|11518796|FG001|STARTED|Overall Study||810
10377786|NCT00589277|11518795|FG000|Completed 2 Week Follow Up|Overall Study||603
10377787|NCT00589277|11518796|FG001|Completed 2 Week Follow Up|Overall Study||424
10377788|NCT00589277|11518795|FG000|Completed 3 Month Follow Up|Overall Study||762
10377789|NCT00589277|11518796|FG001|Completed 3 Month Follow Up|Overall Study||524
10377790|NCT00589277|11518795|FG000|COMPLETED|Overall Study||762
10377791|NCT00589277|11518796|FG001|COMPLETED|Overall Study||524
10377792|NCT00589277|11518795|FG000|NOT COMPLETED|Overall Study||460
10377793|NCT00589277|11518796|FG001|NOT COMPLETED|Overall Study||286
10377794|NCT00589290|11518802|FG000|STARTED|Overall Study||41
10377795|NCT00589290|11518802|FG000|COMPLETED|Overall Study||40
10377796|NCT00589290|11518802|FG000|NOT COMPLETED|Overall Study||1
10377797|NCT00589303|11518810|FG000|STARTED|Overall Study||14
10377798|NCT00589303|11518811|FG001|STARTED|Overall Study||13
10377799|NCT00589303|11518810|FG000|COMPLETED|Overall Study||12
10377800|NCT00589303|11518811|FG001|COMPLETED|Overall Study||12
10377801|NCT00589303|11518810|FG000|NOT COMPLETED|Overall Study||2
10377802|NCT00589303|11518811|FG001|NOT COMPLETED|Overall Study||1
10377803|NCT00589329|11518819|FG000|STARTED|Overall Study||10
10377804|NCT00589329|11518820|FG001|STARTED|Overall Study||10
10377805|NCT00589329|11518819|FG000|COMPLETED|Overall Study||10
10377806|NCT00589329|11518820|FG001|COMPLETED|Overall Study||10
10377807|NCT00589329|11518819|FG000|NOT COMPLETED|Overall Study||0
10377808|NCT00589329|11518820|FG001|NOT COMPLETED|Overall Study||0
10377809|NCT00589472|11518827|FG000|STARTED|Overall Study||19
10377810|NCT00589472|11518827|FG000|COMPLETED|Overall Study||18
10377811|NCT00589472|11518827|FG000|NOT COMPLETED|Overall Study||1
10377812|NCT00589563|11518831|FG000|STARTED|Overall Study||32
10377813|NCT00589563|11518831|FG000|COMPLETED|Overall Study||32
10377814|NCT00589563|11518831|FG000|NOT COMPLETED|Overall Study||0
10377815|NCT00589602|11518835|FG000|STARTED|Overall Study||13
10377816|NCT00589602|11518835|FG000|COMPLETED|Overall Study||12
10377817|NCT00589602|11518835|FG000|NOT COMPLETED|Overall Study||1
10377818|NCT00589628|11518843|FG000|STARTED|Overall Study||7
10377819|NCT00589628|11518844|FG001|STARTED|Overall Study||6
10377820|NCT00589628|11518843|FG000|COMPLETED|Overall Study||7
10377821|NCT00589628|11518844|FG001|COMPLETED|Overall Study||5
10377822|NCT00589628|11518843|FG000|NOT COMPLETED|Overall Study||0
10377823|NCT00589628|11518844|FG001|NOT COMPLETED|Overall Study||1
10377824|NCT00589667|11518850|FG000|STARTED|Overall Study||26
10377825|NCT00589667|11518850|FG000|COMPLETED|Overall Study||23
10377826|NCT00589667|11518850|FG000|NOT COMPLETED|Overall Study||3
10377827|NCT00589693|11518856|FG000|STARTED|Overall Study||115
10377828|NCT00589693|11518857|FG001|STARTED|Overall Study||112
10377829|NCT00589693|11518856|FG000|COMPLETED|Overall Study||71
10377830|NCT00589693|11518857|FG001|COMPLETED|Overall Study||83
10377831|NCT00589693|11518856|FG000|NOT COMPLETED|Overall Study||44
10377832|NCT00589693|11518857|FG001|NOT COMPLETED|Overall Study||29
10377833|NCT00589784|11518865|FG000|STARTED|Overall Study||36
10377834|NCT00589784|11518866|FG001|STARTED|Overall Study||14
10377835|NCT00589784|11518865|FG000|COMPLETED|Overall Study||35
10377836|NCT00589784|11518866|FG001|COMPLETED|Overall Study||4
10377837|NCT00589784|11518865|FG000|NOT COMPLETED|Overall Study||1
10377838|NCT00589784|11518866|FG001|NOT COMPLETED|Overall Study||10
10377839|NCT00589797|11518873|FG000|STARTED|Overall Study||264
10377840|NCT00589797|11518874|FG001|STARTED|Overall Study||112
10377841|NCT00589797|11518873|FG000|Baseline|Overall Study||218
10538894|NCT01458106|11691755|FG001|COMPLETED|Overall Study||34
10538895|NCT01458106|11691754|FG000|NOT COMPLETED|Overall Study||3
10538896|NCT01458106|11691755|FG001|NOT COMPLETED|Overall Study||1
10538897|NCT01458119|11691764|FG000|STARTED|Overall Study||85
10538898|NCT01458119|11691764|FG000|Received at Least 1 Dose of Study Drug|Overall Study||85
10538899|NCT01458119|11691764|FG000|Safety Population|Overall Study||85
10538900|NCT01458119|11691764|FG000|Intent to Treat (ITT) Population|Overall Study||85
10538901|NCT01458119|11691764|FG000|ITT-Amenable Population|Overall Study||68
10538902|NCT01458119|11691764|FG000|COMPLETED|Overall Study||65
10538903|NCT01458119|11691764|FG000|NOT COMPLETED|Overall Study||20
10538904|NCT01458132|11691771|FG000|STARTED|Overall Study||15
10538905|NCT01458132|11691772|FG001|STARTED|Overall Study||4
10538906|NCT01458132|11691771|FG000|COMPLETED|Overall Study||0
10538907|NCT01458132|11691772|FG001|COMPLETED|Overall Study||1
10538908|NCT01458132|11691771|FG000|NOT COMPLETED|Overall Study||15
10538909|NCT01458132|11691772|FG001|NOT COMPLETED|Overall Study||3
10538910|NCT01458171|11691778|FG000|STARTED|Overall Study||23
10538911|NCT01458171|11691778|FG000|COMPLETED|Overall Study||22
10538912|NCT01458171|11691778|FG000|NOT COMPLETED|Overall Study||1
10538913|NCT01458210|11691784|FG000|STARTED|Lead-in (1st Course of Ortho-Cyclen)||22
10377842|NCT00589797|11518874|FG001|Baseline|Overall Study||106
10377843|NCT00589797|11518873|FG000|24 Months|Overall Study||191
10377844|NCT00589797|11518874|FG001|24 Months|Overall Study||89
10377845|NCT00589797|11518873|FG000|COMPLETED|Overall Study||191
10377846|NCT00589797|11518874|FG001|COMPLETED|Overall Study||89
10377847|NCT00589797|11518873|FG000|NOT COMPLETED|Overall Study||73
10538914|NCT01458210|11691784|FG000|Received at Least One Dose of Study Drug|Lead-in (1st Course of Ortho-Cyclen)||22
10538915|NCT01458210|11691784|FG000|COMPLETED|Lead-in (1st Course of Ortho-Cyclen)||22
10538916|NCT01458210|11691784|FG000|NOT COMPLETED|Lead-in (1st Course of Ortho-Cyclen)||0
10377848|NCT00589797|11518874|FG001|NOT COMPLETED|Overall Study||23
10377849|NCT00589836|11518880|FG000|STARTED|Overall Study||20
10377850|NCT00589836|11518880|FG000|COMPLETED|Overall Study||20
10377851|NCT00589836|11518880|FG000|NOT COMPLETED|Overall Study||0
10377852|NCT00589849|11518884|FG000|STARTED|Overall Study||32
10377853|NCT00589849|11518884|FG000|COMPLETED|Overall Study||32
10377854|NCT00589849|11518884|FG000|NOT COMPLETED|Overall Study||0
10377855|NCT00589888|11518888|FG000|STARTED|Normal Saline @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|13
10377856|NCT00589888|11518889|FG001|STARTED|Normal Saline @ 40cc/Hour||0
10377857|NCT00589888|11518890|FG002|STARTED|Normal Saline @ 40cc/Hour||0
10377858|NCT00589888|11518891|FG003|STARTED|Normal Saline @ 40cc/Hour||0
10377859|NCT00589888|11518892|FG004|STARTED|Normal Saline @ 40cc/Hour||0
10377860|NCT00589888|11518888|FG000|COMPLETED|Normal Saline @ 40cc/Hour||13
10377861|NCT00589888|11518889|FG001|COMPLETED|Normal Saline @ 40cc/Hour||0
10377862|NCT00589888|11518890|FG002|COMPLETED|Normal Saline @ 40cc/Hour||0
10377863|NCT00589888|11518891|FG003|COMPLETED|Normal Saline @ 40cc/Hour||0
10377864|NCT00589888|11518892|FG004|COMPLETED|Normal Saline @ 40cc/Hour||0
10377865|NCT00589888|11518888|FG000|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
10377866|NCT00589888|11518889|FG001|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
10377867|NCT00589888|11518890|FG002|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
10377868|NCT00589888|11518891|FG003|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
10377869|NCT00589888|11518892|FG004|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
10377870|NCT00589888|11518888|FG000|STARTED|Intralipid 20% @ 20cc/hr|the same 13 patients did each of the 5 arms at 5 different visits|0
10377871|NCT00589888|11518889|FG001|STARTED|Intralipid 20% @ 20cc/hr||13
10377872|NCT00589888|11518890|FG002|STARTED|Intralipid 20% @ 20cc/hr||0
10377873|NCT00589888|11518891|FG003|STARTED|Intralipid 20% @ 20cc/hr||0
10377874|NCT00589888|11518892|FG004|STARTED|Intralipid 20% @ 20cc/hr||0
10377875|NCT00589888|11518888|FG000|COMPLETED|Intralipid 20% @ 20cc/hr||0
10377876|NCT00589888|11518889|FG001|COMPLETED|Intralipid 20% @ 20cc/hr||13
10377877|NCT00589888|11518890|FG002|COMPLETED|Intralipid 20% @ 20cc/hr||0
10377878|NCT00589888|11518891|FG003|COMPLETED|Intralipid 20% @ 20cc/hr||0
10377879|NCT00589888|11518892|FG004|COMPLETED|Intralipid 20% @ 20cc/hr||0
10717641|NCT02699892|11881613|FG000|NOT COMPLETED|Overall Study||36
10717642|NCT02699970|11881617|FG000|STARTED|Overall Study||399
10717643|NCT02699970|11881617|FG000|Intra-system|Overall Study||399
10377880|NCT00589888|11518888|FG000|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
10377881|NCT00589888|11518889|FG001|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
10377882|NCT00589888|11518890|FG002|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
10377883|NCT00589888|11518891|FG003|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
10377884|NCT00589888|11518892|FG004|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
10377885|NCT00589888|11518888|FG000|STARTED|Intralipid 20% @ 40cc/Hour||0
10377886|NCT00589888|11518889|FG001|STARTED|Intralipid 20% @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|0
10377887|NCT00589888|11518890|FG002|STARTED|Intralipid 20% @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|13
10377888|NCT00589888|11518891|FG003|STARTED|Intralipid 20% @ 40cc/Hour||0
10377889|NCT00589888|11518892|FG004|STARTED|Intralipid 20% @ 40cc/Hour||0
10377890|NCT00589888|11518888|FG000|COMPLETED|Intralipid 20% @ 40cc/Hour||0
10377891|NCT00589888|11518889|FG001|COMPLETED|Intralipid 20% @ 40cc/Hour||0
10377892|NCT00589888|11518890|FG002|COMPLETED|Intralipid 20% @ 40cc/Hour||13
10377893|NCT00589888|11518891|FG003|COMPLETED|Intralipid 20% @ 40cc/Hour||0
10377894|NCT00589888|11518892|FG004|COMPLETED|Intralipid 20% @ 40cc/Hour||0
10377895|NCT00589888|11518888|FG000|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
10377896|NCT00589888|11518889|FG001|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
10377897|NCT00589888|11518890|FG002|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
10377898|NCT00589888|11518891|FG003|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
10377899|NCT00589888|11518892|FG004|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
10377900|NCT00589888|11518888|FG000|STARTED|32-gram Oral Fat Load||0
10377901|NCT00589888|11518889|FG001|STARTED|32-gram Oral Fat Load||0
10377902|NCT00589888|11518890|FG002|STARTED|32-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|0
10377903|NCT00589888|11518891|FG003|STARTED|32-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|13
10377904|NCT00589888|11518892|FG004|STARTED|32-gram Oral Fat Load||0
10377905|NCT00589888|11518888|FG000|COMPLETED|32-gram Oral Fat Load||0
10377906|NCT00589888|11518889|FG001|COMPLETED|32-gram Oral Fat Load||0
10377907|NCT00589888|11518890|FG002|COMPLETED|32-gram Oral Fat Load||0
10377908|NCT00589888|11518891|FG003|COMPLETED|32-gram Oral Fat Load||13
10377909|NCT00589888|11518892|FG004|COMPLETED|32-gram Oral Fat Load||0
10377910|NCT00589888|11518888|FG000|NOT COMPLETED|32-gram Oral Fat Load||0
10377911|NCT00589888|11518889|FG001|NOT COMPLETED|32-gram Oral Fat Load||0
10538917|NCT01458210|11691784|FG000|STARTED|Ortho-Cyclen Alone (Period 1)||22
10538918|NCT01458210|11691784|FG000|COMPLETED|Ortho-Cyclen Alone (Period 1)||18
10538919|NCT01458210|11691784|FG000|NOT COMPLETED|Ortho-Cyclen Alone (Period 1)||4
10538920|NCT01458210|11691784|FG000|STARTED|Ortho-Cyclen + Dulaglutide (Period 2)|1 participant received Ortho-Cyclen, discontinued due to Adverse Event before receiving Dulaglutide.|18
10717644|NCT02699970|11881617|FG000|Inter-system|Overall Study||399
10717645|NCT02699970|11881617|FG000|COMPLETED|Overall Study||399
10377912|NCT00589888|11518890|FG002|NOT COMPLETED|32-gram Oral Fat Load||0
10377913|NCT00589888|11518891|FG003|NOT COMPLETED|32-gram Oral Fat Load||0
10377914|NCT00589888|11518892|FG004|NOT COMPLETED|32-gram Oral Fat Load||0
10377915|NCT00589888|11518888|FG000|STARTED|64-gram Oral Fat Load||0
10377916|NCT00589888|11518889|FG001|STARTED|64-gram Oral Fat Load||0
10377917|NCT00589888|11518890|FG002|STARTED|64-gram Oral Fat Load||0
10377918|NCT00589888|11518891|FG003|STARTED|64-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|0
10377919|NCT00589888|11518892|FG004|STARTED|64-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|13
10377920|NCT00589888|11518888|FG000|COMPLETED|64-gram Oral Fat Load||0
10377921|NCT00589888|11518889|FG001|COMPLETED|64-gram Oral Fat Load||0
10377922|NCT00589888|11518890|FG002|COMPLETED|64-gram Oral Fat Load||0
10377923|NCT00589888|11518891|FG003|COMPLETED|64-gram Oral Fat Load||0
10377924|NCT00589888|11518892|FG004|COMPLETED|64-gram Oral Fat Load||13
10377925|NCT00589888|11518888|FG000|NOT COMPLETED|64-gram Oral Fat Load||0
10377926|NCT00589888|11518889|FG001|NOT COMPLETED|64-gram Oral Fat Load||0
10377927|NCT00589888|11518890|FG002|NOT COMPLETED|64-gram Oral Fat Load||0
10538921|NCT01458210|11691784|FG000|COMPLETED|Ortho-Cyclen + Dulaglutide (Period 2)||15
10538922|NCT01458210|11691784|FG000|NOT COMPLETED|Ortho-Cyclen + Dulaglutide (Period 2)||3
10538923|NCT01458249|11691793|FG000|STARTED|Overall Study||52
10538924|NCT01458249|11691793|FG000|Participants Treated|Overall Study||51
10538925|NCT01458249|11691793|FG000|COMPLETED|Overall Study||44
10538926|NCT01458249|11691793|FG000|NOT COMPLETED|Overall Study||8
10538927|NCT01458275|11691801|FG000|STARTED|Overall Study||283
10538928|NCT01458275|11691802|FG001|STARTED|Overall Study||282
10538929|NCT01458275|11691803|FG002|STARTED|Overall Study||282
10538930|NCT01458275|11691801|FG000|COMPLETED|Overall Study||269
10538931|NCT01458275|11691802|FG001|COMPLETED|Overall Study||269
10538932|NCT01458275|11691803|FG002|COMPLETED|Overall Study||273
10538933|NCT01458275|11691801|FG000|NOT COMPLETED|Overall Study||14
10538934|NCT01458275|11691802|FG001|NOT COMPLETED|Overall Study||13
10538935|NCT01458275|11691803|FG002|NOT COMPLETED|Overall Study||9
10538936|NCT01458288|11691813|FG000|STARTED|Overall Study||12
10538937|NCT01458288|11691813|FG000|COMPLETED|Overall Study||12
10538938|NCT01458288|11691813|FG000|NOT COMPLETED|Overall Study||0
10538939|NCT01458327|11691818|FG000|STARTED|Overall Study||3
10538940|NCT01458327|11691818|FG000|COMPLETED|Overall Study||3
10538941|NCT01458327|11691818|FG000|NOT COMPLETED|Overall Study||0
10377928|NCT00589888|11518891|FG003|NOT COMPLETED|64-gram Oral Fat Load||0
10377929|NCT00589888|11518892|FG004|NOT COMPLETED|64-gram Oral Fat Load||0
10377930|NCT00589914|11518911|FG000|STARTED|Overall Study||606
10377931|NCT00589914|11518912|FG001|STARTED|Overall Study||608
10377932|NCT00589914|11518911|FG000|COMPLETED|Overall Study||456
10377933|NCT00589914|11518912|FG001|COMPLETED|Overall Study||471
10377934|NCT00589914|11518911|FG000|NOT COMPLETED|Overall Study||150
10377935|NCT00589914|11518912|FG001|NOT COMPLETED|Overall Study||137
10377936|NCT00589979|11518920|FG000|STARTED|Run-In Period||169
10377937|NCT00589979|11518921|FG001|STARTED|Run-In Period||0
10377938|NCT00589979|11518922|FG002|STARTED|Run-In Period||0
10377939|NCT00589979|11518920|FG000|COMPLETED|Run-In Period||93
10377940|NCT00589979|11518921|FG001|COMPLETED|Run-In Period||0
10377941|NCT00589979|11518922|FG002|COMPLETED|Run-In Period||0
10377942|NCT00589979|11518920|FG000|NOT COMPLETED|Run-In Period||76
10377943|NCT00589979|11518921|FG001|NOT COMPLETED|Run-In Period||0
10377944|NCT00589979|11518922|FG002|NOT COMPLETED|Run-In Period||0
10377945|NCT00589979|11518920|FG000|STARTED|Double-Blind Treatment Period 1|Participants completing the Run-in Period were then randomized to two different treatment sequences.|0
10377946|NCT00589979|11518921|FG001|STARTED|Double-Blind Treatment Period 1|N=21 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|50
10377947|NCT00589979|11518922|FG002|STARTED|Double-Blind Treatment Period 1|N=21 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|43
10377948|NCT00589979|11518920|FG000|COMPLETED|Double-Blind Treatment Period 1||0
10377949|NCT00589979|11518921|FG001|COMPLETED|Double-Blind Treatment Period 1||48
10377950|NCT00589979|11518922|FG002|COMPLETED|Double-Blind Treatment Period 1||41
10377951|NCT00589979|11518920|FG000|NOT COMPLETED|Double-Blind Treatment Period 1||0
10377952|NCT00589979|11518921|FG001|NOT COMPLETED|Double-Blind Treatment Period 1||2
10377953|NCT00589979|11518922|FG002|NOT COMPLETED|Double-Blind Treatment Period 1||2
10377954|NCT00589979|11518920|FG000|STARTED|Double-Blind Treatment Period 2||0
10377955|NCT00589979|11518921|FG001|STARTED|Double-Blind Treatment Period 2|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|48
10377956|NCT00589979|11518922|FG002|STARTED|Double-Blind Treatment Period 2|N=20 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|41
10377957|NCT00589979|11518920|FG000|COMPLETED|Double-Blind Treatment Period 2||0
10377958|NCT00589979|11518921|FG001|COMPLETED|Double-Blind Treatment Period 2||47
10377959|NCT00589979|11518922|FG002|COMPLETED|Double-Blind Treatment Period 2||39
10377960|NCT00589979|11518920|FG000|NOT COMPLETED|Double-Blind Treatment Period 2||0
10377961|NCT00589979|11518921|FG001|NOT COMPLETED|Double-Blind Treatment Period 2||1
10377962|NCT00589979|11518922|FG002|NOT COMPLETED|Double-Blind Treatment Period 2||2
10377963|NCT00589979|11518920|FG000|STARTED|Double-Blind Treatment Period 3||0
10377964|NCT00589979|11518921|FG001|STARTED|Double-Blind Treatment Period 3|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|47
10377965|NCT00589979|11518922|FG002|STARTED|Double-Blind Treatment Period 3|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|39
10717646|NCT02699970|11881617|FG000|NOT COMPLETED|Overall Study||0
10717647|NCT02699983|11881624|FG000|STARTED|Overall Study||18
10717648|NCT02699983|11881625|FG001|STARTED|Overall Study||17
10717649|NCT02699983|11881624|FG000|COMPLETED|Overall Study||17
10539017|NCT01458392|11691843|FG000|STARTED|Overall Study||2
10539018|NCT01458392|11691844|FG001|STARTED|Overall Study||13
10539019|NCT01458392|11691845|FG002|STARTED|Overall Study||31
10539020|NCT01458392|11691843|FG000|COMPLETED|Overall Study||0
10539021|NCT01458392|11691844|FG001|COMPLETED|Overall Study||0
10539022|NCT01458392|11691845|FG002|COMPLETED|Overall Study||0
10539023|NCT01458392|11691843|FG000|NOT COMPLETED|Overall Study||2
10539024|NCT01458392|11691844|FG001|NOT COMPLETED|Overall Study||13
10539025|NCT01458392|11691845|FG002|NOT COMPLETED|Overall Study||31
10539026|NCT01458418|11691861|FG000|STARTED|Overall Study||0
10539027|NCT01458418|11691862|FG001|STARTED|Overall Study||0
10539028|NCT01458418|11691863|FG002|STARTED|Overall Study||0
10539029|NCT01458418|11691864|FG003|STARTED|Overall Study||4
10717650|NCT02699983|11881625|FG001|COMPLETED|Overall Study||17
10717651|NCT02699983|11881624|FG000|NOT COMPLETED|Overall Study||1
10377966|NCT00589979|11518920|FG000|COMPLETED|Double-Blind Treatment Period 3||0
10377967|NCT00589979|11518921|FG001|COMPLETED|Double-Blind Treatment Period 3||46
10377968|NCT00589979|11518922|FG002|COMPLETED|Double-Blind Treatment Period 3||38
10377969|NCT00589979|11518920|FG000|NOT COMPLETED|Double-Blind Treatment Period 3||0
10377970|NCT00589979|11518921|FG001|NOT COMPLETED|Double-Blind Treatment Period 3||1
10377971|NCT00589979|11518922|FG002|NOT COMPLETED|Double-Blind Treatment Period 3||1
10377972|NCT00590005|11518934|FG000|STARTED|Overall Study||106
10377973|NCT00590005|11518935|FG001|STARTED|Overall Study||119
10377974|NCT00590005|11518934|FG000|COMPLETED|Overall Study||106
10377975|NCT00590005|11518935|FG001|COMPLETED|Overall Study||119
10377976|NCT00590005|11518934|FG000|NOT COMPLETED|Overall Study||0
10377977|NCT00590005|11518935|FG001|NOT COMPLETED|Overall Study||0
10377978|NCT00590018|11518943|FG000|STARTED|Overall Study||9
10377979|NCT00590018|11518944|FG001|STARTED|Overall Study||9
10377980|NCT00590018|11518943|FG000|COMPLETED|Overall Study||9
10377981|NCT00590018|11518944|FG001|COMPLETED|Overall Study||9
10377982|NCT00590018|11518943|FG000|NOT COMPLETED|Overall Study||0
10377983|NCT00590018|11518944|FG001|NOT COMPLETED|Overall Study||0
10377984|NCT00590031|11518950|FG000|STARTED|Overall Study||61
10377985|NCT00590031|11518950|FG000|COMPLETED|Overall Study||55
10377986|NCT00590031|11518950|FG000|NOT COMPLETED|Overall Study||6
10377987|NCT00590044|11518956|FG000|STARTED|Overall Study||38
10377988|NCT00590044|11518957|FG001|STARTED|Overall Study||36
10377989|NCT00590044|11518956|FG000|COMPLETED|Overall Study||34
10377990|NCT00590044|11518957|FG001|COMPLETED|Overall Study||34
10377991|NCT00590044|11518956|FG000|NOT COMPLETED|Overall Study||4
10539030|NCT01458418|11691861|FG000|COMPLETED|Overall Study||0
10539031|NCT01458418|11691862|FG001|COMPLETED|Overall Study||0
10539032|NCT01458418|11691863|FG002|COMPLETED|Overall Study||0
10539033|NCT01458418|11691864|FG003|COMPLETED|Overall Study||4
10539034|NCT01458418|11691861|FG000|NOT COMPLETED|Overall Study||0
10539035|NCT01458418|11691862|FG001|NOT COMPLETED|Overall Study||0
10539036|NCT01458418|11691863|FG002|NOT COMPLETED|Overall Study||0
10539037|NCT01458418|11691864|FG003|NOT COMPLETED|Overall Study||0
10539038|NCT01458522|11691876|FG000|STARTED|Overall Study||37
10539039|NCT01458522|11691877|FG001|STARTED|Overall Study||37
10539040|NCT01458522|11691876|FG000|Received First Drug|Overall Study||35
10539041|NCT01458522|11691877|FG001|Received First Drug|Overall Study||35
10539042|NCT01458522|11691876|FG000|Crossover to Second Drug|Overall Study||15
10539043|NCT01458522|11691877|FG001|Crossover to Second Drug|Overall Study||10
10539044|NCT01458522|11691876|FG000|COMPLETED|Overall Study||34
10539045|NCT01458522|11691877|FG001|COMPLETED|Overall Study||26
10539046|NCT01458522|11691876|FG000|NOT COMPLETED|Overall Study||3
10539047|NCT01458522|11691877|FG001|NOT COMPLETED|Overall Study||11
10539048|NCT01458535|11691895|FG000|STARTED|Overall Study||10
10539049|NCT01458535|11691896|FG001|STARTED|Overall Study||10
10539050|NCT01458535|11691897|FG002|STARTED|Overall Study||10
10539051|NCT01458535|11691898|FG003|STARTED|Overall Study||10
10539052|NCT01458535|11691899|FG004|STARTED|Overall Study||10
10539053|NCT01458535|11691900|FG005|STARTED|Overall Study||11
10539054|NCT01458535|11691895|FG000|COMPLETED|Overall Study||10
10539055|NCT01458535|11691896|FG001|COMPLETED|Overall Study||8
10539056|NCT01458535|11691897|FG002|COMPLETED|Overall Study||8
10539057|NCT01458535|11691898|FG003|COMPLETED|Overall Study||6
10539058|NCT01458535|11691899|FG004|COMPLETED|Overall Study||6
10539059|NCT01458535|11691900|FG005|COMPLETED|Overall Study||7
10539060|NCT01458535|11691895|FG000|NOT COMPLETED|Overall Study||0
10539061|NCT01458535|11691896|FG001|NOT COMPLETED|Overall Study||2
10539062|NCT01458535|11691897|FG002|NOT COMPLETED|Overall Study||2
10539063|NCT01458535|11691898|FG003|NOT COMPLETED|Overall Study||4
10539064|NCT01458535|11691899|FG004|NOT COMPLETED|Overall Study||4
10539065|NCT01458535|11691900|FG005|NOT COMPLETED|Overall Study||4
10539066|NCT01458561|11691916|FG000|STARTED|Overall Study||0
10539067|NCT01458561|11691917|FG001|STARTED|Overall Study||1
10539068|NCT01458561|11691916|FG000|COMPLETED|Overall Study||0
10539069|NCT01458561|11691917|FG001|COMPLETED|Overall Study||1
10539070|NCT01458561|11691916|FG000|NOT COMPLETED|Overall Study||0
10539071|NCT01458561|11691917|FG001|NOT COMPLETED|Overall Study||0
10539072|NCT01458574|11691956|FG000|STARTED|Overall Study||198
10539073|NCT01458574|11691957|FG001|STARTED|Overall Study||197
10539074|NCT01458574|11691958|FG002|STARTED|Overall Study||198
10717652|NCT02699983|11881625|FG001|NOT COMPLETED|Overall Study||0
10377992|NCT00590044|11518957|FG001|NOT COMPLETED|Overall Study||2
10539075|NCT01458574|11691956|FG000|Treated|Overall Study||198
10539076|NCT01458574|11691957|FG001|Treated|Overall Study||196
10717653|NCT02699996|11881637|FG000|STARTED|Overall Study||20
10717654|NCT02699996|11881638|FG001|STARTED|Overall Study||11
10377993|NCT00590161|11518968|FG000|STARTED|Overall Study||26
10377994|NCT00590161|11518969|FG001|STARTED|Overall Study||29
10377995|NCT00590161|11518968|FG000|COMPLETED|Overall Study||23
10377996|NCT00590161|11518969|FG001|COMPLETED|Overall Study||26
10539077|NCT01458574|11691958|FG002|Treated|Overall Study||198
10539078|NCT01458574|11691956|FG000|COMPLETED|Overall Study||111
10539079|NCT01458574|11691957|FG001|COMPLETED|Overall Study||126
10539080|NCT01458574|11691958|FG002|COMPLETED|Overall Study||53
10539081|NCT01458574|11691956|FG000|NOT COMPLETED|Overall Study||87
10539082|NCT01458574|11691957|FG001|NOT COMPLETED|Overall Study||71
10539083|NCT01458574|11691958|FG002|NOT COMPLETED|Overall Study||145
10539084|NCT01458587|11691968|FG000|STARTED|Overall Study||35
10539085|NCT01458587|11691969|FG001|STARTED|Overall Study||35
10539086|NCT01458587|11691968|FG000|COMPLETED|Overall Study||34
10717655|NCT02699996|11881637|FG000|COMPLETED|Overall Study||15
10377997|NCT00590161|11518968|FG000|NOT COMPLETED|Overall Study||3
10377998|NCT00590161|11518969|FG001|NOT COMPLETED|Overall Study||3
10377999|NCT00590226|11518977|FG000|STARTED|Overall Study||67
10378000|NCT00590226|11518978|FG001|STARTED|Overall Study||63
10378001|NCT00590226|11518977|FG000|COMPLETED|Overall Study||67
10378002|NCT00590226|11518978|FG001|COMPLETED|Overall Study||63
10378003|NCT00590226|11518977|FG000|NOT COMPLETED|Overall Study||0
10378004|NCT00590226|11518978|FG001|NOT COMPLETED|Overall Study||0
10378005|NCT00590317|11518986|FG000|STARTED|Overall Study||32
10378006|NCT00590317|11518987|FG001|STARTED|Overall Study||32
10378007|NCT00590317|11518986|FG000|COMPLETED|Overall Study||31
10378008|NCT00590317|11518987|FG001|COMPLETED|Overall Study||27
10378009|NCT00590317|11518986|FG000|NOT COMPLETED|Overall Study||1
10378010|NCT00590317|11518987|FG001|NOT COMPLETED|Overall Study||5
10378011|NCT00590369|11518996|FG000|STARTED|Overall Study||6
10378012|NCT00590369|11518997|FG001|STARTED|Overall Study||5
10378013|NCT00590369|11518996|FG000|COMPLETED|Overall Study|Study stopped early due to difficulty recruiting subjects|6
10378014|NCT00590369|11518997|FG001|COMPLETED|Overall Study||5
10378015|NCT00590369|11518996|FG000|NOT COMPLETED|Overall Study||0
10378016|NCT00590369|11518997|FG001|NOT COMPLETED|Overall Study||0
10378017|NCT00590395|11519003|FG000|STARTED|Overall Study||19
10378018|NCT00590395|11519003|FG000|COMPLETED|Overall Study||19
10378019|NCT00590395|11519003|FG000|NOT COMPLETED|Overall Study||0
10378020|NCT00590460|11519007|FG000|STARTED|Overall Study||5
10378021|NCT00590460|11519007|FG000|COMPLETED|Overall Study||5
10378022|NCT00590460|11519007|FG000|NOT COMPLETED|Overall Study||0
10378023|NCT00590564|11519015|FG000|STARTED|Overall Study||42
10378024|NCT00590564|11519015|FG000|COMPLETED|Overall Study||24
10378025|NCT00590564|11519015|FG000|NOT COMPLETED|Overall Study||18
10378026|NCT00590577|11519023|FG000|STARTED|Overall Study||160
10378027|NCT00590577|11519024|FG001|STARTED|Overall Study||165
10378028|NCT00590577|11519025|FG002|STARTED|Overall Study||163
10378029|NCT00590577|11519026|FG003|STARTED|Overall Study||164
10378030|NCT00590577|11519023|FG000|COMPLETED|Overall Study||83
10378031|NCT00590577|11519024|FG001|COMPLETED|Overall Study||89
10378032|NCT00590577|11519025|FG002|COMPLETED|Overall Study||90
10378033|NCT00590577|11519026|FG003|COMPLETED|Overall Study||71
10378034|NCT00590577|11519023|FG000|NOT COMPLETED|Overall Study||77
10378035|NCT00590577|11519024|FG001|NOT COMPLETED|Overall Study||76
10378036|NCT00590577|11519025|FG002|NOT COMPLETED|Overall Study||73
10378037|NCT00590577|11519026|FG003|NOT COMPLETED|Overall Study||93
10378038|NCT00590590|11519039|FG000|STARTED|Overall Study||39
10378039|NCT00590590|11519040|FG001|STARTED|Overall Study||39
10378040|NCT00590590|11519041|FG002|STARTED|Overall Study||27
10378041|NCT00590590|11519039|FG000|COMPLETED|Overall Study||32
10378042|NCT00590590|11519040|FG001|COMPLETED|Overall Study||33
10378043|NCT00590590|11519041|FG002|COMPLETED|Overall Study||21
10378044|NCT00590590|11519039|FG000|NOT COMPLETED|Overall Study||7
10378045|NCT00590590|11519040|FG001|NOT COMPLETED|Overall Study||6
10378046|NCT00590590|11519041|FG002|NOT COMPLETED|Overall Study||6
10378047|NCT00590681|11519049|FG000|STARTED|Overall Study||62
10378048|NCT00590681|11519049|FG000|COMPLETED|Overall Study|The forty-two participants who did proceed to the post-RT phase|42
10378049|NCT00590681|11519049|FG000|NOT COMPLETED|Overall Study||20
10378050|NCT00590707|11519055|FG000|STARTED|Overall Study||100
10378051|NCT00590707|11519056|FG001|STARTED|Overall Study||100
10378052|NCT00590707|11519055|FG000|COMPLETED|Overall Study||100
10378053|NCT00590707|11519056|FG001|COMPLETED|Overall Study||100
10378054|NCT00590707|11519055|FG000|NOT COMPLETED|Overall Study||0
10378055|NCT00590707|11519056|FG001|NOT COMPLETED|Overall Study||0
10378056|NCT00590720|11519064|FG000|STARTED|Overall Study||4
10378057|NCT00590720|11519065|FG001|STARTED|Overall Study||7
10378058|NCT00590720|11519064|FG000|COMPLETED|Overall Study||3
10378059|NCT00590720|11519065|FG001|COMPLETED|Overall Study||6
10378060|NCT00590720|11519064|FG000|NOT COMPLETED|Overall Study||1
10378061|NCT00590720|11519065|FG001|NOT COMPLETED|Overall Study||1
10378062|NCT00590759|11519071|FG000|STARTED|Overall Study||150
10378063|NCT00590759|11519071|FG000|COMPLETED|Overall Study||70
10378064|NCT00590759|11519071|FG000|NOT COMPLETED|Overall Study||80
10717656|NCT02699996|11881638|FG001|COMPLETED|Overall Study||9
10717657|NCT02699996|11881637|FG000|NOT COMPLETED|Overall Study||5
10717658|NCT02699996|11881638|FG001|NOT COMPLETED|Overall Study||2
10378065|NCT00590772|11519075|FG000|STARTED|Overall Study||31
10378066|NCT00590772|11519075|FG000|COMPLETED|Overall Study||31
10378067|NCT00590772|11519075|FG000|NOT COMPLETED|Overall Study||0
10378068|NCT00590824|11519085|FG000|STARTED|Overall Study||11
10378069|NCT00590824|11519086|FG001|STARTED|Overall Study||9
10378070|NCT00590824|11519087|FG002|STARTED|Overall Study||2
10378071|NCT00590824|11519088|FG003|STARTED|Overall Study||1
10378072|NCT00590824|11519085|FG000|COMPLETED|Overall Study||11
10378073|NCT00590824|11519086|FG001|COMPLETED|Overall Study||7
10378074|NCT00590824|11519087|FG002|COMPLETED|Overall Study||1
10378075|NCT00590824|11519088|FG003|COMPLETED|Overall Study||0
10378076|NCT00590824|11519085|FG000|NOT COMPLETED|Overall Study||0
10378077|NCT00590824|11519086|FG001|NOT COMPLETED|Overall Study||2
10717659|NCT02700165|11881645|FG000|STARTED|Overall Study||14
10378078|NCT00590824|11519087|FG002|NOT COMPLETED|Overall Study||1
10378079|NCT00590824|11519088|FG003|NOT COMPLETED|Overall Study||1
10378080|NCT00590863|11519101|FG000|STARTED|Overall Study||221
10378081|NCT00590863|11519102|FG001|STARTED|Overall Study||220
10378082|NCT00590863|11519103|FG002|STARTED|Overall Study||224
10717660|NCT02700165|11881645|FG000|COMPLETED|Overall Study||14
10717661|NCT02700165|11881645|FG000|NOT COMPLETED|Overall Study||0
10378083|NCT00590863|11519101|FG000|COMPLETED|Overall Study||137
10378084|NCT00590863|11519102|FG001|COMPLETED|Overall Study||138
10378085|NCT00590863|11519103|FG002|COMPLETED|Overall Study||146
10378086|NCT00590863|11519101|FG000|NOT COMPLETED|Overall Study||84
10378087|NCT00590863|11519102|FG001|NOT COMPLETED|Overall Study||82
10378088|NCT00590863|11519103|FG002|NOT COMPLETED|Overall Study||78
10378089|NCT00590889|11519114|FG000|STARTED|Overall Study||404
10539087|NCT01458587|11691969|FG001|COMPLETED|Overall Study||35
10539088|NCT01458587|11691968|FG000|NOT COMPLETED|Overall Study||1
10539089|NCT01458587|11691969|FG001|NOT COMPLETED|Overall Study||0
10539090|NCT01458639|11691977|FG000|STARTED|Overall Study||18
10539091|NCT01458639|11691977|FG000|COMPLETED|Overall Study||12
10539092|NCT01458639|11691977|FG000|NOT COMPLETED|Overall Study||6
10548080|NCT01516970|11701876|FG001|COMPLETED|Overall Study||132
10548081|NCT01516970|11701875|FG000|NOT COMPLETED|Overall Study||18
10548082|NCT01516970|11701876|FG001|NOT COMPLETED|Overall Study||21
10548083|NCT01517074|11701882|FG000|STARTED|Overall Study||5
10548084|NCT01517074|11701882|FG000|COMPLETED|Overall Study||5
10548085|NCT01517074|11701882|FG000|NOT COMPLETED|Overall Study||0
10548086|NCT01517178|11701891|FG000|STARTED|Period 1|One subject (who discontinued due to an adverse event) actually used New ostomy base plate.|16
10548087|NCT01517178|11701892|FG001|STARTED|Period 1||11
10548088|NCT01517178|11701891|FG000|COMPLETED|Period 1||12
10548089|NCT01517178|11701892|FG001|COMPLETED|Period 1||6
10548090|NCT01517178|11701891|FG000|NOT COMPLETED|Period 1||4
10548091|NCT01517178|11701892|FG001|NOT COMPLETED|Period 1||5
10548092|NCT01517178|11701891|FG000|STARTED|Period 2|One subject discontinued during run-in and did not start period 2.|11
10548093|NCT01517178|11701892|FG001|STARTED|Period 2||6
10548094|NCT01517178|11701891|FG000|COMPLETED|Period 2||5
10548095|NCT01517178|11701892|FG001|COMPLETED|Period 2||4
10548096|NCT01517178|11701891|FG000|NOT COMPLETED|Period 2||6
10548097|NCT01517178|11701892|FG001|NOT COMPLETED|Period 2||2
10548098|NCT01517282|11701902|FG000|STARTED|Overall Study|One patient was randomized but did not receive study medication based on the investigator's decision|9
10548099|NCT01517282|11701903|FG001|STARTED|Overall Study||8
10548100|NCT01517282|11701904|FG002|STARTED|Overall Study|1 patient completed the trial, but received only 4 doses of medication and 2 MRIs due to pregnancy|9
10548101|NCT01517282|11701905|FG003|STARTED|Overall Study||6
10548102|NCT01517282|11701902|FG000|COMPLETED|Overall Study||8
10548103|NCT01517282|11701903|FG001|COMPLETED|Overall Study||7
10548104|NCT01517282|11701904|FG002|COMPLETED|Overall Study||8
10548105|NCT01517282|11701905|FG003|COMPLETED|Overall Study||5
10548106|NCT01517282|11701902|FG000|NOT COMPLETED|Overall Study||1
10548107|NCT01517282|11701903|FG001|NOT COMPLETED|Overall Study||1
10548108|NCT01517282|11701904|FG002|NOT COMPLETED|Overall Study||1
10548109|NCT01517282|11701905|FG003|NOT COMPLETED|Overall Study||1
10548110|NCT01517295|11701917|FG000|STARTED|Overall Study||16
10548111|NCT01517295|11701918|FG001|STARTED|Overall Study||14
10548112|NCT01517295|11701917|FG000|COMPLETED|Overall Study||15
10548113|NCT01517295|11701918|FG001|COMPLETED|Overall Study||14
10548114|NCT01517295|11701917|FG000|NOT COMPLETED|Overall Study||1
10548115|NCT01517295|11701918|FG001|NOT COMPLETED|Overall Study||0
10548116|NCT01517373|11701929|FG000|STARTED|Run-in Period||361
10548117|NCT01517373|11701930|FG001|STARTED|Run-in Period||0
10548118|NCT01517373|11701931|FG002|STARTED|Run-in Period||0
10378090|NCT00590889|11519115|FG001|STARTED|Overall Study||403
10378091|NCT00590889|11519114|FG000|COMPLETED|Overall Study||118
10378092|NCT00590889|11519115|FG001|COMPLETED|Overall Study||104
10548119|NCT01517373|11701932|FG003|STARTED|Run-in Period||0
10548120|NCT01517373|11701933|FG004|STARTED|Run-in Period||0
10548121|NCT01517373|11701934|FG005|STARTED|Run-in Period||0
10548122|NCT01517373|11701929|FG000|COMPLETED|Run-in Period||304
10548123|NCT01517373|11701930|FG001|COMPLETED|Run-in Period||0
10548124|NCT01517373|11701931|FG002|COMPLETED|Run-in Period||0
10548125|NCT01517373|11701932|FG003|COMPLETED|Run-in Period||0
10548126|NCT01517373|11701933|FG004|COMPLETED|Run-in Period||0
10548127|NCT01517373|11701934|FG005|COMPLETED|Run-in Period||0
10548128|NCT01517373|11701929|FG000|NOT COMPLETED|Run-in Period||57
10548129|NCT01517373|11701930|FG001|NOT COMPLETED|Run-in Period||0
10548130|NCT01517373|11701931|FG002|NOT COMPLETED|Run-in Period||0
10548131|NCT01517373|11701932|FG003|NOT COMPLETED|Run-in Period||0
10548132|NCT01517373|11701933|FG004|NOT COMPLETED|Run-in Period||0
10548133|NCT01517373|11701934|FG005|NOT COMPLETED|Run-in Period||0
10548134|NCT01517373|11701929|FG000|STARTED|Treatment Period||0
10548135|NCT01517373|11701930|FG001|STARTED|Treatment Period||61
10548136|NCT01517373|11701931|FG002|STARTED|Treatment Period||60
10548137|NCT01517373|11701932|FG003|STARTED|Treatment Period||61
10548138|NCT01517373|11701933|FG004|STARTED|Treatment Period||61
10548139|NCT01517373|11701934|FG005|STARTED|Treatment Period||61
10548140|NCT01517373|11701929|FG000|COMPLETED|Treatment Period||0
10548141|NCT01517373|11701930|FG001|COMPLETED|Treatment Period||57
10548142|NCT01517373|11701931|FG002|COMPLETED|Treatment Period||54
10548143|NCT01517373|11701932|FG003|COMPLETED|Treatment Period||54
10548144|NCT01517373|11701933|FG004|COMPLETED|Treatment Period||55
10548145|NCT01517373|11701934|FG005|COMPLETED|Treatment Period||54
10548146|NCT01517373|11701929|FG000|NOT COMPLETED|Treatment Period||0
10548147|NCT01517373|11701930|FG001|NOT COMPLETED|Treatment Period||4
10548148|NCT01517373|11701931|FG002|NOT COMPLETED|Treatment Period||6
10548149|NCT01517373|11701932|FG003|NOT COMPLETED|Treatment Period||7
10548150|NCT01517373|11701933|FG004|NOT COMPLETED|Treatment Period||6
10548151|NCT01517373|11701934|FG005|NOT COMPLETED|Treatment Period||7
10378093|NCT00590889|11519114|FG000|NOT COMPLETED|Overall Study||286
10378094|NCT00590889|11519115|FG001|NOT COMPLETED|Overall Study||299
10378095|NCT00590902|11519121|FG000|STARTED|Overall Study||81
10378096|NCT00590902|11519121|FG000|COMPLETED|Overall Study||80
10378097|NCT00590902|11519121|FG000|NOT COMPLETED|Overall Study||1
10378098|NCT00590954|11519125|FG000|STARTED|Overall Study||32
10378099|NCT00590954|11519125|FG000|COMPLETED|Overall Study||30
10378100|NCT00590954|11519125|FG000|NOT COMPLETED|Overall Study||2
10378101|NCT00590967|11519133|FG000|STARTED|Overall Study||44
10378102|NCT00590967|11519134|FG001|STARTED|Overall Study||25
10378103|NCT00590967|11519133|FG000|COMPLETED|Overall Study||41
10378104|NCT00590967|11519134|FG001|COMPLETED|Overall Study||20
10378105|NCT00590967|11519133|FG000|NOT COMPLETED|Overall Study||3
10378106|NCT00590967|11519134|FG001|NOT COMPLETED|Overall Study||5
10378107|NCT00590980|11519140|FG000|STARTED|Overall Study||82
10378108|NCT00590980|11519140|FG000|COMPLETED|Overall Study||72
10378109|NCT00590980|11519140|FG000|NOT COMPLETED|Overall Study||10
10378110|NCT00591006|11519144|FG000|STARTED|Overall Study||1
10378111|NCT00591006|11519145|FG001|STARTED|Overall Study||0
10378112|NCT00591006|11519146|FG002|STARTED|Overall Study||1
10378113|NCT00591006|11519147|FG003|STARTED|Overall Study||1
10378114|NCT00591006|11519148|FG004|STARTED|Overall Study||1
10378115|NCT00591006|11519149|FG005|STARTED|Overall Study||0
10378116|NCT00591006|11519150|FG006|STARTED|Overall Study||1
10378117|NCT00591006|11519151|FG007|STARTED|Overall Study||0
10378118|NCT00591006|11519152|FG008|STARTED|Overall Study||1
10378119|NCT00591006|11519153|FG009|STARTED|Overall Study||1
10378120|NCT00591006|11519154|FG010|STARTED|Overall Study||0
10378121|NCT00591006|11519155|FG011|STARTED|Overall Study||1
10378122|NCT00591006|11519156|FG012|STARTED|Overall Study||1
10378123|NCT00591006|11519157|FG013|STARTED|Overall Study||2
10378124|NCT00591006|11519158|FG014|STARTED|Overall Study||0
10378125|NCT00591006|11519159|FG015|STARTED|Overall Study||1
10378126|NCT00591006|11519160|FG016|STARTED|Overall Study||0
10378127|NCT00591006|11519161|FG017|STARTED|Overall Study||1
10378128|NCT00591006|11519162|FG018|STARTED|Overall Study||0
10378129|NCT00591006|11519163|FG019|STARTED|Overall Study||1
10378130|NCT00591006|11519164|FG020|STARTED|Overall Study||0
10378131|NCT00591006|11519165|FG021|STARTED|Overall Study||1
10378132|NCT00591006|11519166|FG022|STARTED|Overall Study||1
10378133|NCT00591006|11519167|FG023|STARTED|Overall Study||1
10378134|NCT00591006|11519144|FG000|Treatment #2|Overall Study||1
10378135|NCT00591006|11519145|FG001|Treatment #2|Overall Study||0
10378136|NCT00591006|11519146|FG002|Treatment #2|Overall Study||1
10378137|NCT00591006|11519147|FG003|Treatment #2|Overall Study||1
10378138|NCT00591006|11519148|FG004|Treatment #2|Overall Study||1
10378139|NCT00591006|11519149|FG005|Treatment #2|Overall Study||0
10378140|NCT00591006|11519150|FG006|Treatment #2|Overall Study||1
10378141|NCT00591006|11519151|FG007|Treatment #2|Overall Study||0
10378142|NCT00591006|11519152|FG008|Treatment #2|Overall Study||1
10378143|NCT00591006|11519153|FG009|Treatment #2|Overall Study||1
10378144|NCT00591006|11519154|FG010|Treatment #2|Overall Study||0
10378145|NCT00591006|11519155|FG011|Treatment #2|Overall Study||1
10378146|NCT00591006|11519156|FG012|Treatment #2|Overall Study||1
10378147|NCT00591006|11519157|FG013|Treatment #2|Overall Study||2
10378148|NCT00591006|11519158|FG014|Treatment #2|Overall Study||0
10378149|NCT00591006|11519159|FG015|Treatment #2|Overall Study||0
10378150|NCT00591006|11519160|FG016|Treatment #2|Overall Study||0
10378151|NCT00591006|11519161|FG017|Treatment #2|Overall Study||1
10378152|NCT00591006|11519162|FG018|Treatment #2|Overall Study||0
10378153|NCT00591006|11519163|FG019|Treatment #2|Overall Study||1
10378154|NCT00591006|11519164|FG020|Treatment #2|Overall Study||0
10539093|NCT01458951|11691984|FG000|STARTED|Overall Study||429
10539094|NCT01458951|11691985|FG001|STARTED|Overall Study||6
10539095|NCT01458951|11691986|FG002|STARTED|Overall Study||112
10539096|NCT01458951|11691984|FG000|COMPLETED|Overall Study||397
10539097|NCT01458951|11691985|FG001|COMPLETED|Overall Study||5
10539098|NCT01458951|11691986|FG002|COMPLETED|Overall Study||97
10539099|NCT01458951|11691984|FG000|NOT COMPLETED|Overall Study||32
10539100|NCT01458951|11691985|FG001|NOT COMPLETED|Overall Study||1
10378155|NCT00591006|11519165|FG021|Treatment #2|Overall Study||1
10378156|NCT00591006|11519166|FG022|Treatment #2|Overall Study||1
10378157|NCT00591006|11519167|FG023|Treatment #2|Overall Study||1
10378158|NCT00591006|11519144|FG000|Treatment #3|Overall Study||1
10378159|NCT00591006|11519145|FG001|Treatment #3|Overall Study||0
10378160|NCT00591006|11519146|FG002|Treatment #3|Overall Study||1
10378161|NCT00591006|11519147|FG003|Treatment #3|Overall Study||1
10378162|NCT00591006|11519148|FG004|Treatment #3|Overall Study||1
10378163|NCT00591006|11519149|FG005|Treatment #3|Overall Study||0
10378164|NCT00591006|11519150|FG006|Treatment #3|Overall Study||1
10378165|NCT00591006|11519151|FG007|Treatment #3|Overall Study||0
10378166|NCT00591006|11519152|FG008|Treatment #3|Overall Study||1
10378167|NCT00591006|11519153|FG009|Treatment #3|Overall Study||1
10378168|NCT00591006|11519154|FG010|Treatment #3|Overall Study||0
10378169|NCT00591006|11519155|FG011|Treatment #3|Overall Study||1
10378170|NCT00591006|11519156|FG012|Treatment #3|Overall Study||1
10539101|NCT01458951|11691986|FG002|NOT COMPLETED|Overall Study||15
10539102|NCT01458990|11691995|FG000|STARTED|Overall Study||45
10378171|NCT00591006|11519157|FG013|Treatment #3|Overall Study||2
10378172|NCT00591006|11519158|FG014|Treatment #3|Overall Study||0
10378173|NCT00591006|11519159|FG015|Treatment #3|Overall Study||0
10539103|NCT01458990|11691996|FG001|STARTED|Overall Study||15
10378174|NCT00591006|11519160|FG016|Treatment #3|Overall Study||0
10378175|NCT00591006|11519161|FG017|Treatment #3|Overall Study||1
10378176|NCT00591006|11519162|FG018|Treatment #3|Overall Study||0
10378177|NCT00591006|11519163|FG019|Treatment #3|Overall Study||1
10378178|NCT00591006|11519164|FG020|Treatment #3|Overall Study||0
10378179|NCT00591006|11519165|FG021|Treatment #3|Overall Study||1
10378180|NCT00591006|11519166|FG022|Treatment #3|Overall Study||1
10378181|NCT00591006|11519167|FG023|Treatment #3|Overall Study||1
10378182|NCT00591006|11519144|FG000|Treatment #4|Overall Study||1
10717662|NCT02700334|11881652|FG000|STARTED|Overall Study||12
10717663|NCT02700334|11881653|FG001|STARTED|Overall Study||12
10717664|NCT02700334|11881652|FG000|COMPLETED|Overall Study||12
10717665|NCT02700334|11881653|FG001|COMPLETED|Overall Study||12
10717666|NCT02700334|11881652|FG000|NOT COMPLETED|Overall Study||0
10717667|NCT02700334|11881653|FG001|NOT COMPLETED|Overall Study||0
10717668|NCT02700412|11881659|FG000|STARTED|Overall Study||80
10717669|NCT02700412|11881659|FG000|COMPLETED|Overall Study||47
10717670|NCT02700412|11881659|FG000|NOT COMPLETED|Overall Study||33
10717671|NCT02700425|11881665|FG000|STARTED|Overall Study||21
10717672|NCT02700425|11881666|FG001|STARTED|Overall Study||20
10717673|NCT02700425|11881665|FG000|COMPLETED|Overall Study||21
10378183|NCT00591006|11519145|FG001|Treatment #4|Overall Study||0
10378184|NCT00591006|11519146|FG002|Treatment #4|Overall Study||1
10378185|NCT00591006|11519147|FG003|Treatment #4|Overall Study||1
10378186|NCT00591006|11519148|FG004|Treatment #4|Overall Study||1
10378187|NCT00591006|11519149|FG005|Treatment #4|Overall Study||0
10378188|NCT00591006|11519150|FG006|Treatment #4|Overall Study||1
10717674|NCT02700425|11881666|FG001|COMPLETED|Overall Study|1 patient withdrew after randomization|19
10717675|NCT02700425|11881665|FG000|NOT COMPLETED|Overall Study||0
10717676|NCT02700425|11881666|FG001|NOT COMPLETED|Overall Study||1
10717677|NCT02700815|11881676|FG000|STARTED|Overall Study||75
10717678|NCT02700815|11881677|FG001|STARTED|Overall Study||223
10717679|NCT02700815|11881678|FG002|STARTED|Overall Study||223
10717680|NCT02700815|11881679|FG003|STARTED|Overall Study||225
10717681|NCT02700815|11881676|FG000|COMPLETED|Overall Study||74
10717682|NCT02700815|11881677|FG001|COMPLETED|Overall Study||216
10378189|NCT00591006|11519151|FG007|Treatment #4|Overall Study||0
10378190|NCT00591006|11519152|FG008|Treatment #4|Overall Study||1
10378191|NCT00591006|11519153|FG009|Treatment #4|Overall Study||1
10378192|NCT00591006|11519154|FG010|Treatment #4|Overall Study||0
10378193|NCT00591006|11519155|FG011|Treatment #4|Overall Study||1
10378194|NCT00591006|11519156|FG012|Treatment #4|Overall Study||1
10378195|NCT00591006|11519157|FG013|Treatment #4|Overall Study||2
10378196|NCT00591006|11519158|FG014|Treatment #4|Overall Study||0
10378197|NCT00591006|11519159|FG015|Treatment #4|Overall Study||0
10378198|NCT00591006|11519160|FG016|Treatment #4|Overall Study||0
10378199|NCT00591006|11519161|FG017|Treatment #4|Overall Study||1
10378200|NCT00591006|11519162|FG018|Treatment #4|Overall Study||0
10717683|NCT02700815|11881678|FG002|COMPLETED|Overall Study||219
10378201|NCT00591006|11519163|FG019|Treatment #4|Overall Study||1
10378202|NCT00591006|11519164|FG020|Treatment #4|Overall Study||0
10378203|NCT00591006|11519165|FG021|Treatment #4|Overall Study||1
10378204|NCT00591006|11519166|FG022|Treatment #4|Overall Study||0
10378205|NCT00591006|11519167|FG023|Treatment #4|Overall Study||0
10378206|NCT00591006|11519144|FG000|COMPLETED|Overall Study||1
10378207|NCT00591006|11519145|FG001|COMPLETED|Overall Study||0
10378208|NCT00591006|11519146|FG002|COMPLETED|Overall Study||1
10378209|NCT00591006|11519147|FG003|COMPLETED|Overall Study||1
10378210|NCT00591006|11519148|FG004|COMPLETED|Overall Study||1
10378211|NCT00591006|11519149|FG005|COMPLETED|Overall Study||0
10378212|NCT00591006|11519150|FG006|COMPLETED|Overall Study||1
10378213|NCT00591006|11519151|FG007|COMPLETED|Overall Study||0
10378214|NCT00591006|11519152|FG008|COMPLETED|Overall Study||1
10378215|NCT00591006|11519153|FG009|COMPLETED|Overall Study||1
10378216|NCT00591006|11519154|FG010|COMPLETED|Overall Study||0
10378217|NCT00591006|11519155|FG011|COMPLETED|Overall Study||1
10378218|NCT00591006|11519156|FG012|COMPLETED|Overall Study||1
10378219|NCT00591006|11519157|FG013|COMPLETED|Overall Study||2
10378220|NCT00591006|11519158|FG014|COMPLETED|Overall Study||0
10378221|NCT00591006|11519159|FG015|COMPLETED|Overall Study||0
10378222|NCT00591006|11519160|FG016|COMPLETED|Overall Study||0
10378223|NCT00591006|11519161|FG017|COMPLETED|Overall Study||1
10378224|NCT00591006|11519162|FG018|COMPLETED|Overall Study||0
10378225|NCT00591006|11519163|FG019|COMPLETED|Overall Study||1
10378226|NCT00591006|11519164|FG020|COMPLETED|Overall Study||0
10378227|NCT00591006|11519165|FG021|COMPLETED|Overall Study||1
10378228|NCT00591006|11519166|FG022|COMPLETED|Overall Study||0
10378229|NCT00591006|11519167|FG023|COMPLETED|Overall Study||0
10717684|NCT02700815|11881679|FG003|COMPLETED|Overall Study||218
10717685|NCT02700815|11881676|FG000|NOT COMPLETED|Overall Study||1
10717686|NCT02700815|11881677|FG001|NOT COMPLETED|Overall Study||7
10717687|NCT02700815|11881678|FG002|NOT COMPLETED|Overall Study||4
10717688|NCT02700815|11881679|FG003|NOT COMPLETED|Overall Study||7
10378230|NCT00591006|11519144|FG000|NOT COMPLETED|Overall Study||0
10378231|NCT00591006|11519145|FG001|NOT COMPLETED|Overall Study||0
10378232|NCT00591006|11519146|FG002|NOT COMPLETED|Overall Study||0
10378233|NCT00591006|11519147|FG003|NOT COMPLETED|Overall Study||0
10378234|NCT00591006|11519148|FG004|NOT COMPLETED|Overall Study||0
10378235|NCT00591006|11519149|FG005|NOT COMPLETED|Overall Study||0
10378236|NCT00591006|11519150|FG006|NOT COMPLETED|Overall Study||0
10717689|NCT02700919|11881692|FG000|STARTED|Overall Study||94
10717690|NCT02700919|11881693|FG001|STARTED|Overall Study||97
10378237|NCT00591006|11519151|FG007|NOT COMPLETED|Overall Study||0
10378238|NCT00591006|11519152|FG008|NOT COMPLETED|Overall Study||0
10378239|NCT00591006|11519153|FG009|NOT COMPLETED|Overall Study||0
10378240|NCT00591006|11519154|FG010|NOT COMPLETED|Overall Study||0
10378241|NCT00591006|11519155|FG011|NOT COMPLETED|Overall Study||0
10378242|NCT00591006|11519156|FG012|NOT COMPLETED|Overall Study||0
10378243|NCT00591006|11519157|FG013|NOT COMPLETED|Overall Study||0
10378244|NCT00591006|11519158|FG014|NOT COMPLETED|Overall Study||0
10378245|NCT00591006|11519159|FG015|NOT COMPLETED|Overall Study||1
10378246|NCT00591006|11519160|FG016|NOT COMPLETED|Overall Study||0
10378247|NCT00591006|11519161|FG017|NOT COMPLETED|Overall Study||0
10378248|NCT00591006|11519162|FG018|NOT COMPLETED|Overall Study||0
10378249|NCT00591006|11519163|FG019|NOT COMPLETED|Overall Study||0
10378250|NCT00591006|11519164|FG020|NOT COMPLETED|Overall Study||0
10378251|NCT00591006|11519165|FG021|NOT COMPLETED|Overall Study||0
10378252|NCT00591006|11519166|FG022|NOT COMPLETED|Overall Study||1
10378253|NCT00591006|11519167|FG023|NOT COMPLETED|Overall Study||1
10378254|NCT00591019|11519184|FG000|STARTED|Baseline (1 Day)||3
10378255|NCT00591019|11519185|FG001|STARTED|Baseline (1 Day)||4
10378256|NCT00591019|11519184|FG000|COMPLETED|Baseline (1 Day)||3
10378257|NCT00591019|11519185|FG001|COMPLETED|Baseline (1 Day)||4
10378258|NCT00591019|11519184|FG000|NOT COMPLETED|Baseline (1 Day)||0
10378259|NCT00591019|11519185|FG001|NOT COMPLETED|Baseline (1 Day)||0
10378260|NCT00591019|11519184|FG000|STARTED|Intervention 1 (14 Days)|One subject dropped out after baseline|2
10378261|NCT00591019|11519185|FG001|STARTED|Intervention 1 (14 Days)|One subject dropped out after baseline|3
10378262|NCT00591019|11519184|FG000|COMPLETED|Intervention 1 (14 Days)||2
10378263|NCT00591019|11519185|FG001|COMPLETED|Intervention 1 (14 Days)||3
10378264|NCT00591019|11519184|FG000|NOT COMPLETED|Intervention 1 (14 Days)||0
10378265|NCT00591019|11519185|FG001|NOT COMPLETED|Intervention 1 (14 Days)||0
10378266|NCT00591019|11519184|FG000|STARTED|Intevention 2 (14 Days)||2
10378267|NCT00591019|11519185|FG001|STARTED|Intevention 2 (14 Days)||3
10378268|NCT00591019|11519184|FG000|COMPLETED|Intevention 2 (14 Days)||2
10378269|NCT00591019|11519185|FG001|COMPLETED|Intevention 2 (14 Days)||3
10378270|NCT00591019|11519184|FG000|NOT COMPLETED|Intevention 2 (14 Days)||0
10378271|NCT00591019|11519185|FG001|NOT COMPLETED|Intevention 2 (14 Days)||0
10378272|NCT00591123|11519193|FG000|STARTED|Overall Study||38
10378273|NCT00591123|11519193|FG000|COMPLETED|Overall Study|38 were analyzed for safety, 33 were included for efficacy.|38
10378274|NCT00591123|11519193|FG000|NOT COMPLETED|Overall Study||0
10378275|NCT00591149|11519197|FG000|STARTED|Overall Study||16
10378276|NCT00591149|11519197|FG000|COMPLETED|Overall Study||11
10378277|NCT00591149|11519197|FG000|NOT COMPLETED|Overall Study||5
10378278|NCT00591214|11519201|FG000|STARTED|Overall Study||10
10378279|NCT00591214|11519201|FG000|COMPLETED|Overall Study||2
10378280|NCT00591214|11519201|FG000|NOT COMPLETED|Overall Study||8
10378281|NCT00591240|11519207|FG000|STARTED|Overall Study||116
10378282|NCT00591240|11519208|FG001|STARTED|Overall Study||222
10378283|NCT00591240|11519207|FG000|COMPLETED|Overall Study||116
10378284|NCT00591240|11519208|FG001|COMPLETED|Overall Study||222
10378285|NCT00591240|11519207|FG000|NOT COMPLETED|Overall Study||0
10378286|NCT00591240|11519208|FG001|NOT COMPLETED|Overall Study||0
10378287|NCT00591253|11519217|FG000|STARTED|Overall Study|Randomized or Treated|140
10378288|NCT00591253|11519218|FG001|STARTED|Overall Study|Randomized or Treated|137
10378289|NCT00591253|11519219|FG002|STARTED|Overall Study|Randomized or Treated|138
10378290|NCT00591253|11519217|FG000|COMPLETED|Overall Study||126
10378291|NCT00591253|11519218|FG001|COMPLETED|Overall Study||116
10378292|NCT00591253|11519219|FG002|COMPLETED|Overall Study||123
10378293|NCT00591253|11519217|FG000|NOT COMPLETED|Overall Study||14
10378294|NCT00591253|11519218|FG001|NOT COMPLETED|Overall Study||21
10378295|NCT00591253|11519219|FG002|NOT COMPLETED|Overall Study||15
10378296|NCT00591266|11519230|FG000|STARTED|Overall Study|Randomized only|189
10378297|NCT00591266|11519231|FG001|STARTED|Overall Study|Randomized only|188
10378298|NCT00591266|11519232|FG002|STARTED|Overall Study|Randomized only|189
10378299|NCT00591266|11519230|FG000|COMPLETED|Overall Study||180
10378300|NCT00591266|11519231|FG001|COMPLETED|Overall Study||177
10378301|NCT00591266|11519232|FG002|COMPLETED|Overall Study||175
10378302|NCT00591266|11519230|FG000|NOT COMPLETED|Overall Study||9
10378303|NCT00591266|11519231|FG001|NOT COMPLETED|Overall Study||11
10378304|NCT00591266|11519232|FG002|NOT COMPLETED|Overall Study||14
10378305|NCT00591305|11519242|FG000|STARTED|Overall Study||1
10378306|NCT00591305|11519243|FG001|STARTED|Overall Study||0
10378307|NCT00591305|11519242|FG000|1st Follow-up in 2 Wks After Surgery|Overall Study||1
10378308|NCT00591305|11519243|FG001|1st Follow-up in 2 Wks After Surgery|Overall Study||0
10378309|NCT00591305|11519242|FG000|COMPLETED|Overall Study||1
10378310|NCT00591305|11519243|FG001|COMPLETED|Overall Study||0
10378311|NCT00591305|11519242|FG000|NOT COMPLETED|Overall Study||0
10378312|NCT00591305|11519243|FG001|NOT COMPLETED|Overall Study||0
10378313|NCT00591344|11519252|FG000|STARTED|Overall Study|25 randomized, 1 withdrew before the 6 month test and was replaced; 24 completed the 6 month test|25
10378314|NCT00591344|11519253|FG001|STARTED|Overall Study|26 randomized, 2 withdrew before the 6 month test and were replaced, 24 completed 6 month test|26
10378315|NCT00591344|11519252|FG000|Completed the 6 Month Test|Overall Study|Number of subjects who completed the 6 month test|24
10378316|NCT00591344|11519253|FG001|Completed the 6 Month Test|Overall Study|Number of subjects who completed the 6 month test|24
10378317|NCT00591344|11519252|FG000|COMPLETED|Overall Study|Number of subjects who completed the final 24 month test|20
10378318|NCT00591344|11519253|FG001|COMPLETED|Overall Study|Number of subjects who completed the final 24 month test|18
10378319|NCT00591344|11519252|FG000|NOT COMPLETED|Overall Study||5
10378320|NCT00591344|11519253|FG001|NOT COMPLETED|Overall Study||8
10378321|NCT00591370|11519263|FG000|STARTED|Overall Study||51
10378322|NCT00591370|11519263|FG000|COMPLETED|Overall Study||49
10378323|NCT00591370|11519263|FG000|NOT COMPLETED|Overall Study||2
10378324|NCT00591409|11519277|FG000|STARTED|Overall Study||10
10378325|NCT00591409|11519278|FG001|STARTED|Overall Study||10
10378326|NCT00591409|11519279|FG002|STARTED|Overall Study||10
10378327|NCT00591409|11519280|FG003|STARTED|Overall Study||10
10378328|NCT00591409|11519281|FG004|STARTED|Overall Study||10
10378329|NCT00591409|11519282|FG005|STARTED|Overall Study||10
10378330|NCT00591409|11519283|FG006|STARTED|Overall Study||10
10378331|NCT00591409|11519284|FG007|STARTED|Overall Study||10
10378332|NCT00591409|11519285|FG008|STARTED|Overall Study||9
10378333|NCT00591409|11519286|FG009|STARTED|Overall Study||11
10378334|NCT00591409|11519277|FG000|Treated|Overall Study||10
10378335|NCT00591409|11519278|FG001|Treated|Overall Study||10
10378336|NCT00591409|11519279|FG002|Treated|Overall Study||10
10378337|NCT00591409|11519280|FG003|Treated|Overall Study||10
10378338|NCT00591409|11519281|FG004|Treated|Overall Study||9
10378339|NCT00591409|11519282|FG005|Treated|Overall Study||10
10378340|NCT00591409|11519283|FG006|Treated|Overall Study||10
10378341|NCT00591409|11519284|FG007|Treated|Overall Study||10
10378342|NCT00591409|11519285|FG008|Treated|Overall Study||9
10378343|NCT00591409|11519286|FG009|Treated|Overall Study||10
10378344|NCT00591409|11519277|FG000|COMPLETED|Overall Study||10
10378345|NCT00591409|11519278|FG001|COMPLETED|Overall Study||10
10378346|NCT00591409|11519279|FG002|COMPLETED|Overall Study||10
10378347|NCT00591409|11519280|FG003|COMPLETED|Overall Study||10
10378348|NCT00591409|11519281|FG004|COMPLETED|Overall Study||9
10378349|NCT00591409|11519282|FG005|COMPLETED|Overall Study||10
10378350|NCT00591409|11519283|FG006|COMPLETED|Overall Study||10
10378351|NCT00591409|11519284|FG007|COMPLETED|Overall Study||10
10378352|NCT00591409|11519285|FG008|COMPLETED|Overall Study||9
10378353|NCT00591409|11519286|FG009|COMPLETED|Overall Study||10
10378354|NCT00591409|11519277|FG000|NOT COMPLETED|Overall Study||0
10378355|NCT00591409|11519278|FG001|NOT COMPLETED|Overall Study||0
10378356|NCT00591409|11519279|FG002|NOT COMPLETED|Overall Study||0
10378357|NCT00591409|11519280|FG003|NOT COMPLETED|Overall Study||0
10378358|NCT00591409|11519281|FG004|NOT COMPLETED|Overall Study||1
10378359|NCT00591409|11519282|FG005|NOT COMPLETED|Overall Study||0
10378360|NCT00591409|11519283|FG006|NOT COMPLETED|Overall Study||0
10378361|NCT00591409|11519284|FG007|NOT COMPLETED|Overall Study||0
10378362|NCT00591409|11519285|FG008|NOT COMPLETED|Overall Study||0
10378363|NCT00591409|11519286|FG009|NOT COMPLETED|Overall Study||1
10378364|NCT00591565|11519308|FG000|STARTED|Overall Study||13
10378365|NCT00591565|11519308|FG000|COMPLETED|Overall Study||8
10378366|NCT00591565|11519308|FG000|NOT COMPLETED|Overall Study||5
10378367|NCT00591578|11519315|FG000|STARTED|Double-Blind Treatment Phase||327
10378368|NCT00591578|11519316|FG001|STARTED|Double-Blind Treatment Phase||329
10378369|NCT00591578|11519317|FG002|STARTED|Double-Blind Treatment Phase|Two participants randomized but not treated.|328
10378370|NCT00591578|11519315|FG000|COMPLETED|Double-Blind Treatment Phase||249
10378371|NCT00591578|11519316|FG001|COMPLETED|Double-Blind Treatment Phase||249
10378372|NCT00591578|11519317|FG002|COMPLETED|Double-Blind Treatment Phase||244
10378373|NCT00591578|11519315|FG000|NOT COMPLETED|Double-Blind Treatment Phase||78
10378374|NCT00591578|11519316|FG001|NOT COMPLETED|Double-Blind Treatment Phase||80
10378375|NCT00591578|11519317|FG002|NOT COMPLETED|Double-Blind Treatment Phase||84
10378376|NCT00591578|11519315|FG000|STARTED|Open-Label Extension Phase||55
10378377|NCT00591578|11519316|FG001|STARTED|Open-Label Extension Phase||115
10378378|NCT00591578|11519317|FG002|STARTED|Open-Label Extension Phase||0
10378379|NCT00591578|11519315|FG000|COMPLETED|Open-Label Extension Phase||49
10378380|NCT00591578|11519316|FG001|COMPLETED|Open-Label Extension Phase||105
10378381|NCT00591578|11519317|FG002|COMPLETED|Open-Label Extension Phase||0
10378382|NCT00591578|11519315|FG000|NOT COMPLETED|Open-Label Extension Phase||6
10378383|NCT00591578|11519316|FG001|NOT COMPLETED|Open-Label Extension Phase||10
10378384|NCT00591578|11519317|FG002|NOT COMPLETED|Open-Label Extension Phase||0
10378385|NCT00591591|11519328|FG000|STARTED|Overall Study||176
10378386|NCT00591591|11519329|FG001|STARTED|Overall Study||133
10378387|NCT00591591|11519328|FG000|COMPLETED|Overall Study||165
10378388|NCT00591591|11519329|FG001|COMPLETED|Overall Study||94
10378389|NCT00591591|11519328|FG000|NOT COMPLETED|Overall Study||11
10378390|NCT00591591|11519329|FG001|NOT COMPLETED|Overall Study||39
10378391|NCT00591630|11519339|FG000|STARTED|Overall Study||6
10378392|NCT00591630|11519340|FG001|STARTED|Overall Study||8
10378393|NCT00591630|11519341|FG002|STARTED|Overall Study||10
10378394|NCT00591630|11519342|FG003|STARTED|Overall Study||6
10378395|NCT00591630|11519339|FG000|COMPLETED|Overall Study||6
10378396|NCT00591630|11519340|FG001|COMPLETED|Overall Study||8
10378397|NCT00591630|11519341|FG002|COMPLETED|Overall Study||9
10378398|NCT00591630|11519342|FG003|COMPLETED|Overall Study||6
10378399|NCT00591630|11519339|FG000|NOT COMPLETED|Overall Study||0
10378400|NCT00591630|11519340|FG001|NOT COMPLETED|Overall Study||0
10378401|NCT00591630|11519341|FG002|NOT COMPLETED|Overall Study||1
10378402|NCT00591630|11519342|FG003|NOT COMPLETED|Overall Study||0
10378403|NCT00591721|11519354|FG000|STARTED|Overall Study||89
10378404|NCT00591721|11519355|FG001|STARTED|Overall Study||92
10378405|NCT00591721|11519354|FG000|COMPLETED|Overall Study||68
10378406|NCT00591721|11519355|FG001|COMPLETED|Overall Study||70
10378407|NCT00591721|11519354|FG000|NOT COMPLETED|Overall Study||21
10378408|NCT00591721|11519355|FG001|NOT COMPLETED|Overall Study||22
10378409|NCT00591734|11519361|FG000|STARTED|Overall Study||57
10378410|NCT00591734|11519361|FG000|COMPLETED|Overall Study||4
10378411|NCT00591734|11519361|FG000|NOT COMPLETED|Overall Study||53
10378412|NCT00591760|11519367|FG000|STARTED|Overall Study||28
10378413|NCT00591760|11519368|FG001|STARTED|Overall Study||28
10378414|NCT00591760|11519367|FG000|COMPLETED|Overall Study||28
10378415|NCT00591760|11519368|FG001|COMPLETED|Overall Study||28
10378416|NCT00591760|11519367|FG000|NOT COMPLETED|Overall Study||0
10378417|NCT00591760|11519368|FG001|NOT COMPLETED|Overall Study||0
10378418|NCT00591773|11519377|FG000|STARTED|Overall Study||185
10378419|NCT00591773|11519378|FG001|STARTED|Overall Study||182
10378420|NCT00591773|11519379|FG002|STARTED|Overall Study||184
10378421|NCT00591773|11519377|FG000|COMPLETED|Overall Study||169
10378422|NCT00591773|11519378|FG001|COMPLETED|Overall Study||158
10378423|NCT00591773|11519379|FG002|COMPLETED|Overall Study||168
10378424|NCT00591773|11519377|FG000|NOT COMPLETED|Overall Study||16
10378425|NCT00591773|11519378|FG001|NOT COMPLETED|Overall Study||24
10378426|NCT00591773|11519379|FG002|NOT COMPLETED|Overall Study||16
10378427|NCT00591786|11519397|FG000|STARTED|Overall Study||9
10378428|NCT00591786|11519398|FG001|STARTED|Overall Study||9
10378429|NCT00591786|11519399|FG002|STARTED|Overall Study||11
10378430|NCT00591786|11519400|FG003|STARTED|Overall Study||11
10378431|NCT00591786|11519401|FG004|STARTED|Overall Study||10
10378432|NCT00591786|11519402|FG005|STARTED|Overall Study||10
10378433|NCT00591786|11519403|FG006|STARTED|Overall Study||10
10378434|NCT00591786|11519404|FG007|STARTED|Overall Study||10
10378435|NCT00591786|11519405|FG008|STARTED|Overall Study||10
10378436|NCT00591786|11519406|FG009|STARTED|Overall Study||10
10378437|NCT00591786|11519397|FG000|Treated Participants|Overall Study||9
10378438|NCT00591786|11519398|FG001|Treated Participants|Overall Study||9
10378439|NCT00591786|11519399|FG002|Treated Participants|Overall Study||10
10378440|NCT00591786|11519400|FG003|Treated Participants|Overall Study||11
10378441|NCT00591786|11519401|FG004|Treated Participants|Overall Study||10
10378442|NCT00591786|11519402|FG005|Treated Participants|Overall Study||10
10378443|NCT00591786|11519403|FG006|Treated Participants|Overall Study||10
10378444|NCT00591786|11519404|FG007|Treated Participants|Overall Study||10
10378445|NCT00591786|11519405|FG008|Treated Participants|Overall Study||10
10378446|NCT00591786|11519406|FG009|Treated Participants|Overall Study||10
10378447|NCT00591786|11519397|FG000|COMPLETED|Overall Study||9
10378448|NCT00591786|11519398|FG001|COMPLETED|Overall Study||9
10378449|NCT00591786|11519399|FG002|COMPLETED|Overall Study||10
10378450|NCT00591786|11519400|FG003|COMPLETED|Overall Study||11
10378451|NCT00591786|11519401|FG004|COMPLETED|Overall Study||10
10378452|NCT00591786|11519402|FG005|COMPLETED|Overall Study||10
10378453|NCT00591786|11519403|FG006|COMPLETED|Overall Study||10
10378454|NCT00591786|11519404|FG007|COMPLETED|Overall Study||10
10378455|NCT00591786|11519405|FG008|COMPLETED|Overall Study||10
10378456|NCT00591786|11519406|FG009|COMPLETED|Overall Study||10
10378457|NCT00591786|11519397|FG000|NOT COMPLETED|Overall Study||0
10378458|NCT00591786|11519398|FG001|NOT COMPLETED|Overall Study||0
10378459|NCT00591786|11519399|FG002|NOT COMPLETED|Overall Study||1
10378460|NCT00591786|11519400|FG003|NOT COMPLETED|Overall Study||0
10378461|NCT00591786|11519401|FG004|NOT COMPLETED|Overall Study||0
10378462|NCT00591786|11519402|FG005|NOT COMPLETED|Overall Study||0
10378463|NCT00591786|11519403|FG006|NOT COMPLETED|Overall Study||0
10378464|NCT00591786|11519404|FG007|NOT COMPLETED|Overall Study||0
10378465|NCT00591786|11519405|FG008|NOT COMPLETED|Overall Study||0
10378466|NCT00591786|11519406|FG009|NOT COMPLETED|Overall Study||0
10378467|NCT00591825|11519432|FG000|STARTED|Overall Study||14
10378468|NCT00591825|11519433|FG001|STARTED|Overall Study||13
10378469|NCT00591825|11519434|FG002|STARTED|Overall Study||13
10378470|NCT00591825|11519435|FG003|STARTED|Overall Study||14
10378471|NCT00591825|11519432|FG000|COMPLETED|Overall Study||14
10378472|NCT00591825|11519433|FG001|COMPLETED|Overall Study||13
10378473|NCT00591825|11519434|FG002|COMPLETED|Overall Study||13
10378474|NCT00591825|11519435|FG003|COMPLETED|Overall Study||14
10378475|NCT00591825|11519432|FG000|NOT COMPLETED|Overall Study||0
10378476|NCT00591825|11519433|FG001|NOT COMPLETED|Overall Study||0
10378477|NCT00591825|11519434|FG002|NOT COMPLETED|Overall Study||0
10378478|NCT00591825|11519435|FG003|NOT COMPLETED|Overall Study||0
10378479|NCT00591838|11519460|FG000|STARTED|Overall Study||5
10378480|NCT00591838|11519461|FG001|STARTED|Overall Study||6
10378481|NCT00591838|11519462|FG002|STARTED|Overall Study||6
10378482|NCT00591838|11519463|FG003|STARTED|Overall Study||6
10378483|NCT00591838|11519464|FG004|STARTED|Overall Study||51
10378484|NCT00591838|11519460|FG000|COMPLETED|Overall Study||5
10378485|NCT00591838|11519461|FG001|COMPLETED|Overall Study||6
10378486|NCT00591838|11519462|FG002|COMPLETED|Overall Study||6
10378487|NCT00591838|11519463|FG003|COMPLETED|Overall Study||5
10378488|NCT00591838|11519464|FG004|COMPLETED|Overall Study||51
10378489|NCT00591838|11519460|FG000|NOT COMPLETED|Overall Study||0
10378490|NCT00591838|11519461|FG001|NOT COMPLETED|Overall Study||0
10378491|NCT00591838|11519462|FG002|NOT COMPLETED|Overall Study||0
10378492|NCT00591838|11519463|FG003|NOT COMPLETED|Overall Study||1
10378493|NCT00591838|11519464|FG004|NOT COMPLETED|Overall Study||0
10378494|NCT00591851|11519477|FG000|STARTED|Overall Study||70
10378495|NCT00591851|11519477|FG000|COMPLETED|Overall Study||64
10378496|NCT00591851|11519477|FG000|NOT COMPLETED|Overall Study||6
10378497|NCT00591864|11519481|FG000|STARTED|Overall Study||89
10378498|NCT00591864|11519481|FG000|COMPLETED|Overall Study||84
10378499|NCT00591864|11519481|FG000|NOT COMPLETED|Overall Study||5
10427993|NCT00856284|11573960|FG002|STARTED|Overall Study||874
10378500|NCT00591942|11519486|FG000|STARTED|Overall Study||36
10378501|NCT00591942|11519487|FG001|STARTED|Overall Study||36
10378502|NCT00591942|11519486|FG000|COMPLETED|Overall Study||36
10378503|NCT00591942|11519487|FG001|COMPLETED|Overall Study||36
10378504|NCT00591942|11519486|FG000|NOT COMPLETED|Overall Study||0
10378505|NCT00591942|11519487|FG001|NOT COMPLETED|Overall Study||0
10378506|NCT00592072|11519493|FG000|STARTED|First Sequence||6
10378507|NCT00592072|11519494|FG001|STARTED|First Sequence||6
10378508|NCT00592072|11519493|FG000|COMPLETED|First Sequence||6
10378509|NCT00592072|11519494|FG001|COMPLETED|First Sequence||6
10378510|NCT00592072|11519493|FG000|NOT COMPLETED|First Sequence||0
10378511|NCT00592072|11519494|FG001|NOT COMPLETED|First Sequence||0
10378512|NCT00592072|11519493|FG000|STARTED|Wash Out Period||6
10378513|NCT00592072|11519494|FG001|STARTED|Wash Out Period||6
10378514|NCT00592072|11519493|FG000|COMPLETED|Wash Out Period||5
10378515|NCT00592072|11519494|FG001|COMPLETED|Wash Out Period||5
10378516|NCT00592072|11519493|FG000|NOT COMPLETED|Wash Out Period||1
10378517|NCT00592072|11519494|FG001|NOT COMPLETED|Wash Out Period||1
10378518|NCT00592072|11519493|FG000|STARTED|Second Sequence||5
10378519|NCT00592072|11519494|FG001|STARTED|Second Sequence||5
10378520|NCT00592072|11519493|FG000|COMPLETED|Second Sequence||5
10378521|NCT00592072|11519494|FG001|COMPLETED|Second Sequence||5
10378522|NCT00592072|11519493|FG000|NOT COMPLETED|Second Sequence||0
10378523|NCT00592072|11519494|FG001|NOT COMPLETED|Second Sequence||0
10378524|NCT00592124|11519506|FG000|STARTED|Overall Study||28
10378525|NCT00592124|11519507|FG001|STARTED|Overall Study||29
10378526|NCT00592124|11519508|FG002|STARTED|Overall Study||30
10378527|NCT00592124|11519509|FG003|STARTED|Overall Study||27
10378528|NCT00592124|11519510|FG004|STARTED|Overall Study||27
10378529|NCT00592124|11519511|FG005|STARTED|Overall Study||27
10378530|NCT00592124|11519506|FG000|COMPLETED|Overall Study||24
10378531|NCT00592124|11519507|FG001|COMPLETED|Overall Study||24
10378532|NCT00592124|11519508|FG002|COMPLETED|Overall Study||24
10717691|NCT02700919|11881694|FG002|STARTED|Overall Study||91
10717692|NCT02700919|11881692|FG000|COMPLETED|Overall Study||82
10717693|NCT02700919|11881693|FG001|COMPLETED|Overall Study||85
10717694|NCT02700919|11881694|FG002|COMPLETED|Overall Study||87
10717695|NCT02700919|11881692|FG000|NOT COMPLETED|Overall Study||12
10717696|NCT02700919|11881693|FG001|NOT COMPLETED|Overall Study||12
10717697|NCT02700919|11881694|FG002|NOT COMPLETED|Overall Study||4
10717698|NCT02700984|11881704|FG000|STARTED|Overall Study||215
10717699|NCT02700984|11881705|FG001|STARTED|Overall Study||67
10717700|NCT02700984|11881704|FG000|COMPLETED|Overall Study||200
10717701|NCT02700984|11881705|FG001|COMPLETED|Overall Study||53
10717702|NCT02700984|11881704|FG000|NOT COMPLETED|Overall Study||15
10717703|NCT02700984|11881705|FG001|NOT COMPLETED|Overall Study||14
10717704|NCT02700997|11881721|FG000|STARTED|Overall Study||17
10717705|NCT02700997|11881721|FG000|COMPLETED|Overall Study||15
10717706|NCT02700997|11881721|FG000|NOT COMPLETED|Overall Study||2
10717707|NCT02701049|11881728|FG000|STARTED|Overall Study|Patients who completed a follow-up survey|209
10717708|NCT02701049|11881729|FG001|STARTED|Overall Study|Patients who completed a follow-up survey|342
10717709|NCT02701049|11881730|FG002|STARTED|Overall Study|Patients who completed a follow-up survey|198
10717710|NCT02701049|11881728|FG000|COMPLETED|Overall Study|Total patients included in analysis|209
10717711|NCT02701049|11881729|FG001|COMPLETED|Overall Study|Total patients included in analysis|342
10717712|NCT02701049|11881730|FG002|COMPLETED|Overall Study|Total patients included in analysis|198
10717713|NCT02701049|11881728|FG000|NOT COMPLETED|Overall Study||0
10717714|NCT02701049|11881729|FG001|NOT COMPLETED|Overall Study||0
10378533|NCT00592124|11519509|FG003|COMPLETED|Overall Study||24
10378534|NCT00592124|11519510|FG004|COMPLETED|Overall Study||24
10378535|NCT00592124|11519511|FG005|COMPLETED|Overall Study||24
10378536|NCT00592124|11519506|FG000|NOT COMPLETED|Overall Study||4
10378537|NCT00592124|11519507|FG001|NOT COMPLETED|Overall Study||5
10378538|NCT00592124|11519508|FG002|NOT COMPLETED|Overall Study||6
10378539|NCT00592124|11519509|FG003|NOT COMPLETED|Overall Study||3
10378540|NCT00592124|11519510|FG004|NOT COMPLETED|Overall Study||3
10378541|NCT00592124|11519511|FG005|NOT COMPLETED|Overall Study||3
10717715|NCT02701049|11881730|FG002|NOT COMPLETED|Overall Study||0
10717716|NCT02701062|11881744|FG000|STARTED|Baseline||376
10717717|NCT02701062|11881745|FG001|STARTED|Baseline||186
10717718|NCT02701062|11881744|FG000|COMPLETED|Baseline||376
10378542|NCT00592176|11519521|FG000|STARTED|Overall Study||5
10378543|NCT00592176|11519521|FG000|COMPLETED|Overall Study||5
10378544|NCT00592176|11519521|FG000|NOT COMPLETED|Overall Study||0
10378545|NCT00592319|11519527|FG000|STARTED|Overall Study||2
10378546|NCT00592319|11519528|FG001|STARTED|Overall Study||8
10378547|NCT00592319|11519527|FG000|COMPLETED|Overall Study||2
10378548|NCT00592319|11519528|FG001|COMPLETED|Overall Study||5
10378549|NCT00592319|11519527|FG000|NOT COMPLETED|Overall Study||0
10717719|NCT02701062|11881745|FG001|COMPLETED|Baseline||186
10717720|NCT02701062|11881744|FG000|NOT COMPLETED|Baseline||0
10378550|NCT00592319|11519528|FG001|NOT COMPLETED|Overall Study||3
10378551|NCT00592358|11519536|FG000|STARTED|Overall Study||17
10378552|NCT00592358|11519536|FG000|COMPLETED|Overall Study||11
10378553|NCT00592358|11519536|FG000|NOT COMPLETED|Overall Study||6
10378554|NCT00592384|11519542|FG000|STARTED|Overall Study||64
10378555|NCT00592384|11519543|FG001|STARTED|Overall Study||69
10378556|NCT00592384|11519542|FG000|COMPLETED|Overall Study||59
10378557|NCT00592384|11519543|FG001|COMPLETED|Overall Study||63
10378558|NCT00592384|11519542|FG000|NOT COMPLETED|Overall Study||5
10378559|NCT00592384|11519543|FG001|NOT COMPLETED|Overall Study||6
10378560|NCT00592475|11519552|FG000|STARTED|Overall Study||6
10378561|NCT00592475|11519553|FG001|STARTED|Overall Study||9
10378562|NCT00592475|11519554|FG002|STARTED|Overall Study||5
10378563|NCT00592475|11519552|FG000|COMPLETED|Overall Study||6
10378564|NCT00592475|11519553|FG001|COMPLETED|Overall Study||9
10378565|NCT00592475|11519554|FG002|COMPLETED|Overall Study||5
10378566|NCT00592475|11519552|FG000|NOT COMPLETED|Overall Study||0
10378567|NCT00592475|11519553|FG001|NOT COMPLETED|Overall Study||0
10378568|NCT00592475|11519554|FG002|NOT COMPLETED|Overall Study||0
10378569|NCT00592488|11519564|FG000|STARTED|Overall Study||6
10378570|NCT00592488|11519565|FG001|STARTED|Overall Study||7
10378571|NCT00592488|11519564|FG000|COMPLETED|Overall Study||6
10378572|NCT00592488|11519565|FG001|COMPLETED|Overall Study||7
10378573|NCT00592488|11519564|FG000|NOT COMPLETED|Overall Study||0
10378574|NCT00592488|11519565|FG001|NOT COMPLETED|Overall Study||0
10378575|NCT00592501|11519573|FG000|STARTED|Overall Study||25
10378576|NCT00592501|11519573|FG000|COMPLETED|Overall Study||23
10378577|NCT00592501|11519573|FG000|NOT COMPLETED|Overall Study||2
10378578|NCT00592553|11519580|FG000|STARTED|Overall Study||60
10378579|NCT00592553|11519581|FG001|STARTED|Overall Study||57
10378580|NCT00592553|11519582|FG002|STARTED|Overall Study||57
10378581|NCT00592553|11519580|FG000|As-treated Population|Overall Study||60
10378582|NCT00592553|11519581|FG001|As-treated Population|Overall Study||57
10378583|NCT00592553|11519582|FG002|As-treated Population|Overall Study||57
10378584|NCT00592553|11519580|FG000|ITT Population|Overall Study||60
10378585|NCT00592553|11519581|FG001|ITT Population|Overall Study||57
10378586|NCT00592553|11519582|FG002|ITT Population|Overall Study||57
10378587|NCT00592553|11519580|FG000|COMPLETED|Overall Study||59
10378588|NCT00592553|11519581|FG001|COMPLETED|Overall Study||57
10378589|NCT00592553|11519582|FG002|COMPLETED|Overall Study||57
10378590|NCT00592553|11519580|FG000|NOT COMPLETED|Overall Study||1
10378591|NCT00592553|11519581|FG001|NOT COMPLETED|Overall Study||0
10378592|NCT00592553|11519582|FG002|NOT COMPLETED|Overall Study||0
10378593|NCT00592631|11519592|FG000|STARTED|Overall Study||16
10378594|NCT00592631|11519593|FG001|STARTED|Overall Study||11
10378595|NCT00592631|11519592|FG000|COMPLETED|Overall Study||16
10378596|NCT00592631|11519593|FG001|COMPLETED|Overall Study||9
10378597|NCT00592631|11519592|FG000|NOT COMPLETED|Overall Study||0
10378598|NCT00592631|11519593|FG001|NOT COMPLETED|Overall Study||2
10378599|NCT00592683|11519601|FG000|STARTED|Overall Study||10
10378600|NCT00592683|11519602|FG001|STARTED|Overall Study||10
10378601|NCT00592683|11519601|FG000|COMPLETED|Overall Study||6
10378602|NCT00592683|11519602|FG001|COMPLETED|Overall Study||6
10378603|NCT00592683|11519601|FG000|NOT COMPLETED|Overall Study||4
10378604|NCT00592683|11519602|FG001|NOT COMPLETED|Overall Study||4
10378605|NCT00592761|11519608|FG000|STARTED|First Intervention (2 Weeks)||9
10378606|NCT00592761|11519609|FG001|STARTED|First Intervention (2 Weeks)||9
10378607|NCT00592761|11519608|FG000|COMPLETED|First Intervention (2 Weeks)||9
10378608|NCT00592761|11519609|FG001|COMPLETED|First Intervention (2 Weeks)||9
10378609|NCT00592761|11519608|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
10378610|NCT00592761|11519609|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
10378611|NCT00592761|11519608|FG000|STARTED|Second Intervention (2 Weeks)||9
10378612|NCT00592761|11519609|FG001|STARTED|Second Intervention (2 Weeks)||9
10378613|NCT00592761|11519608|FG000|COMPLETED|Second Intervention (2 Weeks)||9
10378614|NCT00592761|11519609|FG001|COMPLETED|Second Intervention (2 Weeks)||9
10378615|NCT00592761|11519608|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
10378616|NCT00592761|11519609|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
10378617|NCT00592774|11519620|FG000|STARTED|Overall Study||26
10378618|NCT00592774|11519621|FG001|STARTED|Overall Study||53
10378619|NCT00592774|11519622|FG002|STARTED|Overall Study||22
10378620|NCT00592774|11519623|FG003|STARTED|Overall Study||22
10378621|NCT00592774|11519624|FG004|STARTED|Overall Study||23
10378622|NCT00592774|11519620|FG000|COMPLETED|Overall Study||15
10378623|NCT00592774|11519621|FG001|COMPLETED|Overall Study||21
10378624|NCT00592774|11519622|FG002|COMPLETED|Overall Study||18
10378625|NCT00592774|11519623|FG003|COMPLETED|Overall Study||8
10378626|NCT00592774|11519624|FG004|COMPLETED|Overall Study||9
10378627|NCT00592774|11519620|FG000|NOT COMPLETED|Overall Study||11
10378628|NCT00592774|11519621|FG001|NOT COMPLETED|Overall Study||32
10378629|NCT00592774|11519622|FG002|NOT COMPLETED|Overall Study||4
10378630|NCT00592774|11519623|FG003|NOT COMPLETED|Overall Study||14
10378631|NCT00592774|11519624|FG004|NOT COMPLETED|Overall Study||14
10378632|NCT00592839|11519639|FG000|STARTED|Overall Study||53
10378633|NCT00592839|11519640|FG001|STARTED|Overall Study||52
10378634|NCT00592839|11519641|FG002|STARTED|Overall Study||52
10378635|NCT00592839|11519639|FG000|COMPLETED|Overall Study||51
10378636|NCT00592839|11519640|FG001|COMPLETED|Overall Study||48
10378637|NCT00592839|11519641|FG002|COMPLETED|Overall Study||46
10378638|NCT00592839|11519639|FG000|NOT COMPLETED|Overall Study||2
10378639|NCT00592839|11519640|FG001|NOT COMPLETED|Overall Study||4
10378640|NCT00592839|11519641|FG002|NOT COMPLETED|Overall Study||6
10812683|NCT03379233|11974825|FG001|STARTED|Overall Study||6
10812684|NCT03379233|11974824|FG000|COMPLETED|Overall Study||0
10812685|NCT03379233|11974825|FG001|COMPLETED|Overall Study||0
10812686|NCT03379233|11974824|FG000|NOT COMPLETED|Overall Study||1
10812687|NCT03379233|11974825|FG001|NOT COMPLETED|Overall Study||6
10378641|NCT00592852|11519649|FG000|STARTED|Overall Study||13
10378642|NCT00592852|11519649|FG000|COMPLETED|Overall Study||7
10378643|NCT00592852|11519649|FG000|NOT COMPLETED|Overall Study||6
10378644|NCT00592904|11519657|FG000|STARTED|Overall Study||57
10378645|NCT00592904|11519658|FG001|STARTED|Overall Study||148
10378646|NCT00592904|11519659|FG002|STARTED|Overall Study||27
10378647|NCT00592904|11519660|FG003|STARTED|Overall Study||30
10378648|NCT00592904|11519657|FG000|COMPLETED|Overall Study||32
10378649|NCT00592904|11519658|FG001|COMPLETED|Overall Study||93
10378650|NCT00592904|11519659|FG002|COMPLETED|Overall Study||10
10378651|NCT00592904|11519660|FG003|COMPLETED|Overall Study||19
10378652|NCT00592904|11519657|FG000|NOT COMPLETED|Overall Study||25
10378653|NCT00592904|11519658|FG001|NOT COMPLETED|Overall Study||55
10378654|NCT00592904|11519659|FG002|NOT COMPLETED|Overall Study||17
10378655|NCT00592904|11519660|FG003|NOT COMPLETED|Overall Study||11
10378656|NCT00592943|11519672|FG000|STARTED|Overall Study||6
10378657|NCT00592943|11519673|FG001|STARTED|Overall Study||6
10378658|NCT00592943|11519672|FG000|COMPLETED|Overall Study||6
10378659|NCT00592943|11519673|FG001|COMPLETED|Overall Study||6
10378660|NCT00592943|11519672|FG000|NOT COMPLETED|Overall Study||0
10378661|NCT00592943|11519673|FG001|NOT COMPLETED|Overall Study||0
10378662|NCT00593112|11519681|FG000|STARTED|Overall Study||27
10378663|NCT00593112|11519682|FG001|STARTED|Overall Study||12
10378664|NCT00593112|11519681|FG000|COMPLETED|Overall Study||17
10378665|NCT00593112|11519682|FG001|COMPLETED|Overall Study||12
10378666|NCT00593112|11519681|FG000|NOT COMPLETED|Overall Study||10
10378667|NCT00593112|11519682|FG001|NOT COMPLETED|Overall Study||0
10378668|NCT00593333|11519690|FG000|STARTED|Overall Study||54
10378669|NCT00593333|11519691|FG001|STARTED|Overall Study||56
10378670|NCT00593333|11519690|FG000|COMPLETED|Overall Study||44
10378671|NCT00593333|11519691|FG001|COMPLETED|Overall Study||45
10378672|NCT00593333|11519690|FG000|NOT COMPLETED|Overall Study||10
10378673|NCT00593333|11519691|FG001|NOT COMPLETED|Overall Study||11
10378674|NCT00593346|11519697|FG000|STARTED|Overall Study||151
10378675|NCT00593346|11519697|FG000|COMPLETED|Overall Study||151
10378676|NCT00593346|11519697|FG000|NOT COMPLETED|Overall Study||0
10378677|NCT00593372|11519704|FG000|STARTED|Overall Study|Eight enrolled in behavioral treatment.|8
10378678|NCT00593372|11519705|FG001|STARTED|Overall Study|Three evaluated but only maintained medical treatment.|3
10378679|NCT00593372|11519704|FG000|COMPLETED|Overall Study|Eight completed behavioral treatment.|8
10378680|NCT00593372|11519705|FG001|COMPLETED|Overall Study|Three evaluated and completed protocol.|3
10378681|NCT00593372|11519704|FG000|NOT COMPLETED|Overall Study||0
10378682|NCT00593372|11519705|FG001|NOT COMPLETED|Overall Study||0
10378683|NCT00593385|11519711|FG000|STARTED|Overall Study||165
10378684|NCT00593385|11519711|FG000|Intention to Treat (ITT) Population|Overall Study|Excludes 13 subjects who did not meet inclusion/exclusion criteria.|152
10378685|NCT00593385|11519711|FG000|COMPLETED|Overall Study|125 of 165 enrolled patients completed the study.|125
10378686|NCT00593385|11519711|FG000|NOT COMPLETED|Overall Study||40
10378687|NCT00593450|11519721|FG000|STARTED|Overall Study||301
10378688|NCT00593450|11519722|FG001|STARTED|Overall Study||286
10378689|NCT00593450|11519723|FG002|STARTED|Overall Study||298
10378690|NCT00593450|11519724|FG003|STARTED|Overall Study||300
10378691|NCT00593450|11519721|FG000|COMPLETED|Overall Study||284
10378692|NCT00593450|11519722|FG001|COMPLETED|Overall Study||265
10378693|NCT00593450|11519723|FG002|COMPLETED|Overall Study||285
10378694|NCT00593450|11519724|FG003|COMPLETED|Overall Study||271
10378695|NCT00593450|11519721|FG000|NOT COMPLETED|Overall Study||17
10378696|NCT00593450|11519722|FG001|NOT COMPLETED|Overall Study||21
10378697|NCT00593450|11519723|FG002|NOT COMPLETED|Overall Study||13
10378698|NCT00593450|11519724|FG003|NOT COMPLETED|Overall Study||29
10378699|NCT00593489|11519736|FG000|STARTED|Allocation|allocated to intervention group to receive the intervention|75
10378700|NCT00593489|11519737|FG001|STARTED|Allocation|allocated to usual care group|79
10812688|NCT03370536|11974831|FG000|STARTED|Overall Study||1
10812689|NCT03370536|11974831|FG000|COMPLETED|Overall Study||0
10378701|NCT00593489|11519736|FG000|COMPLETED|Allocation||73
10378702|NCT00593489|11519737|FG001|COMPLETED|Allocation||78
10378703|NCT00593489|11519736|FG000|NOT COMPLETED|Allocation||2
10378704|NCT00593489|11519737|FG001|NOT COMPLETED|Allocation||1
10378705|NCT00593489|11519736|FG000|STARTED|Analysis|physician withdrawal (N=3) primary outcome set to 0|73
10378706|NCT00593489|11519737|FG001|STARTED|Analysis|physician withdrawal (N=3) primary outcome set to 0|78
10378707|NCT00593489|11519736|FG000|COMPLETED|Analysis||73
10378708|NCT00593489|11519737|FG001|COMPLETED|Analysis||78
10378709|NCT00593489|11519736|FG000|NOT COMPLETED|Analysis||0
10378710|NCT00593489|11519737|FG001|NOT COMPLETED|Analysis||0
10378711|NCT00593554|11519747|FG000|STARTED|Overall Study||3
10378712|NCT00593554|11519748|FG001|STARTED|Overall Study||5
10378713|NCT00593554|11519747|FG000|COMPLETED|Overall Study||0
10378714|NCT00593554|11519748|FG001|COMPLETED|Overall Study||0
10378715|NCT00593554|11519747|FG000|NOT COMPLETED|Overall Study||3
10378716|NCT00593554|11519748|FG001|NOT COMPLETED|Overall Study||5
10378717|NCT00593606|11519754|FG000|STARTED|Overall Study||124
10812690|NCT03370536|11974831|FG000|NOT COMPLETED|Overall Study||1
10378718|NCT00593606|11519754|FG000|Start of Treatment - Safety Set|Overall Study||116
10378719|NCT00593606|11519754|FG000|Full Analysis Set|Overall Study||114
10812691|NCT03363633|11974835|FG000|STARTED|Overall Study||12
10378720|NCT00593606|11519754|FG000|Treatment Period Completed|Overall Study||99
10378721|NCT00593606|11519754|FG000|COMPLETED|Overall Study||97
10378722|NCT00593606|11519754|FG000|NOT COMPLETED|Overall Study||27
10378723|NCT00593645|11519758|FG000|STARTED|Overall Study||7
10378724|NCT00593645|11519758|FG000|COMPLETED|Overall Study||7
10378725|NCT00593645|11519758|FG000|NOT COMPLETED|Overall Study||0
10378726|NCT00593684|11519764|FG000|STARTED|Overall Study||25
10378727|NCT00593684|11519765|FG001|STARTED|Overall Study||25
10378728|NCT00593684|11519764|FG000|COMPLETED|Overall Study||23
10378729|NCT00593684|11519765|FG001|COMPLETED|Overall Study||24
10378730|NCT00593684|11519764|FG000|NOT COMPLETED|Overall Study||2
10378731|NCT00593684|11519765|FG001|NOT COMPLETED|Overall Study||1
10378732|NCT00593736|11519775|FG000|STARTED|Screening Period and Placebo Run-in||0
10378733|NCT00593736|11519776|FG001|STARTED|Screening Period and Placebo Run-in||0
10378734|NCT00593736|11519777|FG002|STARTED|Screening Period and Placebo Run-in||0
10378735|NCT00593736|11519778|FG003|STARTED|Screening Period and Placebo Run-in||549
10378736|NCT00593736|11519775|FG000|COMPLETED|Screening Period and Placebo Run-in||0
10378737|NCT00593736|11519776|FG001|COMPLETED|Screening Period and Placebo Run-in||0
10378738|NCT00593736|11519777|FG002|COMPLETED|Screening Period and Placebo Run-in||0
10378739|NCT00593736|11519778|FG003|COMPLETED|Screening Period and Placebo Run-in||132
10378740|NCT00593736|11519775|FG000|NOT COMPLETED|Screening Period and Placebo Run-in||0
10378741|NCT00593736|11519776|FG001|NOT COMPLETED|Screening Period and Placebo Run-in||0
10378742|NCT00593736|11519777|FG002|NOT COMPLETED|Screening Period and Placebo Run-in||0
10378743|NCT00593736|11519778|FG003|NOT COMPLETED|Screening Period and Placebo Run-in||417
10378744|NCT00593736|11519775|FG000|STARTED|Treatment Period and Placebo Run-out||32
10378745|NCT00593736|11519776|FG001|STARTED|Treatment Period and Placebo Run-out||33
10378746|NCT00593736|11519777|FG002|STARTED|Treatment Period and Placebo Run-out||35
10378747|NCT00593736|11519778|FG003|STARTED|Treatment Period and Placebo Run-out||32
10378748|NCT00593736|11519775|FG000|COMPLETED|Treatment Period and Placebo Run-out||29
10378749|NCT00593736|11519776|FG001|COMPLETED|Treatment Period and Placebo Run-out||31
10378750|NCT00593736|11519777|FG002|COMPLETED|Treatment Period and Placebo Run-out||30
10378751|NCT00593736|11519778|FG003|COMPLETED|Treatment Period and Placebo Run-out||28
10378752|NCT00593736|11519775|FG000|NOT COMPLETED|Treatment Period and Placebo Run-out||3
10378753|NCT00593736|11519776|FG001|NOT COMPLETED|Treatment Period and Placebo Run-out||2
10378754|NCT00593736|11519777|FG002|NOT COMPLETED|Treatment Period and Placebo Run-out||5
10378755|NCT00593736|11519778|FG003|NOT COMPLETED|Treatment Period and Placebo Run-out||4
10378756|NCT00593814|11519790|FG000|STARTED|Overall Study||139
10378757|NCT00593814|11519791|FG001|STARTED|Overall Study||120
10378758|NCT00593814|11519790|FG000|COMPLETED|Overall Study||115
10378759|NCT00593814|11519791|FG001|COMPLETED|Overall Study||120
10378760|NCT00593814|11519790|FG000|NOT COMPLETED|Overall Study||24
10378761|NCT00593814|11519791|FG001|NOT COMPLETED|Overall Study||0
10378762|NCT00593827|11519799|FG000|STARTED|Overall Study|Intent-to-Treat (ITT) Population: Participants who were randomized (eligible and ineligible).|85
10378763|NCT00593827|11519800|FG001|STARTED|Overall Study|ITT Population: Participants who were randomized (eligible and ineligible).|91
10378764|NCT00593827|11519799|FG000|Safety Population|Overall Study|Participants (eligible and ineligible) who received at least 1 dose of study drug.|82
10378765|NCT00593827|11519800|FG001|Safety Population|Overall Study|Participants (eligible and ineligible) who received at least 1 dose of study drug.|89
10378766|NCT00593827|11519799|FG000|Evaluable Population|Overall Study|Treated participants with CR, PR, SD, PD, or NE response. Refer outcome measure 3 and 4 for details.|79
10378767|NCT00593827|11519800|FG001|Evaluable Population|Overall Study|Treated participants with CR, PR, SD, PD, or NE response. Refer outcome measure 3 and 4 for details.|89
10378768|NCT00593827|11519799|FG000|COMPLETED|Overall Study|Completed=off-study (Major reasons: Adverse events (AE)=15; disease progression=76; not treated=3).|85
10378769|NCT00593827|11519800|FG001|COMPLETED|Overall Study|Completed=off-study (Major reasons: AEs=30; disease progression=55; not treated=2).|89
10378770|NCT00593827|11519799|FG000|NOT COMPLETED|Overall Study||0
10378771|NCT00593827|11519800|FG001|NOT COMPLETED|Overall Study||2
10378772|NCT00593866|11519806|FG000|STARTED|Overall Study||50
10378773|NCT00593866|11519806|FG000|COMPLETED|Overall Study||50
10378774|NCT00593866|11519806|FG000|NOT COMPLETED|Overall Study||0
10378775|NCT00593918|11519812|FG000|STARTED|Overall Study|Number of children with Toll-like Receptor 4 (TLR4) -2026/GG Genotype|17
10378776|NCT00593918|11519813|FG001|STARTED|Overall Study|Number of children with Toll-like Receptor 4 (TLR4) -2026/AG and AA genotypes|74
10378777|NCT00593918|11519812|FG000|COMPLETED|Overall Study|Some children did not come in for the blood draw at visit 2|12
10378778|NCT00593918|11519813|FG001|COMPLETED|Overall Study|Some children did not come in for the blood draw at visit 2|50
10378779|NCT00593918|11519812|FG000|NOT COMPLETED|Overall Study||5
10378780|NCT00593918|11519813|FG001|NOT COMPLETED|Overall Study||24
10378781|NCT00593957|11519822|FG000|STARTED|Overall Study||13
10378782|NCT00593957|11519823|FG001|STARTED|Overall Study||13
10378783|NCT00593957|11519824|FG002|STARTED|Overall Study||12
10378784|NCT00593957|11519822|FG000|COMPLETED|Overall Study||13
10378785|NCT00593957|11519823|FG001|COMPLETED|Overall Study||12
10378786|NCT00593957|11519824|FG002|COMPLETED|Overall Study||10
10378787|NCT00593957|11519822|FG000|NOT COMPLETED|Overall Study||0
10378788|NCT00593957|11519823|FG001|NOT COMPLETED|Overall Study||1
10378789|NCT00593957|11519824|FG002|NOT COMPLETED|Overall Study||2
10378790|NCT00594009|11519846|FG000|STARTED|Overall Study||1
10378791|NCT00594009|11519846|FG000|COMPLETED|Overall Study||1
10378792|NCT00594009|11519846|FG000|NOT COMPLETED|Overall Study||0
10378793|NCT00594022|11519852|FG000|STARTED|Overall Study||176
10378794|NCT00594022|11519853|FG001|STARTED|Overall Study||173
10378795|NCT00594022|11519852|FG000|COMPLETED|Overall Study||176
10378796|NCT00594022|11519853|FG001|COMPLETED|Overall Study||173
10378797|NCT00594022|11519852|FG000|NOT COMPLETED|Overall Study||0
10378798|NCT00594022|11519853|FG001|NOT COMPLETED|Overall Study||0
10378799|NCT00594035|11519861|FG000|STARTED|Overall Study|102 subjects were randomized to Spinal Sealant|102
10378800|NCT00594035|11519862|FG001|STARTED|Overall Study|56 subjects were randomized to the control group (standard of care)|56
10378801|NCT00594035|11519861|FG000|COMPLETED|Overall Study|100 Spinal Sealant subjects were evaluable at the 90-day visit|100
10378802|NCT00594035|11519862|FG001|COMPLETED|Overall Study|53 control group subjects were evaluable at the 90-day visit|53
10378803|NCT00594035|11519861|FG000|NOT COMPLETED|Overall Study||2
10378804|NCT00594035|11519862|FG001|NOT COMPLETED|Overall Study||3
10378805|NCT00594061|11519868|FG000|STARTED|Overall Study||9
10378806|NCT00594061|11519868|FG000|COMPLETED|Overall Study||9
10378807|NCT00594061|11519868|FG000|NOT COMPLETED|Overall Study||0
10378808|NCT00594100|11519872|FG000|STARTED|Procedure||245
10378809|NCT00594100|11519872|FG000|COMPLETED|Procedure||236
10378810|NCT00594100|11519872|FG000|NOT COMPLETED|Procedure||9
10378811|NCT00594100|11519872|FG000|STARTED|Follow-up Through 30 Days Post Procedure||236
10378812|NCT00594100|11519872|FG000|COMPLETED|Follow-up Through 30 Days Post Procedure||224
10378813|NCT00594100|11519872|FG000|NOT COMPLETED|Follow-up Through 30 Days Post Procedure||12
10378814|NCT00594165|11519876|FG000|STARTED|Overall Study||217
10378815|NCT00594165|11519876|FG000|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
10378816|NCT00594165|11519876|FG000|NOT COMPLETED|Overall Study||217
10378817|NCT00594178|11519880|FG000|STARTED|Overall Study||17
10378818|NCT00594178|11519880|FG000|COMPLETED|Overall Study||12
10378819|NCT00594178|11519880|FG000|NOT COMPLETED|Overall Study||5
10378820|NCT00594204|11519886|FG000|STARTED|Overall Study||394
10378821|NCT00594204|11519887|FG001|STARTED|Overall Study||199
10378822|NCT00594204|11519886|FG000|Received Treatment|Overall Study||390
10378823|NCT00594204|11519887|FG001|Received Treatment|Overall Study||198
10378824|NCT00594204|11519886|FG000|COMPLETED|Overall Study||336
10378825|NCT00594204|11519887|FG001|COMPLETED|Overall Study||154
10378826|NCT00594204|11519886|FG000|NOT COMPLETED|Overall Study||58
10378827|NCT00594204|11519887|FG001|NOT COMPLETED|Overall Study||45
10378828|NCT00594230|11519895|FG000|STARTED|Overall Study||16
10378829|NCT00594230|11519896|FG001|STARTED|Overall Study||10
10378830|NCT00594230|11519895|FG000|COMPLETED|Overall Study||1
10378831|NCT00594230|11519896|FG001|COMPLETED|Overall Study||1
10378832|NCT00594230|11519895|FG000|NOT COMPLETED|Overall Study||15
10378833|NCT00594230|11519896|FG001|NOT COMPLETED|Overall Study||9
10378834|NCT00594256|11519902|FG000|STARTED|Overall Study||8
10378835|NCT00594256|11519902|FG000|COMPLETED|Overall Study||8
10378836|NCT00594256|11519902|FG000|NOT COMPLETED|Overall Study||0
10378837|NCT00594308|11519907|FG000|STARTED|Overall Study||10
10378838|NCT00594308|11519907|FG000|COMPLETED|Overall Study||10
10378839|NCT00594308|11519907|FG000|NOT COMPLETED|Overall Study||0
10378840|NCT00594399|11519913|FG000|STARTED|Initial 3 Month Counseling||180
10378841|NCT00594399|11519914|FG001|STARTED|Initial 3 Month Counseling||122
10378842|NCT00594399|11519915|FG002|STARTED|Initial 3 Month Counseling||0
10378843|NCT00594399|11519913|FG000|COMPLETED|Initial 3 Month Counseling||163
10378844|NCT00594399|11519914|FG001|COMPLETED|Initial 3 Month Counseling||118
10378845|NCT00594399|11519915|FG002|COMPLETED|Initial 3 Month Counseling||0
10378846|NCT00594399|11519913|FG000|NOT COMPLETED|Initial 3 Month Counseling||17
10378847|NCT00594399|11519914|FG001|NOT COMPLETED|Initial 3 Month Counseling||4
10378848|NCT00594399|11519915|FG002|NOT COMPLETED|Initial 3 Month Counseling||0
10378849|NCT00594399|11519913|FG000|STARTED|Rerandomization Arm 1 Only|Total sample in Arm 1 was rerandomized and allocated to remain in Arm 1 or assigned to Arm 3|81
10378850|NCT00594399|11519914|FG001|STARTED|Rerandomization Arm 1 Only||118
10378851|NCT00594399|11519915|FG002|STARTED|Rerandomization Arm 1 Only|This sample reflects newly randomized study Arm|82
10378852|NCT00594399|11519913|FG000|Rerandomization|Rerandomization Arm 1 Only|Rerandomized to continue to receive telephone calls every 2 weeks or at a reduced dose of 1/ month|81
10378853|NCT00594399|11519914|FG001|Rerandomization|Rerandomization Arm 1 Only||114
10378854|NCT00594399|11519915|FG002|Rerandomization|Rerandomization Arm 1 Only||82
10378855|NCT00594399|11519913|FG000|COMPLETED|Rerandomization Arm 1 Only||79
10378856|NCT00594399|11519914|FG001|COMPLETED|Rerandomization Arm 1 Only||114
10378857|NCT00594399|11519915|FG002|COMPLETED|Rerandomization Arm 1 Only||82
10378858|NCT00594399|11519913|FG000|NOT COMPLETED|Rerandomization Arm 1 Only||2
10378859|NCT00594399|11519914|FG001|NOT COMPLETED|Rerandomization Arm 1 Only||4
10378860|NCT00594399|11519915|FG002|NOT COMPLETED|Rerandomization Arm 1 Only||0
10378861|NCT00594425|11519924|FG000|STARTED|Overall Study||50
10378862|NCT00594425|11519925|FG001|STARTED|Overall Study||48
10378863|NCT00594425|11519926|FG002|STARTED|Overall Study||52
10378864|NCT00594425|11519924|FG000|COMPLETED|Overall Study||43
10378865|NCT00594425|11519925|FG001|COMPLETED|Overall Study||34
10378866|NCT00594425|11519926|FG002|COMPLETED|Overall Study||42
10378867|NCT00594425|11519924|FG000|NOT COMPLETED|Overall Study||7
10539104|NCT01458990|11691995|FG000|COMPLETED|Overall Study||45
10539105|NCT01458990|11691996|FG001|COMPLETED|Overall Study||15
10539106|NCT01458990|11691995|FG000|NOT COMPLETED|Overall Study||0
10539107|NCT01458990|11691996|FG001|NOT COMPLETED|Overall Study||0
10539108|NCT01459016|11692004|FG000|STARTED|Overall Study||56
10539109|NCT01459016|11692004|FG000|COMPLETED|Overall Study||41
10539110|NCT01459016|11692004|FG000|NOT COMPLETED|Overall Study||15
10539111|NCT01459068|11692010|FG000|STARTED|Overall Study||165
10378868|NCT00594425|11519925|FG001|NOT COMPLETED|Overall Study||14
10378869|NCT00594425|11519926|FG002|NOT COMPLETED|Overall Study||10
10378870|NCT00594464|11519934|FG000|STARTED|Overall Study||14
10378871|NCT00594464|11519934|FG000|COMPLETED|Overall Study||11
10378872|NCT00594464|11519934|FG000|NOT COMPLETED|Overall Study||3
10378873|NCT00594516|11519944|FG000|STARTED|Open Label (OL): Tapentadol IR|one patient was enrolled but lost to follow up at the start of open label therefore was not included|116
10378874|NCT00594516|11519945|FG001|STARTED|Open Label (OL): Tapentadol IR||0
10378875|NCT00594516|11519946|FG002|STARTED|Open Label (OL): Tapentadol IR||0
10378876|NCT00594516|11519944|FG000|COMPLETED|Open Label (OL): Tapentadol IR||87
10378877|NCT00594516|11519945|FG001|COMPLETED|Open Label (OL): Tapentadol IR||0
10378878|NCT00594516|11519946|FG002|COMPLETED|Open Label (OL): Tapentadol IR||0
10378879|NCT00594516|11519944|FG000|NOT COMPLETED|Open Label (OL): Tapentadol IR||29
10378880|NCT00594516|11519945|FG001|NOT COMPLETED|Open Label (OL): Tapentadol IR||0
10378881|NCT00594516|11519946|FG002|NOT COMPLETED|Open Label (OL): Tapentadol IR||0
10378882|NCT00594516|11519944|FG000|STARTED|DB: Tapentadol IR to ER & ER to IR||0
10378883|NCT00594516|11519945|FG001|STARTED|DB: Tapentadol IR to ER & ER to IR||44
10378884|NCT00594516|11519946|FG002|STARTED|DB: Tapentadol IR to ER & ER to IR||43
10378885|NCT00594516|11519944|FG000|COMPLETED|DB: Tapentadol IR to ER & ER to IR||0
10378886|NCT00594516|11519945|FG001|COMPLETED|DB: Tapentadol IR to ER & ER to IR||37
10378887|NCT00594516|11519946|FG002|COMPLETED|DB: Tapentadol IR to ER & ER to IR||35
10378888|NCT00594516|11519944|FG000|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||0
10378889|NCT00594516|11519945|FG001|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||7
10378890|NCT00594516|11519946|FG002|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||8
10378891|NCT00594568|11519953|FG000|STARTED|Initial Treatment||501
10378892|NCT00594568|11519954|FG001|STARTED|Initial Treatment||507
10378893|NCT00594568|11519955|FG002|STARTED|Initial Treatment||529
10378894|NCT00594568|11519953|FG000|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants (pts) who had at least 1 dose of study drug.|501
10378895|NCT00594568|11519954|FG001|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who had at least 1 dose of study drug.|506
10378896|NCT00594568|11519955|FG002|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who had at least 1 dose of study drug.|527
10378897|NCT00594568|11519953|FG000|COMPLETED|Initial Treatment||189
10378898|NCT00594568|11519954|FG001|COMPLETED|Initial Treatment||153
10378899|NCT00594568|11519955|FG002|COMPLETED|Initial Treatment||121
10378900|NCT00594568|11519953|FG000|NOT COMPLETED|Initial Treatment||312
10378901|NCT00594568|11519954|FG001|NOT COMPLETED|Initial Treatment||354
10378902|NCT00594568|11519955|FG002|NOT COMPLETED|Initial Treatment||408
10378903|NCT00594568|11519953|FG000|STARTED|Delayed Start||189
10378904|NCT00594568|11519954|FG001|STARTED|Delayed Start||153
10378905|NCT00594568|11519955|FG002|STARTED|Delayed Start||121
10378906|NCT00594568|11519953|FG000|COMPLETED|Delayed Start||91
10378907|NCT00594568|11519954|FG001|COMPLETED|Delayed Start||76
10378908|NCT00594568|11519955|FG002|COMPLETED|Delayed Start||55
10378909|NCT00594568|11519953|FG000|NOT COMPLETED|Delayed Start||98
10378910|NCT00594568|11519954|FG001|NOT COMPLETED|Delayed Start||77
10378911|NCT00594568|11519955|FG002|NOT COMPLETED|Delayed Start||66
10378912|NCT00594568|11519953|FG000|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|290
10378913|NCT00594568|11519954|FG001|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|223
10539112|NCT01459068|11692011|FG001|STARTED|Overall Study||182
10539113|NCT01459068|11692010|FG000|COMPLETED|Overall Study||126
10539114|NCT01459068|11692011|FG001|COMPLETED|Overall Study||148
10539115|NCT01459068|11692010|FG000|NOT COMPLETED|Overall Study||39
10539116|NCT01459068|11692011|FG001|NOT COMPLETED|Overall Study||34
10539117|NCT01459588|11692021|FG000|STARTED|Overall Study||105
10539118|NCT01459588|11692022|FG001|STARTED|Overall Study||51
10539119|NCT01459588|11692023|FG002|STARTED|Overall Study||103
10539120|NCT01459588|11692024|FG003|STARTED|Overall Study||56
10539121|NCT01459588|11692021|FG000|COMPLETED|Overall Study||104
10539122|NCT01459588|11692022|FG001|COMPLETED|Overall Study||49
10539123|NCT01459588|11692023|FG002|COMPLETED|Overall Study||102
10539124|NCT01459588|11692024|FG003|COMPLETED|Overall Study||55
10539125|NCT01459588|11692021|FG000|NOT COMPLETED|Overall Study||1
10539126|NCT01459588|11692022|FG001|NOT COMPLETED|Overall Study||2
10539127|NCT01459588|11692023|FG002|NOT COMPLETED|Overall Study||1
10539128|NCT01459588|11692024|FG003|NOT COMPLETED|Overall Study||1
10539129|NCT01459614|11692036|FG000|STARTED|Overall Study||29
10539130|NCT01459614|11692037|FG001|STARTED|Overall Study||10
10539131|NCT01459614|11692036|FG000|COMPLETED|Overall Study||28
10539132|NCT01459614|11692037|FG001|COMPLETED|Overall Study||10
10539133|NCT01459614|11692036|FG000|NOT COMPLETED|Overall Study||1
10539134|NCT01459614|11692037|FG001|NOT COMPLETED|Overall Study||0
10539135|NCT01459653|11692043|FG000|STARTED|Overall Study||1496
10539136|NCT01459653|11692043|FG000|COMPLETED|Overall Study||828
10539137|NCT01459653|11692043|FG000|NOT COMPLETED|Overall Study||668
10539138|NCT01459705|11692117|FG000|STARTED|Overall Study||54
10539139|NCT01459705|11692118|FG001|STARTED|Overall Study||54
10539140|NCT01459705|11692119|FG002|STARTED|Overall Study||54
10539141|NCT01459705|11692117|FG000|COMPLETED|Overall Study||32
10539142|NCT01459705|11692118|FG001|COMPLETED|Overall Study||30
10539143|NCT01459705|11692119|FG002|COMPLETED|Overall Study||47
10539144|NCT01459705|11692117|FG000|NOT COMPLETED|Overall Study||22
10539145|NCT01459705|11692118|FG001|NOT COMPLETED|Overall Study||24
10539146|NCT01459705|11692119|FG002|NOT COMPLETED|Overall Study||7
10378914|NCT00594568|11519955|FG002|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional, pts entered from initial treatment and delayed start or did not enter SFU.|214
10378915|NCT00594568|11519953|FG000|COMPLETED|Safety Follow Up (SFU)-Optional||229
10378916|NCT00594568|11519954|FG001|COMPLETED|Safety Follow Up (SFU)-Optional||168
10378917|NCT00594568|11519955|FG002|COMPLETED|Safety Follow Up (SFU)-Optional||172
10378918|NCT00594568|11519953|FG000|NOT COMPLETED|Safety Follow Up (SFU)-Optional||61
10378919|NCT00594568|11519954|FG001|NOT COMPLETED|Safety Follow Up (SFU)-Optional||55
10378920|NCT00594568|11519955|FG002|NOT COMPLETED|Safety Follow Up (SFU)-Optional||42
10378921|NCT00594646|11519971|FG000|STARTED|Overall Study||100
10378922|NCT00594646|11519971|FG000|COMPLETED|Overall Study||84
10378923|NCT00594646|11519971|FG000|NOT COMPLETED|Overall Study||16
10378924|NCT00594659|11519979|FG000|STARTED|Overall Study||29
10378925|NCT00594659|11519980|FG001|STARTED|Overall Study||30
10378926|NCT00594659|11519981|FG002|STARTED|Overall Study||16
10378927|NCT00594659|11519979|FG000|COMPLETED|Overall Study||16
10378928|NCT00594659|11519980|FG001|COMPLETED|Overall Study||21
10378929|NCT00594659|11519981|FG002|COMPLETED|Overall Study||9
10378930|NCT00594659|11519979|FG000|NOT COMPLETED|Overall Study||13
10378931|NCT00594659|11519980|FG001|NOT COMPLETED|Overall Study||9
10378932|NCT00594659|11519981|FG002|NOT COMPLETED|Overall Study||7
10378933|NCT00594685|11519989|FG000|STARTED|Overall Study||10
10378934|NCT00594685|11519989|FG000|COMPLETED|Overall Study||10
10378935|NCT00594685|11519989|FG000|NOT COMPLETED|Overall Study||0
10378936|NCT00594815|11519993|FG000|STARTED|Overall Study||52
10378937|NCT00594815|11519993|FG000|COMPLETED|Overall Study||43
10378938|NCT00594815|11519993|FG000|NOT COMPLETED|Overall Study||9
10378939|NCT00594854|11519999|FG000|STARTED|Overall Study||9
10378940|NCT00594854|11520000|FG001|STARTED|Overall Study||11
10378941|NCT00594854|11519999|FG000|COMPLETED|Overall Study|POZEN reached an agreement with the FDA to terminate the study due to low and inadequate enrollment.|2
10378942|NCT00594854|11520000|FG001|COMPLETED|Overall Study|POZEN reached an agreement with the FDA to terminate the study due to low and inadequate enrollment.|1
10378943|NCT00594854|11519999|FG000|NOT COMPLETED|Overall Study||7
10378944|NCT00594854|11520000|FG001|NOT COMPLETED|Overall Study||10
10378945|NCT00594880|11520008|FG000|STARTED|Overall Study||12
10378946|NCT00594880|11520009|FG001|STARTED|Overall Study||11
10378947|NCT00594880|11520008|FG000|COMPLETED|Overall Study||10
10378948|NCT00594880|11520009|FG001|COMPLETED|Overall Study||10
10378949|NCT00594880|11520008|FG000|NOT COMPLETED|Overall Study||2
10378950|NCT00594880|11520009|FG001|NOT COMPLETED|Overall Study||1
10378951|NCT00594906|11520021|FG000|STARTED|Overall Study||7
10378952|NCT00594906|11520022|FG001|STARTED|Overall Study||3
10378953|NCT00594906|11520021|FG000|COMPLETED|Overall Study||6
10378954|NCT00594906|11520022|FG001|COMPLETED|Overall Study||1
10378955|NCT00594906|11520021|FG000|NOT COMPLETED|Overall Study||1
10378956|NCT00594906|11520022|FG001|NOT COMPLETED|Overall Study||2
10378957|NCT00594932|11520030|FG000|STARTED|First 3 Months||13
10378958|NCT00594932|11520031|FG001|STARTED|First 3 Months||14
10378959|NCT00594932|11520030|FG000|COMPLETED|First 3 Months||12
10378960|NCT00594932|11520031|FG001|COMPLETED|First 3 Months||11
10378961|NCT00594932|11520030|FG000|NOT COMPLETED|First 3 Months||1
10378962|NCT00594932|11520031|FG001|NOT COMPLETED|First 3 Months||3
10378963|NCT00594932|11520030|FG000|STARTED|Final 3 Months||12
10378964|NCT00594932|11520031|FG001|STARTED|Final 3 Months||11
10378965|NCT00594932|11520030|FG000|COMPLETED|Final 3 Months||8
10378966|NCT00594932|11520031|FG001|COMPLETED|Final 3 Months||8
10378967|NCT00594932|11520030|FG000|NOT COMPLETED|Final 3 Months||4
10378968|NCT00594932|11520031|FG001|NOT COMPLETED|Final 3 Months||3
10378969|NCT00594945|11520040|FG000|STARTED|Cohort 1 / Treatment Period 1||4
10378970|NCT00594945|11520041|FG001|STARTED|Cohort 1 / Treatment Period 1||0
10378971|NCT00594945|11520042|FG002|STARTED|Cohort 1 / Treatment Period 1||2
10378972|NCT00594945|11520040|FG000|COMPLETED|Cohort 1 / Treatment Period 1||4
10378973|NCT00594945|11520041|FG001|COMPLETED|Cohort 1 / Treatment Period 1||0
10378974|NCT00594945|11520042|FG002|COMPLETED|Cohort 1 / Treatment Period 1||2
10378975|NCT00594945|11520040|FG000|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
10378976|NCT00594945|11520041|FG001|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
10378977|NCT00594945|11520042|FG002|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
10378978|NCT00594945|11520040|FG000|STARTED|Cohort 2 / Treatment Period 2||0
10378979|NCT00594945|11520041|FG001|STARTED|Cohort 2 / Treatment Period 2||3
10378980|NCT00594945|11520042|FG002|STARTED|Cohort 2 / Treatment Period 2||2
10378981|NCT00594945|11520040|FG000|COMPLETED|Cohort 2 / Treatment Period 2||0
10378982|NCT00594945|11520041|FG001|COMPLETED|Cohort 2 / Treatment Period 2||3
10378983|NCT00594945|11520042|FG002|COMPLETED|Cohort 2 / Treatment Period 2||2
10539147|NCT01459718|11692127|FG000|STARTED|Overall Study||13
10378984|NCT00594945|11520040|FG000|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
10378985|NCT00594945|11520041|FG001|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
10378986|NCT00594945|11520042|FG002|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
10378987|NCT00594958|11520051|FG000|STARTED|Overall Study||214
10378988|NCT00594958|11520052|FG001|STARTED|Overall Study||213
10378989|NCT00594958|11520053|FG002|STARTED|Overall Study||212
10378990|NCT00594958|11520051|FG000|Randomized and at Least 1 Vaccination|Overall Study||212
10378991|NCT00594958|11520052|FG001|Randomized and at Least 1 Vaccination|Overall Study||213
10378992|NCT00594958|11520053|FG002|Randomized and at Least 1 Vaccination|Overall Study||211
10378993|NCT00594958|11520051|FG000|COMPLETED|Overall Study||200
10378994|NCT00594958|11520052|FG001|COMPLETED|Overall Study||210
10378995|NCT00594958|11520053|FG002|COMPLETED|Overall Study||202
10378996|NCT00594958|11520051|FG000|NOT COMPLETED|Overall Study||14
10378997|NCT00594958|11520052|FG001|NOT COMPLETED|Overall Study||3
10378998|NCT00594958|11520053|FG002|NOT COMPLETED|Overall Study||10
10378999|NCT00594997|11520063|FG000|STARTED|Overall Study||1562
10539148|NCT01459718|11692127|FG000|Safety Analysis Set|Overall Study||13
10539149|NCT01459718|11692127|FG000|COMPLETED|Overall Study||10
10539150|NCT01459718|11692127|FG000|NOT COMPLETED|Overall Study||3
10539151|NCT01459783|11692133|FG000|STARTED|Baseline to 6 Months||71
10539152|NCT01459783|11692134|FG001|STARTED|Baseline to 6 Months||73
10539153|NCT01459783|11692133|FG000|COMPLETED|Baseline to 6 Months||39
10539154|NCT01459783|11692134|FG001|COMPLETED|Baseline to 6 Months||53
10539155|NCT01459783|11692133|FG000|NOT COMPLETED|Baseline to 6 Months||32
10539156|NCT01459783|11692134|FG001|NOT COMPLETED|Baseline to 6 Months||20
10539157|NCT01459783|11692133|FG000|STARTED|6 Months to 12 Months||39
10539158|NCT01459783|11692134|FG001|STARTED|6 Months to 12 Months||53
10539159|NCT01459783|11692133|FG000|COMPLETED|6 Months to 12 Months||20
10539160|NCT01459783|11692134|FG001|COMPLETED|6 Months to 12 Months||23
10539161|NCT01459783|11692133|FG000|NOT COMPLETED|6 Months to 12 Months||19
10539162|NCT01459783|11692134|FG001|NOT COMPLETED|6 Months to 12 Months||30
10539163|NCT01459796|11692142|FG000|STARTED|Overall Study||94
10539164|NCT01459796|11692143|FG001|STARTED|Overall Study||126
10539165|NCT01459796|11692142|FG000|COMPLETED|Overall Study||0
10539166|NCT01459796|11692143|FG001|COMPLETED|Overall Study||0
10539167|NCT01459796|11692142|FG000|NOT COMPLETED|Overall Study||94
10539168|NCT01459796|11692143|FG001|NOT COMPLETED|Overall Study||126
10539169|NCT01459913|11692153|FG000|STARTED|Overall Study||106
10539170|NCT01459913|11692154|FG001|STARTED|Overall Study||52
10539171|NCT01459913|11692155|FG002|STARTED|Overall Study||19
10539172|NCT01459913|11692156|FG003|STARTED|Overall Study||62
10539173|NCT01459913|11692153|FG000|COMPLETED|Overall Study||65
10539174|NCT01459913|11692154|FG001|COMPLETED|Overall Study||32
10539175|NCT01459913|11692155|FG002|COMPLETED|Overall Study||6
10539176|NCT01459913|11692156|FG003|COMPLETED|Overall Study||29
10539177|NCT01459913|11692153|FG000|NOT COMPLETED|Overall Study||41
10539178|NCT01459913|11692154|FG001|NOT COMPLETED|Overall Study||20
10539179|NCT01459913|11692155|FG002|NOT COMPLETED|Overall Study||13
10539180|NCT01459913|11692156|FG003|NOT COMPLETED|Overall Study||33
10539181|NCT01460225|11692168|FG000|STARTED|Overall Study|January 2009.|19
10539182|NCT01460225|11692168|FG000|COMPLETED|Overall Study|November 2010|19
10539183|NCT01460225|11692168|FG000|NOT COMPLETED|Overall Study||0
10539184|NCT01460290|11692173|FG000|STARTED|Overall Study||15
10539185|NCT01460290|11692173|FG000|COMPLETED|Overall Study||11
10539186|NCT01460290|11692173|FG000|NOT COMPLETED|Overall Study||4
10539187|NCT01460303|11692180|FG000|STARTED|Overall Study||25
10539188|NCT01460303|11692181|FG001|STARTED|Overall Study||24
10539189|NCT01460303|11692180|FG000|COMPLETED|Overall Study||25
10539190|NCT01460303|11692181|FG001|COMPLETED|Overall Study||24
10539191|NCT01460303|11692180|FG000|NOT COMPLETED|Overall Study||0
10539192|NCT01460303|11692181|FG001|NOT COMPLETED|Overall Study||0
10539193|NCT01460342|11692189|FG000|STARTED|Overall Study||304
10539194|NCT01460342|11692190|FG001|STARTED|Overall Study||306
10539195|NCT01460342|11692189|FG000|Received at Least 1 Dose of Study Drug|Overall Study||304
10539196|NCT01460342|11692190|FG001|Received at Least 1 Dose of Study Drug|Overall Study||306
10539197|NCT01460342|11692189|FG000|COMPLETED|Overall Study||293
10539198|NCT01460342|11692190|FG001|COMPLETED|Overall Study||292
10539199|NCT01460342|11692189|FG000|NOT COMPLETED|Overall Study||11
10539200|NCT01460342|11692190|FG001|NOT COMPLETED|Overall Study||14
10539201|NCT01460368|11692198|FG000|STARTED|Part A||7
10539202|NCT01460368|11692199|FG001|STARTED|Part A||0
10539203|NCT01460368|11692200|FG002|STARTED|Part A||0
10539204|NCT01460368|11692201|FG003|STARTED|Part A||0
10379000|NCT00594997|11520064|FG001|STARTED|Overall Study||2008
10379001|NCT00594997|11520063|FG000|COMPLETED|Overall Study||1562
10379002|NCT00594997|11520064|FG001|COMPLETED|Overall Study||2008
10379003|NCT00594997|11520063|FG000|NOT COMPLETED|Overall Study||0
10379004|NCT00594997|11520064|FG001|NOT COMPLETED|Overall Study||0
10379005|NCT00595075|11520074|FG000|STARTED|Overall Study||6
10379006|NCT00595075|11520075|FG001|STARTED|Overall Study||5
10379007|NCT00595075|11520074|FG000|COMPLETED|Overall Study||5
10379008|NCT00595075|11520075|FG001|COMPLETED|Overall Study||5
10379009|NCT00595075|11520074|FG000|NOT COMPLETED|Overall Study||1
10379010|NCT00595075|11520075|FG001|NOT COMPLETED|Overall Study||0
10379011|NCT00595088|11520081|FG000|STARTED|Overall Study||47
10379012|NCT00595088|11520081|FG000|COMPLETED|Overall Study|5 patients ongoing, 7 completed the study (week 46)and 35 withdrew prematurely|7
10379013|NCT00595088|11520081|FG000|NOT COMPLETED|Overall Study||40
10379014|NCT00595101|11520089|FG000|STARTED|Overall Study||29
10379015|NCT00595101|11520090|FG001|STARTED|Overall Study||29
10539205|NCT01460368|11692202|FG004|STARTED|Part A||0
10539206|NCT01460368|11692203|FG005|STARTED|Part A||0
10379016|NCT00595101|11520091|FG002|STARTED|Overall Study||29
10379017|NCT00595101|11520092|FG003|STARTED|Overall Study||30
10379018|NCT00595101|11520089|FG000|COMPLETED|Overall Study||29
10379019|NCT00595101|11520090|FG001|COMPLETED|Overall Study||28
10379020|NCT00595101|11520091|FG002|COMPLETED|Overall Study||29
10539207|NCT01460368|11692204|FG006|STARTED|Part A||0
10539208|NCT01460368|11692198|FG000|Received at Least One Dose of Study Drug|Part A||7
10539209|NCT01460368|11692199|FG001|Received at Least One Dose of Study Drug|Part A||0
10539210|NCT01460368|11692200|FG002|Received at Least One Dose of Study Drug|Part A||0
10539211|NCT01460368|11692201|FG003|Received at Least One Dose of Study Drug|Part A||0
10539212|NCT01460368|11692202|FG004|Received at Least One Dose of Study Drug|Part A||0
10379021|NCT00595101|11520092|FG003|COMPLETED|Overall Study||30
10379022|NCT00595101|11520089|FG000|NOT COMPLETED|Overall Study||0
10379023|NCT00595101|11520090|FG001|NOT COMPLETED|Overall Study||1
10379024|NCT00595101|11520091|FG002|NOT COMPLETED|Overall Study||0
10379025|NCT00595101|11520092|FG003|NOT COMPLETED|Overall Study||0
10379026|NCT00595114|11520104|FG000|STARTED|Overall Study||24
10379027|NCT00595114|11520105|FG001|STARTED|Overall Study||19
10379028|NCT00595114|11520104|FG000|COMPLETED|Overall Study||24
10379029|NCT00595114|11520105|FG001|COMPLETED|Overall Study||19
10379030|NCT00595114|11520104|FG000|NOT COMPLETED|Overall Study||0
10379031|NCT00595114|11520105|FG001|NOT COMPLETED|Overall Study||0
10379032|NCT00595127|11520111|FG000|STARTED|Overall Study||21
10379033|NCT00595127|11520111|FG000|COMPLETED|Overall Study||11
10379034|NCT00595127|11520111|FG000|NOT COMPLETED|Overall Study||10
10379035|NCT00595153|11520118|FG000|STARTED|Overall Study||24
10379036|NCT00595153|11520119|FG001|STARTED|Overall Study||42
10379037|NCT00595153|11520120|FG002|STARTED|Overall Study||61
10379038|NCT00595153|11520118|FG000|COMPLETED|Overall Study||20
10379039|NCT00595153|11520119|FG001|COMPLETED|Overall Study||26
10379040|NCT00595153|11520120|FG002|COMPLETED|Overall Study||36
10379041|NCT00595153|11520118|FG000|NOT COMPLETED|Overall Study||4
10379042|NCT00595153|11520119|FG001|NOT COMPLETED|Overall Study||16
10379043|NCT00595153|11520120|FG002|NOT COMPLETED|Overall Study||25
10379044|NCT00595231|11520130|FG000|STARTED|Overall Study||120
10379045|NCT00595231|11520131|FG001|STARTED|Overall Study||119
10379046|NCT00595231|11520130|FG000|COMPLETED|Overall Study||115
10379047|NCT00595231|11520131|FG001|COMPLETED|Overall Study||114
10379048|NCT00595231|11520130|FG000|NOT COMPLETED|Overall Study||5
10379049|NCT00595231|11520131|FG001|NOT COMPLETED|Overall Study||5
10379050|NCT00595270|11520140|FG000|STARTED|Overall Study||116
10379051|NCT00595270|11520141|FG001|STARTED|Overall Study||117
10379052|NCT00595270|11520142|FG002|STARTED|Overall Study||116
10379053|NCT00595270|11520140|FG000|COMPLETED|Overall Study||110
10379054|NCT00595270|11520141|FG001|COMPLETED|Overall Study||107
10379055|NCT00595270|11520142|FG002|COMPLETED|Overall Study||108
10379056|NCT00595270|11520140|FG000|NOT COMPLETED|Overall Study||6
10379057|NCT00595270|11520141|FG001|NOT COMPLETED|Overall Study||10
10379058|NCT00595270|11520142|FG002|NOT COMPLETED|Overall Study||8
10379059|NCT00595309|11520150|FG000|STARTED|Overall Study||198
10379060|NCT00595309|11520150|FG000|COMPLETED|Overall Study||194
10379061|NCT00595309|11520150|FG000|NOT COMPLETED|Overall Study||4
10379062|NCT00595335|11520156|FG000|STARTED|Baseline to Six Months||13
10379063|NCT00595335|11520157|FG001|STARTED|Baseline to Six Months||12
10379064|NCT00595335|11520156|FG000|COMPLETED|Baseline to Six Months||11
10379065|NCT00595335|11520157|FG001|COMPLETED|Baseline to Six Months||10
10379066|NCT00595335|11520156|FG000|NOT COMPLETED|Baseline to Six Months||2
10379067|NCT00595335|11520157|FG001|NOT COMPLETED|Baseline to Six Months||2
10379068|NCT00595335|11520156|FG000|STARTED|Six Months to Twelve Months||11
10379069|NCT00595335|11520157|FG001|STARTED|Six Months to Twelve Months||10
10379070|NCT00595335|11520156|FG000|COMPLETED|Six Months to Twelve Months||10
10379071|NCT00595335|11520157|FG001|COMPLETED|Six Months to Twelve Months||9
10379072|NCT00595335|11520156|FG000|NOT COMPLETED|Six Months to Twelve Months||1
10379073|NCT00595335|11520157|FG001|NOT COMPLETED|Six Months to Twelve Months||1
10379074|NCT00595361|11520169|FG000|STARTED|Overall Study||12
10379075|NCT00595361|11520170|FG001|STARTED|Overall Study||18
10379076|NCT00595361|11520169|FG000|COMPLETED|Overall Study||12
10379077|NCT00595361|11520170|FG001|COMPLETED|Overall Study||18
10379078|NCT00595361|11520169|FG000|NOT COMPLETED|Overall Study||0
10379079|NCT00595361|11520170|FG001|NOT COMPLETED|Overall Study||0
10379080|NCT00595413|11520180|FG000|STARTED|Overall Study||76
10379081|NCT00595413|11520181|FG001|STARTED|Overall Study||78
10379082|NCT00595413|11520182|FG002|STARTED|Overall Study||78
10379083|NCT00595413|11520183|FG003|STARTED|Overall Study||79
10379084|NCT00595413|11520180|FG000|COMPLETED|Overall Study||69
10379085|NCT00595413|11520181|FG001|COMPLETED|Overall Study||73
10379086|NCT00595413|11520182|FG002|COMPLETED|Overall Study||70
10379087|NCT00595413|11520183|FG003|COMPLETED|Overall Study||75
10379088|NCT00595413|11520180|FG000|NOT COMPLETED|Overall Study||7
10539213|NCT01460368|11692203|FG005|Received at Least One Dose of Study Drug|Part A||0
10539214|NCT01460368|11692204|FG006|Received at Least One Dose of Study Drug|Part A||0
10539215|NCT01460368|11692198|FG000|COMPLETED|Part A||7
10539216|NCT01460368|11692199|FG001|COMPLETED|Part A||0
10539217|NCT01460368|11692200|FG002|COMPLETED|Part A||0
10539218|NCT01460368|11692201|FG003|COMPLETED|Part A||0
10539219|NCT01460368|11692202|FG004|COMPLETED|Part A||0
10539220|NCT01460368|11692203|FG005|COMPLETED|Part A||0
10539221|NCT01460368|11692204|FG006|COMPLETED|Part A||0
10539222|NCT01460368|11692198|FG000|NOT COMPLETED|Part A||0
10539223|NCT01460368|11692199|FG001|NOT COMPLETED|Part A||0
10539224|NCT01460368|11692200|FG002|NOT COMPLETED|Part A||0
10539225|NCT01460368|11692201|FG003|NOT COMPLETED|Part A||0
10539226|NCT01460368|11692202|FG004|NOT COMPLETED|Part A||0
10539227|NCT01460368|11692203|FG005|NOT COMPLETED|Part A||0
10539228|NCT01460368|11692204|FG006|NOT COMPLETED|Part A||0
10539229|NCT01460368|11692198|FG000|STARTED|Part B: First Intervention (Period 1)||0
10379089|NCT00595413|11520181|FG001|NOT COMPLETED|Overall Study||5
10379090|NCT00595413|11520182|FG002|NOT COMPLETED|Overall Study||8
10379091|NCT00595413|11520183|FG003|NOT COMPLETED|Overall Study||4
10379092|NCT00595465|11520196|FG000|STARTED|Overall Study||130
10379093|NCT00595465|11520197|FG001|STARTED|Overall Study||129
10379094|NCT00595465|11520198|FG002|STARTED|Overall Study||128
10379095|NCT00595465|11520196|FG000|COMPLETED|Overall Study||124
10379096|NCT00595465|11520197|FG001|COMPLETED|Overall Study||125
10379097|NCT00595465|11520198|FG002|COMPLETED|Overall Study||121
10379098|NCT00595465|11520196|FG000|NOT COMPLETED|Overall Study||6
10379099|NCT00595465|11520197|FG001|NOT COMPLETED|Overall Study||4
10379100|NCT00595465|11520198|FG002|NOT COMPLETED|Overall Study||7
10379101|NCT00595478|11520208|FG000|STARTED|Treatment||37
10379102|NCT00595478|11520209|FG001|STARTED|Treatment||38
10379103|NCT00595478|11520208|FG000|COMPLETED|Treatment||37
10379104|NCT00595478|11520209|FG001|COMPLETED|Treatment||38
10379105|NCT00595478|11520208|FG000|NOT COMPLETED|Treatment||0
10379106|NCT00595478|11520209|FG001|NOT COMPLETED|Treatment||0
10379107|NCT00595478|11520208|FG000|STARTED|36-week Follow-up Period||37
10379108|NCT00595478|11520209|FG001|STARTED|36-week Follow-up Period||38
10379109|NCT00595478|11520208|FG000|COMPLETED|36-week Follow-up Period||28
10379110|NCT00595478|11520209|FG001|COMPLETED|36-week Follow-up Period||30
10379111|NCT00595478|11520208|FG000|NOT COMPLETED|36-week Follow-up Period||9
10379112|NCT00595478|11520209|FG001|NOT COMPLETED|36-week Follow-up Period||8
10379113|NCT00595504|11520217|FG000|STARTED|Overall Study||16
10379114|NCT00595504|11520218|FG001|STARTED|Overall Study||9
10379115|NCT00595504|11520217|FG000|COMPLETED|Overall Study||14
10379116|NCT00595504|11520218|FG001|COMPLETED|Overall Study||6
10379117|NCT00595504|11520217|FG000|NOT COMPLETED|Overall Study||2
10379118|NCT00595504|11520218|FG001|NOT COMPLETED|Overall Study||3
10379119|NCT00595517|11520224|FG000|STARTED|Overall Study||130
10379120|NCT00595517|11520224|FG000|COMPLETED|Overall Study||111
10379121|NCT00595517|11520224|FG000|NOT COMPLETED|Overall Study||19
10379122|NCT00595530|11520228|FG000|STARTED|Overall Study||3
10379123|NCT00595530|11520228|FG000|COMPLETED|Overall Study||3
10539230|NCT01460368|11692199|FG001|STARTED|Part B: First Intervention (Period 1)||10
10539231|NCT01460368|11692200|FG002|STARTED|Part B: First Intervention (Period 1)||10
10539232|NCT01460368|11692201|FG003|STARTED|Part B: First Intervention (Period 1)||10
10539233|NCT01460368|11692202|FG004|STARTED|Part B: First Intervention (Period 1)||10
10539234|NCT01460368|11692203|FG005|STARTED|Part B: First Intervention (Period 1)||10
10539235|NCT01460368|11692204|FG006|STARTED|Part B: First Intervention (Period 1)||10
10539236|NCT01460368|11692198|FG000|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||0
10539237|NCT01460368|11692199|FG001|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
10539238|NCT01460368|11692200|FG002|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
10539239|NCT01460368|11692201|FG003|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
10539240|NCT01460368|11692202|FG004|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
10379168|NCT00595946|11520291|FG001|STARTED|Overall Study||221
10539241|NCT01460368|11692203|FG005|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
10539242|NCT01460368|11692204|FG006|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
10539243|NCT01460368|11692198|FG000|COMPLETED|Part B: First Intervention (Period 1)||0
10539244|NCT01460368|11692199|FG001|COMPLETED|Part B: First Intervention (Period 1)||10
10539245|NCT01460368|11692200|FG002|COMPLETED|Part B: First Intervention (Period 1)||10
10539246|NCT01460368|11692201|FG003|COMPLETED|Part B: First Intervention (Period 1)||10
10539247|NCT01460368|11692202|FG004|COMPLETED|Part B: First Intervention (Period 1)||9
10539248|NCT01460368|11692203|FG005|COMPLETED|Part B: First Intervention (Period 1)||10
10539249|NCT01460368|11692204|FG006|COMPLETED|Part B: First Intervention (Period 1)||10
10539250|NCT01460368|11692198|FG000|NOT COMPLETED|Part B: First Intervention (Period 1)||0
10539251|NCT01460368|11692199|FG001|NOT COMPLETED|Part B: First Intervention (Period 1)||0
10539252|NCT01460368|11692200|FG002|NOT COMPLETED|Part B: First Intervention (Period 1)||0
10539253|NCT01460368|11692201|FG003|NOT COMPLETED|Part B: First Intervention (Period 1)||0
10539254|NCT01460368|11692202|FG004|NOT COMPLETED|Part B: First Intervention (Period 1)||1
10539255|NCT01460368|11692203|FG005|NOT COMPLETED|Part B: First Intervention (Period 1)||0
10539256|NCT01460368|11692204|FG006|NOT COMPLETED|Part B: First Intervention (Period 1)||0
10539257|NCT01460368|11692198|FG000|STARTED|Part B: Washout (up to 15 Days)||0
10539258|NCT01460368|11692199|FG001|STARTED|Part B: Washout (up to 15 Days)||10
10657751|NCT02228395|11818917|FG001|STARTED|Washout Period (at Least 10 Days)|One participant discontinued in the First Intervention Period and was replaced.|3
10657752|NCT02228395|11818918|FG002|STARTED|Washout Period (at Least 10 Days)|One participant discontinued in the First Intervention Period and was replaced.|3
10657753|NCT02228395|11818916|FG000|COMPLETED|Washout Period (at Least 10 Days)||3
10657754|NCT02228395|11818917|FG001|COMPLETED|Washout Period (at Least 10 Days)||3
10657755|NCT02228395|11818918|FG002|COMPLETED|Washout Period (at Least 10 Days)||3
10657756|NCT02228395|11818916|FG000|NOT COMPLETED|Washout Period (at Least 10 Days)||0
10657757|NCT02228395|11818917|FG001|NOT COMPLETED|Washout Period (at Least 10 Days)||0
10657758|NCT02228395|11818918|FG002|NOT COMPLETED|Washout Period (at Least 10 Days)||0
10657759|NCT02228395|11818916|FG000|STARTED|Second Intervention Period||3
10657760|NCT02228395|11818917|FG001|STARTED|Second Intervention Period||3
10657761|NCT02228395|11818918|FG002|STARTED|Second Intervention Period||3
10657762|NCT02228395|11818916|FG000|COMPLETED|Second Intervention Period||3
10657763|NCT02228395|11818917|FG001|COMPLETED|Second Intervention Period||3
10657764|NCT02228395|11818918|FG002|COMPLETED|Second Intervention Period||3
10657765|NCT02228395|11818916|FG000|NOT COMPLETED|Second Intervention Period||0
10379124|NCT00595530|11520228|FG000|NOT COMPLETED|Overall Study||0
10379125|NCT00595556|11520235|FG000|STARTED|Overall Study||20
10379126|NCT00595556|11520236|FG001|STARTED|Overall Study||20
10379127|NCT00595556|11520235|FG000|COMPLETED|Overall Study||17
10379128|NCT00595556|11520236|FG001|COMPLETED|Overall Study||19
10379129|NCT00595556|11520235|FG000|NOT COMPLETED|Overall Study||3
10379130|NCT00595556|11520236|FG001|NOT COMPLETED|Overall Study||1
10379131|NCT00595621|11520244|FG000|STARTED|Open Label Run in||22
10379132|NCT00595621|11520245|FG001|STARTED|Open Label Run in||0
10379133|NCT00595621|11520244|FG000|COMPLETED|Open Label Run in||19
10379134|NCT00595621|11520245|FG001|COMPLETED|Open Label Run in||0
10379135|NCT00595621|11520244|FG000|NOT COMPLETED|Open Label Run in||3
10379136|NCT00595621|11520245|FG001|NOT COMPLETED|Open Label Run in||0
10379137|NCT00595621|11520244|FG000|STARTED|Randomization and Study||10
10379138|NCT00595621|11520245|FG001|STARTED|Randomization and Study||9
10379139|NCT00595621|11520244|FG000|COMPLETED|Randomization and Study||8
10379140|NCT00595621|11520245|FG001|COMPLETED|Randomization and Study||8
10379141|NCT00595621|11520244|FG000|NOT COMPLETED|Randomization and Study||2
10379142|NCT00595621|11520245|FG001|NOT COMPLETED|Randomization and Study||1
10379143|NCT00595764|11520254|FG000|STARTED|Overall Study||71
10379144|NCT00595764|11520255|FG001|STARTED|Overall Study||70
10379145|NCT00595764|11520254|FG000|COMPLETED|Overall Study||32
10379146|NCT00595764|11520255|FG001|COMPLETED|Overall Study||27
10379147|NCT00595764|11520254|FG000|NOT COMPLETED|Overall Study||39
10379148|NCT00595764|11520255|FG001|NOT COMPLETED|Overall Study||43
10379149|NCT00595790|11520264|FG000|STARTED|Overall Study||125
10379150|NCT00595790|11520265|FG001|STARTED|Overall Study|124 subjects randomized to this group, 125 subjects received 1x12 mcg.(Safety Population: N=125)|124
10379151|NCT00595790|11520266|FG002|STARTED|Overall Study|125 subjects randomized to this group, 124 subjects received 1x6 mcg.(Safety Population: N=124)|125
10379152|NCT00595790|11520264|FG000|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|123
10379153|NCT00595790|11520265|FG001|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|123
10379154|NCT00595790|11520266|FG002|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|122
10379155|NCT00595790|11520264|FG000|NOT COMPLETED|Overall Study||2
10379156|NCT00595790|11520265|FG001|NOT COMPLETED|Overall Study||1
10379157|NCT00595790|11520266|FG002|NOT COMPLETED|Overall Study||3
10379158|NCT00595868|11520276|FG000|STARTED|Overall Study||107
10379159|NCT00595868|11520277|FG001|STARTED|Overall Study||111
10379160|NCT00595868|11520276|FG000|COMPLETED|Overall Study||62
10379161|NCT00595868|11520277|FG001|COMPLETED|Overall Study||61
10379162|NCT00595868|11520276|FG000|NOT COMPLETED|Overall Study||45
10379163|NCT00595868|11520277|FG001|NOT COMPLETED|Overall Study||50
10379164|NCT00595881|11520283|FG000|STARTED|Overall Study||420
10379165|NCT00595881|11520283|FG000|COMPLETED|Overall Study||420
10379166|NCT00595881|11520283|FG000|NOT COMPLETED|Overall Study||0
10379167|NCT00595946|11520290|FG000|STARTED|Overall Study||218
10379169|NCT00595946|11520290|FG000|COMPLETED|Overall Study||154
10379170|NCT00595946|11520291|FG001|COMPLETED|Overall Study||152
10379171|NCT00595946|11520290|FG000|NOT COMPLETED|Overall Study||64
10379172|NCT00595946|11520291|FG001|NOT COMPLETED|Overall Study||69
10379173|NCT00595959|11520297|FG000|STARTED|Overall Study||65
10379174|NCT00595959|11520297|FG000|COMPLETED|Overall Study||63
10379175|NCT00595959|11520297|FG000|NOT COMPLETED|Overall Study||2
10379176|NCT00596011|11520303|FG000|STARTED|Overall Study||49
10379177|NCT00596011|11520304|FG001|STARTED|Overall Study||48
10379178|NCT00596011|11520303|FG000|COMPLETED|Overall Study||36
10379179|NCT00596011|11520304|FG001|COMPLETED|Overall Study||38
10379180|NCT00596011|11520303|FG000|NOT COMPLETED|Overall Study||13
10379181|NCT00596011|11520304|FG001|NOT COMPLETED|Overall Study||10
10379182|NCT00596102|11520313|FG000|STARTED|Up to Month 6||2283
10379183|NCT00596102|11520314|FG001|STARTED|Up to Month 6||338
10379184|NCT00596102|11520315|FG002|STARTED|Up to Month 6||637
10379185|NCT00596102|11520313|FG000|COMPLETED|Up to Month 6||2283
10379186|NCT00596102|11520314|FG001|COMPLETED|Up to Month 6||338
10379187|NCT00596102|11520315|FG002|COMPLETED|Up to Month 6||637
10379188|NCT00596102|11520313|FG000|NOT COMPLETED|Up to Month 6||0
10379189|NCT00596102|11520314|FG001|NOT COMPLETED|Up to Month 6||0
10379190|NCT00596102|11520315|FG002|NOT COMPLETED|Up to Month 6||0
10379191|NCT00596102|11520313|FG000|STARTED|Up to Month 60||2283
10379192|NCT00596102|11520314|FG001|STARTED|Up to Month 60||338
10379193|NCT00596102|11520315|FG002|STARTED|Up to Month 60||637
10379194|NCT00596102|11520313|FG000|COMPLETED|Up to Month 60|"long-term safety follow-up beyond Month 6 for a sub-set of subjects in IC51 group only"|102
10379195|NCT00596102|11520314|FG001|COMPLETED|Up to Month 60||0
10379196|NCT00596102|11520315|FG002|COMPLETED|Up to Month 60||0
10379197|NCT00596102|11520313|FG000|NOT COMPLETED|Up to Month 60||2181
10379198|NCT00596102|11520314|FG001|NOT COMPLETED|Up to Month 60||338
10379199|NCT00596102|11520315|FG002|NOT COMPLETED|Up to Month 60||637
10379200|NCT00596167|11520322|FG000|STARTED|Overall Study|All recruited subjects completed the study.|6
10379201|NCT00596167|11520322|FG000|COMPLETED|Overall Study||6
10379202|NCT00596167|11520322|FG000|NOT COMPLETED|Overall Study||0
10379203|NCT00596271|11520329|FG000|STARTED|Overall Study||65
10379204|NCT00596271|11520330|FG001|STARTED|Overall Study||65
10379205|NCT00596271|11520331|FG002|STARTED|Overall Study||62
10379206|NCT00596271|11520329|FG000|COMPLETED|Overall Study||60
10379207|NCT00596271|11520330|FG001|COMPLETED|Overall Study||59
10379208|NCT00596271|11520331|FG002|COMPLETED|Overall Study||61
10379209|NCT00596271|11520329|FG000|NOT COMPLETED|Overall Study||5
10379210|NCT00596271|11520330|FG001|NOT COMPLETED|Overall Study||6
10379211|NCT00596271|11520331|FG002|NOT COMPLETED|Overall Study||1
10379212|NCT00596362|11520340|FG000|STARTED|Overall Study||1
10379213|NCT00596362|11520340|FG000|COMPLETED|Overall Study||0
10379214|NCT00596362|11520340|FG000|NOT COMPLETED|Overall Study||1
10379215|NCT00596427|11520346|FG000|STARTED|Overall Study||30
10379216|NCT00596427|11520347|FG001|STARTED|Overall Study||30
10379217|NCT00596427|11520346|FG000|COMPLETED|Overall Study||26
10379218|NCT00596427|11520347|FG001|COMPLETED|Overall Study||28
10379219|NCT00596427|11520346|FG000|NOT COMPLETED|Overall Study||4
10379220|NCT00596427|11520347|FG001|NOT COMPLETED|Overall Study||2
10379221|NCT00596440|11520356|FG000|STARTED|Overall Study||113
10379222|NCT00596440|11520357|FG001|STARTED|Overall Study||121
10379223|NCT00596440|11520356|FG000|Showed to Eligibility Visit|Overall Study||85
10379224|NCT00596440|11520357|FG001|Showed to Eligibility Visit|Overall Study||72
10379225|NCT00596440|11520356|FG000|Showed to First Treatment Session|Overall Study||61
10379226|NCT00596440|11520357|FG001|Showed to First Treatment Session|Overall Study||52
10379227|NCT00596440|11520356|FG000|COMPLETED|Overall Study||48
10379228|NCT00596440|11520357|FG001|COMPLETED|Overall Study||41
10379229|NCT00596440|11520356|FG000|NOT COMPLETED|Overall Study||65
10379230|NCT00596440|11520357|FG001|NOT COMPLETED|Overall Study||80
10379231|NCT00596453|11520365|FG000|STARTED|Overall Study||13
10379232|NCT00596453|11520366|FG001|STARTED|Overall Study||15
10379233|NCT00596453|11520365|FG000|COMPLETED|Overall Study||12
10379234|NCT00596453|11520366|FG001|COMPLETED|Overall Study||12
10379235|NCT00596453|11520365|FG000|NOT COMPLETED|Overall Study||1
10379236|NCT00596453|11520366|FG001|NOT COMPLETED|Overall Study||3
10379237|NCT00596466|11520372|FG000|STARTED|Overall Study||75
10379238|NCT00596466|11520372|FG000|Enrolled, Treated|Overall Study||73
10379239|NCT00596466|11520372|FG000|COMPLETED|Overall Study||58
10379240|NCT00596466|11520372|FG000|NOT COMPLETED|Overall Study||17
10379241|NCT00596622|11520379|FG000|STARTED|Overall Study||46
10379242|NCT00596622|11520379|FG000|COMPLETED|Overall Study||33
10379243|NCT00596622|11520379|FG000|NOT COMPLETED|Overall Study||13
10539259|NCT01460368|11692200|FG002|STARTED|Part B: Washout (up to 15 Days)||10
10539260|NCT01460368|11692201|FG003|STARTED|Part B: Washout (up to 15 Days)||10
10539261|NCT01460368|11692202|FG004|STARTED|Part B: Washout (up to 15 Days)||9
10539262|NCT01460368|11692203|FG005|STARTED|Part B: Washout (up to 15 Days)||10
10539263|NCT01460368|11692204|FG006|STARTED|Part B: Washout (up to 15 Days)||10
10539264|NCT01460368|11692198|FG000|COMPLETED|Part B: Washout (up to 15 Days)||0
10539265|NCT01460368|11692199|FG001|COMPLETED|Part B: Washout (up to 15 Days)||10
10539266|NCT01460368|11692200|FG002|COMPLETED|Part B: Washout (up to 15 Days)||10
10539267|NCT01460368|11692201|FG003|COMPLETED|Part B: Washout (up to 15 Days)||10
10539268|NCT01460368|11692202|FG004|COMPLETED|Part B: Washout (up to 15 Days)||9
10539269|NCT01460368|11692203|FG005|COMPLETED|Part B: Washout (up to 15 Days)||10
10539270|NCT01460368|11692204|FG006|COMPLETED|Part B: Washout (up to 15 Days)||10
10539271|NCT01460368|11692198|FG000|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
10539272|NCT01460368|11692199|FG001|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
10539273|NCT01460368|11692200|FG002|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
10539274|NCT01460368|11692201|FG003|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
10539275|NCT01460368|11692202|FG004|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
10539276|NCT01460368|11692203|FG005|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
10539277|NCT01460368|11692204|FG006|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
10539278|NCT01460368|11692198|FG000|STARTED|Part B: Second Intervention (Period 2)||0
10539279|NCT01460368|11692199|FG001|STARTED|Part B: Second Intervention (Period 2)||10
10539280|NCT01460368|11692200|FG002|STARTED|Part B: Second Intervention (Period 2)||10
10539281|NCT01460368|11692201|FG003|STARTED|Part B: Second Intervention (Period 2)||10
10539282|NCT01460368|11692202|FG004|STARTED|Part B: Second Intervention (Period 2)||9
10539283|NCT01460368|11692203|FG005|STARTED|Part B: Second Intervention (Period 2)||10
10539284|NCT01460368|11692204|FG006|STARTED|Part B: Second Intervention (Period 2)||10
10539285|NCT01460368|11692198|FG000|COMPLETED|Part B: Second Intervention (Period 2)||0
10539286|NCT01460368|11692199|FG001|COMPLETED|Part B: Second Intervention (Period 2)||8
10539287|NCT01460368|11692200|FG002|COMPLETED|Part B: Second Intervention (Period 2)||10
10539288|NCT01460368|11692201|FG003|COMPLETED|Part B: Second Intervention (Period 2)||10
10539289|NCT01460368|11692202|FG004|COMPLETED|Part B: Second Intervention (Period 2)||9
10539290|NCT01460368|11692203|FG005|COMPLETED|Part B: Second Intervention (Period 2)||10
10539291|NCT01460368|11692204|FG006|COMPLETED|Part B: Second Intervention (Period 2)||9
10539292|NCT01460368|11692198|FG000|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
10539293|NCT01460368|11692199|FG001|NOT COMPLETED|Part B: Second Intervention (Period 2)||2
10539294|NCT01460368|11692200|FG002|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
10539295|NCT01460368|11692201|FG003|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
10539296|NCT01460368|11692202|FG004|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
10539297|NCT01460368|11692203|FG005|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
10657766|NCT02228395|11818917|FG001|NOT COMPLETED|Second Intervention Period||0
10657767|NCT02228395|11818918|FG002|NOT COMPLETED|Second Intervention Period||0
10657768|NCT02228395|11818916|FG000|STARTED|Washout Period (at Least 10 Days)||3
10657769|NCT02228395|11818917|FG001|STARTED|Washout Period (at Least 10 Days)||3
10657770|NCT02228395|11818918|FG002|STARTED|Washout Period (at Least 10 Days)||3
10657771|NCT02228395|11818916|FG000|COMPLETED|Washout Period (at Least 10 Days)||3
10657772|NCT02228395|11818917|FG001|COMPLETED|Washout Period (at Least 10 Days)||3
10657773|NCT02228395|11818918|FG002|COMPLETED|Washout Period (at Least 10 Days)||3
10379244|NCT00596635|11520391|FG000|STARTED|Overall Study||17
10379245|NCT00596635|11520392|FG001|STARTED|Overall Study||20
10379246|NCT00596635|11520393|FG002|STARTED|Overall Study||19
10379247|NCT00596635|11520391|FG000|COMPLETED|Overall Study||10
10379248|NCT00596635|11520392|FG001|COMPLETED|Overall Study||7
10379249|NCT00596635|11520393|FG002|COMPLETED|Overall Study||11
10379250|NCT00596635|11520391|FG000|NOT COMPLETED|Overall Study||7
10379251|NCT00596635|11520392|FG001|NOT COMPLETED|Overall Study||13
10379252|NCT00596635|11520393|FG002|NOT COMPLETED|Overall Study||8
10379253|NCT00596687|11520403|FG000|STARTED|Overall Study||118
10379254|NCT00596687|11520404|FG001|STARTED|Overall Study||116
10379255|NCT00596687|11520403|FG000|COMPLETED|Overall Study||104
10379256|NCT00596687|11520404|FG001|COMPLETED|Overall Study||107
10379257|NCT00596687|11520403|FG000|NOT COMPLETED|Overall Study||14
10379258|NCT00596687|11520404|FG001|NOT COMPLETED|Overall Study||9
10427994|NCT00856284|11573958|FG000|Received Study Drug|Overall Study||873
10427995|NCT00856284|11573959|FG001|Received Study Drug|Overall Study||878
10427996|NCT00856284|11573960|FG002|Received Study Drug|Overall Study||869
10427997|NCT00856284|11573958|FG000|COMPLETED|Overall Study||472
10427998|NCT00856284|11573959|FG001|COMPLETED|Overall Study||493
10427999|NCT00856284|11573960|FG002|COMPLETED|Overall Study||427
10428000|NCT00856284|11573958|FG000|NOT COMPLETED|Overall Study||408
10428001|NCT00856284|11573959|FG001|NOT COMPLETED|Overall Study||392
10428002|NCT00856284|11573960|FG002|NOT COMPLETED|Overall Study||447
10428003|NCT00856297|11573973|FG000|STARTED|Overall Study||131
10428004|NCT00856297|11573974|FG001|STARTED|Overall Study||76
10428005|NCT00856297|11573975|FG002|STARTED|Overall Study||107
10428006|NCT00856297|11573976|FG003|STARTED|Overall Study||44
10428007|NCT00856297|11573977|FG004|STARTED|Overall Study||31
10428008|NCT00856297|11573973|FG000|COMPLETED|Overall Study||129
10428009|NCT00856297|11573974|FG001|COMPLETED|Overall Study||76
10428010|NCT00856297|11573975|FG002|COMPLETED|Overall Study||107
10428011|NCT00856297|11573976|FG003|COMPLETED|Overall Study||44
10428012|NCT00856297|11573977|FG004|COMPLETED|Overall Study||31
10428013|NCT00856297|11573973|FG000|NOT COMPLETED|Overall Study||2
10428014|NCT00856297|11573974|FG001|NOT COMPLETED|Overall Study||0
10428015|NCT00856297|11573975|FG002|NOT COMPLETED|Overall Study||0
10428016|NCT00856297|11573976|FG003|NOT COMPLETED|Overall Study||0
10428017|NCT00856297|11573977|FG004|NOT COMPLETED|Overall Study||0
10428018|NCT00856323|11573994|FG000|STARTED|Overall Study||53
10428019|NCT00856323|11573994|FG000|COMPLETED|Overall Study||51
10428020|NCT00856323|11573994|FG000|NOT COMPLETED|Overall Study||2
10428021|NCT00856349|11573998|FG000|STARTED|Overall Study||4132
10428022|NCT00856349|11573998|FG000|12 Month Follow-up|Overall Study||3228
10428023|NCT00856349|11573998|FG000|18 Month Follow-up|Overall Study||2467
10428024|NCT00856349|11573998|FG000|24 Month Follow-up|Overall Study||1698
10428025|NCT00856349|11573998|FG000|COMPLETED|Overall Study||3111
10428026|NCT00856349|11573998|FG000|NOT COMPLETED|Overall Study||1021
10428027|NCT00856375|11574006|FG000|STARTED|Overall Study||42
10428028|NCT00856375|11574007|FG001|STARTED|Overall Study||41
10428029|NCT00856375|11574006|FG000|COMPLETED|Overall Study||0
10428030|NCT00856375|11574007|FG001|COMPLETED|Overall Study||0
10428031|NCT00856375|11574006|FG000|NOT COMPLETED|Overall Study||42
10428032|NCT00856375|11574007|FG001|NOT COMPLETED|Overall Study||41
10428033|NCT00856388|11574013|FG000|STARTED|Overall Study||62
10428034|NCT00856388|11574013|FG000|COMPLETED|Overall Study||61
10428035|NCT00856388|11574013|FG000|NOT COMPLETED|Overall Study||1
10428036|NCT00856414|11574018|FG000|STARTED|Overall Study||45
10428037|NCT00856414|11574018|FG000|COMPLETED|Overall Study||45
10428038|NCT00856414|11574018|FG000|NOT COMPLETED|Overall Study||0
10428039|NCT00856492|11574025|FG000|STARTED|Overall Study||99
10428040|NCT00856492|11574026|FG001|STARTED|Overall Study||63
10428041|NCT00856492|11574027|FG002|STARTED|Overall Study||53
10428042|NCT00856492|11574025|FG000|Toxicity Eval|Overall Study||96
10428043|NCT00856492|11574026|FG001|Toxicity Eval|Overall Study||60
10428044|NCT00856492|11574027|FG002|Toxicity Eval|Overall Study||51
10428045|NCT00856492|11574025|FG000|COMPLETED|Overall Study||98
10428046|NCT00856492|11574026|FG001|COMPLETED|Overall Study||62
10428047|NCT00856492|11574027|FG002|COMPLETED|Overall Study||51
10428048|NCT00856492|11574025|FG000|NOT COMPLETED|Overall Study||1
10428049|NCT00856492|11574026|FG001|NOT COMPLETED|Overall Study||1
10428050|NCT00856492|11574027|FG002|NOT COMPLETED|Overall Study||2
10428051|NCT00856518|11574040|FG000|STARTED|Overall Study||24
10428052|NCT00856518|11574041|FG001|STARTED|Overall Study||18
10428053|NCT00856518|11574040|FG000|COMPLETED|Overall Study||20
10428054|NCT00856518|11574041|FG001|COMPLETED|Overall Study||16
10428055|NCT00856518|11574040|FG000|NOT COMPLETED|Overall Study||4
10428056|NCT00856518|11574041|FG001|NOT COMPLETED|Overall Study||2
10428057|NCT00856544|11574053|FG000|STARTED|Overall Study||318
10428058|NCT00856544|11574054|FG001|STARTED|Overall Study||318
10428059|NCT00856544|11574055|FG002|STARTED|Overall Study||79
10428060|NCT00856544|11574056|FG003|STARTED|Overall Study||80
10428061|NCT00856544|11574053|FG000|Treated|Overall Study||315
10428062|NCT00856544|11574054|FG001|Treated|Overall Study||318
10428063|NCT00856544|11574055|FG002|Treated|Overall Study||79
10428064|NCT00856544|11574056|FG003|Treated|Overall Study||80
10428065|NCT00856544|11574053|FG000|COMPLETED|Overall Study||261
10428066|NCT00856544|11574054|FG001|COMPLETED|Overall Study||252
10428067|NCT00856544|11574055|FG002|COMPLETED|Overall Study||71
10428068|NCT00856544|11574056|FG003|COMPLETED|Overall Study||67
10428069|NCT00856544|11574053|FG000|NOT COMPLETED|Overall Study||57
10428070|NCT00856544|11574054|FG001|NOT COMPLETED|Overall Study||66
10428071|NCT00856544|11574055|FG002|NOT COMPLETED|Overall Study||8
10428072|NCT00856544|11574056|FG003|NOT COMPLETED|Overall Study||13
10428073|NCT00856557|11574080|FG000|STARTED|Overall Study||62
10428074|NCT00856557|11574081|FG001|STARTED|Overall Study||76
10428075|NCT00856557|11574080|FG000|Received Intervention/Control|Overall Study||62
10428076|NCT00856557|11574081|FG001|Received Intervention/Control|Overall Study||76
10379259|NCT00596752|11520412|FG000|STARTED|Overall Study||415
10379260|NCT00596752|11520413|FG001|STARTED|Overall Study||425
10379261|NCT00596752|11520412|FG000|Randomized and Treated|Overall Study||415
10379262|NCT00596752|11520413|FG001|Randomized and Treated|Overall Study||424
10379263|NCT00596752|11520412|FG000|COMPLETED|Overall Study||289
10379264|NCT00596752|11520413|FG001|COMPLETED|Overall Study||282
10379265|NCT00596752|11520412|FG000|NOT COMPLETED|Overall Study||126
10379266|NCT00596752|11520413|FG001|NOT COMPLETED|Overall Study||143
10717721|NCT02701062|11881745|FG001|NOT COMPLETED|Baseline||0
10717722|NCT02701062|11881744|FG000|STARTED|Index Procedure||376
10717723|NCT02701062|11881745|FG001|STARTED|Index Procedure||186
10717724|NCT02701062|11881744|FG000|COMPLETED|Index Procedure||376
10717725|NCT02701062|11881745|FG001|COMPLETED|Index Procedure||186
10717726|NCT02701062|11881744|FG000|NOT COMPLETED|Index Procedure||0
10379267|NCT00594386|11520419|FG000|STARTED|Overall Study||258
10379268|NCT00594386|11520419|FG000|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
10379269|NCT00594386|11520419|FG000|NOT COMPLETED|Overall Study||258
10379270|NCT00596817|11520426|FG000|STARTED|Open-label Period||0
10379271|NCT00596817|11520427|FG001|STARTED|Open-label Period||639
10379272|NCT00596817|11520426|FG000|COMPLETED|Open-label Period||0
10379273|NCT00596817|11520427|FG001|COMPLETED|Open-label Period||492
10379274|NCT00596817|11520426|FG000|NOT COMPLETED|Open-label Period||0
10379275|NCT00596817|11520427|FG001|NOT COMPLETED|Open-label Period||147
10717727|NCT02701062|11881745|FG001|NOT COMPLETED|Index Procedure||0
10717728|NCT02701062|11881744|FG000|STARTED|Discharge||376
10379276|NCT00596817|11520426|FG000|STARTED|Open-label Period to Double-blind Period||0
10379277|NCT00596817|11520427|FG001|STARTED|Open-label Period to Double-blind Period||492
10379278|NCT00596817|11520426|FG000|COMPLETED|Open-label Period to Double-blind Period||0
10379279|NCT00596817|11520427|FG001|COMPLETED|Open-label Period to Double-blind Period||400
10379280|NCT00596817|11520426|FG000|NOT COMPLETED|Open-label Period to Double-blind Period||0
10379281|NCT00596817|11520427|FG001|NOT COMPLETED|Open-label Period to Double-blind Period||92
10379282|NCT00596817|11520426|FG000|STARTED|Double-blind Period|194 patients were randomised. 2 did not receive study medication. 192 is full-analysis set (FAS).|192
10379283|NCT00596817|11520427|FG001|STARTED|Double-blind Period|206 patients were randomised. 2 did not receive study medication. 204 is FAS.|204
10379284|NCT00596817|11520426|FG000|COMPLETED|Double-blind Period||104
10379285|NCT00596817|11520427|FG001|COMPLETED|Double-blind Period||125
10379286|NCT00596817|11520426|FG000|NOT COMPLETED|Double-blind Period||88
10379287|NCT00596817|11520427|FG001|NOT COMPLETED|Double-blind Period||79
10379288|NCT00596830|11520436|FG000|STARTED|Overall Study|1 participant in this group only received paclitaxel and carboplatin (chemo).|342
10379289|NCT00596830|11520437|FG001|STARTED|Overall Study||339
10379290|NCT00596830|11520436|FG000|Treated|Overall Study|1 participant in this group only received chemo and did not complete due to death.|339
10379291|NCT00596830|11520437|FG001|Treated|Overall Study||332
10379292|NCT00596830|11520436|FG000|COMPLETED|Overall Study||0
10379293|NCT00596830|11520437|FG001|COMPLETED|Overall Study||0
10379294|NCT00596830|11520436|FG000|NOT COMPLETED|Overall Study||342
10379295|NCT00596830|11520437|FG001|NOT COMPLETED|Overall Study||339
10379296|NCT00596934|11520443|FG000|STARTED|Overall Study||9
10379297|NCT00596934|11520443|FG000|COMPLETED|Overall Study||7
10379298|NCT00596934|11520443|FG000|NOT COMPLETED|Overall Study||2
10379299|NCT00596960|11520451|FG000|STARTED|Overall Study||70
10379300|NCT00596960|11520452|FG001|STARTED|Overall Study|One subject did not have any alcohol use data and thus was excluded from the statistical analysis|69
10379301|NCT00596960|11520451|FG000|COMPLETED|Overall Study||59
10379302|NCT00596960|11520452|FG001|COMPLETED|Overall Study||60
10379303|NCT00596960|11520451|FG000|NOT COMPLETED|Overall Study||11
10379304|NCT00596960|11520452|FG001|NOT COMPLETED|Overall Study||9
10379311|NCT00597038|11520471|FG000|STARTED|Overall Study||16
10379312|NCT00597038|11520472|FG001|STARTED|Overall Study||34
10379313|NCT00597038|11520471|FG000|COMPLETED|Overall Study|One did not complete due to PI decision, one did not complete due to progressive disease.|14
10379314|NCT00597038|11520472|FG001|COMPLETED|Overall Study|Two patients withdrew, one did not complete due to progressive disease, one patient died.|30
10379315|NCT00597038|11520471|FG000|NOT COMPLETED|Overall Study||2
10379316|NCT00597038|11520472|FG001|NOT COMPLETED|Overall Study||4
10379317|NCT00597116|11520482|FG000|STARTED|Overall Study||14
10379318|NCT00597116|11520483|FG001|STARTED|Overall Study||11
10379319|NCT00597116|11520482|FG000|COMPLETED|Overall Study|Randomised patients ongoing study treatment at data cut-off|0
10379320|NCT00597116|11520483|FG001|COMPLETED|Overall Study|Randomised patients ongoing study treatment at data cut-off|0
10379321|NCT00597116|11520482|FG000|NOT COMPLETED|Overall Study||14
10379322|NCT00597116|11520483|FG001|NOT COMPLETED|Overall Study||11
10379323|NCT00597207|11520491|FG000|STARTED|Overall Study||2099
10379324|NCT00597207|11520492|FG001|STARTED|Overall Study||2132
10379325|NCT00597207|11520491|FG000|COMPLETED|Overall Study||2094
10379326|NCT00597207|11520492|FG001|COMPLETED|Overall Study||2125
10379327|NCT00597207|11520491|FG000|NOT COMPLETED|Overall Study||5
10379328|NCT00597207|11520492|FG001|NOT COMPLETED|Overall Study||7
10717729|NCT02701062|11881745|FG001|STARTED|Discharge||186
10717730|NCT02701062|11881744|FG000|COMPLETED|Discharge||376
10717731|NCT02701062|11881745|FG001|COMPLETED|Discharge||186
10379329|NCT00597246|11520498|FG000|STARTED|Overall Study||30
10379330|NCT00597246|11520498|FG000|COMPLETED|Overall Study||30
10379331|NCT00597246|11520498|FG000|NOT COMPLETED|Overall Study||0
10379332|NCT00597272|11520509|FG000|STARTED|Overall Study||1
10379333|NCT00597272|11520510|FG001|STARTED|Overall Study||1
10379334|NCT00597272|11520511|FG002|STARTED|Overall Study||10
10379335|NCT00597272|11520512|FG003|STARTED|Overall Study||1
10379336|NCT00597272|11520513|FG004|STARTED|Overall Study||1
10379337|NCT00597272|11520514|FG005|STARTED|Overall Study||10
10379338|NCT00597272|11520515|FG006|STARTED|Overall Study||10
10379339|NCT00597272|11520509|FG000|COMPLETED|Overall Study||1
10379340|NCT00597272|11520510|FG001|COMPLETED|Overall Study||1
10379341|NCT00597272|11520511|FG002|COMPLETED|Overall Study||10
10379342|NCT00597272|11520512|FG003|COMPLETED|Overall Study||1
10379343|NCT00597272|11520513|FG004|COMPLETED|Overall Study||1
10379344|NCT00597272|11520514|FG005|COMPLETED|Overall Study||10
10379345|NCT00597272|11520515|FG006|COMPLETED|Overall Study||10
10379346|NCT00597272|11520509|FG000|NOT COMPLETED|Overall Study||0
10379347|NCT00597272|11520510|FG001|NOT COMPLETED|Overall Study||0
10379348|NCT00597272|11520511|FG002|NOT COMPLETED|Overall Study||0
10379349|NCT00597272|11520512|FG003|NOT COMPLETED|Overall Study||0
10379350|NCT00597272|11520513|FG004|NOT COMPLETED|Overall Study||0
10379351|NCT00597272|11520514|FG005|NOT COMPLETED|Overall Study||0
10379352|NCT00597272|11520515|FG006|NOT COMPLETED|Overall Study||0
10379353|NCT00597376|11520533|FG000|STARTED|Overall Study||51
10379354|NCT00597376|11520534|FG001|STARTED|Overall Study||53
10379355|NCT00597376|11520533|FG000|COMPLETED|Overall Study|All participants started (51) were included in primary analyses.|43
10379356|NCT00597376|11520534|FG001|COMPLETED|Overall Study|All participants started (53) were included in primary analyses.|49
10379357|NCT00597376|11520533|FG000|NOT COMPLETED|Overall Study||8
10379358|NCT00597376|11520534|FG001|NOT COMPLETED|Overall Study||4
10379359|NCT00597402|11520540|FG000|STARTED|Overall Study||125
10379360|NCT00597402|11520540|FG000|COMPLETED|Overall Study||125
10379361|NCT00597402|11520540|FG000|NOT COMPLETED|Overall Study||0
10379362|NCT00597428|11520546|FG000|STARTED|Overall Study||214
10379363|NCT00597428|11520547|FG001|STARTED|Overall Study||223
10379364|NCT00597428|11520546|FG000|COMPLETED|Overall Study||153
10379365|NCT00597428|11520547|FG001|COMPLETED|Overall Study||152
10379366|NCT00597428|11520546|FG000|NOT COMPLETED|Overall Study||61
10379367|NCT00597428|11520547|FG001|NOT COMPLETED|Overall Study||71
10539298|NCT01460368|11692204|FG006|NOT COMPLETED|Part B: Second Intervention (Period 2)||1
10539299|NCT01460368|11692198|FG000|STARTED|Part B: Washout (up to 15 Days)||0
10539300|NCT01460368|11692199|FG001|STARTED|Part B: Washout (up to 15 Days)||8
10539301|NCT01460368|11692200|FG002|STARTED|Part B: Washout (up to 15 Days)||10
10539302|NCT01460368|11692201|FG003|STARTED|Part B: Washout (up to 15 Days)||10
10539303|NCT01460368|11692202|FG004|STARTED|Part B: Washout (up to 15 Days)||9
10539304|NCT01460368|11692203|FG005|STARTED|Part B: Washout (up to 15 Days)||10
10657774|NCT02228395|11818916|FG000|NOT COMPLETED|Washout Period (at Least 10 Days)||0
10657775|NCT02228395|11818917|FG001|NOT COMPLETED|Washout Period (at Least 10 Days)||0
10657776|NCT02228395|11818918|FG002|NOT COMPLETED|Washout Period (at Least 10 Days)||0
10657777|NCT02228395|11818916|FG000|STARTED|Third Intervention Period||3
10657778|NCT02228395|11818917|FG001|STARTED|Third Intervention Period||3
10657779|NCT02228395|11818918|FG002|STARTED|Third Intervention Period||3
10657780|NCT02228395|11818916|FG000|COMPLETED|Third Intervention Period||3
10657781|NCT02228395|11818917|FG001|COMPLETED|Third Intervention Period||3
10657782|NCT02228395|11818918|FG002|COMPLETED|Third Intervention Period||3
10657783|NCT02228395|11818916|FG000|NOT COMPLETED|Third Intervention Period||0
10657784|NCT02228395|11818917|FG001|NOT COMPLETED|Third Intervention Period||0
10657785|NCT02228395|11818918|FG002|NOT COMPLETED|Third Intervention Period||0
10657786|NCT02228408|11818930|FG000|STARTED|Overall Study||7
10657787|NCT02228408|11818931|FG001|STARTED|Overall Study||10
10657788|NCT02228408|11818930|FG000|COMPLETED|Overall Study||7
10657789|NCT02228408|11818931|FG001|COMPLETED|Overall Study||10
10657790|NCT02228408|11818930|FG000|NOT COMPLETED|Overall Study||0
10657791|NCT02228408|11818931|FG001|NOT COMPLETED|Overall Study||0
10657792|NCT02228460|11818937|FG000|STARTED|Overall Study||11
10717732|NCT02701062|11881744|FG000|NOT COMPLETED|Discharge||0
10539305|NCT01460368|11692204|FG006|STARTED|Part B: Washout (up to 15 Days)||9
10657793|NCT02228460|11818937|FG000|COMPLETED|Overall Study||9
10657794|NCT02228460|11818937|FG000|NOT COMPLETED|Overall Study||2
10657795|NCT02228499|11818944|FG000|STARTED|Overall Study||30
10657796|NCT02228499|11818945|FG001|STARTED|Overall Study||36
10657797|NCT02228499|11818944|FG000|COMPLETED|Overall Study||7
10657798|NCT02228499|11818945|FG001|COMPLETED|Overall Study||10
10657799|NCT02228499|11818944|FG000|NOT COMPLETED|Overall Study||23
10657800|NCT02228499|11818945|FG001|NOT COMPLETED|Overall Study||26
10717733|NCT02701062|11881745|FG001|NOT COMPLETED|Discharge||0
10657801|NCT02228564|11818951|FG000|STARTED|Overall Study||155
10379368|NCT00597493|11520553|FG000|STARTED|Overall Study||32
10379369|NCT00597493|11520553|FG000|COMPLETED|Overall Study||32
10379370|NCT00597493|11520553|FG000|NOT COMPLETED|Overall Study||0
10379371|NCT00597506|11520561|FG000|STARTED|Overall Study||50
10657802|NCT02228564|11818951|FG000|COMPLETED|Overall Study||106
10657803|NCT02228564|11818951|FG000|NOT COMPLETED|Overall Study||49
10657804|NCT02228590|11818955|FG000|STARTED|Overall Study||20
10657805|NCT02228590|11818955|FG000|COMPLETED|Overall Study||19
10657806|NCT02228590|11818955|FG000|NOT COMPLETED|Overall Study||1
10379372|NCT00597506|11520561|FG000|COMPLETED|Overall Study||49
10379373|NCT00597506|11520561|FG000|NOT COMPLETED|Overall Study||1
10717734|NCT02701062|11881744|FG000|STARTED|30 Day Follow-up||376
10379374|NCT00597519|11520565|FG000|STARTED|Overall Study||28
10539306|NCT01460368|11692198|FG000|COMPLETED|Part B: Washout (up to 15 Days)||0
10539307|NCT01460368|11692199|FG001|COMPLETED|Part B: Washout (up to 15 Days)||8
10539308|NCT01460368|11692200|FG002|COMPLETED|Part B: Washout (up to 15 Days)||9
10539309|NCT01460368|11692201|FG003|COMPLETED|Part B: Washout (up to 15 Days)||10
10539310|NCT01460368|11692202|FG004|COMPLETED|Part B: Washout (up to 15 Days)||9
10539311|NCT01460368|11692203|FG005|COMPLETED|Part B: Washout (up to 15 Days)||10
10539312|NCT01460368|11692204|FG006|COMPLETED|Part B: Washout (up to 15 Days)||9
10539313|NCT01460368|11692198|FG000|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
10539314|NCT01460368|11692199|FG001|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
10539315|NCT01460368|11692200|FG002|NOT COMPLETED|Part B: Washout (up to 15 Days)||1
10539316|NCT01460368|11692201|FG003|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
10539317|NCT01460368|11692202|FG004|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
10539318|NCT01460368|11692203|FG005|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
10539319|NCT01460368|11692204|FG006|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
10539320|NCT01460368|11692198|FG000|STARTED|Part B: Third Interventions (Period 3)||0
10539321|NCT01460368|11692199|FG001|STARTED|Part B: Third Interventions (Period 3)||8
10539322|NCT01460368|11692200|FG002|STARTED|Part B: Third Interventions (Period 3)||9
10539323|NCT01460368|11692201|FG003|STARTED|Part B: Third Interventions (Period 3)||10
10539324|NCT01460368|11692202|FG004|STARTED|Part B: Third Interventions (Period 3)||9
10539325|NCT01460368|11692203|FG005|STARTED|Part B: Third Interventions (Period 3)||10
10539326|NCT01460368|11692204|FG006|STARTED|Part B: Third Interventions (Period 3)||9
10539327|NCT01460368|11692198|FG000|COMPLETED|Part B: Third Interventions (Period 3)||0
10539328|NCT01460368|11692199|FG001|COMPLETED|Part B: Third Interventions (Period 3)||8
10539329|NCT01460368|11692200|FG002|COMPLETED|Part B: Third Interventions (Period 3)||8
10539330|NCT01460368|11692201|FG003|COMPLETED|Part B: Third Interventions (Period 3)||9
10539331|NCT01460368|11692202|FG004|COMPLETED|Part B: Third Interventions (Period 3)||9
10539332|NCT01460368|11692203|FG005|COMPLETED|Part B: Third Interventions (Period 3)||9
10539333|NCT01460368|11692204|FG006|COMPLETED|Part B: Third Interventions (Period 3)||9
10539334|NCT01460368|11692198|FG000|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
10539335|NCT01460368|11692199|FG001|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
10539336|NCT01460368|11692200|FG002|NOT COMPLETED|Part B: Third Interventions (Period 3)||1
10539337|NCT01460368|11692201|FG003|NOT COMPLETED|Part B: Third Interventions (Period 3)||1
10539338|NCT01460368|11692202|FG004|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
10539339|NCT01460368|11692203|FG005|NOT COMPLETED|Part B: Third Interventions (Period 3)||1
10539340|NCT01460368|11692204|FG006|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
10539341|NCT01460381|11692215|FG000|STARTED|Period 1 (Days 1-7)||7
10539342|NCT01460381|11692216|FG001|STARTED|Period 1 (Days 1-7)||11
10539343|NCT01460381|11692215|FG000|Received at Least 1 Dose of Study Drug|Period 1 (Days 1-7)||7
10379409|NCT00597701|11520605|FG001|NOT COMPLETED|Overall Study||8
10539344|NCT01460381|11692216|FG001|Received at Least 1 Dose of Study Drug|Period 1 (Days 1-7)||11
10539345|NCT01460381|11692215|FG000|COMPLETED|Period 1 (Days 1-7)||7
10539346|NCT01460381|11692216|FG001|COMPLETED|Period 1 (Days 1-7)||11
10539347|NCT01460381|11692215|FG000|NOT COMPLETED|Period 1 (Days 1-7)||0
10539348|NCT01460381|11692216|FG001|NOT COMPLETED|Period 1 (Days 1-7)||0
10539349|NCT01460381|11692215|FG000|STARTED|Period 2 (Days 8-15)||7
10539350|NCT01460381|11692216|FG001|STARTED|Period 2 (Days 8-15)|CYP2C19 extensive metabolizers did not participate in Period 2.|0
10539351|NCT01460381|11692215|FG000|COMPLETED|Period 2 (Days 8-15)|One participant was lost to follow-up after completing Period 2 and did not complete the study.|6
10539352|NCT01460381|11692216|FG001|COMPLETED|Period 2 (Days 8-15)|CYP2C19 extensive metabolizers did not participate in Period 2|0
10539353|NCT01460381|11692215|FG000|NOT COMPLETED|Period 2 (Days 8-15)||1
10539354|NCT01460381|11692216|FG001|NOT COMPLETED|Period 2 (Days 8-15)||0
10539355|NCT01460407|11692224|FG000|STARTED|Period 1: Day 1 to Day 5||14
10539356|NCT01460407|11692225|FG001|STARTED|Period 1: Day 1 to Day 5||0
10539357|NCT01460407|11692224|FG000|COMPLETED|Period 1: Day 1 to Day 5||14
10539358|NCT01460407|11692225|FG001|COMPLETED|Period 1: Day 1 to Day 5||0
10539359|NCT01460407|11692224|FG000|NOT COMPLETED|Period 1: Day 1 to Day 5||0
10539360|NCT01460407|11692225|FG001|NOT COMPLETED|Period 1: Day 1 to Day 5||0
10539361|NCT01460407|11692224|FG000|STARTED|Period 2: Day 6 to Day 14||0
10539362|NCT01460407|11692225|FG001|STARTED|Period 2: Day 6 to Day 14||14
10539363|NCT01460407|11692224|FG000|COMPLETED|Period 2: Day 6 to Day 14||0
10539364|NCT01460407|11692225|FG001|COMPLETED|Period 2: Day 6 to Day 14||13
10539365|NCT01460407|11692224|FG000|NOT COMPLETED|Period 2: Day 6 to Day 14||0
10539366|NCT01460407|11692225|FG001|NOT COMPLETED|Period 2: Day 6 to Day 14||1
10539367|NCT01460446|11692234|FG000|STARTED|Overall Study||105
10539368|NCT01460446|11692235|FG001|STARTED|Overall Study||113
10539369|NCT01460446|11692234|FG000|COMPLETED|Overall Study||100
10539370|NCT01460446|11692235|FG001|COMPLETED|Overall Study||93
10539371|NCT01460446|11692234|FG000|NOT COMPLETED|Overall Study||5
10539372|NCT01460446|11692235|FG001|NOT COMPLETED|Overall Study||20
10539373|NCT01460628|11692242|FG000|STARTED|Overall Study||25
10539374|NCT01460628|11692242|FG000|COMPLETED|Overall Study||20
10539375|NCT01460628|11692242|FG000|NOT COMPLETED|Overall Study||5
10539376|NCT01460719|11692246|FG000|STARTED|Overall Study||80
10539377|NCT01460719|11692246|FG000|Vaccination 1 (Day 1)|Overall Study||80
10539378|NCT01460719|11692246|FG000|Vaccination 2 (~Day 30)|Overall Study||78
10539379|NCT01460719|11692246|FG000|Vaccination 3 (~Day 60)|Overall Study||78
10539380|NCT01460719|11692246|FG000|Vaccination 4 (~Day 90)|Overall Study||78
10657807|NCT02228681|11818962|FG000|STARTED|Overall Study||37
10539381|NCT01460719|11692246|FG000|COMPLETED|Overall Study||78
10717735|NCT02701062|11881745|FG001|STARTED|30 Day Follow-up||186
10717736|NCT02701062|11881744|FG000|COMPLETED|30 Day Follow-up||366
10717737|NCT02701062|11881745|FG001|COMPLETED|30 Day Follow-up||183
10717738|NCT02701062|11881744|FG000|NOT COMPLETED|30 Day Follow-up||10
10717739|NCT02701062|11881745|FG001|NOT COMPLETED|30 Day Follow-up||3
10717740|NCT02701062|11881744|FG000|STARTED|90 Day Follow-up||366
10717741|NCT02701062|11881745|FG001|STARTED|90 Day Follow-up||183
10717742|NCT02701062|11881744|FG000|COMPLETED|90 Day Follow-up||308
10717743|NCT02701062|11881745|FG001|COMPLETED|90 Day Follow-up||72
10379375|NCT00597519|11520565|FG000|COMPLETED|Overall Study||27
10379376|NCT00597519|11520565|FG000|NOT COMPLETED|Overall Study||1
10379377|NCT00597545|11520571|FG000|STARTED|Overall Study||4
10379378|NCT00597545|11520572|FG001|STARTED|Overall Study||6
10379379|NCT00597545|11520571|FG000|COMPLETED|Overall Study||4
10379380|NCT00597545|11520572|FG001|COMPLETED|Overall Study||6
10379381|NCT00597545|11520571|FG000|NOT COMPLETED|Overall Study||0
10379382|NCT00597545|11520572|FG001|NOT COMPLETED|Overall Study||0
10379383|NCT00597558|11520578|FG000|STARTED|Overall Study||13
10379384|NCT00597558|11520578|FG000|COMPLETED|Overall Study||9
10379385|NCT00597558|11520578|FG000|NOT COMPLETED|Overall Study||4
10379386|NCT00597584|11520584|FG000|STARTED|Overall Study|Randomization was 2:1 peginesatide to epoetin|549
10379387|NCT00597584|11520585|FG001|STARTED|Overall Study||274
10379388|NCT00597584|11520584|FG000|COMPLETED|Overall Study||421
10379389|NCT00597584|11520585|FG001|COMPLETED|Overall Study||211
10379390|NCT00597584|11520584|FG000|NOT COMPLETED|Overall Study||128
10379391|NCT00597584|11520585|FG001|NOT COMPLETED|Overall Study||63
10379392|NCT00597675|11520593|FG000|STARTED|Blinded Phase||4
10379393|NCT00597675|11520594|FG001|STARTED|Blinded Phase||6
10379394|NCT00597675|11520593|FG000|COMPLETED|Blinded Phase||2
10379395|NCT00597675|11520594|FG001|COMPLETED|Blinded Phase||5
10717744|NCT02701062|11881744|FG000|NOT COMPLETED|90 Day Follow-up||58
10717745|NCT02701062|11881745|FG001|NOT COMPLETED|90 Day Follow-up||111
10717746|NCT02701062|11881744|FG000|STARTED|365 Day Follow-up||308
10717747|NCT02701062|11881745|FG001|STARTED|365 Day Follow-up||72
10379396|NCT00597675|11520593|FG000|NOT COMPLETED|Blinded Phase||2
10379397|NCT00597675|11520594|FG001|NOT COMPLETED|Blinded Phase||1
10379398|NCT00597675|11520593|FG000|STARTED|Open Label Phase|Patients previously on placebo were crossed over onto open label peanut OIT|2
10379399|NCT00597675|11520594|FG001|STARTED|Open Label Phase||5
10379400|NCT00597675|11520593|FG000|COMPLETED|Open Label Phase||2
10379401|NCT00597675|11520594|FG001|COMPLETED|Open Label Phase||5
10379402|NCT00597675|11520593|FG000|NOT COMPLETED|Open Label Phase||0
10379403|NCT00597675|11520594|FG001|NOT COMPLETED|Open Label Phase||0
10379404|NCT00597701|11520604|FG000|STARTED|Overall Study||25
10379405|NCT00597701|11520605|FG001|STARTED|Overall Study||21
10379406|NCT00597701|11520604|FG000|COMPLETED|Overall Study||18
10379407|NCT00597701|11520605|FG001|COMPLETED|Overall Study||13
10379408|NCT00597701|11520604|FG000|NOT COMPLETED|Overall Study||7
10379410|NCT00597714|11520613|FG000|STARTED|Overall Study||80
10379411|NCT00597714|11520614|FG001|STARTED|Overall Study||57
10379412|NCT00597714|11520615|FG002|STARTED|Overall Study||94
10379413|NCT00597714|11520613|FG000|COMPLETED|Overall Study||24
10379414|NCT00597714|11520614|FG001|COMPLETED|Overall Study||11
10717748|NCT02701062|11881744|FG000|COMPLETED|365 Day Follow-up||294
10379415|NCT00597714|11520615|FG002|COMPLETED|Overall Study||84
10379416|NCT00597714|11520613|FG000|NOT COMPLETED|Overall Study||56
10379417|NCT00597714|11520614|FG001|NOT COMPLETED|Overall Study||46
10379418|NCT00597714|11520615|FG002|NOT COMPLETED|Overall Study||10
10379419|NCT00597727|11520628|FG000|STARTED|12 Month Blinded Phase||14
10379420|NCT00597727|11520629|FG001|STARTED|12 Month Blinded Phase||15
10379421|NCT00597727|11520630|FG002|STARTED|12 Month Blinded Phase||0
10379422|NCT00597727|11520631|FG003|STARTED|12 Month Blinded Phase||27
10379423|NCT00597727|11520632|FG004|STARTED|12 Month Blinded Phase||4
10379424|NCT00597727|11520628|FG000|COMPLETED|12 Month Blinded Phase||14
10379425|NCT00597727|11520629|FG001|COMPLETED|12 Month Blinded Phase||15
10379426|NCT00597727|11520630|FG002|COMPLETED|12 Month Blinded Phase||0
10379427|NCT00597727|11520631|FG003|COMPLETED|12 Month Blinded Phase||17
10379428|NCT00597727|11520632|FG004|COMPLETED|12 Month Blinded Phase||3
10379429|NCT00597727|11520628|FG000|NOT COMPLETED|12 Month Blinded Phase||0
10379430|NCT00597727|11520629|FG001|NOT COMPLETED|12 Month Blinded Phase||0
10379431|NCT00597727|11520630|FG002|NOT COMPLETED|12 Month Blinded Phase||0
10379432|NCT00597727|11520631|FG003|NOT COMPLETED|12 Month Blinded Phase||10
10379433|NCT00597727|11520632|FG004|NOT COMPLETED|12 Month Blinded Phase||1
10379434|NCT00597727|11520628|FG000|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding|0
10379435|NCT00597727|11520629|FG001|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding|0
10379436|NCT00597727|11520630|FG002|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding.|29
10379437|NCT00597727|11520631|FG003|STARTED|Open-label Extended Maintenance Phase||17
10379438|NCT00597727|11520632|FG004|STARTED|Open-label Extended Maintenance Phase||3
10379439|NCT00597727|11520628|FG000|COMPLETED|Open-label Extended Maintenance Phase||0
10379440|NCT00597727|11520629|FG001|COMPLETED|Open-label Extended Maintenance Phase||0
10379441|NCT00597727|11520630|FG002|COMPLETED|Open-label Extended Maintenance Phase||23
10379442|NCT00597727|11520631|FG003|COMPLETED|Open-label Extended Maintenance Phase||14
10379443|NCT00597727|11520632|FG004|COMPLETED|Open-label Extended Maintenance Phase||1
10379444|NCT00597727|11520628|FG000|NOT COMPLETED|Open-label Extended Maintenance Phase||0
10379445|NCT00597727|11520629|FG001|NOT COMPLETED|Open-label Extended Maintenance Phase||0
10717749|NCT02701062|11881745|FG001|COMPLETED|365 Day Follow-up||69
10717750|NCT02701062|11881744|FG000|NOT COMPLETED|365 Day Follow-up||14
10717751|NCT02701062|11881745|FG001|NOT COMPLETED|365 Day Follow-up||3
10717752|NCT02701101|11881759|FG000|STARTED|Overall Study||189
10717753|NCT02701101|11881759|FG000|COMPLETED|Overall Study||189
10379446|NCT00597727|11520630|FG002|NOT COMPLETED|Open-label Extended Maintenance Phase||6
10379447|NCT00597727|11520631|FG003|NOT COMPLETED|Open-label Extended Maintenance Phase||3
10379448|NCT00597727|11520632|FG004|NOT COMPLETED|Open-label Extended Maintenance Phase||2
10379449|NCT00597753|11520648|FG000|STARTED|Overall Study|Randomization was 2:1 peginesatide to epoetin alfa|532
10379450|NCT00597753|11520649|FG001|STARTED|Overall Study||271
10379451|NCT00597753|11520648|FG000|COMPLETED|Overall Study||366
10379452|NCT00597753|11520649|FG001|COMPLETED|Overall Study||202
10379453|NCT00597753|11520648|FG000|NOT COMPLETED|Overall Study||166
10379454|NCT00597753|11520649|FG001|NOT COMPLETED|Overall Study||69
10379455|NCT00597766|11520658|FG000|STARTED|Enrolled||9
10379456|NCT00597766|11520659|FG001|STARTED|Enrolled||9
10379457|NCT00597766|11520660|FG002|STARTED|Enrolled||10
10379458|NCT00597766|11520658|FG000|COMPLETED|Enrolled||9
10379459|NCT00597766|11520659|FG001|COMPLETED|Enrolled||9
10379460|NCT00597766|11520660|FG002|COMPLETED|Enrolled||10
10379461|NCT00597766|11520658|FG000|NOT COMPLETED|Enrolled||0
10379462|NCT00597766|11520659|FG001|NOT COMPLETED|Enrolled||0
10379463|NCT00597766|11520660|FG002|NOT COMPLETED|Enrolled||0
10379464|NCT00597766|11520658|FG000|STARTED|Follow-up 1, Week 4||9
10379465|NCT00597766|11520659|FG001|STARTED|Follow-up 1, Week 4||9
10379466|NCT00597766|11520660|FG002|STARTED|Follow-up 1, Week 4||10
10379467|NCT00597766|11520658|FG000|COMPLETED|Follow-up 1, Week 4||8
10379468|NCT00597766|11520659|FG001|COMPLETED|Follow-up 1, Week 4||9
10379469|NCT00597766|11520660|FG002|COMPLETED|Follow-up 1, Week 4||10
10379470|NCT00597766|11520658|FG000|NOT COMPLETED|Follow-up 1, Week 4||1
10379471|NCT00597766|11520659|FG001|NOT COMPLETED|Follow-up 1, Week 4||0
10379472|NCT00597766|11520660|FG002|NOT COMPLETED|Follow-up 1, Week 4||0
10379473|NCT00597766|11520658|FG000|STARTED|Follow-up 2, Week 8||8
10379474|NCT00597766|11520659|FG001|STARTED|Follow-up 2, Week 8||9
10539382|NCT01460719|11692246|FG000|NOT COMPLETED|Overall Study||2
10539383|NCT01460732|11692250|FG000|STARTED|Overall Study||81
10539384|NCT01460732|11692250|FG000|COMPLETED|Overall Study||81
10539385|NCT01460732|11692250|FG000|NOT COMPLETED|Overall Study||0
10539386|NCT01460875|11692256|FG000|STARTED|Overall Study||34
10539387|NCT01460875|11692256|FG000|COMPLETED|Overall Study||34
10539388|NCT01460875|11692256|FG000|NOT COMPLETED|Overall Study||0
10539389|NCT01460901|11692260|FG000|STARTED|Overall Study|First enrollment|5
10539390|NCT01460901|11692260|FG000|tV-CTL Infusion|Overall Study||3
10539391|NCT01460901|11692260|FG000|COMPLETED|Overall Study|Follow-up completed|3
10379475|NCT00597766|11520660|FG002|STARTED|Follow-up 2, Week 8||10
10379476|NCT00597766|11520658|FG000|COMPLETED|Follow-up 2, Week 8||8
10379477|NCT00597766|11520659|FG001|COMPLETED|Follow-up 2, Week 8||9
10379478|NCT00597766|11520660|FG002|COMPLETED|Follow-up 2, Week 8||9
10379479|NCT00597766|11520658|FG000|NOT COMPLETED|Follow-up 2, Week 8||0
10379480|NCT00597766|11520659|FG001|NOT COMPLETED|Follow-up 2, Week 8||0
10379481|NCT00597766|11520660|FG002|NOT COMPLETED|Follow-up 2, Week 8||1
10379482|NCT00597766|11520658|FG000|STARTED|Follow-up 3, Week 12||8
10379483|NCT00597766|11520659|FG001|STARTED|Follow-up 3, Week 12||9
10379484|NCT00597766|11520660|FG002|STARTED|Follow-up 3, Week 12||9
10379485|NCT00597766|11520658|FG000|COMPLETED|Follow-up 3, Week 12||8
10379486|NCT00597766|11520659|FG001|COMPLETED|Follow-up 3, Week 12||9
10379487|NCT00597766|11520660|FG002|COMPLETED|Follow-up 3, Week 12||9
10379488|NCT00597766|11520658|FG000|NOT COMPLETED|Follow-up 3, Week 12||0
10379489|NCT00597766|11520659|FG001|NOT COMPLETED|Follow-up 3, Week 12||0
10717754|NCT02701101|11881759|FG000|NOT COMPLETED|Overall Study||0
10379490|NCT00597766|11520660|FG002|NOT COMPLETED|Follow-up 3, Week 12||0
10379491|NCT00597818|11520672|FG000|STARTED|Overall Study||30
10379492|NCT00597818|11520673|FG001|STARTED|Overall Study||30
10379493|NCT00597818|11520674|FG002|STARTED|Overall Study||31
10379494|NCT00597818|11520675|FG003|STARTED|Overall Study||30
10379495|NCT00597818|11520672|FG000|COMPLETED|Overall Study||12
10379496|NCT00597818|11520673|FG001|COMPLETED|Overall Study||14
10379497|NCT00597818|11520674|FG002|COMPLETED|Overall Study||12
10379498|NCT00597818|11520675|FG003|COMPLETED|Overall Study||20
10379499|NCT00597818|11520672|FG000|NOT COMPLETED|Overall Study||18
10379500|NCT00597818|11520673|FG001|NOT COMPLETED|Overall Study||16
10379501|NCT00597818|11520674|FG002|NOT COMPLETED|Overall Study||19
10379502|NCT00597818|11520675|FG003|NOT COMPLETED|Overall Study||10
10379503|NCT00597896|11520687|FG000|STARTED|Overall Study||24
10379504|NCT00597896|11520688|FG001|STARTED|Overall Study||26
10379505|NCT00597896|11520687|FG000|COMPLETED|Overall Study||21
10379506|NCT00597896|11520688|FG001|COMPLETED|Overall Study||24
10379507|NCT00597896|11520687|FG000|NOT COMPLETED|Overall Study||3
10379508|NCT00597896|11520688|FG001|NOT COMPLETED|Overall Study||2
10379509|NCT00597935|11520699|FG000|STARTED|Randomized to Surgical and BPMT Arms||95
10379510|NCT00597935|11520700|FG001|STARTED|Randomized to Surgical and BPMT Arms||91
10379511|NCT00597935|11520701|FG002|STARTED|Randomized to Surgical and BPMT Arms||91
10379512|NCT00597935|11520702|FG003|STARTED|Randomized to Surgical and BPMT Arms||97
10379513|NCT00597935|11520699|FG000|COMPLETED|Randomized to Surgical and BPMT Arms||95
10379514|NCT00597935|11520700|FG001|COMPLETED|Randomized to Surgical and BPMT Arms||91
10379515|NCT00597935|11520701|FG002|COMPLETED|Randomized to Surgical and BPMT Arms||91
10379516|NCT00597935|11520702|FG003|COMPLETED|Randomized to Surgical and BPMT Arms||97
10539392|NCT01460901|11692260|FG000|NOT COMPLETED|Overall Study||2
10539393|NCT01460927|11692267|FG000|STARTED|Overall Study||25
10539394|NCT01460927|11692267|FG000|COMPLETED|Overall Study||25
10717755|NCT02701257|11881769|FG000|STARTED|Overall Study||6
10717756|NCT02701257|11881770|FG001|STARTED|Overall Study||6
10717757|NCT02701257|11881771|FG002|STARTED|Overall Study||0
10717758|NCT02701257|11881772|FG003|STARTED|Overall Study||4
10379517|NCT00597935|11520699|FG000|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0
10539395|NCT01460927|11692267|FG000|NOT COMPLETED|Overall Study||0
10539396|NCT01460940|11692275|FG000|STARTED|Overall Study||24
10539397|NCT01460940|11692275|FG000|COMPLETED|Overall Study||24
10539398|NCT01460940|11692275|FG000|NOT COMPLETED|Overall Study||0
10539399|NCT01461005|11692279|FG000|STARTED|Overall Study||1
10539400|NCT01461005|11692279|FG000|COMPLETED|Overall Study||0
10539401|NCT01461005|11692279|FG000|NOT COMPLETED|Overall Study||1
10539402|NCT01461044|11692286|FG000|STARTED|Overall Study||150
10539403|NCT01461044|11692287|FG001|STARTED|Overall Study||77
10539404|NCT01461044|11692286|FG000|Participants Alive at Inclusion|Overall Study||127
10539405|NCT01461044|11692287|FG001|Participants Alive at Inclusion|Overall Study||58
10539406|NCT01461044|11692286|FG000|COMPLETED|Overall Study||80
10539407|NCT01461044|11692287|FG001|COMPLETED|Overall Study||37
10539408|NCT01461044|11692286|FG000|NOT COMPLETED|Overall Study||70
10717759|NCT02701257|11881773|FG004|STARTED|Overall Study||4
10717760|NCT02701257|11881769|FG000|COMPLETED|Overall Study||6
10379518|NCT00597935|11520700|FG001|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0
10379519|NCT00597935|11520701|FG002|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0
10379520|NCT00597935|11520702|FG003|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0
10379521|NCT00597935|11520699|FG000|STARTED|Baseline to 6-Months||95
10379522|NCT00597935|11520700|FG001|STARTED|Baseline to 6-Months||91
10379523|NCT00597935|11520701|FG002|STARTED|Baseline to 6-Months||91
10379524|NCT00597935|11520702|FG003|STARTED|Baseline to 6-Months||97
10379525|NCT00597935|11520699|FG000|COMPLETED|Baseline to 6-Months||93
10379526|NCT00597935|11520700|FG001|COMPLETED|Baseline to 6-Months||87
10379527|NCT00597935|11520701|FG002|COMPLETED|Baseline to 6-Months||87
10379528|NCT00597935|11520702|FG003|COMPLETED|Baseline to 6-Months||93
10379529|NCT00597935|11520699|FG000|NOT COMPLETED|Baseline to 6-Months||2
10379530|NCT00597935|11520700|FG001|NOT COMPLETED|Baseline to 6-Months||4
10379531|NCT00597935|11520701|FG002|NOT COMPLETED|Baseline to 6-Months||4
10379532|NCT00597935|11520702|FG003|NOT COMPLETED|Baseline to 6-Months||4
10379533|NCT00597935|11520699|FG000|STARTED|6-Months to 24-Months||93
10379534|NCT00597935|11520700|FG001|STARTED|6-Months to 24-Months||87
10379535|NCT00597935|11520701|FG002|STARTED|6-Months to 24-Months||87
10379536|NCT00597935|11520702|FG003|STARTED|6-Months to 24-Months||93
10379537|NCT00597935|11520699|FG000|COMPLETED|6-Months to 24-Months||76
10379538|NCT00597935|11520700|FG001|COMPLETED|6-Months to 24-Months||79
10379539|NCT00597935|11520701|FG002|COMPLETED|6-Months to 24-Months||77
10379540|NCT00597935|11520702|FG003|COMPLETED|6-Months to 24-Months||85
10379541|NCT00597935|11520699|FG000|NOT COMPLETED|6-Months to 24-Months||17
10379542|NCT00597935|11520700|FG001|NOT COMPLETED|6-Months to 24-Months||8
10379543|NCT00597935|11520701|FG002|NOT COMPLETED|6-Months to 24-Months||10
10379544|NCT00597935|11520702|FG003|NOT COMPLETED|6-Months to 24-Months||8
10379545|NCT00598078|11520712|FG000|STARTED|Period 1 (Day 1)||10
10539409|NCT01461044|11692287|FG001|NOT COMPLETED|Overall Study||40
10539410|NCT01461057|11692298|FG000|STARTED|Overall Study||15
10539411|NCT01461057|11692299|FG001|STARTED|Overall Study||15
10379546|NCT00598078|11520713|FG001|STARTED|Period 1 (Day 1)||10
10379547|NCT00598078|11520712|FG000|COMPLETED|Period 1 (Day 1)||10
10379548|NCT00598078|11520713|FG001|COMPLETED|Period 1 (Day 1)||10
10379549|NCT00598078|11520712|FG000|NOT COMPLETED|Period 1 (Day 1)||0
10539412|NCT01461057|11692298|FG000|COMPLETED|Overall Study||0
10539413|NCT01461057|11692299|FG001|COMPLETED|Overall Study||0
10539414|NCT01461057|11692298|FG000|NOT COMPLETED|Overall Study||15
10539415|NCT01461057|11692299|FG001|NOT COMPLETED|Overall Study||15
10539416|NCT01461096|11692307|FG000|STARTED|Overall Study||288
10539417|NCT01461096|11692308|FG001|STARTED|Overall Study||287
10539418|NCT01461096|11692307|FG000|Did Not Start Treatment|Overall Study||0
10539419|NCT01461096|11692308|FG001|Did Not Start Treatment|Overall Study|Randomized but never started treatment and was discontinued from the study|1
10539420|NCT01461096|11692307|FG000|COMPLETED|Overall Study||226
10539421|NCT01461096|11692308|FG001|COMPLETED|Overall Study||226
10539422|NCT01461096|11692307|FG000|NOT COMPLETED|Overall Study||62
10539423|NCT01461096|11692308|FG001|NOT COMPLETED|Overall Study||61
10539424|NCT01461369|11692318|FG000|STARTED|Overall Study||104
10539425|NCT01461369|11692319|FG001|STARTED|Overall Study||98
10539426|NCT01461369|11692320|FG002|STARTED|Overall Study||103
10539427|NCT01461369|11692318|FG000|COMPLETED|Overall Study||91
10539428|NCT01461369|11692319|FG001|COMPLETED|Overall Study||81
10539429|NCT01461369|11692320|FG002|COMPLETED|Overall Study||86
10539430|NCT01461369|11692318|FG000|NOT COMPLETED|Overall Study||13
10539431|NCT01461369|11692319|FG001|NOT COMPLETED|Overall Study||17
10539432|NCT01461369|11692320|FG002|NOT COMPLETED|Overall Study||17
10539433|NCT01461473|11692330|FG000|STARTED|Overall Study||72
10539434|NCT01461473|11692331|FG001|STARTED|Overall Study||59
10657808|NCT02228681|11818963|FG001|STARTED|Overall Study||37
10657809|NCT02228681|11818962|FG000|COMPLETED|Overall Study||37
10657810|NCT02228681|11818963|FG001|COMPLETED|Overall Study||37
10657811|NCT02228681|11818962|FG000|NOT COMPLETED|Overall Study||0
10657812|NCT02228681|11818963|FG001|NOT COMPLETED|Overall Study||0
10657813|NCT02228720|11818969|FG000|STARTED|Open Label - Baseline||15
10657814|NCT02228720|11818969|FG000|COMPLETED|Open Label - Baseline||15
10657815|NCT02228720|11818969|FG000|NOT COMPLETED|Open Label - Baseline||0
10657816|NCT02228720|11818969|FG000|STARTED|Open Label - Day 30||15
10657817|NCT02228720|11818969|FG000|COMPLETED|Open Label - Day 30||14
10657818|NCT02228720|11818969|FG000|NOT COMPLETED|Open Label - Day 30||1
10657819|NCT02228720|11818969|FG000|STARTED|Open Label - Day 90||14
10657820|NCT02228720|11818969|FG000|COMPLETED|Open Label - Day 90||14
10657821|NCT02228720|11818969|FG000|NOT COMPLETED|Open Label - Day 90||0
10657822|NCT02228824|11818975|FG000|STARTED|Overall Study||118
10657823|NCT02228824|11818976|FG001|STARTED|Overall Study||120
10657824|NCT02228824|11818975|FG000|COMPLETED|Overall Study||89
10657825|NCT02228824|11818976|FG001|COMPLETED|Overall Study||98
10657826|NCT02228824|11818975|FG000|NOT COMPLETED|Overall Study||29
10657827|NCT02228824|11818976|FG001|NOT COMPLETED|Overall Study||22
10657828|NCT02228967|11818984|FG000|STARTED|Overall Study||403
10657829|NCT02228967|11818985|FG001|STARTED|Overall Study||388
10657830|NCT02228967|11818984|FG000|COMPLETED|Overall Study||244
10657831|NCT02228967|11818985|FG001|COMPLETED|Overall Study||228
10657832|NCT02228967|11818984|FG000|NOT COMPLETED|Overall Study||159
10657833|NCT02228967|11818985|FG001|NOT COMPLETED|Overall Study||160
10657834|NCT02228980|11818995|FG000|STARTED|Overall Study||150
10657835|NCT02228980|11818996|FG001|STARTED|Overall Study||150
10657836|NCT02228980|11818997|FG002|STARTED|Overall Study||151
10657837|NCT02228980|11818998|FG003|STARTED|Overall Study||151
10657838|NCT02228980|11818995|FG000|COMPLETED|Overall Study||126
10657839|NCT02228980|11818996|FG001|COMPLETED|Overall Study||147
10657840|NCT02228980|11818997|FG002|COMPLETED|Overall Study||149
10657841|NCT02228980|11818998|FG003|COMPLETED|Overall Study||148
10657842|NCT02228980|11818995|FG000|NOT COMPLETED|Overall Study||24
10657843|NCT02228980|11818996|FG001|NOT COMPLETED|Overall Study||3
10657844|NCT02228980|11818997|FG002|NOT COMPLETED|Overall Study||2
10657845|NCT02228980|11818998|FG003|NOT COMPLETED|Overall Study||3
10657846|NCT02229214|11819014|FG000|STARTED|Overall Study||41
10657847|NCT02229214|11819015|FG001|STARTED|Overall Study||10
10657848|NCT02229214|11819014|FG000|COMPLETED|Overall Study||35
10657849|NCT02229214|11819015|FG001|COMPLETED|Overall Study||10
10657850|NCT02229214|11819014|FG000|NOT COMPLETED|Overall Study||6
10657851|NCT02229214|11819015|FG001|NOT COMPLETED|Overall Study||0
10657852|NCT02229227|11819025|FG000|STARTED|Overall Study||402
10657853|NCT02229227|11819026|FG001|STARTED|Overall Study||412
10657854|NCT02229227|11819025|FG000|COMPLETED|Overall Study||351
10657855|NCT02229227|11819026|FG001|COMPLETED|Overall Study||350
10657856|NCT02229227|11819025|FG000|NOT COMPLETED|Overall Study||51
10657857|NCT02229227|11819026|FG001|NOT COMPLETED|Overall Study||62
10657858|NCT02229318|11819032|FG000|STARTED|Overall Study|September 6th 2014 11 enrolled|11
10657859|NCT02229318|11819032|FG000|COMPLETED|Overall Study|September 15th 2014 11 completed|11
10657860|NCT02229318|11819032|FG000|NOT COMPLETED|Overall Study||0
10657861|NCT02229383|11819039|FG000|STARTED|Overall Study||232
10657862|NCT02229383|11819040|FG001|STARTED|Overall Study||229
10657863|NCT02229383|11819039|FG000|Received Treatment|Overall Study||231
10657864|NCT02229383|11819040|FG001|Received Treatment|Overall Study||229
10657865|NCT02229383|11819039|FG000|Safety Analysis Set|Overall Study||231
10657866|NCT02229383|11819040|FG001|Safety Analysis Set|Overall Study||229
10539435|NCT01461473|11692330|FG000|COMPLETED|Overall Study||67
10539436|NCT01461473|11692331|FG001|COMPLETED|Overall Study||55
10539437|NCT01461473|11692330|FG000|NOT COMPLETED|Overall Study||5
10539438|NCT01461473|11692331|FG001|NOT COMPLETED|Overall Study||4
10657867|NCT02229383|11819039|FG000|Intent-to-treat (ITT) Analysis Set|Overall Study||230
10657868|NCT02229383|11819040|FG001|Intent-to-treat (ITT) Analysis Set|Overall Study||228
10657869|NCT02229383|11819039|FG000|COMPLETED|Overall Study||212
10657870|NCT02229383|11819040|FG001|COMPLETED|Overall Study||207
10539439|NCT01461499|11692339|FG000|STARTED|Overall Study||119
10539440|NCT01461499|11692340|FG001|STARTED|Overall Study||118
10539441|NCT01461499|11692339|FG000|COMPLETED|Overall Study||111
10539442|NCT01461499|11692340|FG001|COMPLETED|Overall Study||114
10539443|NCT01461499|11692339|FG000|NOT COMPLETED|Overall Study||8
10539444|NCT01461499|11692340|FG001|NOT COMPLETED|Overall Study||4
10379550|NCT00598078|11520713|FG001|NOT COMPLETED|Period 1 (Day 1)||0
10379551|NCT00598078|11520712|FG000|STARTED|Period 2 (Day 2)||10
10379552|NCT00598078|11520713|FG001|STARTED|Period 2 (Day 2)||10
10379553|NCT00598078|11520712|FG000|COMPLETED|Period 2 (Day 2)||9
10379554|NCT00598078|11520713|FG001|COMPLETED|Period 2 (Day 2)||10
10379555|NCT00598078|11520712|FG000|NOT COMPLETED|Period 2 (Day 2)||1
10379556|NCT00598078|11520713|FG001|NOT COMPLETED|Period 2 (Day 2)||0
10379557|NCT00598078|11520712|FG000|STARTED|Period 3 (Day 3)||9
10379558|NCT00598078|11520713|FG001|STARTED|Period 3 (Day 3)||10
10379559|NCT00598078|11520712|FG000|COMPLETED|Period 3 (Day 3)||9
10379560|NCT00598078|11520713|FG001|COMPLETED|Period 3 (Day 3)||10
10379561|NCT00598078|11520712|FG000|NOT COMPLETED|Period 3 (Day 3)||0
10379562|NCT00598078|11520713|FG001|NOT COMPLETED|Period 3 (Day 3)||0
10379563|NCT00598273|11520724|FG000|STARTED|Overall Study||161
10379564|NCT00598273|11520725|FG001|STARTED|Overall Study||165
10539445|NCT01461538|11692351|FG000|STARTED|Overall Study||46
10539446|NCT01461538|11692352|FG001|STARTED|Overall Study||28
10539447|NCT01461538|11692353|FG002|STARTED|Overall Study||9
10539448|NCT01461538|11692351|FG000|COMPLETED|Overall Study||28
10539449|NCT01461538|11692352|FG001|COMPLETED|Overall Study||20
10539450|NCT01461538|11692353|FG002|COMPLETED|Overall Study||7
10539451|NCT01461538|11692351|FG000|NOT COMPLETED|Overall Study||18
10539452|NCT01461538|11692352|FG001|NOT COMPLETED|Overall Study||8
10379565|NCT00598273|11520726|FG002|STARTED|Overall Study||164
10379566|NCT00598273|11520724|FG000|COMPLETED|Overall Study||120
10379567|NCT00598273|11520725|FG001|COMPLETED|Overall Study||127
10379568|NCT00598273|11520726|FG002|COMPLETED|Overall Study||125
10379569|NCT00598273|11520724|FG000|NOT COMPLETED|Overall Study||41
10379570|NCT00598273|11520725|FG001|NOT COMPLETED|Overall Study||38
10379571|NCT00598273|11520726|FG002|NOT COMPLETED|Overall Study||39
10379572|NCT00598442|11520737|FG000|STARTED|Overall Study||167
10379573|NCT00598442|11520738|FG001|STARTED|Overall Study||163
10379574|NCT00598442|11520739|FG002|STARTED|Overall Study||163
10379575|NCT00598442|11520737|FG000|COMPLETED|Overall Study||124
10379576|NCT00598442|11520738|FG001|COMPLETED|Overall Study||124
10379577|NCT00598442|11520739|FG002|COMPLETED|Overall Study||139
10379578|NCT00598442|11520737|FG000|NOT COMPLETED|Overall Study||43
10379579|NCT00598442|11520738|FG001|NOT COMPLETED|Overall Study||39
10379580|NCT00598442|11520739|FG002|NOT COMPLETED|Overall Study||24
10379581|NCT00598481|11520747|FG000|STARTED|Baseline||12
10379582|NCT00598481|11520747|FG000|COMPLETED|Baseline||12
10379583|NCT00598481|11520747|FG000|NOT COMPLETED|Baseline||0
10379584|NCT00598481|11520747|FG000|STARTED|Treatment||12
10379585|NCT00598481|11520747|FG000|COMPLETED|Treatment||11
10379586|NCT00598481|11520747|FG000|NOT COMPLETED|Treatment||1
10379587|NCT00598507|11520754|FG000|STARTED|Overall Study||35
10379588|NCT00598507|11520754|FG000|COMPLETED|Overall Study||35
10379589|NCT00598507|11520754|FG000|NOT COMPLETED|Overall Study||0
10379590|NCT00598559|11520761|FG000|STARTED|Overall Study||92
10379591|NCT00598559|11520762|FG001|STARTED|Overall Study||91
10379592|NCT00598559|11520763|FG002|STARTED|Overall Study||30
10379593|NCT00598559|11520761|FG000|COMPLETED|Overall Study|Subjects completed 5 days of treatment|65
10379594|NCT00598559|11520762|FG001|COMPLETED|Overall Study|Subjects completed 5 days of treatment|63
10379595|NCT00598559|11520763|FG002|COMPLETED|Overall Study|Subjects completed 5 days of treatment|27
10379596|NCT00598559|11520761|FG000|NOT COMPLETED|Overall Study||27
10379597|NCT00598559|11520762|FG001|NOT COMPLETED|Overall Study||28
10379598|NCT00598559|11520763|FG002|NOT COMPLETED|Overall Study||3
10379599|NCT00598585|11520773|FG000|STARTED|Overall Study||6
10379600|NCT00598585|11520774|FG001|STARTED|Overall Study||6
10379601|NCT00598585|11520773|FG000|COMPLETED|Overall Study||5
10379602|NCT00598585|11520774|FG001|COMPLETED|Overall Study||6
10379603|NCT00598585|11520773|FG000|NOT COMPLETED|Overall Study||1
10379604|NCT00598585|11520774|FG001|NOT COMPLETED|Overall Study||0
10379605|NCT00598650|11520780|FG000|STARTED|Overall Study||108
10379606|NCT00598650|11520780|FG000|COMPLETED|Overall Study|5 subjects withdrew for multiple reasons|81
10379607|NCT00598650|11520780|FG000|NOT COMPLETED|Overall Study||27
10379608|NCT00598663|11520787|FG000|STARTED|First Intervention (6 Months)||76
10717761|NCT02701257|11881770|FG001|COMPLETED|Overall Study||3
10717762|NCT02701257|11881771|FG002|COMPLETED|Overall Study||0
10379609|NCT00598663|11520788|FG001|STARTED|First Intervention (6 Months)||77
10379610|NCT00598663|11520787|FG000|COMPLETED|First Intervention (6 Months)||73
10379611|NCT00598663|11520788|FG001|COMPLETED|First Intervention (6 Months)||71
10379612|NCT00598663|11520787|FG000|NOT COMPLETED|First Intervention (6 Months)||3
10379613|NCT00598663|11520788|FG001|NOT COMPLETED|First Intervention (6 Months)||6
10379614|NCT00598663|11520787|FG000|STARTED|Washout (4 Months)||73
10379615|NCT00598663|11520788|FG001|STARTED|Washout (4 Months)||71
10379616|NCT00598663|11520787|FG000|COMPLETED|Washout (4 Months)||73
10379617|NCT00598663|11520788|FG001|COMPLETED|Washout (4 Months)||70
10379618|NCT00598663|11520787|FG000|NOT COMPLETED|Washout (4 Months)||0
10379619|NCT00598663|11520788|FG001|NOT COMPLETED|Washout (4 Months)||1
10379620|NCT00598663|11520787|FG000|STARTED|Second Intervention (6 Months)||73
10379621|NCT00598663|11520788|FG001|STARTED|Second Intervention (6 Months)||70
10539453|NCT01461538|11692353|FG002|NOT COMPLETED|Overall Study||2
10539454|NCT01461551|11692366|FG000|STARTED|Overall Study||35
10379622|NCT00598663|11520787|FG000|COMPLETED|Second Intervention (6 Months)||69
10379623|NCT00598663|11520788|FG001|COMPLETED|Second Intervention (6 Months)||69
10379624|NCT00598663|11520787|FG000|NOT COMPLETED|Second Intervention (6 Months)||4
10379625|NCT00598663|11520788|FG001|NOT COMPLETED|Second Intervention (6 Months)||1
10379626|NCT00598689|11520799|FG000|STARTED|Overall Study||40
10379627|NCT00598689|11520800|FG001|STARTED|Overall Study||40
10379628|NCT00598689|11520799|FG000|COMPLETED|Overall Study||40
10379629|NCT00598689|11520800|FG001|COMPLETED|Overall Study||40
10379630|NCT00598689|11520799|FG000|NOT COMPLETED|Overall Study||0
10379631|NCT00598689|11520800|FG001|NOT COMPLETED|Overall Study||0
10379632|NCT00598702|11520814|FG000|STARTED|Overall Study||1
10539455|NCT01461551|11692367|FG001|STARTED|Overall Study||35
10539456|NCT01461551|11692368|FG002|STARTED|Overall Study||35
10539457|NCT01461551|11692366|FG000|COMPLETED|Overall Study||33
10539458|NCT01461551|11692367|FG001|COMPLETED|Overall Study||34
10539459|NCT01461551|11692368|FG002|COMPLETED|Overall Study||33
10539460|NCT01461551|11692366|FG000|NOT COMPLETED|Overall Study||2
10539461|NCT01461551|11692367|FG001|NOT COMPLETED|Overall Study||1
10539462|NCT01461551|11692368|FG002|NOT COMPLETED|Overall Study||2
10539463|NCT01461655|11692376|FG000|STARTED|Overall Study||40
10539464|NCT01461655|11692376|FG000|COMPLETED|Overall Study||40
10539465|NCT01461655|11692376|FG000|NOT COMPLETED|Overall Study||0
10539466|NCT01461668|11692383|FG000|STARTED|Overall Study||27
10539467|NCT01461668|11692384|FG001|STARTED|Overall Study||26
10539468|NCT01461668|11692383|FG000|COMPLETED|Overall Study||25
10539469|NCT01461668|11692384|FG001|COMPLETED|Overall Study||25
10539470|NCT01461668|11692383|FG000|NOT COMPLETED|Overall Study||2
10539471|NCT01461668|11692384|FG001|NOT COMPLETED|Overall Study||1
10717763|NCT02701257|11881772|FG003|COMPLETED|Overall Study||3
10379633|NCT00598702|11520815|FG001|STARTED|Overall Study||3
10379634|NCT00598702|11520816|FG002|STARTED|Overall Study||7
10379635|NCT00598702|11520817|FG003|STARTED|Overall Study||33
10379636|NCT00598702|11520818|FG004|STARTED|Overall Study||9
10379637|NCT00598702|11520819|FG005|STARTED|Overall Study||42
10379638|NCT00598702|11520820|FG006|STARTED|Overall Study||1
10717764|NCT02701257|11881773|FG004|COMPLETED|Overall Study||1
10717765|NCT02701257|11881769|FG000|NOT COMPLETED|Overall Study||0
10717766|NCT02701257|11881770|FG001|NOT COMPLETED|Overall Study||3
10717767|NCT02701257|11881771|FG002|NOT COMPLETED|Overall Study||0
10379639|NCT00598702|11520821|FG007|STARTED|Overall Study||4
10379640|NCT00598702|11520814|FG000|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|1
10379641|NCT00598702|11520815|FG001|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|1
10379642|NCT00598702|11520816|FG002|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|5
10379643|NCT00598702|11520817|FG003|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|25
10379644|NCT00598702|11520818|FG004|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|6
10379645|NCT00598702|11520819|FG005|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|30
10379646|NCT00598702|11520820|FG006|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|0
10379647|NCT00598702|11520821|FG007|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|4
10379648|NCT00598702|11520814|FG000|NOT COMPLETED|Overall Study||0
10379649|NCT00598702|11520815|FG001|NOT COMPLETED|Overall Study||2
10379650|NCT00598702|11520816|FG002|NOT COMPLETED|Overall Study||2
10379651|NCT00598702|11520817|FG003|NOT COMPLETED|Overall Study||8
10379652|NCT00598702|11520818|FG004|NOT COMPLETED|Overall Study||3
10379653|NCT00598702|11520819|FG005|NOT COMPLETED|Overall Study||12
10379654|NCT00598702|11520820|FG006|NOT COMPLETED|Overall Study||1
10379655|NCT00598702|11520821|FG007|NOT COMPLETED|Overall Study||0
10379656|NCT00598806|11520841|FG000|STARTED|Overall Study||402
10379657|NCT00598806|11520842|FG001|STARTED|Overall Study||410
10379658|NCT00598806|11520841|FG000|COMPLETED|Overall Study||329
10379659|NCT00598806|11520842|FG001|COMPLETED|Overall Study||346
10379660|NCT00598806|11520841|FG000|NOT COMPLETED|Overall Study||73
10379661|NCT00598806|11520842|FG001|NOT COMPLETED|Overall Study||64
10379662|NCT00598819|11520848|FG000|STARTED|Overall Study||14
10379663|NCT00598819|11520848|FG000|COMPLETED|Overall Study||14
10379664|NCT00598819|11520848|FG000|NOT COMPLETED|Overall Study||0
10379665|NCT00598832|11520854|FG000|STARTED|Overall Study||533
10379666|NCT00598832|11520855|FG001|STARTED|Overall Study||542
10379667|NCT00598832|11520854|FG000|COMPLETED|Overall Study||471
10379668|NCT00598832|11520855|FG001|COMPLETED|Overall Study||460
10379669|NCT00598832|11520854|FG000|NOT COMPLETED|Overall Study||62
10379670|NCT00598832|11520855|FG001|NOT COMPLETED|Overall Study||82
10379671|NCT00598871|11520863|FG000|STARTED|Overall Study||3
10379672|NCT00598871|11520864|FG001|STARTED|Overall Study||9
10379673|NCT00598871|11520863|FG000|COMPLETED|Overall Study||3
10379674|NCT00598871|11520864|FG001|COMPLETED|Overall Study||8
10379675|NCT00598871|11520863|FG000|NOT COMPLETED|Overall Study||0
10379676|NCT00598871|11520864|FG001|NOT COMPLETED|Overall Study||1
10379677|NCT00598975|11520872|FG000|STARTED|Overall Study||12
10379678|NCT00598975|11520873|FG001|STARTED|Overall Study||6
10379679|NCT00598975|11520872|FG000|Completed Cycle 1|Overall Study||12
10379680|NCT00598975|11520873|FG001|Completed Cycle 1|Overall Study||6
10379681|NCT00598975|11520872|FG000|COMPLETED|Overall Study||0
10379682|NCT00598975|11520873|FG001|COMPLETED|Overall Study||0
10379683|NCT00598975|11520872|FG000|NOT COMPLETED|Overall Study||12
10379684|NCT00598975|11520873|FG001|NOT COMPLETED|Overall Study||6
10379685|NCT00599014|11520881|FG000|STARTED|Overall Study||335
10379686|NCT00599014|11520881|FG000|COMPLETED|Overall Study||335
10379687|NCT00599014|11520881|FG000|NOT COMPLETED|Overall Study||0
10379688|NCT00599053|11520887|FG000|STARTED|Overall Study||5
10379689|NCT00599053|11520888|FG001|STARTED|Overall Study||2
10379690|NCT00599053|11520887|FG000|COMPLETED|Overall Study||5
10379691|NCT00599053|11520888|FG001|COMPLETED|Overall Study||2
10379692|NCT00599053|11520887|FG000|NOT COMPLETED|Overall Study||0
10379693|NCT00599053|11520888|FG001|NOT COMPLETED|Overall Study||0
10379694|NCT00599196|11520894|FG000|STARTED|Overall Study||381
10379695|NCT00599196|11520894|FG000|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
10379696|NCT00599196|11520894|FG000|NOT COMPLETED|Overall Study||381
10379697|NCT00599248|11520900|FG000|STARTED|Overall Study||3
10379698|NCT00599248|11520901|FG001|STARTED|Overall Study||3
10379699|NCT00599248|11520902|FG002|STARTED|Overall Study||3
10379700|NCT00599248|11520903|FG003|STARTED|Overall Study||3
10379701|NCT00599248|11520900|FG000|COMPLETED|Overall Study||3
10379702|NCT00599248|11520901|FG001|COMPLETED|Overall Study||3
10379703|NCT00599248|11520902|FG002|COMPLETED|Overall Study||3
10379704|NCT00599248|11520903|FG003|COMPLETED|Overall Study||3
10379705|NCT00599248|11520900|FG000|NOT COMPLETED|Overall Study||0
10379706|NCT00599248|11520901|FG001|NOT COMPLETED|Overall Study||0
10379707|NCT00599248|11520902|FG002|NOT COMPLETED|Overall Study||0
10379708|NCT00599248|11520903|FG003|NOT COMPLETED|Overall Study||0
10379709|NCT00599313|11520912|FG000|STARTED|Overall Study||36
10379710|NCT00599313|11520912|FG000|COMPLETED|Overall Study||0
10379711|NCT00599313|11520912|FG000|NOT COMPLETED|Overall Study||36
10379712|NCT00599326|11520916|FG000|STARTED|Overall Study||10
10379713|NCT00599326|11520916|FG000|COMPLETED|Overall Study||8
10379714|NCT00599326|11520916|FG000|NOT COMPLETED|Overall Study||2
10379715|NCT00599339|11520920|FG000|STARTED|Overall Study||2195
10379716|NCT00599339|11520920|FG000|Safety Set|Overall Study||2179
10379717|NCT00599339|11520920|FG000|COMPLETED|Overall Study||1531
10379718|NCT00599339|11520920|FG000|NOT COMPLETED|Overall Study||664
10379719|NCT00599521|11520944|FG000|STARTED|Overall Study||535
10379720|NCT00599521|11520945|FG001|STARTED|Overall Study||531
10379721|NCT00599521|11520944|FG000|COMPLETED|Overall Study||475
10379722|NCT00599521|11520945|FG001|COMPLETED|Overall Study||462
10379723|NCT00599521|11520944|FG000|NOT COMPLETED|Overall Study||60
10379724|NCT00599521|11520945|FG001|NOT COMPLETED|Overall Study||69
10379725|NCT00599638|11520955|FG000|STARTED|First Intervention Period (2 Weeks)||16
10379726|NCT00599638|11520956|FG001|STARTED|First Intervention Period (2 Weeks)||14
10379727|NCT00599638|11520957|FG002|STARTED|First Intervention Period (2 Weeks)||20
10379728|NCT00599638|11520958|FG003|STARTED|First Intervention Period (2 Weeks)||22
10379729|NCT00599638|11520955|FG000|Treated|First Intervention Period (2 Weeks)||16
10379730|NCT00599638|11520956|FG001|Treated|First Intervention Period (2 Weeks)||13
10379731|NCT00599638|11520957|FG002|Treated|First Intervention Period (2 Weeks)||20
10379732|NCT00599638|11520958|FG003|Treated|First Intervention Period (2 Weeks)||21
10379733|NCT00599638|11520955|FG000|COMPLETED|First Intervention Period (2 Weeks)||14
10379734|NCT00599638|11520956|FG001|COMPLETED|First Intervention Period (2 Weeks)||12
10379735|NCT00599638|11520957|FG002|COMPLETED|First Intervention Period (2 Weeks)||17
10379736|NCT00599638|11520958|FG003|COMPLETED|First Intervention Period (2 Weeks)||17
10379737|NCT00599638|11520955|FG000|NOT COMPLETED|First Intervention Period (2 Weeks)||2
10379738|NCT00599638|11520956|FG001|NOT COMPLETED|First Intervention Period (2 Weeks)||2
10379739|NCT00599638|11520957|FG002|NOT COMPLETED|First Intervention Period (2 Weeks)||3
10379740|NCT00599638|11520958|FG003|NOT COMPLETED|First Intervention Period (2 Weeks)||5
10379741|NCT00599638|11520955|FG000|STARTED|Washout Period (2 Weeks)||14
10379742|NCT00599638|11520956|FG001|STARTED|Washout Period (2 Weeks)||12
10379743|NCT00599638|11520957|FG002|STARTED|Washout Period (2 Weeks)||17
10379744|NCT00599638|11520958|FG003|STARTED|Washout Period (2 Weeks)||17
10539472|NCT01461707|11692392|FG000|STARTED|Overall Study||15
10539473|NCT01461707|11692393|FG001|STARTED|Overall Study||15
10539474|NCT01461707|11692392|FG000|COMPLETED|Overall Study||14
10539475|NCT01461707|11692393|FG001|COMPLETED|Overall Study||15
10539476|NCT01461707|11692392|FG000|NOT COMPLETED|Overall Study||1
10539477|NCT01461707|11692393|FG001|NOT COMPLETED|Overall Study||0
10539478|NCT01461733|11692401|FG000|STARTED|Overall Study||12
10539479|NCT01461733|11692402|FG001|STARTED|Overall Study||12
10539480|NCT01461733|11692401|FG000|COMPLETED|Overall Study||8
10539481|NCT01461733|11692402|FG001|COMPLETED|Overall Study||8
10539482|NCT01461733|11692401|FG000|NOT COMPLETED|Overall Study||4
10539483|NCT01461733|11692402|FG001|NOT COMPLETED|Overall Study||4
10539484|NCT01461811|11692410|FG000|STARTED|Overall Study||95
10539485|NCT01461811|11692411|FG001|STARTED|Overall Study||49
10539486|NCT01461811|11692410|FG000|COMPLETED|Overall Study||91
10539487|NCT01461811|11692411|FG001|COMPLETED|Overall Study||46
10539488|NCT01461811|11692410|FG000|NOT COMPLETED|Overall Study||4
10539489|NCT01461811|11692411|FG001|NOT COMPLETED|Overall Study||3
10379745|NCT00599638|11520955|FG000|COMPLETED|Washout Period (2 Weeks)||13
10379746|NCT00599638|11520956|FG001|COMPLETED|Washout Period (2 Weeks)||11
10379747|NCT00599638|11520957|FG002|COMPLETED|Washout Period (2 Weeks)||17
10379748|NCT00599638|11520958|FG003|COMPLETED|Washout Period (2 Weeks)||14
10379749|NCT00599638|11520955|FG000|NOT COMPLETED|Washout Period (2 Weeks)||1
10379750|NCT00599638|11520956|FG001|NOT COMPLETED|Washout Period (2 Weeks)||1
10539490|NCT01461824|11692420|FG000|STARTED|Overall Study||12
10379751|NCT00599638|11520957|FG002|NOT COMPLETED|Washout Period (2 Weeks)||0
10379752|NCT00599638|11520958|FG003|NOT COMPLETED|Washout Period (2 Weeks)||3
10379753|NCT00599638|11520955|FG000|STARTED|Second Intervention Period (2 Weeks)||13
10379754|NCT00599638|11520956|FG001|STARTED|Second Intervention Period (2 Weeks)||11
10379755|NCT00599638|11520957|FG002|STARTED|Second Intervention Period (2 Weeks)||17
10379756|NCT00599638|11520958|FG003|STARTED|Second Intervention Period (2 Weeks)||14
10379757|NCT00599638|11520955|FG000|COMPLETED|Second Intervention Period (2 Weeks)||12
10379758|NCT00599638|11520956|FG001|COMPLETED|Second Intervention Period (2 Weeks)||11
10379759|NCT00599638|11520957|FG002|COMPLETED|Second Intervention Period (2 Weeks)||17
10379760|NCT00599638|11520958|FG003|COMPLETED|Second Intervention Period (2 Weeks)||14
10379761|NCT00599638|11520955|FG000|NOT COMPLETED|Second Intervention Period (2 Weeks)||1
10379762|NCT00599638|11520956|FG001|NOT COMPLETED|Second Intervention Period (2 Weeks)||0
10379763|NCT00599638|11520957|FG002|NOT COMPLETED|Second Intervention Period (2 Weeks)||0
10379764|NCT00599638|11520958|FG003|NOT COMPLETED|Second Intervention Period (2 Weeks)||0
10379765|NCT00599755|11520966|FG000|STARTED|Overall Study||68
10379766|NCT00599755|11520966|FG000|COMPLETED|Overall Study||49
10379767|NCT00599755|11520966|FG000|NOT COMPLETED|Overall Study||19
10379768|NCT00599872|11520972|FG000|STARTED|Overall Study||216
10379769|NCT00599872|11520973|FG001|STARTED|Overall Study||214
10379770|NCT00599872|11520972|FG000|COMPLETED|Overall Study||167
10379771|NCT00599872|11520973|FG001|COMPLETED|Overall Study||181
10379772|NCT00599872|11520972|FG000|NOT COMPLETED|Overall Study||49
10379773|NCT00599872|11520973|FG001|NOT COMPLETED|Overall Study||33
10379774|NCT00599924|11520990|FG000|STARTED|Overall Study||4
10379775|NCT00599924|11520991|FG001|STARTED|Overall Study||9
10379776|NCT00599924|11520992|FG002|STARTED|Overall Study||5
10379777|NCT00599924|11520993|FG003|STARTED|Overall Study||12
10379778|NCT00599924|11520994|FG004|STARTED|Overall Study||9
10379779|NCT00599924|11520995|FG005|STARTED|Overall Study||6
10379780|NCT00599924|11520996|FG006|STARTED|Overall Study||8
10379781|NCT00599924|11520990|FG000|COMPLETED|Overall Study||1
10379782|NCT00599924|11520991|FG001|COMPLETED|Overall Study||4
10379783|NCT00599924|11520992|FG002|COMPLETED|Overall Study||3
10379784|NCT00599924|11520993|FG003|COMPLETED|Overall Study||4
10379785|NCT00599924|11520994|FG004|COMPLETED|Overall Study||3
10379786|NCT00599924|11520995|FG005|COMPLETED|Overall Study||2
10379787|NCT00599924|11520996|FG006|COMPLETED|Overall Study||3
10379788|NCT00599924|11520990|FG000|NOT COMPLETED|Overall Study||3
10379789|NCT00599924|11520991|FG001|NOT COMPLETED|Overall Study||5
10379790|NCT00599924|11520992|FG002|NOT COMPLETED|Overall Study||2
10379791|NCT00599924|11520993|FG003|NOT COMPLETED|Overall Study||8
10379792|NCT00599924|11520994|FG004|NOT COMPLETED|Overall Study||6
10379793|NCT00599924|11520995|FG005|NOT COMPLETED|Overall Study||4
10379794|NCT00599924|11520996|FG006|NOT COMPLETED|Overall Study||5
10717768|NCT02701257|11881772|FG003|NOT COMPLETED|Overall Study||1
10717769|NCT02701257|11881773|FG004|NOT COMPLETED|Overall Study||3
10717770|NCT02701270|11881789|FG000|STARTED|First Intervention at Visit 1||2
10717771|NCT02701270|11881790|FG001|STARTED|First Intervention at Visit 1||3
10717772|NCT02701270|11881791|FG002|STARTED|First Intervention at Visit 1||3
10379795|NCT00600028|11521019|FG000|STARTED|First Intervention (12 Weeks)|Number of participants starting the first intervention (prior to washout)|13
10379796|NCT00600028|11521020|FG001|STARTED|First Intervention (12 Weeks)|Number of participants starting the first intervention (prior to washout)|11
10379797|NCT00600028|11521019|FG000|COMPLETED|First Intervention (12 Weeks)||12
10379798|NCT00600028|11521020|FG001|COMPLETED|First Intervention (12 Weeks)||10
10379799|NCT00600028|11521019|FG000|NOT COMPLETED|First Intervention (12 Weeks)||1
10379800|NCT00600028|11521020|FG001|NOT COMPLETED|First Intervention (12 Weeks)||1
10379801|NCT00600028|11521019|FG000|STARTED|Second Intervention (12 Weeks)|Number of participants starting the second intervention (after a 2-week washout)|12
10379802|NCT00600028|11521020|FG001|STARTED|Second Intervention (12 Weeks)|Number of participants starting the second intervention (after a 2-week washout)|10
10379803|NCT00600028|11521019|FG000|COMPLETED|Second Intervention (12 Weeks)||12
10379804|NCT00600028|11521020|FG001|COMPLETED|Second Intervention (12 Weeks)||8
10379805|NCT00600028|11521019|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0
10379806|NCT00600028|11521020|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||2
10379807|NCT00600067|11521031|FG000|STARTED|Overall Study||55
10379808|NCT00600067|11521032|FG001|STARTED|Overall Study||75
10379809|NCT00600067|11521031|FG000|COMPLETED|Overall Study||52
10379810|NCT00600067|11521032|FG001|COMPLETED|Overall Study||68
10379811|NCT00600067|11521031|FG000|NOT COMPLETED|Overall Study||3
10539491|NCT01461824|11692421|FG001|STARTED|Overall Study||11
10539492|NCT01461824|11692422|FG002|STARTED|Overall Study||11
10539493|NCT01461824|11692420|FG000|COMPLETED|Overall Study||10
10539494|NCT01461824|11692421|FG001|COMPLETED|Overall Study||7
10717773|NCT02701270|11881792|FG003|STARTED|First Intervention at Visit 1||3
10717774|NCT02701270|11881789|FG000|COMPLETED|First Intervention at Visit 1||2
10717775|NCT02701270|11881790|FG001|COMPLETED|First Intervention at Visit 1||3
10539495|NCT01461824|11692422|FG002|COMPLETED|Overall Study||8
10379812|NCT00600067|11521032|FG001|NOT COMPLETED|Overall Study||7
10379813|NCT00600080|11521039|FG000|STARTED|Period 1: Baseline to One-week||28
10379814|NCT00600080|11521040|FG001|STARTED|Period 1: Baseline to One-week||32
10379815|NCT00600080|11521039|FG000|COMPLETED|Period 1: Baseline to One-week||28
10379816|NCT00600080|11521040|FG001|COMPLETED|Period 1: Baseline to One-week||32
10379817|NCT00600080|11521039|FG000|NOT COMPLETED|Period 1: Baseline to One-week||0
10379818|NCT00600080|11521040|FG001|NOT COMPLETED|Period 1: Baseline to One-week||0
10539496|NCT01461824|11692420|FG000|NOT COMPLETED|Overall Study||2
10379819|NCT00600080|11521039|FG000|STARTED|Period 2: One-week to Two-weeks|This is a crossover study, arms are switched at period change.|28
10379820|NCT00600080|11521040|FG001|STARTED|Period 2: One-week to Two-weeks|This is a crossover study, arms are switched at period change.|32
10379821|NCT00600080|11521039|FG000|COMPLETED|Period 2: One-week to Two-weeks||28
10379822|NCT00600080|11521040|FG001|COMPLETED|Period 2: One-week to Two-weeks||32
10379823|NCT00600080|11521039|FG000|NOT COMPLETED|Period 2: One-week to Two-weeks||0
10379824|NCT00600080|11521040|FG001|NOT COMPLETED|Period 2: One-week to Two-weeks||0
10717776|NCT02701270|11881791|FG002|COMPLETED|First Intervention at Visit 1||3
10717777|NCT02701270|11881792|FG003|COMPLETED|First Intervention at Visit 1||3
10717778|NCT02701270|11881789|FG000|NOT COMPLETED|First Intervention at Visit 1||0
10717779|NCT02701270|11881790|FG001|NOT COMPLETED|First Intervention at Visit 1||0
10717780|NCT02701270|11881791|FG002|NOT COMPLETED|First Intervention at Visit 1||0
10717781|NCT02701270|11881792|FG003|NOT COMPLETED|First Intervention at Visit 1||0
10379825|NCT00600106|11521048|FG000|STARTED|Overall Study||18
10379826|NCT00600106|11521049|FG001|STARTED|Overall Study||19
10379827|NCT00600106|11521048|FG000|COMPLETED|Overall Study||17
10379828|NCT00600106|11521049|FG001|COMPLETED|Overall Study||18
10379829|NCT00600106|11521048|FG000|NOT COMPLETED|Overall Study||1
10379830|NCT00600106|11521049|FG001|NOT COMPLETED|Overall Study||1
10379831|NCT00600119|11521061|FG000|STARTED|Single-blind Placebo run-in Period||36
10379832|NCT00600119|11521062|FG001|STARTED|Single-blind Placebo run-in Period||35
10379833|NCT00600119|11521063|FG002|STARTED|Single-blind Placebo run-in Period||29
10379834|NCT00600119|11521064|FG003|STARTED|Single-blind Placebo run-in Period||31
10379835|NCT00600119|11521065|FG004|STARTED|Single-blind Placebo run-in Period||39
10379836|NCT00600119|11521066|FG005|STARTED|Single-blind Placebo run-in Period||37
10379837|NCT00600119|11521061|FG000|COMPLETED|Single-blind Placebo run-in Period||32
10379838|NCT00600119|11521062|FG001|COMPLETED|Single-blind Placebo run-in Period||33
10379839|NCT00600119|11521063|FG002|COMPLETED|Single-blind Placebo run-in Period||27
10379840|NCT00600119|11521064|FG003|COMPLETED|Single-blind Placebo run-in Period||30
10379841|NCT00600119|11521065|FG004|COMPLETED|Single-blind Placebo run-in Period||37
10379842|NCT00600119|11521066|FG005|COMPLETED|Single-blind Placebo run-in Period||35
10379843|NCT00600119|11521061|FG000|NOT COMPLETED|Single-blind Placebo run-in Period||4
10379844|NCT00600119|11521062|FG001|NOT COMPLETED|Single-blind Placebo run-in Period||2
10379845|NCT00600119|11521063|FG002|NOT COMPLETED|Single-blind Placebo run-in Period||2
10379846|NCT00600119|11521064|FG003|NOT COMPLETED|Single-blind Placebo run-in Period||1
10379847|NCT00600119|11521065|FG004|NOT COMPLETED|Single-blind Placebo run-in Period||2
10379848|NCT00600119|11521066|FG005|NOT COMPLETED|Single-blind Placebo run-in Period||2
10379849|NCT00600119|11521061|FG000|STARTED|Double-blind Treatment Period||32
10379850|NCT00600119|11521062|FG001|STARTED|Double-blind Treatment Period||33
10379851|NCT00600119|11521063|FG002|STARTED|Double-blind Treatment Period||27
10379852|NCT00600119|11521064|FG003|STARTED|Double-blind Treatment Period||30
10379853|NCT00600119|11521065|FG004|STARTED|Double-blind Treatment Period||37
10379854|NCT00600119|11521066|FG005|STARTED|Double-blind Treatment Period||35
10379855|NCT00600119|11521061|FG000|COMPLETED|Double-blind Treatment Period||27
10379856|NCT00600119|11521062|FG001|COMPLETED|Double-blind Treatment Period||28
10379857|NCT00600119|11521063|FG002|COMPLETED|Double-blind Treatment Period||27
10379858|NCT00600119|11521064|FG003|COMPLETED|Double-blind Treatment Period||28
10379859|NCT00600119|11521065|FG004|COMPLETED|Double-blind Treatment Period||31
10379860|NCT00600119|11521066|FG005|COMPLETED|Double-blind Treatment Period||21
10379861|NCT00600119|11521061|FG000|NOT COMPLETED|Double-blind Treatment Period||5
10379862|NCT00600119|11521062|FG001|NOT COMPLETED|Double-blind Treatment Period||5
10379863|NCT00600119|11521063|FG002|NOT COMPLETED|Double-blind Treatment Period||0
10379864|NCT00600119|11521064|FG003|NOT COMPLETED|Double-blind Treatment Period||2
10379865|NCT00600119|11521065|FG004|NOT COMPLETED|Double-blind Treatment Period||6
10379866|NCT00600119|11521066|FG005|NOT COMPLETED|Double-blind Treatment Period||14
10379867|NCT00600119|11521061|FG000|STARTED|Follow-up Period||27
10379868|NCT00600119|11521062|FG001|STARTED|Follow-up Period||28
10379869|NCT00600119|11521063|FG002|STARTED|Follow-up Period||27
10379870|NCT00600119|11521064|FG003|STARTED|Follow-up Period||28
10379871|NCT00600119|11521065|FG004|STARTED|Follow-up Period||31
10379872|NCT00600119|11521066|FG005|STARTED|Follow-up Period||21
10379873|NCT00600119|11521061|FG000|COMPLETED|Follow-up Period||26
10379874|NCT00600119|11521062|FG001|COMPLETED|Follow-up Period||28
10379875|NCT00600119|11521063|FG002|COMPLETED|Follow-up Period||27
10379876|NCT00600119|11521064|FG003|COMPLETED|Follow-up Period||28
10379877|NCT00600119|11521065|FG004|COMPLETED|Follow-up Period||31
10379878|NCT00600119|11521066|FG005|COMPLETED|Follow-up Period||20
10379879|NCT00600119|11521061|FG000|NOT COMPLETED|Follow-up Period||1
10379880|NCT00600119|11521062|FG001|NOT COMPLETED|Follow-up Period||0
10379881|NCT00600119|11521063|FG002|NOT COMPLETED|Follow-up Period||0
10379882|NCT00600119|11521064|FG003|NOT COMPLETED|Follow-up Period||0
10379883|NCT00600119|11521065|FG004|NOT COMPLETED|Follow-up Period||0
10379884|NCT00600119|11521066|FG005|NOT COMPLETED|Follow-up Period||1
10379885|NCT00600171|11521086|FG000|STARTED|Overall Study||102
10379886|NCT00600171|11521087|FG001|STARTED|Overall Study||101
10379887|NCT00600171|11521088|FG002|STARTED|Overall Study||101
10379888|NCT00600171|11521089|FG003|STARTED|Overall Study||100
10379889|NCT00600171|11521090|FG004|STARTED|Overall Study||101
10379890|NCT00600171|11521091|FG005|STARTED|Overall Study||102
10379891|NCT00600171|11521086|FG000|COMPLETED|Overall Study||86
10379892|NCT00600171|11521087|FG001|COMPLETED|Overall Study||84
10717782|NCT02701270|11881789|FG000|STARTED|Second Intervention at Visit 2||2
10379893|NCT00600171|11521088|FG002|COMPLETED|Overall Study||91
10379894|NCT00600171|11521089|FG003|COMPLETED|Overall Study||88
10379895|NCT00600171|11521090|FG004|COMPLETED|Overall Study||93
10379896|NCT00600171|11521091|FG005|COMPLETED|Overall Study||97
10379897|NCT00600171|11521086|FG000|NOT COMPLETED|Overall Study||16
10379898|NCT00600171|11521087|FG001|NOT COMPLETED|Overall Study||17
10379899|NCT00600171|11521088|FG002|NOT COMPLETED|Overall Study||10
10379900|NCT00600171|11521089|FG003|NOT COMPLETED|Overall Study||12
10379901|NCT00600171|11521090|FG004|NOT COMPLETED|Overall Study||8
10379902|NCT00600171|11521091|FG005|NOT COMPLETED|Overall Study||5
10379903|NCT00600340|11521109|FG000|STARTED|Overall Study||285
10379904|NCT00600340|11521110|FG001|STARTED|Overall Study||279
10379905|NCT00600340|11521109|FG000|COMPLETED|Overall Study||285
10379906|NCT00600340|11521110|FG001|COMPLETED|Overall Study||279
10379907|NCT00600340|11521109|FG000|NOT COMPLETED|Overall Study||0
10379908|NCT00600340|11521110|FG001|NOT COMPLETED|Overall Study||0
10379909|NCT00600353|11521118|FG000|STARTED|Overall Study||10
10379910|NCT00600353|11521119|FG001|STARTED|Overall Study||10
10379911|NCT00600353|11521118|FG000|COMPLETED|Overall Study||9
10379912|NCT00600353|11521119|FG001|COMPLETED|Overall Study||9
10379913|NCT00600353|11521118|FG000|NOT COMPLETED|Overall Study||1
10379914|NCT00600353|11521119|FG001|NOT COMPLETED|Overall Study||1
10379915|NCT00600613|11521125|FG000|STARTED|Overall Study||6
10379916|NCT00600613|11521125|FG000|COMPLETED|Overall Study||5
10379917|NCT00600613|11521125|FG000|NOT COMPLETED|Overall Study||1
10379918|NCT00600704|11521131|FG000|STARTED|Overall Study||100
10379919|NCT00600704|11521132|FG001|STARTED|Overall Study||92
10379920|NCT00600704|11521131|FG000|COMPLETED|Overall Study||100
10379921|NCT00600704|11521132|FG001|COMPLETED|Overall Study||92
10379922|NCT00600704|11521131|FG000|NOT COMPLETED|Overall Study||0
10379923|NCT00600704|11521132|FG001|NOT COMPLETED|Overall Study||0
10379924|NCT00600743|11521142|FG000|STARTED|Overall Study||4
10379925|NCT00600743|11521143|FG001|STARTED|Overall Study||4
10379926|NCT00600743|11521144|FG002|STARTED|Overall Study||8
10379927|NCT00600743|11521145|FG003|STARTED|Overall Study||7
10379928|NCT00600743|11521142|FG000|COMPLETED|Overall Study||4
10379929|NCT00600743|11521143|FG001|COMPLETED|Overall Study||4
10379930|NCT00600743|11521144|FG002|COMPLETED|Overall Study||8
10379931|NCT00600743|11521145|FG003|COMPLETED|Overall Study||7
10379932|NCT00600743|11521142|FG000|NOT COMPLETED|Overall Study||0
10379933|NCT00600743|11521143|FG001|NOT COMPLETED|Overall Study||0
10379934|NCT00600743|11521144|FG002|NOT COMPLETED|Overall Study||0
10379935|NCT00600743|11521145|FG003|NOT COMPLETED|Overall Study||0
10379936|NCT00600756|11521166|FG000|STARTED|Analysis After 6 Months||395
10379937|NCT00600756|11521167|FG001|STARTED|Analysis After 6 Months||403
10379938|NCT00600756|11521166|FG000|COMPLETED|Analysis After 6 Months|Completers are all patients who completed the study up to Visit 5 (including premature withdraw)|264
10379939|NCT00600756|11521167|FG001|COMPLETED|Analysis After 6 Months|Completers are all patients who completed the study up to Visit 5 (including premature withdraw)|283
10379940|NCT00600756|11521166|FG000|NOT COMPLETED|Analysis After 6 Months||131
10379941|NCT00600756|11521167|FG001|NOT COMPLETED|Analysis After 6 Months||120
10379942|NCT00600756|11521166|FG000|STARTED|Overall Study Analysis After 12 Months||395
10379943|NCT00600756|11521167|FG001|STARTED|Overall Study Analysis After 12 Months||403
10379944|NCT00600756|11521166|FG000|Randomized Analysis|Overall Study Analysis After 12 Months||395
10379945|NCT00600756|11521167|FG001|Randomized Analysis|Overall Study Analysis After 12 Months||403
10379946|NCT00600756|11521166|FG000|Safety Analysis|Overall Study Analysis After 12 Months||391
10379947|NCT00600756|11521167|FG001|Safety Analysis|Overall Study Analysis After 12 Months||402
10379948|NCT00600756|11521166|FG000|ITT Analysis|Overall Study Analysis After 12 Months||379
10379949|NCT00600756|11521167|FG001|ITT Analysis|Overall Study Analysis After 12 Months||392
10379950|NCT00600756|11521166|FG000|COMPLETED|Overall Study Analysis After 12 Months|Completed study to Visit 7 (includes premature withdrawals with final visit in the Visit 7 window)|212
10379951|NCT00600756|11521167|FG001|COMPLETED|Overall Study Analysis After 12 Months|Completed study to Visit 7 (includes premature withdrawals with final visit in the Visit 7 window)|227
10379952|NCT00600756|11521166|FG000|NOT COMPLETED|Overall Study Analysis After 12 Months||183
10379953|NCT00600756|11521167|FG001|NOT COMPLETED|Overall Study Analysis After 12 Months||176
10379954|NCT00600821|11521175|FG000|STARTED|Overall Study||58
10379955|NCT00600821|11521176|FG001|STARTED|Overall Study||60
10379956|NCT00600821|11521175|FG000|Treated|Overall Study||58
10379957|NCT00600821|11521176|FG001|Treated|Overall Study||59
10717783|NCT02701270|11881790|FG001|STARTED|Second Intervention at Visit 2||3
10717784|NCT02701270|11881791|FG002|STARTED|Second Intervention at Visit 2||3
10717785|NCT02701270|11881792|FG003|STARTED|Second Intervention at Visit 2||3
10717786|NCT02701270|11881789|FG000|COMPLETED|Second Intervention at Visit 2||2
10717787|NCT02701270|11881790|FG001|COMPLETED|Second Intervention at Visit 2||3
10717788|NCT02701270|11881791|FG002|COMPLETED|Second Intervention at Visit 2||3
10717789|NCT02701270|11881792|FG003|COMPLETED|Second Intervention at Visit 2||3
10717790|NCT02701270|11881789|FG000|NOT COMPLETED|Second Intervention at Visit 2||0
10717791|NCT02701270|11881790|FG001|NOT COMPLETED|Second Intervention at Visit 2||0
10717792|NCT02701270|11881791|FG002|NOT COMPLETED|Second Intervention at Visit 2||0
10717793|NCT02701270|11881792|FG003|NOT COMPLETED|Second Intervention at Visit 2||0
10717794|NCT02701270|11881789|FG000|STARTED|Third Intervention at Visit 3||2
10379958|NCT00600821|11521175|FG000|COMPLETED|Overall Study||0
10379959|NCT00600821|11521176|FG001|COMPLETED|Overall Study||0
10379960|NCT00600821|11521175|FG000|NOT COMPLETED|Overall Study||58
10379961|NCT00600821|11521176|FG001|NOT COMPLETED|Overall Study||60
10717795|NCT02701270|11881790|FG001|STARTED|Third Intervention at Visit 3||3
10379962|NCT00600886|11521186|FG000|STARTED|Core Phase - Full Analysis Set (FAS)||176
10379963|NCT00600886|11521187|FG001|STARTED|Core Phase - Full Analysis Set (FAS)||182
10379964|NCT00600886|11521186|FG000|Did Not Enter Extension|Core Phase - Full Analysis Set (FAS)||29
10379965|NCT00600886|11521187|FG001|Did Not Enter Extension|Core Phase - Full Analysis Set (FAS)||29
10379966|NCT00600886|11521186|FG000|Entered Extension, Crossed Over|Core Phase - Full Analysis Set (FAS)||38
10379967|NCT00600886|11521187|FG001|Entered Extension, Crossed Over|Core Phase - Full Analysis Set (FAS)||81
10379968|NCT00600886|11521186|FG000|Entered Ext Continued Same Treatment|Core Phase - Full Analysis Set (FAS)||74
10379969|NCT00600886|11521187|FG001|Entered Ext Continued Same Treatment|Core Phase - Full Analysis Set (FAS)||46
10379970|NCT00600886|11521186|FG000|COMPLETED|Core Phase - Full Analysis Set (FAS)|Completed = anyone who did not discontinue prior to month 12.|141
10379971|NCT00600886|11521187|FG001|COMPLETED|Core Phase - Full Analysis Set (FAS)|Completed = anyone who did not discontinue prior to month 12.|156
10379972|NCT00600886|11521186|FG000|NOT COMPLETED|Core Phase - Full Analysis Set (FAS)||35
10379973|NCT00600886|11521187|FG001|NOT COMPLETED|Core Phase - Full Analysis Set (FAS)||26
10379974|NCT00600886|11521186|FG000|STARTED|Extension - Same Treatment (FAS)|Started = anyone who entered the extension and continued the same treatment of Pasireotide LAR|74
10379975|NCT00600886|11521187|FG001|STARTED|Extension - Same Treatment (FAS)|Started = anyone who entered the extension and continued the same treatment of Octreotide LAR|46
10379976|NCT00600886|11521186|FG000|Completed Study at Month 26|Extension - Same Treatment (FAS)|Pas. LAR pts in Ext. were not considered completers at M26 as treatment could continue after M26.|0
10379977|NCT00600886|11521187|FG001|Completed Study at Month 26|Extension - Same Treatment (FAS)|Per protocol, pts who received Octreotide LAR in ext. phase were not followed in the study after M26|31
10379978|NCT00600886|11521186|FG000|Completed Study After Month 26|Extension - Same Treatment (FAS)|Completed = Pts who transferred to a roll-over protocol or commercial supply of Pasireotide LAR|28
10379979|NCT00600886|11521187|FG001|Completed Study After Month 26|Extension - Same Treatment (FAS)|Received treatment and completed after M26: Recorded as protocol deviation|4
10379980|NCT00600886|11521186|FG000|Discontinued After Month 26|Extension - Same Treatment (FAS)||23
10379981|NCT00600886|11521187|FG001|Discontinued After Month 26|Extension - Same Treatment (FAS)|Received treatment and discontinued after M26: Recorded as protocol deviation|1
10379982|NCT00600886|11521186|FG000|Discontinued Between M12 and M26|Extension - Same Treatment (FAS)||23
10379983|NCT00600886|11521187|FG001|Discontinued Between M12 and M26|Extension - Same Treatment (FAS)||10
10379984|NCT00600886|11521186|FG000|COMPLETED|Extension - Same Treatment (FAS)|Completed= completed after M26, switched to commercial pasireotide LAR or entered roll-over protocol|28
10379985|NCT00600886|11521187|FG001|COMPLETED|Extension - Same Treatment (FAS)|Completed = completed the study|35
10379986|NCT00600886|11521186|FG000|NOT COMPLETED|Extension - Same Treatment (FAS)||46
10379987|NCT00600886|11521187|FG001|NOT COMPLETED|Extension - Same Treatment (FAS)||11
10379988|NCT00600886|11521186|FG000|STARTED|Extension - After Crossover (CAS)|Started = anyone who entered the extension and crossed over to Pasireotide LAR|81
10379989|NCT00600886|11521187|FG001|STARTED|Extension - After Crossover (CAS)|Started = anyone who entered the extension and crossed over to Octreotide LAR|38
10379990|NCT00600886|11521186|FG000|Completed Study at Month 26|Extension - After Crossover (CAS)|Pas. LAR pts in Ext. were not considered completers at M26 as treatment could continue after M26.|0
10379991|NCT00600886|11521187|FG001|Completed Study at Month 26|Extension - After Crossover (CAS)|Per protocol, Pts who received Octreotide LAR in Ext. phase were not followed in study after M26|25
10379992|NCT00600886|11521186|FG000|Completed After Month 26|Extension - After Crossover (CAS)|Completed = Pts who transferred to a roll-over protocol or commercial supply of Pasireotide LAR|19
10379993|NCT00600886|11521187|FG001|Completed After Month 26|Extension - After Crossover (CAS)|Per protocol, pts who received Octreotide LAR in ext. phase were not followed in study after M26|0
10379994|NCT00600886|11521186|FG000|Discontinued Between M12 and M26|Extension - After Crossover (CAS)||31
10379995|NCT00600886|11521187|FG001|Discontinued Between M12 and M26|Extension - After Crossover (CAS)||13
10379996|NCT00600886|11521186|FG000|Discontinued After M26|Extension - After Crossover (CAS)||31
10379997|NCT00600886|11521187|FG001|Discontinued After M26|Extension - After Crossover (CAS)|Per protocol, Pts who received Octreotide LAR in Ext. phase were not followed in study after M26|0
10379998|NCT00600886|11521186|FG000|COMPLETED|Extension - After Crossover (CAS)|Completed after month 26: transferred to a roll-over protocol or commercial supply of Pas.LAR|19
10379999|NCT00600886|11521187|FG001|COMPLETED|Extension - After Crossover (CAS)|Completed the study|25
10380000|NCT00600886|11521186|FG000|NOT COMPLETED|Extension - After Crossover (CAS)||62
10380001|NCT00600886|11521187|FG001|NOT COMPLETED|Extension - After Crossover (CAS)||13
10380002|NCT00600925|11521209|FG000|STARTED|Overall Study||300
10380003|NCT00600925|11521210|FG001|STARTED|Overall Study||302
10380004|NCT00600925|11521209|FG000|COMPLETED|Overall Study||300
10380005|NCT00600925|11521210|FG001|COMPLETED|Overall Study||302
10380006|NCT00600925|11521209|FG000|NOT COMPLETED|Overall Study||0
10380007|NCT00600925|11521210|FG001|NOT COMPLETED|Overall Study||0
10380008|NCT00600938|11521218|FG000|STARTED|Core Study||98
10717796|NCT02701270|11881791|FG002|STARTED|Third Intervention at Visit 3||3
10717797|NCT02701270|11881792|FG003|STARTED|Third Intervention at Visit 3||3
10717798|NCT02701270|11881789|FG000|COMPLETED|Third Intervention at Visit 3||2
10717799|NCT02701270|11881790|FG001|COMPLETED|Third Intervention at Visit 3||3
10717800|NCT02701270|11881791|FG002|COMPLETED|Third Intervention at Visit 3||3
10717801|NCT02701270|11881792|FG003|COMPLETED|Third Intervention at Visit 3||3
10717802|NCT02701270|11881789|FG000|NOT COMPLETED|Third Intervention at Visit 3||0
10717803|NCT02701270|11881790|FG001|NOT COMPLETED|Third Intervention at Visit 3||0
10717804|NCT02701270|11881791|FG002|NOT COMPLETED|Third Intervention at Visit 3||0
10380009|NCT00600938|11521219|FG001|STARTED|Core Study||99
10380010|NCT00600938|11521220|FG002|STARTED|Core Study||0
10380011|NCT00600938|11521221|FG003|STARTED|Core Study||0
10380012|NCT00600938|11521218|FG000|Core Safety Set|Core Study||96
10380013|NCT00600938|11521219|FG001|Core Safety Set|Core Study||91
10380014|NCT00600938|11521220|FG002|Core Safety Set|Core Study||0
10380015|NCT00600938|11521221|FG003|Core Safety Set|Core Study||0
10380016|NCT00600938|11521218|FG000|Per Protocol Set (PPS)|Core Study||91
10380017|NCT00600938|11521219|FG001|Per Protocol Set (PPS)|Core Study||81
10380018|NCT00600938|11521220|FG002|Per Protocol Set (PPS)|Core Study||0
10380019|NCT00600938|11521221|FG003|Per Protocol Set (PPS)|Core Study||0
10380020|NCT00600938|11521218|FG000|COMPLETED|Core Study||82
10380021|NCT00600938|11521219|FG001|COMPLETED|Core Study||78
10380022|NCT00600938|11521220|FG002|COMPLETED|Core Study||0
10380023|NCT00600938|11521221|FG003|COMPLETED|Core Study||0
10380024|NCT00600938|11521218|FG000|NOT COMPLETED|Core Study||16
10380025|NCT00600938|11521219|FG001|NOT COMPLETED|Core Study||21
10380026|NCT00600938|11521220|FG002|NOT COMPLETED|Core Study||0
10380027|NCT00600938|11521221|FG003|NOT COMPLETED|Core Study||0
10380028|NCT00600938|11521218|FG000|STARTED|Extension Study|Of the 82 patients who completed the ICL core, 74 continued on the ICL ext. phase; 1 went to ICL-DFO|74
10380029|NCT00600938|11521219|FG001|STARTED|Extension Study|Of the 78 patients who completed the DFO core, 29 went on DFO ext. phase; 42 went to the DFO-ICL|29
10539497|NCT01461824|11692421|FG001|NOT COMPLETED|Overall Study||4
10539498|NCT01461824|11692422|FG002|NOT COMPLETED|Overall Study||3
10539499|NCT01461863|11692432|FG000|STARTED|Overall Study||48
10539500|NCT01461863|11692433|FG001|STARTED|Overall Study||48
10539501|NCT01461863|11692432|FG000|COMPLETED|Overall Study||48
10539502|NCT01461863|11692433|FG001|COMPLETED|Overall Study||48
10539503|NCT01461863|11692432|FG000|NOT COMPLETED|Overall Study||0
10539504|NCT01461863|11692433|FG001|NOT COMPLETED|Overall Study||0
10657871|NCT02229383|11819039|FG000|NOT COMPLETED|Overall Study||20
10657872|NCT02229383|11819040|FG001|NOT COMPLETED|Overall Study||22
10657873|NCT02229396|11819049|FG000|STARTED|Overall Study||233
10657874|NCT02229396|11819050|FG001|STARTED|Overall Study||231
10657875|NCT02229396|11819051|FG002|STARTED|Overall Study||231
10657876|NCT02229396|11819049|FG000|Randomization Code Allocated|Overall Study||233
10657877|NCT02229396|11819050|FG001|Randomization Code Allocated|Overall Study||231
10657878|NCT02229396|11819051|FG002|Randomization Code Allocated|Overall Study||231
10657879|NCT02229396|11819049|FG000|Safety Analysis Set|Overall Study||233
10657880|NCT02229396|11819050|FG001|Safety Analysis Set|Overall Study||231
10657881|NCT02229396|11819051|FG002|Safety Analysis Set|Overall Study||230
10657882|NCT02229396|11819049|FG000|Intent-to-Treat (ITT) Analysis Set|Overall Study||230
10657883|NCT02229396|11819050|FG001|Intent-to-Treat (ITT) Analysis Set|Overall Study||228
10657884|NCT02229396|11819051|FG002|Intent-to-Treat (ITT) Analysis Set|Overall Study||227
10657885|NCT02229396|11819049|FG000|Completed 28-Week Study Period|Overall Study||208
10657886|NCT02229396|11819050|FG001|Completed 28-Week Study Period|Overall Study||202
10657887|NCT02229396|11819051|FG002|Completed 28-Week Study Period|Overall Study||193
10657888|NCT02229396|11819049|FG000|Completed 52-Week Study Period|Overall Study||194
10657889|NCT02229396|11819050|FG001|Completed 52-Week Study Period|Overall Study||193
10657890|NCT02229396|11819051|FG002|Completed 52-Week Study Period|Overall Study||177
10657891|NCT02229396|11819049|FG000|COMPLETED|Overall Study||155
10657892|NCT02229396|11819050|FG001|COMPLETED|Overall Study||154
10657893|NCT02229396|11819051|FG002|COMPLETED|Overall Study||136
10657894|NCT02229396|11819049|FG000|NOT COMPLETED|Overall Study||78
10657895|NCT02229396|11819050|FG001|NOT COMPLETED|Overall Study||77
10657896|NCT02229396|11819051|FG002|NOT COMPLETED|Overall Study||95
10657897|NCT02229461|11819066|FG000|STARTED|Overall Study|Randomized and received treatment|17
10657898|NCT02229461|11819067|FG001|STARTED|Overall Study|Randomized and received treatment|17
10657899|NCT02229461|11819068|FG002|STARTED|Overall Study|Randomized and received treatment|17
10657900|NCT02229461|11819069|FG003|STARTED|Overall Study|Randomized and received treatment|17
10657901|NCT02229461|11819070|FG004|STARTED|Overall Study|Randomized and received treatment|17
10657902|NCT02229461|11819071|FG005|STARTED|Overall Study|Randomized and received treatment|17
10380030|NCT00600938|11521220|FG002|STARTED|Extension Study|Of the 78 patients who completed the DFO core, 29 went on DFO ext. phase; 42 went to the DFO-ICL|42
10380031|NCT00600938|11521221|FG003|STARTED|Extension Study|Of the 82 patients who completed the ICL core, 74 continued on the ICL ext. phase; 1 went to ICL-DFO|1
10380032|NCT00600938|11521218|FG000|Extension Safety Set|Extension Study|1 patient did not receive drug in the ext. phase but received drug in the core phase|73
10539505|NCT01461928|11692441|FG000|STARTED|Induction (up to 8 Months)||692
10539506|NCT01461928|11692442|FG001|STARTED|Induction (up to 8 Months)||0
10539507|NCT01461928|11692443|FG002|STARTED|Induction (up to 8 Months)||0
10657903|NCT02229461|11819066|FG000|COMPLETED|Overall Study||17
10657904|NCT02229461|11819067|FG001|COMPLETED|Overall Study||17
10657905|NCT02229461|11819068|FG002|COMPLETED|Overall Study||17
10657906|NCT02229461|11819069|FG003|COMPLETED|Overall Study||17
10657907|NCT02229461|11819070|FG004|COMPLETED|Overall Study||17
10657908|NCT02229461|11819071|FG005|COMPLETED|Overall Study||17
10657909|NCT02229461|11819066|FG000|NOT COMPLETED|Overall Study||0
10657910|NCT02229461|11819067|FG001|NOT COMPLETED|Overall Study||0
10657911|NCT02229461|11819068|FG002|NOT COMPLETED|Overall Study||0
10657912|NCT02229461|11819069|FG003|NOT COMPLETED|Overall Study||0
10657913|NCT02229461|11819070|FG004|NOT COMPLETED|Overall Study||0
10657914|NCT02229461|11819071|FG005|NOT COMPLETED|Overall Study||0
10657915|NCT02229474|11819088|FG000|STARTED|Overall Study||16
10657916|NCT02229474|11819089|FG001|STARTED|Overall Study||18
10657917|NCT02229474|11819088|FG000|COMPLETED|Overall Study||16
10380033|NCT00600938|11521219|FG001|Extension Safety Set|Extension Study||29
10380034|NCT00600938|11521220|FG002|Extension Safety Set|Extension Study||42
10380035|NCT00600938|11521221|FG003|Extension Safety Set|Extension Study||1
10380036|NCT00600938|11521218|FG000|COMPLETED|Extension Study||65
10380037|NCT00600938|11521219|FG001|COMPLETED|Extension Study||24
10380038|NCT00600938|11521220|FG002|COMPLETED|Extension Study||33
10380039|NCT00600938|11521221|FG003|COMPLETED|Extension Study||0
10380040|NCT00600938|11521218|FG000|NOT COMPLETED|Extension Study||9
10380041|NCT00600938|11521219|FG001|NOT COMPLETED|Extension Study||5
10380042|NCT00600938|11521220|FG002|NOT COMPLETED|Extension Study||9
10380043|NCT00600938|11521221|FG003|NOT COMPLETED|Extension Study||1
10380044|NCT00601107|11521250|FG000|STARTED|Overall Study|Randomized.|27
10380045|NCT00601107|11521251|FG001|STARTED|Overall Study||31
10380046|NCT00601107|11521252|FG002|STARTED|Overall Study||28
10380047|NCT00601107|11521253|FG003|STARTED|Overall Study||25
10380048|NCT00601107|11521250|FG000|Treated|Overall Study||27
10380049|NCT00601107|11521251|FG001|Treated|Overall Study||31
10380050|NCT00601107|11521252|FG002|Treated|Overall Study||28
10380051|NCT00601107|11521253|FG003|Treated|Overall Study||25
10380052|NCT00601107|11521250|FG000|COMPLETED|Overall Study||14
10380053|NCT00601107|11521251|FG001|COMPLETED|Overall Study||22
10380054|NCT00601107|11521252|FG002|COMPLETED|Overall Study||16
10380055|NCT00601107|11521253|FG003|COMPLETED|Overall Study||13
10380056|NCT00601107|11521250|FG000|NOT COMPLETED|Overall Study||13
10380057|NCT00601107|11521251|FG001|NOT COMPLETED|Overall Study||9
10380058|NCT00601107|11521252|FG002|NOT COMPLETED|Overall Study||12
10380059|NCT00601107|11521253|FG003|NOT COMPLETED|Overall Study||12
10380060|NCT00601146|11521263|FG000|STARTED|Overall Study||39
10380061|NCT00601146|11521263|FG000|COMPLETED|Overall Study||39
10380062|NCT00601146|11521263|FG000|NOT COMPLETED|Overall Study||0
10380063|NCT00601172|11521269|FG000|STARTED|Overall Study||355
10380064|NCT00601172|11521270|FG001|STARTED|Overall Study||355
10380065|NCT00601172|11521269|FG000|COMPLETED|Overall Study||214
10380066|NCT00601172|11521270|FG001|COMPLETED|Overall Study||228
10380067|NCT00601172|11521269|FG000|NOT COMPLETED|Overall Study||141
10380068|NCT00601172|11521270|FG001|NOT COMPLETED|Overall Study||127
10380069|NCT00601250|11521279|FG000|STARTED|Overall Study|number who started treatment|177
10380070|NCT00601250|11521280|FG001|STARTED|Overall Study|number who started treatment. One additional patient was randomised but not treated.|523
10380071|NCT00601250|11521279|FG000|COMPLETED|Overall Study|number who completed treatment|163
10380072|NCT00601250|11521280|FG001|COMPLETED|Overall Study|number who completed treatment|484
10380073|NCT00601250|11521279|FG000|NOT COMPLETED|Overall Study||14
10380074|NCT00601250|11521280|FG001|NOT COMPLETED|Overall Study||39
10380075|NCT00601354|11521288|FG000|STARTED|Overall Study||8
10380076|NCT00601354|11521289|FG001|STARTED|Overall Study||9
10380077|NCT00601354|11521288|FG000|COMPLETED|Overall Study||4
10380078|NCT00601354|11521289|FG001|COMPLETED|Overall Study||4
10380079|NCT00601354|11521288|FG000|NOT COMPLETED|Overall Study||4
10380080|NCT00601354|11521289|FG001|NOT COMPLETED|Overall Study||5
10380081|NCT00601367|11521295|FG000|STARTED|Overall Study||480
10380082|NCT00601367|11521295|FG000|COMPLETED|Overall Study||293
10380083|NCT00601367|11521295|FG000|NOT COMPLETED|Overall Study||187
10380084|NCT00601419|11521299|FG000|STARTED|Overall Study||230
10380085|NCT00601419|11521299|FG000|COMPLETED|Overall Study||226
10380086|NCT00601419|11521299|FG000|NOT COMPLETED|Overall Study||4
10380087|NCT00601458|11521322|FG000|STARTED|Overall Study||36
10380088|NCT00601458|11521323|FG001|STARTED|Overall Study||34
10380089|NCT00601458|11521324|FG002|STARTED|Overall Study||30
10380090|NCT00601458|11521322|FG000|COMPLETED|Overall Study||32
10380091|NCT00601458|11521323|FG001|COMPLETED|Overall Study||29
10380092|NCT00601458|11521324|FG002|COMPLETED|Overall Study||28
10380093|NCT00601458|11521322|FG000|NOT COMPLETED|Overall Study||4
10380094|NCT00601458|11521323|FG001|NOT COMPLETED|Overall Study||5
10380095|NCT00601458|11521324|FG002|NOT COMPLETED|Overall Study||2
10380096|NCT00601484|11521334|FG000|STARTED|Overall Study||34
10380097|NCT00601484|11521335|FG001|STARTED|Overall Study||31
10380098|NCT00601484|11521334|FG000|Treated|Overall Study||34
10380099|NCT00601484|11521335|FG001|Treated|Overall Study||30
10380100|NCT00601484|11521334|FG000|COMPLETED|Overall Study||29
10380101|NCT00601484|11521335|FG001|COMPLETED|Overall Study||23
10380102|NCT00601484|11521334|FG000|NOT COMPLETED|Overall Study||5
10380103|NCT00601484|11521335|FG001|NOT COMPLETED|Overall Study||8
10380104|NCT00601523|11521343|FG000|STARTED|Overall Study||368
10380105|NCT00601523|11521344|FG001|STARTED|Overall Study||143
10380106|NCT00601523|11521343|FG000|COMPLETED|Overall Study||291
10380107|NCT00601523|11521344|FG001|COMPLETED|Overall Study||117
10380108|NCT00601523|11521343|FG000|NOT COMPLETED|Overall Study||77
10380109|NCT00601523|11521344|FG001|NOT COMPLETED|Overall Study||26
10380110|NCT00601627|11521350|FG000|STARTED|Overall Study||51
10380111|NCT00601627|11521350|FG000|COMPLETED|Overall Study||51
10380112|NCT00601627|11521350|FG000|NOT COMPLETED|Overall Study||0
10380113|NCT00601640|11521357|FG000|STARTED|Overall Study||52
10380114|NCT00601640|11521358|FG001|STARTED|Overall Study||52
10380115|NCT00601640|11521359|FG002|STARTED|Overall Study||52
10380116|NCT00601640|11521357|FG000|COMPLETED|Overall Study||47
10380117|NCT00601640|11521358|FG001|COMPLETED|Overall Study||47
10380118|NCT00601640|11521359|FG002|COMPLETED|Overall Study||42
10380119|NCT00601640|11521357|FG000|NOT COMPLETED|Overall Study||5
10380120|NCT00601640|11521358|FG001|NOT COMPLETED|Overall Study||5
10380121|NCT00601640|11521359|FG002|NOT COMPLETED|Overall Study||10
10380122|NCT00601705|11521369|FG000|STARTED|Overall Study||61
10380123|NCT00601705|11521369|FG000|COMPLETED|Overall Study||60
10717805|NCT02701270|11881792|FG003|NOT COMPLETED|Third Intervention at Visit 3||0
10380124|NCT00601705|11521369|FG000|NOT COMPLETED|Overall Study||1
10380125|NCT00601718|11521374|FG000|STARTED|Overall Study||29
10380126|NCT00601718|11521374|FG000|COMPLETED|Overall Study||29
10380127|NCT00601718|11521374|FG000|NOT COMPLETED|Overall Study||0
10380128|NCT00601731|11521390|FG000|STARTED|Overall Study||143
10380129|NCT00601731|11521391|FG001|STARTED|Overall Study||43
10380130|NCT00601731|11521392|FG002|STARTED|Overall Study||166
10380131|NCT00601731|11521393|FG003|STARTED|Overall Study||30
10380132|NCT00601731|11521390|FG000|COMPLETED|Overall Study||120
10380133|NCT00601731|11521391|FG001|COMPLETED|Overall Study||43
10380134|NCT00601731|11521392|FG002|COMPLETED|Overall Study||151
10380135|NCT00601731|11521393|FG003|COMPLETED|Overall Study||29
10380136|NCT00601731|11521390|FG000|NOT COMPLETED|Overall Study||23
10380137|NCT00601731|11521391|FG001|NOT COMPLETED|Overall Study||0
10380138|NCT00601731|11521392|FG002|NOT COMPLETED|Overall Study||15
10380139|NCT00601731|11521393|FG003|NOT COMPLETED|Overall Study||1
10380140|NCT00601796|11521419|FG000|STARTED|Overall Study||24
10380141|NCT00601796|11521419|FG000|COMPLETED|Overall Study||24
10380142|NCT00601796|11521419|FG000|NOT COMPLETED|Overall Study||0
10380143|NCT00601835|11521425|FG000|STARTED|Overall Study||2950
10380144|NCT00601835|11521426|FG001|STARTED|Overall Study||700
10380145|NCT00601835|11521425|FG000|COMPLETED|Overall Study||2890
10380146|NCT00601835|11521426|FG001|COMPLETED|Overall Study||686
10380147|NCT00601835|11521425|FG000|NOT COMPLETED|Overall Study||60
10380148|NCT00601835|11521426|FG001|NOT COMPLETED|Overall Study||14
10380149|NCT00601926|11521432|FG000|STARTED|Overall Study||5
10380150|NCT00601926|11521432|FG000|COMPLETED|Overall Study||5
10380151|NCT00601926|11521432|FG000|NOT COMPLETED|Overall Study||0
10380152|NCT00601952|11521438|FG000|STARTED|Overall Study||14
10380153|NCT00601952|11521439|FG001|STARTED|Overall Study||17
10380154|NCT00601952|11521438|FG000|COMPLETED|Overall Study||12
10380155|NCT00601952|11521439|FG001|COMPLETED|Overall Study||17
10380156|NCT00601952|11521438|FG000|NOT COMPLETED|Overall Study||2
10380157|NCT00601952|11521439|FG001|NOT COMPLETED|Overall Study||0
10380158|NCT00601965|11521449|FG000|STARTED|Overall Study||18
10380159|NCT00601965|11521450|FG001|STARTED|Overall Study||18
10380160|NCT00601965|11521451|FG002|STARTED|Overall Study||19
10380161|NCT00601965|11521452|FG003|STARTED|Overall Study||18
10380162|NCT00601965|11521449|FG000|COMPLETED|Overall Study||18
10380163|NCT00601965|11521450|FG001|COMPLETED|Overall Study||16
10380164|NCT00601965|11521451|FG002|COMPLETED|Overall Study||19
10380165|NCT00601965|11521452|FG003|COMPLETED|Overall Study||17
10380166|NCT00601965|11521449|FG000|NOT COMPLETED|Overall Study||0
10380167|NCT00601965|11521450|FG001|NOT COMPLETED|Overall Study||2
10380168|NCT00601965|11521451|FG002|NOT COMPLETED|Overall Study||0
10380169|NCT00601965|11521452|FG003|NOT COMPLETED|Overall Study||1
10380170|NCT00602043|11521462|FG000|STARTED|Overall Study||20
10380171|NCT00602043|11521462|FG000|COMPLETED|Overall Study||15
10380172|NCT00602043|11521462|FG000|NOT COMPLETED|Overall Study||5
10380173|NCT00602225|11521469|FG000|STARTED|Overall Study||50
10380174|NCT00602225|11521469|FG000|COMPLETED|Overall Study||50
10380175|NCT00602225|11521469|FG000|NOT COMPLETED|Overall Study||0
10380176|NCT00602290|11521477|FG000|STARTED|Overall Study||48
10380177|NCT00602290|11521478|FG001|STARTED|Overall Study||48
10380178|NCT00602290|11521479|FG002|STARTED|Overall Study||47
10380179|NCT00602290|11521477|FG000|COMPLETED|Overall Study||46
10380180|NCT00602290|11521478|FG001|COMPLETED|Overall Study||46
10380181|NCT00602290|11521479|FG002|COMPLETED|Overall Study||46
10380182|NCT00602290|11521477|FG000|NOT COMPLETED|Overall Study||2
10380183|NCT00602290|11521478|FG001|NOT COMPLETED|Overall Study||2
10380184|NCT00602290|11521479|FG002|NOT COMPLETED|Overall Study||1
10380185|NCT00602355|11521490|FG000|STARTED|Overall Study||53
10380186|NCT00602355|11521491|FG001|STARTED|Overall Study||56
10380187|NCT00602355|11521492|FG002|STARTED|Overall Study||53
10380188|NCT00602355|11521490|FG000|COMPLETED|Overall Study||44
10380189|NCT00602355|11521491|FG001|COMPLETED|Overall Study||38
10380190|NCT00602355|11521492|FG002|COMPLETED|Overall Study||43
10380191|NCT00602355|11521490|FG000|NOT COMPLETED|Overall Study||9
10380192|NCT00602355|11521491|FG001|NOT COMPLETED|Overall Study||18
10539508|NCT01461928|11692441|FG000|COMPLETED|Induction (up to 8 Months)||494
10539509|NCT01461928|11692442|FG001|COMPLETED|Induction (up to 8 Months)||0
10539510|NCT01461928|11692443|FG002|COMPLETED|Induction (up to 8 Months)||0
10539511|NCT01461928|11692441|FG000|NOT COMPLETED|Induction (up to 8 Months)||198
10539512|NCT01461928|11692442|FG001|NOT COMPLETED|Induction (up to 8 Months)||0
10539513|NCT01461928|11692443|FG002|NOT COMPLETED|Induction (up to 8 Months)||0
10539514|NCT01461928|11692441|FG000|STARTED|Maintenance I (24 Months)||494
10380193|NCT00602355|11521492|FG002|NOT COMPLETED|Overall Study||10
10380194|NCT00602420|11521502|FG000|STARTED|Overall Study||257
10380195|NCT00602420|11521503|FG001|STARTED|Overall Study||253
10380196|NCT00602420|11521502|FG000|COMPLETED|Overall Study||232
10380197|NCT00602420|11521503|FG001|COMPLETED|Overall Study||229
10380198|NCT00602420|11521502|FG000|NOT COMPLETED|Overall Study||25
10380199|NCT00602420|11521503|FG001|NOT COMPLETED|Overall Study||24
10380200|NCT00602446|11521509|FG000|STARTED|Overall Study||3
10380201|NCT00602446|11521509|FG000|COMPLETED|Overall Study||3
10380202|NCT00602446|11521509|FG000|NOT COMPLETED|Overall Study||0
10428077|NCT00856557|11574080|FG000|Tested With Standardized Patients|Overall Study||62
10428078|NCT00856557|11574081|FG001|Tested With Standardized Patients|Overall Study||76
10428079|NCT00856557|11574080|FG000|With Patients With Contextual Flags|Overall Study||50
10428080|NCT00856557|11574081|FG001|With Patients With Contextual Flags|Overall Study||60
10380203|NCT00602472|11521515|FG000|STARTED|Overall Study|3 randomised patients never took medication.|263
10380204|NCT00602472|11521516|FG001|STARTED|Overall Study|3 randomised patients never took medication.|792
10380205|NCT00602472|11521515|FG000|COMPLETED|Overall Study|number who completed treatment|242
10380206|NCT00602472|11521516|FG001|COMPLETED|Overall Study|number who completed treatment|734
10380207|NCT00602472|11521515|FG000|NOT COMPLETED|Overall Study||21
10380208|NCT00602472|11521516|FG001|NOT COMPLETED|Overall Study||58
10380209|NCT00602537|11521524|FG000|STARTED|12 Week Double Blind Comparison||65
10380210|NCT00602537|11521525|FG001|STARTED|12 Week Double Blind Comparison||64
10380211|NCT00602537|11521524|FG000|Responded|12 Week Double Blind Comparison||44
10380212|NCT00602537|11521525|FG001|Responded|12 Week Double Blind Comparison||22
10380213|NCT00602537|11521524|FG000|COMPLETED|12 Week Double Blind Comparison||42
10380214|NCT00602537|11521525|FG001|COMPLETED|12 Week Double Blind Comparison||17
10380215|NCT00602537|11521524|FG000|NOT COMPLETED|12 Week Double Blind Comparison||23
10380216|NCT00602537|11521525|FG001|NOT COMPLETED|12 Week Double Blind Comparison||47
10380217|NCT00602537|11521524|FG000|STARTED|Follow Up Study Comparison||42
10380218|NCT00602537|11521525|FG001|STARTED|Follow Up Study Comparison||17
10380219|NCT00602537|11521524|FG000|COMPLETED|Follow Up Study Comparison||31
10380220|NCT00602537|11521525|FG001|COMPLETED|Follow Up Study Comparison||14
10380221|NCT00602537|11521524|FG000|NOT COMPLETED|Follow Up Study Comparison||11
10380222|NCT00602537|11521525|FG001|NOT COMPLETED|Follow Up Study Comparison||3
10380223|NCT00602771|11521533|FG000|STARTED|Overall Study||63
10380224|NCT00602771|11521534|FG001|STARTED|Overall Study||21
10380225|NCT00602771|11521533|FG000|COMPLETED|Overall Study||62
10380226|NCT00602771|11521534|FG001|COMPLETED|Overall Study||21
10380227|NCT00602771|11521533|FG000|NOT COMPLETED|Overall Study||1
10380228|NCT00602771|11521534|FG001|NOT COMPLETED|Overall Study||0
10380229|NCT00602797|11521540|FG000|STARTED|Overall Study||20
10380230|NCT00602797|11521540|FG000|COMPLETED|Overall Study||19
10380231|NCT00602797|11521540|FG000|NOT COMPLETED|Overall Study||1
10380232|NCT00602836|11521545|FG000|STARTED|Overall Study||44
10380233|NCT00602836|11521545|FG000|COMPLETED|Overall Study||39
10380234|NCT00602836|11521545|FG000|NOT COMPLETED|Overall Study||5
10380235|NCT00602927|11521551|FG000|STARTED|Period 1: 13 Days||19
10380236|NCT00602927|11521552|FG001|STARTED|Period 1: 13 Days||19
10380237|NCT00602927|11521551|FG000|COMPLETED|Period 1: 13 Days||15
10380238|NCT00602927|11521552|FG001|COMPLETED|Period 1: 13 Days||14
10380239|NCT00602927|11521551|FG000|NOT COMPLETED|Period 1: 13 Days||4
10380240|NCT00602927|11521552|FG001|NOT COMPLETED|Period 1: 13 Days||5
10380241|NCT00602927|11521551|FG000|STARTED|Period 2: 14 Days||15
10380242|NCT00602927|11521552|FG001|STARTED|Period 2: 14 Days||14
10380243|NCT00602927|11521551|FG000|COMPLETED|Period 2: 14 Days||15
10380244|NCT00602927|11521552|FG001|COMPLETED|Period 2: 14 Days||12
10380245|NCT00602927|11521551|FG000|NOT COMPLETED|Period 2: 14 Days||0
10380246|NCT00602927|11521552|FG001|NOT COMPLETED|Period 2: 14 Days||2
10380247|NCT00602927|11521551|FG000|STARTED|Period 3: 13 Days||15
10380248|NCT00602927|11521552|FG001|STARTED|Period 3: 13 Days||12
10380249|NCT00602927|11521551|FG000|COMPLETED|Period 3: 13 Days||13
10380250|NCT00602927|11521552|FG001|COMPLETED|Period 3: 13 Days||9
10380251|NCT00602927|11521551|FG000|NOT COMPLETED|Period 3: 13 Days||2
10380252|NCT00602927|11521552|FG001|NOT COMPLETED|Period 3: 13 Days||3
10380253|NCT00602953|11521563|FG000|STARTED|Overall Study||15
10380254|NCT00602953|11521564|FG001|STARTED|Overall Study||26
10380255|NCT00602953|11521565|FG002|STARTED|Overall Study||47
10380256|NCT00602953|11521566|FG003|STARTED|Overall Study||13
10380257|NCT00602953|11521567|FG004|STARTED|Overall Study||0
10380258|NCT00602953|11521563|FG000|COMPLETED|Overall Study||15
10380259|NCT00602953|11521564|FG001|COMPLETED|Overall Study||26
10380260|NCT00602953|11521565|FG002|COMPLETED|Overall Study||47
10380261|NCT00602953|11521566|FG003|COMPLETED|Overall Study||13
10380262|NCT00602953|11521567|FG004|COMPLETED|Overall Study||0
10380263|NCT00602953|11521563|FG000|NOT COMPLETED|Overall Study||0
10380264|NCT00602953|11521564|FG001|NOT COMPLETED|Overall Study||0
10380265|NCT00602953|11521565|FG002|NOT COMPLETED|Overall Study||0
10380266|NCT00602953|11521566|FG003|NOT COMPLETED|Overall Study||0
10380267|NCT00602953|11521567|FG004|NOT COMPLETED|Overall Study||0
10380268|NCT00602979|11521584|FG000|STARTED|Overall Study||48
10380269|NCT00602979|11521585|FG001|STARTED|Overall Study||48
10380270|NCT00602979|11521586|FG002|STARTED|Overall Study||48
10380271|NCT00602979|11521587|FG003|STARTED|Overall Study||48
10380272|NCT00602979|11521588|FG004|STARTED|Overall Study||48
10380273|NCT00602979|11521584|FG000|COMPLETED|Overall Study||45
10380274|NCT00602979|11521585|FG001|COMPLETED|Overall Study||45
10380275|NCT00602979|11521586|FG002|COMPLETED|Overall Study||45
10380276|NCT00602979|11521587|FG003|COMPLETED|Overall Study||45
10380277|NCT00602979|11521588|FG004|COMPLETED|Overall Study||45
10380278|NCT00602979|11521584|FG000|NOT COMPLETED|Overall Study||3
10380279|NCT00602979|11521585|FG001|NOT COMPLETED|Overall Study||3
10380280|NCT00602979|11521586|FG002|NOT COMPLETED|Overall Study||3
10380281|NCT00602979|11521587|FG003|NOT COMPLETED|Overall Study||3
10380282|NCT00602979|11521588|FG004|NOT COMPLETED|Overall Study||3
10380283|NCT00603018|11521600|FG000|STARTED|Overall Study||23
10380284|NCT00603018|11521600|FG000|COMPLETED|Overall Study||23
10380285|NCT00603018|11521600|FG000|NOT COMPLETED|Overall Study||0
10380286|NCT00603044|11521607|FG000|STARTED|Overall Study||11
10380287|NCT00603044|11521608|FG001|STARTED|Overall Study||13
10380288|NCT00603044|11521607|FG000|COMPLETED|Overall Study||11
10380289|NCT00603044|11521608|FG001|COMPLETED|Overall Study||13
10380290|NCT00603044|11521607|FG000|NOT COMPLETED|Overall Study||0
10380291|NCT00603044|11521608|FG001|NOT COMPLETED|Overall Study||0
10380292|NCT00603187|11521614|FG000|STARTED|Overall Study||4
10380293|NCT00603187|11521614|FG000|COMPLETED|Overall Study||4
10380294|NCT00603187|11521614|FG000|NOT COMPLETED|Overall Study||0
10380295|NCT00603239|11521620|FG000|STARTED|Overall Study||111
10380296|NCT00603239|11521621|FG001|STARTED|Overall Study||54
10380297|NCT00603239|11521620|FG000|COMPLETED|Overall Study||96
10380298|NCT00603239|11521621|FG001|COMPLETED|Overall Study||50
10380299|NCT00603239|11521620|FG000|NOT COMPLETED|Overall Study||15
10380300|NCT00603239|11521621|FG001|NOT COMPLETED|Overall Study||4
10380301|NCT00603265|11521630|FG000|STARTED|Overall Study|1 participant was randomized in error and did not receive study medication|76
10380302|NCT00603265|11521631|FG001|STARTED|Overall Study||78
10380303|NCT00603265|11521632|FG002|STARTED|Overall Study||72
10380304|NCT00603265|11521630|FG000|Received at Least 1 Dose of Study Drug|Overall Study||75
10380305|NCT00603265|11521631|FG001|Received at Least 1 Dose of Study Drug|Overall Study||78
10380306|NCT00603265|11521632|FG002|Received at Least 1 Dose of Study Drug|Overall Study||72
10380307|NCT00603265|11521630|FG000|COMPLETED|Overall Study||69
10380308|NCT00603265|11521631|FG001|COMPLETED|Overall Study||62
10380309|NCT00603265|11521632|FG002|COMPLETED|Overall Study||67
10380310|NCT00603265|11521630|FG000|NOT COMPLETED|Overall Study||7
10380311|NCT00603265|11521631|FG001|NOT COMPLETED|Overall Study||16
10380312|NCT00603265|11521632|FG002|NOT COMPLETED|Overall Study||5
10380313|NCT00603278|11521646|FG000|STARTED|Overall Study||107
10380314|NCT00603278|11521647|FG001|STARTED|Overall Study||105
10380315|NCT00603278|11521648|FG002|STARTED|Overall Study||101
10380316|NCT00603278|11521649|FG003|STARTED|Overall Study||103
10380317|NCT00603278|11521650|FG004|STARTED|Overall Study||99
10380318|NCT00603278|11521651|FG005|STARTED|Overall Study||100
10380319|NCT00603278|11521646|FG000|COMPLETED|Overall Study||66
10380320|NCT00603278|11521647|FG001|COMPLETED|Overall Study||88
10380321|NCT00603278|11521648|FG002|COMPLETED|Overall Study||87
10380322|NCT00603278|11521649|FG003|COMPLETED|Overall Study||92
10380323|NCT00603278|11521650|FG004|COMPLETED|Overall Study||86
10380324|NCT00603278|11521651|FG005|COMPLETED|Overall Study||81
10380325|NCT00603278|11521646|FG000|NOT COMPLETED|Overall Study||41
10380326|NCT00603278|11521647|FG001|NOT COMPLETED|Overall Study||17
10380327|NCT00603278|11521648|FG002|NOT COMPLETED|Overall Study||14
10380328|NCT00603278|11521649|FG003|NOT COMPLETED|Overall Study||11
10380329|NCT00603278|11521650|FG004|NOT COMPLETED|Overall Study||13
10380330|NCT00603278|11521651|FG005|NOT COMPLETED|Overall Study||19
10380331|NCT00603291|11521668|FG000|STARTED|Overall Study||95
10380332|NCT00603291|11521669|FG001|STARTED|Overall Study||256
10380333|NCT00603291|11521670|FG002|STARTED|Overall Study||253
10380334|NCT00603291|11521668|FG000|COMPLETED|Overall Study||75
10380335|NCT00603291|11521669|FG001|COMPLETED|Overall Study||169
10380336|NCT00603291|11521670|FG002|COMPLETED|Overall Study||157
10380337|NCT00603291|11521668|FG000|NOT COMPLETED|Overall Study||20
10380338|NCT00603291|11521669|FG001|NOT COMPLETED|Overall Study||87
10380339|NCT00603291|11521670|FG002|NOT COMPLETED|Overall Study||96
10380340|NCT00603304|11521680|FG000|STARTED|Overall Study||183
10380341|NCT00603304|11521681|FG001|STARTED|Overall Study||186
10380342|NCT00603304|11521680|FG000|COMPLETED|Overall Study||151
10380343|NCT00603304|11521681|FG001|COMPLETED|Overall Study||155
10380344|NCT00603304|11521680|FG000|NOT COMPLETED|Overall Study||32
10380345|NCT00603304|11521681|FG001|NOT COMPLETED|Overall Study||31
10380346|NCT00603382|11521695|FG000|STARTED|Overall Study||94
10380347|NCT00603382|11521696|FG001|STARTED|Overall Study||97
10380348|NCT00603382|11521697|FG002|STARTED|Overall Study||100
10380349|NCT00603382|11521698|FG003|STARTED|Overall Study||110
10380350|NCT00603382|11521699|FG004|STARTED|Overall Study||95
10380351|NCT00603382|11521700|FG005|STARTED|Overall Study||102
10539515|NCT01461928|11692442|FG001|STARTED|Maintenance I (24 Months)||0
10539516|NCT01461928|11692443|FG002|STARTED|Maintenance I (24 Months)||0
10539517|NCT01461928|11692441|FG000|COMPLETED|Maintenance I (24 Months)|Responders during 2 yrs Maint I treatment|276
10539518|NCT01461928|11692442|FG001|COMPLETED|Maintenance I (24 Months)||0
10539519|NCT01461928|11692443|FG002|COMPLETED|Maintenance I (24 Months)||0
10539520|NCT01461928|11692441|FG000|NOT COMPLETED|Maintenance I (24 Months)||218
10539521|NCT01461928|11692442|FG001|NOT COMPLETED|Maintenance I (24 Months)||0
10539522|NCT01461928|11692443|FG002|NOT COMPLETED|Maintenance I (24 Months)||0
10539523|NCT01461928|11692441|FG000|STARTED|Maintenance II (15 Months)||0
10539524|NCT01461928|11692442|FG001|STARTED|Maintenance II (15 Months)||138
10539525|NCT01461928|11692443|FG002|STARTED|Maintenance II (15 Months)||138
10539526|NCT01461928|11692441|FG000|COMPLETED|Maintenance II (15 Months)||0
10539527|NCT01461928|11692442|FG001|COMPLETED|Maintenance II (15 Months)|6 participants did not receive treatment|115
10539528|NCT01461928|11692443|FG002|COMPLETED|Maintenance II (15 Months)||111
10539529|NCT01461928|11692441|FG000|NOT COMPLETED|Maintenance II (15 Months)||0
10539530|NCT01461928|11692442|FG001|NOT COMPLETED|Maintenance II (15 Months)||23
10539531|NCT01461928|11692443|FG002|NOT COMPLETED|Maintenance II (15 Months)||27
10539532|NCT01461980|11692457|FG000|STARTED|Overall Study||888
10539533|NCT01461980|11692458|FG001|STARTED|Overall Study||878
10539534|NCT01461980|11692459|FG002|STARTED|Overall Study||882
10539535|NCT01461980|11692457|FG000|Vaccination 1|Overall Study||884
10539536|NCT01461980|11692458|FG001|Vaccination 1|Overall Study||870
10539537|NCT01461980|11692459|FG002|Vaccination 1|Overall Study||875
10539538|NCT01461980|11692457|FG000|Vaccination 2|Overall Study||802
10539539|NCT01461980|11692458|FG001|Vaccination 2|Overall Study||819
10539540|NCT01461980|11692459|FG002|Vaccination 2|Overall Study||799
10539541|NCT01461980|11692457|FG000|Vaccination 3|Overall Study||757
10539542|NCT01461980|11692458|FG001|Vaccination 3|Overall Study||777
10539543|NCT01461980|11692459|FG002|Vaccination 3|Overall Study||748
10539544|NCT01461980|11692457|FG000|COMPLETED|Overall Study||722
10539545|NCT01461980|11692458|FG001|COMPLETED|Overall Study||733
10539546|NCT01461980|11692459|FG002|COMPLETED|Overall Study||717
10539547|NCT01461980|11692457|FG000|NOT COMPLETED|Overall Study||166
10539548|NCT01461980|11692458|FG001|NOT COMPLETED|Overall Study||145
10539549|NCT01461980|11692459|FG002|NOT COMPLETED|Overall Study||165
10539550|NCT01461993|11692471|FG000|STARTED|Overall Study||999
10539551|NCT01461993|11692472|FG001|STARTED|Overall Study||998
10539552|NCT01461993|11692473|FG002|STARTED|Overall Study||502
10539553|NCT01461993|11692471|FG000|COMPLETED|Overall Study||848
10539554|NCT01461993|11692472|FG001|COMPLETED|Overall Study||841
10539555|NCT01461993|11692473|FG002|COMPLETED|Overall Study||438
10539556|NCT01461993|11692471|FG000|NOT COMPLETED|Overall Study||151
10539557|NCT01461993|11692472|FG001|NOT COMPLETED|Overall Study||157
10380352|NCT00603382|11521695|FG000|COMPLETED|Overall Study||76
10380353|NCT00603382|11521696|FG001|COMPLETED|Overall Study||83
10380354|NCT00603382|11521697|FG002|COMPLETED|Overall Study||91
10380355|NCT00603382|11521698|FG003|COMPLETED|Overall Study||98
10380356|NCT00603382|11521699|FG004|COMPLETED|Overall Study||86
10380357|NCT00603382|11521700|FG005|COMPLETED|Overall Study||84
10380358|NCT00603382|11521695|FG000|NOT COMPLETED|Overall Study||18
10380359|NCT00603382|11521696|FG001|NOT COMPLETED|Overall Study||14
10380360|NCT00603382|11521697|FG002|NOT COMPLETED|Overall Study||9
10380361|NCT00603382|11521698|FG003|NOT COMPLETED|Overall Study||12
10380362|NCT00603382|11521699|FG004|NOT COMPLETED|Overall Study||9
10539558|NCT01461993|11692473|FG002|NOT COMPLETED|Overall Study||64
10717806|NCT02701270|11881789|FG000|STARTED|Fourth Intervention at Visit 4||2
10539559|NCT01462045|11692485|FG000|STARTED|Overall Study||11
10539560|NCT01462045|11692486|FG001|STARTED|Overall Study||11
10539561|NCT01462045|11692487|FG002|STARTED|Overall Study||7
10539562|NCT01462045|11692485|FG000|COMPLETED|Overall Study||11
10539563|NCT01462045|11692486|FG001|COMPLETED|Overall Study||10
10539564|NCT01462045|11692487|FG002|COMPLETED|Overall Study||7
10539565|NCT01462045|11692485|FG000|NOT COMPLETED|Overall Study||0
10539566|NCT01462045|11692486|FG001|NOT COMPLETED|Overall Study||1
10539567|NCT01462045|11692487|FG002|NOT COMPLETED|Overall Study||0
10539568|NCT01462084|11692495|FG000|STARTED|Overall Study||11
10539569|NCT01462084|11692496|FG001|STARTED|Overall Study||10
10539570|NCT01462084|11692495|FG000|Included for Analysis|Overall Study||9
10539571|NCT01462084|11692496|FG001|Included for Analysis|Overall Study||9
10539572|NCT01462084|11692495|FG000|COMPLETED|Overall Study||9
10539573|NCT01462084|11692496|FG001|COMPLETED|Overall Study||9
10539574|NCT01462084|11692495|FG000|NOT COMPLETED|Overall Study||2
10539575|NCT01462084|11692496|FG001|NOT COMPLETED|Overall Study||1
10539576|NCT01462110|11692505|FG000|STARTED|Overall Study||44
10539577|NCT01462110|11692506|FG001|STARTED|Overall Study||43
10539578|NCT01462110|11692505|FG000|COMPLETED|Overall Study||43
10539579|NCT01462110|11692506|FG001|COMPLETED|Overall Study||43
10539580|NCT01462110|11692505|FG000|NOT COMPLETED|Overall Study||1
10539581|NCT01462110|11692506|FG001|NOT COMPLETED|Overall Study||0
10539582|NCT01462162|11692512|FG000|STARTED|Overall Study||120
10539583|NCT01462162|11692512|FG000|COMPLETED|Overall Study||108
10539584|NCT01462162|11692512|FG000|NOT COMPLETED|Overall Study||12
10539585|NCT01462227|11692519|FG000|STARTED|First Assignment||4
10539586|NCT01462227|11692520|FG001|STARTED|First Assignment||2
10539587|NCT01462227|11692521|FG002|STARTED|First Assignment||6
10539588|NCT01462227|11692522|FG003|STARTED|First Assignment||5
10539589|NCT01462227|11692519|FG000|COMPLETED|First Assignment||4
10539590|NCT01462227|11692520|FG001|COMPLETED|First Assignment||2
10539591|NCT01462227|11692521|FG002|COMPLETED|First Assignment||6
10539592|NCT01462227|11692522|FG003|COMPLETED|First Assignment||5
10539593|NCT01462227|11692519|FG000|NOT COMPLETED|First Assignment||0
10539594|NCT01462227|11692520|FG001|NOT COMPLETED|First Assignment||0
10539595|NCT01462227|11692521|FG002|NOT COMPLETED|First Assignment||0
10657918|NCT02229474|11819089|FG001|COMPLETED|Overall Study||15
10657919|NCT02229474|11819088|FG000|NOT COMPLETED|Overall Study||0
10657920|NCT02229474|11819089|FG001|NOT COMPLETED|Overall Study||3
10657921|NCT02229487|11819098|FG000|STARTED|Overall Study||24
10657922|NCT02229487|11819099|FG001|STARTED|Overall Study||27
10657923|NCT02229487|11819098|FG000|COMPLETED|Overall Study||24
10657924|NCT02229487|11819099|FG001|COMPLETED|Overall Study||27
10657925|NCT02229487|11819098|FG000|NOT COMPLETED|Overall Study||0
10657926|NCT02229487|11819099|FG001|NOT COMPLETED|Overall Study||0
10657927|NCT02229513|11819107|FG000|STARTED|Overall Study||100
10657928|NCT02229513|11819108|FG001|STARTED|Overall Study||100
10657929|NCT02229513|11819107|FG000|COMPLETED|Overall Study||100
10657930|NCT02229513|11819108|FG001|COMPLETED|Overall Study||100
10657931|NCT02229513|11819107|FG000|NOT COMPLETED|Overall Study||0
10657932|NCT02229513|11819108|FG001|NOT COMPLETED|Overall Study||0
10657933|NCT02229539|11819117|FG000|STARTED|Cycle 1 (Treatment Per Protocol)||77
10380363|NCT00603382|11521700|FG005|NOT COMPLETED|Overall Study||18
10380364|NCT00603408|11521714|FG000|STARTED|Overall Study||5
10539596|NCT01462227|11692522|FG003|NOT COMPLETED|First Assignment||0
10539597|NCT01462227|11692519|FG000|STARTED|Second Assignment||4
10539598|NCT01462227|11692520|FG001|STARTED|Second Assignment||2
10539599|NCT01462227|11692521|FG002|STARTED|Second Assignment||6
10539600|NCT01462227|11692522|FG003|STARTED|Second Assignment||5
10539601|NCT01462227|11692519|FG000|COMPLETED|Second Assignment||3
10539602|NCT01462227|11692520|FG001|COMPLETED|Second Assignment||1
10539603|NCT01462227|11692521|FG002|COMPLETED|Second Assignment||5
10539604|NCT01462227|11692522|FG003|COMPLETED|Second Assignment||5
10539605|NCT01462227|11692519|FG000|NOT COMPLETED|Second Assignment||1
10539606|NCT01462227|11692520|FG001|NOT COMPLETED|Second Assignment||1
10539607|NCT01462227|11692521|FG002|NOT COMPLETED|Second Assignment||1
10539608|NCT01462227|11692522|FG003|NOT COMPLETED|Second Assignment||0
10539609|NCT01462253|11692530|FG000|STARTED|Overall Study||35
10539610|NCT01462253|11692530|FG000|COMPLETED|Overall Study||27
10539611|NCT01462253|11692530|FG000|NOT COMPLETED|Overall Study||8
10539612|NCT01462266|11692536|FG000|STARTED|Overall Study||330
10539613|NCT01462266|11692537|FG001|STARTED|Overall Study||330
10380365|NCT00603408|11521714|FG000|COMPLETED|Overall Study||5
10380366|NCT00603408|11521714|FG000|NOT COMPLETED|Overall Study||0
10380367|NCT00603447|11521726|FG000|STARTED|Overall Study||6
10380368|NCT00603447|11521727|FG001|STARTED|Overall Study||6
10380369|NCT00603447|11521728|FG002|STARTED|Overall Study||8
10380370|NCT00603447|11521729|FG003|STARTED|Overall Study||6
10380371|NCT00603447|11521730|FG004|STARTED|Overall Study||6
10539614|NCT01462266|11692536|FG000|Treated|Overall Study|One participant was randomized in error and did not receive study medication.|329
10539615|NCT01462266|11692537|FG001|Treated|Overall Study|One participant was randomized in error and did not receive study medication.|329
10539616|NCT01462266|11692536|FG000|COMPLETED|Overall Study||295
10539617|NCT01462266|11692537|FG001|COMPLETED|Overall Study||303
10539618|NCT01462266|11692536|FG000|NOT COMPLETED|Overall Study||35
10539619|NCT01462266|11692537|FG001|NOT COMPLETED|Overall Study||27
10539620|NCT01462279|11692543|FG000|STARTED|Overall Study||20
10539621|NCT01462279|11692543|FG000|COMPLETED|Overall Study||17
10539622|NCT01462279|11692543|FG000|NOT COMPLETED|Overall Study||3
10539623|NCT01462292|11692550|FG000|STARTED|Overall Study||16
10539624|NCT01462292|11692551|FG001|STARTED|Overall Study||17
10539625|NCT01462292|11692552|FG002|STARTED|Overall Study||18
10539626|NCT01462292|11692550|FG000|COMPLETED|Overall Study||16
10657934|NCT02229539|11819118|FG001|STARTED|Cycle 1 (Treatment Per Protocol)||76
10657935|NCT02229539|11819119|FG002|STARTED|Cycle 1 (Treatment Per Protocol)||75
10657936|NCT02229539|11819117|FG000|COMPLETED|Cycle 1 (Treatment Per Protocol)||74
10657937|NCT02229539|11819118|FG001|COMPLETED|Cycle 1 (Treatment Per Protocol)||71
10657938|NCT02229539|11819119|FG002|COMPLETED|Cycle 1 (Treatment Per Protocol)||72
10657939|NCT02229539|11819117|FG000|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||3
10657940|NCT02229539|11819118|FG001|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||5
10657941|NCT02229539|11819119|FG002|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||3
10657942|NCT02229539|11819117|FG000|STARTED|Cycle 2 (Optional Continuation Phase)||35
10657943|NCT02229539|11819118|FG001|STARTED|Cycle 2 (Optional Continuation Phase)||36
10657944|NCT02229539|11819119|FG002|STARTED|Cycle 2 (Optional Continuation Phase)||32
10657945|NCT02229539|11819117|FG000|COMPLETED|Cycle 2 (Optional Continuation Phase)||26
10657946|NCT02229539|11819118|FG001|COMPLETED|Cycle 2 (Optional Continuation Phase)||29
10657947|NCT02229539|11819119|FG002|COMPLETED|Cycle 2 (Optional Continuation Phase)||22
10657948|NCT02229539|11819117|FG000|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||9
10657949|NCT02229539|11819118|FG001|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||7
10657950|NCT02229539|11819119|FG002|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||10
10657951|NCT02229552|11819127|FG000|STARTED|Baseline||237
10657952|NCT02229552|11819127|FG000|COMPLETED|Baseline||231
10657953|NCT02229552|11819127|FG000|NOT COMPLETED|Baseline||6
10657954|NCT02229552|11819127|FG000|STARTED|1-year Follow up||231
10657955|NCT02229552|11819127|FG000|COMPLETED|1-year Follow up||206
10657956|NCT02229552|11819127|FG000|NOT COMPLETED|1-year Follow up||25
10657957|NCT02229552|11819127|FG000|STARTED|2-Year Follow up|All baseline participants were eligible for year 2 follow up, regardless of completion of year 1.|231
10657958|NCT02229552|11819127|FG000|COMPLETED|2-Year Follow up||205
10657959|NCT02229552|11819127|FG000|NOT COMPLETED|2-Year Follow up||26
10657960|NCT02229851|11819134|FG000|STARTED|Main Phase (Double-blind Phase)||61
10657961|NCT02229851|11819135|FG001|STARTED|Main Phase (Double-blind Phase)||119
10657962|NCT02229851|11819136|FG002|STARTED|Main Phase (Double-blind Phase)||120
10657963|NCT02229851|11819137|FG003|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0
10657964|NCT02229851|11819138|FG004|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0
10657965|NCT02229851|11819139|FG005|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0
10657966|NCT02229851|11819140|FG006|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0
10657967|NCT02229851|11819134|FG000|Full Analysis Set|Main Phase (Double-blind Phase)||61
10657968|NCT02229851|11819135|FG001|Full Analysis Set|Main Phase (Double-blind Phase)||119
10657969|NCT02229851|11819136|FG002|Full Analysis Set|Main Phase (Double-blind Phase)||120
10657970|NCT02229851|11819137|FG003|Full Analysis Set|Main Phase (Double-blind Phase)||0
10657971|NCT02229851|11819138|FG004|Full Analysis Set|Main Phase (Double-blind Phase)||0
10657972|NCT02229851|11819139|FG005|Full Analysis Set|Main Phase (Double-blind Phase)||0
10657973|NCT02229851|11819140|FG006|Full Analysis Set|Main Phase (Double-blind Phase)||0
10657974|NCT02229851|11819134|FG000|Safety Analysis Set|Main Phase (Double-blind Phase)||61
10657975|NCT02229851|11819135|FG001|Safety Analysis Set|Main Phase (Double-blind Phase)||119
10657976|NCT02229851|11819136|FG002|Safety Analysis Set|Main Phase (Double-blind Phase)||120
10657977|NCT02229851|11819137|FG003|Safety Analysis Set|Main Phase (Double-blind Phase)||0
10657978|NCT02229851|11819138|FG004|Safety Analysis Set|Main Phase (Double-blind Phase)||0
10657979|NCT02229851|11819139|FG005|Safety Analysis Set|Main Phase (Double-blind Phase)||0
10717807|NCT02701270|11881790|FG001|STARTED|Fourth Intervention at Visit 4||3
10539627|NCT01462292|11692551|FG001|COMPLETED|Overall Study||17
10380372|NCT00603447|11521731|FG005|STARTED|Overall Study||8
10380373|NCT00603447|11521732|FG006|STARTED|Overall Study||44
10380374|NCT00603447|11521726|FG000|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
10380375|NCT00603447|11521727|FG001|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|3
10380376|NCT00603447|11521728|FG002|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
10380377|NCT00603447|11521729|FG003|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|4
10380378|NCT00603447|11521730|FG004|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|1
10380379|NCT00603447|11521731|FG005|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
10380380|NCT00603447|11521732|FG006|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|20
10380381|NCT00603447|11521726|FG000|NOT COMPLETED|Overall Study||0
10380382|NCT00603447|11521727|FG001|NOT COMPLETED|Overall Study||3
10380383|NCT00603447|11521728|FG002|NOT COMPLETED|Overall Study||2
10380384|NCT00603447|11521729|FG003|NOT COMPLETED|Overall Study||2
10380385|NCT00603447|11521730|FG004|NOT COMPLETED|Overall Study||5
10380386|NCT00603447|11521731|FG005|NOT COMPLETED|Overall Study||2
10380387|NCT00603447|11521732|FG006|NOT COMPLETED|Overall Study||24
10380388|NCT00603473|11521748|FG000|STARTED|Overall Study||89
10380389|NCT00603473|11521748|FG000|COMPLETED|Overall Study||80
10380390|NCT00603473|11521748|FG000|NOT COMPLETED|Overall Study||9
10380391|NCT00603512|11521757|FG000|STARTED|Overall Study||28
10380392|NCT00603512|11521758|FG001|STARTED|Overall Study||28
10380393|NCT00603512|11521759|FG002|STARTED|Overall Study||28
10380394|NCT00603512|11521760|FG003|STARTED|Overall Study||28
10380395|NCT00603512|11521761|FG004|STARTED|Overall Study||28
10380396|NCT00603512|11521757|FG000|Treated|Overall Study||28
10380397|NCT00603512|11521758|FG001|Treated|Overall Study||27
10380398|NCT00603512|11521759|FG002|Treated|Overall Study||27
10380399|NCT00603512|11521760|FG003|Treated|Overall Study||26
10380400|NCT00603512|11521761|FG004|Treated|Overall Study||28
10380401|NCT00603512|11521757|FG000|COMPLETED|Overall Study||26
10380402|NCT00603512|11521758|FG001|COMPLETED|Overall Study||23
10380403|NCT00603512|11521759|FG002|COMPLETED|Overall Study||23
10380404|NCT00603512|11521760|FG003|COMPLETED|Overall Study||21
10380405|NCT00603512|11521761|FG004|COMPLETED|Overall Study||23
10380406|NCT00603512|11521757|FG000|NOT COMPLETED|Overall Study||2
10380407|NCT00603512|11521758|FG001|NOT COMPLETED|Overall Study||5
10380408|NCT00603512|11521759|FG002|NOT COMPLETED|Overall Study||5
10380409|NCT00603512|11521760|FG003|NOT COMPLETED|Overall Study||7
10380410|NCT00603512|11521761|FG004|NOT COMPLETED|Overall Study||5
10380411|NCT00603525|11521775|FG000|STARTED|DB Treatment Period (24 Weeks)||84
10380412|NCT00603525|11521776|FG001|STARTED|DB Treatment Period (24 Weeks)||85
10380413|NCT00603525|11521777|FG002|STARTED|DB Treatment Period (24 Weeks)||0
10380414|NCT00603525|11521775|FG000|COMPLETED|DB Treatment Period (24 Weeks)||67
10380415|NCT00603525|11521776|FG001|COMPLETED|DB Treatment Period (24 Weeks)||63
10380416|NCT00603525|11521777|FG002|COMPLETED|DB Treatment Period (24 Weeks)||0
10380417|NCT00603525|11521775|FG000|NOT COMPLETED|DB Treatment Period (24 Weeks)||17
10380418|NCT00603525|11521776|FG001|NOT COMPLETED|DB Treatment Period (24 Weeks)||22
10380419|NCT00603525|11521777|FG002|NOT COMPLETED|DB Treatment Period (24 Weeks)||0
10380420|NCT00603525|11521775|FG000|STARTED|OL Treatment Period (120 Weeks)||0
10380421|NCT00603525|11521776|FG001|STARTED|OL Treatment Period (120 Weeks)|61 participants received OFA during the DB Period; 64 received placebo during the DB Period.|125
10380422|NCT00603525|11521777|FG002|STARTED|OL Treatment Period (120 Weeks)||0
10380423|NCT00603525|11521775|FG000|COMPLETED|OL Treatment Period (120 Weeks)||0
10380424|NCT00603525|11521776|FG001|COMPLETED|OL Treatment Period (120 Weeks)||13
10380425|NCT00603525|11521777|FG002|COMPLETED|OL Treatment Period (120 Weeks)||0
10380426|NCT00603525|11521775|FG000|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
10380427|NCT00603525|11521776|FG001|NOT COMPLETED|OL Treatment Period (120 Weeks)||112
10717808|NCT02701270|11881791|FG002|STARTED|Fourth Intervention at Visit 4||3
10717809|NCT02701270|11881792|FG003|STARTED|Fourth Intervention at Visit 4||3
10380428|NCT00603525|11521777|FG002|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
10380429|NCT00603525|11521775|FG000|STARTED|Follow-up Period (Approximately 2 Years)||0
10539628|NCT01462292|11692552|FG002|COMPLETED|Overall Study||18
10539629|NCT01462292|11692550|FG000|NOT COMPLETED|Overall Study||0
10539630|NCT01462292|11692551|FG001|NOT COMPLETED|Overall Study||0
10539631|NCT01462292|11692552|FG002|NOT COMPLETED|Overall Study||0
10539632|NCT01462305|11692565|FG000|STARTED|Overall Study||18
10539633|NCT01462305|11692566|FG001|STARTED|Overall Study||17
10539634|NCT01462305|11692565|FG000|COMPLETED|Overall Study||16
10717810|NCT02701270|11881789|FG000|COMPLETED|Fourth Intervention at Visit 4||2
10717811|NCT02701270|11881790|FG001|COMPLETED|Fourth Intervention at Visit 4||3
10380430|NCT00603525|11521776|FG001|STARTED|Follow-up Period (Approximately 2 Years)||0
10380431|NCT00603525|11521777|FG002|STARTED|Follow-up Period (Approximately 2 Years)|124 participants (par) completing/withdrawing from the DB or OL Periods attended >=1 follow-up visit|124
10380432|NCT00603525|11521775|FG000|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)||0
10380500|NCT00603733|11521855|FG001|NOT COMPLETED|Run-In Phase - 4 Weeks||13
10380433|NCT00603525|11521776|FG001|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)||0
10380434|NCT00603525|11521777|FG002|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)|As par. were not on active drug during the Follow-up Period, withdrawal reasons were not collected.|111
10380435|NCT00603525|11521775|FG000|COMPLETED|Follow-up Period (Approximately 2 Years)||0
10380436|NCT00603525|11521776|FG001|COMPLETED|Follow-up Period (Approximately 2 Years)||0
10380437|NCT00603525|11521777|FG002|COMPLETED|Follow-up Period (Approximately 2 Years)||13
10380438|NCT00603525|11521775|FG000|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
10380439|NCT00603525|11521776|FG001|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
10380440|NCT00603525|11521777|FG002|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||111
10380441|NCT00603538|11521791|FG000|STARTED|Overall Study||6
10380442|NCT00603538|11521792|FG001|STARTED|Overall Study|Including one participant who discontinued from the study prior to CP-751,871 administration.|7
10380443|NCT00603538|11521793|FG002|STARTED|Overall Study||6
10380444|NCT00603538|11521791|FG000|COMPLETED|Overall Study||3
10380445|NCT00603538|11521792|FG001|COMPLETED|Overall Study||3
10380446|NCT00603538|11521793|FG002|COMPLETED|Overall Study||4
10380447|NCT00603538|11521791|FG000|NOT COMPLETED|Overall Study||3
10380448|NCT00603538|11521792|FG001|NOT COMPLETED|Overall Study||4
10380449|NCT00603538|11521793|FG002|NOT COMPLETED|Overall Study||2
10380450|NCT00603564|11521806|FG000|STARTED|Overall Study|January 2006|20
10380451|NCT00603564|11521807|FG001|STARTED|Overall Study|January 2006|27
10380452|NCT00603564|11521806|FG000|COMPLETED|Overall Study|February 2008|20
10380453|NCT00603564|11521807|FG001|COMPLETED|Overall Study|February 2008|27
10380454|NCT00603564|11521806|FG000|NOT COMPLETED|Overall Study||0
10380455|NCT00603564|11521807|FG001|NOT COMPLETED|Overall Study||0
10380456|NCT00603590|11521815|FG000|STARTED|Overall Study||241
10380457|NCT00603590|11521816|FG001|STARTED|Overall Study||234
10380458|NCT00603590|11521815|FG000|One Month|Overall Study||204
10380459|NCT00603590|11521816|FG001|One Month|Overall Study||212
10380460|NCT00603590|11521815|FG000|Four Months|Overall Study||187
10380461|NCT00603590|11521816|FG001|Four Months|Overall Study||200
10380462|NCT00603590|11521815|FG000|Eight Months|Overall Study||178
10380463|NCT00603590|11521816|FG001|Eight Months|Overall Study||194
10380464|NCT00603590|11521815|FG000|COMPLETED|Overall Study||165
10380465|NCT00603590|11521816|FG001|COMPLETED|Overall Study||183
10380466|NCT00603590|11521815|FG000|NOT COMPLETED|Overall Study||76
10380467|NCT00603590|11521816|FG001|NOT COMPLETED|Overall Study||51
10380468|NCT00603642|11521824|FG000|STARTED|Overall Study||12
10380469|NCT00603642|11521825|FG001|STARTED|Overall Study||22
10380470|NCT00603642|11521824|FG000|COMPLETED|Overall Study||12
10380471|NCT00603642|11521825|FG001|COMPLETED|Overall Study||22
10380472|NCT00603642|11521824|FG000|NOT COMPLETED|Overall Study||0
10380473|NCT00603642|11521825|FG001|NOT COMPLETED|Overall Study||0
10380474|NCT00603720|11521836|FG000|STARTED|Overall Study||10
10539635|NCT01462305|11692566|FG001|COMPLETED|Overall Study||13
10539636|NCT01462305|11692565|FG000|NOT COMPLETED|Overall Study||2
10539637|NCT01462305|11692566|FG001|NOT COMPLETED|Overall Study||4
10539638|NCT01462318|11692574|FG000|STARTED|Main Study / TP-DI Study||113
10539639|NCT01462318|11692575|FG001|STARTED|Main Study / TP-DI Study||20
10539640|NCT01462318|11692576|FG002|STARTED|Main Study / TP-DI Study||0
10539641|NCT01462318|11692574|FG000|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||26
10539642|NCT01462318|11692575|FG001|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||0
10539643|NCT01462318|11692576|FG002|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||0
10539644|NCT01462318|11692574|FG000|COMPLETED|Main Study / TP-DI Study||105
10539645|NCT01462318|11692575|FG001|COMPLETED|Main Study / TP-DI Study||20
10539646|NCT01462318|11692576|FG002|COMPLETED|Main Study / TP-DI Study||0
10539647|NCT01462318|11692574|FG000|NOT COMPLETED|Main Study / TP-DI Study||8
10539648|NCT01462318|11692575|FG001|NOT COMPLETED|Main Study / TP-DI Study||0
10539649|NCT01462318|11692576|FG002|NOT COMPLETED|Main Study / TP-DI Study||0
10380475|NCT00603720|11521837|FG001|STARTED|Overall Study||10
10380476|NCT00603720|11521838|FG002|STARTED|Overall Study||12
10380477|NCT00603720|11521839|FG003|STARTED|Overall Study||10
10380478|NCT00603720|11521840|FG004|STARTED|Overall Study||12
10380479|NCT00603720|11521836|FG000|COMPLETED|Overall Study||10
10380480|NCT00603720|11521837|FG001|COMPLETED|Overall Study||10
10380481|NCT00603720|11521838|FG002|COMPLETED|Overall Study||12
10380482|NCT00603720|11521839|FG003|COMPLETED|Overall Study||10
10380483|NCT00603720|11521840|FG004|COMPLETED|Overall Study||12
10380484|NCT00603720|11521836|FG000|NOT COMPLETED|Overall Study||0
10380485|NCT00603720|11521837|FG001|NOT COMPLETED|Overall Study||0
10380486|NCT00603720|11521838|FG002|NOT COMPLETED|Overall Study||0
10380487|NCT00603720|11521839|FG003|NOT COMPLETED|Overall Study||0
10380488|NCT00603720|11521840|FG004|NOT COMPLETED|Overall Study||0
10380489|NCT00603733|11521854|FG000|STARTED|Active Phase ITT|Note: a total of 190 new participants were enrolled and randomized in the Active Phase|95
10380490|NCT00603733|11521855|FG001|STARTED|Active Phase ITT||95
10380491|NCT00603733|11521854|FG000|COMPLETED|Active Phase ITT||84
10380492|NCT00603733|11521855|FG001|COMPLETED|Active Phase ITT||78
10380493|NCT00603733|11521854|FG000|NOT COMPLETED|Active Phase ITT||11
10380494|NCT00603733|11521855|FG001|NOT COMPLETED|Active Phase ITT||17
10548152|NCT01517412|11701949|FG000|STARTED|Overall Study||225
10380495|NCT00603733|11521854|FG000|STARTED|Run-In Phase - 4 Weeks|Note: Of the 98 subjects randomized at Run-In, 71 progressed into the maintenance phase.|49
10380496|NCT00603733|11521855|FG001|STARTED|Run-In Phase - 4 Weeks||49
10380497|NCT00603733|11521854|FG000|COMPLETED|Run-In Phase - 4 Weeks||35
10380498|NCT00603733|11521855|FG001|COMPLETED|Run-In Phase - 4 Weeks||36
10380499|NCT00603733|11521854|FG000|NOT COMPLETED|Run-In Phase - 4 Weeks||14
10380501|NCT00603733|11521854|FG000|STARTED|Maintenance Phase ITT|Note:82 subjects randomized at Active phase & 71 at Run-In phase progressed to the maintenance phase|71
10380502|NCT00603733|11521855|FG001|STARTED|Maintenance Phase ITT||82
10380503|NCT00603733|11521854|FG000|COMPLETED|Maintenance Phase ITT||61
10380504|NCT00603733|11521855|FG001|COMPLETED|Maintenance Phase ITT||66
10380505|NCT00603733|11521854|FG000|NOT COMPLETED|Maintenance Phase ITT||10
10380506|NCT00603733|11521855|FG001|NOT COMPLETED|Maintenance Phase ITT||16
10380507|NCT00603746|11521867|FG000|STARTED|Overall Study||103
10380508|NCT00603746|11521868|FG001|STARTED|Overall Study||99
10380509|NCT00603746|11521869|FG002|STARTED|Overall Study||101
10657980|NCT02229851|11819140|FG006|Safety Analysis Set|Main Phase (Double-blind Phase)||0
10657981|NCT02229851|11819134|FG000|COMPLETED|Main Phase (Double-blind Phase)||55
10657982|NCT02229851|11819135|FG001|COMPLETED|Main Phase (Double-blind Phase)||103
10657983|NCT02229851|11819136|FG002|COMPLETED|Main Phase (Double-blind Phase)||114
10657984|NCT02229851|11819137|FG003|COMPLETED|Main Phase (Double-blind Phase)||0
10657985|NCT02229851|11819138|FG004|COMPLETED|Main Phase (Double-blind Phase)||0
10657986|NCT02229851|11819139|FG005|COMPLETED|Main Phase (Double-blind Phase)||0
10657987|NCT02229851|11819140|FG006|COMPLETED|Main Phase (Double-blind Phase)||0
10657988|NCT02229851|11819134|FG000|NOT COMPLETED|Main Phase (Double-blind Phase)||6
10657989|NCT02229851|11819135|FG001|NOT COMPLETED|Main Phase (Double-blind Phase)||16
10657990|NCT02229851|11819136|FG002|NOT COMPLETED|Main Phase (Double-blind Phase)||6
10657991|NCT02229851|11819137|FG003|NOT COMPLETED|Main Phase (Double-blind Phase)||0
10657992|NCT02229851|11819138|FG004|NOT COMPLETED|Main Phase (Double-blind Phase)||0
10306803|NCT00101582|11439684|FG000|COMPLETED|Overall Study|Participants who completed the acute oral mucositis evaluation phase|83
10306804|NCT00101582|11439685|FG001|COMPLETED|Overall Study|Participants who completed the acute oral mucositis evaluation phase|79
10306805|NCT00101582|11439684|FG000|NOT COMPLETED|Overall Study||11
10306806|NCT00101582|11439685|FG001|NOT COMPLETED|Overall Study||15
10306807|NCT00101647|11439693|FG000|STARTED|Overall Study|Randomized|13
10306808|NCT00101647|11439694|FG001|STARTED|Overall Study|Randomized|161
10306809|NCT00101647|11439693|FG000|COMPLETED|Overall Study||13
10306810|NCT00101647|11439694|FG001|COMPLETED|Overall Study||161
10306811|NCT00101647|11439693|FG000|NOT COMPLETED|Overall Study||0
10306812|NCT00101647|11439694|FG001|NOT COMPLETED|Overall Study||0
10306813|NCT00101660|11439712|FG000|STARTED|Overall Study||99
10306814|NCT00101660|11439713|FG001|STARTED|Overall Study||288
10306815|NCT00101660|11439712|FG000|COMPLETED|Overall Study||99
10306816|NCT00101660|11439713|FG001|COMPLETED|Overall Study||288
10306817|NCT00101660|11439712|FG000|NOT COMPLETED|Overall Study||0
10306818|NCT00101660|11439713|FG001|NOT COMPLETED|Overall Study||0
10306819|NCT00101686|11439735|FG000|STARTED|Overall Study||71
10306820|NCT00101686|11439736|FG001|STARTED|Overall Study||73
10306821|NCT00101686|11439737|FG002|STARTED|Overall Study||69
10306822|NCT00101686|11439738|FG003|STARTED|Overall Study||72
10306823|NCT00101686|11439739|FG004|STARTED|Overall Study||73
10306824|NCT00101686|11439740|FG005|STARTED|Overall Study||72
10306825|NCT00101686|11439741|FG006|STARTED|Overall Study||27
10306826|NCT00101686|11439742|FG007|STARTED|Overall Study||30
10306827|NCT00101686|11439743|FG008|STARTED|Overall Study||30
10306828|NCT00101686|11439744|FG009|STARTED|Overall Study||30
10306829|NCT00101686|11439735|FG000|Received Treatment|Overall Study||70
10306830|NCT00101686|11439736|FG001|Received Treatment|Overall Study||67
10306831|NCT00101686|11439737|FG002|Received Treatment|Overall Study||67
10306832|NCT00101686|11439738|FG003|Received Treatment|Overall Study||70
10306833|NCT00101686|11439739|FG004|Received Treatment|Overall Study||71
10306834|NCT00101686|11439740|FG005|Received Treatment|Overall Study||70
10306835|NCT00101686|11439741|FG006|Received Treatment|Overall Study||27
10306836|NCT00101686|11439742|FG007|Received Treatment|Overall Study||29
10306837|NCT00101686|11439743|FG008|Received Treatment|Overall Study||30
10306838|NCT00101686|11439744|FG009|Received Treatment|Overall Study||29
10306839|NCT00101686|11439735|FG000|COMPLETED|Overall Study|Patients treated until disease progression.|0
10306840|NCT00101686|11439736|FG001|COMPLETED|Overall Study|Patients treated until disease progression.|0
10380510|NCT00603746|11521870|FG003|STARTED|Overall Study||107
10380511|NCT00603746|11521871|FG004|STARTED|Overall Study||102
10380512|NCT00603746|11521872|FG005|STARTED|Overall Study||110
10380513|NCT00603746|11521867|FG000|COMPLETED|Overall Study||65
10380514|NCT00603746|11521868|FG001|COMPLETED|Overall Study||81
10380515|NCT00603746|11521869|FG002|COMPLETED|Overall Study||93
10380516|NCT00603746|11521870|FG003|COMPLETED|Overall Study||94
10380517|NCT00603746|11521871|FG004|COMPLETED|Overall Study||85
10380518|NCT00603746|11521872|FG005|COMPLETED|Overall Study||97
10380519|NCT00603746|11521867|FG000|NOT COMPLETED|Overall Study||38
10380520|NCT00603746|11521868|FG001|NOT COMPLETED|Overall Study||18
10380521|NCT00603746|11521869|FG002|NOT COMPLETED|Overall Study||8
10380522|NCT00603746|11521870|FG003|NOT COMPLETED|Overall Study||13
10380523|NCT00603746|11521871|FG004|NOT COMPLETED|Overall Study||17
10380524|NCT00603746|11521872|FG005|NOT COMPLETED|Overall Study||13
10380525|NCT00603798|11521889|FG000|STARTED|Overall Study||162
10380526|NCT00603798|11521890|FG001|STARTED|Overall Study||164
10380527|NCT00603798|11521891|FG002|STARTED|Overall Study||164
10380528|NCT00603798|11521889|FG000|COMPLETED|Overall Study||152
10380529|NCT00603798|11521890|FG001|COMPLETED|Overall Study||157
10380530|NCT00603798|11521891|FG002|COMPLETED|Overall Study||154
10380531|NCT00603798|11521889|FG000|NOT COMPLETED|Overall Study||10
10380532|NCT00603798|11521890|FG001|NOT COMPLETED|Overall Study||7
10380533|NCT00603798|11521891|FG002|NOT COMPLETED|Overall Study||10
10380534|NCT00603837|11521901|FG000|STARTED|Overall Study||20
10380535|NCT00603837|11521902|FG001|STARTED|Overall Study||19
10380536|NCT00603837|11521901|FG000|COMPLETED|Overall Study||17
10380537|NCT00603837|11521902|FG001|COMPLETED|Overall Study||19
10380538|NCT00603837|11521901|FG000|NOT COMPLETED|Overall Study||3
10380539|NCT00603837|11521902|FG001|NOT COMPLETED|Overall Study||0
10380540|NCT00603889|11521908|FG000|STARTED|Overall Study||12
10380541|NCT00603889|11521908|FG000|COMPLETED|Overall Study||12
10380542|NCT00603889|11521908|FG000|NOT COMPLETED|Overall Study||0
10380543|NCT00603902|11521915|FG000|STARTED|Overall Study||802
10380544|NCT00603902|11521916|FG001|STARTED|Overall Study||1603
10380545|NCT00603902|11521917|FG002|STARTED|Overall Study||1603
10380546|NCT00603902|11521915|FG000|COMPLETED|Overall Study||473
10380547|NCT00603902|11521916|FG001|COMPLETED|Overall Study||917
10380548|NCT00603902|11521917|FG002|COMPLETED|Overall Study||834
10380549|NCT00603902|11521915|FG000|NOT COMPLETED|Overall Study||329
10380550|NCT00603902|11521916|FG001|NOT COMPLETED|Overall Study||686
10380551|NCT00603902|11521917|FG002|NOT COMPLETED|Overall Study||769
10380552|NCT00603915|11521925|FG000|STARTED|Overall Study||20
10380553|NCT00603915|11521925|FG000|COMPLETED|Overall Study||19
10380554|NCT00603915|11521925|FG000|NOT COMPLETED|Overall Study||1
10380555|NCT00603941|11521932|FG000|STARTED|Overall Study||7
10380556|NCT00603941|11521933|FG001|STARTED|Overall Study||10
10380557|NCT00603941|11521934|FG002|STARTED|Overall Study||2
10380558|NCT00603941|11521932|FG000|COMPLETED|Overall Study||0
10380559|NCT00603941|11521933|FG001|COMPLETED|Overall Study||0
10380560|NCT00603941|11521934|FG002|COMPLETED|Overall Study||0
10380561|NCT00603941|11521932|FG000|NOT COMPLETED|Overall Study||7
10380562|NCT00603941|11521933|FG001|NOT COMPLETED|Overall Study||10
10380563|NCT00603941|11521934|FG002|NOT COMPLETED|Overall Study||2
10380564|NCT00603980|11521943|FG000|STARTED|Study Qualification||31
10380565|NCT00603980|11521943|FG000|COMPLETED|Study Qualification||15
10380566|NCT00603980|11521943|FG000|NOT COMPLETED|Study Qualification||16
10380567|NCT00603980|11521943|FG000|STARTED|Main Study||15
10380568|NCT00603980|11521943|FG000|COMPLETED|Main Study||14
10380569|NCT00603980|11521943|FG000|NOT COMPLETED|Main Study||1
10380570|NCT00603993|11521963|FG000|STARTED|Overall Study||88
10380571|NCT00603993|11521963|FG000|COMPLETED|Overall Study||68
10380572|NCT00603993|11521963|FG000|NOT COMPLETED|Overall Study||20
10380573|NCT00604019|11521969|FG000|STARTED|Overall Study||134
10380574|NCT00604019|11521970|FG001|STARTED|Overall Study||118
10380575|NCT00604019|11521969|FG000|COMPLETED|Overall Study||134
10380576|NCT00604019|11521970|FG001|COMPLETED|Overall Study||118
10717812|NCT02701270|11881791|FG002|COMPLETED|Fourth Intervention at Visit 4||3
10717813|NCT02701270|11881792|FG003|COMPLETED|Fourth Intervention at Visit 4||3
10717814|NCT02701270|11881789|FG000|NOT COMPLETED|Fourth Intervention at Visit 4||0
10717815|NCT02701270|11881790|FG001|NOT COMPLETED|Fourth Intervention at Visit 4||0
10380577|NCT00604019|11521969|FG000|NOT COMPLETED|Overall Study||0
10380578|NCT00604019|11521970|FG001|NOT COMPLETED|Overall Study||0
10380579|NCT00604045|11521978|FG000|STARTED|Overall Study||15
10380580|NCT00604045|11521979|FG001|STARTED|Overall Study||10
10380581|NCT00604045|11521978|FG000|COMPLETED|Overall Study||14
10380582|NCT00604045|11521979|FG001|COMPLETED|Overall Study||9
10539650|NCT01462318|11692574|FG000|STARTED|Extension Phase|95 participants from the Main Study entered the Extension Phase|0
10539651|NCT01462318|11692575|FG001|STARTED|Extension Phase|20 participants from the TP-DI Study entered the Extension Phase|0
10717816|NCT02701270|11881791|FG002|NOT COMPLETED|Fourth Intervention at Visit 4||0
10380583|NCT00604045|11521978|FG000|NOT COMPLETED|Overall Study||1
10380584|NCT00604045|11521979|FG001|NOT COMPLETED|Overall Study||1
10380585|NCT00604162|11521985|FG000|STARTED|Overall Study||332
10380586|NCT00604162|11521985|FG000|COMPLETED|Overall Study||328
10380587|NCT00604162|11521985|FG000|NOT COMPLETED|Overall Study||4
10380588|NCT00604175|11521995|FG000|STARTED|Entry Through Week 28||130
10380589|NCT00604175|11521996|FG001|STARTED|Entry Through Week 28||95
10380590|NCT00604175|11521997|FG002|STARTED|Entry Through Week 28||94
10380591|NCT00604175|11521995|FG000|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|120
10539652|NCT01462318|11692576|FG002|STARTED|Extension Phase|10 participants from the Main Study did not enter the Extension Phase.|115
10539653|NCT01462318|11692574|FG000|COMPLETED|Extension Phase||0
10539654|NCT01462318|11692575|FG001|COMPLETED|Extension Phase||0
10539655|NCT01462318|11692576|FG002|COMPLETED|Extension Phase||70
10539656|NCT01462318|11692574|FG000|NOT COMPLETED|Extension Phase||0
10539657|NCT01462318|11692575|FG001|NOT COMPLETED|Extension Phase||0
10539658|NCT01462318|11692576|FG002|NOT COMPLETED|Extension Phase||45
10539659|NCT01462344|11692583|FG000|STARTED|Overall Study||3107
10539660|NCT01462344|11692584|FG001|STARTED|Overall Study||3101
10539661|NCT01462344|11692583|FG000|COMPLETED|Overall Study||2724
10539662|NCT01462344|11692584|FG001|COMPLETED|Overall Study||2751
10539663|NCT01462344|11692583|FG000|NOT COMPLETED|Overall Study||383
10539664|NCT01462344|11692584|FG001|NOT COMPLETED|Overall Study||350
10539665|NCT01462357|11692593|FG000|STARTED|Overall Study||359
10539666|NCT01462357|11692594|FG001|STARTED|Overall Study||358
10539667|NCT01462357|11692595|FG002|STARTED|Overall Study||358
10539668|NCT01462357|11692593|FG000|COMPLETED|Overall Study||351
10539669|NCT01462357|11692594|FG001|COMPLETED|Overall Study||339
10539670|NCT01462357|11692595|FG002|COMPLETED|Overall Study||346
10539671|NCT01462357|11692593|FG000|NOT COMPLETED|Overall Study||8
10539672|NCT01462357|11692594|FG001|NOT COMPLETED|Overall Study||19
10657993|NCT02229851|11819139|FG005|NOT COMPLETED|Main Phase (Double-blind Phase)||0
10657994|NCT02229851|11819140|FG006|NOT COMPLETED|Main Phase (Double-blind Phase)||0
10657995|NCT02229851|11819134|FG000|STARTED|Extension Phase (Open-label Phase)|This arm is not applicable for the Extension phase.|0
10657996|NCT02229851|11819135|FG001|STARTED|Extension Phase (Open-label Phase)|This arm is not applicable for the Extension phase.|0
10657997|NCT02229851|11819136|FG002|STARTED|Extension Phase (Open-label Phase)|This arm is not applicable for the Extension phase.|0
10657998|NCT02229851|11819137|FG003|STARTED|Extension Phase (Open-label Phase)||55
10657999|NCT02229851|11819138|FG004|STARTED|Extension Phase (Open-label Phase)||114
10658000|NCT02229851|11819139|FG005|STARTED|Extension Phase (Open-label Phase)||52
10658001|NCT02229851|11819140|FG006|STARTED|Extension Phase (Open-label Phase)||51
10658002|NCT02229851|11819134|FG000|COMPLETED|Extension Phase (Open-label Phase)||0
10658003|NCT02229851|11819135|FG001|COMPLETED|Extension Phase (Open-label Phase)||0
10658004|NCT02229851|11819136|FG002|COMPLETED|Extension Phase (Open-label Phase)||0
10658005|NCT02229851|11819137|FG003|COMPLETED|Extension Phase (Open-label Phase)||53
10658006|NCT02229851|11819138|FG004|COMPLETED|Extension Phase (Open-label Phase)||109
10658007|NCT02229851|11819139|FG005|COMPLETED|Extension Phase (Open-label Phase)||47
10658008|NCT02229851|11819140|FG006|COMPLETED|Extension Phase (Open-label Phase)||48
10658009|NCT02229851|11819134|FG000|NOT COMPLETED|Extension Phase (Open-label Phase)||0
10658010|NCT02229851|11819135|FG001|NOT COMPLETED|Extension Phase (Open-label Phase)||0
10658011|NCT02229851|11819136|FG002|NOT COMPLETED|Extension Phase (Open-label Phase)||0
10658012|NCT02229851|11819137|FG003|NOT COMPLETED|Extension Phase (Open-label Phase)||2
10658013|NCT02229851|11819138|FG004|NOT COMPLETED|Extension Phase (Open-label Phase)||5
10658014|NCT02229851|11819139|FG005|NOT COMPLETED|Extension Phase (Open-label Phase)||5
10658015|NCT02229851|11819140|FG006|NOT COMPLETED|Extension Phase (Open-label Phase)||3
10658016|NCT02229864|11819155|FG000|STARTED|Overall Study||12
10658017|NCT02229864|11819155|FG000|COMPLETED|Overall Study||9
10658018|NCT02229864|11819155|FG000|NOT COMPLETED|Overall Study||3
10658019|NCT02230085|11819159|FG000|STARTED|Overall Study||110
10658020|NCT02230085|11819159|FG000|COMPLETED|Overall Study||106
10658021|NCT02230085|11819159|FG000|NOT COMPLETED|Overall Study||4
10658022|NCT02230306|11819163|FG000|STARTED|Overall Study||5
10658023|NCT02230306|11819163|FG000|COMPLETED|Overall Study||4
10658024|NCT02230306|11819163|FG000|NOT COMPLETED|Overall Study||1
10658025|NCT02230332|11819169|FG000|STARTED|Overall Study||38
10658026|NCT02230332|11819170|FG001|STARTED|Overall Study||40
10658027|NCT02230332|11819169|FG000|COMPLETED|Overall Study||34
10658028|NCT02230332|11819170|FG001|COMPLETED|Overall Study||39
10658029|NCT02230332|11819169|FG000|NOT COMPLETED|Overall Study||4
10658030|NCT02230332|11819170|FG001|NOT COMPLETED|Overall Study||1
10658031|NCT02230384|11819178|FG000|STARTED|Phase 1||30
10658032|NCT02230384|11819179|FG001|STARTED|Phase 1||32
10658033|NCT02230384|11819178|FG000|COMPLETED|Phase 1||29
10658034|NCT02230384|11819179|FG001|COMPLETED|Phase 1||31
10658035|NCT02230384|11819178|FG000|NOT COMPLETED|Phase 1||1
10658036|NCT02230384|11819179|FG001|NOT COMPLETED|Phase 1||1
10315305|NCT00176917|11449134|FG000|STARTED|Overall Study||41
10315306|NCT00176917|11449134|FG000|COMPLETED|Overall Study||41
10315307|NCT00176917|11449134|FG000|NOT COMPLETED|Overall Study||0
10315308|NCT00176930|11449146|FG000|STARTED|Overall Study||12
10315309|NCT00176930|11449147|FG001|STARTED|Overall Study||13
10315310|NCT00176930|11449148|FG002|STARTED|Overall Study||1
10315311|NCT00176930|11449149|FG003|STARTED|Overall Study||1
10315312|NCT00176930|11449150|FG004|STARTED|Overall Study||213
10315313|NCT00176930|11449151|FG005|STARTED|Overall Study||85
10315314|NCT00176930|11449152|FG006|STARTED|Overall Study||2
10315315|NCT00176930|11449153|FG007|STARTED|Overall Study||2
10315316|NCT00176930|11449146|FG000|COMPLETED|Overall Study||12
10315317|NCT00176930|11449147|FG001|COMPLETED|Overall Study||13
10315318|NCT00176930|11449148|FG002|COMPLETED|Overall Study||1
10315319|NCT00176930|11449149|FG003|COMPLETED|Overall Study||1
10315320|NCT00176930|11449150|FG004|COMPLETED|Overall Study||213
10315321|NCT00176930|11449151|FG005|COMPLETED|Overall Study||85
10315322|NCT00176930|11449152|FG006|COMPLETED|Overall Study||2
10315323|NCT00176930|11449153|FG007|COMPLETED|Overall Study||2
10315324|NCT00176930|11449146|FG000|NOT COMPLETED|Overall Study||0
10315325|NCT00176930|11449147|FG001|NOT COMPLETED|Overall Study||0
10380592|NCT00604175|11521996|FG001|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|92
10380593|NCT00604175|11521997|FG002|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|93
10380594|NCT00604175|11521995|FG000|NOT COMPLETED|Entry Through Week 28||10
10380595|NCT00604175|11521996|FG001|NOT COMPLETED|Entry Through Week 28||3
10380596|NCT00604175|11521997|FG002|NOT COMPLETED|Entry Through Week 28||1
10380597|NCT00604175|11521995|FG000|STARTED|Week 29 Through Week 72||120
10380598|NCT00604175|11521996|FG001|STARTED|Week 29 Through Week 72||92
10380599|NCT00604175|11521997|FG002|STARTED|Week 29 Through Week 72||93
10380600|NCT00604175|11521995|FG000|COMPLETED|Week 29 Through Week 72||108
10380601|NCT00604175|11521996|FG001|COMPLETED|Week 29 Through Week 72||85
10380602|NCT00604175|11521997|FG002|COMPLETED|Week 29 Through Week 72||89
10380603|NCT00604175|11521995|FG000|NOT COMPLETED|Week 29 Through Week 72||12
10380604|NCT00604175|11521996|FG001|NOT COMPLETED|Week 29 Through Week 72||7
10380605|NCT00604175|11521997|FG002|NOT COMPLETED|Week 29 Through Week 72||4
10380606|NCT00604188|11522031|FG000|STARTED|Overall Study||93
10380607|NCT00604188|11522032|FG001|STARTED|Overall Study|The ITT population for Subutex-to-Suboxone Induction is 94 participants|95
10380608|NCT00604188|11522031|FG000|COMPLETED|Overall Study||66
10380609|NCT00604188|11522032|FG001|COMPLETED|Overall Study||70
10380610|NCT00604188|11522031|FG000|NOT COMPLETED|Overall Study||27
10380611|NCT00604188|11522032|FG001|NOT COMPLETED|Overall Study||25
10380612|NCT00604214|11522040|FG000|STARTED|Baseline to Day 28||851
10380613|NCT00604214|11522041|FG001|STARTED|Baseline to Day 28||845
10380614|NCT00604214|11522040|FG000|Received Study Drug|Baseline to Day 28||833
10380615|NCT00604214|11522041|FG001|Received Study Drug|Baseline to Day 28||833
10380616|NCT00604214|11522040|FG000|COMPLETED|Baseline to Day 28||623
10380617|NCT00604214|11522041|FG001|COMPLETED|Baseline to Day 28||632
10380618|NCT00604214|11522040|FG000|NOT COMPLETED|Baseline to Day 28||228
10380619|NCT00604214|11522041|FG001|NOT COMPLETED|Baseline to Day 28||213
10380620|NCT00604214|11522040|FG000|STARTED|Day 29 to Day 90||623
10380621|NCT00604214|11522041|FG001|STARTED|Day 29 to Day 90||632
10380622|NCT00604214|11522040|FG000|COMPLETED|Day 29 to Day 90||555
10380623|NCT00604214|11522041|FG001|COMPLETED|Day 29 to Day 90||553
10380624|NCT00604214|11522040|FG000|NOT COMPLETED|Day 29 to Day 90||68
10380625|NCT00604214|11522041|FG001|NOT COMPLETED|Day 29 to Day 90||79
10380626|NCT00604214|11522040|FG000|STARTED|Day 91 to Day 180||555
10380627|NCT00604214|11522041|FG001|STARTED|Day 91 to Day 180||553
10380628|NCT00604214|11522040|FG000|COMPLETED|Day 91 to Day 180||529
10380629|NCT00604214|11522041|FG001|COMPLETED|Day 91 to Day 180||521
10380630|NCT00604214|11522040|FG000|NOT COMPLETED|Day 91 to Day 180||26
10380631|NCT00604214|11522041|FG001|NOT COMPLETED|Day 91 to Day 180||32
10380632|NCT00604279|11522049|FG000|STARTED|Overall Study||229
10380633|NCT00604279|11522050|FG001|STARTED|Overall Study||223
10380634|NCT00604279|11522049|FG000|COMPLETED|Overall Study||165
10380635|NCT00604279|11522050|FG001|COMPLETED|Overall Study||185
10380636|NCT00604279|11522049|FG000|NOT COMPLETED|Overall Study||64
10380637|NCT00604279|11522050|FG001|NOT COMPLETED|Overall Study||38
10380638|NCT00604383|11522058|FG000|STARTED|Overall Study||345
10380639|NCT00604383|11522059|FG001|STARTED|Overall Study||340
10380640|NCT00604383|11522058|FG000|Received at Least 1 Dose of Study Drug|Overall Study||345
10380641|NCT00604383|11522059|FG001|Received at Least 1 Dose of Study Drug|Overall Study||340
10380642|NCT00604383|11522058|FG000|Received Extended Treatment|Overall Study||136
10380643|NCT00604383|11522059|FG001|Received Extended Treatment|Overall Study||141
10380644|NCT00604383|11522058|FG000|COMPLETED|Overall Study||258
10380645|NCT00604383|11522059|FG001|COMPLETED|Overall Study||256
10380646|NCT00604383|11522058|FG000|NOT COMPLETED|Overall Study||87
10380647|NCT00604383|11522059|FG001|NOT COMPLETED|Overall Study||84
10380648|NCT00604461|11522065|FG000|STARTED|Overall Study||13
10380649|NCT00604461|11522065|FG000|COMPLETED|Overall Study|Death within 30 days of treatment occurred in 1 patient.|12
10380650|NCT00604461|11522065|FG000|NOT COMPLETED|Overall Study||1
10380651|NCT00604552|11522071|FG000|STARTED|Overall Study||189
10539673|NCT01462357|11692595|FG002|NOT COMPLETED|Overall Study||12
10539674|NCT01462435|11692607|FG000|STARTED|Overall Study||106
10539675|NCT01462435|11692608|FG001|STARTED|Overall Study||109
10380652|NCT00604552|11522072|FG001|STARTED|Overall Study||160
10380653|NCT00604552|11522071|FG000|COMPLETED|Overall Study||189
10380654|NCT00604552|11522072|FG001|COMPLETED|Overall Study||160
10380655|NCT00604552|11522071|FG000|NOT COMPLETED|Overall Study||0
10380656|NCT00604552|11522072|FG001|NOT COMPLETED|Overall Study||0
10380657|NCT00604565|11522082|FG000|STARTED|Overall Study||4
10380658|NCT00604565|11522083|FG001|STARTED|Overall Study||7
10380659|NCT00604565|11522082|FG000|COMPLETED|Overall Study||4
10380660|NCT00604565|11522083|FG001|COMPLETED|Overall Study||4
10380661|NCT00604565|11522082|FG000|NOT COMPLETED|Overall Study||0
10380662|NCT00604565|11522083|FG001|NOT COMPLETED|Overall Study||3
10380663|NCT00604669|11522089|FG000|STARTED|Overall Study||170
10380664|NCT00604669|11522089|FG000|COMPLETED|Overall Study||163
10380665|NCT00604669|11522089|FG000|NOT COMPLETED|Overall Study||7
10380666|NCT00604695|11522095|FG000|STARTED|Overall Study||20
10380667|NCT00604695|11522096|FG001|STARTED|Overall Study||20
10380668|NCT00604695|11522095|FG000|COMPLETED|Overall Study||20
10380669|NCT00604695|11522096|FG001|COMPLETED|Overall Study||16
10380670|NCT00604695|11522095|FG000|NOT COMPLETED|Overall Study||0
10380671|NCT00604695|11522096|FG001|NOT COMPLETED|Overall Study||4
10380672|NCT00604708|11522104|FG000|STARTED|Overall Study||430
10380673|NCT00604708|11522105|FG001|STARTED|Overall Study||437
10380674|NCT00604708|11522104|FG000|COMPLETED|Overall Study||399
10380675|NCT00604708|11522105|FG001|COMPLETED|Overall Study||397
10380676|NCT00604708|11522104|FG000|NOT COMPLETED|Overall Study||31
10380677|NCT00604708|11522105|FG001|NOT COMPLETED|Overall Study||40
10380678|NCT00604721|11522111|FG000|STARTED|Overall Study||19
10380679|NCT00604721|11522111|FG000|COMPLETED|Overall Study|2 patients failed to complete a full cycle of therapy.|17
10380680|NCT00604721|11522111|FG000|NOT COMPLETED|Overall Study||2
10380681|NCT00604786|11522118|FG000|STARTED|Overall Study||14
10380682|NCT00604786|11522119|FG001|STARTED|Overall Study||4
10380683|NCT00604786|11522118|FG000|COMPLETED|Overall Study||12
10380684|NCT00604786|11522119|FG001|COMPLETED|Overall Study||4
10380685|NCT00604786|11522118|FG000|NOT COMPLETED|Overall Study||2
10380686|NCT00604786|11522119|FG001|NOT COMPLETED|Overall Study||0
10380687|NCT00604825|11522129|FG000|STARTED|Overall Study||90
10380688|NCT00604825|11522130|FG001|STARTED|Overall Study||87
10380689|NCT00604825|11522131|FG002|STARTED|Overall Study||89
10380690|NCT00604825|11522132|FG003|STARTED|Overall Study||90
10380691|NCT00604825|11522129|FG000|COMPLETED|Overall Study||81
10380692|NCT00604825|11522130|FG001|COMPLETED|Overall Study||72
10380693|NCT00604825|11522131|FG002|COMPLETED|Overall Study||73
10380694|NCT00604825|11522132|FG003|COMPLETED|Overall Study||79
10717817|NCT02701270|11881792|FG003|NOT COMPLETED|Fourth Intervention at Visit 4||0
10717818|NCT02701296|11881805|FG000|STARTED|Overall Study||42
10717819|NCT02701296|11881806|FG001|STARTED|Overall Study||38
10717820|NCT02701296|11881805|FG000|COMPLETED|Overall Study||42
10717821|NCT02701296|11881806|FG001|COMPLETED|Overall Study|Data was incomplete for two participants their data was not included in the overall data analysis.|36
10717822|NCT02701296|11881805|FG000|NOT COMPLETED|Overall Study||0
10717823|NCT02701296|11881806|FG001|NOT COMPLETED|Overall Study||2
10717824|NCT02701361|11881815|FG000|STARTED|Overall Study||31
10380695|NCT00604825|11522129|FG000|NOT COMPLETED|Overall Study||9
10380696|NCT00604825|11522130|FG001|NOT COMPLETED|Overall Study||15
10380697|NCT00604825|11522131|FG002|NOT COMPLETED|Overall Study||16
10380698|NCT00604825|11522132|FG003|NOT COMPLETED|Overall Study||11
10380699|NCT00604890|11522146|FG000|STARTED|Overall Study||47
10380700|NCT00604890|11522147|FG001|STARTED|Overall Study||45
10380701|NCT00604890|11522148|FG002|STARTED|Overall Study||48
10380702|NCT00604890|11522149|FG003|STARTED|Overall Study||46
10380703|NCT00604890|11522146|FG000|COMPLETED|Overall Study||44
10380704|NCT00604890|11522147|FG001|COMPLETED|Overall Study||45
10380705|NCT00604890|11522148|FG002|COMPLETED|Overall Study||47
10380706|NCT00604890|11522149|FG003|COMPLETED|Overall Study||42
10717825|NCT02701361|11881816|FG001|STARTED|Overall Study||31
10717826|NCT02701361|11881817|FG002|STARTED|Overall Study||18
10717827|NCT02701361|11881815|FG000|COMPLETED|Overall Study||22
10717828|NCT02701361|11881816|FG001|COMPLETED|Overall Study||28
10717829|NCT02701361|11881817|FG002|COMPLETED|Overall Study||16
10717830|NCT02701361|11881815|FG000|NOT COMPLETED|Overall Study||9
10380707|NCT00604890|11522146|FG000|NOT COMPLETED|Overall Study||3
10380708|NCT00604890|11522147|FG001|NOT COMPLETED|Overall Study||0
10380709|NCT00604890|11522148|FG002|NOT COMPLETED|Overall Study||1
10380710|NCT00604890|11522149|FG003|NOT COMPLETED|Overall Study||4
10380711|NCT00604968|11522160|FG000|STARTED|Overall Study||25
10380712|NCT00604968|11522160|FG000|COMPLETED|Overall Study|Due to the nature of study, all subjects receiving drug were considered to have completed.|25
10539676|NCT01462435|11692609|FG002|STARTED|Overall Study||107
10539677|NCT01462435|11692610|FG003|STARTED|Overall Study||106
10539678|NCT01462435|11692607|FG000|COMPLETED|Overall Study||105
10539679|NCT01462435|11692608|FG001|COMPLETED|Overall Study||109
10539680|NCT01462435|11692609|FG002|COMPLETED|Overall Study||106
10539681|NCT01462435|11692610|FG003|COMPLETED|Overall Study||101
10539682|NCT01462435|11692607|FG000|NOT COMPLETED|Overall Study||1
10539683|NCT01462435|11692608|FG001|NOT COMPLETED|Overall Study||0
10539684|NCT01462435|11692609|FG002|NOT COMPLETED|Overall Study||1
10539685|NCT01462435|11692610|FG003|NOT COMPLETED|Overall Study||5
10539686|NCT01462565|11692620|FG000|STARTED|Overall Study||16
10539687|NCT01462565|11692620|FG000|COMPLETED|Overall Study||16
10380713|NCT00604968|11522160|FG000|NOT COMPLETED|Overall Study||0
10380714|NCT00605033|11522166|FG000|STARTED|Overall Study||143
10380715|NCT00605033|11522167|FG001|STARTED|Overall Study|One participant was randomized but withdrew before taking any study medication (treated n=97).|98
10380716|NCT00605033|11522166|FG000|COMPLETED|Overall Study||136
10380717|NCT00605033|11522167|FG001|COMPLETED|Overall Study||90
10380718|NCT00605033|11522166|FG000|NOT COMPLETED|Overall Study||7
10380719|NCT00605033|11522167|FG001|NOT COMPLETED|Overall Study||8
10380720|NCT00605072|11522176|FG000|STARTED|Overall Study||18
10380721|NCT00605072|11522177|FG001|STARTED|Overall Study||20
10380722|NCT00605072|11522178|FG002|STARTED|Overall Study||15
10380723|NCT00605072|11522176|FG000|COMPLETED|Overall Study||11
10380724|NCT00605072|11522177|FG001|COMPLETED|Overall Study||9
10380725|NCT00605072|11522178|FG002|COMPLETED|Overall Study||11
10380726|NCT00605072|11522176|FG000|NOT COMPLETED|Overall Study||7
10380727|NCT00605072|11522177|FG001|NOT COMPLETED|Overall Study||11
10380728|NCT00605072|11522178|FG002|NOT COMPLETED|Overall Study||4
10380729|NCT00605085|11522188|FG000|STARTED|Overall Study||2012
10380730|NCT00605085|11522189|FG001|STARTED|Overall Study||663
10380731|NCT00605085|11522188|FG000|COMPLETED|Overall Study||1962
10717831|NCT02701361|11881816|FG001|NOT COMPLETED|Overall Study||3
10717832|NCT02701361|11881817|FG002|NOT COMPLETED|Overall Study||2
10380732|NCT00605085|11522189|FG001|COMPLETED|Overall Study||638
10380733|NCT00605085|11522188|FG000|NOT COMPLETED|Overall Study||50
10380734|NCT00605085|11522189|FG001|NOT COMPLETED|Overall Study||25
10380735|NCT00605176|11522198|FG000|STARTED|Overall Study||160
10380736|NCT00605176|11522199|FG001|STARTED|Overall Study||160
10380737|NCT00605176|11522200|FG002|STARTED|Overall Study||159
10380738|NCT00605176|11522198|FG000|COMPLETED|Overall Study||149
10380739|NCT00605176|11522199|FG001|COMPLETED|Overall Study||154
10380740|NCT00605176|11522200|FG002|COMPLETED|Overall Study||150
10380741|NCT00605176|11522198|FG000|NOT COMPLETED|Overall Study||11
10380742|NCT00605176|11522199|FG001|NOT COMPLETED|Overall Study||6
10380743|NCT00605176|11522200|FG002|NOT COMPLETED|Overall Study||9
10539688|NCT01462565|11692620|FG000|NOT COMPLETED|Overall Study||0
10539689|NCT01462695|11692626|FG000|STARTED|Overall Study||17
10539690|NCT01462695|11692627|FG001|STARTED|Overall Study||13
10539691|NCT01462695|11692626|FG000|COMPLETED|Overall Study||0
10539692|NCT01462695|11692627|FG001|COMPLETED|Overall Study||0
10539693|NCT01462695|11692626|FG000|NOT COMPLETED|Overall Study||17
10539694|NCT01462695|11692627|FG001|NOT COMPLETED|Overall Study||13
10539695|NCT01462773|11692633|FG000|STARTED|Overall Study||16
10539696|NCT01462773|11692633|FG000|COMPLETED|Overall Study||16
10539697|NCT01462773|11692633|FG000|NOT COMPLETED|Overall Study||0
10539698|NCT01462812|11692640|FG000|STARTED|Overall Study||111
10539699|NCT01462812|11692641|FG001|STARTED|Overall Study||112
10539700|NCT01462812|11692640|FG000|COMPLETED|Overall Study||111
10539701|NCT01462812|11692641|FG001|COMPLETED|Overall Study||111
10539702|NCT01462812|11692640|FG000|NOT COMPLETED|Overall Study||0
10539703|NCT01462812|11692641|FG001|NOT COMPLETED|Overall Study||1
10539704|NCT01462877|11692647|FG000|STARTED|Overall Study||506
10539705|NCT01462877|11692647|FG000|Safety Set|Overall Study||492
10539706|NCT01462877|11692647|FG000|Full Analysis Set|Overall Study||468
10539707|NCT01462877|11692647|FG000|Per-protocol Set|Overall Study||364
10539708|NCT01462877|11692647|FG000|COMPLETED|Overall Study||435
10539709|NCT01462877|11692647|FG000|NOT COMPLETED|Overall Study||71
10539710|NCT01462929|11692654|FG000|STARTED|Overall Study||171
10539711|NCT01462929|11692655|FG001|STARTED|Overall Study||158
10539712|NCT01462929|11692656|FG002|STARTED|Overall Study||85
10539713|NCT01462929|11692654|FG000|COMPLETED|Overall Study||166
10539714|NCT01462929|11692655|FG001|COMPLETED|Overall Study||154
10539715|NCT01462929|11692656|FG002|COMPLETED|Overall Study||80
10539716|NCT01462929|11692654|FG000|NOT COMPLETED|Overall Study||5
10539717|NCT01462929|11692655|FG001|NOT COMPLETED|Overall Study||4
10539718|NCT01462929|11692656|FG002|NOT COMPLETED|Overall Study||5
10539719|NCT01462942|11692669|FG000|STARTED|Overall Study||194
10539720|NCT01462942|11692670|FG001|STARTED|Overall Study||385
10539721|NCT01462942|11692671|FG002|STARTED|Overall Study||381
10539722|NCT01462942|11692672|FG003|STARTED|Overall Study||385
10539723|NCT01462942|11692673|FG004|STARTED|Overall Study||384
10539724|NCT01462942|11692669|FG000|COMPLETED|Overall Study||160
10539725|NCT01462942|11692670|FG001|COMPLETED|Overall Study||351
10539726|NCT01462942|11692671|FG002|COMPLETED|Overall Study||341
10539727|NCT01462942|11692672|FG003|COMPLETED|Overall Study||335
10539728|NCT01462942|11692673|FG004|COMPLETED|Overall Study||339
10539729|NCT01462942|11692669|FG000|NOT COMPLETED|Overall Study||34
10539730|NCT01462942|11692670|FG001|NOT COMPLETED|Overall Study||34
10539731|NCT01462942|11692671|FG002|NOT COMPLETED|Overall Study||40
10539732|NCT01462942|11692672|FG003|NOT COMPLETED|Overall Study||50
10539733|NCT01462942|11692673|FG004|NOT COMPLETED|Overall Study||45
10539734|NCT01463007|11692685|FG000|STARTED|Overall Study||41
10539735|NCT01463007|11692685|FG000|COMPLETED|Overall Study||40
10539736|NCT01463007|11692685|FG000|NOT COMPLETED|Overall Study||1
10539737|NCT01463033|11692692|FG000|STARTED|Overall Study||66
10539738|NCT01463033|11692693|FG001|STARTED|Overall Study||60
10539739|NCT01463033|11692692|FG000|COMPLETED|Overall Study|3 deaths, 4 lost to follow up|59
10539740|NCT01463033|11692693|FG001|COMPLETED|Overall Study|2 deaths, 4 lost to follow up|54
10539741|NCT01463033|11692692|FG000|NOT COMPLETED|Overall Study||7
10539742|NCT01463033|11692693|FG001|NOT COMPLETED|Overall Study||6
10539743|NCT01463098|11692714|FG000|STARTED|Part A (11 Days)||16
10539744|NCT01463098|11692715|FG001|STARTED|Part A (11 Days)||6
10539745|NCT01463098|11692716|FG002|STARTED|Part A (11 Days)||6
10539746|NCT01463098|11692717|FG003|STARTED|Part A (11 Days)||6
10539747|NCT01463098|11692718|FG004|STARTED|Part A (11 Days)||6
10539748|NCT01463098|11692719|FG005|STARTED|Part A (11 Days)||6
10539749|NCT01463098|11692720|FG006|STARTED|Part A (11 Days)||6
10539750|NCT01463098|11692721|FG007|STARTED|Part A (11 Days)||6
10539751|NCT01463098|11692722|FG008|STARTED|Part A (11 Days)||6
10539752|NCT01463098|11692723|FG009|STARTED|Part A (11 Days)||0
10539753|NCT01463098|11692724|FG010|STARTED|Part A (11 Days)||0
10539754|NCT01463098|11692725|FG011|STARTED|Part A (11 Days)||0
10539755|NCT01463098|11692726|FG012|STARTED|Part A (11 Days)||0
10539756|NCT01463098|11692727|FG013|STARTED|Part A (11 Days)||0
10539757|NCT01463098|11692714|FG000|COMPLETED|Part A (11 Days)||14
10539758|NCT01463098|11692715|FG001|COMPLETED|Part A (11 Days)||6
10539759|NCT01463098|11692716|FG002|COMPLETED|Part A (11 Days)||6
10539760|NCT01463098|11692717|FG003|COMPLETED|Part A (11 Days)||6
10539761|NCT01463098|11692718|FG004|COMPLETED|Part A (11 Days)||5
10539762|NCT01463098|11692719|FG005|COMPLETED|Part A (11 Days)||6
10539763|NCT01463098|11692720|FG006|COMPLETED|Part A (11 Days)||6
10539764|NCT01463098|11692721|FG007|COMPLETED|Part A (11 Days)||6
10539765|NCT01463098|11692722|FG008|COMPLETED|Part A (11 Days)||5
10539766|NCT01463098|11692723|FG009|COMPLETED|Part A (11 Days)||0
10539767|NCT01463098|11692724|FG010|COMPLETED|Part A (11 Days)||0
10539768|NCT01463098|11692725|FG011|COMPLETED|Part A (11 Days)||0
10380753|NCT00605202|11522221|FG000|STARTED|First Intervention||5
10380754|NCT00605202|11522222|FG001|STARTED|First Intervention||5
10380755|NCT00605202|11522221|FG000|COMPLETED|First Intervention||5
10380756|NCT00605202|11522222|FG001|COMPLETED|First Intervention||5
10380757|NCT00605202|11522221|FG000|NOT COMPLETED|First Intervention||0
10380758|NCT00605202|11522222|FG001|NOT COMPLETED|First Intervention||0
10380759|NCT00605202|11522221|FG000|STARTED|Washout Period of 3 Weeks||5
10380760|NCT00605202|11522222|FG001|STARTED|Washout Period of 3 Weeks||5
10380761|NCT00605202|11522221|FG000|COMPLETED|Washout Period of 3 Weeks||5
10380762|NCT00605202|11522222|FG001|COMPLETED|Washout Period of 3 Weeks||5
10380763|NCT00605202|11522221|FG000|NOT COMPLETED|Washout Period of 3 Weeks||0
10380764|NCT00605202|11522222|FG001|NOT COMPLETED|Washout Period of 3 Weeks||0
10380765|NCT00605202|11522221|FG000|STARTED|Second Intervention||5
10380766|NCT00605202|11522222|FG001|STARTED|Second Intervention||5
10380767|NCT00605202|11522221|FG000|COMPLETED|Second Intervention||5
10380768|NCT00605202|11522222|FG001|COMPLETED|Second Intervention||5
10380769|NCT00605202|11522221|FG000|NOT COMPLETED|Second Intervention||0
10380770|NCT00605202|11522222|FG001|NOT COMPLETED|Second Intervention||0
10380771|NCT00605267|11522230|FG000|STARTED|Overall Study||98
10380772|NCT00605267|11522231|FG001|STARTED|Overall Study||99
10380773|NCT00605267|11522230|FG000|COMPLETED|Overall Study|Breast surgery performed|95
10380774|NCT00605267|11522231|FG001|COMPLETED|Overall Study|Breast surgery performed|90
10380775|NCT00605267|11522230|FG000|NOT COMPLETED|Overall Study||3
10380776|NCT00605267|11522231|FG001|NOT COMPLETED|Overall Study||9
10380777|NCT00605280|11522241|FG000|STARTED|Year 1||145
10380778|NCT00605280|11522242|FG001|STARTED|Year 1||22
10380779|NCT00605280|11522243|FG002|STARTED|Year 1||7
10380780|NCT00605280|11522244|FG003|STARTED|Year 1||143
10380781|NCT00605280|11522241|FG000|Received 0.3 mg Treatment|Year 1||144
10380782|NCT00605280|11522242|FG001|Received 0.3 mg Treatment|Year 1||13
10380783|NCT00605280|11522243|FG002|Received 0.3 mg Treatment|Year 1||3
10380784|NCT00605280|11522244|FG003|Received 0.3 mg Treatment|Year 1||0
10380785|NCT00605280|11522241|FG000|COMPLETED|Year 1||126
10380786|NCT00605280|11522242|FG001|COMPLETED|Year 1||11
10380787|NCT00605280|11522243|FG002|COMPLETED|Year 1||6
10380788|NCT00605280|11522244|FG003|COMPLETED|Year 1||124
10380789|NCT00605280|11522241|FG000|NOT COMPLETED|Year 1||19
10380790|NCT00605280|11522242|FG001|NOT COMPLETED|Year 1||11
10380791|NCT00605280|11522243|FG002|NOT COMPLETED|Year 1||1
10380792|NCT00605280|11522244|FG003|NOT COMPLETED|Year 1||19
10380793|NCT00605280|11522241|FG000|STARTED|Year 2||126
10380794|NCT00605280|11522242|FG001|STARTED|Year 2||11
10380795|NCT00605280|11522243|FG002|STARTED|Year 2||6
10380796|NCT00605280|11522244|FG003|STARTED|Year 2||124
10380797|NCT00605280|11522241|FG000|Received 0.3 mg Treatment|Year 2||126
10380798|NCT00605280|11522242|FG001|Received 0.3 mg Treatment|Year 2||3
10380799|NCT00605280|11522243|FG002|Received 0.3 mg Treatment|Year 2||2
10380800|NCT00605280|11522244|FG003|Received 0.3 mg Treatment|Year 2||0
10380801|NCT00605280|11522241|FG000|COMPLETED|Year 2||102
10380802|NCT00605280|11522242|FG001|COMPLETED|Year 2||5
10380803|NCT00605280|11522243|FG002|COMPLETED|Year 2||0
10380804|NCT00605280|11522244|FG003|COMPLETED|Year 2||102
10380805|NCT00605280|11522241|FG000|NOT COMPLETED|Year 2||24
10380806|NCT00605280|11522242|FG001|NOT COMPLETED|Year 2||6
10380807|NCT00605280|11522243|FG002|NOT COMPLETED|Year 2||6
10380808|NCT00605280|11522244|FG003|NOT COMPLETED|Year 2||22
10380809|NCT00605280|11522241|FG000|STARTED|Year 3 Extension||46
10380810|NCT00605280|11522242|FG001|STARTED|Year 3 Extension||0
10380811|NCT00605280|11522243|FG002|STARTED|Year 3 Extension||0
10380812|NCT00605280|11522244|FG003|STARTED|Year 3 Extension||54
10380813|NCT00605280|11522241|FG000|Received 0.3 mg Treatment|Year 3 Extension||46
10380814|NCT00605280|11522242|FG001|Received 0.3 mg Treatment|Year 3 Extension||0
10380815|NCT00605280|11522243|FG002|Received 0.3 mg Treatment|Year 3 Extension||0
10380816|NCT00605280|11522244|FG003|Received 0.3 mg Treatment|Year 3 Extension||54
10380817|NCT00605280|11522241|FG000|COMPLETED|Year 3 Extension||38
10380818|NCT00605280|11522242|FG001|COMPLETED|Year 3 Extension||0
10380819|NCT00605280|11522243|FG002|COMPLETED|Year 3 Extension||0
10380820|NCT00605280|11522244|FG003|COMPLETED|Year 3 Extension||45
10380821|NCT00605280|11522241|FG000|NOT COMPLETED|Year 3 Extension||8
10380822|NCT00605280|11522242|FG001|NOT COMPLETED|Year 3 Extension||0
10380823|NCT00605280|11522243|FG002|NOT COMPLETED|Year 3 Extension||0
10380824|NCT00605280|11522244|FG003|NOT COMPLETED|Year 3 Extension||9
10380825|NCT00605293|11522256|FG000|STARTED|Overall Study||65
10380826|NCT00605293|11522257|FG001|STARTED|Overall Study||36
10380827|NCT00605293|11522256|FG000|COMPLETED|Overall Study||48
10380828|NCT00605293|11522257|FG001|COMPLETED|Overall Study||31
10380829|NCT00605293|11522256|FG000|NOT COMPLETED|Overall Study||17
10380830|NCT00605293|11522257|FG001|NOT COMPLETED|Overall Study||5
10380831|NCT00605306|11522265|FG000|STARTED|Overall Study||14
10380832|NCT00605306|11522266|FG001|STARTED|Overall Study||14
10380833|NCT00605306|11522265|FG000|COMPLETED|Overall Study||14
10380834|NCT00605306|11522266|FG001|COMPLETED|Overall Study||13
10380835|NCT00605306|11522265|FG000|NOT COMPLETED|Overall Study||0
10380836|NCT00605306|11522266|FG001|NOT COMPLETED|Overall Study||1
10380837|NCT00605319|11522272|FG000|STARTED|Overall Study||17
10380838|NCT00605319|11522272|FG000|COMPLETED|Overall Study||11
10539769|NCT01463098|11692726|FG012|COMPLETED|Part A (11 Days)||0
10380839|NCT00605319|11522272|FG000|NOT COMPLETED|Overall Study||6
10380840|NCT00605345|11522284|FG000|STARTED|Overall Study||46
10380841|NCT00605345|11522285|FG001|STARTED|Overall Study||25
10380842|NCT00605345|11522284|FG000|COMPLETED|Overall Study||45
10380843|NCT00605345|11522285|FG001|COMPLETED|Overall Study||22
10380844|NCT00605345|11522284|FG000|NOT COMPLETED|Overall Study||1
10380845|NCT00605345|11522285|FG001|NOT COMPLETED|Overall Study||3
10380846|NCT00605358|11522293|FG000|STARTED|Overall Study||81
10380847|NCT00605358|11522294|FG001|STARTED|Overall Study||80
10380848|NCT00605358|11522293|FG000|COMPLETED|Overall Study||81
10380849|NCT00605358|11522294|FG001|COMPLETED|Overall Study||80
10380850|NCT00605358|11522293|FG000|NOT COMPLETED|Overall Study||0
10380851|NCT00605358|11522294|FG001|NOT COMPLETED|Overall Study||0
10380852|NCT00605384|11522302|FG000|STARTED|Overall Study||1
10380853|NCT00605384|11522303|FG001|STARTED|Overall Study||1
10380854|NCT00605384|11522302|FG000|COMPLETED|Overall Study|study terminated early|0
10380855|NCT00605384|11522303|FG001|COMPLETED|Overall Study|study terminated early|0
10380856|NCT00605384|11522302|FG000|NOT COMPLETED|Overall Study||1
10380857|NCT00605384|11522303|FG001|NOT COMPLETED|Overall Study||1
10380858|NCT00605423|11522311|FG000|STARTED|Overall Study||4
10380859|NCT00605423|11522312|FG001|STARTED|Overall Study||2
10380860|NCT00605423|11522311|FG000|COMPLETED|Overall Study||4
10380861|NCT00605423|11522312|FG001|COMPLETED|Overall Study||2
10380862|NCT00605423|11522311|FG000|NOT COMPLETED|Overall Study||0
10380863|NCT00605423|11522312|FG001|NOT COMPLETED|Overall Study||0
10380864|NCT00605475|11522328|FG000|STARTED|Overall Study||10
10380865|NCT00605475|11522329|FG001|STARTED|Overall Study||5
10380866|NCT00605475|11522330|FG002|STARTED|Overall Study||45
10380867|NCT00605475|11522331|FG003|STARTED|Overall Study||45
10380868|NCT00605475|11522332|FG004|STARTED|Overall Study||25
10380869|NCT00605475|11522333|FG005|STARTED|Overall Study||24
10380870|NCT00605475|11522334|FG006|STARTED|Overall Study||23
10380871|NCT00605475|11522335|FG007|STARTED|Overall Study||24
10380872|NCT00605475|11522336|FG008|STARTED|Overall Study||20
10380873|NCT00605475|11522337|FG009|STARTED|Overall Study||10
10380874|NCT00605475|11522328|FG000|COMPLETED|Overall Study||10
10380875|NCT00605475|11522329|FG001|COMPLETED|Overall Study||5
10380876|NCT00605475|11522330|FG002|COMPLETED|Overall Study||45
10380877|NCT00605475|11522331|FG003|COMPLETED|Overall Study||45
10380878|NCT00605475|11522332|FG004|COMPLETED|Overall Study||24
10380879|NCT00605475|11522333|FG005|COMPLETED|Overall Study||22
10380880|NCT00605475|11522334|FG006|COMPLETED|Overall Study||22
10380881|NCT00605475|11522335|FG007|COMPLETED|Overall Study||24
10380882|NCT00605475|11522336|FG008|COMPLETED|Overall Study||18
10380883|NCT00605475|11522337|FG009|COMPLETED|Overall Study||8
10380884|NCT00605475|11522328|FG000|NOT COMPLETED|Overall Study||0
10380885|NCT00605475|11522329|FG001|NOT COMPLETED|Overall Study||0
10380886|NCT00605475|11522330|FG002|NOT COMPLETED|Overall Study||0
10380887|NCT00605475|11522331|FG003|NOT COMPLETED|Overall Study||0
10380888|NCT00605475|11522332|FG004|NOT COMPLETED|Overall Study||1
10380889|NCT00605475|11522333|FG005|NOT COMPLETED|Overall Study||2
10380890|NCT00605475|11522334|FG006|NOT COMPLETED|Overall Study||1
10380891|NCT00605475|11522335|FG007|NOT COMPLETED|Overall Study||0
10380892|NCT00605475|11522336|FG008|NOT COMPLETED|Overall Study||2
10380893|NCT00605475|11522337|FG009|NOT COMPLETED|Overall Study||2
10380894|NCT00605540|11522380|FG000|STARTED|Overall Study||133
10380895|NCT00605540|11522380|FG000|COMPLETED|Overall Study||95
10380896|NCT00605540|11522380|FG000|NOT COMPLETED|Overall Study||38
10380897|NCT00605566|11522384|FG000|STARTED|Overall Study||22
10380898|NCT00605566|11522384|FG000|COMPLETED|Overall Study||19
10380899|NCT00605566|11522384|FG000|NOT COMPLETED|Overall Study||3
10380900|NCT00605644|11522393|FG000|STARTED|Overall Study||29
10380901|NCT00605644|11522394|FG001|STARTED|Overall Study||19
10380902|NCT00605644|11522395|FG002|STARTED|Overall Study||20
10380903|NCT00605644|11522396|FG003|STARTED|Overall Study||30
10380904|NCT00605644|11522397|FG004|STARTED|Overall Study||30
10380905|NCT00605644|11522393|FG000|COMPLETED|Overall Study||28
10380906|NCT00605644|11522394|FG001|COMPLETED|Overall Study||18
10380907|NCT00605644|11522395|FG002|COMPLETED|Overall Study||18
10380908|NCT00605644|11522396|FG003|COMPLETED|Overall Study||25
10380909|NCT00605644|11522397|FG004|COMPLETED|Overall Study||22
10380910|NCT00605644|11522393|FG000|NOT COMPLETED|Overall Study||1
10380911|NCT00605644|11522394|FG001|NOT COMPLETED|Overall Study||1
10380912|NCT00605644|11522395|FG002|NOT COMPLETED|Overall Study||2
10380913|NCT00605644|11522396|FG003|NOT COMPLETED|Overall Study||5
10380914|NCT00605644|11522397|FG004|NOT COMPLETED|Overall Study||8
10380915|NCT00605657|11522409|FG000|STARTED|Overall Study||5
10380916|NCT00605657|11522409|FG000|COMPLETED|Overall Study||3
10380917|NCT00605657|11522409|FG000|NOT COMPLETED|Overall Study||2
10380918|NCT00605696|11522415|FG000|STARTED|Overall Study||7
10380919|NCT00605696|11522416|FG001|STARTED|Overall Study||11
10380920|NCT00605696|11522415|FG000|COMPLETED|Overall Study||7
10380921|NCT00605696|11522416|FG001|COMPLETED|Overall Study||11
10380922|NCT00605696|11522415|FG000|NOT COMPLETED|Overall Study||0
10380923|NCT00605696|11522416|FG001|NOT COMPLETED|Overall Study||0
10380924|NCT00605722|11522422|FG000|STARTED|Overall Study||51
10380925|NCT00605722|11522422|FG000|COMPLETED|Overall Study|Completed=Completed Treatment.|0
10380926|NCT00605722|11522422|FG000|NOT COMPLETED|Overall Study||51
10380927|NCT00605813|11522426|FG000|STARTED|Overall Study||542
10380928|NCT00605813|11522426|FG000|COMPLETED|Overall Study||517
10380929|NCT00605813|11522426|FG000|NOT COMPLETED|Overall Study||25
10380930|NCT00605826|11522441|FG000|STARTED|Overall Study||136
10380931|NCT00605826|11522442|FG001|STARTED|Overall Study||70
10380932|NCT00605826|11522441|FG000|COMPLETED|Overall Study||129
10380933|NCT00605826|11522442|FG001|COMPLETED|Overall Study||60
10380934|NCT00605826|11522441|FG000|NOT COMPLETED|Overall Study||7
10380935|NCT00605826|11522442|FG001|NOT COMPLETED|Overall Study||10
10380936|NCT00605839|11522451|FG000|STARTED|Overall Study||40
10380937|NCT00605839|11522452|FG001|STARTED|Overall Study||37
10380938|NCT00605839|11522453|FG002|STARTED|Overall Study||28
10380939|NCT00605839|11522451|FG000|COMPLETED|Overall Study|One patient would not keep to the text messaging constraints and had to be removed.|39
10380940|NCT00605839|11522452|FG001|COMPLETED|Overall Study||37
10380941|NCT00605839|11522453|FG002|COMPLETED|Overall Study||28
10380942|NCT00605839|11522451|FG000|NOT COMPLETED|Overall Study||1
10380943|NCT00605839|11522452|FG001|NOT COMPLETED|Overall Study||0
10380944|NCT00605839|11522453|FG002|NOT COMPLETED|Overall Study||0
10380945|NCT00605865|11522461|FG000|STARTED|Overall Study||2272
10380946|NCT00605865|11522461|FG000|COMPLETED|Overall Study||2157
10380947|NCT00605865|11522461|FG000|NOT COMPLETED|Overall Study||115
10380948|NCT00605904|11522495|FG000|STARTED|Baseline Data Collection and Dosing|While 37 subjects were enrolled in the protocol, only 34 were randomized to a study arm|13
10380949|NCT00605904|11522496|FG001|STARTED|Baseline Data Collection and Dosing|While 37 subjects were enrolled in the protocol, only 34 were randomized to a study arm|21
10380950|NCT00605904|11522495|FG000|COMPLETED|Baseline Data Collection and Dosing||13
10380951|NCT00605904|11522496|FG001|COMPLETED|Baseline Data Collection and Dosing||16
10380952|NCT00605904|11522495|FG000|NOT COMPLETED|Baseline Data Collection and Dosing||0
10380953|NCT00605904|11522496|FG001|NOT COMPLETED|Baseline Data Collection and Dosing||5
10380954|NCT00605904|11522495|FG000|STARTED|Infusion Sessions||13
10380955|NCT00605904|11522496|FG001|STARTED|Infusion Sessions||16
10380956|NCT00605904|11522495|FG000|Saline Infusion|Infusion Sessions||13
10380957|NCT00605904|11522496|FG001|Saline Infusion|Infusion Sessions||14
10380958|NCT00605904|11522495|FG000|mCPP Infusion|Infusion Sessions||12
10380959|NCT00605904|11522496|FG001|mCPP Infusion|Infusion Sessions||13
10380960|NCT00605904|11522495|FG000|Yohimbine Infusion|Infusion Sessions||12
10380961|NCT00605904|11522496|FG001|Yohimbine Infusion|Infusion Sessions|Milestones (infusions) were not received in the same order for each subjects so are not consecutive.|15
10717833|NCT02701387|11881827|FG000|STARTED|Overall Study||7
10717834|NCT02701387|11881827|FG000|COMPLETED|Overall Study||7
10717835|NCT02701387|11881827|FG000|NOT COMPLETED|Overall Study||0
10717836|NCT02701400|11881834|FG000|STARTED|Overall Study||9
10380962|NCT00605904|11522495|FG000|COMPLETED|Infusion Sessions|Subjects who completed all three types of infusion (given in a different order for each subject)|12
10380963|NCT00605904|11522496|FG001|COMPLETED|Infusion Sessions|Subjects who completed all three types of infusion (given in a different order for each subject)|13
10380964|NCT00605904|11522495|FG000|NOT COMPLETED|Infusion Sessions||1
10380965|NCT00605904|11522496|FG001|NOT COMPLETED|Infusion Sessions||3
10380966|NCT00605917|11522502|FG000|STARTED|Overall Study||987
10380967|NCT00605917|11522502|FG000|COMPLETED|Overall Study||908
10380968|NCT00605917|11522502|FG000|NOT COMPLETED|Overall Study||79
10380969|NCT00606008|11522537|FG000|STARTED|Overall Study||30
10380970|NCT00606008|11522537|FG000|COMPLETED|Overall Study||25
10380971|NCT00606008|11522537|FG000|NOT COMPLETED|Overall Study||5
10380972|NCT00606021|11522547|FG000|STARTED|Induction Phase||106
10380973|NCT00606021|11522548|FG001|STARTED|Induction Phase||0
10380974|NCT00606021|11522549|FG002|STARTED|Induction Phase||0
10380975|NCT00606021|11522547|FG000|COMPLETED|Induction Phase||19
10380976|NCT00606021|11522548|FG001|COMPLETED|Induction Phase||0
10380977|NCT00606021|11522549|FG002|COMPLETED|Induction Phase||0
10380978|NCT00606021|11522547|FG000|NOT COMPLETED|Induction Phase||87
10380979|NCT00606021|11522548|FG001|NOT COMPLETED|Induction Phase||0
10380980|NCT00606021|11522549|FG002|NOT COMPLETED|Induction Phase||0
10380981|NCT00606021|11522547|FG000|STARTED|Maintenance Phase||0
10380982|NCT00606021|11522548|FG001|STARTED|Maintenance Phase||28
10380983|NCT00606021|11522549|FG002|STARTED|Maintenance Phase||27
10380984|NCT00606021|11522547|FG000|COMPLETED|Maintenance Phase||0
10380985|NCT00606021|11522548|FG001|COMPLETED|Maintenance Phase||5
10380986|NCT00606021|11522549|FG002|COMPLETED|Maintenance Phase||10
10380987|NCT00606021|11522547|FG000|NOT COMPLETED|Maintenance Phase||0
10380988|NCT00606021|11522548|FG001|NOT COMPLETED|Maintenance Phase||23
10380989|NCT00606021|11522549|FG002|NOT COMPLETED|Maintenance Phase||17
10380990|NCT00606034|11522557|FG000|STARTED|Overall Study||21
10380991|NCT00606034|11522557|FG000|COMPLETED|Overall Study||20
10380992|NCT00606034|11522557|FG000|NOT COMPLETED|Overall Study||1
10380993|NCT00606047|11522563|FG000|STARTED|Overall Study||200
10380994|NCT00606047|11522563|FG000|COMPLETED|Overall Study||200
10380995|NCT00606047|11522563|FG000|NOT COMPLETED|Overall Study||0
10380996|NCT00606086|11522569|FG000|STARTED|Overall Study||72
10380997|NCT00606086|11522570|FG001|STARTED|Overall Study||68
10380998|NCT00606086|11522569|FG000|COMPLETED|Overall Study||60
10380999|NCT00606086|11522570|FG001|COMPLETED|Overall Study||53
10381000|NCT00606086|11522569|FG000|NOT COMPLETED|Overall Study||12
10381001|NCT00606086|11522570|FG001|NOT COMPLETED|Overall Study||15
10381002|NCT00606138|11522578|FG000|STARTED|Overall Study||6
10717837|NCT02701400|11881835|FG001|STARTED|Overall Study||9
10381003|NCT00606138|11522579|FG001|STARTED|Overall Study||2
10381004|NCT00606138|11522578|FG000|COMPLETED|Overall Study||6
10381005|NCT00606138|11522579|FG001|COMPLETED|Overall Study||2
10381006|NCT00606138|11522578|FG000|NOT COMPLETED|Overall Study||0
10381007|NCT00606138|11522579|FG001|NOT COMPLETED|Overall Study||0
10717838|NCT02701400|11881834|FG000|COMPLETED|Overall Study||9
10717839|NCT02701400|11881835|FG001|COMPLETED|Overall Study||9
10381008|NCT00606177|11522587|FG000|STARTED|Overall Study||55
10539770|NCT01463098|11692727|FG013|COMPLETED|Part A (11 Days)||0
10539771|NCT01463098|11692714|FG000|NOT COMPLETED|Part A (11 Days)||2
10539772|NCT01463098|11692715|FG001|NOT COMPLETED|Part A (11 Days)||0
10539773|NCT01463098|11692716|FG002|NOT COMPLETED|Part A (11 Days)||0
10539774|NCT01463098|11692717|FG003|NOT COMPLETED|Part A (11 Days)||0
10539775|NCT01463098|11692718|FG004|NOT COMPLETED|Part A (11 Days)||1
10539776|NCT01463098|11692719|FG005|NOT COMPLETED|Part A (11 Days)||0
10539777|NCT01463098|11692720|FG006|NOT COMPLETED|Part A (11 Days)||0
10539778|NCT01463098|11692721|FG007|NOT COMPLETED|Part A (11 Days)||0
10539779|NCT01463098|11692722|FG008|NOT COMPLETED|Part A (11 Days)||1
10539780|NCT01463098|11692723|FG009|NOT COMPLETED|Part A (11 Days)||0
10539781|NCT01463098|11692724|FG010|NOT COMPLETED|Part A (11 Days)||0
10539782|NCT01463098|11692725|FG011|NOT COMPLETED|Part A (11 Days)||0
10539783|NCT01463098|11692726|FG012|NOT COMPLETED|Part A (11 Days)||0
10539784|NCT01463098|11692727|FG013|NOT COMPLETED|Part A (11 Days)||0
10539785|NCT01463098|11692714|FG000|STARTED|Part B (11 Days)||0
10539786|NCT01463098|11692715|FG001|STARTED|Part B (11 Days)||0
10539787|NCT01463098|11692716|FG002|STARTED|Part B (11 Days)||0
10539788|NCT01463098|11692717|FG003|STARTED|Part B (11 Days)||0
10539789|NCT01463098|11692718|FG004|STARTED|Part B (11 Days)||0
10539790|NCT01463098|11692719|FG005|STARTED|Part B (11 Days)||0
10539791|NCT01463098|11692720|FG006|STARTED|Part B (11 Days)||0
10539792|NCT01463098|11692721|FG007|STARTED|Part B (11 Days)||0
10539793|NCT01463098|11692722|FG008|STARTED|Part B (11 Days)||0
10539794|NCT01463098|11692723|FG009|STARTED|Part B (11 Days)||12
10539795|NCT01463098|11692724|FG010|STARTED|Part B (11 Days)||11
10539796|NCT01463098|11692725|FG011|STARTED|Part B (11 Days)||13
10539797|NCT01463098|11692726|FG012|STARTED|Part B (11 Days)||10
10539798|NCT01463098|11692727|FG013|STARTED|Part B (11 Days)||12
10539799|NCT01463098|11692714|FG000|COMPLETED|Part B (11 Days)||0
10539800|NCT01463098|11692715|FG001|COMPLETED|Part B (11 Days)||0
10717840|NCT02701400|11881834|FG000|NOT COMPLETED|Overall Study||0
10381009|NCT00606177|11522588|FG001|STARTED|Overall Study||44
10381010|NCT00606177|11522587|FG000|COMPLETED|Overall Study||28
10381011|NCT00606177|11522588|FG001|COMPLETED|Overall Study||19
10539801|NCT01463098|11692716|FG002|COMPLETED|Part B (11 Days)||0
10539802|NCT01463098|11692717|FG003|COMPLETED|Part B (11 Days)||0
10381012|NCT00606177|11522587|FG000|NOT COMPLETED|Overall Study||27
10381013|NCT00606177|11522588|FG001|NOT COMPLETED|Overall Study||25
10381014|NCT00606229|11522594|FG000|STARTED|Overall Study||41
10381015|NCT00606229|11522594|FG000|COMPLETED|Overall Study||19
10381016|NCT00606229|11522594|FG000|NOT COMPLETED|Overall Study||22
10381017|NCT00606281|11522600|FG000|STARTED|Overall Study||128
10381018|NCT00606281|11522601|FG001|STARTED|Overall Study||130
10381019|NCT00606281|11522600|FG000|COMPLETED|Overall Study||72
10381020|NCT00606281|11522601|FG001|COMPLETED|Overall Study||64
10381021|NCT00606281|11522600|FG000|NOT COMPLETED|Overall Study||56
10381022|NCT00606281|11522601|FG001|NOT COMPLETED|Overall Study||66
10539803|NCT01463098|11692718|FG004|COMPLETED|Part B (11 Days)||0
10539804|NCT01463098|11692719|FG005|COMPLETED|Part B (11 Days)||0
10539805|NCT01463098|11692720|FG006|COMPLETED|Part B (11 Days)||0
10381029|NCT00606307|11522616|FG000|STARTED|Overall Study||29
10381030|NCT00606307|11522616|FG000|COMPLETED|Overall Study||18
10381031|NCT00606307|11522616|FG000|NOT COMPLETED|Overall Study||11
10381032|NCT00606320|11522620|FG000|STARTED|Overall Study||59
10381033|NCT00606320|11522620|FG000|COMPLETED|Overall Study||22
10381034|NCT00606320|11522620|FG000|NOT COMPLETED|Overall Study||37
10381035|NCT00606489|11522626|FG000|STARTED|Overall Study||21
10381036|NCT00606489|11522627|FG001|STARTED|Overall Study||40
10381037|NCT00606489|11522626|FG000|COMPLETED|Overall Study||21
10381038|NCT00606489|11522627|FG001|COMPLETED|Overall Study||40
10381039|NCT00606489|11522626|FG000|NOT COMPLETED|Overall Study||0
10381040|NCT00606489|11522627|FG001|NOT COMPLETED|Overall Study||0
10381041|NCT00606502|11522635|FG000|STARTED|Randomization||100
10381042|NCT00606502|11522636|FG001|STARTED|Randomization||101
10381043|NCT00606502|11522635|FG000|COMPLETED|Randomization||97
10381044|NCT00606502|11522636|FG001|COMPLETED|Randomization||101
10381045|NCT00606502|11522635|FG000|NOT COMPLETED|Randomization||3
10381046|NCT00606502|11522636|FG001|NOT COMPLETED|Randomization||0
10381047|NCT00606502|11522635|FG000|STARTED|Treatment||97
10381048|NCT00606502|11522636|FG001|STARTED|Treatment||101
10381049|NCT00606502|11522635|FG000|COMPLETED|Treatment||97
10381050|NCT00606502|11522636|FG001|COMPLETED|Treatment||98
10381051|NCT00606502|11522635|FG000|NOT COMPLETED|Treatment||0
10381052|NCT00606502|11522636|FG001|NOT COMPLETED|Treatment||3
10381053|NCT00606554|11522644|FG000|STARTED|Overall Study||15
10381054|NCT00606554|11522645|FG001|STARTED|Overall Study||18
10381055|NCT00606554|11522644|FG000|COMPLETED|Overall Study||15
10381056|NCT00606554|11522645|FG001|COMPLETED|Overall Study||18
10381057|NCT00606554|11522644|FG000|NOT COMPLETED|Overall Study||0
10381058|NCT00606554|11522645|FG001|NOT COMPLETED|Overall Study||0
10381059|NCT00606580|11522658|FG000|STARTED|Overall Study||125
10381060|NCT00606580|11522659|FG001|STARTED|Overall Study||125
10381061|NCT00606580|11522660|FG002|STARTED|Overall Study||125
10381062|NCT00606580|11522658|FG000|COMPLETED|Overall Study||123
10381063|NCT00606580|11522659|FG001|COMPLETED|Overall Study||122
10381064|NCT00606580|11522660|FG002|COMPLETED|Overall Study||103
10381065|NCT00606580|11522658|FG000|NOT COMPLETED|Overall Study||2
10381066|NCT00606580|11522659|FG001|NOT COMPLETED|Overall Study||3
10381067|NCT00606580|11522660|FG002|NOT COMPLETED|Overall Study||22
10428081|NCT00856557|11574080|FG000|COMPLETED|Overall Study||50
10428082|NCT00856557|11574081|FG001|COMPLETED|Overall Study||60
10428083|NCT00856557|11574080|FG000|NOT COMPLETED|Overall Study||12
10428084|NCT00856557|11574081|FG001|NOT COMPLETED|Overall Study||16
10428085|NCT00856583|11574089|FG000|STARTED|Overall Study|Patients treated|4905
10428086|NCT00856583|11574090|FG001|STARTED|Overall Study|Patients treated|4904
10428087|NCT00856583|11574089|FG000|COMPLETED|Overall Study|Patients who were still on study drug at the time of study closure|1768
10428088|NCT00856583|11574090|FG001|COMPLETED|Overall Study|Patients who were still on study drug at the time of study closure|2307
10428089|NCT00856583|11574089|FG000|NOT COMPLETED|Overall Study||3137
10428090|NCT00856583|11574090|FG001|NOT COMPLETED|Overall Study||2597
10428091|NCT00856609|11574098|FG000|STARTED|Overall Study||41
10428092|NCT00856609|11574099|FG001|STARTED|Overall Study||39
10428093|NCT00856609|11574098|FG000|COMPLETED|Overall Study||40
10428094|NCT00856609|11574099|FG001|COMPLETED|Overall Study||39
10428095|NCT00856609|11574098|FG000|NOT COMPLETED|Overall Study||1
10428096|NCT00856609|11574099|FG001|NOT COMPLETED|Overall Study||0
10428097|NCT00856635|11574107|FG000|STARTED|Overall Study||22
10428098|NCT00856635|11574108|FG001|STARTED|Overall Study||22
10428099|NCT00856635|11574107|FG000|Received Study Drug|Overall Study||20
10428100|NCT00856635|11574108|FG001|Received Study Drug|Overall Study||20
10428101|NCT00856635|11574107|FG000|COMPLETED|Overall Study||12
10428102|NCT00856635|11574108|FG001|COMPLETED|Overall Study||14
10428103|NCT00856635|11574107|FG000|NOT COMPLETED|Overall Study||10
10428104|NCT00856635|11574108|FG001|NOT COMPLETED|Overall Study||8
10428105|NCT00856661|11574118|FG000|STARTED|Overall Study|Randomised|135
10428106|NCT00856661|11574119|FG001|STARTED|Overall Study|Randomised|135
10428107|NCT00856661|11574118|FG000|Treated|Overall Study||126
10428108|NCT00856661|11574119|FG001|Treated|Overall Study||131
10428109|NCT00856661|11574118|FG000|Randomized Not Treated|Overall Study||9
10428110|NCT00856661|11574119|FG001|Randomized Not Treated|Overall Study||4
10428111|NCT00856661|11574118|FG000|COMPLETED|Overall Study||108
10428112|NCT00856661|11574119|FG001|COMPLETED|Overall Study||106
10428113|NCT00856661|11574118|FG000|NOT COMPLETED|Overall Study||27
10428114|NCT00856661|11574119|FG001|NOT COMPLETED|Overall Study||29
10428115|NCT00856726|11574125|FG000|STARTED|Overall Study||26
10428116|NCT00856726|11574125|FG000|COMPLETED|Overall Study||26
10428117|NCT00856726|11574125|FG000|NOT COMPLETED|Overall Study||0
10428118|NCT00856739|11574132|FG000|STARTED|Overall Study||70
10717841|NCT02701400|11881835|FG001|NOT COMPLETED|Overall Study||0
10717842|NCT02701413|11881844|FG000|STARTED|Overall Study||33
10428119|NCT00856739|11574133|FG001|STARTED|Overall Study||52
10428120|NCT00856739|11574134|FG002|STARTED|Overall Study||55
10428121|NCT00856739|11574132|FG000|COMPLETED|Overall Study||70
10428122|NCT00856739|11574133|FG001|COMPLETED|Overall Study||52
10428123|NCT00856739|11574134|FG002|COMPLETED|Overall Study||55
10428124|NCT00856739|11574132|FG000|NOT COMPLETED|Overall Study||0
10428125|NCT00856739|11574133|FG001|NOT COMPLETED|Overall Study||0
10381068|NCT00606593|11522668|FG000|STARTED|Overall Study|Randomized participants|11
10381069|NCT00606593|11522669|FG001|STARTED|Overall Study|Randomized participants|11
10381070|NCT00606593|11522670|FG002|STARTED|Overall Study|Randomized participants|11
10381071|NCT00606593|11522671|FG003|STARTED|Overall Study|Randomized participants|11
10381072|NCT00606593|11522672|FG004|STARTED|Overall Study|Randomized participants|12
10381073|NCT00606593|11522673|FG005|STARTED|Overall Study|Randomized participants|11
10381074|NCT00606593|11522674|FG006|STARTED|Overall Study|Randomized participants|11
10381075|NCT00606593|11522675|FG007|STARTED|Overall Study|Randomized participants. One participant actually received the treatment sequence 200/P/100/ 50/25|11
10381076|NCT00606593|11522676|FG008|STARTED|Overall Study|Randomized participants|12
10381077|NCT00606593|11522677|FG009|STARTED|Overall Study|Randomized participants|11
10381078|NCT00606593|11522668|FG000|1st Double-blind Treatment|Overall Study||11
10381079|NCT00606593|11522669|FG001|1st Double-blind Treatment|Overall Study||11
10381080|NCT00606593|11522670|FG002|1st Double-blind Treatment|Overall Study||11
10381081|NCT00606593|11522671|FG003|1st Double-blind Treatment|Overall Study||11
10381082|NCT00606593|11522672|FG004|1st Double-blind Treatment|Overall Study||12
10381083|NCT00606593|11522673|FG005|1st Double-blind Treatment|Overall Study||11
10381084|NCT00606593|11522674|FG006|1st Double-blind Treatment|Overall Study||11
10381085|NCT00606593|11522675|FG007|1st Double-blind Treatment|Overall Study||11
10381086|NCT00606593|11522676|FG008|1st Double-blind Treatment|Overall Study||12
10381087|NCT00606593|11522677|FG009|1st Double-blind Treatment|Overall Study||11
10381088|NCT00606593|11522668|FG000|2nd Double-blind Treatment|Overall Study||11
10381089|NCT00606593|11522669|FG001|2nd Double-blind Treatment|Overall Study||11
10381090|NCT00606593|11522670|FG002|2nd Double-blind Treatment|Overall Study||11
10381091|NCT00606593|11522671|FG003|2nd Double-blind Treatment|Overall Study||10
10381092|NCT00606593|11522672|FG004|2nd Double-blind Treatment|Overall Study||12
10381093|NCT00606593|11522673|FG005|2nd Double-blind Treatment|Overall Study||11
10381094|NCT00606593|11522674|FG006|2nd Double-blind Treatment|Overall Study||10
10381095|NCT00606593|11522675|FG007|2nd Double-blind Treatment|Overall Study||9
10381096|NCT00606593|11522676|FG008|2nd Double-blind Treatment|Overall Study||12
10381097|NCT00606593|11522677|FG009|2nd Double-blind Treatment|Overall Study||11
10381098|NCT00606593|11522668|FG000|3rd Double-blind Treatment|Overall Study||11
10381099|NCT00606593|11522669|FG001|3rd Double-blind Treatment|Overall Study||11
10381100|NCT00606593|11522670|FG002|3rd Double-blind Treatment|Overall Study||10
10381101|NCT00606593|11522671|FG003|3rd Double-blind Treatment|Overall Study||10
10381102|NCT00606593|11522672|FG004|3rd Double-blind Treatment|Overall Study||11
10381103|NCT00606593|11522673|FG005|3rd Double-blind Treatment|Overall Study||11
10381104|NCT00606593|11522674|FG006|3rd Double-blind Treatment|Overall Study||10
10381105|NCT00606593|11522675|FG007|3rd Double-blind Treatment|Overall Study||9
10381106|NCT00606593|11522676|FG008|3rd Double-blind Treatment|Overall Study||12
10381107|NCT00606593|11522677|FG009|3rd Double-blind Treatment|Overall Study||11
10381108|NCT00606593|11522668|FG000|4th Double-blind Treatment|Overall Study||10
10381109|NCT00606593|11522669|FG001|4th Double-blind Treatment|Overall Study||11
10381110|NCT00606593|11522670|FG002|4th Double-blind Treatment|Overall Study||10
10381111|NCT00606593|11522671|FG003|4th Double-blind Treatment|Overall Study||10
10381112|NCT00606593|11522672|FG004|4th Double-blind Treatment|Overall Study||11
10381113|NCT00606593|11522673|FG005|4th Double-blind Treatment|Overall Study||11
10381114|NCT00606593|11522674|FG006|4th Double-blind Treatment|Overall Study||10
10381115|NCT00606593|11522675|FG007|4th Double-blind Treatment|Overall Study||9
10381116|NCT00606593|11522676|FG008|4th Double-blind Treatment|Overall Study||11
10381117|NCT00606593|11522677|FG009|4th Double-blind Treatment|Overall Study||11
10381118|NCT00606593|11522668|FG000|5th Double-blind Treatment|Overall Study||10
10381119|NCT00606593|11522669|FG001|5th Double-blind Treatment|Overall Study||11
10539806|NCT01463098|11692721|FG007|COMPLETED|Part B (11 Days)||0
10539807|NCT01463098|11692722|FG008|COMPLETED|Part B (11 Days)||0
10539808|NCT01463098|11692723|FG009|COMPLETED|Part B (11 Days)||12
10539809|NCT01463098|11692724|FG010|COMPLETED|Part B (11 Days)||11
10539810|NCT01463098|11692725|FG011|COMPLETED|Part B (11 Days)||12
10539811|NCT01463098|11692726|FG012|COMPLETED|Part B (11 Days)||10
10539812|NCT01463098|11692727|FG013|COMPLETED|Part B (11 Days)||12
10539813|NCT01463098|11692714|FG000|NOT COMPLETED|Part B (11 Days)||0
10658037|NCT02230384|11819178|FG000|STARTED|Phase 1 Wash Out||29
10658038|NCT02230384|11819179|FG001|STARTED|Phase 1 Wash Out||31
10658039|NCT02230384|11819178|FG000|COMPLETED|Phase 1 Wash Out||29
10658040|NCT02230384|11819179|FG001|COMPLETED|Phase 1 Wash Out||31
10658041|NCT02230384|11819178|FG000|NOT COMPLETED|Phase 1 Wash Out||0
10658042|NCT02230384|11819179|FG001|NOT COMPLETED|Phase 1 Wash Out||0
10658043|NCT02230384|11819178|FG000|STARTED|Phase 2 - Switch||29
10539814|NCT01463098|11692715|FG001|NOT COMPLETED|Part B (11 Days)||0
10539815|NCT01463098|11692716|FG002|NOT COMPLETED|Part B (11 Days)||0
10539816|NCT01463098|11692717|FG003|NOT COMPLETED|Part B (11 Days)||0
10539817|NCT01463098|11692718|FG004|NOT COMPLETED|Part B (11 Days)||0
10539818|NCT01463098|11692719|FG005|NOT COMPLETED|Part B (11 Days)||0
10539819|NCT01463098|11692720|FG006|NOT COMPLETED|Part B (11 Days)||0
10539820|NCT01463098|11692721|FG007|NOT COMPLETED|Part B (11 Days)||0
10539821|NCT01463098|11692722|FG008|NOT COMPLETED|Part B (11 Days)||0
10539822|NCT01463098|11692723|FG009|NOT COMPLETED|Part B (11 Days)||0
10658044|NCT02230384|11819179|FG001|STARTED|Phase 2 - Switch||31
10658045|NCT02230384|11819178|FG000|COMPLETED|Phase 2 - Switch||26
10658046|NCT02230384|11819179|FG001|COMPLETED|Phase 2 - Switch||30
10658047|NCT02230384|11819178|FG000|NOT COMPLETED|Phase 2 - Switch||3
10658048|NCT02230384|11819179|FG001|NOT COMPLETED|Phase 2 - Switch||1
10658049|NCT02230384|11819178|FG000|STARTED|Phase 2 Wash Out||26
10381120|NCT00606593|11522670|FG002|5th Double-blind Treatment|Overall Study||9
10381121|NCT00606593|11522671|FG003|5th Double-blind Treatment|Overall Study||10
10381122|NCT00606593|11522672|FG004|5th Double-blind Treatment|Overall Study||11
10381123|NCT00606593|11522673|FG005|5th Double-blind Treatment|Overall Study||11
10381124|NCT00606593|11522674|FG006|5th Double-blind Treatment|Overall Study||10
10381125|NCT00606593|11522675|FG007|5th Double-blind Treatment|Overall Study||9
10381126|NCT00606593|11522676|FG008|5th Double-blind Treatment|Overall Study||11
10381127|NCT00606593|11522677|FG009|5th Double-blind Treatment|Overall Study||11
10381128|NCT00606593|11522668|FG000|COMPLETED|Overall Study||10
10381129|NCT00606593|11522669|FG001|COMPLETED|Overall Study||11
10381130|NCT00606593|11522670|FG002|COMPLETED|Overall Study||9
10381131|NCT00606593|11522671|FG003|COMPLETED|Overall Study||10
10381132|NCT00606593|11522672|FG004|COMPLETED|Overall Study||11
10381133|NCT00606593|11522673|FG005|COMPLETED|Overall Study||11
10381134|NCT00606593|11522674|FG006|COMPLETED|Overall Study||10
10381135|NCT00606593|11522675|FG007|COMPLETED|Overall Study||9
10381136|NCT00606593|11522676|FG008|COMPLETED|Overall Study||11
10381137|NCT00606593|11522677|FG009|COMPLETED|Overall Study||11
10381138|NCT00606593|11522668|FG000|NOT COMPLETED|Overall Study||1
10381139|NCT00606593|11522669|FG001|NOT COMPLETED|Overall Study||0
10381140|NCT00606593|11522670|FG002|NOT COMPLETED|Overall Study||2
10381141|NCT00606593|11522671|FG003|NOT COMPLETED|Overall Study||1
10381142|NCT00606593|11522672|FG004|NOT COMPLETED|Overall Study||1
10381143|NCT00606593|11522673|FG005|NOT COMPLETED|Overall Study||0
10381144|NCT00606593|11522674|FG006|NOT COMPLETED|Overall Study||1
10381145|NCT00606593|11522675|FG007|NOT COMPLETED|Overall Study||2
10381146|NCT00606593|11522676|FG008|NOT COMPLETED|Overall Study||1
10381147|NCT00606593|11522677|FG009|NOT COMPLETED|Overall Study||0
10381148|NCT00606632|11522690|FG000|STARTED|Overall Study||226
10381149|NCT00606632|11522690|FG000|COMPLETED|Overall Study||204
10381150|NCT00606632|11522690|FG000|NOT COMPLETED|Overall Study||22
10381151|NCT00606684|11522705|FG000|STARTED|2-week Single-Blind Run-in Period||851
10381152|NCT00606684|11522706|FG001|STARTED|2-week Single-Blind Run-in Period||0
10381153|NCT00606684|11522707|FG002|STARTED|2-week Single-Blind Run-in Period||0
10381154|NCT00606684|11522708|FG003|STARTED|2-week Single-Blind Run-in Period||0
10381155|NCT00606684|11522709|FG004|STARTED|2-week Single-Blind Run-in Period||0
10381156|NCT00606684|11522710|FG005|STARTED|2-week Single-Blind Run-in Period||0
10539823|NCT01463098|11692724|FG010|NOT COMPLETED|Part B (11 Days)||0
10539824|NCT01463098|11692725|FG011|NOT COMPLETED|Part B (11 Days)||1
10539825|NCT01463098|11692726|FG012|NOT COMPLETED|Part B (11 Days)||0
10539826|NCT01463098|11692727|FG013|NOT COMPLETED|Part B (11 Days)||0
10539827|NCT01463111|11692776|FG000|STARTED|Overall Study||26
10539828|NCT01463111|11692776|FG000|COMPLETED|Overall Study||17
10539829|NCT01463111|11692776|FG000|NOT COMPLETED|Overall Study||9
10539830|NCT01463202|11692782|FG000|STARTED|Overall Study||79
10539831|NCT01463202|11692783|FG001|STARTED|Overall Study||78
10539832|NCT01463202|11692782|FG000|COMPLETED|Overall Study||79
10539833|NCT01463202|11692783|FG001|COMPLETED|Overall Study||78
10539834|NCT01463202|11692782|FG000|NOT COMPLETED|Overall Study||0
10539835|NCT01463202|11692783|FG001|NOT COMPLETED|Overall Study||0
10539836|NCT01463267|11692793|FG000|STARTED|Overall Study||15
10539837|NCT01463267|11692794|FG001|STARTED|Overall Study||15
10539838|NCT01463267|11692795|FG002|STARTED|Overall Study||15
10539839|NCT01463267|11692796|FG003|STARTED|Overall Study||15
10658050|NCT02230384|11819179|FG001|STARTED|Phase 2 Wash Out||30
10658051|NCT02230384|11819178|FG000|COMPLETED|Phase 2 Wash Out||26
10658052|NCT02230384|11819179|FG001|COMPLETED|Phase 2 Wash Out||30
10658053|NCT02230384|11819178|FG000|NOT COMPLETED|Phase 2 Wash Out||0
10658054|NCT02230384|11819179|FG001|NOT COMPLETED|Phase 2 Wash Out||0
10658055|NCT02230527|11819195|FG000|STARTED|Overall Study||23
10658056|NCT02230527|11819196|FG001|STARTED|Overall Study||23
10658057|NCT02230527|11819195|FG000|COMPLETED|Overall Study||18
10658058|NCT02230527|11819196|FG001|COMPLETED|Overall Study||21
10658059|NCT02230527|11819195|FG000|NOT COMPLETED|Overall Study||5
10658060|NCT02230527|11819196|FG001|NOT COMPLETED|Overall Study||2
10658061|NCT02230540|11819202|FG000|STARTED|Overall Study||8
10658062|NCT02230540|11819203|FG001|STARTED|Overall Study|The study was terminated before initiation of sequence B. Sequence B was therefore not initiated.|0
10658063|NCT02230540|11819202|FG000|COMPLETED|Overall Study||8
10658064|NCT02230540|11819203|FG001|COMPLETED|Overall Study||0
10658065|NCT02230540|11819202|FG000|NOT COMPLETED|Overall Study||0
10658066|NCT02230540|11819203|FG001|NOT COMPLETED|Overall Study||0
10658067|NCT02230566|11819211|FG000|STARTED|Overall Study||3
10658068|NCT02230566|11819212|FG001|STARTED|Overall Study||3
10658069|NCT02230566|11819213|FG002|STARTED|Overall Study||3
10658070|NCT02230566|11819214|FG003|STARTED|Overall Study||3
10658071|NCT02230566|11819211|FG000|COMPLETED|Overall Study||3
10658072|NCT02230566|11819212|FG001|COMPLETED|Overall Study||3
10658073|NCT02230566|11819213|FG002|COMPLETED|Overall Study||3
10658074|NCT02230566|11819214|FG003|COMPLETED|Overall Study||3
10717843|NCT02701413|11881845|FG001|STARTED|Overall Study||33
10381157|NCT00606684|11522711|FG006|STARTED|2-week Single-Blind Run-in Period||0
10381158|NCT00606684|11522705|FG000|COMPLETED|2-week Single-Blind Run-in Period||605
10381159|NCT00606684|11522706|FG001|COMPLETED|2-week Single-Blind Run-in Period||0
10381160|NCT00606684|11522707|FG002|COMPLETED|2-week Single-Blind Run-in Period||0
10381161|NCT00606684|11522708|FG003|COMPLETED|2-week Single-Blind Run-in Period||0
10381162|NCT00606684|11522709|FG004|COMPLETED|2-week Single-Blind Run-in Period||0
10381163|NCT00606684|11522710|FG005|COMPLETED|2-week Single-Blind Run-in Period||0
10381164|NCT00606684|11522711|FG006|COMPLETED|2-week Single-Blind Run-in Period||0
10381165|NCT00606684|11522705|FG000|NOT COMPLETED|2-week Single-Blind Run-in Period||246
10381166|NCT00606684|11522706|FG001|NOT COMPLETED|2-week Single-Blind Run-in Period||0
10381167|NCT00606684|11522707|FG002|NOT COMPLETED|2-week Single-Blind Run-in Period||0
10381168|NCT00606684|11522708|FG003|NOT COMPLETED|2-week Single-Blind Run-in Period||0
10381169|NCT00606684|11522709|FG004|NOT COMPLETED|2-week Single-Blind Run-in Period||0
10381170|NCT00606684|11522710|FG005|NOT COMPLETED|2-week Single-Blind Run-in Period||0
10381171|NCT00606684|11522711|FG006|NOT COMPLETED|2-week Single-Blind Run-in Period||0
10381172|NCT00606684|11522705|FG000|STARTED|Double-Blind Treatment Period||0
10539840|NCT01463267|11692793|FG000|COMPLETED|Overall Study||14
10539841|NCT01463267|11692794|FG001|COMPLETED|Overall Study||15
10539842|NCT01463267|11692795|FG002|COMPLETED|Overall Study||13
10539843|NCT01463267|11692796|FG003|COMPLETED|Overall Study||13
10539844|NCT01463267|11692793|FG000|NOT COMPLETED|Overall Study||1
10539845|NCT01463267|11692794|FG001|NOT COMPLETED|Overall Study||0
10539846|NCT01463267|11692795|FG002|NOT COMPLETED|Overall Study||2
10539847|NCT01463267|11692796|FG003|NOT COMPLETED|Overall Study||2
10539848|NCT01463306|11692809|FG000|STARTED|Overall Study||384
10539849|NCT01463306|11692810|FG001|STARTED|Overall Study||210
10539850|NCT01463306|11692811|FG002|STARTED|Overall Study||11
10539851|NCT01463306|11692809|FG000|COMPLETED|Overall Study||298
10539852|NCT01463306|11692810|FG001|COMPLETED|Overall Study||158
10539853|NCT01463306|11692811|FG002|COMPLETED|Overall Study||6
10539854|NCT01463306|11692809|FG000|NOT COMPLETED|Overall Study||86
10539855|NCT01463306|11692810|FG001|NOT COMPLETED|Overall Study||52
10539856|NCT01463306|11692811|FG002|NOT COMPLETED|Overall Study||5
10539857|NCT01463358|11692821|FG000|STARTED|Overall Study||49
10539858|NCT01463358|11692822|FG001|STARTED|Overall Study||52
10539859|NCT01463358|11692821|FG000|COMPLETED|Overall Study||46
10539860|NCT01463358|11692822|FG001|COMPLETED|Overall Study||47
10539861|NCT01463358|11692821|FG000|NOT COMPLETED|Overall Study||3
10539862|NCT01463358|11692822|FG001|NOT COMPLETED|Overall Study||5
10539863|NCT01463384|11692828|FG000|STARTED|Overall Study||13
10539864|NCT01463384|11692828|FG000|COMPLETED|Overall Study||13
10539865|NCT01463384|11692828|FG000|NOT COMPLETED|Overall Study||0
10539866|NCT01463527|11692836|FG000|STARTED|Overall Study||83
10539867|NCT01463527|11692837|FG001|STARTED|Overall Study||84
10539868|NCT01463527|11692836|FG000|COMPLETED|Overall Study||77
10539869|NCT01463527|11692837|FG001|COMPLETED|Overall Study||77
10539870|NCT01463527|11692836|FG000|NOT COMPLETED|Overall Study||6
10539871|NCT01463527|11692837|FG001|NOT COMPLETED|Overall Study||7
10539872|NCT01463631|11692847|FG000|STARTED|Overall Study||3
10539873|NCT01463631|11692848|FG001|STARTED|Overall Study||4
10539874|NCT01463631|11692849|FG002|STARTED|Overall Study||5
10539875|NCT01463631|11692850|FG003|STARTED|Overall Study||15
10539876|NCT01463631|11692847|FG000|Received at Least One Dose of Study Drug|Overall Study||3
10539877|NCT01463631|11692848|FG001|Received at Least One Dose of Study Drug|Overall Study||4
10539878|NCT01463631|11692849|FG002|Received at Least One Dose of Study Drug|Overall Study||5
10539879|NCT01463631|11692850|FG003|Received at Least One Dose of Study Drug|Overall Study||15
10539880|NCT01463631|11692847|FG000|COMPLETED|Overall Study||3
10539881|NCT01463631|11692848|FG001|COMPLETED|Overall Study||4
10539882|NCT01463631|11692849|FG002|COMPLETED|Overall Study||4
10539883|NCT01463631|11692850|FG003|COMPLETED|Overall Study||9
10539884|NCT01463631|11692847|FG000|NOT COMPLETED|Overall Study||0
10539885|NCT01463631|11692848|FG001|NOT COMPLETED|Overall Study||0
10539886|NCT01463631|11692849|FG002|NOT COMPLETED|Overall Study||1
10539887|NCT01463631|11692850|FG003|NOT COMPLETED|Overall Study||6
10539888|NCT01463683|11692865|FG000|STARTED|Overall Study||309
10539889|NCT01463683|11692866|FG001|STARTED|Overall Study||309
10539890|NCT01463683|11692867|FG002|STARTED|Overall Study||104
10539891|NCT01463683|11692865|FG000|Received Vaccination 1 (Day 1)|Overall Study||309
10381173|NCT00606684|11522706|FG001|STARTED|Double-Blind Treatment Period||101
10381174|NCT00606684|11522707|FG002|STARTED|Double-Blind Treatment Period||99
10381175|NCT00606684|11522708|FG003|STARTED|Double-Blind Treatment Period||101
10381176|NCT00606684|11522709|FG004|STARTED|Double-Blind Treatment Period||101
10381177|NCT00606684|11522710|FG005|STARTED|Double-Blind Treatment Period||101
10381178|NCT00606684|11522711|FG006|STARTED|Double-Blind Treatment Period||99
10381179|NCT00606684|11522705|FG000|COMPLETED|Double-Blind Treatment Period||0
10381180|NCT00606684|11522706|FG001|COMPLETED|Double-Blind Treatment Period||85
10381181|NCT00606684|11522707|FG002|COMPLETED|Double-Blind Treatment Period||88
10381182|NCT00606684|11522708|FG003|COMPLETED|Double-Blind Treatment Period||91
10381183|NCT00606684|11522709|FG004|COMPLETED|Double-Blind Treatment Period||92
10381184|NCT00606684|11522710|FG005|COMPLETED|Double-Blind Treatment Period||92
10381185|NCT00606684|11522711|FG006|COMPLETED|Double-Blind Treatment Period||91
10381186|NCT00606684|11522705|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
10381187|NCT00606684|11522706|FG001|NOT COMPLETED|Double-Blind Treatment Period||16
10381188|NCT00606684|11522707|FG002|NOT COMPLETED|Double-Blind Treatment Period||11
10381189|NCT00606684|11522708|FG003|NOT COMPLETED|Double-Blind Treatment Period||10
10381190|NCT00606684|11522709|FG004|NOT COMPLETED|Double-Blind Treatment Period||9
10381191|NCT00606684|11522710|FG005|NOT COMPLETED|Double-Blind Treatment Period||9
10381192|NCT00606684|11522711|FG006|NOT COMPLETED|Double-Blind Treatment Period||8
10539892|NCT01463683|11692866|FG001|Received Vaccination 1 (Day 1)|Overall Study||308
10539893|NCT01463683|11692867|FG002|Received Vaccination 1 (Day 1)|Overall Study||104
10539894|NCT01463683|11692865|FG000|Received Vaccination 2 (Month 1)|Overall Study||302
10539895|NCT01463683|11692866|FG001|Received Vaccination 2 (Month 1)|Overall Study||300
10381193|NCT00606801|11522727|FG000|STARTED|Adaptation||17
10381194|NCT00606801|11522728|FG001|STARTED|Adaptation||17
10381195|NCT00606801|11522727|FG000|COMPLETED|Adaptation||17
10381196|NCT00606801|11522728|FG001|COMPLETED|Adaptation||17
10381197|NCT00606801|11522727|FG000|NOT COMPLETED|Adaptation||0
10381198|NCT00606801|11522728|FG001|NOT COMPLETED|Adaptation||0
10717844|NCT02701413|11881844|FG000|COMPLETED|Overall Study||26
10717845|NCT02701413|11881845|FG001|COMPLETED|Overall Study||22
10717846|NCT02701413|11881844|FG000|NOT COMPLETED|Overall Study||7
10717847|NCT02701413|11881845|FG001|NOT COMPLETED|Overall Study||11
10717848|NCT02701582|11881853|FG000|STARTED|Overall Study||35
10717849|NCT02701582|11881854|FG001|STARTED|Overall Study||33
10381199|NCT00606801|11522727|FG000|STARTED|Intervention||17
10381200|NCT00606801|11522728|FG001|STARTED|Intervention||17
10381201|NCT00606801|11522727|FG000|COMPLETED|Intervention||14
10717850|NCT02701582|11881853|FG000|COMPLETED|Overall Study||33
10717851|NCT02701582|11881854|FG001|COMPLETED|Overall Study||33
10717852|NCT02701582|11881853|FG000|NOT COMPLETED|Overall Study||2
10717853|NCT02701582|11881854|FG001|NOT COMPLETED|Overall Study||0
10381202|NCT00606801|11522728|FG001|COMPLETED|Intervention||14
10381203|NCT00606801|11522727|FG000|NOT COMPLETED|Intervention||3
10381204|NCT00606801|11522728|FG001|NOT COMPLETED|Intervention||3
10381205|NCT00606892|11522738|FG000|STARTED|Adaptation||9
10381206|NCT00606892|11522739|FG001|STARTED|Adaptation||8
10381207|NCT00606892|11522738|FG000|COMPLETED|Adaptation||9
10381208|NCT00606892|11522739|FG001|COMPLETED|Adaptation||8
10381209|NCT00606892|11522738|FG000|NOT COMPLETED|Adaptation||0
10381210|NCT00606892|11522739|FG001|NOT COMPLETED|Adaptation||0
10381211|NCT00606892|11522738|FG000|STARTED|First Intervention||9
10381212|NCT00606892|11522739|FG001|STARTED|First Intervention||8
10381213|NCT00606892|11522738|FG000|COMPLETED|First Intervention||8
10381214|NCT00606892|11522739|FG001|COMPLETED|First Intervention||4
10381215|NCT00606892|11522738|FG000|NOT COMPLETED|First Intervention||1
10381216|NCT00606892|11522739|FG001|NOT COMPLETED|First Intervention||4
10381217|NCT00606892|11522738|FG000|STARTED|Washout Period||8
10381218|NCT00606892|11522739|FG001|STARTED|Washout Period||4
10381219|NCT00606892|11522738|FG000|COMPLETED|Washout Period||8
10381220|NCT00606892|11522739|FG001|COMPLETED|Washout Period||4
10381221|NCT00606892|11522738|FG000|NOT COMPLETED|Washout Period||0
10381222|NCT00606892|11522739|FG001|NOT COMPLETED|Washout Period||0
10381223|NCT00606892|11522738|FG000|STARTED|Second Intervention||8
10381224|NCT00606892|11522739|FG001|STARTED|Second Intervention||4
10381225|NCT00606892|11522738|FG000|COMPLETED|Second Intervention||8
10381226|NCT00606892|11522739|FG001|COMPLETED|Second Intervention||4
10381227|NCT00606892|11522738|FG000|NOT COMPLETED|Second Intervention||0
10381228|NCT00606892|11522739|FG001|NOT COMPLETED|Second Intervention||0
10381229|NCT00606905|11522773|FG000|STARTED|Overall Study||38
10381230|NCT00606905|11522774|FG001|STARTED|Overall Study||39
10381231|NCT00606905|11522773|FG000|Pregnancy|Overall Study||29
10381232|NCT00606905|11522774|FG001|Pregnancy|Overall Study||33
10381233|NCT00606905|11522773|FG000|COMPLETED|Overall Study||23
10381234|NCT00606905|11522774|FG001|COMPLETED|Overall Study||24
10381235|NCT00606905|11522773|FG000|NOT COMPLETED|Overall Study||15
10381236|NCT00606905|11522774|FG001|NOT COMPLETED|Overall Study||15
10381237|NCT00606931|11522780|FG000|STARTED|Overall Study||22
10381238|NCT00606931|11522780|FG000|COMPLETED|Overall Study||19
10381239|NCT00606931|11522780|FG000|NOT COMPLETED|Overall Study||3
10717854|NCT02701634|11881864|FG000|STARTED|Overall Study||33
10717855|NCT02701634|11881865|FG001|STARTED|Overall Study||33
10717856|NCT02701634|11881864|FG000|COMPLETED|Overall Study||1
10381240|NCT00606944|11522786|FG000|STARTED|Overall Study||98
10381241|NCT00606944|11522787|FG001|STARTED|Overall Study||100
10381242|NCT00606944|11522786|FG000|COMPLETED|Overall Study||98
10381243|NCT00606944|11522787|FG001|COMPLETED|Overall Study||100
10381244|NCT00606944|11522786|FG000|NOT COMPLETED|Overall Study||0
10381245|NCT00606944|11522787|FG001|NOT COMPLETED|Overall Study||0
10381246|NCT00607022|11522796|FG000|STARTED|Overall Study||7
10381247|NCT00607022|11522797|FG001|STARTED|Overall Study||15
10381248|NCT00607022|11522798|FG002|STARTED|Overall Study||19
10381249|NCT00607022|11522796|FG000|COMPLETED|Overall Study||6
10381250|NCT00607022|11522797|FG001|COMPLETED|Overall Study||15
10381251|NCT00607022|11522798|FG002|COMPLETED|Overall Study||19
10381252|NCT00607022|11522796|FG000|NOT COMPLETED|Overall Study||1
10381253|NCT00607022|11522797|FG001|NOT COMPLETED|Overall Study||0
10381254|NCT00607022|11522798|FG002|NOT COMPLETED|Overall Study||0
10381255|NCT00607048|11522808|FG000|STARTED|Overall Study||3
10381256|NCT00607048|11522809|FG001|STARTED|Overall Study||6
10381257|NCT00607048|11522810|FG002|STARTED|Overall Study||7
10381258|NCT00607048|11522811|FG003|STARTED|Overall Study||3
10381259|NCT00607048|11522812|FG004|STARTED|Overall Study||6
10381260|NCT00607048|11522813|FG005|STARTED|Overall Study||7
10381261|NCT00607048|11522808|FG000|COMPLETED|Overall Study||0
10381262|NCT00607048|11522809|FG001|COMPLETED|Overall Study||2
10381263|NCT00607048|11522810|FG002|COMPLETED|Overall Study||3
10381264|NCT00607048|11522811|FG003|COMPLETED|Overall Study||0
10381265|NCT00607048|11522812|FG004|COMPLETED|Overall Study||0
10381266|NCT00607048|11522813|FG005|COMPLETED|Overall Study||2
10381267|NCT00607048|11522808|FG000|NOT COMPLETED|Overall Study||3
10381268|NCT00607048|11522809|FG001|NOT COMPLETED|Overall Study||4
10381269|NCT00607048|11522810|FG002|NOT COMPLETED|Overall Study||4
10381270|NCT00607048|11522811|FG003|NOT COMPLETED|Overall Study||3
10717857|NCT02701634|11881865|FG001|COMPLETED|Overall Study||2
10717858|NCT02701634|11881864|FG000|NOT COMPLETED|Overall Study||32
10381271|NCT00607048|11522812|FG004|NOT COMPLETED|Overall Study||6
10381272|NCT00607048|11522813|FG005|NOT COMPLETED|Overall Study||5
10381273|NCT00607087|11522832|FG000|STARTED|Overall Study||99
10381274|NCT00607087|11522833|FG001|STARTED|Overall Study||95
10381275|NCT00607087|11522834|FG002|STARTED|Overall Study||94
10381276|NCT00607087|11522832|FG000|COMPLETED|Overall Study||84
10381277|NCT00607087|11522833|FG001|COMPLETED|Overall Study||84
10381278|NCT00607087|11522834|FG002|COMPLETED|Overall Study||84
10381279|NCT00607087|11522832|FG000|NOT COMPLETED|Overall Study||15
10381280|NCT00607087|11522833|FG001|NOT COMPLETED|Overall Study||11
10381281|NCT00607087|11522834|FG002|NOT COMPLETED|Overall Study||10
10381282|NCT00607087|11522832|FG000|STARTED|Period 1||99
10381283|NCT00607087|11522833|FG001|STARTED|Period 1||95
10381284|NCT00607087|11522834|FG002|STARTED|Period 1||94
10381285|NCT00607087|11522832|FG000|COMPLETED|Period 1||87
10381286|NCT00607087|11522833|FG001|COMPLETED|Period 1||89
10381287|NCT00607087|11522834|FG002|COMPLETED|Period 1||89
10381288|NCT00607087|11522832|FG000|NOT COMPLETED|Period 1||12
10381289|NCT00607087|11522833|FG001|NOT COMPLETED|Period 1||6
10539896|NCT01463683|11692867|FG002|Received Vaccination 2 (Month 1)|Overall Study||103
10539897|NCT01463683|11692865|FG000|Received Vaccination 3 (Month 6)|Overall Study||290
10539898|NCT01463683|11692866|FG001|Received Vaccination 3 (Month 6)|Overall Study||281
10539899|NCT01463683|11692867|FG002|Received Vaccination 3 (Month 6)|Overall Study||93
10539900|NCT01463683|11692865|FG000|COMPLETED|Overall Study||290
10539901|NCT01463683|11692866|FG001|COMPLETED|Overall Study||278
10539902|NCT01463683|11692867|FG002|COMPLETED|Overall Study||93
10539903|NCT01463683|11692865|FG000|NOT COMPLETED|Overall Study||19
10539904|NCT01463683|11692866|FG001|NOT COMPLETED|Overall Study||31
10539905|NCT01463683|11692867|FG002|NOT COMPLETED|Overall Study||11
10539906|NCT01463696|11692883|FG000|STARTED|Overall Study||1
10539907|NCT01463696|11692884|FG001|STARTED|Overall Study||6
10539908|NCT01463696|11692885|FG002|STARTED|Overall Study||3
10539909|NCT01463696|11692886|FG003|STARTED|Overall Study||7
10539910|NCT01463696|11692887|FG004|STARTED|Overall Study||3
10539911|NCT01463696|11692888|FG005|STARTED|Overall Study||6
10539912|NCT01463696|11692889|FG006|STARTED|Overall Study||16
10539913|NCT01463696|11692890|FG007|STARTED|Overall Study||6
10539914|NCT01463696|11692883|FG000|Treated|Overall Study||1
10539915|NCT01463696|11692884|FG001|Treated|Overall Study||6
10539916|NCT01463696|11692885|FG002|Treated|Overall Study||3
10539917|NCT01463696|11692886|FG003|Treated|Overall Study||7
10539918|NCT01463696|11692887|FG004|Treated|Overall Study||3
10539919|NCT01463696|11692888|FG005|Treated|Overall Study||6
10539920|NCT01463696|11692889|FG006|Treated|Overall Study||15
10539921|NCT01463696|11692890|FG007|Treated|Overall Study||6
10539922|NCT01463696|11692883|FG000|COMPLETED|Overall Study||1
10539923|NCT01463696|11692884|FG001|COMPLETED|Overall Study||4
10539924|NCT01463696|11692885|FG002|COMPLETED|Overall Study||2
10539925|NCT01463696|11692886|FG003|COMPLETED|Overall Study||3
10539926|NCT01463696|11692887|FG004|COMPLETED|Overall Study||2
10539927|NCT01463696|11692888|FG005|COMPLETED|Overall Study||3
10539928|NCT01463696|11692889|FG006|COMPLETED|Overall Study||6
10539929|NCT01463696|11692890|FG007|COMPLETED|Overall Study||2
10539930|NCT01463696|11692883|FG000|NOT COMPLETED|Overall Study||0
10539931|NCT01463696|11692884|FG001|NOT COMPLETED|Overall Study||2
10539932|NCT01463696|11692885|FG002|NOT COMPLETED|Overall Study||1
10539933|NCT01463696|11692886|FG003|NOT COMPLETED|Overall Study||4
10539934|NCT01463696|11692887|FG004|NOT COMPLETED|Overall Study||1
10539935|NCT01463696|11692888|FG005|NOT COMPLETED|Overall Study||3
10539936|NCT01463696|11692889|FG006|NOT COMPLETED|Overall Study||10
10539937|NCT01463696|11692890|FG007|NOT COMPLETED|Overall Study||4
10539938|NCT01463878|11692910|FG000|STARTED|Overall Study||9
10539939|NCT01463878|11692911|FG001|STARTED|Overall Study||9
10381290|NCT00607087|11522834|FG002|NOT COMPLETED|Period 1||5
10381291|NCT00607087|11522832|FG000|STARTED|Period 2||87
10658075|NCT02230566|11819211|FG000|NOT COMPLETED|Overall Study||0
10658076|NCT02230566|11819212|FG001|NOT COMPLETED|Overall Study||0
10658077|NCT02230566|11819213|FG002|NOT COMPLETED|Overall Study||0
10381292|NCT00607087|11522833|FG001|STARTED|Period 2||89
10381293|NCT00607087|11522834|FG002|STARTED|Period 2||89
10539940|NCT01463878|11692910|FG000|COMPLETED|Overall Study||7
10539941|NCT01463878|11692911|FG001|COMPLETED|Overall Study||7
10539942|NCT01463878|11692910|FG000|NOT COMPLETED|Overall Study||2
10658078|NCT02230566|11819214|FG003|NOT COMPLETED|Overall Study||0
10381294|NCT00607087|11522832|FG000|COMPLETED|Period 2||86
10539943|NCT01463878|11692911|FG001|NOT COMPLETED|Overall Study||2
10539944|NCT01463982|11692921|FG000|STARTED|Overall Study||3
10539945|NCT01463982|11692922|FG001|STARTED|Overall Study||8
10381295|NCT00607087|11522833|FG001|COMPLETED|Period 2||86
10381296|NCT00607087|11522834|FG002|COMPLETED|Period 2||84
10381297|NCT00607087|11522832|FG000|NOT COMPLETED|Period 2||1
10381298|NCT00607087|11522833|FG001|NOT COMPLETED|Period 2||3
10381299|NCT00607087|11522834|FG002|NOT COMPLETED|Period 2||5
10381300|NCT00607087|11522832|FG000|STARTED|Period 3||86
10381301|NCT00607087|11522833|FG001|STARTED|Period 3||86
10381302|NCT00607087|11522834|FG002|STARTED|Period 3||84
10381303|NCT00607087|11522832|FG000|COMPLETED|Period 3||84
10381304|NCT00607087|11522833|FG001|COMPLETED|Period 3||84
10381305|NCT00607087|11522834|FG002|COMPLETED|Period 3||84
10381306|NCT00607087|11522832|FG000|NOT COMPLETED|Period 3||2
10381307|NCT00607087|11522833|FG001|NOT COMPLETED|Period 3||2
10381308|NCT00607087|11522834|FG002|NOT COMPLETED|Period 3||0
10381309|NCT00607113|11522844|FG000|STARTED|Overall Study||19
10381310|NCT00607113|11522845|FG001|STARTED|Overall Study||20
10381311|NCT00607113|11522844|FG000|COMPLETED|Overall Study||19
10381312|NCT00607113|11522845|FG001|COMPLETED|Overall Study||20
10381313|NCT00607113|11522844|FG000|NOT COMPLETED|Overall Study||0
10381314|NCT00607113|11522845|FG001|NOT COMPLETED|Overall Study||0
10381315|NCT00607126|11522852|FG000|STARTED|Overall Study||17
10381316|NCT00607126|11522853|FG001|STARTED|Overall Study||19
10381317|NCT00607126|11522852|FG000|COMPLETED|Overall Study||17
10381318|NCT00607126|11522853|FG001|COMPLETED|Overall Study||19
10381319|NCT00607126|11522852|FG000|NOT COMPLETED|Overall Study||0
10381320|NCT00607126|11522853|FG001|NOT COMPLETED|Overall Study||0
10381321|NCT00607243|11522861|FG000|STARTED|Initial Post-vaccination Period||82
10381322|NCT00607243|11522862|FG001|STARTED|Initial Post-vaccination Period||41
10381323|NCT00607243|11522861|FG000|COMPLETED|Initial Post-vaccination Period||82
10381324|NCT00607243|11522862|FG001|COMPLETED|Initial Post-vaccination Period||41
10381325|NCT00607243|11522861|FG000|NOT COMPLETED|Initial Post-vaccination Period||0
10381326|NCT00607243|11522862|FG001|NOT COMPLETED|Initial Post-vaccination Period||0
10381327|NCT00607243|11522861|FG000|STARTED|Telephone Safety Assessment Period||82
10381328|NCT00607243|11522862|FG001|STARTED|Telephone Safety Assessment Period||41
10381329|NCT00607243|11522861|FG000|COMPLETED|Telephone Safety Assessment Period|80 Available for 3 months 77 Available for 6 months|77
10381330|NCT00607243|11522862|FG001|COMPLETED|Telephone Safety Assessment Period|40 Available for 3 months 39 Available for 6 months|39
10381331|NCT00607243|11522861|FG000|NOT COMPLETED|Telephone Safety Assessment Period||5
10381332|NCT00607243|11522862|FG001|NOT COMPLETED|Telephone Safety Assessment Period||2
10381333|NCT00607269|11522870|FG000|STARTED|Overall Study||67
10381334|NCT00607269|11522871|FG001|STARTED|Overall Study||64
10381335|NCT00607269|11522870|FG000|COMPLETED|Overall Study||67
10381336|NCT00607269|11522871|FG001|COMPLETED|Overall Study||64
10381337|NCT00607269|11522870|FG000|NOT COMPLETED|Overall Study||0
10381338|NCT00607269|11522871|FG001|NOT COMPLETED|Overall Study||0
10381339|NCT00607321|11522877|FG000|STARTED|Overall Study||60
10381340|NCT00607321|11522877|FG000|COMPLETED|Overall Study||60
10381341|NCT00607321|11522877|FG000|NOT COMPLETED|Overall Study||0
10381342|NCT00607373|11522885|FG000|STARTED|Treatment Period||17
10381343|NCT00607373|11522886|FG001|STARTED|Treatment Period||34
10381344|NCT00607373|11522885|FG000|COMPLETED|Treatment Period|16 enrolled in open-label extension study NCT00694109|17
10381345|NCT00607373|11522886|FG001|COMPLETED|Treatment Period|23 enrolled in open-label extension study NCT00694109|28
10381346|NCT00607373|11522885|FG000|NOT COMPLETED|Treatment Period||0
10381347|NCT00607373|11522886|FG001|NOT COMPLETED|Treatment Period||6
10381348|NCT00607373|11522885|FG000|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|1
10381349|NCT00607373|11522886|FG001|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|11
10381350|NCT00607373|11522885|FG000|COMPLETED|Follow-up Period||0
10381351|NCT00607373|11522886|FG001|COMPLETED|Follow-up Period||6
10381352|NCT00607373|11522885|FG000|NOT COMPLETED|Follow-up Period||1
10381353|NCT00607373|11522886|FG001|NOT COMPLETED|Follow-up Period||5
10381354|NCT00607386|11522892|FG000|STARTED|Overall Study||28
10381355|NCT00607386|11522892|FG000|COMPLETED|Overall Study||27
10381356|NCT00607386|11522892|FG000|NOT COMPLETED|Overall Study||1
10381357|NCT00607594|11522896|FG000|STARTED|Overall Study||21
10381358|NCT00607594|11522896|FG000|COMPLETED|Overall Study||21
10381359|NCT00607594|11522896|FG000|NOT COMPLETED|Overall Study||0
10381360|NCT00607620|11522904|FG000|STARTED|Overall Study||409
10381361|NCT00607620|11522905|FG001|STARTED|Overall Study||469
10381362|NCT00607620|11522904|FG000|COMPLETED|Overall Study||409
10381363|NCT00607620|11522905|FG001|COMPLETED|Overall Study||469
10381364|NCT00607620|11522904|FG000|NOT COMPLETED|Overall Study||0
10381365|NCT00607620|11522905|FG001|NOT COMPLETED|Overall Study||0
10381366|NCT00607672|11522914|FG000|STARTED|Overall Study||32
10381367|NCT00607672|11522915|FG001|STARTED|Overall Study||27
10381368|NCT00607672|11522916|FG002|STARTED|Overall Study||27
10381369|NCT00607672|11522914|FG000|COMPLETED|Overall Study||28
10381370|NCT00607672|11522915|FG001|COMPLETED|Overall Study||24
10381371|NCT00607672|11522916|FG002|COMPLETED|Overall Study||22
10381372|NCT00607672|11522914|FG000|NOT COMPLETED|Overall Study||4
10381373|NCT00607672|11522915|FG001|NOT COMPLETED|Overall Study||3
10381374|NCT00607672|11522916|FG002|NOT COMPLETED|Overall Study||5
10381375|NCT00607724|11522934|FG000|STARTED|Stage 1: Dose Escalation||7
10381376|NCT00607724|11522935|FG001|STARTED|Stage 1: Dose Escalation||9
10381377|NCT00607724|11522936|FG002|STARTED|Stage 1: Dose Escalation||4
10381378|NCT00607724|11522937|FG003|STARTED|Stage 1: Dose Escalation||0
10381379|NCT00607724|11522938|FG004|STARTED|Stage 1: Dose Escalation||0
10381380|NCT00607724|11522939|FG005|STARTED|Stage 1: Dose Escalation||0
10381381|NCT00607724|11522940|FG006|STARTED|Stage 1: Dose Escalation||0
10381382|NCT00607724|11522934|FG000|COMPLETED|Stage 1: Dose Escalation||0
10381383|NCT00607724|11522935|FG001|COMPLETED|Stage 1: Dose Escalation|Participants still on treatment at time of study closure were considered 'completers'.|1
10381384|NCT00607724|11522936|FG002|COMPLETED|Stage 1: Dose Escalation||0
10381385|NCT00607724|11522937|FG003|COMPLETED|Stage 1: Dose Escalation||0
10381386|NCT00607724|11522938|FG004|COMPLETED|Stage 1: Dose Escalation||0
10381387|NCT00607724|11522939|FG005|COMPLETED|Stage 1: Dose Escalation||0
10381388|NCT00607724|11522940|FG006|COMPLETED|Stage 1: Dose Escalation||0
10381389|NCT00607724|11522934|FG000|NOT COMPLETED|Stage 1: Dose Escalation||7
10381390|NCT00607724|11522935|FG001|NOT COMPLETED|Stage 1: Dose Escalation||8
10381391|NCT00607724|11522936|FG002|NOT COMPLETED|Stage 1: Dose Escalation||4
10381392|NCT00607724|11522937|FG003|NOT COMPLETED|Stage 1: Dose Escalation||0
10381393|NCT00607724|11522938|FG004|NOT COMPLETED|Stage 1: Dose Escalation||0
10381394|NCT00607724|11522939|FG005|NOT COMPLETED|Stage 1: Dose Escalation||0
10381395|NCT00607724|11522940|FG006|NOT COMPLETED|Stage 1: Dose Escalation||0
10381396|NCT00607724|11522934|FG000|STARTED|Stage 2: Expanded Cohort||0
10381397|NCT00607724|11522935|FG001|STARTED|Stage 2: Expanded Cohort||0
10381398|NCT00607724|11522936|FG002|STARTED|Stage 2: Expanded Cohort||0
10381399|NCT00607724|11522937|FG003|STARTED|Stage 2: Expanded Cohort||6
10381400|NCT00607724|11522938|FG004|STARTED|Stage 2: Expanded Cohort||14
10381401|NCT00607724|11522939|FG005|STARTED|Stage 2: Expanded Cohort||12
10381402|NCT00607724|11522940|FG006|STARTED|Stage 2: Expanded Cohort||16
10381403|NCT00607724|11522934|FG000|COMPLETED|Stage 2: Expanded Cohort||0
10381404|NCT00607724|11522935|FG001|COMPLETED|Stage 2: Expanded Cohort||0
10381405|NCT00607724|11522936|FG002|COMPLETED|Stage 2: Expanded Cohort||0
10381406|NCT00607724|11522937|FG003|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered 'completers'.|1
10381407|NCT00607724|11522938|FG004|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered 'completers'.|5
10381408|NCT00607724|11522939|FG005|COMPLETED|Stage 2: Expanded Cohort||0
10381409|NCT00607724|11522940|FG006|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered 'completers'.|5
10381410|NCT00607724|11522934|FG000|NOT COMPLETED|Stage 2: Expanded Cohort||0
10381411|NCT00607724|11522935|FG001|NOT COMPLETED|Stage 2: Expanded Cohort||0
10381412|NCT00607724|11522936|FG002|NOT COMPLETED|Stage 2: Expanded Cohort||0
10381413|NCT00607724|11522937|FG003|NOT COMPLETED|Stage 2: Expanded Cohort||5
10381414|NCT00607724|11522938|FG004|NOT COMPLETED|Stage 2: Expanded Cohort||9
10381415|NCT00607724|11522939|FG005|NOT COMPLETED|Stage 2: Expanded Cohort||12
10381416|NCT00607724|11522940|FG006|NOT COMPLETED|Stage 2: Expanded Cohort||11
10381417|NCT00607789|11522966|FG000|STARTED|Overall Study|20 participants were randomized in each group|20
10381418|NCT00607789|11522967|FG001|STARTED|Overall Study||20
10381419|NCT00607789|11522966|FG000|COMPLETED|Overall Study||13
10381420|NCT00607789|11522967|FG001|COMPLETED|Overall Study||14
10381421|NCT00607789|11522966|FG000|NOT COMPLETED|Overall Study||7
10381422|NCT00607789|11522967|FG001|NOT COMPLETED|Overall Study||6
10381423|NCT00607815|11522975|FG000|STARTED|Overall Study||43
10381424|NCT00607815|11522976|FG001|STARTED|Overall Study||36
10381425|NCT00607815|11522975|FG000|COMPLETED|Overall Study||20
10381426|NCT00607815|11522976|FG001|COMPLETED|Overall Study||25
10381427|NCT00607815|11522975|FG000|NOT COMPLETED|Overall Study||23
10381428|NCT00607815|11522976|FG001|NOT COMPLETED|Overall Study||11
10381429|NCT00607867|11522986|FG000|STARTED|Overall Study||7
10381430|NCT00607867|11522987|FG001|STARTED|Overall Study||7
10381431|NCT00607867|11522986|FG000|COMPLETED|Overall Study||7
10381432|NCT00607867|11522987|FG001|COMPLETED|Overall Study||7
10381433|NCT00607867|11522986|FG000|NOT COMPLETED|Overall Study||0
10381434|NCT00607867|11522987|FG001|NOT COMPLETED|Overall Study||0
10381435|NCT00607880|11522995|FG000|STARTED|Overall Study||50
10381436|NCT00607880|11522996|FG001|STARTED|Overall Study||50
10381437|NCT00607880|11522995|FG000|COMPLETED|Overall Study||49
10381438|NCT00607880|11522996|FG001|COMPLETED|Overall Study||50
10381439|NCT00607880|11522995|FG000|NOT COMPLETED|Overall Study||1
10381440|NCT00607880|11522996|FG001|NOT COMPLETED|Overall Study||0
10381441|NCT00607893|11523004|FG000|STARTED|Overall Study||77
10381442|NCT00607893|11523005|FG001|STARTED|Overall Study||76
10381443|NCT00607893|11523004|FG000|Completed Baseline Visit|Overall Study||74
10381444|NCT00607893|11523005|FG001|Completed Baseline Visit|Overall Study||75
10381445|NCT00607893|11523004|FG000|Completed 8 Week Visit|Overall Study||71
10381446|NCT00607893|11523005|FG001|Completed 8 Week Visit|Overall Study||72
10381447|NCT00607893|11523004|FG000|Completed 12 Week Visit|Overall Study|12 Week Visit only offered to participants on actual CPAP Treatment|0
10381448|NCT00607893|11523005|FG001|Completed 12 Week Visit|Overall Study|12 Week Visit only offered to participants on actual CPAP Treatment|29
10381449|NCT00607893|11523004|FG000|COMPLETED|Overall Study||71
10381450|NCT00607893|11523005|FG001|COMPLETED|Overall Study||72
10381451|NCT00607893|11523004|FG000|NOT COMPLETED|Overall Study||6
10381452|NCT00607893|11523005|FG001|NOT COMPLETED|Overall Study||4
10381453|NCT00607919|11523015|FG000|STARTED|Acute Phase||120
10381454|NCT00607919|11523016|FG001|STARTED|Acute Phase||89
10381455|NCT00607919|11523015|FG000|COMPLETED|Acute Phase|2 participants completed acute phase but did not continue into open-label.|86
10381456|NCT00607919|11523016|FG001|COMPLETED|Acute Phase|2 participants completed acute phase but did not continue into open-label.|73
10381457|NCT00607919|11523015|FG000|NOT COMPLETED|Acute Phase||34
10381458|NCT00607919|11523016|FG001|NOT COMPLETED|Acute Phase||16
10381459|NCT00607919|11523015|FG000|STARTED|Open-Label Phase||84
10381460|NCT00607919|11523016|FG001|STARTED|Open-Label Phase||71
10381461|NCT00607919|11523015|FG000|COMPLETED|Open-Label Phase||74
10381462|NCT00607919|11523016|FG001|COMPLETED|Open-Label Phase||59
10381463|NCT00607919|11523015|FG000|NOT COMPLETED|Open-Label Phase||10
10381464|NCT00607919|11523016|FG001|NOT COMPLETED|Open-Label Phase||12
10381465|NCT00607997|11523028|FG000|STARTED|Overall Study||29
10381466|NCT00607997|11523029|FG001|STARTED|Overall Study||35
10381467|NCT00607997|11523030|FG002|STARTED|Overall Study||29
10381468|NCT00607997|11523031|FG003|STARTED|Overall Study||20
10381469|NCT00607997|11523028|FG000|COMPLETED|Overall Study||2
10381470|NCT00607997|11523029|FG001|COMPLETED|Overall Study||8
10381471|NCT00607997|11523030|FG002|COMPLETED|Overall Study||5
10381472|NCT00607997|11523031|FG003|COMPLETED|Overall Study||4
10381473|NCT00607997|11523028|FG000|NOT COMPLETED|Overall Study||27
10381474|NCT00607997|11523029|FG001|NOT COMPLETED|Overall Study||27
10381475|NCT00607997|11523030|FG002|NOT COMPLETED|Overall Study||24
10381476|NCT00607997|11523031|FG003|NOT COMPLETED|Overall Study||16
10381477|NCT00608062|11523052|FG000|STARTED|Overall Study|25 women completed baseline testing, 4 women withdrew prior to randomization|12
10381478|NCT00608062|11523053|FG001|STARTED|Overall Study||12
10381479|NCT00608062|11523054|FG002|STARTED|Overall Study|43 women completed baseline testing, 3 women withdrew prior to randomization|19
10381480|NCT00608062|11523055|FG003|STARTED|Overall Study||21
10381481|NCT00608062|11523056|FG004|STARTED|Overall Study||13
10381482|NCT00608062|11523057|FG005|STARTED|Overall Study||15
10381483|NCT00608062|11523052|FG000|COMPLETED|Overall Study||12
10381484|NCT00608062|11523053|FG001|COMPLETED|Overall Study||12
10381485|NCT00608062|11523054|FG002|COMPLETED|Overall Study||19
10381486|NCT00608062|11523055|FG003|COMPLETED|Overall Study||21
10381487|NCT00608062|11523056|FG004|COMPLETED|Overall Study||13
10381488|NCT00608062|11523057|FG005|COMPLETED|Overall Study||15
10381489|NCT00608062|11523052|FG000|NOT COMPLETED|Overall Study||0
10381490|NCT00608062|11523053|FG001|NOT COMPLETED|Overall Study||0
10381491|NCT00608062|11523054|FG002|NOT COMPLETED|Overall Study||0
10381492|NCT00608062|11523055|FG003|NOT COMPLETED|Overall Study||0
10381493|NCT00608062|11523056|FG004|NOT COMPLETED|Overall Study||0
10381494|NCT00608062|11523057|FG005|NOT COMPLETED|Overall Study||0
10381495|NCT00608140|11523075|FG000|STARTED|Overall Study||1
10381496|NCT00608140|11523076|FG001|STARTED|Overall Study||1
10539946|NCT01463982|11692923|FG002|STARTED|Overall Study||4
10539947|NCT01463982|11692924|FG003|STARTED|Overall Study||6
10539948|NCT01463982|11692921|FG000|COMPLETED|Overall Study||3
10539949|NCT01463982|11692922|FG001|COMPLETED|Overall Study||7
10539950|NCT01463982|11692923|FG002|COMPLETED|Overall Study||2
10539951|NCT01463982|11692924|FG003|COMPLETED|Overall Study||6
10539952|NCT01463982|11692921|FG000|NOT COMPLETED|Overall Study||0
10539953|NCT01463982|11692922|FG001|NOT COMPLETED|Overall Study||1
10539954|NCT01463982|11692923|FG002|NOT COMPLETED|Overall Study||2
10539955|NCT01463982|11692924|FG003|NOT COMPLETED|Overall Study||0
10539956|NCT01464021|11692934|FG000|STARTED|Overall Study||26
10539957|NCT01464021|11692934|FG000|COMPLETED|Overall Study||0
10539958|NCT01464021|11692934|FG000|NOT COMPLETED|Overall Study||26
10539959|NCT01464190|11692940|FG000|STARTED|Overall Study||391
10539960|NCT01464190|11692941|FG001|STARTED|Overall Study||268
10539961|NCT01464190|11692940|FG000|COMPLETED|Overall Study||322
10539962|NCT01464190|11692941|FG001|COMPLETED|Overall Study||227
10539963|NCT01464190|11692940|FG000|NOT COMPLETED|Overall Study||69
10658079|NCT02230579|11819226|FG000|STARTED|Overall Study||6
10658080|NCT02230579|11819227|FG001|STARTED|Overall Study||6
10658081|NCT02230579|11819228|FG002|STARTED|Overall Study||6
10658082|NCT02230579|11819229|FG003|STARTED|Overall Study||6
10658083|NCT02230579|11819230|FG004|STARTED|Overall Study||6
10658084|NCT02230579|11819231|FG005|STARTED|Overall Study||6
10658085|NCT02230579|11819232|FG006|STARTED|Overall Study||12
10717859|NCT02701634|11881865|FG001|NOT COMPLETED|Overall Study||31
10717860|NCT02701647|11881875|FG000|STARTED|Overall Study||17
10717861|NCT02701647|11881876|FG001|STARTED|Overall Study||17
10717862|NCT02701647|11881877|FG002|STARTED|Overall Study||17
10717863|NCT02701647|11881875|FG000|COMPLETED|Overall Study||17
10717864|NCT02701647|11881876|FG001|COMPLETED|Overall Study||17
10717865|NCT02701647|11881877|FG002|COMPLETED|Overall Study|One participant from sham-TT withdraw due a back injury unrelated to study.|16
10717866|NCT02701647|11881875|FG000|NOT COMPLETED|Overall Study||0
10717867|NCT02701647|11881876|FG001|NOT COMPLETED|Overall Study||0
10717868|NCT02701647|11881877|FG002|NOT COMPLETED|Overall Study||1
10539964|NCT01464190|11692941|FG001|NOT COMPLETED|Overall Study||41
10539965|NCT01464229|11692949|FG000|STARTED|Overall Study||10
10539966|NCT01464229|11692950|FG001|STARTED|Overall Study||10
10539967|NCT01464229|11692949|FG000|COMPLETED|Overall Study||5
10717869|NCT02701764|11881893|FG000|STARTED|Overall Study||21
10717870|NCT02701764|11881894|FG001|STARTED|Overall Study||22
10717871|NCT02701764|11881893|FG000|COMPLETED|Overall Study||21
10717872|NCT02701764|11881894|FG001|COMPLETED|Overall Study||21
10717873|NCT02701764|11881893|FG000|NOT COMPLETED|Overall Study||0
10539968|NCT01464229|11692950|FG001|COMPLETED|Overall Study||8
10539969|NCT01464229|11692949|FG000|NOT COMPLETED|Overall Study||5
10717874|NCT02701764|11881894|FG001|NOT COMPLETED|Overall Study||1
10717875|NCT02701868|11881903|FG000|STARTED|Overall Study||21
10717876|NCT02701868|11881904|FG001|STARTED|Overall Study||75
10381497|NCT00608140|11523075|FG000|COMPLETED|Overall Study|Study ended early due to low enrollment|0
10381498|NCT00608140|11523076|FG001|COMPLETED|Overall Study|Study ended early due to low enrollment|0
10381499|NCT00608140|11523075|FG000|NOT COMPLETED|Overall Study||1
10381500|NCT00608140|11523076|FG001|NOT COMPLETED|Overall Study||1
10658086|NCT02230579|11819226|FG000|COMPLETED|Overall Study||6
10381501|NCT00608205|11523093|FG000|STARTED|Overall Study||35
10381502|NCT00608205|11523094|FG001|STARTED|Overall Study||34
10381503|NCT00608205|11523093|FG000|COMPLETED|Overall Study||32
10381504|NCT00608205|11523094|FG001|COMPLETED|Overall Study||31
10381505|NCT00608205|11523093|FG000|NOT COMPLETED|Overall Study||3
10381506|NCT00608205|11523094|FG001|NOT COMPLETED|Overall Study||3
10381507|NCT00608244|11523102|FG000|STARTED|Overall Study||59
10381508|NCT00608244|11523102|FG000|COMPLETED|Overall Study||57
10381509|NCT00608244|11523102|FG000|NOT COMPLETED|Overall Study||2
10381510|NCT00608322|11523110|FG000|STARTED|Overall Study||26
10381511|NCT00608322|11523111|FG001|STARTED|Overall Study||23
10381512|NCT00608322|11523110|FG000|COMPLETED|Overall Study||24
10381513|NCT00608322|11523111|FG001|COMPLETED|Overall Study||22
10381514|NCT00608322|11523110|FG000|NOT COMPLETED|Overall Study||2
10381515|NCT00608322|11523111|FG001|NOT COMPLETED|Overall Study||1
10381516|NCT00608426|11523119|FG000|STARTED|Overall Study||2604
10381517|NCT00608426|11523120|FG001|STARTED|Overall Study||2519
10381518|NCT00608426|11523119|FG000|COMPLETED|Overall Study|This is total # of completed surveys. Not completed primary outcome.|1768
10381519|NCT00608426|11523120|FG001|COMPLETED|Overall Study|This is total # of completed surveys. Not completed primary outcome.|1614
10381520|NCT00608426|11523119|FG000|NOT COMPLETED|Overall Study||836
10381521|NCT00608426|11523120|FG001|NOT COMPLETED|Overall Study||905
10381522|NCT00608491|11523128|FG000|STARTED|Overall Study||94
10381523|NCT00608491|11523129|FG001|STARTED|Overall Study||94
10381524|NCT00608491|11523128|FG000|COMPLETED|Overall Study||73
10381525|NCT00608491|11523129|FG001|COMPLETED|Overall Study||72
10381526|NCT00608491|11523128|FG000|NOT COMPLETED|Overall Study||21
10381527|NCT00608491|11523129|FG001|NOT COMPLETED|Overall Study||22
10381528|NCT00608517|11523138|FG000|STARTED|Overall Study||2
10381529|NCT00608517|11523139|FG001|STARTED|Overall Study||3
10381530|NCT00608517|11523140|FG002|STARTED|Overall Study||1
10381531|NCT00608517|11523138|FG000|COMPLETED|Overall Study||1
10381532|NCT00608517|11523139|FG001|COMPLETED|Overall Study||3
10381533|NCT00608517|11523140|FG002|COMPLETED|Overall Study||1
10381534|NCT00608517|11523138|FG000|NOT COMPLETED|Overall Study||1
10381535|NCT00608517|11523139|FG001|NOT COMPLETED|Overall Study||0
10381536|NCT00608517|11523140|FG002|NOT COMPLETED|Overall Study||0
10539970|NCT01464229|11692950|FG001|NOT COMPLETED|Overall Study||2
10539971|NCT01464255|11692958|FG000|STARTED|Overall Study||25
10539972|NCT01464255|11692959|FG001|STARTED|Overall Study||25
10539973|NCT01464255|11692958|FG000|COMPLETED|Overall Study||25
10539974|NCT01464255|11692959|FG001|COMPLETED|Overall Study||24
10539975|NCT01464255|11692958|FG000|NOT COMPLETED|Overall Study||0
10381537|NCT00608530|11523153|FG000|STARTED|Study 1 Psychologist-delivered Treatment|Randomized|33
10381538|NCT00608530|11523154|FG001|STARTED|Study 1 Psychologist-delivered Treatment|Randomized|33
10381539|NCT00608530|11523155|FG002|STARTED|Study 1 Psychologist-delivered Treatment||0
10381540|NCT00608530|11523156|FG003|STARTED|Study 1 Psychologist-delivered Treatment||0
10381541|NCT00608530|11523153|FG000|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||28
10381542|NCT00608530|11523154|FG001|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||31
10381543|NCT00608530|11523155|FG002|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||0
10381544|NCT00608530|11523156|FG003|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||0
10381545|NCT00608530|11523153|FG000|COMPLETED|Study 1 Psychologist-delivered Treatment||22
10381546|NCT00608530|11523154|FG001|COMPLETED|Study 1 Psychologist-delivered Treatment||28
10381547|NCT00608530|11523155|FG002|COMPLETED|Study 1 Psychologist-delivered Treatment||0
10381548|NCT00608530|11523156|FG003|COMPLETED|Study 1 Psychologist-delivered Treatment||0
10381549|NCT00608530|11523153|FG000|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||11
10381550|NCT00608530|11523154|FG001|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||5
10381551|NCT00608530|11523155|FG002|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||0
10381552|NCT00608530|11523156|FG003|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||0
10381553|NCT00608530|11523153|FG000|STARTED|Study 2 Nurse-delivered Treatments||0
10381554|NCT00608530|11523154|FG001|STARTED|Study 2 Nurse-delivered Treatments||0
10381555|NCT00608530|11523155|FG002|STARTED|Study 2 Nurse-delivered Treatments||33
10381556|NCT00608530|11523156|FG003|STARTED|Study 2 Nurse-delivered Treatments||34
10381557|NCT00608530|11523153|FG000|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||0
10381558|NCT00608530|11523154|FG001|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||0
10381559|NCT00608530|11523155|FG002|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||30
10381560|NCT00608530|11523156|FG003|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||31
10381561|NCT00608530|11523153|FG000|COMPLETED|Study 2 Nurse-delivered Treatments||0
10381562|NCT00608530|11523154|FG001|COMPLETED|Study 2 Nurse-delivered Treatments||0
10381563|NCT00608530|11523155|FG002|COMPLETED|Study 2 Nurse-delivered Treatments||21
10381564|NCT00608530|11523156|FG003|COMPLETED|Study 2 Nurse-delivered Treatments||27
10381565|NCT00608530|11523153|FG000|NOT COMPLETED|Study 2 Nurse-delivered Treatments||0
10381566|NCT00608530|11523154|FG001|NOT COMPLETED|Study 2 Nurse-delivered Treatments||0
10381567|NCT00608530|11523155|FG002|NOT COMPLETED|Study 2 Nurse-delivered Treatments||12
10381568|NCT00608530|11523156|FG003|NOT COMPLETED|Study 2 Nurse-delivered Treatments||7
10381569|NCT00608543|11523171|FG000|STARTED|Overall Study||17
10381570|NCT00608543|11523171|FG000|COMPLETED|Overall Study||13
10381571|NCT00608543|11523171|FG000|NOT COMPLETED|Overall Study||4
10381572|NCT00608569|11523178|FG000|STARTED|Overall Study||129
10381573|NCT00608569|11523179|FG001|STARTED|Overall Study||128
10381574|NCT00608569|11523178|FG000|COMPLETED|Overall Study||119
10381575|NCT00608569|11523179|FG001|COMPLETED|Overall Study||119
10381576|NCT00608569|11523178|FG000|NOT COMPLETED|Overall Study||10
10381577|NCT00608569|11523179|FG001|NOT COMPLETED|Overall Study||9
10381578|NCT00608582|11523187|FG000|STARTED|Overall Study||14
10381579|NCT00608582|11523188|FG001|STARTED|Overall Study||11
10381580|NCT00608582|11523187|FG000|COMPLETED|Overall Study||10
10381581|NCT00608582|11523188|FG001|COMPLETED|Overall Study||7
10381582|NCT00608582|11523187|FG000|NOT COMPLETED|Overall Study||4
10381583|NCT00608582|11523188|FG001|NOT COMPLETED|Overall Study||4
10381584|NCT00608634|11523199|FG000|STARTED|Overall Study||28
10381585|NCT00608634|11523200|FG001|STARTED|Overall Study||27
10381586|NCT00608634|11523201|FG002|STARTED|Overall Study||28
10381587|NCT00608634|11523199|FG000|COMPLETED|Overall Study||26
10381588|NCT00608634|11523200|FG001|COMPLETED|Overall Study||26
10381589|NCT00608634|11523201|FG002|COMPLETED|Overall Study||27
10381590|NCT00608634|11523199|FG000|NOT COMPLETED|Overall Study||2
10381591|NCT00608634|11523200|FG001|NOT COMPLETED|Overall Study||1
10381592|NCT00608634|11523201|FG002|NOT COMPLETED|Overall Study||1
10381593|NCT00608829|11523211|FG000|STARTED|Overall Study||23
10381594|NCT00608829|11523211|FG000|COMPLETED|Overall Study||8
10381595|NCT00608829|11523211|FG000|NOT COMPLETED|Overall Study||15
10381596|NCT00608842|11523219|FG000|STARTED|Overall Study||15
10381597|NCT00608842|11523220|FG001|STARTED|Overall Study||15
10381598|NCT00608842|11523221|FG002|STARTED|Overall Study||15
10381599|NCT00608842|11523222|FG003|STARTED|Overall Study||17
10381600|NCT00608842|11523219|FG000|COMPLETED|Overall Study||14
10381601|NCT00608842|11523220|FG001|COMPLETED|Overall Study||14
10381602|NCT00608842|11523221|FG002|COMPLETED|Overall Study||13
10381603|NCT00608842|11523222|FG003|COMPLETED|Overall Study||16
10381604|NCT00608842|11523219|FG000|NOT COMPLETED|Overall Study||1
10381605|NCT00608842|11523220|FG001|NOT COMPLETED|Overall Study||1
10381606|NCT00608842|11523221|FG002|NOT COMPLETED|Overall Study||2
10381607|NCT00608842|11523222|FG003|NOT COMPLETED|Overall Study||1
10381608|NCT00608868|11523232|FG000|STARTED|Overall Study||156
10381609|NCT00608868|11523232|FG000|Enrolled|Overall Study||156
10381610|NCT00608868|11523232|FG000|Safety Population|Overall Study|2 patients who received no study treatment were excluded|154
10381611|NCT00608868|11523232|FG000|Treatment Completed|Overall Study||141
10381612|NCT00608868|11523232|FG000|Intention to Treat (ITT) Population|Overall Study|8 patients who had no target lesion and 8 who had no tumor assessment after baseline were excluded|138
10381613|NCT00608868|11523232|FG000|Per Protocol (PP) Population|Overall Study||121
10381614|NCT00608868|11523232|FG000|COMPLETED|Overall Study||141
10381615|NCT00608868|11523232|FG000|NOT COMPLETED|Overall Study||15
10381616|NCT00608881|11523238|FG000|STARTED|Overall Study||303
10381617|NCT00608881|11523239|FG001|STARTED|Overall Study||306
10381618|NCT00608881|11523238|FG000|COMPLETED|Overall Study||224
10381619|NCT00608881|11523239|FG001|COMPLETED|Overall Study||240
10381620|NCT00608881|11523238|FG000|NOT COMPLETED|Overall Study||79
10381621|NCT00608881|11523239|FG001|NOT COMPLETED|Overall Study||66
10381622|NCT00608894|11523247|FG000|STARTED|Overall Study||7
10381623|NCT00608894|11523248|FG001|STARTED|Overall Study||6
10381624|NCT00608894|11523247|FG000|COMPLETED|Overall Study||7
10381625|NCT00608894|11523248|FG001|COMPLETED|Overall Study|One patient was granted permission to crossover to LCP-Tacro due to treatment intolerance|4
10381626|NCT00608894|11523247|FG000|NOT COMPLETED|Overall Study||0
10381627|NCT00608894|11523248|FG001|NOT COMPLETED|Overall Study||2
10381628|NCT00608907|11523259|FG000|STARTED|Overall Study||30
10381629|NCT00608907|11523260|FG001|STARTED|Overall Study||13
10381630|NCT00608907|11523261|FG002|STARTED|Overall Study||18
10381631|NCT00608907|11523259|FG000|COMPLETED|Overall Study||18
10381632|NCT00608907|11523260|FG001|COMPLETED|Overall Study||13
10381633|NCT00608907|11523261|FG002|COMPLETED|Overall Study||17
10381634|NCT00608907|11523259|FG000|NOT COMPLETED|Overall Study||12
10381635|NCT00608907|11523260|FG001|NOT COMPLETED|Overall Study||0
10381636|NCT00608907|11523261|FG002|NOT COMPLETED|Overall Study||1
10381637|NCT00608959|11523271|FG000|STARTED|Part 1|25 subjects each participated in Parts 1 and 2 .A total of 20 subjects participated in both parts.|25
10381638|NCT00608959|11523271|FG000|COMPLETED|Part 1||24
10381639|NCT00608959|11523271|FG000|NOT COMPLETED|Part 1||1
10381640|NCT00608959|11523271|FG000|STARTED|Part 2|20 Part 1 subjects also participated in Part 2.Five more subjects were enrolled for a total of 25.|25
10381641|NCT00608959|11523271|FG000|COMPLETED|Part 2||25
10381642|NCT00608959|11523271|FG000|NOT COMPLETED|Part 2||0
10381643|NCT00608985|11523285|FG000|STARTED|Overall Study|Randomized and started double-blind treatment|177
10381644|NCT00608985|11523286|FG001|STARTED|Overall Study|Randomized and started double-blind treatment|186
10381645|NCT00608985|11523287|FG002|STARTED|Overall Study|Randomized and started double-blind treatment|176
10381646|NCT00608985|11523288|FG003|STARTED|Overall Study|Randomized and started double-blind treatment|168
10539976|NCT01464255|11692959|FG001|NOT COMPLETED|Overall Study||1
10381647|NCT00608985|11523285|FG000|Completed Double-blind Treatment|Overall Study||163
10381648|NCT00608985|11523286|FG001|Completed Double-blind Treatment|Overall Study||174
10381649|NCT00608985|11523287|FG002|Completed Double-blind Treatment|Overall Study||171
10381650|NCT00608985|11523288|FG003|Completed Double-blind Treatment|Overall Study||161
10381651|NCT00608985|11523285|FG000|COMPLETED|Overall Study|Completed follow-up|161
10381652|NCT00608985|11523286|FG001|COMPLETED|Overall Study|Completed follow-up|173
10381653|NCT00608985|11523287|FG002|COMPLETED|Overall Study|Completed follow-up|170
10381654|NCT00608985|11523288|FG003|COMPLETED|Overall Study|Completed follow-up|159
10381655|NCT00608985|11523285|FG000|NOT COMPLETED|Overall Study||16
10381656|NCT00608985|11523286|FG001|NOT COMPLETED|Overall Study||13
10381657|NCT00608985|11523287|FG002|NOT COMPLETED|Overall Study||6
10539977|NCT01464307|11692968|FG000|STARTED|Main Period||144
10381658|NCT00608985|11523288|FG003|NOT COMPLETED|Overall Study||9
10717877|NCT02701868|11881905|FG002|STARTED|Overall Study||75
10717878|NCT02701868|11881903|FG000|COMPLETED|Overall Study||21
10717879|NCT02701868|11881904|FG001|COMPLETED|Overall Study||75
10717880|NCT02701868|11881905|FG002|COMPLETED|Overall Study||75
10381659|NCT00609128|11523298|FG000|STARTED|Overall Study||21
10381660|NCT00609128|11523298|FG000|COMPLETED|Overall Study||21
10381661|NCT00609128|11523298|FG000|NOT COMPLETED|Overall Study||0
10381662|NCT00609167|11523305|FG000|STARTED|Overall Study||33
10381663|NCT00609167|11523306|FG001|STARTED|Overall Study||30
10381664|NCT00609167|11523305|FG000|COMPLETED|Overall Study||25
10381665|NCT00609167|11523306|FG001|COMPLETED|Overall Study||23
10381666|NCT00609167|11523305|FG000|NOT COMPLETED|Overall Study||8
10381667|NCT00609167|11523306|FG001|NOT COMPLETED|Overall Study||7
10381668|NCT00609245|11523312|FG000|STARTED|Overall Study||13
10381669|NCT00609245|11523312|FG000|COMPLETED|Overall Study||12
10381670|NCT00609245|11523312|FG000|NOT COMPLETED|Overall Study||1
10381671|NCT00609271|11523320|FG000|STARTED|Overall Study||75
10381672|NCT00609271|11523321|FG001|STARTED|Overall Study||73
10381673|NCT00609271|11523320|FG000|COMPLETED|Overall Study||59
10381674|NCT00609271|11523321|FG001|COMPLETED|Overall Study||60
10381675|NCT00609271|11523320|FG000|NOT COMPLETED|Overall Study||16
10381676|NCT00609271|11523321|FG001|NOT COMPLETED|Overall Study||13
10381677|NCT00609336|11523327|FG000|STARTED|Overall Study||35
10381678|NCT00609336|11523327|FG000|Surgery|Overall Study||22
10381679|NCT00609336|11523327|FG000|COMPLETED|Overall Study||22
10381680|NCT00609336|11523327|FG000|NOT COMPLETED|Overall Study||13
10381681|NCT00609362|11523334|FG000|STARTED|Overall Study||29
10381682|NCT00609362|11523335|FG001|STARTED|Overall Study||28
10381683|NCT00609362|11523334|FG000|COMPLETED|Overall Study||26
10381684|NCT00609362|11523335|FG001|COMPLETED|Overall Study||27
10381685|NCT00609362|11523334|FG000|NOT COMPLETED|Overall Study||3
10381686|NCT00609362|11523335|FG001|NOT COMPLETED|Overall Study||1
10381687|NCT00609466|11523344|FG000|STARTED|Overall Study||96
10381688|NCT00609466|11523345|FG001|STARTED|Overall Study||96
10381689|NCT00609466|11523346|FG002|STARTED|Overall Study||99
10381690|NCT00609466|11523344|FG000|COMPLETED|Overall Study||94
10381691|NCT00609466|11523345|FG001|COMPLETED|Overall Study||90
10381692|NCT00609466|11523346|FG002|COMPLETED|Overall Study||95
10381693|NCT00609466|11523344|FG000|NOT COMPLETED|Overall Study||2
10381694|NCT00609466|11523345|FG001|NOT COMPLETED|Overall Study||6
10381695|NCT00609466|11523346|FG002|NOT COMPLETED|Overall Study||4
10381696|NCT00609492|11523357|FG000|STARTED|Overall Study||44
10381697|NCT00609492|11523358|FG001|STARTED|Overall Study||72
10381698|NCT00609492|11523359|FG002|STARTED|Overall Study||129
10381699|NCT00609492|11523357|FG000|COMPLETED|Overall Study||43
10381700|NCT00609492|11523358|FG001|COMPLETED|Overall Study||69
10381701|NCT00609492|11523359|FG002|COMPLETED|Overall Study||122
10381702|NCT00609492|11523357|FG000|NOT COMPLETED|Overall Study||1
10381703|NCT00609492|11523358|FG001|NOT COMPLETED|Overall Study||3
10381704|NCT00609492|11523359|FG002|NOT COMPLETED|Overall Study||7
10381705|NCT00609518|11523371|FG000|STARTED|Overall Study||54
10381706|NCT00609518|11523372|FG001|STARTED|Overall Study||57
10381707|NCT00609518|11523371|FG000|Completed 6 Treatment Cycles|Overall Study||19
10381708|NCT00609518|11523372|FG001|Completed 6 Treatment Cycles|Overall Study||22
10381709|NCT00609518|11523371|FG000|COMPLETED|Overall Study||11
10381710|NCT00609518|11523372|FG001|COMPLETED|Overall Study||17
10381711|NCT00609518|11523371|FG000|NOT COMPLETED|Overall Study||43
10381712|NCT00609518|11523372|FG001|NOT COMPLETED|Overall Study||40
10381713|NCT00609609|11523380|FG000|STARTED|Overall Study||30
10381714|NCT00609609|11523381|FG001|STARTED|Overall Study||51
10381715|NCT00609609|11523380|FG000|COMPLETED|Overall Study||24
10381716|NCT00609609|11523381|FG001|COMPLETED|Overall Study||49
10381717|NCT00609609|11523380|FG000|NOT COMPLETED|Overall Study||6
10381718|NCT00609609|11523381|FG001|NOT COMPLETED|Overall Study||2
10381719|NCT00609622|11523389|FG000|STARTED|Overall Study||96
10381720|NCT00609622|11523390|FG001|STARTED|Overall Study||95
10381721|NCT00609622|11523389|FG000|COMPLETED|Overall Study||0
10381722|NCT00609622|11523390|FG001|COMPLETED|Overall Study||0
10381723|NCT00609622|11523389|FG000|NOT COMPLETED|Overall Study||96
10381724|NCT00609622|11523390|FG001|NOT COMPLETED|Overall Study||95
10717881|NCT02701868|11881903|FG000|NOT COMPLETED|Overall Study||0
10717882|NCT02701868|11881904|FG001|NOT COMPLETED|Overall Study||0
10381725|NCT00609674|11523398|FG000|STARTED|Overall Study||155
10381726|NCT00609674|11523399|FG001|STARTED|Overall Study||160
10381727|NCT00609674|11523398|FG000|COMPLETED|Overall Study||148
10381728|NCT00609674|11523399|FG001|COMPLETED|Overall Study||153
10381729|NCT00609674|11523398|FG000|NOT COMPLETED|Overall Study||7
10381730|NCT00609674|11523399|FG001|NOT COMPLETED|Overall Study||7
10381731|NCT00609739|11523405|FG000|STARTED|Overall Study||1
10381732|NCT00609739|11523405|FG000|COMPLETED|Overall Study||1
10381733|NCT00609739|11523405|FG000|NOT COMPLETED|Overall Study||0
10381734|NCT00609804|11523411|FG000|STARTED|Overall Study||25
10381735|NCT00609804|11523412|FG001|STARTED|Overall Study||28
10381736|NCT00609804|11523411|FG000|COMPLETED|Overall Study|Pts remained on study until required to end treatment due to progression/toxicity/MD decision/etc|0
10381737|NCT00609804|11523412|FG001|COMPLETED|Overall Study|Pts remained on study until required to end treatment due to progression/toxicity/MD decision/etc|0
10381738|NCT00609804|11523411|FG000|NOT COMPLETED|Overall Study||25
10381739|NCT00609804|11523412|FG001|NOT COMPLETED|Overall Study||28
10381740|NCT00609869|11523421|FG000|STARTED|Overall Study||29
10717883|NCT02701868|11881905|FG002|NOT COMPLETED|Overall Study||0
10717884|NCT02701985|11881916|FG000|STARTED|Overall Study||37
10381741|NCT00609869|11523421|FG000|COMPLETED|Overall Study||18
10381742|NCT00609869|11523421|FG000|NOT COMPLETED|Overall Study||11
10381743|NCT00609947|11523425|FG000|STARTED|Overall Study||241
10381744|NCT00609947|11523425|FG000|COMPLETED|Overall Study|One death due to automobile accident.|240
10381745|NCT00609947|11523425|FG000|NOT COMPLETED|Overall Study||1
10381746|NCT00609973|11523432|FG000|STARTED|Overall Study||17
10381747|NCT00609973|11523433|FG001|STARTED|Overall Study||16
10381748|NCT00609973|11523432|FG000|COMPLETED|Overall Study||9
10381749|NCT00609973|11523433|FG001|COMPLETED|Overall Study||10
10381750|NCT00609973|11523432|FG000|NOT COMPLETED|Overall Study||8
10381751|NCT00609973|11523433|FG001|NOT COMPLETED|Overall Study||6
10381752|NCT00609986|11523441|FG000|STARTED|Overall Study||52
10381753|NCT00609986|11523442|FG001|STARTED|Overall Study||52
10381754|NCT00609986|11523441|FG000|Received Transplant|Overall Study||44
10381755|NCT00609986|11523442|FG001|Received Transplant|Overall Study||49
10381756|NCT00609986|11523441|FG000|COMPLETED|Overall Study||44
10381757|NCT00609986|11523442|FG001|COMPLETED|Overall Study||49
10381758|NCT00609986|11523441|FG000|NOT COMPLETED|Overall Study||8
10381759|NCT00609986|11523442|FG001|NOT COMPLETED|Overall Study||3
10381760|NCT00610116|11523448|FG000|STARTED|Overall Study||305
10381761|NCT00610116|11523448|FG000|COMPLETED|Overall Study|Number of analyzable patients|292
10381762|NCT00610116|11523448|FG000|NOT COMPLETED|Overall Study||13
10381763|NCT00610129|11523452|FG000|STARTED|Overall Study||28
10381764|NCT00610129|11523452|FG000|COMPLETED|Overall Study||25
10381765|NCT00610129|11523452|FG000|NOT COMPLETED|Overall Study||3
10381766|NCT00610155|11523456|FG000|STARTED|Period 1||4
10381767|NCT00610155|11523457|FG001|STARTED|Period 1||3
10381768|NCT00610155|11523458|FG002|STARTED|Period 1||4
10381769|NCT00610155|11523459|FG003|STARTED|Period 1||3
10381770|NCT00610155|11523460|FG004|STARTED|Period 1||3
10381771|NCT00610155|11523461|FG005|STARTED|Period 1||1
10381772|NCT00610155|11523456|FG000|COMPLETED|Period 1||4
10381773|NCT00610155|11523457|FG001|COMPLETED|Period 1||3
10381774|NCT00610155|11523458|FG002|COMPLETED|Period 1||3
10381775|NCT00610155|11523459|FG003|COMPLETED|Period 1||3
10381776|NCT00610155|11523460|FG004|COMPLETED|Period 1||3
10381777|NCT00610155|11523461|FG005|COMPLETED|Period 1||1
10381778|NCT00610155|11523456|FG000|NOT COMPLETED|Period 1||0
10381779|NCT00610155|11523457|FG001|NOT COMPLETED|Period 1||0
10381780|NCT00610155|11523458|FG002|NOT COMPLETED|Period 1||1
10381781|NCT00610155|11523459|FG003|NOT COMPLETED|Period 1||0
10381782|NCT00610155|11523460|FG004|NOT COMPLETED|Period 1||0
10381783|NCT00610155|11523461|FG005|NOT COMPLETED|Period 1||0
10381784|NCT00610155|11523456|FG000|STARTED|Washout Period 1 (7 Days)||4
10381785|NCT00610155|11523457|FG001|STARTED|Washout Period 1 (7 Days)||3
10381786|NCT00610155|11523458|FG002|STARTED|Washout Period 1 (7 Days)||3
10717885|NCT02701985|11881917|FG001|STARTED|Overall Study||38
10381787|NCT00610155|11523459|FG003|STARTED|Washout Period 1 (7 Days)||3
10381788|NCT00610155|11523460|FG004|STARTED|Washout Period 1 (7 Days)||3
10381789|NCT00610155|11523461|FG005|STARTED|Washout Period 1 (7 Days)||1
10381790|NCT00610155|11523456|FG000|COMPLETED|Washout Period 1 (7 Days)||4
10381791|NCT00610155|11523457|FG001|COMPLETED|Washout Period 1 (7 Days)||3
10381792|NCT00610155|11523458|FG002|COMPLETED|Washout Period 1 (7 Days)||3
10381793|NCT00610155|11523459|FG003|COMPLETED|Washout Period 1 (7 Days)||3
10381794|NCT00610155|11523460|FG004|COMPLETED|Washout Period 1 (7 Days)||3
10381795|NCT00610155|11523461|FG005|COMPLETED|Washout Period 1 (7 Days)||1
10381796|NCT00610155|11523456|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
10381797|NCT00610155|11523457|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
10381798|NCT00610155|11523458|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
10381799|NCT00610155|11523459|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
10381800|NCT00610155|11523460|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
10381801|NCT00610155|11523461|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
10381802|NCT00610155|11523456|FG000|STARTED|Period 2||4
10381803|NCT00610155|11523457|FG001|STARTED|Period 2||3
10381804|NCT00610155|11523458|FG002|STARTED|Period 2||3
10381805|NCT00610155|11523459|FG003|STARTED|Period 2||3
10381806|NCT00610155|11523460|FG004|STARTED|Period 2||3
10381807|NCT00610155|11523461|FG005|STARTED|Period 2||1
10381808|NCT00610155|11523456|FG000|COMPLETED|Period 2||4
10381809|NCT00610155|11523457|FG001|COMPLETED|Period 2||3
10381810|NCT00610155|11523458|FG002|COMPLETED|Period 2||3
10381811|NCT00610155|11523459|FG003|COMPLETED|Period 2||3
10381812|NCT00610155|11523460|FG004|COMPLETED|Period 2||3
10381813|NCT00610155|11523461|FG005|COMPLETED|Period 2||1
10381814|NCT00610155|11523456|FG000|NOT COMPLETED|Period 2||0
10381815|NCT00610155|11523457|FG001|NOT COMPLETED|Period 2||0
10381816|NCT00610155|11523458|FG002|NOT COMPLETED|Period 2||0
10381817|NCT00610155|11523459|FG003|NOT COMPLETED|Period 2||0
10381818|NCT00610155|11523460|FG004|NOT COMPLETED|Period 2||0
10381819|NCT00610155|11523461|FG005|NOT COMPLETED|Period 2||0
10381820|NCT00610155|11523456|FG000|STARTED|Washout Period 2 (7 Days)||4
10381821|NCT00610155|11523457|FG001|STARTED|Washout Period 2 (7 Days)||3
10381822|NCT00610155|11523458|FG002|STARTED|Washout Period 2 (7 Days)||3
10381823|NCT00610155|11523459|FG003|STARTED|Washout Period 2 (7 Days)||3
10381824|NCT00610155|11523460|FG004|STARTED|Washout Period 2 (7 Days)||3
10381825|NCT00610155|11523461|FG005|STARTED|Washout Period 2 (7 Days)||1
10381826|NCT00610155|11523456|FG000|COMPLETED|Washout Period 2 (7 Days)||4
10381827|NCT00610155|11523457|FG001|COMPLETED|Washout Period 2 (7 Days)||3
10381828|NCT00610155|11523458|FG002|COMPLETED|Washout Period 2 (7 Days)||3
10381829|NCT00610155|11523459|FG003|COMPLETED|Washout Period 2 (7 Days)||3
10381830|NCT00610155|11523460|FG004|COMPLETED|Washout Period 2 (7 Days)||3
10717886|NCT02701985|11881916|FG000|COMPLETED|Overall Study||34
10381831|NCT00610155|11523461|FG005|COMPLETED|Washout Period 2 (7 Days)||1
10381832|NCT00610155|11523456|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
10381833|NCT00610155|11523457|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
10381834|NCT00610155|11523458|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
10381835|NCT00610155|11523459|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
10381836|NCT00610155|11523460|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
10381837|NCT00610155|11523461|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
10381838|NCT00610155|11523456|FG000|STARTED|Period 3||4
10381839|NCT00610155|11523457|FG001|STARTED|Period 3||3
10381840|NCT00610155|11523458|FG002|STARTED|Period 3||3
10381841|NCT00610155|11523459|FG003|STARTED|Period 3||3
10381842|NCT00610155|11523460|FG004|STARTED|Period 3||3
10717887|NCT02701985|11881917|FG001|COMPLETED|Overall Study||32
10717888|NCT02701985|11881916|FG000|NOT COMPLETED|Overall Study||3
10717889|NCT02701985|11881917|FG001|NOT COMPLETED|Overall Study||6
10717890|NCT02702011|11881928|FG000|STARTED|Overall Study|Started are the treated patients.|11
10717891|NCT02702011|11881929|FG001|STARTED|Overall Study|Started are the treated patients.|13
10717892|NCT02702011|11881930|FG002|STARTED|Overall Study|Started are the treated patients.|12
10717893|NCT02702011|11881931|FG003|STARTED|Overall Study|Started are the treated patients.|12
10717894|NCT02702011|11881928|FG000|COMPLETED|Overall Study||11
10717895|NCT02702011|11881929|FG001|COMPLETED|Overall Study||12
10717896|NCT02702011|11881930|FG002|COMPLETED|Overall Study||12
10717897|NCT02702011|11881931|FG003|COMPLETED|Overall Study||12
10717898|NCT02702011|11881928|FG000|NOT COMPLETED|Overall Study||0
10717899|NCT02702011|11881929|FG001|NOT COMPLETED|Overall Study||1
10717900|NCT02702011|11881930|FG002|NOT COMPLETED|Overall Study||0
10717901|NCT02702011|11881931|FG003|NOT COMPLETED|Overall Study||0
10381843|NCT00610155|11523461|FG005|STARTED|Period 3||1
10381844|NCT00610155|11523456|FG000|COMPLETED|Period 3||3
10381845|NCT00610155|11523457|FG001|COMPLETED|Period 3||3
10381846|NCT00610155|11523458|FG002|COMPLETED|Period 3||3
10381847|NCT00610155|11523459|FG003|COMPLETED|Period 3||3
10381848|NCT00610155|11523460|FG004|COMPLETED|Period 3||3
10381849|NCT00610155|11523461|FG005|COMPLETED|Period 3||1
10381850|NCT00610155|11523456|FG000|NOT COMPLETED|Period 3||1
10381851|NCT00610155|11523457|FG001|NOT COMPLETED|Period 3||0
10381852|NCT00610155|11523458|FG002|NOT COMPLETED|Period 3||0
10381853|NCT00610155|11523459|FG003|NOT COMPLETED|Period 3||0
10381854|NCT00610155|11523460|FG004|NOT COMPLETED|Period 3||0
10381855|NCT00610155|11523461|FG005|NOT COMPLETED|Period 3||0
10381856|NCT00610168|11523471|FG000|STARTED|Overall Study||75
10381857|NCT00610168|11523472|FG001|STARTED|Overall Study||7
10381858|NCT00610168|11523471|FG000|COMPLETED|Overall Study||73
10381859|NCT00610168|11523472|FG001|COMPLETED|Overall Study||7
10381860|NCT00610168|11523471|FG000|NOT COMPLETED|Overall Study||2
10381861|NCT00610168|11523472|FG001|NOT COMPLETED|Overall Study||0
10381862|NCT00610207|11523478|FG000|STARTED|Overall Study||21
10381863|NCT00610207|11523478|FG000|COMPLETED|Overall Study||18
10381864|NCT00610207|11523478|FG000|NOT COMPLETED|Overall Study||3
10381865|NCT00610311|11523482|FG000|STARTED|Overall Study||3
10381866|NCT00610311|11523482|FG000|COMPLETED|Overall Study||3
10381867|NCT00610311|11523482|FG000|NOT COMPLETED|Overall Study||0
10381868|NCT00610363|11523488|FG000|STARTED|Overall Study||42
10539978|NCT01464307|11692969|FG001|STARTED|Main Period||145
10539979|NCT01464307|11692968|FG000|Treated|Main Period||144
10539980|NCT01464307|11692969|FG001|Treated|Main Period||145
10539981|NCT01464307|11692968|FG000|COMPLETED|Main Period||129
10539982|NCT01464307|11692969|FG001|COMPLETED|Main Period||140
10539983|NCT01464307|11692968|FG000|NOT COMPLETED|Main Period||15
10539984|NCT01464307|11692969|FG001|NOT COMPLETED|Main Period||5
10539985|NCT01464307|11692968|FG000|STARTED|Open-Label Extension Period||269
10539986|NCT01464307|11692969|FG001|STARTED|Open-Label Extension Period||0
10539987|NCT01464307|11692968|FG000|Treated|Open-Label Extension Period||269
10539988|NCT01464307|11692969|FG001|Treated|Open-Label Extension Period||0
10539989|NCT01464307|11692968|FG000|COMPLETED|Open-Label Extension Period||218
10539990|NCT01464307|11692969|FG001|COMPLETED|Open-Label Extension Period||0
10539991|NCT01464307|11692968|FG000|NOT COMPLETED|Open-Label Extension Period||51
10539992|NCT01464307|11692969|FG001|NOT COMPLETED|Open-Label Extension Period||0
10539993|NCT01464333|11692976|FG000|STARTED|Overall Study||389
10539994|NCT01464333|11692976|FG000|COMPLETED|Overall Study||226
10539995|NCT01464333|11692976|FG000|NOT COMPLETED|Overall Study||163
10539996|NCT01464346|11692980|FG000|STARTED|Overall Study||29
10539997|NCT01464346|11692981|FG001|STARTED|Overall Study||32
10539998|NCT01464346|11692982|FG002|STARTED|Overall Study||29
10539999|NCT01464346|11692980|FG000|COMPLETED|Overall Study||29
10540000|NCT01464346|11692981|FG001|COMPLETED|Overall Study||32
10540001|NCT01464346|11692982|FG002|COMPLETED|Overall Study||28
10540002|NCT01464346|11692980|FG000|NOT COMPLETED|Overall Study||0
10540003|NCT01464346|11692981|FG001|NOT COMPLETED|Overall Study||0
10540004|NCT01464346|11692982|FG002|NOT COMPLETED|Overall Study||1
10540005|NCT01464359|11692990|FG000|STARTED|Overall Study||3
10540006|NCT01464359|11692990|FG000|COMPLETED|Overall Study||3
10540007|NCT01464359|11692990|FG000|NOT COMPLETED|Overall Study||0
10540008|NCT01464424|11692994|FG000|STARTED|Period 1, First 6 Weeks||42
10540009|NCT01464424|11692995|FG001|STARTED|Period 1, First 6 Weeks||42
10540010|NCT01464424|11692994|FG000|COMPLETED|Period 1, First 6 Weeks||42
10540011|NCT01464424|11692995|FG001|COMPLETED|Period 1, First 6 Weeks||41
10540012|NCT01464424|11692994|FG000|NOT COMPLETED|Period 1, First 6 Weeks||0
10540013|NCT01464424|11692995|FG001|NOT COMPLETED|Period 1, First 6 Weeks||1
10540014|NCT01464424|11692994|FG000|STARTED|Period 2, Second 6 Weeks||42
10540015|NCT01464424|11692995|FG001|STARTED|Period 2, Second 6 Weeks||41
10540016|NCT01464424|11692994|FG000|COMPLETED|Period 2, Second 6 Weeks||42
10540017|NCT01464424|11692995|FG001|COMPLETED|Period 2, Second 6 Weeks||41
10540018|NCT01464424|11692994|FG000|NOT COMPLETED|Period 2, Second 6 Weeks||0
10540019|NCT01464424|11692995|FG001|NOT COMPLETED|Period 2, Second 6 Weeks||0
10717902|NCT02702193|11881943|FG000|STARTED|Baseline Assessment/Randomization||86
10717903|NCT02702193|11881944|FG001|STARTED|Baseline Assessment/Randomization||87
10717904|NCT02702193|11881943|FG000|COMPLETED|Baseline Assessment/Randomization||85
10540020|NCT01464619|11693003|FG000|STARTED|Overall Study||32
10540021|NCT01464619|11693004|FG001|STARTED|Overall Study||29
10540022|NCT01464619|11693003|FG000|COMPLETED|Overall Study||29
10540023|NCT01464619|11693004|FG001|COMPLETED|Overall Study||25
10540024|NCT01464619|11693003|FG000|NOT COMPLETED|Overall Study||3
10540025|NCT01464619|11693004|FG001|NOT COMPLETED|Overall Study||4
10540026|NCT01464697|11693014|FG000|STARTED|Overall Study||93
10540027|NCT01464697|11693015|FG001|STARTED|Overall Study||96
10540028|NCT01464697|11693014|FG000|COMPLETED|Overall Study||90
10540029|NCT01464697|11693015|FG001|COMPLETED|Overall Study||86
10540030|NCT01464697|11693014|FG000|NOT COMPLETED|Overall Study||3
10540031|NCT01464697|11693015|FG001|NOT COMPLETED|Overall Study||10
10381869|NCT00610363|11523489|FG001|STARTED|Overall Study||41
10381870|NCT00610363|11523488|FG000|COMPLETED|Overall Study||31
10381871|NCT00610363|11523489|FG001|COMPLETED|Overall Study||38
10381872|NCT00610363|11523488|FG000|NOT COMPLETED|Overall Study||11
10540032|NCT01464775|11693023|FG000|STARTED|Overall Study||123
10540033|NCT01464775|11693024|FG001|STARTED|Overall Study||44
10540034|NCT01464775|11693023|FG000|COMPLETED|Overall Study||112
10381873|NCT00610363|11523489|FG001|NOT COMPLETED|Overall Study||3
10381874|NCT00610428|11523499|FG000|STARTED|Overall Study||24
10381875|NCT00610428|11523500|FG001|STARTED|Overall Study||24
10381876|NCT00610428|11523501|FG002|STARTED|Overall Study||27
10381877|NCT00610428|11523499|FG000|COMPLETED|Overall Study||24
10381878|NCT00610428|11523500|FG001|COMPLETED|Overall Study||23
10381879|NCT00610428|11523501|FG002|COMPLETED|Overall Study||25
10381880|NCT00610428|11523499|FG000|NOT COMPLETED|Overall Study||0
10381881|NCT00610428|11523500|FG001|NOT COMPLETED|Overall Study||1
10381882|NCT00610428|11523501|FG002|NOT COMPLETED|Overall Study||2
10381883|NCT00610441|11523513|FG000|STARTED|Treatment Period 1 - 3 Weeks||15
10717905|NCT02702193|11881944|FG001|COMPLETED|Baseline Assessment/Randomization||87
10717906|NCT02702193|11881943|FG000|NOT COMPLETED|Baseline Assessment/Randomization||1
10717907|NCT02702193|11881944|FG001|NOT COMPLETED|Baseline Assessment/Randomization||0
10717908|NCT02702193|11881943|FG000|STARTED|4 Month Follow up||86
10717909|NCT02702193|11881944|FG001|STARTED|4 Month Follow up||87
10381884|NCT00610441|11523514|FG001|STARTED|Treatment Period 1 - 3 Weeks||16
10381885|NCT00610441|11523515|FG002|STARTED|Treatment Period 1 - 3 Weeks||18
10381886|NCT00610441|11523516|FG003|STARTED|Treatment Period 1 - 3 Weeks||18
10381887|NCT00610441|11523513|FG000|COMPLETED|Treatment Period 1 - 3 Weeks||12
10381888|NCT00610441|11523514|FG001|COMPLETED|Treatment Period 1 - 3 Weeks||14
10381889|NCT00610441|11523515|FG002|COMPLETED|Treatment Period 1 - 3 Weeks||11
10381890|NCT00610441|11523516|FG003|COMPLETED|Treatment Period 1 - 3 Weeks||16
10381891|NCT00610441|11523513|FG000|NOT COMPLETED|Treatment Period 1 - 3 Weeks||3
10381892|NCT00610441|11523514|FG001|NOT COMPLETED|Treatment Period 1 - 3 Weeks||2
10381893|NCT00610441|11523515|FG002|NOT COMPLETED|Treatment Period 1 - 3 Weeks||7
10381894|NCT00610441|11523516|FG003|NOT COMPLETED|Treatment Period 1 - 3 Weeks||2
10381895|NCT00610441|11523513|FG000|STARTED|Placebo Washout Period - 2 Weeks||12
10381896|NCT00610441|11523514|FG001|STARTED|Placebo Washout Period - 2 Weeks||14
10381897|NCT00610441|11523515|FG002|STARTED|Placebo Washout Period - 2 Weeks||11
10381898|NCT00610441|11523516|FG003|STARTED|Placebo Washout Period - 2 Weeks||16
10381899|NCT00610441|11523513|FG000|COMPLETED|Placebo Washout Period - 2 Weeks||12
10381900|NCT00610441|11523514|FG001|COMPLETED|Placebo Washout Period - 2 Weeks||13
10381901|NCT00610441|11523515|FG002|COMPLETED|Placebo Washout Period - 2 Weeks||9
10381902|NCT00610441|11523516|FG003|COMPLETED|Placebo Washout Period - 2 Weeks||16
10381903|NCT00610441|11523513|FG000|NOT COMPLETED|Placebo Washout Period - 2 Weeks||0
10381904|NCT00610441|11523514|FG001|NOT COMPLETED|Placebo Washout Period - 2 Weeks||1
10381905|NCT00610441|11523515|FG002|NOT COMPLETED|Placebo Washout Period - 2 Weeks||2
10381906|NCT00610441|11523516|FG003|NOT COMPLETED|Placebo Washout Period - 2 Weeks||0
10381907|NCT00610441|11523513|FG000|STARTED|Treatment Period 2 - 3 Weeks||12
10381908|NCT00610441|11523514|FG001|STARTED|Treatment Period 2 - 3 Weeks||13
10381909|NCT00610441|11523515|FG002|STARTED|Treatment Period 2 - 3 Weeks||9
10381910|NCT00610441|11523516|FG003|STARTED|Treatment Period 2 - 3 Weeks||16
10381911|NCT00610441|11523513|FG000|COMPLETED|Treatment Period 2 - 3 Weeks||10
10381912|NCT00610441|11523514|FG001|COMPLETED|Treatment Period 2 - 3 Weeks||12
10381913|NCT00610441|11523515|FG002|COMPLETED|Treatment Period 2 - 3 Weeks||9
10381914|NCT00610441|11523516|FG003|COMPLETED|Treatment Period 2 - 3 Weeks||14
10381915|NCT00610441|11523513|FG000|NOT COMPLETED|Treatment Period 2 - 3 Weeks||2
10381916|NCT00610441|11523514|FG001|NOT COMPLETED|Treatment Period 2 - 3 Weeks||1
10381917|NCT00610441|11523515|FG002|NOT COMPLETED|Treatment Period 2 - 3 Weeks||0
10381918|NCT00610441|11523516|FG003|NOT COMPLETED|Treatment Period 2 - 3 Weeks||2
10381919|NCT00610480|11523530|FG000|STARTED|Overall Study|10 assigned patients x 2 interventions.|10
10381920|NCT00610480|11523531|FG001|STARTED|Overall Study|10 assigned patients x 2 interventions.|10
10381921|NCT00610480|11523530|FG000|COMPLETED|Overall Study|10 assigned patients x 2 interventions.|10
10381922|NCT00610480|11523531|FG001|COMPLETED|Overall Study|10 assigned patients x 2 interventions.|10
10381923|NCT00610480|11523530|FG000|NOT COMPLETED|Overall Study||0
10381924|NCT00610480|11523531|FG001|NOT COMPLETED|Overall Study||0
10381925|NCT00610649|11523548|FG000|STARTED|Overall Study||4
10381926|NCT00610649|11523549|FG001|STARTED|Overall Study||2
10381927|NCT00610649|11523550|FG002|STARTED|Overall Study||4
10381928|NCT00610649|11523551|FG003|STARTED|Overall Study||2
10381929|NCT00610649|11523552|FG004|STARTED|Overall Study||4
10381930|NCT00610649|11523553|FG005|STARTED|Overall Study||2
10381931|NCT00610649|11523554|FG006|STARTED|Overall Study||4
10381932|NCT00610649|11523555|FG007|STARTED|Overall Study||2
10381933|NCT00610649|11523556|FG008|STARTED|Overall Study||10
10381934|NCT00610649|11523557|FG009|STARTED|Overall Study||10
10717910|NCT02702193|11881943|FG000|COMPLETED|4 Month Follow up||68
10717911|NCT02702193|11881944|FG001|COMPLETED|4 Month Follow up||69
10381935|NCT00610649|11523558|FG010|STARTED|Overall Study||10
10381936|NCT00610649|11523548|FG000|COMPLETED|Overall Study||3
10381937|NCT00610649|11523549|FG001|COMPLETED|Overall Study||1
10381938|NCT00610649|11523550|FG002|COMPLETED|Overall Study||4
10381939|NCT00610649|11523551|FG003|COMPLETED|Overall Study||2
10381940|NCT00610649|11523552|FG004|COMPLETED|Overall Study||4
10381941|NCT00610649|11523553|FG005|COMPLETED|Overall Study||2
10381942|NCT00610649|11523554|FG006|COMPLETED|Overall Study||4
10381943|NCT00610649|11523555|FG007|COMPLETED|Overall Study||2
10381944|NCT00610649|11523556|FG008|COMPLETED|Overall Study||10
10381945|NCT00610649|11523557|FG009|COMPLETED|Overall Study||9
10381946|NCT00610649|11523558|FG010|COMPLETED|Overall Study||9
10381947|NCT00610649|11523548|FG000|NOT COMPLETED|Overall Study||1
10381948|NCT00610649|11523549|FG001|NOT COMPLETED|Overall Study||1
10381949|NCT00610649|11523550|FG002|NOT COMPLETED|Overall Study||0
10381950|NCT00610649|11523551|FG003|NOT COMPLETED|Overall Study||0
10381951|NCT00610649|11523552|FG004|NOT COMPLETED|Overall Study||0
10381952|NCT00610649|11523553|FG005|NOT COMPLETED|Overall Study||0
10381953|NCT00610649|11523554|FG006|NOT COMPLETED|Overall Study||0
10381954|NCT00610649|11523555|FG007|NOT COMPLETED|Overall Study||0
10381955|NCT00610649|11523556|FG008|NOT COMPLETED|Overall Study||0
10381956|NCT00610649|11523557|FG009|NOT COMPLETED|Overall Study||1
10381957|NCT00610649|11523558|FG010|NOT COMPLETED|Overall Study||1
10717912|NCT02702193|11881943|FG000|NOT COMPLETED|4 Month Follow up||18
10717913|NCT02702193|11881944|FG001|NOT COMPLETED|4 Month Follow up||18
10717914|NCT02702193|11881943|FG000|STARTED|8 Month Follow up||86
10381958|NCT00610675|11523582|FG000|STARTED|Overall Study||346
10381959|NCT00610675|11523582|FG000|Treated|Overall Study||342
10381960|NCT00610675|11523582|FG000|COMPLETED|Overall Study||126
10381961|NCT00610675|11523582|FG000|NOT COMPLETED|Overall Study||220
10381962|NCT00610688|11523589|FG000|STARTED|Overall Study||64
10381963|NCT00610688|11523590|FG001|STARTED|Overall Study||65
10381964|NCT00610688|11523591|FG002|STARTED|Overall Study||63
10381965|NCT00610688|11523589|FG000|COMPLETED|Overall Study||55
10381966|NCT00610688|11523590|FG001|COMPLETED|Overall Study||52
10381967|NCT00610688|11523591|FG002|COMPLETED|Overall Study||55
10540035|NCT01464775|11693024|FG001|COMPLETED|Overall Study||38
10540036|NCT01464775|11693023|FG000|NOT COMPLETED|Overall Study||11
10540037|NCT01464775|11693024|FG001|NOT COMPLETED|Overall Study||6
10540038|NCT01464788|11693035|FG000|STARTED|Overall Study||30
10540039|NCT01464788|11693036|FG001|STARTED|Overall Study||31
10540040|NCT01464788|11693037|FG002|STARTED|Overall Study||29
10540041|NCT01464788|11693035|FG000|COMPLETED|Overall Study||30
10540042|NCT01464788|11693036|FG001|COMPLETED|Overall Study||29
10540043|NCT01464788|11693037|FG002|COMPLETED|Overall Study||29
10540044|NCT01464788|11693035|FG000|NOT COMPLETED|Overall Study||0
10540045|NCT01464788|11693036|FG001|NOT COMPLETED|Overall Study||2
10540046|NCT01464788|11693037|FG002|NOT COMPLETED|Overall Study||0
10540047|NCT01464827|11693061|FG000|STARTED|Overall Study||80
10540048|NCT01464827|11693062|FG001|STARTED|Overall Study||43
10540049|NCT01464827|11693063|FG002|STARTED|Overall Study||39
10540050|NCT01464827|11693064|FG003|STARTED|Overall Study||40
10540051|NCT01464827|11693065|FG004|STARTED|Overall Study||80
10540052|NCT01464827|11693066|FG005|STARTED|Overall Study||39
10540053|NCT01464827|11693067|FG006|STARTED|Overall Study||41
10540054|NCT01464827|11693068|FG007|STARTED|Overall Study||40
10540055|NCT01464827|11693069|FG008|STARTED|Overall Study||40
10540056|NCT01464827|11693070|FG009|STARTED|Overall Study||47
10658087|NCT02230579|11819227|FG001|COMPLETED|Overall Study||6
10658088|NCT02230579|11819228|FG002|COMPLETED|Overall Study||6
10658089|NCT02230579|11819229|FG003|COMPLETED|Overall Study||6
10658090|NCT02230579|11819230|FG004|COMPLETED|Overall Study||6
10658091|NCT02230579|11819231|FG005|COMPLETED|Overall Study||6
10658092|NCT02230579|11819232|FG006|COMPLETED|Overall Study||12
10658093|NCT02230579|11819226|FG000|NOT COMPLETED|Overall Study||0
10658094|NCT02230579|11819227|FG001|NOT COMPLETED|Overall Study||0
10658095|NCT02230579|11819228|FG002|NOT COMPLETED|Overall Study||0
10658096|NCT02230579|11819229|FG003|NOT COMPLETED|Overall Study||0
10658097|NCT02230579|11819230|FG004|NOT COMPLETED|Overall Study||0
10658098|NCT02230579|11819231|FG005|NOT COMPLETED|Overall Study||0
10658099|NCT02230579|11819232|FG006|NOT COMPLETED|Overall Study||0
10658100|NCT02230670|11819250|FG000|STARTED|Overall Study||44
10658101|NCT02230670|11819251|FG001|STARTED|Overall Study|One subject randomized to placebo withdrew from the study before receiving any study treatment.|42
10658102|NCT02230670|11819250|FG000|COMPLETED|Overall Study||40
10717915|NCT02702193|11881944|FG001|STARTED|8 Month Follow up||87
10658103|NCT02230670|11819251|FG001|COMPLETED|Overall Study||34
10658104|NCT02230670|11819250|FG000|NOT COMPLETED|Overall Study||4
10658105|NCT02230670|11819251|FG001|NOT COMPLETED|Overall Study||8
10717916|NCT02702193|11881943|FG000|COMPLETED|8 Month Follow up||71
10717917|NCT02702193|11881944|FG001|COMPLETED|8 Month Follow up||69
10717918|NCT02702193|11881943|FG000|NOT COMPLETED|8 Month Follow up||15
10717919|NCT02702193|11881944|FG001|NOT COMPLETED|8 Month Follow up||18
10717920|NCT02702193|11881943|FG000|STARTED|12 Month Follow up||86
10381968|NCT00610688|11523589|FG000|NOT COMPLETED|Overall Study||9
10381969|NCT00610688|11523590|FG001|NOT COMPLETED|Overall Study||13
10381970|NCT00610688|11523591|FG002|NOT COMPLETED|Overall Study||8
10381971|NCT00610701|11523601|FG000|STARTED|Overall Study||15
10381972|NCT00610701|11523602|FG001|STARTED|Overall Study||20
10381973|NCT00610701|11523601|FG000|COMPLETED|Overall Study||5
10381974|NCT00610701|11523602|FG001|COMPLETED|Overall Study||9
10381975|NCT00610701|11523601|FG000|NOT COMPLETED|Overall Study||10
10381976|NCT00610701|11523602|FG001|NOT COMPLETED|Overall Study||11
10381977|NCT00610714|11523610|FG000|STARTED|Overall Study||105
10381978|NCT00610714|11523611|FG001|STARTED|Overall Study||106
10381979|NCT00610714|11523610|FG000|COMPLETED|Overall Study||79
10381980|NCT00610714|11523611|FG001|COMPLETED|Overall Study||82
10381981|NCT00610714|11523610|FG000|NOT COMPLETED|Overall Study||26
10381982|NCT00610714|11523611|FG001|NOT COMPLETED|Overall Study||24
10540057|NCT01464827|11693071|FG010|STARTED|Overall Study||23
10381983|NCT00610727|11523623|FG000|STARTED|Overall Study||14
10381984|NCT00610727|11523624|FG001|STARTED|Overall Study||8
10381985|NCT00610727|11523625|FG002|STARTED|Overall Study||8
10381986|NCT00610727|11523626|FG003|STARTED|Overall Study||8
10381987|NCT00610727|11523627|FG004|STARTED|Overall Study||8
10381988|NCT00610727|11523628|FG005|STARTED|Overall Study||8
10381989|NCT00610727|11523623|FG000|COMPLETED|Overall Study||14
10381990|NCT00610727|11523624|FG001|COMPLETED|Overall Study||8
10381991|NCT00610727|11523625|FG002|COMPLETED|Overall Study||8
10381992|NCT00610727|11523626|FG003|COMPLETED|Overall Study||8
10381993|NCT00610727|11523627|FG004|COMPLETED|Overall Study||8
10381994|NCT00610727|11523628|FG005|COMPLETED|Overall Study||8
10381995|NCT00610727|11523623|FG000|NOT COMPLETED|Overall Study||0
10381996|NCT00610727|11523624|FG001|NOT COMPLETED|Overall Study||0
10381997|NCT00610727|11523625|FG002|NOT COMPLETED|Overall Study||0
10381998|NCT00610727|11523626|FG003|NOT COMPLETED|Overall Study||0
10381999|NCT00610727|11523627|FG004|NOT COMPLETED|Overall Study||0
10382000|NCT00610727|11523628|FG005|NOT COMPLETED|Overall Study||0
10382001|NCT00610740|11523646|FG000|STARTED|Overall Study||18
10382002|NCT00610740|11523646|FG000|COMPLETED|Overall Study||18
10382003|NCT00610740|11523646|FG000|NOT COMPLETED|Overall Study||0
10382004|NCT00610857|11523650|FG000|STARTED|Overall Study||37
10382005|NCT00610857|11523650|FG000|COMPLETED|Overall Study||35
10382006|NCT00610857|11523650|FG000|NOT COMPLETED|Overall Study||2
10382007|NCT00610883|11523654|FG000|STARTED|Overall Study||17
10382008|NCT00610883|11523654|FG000|COMPLETED|Overall Study||17
10382009|NCT00610883|11523654|FG000|NOT COMPLETED|Overall Study||0
10382010|NCT00610935|11523660|FG000|STARTED|Overall Study||25
10382011|NCT00610935|11523661|FG001|STARTED|Overall Study||57
10382012|NCT00610935|11523660|FG000|ITTI Population|Overall Study||25
10382013|NCT00610935|11523661|FG001|ITTI Population|Overall Study||55
10382014|NCT00610935|11523660|FG000|ITT Population|Overall Study||25
10382015|NCT00610935|11523661|FG001|ITT Population|Overall Study||57
10382016|NCT00610935|11523660|FG000|COMPLETED|Overall Study||24
10382017|NCT00610935|11523661|FG001|COMPLETED|Overall Study||54
10382018|NCT00610935|11523660|FG000|NOT COMPLETED|Overall Study||1
10382019|NCT00610935|11523661|FG001|NOT COMPLETED|Overall Study||3
10382020|NCT00610987|11523669|FG000|STARTED|Overall Study||75
10382021|NCT00610987|11523670|FG001|STARTED|Overall Study||71
10382022|NCT00610987|11523669|FG000|COMPLETED|Overall Study||75
10382023|NCT00610987|11523670|FG001|COMPLETED|Overall Study||71
10382024|NCT00610987|11523669|FG000|NOT COMPLETED|Overall Study||0
10382025|NCT00610987|11523670|FG001|NOT COMPLETED|Overall Study||0
10382026|NCT00611026|11523679|FG000|STARTED|Randomized to Double-blind Treatment||480
10382027|NCT00611026|11523680|FG001|STARTED|Randomized to Double-blind Treatment||974
10382028|NCT00611026|11523681|FG002|STARTED|Randomized to Double-blind Treatment||963
10382029|NCT00611026|11523679|FG000|COMPLETED|Randomized to Double-blind Treatment||478
10382030|NCT00611026|11523680|FG001|COMPLETED|Randomized to Double-blind Treatment||973
10382031|NCT00611026|11523681|FG002|COMPLETED|Randomized to Double-blind Treatment||960
10382032|NCT00611026|11523679|FG000|NOT COMPLETED|Randomized to Double-blind Treatment||2
10382033|NCT00611026|11523680|FG001|NOT COMPLETED|Randomized to Double-blind Treatment||1
10382034|NCT00611026|11523681|FG002|NOT COMPLETED|Randomized to Double-blind Treatment||3
10382035|NCT00611026|11523679|FG000|STARTED|Double-blind Treatment Period||478
10382036|NCT00611026|11523680|FG001|STARTED|Double-blind Treatment Period||973
10382037|NCT00611026|11523681|FG002|STARTED|Double-blind Treatment Period||960
10382038|NCT00611026|11523679|FG000|COMPLETED|Double-blind Treatment Period||431
10382039|NCT00611026|11523680|FG001|COMPLETED|Double-blind Treatment Period||885
10382040|NCT00611026|11523681|FG002|COMPLETED|Double-blind Treatment Period||862
10540058|NCT01464827|11693072|FG011|STARTED|Overall Study||23
10540059|NCT01464827|11693073|FG012|STARTED|Overall Study||23
10540060|NCT01464827|11693074|FG013|STARTED|Overall Study||22
10540061|NCT01464827|11693061|FG000|Treated|Overall Study||80
10540062|NCT01464827|11693062|FG001|Treated|Overall Study||41
10540063|NCT01464827|11693063|FG002|Treated|Overall Study||39
10540064|NCT01464827|11693064|FG003|Treated|Overall Study||40
10658106|NCT02230683|11819257|FG000|STARTED|Overall Study||23
10540065|NCT01464827|11693065|FG004|Treated|Overall Study||79
10540066|NCT01464827|11693066|FG005|Treated|Overall Study||39
10540067|NCT01464827|11693067|FG006|Treated|Overall Study||40
10658107|NCT02230683|11819257|FG000|COMPLETED|Overall Study||22
10658108|NCT02230683|11819257|FG000|NOT COMPLETED|Overall Study||1
10658109|NCT02230696|11819270|FG000|STARTED|Overall Study||381
10658110|NCT02230696|11819271|FG001|STARTED|Overall Study||376
10658111|NCT02230696|11819272|FG002|STARTED|Overall Study||194
10658112|NCT02230696|11819270|FG000|COMPLETED|Overall Study||366
10382041|NCT00611026|11523679|FG000|NOT COMPLETED|Double-blind Treatment Period||47
10382042|NCT00611026|11523680|FG001|NOT COMPLETED|Double-blind Treatment Period||88
10382043|NCT00611026|11523681|FG002|NOT COMPLETED|Double-blind Treatment Period||98
10382044|NCT00611130|11523693|FG000|STARTED|Overall Study||92
10382045|NCT00611130|11523694|FG001|STARTED|Overall Study||94
10382046|NCT00611130|11523693|FG000|Completed 12 Week Treatment Phase|Overall Study||61
10382047|NCT00611130|11523694|FG001|Completed 12 Week Treatment Phase|Overall Study||64
10382048|NCT00611130|11523693|FG000|COMPLETED|Overall Study||43
10382049|NCT00611130|11523694|FG001|COMPLETED|Overall Study||47
10382050|NCT00611130|11523693|FG000|NOT COMPLETED|Overall Study||49
10382051|NCT00611130|11523694|FG001|NOT COMPLETED|Overall Study||47
10382052|NCT00611247|11523703|FG000|STARTED|Overall Study||5
10540068|NCT01464827|11693068|FG007|Treated|Overall Study||40
10658113|NCT02230696|11819271|FG001|COMPLETED|Overall Study||365
10382053|NCT00611247|11523704|FG001|STARTED|Overall Study||31
10382054|NCT00611247|11523703|FG000|COMPLETED|Overall Study||3
10382055|NCT00611247|11523704|FG001|COMPLETED|Overall Study||10
10382056|NCT00611247|11523703|FG000|NOT COMPLETED|Overall Study||2
10382057|NCT00611247|11523704|FG001|NOT COMPLETED|Overall Study||21
10382058|NCT00611325|11523713|FG000|STARTED|Overall Study||28
10382059|NCT00611325|11523714|FG001|STARTED|Overall Study||28
10382060|NCT00611325|11523713|FG000|COMPLETED|Overall Study||28
10382061|NCT00611325|11523714|FG001|COMPLETED|Overall Study||28
10717921|NCT02702193|11881944|FG001|STARTED|12 Month Follow up||87
10717922|NCT02702193|11881943|FG000|COMPLETED|12 Month Follow up||69
10717923|NCT02702193|11881944|FG001|COMPLETED|12 Month Follow up||69
10717924|NCT02702193|11881943|FG000|NOT COMPLETED|12 Month Follow up||17
10382062|NCT00611325|11523713|FG000|NOT COMPLETED|Overall Study||0
10382063|NCT00611325|11523714|FG001|NOT COMPLETED|Overall Study||0
10382064|NCT00611351|11523720|FG000|STARTED|Overall Study||5
10382065|NCT00611351|11523720|FG000|COMPLETED|Overall Study||3
10382066|NCT00611351|11523720|FG000|NOT COMPLETED|Overall Study||2
10382067|NCT00611403|11523726|FG000|STARTED|Treatment Phase||68
10382068|NCT00611403|11523727|FG001|STARTED|Treatment Phase||69
10382069|NCT00611403|11523726|FG000|COMPLETED|Treatment Phase||62
10382070|NCT00611403|11523727|FG001|COMPLETED|Treatment Phase||58
10382071|NCT00611403|11523726|FG000|NOT COMPLETED|Treatment Phase||6
10382072|NCT00611403|11523727|FG001|NOT COMPLETED|Treatment Phase||11
10382073|NCT00611403|11523726|FG000|STARTED|Post Treatment Extension Phase|26 of 68 pts who received RESTASIS® in the Treatment Phase entered the Post Treatment Ext. Phase|26
10382074|NCT00611403|11523727|FG001|STARTED|Post Treatment Extension Phase|25 of 69 pts who received ENDURA® in the Treatment Phase entered the Post Treatment Extension Phase|25
10382075|NCT00611403|11523726|FG000|COMPLETED|Post Treatment Extension Phase||22
10382076|NCT00611403|11523727|FG001|COMPLETED|Post Treatment Extension Phase||24
10382077|NCT00611403|11523726|FG000|NOT COMPLETED|Post Treatment Extension Phase||4
10382078|NCT00611403|11523727|FG001|NOT COMPLETED|Post Treatment Extension Phase||1
10382079|NCT00611442|11523735|FG000|STARTED|Overall Study||95
10382080|NCT00611442|11523736|FG001|STARTED|Overall Study||96
10382081|NCT00611442|11523735|FG000|COMPLETED|Overall Study||94
10382082|NCT00611442|11523736|FG001|COMPLETED|Overall Study||94
10382083|NCT00611442|11523735|FG000|NOT COMPLETED|Overall Study||1
10382084|NCT00611442|11523736|FG001|NOT COMPLETED|Overall Study||2
10382085|NCT00611455|11523744|FG000|STARTED|DB Treatment Period (24 Weeks)||134
10382086|NCT00611455|11523745|FG001|STARTED|DB Treatment Period (24 Weeks)||131
10382087|NCT00611455|11523746|FG002|STARTED|DB Treatment Period (24 Weeks)||0
10382088|NCT00611455|11523744|FG000|COMPLETED|DB Treatment Period (24 Weeks)||121
10382089|NCT00611455|11523745|FG001|COMPLETED|DB Treatment Period (24 Weeks)||117
10382090|NCT00611455|11523746|FG002|COMPLETED|DB Treatment Period (24 Weeks)||0
10540069|NCT01464827|11693069|FG008|Treated|Overall Study||40
10540070|NCT01464827|11693070|FG009|Treated|Overall Study||45
10540071|NCT01464827|11693071|FG010|Treated|Overall Study||23
10540072|NCT01464827|11693072|FG011|Treated|Overall Study||22
10540073|NCT01464827|11693073|FG012|Treated|Overall Study||23
10540074|NCT01464827|11693074|FG013|Treated|Overall Study||20
10540075|NCT01464827|11693061|FG000|COMPLETED|Overall Study||77
10540076|NCT01464827|11693062|FG001|COMPLETED|Overall Study||36
10540077|NCT01464827|11693063|FG002|COMPLETED|Overall Study||39
10540078|NCT01464827|11693064|FG003|COMPLETED|Overall Study||36
10540079|NCT01464827|11693065|FG004|COMPLETED|Overall Study||72
10540080|NCT01464827|11693066|FG005|COMPLETED|Overall Study||38
10540081|NCT01464827|11693067|FG006|COMPLETED|Overall Study||37
10540082|NCT01464827|11693068|FG007|COMPLETED|Overall Study||37
10540083|NCT01464827|11693069|FG008|COMPLETED|Overall Study||37
10540084|NCT01464827|11693070|FG009|COMPLETED|Overall Study||44
10540085|NCT01464827|11693071|FG010|COMPLETED|Overall Study||21
10540086|NCT01464827|11693072|FG011|COMPLETED|Overall Study||21
10540087|NCT01464827|11693073|FG012|COMPLETED|Overall Study||21
10540088|NCT01464827|11693074|FG013|COMPLETED|Overall Study||19
10540089|NCT01464827|11693061|FG000|NOT COMPLETED|Overall Study||3
10540090|NCT01464827|11693062|FG001|NOT COMPLETED|Overall Study||7
10540091|NCT01464827|11693063|FG002|NOT COMPLETED|Overall Study||0
10540092|NCT01464827|11693064|FG003|NOT COMPLETED|Overall Study||4
10540093|NCT01464827|11693065|FG004|NOT COMPLETED|Overall Study||8
10540094|NCT01464827|11693066|FG005|NOT COMPLETED|Overall Study||1
10540095|NCT01464827|11693067|FG006|NOT COMPLETED|Overall Study||4
10540096|NCT01464827|11693068|FG007|NOT COMPLETED|Overall Study||3
10717925|NCT02702193|11881944|FG001|NOT COMPLETED|12 Month Follow up||18
10717926|NCT02702388|11881952|FG000|STARTED|Overall Study||75
10717927|NCT02702388|11881953|FG001|STARTED|Overall Study||77
10717928|NCT02702388|11881952|FG000|COMPLETED|Overall Study||35
10382091|NCT00611455|11523744|FG000|NOT COMPLETED|DB Treatment Period (24 Weeks)||13
10382092|NCT00611455|11523745|FG001|NOT COMPLETED|DB Treatment Period (24 Weeks)||14
10382093|NCT00611455|11523746|FG002|NOT COMPLETED|DB Treatment Period (24 Weeks)||0
10382094|NCT00611455|11523744|FG000|STARTED|OL Treatment Period (120 Weeks)||0
10428126|NCT00856739|11574134|FG002|NOT COMPLETED|Overall Study||0
10428127|NCT00856778|11574145|FG000|STARTED|Overall Study||98
10428128|NCT00856778|11574145|FG000|COMPLETED|Overall Study||74
10428129|NCT00856778|11574145|FG000|NOT COMPLETED|Overall Study||24
10428130|NCT00856791|11574149|FG000|STARTED|Overall Study||1
10428131|NCT00856791|11574149|FG000|COMPLETED|Overall Study||1
10428132|NCT00856791|11574149|FG000|NOT COMPLETED|Overall Study||0
10428133|NCT00856830|11574157|FG000|STARTED|Irinotecan & Bendamustine||3
10428134|NCT00856830|11574158|FG001|STARTED|Irinotecan & Bendamustine||6
10428135|NCT00856830|11574159|FG002|STARTED|Irinotecan & Bendamustine||6
10382095|NCT00611455|11523745|FG001|STARTED|OL Treatment Period (120 Weeks)|118 participants received OFA during the DB Period; 113 received placebo during the DB Period.|231
10382096|NCT00611455|11523746|FG002|STARTED|OL Treatment Period (120 Weeks)||0
10382097|NCT00611455|11523744|FG000|COMPLETED|OL Treatment Period (120 Weeks)||0
10382098|NCT00611455|11523745|FG001|COMPLETED|OL Treatment Period (120 Weeks)||52
10382099|NCT00611455|11523746|FG002|COMPLETED|OL Treatment Period (120 Weeks)||0
10382100|NCT00611455|11523744|FG000|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
10382101|NCT00611455|11523745|FG001|NOT COMPLETED|OL Treatment Period (120 Weeks)||179
10382102|NCT00611455|11523746|FG002|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
10382103|NCT00611455|11523744|FG000|STARTED|Follow-up Period (Approximately 2 Years)||0
10382104|NCT00611455|11523745|FG001|STARTED|Follow-up Period (Approximately 2 Years)||0
10382105|NCT00611455|11523746|FG002|STARTED|Follow-up Period (Approximately 2 Years)|These participants received at least one infusion of placebo or ofatumumab.|260
10382106|NCT00611455|11523744|FG000|COMPLETED|Follow-up Period (Approximately 2 Years)||0
10382107|NCT00611455|11523745|FG001|COMPLETED|Follow-up Period (Approximately 2 Years)||0
10382108|NCT00611455|11523746|FG002|COMPLETED|Follow-up Period (Approximately 2 Years)||49
10382109|NCT00611455|11523744|FG000|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
10382110|NCT00611455|11523745|FG001|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
10382111|NCT00611455|11523746|FG002|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||211
10382112|NCT00611468|11523756|FG000|STARTED|Overall Study||3
10382113|NCT00611468|11523757|FG001|STARTED|Overall Study||7
10382114|NCT00611468|11523758|FG002|STARTED|Overall Study||6
10382115|NCT00611468|11523759|FG003|STARTED|Overall Study||13
10382116|NCT00611468|11523756|FG000|COMPLETED|Overall Study||3
10382117|NCT00611468|11523757|FG001|COMPLETED|Overall Study|One subject did not complete Cycle 1 of treatment and was replaced.|6
10382118|NCT00611468|11523758|FG002|COMPLETED|Overall Study||6
10382119|NCT00611468|11523759|FG003|COMPLETED|Overall Study||13
10382120|NCT00611468|11523756|FG000|NOT COMPLETED|Overall Study||0
10382121|NCT00611468|11523757|FG001|NOT COMPLETED|Overall Study||1
10382122|NCT00611468|11523758|FG002|NOT COMPLETED|Overall Study||0
10382123|NCT00611468|11523759|FG003|NOT COMPLETED|Overall Study||0
10382124|NCT00611533|11523763|FG000|STARTED|First Intervention (6 Weeks)||8
10382125|NCT00611533|11523764|FG001|STARTED|First Intervention (6 Weeks)||8
10382126|NCT00611533|11523763|FG000|COMPLETED|First Intervention (6 Weeks)||8
10382127|NCT00611533|11523764|FG001|COMPLETED|First Intervention (6 Weeks)||6
10382128|NCT00611533|11523763|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
10382129|NCT00611533|11523764|FG001|NOT COMPLETED|First Intervention (6 Weeks)||2
10382130|NCT00611533|11523763|FG000|STARTED|Second Intervention (6 Weeks)||8
10382131|NCT00611533|11523764|FG001|STARTED|Second Intervention (6 Weeks)||6
10382132|NCT00611533|11523763|FG000|COMPLETED|Second Intervention (6 Weeks)||8
10382133|NCT00611533|11523764|FG001|COMPLETED|Second Intervention (6 Weeks)||4
10382134|NCT00611533|11523763|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
10382135|NCT00611533|11523764|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||2
10382136|NCT00611559|11523774|FG000|STARTED|Overall Study||111
10382137|NCT00611559|11523775|FG001|STARTED|Overall Study||115
10382138|NCT00611559|11523776|FG002|STARTED|Overall Study||57
10382139|NCT00611559|11523774|FG000|COMPLETED|Overall Study||110
10382140|NCT00611559|11523775|FG001|COMPLETED|Overall Study||114
10382141|NCT00611559|11523776|FG002|COMPLETED|Overall Study||56
10382142|NCT00611559|11523774|FG000|NOT COMPLETED|Overall Study||1
10382143|NCT00611559|11523775|FG001|NOT COMPLETED|Overall Study||1
10382144|NCT00611559|11523776|FG002|NOT COMPLETED|Overall Study||1
10428136|NCT00856830|11574160|FG003|STARTED|Irinotecan & Bendamustine||15
10428137|NCT00856830|11574157|FG000|Maximum Tolerated Dose|Irinotecan & Bendamustine||3
10428138|NCT00856830|11574158|FG001|Maximum Tolerated Dose|Irinotecan & Bendamustine||6
10428139|NCT00856830|11574159|FG002|Maximum Tolerated Dose|Irinotecan & Bendamustine||6
10428140|NCT00856830|11574160|FG003|Maximum Tolerated Dose|Irinotecan & Bendamustine||12
10428141|NCT00856830|11574157|FG000|COMPLETED|Irinotecan & Bendamustine||3
10428142|NCT00856830|11574158|FG001|COMPLETED|Irinotecan & Bendamustine||6
10428143|NCT00856830|11574159|FG002|COMPLETED|Irinotecan & Bendamustine||6
10428144|NCT00856830|11574160|FG003|COMPLETED|Irinotecan & Bendamustine||12
10428145|NCT00856830|11574157|FG000|NOT COMPLETED|Irinotecan & Bendamustine||0
10428146|NCT00856830|11574158|FG001|NOT COMPLETED|Irinotecan & Bendamustine||0
10428147|NCT00856830|11574159|FG002|NOT COMPLETED|Irinotecan & Bendamustine||0
10428148|NCT00856830|11574160|FG003|NOT COMPLETED|Irinotecan & Bendamustine||3
10428149|NCT00856830|11574157|FG000|STARTED|Regimen - B (Carboplatin & Etoposide)||3
10428150|NCT00856830|11574158|FG001|STARTED|Regimen - B (Carboplatin & Etoposide)||6
10428151|NCT00856830|11574159|FG002|STARTED|Regimen - B (Carboplatin & Etoposide)||6
10428152|NCT00856830|11574160|FG003|STARTED|Regimen - B (Carboplatin & Etoposide)||12
10428153|NCT00856830|11574157|FG000|COMPLETED|Regimen - B (Carboplatin & Etoposide)||3
10428154|NCT00856830|11574158|FG001|COMPLETED|Regimen - B (Carboplatin & Etoposide)||6
10540097|NCT01464827|11693069|FG008|NOT COMPLETED|Overall Study||3
10540098|NCT01464827|11693070|FG009|NOT COMPLETED|Overall Study||3
10717929|NCT02702388|11881953|FG001|COMPLETED|Overall Study||26
10717930|NCT02702388|11881952|FG000|NOT COMPLETED|Overall Study||40
10717931|NCT02702388|11881953|FG001|NOT COMPLETED|Overall Study||51
10428155|NCT00856830|11574159|FG002|COMPLETED|Regimen - B (Carboplatin & Etoposide)||6
10428156|NCT00856830|11574160|FG003|COMPLETED|Regimen - B (Carboplatin & Etoposide)||12
10428157|NCT00856830|11574157|FG000|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
10428158|NCT00856830|11574158|FG001|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
10540099|NCT01464827|11693071|FG010|NOT COMPLETED|Overall Study||2
10540100|NCT01464827|11693072|FG011|NOT COMPLETED|Overall Study||2
10540101|NCT01464827|11693073|FG012|NOT COMPLETED|Overall Study||2
10540102|NCT01464827|11693074|FG013|NOT COMPLETED|Overall Study||3
10540103|NCT01464840|11693118|FG000|STARTED|Overall Study||10
10540104|NCT01464840|11693119|FG001|STARTED|Overall Study||10
10540105|NCT01464840|11693120|FG002|STARTED|Overall Study||10
10540106|NCT01464840|11693118|FG000|COMPLETED|Overall Study||10
10540107|NCT01464840|11693119|FG001|COMPLETED|Overall Study||10
10540108|NCT01464840|11693120|FG002|COMPLETED|Overall Study||10
10540109|NCT01464840|11693118|FG000|NOT COMPLETED|Overall Study||0
10540110|NCT01464840|11693119|FG001|NOT COMPLETED|Overall Study||0
10382145|NCT00611624|11523784|FG000|STARTED|Overall Study||28
10382146|NCT00611624|11523784|FG000|COMPLETED|Overall Study||28
10382147|NCT00611624|11523784|FG000|NOT COMPLETED|Overall Study||0
10382148|NCT00611715|11523791|FG000|STARTED|Overall Study||42
10382149|NCT00611715|11523792|FG001|STARTED|Overall Study||6
10382150|NCT00611715|11523791|FG000|COMPLETED|Overall Study|"2 pts in Arm 1 remain on-tx. They are not accounted for in off-tx reasonor completed data fields"|1
10382151|NCT00611715|11523792|FG001|COMPLETED|Overall Study||0
10382152|NCT00611715|11523791|FG000|NOT COMPLETED|Overall Study||41
10382153|NCT00611715|11523792|FG001|NOT COMPLETED|Overall Study||6
10382154|NCT00611767|11523806|FG000|STARTED|Overall Study||49
10382155|NCT00611767|11523807|FG001|STARTED|Overall Study||24
10382156|NCT00611767|11523806|FG000|Thiopental Test Day|Overall Study||3
10382157|NCT00611767|11523807|FG001|Thiopental Test Day|Overall Study||1
10382158|NCT00611767|11523806|FG000|Placebo Test Day|Overall Study||6
10382159|NCT00611767|11523807|FG001|Placebo Test Day|Overall Study||1
10382160|NCT00611767|11523806|FG000|COMPLETED|Overall Study||40
10382161|NCT00611767|11523807|FG001|COMPLETED|Overall Study||22
10382162|NCT00611767|11523806|FG000|NOT COMPLETED|Overall Study||9
10382163|NCT00611767|11523807|FG001|NOT COMPLETED|Overall Study||2
10382164|NCT00611806|11523815|FG000|STARTED|Overall Study||94
10382165|NCT00611806|11523816|FG001|STARTED|Overall Study||46
10382166|NCT00611806|11523815|FG000|COMPLETED|Overall Study||78
10382167|NCT00611806|11523816|FG001|COMPLETED|Overall Study||43
10382168|NCT00611806|11523815|FG000|NOT COMPLETED|Overall Study||16
10382169|NCT00611806|11523816|FG001|NOT COMPLETED|Overall Study||3
10382170|NCT00611858|11523822|FG000|STARTED|Overall Study||13
10382171|NCT00611858|11523822|FG000|COMPLETED|Overall Study||9
10382172|NCT00611858|11523822|FG000|NOT COMPLETED|Overall Study||4
10382173|NCT00611884|11523832|FG000|STARTED|Overall Study||61
10382174|NCT00611884|11523833|FG001|STARTED|Overall Study||60
10382175|NCT00611884|11523834|FG002|STARTED|Overall Study||62
10382176|NCT00611884|11523835|FG003|STARTED|Overall Study||62
10382177|NCT00611884|11523832|FG000|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug|58
10382178|NCT00611884|11523833|FG001|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|59
10382179|NCT00611884|11523834|FG002|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|61
10382180|NCT00611884|11523835|FG003|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|61
10382181|NCT00611884|11523832|FG000|COMPLETED|Overall Study||52
10382182|NCT00611884|11523833|FG001|COMPLETED|Overall Study||51
10382183|NCT00611884|11523834|FG002|COMPLETED|Overall Study||58
10382184|NCT00611884|11523835|FG003|COMPLETED|Overall Study||56
10382185|NCT00611884|11523832|FG000|NOT COMPLETED|Overall Study||9
10382186|NCT00611884|11523833|FG001|NOT COMPLETED|Overall Study||9
10382187|NCT00611884|11523834|FG002|NOT COMPLETED|Overall Study||4
10382188|NCT00611884|11523835|FG003|NOT COMPLETED|Overall Study||6
10382189|NCT00611897|11523845|FG000|STARTED|Day 1: Initial Treatment||8
10382190|NCT00611897|11523846|FG001|STARTED|Day 1: Initial Treatment||8
10382191|NCT00611897|11523845|FG000|COMPLETED|Day 1: Initial Treatment||8
10382192|NCT00611897|11523846|FG001|COMPLETED|Day 1: Initial Treatment||8
10382193|NCT00611897|11523845|FG000|NOT COMPLETED|Day 1: Initial Treatment||0
10382194|NCT00611897|11523846|FG001|NOT COMPLETED|Day 1: Initial Treatment||0
10382195|NCT00611897|11523845|FG000|STARTED|Day 2: Crossover Treatment||8
10382196|NCT00611897|11523846|FG001|STARTED|Day 2: Crossover Treatment||8
10382197|NCT00611897|11523845|FG000|COMPLETED|Day 2: Crossover Treatment||8
10382198|NCT00611897|11523846|FG001|COMPLETED|Day 2: Crossover Treatment||8
10382199|NCT00611897|11523845|FG000|NOT COMPLETED|Day 2: Crossover Treatment||0
10382200|NCT00611897|11523846|FG001|NOT COMPLETED|Day 2: Crossover Treatment||0
10382201|NCT00611923|11523856|FG000|STARTED|Overall Study||12
10382202|NCT00611923|11523857|FG001|STARTED|Overall Study||13
10540111|NCT01464840|11693120|FG002|NOT COMPLETED|Overall Study||0
10540112|NCT01464879|11693128|FG000|STARTED|Overall Study||20
10540113|NCT01464879|11693128|FG000|Hand Application (2.50 mL)|Overall Study||20
10540114|NCT01464879|11693128|FG000|Washout Period|Overall Study||20
10540115|NCT01464879|11693128|FG000|Applicator Application (1.25 mL)|Overall Study|One subject discontinued due to non-compliance.|19
10540116|NCT01464879|11693128|FG000|Applicator Application (2.50 mL)|Overall Study|One subject discontinued due to physician's decision.|18
10540117|NCT01464879|11693128|FG000|Applicator Application (3.75 mL)|Overall Study||18
10540118|NCT01464879|11693128|FG000|COMPLETED|Overall Study||18
10540119|NCT01464879|11693128|FG000|NOT COMPLETED|Overall Study||2
10540120|NCT01464931|11693140|FG000|STARTED|Overall Study||16
10540121|NCT01464931|11693141|FG001|STARTED|Overall Study||16
10540122|NCT01464931|11693140|FG000|COMPLETED|Overall Study||15
10540123|NCT01464931|11693141|FG001|COMPLETED|Overall Study||16
10382203|NCT00611923|11523856|FG000|COMPLETED|Overall Study||10
10382204|NCT00611923|11523857|FG001|COMPLETED|Overall Study||11
10382205|NCT00611923|11523856|FG000|NOT COMPLETED|Overall Study||2
10382206|NCT00611923|11523857|FG001|NOT COMPLETED|Overall Study||2
10382207|NCT00611975|11523867|FG000|STARTED|Overall Study||45
10382208|NCT00611975|11523868|FG001|STARTED|Overall Study||38
10382209|NCT00611975|11523867|FG000|COMPLETED|Overall Study||40
10382210|NCT00611975|11523868|FG001|COMPLETED|Overall Study||30
10717932|NCT02702401|11881970|FG000|STARTED|Overall Study||278
10717933|NCT02702401|11881971|FG001|STARTED|Overall Study||135
10717934|NCT02702401|11881970|FG000|Treated|Overall Study||278
10382211|NCT00611975|11523867|FG000|NOT COMPLETED|Overall Study||5
10382212|NCT00611975|11523868|FG001|NOT COMPLETED|Overall Study||8
10382213|NCT00612040|11523877|FG000|STARTED|Overall Study||60
10382214|NCT00612040|11523878|FG001|STARTED|Overall Study||59
10382215|NCT00612040|11523879|FG002|STARTED|Overall Study||59
10382216|NCT00612040|11523877|FG000|Exposed|Overall Study||60
10382217|NCT00612040|11523878|FG001|Exposed|Overall Study||59
10382218|NCT00612040|11523879|FG002|Exposed|Overall Study||59
10382219|NCT00612040|11523877|FG000|COMPLETED|Overall Study||55
10382220|NCT00612040|11523878|FG001|COMPLETED|Overall Study||52
10382221|NCT00612040|11523879|FG002|COMPLETED|Overall Study||52
10382222|NCT00612040|11523877|FG000|NOT COMPLETED|Overall Study||5
10382223|NCT00612040|11523878|FG001|NOT COMPLETED|Overall Study||7
10382224|NCT00612040|11523879|FG002|NOT COMPLETED|Overall Study||7
10382225|NCT00612066|11523887|FG000|STARTED|Overall Study||2
10382226|NCT00612066|11523887|FG000|COMPLETED|Overall Study||1
10382227|NCT00612066|11523887|FG000|NOT COMPLETED|Overall Study||1
10540124|NCT01464931|11693140|FG000|NOT COMPLETED|Overall Study||1
10540125|NCT01464931|11693141|FG001|NOT COMPLETED|Overall Study||0
10540126|NCT01464996|11693154|FG000|STARTED|Overall Study||24
10540127|NCT01464996|11693154|FG000|OptiBond XTR|Overall Study||23
10540128|NCT01464996|11693154|FG000|OptiBond FL|Overall Study||24
10540129|NCT01464996|11693154|FG000|COMPLETED|Overall Study||24
10540130|NCT01464996|11693154|FG000|NOT COMPLETED|Overall Study||0
10548153|NCT01517412|11701950|FG001|STARTED|Overall Study||226
10548154|NCT01517412|11701949|FG000|COMPLETED|Overall Study||189
10548155|NCT01517412|11701950|FG001|COMPLETED|Overall Study||202
10548156|NCT01517412|11701949|FG000|NOT COMPLETED|Overall Study||36
10548157|NCT01517412|11701950|FG001|NOT COMPLETED|Overall Study||24
10548158|NCT01517529|11701956|FG000|STARTED|Overall Study||10
10548159|NCT01517529|11701956|FG000|COMPLETED|Overall Study||10
10548160|NCT01517529|11701956|FG000|NOT COMPLETED|Overall Study||0
10548161|NCT01517750|11701964|FG000|STARTED|Overall Study||21
10382228|NCT00612105|11523893|FG000|STARTED|Period Title 1: 6-Week Titration Phase||125
10382229|NCT00612105|11523894|FG001|STARTED|Period Title 1: 6-Week Titration Phase||62
10382230|NCT00612105|11523893|FG000|COMPLETED|Period Title 1: 6-Week Titration Phase||89
10382231|NCT00612105|11523894|FG001|COMPLETED|Period Title 1: 6-Week Titration Phase||57
10382232|NCT00612105|11523893|FG000|NOT COMPLETED|Period Title 1: 6-Week Titration Phase||36
10382233|NCT00612105|11523894|FG001|NOT COMPLETED|Period Title 1: 6-Week Titration Phase||5
10382234|NCT00612105|11523893|FG000|STARTED|Period Title 2: 4-Week Maintenance Phase||89
10382235|NCT00612105|11523894|FG001|STARTED|Period Title 2: 4-Week Maintenance Phase||57
10382236|NCT00612105|11523893|FG000|COMPLETED|Period Title 2: 4-Week Maintenance Phase||78
10382237|NCT00612105|11523894|FG001|COMPLETED|Period Title 2: 4-Week Maintenance Phase||55
10382238|NCT00612105|11523893|FG000|NOT COMPLETED|Period Title 2: 4-Week Maintenance Phase||11
10382239|NCT00612105|11523894|FG001|NOT COMPLETED|Period Title 2: 4-Week Maintenance Phase||2
10382240|NCT00612105|11523893|FG000|STARTED|Period Title 3: 3-Week Taper Phase|Includes participants who discontinued during the titration phase and entered taper phase.|86
10382241|NCT00612105|11523894|FG001|STARTED|Period Title 3: 3-Week Taper Phase|Includes participants who discontinued during the titration phase and entered taper phase.|58
10382242|NCT00612105|11523893|FG000|COMPLETED|Period Title 3: 3-Week Taper Phase||85
10382243|NCT00612105|11523894|FG001|COMPLETED|Period Title 3: 3-Week Taper Phase||58
10382244|NCT00612105|11523893|FG000|NOT COMPLETED|Period Title 3: 3-Week Taper Phase||1
10382245|NCT00612105|11523894|FG001|NOT COMPLETED|Period Title 3: 3-Week Taper Phase||0
10382246|NCT00612222|11523900|FG000|STARTED|Overall Study||4
10382247|NCT00612222|11523900|FG000|COMPLETED|Overall Study||4
10382248|NCT00612222|11523900|FG000|NOT COMPLETED|Overall Study||0
10382249|NCT00612235|11523908|FG000|STARTED|Overall Study||20
10382250|NCT00612235|11523909|FG001|STARTED|Overall Study||20
10382251|NCT00612235|11523910|FG002|STARTED|Overall Study||20
10382252|NCT00612235|11523911|FG003|STARTED|Overall Study||20
10382253|NCT00612235|11523908|FG000|COMPLETED|Overall Study||20
10382254|NCT00612235|11523909|FG001|COMPLETED|Overall Study||20
10382255|NCT00612235|11523910|FG002|COMPLETED|Overall Study||20
10382256|NCT00612235|11523911|FG003|COMPLETED|Overall Study||20
10382257|NCT00612235|11523908|FG000|NOT COMPLETED|Overall Study||0
10717935|NCT02702401|11881971|FG001|Treated|Overall Study||135
10382258|NCT00612235|11523909|FG001|NOT COMPLETED|Overall Study||0
10382259|NCT00612235|11523910|FG002|NOT COMPLETED|Overall Study||0
10382260|NCT00612235|11523911|FG003|NOT COMPLETED|Overall Study||0
10382261|NCT00612313|11523924|FG000|STARTED|Overall Study||69
10382262|NCT00612313|11523925|FG001|STARTED|Overall Study||75
10382263|NCT00612313|11523924|FG000|COMPLETED|Overall Study||52
10548162|NCT01517750|11701965|FG001|STARTED|Overall Study||19
10548163|NCT01517750|11701966|FG002|STARTED|Overall Study||21
10548164|NCT01517750|11701967|FG003|STARTED|Overall Study||19
10548165|NCT01517750|11701964|FG000|COMPLETED|Overall Study||20
10548166|NCT01517750|11701965|FG001|COMPLETED|Overall Study||17
10382264|NCT00612313|11523925|FG001|COMPLETED|Overall Study||62
10548167|NCT01517750|11701966|FG002|COMPLETED|Overall Study||17
10717936|NCT02702401|11881970|FG000|COMPLETED|Overall Study||0
10382265|NCT00612313|11523924|FG000|NOT COMPLETED|Overall Study||17
10382266|NCT00612313|11523925|FG001|NOT COMPLETED|Overall Study||13
10382267|NCT00612339|11523937|FG000|STARTED|Overall Study||41
10382268|NCT00612339|11523937|FG000|COMPLETED|Overall Study||41
10382269|NCT00612339|11523937|FG000|NOT COMPLETED|Overall Study||0
10382270|NCT00612352|11523943|FG000|STARTED|Overall Study||65
10382271|NCT00612352|11523944|FG001|STARTED|Overall Study||115
10382272|NCT00612352|11523943|FG000|40%mg & 100%mg|Overall Study||1
10382273|NCT00612352|11523944|FG001|40%mg & 100%mg|Overall Study||1
10382274|NCT00612352|11523943|FG000|Placebo & 100%mg|Overall Study||1
10382275|NCT00612352|11523944|FG001|Placebo & 100%mg|Overall Study||0
10382276|NCT00612352|11523943|FG000|100%mg|Overall Study||2
10382277|NCT00612352|11523944|FG001|100%mg|Overall Study||1
10382278|NCT00612352|11523943|FG000|40%mg|Overall Study||1
10382279|NCT00612352|11523944|FG001|40%mg|Overall Study||0
10382280|NCT00612352|11523943|FG000|Placebo|Overall Study||4
10382281|NCT00612352|11523944|FG001|Placebo|Overall Study||4
10382282|NCT00612352|11523943|FG000|COMPLETED|Overall Study||56
10382283|NCT00612352|11523944|FG001|COMPLETED|Overall Study||109
10382284|NCT00612352|11523943|FG000|NOT COMPLETED|Overall Study||9
10382285|NCT00612352|11523944|FG001|NOT COMPLETED|Overall Study||6
10382286|NCT00612430|11523952|FG000|STARTED|Overall Study||32
10382287|NCT00612430|11523953|FG001|STARTED|Overall Study||27
10382288|NCT00612430|11523952|FG000|COMPLETED|Overall Study||32
10382289|NCT00612430|11523953|FG001|COMPLETED|Overall Study||27
10382290|NCT00612430|11523952|FG000|NOT COMPLETED|Overall Study||0
10382291|NCT00612430|11523953|FG001|NOT COMPLETED|Overall Study||0
10382292|NCT00612456|11523964|FG000|STARTED|Overall Study||27
10382293|NCT00612456|11523965|FG001|STARTED|Overall Study||27
10382294|NCT00612456|11523966|FG002|STARTED|Overall Study||16
10382295|NCT00612456|11523964|FG000|COMPLETED|Overall Study||25
10382296|NCT00612456|11523965|FG001|COMPLETED|Overall Study||25
10382297|NCT00612456|11523966|FG002|COMPLETED|Overall Study||16
10382298|NCT00612456|11523964|FG000|NOT COMPLETED|Overall Study||2
10382299|NCT00612456|11523965|FG001|NOT COMPLETED|Overall Study||2
10382300|NCT00612456|11523966|FG002|NOT COMPLETED|Overall Study||0
10382301|NCT00612508|11523978|FG000|STARTED|Overall Study||7
10382302|NCT00612508|11523979|FG001|STARTED|Overall Study||7
10382303|NCT00612508|11523978|FG000|COMPLETED|Overall Study|5 desogen users returned for the 84 day biopsy|4
10382304|NCT00612508|11523979|FG001|COMPLETED|Overall Study|6 nuvaring users returned for the 84 day biopsy|3
10382305|NCT00612508|11523978|FG000|NOT COMPLETED|Overall Study||3
10382306|NCT00612508|11523979|FG001|NOT COMPLETED|Overall Study||4
10382307|NCT00612534|11523991|FG000|STARTED|Overall Study||24
10382308|NCT00612534|11523992|FG001|STARTED|Overall Study||26
10382309|NCT00612534|11523993|FG002|STARTED|Overall Study||20
10382310|NCT00612534|11523994|FG003|STARTED|Overall Study||24
10382311|NCT00612534|11523991|FG000|COMPLETED|Overall Study||11
10382312|NCT00612534|11523992|FG001|COMPLETED|Overall Study||9
10382313|NCT00612534|11523993|FG002|COMPLETED|Overall Study||13
10382314|NCT00612534|11523994|FG003|COMPLETED|Overall Study||7
10382315|NCT00612534|11523991|FG000|NOT COMPLETED|Overall Study||13
10382316|NCT00612534|11523992|FG001|NOT COMPLETED|Overall Study||17
10382317|NCT00612534|11523993|FG002|NOT COMPLETED|Overall Study||7
10382318|NCT00612534|11523994|FG003|NOT COMPLETED|Overall Study||17
10382319|NCT00612560|11524008|FG000|STARTED|Overall Study||7
10382320|NCT00612560|11524009|FG001|STARTED|Overall Study||7
10382321|NCT00612560|11524010|FG002|STARTED|Overall Study||8
10382322|NCT00612560|11524011|FG003|STARTED|Overall Study||6
10382323|NCT00612560|11524008|FG000|COMPLETED|Overall Study||7
10382324|NCT00612560|11524009|FG001|COMPLETED|Overall Study||7
10382325|NCT00612560|11524010|FG002|COMPLETED|Overall Study||8
10382326|NCT00612560|11524011|FG003|COMPLETED|Overall Study||6
10382327|NCT00612560|11524008|FG000|NOT COMPLETED|Overall Study||0
10540131|NCT01465022|11693163|FG000|STARTED|Overall Study||64
10540132|NCT01465022|11693164|FG001|STARTED|Overall Study||63
10540133|NCT01465022|11693165|FG002|STARTED|Overall Study||70
10540134|NCT01465022|11693163|FG000|COMPLETED|Overall Study||41
10540135|NCT01465022|11693164|FG001|COMPLETED|Overall Study||40
10540136|NCT01465022|11693165|FG002|COMPLETED|Overall Study||0
10540137|NCT01465022|11693163|FG000|NOT COMPLETED|Overall Study||23
10540138|NCT01465022|11693164|FG001|NOT COMPLETED|Overall Study||23
10540139|NCT01465022|11693165|FG002|NOT COMPLETED|Overall Study||70
10540140|NCT01465048|11693174|FG000|STARTED|Overall Study||6
10540141|NCT01465048|11693175|FG001|STARTED|Overall Study||6
10540142|NCT01465048|11693176|FG002|STARTED|Overall Study||6
10382328|NCT00612560|11524009|FG001|NOT COMPLETED|Overall Study||0
10382329|NCT00612560|11524010|FG002|NOT COMPLETED|Overall Study||0
10382330|NCT00612560|11524011|FG003|NOT COMPLETED|Overall Study||0
10382331|NCT00612573|11524025|FG000|STARTED|Overall Study||64
10382332|NCT00612573|11524026|FG001|STARTED|Overall Study||65
10382333|NCT00612573|11524027|FG002|STARTED|Overall Study||61
10382334|NCT00612573|11524028|FG003|STARTED|Overall Study||67
10382335|NCT00612573|11524025|FG000|COMPLETED|Overall Study||52
10382336|NCT00612573|11524026|FG001|COMPLETED|Overall Study||51
10382337|NCT00612573|11524027|FG002|COMPLETED|Overall Study||52
10382338|NCT00612573|11524028|FG003|COMPLETED|Overall Study||54
10382339|NCT00612573|11524025|FG000|NOT COMPLETED|Overall Study||12
10382340|NCT00612573|11524026|FG001|NOT COMPLETED|Overall Study||14
10382341|NCT00612573|11524027|FG002|NOT COMPLETED|Overall Study||9
10540143|NCT01465048|11693174|FG000|COMPLETED|Overall Study||6
10540144|NCT01465048|11693175|FG001|COMPLETED|Overall Study||6
10540145|NCT01465048|11693176|FG002|COMPLETED|Overall Study||6
10540146|NCT01465048|11693174|FG000|NOT COMPLETED|Overall Study||0
10382342|NCT00612573|11524028|FG003|NOT COMPLETED|Overall Study||13
10382343|NCT00612586|11524040|FG000|STARTED|Overall Study||58
10382344|NCT00612586|11524041|FG001|STARTED|Overall Study||59
10382345|NCT00612586|11524040|FG000|Received at Least 1 Dose|Overall Study||57
10382346|NCT00612586|11524041|FG001|Received at Least 1 Dose|Overall Study||58
10382347|NCT00612586|11524040|FG000|COMPLETED|Overall Study||15
10382348|NCT00612586|11524041|FG001|COMPLETED|Overall Study||18
10382349|NCT00612586|11524040|FG000|NOT COMPLETED|Overall Study||43
10382350|NCT00612586|11524041|FG001|NOT COMPLETED|Overall Study||41
10382351|NCT00612690|11524050|FG000|STARTED|Overall Study||275
10382352|NCT00612690|11524051|FG001|STARTED|Overall Study||207
10382353|NCT00612690|11524050|FG000|COMPLETED|Overall Study||160
10382354|NCT00612690|11524051|FG001|COMPLETED|Overall Study||89
10382355|NCT00612690|11524050|FG000|NOT COMPLETED|Overall Study||115
10382356|NCT00612690|11524051|FG001|NOT COMPLETED|Overall Study||118
10382357|NCT00612716|11524059|FG000|STARTED|Overall Study||6
10382358|NCT00612716|11524059|FG000|COMPLETED|Overall Study||6
10382359|NCT00612716|11524059|FG000|NOT COMPLETED|Overall Study||0
10382360|NCT00612768|11524063|FG000|STARTED|Overall Study||50
10382361|NCT00612768|11524063|FG000|COMPLETED|Overall Study||50
10382362|NCT00612768|11524063|FG000|NOT COMPLETED|Overall Study||0
10382363|NCT00612807|11524090|FG000|STARTED|Overall Study||14
10382364|NCT00612807|11524091|FG001|STARTED|Overall Study||28
10382365|NCT00612807|11524090|FG000|COMPLETED|Overall Study||12
10382366|NCT00612807|11524091|FG001|COMPLETED|Overall Study||28
10382367|NCT00612807|11524090|FG000|NOT COMPLETED|Overall Study||2
10382368|NCT00612807|11524091|FG001|NOT COMPLETED|Overall Study||0
10382369|NCT00612924|11524099|FG000|STARTED|Overall Study||101
10382370|NCT00612924|11524100|FG001|STARTED|Overall Study||94
10382371|NCT00612924|11524099|FG000|COMPLETED|Overall Study||94
10382372|NCT00612924|11524100|FG001|COMPLETED|Overall Study||85
10382373|NCT00612924|11524099|FG000|NOT COMPLETED|Overall Study||7
10382374|NCT00612924|11524100|FG001|NOT COMPLETED|Overall Study||9
10382375|NCT00613015|11524113|FG000|STARTED|Overall Study||13
10382376|NCT00613015|11524114|FG001|STARTED|Overall Study||12
10382377|NCT00613015|11524115|FG002|STARTED|Overall Study||26
10382378|NCT00613015|11524116|FG003|STARTED|Overall Study||24
10382379|NCT00613015|11524117|FG004|STARTED|Overall Study||15
10382380|NCT00613015|11524118|FG005|STARTED|Overall Study||19
10382381|NCT00613015|11524113|FG000|COMPLETED|Overall Study||13
10382382|NCT00613015|11524114|FG001|COMPLETED|Overall Study|One participant did not complete the one-week follow-up visit.|11
10382383|NCT00613015|11524115|FG002|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|23
10382384|NCT00613015|11524116|FG003|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|21
10382385|NCT00613015|11524117|FG004|COMPLETED|Overall Study|Two participants did not complete one-week follow-up visit.|13
10382386|NCT00613015|11524118|FG005|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|16
10382387|NCT00613015|11524113|FG000|NOT COMPLETED|Overall Study||0
10382388|NCT00613015|11524114|FG001|NOT COMPLETED|Overall Study||1
10382389|NCT00613015|11524115|FG002|NOT COMPLETED|Overall Study||3
10382390|NCT00613015|11524116|FG003|NOT COMPLETED|Overall Study||3
10382391|NCT00613015|11524117|FG004|NOT COMPLETED|Overall Study||2
10382392|NCT00613015|11524118|FG005|NOT COMPLETED|Overall Study||3
10382393|NCT00613028|11524134|FG000|STARTED|Overall Study||10
10382394|NCT00613028|11524135|FG001|STARTED|Overall Study||13
10382395|NCT00613028|11524134|FG000|COMPLETED|Overall Study||10
10382396|NCT00613028|11524135|FG001|COMPLETED|Overall Study||12
10382397|NCT00613028|11524134|FG000|NOT COMPLETED|Overall Study||0
10382398|NCT00613028|11524135|FG001|NOT COMPLETED|Overall Study||1
10382399|NCT00613080|11524141|FG000|STARTED|Overall Study||79
10382400|NCT00613080|11524141|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|68
10382401|NCT00613080|11524141|FG000|NOT COMPLETED|Overall Study||11
10382402|NCT00613106|11524147|FG000|STARTED|Overall Study||132
10382403|NCT00613106|11524148|FG001|STARTED|Overall Study||47
10382404|NCT00613106|11524147|FG000|COMPLETED|Overall Study||112
10382405|NCT00613106|11524148|FG001|COMPLETED|Overall Study||38
10812692|NCT03363633|11974835|FG000|COMPLETED|Overall Study|See note in Pre-Assignment Details|0
10812693|NCT03363633|11974835|FG000|NOT COMPLETED|Overall Study||12
10382406|NCT00613106|11524147|FG000|NOT COMPLETED|Overall Study||20
10717937|NCT02702401|11881971|FG001|COMPLETED|Overall Study||0
10717938|NCT02702401|11881970|FG000|NOT COMPLETED|Overall Study||278
10717939|NCT02702401|11881971|FG001|NOT COMPLETED|Overall Study||135
10717940|NCT02702518|11881979|FG000|STARTED|Overall Study||29
10717941|NCT02702518|11881980|FG001|STARTED|Overall Study||29
10717942|NCT02702518|11881979|FG000|COMPLETED|Overall Study||26
10717943|NCT02702518|11881980|FG001|COMPLETED|Overall Study||25
10717944|NCT02702518|11881979|FG000|NOT COMPLETED|Overall Study||3
10717945|NCT02702518|11881980|FG001|NOT COMPLETED|Overall Study||4
10717946|NCT02702609|11881988|FG000|STARTED|Overall Study||24
10717947|NCT02702609|11881989|FG001|STARTED|Overall Study||21
10717948|NCT02702609|11881988|FG000|Implant Placement|Overall Study||23
10382407|NCT00613106|11524148|FG001|NOT COMPLETED|Overall Study||9
10382408|NCT00613171|11524154|FG000|STARTED|Overall Study||27
10382409|NCT00613171|11524154|FG000|COMPLETED|Overall Study||13
10717949|NCT02702609|11881989|FG001|Implant Placement|Overall Study||21
10717950|NCT02702609|11881988|FG000|Crown Delivery|Overall Study||16
10717951|NCT02702609|11881989|FG001|Crown Delivery|Overall Study||18
10717952|NCT02702609|11881988|FG000|COMPLETED|Overall Study||15
10382410|NCT00613171|11524154|FG000|NOT COMPLETED|Overall Study||14
10382411|NCT00613301|11524159|FG000|STARTED|Overall Study||416
10382412|NCT00613301|11524159|FG000|COMPLETED|Overall Study||188
10382413|NCT00613301|11524159|FG000|NOT COMPLETED|Overall Study||228
10382414|NCT00613314|11524164|FG000|STARTED|Overall Study||15268
10382415|NCT00613314|11524164|FG000|COMPLETED|Overall Study||15113
10382416|NCT00613314|11524164|FG000|NOT COMPLETED|Overall Study||155
10382417|NCT00613327|11524168|FG000|STARTED|Overall Study||345
10382418|NCT00613327|11524168|FG000|COMPLETED|Overall Study||244
10382419|NCT00613327|11524168|FG000|NOT COMPLETED|Overall Study||101
10382420|NCT00613366|11524174|FG000|STARTED|Overall Study||20
10382421|NCT00613366|11524175|FG001|STARTED|Overall Study||20
10540147|NCT01465048|11693175|FG001|NOT COMPLETED|Overall Study||0
10540148|NCT01465048|11693176|FG002|NOT COMPLETED|Overall Study||0
10540149|NCT01465178|11693186|FG000|STARTED|Overall Study||31
10540150|NCT01465178|11693187|FG001|STARTED|Overall Study||31
10540151|NCT01465178|11693186|FG000|COMPLETED|Overall Study||30
10540152|NCT01465178|11693187|FG001|COMPLETED|Overall Study||31
10540153|NCT01465178|11693186|FG000|NOT COMPLETED|Overall Study||1
10540154|NCT01465178|11693187|FG001|NOT COMPLETED|Overall Study||0
10540155|NCT01465191|11693196|FG000|STARTED|Overall Study||56
10540156|NCT01465191|11693197|FG001|STARTED|Overall Study||63
10540157|NCT01465191|11693198|FG002|STARTED|Overall Study||50
10540158|NCT01465191|11693196|FG000|COMPLETED|Overall Study||47
10540159|NCT01465191|11693197|FG001|COMPLETED|Overall Study||54
10540160|NCT01465191|11693198|FG002|COMPLETED|Overall Study||43
10658114|NCT02230696|11819272|FG002|COMPLETED|Overall Study||190
10658115|NCT02230696|11819270|FG000|NOT COMPLETED|Overall Study||15
10658116|NCT02230696|11819271|FG001|NOT COMPLETED|Overall Study||11
10658117|NCT02230696|11819272|FG002|NOT COMPLETED|Overall Study||4
10658118|NCT02230761|11819282|FG000|STARTED|Overall Study||60
10658119|NCT02230761|11819283|FG001|STARTED|Overall Study||30
10658120|NCT02230761|11819282|FG000|COMPLETED|Overall Study||60
10658121|NCT02230761|11819283|FG001|COMPLETED|Overall Study||29
10658122|NCT02230761|11819282|FG000|NOT COMPLETED|Overall Study||0
10658123|NCT02230761|11819283|FG001|NOT COMPLETED|Overall Study||1
10658124|NCT02230904|11819291|FG000|STARTED|Overall Study||29
10658125|NCT02230904|11819292|FG001|STARTED|Overall Study||28
10658126|NCT02230904|11819291|FG000|COMPLETED|Overall Study||29
10658127|NCT02230904|11819292|FG001|COMPLETED|Overall Study||27
10658128|NCT02230904|11819291|FG000|NOT COMPLETED|Overall Study||0
10658129|NCT02230904|11819292|FG001|NOT COMPLETED|Overall Study||1
10717953|NCT02702609|11881989|FG001|COMPLETED|Overall Study||17
10717954|NCT02702609|11881988|FG000|NOT COMPLETED|Overall Study||9
10717955|NCT02702609|11881989|FG001|NOT COMPLETED|Overall Study||4
10382422|NCT00613366|11524174|FG000|COMPLETED|Overall Study||17
10382423|NCT00613366|11524175|FG001|COMPLETED|Overall Study||18
10658130|NCT02230956|11819303|FG000|STARTED|Overall Study||44
10382424|NCT00613366|11524174|FG000|NOT COMPLETED|Overall Study||3
10382425|NCT00613366|11524175|FG001|NOT COMPLETED|Overall Study||2
10382426|NCT00613379|11524184|FG000|STARTED|Overall Study||10
10382427|NCT00613379|11524185|FG001|STARTED|Overall Study||10
10382428|NCT00613379|11524186|FG002|STARTED|Overall Study||11
10382429|NCT00613379|11524184|FG000|COMPLETED|Overall Study||10
10382430|NCT00613379|11524185|FG001|COMPLETED|Overall Study||10
10540161|NCT01465191|11693196|FG000|NOT COMPLETED|Overall Study||9
10658131|NCT02230956|11819304|FG001|STARTED|Overall Study||43
10658132|NCT02230956|11819305|FG002|STARTED|Overall Study||89
10382431|NCT00613379|11524186|FG002|COMPLETED|Overall Study||11
10382432|NCT00613379|11524184|FG000|NOT COMPLETED|Overall Study||0
10382433|NCT00613379|11524185|FG001|NOT COMPLETED|Overall Study||0
10382434|NCT00613379|11524186|FG002|NOT COMPLETED|Overall Study||0
10382435|NCT00613405|11524196|FG000|STARTED|Overall Study||45
10382436|NCT00613405|11524197|FG001|STARTED|Overall Study||42
10382437|NCT00613405|11524196|FG000|COMPLETED|Overall Study||45
10382438|NCT00613405|11524197|FG001|COMPLETED|Overall Study||42
10382439|NCT00613405|11524196|FG000|NOT COMPLETED|Overall Study||0
10382440|NCT00613405|11524197|FG001|NOT COMPLETED|Overall Study||0
10382441|NCT00613509|11524205|FG000|STARTED|Cycle 1||11
10382442|NCT00613509|11524206|FG001|STARTED|Cycle 1||12
10382443|NCT00613509|11524205|FG000|COMPLETED|Cycle 1|Completion of Cycle 1. 9 participants were deemed evaluable|6
10382444|NCT00613509|11524206|FG001|COMPLETED|Cycle 1|Completion of Cycle 1. 12 participants were deemed evaluable|4
10382445|NCT00613509|11524205|FG000|NOT COMPLETED|Cycle 1||5
10382446|NCT00613509|11524206|FG001|NOT COMPLETED|Cycle 1||8
10382447|NCT00613509|11524205|FG000|STARTED|Cycle 2 (Group 2 = Crossover)||11
10382448|NCT00613509|11524206|FG001|STARTED|Cycle 2 (Group 2 = Crossover)||4
10382449|NCT00613509|11524205|FG000|COMPLETED|Cycle 2 (Group 2 = Crossover)||11
10717956|NCT02702921|11881997|FG000|STARTED|Overall Study||98
10717957|NCT02702921|11881998|FG001|STARTED|Overall Study||103
10717958|NCT02702921|11881997|FG000|COMPLETED|Overall Study||84
10717959|NCT02702921|11881998|FG001|COMPLETED|Overall Study||95
10717960|NCT02702921|11881997|FG000|NOT COMPLETED|Overall Study||14
10382450|NCT00613509|11524206|FG001|COMPLETED|Cycle 2 (Group 2 = Crossover)||4
10382451|NCT00613509|11524205|FG000|NOT COMPLETED|Cycle 2 (Group 2 = Crossover)||0
10382452|NCT00613509|11524206|FG001|NOT COMPLETED|Cycle 2 (Group 2 = Crossover)||0
10382453|NCT00613574|11524212|FG000|STARTED|Overall Study||407
10382454|NCT00613574|11524212|FG000|COMPLETED|Overall Study||401
10382455|NCT00613574|11524212|FG000|NOT COMPLETED|Overall Study||6
10382456|NCT00613626|11524219|FG000|STARTED|Overall Study||33
10382457|NCT00613626|11524220|FG001|STARTED|Overall Study||34
10382458|NCT00613626|11524221|FG002|STARTED|Overall Study|These participants provided the toxicity data to determine if ZD6474+Etopiside+Cisplatin was safe.|7
10382459|NCT00613626|11524219|FG000|1st Dose ZD6474|Overall Study||33
10382460|NCT00613626|11524220|FG001|1st Dose ZD6474|Overall Study||34
10382461|NCT00613626|11524221|FG002|1st Dose ZD6474|Overall Study||7
10382462|NCT00613626|11524219|FG000|COMPLETED|Overall Study||33
10382463|NCT00613626|11524220|FG001|COMPLETED|Overall Study||33
10382464|NCT00613626|11524221|FG002|COMPLETED|Overall Study||7
10382465|NCT00613626|11524219|FG000|NOT COMPLETED|Overall Study||0
10382466|NCT00613626|11524220|FG001|NOT COMPLETED|Overall Study||1
10382467|NCT00613626|11524221|FG002|NOT COMPLETED|Overall Study||0
10382468|NCT00613821|11524230|FG000|STARTED|Overall Study||40
10382469|NCT00613821|11524231|FG001|STARTED|Overall Study||40
10382470|NCT00613821|11524230|FG000|COMPLETED|Overall Study||38
10382471|NCT00613821|11524231|FG001|COMPLETED|Overall Study||39
10382472|NCT00613821|11524230|FG000|NOT COMPLETED|Overall Study||2
10382473|NCT00613821|11524231|FG001|NOT COMPLETED|Overall Study||1
10382474|NCT00613834|11524239|FG000|STARTED|Overall Study||29
10382475|NCT00613834|11524240|FG001|STARTED|Overall Study||29
10382476|NCT00613834|11524239|FG000|COMPLETED|Overall Study||29
10382477|NCT00613834|11524240|FG001|COMPLETED|Overall Study||26
10382478|NCT00613834|11524239|FG000|NOT COMPLETED|Overall Study||0
10382479|NCT00613834|11524240|FG001|NOT COMPLETED|Overall Study||3
10382480|NCT00613925|11524250|FG000|STARTED|Overall Study||37
10382481|NCT00613925|11524251|FG001|STARTED|Overall Study||33
10382482|NCT00613925|11524250|FG000|COMPLETED|Overall Study||37
10382483|NCT00613925|11524251|FG001|COMPLETED|Overall Study||32
10382484|NCT00613925|11524250|FG000|NOT COMPLETED|Overall Study||0
10382485|NCT00613925|11524251|FG001|NOT COMPLETED|Overall Study||1
10382486|NCT00613938|11524261|FG000|STARTED|Overall Study||69
10382487|NCT00613938|11524262|FG001|STARTED|Overall Study||275
10382488|NCT00613938|11524263|FG002|STARTED|Overall Study||278
10382489|NCT00613938|11524264|FG003|STARTED|Overall Study|one patient did not have a valid baseline score therefore excluded from above|279
10382490|NCT00613938|11524261|FG000|COMPLETED|Overall Study||49
10382491|NCT00613938|11524262|FG001|COMPLETED|Overall Study||247
10382492|NCT00613938|11524263|FG002|COMPLETED|Overall Study||255
10382493|NCT00613938|11524264|FG003|COMPLETED|Overall Study||253
10382494|NCT00613938|11524261|FG000|NOT COMPLETED|Overall Study||20
10382495|NCT00613938|11524262|FG001|NOT COMPLETED|Overall Study||28
10382496|NCT00613938|11524263|FG002|NOT COMPLETED|Overall Study||23
10382497|NCT00613938|11524264|FG003|NOT COMPLETED|Overall Study||26
10382498|NCT00613951|11524277|FG000|STARTED|Overall Study||61
10382499|NCT00613951|11524278|FG001|STARTED|Overall Study||59
10382500|NCT00613951|11524279|FG002|STARTED|Overall Study||62
10382501|NCT00613951|11524277|FG000|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|60
10382502|NCT00613951|11524278|FG001|Exposed|Overall Study||59
10382503|NCT00613951|11524279|FG002|Exposed|Overall Study||62
10382504|NCT00613951|11524277|FG000|COMPLETED|Overall Study||54
10382505|NCT00613951|11524278|FG001|COMPLETED|Overall Study||54
10382506|NCT00613951|11524279|FG002|COMPLETED|Overall Study||57
10382507|NCT00613951|11524277|FG000|NOT COMPLETED|Overall Study||7
10382508|NCT00613951|11524278|FG001|NOT COMPLETED|Overall Study||5
10382509|NCT00613951|11524279|FG002|NOT COMPLETED|Overall Study||5
10382510|NCT00614055|11524293|FG000|STARTED|Overall Study||59
10382511|NCT00614055|11524294|FG001|STARTED|Overall Study||59
10382512|NCT00614055|11524295|FG002|STARTED|Overall Study||60
10382513|NCT00614055|11524293|FG000|Exposed|Overall Study||59
10382514|NCT00614055|11524294|FG001|Exposed|Overall Study||59
10382515|NCT00614055|11524295|FG002|Exposed|Overall Study||60
10717961|NCT02702921|11881998|FG001|NOT COMPLETED|Overall Study||8
10717962|NCT02702999|11882006|FG000|STARTED|Overall Study||102
10717963|NCT02702999|11882007|FG001|STARTED|Overall Study||104
10382516|NCT00614055|11524293|FG000|COMPLETED|Overall Study||55
10382517|NCT00614055|11524294|FG001|COMPLETED|Overall Study||53
10382518|NCT00614055|11524295|FG002|COMPLETED|Overall Study||55
10382519|NCT00614055|11524293|FG000|NOT COMPLETED|Overall Study||4
10382520|NCT00614055|11524294|FG001|NOT COMPLETED|Overall Study||6
10382521|NCT00614055|11524295|FG002|NOT COMPLETED|Overall Study||5
10717964|NCT02702999|11882006|FG000|COMPLETED|Overall Study||102
10717965|NCT02702999|11882007|FG001|COMPLETED|Overall Study||104
10717966|NCT02702999|11882006|FG000|NOT COMPLETED|Overall Study||0
10717967|NCT02702999|11882007|FG001|NOT COMPLETED|Overall Study||0
10717968|NCT02703259|11882015|FG000|STARTED|24 Hours Postoperative Assessment||70
10717969|NCT02703259|11882016|FG001|STARTED|24 Hours Postoperative Assessment||67
10382522|NCT00614120|11524310|FG000|STARTED|Overall Study|Randomised|231
10382523|NCT00614120|11524311|FG001|STARTED|Overall Study|Randomised|233
10382524|NCT00614120|11524312|FG002|STARTED|Overall Study|Randomised|234
10382525|NCT00614120|11524313|FG003|STARTED|Overall Study|Randomised|231
10382526|NCT00614120|11524310|FG000|Exposed to Study Drug|Overall Study||231
10382527|NCT00614120|11524311|FG001|Exposed to Study Drug|Overall Study||233
10382528|NCT00614120|11524312|FG002|Exposed to Study Drug|Overall Study|Subject withdrew before exposure to study products, and thus not included in full analysis set.|233
10382529|NCT00614120|11524313|FG003|Exposed to Study Drug|Overall Study||231
10382530|NCT00614120|11524310|FG000|COMPLETED|Overall Study||202
10382531|NCT00614120|11524311|FG001|COMPLETED|Overall Study||187
10382532|NCT00614120|11524312|FG002|COMPLETED|Overall Study||175
10382533|NCT00614120|11524313|FG003|COMPLETED|Overall Study||215
10382534|NCT00614120|11524310|FG000|NOT COMPLETED|Overall Study||29
10717970|NCT02703259|11882015|FG000|COMPLETED|24 Hours Postoperative Assessment||68
10382535|NCT00614120|11524311|FG001|NOT COMPLETED|Overall Study||46
10382536|NCT00614120|11524312|FG002|NOT COMPLETED|Overall Study||59
10382537|NCT00614120|11524313|FG003|NOT COMPLETED|Overall Study||16
10382538|NCT00614198|11524325|FG000|STARTED|Stage 1||38
10382539|NCT00614198|11524326|FG001|STARTED|Stage 1||34
10382540|NCT00614198|11524325|FG000|COMPLETED|Stage 1||26
10382541|NCT00614198|11524326|FG001|COMPLETED|Stage 1||29
10382542|NCT00614198|11524325|FG000|NOT COMPLETED|Stage 1||12
10382543|NCT00614198|11524326|FG001|NOT COMPLETED|Stage 1||5
10382544|NCT00614198|11524325|FG000|STARTED|Stage 2||26
10382545|NCT00614198|11524326|FG001|STARTED|Stage 2|Reallocated to gluten- and casein-free dietary intervention|29
10382546|NCT00614198|11524325|FG000|COMPLETED|Stage 2||18
10382547|NCT00614198|11524326|FG001|COMPLETED|Stage 2||17
10382548|NCT00614198|11524325|FG000|NOT COMPLETED|Stage 2||8
10382549|NCT00614198|11524326|FG001|NOT COMPLETED|Stage 2||12
10382550|NCT00614315|11524332|FG000|STARTED|Overall Study||30
10382551|NCT00614315|11524332|FG000|COMPLETED|Overall Study||30
10382552|NCT00614315|11524332|FG000|NOT COMPLETED|Overall Study||0
10382553|NCT00614380|11524340|FG000|STARTED|Overall Study||564
10382554|NCT00614380|11524341|FG001|STARTED|Overall Study||206
10382555|NCT00614380|11524342|FG002|STARTED|Overall Study||25
10382556|NCT00614380|11524343|FG003|STARTED|Overall Study||181
10382557|NCT00614380|11524340|FG000|COMPLETED|Overall Study||529
10382558|NCT00614380|11524341|FG001|COMPLETED|Overall Study||198
10382559|NCT00614380|11524342|FG002|COMPLETED|Overall Study||24
10382560|NCT00614380|11524343|FG003|COMPLETED|Overall Study||179
10382561|NCT00614380|11524340|FG000|NOT COMPLETED|Overall Study||35
10382562|NCT00614380|11524341|FG001|NOT COMPLETED|Overall Study||8
10382563|NCT00614380|11524342|FG002|NOT COMPLETED|Overall Study||1
10382564|NCT00614380|11524343|FG003|NOT COMPLETED|Overall Study||2
10382565|NCT00614393|11524363|FG000|STARTED|Overall Study||180
10382566|NCT00614393|11524364|FG001|STARTED|Overall Study||8
10382567|NCT00614393|11524365|FG002|STARTED|Overall Study||10
10382568|NCT00614393|11524366|FG003|STARTED|Overall Study||180
10382569|NCT00614393|11524367|FG004|STARTED|Overall Study||180
10382570|NCT00614393|11524363|FG000|Treated|Overall Study||180
10382571|NCT00614393|11524364|FG001|Treated|Overall Study||8
10382572|NCT00614393|11524365|FG002|Treated|Overall Study||10
10382573|NCT00614393|11524366|FG003|Treated|Overall Study||180
10382574|NCT00614393|11524367|FG004|Treated|Overall Study||178
10382575|NCT00614393|11524363|FG000|COMPLETED|Overall Study||0
10382576|NCT00614393|11524364|FG001|COMPLETED|Overall Study||0
10382577|NCT00614393|11524365|FG002|COMPLETED|Overall Study||0
10382578|NCT00614393|11524366|FG003|COMPLETED|Overall Study||0
10382579|NCT00614393|11524367|FG004|COMPLETED|Overall Study||0
10382580|NCT00614393|11524363|FG000|NOT COMPLETED|Overall Study||180
10382581|NCT00614393|11524364|FG001|NOT COMPLETED|Overall Study||8
10382582|NCT00614393|11524365|FG002|NOT COMPLETED|Overall Study||10
10382583|NCT00614393|11524366|FG003|NOT COMPLETED|Overall Study||180
10382584|NCT00614393|11524367|FG004|NOT COMPLETED|Overall Study||180
10382585|NCT00614406|11524381|FG000|STARTED|Overall Study||7
10382586|NCT00614406|11524382|FG001|STARTED|Overall Study||4
10382587|NCT00614406|11524381|FG000|COMPLETED|Overall Study||7
10382588|NCT00614406|11524382|FG001|COMPLETED|Overall Study||4
10382589|NCT00614406|11524381|FG000|NOT COMPLETED|Overall Study||0
10382590|NCT00614406|11524382|FG001|NOT COMPLETED|Overall Study||0
10717971|NCT02703259|11882016|FG001|COMPLETED|24 Hours Postoperative Assessment||61
10382597|NCT00614445|11524399|FG000|STARTED|Overall Study||140
10382598|NCT00614445|11524400|FG001|STARTED|Overall Study||140
10382599|NCT00614445|11524399|FG000|COMPLETED|Overall Study||112
10382600|NCT00614445|11524400|FG001|COMPLETED|Overall Study||91
10382601|NCT00614445|11524399|FG000|NOT COMPLETED|Overall Study||28
10382602|NCT00614445|11524400|FG001|NOT COMPLETED|Overall Study||49
10382603|NCT00614458|11524406|FG000|STARTED|Overall Study||6
10382604|NCT00614458|11524406|FG000|COMPLETED|Overall Study||6
10382605|NCT00614458|11524406|FG000|NOT COMPLETED|Overall Study||0
10382606|NCT00614484|11524410|FG000|STARTED|Overall Study||28
10382607|NCT00614484|11524410|FG000|COMPLETED|Overall Study||28
10382608|NCT00614484|11524410|FG000|NOT COMPLETED|Overall Study||0
10382609|NCT00614523|11524417|FG000|STARTED|Overall Study||83
10382610|NCT00614523|11524418|FG001|STARTED|Overall Study||167
10382611|NCT00614523|11524417|FG000|COMPLETED|Overall Study||20
10382612|NCT00614523|11524418|FG001|COMPLETED|Overall Study||36
10382613|NCT00614523|11524417|FG000|NOT COMPLETED|Overall Study||63
10382614|NCT00614523|11524418|FG001|NOT COMPLETED|Overall Study||131
10382615|NCT00614575|11524424|FG000|STARTED|Overall Study|The number of patients enrolled.|1089
10382616|NCT00614575|11524424|FG000|COMPLETED|Overall Study||861
10382617|NCT00614575|11524424|FG000|NOT COMPLETED|Overall Study||228
10382618|NCT00614614|11524430|FG000|STARTED|Primary Vaccination Phase||1272
10382619|NCT00614614|11524431|FG001|STARTED|Primary Vaccination Phase||282
10382620|NCT00614614|11524432|FG002|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
10382621|NCT00614614|11524433|FG003|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
10382622|NCT00614614|11524434|FG004|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
10382623|NCT00614614|11524430|FG000|COMPLETED|Primary Vaccination Phase||1182
10382624|NCT00614614|11524431|FG001|COMPLETED|Primary Vaccination Phase||265
10382625|NCT00614614|11524432|FG002|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
10382626|NCT00614614|11524433|FG003|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
10382627|NCT00614614|11524434|FG004|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
10382628|NCT00614614|11524430|FG000|NOT COMPLETED|Primary Vaccination Phase||90
10382629|NCT00614614|11524431|FG001|NOT COMPLETED|Primary Vaccination Phase||17
10382630|NCT00614614|11524432|FG002|NOT COMPLETED|Primary Vaccination Phase||0
10382631|NCT00614614|11524433|FG003|NOT COMPLETED|Primary Vaccination Phase||0
10382632|NCT00614614|11524434|FG004|NOT COMPLETED|Primary Vaccination Phase||0
10382633|NCT00614614|11524430|FG000|STARTED|Booster Vaccination Phase|Menhibrix 1 Group was re-randomized to Nimenrix 1,Menhibrix 2 and Nimenrix 2 Groups in booster phase|0
10382634|NCT00614614|11524431|FG001|STARTED|Booster Vaccination Phase||233
10382635|NCT00614614|11524432|FG002|STARTED|Booster Vaccination Phase||432
10382636|NCT00614614|11524433|FG003|STARTED|Booster Vaccination Phase||229
10382637|NCT00614614|11524434|FG004|STARTED|Booster Vaccination Phase||409
10382638|NCT00614614|11524430|FG000|COMPLETED|Booster Vaccination Phase|Menhibrix 1 Group was re-randomized to Nimenrix 1,Menhibrix 2 and Nimenrix 2 Groups in booster phase|0
10382639|NCT00614614|11524431|FG001|COMPLETED|Booster Vaccination Phase||227
10382640|NCT00614614|11524432|FG002|COMPLETED|Booster Vaccination Phase||405
10382641|NCT00614614|11524433|FG003|COMPLETED|Booster Vaccination Phase||210
10382642|NCT00614614|11524434|FG004|COMPLETED|Booster Vaccination Phase||396
10382643|NCT00614614|11524430|FG000|NOT COMPLETED|Booster Vaccination Phase||0
10382644|NCT00614614|11524431|FG001|NOT COMPLETED|Booster Vaccination Phase||6
10382645|NCT00614614|11524432|FG002|NOT COMPLETED|Booster Vaccination Phase||27
10382646|NCT00614614|11524433|FG003|NOT COMPLETED|Booster Vaccination Phase||19
10382647|NCT00614614|11524434|FG004|NOT COMPLETED|Booster Vaccination Phase||13
10382648|NCT00614744|11524451|FG000|STARTED|Overall Study||83
10382649|NCT00614744|11524452|FG001|STARTED|Overall Study||85
10382650|NCT00614744|11524451|FG000|COMPLETED|Overall Study||78
10382651|NCT00614744|11524452|FG001|COMPLETED|Overall Study||79
10382652|NCT00614744|11524451|FG000|NOT COMPLETED|Overall Study||5
10382653|NCT00614744|11524452|FG001|NOT COMPLETED|Overall Study||6
10382654|NCT00614822|11524458|FG000|STARTED|Overall Study||50
10382655|NCT00614822|11524458|FG000|COMPLETED|Overall Study||47
10382656|NCT00614822|11524458|FG000|NOT COMPLETED|Overall Study||3
10382657|NCT00614874|11524463|FG000|STARTED|Overall Study||16
10382658|NCT00614874|11524463|FG000|COMPLETED|Overall Study||14
10382659|NCT00614874|11524463|FG000|NOT COMPLETED|Overall Study||2
10382660|NCT00614913|11524467|FG000|STARTED|Overall Study||76
10382661|NCT00614913|11524467|FG000|COMPLETED|Overall Study||76
10382662|NCT00614913|11524467|FG000|NOT COMPLETED|Overall Study||0
10382663|NCT00614926|11524473|FG000|STARTED|Overall Study||25
10382664|NCT00614926|11524474|FG001|STARTED|Overall Study||7
10382665|NCT00614926|11524473|FG000|COMPLETED|Overall Study||21
10382666|NCT00614926|11524474|FG001|COMPLETED|Overall Study||7
10382667|NCT00614926|11524473|FG000|NOT COMPLETED|Overall Study||4
10382668|NCT00614926|11524474|FG001|NOT COMPLETED|Overall Study||0
10382669|NCT00614939|11524482|FG000|STARTED|Overall Study|Randomized and treated|85
10382670|NCT00614939|11524483|FG001|STARTED|Overall Study|Randomized and treated|85
10382671|NCT00614939|11524482|FG000|COMPLETED|Overall Study|Completed 52 weeks of treatment|50
10382672|NCT00614939|11524483|FG001|COMPLETED|Overall Study|Completed 52 weeks of treatment|42
10382673|NCT00614939|11524482|FG000|NOT COMPLETED|Overall Study||35
10382674|NCT00614939|11524483|FG001|NOT COMPLETED|Overall Study||43
10382675|NCT00614991|11524495|FG000|STARTED|Overall Study||8
10382676|NCT00614991|11524496|FG001|STARTED|Overall Study||9
10382677|NCT00614991|11524497|FG002|STARTED|Overall Study||7
10382678|NCT00614991|11524498|FG003|STARTED|Overall Study||7
10382679|NCT00614991|11524499|FG004|STARTED|Overall Study||7
10382680|NCT00614991|11524500|FG005|STARTED|Overall Study||6
10382681|NCT00614991|11524495|FG000|COMPLETED|Overall Study||5
10382682|NCT00614991|11524496|FG001|COMPLETED|Overall Study||6
10382683|NCT00614991|11524497|FG002|COMPLETED|Overall Study||7
10382684|NCT00614991|11524498|FG003|COMPLETED|Overall Study||7
10382685|NCT00614991|11524499|FG004|COMPLETED|Overall Study||6
10382686|NCT00614991|11524500|FG005|COMPLETED|Overall Study||6
10382687|NCT00614991|11524495|FG000|NOT COMPLETED|Overall Study||3
10382688|NCT00614991|11524496|FG001|NOT COMPLETED|Overall Study||3
10382689|NCT00614991|11524497|FG002|NOT COMPLETED|Overall Study||0
10382690|NCT00614991|11524498|FG003|NOT COMPLETED|Overall Study||0
10382691|NCT00614991|11524499|FG004|NOT COMPLETED|Overall Study||1
10382692|NCT00614991|11524500|FG005|NOT COMPLETED|Overall Study||0
10382693|NCT00615017|11524525|FG000|STARTED|Overall Study|Patients received treatment|8
10382694|NCT00615017|11524526|FG001|STARTED|Overall Study|Patients received treatment|9
10382695|NCT00615017|11524527|FG002|STARTED|Overall Study|Patients received treatment|12
10382696|NCT00615017|11524528|FG003|STARTED|Overall Study|Patients received treatment|10
10382697|NCT00615017|11524529|FG004|STARTED|Overall Study|Patients received treatment|8
10382698|NCT00615017|11524530|FG005|STARTED|Overall Study|Patients received treatment|23
10382699|NCT00615017|11524525|FG000|COMPLETED|Overall Study|Patient completed the study drug|8
10382700|NCT00615017|11524526|FG001|COMPLETED|Overall Study|Patient completed the study drug|8
10382701|NCT00615017|11524527|FG002|COMPLETED|Overall Study|Patient completed the study drug|7
10382702|NCT00615017|11524528|FG003|COMPLETED|Overall Study|Patient completed the study drug|9
10382703|NCT00615017|11524529|FG004|COMPLETED|Overall Study|Patient completed the study drug|7
10382704|NCT00615017|11524530|FG005|COMPLETED|Overall Study|Patient completed the study drug|20
10382705|NCT00615017|11524525|FG000|NOT COMPLETED|Overall Study||0
10540162|NCT01465191|11693197|FG001|NOT COMPLETED|Overall Study||9
10540163|NCT01465191|11693198|FG002|NOT COMPLETED|Overall Study||7
10540164|NCT01465347|11693209|FG000|STARTED|Overall Study||3
10540165|NCT01465347|11693210|FG001|STARTED|Overall Study||56
10540166|NCT01465347|11693209|FG000|COMPLETED|Overall Study||2
10540167|NCT01465347|11693210|FG001|COMPLETED|Overall Study||53
10540168|NCT01465347|11693209|FG000|NOT COMPLETED|Overall Study||1
10540169|NCT01465347|11693210|FG001|NOT COMPLETED|Overall Study||3
10382706|NCT00615017|11524526|FG001|NOT COMPLETED|Overall Study||1
10382707|NCT00615017|11524527|FG002|NOT COMPLETED|Overall Study||5
10382708|NCT00615017|11524528|FG003|NOT COMPLETED|Overall Study||1
10382709|NCT00615017|11524529|FG004|NOT COMPLETED|Overall Study||1
10382710|NCT00615017|11524530|FG005|NOT COMPLETED|Overall Study||3
10382711|NCT00615030|11524544|FG000|STARTED|Period I||9
10382712|NCT00615030|11524545|FG001|STARTED|Period I||8
10382713|NCT00615030|11524546|FG002|STARTED|Period I||9
10382714|NCT00615030|11524547|FG003|STARTED|Period I||8
10382715|NCT00615030|11524548|FG004|STARTED|Period I||9
10382716|NCT00615030|11524549|FG005|STARTED|Period I|1 randomized patient in this sequence dropped out before exposure to study drug in Period I.|6
10382717|NCT00615030|11524550|FG006|STARTED|Period I||7
10382718|NCT00615030|11524551|FG007|STARTED|Period I||7
10382719|NCT00615030|11524552|FG008|STARTED|Period I||9
10382720|NCT00615030|11524553|FG009|STARTED|Period I||8
10382721|NCT00615030|11524554|FG010|STARTED|Period I||8
10382722|NCT00615030|11524555|FG011|STARTED|Period I||7
10382723|NCT00615030|11524544|FG000|COMPLETED|Period I||8
10382724|NCT00615030|11524545|FG001|COMPLETED|Period I||8
10382725|NCT00615030|11524546|FG002|COMPLETED|Period I||9
10382726|NCT00615030|11524547|FG003|COMPLETED|Period I||8
10382727|NCT00615030|11524548|FG004|COMPLETED|Period I||8
10382728|NCT00615030|11524549|FG005|COMPLETED|Period I||5
10382729|NCT00615030|11524550|FG006|COMPLETED|Period I||7
10382730|NCT00615030|11524551|FG007|COMPLETED|Period I||7
10382731|NCT00615030|11524552|FG008|COMPLETED|Period I||8
10382732|NCT00615030|11524553|FG009|COMPLETED|Period I||8
10382733|NCT00615030|11524554|FG010|COMPLETED|Period I||7
10382734|NCT00615030|11524555|FG011|COMPLETED|Period I||6
10382735|NCT00615030|11524544|FG000|NOT COMPLETED|Period I||1
10382736|NCT00615030|11524545|FG001|NOT COMPLETED|Period I||0
10382737|NCT00615030|11524546|FG002|NOT COMPLETED|Period I||0
10382738|NCT00615030|11524547|FG003|NOT COMPLETED|Period I||0
10382739|NCT00615030|11524548|FG004|NOT COMPLETED|Period I||1
10382740|NCT00615030|11524549|FG005|NOT COMPLETED|Period I||1
10382741|NCT00615030|11524550|FG006|NOT COMPLETED|Period I||0
10382742|NCT00615030|11524551|FG007|NOT COMPLETED|Period I||0
10382743|NCT00615030|11524552|FG008|NOT COMPLETED|Period I||1
10382744|NCT00615030|11524553|FG009|NOT COMPLETED|Period I||0
10382745|NCT00615030|11524554|FG010|NOT COMPLETED|Period I||1
10382746|NCT00615030|11524555|FG011|NOT COMPLETED|Period I||1
10382747|NCT00615030|11524544|FG000|STARTED|Period II||8
10382748|NCT00615030|11524545|FG001|STARTED|Period II||8
10382749|NCT00615030|11524546|FG002|STARTED|Period II||9
10382750|NCT00615030|11524547|FG003|STARTED|Period II||8
10382751|NCT00615030|11524548|FG004|STARTED|Period II||8
10382752|NCT00615030|11524549|FG005|STARTED|Period II||5
10382753|NCT00615030|11524550|FG006|STARTED|Period II||7
10382754|NCT00615030|11524551|FG007|STARTED|Period II||7
10382755|NCT00615030|11524552|FG008|STARTED|Period II||8
10540170|NCT01465386|11693219|FG000|STARTED|Overall Study||6
10382756|NCT00615030|11524553|FG009|STARTED|Period II||8
10382757|NCT00615030|11524554|FG010|STARTED|Period II||7
10382758|NCT00615030|11524555|FG011|STARTED|Period II||6
10382759|NCT00615030|11524544|FG000|COMPLETED|Period II||8
10382760|NCT00615030|11524545|FG001|COMPLETED|Period II||8
10382761|NCT00615030|11524546|FG002|COMPLETED|Period II||8
10382762|NCT00615030|11524547|FG003|COMPLETED|Period II||7
10382763|NCT00615030|11524548|FG004|COMPLETED|Period II||8
10382764|NCT00615030|11524549|FG005|COMPLETED|Period II||5
10382765|NCT00615030|11524550|FG006|COMPLETED|Period II||6
10382766|NCT00615030|11524551|FG007|COMPLETED|Period II||7
10382767|NCT00615030|11524552|FG008|COMPLETED|Period II||7
10382768|NCT00615030|11524553|FG009|COMPLETED|Period II||8
10382769|NCT00615030|11524554|FG010|COMPLETED|Period II||7
10382770|NCT00615030|11524555|FG011|COMPLETED|Period II||6
10382771|NCT00615030|11524544|FG000|NOT COMPLETED|Period II||0
10382772|NCT00615030|11524545|FG001|NOT COMPLETED|Period II||0
10382773|NCT00615030|11524546|FG002|NOT COMPLETED|Period II||1
10382774|NCT00615030|11524547|FG003|NOT COMPLETED|Period II||1
10382775|NCT00615030|11524548|FG004|NOT COMPLETED|Period II||0
10382776|NCT00615030|11524549|FG005|NOT COMPLETED|Period II||0
10382777|NCT00615030|11524550|FG006|NOT COMPLETED|Period II||1
10382778|NCT00615030|11524551|FG007|NOT COMPLETED|Period II||0
10382779|NCT00615030|11524552|FG008|NOT COMPLETED|Period II||1
10382780|NCT00615030|11524553|FG009|NOT COMPLETED|Period II||0
10382781|NCT00615030|11524554|FG010|NOT COMPLETED|Period II||0
10382782|NCT00615030|11524555|FG011|NOT COMPLETED|Period II||0
10382783|NCT00615030|11524544|FG000|STARTED|Period III||8
10382784|NCT00615030|11524545|FG001|STARTED|Period III||8
10382785|NCT00615030|11524546|FG002|STARTED|Period III||8
10382786|NCT00615030|11524547|FG003|STARTED|Period III||7
10382787|NCT00615030|11524548|FG004|STARTED|Period III||8
10382788|NCT00615030|11524549|FG005|STARTED|Period III||5
10382789|NCT00615030|11524550|FG006|STARTED|Period III||6
10382790|NCT00615030|11524551|FG007|STARTED|Period III||7
10382791|NCT00615030|11524552|FG008|STARTED|Period III||7
10382792|NCT00615030|11524553|FG009|STARTED|Period III||8
10382793|NCT00615030|11524554|FG010|STARTED|Period III||7
10382794|NCT00615030|11524555|FG011|STARTED|Period III||6
10382795|NCT00615030|11524544|FG000|COMPLETED|Period III||7
10382796|NCT00615030|11524545|FG001|COMPLETED|Period III||8
10382797|NCT00615030|11524546|FG002|COMPLETED|Period III||8
10382798|NCT00615030|11524547|FG003|COMPLETED|Period III||6
10382799|NCT00615030|11524548|FG004|COMPLETED|Period III||8
10382800|NCT00615030|11524549|FG005|COMPLETED|Period III||5
10382801|NCT00615030|11524550|FG006|COMPLETED|Period III||6
10382802|NCT00615030|11524551|FG007|COMPLETED|Period III||7
10382803|NCT00615030|11524552|FG008|COMPLETED|Period III||7
10382804|NCT00615030|11524553|FG009|COMPLETED|Period III||8
10382805|NCT00615030|11524554|FG010|COMPLETED|Period III||7
10382806|NCT00615030|11524555|FG011|COMPLETED|Period III||6
10382807|NCT00615030|11524544|FG000|NOT COMPLETED|Period III||1
10382808|NCT00615030|11524545|FG001|NOT COMPLETED|Period III||0
10540171|NCT01465386|11693219|FG000|COMPLETED|Overall Study||2
10540172|NCT01465386|11693219|FG000|NOT COMPLETED|Overall Study||4
10540173|NCT01465412|11693227|FG000|STARTED|Overall Study||12
10540174|NCT01465412|11693228|FG001|STARTED|Overall Study||12
10540175|NCT01465412|11693229|FG002|STARTED|Overall Study||9
10540176|NCT01465412|11693230|FG003|STARTED|Overall Study||9
10540177|NCT01465412|11693227|FG000|COMPLETED|Overall Study||12
10540178|NCT01465412|11693228|FG001|COMPLETED|Overall Study||12
10540179|NCT01465412|11693229|FG002|COMPLETED|Overall Study||9
10540180|NCT01465412|11693230|FG003|COMPLETED|Overall Study||9
10540181|NCT01465412|11693227|FG000|NOT COMPLETED|Overall Study||0
10540182|NCT01465412|11693228|FG001|NOT COMPLETED|Overall Study||0
10540183|NCT01465412|11693229|FG002|NOT COMPLETED|Overall Study||0
10540184|NCT01465412|11693230|FG003|NOT COMPLETED|Overall Study||0
10540185|NCT01465464|11693242|FG000|STARTED|Overall Study||444
10540186|NCT01465464|11693243|FG001|STARTED|Overall Study||444
10540187|NCT01465464|11693242|FG000|COMPLETED|Overall Study||0
10540188|NCT01465464|11693243|FG001|COMPLETED|Overall Study||0
10540189|NCT01465464|11693242|FG000|NOT COMPLETED|Overall Study||444
10540190|NCT01465464|11693243|FG001|NOT COMPLETED|Overall Study||444
10540191|NCT01465659|11693253|FG000|STARTED|Completed 1 Cycle of Treatment||7
10382809|NCT00615030|11524546|FG002|NOT COMPLETED|Period III||0
10382810|NCT00615030|11524547|FG003|NOT COMPLETED|Period III||1
10382811|NCT00615030|11524548|FG004|NOT COMPLETED|Period III||0
10382812|NCT00615030|11524549|FG005|NOT COMPLETED|Period III||0
10382813|NCT00615030|11524550|FG006|NOT COMPLETED|Period III||0
10382814|NCT00615030|11524551|FG007|NOT COMPLETED|Period III||0
10382815|NCT00615030|11524552|FG008|NOT COMPLETED|Period III||0
10540192|NCT01465659|11693254|FG001|STARTED|Completed 1 Cycle of Treatment||5
10540193|NCT01465659|11693255|FG002|STARTED|Completed 1 Cycle of Treatment||6
10540194|NCT01465659|11693256|FG003|STARTED|Completed 1 Cycle of Treatment||11
10540195|NCT01465659|11693253|FG000|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||7
10382816|NCT00615030|11524553|FG009|NOT COMPLETED|Period III||0
10382817|NCT00615030|11524554|FG010|NOT COMPLETED|Period III||0
10382818|NCT00615030|11524555|FG011|NOT COMPLETED|Period III||0
10382819|NCT00615056|11524573|FG000|STARTED|Overall Study||49
10382820|NCT00615056|11524574|FG001|STARTED|Overall Study||51
10382821|NCT00615056|11524575|FG002|STARTED|Overall Study||36
10382822|NCT00615056|11524576|FG003|STARTED|Overall Study||35
10382823|NCT00615056|11524573|FG000|Treated|Overall Study||46
10382824|NCT00615056|11524574|FG001|Treated|Overall Study||51
10540196|NCT01465659|11693254|FG001|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||4
10382825|NCT00615056|11524575|FG002|Treated|Overall Study||36
10382826|NCT00615056|11524576|FG003|Treated|Overall Study||35
10382827|NCT00615056|11524573|FG000|COMPLETED|Overall Study||0
10382828|NCT00615056|11524574|FG001|COMPLETED|Overall Study||0
10382829|NCT00615056|11524575|FG002|COMPLETED|Overall Study||0
10382830|NCT00615056|11524576|FG003|COMPLETED|Overall Study||0
10382831|NCT00615056|11524573|FG000|NOT COMPLETED|Overall Study||49
10382832|NCT00615056|11524574|FG001|NOT COMPLETED|Overall Study||51
10382833|NCT00615056|11524575|FG002|NOT COMPLETED|Overall Study||36
10382834|NCT00615056|11524576|FG003|NOT COMPLETED|Overall Study||35
10382835|NCT00615069|11524586|FG000|STARTED|Overall Study||35
10382836|NCT00615069|11524586|FG000|COMPLETED|Overall Study||19
10382837|NCT00615069|11524586|FG000|NOT COMPLETED|Overall Study||16
10382838|NCT00615108|11524590|FG000|STARTED|Overall Study||3148
10382839|NCT00615108|11524590|FG000|COMPLETED|Overall Study||2641
10382840|NCT00615108|11524590|FG000|NOT COMPLETED|Overall Study||507
10382841|NCT00615199|11524600|FG000|STARTED|Overall Study||34
10382842|NCT00615199|11524601|FG001|STARTED|Overall Study||36
10382843|NCT00615199|11524602|FG002|STARTED|Overall Study||34
10382844|NCT00615199|11524603|FG003|STARTED|Overall Study||35
10382845|NCT00615199|11524600|FG000|COMPLETED|Overall Study||26
10382846|NCT00615199|11524601|FG001|COMPLETED|Overall Study||34
10382847|NCT00615199|11524602|FG002|COMPLETED|Overall Study||33
10382848|NCT00615199|11524603|FG003|COMPLETED|Overall Study||33
10382849|NCT00615199|11524600|FG000|NOT COMPLETED|Overall Study||8
10382850|NCT00615199|11524601|FG001|NOT COMPLETED|Overall Study||2
10382851|NCT00615199|11524602|FG002|NOT COMPLETED|Overall Study||1
10382852|NCT00615199|11524603|FG003|NOT COMPLETED|Overall Study||2
10382853|NCT00615264|11524615|FG000|STARTED|Overall Study||225
10382854|NCT00615264|11524616|FG001|STARTED|Overall Study||232
10382855|NCT00615264|11524615|FG000|Received at Least One Dose (ITT)|Overall Study||225
10382856|NCT00615264|11524616|FG001|Received at Least One Dose (ITT)|Overall Study||231
10382857|NCT00615264|11524615|FG000|ITT Patients Who Met Inc/Excl (MITT)|Overall Study||209
10382858|NCT00615264|11524616|FG001|ITT Patients Who Met Inc/Excl (MITT)|Overall Study||213
10382859|NCT00615264|11524615|FG000|COMPLETED|Overall Study||175
10382860|NCT00615264|11524616|FG001|COMPLETED|Overall Study||180
10382861|NCT00615264|11524615|FG000|NOT COMPLETED|Overall Study||50
10382862|NCT00615264|11524616|FG001|NOT COMPLETED|Overall Study||52
10382863|NCT00615290|11524622|FG000|STARTED|Overall Study||42
10382864|NCT00615290|11524622|FG000|COMPLETED|Overall Study||34
10382865|NCT00615290|11524622|FG000|NOT COMPLETED|Overall Study||8
10382866|NCT00615420|11524628|FG000|STARTED|Overall Study||54
10382867|NCT00615420|11524629|FG001|STARTED|Overall Study||52
10382868|NCT00615420|11524628|FG000|COMPLETED|Overall Study||23
10382869|NCT00615420|11524629|FG001|COMPLETED|Overall Study||25
10382870|NCT00615420|11524628|FG000|NOT COMPLETED|Overall Study||31
10382871|NCT00615420|11524629|FG001|NOT COMPLETED|Overall Study||27
10382872|NCT00615433|11524639|FG000|STARTED|Overall Study||120
10382873|NCT00615433|11524640|FG001|STARTED|Overall Study||119
10382874|NCT00615433|11524641|FG002|STARTED|Overall Study||123
10382875|NCT00615433|11524642|FG003|STARTED|Overall Study||116
10382876|NCT00615433|11524639|FG000|COMPLETED|Overall Study||77
10382877|NCT00615433|11524640|FG001|COMPLETED|Overall Study||66
10382878|NCT00615433|11524641|FG002|COMPLETED|Overall Study||84
10382879|NCT00615433|11524642|FG003|COMPLETED|Overall Study||71
10382880|NCT00615433|11524639|FG000|NOT COMPLETED|Overall Study||43
10382881|NCT00615433|11524640|FG001|NOT COMPLETED|Overall Study||53
10382882|NCT00615433|11524641|FG002|NOT COMPLETED|Overall Study||39
10382883|NCT00615433|11524642|FG003|NOT COMPLETED|Overall Study||45
10382884|NCT00615459|11524653|FG000|STARTED|Period I||41
10382885|NCT00615459|11524654|FG001|STARTED|Period I|1 randomized patient of this sequence was never exposed to drug. Hence, dropped out before Period I.|41
10382886|NCT00615459|11524655|FG002|STARTED|Period I|1 randomized patient of this sequence was never exposed to drug. Hence, dropped out before Period I.|42
10382887|NCT00615459|11524656|FG003|STARTED|Period I||43
10382888|NCT00615459|11524653|FG000|COMPLETED|Period I||37
10382889|NCT00615459|11524654|FG001|COMPLETED|Period I||40
10540197|NCT01465659|11693255|FG002|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||6
10382890|NCT00615459|11524655|FG002|COMPLETED|Period I||40
10382891|NCT00615459|11524656|FG003|COMPLETED|Period I||42
10382892|NCT00615459|11524653|FG000|NOT COMPLETED|Period I||4
10382893|NCT00615459|11524654|FG001|NOT COMPLETED|Period I||1
10382894|NCT00615459|11524655|FG002|NOT COMPLETED|Period I||2
10382895|NCT00615459|11524656|FG003|NOT COMPLETED|Period I||1
10382896|NCT00615459|11524653|FG000|STARTED|Period II||37
10382897|NCT00615459|11524654|FG001|STARTED|Period II||40
10382898|NCT00615459|11524655|FG002|STARTED|Period II||40
10382899|NCT00615459|11524656|FG003|STARTED|Period II||42
10382900|NCT00615459|11524653|FG000|COMPLETED|Period II||36
10658133|NCT02230956|11819303|FG000|COMPLETED|Overall Study||39
10382901|NCT00615459|11524654|FG001|COMPLETED|Period II||40
10382902|NCT00615459|11524655|FG002|COMPLETED|Period II||40
10382903|NCT00615459|11524656|FG003|COMPLETED|Period II||41
10382904|NCT00615459|11524653|FG000|NOT COMPLETED|Period II||1
10382905|NCT00615459|11524654|FG001|NOT COMPLETED|Period II||0
10382906|NCT00615459|11524655|FG002|NOT COMPLETED|Period II||0
10382907|NCT00615459|11524656|FG003|NOT COMPLETED|Period II||1
10382908|NCT00615459|11524653|FG000|STARTED|Period III||36
10382909|NCT00615459|11524654|FG001|STARTED|Period III||40
10382910|NCT00615459|11524655|FG002|STARTED|Period III||40
10382911|NCT00615459|11524656|FG003|STARTED|Period III||41
10382912|NCT00615459|11524653|FG000|COMPLETED|Period III||36
10382913|NCT00615459|11524654|FG001|COMPLETED|Period III||37
10382914|NCT00615459|11524655|FG002|COMPLETED|Period III||39
10382915|NCT00615459|11524656|FG003|COMPLETED|Period III||41
10382916|NCT00615459|11524653|FG000|NOT COMPLETED|Period III||0
10382917|NCT00615459|11524654|FG001|NOT COMPLETED|Period III||3
10382918|NCT00615459|11524655|FG002|NOT COMPLETED|Period III||1
10382919|NCT00615459|11524656|FG003|NOT COMPLETED|Period III||0
10382920|NCT00615472|11524668|FG000|STARTED|Overall Study||30
10382921|NCT00615472|11524669|FG001|STARTED|Overall Study||28
10382922|NCT00615472|11524668|FG000|COMPLETED|Overall Study||30
10382923|NCT00615472|11524669|FG001|COMPLETED|Overall Study||28
10382924|NCT00615472|11524668|FG000|NOT COMPLETED|Overall Study||0
10382925|NCT00615472|11524669|FG001|NOT COMPLETED|Overall Study||0
10382926|NCT00615550|11524677|FG000|STARTED|Overall Study||229
10382927|NCT00615550|11524678|FG001|STARTED|Overall Study||236
10382928|NCT00615550|11524677|FG000|COMPLETED|Overall Study||223
10382929|NCT00615550|11524678|FG001|COMPLETED|Overall Study||235
10382930|NCT00615550|11524677|FG000|NOT COMPLETED|Overall Study||6
10382931|NCT00615550|11524678|FG001|NOT COMPLETED|Overall Study||1
10382932|NCT00615589|11524684|FG000|STARTED|Overall Study||22
10382933|NCT00615589|11524684|FG000|COMPLETED|Overall Study||22
10382934|NCT00615589|11524684|FG000|NOT COMPLETED|Overall Study||0
10382935|NCT00615719|11524689|FG000|STARTED|Overall Study||35
10382936|NCT00615719|11524689|FG000|COMPLETED|Overall Study||30
10382937|NCT00615719|11524689|FG000|NOT COMPLETED|Overall Study||5
10382938|NCT00615784|11524693|FG000|STARTED|Overall Study||24
10382939|NCT00615784|11524693|FG000|COMPLETED|Overall Study||24
10382940|NCT00615784|11524693|FG000|NOT COMPLETED|Overall Study||0
10382941|NCT00615836|11524701|FG000|STARTED|Part I of Core Study (FE992026 CS29)||163
10382942|NCT00615836|11524702|FG001|STARTED|Part I of Core Study (FE992026 CS29)||158
10382943|NCT00615836|11524703|FG002|STARTED|Part I of Core Study (FE992026 CS29)||158
10382944|NCT00615836|11524704|FG003|STARTED|Part I of Core Study (FE992026 CS29)||160
10382945|NCT00615836|11524705|FG004|STARTED|Part I of Core Study (FE992026 CS29)||160
10382946|NCT00615836|11524701|FG000|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|155
10382947|NCT00615836|11524702|FG001|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|152
10540198|NCT01465659|11693256|FG003|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||11
10540199|NCT01465659|11693253|FG000|COMPLETED|Completed 1 Cycle of Treatment||7
10540200|NCT01465659|11693254|FG001|COMPLETED|Completed 1 Cycle of Treatment||4
10540201|NCT01465659|11693255|FG002|COMPLETED|Completed 1 Cycle of Treatment||6
10540202|NCT01465659|11693256|FG003|COMPLETED|Completed 1 Cycle of Treatment||10
10540203|NCT01465659|11693253|FG000|NOT COMPLETED|Completed 1 Cycle of Treatment||0
10540204|NCT01465659|11693254|FG001|NOT COMPLETED|Completed 1 Cycle of Treatment||1
10658134|NCT02230956|11819304|FG001|COMPLETED|Overall Study||37
10658135|NCT02230956|11819305|FG002|COMPLETED|Overall Study||82
10658136|NCT02230956|11819303|FG000|NOT COMPLETED|Overall Study||5
10658137|NCT02230956|11819304|FG001|NOT COMPLETED|Overall Study||6
10658138|NCT02230956|11819305|FG002|NOT COMPLETED|Overall Study||7
10658139|NCT02230995|11819315|FG000|STARTED|Period 1 + Washout||15
10658140|NCT02230995|11819316|FG001|STARTED|Period 1 + Washout||15
10658141|NCT02230995|11819315|FG000|COMPLETED|Period 1 + Washout||15
10658142|NCT02230995|11819316|FG001|COMPLETED|Period 1 + Washout||15
10658143|NCT02230995|11819315|FG000|NOT COMPLETED|Period 1 + Washout||0
10658144|NCT02230995|11819316|FG001|NOT COMPLETED|Period 1 + Washout||0
10658145|NCT02230995|11819315|FG000|STARTED|Period 2 + Washout||15
10658146|NCT02230995|11819316|FG001|STARTED|Period 2 + Washout||15
10658147|NCT02230995|11819315|FG000|COMPLETED|Period 2 + Washout||15
10658148|NCT02230995|11819316|FG001|COMPLETED|Period 2 + Washout||15
10658149|NCT02230995|11819315|FG000|NOT COMPLETED|Period 2 + Washout||0
10658150|NCT02230995|11819316|FG001|NOT COMPLETED|Period 2 + Washout||0
10658151|NCT02231086|11819324|FG000|STARTED|Overall Study||102
10658152|NCT02231086|11819325|FG001|STARTED|Overall Study||102
10382948|NCT00615836|11524703|FG002|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|148
10382949|NCT00615836|11524704|FG003|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|146
10540205|NCT01465659|11693255|FG002|NOT COMPLETED|Completed 1 Cycle of Treatment||0
10540206|NCT01465659|11693256|FG003|NOT COMPLETED|Completed 1 Cycle of Treatment||1
10540207|NCT01465659|11693253|FG000|STARTED|Completed 2 Cycles/Reached 1st Response||7
10540208|NCT01465659|11693254|FG001|STARTED|Completed 2 Cycles/Reached 1st Response||4
10540209|NCT01465659|11693255|FG002|STARTED|Completed 2 Cycles/Reached 1st Response||6
10540210|NCT01465659|11693256|FG003|STARTED|Completed 2 Cycles/Reached 1st Response||10
10540211|NCT01465659|11693253|FG000|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||7
10540212|NCT01465659|11693254|FG001|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||4
10540213|NCT01465659|11693255|FG002|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||6
10540214|NCT01465659|11693256|FG003|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||10
10540215|NCT01465659|11693253|FG000|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||7
10658153|NCT02231086|11819324|FG000|COMPLETED|Overall Study||63
10658154|NCT02231086|11819325|FG001|COMPLETED|Overall Study||65
10658155|NCT02231086|11819324|FG000|NOT COMPLETED|Overall Study||39
10658156|NCT02231086|11819325|FG001|NOT COMPLETED|Overall Study||37
10658157|NCT02231164|11819333|FG000|STARTED|Overall Study||6
10658158|NCT02231164|11819334|FG001|STARTED|Overall Study||6
10658159|NCT02231164|11819333|FG000|COMPLETED|Overall Study||0
10382950|NCT00615836|11524705|FG004|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|156
10382951|NCT00615836|11524701|FG000|COMPLETED|Part I of Core Study (FE992026 CS29)||144
10382952|NCT00615836|11524702|FG001|COMPLETED|Part I of Core Study (FE992026 CS29)||148
10382953|NCT00615836|11524703|FG002|COMPLETED|Part I of Core Study (FE992026 CS29)||138
10382954|NCT00615836|11524704|FG003|COMPLETED|Part I of Core Study (FE992026 CS29)||135
10382955|NCT00615836|11524705|FG004|COMPLETED|Part I of Core Study (FE992026 CS29)||145
10382956|NCT00615836|11524701|FG000|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||19
10382957|NCT00615836|11524702|FG001|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||10
10382958|NCT00615836|11524703|FG002|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||20
10382959|NCT00615836|11524704|FG003|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||25
10382960|NCT00615836|11524705|FG004|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||15
10382961|NCT00615836|11524701|FG000|STARTED|Extension Study (FE992026 CS31)||141
10382962|NCT00615836|11524702|FG001|STARTED|Extension Study (FE992026 CS31)||144
10382963|NCT00615836|11524703|FG002|STARTED|Extension Study (FE992026 CS31)||132
10382964|NCT00615836|11524704|FG003|STARTED|Extension Study (FE992026 CS31)||137
10382965|NCT00615836|11524705|FG004|STARTED|Extension Study (FE992026 CS31)||0
10382966|NCT00615836|11524701|FG000|COMPLETED|Extension Study (FE992026 CS31)||0
10382967|NCT00615836|11524702|FG001|COMPLETED|Extension Study (FE992026 CS31)||58
10382968|NCT00615836|11524703|FG002|COMPLETED|Extension Study (FE992026 CS31)||59
10382969|NCT00615836|11524704|FG003|COMPLETED|Extension Study (FE992026 CS31)||53
10382970|NCT00615836|11524705|FG004|COMPLETED|Extension Study (FE992026 CS31)||0
10382971|NCT00615836|11524701|FG000|NOT COMPLETED|Extension Study (FE992026 CS31)||141
10382972|NCT00615836|11524702|FG001|NOT COMPLETED|Extension Study (FE992026 CS31)||86
10382973|NCT00615836|11524703|FG002|NOT COMPLETED|Extension Study (FE992026 CS31)||73
10382974|NCT00615836|11524704|FG003|NOT COMPLETED|Extension Study (FE992026 CS31)||84
10382975|NCT00615836|11524705|FG004|NOT COMPLETED|Extension Study (FE992026 CS31)||0
10382976|NCT00615901|11524721|FG000|STARTED|Overall Study||38
10382977|NCT00615901|11524721|FG000|COMPLETED|Overall Study||29
10382978|NCT00615901|11524721|FG000|NOT COMPLETED|Overall Study||9
10382979|NCT00615914|11524725|FG000|STARTED|Overall Study|The number of patients enrolled|1645
10382980|NCT00615914|11524725|FG000|COMPLETED|Overall Study||1008
10382981|NCT00615914|11524725|FG000|NOT COMPLETED|Overall Study||637
10382982|NCT00615927|11524732|FG000|STARTED|Overall Study||32
10382983|NCT00615927|11524733|FG001|STARTED|Overall Study||32
10382984|NCT00615927|11524732|FG000|COMPLETED|Overall Study||32
10382985|NCT00615927|11524733|FG001|COMPLETED|Overall Study||32
10382986|NCT00615927|11524732|FG000|NOT COMPLETED|Overall Study||0
10382987|NCT00615927|11524733|FG001|NOT COMPLETED|Overall Study||0
10382988|NCT00615992|11524739|FG000|STARTED|Overall Study||754
10382989|NCT00615992|11524739|FG000|COMPLETED|Overall Study||687
10382990|NCT00615992|11524739|FG000|NOT COMPLETED|Overall Study||67
10382991|NCT00616018|11524743|FG000|STARTED|Overall Study||27
10382992|NCT00616018|11524743|FG000|COMPLETED|Overall Study||24
10382993|NCT00616018|11524743|FG000|NOT COMPLETED|Overall Study||3
10382994|NCT00616109|11524748|FG000|STARTED|Overall Study||16
10540216|NCT01465659|11693254|FG001|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||4
10540217|NCT01465659|11693255|FG002|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||6
10540218|NCT01465659|11693256|FG003|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||10
10540219|NCT01465659|11693253|FG000|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||7
10540220|NCT01465659|11693254|FG001|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||4
10540221|NCT01465659|11693255|FG002|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||4
10540222|NCT01465659|11693256|FG003|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||10
10540223|NCT01465659|11693253|FG000|COMPLETED|Completed 2 Cycles/Reached 1st Response||5
10540224|NCT01465659|11693254|FG001|COMPLETED|Completed 2 Cycles/Reached 1st Response||4
10540225|NCT01465659|11693255|FG002|COMPLETED|Completed 2 Cycles/Reached 1st Response||4
10540226|NCT01465659|11693256|FG003|COMPLETED|Completed 2 Cycles/Reached 1st Response||9
10540227|NCT01465659|11693253|FG000|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||2
10540228|NCT01465659|11693254|FG001|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
10540229|NCT01465659|11693255|FG002|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||2
10540230|NCT01465659|11693256|FG003|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||1
10540231|NCT01465659|11693253|FG000|STARTED|Went on to Cycle 3 and Beyond||5
10540232|NCT01465659|11693254|FG001|STARTED|Went on to Cycle 3 and Beyond||4
10540233|NCT01465659|11693255|FG002|STARTED|Went on to Cycle 3 and Beyond||4
10540234|NCT01465659|11693256|FG003|STARTED|Went on to Cycle 3 and Beyond||9
10540235|NCT01465659|11693253|FG000|COMPLETED|Went on to Cycle 3 and Beyond||5
10540236|NCT01465659|11693254|FG001|COMPLETED|Went on to Cycle 3 and Beyond||4
10540237|NCT01465659|11693255|FG002|COMPLETED|Went on to Cycle 3 and Beyond||4
10540238|NCT01465659|11693256|FG003|COMPLETED|Went on to Cycle 3 and Beyond||9
10540239|NCT01465659|11693253|FG000|NOT COMPLETED|Went on to Cycle 3 and Beyond||0
10540240|NCT01465659|11693254|FG001|NOT COMPLETED|Went on to Cycle 3 and Beyond||0
10540241|NCT01465659|11693255|FG002|NOT COMPLETED|Went on to Cycle 3 and Beyond||0
10540242|NCT01465659|11693256|FG003|NOT COMPLETED|Went on to Cycle 3 and Beyond||0
10540243|NCT01465659|11693253|FG000|STARTED|Completed Follow for 1 Year||7
10540244|NCT01465659|11693254|FG001|STARTED|Completed Follow for 1 Year||4
10540245|NCT01465659|11693255|FG002|STARTED|Completed Follow for 1 Year||6
10540246|NCT01465659|11693256|FG003|STARTED|Completed Follow for 1 Year||11
10540247|NCT01465659|11693253|FG000|COMPLETED|Completed Follow for 1 Year||1
10382995|NCT00616109|11524748|FG000|COMPLETED|Overall Study||16
10382996|NCT00616109|11524748|FG000|NOT COMPLETED|Overall Study||0
10382997|NCT00616122|11524753|FG000|STARTED|Overall Study||4
10382998|NCT00616122|11524754|FG001|STARTED|Overall Study||7
10382999|NCT00616122|11524755|FG002|STARTED|Overall Study||10
10383000|NCT00616122|11524756|FG003|STARTED|Overall Study||11
10383001|NCT00616122|11524753|FG000|COMPLETED|Overall Study||4
10383002|NCT00616122|11524754|FG001|COMPLETED|Overall Study||7
10383003|NCT00616122|11524755|FG002|COMPLETED|Overall Study||10
10540248|NCT01465659|11693254|FG001|COMPLETED|Completed Follow for 1 Year||1
10540249|NCT01465659|11693255|FG002|COMPLETED|Completed Follow for 1 Year||4
10540250|NCT01465659|11693256|FG003|COMPLETED|Completed Follow for 1 Year||7
10540251|NCT01465659|11693253|FG000|NOT COMPLETED|Completed Follow for 1 Year||6
10540252|NCT01465659|11693254|FG001|NOT COMPLETED|Completed Follow for 1 Year||3
10540253|NCT01465659|11693255|FG002|NOT COMPLETED|Completed Follow for 1 Year||2
10540254|NCT01465659|11693256|FG003|NOT COMPLETED|Completed Follow for 1 Year||4
10540255|NCT01465763|11693272|FG000|STARTED|Overall Study||476
10540256|NCT01465763|11693273|FG001|STARTED|Overall Study||16
10540257|NCT01465763|11693274|FG002|STARTED|Overall Study||122
10540258|NCT01465763|11693272|FG000|COMPLETED|Overall Study||445
10540259|NCT01465763|11693273|FG001|COMPLETED|Overall Study||15
10540260|NCT01465763|11693274|FG002|COMPLETED|Overall Study||118
10540261|NCT01465763|11693272|FG000|NOT COMPLETED|Overall Study||31
10540262|NCT01465763|11693273|FG001|NOT COMPLETED|Overall Study||1
10540263|NCT01465763|11693274|FG002|NOT COMPLETED|Overall Study||4
10540264|NCT01465802|11693286|FG000|STARTED|Overall Study||66
10540265|NCT01465802|11693287|FG001|STARTED|Overall Study||66
10540266|NCT01465802|11693288|FG002|STARTED|Overall Study||7
10540267|NCT01465802|11693289|FG003|STARTED|Overall Study|An additional 5 participants were enrolled in Cohort II but not treated.|67
10540268|NCT01465802|11693290|FG004|STARTED|Overall Study||25
10540269|NCT01465802|11693286|FG000|COMPLETED|Overall Study||33
10540270|NCT01465802|11693287|FG001|COMPLETED|Overall Study||42
10540271|NCT01465802|11693288|FG002|COMPLETED|Overall Study||7
10540272|NCT01465802|11693289|FG003|COMPLETED|Overall Study||38
10540273|NCT01465802|11693290|FG004|COMPLETED|Overall Study||13
10540274|NCT01465802|11693286|FG000|NOT COMPLETED|Overall Study||33
10540275|NCT01465802|11693287|FG001|NOT COMPLETED|Overall Study||24
10540276|NCT01465802|11693288|FG002|NOT COMPLETED|Overall Study||0
10540277|NCT01465802|11693289|FG003|NOT COMPLETED|Overall Study||29
10540278|NCT01465802|11693290|FG004|NOT COMPLETED|Overall Study||12
10540279|NCT01465841|11693304|FG000|STARTED|Overall Study||517
10540280|NCT01465841|11693304|FG000|COMPLETED|Overall Study||449
10540281|NCT01465841|11693304|FG000|NOT COMPLETED|Overall Study||68
10540282|NCT01465958|11693308|FG000|STARTED|Run-in Phase||11
10540283|NCT01465958|11693309|FG001|STARTED|Run-in Phase||0
10540284|NCT01465958|11693308|FG000|COMPLETED|Run-in Phase||10
10540285|NCT01465958|11693309|FG001|COMPLETED|Run-in Phase||0
10540286|NCT01465958|11693308|FG000|NOT COMPLETED|Run-in Phase||1
10540287|NCT01465958|11693309|FG001|NOT COMPLETED|Run-in Phase||0
10540288|NCT01465958|11693308|FG000|STARTED|Intravenous (IV) Phase|One subject entered the IV phase directly.|11
10540289|NCT01465958|11693309|FG001|STARTED|Intravenous (IV) Phase||0
10540290|NCT01465958|11693308|FG000|COMPLETED|Intravenous (IV) Phase||11
10540291|NCT01465958|11693309|FG001|COMPLETED|Intravenous (IV) Phase||0
10540292|NCT01465958|11693308|FG000|NOT COMPLETED|Intravenous (IV) Phase||0
10540293|NCT01465958|11693309|FG001|NOT COMPLETED|Intravenous (IV) Phase||0
10540294|NCT01465958|11693308|FG000|STARTED|Subcutaneous (SC) Phase|After completing the intravenous (IV) phase, subjects entered the subcutaneous (SC) phase.|0
10540295|NCT01465958|11693309|FG001|STARTED|Subcutaneous (SC) Phase|Eleven subjects completed the IV phase and entered the SC phase.|11
10540296|NCT01465958|11693308|FG000|COMPLETED|Subcutaneous (SC) Phase||0
10540297|NCT01465958|11693309|FG001|COMPLETED|Subcutaneous (SC) Phase||10
10717972|NCT02703259|11882015|FG000|NOT COMPLETED|24 Hours Postoperative Assessment||2
10717973|NCT02703259|11882016|FG001|NOT COMPLETED|24 Hours Postoperative Assessment||6
10717974|NCT02703259|11882015|FG000|STARTED|2 Weeks Postoperative Assessment||68
10717975|NCT02703259|11882016|FG001|STARTED|2 Weeks Postoperative Assessment||61
10717976|NCT02703259|11882015|FG000|COMPLETED|2 Weeks Postoperative Assessment||58
10540298|NCT01465958|11693308|FG000|NOT COMPLETED|Subcutaneous (SC) Phase||0
10540299|NCT01465958|11693309|FG001|NOT COMPLETED|Subcutaneous (SC) Phase||1
10540300|NCT01465997|11693318|FG000|STARTED|Overall Study||279
10540301|NCT01465997|11693319|FG001|STARTED|Overall Study||269
10540302|NCT01465997|11693318|FG000|COMPLETED|Overall Study||211
10540303|NCT01465997|11693319|FG001|COMPLETED|Overall Study||180
10540304|NCT01465997|11693318|FG000|NOT COMPLETED|Overall Study||68
10383004|NCT00616122|11524756|FG003|COMPLETED|Overall Study||0
10540305|NCT01465997|11693319|FG001|NOT COMPLETED|Overall Study||89
10540306|NCT01466062|11693327|FG000|STARTED|Overall Study||28
10540307|NCT01466062|11693327|FG000|COMPLETED|Overall Study||26
10540308|NCT01466062|11693327|FG000|NOT COMPLETED|Overall Study||2
10540309|NCT01466075|11693331|FG000|STARTED|Overall Study||207
10540310|NCT01466075|11693331|FG000|COMPLETED|Overall Study||207
10540311|NCT01466075|11693331|FG000|NOT COMPLETED|Overall Study||0
10540312|NCT01466127|11693337|FG000|STARTED|Overall Study||30
10540313|NCT01466127|11693338|FG001|STARTED|Overall Study||30
10540314|NCT01466127|11693337|FG000|COMPLETED|Overall Study||16
10383005|NCT00616122|11524753|FG000|NOT COMPLETED|Overall Study||0
10540315|NCT01466127|11693338|FG001|COMPLETED|Overall Study||14
10540316|NCT01466127|11693337|FG000|NOT COMPLETED|Overall Study||14
10540317|NCT01466127|11693338|FG001|NOT COMPLETED|Overall Study||16
10540318|NCT01466153|11693347|FG000|STARTED|Overall Study||62
10383006|NCT00616122|11524754|FG001|NOT COMPLETED|Overall Study||0
10383007|NCT00616122|11524755|FG002|NOT COMPLETED|Overall Study||0
10383008|NCT00616122|11524756|FG003|NOT COMPLETED|Overall Study||11
10383009|NCT00616200|11524763|FG000|STARTED|Two Week Standard Diet||17
10383010|NCT00616200|11524763|FG000|COMPLETED|Two Week Standard Diet||16
10383011|NCT00616200|11524763|FG000|NOT COMPLETED|Two Week Standard Diet||1
10383012|NCT00616200|11524763|FG000|STARTED|Four Week Very Low Carbohydrate Diet||16
10383013|NCT00616200|11524763|FG000|COMPLETED|Four Week Very Low Carbohydrate Diet||13
10383014|NCT00616200|11524763|FG000|NOT COMPLETED|Four Week Very Low Carbohydrate Diet||3
10383015|NCT00616239|11524767|FG000|STARTED|Overall Study||20
10383016|NCT00616239|11524767|FG000|COMPLETED|Overall Study||18
10383017|NCT00616239|11524767|FG000|NOT COMPLETED|Overall Study||2
10383018|NCT00616421|11524774|FG000|STARTED|Overall Study||359
10383019|NCT00616421|11524775|FG001|STARTED|Overall Study||1278
10383020|NCT00616421|11524776|FG002|STARTED|Overall Study||1270
10383021|NCT00616421|11524774|FG000|COMPLETED|Overall Study||333
10383022|NCT00616421|11524775|FG001|COMPLETED|Overall Study||1240
10383023|NCT00616421|11524776|FG002|COMPLETED|Overall Study||1229
10383024|NCT00616421|11524774|FG000|NOT COMPLETED|Overall Study||26
10383025|NCT00616421|11524775|FG001|NOT COMPLETED|Overall Study||38
10383026|NCT00616421|11524776|FG002|NOT COMPLETED|Overall Study||41
10383027|NCT00616434|11524800|FG000|STARTED|Overall Study||62
10383028|NCT00616434|11524801|FG001|STARTED|Overall Study||61
10383029|NCT00616434|11524800|FG000|COMPLETED|Overall Study||56
10383030|NCT00616434|11524801|FG001|COMPLETED|Overall Study||53
10383031|NCT00616434|11524800|FG000|NOT COMPLETED|Overall Study||6
10383032|NCT00616434|11524801|FG001|NOT COMPLETED|Overall Study||8
10383033|NCT00616629|11524812|FG000|STARTED|Overall Study|Two patients never received study drug|13
10383034|NCT00616629|11524813|FG001|STARTED|Overall Study|Two patients never received study drug|14
10383035|NCT00616629|11524814|FG002|STARTED|Overall Study|One patient never received study drug|14
10383036|NCT00616629|11524815|FG003|STARTED|Overall Study||2
10383037|NCT00616629|11524816|FG004|STARTED|Overall Study||12
10383038|NCT00616629|11524812|FG000|COMPLETED|Overall Study||11
10383039|NCT00616629|11524813|FG001|COMPLETED|Overall Study||12
10383040|NCT00616629|11524814|FG002|COMPLETED|Overall Study||13
10383041|NCT00616629|11524815|FG003|COMPLETED|Overall Study||2
10383042|NCT00616629|11524816|FG004|COMPLETED|Overall Study||12
10383043|NCT00616629|11524812|FG000|NOT COMPLETED|Overall Study||2
10383044|NCT00616629|11524813|FG001|NOT COMPLETED|Overall Study||2
10383045|NCT00616629|11524814|FG002|NOT COMPLETED|Overall Study||1
10383046|NCT00616629|11524815|FG003|NOT COMPLETED|Overall Study||0
10383047|NCT00616629|11524816|FG004|NOT COMPLETED|Overall Study||0
10383048|NCT00616655|11524831|FG000|STARTED|Overall Study||152
10383049|NCT00616655|11524832|FG001|STARTED|Overall Study||153
10383050|NCT00616655|11524833|FG002|STARTED|Overall Study||151
10383051|NCT00616655|11524831|FG000|COMPLETED|Overall Study||117
10383052|NCT00616655|11524832|FG001|COMPLETED|Overall Study||112
10383053|NCT00616655|11524833|FG002|COMPLETED|Overall Study||103
10383054|NCT00616655|11524831|FG000|NOT COMPLETED|Overall Study||35
10383055|NCT00616655|11524832|FG001|NOT COMPLETED|Overall Study||41
10383056|NCT00616655|11524833|FG002|NOT COMPLETED|Overall Study||48
10383057|NCT00616772|11524843|FG000|STARTED|Overall Study||340
10383058|NCT00616772|11524844|FG001|STARTED|Overall Study||342
10383059|NCT00616772|11524843|FG000|Treated|Overall Study||337
10383060|NCT00616772|11524844|FG001|Treated|Overall Study||339
10383061|NCT00616772|11524843|FG000|COMPLETED|Overall Study||225
10383062|NCT00616772|11524844|FG001|COMPLETED|Overall Study||240
10383063|NCT00616772|11524843|FG000|NOT COMPLETED|Overall Study||115
10383064|NCT00616772|11524844|FG001|NOT COMPLETED|Overall Study||102
10428159|NCT00856830|11574159|FG002|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
10428160|NCT00856830|11574160|FG003|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
10428161|NCT00856843|11574167|FG000|STARTED|Overall Study||68
10428162|NCT00856843|11574168|FG001|STARTED|Overall Study||68
10428163|NCT00856843|11574167|FG000|COMPLETED|Overall Study||66
10428164|NCT00856843|11574168|FG001|COMPLETED|Overall Study||63
10428165|NCT00856843|11574167|FG000|NOT COMPLETED|Overall Study||2
10428166|NCT00856843|11574168|FG001|NOT COMPLETED|Overall Study||5
10428167|NCT00856856|11574174|FG000|STARTED|Baseline||101
10428168|NCT00856856|11574174|FG000|COMPLETED|Baseline||101
10428169|NCT00856856|11574174|FG000|NOT COMPLETED|Baseline||0
10428170|NCT00856856|11574174|FG000|STARTED|30-day Clinical Follow-up||101
10428171|NCT00856856|11574174|FG000|COMPLETED|30-day Clinical Follow-up||101
10428172|NCT00856856|11574174|FG000|NOT COMPLETED|30-day Clinical Follow-up||0
10428173|NCT00856856|11574174|FG000|STARTED|180-day Clinical Follow-up||101
10428174|NCT00856856|11574174|FG000|COMPLETED|180-day Clinical Follow-up||101
10428175|NCT00856856|11574174|FG000|NOT COMPLETED|180-day Clinical Follow-up||0
10428176|NCT00856856|11574174|FG000|STARTED|270-day Clinical Follow-up||101
10428177|NCT00856856|11574174|FG000|COMPLETED|270-day Clinical Follow-up||101
10428178|NCT00856856|11574174|FG000|NOT COMPLETED|270-day Clinical Follow-up||0
10428179|NCT00856856|11574174|FG000|STARTED|1-year Clinical Follow-up||101
10428180|NCT00856856|11574174|FG000|COMPLETED|1-year Clinical Follow-up||101
10428181|NCT00856856|11574174|FG000|NOT COMPLETED|1-year Clinical Follow-up||0
10428182|NCT00856856|11574174|FG000|STARTED|2-year Clinical Follow-up||101
10428183|NCT00856856|11574174|FG000|COMPLETED|2-year Clinical Follow-up||100
10428184|NCT00856856|11574174|FG000|NOT COMPLETED|2-year Clinical Follow-up||1
10428185|NCT00856856|11574174|FG000|STARTED|3-year Clinical Follow-up||100
10428186|NCT00856856|11574174|FG000|COMPLETED|3-year Clinical Follow-up||100
10428187|NCT00856856|11574174|FG000|NOT COMPLETED|3-year Clinical Follow-up||0
10383065|NCT00616902|11524852|FG000|STARTED|Overall Study||6
10383066|NCT00616902|11524853|FG001|STARTED|Overall Study||6
10383067|NCT00616902|11524852|FG000|COMPLETED|Overall Study||0
10383068|NCT00616902|11524853|FG001|COMPLETED|Overall Study||0
10383069|NCT00616902|11524852|FG000|NOT COMPLETED|Overall Study||6
10383070|NCT00616902|11524853|FG001|NOT COMPLETED|Overall Study||6
10383071|NCT00616928|11524863|FG000|STARTED|Overall Study||2304
10383072|NCT00616928|11524864|FG001|STARTED|Overall Study||768
10383073|NCT00616928|11524865|FG002|STARTED|Overall Study||1118
10383074|NCT00616928|11524866|FG003|STARTED|Overall Study||371
10383075|NCT00616928|11524863|FG000|COMPLETED|Overall Study||2242
10383076|NCT00616928|11524864|FG001|COMPLETED|Overall Study||750
10383077|NCT00616928|11524865|FG002|COMPLETED|Overall Study||1101
10383078|NCT00616928|11524866|FG003|COMPLETED|Overall Study||364
10383079|NCT00616928|11524863|FG000|NOT COMPLETED|Overall Study||62
10383080|NCT00616928|11524864|FG001|NOT COMPLETED|Overall Study||18
10383081|NCT00616928|11524865|FG002|NOT COMPLETED|Overall Study||17
10383082|NCT00616928|11524866|FG003|NOT COMPLETED|Overall Study||7
10383083|NCT00616941|11524891|FG000|STARTED|Overall Study||4
10383084|NCT00616941|11524892|FG001|STARTED|Overall Study||13
10383085|NCT00616941|11524893|FG002|STARTED|Overall Study||11
10383086|NCT00616941|11524891|FG000|COMPLETED|Overall Study||3
10383087|NCT00616941|11524892|FG001|COMPLETED|Overall Study||8
10383088|NCT00616941|11524893|FG002|COMPLETED|Overall Study||5
10383089|NCT00616941|11524891|FG000|NOT COMPLETED|Overall Study||1
10383090|NCT00616941|11524892|FG001|NOT COMPLETED|Overall Study||5
10383091|NCT00616941|11524893|FG002|NOT COMPLETED|Overall Study||6
10383092|NCT00617058|11524904|FG000|STARTED|Overall Study||1
10383093|NCT00617058|11524905|FG001|STARTED|Overall Study||0
10383094|NCT00617058|11524906|FG002|STARTED|Overall Study||0
10383095|NCT00617058|11524904|FG000|COMPLETED|Overall Study||1
10383096|NCT00617058|11524905|FG001|COMPLETED|Overall Study||0
10383097|NCT00617058|11524906|FG002|COMPLETED|Overall Study||0
10383098|NCT00617058|11524904|FG000|NOT COMPLETED|Overall Study||0
10383099|NCT00617058|11524905|FG001|NOT COMPLETED|Overall Study||0
10383100|NCT00617058|11524906|FG002|NOT COMPLETED|Overall Study||0
10383101|NCT00617084|11524916|FG000|STARTED|Overall Study||1140
10383102|NCT00617084|11524917|FG001|STARTED|Overall Study||1152
10383103|NCT00617084|11524916|FG000|COMPLETED|Overall Study||1119
10383104|NCT00617084|11524917|FG001|COMPLETED|Overall Study||1126
10717977|NCT02703259|11882016|FG001|COMPLETED|2 Weeks Postoperative Assessment||51
10717978|NCT02703259|11882015|FG000|NOT COMPLETED|2 Weeks Postoperative Assessment||10
10717979|NCT02703259|11882016|FG001|NOT COMPLETED|2 Weeks Postoperative Assessment||10
10717980|NCT02703311|11882022|FG000|STARTED|Overall Study||11
10717981|NCT02703311|11882022|FG000|Implanted|Overall Study||11
10383105|NCT00617084|11524916|FG000|NOT COMPLETED|Overall Study||21
10383106|NCT00617084|11524917|FG001|NOT COMPLETED|Overall Study||26
10383107|NCT00617097|11524925|FG000|STARTED|Overall Study||25
10383108|NCT00617097|11524926|FG001|STARTED|Overall Study||25
10383109|NCT00617097|11524925|FG000|COMPLETED|Overall Study||25
10540319|NCT01466153|11693348|FG001|STARTED|Overall Study||36
10540320|NCT01466153|11693349|FG002|STARTED|Overall Study||61
10540321|NCT01466153|11693347|FG000|COMPLETED|Overall Study||33
10540322|NCT01466153|11693348|FG001|COMPLETED|Overall Study||12
10540323|NCT01466153|11693349|FG002|COMPLETED|Overall Study||36
10540324|NCT01466153|11693347|FG000|NOT COMPLETED|Overall Study||29
10540325|NCT01466153|11693348|FG001|NOT COMPLETED|Overall Study||24
10658160|NCT02231164|11819334|FG001|COMPLETED|Overall Study||0
10658161|NCT02231164|11819333|FG000|NOT COMPLETED|Overall Study||6
10658162|NCT02231164|11819334|FG001|NOT COMPLETED|Overall Study||6
10658163|NCT02231177|11819340|FG000|STARTED|Treatment Period 1 (21 Days)||8
10658164|NCT02231177|11819341|FG001|STARTED|Treatment Period 1 (21 Days)||7
10658165|NCT02231177|11819342|FG002|STARTED|Treatment Period 1 (21 Days)||8
10658166|NCT02231177|11819343|FG003|STARTED|Treatment Period 1 (21 Days)||7
10658167|NCT02231177|11819344|FG004|STARTED|Treatment Period 1 (21 Days)||8
10658168|NCT02231177|11819345|FG005|STARTED|Treatment Period 1 (21 Days)||9
10658169|NCT02231177|11819340|FG000|COMPLETED|Treatment Period 1 (21 Days)||8
10658170|NCT02231177|11819341|FG001|COMPLETED|Treatment Period 1 (21 Days)||7
10658171|NCT02231177|11819342|FG002|COMPLETED|Treatment Period 1 (21 Days)||8
10658172|NCT02231177|11819343|FG003|COMPLETED|Treatment Period 1 (21 Days)||7
10658173|NCT02231177|11819344|FG004|COMPLETED|Treatment Period 1 (21 Days)||8
10658174|NCT02231177|11819345|FG005|COMPLETED|Treatment Period 1 (21 Days)||9
10658175|NCT02231177|11819340|FG000|NOT COMPLETED|Treatment Period 1 (21 Days)||0
10658176|NCT02231177|11819341|FG001|NOT COMPLETED|Treatment Period 1 (21 Days)||0
10717982|NCT02703311|11882022|FG000|30 Day Follow-Up Completed|Overall Study||9
10717983|NCT02703311|11882022|FG000|COMPLETED|Overall Study||3
10383110|NCT00617097|11524926|FG001|COMPLETED|Overall Study||25
10383111|NCT00617097|11524925|FG000|NOT COMPLETED|Overall Study||0
10383112|NCT00617097|11524926|FG001|NOT COMPLETED|Overall Study||0
10383113|NCT00617123|11524936|FG000|STARTED|Referral Screening Period||137
10383114|NCT00617123|11524937|FG001|STARTED|Referral Screening Period||121
10540326|NCT01466153|11693349|FG002|NOT COMPLETED|Overall Study||25
10540327|NCT01466166|11693359|FG000|STARTED|Overall Study||188
10540328|NCT01466166|11693359|FG000|Received Treatment|Overall Study||188
10540329|NCT01466166|11693359|FG000|Completed 24 Weeks of Treatment|Overall Study||55
10658177|NCT02231177|11819342|FG002|NOT COMPLETED|Treatment Period 1 (21 Days)||0
10658178|NCT02231177|11819343|FG003|NOT COMPLETED|Treatment Period 1 (21 Days)||0
10383115|NCT00617123|11524936|FG000|COMPLETED|Referral Screening Period||98
10383116|NCT00617123|11524937|FG001|COMPLETED|Referral Screening Period||95
10383117|NCT00617123|11524936|FG000|NOT COMPLETED|Referral Screening Period||39
10383118|NCT00617123|11524937|FG001|NOT COMPLETED|Referral Screening Period||26
10383119|NCT00617123|11524936|FG000|STARTED|Study Treatment Period||98
10383120|NCT00617123|11524937|FG001|STARTED|Study Treatment Period||95
10383121|NCT00617123|11524936|FG000|Treated|Study Treatment Period|1 participant was not treated|97
10383122|NCT00617123|11524937|FG001|Treated|Study Treatment Period||95
10383123|NCT00617123|11524936|FG000|COMPLETED|Study Treatment Period||81
10383124|NCT00617123|11524937|FG001|COMPLETED|Study Treatment Period||79
10383125|NCT00617123|11524936|FG000|NOT COMPLETED|Study Treatment Period||17
10383126|NCT00617123|11524937|FG001|NOT COMPLETED|Study Treatment Period||16
10383127|NCT00617175|11524945|FG000|STARTED|Overall Study||954
10383128|NCT00617175|11524946|FG001|STARTED|Overall Study||948
10540330|NCT01466166|11693359|FG000|COMPLETED|Overall Study||25
10540331|NCT01466166|11693359|FG000|NOT COMPLETED|Overall Study||163
10540332|NCT01466179|11693363|FG000|STARTED|Overall Study|Participants enrolled during the first 3 stages of the study|189
10540333|NCT01466179|11693363|FG000|COMPLETED|Overall Study|Completed 5 cycles of treatment; Data as of the time of the data cut-off date (10 October 2013).|10
10540334|NCT01466179|11693363|FG000|NOT COMPLETED|Overall Study||179
10540335|NCT01466192|11693370|FG000|STARTED|Overall Study||108
10540336|NCT01466192|11693370|FG000|COMPLETED|Overall Study||104
10383129|NCT00617175|11524945|FG000|COMPLETED|Overall Study||954
10383130|NCT00617175|11524946|FG001|COMPLETED|Overall Study||948
10383131|NCT00617175|11524945|FG000|NOT COMPLETED|Overall Study||0
10383132|NCT00617175|11524946|FG001|NOT COMPLETED|Overall Study||0
10383133|NCT00617188|11524952|FG000|STARTED|Overall Study||26
10383134|NCT00617188|11524952|FG000|COMPLETED|Overall Study||26
10383135|NCT00617188|11524952|FG000|NOT COMPLETED|Overall Study||0
10383136|NCT00617201|11524958|FG000|STARTED|Overall Study||25
10383137|NCT00617201|11524959|FG001|STARTED|Overall Study||25
10383138|NCT00617201|11524958|FG000|COMPLETED|Overall Study||16
10383139|NCT00617201|11524959|FG001|COMPLETED|Overall Study||12
10383140|NCT00617201|11524958|FG000|NOT COMPLETED|Overall Study||9
10383141|NCT00617201|11524959|FG001|NOT COMPLETED|Overall Study||13
10383142|NCT00617240|11524969|FG000|STARTED|Overall Study||5
10383143|NCT00617240|11524970|FG001|STARTED|Overall Study||4
10383144|NCT00617240|11524969|FG000|COMPLETED|Overall Study||4
10383145|NCT00617240|11524970|FG001|COMPLETED|Overall Study||4
10383146|NCT00617240|11524969|FG000|NOT COMPLETED|Overall Study||1
10383147|NCT00617240|11524970|FG001|NOT COMPLETED|Overall Study||0
10383148|NCT00617279|11524978|FG000|STARTED|Overall Study||14
10383149|NCT00617279|11524979|FG001|STARTED|Overall Study||17
10383150|NCT00617279|11524978|FG000|COMPLETED|Overall Study||0
10383151|NCT00617279|11524979|FG001|COMPLETED|Overall Study||0
10383152|NCT00617279|11524978|FG000|NOT COMPLETED|Overall Study||14
10383153|NCT00617279|11524979|FG001|NOT COMPLETED|Overall Study||17
10383154|NCT00617305|11524988|FG000|STARTED|Overall Study||33
10383155|NCT00617305|11524989|FG001|STARTED|Overall Study||4
10383156|NCT00617305|11524990|FG002|STARTED|Overall Study||1
10383157|NCT00617305|11524988|FG000|Completed 24-week Primary Analysis|Overall Study||31
10383158|NCT00617305|11524989|FG001|Completed 24-week Primary Analysis|Overall Study||4
10383159|NCT00617305|11524990|FG002|Completed 24-week Primary Analysis|Overall Study||0
10383160|NCT00617305|11524988|FG000|COMPLETED|Overall Study||25
10383161|NCT00617305|11524989|FG001|COMPLETED|Overall Study||4
10383162|NCT00617305|11524990|FG002|COMPLETED|Overall Study||0
10383163|NCT00617305|11524988|FG000|NOT COMPLETED|Overall Study||8
10383164|NCT00617305|11524989|FG001|NOT COMPLETED|Overall Study||0
10383165|NCT00617305|11524990|FG002|NOT COMPLETED|Overall Study||1
10383166|NCT00617344|11525004|FG000|STARTED|Overall Study||104
10383167|NCT00617344|11525005|FG001|STARTED|Overall Study||103
10383168|NCT00617344|11525006|FG002|STARTED|Overall Study||53
10383169|NCT00617344|11525004|FG000|Received Vaccination 1|Overall Study||104
10383170|NCT00617344|11525005|FG001|Received Vaccination 1|Overall Study||103
10383171|NCT00617344|11525006|FG002|Received Vaccination 1|Overall Study||53
10383172|NCT00617344|11525004|FG000|Received Vaccination 2|Overall Study||86
10383173|NCT00617344|11525005|FG001|Received Vaccination 2|Overall Study||85
10383174|NCT00617344|11525006|FG002|Received Vaccination 2|Overall Study||46
10383175|NCT00617344|11525004|FG000|Received Vaccination 3|Overall Study||79
10383176|NCT00617344|11525005|FG001|Received Vaccination 3|Overall Study||81
10383177|NCT00617344|11525006|FG002|Received Vaccination 3|Overall Study||45
10383178|NCT00617344|11525004|FG000|COMPLETED|Overall Study||79
10383179|NCT00617344|11525005|FG001|COMPLETED|Overall Study||81
10383180|NCT00617344|11525006|FG002|COMPLETED|Overall Study||45
10383181|NCT00617344|11525004|FG000|NOT COMPLETED|Overall Study||25
10383182|NCT00617344|11525005|FG001|NOT COMPLETED|Overall Study||22
10383183|NCT00617344|11525006|FG002|NOT COMPLETED|Overall Study||8
10383184|NCT00617357|11525014|FG000|STARTED|Overall Study|83 subjects enrolled, 80 subjects received Strattice reinforcement of hernia repair|83
10383185|NCT00617357|11525014|FG000|COMPLETED|Overall Study|67 subjects completed study; 7 completed early, 60 completed 24 month visit|67
10383186|NCT00617357|11525014|FG000|NOT COMPLETED|Overall Study||16
10383187|NCT00617396|11525019|FG000|STARTED|Overall Study||25
10383188|NCT00617396|11525019|FG000|COMPLETED|Overall Study||25
10383189|NCT00617396|11525019|FG000|NOT COMPLETED|Overall Study||0
10383190|NCT00617409|11525026|FG000|STARTED|Overall Study||18
10383191|NCT00617409|11525027|FG001|STARTED|Overall Study||20
10383192|NCT00617409|11525028|FG002|STARTED|Overall Study||31
10383193|NCT00617409|11525026|FG000|COMPLETED|Overall Study||2
10383194|NCT00617409|11525027|FG001|COMPLETED|Overall Study||2
10383195|NCT00617409|11525028|FG002|COMPLETED|Overall Study||4
10383196|NCT00617409|11525026|FG000|NOT COMPLETED|Overall Study||16
10383197|NCT00617409|11525027|FG001|NOT COMPLETED|Overall Study||18
10383198|NCT00617409|11525028|FG002|NOT COMPLETED|Overall Study||27
10383199|NCT00617461|11525037|FG000|STARTED|First Treatment Intervention Period|2 par. (1 withdrawal due to inv. discretion, 1 withdrawal by subject) did not take study drug.|52
10383200|NCT00617461|11525038|FG001|STARTED|First Treatment Intervention Period||44
10383201|NCT00617461|11525037|FG000|COMPLETED|First Treatment Intervention Period||42
10383202|NCT00617461|11525038|FG001|COMPLETED|First Treatment Intervention Period||41
10383203|NCT00617461|11525037|FG000|NOT COMPLETED|First Treatment Intervention Period||10
10383204|NCT00617461|11525038|FG001|NOT COMPLETED|First Treatment Intervention Period||3
10383205|NCT00617461|11525037|FG000|STARTED|4-Day Crossover Period||42
10383206|NCT00617461|11525038|FG001|STARTED|4-Day Crossover Period|One 3600:1200 participant skipped the Crossover period, going directly to second Treatment Period.|40
10383207|NCT00617461|11525037|FG000|COMPLETED|4-Day Crossover Period||41
10383208|NCT00617461|11525038|FG001|COMPLETED|4-Day Crossover Period||40
10383209|NCT00617461|11525037|FG000|NOT COMPLETED|4-Day Crossover Period||1
10383210|NCT00617461|11525038|FG001|NOT COMPLETED|4-Day Crossover Period||0
10383211|NCT00617461|11525037|FG000|STARTED|Second Treatment Intervention Period||41
10383212|NCT00617461|11525038|FG001|STARTED|Second Treatment Intervention Period||41
10383213|NCT00617461|11525037|FG000|COMPLETED|Second Treatment Intervention Period||41
10383214|NCT00617461|11525038|FG001|COMPLETED|Second Treatment Intervention Period||37
10383215|NCT00617461|11525037|FG000|NOT COMPLETED|Second Treatment Intervention Period||0
10383216|NCT00617461|11525038|FG001|NOT COMPLETED|Second Treatment Intervention Period||4
10383217|NCT00617461|11525037|FG000|STARTED|6-Day Down-Titration Period||41
10383218|NCT00617461|11525038|FG001|STARTED|6-Day Down-Titration Period||37
10383219|NCT00617461|11525037|FG000|COMPLETED|6-Day Down-Titration Period||39
10383220|NCT00617461|11525038|FG001|COMPLETED|6-Day Down-Titration Period||35
10383221|NCT00617461|11525037|FG000|NOT COMPLETED|6-Day Down-Titration Period||2
10383222|NCT00617461|11525038|FG001|NOT COMPLETED|6-Day Down-Titration Period||2
10383223|NCT00617539|11525060|FG000|STARTED|Overall Study||30
10383224|NCT00617539|11525060|FG000|COMPLETED|Overall Study||30
10383225|NCT00617539|11525060|FG000|NOT COMPLETED|Overall Study||0
10383226|NCT00617591|11525065|FG000|STARTED|Overall Study||57
10383227|NCT00617591|11525065|FG000|COMPLETED|Overall Study||47
10383228|NCT00617591|11525065|FG000|NOT COMPLETED|Overall Study||10
10383229|NCT00617604|11525072|FG000|STARTED|Overall Study||110
10383230|NCT00617604|11525073|FG001|STARTED|Overall Study||108
10383231|NCT00617604|11525072|FG000|Received Treatment|Overall Study||107
10383232|NCT00617604|11525073|FG001|Received Treatment|Overall Study||105
10717984|NCT02703311|11882022|FG000|NOT COMPLETED|Overall Study||8
10717985|NCT02703324|11882026|FG000|STARTED|Period One||5
10717986|NCT02703324|11882027|FG001|STARTED|Period One||5
10717987|NCT02703324|11882028|FG002|STARTED|Period One||5
10717988|NCT02703324|11882029|FG003|STARTED|Period One||5
10717989|NCT02703324|11882030|FG004|STARTED|Period One||5
10717990|NCT02703324|11882031|FG005|STARTED|Period One||5
10717991|NCT02703324|11882026|FG000|Received Study Drug|Period One||5
10717992|NCT02703324|11882027|FG001|Received Study Drug|Period One||5
10383233|NCT00617604|11525072|FG000|Completed 12 Weeks of Treatment|Overall Study||89
10383234|NCT00617604|11525073|FG001|Completed 12 Weeks of Treatment|Overall Study||83
10383235|NCT00617604|11525072|FG000|COMPLETED|Overall Study|Completed Month 6 assessment|92
10383236|NCT00617604|11525073|FG001|COMPLETED|Overall Study|Completed Month 6 assessment|88
10383237|NCT00617604|11525072|FG000|NOT COMPLETED|Overall Study||18
10383238|NCT00617604|11525073|FG001|NOT COMPLETED|Overall Study||20
10383239|NCT00617669|11525081|FG000|STARTED|Overall Study||524
10383240|NCT00617669|11525082|FG001|STARTED|Overall Study||528
10383241|NCT00617669|11525081|FG000|Patients Who Received IP|Overall Study||522
10383242|NCT00617669|11525082|FG001|Patients Who Received IP|Overall Study||525
10383243|NCT00617669|11525081|FG000|COMPLETED|Overall Study|Patients receiving ZD4054 10 mg at data cut-off|94
10383244|NCT00617669|11525082|FG001|COMPLETED|Overall Study|Patients receiving placebo at data cut-off|77
10383245|NCT00617669|11525081|FG000|NOT COMPLETED|Overall Study||430
10383246|NCT00617669|11525082|FG001|NOT COMPLETED|Overall Study||451
10383247|NCT00617734|11525090|FG000|STARTED|Overall Study||49
10383248|NCT00617734|11525091|FG001|STARTED|Overall Study||48
10383249|NCT00617734|11525090|FG000|Received at Least 1 Dose of Study Drug|Overall Study||47
10383250|NCT00617734|11525091|FG001|Received at Least 1 Dose of Study Drug|Overall Study||44
10383251|NCT00617734|11525090|FG000|COMPLETED|Overall Study||41
10383252|NCT00617734|11525091|FG001|COMPLETED|Overall Study||42
10383253|NCT00617734|11525090|FG000|NOT COMPLETED|Overall Study||8
10383254|NCT00617734|11525091|FG001|NOT COMPLETED|Overall Study||6
10383255|NCT00617773|11525097|FG000|STARTED|Overall Study||31
10383256|NCT00617773|11525097|FG000|COMPLETED|Overall Study|Patients COMPLETED were evaluated as having no disease progression at the end of cycle 3.|7
10383257|NCT00617773|11525097|FG000|NOT COMPLETED|Overall Study||24
10383258|NCT00617851|11525105|FG000|STARTED|Overall Study||430
10383259|NCT00617851|11525106|FG001|STARTED|Overall Study||431
10383260|NCT00617851|11525107|FG002|STARTED|Overall Study||429
10383261|NCT00617851|11525108|FG003|STARTED|Overall Study||217
10540337|NCT01466192|11693370|FG000|NOT COMPLETED|Overall Study||4
10540338|NCT01466270|11693376|FG000|STARTED|Overall Study||31
10540339|NCT01466270|11693377|FG001|STARTED|Overall Study||31
10383262|NCT00617851|11525105|FG000|COMPLETED|Overall Study||383
10717993|NCT02703324|11882028|FG002|Received Study Drug|Period One||5
10717994|NCT02703324|11882029|FG003|Received Study Drug|Period One||5
10717995|NCT02703324|11882030|FG004|Received Study Drug|Period One||5
10383263|NCT00617851|11525106|FG001|COMPLETED|Overall Study||391
10383264|NCT00617851|11525107|FG002|COMPLETED|Overall Study||384
10383265|NCT00617851|11525108|FG003|COMPLETED|Overall Study||192
10383266|NCT00617851|11525105|FG000|NOT COMPLETED|Overall Study||47
10383267|NCT00617851|11525106|FG001|NOT COMPLETED|Overall Study||40
10383268|NCT00617851|11525107|FG002|NOT COMPLETED|Overall Study||45
10383269|NCT00617851|11525108|FG003|NOT COMPLETED|Overall Study||25
10383270|NCT00617890|11525132|FG000|STARTED|Overall Study||35
10383271|NCT00617890|11525133|FG001|STARTED|Overall Study||33
10383272|NCT00617890|11525134|FG002|STARTED|Overall Study||35
10383273|NCT00617890|11525135|FG003|STARTED|Overall Study||116
10383274|NCT00617890|11525132|FG000|Received Treatment|Overall Study||34
10383275|NCT00617890|11525133|FG001|Received Treatment|Overall Study||33
10383276|NCT00617890|11525134|FG002|Received Treatment|Overall Study||34
10383277|NCT00617890|11525135|FG003|Received Treatment|Overall Study||115
10383278|NCT00617890|11525132|FG000|COMPLETED|Overall Study||4
10383279|NCT00617890|11525133|FG001|COMPLETED|Overall Study||5
10383280|NCT00617890|11525134|FG002|COMPLETED|Overall Study||0
10383281|NCT00617890|11525135|FG003|COMPLETED|Overall Study||1
10383282|NCT00617890|11525132|FG000|NOT COMPLETED|Overall Study||31
10383283|NCT00617890|11525133|FG001|NOT COMPLETED|Overall Study||28
10383284|NCT00617890|11525134|FG002|NOT COMPLETED|Overall Study||35
10383285|NCT00617890|11525135|FG003|NOT COMPLETED|Overall Study||115
10383286|NCT00617903|11525150|FG000|STARTED|Overall Study||41
10383287|NCT00617903|11525151|FG001|STARTED|Overall Study||42
10383288|NCT00617903|11525150|FG000|COMPLETED|Overall Study||38
10383289|NCT00617903|11525151|FG001|COMPLETED|Overall Study||35
10383290|NCT00617903|11525150|FG000|NOT COMPLETED|Overall Study||3
10383291|NCT00617903|11525151|FG001|NOT COMPLETED|Overall Study||7
10383292|NCT00617929|11525157|FG000|STARTED|Overall Study||12
10383293|NCT00617929|11525157|FG000|COMPLETED|Overall Study||11
10383294|NCT00617929|11525157|FG000|NOT COMPLETED|Overall Study||1
10383295|NCT00617942|11525163|FG000|STARTED|Overall Study||37
10383296|NCT00617942|11525164|FG001|STARTED|Overall Study||23
10383297|NCT00617942|11525163|FG000|COMPLETED|Overall Study||29
10383298|NCT00617942|11525164|FG001|COMPLETED|Overall Study||19
10383299|NCT00617942|11525163|FG000|NOT COMPLETED|Overall Study||8
10383300|NCT00617942|11525164|FG001|NOT COMPLETED|Overall Study||4
10383301|NCT00617981|11525178|FG000|STARTED|Overall Study||354
10383302|NCT00617981|11525179|FG001|STARTED|Overall Study||347
10383303|NCT00617981|11525178|FG000|COMPLETED|Overall Study||244
10383304|NCT00617981|11525179|FG001|COMPLETED|Overall Study||245
10383305|NCT00617981|11525178|FG000|NOT COMPLETED|Overall Study||110
10383306|NCT00617981|11525179|FG001|NOT COMPLETED|Overall Study||102
10383307|NCT00618072|11525188|FG000|STARTED|Overall Study||16
10383308|NCT00618072|11525189|FG001|STARTED|Overall Study||15
10383309|NCT00618072|11525190|FG002|STARTED|Overall Study||15
10383310|NCT00618072|11525188|FG000|COMPLETED|Overall Study||14
10383311|NCT00618072|11525189|FG001|COMPLETED|Overall Study||14
10383312|NCT00618072|11525190|FG002|COMPLETED|Overall Study||11
10383313|NCT00618072|11525188|FG000|NOT COMPLETED|Overall Study||2
10383314|NCT00618072|11525189|FG001|NOT COMPLETED|Overall Study||1
10383315|NCT00618072|11525190|FG002|NOT COMPLETED|Overall Study||4
10383316|NCT00618332|11525200|FG000|STARTED|Overall Study||20
10383317|NCT00618332|11525201|FG001|STARTED|Overall Study||20
10383318|NCT00618332|11525200|FG000|COMPLETED|Overall Study||20
10383319|NCT00618332|11525201|FG001|COMPLETED|Overall Study||20
10383320|NCT00618332|11525200|FG000|NOT COMPLETED|Overall Study||0
10383321|NCT00618332|11525201|FG001|NOT COMPLETED|Overall Study||0
10383322|NCT00618371|11525207|FG000|STARTED|Overall Study||12
10383323|NCT00618371|11525207|FG000|COMPLETED|Overall Study||10
10383324|NCT00618371|11525207|FG000|NOT COMPLETED|Overall Study||2
10383325|NCT00618410|11525212|FG000|STARTED|First Intervention||7
10383326|NCT00618410|11525213|FG001|STARTED|First Intervention||6
10383327|NCT00618410|11525212|FG000|COMPLETED|First Intervention||7
10383328|NCT00618410|11525213|FG001|COMPLETED|First Intervention||6
10383329|NCT00618410|11525212|FG000|NOT COMPLETED|First Intervention||0
10383330|NCT00618410|11525213|FG001|NOT COMPLETED|First Intervention||0
10383331|NCT00618410|11525212|FG000|STARTED|Washout Period (2 Weeks)||7
10383332|NCT00618410|11525213|FG001|STARTED|Washout Period (2 Weeks)||6
10383333|NCT00618410|11525212|FG000|COMPLETED|Washout Period (2 Weeks)||7
10383334|NCT00618410|11525213|FG001|COMPLETED|Washout Period (2 Weeks)||5
10383335|NCT00618410|11525212|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
10383336|NCT00618410|11525213|FG001|NOT COMPLETED|Washout Period (2 Weeks)||1
10383337|NCT00618410|11525212|FG000|STARTED|Second Intervention||7
10383338|NCT00618410|11525213|FG001|STARTED|Second Intervention||5
10540340|NCT01466270|11693376|FG000|COMPLETED|Overall Study||19
10383339|NCT00618410|11525212|FG000|COMPLETED|Second Intervention||7
10383340|NCT00618410|11525213|FG001|COMPLETED|Second Intervention||5
10383341|NCT00618410|11525212|FG000|NOT COMPLETED|Second Intervention||0
10383342|NCT00618410|11525213|FG001|NOT COMPLETED|Second Intervention||0
10383343|NCT00618436|11525221|FG000|STARTED|Overall Study||34
10383344|NCT00618436|11525222|FG001|STARTED|Overall Study||18
10383345|NCT00618436|11525221|FG000|COMPLETED|Overall Study||34
10383346|NCT00618436|11525222|FG001|COMPLETED|Overall Study||18
10383347|NCT00618436|11525221|FG000|NOT COMPLETED|Overall Study||0
10383348|NCT00618436|11525222|FG001|NOT COMPLETED|Overall Study||0
10383349|NCT00618449|11525230|FG000|STARTED|Overall Study||679
10383350|NCT00618449|11525231|FG001|STARTED|Overall Study||668
10383351|NCT00618449|11525230|FG000|1-month, Post-treatment|Overall Study||666
10383352|NCT00618449|11525231|FG001|1-month, Post-treatment|Overall Study||656
10540341|NCT01466270|11693377|FG001|COMPLETED|Overall Study||25
10383353|NCT00618449|11525230|FG000|1-year, Post-treatment|Overall Study||581
10383354|NCT00618449|11525231|FG001|1-year, Post-treatment|Overall Study||558
10383355|NCT00618449|11525230|FG000|COMPLETED|Overall Study||581
10383356|NCT00618449|11525231|FG001|COMPLETED|Overall Study||558
10383357|NCT00618449|11525230|FG000|NOT COMPLETED|Overall Study||98
10383358|NCT00618449|11525231|FG001|NOT COMPLETED|Overall Study||110
10383359|NCT00618514|11525239|FG000|STARTED|Overall Study||36
10383360|NCT00618514|11525240|FG001|STARTED|Overall Study||38
10383361|NCT00618514|11525241|FG002|STARTED|Overall Study||16
10383362|NCT00618514|11525239|FG000|COMPLETED|Overall Study||25
10383363|NCT00618514|11525240|FG001|COMPLETED|Overall Study||26
10383364|NCT00618514|11525241|FG002|COMPLETED|Overall Study||12
10383365|NCT00618514|11525239|FG000|NOT COMPLETED|Overall Study||11
10383366|NCT00618514|11525240|FG001|NOT COMPLETED|Overall Study||12
10383367|NCT00618514|11525241|FG002|NOT COMPLETED|Overall Study||4
10383368|NCT00618540|11525247|FG000|STARTED|Overall Study||1
10383369|NCT00618540|11525247|FG000|COMPLETED|Overall Study||1
10383370|NCT00618540|11525247|FG000|NOT COMPLETED|Overall Study||0
10383371|NCT00618618|11525256|FG000|STARTED|Overall Study||24
10383372|NCT00618618|11525257|FG001|STARTED|Overall Study||14
10383373|NCT00618618|11525258|FG002|STARTED|Overall Study||21
10383374|NCT00618618|11525259|FG003|STARTED|Overall Study||14
10383375|NCT00618618|11525256|FG000|Received Treatment|Overall Study||24
10383376|NCT00618618|11525257|FG001|Received Treatment|Overall Study||13
10383377|NCT00618618|11525258|FG002|Received Treatment|Overall Study||20
10383378|NCT00618618|11525259|FG003|Received Treatment|Overall Study||14
10383379|NCT00618618|11525256|FG000|COMPLETED|Overall Study||20
10383380|NCT00618618|11525257|FG001|COMPLETED|Overall Study||11
10383381|NCT00618618|11525258|FG002|COMPLETED|Overall Study||18
10383382|NCT00618618|11525259|FG003|COMPLETED|Overall Study||13
10383383|NCT00618618|11525256|FG000|NOT COMPLETED|Overall Study||4
10717996|NCT02703324|11882031|FG005|Received Study Drug|Period One||5
10717997|NCT02703324|11882026|FG000|COMPLETED|Period One||5
10717998|NCT02703324|11882027|FG001|COMPLETED|Period One||5
10383384|NCT00618618|11525257|FG001|NOT COMPLETED|Overall Study||3
10383385|NCT00618618|11525258|FG002|NOT COMPLETED|Overall Study||3
10717999|NCT02703324|11882028|FG002|COMPLETED|Period One||5
10383386|NCT00618618|11525259|FG003|NOT COMPLETED|Overall Study||1
10383387|NCT00618722|11525274|FG000|STARTED|Overall Study||21
10383388|NCT00618722|11525275|FG001|STARTED|Overall Study||20
10383389|NCT00618722|11525276|FG002|STARTED|Overall Study||22
10383390|NCT00618722|11525277|FG003|STARTED|Overall Study||22
10383391|NCT00618722|11525274|FG000|Received Treatment|Overall Study||20
10383392|NCT00618722|11525275|FG001|Received Treatment|Overall Study||20
10383393|NCT00618722|11525276|FG002|Received Treatment|Overall Study||22
10383394|NCT00618722|11525277|FG003|Received Treatment|Overall Study||22
10383395|NCT00618722|11525274|FG000|COMPLETED|Overall Study||18
10383396|NCT00618722|11525275|FG001|COMPLETED|Overall Study||18
10383397|NCT00618722|11525276|FG002|COMPLETED|Overall Study||19
10383398|NCT00618722|11525277|FG003|COMPLETED|Overall Study||18
10383399|NCT00618722|11525274|FG000|NOT COMPLETED|Overall Study||3
10383400|NCT00618722|11525275|FG001|NOT COMPLETED|Overall Study||2
10383401|NCT00618722|11525276|FG002|NOT COMPLETED|Overall Study||3
10383402|NCT00618722|11525277|FG003|NOT COMPLETED|Overall Study||4
10383403|NCT00618748|11525290|FG000|STARTED|Overall Study||56
10383404|NCT00618748|11525291|FG001|STARTED|Overall Study||25
10383405|NCT00618748|11525292|FG002|STARTED|Overall Study||20
10383406|NCT00618748|11525290|FG000|COMPLETED|Overall Study||45
10383407|NCT00618748|11525291|FG001|COMPLETED|Overall Study||20
10383408|NCT00618748|11525292|FG002|COMPLETED|Overall Study||6
10383409|NCT00618748|11525290|FG000|NOT COMPLETED|Overall Study||11
10383410|NCT00618748|11525291|FG001|NOT COMPLETED|Overall Study||5
10383411|NCT00618748|11525292|FG002|NOT COMPLETED|Overall Study||14
10383412|NCT00618774|11525302|FG000|STARTED|Overall Study||211
10383413|NCT00618774|11525303|FG001|STARTED|Overall Study||48
10383414|NCT00618774|11525302|FG000|COMPLETED|Overall Study||205
10383415|NCT00618774|11525303|FG001|COMPLETED|Overall Study||45
10383416|NCT00618774|11525302|FG000|NOT COMPLETED|Overall Study||6
10383417|NCT00618774|11525303|FG001|NOT COMPLETED|Overall Study||3
10383418|NCT00618787|11525311|FG000|STARTED|Overall Study||22
10383419|NCT00618787|11525312|FG001|STARTED|Overall Study||23
10383420|NCT00618787|11525311|FG000|COMPLETED|Overall Study||19
10383421|NCT00618787|11525312|FG001|COMPLETED|Overall Study||21
10383422|NCT00618787|11525311|FG000|NOT COMPLETED|Overall Study||3
10383423|NCT00618787|11525312|FG001|NOT COMPLETED|Overall Study||2
10718000|NCT02703324|11882029|FG003|COMPLETED|Period One||5
10383424|NCT00618813|11525318|FG000|STARTED|Overall Study||35
10383425|NCT00618813|11525318|FG000|Completed Enrollment - Week 12 Treatment|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|35
10383426|NCT00618813|11525318|FG000|Completed Week 13 to Week 22 Treatment|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|34
10383427|NCT00618813|11525318|FG000|Completed Week 23 to Week 28 Therapy|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|34
10383428|NCT00618813|11525318|FG000|Completed Week 29 to Week 37 Therapy|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|33
10383429|NCT00618813|11525318|FG000|COMPLETED|Overall Study||31
10383430|NCT00618813|11525318|FG000|NOT COMPLETED|Overall Study||4
10383431|NCT00618826|11525322|FG000|STARTED|Overall Study||14
10383432|NCT00618826|11525322|FG000|COMPLETED|Overall Study||13
10383433|NCT00618826|11525322|FG000|NOT COMPLETED|Overall Study||1
10383434|NCT00618839|11525327|FG000|STARTED|Overall Study||15
10383435|NCT00618839|11525327|FG000|COMPLETED|Overall Study||15
10383436|NCT00618839|11525327|FG000|NOT COMPLETED|Overall Study||0
10383437|NCT00618917|11525337|FG000|STARTED|Overall Study||4
10383438|NCT00618917|11525338|FG001|STARTED|Overall Study||3
10383439|NCT00618917|11525339|FG002|STARTED|Overall Study||11
10383440|NCT00618917|11525337|FG000|COMPLETED|Overall Study||3
10383441|NCT00618917|11525338|FG001|COMPLETED|Overall Study||3
10383442|NCT00618917|11525339|FG002|COMPLETED|Overall Study||11
10383443|NCT00618917|11525337|FG000|NOT COMPLETED|Overall Study||1
10383444|NCT00618917|11525338|FG001|NOT COMPLETED|Overall Study||0
10383445|NCT00618917|11525339|FG002|NOT COMPLETED|Overall Study||0
10383446|NCT00618956|11525349|FG000|STARTED|Overall Study||111
10383447|NCT00618956|11525350|FG001|STARTED|Overall Study||210
10383448|NCT00618956|11525349|FG000|COMPLETED|Overall Study||86
10383449|NCT00618956|11525350|FG001|COMPLETED|Overall Study||160
10383450|NCT00618956|11525349|FG000|NOT COMPLETED|Overall Study||25
10383451|NCT00618956|11525350|FG001|NOT COMPLETED|Overall Study||50
10383452|NCT00618982|11525362|FG000|STARTED|Overall Study||83
10383453|NCT00618982|11525362|FG000|COMPLETED|Overall Study||33
10383454|NCT00618982|11525362|FG000|NOT COMPLETED|Overall Study||50
10383455|NCT00618995|11525369|FG000|STARTED|Period 1||6
10383456|NCT00618995|11525370|FG001|STARTED|Period 1||7
10383457|NCT00618995|11525371|FG002|STARTED|Period 1||7
10383458|NCT00618995|11525372|FG003|STARTED|Period 1||6
10383459|NCT00618995|11525369|FG000|COMPLETED|Period 1||6
10383460|NCT00618995|11525370|FG001|COMPLETED|Period 1||6
10383461|NCT00618995|11525371|FG002|COMPLETED|Period 1||5
10383462|NCT00618995|11525372|FG003|COMPLETED|Period 1||6
10383463|NCT00618995|11525369|FG000|NOT COMPLETED|Period 1||0
10383464|NCT00618995|11525370|FG001|NOT COMPLETED|Period 1||1
10718001|NCT02703324|11882030|FG004|COMPLETED|Period One||5
10718002|NCT02703324|11882031|FG005|COMPLETED|Period One||5
10718003|NCT02703324|11882026|FG000|NOT COMPLETED|Period One||0
10718004|NCT02703324|11882027|FG001|NOT COMPLETED|Period One||0
10718005|NCT02703324|11882028|FG002|NOT COMPLETED|Period One||0
10718006|NCT02703324|11882029|FG003|NOT COMPLETED|Period One||0
10383465|NCT00618995|11525371|FG002|NOT COMPLETED|Period 1||2
10383466|NCT00618995|11525372|FG003|NOT COMPLETED|Period 1||0
10383467|NCT00618995|11525369|FG000|STARTED|Period 2||6
10383468|NCT00618995|11525370|FG001|STARTED|Period 2||6
10383469|NCT00618995|11525371|FG002|STARTED|Period 2||5
10383470|NCT00618995|11525372|FG003|STARTED|Period 2||6
10383471|NCT00618995|11525369|FG000|COMPLETED|Period 2||6
10383472|NCT00618995|11525370|FG001|COMPLETED|Period 2||6
10383473|NCT00618995|11525371|FG002|COMPLETED|Period 2||4
10540342|NCT01466270|11693376|FG000|NOT COMPLETED|Overall Study||12
10540343|NCT01466270|11693377|FG001|NOT COMPLETED|Overall Study||6
10540344|NCT01466348|11693385|FG000|STARTED|Period I - First Intervention||36
10540345|NCT01466348|11693386|FG001|STARTED|Period I - First Intervention||36
10540346|NCT01466348|11693385|FG000|Intent To Treat (ITT) Population|Period I - First Intervention||36
10540347|NCT01466348|11693386|FG001|Intent To Treat (ITT) Population|Period I - First Intervention|1 participant withdrew prior receiving the treatment|35
10540348|NCT01466348|11693385|FG000|COMPLETED|Period I - First Intervention||36
10540349|NCT01466348|11693386|FG001|COMPLETED|Period I - First Intervention||35
10540350|NCT01466348|11693385|FG000|NOT COMPLETED|Period I - First Intervention||0
10540351|NCT01466348|11693386|FG001|NOT COMPLETED|Period I - First Intervention||1
10540352|NCT01466348|11693385|FG000|STARTED|Period II - Second Intervention||35
10540353|NCT01466348|11693386|FG001|STARTED|Period II - Second Intervention||36
10540354|NCT01466348|11693385|FG000|COMPLETED|Period II - Second Intervention||35
10540355|NCT01466348|11693386|FG001|COMPLETED|Period II - Second Intervention||36
10540356|NCT01466348|11693385|FG000|NOT COMPLETED|Period II - Second Intervention||0
10718007|NCT02703324|11882030|FG004|NOT COMPLETED|Period One||0
10718008|NCT02703324|11882031|FG005|NOT COMPLETED|Period One||0
10718009|NCT02703324|11882026|FG000|STARTED|Period Two||5
10383474|NCT00618995|11525372|FG003|COMPLETED|Period 2||6
10383475|NCT00618995|11525369|FG000|NOT COMPLETED|Period 2||0
10718010|NCT02703324|11882027|FG001|STARTED|Period Two||5
10718011|NCT02703324|11882028|FG002|STARTED|Period Two||5
10718012|NCT02703324|11882029|FG003|STARTED|Period Two||5
10383476|NCT00618995|11525370|FG001|NOT COMPLETED|Period 2||0
10383477|NCT00618995|11525371|FG002|NOT COMPLETED|Period 2||1
10383478|NCT00618995|11525372|FG003|NOT COMPLETED|Period 2||0
10383479|NCT00618995|11525369|FG000|STARTED|Period 3||6
10383480|NCT00618995|11525370|FG001|STARTED|Period 3||6
10383481|NCT00618995|11525371|FG002|STARTED|Period 3||4
10383482|NCT00618995|11525372|FG003|STARTED|Period 3||6
10383483|NCT00618995|11525369|FG000|COMPLETED|Period 3||6
10383484|NCT00618995|11525370|FG001|COMPLETED|Period 3||6
10383485|NCT00618995|11525371|FG002|COMPLETED|Period 3||4
10383486|NCT00618995|11525372|FG003|COMPLETED|Period 3||6
10383487|NCT00618995|11525369|FG000|NOT COMPLETED|Period 3||0
10383488|NCT00618995|11525370|FG001|NOT COMPLETED|Period 3||0
10383489|NCT00618995|11525371|FG002|NOT COMPLETED|Period 3||0
10383490|NCT00618995|11525372|FG003|NOT COMPLETED|Period 3||0
10383491|NCT00618995|11525369|FG000|STARTED|Period 4||6
10383492|NCT00618995|11525370|FG001|STARTED|Period 4||6
10383493|NCT00618995|11525371|FG002|STARTED|Period 4||4
10383494|NCT00618995|11525372|FG003|STARTED|Period 4||6
10383495|NCT00618995|11525369|FG000|COMPLETED|Period 4||5
10383496|NCT00618995|11525370|FG001|COMPLETED|Period 4||6
10383497|NCT00618995|11525371|FG002|COMPLETED|Period 4||4
10383498|NCT00618995|11525372|FG003|COMPLETED|Period 4||6
10383499|NCT00618995|11525369|FG000|NOT COMPLETED|Period 4||1
10383500|NCT00618995|11525370|FG001|NOT COMPLETED|Period 4||0
10383501|NCT00618995|11525371|FG002|NOT COMPLETED|Period 4||0
10383502|NCT00618995|11525372|FG003|NOT COMPLETED|Period 4||0
10383503|NCT00619060|11525382|FG000|STARTED|Overall Study||10
10383504|NCT00619060|11525383|FG001|STARTED|Overall Study||12
10383505|NCT00619060|11525382|FG000|COMPLETED|Overall Study||10
10383506|NCT00619060|11525383|FG001|COMPLETED|Overall Study||12
10383507|NCT00619060|11525382|FG000|NOT COMPLETED|Overall Study||0
10383508|NCT00619060|11525383|FG001|NOT COMPLETED|Overall Study||0
10383509|NCT00619073|11525391|FG000|STARTED|First Intervention - 60 Days||8
10383510|NCT00619073|11525392|FG001|STARTED|First Intervention - 60 Days||8
10383511|NCT00619073|11525391|FG000|COMPLETED|First Intervention - 60 Days||8
10383512|NCT00619073|11525392|FG001|COMPLETED|First Intervention - 60 Days||8
10383513|NCT00619073|11525391|FG000|NOT COMPLETED|First Intervention - 60 Days||0
10383514|NCT00619073|11525392|FG001|NOT COMPLETED|First Intervention - 60 Days||0
10383515|NCT00619073|11525391|FG000|STARTED|Washout Period (30 Days)||8
10383516|NCT00619073|11525392|FG001|STARTED|Washout Period (30 Days)||8
10383517|NCT00619073|11525391|FG000|COMPLETED|Washout Period (30 Days)||8
10383518|NCT00619073|11525392|FG001|COMPLETED|Washout Period (30 Days)||8
10383519|NCT00619073|11525391|FG000|NOT COMPLETED|Washout Period (30 Days)||0
10383520|NCT00619073|11525392|FG001|NOT COMPLETED|Washout Period (30 Days)||0
10383521|NCT00619073|11525391|FG000|STARTED|Second Intervention - 60 Days||8
10383522|NCT00619073|11525392|FG001|STARTED|Second Intervention - 60 Days||8
10383523|NCT00619073|11525391|FG000|COMPLETED|Second Intervention - 60 Days||8
10383524|NCT00619073|11525392|FG001|COMPLETED|Second Intervention - 60 Days||8
10383525|NCT00619073|11525391|FG000|NOT COMPLETED|Second Intervention - 60 Days||0
10383526|NCT00619073|11525392|FG001|NOT COMPLETED|Second Intervention - 60 Days||0
10383527|NCT00619099|11525400|FG000|STARTED|Overall Study|All randomized subjects|44
10383528|NCT00619099|11525401|FG001|STARTED|Overall Study|All randomized subjects|23
10383529|NCT00619099|11525400|FG000|Received at Least 2 Cycles of Treatment|Overall Study|Subjects included in the Modified Intent to Treat Population|43
10383530|NCT00619099|11525401|FG001|Received at Least 2 Cycles of Treatment|Overall Study|Subjects included in the Modified Intent to Treat Population|22
10383531|NCT00619099|11525400|FG000|COMPLETED|Overall Study||11
10383532|NCT00619099|11525401|FG001|COMPLETED|Overall Study||4
10383533|NCT00619099|11525400|FG000|NOT COMPLETED|Overall Study||33
10383534|NCT00619099|11525401|FG001|NOT COMPLETED|Overall Study||19
10383535|NCT00619112|11525409|FG000|STARTED|Overall Study||40
10383536|NCT00619112|11525410|FG001|STARTED|Overall Study||20
10383537|NCT00619112|11525409|FG000|COMPLETED|Overall Study|Data from patient who didn't complete study was still included in the final analysis.|39
10383538|NCT00619112|11525410|FG001|COMPLETED|Overall Study|Data from patients who didn't complete study was still included in the final analysis.|18
10383539|NCT00619112|11525409|FG000|NOT COMPLETED|Overall Study||1
10383540|NCT00619112|11525410|FG001|NOT COMPLETED|Overall Study||2
10383541|NCT00619177|11525419|FG000|STARTED|Overall Study|treated set = 3569 (treated with Movalis)|3569
10383542|NCT00619177|11525419|FG000|COMPLETED|Overall Study|"Due to some missing termination information, the number of completed may be larger than 3061."|3061
10383543|NCT00619177|11525419|FG000|NOT COMPLETED|Overall Study||508
10383544|NCT00619190|11525425|FG000|STARTED|Overall Study||21
10383545|NCT00619190|11525426|FG001|STARTED|Overall Study||9
10383546|NCT00619190|11525425|FG000|COMPLETED|Overall Study||20
10383547|NCT00619190|11525426|FG001|COMPLETED|Overall Study||9
10383548|NCT00619190|11525425|FG000|NOT COMPLETED|Overall Study||1
10383549|NCT00619190|11525426|FG001|NOT COMPLETED|Overall Study||0
10383550|NCT00619229|11525434|FG000|STARTED|Overall Study||18
10383551|NCT00619229|11525435|FG001|STARTED|Overall Study||18
10383552|NCT00619229|11525434|FG000|Full Analysis Set (FAS)|Overall Study||16
10383553|NCT00619229|11525435|FG001|Full Analysis Set (FAS)|Overall Study||17
10383554|NCT00619229|11525434|FG000|COMPLETED|Overall Study||14
10383555|NCT00619229|11525435|FG001|COMPLETED|Overall Study||16
10383556|NCT00619229|11525434|FG000|NOT COMPLETED|Overall Study||4
10383557|NCT00619229|11525435|FG001|NOT COMPLETED|Overall Study||2
10383558|NCT00619255|11525443|FG000|STARTED|Overall Study||59
10383559|NCT00619255|11525444|FG001|STARTED|Overall Study||61
10383560|NCT00619255|11525443|FG000|COMPLETED|Overall Study||57
10383561|NCT00619255|11525444|FG001|COMPLETED|Overall Study||61
10383562|NCT00619255|11525443|FG000|NOT COMPLETED|Overall Study||2
10383563|NCT00619255|11525444|FG001|NOT COMPLETED|Overall Study||0
10383564|NCT00619307|11525452|FG000|STARTED|Overall Study||60
10383565|NCT00619307|11525453|FG001|STARTED|Overall Study||57
10383566|NCT00619307|11525452|FG000|COMPLETED|Overall Study||56
10383567|NCT00619307|11525453|FG001|COMPLETED|Overall Study||53
10383568|NCT00619307|11525452|FG000|NOT COMPLETED|Overall Study||4
10383569|NCT00619307|11525453|FG001|NOT COMPLETED|Overall Study||4
10383570|NCT00619359|11525461|FG000|STARTED|Overall Study||1147
10383571|NCT00619359|11525462|FG001|STARTED|Overall Study||1175
10383572|NCT00619359|11525461|FG000|COMPLETED|Overall Study||1080
10383573|NCT00619359|11525462|FG001|COMPLETED|Overall Study||1094
10383574|NCT00619359|11525461|FG000|NOT COMPLETED|Overall Study||67
10383575|NCT00619359|11525462|FG001|NOT COMPLETED|Overall Study||81
10383576|NCT00619385|11525471|FG000|STARTED|Overall Study||7
10383577|NCT00619385|11525472|FG001|STARTED|Overall Study||8
10383578|NCT00619385|11525473|FG002|STARTED|Overall Study||10
10383579|NCT00619385|11525471|FG000|COMPLETED|Overall Study||6
10383580|NCT00619385|11525472|FG001|COMPLETED|Overall Study||6
10383581|NCT00619385|11525473|FG002|COMPLETED|Overall Study||6
10383582|NCT00619385|11525471|FG000|NOT COMPLETED|Overall Study||1
10383583|NCT00619385|11525472|FG001|NOT COMPLETED|Overall Study||2
10383584|NCT00619385|11525473|FG002|NOT COMPLETED|Overall Study||4
10383585|NCT00619476|11525488|FG000|STARTED|Overall Study||95
10383586|NCT00619476|11525489|FG001|STARTED|Overall Study||107
10383587|NCT00619476|11525490|FG002|STARTED|Overall Study||84
10383588|NCT00619476|11525491|FG003|STARTED|Overall Study||90
10383589|NCT00619476|11525488|FG000|Intent-to-Treat Population|Overall Study||95
10383590|NCT00619476|11525489|FG001|Intent-to-Treat Population|Overall Study||107
10383591|NCT00619476|11525490|FG002|Intent-to-Treat Population|Overall Study||82
10383592|NCT00619476|11525491|FG003|Intent-to-Treat Population|Overall Study||87
10383593|NCT00619476|11525488|FG000|Safety Population|Overall Study||95
10383594|NCT00619476|11525489|FG001|Safety Population|Overall Study||107
10383595|NCT00619476|11525490|FG002|Safety Population|Overall Study||82
10383596|NCT00619476|11525491|FG003|Safety Population|Overall Study||87
10383597|NCT00619476|11525488|FG000|COMPLETED|Overall Study||64
10718013|NCT02703324|11882030|FG004|STARTED|Period Two||5
10718014|NCT02703324|11882031|FG005|STARTED|Period Two||5
10718015|NCT02703324|11882026|FG000|Received Study Drug|Period Two||5
10383598|NCT00619476|11525489|FG001|COMPLETED|Overall Study||85
10383599|NCT00619476|11525490|FG002|COMPLETED|Overall Study||60
10383600|NCT00619476|11525491|FG003|COMPLETED|Overall Study||56
10383601|NCT00619476|11525488|FG000|NOT COMPLETED|Overall Study||31
10383602|NCT00619476|11525489|FG001|NOT COMPLETED|Overall Study||22
10383603|NCT00619476|11525490|FG002|NOT COMPLETED|Overall Study||24
10383604|NCT00619476|11525491|FG003|NOT COMPLETED|Overall Study||34
10383605|NCT00619489|11525503|FG000|STARTED|Overall Study||37
10383606|NCT00619489|11525504|FG001|STARTED|Overall Study||35
10718016|NCT02703324|11882027|FG001|Received Study Drug|Period Two||5
10718017|NCT02703324|11882028|FG002|Received Study Drug|Period Two||5
10718018|NCT02703324|11882029|FG003|Received Study Drug|Period Two||5
10383607|NCT00619489|11525503|FG000|COMPLETED|Overall Study||14
10383608|NCT00619489|11525504|FG001|COMPLETED|Overall Study||1
10383609|NCT00619489|11525503|FG000|NOT COMPLETED|Overall Study||23
10383610|NCT00619489|11525504|FG001|NOT COMPLETED|Overall Study||34
10383611|NCT00619502|11525512|FG000|STARTED|Overall Study||130
10383612|NCT00619502|11525513|FG001|STARTED|Overall Study||124
10383613|NCT00619502|11525512|FG000|COMPLETED|Overall Study||122
10383614|NCT00619502|11525513|FG001|COMPLETED|Overall Study||114
10383615|NCT00619502|11525512|FG000|NOT COMPLETED|Overall Study||8
10383616|NCT00619502|11525513|FG001|NOT COMPLETED|Overall Study||10
10383617|NCT00619619|11525529|FG000|STARTED|Overall Study||6
10383618|NCT00619619|11525530|FG001|STARTED|Overall Study||7
10383619|NCT00619619|11525531|FG002|STARTED|Overall Study||9
10383620|NCT00619619|11525532|FG003|STARTED|Overall Study||7
10383621|NCT00619619|11525533|FG004|STARTED|Overall Study||7
10383622|NCT00619619|11525534|FG005|STARTED|Overall Study||7
10383623|NCT00619619|11525535|FG006|STARTED|Overall Study||8
10383624|NCT00619619|11525536|FG007|STARTED|Overall Study||8
10383625|NCT00619619|11525529|FG000|Entered the Extension Study|Overall Study|Extension study: 3151A6-2001 (NCT00669110)|6
10383626|NCT00619619|11525530|FG001|Entered the Extension Study|Overall Study||5
10383627|NCT00619619|11525531|FG002|Entered the Extension Study|Overall Study||8
10383628|NCT00619619|11525532|FG003|Entered the Extension Study|Overall Study||3
10383629|NCT00619619|11525533|FG004|Entered the Extension Study|Overall Study||7
10383630|NCT00619619|11525534|FG005|Entered the Extension Study|Overall Study||6
10383631|NCT00619619|11525535|FG006|Entered the Extension Study|Overall Study||6
10383632|NCT00619619|11525536|FG007|Entered the Extension Study|Overall Study||7
10383633|NCT00619619|11525529|FG000|COMPLETED|Overall Study|Completed=conclusion of Test Article (treatment) phase for all treatment groups in 3151A6-2000.|6
10383634|NCT00619619|11525530|FG001|COMPLETED|Overall Study||7
10383635|NCT00619619|11525531|FG002|COMPLETED|Overall Study||8
10383636|NCT00619619|11525532|FG003|COMPLETED|Overall Study||6
10383637|NCT00619619|11525533|FG004|COMPLETED|Overall Study||5
10383638|NCT00619619|11525534|FG005|COMPLETED|Overall Study||7
10383639|NCT00619619|11525535|FG006|COMPLETED|Overall Study||7
10383640|NCT00619619|11525536|FG007|COMPLETED|Overall Study||5
10383641|NCT00619619|11525529|FG000|NOT COMPLETED|Overall Study||0
10383642|NCT00619619|11525530|FG001|NOT COMPLETED|Overall Study||0
10383643|NCT00619619|11525531|FG002|NOT COMPLETED|Overall Study||1
10383644|NCT00619619|11525532|FG003|NOT COMPLETED|Overall Study||1
10383645|NCT00619619|11525533|FG004|NOT COMPLETED|Overall Study||2
10383646|NCT00619619|11525534|FG005|NOT COMPLETED|Overall Study||0
10383647|NCT00619619|11525535|FG006|NOT COMPLETED|Overall Study||1
10383648|NCT00619619|11525536|FG007|NOT COMPLETED|Overall Study||3
10383649|NCT00619645|11525557|FG000|STARTED|Overall Study||8
10383650|NCT00619645|11525557|FG000|COMPLETED|Overall Study||7
10383651|NCT00619645|11525557|FG000|NOT COMPLETED|Overall Study||1
10383652|NCT00619684|11525561|FG000|STARTED|Overall Study||18
10383653|NCT00619684|11525561|FG000|COMPLETED|Overall Study||18
10383654|NCT00619684|11525561|FG000|NOT COMPLETED|Overall Study||0
10383655|NCT00619723|11525567|FG000|STARTED|Overall Study||63
10383656|NCT00619723|11525568|FG001|STARTED|Overall Study||67
10383657|NCT00619723|11525567|FG000|COMPLETED|Overall Study||61
10383658|NCT00619723|11525568|FG001|COMPLETED|Overall Study||61
10383659|NCT00619723|11525567|FG000|NOT COMPLETED|Overall Study||2
10383660|NCT00619723|11525568|FG001|NOT COMPLETED|Overall Study||6
10383661|NCT00619762|11525574|FG000|STARTED|Overall Study|(29 breasts) First patient implanted 10/23/2007|17
10383662|NCT00619762|11525574|FG000|COMPLETED|Overall Study|(25 breasts) last patient visit 11/09/2009|14
10383663|NCT00619762|11525574|FG000|NOT COMPLETED|Overall Study||3
10383664|NCT00619801|11525581|FG000|STARTED|Overall Study||59
10383665|NCT00619801|11525582|FG001|STARTED|Overall Study||114
10383666|NCT00619801|11525581|FG000|Safety Population|Overall Study||59
10383667|NCT00619801|11525582|FG001|Safety Population|Overall Study||114
10383668|NCT00619801|11525581|FG000|COMPLETED|Overall Study||58
10383669|NCT00619801|11525582|FG001|COMPLETED|Overall Study||111
10383670|NCT00619801|11525581|FG000|NOT COMPLETED|Overall Study||1
10383671|NCT00619801|11525582|FG001|NOT COMPLETED|Overall Study||3
10383672|NCT00619827|11525590|FG000|STARTED|Overall Study||45
10383673|NCT00619827|11525591|FG001|STARTED|Overall Study||44
10383674|NCT00619827|11525590|FG000|COMPLETED|Overall Study||42
10383675|NCT00619827|11525591|FG001|COMPLETED|Overall Study||40
10383676|NCT00619827|11525590|FG000|NOT COMPLETED|Overall Study||3
10383677|NCT00619827|11525591|FG001|NOT COMPLETED|Overall Study||4
10383678|NCT00619866|11525600|FG000|STARTED|Weeks 1 - 12||52
10383679|NCT00619866|11525601|FG001|STARTED|Weeks 1 - 12||51
10383680|NCT00619866|11525602|FG002|STARTED|Weeks 1 - 12||52
10383681|NCT00619866|11525603|FG003|STARTED|Weeks 1 - 12||0
10383682|NCT00619866|11525604|FG004|STARTED|Weeks 1 - 12||0
10383683|NCT00619866|11525600|FG000|COMPLETED|Weeks 1 - 12||38
10383684|NCT00619866|11525601|FG001|COMPLETED|Weeks 1 - 12||45
10383685|NCT00619866|11525602|FG002|COMPLETED|Weeks 1 - 12||42
10383686|NCT00619866|11525603|FG003|COMPLETED|Weeks 1 - 12||0
10383687|NCT00619866|11525604|FG004|COMPLETED|Weeks 1 - 12||0
10383688|NCT00619866|11525600|FG000|NOT COMPLETED|Weeks 1 - 12||14
10383689|NCT00619866|11525601|FG001|NOT COMPLETED|Weeks 1 - 12||6
10383690|NCT00619866|11525602|FG002|NOT COMPLETED|Weeks 1 - 12||10
10383691|NCT00619866|11525603|FG003|NOT COMPLETED|Weeks 1 - 12||0
10383692|NCT00619866|11525604|FG004|NOT COMPLETED|Weeks 1 - 12||0
10383693|NCT00619866|11525600|FG000|STARTED|Weeks 13 - 24||0
10383694|NCT00619866|11525601|FG001|STARTED|Weeks 13 - 24||45
10383695|NCT00619866|11525602|FG002|STARTED|Weeks 13 - 24||42
10383696|NCT00619866|11525603|FG003|STARTED|Weeks 13 - 24||18
10383697|NCT00619866|11525604|FG004|STARTED|Weeks 13 - 24||20
10383698|NCT00619866|11525600|FG000|COMPLETED|Weeks 13 - 24||0
10383699|NCT00619866|11525601|FG001|COMPLETED|Weeks 13 - 24||38
10383700|NCT00619866|11525602|FG002|COMPLETED|Weeks 13 - 24||37
10383701|NCT00619866|11525603|FG003|COMPLETED|Weeks 13 - 24||14
10383702|NCT00619866|11525604|FG004|COMPLETED|Weeks 13 - 24||18
10383703|NCT00619866|11525600|FG000|NOT COMPLETED|Weeks 13 - 24||0
10383704|NCT00619866|11525601|FG001|NOT COMPLETED|Weeks 13 - 24||7
10383705|NCT00619866|11525602|FG002|NOT COMPLETED|Weeks 13 - 24||5
10540357|NCT01466348|11693386|FG001|NOT COMPLETED|Period II - Second Intervention||0
10540358|NCT01466361|11693398|FG000|STARTED|Overall Study||52
10540359|NCT01466361|11693399|FG001|STARTED|Overall Study||34
10718019|NCT02703324|11882030|FG004|Received Study Drug|Period Two||5
10718020|NCT02703324|11882031|FG005|Received Study Drug|Period Two||5
10718021|NCT02703324|11882026|FG000|COMPLETED|Period Two||5
10718022|NCT02703324|11882027|FG001|COMPLETED|Period Two||5
10718023|NCT02703324|11882028|FG002|COMPLETED|Period Two||4
10718024|NCT02703324|11882029|FG003|COMPLETED|Period Two||5
10718025|NCT02703324|11882030|FG004|COMPLETED|Period Two||5
10718026|NCT02703324|11882031|FG005|COMPLETED|Period Two||5
10718027|NCT02703324|11882026|FG000|NOT COMPLETED|Period Two||0
10540360|NCT01466361|11693400|FG002|STARTED|Overall Study||60
10540361|NCT01466361|11693401|FG003|STARTED|Overall Study||41
10540362|NCT01466361|11693398|FG000|COMPLETED|Overall Study||52
10540363|NCT01466361|11693399|FG001|COMPLETED|Overall Study||34
10540364|NCT01466361|11693400|FG002|COMPLETED|Overall Study||60
10540365|NCT01466361|11693401|FG003|COMPLETED|Overall Study||41
10540366|NCT01466361|11693398|FG000|NOT COMPLETED|Overall Study||0
10540367|NCT01466361|11693399|FG001|NOT COMPLETED|Overall Study||0
10540368|NCT01466361|11693400|FG002|NOT COMPLETED|Overall Study||0
10540369|NCT01466361|11693401|FG003|NOT COMPLETED|Overall Study||0
10540370|NCT01466387|11693422|FG000|STARTED|Overall Study||101
10540371|NCT01466387|11693423|FG001|STARTED|Overall Study||100
10540372|NCT01466387|11693424|FG002|STARTED|Overall Study||99
10540373|NCT01466387|11693425|FG003|STARTED|Overall Study||101
10540374|NCT01466387|11693426|FG004|STARTED|Overall Study||51
10718028|NCT02703324|11882027|FG001|NOT COMPLETED|Period Two||0
10718029|NCT02703324|11882028|FG002|NOT COMPLETED|Period Two||1
10383706|NCT00619866|11525603|FG003|NOT COMPLETED|Weeks 13 - 24||4
10540375|NCT01466387|11693427|FG005|STARTED|Overall Study||100
10540376|NCT01466387|11693422|FG000|COMPLETED|Overall Study||100
10540377|NCT01466387|11693423|FG001|COMPLETED|Overall Study||100
10540378|NCT01466387|11693424|FG002|COMPLETED|Overall Study||98
10540379|NCT01466387|11693425|FG003|COMPLETED|Overall Study||99
10718030|NCT02703324|11882029|FG003|NOT COMPLETED|Period Two||0
10718031|NCT02703324|11882030|FG004|NOT COMPLETED|Period Two||0
10718032|NCT02703324|11882031|FG005|NOT COMPLETED|Period Two||0
10383707|NCT00619866|11525604|FG004|NOT COMPLETED|Weeks 13 - 24||2
10383708|NCT00619892|11525618|FG000|STARTED|Overall Study||13
10383709|NCT00619892|11525619|FG001|STARTED|Overall Study||13
10383710|NCT00619892|11525618|FG000|COMPLETED|Overall Study||10
10383711|NCT00619892|11525619|FG001|COMPLETED|Overall Study||11
10383712|NCT00619892|11525618|FG000|NOT COMPLETED|Overall Study||3
10383713|NCT00619892|11525619|FG001|NOT COMPLETED|Overall Study||2
10383714|NCT00619918|11525629|FG000|STARTED|Overall Study||230
10383715|NCT00619918|11525630|FG001|STARTED|Overall Study||217
10383716|NCT00619918|11525629|FG000|COMPLETED|Overall Study||210
10383717|NCT00619918|11525630|FG001|COMPLETED|Overall Study||195
10383718|NCT00619918|11525629|FG000|NOT COMPLETED|Overall Study||20
10383719|NCT00619918|11525630|FG001|NOT COMPLETED|Overall Study||22
10383720|NCT00619957|11525638|FG000|STARTED|Month 24 Double-Blind||93
10383721|NCT00619957|11525639|FG001|STARTED|Month 24 Double-Blind||192
10383722|NCT00619957|11525638|FG000|Intent to Treat (ITT Population)|Month 24 Double-Blind||93
10383723|NCT00619957|11525639|FG001|Intent to Treat (ITT Population)|Month 24 Double-Blind|One subject did not take any study medication.|191
10383724|NCT00619957|11525638|FG000|COMPLETED|Month 24 Double-Blind||75
10383725|NCT00619957|11525639|FG001|COMPLETED|Month 24 Double-Blind||175
10383726|NCT00619957|11525638|FG000|NOT COMPLETED|Month 24 Double-Blind||18
10383727|NCT00619957|11525639|FG001|NOT COMPLETED|Month 24 Double-Blind||17
10383728|NCT00619957|11525638|FG000|STARTED|Month 48 Open-Label||67
10383729|NCT00619957|11525639|FG001|STARTED|Month 48 Open-Label||151
10383730|NCT00619957|11525638|FG000|COMPLETED|Month 48 Open-Label||55
10383731|NCT00619957|11525639|FG001|COMPLETED|Month 48 Open-Label||134
10383732|NCT00619957|11525638|FG000|NOT COMPLETED|Month 48 Open-Label||12
10383733|NCT00619957|11525639|FG001|NOT COMPLETED|Month 48 Open-Label||17
10383734|NCT00619970|11525650|FG000|STARTED|Overall Study||40
10383735|NCT00619970|11525651|FG001|STARTED|Overall Study||49
10383736|NCT00619970|11525652|FG002|STARTED|Overall Study||26
10383737|NCT00619970|11525650|FG000|COMPLETED|Overall Study||40
10383738|NCT00619970|11525651|FG001|COMPLETED|Overall Study||46
10383739|NCT00619970|11525652|FG002|COMPLETED|Overall Study||24
10383740|NCT00619970|11525650|FG000|NOT COMPLETED|Overall Study||0
10383741|NCT00619970|11525651|FG001|NOT COMPLETED|Overall Study||3
10383742|NCT00619970|11525652|FG002|NOT COMPLETED|Overall Study||2
10383743|NCT00619983|11525666|FG000|STARTED|Test Drug Alone||5
10383744|NCT00619983|11525667|FG001|STARTED|Test Drug Alone||5
10383745|NCT00619983|11525668|FG002|STARTED|Test Drug Alone||6
10383746|NCT00619983|11525669|FG003|STARTED|Test Drug Alone||6
10383747|NCT00619983|11525666|FG000|COMPLETED|Test Drug Alone||3
10383748|NCT00619983|11525667|FG001|COMPLETED|Test Drug Alone||4
10383749|NCT00619983|11525668|FG002|COMPLETED|Test Drug Alone||4
10383750|NCT00619983|11525669|FG003|COMPLETED|Test Drug Alone||3
10383751|NCT00619983|11525666|FG000|NOT COMPLETED|Test Drug Alone||2
10383752|NCT00619983|11525667|FG001|NOT COMPLETED|Test Drug Alone||1
10383753|NCT00619983|11525668|FG002|NOT COMPLETED|Test Drug Alone||2
10383754|NCT00619983|11525669|FG003|NOT COMPLETED|Test Drug Alone||3
10383755|NCT00619983|11525666|FG000|STARTED|Test Drug Plus Gabapentin||3
10383756|NCT00619983|11525667|FG001|STARTED|Test Drug Plus Gabapentin||4
10383757|NCT00619983|11525668|FG002|STARTED|Test Drug Plus Gabapentin||4
10383758|NCT00619983|11525669|FG003|STARTED|Test Drug Plus Gabapentin||3
10383759|NCT00619983|11525666|FG000|COMPLETED|Test Drug Plus Gabapentin||3
10383760|NCT00619983|11525667|FG001|COMPLETED|Test Drug Plus Gabapentin||4
10383761|NCT00619983|11525668|FG002|COMPLETED|Test Drug Plus Gabapentin||4
10383762|NCT00619983|11525669|FG003|COMPLETED|Test Drug Plus Gabapentin||3
10383763|NCT00619983|11525666|FG000|NOT COMPLETED|Test Drug Plus Gabapentin||0
10383764|NCT00619983|11525667|FG001|NOT COMPLETED|Test Drug Plus Gabapentin||0
10383765|NCT00619983|11525668|FG002|NOT COMPLETED|Test Drug Plus Gabapentin||0
10383766|NCT00619983|11525669|FG003|NOT COMPLETED|Test Drug Plus Gabapentin||0
10383767|NCT00619983|11525666|FG000|STARTED|Gabapentin Alone||3
10383768|NCT00619983|11525667|FG001|STARTED|Gabapentin Alone||4
10383769|NCT00619983|11525668|FG002|STARTED|Gabapentin Alone||4
10383770|NCT00619983|11525669|FG003|STARTED|Gabapentin Alone||3
10383771|NCT00619983|11525666|FG000|COMPLETED|Gabapentin Alone||3
10383772|NCT00619983|11525667|FG001|COMPLETED|Gabapentin Alone||4
10383773|NCT00619983|11525668|FG002|COMPLETED|Gabapentin Alone||4
10383774|NCT00619983|11525669|FG003|COMPLETED|Gabapentin Alone||3
10383775|NCT00619983|11525666|FG000|NOT COMPLETED|Gabapentin Alone||0
10383776|NCT00619983|11525667|FG001|NOT COMPLETED|Gabapentin Alone||0
10383777|NCT00619983|11525668|FG002|NOT COMPLETED|Gabapentin Alone||0
10383778|NCT00619983|11525669|FG003|NOT COMPLETED|Gabapentin Alone||0
10383779|NCT00620022|11525679|FG000|STARTED|Treatment Period 1||46
10383780|NCT00620022|11525680|FG001|STARTED|Treatment Period 1|Of 44 randomized patients, 1 patient discontinued before receiving any study treatment.|43
10383781|NCT00620022|11525679|FG000|COMPLETED|Treatment Period 1||41
10383782|NCT00620022|11525680|FG001|COMPLETED|Treatment Period 1||37
10383783|NCT00620022|11525679|FG000|NOT COMPLETED|Treatment Period 1||5
10383784|NCT00620022|11525680|FG001|NOT COMPLETED|Treatment Period 1||6
10383785|NCT00620022|11525679|FG000|STARTED|Treatment Period 2||41
10383786|NCT00620022|11525680|FG001|STARTED|Treatment Period 2||37
10383787|NCT00620022|11525679|FG000|COMPLETED|Treatment Period 2||39
10383788|NCT00620022|11525680|FG001|COMPLETED|Treatment Period 2||35
10383789|NCT00620022|11525679|FG000|NOT COMPLETED|Treatment Period 2||2
10383790|NCT00620022|11525680|FG001|NOT COMPLETED|Treatment Period 2||2
10383791|NCT00620061|11525686|FG000|STARTED|Overall Study||439
10383792|NCT00620061|11525686|FG000|COMPLETED|Overall Study||286
10383793|NCT00620061|11525686|FG000|NOT COMPLETED|Overall Study||153
10383794|NCT00620074|11525691|FG000|STARTED|Overall Study||6
10383795|NCT00620074|11525691|FG000|COMPLETED|Overall Study||5
10383796|NCT00620074|11525691|FG000|NOT COMPLETED|Overall Study||1
10383797|NCT00620113|11525699|FG000|STARTED|Overall Study||73
10383798|NCT00620113|11525700|FG001|STARTED|Overall Study||74
10383799|NCT00620113|11525701|FG002|STARTED|Overall Study|Includes 1 participant who also received 50 mg dose by accident during study.|71
10383800|NCT00620113|11525702|FG003|STARTED|Overall Study||69
10383801|NCT00620113|11525699|FG000|Efficacy/Safety Population|Overall Study||73
10383802|NCT00620113|11525700|FG001|Efficacy/Safety Population|Overall Study||74
10383803|NCT00620113|11525701|FG002|Efficacy/Safety Population|Overall Study||70
10383804|NCT00620113|11525702|FG003|Efficacy/Safety Population|Overall Study||69
10383805|NCT00620113|11525699|FG000|COMPLETED|Overall Study||60
10383806|NCT00620113|11525700|FG001|COMPLETED|Overall Study||67
10383807|NCT00620113|11525701|FG002|COMPLETED|Overall Study|Includes 1 participant who also received 50 mg dose by accident during study.|66
10383808|NCT00620113|11525702|FG003|COMPLETED|Overall Study||59
10383809|NCT00620113|11525699|FG000|NOT COMPLETED|Overall Study||13
10383810|NCT00620113|11525700|FG001|NOT COMPLETED|Overall Study||7
10383811|NCT00620113|11525701|FG002|NOT COMPLETED|Overall Study||5
10383812|NCT00620113|11525702|FG003|NOT COMPLETED|Overall Study||10
10383813|NCT00620126|11525714|FG000|STARTED|Overall Study||25
10383814|NCT00620126|11525715|FG001|STARTED|Overall Study||22
10383815|NCT00620126|11525714|FG000|COMPLETED|Overall Study||14
10383816|NCT00620126|11525715|FG001|COMPLETED|Overall Study||17
10383817|NCT00620126|11525714|FG000|NOT COMPLETED|Overall Study||11
10383818|NCT00620126|11525715|FG001|NOT COMPLETED|Overall Study||5
10383819|NCT00620191|11525723|FG000|STARTED|Overall Study||40
10383820|NCT00620191|11525724|FG001|STARTED|Overall Study||40
10383821|NCT00620191|11525723|FG000|3 Month Follow-up|Overall Study||39
10383822|NCT00620191|11525724|FG001|3 Month Follow-up|Overall Study||39
10383823|NCT00620191|11525723|FG000|6 Month Follow-up|Overall Study||38
10383824|NCT00620191|11525724|FG001|6 Month Follow-up|Overall Study||36
10383825|NCT00620191|11525723|FG000|9 Month Follow-up|Overall Study||37
10383826|NCT00620191|11525724|FG001|9 Month Follow-up|Overall Study||34
10383827|NCT00620191|11525723|FG000|COMPLETED|Overall Study|12 month follow-up|33
10383828|NCT00620191|11525724|FG001|COMPLETED|Overall Study|12 month follow-up|32
10383829|NCT00620191|11525723|FG000|NOT COMPLETED|Overall Study||7
10383830|NCT00620191|11525724|FG001|NOT COMPLETED|Overall Study||8
10383831|NCT00620282|11525738|FG000|STARTED|Overall Study||16
10383832|NCT00620282|11525739|FG001|STARTED|Overall Study||16
10383833|NCT00620282|11525740|FG002|STARTED|Overall Study||17
10540380|NCT01466387|11693426|FG004|COMPLETED|Overall Study||51
10540381|NCT01466387|11693427|FG005|COMPLETED|Overall Study||99
10540382|NCT01466387|11693422|FG000|NOT COMPLETED|Overall Study||1
10540383|NCT01466387|11693423|FG001|NOT COMPLETED|Overall Study||0
10540384|NCT01466387|11693424|FG002|NOT COMPLETED|Overall Study||1
10540385|NCT01466387|11693425|FG003|NOT COMPLETED|Overall Study||2
10540386|NCT01466387|11693426|FG004|NOT COMPLETED|Overall Study||0
10658179|NCT02231177|11819344|FG004|NOT COMPLETED|Treatment Period 1 (21 Days)||0
10658180|NCT02231177|11819345|FG005|NOT COMPLETED|Treatment Period 1 (21 Days)||0
10658181|NCT02231177|11819340|FG000|STARTED|Treatment Period 2 (21 Days)||8
10658182|NCT02231177|11819341|FG001|STARTED|Treatment Period 2 (21 Days)||7
10658183|NCT02231177|11819342|FG002|STARTED|Treatment Period 2 (21 Days)||8
10658184|NCT02231177|11819343|FG003|STARTED|Treatment Period 2 (21 Days)||7
10658185|NCT02231177|11819344|FG004|STARTED|Treatment Period 2 (21 Days)||8
10658186|NCT02231177|11819345|FG005|STARTED|Treatment Period 2 (21 Days)||9
10658187|NCT02231177|11819340|FG000|COMPLETED|Treatment Period 2 (21 Days)||8
10658188|NCT02231177|11819341|FG001|COMPLETED|Treatment Period 2 (21 Days)||7
10658189|NCT02231177|11819342|FG002|COMPLETED|Treatment Period 2 (21 Days)||8
10658190|NCT02231177|11819343|FG003|COMPLETED|Treatment Period 2 (21 Days)||7
10658191|NCT02231177|11819344|FG004|COMPLETED|Treatment Period 2 (21 Days)||8
10658192|NCT02231177|11819345|FG005|COMPLETED|Treatment Period 2 (21 Days)||9
10658193|NCT02231177|11819340|FG000|NOT COMPLETED|Treatment Period 2 (21 Days)||0
10658194|NCT02231177|11819341|FG001|NOT COMPLETED|Treatment Period 2 (21 Days)||0
10658195|NCT02231177|11819342|FG002|NOT COMPLETED|Treatment Period 2 (21 Days)||0
10658196|NCT02231177|11819343|FG003|NOT COMPLETED|Treatment Period 2 (21 Days)||0
10658197|NCT02231177|11819344|FG004|NOT COMPLETED|Treatment Period 2 (21 Days)||0
10658198|NCT02231177|11819345|FG005|NOT COMPLETED|Treatment Period 2 (21 Days)||0
10658199|NCT02231177|11819340|FG000|STARTED|Treatment Period 3 (21 Days)||8
10658200|NCT02231177|11819341|FG001|STARTED|Treatment Period 3 (21 Days)||7
10658201|NCT02231177|11819342|FG002|STARTED|Treatment Period 3 (21 Days)||8
10658202|NCT02231177|11819343|FG003|STARTED|Treatment Period 3 (21 Days)||7
10383834|NCT00620282|11525738|FG000|COMPLETED|Overall Study||16
10383835|NCT00620282|11525739|FG001|COMPLETED|Overall Study||14
10383836|NCT00620282|11525740|FG002|COMPLETED|Overall Study||16
10383837|NCT00620282|11525738|FG000|NOT COMPLETED|Overall Study||0
10383838|NCT00620282|11525739|FG001|NOT COMPLETED|Overall Study||2
10383839|NCT00620282|11525740|FG002|NOT COMPLETED|Overall Study||1
10383840|NCT00620321|11525750|FG000|STARTED|Overall Study||8
10540387|NCT01466387|11693427|FG005|NOT COMPLETED|Overall Study||1
10540388|NCT01466491|11693454|FG000|STARTED|Overall Study||83
10540389|NCT01466491|11693455|FG001|STARTED|Overall Study||83
10540390|NCT01466491|11693456|FG002|STARTED|Overall Study||83
10540391|NCT01466491|11693457|FG003|STARTED|Overall Study||83
10540392|NCT01466491|11693454|FG000|COMPLETED|Overall Study||83
10540393|NCT01466491|11693455|FG001|COMPLETED|Overall Study||80
10658203|NCT02231177|11819344|FG004|STARTED|Treatment Period 3 (21 Days)||8
10718033|NCT02703324|11882026|FG000|STARTED|Period Three||5
10718034|NCT02703324|11882027|FG001|STARTED|Period Three||5
10383841|NCT00620321|11525751|FG001|STARTED|Overall Study||16
10383842|NCT00620321|11525750|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
10383843|NCT00620321|11525751|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16
10383844|NCT00620321|11525750|FG000|COMPLETED|Overall Study||0
10383845|NCT00620321|11525751|FG001|COMPLETED|Overall Study||0
10383846|NCT00620321|11525750|FG000|NOT COMPLETED|Overall Study||8
10383847|NCT00620321|11525751|FG001|NOT COMPLETED|Overall Study||16
10383848|NCT00620373|11525757|FG000|STARTED|Overall Study||969
10383849|NCT00620373|11525757|FG000|COMPLETED|Overall Study||936
10383850|NCT00620373|11525757|FG000|NOT COMPLETED|Overall Study||33
10383851|NCT00620425|11525764|FG000|STARTED|Overall Study||18
10383852|NCT00620425|11525764|FG000|COMPLETED|Overall Study||18
10383853|NCT00620425|11525764|FG000|NOT COMPLETED|Overall Study||0
10383854|NCT00620503|11525775|FG000|STARTED|Screening (up to 21 Days)||2
10383855|NCT00620503|11525776|FG001|STARTED|Screening (up to 21 Days)||2
10383856|NCT00620503|11525777|FG002|STARTED|Screening (up to 21 Days)||2
10383857|NCT00620503|11525778|FG003|STARTED|Screening (up to 21 Days)||2
10383858|NCT00620503|11525779|FG004|STARTED|Screening (up to 21 Days)||2
10383859|NCT00620503|11525780|FG005|STARTED|Screening (up to 21 Days)||2
10383860|NCT00620503|11525775|FG000|COMPLETED|Screening (up to 21 Days)||2
10383861|NCT00620503|11525776|FG001|COMPLETED|Screening (up to 21 Days)||2
10383862|NCT00620503|11525777|FG002|COMPLETED|Screening (up to 21 Days)||2
10383863|NCT00620503|11525778|FG003|COMPLETED|Screening (up to 21 Days)||2
10383864|NCT00620503|11525779|FG004|COMPLETED|Screening (up to 21 Days)||2
10718035|NCT02703324|11882028|FG002|STARTED|Period Three||4
10718036|NCT02703324|11882029|FG003|STARTED|Period Three||5
10718037|NCT02703324|11882030|FG004|STARTED|Period Three||5
10718038|NCT02703324|11882031|FG005|STARTED|Period Three||5
10718039|NCT02703324|11882026|FG000|Received Study Drug|Period Three||5
10718040|NCT02703324|11882027|FG001|Received Study Drug|Period Three||5
10718041|NCT02703324|11882028|FG002|Received Study Drug|Period Three||4
10718042|NCT02703324|11882029|FG003|Received Study Drug|Period Three||5
10383865|NCT00620503|11525780|FG005|COMPLETED|Screening (up to 21 Days)||2
10383866|NCT00620503|11525775|FG000|NOT COMPLETED|Screening (up to 21 Days)||0
10383867|NCT00620503|11525776|FG001|NOT COMPLETED|Screening (up to 21 Days)||0
10383868|NCT00620503|11525777|FG002|NOT COMPLETED|Screening (up to 21 Days)||0
10383869|NCT00620503|11525778|FG003|NOT COMPLETED|Screening (up to 21 Days)||0
10383870|NCT00620503|11525779|FG004|NOT COMPLETED|Screening (up to 21 Days)||0
10383871|NCT00620503|11525780|FG005|NOT COMPLETED|Screening (up to 21 Days)||0
10383872|NCT00620503|11525775|FG000|STARTED|Treatment Period 1 (TP1) (7days)||2
10383873|NCT00620503|11525776|FG001|STARTED|Treatment Period 1 (TP1) (7days)||2
10383874|NCT00620503|11525777|FG002|STARTED|Treatment Period 1 (TP1) (7days)||2
10383875|NCT00620503|11525778|FG003|STARTED|Treatment Period 1 (TP1) (7days)||2
10383876|NCT00620503|11525779|FG004|STARTED|Treatment Period 1 (TP1) (7days)||2
10383877|NCT00620503|11525780|FG005|STARTED|Treatment Period 1 (TP1) (7days)||2
10383878|NCT00620503|11525775|FG000|COMPLETED|Treatment Period 1 (TP1) (7days)||2
10383879|NCT00620503|11525776|FG001|COMPLETED|Treatment Period 1 (TP1) (7days)||2
10383880|NCT00620503|11525777|FG002|COMPLETED|Treatment Period 1 (TP1) (7days)||2
10383881|NCT00620503|11525778|FG003|COMPLETED|Treatment Period 1 (TP1) (7days)||2
10383882|NCT00620503|11525779|FG004|COMPLETED|Treatment Period 1 (TP1) (7days)||2
10383883|NCT00620503|11525780|FG005|COMPLETED|Treatment Period 1 (TP1) (7days)||2
10383884|NCT00620503|11525775|FG000|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
10383885|NCT00620503|11525776|FG001|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
10383886|NCT00620503|11525777|FG002|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
10383887|NCT00620503|11525778|FG003|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
10383888|NCT00620503|11525779|FG004|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
10383889|NCT00620503|11525780|FG005|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
10383890|NCT00620503|11525775|FG000|STARTED|Washout (at Least 1 Day)||2
10383891|NCT00620503|11525776|FG001|STARTED|Washout (at Least 1 Day)||2
10383892|NCT00620503|11525777|FG002|STARTED|Washout (at Least 1 Day)||2
10383893|NCT00620503|11525778|FG003|STARTED|Washout (at Least 1 Day)||2
10383894|NCT00620503|11525779|FG004|STARTED|Washout (at Least 1 Day)||2
10383895|NCT00620503|11525780|FG005|STARTED|Washout (at Least 1 Day)||2
10383896|NCT00620503|11525775|FG000|COMPLETED|Washout (at Least 1 Day)||2
10383897|NCT00620503|11525776|FG001|COMPLETED|Washout (at Least 1 Day)||2
10383898|NCT00620503|11525777|FG002|COMPLETED|Washout (at Least 1 Day)||2
10383899|NCT00620503|11525778|FG003|COMPLETED|Washout (at Least 1 Day)||2
10383900|NCT00620503|11525779|FG004|COMPLETED|Washout (at Least 1 Day)||2
10383901|NCT00620503|11525780|FG005|COMPLETED|Washout (at Least 1 Day)||2
10383902|NCT00620503|11525775|FG000|NOT COMPLETED|Washout (at Least 1 Day)||0
10718043|NCT02703324|11882030|FG004|Received Study Drug|Period Three||5
10718044|NCT02703324|11882031|FG005|Received Study Drug|Period Three||5
10718045|NCT02703324|11882026|FG000|COMPLETED|Period Three||5
10718046|NCT02703324|11882027|FG001|COMPLETED|Period Three|One participant discontinued after Period 3. Did not enter Period 4.|5
10383903|NCT00620503|11525776|FG001|NOT COMPLETED|Washout (at Least 1 Day)||0
10383904|NCT00620503|11525777|FG002|NOT COMPLETED|Washout (at Least 1 Day)||0
10383905|NCT00620503|11525778|FG003|NOT COMPLETED|Washout (at Least 1 Day)||0
10383906|NCT00620503|11525779|FG004|NOT COMPLETED|Washout (at Least 1 Day)||0
10383907|NCT00620503|11525780|FG005|NOT COMPLETED|Washout (at Least 1 Day)||0
10383908|NCT00620503|11525775|FG000|STARTED|Treatment Period 2 (TP2) (7days)||2
10383909|NCT00620503|11525776|FG001|STARTED|Treatment Period 2 (TP2) (7days)||2
10383910|NCT00620503|11525777|FG002|STARTED|Treatment Period 2 (TP2) (7days)||2
10383911|NCT00620503|11525778|FG003|STARTED|Treatment Period 2 (TP2) (7days)||2
10383912|NCT00620503|11525779|FG004|STARTED|Treatment Period 2 (TP2) (7days)||2
10383913|NCT00620503|11525780|FG005|STARTED|Treatment Period 2 (TP2) (7days)||2
10383914|NCT00620503|11525775|FG000|COMPLETED|Treatment Period 2 (TP2) (7days)||2
10383915|NCT00620503|11525776|FG001|COMPLETED|Treatment Period 2 (TP2) (7days)||2
10383916|NCT00620503|11525777|FG002|COMPLETED|Treatment Period 2 (TP2) (7days)||2
10383917|NCT00620503|11525778|FG003|COMPLETED|Treatment Period 2 (TP2) (7days)||2
10383918|NCT00620503|11525779|FG004|COMPLETED|Treatment Period 2 (TP2) (7days)||2
10383919|NCT00620503|11525780|FG005|COMPLETED|Treatment Period 2 (TP2) (7days)||2
10383920|NCT00620503|11525775|FG000|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
10383921|NCT00620503|11525776|FG001|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
10383922|NCT00620503|11525777|FG002|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
10383923|NCT00620503|11525778|FG003|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
10540394|NCT01466491|11693456|FG002|COMPLETED|Overall Study||80
10540395|NCT01466491|11693457|FG003|COMPLETED|Overall Study||83
10540396|NCT01466491|11693454|FG000|NOT COMPLETED|Overall Study||0
10540397|NCT01466491|11693455|FG001|NOT COMPLETED|Overall Study||3
10540398|NCT01466491|11693456|FG002|NOT COMPLETED|Overall Study||3
10540399|NCT01466491|11693457|FG003|NOT COMPLETED|Overall Study||0
10383924|NCT00620503|11525779|FG004|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
10383925|NCT00620503|11525780|FG005|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
10383926|NCT00620503|11525775|FG000|STARTED|Washout (at Least 1 Day)||2
10383927|NCT00620503|11525776|FG001|STARTED|Washout (at Least 1 Day)||2
10383928|NCT00620503|11525777|FG002|STARTED|Washout (at Least 1 Day)||2
10383929|NCT00620503|11525778|FG003|STARTED|Washout (at Least 1 Day)||2
10540400|NCT01466595|11693469|FG000|STARTED|Overall Study||49
10540401|NCT01466595|11693470|FG001|STARTED|Overall Study||24
10540402|NCT01466595|11693469|FG000|COMPLETED|Overall Study||49
10540403|NCT01466595|11693470|FG001|COMPLETED|Overall Study||23
10540404|NCT01466595|11693469|FG000|NOT COMPLETED|Overall Study||0
10540405|NCT01466595|11693470|FG001|NOT COMPLETED|Overall Study||1
10540406|NCT01466660|11693478|FG000|STARTED|Overall Study||160
10540407|NCT01466660|11693479|FG001|STARTED|Overall Study||159
10540408|NCT01466660|11693478|FG000|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12 April 2019|0
10540409|NCT01466660|11693479|FG001|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12 April 2019|0
10540410|NCT01466660|11693478|FG000|NOT COMPLETED|Overall Study||160
10540411|NCT01466660|11693479|FG001|NOT COMPLETED|Overall Study||159
10540412|NCT01466673|11693487|FG000|STARTED|Overall Study||100
10540413|NCT01466673|11693488|FG001|STARTED|Overall Study||101
10540414|NCT01466673|11693487|FG000|COMPLETED|Overall Study||93
10540415|NCT01466673|11693488|FG001|COMPLETED|Overall Study||95
10540416|NCT01466673|11693487|FG000|NOT COMPLETED|Overall Study||7
10540417|NCT01466673|11693488|FG001|NOT COMPLETED|Overall Study||6
10540418|NCT01466751|11693496|FG000|STARTED|Overall Study||14
10540419|NCT01466751|11693497|FG001|STARTED|Overall Study||14
10540420|NCT01466751|11693496|FG000|COMPLETED|Overall Study||13
10540421|NCT01466751|11693497|FG001|COMPLETED|Overall Study||14
10540422|NCT01466751|11693496|FG000|NOT COMPLETED|Overall Study||1
10540423|NCT01466751|11693497|FG001|NOT COMPLETED|Overall Study||0
10540424|NCT01466764|11693507|FG000|STARTED|Overall Study||5
10540425|NCT01466764|11693508|FG001|STARTED|Overall Study||5
10540426|NCT01466764|11693507|FG000|COMPLETED|Overall Study||5
10540427|NCT01466764|11693508|FG001|COMPLETED|Overall Study||5
10540428|NCT01466764|11693507|FG000|NOT COMPLETED|Overall Study||0
10540429|NCT01466764|11693508|FG001|NOT COMPLETED|Overall Study||0
10540430|NCT01466790|11693522|FG000|STARTED|Overall Study|Not including 1 participant who was randomized to this group, but never received treatment.|24
10540431|NCT01466790|11693523|FG001|STARTED|Overall Study||15
10540432|NCT01466790|11693524|FG002|STARTED|Overall Study||27
10540433|NCT01466790|11693525|FG003|STARTED|Overall Study||14
10540434|NCT01466790|11693526|FG004|STARTED|Overall Study||30
10540435|NCT01466790|11693527|FG005|STARTED|Overall Study||16
10540436|NCT01466790|11693528|FG006|STARTED|Overall Study||27
10540437|NCT01466790|11693529|FG007|STARTED|Overall Study||14
10540438|NCT01466790|11693522|FG000|COMPLETED|Overall Study||20
10540439|NCT01466790|11693523|FG001|COMPLETED|Overall Study||14
10540440|NCT01466790|11693524|FG002|COMPLETED|Overall Study||27
10540441|NCT01466790|11693525|FG003|COMPLETED|Overall Study||14
10540442|NCT01466790|11693526|FG004|COMPLETED|Overall Study||27
10540443|NCT01466790|11693527|FG005|COMPLETED|Overall Study||16
10540444|NCT01466790|11693528|FG006|COMPLETED|Overall Study||26
10540445|NCT01466790|11693529|FG007|COMPLETED|Overall Study||13
10540446|NCT01466790|11693522|FG000|NOT COMPLETED|Overall Study||4
10383930|NCT00620503|11525779|FG004|STARTED|Washout (at Least 1 Day)||2
10383931|NCT00620503|11525780|FG005|STARTED|Washout (at Least 1 Day)||2
10540447|NCT01466790|11693523|FG001|NOT COMPLETED|Overall Study||1
10540448|NCT01466790|11693524|FG002|NOT COMPLETED|Overall Study||0
10540449|NCT01466790|11693525|FG003|NOT COMPLETED|Overall Study||0
10540450|NCT01466790|11693526|FG004|NOT COMPLETED|Overall Study||3
10540451|NCT01466790|11693527|FG005|NOT COMPLETED|Overall Study||0
10540452|NCT01466790|11693528|FG006|NOT COMPLETED|Overall Study||1
10540453|NCT01466790|11693529|FG007|NOT COMPLETED|Overall Study||1
10540454|NCT01466881|11693543|FG000|STARTED|Overall Study||42
10540455|NCT01466881|11693543|FG000|Eligible and Treated|Overall Study||37
10540456|NCT01466881|11693543|FG000|COMPLETED|Overall Study||2
10540457|NCT01466881|11693543|FG000|NOT COMPLETED|Overall Study||40
10540458|NCT01466972|11693549|FG000|STARTED|Overall Study||30
10383932|NCT00620503|11525775|FG000|COMPLETED|Washout (at Least 1 Day)||2
10383933|NCT00620503|11525776|FG001|COMPLETED|Washout (at Least 1 Day)||2
10383934|NCT00620503|11525777|FG002|COMPLETED|Washout (at Least 1 Day)||2
10383935|NCT00620503|11525778|FG003|COMPLETED|Washout (at Least 1 Day)||2
10383936|NCT00620503|11525779|FG004|COMPLETED|Washout (at Least 1 Day)||2
10383937|NCT00620503|11525780|FG005|COMPLETED|Washout (at Least 1 Day)||2
10383938|NCT00620503|11525775|FG000|NOT COMPLETED|Washout (at Least 1 Day)||0
10383939|NCT00620503|11525776|FG001|NOT COMPLETED|Washout (at Least 1 Day)||0
10383940|NCT00620503|11525777|FG002|NOT COMPLETED|Washout (at Least 1 Day)||0
10383941|NCT00620503|11525778|FG003|NOT COMPLETED|Washout (at Least 1 Day)||0
10383942|NCT00620503|11525779|FG004|NOT COMPLETED|Washout (at Least 1 Day)||0
10383943|NCT00620503|11525780|FG005|NOT COMPLETED|Washout (at Least 1 Day)||0
10383944|NCT00620503|11525775|FG000|STARTED|Treatment Period 3 (TP3) (7 Days)||2
10383945|NCT00620503|11525776|FG001|STARTED|Treatment Period 3 (TP3) (7 Days)||2
10383946|NCT00620503|11525777|FG002|STARTED|Treatment Period 3 (TP3) (7 Days)||2
10383947|NCT00620503|11525778|FG003|STARTED|Treatment Period 3 (TP3) (7 Days)||2
10383948|NCT00620503|11525779|FG004|STARTED|Treatment Period 3 (TP3) (7 Days)||2
10383949|NCT00620503|11525780|FG005|STARTED|Treatment Period 3 (TP3) (7 Days)||2
10383950|NCT00620503|11525775|FG000|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
10383951|NCT00620503|11525776|FG001|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
10383952|NCT00620503|11525777|FG002|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
10383953|NCT00620503|11525778|FG003|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
10383954|NCT00620503|11525779|FG004|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
10383955|NCT00620503|11525780|FG005|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
10383956|NCT00620503|11525775|FG000|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
10383957|NCT00620503|11525776|FG001|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
10383958|NCT00620503|11525777|FG002|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
10383959|NCT00620503|11525778|FG003|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
10383960|NCT00620503|11525779|FG004|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
10383961|NCT00620503|11525780|FG005|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
10383962|NCT00620503|11525775|FG000|STARTED|Follow-up (up to 14 Days)||2
10383963|NCT00620503|11525776|FG001|STARTED|Follow-up (up to 14 Days)||2
10383964|NCT00620503|11525777|FG002|STARTED|Follow-up (up to 14 Days)||2
10383965|NCT00620503|11525778|FG003|STARTED|Follow-up (up to 14 Days)||2
10383966|NCT00620503|11525779|FG004|STARTED|Follow-up (up to 14 Days)||2
10383967|NCT00620503|11525780|FG005|STARTED|Follow-up (up to 14 Days)||2
10383968|NCT00620503|11525775|FG000|COMPLETED|Follow-up (up to 14 Days)||2
10383969|NCT00620503|11525776|FG001|COMPLETED|Follow-up (up to 14 Days)||2
10383970|NCT00620503|11525777|FG002|COMPLETED|Follow-up (up to 14 Days)||2
10383971|NCT00620503|11525778|FG003|COMPLETED|Follow-up (up to 14 Days)||2
10383972|NCT00620503|11525779|FG004|COMPLETED|Follow-up (up to 14 Days)||2
10383973|NCT00620503|11525780|FG005|COMPLETED|Follow-up (up to 14 Days)||2
10383974|NCT00620503|11525775|FG000|NOT COMPLETED|Follow-up (up to 14 Days)||0
10383975|NCT00620503|11525776|FG001|NOT COMPLETED|Follow-up (up to 14 Days)||0
10383976|NCT00620503|11525777|FG002|NOT COMPLETED|Follow-up (up to 14 Days)||0
10383977|NCT00620503|11525778|FG003|NOT COMPLETED|Follow-up (up to 14 Days)||0
10383978|NCT00620503|11525779|FG004|NOT COMPLETED|Follow-up (up to 14 Days)||0
10383979|NCT00620503|11525780|FG005|NOT COMPLETED|Follow-up (up to 14 Days)||0
10383980|NCT00620542|11525790|FG000|STARTED|Part A (Run-in - 2 Weeks)|Of 1167 randomized, N=783 received treatment.|1167
10383981|NCT00620542|11525791|FG001|STARTED|Part A (Run-in - 2 Weeks)|Of 1166 randomized, N=795 received treatment.|1166
10383982|NCT00620542|11525792|FG002|STARTED|Part A (Run-in - 2 Weeks)||0
10383983|NCT00620542|11525793|FG003|STARTED|Part A (Run-in - 2 Weeks)||0
10383984|NCT00620542|11525790|FG000|Received Treatment|Part A (Run-in - 2 Weeks)||783
10383985|NCT00620542|11525791|FG001|Received Treatment|Part A (Run-in - 2 Weeks)||795
10383986|NCT00620542|11525792|FG002|Received Treatment|Part A (Run-in - 2 Weeks)||0
10383987|NCT00620542|11525793|FG003|Received Treatment|Part A (Run-in - 2 Weeks)||0
10383988|NCT00620542|11525790|FG000|COMPLETED|Part A (Run-in - 2 Weeks)||695
10383989|NCT00620542|11525791|FG001|COMPLETED|Part A (Run-in - 2 Weeks)||690
10383990|NCT00620542|11525792|FG002|COMPLETED|Part A (Run-in - 2 Weeks)||0
10383991|NCT00620542|11525793|FG003|COMPLETED|Part A (Run-in - 2 Weeks)||0
10383992|NCT00620542|11525790|FG000|NOT COMPLETED|Part A (Run-in - 2 Weeks)||472
10383993|NCT00620542|11525791|FG001|NOT COMPLETED|Part A (Run-in - 2 Weeks)||476
10383994|NCT00620542|11525792|FG002|NOT COMPLETED|Part A (Run-in - 2 Weeks)||0
10383995|NCT00620542|11525793|FG003|NOT COMPLETED|Part A (Run-in - 2 Weeks)||0
10383996|NCT00620542|11525790|FG000|STARTED|Part B (2 Year Core Study)||0
10383997|NCT00620542|11525791|FG001|STARTED|Part B (2 Year Core Study)||0
10383998|NCT00620542|11525792|FG002|STARTED|Part B (2 Year Core Study)|Of 694 patients randomized, N=691 received treatment.|694
10383999|NCT00620542|11525793|FG003|STARTED|Part B (2 Year Core Study)|Of 691 patients randomized, N=689 received treatment.|691
10384000|NCT00620542|11525790|FG000|Received Treatment|Part B (2 Year Core Study)||0
10384001|NCT00620542|11525791|FG001|Received Treatment|Part B (2 Year Core Study)||0
10384002|NCT00620542|11525792|FG002|Received Treatment|Part B (2 Year Core Study)||691
10384003|NCT00620542|11525793|FG003|Received Treatment|Part B (2 Year Core Study)||689
10384004|NCT00620542|11525790|FG000|Intent-to-treat Population|Part B (2 Year Core Study)||0
10384005|NCT00620542|11525791|FG001|Intent-to-treat Population|Part B (2 Year Core Study)||0
10384006|NCT00620542|11525792|FG002|Intent-to-treat Population|Part B (2 Year Core Study)|Patients who received treatment and had a baseline and end of study (Week 104) IVUS|520
10384007|NCT00620542|11525793|FG003|Intent-to-treat Population|Part B (2 Year Core Study)|Patients who received treatment and had a baseline and end of study (Week 104) IVUS|519
10384008|NCT00620542|11525790|FG000|COMPLETED|Part B (2 Year Core Study)||0
10384009|NCT00620542|11525791|FG001|COMPLETED|Part B (2 Year Core Study)||0
10384010|NCT00620542|11525792|FG002|COMPLETED|Part B (2 Year Core Study)||546
10384011|NCT00620542|11525793|FG003|COMPLETED|Part B (2 Year Core Study)||547
10384012|NCT00620542|11525790|FG000|NOT COMPLETED|Part B (2 Year Core Study)||0
10384013|NCT00620542|11525791|FG001|NOT COMPLETED|Part B (2 Year Core Study)||0
10384014|NCT00620542|11525792|FG002|NOT COMPLETED|Part B (2 Year Core Study)||148
10384015|NCT00620542|11525793|FG003|NOT COMPLETED|Part B (2 Year Core Study)||144
10384016|NCT00620555|11525801|FG000|STARTED|Overall Study||65
10384017|NCT00620555|11525801|FG000|COMPLETED|Overall Study||44
10384018|NCT00620555|11525801|FG000|NOT COMPLETED|Overall Study||21
10384019|NCT00620659|11525805|FG000|STARTED|Treatment Period 1||21
10384020|NCT00620659|11525806|FG001|STARTED|Treatment Period 1||21
10384021|NCT00620659|11525807|FG002|STARTED|Treatment Period 1||21
10384022|NCT00620659|11525808|FG003|STARTED|Treatment Period 1||21
10384023|NCT00620659|11525809|FG004|STARTED|Treatment Period 1||21
10384024|NCT00620659|11525810|FG005|STARTED|Treatment Period 1||20
10384025|NCT00620659|11525805|FG000|COMPLETED|Treatment Period 1||18
10384026|NCT00620659|11525806|FG001|COMPLETED|Treatment Period 1||21
10384027|NCT00620659|11525807|FG002|COMPLETED|Treatment Period 1||20
10384028|NCT00620659|11525808|FG003|COMPLETED|Treatment Period 1|1 patient discontinued from MK0249, but continued in following periods, & completed the study|18
10384029|NCT00620659|11525809|FG004|COMPLETED|Treatment Period 1||20
10384030|NCT00620659|11525810|FG005|COMPLETED|Treatment Period 1||20
10384031|NCT00620659|11525805|FG000|NOT COMPLETED|Treatment Period 1||3
10384032|NCT00620659|11525806|FG001|NOT COMPLETED|Treatment Period 1||0
10384033|NCT00620659|11525807|FG002|NOT COMPLETED|Treatment Period 1||1
10384034|NCT00620659|11525808|FG003|NOT COMPLETED|Treatment Period 1||3
10384035|NCT00620659|11525809|FG004|NOT COMPLETED|Treatment Period 1||1
10384036|NCT00620659|11525810|FG005|NOT COMPLETED|Treatment Period 1||0
10384037|NCT00620659|11525805|FG000|STARTED|Placebo Washout Period 1||18
10384038|NCT00620659|11525806|FG001|STARTED|Placebo Washout Period 1||21
10384039|NCT00620659|11525807|FG002|STARTED|Placebo Washout Period 1||20
10384040|NCT00620659|11525808|FG003|STARTED|Placebo Washout Period 1||19
10384041|NCT00620659|11525809|FG004|STARTED|Placebo Washout Period 1||20
10384042|NCT00620659|11525810|FG005|STARTED|Placebo Washout Period 1||20
10384043|NCT00620659|11525805|FG000|COMPLETED|Placebo Washout Period 1||18
10384044|NCT00620659|11525806|FG001|COMPLETED|Placebo Washout Period 1||21
10384045|NCT00620659|11525807|FG002|COMPLETED|Placebo Washout Period 1||20
10384046|NCT00620659|11525808|FG003|COMPLETED|Placebo Washout Period 1||18
10384047|NCT00620659|11525809|FG004|COMPLETED|Placebo Washout Period 1||20
10384048|NCT00620659|11525810|FG005|COMPLETED|Placebo Washout Period 1||20
10384049|NCT00620659|11525805|FG000|NOT COMPLETED|Placebo Washout Period 1||0
10384050|NCT00620659|11525806|FG001|NOT COMPLETED|Placebo Washout Period 1||0
10384051|NCT00620659|11525807|FG002|NOT COMPLETED|Placebo Washout Period 1||0
10384052|NCT00620659|11525808|FG003|NOT COMPLETED|Placebo Washout Period 1||1
10384053|NCT00620659|11525809|FG004|NOT COMPLETED|Placebo Washout Period 1||0
10384054|NCT00620659|11525810|FG005|NOT COMPLETED|Placebo Washout Period 1||0
10384055|NCT00620659|11525805|FG000|STARTED|Treatment Period 2||18
10384056|NCT00620659|11525806|FG001|STARTED|Treatment Period 2||21
10384057|NCT00620659|11525807|FG002|STARTED|Treatment Period 2||20
10384058|NCT00620659|11525808|FG003|STARTED|Treatment Period 2||18
10384059|NCT00620659|11525809|FG004|STARTED|Treatment Period 2||20
10384060|NCT00620659|11525810|FG005|STARTED|Treatment Period 2||20
10384061|NCT00620659|11525805|FG000|COMPLETED|Treatment Period 2||18
10384062|NCT00620659|11525806|FG001|COMPLETED|Treatment Period 2||18
10384063|NCT00620659|11525807|FG002|COMPLETED|Treatment Period 2||19
10384064|NCT00620659|11525808|FG003|COMPLETED|Treatment Period 2||18
10384065|NCT00620659|11525809|FG004|COMPLETED|Treatment Period 2||15
10384066|NCT00620659|11525810|FG005|COMPLETED|Treatment Period 2||20
10540459|NCT01466972|11693549|FG000|COMPLETED|Overall Study||30
10540460|NCT01466972|11693549|FG000|NOT COMPLETED|Overall Study||0
10540461|NCT01466985|11693556|FG000|STARTED|Overall Study||6
10540462|NCT01466985|11693557|FG001|STARTED|Overall Study||6
10540463|NCT01466985|11693558|FG002|STARTED|Overall Study||6
10540464|NCT01466985|11693556|FG000|COMPLETED|Overall Study||6
10540465|NCT01466985|11693557|FG001|COMPLETED|Overall Study||6
10540466|NCT01466985|11693558|FG002|COMPLETED|Overall Study||6
10540467|NCT01466985|11693556|FG000|NOT COMPLETED|Overall Study||0
10540468|NCT01466985|11693557|FG001|NOT COMPLETED|Overall Study||0
10540469|NCT01466985|11693558|FG002|NOT COMPLETED|Overall Study||0
10540470|NCT01467037|11693569|FG000|STARTED|Overall Study||374
10540471|NCT01467037|11693569|FG000|COMPLETED|Overall Study||374
10540472|NCT01467037|11693569|FG000|NOT COMPLETED|Overall Study||0
10540473|NCT01467063|11693576|FG000|STARTED|Overall Study||6
10540474|NCT01467063|11693577|FG001|STARTED|Overall Study||7
10540475|NCT01467063|11693576|FG000|COMPLETED|Overall Study||5
10540476|NCT01467063|11693577|FG001|COMPLETED|Overall Study||7
10540477|NCT01467063|11693576|FG000|NOT COMPLETED|Overall Study||1
10384067|NCT00620659|11525805|FG000|NOT COMPLETED|Treatment Period 2||0
10540478|NCT01467063|11693577|FG001|NOT COMPLETED|Overall Study||0
10540479|NCT01467076|11693586|FG000|STARTED|Overall Study||3
10540480|NCT01467076|11693587|FG001|STARTED|Overall Study||2
10540481|NCT01467076|11693588|FG002|STARTED|Overall Study||2
10540482|NCT01467076|11693586|FG000|COMPLETED|Overall Study||2
10540483|NCT01467076|11693587|FG001|COMPLETED|Overall Study||2
10384068|NCT00620659|11525806|FG001|NOT COMPLETED|Treatment Period 2||3
10384069|NCT00620659|11525807|FG002|NOT COMPLETED|Treatment Period 2||1
10384070|NCT00620659|11525808|FG003|NOT COMPLETED|Treatment Period 2||0
10384071|NCT00620659|11525809|FG004|NOT COMPLETED|Treatment Period 2||5
10384072|NCT00620659|11525810|FG005|NOT COMPLETED|Treatment Period 2||0
10384073|NCT00620659|11525805|FG000|STARTED|Placebo Washout Period 2||18
10384074|NCT00620659|11525806|FG001|STARTED|Placebo Washout Period 2||18
10384075|NCT00620659|11525807|FG002|STARTED|Placebo Washout Period 2||19
10384076|NCT00620659|11525808|FG003|STARTED|Placebo Washout Period 2||18
10384077|NCT00620659|11525809|FG004|STARTED|Placebo Washout Period 2||15
10384078|NCT00620659|11525810|FG005|STARTED|Placebo Washout Period 2||20
10384079|NCT00620659|11525805|FG000|COMPLETED|Placebo Washout Period 2||16
10384080|NCT00620659|11525806|FG001|COMPLETED|Placebo Washout Period 2||18
10384081|NCT00620659|11525807|FG002|COMPLETED|Placebo Washout Period 2||19
10384082|NCT00620659|11525808|FG003|COMPLETED|Placebo Washout Period 2||18
10384083|NCT00620659|11525809|FG004|COMPLETED|Placebo Washout Period 2||15
10384084|NCT00620659|11525810|FG005|COMPLETED|Placebo Washout Period 2||20
10384085|NCT00620659|11525805|FG000|NOT COMPLETED|Placebo Washout Period 2||2
10384086|NCT00620659|11525806|FG001|NOT COMPLETED|Placebo Washout Period 2||0
10384087|NCT00620659|11525807|FG002|NOT COMPLETED|Placebo Washout Period 2||0
10384088|NCT00620659|11525808|FG003|NOT COMPLETED|Placebo Washout Period 2||0
10384089|NCT00620659|11525809|FG004|NOT COMPLETED|Placebo Washout Period 2||0
10384090|NCT00620659|11525810|FG005|NOT COMPLETED|Placebo Washout Period 2||0
10384091|NCT00620659|11525805|FG000|STARTED|Treatment Period 3||16
10384092|NCT00620659|11525806|FG001|STARTED|Treatment Period 3||18
10384093|NCT00620659|11525807|FG002|STARTED|Treatment Period 3||19
10384094|NCT00620659|11525808|FG003|STARTED|Treatment Period 3||18
10384095|NCT00620659|11525809|FG004|STARTED|Treatment Period 3||15
10384096|NCT00620659|11525810|FG005|STARTED|Treatment Period 3||20
10384097|NCT00620659|11525805|FG000|COMPLETED|Treatment Period 3||16
10384098|NCT00620659|11525806|FG001|COMPLETED|Treatment Period 3||16
10384099|NCT00620659|11525807|FG002|COMPLETED|Treatment Period 3||19
10384100|NCT00620659|11525808|FG003|COMPLETED|Treatment Period 3||17
10384101|NCT00620659|11525809|FG004|COMPLETED|Treatment Period 3||15
10384102|NCT00620659|11525810|FG005|COMPLETED|Treatment Period 3||20
10384103|NCT00620659|11525805|FG000|NOT COMPLETED|Treatment Period 3||0
10384104|NCT00620659|11525806|FG001|NOT COMPLETED|Treatment Period 3||2
10384105|NCT00620659|11525807|FG002|NOT COMPLETED|Treatment Period 3||0
10384106|NCT00620659|11525808|FG003|NOT COMPLETED|Treatment Period 3||1
10384107|NCT00620659|11525809|FG004|NOT COMPLETED|Treatment Period 3||0
10384108|NCT00620659|11525810|FG005|NOT COMPLETED|Treatment Period 3||0
10384109|NCT00620698|11525823|FG000|STARTED|Overall Study||89
10384110|NCT00620698|11525823|FG000|COMPLETED|Overall Study||60
10384111|NCT00620698|11525823|FG000|NOT COMPLETED|Overall Study||29
10384112|NCT00620711|11525827|FG000|STARTED|Overall Study||4
10384113|NCT00620711|11525827|FG000|COMPLETED|Overall Study||4
10384114|NCT00620711|11525827|FG000|NOT COMPLETED|Overall Study||0
10384115|NCT00620750|11525831|FG000|STARTED|Overall Study||65
10384116|NCT00620750|11525831|FG000|COMPLETED|Overall Study||40
10384117|NCT00620750|11525831|FG000|NOT COMPLETED|Overall Study||25
10384118|NCT00620763|11525835|FG000|STARTED|Period: First Intervention||10
10384119|NCT00620763|11525836|FG001|STARTED|Period: First Intervention||12
10384120|NCT00620763|11525835|FG000|COMPLETED|Period: First Intervention||10
10384121|NCT00620763|11525836|FG001|COMPLETED|Period: First Intervention||7
10384122|NCT00620763|11525835|FG000|NOT COMPLETED|Period: First Intervention||0
10384123|NCT00620763|11525836|FG001|NOT COMPLETED|Period: First Intervention||5
10384124|NCT00620763|11525835|FG000|STARTED|Period: Washout Period of 1 Week||10
10384125|NCT00620763|11525836|FG001|STARTED|Period: Washout Period of 1 Week||7
10384126|NCT00620763|11525835|FG000|COMPLETED|Period: Washout Period of 1 Week||10
10384127|NCT00620763|11525836|FG001|COMPLETED|Period: Washout Period of 1 Week||7
10384128|NCT00620763|11525835|FG000|NOT COMPLETED|Period: Washout Period of 1 Week||0
10384129|NCT00620763|11525836|FG001|NOT COMPLETED|Period: Washout Period of 1 Week||0
10384130|NCT00620763|11525835|FG000|STARTED|Period: Second Intervention||10
10384131|NCT00620763|11525836|FG001|STARTED|Period: Second Intervention||7
10384132|NCT00620763|11525835|FG000|COMPLETED|Period: Second Intervention||9
10384133|NCT00620763|11525836|FG001|COMPLETED|Period: Second Intervention||7
10384134|NCT00620763|11525835|FG000|NOT COMPLETED|Period: Second Intervention||1
10384135|NCT00620763|11525836|FG001|NOT COMPLETED|Period: Second Intervention||0
10384136|NCT00620776|11525844|FG000|STARTED|Overall Study|29 patients (of the 77 that were randomly assigned to add on CBT) consented to this option.|29
10384137|NCT00620776|11525845|FG001|STARTED|Overall Study|All 40 patients that were randomly assigned to not be offered CBT consented to this option.|40
10384138|NCT00620776|11525844|FG000|Received at Least One Session/Dose|Overall Study|26 out of 29 that consented to the combined treatment option received at least one session of CBT.|26
10384139|NCT00620776|11525845|FG001|Received at Least One Session/Dose|Overall Study|35 out of 40 that consented to receive medication alone received at least one dose of medication.|35
10384140|NCT00620776|11525844|FG000|COMPLETED|Overall Study|17 out of 26 attended the week 24 (last) assessment.|17
10384141|NCT00620776|11525845|FG001|COMPLETED|Overall Study|24 out of 35 attended the week 24 (last) assessment.|24
10384142|NCT00620776|11525844|FG000|NOT COMPLETED|Overall Study||12
10384143|NCT00620776|11525845|FG001|NOT COMPLETED|Overall Study||16
10384144|NCT00620815|11525854|FG000|STARTED|Overall Study||199
10384145|NCT00620815|11525855|FG001|STARTED|Overall Study||203
10384146|NCT00620815|11525856|FG002|STARTED|Overall Study||199
10384147|NCT00620815|11525854|FG000|COMPLETED|Overall Study||195
10384148|NCT00620815|11525855|FG001|COMPLETED|Overall Study||192
10384149|NCT00620815|11525856|FG002|COMPLETED|Overall Study||192
10384150|NCT00620815|11525854|FG000|NOT COMPLETED|Overall Study||4
10384151|NCT00620815|11525855|FG001|NOT COMPLETED|Overall Study||11
10384152|NCT00620815|11525856|FG002|NOT COMPLETED|Overall Study||7
10384153|NCT00620828|11525882|FG000|STARTED|Overall Study||32
10384154|NCT00620828|11525883|FG001|STARTED|Overall Study||35
10384155|NCT00620828|11525882|FG000|Number of Subjects Enrolled = 67|Overall Study||32
10384156|NCT00620828|11525883|FG001|Number of Subjects Enrolled = 67|Overall Study||35
10384157|NCT00620828|11525882|FG000|COMPLETED|Overall Study||32
10384158|NCT00620828|11525883|FG001|COMPLETED|Overall Study||35
10384159|NCT00620828|11525882|FG000|NOT COMPLETED|Overall Study||0
10384160|NCT00620828|11525883|FG001|NOT COMPLETED|Overall Study||0
10384161|NCT00620854|11525895|FG000|STARTED|Period 1||4
10384162|NCT00620854|11525896|FG001|STARTED|Period 1||4
10384163|NCT00620854|11525897|FG002|STARTED|Period 1||4
10384164|NCT00620854|11525898|FG003|STARTED|Period 1||4
10384165|NCT00620854|11525899|FG004|STARTED|Period 1||4
10384166|NCT00620854|11525900|FG005|STARTED|Period 1||4
10384167|NCT00620854|11525895|FG000|COMPLETED|Period 1||4
10384168|NCT00620854|11525896|FG001|COMPLETED|Period 1||4
10384169|NCT00620854|11525897|FG002|COMPLETED|Period 1||4
10384170|NCT00620854|11525898|FG003|COMPLETED|Period 1||4
10384171|NCT00620854|11525899|FG004|COMPLETED|Period 1||4
10384172|NCT00620854|11525900|FG005|COMPLETED|Period 1||4
10384173|NCT00620854|11525895|FG000|NOT COMPLETED|Period 1||0
10384174|NCT00620854|11525896|FG001|NOT COMPLETED|Period 1||0
10384175|NCT00620854|11525897|FG002|NOT COMPLETED|Period 1||0
10384176|NCT00620854|11525898|FG003|NOT COMPLETED|Period 1||0
10384177|NCT00620854|11525899|FG004|NOT COMPLETED|Period 1||0
10384178|NCT00620854|11525900|FG005|NOT COMPLETED|Period 1||0
10384179|NCT00620854|11525895|FG000|STARTED|Washout 1||4
10384180|NCT00620854|11525896|FG001|STARTED|Washout 1||4
10384181|NCT00620854|11525897|FG002|STARTED|Washout 1||4
10384182|NCT00620854|11525898|FG003|STARTED|Washout 1||4
10384183|NCT00620854|11525899|FG004|STARTED|Washout 1||4
10384184|NCT00620854|11525900|FG005|STARTED|Washout 1||4
10384185|NCT00620854|11525895|FG000|COMPLETED|Washout 1||4
10384186|NCT00620854|11525896|FG001|COMPLETED|Washout 1||4
10384187|NCT00620854|11525897|FG002|COMPLETED|Washout 1||3
10384188|NCT00620854|11525898|FG003|COMPLETED|Washout 1||3
10384189|NCT00620854|11525899|FG004|COMPLETED|Washout 1||4
10384190|NCT00620854|11525900|FG005|COMPLETED|Washout 1||4
10384191|NCT00620854|11525895|FG000|NOT COMPLETED|Washout 1||0
10384192|NCT00620854|11525896|FG001|NOT COMPLETED|Washout 1||0
10384193|NCT00620854|11525897|FG002|NOT COMPLETED|Washout 1||1
10384194|NCT00620854|11525898|FG003|NOT COMPLETED|Washout 1||1
10384195|NCT00620854|11525899|FG004|NOT COMPLETED|Washout 1||0
10384196|NCT00620854|11525900|FG005|NOT COMPLETED|Washout 1||0
10384197|NCT00620854|11525895|FG000|STARTED|Period 2||4
10384198|NCT00620854|11525896|FG001|STARTED|Period 2||4
10384199|NCT00620854|11525897|FG002|STARTED|Period 2||3
10384200|NCT00620854|11525898|FG003|STARTED|Period 2||3
10384201|NCT00620854|11525899|FG004|STARTED|Period 2||4
10384202|NCT00620854|11525900|FG005|STARTED|Period 2||4
10384203|NCT00620854|11525895|FG000|COMPLETED|Period 2||4
10384204|NCT00620854|11525896|FG001|COMPLETED|Period 2||4
10384205|NCT00620854|11525897|FG002|COMPLETED|Period 2||3
10384206|NCT00620854|11525898|FG003|COMPLETED|Period 2||3
10384207|NCT00620854|11525899|FG004|COMPLETED|Period 2||4
10384208|NCT00620854|11525900|FG005|COMPLETED|Period 2||4
10384209|NCT00620854|11525895|FG000|NOT COMPLETED|Period 2||0
10384210|NCT00620854|11525896|FG001|NOT COMPLETED|Period 2||0
10384211|NCT00620854|11525897|FG002|NOT COMPLETED|Period 2||0
10384212|NCT00620854|11525898|FG003|NOT COMPLETED|Period 2||0
10384213|NCT00620854|11525899|FG004|NOT COMPLETED|Period 2||0
10384214|NCT00620854|11525900|FG005|NOT COMPLETED|Period 2||0
10384215|NCT00620854|11525895|FG000|STARTED|Washout 2||4
10384216|NCT00620854|11525896|FG001|STARTED|Washout 2||4
10384217|NCT00620854|11525897|FG002|STARTED|Washout 2||3
10384218|NCT00620854|11525898|FG003|STARTED|Washout 2||3
10384219|NCT00620854|11525899|FG004|STARTED|Washout 2||4
10384220|NCT00620854|11525900|FG005|STARTED|Washout 2||4
10384221|NCT00620854|11525895|FG000|COMPLETED|Washout 2||4
10384222|NCT00620854|11525896|FG001|COMPLETED|Washout 2||4
10384223|NCT00620854|11525897|FG002|COMPLETED|Washout 2||3
10384224|NCT00620854|11525898|FG003|COMPLETED|Washout 2||3
10384225|NCT00620854|11525899|FG004|COMPLETED|Washout 2||4
10384226|NCT00620854|11525900|FG005|COMPLETED|Washout 2||4
10384227|NCT00620854|11525895|FG000|NOT COMPLETED|Washout 2||0
10384228|NCT00620854|11525896|FG001|NOT COMPLETED|Washout 2||0
10384229|NCT00620854|11525897|FG002|NOT COMPLETED|Washout 2||0
10384230|NCT00620854|11525898|FG003|NOT COMPLETED|Washout 2||0
10384231|NCT00620854|11525899|FG004|NOT COMPLETED|Washout 2||0
10384232|NCT00620854|11525900|FG005|NOT COMPLETED|Washout 2||0
10384233|NCT00620854|11525895|FG000|STARTED|Period 3||4
10384234|NCT00620854|11525896|FG001|STARTED|Period 3||4
10384235|NCT00620854|11525897|FG002|STARTED|Period 3||3
10384236|NCT00620854|11525898|FG003|STARTED|Period 3||3
10384237|NCT00620854|11525899|FG004|STARTED|Period 3||4
10384238|NCT00620854|11525900|FG005|STARTED|Period 3||4
10384239|NCT00620854|11525895|FG000|COMPLETED|Period 3||4
10384240|NCT00620854|11525896|FG001|COMPLETED|Period 3||4
10384241|NCT00620854|11525897|FG002|COMPLETED|Period 3||3
10384242|NCT00620854|11525898|FG003|COMPLETED|Period 3||3
10384243|NCT00620854|11525899|FG004|COMPLETED|Period 3||4
10384244|NCT00620854|11525900|FG005|COMPLETED|Period 3||4
10384245|NCT00620854|11525895|FG000|NOT COMPLETED|Period 3||0
10384246|NCT00620854|11525896|FG001|NOT COMPLETED|Period 3||0
10384247|NCT00620854|11525897|FG002|NOT COMPLETED|Period 3||0
10540484|NCT01467076|11693588|FG002|COMPLETED|Overall Study||2
10540485|NCT01467076|11693586|FG000|NOT COMPLETED|Overall Study||1
10540486|NCT01467076|11693587|FG001|NOT COMPLETED|Overall Study||0
10540487|NCT01467076|11693588|FG002|NOT COMPLETED|Overall Study||0
10540488|NCT01467271|11693596|FG000|STARTED|Overall Study||540
10540489|NCT01467271|11693596|FG000|COMPLETED|Overall Study||338
10540490|NCT01467271|11693596|FG000|NOT COMPLETED|Overall Study||202
10540491|NCT01467427|11693602|FG000|STARTED|Overall Study||12
10540492|NCT01467427|11693603|FG001|STARTED|Overall Study||13
10540493|NCT01467427|11693602|FG000|Completed Main Phase|Overall Study||11
10540494|NCT01467427|11693603|FG001|Completed Main Phase|Overall Study||13
10540495|NCT01467427|11693602|FG000|COMPLETED|Overall Study||0
10540496|NCT01467427|11693603|FG001|COMPLETED|Overall Study||0
10540497|NCT01467427|11693602|FG000|NOT COMPLETED|Overall Study||12
10540498|NCT01467427|11693603|FG001|NOT COMPLETED|Overall Study||13
10540511|NCT01467479|11693629|FG000|STARTED|Overall Study||55
10540512|NCT01467479|11693630|FG001|STARTED|Overall Study||69
10540513|NCT01467479|11693631|FG002|STARTED|Overall Study||61
10540514|NCT01467479|11693629|FG000|Treated|Overall Study||54
10540515|NCT01467479|11693630|FG001|Treated|Overall Study||69
10540516|NCT01467479|11693631|FG002|Treated|Overall Study||59
10540517|NCT01467479|11693629|FG000|COMPLETED|Overall Study||46
10540518|NCT01467479|11693630|FG001|COMPLETED|Overall Study||52
10540519|NCT01467479|11693631|FG002|COMPLETED|Overall Study||45
10540520|NCT01467479|11693629|FG000|NOT COMPLETED|Overall Study||9
10540521|NCT01467479|11693630|FG001|NOT COMPLETED|Overall Study||17
10540522|NCT01467479|11693631|FG002|NOT COMPLETED|Overall Study||16
10540523|NCT01467492|11693642|FG000|STARTED|Overall Study||83
10540524|NCT01467492|11693643|FG001|STARTED|Overall Study||38
10540525|NCT01467492|11693642|FG000|COMPLETED|Overall Study||61
10540526|NCT01467492|11693643|FG001|COMPLETED|Overall Study||25
10540527|NCT01467492|11693642|FG000|NOT COMPLETED|Overall Study||22
10540528|NCT01467492|11693643|FG001|NOT COMPLETED|Overall Study||13
10540529|NCT01467505|11693652|FG000|STARTED|Overall Study||51
10540530|NCT01467505|11693653|FG001|STARTED|Overall Study||10
10540531|NCT01467505|11693652|FG000|COMPLETED|Overall Study||18
10540532|NCT01467505|11693653|FG001|COMPLETED|Overall Study||7
10540533|NCT01467505|11693652|FG000|NOT COMPLETED|Overall Study||33
10540534|NCT01467505|11693653|FG001|NOT COMPLETED|Overall Study||3
10540535|NCT01467557|11693661|FG000|STARTED|Overall Study||601
10540536|NCT01467557|11693662|FG001|STARTED|Overall Study||570
10540537|NCT01467557|11693661|FG000|2 Week Survey Completed|Overall Study||551
10540538|NCT01467557|11693662|FG001|2 Week Survey Completed|Overall Study||522
10540539|NCT01467557|11693661|FG000|4 Month Survey Completed|Overall Study||533
10540540|NCT01467557|11693662|FG001|4 Month Survey Completed|Overall Study||493
10540541|NCT01467557|11693661|FG000|12 Month Survey Completed|Overall Study||502
10540542|NCT01467557|11693662|FG001|12 Month Survey Completed|Overall Study||463
10540543|NCT01467557|11693661|FG000|COMPLETED|Overall Study||502
10540544|NCT01467557|11693662|FG001|COMPLETED|Overall Study||463
10540545|NCT01467557|11693661|FG000|NOT COMPLETED|Overall Study||99
10540546|NCT01467557|11693662|FG001|NOT COMPLETED|Overall Study||107
10540547|NCT01467570|11693670|FG000|STARTED|Overall Study||75
10540548|NCT01467570|11693671|FG001|STARTED|Overall Study||72
10540549|NCT01467570|11693670|FG000|COMPLETED|Overall Study||67
10540550|NCT01467570|11693671|FG001|COMPLETED|Overall Study||63
10540551|NCT01467570|11693670|FG000|NOT COMPLETED|Overall Study||8
10540552|NCT01467570|11693671|FG001|NOT COMPLETED|Overall Study||9
10540553|NCT01467583|11693682|FG000|STARTED|Overall Study||16
10540554|NCT01467583|11693683|FG001|STARTED|Overall Study||4
10384248|NCT00620854|11525898|FG003|NOT COMPLETED|Period 3||0
10540555|NCT01467583|11693684|FG002|STARTED|Overall Study||12
10540556|NCT01467583|11693682|FG000|COMPLETED|Overall Study|Both patients completed > 1 dose and so their data was included in the results.|14
10540557|NCT01467583|11693683|FG001|COMPLETED|Overall Study|Death unrelated to study drug on day #3. Data to that point is included in the results|3
10540558|NCT01467583|11693684|FG002|COMPLETED|Overall Study||10
10540559|NCT01467583|11693682|FG000|NOT COMPLETED|Overall Study||2
10540560|NCT01467583|11693683|FG001|NOT COMPLETED|Overall Study||1
10540561|NCT01467583|11693684|FG002|NOT COMPLETED|Overall Study||2
10540562|NCT01467661|11693695|FG000|STARTED|Overall Study||53
10540563|NCT01467661|11693695|FG000|Completed SPD422-308 (NCT01214915)|Overall Study||42
10540564|NCT01467661|11693695|FG000|Started SPD422-309 (NCT01467661)|Overall Study||41
10540565|NCT01467661|11693695|FG000|Started Post Marketing Trial|Overall Study||33
10540566|NCT01467661|11693695|FG000|COMPLETED|Overall Study||32
10540567|NCT01467661|11693695|FG000|NOT COMPLETED|Overall Study||21
10540568|NCT01467700|11693705|FG000|STARTED|Overall Study||115
10540569|NCT01467700|11693706|FG001|STARTED|Overall Study||128
10540570|NCT01467700|11693707|FG002|STARTED|Overall Study||124
10540571|NCT01467700|11693708|FG003|STARTED|Overall Study||123
10384249|NCT00620854|11525899|FG004|NOT COMPLETED|Period 3||0
10384250|NCT00620854|11525900|FG005|NOT COMPLETED|Period 3||0
10384251|NCT00620945|11525911|FG000|STARTED|Overall Study|Total number in the study|87
10384252|NCT00620945|11525911|FG000|COMPLETED|Overall Study||87
10384253|NCT00620945|11525911|FG000|NOT COMPLETED|Overall Study||0
10428188|NCT00856856|11574174|FG000|STARTED|4-year Clinical Follow-up||100
10428189|NCT00856856|11574174|FG000|COMPLETED|4-year Clinical Follow-up||99
10428190|NCT00856856|11574174|FG000|NOT COMPLETED|4-year Clinical Follow-up||1
10428191|NCT00856856|11574174|FG000|STARTED|5-year Clinical Follow-up||100
10428192|NCT00856856|11574174|FG000|COMPLETED|5-year Clinical Follow-up|One patient missed the 4-year clinical follow-up but returned at 5 year.|100
10428193|NCT00856856|11574174|FG000|NOT COMPLETED|5-year Clinical Follow-up||0
10428194|NCT00856908|11574185|FG000|STARTED|Overall Study||15
10428195|NCT00856908|11574186|FG001|STARTED|Overall Study||5
10428196|NCT00856908|11574185|FG000|COMPLETED|Overall Study||14
10428197|NCT00856908|11574186|FG001|COMPLETED|Overall Study||5
10428198|NCT00856908|11574185|FG000|NOT COMPLETED|Overall Study||1
10428199|NCT00856908|11574186|FG001|NOT COMPLETED|Overall Study||0
10428200|NCT00856973|11574195|FG000|STARTED|Overall Study||162
10428201|NCT00856973|11574196|FG001|STARTED|Overall Study||163
10428202|NCT00856973|11574197|FG002|STARTED|Overall Study||161
10428203|NCT00856973|11574195|FG000|COMPLETED|Overall Study||126
10428204|NCT00856973|11574196|FG001|COMPLETED|Overall Study||122
10428205|NCT00856973|11574197|FG002|COMPLETED|Overall Study||123
10428206|NCT00856973|11574195|FG000|NOT COMPLETED|Overall Study||36
10428207|NCT00856973|11574196|FG001|NOT COMPLETED|Overall Study||41
10428208|NCT00856973|11574197|FG002|NOT COMPLETED|Overall Study||38
10428209|NCT00856986|11574214|FG000|STARTED|Run-in Period, Weeks -12-0||161
10428210|NCT00856986|11574215|FG001|STARTED|Run-in Period, Weeks -12-0||162
10428211|NCT00856986|11574216|FG002|STARTED|Run-in Period, Weeks -12-0||498
10428212|NCT00856986|11574217|FG003|STARTED|Run-in Period, Weeks -12-0||167
10428213|NCT00856986|11574218|FG004|STARTED|Run-in Period, Weeks -12-0||0
10428214|NCT00856986|11574214|FG000|COMPLETED|Run-in Period, Weeks -12-0||161
10428215|NCT00856986|11574215|FG001|COMPLETED|Run-in Period, Weeks -12-0||162
10428216|NCT00856986|11574216|FG002|COMPLETED|Run-in Period, Weeks -12-0||498
10428217|NCT00856986|11574217|FG003|COMPLETED|Run-in Period, Weeks -12-0|Subjects who withdrew during run-in and before randomisation were Early Withdrawals|0
10428218|NCT00856986|11574218|FG004|COMPLETED|Run-in Period, Weeks -12-0||0
10428219|NCT00856986|11574214|FG000|NOT COMPLETED|Run-in Period, Weeks -12-0||0
10428220|NCT00856986|11574215|FG001|NOT COMPLETED|Run-in Period, Weeks -12-0||0
10428221|NCT00856986|11574216|FG002|NOT COMPLETED|Run-in Period, Weeks -12-0||0
10428222|NCT00856986|11574217|FG003|NOT COMPLETED|Run-in Period, Weeks -12-0||167
10428223|NCT00856986|11574218|FG004|NOT COMPLETED|Run-in Period, Weeks -12-0||0
10428224|NCT00856986|11574214|FG000|STARTED|Main Period, Weeks 0-26||161
10428225|NCT00856986|11574215|FG001|STARTED|Main Period, Weeks 0-26||162
10428226|NCT00856986|11574216|FG002|STARTED|Main Period, Weeks 0-26||498
10428227|NCT00856986|11574217|FG003|STARTED|Main Period, Weeks 0-26||0
10428228|NCT00856986|11574218|FG004|STARTED|Main Period, Weeks 0-26||0
10428229|NCT00856986|11574214|FG000|COMPLETED|Main Period, Weeks 0-26||127
10428230|NCT00856986|11574215|FG001|COMPLETED|Main Period, Weeks 0-26||144
10428231|NCT00856986|11574216|FG002|COMPLETED|Main Period, Weeks 0-26||470
10428232|NCT00856986|11574217|FG003|COMPLETED|Main Period, Weeks 0-26||0
10428233|NCT00856986|11574218|FG004|COMPLETED|Main Period, Weeks 0-26||0
10428234|NCT00856986|11574214|FG000|NOT COMPLETED|Main Period, Weeks 0-26||34
10428235|NCT00856986|11574215|FG001|NOT COMPLETED|Main Period, Weeks 0-26||18
10428236|NCT00856986|11574216|FG002|NOT COMPLETED|Main Period, Weeks 0-26||28
10428237|NCT00856986|11574217|FG003|NOT COMPLETED|Main Period, Weeks 0-26||0
10428238|NCT00856986|11574218|FG004|NOT COMPLETED|Main Period, Weeks 0-26||0
10428239|NCT00856986|11574214|FG000|STARTED|Extension Period, Weeks 26-52|Subjects with HbA1c ≥8.0% who accepted intensification with detemir = 17 (Intensified Group)|127
10428240|NCT00856986|11574215|FG001|STARTED|Extension Period, Weeks 26-52||144
10428241|NCT00856986|11574216|FG002|STARTED|Extension Period, Weeks 26-52|Subjects with HbA1c ≥8.0% who accepted intensification with detemir = 7 (Intensified Group)|470
10428242|NCT00856986|11574217|FG003|STARTED|Extension Period, Weeks 26-52||0
10428243|NCT00856986|11574218|FG004|STARTED|Extension Period, Weeks 26-52||0
10428244|NCT00856986|11574214|FG000|Enrolled in Extension|Extension Period, Weeks 26-52||122
10428245|NCT00856986|11574215|FG001|Enrolled in Extension|Extension Period, Weeks 26-52||140
10428246|NCT00856986|11574216|FG002|Enrolled in Extension|Extension Period, Weeks 26-52||461
10428247|NCT00856986|11574217|FG003|Enrolled in Extension|Extension Period, Weeks 26-52||0
10428248|NCT00856986|11574218|FG004|Enrolled in Extension|Extension Period, Weeks 26-52||0
10428249|NCT00856986|11574214|FG000|COMPLETED|Extension Period, Weeks 26-52||108
10428250|NCT00856986|11574215|FG001|COMPLETED|Extension Period, Weeks 26-52||130
10428251|NCT00856986|11574216|FG002|COMPLETED|Extension Period, Weeks 26-52||432
10428252|NCT00856986|11574217|FG003|COMPLETED|Extension Period, Weeks 26-52||0
10428253|NCT00856986|11574218|FG004|COMPLETED|Extension Period, Weeks 26-52||0
10428254|NCT00856986|11574214|FG000|NOT COMPLETED|Extension Period, Weeks 26-52||19
10428255|NCT00856986|11574215|FG001|NOT COMPLETED|Extension Period, Weeks 26-52||14
10428256|NCT00856986|11574216|FG002|NOT COMPLETED|Extension Period, Weeks 26-52||38
10428257|NCT00856986|11574217|FG003|NOT COMPLETED|Extension Period, Weeks 26-52||0
10428258|NCT00856986|11574218|FG004|NOT COMPLETED|Extension Period, Weeks 26-52||0
10428259|NCT00856999|11574230|FG000|STARTED|Overall Study||50
10428260|NCT00856999|11574230|FG000|COMPLETED|Overall Study||45
10428261|NCT00856999|11574230|FG000|NOT COMPLETED|Overall Study||5
10428262|NCT00857207|11574237|FG000|STARTED|Overall Study||48
10384254|NCT00621023|11525915|FG000|STARTED|Overall Study||6
10384255|NCT00621023|11525915|FG000|COMPLETED|Overall Study|Completed is defined as 5 years of follow up.|0
10384256|NCT00621023|11525915|FG000|NOT COMPLETED|Overall Study||6
10384257|NCT00621049|11525921|FG000|STARTED|Adjuvant Treatment||55
10384258|NCT00621049|11525922|FG001|STARTED|Adjuvant Treatment||57
10384259|NCT00621049|11525921|FG000|COMPLETED|Adjuvant Treatment||52
10384260|NCT00621049|11525922|FG001|COMPLETED|Adjuvant Treatment||47
10384261|NCT00621049|11525921|FG000|NOT COMPLETED|Adjuvant Treatment||3
10384262|NCT00621049|11525922|FG001|NOT COMPLETED|Adjuvant Treatment||10
10384263|NCT00621049|11525921|FG000|STARTED|Maintenance Treatment|3 patients came off study between the end of adjuvant therapy and the start of maintenance|49
10384264|NCT00621049|11525922|FG001|STARTED|Maintenance Treatment|Per protocol, only the Docetaxel/Carboplatin/Bevacizumab/Erlotinib arm enters maintenance therapy|0
10384265|NCT00621049|11525921|FG000|COMPLETED|Maintenance Treatment||34
10384266|NCT00621049|11525922|FG001|COMPLETED|Maintenance Treatment||0
10384267|NCT00621049|11525921|FG000|NOT COMPLETED|Maintenance Treatment||15
10384268|NCT00621049|11525922|FG001|NOT COMPLETED|Maintenance Treatment||0
10384269|NCT00621140|11525930|FG000|STARTED|Overall Study|number who started treatment|167
10384270|NCT00621140|11525931|FG001|STARTED|Overall Study|number who started treatment|336
10384271|NCT00621140|11525930|FG000|COMPLETED|Overall Study|number who completed treatment|152
10384272|NCT00621140|11525931|FG001|COMPLETED|Overall Study|number who completed treatment|318
10384273|NCT00621140|11525930|FG000|NOT COMPLETED|Overall Study||15
10384274|NCT00621140|11525931|FG001|NOT COMPLETED|Overall Study||18
10384275|NCT00621153|11525939|FG000|STARTED|Overall Study|randomised|117
10384276|NCT00621153|11525940|FG001|STARTED|Overall Study|randomised|116
10384277|NCT00621153|11525939|FG000|Discontinued|Overall Study||20
10384278|NCT00621153|11525940|FG001|Discontinued|Overall Study||15
10384279|NCT00621153|11525939|FG000|COMPLETED|Overall Study|completed|97
10384280|NCT00621153|11525940|FG001|COMPLETED|Overall Study|completed|101
10384281|NCT00621153|11525939|FG000|NOT COMPLETED|Overall Study||20
10384282|NCT00621153|11525940|FG001|NOT COMPLETED|Overall Study||15
10384283|NCT00621179|11525950|FG000|STARTED|Overall Study||12
10384284|NCT00621179|11525951|FG001|STARTED|Overall Study||8
10384285|NCT00621179|11525952|FG002|STARTED|Overall Study||7
10384286|NCT00621179|11525953|FG003|STARTED|Overall Study||10
10384287|NCT00621179|11525950|FG000|COMPLETED|Overall Study||12
10384288|NCT00621179|11525951|FG001|COMPLETED|Overall Study||8
10384289|NCT00621179|11525952|FG002|COMPLETED|Overall Study||6
10384290|NCT00621179|11525953|FG003|COMPLETED|Overall Study||9
10384291|NCT00621179|11525950|FG000|NOT COMPLETED|Overall Study||0
10384292|NCT00621179|11525951|FG001|NOT COMPLETED|Overall Study||0
10384293|NCT00621179|11525952|FG002|NOT COMPLETED|Overall Study||1
10384294|NCT00621179|11525953|FG003|NOT COMPLETED|Overall Study||1
10384295|NCT00621192|11525967|FG000|STARTED|Overall Study||39
10384296|NCT00621192|11525968|FG001|STARTED|Overall Study||103
10384297|NCT00621192|11525969|FG002|STARTED|Overall Study||31
10384298|NCT00621192|11525970|FG003|STARTED|Overall Study||27
10384299|NCT00621192|11525967|FG000|Safety Population|Overall Study||39
10384300|NCT00621192|11525968|FG001|Safety Population|Overall Study||103
10384301|NCT00621192|11525969|FG002|Safety Population|Overall Study||31
10384302|NCT00621192|11525970|FG003|Safety Population|Overall Study||27
10384303|NCT00621192|11525967|FG000|Efficacy Population|Overall Study||39
10384304|NCT00621192|11525968|FG001|Efficacy Population|Overall Study||101
10384305|NCT00621192|11525969|FG002|Efficacy Population|Overall Study||28
10384306|NCT00621192|11525970|FG003|Efficacy Population|Overall Study||27
10384307|NCT00621192|11525967|FG000|COMPLETED|Overall Study||35
10384308|NCT00621192|11525968|FG001|COMPLETED|Overall Study||94
10384309|NCT00621192|11525969|FG002|COMPLETED|Overall Study||26
10384310|NCT00621192|11525970|FG003|COMPLETED|Overall Study||24
10384311|NCT00621192|11525967|FG000|NOT COMPLETED|Overall Study||4
10384312|NCT00621192|11525968|FG001|NOT COMPLETED|Overall Study||9
10384313|NCT00621192|11525969|FG002|NOT COMPLETED|Overall Study||5
10384314|NCT00621192|11525970|FG003|NOT COMPLETED|Overall Study||3
10384315|NCT00621244|11525984|FG000|STARTED|Overall Study||86
10384316|NCT00621244|11525985|FG001|STARTED|Overall Study||34
10384317|NCT00621244|11525986|FG002|STARTED|Overall Study||33
10384318|NCT00621244|11525987|FG003|STARTED|Overall Study||23
10384319|NCT00621244|11525984|FG000|COMPLETED|Overall Study||0
10384320|NCT00621244|11525985|FG001|COMPLETED|Overall Study||0
10384321|NCT00621244|11525986|FG002|COMPLETED|Overall Study||0
10384322|NCT00621244|11525987|FG003|COMPLETED|Overall Study||0
10384323|NCT00621244|11525984|FG000|NOT COMPLETED|Overall Study||86
10384324|NCT00621244|11525985|FG001|NOT COMPLETED|Overall Study||34
10384325|NCT00621244|11525986|FG002|NOT COMPLETED|Overall Study||33
10384326|NCT00621244|11525987|FG003|NOT COMPLETED|Overall Study||23
10384327|NCT00621257|11526066|FG000|STARTED|Overall Study||24
10384328|NCT00621257|11526067|FG001|STARTED|Overall Study||24
10384329|NCT00621257|11526068|FG002|STARTED|Overall Study||23
10384330|NCT00621257|11526069|FG003|STARTED|Overall Study||32
10384331|NCT00621257|11526070|FG004|STARTED|Overall Study||31
10384332|NCT00621257|11526066|FG000|COMPLETED|Overall Study||20
10384333|NCT00621257|11526067|FG001|COMPLETED|Overall Study||21
10384334|NCT00621257|11526068|FG002|COMPLETED|Overall Study||20
10384335|NCT00621257|11526069|FG003|COMPLETED|Overall Study||26
10384336|NCT00621257|11526070|FG004|COMPLETED|Overall Study||22
10384337|NCT00621257|11526066|FG000|NOT COMPLETED|Overall Study||4
10384338|NCT00621257|11526067|FG001|NOT COMPLETED|Overall Study||3
10384339|NCT00621257|11526068|FG002|NOT COMPLETED|Overall Study||3
10384340|NCT00621257|11526069|FG003|NOT COMPLETED|Overall Study||6
10384341|NCT00621257|11526070|FG004|NOT COMPLETED|Overall Study||9
10384342|NCT00621296|11526082|FG000|STARTED|Overall Study||15
10384343|NCT00621296|11526082|FG000|COMPLETED|Overall Study||1
10384344|NCT00621296|11526082|FG000|NOT COMPLETED|Overall Study||14
10384345|NCT00621309|11526086|FG000|STARTED|Overall Study||6
10384346|NCT00621309|11526087|FG001|STARTED|Overall Study||4
10384347|NCT00621309|11526088|FG002|STARTED|Overall Study||5
10718047|NCT02703324|11882028|FG002|COMPLETED|Period Three||4
10718048|NCT02703324|11882029|FG003|COMPLETED|Period Three||5
10718049|NCT02703324|11882030|FG004|COMPLETED|Period Three||5
10718050|NCT02703324|11882031|FG005|COMPLETED|Period Three||5
10718051|NCT02703324|11882026|FG000|NOT COMPLETED|Period Three||0
10718052|NCT02703324|11882027|FG001|NOT COMPLETED|Period Three||0
10718053|NCT02703324|11882028|FG002|NOT COMPLETED|Period Three||0
10718054|NCT02703324|11882029|FG003|NOT COMPLETED|Period Three||0
10718055|NCT02703324|11882030|FG004|NOT COMPLETED|Period Three||0
10384348|NCT00621309|11526089|FG003|STARTED|Overall Study||6
10384349|NCT00621309|11526090|FG004|STARTED|Overall Study||4
10384350|NCT00621309|11526091|FG005|STARTED|Overall Study||4
10384351|NCT00621309|11526086|FG000|COMPLETED|Overall Study||4
10384352|NCT00621309|11526087|FG001|COMPLETED|Overall Study||4
10384353|NCT00621309|11526088|FG002|COMPLETED|Overall Study||4
10718056|NCT02703324|11882031|FG005|NOT COMPLETED|Period Three||0
10384354|NCT00621309|11526089|FG003|COMPLETED|Overall Study||5
10384355|NCT00621309|11526090|FG004|COMPLETED|Overall Study||3
10384356|NCT00621309|11526091|FG005|COMPLETED|Overall Study||3
10384357|NCT00621309|11526086|FG000|NOT COMPLETED|Overall Study||2
10384358|NCT00621309|11526087|FG001|NOT COMPLETED|Overall Study||0
10384359|NCT00621309|11526088|FG002|NOT COMPLETED|Overall Study||1
10384360|NCT00621309|11526089|FG003|NOT COMPLETED|Overall Study||1
10384361|NCT00621309|11526090|FG004|NOT COMPLETED|Overall Study||1
10384362|NCT00621309|11526091|FG005|NOT COMPLETED|Overall Study||1
10384363|NCT00621322|11526103|FG000|STARTED|Overall Study||10
10384364|NCT00621322|11526104|FG001|STARTED|Overall Study||10
10384365|NCT00621322|11526105|FG002|STARTED|Overall Study||40
10384366|NCT00621322|11526106|FG003|STARTED|Overall Study||40
10384367|NCT00621322|11526107|FG004|STARTED|Overall Study||40
10384368|NCT00621322|11526108|FG005|STARTED|Overall Study||40
10384369|NCT00621322|11526103|FG000|COMPLETED|Overall Study||9
10384370|NCT00621322|11526104|FG001|COMPLETED|Overall Study||10
10384371|NCT00621322|11526105|FG002|COMPLETED|Overall Study||38
10384372|NCT00621322|11526106|FG003|COMPLETED|Overall Study||37
10384373|NCT00621322|11526107|FG004|COMPLETED|Overall Study||39
10384374|NCT00621322|11526108|FG005|COMPLETED|Overall Study||36
10384375|NCT00621322|11526103|FG000|NOT COMPLETED|Overall Study||1
10384376|NCT00621322|11526104|FG001|NOT COMPLETED|Overall Study||0
10384377|NCT00621322|11526105|FG002|NOT COMPLETED|Overall Study||2
10384378|NCT00621322|11526106|FG003|NOT COMPLETED|Overall Study||3
10384379|NCT00621322|11526107|FG004|NOT COMPLETED|Overall Study||1
10384380|NCT00621322|11526108|FG005|NOT COMPLETED|Overall Study||4
10384381|NCT00621348|11526125|FG000|STARTED|Overall Study||58
10384382|NCT00621348|11526126|FG001|STARTED|Overall Study||53
10384383|NCT00621348|11526127|FG002|STARTED|Overall Study||56
10384384|NCT00621348|11526125|FG000|COMPLETED|Overall Study||58
10384385|NCT00621348|11526126|FG001|COMPLETED|Overall Study||53
10384386|NCT00621348|11526127|FG002|COMPLETED|Overall Study||56
10658204|NCT02231177|11819345|FG005|STARTED|Treatment Period 3 (21 Days)||9
10658205|NCT02231177|11819340|FG000|COMPLETED|Treatment Period 3 (21 Days)||8
10658206|NCT02231177|11819341|FG001|COMPLETED|Treatment Period 3 (21 Days)||7
10658207|NCT02231177|11819342|FG002|COMPLETED|Treatment Period 3 (21 Days)||8
10658208|NCT02231177|11819343|FG003|COMPLETED|Treatment Period 3 (21 Days)||7
10718057|NCT02703324|11882026|FG000|STARTED|Period Four||5
10718058|NCT02703324|11882027|FG001|STARTED|Period Four|One participant discontinued after Period 3. Did not enter Period 4.|4
10718059|NCT02703324|11882028|FG002|STARTED|Period Four||4
10384387|NCT00621348|11526125|FG000|NOT COMPLETED|Overall Study||0
10384388|NCT00621348|11526126|FG001|NOT COMPLETED|Overall Study||0
10384389|NCT00621348|11526127|FG002|NOT COMPLETED|Overall Study||0
10658209|NCT02231177|11819344|FG004|COMPLETED|Treatment Period 3 (21 Days)||8
10384390|NCT00621504|11526137|FG000|STARTED|Overall Study||299
10384391|NCT00621504|11526138|FG001|STARTED|Overall Study||307
10384392|NCT00621504|11526137|FG000|COMPLETED|Overall Study||273
10384393|NCT00621504|11526138|FG001|COMPLETED|Overall Study||282
10384394|NCT00621504|11526137|FG000|NOT COMPLETED|Overall Study||26
10384395|NCT00621504|11526138|FG001|NOT COMPLETED|Overall Study||25
10384396|NCT00621517|11526146|FG000|STARTED|Overall Study||29
10384397|NCT00621517|11526147|FG001|STARTED|Overall Study||31
10384398|NCT00621517|11526146|FG000|COMPLETED|Overall Study||22
10384399|NCT00621517|11526147|FG001|COMPLETED|Overall Study||24
10384400|NCT00621517|11526146|FG000|NOT COMPLETED|Overall Study||7
10384401|NCT00621517|11526147|FG001|NOT COMPLETED|Overall Study||7
10384402|NCT00621530|11526155|FG000|STARTED|Overall Study||30
10384403|NCT00621530|11526156|FG001|STARTED|Overall Study||32
10384404|NCT00621530|11526155|FG000|COMPLETED|Overall Study||28
10384405|NCT00621530|11526156|FG001|COMPLETED|Overall Study||29
10384406|NCT00621530|11526155|FG000|NOT COMPLETED|Overall Study||2
10384407|NCT00621530|11526156|FG001|NOT COMPLETED|Overall Study||3
10384408|NCT00621543|11526165|FG000|STARTED|Overall Study||120
10384409|NCT00621543|11526165|FG000|COMPLETED|Overall Study||97
10384410|NCT00621543|11526165|FG000|NOT COMPLETED|Overall Study||23
10384411|NCT00621582|11526169|FG000|STARTED|Overall Study||4918
10384412|NCT00621582|11526169|FG000|COMPLETED|Overall Study||4812
10384413|NCT00621582|11526169|FG000|NOT COMPLETED|Overall Study||106
10384414|NCT00621621|11526176|FG000|STARTED|Overall Study|Date of Post- Approval Study protocol approval|105
10384415|NCT00621621|11526177|FG001|STARTED|Overall Study||705
10384416|NCT00621621|11526176|FG000|COMPLETED|Overall Study|Treated with the experimental catheter|75
10384417|NCT00621621|11526177|FG001|COMPLETED|Overall Study||705
10384418|NCT00621621|11526176|FG000|NOT COMPLETED|Overall Study||30
10384419|NCT00621621|11526177|FG001|NOT COMPLETED|Overall Study||0
10384420|NCT00621686|11526187|FG000|STARTED|Overall Study||19
10384421|NCT00621686|11526188|FG001|STARTED|Overall Study||35
10384422|NCT00621686|11526187|FG000|COMPLETED|Overall Study||19
10384423|NCT00621686|11526188|FG001|COMPLETED|Overall Study||35
10384424|NCT00621686|11526187|FG000|NOT COMPLETED|Overall Study||0
10384425|NCT00621686|11526188|FG001|NOT COMPLETED|Overall Study||0
10384426|NCT00621764|11526199|FG000|STARTED|Overall Study||50
10384427|NCT00621764|11526200|FG001|STARTED|Overall Study||50
10384428|NCT00621764|11526201|FG002|STARTED|Overall Study||101
10384429|NCT00621764|11526202|FG003|STARTED|Overall Study||99
10384430|NCT00621764|11526199|FG000|COMPLETED|Overall Study||50
10384431|NCT00621764|11526200|FG001|COMPLETED|Overall Study||50
10384432|NCT00621764|11526201|FG002|COMPLETED|Overall Study||101
10384433|NCT00621764|11526202|FG003|COMPLETED|Overall Study||98
10384434|NCT00621764|11526199|FG000|NOT COMPLETED|Overall Study||0
10384435|NCT00621764|11526200|FG001|NOT COMPLETED|Overall Study||0
10384436|NCT00621764|11526201|FG002|NOT COMPLETED|Overall Study||0
10384437|NCT00621764|11526202|FG003|NOT COMPLETED|Overall Study||1
10384438|NCT00621777|11526215|FG000|STARTED|Open Phase||203
10384439|NCT00621777|11526216|FG001|STARTED|Open Phase|During this open label phase, all study participants received varenicline|0
10384440|NCT00621777|11526215|FG000|COMPLETED|Open Phase||87
10384441|NCT00621777|11526216|FG001|COMPLETED|Open Phase||0
10384442|NCT00621777|11526215|FG000|NOT COMPLETED|Open Phase||116
10384443|NCT00621777|11526216|FG001|NOT COMPLETED|Open Phase||0
10384444|NCT00621777|11526215|FG000|STARTED|Randomized Phase|87 open phase participants were continuously abstinent for at least 14 days and were randomized|40
10384445|NCT00621777|11526216|FG001|STARTED|Randomized Phase||47
10384446|NCT00621777|11526215|FG000|COMPLETED|Randomized Phase||33
10384447|NCT00621777|11526216|FG001|COMPLETED|Randomized Phase||28
10384448|NCT00621777|11526215|FG000|NOT COMPLETED|Randomized Phase||7
10384449|NCT00621777|11526216|FG001|NOT COMPLETED|Randomized Phase||19
10384450|NCT00621842|11526224|FG000|STARTED|Overall Study||57
10384451|NCT00621842|11526224|FG000|COMPLETED|Overall Study||38
10384452|NCT00621842|11526224|FG000|NOT COMPLETED|Overall Study||19
10384453|NCT00621855|11526233|FG000|STARTED|Overall Study|Started means randomised to treatment|372
10384454|NCT00621855|11526234|FG001|STARTED|Overall Study|Started means randomised to treatment|371
10384455|NCT00621855|11526235|FG002|STARTED|Overall Study|Started means randomised to treatment|411
10384456|NCT00621855|11526236|FG003|STARTED|Overall Study|Started means randomised to treatment|351
10384457|NCT00621855|11526237|FG004|STARTED|Overall Study|Started means randomised to treatment|373
10384458|NCT00621855|11526233|FG000|COMPLETED|Overall Study|Completed means completed treatment|296
10384459|NCT00621855|11526234|FG001|COMPLETED|Overall Study|Completed means completed treatment|310
10384460|NCT00621855|11526235|FG002|COMPLETED|Overall Study|Completed means completed treatment|330
10540627|NCT01467960|11693769|FG000|NOT COMPLETED|Overall Study||0
10384461|NCT00621855|11526236|FG003|COMPLETED|Overall Study|Completed means completed treatment|284
10384462|NCT00621855|11526237|FG004|COMPLETED|Overall Study|Completed means completed treatment|318
10384463|NCT00621855|11526233|FG000|NOT COMPLETED|Overall Study||76
10384464|NCT00621855|11526234|FG001|NOT COMPLETED|Overall Study||61
10384465|NCT00621855|11526235|FG002|NOT COMPLETED|Overall Study||81
10384466|NCT00621855|11526236|FG003|NOT COMPLETED|Overall Study||67
10384467|NCT00621855|11526237|FG004|NOT COMPLETED|Overall Study||55
10384468|NCT00621933|11526249|FG000|STARTED|Overall Study||399
10384469|NCT00621933|11526249|FG000|COMPLETED|Overall Study||399
10384470|NCT00621933|11526249|FG000|NOT COMPLETED|Overall Study||0
10384471|NCT00621946|11526255|FG000|STARTED|Overall Study||13
10384472|NCT00621946|11526256|FG001|STARTED|Overall Study||13
10384473|NCT00621946|11526255|FG000|COMPLETED|Overall Study||13
10384474|NCT00621946|11526256|FG001|COMPLETED|Overall Study||12
10384475|NCT00621946|11526255|FG000|NOT COMPLETED|Overall Study||0
10384476|NCT00621946|11526256|FG001|NOT COMPLETED|Overall Study||1
10384477|NCT00621959|11526265|FG000|STARTED|Overall Study|In all 791 subjects have been screened and 596 have been randomized|295
10384478|NCT00621959|11526266|FG001|STARTED|Overall Study||301
10384479|NCT00621959|11526265|FG000|COMPLETED|Overall Study||288
10384480|NCT00621959|11526266|FG001|COMPLETED|Overall Study||292
10384481|NCT00621959|11526265|FG000|NOT COMPLETED|Overall Study||7
10384482|NCT00621959|11526266|FG001|NOT COMPLETED|Overall Study||9
10384483|NCT00621985|11526272|FG000|STARTED|Hydrocortisone Admission||5
10384484|NCT00621985|11526272|FG000|COMPLETED|Hydrocortisone Admission||5
10384485|NCT00621985|11526272|FG000|NOT COMPLETED|Hydrocortisone Admission||0
10384486|NCT00621985|11526272|FG000|STARTED|Dexamethasone Admission||5
10384487|NCT00621985|11526272|FG000|COMPLETED|Dexamethasone Admission||4
10384488|NCT00621985|11526272|FG000|NOT COMPLETED|Dexamethasone Admission||1
10384489|NCT00622180|11526278|FG000|STARTED|Overall Study||6
10384490|NCT00622180|11526279|FG001|STARTED|Overall Study||7
10384491|NCT00622180|11526278|FG000|COMPLETED|Overall Study||5
10384492|NCT00622180|11526279|FG001|COMPLETED|Overall Study||5
10384493|NCT00622180|11526278|FG000|NOT COMPLETED|Overall Study||1
10384494|NCT00622180|11526279|FG001|NOT COMPLETED|Overall Study||2
10540572|NCT01467700|11693705|FG000|Safety Set - Received Treatment|Overall Study||115
10540573|NCT01467700|11693706|FG001|Safety Set - Received Treatment|Overall Study||127
10540574|NCT01467700|11693707|FG002|Safety Set - Received Treatment|Overall Study||124
10540575|NCT01467700|11693708|FG003|Safety Set - Received Treatment|Overall Study||123
10540576|NCT01467700|11693705|FG000|COMPLETED|Overall Study||86
10540577|NCT01467700|11693706|FG001|COMPLETED|Overall Study||100
10540578|NCT01467700|11693707|FG002|COMPLETED|Overall Study||97
10540579|NCT01467700|11693708|FG003|COMPLETED|Overall Study||96
10540580|NCT01467700|11693705|FG000|NOT COMPLETED|Overall Study||29
10540581|NCT01467700|11693706|FG001|NOT COMPLETED|Overall Study||28
10540582|NCT01467700|11693707|FG002|NOT COMPLETED|Overall Study||27
10540583|NCT01467700|11693708|FG003|NOT COMPLETED|Overall Study||27
10540584|NCT01467713|11693722|FG000|STARTED|Overall Study||164
10540585|NCT01467713|11693723|FG001|STARTED|Overall Study||164
10540586|NCT01467713|11693724|FG002|STARTED|Overall Study||160
10540587|NCT01467713|11693725|FG003|STARTED|Overall Study||154
10540588|NCT01467713|11693722|FG000|Safety Analysis Set: Received Treatment|Overall Study||163
10540589|NCT01467713|11693723|FG001|Safety Analysis Set: Received Treatment|Overall Study||164
10540590|NCT01467713|11693724|FG002|Safety Analysis Set: Received Treatment|Overall Study||159
10540591|NCT01467713|11693725|FG003|Safety Analysis Set: Received Treatment|Overall Study||154
10540592|NCT01467713|11693722|FG000|COMPLETED|Overall Study||62
10540593|NCT01467713|11693723|FG001|COMPLETED|Overall Study||60
10540594|NCT01467713|11693724|FG002|COMPLETED|Overall Study||58
10540595|NCT01467713|11693725|FG003|COMPLETED|Overall Study||45
10540596|NCT01467713|11693722|FG000|NOT COMPLETED|Overall Study||102
10540597|NCT01467713|11693723|FG001|NOT COMPLETED|Overall Study||104
10540598|NCT01467713|11693724|FG002|NOT COMPLETED|Overall Study||102
10540599|NCT01467713|11693725|FG003|NOT COMPLETED|Overall Study||109
10540600|NCT01467882|11693735|FG000|STARTED|Overall Study||44
10540601|NCT01467882|11693735|FG000|COMPLETED|Overall Study||44
10540602|NCT01467882|11693735|FG000|NOT COMPLETED|Overall Study||0
10540603|NCT01467934|11693749|FG000|STARTED|Overall Study||208
10540604|NCT01467934|11693750|FG001|STARTED|Overall Study||212
10540605|NCT01467934|11693751|FG002|STARTED|Overall Study||110
10540606|NCT01467934|11693749|FG000|COMPLETED|Overall Study||208
10540607|NCT01467934|11693750|FG001|COMPLETED|Overall Study||212
10540608|NCT01467934|11693751|FG002|COMPLETED|Overall Study||110
10540609|NCT01467934|11693749|FG000|NOT COMPLETED|Overall Study||0
10540610|NCT01467934|11693750|FG001|NOT COMPLETED|Overall Study||0
10540611|NCT01467934|11693751|FG002|NOT COMPLETED|Overall Study||0
10540612|NCT01467947|11693759|FG000|STARTED|Overall Study||46
10540613|NCT01467947|11693759|FG000|COMPLETED|Overall Study||46
10540614|NCT01467947|11693759|FG000|NOT COMPLETED|Overall Study||0
10540615|NCT01467960|11693769|FG000|STARTED|Overall Study||30
10540616|NCT01467960|11693770|FG001|STARTED|Overall Study||30
10540617|NCT01467960|11693771|FG002|STARTED|Overall Study||30
10540618|NCT01467960|11693772|FG003|STARTED|Overall Study||30
10540619|NCT01467960|11693773|FG004|STARTED|Overall Study||30
10540620|NCT01467960|11693774|FG005|STARTED|Overall Study||30
10540621|NCT01467960|11693769|FG000|COMPLETED|Overall Study||30
10540622|NCT01467960|11693770|FG001|COMPLETED|Overall Study||30
10540623|NCT01467960|11693771|FG002|COMPLETED|Overall Study||30
10540624|NCT01467960|11693772|FG003|COMPLETED|Overall Study||0
10540625|NCT01467960|11693773|FG004|COMPLETED|Overall Study||0
10540626|NCT01467960|11693774|FG005|COMPLETED|Overall Study||0
10540628|NCT01467960|11693770|FG001|NOT COMPLETED|Overall Study||0
10540629|NCT01467960|11693771|FG002|NOT COMPLETED|Overall Study||0
10540630|NCT01467960|11693772|FG003|NOT COMPLETED|Overall Study||30
10540631|NCT01467960|11693773|FG004|NOT COMPLETED|Overall Study||30
10540632|NCT01467960|11693774|FG005|NOT COMPLETED|Overall Study||30
10540633|NCT01467999|11693788|FG000|STARTED|Overall Study||22
10540634|NCT01467999|11693788|FG000|COMPLETED|Overall Study||9
10540635|NCT01467999|11693788|FG000|NOT COMPLETED|Overall Study||13
10540636|NCT01468012|11693795|FG000|STARTED|Overall Study||9
10384495|NCT00622284|11526287|FG000|STARTED|Overall Study|Number who started treatment. One patient in the Linagliptin group was randomized but not treated.|776
10384496|NCT00622284|11526288|FG001|STARTED|Overall Study|Number who started treatment.|775
10540637|NCT01468012|11693796|FG001|STARTED|Overall Study||10
10540638|NCT01468012|11693797|FG002|STARTED|Overall Study||4
10384497|NCT00622284|11526287|FG000|COMPLETED|Overall Study|Number who completed treatment.|587
10384498|NCT00622284|11526288|FG001|COMPLETED|Overall Study|Number who completed treatment.|604
10384499|NCT00622284|11526287|FG000|NOT COMPLETED|Overall Study||189
10384500|NCT00622284|11526288|FG001|NOT COMPLETED|Overall Study||171
10384501|NCT00622336|11526294|FG000|STARTED|Treatment Phase||330
10384502|NCT00622336|11526294|FG000|Safety Population|Treatment Phase||330
10384503|NCT00622336|11526294|FG000|COMPLETED|Treatment Phase|Completed = those who completed the treatment phase and were ongoing in the extension study|21
10384504|NCT00622336|11526294|FG000|NOT COMPLETED|Treatment Phase||309
10384505|NCT00622336|11526294|FG000|STARTED|Extension Phase||21
10384506|NCT00622336|11526294|FG000|COMPLETED|Extension Phase||0
10384507|NCT00622336|11526294|FG000|NOT COMPLETED|Extension Phase||21
10384508|NCT00622388|11526300|FG000|STARTED|Overall Study||81
10384509|NCT00622388|11526300|FG000|COMPLETED|Overall Study||9
10384510|NCT00622388|11526300|FG000|NOT COMPLETED|Overall Study||72
10384511|NCT00622401|11526308|FG000|STARTED|Overall Study||6
10384512|NCT00622401|11526309|FG001|STARTED|Overall Study||2
10384513|NCT00622401|11526310|FG002|STARTED|Overall Study|Never Opened|0
10384514|NCT00622401|11526308|FG000|COMPLETED|Overall Study||3
10384515|NCT00622401|11526309|FG001|COMPLETED|Overall Study||0
10384516|NCT00622401|11526310|FG002|COMPLETED|Overall Study||0
10384517|NCT00622401|11526308|FG000|NOT COMPLETED|Overall Study||3
10384518|NCT00622401|11526309|FG001|NOT COMPLETED|Overall Study||2
10384519|NCT00622401|11526310|FG002|NOT COMPLETED|Overall Study||0
10384520|NCT00622427|11526319|FG000|STARTED|Overall Study||16
10384521|NCT00622427|11526320|FG001|STARTED|Overall Study||16
10384522|NCT00622427|11526319|FG000|COMPLETED|Overall Study|each subject received 2 weeks of Ramelteon, then 2 weeks of placebo after a two week wash out period|16
10384523|NCT00622427|11526320|FG001|COMPLETED|Overall Study|each subject received 2 weeks of placebo, then 2 weeks of Ramelteon after a two week wash out period|16
10384524|NCT00622427|11526319|FG000|NOT COMPLETED|Overall Study||0
10384525|NCT00622427|11526320|FG001|NOT COMPLETED|Overall Study||0
10384526|NCT00622440|11526330|FG000|STARTED|Baseline - Week 12 (Treatment)||35
10384527|NCT00622440|11526331|FG001|STARTED|Baseline - Week 12 (Treatment)||35
10384528|NCT00622440|11526330|FG000|COMPLETED|Baseline - Week 12 (Treatment)||31
10384529|NCT00622440|11526331|FG001|COMPLETED|Baseline - Week 12 (Treatment)||34
10384530|NCT00622440|11526330|FG000|NOT COMPLETED|Baseline - Week 12 (Treatment)||4
10384531|NCT00622440|11526331|FG001|NOT COMPLETED|Baseline - Week 12 (Treatment)||1
10384532|NCT00622440|11526330|FG000|STARTED|Week 12 - Week 48 (Treatment)||31
10384533|NCT00622440|11526331|FG001|STARTED|Week 12 - Week 48 (Treatment)||34
10384534|NCT00622440|11526330|FG000|COMPLETED|Week 12 - Week 48 (Treatment)||28
10384535|NCT00622440|11526331|FG001|COMPLETED|Week 12 - Week 48 (Treatment)||28
10384536|NCT00622440|11526330|FG000|NOT COMPLETED|Week 12 - Week 48 (Treatment)||3
10384537|NCT00622440|11526331|FG001|NOT COMPLETED|Week 12 - Week 48 (Treatment)||6
10384538|NCT00622440|11526330|FG000|STARTED|Week 60 (Post-treatment Follow-up Visit)||28
10384539|NCT00622440|11526331|FG001|STARTED|Week 60 (Post-treatment Follow-up Visit)||28
10384540|NCT00622440|11526330|FG000|COMPLETED|Week 60 (Post-treatment Follow-up Visit)||28
10384541|NCT00622440|11526331|FG001|COMPLETED|Week 60 (Post-treatment Follow-up Visit)||27
10384542|NCT00622440|11526330|FG000|NOT COMPLETED|Week 60 (Post-treatment Follow-up Visit)||0
10384543|NCT00622440|11526331|FG001|NOT COMPLETED|Week 60 (Post-treatment Follow-up Visit)||1
10384544|NCT00622466|11526337|FG000|STARTED|Overall Study||20
10384545|NCT00622466|11526337|FG000|COMPLETED|Overall Study||16
10384546|NCT00622466|11526337|FG000|NOT COMPLETED|Overall Study||4
10384547|NCT00622505|11526343|FG000|STARTED|Overall Study||79
10384548|NCT00622505|11526344|FG001|STARTED|Overall Study||42
10384549|NCT00622505|11526343|FG000|COMPLETED|Overall Study||50
10384550|NCT00622505|11526344|FG001|COMPLETED|Overall Study||19
10384551|NCT00622505|11526343|FG000|NOT COMPLETED|Overall Study||29
10384552|NCT00622505|11526344|FG001|NOT COMPLETED|Overall Study||23
10384553|NCT00622518|11526352|FG000|STARTED|Overall Study||59
10384554|NCT00622518|11526353|FG001|STARTED|Overall Study||60
10384555|NCT00622518|11526352|FG000|COMPLETED|Overall Study||59
10384556|NCT00622518|11526353|FG001|COMPLETED|Overall Study||60
10384557|NCT00622518|11526352|FG000|NOT COMPLETED|Overall Study||0
10384558|NCT00622518|11526353|FG001|NOT COMPLETED|Overall Study||0
10384559|NCT00622544|11526359|FG000|STARTED|Overall Study||44
10384560|NCT00622544|11526359|FG000|COMPLETED|Overall Study|35|35
10384561|NCT00622544|11526359|FG000|NOT COMPLETED|Overall Study||9
10384562|NCT00622635|11526363|FG000|STARTED|Treatment Period 1||13
10384563|NCT00622635|11526364|FG001|STARTED|Treatment Period 1||11
10384564|NCT00622635|11526365|FG002|STARTED|Treatment Period 1||11
10384565|NCT00622635|11526366|FG003|STARTED|Treatment Period 1||13
10384566|NCT00622635|11526367|FG004|STARTED|Treatment Period 1||10
10384567|NCT00622635|11526368|FG005|STARTED|Treatment Period 1||10
10384568|NCT00622635|11526363|FG000|COMPLETED|Treatment Period 1||13
10384569|NCT00622635|11526364|FG001|COMPLETED|Treatment Period 1||10
10384570|NCT00622635|11526365|FG002|COMPLETED|Treatment Period 1||10
10384571|NCT00622635|11526366|FG003|COMPLETED|Treatment Period 1||13
10384572|NCT00622635|11526367|FG004|COMPLETED|Treatment Period 1||9
10384573|NCT00622635|11526368|FG005|COMPLETED|Treatment Period 1||10
10384574|NCT00622635|11526363|FG000|NOT COMPLETED|Treatment Period 1||0
10384575|NCT00622635|11526364|FG001|NOT COMPLETED|Treatment Period 1||1
10384576|NCT00622635|11526365|FG002|NOT COMPLETED|Treatment Period 1||1
10384577|NCT00622635|11526366|FG003|NOT COMPLETED|Treatment Period 1||0
10384578|NCT00622635|11526367|FG004|NOT COMPLETED|Treatment Period 1||1
10384579|NCT00622635|11526368|FG005|NOT COMPLETED|Treatment Period 1||0
10384580|NCT00622635|11526363|FG000|STARTED|Treatment Period 2||13
10384581|NCT00622635|11526364|FG001|STARTED|Treatment Period 2||10
10384582|NCT00622635|11526365|FG002|STARTED|Treatment Period 2||10
10384583|NCT00622635|11526366|FG003|STARTED|Treatment Period 2||13
10384584|NCT00622635|11526367|FG004|STARTED|Treatment Period 2||9
10384585|NCT00622635|11526368|FG005|STARTED|Treatment Period 2||10
10384586|NCT00622635|11526363|FG000|COMPLETED|Treatment Period 2||12
10384587|NCT00622635|11526364|FG001|COMPLETED|Treatment Period 2||10
10384588|NCT00622635|11526365|FG002|COMPLETED|Treatment Period 2||10
10384589|NCT00622635|11526366|FG003|COMPLETED|Treatment Period 2||13
10384590|NCT00622635|11526367|FG004|COMPLETED|Treatment Period 2||9
10384591|NCT00622635|11526368|FG005|COMPLETED|Treatment Period 2||10
10384592|NCT00622635|11526363|FG000|NOT COMPLETED|Treatment Period 2||1
10384593|NCT00622635|11526364|FG001|NOT COMPLETED|Treatment Period 2||0
10384594|NCT00622635|11526365|FG002|NOT COMPLETED|Treatment Period 2||0
10384595|NCT00622635|11526366|FG003|NOT COMPLETED|Treatment Period 2||0
10384596|NCT00622635|11526367|FG004|NOT COMPLETED|Treatment Period 2||0
10384597|NCT00622635|11526368|FG005|NOT COMPLETED|Treatment Period 2||0
10384598|NCT00622635|11526363|FG000|STARTED|Treatment Period 3||12
10384599|NCT00622635|11526364|FG001|STARTED|Treatment Period 3||10
10384600|NCT00622635|11526365|FG002|STARTED|Treatment Period 3||10
10384601|NCT00622635|11526366|FG003|STARTED|Treatment Period 3||13
10384602|NCT00622635|11526367|FG004|STARTED|Treatment Period 3||9
10384603|NCT00622635|11526368|FG005|STARTED|Treatment Period 3||10
10384604|NCT00622635|11526363|FG000|COMPLETED|Treatment Period 3||12
10384605|NCT00622635|11526364|FG001|COMPLETED|Treatment Period 3||10
10384606|NCT00622635|11526365|FG002|COMPLETED|Treatment Period 3||10
10384607|NCT00622635|11526366|FG003|COMPLETED|Treatment Period 3||10
10384608|NCT00622635|11526367|FG004|COMPLETED|Treatment Period 3||9
10384609|NCT00622635|11526368|FG005|COMPLETED|Treatment Period 3||10
10384610|NCT00622635|11526363|FG000|NOT COMPLETED|Treatment Period 3||0
10384611|NCT00622635|11526364|FG001|NOT COMPLETED|Treatment Period 3||0
10384612|NCT00622635|11526365|FG002|NOT COMPLETED|Treatment Period 3||0
10384613|NCT00622635|11526366|FG003|NOT COMPLETED|Treatment Period 3||3
10384614|NCT00622635|11526367|FG004|NOT COMPLETED|Treatment Period 3||0
10384615|NCT00622635|11526368|FG005|NOT COMPLETED|Treatment Period 3||0
10384616|NCT00622700|11526379|FG000|STARTED|Core Treatment Period||197
10384617|NCT00622700|11526380|FG001|STARTED|Core Treatment Period||205
10384618|NCT00622700|11526381|FG002|STARTED|Core Treatment Period||216
10384619|NCT00622700|11526382|FG003|STARTED|Core Treatment Period||0
10384620|NCT00622700|11526383|FG004|STARTED|Core Treatment Period||0
10384621|NCT00622700|11526384|FG005|STARTED|Core Treatment Period||0
10384622|NCT00622700|11526385|FG006|STARTED|Core Treatment Period||0
10384623|NCT00622700|11526379|FG000|Treated|Core Treatment Period||197
10384624|NCT00622700|11526380|FG001|Treated|Core Treatment Period||203
10384625|NCT00622700|11526381|FG002|Treated|Core Treatment Period||214
10384626|NCT00622700|11526382|FG003|Treated|Core Treatment Period||0
10384627|NCT00622700|11526383|FG004|Treated|Core Treatment Period||0
10384628|NCT00622700|11526384|FG005|Treated|Core Treatment Period||0
10384629|NCT00622700|11526385|FG006|Treated|Core Treatment Period||0
10384630|NCT00622700|11526379|FG000|COMPLETED|Core Treatment Period||141
10384631|NCT00622700|11526380|FG001|COMPLETED|Core Treatment Period||150
10384632|NCT00622700|11526381|FG002|COMPLETED|Core Treatment Period||163
10384633|NCT00622700|11526382|FG003|COMPLETED|Core Treatment Period||0
10384634|NCT00622700|11526383|FG004|COMPLETED|Core Treatment Period||0
10384635|NCT00622700|11526384|FG005|COMPLETED|Core Treatment Period||0
10384636|NCT00622700|11526385|FG006|COMPLETED|Core Treatment Period||0
10384637|NCT00622700|11526379|FG000|NOT COMPLETED|Core Treatment Period||56
10384638|NCT00622700|11526380|FG001|NOT COMPLETED|Core Treatment Period||55
10384639|NCT00622700|11526381|FG002|NOT COMPLETED|Core Treatment Period||53
10384640|NCT00622700|11526382|FG003|NOT COMPLETED|Core Treatment Period||0
10384641|NCT00622700|11526383|FG004|NOT COMPLETED|Core Treatment Period||0
10384642|NCT00622700|11526384|FG005|NOT COMPLETED|Core Treatment Period||0
10384643|NCT00622700|11526385|FG006|NOT COMPLETED|Core Treatment Period||0
10384644|NCT00622700|11526379|FG000|STARTED|Extension Treatment Period|Participants were re-randomized in a 1:1 ratio to either teriflunomide 7 mg or 14 mg treatment arm.|0
10384645|NCT00622700|11526380|FG001|STARTED|Extension Treatment Period||0
10384646|NCT00622700|11526381|FG002|STARTED|Extension Treatment Period||0
10384647|NCT00622700|11526382|FG003|STARTED|Extension Treatment Period|10 participants completed core treatment period but did not enter in extension treatment period.|64
10384648|NCT00622700|11526383|FG004|STARTED|Extension Treatment Period|8 participants completed core treatment period but did not enter in extension treatment period.|142
10384649|NCT00622700|11526384|FG005|STARTED|Extension Treatment Period|10 participants completed core treatment period but did not enter in extension treatment period.|67
10384650|NCT00622700|11526385|FG006|STARTED|Extension Treatment Period|13 participants completed core treatment period but did not enter in extension treatment period.|150
10384651|NCT00622700|11526379|FG000|COMPLETED|Extension Treatment Period||0
10384652|NCT00622700|11526380|FG001|COMPLETED|Extension Treatment Period||0
10384653|NCT00622700|11526381|FG002|COMPLETED|Extension Treatment Period||0
10384654|NCT00622700|11526382|FG003|COMPLETED|Extension Treatment Period||43
10384655|NCT00622700|11526383|FG004|COMPLETED|Extension Treatment Period||103
10384656|NCT00622700|11526384|FG005|COMPLETED|Extension Treatment Period||50
10384657|NCT00622700|11526385|FG006|COMPLETED|Extension Treatment Period||120
10384658|NCT00622700|11526379|FG000|NOT COMPLETED|Extension Treatment Period||0
10384659|NCT00622700|11526380|FG001|NOT COMPLETED|Extension Treatment Period||0
10384660|NCT00622700|11526381|FG002|NOT COMPLETED|Extension Treatment Period||0
10384661|NCT00622700|11526382|FG003|NOT COMPLETED|Extension Treatment Period||21
10384662|NCT00622700|11526383|FG004|NOT COMPLETED|Extension Treatment Period||39
10384663|NCT00622700|11526384|FG005|NOT COMPLETED|Extension Treatment Period||17
10384664|NCT00622700|11526385|FG006|NOT COMPLETED|Extension Treatment Period||30
10384665|NCT00622713|11526402|FG000|STARTED|Overall Study||228
10384666|NCT00622713|11526402|FG000|Exposed to Study Drug|Overall Study||226
10384667|NCT00622713|11526402|FG000|Intent to Treat (ITT) Population|Overall Study||218
10384668|NCT00622713|11526402|FG000|COMPLETED|Overall Study||169
10384669|NCT00622713|11526402|FG000|NOT COMPLETED|Overall Study||59
10384670|NCT00622726|11526408|FG000|STARTED|March, 2008 to August, 2010||75
10384671|NCT00622726|11526409|FG001|STARTED|March, 2008 to August, 2010||75
10384672|NCT00622726|11526408|FG000|COMPLETED|March, 2008 to August, 2010|All infants were extremely immature with multiple neonatal intensive care unit complications.|70
10384673|NCT00622726|11526409|FG001|COMPLETED|March, 2008 to August, 2010|All infants were extremely immature with multiple neonatal intensive care unit complications.|73
10384674|NCT00622726|11526408|FG000|NOT COMPLETED|March, 2008 to August, 2010||5
10384675|NCT00622726|11526409|FG001|NOT COMPLETED|March, 2008 to August, 2010||2
10384676|NCT00622726|11526408|FG000|STARTED|August, 2010 to April, 2013||70
10384677|NCT00622726|11526409|FG001|STARTED|August, 2010 to April, 2013||73
10384678|NCT00622726|11526408|FG000|COMPLETED|August, 2010 to April, 2013||69
10384679|NCT00622726|11526409|FG001|COMPLETED|August, 2010 to April, 2013||68
10384680|NCT00622726|11526408|FG000|NOT COMPLETED|August, 2010 to April, 2013||1
10384681|NCT00622726|11526409|FG001|NOT COMPLETED|August, 2010 to April, 2013||5
10384682|NCT00622739|11526421|FG000|STARTED|Overall Study||13
10384683|NCT00622739|11526422|FG001|STARTED|Overall Study||15
10384684|NCT00622739|11526421|FG000|COMPLETED|Overall Study||11
10384685|NCT00622739|11526422|FG001|COMPLETED|Overall Study||9
10384686|NCT00622739|11526421|FG000|NOT COMPLETED|Overall Study||2
10384687|NCT00622739|11526422|FG001|NOT COMPLETED|Overall Study||6
10384688|NCT00622869|11526433|FG000|STARTED|Overall Study||245
10384689|NCT00622869|11526434|FG001|STARTED|Overall Study||231
10384690|NCT00622869|11526435|FG002|STARTED|Overall Study||243
10384691|NCT00622869|11526433|FG000|COMPLETED|Overall Study||202
10384692|NCT00622869|11526434|FG001|COMPLETED|Overall Study||174
10384693|NCT00622869|11526435|FG002|COMPLETED|Overall Study||204
10384694|NCT00622869|11526433|FG000|NOT COMPLETED|Overall Study||43
10540639|NCT01468012|11693795|FG000|COMPLETED|Overall Study||7
10540640|NCT01468012|11693796|FG001|COMPLETED|Overall Study||9
10540641|NCT01468012|11693797|FG002|COMPLETED|Overall Study||0
10540642|NCT01468012|11693795|FG000|NOT COMPLETED|Overall Study||2
10540643|NCT01468012|11693796|FG001|NOT COMPLETED|Overall Study||1
10540644|NCT01468012|11693797|FG002|NOT COMPLETED|Overall Study||4
10540645|NCT01468077|11693808|FG000|STARTED|Overall Study||22
10540646|NCT01468077|11693809|FG001|STARTED|Overall Study||25
10540647|NCT01468077|11693808|FG000|COMPLETED|Overall Study||18
10540648|NCT01468077|11693809|FG001|COMPLETED|Overall Study||22
10540649|NCT01468077|11693808|FG000|NOT COMPLETED|Overall Study||4
10540650|NCT01468077|11693809|FG001|NOT COMPLETED|Overall Study||3
10540651|NCT01468181|11693820|FG000|STARTED|Overall Study||131
10540652|NCT01468181|11693821|FG001|STARTED|Overall Study||61
10540653|NCT01468181|11693822|FG002|STARTED|Overall Study||65
10658210|NCT02231177|11819345|FG005|COMPLETED|Treatment Period 3 (21 Days)||9
10658211|NCT02231177|11819340|FG000|NOT COMPLETED|Treatment Period 3 (21 Days)||0
10658212|NCT02231177|11819341|FG001|NOT COMPLETED|Treatment Period 3 (21 Days)||0
10658213|NCT02231177|11819342|FG002|NOT COMPLETED|Treatment Period 3 (21 Days)||0
10658214|NCT02231177|11819343|FG003|NOT COMPLETED|Treatment Period 3 (21 Days)||0
10658215|NCT02231177|11819344|FG004|NOT COMPLETED|Treatment Period 3 (21 Days)||0
10658216|NCT02231177|11819345|FG005|NOT COMPLETED|Treatment Period 3 (21 Days)||0
10658217|NCT02231580|11819356|FG000|STARTED|Overall Study||14
10658218|NCT02231580|11819357|FG001|STARTED|Overall Study||3
10658219|NCT02231580|11819356|FG000|Cohort 1|Overall Study||8
10658220|NCT02231580|11819357|FG001|Cohort 1|Overall Study||2
10658221|NCT02231580|11819356|FG000|Cohort 2|Overall Study||6
10658222|NCT02231580|11819357|FG001|Cohort 2|Overall Study||1
10658223|NCT02231580|11819356|FG000|COMPLETED|Overall Study||9
10658224|NCT02231580|11819357|FG001|COMPLETED|Overall Study||3
10658225|NCT02231580|11819356|FG000|NOT COMPLETED|Overall Study||5
10658226|NCT02231580|11819357|FG001|NOT COMPLETED|Overall Study||0
10658227|NCT02231918|11819368|FG000|STARTED|Overall Study||9
10658228|NCT02231918|11819369|FG001|STARTED|Overall Study||15
10658229|NCT02231918|11819370|FG002|STARTED|Overall Study||2
10658230|NCT02231918|11819368|FG000|COMPLETED|Overall Study||9
10658231|NCT02231918|11819369|FG001|COMPLETED|Overall Study||14
10658232|NCT02231918|11819370|FG002|COMPLETED|Overall Study||1
10658233|NCT02231918|11819368|FG000|NOT COMPLETED|Overall Study||0
10658234|NCT02231918|11819369|FG001|NOT COMPLETED|Overall Study||1
10658235|NCT02231918|11819370|FG002|NOT COMPLETED|Overall Study||1
10812694|NCT03361228|11974841|FG000|STARTED|Overall Study||4
10540654|NCT01468181|11693823|FG003|STARTED|Overall Study||66
10540655|NCT01468181|11693824|FG004|STARTED|Overall Study||71
10540656|NCT01468181|11693820|FG000|Received at Least 1 Dose of Study Drug|Overall Study||131
10718060|NCT02703324|11882029|FG003|STARTED|Period Four||5
10718061|NCT02703324|11882030|FG004|STARTED|Period Four||5
10718062|NCT02703324|11882031|FG005|STARTED|Period Four||5
10718063|NCT02703324|11882026|FG000|Received Study Drug|Period Four||5
10718064|NCT02703324|11882027|FG001|Received Study Drug|Period Four||4
10718065|NCT02703324|11882028|FG002|Received Study Drug|Period Four||4
10812695|NCT03361228|11974842|FG001|STARTED|Overall Study||1
10384695|NCT00622869|11526434|FG001|NOT COMPLETED|Overall Study||57
10384696|NCT00622869|11526435|FG002|NOT COMPLETED|Overall Study||39
10384697|NCT00622895|11526443|FG000|STARTED|Overall Study||3
10384698|NCT00622895|11526443|FG000|COMPLETED|Overall Study||3
10384699|NCT00622895|11526443|FG000|NOT COMPLETED|Overall Study||0
10384700|NCT00622908|11526452|FG000|STARTED|Overall Study|Intent to treat population|137
10384701|NCT00622908|11526453|FG001|STARTED|Overall Study|Intent to treat population|132
10384702|NCT00622908|11526452|FG000|COMPLETED|Overall Study||134
10384703|NCT00622908|11526453|FG001|COMPLETED|Overall Study||122
10384704|NCT00622908|11526452|FG000|NOT COMPLETED|Overall Study||3
10384705|NCT00622908|11526453|FG001|NOT COMPLETED|Overall Study||10
10384706|NCT00623012|11526459|FG000|STARTED|Overall Study||2
10384707|NCT00623012|11526459|FG000|COMPLETED|Overall Study||2
10384708|NCT00623012|11526459|FG000|NOT COMPLETED|Overall Study||0
10384709|NCT00623103|11526465|FG000|STARTED|Overall Study||295
10384710|NCT00623103|11526466|FG001|STARTED|Overall Study||288
10384711|NCT00623103|11526465|FG000|Safety Set: Received Study Drug|Overall Study|One randomized participant did not receive study drug and was not included in the Safety set.|294
10384712|NCT00623103|11526466|FG001|Safety Set: Received Study Drug|Overall Study||288
10384713|NCT00623103|11526465|FG000|COMPLETED|Overall Study||184
10384714|NCT00623103|11526466|FG001|COMPLETED|Overall Study||175
10384715|NCT00623103|11526465|FG000|NOT COMPLETED|Overall Study||111
10384716|NCT00623103|11526466|FG001|NOT COMPLETED|Overall Study||113
10384717|NCT00623181|11526474|FG000|STARTED|Overall Study||56
10384718|NCT00623181|11526475|FG001|STARTED|Overall Study||54
10384719|NCT00623181|11526474|FG000|COMPLETED|Overall Study||56
10384720|NCT00623181|11526475|FG001|COMPLETED|Overall Study||54
10384721|NCT00623181|11526474|FG000|NOT COMPLETED|Overall Study||0
10384722|NCT00623181|11526475|FG001|NOT COMPLETED|Overall Study||0
10384723|NCT00623194|11526485|FG000|STARTED|Overall Study||146
10384724|NCT00623194|11526485|FG000|COMPLETED|Overall Study||141
10384725|NCT00623194|11526485|FG000|NOT COMPLETED|Overall Study||5
10384726|NCT00623233|11526489|FG000|STARTED|Overall Study||52
10384727|NCT00623233|11526489|FG000|COMPLETED|Overall Study|Included those who discontinued due to PD or death and those who achieved complete response (CR).|28
10384728|NCT00623233|11526489|FG000|NOT COMPLETED|Overall Study||24
10384729|NCT00623363|11526495|FG000|STARTED|Overall Study||7
10384730|NCT00623363|11526496|FG001|STARTED|Overall Study||20
10384731|NCT00623363|11526495|FG000|COMPLETED|Overall Study||5
10384732|NCT00623363|11526496|FG001|COMPLETED|Overall Study||18
10540657|NCT01468181|11693821|FG001|Received at Least 1 Dose of Study Drug|Overall Study||61
10540658|NCT01468181|11693822|FG002|Received at Least 1 Dose of Study Drug|Overall Study||65
10540659|NCT01468181|11693823|FG003|Received at Least 1 Dose of Study Drug|Overall Study||66
10540660|NCT01468181|11693824|FG004|Received at Least 1 Dose of Study Drug|Overall Study||71
10540661|NCT01468181|11693820|FG000|COMPLETED|Overall Study||121
10540662|NCT01468181|11693821|FG001|COMPLETED|Overall Study||59
10540663|NCT01468181|11693822|FG002|COMPLETED|Overall Study||57
10540664|NCT01468181|11693823|FG003|COMPLETED|Overall Study||63
10540665|NCT01468181|11693824|FG004|COMPLETED|Overall Study||66
10540666|NCT01468181|11693820|FG000|NOT COMPLETED|Overall Study||10
10540667|NCT01468181|11693821|FG001|NOT COMPLETED|Overall Study||2
10540668|NCT01468181|11693822|FG002|NOT COMPLETED|Overall Study||8
10540669|NCT01468181|11693823|FG003|NOT COMPLETED|Overall Study||3
10540670|NCT01468181|11693824|FG004|NOT COMPLETED|Overall Study||5
10540671|NCT01468207|11693838|FG000|STARTED|Treatment Period 1||154
10540672|NCT01468207|11693839|FG001|STARTED|Treatment Period 1||153
10540673|NCT01468207|11693840|FG002|STARTED|Treatment Period 1||0
10540674|NCT01468207|11693841|FG003|STARTED|Treatment Period 1||0
10540675|NCT01468207|11693842|FG004|STARTED|Treatment Period 1||0
10540676|NCT01468207|11693843|FG005|STARTED|Treatment Period 1||0
10540677|NCT01468207|11693838|FG000|Received Study Drug|Treatment Period 1||152
10540678|NCT01468207|11693839|FG001|Received Study Drug|Treatment Period 1||153
10540679|NCT01468207|11693840|FG002|Received Study Drug|Treatment Period 1||0
10718066|NCT02703324|11882029|FG003|Received Study Drug|Period Four||5
10718067|NCT02703324|11882030|FG004|Received Study Drug|Period Four||5
10540680|NCT01468207|11693841|FG003|Received Study Drug|Treatment Period 1||0
10540681|NCT01468207|11693842|FG004|Received Study Drug|Treatment Period 1||0
10540682|NCT01468207|11693843|FG005|Received Study Drug|Treatment Period 1||0
10540683|NCT01468207|11693838|FG000|COMPLETED|Treatment Period 1||145
10540684|NCT01468207|11693839|FG001|COMPLETED|Treatment Period 1||145
10540685|NCT01468207|11693840|FG002|COMPLETED|Treatment Period 1||0
10540686|NCT01468207|11693841|FG003|COMPLETED|Treatment Period 1||0
10540687|NCT01468207|11693842|FG004|COMPLETED|Treatment Period 1||0
10540688|NCT01468207|11693843|FG005|COMPLETED|Treatment Period 1||0
10540689|NCT01468207|11693838|FG000|NOT COMPLETED|Treatment Period 1||9
10384733|NCT00623363|11526495|FG000|NOT COMPLETED|Overall Study||2
10384734|NCT00623363|11526496|FG001|NOT COMPLETED|Overall Study||2
10384735|NCT00623428|11526505|FG000|STARTED|Treatment Period||95
10384736|NCT00623428|11526506|FG001|STARTED|Treatment Period||93
10384737|NCT00623428|11526505|FG000|COMPLETED|Treatment Period|Patients who completed 24 weeks of treatment|95
10384738|NCT00623428|11526506|FG001|COMPLETED|Treatment Period|Patients who completed 48 weeks of treatment|66
10384739|NCT00623428|11526505|FG000|NOT COMPLETED|Treatment Period||0
10540690|NCT01468207|11693839|FG001|NOT COMPLETED|Treatment Period 1||8
10658236|NCT02232009|11819378|FG000|STARTED|Overall Study||9
10658237|NCT02232009|11819378|FG000|COMPLETED|Overall Study||9
10658238|NCT02232009|11819378|FG000|NOT COMPLETED|Overall Study||0
10658239|NCT02232022|11819382|FG000|STARTED|Overall Study||53
10384740|NCT00623428|11526506|FG001|NOT COMPLETED|Treatment Period||27
10384741|NCT00623428|11526505|FG000|STARTED|Follow-up Period||95
10384742|NCT00623428|11526506|FG001|STARTED|Follow-up Period||93
10384743|NCT00623428|11526505|FG000|COMPLETED|Follow-up Period|Patients who had an HCV RNA sample at 48 weeks of follow-up|66
10384744|NCT00623428|11526506|FG001|COMPLETED|Follow-up Period|Patients who had an HCV RNA sample at 24 weeks of follow-up|78
10384745|NCT00623428|11526505|FG000|NOT COMPLETED|Follow-up Period||29
10384746|NCT00623428|11526506|FG001|NOT COMPLETED|Follow-up Period||15
10384747|NCT00623441|11526512|FG000|STARTED|Overall Study||8314
10384748|NCT00623441|11526512|FG000|COMPLETED|Overall Study|12 months follow-up compliance was 94.2%|8314
10384749|NCT00623441|11526512|FG000|NOT COMPLETED|Overall Study||0
10384750|NCT00623467|11526516|FG000|STARTED|Overall Study||343
10384751|NCT00623467|11526516|FG000|COMPLETED|Overall Study||336
10384752|NCT00623467|11526516|FG000|NOT COMPLETED|Overall Study||7
10384753|NCT00623480|11526524|FG000|STARTED|Overall Study||42
10384754|NCT00623480|11526525|FG001|STARTED|Overall Study||42
10384755|NCT00623480|11526524|FG000|COMPLETED|Overall Study||35
10384756|NCT00623480|11526525|FG001|COMPLETED|Overall Study||35
10384757|NCT00623480|11526524|FG000|NOT COMPLETED|Overall Study||7
10384758|NCT00623480|11526525|FG001|NOT COMPLETED|Overall Study||7
10384759|NCT00623506|11526533|FG000|STARTED|Overall Study||15
10384760|NCT00623506|11526534|FG001|STARTED|Overall Study||15
10384761|NCT00623506|11526533|FG000|Week 4|Overall Study||11
10384762|NCT00623506|11526534|FG001|Week 4|Overall Study||11
10384763|NCT00623506|11526533|FG000|COMPLETED|Overall Study||11
10384764|NCT00623506|11526534|FG001|COMPLETED|Overall Study||11
10384765|NCT00623506|11526533|FG000|NOT COMPLETED|Overall Study||4
10384766|NCT00623506|11526534|FG001|NOT COMPLETED|Overall Study||4
10384767|NCT00623545|11526540|FG000|STARTED|Overall Study||28
10384768|NCT00623545|11526540|FG000|COMPLETED|Overall Study||18
10384769|NCT00623545|11526540|FG000|NOT COMPLETED|Overall Study||10
10384770|NCT00623597|11526547|FG000|STARTED|Overall Study||5
10384771|NCT00623597|11526548|FG001|STARTED|Overall Study||13
10384772|NCT00623597|11526547|FG000|COMPLETED|Overall Study||4
10384773|NCT00623597|11526548|FG001|COMPLETED|Overall Study||13
10384774|NCT00623597|11526547|FG000|NOT COMPLETED|Overall Study||1
10384775|NCT00623597|11526548|FG001|NOT COMPLETED|Overall Study||0
10384776|NCT00623623|11526558|FG000|STARTED|Overall Study||950
10384777|NCT00623623|11526559|FG001|STARTED|Overall Study||949
10384778|NCT00623623|11526558|FG000|COMPLETED|Overall Study||949
10384779|NCT00623623|11526559|FG001|COMPLETED|Overall Study||948
10384780|NCT00623623|11526558|FG000|NOT COMPLETED|Overall Study||1
10384781|NCT00623623|11526559|FG001|NOT COMPLETED|Overall Study||1
10384782|NCT00623636|11526567|FG000|STARTED|Double Blind||452
10384783|NCT00623636|11526568|FG001|STARTED|Double Blind||450
10384784|NCT00623636|11526567|FG000|COMPLETED|Double Blind||419
10384785|NCT00623636|11526568|FG001|COMPLETED|Double Blind||422
10384786|NCT00623636|11526567|FG000|NOT COMPLETED|Double Blind||33
10384787|NCT00623636|11526568|FG001|NOT COMPLETED|Double Blind||28
10384788|NCT00623636|11526567|FG000|STARTED|Open Label|Eligible double-blind placebo patients received MAP0004 in the open-label period.|0
10384789|NCT00623636|11526568|FG001|STARTED|Open Label|Includes eligible Placebo and MAP0004 patients from the double-blind period.|675
10384790|NCT00623636|11526567|FG000|COMPLETED|Open Label||0
10384791|NCT00623636|11526568|FG001|COMPLETED|Open Label||263
10384792|NCT00623636|11526567|FG000|NOT COMPLETED|Open Label||0
10384793|NCT00623636|11526568|FG001|NOT COMPLETED|Open Label||412
10384794|NCT00623714|11526575|FG000|STARTED|Period 1||6
10384795|NCT00623714|11526576|FG001|STARTED|Period 1||7
10384796|NCT00623714|11526575|FG000|COMPLETED|Period 1||6
10384797|NCT00623714|11526576|FG001|COMPLETED|Period 1||7
10384798|NCT00623714|11526575|FG000|NOT COMPLETED|Period 1||0
10384799|NCT00623714|11526576|FG001|NOT COMPLETED|Period 1||0
10384800|NCT00623714|11526575|FG000|STARTED|Period 2||6
10384801|NCT00623714|11526576|FG001|STARTED|Period 2||7
10384802|NCT00623714|11526575|FG000|COMPLETED|Period 2||6
10384803|NCT00623714|11526576|FG001|COMPLETED|Period 2||7
10384804|NCT00623714|11526575|FG000|NOT COMPLETED|Period 2||0
10384805|NCT00623714|11526576|FG001|NOT COMPLETED|Period 2||0
10384806|NCT00623727|11526584|FG000|STARTED|Double Blind (DB)|only 67 participants are applicable for baseline characteristic evaluation|70
10384807|NCT00623727|11526585|FG001|STARTED|Double Blind (DB)|only 72 participants are applicable for baseline characteristic evaluation|73
10384808|NCT00623727|11526584|FG000|Participants Received Treatment|Double Blind (DB)||67
10384809|NCT00623727|11526585|FG001|Participants Received Treatment|Double Blind (DB)||72
10384810|NCT00623727|11526584|FG000|COMPLETED|Double Blind (DB)||34
10384811|NCT00623727|11526585|FG001|COMPLETED|Double Blind (DB)||41
10384812|NCT00623727|11526584|FG000|NOT COMPLETED|Double Blind (DB)||36
10384813|NCT00623727|11526585|FG001|NOT COMPLETED|Double Blind (DB)||32
10384814|NCT00623727|11526584|FG000|STARTED|Open Label Follow-up||0
10384815|NCT00623727|11526585|FG001|STARTED|Open Label Follow-up|13 Participants from each group after DB period terminated entered open label follow up.|26
10384816|NCT00623727|11526584|FG000|COMPLETED|Open Label Follow-up||0
10384817|NCT00623727|11526585|FG001|COMPLETED|Open Label Follow-up||18
10384818|NCT00623727|11526584|FG000|NOT COMPLETED|Open Label Follow-up||0
10384819|NCT00623727|11526585|FG001|NOT COMPLETED|Open Label Follow-up||8
10384820|NCT00623727|11526584|FG000|STARTED|Open Label Extension Period|10 participants of each group entered open-label extension period after completion of DB study|20
10384821|NCT00623727|11526585|FG001|STARTED|Open Label Extension Period||0
10384822|NCT00623727|11526584|FG000|COMPLETED|Open Label Extension Period||20
10384823|NCT00623727|11526585|FG001|COMPLETED|Open Label Extension Period||0
10384824|NCT00623727|11526584|FG000|NOT COMPLETED|Open Label Extension Period||0
10384825|NCT00623727|11526585|FG001|NOT COMPLETED|Open Label Extension Period||0
10384826|NCT00623766|11526595|FG000|STARTED|Induction Phase (Day 1 to Week 24)|Participants who received treatment|51
10384827|NCT00623766|11526596|FG001|STARTED|Induction Phase (Day 1 to Week 24)|Participants who received treatment|21
10384828|NCT00623766|11526595|FG000|COMPLETED|Induction Phase (Day 1 to Week 24)|4 patients completed Induction but did not enter Maintenance; they were only followed up with scans.|15
10384829|NCT00623766|11526596|FG001|COMPLETED|Induction Phase (Day 1 to Week 24)|3 patients completed Induction but did not enter Maintenance; they were only followed up with scans.|5
10384830|NCT00623766|11526595|FG000|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||36
10384831|NCT00623766|11526596|FG001|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||16
10384832|NCT00623766|11526595|FG000|STARTED|Maintenance Phase (Week 24 to Year 2)||11
10384833|NCT00623766|11526596|FG001|STARTED|Maintenance Phase (Week 24 to Year 2)||2
10384834|NCT00623766|11526595|FG000|COMPLETED|Maintenance Phase (Week 24 to Year 2)|Inadvertently not noted as discontinued (disease progression); data collection error at site closure|1
10384835|NCT00623766|11526596|FG001|COMPLETED|Maintenance Phase (Week 24 to Year 2)||0
10384836|NCT00623766|11526595|FG000|NOT COMPLETED|Maintenance Phase (Week 24 to Year 2)||10
10384837|NCT00623766|11526596|FG001|NOT COMPLETED|Maintenance Phase (Week 24 to Year 2)||2
10384838|NCT00623779|11526609|FG000|STARTED|Overall Study||41
10384839|NCT00623779|11526610|FG001|STARTED|Overall Study||42
10384840|NCT00623779|11526611|FG002|STARTED|Overall Study||45
10384841|NCT00623779|11526609|FG000|COMPLETED|Overall Study||38
10384842|NCT00623779|11526610|FG001|COMPLETED|Overall Study||39
10384843|NCT00623779|11526611|FG002|COMPLETED|Overall Study||44
10384844|NCT00623779|11526609|FG000|NOT COMPLETED|Overall Study||3
10384845|NCT00623779|11526610|FG001|NOT COMPLETED|Overall Study||3
10384846|NCT00623779|11526611|FG002|NOT COMPLETED|Overall Study||1
10384847|NCT00623805|11526621|FG000|STARTED|Overall Study||62
10384848|NCT00623805|11526622|FG001|STARTED|Overall Study||61
10384849|NCT00623805|11526621|FG000|COMPLETED|Overall Study||42
10384850|NCT00623805|11526622|FG001|COMPLETED|Overall Study||39
10384851|NCT00623805|11526621|FG000|NOT COMPLETED|Overall Study||20
10384852|NCT00623805|11526622|FG001|NOT COMPLETED|Overall Study||22
10384853|NCT00623831|11526630|FG000|STARTED|Overall Study||13
10384854|NCT00623831|11526631|FG001|STARTED|Overall Study||4
10384855|NCT00623831|11526630|FG000|COMPLETED|Overall Study||12
10384856|NCT00623831|11526631|FG001|COMPLETED|Overall Study||3
10384857|NCT00623831|11526630|FG000|NOT COMPLETED|Overall Study||1
10384858|NCT00623831|11526631|FG001|NOT COMPLETED|Overall Study||1
10384859|NCT00623935|11526640|FG000|STARTED|Overall Study||56
10384860|NCT00623935|11526640|FG000|COMPLETED|Overall Study||54
10384861|NCT00623935|11526640|FG000|NOT COMPLETED|Overall Study||2
10384862|NCT00624013|11526646|FG000|STARTED|Overall Study||44
10384863|NCT00624013|11526647|FG001|STARTED|Overall Study||45
10384864|NCT00624013|11526646|FG000|COMPLETED|Overall Study||36
10384865|NCT00624013|11526647|FG001|COMPLETED|Overall Study||39
10384866|NCT00624013|11526646|FG000|NOT COMPLETED|Overall Study||8
10384867|NCT00624013|11526647|FG001|NOT COMPLETED|Overall Study||6
10384868|NCT00624052|11526659|FG000|STARTED|Overall Study||219
10384869|NCT00624052|11526660|FG001|STARTED|Overall Study||436
10384870|NCT00624052|11526661|FG002|STARTED|Overall Study||91
10384871|NCT00624052|11526662|FG003|STARTED|Overall Study||92
10384872|NCT00624052|11526659|FG000|COMPLETED|Overall Study||204
10384873|NCT00624052|11526660|FG001|COMPLETED|Overall Study||422
10384874|NCT00624052|11526661|FG002|COMPLETED|Overall Study||88
10384875|NCT00624052|11526662|FG003|COMPLETED|Overall Study||88
10384876|NCT00624052|11526659|FG000|NOT COMPLETED|Overall Study||15
10384877|NCT00624052|11526660|FG001|NOT COMPLETED|Overall Study||14
10384878|NCT00624052|11526661|FG002|NOT COMPLETED|Overall Study||3
10384879|NCT00624052|11526662|FG003|NOT COMPLETED|Overall Study||4
10384880|NCT00624065|11526678|FG000|STARTED|Overall Study||216
10384881|NCT00624065|11526679|FG001|STARTED|Overall Study||216
10384882|NCT00624065|11526678|FG000|COMPLETED|Overall Study||197
10384883|NCT00624065|11526679|FG001|COMPLETED|Overall Study||192
10384884|NCT00624065|11526678|FG000|NOT COMPLETED|Overall Study||19
10384885|NCT00624065|11526679|FG001|NOT COMPLETED|Overall Study||24
10384886|NCT00624195|11526687|FG000|STARTED|Overall Study||29
10384887|NCT00624195|11526688|FG001|STARTED|Overall Study||30
10384888|NCT00624195|11526687|FG000|COMPLETED|Overall Study||26
10384889|NCT00624195|11526688|FG001|COMPLETED|Overall Study||23
10658240|NCT02232022|11819382|FG000|COMPLETED|Overall Study||51
10384890|NCT00624195|11526687|FG000|NOT COMPLETED|Overall Study||3
10384891|NCT00624195|11526688|FG001|NOT COMPLETED|Overall Study||7
10384892|NCT00624221|11526696|FG000|STARTED|Overall Study||20
10384893|NCT00624221|11526697|FG001|STARTED|Overall Study||20
10384894|NCT00624221|11526696|FG000|COMPLETED|Overall Study||20
10384895|NCT00624221|11526697|FG001|COMPLETED|Overall Study||20
10384896|NCT00624221|11526696|FG000|NOT COMPLETED|Overall Study||0
10384897|NCT00624221|11526697|FG001|NOT COMPLETED|Overall Study||0
10384898|NCT00624286|11526705|FG000|STARTED|Overall Study||211
10384899|NCT00624286|11526706|FG001|STARTED|Overall Study||205
10658241|NCT02232022|11819382|FG000|NOT COMPLETED|Overall Study||2
10658242|NCT02232061|11819388|FG000|STARTED|Overall Study||6
10658243|NCT02232061|11819388|FG000|COMPLETED|Overall Study||4
10658244|NCT02232061|11819388|FG000|NOT COMPLETED|Overall Study||2
10658245|NCT02232074|11819394|FG000|STARTED|Overall Study||154
10658246|NCT02232074|11819395|FG001|STARTED|Overall Study||152
10658247|NCT02232074|11819394|FG000|COMPLETED|Overall Study||113
10658248|NCT02232074|11819395|FG001|COMPLETED|Overall Study||107
10384900|NCT00624286|11526705|FG000|COMPLETED|Overall Study||186
10384901|NCT00624286|11526706|FG001|COMPLETED|Overall Study||178
10384902|NCT00624286|11526705|FG000|NOT COMPLETED|Overall Study||25
10384903|NCT00624286|11526706|FG001|NOT COMPLETED|Overall Study||27
10384904|NCT00624338|11526715|FG000|STARTED|Overall Study||159
10384905|NCT00624338|11526716|FG001|STARTED|Overall Study||145
10384906|NCT00624338|11526717|FG002|STARTED|Overall Study||157
10384907|NCT00624338|11526715|FG000|Treated|Overall Study||157
10384908|NCT00624338|11526716|FG001|Treated|Overall Study||144
10384909|NCT00624338|11526717|FG002|Treated|Overall Study||154
10384910|NCT00624338|11526715|FG000|COMPLETED|Overall Study||112
10384911|NCT00624338|11526716|FG001|COMPLETED|Overall Study||62
10384912|NCT00624338|11526717|FG002|COMPLETED|Overall Study||111
10384913|NCT00624338|11526715|FG000|NOT COMPLETED|Overall Study||47
10384914|NCT00624338|11526716|FG001|NOT COMPLETED|Overall Study||83
10540691|NCT01468207|11693840|FG002|NOT COMPLETED|Treatment Period 1||0
10540692|NCT01468207|11693841|FG003|NOT COMPLETED|Treatment Period 1||0
10540693|NCT01468207|11693842|FG004|NOT COMPLETED|Treatment Period 1||0
10540694|NCT01468207|11693843|FG005|NOT COMPLETED|Treatment Period 1||0
10540695|NCT01468207|11693838|FG000|STARTED|Treatment Period 2||0
10540696|NCT01468207|11693839|FG001|STARTED|Treatment Period 2||0
10540697|NCT01468207|11693840|FG002|STARTED|Treatment Period 2||145
10540698|NCT01468207|11693841|FG003|STARTED|Treatment Period 2||49
10540699|NCT01468207|11693842|FG004|STARTED|Treatment Period 2||48
10540700|NCT01468207|11693843|FG005|STARTED|Treatment Period 2||48
10540701|NCT01468207|11693838|FG000|COMPLETED|Treatment Period 2||0
10540702|NCT01468207|11693839|FG001|COMPLETED|Treatment Period 2||0
10540703|NCT01468207|11693840|FG002|COMPLETED|Treatment Period 2||93
10540704|NCT01468207|11693841|FG003|COMPLETED|Treatment Period 2||22
10812696|NCT03361228|11974841|FG000|COMPLETED|Overall Study||0
10540705|NCT01468207|11693842|FG004|COMPLETED|Treatment Period 2||27
10540706|NCT01468207|11693843|FG005|COMPLETED|Treatment Period 2||28
10540707|NCT01468207|11693838|FG000|NOT COMPLETED|Treatment Period 2||0
10540708|NCT01468207|11693839|FG001|NOT COMPLETED|Treatment Period 2||0
10540709|NCT01468207|11693840|FG002|NOT COMPLETED|Treatment Period 2||52
10540710|NCT01468207|11693841|FG003|NOT COMPLETED|Treatment Period 2||27
10540711|NCT01468207|11693842|FG004|NOT COMPLETED|Treatment Period 2||21
10540712|NCT01468207|11693843|FG005|NOT COMPLETED|Treatment Period 2||20
10540713|NCT01468233|11693863|FG000|STARTED|Treatment Period 1||163
10540714|NCT01468233|11693864|FG001|STARTED|Treatment Period 1||163
10540715|NCT01468233|11693865|FG002|STARTED|Treatment Period 1||0
10540716|NCT01468233|11693866|FG003|STARTED|Treatment Period 1||0
10540717|NCT01468233|11693867|FG004|STARTED|Treatment Period 1||0
10540718|NCT01468233|11693868|FG005|STARTED|Treatment Period 1||0
10540719|NCT01468233|11693863|FG000|COMPLETED|Treatment Period 1||151
10540720|NCT01468233|11693864|FG001|COMPLETED|Treatment Period 1||155
10540721|NCT01468233|11693865|FG002|COMPLETED|Treatment Period 1||0
10540722|NCT01468233|11693866|FG003|COMPLETED|Treatment Period 1||0
10540723|NCT01468233|11693867|FG004|COMPLETED|Treatment Period 1||0
10540724|NCT01468233|11693868|FG005|COMPLETED|Treatment Period 1||0
10540725|NCT01468233|11693863|FG000|NOT COMPLETED|Treatment Period 1||12
10540726|NCT01468233|11693864|FG001|NOT COMPLETED|Treatment Period 1||8
10540727|NCT01468233|11693865|FG002|NOT COMPLETED|Treatment Period 1||0
10540728|NCT01468233|11693866|FG003|NOT COMPLETED|Treatment Period 1||0
10540729|NCT01468233|11693867|FG004|NOT COMPLETED|Treatment Period 1||0
10540730|NCT01468233|11693868|FG005|NOT COMPLETED|Treatment Period 1||0
10540731|NCT01468233|11693863|FG000|STARTED|Treatment Period 2||0
10540732|NCT01468233|11693864|FG001|STARTED|Treatment Period 2||0
10718068|NCT02703324|11882031|FG005|Received Study Drug|Period Four||5
10718069|NCT02703324|11882026|FG000|COMPLETED|Period Four||5
10540733|NCT01468233|11693865|FG002|STARTED|Treatment Period 2||151
10540734|NCT01468233|11693866|FG003|STARTED|Treatment Period 2||51
10540735|NCT01468233|11693867|FG004|STARTED|Treatment Period 2||53
10540736|NCT01468233|11693868|FG005|STARTED|Treatment Period 2||51
10540737|NCT01468233|11693863|FG000|COMPLETED|Treatment Period 2||0
10540738|NCT01468233|11693864|FG001|COMPLETED|Treatment Period 2||0
10540739|NCT01468233|11693865|FG002|COMPLETED|Treatment Period 2||40
10540740|NCT01468233|11693866|FG003|COMPLETED|Treatment Period 2||23
10540741|NCT01468233|11693867|FG004|COMPLETED|Treatment Period 2||25
10540742|NCT01468233|11693868|FG005|COMPLETED|Treatment Period 2||28
10540743|NCT01468233|11693863|FG000|NOT COMPLETED|Treatment Period 2||0
10540744|NCT01468233|11693864|FG001|NOT COMPLETED|Treatment Period 2||0
10718070|NCT02703324|11882027|FG001|COMPLETED|Period Four||4
10718071|NCT02703324|11882028|FG002|COMPLETED|Period Four||4
10718072|NCT02703324|11882029|FG003|COMPLETED|Period Four||5
10718073|NCT02703324|11882030|FG004|COMPLETED|Period Four||5
10718074|NCT02703324|11882031|FG005|COMPLETED|Period Four||5
10718075|NCT02703324|11882026|FG000|NOT COMPLETED|Period Four||0
10718076|NCT02703324|11882027|FG001|NOT COMPLETED|Period Four||0
10718077|NCT02703324|11882028|FG002|NOT COMPLETED|Period Four||0
10718078|NCT02703324|11882029|FG003|NOT COMPLETED|Period Four||0
10718079|NCT02703324|11882030|FG004|NOT COMPLETED|Period Four||0
10718080|NCT02703324|11882031|FG005|NOT COMPLETED|Period Four||0
10384915|NCT00624338|11526717|FG002|NOT COMPLETED|Overall Study||46
10384916|NCT00624377|11526725|FG000|STARTED|Overall Study||2031
10384917|NCT00624377|11526725|FG000|COMPLETED|Overall Study||1387
10384918|NCT00624377|11526725|FG000|NOT COMPLETED|Overall Study||644
10540745|NCT01468233|11693865|FG002|NOT COMPLETED|Treatment Period 2||111
10540746|NCT01468233|11693866|FG003|NOT COMPLETED|Treatment Period 2||28
10718081|NCT02703337|11882040|FG000|STARTED|Period One (Part A)||5
10718082|NCT02703337|11882041|FG001|STARTED|Period One (Part A)||5
10718083|NCT02703337|11882042|FG002|STARTED|Period One (Part A)||5
10718084|NCT02703337|11882043|FG003|STARTED|Period One (Part A)||5
10718085|NCT02703337|11882044|FG004|STARTED|Period One (Part A)||5
10718086|NCT02703337|11882045|FG005|STARTED|Period One (Part A)||5
10718087|NCT02703337|11882046|FG006|STARTED|Period One (Part A)||0
10718088|NCT02703337|11882047|FG007|STARTED|Period One (Part A)||0
10718089|NCT02703337|11882040|FG000|Received Study Drug|Period One (Part A)||5
10384919|NCT00624416|11526729|FG000|STARTED|Overall Study||10
10384920|NCT00624416|11526729|FG000|COMPLETED|Overall Study||10
10384921|NCT00624416|11526729|FG000|NOT COMPLETED|Overall Study||0
10384922|NCT00624442|11526738|FG000|STARTED|Overall Study||8
10384923|NCT00624442|11526739|FG001|STARTED|Overall Study||9
10384924|NCT00624442|11526740|FG002|STARTED|Overall Study||10
10384925|NCT00624442|11526741|FG003|STARTED|Overall Study||8
10384926|NCT00624442|11526742|FG004|STARTED|Overall Study||10
10384927|NCT00624442|11526738|FG000|COMPLETED|Overall Study||8
10384928|NCT00624442|11526739|FG001|COMPLETED|Overall Study|One patient was discontinued after inadvertant overdose.|8
10384929|NCT00624442|11526740|FG002|COMPLETED|Overall Study|Two patients discontinued after meeting termination criteria during dosing.|8
10384930|NCT00624442|11526741|FG003|COMPLETED|Overall Study||8
10384931|NCT00624442|11526742|FG004|COMPLETED|Overall Study|Two patients discontinued after meeting termination criteria during dosing.|8
10384932|NCT00624442|11526738|FG000|NOT COMPLETED|Overall Study||0
10384933|NCT00624442|11526739|FG001|NOT COMPLETED|Overall Study||1
10384934|NCT00624442|11526740|FG002|NOT COMPLETED|Overall Study||2
10384935|NCT00624442|11526741|FG003|NOT COMPLETED|Overall Study||0
10384936|NCT00624442|11526742|FG004|NOT COMPLETED|Overall Study||2
10718090|NCT02703337|11882041|FG001|Received Study Drug|Period One (Part A)||5
10718091|NCT02703337|11882042|FG002|Received Study Drug|Period One (Part A)||5
10718092|NCT02703337|11882043|FG003|Received Study Drug|Period One (Part A)||5
10384937|NCT00624468|11526777|FG000|STARTED|Double-blind Period||17
10384938|NCT00624468|11526778|FG001|STARTED|Double-blind Period||17
10384939|NCT00624468|11526779|FG002|STARTED|Double-blind Period||0
10384940|NCT00624468|11526780|FG003|STARTED|Double-blind Period||0
10384941|NCT00624468|11526777|FG000|COMPLETED|Double-blind Period||3
10384942|NCT00624468|11526778|FG001|COMPLETED|Double-blind Period||4
10384943|NCT00624468|11526779|FG002|COMPLETED|Double-blind Period||0
10384944|NCT00624468|11526780|FG003|COMPLETED|Double-blind Period||0
10384945|NCT00624468|11526777|FG000|NOT COMPLETED|Double-blind Period||14
10384946|NCT00624468|11526778|FG001|NOT COMPLETED|Double-blind Period||13
10384947|NCT00624468|11526779|FG002|NOT COMPLETED|Double-blind Period||0
10384948|NCT00624468|11526780|FG003|NOT COMPLETED|Double-blind Period||0
10384949|NCT00624468|11526777|FG000|STARTED|Safety Follow-up (SFU) Period||0
10384950|NCT00624468|11526778|FG001|STARTED|Safety Follow-up (SFU) Period||0
10384951|NCT00624468|11526779|FG002|STARTED|Safety Follow-up (SFU) Period||13
10384952|NCT00624468|11526780|FG003|STARTED|Safety Follow-up (SFU) Period||14
10384953|NCT00624468|11526777|FG000|COMPLETED|Safety Follow-up (SFU) Period||0
10384954|NCT00624468|11526778|FG001|COMPLETED|Safety Follow-up (SFU) Period||0
10384955|NCT00624468|11526779|FG002|COMPLETED|Safety Follow-up (SFU) Period||11
10384956|NCT00624468|11526780|FG003|COMPLETED|Safety Follow-up (SFU) Period||11
10384957|NCT00624468|11526777|FG000|NOT COMPLETED|Safety Follow-up (SFU) Period||0
10384958|NCT00624468|11526778|FG001|NOT COMPLETED|Safety Follow-up (SFU) Period||0
10384959|NCT00624468|11526779|FG002|NOT COMPLETED|Safety Follow-up (SFU) Period||2
10384960|NCT00624468|11526780|FG003|NOT COMPLETED|Safety Follow-up (SFU) Period||3
10384961|NCT00624520|11526790|FG000|STARTED|Overall Study||56
10384962|NCT00624520|11526791|FG001|STARTED|Overall Study||47
10384963|NCT00624520|11526790|FG000|COMPLETED|Overall Study||44
10384964|NCT00624520|11526791|FG001|COMPLETED|Overall Study||39
10718093|NCT02703337|11882044|FG004|Received Study Drug|Period One (Part A)||5
10718094|NCT02703337|11882045|FG005|Received Study Drug|Period One (Part A)||5
10718095|NCT02703337|11882046|FG006|Received Study Drug|Period One (Part A)||0
10384965|NCT00624520|11526790|FG000|NOT COMPLETED|Overall Study||12
10384966|NCT00624520|11526791|FG001|NOT COMPLETED|Overall Study||8
10384967|NCT00624559|11526801|FG000|STARTED|Overall Study|Celebrex 1st: 3days baseline(100mmol), 7days high(350mmol) followed by 7days low(20mmol) sodium/day|3
10384968|NCT00624559|11526802|FG001|STARTED|Overall Study|Celebrex 1st: 3days baseline(100mmol), 7days low(20mmol) followed by 7days high(350mmol) sodium/day|3
10384969|NCT00624559|11526803|FG002|STARTED|Overall Study|Placebo 1st: 3days baseline(100mmol), 7days low(20mmol) followed by 7days high(350mmol) sodium/day|3
10384970|NCT00624559|11526804|FG003|STARTED|Overall Study|Placebo 1st: 3days baseline(100mmol), 7days high(350mmol) followed by 7days low(20mmol) sodium/day|3
10384971|NCT00624559|11526801|FG000|COMPLETED|Overall Study||3
10384972|NCT00624559|11526802|FG001|COMPLETED|Overall Study||3
10718096|NCT02703337|11882047|FG007|Received Study Drug|Period One (Part A)||0
10540747|NCT01468233|11693867|FG004|NOT COMPLETED|Treatment Period 2||28
10540748|NCT01468233|11693868|FG005|NOT COMPLETED|Treatment Period 2||23
10540749|NCT01468311|11693886|FG000|STARTED|Overall Study||6
10540750|NCT01468311|11693886|FG000|COMPLETED|Overall Study||4
10540751|NCT01468311|11693886|FG000|NOT COMPLETED|Overall Study||2
10540752|NCT01468337|11693890|FG000|STARTED|Overall Study||5
10540753|NCT01468337|11693890|FG000|Week 2|Overall Study||5
10540754|NCT01468337|11693890|FG000|Received Interferon Gamma-1b at Week 4|Overall Study|One participant received additional Interferon gamma-1b dosing at Week 4 and after Week 8|2
10540755|NCT01468337|11693890|FG000|Received Interferon Gamma-1b After Wk 8|Overall Study|Two participants had 2 Interferon gamma-1b dosing cycles after Wk 8|4
10540756|NCT01468337|11693890|FG000|Week 48|Overall Study|Two participants did not have a Week 48 visit but completed the study.|3
10540757|NCT01468337|11693890|FG000|COMPLETED|Overall Study||5
10540758|NCT01468337|11693890|FG000|NOT COMPLETED|Overall Study||0
10658249|NCT02232074|11819394|FG000|NOT COMPLETED|Overall Study||41
10658250|NCT02232074|11819395|FG001|NOT COMPLETED|Overall Study||45
10658251|NCT02232126|11819409|FG000|STARTED|Overall Study||91
10658252|NCT02232126|11819410|FG001|STARTED|Overall Study||90
10658253|NCT02232126|11819409|FG000|COMPLETED|Overall Study||91
10658254|NCT02232126|11819410|FG001|COMPLETED|Overall Study||90
10658255|NCT02232126|11819409|FG000|NOT COMPLETED|Overall Study||0
10658256|NCT02232126|11819410|FG001|NOT COMPLETED|Overall Study||0
10658257|NCT02232178|11819421|FG000|STARTED|Overall Study||26
10384973|NCT00624559|11526803|FG002|COMPLETED|Overall Study||3
10384974|NCT00624559|11526804|FG003|COMPLETED|Overall Study||3
10384975|NCT00624559|11526801|FG000|NOT COMPLETED|Overall Study||0
10384976|NCT00624559|11526802|FG001|NOT COMPLETED|Overall Study||0
10384977|NCT00624559|11526803|FG002|NOT COMPLETED|Overall Study||0
10384978|NCT00624559|11526804|FG003|NOT COMPLETED|Overall Study||0
10384979|NCT00624585|11526814|FG000|STARTED|Overall Study||18
10384980|NCT00624585|11526814|FG000|COMPLETED|Overall Study||6
10384981|NCT00624585|11526814|FG000|NOT COMPLETED|Overall Study||12
10384982|NCT00624780|11526824|FG000|STARTED|Treatment Optimization (Up to Week 12)||154
10384983|NCT00624780|11526825|FG001|STARTED|Treatment Optimization (Up to Week 12)||52
10384984|NCT00624780|11526826|FG002|STARTED|Treatment Optimization (Up to Week 12)||154
10384985|NCT00624780|11526827|FG003|STARTED|Treatment Optimization (Up to Week 12)||52
10540759|NCT01468350|11693898|FG000|STARTED|(PART A) Day 1, Day 3||6
10540760|NCT01468350|11693899|FG001|STARTED|(PART A) Day 1, Day 3||5
10540761|NCT01468350|11693900|FG002|STARTED|(PART A) Day 1, Day 3||0
10540762|NCT01468350|11693901|FG003|STARTED|(PART A) Day 1, Day 3||0
10540763|NCT01468350|11693898|FG000|COMPLETED|(PART A) Day 1, Day 3||6
10540764|NCT01468350|11693899|FG001|COMPLETED|(PART A) Day 1, Day 3||5
10540765|NCT01468350|11693900|FG002|COMPLETED|(PART A) Day 1, Day 3||0
10540766|NCT01468350|11693901|FG003|COMPLETED|(PART A) Day 1, Day 3||0
10540767|NCT01468350|11693898|FG000|NOT COMPLETED|(PART A) Day 1, Day 3||0
10540768|NCT01468350|11693899|FG001|NOT COMPLETED|(PART A) Day 1, Day 3||0
10540769|NCT01468350|11693900|FG002|NOT COMPLETED|(PART A) Day 1, Day 3||0
10540770|NCT01468350|11693901|FG003|NOT COMPLETED|(PART A) Day 1, Day 3||0
10540771|NCT01468350|11693898|FG000|STARTED|(PART B) Day 1, Day 15||0
10540772|NCT01468350|11693899|FG001|STARTED|(PART B) Day 1, Day 15||0
10540773|NCT01468350|11693900|FG002|STARTED|(PART B) Day 1, Day 15||12
10540774|NCT01468350|11693901|FG003|STARTED|(PART B) Day 1, Day 15||12
10658258|NCT02232178|11819422|FG001|STARTED|Overall Study||25
10658259|NCT02232178|11819423|FG002|STARTED|Overall Study||13
10658260|NCT02232178|11819421|FG000|Per Protocol PK Population|Overall Study||26
10658261|NCT02232178|11819422|FG001|Per Protocol PK Population|Overall Study||24
10658262|NCT02232178|11819423|FG002|Per Protocol PK Population|Overall Study||11
10658263|NCT02232178|11819421|FG000|Safety Population|Overall Study||26
10658264|NCT02232178|11819422|FG001|Safety Population|Overall Study||24
10658265|NCT02232178|11819423|FG002|Safety Population|Overall Study||12
10658266|NCT02232178|11819421|FG000|COMPLETED|Overall Study||25
10658267|NCT02232178|11819422|FG001|COMPLETED|Overall Study||24
10658268|NCT02232178|11819423|FG002|COMPLETED|Overall Study||12
10658269|NCT02232178|11819421|FG000|NOT COMPLETED|Overall Study||1
10658270|NCT02232178|11819422|FG001|NOT COMPLETED|Overall Study||1
10658271|NCT02232178|11819423|FG002|NOT COMPLETED|Overall Study||1
10658272|NCT02232243|11819434|FG000|STARTED|First Dose (200mg HCQ Twice Daily)||3
10658273|NCT02232243|11819435|FG001|STARTED|First Dose (200mg HCQ Twice Daily)||0
10658274|NCT02232243|11819436|FG002|STARTED|First Dose (200mg HCQ Twice Daily)||0
10658275|NCT02232243|11819434|FG000|COMPLETED|First Dose (200mg HCQ Twice Daily)||3
10658276|NCT02232243|11819435|FG001|COMPLETED|First Dose (200mg HCQ Twice Daily)||0
10658277|NCT02232243|11819436|FG002|COMPLETED|First Dose (200mg HCQ Twice Daily)||0
10658278|NCT02232243|11819434|FG000|NOT COMPLETED|First Dose (200mg HCQ Twice Daily)||0
10658279|NCT02232243|11819435|FG001|NOT COMPLETED|First Dose (200mg HCQ Twice Daily)||0
10658280|NCT02232243|11819436|FG002|NOT COMPLETED|First Dose (200mg HCQ Twice Daily)||0
10658281|NCT02232243|11819434|FG000|STARTED|Second Dose (400mg HCQ Twice Daily)||0
10658282|NCT02232243|11819435|FG001|STARTED|Second Dose (400mg HCQ Twice Daily)||4
10658283|NCT02232243|11819436|FG002|STARTED|Second Dose (400mg HCQ Twice Daily)||0
10658284|NCT02232243|11819434|FG000|COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
10658285|NCT02232243|11819435|FG001|COMPLETED|Second Dose (400mg HCQ Twice Daily)||3
10658286|NCT02232243|11819436|FG002|COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
10658287|NCT02232243|11819434|FG000|NOT COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
10658288|NCT02232243|11819435|FG001|NOT COMPLETED|Second Dose (400mg HCQ Twice Daily)||1
10658289|NCT02232243|11819436|FG002|NOT COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
10718097|NCT02703337|11882040|FG000|COMPLETED|Period One (Part A)||5
10718098|NCT02703337|11882041|FG001|COMPLETED|Period One (Part A)||5
10718099|NCT02703337|11882042|FG002|COMPLETED|Period One (Part A)||5
10718100|NCT02703337|11882043|FG003|COMPLETED|Period One (Part A)||5
10718101|NCT02703337|11882044|FG004|COMPLETED|Period One (Part A)||4
10718102|NCT02703337|11882045|FG005|COMPLETED|Period One (Part A)||5
10718103|NCT02703337|11882046|FG006|COMPLETED|Period One (Part A)||0
10718104|NCT02703337|11882047|FG007|COMPLETED|Period One (Part A)||0
10718105|NCT02703337|11882040|FG000|NOT COMPLETED|Period One (Part A)||0
10718106|NCT02703337|11882041|FG001|NOT COMPLETED|Period One (Part A)||0
10718107|NCT02703337|11882042|FG002|NOT COMPLETED|Period One (Part A)||0
10718108|NCT02703337|11882043|FG003|NOT COMPLETED|Period One (Part A)||0
10384986|NCT00624780|11526828|FG004|STARTED|Treatment Optimization (Up to Week 12)||153
10718109|NCT02703337|11882044|FG004|NOT COMPLETED|Period One (Part A)||1
10718110|NCT02703337|11882045|FG005|NOT COMPLETED|Period One (Part A)||0
10718111|NCT02703337|11882046|FG006|NOT COMPLETED|Period One (Part A)||0
10718112|NCT02703337|11882047|FG007|NOT COMPLETED|Period One (Part A)||0
10718113|NCT02703337|11882040|FG000|STARTED|Period Two (Part A)||5
10718114|NCT02703337|11882041|FG001|STARTED|Period Two (Part A)||5
10384987|NCT00624780|11526829|FG005|STARTED|Treatment Optimization (Up to Week 12)||50
10540775|NCT01468350|11693898|FG000|COMPLETED|(PART B) Day 1, Day 15||0
10540776|NCT01468350|11693899|FG001|COMPLETED|(PART B) Day 1, Day 15||0
10540777|NCT01468350|11693900|FG002|COMPLETED|(PART B) Day 1, Day 15||12
10384988|NCT00624780|11526824|FG000|COMPLETED|Treatment Optimization (Up to Week 12)||121
10384989|NCT00624780|11526825|FG001|COMPLETED|Treatment Optimization (Up to Week 12)||39
10384990|NCT00624780|11526826|FG002|COMPLETED|Treatment Optimization (Up to Week 12)||112
10384991|NCT00624780|11526827|FG003|COMPLETED|Treatment Optimization (Up to Week 12)||38
10384992|NCT00624780|11526828|FG004|COMPLETED|Treatment Optimization (Up to Week 12)||114
10384993|NCT00624780|11526829|FG005|COMPLETED|Treatment Optimization (Up to Week 12)||39
10384994|NCT00624780|11526824|FG000|NOT COMPLETED|Treatment Optimization (Up to Week 12)||33
10384995|NCT00624780|11526825|FG001|NOT COMPLETED|Treatment Optimization (Up to Week 12)||13
10384996|NCT00624780|11526826|FG002|NOT COMPLETED|Treatment Optimization (Up to Week 12)||42
10384997|NCT00624780|11526827|FG003|NOT COMPLETED|Treatment Optimization (Up to Week 12)||14
10384998|NCT00624780|11526828|FG004|NOT COMPLETED|Treatment Optimization (Up to Week 12)||39
10384999|NCT00624780|11526829|FG005|NOT COMPLETED|Treatment Optimization (Up to Week 12)||11
10385000|NCT00624780|11526824|FG000|STARTED|Fixed Dosing (Week 13 to Week 24)||121
10385001|NCT00624780|11526825|FG001|STARTED|Fixed Dosing (Week 13 to Week 24)||39
10385002|NCT00624780|11526826|FG002|STARTED|Fixed Dosing (Week 13 to Week 24)||112
10385003|NCT00624780|11526827|FG003|STARTED|Fixed Dosing (Week 13 to Week 24)||38
10385004|NCT00624780|11526828|FG004|STARTED|Fixed Dosing (Week 13 to Week 24)||114
10385005|NCT00624780|11526829|FG005|STARTED|Fixed Dosing (Week 13 to Week 24)||39
10385006|NCT00624780|11526824|FG000|COMPLETED|Fixed Dosing (Week 13 to Week 24)||106
10385007|NCT00624780|11526825|FG001|COMPLETED|Fixed Dosing (Week 13 to Week 24)||28
10385008|NCT00624780|11526826|FG002|COMPLETED|Fixed Dosing (Week 13 to Week 24)||94
10385009|NCT00624780|11526827|FG003|COMPLETED|Fixed Dosing (Week 13 to Week 24)||27
10385010|NCT00624780|11526828|FG004|COMPLETED|Fixed Dosing (Week 13 to Week 24)||95
10385011|NCT00624780|11526829|FG005|COMPLETED|Fixed Dosing (Week 13 to Week 24)||30
10385012|NCT00624780|11526824|FG000|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||15
10385013|NCT00624780|11526825|FG001|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||11
10385014|NCT00624780|11526826|FG002|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||18
10385015|NCT00624780|11526827|FG003|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||11
10385016|NCT00624780|11526828|FG004|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||19
10385017|NCT00624780|11526829|FG005|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||9
10385018|NCT00624780|11526824|FG000|STARTED|Treatment Discontinuation (Week 25)||106
10385019|NCT00624780|11526825|FG001|STARTED|Treatment Discontinuation (Week 25)||28
10385020|NCT00624780|11526826|FG002|STARTED|Treatment Discontinuation (Week 25)||94
10385021|NCT00624780|11526827|FG003|STARTED|Treatment Discontinuation (Week 25)||27
10385022|NCT00624780|11526828|FG004|STARTED|Treatment Discontinuation (Week 25)||95
10385023|NCT00624780|11526829|FG005|STARTED|Treatment Discontinuation (Week 25)||30
10385024|NCT00624780|11526824|FG000|COMPLETED|Treatment Discontinuation (Week 25)||104
10385025|NCT00624780|11526825|FG001|COMPLETED|Treatment Discontinuation (Week 25)||28
10385026|NCT00624780|11526826|FG002|COMPLETED|Treatment Discontinuation (Week 25)||91
10385027|NCT00624780|11526827|FG003|COMPLETED|Treatment Discontinuation (Week 25)||26
10385028|NCT00624780|11526828|FG004|COMPLETED|Treatment Discontinuation (Week 25)||95
10385029|NCT00624780|11526829|FG005|COMPLETED|Treatment Discontinuation (Week 25)||29
10385030|NCT00624780|11526824|FG000|NOT COMPLETED|Treatment Discontinuation (Week 25)||2
10385031|NCT00624780|11526825|FG001|NOT COMPLETED|Treatment Discontinuation (Week 25)||0
10385032|NCT00624780|11526826|FG002|NOT COMPLETED|Treatment Discontinuation (Week 25)||3
10385033|NCT00624780|11526827|FG003|NOT COMPLETED|Treatment Discontinuation (Week 25)||1
10718115|NCT02703337|11882042|FG002|STARTED|Period Two (Part A)||5
10385034|NCT00624780|11526828|FG004|NOT COMPLETED|Treatment Discontinuation (Week 25)||0
10385035|NCT00624780|11526829|FG005|NOT COMPLETED|Treatment Discontinuation (Week 25)||1
10385036|NCT00624780|11526824|FG000|STARTED|Follow-up (Week 26)||104
10385037|NCT00624780|11526825|FG001|STARTED|Follow-up (Week 26)||28
10385038|NCT00624780|11526826|FG002|STARTED|Follow-up (Week 26)||91
10385039|NCT00624780|11526827|FG003|STARTED|Follow-up (Week 26)||26
10385040|NCT00624780|11526828|FG004|STARTED|Follow-up (Week 26)||95
10385041|NCT00624780|11526829|FG005|STARTED|Follow-up (Week 26)||29
10385042|NCT00624780|11526824|FG000|COMPLETED|Follow-up (Week 26)||102
10385043|NCT00624780|11526825|FG001|COMPLETED|Follow-up (Week 26)||27
10385044|NCT00624780|11526826|FG002|COMPLETED|Follow-up (Week 26)||89
10385045|NCT00624780|11526827|FG003|COMPLETED|Follow-up (Week 26)||26
10385046|NCT00624780|11526828|FG004|COMPLETED|Follow-up (Week 26)||93
10385047|NCT00624780|11526829|FG005|COMPLETED|Follow-up (Week 26)||29
10385048|NCT00624780|11526824|FG000|NOT COMPLETED|Follow-up (Week 26)||2
10385049|NCT00624780|11526825|FG001|NOT COMPLETED|Follow-up (Week 26)||1
10385050|NCT00624780|11526826|FG002|NOT COMPLETED|Follow-up (Week 26)||2
10385051|NCT00624780|11526827|FG003|NOT COMPLETED|Follow-up (Week 26)||0
10385052|NCT00624780|11526828|FG004|NOT COMPLETED|Follow-up (Week 26)||2
10385053|NCT00624780|11526829|FG005|NOT COMPLETED|Follow-up (Week 26)||0
10385054|NCT00624806|11526848|FG000|STARTED|Overall Study||10
10385055|NCT00624806|11526849|FG001|STARTED|Overall Study||8
10385056|NCT00624806|11526848|FG000|COMPLETED|Overall Study||10
10385057|NCT00624806|11526849|FG001|COMPLETED|Overall Study||8
10385058|NCT00624806|11526848|FG000|NOT COMPLETED|Overall Study||0
10385059|NCT00624806|11526849|FG001|NOT COMPLETED|Overall Study||0
10385060|NCT00624819|11526859|FG000|STARTED|Follow-up Period: Year 1||391
10385061|NCT00624819|11526860|FG001|STARTED|Follow-up Period: Year 1||31
10718116|NCT02703337|11882043|FG003|STARTED|Period Two (Part A)||5
10385062|NCT00624819|11526861|FG002|STARTED|Follow-up Period: Year 1||102
10385063|NCT00624819|11526862|FG003|STARTED|Follow-up Period: Year 1||0
10385064|NCT00624819|11526859|FG000|COMPLETED|Follow-up Period: Year 1||391
10385065|NCT00624819|11526860|FG001|COMPLETED|Follow-up Period: Year 1||31
10385066|NCT00624819|11526861|FG002|COMPLETED|Follow-up Period: Year 1||102
10385067|NCT00624819|11526862|FG003|COMPLETED|Follow-up Period: Year 1||0
10385068|NCT00624819|11526859|FG000|NOT COMPLETED|Follow-up Period: Year 1||0
10385069|NCT00624819|11526860|FG001|NOT COMPLETED|Follow-up Period: Year 1||0
10385070|NCT00624819|11526861|FG002|NOT COMPLETED|Follow-up Period: Year 1||0
10385071|NCT00624819|11526862|FG003|NOT COMPLETED|Follow-up Period: Year 1||0
10385072|NCT00624819|11526859|FG000|STARTED|Follow-up Period: Year 2||370
10385073|NCT00624819|11526860|FG001|STARTED|Follow-up Period: Year 2||31
10385074|NCT00624819|11526861|FG002|STARTED|Follow-up Period: Year 2||96
10385075|NCT00624819|11526862|FG003|STARTED|Follow-up Period: Year 2||0
10385076|NCT00624819|11526859|FG000|COMPLETED|Follow-up Period: Year 2||370
10385077|NCT00624819|11526860|FG001|COMPLETED|Follow-up Period: Year 2||31
10385078|NCT00624819|11526861|FG002|COMPLETED|Follow-up Period: Year 2||96
10385079|NCT00624819|11526862|FG003|COMPLETED|Follow-up Period: Year 2||0
10385080|NCT00624819|11526859|FG000|NOT COMPLETED|Follow-up Period: Year 2||0
10385081|NCT00624819|11526860|FG001|NOT COMPLETED|Follow-up Period: Year 2||0
10385082|NCT00624819|11526861|FG002|NOT COMPLETED|Follow-up Period: Year 2||0
10385083|NCT00624819|11526862|FG003|NOT COMPLETED|Follow-up Period: Year 2||0
10385084|NCT00624819|11526859|FG000|STARTED|Follow-up Period: Year 4||264
10385085|NCT00624819|11526860|FG001|STARTED|Follow-up Period: Year 4||20
10385086|NCT00624819|11526861|FG002|STARTED|Follow-up Period: Year 4||65
10385087|NCT00624819|11526862|FG003|STARTED|Follow-up Period: Year 4||100
10385088|NCT00624819|11526859|FG000|COMPLETED|Follow-up Period: Year 4||263
10385089|NCT00624819|11526860|FG001|COMPLETED|Follow-up Period: Year 4||19
10385090|NCT00624819|11526861|FG002|COMPLETED|Follow-up Period: Year 4||64
10385091|NCT00624819|11526862|FG003|COMPLETED|Follow-up Period: Year 4||100
10385092|NCT00624819|11526859|FG000|NOT COMPLETED|Follow-up Period: Year 4||1
10385093|NCT00624819|11526860|FG001|NOT COMPLETED|Follow-up Period: Year 4||1
10385094|NCT00624819|11526861|FG002|NOT COMPLETED|Follow-up Period: Year 4||1
10385095|NCT00624819|11526862|FG003|NOT COMPLETED|Follow-up Period: Year 4||0
10385096|NCT00624832|11526876|FG000|STARTED|Overall Study||18
10385097|NCT00624832|11526877|FG001|STARTED|Overall Study||16
10385098|NCT00624832|11526878|FG002|STARTED|Overall Study||10
10385099|NCT00624832|11526879|FG003|STARTED|Overall Study||16
10385100|NCT00624832|11526876|FG000|COMPLETED|Overall Study||16
10385101|NCT00624832|11526877|FG001|COMPLETED|Overall Study||15
10385102|NCT00624832|11526878|FG002|COMPLETED|Overall Study||10
10385103|NCT00624832|11526879|FG003|COMPLETED|Overall Study||15
10385104|NCT00624832|11526876|FG000|NOT COMPLETED|Overall Study||2
10385105|NCT00624832|11526877|FG001|NOT COMPLETED|Overall Study||1
10385106|NCT00624832|11526878|FG002|NOT COMPLETED|Overall Study||0
10385107|NCT00624832|11526879|FG003|NOT COMPLETED|Overall Study||1
10385108|NCT00624910|11526891|FG000|STARTED|Overall Study||28
10385109|NCT00624910|11526892|FG001|STARTED|Overall Study||15
10385110|NCT00624910|11526893|FG002|STARTED|Overall Study||11
10385111|NCT00624910|11526891|FG000|COMPLETED|Overall Study||28
10385112|NCT00624910|11526892|FG001|COMPLETED|Overall Study||15
10385113|NCT00624910|11526893|FG002|COMPLETED|Overall Study||11
10385114|NCT00624910|11526891|FG000|NOT COMPLETED|Overall Study||0
10385115|NCT00624910|11526892|FG001|NOT COMPLETED|Overall Study||0
10385116|NCT00624910|11526893|FG002|NOT COMPLETED|Overall Study||0
10385117|NCT00624923|11526903|FG000|STARTED|Overall Study||127
10385118|NCT00624923|11526904|FG001|STARTED|Overall Study||124
10385119|NCT00624923|11526903|FG000|COMPLETED|Overall Study||89
10385120|NCT00624923|11526904|FG001|COMPLETED|Overall Study||101
10385121|NCT00624923|11526903|FG000|NOT COMPLETED|Overall Study||38
10385122|NCT00624923|11526904|FG001|NOT COMPLETED|Overall Study||23
10385123|NCT00625131|11526914|FG000|STARTED|Overall Study||38
10385124|NCT00625131|11526915|FG001|STARTED|Overall Study||44
10385125|NCT00625131|11526916|FG002|STARTED|Overall Study|These participants were not included in any analyses.|5
10385126|NCT00625131|11526914|FG000|COMPLETED|Overall Study||34
10385127|NCT00625131|11526915|FG001|COMPLETED|Overall Study||42
10385128|NCT00625131|11526916|FG002|COMPLETED|Overall Study||0
10385129|NCT00625131|11526914|FG000|NOT COMPLETED|Overall Study||4
10385130|NCT00625131|11526915|FG001|NOT COMPLETED|Overall Study||2
10385131|NCT00625131|11526916|FG002|NOT COMPLETED|Overall Study||5
10385132|NCT00625183|11526922|FG000|STARTED|Overall Study||5
10385133|NCT00625183|11526922|FG000|COMPLETED|Overall Study||4
10385134|NCT00625183|11526922|FG000|NOT COMPLETED|Overall Study||1
10385135|NCT00625365|11526928|FG000|STARTED|Overall Study||1060
10385136|NCT00625365|11526928|FG000|COMPLETED|Overall Study|Participants who were analyzed for safety|1053
10385137|NCT00625365|11526928|FG000|NOT COMPLETED|Overall Study||7
10385138|NCT00625391|11526936|FG000|STARTED|Overall Study||44
10385139|NCT00625391|11526937|FG001|STARTED|Overall Study||47
10385140|NCT00625391|11526938|FG002|STARTED|Overall Study||42
10385141|NCT00625391|11526939|FG003|STARTED|Overall Study||38
10385142|NCT00625391|11526936|FG000|COMPLETED|Overall Study||37
10385143|NCT00625391|11526937|FG001|COMPLETED|Overall Study||39
10385144|NCT00625391|11526938|FG002|COMPLETED|Overall Study||37
10385145|NCT00625391|11526939|FG003|COMPLETED|Overall Study||37
10385146|NCT00625391|11526936|FG000|NOT COMPLETED|Overall Study||7
10385147|NCT00625391|11526937|FG001|NOT COMPLETED|Overall Study||8
10385148|NCT00625391|11526938|FG002|NOT COMPLETED|Overall Study||5
10385149|NCT00625391|11526939|FG003|NOT COMPLETED|Overall Study||1
10385150|NCT00625404|11526951|FG000|STARTED|Overall Study||1062
10385151|NCT00625404|11526952|FG001|STARTED|Overall Study||1058
10385152|NCT00625404|11526951|FG000|COMPLETED|Overall Study||855
10385153|NCT00625404|11526952|FG001|COMPLETED|Overall Study||885
10385154|NCT00625404|11526951|FG000|NOT COMPLETED|Overall Study||207
10385155|NCT00625404|11526952|FG001|NOT COMPLETED|Overall Study||173
10385156|NCT00625443|11526965|FG000|STARTED|Overall Study||12
10385157|NCT00625443|11526966|FG001|STARTED|Overall Study||26
10385158|NCT00625443|11526967|FG002|STARTED|Overall Study||15
10385159|NCT00625443|11526965|FG000|COMPLETED|Overall Study||10
10385160|NCT00625443|11526966|FG001|COMPLETED|Overall Study||15
10385161|NCT00625443|11526967|FG002|COMPLETED|Overall Study||10
10385162|NCT00625443|11526965|FG000|NOT COMPLETED|Overall Study||2
10385163|NCT00625443|11526966|FG001|NOT COMPLETED|Overall Study||11
10385164|NCT00625443|11526967|FG002|NOT COMPLETED|Overall Study||5
10385165|NCT00625729|11526978|FG000|STARTED|Overall Study||6
10385166|NCT00625729|11526978|FG000|COMPLETED|Overall Study||6
10385167|NCT00625729|11526978|FG000|NOT COMPLETED|Overall Study||0
10385168|NCT00625807|11526985|FG000|STARTED|Overall Study||22
10385169|NCT00625807|11526986|FG001|STARTED|Overall Study||28
10385170|NCT00625807|11526985|FG000|COMPLETED|Overall Study||20
10385171|NCT00625807|11526986|FG001|COMPLETED|Overall Study||20
10385172|NCT00625807|11526985|FG000|NOT COMPLETED|Overall Study||2
10385173|NCT00625807|11526986|FG001|NOT COMPLETED|Overall Study||8
10385174|NCT00625820|11526994|FG000|STARTED|Overall Study||17
10385175|NCT00625820|11526994|FG000|COMPLETED|Overall Study||16
10385176|NCT00625820|11526994|FG000|NOT COMPLETED|Overall Study||1
10385177|NCT00625846|11527003|FG000|STARTED|Overall Study||39
10385178|NCT00625846|11527004|FG001|STARTED|Overall Study||35
10385179|NCT00625846|11527005|FG002|STARTED|Overall Study||16
10385180|NCT00625846|11527006|FG003|STARTED|Overall Study||62
10385181|NCT00625846|11527003|FG000|COMPLETED|Overall Study||37
10385182|NCT00625846|11527004|FG001|COMPLETED|Overall Study||35
10385183|NCT00625846|11527005|FG002|COMPLETED|Overall Study||15
10385184|NCT00625846|11527006|FG003|COMPLETED|Overall Study||60
10385185|NCT00625846|11527003|FG000|NOT COMPLETED|Overall Study||2
10385186|NCT00625846|11527004|FG001|NOT COMPLETED|Overall Study||0
10385187|NCT00625846|11527005|FG002|NOT COMPLETED|Overall Study||1
10385188|NCT00625846|11527006|FG003|NOT COMPLETED|Overall Study||2
10385189|NCT00625872|11527022|FG000|STARTED|Overall Study||12
10385190|NCT00625872|11527023|FG001|STARTED|Overall Study||11
10385191|NCT00625872|11527022|FG000|Treated|Overall Study||12
10385192|NCT00625872|11527023|FG001|Treated|Overall Study||10
10385193|NCT00625872|11527022|FG000|COMPLETED|Overall Study||8
10385194|NCT00625872|11527023|FG001|COMPLETED|Overall Study||5
10385195|NCT00625872|11527022|FG000|NOT COMPLETED|Overall Study||4
10385196|NCT00625872|11527023|FG001|NOT COMPLETED|Overall Study||6
10385197|NCT00625989|11527029|FG000|STARTED|Overall Study||6
10385198|NCT00625989|11527030|FG001|STARTED|Overall Study||6
10385199|NCT00625989|11527029|FG000|COMPLETED|Overall Study||6
10385200|NCT00625989|11527030|FG001|COMPLETED|Overall Study||6
10385201|NCT00625989|11527029|FG000|NOT COMPLETED|Overall Study||0
10385202|NCT00625989|11527030|FG001|NOT COMPLETED|Overall Study||0
10428263|NCT00857207|11574238|FG001|STARTED|Overall Study||3
10428264|NCT00857207|11574237|FG000|COMPLETED|Overall Study||14
10428265|NCT00857207|11574238|FG001|COMPLETED|Overall Study||3
10428266|NCT00857207|11574237|FG000|NOT COMPLETED|Overall Study||34
10428267|NCT00857207|11574238|FG001|NOT COMPLETED|Overall Study||0
10428268|NCT00857220|11574245|FG000|STARTED|Overall Study||304
10428269|NCT00857220|11574245|FG000|COMPLETED|Overall Study||121
10428270|NCT00857220|11574245|FG000|NOT COMPLETED|Overall Study||183
10428271|NCT00857233|11574249|FG000|STARTED|Overall Study||297
10428272|NCT00857233|11574249|FG000|COMPLETED|Overall Study||242
10428273|NCT00857233|11574249|FG000|NOT COMPLETED|Overall Study||55
10428274|NCT00857246|11574253|FG000|STARTED|Induction Regimen||30
10428275|NCT00857246|11574253|FG000|COMPLETED|Induction Regimen||27
10428276|NCT00857246|11574253|FG000|NOT COMPLETED|Induction Regimen||3
10428277|NCT00857246|11574253|FG000|STARTED|Surgery (Curative)||27
10428278|NCT00857246|11574253|FG000|COMPLETED|Surgery (Curative)||21
10428279|NCT00857246|11574253|FG000|NOT COMPLETED|Surgery (Curative)||6
10428280|NCT00857246|11574253|FG000|STARTED|ChemoRT|6 did not start adjuvant therapy due to disease-related complications or patient withdrawal.|15
10428281|NCT00857246|11574253|FG000|COMPLETED|ChemoRT||12
10428282|NCT00857246|11574253|FG000|NOT COMPLETED|ChemoRT||3
10428283|NCT00857259|11574263|FG000|STARTED|Overall Study||8
10428284|NCT00857259|11574264|FG001|STARTED|Overall Study||1
10428285|NCT00857259|11574265|FG002|STARTED|Overall Study||7
10428286|NCT00857259|11574263|FG000|COMPLETED|Overall Study||7
10428287|NCT00857259|11574264|FG001|COMPLETED|Overall Study||1
10428288|NCT00857259|11574265|FG002|COMPLETED|Overall Study||6
10428289|NCT00857259|11574263|FG000|NOT COMPLETED|Overall Study||1
10428290|NCT00857259|11574264|FG001|NOT COMPLETED|Overall Study||0
10428291|NCT00857259|11574265|FG002|NOT COMPLETED|Overall Study||1
10428292|NCT00857272|11574277|FG000|STARTED|Overall Study|Includes 6 non-ITT patients that withdrew consent|154
10428293|NCT00857272|11574278|FG001|STARTED|Overall Study|Includes 7 non-ITT patients that withdrew consent|154
10428294|NCT00857272|11574277|FG000|COMPLETED|Overall Study||145
10428295|NCT00857272|11574278|FG001|COMPLETED|Overall Study||145
10428296|NCT00857272|11574277|FG000|NOT COMPLETED|Overall Study||9
10428297|NCT00857272|11574278|FG001|NOT COMPLETED|Overall Study||9
10428298|NCT00857311|11574288|FG000|STARTED|Overall Study||9
10428299|NCT00857311|11574289|FG001|STARTED|Overall Study||0
10428300|NCT00857311|11574290|FG002|STARTED|Overall Study||8
10428301|NCT00857311|11574291|FG003|STARTED|Overall Study||0
10428302|NCT00857311|11574288|FG000|COMPLETED|Overall Study||8
10428303|NCT00857311|11574289|FG001|COMPLETED|Overall Study||0
10428304|NCT00857311|11574290|FG002|COMPLETED|Overall Study||8
10428305|NCT00857311|11574291|FG003|COMPLETED|Overall Study||0
10385203|NCT00626028|11527037|FG000|STARTED|Overall Study||68
10385204|NCT00626028|11527038|FG001|STARTED|Overall Study||68
10385205|NCT00626028|11527037|FG000|COMPLETED|Overall Study||62
10385206|NCT00626028|11527038|FG001|COMPLETED|Overall Study||59
10385207|NCT00626028|11527037|FG000|NOT COMPLETED|Overall Study||6
10385208|NCT00626028|11527038|FG001|NOT COMPLETED|Overall Study||9
10385209|NCT00626093|11527044|FG000|STARTED|Overall Study||77
10385210|NCT00626093|11527044|FG000|COMPLETED|Overall Study||54
10385211|NCT00626093|11527044|FG000|NOT COMPLETED|Overall Study||23
10385212|NCT00626197|11527051|FG000|STARTED|Overall Study||127
10385213|NCT00626197|11527052|FG001|STARTED|Overall Study||128
10385214|NCT00626197|11527053|FG002|STARTED|Overall Study||126
10385215|NCT00626197|11527051|FG000|COMPLETED|Overall Study||83
10385216|NCT00626197|11527052|FG001|COMPLETED|Overall Study||74
10385217|NCT00626197|11527053|FG002|COMPLETED|Overall Study||49
10385218|NCT00626197|11527051|FG000|NOT COMPLETED|Overall Study||44
10385219|NCT00626197|11527052|FG001|NOT COMPLETED|Overall Study||54
10385220|NCT00626197|11527053|FG002|NOT COMPLETED|Overall Study||77
10385221|NCT00626210|11527067|FG000|STARTED|Overall Study||2
10385222|NCT00626210|11527067|FG000|COMPLETED|Overall Study||2
10385223|NCT00626210|11527067|FG000|NOT COMPLETED|Overall Study||0
10385224|NCT00626275|11527071|FG000|STARTED|Part A - Treatment Period 1||7
10385225|NCT00626275|11527072|FG001|STARTED|Part A - Treatment Period 1||7
10385226|NCT00626275|11527073|FG002|STARTED|Part A - Treatment Period 1||7
10385227|NCT00626275|11527074|FG003|STARTED|Part A - Treatment Period 1||8
10385228|NCT00626275|11527075|FG004|STARTED|Part A - Treatment Period 1||9
10385229|NCT00626275|11527076|FG005|STARTED|Part A - Treatment Period 1||8
10385230|NCT00626275|11527077|FG006|STARTED|Part A - Treatment Period 1||0
10385231|NCT00626275|11527078|FG007|STARTED|Part A - Treatment Period 1||0
10385232|NCT00626275|11527071|FG000|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
10385233|NCT00626275|11527072|FG001|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
10385234|NCT00626275|11527073|FG002|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
10385235|NCT00626275|11527074|FG003|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||8
10385236|NCT00626275|11527075|FG004|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||9
10385237|NCT00626275|11527076|FG005|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||8
10385238|NCT00626275|11527077|FG006|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||0
10385239|NCT00626275|11527078|FG007|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||0
10385240|NCT00626275|11527071|FG000|COMPLETED|Part A - Treatment Period 1||6
10385241|NCT00626275|11527072|FG001|COMPLETED|Part A - Treatment Period 1||7
10385242|NCT00626275|11527073|FG002|COMPLETED|Part A - Treatment Period 1||6
10385243|NCT00626275|11527074|FG003|COMPLETED|Part A - Treatment Period 1||8
10385244|NCT00626275|11527075|FG004|COMPLETED|Part A - Treatment Period 1||9
10385245|NCT00626275|11527076|FG005|COMPLETED|Part A - Treatment Period 1||8
10385246|NCT00626275|11527077|FG006|COMPLETED|Part A - Treatment Period 1||0
10385247|NCT00626275|11527078|FG007|COMPLETED|Part A - Treatment Period 1||0
10385248|NCT00626275|11527071|FG000|NOT COMPLETED|Part A - Treatment Period 1||1
10385249|NCT00626275|11527072|FG001|NOT COMPLETED|Part A - Treatment Period 1||0
10385250|NCT00626275|11527073|FG002|NOT COMPLETED|Part A - Treatment Period 1||1
10385251|NCT00626275|11527074|FG003|NOT COMPLETED|Part A - Treatment Period 1||0
10385252|NCT00626275|11527075|FG004|NOT COMPLETED|Part A - Treatment Period 1||0
10385253|NCT00626275|11527076|FG005|NOT COMPLETED|Part A - Treatment Period 1||0
10385254|NCT00626275|11527077|FG006|NOT COMPLETED|Part A - Treatment Period 1||0
10385255|NCT00626275|11527078|FG007|NOT COMPLETED|Part A - Treatment Period 1||0
10385256|NCT00626275|11527071|FG000|STARTED|Part A - Washout Period 1||6
10385257|NCT00626275|11527072|FG001|STARTED|Part A - Washout Period 1||7
10385258|NCT00626275|11527073|FG002|STARTED|Part A - Washout Period 1||6
10385259|NCT00626275|11527074|FG003|STARTED|Part A - Washout Period 1||8
10385260|NCT00626275|11527075|FG004|STARTED|Part A - Washout Period 1||9
10385261|NCT00626275|11527076|FG005|STARTED|Part A - Washout Period 1||8
10385262|NCT00626275|11527077|FG006|STARTED|Part A - Washout Period 1||0
10385263|NCT00626275|11527078|FG007|STARTED|Part A - Washout Period 1||0
10385264|NCT00626275|11527071|FG000|COMPLETED|Part A - Washout Period 1||6
10385265|NCT00626275|11527072|FG001|COMPLETED|Part A - Washout Period 1||7
10385266|NCT00626275|11527073|FG002|COMPLETED|Part A - Washout Period 1||6
10385267|NCT00626275|11527074|FG003|COMPLETED|Part A - Washout Period 1||8
10385268|NCT00626275|11527075|FG004|COMPLETED|Part A - Washout Period 1||9
10385269|NCT00626275|11527076|FG005|COMPLETED|Part A - Washout Period 1||8
10385270|NCT00626275|11527077|FG006|COMPLETED|Part A - Washout Period 1||0
10385271|NCT00626275|11527078|FG007|COMPLETED|Part A - Washout Period 1||0
10385272|NCT00626275|11527071|FG000|NOT COMPLETED|Part A - Washout Period 1||0
10385273|NCT00626275|11527072|FG001|NOT COMPLETED|Part A - Washout Period 1||0
10385274|NCT00626275|11527073|FG002|NOT COMPLETED|Part A - Washout Period 1||0
10385275|NCT00626275|11527074|FG003|NOT COMPLETED|Part A - Washout Period 1||0
10385276|NCT00626275|11527075|FG004|NOT COMPLETED|Part A - Washout Period 1||0
10385277|NCT00626275|11527076|FG005|NOT COMPLETED|Part A - Washout Period 1||0
10385278|NCT00626275|11527077|FG006|NOT COMPLETED|Part A - Washout Period 1||0
10385279|NCT00626275|11527078|FG007|NOT COMPLETED|Part A - Washout Period 1||0
10385280|NCT00626275|11527071|FG000|STARTED|Part A - Treatment Period 2||6
10385281|NCT00626275|11527072|FG001|STARTED|Part A - Treatment Period 2||7
10385282|NCT00626275|11527073|FG002|STARTED|Part A - Treatment Period 2||6
10385283|NCT00626275|11527074|FG003|STARTED|Part A - Treatment Period 2||8
10385284|NCT00626275|11527075|FG004|STARTED|Part A - Treatment Period 2||9
10385285|NCT00626275|11527076|FG005|STARTED|Part A - Treatment Period 2||8
10385286|NCT00626275|11527077|FG006|STARTED|Part A - Treatment Period 2||0
10385287|NCT00626275|11527078|FG007|STARTED|Part A - Treatment Period 2||0
10385288|NCT00626275|11527071|FG000|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||6
10306841|NCT00101686|11439737|FG002|COMPLETED|Overall Study|Patients treated until disease progression.|0
10306842|NCT00101686|11439738|FG003|COMPLETED|Overall Study|Patients treated until disease progression.|0
10306843|NCT00101686|11439739|FG004|COMPLETED|Overall Study|Patients treated until disease progression.|0
10306844|NCT00101686|11439740|FG005|COMPLETED|Overall Study|Patients treated until disease progression.|0
10306845|NCT00101686|11439741|FG006|COMPLETED|Overall Study|Patients treated until disease progression.|0
10306846|NCT00101686|11439742|FG007|COMPLETED|Overall Study|Patients treated until disease progression.|0
10306847|NCT00101686|11439743|FG008|COMPLETED|Overall Study|Patients treated until disease progression.|0
10306848|NCT00101686|11439744|FG009|COMPLETED|Overall Study|Patients treated until disease progression.|0
10306849|NCT00101686|11439735|FG000|NOT COMPLETED|Overall Study||71
10306850|NCT00101686|11439736|FG001|NOT COMPLETED|Overall Study||73
10306851|NCT00101686|11439737|FG002|NOT COMPLETED|Overall Study||69
10306852|NCT00101686|11439738|FG003|NOT COMPLETED|Overall Study||72
10306853|NCT00101686|11439739|FG004|NOT COMPLETED|Overall Study||73
10306854|NCT00101686|11439740|FG005|NOT COMPLETED|Overall Study||72
10306855|NCT00101686|11439741|FG006|NOT COMPLETED|Overall Study||27
10306856|NCT00101686|11439742|FG007|NOT COMPLETED|Overall Study||30
10306857|NCT00101686|11439743|FG008|NOT COMPLETED|Overall Study||30
10306858|NCT00101686|11439744|FG009|NOT COMPLETED|Overall Study||30
10306859|NCT00101816|11439763|FG000|STARTED|Overall Study||10
10306860|NCT00101816|11439764|FG001|STARTED|Overall Study||99
10306861|NCT00101816|11439763|FG000|COMPLETED|Overall Study||10
10306862|NCT00101816|11439764|FG001|COMPLETED|Overall Study||99
10306863|NCT00101816|11439763|FG000|NOT COMPLETED|Overall Study||0
10306864|NCT00101816|11439764|FG001|NOT COMPLETED|Overall Study||0
10306865|NCT00101868|11439780|FG000|STARTED|Overall Study|35 hospital physicians allocated to discharge software|316
10306866|NCT00101868|11439781|FG001|STARTED|Overall Study|35 hospital physicians allocated to usual care discharge|315
10306867|NCT00101868|11439780|FG000|COMPLETED|Overall Study|1 hospital physician with zero patients lost to follow up|287
10306868|NCT00101868|11439781|FG001|COMPLETED|Overall Study|zero hospital physician with zero patients lost to follow up|283
10306869|NCT00101868|11439780|FG000|NOT COMPLETED|Overall Study||29
10306870|NCT00101868|11439781|FG001|NOT COMPLETED|Overall Study||32
10306871|NCT00101907|11439795|FG000|STARTED|Overall Study||8
10306872|NCT00101907|11439796|FG001|STARTED|Overall Study||8
10306873|NCT00101907|11439797|FG002|STARTED|Overall Study||6
10306874|NCT00101907|11439798|FG003|STARTED|Overall Study||6
10306875|NCT00101907|11439799|FG004|STARTED|Overall Study||11
10306876|NCT00101907|11439800|FG005|STARTED|Overall Study||2
10306877|NCT00101907|11439795|FG000|COMPLETED|Overall Study||6
10306878|NCT00101907|11439796|FG001|COMPLETED|Overall Study||7
10306879|NCT00101907|11439797|FG002|COMPLETED|Overall Study||5
10306880|NCT00101907|11439798|FG003|COMPLETED|Overall Study||5
10306881|NCT00101907|11439799|FG004|COMPLETED|Overall Study||6
10306882|NCT00101907|11439800|FG005|COMPLETED|Overall Study||2
10306883|NCT00101907|11439795|FG000|NOT COMPLETED|Overall Study||2
10385289|NCT00626275|11527072|FG001|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||7
10385290|NCT00626275|11527073|FG002|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||6
10385291|NCT00626275|11527074|FG003|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||8
10385292|NCT00626275|11527075|FG004|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||9
10385293|NCT00626275|11527076|FG005|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||8
10385294|NCT00626275|11527077|FG006|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||0
10385295|NCT00626275|11527078|FG007|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||0
10385296|NCT00626275|11527071|FG000|COMPLETED|Part A - Treatment Period 2||6
10385297|NCT00626275|11527072|FG001|COMPLETED|Part A - Treatment Period 2||7
10385298|NCT00626275|11527073|FG002|COMPLETED|Part A - Treatment Period 2||6
10385299|NCT00626275|11527074|FG003|COMPLETED|Part A - Treatment Period 2||8
10385300|NCT00626275|11527075|FG004|COMPLETED|Part A - Treatment Period 2||9
10385301|NCT00626275|11527076|FG005|COMPLETED|Part A - Treatment Period 2||8
10385302|NCT00626275|11527077|FG006|COMPLETED|Part A - Treatment Period 2||0
10385303|NCT00626275|11527078|FG007|COMPLETED|Part A - Treatment Period 2||0
10385304|NCT00626275|11527071|FG000|NOT COMPLETED|Part A - Treatment Period 2||0
10385305|NCT00626275|11527072|FG001|NOT COMPLETED|Part A - Treatment Period 2||0
10385306|NCT00626275|11527073|FG002|NOT COMPLETED|Part A - Treatment Period 2||0
10306884|NCT00101907|11439796|FG001|NOT COMPLETED|Overall Study||1
10306885|NCT00101907|11439797|FG002|NOT COMPLETED|Overall Study||1
10306886|NCT00101907|11439798|FG003|NOT COMPLETED|Overall Study||1
10306887|NCT00101907|11439799|FG004|NOT COMPLETED|Overall Study||5
10306888|NCT00101907|11439800|FG005|NOT COMPLETED|Overall Study||0
10385307|NCT00626275|11527074|FG003|NOT COMPLETED|Part A - Treatment Period 2||0
10385308|NCT00626275|11527075|FG004|NOT COMPLETED|Part A - Treatment Period 2||0
10385309|NCT00626275|11527076|FG005|NOT COMPLETED|Part A - Treatment Period 2||0
10385310|NCT00626275|11527077|FG006|NOT COMPLETED|Part A - Treatment Period 2||0
10385311|NCT00626275|11527078|FG007|NOT COMPLETED|Part A - Treatment Period 2||0
10385312|NCT00626275|11527071|FG000|STARTED|Part A - Washout Period 2||6
10385313|NCT00626275|11527072|FG001|STARTED|Part A - Washout Period 2||7
10385314|NCT00626275|11527073|FG002|STARTED|Part A - Washout Period 2||6
10385315|NCT00626275|11527074|FG003|STARTED|Part A - Washout Period 2||8
10385316|NCT00626275|11527075|FG004|STARTED|Part A - Washout Period 2||9
10385317|NCT00626275|11527076|FG005|STARTED|Part A - Washout Period 2||8
10385318|NCT00626275|11527077|FG006|STARTED|Part A - Washout Period 2||0
10385319|NCT00626275|11527078|FG007|STARTED|Part A - Washout Period 2||0
10385320|NCT00626275|11527071|FG000|COMPLETED|Part A - Washout Period 2||6
10385321|NCT00626275|11527072|FG001|COMPLETED|Part A - Washout Period 2||7
10385322|NCT00626275|11527073|FG002|COMPLETED|Part A - Washout Period 2||6
10385323|NCT00626275|11527074|FG003|COMPLETED|Part A - Washout Period 2||8
10385324|NCT00626275|11527075|FG004|COMPLETED|Part A - Washout Period 2||9
10385325|NCT00626275|11527076|FG005|COMPLETED|Part A - Washout Period 2||8
10385326|NCT00626275|11527077|FG006|COMPLETED|Part A - Washout Period 2||0
10385327|NCT00626275|11527078|FG007|COMPLETED|Part A - Washout Period 2||0
10385328|NCT00626275|11527071|FG000|NOT COMPLETED|Part A - Washout Period 2||0
10385329|NCT00626275|11527072|FG001|NOT COMPLETED|Part A - Washout Period 2||0
10385330|NCT00626275|11527073|FG002|NOT COMPLETED|Part A - Washout Period 2||0
10385331|NCT00626275|11527074|FG003|NOT COMPLETED|Part A - Washout Period 2||0
10385332|NCT00626275|11527075|FG004|NOT COMPLETED|Part A - Washout Period 2||0
10385333|NCT00626275|11527076|FG005|NOT COMPLETED|Part A - Washout Period 2||0
10385334|NCT00626275|11527077|FG006|NOT COMPLETED|Part A - Washout Period 2||0
10385335|NCT00626275|11527078|FG007|NOT COMPLETED|Part A - Washout Period 2||0
10385336|NCT00626275|11527071|FG000|STARTED|Part A - Treatment Period 3||6
10385337|NCT00626275|11527072|FG001|STARTED|Part A - Treatment Period 3||7
10385338|NCT00626275|11527073|FG002|STARTED|Part A - Treatment Period 3||6
10385339|NCT00626275|11527074|FG003|STARTED|Part A - Treatment Period 3||8
10385340|NCT00626275|11527075|FG004|STARTED|Part A - Treatment Period 3||9
10385341|NCT00626275|11527076|FG005|STARTED|Part A - Treatment Period 3||8
10385342|NCT00626275|11527077|FG006|STARTED|Part A - Treatment Period 3||0
10385343|NCT00626275|11527078|FG007|STARTED|Part A - Treatment Period 3||0
10385344|NCT00626275|11527071|FG000|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||6
10385345|NCT00626275|11527072|FG001|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||7
10385346|NCT00626275|11527073|FG002|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||6
10385347|NCT00626275|11527074|FG003|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||8
10385348|NCT00626275|11527075|FG004|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||9
10385349|NCT00626275|11527076|FG005|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||8
10385350|NCT00626275|11527077|FG006|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||0
10385351|NCT00626275|11527078|FG007|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||0
10385352|NCT00626275|11527071|FG000|COMPLETED|Part A - Treatment Period 3||6
10385353|NCT00626275|11527072|FG001|COMPLETED|Part A - Treatment Period 3||7
10385354|NCT00626275|11527073|FG002|COMPLETED|Part A - Treatment Period 3||6
10385355|NCT00626275|11527074|FG003|COMPLETED|Part A - Treatment Period 3||8
10385356|NCT00626275|11527075|FG004|COMPLETED|Part A - Treatment Period 3||9
10385357|NCT00626275|11527076|FG005|COMPLETED|Part A - Treatment Period 3||8
10385358|NCT00626275|11527077|FG006|COMPLETED|Part A - Treatment Period 3||0
10385359|NCT00626275|11527078|FG007|COMPLETED|Part A - Treatment Period 3||0
10385360|NCT00626275|11527071|FG000|NOT COMPLETED|Part A - Treatment Period 3||0
10385361|NCT00626275|11527072|FG001|NOT COMPLETED|Part A - Treatment Period 3||0
10385362|NCT00626275|11527073|FG002|NOT COMPLETED|Part A - Treatment Period 3||0
10385363|NCT00626275|11527074|FG003|NOT COMPLETED|Part A - Treatment Period 3||0
10385364|NCT00626275|11527075|FG004|NOT COMPLETED|Part A - Treatment Period 3||0
10385365|NCT00626275|11527076|FG005|NOT COMPLETED|Part A - Treatment Period 3||0
10385366|NCT00626275|11527077|FG006|NOT COMPLETED|Part A - Treatment Period 3||0
10385367|NCT00626275|11527078|FG007|NOT COMPLETED|Part A - Treatment Period 3||0
10385368|NCT00626275|11527071|FG000|STARTED|Re-randomization Period for Part B||0
10385369|NCT00626275|11527072|FG001|STARTED|Re-randomization Period for Part B||0
10385370|NCT00626275|11527073|FG002|STARTED|Re-randomization Period for Part B||0
10385371|NCT00626275|11527074|FG003|STARTED|Re-randomization Period for Part B||0
10385372|NCT00626275|11527075|FG004|STARTED|Re-randomization Period for Part B||0
10385373|NCT00626275|11527076|FG005|STARTED|Re-randomization Period for Part B||0
10385374|NCT00626275|11527077|FG006|STARTED|Re-randomization Period for Part B||20
10385375|NCT00626275|11527078|FG007|STARTED|Re-randomization Period for Part B||24
10385376|NCT00626275|11527071|FG000|COMPLETED|Re-randomization Period for Part B||0
10385377|NCT00626275|11527072|FG001|COMPLETED|Re-randomization Period for Part B||0
10385378|NCT00626275|11527073|FG002|COMPLETED|Re-randomization Period for Part B||0
10385379|NCT00626275|11527074|FG003|COMPLETED|Re-randomization Period for Part B||0
10385380|NCT00626275|11527075|FG004|COMPLETED|Re-randomization Period for Part B||0
10385381|NCT00626275|11527076|FG005|COMPLETED|Re-randomization Period for Part B||0
10385382|NCT00626275|11527077|FG006|COMPLETED|Re-randomization Period for Part B||20
10385383|NCT00626275|11527078|FG007|COMPLETED|Re-randomization Period for Part B||24
10385384|NCT00626275|11527071|FG000|NOT COMPLETED|Re-randomization Period for Part B||0
10385385|NCT00626275|11527072|FG001|NOT COMPLETED|Re-randomization Period for Part B||0
10385386|NCT00626275|11527073|FG002|NOT COMPLETED|Re-randomization Period for Part B||0
10385387|NCT00626275|11527074|FG003|NOT COMPLETED|Re-randomization Period for Part B||0
10385388|NCT00626275|11527075|FG004|NOT COMPLETED|Re-randomization Period for Part B||0
10385389|NCT00626275|11527076|FG005|NOT COMPLETED|Re-randomization Period for Part B||0
10385390|NCT00626275|11527077|FG006|NOT COMPLETED|Re-randomization Period for Part B||0
10385391|NCT00626275|11527078|FG007|NOT COMPLETED|Re-randomization Period for Part B||0
10385392|NCT00626275|11527071|FG000|STARTED|Part B||0
10385393|NCT00626275|11527072|FG001|STARTED|Part B||0
10385394|NCT00626275|11527073|FG002|STARTED|Part B||0
10385395|NCT00626275|11527074|FG003|STARTED|Part B||0
10385396|NCT00626275|11527075|FG004|STARTED|Part B||0
10385397|NCT00626275|11527076|FG005|STARTED|Part B||0
10385398|NCT00626275|11527077|FG006|STARTED|Part B||20
10385399|NCT00626275|11527078|FG007|STARTED|Part B||24
10385400|NCT00626275|11527071|FG000|COMPLETED|Part B||0
10385401|NCT00626275|11527072|FG001|COMPLETED|Part B||0
10385402|NCT00626275|11527073|FG002|COMPLETED|Part B||0
10385403|NCT00626275|11527074|FG003|COMPLETED|Part B||0
10385404|NCT00626275|11527075|FG004|COMPLETED|Part B||0
10385405|NCT00626275|11527076|FG005|COMPLETED|Part B||0
10385406|NCT00626275|11527077|FG006|COMPLETED|Part B||19
10385407|NCT00626275|11527078|FG007|COMPLETED|Part B||23
10385408|NCT00626275|11527071|FG000|NOT COMPLETED|Part B||0
10385409|NCT00626275|11527072|FG001|NOT COMPLETED|Part B||0
10385410|NCT00626275|11527073|FG002|NOT COMPLETED|Part B||0
10385411|NCT00626275|11527074|FG003|NOT COMPLETED|Part B||0
10385412|NCT00626275|11527075|FG004|NOT COMPLETED|Part B||0
10385413|NCT00626275|11527076|FG005|NOT COMPLETED|Part B||0
10385414|NCT00626275|11527077|FG006|NOT COMPLETED|Part B||1
10385415|NCT00626275|11527078|FG007|NOT COMPLETED|Part B||1
10385416|NCT00626327|11527095|FG000|STARTED|Overall Study||504
10385417|NCT00626327|11527096|FG001|STARTED|Overall Study||616
10385418|NCT00626327|11527097|FG002|STARTED|Overall Study||510
10540778|NCT01468350|11693901|FG003|COMPLETED|(PART B) Day 1, Day 15||12
10540779|NCT01468350|11693898|FG000|NOT COMPLETED|(PART B) Day 1, Day 15||0
10540780|NCT01468350|11693899|FG001|NOT COMPLETED|(PART B) Day 1, Day 15||0
10540781|NCT01468350|11693900|FG002|NOT COMPLETED|(PART B) Day 1, Day 15||0
10540782|NCT01468350|11693901|FG003|NOT COMPLETED|(PART B) Day 1, Day 15||0
10540783|NCT01468454|11693911|FG000|STARTED|Overall Study||128
10540784|NCT01468454|11693911|FG000|PETs Completed|Overall Study||128
10540785|NCT01468454|11693911|FG000|Had Both PET and Surgery|Overall Study||119
10540786|NCT01468454|11693911|FG000|COMPLETED|Overall Study||119
10540787|NCT01468454|11693911|FG000|NOT COMPLETED|Overall Study||9
10540788|NCT01468532|11693916|FG000|STARTED|Overall Study||18
10540789|NCT01468532|11693916|FG000|COMPLETED|Overall Study||18
10540790|NCT01468532|11693916|FG000|NOT COMPLETED|Overall Study||0
10540791|NCT01468558|11693920|FG000|STARTED|Overall Study||24
10540792|NCT01468558|11693920|FG000|COMPLETED|Overall Study||22
10540793|NCT01468558|11693920|FG000|NOT COMPLETED|Overall Study||2
10540794|NCT01468584|11693928|FG000|STARTED|Overall Study||10
10540795|NCT01468584|11693928|FG000|COMPLETED|Overall Study||10
10540796|NCT01468584|11693928|FG000|NOT COMPLETED|Overall Study||0
10540797|NCT01468597|11693932|FG000|STARTED|Overall Study||184
10540798|NCT01468597|11693932|FG000|COMPLETED|Overall Study||149
10540799|NCT01468597|11693932|FG000|NOT COMPLETED|Overall Study||35
10540800|NCT01468675|11693938|FG000|STARTED|Overall Study||2699
10540801|NCT01468675|11693939|FG001|STARTED|Overall Study||3376
10540802|NCT01468675|11693938|FG000|COMPLETED|Overall Study||1699
10540803|NCT01468675|11693939|FG001|COMPLETED|Overall Study||2004
10540804|NCT01468675|11693938|FG000|NOT COMPLETED|Overall Study||1000
10540805|NCT01468675|11693939|FG001|NOT COMPLETED|Overall Study||1372
10540806|NCT01468701|11693962|FG000|STARTED|Overall Study||4964
10540807|NCT01468701|11693963|FG001|STARTED|Overall Study||5103
10540808|NCT01468701|11693964|FG002|STARTED|Overall Study||1784
10540809|NCT01468701|11693965|FG003|STARTED|Overall Study||715
10540810|NCT01468701|11693966|FG004|STARTED|Overall Study||1736
10540811|NCT01468701|11693967|FG005|STARTED|Overall Study||128
10540812|NCT01468701|11693968|FG006|STARTED|Overall Study||1209
10540813|NCT01468701|11693969|FG007|STARTED|Overall Study||5
10540814|NCT01468701|11693970|FG008|STARTED|Overall Study||3879
10658290|NCT02232243|11819434|FG000|STARTED|Third Dose(200mg HCQ Twice Daily)||0
10658291|NCT02232243|11819435|FG001|STARTED|Third Dose(200mg HCQ Twice Daily)||0
10658292|NCT02232243|11819436|FG002|STARTED|Third Dose(200mg HCQ Twice Daily)||3
10658293|NCT02232243|11819434|FG000|COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
10385419|NCT00626327|11527095|FG000|COMPLETED|Overall Study||426
10385420|NCT00626327|11527096|FG001|COMPLETED|Overall Study||557
10385421|NCT00626327|11527097|FG002|COMPLETED|Overall Study||422
10385422|NCT00626327|11527095|FG000|NOT COMPLETED|Overall Study||78
10385423|NCT00626327|11527096|FG001|NOT COMPLETED|Overall Study||59
10385424|NCT00626327|11527097|FG002|NOT COMPLETED|Overall Study||88
10540815|NCT01468701|11693971|FG009|STARTED|Overall Study||4962
10540816|NCT01468701|11693972|FG010|STARTED|Overall Study||4054
10540817|NCT01468701|11693973|FG011|STARTED|Overall Study||4538
10540818|NCT01468701|11693974|FG012|STARTED|Overall Study||333
10540819|NCT01468701|11693975|FG013|STARTED|Overall Study||2182
10385425|NCT00626340|11527113|FG000|STARTED|Overall Study||18
10385426|NCT00626340|11527113|FG000|COMPLETED|Overall Study||18
10385427|NCT00626340|11527113|FG000|NOT COMPLETED|Overall Study||0
10540820|NCT01468701|11693976|FG014|STARTED|Overall Study||214
10540821|NCT01468701|11693977|FG015|STARTED|Overall Study||1418
10540822|NCT01468701|11693978|FG016|STARTED|Overall Study||11
10385428|NCT00626366|11527119|FG000|STARTED|Overall Study||9
10385429|NCT00626366|11527120|FG001|STARTED|Overall Study||9
10385430|NCT00626366|11527119|FG000|COMPLETED|Overall Study||9
10385431|NCT00626366|11527120|FG001|COMPLETED|Overall Study||9
10385432|NCT00626366|11527119|FG000|NOT COMPLETED|Overall Study||0
10385433|NCT00626366|11527120|FG001|NOT COMPLETED|Overall Study||0
10385434|NCT00626392|11527132|FG000|STARTED|Run-in Period||45
10385435|NCT00626392|11527133|FG001|STARTED|Run-in Period||44
10385436|NCT00626392|11527134|FG002|STARTED|Run-in Period||44
10385437|NCT00626392|11527135|FG003|STARTED|Run-in Period||44
10385438|NCT00626392|11527136|FG004|STARTED|Run-in Period||45
10385439|NCT00626392|11527137|FG005|STARTED|Run-in Period||45
10385440|NCT00626392|11527132|FG000|COMPLETED|Run-in Period||44
10385441|NCT00626392|11527133|FG001|COMPLETED|Run-in Period||43
10385442|NCT00626392|11527134|FG002|COMPLETED|Run-in Period||41
10385443|NCT00626392|11527135|FG003|COMPLETED|Run-in Period||43
10385444|NCT00626392|11527136|FG004|COMPLETED|Run-in Period||41
10385445|NCT00626392|11527137|FG005|COMPLETED|Run-in Period||44
10385446|NCT00626392|11527132|FG000|NOT COMPLETED|Run-in Period||1
10385447|NCT00626392|11527133|FG001|NOT COMPLETED|Run-in Period||1
10385448|NCT00626392|11527134|FG002|NOT COMPLETED|Run-in Period||3
10385449|NCT00626392|11527135|FG003|NOT COMPLETED|Run-in Period||1
10385450|NCT00626392|11527136|FG004|NOT COMPLETED|Run-in Period||4
10385451|NCT00626392|11527137|FG005|NOT COMPLETED|Run-in Period||1
10385452|NCT00626392|11527132|FG000|STARTED|Coadministration Period||44
10385453|NCT00626392|11527133|FG001|STARTED|Coadministration Period||43
10385454|NCT00626392|11527134|FG002|STARTED|Coadministration Period||41
10385455|NCT00626392|11527135|FG003|STARTED|Coadministration Period||43
10385456|NCT00626392|11527136|FG004|STARTED|Coadministration Period||41
10385457|NCT00626392|11527137|FG005|STARTED|Coadministration Period||44
10385458|NCT00626392|11527132|FG000|COMPLETED|Coadministration Period||40
10385459|NCT00626392|11527133|FG001|COMPLETED|Coadministration Period||38
10385460|NCT00626392|11527134|FG002|COMPLETED|Coadministration Period||31
10385461|NCT00626392|11527135|FG003|COMPLETED|Coadministration Period||36
10385462|NCT00626392|11527136|FG004|COMPLETED|Coadministration Period||36
10385463|NCT00626392|11527137|FG005|COMPLETED|Coadministration Period||38
10385464|NCT00626392|11527132|FG000|NOT COMPLETED|Coadministration Period||4
10385465|NCT00626392|11527133|FG001|NOT COMPLETED|Coadministration Period||5
10385466|NCT00626392|11527134|FG002|NOT COMPLETED|Coadministration Period||10
10385467|NCT00626392|11527135|FG003|NOT COMPLETED|Coadministration Period||7
10385468|NCT00626392|11527136|FG004|NOT COMPLETED|Coadministration Period||5
10385469|NCT00626392|11527137|FG005|NOT COMPLETED|Coadministration Period||6
10385470|NCT00626405|11527145|FG000|STARTED|Overall Study||43
10385471|NCT00626405|11527146|FG001|STARTED|Overall Study||52
10385472|NCT00626405|11527145|FG000|COMPLETED|Overall Study||42
10385473|NCT00626405|11527146|FG001|COMPLETED|Overall Study||51
10385474|NCT00626405|11527145|FG000|NOT COMPLETED|Overall Study||1
10385475|NCT00626405|11527146|FG001|NOT COMPLETED|Overall Study||1
10385476|NCT00626431|11527154|FG000|STARTED|Overall Study|Separate groups of subjects received Formulation A and B and data were not compared between groups.|151
10385477|NCT00626431|11527155|FG001|STARTED|Overall Study|Separate groups of subjects received Formulation A and B and data were not compared between groups.|159
10385478|NCT00626431|11527154|FG000|COMPLETED|Overall Study||134
10385479|NCT00626431|11527155|FG001|COMPLETED|Overall Study||114
10385480|NCT00626431|11527154|FG000|NOT COMPLETED|Overall Study||17
10385481|NCT00626431|11527155|FG001|NOT COMPLETED|Overall Study||45
10385482|NCT00626522|11527167|FG000|STARTED|Overall Study||121
10385483|NCT00626522|11527168|FG001|STARTED|Overall Study||120
10385484|NCT00626522|11527169|FG002|STARTED|Overall Study||125
10385485|NCT00626522|11527170|FG003|STARTED|Overall Study||76
10385486|NCT00626522|11527171|FG004|STARTED|Overall Study||65
10385487|NCT00626522|11527172|FG005|STARTED|Overall Study||59
10385488|NCT00626522|11527167|FG000|COMPLETED|Overall Study||115
10385489|NCT00626522|11527168|FG001|COMPLETED|Overall Study||113
10385490|NCT00626522|11527169|FG002|COMPLETED|Overall Study||117
10385491|NCT00626522|11527170|FG003|COMPLETED|Overall Study||74
10385492|NCT00626522|11527171|FG004|COMPLETED|Overall Study||58
10385493|NCT00626522|11527172|FG005|COMPLETED|Overall Study||57
10385494|NCT00626522|11527167|FG000|NOT COMPLETED|Overall Study||6
10385495|NCT00626522|11527168|FG001|NOT COMPLETED|Overall Study||7
10385496|NCT00626522|11527169|FG002|NOT COMPLETED|Overall Study||8
10385497|NCT00626522|11527170|FG003|NOT COMPLETED|Overall Study||2
10385498|NCT00626522|11527171|FG004|NOT COMPLETED|Overall Study||7
10385499|NCT00626522|11527172|FG005|NOT COMPLETED|Overall Study||2
10385500|NCT00626548|11527188|FG000|STARTED|Overall Study||705
10385501|NCT00626548|11527189|FG001|STARTED|Overall Study||716
10385502|NCT00626548|11527188|FG000|Patients Received Treatment|Overall Study||703
10385503|NCT00626548|11527189|FG001|Patients Received Treatment|Overall Study||712
10385504|NCT00626548|11527188|FG000|COMPLETED|Overall Study||0
10385505|NCT00626548|11527189|FG001|COMPLETED|Overall Study||0
10385506|NCT00626548|11527188|FG000|NOT COMPLETED|Overall Study||705
10385507|NCT00626548|11527189|FG001|NOT COMPLETED|Overall Study||716
10385508|NCT00626574|11527197|FG000|STARTED|Overall Study||2
10385509|NCT00626574|11527198|FG001|STARTED|Overall Study||1
10385510|NCT00626574|11527197|FG000|COMPLETED|Overall Study||2
10385511|NCT00626574|11527198|FG001|COMPLETED|Overall Study||1
10385512|NCT00626574|11527197|FG000|NOT COMPLETED|Overall Study||0
10385513|NCT00626574|11527198|FG001|NOT COMPLETED|Overall Study||0
10385514|NCT00626626|11527208|FG000|STARTED|Overall Study||5
10385515|NCT00626626|11527209|FG001|STARTED|Overall Study||3
10385516|NCT00626626|11527208|FG000|COMPLETED|Overall Study||5
10385517|NCT00626626|11527209|FG001|COMPLETED|Overall Study||3
10385518|NCT00626626|11527208|FG000|NOT COMPLETED|Overall Study||0
10385519|NCT00626626|11527209|FG001|NOT COMPLETED|Overall Study||0
10385520|NCT00626639|11527218|FG000|STARTED|Overall Study||2
10385521|NCT00626639|11527219|FG001|STARTED|Overall Study||3
10718117|NCT02703337|11882044|FG004|STARTED|Period Two (Part A)||4
10718118|NCT02703337|11882045|FG005|STARTED|Period Two (Part A)||5
10385522|NCT00626639|11527218|FG000|COMPLETED|Overall Study|Participants who received all 8 doses of investigational product.|0
10385523|NCT00626639|11527219|FG001|COMPLETED|Overall Study|Participants who received all 8 doses of investigational product.|1
10385524|NCT00626639|11527218|FG000|NOT COMPLETED|Overall Study||2
10385525|NCT00626639|11527219|FG001|NOT COMPLETED|Overall Study||2
10385526|NCT00626743|11527229|FG000|STARTED|Treatment Period 1||6
10385527|NCT00626743|11527230|FG001|STARTED|Treatment Period 1||7
10385528|NCT00626743|11527229|FG000|COMPLETED|Treatment Period 1||6
10385529|NCT00626743|11527230|FG001|COMPLETED|Treatment Period 1||6
10385530|NCT00626743|11527229|FG000|NOT COMPLETED|Treatment Period 1||0
10385531|NCT00626743|11527230|FG001|NOT COMPLETED|Treatment Period 1||1
10385532|NCT00626743|11527229|FG000|STARTED|Wash-out Period of 6 Days||6
10385533|NCT00626743|11527230|FG001|STARTED|Wash-out Period of 6 Days||6
10385534|NCT00626743|11527229|FG000|COMPLETED|Wash-out Period of 6 Days||6
10385535|NCT00626743|11527230|FG001|COMPLETED|Wash-out Period of 6 Days||6
10385536|NCT00626743|11527229|FG000|NOT COMPLETED|Wash-out Period of 6 Days||0
10385537|NCT00626743|11527230|FG001|NOT COMPLETED|Wash-out Period of 6 Days||0
10385538|NCT00626743|11527229|FG000|STARTED|Treatment Period 2||6
10385539|NCT00626743|11527230|FG001|STARTED|Treatment Period 2||6
10385540|NCT00626743|11527229|FG000|COMPLETED|Treatment Period 2||6
10385541|NCT00626743|11527230|FG001|COMPLETED|Treatment Period 2||6
10385542|NCT00626743|11527229|FG000|NOT COMPLETED|Treatment Period 2||0
10385543|NCT00626743|11527230|FG001|NOT COMPLETED|Treatment Period 2||0
10385544|NCT00626782|11527238|FG000|STARTED|Overall Study||12
10385545|NCT00626782|11527239|FG001|STARTED|Overall Study||12
10385546|NCT00626782|11527238|FG000|COMPLETED|Overall Study||12
10385547|NCT00626782|11527239|FG001|COMPLETED|Overall Study||12
10385548|NCT00626782|11527238|FG000|NOT COMPLETED|Overall Study||0
10385549|NCT00626782|11527239|FG001|NOT COMPLETED|Overall Study||0
10385550|NCT00626795|11527250|FG000|STARTED|Open-label TD1414 Cream TID Treatment||0
10385551|NCT00626795|11527251|FG001|STARTED|Open-label TD1414 Cream TID Treatment||65
10385552|NCT00626795|11527252|FG002|STARTED|Open-label TD1414 Cream TID Treatment||0
10385553|NCT00626795|11527250|FG000|COMPLETED|Open-label TD1414 Cream TID Treatment||0
10385554|NCT00626795|11527251|FG001|COMPLETED|Open-label TD1414 Cream TID Treatment||64
10385555|NCT00626795|11527252|FG002|COMPLETED|Open-label TD1414 Cream TID Treatment||0
10385556|NCT00626795|11527250|FG000|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||0
10385557|NCT00626795|11527251|FG001|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||1
10385558|NCT00626795|11527252|FG002|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||0
10385559|NCT00626795|11527250|FG000|STARTED|Blinded Treatment||204
10385560|NCT00626795|11527251|FG001|STARTED|Blinded Treatment||205
10385561|NCT00626795|11527252|FG002|STARTED|Blinded Treatment||205
10385562|NCT00626795|11527250|FG000|COMPLETED|Blinded Treatment||194
10385563|NCT00626795|11527251|FG001|COMPLETED|Blinded Treatment||200
10385564|NCT00626795|11527252|FG002|COMPLETED|Blinded Treatment||196
10385565|NCT00626795|11527250|FG000|NOT COMPLETED|Blinded Treatment||10
10385566|NCT00626795|11527251|FG001|NOT COMPLETED|Blinded Treatment||5
10385567|NCT00626795|11527252|FG002|NOT COMPLETED|Blinded Treatment||9
10385568|NCT00626808|11527268|FG000|STARTED|Overall Study||254464
10385569|NCT00626808|11527269|FG001|STARTED|Overall Study||34316
10385570|NCT00626808|11527270|FG002|STARTED|Overall Study||30011
10385571|NCT00626808|11527271|FG003|STARTED|Overall Study||2906
10385572|NCT00626808|11527268|FG000|COMPLETED|Overall Study||254464
10385573|NCT00626808|11527269|FG001|COMPLETED|Overall Study||34316
10385574|NCT00626808|11527270|FG002|COMPLETED|Overall Study||30011
10385575|NCT00626808|11527271|FG003|COMPLETED|Overall Study||2906
10385576|NCT00626808|11527268|FG000|NOT COMPLETED|Overall Study||0
10385577|NCT00626808|11527269|FG001|NOT COMPLETED|Overall Study||0
10385578|NCT00626808|11527270|FG002|NOT COMPLETED|Overall Study||0
10385579|NCT00626808|11527271|FG003|NOT COMPLETED|Overall Study||0
10385580|NCT00626821|11527281|FG000|STARTED|Overall Study||3017
10385581|NCT00626821|11527281|FG000|Quality of Life|Overall Study|Attended both visit 1 and visit 2|2672
10385582|NCT00626821|11527281|FG000|COMPLETED|Overall Study||2796
10385583|NCT00626821|11527281|FG000|NOT COMPLETED|Overall Study||221
10385584|NCT00626886|11527287|FG000|STARTED|Overall Study||24
10385585|NCT00626886|11527288|FG001|STARTED|Overall Study||29
10385586|NCT00626886|11527287|FG000|COMPLETED|Overall Study||24
10385587|NCT00626886|11527288|FG001|COMPLETED|Overall Study||29
10385588|NCT00626886|11527287|FG000|NOT COMPLETED|Overall Study||0
10718119|NCT02703337|11882046|FG006|STARTED|Period Two (Part A)||0
10385589|NCT00626886|11527288|FG001|NOT COMPLETED|Overall Study||0
10385590|NCT00626912|11527296|FG000|STARTED|Overall Study||222
10385591|NCT00626912|11527297|FG001|STARTED|Overall Study||225
10385592|NCT00626912|11527296|FG000|COMPLETED|Overall Study||220
10385593|NCT00626912|11527297|FG001|COMPLETED|Overall Study||215
10385594|NCT00626912|11527296|FG000|NOT COMPLETED|Overall Study||2
10385595|NCT00626912|11527297|FG001|NOT COMPLETED|Overall Study||10
10385596|NCT00626925|11527305|FG000|STARTED|Overall Study||67
10385597|NCT00626925|11527306|FG001|STARTED|Overall Study||71
10385598|NCT00626925|11527305|FG000|COMPLETED|Overall Study||55
10385599|NCT00626925|11527306|FG001|COMPLETED|Overall Study||62
10385600|NCT00626925|11527305|FG000|NOT COMPLETED|Overall Study||12
10385601|NCT00626925|11527306|FG001|NOT COMPLETED|Overall Study||9
10385602|NCT00627016|11527328|FG000|STARTED|Overall Study||153
10385603|NCT00627016|11527329|FG001|STARTED|Overall Study||152
10385604|NCT00627016|11527328|FG000|COMPLETED|Overall Study||147
10385605|NCT00627016|11527329|FG001|COMPLETED|Overall Study||146
10385606|NCT00627016|11527328|FG000|NOT COMPLETED|Overall Study||6
10540823|NCT01468701|11693962|FG000|All Eligible Patient|Overall Study||4873
10540824|NCT01468701|11693963|FG001|All Eligible Patient|Overall Study||4963
10540825|NCT01468701|11693964|FG002|All Eligible Patient|Overall Study||1755
10540826|NCT01468701|11693965|FG003|All Eligible Patient|Overall Study||703
10540827|NCT01468701|11693966|FG004|All Eligible Patient|Overall Study||1714
10540828|NCT01468701|11693967|FG005|All Eligible Patient|Overall Study||126
10540829|NCT01468701|11693968|FG006|All Eligible Patient|Overall Study||1170
10540830|NCT01468701|11693969|FG007|All Eligible Patient|Overall Study||4
10540831|NCT01468701|11693970|FG008|All Eligible Patient|Overall Study||3839
10540832|NCT01468701|11693971|FG009|All Eligible Patient|Overall Study||4836
10540833|NCT01468701|11693972|FG010|All Eligible Patient|Overall Study||4015
10540834|NCT01468701|11693973|FG011|All Eligible Patient|Overall Study||4505
10540835|NCT01468701|11693974|FG012|All Eligible Patient|Overall Study||332
10540836|NCT01468701|11693975|FG013|All Eligible Patient|Overall Study||2163
10540837|NCT01468701|11693976|FG014|All Eligible Patient|Overall Study||213
10540838|NCT01468701|11693977|FG015|All Eligible Patient|Overall Study||1386
10540839|NCT01468701|11693978|FG016|All Eligible Patient|Overall Study||11
10540840|NCT01468701|11693962|FG000|COMPLETED|Overall Study||3965
10540841|NCT01468701|11693963|FG001|COMPLETED|Overall Study||0
10540842|NCT01468701|11693964|FG002|COMPLETED|Overall Study||0
10540843|NCT01468701|11693965|FG003|COMPLETED|Overall Study||0
10540844|NCT01468701|11693966|FG004|COMPLETED|Overall Study||0
10540845|NCT01468701|11693967|FG005|COMPLETED|Overall Study||0
10540846|NCT01468701|11693968|FG006|COMPLETED|Overall Study||0
10540847|NCT01468701|11693969|FG007|COMPLETED|Overall Study||0
10540848|NCT01468701|11693970|FG008|COMPLETED|Overall Study||3219
10540849|NCT01468701|11693971|FG009|COMPLETED|Overall Study||3780
10540850|NCT01468701|11693972|FG010|COMPLETED|Overall Study||3256
10540851|NCT01468701|11693973|FG011|COMPLETED|Overall Study||3672
10540852|NCT01468701|11693974|FG012|COMPLETED|Overall Study||284
10540853|NCT01468701|11693975|FG013|COMPLETED|Overall Study||1712
10540854|NCT01468701|11693976|FG014|COMPLETED|Overall Study||151
10540855|NCT01468701|11693977|FG015|COMPLETED|Overall Study||1056
10540856|NCT01468701|11693978|FG016|COMPLETED|Overall Study||10
10540857|NCT01468701|11693962|FG000|NOT COMPLETED|Overall Study||999
10540858|NCT01468701|11693963|FG001|NOT COMPLETED|Overall Study||5103
10540859|NCT01468701|11693964|FG002|NOT COMPLETED|Overall Study||1784
10540860|NCT01468701|11693965|FG003|NOT COMPLETED|Overall Study||715
10540861|NCT01468701|11693966|FG004|NOT COMPLETED|Overall Study||1736
10540862|NCT01468701|11693967|FG005|NOT COMPLETED|Overall Study||128
10540863|NCT01468701|11693968|FG006|NOT COMPLETED|Overall Study||1209
10540864|NCT01468701|11693969|FG007|NOT COMPLETED|Overall Study||5
10540865|NCT01468701|11693970|FG008|NOT COMPLETED|Overall Study||660
10540866|NCT01468701|11693971|FG009|NOT COMPLETED|Overall Study||1182
10540867|NCT01468701|11693972|FG010|NOT COMPLETED|Overall Study||798
10540868|NCT01468701|11693973|FG011|NOT COMPLETED|Overall Study||866
10540869|NCT01468701|11693974|FG012|NOT COMPLETED|Overall Study||49
10540870|NCT01468701|11693975|FG013|NOT COMPLETED|Overall Study||470
10540871|NCT01468701|11693976|FG014|NOT COMPLETED|Overall Study||63
10540872|NCT01468701|11693977|FG015|NOT COMPLETED|Overall Study||362
10540873|NCT01468701|11693978|FG016|NOT COMPLETED|Overall Study||1
10540874|NCT01468818|11693991|FG000|STARTED|Overall Study||18
10540875|NCT01468818|11693991|FG000|COMPLETED|Overall Study||16
10540876|NCT01468818|11693991|FG000|NOT COMPLETED|Overall Study||2
10540877|NCT01468844|11693997|FG000|STARTED|Overall Study||4
10540878|NCT01468844|11693998|FG001|STARTED|Overall Study||2
10540879|NCT01468844|11693997|FG000|COMPLETED|Overall Study||2
10540880|NCT01468844|11693998|FG001|COMPLETED|Overall Study||2
10658294|NCT02232243|11819435|FG001|COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
10658295|NCT02232243|11819436|FG002|COMPLETED|Third Dose(200mg HCQ Twice Daily)||3
10658296|NCT02232243|11819434|FG000|NOT COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
10658297|NCT02232243|11819435|FG001|NOT COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
10658298|NCT02232243|11819436|FG002|NOT COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
10658299|NCT02232425|11819447|FG000|STARTED|Overall Study||58
10385607|NCT00627016|11527329|FG001|NOT COMPLETED|Overall Study||6
10385608|NCT00627042|11527335|FG000|STARTED|Overall Study||42
10385609|NCT00627042|11527335|FG000|Received at Least 1 Dose of Study Drug|Overall Study||42
10385610|NCT00627042|11527335|FG000|COMPLETED|Overall Study||40
10385611|NCT00627042|11527335|FG000|NOT COMPLETED|Overall Study||2
10385612|NCT00627094|11527341|FG000|STARTED|Overall Study||60
10385613|NCT00627094|11527342|FG001|STARTED|Overall Study||60
10385614|NCT00627094|11527341|FG000|COMPLETED|Overall Study||48
10385615|NCT00627094|11527342|FG001|COMPLETED|Overall Study||45
10385616|NCT00627094|11527341|FG000|NOT COMPLETED|Overall Study||12
10385617|NCT00627094|11527342|FG001|NOT COMPLETED|Overall Study||15
10385618|NCT00627367|11527352|FG000|STARTED|Overall Study||112
10385619|NCT00627367|11527353|FG001|STARTED|Overall Study||112
10385620|NCT00627367|11527352|FG000|COMPLETED|Overall Study||112
10385621|NCT00627367|11527353|FG001|COMPLETED|Overall Study||112
10540881|NCT01468844|11693997|FG000|NOT COMPLETED|Overall Study||2
10385622|NCT00627367|11527352|FG000|NOT COMPLETED|Overall Study||0
10540882|NCT01468844|11693998|FG001|NOT COMPLETED|Overall Study||0
10385623|NCT00627367|11527353|FG001|NOT COMPLETED|Overall Study||0
10385624|NCT00627393|11527362|FG000|STARTED|Intention-To-Treat Analysis||58
10385625|NCT00627393|11527363|FG001|STARTED|Intention-To-Treat Analysis||56
10385626|NCT00627393|11527362|FG000|COMPLETED|Intention-To-Treat Analysis||49
10385627|NCT00627393|11527363|FG001|COMPLETED|Intention-To-Treat Analysis||48
10385628|NCT00627393|11527362|FG000|NOT COMPLETED|Intention-To-Treat Analysis||9
10385629|NCT00627393|11527363|FG001|NOT COMPLETED|Intention-To-Treat Analysis||8
10385630|NCT00627393|11527362|FG000|STARTED|Per-Protocol Analysis||49
10385631|NCT00627393|11527363|FG001|STARTED|Per-Protocol Analysis||48
10385632|NCT00627393|11527362|FG000|COMPLETED|Per-Protocol Analysis||39
10385633|NCT00627393|11527363|FG001|COMPLETED|Per-Protocol Analysis||35
10385634|NCT00627393|11527362|FG000|NOT COMPLETED|Per-Protocol Analysis||10
10385635|NCT00627393|11527363|FG001|NOT COMPLETED|Per-Protocol Analysis||13
10385636|NCT00627406|11527375|FG000|STARTED|Overall Study||60
10385637|NCT00627406|11527376|FG001|STARTED|Overall Study||58
10385638|NCT00627406|11527377|FG002|STARTED|Overall Study||125
10385639|NCT00627406|11527378|FG003|STARTED|Overall Study||141
10385640|NCT00627406|11527375|FG000|COMPLETED|Overall Study||60
10385641|NCT00627406|11527376|FG001|COMPLETED|Overall Study||58
10385642|NCT00627406|11527377|FG002|COMPLETED|Overall Study||125
10385643|NCT00627406|11527378|FG003|COMPLETED|Overall Study||141
10385644|NCT00627406|11527375|FG000|NOT COMPLETED|Overall Study||0
10385645|NCT00627406|11527376|FG001|NOT COMPLETED|Overall Study||0
10385646|NCT00627406|11527377|FG002|NOT COMPLETED|Overall Study||0
10385647|NCT00627406|11527378|FG003|NOT COMPLETED|Overall Study||0
10385648|NCT00627445|11527390|FG000|STARTED|Overall Study||219
10385649|NCT00627445|11527391|FG001|STARTED|Overall Study||222
10385650|NCT00627445|11527390|FG000|Exposed to Study Drug|Overall Study||219
10385651|NCT00627445|11527391|FG001|Exposed to Study Drug|Overall Study||222
10385652|NCT00627445|11527390|FG000|COMPLETED|Overall Study||210
10385653|NCT00627445|11527391|FG001|COMPLETED|Overall Study||210
10385654|NCT00627445|11527390|FG000|NOT COMPLETED|Overall Study||9
10385655|NCT00627445|11527391|FG001|NOT COMPLETED|Overall Study||12
10385656|NCT00627458|11527402|FG000|STARTED|Overall Study||127
10385657|NCT00627458|11527403|FG001|STARTED|Overall Study||137
10385658|NCT00627458|11527404|FG002|STARTED|Overall Study||139
10540883|NCT01468909|11694009|FG000|STARTED|Overall Study||52
10540884|NCT01468909|11694010|FG001|STARTED|Overall Study||54
10658300|NCT02232425|11819448|FG001|STARTED|Overall Study||30
10658301|NCT02232425|11819447|FG000|COMPLETED|Overall Study||44
10658302|NCT02232425|11819448|FG001|COMPLETED|Overall Study||22
10658303|NCT02232425|11819447|FG000|NOT COMPLETED|Overall Study||14
10658304|NCT02232425|11819448|FG001|NOT COMPLETED|Overall Study||8
10658305|NCT02232698|11819456|FG000|STARTED|Overall Study||120
10658306|NCT02232698|11819457|FG001|STARTED|Overall Study||121
10658307|NCT02232698|11819456|FG000|COMPLETED|Overall Study||110
10718120|NCT02703337|11882047|FG007|STARTED|Period Two (Part A)||0
10718121|NCT02703337|11882040|FG000|Received Study Drug|Period Two (Part A)||5
10718122|NCT02703337|11882041|FG001|Received Study Drug|Period Two (Part A)||5
10718123|NCT02703337|11882042|FG002|Received Study Drug|Period Two (Part A)||5
10718124|NCT02703337|11882043|FG003|Received Study Drug|Period Two (Part A)||5
10718125|NCT02703337|11882044|FG004|Received Study Drug|Period Two (Part A)||4
10718126|NCT02703337|11882045|FG005|Received Study Drug|Period Two (Part A)||5
10718127|NCT02703337|11882046|FG006|Received Study Drug|Period Two (Part A)||0
10718128|NCT02703337|11882047|FG007|Received Study Drug|Period Two (Part A)||0
10718129|NCT02703337|11882040|FG000|COMPLETED|Period Two (Part A)||5
10718130|NCT02703337|11882041|FG001|COMPLETED|Period Two (Part A)||5
10718131|NCT02703337|11882042|FG002|COMPLETED|Period Two (Part A)||5
10718132|NCT02703337|11882043|FG003|COMPLETED|Period Two (Part A)||5
10718133|NCT02703337|11882044|FG004|COMPLETED|Period Two (Part A)||4
10385659|NCT00627458|11527402|FG000|COMPLETED|Overall Study||123
10385660|NCT00627458|11527403|FG001|COMPLETED|Overall Study||130
10385661|NCT00627458|11527404|FG002|COMPLETED|Overall Study||133
10385662|NCT00627458|11527402|FG000|NOT COMPLETED|Overall Study||4
10385663|NCT00627458|11527403|FG001|NOT COMPLETED|Overall Study||7
10385664|NCT00627458|11527404|FG002|NOT COMPLETED|Overall Study||6
10385665|NCT00627497|11527417|FG000|STARTED|Overall Study||14
10540885|NCT01468909|11694009|FG000|COMPLETED|Overall Study||50
10540886|NCT01468909|11694010|FG001|COMPLETED|Overall Study||52
10540887|NCT01468909|11694009|FG000|NOT COMPLETED|Overall Study||2
10540888|NCT01468909|11694010|FG001|NOT COMPLETED|Overall Study||2
10540889|NCT01468974|11694016|FG000|STARTED|1 Month Follow-up|Intent-to-treat (ITT) population|35
10540890|NCT01468974|11694016|FG000|COMPLETED|1 Month Follow-up||34
10718134|NCT02703337|11882045|FG005|COMPLETED|Period Two (Part A)||5
10718135|NCT02703337|11882046|FG006|COMPLETED|Period Two (Part A)||0
10718136|NCT02703337|11882047|FG007|COMPLETED|Period Two (Part A)||0
10718137|NCT02703337|11882040|FG000|NOT COMPLETED|Period Two (Part A)||0
10385666|NCT00627497|11527418|FG001|STARTED|Overall Study||12
10385667|NCT00627497|11527419|FG002|STARTED|Overall Study||4
10385668|NCT00627497|11527420|FG003|STARTED|Overall Study||2
10385669|NCT00627497|11527417|FG000|COMPLETED|Overall Study||13
10385670|NCT00627497|11527418|FG001|COMPLETED|Overall Study||11
10385671|NCT00627497|11527419|FG002|COMPLETED|Overall Study||4
10540891|NCT01468974|11694016|FG000|NOT COMPLETED|1 Month Follow-up||1
10658308|NCT02232698|11819457|FG001|COMPLETED|Overall Study||101
10658309|NCT02232698|11819456|FG000|NOT COMPLETED|Overall Study||10
10658310|NCT02232698|11819457|FG001|NOT COMPLETED|Overall Study||20
10385672|NCT00627497|11527420|FG003|COMPLETED|Overall Study||2
10385673|NCT00627497|11527417|FG000|NOT COMPLETED|Overall Study||1
10385674|NCT00627497|11527418|FG001|NOT COMPLETED|Overall Study||1
10385675|NCT00627497|11527419|FG002|NOT COMPLETED|Overall Study||0
10385676|NCT00627497|11527420|FG003|NOT COMPLETED|Overall Study||0
10385677|NCT00627523|11527432|FG000|STARTED|Overall Study|22 assigned to Genotropin and 21 in Control; 1 did not take Genotropin, so considered as Control.|21
10385678|NCT00627523|11527433|FG001|STARTED|Overall Study||22
10385679|NCT00627523|11527432|FG000|COMPLETED|Overall Study||19
10385680|NCT00627523|11527433|FG001|COMPLETED|Overall Study||20
10385681|NCT00627523|11527432|FG000|NOT COMPLETED|Overall Study||2
10385682|NCT00627523|11527433|FG001|NOT COMPLETED|Overall Study||2
10385683|NCT00627679|11527439|FG000|STARTED|Overall Study||4
10385684|NCT00627679|11527440|FG001|STARTED|Overall Study||4
10385685|NCT00627679|11527441|FG002|STARTED|Overall Study||4
10385686|NCT00627679|11527442|FG003|STARTED|Overall Study||4
10385687|NCT00627679|11527439|FG000|COMPLETED|Overall Study||4
10385688|NCT00627679|11527440|FG001|COMPLETED|Overall Study||4
10385689|NCT00627679|11527441|FG002|COMPLETED|Overall Study||4
10385690|NCT00627679|11527442|FG003|COMPLETED|Overall Study||4
10385691|NCT00627679|11527439|FG000|NOT COMPLETED|Overall Study||0
10385692|NCT00627679|11527440|FG001|NOT COMPLETED|Overall Study||0
10385693|NCT00627679|11527441|FG002|NOT COMPLETED|Overall Study||0
10385694|NCT00627679|11527442|FG003|NOT COMPLETED|Overall Study||0
10385695|NCT00627705|11527454|FG000|STARTED|Overall Study||15
10385696|NCT00627705|11527455|FG001|STARTED|Overall Study||18
10385697|NCT00627705|11527454|FG000|COMPLETED|Overall Study||13
10540892|NCT01468974|11694016|FG000|STARTED|6 Months Follow-up||34
10540893|NCT01468974|11694016|FG000|COMPLETED|6 Months Follow-up||34
10540894|NCT01468974|11694016|FG000|NOT COMPLETED|6 Months Follow-up||0
10540895|NCT01468974|11694016|FG000|STARTED|1 Year Follow-up||34
10540896|NCT01468974|11694016|FG000|COMPLETED|1 Year Follow-up||34
10540897|NCT01468974|11694016|FG000|NOT COMPLETED|1 Year Follow-up||0
10385698|NCT00627705|11527455|FG001|COMPLETED|Overall Study||12
10385699|NCT00627705|11527454|FG000|NOT COMPLETED|Overall Study||2
10385700|NCT00627705|11527455|FG001|NOT COMPLETED|Overall Study||6
10385701|NCT00627861|11527461|FG000|STARTED|Overall Study||1
10540898|NCT01468974|11694016|FG000|STARTED|2 Years Follow-up||34
10540899|NCT01468974|11694016|FG000|COMPLETED|2 Years Follow-up||32
10718138|NCT02703337|11882041|FG001|NOT COMPLETED|Period Two (Part A)||0
10385702|NCT00627861|11527461|FG000|COMPLETED|Overall Study||1
10385703|NCT00627861|11527461|FG000|NOT COMPLETED|Overall Study||0
10385704|NCT00627926|11527470|FG000|STARTED|Overall Study||361
10385705|NCT00627926|11527471|FG001|STARTED|Overall Study||364
10385706|NCT00627926|11527472|FG002|STARTED|Overall Study||363
10385707|NCT00627926|11527470|FG000|COMPLETED|Overall Study||202
10385708|NCT00627926|11527471|FG001|COMPLETED|Overall Study||260
10385709|NCT00627926|11527472|FG002|COMPLETED|Overall Study||268
10385710|NCT00627926|11527470|FG000|NOT COMPLETED|Overall Study||159
10385711|NCT00627926|11527471|FG001|NOT COMPLETED|Overall Study||104
10385712|NCT00627926|11527472|FG002|NOT COMPLETED|Overall Study||95
10385713|NCT00627978|11527482|FG000|STARTED|Overall Study||10
10385714|NCT00627978|11527483|FG001|STARTED|Overall Study||5
10385715|NCT00627978|11527482|FG000|COMPLETED|Overall Study||10
10385716|NCT00627978|11527483|FG001|COMPLETED|Overall Study||5
10385717|NCT00627978|11527482|FG000|NOT COMPLETED|Overall Study||0
10385718|NCT00627978|11527483|FG001|NOT COMPLETED|Overall Study||0
10385719|NCT00628030|11527491|FG000|STARTED|Baseline to Post-Assessment||92
10385720|NCT00628030|11527492|FG001|STARTED|Baseline to Post-Assessment||92
10385721|NCT00628030|11527491|FG000|COMPLETED|Baseline to Post-Assessment||59
10385722|NCT00628030|11527492|FG001|COMPLETED|Baseline to Post-Assessment||63
10385723|NCT00628030|11527491|FG000|NOT COMPLETED|Baseline to Post-Assessment||33
10385724|NCT00628030|11527492|FG001|NOT COMPLETED|Baseline to Post-Assessment||29
10385725|NCT00628030|11527491|FG000|STARTED|Post to 6 Month Follow-up||59
10385726|NCT00628030|11527492|FG001|STARTED|Post to 6 Month Follow-up||63
10385727|NCT00628030|11527491|FG000|COMPLETED|Post to 6 Month Follow-up||27
10385728|NCT00628030|11527492|FG001|COMPLETED|Post to 6 Month Follow-up||33
10385729|NCT00628030|11527491|FG000|NOT COMPLETED|Post to 6 Month Follow-up||32
10385730|NCT00628030|11527492|FG001|NOT COMPLETED|Post to 6 Month Follow-up||30
10385731|NCT00628108|11527500|FG000|STARTED|Overall Study||23
10385732|NCT00628108|11527501|FG001|STARTED|Overall Study|One subject was randomized to levocetirizine but received placebo.|46
10385733|NCT00628108|11527500|FG000|Safety Population|Overall Study||24
10540900|NCT01468974|11694016|FG000|NOT COMPLETED|2 Years Follow-up||2
10540901|NCT01468974|11694016|FG000|STARTED|3 Years Follow-up||32
10540902|NCT01468974|11694016|FG000|COMPLETED|3 Years Follow-up||26
10540903|NCT01468974|11694016|FG000|NOT COMPLETED|3 Years Follow-up||6
10540904|NCT01468987|11694022|FG000|STARTED|Overall Study||691
10540905|NCT01468987|11694023|FG001|STARTED|Overall Study||678
10540906|NCT01468987|11694022|FG000|Received at Least 1 Dose of Study Drug|Overall Study||691
10540907|NCT01468987|11694023|FG001|Received at Least 1 Dose of Study Drug|Overall Study||677
10385734|NCT00628108|11527501|FG001|Safety Population|Overall Study|Subjects in the Safety Population were analyzed as treated.|45
10385735|NCT00628108|11527500|FG000|COMPLETED|Overall Study||22
10540908|NCT01468987|11694022|FG000|COMPLETED|Overall Study||620
10540909|NCT01468987|11694023|FG001|COMPLETED|Overall Study||618
10540910|NCT01468987|11694022|FG000|NOT COMPLETED|Overall Study||71
10718139|NCT02703337|11882042|FG002|NOT COMPLETED|Period Two (Part A)||0
10385736|NCT00628108|11527501|FG001|COMPLETED|Overall Study||43
10385737|NCT00628108|11527500|FG000|NOT COMPLETED|Overall Study||1
10385738|NCT00628108|11527501|FG001|NOT COMPLETED|Overall Study||3
10385739|NCT00628134|11527507|FG000|STARTED|Overall Study||4
10385740|NCT00628134|11527508|FG001|STARTED|Overall Study||4
10385741|NCT00628134|11527507|FG000|COMPLETED|Overall Study||4
10385742|NCT00628134|11527508|FG001|COMPLETED|Overall Study||4
10385743|NCT00628134|11527507|FG000|NOT COMPLETED|Overall Study||0
10385744|NCT00628134|11527508|FG001|NOT COMPLETED|Overall Study||0
10385745|NCT00628147|11527516|FG000|STARTED|Overall Study||142
10385746|NCT00628147|11527517|FG001|STARTED|Overall Study||142
10385747|NCT00628147|11527516|FG000|COMPLETED|Overall Study||135
10385748|NCT00628147|11527517|FG001|COMPLETED|Overall Study||141
10385749|NCT00628147|11527516|FG000|NOT COMPLETED|Overall Study||7
10385750|NCT00628147|11527517|FG001|NOT COMPLETED|Overall Study||1
10385751|NCT00628212|11527527|FG000|STARTED|Overall Study||80
10385752|NCT00628212|11527528|FG001|STARTED|Overall Study||84
10385753|NCT00628212|11527529|FG002|STARTED|Overall Study||79
10385754|NCT00628212|11527530|FG003|STARTED|Overall Study||81
10385755|NCT00628212|11527527|FG000|COMPLETED|Overall Study||77
10385756|NCT00628212|11527528|FG001|COMPLETED|Overall Study||83
10385757|NCT00628212|11527529|FG002|COMPLETED|Overall Study||76
10385758|NCT00628212|11527530|FG003|COMPLETED|Overall Study||76
10385759|NCT00628212|11527527|FG000|NOT COMPLETED|Overall Study||3
10385760|NCT00628212|11527528|FG001|NOT COMPLETED|Overall Study||1
10385761|NCT00628212|11527529|FG002|NOT COMPLETED|Overall Study||3
10385762|NCT00628212|11527530|FG003|NOT COMPLETED|Overall Study||5
10385763|NCT00628251|11527543|FG000|STARTED|Randomised Part|Patients randomised|32
10385764|NCT00628251|11527544|FG001|STARTED|Randomised Part|Patients randomised|32
10385765|NCT00628251|11527545|FG002|STARTED|Randomised Part|Patients randomised|33
10385766|NCT00628251|11527543|FG000|COMPLETED|Randomised Part|Patients who received olaparib treatment|32
10385767|NCT00628251|11527544|FG001|COMPLETED|Randomised Part|Patients who received olaparib treatment|32
10385768|NCT00628251|11527545|FG002|COMPLETED|Randomised Part|1 of 33 patients did not receive Liposomal Doxorubicin. Patient voluntarily discontinued|32
10385769|NCT00628251|11527543|FG000|NOT COMPLETED|Randomised Part||0
10385770|NCT00628251|11527544|FG001|NOT COMPLETED|Randomised Part||0
10385771|NCT00628251|11527545|FG002|NOT COMPLETED|Randomised Part||1
10385772|NCT00628251|11527543|FG000|STARTED|Ongoing Initial Study Treatment at DCO|Patients who received treatment|32
10385773|NCT00628251|11527544|FG001|STARTED|Ongoing Initial Study Treatment at DCO|Patients who received treatment|32
10385774|NCT00628251|11527545|FG002|STARTED|Ongoing Initial Study Treatment at DCO|Patients who received Liposomal doxorubicin 50 mg/m2|32
10385775|NCT00628251|11527543|FG000|Discontinued Initial Study Treatment|Ongoing Initial Study Treatment at DCO||22
10385776|NCT00628251|11527544|FG001|Discontinued Initial Study Treatment|Ongoing Initial Study Treatment at DCO||20
10385777|NCT00628251|11527545|FG002|Discontinued Initial Study Treatment|Ongoing Initial Study Treatment at DCO||25
10385778|NCT00628251|11527543|FG000|Crossover to Olaparib|Ongoing Initial Study Treatment at DCO||0
10385779|NCT00628251|11527544|FG001|Crossover to Olaparib|Ongoing Initial Study Treatment at DCO||0
10385780|NCT00628251|11527545|FG002|Crossover to Olaparib|Ongoing Initial Study Treatment at DCO|Crossover dosage was 400 mg bd Olaparib|14
10385781|NCT00628251|11527543|FG000|Ongoing Crossover at DCO|Ongoing Initial Study Treatment at DCO||0
10385782|NCT00628251|11527544|FG001|Ongoing Crossover at DCO|Ongoing Initial Study Treatment at DCO||0
10385783|NCT00628251|11527545|FG002|Ongoing Crossover at DCO|Ongoing Initial Study Treatment at DCO||5
10385784|NCT00628251|11527543|FG000|Discontinued Crossover|Ongoing Initial Study Treatment at DCO||0
10385785|NCT00628251|11527544|FG001|Discontinued Crossover|Ongoing Initial Study Treatment at DCO||0
10385786|NCT00628251|11527545|FG002|Discontinued Crossover|Ongoing Initial Study Treatment at DCO||9
10540911|NCT01468987|11694023|FG001|NOT COMPLETED|Overall Study||60
10540912|NCT01469000|11694033|FG000|STARTED|Overall Study||129
10540913|NCT01469000|11694034|FG001|STARTED|Overall Study||66
10540914|NCT01469000|11694033|FG000|Received at Least 1 Dose of Study Drug|Overall Study||126
10540915|NCT01469000|11694034|FG001|Received at Least 1 Dose of Study Drug|Overall Study||65
10718140|NCT02703337|11882043|FG003|NOT COMPLETED|Period Two (Part A)||0
10385787|NCT00628251|11527543|FG000|COMPLETED|Ongoing Initial Study Treatment at DCO|Ongoing initial study treatment at primary data cut-off|10
10385788|NCT00628251|11527544|FG001|COMPLETED|Ongoing Initial Study Treatment at DCO|Ongoing initial study treatment at primary data cut-off|12
10718141|NCT02703337|11882044|FG004|NOT COMPLETED|Period Two (Part A)||0
10385789|NCT00628251|11527545|FG002|COMPLETED|Ongoing Initial Study Treatment at DCO|Patients ongoing initial study treatment (Liposomal doxorubicin)|7
10385790|NCT00628251|11527543|FG000|NOT COMPLETED|Ongoing Initial Study Treatment at DCO||22
10385791|NCT00628251|11527544|FG001|NOT COMPLETED|Ongoing Initial Study Treatment at DCO||20
10385792|NCT00628251|11527545|FG002|NOT COMPLETED|Ongoing Initial Study Treatment at DCO||25
10385793|NCT00628355|11527557|FG000|STARTED|Overall Study||15
10385794|NCT00628355|11527558|FG001|STARTED|Overall Study||15
10385795|NCT00628355|11527557|FG000|COMPLETED|Overall Study||14
10385796|NCT00628355|11527558|FG001|COMPLETED|Overall Study||14
10385797|NCT00628355|11527557|FG000|NOT COMPLETED|Overall Study||1
10385798|NCT00628355|11527558|FG001|NOT COMPLETED|Overall Study||1
10385799|NCT00628394|11527569|FG000|STARTED|Overall Study||14
10385800|NCT00628394|11527570|FG001|STARTED|Overall Study||13
10385801|NCT00628394|11527571|FG002|STARTED|Overall Study||13
10385802|NCT00628394|11527572|FG003|STARTED|Overall Study||13
10385803|NCT00628394|11527569|FG000|COMPLETED|Overall Study||10
10385804|NCT00628394|11527570|FG001|COMPLETED|Overall Study||9
10385805|NCT00628394|11527571|FG002|COMPLETED|Overall Study||11
10385806|NCT00628394|11527572|FG003|COMPLETED|Overall Study||10
10385807|NCT00628394|11527569|FG000|NOT COMPLETED|Overall Study||4
10385808|NCT00628394|11527570|FG001|NOT COMPLETED|Overall Study||4
10385809|NCT00628394|11527571|FG002|NOT COMPLETED|Overall Study||2
10385810|NCT00628394|11527572|FG003|NOT COMPLETED|Overall Study||3
10385811|NCT00628407|11527582|FG000|STARTED|Overall Study||13
10385812|NCT00628407|11527582|FG000|COMPLETED|Overall Study||13
10385813|NCT00628407|11527582|FG000|NOT COMPLETED|Overall Study||0
10385814|NCT00628498|11527586|FG000|STARTED|Overall Study||1206
10385815|NCT00628498|11527586|FG000|COMPLETED|Overall Study||1154
10385816|NCT00628498|11527586|FG000|NOT COMPLETED|Overall Study||52
10385817|NCT00628589|11527593|FG000|STARTED|Overall Study||115
10385818|NCT00628589|11527594|FG001|STARTED|Overall Study||116
10385819|NCT00628589|11527595|FG002|STARTED|Overall Study||113
10385820|NCT00628589|11527593|FG000|COMPLETED|Overall Study||114
10385821|NCT00628589|11527594|FG001|COMPLETED|Overall Study||114
10385822|NCT00628589|11527595|FG002|COMPLETED|Overall Study||110
10385823|NCT00628589|11527593|FG000|NOT COMPLETED|Overall Study||1
10385824|NCT00628589|11527594|FG001|NOT COMPLETED|Overall Study||2
10385825|NCT00628589|11527595|FG002|NOT COMPLETED|Overall Study||3
10385826|NCT00628628|11527605|FG000|STARTED|Overall Study||40
10385827|NCT00628628|11527606|FG001|STARTED|Overall Study||40
10385828|NCT00628628|11527605|FG000|COMPLETED|Overall Study||40
10385829|NCT00628628|11527606|FG001|COMPLETED|Overall Study||40
10385830|NCT00628628|11527605|FG000|NOT COMPLETED|Overall Study||0
10385831|NCT00628628|11527606|FG001|NOT COMPLETED|Overall Study||0
10385832|NCT00628758|11527614|FG000|STARTED|Overall Study||209
10385833|NCT00628758|11527615|FG001|STARTED|Overall Study||221
10385834|NCT00628758|11527614|FG000|COMPLETED|Overall Study||165
10385835|NCT00628758|11527615|FG001|COMPLETED|Overall Study||179
10385836|NCT00628758|11527614|FG000|NOT COMPLETED|Overall Study||44
10540916|NCT01469000|11694033|FG000|COMPLETED|Overall Study||109
10540917|NCT01469000|11694034|FG001|COMPLETED|Overall Study||62
10540918|NCT01469000|11694033|FG000|NOT COMPLETED|Overall Study||20
10540919|NCT01469000|11694034|FG001|NOT COMPLETED|Overall Study||4
10540920|NCT01469013|11694045|FG000|STARTED|Part A (Treatment Period)||24
10540921|NCT01469013|11694046|FG001|STARTED|Part A (Treatment Period)||24
10540922|NCT01469013|11694047|FG002|STARTED|Part A (Treatment Period)||24
10540923|NCT01469013|11694048|FG003|STARTED|Part A (Treatment Period)||24
10540924|NCT01469013|11694049|FG004|STARTED|Part A (Treatment Period)||49
10540925|NCT01469013|11694050|FG005|STARTED|Part A (Treatment Period)||0
10540926|NCT01469013|11694051|FG006|STARTED|Part A (Treatment Period)||0
10540927|NCT01469013|11694052|FG007|STARTED|Part A (Treatment Period)||0
10540928|NCT01469013|11694053|FG008|STARTED|Part A (Treatment Period)||0
10540929|NCT01469013|11694054|FG009|STARTED|Part A (Treatment Period)||0
10540930|NCT01469013|11694055|FG010|STARTED|Part A (Treatment Period)||0
10540931|NCT01469013|11694056|FG011|STARTED|Part A (Treatment Period)||0
10540932|NCT01469013|11694057|FG012|STARTED|Part A (Treatment Period)||0
10540933|NCT01469013|11694045|FG000|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
10540934|NCT01469013|11694046|FG001|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
10540935|NCT01469013|11694047|FG002|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
10658311|NCT02232802|11819465|FG000|STARTED|Period 1||24
10658312|NCT02232802|11819466|FG001|STARTED|Period 1||23
10658313|NCT02232802|11819465|FG000|COMPLETED|Period 1||22
10718142|NCT02703337|11882045|FG005|NOT COMPLETED|Period Two (Part A)||0
10718143|NCT02703337|11882046|FG006|NOT COMPLETED|Period Two (Part A)||0
10658314|NCT02232802|11819466|FG001|COMPLETED|Period 1||22
10658315|NCT02232802|11819465|FG000|NOT COMPLETED|Period 1||2
10658316|NCT02232802|11819466|FG001|NOT COMPLETED|Period 1||1
10658317|NCT02232802|11819465|FG000|STARTED|Washout||22
10658318|NCT02232802|11819466|FG001|STARTED|Washout||22
10658319|NCT02232802|11819465|FG000|COMPLETED|Washout||22
10658320|NCT02232802|11819466|FG001|COMPLETED|Washout||22
10658321|NCT02232802|11819465|FG000|NOT COMPLETED|Washout||0
10658322|NCT02232802|11819466|FG001|NOT COMPLETED|Washout||0
10658323|NCT02232802|11819465|FG000|STARTED|Period 2||22
10658324|NCT02232802|11819466|FG001|STARTED|Period 2||22
10658325|NCT02232802|11819465|FG000|COMPLETED|Period 2||22
10658326|NCT02232802|11819466|FG001|COMPLETED|Period 2||22
10812697|NCT03361228|11974842|FG001|COMPLETED|Overall Study||0
10812698|NCT03361228|11974841|FG000|NOT COMPLETED|Overall Study||4
10385837|NCT00628758|11527615|FG001|NOT COMPLETED|Overall Study||42
10385838|NCT00628862|11527626|FG000|STARTED|Overall Study|randomised patients|206
10385839|NCT00628862|11527627|FG001|STARTED|Overall Study|randomised patients|199
10385840|NCT00628862|11527628|FG002|STARTED|Overall Study|randomised patients|208
10385841|NCT00628862|11527626|FG000|COMPLETED|Overall Study|randomised patients|195
10385842|NCT00628862|11527627|FG001|COMPLETED|Overall Study|randomised patients|182
10385843|NCT00628862|11527628|FG002|COMPLETED|Overall Study|randomised patients|186
10385844|NCT00628862|11527626|FG000|NOT COMPLETED|Overall Study||11
10385845|NCT00628862|11527627|FG001|NOT COMPLETED|Overall Study||17
10385846|NCT00628862|11527628|FG002|NOT COMPLETED|Overall Study||22
10385847|NCT00628901|11527638|FG000|STARTED|Overall Study||30
10385848|NCT00628901|11527639|FG001|STARTED|Overall Study||30
10385849|NCT00628901|11527638|FG000|COMPLETED|Overall Study||27
10540936|NCT01469013|11694048|FG003|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
10540937|NCT01469013|11694049|FG004|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||49
10540938|NCT01469013|11694050|FG005|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
10540939|NCT01469013|11694051|FG006|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
10385850|NCT00628901|11527639|FG001|COMPLETED|Overall Study||29
10385851|NCT00628901|11527638|FG000|NOT COMPLETED|Overall Study||3
10658327|NCT02232802|11819465|FG000|NOT COMPLETED|Period 2||0
10658328|NCT02232802|11819466|FG001|NOT COMPLETED|Period 2||0
10658329|NCT02232802|11819465|FG000|STARTED|Washout||22
10658330|NCT02232802|11819466|FG001|STARTED|Washout||22
10385852|NCT00628901|11527639|FG001|NOT COMPLETED|Overall Study||1
10385853|NCT00628927|11527647|FG000|STARTED|Overall Study||183
10385854|NCT00628927|11527648|FG001|STARTED|Overall Study||30
10385855|NCT00628927|11527647|FG000|COMPLETED|Overall Study||175
10385856|NCT00628927|11527648|FG001|COMPLETED|Overall Study||30
10385857|NCT00628927|11527647|FG000|NOT COMPLETED|Overall Study||8
10385858|NCT00628927|11527648|FG001|NOT COMPLETED|Overall Study||0
10385859|NCT00629018|11527661|FG000|STARTED|Overall Study||55
10385860|NCT00629018|11527662|FG001|STARTED|Overall Study||55
10385861|NCT00629018|11527661|FG000|COMPLETED|Overall Study||55
10385862|NCT00629018|11527662|FG001|COMPLETED|Overall Study||55
10385863|NCT00629018|11527661|FG000|NOT COMPLETED|Overall Study||0
10385864|NCT00629018|11527662|FG001|NOT COMPLETED|Overall Study||0
10385865|NCT00629083|11527670|FG000|STARTED|Overall Study||228
10385866|NCT00629083|11527671|FG001|STARTED|Overall Study||117
10385867|NCT00629083|11527670|FG000|COMPLETED|Overall Study||200
10385868|NCT00629083|11527671|FG001|COMPLETED|Overall Study||103
10385869|NCT00629083|11527670|FG000|NOT COMPLETED|Overall Study||28
10385870|NCT00629083|11527671|FG001|NOT COMPLETED|Overall Study||14
10385871|NCT00629122|11527681|FG000|STARTED|First Period: Day 1- 3 (Sublingual)||2
10385872|NCT00629122|11527682|FG001|STARTED|First Period: Day 1- 3 (Sublingual)||3
10385873|NCT00629122|11527681|FG000|COMPLETED|First Period: Day 1- 3 (Sublingual)||2
10385874|NCT00629122|11527682|FG001|COMPLETED|First Period: Day 1- 3 (Sublingual)||3
10385875|NCT00629122|11527681|FG000|NOT COMPLETED|First Period: Day 1- 3 (Sublingual)||0
10385876|NCT00629122|11527682|FG001|NOT COMPLETED|First Period: Day 1- 3 (Sublingual)||0
10385877|NCT00629122|11527681|FG000|STARTED|Second Period: Day 3-5 (Washout)||2
10385878|NCT00629122|11527682|FG001|STARTED|Second Period: Day 3-5 (Washout)||3
10385879|NCT00629122|11527681|FG000|COMPLETED|Second Period: Day 3-5 (Washout)||2
10385880|NCT00629122|11527682|FG001|COMPLETED|Second Period: Day 3-5 (Washout)||3
10385881|NCT00629122|11527681|FG000|NOT COMPLETED|Second Period: Day 3-5 (Washout)||0
10385882|NCT00629122|11527682|FG001|NOT COMPLETED|Second Period: Day 3-5 (Washout)||0
10385883|NCT00629122|11527681|FG000|STARTED|Third Period: Day 6-8 (Oral)||2
10385884|NCT00629122|11527682|FG001|STARTED|Third Period: Day 6-8 (Oral)||3
10385885|NCT00629122|11527681|FG000|COMPLETED|Third Period: Day 6-8 (Oral)||2
10540940|NCT01469013|11694052|FG007|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
10540941|NCT01469013|11694053|FG008|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
10540942|NCT01469013|11694054|FG009|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
10540943|NCT01469013|11694055|FG010|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
10540944|NCT01469013|11694056|FG011|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
10540945|NCT01469013|11694057|FG012|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
10540946|NCT01469013|11694045|FG000|COMPLETED|Part A (Treatment Period)||23
10540947|NCT01469013|11694046|FG001|COMPLETED|Part A (Treatment Period)||24
10540948|NCT01469013|11694047|FG002|COMPLETED|Part A (Treatment Period)||23
10540949|NCT01469013|11694048|FG003|COMPLETED|Part A (Treatment Period)||24
10540950|NCT01469013|11694049|FG004|COMPLETED|Part A (Treatment Period)||48
10540951|NCT01469013|11694050|FG005|COMPLETED|Part A (Treatment Period)||0
10540952|NCT01469013|11694051|FG006|COMPLETED|Part A (Treatment Period)||0
10540953|NCT01469013|11694052|FG007|COMPLETED|Part A (Treatment Period)||0
10540954|NCT01469013|11694053|FG008|COMPLETED|Part A (Treatment Period)||0
10540955|NCT01469013|11694054|FG009|COMPLETED|Part A (Treatment Period)||0
10540956|NCT01469013|11694055|FG010|COMPLETED|Part A (Treatment Period)||0
10540957|NCT01469013|11694056|FG011|COMPLETED|Part A (Treatment Period)||0
10540958|NCT01469013|11694057|FG012|COMPLETED|Part A (Treatment Period)||0
10540959|NCT01469013|11694045|FG000|NOT COMPLETED|Part A (Treatment Period)||1
10540960|NCT01469013|11694046|FG001|NOT COMPLETED|Part A (Treatment Period)||0
10540961|NCT01469013|11694047|FG002|NOT COMPLETED|Part A (Treatment Period)||1
10540962|NCT01469013|11694048|FG003|NOT COMPLETED|Part A (Treatment Period)||0
10540963|NCT01469013|11694049|FG004|NOT COMPLETED|Part A (Treatment Period)||1
10540964|NCT01469013|11694050|FG005|NOT COMPLETED|Part A (Treatment Period)||0
10540965|NCT01469013|11694051|FG006|NOT COMPLETED|Part A (Treatment Period)||0
10540966|NCT01469013|11694052|FG007|NOT COMPLETED|Part A (Treatment Period)||0
10540967|NCT01469013|11694053|FG008|NOT COMPLETED|Part A (Treatment Period)||0
10540968|NCT01469013|11694054|FG009|NOT COMPLETED|Part A (Treatment Period)||0
10540969|NCT01469013|11694055|FG010|NOT COMPLETED|Part A (Treatment Period)||0
10540970|NCT01469013|11694056|FG011|NOT COMPLETED|Part A (Treatment Period)||0
10540971|NCT01469013|11694057|FG012|NOT COMPLETED|Part A (Treatment Period)||0
10540972|NCT01469013|11694045|FG000|STARTED|Part B (Extension Period)||0
10540973|NCT01469013|11694046|FG001|STARTED|Part B (Extension Period)||0
10540974|NCT01469013|11694047|FG002|STARTED|Part B (Extension Period)||0
10540975|NCT01469013|11694048|FG003|STARTED|Part B (Extension Period)||0
10540976|NCT01469013|11694049|FG004|STARTED|Part B (Extension Period)||0
10540977|NCT01469013|11694050|FG005|STARTED|Part B (Extension Period)||12
10540978|NCT01469013|11694051|FG006|STARTED|Part B (Extension Period)||12
10540979|NCT01469013|11694052|FG007|STARTED|Part B (Extension Period)||23
10540980|NCT01469013|11694053|FG008|STARTED|Part B (Extension Period)||24
10540981|NCT01469013|11694054|FG009|STARTED|Part B (Extension Period)||11
10540982|NCT01469013|11694055|FG010|STARTED|Part B (Extension Period)||12
10540983|NCT01469013|11694056|FG011|STARTED|Part B (Extension Period)||24
10540984|NCT01469013|11694057|FG012|STARTED|Part B (Extension Period)||24
10540985|NCT01469013|11694045|FG000|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
10540986|NCT01469013|11694046|FG001|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
10385886|NCT00629122|11527682|FG001|COMPLETED|Third Period: Day 6-8 (Oral)||3
10385887|NCT00629122|11527681|FG000|NOT COMPLETED|Third Period: Day 6-8 (Oral)||0
10385888|NCT00629122|11527682|FG001|NOT COMPLETED|Third Period: Day 6-8 (Oral)||0
10385889|NCT00629239|11527690|FG000|STARTED|Overall Study||34
10385890|NCT00629239|11527691|FG001|STARTED|Overall Study||32
10385891|NCT00629239|11527690|FG000|COMPLETED|Overall Study||26
10385892|NCT00629239|11527691|FG001|COMPLETED|Overall Study||28
10385893|NCT00629239|11527690|FG000|NOT COMPLETED|Overall Study||8
10385894|NCT00629239|11527691|FG001|NOT COMPLETED|Overall Study||4
10385895|NCT00629265|11527699|FG000|STARTED|Overall Study||116
10385896|NCT00629265|11527700|FG001|STARTED|Overall Study||54
10385897|NCT00629265|11527699|FG000|COMPLETED|Overall Study||84
10385898|NCT00629265|11527700|FG001|COMPLETED|Overall Study||34
10385899|NCT00629265|11527699|FG000|NOT COMPLETED|Overall Study||32
10385900|NCT00629265|11527700|FG001|NOT COMPLETED|Overall Study||20
10385901|NCT00629499|11527706|FG000|STARTED|Overall Study||63
10385902|NCT00629499|11527706|FG000|COMPLETED|Overall Study||63
10385903|NCT00629499|11527706|FG000|NOT COMPLETED|Overall Study||0
10385904|NCT00629525|11527710|FG000|STARTED|Overall Study||35
10385905|NCT00629525|11527710|FG000|COMPLETED|Overall Study||32
10385906|NCT00629525|11527710|FG000|NOT COMPLETED|Overall Study||3
10385907|NCT00629707|11527716|FG000|STARTED|Overall Study||10
10385908|NCT00629707|11527717|FG001|STARTED|Overall Study||10
10385909|NCT00629707|11527716|FG000|COMPLETED|Overall Study||10
10385910|NCT00629707|11527717|FG001|COMPLETED|Overall Study||8
10385911|NCT00629707|11527716|FG000|NOT COMPLETED|Overall Study||0
10385912|NCT00629707|11527717|FG001|NOT COMPLETED|Overall Study||2
10385913|NCT00629772|11527725|FG000|STARTED|First Intervention - Day 0 - Week 14||12
10385914|NCT00629772|11527726|FG001|STARTED|First Intervention - Day 0 - Week 14||12
10385915|NCT00629772|11527725|FG000|COMPLETED|First Intervention - Day 0 - Week 14||12
10385916|NCT00629772|11527726|FG001|COMPLETED|First Intervention - Day 0 - Week 14||12
10385917|NCT00629772|11527725|FG000|NOT COMPLETED|First Intervention - Day 0 - Week 14||0
10385918|NCT00629772|11527726|FG001|NOT COMPLETED|First Intervention - Day 0 - Week 14||0
10385919|NCT00629772|11527725|FG000|STARTED|Second Intervention Week 14 - Week 26|Patient withdrew at Week 14 and therefore never received infliximab.|12
10385920|NCT00629772|11527726|FG001|STARTED|Second Intervention Week 14 - Week 26||12
10385921|NCT00629772|11527725|FG000|COMPLETED|Second Intervention Week 14 - Week 26||11
10385922|NCT00629772|11527726|FG001|COMPLETED|Second Intervention Week 14 - Week 26||10
10385923|NCT00629772|11527725|FG000|NOT COMPLETED|Second Intervention Week 14 - Week 26||1
10385924|NCT00629772|11527726|FG001|NOT COMPLETED|Second Intervention Week 14 - Week 26||2
10385925|NCT00630032|11527735|FG000|STARTED|Overall Study||398
10385926|NCT00630032|11527736|FG001|STARTED|Overall Study||364
10385927|NCT00630032|11527735|FG000|COMPLETED|Overall Study||308
10385928|NCT00630032|11527736|FG001|COMPLETED|Overall Study||269
10385929|NCT00630032|11527735|FG000|NOT COMPLETED|Overall Study||90
10385930|NCT00630032|11527736|FG001|NOT COMPLETED|Overall Study||95
10385931|NCT00630058|11527744|FG000|STARTED|Overall Study||10
10385932|NCT00630058|11527745|FG001|STARTED|Overall Study||10
10385933|NCT00630058|11527744|FG000|COMPLETED|Overall Study||6
10385934|NCT00630058|11527745|FG001|COMPLETED|Overall Study||6
10385935|NCT00630058|11527744|FG000|NOT COMPLETED|Overall Study||4
10385936|NCT00630058|11527745|FG001|NOT COMPLETED|Overall Study||4
10385937|NCT00630253|11527754|FG000|STARTED|Overall Study||16
10385938|NCT00630253|11527755|FG001|STARTED|Overall Study||9
10385939|NCT00630253|11527756|FG002|STARTED|Overall Study||6
10385940|NCT00630253|11527754|FG000|COMPLETED|Overall Study||16
10385941|NCT00630253|11527755|FG001|COMPLETED|Overall Study||9
10385942|NCT00630253|11527756|FG002|COMPLETED|Overall Study||6
10385943|NCT00630253|11527754|FG000|NOT COMPLETED|Overall Study||0
10385944|NCT00630253|11527755|FG001|NOT COMPLETED|Overall Study||0
10385945|NCT00630253|11527756|FG002|NOT COMPLETED|Overall Study||0
10385946|NCT00630305|11527764|FG000|STARTED|Overall Study||37
10385947|NCT00630305|11527764|FG000|COMPLETED|Overall Study||35
10385948|NCT00630305|11527764|FG000|NOT COMPLETED|Overall Study||2
10385949|NCT00630331|11527780|FG000|STARTED|Overall Study||3828
10385950|NCT00630331|11527781|FG001|STARTED|Overall Study||3676
10385951|NCT00630331|11527782|FG002|STARTED|Overall Study||3900
10385952|NCT00630331|11527780|FG000|COMPLETED|Overall Study||3622
10385953|NCT00630331|11527781|FG001|COMPLETED|Overall Study||3510
10385954|NCT00630331|11527782|FG002|COMPLETED|Overall Study||3712
10385955|NCT00630331|11527780|FG000|NOT COMPLETED|Overall Study||206
10385956|NCT00630331|11527781|FG001|NOT COMPLETED|Overall Study||166
10385957|NCT00630331|11527782|FG002|NOT COMPLETED|Overall Study||188
10385958|NCT00630344|11527790|FG000|STARTED|Overall Study||36
10540987|NCT01469013|11694047|FG002|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
10540988|NCT01469013|11694048|FG003|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
10540989|NCT01469013|11694049|FG004|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
10540990|NCT01469013|11694050|FG005|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12
10540991|NCT01469013|11694051|FG006|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12
10385959|NCT00630344|11527790|FG000|COMPLETED|Overall Study||0
10385960|NCT00630344|11527790|FG000|NOT COMPLETED|Overall Study||36
10385961|NCT00630396|11527795|FG000|STARTED|Overall Study||60
10385962|NCT00630396|11527795|FG000|COMPLETED|Overall Study||53
10385963|NCT00630396|11527795|FG000|NOT COMPLETED|Overall Study||7
10385964|NCT00630409|11527799|FG000|STARTED|Overall Study||5
10385965|NCT00630409|11527799|FG000|COMPLETED|Overall Study||4
10385966|NCT00630409|11527799|FG000|NOT COMPLETED|Overall Study||1
10385967|NCT00630539|11527808|FG000|STARTED|Overall Study||34
10385968|NCT00630539|11527809|FG001|STARTED|Overall Study||33
10385969|NCT00630539|11527810|FG002|STARTED|Overall Study||29
10385970|NCT00630539|11527811|FG003|STARTED|Overall Study||30
10385971|NCT00630539|11527808|FG000|COMPLETED|Overall Study||33
10385972|NCT00630539|11527809|FG001|COMPLETED|Overall Study||29
10385973|NCT00630539|11527810|FG002|COMPLETED|Overall Study||28
10385974|NCT00630539|11527811|FG003|COMPLETED|Overall Study||27
10385975|NCT00630539|11527808|FG000|NOT COMPLETED|Overall Study||1
10385976|NCT00630539|11527809|FG001|NOT COMPLETED|Overall Study||4
10385977|NCT00630539|11527810|FG002|NOT COMPLETED|Overall Study||1
10385978|NCT00630539|11527811|FG003|NOT COMPLETED|Overall Study||3
10385979|NCT00630734|11527831|FG000|STARTED|Overall Study||11
10385980|NCT00630734|11527832|FG001|STARTED|Overall Study||13
10385981|NCT00630734|11527833|FG002|STARTED|Overall Study||8
10385982|NCT00630734|11527831|FG000|COMPLETED|Overall Study||9
10385983|NCT00630734|11527832|FG001|COMPLETED|Overall Study||12
10385984|NCT00630734|11527833|FG002|COMPLETED|Overall Study||7
10385985|NCT00630734|11527831|FG000|NOT COMPLETED|Overall Study||2
10385986|NCT00630734|11527832|FG001|NOT COMPLETED|Overall Study||1
10385987|NCT00630734|11527833|FG002|NOT COMPLETED|Overall Study||1
10385988|NCT00630747|11527843|FG000|STARTED|Overall Study||94
10385989|NCT00630747|11527843|FG000|Participants Treated in Phase I of Study|Overall Study||94
10385990|NCT00630747|11527843|FG000|COMPLETED|Overall Study||85
10385991|NCT00630747|11527843|FG000|NOT COMPLETED|Overall Study||9
10385992|NCT00630786|11527850|FG000|STARTED|Overall Study|Includes 2 patients enrolled in Part 1 and 17 patients enrolled in Part 2.|19
10385993|NCT00630786|11527851|FG001|STARTED|Overall Study|Includes 3 patients enrolled in Part 1 and 22 patients enrolled in Part 2.|25
10385994|NCT00630786|11527852|FG002|STARTED|Overall Study|All patients were enrolled in Part 2.|9
10385995|NCT00630786|11527850|FG000|Received Study Medication|Overall Study||19
10385996|NCT00630786|11527851|FG001|Received Study Medication|Overall Study||25
10385997|NCT00630786|11527852|FG002|Received Study Medication|Overall Study||8
10385998|NCT00630786|11527850|FG000|COMPLETED|Overall Study|Completed study defined as participant death|18
10385999|NCT00630786|11527851|FG001|COMPLETED|Overall Study|Completed study defined as participant death|23
10386000|NCT00630786|11527852|FG002|COMPLETED|Overall Study|Completed study defined as participant death|7
10386001|NCT00630786|11527850|FG000|NOT COMPLETED|Overall Study||1
10386002|NCT00630786|11527851|FG001|NOT COMPLETED|Overall Study||2
10386003|NCT00630786|11527852|FG002|NOT COMPLETED|Overall Study||2
10386004|NCT00630812|11527860|FG000|STARTED|Randomisation to First Dose||192
10386005|NCT00630812|11527861|FG001|STARTED|Randomisation to First Dose||126
10386006|NCT00630812|11527860|FG000|COMPLETED|Randomisation to First Dose||184
10386007|NCT00630812|11527861|FG001|COMPLETED|Randomisation to First Dose||121
10386008|NCT00630812|11527860|FG000|NOT COMPLETED|Randomisation to First Dose||8
10386009|NCT00630812|11527861|FG001|NOT COMPLETED|Randomisation to First Dose||5
10386010|NCT00630812|11527860|FG000|STARTED|Double Blind Treatment Period||184
10386011|NCT00630812|11527861|FG001|STARTED|Double Blind Treatment Period||121
10386012|NCT00630812|11527860|FG000|COMPLETED|Double Blind Treatment Period||153
10386013|NCT00630812|11527861|FG001|COMPLETED|Double Blind Treatment Period||107
10386014|NCT00630812|11527860|FG000|NOT COMPLETED|Double Blind Treatment Period||31
10386015|NCT00630812|11527861|FG001|NOT COMPLETED|Double Blind Treatment Period||14
10386016|NCT00630825|11527871|FG000|STARTED|Overall Study||65
10386017|NCT00630825|11527872|FG001|STARTED|Overall Study||65
10386018|NCT00630825|11527873|FG002|STARTED|Overall Study||66
10386019|NCT00630825|11527874|FG003|STARTED|Overall Study||66
10386020|NCT00630825|11527871|FG000|Received at Least One Dose of Study Drug|Overall Study||65
10386021|NCT00630825|11527872|FG001|Received at Least One Dose of Study Drug|Overall Study||65
10386022|NCT00630825|11527873|FG002|Received at Least One Dose of Study Drug|Overall Study||66
10386023|NCT00630825|11527874|FG003|Received at Least One Dose of Study Drug|Overall Study||66
10386024|NCT00630825|11527871|FG000|COMPLETED|Overall Study||56
10386025|NCT00630825|11527872|FG001|COMPLETED|Overall Study||58
10386026|NCT00630825|11527873|FG002|COMPLETED|Overall Study||58
10386027|NCT00630825|11527874|FG003|COMPLETED|Overall Study||60
10386028|NCT00630825|11527871|FG000|NOT COMPLETED|Overall Study||9
10386029|NCT00630825|11527872|FG001|NOT COMPLETED|Overall Study||7
10386030|NCT00630825|11527873|FG002|NOT COMPLETED|Overall Study||8
10386031|NCT00630825|11527874|FG003|NOT COMPLETED|Overall Study||6
10386032|NCT00630838|11527886|FG000|STARTED|Overall Study||32
10386033|NCT00630838|11527887|FG001|STARTED|Overall Study||30
10386034|NCT00630838|11527886|FG000|COMPLETED|Overall Study||32
10386035|NCT00630838|11527887|FG001|COMPLETED|Overall Study||28
10386036|NCT00630838|11527886|FG000|NOT COMPLETED|Overall Study||0
10386037|NCT00630838|11527887|FG001|NOT COMPLETED|Overall Study||2
10386038|NCT00630864|11527895|FG000|STARTED|Part 1 (up to Week 6)||21
10386039|NCT00630864|11527895|FG000|COMPLETED|Part 1 (up to Week 6)||20
10386040|NCT00630864|11527895|FG000|NOT COMPLETED|Part 1 (up to Week 6)||1
10386041|NCT00630864|11527895|FG000|STARTED|Part 2 (After Week 6 up to Month 12)||20
10658331|NCT02232802|11819465|FG000|COMPLETED|Washout||22
10386042|NCT00630864|11527895|FG000|COMPLETED|Part 2 (After Week 6 up to Month 12)||18
10386043|NCT00630864|11527895|FG000|NOT COMPLETED|Part 2 (After Week 6 up to Month 12)||2
10658332|NCT02232802|11819466|FG001|COMPLETED|Washout||22
10658333|NCT02232802|11819465|FG000|NOT COMPLETED|Washout||0
10658334|NCT02232802|11819466|FG001|NOT COMPLETED|Washout||0
10658335|NCT02232893|11819474|FG000|STARTED|Overall Study||35
10658336|NCT02232893|11819475|FG001|STARTED|Overall Study||34
10718144|NCT02703337|11882047|FG007|NOT COMPLETED|Period Two (Part A)||0
10386044|NCT00630877|11527902|FG000|STARTED|Overall Study|For all arms, started means treated.|91
10386045|NCT00630877|11527903|FG001|STARTED|Overall Study||90
10386046|NCT00630877|11527904|FG002|STARTED|Overall Study||90
10386047|NCT00630877|11527902|FG000|COMPLETED|Overall Study||72
10386048|NCT00630877|11527903|FG001|COMPLETED|Overall Study||75
10386049|NCT00630877|11527904|FG002|COMPLETED|Overall Study||80
10386050|NCT00630877|11527902|FG000|NOT COMPLETED|Overall Study||19
10386051|NCT00630877|11527903|FG001|NOT COMPLETED|Overall Study||15
10386052|NCT00630877|11527904|FG002|NOT COMPLETED|Overall Study||10
10386053|NCT00630916|11527916|FG000|STARTED|Overall Study|Total patients enrolled (i.e. consented) to participate in the study.|756
10386054|NCT00630916|11527916|FG000|Study Cohort|Overall Study|Enrolled but did not receive device via physician decision, protocol violation, or lack of efficacy.|699
10386055|NCT00630916|11527916|FG000|COMPLETED|Overall Study|The number of patients that were active (i.e. not drop out) at the end of the study.|546
10540992|NCT01469013|11694052|FG007|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||23
10540993|NCT01469013|11694053|FG008|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||24
10540994|NCT01469013|11694054|FG009|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||11
10540995|NCT01469013|11694055|FG010|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12
10540996|NCT01469013|11694056|FG011|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||24
10540997|NCT01469013|11694057|FG012|Received at Least 1 Dose of Study Drug|Part B (Extension Period)|1 participant discontinued prior to receiving study drug|23
10540998|NCT01469013|11694045|FG000|COMPLETED|Part B (Extension Period)||0
10540999|NCT01469013|11694046|FG001|COMPLETED|Part B (Extension Period)||0
10541000|NCT01469013|11694047|FG002|COMPLETED|Part B (Extension Period)||0
10541001|NCT01469013|11694048|FG003|COMPLETED|Part B (Extension Period)||0
10541002|NCT01469013|11694049|FG004|COMPLETED|Part B (Extension Period)||0
10386056|NCT00630916|11527916|FG000|NOT COMPLETED|Overall Study||210
10386057|NCT00630955|11527923|FG000|STARTED|Overall Study||34
10386058|NCT00630955|11527924|FG001|STARTED|Overall Study||37
10386059|NCT00630955|11527925|FG002|STARTED|Overall Study||40
10386060|NCT00630955|11527923|FG000|COMPLETED|Overall Study||31
10386061|NCT00630955|11527924|FG001|COMPLETED|Overall Study||31
10386062|NCT00630955|11527925|FG002|COMPLETED|Overall Study||28
10386063|NCT00630955|11527923|FG000|NOT COMPLETED|Overall Study||3
10386064|NCT00630955|11527924|FG001|NOT COMPLETED|Overall Study||6
10386065|NCT00630955|11527925|FG002|NOT COMPLETED|Overall Study||12
10386066|NCT00630994|11527933|FG000|STARTED|Overall Study||4
10386067|NCT00630994|11527933|FG000|COMPLETED|Overall Study||0
10386068|NCT00630994|11527933|FG000|NOT COMPLETED|Overall Study||4
10386069|NCT00631007|11527943|FG000|STARTED|Overall Study||60
10386070|NCT00631007|11527944|FG001|STARTED|Overall Study||61
10386071|NCT00631007|11527945|FG002|STARTED|Overall Study||63
10386072|NCT00631007|11527946|FG003|STARTED|Overall Study||62
10386073|NCT00631007|11527947|FG004|STARTED|Overall Study||60
10386074|NCT00631007|11527948|FG005|STARTED|Overall Study||61
10386075|NCT00631007|11527943|FG000|COMPLETED|Overall Study||49
10386076|NCT00631007|11527944|FG001|COMPLETED|Overall Study||50
10386077|NCT00631007|11527945|FG002|COMPLETED|Overall Study||53
10386078|NCT00631007|11527946|FG003|COMPLETED|Overall Study||53
10386079|NCT00631007|11527947|FG004|COMPLETED|Overall Study||48
10386080|NCT00631007|11527948|FG005|COMPLETED|Overall Study||46
10386081|NCT00631007|11527943|FG000|NOT COMPLETED|Overall Study||11
10386082|NCT00631007|11527944|FG001|NOT COMPLETED|Overall Study||11
10386083|NCT00631007|11527945|FG002|NOT COMPLETED|Overall Study||10
10386084|NCT00631007|11527946|FG003|NOT COMPLETED|Overall Study||9
10386085|NCT00631007|11527947|FG004|NOT COMPLETED|Overall Study||12
10386086|NCT00631007|11527948|FG005|NOT COMPLETED|Overall Study||15
10386087|NCT00631020|11527962|FG000|STARTED|Overall Study||34
10386088|NCT00631020|11527962|FG000|COMPLETED|Overall Study||26
10386089|NCT00631020|11527962|FG000|NOT COMPLETED|Overall Study||8
10386090|NCT00631163|11527966|FG000|STARTED|Number of Participants in Year 1||102
10386091|NCT00631163|11527966|FG000|COMPLETED|Number of Participants in Year 1||68
10386092|NCT00631163|11527966|FG000|NOT COMPLETED|Number of Participants in Year 1||34
10386093|NCT00631163|11527966|FG000|STARTED|Number of Participants in Year 2||57
10386094|NCT00631163|11527966|FG000|COMPLETED|Number of Participants in Year 2||52
10386095|NCT00631163|11527966|FG000|NOT COMPLETED|Number of Participants in Year 2||5
10386096|NCT00631189|11527981|FG000|STARTED|Initial Phase||668
10386097|NCT00631189|11527982|FG001|STARTED|Initial Phase||0
10386098|NCT00631189|11527983|FG002|STARTED|Initial Phase||0
10386099|NCT00631189|11527984|FG003|STARTED|Initial Phase||0
10386100|NCT00631189|11527981|FG000|COMPLETED|Initial Phase||317
10386101|NCT00631189|11527982|FG001|COMPLETED|Initial Phase||0
10386102|NCT00631189|11527983|FG002|COMPLETED|Initial Phase||0
10386103|NCT00631189|11527984|FG003|COMPLETED|Initial Phase||0
10386104|NCT00631189|11527981|FG000|NOT COMPLETED|Initial Phase||351
10386105|NCT00631189|11527982|FG001|NOT COMPLETED|Initial Phase||0
10386106|NCT00631189|11527983|FG002|NOT COMPLETED|Initial Phase||0
10386107|NCT00631189|11527984|FG003|NOT COMPLETED|Initial Phase||0
10386108|NCT00631189|11527981|FG000|STARTED|Treatment Phase||0
10386109|NCT00631189|11527982|FG001|STARTED|Treatment Phase||104
10386110|NCT00631189|11527983|FG002|STARTED|Treatment Phase||103
10386111|NCT00631189|11527984|FG003|STARTED|Treatment Phase||110
10386112|NCT00631189|11527981|FG000|COMPLETED|Treatment Phase||0
10386113|NCT00631189|11527982|FG001|COMPLETED|Treatment Phase||97
10386114|NCT00631189|11527983|FG002|COMPLETED|Treatment Phase||92
10386115|NCT00631189|11527984|FG003|COMPLETED|Treatment Phase||103
10386116|NCT00631189|11527981|FG000|NOT COMPLETED|Treatment Phase||0
10386117|NCT00631189|11527982|FG001|NOT COMPLETED|Treatment Phase||7
10386118|NCT00631189|11527983|FG002|NOT COMPLETED|Treatment Phase||11
10386119|NCT00631189|11527984|FG003|NOT COMPLETED|Treatment Phase||7
10386120|NCT00631319|11527996|FG000|STARTED|Conversion and Titration Phase||343
10386121|NCT00631319|11527997|FG001|STARTED|Conversion and Titration Phase|Per the study design, no patients received placebo during this phase.|0
10386122|NCT00631319|11527996|FG000|COMPLETED|Conversion and Titration Phase||200
10386123|NCT00631319|11527997|FG001|COMPLETED|Conversion and Titration Phase||0
10386124|NCT00631319|11527996|FG000|NOT COMPLETED|Conversion and Titration Phase||143
10386125|NCT00631319|11527997|FG001|NOT COMPLETED|Conversion and Titration Phase||0
10386126|NCT00631319|11527996|FG000|STARTED|Double-blind Phase||100
10386127|NCT00631319|11527997|FG001|STARTED|Double-blind Phase||100
10386128|NCT00631319|11527996|FG000|COMPLETED|Double-blind Phase||60
10386129|NCT00631319|11527997|FG001|COMPLETED|Double-blind Phase||65
10386130|NCT00631319|11527996|FG000|NOT COMPLETED|Double-blind Phase||40
10386131|NCT00631319|11527997|FG001|NOT COMPLETED|Double-blind Phase||35
10386132|NCT00631358|11528006|FG000|STARTED|Overall Study||50
10386133|NCT00631358|11528007|FG001|STARTED|Overall Study||47
10386134|NCT00631358|11528006|FG000|COMPLETED|Overall Study||44
10386135|NCT00631358|11528007|FG001|COMPLETED|Overall Study||45
10386136|NCT00631358|11528006|FG000|NOT COMPLETED|Overall Study||6
10386137|NCT00631358|11528007|FG001|NOT COMPLETED|Overall Study||2
10386138|NCT00631371|11528015|FG000|STARTED|Overall Study||400
10386139|NCT00631371|11528016|FG001|STARTED|Overall Study||391
10386140|NCT00631371|11528015|FG000|Treated|Overall Study||393
10386141|NCT00631371|11528016|FG001|Treated|Overall Study||391
10386142|NCT00631371|11528015|FG000|COMPLETED|Overall Study||0
10386143|NCT00631371|11528016|FG001|COMPLETED|Overall Study||0
10386144|NCT00631371|11528015|FG000|NOT COMPLETED|Overall Study||400
10386145|NCT00631371|11528016|FG001|NOT COMPLETED|Overall Study||391
10386146|NCT00631410|11528024|FG000|STARTED|Overall Study||6
10386147|NCT00631410|11528025|FG001|STARTED|Overall Study||6
10386148|NCT00631410|11528024|FG000|COMPLETED|Overall Study||0
10386149|NCT00631410|11528025|FG001|COMPLETED|Overall Study||0
10386150|NCT00631410|11528024|FG000|NOT COMPLETED|Overall Study||6
10386151|NCT00631410|11528025|FG001|NOT COMPLETED|Overall Study||6
10386152|NCT00631449|11528036|FG000|STARTED|Overall Study||15
10386153|NCT00631449|11528037|FG001|STARTED|Overall Study||15
10386154|NCT00631449|11528036|FG000|COMPLETED|Overall Study||15
10386155|NCT00631449|11528037|FG001|COMPLETED|Overall Study||15
10386156|NCT00631449|11528036|FG000|NOT COMPLETED|Overall Study||0
10386157|NCT00631449|11528037|FG001|NOT COMPLETED|Overall Study||0
10386158|NCT00631475|11528045|FG000|STARTED|Overall Study||128
10386159|NCT00631475|11528045|FG000|COMPLETED|Overall Study||83
10386160|NCT00631475|11528045|FG000|NOT COMPLETED|Overall Study||45
10386161|NCT00631488|11528052|FG000|STARTED|Overall Study||48
10386162|NCT00631488|11528053|FG001|STARTED|Overall Study||49
10386163|NCT00631488|11528054|FG002|STARTED|Overall Study||49
10386164|NCT00631488|11528052|FG000|Completed Post-Treatment Period|Overall Study||44
10386165|NCT00631488|11528053|FG001|Completed Post-Treatment Period|Overall Study||47
10386166|NCT00631488|11528054|FG002|Completed Post-Treatment Period|Overall Study||47
10386167|NCT00631488|11528052|FG000|COMPLETED|Overall Study||44
10386168|NCT00631488|11528053|FG001|COMPLETED|Overall Study||47
10386169|NCT00631488|11528054|FG002|COMPLETED|Overall Study||47
10386170|NCT00631488|11528052|FG000|NOT COMPLETED|Overall Study||4
10386171|NCT00631488|11528053|FG001|NOT COMPLETED|Overall Study||2
10386172|NCT00631488|11528054|FG002|NOT COMPLETED|Overall Study||2
10386173|NCT00631540|11528062|FG000|STARTED|Overall Study||100
10386174|NCT00631540|11528062|FG000|COMPLETED|Overall Study||86
10386175|NCT00631540|11528062|FG000|NOT COMPLETED|Overall Study||14
10386176|NCT00631566|11528069|FG000|STARTED|Overall Study||21
10386177|NCT00631566|11528070|FG001|STARTED|Overall Study||28
10386178|NCT00631566|11528071|FG002|STARTED|Overall Study||501
10386179|NCT00631566|11528069|FG000|COMPLETED|Overall Study||19
10386180|NCT00631566|11528070|FG001|COMPLETED|Overall Study||24
10386181|NCT00631566|11528071|FG002|COMPLETED|Overall Study||501
10386182|NCT00631566|11528069|FG000|NOT COMPLETED|Overall Study||2
10386183|NCT00631566|11528070|FG001|NOT COMPLETED|Overall Study||4
10386184|NCT00631566|11528071|FG002|NOT COMPLETED|Overall Study||0
10386185|NCT00631657|11528081|FG000|STARTED|6-Month Treatment Period||344
10386186|NCT00631657|11528082|FG001|STARTED|6-Month Treatment Period||0
10386187|NCT00631657|11528083|FG002|STARTED|6-Month Treatment Period||116
10386188|NCT00631657|11528081|FG000|Treated|6-Month Treatment Period|Two randomized participants were not treated during the 6-month Treatment Period.|342
10386189|NCT00631657|11528082|FG001|Treated|6-Month Treatment Period||0
10386190|NCT00631657|11528083|FG002|Treated|6-Month Treatment Period|One randomized participant was not treated during the 6-month Treatment Period.|115
10386191|NCT00631657|11528081|FG000|COMPLETED|6-Month Treatment Period||203
10386192|NCT00631657|11528082|FG001|COMPLETED|6-Month Treatment Period||0
10386193|NCT00631657|11528083|FG002|COMPLETED|6-Month Treatment Period||66
10386194|NCT00631657|11528081|FG000|NOT COMPLETED|6-Month Treatment Period||141
10386195|NCT00631657|11528082|FG001|NOT COMPLETED|6-Month Treatment Period||0
10386196|NCT00631657|11528083|FG002|NOT COMPLETED|6-Month Treatment Period||50
10386197|NCT00631657|11528081|FG000|STARTED|7-Day Discontinuation Period|One participant was radomized in the Discont. Period, without completing the Treatment Period.|67
10386198|NCT00631657|11528082|FG001|STARTED|7-Day Discontinuation Period||137
10386199|NCT00631657|11528083|FG002|STARTED|7-Day Discontinuation Period||66
10386200|NCT00631657|11528081|FG000|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|66
10386225|NCT00631748|11528118|FG000|STARTED|Overall Study||29
10386201|NCT00631657|11528082|FG001|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|136
10386202|NCT00631657|11528083|FG002|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|65
10386203|NCT00631657|11528081|FG000|COMPLETED|7-Day Discontinuation Period||65
10386204|NCT00631657|11528082|FG001|COMPLETED|7-Day Discontinuation Period||136
10386205|NCT00631657|11528083|FG002|COMPLETED|7-Day Discontinuation Period||65
10386206|NCT00631657|11528081|FG000|NOT COMPLETED|7-Day Discontinuation Period||2
10386207|NCT00631657|11528082|FG001|NOT COMPLETED|7-Day Discontinuation Period||1
10386208|NCT00631657|11528083|FG002|NOT COMPLETED|7-Day Discontinuation Period||1
10386209|NCT00631670|11528096|FG000|STARTED|Overall Study||21
10386210|NCT00631670|11528097|FG001|STARTED|Overall Study||0
10386211|NCT00631670|11528096|FG000|COMPLETED|Overall Study||21
10386212|NCT00631670|11528097|FG001|COMPLETED|Overall Study||0
10386213|NCT00631670|11528096|FG000|NOT COMPLETED|Overall Study||0
10386214|NCT00631670|11528097|FG001|NOT COMPLETED|Overall Study||0
10386215|NCT00631696|11528109|FG000|STARTED|Overall Study||112
10386216|NCT00631696|11528110|FG001|STARTED|Overall Study||110
10386217|NCT00631696|11528109|FG000|Received Study Treatment (Tx)|Overall Study||111
10386218|NCT00631696|11528110|FG001|Received Study Treatment (Tx)|Overall Study||109
10386219|NCT00631696|11528109|FG000|Ongoing at Database Release 18Oct2011|Overall Study|Completed Tx at time of database release 18Oct2011; included in all analyses.|2
10386220|NCT00631696|11528110|FG001|Ongoing at Database Release 18Oct2011|Overall Study||0
10386221|NCT00631696|11528109|FG000|COMPLETED|Overall Study|Completed study at time of database release 18Oct2011.|75
10386222|NCT00631696|11528110|FG001|COMPLETED|Overall Study|Completed study at time of database release 18Oct2011.|70
10386223|NCT00631696|11528109|FG000|NOT COMPLETED|Overall Study||37
10386224|NCT00631696|11528110|FG001|NOT COMPLETED|Overall Study||40
10428306|NCT00857311|11574288|FG000|NOT COMPLETED|Overall Study||1
10428307|NCT00857311|11574289|FG001|NOT COMPLETED|Overall Study||0
10428308|NCT00857311|11574290|FG002|NOT COMPLETED|Overall Study||0
10428309|NCT00857311|11574291|FG003|NOT COMPLETED|Overall Study||0
10428310|NCT00857389|11574297|FG000|STARTED|Overall Study||60
10428311|NCT00857389|11574297|FG000|COMPLETED|Overall Study||58
10428312|NCT00857389|11574297|FG000|NOT COMPLETED|Overall Study||2
10428313|NCT00857415|11574303|FG000|STARTED|Overall Study||152
10428314|NCT00857415|11574304|FG001|STARTED|Overall Study||74
10428315|NCT00857415|11574303|FG000|Deceased Within One Year of AV-45 Scan|Overall Study||37
10428316|NCT00857415|11574304|FG001|Deceased Within One Year of AV-45 Scan|Overall Study|Subjects in the specificity cohort were not followed to autopsy|0
10428317|NCT00857415|11574303|FG000|COMPLETED|Overall Study||35
10428318|NCT00857415|11574304|FG001|COMPLETED|Overall Study||74
10428319|NCT00857415|11574303|FG000|NOT COMPLETED|Overall Study||117
10428320|NCT00857415|11574304|FG001|NOT COMPLETED|Overall Study||0
10428321|NCT00857454|11574310|FG000|STARTED|Overall Study||71
10428322|NCT00857454|11574310|FG000|COMPLETED|Overall Study||51
10428323|NCT00857454|11574310|FG000|NOT COMPLETED|Overall Study||20
10428324|NCT00857493|11574316|FG000|STARTED|Overall Study||62
10428325|NCT00857493|11574317|FG001|STARTED|Overall Study||58
10428326|NCT00857493|11574316|FG000|COMPLETED|Overall Study||59
10428327|NCT00857493|11574317|FG001|COMPLETED|Overall Study||58
10428328|NCT00857493|11574316|FG000|NOT COMPLETED|Overall Study||3
10428329|NCT00857493|11574317|FG001|NOT COMPLETED|Overall Study||0
10428330|NCT00857506|11574326|FG000|STARTED|Overall Study||31
10812699|NCT03361228|11974842|FG001|NOT COMPLETED|Overall Study||1
10812700|NCT03360903|11974850|FG000|STARTED|First Intervention||4
10812701|NCT03360903|11974851|FG001|STARTED|First Intervention||4
10812702|NCT03360903|11974850|FG000|COMPLETED|First Intervention||4
10428331|NCT00857506|11574327|FG001|STARTED|Overall Study||52
10428332|NCT00857506|11574328|FG002|STARTED|Overall Study||69
10428333|NCT00857506|11574326|FG000|COMPLETED|Overall Study||16
10428334|NCT00857506|11574327|FG001|COMPLETED|Overall Study||37
10428335|NCT00857506|11574328|FG002|COMPLETED|Overall Study||51
10428336|NCT00857506|11574326|FG000|NOT COMPLETED|Overall Study||15
10428337|NCT00857506|11574327|FG001|NOT COMPLETED|Overall Study||15
10428338|NCT00857506|11574328|FG002|NOT COMPLETED|Overall Study||18
10428339|NCT00857532|11574348|FG000|STARTED|Overall Study||31
10428340|NCT00857532|11574348|FG000|COMPLETED|Overall Study||31
10428341|NCT00857532|11574348|FG000|NOT COMPLETED|Overall Study||0
10428342|NCT00857545|11574357|FG000|STARTED|Overall Study||86
10428343|NCT00857545|11574358|FG001|STARTED|Overall Study||85
10428344|NCT00857545|11574357|FG000|COMPLETED|Overall Study|Enrolled and randomized participants.|86
10428345|NCT00857545|11574358|FG001|COMPLETED|Overall Study||85
10428346|NCT00857545|11574357|FG000|NOT COMPLETED|Overall Study||0
10428347|NCT00857545|11574358|FG001|NOT COMPLETED|Overall Study||0
10428348|NCT00857584|11574366|FG000|STARTED|Overall Study||14
10428349|NCT00857584|11574367|FG001|STARTED|Overall Study||13
10428350|NCT00857584|11574366|FG000|Week 1|Overall Study||14
10428351|NCT00857584|11574367|FG001|Week 1|Overall Study||13
10428352|NCT00857584|11574366|FG000|Week 2|Overall Study||14
10812703|NCT03360903|11974851|FG001|COMPLETED|First Intervention||4
10812704|NCT03360903|11974850|FG000|NOT COMPLETED|First Intervention||0
10812705|NCT03360903|11974851|FG001|NOT COMPLETED|First Intervention||0
10428353|NCT00857584|11574367|FG001|Week 2|Overall Study||11
10428354|NCT00857584|11574366|FG000|Week 4|Overall Study||11
10428355|NCT00857584|11574367|FG001|Week 4|Overall Study||9
10812706|NCT03360903|11974850|FG000|STARTED|Washout (2 Weeks)||4
10428356|NCT00857584|11574366|FG000|Week 8|Overall Study||10
10428357|NCT00857584|11574367|FG001|Week 8|Overall Study||8
10812707|NCT03360903|11974851|FG001|STARTED|Washout (2 Weeks)||4
10386226|NCT00631748|11528119|FG001|STARTED|Overall Study||31
10386227|NCT00631748|11528118|FG000|COMPLETED|Overall Study|11 participants completed the double-blind portion of the study; 8 participants completed follow-up.|11
10386228|NCT00631748|11528119|FG001|COMPLETED|Overall Study|9 participants completed the double-blind portion of the study; 5 participants completed follow-up.|9
10386229|NCT00631748|11528118|FG000|NOT COMPLETED|Overall Study||18
10386230|NCT00631748|11528119|FG001|NOT COMPLETED|Overall Study||22
10386231|NCT00631852|11528126|FG000|STARTED|Overall Study|Seventeen subjects were consented and 16 were considered enrolled and treated under the protocol. One was a screen fail.|16
10386232|NCT00631852|11528126|FG000|COMPLETED|Overall Study|2 patients were administratively withdrawn after treatment had been completed as they declined sharing of data after PI transfer.|16
10541003|NCT01469013|11694050|FG005|COMPLETED|Part B (Extension Period)||10
10541004|NCT01469013|11694051|FG006|COMPLETED|Part B (Extension Period)||7
10541005|NCT01469013|11694052|FG007|COMPLETED|Part B (Extension Period)||18
10541006|NCT01469013|11694053|FG008|COMPLETED|Part B (Extension Period)||20
10541007|NCT01469013|11694054|FG009|COMPLETED|Part B (Extension Period)||8
10541008|NCT01469013|11694055|FG010|COMPLETED|Part B (Extension Period)||10
10541009|NCT01469013|11694056|FG011|COMPLETED|Part B (Extension Period)||18
10541010|NCT01469013|11694057|FG012|COMPLETED|Part B (Extension Period)||18
10541011|NCT01469013|11694045|FG000|NOT COMPLETED|Part B (Extension Period)||0
10541012|NCT01469013|11694046|FG001|NOT COMPLETED|Part B (Extension Period)||0
10541013|NCT01469013|11694047|FG002|NOT COMPLETED|Part B (Extension Period)||0
10541014|NCT01469013|11694048|FG003|NOT COMPLETED|Part B (Extension Period)||0
10541015|NCT01469013|11694049|FG004|NOT COMPLETED|Part B (Extension Period)||0
10718145|NCT02703337|11882040|FG000|STARTED|Period Three (Part A)||5
10718146|NCT02703337|11882041|FG001|STARTED|Period Three (Part A)||5
10718147|NCT02703337|11882042|FG002|STARTED|Period Three (Part A)||5
10718148|NCT02703337|11882043|FG003|STARTED|Period Three (Part A)||5
10718149|NCT02703337|11882044|FG004|STARTED|Period Three (Part A)||4
10718150|NCT02703337|11882045|FG005|STARTED|Period Three (Part A)||5
10718151|NCT02703337|11882046|FG006|STARTED|Period Three (Part A)||0
10718152|NCT02703337|11882047|FG007|STARTED|Period Three (Part A)||0
10718153|NCT02703337|11882040|FG000|Received Study Drug|Period Three (Part A)||5
10718154|NCT02703337|11882041|FG001|Received Study Drug|Period Three (Part A)||5
10718155|NCT02703337|11882042|FG002|Received Study Drug|Period Three (Part A)||5
10718156|NCT02703337|11882043|FG003|Received Study Drug|Period Three (Part A)||5
10718157|NCT02703337|11882044|FG004|Received Study Drug|Period Three (Part A)||4
10718158|NCT02703337|11882045|FG005|Received Study Drug|Period Three (Part A)||5
10718159|NCT02703337|11882046|FG006|Received Study Drug|Period Three (Part A)||0
10718160|NCT02703337|11882047|FG007|Received Study Drug|Period Three (Part A)||0
10718161|NCT02703337|11882040|FG000|COMPLETED|Period Three (Part A)||5
10718162|NCT02703337|11882041|FG001|COMPLETED|Period Three (Part A)||5
10718163|NCT02703337|11882042|FG002|COMPLETED|Period Three (Part A)||5
10718164|NCT02703337|11882043|FG003|COMPLETED|Period Three (Part A)||5
10718165|NCT02703337|11882044|FG004|COMPLETED|Period Three (Part A)||4
10718166|NCT02703337|11882045|FG005|COMPLETED|Period Three (Part A)||5
10718167|NCT02703337|11882046|FG006|COMPLETED|Period Three (Part A)||0
10718168|NCT02703337|11882047|FG007|COMPLETED|Period Three (Part A)||0
10718169|NCT02703337|11882040|FG000|NOT COMPLETED|Period Three (Part A)||0
10718170|NCT02703337|11882041|FG001|NOT COMPLETED|Period Three (Part A)||0
10718171|NCT02703337|11882042|FG002|NOT COMPLETED|Period Three (Part A)||0
10718172|NCT02703337|11882043|FG003|NOT COMPLETED|Period Three (Part A)||0
10718173|NCT02703337|11882044|FG004|NOT COMPLETED|Period Three (Part A)||0
10718174|NCT02703337|11882045|FG005|NOT COMPLETED|Period Three (Part A)||0
10718175|NCT02703337|11882046|FG006|NOT COMPLETED|Period Three (Part A)||0
10718176|NCT02703337|11882047|FG007|NOT COMPLETED|Period Three (Part A)||0
10718177|NCT02703337|11882040|FG000|STARTED|Period Four (Part A)||5
10718178|NCT02703337|11882041|FG001|STARTED|Period Four (Part A)||5
10718179|NCT02703337|11882042|FG002|STARTED|Period Four (Part A)||5
10718180|NCT02703337|11882043|FG003|STARTED|Period Four (Part A)||5
10718181|NCT02703337|11882044|FG004|STARTED|Period Four (Part A)||4
10718182|NCT02703337|11882045|FG005|STARTED|Period Four (Part A)||5
10718183|NCT02703337|11882046|FG006|STARTED|Period Four (Part A)||0
10718184|NCT02703337|11882047|FG007|STARTED|Period Four (Part A)||0
10718185|NCT02703337|11882040|FG000|Received Study Drug|Period Four (Part A)||5
10718186|NCT02703337|11882041|FG001|Received Study Drug|Period Four (Part A)||5
10718187|NCT02703337|11882042|FG002|Received Study Drug|Period Four (Part A)||5
10718188|NCT02703337|11882043|FG003|Received Study Drug|Period Four (Part A)||5
10718189|NCT02703337|11882044|FG004|Received Study Drug|Period Four (Part A)||4
10718190|NCT02703337|11882045|FG005|Received Study Drug|Period Four (Part A)||5
10718191|NCT02703337|11882046|FG006|Received Study Drug|Period Four (Part A)||0
10718192|NCT02703337|11882047|FG007|Received Study Drug|Period Four (Part A)||0
10718193|NCT02703337|11882040|FG000|COMPLETED|Period Four (Part A)||5
10718194|NCT02703337|11882041|FG001|COMPLETED|Period Four (Part A)||5
10718195|NCT02703337|11882042|FG002|COMPLETED|Period Four (Part A)||5
10718196|NCT02703337|11882043|FG003|COMPLETED|Period Four (Part A)||5
10718197|NCT02703337|11882044|FG004|COMPLETED|Period Four (Part A)||4
10386233|NCT00631852|11528126|FG000|NOT COMPLETED|Overall Study||0
10386234|NCT00631917|11528132|FG000|STARTED|Overall Study||375
10386235|NCT00631917|11528133|FG001|STARTED|Overall Study||399
10386236|NCT00631917|11528132|FG000|COMPLETED|Overall Study||287
10386237|NCT00631917|11528133|FG001|COMPLETED|Overall Study||291
10718198|NCT02703337|11882045|FG005|COMPLETED|Period Four (Part A)||5
10386238|NCT00631917|11528132|FG000|NOT COMPLETED|Overall Study||88
10386239|NCT00631917|11528133|FG001|NOT COMPLETED|Overall Study||108
10386240|NCT00631969|11528141|FG000|STARTED|Overall Study||186
10386241|NCT00631969|11528142|FG001|STARTED|Overall Study||176
10386242|NCT00631969|11528141|FG000|Received Treatment|Overall Study|safety population|184
10386243|NCT00631969|11528142|FG001|Received Treatment|Overall Study|safety population|174
10386244|NCT00631969|11528141|FG000|COMPLETED|Overall Study||171
10386245|NCT00631969|11528142|FG001|COMPLETED|Overall Study||155
10386246|NCT00631969|11528141|FG000|NOT COMPLETED|Overall Study||15
10386247|NCT00631969|11528142|FG001|NOT COMPLETED|Overall Study||21
10386248|NCT00632021|11528152|FG000|STARTED|Overall Study||432
10386249|NCT00632021|11528153|FG001|STARTED|Overall Study||430
10386250|NCT00632021|11528152|FG000|COMPLETED|Overall Study||428
10386251|NCT00632021|11528153|FG001|COMPLETED|Overall Study||423
10386252|NCT00632021|11528152|FG000|NOT COMPLETED|Overall Study||4
10386253|NCT00632021|11528153|FG001|NOT COMPLETED|Overall Study||7
10386254|NCT00632099|11528162|FG000|STARTED|Overall Study||10
10386255|NCT00632099|11528163|FG001|STARTED|Overall Study||11
10386256|NCT00632099|11528162|FG000|COMPLETED|Overall Study||7
10386257|NCT00632099|11528163|FG001|COMPLETED|Overall Study||8
10386258|NCT00632099|11528162|FG000|NOT COMPLETED|Overall Study||3
10386259|NCT00632099|11528163|FG001|NOT COMPLETED|Overall Study||3
10386260|NCT00632125|11528169|FG000|STARTED|Overall Study|1,698 patients were enrolled but 3 patients did not receive any study medication.|1695
10386261|NCT00632125|11528169|FG000|COMPLETED|Overall Study||1393
10386262|NCT00632125|11528169|FG000|NOT COMPLETED|Overall Study||302
10386263|NCT00632203|11528175|FG000|STARTED|Overall Study||26
10386264|NCT00632203|11528176|FG001|STARTED|Overall Study||27
10386265|NCT00632203|11528175|FG000|COMPLETED|Overall Study||25
10386266|NCT00632203|11528176|FG001|COMPLETED|Overall Study||27
10386267|NCT00632203|11528175|FG000|NOT COMPLETED|Overall Study||1
10386268|NCT00632203|11528176|FG001|NOT COMPLETED|Overall Study||0
10386269|NCT00632229|11528184|FG000|STARTED|Overall Study||17
10386270|NCT00632229|11528185|FG001|STARTED|Overall Study||17
10386271|NCT00632229|11528184|FG000|COMPLETED|Overall Study||11
10386272|NCT00632229|11528185|FG001|COMPLETED|Overall Study||11
10386273|NCT00632229|11528184|FG000|NOT COMPLETED|Overall Study||6
10386274|NCT00632229|11528185|FG001|NOT COMPLETED|Overall Study||6
10386275|NCT00632281|11528191|FG000|STARTED|Overall Study||38
10386276|NCT00632281|11528191|FG000|COMPLETED|Overall Study||38
10386277|NCT00632281|11528191|FG000|NOT COMPLETED|Overall Study||0
10386278|NCT00632359|11528195|FG000|STARTED|Overall Study||33
10386279|NCT00632359|11528195|FG000|COMPLETED|Overall Study||31
10386280|NCT00632359|11528195|FG000|NOT COMPLETED|Overall Study||2
10541016|NCT01469013|11694050|FG005|NOT COMPLETED|Part B (Extension Period)||2
10541017|NCT01469013|11694051|FG006|NOT COMPLETED|Part B (Extension Period)||5
10541018|NCT01469013|11694052|FG007|NOT COMPLETED|Part B (Extension Period)||5
10541019|NCT01469013|11694053|FG008|NOT COMPLETED|Part B (Extension Period)||4
10541020|NCT01469013|11694054|FG009|NOT COMPLETED|Part B (Extension Period)||3
10541021|NCT01469013|11694055|FG010|NOT COMPLETED|Part B (Extension Period)||2
10541022|NCT01469013|11694056|FG011|NOT COMPLETED|Part B (Extension Period)||6
10541023|NCT01469013|11694057|FG012|NOT COMPLETED|Part B (Extension Period)||6
10541024|NCT01469039|11694087|FG000|STARTED|Overall Study||207
10541025|NCT01469039|11694088|FG001|STARTED|Overall Study||208
10541026|NCT01469039|11694089|FG002|STARTED|Overall Study||208
10541027|NCT01469039|11694087|FG000|COMPLETED|Overall Study||130
10541028|NCT01469039|11694088|FG001|COMPLETED|Overall Study||135
10541029|NCT01469039|11694089|FG002|COMPLETED|Overall Study||95
10541030|NCT01469039|11694087|FG000|NOT COMPLETED|Overall Study||77
10541031|NCT01469039|11694088|FG001|NOT COMPLETED|Overall Study||73
10541032|NCT01469039|11694089|FG002|NOT COMPLETED|Overall Study||113
10541033|NCT01469052|11694103|FG000|STARTED|Overall Study||6
10541034|NCT01469052|11694104|FG001|STARTED|Overall Study||4
10541035|NCT01469052|11694105|FG002|STARTED|Overall Study||6
10541036|NCT01469052|11694106|FG003|STARTED|Overall Study||6
10541037|NCT01469052|11694107|FG004|STARTED|Overall Study||8
10658337|NCT02232893|11819474|FG000|Safety Population|Overall Study|Pts who rec'd at least 1 dose of study drug. All safety analyses performed using this population.|34
10658338|NCT02232893|11819475|FG001|Safety Population|Overall Study|Pts who rec'd at least 1 dose of study drug. All safety analyses performed using this population.|32
10658339|NCT02232893|11819474|FG000|Primary Endpoint Population|Overall Study|Patients who provided GIQLI scores both at baseline and Visit 4 were analyzed for primary endpoint|24
10658340|NCT02232893|11819475|FG001|Primary Endpoint Population|Overall Study|Patients who provided GIQLI scores both at baseline and Visit 4 were analyzed for primary endpoint|19
10658341|NCT02232893|11819474|FG000|COMPLETED|Overall Study||31
10658342|NCT02232893|11819475|FG001|COMPLETED|Overall Study||27
10658343|NCT02232893|11819474|FG000|NOT COMPLETED|Overall Study||4
10386281|NCT00632411|11528202|FG000|STARTED|Overall Study||649
10386282|NCT00632411|11528203|FG001|STARTED|Overall Study||649
10386283|NCT00632411|11528202|FG000|COMPLETED|Overall Study||489
10386284|NCT00632411|11528203|FG001|COMPLETED|Overall Study||473
10386285|NCT00632411|11528202|FG000|NOT COMPLETED|Overall Study||160
10541038|NCT01469052|11694108|FG005|STARTED|Overall Study||6
10541039|NCT01469052|11694103|FG000|COMPLETED|Overall Study||0
10541040|NCT01469052|11694104|FG001|COMPLETED|Overall Study||0
10541041|NCT01469052|11694105|FG002|COMPLETED|Overall Study||0
10386286|NCT00632411|11528203|FG001|NOT COMPLETED|Overall Study||176
10386287|NCT00632424|11528212|FG000|STARTED|Overall Study||18
10386288|NCT00632424|11528212|FG000|COMPLETED|Overall Study||0
10541042|NCT01469052|11694106|FG003|COMPLETED|Overall Study||1
10386289|NCT00632424|11528212|FG000|NOT COMPLETED|Overall Study||18
10386290|NCT00632463|11528229|FG000|STARTED|Overall Study||7
10386291|NCT00632463|11528230|FG001|STARTED|Overall Study||7
10386292|NCT00632463|11528231|FG002|STARTED|Overall Study||7
10386293|NCT00632463|11528229|FG000|COMPLETED|Overall Study||7
10386294|NCT00632463|11528230|FG001|COMPLETED|Overall Study||6
10386295|NCT00632463|11528231|FG002|COMPLETED|Overall Study||7
10386296|NCT00632463|11528229|FG000|NOT COMPLETED|Overall Study||0
10386297|NCT00632463|11528230|FG001|NOT COMPLETED|Overall Study||1
10386298|NCT00632463|11528231|FG002|NOT COMPLETED|Overall Study||0
10386299|NCT00632489|11528242|FG000|STARTED|Overall Study||15
10386300|NCT00632489|11528243|FG001|STARTED|Overall Study||5
10386301|NCT00632489|11528244|FG002|STARTED|Overall Study||0
10386302|NCT00632489|11528242|FG000|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
10386303|NCT00632489|11528243|FG001|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
10386304|NCT00632489|11528244|FG002|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
10386305|NCT00632489|11528242|FG000|NOT COMPLETED|Overall Study||15
10386306|NCT00632489|11528243|FG001|NOT COMPLETED|Overall Study||5
10386307|NCT00632489|11528244|FG002|NOT COMPLETED|Overall Study||0
10386308|NCT00632502|11528254|FG000|STARTED|Overall Study||25
10386309|NCT00632502|11528255|FG001|STARTED|Overall Study||12
10386310|NCT00632502|11528254|FG000|Treated|Overall Study||22
10386311|NCT00632502|11528255|FG001|Treated|Overall Study||12
10386312|NCT00632502|11528254|FG000|Completed Treatment|Overall Study||19
10386313|NCT00632502|11528255|FG001|Completed Treatment|Overall Study||9
10386314|NCT00632502|11528254|FG000|COMPLETED|Overall Study||22
10386315|NCT00632502|11528255|FG001|COMPLETED|Overall Study||11
10386316|NCT00632502|11528254|FG000|NOT COMPLETED|Overall Study||3
10386317|NCT00632502|11528255|FG001|NOT COMPLETED|Overall Study||1
10386318|NCT00632541|11528262|FG000|STARTED|Overall Study|18 subjects were accrued to the study|18
10386319|NCT00632541|11528262|FG000|COMPLETED|Overall Study||11
10386320|NCT00632541|11528262|FG000|NOT COMPLETED|Overall Study||7
10386321|NCT00632619|11528268|FG000|STARTED|Overall Study|first cohort started 9/11/09 second cohort started 12/7/11|33
10386322|NCT00632619|11528269|FG001|STARTED|Overall Study|first cohort started 9/11/09 second cohort started 12/7/11|35
10386323|NCT00632619|11528268|FG000|COMPLETED|Overall Study|"st cohort completed follow up by 5/24/10~nd cohort completed follow up 7/18/11"|25
10386324|NCT00632619|11528269|FG001|COMPLETED|Overall Study|"st cohort completed follow up by 5/24/10~nd cohort completed follow up 7/18/11"|31
10386325|NCT00632619|11528268|FG000|NOT COMPLETED|Overall Study||8
10386326|NCT00632619|11528269|FG001|NOT COMPLETED|Overall Study||4
10386327|NCT00632632|11528277|FG000|STARTED|Overall Study||13
10386328|NCT00632632|11528278|FG001|STARTED|Overall Study||12
10386329|NCT00632632|11528277|FG000|COMPLETED|Overall Study||13
10386330|NCT00632632|11528278|FG001|COMPLETED|Overall Study||9
10386331|NCT00632632|11528277|FG000|NOT COMPLETED|Overall Study||0
10386332|NCT00632632|11528278|FG001|NOT COMPLETED|Overall Study||3
10386333|NCT00632736|11528284|FG000|STARTED|Overall Study||419
10386334|NCT00632736|11528284|FG000|COMPLETED|Overall Study||151
10386335|NCT00632736|11528284|FG000|NOT COMPLETED|Overall Study||268
10386336|NCT00632749|11528302|FG000|STARTED|Overall Study||4
10386337|NCT00632749|11528303|FG001|STARTED|Overall Study||5
10386338|NCT00632749|11528304|FG002|STARTED|Overall Study||3
10386339|NCT00632749|11528305|FG003|STARTED|Overall Study||4
10386340|NCT00632749|11528306|FG004|STARTED|Overall Study||7
10386341|NCT00632749|11528307|FG005|STARTED|Overall Study||8
10386342|NCT00632749|11528308|FG006|STARTED|Overall Study||5
10386343|NCT00632749|11528309|FG007|STARTED|Overall Study||4
10386344|NCT00632749|11528310|FG008|STARTED|Overall Study||5
10386345|NCT00632749|11528311|FG009|STARTED|Overall Study||3
10386346|NCT00632749|11528312|FG010|STARTED|Overall Study||7
10386347|NCT00632749|11528313|FG011|STARTED|Overall Study||4
10386348|NCT00632749|11528314|FG012|STARTED|Overall Study||3
10386349|NCT00632749|11528315|FG013|STARTED|Overall Study||6
10386350|NCT00632749|11528302|FG000|Treated|Overall Study||4
10386351|NCT00632749|11528303|FG001|Treated|Overall Study||3
10386352|NCT00632749|11528304|FG002|Treated|Overall Study||3
10386353|NCT00632749|11528305|FG003|Treated|Overall Study||4
10386354|NCT00632749|11528306|FG004|Treated|Overall Study||7
10386355|NCT00632749|11528307|FG005|Treated|Overall Study||7
10386356|NCT00632749|11528308|FG006|Treated|Overall Study||4
10386357|NCT00632749|11528309|FG007|Treated|Overall Study||4
10718199|NCT02703337|11882046|FG006|COMPLETED|Period Four (Part A)||0
10718200|NCT02703337|11882047|FG007|COMPLETED|Period Four (Part A)||0
10718201|NCT02703337|11882040|FG000|NOT COMPLETED|Period Four (Part A)||0
10718202|NCT02703337|11882041|FG001|NOT COMPLETED|Period Four (Part A)||0
10718203|NCT02703337|11882042|FG002|NOT COMPLETED|Period Four (Part A)||0
10386358|NCT00632749|11528310|FG008|Treated|Overall Study||5
10386359|NCT00632749|11528311|FG009|Treated|Overall Study||3
10718204|NCT02703337|11882043|FG003|NOT COMPLETED|Period Four (Part A)||0
10386360|NCT00632749|11528312|FG010|Treated|Overall Study||7
10386361|NCT00632749|11528313|FG011|Treated|Overall Study||4
10386362|NCT00632749|11528314|FG012|Treated|Overall Study||3
10386363|NCT00632749|11528315|FG013|Treated|Overall Study||6
10386364|NCT00632749|11528302|FG000|Not Treated|Overall Study||0
10386365|NCT00632749|11528303|FG001|Not Treated|Overall Study||2
10386366|NCT00632749|11528304|FG002|Not Treated|Overall Study||0
10386367|NCT00632749|11528305|FG003|Not Treated|Overall Study||0
10386368|NCT00632749|11528306|FG004|Not Treated|Overall Study||0
10386369|NCT00632749|11528307|FG005|Not Treated|Overall Study||1
10386370|NCT00632749|11528308|FG006|Not Treated|Overall Study||1
10718205|NCT02703337|11882044|FG004|NOT COMPLETED|Period Four (Part A)||0
10718206|NCT02703337|11882045|FG005|NOT COMPLETED|Period Four (Part A)||0
10718207|NCT02703337|11882046|FG006|NOT COMPLETED|Period Four (Part A)||0
10386371|NCT00632749|11528309|FG007|Not Treated|Overall Study||0
10386372|NCT00632749|11528310|FG008|Not Treated|Overall Study||0
10386373|NCT00632749|11528311|FG009|Not Treated|Overall Study||0
10386374|NCT00632749|11528312|FG010|Not Treated|Overall Study||0
10386375|NCT00632749|11528313|FG011|Not Treated|Overall Study||0
10386376|NCT00632749|11528314|FG012|Not Treated|Overall Study||0
10386377|NCT00632749|11528315|FG013|Not Treated|Overall Study||0
10386378|NCT00632749|11528302|FG000|COMPLETED|Overall Study||0
10386379|NCT00632749|11528303|FG001|COMPLETED|Overall Study||0
10386380|NCT00632749|11528304|FG002|COMPLETED|Overall Study||0
10386381|NCT00632749|11528305|FG003|COMPLETED|Overall Study||0
10386382|NCT00632749|11528306|FG004|COMPLETED|Overall Study||0
10386383|NCT00632749|11528307|FG005|COMPLETED|Overall Study||0
10386384|NCT00632749|11528308|FG006|COMPLETED|Overall Study||0
10386385|NCT00632749|11528309|FG007|COMPLETED|Overall Study||0
10386386|NCT00632749|11528310|FG008|COMPLETED|Overall Study||0
10386387|NCT00632749|11528311|FG009|COMPLETED|Overall Study||0
10386388|NCT00632749|11528312|FG010|COMPLETED|Overall Study||0
10386389|NCT00632749|11528313|FG011|COMPLETED|Overall Study||0
10386390|NCT00632749|11528314|FG012|COMPLETED|Overall Study||0
10386391|NCT00632749|11528315|FG013|COMPLETED|Overall Study||0
10386392|NCT00632749|11528302|FG000|NOT COMPLETED|Overall Study||4
10386393|NCT00632749|11528303|FG001|NOT COMPLETED|Overall Study||5
10386394|NCT00632749|11528304|FG002|NOT COMPLETED|Overall Study||3
10386395|NCT00632749|11528305|FG003|NOT COMPLETED|Overall Study||4
10386396|NCT00632749|11528306|FG004|NOT COMPLETED|Overall Study||7
10386397|NCT00632749|11528307|FG005|NOT COMPLETED|Overall Study||8
10386398|NCT00632749|11528308|FG006|NOT COMPLETED|Overall Study||5
10386399|NCT00632749|11528309|FG007|NOT COMPLETED|Overall Study||4
10386400|NCT00632749|11528310|FG008|NOT COMPLETED|Overall Study||5
10386401|NCT00632749|11528311|FG009|NOT COMPLETED|Overall Study||3
10386402|NCT00632749|11528312|FG010|NOT COMPLETED|Overall Study||7
10386403|NCT00632749|11528313|FG011|NOT COMPLETED|Overall Study||4
10386404|NCT00632749|11528314|FG012|NOT COMPLETED|Overall Study||3
10386405|NCT00632749|11528315|FG013|NOT COMPLETED|Overall Study||6
10386406|NCT00632814|11528354|FG000|STARTED|Overall Study||11
10386407|NCT00632814|11528355|FG001|STARTED|Overall Study||13
10386408|NCT00632814|11528356|FG002|STARTED|Overall Study||8
10386409|NCT00632814|11528354|FG000|COMPLETED|Overall Study||11
10386410|NCT00632814|11528355|FG001|COMPLETED|Overall Study||13
10386411|NCT00632814|11528356|FG002|COMPLETED|Overall Study||8
10386412|NCT00632814|11528354|FG000|NOT COMPLETED|Overall Study||0
10386413|NCT00632814|11528355|FG001|NOT COMPLETED|Overall Study||0
10386414|NCT00632814|11528356|FG002|NOT COMPLETED|Overall Study||0
10386415|NCT00632827|11528364|FG000|STARTED|Overall Study||21
10386416|NCT00632827|11528364|FG000|Received GVD|Overall Study||21
10386417|NCT00632827|11528364|FG000|Received M-CHOP|Overall Study||18
10386418|NCT00632827|11528364|FG000|Evaluated Post Stem Cell Transplant|Overall Study||16
10386419|NCT00632827|11528364|FG000|COMPLETED|Overall Study||11
10386420|NCT00632827|11528364|FG000|NOT COMPLETED|Overall Study||10
10386421|NCT00632931|11528369|FG000|STARTED|Part 1, Period 1||13
10386422|NCT00632931|11528370|FG001|STARTED|Part 1, Period 1||12
10386423|NCT00632931|11528371|FG002|STARTED|Part 1, Period 1||0
10386424|NCT00632931|11528369|FG000|COMPLETED|Part 1, Period 1||11
10386425|NCT00632931|11528370|FG001|COMPLETED|Part 1, Period 1||12
10386426|NCT00632931|11528371|FG002|COMPLETED|Part 1, Period 1||0
10386427|NCT00632931|11528369|FG000|NOT COMPLETED|Part 1, Period 1||2
10386428|NCT00632931|11528370|FG001|NOT COMPLETED|Part 1, Period 1||0
10386429|NCT00632931|11528371|FG002|NOT COMPLETED|Part 1, Period 1||0
10386430|NCT00632931|11528369|FG000|STARTED|Part 1, Washout||11
10386431|NCT00632931|11528370|FG001|STARTED|Part 1, Washout||12
10386432|NCT00632931|11528371|FG002|STARTED|Part 1, Washout||0
10386433|NCT00632931|11528369|FG000|COMPLETED|Part 1, Washout||11
10386434|NCT00632931|11528370|FG001|COMPLETED|Part 1, Washout||12
10386435|NCT00632931|11528371|FG002|COMPLETED|Part 1, Washout||0
10386436|NCT00632931|11528369|FG000|NOT COMPLETED|Part 1, Washout||0
10386437|NCT00632931|11528370|FG001|NOT COMPLETED|Part 1, Washout||0
10386438|NCT00632931|11528371|FG002|NOT COMPLETED|Part 1, Washout||0
10386439|NCT00632931|11528369|FG000|STARTED|Part 1, Period 2||11
10386440|NCT00632931|11528370|FG001|STARTED|Part 1, Period 2||12
10386441|NCT00632931|11528371|FG002|STARTED|Part 1, Period 2||0
10386442|NCT00632931|11528369|FG000|COMPLETED|Part 1, Period 2||11
10386443|NCT00632931|11528370|FG001|COMPLETED|Part 1, Period 2||12
10386444|NCT00632931|11528371|FG002|COMPLETED|Part 1, Period 2||0
10386445|NCT00632931|11528369|FG000|NOT COMPLETED|Part 1, Period 2||0
10386446|NCT00632931|11528370|FG001|NOT COMPLETED|Part 1, Period 2||0
10386447|NCT00632931|11528371|FG002|NOT COMPLETED|Part 1, Period 2||0
10386448|NCT00632931|11528369|FG000|STARTED|Post-Part 1 Washout|1 patient who did not complete Period 1 was subsequently enrolled into Post Part 1|12
10386449|NCT00632931|11528370|FG001|STARTED|Post-Part 1 Washout||12
10386450|NCT00632931|11528371|FG002|STARTED|Post-Part 1 Washout||0
10386451|NCT00632931|11528369|FG000|COMPLETED|Post-Part 1 Washout||12
10386452|NCT00632931|11528370|FG001|COMPLETED|Post-Part 1 Washout||12
10386453|NCT00632931|11528371|FG002|COMPLETED|Post-Part 1 Washout||0
10386454|NCT00632931|11528369|FG000|NOT COMPLETED|Post-Part 1 Washout||0
10386455|NCT00632931|11528370|FG001|NOT COMPLETED|Post-Part 1 Washout||0
10386456|NCT00632931|11528371|FG002|NOT COMPLETED|Post-Part 1 Washout||0
10718208|NCT02703337|11882047|FG007|NOT COMPLETED|Period Four (Part A)||0
10718209|NCT02703337|11882040|FG000|STARTED|Period Five (Part A)||5
10718210|NCT02703337|11882041|FG001|STARTED|Period Five (Part A)||5
10718211|NCT02703337|11882042|FG002|STARTED|Period Five (Part A)||5
10718212|NCT02703337|11882043|FG003|STARTED|Period Five (Part A)||5
10718213|NCT02703337|11882044|FG004|STARTED|Period Five (Part A)||4
10386457|NCT00632931|11528369|FG000|STARTED|Part 2||0
10386458|NCT00632931|11528370|FG001|STARTED|Part 2||0
10386459|NCT00632931|11528371|FG002|STARTED|Part 2||24
10386460|NCT00632931|11528369|FG000|COMPLETED|Part 2||0
10386461|NCT00632931|11528370|FG001|COMPLETED|Part 2||0
10386462|NCT00632931|11528371|FG002|COMPLETED|Part 2||0
10386463|NCT00632931|11528369|FG000|NOT COMPLETED|Part 2||0
10386464|NCT00632931|11528370|FG001|NOT COMPLETED|Part 2||0
10386465|NCT00632931|11528371|FG002|NOT COMPLETED|Part 2||24
10386466|NCT00632970|11528378|FG000|STARTED|Overall Study||3
10386467|NCT00632970|11528379|FG001|STARTED|Overall Study||3
10386468|NCT00632970|11528378|FG000|COMPLETED|Overall Study||3
10386469|NCT00632970|11528379|FG001|COMPLETED|Overall Study||3
10386470|NCT00632970|11528378|FG000|NOT COMPLETED|Overall Study||0
10386471|NCT00632970|11528379|FG001|NOT COMPLETED|Overall Study||0
10386472|NCT00633009|11528388|FG000|STARTED|Overall Study||12
10386473|NCT00633009|11528389|FG001|STARTED|Overall Study||27
10386474|NCT00633009|11528390|FG002|STARTED|Overall Study||11
10386475|NCT00633009|11528388|FG000|COMPLETED|Overall Study||8
10386476|NCT00633009|11528389|FG001|COMPLETED|Overall Study||23
10386477|NCT00633009|11528390|FG002|COMPLETED|Overall Study||10
10386478|NCT00633009|11528388|FG000|NOT COMPLETED|Overall Study||4
10386479|NCT00633009|11528389|FG001|NOT COMPLETED|Overall Study||4
10386480|NCT00633009|11528390|FG002|NOT COMPLETED|Overall Study||1
10386481|NCT00633022|11528404|FG000|STARTED|Overall Study||34
10386482|NCT00633022|11528405|FG001|STARTED|Overall Study||33
10386483|NCT00633022|11528406|FG002|STARTED|Overall Study||32
10386484|NCT00633022|11528404|FG000|COMPLETED|Overall Study||33
10386485|NCT00633022|11528405|FG001|COMPLETED|Overall Study||32
10386486|NCT00633022|11528406|FG002|COMPLETED|Overall Study||27
10386487|NCT00633022|11528404|FG000|NOT COMPLETED|Overall Study||1
10386488|NCT00633022|11528405|FG001|NOT COMPLETED|Overall Study||1
10386489|NCT00633022|11528406|FG002|NOT COMPLETED|Overall Study||5
10386490|NCT00633074|11528416|FG000|STARTED|Overall Study||360
10386491|NCT00633074|11528417|FG001|STARTED|Overall Study||360
10386492|NCT00633074|11528416|FG000|COMPLETED|Overall Study||359
10386493|NCT00633074|11528417|FG001|COMPLETED|Overall Study||360
10386494|NCT00633074|11528416|FG000|NOT COMPLETED|Overall Study||1
10386495|NCT00633074|11528417|FG001|NOT COMPLETED|Overall Study||0
10386496|NCT00633126|11528423|FG000|STARTED|Overall Study||9
10386497|NCT00633126|11528423|FG000|COMPLETED|Overall Study||8
10386498|NCT00633126|11528423|FG000|NOT COMPLETED|Overall Study||1
10386499|NCT00633139|11528430|FG000|STARTED|Overall Study||4
10386500|NCT00633139|11528431|FG001|STARTED|Overall Study||5
10386501|NCT00633139|11528432|FG002|STARTED|Overall Study||4
10386502|NCT00633139|11528430|FG000|COMPLETED|Overall Study||4
10386503|NCT00633139|11528431|FG001|COMPLETED|Overall Study||4
10386504|NCT00633139|11528432|FG002|COMPLETED|Overall Study||3
10386505|NCT00633139|11528430|FG000|NOT COMPLETED|Overall Study||0
10386506|NCT00633139|11528431|FG001|NOT COMPLETED|Overall Study||1
10386507|NCT00633139|11528432|FG002|NOT COMPLETED|Overall Study||1
10386508|NCT00633152|11528442|FG000|STARTED|Overall Study||103
10386509|NCT00633152|11528443|FG001|STARTED|Overall Study||47
10386510|NCT00633152|11528442|FG000|MITT and Safety Population|Overall Study||98
10386511|NCT00633152|11528443|FG001|MITT and Safety Population|Overall Study||45
10386512|NCT00633152|11528442|FG000|Clinically Evaluable Population|Overall Study||86
10386513|NCT00633152|11528443|FG001|Clinically Evaluable Population|Overall Study||39
10386514|NCT00633152|11528442|FG000|COMPLETED|Overall Study||89
10386515|NCT00633152|11528443|FG001|COMPLETED|Overall Study||41
10386516|NCT00633152|11528442|FG000|NOT COMPLETED|Overall Study||14
10386517|NCT00633152|11528443|FG001|NOT COMPLETED|Overall Study||6
10386518|NCT00633217|11528453|FG000|STARTED|Overall Study||121
10386519|NCT00633217|11528454|FG001|STARTED|Overall Study||126
10386520|NCT00633217|11528453|FG000|COMPLETED|Overall Study||106
10386521|NCT00633217|11528454|FG001|COMPLETED|Overall Study||103
10386522|NCT00633217|11528453|FG000|NOT COMPLETED|Overall Study||15
10386523|NCT00633217|11528454|FG001|NOT COMPLETED|Overall Study||23
10386524|NCT00633243|11528462|FG000|STARTED|Overall Study||12
10386525|NCT00633243|11528463|FG001|STARTED|Overall Study||9
10386526|NCT00633243|11528462|FG000|COMPLETED|Overall Study||11
10386527|NCT00633243|11528463|FG001|COMPLETED|Overall Study||2
10386528|NCT00633243|11528462|FG000|NOT COMPLETED|Overall Study||1
10386529|NCT00633243|11528463|FG001|NOT COMPLETED|Overall Study||7
10386530|NCT00633256|11528471|FG000|STARTED|Overall Study||12
10386531|NCT00633256|11528472|FG001|STARTED|Overall Study||13
10386532|NCT00633256|11528471|FG000|COMPLETED|Overall Study||8
10386533|NCT00633256|11528472|FG001|COMPLETED|Overall Study||10
10386534|NCT00633256|11528471|FG000|NOT COMPLETED|Overall Study||4
10386535|NCT00633256|11528472|FG001|NOT COMPLETED|Overall Study||3
10386536|NCT00633360|11528480|FG000|STARTED|Overall Study||16
10386537|NCT00633360|11528481|FG001|STARTED|Overall Study||16
10386538|NCT00633360|11528480|FG000|COMPLETED|Overall Study||12
10386539|NCT00633360|11528481|FG001|COMPLETED|Overall Study||13
10386540|NCT00633360|11528480|FG000|NOT COMPLETED|Overall Study||4
10386541|NCT00633360|11528481|FG001|NOT COMPLETED|Overall Study||3
10386542|NCT00633399|11528491|FG000|STARTED|Overall Study||71
10718214|NCT02703337|11882045|FG005|STARTED|Period Five (Part A)||5
10386543|NCT00633399|11528492|FG001|STARTED|Overall Study||68
10386544|NCT00633399|11528491|FG000|COMPLETED|Overall Study||49
10386545|NCT00633399|11528492|FG001|COMPLETED|Overall Study||53
10386546|NCT00633399|11528491|FG000|NOT COMPLETED|Overall Study||22
10386547|NCT00633399|11528492|FG001|NOT COMPLETED|Overall Study||15
10386548|NCT00633464|11528500|FG000|STARTED|Overall Study||40
10386549|NCT00633464|11528501|FG001|STARTED|Overall Study||39
10386550|NCT00633464|11528500|FG000|Treated|Overall Study||40
10386551|NCT00633464|11528501|FG001|Treated|Overall Study||37
10386552|NCT00633464|11528500|FG000|COMPLETED|Overall Study|Completed=Offstudy;major reasons:Disease progression-27,study drug toxicity-7,max clinical benefit-3|40
10386553|NCT00633464|11528501|FG001|COMPLETED|Overall Study|Completed=Offstudy;major reasons:Disease progression-25,study drug toxicity-4,subject request-3|37
10386554|NCT00633464|11528500|FG000|NOT COMPLETED|Overall Study||0
10386555|NCT00633464|11528501|FG001|NOT COMPLETED|Overall Study||2
10386556|NCT00633477|11528509|FG000|STARTED|Overall Study|Seven subjects were randomized, however, one was not treated.|7
10386557|NCT00633477|11528510|FG001|STARTED|Overall Study||11
10386558|NCT00633477|11528509|FG000|Randomized But Not Treated|Overall Study||1
10386559|NCT00633477|11528510|FG001|Randomized But Not Treated|Overall Study||0
10386560|NCT00633477|11528509|FG000|Prematurely Discontinued Study Drug|Overall Study||1
10386561|NCT00633477|11528510|FG001|Prematurely Discontinued Study Drug|Overall Study||0
10386562|NCT00633477|11528509|FG000|Completed Study Through Day 28|Overall Study||4
10386563|NCT00633477|11528510|FG001|Completed Study Through Day 28|Overall Study||8
10386564|NCT00633477|11528509|FG000|COMPLETED|Overall Study|Include all subjects who could be evaluated for 28-d survival.|5
10386565|NCT00633477|11528510|FG001|COMPLETED|Overall Study|Include all subjects who could be evaluated for 28-d survival.|11
10386566|NCT00633477|11528509|FG000|NOT COMPLETED|Overall Study||2
10386567|NCT00633477|11528510|FG001|NOT COMPLETED|Overall Study||0
10386568|NCT00633594|11528519|FG000|STARTED|Overall Study||5
10386569|NCT00633594|11528520|FG001|STARTED|Overall Study||8
10386570|NCT00633594|11528521|FG002|STARTED|Overall Study||26
10386571|NCT00633594|11528519|FG000|COMPLETED|Overall Study||5
10386572|NCT00633594|11528520|FG001|COMPLETED|Overall Study||3
10386573|NCT00633594|11528521|FG002|COMPLETED|Overall Study||16
10386574|NCT00633594|11528519|FG000|NOT COMPLETED|Overall Study||0
10386575|NCT00633594|11528520|FG001|NOT COMPLETED|Overall Study||5
10541043|NCT01469052|11694107|FG004|COMPLETED|Overall Study||0
10541044|NCT01469052|11694108|FG005|COMPLETED|Overall Study||0
10541045|NCT01469052|11694103|FG000|NOT COMPLETED|Overall Study||6
10541046|NCT01469052|11694104|FG001|NOT COMPLETED|Overall Study||4
10541047|NCT01469052|11694105|FG002|NOT COMPLETED|Overall Study||6
10541048|NCT01469052|11694106|FG003|NOT COMPLETED|Overall Study||5
10541049|NCT01469052|11694107|FG004|NOT COMPLETED|Overall Study||8
10541050|NCT01469052|11694108|FG005|NOT COMPLETED|Overall Study||6
10718215|NCT02703337|11882046|FG006|STARTED|Period Five (Part A)||0
10718216|NCT02703337|11882047|FG007|STARTED|Period Five (Part A)||0
10718217|NCT02703337|11882040|FG000|Received Study Drug|Period Five (Part A)||5
10541051|NCT01469065|11694125|FG000|STARTED|Overall Study||16
10541052|NCT01469065|11694126|FG001|STARTED|Overall Study||17
10541053|NCT01469065|11694127|FG002|STARTED|Overall Study||16
10541054|NCT01469065|11694128|FG003|STARTED|Overall Study||16
10541055|NCT01469065|11694129|FG004|STARTED|Overall Study||17
10541056|NCT01469065|11694125|FG000|COMPLETED|Overall Study||16
10541057|NCT01469065|11694126|FG001|COMPLETED|Overall Study||16
10541058|NCT01469065|11694127|FG002|COMPLETED|Overall Study||16
10541059|NCT01469065|11694128|FG003|COMPLETED|Overall Study||16
10541060|NCT01469065|11694129|FG004|COMPLETED|Overall Study||16
10541061|NCT01469065|11694125|FG000|NOT COMPLETED|Overall Study||0
10541062|NCT01469065|11694126|FG001|NOT COMPLETED|Overall Study||1
10541063|NCT01469065|11694127|FG002|NOT COMPLETED|Overall Study||0
10541064|NCT01469065|11694128|FG003|NOT COMPLETED|Overall Study||0
10541065|NCT01469065|11694129|FG004|NOT COMPLETED|Overall Study||1
10541066|NCT01469182|11694147|FG000|STARTED|Overall Study||610
10541067|NCT01469182|11694148|FG001|STARTED|Overall Study||304
10541068|NCT01469182|11694147|FG000|Treated|Overall Study||609
10541069|NCT01469182|11694148|FG001|Treated|Overall Study||304
10541070|NCT01469182|11694147|FG000|COMPLETED|Overall Study||575
10541071|NCT01469182|11694148|FG001|COMPLETED|Overall Study||298
10541072|NCT01469182|11694147|FG000|NOT COMPLETED|Overall Study||35
10541073|NCT01469182|11694148|FG001|NOT COMPLETED|Overall Study||6
10541074|NCT01469221|11694156|FG000|STARTED|Open Label Phase||0
10541075|NCT01469221|11694157|FG001|STARTED|Open Label Phase||0
10541076|NCT01469221|11694158|FG002|STARTED|Open Label Phase||47
10658344|NCT02232893|11819475|FG001|NOT COMPLETED|Overall Study||7
10658345|NCT02232984|11819481|FG000|STARTED|Overall Study|Enrolled subjects|749
10718218|NCT02703337|11882041|FG001|Received Study Drug|Period Five (Part A)||5
10718219|NCT02703337|11882042|FG002|Received Study Drug|Period Five (Part A)||5
10386576|NCT00633594|11528521|FG002|NOT COMPLETED|Overall Study||10
10386577|NCT00633750|11528532|FG000|STARTED|Overall Study||47
10386578|NCT00633750|11528532|FG000|COMPLETED|Overall Study||42
10541077|NCT01469221|11694156|FG000|COMPLETED|Open Label Phase||0
10541078|NCT01469221|11694157|FG001|COMPLETED|Open Label Phase||0
10541079|NCT01469221|11694158|FG002|COMPLETED|Open Label Phase||44
10541080|NCT01469221|11694156|FG000|NOT COMPLETED|Open Label Phase||0
10541081|NCT01469221|11694157|FG001|NOT COMPLETED|Open Label Phase||0
10541082|NCT01469221|11694158|FG002|NOT COMPLETED|Open Label Phase||3
10541083|NCT01469221|11694156|FG000|STARTED|Double Blind Phase||14
10541084|NCT01469221|11694157|FG001|STARTED|Double Blind Phase||17
10541085|NCT01469221|11694158|FG002|STARTED|Double Blind Phase||0
10386579|NCT00633750|11528532|FG000|NOT COMPLETED|Overall Study||5
10386580|NCT00633867|11528540|FG000|STARTED|Overall Study||60
10541086|NCT01469221|11694156|FG000|COMPLETED|Double Blind Phase||0
10541087|NCT01469221|11694157|FG001|COMPLETED|Double Blind Phase||0
10541088|NCT01469221|11694158|FG002|COMPLETED|Double Blind Phase||0
10541089|NCT01469221|11694156|FG000|NOT COMPLETED|Double Blind Phase||14
10541090|NCT01469221|11694157|FG001|NOT COMPLETED|Double Blind Phase||17
10541091|NCT01469221|11694158|FG002|NOT COMPLETED|Double Blind Phase||0
10541092|NCT01469234|11694168|FG000|STARTED|Overall Study||85
10541093|NCT01469234|11694169|FG001|STARTED|Overall Study||85
10541094|NCT01469234|11694170|FG002|STARTED|Overall Study||85
10541095|NCT01469234|11694168|FG000|COMPLETED|Overall Study||85
10541096|NCT01469234|11694169|FG001|COMPLETED|Overall Study||85
10541097|NCT01469234|11694170|FG002|COMPLETED|Overall Study||85
10541098|NCT01469234|11694168|FG000|NOT COMPLETED|Overall Study||0
10541099|NCT01469234|11694169|FG001|NOT COMPLETED|Overall Study||0
10541100|NCT01469234|11694170|FG002|NOT COMPLETED|Overall Study||0
10541101|NCT01469364|11694178|FG000|STARTED|Overall Study||30
10541102|NCT01469364|11694178|FG000|COMPLETED|Overall Study||28
10541103|NCT01469364|11694178|FG000|NOT COMPLETED|Overall Study||2
10541104|NCT01469377|11694185|FG000|STARTED|Overall Study||269
10541105|NCT01469377|11694186|FG001|STARTED|Overall Study||274
10541106|NCT01469377|11694187|FG002|STARTED|Overall Study||276
10541107|NCT01469377|11694185|FG000|COMPLETED|Overall Study||234
10541108|NCT01469377|11694186|FG001|COMPLETED|Overall Study||226
10541109|NCT01469377|11694187|FG002|COMPLETED|Overall Study||210
10541110|NCT01469377|11694185|FG000|NOT COMPLETED|Overall Study||35
10541111|NCT01469377|11694186|FG001|NOT COMPLETED|Overall Study||48
10541112|NCT01469377|11694187|FG002|NOT COMPLETED|Overall Study||66
10541113|NCT01469546|11694195|FG000|STARTED|Received 5 mg Dose||42
10541114|NCT01469546|11694195|FG000|Completed First Cycle|Received 5 mg Dose||30
10541115|NCT01469546|11694195|FG000|COMPLETED|Received 5 mg Dose||19
10541116|NCT01469546|11694195|FG000|NOT COMPLETED|Received 5 mg Dose||23
10541117|NCT01469546|11694195|FG000|STARTED|Dose Escalation to 10 mg||19
10541118|NCT01469546|11694195|FG000|COMPLETED|Dose Escalation to 10 mg||19
10541119|NCT01469546|11694195|FG000|NOT COMPLETED|Dose Escalation to 10 mg||0
10541120|NCT01469585|11694201|FG000|STARTED|Overall Study||11
10541121|NCT01469585|11694202|FG001|STARTED|Overall Study||9
10541122|NCT01469585|11694201|FG000|COMPLETED|Overall Study||4
10541123|NCT01469585|11694202|FG001|COMPLETED|Overall Study||6
10541124|NCT01469585|11694201|FG000|NOT COMPLETED|Overall Study||7
10541125|NCT01469585|11694202|FG001|NOT COMPLETED|Overall Study||3
10541126|NCT01469637|11694212|FG000|STARTED|First Intervention||22
10541127|NCT01469637|11694213|FG001|STARTED|First Intervention||22
10541128|NCT01469637|11694212|FG000|COMPLETED|First Intervention||22
10541129|NCT01469637|11694213|FG001|COMPLETED|First Intervention||21
10541130|NCT01469637|11694212|FG000|NOT COMPLETED|First Intervention||0
10541131|NCT01469637|11694213|FG001|NOT COMPLETED|First Intervention||1
10541132|NCT01469637|11694212|FG000|STARTED|Second Intervention||22
10541133|NCT01469637|11694213|FG001|STARTED|Second Intervention||21
10541134|NCT01469637|11694212|FG000|COMPLETED|Second Intervention||21
10541135|NCT01469637|11694213|FG001|COMPLETED|Second Intervention||21
10541136|NCT01469637|11694212|FG000|NOT COMPLETED|Second Intervention||1
10541137|NCT01469637|11694213|FG001|NOT COMPLETED|Second Intervention||0
10541138|NCT01469715|11694219|FG000|STARTED|Overall Study||16
10541139|NCT01469715|11694219|FG000|COMPLETED|Overall Study||16
10541140|NCT01469715|11694219|FG000|NOT COMPLETED|Overall Study||0
10541141|NCT01469767|11694223|FG000|STARTED|Overall Study||10
10541142|NCT01469767|11694223|FG000|COMPLETED|Overall Study||10
10541143|NCT01469767|11694223|FG000|NOT COMPLETED|Overall Study||0
10541144|NCT01469819|11694227|FG000|STARTED|Overall Study||37
10541145|NCT01469819|11694227|FG000|COMPLETED|Overall Study||29
10541146|NCT01469819|11694227|FG000|NOT COMPLETED|Overall Study||8
10541147|NCT01470001|11694239|FG000|STARTED|Overall Study||58
10541148|NCT01470001|11694240|FG001|STARTED|Overall Study||60
10541149|NCT01470001|11694239|FG000|COMPLETED|Overall Study||53
10541150|NCT01470001|11694240|FG001|COMPLETED|Overall Study||58
10541151|NCT01470001|11694239|FG000|NOT COMPLETED|Overall Study||5
10541152|NCT01470001|11694240|FG001|NOT COMPLETED|Overall Study||2
10541153|NCT01470027|11694252|FG000|STARTED|Overall Study||16
10541154|NCT01470027|11694253|FG001|STARTED|Overall Study||15
10541155|NCT01470027|11694254|FG002|STARTED|Overall Study||16
10541156|NCT01470027|11694252|FG000|COMPLETED|Overall Study||15
10541157|NCT01470027|11694253|FG001|COMPLETED|Overall Study||14
10541158|NCT01470027|11694254|FG002|COMPLETED|Overall Study||15
10541159|NCT01470027|11694252|FG000|NOT COMPLETED|Overall Study||1
10541160|NCT01470027|11694253|FG001|NOT COMPLETED|Overall Study||1
10541161|NCT01470027|11694254|FG002|NOT COMPLETED|Overall Study||1
10541162|NCT01470118|11694271|FG000|STARTED|Overall Study||43
10541163|NCT01470118|11694272|FG001|STARTED|Overall Study||43
10386581|NCT00633867|11528541|FG001|STARTED|Overall Study||60
10386582|NCT00633867|11528540|FG000|COMPLETED|Overall Study||60
10386583|NCT00633867|11528541|FG001|COMPLETED|Overall Study||60
10386584|NCT00633867|11528540|FG000|NOT COMPLETED|Overall Study||0
10386585|NCT00633867|11528541|FG001|NOT COMPLETED|Overall Study||0
10386586|NCT00633880|11528550|FG000|STARTED|Open Label Titration||181
10386587|NCT00633880|11528551|FG001|STARTED|Open Label Titration||0
10541164|NCT01470118|11694273|FG002|STARTED|Overall Study||41
10541165|NCT01470118|11694271|FG000|COMPLETED|Overall Study||38
10541166|NCT01470118|11694272|FG001|COMPLETED|Overall Study||38
10541167|NCT01470118|11694273|FG002|COMPLETED|Overall Study||39
10541168|NCT01470118|11694271|FG000|NOT COMPLETED|Overall Study||5
10386588|NCT00633880|11528552|FG002|STARTED|Open Label Titration||0
10386589|NCT00633880|11528550|FG000|COMPLETED|Open Label Titration||101
10386590|NCT00633880|11528551|FG001|COMPLETED|Open Label Titration||0
10386591|NCT00633880|11528552|FG002|COMPLETED|Open Label Titration||0
10386592|NCT00633880|11528550|FG000|NOT COMPLETED|Open Label Titration||80
10386593|NCT00633880|11528551|FG001|NOT COMPLETED|Open Label Titration||0
10386594|NCT00633880|11528552|FG002|NOT COMPLETED|Open Label Titration||0
10386595|NCT00633880|11528550|FG000|STARTED|Randomized Double Blind||0
10386596|NCT00633880|11528551|FG001|STARTED|Randomized Double Blind||50
10386597|NCT00633880|11528552|FG002|STARTED|Randomized Double Blind||51
10386598|NCT00633880|11528550|FG000|COMPLETED|Randomized Double Blind||0
10386599|NCT00633880|11528551|FG001|COMPLETED|Randomized Double Blind||50
10386600|NCT00633880|11528552|FG002|COMPLETED|Randomized Double Blind||51
10386601|NCT00633880|11528550|FG000|NOT COMPLETED|Randomized Double Blind||0
10386602|NCT00633880|11528551|FG001|NOT COMPLETED|Randomized Double Blind||0
10386603|NCT00633880|11528552|FG002|NOT COMPLETED|Randomized Double Blind||0
10386604|NCT00633893|11528562|FG000|STARTED|Overall Study||840
10386605|NCT00633893|11528563|FG001|STARTED|Overall Study|2 participants were randomized to 5 mg study drug but not treated.|813
10386606|NCT00633893|11528564|FG002|STARTED|Overall Study|3 participants were randomized to placebo but not treated.|829
10386607|NCT00633893|11528562|FG000|COMPLETED|Overall Study||726
10386608|NCT00633893|11528563|FG001|COMPLETED|Overall Study||684
10386609|NCT00633893|11528564|FG002|COMPLETED|Overall Study||641
10386610|NCT00633893|11528562|FG000|NOT COMPLETED|Overall Study||114
10386611|NCT00633893|11528563|FG001|NOT COMPLETED|Overall Study||129
10386612|NCT00633893|11528564|FG002|NOT COMPLETED|Overall Study||188
10386613|NCT00633919|11528574|FG000|STARTED|Overall Study||63
10386614|NCT00633919|11528575|FG001|STARTED|Overall Study||61
10386615|NCT00633919|11528574|FG000|COMPLETED|Overall Study||36
10386616|NCT00633919|11528575|FG001|COMPLETED|Overall Study||39
10386617|NCT00633919|11528574|FG000|NOT COMPLETED|Overall Study||27
10386618|NCT00633919|11528575|FG001|NOT COMPLETED|Overall Study||22
10386619|NCT00633932|11528584|FG000|STARTED|Overall Study|Randomised|191
10386620|NCT00633932|11528585|FG001|STARTED|Overall Study|Randomised|190
10386621|NCT00633932|11528586|FG002|STARTED|Overall Study|Randomised|191
10386622|NCT00633932|11528584|FG000|COMPLETED|Overall Study||179
10386623|NCT00633932|11528585|FG001|COMPLETED|Overall Study||176
10386624|NCT00633932|11528586|FG002|COMPLETED|Overall Study||180
10386625|NCT00633932|11528584|FG000|NOT COMPLETED|Overall Study||12
10386626|NCT00633932|11528585|FG001|NOT COMPLETED|Overall Study||14
10386627|NCT00633932|11528586|FG002|NOT COMPLETED|Overall Study||11
10386628|NCT00633945|11528594|FG000|STARTED|Overall Study||5
10386629|NCT00633945|11528594|FG000|COMPLETED|Overall Study||3
10386630|NCT00633945|11528594|FG000|NOT COMPLETED|Overall Study||2
10386631|NCT00633984|11528602|FG000|STARTED|Overall Study||87
10386632|NCT00633984|11528603|FG001|STARTED|Overall Study||82
10386633|NCT00633984|11528602|FG000|COMPLETED|Overall Study||78
10386634|NCT00633984|11528603|FG001|COMPLETED|Overall Study||69
10386635|NCT00633984|11528602|FG000|NOT COMPLETED|Overall Study||9
10386636|NCT00633984|11528603|FG001|NOT COMPLETED|Overall Study||13
10386637|NCT00634036|11528611|FG000|STARTED|Overall Study||12
10386638|NCT00634036|11528612|FG001|STARTED|Overall Study||11
10386639|NCT00634036|11528611|FG000|COMPLETED|Overall Study||10
10386640|NCT00634036|11528612|FG001|COMPLETED|Overall Study||9
10386641|NCT00634036|11528611|FG000|NOT COMPLETED|Overall Study||2
10386642|NCT00634036|11528612|FG001|NOT COMPLETED|Overall Study||2
10386643|NCT00634049|11528618|FG000|STARTED|Overall Study||149
10386644|NCT00634049|11528618|FG000|COMPLETED|Overall Study||146
10386645|NCT00634049|11528618|FG000|NOT COMPLETED|Overall Study||3
10386646|NCT00634088|11528655|FG000|STARTED|Time Period 1: Dose Level 1||6
10386647|NCT00634088|11528656|FG001|STARTED|Time Period 1: Dose Level 1||0
10386648|NCT00634088|11528657|FG002|STARTED|Time Period 1: Dose Level 1||0
10386649|NCT00634088|11528658|FG003|STARTED|Time Period 1: Dose Level 1||0
10386650|NCT00634088|11528655|FG000|COMPLETED|Time Period 1: Dose Level 1||0
10386651|NCT00634088|11528656|FG001|COMPLETED|Time Period 1: Dose Level 1||0
10386652|NCT00634088|11528657|FG002|COMPLETED|Time Period 1: Dose Level 1||0
10386653|NCT00634088|11528658|FG003|COMPLETED|Time Period 1: Dose Level 1||0
10386654|NCT00634088|11528655|FG000|NOT COMPLETED|Time Period 1: Dose Level 1||6
10386655|NCT00634088|11528656|FG001|NOT COMPLETED|Time Period 1: Dose Level 1||0
10386656|NCT00634088|11528657|FG002|NOT COMPLETED|Time Period 1: Dose Level 1||0
10386657|NCT00634088|11528658|FG003|NOT COMPLETED|Time Period 1: Dose Level 1||0
10386658|NCT00634088|11528655|FG000|STARTED|Time Period 2: Dose Level 2||0
10386659|NCT00634088|11528656|FG001|STARTED|Time Period 2: Dose Level 2||3
10386660|NCT00634088|11528657|FG002|STARTED|Time Period 2: Dose Level 2||0
10386661|NCT00634088|11528658|FG003|STARTED|Time Period 2: Dose Level 2||0
10386662|NCT00634088|11528655|FG000|COMPLETED|Time Period 2: Dose Level 2||0
10386663|NCT00634088|11528656|FG001|COMPLETED|Time Period 2: Dose Level 2||0
10386664|NCT00634088|11528657|FG002|COMPLETED|Time Period 2: Dose Level 2||0
10386665|NCT00634088|11528658|FG003|COMPLETED|Time Period 2: Dose Level 2||0
10386666|NCT00634088|11528655|FG000|NOT COMPLETED|Time Period 2: Dose Level 2||0
10386667|NCT00634088|11528656|FG001|NOT COMPLETED|Time Period 2: Dose Level 2||3
10386668|NCT00634088|11528657|FG002|NOT COMPLETED|Time Period 2: Dose Level 2||0
10386669|NCT00634088|11528658|FG003|NOT COMPLETED|Time Period 2: Dose Level 2||0
10386670|NCT00634088|11528655|FG000|STARTED|Time Period 3: Dose Level 3||0
10386671|NCT00634088|11528656|FG001|STARTED|Time Period 3: Dose Level 3||0
10386672|NCT00634088|11528657|FG002|STARTED|Time Period 3: Dose Level 3||1
10386673|NCT00634088|11528658|FG003|STARTED|Time Period 3: Dose Level 3||0
10386674|NCT00634088|11528655|FG000|COMPLETED|Time Period 3: Dose Level 3||0
10386675|NCT00634088|11528656|FG001|COMPLETED|Time Period 3: Dose Level 3||0
10541169|NCT01470118|11694272|FG001|NOT COMPLETED|Overall Study||5
10541170|NCT01470118|11694273|FG002|NOT COMPLETED|Overall Study||2
10541171|NCT01470144|11694281|FG000|STARTED|Overall Study||41
10541172|NCT01470144|11694281|FG000|COMPLETED|Overall Study|"Completed corresponds to subjects switching to commercial EFI upon market approval/reimbursement"|31
10541173|NCT01470144|11694281|FG000|NOT COMPLETED|Overall Study||10
10386676|NCT00634088|11528657|FG002|COMPLETED|Time Period 3: Dose Level 3||0
10541174|NCT01470170|11694290|FG000|STARTED|Overall Study||34
10541175|NCT01470170|11694291|FG001|STARTED|Overall Study||35
10541176|NCT01470170|11694292|FG002|STARTED|Overall Study||34
10541177|NCT01470170|11694293|FG003|STARTED|Overall Study||36
10541178|NCT01470170|11694294|FG004|STARTED|Overall Study||34
10541179|NCT01470170|11694290|FG000|COMPLETED|Overall Study||34
10541180|NCT01470170|11694291|FG001|COMPLETED|Overall Study||35
10541181|NCT01470170|11694292|FG002|COMPLETED|Overall Study||34
10541182|NCT01470170|11694293|FG003|COMPLETED|Overall Study||36
10541183|NCT01470170|11694294|FG004|COMPLETED|Overall Study||34
10541184|NCT01470170|11694290|FG000|NOT COMPLETED|Overall Study||0
10541185|NCT01470170|11694291|FG001|NOT COMPLETED|Overall Study||0
10541186|NCT01470170|11694292|FG002|NOT COMPLETED|Overall Study||0
10541187|NCT01470170|11694293|FG003|NOT COMPLETED|Overall Study||0
10541188|NCT01470170|11694294|FG004|NOT COMPLETED|Overall Study||0
10541189|NCT01470196|11694306|FG000|STARTED|Overall Study||31
10541190|NCT01470196|11694306|FG000|COMPLETED|Overall Study||31
10541191|NCT01470196|11694306|FG000|NOT COMPLETED|Overall Study||0
10541192|NCT01470248|11694310|FG000|STARTED|Overall Study||20
10541193|NCT01470248|11694310|FG000|COMPLETED|Overall Study||19
10541194|NCT01470248|11694310|FG000|NOT COMPLETED|Overall Study||1
10541195|NCT01470417|11694316|FG000|STARTED|Overall Study||3
10541196|NCT01470417|11694317|FG001|STARTED|Overall Study||7
10541197|NCT01470417|11694316|FG000|COMPLETED|Overall Study||3
10541198|NCT01470417|11694317|FG001|COMPLETED|Overall Study||5
10541199|NCT01470417|11694316|FG000|NOT COMPLETED|Overall Study||0
10541200|NCT01470417|11694317|FG001|NOT COMPLETED|Overall Study||2
10541201|NCT01470469|11694325|FG000|STARTED|Overall Study||21
10541202|NCT01470469|11694326|FG001|STARTED|Overall Study||62
10541203|NCT01470469|11694325|FG000|COMPLETED|Overall Study||11
10541204|NCT01470469|11694326|FG001|COMPLETED|Overall Study||38
10541205|NCT01470469|11694325|FG000|NOT COMPLETED|Overall Study||10
10541206|NCT01470469|11694326|FG001|NOT COMPLETED|Overall Study||24
10548168|NCT01517750|11701967|FG003|COMPLETED|Overall Study||18
10548169|NCT01517750|11701964|FG000|NOT COMPLETED|Overall Study||1
10548170|NCT01517750|11701965|FG001|NOT COMPLETED|Overall Study||2
10548171|NCT01517750|11701966|FG002|NOT COMPLETED|Overall Study||4
10548172|NCT01517750|11701967|FG003|NOT COMPLETED|Overall Study||1
10548173|NCT01517867|11701983|FG000|STARTED|Overall Study||81
10548174|NCT01517867|11701984|FG001|STARTED|Overall Study||80
10548175|NCT01517867|11701983|FG000|COMPLETED|Overall Study||18
10548176|NCT01517867|11701984|FG001|COMPLETED|Overall Study||15
10548177|NCT01517867|11701983|FG000|NOT COMPLETED|Overall Study||63
10548178|NCT01517867|11701984|FG001|NOT COMPLETED|Overall Study||65
10548179|NCT01517893|11701992|FG000|STARTED|Overall Study||8
10548180|NCT01517893|11701993|FG001|STARTED|Overall Study||7
10548181|NCT01517893|11701992|FG000|COMPLETED|Overall Study||5
10548182|NCT01517893|11701993|FG001|COMPLETED|Overall Study||7
10548183|NCT01517893|11701992|FG000|NOT COMPLETED|Overall Study||3
10548184|NCT01517893|11701993|FG001|NOT COMPLETED|Overall Study||0
10548185|NCT01517984|11702002|FG000|STARTED|Overall Study||5
10548186|NCT01517984|11702003|FG001|STARTED|Overall Study||26
10548187|NCT01517984|11702004|FG002|STARTED|Overall Study||14
10548188|NCT01517984|11702005|FG003|STARTED|Overall Study||7
10548189|NCT01517984|11702002|FG000|COMPLETED|Overall Study||0
10548190|NCT01517984|11702003|FG001|COMPLETED|Overall Study||3
10548191|NCT01517984|11702004|FG002|COMPLETED|Overall Study||10
10548192|NCT01517984|11702005|FG003|COMPLETED|Overall Study||6
10548193|NCT01517984|11702002|FG000|NOT COMPLETED|Overall Study||5
10548194|NCT01517984|11702003|FG001|NOT COMPLETED|Overall Study||23
10548195|NCT01517984|11702004|FG002|NOT COMPLETED|Overall Study||4
10548196|NCT01517984|11702005|FG003|NOT COMPLETED|Overall Study||1
10548197|NCT01518153|11702012|FG000|STARTED|Stem Cell Transplant||16
10548198|NCT01518153|11702013|FG001|STARTED|Stem Cell Transplant||0
10548199|NCT01518153|11702014|FG002|STARTED|Stem Cell Transplant||0
10548200|NCT01518153|11702012|FG000|COMPLETED|Stem Cell Transplant||7
10548201|NCT01518153|11702013|FG001|COMPLETED|Stem Cell Transplant||0
10548202|NCT01518153|11702014|FG002|COMPLETED|Stem Cell Transplant||0
10548203|NCT01518153|11702012|FG000|NOT COMPLETED|Stem Cell Transplant||9
10548204|NCT01518153|11702013|FG001|NOT COMPLETED|Stem Cell Transplant||0
10548205|NCT01518153|11702014|FG002|NOT COMPLETED|Stem Cell Transplant||0
10548206|NCT01518153|11702012|FG000|STARTED|Donor Lymphocyte Infusion||0
10548207|NCT01518153|11702013|FG001|STARTED|Donor Lymphocyte Infusion||3
10548208|NCT01518153|11702014|FG002|STARTED|Donor Lymphocyte Infusion||4
10548209|NCT01518153|11702012|FG000|COMPLETED|Donor Lymphocyte Infusion||0
10548210|NCT01518153|11702013|FG001|COMPLETED|Donor Lymphocyte Infusion||1
10548211|NCT01518153|11702014|FG002|COMPLETED|Donor Lymphocyte Infusion||3
10548212|NCT01518153|11702012|FG000|NOT COMPLETED|Donor Lymphocyte Infusion||0
10548213|NCT01518153|11702013|FG001|NOT COMPLETED|Donor Lymphocyte Infusion||2
10386677|NCT00634088|11528658|FG003|COMPLETED|Time Period 3: Dose Level 3||0
10386678|NCT00634088|11528655|FG000|NOT COMPLETED|Time Period 3: Dose Level 3||0
10386679|NCT00634088|11528656|FG001|NOT COMPLETED|Time Period 3: Dose Level 3||0
10386680|NCT00634088|11528657|FG002|NOT COMPLETED|Time Period 3: Dose Level 3||1
10386681|NCT00634088|11528658|FG003|NOT COMPLETED|Time Period 3: Dose Level 3||0
10386682|NCT00634088|11528655|FG000|STARTED|Time Period 4: Triplet Combination||0
10386683|NCT00634088|11528656|FG001|STARTED|Time Period 4: Triplet Combination||0
10386684|NCT00634088|11528657|FG002|STARTED|Time Period 4: Triplet Combination||0
10386685|NCT00634088|11528658|FG003|STARTED|Time Period 4: Triplet Combination||0
10386686|NCT00634088|11528655|FG000|COMPLETED|Time Period 4: Triplet Combination||0
10386687|NCT00634088|11528656|FG001|COMPLETED|Time Period 4: Triplet Combination||0
10386688|NCT00634088|11528657|FG002|COMPLETED|Time Period 4: Triplet Combination||0
10386689|NCT00634088|11528658|FG003|COMPLETED|Time Period 4: Triplet Combination||0
10386690|NCT00634088|11528655|FG000|NOT COMPLETED|Time Period 4: Triplet Combination||0
10386691|NCT00634088|11528656|FG001|NOT COMPLETED|Time Period 4: Triplet Combination||0
10386692|NCT00634088|11528657|FG002|NOT COMPLETED|Time Period 4: Triplet Combination||0
10386693|NCT00634088|11528658|FG003|NOT COMPLETED|Time Period 4: Triplet Combination||0
10386694|NCT00634101|11528670|FG000|STARTED|Overall Study||66
10386695|NCT00634101|11528671|FG001|STARTED|Overall Study||59
10386696|NCT00634101|11528670|FG000|COMPLETED|Overall Study||61
10386697|NCT00634101|11528671|FG001|COMPLETED|Overall Study||56
10386698|NCT00634101|11528670|FG000|NOT COMPLETED|Overall Study||5
10386699|NCT00634101|11528671|FG001|NOT COMPLETED|Overall Study||3
10386700|NCT00634114|11528680|FG000|STARTED|Overall Study|Randomised|188
10386701|NCT00634114|11528681|FG001|STARTED|Overall Study|Randomised|189
10386702|NCT00634114|11528682|FG002|STARTED|Overall Study|Randomised|187
10386703|NCT00634114|11528680|FG000|COMPLETED|Overall Study|Completed|160
10386704|NCT00634114|11528681|FG001|COMPLETED|Overall Study|Completed|154
10386705|NCT00634114|11528682|FG002|COMPLETED|Overall Study|Completed|148
10386706|NCT00634114|11528680|FG000|NOT COMPLETED|Overall Study||28
10386707|NCT00634114|11528681|FG001|NOT COMPLETED|Overall Study||35
10386708|NCT00634114|11528682|FG002|NOT COMPLETED|Overall Study||39
10386709|NCT00634166|11528692|FG000|STARTED|Overall Study||82
10386710|NCT00634166|11528693|FG001|STARTED|Overall Study||138
10386711|NCT00634166|11528692|FG000|COMPLETED|Overall Study||22
10386712|NCT00634166|11528693|FG001|COMPLETED|Overall Study||78
10386713|NCT00634166|11528692|FG000|NOT COMPLETED|Overall Study||60
10386714|NCT00634166|11528693|FG001|NOT COMPLETED|Overall Study||60
10386715|NCT00634179|11528699|FG000|STARTED|Phase I: Induction||19
10386716|NCT00634179|11528699|FG000|COMPLETED|Phase I: Induction||19
10386717|NCT00634179|11528699|FG000|NOT COMPLETED|Phase I: Induction||0
10386718|NCT00634179|11528699|FG000|STARTED|Phase II: Maintenance||30
10386719|NCT00634179|11528699|FG000|COMPLETED|Phase II: Maintenance||29
10386720|NCT00634179|11528699|FG000|NOT COMPLETED|Phase II: Maintenance||1
10386721|NCT00634244|11528709|FG000|STARTED|Overall Study||35
10386722|NCT00634244|11528710|FG001|STARTED|Overall Study||37
10386723|NCT00634244|11528711|FG002|STARTED|Overall Study||20
10386724|NCT00634244|11528709|FG000|Eligible and Treated|Overall Study||35
10386725|NCT00634244|11528710|FG001|Eligible and Treated|Overall Study||36
10386726|NCT00634244|11528711|FG002|Eligible and Treated|Overall Study||20
10386727|NCT00634244|11528709|FG000|COMPLETED|Overall Study||34
10386728|NCT00634244|11528710|FG001|COMPLETED|Overall Study||24
10386729|NCT00634244|11528711|FG002|COMPLETED|Overall Study||20
10386730|NCT00634244|11528709|FG000|NOT COMPLETED|Overall Study||1
10386731|NCT00634244|11528710|FG001|NOT COMPLETED|Overall Study||13
10386732|NCT00634244|11528711|FG002|NOT COMPLETED|Overall Study||0
10386733|NCT00634270|11528721|FG000|STARTED|Overall Study|February 12, 2008|49
10386734|NCT00634270|11528722|FG001|STARTED|Overall Study||13
10386735|NCT00634270|11528721|FG000|COMPLETED|Overall Study||46
10386736|NCT00634270|11528722|FG001|COMPLETED|Overall Study||12
10386737|NCT00634270|11528721|FG000|NOT COMPLETED|Overall Study||3
10386738|NCT00634270|11528722|FG001|NOT COMPLETED|Overall Study||1
10386739|NCT00634283|11528734|FG000|STARTED|Overall Study||6
10386740|NCT00634283|11528734|FG000|COMPLETED|Overall Study||6
10386741|NCT00634283|11528734|FG000|NOT COMPLETED|Overall Study||0
10386742|NCT00634543|11528742|FG000|STARTED|Overall Study||78
10386743|NCT00634543|11528743|FG001|STARTED|Overall Study||84
10386744|NCT00634543|11528742|FG000|Treated|Overall Study||76
10386745|NCT00634543|11528743|FG001|Treated|Overall Study||80
10386746|NCT00634543|11528742|FG000|COMPLETED|Overall Study||59
10386747|NCT00634543|11528743|FG001|COMPLETED|Overall Study||63
10386748|NCT00634543|11528742|FG000|NOT COMPLETED|Overall Study||19
10386749|NCT00634543|11528743|FG001|NOT COMPLETED|Overall Study||21
10386750|NCT00634569|11528751|FG000|STARTED|Overall Study||14
10386751|NCT00634569|11528752|FG001|STARTED|Overall Study||10
10386752|NCT00634569|11528751|FG000|COMPLETED|Overall Study||14
10386753|NCT00634569|11528752|FG001|COMPLETED|Overall Study||5
10386754|NCT00634569|11528751|FG000|NOT COMPLETED|Overall Study||0
10386755|NCT00634569|11528752|FG001|NOT COMPLETED|Overall Study||5
10386756|NCT00634621|11528758|FG000|STARTED|Overall Study||283
10386757|NCT00634621|11528758|FG000|COMPLETED|Overall Study||283
10386758|NCT00634621|11528758|FG000|NOT COMPLETED|Overall Study||0
10386759|NCT00634647|11528766|FG000|STARTED|Overall Study||24
10386760|NCT00634647|11528766|FG000|COMPLETED|Overall Study||17
10386761|NCT00634647|11528766|FG000|NOT COMPLETED|Overall Study||7
10386762|NCT00634751|11528774|FG000|STARTED|Phase I: 200mg Sorafenib+2DOC||9
10386763|NCT00634751|11528775|FG001|STARTED|Phase I: 200mg Sorafenib+2DOC||0
10386764|NCT00634751|11528776|FG002|STARTED|Phase I: 200mg Sorafenib+2DOC||0
10386765|NCT00634751|11528777|FG003|STARTED|Phase I: 200mg Sorafenib+2DOC||0
10386766|NCT00634751|11528774|FG000|COMPLETED|Phase I: 200mg Sorafenib+2DOC||8
10386767|NCT00634751|11528775|FG001|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
10386768|NCT00634751|11528776|FG002|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
10386769|NCT00634751|11528777|FG003|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
10386770|NCT00634751|11528774|FG000|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||1
10386771|NCT00634751|11528775|FG001|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
10386772|NCT00634751|11528776|FG002|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
10386773|NCT00634751|11528777|FG003|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
10386774|NCT00634751|11528774|FG000|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
10386775|NCT00634751|11528775|FG001|STARTED|Phase I: 400mg Sorafenib BID+2DOC||7
10386776|NCT00634751|11528776|FG002|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
10386777|NCT00634751|11528777|FG003|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
10386778|NCT00634751|11528774|FG000|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
10386779|NCT00634751|11528775|FG001|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||6
10386780|NCT00634751|11528776|FG002|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
10386781|NCT00634751|11528777|FG003|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
10386782|NCT00634751|11528774|FG000|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
10386783|NCT00634751|11528775|FG001|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||1
10386784|NCT00634751|11528776|FG002|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
10386785|NCT00634751|11528777|FG003|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
10386786|NCT00634751|11528774|FG000|STARTED|Pancreatic and Bilial Tract Cancer||0
10386787|NCT00634751|11528775|FG001|STARTED|Pancreatic and Bilial Tract Cancer||0
10386788|NCT00634751|11528776|FG002|STARTED|Pancreatic and Bilial Tract Cancer||24
10386789|NCT00634751|11528777|FG003|STARTED|Pancreatic and Bilial Tract Cancer||8
10386790|NCT00634751|11528774|FG000|COMPLETED|Pancreatic and Bilial Tract Cancer||0
10386791|NCT00634751|11528775|FG001|COMPLETED|Pancreatic and Bilial Tract Cancer||0
10386792|NCT00634751|11528776|FG002|COMPLETED|Pancreatic and Bilial Tract Cancer||23
10386793|NCT00634751|11528777|FG003|COMPLETED|Pancreatic and Bilial Tract Cancer||7
10386794|NCT00634751|11528774|FG000|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||0
10386795|NCT00634751|11528775|FG001|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||0
10386796|NCT00634751|11528776|FG002|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||1
10386797|NCT00634751|11528777|FG003|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||1
10386798|NCT00634803|11528790|FG000|STARTED|Overall Study||30
10718220|NCT02703337|11882043|FG003|Received Study Drug|Period Five (Part A)||5
10718221|NCT02703337|11882044|FG004|Received Study Drug|Period Five (Part A)||4
10386799|NCT00634803|11528791|FG001|STARTED|Overall Study||30
10386800|NCT00634803|11528792|FG002|STARTED|Overall Study||30
10718222|NCT02703337|11882045|FG005|Received Study Drug|Period Five (Part A)||5
10386801|NCT00634803|11528790|FG000|Month 1|Overall Study||29
10386802|NCT00634803|11528791|FG001|Month 1|Overall Study||29
10386803|NCT00634803|11528792|FG002|Month 1|Overall Study||29
10386804|NCT00634803|11528790|FG000|Month 2|Overall Study||26
10386805|NCT00634803|11528791|FG001|Month 2|Overall Study||26
10386806|NCT00634803|11528792|FG002|Month 2|Overall Study||28
10386807|NCT00634803|11528790|FG000|Month 3|Overall Study||25
10386808|NCT00634803|11528791|FG001|Month 3|Overall Study||23
10386809|NCT00634803|11528792|FG002|Month 3|Overall Study||26
10386810|NCT00634803|11528790|FG000|COMPLETED|Overall Study||24
10386811|NCT00634803|11528791|FG001|COMPLETED|Overall Study||23
10386812|NCT00634803|11528792|FG002|COMPLETED|Overall Study||23
10386813|NCT00634803|11528790|FG000|NOT COMPLETED|Overall Study||6
10386814|NCT00634803|11528791|FG001|NOT COMPLETED|Overall Study||7
10386815|NCT00634803|11528792|FG002|NOT COMPLETED|Overall Study||7
10386816|NCT00634842|11528802|FG000|STARTED|Overall Study||122
10386817|NCT00634842|11528803|FG001|STARTED|Overall Study||122
10386818|NCT00634842|11528802|FG000|COMPLETED|Overall Study||107
10386819|NCT00634842|11528803|FG001|COMPLETED|Overall Study||104
10386820|NCT00634842|11528802|FG000|NOT COMPLETED|Overall Study||15
10386821|NCT00634842|11528803|FG001|NOT COMPLETED|Overall Study||18
10386822|NCT00634907|11528811|FG000|STARTED|Overall Study||131
10386823|NCT00634907|11528812|FG001|STARTED|Overall Study||132
10386824|NCT00634907|11528811|FG000|COMPLETED|Overall Study||114
10386825|NCT00634907|11528812|FG001|COMPLETED|Overall Study||115
10386826|NCT00634907|11528811|FG000|NOT COMPLETED|Overall Study||17
10386827|NCT00634907|11528812|FG001|NOT COMPLETED|Overall Study||17
10386828|NCT00634920|11528821|FG000|STARTED|Period 1 - Pre-Randomization||0
10386829|NCT00634920|11528822|FG001|STARTED|Period 1 - Pre-Randomization||0
10386830|NCT00634920|11528823|FG002|STARTED|Period 1 - Pre-Randomization|Total number of Enrolled patients|341
10386831|NCT00634920|11528821|FG000|COMPLETED|Period 1 - Pre-Randomization||0
10386832|NCT00634920|11528822|FG001|COMPLETED|Period 1 - Pre-Randomization||0
10386833|NCT00634920|11528823|FG002|COMPLETED|Period 1 - Pre-Randomization|Total number of patients who became randomized|204
10386834|NCT00634920|11528821|FG000|NOT COMPLETED|Period 1 - Pre-Randomization||0
10386835|NCT00634920|11528822|FG001|NOT COMPLETED|Period 1 - Pre-Randomization||0
10386836|NCT00634920|11528823|FG002|NOT COMPLETED|Period 1 - Pre-Randomization||137
10386837|NCT00634920|11528821|FG000|STARTED|Period 2 - Post-Randomization|2 patients randomized in this group did not receive at least one dose of study drug.|104
10386838|NCT00634920|11528822|FG001|STARTED|Period 2 - Post-Randomization||100
10386839|NCT00634920|11528823|FG002|STARTED|Period 2 - Post-Randomization|This group included patients who had renal TX but did not qualify for randomization at Visit 2.|0
10386840|NCT00634920|11528821|FG000|Full Analysis Set (FAS)|Period 2 - Post-Randomization||92
10428358|NCT00857584|11574366|FG000|COMPLETED|Overall Study||10
10386841|NCT00634920|11528822|FG001|Full Analysis Set (FAS)|Period 2 - Post-Randomization||90
10386842|NCT00634920|11528823|FG002|Full Analysis Set (FAS)|Period 2 - Post-Randomization||0
10386843|NCT00634920|11528821|FG000|COMPLETED|Period 2 - Post-Randomization||43
10386844|NCT00634920|11528822|FG001|COMPLETED|Period 2 - Post-Randomization||68
10386845|NCT00634920|11528823|FG002|COMPLETED|Period 2 - Post-Randomization||0
10386846|NCT00634920|11528821|FG000|NOT COMPLETED|Period 2 - Post-Randomization||61
10386847|NCT00634920|11528822|FG001|NOT COMPLETED|Period 2 - Post-Randomization||32
10386848|NCT00634920|11528823|FG002|NOT COMPLETED|Period 2 - Post-Randomization||0
10386849|NCT00634933|11528832|FG000|STARTED|Part A: Baseline to Week 24||74
10386850|NCT00634933|11528833|FG001|STARTED|Part A: Baseline to Week 24||75
10386851|NCT00634933|11528834|FG002|STARTED|Part A: Baseline to Week 24||73
10386852|NCT00634933|11528835|FG003|STARTED|Part A: Baseline to Week 24||0
10386853|NCT00634933|11528836|FG004|STARTED|Part A: Baseline to Week 24||0
10386854|NCT00634933|11528832|FG000|COMPLETED|Part A: Baseline to Week 24||63
10386855|NCT00634933|11528833|FG001|COMPLETED|Part A: Baseline to Week 24||57
10386856|NCT00634933|11528834|FG002|COMPLETED|Part A: Baseline to Week 24||55
10386857|NCT00634933|11528835|FG003|COMPLETED|Part A: Baseline to Week 24||0
10386858|NCT00634933|11528836|FG004|COMPLETED|Part A: Baseline to Week 24||0
10386859|NCT00634933|11528832|FG000|NOT COMPLETED|Part A: Baseline to Week 24||11
10386860|NCT00634933|11528833|FG001|NOT COMPLETED|Part A: Baseline to Week 24||18
10386861|NCT00634933|11528834|FG002|NOT COMPLETED|Part A: Baseline to Week 24||18
10386862|NCT00634933|11528835|FG003|NOT COMPLETED|Part A: Baseline to Week 24||0
10386863|NCT00634933|11528836|FG004|NOT COMPLETED|Part A: Baseline to Week 24||0
10386864|NCT00634933|11528832|FG000|STARTED|Between Part A and Part B||0
10386865|NCT00634933|11528833|FG001|STARTED|Between Part A and Part B||57
10386866|NCT00634933|11528834|FG002|STARTED|Between Part A and Part B||55
10386867|NCT00634933|11528835|FG003|STARTED|Between Part A and Part B||31
10386868|NCT00634933|11528836|FG004|STARTED|Between Part A and Part B||32
10386869|NCT00634933|11528832|FG000|COMPLETED|Between Part A and Part B||0
10386870|NCT00634933|11528833|FG001|COMPLETED|Between Part A and Part B||56
10386871|NCT00634933|11528834|FG002|COMPLETED|Between Part A and Part B||55
10386872|NCT00634933|11528835|FG003|COMPLETED|Between Part A and Part B||31
10386873|NCT00634933|11528836|FG004|COMPLETED|Between Part A and Part B||32
10386874|NCT00634933|11528832|FG000|NOT COMPLETED|Between Part A and Part B||0
10386875|NCT00634933|11528833|FG001|NOT COMPLETED|Between Part A and Part B||1
10386876|NCT00634933|11528834|FG002|NOT COMPLETED|Between Part A and Part B||0
10386877|NCT00634933|11528835|FG003|NOT COMPLETED|Between Part A and Part B||0
10386878|NCT00634933|11528836|FG004|NOT COMPLETED|Between Part A and Part B||0
10386879|NCT00634933|11528832|FG000|STARTED|Part B: Week 24 to Week 52||0
10386880|NCT00634933|11528833|FG001|STARTED|Part B: Week 24 to Week 52||56
10386881|NCT00634933|11528834|FG002|STARTED|Part B: Week 24 to Week 52||55
10386882|NCT00634933|11528835|FG003|STARTED|Part B: Week 24 to Week 52||31
10386883|NCT00634933|11528836|FG004|STARTED|Part B: Week 24 to Week 52||32
10386884|NCT00634933|11528832|FG000|COMPLETED|Part B: Week 24 to Week 52||0
10386885|NCT00634933|11528833|FG001|COMPLETED|Part B: Week 24 to Week 52||42
10386886|NCT00634933|11528834|FG002|COMPLETED|Part B: Week 24 to Week 52||33
10386887|NCT00634933|11528835|FG003|COMPLETED|Part B: Week 24 to Week 52||25
10386888|NCT00634933|11528836|FG004|COMPLETED|Part B: Week 24 to Week 52||22
10386889|NCT00634933|11528832|FG000|NOT COMPLETED|Part B: Week 24 to Week 52||0
10386890|NCT00634933|11528833|FG001|NOT COMPLETED|Part B: Week 24 to Week 52||14
10386891|NCT00634933|11528834|FG002|NOT COMPLETED|Part B: Week 24 to Week 52||22
10386892|NCT00634933|11528835|FG003|NOT COMPLETED|Part B: Week 24 to Week 52||6
10386893|NCT00634933|11528836|FG004|NOT COMPLETED|Part B: Week 24 to Week 52||10
10386894|NCT00635024|11528848|FG000|STARTED|Overall Study||1
10386895|NCT00635024|11528848|FG000|COMPLETED|Overall Study||0
10386896|NCT00635024|11528848|FG000|NOT COMPLETED|Overall Study||1
10386897|NCT00635050|11528852|FG000|STARTED|Overall Study|No patient received regimen B due to grade 3 toxicity in the third patient treated on regimen A.|32
10386898|NCT00635050|11528852|FG000|COMPLETED|Overall Study|Followup through 10 years planned.|31
10386899|NCT00635050|11528852|FG000|NOT COMPLETED|Overall Study||1
10386900|NCT00635089|11528859|FG000|STARTED|Overall Study||190
10386901|NCT00635089|11528859|FG000|Completed >/= 16 Weeks of Study|Overall Study||181
10386902|NCT00635089|11528859|FG000|COMPLETED|Overall Study|Participants who had not withdrawn at the time of study termination.|112
10386903|NCT00635089|11528859|FG000|NOT COMPLETED|Overall Study||78
10386904|NCT00635102|11528878|FG000|STARTED|Overall Study||27
10386905|NCT00635102|11528879|FG001|STARTED|Overall Study||30
10386906|NCT00635102|11528878|FG000|COMPLETED|Overall Study||20
10386907|NCT00635102|11528879|FG001|COMPLETED|Overall Study||22
10386908|NCT00635102|11528878|FG000|NOT COMPLETED|Overall Study||7
10386909|NCT00635102|11528879|FG001|NOT COMPLETED|Overall Study||8
10386910|NCT00635128|11528887|FG000|STARTED|Overall Study||351
10386911|NCT00635128|11528888|FG001|STARTED|Overall Study||64
10386912|NCT00635128|11528887|FG000|COMPLETED|Overall Study||351
10386913|NCT00635128|11528888|FG001|COMPLETED|Overall Study||64
10386914|NCT00635128|11528887|FG000|NOT COMPLETED|Overall Study||0
10386915|NCT00635128|11528888|FG001|NOT COMPLETED|Overall Study||0
10386916|NCT00635154|11528896|FG000|STARTED|Overall Study||54
10386917|NCT00635154|11528896|FG000|COMPLETED|Overall Study||21
10386918|NCT00635154|11528896|FG000|NOT COMPLETED|Overall Study||33
10386919|NCT00635219|11528907|FG000|STARTED|Overall Study||148
10386920|NCT00635219|11528908|FG001|STARTED|Overall Study||155
10386921|NCT00635219|11528909|FG002|STARTED|Overall Study||157
10386922|NCT00635219|11528910|FG003|STARTED|Overall Study||151
10386923|NCT00635219|11528911|FG004|STARTED|Overall Study||155
10386924|NCT00635219|11528907|FG000|COMPLETED|Overall Study||123
10386925|NCT00635219|11528908|FG001|COMPLETED|Overall Study||130
10386926|NCT00635219|11528909|FG002|COMPLETED|Overall Study||122
10386927|NCT00635219|11528910|FG003|COMPLETED|Overall Study||117
10718223|NCT02703337|11882046|FG006|Received Study Drug|Period Five (Part A)||0
10386928|NCT00635219|11528911|FG004|COMPLETED|Overall Study||113
10386929|NCT00635219|11528907|FG000|NOT COMPLETED|Overall Study||25
10386930|NCT00635219|11528908|FG001|NOT COMPLETED|Overall Study||25
10386931|NCT00635219|11528909|FG002|NOT COMPLETED|Overall Study||35
10386932|NCT00635219|11528910|FG003|NOT COMPLETED|Overall Study||34
10386933|NCT00635219|11528911|FG004|NOT COMPLETED|Overall Study||42
10386934|NCT00635232|11528928|FG000|STARTED|Overall Study||58
10386935|NCT00635232|11528929|FG001|STARTED|Overall Study||59
10386936|NCT00635232|11528930|FG002|STARTED|Overall Study||58
10386937|NCT00635232|11528931|FG003|STARTED|Overall Study||58
10386938|NCT00635232|11528932|FG004|STARTED|Overall Study||28
10386939|NCT00635232|11528928|FG000|COMPLETED|Overall Study||44
10386940|NCT00635232|11528929|FG001|COMPLETED|Overall Study||39
10386941|NCT00635232|11528930|FG002|COMPLETED|Overall Study||55
10386942|NCT00635232|11528931|FG003|COMPLETED|Overall Study||48
10386943|NCT00635232|11528932|FG004|COMPLETED|Overall Study||20
10386944|NCT00635232|11528928|FG000|NOT COMPLETED|Overall Study||14
10386945|NCT00635232|11528929|FG001|NOT COMPLETED|Overall Study||20
10386946|NCT00635232|11528930|FG002|NOT COMPLETED|Overall Study||3
10386947|NCT00635232|11528931|FG003|NOT COMPLETED|Overall Study||10
10386948|NCT00635232|11528932|FG004|NOT COMPLETED|Overall Study||8
10386949|NCT00635349|11528946|FG000|STARTED|Overall Study||73
10386950|NCT00635349|11528947|FG001|STARTED|Overall Study||67
10386951|NCT00635349|11528946|FG000|COMPLETED|Overall Study||29
10386952|NCT00635349|11528947|FG001|COMPLETED|Overall Study||19
10386953|NCT00635349|11528946|FG000|NOT COMPLETED|Overall Study||44
10386954|NCT00635349|11528947|FG001|NOT COMPLETED|Overall Study||48
10386955|NCT00635362|11528955|FG000|STARTED|Overall Study||22
10386956|NCT00635362|11528956|FG001|STARTED|Overall Study||20
10386957|NCT00635362|11528955|FG000|COMPLETED|Overall Study||9
10386958|NCT00635362|11528956|FG001|COMPLETED|Overall Study||12
10386959|NCT00635362|11528955|FG000|NOT COMPLETED|Overall Study||13
10386960|NCT00635362|11528956|FG001|NOT COMPLETED|Overall Study||8
10386961|NCT00635427|11528967|FG000|STARTED|Overall Study|12 participants were considered ITT population as 1 participant did not have type 1 Gaucher disease|13
10386962|NCT00635427|11528968|FG001|STARTED|Overall Study|11 participants were considered ITT population as 1 participant did not have type 1 Gaucher disease|12
10386963|NCT00635427|11528969|FG002|STARTED|Overall Study||16
10386964|NCT00635427|11528970|FG003|STARTED|Overall Study||16
10386965|NCT00635427|11528971|FG004|STARTED|Overall Study||38
10386966|NCT00635427|11528967|FG000|COMPLETED|Overall Study||1
10386967|NCT00635427|11528968|FG001|COMPLETED|Overall Study||6
10386968|NCT00635427|11528969|FG002|COMPLETED|Overall Study||5
10386969|NCT00635427|11528970|FG003|COMPLETED|Overall Study||7
10386970|NCT00635427|11528971|FG004|COMPLETED|Overall Study||30
10386971|NCT00635427|11528967|FG000|NOT COMPLETED|Overall Study||12
10386972|NCT00635427|11528968|FG001|NOT COMPLETED|Overall Study||6
10386973|NCT00635427|11528969|FG002|NOT COMPLETED|Overall Study||11
10386974|NCT00635427|11528970|FG003|NOT COMPLETED|Overall Study||9
10386975|NCT00635427|11528971|FG004|NOT COMPLETED|Overall Study||8
10386976|NCT00635453|11528983|FG000|STARTED|Overall Study||360
10386977|NCT00635453|11528984|FG001|STARTED|Overall Study||355
10386978|NCT00635453|11528983|FG000|6 Months Assessment|Overall Study||322
10386979|NCT00635453|11528984|FG001|6 Months Assessment|Overall Study||311
10386980|NCT00635453|11528983|FG000|12 Months Assessment|Overall Study||285
10386981|NCT00635453|11528984|FG001|12 Months Assessment|Overall Study||260
10386982|NCT00635453|11528983|FG000|3 Years Assessment|Overall Study||246
10386983|NCT00635453|11528984|FG001|3 Years Assessment|Overall Study||204
10386984|NCT00635453|11528983|FG000|COMPLETED|Overall Study||206
10386985|NCT00635453|11528984|FG001|COMPLETED|Overall Study||181
10658346|NCT02232984|11819481|FG000|Successfully Implanted|Overall Study|Successfully implanted subjects|675
10658347|NCT02232984|11819481|FG000|COMPLETED|Overall Study|Total number of subjects who completed study|672
10658348|NCT02232984|11819481|FG000|NOT COMPLETED|Overall Study||77
10658349|NCT02233101|11819490|FG000|STARTED|Overall Study||86
10658350|NCT02233101|11819491|FG001|STARTED|Overall Study||81
10658351|NCT02233101|11819490|FG000|COMPLETED|Overall Study||74
10658352|NCT02233101|11819491|FG001|COMPLETED|Overall Study||80
10658353|NCT02233101|11819490|FG000|NOT COMPLETED|Overall Study||12
10386986|NCT00635453|11528983|FG000|NOT COMPLETED|Overall Study||154
10386987|NCT00635453|11528984|FG001|NOT COMPLETED|Overall Study||174
10386988|NCT00635479|11528992|FG000|STARTED|Overall Study||55
10386989|NCT00635479|11528993|FG001|STARTED|Overall Study||60
10386990|NCT00635479|11528992|FG000|COMPLETED|Overall Study||49
10386991|NCT00635479|11528993|FG001|COMPLETED|Overall Study||42
10386992|NCT00635479|11528992|FG000|NOT COMPLETED|Overall Study||6
10386993|NCT00635479|11528993|FG001|NOT COMPLETED|Overall Study||18
10386994|NCT00635492|11529001|FG000|STARTED|Overall Study|This population consists of the analysis population.|1114
10386995|NCT00635492|11529002|FG001|STARTED|Overall Study|This population consists of the analysis population.|1274
10386996|NCT00635492|11529001|FG000|COMPLETED|Overall Study|This population consists of patients that completed the 24 month study.|835
10386997|NCT00635492|11529002|FG001|COMPLETED|Overall Study|This population consists of patients that completed the 24 month study.|992
10386998|NCT00635492|11529001|FG000|NOT COMPLETED|Overall Study||279
10386999|NCT00635492|11529002|FG001|NOT COMPLETED|Overall Study||282
10387000|NCT00635570|11529014|FG000|STARTED|Overall Study||136
10387001|NCT00635570|11529015|FG001|STARTED|Overall Study||137
10387002|NCT00635570|11529014|FG000|COMPLETED|Overall Study||121
10387003|NCT00635570|11529015|FG001|COMPLETED|Overall Study||126
10387004|NCT00635570|11529014|FG000|NOT COMPLETED|Overall Study||15
10387005|NCT00635570|11529015|FG001|NOT COMPLETED|Overall Study||11
10387006|NCT00635609|11529023|FG000|STARTED|Overall Study||48
10387007|NCT00635609|11529024|FG001|STARTED|Overall Study||45
10387008|NCT00635609|11529023|FG000|COMPLETED|Overall Study||41
10387009|NCT00635609|11529024|FG001|COMPLETED|Overall Study||42
10387010|NCT00635609|11529023|FG000|NOT COMPLETED|Overall Study||7
10387011|NCT00635609|11529024|FG001|NOT COMPLETED|Overall Study||3
10387012|NCT00635648|11529030|FG000|STARTED|Overall Study||63
10387013|NCT00635648|11529030|FG000|COMPLETED|Overall Study||26
10387014|NCT00635648|11529030|FG000|NOT COMPLETED|Overall Study||37
10387015|NCT00635661|11529034|FG000|STARTED|Overall Study||34
10387016|NCT00635661|11529034|FG000|COMPLETED|Overall Study||30
10387017|NCT00635661|11529034|FG000|NOT COMPLETED|Overall Study||4
10387024|NCT00635739|11529049|FG000|STARTED|Overall Study||42
10387025|NCT00635739|11529050|FG001|STARTED|Overall Study||38
10387026|NCT00635739|11529049|FG000|COMPLETED|Overall Study||39
10387027|NCT00635739|11529050|FG001|COMPLETED|Overall Study||36
10387028|NCT00635739|11529049|FG000|NOT COMPLETED|Overall Study||3
10387029|NCT00635739|11529050|FG001|NOT COMPLETED|Overall Study||2
10387030|NCT00635778|11529063|FG000|STARTED|Overall Study||1
10387031|NCT00635778|11529064|FG001|STARTED|Overall Study||3
10387032|NCT00635778|11529065|FG002|STARTED|Overall Study||3
10387033|NCT00635778|11529066|FG003|STARTED|Overall Study||8
10387034|NCT00635778|11529067|FG004|STARTED|Overall Study||8
10387035|NCT00635778|11529068|FG005|STARTED|Overall Study||21
10387036|NCT00635778|11529069|FG006|STARTED|Overall Study||6
10387037|NCT00635778|11529063|FG000|COMPLETED|Overall Study||0
10387038|NCT00635778|11529064|FG001|COMPLETED|Overall Study||0
10387039|NCT00635778|11529065|FG002|COMPLETED|Overall Study||0
10387040|NCT00635778|11529066|FG003|COMPLETED|Overall Study||0
10387041|NCT00635778|11529067|FG004|COMPLETED|Overall Study||0
10387042|NCT00635778|11529068|FG005|COMPLETED|Overall Study||0
10387043|NCT00635778|11529069|FG006|COMPLETED|Overall Study||0
10387044|NCT00635778|11529063|FG000|NOT COMPLETED|Overall Study||1
10387045|NCT00635778|11529064|FG001|NOT COMPLETED|Overall Study||3
10387046|NCT00635778|11529065|FG002|NOT COMPLETED|Overall Study||3
10387047|NCT00635778|11529066|FG003|NOT COMPLETED|Overall Study||8
10387048|NCT00635778|11529067|FG004|NOT COMPLETED|Overall Study||8
10387049|NCT00635778|11529068|FG005|NOT COMPLETED|Overall Study||21
10387050|NCT00635778|11529069|FG006|NOT COMPLETED|Overall Study||6
10387051|NCT00635804|11529094|FG000|STARTED|Overall Study||7
10387052|NCT00635804|11529095|FG001|STARTED|Overall Study||6
10387053|NCT00635804|11529096|FG002|STARTED|Overall Study||6
10387054|NCT00635804|11529097|FG003|STARTED|Overall Study||6
10387055|NCT00635804|11529098|FG004|STARTED|Overall Study||6
10387056|NCT00635804|11529099|FG005|STARTED|Overall Study||12
10387057|NCT00635804|11529100|FG006|STARTED|Overall Study||3
10387058|NCT00635804|11529101|FG007|STARTED|Overall Study||14
10387059|NCT00635804|11529094|FG000|COMPLETED|Overall Study||6
10387060|NCT00635804|11529095|FG001|COMPLETED|Overall Study||6
10387061|NCT00635804|11529096|FG002|COMPLETED|Overall Study||6
10387062|NCT00635804|11529097|FG003|COMPLETED|Overall Study||6
10387063|NCT00635804|11529098|FG004|COMPLETED|Overall Study||6
10387064|NCT00635804|11529099|FG005|COMPLETED|Overall Study||11
10387065|NCT00635804|11529100|FG006|COMPLETED|Overall Study||3
10387066|NCT00635804|11529101|FG007|COMPLETED|Overall Study||14
10387067|NCT00635804|11529094|FG000|NOT COMPLETED|Overall Study||1
10387068|NCT00635804|11529095|FG001|NOT COMPLETED|Overall Study||0
10387069|NCT00635804|11529096|FG002|NOT COMPLETED|Overall Study||0
10387070|NCT00635804|11529097|FG003|NOT COMPLETED|Overall Study||0
10387071|NCT00635804|11529098|FG004|NOT COMPLETED|Overall Study||0
10387072|NCT00635804|11529099|FG005|NOT COMPLETED|Overall Study||1
10387073|NCT00635804|11529100|FG006|NOT COMPLETED|Overall Study||0
10387074|NCT00635804|11529101|FG007|NOT COMPLETED|Overall Study||0
10387075|NCT00635817|11529126|FG000|STARTED|Overall Study||21
10387076|NCT00635817|11529127|FG001|STARTED|Overall Study||21
10387077|NCT00635817|11529128|FG002|STARTED|Overall Study||21
10387078|NCT00635817|11529129|FG003|STARTED|Overall Study||21
10387079|NCT00635817|11529126|FG000|COMPLETED|Overall Study||15
10387080|NCT00635817|11529127|FG001|COMPLETED|Overall Study||19
10387081|NCT00635817|11529128|FG002|COMPLETED|Overall Study||19
10387082|NCT00635817|11529129|FG003|COMPLETED|Overall Study||21
10387083|NCT00635817|11529126|FG000|NOT COMPLETED|Overall Study||6
10387084|NCT00635817|11529127|FG001|NOT COMPLETED|Overall Study||2
10387085|NCT00635817|11529128|FG002|NOT COMPLETED|Overall Study||2
10387086|NCT00635817|11529129|FG003|NOT COMPLETED|Overall Study||0
10387087|NCT00635830|11529143|FG000|STARTED|Overall Study||20
10387088|NCT00635830|11529144|FG001|STARTED|Overall Study||20
10387089|NCT00635830|11529143|FG000|COMPLETED|Overall Study||20
10387090|NCT00635830|11529144|FG001|COMPLETED|Overall Study||20
10387091|NCT00635830|11529143|FG000|NOT COMPLETED|Overall Study||0
10387092|NCT00635830|11529144|FG001|NOT COMPLETED|Overall Study||0
10387093|NCT00635999|11529153|FG000|STARTED|Overall Study||27
10387094|NCT00635999|11529154|FG001|STARTED|Overall Study||25
10387095|NCT00635999|11529155|FG002|STARTED|Overall Study||24
10387096|NCT00635999|11529153|FG000|COMPLETED|Overall Study||23
10387097|NCT00635999|11529154|FG001|COMPLETED|Overall Study||23
10387098|NCT00635999|11529155|FG002|COMPLETED|Overall Study||23
10387099|NCT00635999|11529153|FG000|NOT COMPLETED|Overall Study||4
10387100|NCT00635999|11529154|FG001|NOT COMPLETED|Overall Study||2
10387101|NCT00635999|11529155|FG002|NOT COMPLETED|Overall Study||1
10387102|NCT00636077|11529163|FG000|STARTED|Week 1||3
10387103|NCT00636077|11529164|FG001|STARTED|Week 1||3
10387104|NCT00636077|11529165|FG002|STARTED|Week 1||3
10387105|NCT00636077|11529166|FG003|STARTED|Week 1||3
10387106|NCT00636077|11529163|FG000|COMPLETED|Week 1||3
10387107|NCT00636077|11529164|FG001|COMPLETED|Week 1||3
10387108|NCT00636077|11529165|FG002|COMPLETED|Week 1||3
10387109|NCT00636077|11529166|FG003|COMPLETED|Week 1||3
10387110|NCT00636077|11529163|FG000|NOT COMPLETED|Week 1||0
10387111|NCT00636077|11529164|FG001|NOT COMPLETED|Week 1||0
10387112|NCT00636077|11529165|FG002|NOT COMPLETED|Week 1||0
10387113|NCT00636077|11529166|FG003|NOT COMPLETED|Week 1||0
10387114|NCT00636077|11529163|FG000|STARTED|Week 2||3
10387115|NCT00636077|11529164|FG001|STARTED|Week 2||3
10387116|NCT00636077|11529165|FG002|STARTED|Week 2||3
10387117|NCT00636077|11529166|FG003|STARTED|Week 2||3
10387118|NCT00636077|11529163|FG000|COMPLETED|Week 2||3
10387119|NCT00636077|11529164|FG001|COMPLETED|Week 2||3
10387120|NCT00636077|11529165|FG002|COMPLETED|Week 2||3
10387121|NCT00636077|11529166|FG003|COMPLETED|Week 2||3
10387122|NCT00636077|11529163|FG000|NOT COMPLETED|Week 2||0
10387123|NCT00636077|11529164|FG001|NOT COMPLETED|Week 2||0
10387124|NCT00636077|11529165|FG002|NOT COMPLETED|Week 2||0
10387125|NCT00636077|11529166|FG003|NOT COMPLETED|Week 2||0
10387126|NCT00636077|11529163|FG000|STARTED|Week 3||3
10387127|NCT00636077|11529164|FG001|STARTED|Week 3||3
10387128|NCT00636077|11529165|FG002|STARTED|Week 3||3
10387129|NCT00636077|11529166|FG003|STARTED|Week 3||3
10387130|NCT00636077|11529163|FG000|COMPLETED|Week 3||3
10387131|NCT00636077|11529164|FG001|COMPLETED|Week 3||3
10387132|NCT00636077|11529165|FG002|COMPLETED|Week 3||3
10387133|NCT00636077|11529166|FG003|COMPLETED|Week 3||3
10387134|NCT00636077|11529163|FG000|NOT COMPLETED|Week 3||0
10387135|NCT00636077|11529164|FG001|NOT COMPLETED|Week 3||0
10387136|NCT00636077|11529165|FG002|NOT COMPLETED|Week 3||0
10387137|NCT00636077|11529166|FG003|NOT COMPLETED|Week 3||0
10387138|NCT00636077|11529163|FG000|STARTED|Week 4||3
10387139|NCT00636077|11529164|FG001|STARTED|Week 4||3
10387140|NCT00636077|11529165|FG002|STARTED|Week 4||3
10387141|NCT00636077|11529166|FG003|STARTED|Week 4||3
10387142|NCT00636077|11529163|FG000|COMPLETED|Week 4||3
10387143|NCT00636077|11529164|FG001|COMPLETED|Week 4||3
10387144|NCT00636077|11529165|FG002|COMPLETED|Week 4||3
10387145|NCT00636077|11529166|FG003|COMPLETED|Week 4||3
10387146|NCT00636077|11529163|FG000|NOT COMPLETED|Week 4||0
10387147|NCT00636077|11529164|FG001|NOT COMPLETED|Week 4||0
10387148|NCT00636077|11529165|FG002|NOT COMPLETED|Week 4||0
10387149|NCT00636077|11529166|FG003|NOT COMPLETED|Week 4||0
10387150|NCT00636155|11529176|FG000|STARTED|Overall Study||20
10387151|NCT00636155|11529176|FG000|COMPLETED|Overall Study|Completed maximum 6 cycles of treatment|2
10387152|NCT00636155|11529176|FG000|NOT COMPLETED|Overall Study||18
10387153|NCT00636168|11529182|FG000|STARTED|Randomized to Study Drug||475
10387154|NCT00636168|11529183|FG001|STARTED|Randomized to Study Drug||476
10387155|NCT00636168|11529182|FG000|COMPLETED|Randomized to Study Drug||471
10387156|NCT00636168|11529183|FG001|COMPLETED|Randomized to Study Drug||474
10387157|NCT00636168|11529182|FG000|NOT COMPLETED|Randomized to Study Drug||4
10387158|NCT00636168|11529183|FG001|NOT COMPLETED|Randomized to Study Drug||2
10387159|NCT00636168|11529182|FG000|STARTED|Treated With Study Drug||471
10387160|NCT00636168|11529183|FG001|STARTED|Treated With Study Drug||474
10387161|NCT00636168|11529182|FG000|COMPLETED|Treated With Study Drug||63
10387162|NCT00636168|11529183|FG001|COMPLETED|Treated With Study Drug||143
10387163|NCT00636168|11529182|FG000|NOT COMPLETED|Treated With Study Drug||408
10387164|NCT00636168|11529183|FG001|NOT COMPLETED|Treated With Study Drug||331
10387165|NCT00636168|11529182|FG000|STARTED|Long Term Follow-Up||141
10387166|NCT00636168|11529183|FG001|STARTED|Long Term Follow-Up||143
10387167|NCT00636168|11529182|FG000|COMPLETED|Long Term Follow-Up||130
10387168|NCT00636168|11529183|FG001|COMPLETED|Long Term Follow-Up||129
10387169|NCT00636168|11529182|FG000|NOT COMPLETED|Long Term Follow-Up||11
10387170|NCT00636168|11529183|FG001|NOT COMPLETED|Long Term Follow-Up||14
10387171|NCT00636181|11529192|FG000|STARTED|Overall Study||54
10387172|NCT00636181|11529193|FG001|STARTED|Overall Study||53
10387173|NCT00636181|11529194|FG002|STARTED|Overall Study||57
10387174|NCT00636181|11529192|FG000|COMPLETED|Overall Study||46
10387175|NCT00636181|11529193|FG001|COMPLETED|Overall Study||47
10387176|NCT00636181|11529194|FG002|COMPLETED|Overall Study||47
10387177|NCT00636181|11529192|FG000|NOT COMPLETED|Overall Study||8
10387178|NCT00636181|11529193|FG001|NOT COMPLETED|Overall Study||6
10387179|NCT00636181|11529194|FG002|NOT COMPLETED|Overall Study||10
10387180|NCT00636194|11529204|FG000|STARTED|Overall Study||175
10387181|NCT00636194|11529205|FG001|STARTED|Overall Study||175
10387182|NCT00636194|11529204|FG000|COMPLETED|Overall Study||172
10541207|NCT01470599|11694334|FG000|STARTED|Overall Study||62
10541208|NCT01470599|11694335|FG001|STARTED|Overall Study||88
10541209|NCT01470599|11694334|FG000|COMPLETED|Overall Study||43
10541210|NCT01470599|11694335|FG001|COMPLETED|Overall Study||45
10541211|NCT01470599|11694334|FG000|NOT COMPLETED|Overall Study||19
10541212|NCT01470599|11694335|FG001|NOT COMPLETED|Overall Study||43
10541213|NCT01470612|11694343|FG000|STARTED|Overall Study||175
10541214|NCT01470612|11694344|FG001|STARTED|Overall Study||769
10541215|NCT01470612|11694343|FG000|COMPLETED|Overall Study||91
10541216|NCT01470612|11694344|FG001|COMPLETED|Overall Study||104
10541217|NCT01470612|11694343|FG000|NOT COMPLETED|Overall Study||84
10541218|NCT01470612|11694344|FG001|NOT COMPLETED|Overall Study||665
10541219|NCT01470651|11694352|FG000|STARTED|Overall Study||13
10541220|NCT01470651|11694353|FG001|STARTED|Overall Study||13
10541221|NCT01470651|11694352|FG000|COMPLETED|Overall Study||6
10541222|NCT01470651|11694353|FG001|COMPLETED|Overall Study||10
10541223|NCT01470651|11694352|FG000|NOT COMPLETED|Overall Study||7
10541224|NCT01470651|11694353|FG001|NOT COMPLETED|Overall Study||3
10541225|NCT01470781|11694361|FG000|STARTED|Overall Study||39
10541226|NCT01470781|11694362|FG001|STARTED|Overall Study||33
10541227|NCT01470781|11694361|FG000|Midpoint Assessment|Overall Study||30
10541228|NCT01470781|11694362|FG001|Midpoint Assessment|Overall Study||30
10541229|NCT01470781|11694361|FG000|Post-Treatment Assessment|Overall Study||22
10541230|NCT01470781|11694362|FG001|Post-Treatment Assessment|Overall Study||23
10541231|NCT01470781|11694361|FG000|COMPLETED|Overall Study||21
10541232|NCT01470781|11694362|FG001|COMPLETED|Overall Study||21
10541233|NCT01470781|11694361|FG000|NOT COMPLETED|Overall Study||18
10541234|NCT01470781|11694362|FG001|NOT COMPLETED|Overall Study||12
10541235|NCT01470859|11694371|FG000|STARTED|Overall Study||15
10541236|NCT01470859|11694372|FG001|STARTED|Overall Study||15
10541237|NCT01470859|11694371|FG000|COMPLETED|Overall Study||14
10541238|NCT01470859|11694372|FG001|COMPLETED|Overall Study||15
10541239|NCT01470859|11694371|FG000|NOT COMPLETED|Overall Study||1
10541240|NCT01470859|11694372|FG001|NOT COMPLETED|Overall Study||0
10541241|NCT01470989|11694380|FG000|STARTED|Overall Study||227
10541242|NCT01470989|11694381|FG001|STARTED|Overall Study||229
10541243|NCT01470989|11694380|FG000|Completed Core Study|Overall Study||208
10541244|NCT01470989|11694381|FG001|Completed Core Study|Overall Study||208
10541245|NCT01470989|11694380|FG000|Entered Extension 1 Study|Overall Study||174
10541246|NCT01470989|11694381|FG001|Entered Extension 1 Study|Overall Study||161
10541247|NCT01470989|11694380|FG000|Completed Extension 1 Study|Overall Study||165
10541248|NCT01470989|11694381|FG001|Completed Extension 1 Study|Overall Study||152
10541249|NCT01470989|11694380|FG000|Entered Extension 2 Study|Overall Study||141
10541250|NCT01470989|11694381|FG001|Entered Extension 2 Study|Overall Study||131
10387183|NCT00636194|11529205|FG001|COMPLETED|Overall Study||175
10387184|NCT00636194|11529204|FG000|NOT COMPLETED|Overall Study||3
10387185|NCT00636194|11529205|FG001|NOT COMPLETED|Overall Study||0
10387186|NCT00636207|11529214|FG000|STARTED|Overall Study|One participant discontinued after completing Period 2. Doses in Periods 1 and 2 were Montelukast.|1
10428359|NCT00857584|11574367|FG001|COMPLETED|Overall Study||8
10428360|NCT00857584|11574366|FG000|NOT COMPLETED|Overall Study||4
10428361|NCT00857584|11574367|FG001|NOT COMPLETED|Overall Study||5
10428362|NCT00857623|11574375|FG000|STARTED|Overall Study||62
10428363|NCT00857623|11574376|FG001|STARTED|Overall Study||65
10428364|NCT00857623|11574375|FG000|COMPLETED|Overall Study||48
10428365|NCT00857623|11574376|FG001|COMPLETED|Overall Study||55
10428366|NCT00857623|11574375|FG000|NOT COMPLETED|Overall Study||14
10428367|NCT00857623|11574376|FG001|NOT COMPLETED|Overall Study||10
10428368|NCT00857649|11574384|FG000|STARTED|Overall Study||182
10428369|NCT00857649|11574385|FG001|STARTED|Overall Study||187
10428370|NCT00857649|11574384|FG000|COMPLETED|Overall Study||151
10428371|NCT00857649|11574385|FG001|COMPLETED|Overall Study||155
10428372|NCT00857649|11574384|FG000|NOT COMPLETED|Overall Study||31
10428373|NCT00857649|11574385|FG001|NOT COMPLETED|Overall Study||32
10428374|NCT00857714|11574391|FG000|STARTED|Overall Study||1
10428375|NCT00857714|11574391|FG000|COMPLETED|Overall Study||1
10428376|NCT00857714|11574391|FG000|NOT COMPLETED|Overall Study||0
10428377|NCT00857727|11574397|FG000|STARTED|Overall Study||14
10428378|NCT00857727|11574398|FG001|STARTED|Overall Study||14
10428379|NCT00857727|11574397|FG000|COMPLETED|Overall Study||14
10428380|NCT00857727|11574398|FG001|COMPLETED|Overall Study||14
10387187|NCT00636207|11529215|FG001|STARTED|Overall Study|One participant withdrew consent after completing all study doses.|8
10387188|NCT00636207|11529216|FG002|STARTED|Overall Study||18
10541251|NCT01470989|11694380|FG000|Completed Extension 2 Study|Overall Study||132
10541252|NCT01470989|11694381|FG001|Completed Extension 2 Study|Overall Study||117
10541253|NCT01470989|11694380|FG000|Entered Extension 3|Overall Study||87
10541254|NCT01470989|11694381|FG001|Entered Extension 3|Overall Study||49
10541255|NCT01470989|11694380|FG000|COMPLETED|Overall Study||79
10541256|NCT01470989|11694381|FG001|COMPLETED|Overall Study||43
10541257|NCT01470989|11694380|FG000|NOT COMPLETED|Overall Study||148
10541258|NCT01470989|11694381|FG001|NOT COMPLETED|Overall Study||186
10541259|NCT01471015|11694392|FG000|STARTED|Overall Study||10
10541260|NCT01471015|11694393|FG001|STARTED|Overall Study||10
10541261|NCT01471015|11694394|FG002|STARTED|Overall Study||10
10541262|NCT01471015|11694392|FG000|COMPLETED|Overall Study||10
10541263|NCT01471015|11694393|FG001|COMPLETED|Overall Study||9
10541264|NCT01471015|11694394|FG002|COMPLETED|Overall Study||9
10541265|NCT01471015|11694392|FG000|NOT COMPLETED|Overall Study||0
10541266|NCT01471015|11694393|FG001|NOT COMPLETED|Overall Study||1
10541267|NCT01471015|11694394|FG002|NOT COMPLETED|Overall Study||1
10541268|NCT01471028|11694404|FG000|STARTED|VTI-208||96
10541269|NCT01471028|11694405|FG001|STARTED|VTI-208||107
10541270|NCT01471028|11694404|FG000|COMPLETED|VTI-208||56
10541271|NCT01471028|11694405|FG001|COMPLETED|VTI-208||63
10541272|NCT01471028|11694404|FG000|NOT COMPLETED|VTI-208||40
10541273|NCT01471028|11694405|FG001|NOT COMPLETED|VTI-208||44
10541274|NCT01471028|11694404|FG000|STARTED|VTI-208E||56
10541275|NCT01471028|11694405|FG001|STARTED|VTI-208E||63
10541276|NCT01471028|11694404|FG000|Database Lock, 31 July 2015|VTI-208E||56
10541277|NCT01471028|11694405|FG001|Database Lock, 31 July 2015|VTI-208E||63
10541278|NCT01471028|11694404|FG000|COMPLETED|VTI-208E||48
10541279|NCT01471028|11694405|FG001|COMPLETED|VTI-208E||51
10541280|NCT01471028|11694404|FG000|NOT COMPLETED|VTI-208E||8
10541281|NCT01471028|11694405|FG001|NOT COMPLETED|VTI-208E||12
10541282|NCT01471041|11694414|FG000|STARTED|Overall Study||54
10541283|NCT01471041|11694414|FG000|COMPLETED|Overall Study||47
10541284|NCT01471041|11694414|FG000|NOT COMPLETED|Overall Study||7
10541285|NCT01471054|11694420|FG000|STARTED|Overall Study||5
10541286|NCT01471054|11694421|FG001|STARTED|Overall Study||1
10541287|NCT01471054|11694420|FG000|COMPLETED|Overall Study||1
10541288|NCT01471054|11694421|FG001|COMPLETED|Overall Study||1
10541289|NCT01471054|11694420|FG000|NOT COMPLETED|Overall Study||4
10541290|NCT01471054|11694421|FG001|NOT COMPLETED|Overall Study||0
10541291|NCT01471093|11694439|FG000|STARTED|Overall Study||25
10541292|NCT01471093|11694440|FG001|STARTED|Overall Study||25
10541293|NCT01471093|11694441|FG002|STARTED|Overall Study||25
10541294|NCT01471093|11694442|FG003|STARTED|Overall Study||25
10541295|NCT01471093|11694439|FG000|COMPLETED|Overall Study||24
10541296|NCT01471093|11694440|FG001|COMPLETED|Overall Study||25
10541297|NCT01471093|11694441|FG002|COMPLETED|Overall Study||25
10541298|NCT01471093|11694442|FG003|COMPLETED|Overall Study||25
10541299|NCT01471093|11694439|FG000|NOT COMPLETED|Overall Study||1
10541300|NCT01471093|11694440|FG001|NOT COMPLETED|Overall Study||0
10541301|NCT01471093|11694441|FG002|NOT COMPLETED|Overall Study||0
10541302|NCT01471093|11694442|FG003|NOT COMPLETED|Overall Study||0
10541303|NCT01471171|11694448|FG000|STARTED|Treatment Period 1||57
10541304|NCT01471171|11694449|FG001|STARTED|Treatment Period 1||55
10541305|NCT01471171|11694448|FG000|COMPLETED|Treatment Period 1||53
10541306|NCT01471171|11694449|FG001|COMPLETED|Treatment Period 1||54
10541307|NCT01471171|11694448|FG000|NOT COMPLETED|Treatment Period 1||4
10541308|NCT01471171|11694449|FG001|NOT COMPLETED|Treatment Period 1||1
10541309|NCT01471171|11694448|FG000|STARTED|Treatment Period 2||53
10541310|NCT01471171|11694449|FG001|STARTED|Treatment Period 2||54
10541311|NCT01471171|11694448|FG000|COMPLETED|Treatment Period 2||52
10541312|NCT01471171|11694449|FG001|COMPLETED|Treatment Period 2||54
10541313|NCT01471171|11694448|FG000|NOT COMPLETED|Treatment Period 2||1
10541314|NCT01471171|11694449|FG001|NOT COMPLETED|Treatment Period 2||0
10541315|NCT01471197|11694457|FG000|STARTED|Overall Study||6
10541316|NCT01471197|11694458|FG001|STARTED|Overall Study||2
10541317|NCT01471197|11694457|FG000|COMPLETED|Overall Study||0
10541318|NCT01471197|11694458|FG001|COMPLETED|Overall Study||0
10541319|NCT01471197|11694457|FG000|NOT COMPLETED|Overall Study||6
10541320|NCT01471197|11694458|FG001|NOT COMPLETED|Overall Study||2
10541321|NCT01471353|11694464|FG000|STARTED|Overall Study||42
10541322|NCT01471353|11694464|FG000|COMPLETED|Overall Study||39
10541323|NCT01471353|11694464|FG000|NOT COMPLETED|Overall Study||3
10541324|NCT01471379|11694471|FG000|STARTED|Overall Study||1
10541325|NCT01471379|11694472|FG001|STARTED|Overall Study||1
10541326|NCT01471379|11694473|FG002|STARTED|Overall Study||0
10541327|NCT01471379|11694471|FG000|COMPLETED|Overall Study||0
10541328|NCT01471379|11694472|FG001|COMPLETED|Overall Study||0
10387189|NCT00636207|11529217|FG003|STARTED|Overall Study||6
10387190|NCT00636207|11529218|FG004|STARTED|Overall Study|One participant withdrew consent after completing all study doses.|9
10387191|NCT00636207|11529219|FG005|STARTED|Overall Study||1
10387192|NCT00636207|11529220|FG006|STARTED|Overall Study||3
10387193|NCT00636207|11529214|FG000|COMPLETED|Overall Study||0
10387194|NCT00636207|11529215|FG001|COMPLETED|Overall Study||7
10387195|NCT00636207|11529216|FG002|COMPLETED|Overall Study||18
10387196|NCT00636207|11529217|FG003|COMPLETED|Overall Study||6
10387197|NCT00636207|11529218|FG004|COMPLETED|Overall Study||8
10387198|NCT00636207|11529219|FG005|COMPLETED|Overall Study||1
10387199|NCT00636207|11529220|FG006|COMPLETED|Overall Study||3
10387200|NCT00636207|11529214|FG000|NOT COMPLETED|Overall Study||1
10387201|NCT00636207|11529215|FG001|NOT COMPLETED|Overall Study||1
10387202|NCT00636207|11529216|FG002|NOT COMPLETED|Overall Study||0
10387203|NCT00636207|11529217|FG003|NOT COMPLETED|Overall Study||0
10387204|NCT00636207|11529218|FG004|NOT COMPLETED|Overall Study||1
10387205|NCT00636207|11529219|FG005|NOT COMPLETED|Overall Study||0
10387206|NCT00636207|11529220|FG006|NOT COMPLETED|Overall Study||0
10387207|NCT00636220|11529241|FG000|STARTED|Overall Study||101
10387208|NCT00636220|11529241|FG000|COMPLETED|Overall Study||101
10387209|NCT00636220|11529241|FG000|NOT COMPLETED|Overall Study||0
10387210|NCT00636363|11529248|FG000|STARTED|Overall Study||178
10387211|NCT00636363|11529249|FG001|STARTED|Overall Study||176
10387212|NCT00636363|11529250|FG002|STARTED|Overall Study||181
10387213|NCT00636363|11529248|FG000|COMPLETED|Overall Study||165
10387214|NCT00636363|11529249|FG001|COMPLETED|Overall Study||156
10387215|NCT00636363|11529250|FG002|COMPLETED|Overall Study||163
10387216|NCT00636363|11529248|FG000|NOT COMPLETED|Overall Study||13
10387217|NCT00636363|11529249|FG001|NOT COMPLETED|Overall Study||20
10387218|NCT00636363|11529250|FG002|NOT COMPLETED|Overall Study||18
10428381|NCT00857727|11574397|FG000|NOT COMPLETED|Overall Study||0
10428382|NCT00857727|11574398|FG001|NOT COMPLETED|Overall Study||0
10428383|NCT00857766|11574406|FG000|STARTED|Overall Study||123
10428384|NCT00857766|11574407|FG001|STARTED|Overall Study||126
10428385|NCT00857766|11574406|FG000|COMPLETED|Overall Study||92
10428386|NCT00857766|11574407|FG001|COMPLETED|Overall Study||96
10428387|NCT00857766|11574406|FG000|NOT COMPLETED|Overall Study||31
10428388|NCT00857766|11574407|FG001|NOT COMPLETED|Overall Study||30
10428389|NCT00857792|11574413|FG000|STARTED|Overall Study||120
10428390|NCT00857792|11574413|FG000|COMPLETED|Overall Study||108
10428391|NCT00857792|11574413|FG000|NOT COMPLETED|Overall Study||12
10428392|NCT00857818|11574419|FG000|STARTED|Overall Study||14
10428393|NCT00857818|11574420|FG001|STARTED|Overall Study||14
10428394|NCT00857818|11574419|FG000|Received Treatment|Overall Study||14
10428395|NCT00857818|11574420|FG001|Received Treatment|Overall Study||12
10428396|NCT00857818|11574419|FG000|COMPLETED|Overall Study||3
10428397|NCT00857818|11574420|FG001|COMPLETED|Overall Study||6
10428398|NCT00857818|11574419|FG000|NOT COMPLETED|Overall Study||11
10428399|NCT00857818|11574420|FG001|NOT COMPLETED|Overall Study||8
10428400|NCT00857857|11574426|FG000|STARTED|Overall Study||24
10428401|NCT00857857|11574426|FG000|COMPLETED|Overall Study||24
10428402|NCT00857857|11574426|FG000|NOT COMPLETED|Overall Study||0
10428403|NCT00857896|11574438|FG000|STARTED|Baseline to Week 4||21
10428404|NCT00857896|11574438|FG000|COMPLETED|Baseline to Week 4||20
10428405|NCT00857896|11574438|FG000|NOT COMPLETED|Baseline to Week 4||1
10428406|NCT00857896|11574438|FG000|STARTED|Week 5 to Week 8||20
10428407|NCT00857896|11574438|FG000|COMPLETED|Week 5 to Week 8||20
10428408|NCT00857896|11574438|FG000|NOT COMPLETED|Week 5 to Week 8||0
10428409|NCT00857948|11574447|FG000|STARTED|Overall Study||18
10428410|NCT00857948|11574448|FG001|STARTED|Overall Study||18
10541329|NCT01471379|11694473|FG002|COMPLETED|Overall Study||0
10541330|NCT01471379|11694471|FG000|NOT COMPLETED|Overall Study||1
10541331|NCT01471379|11694472|FG001|NOT COMPLETED|Overall Study||1
10541332|NCT01471379|11694473|FG002|NOT COMPLETED|Overall Study||0
10658354|NCT02233101|11819491|FG001|NOT COMPLETED|Overall Study||1
10428411|NCT00857948|11574449|FG002|STARTED|Overall Study||19
10428412|NCT00857948|11574450|FG003|STARTED|Overall Study||23
10428413|NCT00857948|11574447|FG000|COMPLETED|Overall Study||15
10428414|NCT00857948|11574448|FG001|COMPLETED|Overall Study||18
10428415|NCT00857948|11574449|FG002|COMPLETED|Overall Study||18
10428416|NCT00857948|11574450|FG003|COMPLETED|Overall Study||23
10428417|NCT00857948|11574447|FG000|NOT COMPLETED|Overall Study||3
10428418|NCT00857948|11574448|FG001|NOT COMPLETED|Overall Study||0
10428419|NCT00857948|11574449|FG002|NOT COMPLETED|Overall Study||1
10428420|NCT00857948|11574450|FG003|NOT COMPLETED|Overall Study||0
10428421|NCT00857961|11574460|FG000|STARTED|Overall Study||21
10428422|NCT00857961|11574460|FG000|COMPLETED|Overall Study||21
10428423|NCT00857961|11574460|FG000|NOT COMPLETED|Overall Study||0
10428424|NCT00858013|11574472|FG000|STARTED|Overall Study||46
10428425|NCT00858013|11574473|FG001|STARTED|Overall Study||42
10428426|NCT00858013|11574472|FG000|COMPLETED|Overall Study||24
10428427|NCT00858013|11574473|FG001|COMPLETED|Overall Study||23
10428428|NCT00858013|11574472|FG000|NOT COMPLETED|Overall Study||22
10428429|NCT00858013|11574473|FG001|NOT COMPLETED|Overall Study||19
10428430|NCT00858117|11574479|FG000|STARTED|Treatment on Study||30
10428431|NCT00858117|11574479|FG000|Completed 18 Weeks of Treatment|Treatment on Study||28
10428432|NCT00858117|11574479|FG000|COMPLETED|Treatment on Study||28
10428433|NCT00858117|11574479|FG000|NOT COMPLETED|Treatment on Study||2
10428434|NCT00858117|11574479|FG000|STARTED|Follow up for 5 Years|All patients who receive at least one dose of drug under the protocol go into follow up for survival|30
10428435|NCT00858117|11574479|FG000|COMPLETED|Follow up for 5 Years||17
10718224|NCT02703337|11882047|FG007|Received Study Drug|Period Five (Part A)||0
10718225|NCT02703337|11882040|FG000|COMPLETED|Period Five (Part A)||5
10718226|NCT02703337|11882041|FG001|COMPLETED|Period Five (Part A)||5
10718227|NCT02703337|11882042|FG002|COMPLETED|Period Five (Part A)||5
10718228|NCT02703337|11882043|FG003|COMPLETED|Period Five (Part A)||5
10718229|NCT02703337|11882044|FG004|COMPLETED|Period Five (Part A)||4
10718230|NCT02703337|11882045|FG005|COMPLETED|Period Five (Part A)||5
10718231|NCT02703337|11882046|FG006|COMPLETED|Period Five (Part A)||0
10718232|NCT02703337|11882047|FG007|COMPLETED|Period Five (Part A)||0
10718233|NCT02703337|11882040|FG000|NOT COMPLETED|Period Five (Part A)||0
10718234|NCT02703337|11882041|FG001|NOT COMPLETED|Period Five (Part A)||0
10306889|NCT00101933|11439823|FG000|STARTED|Overall Study||54
10306890|NCT00101933|11439824|FG001|STARTED|Overall Study||55
10306891|NCT00101933|11439823|FG000|COMPLETED|Overall Study||54
10306892|NCT00101933|11439824|FG001|COMPLETED|Overall Study||55
10306893|NCT00101933|11439823|FG000|NOT COMPLETED|Overall Study||0
10306894|NCT00101933|11439824|FG001|NOT COMPLETED|Overall Study||0
10306895|NCT00102063|11439834|FG000|STARTED|Overall Study||100
10306896|NCT00102063|11439835|FG001|STARTED|Overall Study||102
10306897|NCT00102063|11439836|FG002|STARTED|Overall Study||100
10306898|NCT00102063|11439834|FG000|COMPLETED|Overall Study||84
10306899|NCT00102063|11439835|FG001|COMPLETED|Overall Study||84
10306900|NCT00102063|11439836|FG002|COMPLETED|Overall Study||90
10306901|NCT00102063|11439834|FG000|NOT COMPLETED|Overall Study||16
10306902|NCT00102063|11439835|FG001|NOT COMPLETED|Overall Study||18
10306903|NCT00102063|11439836|FG002|NOT COMPLETED|Overall Study||10
10306904|NCT00102440|11439847|FG000|STARTED|Overall Study||256
10306905|NCT00102440|11439848|FG001|STARTED|Overall Study||251
10306906|NCT00102440|11439849|FG002|STARTED|Overall Study||253
10306907|NCT00102440|11439847|FG000|COMPLETED|Overall Study||168
10306908|NCT00102440|11439848|FG001|COMPLETED|Overall Study||153
10306909|NCT00102440|11439849|FG002|COMPLETED|Overall Study||187
10306910|NCT00102440|11439847|FG000|NOT COMPLETED|Overall Study||88
10306911|NCT00102440|11439848|FG001|NOT COMPLETED|Overall Study||98
10306912|NCT00102440|11439849|FG002|NOT COMPLETED|Overall Study||66
10306913|NCT00102518|11439857|FG000|STARTED|Overall Study||325
10306914|NCT00102518|11439857|FG000|COMPLETED|Overall Study||238
10306915|NCT00102518|11439857|FG000|NOT COMPLETED|Overall Study||87
10306916|NCT00102531|11439863|FG000|STARTED|Overall Study||7
10306917|NCT00102531|11439864|FG001|STARTED|Overall Study||12
10306918|NCT00102531|11439863|FG000|COMPLETED|Overall Study||2
10306919|NCT00102531|11439864|FG001|COMPLETED|Overall Study||1
10306920|NCT00102531|11439863|FG000|NOT COMPLETED|Overall Study||5
10306921|NCT00102531|11439864|FG001|NOT COMPLETED|Overall Study||11
10306922|NCT00102596|11439870|FG000|STARTED|Part A||11
10306923|NCT00102596|11439871|FG001|STARTED|Part A||0
10306924|NCT00102596|11439870|FG000|Participants Assigned Treatment|Part A||5
10306925|NCT00102596|11439871|FG001|Participants Assigned Treatment|Part A||0
10306926|NCT00102596|11439870|FG000|COMPLETED|Part A||4
10306927|NCT00102596|11439871|FG001|COMPLETED|Part A||0
10306928|NCT00102596|11439870|FG000|NOT COMPLETED|Part A||7
10306929|NCT00102596|11439871|FG001|NOT COMPLETED|Part A||0
10306930|NCT00102596|11439870|FG000|STARTED|Part B|Participants from Part A did not continue to Part B|0
10306931|NCT00102596|11439871|FG001|STARTED|Part B||10
10306932|NCT00102596|11439870|FG000|COMPLETED|Part B||0
10306933|NCT00102596|11439871|FG001|COMPLETED|Part B||10
10306934|NCT00102596|11439870|FG000|NOT COMPLETED|Part B||0
10306935|NCT00102596|11439871|FG001|NOT COMPLETED|Part B||0
10306936|NCT00102596|11439870|FG000|STARTED|Part C||0
10306937|NCT00102596|11439871|FG001|STARTED|Part C|Only 2 patients participated in Part C|2
10306938|NCT00102596|11439870|FG000|COMPLETED|Part C||0
10306939|NCT00102596|11439871|FG001|COMPLETED|Part C||2
10306940|NCT00102596|11439870|FG000|NOT COMPLETED|Part C||0
10306941|NCT00102596|11439871|FG001|NOT COMPLETED|Part C||0
10306942|NCT00102687|11439881|FG000|STARTED|Initial Period||50
10306943|NCT00102687|11439882|FG001|STARTED|Initial Period||50
10306944|NCT00102687|11439883|FG002|STARTED|Initial Period|3 randomized participants did not receive treatment.|51
10306945|NCT00102687|11439884|FG003|STARTED|Initial Period||0
10306946|NCT00102687|11439885|FG004|STARTED|Initial Period||0
10306947|NCT00102687|11439881|FG000|COMPLETED|Initial Period||32
10306948|NCT00102687|11439882|FG001|COMPLETED|Initial Period||22
10306949|NCT00102687|11439883|FG002|COMPLETED|Initial Period||25
10306950|NCT00102687|11439884|FG003|COMPLETED|Initial Period||0
10306951|NCT00102687|11439885|FG004|COMPLETED|Initial Period||0
10306952|NCT00102687|11439881|FG000|NOT COMPLETED|Initial Period||18
10306953|NCT00102687|11439882|FG001|NOT COMPLETED|Initial Period||28
10387219|NCT00636389|11529258|FG000|STARTED|Period 1 - 1 Week||7
10387220|NCT00636389|11529259|FG001|STARTED|Period 1 - 1 Week||5
10387221|NCT00636389|11529258|FG000|COMPLETED|Period 1 - 1 Week||7
10387222|NCT00636389|11529259|FG001|COMPLETED|Period 1 - 1 Week||5
10387223|NCT00636389|11529258|FG000|NOT COMPLETED|Period 1 - 1 Week||0
10387224|NCT00636389|11529259|FG001|NOT COMPLETED|Period 1 - 1 Week||0
10387225|NCT00636389|11529258|FG000|STARTED|Period 2 - 1 Week||7
10387226|NCT00636389|11529259|FG001|STARTED|Period 2 - 1 Week||5
10387227|NCT00636389|11529258|FG000|COMPLETED|Period 2 - 1 Week||7
10387228|NCT00636389|11529259|FG001|COMPLETED|Period 2 - 1 Week||5
10387229|NCT00636389|11529258|FG000|NOT COMPLETED|Period 2 - 1 Week||0
10387230|NCT00636389|11529259|FG001|NOT COMPLETED|Period 2 - 1 Week||0
10387231|NCT00636441|11529272|FG000|STARTED|Overall Study||6
10387232|NCT00636441|11529273|FG001|STARTED|Overall Study||7
10387233|NCT00636441|11529274|FG002|STARTED|Overall Study||6
10387234|NCT00636441|11529275|FG003|STARTED|Overall Study||6
10387235|NCT00636441|11529276|FG004|STARTED|Overall Study||6
10387236|NCT00636441|11529277|FG005|STARTED|Overall Study||7
10387237|NCT00636441|11529278|FG006|STARTED|Overall Study||18
10387238|NCT00636441|11529272|FG000|Assigned Treatment|Overall Study||6
10387239|NCT00636441|11529273|FG001|Assigned Treatment|Overall Study||7
10387240|NCT00636441|11529274|FG002|Assigned Treatment|Overall Study||6
10387241|NCT00636441|11529275|FG003|Assigned Treatment|Overall Study||6
10387242|NCT00636441|11529276|FG004|Assigned Treatment|Overall Study||6
10387243|NCT00636441|11529277|FG005|Assigned Treatment|Overall Study||7
10387244|NCT00636441|11529278|FG006|Assigned Treatment|Overall Study|This is a late determined ineligibility.|1
10387245|NCT00636441|11529272|FG000|COMPLETED|Overall Study||6
10387246|NCT00636441|11529273|FG001|COMPLETED|Overall Study||6
10387247|NCT00636441|11529274|FG002|COMPLETED|Overall Study||5
10387248|NCT00636441|11529275|FG003|COMPLETED|Overall Study||6
10387249|NCT00636441|11529276|FG004|COMPLETED|Overall Study||6
10387250|NCT00636441|11529277|FG005|COMPLETED|Overall Study||6
10387251|NCT00636441|11529278|FG006|COMPLETED|Overall Study||0
10387252|NCT00636441|11529272|FG000|NOT COMPLETED|Overall Study||0
10387253|NCT00636441|11529273|FG001|NOT COMPLETED|Overall Study||1
10387254|NCT00636441|11529274|FG002|NOT COMPLETED|Overall Study||1
10387255|NCT00636441|11529275|FG003|NOT COMPLETED|Overall Study||0
10387256|NCT00636441|11529276|FG004|NOT COMPLETED|Overall Study||0
10387257|NCT00636441|11529277|FG005|NOT COMPLETED|Overall Study||1
10387258|NCT00636441|11529278|FG006|NOT COMPLETED|Overall Study||18
10387259|NCT00636506|11529289|FG000|STARTED|Overall Study||76
10387260|NCT00636506|11529289|FG000|COMPLETED|Overall Study||60
10387261|NCT00636506|11529289|FG000|NOT COMPLETED|Overall Study||16
10387262|NCT00636610|11529313|FG000|STARTED|Overall Study||98
10387263|NCT00636610|11529314|FG001|STARTED|Overall Study||101
10387264|NCT00636610|11529313|FG000|COMPLETED|Overall Study||6
10387265|NCT00636610|11529314|FG001|COMPLETED|Overall Study||18
10387266|NCT00636610|11529313|FG000|NOT COMPLETED|Overall Study||92
10387267|NCT00636610|11529314|FG001|NOT COMPLETED|Overall Study||83
10387268|NCT00636636|11529324|FG000|STARTED|Overall Study||221
10387269|NCT00636636|11529325|FG001|STARTED|Overall Study||231
10387270|NCT00636636|11529324|FG000|Safety & Efficacy of Gabapentin ER|Overall Study||186
10387271|NCT00636636|11529325|FG001|Safety & Efficacy of Gabapentin ER|Overall Study|1 patient randomized twice, not included in ITT, but completed medication and counted as completer|194
10387272|NCT00636636|11529324|FG000|379|Overall Study||186
10387273|NCT00636636|11529325|FG001|379|Overall Study|1 patient randomized twice, not included in ITT, but completed medication and counted as completer|194
10387274|NCT00636636|11529324|FG000|COMPLETED|Overall Study||185
10387275|NCT00636636|11529325|FG001|COMPLETED|Overall Study||192
10387276|NCT00636636|11529324|FG000|NOT COMPLETED|Overall Study||36
10387277|NCT00636636|11529325|FG001|NOT COMPLETED|Overall Study||39
10387278|NCT00636649|11529333|FG000|STARTED|Overall Study||20
10387279|NCT00636649|11529334|FG001|STARTED|Overall Study||20
10387280|NCT00636649|11529333|FG000|COMPLETED|Overall Study||20
10387281|NCT00636649|11529334|FG001|COMPLETED|Overall Study||20
10387282|NCT00636649|11529333|FG000|NOT COMPLETED|Overall Study||0
10387283|NCT00636649|11529334|FG001|NOT COMPLETED|Overall Study||0
10387284|NCT00636675|11529346|FG000|STARTED|Overall Study||951
10387285|NCT00636675|11529347|FG001|STARTED|Overall Study||775
10387286|NCT00636675|11529346|FG000|COMPLETED|Overall Study||811
10387287|NCT00636675|11529347|FG001|COMPLETED|Overall Study||734
10387288|NCT00636675|11529346|FG000|NOT COMPLETED|Overall Study||140
10387289|NCT00636675|11529347|FG001|NOT COMPLETED|Overall Study||41
10387290|NCT00636701|11529355|FG000|STARTED|Overall Study||2
10387291|NCT00636701|11529356|FG001|STARTED|Overall Study||2
10387292|NCT00636701|11529355|FG000|COMPLETED|Overall Study||2
10387293|NCT00636701|11529356|FG001|COMPLETED|Overall Study||2
10387294|NCT00636701|11529355|FG000|NOT COMPLETED|Overall Study||0
10387295|NCT00636701|11529356|FG001|NOT COMPLETED|Overall Study||0
10387296|NCT00636792|11529362|FG000|STARTED|Overall Study||73
10387297|NCT00636792|11529362|FG000|COMPLETED|Overall Study||40
10387298|NCT00636792|11529362|FG000|NOT COMPLETED|Overall Study||33
10387299|NCT00636805|11529366|FG000|STARTED|Overall Study||63
10387300|NCT00636805|11529366|FG000|COMPLETED|Overall Study||63
10387301|NCT00636805|11529366|FG000|NOT COMPLETED|Overall Study||0
10387302|NCT00636818|11529370|FG000|STARTED|Overall Study||45
10387303|NCT00636818|11529370|FG000|Received at Least One Dose of Study Drug|Overall Study|One patient was lost to follow up and did not receive any study drug.|44
10387304|NCT00636818|11529370|FG000|COMPLETED|Overall Study||34
10387305|NCT00636818|11529370|FG000|NOT COMPLETED|Overall Study||11
10387306|NCT00636961|11529376|FG000|STARTED|Period 1||14
10387307|NCT00636961|11529377|FG001|STARTED|Period 1||13
10387308|NCT00636961|11529376|FG000|COMPLETED|Period 1||13
10387309|NCT00636961|11529377|FG001|COMPLETED|Period 1||12
10387310|NCT00636961|11529376|FG000|NOT COMPLETED|Period 1||1
10387311|NCT00636961|11529377|FG001|NOT COMPLETED|Period 1||1
10387312|NCT00636961|11529376|FG000|STARTED|Period 2||13
10387313|NCT00636961|11529377|FG001|STARTED|Period 2||12
10387314|NCT00636961|11529376|FG000|COMPLETED|Period 2||12
10387315|NCT00636961|11529377|FG001|COMPLETED|Period 2||12
10387316|NCT00636961|11529376|FG000|NOT COMPLETED|Period 2||1
10387317|NCT00636961|11529377|FG001|NOT COMPLETED|Period 2||0
10387318|NCT00636987|11529383|FG000|STARTED|Overall Study||297
10387319|NCT00636987|11529383|FG000|COMPLETED|Overall Study||108
10387320|NCT00636987|11529383|FG000|NOT COMPLETED|Overall Study||189
10387321|NCT00637000|11529393|FG000|STARTED|Overall Study|Randomized and treated|20
10387322|NCT00637000|11529394|FG001|STARTED|Overall Study|Randomized and treated|18
10387323|NCT00637000|11529393|FG000|Evaluable|Overall Study||18
10387324|NCT00637000|11529394|FG001|Evaluable|Overall Study||16
10387325|NCT00637000|11529393|FG000|COMPLETED|Overall Study||16
10387326|NCT00637000|11529394|FG001|COMPLETED|Overall Study||15
10387327|NCT00637000|11529393|FG000|NOT COMPLETED|Overall Study||4
10387328|NCT00637000|11529394|FG001|NOT COMPLETED|Overall Study||3
10387329|NCT00637156|11529402|FG000|STARTED|Overall Study||209
10387330|NCT00637156|11529403|FG001|STARTED|Overall Study||188
10387331|NCT00637156|11529402|FG000|COMPLETED|Overall Study||199
10541333|NCT01471457|11694484|FG000|STARTED|Overall Study||92
10541334|NCT01471457|11694485|FG001|STARTED|Overall Study||92
10541335|NCT01471457|11694484|FG000|COMPLETED|Overall Study||73
10541336|NCT01471457|11694485|FG001|COMPLETED|Overall Study||74
10541337|NCT01471457|11694484|FG000|NOT COMPLETED|Overall Study||19
10541338|NCT01471457|11694485|FG001|NOT COMPLETED|Overall Study||18
10541345|NCT01471574|11694505|FG000|STARTED|Treatment Period||132
10541346|NCT01471574|11694506|FG001|STARTED|Treatment Period||39
10541347|NCT01471574|11694507|FG002|STARTED|Treatment Period||106
10541348|NCT01471574|11694508|FG003|STARTED|Treatment Period||24
10541349|NCT01471574|11694505|FG000|COMPLETED|Treatment Period||101
10541350|NCT01471574|11694506|FG001|COMPLETED|Treatment Period||29
10541351|NCT01471574|11694507|FG002|COMPLETED|Treatment Period||82
10541352|NCT01471574|11694508|FG003|COMPLETED|Treatment Period||21
10541353|NCT01471574|11694505|FG000|NOT COMPLETED|Treatment Period||31
10541354|NCT01471574|11694506|FG001|NOT COMPLETED|Treatment Period||10
10541355|NCT01471574|11694507|FG002|NOT COMPLETED|Treatment Period||24
10541356|NCT01471574|11694508|FG003|NOT COMPLETED|Treatment Period||3
10541357|NCT01471574|11694505|FG000|STARTED|Follow-up Period||121
10541358|NCT01471574|11694506|FG001|STARTED|Follow-up Period||34
10541359|NCT01471574|11694507|FG002|STARTED|Follow-up Period||102
10541360|NCT01471574|11694508|FG003|STARTED|Follow-up Period||24
10541361|NCT01471574|11694505|FG000|COMPLETED|Follow-up Period||114
10541362|NCT01471574|11694506|FG001|COMPLETED|Follow-up Period||32
10541363|NCT01471574|11694507|FG002|COMPLETED|Follow-up Period||95
10541364|NCT01471574|11694508|FG003|COMPLETED|Follow-up Period||21
10541365|NCT01471574|11694505|FG000|NOT COMPLETED|Follow-up Period||7
10541366|NCT01471574|11694506|FG001|NOT COMPLETED|Follow-up Period||2
10541367|NCT01471574|11694507|FG002|NOT COMPLETED|Follow-up Period||7
10541368|NCT01471574|11694508|FG003|NOT COMPLETED|Follow-up Period||3
10541369|NCT01471626|11694524|FG000|STARTED|Overall Study||21
10541370|NCT01471626|11694524|FG000|COMPLETED|Overall Study||21
10541371|NCT01471626|11694524|FG000|NOT COMPLETED|Overall Study||0
10541372|NCT01471639|11694528|FG000|STARTED|Overall Study||37
10541373|NCT01471639|11694528|FG000|COMPLETED|Overall Study||37
10541374|NCT01471639|11694528|FG000|NOT COMPLETED|Overall Study||0
10541375|NCT01471691|11694534|FG000|STARTED|Overall Study||8
10541376|NCT01471691|11694535|FG001|STARTED|Overall Study||6
10541377|NCT01471691|11694534|FG000|COMPLETED|Overall Study||8
10541378|NCT01471691|11694535|FG001|COMPLETED|Overall Study||5
10541379|NCT01471691|11694534|FG000|NOT COMPLETED|Overall Study||0
10541380|NCT01471691|11694535|FG001|NOT COMPLETED|Overall Study||1
10658355|NCT02233296|11819499|FG000|STARTED|Overall Study||16
10658356|NCT02233296|11819500|FG001|STARTED|Overall Study||14
10658357|NCT02233296|11819499|FG000|COMPLETED|Overall Study||16
10658358|NCT02233296|11819500|FG001|COMPLETED|Overall Study||14
10658359|NCT02233296|11819499|FG000|NOT COMPLETED|Overall Study||0
10658360|NCT02233296|11819500|FG001|NOT COMPLETED|Overall Study||0
10387332|NCT00637156|11529403|FG001|COMPLETED|Overall Study||164
10387333|NCT00637156|11529402|FG000|NOT COMPLETED|Overall Study||10
10387334|NCT00637156|11529403|FG001|NOT COMPLETED|Overall Study||24
10387335|NCT00637195|11529411|FG000|STARTED|Overall Study||76
10387336|NCT00637195|11529412|FG001|STARTED|Overall Study||76
10387337|NCT00637195|11529411|FG000|COMPLETED|Overall Study||73
10387338|NCT00637195|11529412|FG001|COMPLETED|Overall Study||75
10387339|NCT00637195|11529411|FG000|NOT COMPLETED|Overall Study||3
10387340|NCT00637195|11529412|FG001|NOT COMPLETED|Overall Study||1
10541381|NCT01471782|11694547|FG000|STARTED|Overall Study||5
10541382|NCT01471782|11694548|FG001|STARTED|Overall Study||7
10541383|NCT01471782|11694549|FG002|STARTED|Overall Study||5
10541384|NCT01471782|11694550|FG003|STARTED|Overall Study||6
10541385|NCT01471782|11694551|FG004|STARTED|Overall Study||26
10387341|NCT00637247|11529420|FG000|STARTED|Overall Study||72
10387342|NCT00637247|11529421|FG001|STARTED|Overall Study||70
10387343|NCT00637247|11529420|FG000|COMPLETED|Overall Study||72
10387344|NCT00637247|11529421|FG001|COMPLETED|Overall Study||70
10387345|NCT00637247|11529420|FG000|NOT COMPLETED|Overall Study||0
10387346|NCT00637247|11529421|FG001|NOT COMPLETED|Overall Study||0
10387347|NCT00637273|11529432|FG000|STARTED|Overall Study||170
10387348|NCT00637273|11529433|FG001|STARTED|Overall Study||172
10387349|NCT00637273|11529434|FG002|STARTED|Overall Study||172
10387350|NCT00637273|11529432|FG000|Intent to Treat (ITT)|Overall Study||160
10387351|NCT00637273|11529433|FG001|Intent to Treat (ITT)|Overall Study||166
10387352|NCT00637273|11529434|FG002|Intent to Treat (ITT)|Overall Study||165
10387353|NCT00637273|11529432|FG000|COMPLETED|Overall Study||127
10387354|NCT00637273|11529433|FG001|COMPLETED|Overall Study||144
10387355|NCT00637273|11529434|FG002|COMPLETED|Overall Study||131
10387356|NCT00637273|11529432|FG000|NOT COMPLETED|Overall Study||43
10387357|NCT00637273|11529433|FG001|NOT COMPLETED|Overall Study||28
10387358|NCT00637273|11529434|FG002|NOT COMPLETED|Overall Study||41
10387359|NCT00637299|11529444|FG000|STARTED|Overall Study||10
10387360|NCT00637299|11529445|FG001|STARTED|Overall Study||10
10387361|NCT00637299|11529444|FG000|COMPLETED|Overall Study||10
10387362|NCT00637299|11529445|FG001|COMPLETED|Overall Study||10
10387363|NCT00637299|11529444|FG000|NOT COMPLETED|Overall Study||0
10387364|NCT00637299|11529445|FG001|NOT COMPLETED|Overall Study||0
10387365|NCT00637377|11529455|FG000|STARTED|Overall Study||303
10387366|NCT00637377|11529456|FG001|STARTED|Overall Study||313
10387367|NCT00637377|11529457|FG002|STARTED|Overall Study||311
10387368|NCT00637377|11529458|FG003|STARTED|Overall Study||313
10387369|NCT00637377|11529455|FG000|Participants Received Treatment|Overall Study|safety population|291
10387370|NCT00637377|11529456|FG001|Participants Received Treatment|Overall Study|safety population|309
10387371|NCT00637377|11529457|FG002|Participants Received Treatment|Overall Study|safety population|297
10387372|NCT00637377|11529458|FG003|Participants Received Treatment|Overall Study|safety population|307
10387373|NCT00637377|11529455|FG000|Participants Treated (FAS)|Overall Study||291
10387374|NCT00637377|11529456|FG001|Participants Treated (FAS)|Overall Study||309
10387375|NCT00637377|11529457|FG002|Participants Treated (FAS)|Overall Study||296
10387376|NCT00637377|11529458|FG003|Participants Treated (FAS)|Overall Study||306
10387377|NCT00637377|11529455|FG000|COMPLETED|Overall Study||276
10387378|NCT00637377|11529456|FG001|COMPLETED|Overall Study||281
10387379|NCT00637377|11529457|FG002|COMPLETED|Overall Study||274
10387380|NCT00637377|11529458|FG003|COMPLETED|Overall Study||284
10387381|NCT00637377|11529455|FG000|NOT COMPLETED|Overall Study||27
10387382|NCT00637377|11529456|FG001|NOT COMPLETED|Overall Study||32
10387383|NCT00637377|11529457|FG002|NOT COMPLETED|Overall Study||37
10387384|NCT00637377|11529458|FG003|NOT COMPLETED|Overall Study||29
10387385|NCT00637494|11529470|FG000|STARTED|Overall Study||141
10387386|NCT00637494|11529471|FG001|STARTED|Overall Study||151
10387387|NCT00637494|11529470|FG000|COMPLETED|Overall Study||109
10387388|NCT00637494|11529471|FG001|COMPLETED|Overall Study||108
10387389|NCT00637494|11529470|FG000|NOT COMPLETED|Overall Study||32
10387390|NCT00637494|11529471|FG001|NOT COMPLETED|Overall Study||43
10387391|NCT00637572|11529479|FG000|STARTED|Overall Study||32
10387392|NCT00637572|11529480|FG001|STARTED|Overall Study||31
10387393|NCT00637572|11529479|FG000|COMPLETED|Overall Study||29
10387394|NCT00637572|11529480|FG001|COMPLETED|Overall Study||24
10387395|NCT00637572|11529479|FG000|NOT COMPLETED|Overall Study||3
10387396|NCT00637572|11529480|FG001|NOT COMPLETED|Overall Study||7
10387397|NCT00637780|11529486|FG000|STARTED|Overall Study||2
10387398|NCT00637780|11529486|FG000|COMPLETED|Overall Study||2
10387399|NCT00637780|11529486|FG000|NOT COMPLETED|Overall Study||0
10387400|NCT00637923|11529492|FG000|STARTED|Overall Study||75
10541386|NCT01471782|11694552|FG005|STARTED|Overall Study||44
10541387|NCT01471782|11694547|FG000|COMPLETED|Overall Study|Completed 5 cycles|0
10541388|NCT01471782|11694548|FG001|COMPLETED|Overall Study|Completed 5 cycles|1
10541389|NCT01471782|11694549|FG002|COMPLETED|Overall Study|Completed 5 cycles|0
10541390|NCT01471782|11694550|FG003|COMPLETED|Overall Study|Completed 5 cycles|1
10541391|NCT01471782|11694551|FG004|COMPLETED|Overall Study|Completed 5 cycles|0
10541392|NCT01471782|11694552|FG005|COMPLETED|Overall Study|Completed 5 cycles|3
10387401|NCT00637923|11529493|FG001|STARTED|Overall Study||37
10387402|NCT00637923|11529492|FG000|COMPLETED|Overall Study||45
10387403|NCT00637923|11529493|FG001|COMPLETED|Overall Study||18
10387404|NCT00637923|11529492|FG000|NOT COMPLETED|Overall Study||30
10387405|NCT00637923|11529493|FG001|NOT COMPLETED|Overall Study||19
10387406|NCT00638014|11529501|FG000|STARTED|Overall Study||23
10387407|NCT00638014|11529502|FG001|STARTED|Overall Study||28
10387408|NCT00638014|11529501|FG000|COMPLETED|Overall Study||23
10387409|NCT00638014|11529502|FG001|COMPLETED|Overall Study||28
10387410|NCT00638014|11529501|FG000|NOT COMPLETED|Overall Study||0
10387411|NCT00638014|11529502|FG001|NOT COMPLETED|Overall Study||0
10387412|NCT00638027|11529510|FG000|STARTED|Overall Study||11
10387413|NCT00638027|11529511|FG001|STARTED|Overall Study||10
10387414|NCT00638027|11529510|FG000|COMPLETED|Overall Study||11
10387415|NCT00638027|11529511|FG001|COMPLETED|Overall Study|all 10 included in analyses|8
10387416|NCT00638027|11529510|FG000|NOT COMPLETED|Overall Study||0
10387417|NCT00638027|11529511|FG001|NOT COMPLETED|Overall Study||2
10387418|NCT00638157|11529519|FG000|STARTED|Overall Study||12
10387419|NCT00638157|11529520|FG001|STARTED|Overall Study||12
10387420|NCT00638157|11529519|FG000|Treated|Overall Study||10
10387421|NCT00638157|11529520|FG001|Treated|Overall Study||12
10387422|NCT00638157|11529519|FG000|COMPLETED|Overall Study|4 subjects completed study drug in this arm|5
10387423|NCT00638157|11529520|FG001|COMPLETED|Overall Study|4 subjects completed study drug in this arm|8
10387424|NCT00638157|11529519|FG000|NOT COMPLETED|Overall Study||7
10387425|NCT00638157|11529520|FG001|NOT COMPLETED|Overall Study||4
10387426|NCT00638183|11529527|FG000|STARTED|Overall Study||385
10387427|NCT00638183|11529527|FG000|COMPLETED|Overall Study||266
10387428|NCT00638183|11529527|FG000|NOT COMPLETED|Overall Study||119
10387429|NCT00638235|11529540|FG000|STARTED|Overall Study||141
10387430|NCT00638235|11529541|FG001|STARTED|Overall Study||26
10387431|NCT00638235|11529542|FG002|STARTED|Overall Study||81
10387432|NCT00638235|11529543|FG003|STARTED|Overall Study||56
10387433|NCT00638235|11529544|FG004|STARTED|Overall Study||55
10387434|NCT00638235|11529545|FG005|STARTED|Overall Study||139
10387435|NCT00638235|11529546|FG006|STARTED|Overall Study||23
10387436|NCT00638235|11529547|FG007|STARTED|Overall Study||35
10387437|NCT00638235|11529548|FG008|STARTED|Overall Study||142
10387438|NCT00638235|11529540|FG000|COMPLETED|Overall Study||110
10387439|NCT00638235|11529541|FG001|COMPLETED|Overall Study||23
10387440|NCT00638235|11529542|FG002|COMPLETED|Overall Study|Ph-II ended before all subjects had 24M b/c Perigee next generation was already under trial P-III/IV|63
10387441|NCT00638235|11529543|FG003|COMPLETED|Overall Study||46
10387442|NCT00638235|11529544|FG004|COMPLETED|Overall Study||42
10387443|NCT00638235|11529545|FG005|COMPLETED|Overall Study||113
10387444|NCT00638235|11529546|FG006|COMPLETED|Overall Study||23
10387445|NCT00638235|11529547|FG007|COMPLETED|Overall Study|Ph-VI ended after 12M b/c next generation of Elevate Anterior was already under trial in Phase VII|34
10387446|NCT00638235|11529548|FG008|COMPLETED|Overall Study||124
10387447|NCT00638235|11529540|FG000|NOT COMPLETED|Overall Study||31
10387448|NCT00638235|11529541|FG001|NOT COMPLETED|Overall Study||3
10387449|NCT00638235|11529542|FG002|NOT COMPLETED|Overall Study||18
10387450|NCT00638235|11529543|FG003|NOT COMPLETED|Overall Study||10
10387451|NCT00638235|11529544|FG004|NOT COMPLETED|Overall Study||13
10387452|NCT00638235|11529545|FG005|NOT COMPLETED|Overall Study||26
10387453|NCT00638235|11529546|FG006|NOT COMPLETED|Overall Study||0
10387454|NCT00638235|11529547|FG007|NOT COMPLETED|Overall Study||1
10387455|NCT00638235|11529548|FG008|NOT COMPLETED|Overall Study||18
10387456|NCT00638274|11529577|FG000|STARTED|Overall Study||179
10387457|NCT00638274|11529578|FG001|STARTED|Overall Study||177
10387458|NCT00638274|11529577|FG000|COMPLETED|Overall Study||173
10387459|NCT00638274|11529578|FG001|COMPLETED|Overall Study||172
10387460|NCT00638274|11529577|FG000|NOT COMPLETED|Overall Study||6
10387461|NCT00638274|11529578|FG001|NOT COMPLETED|Overall Study||5
10387462|NCT00638365|11529587|FG000|STARTED|Overall Study||9
10387463|NCT00638365|11529588|FG001|STARTED|Overall Study||10
10387464|NCT00638365|11529589|FG002|STARTED|Overall Study||8
10387465|NCT00638365|11529587|FG000|COMPLETED|Overall Study||9
10387466|NCT00638365|11529588|FG001|COMPLETED|Overall Study||10
10387467|NCT00638365|11529589|FG002|COMPLETED|Overall Study||8
10387468|NCT00638365|11529587|FG000|NOT COMPLETED|Overall Study||0
10387469|NCT00638365|11529588|FG001|NOT COMPLETED|Overall Study||0
10387470|NCT00638365|11529589|FG002|NOT COMPLETED|Overall Study||0
10387471|NCT00638378|11529597|FG000|STARTED|Overall Study||22
10387472|NCT00638378|11529597|FG000|COMPLETED|Overall Study||0
10387473|NCT00638378|11529597|FG000|NOT COMPLETED|Overall Study||22
10387474|NCT00638404|11529603|FG000|STARTED|Overall Study||200
10387475|NCT00638404|11529604|FG001|STARTED|Overall Study||100
10387476|NCT00638404|11529603|FG000|COMPLETED|Overall Study||192
10718235|NCT02703337|11882042|FG002|NOT COMPLETED|Period Five (Part A)||0
10718236|NCT02703337|11882043|FG003|NOT COMPLETED|Period Five (Part A)||0
10387477|NCT00638404|11529604|FG001|COMPLETED|Overall Study||100
10387478|NCT00638404|11529603|FG000|NOT COMPLETED|Overall Study||8
10387479|NCT00638404|11529604|FG001|NOT COMPLETED|Overall Study||0
10387480|NCT00638443|11529614|FG000|STARTED|First Intervention||14
10387481|NCT00638443|11529615|FG001|STARTED|First Intervention||15
10387482|NCT00638443|11529614|FG000|COMPLETED|First Intervention||12
10387483|NCT00638443|11529615|FG001|COMPLETED|First Intervention||14
10387484|NCT00638443|11529614|FG000|NOT COMPLETED|First Intervention||2
10387485|NCT00638443|11529615|FG001|NOT COMPLETED|First Intervention||1
10387486|NCT00638443|11529614|FG000|STARTED|Washout||12
10387487|NCT00638443|11529615|FG001|STARTED|Washout||14
10387488|NCT00638443|11529614|FG000|COMPLETED|Washout||12
10387489|NCT00638443|11529615|FG001|COMPLETED|Washout||14
10387490|NCT00638443|11529614|FG000|NOT COMPLETED|Washout||0
10387491|NCT00638443|11529615|FG001|NOT COMPLETED|Washout||0
10387492|NCT00638443|11529614|FG000|STARTED|Second Intervention||12
10387493|NCT00638443|11529615|FG001|STARTED|Second Intervention||14
10387494|NCT00638443|11529614|FG000|COMPLETED|Second Intervention||12
10387495|NCT00638443|11529615|FG001|COMPLETED|Second Intervention||14
10387496|NCT00638443|11529614|FG000|NOT COMPLETED|Second Intervention||0
10718237|NCT02703337|11882044|FG004|NOT COMPLETED|Period Five (Part A)||0
10387497|NCT00638443|11529615|FG001|NOT COMPLETED|Second Intervention||0
10387498|NCT00638456|11529625|FG000|STARTED|Overall Study||21
10387499|NCT00638456|11529626|FG001|STARTED|Overall Study||11
10387500|NCT00638456|11529625|FG000|COMPLETED|Overall Study||15
10387501|NCT00638456|11529626|FG001|COMPLETED|Overall Study||9
10387502|NCT00638456|11529625|FG000|NOT COMPLETED|Overall Study||6
10387503|NCT00638456|11529626|FG001|NOT COMPLETED|Overall Study||2
10387504|NCT00638508|11529634|FG000|STARTED|Overall Study||35
10387505|NCT00638508|11529635|FG001|STARTED|Overall Study||32
10387506|NCT00638508|11529634|FG000|COMPLETED|Overall Study||30
10387507|NCT00638508|11529635|FG001|COMPLETED|Overall Study||30
10387508|NCT00638508|11529634|FG000|NOT COMPLETED|Overall Study||5
10387509|NCT00638508|11529635|FG001|NOT COMPLETED|Overall Study||2
10387510|NCT00638651|11529645|FG000|STARTED|Overall Study||3
10387511|NCT00638651|11529645|FG000|COMPLETED|Overall Study||3
10387512|NCT00638651|11529645|FG000|NOT COMPLETED|Overall Study||0
10387513|NCT00638690|11529652|FG000|STARTED|Overall Study||797
10387514|NCT00638690|11529653|FG001|STARTED|Overall Study||398
10387515|NCT00638690|11529652|FG000|COMPLETED|Overall Study||116
10387516|NCT00638690|11529653|FG001|COMPLETED|Overall Study||56
10387517|NCT00638690|11529652|FG000|NOT COMPLETED|Overall Study||681
10387518|NCT00638690|11529653|FG001|NOT COMPLETED|Overall Study||342
10387519|NCT00638716|11529663|FG000|STARTED|Overall Study||50
10387520|NCT00638716|11529664|FG001|STARTED|Overall Study||52
10387521|NCT00638716|11529665|FG002|STARTED|Overall Study||58
10387522|NCT00638716|11529663|FG000|COMPLETED|Overall Study||43
10387523|NCT00638716|11529664|FG001|COMPLETED|Overall Study||37
10387524|NCT00638716|11529665|FG002|COMPLETED|Overall Study||46
10387525|NCT00638716|11529663|FG000|NOT COMPLETED|Overall Study||7
10387526|NCT00638716|11529664|FG001|NOT COMPLETED|Overall Study||15
10387527|NCT00638716|11529665|FG002|NOT COMPLETED|Overall Study||12
10387528|NCT00638820|11529673|FG000|STARTED|Overall Study||3
10387529|NCT00638820|11529673|FG000|COMPLETED|Overall Study||3
10387530|NCT00638820|11529673|FG000|NOT COMPLETED|Overall Study||0
10387531|NCT00638846|11529679|FG000|STARTED|Overall Study||137
10387532|NCT00638846|11529680|FG001|STARTED|Overall Study||139
10387533|NCT00638846|11529679|FG000|COMPLETED|Overall Study||133
10387534|NCT00638846|11529680|FG001|COMPLETED|Overall Study||133
10387535|NCT00638846|11529679|FG000|NOT COMPLETED|Overall Study||4
10387536|NCT00638846|11529680|FG001|NOT COMPLETED|Overall Study||6
10387537|NCT00638885|11529686|FG000|STARTED|Overall Study||142
10387538|NCT00638885|11529686|FG000|COMPLETED|Overall Study||142
10387539|NCT00638885|11529686|FG000|NOT COMPLETED|Overall Study||0
10387540|NCT00638924|11529690|FG000|STARTED|Overall Study||40
10387541|NCT00638924|11529690|FG000|2 Months|Overall Study||40
10387542|NCT00638924|11529690|FG000|COMPLETED|Overall Study||40
10387543|NCT00638924|11529690|FG000|NOT COMPLETED|Overall Study||0
10387544|NCT00638937|11529694|FG000|STARTED|Overall Study||37
10387545|NCT00638937|11529694|FG000|COMPLETED|Overall Study||37
10387546|NCT00638937|11529694|FG000|NOT COMPLETED|Overall Study||0
10387547|NCT00638963|11529702|FG000|STARTED|Overall Study|Received randomized treatment assignment|3
10387548|NCT00638963|11529703|FG001|STARTED|Overall Study|Received randomized treatment assignment|3
10387549|NCT00638963|11529702|FG000|COMPLETED|Overall Study|including follow-up at Week 38 & Week 52|2
10387550|NCT00638963|11529703|FG001|COMPLETED|Overall Study|including follow-up at Week 38 & Week 52|3
10387551|NCT00638963|11529702|FG000|NOT COMPLETED|Overall Study||1
10387552|NCT00638963|11529703|FG001|NOT COMPLETED|Overall Study||0
10387553|NCT00638989|11529712|FG000|STARTED|Overall Study||10
10387554|NCT00638989|11529713|FG001|STARTED|Overall Study||10
10387555|NCT00638989|11529714|FG002|STARTED|Overall Study||10
10387556|NCT00638989|11529712|FG000|COMPLETED|Overall Study||10
10387557|NCT00638989|11529713|FG001|COMPLETED|Overall Study||10
10387558|NCT00638989|11529714|FG002|COMPLETED|Overall Study||9
10387559|NCT00638989|11529712|FG000|NOT COMPLETED|Overall Study||0
10387560|NCT00638989|11529713|FG001|NOT COMPLETED|Overall Study||0
10387561|NCT00638989|11529714|FG002|NOT COMPLETED|Overall Study||1
10387562|NCT00639002|11529724|FG000|STARTED|Overall Study||13
10387563|NCT00639002|11529724|FG000|Received Ruxolitinib|Overall Study||13
10387564|NCT00639002|11529724|FG000|Received Ruxolitinib + Dexamethasone|Overall Study||7
10387565|NCT00639002|11529724|FG000|COMPLETED|Overall Study||0
10387566|NCT00639002|11529724|FG000|NOT COMPLETED|Overall Study||13
10387567|NCT00639093|11529731|FG000|STARTED|Overall Study|45|45
10387568|NCT00639093|11529732|FG001|STARTED|Overall Study|46|46
10387569|NCT00639093|11529731|FG000|COMPLETED|Overall Study|45|45
10387570|NCT00639093|11529732|FG001|COMPLETED|Overall Study|46|46
10387571|NCT00639093|11529731|FG000|NOT COMPLETED|Overall Study||0
10387572|NCT00639093|11529732|FG001|NOT COMPLETED|Overall Study||0
10387573|NCT00639158|11529740|FG000|STARTED|Overall Study|All randomized subjects were treated.|272
10387574|NCT00639158|11529741|FG001|STARTED|Overall Study|1 subject was randomized but not treated because of an abnormal ECG that precluded treatment.|270
10387575|NCT00639158|11529740|FG000|COMPLETED|Overall Study|26 subjects prematurely discontinued treatment.|246
10387576|NCT00639158|11529741|FG001|COMPLETED|Overall Study|30 subjects prematurely discontinued treatment|240
10387577|NCT00639158|11529740|FG000|NOT COMPLETED|Overall Study||26
10387578|NCT00639158|11529741|FG001|NOT COMPLETED|Overall Study||30
10387579|NCT00639223|11529749|FG000|STARTED|Overall Study||22
10387580|NCT00639223|11529750|FG001|STARTED|Overall Study||21
10387581|NCT00639223|11529749|FG000|COMPLETED|Overall Study||22
10387582|NCT00639223|11529750|FG001|COMPLETED|Overall Study||19
10387583|NCT00639223|11529749|FG000|NOT COMPLETED|Overall Study||0
10387584|NCT00639223|11529750|FG001|NOT COMPLETED|Overall Study||2
10387585|NCT00639379|11529756|FG000|STARTED|Period 1 - 2 Weeks||44
10387586|NCT00639379|11529757|FG001|STARTED|Period 1 - 2 Weeks||45
10387587|NCT00639379|11529756|FG000|COMPLETED|Period 1 - 2 Weeks||39
10541393|NCT01471782|11694547|FG000|NOT COMPLETED|Overall Study||5
10387588|NCT00639379|11529757|FG001|COMPLETED|Period 1 - 2 Weeks||45
10387589|NCT00639379|11529756|FG000|NOT COMPLETED|Period 1 - 2 Weeks||5
10387590|NCT00639379|11529757|FG001|NOT COMPLETED|Period 1 - 2 Weeks||0
10387591|NCT00639379|11529756|FG000|STARTED|Period 2 - 2 Weeks||39
10387592|NCT00639379|11529757|FG001|STARTED|Period 2 - 2 Weeks||45
10387593|NCT00639379|11529756|FG000|COMPLETED|Period 2 - 2 Weeks||39
10387594|NCT00639379|11529757|FG001|COMPLETED|Period 2 - 2 Weeks||45
10387595|NCT00639379|11529756|FG000|NOT COMPLETED|Period 2 - 2 Weeks||0
10387596|NCT00639379|11529757|FG001|NOT COMPLETED|Period 2 - 2 Weeks||0
10387597|NCT00639418|11529767|FG000|STARTED|Overall Study||28101
10387598|NCT00639418|11529768|FG001|STARTED|Overall Study||35967
10387599|NCT00639418|11529769|FG002|STARTED|Overall Study||36496
10387600|NCT00639418|11529770|FG003|STARTED|Overall Study||46930
10387601|NCT00639418|11529767|FG000|COMPLETED|Overall Study||28101
10387602|NCT00639418|11529768|FG001|COMPLETED|Overall Study||35967
10387603|NCT00639418|11529769|FG002|COMPLETED|Overall Study||36496
10387604|NCT00639418|11529770|FG003|COMPLETED|Overall Study||46930
10387605|NCT00639418|11529767|FG000|NOT COMPLETED|Overall Study||0
10387606|NCT00639418|11529768|FG001|NOT COMPLETED|Overall Study||0
10387607|NCT00639418|11529769|FG002|NOT COMPLETED|Overall Study||0
10387608|NCT00639418|11529770|FG003|NOT COMPLETED|Overall Study||0
10387609|NCT00639457|11529786|FG000|STARTED|Overall Study||22
10387610|NCT00639457|11529787|FG001|STARTED|Overall Study||22
10387611|NCT00639457|11529786|FG000|COMPLETED|Overall Study||20
10387612|NCT00639457|11529787|FG001|COMPLETED|Overall Study||19
10387613|NCT00639457|11529786|FG000|NOT COMPLETED|Overall Study||2
10387614|NCT00639457|11529787|FG001|NOT COMPLETED|Overall Study||3
10387615|NCT00639509|11529793|FG000|STARTED|Overall Study||24
10387616|NCT00639509|11529793|FG000|COMPLETED|Overall Study||23
10387617|NCT00639509|11529793|FG000|NOT COMPLETED|Overall Study||1
10387618|NCT00639678|11529801|FG000|STARTED|Overall Study||74
10387619|NCT00639678|11529802|FG001|STARTED|Overall Study||6
10387620|NCT00639678|11529803|FG002|STARTED|Overall Study||217
10387621|NCT00639678|11529804|FG003|STARTED|Overall Study||23
10387622|NCT00639678|11529801|FG000|COMPLETED|Overall Study||70
10387623|NCT00639678|11529802|FG001|COMPLETED|Overall Study||5
10387624|NCT00639678|11529803|FG002|COMPLETED|Overall Study||206
10387625|NCT00639678|11529804|FG003|COMPLETED|Overall Study||23
10387626|NCT00639678|11529801|FG000|NOT COMPLETED|Overall Study||4
10387627|NCT00639678|11529802|FG001|NOT COMPLETED|Overall Study||1
10387628|NCT00639678|11529803|FG002|NOT COMPLETED|Overall Study||11
10387629|NCT00639678|11529804|FG003|NOT COMPLETED|Overall Study||0
10387630|NCT00639717|11529816|FG000|STARTED|Overall Study||48
10387631|NCT00639717|11529816|FG000|COMPLETED|Overall Study||48
10387632|NCT00639717|11529816|FG000|NOT COMPLETED|Overall Study||0
10387633|NCT00639769|11529820|FG000|STARTED|Overall Study||40
10387634|NCT00639769|11529820|FG000|COMPLETED|Overall Study||0
10387635|NCT00639769|11529820|FG000|NOT COMPLETED|Overall Study||40
10387636|NCT00639860|11529824|FG000|STARTED|Overall Study||10
10387637|NCT00639860|11529824|FG000|COMPLETED|Overall Study||10
10387638|NCT00639860|11529824|FG000|NOT COMPLETED|Overall Study||0
10387639|NCT00640016|11529832|FG000|STARTED|Overall Study||3
10387640|NCT00640016|11529833|FG001|STARTED|Overall Study||3
10387641|NCT00640016|11529834|FG002|STARTED|Overall Study||4
10387642|NCT00640016|11529835|FG003|STARTED|Overall Study||4
10387643|NCT00640016|11529832|FG000|Treated|Overall Study||3
10387644|NCT00640016|11529833|FG001|Treated|Overall Study||2
10387645|NCT00640016|11529834|FG002|Treated|Overall Study||4
10387646|NCT00640016|11529835|FG003|Treated|Overall Study||4
10387647|NCT00640016|11529832|FG000|COMPLETED|Overall Study||1
10387648|NCT00640016|11529833|FG001|COMPLETED|Overall Study||1
10387649|NCT00640016|11529834|FG002|COMPLETED|Overall Study||1
10387650|NCT00640016|11529835|FG003|COMPLETED|Overall Study||1
10387651|NCT00640016|11529832|FG000|NOT COMPLETED|Overall Study||2
10387652|NCT00640016|11529833|FG001|NOT COMPLETED|Overall Study||2
10387653|NCT00640016|11529834|FG002|NOT COMPLETED|Overall Study||3
10387654|NCT00640016|11529835|FG003|NOT COMPLETED|Overall Study||3
10387655|NCT00640042|11529852|FG000|STARTED|Enrollment|Number of patients with evidence of prescription card receipt|1570
10387656|NCT00640042|11529852|FG000|COMPLETED|Enrollment|Number of patients with evidence of study drug receipt|1487
10387657|NCT00640042|11529852|FG000|NOT COMPLETED|Enrollment||83
10387658|NCT00640042|11529852|FG000|STARTED|Treatment||1487
10387659|NCT00640042|11529852|FG000|COMPLETED|Treatment||561
10387660|NCT00640042|11529852|FG000|NOT COMPLETED|Treatment||926
10387661|NCT00640146|11529858|FG000|STARTED|Overall Study||19
10387662|NCT00640146|11529859|FG001|STARTED|Overall Study||18
10387663|NCT00640146|11529858|FG000|Received at Least 1 Dose of Study Drug|Overall Study||18
10387664|NCT00640146|11529859|FG001|Received at Least 1 Dose of Study Drug|Overall Study||15
10387665|NCT00640146|11529858|FG000|COMPLETED|Overall Study||15
10387666|NCT00640146|11529859|FG001|COMPLETED|Overall Study||12
10387667|NCT00640146|11529858|FG000|NOT COMPLETED|Overall Study||4
10387668|NCT00640146|11529859|FG001|NOT COMPLETED|Overall Study||6
10387669|NCT00640224|11529869|FG000|STARTED|Overall Study||23
10387670|NCT00640224|11529870|FG001|STARTED|Overall Study||23
10387671|NCT00640224|11529871|FG002|STARTED|Overall Study||0
10387672|NCT00640224|11529872|FG003|STARTED|Overall Study||0
10387673|NCT00640224|11529869|FG000|COMPLETED|Overall Study||17
10387674|NCT00640224|11529870|FG001|COMPLETED|Overall Study||20
10387675|NCT00640224|11529871|FG002|COMPLETED|Overall Study||0
10387676|NCT00640224|11529872|FG003|COMPLETED|Overall Study||0
10387677|NCT00640224|11529869|FG000|NOT COMPLETED|Overall Study||6
10387678|NCT00640224|11529870|FG001|NOT COMPLETED|Overall Study||3
10387679|NCT00640224|11529871|FG002|NOT COMPLETED|Overall Study||0
10387680|NCT00640224|11529872|FG003|NOT COMPLETED|Overall Study||0
10387681|NCT00640250|11529882|FG000|STARTED|Overall Study||48
10387682|NCT00640250|11529882|FG000|COMPLETED|Overall Study||48
10387683|NCT00640250|11529882|FG000|NOT COMPLETED|Overall Study||0
10387684|NCT00640289|11529985|FG000|STARTED|Overall Study||72
10387685|NCT00640289|11529985|FG000|COMPLETED|Overall Study||59
10387686|NCT00640289|11529985|FG000|NOT COMPLETED|Overall Study||13
10387687|NCT00640315|11529991|FG000|STARTED|Overall Study||10
10387688|NCT00640315|11529992|FG001|STARTED|Overall Study||13
10387689|NCT00640315|11529991|FG000|Participants Received Treatment|Overall Study||10
10387690|NCT00640315|11529992|FG001|Participants Received Treatment|Overall Study||13
10387691|NCT00640315|11529991|FG000|COMPLETED|Overall Study||10
10541394|NCT01471782|11694548|FG001|NOT COMPLETED|Overall Study||6
10541395|NCT01471782|11694549|FG002|NOT COMPLETED|Overall Study||5
10541396|NCT01471782|11694550|FG003|NOT COMPLETED|Overall Study||5
10541397|NCT01471782|11694551|FG004|NOT COMPLETED|Overall Study||26
10541398|NCT01471782|11694552|FG005|NOT COMPLETED|Overall Study||41
10541399|NCT01472185|11694579|FG000|STARTED|Overall Study||232
10541400|NCT01472185|11694580|FG001|STARTED|Overall Study||233
10541401|NCT01472185|11694579|FG000|COMPLETED|Overall Study||198
10541402|NCT01472185|11694580|FG001|COMPLETED|Overall Study||199
10541403|NCT01472185|11694579|FG000|NOT COMPLETED|Overall Study||34
10541404|NCT01472185|11694580|FG001|NOT COMPLETED|Overall Study||34
10541405|NCT01472289|11694586|FG000|STARTED|Overall Study||17
10541406|NCT01472289|11694586|FG000|COMPLETED|Overall Study||15
10541407|NCT01472289|11694586|FG000|NOT COMPLETED|Overall Study||2
10541408|NCT01472341|11694590|FG000|STARTED|Overall Study||507
10541409|NCT01472341|11694590|FG000|COMPLETED|Overall Study||235
10541410|NCT01472341|11694590|FG000|NOT COMPLETED|Overall Study||272
10541411|NCT01472380|11694594|FG000|STARTED|Efavirenz Alone||30
10541412|NCT01472380|11694594|FG000|COMPLETED|Efavirenz Alone||29
10541413|NCT01472380|11694594|FG000|NOT COMPLETED|Efavirenz Alone||1
10541414|NCT01472380|11694594|FG000|STARTED|Fenofibric Acid (FFA) Alone||29
10541415|NCT01472380|11694594|FG000|COMPLETED|Fenofibric Acid (FFA) Alone||29
10541416|NCT01472380|11694594|FG000|NOT COMPLETED|Fenofibric Acid (FFA) Alone||0
10541417|NCT01472380|11694594|FG000|STARTED|1 Day Period Between Dosing||29
10541418|NCT01472380|11694594|FG000|COMPLETED|1 Day Period Between Dosing||28
10541419|NCT01472380|11694594|FG000|NOT COMPLETED|1 Day Period Between Dosing||1
10541420|NCT01472380|11694594|FG000|STARTED|Efavirenz and FFA||28
10541421|NCT01472380|11694594|FG000|COMPLETED|Efavirenz and FFA||28
10541422|NCT01472380|11694594|FG000|NOT COMPLETED|Efavirenz and FFA||0
10541423|NCT01472432|11694603|FG000|STARTED|Overall Study||53
10541424|NCT01472432|11694604|FG001|STARTED|Overall Study||53
10541425|NCT01472432|11694603|FG000|Ulcer Reduction|Overall Study||13
10541426|NCT01472432|11694604|FG001|Ulcer Reduction|Overall Study||33
10541427|NCT01472432|11694603|FG000|COMPLETED|Overall Study||53
10541428|NCT01472432|11694604|FG001|COMPLETED|Overall Study||53
10541429|NCT01472432|11694603|FG000|NOT COMPLETED|Overall Study||0
10541430|NCT01472432|11694604|FG001|NOT COMPLETED|Overall Study||0
10541431|NCT01472445|11694614|FG000|STARTED|Overall Study||25
10541432|NCT01472445|11694615|FG001|STARTED|Overall Study||16
10541433|NCT01472445|11694614|FG000|COMPLETED|Overall Study||25
10541434|NCT01472445|11694615|FG001|COMPLETED|Overall Study||16
10541435|NCT01472445|11694614|FG000|NOT COMPLETED|Overall Study||0
10541436|NCT01472445|11694615|FG001|NOT COMPLETED|Overall Study||0
10541437|NCT01472549|11694625|FG000|STARTED|Overall Study||572
10541438|NCT01472549|11694626|FG001|STARTED|Overall Study||575
10541439|NCT01472549|11694625|FG000|COMPLETED|Overall Study||572
10541440|NCT01472549|11694626|FG001|COMPLETED|Overall Study||575
10541441|NCT01472549|11694625|FG000|NOT COMPLETED|Overall Study||0
10541442|NCT01472549|11694626|FG001|NOT COMPLETED|Overall Study||0
10541443|NCT01472718|11694634|FG000|STARTED|Overall Study||104
10541444|NCT01472718|11694635|FG001|STARTED|Overall Study||104
10541445|NCT01472718|11694634|FG000|COMPLETED|Overall Study||98
10541446|NCT01472718|11694635|FG001|COMPLETED|Overall Study||97
10541447|NCT01472718|11694634|FG000|NOT COMPLETED|Overall Study||6
10541448|NCT01472718|11694635|FG001|NOT COMPLETED|Overall Study||7
10541449|NCT01472757|11694645|FG000|STARTED|Overall Study||91
10541450|NCT01472757|11694646|FG001|STARTED|Overall Study||93
10541451|NCT01472757|11694647|FG002|STARTED|Overall Study||95
10541452|NCT01472757|11694648|FG003|STARTED|Overall Study||94
10387692|NCT00640315|11529992|FG001|COMPLETED|Overall Study||12
10387693|NCT00640315|11529991|FG000|NOT COMPLETED|Overall Study||0
10387694|NCT00640315|11529992|FG001|NOT COMPLETED|Overall Study||1
10387695|NCT00640328|11530004|FG000|STARTED|First Treatment Period (Weeks 0-24)||8
10387696|NCT00640328|11530005|FG001|STARTED|First Treatment Period (Weeks 0-24)||11
10387697|NCT00640328|11530006|FG002|STARTED|First Treatment Period (Weeks 0-24)||7
10387698|NCT00640328|11530007|FG003|STARTED|First Treatment Period (Weeks 0-24)||4
10387699|NCT00640328|11530008|FG004|STARTED|First Treatment Period (Weeks 0-24)||4
10387700|NCT00640328|11530009|FG005|STARTED|First Treatment Period (Weeks 0-24)||4
10387701|NCT00640328|11530004|FG000|COMPLETED|First Treatment Period (Weeks 0-24)||8
10387702|NCT00640328|11530005|FG001|COMPLETED|First Treatment Period (Weeks 0-24)||10
10387703|NCT00640328|11530006|FG002|COMPLETED|First Treatment Period (Weeks 0-24)||7
10387704|NCT00640328|11530007|FG003|COMPLETED|First Treatment Period (Weeks 0-24)||4
10387705|NCT00640328|11530008|FG004|COMPLETED|First Treatment Period (Weeks 0-24)||4
10387706|NCT00640328|11530009|FG005|COMPLETED|First Treatment Period (Weeks 0-24)||4
10387707|NCT00640328|11530004|FG000|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
10541453|NCT01472757|11694645|FG000|Full Analysis Set|Overall Study||91
10387708|NCT00640328|11530005|FG001|NOT COMPLETED|First Treatment Period (Weeks 0-24)||1
10541454|NCT01472757|11694646|FG001|Full Analysis Set|Overall Study||93
10541455|NCT01472757|11694647|FG002|Full Analysis Set|Overall Study||92
10541456|NCT01472757|11694648|FG003|Full Analysis Set|Overall Study||92
10541457|NCT01472757|11694645|FG000|COMPLETED|Overall Study||61
10541458|NCT01472757|11694646|FG001|COMPLETED|Overall Study||80
10541459|NCT01472757|11694647|FG002|COMPLETED|Overall Study||76
10541460|NCT01472757|11694648|FG003|COMPLETED|Overall Study||75
10387709|NCT00640328|11530006|FG002|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
10387710|NCT00640328|11530007|FG003|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
10387711|NCT00640328|11530008|FG004|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
10387712|NCT00640328|11530009|FG005|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
10387713|NCT00640328|11530004|FG000|STARTED|Second Treatment Period (Weeks 24-48)||8
10387714|NCT00640328|11530005|FG001|STARTED|Second Treatment Period (Weeks 24-48)||10
10387715|NCT00640328|11530006|FG002|STARTED|Second Treatment Period (Weeks 24-48)||7
10387716|NCT00640328|11530007|FG003|STARTED|Second Treatment Period (Weeks 24-48)||4
10387717|NCT00640328|11530008|FG004|STARTED|Second Treatment Period (Weeks 24-48)||4
10387718|NCT00640328|11530009|FG005|STARTED|Second Treatment Period (Weeks 24-48)||4
10387719|NCT00640328|11530004|FG000|COMPLETED|Second Treatment Period (Weeks 24-48)||8
10387720|NCT00640328|11530005|FG001|COMPLETED|Second Treatment Period (Weeks 24-48)||10
10387721|NCT00640328|11530006|FG002|COMPLETED|Second Treatment Period (Weeks 24-48)||7
10387722|NCT00640328|11530007|FG003|COMPLETED|Second Treatment Period (Weeks 24-48)||4
10387723|NCT00640328|11530008|FG004|COMPLETED|Second Treatment Period (Weeks 24-48)||3
10387724|NCT00640328|11530009|FG005|COMPLETED|Second Treatment Period (Weeks 24-48)||4
10387725|NCT00640328|11530004|FG000|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
10387726|NCT00640328|11530005|FG001|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
10387727|NCT00640328|11530006|FG002|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
10387728|NCT00640328|11530007|FG003|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
10387729|NCT00640328|11530008|FG004|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||1
10387730|NCT00640328|11530009|FG005|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
10387731|NCT00640328|11530004|FG000|STARTED|IFUP (Week 48 to Individual Termination)||8
10387732|NCT00640328|11530005|FG001|STARTED|IFUP (Week 48 to Individual Termination)||11
10387733|NCT00640328|11530006|FG002|STARTED|IFUP (Week 48 to Individual Termination)||7
10387734|NCT00640328|11530007|FG003|STARTED|IFUP (Week 48 to Individual Termination)||4
10387735|NCT00640328|11530008|FG004|STARTED|IFUP (Week 48 to Individual Termination)||4
10387736|NCT00640328|11530009|FG005|STARTED|IFUP (Week 48 to Individual Termination)||4
10387737|NCT00640328|11530004|FG000|COMPLETED|IFUP (Week 48 to Individual Termination)||8
10387738|NCT00640328|11530005|FG001|COMPLETED|IFUP (Week 48 to Individual Termination)||10
10387739|NCT00640328|11530006|FG002|COMPLETED|IFUP (Week 48 to Individual Termination)||6
10387740|NCT00640328|11530007|FG003|COMPLETED|IFUP (Week 48 to Individual Termination)||3
10387741|NCT00640328|11530008|FG004|COMPLETED|IFUP (Week 48 to Individual Termination)||4
10387742|NCT00640328|11530009|FG005|COMPLETED|IFUP (Week 48 to Individual Termination)||4
10387743|NCT00640328|11530004|FG000|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
10387744|NCT00640328|11530005|FG001|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
10387745|NCT00640328|11530006|FG002|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
10387746|NCT00640328|11530007|FG003|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
10387747|NCT00640328|11530008|FG004|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
10718238|NCT02703337|11882045|FG005|NOT COMPLETED|Period Five (Part A)||0
10718239|NCT02703337|11882046|FG006|NOT COMPLETED|Period Five (Part A)||0
10718240|NCT02703337|11882047|FG007|NOT COMPLETED|Period Five (Part A)||0
10718241|NCT02703337|11882040|FG000|STARTED|Period Six (Part A)||5
10387748|NCT00640328|11530009|FG005|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
10387749|NCT00640341|11530033|FG000|STARTED|Overall Study|All Starting participants were dispensed lenses|170
10387750|NCT00640341|11530034|FG001|STARTED|Overall Study||170
10387751|NCT00640341|11530035|FG002|STARTED|Overall Study||170
10387752|NCT00640341|11530033|FG000|Eligible Participants at Baseline|Overall Study||165
10718242|NCT02703337|11882041|FG001|STARTED|Period Six (Part A)||5
10387753|NCT00640341|11530034|FG001|Eligible Participants at Baseline|Overall Study||167
10387754|NCT00640341|11530035|FG002|Eligible Participants at Baseline|Overall Study||168
10387755|NCT00640341|11530033|FG000|COMPLETED|Overall Study||149
10387756|NCT00640341|11530034|FG001|COMPLETED|Overall Study||165
10387757|NCT00640341|11530035|FG002|COMPLETED|Overall Study||163
10387758|NCT00640341|11530033|FG000|NOT COMPLETED|Overall Study||21
10387759|NCT00640341|11530034|FG001|NOT COMPLETED|Overall Study||5
10387760|NCT00640341|11530035|FG002|NOT COMPLETED|Overall Study||7
10387761|NCT00640393|11530043|FG000|STARTED|Part 1||99
10387762|NCT00640393|11530044|FG001|STARTED|Part 1||0
10387763|NCT00640393|11530045|FG002|STARTED|Part 1||0
10387764|NCT00640393|11530043|FG000|COMPLETED|Part 1||94
10387765|NCT00640393|11530044|FG001|COMPLETED|Part 1||0
10387766|NCT00640393|11530045|FG002|COMPLETED|Part 1||0
10387767|NCT00640393|11530043|FG000|NOT COMPLETED|Part 1||5
10387768|NCT00640393|11530044|FG001|NOT COMPLETED|Part 1||0
10387769|NCT00640393|11530045|FG002|NOT COMPLETED|Part 1||0
10387770|NCT00640393|11530043|FG000|STARTED|Randomization||94
10387771|NCT00640393|11530044|FG001|STARTED|Randomization||0
10387772|NCT00640393|11530045|FG002|STARTED|Randomization||0
10387773|NCT00640393|11530043|FG000|COMPLETED|Randomization||75
10387774|NCT00640393|11530044|FG001|COMPLETED|Randomization||0
10387775|NCT00640393|11530045|FG002|COMPLETED|Randomization||0
10387776|NCT00640393|11530043|FG000|NOT COMPLETED|Randomization||19
10387777|NCT00640393|11530044|FG001|NOT COMPLETED|Randomization||0
10387778|NCT00640393|11530045|FG002|NOT COMPLETED|Randomization||0
10387779|NCT00640393|11530043|FG000|STARTED|Part 2||0
10387780|NCT00640393|11530044|FG001|STARTED|Part 2||37
10387781|NCT00640393|11530045|FG002|STARTED|Part 2||38
10387782|NCT00640393|11530043|FG000|COMPLETED|Part 2||0
10387783|NCT00640393|11530044|FG001|COMPLETED|Part 2|Per Protocol analysis is of 7 participants that were compliant to protocol|27
10387784|NCT00640393|11530045|FG002|COMPLETED|Part 2|Per protocol analysis of 27 to 29 participants that were compliant depending on evaluation or visit|35
10387785|NCT00640393|11530043|FG000|NOT COMPLETED|Part 2||0
10387786|NCT00640393|11530044|FG001|NOT COMPLETED|Part 2||10
10387787|NCT00640393|11530045|FG002|NOT COMPLETED|Part 2||3
10387788|NCT00640510|11530055|FG000|STARTED|Overall Study||17
10387789|NCT00640510|11530056|FG001|STARTED|Overall Study|One patient randomized to placebo discontinued prior to receiving study drug.|17
10387790|NCT00640510|11530055|FG000|COMPLETED|Overall Study||16
10387791|NCT00640510|11530056|FG001|COMPLETED|Overall Study||15
10387792|NCT00640510|11530055|FG000|NOT COMPLETED|Overall Study||1
10387793|NCT00640510|11530056|FG001|NOT COMPLETED|Overall Study||2
10387794|NCT00640562|11530064|FG000|STARTED|Overall Study||109
10387795|NCT00640562|11530065|FG001|STARTED|Overall Study||107
10387796|NCT00640562|11530064|FG000|COMPLETED|Overall Study||91
10387797|NCT00640562|11530065|FG001|COMPLETED|Overall Study||81
10387798|NCT00640562|11530064|FG000|NOT COMPLETED|Overall Study||18
10387799|NCT00640562|11530065|FG001|NOT COMPLETED|Overall Study||26
10387800|NCT00640601|11530071|FG000|STARTED|Overall Study|331 patients enrolled and 295 patients started investigational product (IP)|295
10387801|NCT00640601|11530071|FG000|COMPLETED|Overall Study||183
10387802|NCT00640601|11530071|FG000|NOT COMPLETED|Overall Study||112
10387803|NCT00640614|11530077|FG000|STARTED|Overall Study||125
10387804|NCT00640614|11530078|FG001|STARTED|Overall Study||110
10387805|NCT00640614|11530077|FG000|COMPLETED|Overall Study||124
10387806|NCT00640614|11530078|FG001|COMPLETED|Overall Study||110
10387807|NCT00640614|11530077|FG000|NOT COMPLETED|Overall Study||1
10387808|NCT00640614|11530078|FG001|NOT COMPLETED|Overall Study||0
10387809|NCT00640653|11530112|FG000|STARTED|Overall Study||131
10387810|NCT00640653|11530113|FG001|STARTED|Overall Study||134
10387811|NCT00640653|11530114|FG002|STARTED|Overall Study||129
10387812|NCT00640653|11530115|FG003|STARTED|Overall Study||134
10387813|NCT00640653|11530116|FG004|STARTED|Overall Study||134
10387814|NCT00640653|11530112|FG000|Followed-up at 3 mo|Overall Study||126
10387815|NCT00640653|11530113|FG001|Followed-up at 3 mo|Overall Study||127
10387816|NCT00640653|11530114|FG002|Followed-up at 3 mo|Overall Study||125
10387817|NCT00640653|11530115|FG003|Followed-up at 3 mo|Overall Study||129
10387818|NCT00640653|11530116|FG004|Followed-up at 3 mo|Overall Study||126
10387819|NCT00640653|11530112|FG000|Followed-up at 6 mo|Overall Study||127
10387820|NCT00640653|11530113|FG001|Followed-up at 6 mo|Overall Study||130
10387821|NCT00640653|11530114|FG002|Followed-up at 6 mo|Overall Study||124
10387822|NCT00640653|11530115|FG003|Followed-up at 6 mo|Overall Study||130
10387823|NCT00640653|11530116|FG004|Followed-up at 6 mo|Overall Study||125
10387824|NCT00640653|11530112|FG000|Followed-up at 12 mo|Overall Study||124
10387825|NCT00640653|11530113|FG001|Followed-up at 12 mo|Overall Study||121
10387826|NCT00640653|11530114|FG002|Followed-up at 12 mo|Overall Study||115
10387827|NCT00640653|11530115|FG003|Followed-up at 12 mo|Overall Study||122
10387828|NCT00640653|11530116|FG004|Followed-up at 12 mo|Overall Study||116
10387829|NCT00640653|11530112|FG000|Followed-up at 18 mo|Overall Study||118
10387830|NCT00640653|11530113|FG001|Followed-up at 18 mo|Overall Study||112
10387831|NCT00640653|11530114|FG002|Followed-up at 18 mo|Overall Study||113
10387832|NCT00640653|11530115|FG003|Followed-up at 18 mo|Overall Study||117
10387833|NCT00640653|11530116|FG004|Followed-up at 18 mo|Overall Study||117
10387834|NCT00640653|11530112|FG000|Followed-up at 24 mo|Overall Study||114
10387835|NCT00640653|11530113|FG001|Followed-up at 24 mo|Overall Study||116
10387836|NCT00640653|11530114|FG002|Followed-up at 24 mo|Overall Study||105
10387837|NCT00640653|11530115|FG003|Followed-up at 24 mo|Overall Study||112
10387838|NCT00640653|11530116|FG004|Followed-up at 24 mo|Overall Study||112
10387839|NCT00640653|11530112|FG000|COMPLETED|Overall Study||128
10387840|NCT00640653|11530113|FG001|COMPLETED|Overall Study||131
10387841|NCT00640653|11530114|FG002|COMPLETED|Overall Study||129
10387842|NCT00640653|11530115|FG003|COMPLETED|Overall Study||132
10387843|NCT00640653|11530116|FG004|COMPLETED|Overall Study||129
10387844|NCT00640653|11530112|FG000|NOT COMPLETED|Overall Study||3
10387845|NCT00640653|11530113|FG001|NOT COMPLETED|Overall Study||3
10387846|NCT00640653|11530114|FG002|NOT COMPLETED|Overall Study||0
10387847|NCT00640653|11530115|FG003|NOT COMPLETED|Overall Study||2
10387848|NCT00640653|11530116|FG004|NOT COMPLETED|Overall Study||5
10387849|NCT00640822|11530131|FG000|STARTED|Overall Study||322
10387850|NCT00640822|11530132|FG001|STARTED|Overall Study||317
10387851|NCT00640822|11530133|FG002|STARTED|Overall Study||102
10387852|NCT00640822|11530131|FG000|COMPLETED|Overall Study||279
10387853|NCT00640822|11530132|FG001|COMPLETED|Overall Study||258
10387854|NCT00640822|11530133|FG002|COMPLETED|Overall Study||77
10387855|NCT00640822|11530131|FG000|NOT COMPLETED|Overall Study||43
10387856|NCT00640822|11530132|FG001|NOT COMPLETED|Overall Study||59
10387857|NCT00640822|11530133|FG002|NOT COMPLETED|Overall Study||25
10387858|NCT00640835|11530143|FG000|STARTED|Overall Study||194
10387859|NCT00640835|11530144|FG001|STARTED|Overall Study||188
10387860|NCT00640835|11530143|FG000|COMPLETED|Overall Study||118
10387861|NCT00640835|11530144|FG001|COMPLETED|Overall Study||131
10387862|NCT00640835|11530143|FG000|NOT COMPLETED|Overall Study||76
10387863|NCT00640835|11530144|FG001|NOT COMPLETED|Overall Study||57
10387864|NCT00640926|11530153|FG000|STARTED|Overall Study||53
10387865|NCT00640926|11530154|FG001|STARTED|Overall Study||52
10387866|NCT00640926|11530155|FG002|STARTED|Overall Study||53
10387867|NCT00640926|11530153|FG000|COMPLETED|Overall Study||45
10387868|NCT00640926|11530154|FG001|COMPLETED|Overall Study||46
10387869|NCT00640926|11530155|FG002|COMPLETED|Overall Study||45
10387870|NCT00640926|11530153|FG000|NOT COMPLETED|Overall Study||8
10387871|NCT00640926|11530154|FG001|NOT COMPLETED|Overall Study||6
10541461|NCT01472757|11694645|FG000|NOT COMPLETED|Overall Study||30
10541462|NCT01472757|11694646|FG001|NOT COMPLETED|Overall Study||13
10541463|NCT01472757|11694647|FG002|NOT COMPLETED|Overall Study||19
10541464|NCT01472757|11694648|FG003|NOT COMPLETED|Overall Study||19
10541465|NCT01472822|11694660|FG000|STARTED|Overall Study||30
10541466|NCT01472822|11694661|FG001|STARTED|Overall Study||30
10541467|NCT01472822|11694660|FG000|COMPLETED|Overall Study||28
10541468|NCT01472822|11694661|FG001|COMPLETED|Overall Study||28
10541469|NCT01472822|11694660|FG000|NOT COMPLETED|Overall Study||2
10541470|NCT01472822|11694661|FG001|NOT COMPLETED|Overall Study||2
10541471|NCT01472835|11694669|FG000|STARTED|Overall Study||37
10541472|NCT01472835|11694670|FG001|STARTED|Overall Study||36
10541473|NCT01472835|11694669|FG000|COMPLETED|Overall Study||35
10541474|NCT01472835|11694670|FG001|COMPLETED|Overall Study||36
10541475|NCT01472835|11694669|FG000|NOT COMPLETED|Overall Study||2
10541476|NCT01472835|11694670|FG001|NOT COMPLETED|Overall Study||0
10541477|NCT01472874|11694679|FG000|STARTED|Overall Study||8
10541478|NCT01472874|11694679|FG000|COMPLETED|Overall Study||8
10541479|NCT01472874|11694679|FG000|NOT COMPLETED|Overall Study||0
10541480|NCT01472939|11694687|FG000|STARTED|Overall Study||123
10541481|NCT01472939|11694688|FG001|STARTED|Overall Study||119
10541482|NCT01472939|11694689|FG002|STARTED|Overall Study||119
10541483|NCT01472939|11694690|FG003|STARTED|Overall Study||119
10541484|NCT01472939|11694687|FG000|COMPLETED|Overall Study||103
10541485|NCT01472939|11694688|FG001|COMPLETED|Overall Study||105
10541486|NCT01472939|11694689|FG002|COMPLETED|Overall Study||108
10658361|NCT02233309|11819510|FG000|STARTED|Overall Study||36
10658362|NCT02233309|11819510|FG000|COMPLETED|Overall Study||31
10658363|NCT02233309|11819510|FG000|NOT COMPLETED|Overall Study||5
10658364|NCT02233413|11819516|FG000|STARTED|Overall Study||35
10658365|NCT02233413|11819517|FG001|STARTED|Overall Study||33
10658366|NCT02233413|11819516|FG000|COMPLETED|Overall Study||24
10658367|NCT02233413|11819517|FG001|COMPLETED|Overall Study||19
10658368|NCT02233413|11819516|FG000|NOT COMPLETED|Overall Study||11
10658369|NCT02233413|11819517|FG001|NOT COMPLETED|Overall Study||14
10658370|NCT02233478|11819523|FG000|STARTED|First Intervention (1 Day)||3
10658371|NCT02233478|11819524|FG001|STARTED|First Intervention (1 Day)||3
10658372|NCT02233478|11819525|FG002|STARTED|First Intervention (1 Day)||3
10658373|NCT02233478|11819526|FG003|STARTED|First Intervention (1 Day)||3
10658374|NCT02233478|11819527|FG004|STARTED|First Intervention (1 Day)||3
10387872|NCT00640926|11530155|FG002|NOT COMPLETED|Overall Study||8
10387873|NCT00640978|11530163|FG000|STARTED|Overall Study||15
10387874|NCT00640978|11530163|FG000|COMPLETED|Overall Study||15
10387875|NCT00640978|11530163|FG000|NOT COMPLETED|Overall Study||0
10387876|NCT00641043|11530169|FG000|STARTED|Overall Study|number who started treatment|130
10387877|NCT00641043|11530170|FG001|STARTED|Overall Study|number who started treatment|259
10387878|NCT00641043|11530169|FG000|COMPLETED|Overall Study|number who completed treatment|111
10387879|NCT00641043|11530170|FG001|COMPLETED|Overall Study|number who completed treatment|244
10387880|NCT00641043|11530169|FG000|NOT COMPLETED|Overall Study||19
10658375|NCT02233478|11819528|FG005|STARTED|First Intervention (1 Day)||3
10387881|NCT00641043|11530170|FG001|NOT COMPLETED|Overall Study||15
10387882|NCT00641056|11530178|FG000|STARTED|Overall Study||233
10541487|NCT01472939|11694690|FG003|COMPLETED|Overall Study||99
10541488|NCT01472939|11694687|FG000|NOT COMPLETED|Overall Study||20
10541489|NCT01472939|11694688|FG001|NOT COMPLETED|Overall Study||14
10541490|NCT01472939|11694689|FG002|NOT COMPLETED|Overall Study||11
10658376|NCT02233478|11819523|FG000|COMPLETED|First Intervention (1 Day)||3
10387883|NCT00641056|11530179|FG001|STARTED|Overall Study||234
10387884|NCT00641056|11530178|FG000|Intent to Treat (ITT)|Overall Study||233
10387885|NCT00641056|11530179|FG001|Intent to Treat (ITT)|Overall Study||223
10387886|NCT00641056|11530178|FG000|COMPLETED|Overall Study||204
10387887|NCT00641056|11530179|FG001|COMPLETED|Overall Study||209
10387888|NCT00641056|11530178|FG000|NOT COMPLETED|Overall Study||29
10387889|NCT00641056|11530179|FG001|NOT COMPLETED|Overall Study||25
10387890|NCT00641147|11530191|FG000|STARTED|Completed 4 Months.||21
10387891|NCT00641147|11530192|FG001|STARTED|Completed 4 Months.||23
10387892|NCT00641147|11530191|FG000|COMPLETED|Completed 4 Months.||19
10387893|NCT00641147|11530192|FG001|COMPLETED|Completed 4 Months.||23
10387894|NCT00641147|11530191|FG000|NOT COMPLETED|Completed 4 Months.||2
10387895|NCT00641147|11530192|FG001|NOT COMPLETED|Completed 4 Months.||0
10387896|NCT00641147|11530191|FG000|STARTED|Completed 8 Months.||19
10387897|NCT00641147|11530192|FG001|STARTED|Completed 8 Months.||23
10387898|NCT00641147|11530191|FG000|COMPLETED|Completed 8 Months.||16
10387899|NCT00641147|11530192|FG001|COMPLETED|Completed 8 Months.||21
10387900|NCT00641147|11530191|FG000|NOT COMPLETED|Completed 8 Months.||3
10387901|NCT00641147|11530192|FG001|NOT COMPLETED|Completed 8 Months.||2
10387902|NCT00641147|11530191|FG000|STARTED|Completed 12 Months.||16
10387903|NCT00641147|11530192|FG001|STARTED|Completed 12 Months.||21
10387904|NCT00641147|11530191|FG000|COMPLETED|Completed 12 Months.||15
10387905|NCT00641147|11530192|FG001|COMPLETED|Completed 12 Months.||19
10387906|NCT00641147|11530191|FG000|NOT COMPLETED|Completed 12 Months.||1
10387907|NCT00641147|11530192|FG001|NOT COMPLETED|Completed 12 Months.||2
10387908|NCT00641147|11530191|FG000|STARTED|Completed 16 Months.||15
10387909|NCT00641147|11530192|FG001|STARTED|Completed 16 Months.||19
10387910|NCT00641147|11530191|FG000|COMPLETED|Completed 16 Months.||13
10387911|NCT00641147|11530192|FG001|COMPLETED|Completed 16 Months.||19
10387912|NCT00641147|11530191|FG000|NOT COMPLETED|Completed 16 Months.||2
10387913|NCT00641147|11530192|FG001|NOT COMPLETED|Completed 16 Months.||0
10387914|NCT00641563|11530202|FG000|STARTED|Infusion 1||5
10387915|NCT00641563|11530203|FG001|STARTED|Infusion 1||5
10387916|NCT00641563|11530202|FG000|COMPLETED|Infusion 1||5
10387917|NCT00641563|11530203|FG001|COMPLETED|Infusion 1||5
10387918|NCT00641563|11530202|FG000|NOT COMPLETED|Infusion 1||0
10387919|NCT00641563|11530203|FG001|NOT COMPLETED|Infusion 1||0
10387920|NCT00641563|11530202|FG000|STARTED|Infusion 2||5
10387921|NCT00641563|11530203|FG001|STARTED|Infusion 2||5
10387922|NCT00641563|11530202|FG000|COMPLETED|Infusion 2||5
10387923|NCT00641563|11530203|FG001|COMPLETED|Infusion 2||5
10387924|NCT00641563|11530202|FG000|NOT COMPLETED|Infusion 2||0
10387925|NCT00641563|11530203|FG001|NOT COMPLETED|Infusion 2||0
10387926|NCT00641641|11530209|FG000|STARTED|Overall Study||16
10387927|NCT00641641|11530209|FG000|COMPLETED|Overall Study||16
10387928|NCT00641641|11530209|FG000|NOT COMPLETED|Overall Study||0
10387929|NCT00641667|11530213|FG000|STARTED|Overall Study||66
10387930|NCT00641667|11530213|FG000|COMPLETED|Overall Study||60
10387931|NCT00641667|11530213|FG000|NOT COMPLETED|Overall Study||6
10387932|NCT00641706|11530219|FG000|STARTED|Overall Study||37
10387933|NCT00641706|11530220|FG001|STARTED|Overall Study||7
10387934|NCT00641706|11530219|FG000|COMPLETED|Overall Study||28
10387935|NCT00641706|11530220|FG001|COMPLETED|Overall Study||4
10387936|NCT00641706|11530219|FG000|NOT COMPLETED|Overall Study||9
10387937|NCT00641706|11530220|FG001|NOT COMPLETED|Overall Study||3
10387938|NCT00641719|11530228|FG000|STARTED|Overall Study||129
10387939|NCT00641719|11530229|FG001|STARTED|Overall Study||129
10387940|NCT00641719|11530228|FG000|COMPLETED|Overall Study||99
10387941|NCT00641719|11530229|FG001|COMPLETED|Overall Study|1 participant discontinued during taper phase, not during treatment phase.|92
10718243|NCT02703337|11882042|FG002|STARTED|Period Six (Part A)||5
10718244|NCT02703337|11882043|FG003|STARTED|Period Six (Part A)||5
10387942|NCT00641719|11530228|FG000|NOT COMPLETED|Overall Study||30
10387943|NCT00641719|11530229|FG001|NOT COMPLETED|Overall Study||37
10387944|NCT00641745|11530237|FG000|STARTED|Overall Study||427
10387945|NCT00641745|11530238|FG001|STARTED|Overall Study||202
10387946|NCT00641745|11530237|FG000|COMPLETED|Overall Study||147
10387947|NCT00641745|11530238|FG001|COMPLETED|Overall Study||89
10387948|NCT00641745|11530237|FG000|NOT COMPLETED|Overall Study||280
10387949|NCT00641745|11530238|FG001|NOT COMPLETED|Overall Study||113
10387950|NCT00641797|11530246|FG000|STARTED|Overall Study||11
10387951|NCT00641797|11530247|FG001|STARTED|Overall Study||15
10387952|NCT00641797|11530246|FG000|COMPLETED|Overall Study||11
10387953|NCT00641797|11530247|FG001|COMPLETED|Overall Study||15
10387954|NCT00641797|11530246|FG000|NOT COMPLETED|Overall Study||0
10387955|NCT00641797|11530247|FG001|NOT COMPLETED|Overall Study||0
10718245|NCT02703337|11882044|FG004|STARTED|Period Six (Part A)||4
10387956|NCT00641862|11530255|FG000|STARTED|Overall Study||183
10387957|NCT00641862|11530256|FG001|STARTED|Overall Study||183
10387958|NCT00641862|11530255|FG000|COMPLETED|Overall Study||139
10387959|NCT00641862|11530256|FG001|COMPLETED|Overall Study||145
10387960|NCT00641862|11530255|FG000|NOT COMPLETED|Overall Study||44
10387961|NCT00641862|11530256|FG001|NOT COMPLETED|Overall Study||38
10387962|NCT00642018|11530264|FG000|STARTED|Overall Study||52
10387963|NCT00642018|11530265|FG001|STARTED|Overall Study||102
10387964|NCT00642018|11530264|FG000|Received at Least One Dose of Study Drug|Overall Study||51
10387965|NCT00642018|11530265|FG001|Received at Least One Dose of Study Drug|Overall Study||98
10387966|NCT00642018|11530264|FG000|COMPLETED|Overall Study|Participants who completed 10 cycles of treatment.|24
10387967|NCT00642018|11530265|FG001|COMPLETED|Overall Study|Participants who completed 10 cycles of treatment.|23
10387968|NCT00642018|11530264|FG000|NOT COMPLETED|Overall Study||28
10387969|NCT00642018|11530265|FG001|NOT COMPLETED|Overall Study||79
10387970|NCT00642174|11530274|FG000|STARTED|Period 1 - Initial Drug||18
10387971|NCT00642174|11530275|FG001|STARTED|Period 1 - Initial Drug||17
10387972|NCT00642174|11530274|FG000|COMPLETED|Period 1 - Initial Drug||18
10387973|NCT00642174|11530275|FG001|COMPLETED|Period 1 - Initial Drug||16
10387974|NCT00642174|11530274|FG000|NOT COMPLETED|Period 1 - Initial Drug||0
10387975|NCT00642174|11530275|FG001|NOT COMPLETED|Period 1 - Initial Drug||1
10387976|NCT00642174|11530274|FG000|STARTED|Period 2 - Crossover Drug||18
10387977|NCT00642174|11530275|FG001|STARTED|Period 2 - Crossover Drug||16
10387978|NCT00642174|11530274|FG000|COMPLETED|Period 2 - Crossover Drug||18
10387979|NCT00642174|11530275|FG001|COMPLETED|Period 2 - Crossover Drug||16
10387980|NCT00642174|11530274|FG000|NOT COMPLETED|Period 2 - Crossover Drug||0
10387981|NCT00642174|11530275|FG001|NOT COMPLETED|Period 2 - Crossover Drug||0
10387982|NCT00642278|11530288|FG000|STARTED|Overall Study||65
10387983|NCT00642278|11530289|FG001|STARTED|Overall Study||64
10387984|NCT00642278|11530290|FG002|STARTED|Overall Study||64
10387985|NCT00642278|11530291|FG003|STARTED|Overall Study||65
10387986|NCT00642278|11530292|FG004|STARTED|Overall Study||64
10387987|NCT00642278|11530293|FG005|STARTED|Overall Study||64
10387988|NCT00642278|11530294|FG006|STARTED|Overall Study||65
10387989|NCT00642278|11530288|FG000|COMPLETED|Overall Study||55
10387990|NCT00642278|11530289|FG001|COMPLETED|Overall Study||59
10387991|NCT00642278|11530290|FG002|COMPLETED|Overall Study||59
10387992|NCT00642278|11530291|FG003|COMPLETED|Overall Study||56
10387993|NCT00642278|11530292|FG004|COMPLETED|Overall Study||56
10387994|NCT00642278|11530293|FG005|COMPLETED|Overall Study||57
10541491|NCT01472939|11694690|FG003|NOT COMPLETED|Overall Study||20
10541492|NCT01472965|11694705|FG000|STARTED|Overall Study||49
10541493|NCT01472965|11694706|FG001|STARTED|Overall Study||46
10541494|NCT01472965|11694705|FG000|COMPLETED|Overall Study||48
10541495|NCT01472965|11694706|FG001|COMPLETED|Overall Study||46
10541496|NCT01472965|11694705|FG000|NOT COMPLETED|Overall Study||1
10812708|NCT03360903|11974850|FG000|COMPLETED|Washout (2 Weeks)||4
10812709|NCT03360903|11974851|FG001|COMPLETED|Washout (2 Weeks)||4
10812710|NCT03360903|11974850|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10812711|NCT03360903|11974851|FG001|NOT COMPLETED|Washout (2 Weeks)||0
10812712|NCT03360903|11974850|FG000|STARTED|Second Intervention||4
10812713|NCT03360903|11974851|FG001|STARTED|Second Intervention||4
10812714|NCT03360903|11974850|FG000|COMPLETED|Second Intervention||4
10812715|NCT03360903|11974851|FG001|COMPLETED|Second Intervention||4
10812716|NCT03360903|11974850|FG000|NOT COMPLETED|Second Intervention||0
10812717|NCT03360903|11974851|FG001|NOT COMPLETED|Second Intervention||0
10812718|NCT03359174|11974857|FG000|STARTED|Overall Study||2
10387995|NCT00642278|11530294|FG006|COMPLETED|Overall Study||60
10541497|NCT01472965|11694706|FG001|NOT COMPLETED|Overall Study||0
10541498|NCT01473160|11694712|FG000|STARTED|Overall Study||9
10541499|NCT01473160|11694712|FG000|COMPLETED|Overall Study||9
10541500|NCT01473160|11694712|FG000|NOT COMPLETED|Overall Study||0
10541501|NCT01473355|11694718|FG000|STARTED|Overall Study||45
10541502|NCT01473355|11694718|FG000|COMPLETED|Overall Study||39
10541503|NCT01473355|11694718|FG000|NOT COMPLETED|Overall Study||6
10541504|NCT01473368|11694726|FG000|STARTED|Overall Study||14
10541505|NCT01473368|11694727|FG001|STARTED|Overall Study||12
10812719|NCT03359174|11974857|FG000|COMPLETED|Overall Study||1
10812720|NCT03359174|11974857|FG000|NOT COMPLETED|Overall Study||1
10387996|NCT00642278|11530288|FG000|NOT COMPLETED|Overall Study||10
10387997|NCT00642278|11530289|FG001|NOT COMPLETED|Overall Study||5
10387998|NCT00642278|11530290|FG002|NOT COMPLETED|Overall Study||5
10387999|NCT00642278|11530291|FG003|NOT COMPLETED|Overall Study||9
10388000|NCT00642278|11530292|FG004|NOT COMPLETED|Overall Study||8
10388001|NCT00642278|11530293|FG005|NOT COMPLETED|Overall Study||7
10388002|NCT00642278|11530294|FG006|NOT COMPLETED|Overall Study||5
10388003|NCT00642304|11530310|FG000|STARTED|Overall Study||20
10388004|NCT00642304|11530310|FG000|COMPLETED|Overall Study||14
10388005|NCT00642304|11530310|FG000|NOT COMPLETED|Overall Study||6
10388006|NCT00642356|11530316|FG000|STARTED|Overall Study||7
10388007|NCT00642356|11530317|FG001|STARTED|Overall Study||7
10388008|NCT00642356|11530316|FG000|COMPLETED|Overall Study||5
10388009|NCT00642356|11530317|FG001|COMPLETED|Overall Study||4
10388010|NCT00642356|11530316|FG000|NOT COMPLETED|Overall Study||2
10388011|NCT00642356|11530317|FG001|NOT COMPLETED|Overall Study||3
10388012|NCT00642369|11530325|FG000|STARTED|Overall Study||30
10388013|NCT00642369|11530326|FG001|STARTED|Overall Study||30
10388014|NCT00642369|11530325|FG000|COMPLETED|Overall Study||25
10388015|NCT00642369|11530326|FG001|COMPLETED|Overall Study||24
10388016|NCT00642369|11530325|FG000|NOT COMPLETED|Overall Study||5
10388017|NCT00642369|11530326|FG001|NOT COMPLETED|Overall Study||6
10541506|NCT01473368|11694728|FG002|STARTED|Overall Study||15
10541507|NCT01473368|11694729|FG003|STARTED|Overall Study||12
10541508|NCT01473368|11694726|FG000|COMPLETED|Overall Study||13
10541509|NCT01473368|11694727|FG001|COMPLETED|Overall Study||12
10541510|NCT01473368|11694728|FG002|COMPLETED|Overall Study||12
10388018|NCT00642460|11530336|FG000|STARTED|Part I: 12 Week Double-Blind||37
10388019|NCT00642460|11530337|FG001|STARTED|Part I: 12 Week Double-Blind||38
10388020|NCT00642460|11530338|FG002|STARTED|Part I: 12 Week Double-Blind||37
10388021|NCT00642460|11530339|FG003|STARTED|Part I: 12 Week Double-Blind||0
10388022|NCT00642460|11530340|FG004|STARTED|Part I: 12 Week Double-Blind||0
10388023|NCT00642460|11530341|FG005|STARTED|Part I: 12 Week Double-Blind||0
10388024|NCT00642460|11530336|FG000|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||37
10388025|NCT00642460|11530337|FG001|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||38
10388026|NCT00642460|11530338|FG002|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||37
10388027|NCT00642460|11530339|FG003|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
10388028|NCT00642460|11530340|FG004|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
10388029|NCT00642460|11530341|FG005|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
10388030|NCT00642460|11530336|FG000|COMPLETED|Part I: 12 Week Double-Blind||36
10388031|NCT00642460|11530337|FG001|COMPLETED|Part I: 12 Week Double-Blind||37
10388032|NCT00642460|11530338|FG002|COMPLETED|Part I: 12 Week Double-Blind||36
10388033|NCT00642460|11530339|FG003|COMPLETED|Part I: 12 Week Double-Blind||0
10388034|NCT00642460|11530340|FG004|COMPLETED|Part I: 12 Week Double-Blind||0
10388035|NCT00642460|11530341|FG005|COMPLETED|Part I: 12 Week Double-Blind||0
10388036|NCT00642460|11530336|FG000|NOT COMPLETED|Part I: 12 Week Double-Blind||1
10388037|NCT00642460|11530337|FG001|NOT COMPLETED|Part I: 12 Week Double-Blind||1
10388038|NCT00642460|11530338|FG002|NOT COMPLETED|Part I: 12 Week Double-Blind||1
10541511|NCT01473368|11694729|FG003|COMPLETED|Overall Study||12
10541512|NCT01473368|11694726|FG000|NOT COMPLETED|Overall Study||1
10541513|NCT01473368|11694727|FG001|NOT COMPLETED|Overall Study||0
10541514|NCT01473368|11694728|FG002|NOT COMPLETED|Overall Study||3
10541515|NCT01473368|11694729|FG003|NOT COMPLETED|Overall Study||0
10541516|NCT01473381|11694759|FG000|STARTED|Overall Study||290
10541517|NCT01473381|11694760|FG001|STARTED|Overall Study||292
10541518|NCT01473381|11694761|FG002|STARTED|Overall Study||291
10541519|NCT01473381|11694762|FG003|STARTED|Overall Study||289
10541520|NCT01473381|11694759|FG000|Safety Population|Overall Study||281
10541521|NCT01473381|11694760|FG001|Safety Population|Overall Study||288
10541522|NCT01473381|11694761|FG002|Safety Population|Overall Study||287
10541523|NCT01473381|11694762|FG003|Safety Population|Overall Study||282
10541524|NCT01473381|11694759|FG000|COMPLETED|Overall Study||210
10541525|NCT01473381|11694760|FG001|COMPLETED|Overall Study||199
10541526|NCT01473381|11694761|FG002|COMPLETED|Overall Study||189
10541527|NCT01473381|11694762|FG003|COMPLETED|Overall Study||200
10541528|NCT01473381|11694759|FG000|NOT COMPLETED|Overall Study||80
10541529|NCT01473381|11694760|FG001|NOT COMPLETED|Overall Study||93
10541530|NCT01473381|11694761|FG002|NOT COMPLETED|Overall Study||102
10541531|NCT01473381|11694762|FG003|NOT COMPLETED|Overall Study||89
10541532|NCT01473394|11694775|FG000|STARTED|Overall Study||253
10541533|NCT01473394|11694776|FG001|STARTED|Overall Study||255
10541534|NCT01473394|11694775|FG000|COMPLETED|Overall Study||208
10541535|NCT01473394|11694776|FG001|COMPLETED|Overall Study||212
10541536|NCT01473394|11694775|FG000|NOT COMPLETED|Overall Study||45
10541537|NCT01473394|11694776|FG001|NOT COMPLETED|Overall Study||43
10541538|NCT01473407|11694784|FG000|STARTED|Overall Study||306
10541539|NCT01473407|11694785|FG001|STARTED|Overall Study||306
10541540|NCT01473407|11694784|FG000|COMPLETED|Overall Study||252
10541541|NCT01473407|11694785|FG001|COMPLETED|Overall Study||259
10541542|NCT01473407|11694784|FG000|NOT COMPLETED|Overall Study||54
10541543|NCT01473407|11694785|FG001|NOT COMPLETED|Overall Study||47
10541544|NCT01473420|11694793|FG000|STARTED|Titration Period (18 Weeks)||160
10541545|NCT01473420|11694794|FG001|STARTED|Titration Period (18 Weeks)||160
10541546|NCT01473420|11694793|FG000|Treated|Titration Period (18 Weeks)||80
10541547|NCT01473420|11694794|FG001|Treated|Titration Period (18 Weeks)||86
10541548|NCT01473420|11694793|FG000|COMPLETED|Titration Period (18 Weeks)||124
10541549|NCT01473420|11694794|FG001|COMPLETED|Titration Period (18 Weeks)||122
10541550|NCT01473420|11694793|FG000|NOT COMPLETED|Titration Period (18 Weeks)||36
10541551|NCT01473420|11694794|FG001|NOT COMPLETED|Titration Period (18 Weeks)||38
10541552|NCT01473420|11694793|FG000|STARTED|Maintenance Period (16 Weeks)||124
10541553|NCT01473420|11694794|FG001|STARTED|Maintenance Period (16 Weeks)||122
10541554|NCT01473420|11694793|FG000|COMPLETED|Maintenance Period (16 Weeks)||106
10541555|NCT01473420|11694794|FG001|COMPLETED|Maintenance Period (16 Weeks)||105
10541556|NCT01473420|11694793|FG000|NOT COMPLETED|Maintenance Period (16 Weeks)||18
10541557|NCT01473420|11694794|FG001|NOT COMPLETED|Maintenance Period (16 Weeks)||17
10541558|NCT01473524|11694809|FG000|STARTED|DB Phase||71
10541559|NCT01473524|11694810|FG001|STARTED|DB Phase||73
10541560|NCT01473524|11694811|FG002|STARTED|DB Phase||73
10541561|NCT01473524|11694812|FG003|STARTED|DB Phase||0
10541562|NCT01473524|11694813|FG004|STARTED|DB Phase||0
10541563|NCT01473524|11694814|FG005|STARTED|DB Phase||0
10388039|NCT00642460|11530339|FG003|NOT COMPLETED|Part I: 12 Week Double-Blind||0
10388040|NCT00642460|11530340|FG004|NOT COMPLETED|Part I: 12 Week Double-Blind||0
10388041|NCT00642460|11530341|FG005|NOT COMPLETED|Part I: 12 Week Double-Blind||0
10388042|NCT00642460|11530336|FG000|STARTED|Part II: Open-Label Up to Week 92|Includes Participants who received Open-Label in Part II or Open-Label escape therapy in Part I.|52
10388043|NCT00642460|11530337|FG001|STARTED|Part II: Open-Label Up to Week 92||40
10388044|NCT00642460|11530338|FG002|STARTED|Part II: Open-Label Up to Week 92|Placebo group received open-label Tocilizumab 8 mg/kg or 12 mg/kg based on body weight in Part II.|0
10388045|NCT00642460|11530339|FG003|STARTED|Part II: Open-Label Up to Week 92|19 Participants switched from 12 mg/kg to 8 mg/kg and 1 Participant switched from 8mg/kg to 12 mg/kg|20
10388046|NCT00642460|11530340|FG004|STARTED|Part II: Open-Label Up to Week 92||0
10388047|NCT00642460|11530341|FG005|STARTED|Part II: Open-Label Up to Week 92||0
10388048|NCT00642460|11530336|FG000|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||52
10388049|NCT00642460|11530337|FG001|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||40
10388050|NCT00642460|11530338|FG002|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
10388051|NCT00642460|11530339|FG003|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||20
10388052|NCT00642460|11530340|FG004|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
10388053|NCT00642460|11530341|FG005|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
10388054|NCT00642460|11530336|FG000|COMPLETED|Part II: Open-Label Up to Week 92||43
10388055|NCT00642460|11530337|FG001|COMPLETED|Part II: Open-Label Up to Week 92||32
10388056|NCT00642460|11530338|FG002|COMPLETED|Part II: Open-Label Up to Week 92||0
10388057|NCT00642460|11530339|FG003|COMPLETED|Part II: Open-Label Up to Week 92||17
10388058|NCT00642460|11530340|FG004|COMPLETED|Part II: Open-Label Up to Week 92||0
10388059|NCT00642460|11530341|FG005|COMPLETED|Part II: Open-Label Up to Week 92||0
10388060|NCT00642460|11530336|FG000|NOT COMPLETED|Part II: Open-Label Up to Week 92||9
10388061|NCT00642460|11530337|FG001|NOT COMPLETED|Part II: Open-Label Up to Week 92||8
10388062|NCT00642460|11530338|FG002|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
10388063|NCT00642460|11530339|FG003|NOT COMPLETED|Part II: Open-Label Up to Week 92||3
10388064|NCT00642460|11530340|FG004|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
10388065|NCT00642460|11530341|FG005|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
10388066|NCT00642460|11530336|FG000|STARTED|Part III: Open-Label Up to Week 260||0
10388067|NCT00642460|11530337|FG001|STARTED|Part III: Open-Label Up to Week 260||0
10388068|NCT00642460|11530338|FG002|STARTED|Part III: Open-Label Up to Week 260||0
10388069|NCT00642460|11530339|FG003|STARTED|Part III: Open-Label Up to Week 260||0
10388070|NCT00642460|11530340|FG004|STARTED|Part III: Open-Label Up to Week 260||53
10388071|NCT00642460|11530341|FG005|STARTED|Part III: Open-Label Up to Week 260||59
10388072|NCT00642460|11530336|FG000|COMPLETED|Part III: Open-Label Up to Week 260||0
10388073|NCT00642460|11530337|FG001|COMPLETED|Part III: Open-Label Up to Week 260||0
10388074|NCT00642460|11530338|FG002|COMPLETED|Part III: Open-Label Up to Week 260||0
10388075|NCT00642460|11530339|FG003|COMPLETED|Part III: Open-Label Up to Week 260||0
10388076|NCT00642460|11530340|FG004|COMPLETED|Part III: Open-Label Up to Week 260||28
10388077|NCT00642460|11530341|FG005|COMPLETED|Part III: Open-Label Up to Week 260||38
10388078|NCT00642460|11530336|FG000|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
10388079|NCT00642460|11530337|FG001|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
10388080|NCT00642460|11530338|FG002|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
10388081|NCT00642460|11530339|FG003|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
10388082|NCT00642460|11530340|FG004|NOT COMPLETED|Part III: Open-Label Up to Week 260||25
10388083|NCT00642460|11530341|FG005|NOT COMPLETED|Part III: Open-Label Up to Week 260||21
10388084|NCT00642473|11530353|FG000|STARTED|Overall Study||18
10388085|NCT00642473|11530354|FG001|STARTED|Overall Study||16
10388086|NCT00642473|11530353|FG000|COMPLETED|Overall Study||14
10388087|NCT00642473|11530354|FG001|COMPLETED|Overall Study||5
10388088|NCT00642473|11530353|FG000|NOT COMPLETED|Overall Study||4
10388089|NCT00642473|11530354|FG001|NOT COMPLETED|Overall Study||11
10388090|NCT00642616|11530367|FG000|STARTED|Overall Study||9
10388091|NCT00642616|11530368|FG001|STARTED|Overall Study||8
10388092|NCT00642616|11530369|FG002|STARTED|Overall Study||9
10388093|NCT00642616|11530370|FG003|STARTED|Overall Study||8
10388094|NCT00642616|11530367|FG000|COMPLETED|Overall Study||0
10388095|NCT00642616|11530368|FG001|COMPLETED|Overall Study||1
10388096|NCT00642616|11530369|FG002|COMPLETED|Overall Study||0
10388097|NCT00642616|11530370|FG003|COMPLETED|Overall Study||1
10388098|NCT00642616|11530367|FG000|NOT COMPLETED|Overall Study||9
10388099|NCT00642616|11530368|FG001|NOT COMPLETED|Overall Study||7
10388100|NCT00642616|11530369|FG002|NOT COMPLETED|Overall Study||9
10388101|NCT00642616|11530370|FG003|NOT COMPLETED|Overall Study||7
10388102|NCT00642642|11530382|FG000|STARTED|Biopsy & Product Manufacture||122
10388103|NCT00642642|11530382|FG000|COMPLETED|Biopsy & Product Manufacture|Patients biopsied and for whom study product could be produced are considered completed|109
10388104|NCT00642642|11530382|FG000|NOT COMPLETED|Biopsy & Product Manufacture||13
10388105|NCT00642642|11530382|FG000|STARTED|Treatment & Follow Up||109
10388106|NCT00642642|11530382|FG000|COMPLETED|Treatment & Follow Up||92
10388107|NCT00642642|11530382|FG000|NOT COMPLETED|Treatment & Follow Up||17
10388108|NCT00642668|11530392|FG000|STARTED|Overall Study||35
10388109|NCT00642668|11530392|FG000|COMPLETED|Overall Study||21
10388110|NCT00642668|11530392|FG000|NOT COMPLETED|Overall Study||14
10388111|NCT00642694|11530398|FG000|STARTED|Overall Study||14
10388112|NCT00642694|11530399|FG001|STARTED|Overall Study||15
10388113|NCT00642694|11530398|FG000|COMPLETED|Overall Study||8
10388114|NCT00642694|11530399|FG001|COMPLETED|Overall Study||11
10388115|NCT00642694|11530398|FG000|NOT COMPLETED|Overall Study||6
10388116|NCT00642694|11530399|FG001|NOT COMPLETED|Overall Study||4
10428436|NCT00858117|11574479|FG000|NOT COMPLETED|Follow up for 5 Years||13
10428437|NCT00858130|11574483|FG000|STARTED|Overall Study||12
10428438|NCT00858130|11574483|FG000|COMPLETED|Overall Study||12
10428439|NCT00858130|11574483|FG000|NOT COMPLETED|Overall Study||0
10428440|NCT00858143|11574488|FG000|STARTED|Overall Study|Baseline|311
10428441|NCT00858143|11574488|FG000|COMPLETED|Overall Study||261
10428442|NCT00858143|11574488|FG000|NOT COMPLETED|Overall Study||50
10428443|NCT00858208|11574492|FG000|STARTED|Overall Study||85
10428444|NCT00858208|11574492|FG000|COMPLETED|Overall Study||6
10428445|NCT00858208|11574492|FG000|NOT COMPLETED|Overall Study||79
10428446|NCT00858234|11574496|FG000|STARTED|Overall Study||9
10428447|NCT00858234|11574496|FG000|COMPLETED|Overall Study||0
10428448|NCT00858234|11574496|FG000|NOT COMPLETED|Overall Study||9
10428449|NCT00858247|11574502|FG000|STARTED|Baseline Assessment||25
10428450|NCT00858247|11574503|FG001|STARTED|Baseline Assessment||26
10428451|NCT00858247|11574502|FG000|COMPLETED|Baseline Assessment||23
10718246|NCT02703337|11882045|FG005|STARTED|Period Six (Part A)||5
10718247|NCT02703337|11882046|FG006|STARTED|Period Six (Part A)||0
10718248|NCT02703337|11882047|FG007|STARTED|Period Six (Part A)||0
10718249|NCT02703337|11882040|FG000|Received Study Drug|Period Six (Part A)||5
10718250|NCT02703337|11882041|FG001|Received Study Drug|Period Six (Part A)||5
10718251|NCT02703337|11882042|FG002|Received Study Drug|Period Six (Part A)||5
10718252|NCT02703337|11882043|FG003|Received Study Drug|Period Six (Part A)||5
10718253|NCT02703337|11882044|FG004|Received Study Drug|Period Six (Part A)||4
10718254|NCT02703337|11882045|FG005|Received Study Drug|Period Six (Part A)||5
10306954|NCT00102687|11439883|FG002|NOT COMPLETED|Initial Period||26
10306955|NCT00102687|11439884|FG003|NOT COMPLETED|Initial Period||0
10306956|NCT00102687|11439885|FG004|NOT COMPLETED|Initial Period||0
10306957|NCT00102687|11439881|FG000|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|13
10306958|NCT00102687|11439882|FG001|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|6
10306959|NCT00102687|11439883|FG002|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|8
10306960|NCT00102687|11439884|FG003|STARTED|Maintenance Period|Second randomization to one of two maintenance regimens|22
10306961|NCT00102687|11439885|FG004|STARTED|Maintenance Period|Second randomization to one of two maintenance regimens|21
10306962|NCT00102687|11439881|FG000|COMPLETED|Maintenance Period||6
10306963|NCT00102687|11439882|FG001|COMPLETED|Maintenance Period||2
10306964|NCT00102687|11439883|FG002|COMPLETED|Maintenance Period||2
10428452|NCT00858247|11574503|FG001|COMPLETED|Baseline Assessment||24
10428453|NCT00858247|11574502|FG000|NOT COMPLETED|Baseline Assessment||2
10428454|NCT00858247|11574503|FG001|NOT COMPLETED|Baseline Assessment||2
10428455|NCT00858247|11574502|FG000|STARTED|Week 12 Follow-up||23
10428456|NCT00858247|11574503|FG001|STARTED|Week 12 Follow-up||24
10428457|NCT00858247|11574502|FG000|COMPLETED|Week 12 Follow-up||23
10428458|NCT00858247|11574503|FG001|COMPLETED|Week 12 Follow-up||23
10428459|NCT00858247|11574502|FG000|NOT COMPLETED|Week 12 Follow-up||0
10428460|NCT00858247|11574503|FG001|NOT COMPLETED|Week 12 Follow-up||1
10428461|NCT00858364|11574511|FG000|STARTED|Overall Study||846
10428462|NCT00858364|11574512|FG001|STARTED|Overall Study||1703
10428463|NCT00858364|11574511|FG000|Received Study Drug|Overall Study||837
10388117|NCT00642707|11530409|FG000|STARTED|Overall Study||11
10388118|NCT00642707|11530410|FG001|STARTED|Overall Study||11
10388119|NCT00642707|11530411|FG002|STARTED|Overall Study||12
10388120|NCT00642707|11530412|FG003|STARTED|Overall Study||10
10388121|NCT00642707|11530409|FG000|COMPLETED|Overall Study||10
10388122|NCT00642707|11530410|FG001|COMPLETED|Overall Study||11
10388123|NCT00642707|11530411|FG002|COMPLETED|Overall Study||12
10388124|NCT00642707|11530412|FG003|COMPLETED|Overall Study||8
10388125|NCT00642707|11530409|FG000|NOT COMPLETED|Overall Study||1
10388126|NCT00642707|11530410|FG001|NOT COMPLETED|Overall Study||0
10388127|NCT00642707|11530411|FG002|NOT COMPLETED|Overall Study||0
10388128|NCT00642707|11530412|FG003|NOT COMPLETED|Overall Study||2
10388129|NCT00642746|11530424|FG000|STARTED|Overall Study||10
10388130|NCT00642746|11530425|FG001|STARTED|Overall Study||1
10388131|NCT00642746|11530424|FG000|COMPLETED|Overall Study||9
10388132|NCT00642746|11530425|FG001|COMPLETED|Overall Study||1
10388133|NCT00642746|11530424|FG000|NOT COMPLETED|Overall Study||1
10388134|NCT00642746|11530425|FG001|NOT COMPLETED|Overall Study||0
10388135|NCT00642759|11530431|FG000|STARTED|Overall Study||36
10388136|NCT00642759|11530431|FG000|COMPLETED|Overall Study||35
10388137|NCT00642759|11530431|FG000|NOT COMPLETED|Overall Study||1
10388138|NCT00642772|11530436|FG000|STARTED|Overall Study||24
10388139|NCT00642772|11530436|FG000|COMPLETED|Overall Study||14
10388140|NCT00642772|11530436|FG000|NOT COMPLETED|Overall Study||10
10388141|NCT00642811|11530446|FG000|STARTED|Overall Study||20
10388142|NCT00642811|11530447|FG001|STARTED|Overall Study||21
10388143|NCT00642811|11530448|FG002|STARTED|Overall Study||13
10388144|NCT00642811|11530449|FG003|STARTED|Overall Study||16
10388145|NCT00642811|11530450|FG004|STARTED|Overall Study||14
10541564|NCT01473524|11694809|FG000|Received at Least 1 Dose of Study Drug|DB Phase||70
10541565|NCT01473524|11694810|FG001|Received at Least 1 Dose of Study Drug|DB Phase||73
10541566|NCT01473524|11694811|FG002|Received at Least 1 Dose of Study Drug|DB Phase||73
10541567|NCT01473524|11694812|FG003|Received at Least 1 Dose of Study Drug|DB Phase||0
10541568|NCT01473524|11694813|FG004|Received at Least 1 Dose of Study Drug|DB Phase||0
10541569|NCT01473524|11694814|FG005|Received at Least 1 Dose of Study Drug|DB Phase||0
10541570|NCT01473524|11694809|FG000|COMPLETED|DB Phase||64
10541571|NCT01473524|11694810|FG001|COMPLETED|DB Phase||64
10388146|NCT00642811|11530451|FG005|STARTED|Overall Study||14
10388147|NCT00642811|11530446|FG000|COMPLETED|Overall Study||17
10388148|NCT00642811|11530447|FG001|COMPLETED|Overall Study||17
10388149|NCT00642811|11530448|FG002|COMPLETED|Overall Study||13
10388150|NCT00642811|11530449|FG003|COMPLETED|Overall Study||15
10388151|NCT00642811|11530450|FG004|COMPLETED|Overall Study||13
10388152|NCT00642811|11530451|FG005|COMPLETED|Overall Study||13
10388153|NCT00642811|11530446|FG000|NOT COMPLETED|Overall Study||3
10388154|NCT00642811|11530447|FG001|NOT COMPLETED|Overall Study||4
10388155|NCT00642811|11530448|FG002|NOT COMPLETED|Overall Study||0
10388156|NCT00642811|11530449|FG003|NOT COMPLETED|Overall Study||1
10388157|NCT00642811|11530450|FG004|NOT COMPLETED|Overall Study||1
10388158|NCT00642811|11530451|FG005|NOT COMPLETED|Overall Study||1
10388159|NCT00642850|11530465|FG000|STARTED|Overall Study||188
10388160|NCT00642850|11530465|FG000|COMPLETED|Overall Study||155
10388161|NCT00642850|11530465|FG000|NOT COMPLETED|Overall Study||33
10388162|NCT00642902|11530473|FG000|STARTED|Overall Study||63
10388163|NCT00642902|11530474|FG001|STARTED|Overall Study||63
10388164|NCT00642902|11530475|FG002|STARTED|Overall Study||64
10388165|NCT00642902|11530476|FG003|STARTED|Overall Study||65
10388166|NCT00642902|11530473|FG000|Treated|Overall Study||63
10388167|NCT00642902|11530474|FG001|Treated|Overall Study||63
10388168|NCT00642902|11530475|FG002|Treated|Overall Study||63
10388169|NCT00642902|11530476|FG003|Treated|Overall Study||65
10718255|NCT02703337|11882046|FG006|Received Study Drug|Period Six (Part A)||0
10718256|NCT02703337|11882047|FG007|Received Study Drug|Period Six (Part A)||0
10718257|NCT02703337|11882040|FG000|COMPLETED|Period Six (Part A)||5
10718258|NCT02703337|11882041|FG001|COMPLETED|Period Six (Part A)||5
10718259|NCT02703337|11882042|FG002|COMPLETED|Period Six (Part A)||5
10388170|NCT00642902|11530473|FG000|COMPLETED|Overall Study||23
10388171|NCT00642902|11530474|FG001|COMPLETED|Overall Study||21
10388172|NCT00642902|11530475|FG002|COMPLETED|Overall Study||21
10388173|NCT00642902|11530476|FG003|COMPLETED|Overall Study||25
10388174|NCT00642902|11530473|FG000|NOT COMPLETED|Overall Study||40
10388175|NCT00642902|11530474|FG001|NOT COMPLETED|Overall Study||42
10388176|NCT00642902|11530475|FG002|NOT COMPLETED|Overall Study||43
10388177|NCT00642902|11530476|FG003|NOT COMPLETED|Overall Study||40
10388178|NCT00642941|11530498|FG000|STARTED|Overall Study||70
10388179|NCT00642941|11530499|FG001|STARTED|Overall Study||54
10388180|NCT00642941|11530500|FG002|STARTED|Overall Study||7
10388181|NCT00642941|11530501|FG003|STARTED|Overall Study||40
10388182|NCT00642941|11530502|FG004|STARTED|Overall Study||25
10388183|NCT00642941|11530503|FG005|STARTED|Overall Study||41
10388184|NCT00642941|11530504|FG006|STARTED|Overall Study||23
10388185|NCT00642941|11530505|FG007|STARTED|Overall Study||14
10388186|NCT00642941|11530506|FG008|STARTED|Overall Study||11
10388187|NCT00642941|11530507|FG009|STARTED|Overall Study||9
10388188|NCT00642941|11530508|FG010|STARTED|Overall Study||12
10388189|NCT00642941|11530509|FG011|STARTED|Overall Study||11
10388190|NCT00642941|11530498|FG000|COMPLETED|Overall Study||0
10388191|NCT00642941|11530499|FG001|COMPLETED|Overall Study||0
10388192|NCT00642941|11530500|FG002|COMPLETED|Overall Study||0
10388193|NCT00642941|11530501|FG003|COMPLETED|Overall Study||0
10388194|NCT00642941|11530502|FG004|COMPLETED|Overall Study||0
10388195|NCT00642941|11530503|FG005|COMPLETED|Overall Study||0
10388196|NCT00642941|11530504|FG006|COMPLETED|Overall Study||0
10388197|NCT00642941|11530505|FG007|COMPLETED|Overall Study||0
10388198|NCT00642941|11530506|FG008|COMPLETED|Overall Study||0
10388199|NCT00642941|11530507|FG009|COMPLETED|Overall Study||0
10388200|NCT00642941|11530508|FG010|COMPLETED|Overall Study||0
10388201|NCT00642941|11530509|FG011|COMPLETED|Overall Study||0
10388202|NCT00642941|11530498|FG000|NOT COMPLETED|Overall Study||70
10388203|NCT00642941|11530499|FG001|NOT COMPLETED|Overall Study||54
10388204|NCT00642941|11530500|FG002|NOT COMPLETED|Overall Study||7
10388205|NCT00642941|11530501|FG003|NOT COMPLETED|Overall Study||40
10388206|NCT00642941|11530502|FG004|NOT COMPLETED|Overall Study||25
10388207|NCT00642941|11530503|FG005|NOT COMPLETED|Overall Study||41
10388208|NCT00642941|11530504|FG006|NOT COMPLETED|Overall Study||23
10388209|NCT00642941|11530505|FG007|NOT COMPLETED|Overall Study||14
10388210|NCT00642941|11530506|FG008|NOT COMPLETED|Overall Study||11
10388211|NCT00642941|11530507|FG009|NOT COMPLETED|Overall Study||9
10388212|NCT00642941|11530508|FG010|NOT COMPLETED|Overall Study||12
10388213|NCT00642941|11530509|FG011|NOT COMPLETED|Overall Study||11
10388214|NCT00642954|11530561|FG000|STARTED|Overall Study||4
10388215|NCT00642954|11530562|FG001|STARTED|Overall Study||4
10388216|NCT00642954|11530563|FG002|STARTED|Overall Study||3
10388217|NCT00642954|11530564|FG003|STARTED|Overall Study||3
10388218|NCT00642954|11530565|FG004|STARTED|Overall Study||17
10388219|NCT00642954|11530561|FG000|COMPLETED|Overall Study||0
10388220|NCT00642954|11530562|FG001|COMPLETED|Overall Study||0
10388221|NCT00642954|11530563|FG002|COMPLETED|Overall Study||0
10388222|NCT00642954|11530564|FG003|COMPLETED|Overall Study||0
10388223|NCT00642954|11530565|FG004|COMPLETED|Overall Study||1
10388224|NCT00642954|11530561|FG000|NOT COMPLETED|Overall Study||4
10388225|NCT00642954|11530562|FG001|NOT COMPLETED|Overall Study||4
10388226|NCT00642954|11530563|FG002|NOT COMPLETED|Overall Study||3
10388227|NCT00642954|11530564|FG003|NOT COMPLETED|Overall Study||3
10388228|NCT00642954|11530565|FG004|NOT COMPLETED|Overall Study||16
10388229|NCT00642993|11530579|FG000|STARTED|Overall Study||267
10388230|NCT00642993|11530580|FG001|STARTED|Overall Study||134
10388231|NCT00642993|11530579|FG000|COMPLETED|Overall Study||161
10388232|NCT00642993|11530580|FG001|COMPLETED|Overall Study||118
10388233|NCT00642993|11530579|FG000|NOT COMPLETED|Overall Study||106
10388234|NCT00642993|11530580|FG001|NOT COMPLETED|Overall Study||16
10388235|NCT00643006|11530588|FG000|STARTED|Overall Study||34
10388236|NCT00643006|11530589|FG001|STARTED|Overall Study||33
10388237|NCT00643006|11530588|FG000|COMPLETED|Overall Study||29
10388238|NCT00643006|11530589|FG001|COMPLETED|Overall Study||29
10388239|NCT00643006|11530588|FG000|NOT COMPLETED|Overall Study||5
10388240|NCT00643006|11530589|FG001|NOT COMPLETED|Overall Study||4
10388241|NCT00643097|11530600|FG000|STARTED|Overall Study||18
10388242|NCT00643097|11530601|FG001|STARTED|Overall Study||12
10388243|NCT00643097|11530602|FG002|STARTED|Overall Study||10
10388244|NCT00643097|11530600|FG000|COMPLETED|Overall Study||18
10388245|NCT00643097|11530601|FG001|COMPLETED|Overall Study||12
10388246|NCT00643097|11530602|FG002|COMPLETED|Overall Study||10
10388247|NCT00643097|11530600|FG000|NOT COMPLETED|Overall Study||0
10388248|NCT00643097|11530601|FG001|NOT COMPLETED|Overall Study||0
10388249|NCT00643097|11530602|FG002|NOT COMPLETED|Overall Study||0
10388250|NCT00643123|11530612|FG000|STARTED|Overall Study||15
10388251|NCT00643123|11530613|FG001|STARTED|Overall Study||12
10388252|NCT00643123|11530612|FG000|COMPLETED|Overall Study||10
10388253|NCT00643123|11530613|FG001|COMPLETED|Overall Study||11
10388254|NCT00643123|11530612|FG000|NOT COMPLETED|Overall Study||5
10388255|NCT00643123|11530613|FG001|NOT COMPLETED|Overall Study||1
10388256|NCT00643162|11530621|FG000|STARTED|Overall Study||7
10388257|NCT00643162|11530622|FG001|STARTED|Overall Study||5
10388258|NCT00643162|11530621|FG000|COMPLETED|Overall Study||6
10388259|NCT00643162|11530622|FG001|COMPLETED|Overall Study||4
10388260|NCT00643162|11530621|FG000|NOT COMPLETED|Overall Study||1
10388261|NCT00643162|11530622|FG001|NOT COMPLETED|Overall Study||1
10388262|NCT00643201|11530630|FG000|STARTED|Randomized, Completed 6 Months of Study|15 participants were randomized to treatment but not treated.|2691
10718260|NCT02703337|11882043|FG003|COMPLETED|Period Six (Part A)||5
10718261|NCT02703337|11882044|FG004|COMPLETED|Period Six (Part A)||4
10388263|NCT00643201|11530631|FG001|STARTED|Randomized, Completed 6 Months of Study|15 participants were randomized to treatment but not treated.|2704
10388264|NCT00643201|11530630|FG000|COMPLETED|Randomized, Completed 6 Months of Study||2314
10388265|NCT00643201|11530631|FG001|COMPLETED|Randomized, Completed 6 Months of Study||2291
10718262|NCT02703337|11882045|FG005|COMPLETED|Period Six (Part A)||5
10388266|NCT00643201|11530630|FG000|NOT COMPLETED|Randomized, Completed 6 Months of Study||377
10388267|NCT00643201|11530631|FG001|NOT COMPLETED|Randomized, Completed 6 Months of Study||413
10388268|NCT00643201|11530630|FG000|STARTED|Completed Study Follow Up||2617
10388269|NCT00643201|11530631|FG001|STARTED|Completed Study Follow Up||2639
10388270|NCT00643201|11530630|FG000|COMPLETED|Completed Study Follow Up|Of 70 who did not complete follow up: 7 completed treatment; 63 discontinued treatment|2547
10388271|NCT00643201|11530631|FG001|COMPLETED|Completed Study Follow Up|Of 79 who did not complete follow up: 3 completed treatment, 76 discontinued treatment|2560
10388272|NCT00643201|11530630|FG000|NOT COMPLETED|Completed Study Follow Up||70
10388273|NCT00643201|11530631|FG001|NOT COMPLETED|Completed Study Follow Up||79
10388274|NCT00643279|11530641|FG000|STARTED|Overall Study||134
10388275|NCT00643279|11530642|FG001|STARTED|Overall Study||140
10388276|NCT00643279|11530641|FG000|COMPLETED|Overall Study||118
10388277|NCT00643279|11530642|FG001|COMPLETED|Overall Study||127
10718263|NCT02703337|11882046|FG006|COMPLETED|Period Six (Part A)||0
10718264|NCT02703337|11882047|FG007|COMPLETED|Period Six (Part A)||0
10388278|NCT00643279|11530641|FG000|NOT COMPLETED|Overall Study||16
10388279|NCT00643279|11530642|FG001|NOT COMPLETED|Overall Study||13
10388280|NCT00643448|11530653|FG000|STARTED|Overall Study||21
10388281|NCT00643448|11530654|FG001|STARTED|Overall Study||22
10388282|NCT00643448|11530655|FG002|STARTED|Overall Study||22
10388283|NCT00643448|11530653|FG000|COMPLETED|Overall Study||17
10388284|NCT00643448|11530654|FG001|COMPLETED|Overall Study||17
10388285|NCT00643448|11530655|FG002|COMPLETED|Overall Study||16
10388286|NCT00643448|11530653|FG000|NOT COMPLETED|Overall Study||4
10388287|NCT00643448|11530654|FG001|NOT COMPLETED|Overall Study||5
10388288|NCT00643448|11530655|FG002|NOT COMPLETED|Overall Study||6
10388289|NCT00643487|11530665|FG000|STARTED|Overall Study||8
10388290|NCT00643487|11530665|FG000|COMPLETED|Overall Study||5
10388291|NCT00643487|11530665|FG000|NOT COMPLETED|Overall Study||3
10388292|NCT00643565|11530671|FG000|STARTED|Overall Study||80
10388293|NCT00643565|11530672|FG001|STARTED|Overall Study||74
10388294|NCT00643565|11530671|FG000|COMPLETED|Overall Study||7
10718265|NCT02703337|11882040|FG000|NOT COMPLETED|Period Six (Part A)||0
10718266|NCT02703337|11882041|FG001|NOT COMPLETED|Period Six (Part A)||0
10718267|NCT02703337|11882042|FG002|NOT COMPLETED|Period Six (Part A)||0
10718268|NCT02703337|11882043|FG003|NOT COMPLETED|Period Six (Part A)||0
10718269|NCT02703337|11882044|FG004|NOT COMPLETED|Period Six (Part A)||0
10718270|NCT02703337|11882045|FG005|NOT COMPLETED|Period Six (Part A)||0
10718271|NCT02703337|11882046|FG006|NOT COMPLETED|Period Six (Part A)||0
10718272|NCT02703337|11882047|FG007|NOT COMPLETED|Period Six (Part A)||0
10718273|NCT02703337|11882040|FG000|STARTED|Part B||0
10718274|NCT02703337|11882041|FG001|STARTED|Part B||0
10718275|NCT02703337|11882042|FG002|STARTED|Part B||0
10718276|NCT02703337|11882043|FG003|STARTED|Part B||0
10718277|NCT02703337|11882044|FG004|STARTED|Part B||0
10718278|NCT02703337|11882045|FG005|STARTED|Part B||0
10718279|NCT02703337|11882046|FG006|STARTED|Part B||15
10718280|NCT02703337|11882047|FG007|STARTED|Part B||14
10718281|NCT02703337|11882040|FG000|Received Study Drug|Part B||0
10718282|NCT02703337|11882041|FG001|Received Study Drug|Part B||0
10388295|NCT00643565|11530672|FG001|COMPLETED|Overall Study||7
10388296|NCT00643565|11530671|FG000|NOT COMPLETED|Overall Study||73
10388297|NCT00643565|11530672|FG001|NOT COMPLETED|Overall Study||67
10388298|NCT00643578|11530679|FG000|STARTED|Overall Study||6
10388299|NCT00643578|11530680|FG001|STARTED|Overall Study||6
10388300|NCT00643578|11530679|FG000|COMPLETED|Overall Study||4
10388301|NCT00643578|11530680|FG001|COMPLETED|Overall Study||6
10388302|NCT00643578|11530679|FG000|NOT COMPLETED|Overall Study||2
10388303|NCT00643578|11530680|FG001|NOT COMPLETED|Overall Study||0
10388304|NCT00643604|11530688|FG000|STARTED|Overall Study||7
10388305|NCT00643604|11530688|FG000|COMPLETED|Overall Study||6
10388306|NCT00643604|11530688|FG000|NOT COMPLETED|Overall Study||1
10388307|NCT00643682|11530694|FG000|STARTED|Overall Study||999
10388308|NCT00643682|11530695|FG001|STARTED|Overall Study||1001
10388309|NCT00643682|11530694|FG000|COMPLETED|Overall Study||477
10388310|NCT00643682|11530695|FG001|COMPLETED|Overall Study||492
10388311|NCT00643682|11530694|FG000|NOT COMPLETED|Overall Study||522
10388312|NCT00643682|11530695|FG001|NOT COMPLETED|Overall Study||509
10541572|NCT01473524|11694811|FG002|COMPLETED|DB Phase||70
10541573|NCT01473524|11694812|FG003|COMPLETED|DB Phase||0
10541574|NCT01473524|11694813|FG004|COMPLETED|DB Phase||0
10541575|NCT01473524|11694814|FG005|COMPLETED|DB Phase||0
10541576|NCT01473524|11694809|FG000|NOT COMPLETED|DB Phase||7
10541577|NCT01473524|11694810|FG001|NOT COMPLETED|DB Phase||9
10541578|NCT01473524|11694811|FG002|NOT COMPLETED|DB Phase||3
10541579|NCT01473524|11694812|FG003|NOT COMPLETED|DB Phase||0
10541580|NCT01473524|11694813|FG004|NOT COMPLETED|DB Phase||0
10541581|NCT01473524|11694814|FG005|NOT COMPLETED|DB Phase||0
10541582|NCT01473524|11694809|FG000|STARTED|LTSE Phase||0
10658377|NCT02233478|11819524|FG001|COMPLETED|First Intervention (1 Day)||3
10658378|NCT02233478|11819525|FG002|COMPLETED|First Intervention (1 Day)||3
10658379|NCT02233478|11819526|FG003|COMPLETED|First Intervention (1 Day)||3
10658380|NCT02233478|11819527|FG004|COMPLETED|First Intervention (1 Day)||3
10658381|NCT02233478|11819528|FG005|COMPLETED|First Intervention (1 Day)||3
10658382|NCT02233478|11819523|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10658383|NCT02233478|11819524|FG001|NOT COMPLETED|First Intervention (1 Day)||0
10718283|NCT02703337|11882042|FG002|Received Study Drug|Part B||0
10718284|NCT02703337|11882043|FG003|Received Study Drug|Part B||0
10388313|NCT00643760|11530706|FG000|STARTED|Overall Study||120
10388314|NCT00643760|11530707|FG001|STARTED|Overall Study||62
10388315|NCT00643760|11530708|FG002|STARTED|Overall Study||56
10388316|NCT00643760|11530709|FG003|STARTED|Overall Study||117
10388317|NCT00643760|11530710|FG004|STARTED|Overall Study||66
10541583|NCT01473524|11694810|FG001|STARTED|LTSE Phase||0
10658384|NCT02233478|11819525|FG002|NOT COMPLETED|First Intervention (1 Day)||0
10658385|NCT02233478|11819526|FG003|NOT COMPLETED|First Intervention (1 Day)||0
10388318|NCT00643760|11530706|FG000|Safety Population/Treated With Drug|Overall Study||120
10388319|NCT00643760|11530707|FG001|Safety Population/Treated With Drug|Overall Study||62
10388320|NCT00643760|11530708|FG002|Safety Population/Treated With Drug|Overall Study||56
10388321|NCT00643760|11530709|FG003|Safety Population/Treated With Drug|Overall Study||116
10541584|NCT01473524|11694811|FG002|STARTED|LTSE Phase||0
10718285|NCT02703337|11882044|FG004|Received Study Drug|Part B||0
10718286|NCT02703337|11882045|FG005|Received Study Drug|Part B||0
10718287|NCT02703337|11882046|FG006|Received Study Drug|Part B||15
10718288|NCT02703337|11882047|FG007|Received Study Drug|Part B||14
10718289|NCT02703337|11882040|FG000|COMPLETED|Part B||0
10718290|NCT02703337|11882041|FG001|COMPLETED|Part B||0
10388322|NCT00643760|11530710|FG004|Safety Population/Treated With Drug|Overall Study||66
10388323|NCT00643760|11530706|FG000|ITT Population|Overall Study||120
10388324|NCT00643760|11530707|FG001|ITT Population|Overall Study||62
10388325|NCT00643760|11530708|FG002|ITT Population|Overall Study||56
10388326|NCT00643760|11530709|FG003|ITT Population|Overall Study||116
10388327|NCT00643760|11530710|FG004|ITT Population|Overall Study||66
10388328|NCT00643760|11530706|FG000|COMPLETED|Overall Study||90
10388329|NCT00643760|11530707|FG001|COMPLETED|Overall Study||47
10388330|NCT00643760|11530708|FG002|COMPLETED|Overall Study||37
10388331|NCT00643760|11530709|FG003|COMPLETED|Overall Study||79
10388332|NCT00643760|11530710|FG004|COMPLETED|Overall Study||47
10388333|NCT00643760|11530706|FG000|NOT COMPLETED|Overall Study||30
10388334|NCT00643760|11530707|FG001|NOT COMPLETED|Overall Study||15
10388335|NCT00643760|11530708|FG002|NOT COMPLETED|Overall Study||19
10388336|NCT00643760|11530709|FG003|NOT COMPLETED|Overall Study||38
10388337|NCT00643760|11530710|FG004|NOT COMPLETED|Overall Study||19
10388338|NCT00643851|11530725|FG000|STARTED|Overall Study||194
10388339|NCT00643851|11530726|FG001|STARTED|Overall Study||203
10388340|NCT00643851|11530727|FG002|STARTED|Overall Study||201
10388341|NCT00643851|11530725|FG000|COMPLETED|Overall Study||177
10388342|NCT00643851|11530726|FG001|COMPLETED|Overall Study||170
10388343|NCT00643851|11530727|FG002|COMPLETED|Overall Study||171
10388344|NCT00643851|11530725|FG000|NOT COMPLETED|Overall Study||17
10388345|NCT00643851|11530726|FG001|NOT COMPLETED|Overall Study||33
10388346|NCT00643851|11530727|FG002|NOT COMPLETED|Overall Study||30
10388347|NCT00643916|11530741|FG000|STARTED|Overall Study||55
10388348|NCT00643916|11530742|FG001|STARTED|Overall Study||67
10388349|NCT00643916|11530743|FG002|STARTED|Overall Study||68
10388350|NCT00643916|11530744|FG003|STARTED|Overall Study||62
10388351|NCT00643916|11530745|FG004|STARTED|Overall Study||59
10388352|NCT00643916|11530746|FG005|STARTED|Overall Study||67
10388353|NCT00643916|11530741|FG000|COMPLETED|Overall Study||51
10388354|NCT00643916|11530742|FG001|COMPLETED|Overall Study||61
10388355|NCT00643916|11530743|FG002|COMPLETED|Overall Study||62
10388356|NCT00643916|11530744|FG003|COMPLETED|Overall Study||60
10388357|NCT00643916|11530745|FG004|COMPLETED|Overall Study||57
10388358|NCT00643916|11530746|FG005|COMPLETED|Overall Study||66
10388359|NCT00643916|11530741|FG000|NOT COMPLETED|Overall Study||4
10388360|NCT00643916|11530742|FG001|NOT COMPLETED|Overall Study||6
10388361|NCT00643916|11530743|FG002|NOT COMPLETED|Overall Study||6
10388362|NCT00643916|11530744|FG003|NOT COMPLETED|Overall Study||2
10388363|NCT00643916|11530745|FG004|NOT COMPLETED|Overall Study||2
10388364|NCT00643916|11530746|FG005|NOT COMPLETED|Overall Study||1
10388365|NCT00644059|11530763|FG000|STARTED|Overall Study||2019
10388366|NCT00644059|11530764|FG001|STARTED|Overall Study||1849
10388367|NCT00644059|11530765|FG002|STARTED|Overall Study||1034
10388368|NCT00644059|11530763|FG000|COMPLETED|Overall Study||1895
10388369|NCT00644059|11530764|FG001|COMPLETED|Overall Study||1726
10388370|NCT00644059|11530765|FG002|COMPLETED|Overall Study||969
10388371|NCT00644059|11530763|FG000|NOT COMPLETED|Overall Study||124
10388372|NCT00644059|11530764|FG001|NOT COMPLETED|Overall Study||123
10388373|NCT00644059|11530765|FG002|NOT COMPLETED|Overall Study||65
10388374|NCT00644189|11530814|FG000|STARTED|Phase I||3
10388375|NCT00644189|11530815|FG001|STARTED|Phase I||3
10388376|NCT00644189|11530816|FG002|STARTED|Phase I||6
10718291|NCT02703337|11882042|FG002|COMPLETED|Part B||0
10388377|NCT00644189|11530817|FG003|STARTED|Phase I||18
10388378|NCT00644189|11530814|FG000|COMPLETED|Phase I||3
10388379|NCT00644189|11530815|FG001|COMPLETED|Phase I||3
10388380|NCT00644189|11530816|FG002|COMPLETED|Phase I||6
10388381|NCT00644189|11530817|FG003|COMPLETED|Phase I||18
10388382|NCT00644189|11530814|FG000|NOT COMPLETED|Phase I||0
10388383|NCT00644189|11530815|FG001|NOT COMPLETED|Phase I||0
10388384|NCT00644189|11530816|FG002|NOT COMPLETED|Phase I||0
10388385|NCT00644189|11530817|FG003|NOT COMPLETED|Phase I||0
10388386|NCT00644189|11530814|FG000|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
10388387|NCT00644189|11530815|FG001|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
10718292|NCT02703337|11882043|FG003|COMPLETED|Part B||0
10718293|NCT02703337|11882044|FG004|COMPLETED|Part B||0
10718294|NCT02703337|11882045|FG005|COMPLETED|Part B||0
10388388|NCT00644189|11530816|FG002|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
10388389|NCT00644189|11530817|FG003|STARTED|Phase II|Additional participants were added to the phase I sample at the phase II 3mg dose level|50
10388390|NCT00644189|11530814|FG000|Completed All 6 Cycles of Treatment|Phase II||0
10388391|NCT00644189|11530815|FG001|Completed All 6 Cycles of Treatment|Phase II||0
10388392|NCT00644189|11530816|FG002|Completed All 6 Cycles of Treatment|Phase II||0
10388393|NCT00644189|11530817|FG003|Completed All 6 Cycles of Treatment|Phase II||19
10388394|NCT00644189|11530814|FG000|COMPLETED|Phase II||0
10388395|NCT00644189|11530815|FG001|COMPLETED|Phase II||0
10388396|NCT00644189|11530816|FG002|COMPLETED|Phase II||0
10388397|NCT00644189|11530817|FG003|COMPLETED|Phase II||50
10388398|NCT00644189|11530814|FG000|NOT COMPLETED|Phase II||0
10388399|NCT00644189|11530815|FG001|NOT COMPLETED|Phase II||0
10388400|NCT00644189|11530816|FG002|NOT COMPLETED|Phase II||0
10388401|NCT00644189|11530817|FG003|NOT COMPLETED|Phase II||0
10388408|NCT00644332|11530832|FG000|STARTED|Overall Study|172 patients were enrolled; one withdrew consent prior to starting treatment|171
10388409|NCT00644332|11530832|FG000|COMPLETED|Overall Study||150
10388410|NCT00644332|11530832|FG000|NOT COMPLETED|Overall Study||21
10388411|NCT00644358|11530836|FG000|STARTED|Overall Study||616
10388412|NCT00644358|11530836|FG000|COMPLETED|Overall Study||254
10388413|NCT00644358|11530836|FG000|NOT COMPLETED|Overall Study||362
10388414|NCT00644423|11530842|FG000|STARTED|Overall Study||6
10388415|NCT00644423|11530843|FG001|STARTED|Overall Study||5
10541585|NCT01473524|11694812|FG003|STARTED|LTSE Phase|One participant in the double-blind OCA 5-10 mg group did not enroll in the LTSE phase.|63
10541586|NCT01473524|11694813|FG004|STARTED|LTSE Phase||64
10541587|NCT01473524|11694814|FG005|STARTED|LTSE Phase|Four participants in the double-blind placebo group did not enroll in the LTSE phase.|66
10541588|NCT01473524|11694809|FG000|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||0
10548214|NCT01518153|11702014|FG002|NOT COMPLETED|Donor Lymphocyte Infusion||1
10718295|NCT02703337|11882046|FG006|COMPLETED|Part B||15
10718296|NCT02703337|11882047|FG007|COMPLETED|Part B||14
10718297|NCT02703337|11882040|FG000|NOT COMPLETED|Part B||0
10388416|NCT00644423|11530842|FG000|COMPLETED|Overall Study||5
10388417|NCT00644423|11530843|FG001|COMPLETED|Overall Study||4
10388418|NCT00644423|11530842|FG000|NOT COMPLETED|Overall Study||1
10388419|NCT00644423|11530843|FG001|NOT COMPLETED|Overall Study||1
10388420|NCT00644592|11530851|FG000|STARTED|Overall Study||5
10388421|NCT00644592|11530852|FG001|STARTED|Overall Study||6
10388422|NCT00644592|11530851|FG000|COMPLETED|Overall Study||5
10388423|NCT00644592|11530852|FG001|COMPLETED|Overall Study||6
10388424|NCT00644592|11530851|FG000|NOT COMPLETED|Overall Study||0
10388425|NCT00644592|11530852|FG001|NOT COMPLETED|Overall Study||0
10388426|NCT00644657|11530858|FG000|STARTED|Overall Study||27
10388427|NCT00644657|11530858|FG000|COMPLETED|Overall Study||27
10388428|NCT00644657|11530858|FG000|NOT COMPLETED|Overall Study||0
10388429|NCT00644787|11530862|FG000|STARTED|Period 1: Titration Phase||156
10388430|NCT00644787|11530863|FG001|STARTED|Period 1: Titration Phase||0
10388431|NCT00644787|11530864|FG002|STARTED|Period 1: Titration Phase||0
10388432|NCT00644787|11530862|FG000|COMPLETED|Period 1: Titration Phase||129
10388433|NCT00644787|11530863|FG001|COMPLETED|Period 1: Titration Phase||0
10388434|NCT00644787|11530864|FG002|COMPLETED|Period 1: Titration Phase||0
10388435|NCT00644787|11530862|FG000|NOT COMPLETED|Period 1: Titration Phase||27
10388436|NCT00644787|11530863|FG001|NOT COMPLETED|Period 1: Titration Phase||0
10388437|NCT00644787|11530864|FG002|NOT COMPLETED|Period 1: Titration Phase||0
10388438|NCT00644787|11530862|FG000|STARTED|Period 2: Double Blind Phase||0
10388439|NCT00644787|11530863|FG001|STARTED|Period 2: Double Blind Phase||58
10388440|NCT00644787|11530864|FG002|STARTED|Period 2: Double Blind Phase||62
10388441|NCT00644787|11530862|FG000|COMPLETED|Period 2: Double Blind Phase||0
10388442|NCT00644787|11530863|FG001|COMPLETED|Period 2: Double Blind Phase||49
10388443|NCT00644787|11530864|FG002|COMPLETED|Period 2: Double Blind Phase||55
10718298|NCT02703337|11882041|FG001|NOT COMPLETED|Part B||0
10388444|NCT00644787|11530862|FG000|NOT COMPLETED|Period 2: Double Blind Phase||0
10388445|NCT00644787|11530863|FG001|NOT COMPLETED|Period 2: Double Blind Phase||9
10388446|NCT00644787|11530864|FG002|NOT COMPLETED|Period 2: Double Blind Phase||7
10388447|NCT00644878|11530872|FG000|STARTED|Overall Study||18
10388448|NCT00644878|11530872|FG000|COMPLETED|Overall Study||0
10388449|NCT00644878|11530872|FG000|NOT COMPLETED|Overall Study||18
10388450|NCT00644917|11530876|FG000|STARTED|Overall Study||38
10388451|NCT00644917|11530876|FG000|COMPLETED|Overall Study||36
10388452|NCT00644917|11530876|FG000|NOT COMPLETED|Overall Study||2
10388453|NCT00644969|11530886|FG000|STARTED|Treatment Phase||85
10388454|NCT00644969|11530887|FG001|STARTED|Treatment Phase||43
10388455|NCT00644969|11530886|FG000|COMPLETED|Treatment Phase||71
10388456|NCT00644969|11530887|FG001|COMPLETED|Treatment Phase||40
10388457|NCT00644969|11530886|FG000|NOT COMPLETED|Treatment Phase||14
10388458|NCT00644969|11530887|FG001|NOT COMPLETED|Treatment Phase||3
10388459|NCT00644969|11530886|FG000|STARTED|Post Treatment Phase||71
10388460|NCT00644969|11530887|FG001|STARTED|Post Treatment Phase||40
10388461|NCT00644969|11530886|FG000|COMPLETED|Post Treatment Phase||61
10388462|NCT00644969|11530887|FG001|COMPLETED|Post Treatment Phase||37
10388463|NCT00644969|11530886|FG000|NOT COMPLETED|Post Treatment Phase||10
10388464|NCT00644969|11530887|FG001|NOT COMPLETED|Post Treatment Phase||3
10388465|NCT00644995|11530895|FG000|STARTED|Overall Study||25
10388466|NCT00644995|11530896|FG001|STARTED|Overall Study||27
10388467|NCT00644995|11530895|FG000|Completed 4 Month Assessment|Overall Study||23
10388468|NCT00644995|11530896|FG001|Completed 4 Month Assessment|Overall Study||24
10388469|NCT00644995|11530895|FG000|COMPLETED|Overall Study|Completed 6 month assessment|23
10388470|NCT00644995|11530896|FG001|COMPLETED|Overall Study||23
10388471|NCT00644995|11530895|FG000|NOT COMPLETED|Overall Study||2
10388472|NCT00644995|11530896|FG001|NOT COMPLETED|Overall Study||4
10388473|NCT00645047|11530906|FG000|STARTED|Overall Study||103
10388474|NCT00645047|11530907|FG001|STARTED|Overall Study||104
10388475|NCT00645047|11530906|FG000|Post|Overall Study||74
10388476|NCT00645047|11530907|FG001|Post|Overall Study||80
10388477|NCT00645047|11530906|FG000|COMPLETED|Overall Study|6 month follow up|60
10388478|NCT00645047|11530907|FG001|COMPLETED|Overall Study||65
10388479|NCT00645047|11530906|FG000|NOT COMPLETED|Overall Study||43
10388480|NCT00645047|11530907|FG001|NOT COMPLETED|Overall Study||39
10388481|NCT00645099|11530915|FG000|STARTED|Overall Study||239
10388482|NCT00645099|11530916|FG001|STARTED|Overall Study||220
10388483|NCT00645099|11530915|FG000|COMPLETED|Overall Study||168
10388484|NCT00645099|11530916|FG001|COMPLETED|Overall Study||178
10388485|NCT00645099|11530915|FG000|NOT COMPLETED|Overall Study||71
10388486|NCT00645099|11530916|FG001|NOT COMPLETED|Overall Study||42
10388487|NCT00645164|11530922|FG000|STARTED|Overall Study||59
10388488|NCT00645164|11530922|FG000|COMPLETED|Overall Study||52
10388489|NCT00645164|11530922|FG000|NOT COMPLETED|Overall Study||7
10388490|NCT00645333|11530926|FG000|STARTED|Overall Study||30
10388491|NCT00645333|11530926|FG000|COMPLETED|Overall Study||30
10388492|NCT00645333|11530926|FG000|NOT COMPLETED|Overall Study||0
10388493|NCT00645411|11530934|FG000|STARTED|Overall Study||656
10388494|NCT00645411|11530935|FG001|STARTED|Overall Study||318
10388495|NCT00645411|11530936|FG002|STARTED|Overall Study||1608
10388496|NCT00645411|11530937|FG003|STARTED|Overall Study||1022
10388497|NCT00645411|11530934|FG000|COMPLETED|Overall Study||643
10541589|NCT01473524|11694810|FG001|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||0
10541590|NCT01473524|11694811|FG002|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||0
10541591|NCT01473524|11694812|FG003|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||63
10658386|NCT02233478|11819527|FG004|NOT COMPLETED|First Intervention (1 Day)||0
10541592|NCT01473524|11694813|FG004|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||64
10541593|NCT01473524|11694814|FG005|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||66
10541594|NCT01473524|11694809|FG000|COMPLETED|LTSE Phase||0
10541595|NCT01473524|11694810|FG001|COMPLETED|LTSE Phase||0
10541596|NCT01473524|11694811|FG002|COMPLETED|LTSE Phase||0
10541597|NCT01473524|11694812|FG003|COMPLETED|LTSE Phase||54
10658387|NCT02233478|11819528|FG005|NOT COMPLETED|First Intervention (1 Day)||0
10388498|NCT00645411|11530935|FG001|COMPLETED|Overall Study||312
10388499|NCT00645411|11530936|FG002|COMPLETED|Overall Study||1457
10388500|NCT00645411|11530937|FG003|COMPLETED|Overall Study||919
10388501|NCT00645411|11530934|FG000|NOT COMPLETED|Overall Study||13
10388502|NCT00645411|11530935|FG001|NOT COMPLETED|Overall Study||6
10388503|NCT00645411|11530936|FG002|NOT COMPLETED|Overall Study||151
10388504|NCT00645411|11530937|FG003|NOT COMPLETED|Overall Study||103
10388505|NCT00645450|11530956|FG000|STARTED|Overall Study||5
10388506|NCT00645450|11530957|FG001|STARTED|Overall Study||4
10388507|NCT00645450|11530956|FG000|COMPLETED|Overall Study||5
10388508|NCT00645450|11530957|FG001|COMPLETED|Overall Study||4
10388509|NCT00645450|11530956|FG000|NOT COMPLETED|Overall Study||0
10388510|NCT00645450|11530957|FG001|NOT COMPLETED|Overall Study||0
10388511|NCT00645528|11530963|FG000|STARTED|Overall Study||39
10388512|NCT00645528|11530963|FG000|COMPLETED|Overall Study||32
10388513|NCT00645528|11530963|FG000|NOT COMPLETED|Overall Study||7
10388514|NCT00645593|11530969|FG000|STARTED|Overall Study||29
10388515|NCT00645593|11530970|FG001|STARTED|Overall Study||60
10388516|NCT00645593|11530969|FG000|COMPLETED|Overall Study||28
10388517|NCT00645593|11530970|FG001|COMPLETED|Overall Study||60
10388518|NCT00645593|11530969|FG000|NOT COMPLETED|Overall Study||1
10388519|NCT00645593|11530970|FG001|NOT COMPLETED|Overall Study||0
10388520|NCT00645671|11530978|FG000|STARTED|Overall Study||201
10388521|NCT00645671|11530979|FG001|STARTED|Overall Study||199
10388522|NCT00645671|11530978|FG000|COMPLETED|Overall Study||200
10388523|NCT00645671|11530979|FG001|COMPLETED|Overall Study||193
10388524|NCT00645671|11530978|FG000|NOT COMPLETED|Overall Study||1
10388525|NCT00645671|11530979|FG001|NOT COMPLETED|Overall Study||6
10388526|NCT00645710|11530988|FG000|STARTED|Overall Study||3
10718299|NCT02703337|11882042|FG002|NOT COMPLETED|Part B||0
10718300|NCT02703337|11882043|FG003|NOT COMPLETED|Part B||0
10718301|NCT02703337|11882044|FG004|NOT COMPLETED|Part B||0
10388527|NCT00645710|11530989|FG001|STARTED|Overall Study||3
10388528|NCT00645710|11530990|FG002|STARTED|Overall Study||10
10658388|NCT02233478|11819523|FG000|STARTED|Washout (7 Days)||3
10658389|NCT02233478|11819524|FG001|STARTED|Washout (7 Days)||3
10658390|NCT02233478|11819525|FG002|STARTED|Washout (7 Days)||3
10658391|NCT02233478|11819526|FG003|STARTED|Washout (7 Days)||3
10658392|NCT02233478|11819527|FG004|STARTED|Washout (7 Days)||3
10658393|NCT02233478|11819528|FG005|STARTED|Washout (7 Days)||3
10388529|NCT00645710|11530988|FG000|COMPLETED|Overall Study||3
10388530|NCT00645710|11530989|FG001|COMPLETED|Overall Study||3
10388531|NCT00645710|11530990|FG002|COMPLETED|Overall Study||10
10388532|NCT00645710|11530988|FG000|NOT COMPLETED|Overall Study||0
10388533|NCT00645710|11530989|FG001|NOT COMPLETED|Overall Study||0
10388534|NCT00645710|11530990|FG002|NOT COMPLETED|Overall Study||0
10388535|NCT00645762|11530999|FG000|STARTED|Overall Study||71
10388536|NCT00645762|11530999|FG000|COMPLETED|Overall Study||67
10388537|NCT00645762|11530999|FG000|NOT COMPLETED|Overall Study||4
10388538|NCT00645788|11531009|FG000|STARTED|Overall Study||94
10388539|NCT00645788|11531010|FG001|STARTED|Overall Study||94
10388540|NCT00645788|11531011|FG002|STARTED|Overall Study||65
10388541|NCT00645788|11531012|FG003|STARTED|Overall Study||35
10388542|NCT00645788|11531009|FG000|Participants Receive Treatment|Overall Study||93
10388543|NCT00645788|11531010|FG001|Participants Receive Treatment|Overall Study||93
10388544|NCT00645788|11531011|FG002|Participants Receive Treatment|Overall Study||65
10388545|NCT00645788|11531012|FG003|Participants Receive Treatment|Overall Study||35
10388546|NCT00645788|11531009|FG000|COMPLETED|Overall Study||74
10388547|NCT00645788|11531010|FG001|COMPLETED|Overall Study||67
10388548|NCT00645788|11531011|FG002|COMPLETED|Overall Study||47
10388549|NCT00645788|11531012|FG003|COMPLETED|Overall Study||21
10388550|NCT00645788|11531009|FG000|NOT COMPLETED|Overall Study||20
10718302|NCT02703337|11882045|FG005|NOT COMPLETED|Part B||0
10718303|NCT02703337|11882046|FG006|NOT COMPLETED|Part B||0
10658394|NCT02233478|11819523|FG000|COMPLETED|Washout (7 Days)||3
10658395|NCT02233478|11819524|FG001|COMPLETED|Washout (7 Days)||3
10658396|NCT02233478|11819525|FG002|COMPLETED|Washout (7 Days)||3
10658397|NCT02233478|11819526|FG003|COMPLETED|Washout (7 Days)||3
10658398|NCT02233478|11819527|FG004|COMPLETED|Washout (7 Days)||3
10658399|NCT02233478|11819528|FG005|COMPLETED|Washout (7 Days)||3
10718304|NCT02703337|11882047|FG007|NOT COMPLETED|Part B||0
10718305|NCT02703350|11882065|FG000|STARTED|Period One (Part A)||5
10718306|NCT02703350|11882066|FG001|STARTED|Period One (Part A)||5
10388551|NCT00645788|11531010|FG001|NOT COMPLETED|Overall Study||27
10388552|NCT00645788|11531011|FG002|NOT COMPLETED|Overall Study||18
10388553|NCT00645788|11531012|FG003|NOT COMPLETED|Overall Study||14
10388554|NCT00645827|11531024|FG000|STARTED|Overall Study||14
10388555|NCT00645827|11531025|FG001|STARTED|Overall Study||17
10388556|NCT00645827|11531024|FG000|COMPLETED|Overall Study||14
10388557|NCT00645827|11531025|FG001|COMPLETED|Overall Study||17
10388558|NCT00645827|11531024|FG000|NOT COMPLETED|Overall Study||0
10388559|NCT00645827|11531025|FG001|NOT COMPLETED|Overall Study||0
10388560|NCT00645840|11531031|FG000|STARTED|Overall Study||15
10718307|NCT02703350|11882067|FG002|STARTED|Period One (Part A)||5
10718308|NCT02703350|11882068|FG003|STARTED|Period One (Part A)||5
10388561|NCT00645840|11531031|FG000|COMPLETED|Overall Study||12
10388562|NCT00645840|11531031|FG000|NOT COMPLETED|Overall Study||3
10388563|NCT00645853|11531037|FG000|STARTED|Overall Study||288
10388564|NCT00645853|11531038|FG001|STARTED|Overall Study||235
10388565|NCT00645853|11531037|FG000|No of Patients After Dose Switch|Overall Study|All patients in the AZD0837 arm switched from their initial doses, to a general dose of 300 mg od|209
10388566|NCT00645853|11531038|FG001|No of Patients After Dose Switch|Overall Study|No changes for VKA patients|188
10388567|NCT00645853|11531037|FG000|Discontinued Patient No Due to Closure|Overall Study|No of patients discontinued due the study termination caused tablet formulation stability problems|196
10388568|NCT00645853|11531038|FG001|Discontinued Patient No Due to Closure|Overall Study|No of patients discontinued due the study termination caused tablet formulation stability problems|178
10388569|NCT00645853|11531037|FG000|AZ Study Closure in Hungary|Overall Study||60
10388570|NCT00645853|11531038|FG001|AZ Study Closure in Hungary|Overall Study||40
10388571|NCT00645853|11531037|FG000|COMPLETED|Overall Study||196
10718309|NCT02703350|11882069|FG004|STARTED|Period One (Part A)||5
10718310|NCT02703350|11882070|FG005|STARTED|Period One (Part A)||5
10718311|NCT02703350|11882071|FG006|STARTED|Period One (Part A)||0
10718312|NCT02703350|11882072|FG007|STARTED|Period One (Part A)||0
10718313|NCT02703350|11882065|FG000|Received Study Drug|Period One (Part A)||5
10718314|NCT02703350|11882066|FG001|Received Study Drug|Period One (Part A)||5
10718315|NCT02703350|11882067|FG002|Received Study Drug|Period One (Part A)||5
10718316|NCT02703350|11882068|FG003|Received Study Drug|Period One (Part A)||5
10718317|NCT02703350|11882069|FG004|Received Study Drug|Period One (Part A)||5
10388572|NCT00645853|11531038|FG001|COMPLETED|Overall Study||178
10388573|NCT00645853|11531037|FG000|NOT COMPLETED|Overall Study||92
10388574|NCT00645853|11531038|FG001|NOT COMPLETED|Overall Study||57
10388575|NCT00645944|11531046|FG000|STARTED|Randomized||20
10388576|NCT00645944|11531047|FG001|STARTED|Randomized||19
10388577|NCT00645944|11531046|FG000|COMPLETED|Randomized||19
10388578|NCT00645944|11531047|FG001|COMPLETED|Randomized||17
10388579|NCT00645944|11531046|FG000|NOT COMPLETED|Randomized||1
10388580|NCT00645944|11531047|FG001|NOT COMPLETED|Randomized||2
10388581|NCT00645944|11531046|FG000|STARTED|Received Medication||19
10388582|NCT00645944|11531047|FG001|STARTED|Received Medication||17
10388583|NCT00645944|11531046|FG000|COMPLETED|Received Medication||13
10388584|NCT00645944|11531047|FG001|COMPLETED|Received Medication||14
10718318|NCT02703350|11882070|FG005|Received Study Drug|Period One (Part A)||5
10718319|NCT02703350|11882071|FG006|Received Study Drug|Period One (Part A)||0
10388585|NCT00645944|11531046|FG000|NOT COMPLETED|Received Medication||6
10388586|NCT00645944|11531047|FG001|NOT COMPLETED|Received Medication||3
10388587|NCT00645970|11531055|FG000|STARTED|Overall Study||141
10388588|NCT00645970|11531056|FG001|STARTED|Overall Study||218
10388589|NCT00645970|11531055|FG000|6 Months|Overall Study||58
10388590|NCT00645970|11531056|FG001|6 Months|Overall Study||97
10388591|NCT00645970|11531055|FG000|1 Year|Overall Study||37
10388592|NCT00645970|11531056|FG001|1 Year|Overall Study||42
10388593|NCT00645970|11531055|FG000|COMPLETED|Overall Study||32
10388594|NCT00645970|11531056|FG001|COMPLETED|Overall Study||32
10388595|NCT00645970|11531055|FG000|NOT COMPLETED|Overall Study||109
10388596|NCT00645970|11531056|FG001|NOT COMPLETED|Overall Study||186
10388597|NCT00646048|11531062|FG000|STARTED|Overall Study||43
10388598|NCT00646048|11531062|FG000|COMPLETED|Overall Study||27
10388599|NCT00646048|11531062|FG000|NOT COMPLETED|Overall Study||16
10388600|NCT00646113|11531066|FG000|STARTED|Overall Study|3 of the 72 enrolled participants were excluded before surgery.|69
10388601|NCT00646113|11531066|FG000|COMPLETED|Overall Study||61
10388602|NCT00646113|11531066|FG000|NOT COMPLETED|Overall Study||8
10388603|NCT00646399|11531072|FG000|STARTED|Overall Study||792
10388604|NCT00646399|11531073|FG001|STARTED|Overall Study||787
10388605|NCT00646399|11531072|FG000|COMPLETED|Overall Study||709
10388606|NCT00646399|11531073|FG001|COMPLETED|Overall Study||713
10388607|NCT00646399|11531072|FG000|NOT COMPLETED|Overall Study||83
10388608|NCT00646399|11531073|FG001|NOT COMPLETED|Overall Study||74
10388609|NCT00646451|11531079|FG000|STARTED|Overall Study||10
10388610|NCT00646451|11531080|FG001|STARTED|Overall Study||10
10388611|NCT00646451|11531079|FG000|COMPLETED|Overall Study||6
10388612|NCT00646451|11531080|FG001|COMPLETED|Overall Study||10
10388613|NCT00646451|11531079|FG000|NOT COMPLETED|Overall Study||4
10388614|NCT00646451|11531080|FG001|NOT COMPLETED|Overall Study||0
10388615|NCT00646581|11531090|FG000|STARTED|Overall Study||15
10388616|NCT00646581|11531091|FG001|STARTED|Overall Study||15
10388617|NCT00646581|11531090|FG000|COMPLETED|Overall Study||15
10388618|NCT00646581|11531091|FG001|COMPLETED|Overall Study||15
10388619|NCT00646581|11531090|FG000|NOT COMPLETED|Overall Study||0
10388620|NCT00646581|11531091|FG001|NOT COMPLETED|Overall Study||0
10388621|NCT00646646|11531101|FG000|STARTED|Overall Study||15
10388622|NCT00646646|11531102|FG001|STARTED|Overall Study||15
10388623|NCT00646646|11531103|FG002|STARTED|Overall Study||15
10388624|NCT00646646|11531104|FG003|STARTED|Overall Study||20
10388625|NCT00646646|11531101|FG000|COMPLETED|Overall Study||15
10388626|NCT00646646|11531102|FG001|COMPLETED|Overall Study||15
10388627|NCT00646646|11531103|FG002|COMPLETED|Overall Study||15
10388628|NCT00646646|11531104|FG003|COMPLETED|Overall Study||20
10388629|NCT00646646|11531101|FG000|NOT COMPLETED|Overall Study||0
10388630|NCT00646646|11531102|FG001|NOT COMPLETED|Overall Study||0
10388631|NCT00646646|11531103|FG002|NOT COMPLETED|Overall Study||0
10388632|NCT00646646|11531104|FG003|NOT COMPLETED|Overall Study||0
10388633|NCT00646763|11531116|FG000|STARTED|Overall Study||18
10388634|NCT00646763|11531117|FG001|STARTED|Overall Study||17
10388635|NCT00646763|11531116|FG000|COMPLETED|Overall Study||18
10388636|NCT00646763|11531117|FG001|COMPLETED|Overall Study||17
10388637|NCT00646763|11531116|FG000|NOT COMPLETED|Overall Study||0
10388638|NCT00646763|11531117|FG001|NOT COMPLETED|Overall Study||0
10388639|NCT00646776|11531125|FG000|STARTED|Overall Study|Treated on Day 1|15
10388640|NCT00646776|11531126|FG001|STARTED|Overall Study|Treated on Day 1|18
10388641|NCT00646776|11531125|FG000|COMPLETED|Overall Study||14
10388642|NCT00646776|11531126|FG001|COMPLETED|Overall Study||5
10388643|NCT00646776|11531125|FG000|NOT COMPLETED|Overall Study||1
10388644|NCT00646776|11531126|FG001|NOT COMPLETED|Overall Study||13
10388645|NCT00646906|11531139|FG000|STARTED|Crossover Period 1||9
10388646|NCT00646906|11531140|FG001|STARTED|Crossover Period 1||9
10388647|NCT00646906|11531141|FG002|STARTED|Crossover Period 1||10
10388648|NCT00646906|11531142|FG003|STARTED|Crossover Period 1||9
10388649|NCT00646906|11531143|FG004|STARTED|Crossover Period 1||8
10388650|NCT00646906|11531144|FG005|STARTED|Crossover Period 1||5
10388651|NCT00646906|11531145|FG006|STARTED|Crossover Period 1||5
10388652|NCT00646906|11531139|FG000|COMPLETED|Crossover Period 1||8
10388653|NCT00646906|11531140|FG001|COMPLETED|Crossover Period 1||9
10388654|NCT00646906|11531141|FG002|COMPLETED|Crossover Period 1||10
10388655|NCT00646906|11531142|FG003|COMPLETED|Crossover Period 1||9
10388656|NCT00646906|11531143|FG004|COMPLETED|Crossover Period 1|Phase 1b had only one treatment period and no crossover. Phase 1b ended here.|8
10388657|NCT00646906|11531144|FG005|COMPLETED|Crossover Period 1||4
10388658|NCT00646906|11531145|FG006|COMPLETED|Crossover Period 1||5
10388659|NCT00646906|11531139|FG000|NOT COMPLETED|Crossover Period 1||1
10388660|NCT00646906|11531140|FG001|NOT COMPLETED|Crossover Period 1||0
10388661|NCT00646906|11531141|FG002|NOT COMPLETED|Crossover Period 1||0
10388662|NCT00646906|11531142|FG003|NOT COMPLETED|Crossover Period 1||0
10388663|NCT00646906|11531143|FG004|NOT COMPLETED|Crossover Period 1||0
10388664|NCT00646906|11531144|FG005|NOT COMPLETED|Crossover Period 1||1
10388665|NCT00646906|11531145|FG006|NOT COMPLETED|Crossover Period 1||0
10388666|NCT00646906|11531139|FG000|STARTED|Washout (>/= 14 Days)||8
10388667|NCT00646906|11531140|FG001|STARTED|Washout (>/= 14 Days)||9
10388668|NCT00646906|11531141|FG002|STARTED|Washout (>/= 14 Days)||10
10388669|NCT00646906|11531142|FG003|STARTED|Washout (>/= 14 Days)||9
10388670|NCT00646906|11531143|FG004|STARTED|Washout (>/= 14 Days)|Phase 1b had only one treatment period and no crossover.|0
10388671|NCT00646906|11531144|FG005|STARTED|Washout (>/= 14 Days)||4
10388672|NCT00646906|11531145|FG006|STARTED|Washout (>/= 14 Days)||5
10388673|NCT00646906|11531139|FG000|COMPLETED|Washout (>/= 14 Days)||8
10388674|NCT00646906|11531140|FG001|COMPLETED|Washout (>/= 14 Days)||9
10388675|NCT00646906|11531141|FG002|COMPLETED|Washout (>/= 14 Days)||10
10388676|NCT00646906|11531142|FG003|COMPLETED|Washout (>/= 14 Days)||9
10388677|NCT00646906|11531143|FG004|COMPLETED|Washout (>/= 14 Days)|Phase 1b had only one treatment period and no crossover.|0
10388678|NCT00646906|11531144|FG005|COMPLETED|Washout (>/= 14 Days)||4
10388679|NCT00646906|11531145|FG006|COMPLETED|Washout (>/= 14 Days)||5
10388680|NCT00646906|11531139|FG000|NOT COMPLETED|Washout (>/= 14 Days)||0
10388681|NCT00646906|11531140|FG001|NOT COMPLETED|Washout (>/= 14 Days)||0
10388682|NCT00646906|11531141|FG002|NOT COMPLETED|Washout (>/= 14 Days)||0
10388683|NCT00646906|11531142|FG003|NOT COMPLETED|Washout (>/= 14 Days)||0
10388684|NCT00646906|11531143|FG004|NOT COMPLETED|Washout (>/= 14 Days)||0
10388685|NCT00646906|11531144|FG005|NOT COMPLETED|Washout (>/= 14 Days)||0
10388686|NCT00646906|11531145|FG006|NOT COMPLETED|Washout (>/= 14 Days)||0
10388687|NCT00646906|11531139|FG000|STARTED|Crossover Period 2||8
10388688|NCT00646906|11531140|FG001|STARTED|Crossover Period 2||9
10388689|NCT00646906|11531141|FG002|STARTED|Crossover Period 2||10
10388690|NCT00646906|11531142|FG003|STARTED|Crossover Period 2||9
10388691|NCT00646906|11531143|FG004|STARTED|Crossover Period 2|Phase 1b had only one treatment period and no crossover.|0
10388692|NCT00646906|11531144|FG005|STARTED|Crossover Period 2||4
10388693|NCT00646906|11531145|FG006|STARTED|Crossover Period 2||5
10388694|NCT00646906|11531139|FG000|COMPLETED|Crossover Period 2||8
10388695|NCT00646906|11531140|FG001|COMPLETED|Crossover Period 2||8
10388696|NCT00646906|11531141|FG002|COMPLETED|Crossover Period 2||8
10388697|NCT00646906|11531142|FG003|COMPLETED|Crossover Period 2||8
10388698|NCT00646906|11531143|FG004|COMPLETED|Crossover Period 2|Phase 1b had only one treatment period and no crossover.|0
10388699|NCT00646906|11531144|FG005|COMPLETED|Crossover Period 2||4
10388700|NCT00646906|11531145|FG006|COMPLETED|Crossover Period 2||4
10388701|NCT00646906|11531139|FG000|NOT COMPLETED|Crossover Period 2||0
10388702|NCT00646906|11531140|FG001|NOT COMPLETED|Crossover Period 2||1
10388703|NCT00646906|11531141|FG002|NOT COMPLETED|Crossover Period 2||2
10388704|NCT00646906|11531142|FG003|NOT COMPLETED|Crossover Period 2||1
10388705|NCT00646906|11531143|FG004|NOT COMPLETED|Crossover Period 2||0
10388706|NCT00646906|11531144|FG005|NOT COMPLETED|Crossover Period 2||0
10388707|NCT00646906|11531145|FG006|NOT COMPLETED|Crossover Period 2||1
10658400|NCT02233478|11819523|FG000|NOT COMPLETED|Washout (7 Days)||0
10658401|NCT02233478|11819524|FG001|NOT COMPLETED|Washout (7 Days)||0
10658402|NCT02233478|11819525|FG002|NOT COMPLETED|Washout (7 Days)||0
10658403|NCT02233478|11819526|FG003|NOT COMPLETED|Washout (7 Days)||0
10658404|NCT02233478|11819527|FG004|NOT COMPLETED|Washout (7 Days)||0
10658405|NCT02233478|11819528|FG005|NOT COMPLETED|Washout (7 Days)||0
10658406|NCT02233478|11819523|FG000|STARTED|Second Intervention (1 Day)||3
10658407|NCT02233478|11819524|FG001|STARTED|Second Intervention (1 Day)||3
10658408|NCT02233478|11819525|FG002|STARTED|Second Intervention (1 Day)||3
10658409|NCT02233478|11819526|FG003|STARTED|Second Intervention (1 Day)||3
10658410|NCT02233478|11819527|FG004|STARTED|Second Intervention (1 Day)||3
10388708|NCT00646958|11531161|FG000|STARTED|Overall Study|Number (No.) Participants Randomized|51
10388709|NCT00646958|11531162|FG001|STARTED|Overall Study|No. Participants Randomized|50
10388710|NCT00646958|11531163|FG002|STARTED|Overall Study|No. Participants Randomized|49
10388711|NCT00646958|11531161|FG000|COMPLETED|Overall Study||40
10388712|NCT00646958|11531162|FG001|COMPLETED|Overall Study||41
10388713|NCT00646958|11531163|FG002|COMPLETED|Overall Study||40
10388714|NCT00646958|11531161|FG000|NOT COMPLETED|Overall Study||11
10388715|NCT00646958|11531162|FG001|NOT COMPLETED|Overall Study||9
10388716|NCT00646958|11531163|FG002|NOT COMPLETED|Overall Study||9
10388717|NCT00647270|11531174|FG000|STARTED|Period 1, Placebo-control (12 Weeks)|Placebo subjects in Period 1 received adalimumab 40 mg every other week in Period 2.|56
10388718|NCT00647270|11531175|FG001|STARTED|Period 1, Placebo-control (12 Weeks)||159
10388719|NCT00647270|11531176|FG002|STARTED|Period 1, Placebo-control (12 Weeks)||205
10388720|NCT00647270|11531174|FG000|COMPLETED|Period 1, Placebo-control (12 Weeks)||48
10388721|NCT00647270|11531175|FG001|COMPLETED|Period 1, Placebo-control (12 Weeks)||146
10388722|NCT00647270|11531176|FG002|COMPLETED|Period 1, Placebo-control (12 Weeks)||182
10388723|NCT00647270|11531174|FG000|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||8
10388724|NCT00647270|11531175|FG001|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||13
10388725|NCT00647270|11531176|FG002|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||23
10388726|NCT00647270|11531174|FG000|STARTED|Period 2, Placebo Switched to Adalimumab|Placebo subjects in Period 1 received adalimumab 40 mg eow in Period 2|48
10388727|NCT00647270|11531175|FG001|STARTED|Period 2, Placebo Switched to Adalimumab||146
10388728|NCT00647270|11531176|FG002|STARTED|Period 2, Placebo Switched to Adalimumab||182
10388729|NCT00647270|11531174|FG000|COMPLETED|Period 2, Placebo Switched to Adalimumab||45
10388730|NCT00647270|11531175|FG001|COMPLETED|Period 2, Placebo Switched to Adalimumab||137
10388731|NCT00647270|11531176|FG002|COMPLETED|Period 2, Placebo Switched to Adalimumab||175
10388732|NCT00647270|11531174|FG000|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||3
10718320|NCT02703350|11882072|FG007|Received Study Drug|Period One (Part A)||0
10718321|NCT02703350|11882065|FG000|COMPLETED|Period One (Part A)||5
10718322|NCT02703350|11882066|FG001|COMPLETED|Period One (Part A)||5
10718323|NCT02703350|11882067|FG002|COMPLETED|Period One (Part A)||5
10388733|NCT00647270|11531175|FG001|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||9
10388734|NCT00647270|11531176|FG002|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||7
10388735|NCT00647296|11531191|FG000|STARTED|Part 1: 12-week Double-Blind Treatment||27
10388736|NCT00647296|11531192|FG001|STARTED|Part 1: 12-week Double-Blind Treatment||23
10388737|NCT00647296|11531193|FG002|STARTED|Part 1: 12-week Double-Blind Treatment||26
10388738|NCT00647296|11531194|FG003|STARTED|Part 1: 12-week Double-Blind Treatment||26
10388739|NCT00647296|11531191|FG000|COMPLETED|Part 1: 12-week Double-Blind Treatment||26
10388740|NCT00647296|11531192|FG001|COMPLETED|Part 1: 12-week Double-Blind Treatment||22
10388741|NCT00647296|11531193|FG002|COMPLETED|Part 1: 12-week Double-Blind Treatment||26
10388742|NCT00647296|11531194|FG003|COMPLETED|Part 1: 12-week Double-Blind Treatment||24
10388743|NCT00647296|11531191|FG000|NOT COMPLETED|Part 1: 12-week Double-Blind Treatment||1
10388744|NCT00647296|11531192|FG001|NOT COMPLETED|Part 1: 12-week Double-Blind Treatment||1
10388745|NCT00647296|11531193|FG002|NOT COMPLETED|Part 1: 12-week Double-Blind Treatment||0
10388746|NCT00647296|11531194|FG003|NOT COMPLETED|Part 1: 12-week Double-Blind Treatment||2
10388747|NCT00647296|11531191|FG000|STARTED|Part 2: 4-week Placebo Washout||97
10718324|NCT02703350|11882068|FG003|COMPLETED|Period One (Part A)||5
10718325|NCT02703350|11882069|FG004|COMPLETED|Period One (Part A)||5
10388748|NCT00647296|11531192|FG001|STARTED|Part 2: 4-week Placebo Washout||0
10388749|NCT00647296|11531193|FG002|STARTED|Part 2: 4-week Placebo Washout||0
10388750|NCT00647296|11531194|FG003|STARTED|Part 2: 4-week Placebo Washout||0
10388751|NCT00647296|11531191|FG000|COMPLETED|Part 2: 4-week Placebo Washout||92
10388752|NCT00647296|11531192|FG001|COMPLETED|Part 2: 4-week Placebo Washout||0
10388753|NCT00647296|11531193|FG002|COMPLETED|Part 2: 4-week Placebo Washout||0
10388754|NCT00647296|11531194|FG003|COMPLETED|Part 2: 4-week Placebo Washout||0
10388755|NCT00647296|11531191|FG000|NOT COMPLETED|Part 2: 4-week Placebo Washout||5
10388756|NCT00647296|11531192|FG001|NOT COMPLETED|Part 2: 4-week Placebo Washout||0
10388757|NCT00647296|11531193|FG002|NOT COMPLETED|Part 2: 4-week Placebo Washout||0
10388758|NCT00647296|11531194|FG003|NOT COMPLETED|Part 2: 4-week Placebo Washout||0
10388759|NCT00647296|11531191|FG000|STARTED|Part 2: 76-week Double-Blind Treatment||0
10541598|NCT01473524|11694813|FG004|COMPLETED|LTSE Phase||47
10541599|NCT01473524|11694814|FG005|COMPLETED|LTSE Phase||45
10541600|NCT01473524|11694809|FG000|NOT COMPLETED|LTSE Phase||0
10541601|NCT01473524|11694810|FG001|NOT COMPLETED|LTSE Phase||0
10541602|NCT01473524|11694811|FG002|NOT COMPLETED|LTSE Phase||0
10541603|NCT01473524|11694812|FG003|NOT COMPLETED|LTSE Phase||9
10541604|NCT01473524|11694813|FG004|NOT COMPLETED|LTSE Phase||17
10541605|NCT01473524|11694814|FG005|NOT COMPLETED|LTSE Phase||21
10541606|NCT01473563|11694836|FG000|STARTED|Overall Study||52
10541607|NCT01473563|11694836|FG000|Received at Least 1 Dose of Study Drug|Overall Study||52
10541608|NCT01473563|11694836|FG000|COMPLETED|Overall Study||51
10541609|NCT01473563|11694836|FG000|NOT COMPLETED|Overall Study||1
10541610|NCT01473589|11694842|FG000|STARTED|Overall Study||60
10541611|NCT01473589|11694843|FG001|STARTED|Overall Study||62
10541612|NCT01473589|11694842|FG000|Received at Least 1 Dose of Study Drug|Overall Study|Randomized participants who received at least 1 dose of study drug.|60
10658411|NCT02233478|11819528|FG005|STARTED|Second Intervention (1 Day)||3
10658412|NCT02233478|11819523|FG000|COMPLETED|Second Intervention (1 Day)||3
10658413|NCT02233478|11819524|FG001|COMPLETED|Second Intervention (1 Day)||3
10658414|NCT02233478|11819525|FG002|COMPLETED|Second Intervention (1 Day)||3
10658415|NCT02233478|11819526|FG003|COMPLETED|Second Intervention (1 Day)||3
10658416|NCT02233478|11819527|FG004|COMPLETED|Second Intervention (1 Day)||3
10658417|NCT02233478|11819528|FG005|COMPLETED|Second Intervention (1 Day)||3
10658418|NCT02233478|11819523|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10658419|NCT02233478|11819524|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10658420|NCT02233478|11819525|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
10658421|NCT02233478|11819526|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
10658422|NCT02233478|11819527|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
10658423|NCT02233478|11819528|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
10658424|NCT02233478|11819523|FG000|STARTED|Washout (7 Days)||3
10658425|NCT02233478|11819524|FG001|STARTED|Washout (7 Days)||3
10658426|NCT02233478|11819525|FG002|STARTED|Washout (7 Days)||3
10658427|NCT02233478|11819526|FG003|STARTED|Washout (7 Days)||3
10658428|NCT02233478|11819527|FG004|STARTED|Washout (7 Days)||3
10658429|NCT02233478|11819528|FG005|STARTED|Washout (7 Days)||3
10658430|NCT02233478|11819523|FG000|COMPLETED|Washout (7 Days)||3
10658431|NCT02233478|11819524|FG001|COMPLETED|Washout (7 Days)||3
10658432|NCT02233478|11819525|FG002|COMPLETED|Washout (7 Days)||3
10658433|NCT02233478|11819526|FG003|COMPLETED|Washout (7 Days)||3
10658434|NCT02233478|11819527|FG004|COMPLETED|Washout (7 Days)||3
10658435|NCT02233478|11819528|FG005|COMPLETED|Washout (7 Days)||3
10658436|NCT02233478|11819523|FG000|NOT COMPLETED|Washout (7 Days)||0
10658437|NCT02233478|11819524|FG001|NOT COMPLETED|Washout (7 Days)||0
10658438|NCT02233478|11819525|FG002|NOT COMPLETED|Washout (7 Days)||0
10658439|NCT02233478|11819526|FG003|NOT COMPLETED|Washout (7 Days)||0
10658440|NCT02233478|11819527|FG004|NOT COMPLETED|Washout (7 Days)||0
10658441|NCT02233478|11819528|FG005|NOT COMPLETED|Washout (7 Days)||0
10658442|NCT02233478|11819523|FG000|STARTED|Third Intervention (1 Day)||3
10658443|NCT02233478|11819524|FG001|STARTED|Third Intervention (1 Day)||3
10658444|NCT02233478|11819525|FG002|STARTED|Third Intervention (1 Day)||3
10658445|NCT02233478|11819526|FG003|STARTED|Third Intervention (1 Day)||3
10658446|NCT02233478|11819527|FG004|STARTED|Third Intervention (1 Day)||3
10658447|NCT02233478|11819528|FG005|STARTED|Third Intervention (1 Day)||3
10658448|NCT02233478|11819523|FG000|COMPLETED|Third Intervention (1 Day)||3
10658449|NCT02233478|11819524|FG001|COMPLETED|Third Intervention (1 Day)||3
10658450|NCT02233478|11819525|FG002|COMPLETED|Third Intervention (1 Day)||3
10658451|NCT02233478|11819526|FG003|COMPLETED|Third Intervention (1 Day)||3
10658452|NCT02233478|11819527|FG004|COMPLETED|Third Intervention (1 Day)||3
10658453|NCT02233478|11819528|FG005|COMPLETED|Third Intervention (1 Day)||3
10658454|NCT02233478|11819523|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
10658455|NCT02233478|11819524|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
10658456|NCT02233478|11819525|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
10658457|NCT02233478|11819526|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
10658458|NCT02233478|11819527|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
10658459|NCT02233478|11819528|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
10658460|NCT02233517|11819538|FG000|STARTED|Overall Study||19
10658461|NCT02233517|11819539|FG001|STARTED|Overall Study||17
10658462|NCT02233517|11819538|FG000|COMPLETED|Overall Study||12
10658463|NCT02233517|11819539|FG001|COMPLETED|Overall Study||13
10658464|NCT02233517|11819538|FG000|NOT COMPLETED|Overall Study||7
10658465|NCT02233517|11819539|FG001|NOT COMPLETED|Overall Study||4
10658466|NCT02233530|11819545|FG000|STARTED|Overall Study||8
10388760|NCT00647296|11531192|FG001|STARTED|Part 2: 76-week Double-Blind Treatment||48
10388761|NCT00647296|11531193|FG002|STARTED|Part 2: 76-week Double-Blind Treatment||0
10718326|NCT02703350|11882070|FG005|COMPLETED|Period One (Part A)||5
10718327|NCT02703350|11882071|FG006|COMPLETED|Period One (Part A)||0
10718328|NCT02703350|11882072|FG007|COMPLETED|Period One (Part A)||0
10718329|NCT02703350|11882065|FG000|NOT COMPLETED|Period One (Part A)||0
10718330|NCT02703350|11882066|FG001|NOT COMPLETED|Period One (Part A)||0
10718331|NCT02703350|11882067|FG002|NOT COMPLETED|Period One (Part A)||0
10388762|NCT00647296|11531194|FG003|STARTED|Part 2: 76-week Double-Blind Treatment||44
10388763|NCT00647296|11531191|FG000|COMPLETED|Part 2: 76-week Double-Blind Treatment||0
10388764|NCT00647296|11531192|FG001|COMPLETED|Part 2: 76-week Double-Blind Treatment||33
10388765|NCT00647296|11531193|FG002|COMPLETED|Part 2: 76-week Double-Blind Treatment||0
10388766|NCT00647296|11531194|FG003|COMPLETED|Part 2: 76-week Double-Blind Treatment||30
10388767|NCT00647296|11531191|FG000|NOT COMPLETED|Part 2: 76-week Double-Blind Treatment||0
10388768|NCT00647296|11531192|FG001|NOT COMPLETED|Part 2: 76-week Double-Blind Treatment||15
10388769|NCT00647296|11531193|FG002|NOT COMPLETED|Part 2: 76-week Double-Blind Treatment||0
10388770|NCT00647296|11531194|FG003|NOT COMPLETED|Part 2: 76-week Double-Blind Treatment||14
10388771|NCT00647348|11531218|FG000|STARTED|Overall Study||70
10388772|NCT00647348|11531219|FG001|STARTED|Overall Study||70
10388773|NCT00647348|11531218|FG000|COMPLETED|Overall Study||67
10388774|NCT00647348|11531219|FG001|COMPLETED|Overall Study||64
10388775|NCT00647348|11531218|FG000|NOT COMPLETED|Overall Study||3
10388776|NCT00647348|11531219|FG001|NOT COMPLETED|Overall Study||6
10388777|NCT00647400|11531227|FG000|STARTED|Overall Study||89
10388778|NCT00647400|11531228|FG001|STARTED|Overall Study||58
10388779|NCT00647400|11531227|FG000|COMPLETED|Overall Study||67
10388780|NCT00647400|11531228|FG001|COMPLETED|Overall Study||45
10388781|NCT00647400|11531227|FG000|NOT COMPLETED|Overall Study||22
10388782|NCT00647400|11531228|FG001|NOT COMPLETED|Overall Study||13
10388789|NCT00647699|11531245|FG000|STARTED|Overall Study||73
10388790|NCT00647699|11531246|FG001|STARTED|Overall Study||74
10388791|NCT00647699|11531245|FG000|COMPLETED|Overall Study||65
10388792|NCT00647699|11531246|FG001|COMPLETED|Overall Study||62
10388793|NCT00647699|11531245|FG000|NOT COMPLETED|Overall Study||8
10388794|NCT00647699|11531246|FG001|NOT COMPLETED|Overall Study||12
10388795|NCT00647998|11531254|FG000|STARTED|Overall Study||9
10388796|NCT00647998|11531255|FG001|STARTED|Overall Study||9
10388797|NCT00647998|11531254|FG000|COMPLETED|Overall Study||9
10388798|NCT00647998|11531255|FG001|COMPLETED|Overall Study||9
10388799|NCT00647998|11531254|FG000|NOT COMPLETED|Overall Study||0
10388800|NCT00647998|11531255|FG001|NOT COMPLETED|Overall Study||0
10388801|NCT00648037|11531263|FG000|STARTED|Overall Study||26
10388802|NCT00648037|11531263|FG000|COMPLETED|Overall Study||10
10388803|NCT00648037|11531263|FG000|NOT COMPLETED|Overall Study||16
10388804|NCT00648115|11531270|FG000|STARTED|Overall Study||42
10388805|NCT00648115|11531271|FG001|STARTED|Overall Study||42
10388806|NCT00648115|11531272|FG002|STARTED|Overall Study||27
10718332|NCT02703350|11882068|FG003|NOT COMPLETED|Period One (Part A)||0
10718333|NCT02703350|11882069|FG004|NOT COMPLETED|Period One (Part A)||0
10718334|NCT02703350|11882070|FG005|NOT COMPLETED|Period One (Part A)||0
10812721|NCT03352882|11974861|FG000|STARTED|Overall Study||1
10812722|NCT03352882|11974861|FG000|COMPLETED|Overall Study||1
10306965|NCT00102687|11439884|FG003|COMPLETED|Maintenance Period||12
10306966|NCT00102687|11439885|FG004|COMPLETED|Maintenance Period||8
10306967|NCT00102687|11439881|FG000|NOT COMPLETED|Maintenance Period||7
10306968|NCT00102687|11439882|FG001|NOT COMPLETED|Maintenance Period||4
10306969|NCT00102687|11439883|FG002|NOT COMPLETED|Maintenance Period||6
10306970|NCT00102687|11439884|FG003|NOT COMPLETED|Maintenance Period||10
10306971|NCT00102687|11439885|FG004|NOT COMPLETED|Maintenance Period||13
10306972|NCT00102804|11439903|FG000|STARTED|Overall Study||441
10306973|NCT00102804|11439904|FG001|STARTED|Overall Study||222
10306974|NCT00102804|11439903|FG000|Received at Least 1 Dose of Study Drug|Overall Study||434
10306975|NCT00102804|11439904|FG001|Received at Least 1 Dose of Study Drug|Overall Study|Four participants randomized to placebo received pemetrexed.|222
10306976|NCT00102804|11439903|FG000|COMPLETED|Overall Study||0
10306977|NCT00102804|11439904|FG001|COMPLETED|Overall Study||0
10306978|NCT00102804|11439903|FG000|NOT COMPLETED|Overall Study||441
10306979|NCT00102804|11439904|FG001|NOT COMPLETED|Overall Study||222
10388807|NCT00648115|11531270|FG000|COMPLETED|Overall Study||42
10388808|NCT00648115|11531271|FG001|COMPLETED|Overall Study||42
10388809|NCT00648115|11531272|FG002|COMPLETED|Overall Study||27
10388810|NCT00648115|11531270|FG000|NOT COMPLETED|Overall Study||0
10388811|NCT00648115|11531271|FG001|NOT COMPLETED|Overall Study||0
10388812|NCT00648115|11531272|FG002|NOT COMPLETED|Overall Study||0
10388813|NCT00648167|11531280|FG000|STARTED|Overall Study||55
10388814|NCT00648167|11531280|FG000|Start Dose 4.5 g/Day|Overall Study||34
10388815|NCT00648167|11531280|FG000|Start Dose 6 g/Day|Overall Study||21
10388816|NCT00648167|11531280|FG000|COMPLETED|Overall Study||48
10388817|NCT00648167|11531280|FG000|NOT COMPLETED|Overall Study||7
10388818|NCT00648375|11531286|FG000|STARTED|Overall Study||1
10388819|NCT00648375|11531287|FG001|STARTED|Overall Study||2
10388820|NCT00648375|11531286|FG000|COMPLETED|Overall Study||1
10388821|NCT00648375|11531287|FG001|COMPLETED|Overall Study||2
10388822|NCT00648375|11531286|FG000|NOT COMPLETED|Overall Study||0
10388823|NCT00648375|11531287|FG001|NOT COMPLETED|Overall Study||0
10388824|NCT00648648|11531321|FG000|STARTED|Overall Study||3
10388825|NCT00648648|11531322|FG001|STARTED|Overall Study||3
10388826|NCT00648648|11531323|FG002|STARTED|Overall Study||3
10388827|NCT00648648|11531324|FG003|STARTED|Overall Study|Does not include two Part 1 participants who were randomized to this arm.|4
10388828|NCT00648648|11531325|FG004|STARTED|Overall Study||9
10388829|NCT00648648|11531326|FG005|STARTED|Overall Study|Does not include two Part 1 participants who were randomized to this arm.|1
10388830|NCT00648648|11531327|FG006|STARTED|Overall Study|Does not include one Part 1 participant who was randomized to this arm.|10
10388831|NCT00648648|11531328|FG007|STARTED|Overall Study|Does not include two Part 1 participants who were randomized to this arm.|1
10388832|NCT00648648|11531329|FG008|STARTED|Overall Study|Does not include one Part 1 participant who was randomized to this arm.|3
10388833|NCT00648648|11531330|FG009|STARTED|Overall Study||10
10388834|NCT00648648|11531331|FG010|STARTED|Overall Study||6
10388835|NCT00648648|11531332|FG011|STARTED|Overall Study||13
10388836|NCT00648648|11531333|FG012|STARTED|Overall Study||6
10388837|NCT00648648|11531334|FG013|STARTED|Overall Study||5
10388838|NCT00648648|11531335|FG014|STARTED|Overall Study||4
10388839|NCT00648648|11531336|FG015|STARTED|Overall Study||11
10388840|NCT00648648|11531337|FG016|STARTED|Overall Study||16
10388841|NCT00648648|11531338|FG017|STARTED|Overall Study||6
10388842|NCT00648648|11531339|FG018|STARTED|Overall Study||5
10388843|NCT00648648|11531340|FG019|STARTED|Overall Study||7
10388844|NCT00648648|11531341|FG020|STARTED|Overall Study||6
10388845|NCT00648648|11531342|FG021|STARTED|Overall Study||10
10388846|NCT00648648|11531343|FG022|STARTED|Overall Study||14
10388847|NCT00648648|11531344|FG023|STARTED|Overall Study||4
10388848|NCT00648648|11531345|FG024|STARTED|Overall Study||4
10388849|NCT00648648|11531346|FG025|STARTED|Overall Study||4
10388850|NCT00648648|11531347|FG026|STARTED|Overall Study||26
10388851|NCT00648648|11531348|FG027|STARTED|Overall Study||12
10388852|NCT00648648|11531321|FG000|Treated|Overall Study||3
10388853|NCT00648648|11531322|FG001|Treated|Overall Study||3
10388854|NCT00648648|11531323|FG002|Treated|Overall Study||3
10388855|NCT00648648|11531324|FG003|Treated|Overall Study|Does not include two Part 1 participants who were treated in this arm.|4
10388856|NCT00648648|11531325|FG004|Treated|Overall Study||8
10388857|NCT00648648|11531326|FG005|Treated|Overall Study|Does not include two Part 1 participants who were treated in this arm.|1
10388858|NCT00648648|11531327|FG006|Treated|Overall Study|Does not include one treated participant who was excluded from analysis.|9
10388859|NCT00648648|11531328|FG007|Treated|Overall Study|Does not include two Part 1 participants who were treated in this arm.|1
10388860|NCT00648648|11531329|FG008|Treated|Overall Study|Does not include one Part 1 participant who was treated in this arm.|3
10388861|NCT00648648|11531330|FG009|Treated|Overall Study|Does not include one treated participant who was excluded from analysis.|9
10388862|NCT00648648|11531331|FG010|Treated|Overall Study||6
10388863|NCT00648648|11531332|FG011|Treated|Overall Study||13
10388864|NCT00648648|11531333|FG012|Treated|Overall Study||6
10388865|NCT00648648|11531334|FG013|Treated|Overall Study||5
10388866|NCT00648648|11531335|FG014|Treated|Overall Study||4
10388867|NCT00648648|11531336|FG015|Treated|Overall Study||11
10388868|NCT00648648|11531337|FG016|Treated|Overall Study||16
10388869|NCT00648648|11531338|FG017|Treated|Overall Study||6
10388870|NCT00648648|11531339|FG018|Treated|Overall Study||4
10388871|NCT00648648|11531340|FG019|Treated|Overall Study||7
10388872|NCT00648648|11531341|FG020|Treated|Overall Study||6
10388873|NCT00648648|11531342|FG021|Treated|Overall Study||10
10388874|NCT00648648|11531343|FG022|Treated|Overall Study||14
10388875|NCT00648648|11531344|FG023|Treated|Overall Study||4
10388876|NCT00648648|11531345|FG024|Treated|Overall Study||4
10388877|NCT00648648|11531346|FG025|Treated|Overall Study||4
10388878|NCT00648648|11531347|FG026|Treated|Overall Study||26
10388879|NCT00648648|11531348|FG027|Treated|Overall Study||12
10388880|NCT00648648|11531321|FG000|COMPLETED|Overall Study||3
10388881|NCT00648648|11531322|FG001|COMPLETED|Overall Study||3
10388882|NCT00648648|11531323|FG002|COMPLETED|Overall Study||3
10388883|NCT00648648|11531324|FG003|COMPLETED|Overall Study||0
10388884|NCT00648648|11531325|FG004|COMPLETED|Overall Study||0
10388885|NCT00648648|11531326|FG005|COMPLETED|Overall Study||0
10388886|NCT00648648|11531327|FG006|COMPLETED|Overall Study||0
10388887|NCT00648648|11531328|FG007|COMPLETED|Overall Study||0
10388888|NCT00648648|11531329|FG008|COMPLETED|Overall Study||0
10388889|NCT00648648|11531330|FG009|COMPLETED|Overall Study||0
10388890|NCT00648648|11531331|FG010|COMPLETED|Overall Study||0
10388891|NCT00648648|11531332|FG011|COMPLETED|Overall Study||0
10388892|NCT00648648|11531333|FG012|COMPLETED|Overall Study||0
10388893|NCT00648648|11531334|FG013|COMPLETED|Overall Study||0
10388894|NCT00648648|11531335|FG014|COMPLETED|Overall Study||0
10388895|NCT00648648|11531336|FG015|COMPLETED|Overall Study||0
10388896|NCT00648648|11531337|FG016|COMPLETED|Overall Study||2
10388897|NCT00648648|11531338|FG017|COMPLETED|Overall Study||0
10388898|NCT00648648|11531339|FG018|COMPLETED|Overall Study||0
10388899|NCT00648648|11531340|FG019|COMPLETED|Overall Study||0
10388900|NCT00648648|11531341|FG020|COMPLETED|Overall Study||0
10388901|NCT00648648|11531342|FG021|COMPLETED|Overall Study||0
10388902|NCT00648648|11531343|FG022|COMPLETED|Overall Study||0
10388903|NCT00648648|11531344|FG023|COMPLETED|Overall Study||0
10388904|NCT00648648|11531345|FG024|COMPLETED|Overall Study||0
10388905|NCT00648648|11531346|FG025|COMPLETED|Overall Study||0
10388906|NCT00648648|11531347|FG026|COMPLETED|Overall Study||0
10388907|NCT00648648|11531348|FG027|COMPLETED|Overall Study||0
10388908|NCT00648648|11531321|FG000|NOT COMPLETED|Overall Study||0
10388909|NCT00648648|11531322|FG001|NOT COMPLETED|Overall Study||0
10388910|NCT00648648|11531323|FG002|NOT COMPLETED|Overall Study||0
10388911|NCT00648648|11531324|FG003|NOT COMPLETED|Overall Study||4
10388912|NCT00648648|11531325|FG004|NOT COMPLETED|Overall Study||9
10388913|NCT00648648|11531326|FG005|NOT COMPLETED|Overall Study||1
10388914|NCT00648648|11531327|FG006|NOT COMPLETED|Overall Study||10
10388915|NCT00648648|11531328|FG007|NOT COMPLETED|Overall Study||1
10388916|NCT00648648|11531329|FG008|NOT COMPLETED|Overall Study||3
10388917|NCT00648648|11531330|FG009|NOT COMPLETED|Overall Study||10
10388918|NCT00648648|11531331|FG010|NOT COMPLETED|Overall Study||6
10388919|NCT00648648|11531332|FG011|NOT COMPLETED|Overall Study||13
10388920|NCT00648648|11531333|FG012|NOT COMPLETED|Overall Study||6
10388921|NCT00648648|11531334|FG013|NOT COMPLETED|Overall Study||5
10388922|NCT00648648|11531335|FG014|NOT COMPLETED|Overall Study||4
10388923|NCT00648648|11531336|FG015|NOT COMPLETED|Overall Study||11
10388924|NCT00648648|11531337|FG016|NOT COMPLETED|Overall Study||14
10388925|NCT00648648|11531338|FG017|NOT COMPLETED|Overall Study||6
10388926|NCT00648648|11531339|FG018|NOT COMPLETED|Overall Study||5
10388927|NCT00648648|11531340|FG019|NOT COMPLETED|Overall Study||7
10388928|NCT00648648|11531341|FG020|NOT COMPLETED|Overall Study||6
10388929|NCT00648648|11531342|FG021|NOT COMPLETED|Overall Study||10
10388930|NCT00648648|11531343|FG022|NOT COMPLETED|Overall Study||14
10388931|NCT00648648|11531344|FG023|NOT COMPLETED|Overall Study||4
10388932|NCT00648648|11531345|FG024|NOT COMPLETED|Overall Study||4
10388933|NCT00648648|11531346|FG025|NOT COMPLETED|Overall Study||4
10388934|NCT00648648|11531347|FG026|NOT COMPLETED|Overall Study||26
10388935|NCT00648648|11531348|FG027|NOT COMPLETED|Overall Study||12
10388936|NCT00648739|11531406|FG000|STARTED|Overall Study||4
10388937|NCT00648739|11531407|FG001|STARTED|Overall Study||5
10388938|NCT00648739|11531408|FG002|STARTED|Overall Study||3
10388939|NCT00648739|11531409|FG003|STARTED|Overall Study||3
10388940|NCT00648739|11531410|FG004|STARTED|Overall Study||3
10388941|NCT00648739|11531411|FG005|STARTED|Overall Study||7
10388942|NCT00648739|11531412|FG006|STARTED|Overall Study||1
10388943|NCT00648739|11531406|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
10388944|NCT00648739|11531407|FG001|Received at Least 1 Dose of Study Drug|Overall Study||5
10388945|NCT00648739|11531408|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
10388946|NCT00648739|11531409|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
10388947|NCT00648739|11531410|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3
10388948|NCT00648739|11531411|FG005|Received at Least 1 Dose of Study Drug|Overall Study||7
10388949|NCT00648739|11531412|FG006|Received at Least 1 Dose of Study Drug|Overall Study||1
10388950|NCT00648739|11531406|FG000|COMPLETED|Overall Study||2
10388951|NCT00648739|11531407|FG001|COMPLETED|Overall Study||3
10388952|NCT00648739|11531408|FG002|COMPLETED|Overall Study||0
10388953|NCT00648739|11531409|FG003|COMPLETED|Overall Study||1
10388954|NCT00648739|11531410|FG004|COMPLETED|Overall Study||1
10388955|NCT00648739|11531411|FG005|COMPLETED|Overall Study||2
10388956|NCT00648739|11531412|FG006|COMPLETED|Overall Study||0
10388957|NCT00648739|11531406|FG000|NOT COMPLETED|Overall Study||2
10718335|NCT02703350|11882071|FG006|NOT COMPLETED|Period One (Part A)||0
10388958|NCT00648739|11531407|FG001|NOT COMPLETED|Overall Study||2
10718336|NCT02703350|11882072|FG007|NOT COMPLETED|Period One (Part A)||0
10388959|NCT00648739|11531408|FG002|NOT COMPLETED|Overall Study||3
10388960|NCT00648739|11531409|FG003|NOT COMPLETED|Overall Study||2
10388961|NCT00648739|11531410|FG004|NOT COMPLETED|Overall Study||2
10388962|NCT00648739|11531411|FG005|NOT COMPLETED|Overall Study||5
10388963|NCT00648739|11531412|FG006|NOT COMPLETED|Overall Study||1
10388964|NCT00648908|11531433|FG000|STARTED|Overall Study||269
10388965|NCT00648908|11531433|FG000|COMPLETED|Overall Study||154
10388966|NCT00648908|11531433|FG000|NOT COMPLETED|Overall Study||115
10388967|NCT00649220|11531438|FG000|STARTED|Overall Study||19
10388968|NCT00649220|11531438|FG000|COMPLETED|Overall Study||16
10388969|NCT00649220|11531438|FG000|NOT COMPLETED|Overall Study||3
10388970|NCT00649389|11531446|FG000|STARTED|Overall Study||628
10388971|NCT00649389|11531447|FG001|STARTED|Overall Study||637
10388972|NCT00649389|11531448|FG002|STARTED|Overall Study||600
10388973|NCT00649389|11531449|FG003|STARTED|Overall Study||627
10388974|NCT00649389|11531446|FG000|COMPLETED|Overall Study||557
10388975|NCT00649389|11531447|FG001|COMPLETED|Overall Study||531
10388976|NCT00649389|11531448|FG002|COMPLETED|Overall Study||512
10388977|NCT00649389|11531449|FG003|COMPLETED|Overall Study||516
10388978|NCT00649389|11531446|FG000|NOT COMPLETED|Overall Study||71
10388979|NCT00649389|11531447|FG001|NOT COMPLETED|Overall Study||106
10388980|NCT00649389|11531448|FG002|NOT COMPLETED|Overall Study||88
10388981|NCT00649389|11531449|FG003|NOT COMPLETED|Overall Study||111
10388982|NCT00649428|11531461|FG000|STARTED|Overall Study||100
10388983|NCT00649428|11531462|FG001|STARTED|Overall Study||103
10388984|NCT00649428|11531461|FG000|COMPLETED|Overall Study||80
10388985|NCT00649428|11531462|FG001|COMPLETED|Overall Study||88
10388986|NCT00649428|11531461|FG000|NOT COMPLETED|Overall Study||20
10388987|NCT00649428|11531462|FG001|NOT COMPLETED|Overall Study||15
10388988|NCT00649792|11531469|FG000|STARTED|Overall Study||214
10388989|NCT00649792|11531469|FG000|COMPLETED|Overall Study||146
10388990|NCT00649792|11531469|FG000|NOT COMPLETED|Overall Study||68
10388991|NCT00649961|11531473|FG000|STARTED|Overall Study||18
10388992|NCT00649961|11531473|FG000|COMPLETED|Overall Study||18
10388993|NCT00649961|11531473|FG000|NOT COMPLETED|Overall Study||0
10388994|NCT00650078|11531479|FG000|STARTED|Overall Study||231
10388995|NCT00650078|11531480|FG001|STARTED|Overall Study||119
10388996|NCT00650078|11531479|FG000|COMPLETED|Overall Study||217
10388997|NCT00650078|11531480|FG001|COMPLETED|Overall Study||106
10388998|NCT00650078|11531479|FG000|NOT COMPLETED|Overall Study||14
10388999|NCT00650078|11531480|FG001|NOT COMPLETED|Overall Study||13
10389000|NCT00650091|11531488|FG000|STARTED|Initial Study Design - Interim Analysis||81
10389001|NCT00650091|11531489|FG001|STARTED|Initial Study Design - Interim Analysis||78
10389002|NCT00650091|11531490|FG002|STARTED|Initial Study Design - Interim Analysis||77
10389003|NCT00650091|11531488|FG000|COMPLETED|Initial Study Design - Interim Analysis||81
10389004|NCT00650091|11531489|FG001|COMPLETED|Initial Study Design - Interim Analysis||78
10389005|NCT00650091|11531490|FG002|COMPLETED|Initial Study Design - Interim Analysis||77
10389006|NCT00650091|11531488|FG000|NOT COMPLETED|Initial Study Design - Interim Analysis||0
10389007|NCT00650091|11531489|FG001|NOT COMPLETED|Initial Study Design - Interim Analysis||0
10389008|NCT00650091|11531490|FG002|NOT COMPLETED|Initial Study Design - Interim Analysis||0
10389009|NCT00650091|11531488|FG000|STARTED|Amended Study Design||133
10389010|NCT00650091|11531489|FG001|STARTED|Amended Study Design||131
10389011|NCT00650091|11531490|FG002|STARTED|Amended Study Design|Study Drug was discontinued for all subjects due to safety concerns.|0
10389012|NCT00650091|11531488|FG000|COMPLETED|Amended Study Design||110
10389013|NCT00650091|11531489|FG001|COMPLETED|Amended Study Design||111
10541613|NCT01473589|11694843|FG001|Received at Least 1 Dose of Study Drug|Overall Study|Randomized participants who received at least 1 dose of study drug.|61
10541614|NCT01473589|11694842|FG000|Completed 6 Months|Overall Study||51
10541615|NCT01473589|11694843|FG001|Completed 6 Months|Overall Study||54
10541616|NCT01473589|11694842|FG000|Completed 12 Months|Overall Study||49
10541617|NCT01473589|11694843|FG001|Completed 12 Months|Overall Study||48
10541618|NCT01473589|11694842|FG000|COMPLETED|Overall Study||49
10541619|NCT01473589|11694843|FG001|COMPLETED|Overall Study||46
10541620|NCT01473589|11694842|FG000|NOT COMPLETED|Overall Study||11
10541621|NCT01473589|11694843|FG001|NOT COMPLETED|Overall Study||16
10541622|NCT01473602|11694853|FG000|STARTED|Overall Study||18
10541623|NCT01473602|11694854|FG001|STARTED|Overall Study||21
10541624|NCT01473602|11694853|FG000|Received at Least 1 Dose of Study Drug|Overall Study||18
10541625|NCT01473602|11694854|FG001|Received at Least 1 Dose of Study Drug|Overall Study||20
10306980|NCT00102960|11439913|FG000|STARTED|Overall Study||125
10306981|NCT00102960|11439914|FG001|STARTED|Overall Study||126
10306982|NCT00102960|11439915|FG002|STARTED|Overall Study||126
10306983|NCT00102960|11439913|FG000|COMPLETED|Overall Study||95
10306984|NCT00102960|11439914|FG001|COMPLETED|Overall Study||103
10306985|NCT00102960|11439915|FG002|COMPLETED|Overall Study||98
10306986|NCT00102960|11439913|FG000|NOT COMPLETED|Overall Study||30
10306987|NCT00102960|11439914|FG001|NOT COMPLETED|Overall Study||23
10306988|NCT00102960|11439915|FG002|NOT COMPLETED|Overall Study||28
10306989|NCT00103012|11439930|FG000|STARTED|Overall Study||17
10306990|NCT00103012|11439931|FG001|STARTED|Overall Study||14
10306991|NCT00103012|11439932|FG002|STARTED|Overall Study||16
10306992|NCT00103012|11439930|FG000|COMPLETED|Overall Study||14
10541626|NCT01473602|11694853|FG000|Completed 6 Months|Overall Study||12
10541627|NCT01473602|11694854|FG001|Completed 6 Months|Overall Study||15
10541628|NCT01473602|11694853|FG000|Completed 12 Months|Overall Study||10
10541629|NCT01473602|11694854|FG001|Completed 12 Months|Overall Study||13
10541630|NCT01473602|11694853|FG000|COMPLETED|Overall Study||10
10541631|NCT01473602|11694854|FG001|COMPLETED|Overall Study||13
10541632|NCT01473602|11694853|FG000|NOT COMPLETED|Overall Study||8
10306993|NCT00103012|11439931|FG001|COMPLETED|Overall Study||13
10306994|NCT00103012|11439932|FG002|COMPLETED|Overall Study||12
10389014|NCT00650091|11531490|FG002|COMPLETED|Amended Study Design||0
10389015|NCT00650091|11531488|FG000|NOT COMPLETED|Amended Study Design||23
10389016|NCT00650091|11531489|FG001|NOT COMPLETED|Amended Study Design||20
10389017|NCT00650091|11531490|FG002|NOT COMPLETED|Amended Study Design||0
10389018|NCT00650104|11531498|FG000|STARTED|Overall Study||83
10389019|NCT00650104|11531498|FG000|COMPLETED|Overall Study||42
10306995|NCT00103012|11439930|FG000|NOT COMPLETED|Overall Study||3
10306996|NCT00103012|11439931|FG001|NOT COMPLETED|Overall Study||1
10306997|NCT00103012|11439932|FG002|NOT COMPLETED|Overall Study||4
10306998|NCT00103116|11439940|FG000|STARTED|Overall Study||32
10389020|NCT00650104|11531498|FG000|NOT COMPLETED|Overall Study||41
10389021|NCT00650260|11531504|FG000|STARTED|Overall Study||21
10389022|NCT00650260|11531505|FG001|STARTED|Overall Study||21
10389023|NCT00650260|11531504|FG000|COMPLETED|Overall Study||21
10541633|NCT01473602|11694854|FG001|NOT COMPLETED|Overall Study||8
10541634|NCT01473745|11694864|FG000|STARTED|Overall Study||24
10541635|NCT01473745|11694865|FG001|STARTED|Overall Study||24
10541636|NCT01473745|11694864|FG000|COMPLETED|Overall Study||24
10541637|NCT01473745|11694865|FG001|COMPLETED|Overall Study||24
10541638|NCT01473745|11694864|FG000|NOT COMPLETED|Overall Study||0
10541639|NCT01473745|11694865|FG001|NOT COMPLETED|Overall Study||0
10541640|NCT01473758|11694873|FG000|STARTED|Cycle 1||38
10541641|NCT01473758|11694874|FG001|STARTED|Cycle 1||43
10541642|NCT01473758|11694875|FG002|STARTED|Cycle 1||0
10541643|NCT01473758|11694876|FG003|STARTED|Cycle 1||0
10541644|NCT01473758|11694873|FG000|COMPLETED|Cycle 1||27
10541645|NCT01473758|11694874|FG001|COMPLETED|Cycle 1||40
10541646|NCT01473758|11694875|FG002|COMPLETED|Cycle 1||0
10541647|NCT01473758|11694876|FG003|COMPLETED|Cycle 1||0
10541648|NCT01473758|11694873|FG000|NOT COMPLETED|Cycle 1||11
10541649|NCT01473758|11694874|FG001|NOT COMPLETED|Cycle 1||3
10541650|NCT01473758|11694875|FG002|NOT COMPLETED|Cycle 1||0
10541651|NCT01473758|11694876|FG003|NOT COMPLETED|Cycle 1||0
10541652|NCT01473758|11694873|FG000|STARTED|Cycle 2||0
10541653|NCT01473758|11694874|FG001|STARTED|Cycle 2||0
10541654|NCT01473758|11694875|FG002|STARTED|Cycle 2||10
10541655|NCT01473758|11694876|FG003|STARTED|Cycle 2||4
10541656|NCT01473758|11694873|FG000|COMPLETED|Cycle 2||0
10541657|NCT01473758|11694874|FG001|COMPLETED|Cycle 2||0
10541658|NCT01473758|11694875|FG002|COMPLETED|Cycle 2||5
10541659|NCT01473758|11694876|FG003|COMPLETED|Cycle 2||4
10541660|NCT01473758|11694873|FG000|NOT COMPLETED|Cycle 2||0
10541661|NCT01473758|11694874|FG001|NOT COMPLETED|Cycle 2||0
10541662|NCT01473758|11694875|FG002|NOT COMPLETED|Cycle 2||5
10541663|NCT01473758|11694876|FG003|NOT COMPLETED|Cycle 2||0
10541664|NCT01473836|11694884|FG000|STARTED|Overall Study||38
10541665|NCT01473836|11694884|FG000|COMPLETED|Overall Study||32
10541666|NCT01473836|11694884|FG000|NOT COMPLETED|Overall Study||6
10541667|NCT01473940|11694892|FG000|STARTED|Induction Therapy||3
10541668|NCT01473940|11694893|FG001|STARTED|Induction Therapy||4
10541669|NCT01473940|11694894|FG002|STARTED|Induction Therapy||6
10658467|NCT02233530|11819545|FG000|COMPLETED|Overall Study||8
10658468|NCT02233530|11819545|FG000|NOT COMPLETED|Overall Study||0
10658469|NCT02233543|11819549|FG000|STARTED|Period 1||22
10658470|NCT02233543|11819550|FG001|STARTED|Period 1||16
10658471|NCT02233543|11819549|FG000|COMPLETED|Period 1||19
10658472|NCT02233543|11819550|FG001|COMPLETED|Period 1||13
10658473|NCT02233543|11819549|FG000|NOT COMPLETED|Period 1||3
10658474|NCT02233543|11819550|FG001|NOT COMPLETED|Period 1||3
10658475|NCT02233543|11819549|FG000|STARTED|Period 2||19
10658476|NCT02233543|11819550|FG001|STARTED|Period 2||13
10658477|NCT02233543|11819549|FG000|COMPLETED|Period 2|1 participant erroneously received QVA149 during both periods.|17
10658478|NCT02233543|11819550|FG001|COMPLETED|Period 2||12
10658479|NCT02233543|11819549|FG000|NOT COMPLETED|Period 2||2
10658480|NCT02233543|11819550|FG001|NOT COMPLETED|Period 2||1
10658481|NCT02233647|11819556|FG000|STARTED|Overall Study||11
10389024|NCT00650260|11531505|FG001|COMPLETED|Overall Study||21
10541670|NCT01473940|11694895|FG003|STARTED|Induction Therapy||8
10389025|NCT00650260|11531504|FG000|NOT COMPLETED|Overall Study||0
10541671|NCT01473940|11694892|FG000|Started Treatment|Induction Therapy||3
10541672|NCT01473940|11694893|FG001|Started Treatment|Induction Therapy||4
10541673|NCT01473940|11694894|FG002|Started Treatment|Induction Therapy||6
10541674|NCT01473940|11694895|FG003|Started Treatment|Induction Therapy||8
10541675|NCT01473940|11694892|FG000|Completed Induction- 12 Weeks|Induction Therapy||3
10541676|NCT01473940|11694893|FG001|Completed Induction- 12 Weeks|Induction Therapy||3
10658482|NCT02233647|11819556|FG000|0 mg Cocaine With 0 mg Phendimetrazine|Overall Study||11
10718337|NCT02703350|11882065|FG000|STARTED|Period Two (Part A)||5
10541677|NCT01473940|11694894|FG002|Completed Induction- 12 Weeks|Induction Therapy||4
10541678|NCT01473940|11694895|FG003|Completed Induction- 12 Weeks|Induction Therapy||7
10541679|NCT01473940|11694892|FG000|COMPLETED|Induction Therapy||3
10541680|NCT01473940|11694893|FG001|COMPLETED|Induction Therapy||3
10541681|NCT01473940|11694894|FG002|COMPLETED|Induction Therapy||4
10541682|NCT01473940|11694895|FG003|COMPLETED|Induction Therapy||7
10389026|NCT00650260|11531505|FG001|NOT COMPLETED|Overall Study||0
10389027|NCT00650546|11531511|FG000|STARTED|Overall Study||8
10389028|NCT00650546|11531511|FG000|COMPLETED|Overall Study||8
10389029|NCT00650546|11531511|FG000|NOT COMPLETED|Overall Study||0
10389030|NCT00650585|11531518|FG000|STARTED|Overall Study||4348
10389031|NCT00650585|11531519|FG001|STARTED|Overall Study||3990
10389032|NCT00650585|11531518|FG000|COMPLETED|Overall Study|Completed posttest--a self-report survey administered 30 approximately 30 days after treatment|2551
10389033|NCT00650585|11531519|FG001|COMPLETED|Overall Study|Completed posttest--a self-report survey administered 30 approximately 30 days after treatment|2513
10389034|NCT00650585|11531518|FG000|NOT COMPLETED|Overall Study||1797
10389035|NCT00650585|11531519|FG001|NOT COMPLETED|Overall Study||1477
10389036|NCT00650767|11531529|FG000|STARTED|Overall Study||51
10389037|NCT00650767|11531530|FG001|STARTED|Overall Study||50
10389038|NCT00650767|11531531|FG002|STARTED|Overall Study||50
10389039|NCT00650767|11531532|FG003|STARTED|Overall Study||50
10389040|NCT00650767|11531529|FG000|COMPLETED|Overall Study||46
10389041|NCT00650767|11531530|FG001|COMPLETED|Overall Study||41
10389042|NCT00650767|11531531|FG002|COMPLETED|Overall Study||36
10389043|NCT00650767|11531532|FG003|COMPLETED|Overall Study||39
10389044|NCT00650767|11531529|FG000|NOT COMPLETED|Overall Study||5
10389045|NCT00650767|11531530|FG001|NOT COMPLETED|Overall Study||9
10389046|NCT00650767|11531531|FG002|NOT COMPLETED|Overall Study||14
10389047|NCT00650767|11531532|FG003|NOT COMPLETED|Overall Study||11
10389048|NCT00650806|11531546|FG000|STARTED|Overall Study||89
10389049|NCT00650806|11531547|FG001|STARTED|Overall Study||98
10389050|NCT00650806|11531548|FG002|STARTED|Overall Study||93
10389051|NCT00650806|11531549|FG003|STARTED|Overall Study||96
10389052|NCT00650806|11531546|FG000|COMPLETED|Overall Study||71
10541683|NCT01473940|11694892|FG000|NOT COMPLETED|Induction Therapy||0
10541684|NCT01473940|11694893|FG001|NOT COMPLETED|Induction Therapy||1
10541685|NCT01473940|11694894|FG002|NOT COMPLETED|Induction Therapy||2
10541686|NCT01473940|11694895|FG003|NOT COMPLETED|Induction Therapy||1
10541687|NCT01473940|11694892|FG000|STARTED|Maintenance Therapy||3
10541688|NCT01473940|11694893|FG001|STARTED|Maintenance Therapy||3
10541689|NCT01473940|11694894|FG002|STARTED|Maintenance Therapy||4
10541690|NCT01473940|11694895|FG003|STARTED|Maintenance Therapy||7
10541691|NCT01473940|11694892|FG000|Evaluated for Response|Maintenance Therapy||3
10541692|NCT01473940|11694893|FG001|Evaluated for Response|Maintenance Therapy||3
10541693|NCT01473940|11694894|FG002|Evaluated for Response|Maintenance Therapy||4
10541694|NCT01473940|11694895|FG003|Evaluated for Response|Maintenance Therapy||7
10541695|NCT01473940|11694892|FG000|Went on to Start Maintenance Therapy|Maintenance Therapy||2
10541696|NCT01473940|11694893|FG001|Went on to Start Maintenance Therapy|Maintenance Therapy||1
10541697|NCT01473940|11694894|FG002|Went on to Start Maintenance Therapy|Maintenance Therapy||3
10541698|NCT01473940|11694895|FG003|Went on to Start Maintenance Therapy|Maintenance Therapy||3
10541699|NCT01473940|11694892|FG000|COMPLETED|Maintenance Therapy||2
10541700|NCT01473940|11694893|FG001|COMPLETED|Maintenance Therapy||1
10541701|NCT01473940|11694894|FG002|COMPLETED|Maintenance Therapy||3
10541702|NCT01473940|11694895|FG003|COMPLETED|Maintenance Therapy||3
10541703|NCT01473940|11694892|FG000|NOT COMPLETED|Maintenance Therapy||1
10541704|NCT01473940|11694893|FG001|NOT COMPLETED|Maintenance Therapy||2
10541705|NCT01473940|11694894|FG002|NOT COMPLETED|Maintenance Therapy||1
10541706|NCT01473940|11694895|FG003|NOT COMPLETED|Maintenance Therapy||4
10541707|NCT01473940|11694892|FG000|STARTED|Follow-up Until Death||3
10541708|NCT01473940|11694893|FG001|STARTED|Follow-up Until Death||4
10541709|NCT01473940|11694894|FG002|STARTED|Follow-up Until Death||5
10541710|NCT01473940|11694895|FG003|STARTED|Follow-up Until Death||7
10541711|NCT01473940|11694892|FG000|COMPLETED|Follow-up Until Death||3
10541712|NCT01473940|11694893|FG001|COMPLETED|Follow-up Until Death||4
10541713|NCT01473940|11694894|FG002|COMPLETED|Follow-up Until Death||5
10541714|NCT01473940|11694895|FG003|COMPLETED|Follow-up Until Death||7
10389053|NCT00650806|11531547|FG001|COMPLETED|Overall Study||77
10389054|NCT00650806|11531548|FG002|COMPLETED|Overall Study||64
10389055|NCT00650806|11531549|FG003|COMPLETED|Overall Study||70
10389056|NCT00650806|11531546|FG000|NOT COMPLETED|Overall Study||18
10389057|NCT00650806|11531547|FG001|NOT COMPLETED|Overall Study||21
10389058|NCT00650806|11531548|FG002|NOT COMPLETED|Overall Study||29
10389059|NCT00650806|11531549|FG003|NOT COMPLETED|Overall Study||26
10389060|NCT00650845|11531563|FG000|STARTED|Overall Study||75
10389061|NCT00650845|11531564|FG001|STARTED|Overall Study||57
10389062|NCT00650845|11531563|FG000|COMPLETED|Overall Study||70
10389063|NCT00650845|11531564|FG001|COMPLETED|Overall Study||44
10389064|NCT00650845|11531563|FG000|NOT COMPLETED|Overall Study||5
10389065|NCT00650845|11531564|FG001|NOT COMPLETED|Overall Study||13
10541715|NCT01473940|11694892|FG000|NOT COMPLETED|Follow-up Until Death||0
10389066|NCT00650858|11531574|FG000|STARTED|Overall Study||8
10389067|NCT00650858|11531575|FG001|STARTED|Overall Study||8
10389068|NCT00650858|11531576|FG002|STARTED|Overall Study||36
10389069|NCT00650858|11531574|FG000|COMPLETED|Overall Study||8
10389070|NCT00650858|11531575|FG001|COMPLETED|Overall Study||8
10389071|NCT00650858|11531576|FG002|COMPLETED|Overall Study||36
10389072|NCT00650858|11531574|FG000|NOT COMPLETED|Overall Study||0
10389073|NCT00650858|11531575|FG001|NOT COMPLETED|Overall Study||0
10389074|NCT00650858|11531576|FG002|NOT COMPLETED|Overall Study||0
10389075|NCT00650936|11531584|FG000|STARTED|Overall Study||1000
10389076|NCT00650936|11531584|FG000|COMPLETED|Overall Study||930
10389077|NCT00650936|11531584|FG000|NOT COMPLETED|Overall Study||70
10389078|NCT00651040|11531590|FG000|STARTED|Overall Study||16
10389079|NCT00651040|11531591|FG001|STARTED|Overall Study||15
10389080|NCT00651040|11531590|FG000|COMPLETED|Overall Study||13
10389081|NCT00651040|11531591|FG001|COMPLETED|Overall Study||14
10389082|NCT00651040|11531590|FG000|NOT COMPLETED|Overall Study||3
10389083|NCT00651040|11531591|FG001|NOT COMPLETED|Overall Study||1
10389084|NCT00651118|11531601|FG000|STARTED|Overall Study||207
10389085|NCT00651118|11531602|FG001|STARTED|Overall Study||207
10389086|NCT00651118|11531603|FG002|STARTED|Overall Study||208
10389087|NCT00651118|11531604|FG003|STARTED|Overall Study||210
10389088|NCT00651118|11531601|FG000|COMPLETED|Overall Study||198
10389089|NCT00651118|11531602|FG001|COMPLETED|Overall Study||200
10389090|NCT00651118|11531603|FG002|COMPLETED|Overall Study||197
10389091|NCT00651118|11531604|FG003|COMPLETED|Overall Study||203
10389092|NCT00651118|11531601|FG000|NOT COMPLETED|Overall Study||9
10389093|NCT00651118|11531602|FG001|NOT COMPLETED|Overall Study||7
10389094|NCT00651118|11531603|FG002|NOT COMPLETED|Overall Study||11
10389095|NCT00651118|11531604|FG003|NOT COMPLETED|Overall Study||7
10389096|NCT00651157|11531617|FG000|STARTED|Overall Study||23
10389097|NCT00651157|11531617|FG000|COMPLETED|Overall Study||21
10389098|NCT00651157|11531617|FG000|NOT COMPLETED|Overall Study||2
10389099|NCT00651183|11531623|FG000|STARTED|Overall Study|"For one patient the information was not given, therefore, the patient was listed missing"|189
10389100|NCT00651183|11531624|FG001|STARTED|Overall Study||97
10389101|NCT00651183|11531623|FG000|COMPLETED|Overall Study|Case Report Form (CRF) listed reasons for early termination, of which one was|169
10389102|NCT00651183|11531624|FG001|COMPLETED|Overall Study|"other reasons. No explanation was required to be given by the physicians"|87
10389103|NCT00651183|11531623|FG000|NOT COMPLETED|Overall Study||20
10389104|NCT00651183|11531624|FG001|NOT COMPLETED|Overall Study||10
10389105|NCT00651261|11531632|FG000|STARTED|Overall Study||360
10389106|NCT00651261|11531633|FG001|STARTED|Overall Study||357
10389107|NCT00651261|11531632|FG000|COMPLETED|Overall Study||69
10389108|NCT00651261|11531633|FG001|COMPLETED|Overall Study||51
10389109|NCT00651261|11531632|FG000|NOT COMPLETED|Overall Study||291
10389110|NCT00651261|11531633|FG001|NOT COMPLETED|Overall Study||306
10306999|NCT00103116|11439940|FG000|COMPLETED|Overall Study||32
10307000|NCT00103116|11439940|FG000|NOT COMPLETED|Overall Study||0
10307001|NCT00103142|11439946|FG000|STARTED|Overall Study||36
10307002|NCT00103142|11439947|FG001|STARTED|Overall Study||37
10307003|NCT00103142|11439946|FG000|COMPLETED|Overall Study||33
10307004|NCT00103142|11439947|FG001|COMPLETED|Overall Study||36
10307005|NCT00103142|11439946|FG000|NOT COMPLETED|Overall Study||3
10307006|NCT00103142|11439947|FG001|NOT COMPLETED|Overall Study||1
10307007|NCT00103194|11439955|FG000|STARTED|Overall Study||49
10307008|NCT00103194|11439955|FG000|Treated|Overall Study||49
10307009|NCT00103194|11439955|FG000|Eligible|Overall Study||35
10307010|NCT00103194|11439955|FG000|Eligible and Treated|Overall Study||35
10307011|NCT00103194|11439955|FG000|COMPLETED|Overall Study||18
10307012|NCT00103194|11439955|FG000|NOT COMPLETED|Overall Study||31
10307013|NCT00103207|11439959|FG000|STARTED|Overall Study||72
10307014|NCT00103207|11439959|FG000|Eligible Patients w/ Confirmed Diagnosis|Overall Study||41
10428464|NCT00858364|11574512|FG001|Received Study Drug|Overall Study||1681
10428465|NCT00858364|11574511|FG000|COMPLETED|Overall Study||642
10428466|NCT00858364|11574512|FG001|COMPLETED|Overall Study||1246
10428467|NCT00858364|11574511|FG000|NOT COMPLETED|Overall Study||204
10428468|NCT00858364|11574512|FG001|NOT COMPLETED|Overall Study||457
10307015|NCT00103207|11439959|FG000|Eligible Patients w/ Smoking Status Data|Overall Study||37
10307016|NCT00103207|11439959|FG000|COMPLETED|Overall Study||34
10307017|NCT00103207|11439959|FG000|NOT COMPLETED|Overall Study||38
10307018|NCT00103259|11439967|FG000|STARTED|Overall Study||27
10307019|NCT00103259|11439968|FG001|STARTED|Overall Study||44
10428469|NCT00858390|11574520|FG000|STARTED|Overall Study||18
10428470|NCT00858390|11574521|FG001|STARTED|Overall Study||18
10428471|NCT00858390|11574520|FG000|COMPLETED|Overall Study||18
10428472|NCT00858390|11574521|FG001|COMPLETED|Overall Study||18
10428473|NCT00858390|11574520|FG000|NOT COMPLETED|Overall Study||0
10428474|NCT00858390|11574521|FG001|NOT COMPLETED|Overall Study||0
10428475|NCT00858403|11574527|FG000|STARTED|Overall Study||7
10428476|NCT00858403|11574527|FG000|COMPLETED|Overall Study||2
10428477|NCT00858403|11574527|FG000|NOT COMPLETED|Overall Study||5
10389111|NCT00651313|11531641|FG000|STARTED|Overall Study||41
10389112|NCT00651313|11531642|FG001|STARTED|Overall Study||43
10389113|NCT00651313|11531641|FG000|COMPLETED|Overall Study||35
10389114|NCT00651313|11531642|FG001|COMPLETED|Overall Study||37
10389115|NCT00651313|11531641|FG000|NOT COMPLETED|Overall Study||6
10389116|NCT00651313|11531642|FG001|NOT COMPLETED|Overall Study||6
10389117|NCT00651482|11531648|FG000|STARTED|Overall Study||10
10389118|NCT00651482|11531648|FG000|COMPLETED|Overall Study||10
10389119|NCT00651482|11531648|FG000|NOT COMPLETED|Overall Study||0
10389120|NCT00651573|11531655|FG000|STARTED|Overall Study||365
10389121|NCT00651573|11531656|FG001|STARTED|Overall Study||357
10389122|NCT00651573|11531655|FG000|COMPLETED|Overall Study||363
10389123|NCT00651573|11531656|FG001|COMPLETED|Overall Study||354
10389124|NCT00651573|11531655|FG000|NOT COMPLETED|Overall Study||2
10389125|NCT00651573|11531656|FG001|NOT COMPLETED|Overall Study||3
10389126|NCT00651625|11531664|FG000|STARTED|Overall Study||219
10389127|NCT00651625|11531665|FG001|STARTED|Overall Study||218
10389128|NCT00651625|11531664|FG000|COMPLETED|Overall Study||219
10389129|NCT00651625|11531665|FG001|COMPLETED|Overall Study||218
10389130|NCT00651625|11531664|FG000|NOT COMPLETED|Overall Study||0
10389131|NCT00651625|11531665|FG001|NOT COMPLETED|Overall Study||0
10389132|NCT00651664|11531681|FG000|STARTED|Overall Study||3
10389133|NCT00651664|11531682|FG001|STARTED|Overall Study||3
10389134|NCT00651664|11531683|FG002|STARTED|Overall Study||3
10389135|NCT00651664|11531684|FG003|STARTED|Overall Study||14
10389136|NCT00651664|11531685|FG004|STARTED|Overall Study||6
10389137|NCT00651664|11531686|FG005|STARTED|Overall Study||3
10389138|NCT00651664|11531687|FG006|STARTED|Overall Study||6
10389139|NCT00651664|11531688|FG007|STARTED|Overall Study||7
10389140|NCT00651664|11531689|FG008|STARTED|Overall Study||7
10389141|NCT00651664|11531690|FG009|STARTED|Overall Study||7
10389142|NCT00651664|11531681|FG000|COMPLETED|Overall Study||0
10389143|NCT00651664|11531682|FG001|COMPLETED|Overall Study||0
10389144|NCT00651664|11531683|FG002|COMPLETED|Overall Study||0
10389145|NCT00651664|11531684|FG003|COMPLETED|Overall Study||0
10389146|NCT00651664|11531685|FG004|COMPLETED|Overall Study||0
10389147|NCT00651664|11531686|FG005|COMPLETED|Overall Study||0
10389148|NCT00651664|11531687|FG006|COMPLETED|Overall Study||0
10389149|NCT00651664|11531688|FG007|COMPLETED|Overall Study||0
10389150|NCT00651664|11531689|FG008|COMPLETED|Overall Study||0
10389151|NCT00651664|11531690|FG009|COMPLETED|Overall Study||0
10389152|NCT00651664|11531681|FG000|NOT COMPLETED|Overall Study||3
10389153|NCT00651664|11531682|FG001|NOT COMPLETED|Overall Study||3
10389154|NCT00651664|11531683|FG002|NOT COMPLETED|Overall Study||3
10389155|NCT00651664|11531684|FG003|NOT COMPLETED|Overall Study||14
10389156|NCT00651664|11531685|FG004|NOT COMPLETED|Overall Study||6
10389157|NCT00651664|11531686|FG005|NOT COMPLETED|Overall Study||3
10389158|NCT00651664|11531687|FG006|NOT COMPLETED|Overall Study||6
10389159|NCT00651664|11531688|FG007|NOT COMPLETED|Overall Study||7
10389160|NCT00651664|11531689|FG008|NOT COMPLETED|Overall Study||7
10389161|NCT00651664|11531690|FG009|NOT COMPLETED|Overall Study||7
10389162|NCT00651755|11531716|FG000|STARTED|Cycle 1 (First 21 Days)||11
10389163|NCT00651755|11531717|FG001|STARTED|Cycle 1 (First 21 Days)||9
10389164|NCT00651755|11531716|FG000|COMPLETED|Cycle 1 (First 21 Days)||10
10389165|NCT00651755|11531717|FG001|COMPLETED|Cycle 1 (First 21 Days)||9
10389166|NCT00651755|11531716|FG000|NOT COMPLETED|Cycle 1 (First 21 Days)||1
10389167|NCT00651755|11531717|FG001|NOT COMPLETED|Cycle 1 (First 21 Days)||0
10389168|NCT00651755|11531716|FG000|STARTED|Cycle 2 (Second 21 Days)||10
10389169|NCT00651755|11531717|FG001|STARTED|Cycle 2 (Second 21 Days)||9
10389170|NCT00651755|11531716|FG000|COMPLETED|Cycle 2 (Second 21 Days)||10
10389171|NCT00651755|11531717|FG001|COMPLETED|Cycle 2 (Second 21 Days)||8
10389172|NCT00651755|11531716|FG000|NOT COMPLETED|Cycle 2 (Second 21 Days)||0
10389173|NCT00651755|11531717|FG001|NOT COMPLETED|Cycle 2 (Second 21 Days)||1
10389174|NCT00651794|11531727|FG000|STARTED|Overall Study||36
10389175|NCT00651794|11531728|FG001|STARTED|Overall Study||31
10389176|NCT00651794|11531729|FG002|STARTED|Overall Study||31
10389177|NCT00651794|11531727|FG000|COMPLETED|Overall Study||15
10389178|NCT00651794|11531728|FG001|COMPLETED|Overall Study||9
10389179|NCT00651794|11531729|FG002|COMPLETED|Overall Study||10
10389180|NCT00651794|11531727|FG000|NOT COMPLETED|Overall Study||21
10389181|NCT00651794|11531728|FG001|NOT COMPLETED|Overall Study||22
10389182|NCT00651794|11531729|FG002|NOT COMPLETED|Overall Study||21
10389183|NCT00651820|11531737|FG000|STARTED|Overall Study||28
10389184|NCT00651820|11531737|FG000|COMPLETED|Overall Study||26
10389185|NCT00651820|11531737|FG000|NOT COMPLETED|Overall Study||2
10389186|NCT00651924|11531745|FG000|STARTED|Overall Study||18
10389187|NCT00651924|11531746|FG001|STARTED|Overall Study||9
10389188|NCT00651924|11531745|FG000|COMPLETED|Overall Study||18
10389189|NCT00651924|11531746|FG001|COMPLETED|Overall Study||2
10718338|NCT02703350|11882066|FG001|STARTED|Period Two (Part A)||5
10718339|NCT02703350|11882067|FG002|STARTED|Period Two (Part A)||5
10718340|NCT02703350|11882068|FG003|STARTED|Period Two (Part A)||5
10718341|NCT02703350|11882069|FG004|STARTED|Period Two (Part A)||5
10718342|NCT02703350|11882070|FG005|STARTED|Period Two (Part A)||5
10389190|NCT00651924|11531745|FG000|NOT COMPLETED|Overall Study||0
10389191|NCT00651924|11531746|FG001|NOT COMPLETED|Overall Study||7
10389192|NCT00651937|11531754|FG000|STARTED|Overall Study||39
10389193|NCT00651937|11531755|FG001|STARTED|Overall Study||41
10541716|NCT01473940|11694893|FG001|NOT COMPLETED|Follow-up Until Death||0
10541717|NCT01473940|11694894|FG002|NOT COMPLETED|Follow-up Until Death||0
10541718|NCT01473940|11694895|FG003|NOT COMPLETED|Follow-up Until Death||0
10541719|NCT01473953|11694913|FG000|STARTED|Overall Study||6
10541720|NCT01473953|11694914|FG001|STARTED|Overall Study||6
10541721|NCT01473953|11694915|FG002|STARTED|Overall Study||6
10541722|NCT01473953|11694916|FG003|STARTED|Overall Study||5
10718343|NCT02703350|11882071|FG006|STARTED|Period Two (Part A)||0
10718344|NCT02703350|11882072|FG007|STARTED|Period Two (Part A)||0
10389194|NCT00651937|11531754|FG000|COMPLETED|Overall Study||35
10389195|NCT00651937|11531755|FG001|COMPLETED|Overall Study||40
10389196|NCT00651937|11531754|FG000|NOT COMPLETED|Overall Study||4
10541723|NCT01473953|11694917|FG004|STARTED|Overall Study||8
10718345|NCT02703350|11882065|FG000|Received Study Drug|Period Two (Part A)||5
10389197|NCT00651937|11531755|FG001|NOT COMPLETED|Overall Study||1
10389198|NCT00652028|11531765|FG000|STARTED|Overall Study||16
10389199|NCT00652028|11531766|FG001|STARTED|Overall Study||14
10389200|NCT00652028|11531767|FG002|STARTED|Overall Study||15
10389201|NCT00652028|11531768|FG003|STARTED|Overall Study||14
10389202|NCT00652028|11531765|FG000|COMPLETED|Overall Study||15
10389203|NCT00652028|11531766|FG001|COMPLETED|Overall Study||13
10389204|NCT00652028|11531767|FG002|COMPLETED|Overall Study||14
10389205|NCT00652028|11531768|FG003|COMPLETED|Overall Study||14
10389206|NCT00652028|11531765|FG000|NOT COMPLETED|Overall Study||1
10389207|NCT00652028|11531766|FG001|NOT COMPLETED|Overall Study||1
10389208|NCT00652028|11531767|FG002|NOT COMPLETED|Overall Study||1
10389209|NCT00652028|11531768|FG003|NOT COMPLETED|Overall Study||0
10389210|NCT00652080|11531778|FG000|STARTED|Overall Study||35
10389211|NCT00652080|11531778|FG000|COMPLETED|Overall Study||31
10389212|NCT00652080|11531778|FG000|NOT COMPLETED|Overall Study||4
10389213|NCT00652093|11531790|FG000|STARTED|Overall Study||4
10389214|NCT00652093|11531791|FG001|STARTED|Overall Study||4
10389215|NCT00652093|11531792|FG002|STARTED|Overall Study||4
10389216|NCT00652093|11531793|FG003|STARTED|Overall Study||4
10389217|NCT00652093|11531794|FG004|STARTED|Overall Study||4
10389218|NCT00652093|11531795|FG005|STARTED|Overall Study||4
10389219|NCT00652093|11531790|FG000|COMPLETED|Overall Study||4
10389220|NCT00652093|11531791|FG001|COMPLETED|Overall Study||4
10389221|NCT00652093|11531792|FG002|COMPLETED|Overall Study||3
10389222|NCT00652093|11531793|FG003|COMPLETED|Overall Study||4
10389223|NCT00652093|11531794|FG004|COMPLETED|Overall Study||2
10389224|NCT00652093|11531795|FG005|COMPLETED|Overall Study||4
10389225|NCT00652093|11531790|FG000|NOT COMPLETED|Overall Study||0
10389226|NCT00652093|11531791|FG001|NOT COMPLETED|Overall Study||0
10389227|NCT00652093|11531792|FG002|NOT COMPLETED|Overall Study||1
10389228|NCT00652093|11531793|FG003|NOT COMPLETED|Overall Study||0
10389229|NCT00652093|11531794|FG004|NOT COMPLETED|Overall Study||2
10389230|NCT00652093|11531795|FG005|NOT COMPLETED|Overall Study||0
10389231|NCT00652145|11531811|FG000|STARTED|Overall Study||26
10389232|NCT00652145|11531812|FG001|STARTED|Overall Study||26
10389233|NCT00652145|11531811|FG000|COMPLETED|Overall Study||26
10389234|NCT00652145|11531812|FG001|COMPLETED|Overall Study||26
10718346|NCT02703350|11882066|FG001|Received Study Drug|Period Two (Part A)||5
10389235|NCT00652145|11531811|FG000|NOT COMPLETED|Overall Study||0
10389236|NCT00652145|11531812|FG001|NOT COMPLETED|Overall Study||0
10389237|NCT00652314|11531822|FG000|STARTED|Overall Study||62
10389238|NCT00652314|11531823|FG001|STARTED|Overall Study||35
10389239|NCT00652314|11531822|FG000|COMPLETED|Overall Study||53
10389240|NCT00652314|11531823|FG001|COMPLETED|Overall Study||26
10389241|NCT00652314|11531822|FG000|NOT COMPLETED|Overall Study||9
10389242|NCT00652314|11531823|FG001|NOT COMPLETED|Overall Study||9
10389243|NCT00652340|11531831|FG000|STARTED|Overall Study||78
10389244|NCT00652340|11531832|FG001|STARTED|Overall Study||42
10389245|NCT00652340|11531831|FG000|COMPLETED|Overall Study|4 patients remained on study at database lock.|74
10389246|NCT00652340|11531832|FG001|COMPLETED|Overall Study|3 patients remained on study at database lock.|39
10389247|NCT00652340|11531831|FG000|NOT COMPLETED|Overall Study||4
10389248|NCT00652340|11531832|FG001|NOT COMPLETED|Overall Study||3
10389249|NCT00652366|11531843|FG000|STARTED|Overall Study||106
10389250|NCT00652366|11531844|FG001|STARTED|Overall Study||75
10389251|NCT00652366|11531845|FG002|STARTED|Overall Study||71
10389252|NCT00652366|11531846|FG003|STARTED|Overall Study||179
10389253|NCT00652366|11531847|FG004|STARTED|Overall Study||36
10389254|NCT00652366|11531843|FG000|COMPLETED|Overall Study||0
10389255|NCT00652366|11531844|FG001|COMPLETED|Overall Study||0
10389256|NCT00652366|11531845|FG002|COMPLETED|Overall Study||0
10389257|NCT00652366|11531846|FG003|COMPLETED|Overall Study||0
10389258|NCT00652366|11531847|FG004|COMPLETED|Overall Study||0
10389259|NCT00652366|11531843|FG000|NOT COMPLETED|Overall Study||106
10389260|NCT00652366|11531844|FG001|NOT COMPLETED|Overall Study||75
10389261|NCT00652366|11531845|FG002|NOT COMPLETED|Overall Study||71
10389262|NCT00652366|11531846|FG003|NOT COMPLETED|Overall Study||179
10389263|NCT00652366|11531847|FG004|NOT COMPLETED|Overall Study||36
10389264|NCT00652626|11531868|FG000|STARTED|Initial Treatment Phase||5
10389265|NCT00652626|11531869|FG001|STARTED|Initial Treatment Phase||5
10389266|NCT00652626|11531870|FG002|STARTED|Initial Treatment Phase||7
10389267|NCT00652626|11531871|FG003|STARTED|Initial Treatment Phase||6
10389268|NCT00652626|11531872|FG004|STARTED|Initial Treatment Phase||8
10389269|NCT00652626|11531873|FG005|STARTED|Initial Treatment Phase||0
10389270|NCT00652626|11531874|FG006|STARTED|Initial Treatment Phase||0
10389271|NCT00652626|11531868|FG000|Received Study Drug|Initial Treatment Phase||5
10389272|NCT00652626|11531869|FG001|Received Study Drug|Initial Treatment Phase||5
10389273|NCT00652626|11531870|FG002|Received Study Drug|Initial Treatment Phase||6
10389274|NCT00652626|11531871|FG003|Received Study Drug|Initial Treatment Phase||5
10389275|NCT00652626|11531872|FG004|Received Study Drug|Initial Treatment Phase||6
10389276|NCT00652626|11531873|FG005|Received Study Drug|Initial Treatment Phase||0
10389277|NCT00652626|11531874|FG006|Received Study Drug|Initial Treatment Phase||0
10389278|NCT00652626|11531868|FG000|COMPLETED|Initial Treatment Phase||5
10389279|NCT00652626|11531869|FG001|COMPLETED|Initial Treatment Phase||5
10389280|NCT00652626|11531870|FG002|COMPLETED|Initial Treatment Phase||6
10389281|NCT00652626|11531871|FG003|COMPLETED|Initial Treatment Phase||5
10389282|NCT00652626|11531872|FG004|COMPLETED|Initial Treatment Phase||5
10389283|NCT00652626|11531873|FG005|COMPLETED|Initial Treatment Phase||0
10389284|NCT00652626|11531874|FG006|COMPLETED|Initial Treatment Phase||0
10389285|NCT00652626|11531868|FG000|NOT COMPLETED|Initial Treatment Phase||0
10389286|NCT00652626|11531869|FG001|NOT COMPLETED|Initial Treatment Phase||0
10389287|NCT00652626|11531870|FG002|NOT COMPLETED|Initial Treatment Phase||1
10389288|NCT00652626|11531871|FG003|NOT COMPLETED|Initial Treatment Phase||1
10389289|NCT00652626|11531872|FG004|NOT COMPLETED|Initial Treatment Phase||3
10389290|NCT00652626|11531873|FG005|NOT COMPLETED|Initial Treatment Phase||0
10389291|NCT00652626|11531874|FG006|NOT COMPLETED|Initial Treatment Phase||0
10389292|NCT00652626|11531868|FG000|STARTED|Extension Phase||0
10389293|NCT00652626|11531869|FG001|STARTED|Extension Phase||0
10389294|NCT00652626|11531870|FG002|STARTED|Extension Phase||0
10389295|NCT00652626|11531871|FG003|STARTED|Extension Phase||0
10389296|NCT00652626|11531872|FG004|STARTED|Extension Phase||0
10389297|NCT00652626|11531873|FG005|STARTED|Extension Phase||14
10389298|NCT00652626|11531874|FG006|STARTED|Extension Phase||4
10389299|NCT00652626|11531868|FG000|COMPLETED|Extension Phase||0
10389300|NCT00652626|11531869|FG001|COMPLETED|Extension Phase||0
10389301|NCT00652626|11531870|FG002|COMPLETED|Extension Phase||0
10389302|NCT00652626|11531871|FG003|COMPLETED|Extension Phase||0
10389303|NCT00652626|11531872|FG004|COMPLETED|Extension Phase||0
10389304|NCT00652626|11531873|FG005|COMPLETED|Extension Phase|A participant was considered completed if they had completed 6 cycles of therapy.|2
10389305|NCT00652626|11531874|FG006|COMPLETED|Extension Phase|A participant was considered completed if they had completed 6 cycles of therapy.|1
10389306|NCT00652626|11531868|FG000|NOT COMPLETED|Extension Phase||0
10389307|NCT00652626|11531869|FG001|NOT COMPLETED|Extension Phase||0
10389308|NCT00652626|11531870|FG002|NOT COMPLETED|Extension Phase||0
10389309|NCT00652626|11531871|FG003|NOT COMPLETED|Extension Phase||0
10389310|NCT00652626|11531872|FG004|NOT COMPLETED|Extension Phase||0
10389311|NCT00652626|11531873|FG005|NOT COMPLETED|Extension Phase||12
10389312|NCT00652626|11531874|FG006|NOT COMPLETED|Extension Phase||3
10389313|NCT00652743|11531895|FG000|STARTED|Months 12-18||219
10389314|NCT00652743|11531896|FG001|STARTED|Months 12-18||188
10389315|NCT00652743|11531897|FG002|STARTED|Months 12-18||437
10389316|NCT00652743|11531895|FG000|COMPLETED|Months 12-18||218
10389317|NCT00652743|11531896|FG001|COMPLETED|Months 12-18||186
10389318|NCT00652743|11531897|FG002|COMPLETED|Months 12-18||430
10389319|NCT00652743|11531895|FG000|NOT COMPLETED|Months 12-18||1
10389320|NCT00652743|11531896|FG001|NOT COMPLETED|Months 12-18||2
10389321|NCT00652743|11531897|FG002|NOT COMPLETED|Months 12-18||7
10389322|NCT00652743|11531895|FG000|STARTED|Months 24-30||212
10389323|NCT00652743|11531896|FG001|STARTED|Months 24-30||186
10389324|NCT00652743|11531897|FG002|STARTED|Months 24-30||433
10389325|NCT00652743|11531895|FG000|COMPLETED|Months 24-30||207
10389326|NCT00652743|11531896|FG001|COMPLETED|Months 24-30||185
10389327|NCT00652743|11531897|FG002|COMPLETED|Months 24-30||422
10389328|NCT00652743|11531895|FG000|NOT COMPLETED|Months 24-30||5
10389329|NCT00652743|11531896|FG001|NOT COMPLETED|Months 24-30||1
10389330|NCT00652743|11531897|FG002|NOT COMPLETED|Months 24-30||11
10389331|NCT00652743|11531895|FG000|STARTED|Months 36-42||216
10389332|NCT00652743|11531896|FG001|STARTED|Months 36-42||185
10389333|NCT00652743|11531897|FG002|STARTED|Months 36-42||390
10389334|NCT00652743|11531895|FG000|COMPLETED|Months 36-42||210
10389335|NCT00652743|11531896|FG001|COMPLETED|Months 36-42||180
10389336|NCT00652743|11531897|FG002|COMPLETED|Months 36-42||381
10389337|NCT00652743|11531895|FG000|NOT COMPLETED|Months 36-42||6
10389338|NCT00652743|11531896|FG001|NOT COMPLETED|Months 36-42||5
10389339|NCT00652743|11531897|FG002|NOT COMPLETED|Months 36-42||9
10389340|NCT00652743|11531895|FG000|STARTED|Months 42-48||196
10389341|NCT00652743|11531896|FG001|STARTED|Months 42-48||170
10389342|NCT00652743|11531897|FG002|STARTED|Months 42-48||367
10389343|NCT00652743|11531895|FG000|COMPLETED|Months 42-48||196
10389344|NCT00652743|11531896|FG001|COMPLETED|Months 42-48||170
10389345|NCT00652743|11531897|FG002|COMPLETED|Months 42-48||367
10389346|NCT00652743|11531895|FG000|NOT COMPLETED|Months 42-48||0
10389347|NCT00652743|11531896|FG001|NOT COMPLETED|Months 42-48||0
10389348|NCT00652743|11531897|FG002|NOT COMPLETED|Months 42-48||0
10389349|NCT00652834|11531908|FG000|STARTED|Overall Study||23
10389350|NCT00652834|11531908|FG000|COMPLETED|Overall Study|3 subjects withdrew after completing baseline questionnaire. 2 did not complete 30-day visit.|18
10389351|NCT00652834|11531908|FG000|NOT COMPLETED|Overall Study||5
10389352|NCT00652899|11531912|FG000|STARTED|Overall Study||14
10389353|NCT00652899|11531912|FG000|COMPLETED|Overall Study||12
10389354|NCT00652899|11531912|FG000|NOT COMPLETED|Overall Study||2
10541724|NCT01473953|11694913|FG000|COMPLETED|Overall Study||5
10541725|NCT01473953|11694914|FG001|COMPLETED|Overall Study||6
10541726|NCT01473953|11694915|FG002|COMPLETED|Overall Study||6
10541727|NCT01473953|11694916|FG003|COMPLETED|Overall Study||5
10541728|NCT01473953|11694917|FG004|COMPLETED|Overall Study||8
10541729|NCT01473953|11694913|FG000|NOT COMPLETED|Overall Study||1
10541730|NCT01473953|11694914|FG001|NOT COMPLETED|Overall Study||0
10541731|NCT01473953|11694915|FG002|NOT COMPLETED|Overall Study||0
10541732|NCT01473953|11694916|FG003|NOT COMPLETED|Overall Study||0
10541733|NCT01473953|11694917|FG004|NOT COMPLETED|Overall Study||0
10541734|NCT01473992|11694931|FG000|STARTED|Overall Study||10
10541735|NCT01473992|11694932|FG001|STARTED|Overall Study||10
10541736|NCT01473992|11694933|FG002|STARTED|Overall Study||5
10541737|NCT01473992|11694931|FG000|COMPLETED|Overall Study||10
10541738|NCT01473992|11694932|FG001|COMPLETED|Overall Study||10
10541739|NCT01473992|11694933|FG002|COMPLETED|Overall Study||5
10541740|NCT01473992|11694931|FG000|NOT COMPLETED|Overall Study||0
10541741|NCT01473992|11694932|FG001|NOT COMPLETED|Overall Study||0
10541742|NCT01473992|11694933|FG002|NOT COMPLETED|Overall Study||0
10541743|NCT01474018|11694943|FG000|STARTED|Overall Study||5
10541744|NCT01474018|11694944|FG001|STARTED|Overall Study||10
10541745|NCT01474018|11694943|FG000|COMPLETED|Overall Study|Writing paper|5
10541746|NCT01474018|11694944|FG001|COMPLETED|Overall Study||7
10541747|NCT01474018|11694943|FG000|NOT COMPLETED|Overall Study||0
10541748|NCT01474018|11694944|FG001|NOT COMPLETED|Overall Study||3
10541749|NCT01474109|11694953|FG000|STARTED|Period 1: Baseline to Week 16||95
10541750|NCT01474109|11694954|FG001|STARTED|Period 1: Baseline to Week 16||97
10541751|NCT01474109|11694955|FG002|STARTED|Period 1: Baseline to Week 16||97
10541752|NCT01474109|11694953|FG000|COMPLETED|Period 1: Baseline to Week 16||88
10541753|NCT01474109|11694954|FG001|COMPLETED|Period 1: Baseline to Week 16||91
10541754|NCT01474109|11694955|FG002|COMPLETED|Period 1: Baseline to Week 16||95
10541755|NCT01474109|11694953|FG000|NOT COMPLETED|Period 1: Baseline to Week 16||7
10541756|NCT01474109|11694954|FG001|NOT COMPLETED|Period 1: Baseline to Week 16||6
10541757|NCT01474109|11694955|FG002|NOT COMPLETED|Period 1: Baseline to Week 16||2
10541758|NCT01474109|11694953|FG000|STARTED|Period 2: Week 16 to End of Study||88
10541759|NCT01474109|11694954|FG001|STARTED|Period 2: Week 16 to End of Study||91
10658483|NCT02233647|11819556|FG000|10 mg Cocaine With 0 mg Phendimetrazine|Overall Study||11
10658484|NCT02233647|11819556|FG000|20 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
10658485|NCT02233647|11819556|FG000|40 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
10658486|NCT02233647|11819556|FG000|80 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
10658487|NCT02233647|11819556|FG000|0 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
10658488|NCT02233647|11819556|FG000|10 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
10658489|NCT02233647|11819556|FG000|20 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
10658490|NCT02233647|11819556|FG000|40 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
10658491|NCT02233647|11819556|FG000|80 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
10658492|NCT02233647|11819556|FG000|0 mg Cocaine With 140 mg Phendimetrazine|Overall Study||10
10658493|NCT02233647|11819556|FG000|10 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
10658494|NCT02233647|11819556|FG000|20 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
10658495|NCT02233647|11819556|FG000|40 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
10658496|NCT02233647|11819556|FG000|80 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
10658497|NCT02233647|11819556|FG000|0 mg Cocaine With 210 mg Phendimetrazine|Overall Study||10
10658498|NCT02233647|11819556|FG000|10 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
10658499|NCT02233647|11819556|FG000|20 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
10541760|NCT01474109|11694955|FG002|STARTED|Period 2: Week 16 to End of Study||95
10389355|NCT00652938|11531923|FG000|STARTED|Overall Study||247
10389356|NCT00652938|11531924|FG001|STARTED|Overall Study||247
10389357|NCT00652938|11531925|FG002|STARTED|Overall Study||247
10389358|NCT00652938|11531923|FG000|COMPLETED|Overall Study||246
10389359|NCT00652938|11531924|FG001|COMPLETED|Overall Study||240
10541761|NCT01474109|11694953|FG000|COMPLETED|Period 2: Week 16 to End of Study||70
10541762|NCT01474109|11694954|FG001|COMPLETED|Period 2: Week 16 to End of Study||73
10541763|NCT01474109|11694955|FG002|COMPLETED|Period 2: Week 16 to End of Study||83
10389360|NCT00652938|11531925|FG002|COMPLETED|Overall Study||242
10389361|NCT00652938|11531923|FG000|NOT COMPLETED|Overall Study||1
10389362|NCT00652938|11531924|FG001|NOT COMPLETED|Overall Study||7
10389363|NCT00652938|11531925|FG002|NOT COMPLETED|Overall Study||5
10389364|NCT00652951|11531936|FG000|STARTED|Primary Phase||260
10389365|NCT00652951|11531937|FG001|STARTED|Primary Phase||260
10389366|NCT00652951|11531938|FG002|STARTED|Primary Phase||260
10389367|NCT00652951|11531936|FG000|COMPLETED|Primary Phase||260
10389368|NCT00652951|11531937|FG001|COMPLETED|Primary Phase||260
10389369|NCT00652951|11531938|FG002|COMPLETED|Primary Phase||260
10389370|NCT00652951|11531936|FG000|NOT COMPLETED|Primary Phase||0
10389371|NCT00652951|11531937|FG001|NOT COMPLETED|Primary Phase||0
10389372|NCT00652951|11531938|FG002|NOT COMPLETED|Primary Phase||0
10389373|NCT00652951|11531936|FG000|STARTED|Booster Phase||257
10389374|NCT00652951|11531937|FG001|STARTED|Booster Phase||259
10389375|NCT00652951|11531938|FG002|STARTED|Booster Phase||258
10389376|NCT00652951|11531936|FG000|COMPLETED|Booster Phase||256
10389377|NCT00652951|11531937|FG001|COMPLETED|Booster Phase||258
10389378|NCT00652951|11531938|FG002|COMPLETED|Booster Phase||258
10389379|NCT00652951|11531936|FG000|NOT COMPLETED|Booster Phase||1
10389380|NCT00652951|11531937|FG001|NOT COMPLETED|Booster Phase||1
10389381|NCT00652951|11531938|FG002|NOT COMPLETED|Booster Phase||0
10389382|NCT00653133|11531948|FG000|STARTED|Overall Study||1324
10389383|NCT00653133|11531949|FG001|STARTED|Overall Study||497
10389384|NCT00653133|11531948|FG000|COMPLETED|Overall Study||1324
10389385|NCT00653133|11531949|FG001|COMPLETED|Overall Study||497
10389386|NCT00653133|11531948|FG000|NOT COMPLETED|Overall Study||0
10389387|NCT00653133|11531949|FG001|NOT COMPLETED|Overall Study||0
10389388|NCT00653159|11531957|FG000|STARTED|Overall Study||11
10389389|NCT00653159|11531958|FG001|STARTED|Overall Study||12
10389390|NCT00653159|11531957|FG000|COMPLETED|Overall Study||6
10389391|NCT00653159|11531958|FG001|COMPLETED|Overall Study||9
10389392|NCT00653159|11531957|FG000|NOT COMPLETED|Overall Study||5
10389393|NCT00653159|11531958|FG001|NOT COMPLETED|Overall Study||3
10389394|NCT00653224|11531966|FG000|STARTED|Overall Study||293
10389395|NCT00653224|11531967|FG001|STARTED|Overall Study||287
10389396|NCT00653224|11531966|FG000|COMPLETED|Overall Study||286
10389397|NCT00653224|11531967|FG001|COMPLETED|Overall Study||280
10389398|NCT00653224|11531966|FG000|NOT COMPLETED|Overall Study||7
10389399|NCT00653224|11531967|FG001|NOT COMPLETED|Overall Study||7
10389400|NCT00653263|11531973|FG000|STARTED|Overall Study|1 dropped out of treatment and the other had untreated hypertension|8
10389401|NCT00653263|11531973|FG000|COMPLETED|Overall Study||6
10389402|NCT00653263|11531973|FG000|NOT COMPLETED|Overall Study||2
10389403|NCT00653328|11531977|FG000|STARTED|Overall Study||15
10389404|NCT00653328|11531977|FG000|COMPLETED|Overall Study||0
10389405|NCT00653328|11531977|FG000|NOT COMPLETED|Overall Study||15
10389406|NCT00653432|11531983|FG000|STARTED|Overall Study||184
10389407|NCT00653432|11531984|FG001|STARTED|Overall Study||185
10389408|NCT00653432|11531983|FG000|Intend-to-treat ITT|Overall Study|3 of 184 excluded from ITT group for not having at least 1 post-injection visit. ITT=181 subjects|181
10389409|NCT00653432|11531984|FG001|Intend-to-treat ITT|Overall Study|1 of 185 excluded from ITT group for not having at least 1 post-injection visit. ITT=184 subjects|184
10389410|NCT00653432|11531983|FG000|COMPLETED|Overall Study||162
10389411|NCT00653432|11531984|FG001|COMPLETED|Overall Study||169
10389412|NCT00653432|11531983|FG000|NOT COMPLETED|Overall Study||22
10389413|NCT00653432|11531984|FG001|NOT COMPLETED|Overall Study||16
10389414|NCT00653861|11531990|FG000|STARTED|Overall Study||72
10541764|NCT01474109|11694953|FG000|NOT COMPLETED|Period 2: Week 16 to End of Study||18
10541765|NCT01474109|11694954|FG001|NOT COMPLETED|Period 2: Week 16 to End of Study||18
10541766|NCT01474109|11694955|FG002|NOT COMPLETED|Period 2: Week 16 to End of Study||12
10541767|NCT01474122|11694966|FG000|STARTED|Period 1: Baseline to Week 16||88
10541768|NCT01474122|11694967|FG001|STARTED|Period 1: Baseline to Week 16|One patient was randomised but did not receive study treatment|88
10541769|NCT01474122|11694968|FG002|STARTED|Period 1: Baseline to Week 16||89
10541770|NCT01474122|11694966|FG000|COMPLETED|Period 1: Baseline to Week 16||87
10541771|NCT01474122|11694967|FG001|COMPLETED|Period 1: Baseline to Week 16||86
10541772|NCT01474122|11694968|FG002|COMPLETED|Period 1: Baseline to Week 16||88
10541773|NCT01474122|11694966|FG000|NOT COMPLETED|Period 1: Baseline to Week 16||1
10541774|NCT01474122|11694967|FG001|NOT COMPLETED|Period 1: Baseline to Week 16||2
10541775|NCT01474122|11694968|FG002|NOT COMPLETED|Period 1: Baseline to Week 16||1
10541776|NCT01474122|11694966|FG000|STARTED|Period 2: Week 16 to End of Study||87
10389415|NCT00653861|11531990|FG000|COMPLETED|Overall Study||72
10389416|NCT00653861|11531990|FG000|NOT COMPLETED|Overall Study||0
10389417|NCT00653939|11532001|FG000|STARTED|Overall Study|2 patients randomized did not receive treatment due to brain metastasis or consent withdrawal.|31
10389418|NCT00653939|11532002|FG001|STARTED|Overall Study|1 patient randomized did not receive treatment due to acute renal failure.|32
10389419|NCT00653939|11532001|FG000|COMPLETED|Overall Study||19
10389420|NCT00653939|11532002|FG001|COMPLETED|Overall Study||17
10389421|NCT00653939|11532001|FG000|NOT COMPLETED|Overall Study||12
10389422|NCT00653939|11532002|FG001|NOT COMPLETED|Overall Study||15
10389423|NCT00653991|11532012|FG000|STARTED|3 Month Follow-up||444
10389424|NCT00653991|11532013|FG001|STARTED|3 Month Follow-up||491
10389425|NCT00653991|11532012|FG000|COMPLETED|3 Month Follow-up||294
10389426|NCT00653991|11532013|FG001|COMPLETED|3 Month Follow-up||334
10389427|NCT00653991|11532012|FG000|NOT COMPLETED|3 Month Follow-up||150
10389428|NCT00653991|11532013|FG001|NOT COMPLETED|3 Month Follow-up||157
10389429|NCT00653991|11532012|FG000|STARTED|6 Month Follow-up|Completion of 3 month follow-up was not required for 6-month eligibility.|444
10389430|NCT00653991|11532013|FG001|STARTED|6 Month Follow-up|Completion of 3 month follow-up was not required for 6-month eligibility.|491
10389431|NCT00653991|11532012|FG000|COMPLETED|6 Month Follow-up||311
10389432|NCT00653991|11532013|FG001|COMPLETED|6 Month Follow-up||350
10389433|NCT00653991|11532012|FG000|NOT COMPLETED|6 Month Follow-up||133
10389434|NCT00653991|11532013|FG001|NOT COMPLETED|6 Month Follow-up||141
10389435|NCT00654004|11532023|FG000|STARTED|Overall Study||14
10389436|NCT00654004|11532024|FG001|STARTED|Overall Study||12
10389437|NCT00654004|11532023|FG000|COMPLETED|Overall Study||13
10389438|NCT00654004|11532024|FG001|COMPLETED|Overall Study||12
10389439|NCT00654004|11532023|FG000|NOT COMPLETED|Overall Study||1
10389440|NCT00654004|11532024|FG001|NOT COMPLETED|Overall Study||0
10389441|NCT00654030|11532030|FG000|STARTED|Overall Study||12
10389442|NCT00654030|11532030|FG000|COMPLETED|Overall Study||11
10389443|NCT00654030|11532030|FG000|NOT COMPLETED|Overall Study||1
10389444|NCT00654069|11532037|FG000|STARTED|Overall Study||136
10389445|NCT00654069|11532038|FG001|STARTED|Overall Study||135
10389446|NCT00654069|11532039|FG002|STARTED|Overall Study||134
10389447|NCT00654069|11532037|FG000|COMPLETED|Overall Study||119
10389448|NCT00654069|11532038|FG001|COMPLETED|Overall Study||124
10389449|NCT00654069|11532039|FG002|COMPLETED|Overall Study||116
10389450|NCT00654069|11532037|FG000|NOT COMPLETED|Overall Study||17
10389451|NCT00654069|11532038|FG001|NOT COMPLETED|Overall Study||11
10389452|NCT00654069|11532039|FG002|NOT COMPLETED|Overall Study||18
10389453|NCT00654147|11532049|FG000|STARTED|Overall Study||21
10389454|NCT00654147|11532050|FG001|STARTED|Overall Study||23
10389455|NCT00654147|11532049|FG000|COMPLETED|Overall Study||19
10389456|NCT00654147|11532050|FG001|COMPLETED|Overall Study||19
10389457|NCT00654147|11532049|FG000|NOT COMPLETED|Overall Study||2
10389458|NCT00654147|11532050|FG001|NOT COMPLETED|Overall Study||4
10389459|NCT00654186|11532056|FG000|STARTED|Overall Study||32
10389460|NCT00654186|11532056|FG000|COMPLETED|Overall Study||27
10389461|NCT00654186|11532056|FG000|NOT COMPLETED|Overall Study||5
10389462|NCT00654238|11532060|FG000|STARTED|Overall Study||59
10389463|NCT00654238|11532060|FG000|COMPLETED|Overall Study||55
10389464|NCT00654238|11532060|FG000|NOT COMPLETED|Overall Study||4
10389465|NCT00654329|11532069|FG000|STARTED|Overall Study||23
10389466|NCT00654329|11532070|FG001|STARTED|Overall Study||28
10389467|NCT00654329|11532071|FG002|STARTED|Overall Study||23
10389468|NCT00654329|11532072|FG003|STARTED|Overall Study||27
10389469|NCT00654329|11532069|FG000|COMPLETED|Overall Study||23
10389470|NCT00654329|11532070|FG001|COMPLETED|Overall Study||28
10389471|NCT00654329|11532071|FG002|COMPLETED|Overall Study||23
10718347|NCT02703350|11882067|FG002|Received Study Drug|Period Two (Part A)||5
10718348|NCT02703350|11882068|FG003|Received Study Drug|Period Two (Part A)||5
10389472|NCT00654329|11532072|FG003|COMPLETED|Overall Study||27
10389473|NCT00654329|11532069|FG000|NOT COMPLETED|Overall Study||0
10389474|NCT00654329|11532070|FG001|NOT COMPLETED|Overall Study||0
10389475|NCT00654329|11532071|FG002|NOT COMPLETED|Overall Study||0
10389476|NCT00654329|11532072|FG003|NOT COMPLETED|Overall Study||0
10389477|NCT00654355|11532084|FG000|STARTED|Overall Study||15
10389478|NCT00654355|11532085|FG001|STARTED|Overall Study||15
10389479|NCT00654355|11532084|FG000|COMPLETED|Overall Study||13
10389480|NCT00654355|11532085|FG001|COMPLETED|Overall Study||13
10389481|NCT00654355|11532084|FG000|NOT COMPLETED|Overall Study||2
10389482|NCT00654355|11532085|FG001|NOT COMPLETED|Overall Study||2
10389483|NCT00654368|11532094|FG000|STARTED|Overall Study||53
10389484|NCT00654368|11532095|FG001|STARTED|Overall Study||98
10389485|NCT00654368|11532096|FG002|STARTED|Overall Study||107
10389486|NCT00654368|11532094|FG000|COMPLETED|Overall Study||0
10389487|NCT00654368|11532095|FG001|COMPLETED|Overall Study||50
10389488|NCT00654368|11532096|FG002|COMPLETED|Overall Study||75
10718349|NCT02703350|11882069|FG004|Received Study Drug|Period Two (Part A)||5
10718350|NCT02703350|11882070|FG005|Received Study Drug|Period Two (Part A)||5
10389489|NCT00654368|11532094|FG000|NOT COMPLETED|Overall Study||53
10389490|NCT00654368|11532095|FG001|NOT COMPLETED|Overall Study||48
10389491|NCT00654368|11532096|FG002|NOT COMPLETED|Overall Study||32
10389492|NCT00654381|11532107|FG000|STARTED|1st Stage||39
10389493|NCT00654381|11532108|FG001|STARTED|1st Stage||41
10389494|NCT00654381|11532109|FG002|STARTED|1st Stage||159
10389495|NCT00654381|11532110|FG003|STARTED|1st Stage||160
10389496|NCT00654381|11532111|FG004|STARTED|1st Stage||81
10389497|NCT00654381|11532112|FG005|STARTED|1st Stage||81
10389498|NCT00654381|11532107|FG000|COMPLETED|1st Stage||36
10389499|NCT00654381|11532108|FG001|COMPLETED|1st Stage||38
10389500|NCT00654381|11532109|FG002|COMPLETED|1st Stage||156
10389501|NCT00654381|11532110|FG003|COMPLETED|1st Stage||155
10389502|NCT00654381|11532111|FG004|COMPLETED|1st Stage||79
10389503|NCT00654381|11532112|FG005|COMPLETED|1st Stage||79
10389504|NCT00654381|11532107|FG000|NOT COMPLETED|1st Stage||3
10389505|NCT00654381|11532108|FG001|NOT COMPLETED|1st Stage||3
10389506|NCT00654381|11532109|FG002|NOT COMPLETED|1st Stage||3
10389507|NCT00654381|11532110|FG003|NOT COMPLETED|1st Stage||5
10389508|NCT00654381|11532111|FG004|NOT COMPLETED|1st Stage||2
10389509|NCT00654381|11532112|FG005|NOT COMPLETED|1st Stage||2
10389510|NCT00654381|11532107|FG000|STARTED|2nd Stage||36
10389511|NCT00654381|11532108|FG001|STARTED|2nd Stage||38
10389512|NCT00654381|11532109|FG002|STARTED|2nd Stage||156
10389513|NCT00654381|11532110|FG003|STARTED|2nd Stage||155
10389514|NCT00654381|11532111|FG004|STARTED|2nd Stage||79
10389515|NCT00654381|11532112|FG005|STARTED|2nd Stage||79
10389516|NCT00654381|11532107|FG000|COMPLETED|2nd Stage||34
10389517|NCT00654381|11532108|FG001|COMPLETED|2nd Stage||38
10389518|NCT00654381|11532109|FG002|COMPLETED|2nd Stage||153
10389519|NCT00654381|11532110|FG003|COMPLETED|2nd Stage||151
10389520|NCT00654381|11532111|FG004|COMPLETED|2nd Stage||71
10389521|NCT00654381|11532112|FG005|COMPLETED|2nd Stage||76
10389522|NCT00654381|11532107|FG000|NOT COMPLETED|2nd Stage||2
10389523|NCT00654381|11532108|FG001|NOT COMPLETED|2nd Stage||0
10389524|NCT00654381|11532109|FG002|NOT COMPLETED|2nd Stage||3
10389525|NCT00654381|11532110|FG003|NOT COMPLETED|2nd Stage||4
10389526|NCT00654381|11532111|FG004|NOT COMPLETED|2nd Stage||8
10389527|NCT00654381|11532112|FG005|NOT COMPLETED|2nd Stage||3
10389528|NCT00654381|11532107|FG000|STARTED|Extension Stage||34
10389529|NCT00654381|11532108|FG001|STARTED|Extension Stage||38
10389530|NCT00654381|11532109|FG002|STARTED|Extension Stage||153
10389531|NCT00654381|11532110|FG003|STARTED|Extension Stage||151
10389532|NCT00654381|11532111|FG004|STARTED|Extension Stage||71
10389533|NCT00654381|11532112|FG005|STARTED|Extension Stage||76
10389534|NCT00654381|11532107|FG000|COMPLETED|Extension Stage||33
10389535|NCT00654381|11532108|FG001|COMPLETED|Extension Stage||36
10389536|NCT00654381|11532109|FG002|COMPLETED|Extension Stage||142
10389537|NCT00654381|11532110|FG003|COMPLETED|Extension Stage||142
10389538|NCT00654381|11532111|FG004|COMPLETED|Extension Stage||68
10389539|NCT00654381|11532112|FG005|COMPLETED|Extension Stage||73
10389540|NCT00654381|11532107|FG000|NOT COMPLETED|Extension Stage||1
10389541|NCT00654381|11532108|FG001|NOT COMPLETED|Extension Stage||2
10389542|NCT00654381|11532109|FG002|NOT COMPLETED|Extension Stage||11
10389543|NCT00654381|11532110|FG003|NOT COMPLETED|Extension Stage||9
10389544|NCT00654381|11532111|FG004|NOT COMPLETED|Extension Stage||3
10389545|NCT00654381|11532112|FG005|NOT COMPLETED|Extension Stage||3
10389546|NCT00654420|11532133|FG000|STARTED|Phase I (Dose Escalation)||4
10389547|NCT00654420|11532134|FG001|STARTED|Phase I (Dose Escalation)||16
10389548|NCT00654420|11532135|FG002|STARTED|Phase I (Dose Escalation)||0
10389549|NCT00654420|11532136|FG003|STARTED|Phase I (Dose Escalation)||0
10389550|NCT00654420|11532133|FG000|COMPLETED|Phase I (Dose Escalation)||0
10389551|NCT00654420|11532134|FG001|COMPLETED|Phase I (Dose Escalation)||0
10389552|NCT00654420|11532135|FG002|COMPLETED|Phase I (Dose Escalation)||0
10389553|NCT00654420|11532136|FG003|COMPLETED|Phase I (Dose Escalation)||0
10389554|NCT00654420|11532133|FG000|NOT COMPLETED|Phase I (Dose Escalation)||4
10389555|NCT00654420|11532134|FG001|NOT COMPLETED|Phase I (Dose Escalation)||16
10389556|NCT00654420|11532135|FG002|NOT COMPLETED|Phase I (Dose Escalation)||0
10389557|NCT00654420|11532136|FG003|NOT COMPLETED|Phase I (Dose Escalation)||0
10389558|NCT00654420|11532133|FG000|STARTED|Phase II||0
10541777|NCT01474122|11694967|FG001|STARTED|Period 2: Week 16 to End of Study||86
10541778|NCT01474122|11694968|FG002|STARTED|Period 2: Week 16 to End of Study||88
10541779|NCT01474122|11694966|FG000|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|70
10541780|NCT01474122|11694967|FG001|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|73
10541781|NCT01474122|11694968|FG002|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|73
10541782|NCT01474122|11694966|FG000|NOT COMPLETED|Period 2: Week 16 to End of Study||17
10541783|NCT01474122|11694967|FG001|NOT COMPLETED|Period 2: Week 16 to End of Study||13
10541784|NCT01474122|11694968|FG002|NOT COMPLETED|Period 2: Week 16 to End of Study||15
10541785|NCT01474200|11694980|FG000|STARTED|Overall Study||110
10541786|NCT01474200|11694981|FG001|STARTED|Overall Study||114
10541787|NCT01474200|11694980|FG000|COMPLETED|Overall Study||81
10541788|NCT01474200|11694981|FG001|COMPLETED|Overall Study||84
10541789|NCT01474200|11694980|FG000|NOT COMPLETED|Overall Study||29
10541790|NCT01474200|11694981|FG001|NOT COMPLETED|Overall Study||30
10541791|NCT01474213|11694989|FG000|STARTED|Overall Study||20
10541792|NCT01474213|11694990|FG001|STARTED|Overall Study||20
10541793|NCT01474213|11694989|FG000|COMPLETED|Overall Study||20
10541794|NCT01474213|11694990|FG001|COMPLETED|Overall Study||20
10541795|NCT01474213|11694989|FG000|NOT COMPLETED|Overall Study||0
10541796|NCT01474213|11694990|FG001|NOT COMPLETED|Overall Study||0
10541797|NCT01474239|11695002|FG000|STARTED|Overall Study||59
10541798|NCT01474239|11695003|FG001|STARTED|Overall Study||32
10541799|NCT01474239|11695002|FG000|COMPLETED|Overall Study||0
10541800|NCT01474239|11695003|FG001|COMPLETED|Overall Study||0
10541801|NCT01474239|11695002|FG000|NOT COMPLETED|Overall Study||59
10541802|NCT01474239|11695003|FG001|NOT COMPLETED|Overall Study||32
10541803|NCT01474291|11695011|FG000|STARTED|Overall Study||603
10541804|NCT01474291|11695011|FG000|Evaluable for Efficacy|Overall Study|Received tocilizumab infusion and met all inclusion/exclusion criteria|577
10541805|NCT01474291|11695011|FG000|COMPLETED|Overall Study||383
10541806|NCT01474291|11695011|FG000|NOT COMPLETED|Overall Study||220
10541807|NCT01474317|11695018|FG000|STARTED|Overall Study||226
10541808|NCT01474317|11695018|FG000|COMPLETED|Overall Study||224
10541809|NCT01474317|11695018|FG000|NOT COMPLETED|Overall Study||2
10541810|NCT01474434|11695026|FG000|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||8
10541811|NCT01474434|11695027|FG001|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||9
10541812|NCT01474434|11695028|FG002|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||11
10541813|NCT01474434|11695029|FG003|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||13
10541814|NCT01474434|11695026|FG000|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||7
10541815|NCT01474434|11695027|FG001|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||9
10541816|NCT01474434|11695028|FG002|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||10
10541817|NCT01474434|11695029|FG003|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||11
10541818|NCT01474434|11695026|FG000|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||1
10541819|NCT01474434|11695027|FG001|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||0
10541820|NCT01474434|11695028|FG002|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||1
10541821|NCT01474434|11695029|FG003|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||2
10541822|NCT01474434|11695026|FG000|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||7
10541823|NCT01474434|11695027|FG001|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||9
10541824|NCT01474434|11695028|FG002|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||10
10541825|NCT01474434|11695029|FG003|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||11
10541826|NCT01474434|11695026|FG000|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||7
10541827|NCT01474434|11695027|FG001|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||9
10541828|NCT01474434|11695028|FG002|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||10
10541829|NCT01474434|11695029|FG003|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||11
10541830|NCT01474434|11695026|FG000|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
10541831|NCT01474434|11695027|FG001|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
10541832|NCT01474434|11695028|FG002|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
10541833|NCT01474434|11695029|FG003|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
10541834|NCT01474486|11695043|FG000|STARTED|Overall Study||28
10541835|NCT01474486|11695043|FG000|Treated|Overall Study||22
10541836|NCT01474486|11695043|FG000|COMPLETED|Overall Study||20
10541837|NCT01474486|11695043|FG000|NOT COMPLETED|Overall Study||8
10541838|NCT01474512|11695054|FG000|STARTED|Induction Period||431
10541839|NCT01474512|11695055|FG001|STARTED|Induction Period||432
10541840|NCT01474512|11695056|FG002|STARTED|Induction Period||433
10541841|NCT01474512|11695057|FG003|STARTED|Induction Period||0
10541842|NCT01474512|11695058|FG004|STARTED|Induction Period||0
10541843|NCT01474512|11695059|FG005|STARTED|Induction Period||0
10541844|NCT01474512|11695060|FG006|STARTED|Induction Period||0
10541845|NCT01474512|11695061|FG007|STARTED|Induction Period||0
10541846|NCT01474512|11695062|FG008|STARTED|Induction Period||0
10541847|NCT01474512|11695063|FG009|STARTED|Induction Period||0
10541848|NCT01474512|11695064|FG010|STARTED|Induction Period||0
10541849|NCT01474512|11695065|FG011|STARTED|Induction Period||0
10541850|NCT01474512|11695066|FG012|STARTED|Induction Period||0
10541851|NCT01474512|11695067|FG013|STARTED|Induction Period||0
10541852|NCT01474512|11695068|FG014|STARTED|Induction Period||0
10541853|NCT01474512|11695069|FG015|STARTED|Induction Period||0
10541854|NCT01474512|11695070|FG016|STARTED|Induction Period||0
10541855|NCT01474512|11695071|FG017|STARTED|Induction Period||0
10718351|NCT02703350|11882071|FG006|Received Study Drug|Period Two (Part A)||0
10718352|NCT02703350|11882072|FG007|Received Study Drug|Period Two (Part A)||0
10541856|NCT01474512|11695054|FG000|Received Study Drug|Induction Period||431
10541857|NCT01474512|11695055|FG001|Received Study Drug|Induction Period||432
10718353|NCT02703350|11882065|FG000|COMPLETED|Period Two (Part A)||5
10541858|NCT01474512|11695056|FG002|Received Study Drug|Induction Period||433
10541859|NCT01474512|11695057|FG003|Received Study Drug|Induction Period||0
10541860|NCT01474512|11695058|FG004|Received Study Drug|Induction Period||0
10541861|NCT01474512|11695059|FG005|Received Study Drug|Induction Period||0
10541862|NCT01474512|11695060|FG006|Received Study Drug|Induction Period||0
10541863|NCT01474512|11695061|FG007|Received Study Drug|Induction Period||0
10541864|NCT01474512|11695062|FG008|Received Study Drug|Induction Period||0
10541865|NCT01474512|11695063|FG009|Received Study Drug|Induction Period||0
10541866|NCT01474512|11695064|FG010|Received Study Drug|Induction Period||0
10541867|NCT01474512|11695065|FG011|Received Study Drug|Induction Period||0
10541868|NCT01474512|11695066|FG012|Received Study Drug|Induction Period||0
10541869|NCT01474512|11695067|FG013|Received Study Drug|Induction Period||0
10541870|NCT01474512|11695068|FG014|Received Study Drug|Induction Period||0
10541871|NCT01474512|11695069|FG015|Received Study Drug|Induction Period||0
10541872|NCT01474512|11695070|FG016|Received Study Drug|Induction Period||0
10541873|NCT01474512|11695071|FG017|Received Study Drug|Induction Period||0
10541874|NCT01474512|11695054|FG000|COMPLETED|Induction Period||407
10541875|NCT01474512|11695055|FG001|COMPLETED|Induction Period||408
10541876|NCT01474512|11695056|FG002|COMPLETED|Induction Period||415
10541877|NCT01474512|11695057|FG003|COMPLETED|Induction Period||0
10541878|NCT01474512|11695058|FG004|COMPLETED|Induction Period||0
10541879|NCT01474512|11695059|FG005|COMPLETED|Induction Period||0
10541880|NCT01474512|11695060|FG006|COMPLETED|Induction Period||0
10541881|NCT01474512|11695061|FG007|COMPLETED|Induction Period||0
10541882|NCT01474512|11695062|FG008|COMPLETED|Induction Period||0
10541883|NCT01474512|11695063|FG009|COMPLETED|Induction Period||0
10541884|NCT01474512|11695064|FG010|COMPLETED|Induction Period||0
10541885|NCT01474512|11695065|FG011|COMPLETED|Induction Period||0
10541886|NCT01474512|11695066|FG012|COMPLETED|Induction Period||0
10541887|NCT01474512|11695067|FG013|COMPLETED|Induction Period||0
10541888|NCT01474512|11695068|FG014|COMPLETED|Induction Period||0
10541889|NCT01474512|11695069|FG015|COMPLETED|Induction Period||0
10541890|NCT01474512|11695070|FG016|COMPLETED|Induction Period||0
10541891|NCT01474512|11695071|FG017|COMPLETED|Induction Period||0
10541892|NCT01474512|11695054|FG000|NOT COMPLETED|Induction Period||24
10541893|NCT01474512|11695055|FG001|NOT COMPLETED|Induction Period||24
10541894|NCT01474512|11695056|FG002|NOT COMPLETED|Induction Period||18
10541895|NCT01474512|11695057|FG003|NOT COMPLETED|Induction Period||0
10541896|NCT01474512|11695058|FG004|NOT COMPLETED|Induction Period||0
10541897|NCT01474512|11695059|FG005|NOT COMPLETED|Induction Period||0
10541898|NCT01474512|11695060|FG006|NOT COMPLETED|Induction Period||0
10541899|NCT01474512|11695061|FG007|NOT COMPLETED|Induction Period||0
10541900|NCT01474512|11695062|FG008|NOT COMPLETED|Induction Period||0
10541901|NCT01474512|11695063|FG009|NOT COMPLETED|Induction Period||0
10541902|NCT01474512|11695064|FG010|NOT COMPLETED|Induction Period||0
10541903|NCT01474512|11695065|FG011|NOT COMPLETED|Induction Period||0
10541904|NCT01474512|11695066|FG012|NOT COMPLETED|Induction Period||0
10541905|NCT01474512|11695067|FG013|NOT COMPLETED|Induction Period||0
10541906|NCT01474512|11695068|FG014|NOT COMPLETED|Induction Period||0
10541907|NCT01474512|11695069|FG015|NOT COMPLETED|Induction Period||0
10541908|NCT01474512|11695070|FG016|NOT COMPLETED|Induction Period||0
10541909|NCT01474512|11695071|FG017|NOT COMPLETED|Induction Period||0
10541910|NCT01474512|11695054|FG000|STARTED|Maintenance Period||0
10541911|NCT01474512|11695055|FG001|STARTED|Maintenance Period||0
10541912|NCT01474512|11695056|FG002|STARTED|Maintenance Period||0
10541913|NCT01474512|11695057|FG003|STARTED|Maintenance Period||226
10541914|NCT01474512|11695058|FG004|STARTED|Maintenance Period|One participant withdrew end of Induction but re-randomized and treated with maintenance dose ixe.|227
10541915|NCT01474512|11695059|FG005|STARTED|Maintenance Period||229
10541916|NCT01474512|11695060|FG006|STARTED|Maintenance Period||16
10541917|NCT01474512|11695061|FG007|STARTED|Maintenance Period||391
10658500|NCT02233647|11819556|FG000|40 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
10658501|NCT02233647|11819556|FG000|80 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
10658502|NCT02233647|11819556|FG000|COMPLETED|Overall Study||10
10658503|NCT02233647|11819556|FG000|NOT COMPLETED|Overall Study||1
10658504|NCT02233738|11819562|FG000|STARTED|Overall Study||93
10658505|NCT02233738|11819563|FG001|STARTED|Overall Study||91
10658506|NCT02233738|11819562|FG000|1 Month Follow-Up|Overall Study||89
10658507|NCT02233738|11819563|FG001|1 Month Follow-Up|Overall Study||82
10658508|NCT02233738|11819562|FG000|3 Month Follow-Up|Overall Study||87
10658509|NCT02233738|11819563|FG001|3 Month Follow-Up|Overall Study||77
10541918|NCT01474512|11695062|FG008|STARTED|Maintenance Period||78
10541919|NCT01474512|11695063|FG009|STARTED|Maintenance Period||62
10541920|NCT01474512|11695064|FG010|STARTED|Maintenance Period||0
10541921|NCT01474512|11695065|FG011|STARTED|Maintenance Period||0
10541922|NCT01474512|11695066|FG012|STARTED|Maintenance Period||0
10541923|NCT01474512|11695067|FG013|STARTED|Maintenance Period||0
10658510|NCT02233738|11819562|FG000|6 Month Follow-Up|Overall Study||85
10658511|NCT02233738|11819563|FG001|6 Month Follow-Up|Overall Study||75
10658512|NCT02233738|11819562|FG000|COMPLETED|Overall Study||85
10541924|NCT01474512|11695068|FG014|STARTED|Maintenance Period||0
10541925|NCT01474512|11695069|FG015|STARTED|Maintenance Period||0
10541926|NCT01474512|11695070|FG016|STARTED|Maintenance Period||0
10541927|NCT01474512|11695071|FG017|STARTED|Maintenance Period||0
10541928|NCT01474512|11695054|FG000|Received Study Drug|Maintenance Period||0
10541929|NCT01474512|11695055|FG001|Received Study Drug|Maintenance Period||0
10541930|NCT01474512|11695056|FG002|Received Study Drug|Maintenance Period||0
10541931|NCT01474512|11695057|FG003|Received Study Drug|Maintenance Period||226
10541932|NCT01474512|11695058|FG004|Received Study Drug|Maintenance Period||227
10541933|NCT01474512|11695059|FG005|Received Study Drug|Maintenance Period||229
10541934|NCT01474512|11695060|FG006|Received Study Drug|Maintenance Period||16
10541935|NCT01474512|11695061|FG007|Received Study Drug|Maintenance Period||391
10541936|NCT01474512|11695062|FG008|Received Study Drug|Maintenance Period||78
10541937|NCT01474512|11695063|FG009|Received Study Drug|Maintenance Period||62
10541938|NCT01474512|11695064|FG010|Received Study Drug|Maintenance Period||0
10541939|NCT01474512|11695065|FG011|Received Study Drug|Maintenance Period||0
10541940|NCT01474512|11695066|FG012|Received Study Drug|Maintenance Period||0
10541941|NCT01474512|11695067|FG013|Received Study Drug|Maintenance Period||0
10541942|NCT01474512|11695068|FG014|Received Study Drug|Maintenance Period||0
10541943|NCT01474512|11695069|FG015|Received Study Drug|Maintenance Period||0
10541944|NCT01474512|11695070|FG016|Received Study Drug|Maintenance Period||0
10541945|NCT01474512|11695071|FG017|Received Study Drug|Maintenance Period||0
10541946|NCT01474512|11695054|FG000|Relapsed Population Received Drug|Maintenance Period||0
10541947|NCT01474512|11695055|FG001|Relapsed Population Received Drug|Maintenance Period||0
10541948|NCT01474512|11695056|FG002|Relapsed Population Received Drug|Maintenance Period||0
10541949|NCT01474512|11695057|FG003|Relapsed Population Received Drug|Maintenance Period||0
10541950|NCT01474512|11695058|FG004|Relapsed Population Received Drug|Maintenance Period||0
10541951|NCT01474512|11695059|FG005|Relapsed Population Received Drug|Maintenance Period||0
10541952|NCT01474512|11695060|FG006|Relapsed Population Received Drug|Maintenance Period||0
10541953|NCT01474512|11695061|FG007|Relapsed Population Received Drug|Maintenance Period||0
10541954|NCT01474512|11695062|FG008|Relapsed Population Received Drug|Maintenance Period||0
10541955|NCT01474512|11695063|FG009|Relapsed Population Received Drug|Maintenance Period||0
10541956|NCT01474512|11695064|FG010|Relapsed Population Received Drug|Maintenance Period||348
10541957|NCT01474512|11695065|FG011|Relapsed Population Received Drug|Maintenance Period||0
10541958|NCT01474512|11695066|FG012|Relapsed Population Received Drug|Maintenance Period||0
10541959|NCT01474512|11695067|FG013|Relapsed Population Received Drug|Maintenance Period||0
10541960|NCT01474512|11695068|FG014|Relapsed Population Received Drug|Maintenance Period||0
10541961|NCT01474512|11695069|FG015|Relapsed Population Received Drug|Maintenance Period||0
10541962|NCT01474512|11695070|FG016|Relapsed Population Received Drug|Maintenance Period||0
10541963|NCT01474512|11695071|FG017|Relapsed Population Received Drug|Maintenance Period||0
10541964|NCT01474512|11695054|FG000|Relapsed Population Completers|Maintenance Period||0
10541965|NCT01474512|11695055|FG001|Relapsed Population Completers|Maintenance Period||0
10541966|NCT01474512|11695056|FG002|Relapsed Population Completers|Maintenance Period||0
10541967|NCT01474512|11695057|FG003|Relapsed Population Completers|Maintenance Period||0
10541968|NCT01474512|11695058|FG004|Relapsed Population Completers|Maintenance Period||0
10541969|NCT01474512|11695059|FG005|Relapsed Population Completers|Maintenance Period||0
10541970|NCT01474512|11695060|FG006|Relapsed Population Completers|Maintenance Period||0
10541971|NCT01474512|11695061|FG007|Relapsed Population Completers|Maintenance Period||0
10541972|NCT01474512|11695062|FG008|Relapsed Population Completers|Maintenance Period||0
10541973|NCT01474512|11695063|FG009|Relapsed Population Completers|Maintenance Period||0
10541974|NCT01474512|11695064|FG010|Relapsed Population Completers|Maintenance Period||321
10541975|NCT01474512|11695065|FG011|Relapsed Population Completers|Maintenance Period||0
10541976|NCT01474512|11695066|FG012|Relapsed Population Completers|Maintenance Period||0
10541977|NCT01474512|11695067|FG013|Relapsed Population Completers|Maintenance Period||0
10541978|NCT01474512|11695068|FG014|Relapsed Population Completers|Maintenance Period||0
10541979|NCT01474512|11695069|FG015|Relapsed Population Completers|Maintenance Period||0
10541980|NCT01474512|11695070|FG016|Relapsed Population Completers|Maintenance Period||0
10541981|NCT01474512|11695071|FG017|Relapsed Population Completers|Maintenance Period||0
10541982|NCT01474512|11695054|FG000|COMPLETED|Maintenance Period||0
10541983|NCT01474512|11695055|FG001|COMPLETED|Maintenance Period||0
10541984|NCT01474512|11695056|FG002|COMPLETED|Maintenance Period||0
10541985|NCT01474512|11695057|FG003|COMPLETED|Maintenance Period||24
10718354|NCT02703350|11882066|FG001|COMPLETED|Period Two (Part A)||5
10812723|NCT03352882|11974861|FG000|NOT COMPLETED|Overall Study||0
10812724|NCT03348904|11974868|FG000|STARTED|Overall Study||0
10812725|NCT03348904|11974869|FG001|STARTED|Overall Study||2
10812726|NCT03348904|11974870|FG002|STARTED|Overall Study||0
10812727|NCT03348904|11974868|FG000|COMPLETED|Overall Study||0
10812728|NCT03348904|11974869|FG001|COMPLETED|Overall Study||1
10541986|NCT01474512|11695058|FG004|COMPLETED|Maintenance Period||108
10541987|NCT01474512|11695059|FG005|COMPLETED|Maintenance Period||177
10718355|NCT02703350|11882067|FG002|COMPLETED|Period Two (Part A)||5
10541988|NCT01474512|11695060|FG006|COMPLETED|Maintenance Period||6
10541989|NCT01474512|11695061|FG007|COMPLETED|Maintenance Period||350
10541990|NCT01474512|11695062|FG008|COMPLETED|Maintenance Period||62
10541991|NCT01474512|11695063|FG009|COMPLETED|Maintenance Period||44
10541992|NCT01474512|11695064|FG010|COMPLETED|Maintenance Period||0
10541993|NCT01474512|11695065|FG011|COMPLETED|Maintenance Period||0
10541994|NCT01474512|11695066|FG012|COMPLETED|Maintenance Period||0
10541995|NCT01474512|11695067|FG013|COMPLETED|Maintenance Period||0
10541996|NCT01474512|11695068|FG014|COMPLETED|Maintenance Period||0
10541997|NCT01474512|11695069|FG015|COMPLETED|Maintenance Period||0
10541998|NCT01474512|11695070|FG016|COMPLETED|Maintenance Period||0
10541999|NCT01474512|11695071|FG017|COMPLETED|Maintenance Period||0
10542000|NCT01474512|11695054|FG000|NOT COMPLETED|Maintenance Period||0
10542001|NCT01474512|11695055|FG001|NOT COMPLETED|Maintenance Period||0
10542002|NCT01474512|11695056|FG002|NOT COMPLETED|Maintenance Period||0
10542003|NCT01474512|11695057|FG003|NOT COMPLETED|Maintenance Period||202
10542004|NCT01474512|11695058|FG004|NOT COMPLETED|Maintenance Period||119
10542005|NCT01474512|11695059|FG005|NOT COMPLETED|Maintenance Period||52
10542006|NCT01474512|11695060|FG006|NOT COMPLETED|Maintenance Period||10
10542007|NCT01474512|11695061|FG007|NOT COMPLETED|Maintenance Period||41
10718356|NCT02703350|11882068|FG003|COMPLETED|Period Two (Part A)||5
10718357|NCT02703350|11882069|FG004|COMPLETED|Period Two (Part A)||5
10718358|NCT02703350|11882070|FG005|COMPLETED|Period Two (Part A)||5
10718359|NCT02703350|11882071|FG006|COMPLETED|Period Two (Part A)||0
10718360|NCT02703350|11882072|FG007|COMPLETED|Period Two (Part A)||0
10718361|NCT02703350|11882065|FG000|NOT COMPLETED|Period Two (Part A)||0
10542008|NCT01474512|11695062|FG008|NOT COMPLETED|Maintenance Period||16
10542009|NCT01474512|11695063|FG009|NOT COMPLETED|Maintenance Period||18
10542010|NCT01474512|11695064|FG010|NOT COMPLETED|Maintenance Period||0
10542011|NCT01474512|11695065|FG011|NOT COMPLETED|Maintenance Period||0
10542012|NCT01474512|11695066|FG012|NOT COMPLETED|Maintenance Period||0
10542013|NCT01474512|11695067|FG013|NOT COMPLETED|Maintenance Period||0
10542014|NCT01474512|11695068|FG014|NOT COMPLETED|Maintenance Period||0
10542015|NCT01474512|11695069|FG015|NOT COMPLETED|Maintenance Period||0
10542016|NCT01474512|11695070|FG016|NOT COMPLETED|Maintenance Period||0
10542017|NCT01474512|11695071|FG017|NOT COMPLETED|Maintenance Period||0
10542018|NCT01474512|11695054|FG000|STARTED|Long-Term Extension Period||0
10542019|NCT01474512|11695055|FG001|STARTED|Long-Term Extension Period||0
10542020|NCT01474512|11695056|FG002|STARTED|Long-Term Extension Period||0
10542021|NCT01474512|11695057|FG003|STARTED|Long-Term Extension Period||0
10542022|NCT01474512|11695058|FG004|STARTED|Long-Term Extension Period||0
10718362|NCT02703350|11882066|FG001|NOT COMPLETED|Period Two (Part A)||0
10718363|NCT02703350|11882067|FG002|NOT COMPLETED|Period Two (Part A)||0
10718364|NCT02703350|11882068|FG003|NOT COMPLETED|Period Two (Part A)||0
10718365|NCT02703350|11882069|FG004|NOT COMPLETED|Period Two (Part A)||0
10542023|NCT01474512|11695059|FG005|STARTED|Long-Term Extension Period||0
10542024|NCT01474512|11695060|FG006|STARTED|Long-Term Extension Period||0
10658513|NCT02233738|11819563|FG001|COMPLETED|Overall Study||75
10658514|NCT02233738|11819562|FG000|NOT COMPLETED|Overall Study||8
10658515|NCT02233738|11819563|FG001|NOT COMPLETED|Overall Study||16
10658516|NCT02233751|11819733|FG000|STARTED|Overall Study||6
10658517|NCT02233751|11819734|FG001|STARTED|Overall Study||6
10658518|NCT02233751|11819733|FG000|COMPLETED|Overall Study||6
10658519|NCT02233751|11819734|FG001|COMPLETED|Overall Study||6
10658520|NCT02233751|11819733|FG000|NOT COMPLETED|Overall Study||0
10658521|NCT02233751|11819734|FG001|NOT COMPLETED|Overall Study||0
10658522|NCT02233803|11819740|FG000|STARTED|Treatment Period 1 (4-Wks)||100
10658523|NCT02233803|11819741|FG001|STARTED|Treatment Period 1 (4-Wks)||99
10658524|NCT02233803|11819740|FG000|COMPLETED|Treatment Period 1 (4-Wks)||97
10658525|NCT02233803|11819741|FG001|COMPLETED|Treatment Period 1 (4-Wks)||95
10658526|NCT02233803|11819740|FG000|NOT COMPLETED|Treatment Period 1 (4-Wks)||3
10658527|NCT02233803|11819741|FG001|NOT COMPLETED|Treatment Period 1 (4-Wks)||4
10658528|NCT02233803|11819740|FG000|STARTED|Washout Period (4-Wks)||97
10658529|NCT02233803|11819741|FG001|STARTED|Washout Period (4-Wks)||95
10658530|NCT02233803|11819740|FG000|COMPLETED|Washout Period (4-Wks)||95
10658531|NCT02233803|11819741|FG001|COMPLETED|Washout Period (4-Wks)||93
10658532|NCT02233803|11819740|FG000|NOT COMPLETED|Washout Period (4-Wks)||2
10658533|NCT02233803|11819741|FG001|NOT COMPLETED|Washout Period (4-Wks)||2
10658534|NCT02233803|11819740|FG000|STARTED|Treatment Period 2 (4-Wks)||95
10658535|NCT02233803|11819741|FG001|STARTED|Treatment Period 2 (4-Wks)||93
10658536|NCT02233803|11819740|FG000|COMPLETED|Treatment Period 2 (4-Wks)||93
10658537|NCT02233803|11819741|FG001|COMPLETED|Treatment Period 2 (4-Wks)||91
10658538|NCT02233803|11819740|FG000|NOT COMPLETED|Treatment Period 2 (4-Wks)||2
10658539|NCT02233803|11819741|FG001|NOT COMPLETED|Treatment Period 2 (4-Wks)||2
10658540|NCT02233842|11819749|FG000|STARTED|Questionnaire 1 Version 1||5
10658541|NCT02233842|11819749|FG000|COMPLETED|Questionnaire 1 Version 1||5
10658542|NCT02233842|11819749|FG000|NOT COMPLETED|Questionnaire 1 Version 1||0
10658543|NCT02233842|11819749|FG000|STARTED|Questionnaire 1 Version 2||5
10658544|NCT02233842|11819749|FG000|COMPLETED|Questionnaire 1 Version 2||5
10658545|NCT02233842|11819749|FG000|NOT COMPLETED|Questionnaire 1 Version 2||0
10658546|NCT02233842|11819749|FG000|STARTED|Questionnaire 2 Version 1||5
10658547|NCT02233842|11819749|FG000|COMPLETED|Questionnaire 2 Version 1||5
10658548|NCT02233842|11819749|FG000|NOT COMPLETED|Questionnaire 2 Version 1||0
10658549|NCT02233842|11819749|FG000|STARTED|Questionnaire 2 Version 2||5
10658550|NCT02233842|11819749|FG000|COMPLETED|Questionnaire 2 Version 2||5
10658551|NCT02233842|11819749|FG000|NOT COMPLETED|Questionnaire 2 Version 2||0
10658552|NCT02233842|11819749|FG000|STARTED|Questionnaire 3 Version 1||5
10658553|NCT02233842|11819749|FG000|COMPLETED|Questionnaire 3 Version 1||5
10658554|NCT02233842|11819749|FG000|NOT COMPLETED|Questionnaire 3 Version 1||0
10658555|NCT02233842|11819749|FG000|STARTED|Questionnaire 3 Version 2||5
10658556|NCT02233842|11819749|FG000|COMPLETED|Questionnaire 3 Version 2||5
10658557|NCT02233842|11819749|FG000|NOT COMPLETED|Questionnaire 3 Version 2||0
10542025|NCT01474512|11695061|FG007|STARTED|Long-Term Extension Period||0
10542026|NCT01474512|11695062|FG008|STARTED|Long-Term Extension Period||0
10542027|NCT01474512|11695063|FG009|STARTED|Long-Term Extension Period||0
10542028|NCT01474512|11695064|FG010|STARTED|Long-Term Extension Period||0
10542029|NCT01474512|11695065|FG011|STARTED|Long-Term Extension Period|9 participants did not start the long-term extension period.|26
10542030|NCT01474512|11695066|FG012|STARTED|Long-Term Extension Period|Participants received Ixe alone at the start of long-term extension.|1054
10542031|NCT01474512|11695067|FG013|STARTED|Long-Term Extension Period|Participants received Ixe in all dosing regimens, including participants who switched PBO to Ixe.|1075
10542032|NCT01474512|11695068|FG014|STARTED|Long-Term Extension Period||0
10542033|NCT01474512|11695069|FG015|STARTED|Long-Term Extension Period||0
10542034|NCT01474512|11695070|FG016|STARTED|Long-Term Extension Period||0
10542035|NCT01474512|11695071|FG017|STARTED|Long-Term Extension Period||0
10542036|NCT01474512|11695054|FG000|COMPLETED|Long-Term Extension Period||0
10307020|NCT00103259|11439967|FG000|Eligible|Overall Study||27
10307021|NCT00103259|11439968|FG001|Eligible|Overall Study||41
10307022|NCT00103259|11439967|FG000|Treated|Overall Study||23
10307023|NCT00103259|11439968|FG001|Treated|Overall Study||41
10307024|NCT00103259|11439967|FG000|Eligible and Treated|Overall Study||23
10307025|NCT00103259|11439968|FG001|Eligible and Treated|Overall Study||38
10307026|NCT00103259|11439967|FG000|Cross Over to the Other Arm|Overall Study||0
10307027|NCT00103259|11439968|FG001|Cross Over to the Other Arm|Overall Study|11 patients who progressed on bortezomib crossed over to Arm I. 10 of them were eligible|11
10307028|NCT00103259|11439967|FG000|Eligible Patients Who Cross Over|Overall Study||0
10307029|NCT00103259|11439968|FG001|Eligible Patients Who Cross Over|Overall Study||10
10307030|NCT00103259|11439967|FG000|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.|15
10315326|NCT00176930|11449148|FG002|NOT COMPLETED|Overall Study||0
10542037|NCT01474512|11695055|FG001|COMPLETED|Long-Term Extension Period||0
10542038|NCT01474512|11695056|FG002|COMPLETED|Long-Term Extension Period||0
10542039|NCT01474512|11695057|FG003|COMPLETED|Long-Term Extension Period||0
10542040|NCT01474512|11695058|FG004|COMPLETED|Long-Term Extension Period||0
10542041|NCT01474512|11695059|FG005|COMPLETED|Long-Term Extension Period||0
10542042|NCT01474512|11695060|FG006|COMPLETED|Long-Term Extension Period||0
10542043|NCT01474512|11695061|FG007|COMPLETED|Long-Term Extension Period||0
10542044|NCT01474512|11695062|FG008|COMPLETED|Long-Term Extension Period||0
10542045|NCT01474512|11695063|FG009|COMPLETED|Long-Term Extension Period||0
10542046|NCT01474512|11695064|FG010|COMPLETED|Long-Term Extension Period||0
10542047|NCT01474512|11695065|FG011|COMPLETED|Long-Term Extension Period||0
10542048|NCT01474512|11695066|FG012|COMPLETED|Long-Term Extension Period||836
10542049|NCT01474512|11695067|FG013|COMPLETED|Long-Term Extension Period||855
10542050|NCT01474512|11695068|FG014|COMPLETED|Long-Term Extension Period||0
10542051|NCT01474512|11695069|FG015|COMPLETED|Long-Term Extension Period||0
10542052|NCT01474512|11695070|FG016|COMPLETED|Long-Term Extension Period||0
10718366|NCT02703350|11882070|FG005|NOT COMPLETED|Period Two (Part A)||0
10542053|NCT01474512|11695071|FG017|COMPLETED|Long-Term Extension Period||0
10542054|NCT01474512|11695054|FG000|NOT COMPLETED|Long-Term Extension Period||0
10542055|NCT01474512|11695055|FG001|NOT COMPLETED|Long-Term Extension Period||0
10718367|NCT02703350|11882071|FG006|NOT COMPLETED|Period Two (Part A)||0
10542056|NCT01474512|11695056|FG002|NOT COMPLETED|Long-Term Extension Period||0
10542057|NCT01474512|11695057|FG003|NOT COMPLETED|Long-Term Extension Period||0
10542058|NCT01474512|11695058|FG004|NOT COMPLETED|Long-Term Extension Period||0
10542059|NCT01474512|11695059|FG005|NOT COMPLETED|Long-Term Extension Period||0
10542060|NCT01474512|11695060|FG006|NOT COMPLETED|Long-Term Extension Period||0
10542061|NCT01474512|11695061|FG007|NOT COMPLETED|Long-Term Extension Period||0
10542062|NCT01474512|11695062|FG008|NOT COMPLETED|Long-Term Extension Period||0
10542063|NCT01474512|11695063|FG009|NOT COMPLETED|Long-Term Extension Period||0
10542064|NCT01474512|11695064|FG010|NOT COMPLETED|Long-Term Extension Period||0
10542065|NCT01474512|11695065|FG011|NOT COMPLETED|Long-Term Extension Period||26
10542066|NCT01474512|11695066|FG012|NOT COMPLETED|Long-Term Extension Period||218
10542067|NCT01474512|11695067|FG013|NOT COMPLETED|Long-Term Extension Period||220
10542068|NCT01474512|11695068|FG014|NOT COMPLETED|Long-Term Extension Period||0
10542069|NCT01474512|11695069|FG015|NOT COMPLETED|Long-Term Extension Period||0
10542070|NCT01474512|11695070|FG016|NOT COMPLETED|Long-Term Extension Period||0
10542071|NCT01474512|11695071|FG017|NOT COMPLETED|Long-Term Extension Period||0
10542072|NCT01474512|11695054|FG000|STARTED|Post-Treatment Follow-Up||0
10542073|NCT01474512|11695055|FG001|STARTED|Post-Treatment Follow-Up||0
10542074|NCT01474512|11695056|FG002|STARTED|Post-Treatment Follow-Up||0
10542075|NCT01474512|11695057|FG003|STARTED|Post-Treatment Follow-Up||0
10542076|NCT01474512|11695058|FG004|STARTED|Post-Treatment Follow-Up||0
10542077|NCT01474512|11695059|FG005|STARTED|Post-Treatment Follow-Up||0
10542078|NCT01474512|11695060|FG006|STARTED|Post-Treatment Follow-Up||0
10542079|NCT01474512|11695061|FG007|STARTED|Post-Treatment Follow-Up||0
10542080|NCT01474512|11695062|FG008|STARTED|Post-Treatment Follow-Up||0
10542081|NCT01474512|11695063|FG009|STARTED|Post-Treatment Follow-Up||0
10542082|NCT01474512|11695064|FG010|STARTED|Post-Treatment Follow-Up||0
10542083|NCT01474512|11695065|FG011|STARTED|Post-Treatment Follow-Up||0
10542084|NCT01474512|11695066|FG012|STARTED|Post-Treatment Follow-Up||0
10542085|NCT01474512|11695067|FG013|STARTED|Post-Treatment Follow-Up||0
10542086|NCT01474512|11695068|FG014|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|18
10542087|NCT01474512|11695069|FG015|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|25
10542088|NCT01474512|11695070|FG016|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|700
10542089|NCT01474512|11695071|FG017|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|285
10542090|NCT01474512|11695054|FG000|COMPLETED|Post-Treatment Follow-Up||0
10542091|NCT01474512|11695055|FG001|COMPLETED|Post-Treatment Follow-Up||0
10542092|NCT01474512|11695056|FG002|COMPLETED|Post-Treatment Follow-Up||0
10542093|NCT01474512|11695057|FG003|COMPLETED|Post-Treatment Follow-Up||0
10542094|NCT01474512|11695058|FG004|COMPLETED|Post-Treatment Follow-Up||0
10542095|NCT01474512|11695059|FG005|COMPLETED|Post-Treatment Follow-Up||0
10542096|NCT01474512|11695060|FG006|COMPLETED|Post-Treatment Follow-Up||0
10542097|NCT01474512|11695061|FG007|COMPLETED|Post-Treatment Follow-Up||0
10542098|NCT01474512|11695062|FG008|COMPLETED|Post-Treatment Follow-Up||0
10542099|NCT01474512|11695063|FG009|COMPLETED|Post-Treatment Follow-Up||0
10542100|NCT01474512|11695064|FG010|COMPLETED|Post-Treatment Follow-Up||0
10542101|NCT01474512|11695065|FG011|COMPLETED|Post-Treatment Follow-Up||0
10542102|NCT01474512|11695066|FG012|COMPLETED|Post-Treatment Follow-Up||0
10542103|NCT01474512|11695067|FG013|COMPLETED|Post-Treatment Follow-Up||0
10542104|NCT01474512|11695068|FG014|COMPLETED|Post-Treatment Follow-Up||0
10542105|NCT01474512|11695069|FG015|COMPLETED|Post-Treatment Follow-Up||17
10542106|NCT01474512|11695070|FG016|COMPLETED|Post-Treatment Follow-Up||544
10542107|NCT01474512|11695071|FG017|COMPLETED|Post-Treatment Follow-Up||239
10542108|NCT01474512|11695054|FG000|NOT COMPLETED|Post-Treatment Follow-Up||0
10542109|NCT01474512|11695055|FG001|NOT COMPLETED|Post-Treatment Follow-Up||0
10542110|NCT01474512|11695056|FG002|NOT COMPLETED|Post-Treatment Follow-Up||0
10542111|NCT01474512|11695057|FG003|NOT COMPLETED|Post-Treatment Follow-Up||0
10542112|NCT01474512|11695058|FG004|NOT COMPLETED|Post-Treatment Follow-Up||0
10542113|NCT01474512|11695059|FG005|NOT COMPLETED|Post-Treatment Follow-Up||0
10542114|NCT01474512|11695060|FG006|NOT COMPLETED|Post-Treatment Follow-Up||0
10542115|NCT01474512|11695061|FG007|NOT COMPLETED|Post-Treatment Follow-Up||0
10542116|NCT01474512|11695062|FG008|NOT COMPLETED|Post-Treatment Follow-Up||0
10542117|NCT01474512|11695063|FG009|NOT COMPLETED|Post-Treatment Follow-Up||0
10542118|NCT01474512|11695064|FG010|NOT COMPLETED|Post-Treatment Follow-Up||0
10542119|NCT01474512|11695065|FG011|NOT COMPLETED|Post-Treatment Follow-Up||0
10542120|NCT01474512|11695066|FG012|NOT COMPLETED|Post-Treatment Follow-Up||0
10542121|NCT01474512|11695067|FG013|NOT COMPLETED|Post-Treatment Follow-Up||0
10542122|NCT01474512|11695068|FG014|NOT COMPLETED|Post-Treatment Follow-Up||18
10542123|NCT01474512|11695069|FG015|NOT COMPLETED|Post-Treatment Follow-Up||8
10542124|NCT01474512|11695070|FG016|NOT COMPLETED|Post-Treatment Follow-Up||156
10542125|NCT01474512|11695071|FG017|NOT COMPLETED|Post-Treatment Follow-Up||46
10542126|NCT01474538|11695103|FG000|STARTED|Treatment Period 1||60
10542127|NCT01474538|11695104|FG001|STARTED|Treatment Period 1||62
10542128|NCT01474538|11695103|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||60
10542129|NCT01474538|11695104|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1||62
10542130|NCT01474538|11695103|FG000|COMPLETED|Treatment Period 1||57
10542131|NCT01474538|11695104|FG001|COMPLETED|Treatment Period 1||58
10542132|NCT01474538|11695103|FG000|NOT COMPLETED|Treatment Period 1||3
10542133|NCT01474538|11695104|FG001|NOT COMPLETED|Treatment Period 1||4
10542134|NCT01474538|11695103|FG000|STARTED|Treatment Period 2||57
10542135|NCT01474538|11695104|FG001|STARTED|Treatment Period 2||58
10542136|NCT01474538|11695103|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 2||57
10542137|NCT01474538|11695104|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 2||58
10542138|NCT01474538|11695103|FG000|COMPLETED|Treatment Period 2||51
10542139|NCT01474538|11695104|FG001|COMPLETED|Treatment Period 2||56
10542140|NCT01474538|11695103|FG000|NOT COMPLETED|Treatment Period 2||6
10542141|NCT01474538|11695104|FG001|NOT COMPLETED|Treatment Period 2||2
10542142|NCT01474551|11695110|FG000|STARTED|Overall Study||2
10542143|NCT01474551|11695110|FG000|COMPLETED|Overall Study||1
10542144|NCT01474551|11695110|FG000|NOT COMPLETED|Overall Study||1
10542145|NCT01474590|11695116|FG000|STARTED|Overall Study||133
10542146|NCT01474590|11695117|FG001|STARTED|Overall Study||133
10542147|NCT01474590|11695116|FG000|COMPLETED|Overall Study||105
10542148|NCT01474590|11695117|FG001|COMPLETED|Overall Study||116
10542149|NCT01474590|11695116|FG000|NOT COMPLETED|Overall Study||28
10542150|NCT01474590|11695117|FG001|NOT COMPLETED|Overall Study||17
10542151|NCT01474681|11695125|FG000|STARTED|Overall Study||1
10542152|NCT01474681|11695126|FG001|STARTED|Overall Study||8
10542153|NCT01474681|11695127|FG002|STARTED|Overall Study||3
10542154|NCT01474681|11695128|FG003|STARTED|Overall Study||15
10542155|NCT01474681|11695125|FG000|COMPLETED|Overall Study||1
10542156|NCT01474681|11695126|FG001|COMPLETED|Overall Study||5
10542157|NCT01474681|11695127|FG002|COMPLETED|Overall Study||1
10542158|NCT01474681|11695128|FG003|COMPLETED|Overall Study||9
10542159|NCT01474681|11695125|FG000|NOT COMPLETED|Overall Study||0
10542160|NCT01474681|11695126|FG001|NOT COMPLETED|Overall Study||3
10542161|NCT01474681|11695127|FG002|NOT COMPLETED|Overall Study||2
10542162|NCT01474681|11695128|FG003|NOT COMPLETED|Overall Study||6
10542163|NCT01474746|11695144|FG000|STARTED|Overall Study||30
10542164|NCT01474746|11695145|FG001|STARTED|Overall Study||27
10542165|NCT01474746|11695144|FG000|COMPLETED|Overall Study||27
10542166|NCT01474746|11695145|FG001|COMPLETED|Overall Study||25
10542167|NCT01474746|11695144|FG000|NOT COMPLETED|Overall Study||3
10542168|NCT01474746|11695145|FG001|NOT COMPLETED|Overall Study||2
10542169|NCT01474772|11695153|FG000|STARTED|Period 1|STARTED=treated. In Period 1 a participant discontinued due to an AE and later died due to the AE.|101
10542170|NCT01474772|11695154|FG001|STARTED|Period 1|STARTED=treated|102
10542171|NCT01474772|11695153|FG000|COMPLETED|Period 1||89
10542172|NCT01474772|11695154|FG001|COMPLETED|Period 1||99
10542173|NCT01474772|11695153|FG000|NOT COMPLETED|Period 1||12
10542174|NCT01474772|11695154|FG001|NOT COMPLETED|Period 1||3
10542175|NCT01474772|11695153|FG000|STARTED|Washout||89
10542176|NCT01474772|11695154|FG001|STARTED|Washout||99
10542177|NCT01474772|11695153|FG000|COMPLETED|Washout||86
10542178|NCT01474772|11695154|FG001|COMPLETED|Washout||97
10542179|NCT01474772|11695153|FG000|NOT COMPLETED|Washout||3
10542180|NCT01474772|11695154|FG001|NOT COMPLETED|Washout||2
10542181|NCT01474772|11695153|FG000|STARTED|Period 2||86
10542182|NCT01474772|11695154|FG001|STARTED|Period 2||97
10542183|NCT01474772|11695153|FG000|COMPLETED|Period 2||77
10542184|NCT01474772|11695154|FG001|COMPLETED|Period 2||87
10542185|NCT01474772|11695153|FG000|NOT COMPLETED|Period 2||9
10542186|NCT01474772|11695154|FG001|NOT COMPLETED|Period 2||10
10542187|NCT01474772|11695153|FG000|STARTED|Follow-up||77
10542188|NCT01474772|11695154|FG001|STARTED|Follow-up||87
10315327|NCT00176930|11449149|FG003|NOT COMPLETED|Overall Study||0
10718368|NCT02703350|11882072|FG007|NOT COMPLETED|Period Two (Part A)||0
10718369|NCT02703350|11882065|FG000|STARTED|Period Three (Part A)||5
10718370|NCT02703350|11882066|FG001|STARTED|Period Three (Part A)||5
10718371|NCT02703350|11882067|FG002|STARTED|Period Three (Part A)||5
10718372|NCT02703350|11882068|FG003|STARTED|Period Three (Part A)||5
10542189|NCT01474772|11695153|FG000|COMPLETED|Follow-up||77
10542190|NCT01474772|11695154|FG001|COMPLETED|Follow-up||86
10542191|NCT01474772|11695153|FG000|NOT COMPLETED|Follow-up||0
10542192|NCT01474772|11695154|FG001|NOT COMPLETED|Follow-up||1
10307031|NCT00103259|11439968|FG001|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.This number is for stage I.|32
10307032|NCT00103259|11439967|FG000|NOT COMPLETED|Overall Study||12
10307033|NCT00103259|11439968|FG001|NOT COMPLETED|Overall Study||12
10315328|NCT00176930|11449150|FG004|NOT COMPLETED|Overall Study||0
10315329|NCT00176930|11449151|FG005|NOT COMPLETED|Overall Study||0
10315330|NCT00176930|11449152|FG006|NOT COMPLETED|Overall Study||0
10315331|NCT00176930|11449153|FG007|NOT COMPLETED|Overall Study||0
10315332|NCT00177047|11449171|FG000|STARTED|Overall Study||363
10315333|NCT00177047|11449171|FG000|COMPLETED|Overall Study||363
10315334|NCT00177047|11449171|FG000|NOT COMPLETED|Overall Study||0
10315335|NCT00177164|11449177|FG000|STARTED|Overall Study||23
10315336|NCT00177164|11449178|FG001|STARTED|Overall Study||25
10315337|NCT00177164|11449177|FG000|COMPLETED|Overall Study||14
10315338|NCT00177164|11449178|FG001|COMPLETED|Overall Study||9
10315339|NCT00177164|11449177|FG000|NOT COMPLETED|Overall Study||9
10315340|NCT00177164|11449178|FG001|NOT COMPLETED|Overall Study||16
10315341|NCT00177216|11449187|FG000|STARTED|Overall Study||26
10542193|NCT01474863|11695163|FG000|STARTED|Overall Study||26
10315342|NCT00177216|11449188|FG001|STARTED|Overall Study||23
10542194|NCT01474863|11695164|FG001|STARTED|Overall Study||22
10718373|NCT02703350|11882069|FG004|STARTED|Period Three (Part A)||5
10718374|NCT02703350|11882070|FG005|STARTED|Period Three (Part A)||5
10718375|NCT02703350|11882071|FG006|STARTED|Period Three (Part A)||0
10718376|NCT02703350|11882072|FG007|STARTED|Period Three (Part A)||0
10718377|NCT02703350|11882065|FG000|Received Study Drug|Period Three (Part A)||5
10718378|NCT02703350|11882066|FG001|Received Study Drug|Period Three (Part A)||5
10542195|NCT01474863|11695165|FG002|STARTED|Overall Study||24
10542196|NCT01474863|11695163|FG000|COMPLETED|Overall Study||26
10542197|NCT01474863|11695164|FG001|COMPLETED|Overall Study||22
10542198|NCT01474863|11695165|FG002|COMPLETED|Overall Study||24
10542199|NCT01474863|11695163|FG000|NOT COMPLETED|Overall Study||0
10542200|NCT01474863|11695164|FG001|NOT COMPLETED|Overall Study||0
10542201|NCT01474863|11695165|FG002|NOT COMPLETED|Overall Study||0
10718379|NCT02703350|11882067|FG002|Received Study Drug|Period Three (Part A)||5
10718380|NCT02703350|11882068|FG003|Received Study Drug|Period Three (Part A)||5
10542202|NCT01474876|11695176|FG000|STARTED|Overall Study||403
10542203|NCT01474876|11695177|FG001|STARTED|Overall Study||151
10542204|NCT01474876|11695178|FG002|STARTED|Overall Study||1
10542205|NCT01474876|11695176|FG000|COMPLETED|Overall Study||337
10542206|NCT01474876|11695177|FG001|COMPLETED|Overall Study||128
10542207|NCT01474876|11695178|FG002|COMPLETED|Overall Study||1
10542208|NCT01474876|11695176|FG000|NOT COMPLETED|Overall Study||66
10542209|NCT01474876|11695177|FG001|NOT COMPLETED|Overall Study||23
10542210|NCT01474876|11695178|FG002|NOT COMPLETED|Overall Study||0
10542211|NCT01474915|11695186|FG000|STARTED|Overall Study||60
10542212|NCT01474915|11695187|FG001|STARTED|Overall Study||61
10542213|NCT01474915|11695186|FG000|COMPLETED|Overall Study||50
10542214|NCT01474915|11695187|FG001|COMPLETED|Overall Study||51
10542215|NCT01474915|11695186|FG000|NOT COMPLETED|Overall Study||10
10542216|NCT01474915|11695187|FG001|NOT COMPLETED|Overall Study||10
10542217|NCT01474993|11695196|FG000|STARTED|Overall Study||15
10542218|NCT01474993|11695197|FG001|STARTED|Overall Study||29
10542219|NCT01474993|11695196|FG000|COMPLETED|Overall Study||14
10542220|NCT01474993|11695197|FG001|COMPLETED|Overall Study||26
10542221|NCT01474993|11695196|FG000|NOT COMPLETED|Overall Study||1
10542222|NCT01474993|11695197|FG001|NOT COMPLETED|Overall Study||3
10542223|NCT01475071|11695205|FG000|STARTED|Overall Study||100
10542224|NCT01475071|11695205|FG000|COMPLETED|Overall Study||92
10542225|NCT01475071|11695205|FG000|NOT COMPLETED|Overall Study||8
10542226|NCT01475097|11695213|FG000|STARTED|Overall Study||128
10542227|NCT01475097|11695214|FG001|STARTED|Overall Study||127
10542228|NCT01475097|11695213|FG000|COMPLETED|Overall Study||127
10542229|NCT01475097|11695214|FG001|COMPLETED|Overall Study||126
10542230|NCT01475097|11695213|FG000|NOT COMPLETED|Overall Study||1
10718381|NCT02703350|11882069|FG004|Received Study Drug|Period Three (Part A)||5
10307034|NCT00103285|11439976|FG000|STARTED|Induction||5377
10307035|NCT00103285|11439977|FG001|STARTED|Induction||0
10307036|NCT00103285|11439978|FG002|STARTED|Induction||0
10307037|NCT00103285|11439979|FG003|STARTED|Induction||0
10307038|NCT00103285|11439980|FG004|STARTED|Induction||0
10307039|NCT00103285|11439981|FG005|STARTED|Induction||0
10307040|NCT00103285|11439982|FG006|STARTED|Induction||0
10307041|NCT00103285|11439983|FG007|STARTED|Induction||0
10307042|NCT00103285|11439976|FG000|COMPLETED|Induction||4028
10307043|NCT00103285|11439977|FG001|COMPLETED|Induction||0
10307044|NCT00103285|11439978|FG002|COMPLETED|Induction||0
10307045|NCT00103285|11439979|FG003|COMPLETED|Induction||0
10307046|NCT00103285|11439980|FG004|COMPLETED|Induction||0
10307047|NCT00103285|11439981|FG005|COMPLETED|Induction||0
10542231|NCT01475097|11695214|FG001|NOT COMPLETED|Overall Study||1
10542232|NCT01475136|11695224|FG000|STARTED|Overall Study||7
10542233|NCT01475136|11695225|FG001|STARTED|Overall Study||9
10542234|NCT01475136|11695226|FG002|STARTED|Overall Study||9
10542235|NCT01475136|11695227|FG003|STARTED|Overall Study||12
10542236|NCT01475136|11695224|FG000|Received 1 Dose of Study Drug|Overall Study||7
10542237|NCT01475136|11695225|FG001|Received 1 Dose of Study Drug|Overall Study||6
10542238|NCT01475136|11695226|FG002|Received 1 Dose of Study Drug|Overall Study||6
10542239|NCT01475136|11695227|FG003|Received 1 Dose of Study Drug|Overall Study||7
10542240|NCT01475136|11695224|FG000|COMPLETED|Overall Study||6
10542241|NCT01475136|11695225|FG001|COMPLETED|Overall Study||6
10542242|NCT01475136|11695226|FG002|COMPLETED|Overall Study||6
10542243|NCT01475136|11695227|FG003|COMPLETED|Overall Study||7
10542244|NCT01475136|11695224|FG000|NOT COMPLETED|Overall Study||1
10542245|NCT01475136|11695225|FG001|NOT COMPLETED|Overall Study||3
10542246|NCT01475136|11695226|FG002|NOT COMPLETED|Overall Study||3
10542247|NCT01475136|11695227|FG003|NOT COMPLETED|Overall Study||5
10542248|NCT01475162|11695237|FG000|STARTED|Overall Study||14
10718382|NCT02703350|11882070|FG005|Received Study Drug|Period Three (Part A)||5
10718383|NCT02703350|11882071|FG006|Received Study Drug|Period Three (Part A)||0
10718384|NCT02703350|11882072|FG007|Received Study Drug|Period Three (Part A)||0
10718385|NCT02703350|11882065|FG000|COMPLETED|Period Three (Part A)||5
10718386|NCT02703350|11882066|FG001|COMPLETED|Period Three (Part A)||5
10718387|NCT02703350|11882067|FG002|COMPLETED|Period Three (Part A)||5
10718388|NCT02703350|11882068|FG003|COMPLETED|Period Three (Part A)||5
10718389|NCT02703350|11882069|FG004|COMPLETED|Period Three (Part A)||5
10718390|NCT02703350|11882070|FG005|COMPLETED|Period Three (Part A)||5
10307048|NCT00103285|11439982|FG006|COMPLETED|Induction||0
10307049|NCT00103285|11439983|FG007|COMPLETED|Induction||0
10307050|NCT00103285|11439976|FG000|NOT COMPLETED|Induction||1349
10307051|NCT00103285|11439977|FG001|NOT COMPLETED|Induction||0
10307052|NCT00103285|11439978|FG002|NOT COMPLETED|Induction||0
10307053|NCT00103285|11439979|FG003|NOT COMPLETED|Induction||0
10307054|NCT00103285|11439980|FG004|NOT COMPLETED|Induction||0
10307055|NCT00103285|11439981|FG005|NOT COMPLETED|Induction||0
10307056|NCT00103285|11439982|FG006|NOT COMPLETED|Induction||0
10307057|NCT00103285|11439983|FG007|NOT COMPLETED|Induction||0
10307058|NCT00103285|11439976|FG000|STARTED|Response Assignment||0
10307059|NCT00103285|11439977|FG001|STARTED|Response Assignment||939
10307060|NCT00103285|11439978|FG002|STARTED|Response Assignment||937
10307061|NCT00103285|11439979|FG003|STARTED|Response Assignment||503
10307062|NCT00103285|11439980|FG004|STARTED|Response Assignment||509
10307063|NCT00103285|11439981|FG005|STARTED|Response Assignment||249
10307064|NCT00103285|11439982|FG006|STARTED|Response Assignment||248
10307065|NCT00103285|11439983|FG007|STARTED|Response Assignment||643
10307066|NCT00103285|11439976|FG000|COMPLETED|Response Assignment||0
10307067|NCT00103285|11439977|FG001|COMPLETED|Response Assignment||807
10307068|NCT00103285|11439978|FG002|COMPLETED|Response Assignment||853
10307069|NCT00103285|11439979|FG003|COMPLETED|Response Assignment||441
10307070|NCT00103285|11439980|FG004|COMPLETED|Response Assignment||425
10307071|NCT00103285|11439981|FG005|COMPLETED|Response Assignment||201
10307072|NCT00103285|11439982|FG006|COMPLETED|Response Assignment||199
10307073|NCT00103285|11439983|FG007|COMPLETED|Response Assignment||523
10307074|NCT00103285|11439976|FG000|NOT COMPLETED|Response Assignment||0
10307075|NCT00103285|11439977|FG001|NOT COMPLETED|Response Assignment||132
10307076|NCT00103285|11439978|FG002|NOT COMPLETED|Response Assignment||84
10307077|NCT00103285|11439979|FG003|NOT COMPLETED|Response Assignment||62
10307078|NCT00103285|11439980|FG004|NOT COMPLETED|Response Assignment||84
10307079|NCT00103285|11439981|FG005|NOT COMPLETED|Response Assignment||48
10307080|NCT00103285|11439982|FG006|NOT COMPLETED|Response Assignment||49
10307081|NCT00103285|11439983|FG007|NOT COMPLETED|Response Assignment||120
10307082|NCT00103311|11440010|FG000|STARTED|Overall Study||33
10307083|NCT00103311|11440011|FG001|STARTED|Overall Study||31
10307084|NCT00103311|11440010|FG000|COMPLETED|Overall Study||29
10307085|NCT00103311|11440011|FG001|COMPLETED|Overall Study||30
10307086|NCT00103311|11440010|FG000|NOT COMPLETED|Overall Study||4
10307087|NCT00103311|11440011|FG001|NOT COMPLETED|Overall Study||1
10307088|NCT00103376|11440020|FG000|STARTED|Overall Study||8
10307089|NCT00103376|11440021|FG001|STARTED|Overall Study||7
10307090|NCT00103376|11440022|FG002|STARTED|Overall Study||8
10307091|NCT00103376|11440020|FG000|COMPLETED|Overall Study||8
10307092|NCT00103376|11440021|FG001|COMPLETED|Overall Study||7
10718391|NCT02703350|11882071|FG006|COMPLETED|Period Three (Part A)||0
10718392|NCT02703350|11882072|FG007|COMPLETED|Period Three (Part A)||0
10718393|NCT02703350|11882065|FG000|NOT COMPLETED|Period Three (Part A)||0
10542249|NCT01475162|11695237|FG000|COMPLETED|Overall Study||0
10542250|NCT01475162|11695237|FG000|NOT COMPLETED|Overall Study||14
10542251|NCT01475175|11695242|FG000|STARTED|Overall Study||12
10542252|NCT01475175|11695242|FG000|COMPLETED|Overall Study||12
10542253|NCT01475175|11695242|FG000|NOT COMPLETED|Overall Study||0
10542254|NCT01475214|11695249|FG000|STARTED|Overall Study||84
10542255|NCT01475214|11695250|FG001|STARTED|Overall Study||79
10542256|NCT01475214|11695251|FG002|STARTED|Overall Study||81
10542257|NCT01475214|11695249|FG000|COMPLETED|Overall Study||79
10542258|NCT01475214|11695250|FG001|COMPLETED|Overall Study||75
10542259|NCT01475214|11695251|FG002|COMPLETED|Overall Study||79
10542260|NCT01475214|11695249|FG000|NOT COMPLETED|Overall Study||5
10542261|NCT01475214|11695250|FG001|NOT COMPLETED|Overall Study||4
10542262|NCT01475214|11695251|FG002|NOT COMPLETED|Overall Study||2
10542263|NCT01475253|11695263|FG000|STARTED|Randomized, Blinded Study||47
10542264|NCT01475253|11695264|FG001|STARTED|Randomized, Blinded Study||46
10542265|NCT01475253|11695265|FG002|STARTED|Randomized, Blinded Study||11
10542266|NCT01475253|11695266|FG003|STARTED|Randomized, Blinded Study||0
10542267|NCT01475253|11695263|FG000|COMPLETED|Randomized, Blinded Study||45
10542268|NCT01475253|11695264|FG001|COMPLETED|Randomized, Blinded Study||45
10542269|NCT01475253|11695265|FG002|COMPLETED|Randomized, Blinded Study||11
10542270|NCT01475253|11695266|FG003|COMPLETED|Randomized, Blinded Study||0
10542271|NCT01475253|11695263|FG000|NOT COMPLETED|Randomized, Blinded Study||2
10542272|NCT01475253|11695264|FG001|NOT COMPLETED|Randomized, Blinded Study||1
10542273|NCT01475253|11695265|FG002|NOT COMPLETED|Randomized, Blinded Study||0
10718394|NCT02703350|11882066|FG001|NOT COMPLETED|Period Three (Part A)||0
10307093|NCT00103376|11440022|FG002|COMPLETED|Overall Study||8
10307094|NCT00103376|11440020|FG000|NOT COMPLETED|Overall Study||0
10307095|NCT00103376|11440021|FG001|NOT COMPLETED|Overall Study||0
10307096|NCT00103376|11440022|FG002|NOT COMPLETED|Overall Study||0
10307097|NCT00103402|11440038|FG000|STARTED|Overall Study||138
10307098|NCT00103402|11440039|FG001|STARTED|Overall Study||134
10307099|NCT00103402|11440038|FG000|COMPLETED|Overall Study||116
10307100|NCT00103402|11440039|FG001|COMPLETED|Overall Study||117
10307101|NCT00103402|11440038|FG000|NOT COMPLETED|Overall Study||22
10307102|NCT00103402|11440039|FG001|NOT COMPLETED|Overall Study||17
10307103|NCT00103506|11440047|FG000|STARTED|Overall Study||322
10307104|NCT00103506|11440048|FG001|STARTED|Overall Study||324
10307105|NCT00103506|11440047|FG000|COMPLETED|Overall Study||0
10307106|NCT00103506|11440048|FG001|COMPLETED|Overall Study||0
10307107|NCT00103506|11440047|FG000|NOT COMPLETED|Overall Study||322
10307108|NCT00103506|11440048|FG001|NOT COMPLETED|Overall Study||324
10307109|NCT00103610|11440056|FG000|STARTED|Overall Study||150
10307110|NCT00103610|11440057|FG001|STARTED|Overall Study||148
10307111|NCT00103610|11440056|FG000|COMPLETED|Overall Study||112
10307112|NCT00103610|11440057|FG001|COMPLETED|Overall Study||68
10307113|NCT00103610|11440056|FG000|NOT COMPLETED|Overall Study||38
10307114|NCT00103610|11440057|FG001|NOT COMPLETED|Overall Study||80
10307115|NCT00103662|11440066|FG000|STARTED|Overall Study||148
10307116|NCT00103662|11440067|FG001|STARTED|Overall Study||154
10307117|NCT00103662|11440066|FG000|COMPLETED|Overall Study|1 participant was wrongly terminated due to 'other'; the participant stayed on study until death.|129
10307118|NCT00103662|11440067|FG001|COMPLETED|Overall Study|1 participant was wrongly terminated due to 'other'; the participant stayed on study until death.|121
10307119|NCT00103662|11440066|FG000|NOT COMPLETED|Overall Study||19
10307120|NCT00103662|11440067|FG001|NOT COMPLETED|Overall Study||33
10307121|NCT00103740|11440075|FG000|STARTED|Period 1 - Core||92
10307122|NCT00103740|11440076|FG001|STARTED|Period 1 - Core||93
10307123|NCT00103740|11440075|FG000|COMPLETED|Period 1 - Core||85
10307124|NCT00103740|11440076|FG001|COMPLETED|Period 1 - Core||89
10307125|NCT00103740|11440075|FG000|NOT COMPLETED|Period 1 - Core||7
10307126|NCT00103740|11440076|FG001|NOT COMPLETED|Period 1 - Core||4
10307127|NCT00103740|11440075|FG000|STARTED|Period 2 - Extended Observation Period||78
10307128|NCT00103740|11440076|FG001|STARTED|Period 2 - Extended Observation Period||63
10307129|NCT00103740|11440075|FG000|COMPLETED|Period 2 - Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|9
10307130|NCT00103740|11440076|FG001|COMPLETED|Period 2 - Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|27
10307131|NCT00103740|11440075|FG000|NOT COMPLETED|Period 2 - Extended Observation Period||69
10307132|NCT00103740|11440076|FG001|NOT COMPLETED|Period 2 - Extended Observation Period||36
10307133|NCT00103844|11440084|FG000|STARTED|Overall Study||101
10307134|NCT00103844|11440085|FG001|STARTED|Overall Study||49
10307135|NCT00103844|11440084|FG000|Crossed Over|Overall Study|22 participants from the dasatinib arm crossed over to imatinib|22
10542274|NCT01475253|11695266|FG003|NOT COMPLETED|Randomized, Blinded Study||0
10542275|NCT01475253|11695263|FG000|STARTED|Open Label Extension||0
10542276|NCT01475253|11695264|FG001|STARTED|Open Label Extension||0
10718395|NCT02703350|11882067|FG002|NOT COMPLETED|Period Three (Part A)||0
10718396|NCT02703350|11882068|FG003|NOT COMPLETED|Period Three (Part A)||0
10307136|NCT00103844|11440085|FG001|Crossed Over|Overall Study|40 participants from the imatinib arm crossed over the dasatinib|40
10307137|NCT00103844|11440084|FG000|COMPLETED|Overall Study|Completed=no longer on treatment.Treatment continued until disease progression/intolerable toxicity.|101
10307138|NCT00103844|11440085|FG001|COMPLETED|Overall Study|Completed=no longer on treatment.Treatment continued until disease progression/intolerable toxicity.|49
10307139|NCT00103844|11440084|FG000|NOT COMPLETED|Overall Study||0
10307140|NCT00103844|11440085|FG001|NOT COMPLETED|Overall Study||0
10307141|NCT00103857|11440098|FG000|STARTED|54-Week Base Study||179
10307142|NCT00103857|11440099|FG001|STARTED|54-Week Base Study||182
10307143|NCT00103857|11440100|FG002|STARTED|54-Week Base Study||182
10307144|NCT00103857|11440101|FG003|STARTED|54-Week Base Study||190
10307145|NCT00103857|11440102|FG004|STARTED|54-Week Base Study||182
10307146|NCT00103857|11440103|FG005|STARTED|54-Week Base Study||176
10307147|NCT00103857|11440104|FG006|STARTED|54-Week Base Study|Results for the OLC are through Week 24. Results for the 6 randomized groups are through Week 54.|117
10542277|NCT01475253|11695265|FG002|STARTED|Open Label Extension||0
10542278|NCT01475253|11695266|FG003|STARTED|Open Label Extension||56
10542279|NCT01475253|11695263|FG000|COMPLETED|Open Label Extension||0
10542280|NCT01475253|11695264|FG001|COMPLETED|Open Label Extension||0
10542281|NCT01475253|11695265|FG002|COMPLETED|Open Label Extension||0
10542282|NCT01475253|11695266|FG003|COMPLETED|Open Label Extension||56
10542283|NCT01475253|11695263|FG000|NOT COMPLETED|Open Label Extension||0
10542284|NCT01475253|11695264|FG001|NOT COMPLETED|Open Label Extension||0
10542285|NCT01475253|11695265|FG002|NOT COMPLETED|Open Label Extension||0
10542286|NCT01475253|11695266|FG003|NOT COMPLETED|Open Label Extension||0
10542287|NCT01475305|11695276|FG000|STARTED|Overall Study||4
10542288|NCT01475305|11695277|FG001|STARTED|Overall Study||3
10542289|NCT01475305|11695276|FG000|End of Quarantine, Day 15|Overall Study||4
10542290|NCT01475305|11695277|FG001|End of Quarantine, Day 15|Overall Study||3
10542291|NCT01475305|11695276|FG000|COMPLETED|Overall Study||4
10542292|NCT01475305|11695277|FG001|COMPLETED|Overall Study||3
10542293|NCT01475305|11695276|FG000|NOT COMPLETED|Overall Study||0
10542294|NCT01475305|11695277|FG001|NOT COMPLETED|Overall Study||0
10542295|NCT01475331|11695286|FG000|STARTED|Overall Study||23
10542296|NCT01475331|11695287|FG001|STARTED|Overall Study||23
10542297|NCT01475331|11695286|FG000|COMPLETED|Overall Study||18
10542298|NCT01475331|11695287|FG001|COMPLETED|Overall Study||21
10542299|NCT01475331|11695286|FG000|NOT COMPLETED|Overall Study||5
10542300|NCT01475331|11695287|FG001|NOT COMPLETED|Overall Study||2
10542301|NCT01475370|11695296|FG000|STARTED|Overall Study||3
10542302|NCT01475370|11695297|FG001|STARTED|Overall Study||3
10542303|NCT01475370|11695298|FG002|STARTED|Overall Study||3
10542304|NCT01475370|11695296|FG000|COMPLETED|Overall Study||0
10542305|NCT01475370|11695297|FG001|COMPLETED|Overall Study||0
10542306|NCT01475370|11695298|FG002|COMPLETED|Overall Study||0
10542307|NCT01475370|11695296|FG000|NOT COMPLETED|Overall Study||3
10542308|NCT01475370|11695297|FG001|NOT COMPLETED|Overall Study||3
10542309|NCT01475370|11695298|FG002|NOT COMPLETED|Overall Study||3
10542310|NCT01475461|11695312|FG000|STARTED|Run-in Period||376
10542311|NCT01475461|11695313|FG001|STARTED|Run-in Period||0
10542312|NCT01475461|11695314|FG002|STARTED|Run-in Period||0
10542313|NCT01475461|11695315|FG003|STARTED|Run-in Period||0
10542314|NCT01475461|11695316|FG004|STARTED|Run-in Period||0
10542315|NCT01475461|11695317|FG005|STARTED|Run-in Period||0
10542316|NCT01475461|11695318|FG006|STARTED|Run-in Period||0
10542317|NCT01475461|11695312|FG000|COMPLETED|Run-in Period||335
10542318|NCT01475461|11695313|FG001|COMPLETED|Run-in Period||0
10542319|NCT01475461|11695314|FG002|COMPLETED|Run-in Period||0
10542320|NCT01475461|11695315|FG003|COMPLETED|Run-in Period||0
10542321|NCT01475461|11695316|FG004|COMPLETED|Run-in Period||0
10542322|NCT01475461|11695317|FG005|COMPLETED|Run-in Period||0
10542323|NCT01475461|11695318|FG006|COMPLETED|Run-in Period||0
10542324|NCT01475461|11695312|FG000|NOT COMPLETED|Run-in Period||41
10542325|NCT01475461|11695313|FG001|NOT COMPLETED|Run-in Period||0
10542326|NCT01475461|11695314|FG002|NOT COMPLETED|Run-in Period||0
10542327|NCT01475461|11695315|FG003|NOT COMPLETED|Run-in Period||0
10542328|NCT01475461|11695316|FG004|NOT COMPLETED|Run-in Period||0
10542329|NCT01475461|11695317|FG005|NOT COMPLETED|Run-in Period||0
10542330|NCT01475461|11695318|FG006|NOT COMPLETED|Run-in Period||0
10542331|NCT01475461|11695312|FG000|STARTED|Treatment Period||0
10542332|NCT01475461|11695313|FG001|STARTED|Treatment Period||57
10542333|NCT01475461|11695314|FG002|STARTED|Treatment Period||57
10542334|NCT01475461|11695315|FG003|STARTED|Treatment Period||54
10542335|NCT01475461|11695316|FG004|STARTED|Treatment Period||56
10542336|NCT01475461|11695317|FG005|STARTED|Treatment Period||56
10542337|NCT01475461|11695318|FG006|STARTED|Treatment Period||55
10542338|NCT01475461|11695312|FG000|COMPLETED|Treatment Period||0
10542339|NCT01475461|11695313|FG001|COMPLETED|Treatment Period||48
10542340|NCT01475461|11695314|FG002|COMPLETED|Treatment Period||53
10542341|NCT01475461|11695315|FG003|COMPLETED|Treatment Period||46
10542342|NCT01475461|11695316|FG004|COMPLETED|Treatment Period||52
10542343|NCT01475461|11695317|FG005|COMPLETED|Treatment Period||51
10542344|NCT01475461|11695318|FG006|COMPLETED|Treatment Period||53
10542345|NCT01475461|11695312|FG000|NOT COMPLETED|Treatment Period||0
10542346|NCT01475461|11695313|FG001|NOT COMPLETED|Treatment Period||9
10542347|NCT01475461|11695314|FG002|NOT COMPLETED|Treatment Period||4
10542348|NCT01475461|11695315|FG003|NOT COMPLETED|Treatment Period||8
10542349|NCT01475461|11695316|FG004|NOT COMPLETED|Treatment Period||4
10542350|NCT01475461|11695317|FG005|NOT COMPLETED|Treatment Period||5
10542351|NCT01475461|11695318|FG006|NOT COMPLETED|Treatment Period||2
10542352|NCT01475474|11695351|FG000|STARTED|Baseline Period - 4 Weeks||97
10542353|NCT01475474|11695351|FG000|COMPLETED|Baseline Period - 4 Weeks||91
10542354|NCT01475474|11695351|FG000|NOT COMPLETED|Baseline Period - 4 Weeks||6
10542355|NCT01475474|11695351|FG000|STARTED|Treatment Period - 12 Weeks||91
10307148|NCT00103857|11440098|FG000|COMPLETED|54-Week Base Study||122
10307149|NCT00103857|11440099|FG001|COMPLETED|54-Week Base Study||126
10307150|NCT00103857|11440100|FG002|COMPLETED|54-Week Base Study||135
10307151|NCT00103857|11440101|FG003|COMPLETED|54-Week Base Study||148
10307152|NCT00103857|11440102|FG004|COMPLETED|54-Week Base Study||141
10307153|NCT00103857|11440103|FG005|COMPLETED|54-Week Base Study||115
10307154|NCT00103857|11440104|FG006|COMPLETED|54-Week Base Study||79
10307155|NCT00103857|11440098|FG000|NOT COMPLETED|54-Week Base Study||57
10307156|NCT00103857|11440099|FG001|NOT COMPLETED|54-Week Base Study||56
10307157|NCT00103857|11440100|FG002|NOT COMPLETED|54-Week Base Study||47
10542356|NCT01475474|11695351|FG000|COMPLETED|Treatment Period - 12 Weeks||73
10307158|NCT00103857|11440101|FG003|NOT COMPLETED|54-Week Base Study||42
10307159|NCT00103857|11440102|FG004|NOT COMPLETED|54-Week Base Study||41
10307160|NCT00103857|11440103|FG005|NOT COMPLETED|54-Week Base Study||61
10307161|NCT00103857|11440104|FG006|NOT COMPLETED|54-Week Base Study||38
10307162|NCT00103857|11440098|FG000|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|103
10307163|NCT00103857|11440099|FG001|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|107
10315343|NCT00177216|11449189|FG002|STARTED|Overall Study||20
10718397|NCT02703350|11882069|FG004|NOT COMPLETED|Period Three (Part A)||0
10718398|NCT02703350|11882070|FG005|NOT COMPLETED|Period Three (Part A)||0
10718399|NCT02703350|11882071|FG006|NOT COMPLETED|Period Three (Part A)||0
10718400|NCT02703350|11882072|FG007|NOT COMPLETED|Period Three (Part A)||0
10718401|NCT02703350|11882065|FG000|STARTED|Period Four (Part A)||5
10718402|NCT02703350|11882066|FG001|STARTED|Period Four (Part A)||5
10718403|NCT02703350|11882067|FG002|STARTED|Period Four (Part A)||5
10718404|NCT02703350|11882068|FG003|STARTED|Period Four (Part A)||5
10307164|NCT00103857|11440100|FG002|STARTED|50-Week Extension Study|14 randomized patients completed Period 1 but did not enter Period 2.|121
10307165|NCT00103857|11440101|FG003|STARTED|50-Week Extension Study|14 randomized patients completed Period 1 but did not enter Period 2.|134
10307166|NCT00103857|11440102|FG004|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|122
10307167|NCT00103857|11440103|FG005|STARTED|50-Week Extension Study|17 randomized patients completed Period 1 but did not enter Period 2.|98
10307168|NCT00103857|11440104|FG006|STARTED|50-Week Extension Study||0
10307169|NCT00103857|11440098|FG000|COMPLETED|50-Week Extension Study||65
10307170|NCT00103857|11440099|FG001|COMPLETED|50-Week Extension Study||80
10307171|NCT00103857|11440100|FG002|COMPLETED|50-Week Extension Study||95
10307172|NCT00103857|11440101|FG003|COMPLETED|50-Week Extension Study||98
10307173|NCT00103857|11440102|FG004|COMPLETED|50-Week Extension Study||101
10307174|NCT00103857|11440103|FG005|COMPLETED|50-Week Extension Study||78
10307175|NCT00103857|11440104|FG006|COMPLETED|50-Week Extension Study||0
10307176|NCT00103857|11440098|FG000|NOT COMPLETED|50-Week Extension Study||38
10307177|NCT00103857|11440099|FG001|NOT COMPLETED|50-Week Extension Study||27
10307178|NCT00103857|11440100|FG002|NOT COMPLETED|50-Week Extension Study||26
10307179|NCT00103857|11440101|FG003|NOT COMPLETED|50-Week Extension Study||36
10307180|NCT00103857|11440102|FG004|NOT COMPLETED|50-Week Extension Study||21
10307181|NCT00103857|11440103|FG005|NOT COMPLETED|50-Week Extension Study||20
10307182|NCT00103857|11440104|FG006|NOT COMPLETED|50-Week Extension Study||0
10307183|NCT00104052|11440119|FG000|STARTED|Overall Study||107
10307184|NCT00104052|11440119|FG000|COMPLETED|Overall Study||78
10307185|NCT00104052|11440119|FG000|NOT COMPLETED|Overall Study||29
10307186|NCT00104104|11440125|FG000|STARTED|Overall Study|2 Participants in the 15-minute infusion group did not receive study drug.|90
10307187|NCT00104104|11440126|FG001|STARTED|Overall Study|1 Participants in the 30-minute infusion group did not receive study drug.|89
10307188|NCT00104104|11440125|FG000|Safety Population (Including Site 74)|Overall Study||88
10307189|NCT00104104|11440126|FG001|Safety Population (Including Site 74)|Overall Study||88
10307190|NCT00104104|11440125|FG000|Safety Population (Excluding Site 74)|Overall Study|Because of GCP violations at Site 74, post-baseline data for 3 patients in this arm were excluded.|85
10542357|NCT01475474|11695351|FG000|NOT COMPLETED|Treatment Period - 12 Weeks||18
10542358|NCT01475474|11695351|FG000|STARTED|Return to Baseline Period - 4 Weeks||73
10542359|NCT01475474|11695351|FG000|COMPLETED|Return to Baseline Period - 4 Weeks||71
10542360|NCT01475474|11695351|FG000|NOT COMPLETED|Return to Baseline Period - 4 Weeks||2
10542361|NCT01475487|11695358|FG000|STARTED|Overall Study||25
10542362|NCT01475487|11695359|FG001|STARTED|Overall Study||25
10542363|NCT01475487|11695358|FG000|COMPLETED|Overall Study||23
10542364|NCT01475487|11695359|FG001|COMPLETED|Overall Study||24
10542365|NCT01475487|11695358|FG000|NOT COMPLETED|Overall Study||2
10542366|NCT01475487|11695359|FG001|NOT COMPLETED|Overall Study||1
10542367|NCT01475513|11695367|FG000|STARTED|Overall Study||20
10542368|NCT01475513|11695368|FG001|STARTED|Overall Study||26
10542369|NCT01475513|11695367|FG000|COMPLETED|Overall Study||17
10315344|NCT00177216|11449187|FG000|COMPLETED|Overall Study||20
10542370|NCT01475513|11695368|FG001|COMPLETED|Overall Study||16
10542371|NCT01475513|11695367|FG000|NOT COMPLETED|Overall Study||3
10542372|NCT01475513|11695368|FG001|NOT COMPLETED|Overall Study||10
10542373|NCT01475643|11695378|FG000|STARTED|Overall Study|53 included in Intent-to-treat (ITT) population, due to no post-treatment assessment.|54
10542374|NCT01475643|11695379|FG001|STARTED|Overall Study|52 included in Intent-to-treat (ITT) population, due to no post-treatment assessment.|53
10542375|NCT01475643|11695378|FG000|COMPLETED|Overall Study||40
10542376|NCT01475643|11695379|FG001|COMPLETED|Overall Study||43
10542377|NCT01475643|11695378|FG000|NOT COMPLETED|Overall Study||14
10542378|NCT01475643|11695379|FG001|NOT COMPLETED|Overall Study||10
10542379|NCT01475721|11695387|FG000|STARTED|Overall Study||5834
10542380|NCT01475721|11695388|FG001|STARTED|Overall Study||5845
10542381|NCT01475721|11695387|FG000|COMPLETED|Overall Study||5823
10542382|NCT01475721|11695388|FG001|COMPLETED|Overall Study||5831
10542383|NCT01475721|11695387|FG000|NOT COMPLETED|Overall Study||11
10542384|NCT01475721|11695388|FG001|NOT COMPLETED|Overall Study||14
10542385|NCT01475734|11695396|FG000|STARTED|Overall Study||22
10542386|NCT01475734|11695397|FG001|STARTED|Overall Study||22
10542387|NCT01475734|11695396|FG000|COMPLETED|Overall Study||20
10542388|NCT01475734|11695397|FG001|COMPLETED|Overall Study||21
10542389|NCT01475734|11695396|FG000|NOT COMPLETED|Overall Study||2
10542390|NCT01475734|11695397|FG001|NOT COMPLETED|Overall Study||1
10542391|NCT01475825|11695407|FG000|STARTED|Overall Study||104
10542392|NCT01475825|11695408|FG001|STARTED|Overall Study||51
10542393|NCT01475825|11695409|FG002|STARTED|Overall Study||102
10542394|NCT01475825|11695410|FG003|STARTED|Overall Study||52
10542395|NCT01475825|11695407|FG000|Randomized and Treated|Overall Study||104
10542396|NCT01475825|11695408|FG001|Randomized and Treated|Overall Study||51
10542397|NCT01475825|11695409|FG002|Randomized and Treated|Overall Study||102
10542398|NCT01475825|11695410|FG003|Randomized and Treated|Overall Study||52
10542399|NCT01475825|11695407|FG000|Completed Blinded Treatment Period|Overall Study||60
10542400|NCT01475825|11695408|FG001|Completed Blinded Treatment Period|Overall Study||42
10542401|NCT01475825|11695409|FG002|Completed Blinded Treatment Period|Overall Study||59
10542402|NCT01475825|11695410|FG003|Completed Blinded Treatment Period|Overall Study||40
10542403|NCT01475825|11695407|FG000|Entered Open-Label Continuation|Overall Study||45
10542404|NCT01475825|11695408|FG001|Entered Open-Label Continuation|Overall Study||31
10542405|NCT01475825|11695409|FG002|Entered Open-Label Continuation|Overall Study||44
10542406|NCT01475825|11695410|FG003|Entered Open-Label Continuation|Overall Study||29
10542407|NCT01475825|11695407|FG000|Completed Open-Label Continuation|Overall Study||37
10542408|NCT01475825|11695408|FG001|Completed Open-Label Continuation|Overall Study||19
10542409|NCT01475825|11695409|FG002|Completed Open-Label Continuation|Overall Study||38
10542410|NCT01475825|11695410|FG003|Completed Open-Label Continuation|Overall Study||22
10542411|NCT01475825|11695407|FG000|COMPLETED|Overall Study||37
10542412|NCT01475825|11695408|FG001|COMPLETED|Overall Study||19
10542413|NCT01475825|11695409|FG002|COMPLETED|Overall Study||38
10542414|NCT01475825|11695410|FG003|COMPLETED|Overall Study||22
10542415|NCT01475825|11695407|FG000|NOT COMPLETED|Overall Study||67
10542416|NCT01475825|11695408|FG001|NOT COMPLETED|Overall Study||32
10542417|NCT01475825|11695409|FG002|NOT COMPLETED|Overall Study||64
10542418|NCT01475825|11695410|FG003|NOT COMPLETED|Overall Study||30
10542419|NCT01475838|11695422|FG000|STARTED|Randomized Phase||293
10542420|NCT01475838|11695423|FG001|STARTED|Randomized Phase||145
10542421|NCT01475838|11695422|FG000|COMPLETED|Randomized Phase||263
10542422|NCT01475838|11695423|FG001|COMPLETED|Randomized Phase||109
10542423|NCT01475838|11695422|FG000|NOT COMPLETED|Randomized Phase||30
10542424|NCT01475838|11695423|FG001|NOT COMPLETED|Randomized Phase||36
10542425|NCT01475838|11695422|FG000|STARTED|Extension Phase||42
10542426|NCT01475838|11695423|FG001|STARTED|Extension Phase||20
10542427|NCT01475838|11695422|FG000|COMPLETED|Extension Phase||41
10542428|NCT01475838|11695423|FG001|COMPLETED|Extension Phase||20
10315345|NCT00177216|11449188|FG001|COMPLETED|Overall Study||20
10542429|NCT01475838|11695422|FG000|NOT COMPLETED|Extension Phase||1
10542430|NCT01475838|11695423|FG001|NOT COMPLETED|Extension Phase||0
10542431|NCT01475851|11695432|FG000|STARTED|Overall Study||13
10542432|NCT01475851|11695433|FG001|STARTED|Overall Study||21
10307191|NCT00104104|11440126|FG001|Safety Population (Excluding Site 74)|Overall Study|Because of GCP violations at Site 74, post-baseline data for 4 patients in this arm were excluded.|84
10307192|NCT00104104|11440125|FG000|COMPLETED|Overall Study||15
10307193|NCT00104104|11440126|FG001|COMPLETED|Overall Study||17
10542433|NCT01475851|11695432|FG000|COMPLETED|Overall Study||12
10542434|NCT01475851|11695433|FG001|COMPLETED|Overall Study||21
10542435|NCT01475851|11695432|FG000|NOT COMPLETED|Overall Study||1
10542436|NCT01475851|11695433|FG001|NOT COMPLETED|Overall Study||0
10542437|NCT01475955|11695444|FG000|STARTED|Overall Study||48
10542438|NCT01475955|11695445|FG001|STARTED|Overall Study||48
10542439|NCT01475955|11695446|FG002|STARTED|Overall Study||47
10542440|NCT01475955|11695447|FG003|STARTED|Overall Study||46
10542441|NCT01475955|11695448|FG004|STARTED|Overall Study||46
10307194|NCT00104104|11440125|FG000|NOT COMPLETED|Overall Study||75
10307195|NCT00104104|11440126|FG001|NOT COMPLETED|Overall Study||72
10307196|NCT00104234|11440134|FG000|STARTED|Overall Study||19
10307197|NCT00104234|11440135|FG001|STARTED|Overall Study||20
10307198|NCT00104234|11440134|FG000|COMPLETED|Overall Study||19
10307199|NCT00104234|11440135|FG001|COMPLETED|Overall Study||19
10307200|NCT00104234|11440134|FG000|NOT COMPLETED|Overall Study||0
10307201|NCT00104234|11440135|FG001|NOT COMPLETED|Overall Study||1
10307202|NCT00104247|11440143|FG000|STARTED|Overall Study||42
10307203|NCT00104247|11440144|FG001|STARTED|Overall Study||47
10307204|NCT00104247|11440143|FG000|COMPLETED|Overall Study|Subject withdrew prior to dosing|41
10307205|NCT00104247|11440144|FG001|COMPLETED|Overall Study|One subject withdrew at Week 4, but is included in the data analysis|46
10307206|NCT00104247|11440143|FG000|NOT COMPLETED|Overall Study||1
10307207|NCT00104247|11440144|FG001|NOT COMPLETED|Overall Study||1
10307208|NCT00104299|11440152|FG000|STARTED|Overall Study||99
10307209|NCT00104299|11440153|FG001|STARTED|Overall Study||98
10307210|NCT00104299|11440152|FG000|COMPLETED|Overall Study|Number of participants who completed 18 months post-randomization|90
10307211|NCT00104299|11440153|FG001|COMPLETED|Overall Study|Number of participants who completed 18 months post-randomization|88
10307212|NCT00104299|11440152|FG000|NOT COMPLETED|Overall Study||9
10307213|NCT00104299|11440153|FG001|NOT COMPLETED|Overall Study||10
10307214|NCT00104416|11440161|FG000|STARTED|Double-Blind Phase||77
10307215|NCT00104416|11440162|FG001|STARTED|Double-Blind Phase||76
10307216|NCT00104416|11440163|FG002|STARTED|Double-Blind Phase||0
10307217|NCT00104416|11440164|FG003|STARTED|Double-Blind Phase||0
10307218|NCT00104416|11440165|FG004|STARTED|Double-Blind Phase||0
10307219|NCT00104416|11440161|FG000|COMPLETED|Double-Blind Phase||69
10307220|NCT00104416|11440162|FG001|COMPLETED|Double-Blind Phase||66
10307221|NCT00104416|11440163|FG002|COMPLETED|Double-Blind Phase||0
10307222|NCT00104416|11440164|FG003|COMPLETED|Double-Blind Phase||0
10542442|NCT01475955|11695444|FG000|COMPLETED|Overall Study||47
10542443|NCT01475955|11695445|FG001|COMPLETED|Overall Study||48
10542444|NCT01475955|11695446|FG002|COMPLETED|Overall Study||44
10542445|NCT01475955|11695447|FG003|COMPLETED|Overall Study||46
10542446|NCT01475955|11695448|FG004|COMPLETED|Overall Study||46
10542447|NCT01475955|11695444|FG000|NOT COMPLETED|Overall Study||1
10542448|NCT01475955|11695445|FG001|NOT COMPLETED|Overall Study||0
10542449|NCT01475955|11695446|FG002|NOT COMPLETED|Overall Study||3
10542450|NCT01475955|11695447|FG003|NOT COMPLETED|Overall Study||0
10542451|NCT01475955|11695448|FG004|NOT COMPLETED|Overall Study||0
10542452|NCT01476202|11695482|FG000|STARTED|Overall Study||40
10542453|NCT01476202|11695483|FG001|STARTED|Overall Study||40
10542454|NCT01476202|11695484|FG002|STARTED|Overall Study||40
10542455|NCT01476202|11695482|FG000|COMPLETED|Overall Study||40
10542456|NCT01476202|11695483|FG001|COMPLETED|Overall Study||40
10542457|NCT01476202|11695484|FG002|COMPLETED|Overall Study||40
10542458|NCT01476202|11695482|FG000|NOT COMPLETED|Overall Study||0
10542459|NCT01476202|11695483|FG001|NOT COMPLETED|Overall Study||0
10542460|NCT01476202|11695484|FG002|NOT COMPLETED|Overall Study||0
10542461|NCT01476267|11695495|FG000|STARTED|Overall Study||6
10542462|NCT01476267|11695495|FG000|COMPLETED|Overall Study||6
10542463|NCT01476267|11695495|FG000|NOT COMPLETED|Overall Study||0
10542464|NCT01476345|11695499|FG000|STARTED|Period 1||40
10542465|NCT01476345|11695500|FG001|STARTED|Period 1||40
10542466|NCT01476345|11695499|FG000|Received at Least 1 Dose of Study Drug|Period 1||40
10542467|NCT01476345|11695500|FG001|Received at Least 1 Dose of Study Drug|Period 1||40
10542468|NCT01476345|11695499|FG000|COMPLETED|Period 1||40
10542469|NCT01476345|11695500|FG001|COMPLETED|Period 1||40
10542470|NCT01476345|11695499|FG000|NOT COMPLETED|Period 1||0
10542471|NCT01476345|11695500|FG001|NOT COMPLETED|Period 1||0
10542472|NCT01476345|11695499|FG000|STARTED|Period 2||40
10542473|NCT01476345|11695500|FG001|STARTED|Period 2||40
10542474|NCT01476345|11695499|FG000|COMPLETED|Period 2|1 did not enter Period 3 due to participant's decision.|40
10542475|NCT01476345|11695500|FG001|COMPLETED|Period 2|1 did not enter Period 3 due to participant's decision.|40
10542476|NCT01476345|11695499|FG000|NOT COMPLETED|Period 2||0
10542477|NCT01476345|11695500|FG001|NOT COMPLETED|Period 2||0
10718405|NCT02703350|11882069|FG004|STARTED|Period Four (Part A)||5
10718406|NCT02703350|11882070|FG005|STARTED|Period Four (Part A)||5
10718407|NCT02703350|11882071|FG006|STARTED|Period Four (Part A)||0
10718408|NCT02703350|11882072|FG007|STARTED|Period Four (Part A)||0
10718409|NCT02703350|11882065|FG000|Received Study Drug|Period Four (Part A)||5
10542478|NCT01476345|11695499|FG000|STARTED|Period 3||39
10542479|NCT01476345|11695500|FG001|STARTED|Period 3||39
10542480|NCT01476345|11695499|FG000|COMPLETED|Period 3||39
10542481|NCT01476345|11695500|FG001|COMPLETED|Period 3||39
10718410|NCT02703350|11882066|FG001|Received Study Drug|Period Four (Part A)||5
10542482|NCT01476345|11695499|FG000|NOT COMPLETED|Period 3||0
10542483|NCT01476345|11695500|FG001|NOT COMPLETED|Period 3||0
10542484|NCT01476345|11695499|FG000|STARTED|Period 4||39
10542485|NCT01476345|11695500|FG001|STARTED|Period 4||39
10542486|NCT01476345|11695499|FG000|COMPLETED|Period 4||39
10542487|NCT01476345|11695500|FG001|COMPLETED|Period 4||39
10542488|NCT01476345|11695499|FG000|NOT COMPLETED|Period 4||0
10542489|NCT01476345|11695500|FG001|NOT COMPLETED|Period 4||0
10542490|NCT01476449|11695508|FG000|STARTED|Overall Study||10
10542491|NCT01476449|11695509|FG001|STARTED|Overall Study||10
10542492|NCT01476449|11695508|FG000|COMPLETED|Overall Study||8
10542493|NCT01476449|11695509|FG001|COMPLETED|Overall Study||8
10718411|NCT02703350|11882067|FG002|Received Study Drug|Period Four (Part A)||5
10718412|NCT02703350|11882068|FG003|Received Study Drug|Period Four (Part A)||5
10718413|NCT02703350|11882069|FG004|Received Study Drug|Period Four (Part A)||5
10718414|NCT02703350|11882070|FG005|Received Study Drug|Period Four (Part A)||5
10718415|NCT02703350|11882071|FG006|Received Study Drug|Period Four (Part A)||0
10718416|NCT02703350|11882072|FG007|Received Study Drug|Period Four (Part A)||0
10718417|NCT02703350|11882065|FG000|COMPLETED|Period Four (Part A)||5
10718418|NCT02703350|11882066|FG001|COMPLETED|Period Four (Part A)||5
10718419|NCT02703350|11882067|FG002|COMPLETED|Period Four (Part A)||5
10718420|NCT02703350|11882068|FG003|COMPLETED|Period Four (Part A)||5
10718421|NCT02703350|11882069|FG004|COMPLETED|Period Four (Part A)||5
10718422|NCT02703350|11882070|FG005|COMPLETED|Period Four (Part A)||5
10718423|NCT02703350|11882071|FG006|COMPLETED|Period Four (Part A)||0
10718424|NCT02703350|11882072|FG007|COMPLETED|Period Four (Part A)||0
10718425|NCT02703350|11882065|FG000|NOT COMPLETED|Period Four (Part A)||0
10718426|NCT02703350|11882066|FG001|NOT COMPLETED|Period Four (Part A)||0
10718427|NCT02703350|11882067|FG002|NOT COMPLETED|Period Four (Part A)||0
10718428|NCT02703350|11882068|FG003|NOT COMPLETED|Period Four (Part A)||0
10718429|NCT02703350|11882069|FG004|NOT COMPLETED|Period Four (Part A)||0
10718430|NCT02703350|11882070|FG005|NOT COMPLETED|Period Four (Part A)||0
10812729|NCT03348904|11974870|FG002|COMPLETED|Overall Study||0
10542494|NCT01476449|11695508|FG000|NOT COMPLETED|Overall Study||2
10542495|NCT01476449|11695509|FG001|NOT COMPLETED|Overall Study||2
10542496|NCT01476475|11695517|FG000|STARTED|Overall Study||161
10542497|NCT01476475|11695518|FG001|STARTED|Overall Study||162
10542498|NCT01476475|11695517|FG000|COMPLETED|Overall Study||150
10542499|NCT01476475|11695518|FG001|COMPLETED|Overall Study||159
10542500|NCT01476475|11695517|FG000|NOT COMPLETED|Overall Study||11
10542501|NCT01476475|11695518|FG001|NOT COMPLETED|Overall Study||3
10548215|NCT01518192|11702025|FG000|STARTED|Overall Study||145
10548216|NCT01518192|11702026|FG001|STARTED|Overall Study||140
10548217|NCT01518192|11702027|FG002|STARTED|Overall Study||259
10548218|NCT01518192|11702025|FG000|COMPLETED|Overall Study||116
10548219|NCT01518192|11702026|FG001|COMPLETED|Overall Study||114
10548220|NCT01518192|11702027|FG002|COMPLETED|Overall Study||224
10548221|NCT01518192|11702025|FG000|NOT COMPLETED|Overall Study||29
10548222|NCT01518192|11702026|FG001|NOT COMPLETED|Overall Study||26
10548223|NCT01518192|11702027|FG002|NOT COMPLETED|Overall Study||35
10718431|NCT02703350|11882071|FG006|NOT COMPLETED|Period Four (Part A)||0
10718432|NCT02703350|11882072|FG007|NOT COMPLETED|Period Four (Part A)||0
10812730|NCT03348904|11974868|FG000|NOT COMPLETED|Overall Study||0
10718433|NCT02703350|11882065|FG000|STARTED|Period Five (Part A)||5
10718434|NCT02703350|11882066|FG001|STARTED|Period Five (Part A)||5
10718435|NCT02703350|11882067|FG002|STARTED|Period Five (Part A)||5
10542502|NCT01476644|11695525|FG000|STARTED|Overall Study||161
10542503|NCT01476644|11695525|FG000|COMPLETED|Overall Study||122
10542504|NCT01476644|11695525|FG000|NOT COMPLETED|Overall Study||39
10542505|NCT01476696|11695530|FG000|STARTED|Overall Study||15
10542506|NCT01476696|11695531|FG001|STARTED|Overall Study||9
10542507|NCT01476696|11695532|FG002|STARTED|Overall Study||9
10542508|NCT01476696|11695530|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
10542509|NCT01476696|11695531|FG001|Received at Least 1 Dose of Study Drug|Overall Study||9
10542510|NCT01476696|11695532|FG002|Received at Least 1 Dose of Study Drug|Overall Study||9
10542511|NCT01476696|11695530|FG000|COMPLETED|Overall Study||12
10542512|NCT01476696|11695531|FG001|COMPLETED|Overall Study||8
10542513|NCT01476696|11695532|FG002|COMPLETED|Overall Study||9
10542514|NCT01476696|11695530|FG000|NOT COMPLETED|Overall Study||3
10542515|NCT01476696|11695531|FG001|NOT COMPLETED|Overall Study||1
10718436|NCT02703350|11882068|FG003|STARTED|Period Five (Part A)||5
10718437|NCT02703350|11882069|FG004|STARTED|Period Five (Part A)||5
10718438|NCT02703350|11882070|FG005|STARTED|Period Five (Part A)||5
10542516|NCT01476696|11695532|FG002|NOT COMPLETED|Overall Study||0
10542517|NCT01476722|11695545|FG000|STARTED|Overall Study||125
10542518|NCT01476722|11695545|FG000|COMPLETED|Overall Study||124
10542519|NCT01476722|11695545|FG000|NOT COMPLETED|Overall Study||1
10542520|NCT01476748|11695552|FG000|STARTED|Overall Study||5
10542521|NCT01476748|11695553|FG001|STARTED|Overall Study||5
10542522|NCT01476748|11695554|FG002|STARTED|Overall Study||5
10542523|NCT01476748|11695552|FG000|COMPLETED|Overall Study||5
10542524|NCT01476748|11695553|FG001|COMPLETED|Overall Study||5
10542525|NCT01476748|11695554|FG002|COMPLETED|Overall Study||5
10542526|NCT01476748|11695552|FG000|NOT COMPLETED|Overall Study||0
10542527|NCT01476748|11695553|FG001|NOT COMPLETED|Overall Study||0
10542528|NCT01476748|11695554|FG002|NOT COMPLETED|Overall Study||0
10542529|NCT01477320|11695564|FG000|STARTED|Overall Study||62
10542530|NCT01477320|11695565|FG001|STARTED|Overall Study||62
10542531|NCT01477320|11695564|FG000|COMPLETED|Overall Study||55
10542532|NCT01477320|11695565|FG001|COMPLETED|Overall Study||47
10542533|NCT01477320|11695564|FG000|NOT COMPLETED|Overall Study||7
10542534|NCT01477320|11695565|FG001|NOT COMPLETED|Overall Study||15
10542535|NCT01477333|11695571|FG000|STARTED|Overall Study||18
10542536|NCT01477333|11695571|FG000|COMPLETED|Overall Study||15
10542537|NCT01477333|11695571|FG000|NOT COMPLETED|Overall Study||3
10542538|NCT01477450|11695582|FG000|STARTED|Overall Study||10
10542539|NCT01477450|11695583|FG001|STARTED|Overall Study||10
10542540|NCT01477450|11695584|FG002|STARTED|Overall Study||10
10542541|NCT01477450|11695582|FG000|COMPLETED|Overall Study||10
10542542|NCT01477450|11695583|FG001|COMPLETED|Overall Study||10
10542543|NCT01477450|11695584|FG002|COMPLETED|Overall Study||10
10542544|NCT01477450|11695582|FG000|NOT COMPLETED|Overall Study||0
10542545|NCT01477450|11695583|FG001|NOT COMPLETED|Overall Study||0
10542546|NCT01477450|11695584|FG002|NOT COMPLETED|Overall Study||0
10542547|NCT01477463|11695594|FG000|STARTED|Overall Study||18
10542548|NCT01477463|11695595|FG001|STARTED|Overall Study||6
10542549|NCT01477463|11695594|FG000|COMPLETED|Overall Study||18
10542550|NCT01477463|11695595|FG001|COMPLETED|Overall Study||6
10542551|NCT01477463|11695594|FG000|NOT COMPLETED|Overall Study||0
10542552|NCT01477463|11695595|FG001|NOT COMPLETED|Overall Study||0
10542553|NCT01477567|11695610|FG000|STARTED|Overall Study||5
10542554|NCT01477567|11695611|FG001|STARTED|Overall Study||6
10542555|NCT01477567|11695612|FG002|STARTED|Overall Study||6
10542556|NCT01477567|11695613|FG003|STARTED|Overall Study||6
10542557|NCT01477567|11695614|FG004|STARTED|Overall Study||6
10542558|NCT01477567|11695615|FG005|STARTED|Overall Study||5
10718439|NCT02703350|11882071|FG006|STARTED|Period Five (Part A)||0
10542559|NCT01477567|11695616|FG006|STARTED|Overall Study||6
10542560|NCT01477567|11695610|FG000|Received at Least 1 Dose of Study Drug|Overall Study||5
10542561|NCT01477567|11695611|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
10542562|NCT01477567|11695612|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
10542563|NCT01477567|11695613|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
10718440|NCT02703350|11882072|FG007|STARTED|Period Five (Part A)||0
10542564|NCT01477567|11695614|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
10542565|NCT01477567|11695615|FG005|Received at Least 1 Dose of Study Drug|Overall Study||5
10542566|NCT01477567|11695616|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
10542567|NCT01477567|11695610|FG000|COMPLETED|Overall Study||5
10542568|NCT01477567|11695611|FG001|COMPLETED|Overall Study||6
10542569|NCT01477567|11695612|FG002|COMPLETED|Overall Study||6
10542570|NCT01477567|11695613|FG003|COMPLETED|Overall Study||6
10542571|NCT01477567|11695614|FG004|COMPLETED|Overall Study||6
10542572|NCT01477567|11695615|FG005|COMPLETED|Overall Study||5
10542573|NCT01477567|11695616|FG006|COMPLETED|Overall Study||6
10542574|NCT01477567|11695610|FG000|NOT COMPLETED|Overall Study||0
10542575|NCT01477567|11695611|FG001|NOT COMPLETED|Overall Study||0
10542576|NCT01477567|11695612|FG002|NOT COMPLETED|Overall Study||0
10542577|NCT01477567|11695613|FG003|NOT COMPLETED|Overall Study||0
10718441|NCT02703350|11882065|FG000|Received Study Drug|Period Five (Part A)||5
10718442|NCT02703350|11882066|FG001|Received Study Drug|Period Five (Part A)||5
10389559|NCT00654420|11532134|FG001|STARTED|Phase II||0
10389560|NCT00654420|11532135|FG002|STARTED|Phase II|New participants were enrolled in the Phase II part of the study that did not participate in Phase 1|37
10389561|NCT00654420|11532136|FG003|STARTED|Phase II|New participants were enrolled in the Phase II part of the study that did not participate in Phase 1|38
10389562|NCT00654420|11532133|FG000|COMPLETED|Phase II||0
10389563|NCT00654420|11532134|FG001|COMPLETED|Phase II||0
10389564|NCT00654420|11532135|FG002|COMPLETED|Phase II||0
10389565|NCT00654420|11532136|FG003|COMPLETED|Phase II||0
10389566|NCT00654420|11532133|FG000|NOT COMPLETED|Phase II||0
10389567|NCT00654420|11532134|FG001|NOT COMPLETED|Phase II||0
10542578|NCT01477567|11695614|FG004|NOT COMPLETED|Overall Study||0
10542579|NCT01477567|11695615|FG005|NOT COMPLETED|Overall Study||0
10542580|NCT01477567|11695616|FG006|NOT COMPLETED|Overall Study||0
10542581|NCT01477710|11695637|FG000|STARTED|Overall Study||30
10542582|NCT01477710|11695637|FG000|COMPLETED|Overall Study||30
10718443|NCT02703350|11882067|FG002|Received Study Drug|Period Five (Part A)||5
10718444|NCT02703350|11882068|FG003|Received Study Drug|Period Five (Part A)||5
10718445|NCT02703350|11882069|FG004|Received Study Drug|Period Five (Part A)||5
10389568|NCT00654420|11532135|FG002|NOT COMPLETED|Phase II||37
10389569|NCT00654420|11532136|FG003|NOT COMPLETED|Phase II||38
10389570|NCT00654498|11532148|FG000|STARTED|Overall Study||203
10389571|NCT00654498|11532149|FG001|STARTED|Overall Study||103
10389572|NCT00654498|11532148|FG000|COMPLETED|Overall Study||189
10389573|NCT00654498|11532149|FG001|COMPLETED|Overall Study||91
10389574|NCT00654498|11532148|FG000|NOT COMPLETED|Overall Study||14
10812731|NCT03348904|11974869|FG001|NOT COMPLETED|Overall Study||1
10812732|NCT03348904|11974870|FG002|NOT COMPLETED|Overall Study||0
10718446|NCT02703350|11882070|FG005|Received Study Drug|Period Five (Part A)||5
10718447|NCT02703350|11882071|FG006|Received Study Drug|Period Five (Part A)||0
10718448|NCT02703350|11882072|FG007|Received Study Drug|Period Five (Part A)||0
10718449|NCT02703350|11882065|FG000|COMPLETED|Period Five (Part A)||5
10718450|NCT02703350|11882066|FG001|COMPLETED|Period Five (Part A)||5
10718451|NCT02703350|11882067|FG002|COMPLETED|Period Five (Part A)||5
10718452|NCT02703350|11882068|FG003|COMPLETED|Period Five (Part A)||5
10718453|NCT02703350|11882069|FG004|COMPLETED|Period Five (Part A)||5
10718454|NCT02703350|11882070|FG005|COMPLETED|Period Five (Part A)||5
10718455|NCT02703350|11882071|FG006|COMPLETED|Period Five (Part A)||0
10718456|NCT02703350|11882072|FG007|COMPLETED|Period Five (Part A)||0
10718457|NCT02703350|11882065|FG000|NOT COMPLETED|Period Five (Part A)||0
10718458|NCT02703350|11882066|FG001|NOT COMPLETED|Period Five (Part A)||0
10812733|NCT03345901|11974878|FG000|STARTED|Overall Study||18
10812734|NCT03345901|11974878|FG000|COMPLETED|Overall Study||0
10812735|NCT03345901|11974878|FG000|NOT COMPLETED|Overall Study||18
10812736|NCT03344562|11974885|FG000|STARTED|Overall Study||10
10307223|NCT00104416|11440165|FG004|COMPLETED|Double-Blind Phase||0
10307224|NCT00104416|11440161|FG000|NOT COMPLETED|Double-Blind Phase||8
10307225|NCT00104416|11440162|FG001|NOT COMPLETED|Double-Blind Phase||10
10307226|NCT00104416|11440163|FG002|NOT COMPLETED|Double-Blind Phase||0
10307227|NCT00104416|11440164|FG003|NOT COMPLETED|Double-Blind Phase||0
10307228|NCT00104416|11440165|FG004|NOT COMPLETED|Double-Blind Phase||0
10307229|NCT00104416|11440161|FG000|STARTED|Continuation Phase||0
10307230|NCT00104416|11440162|FG001|STARTED|Continuation Phase||0
10389575|NCT00654498|11532149|FG001|NOT COMPLETED|Overall Study||12
10389576|NCT00654511|11532159|FG000|STARTED|Overall Study||26
10389577|NCT00654511|11532160|FG001|STARTED|Overall Study||25
10389578|NCT00654511|11532161|FG002|STARTED|Overall Study||25
10389579|NCT00654511|11532162|FG003|STARTED|Overall Study||25
10389580|NCT00654511|11532159|FG000|COMPLETED|Overall Study||26
10389581|NCT00654511|11532160|FG001|COMPLETED|Overall Study||25
10389582|NCT00654511|11532161|FG002|COMPLETED|Overall Study||25
10389583|NCT00654511|11532162|FG003|COMPLETED|Overall Study||25
10389584|NCT00654511|11532159|FG000|NOT COMPLETED|Overall Study||0
10389585|NCT00654511|11532160|FG001|NOT COMPLETED|Overall Study||0
10389586|NCT00654511|11532161|FG002|NOT COMPLETED|Overall Study||0
10389587|NCT00654511|11532162|FG003|NOT COMPLETED|Overall Study||0
10389588|NCT00654615|11532178|FG000|STARTED|Overall Study||30
10389589|NCT00654615|11532179|FG001|STARTED|Overall Study||30
10389590|NCT00654615|11532178|FG000|COMPLETED|Overall Study||22
10389591|NCT00654615|11532179|FG001|COMPLETED|Overall Study||23
10389592|NCT00654615|11532178|FG000|NOT COMPLETED|Overall Study||8
10389593|NCT00654615|11532179|FG001|NOT COMPLETED|Overall Study||7
10389594|NCT00654641|11532187|FG000|STARTED|Overall Study||28
10389595|NCT00654641|11532188|FG001|STARTED|Overall Study||26
10389596|NCT00654641|11532187|FG000|COMPLETED|Overall Study||26
10389597|NCT00654641|11532188|FG001|COMPLETED|Overall Study||23
10389598|NCT00654641|11532187|FG000|NOT COMPLETED|Overall Study||2
10389599|NCT00654641|11532188|FG001|NOT COMPLETED|Overall Study||3
10389600|NCT00654654|11532194|FG000|STARTED|Overall Study||50
10389601|NCT00654654|11532194|FG000|COMPLETED|Overall Study||43
10389602|NCT00654654|11532194|FG000|NOT COMPLETED|Overall Study||7
10389603|NCT00654732|11532200|FG000|STARTED|Overall Study||26
10389604|NCT00654732|11532201|FG001|STARTED|Overall Study||32
10389605|NCT00654732|11532200|FG000|COMPLETED|Overall Study||22
10389606|NCT00654732|11532201|FG001|COMPLETED|Overall Study||26
10389607|NCT00654732|11532200|FG000|NOT COMPLETED|Overall Study||4
10389608|NCT00654732|11532201|FG001|NOT COMPLETED|Overall Study||6
10389609|NCT00654745|11532207|FG000|STARTED|Overall Study|This is single group study in which subjects were titrated to the next of 7 arms if BP goal not met.|207
10389610|NCT00654745|11532207|FG000|COMPLETED|Overall Study||164
10389611|NCT00654745|11532207|FG000|NOT COMPLETED|Overall Study||43
10389612|NCT00654784|11532219|FG000|STARTED|Overall Study||13
10389613|NCT00654784|11532220|FG001|STARTED|Overall Study||8
10389614|NCT00654784|11532219|FG000|COMPLETED|Overall Study||13
10389615|NCT00654784|11532220|FG001|COMPLETED|Overall Study||8
10389616|NCT00654784|11532219|FG000|NOT COMPLETED|Overall Study||0
10389617|NCT00654784|11532220|FG001|NOT COMPLETED|Overall Study||0
10389618|NCT00654836|11532226|FG000|STARTED|Overall Study||32
10389619|NCT00654836|11532226|FG000|COMPLETED|Overall Study||32
10389620|NCT00654836|11532226|FG000|NOT COMPLETED|Overall Study||0
10389621|NCT00654875|11532232|FG000|STARTED|Overall Study||164
10389622|NCT00654875|11532233|FG001|STARTED|Overall Study||164
10389623|NCT00654875|11532232|FG000|COMPLETED|Overall Study||147
10389624|NCT00654875|11532233|FG001|COMPLETED|Overall Study||147
10389625|NCT00654875|11532232|FG000|NOT COMPLETED|Overall Study||17
10389626|NCT00654875|11532233|FG001|NOT COMPLETED|Overall Study||17
10389627|NCT00654901|11532243|FG000|STARTED|Overall Study||254
10389628|NCT00654901|11532244|FG001|STARTED|Overall Study||262
10389629|NCT00654901|11532245|FG002|STARTED|Overall Study||252
10389630|NCT00654901|11532246|FG003|STARTED|Overall Study||113
10389631|NCT00654901|11532243|FG000|COMPLETED|Overall Study||250
10389632|NCT00654901|11532244|FG001|COMPLETED|Overall Study||262
10389633|NCT00654901|11532245|FG002|COMPLETED|Overall Study||250
10389634|NCT00654901|11532246|FG003|COMPLETED|Overall Study||113
10389635|NCT00654901|11532243|FG000|NOT COMPLETED|Overall Study||4
10389636|NCT00654901|11532244|FG001|NOT COMPLETED|Overall Study||0
10389637|NCT00654901|11532245|FG002|NOT COMPLETED|Overall Study||2
10389638|NCT00654901|11532246|FG003|NOT COMPLETED|Overall Study||0
10389639|NCT00654927|11532256|FG000|STARTED|Overall Study||177
10389640|NCT00654927|11532256|FG000|COMPLETED|Overall Study||70
10389641|NCT00654927|11532256|FG000|NOT COMPLETED|Overall Study||107
10389642|NCT00654940|11532262|FG000|STARTED|Period 1|Assigned to study treatment.|13
10389643|NCT00654940|11532263|FG001|STARTED|Period 1|Assigned to study treatment.|12
10389644|NCT00654940|11532262|FG000|Received Study Treatment|Period 1||12
10389645|NCT00654940|11532263|FG001|Received Study Treatment|Period 1||12
10389646|NCT00654940|11532262|FG000|COMPLETED|Period 1||12
10389647|NCT00654940|11532263|FG001|COMPLETED|Period 1||11
10389648|NCT00654940|11532262|FG000|NOT COMPLETED|Period 1||1
10389649|NCT00654940|11532263|FG001|NOT COMPLETED|Period 1||1
10389650|NCT00654940|11532262|FG000|STARTED|Washout Period of 2 Weeks||12
10307231|NCT00104416|11440163|FG002|STARTED|Continuation Phase||69
10307232|NCT00104416|11440164|FG003|STARTED|Continuation Phase|One participant did not complete the Double-Blind Phase but was enrolled in the Continuation Phase.|67
10307233|NCT00104416|11440165|FG004|STARTED|Continuation Phase||32
10307234|NCT00104416|11440161|FG000|COMPLETED|Continuation Phase||0
10307235|NCT00104416|11440162|FG001|COMPLETED|Continuation Phase||0
10307236|NCT00104416|11440163|FG002|COMPLETED|Continuation Phase||63
10307237|NCT00104416|11440164|FG003|COMPLETED|Continuation Phase||65
10307238|NCT00104416|11440165|FG004|COMPLETED|Continuation Phase||27
10307239|NCT00104416|11440161|FG000|NOT COMPLETED|Continuation Phase||0
10307240|NCT00104416|11440162|FG001|NOT COMPLETED|Continuation Phase||0
10307241|NCT00104416|11440163|FG002|NOT COMPLETED|Continuation Phase||6
10307242|NCT00104416|11440164|FG003|NOT COMPLETED|Continuation Phase||2
10307243|NCT00104416|11440165|FG004|NOT COMPLETED|Continuation Phase||5
10307244|NCT00104520|11440179|FG000|STARTED|Overall Study||76
10307245|NCT00104520|11440180|FG001|STARTED|Overall Study||135
10307246|NCT00104520|11440179|FG000|COMPLETED|Overall Study||26
10307247|NCT00104520|11440180|FG001|COMPLETED|Overall Study||64
10307248|NCT00104520|11440179|FG000|NOT COMPLETED|Overall Study||50
10307249|NCT00104520|11440180|FG001|NOT COMPLETED|Overall Study||71
10307250|NCT00104572|11440189|FG000|STARTED|Overall Study|These are the analysed subjects|13
10307251|NCT00104572|11440190|FG001|STARTED|Overall Study|These are the analysed subjects|13
10307252|NCT00104572|11440191|FG002|STARTED|Overall Study|(N=11) in placebo, physician removed 2 men due to total testosterone>450 ng/DL, N=9 analysed.|9
10307253|NCT00104572|11440189|FG000|COMPLETED|Overall Study||10
10307254|NCT00104572|11440190|FG001|COMPLETED|Overall Study||10
10307255|NCT00104572|11440191|FG002|COMPLETED|Overall Study||9
10307256|NCT00104572|11440189|FG000|NOT COMPLETED|Overall Study||3
10307257|NCT00104572|11440190|FG001|NOT COMPLETED|Overall Study||3
10307258|NCT00104572|11440191|FG002|NOT COMPLETED|Overall Study||0
10307259|NCT00104637|11440199|FG000|STARTED|Period 1: ( TREATMENT: 4 Weeks)||6
10307260|NCT00104637|11440200|FG001|STARTED|Period 1: ( TREATMENT: 4 Weeks)||4
10307261|NCT00104637|11440199|FG000|COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||5
10307262|NCT00104637|11440200|FG001|COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||4
10307263|NCT00104637|11440199|FG000|NOT COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||1
10307264|NCT00104637|11440200|FG001|NOT COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||0
10307265|NCT00104637|11440199|FG000|STARTED|Period 2 (WASHOUT: 1 Week)||5
10658558|NCT02233946|11819756|FG000|STARTED|Baseline|Allocated to and received the intervention|628
10307266|NCT00104637|11440200|FG001|STARTED|Period 2 (WASHOUT: 1 Week)||4
10307267|NCT00104637|11440199|FG000|COMPLETED|Period 2 (WASHOUT: 1 Week)||5
10307268|NCT00104637|11440200|FG001|COMPLETED|Period 2 (WASHOUT: 1 Week)||4
10307269|NCT00104637|11440199|FG000|NOT COMPLETED|Period 2 (WASHOUT: 1 Week)||0
10307270|NCT00104637|11440200|FG001|NOT COMPLETED|Period 2 (WASHOUT: 1 Week)||0
10307271|NCT00104637|11440199|FG000|STARTED|Period 3 ( TREATMENT: 4 Weeks)||5
10307272|NCT00104637|11440200|FG001|STARTED|Period 3 ( TREATMENT: 4 Weeks)||4
10307273|NCT00104637|11440199|FG000|COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||5
10307274|NCT00104637|11440200|FG001|COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||4
10307275|NCT00104637|11440199|FG000|NOT COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||0
10307276|NCT00104637|11440200|FG001|NOT COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||0
10389651|NCT00654940|11532263|FG001|STARTED|Washout Period of 2 Weeks||11
10389652|NCT00654940|11532262|FG000|COMPLETED|Washout Period of 2 Weeks||12
10389653|NCT00654940|11532263|FG001|COMPLETED|Washout Period of 2 Weeks||11
10389654|NCT00654940|11532262|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
10389655|NCT00654940|11532263|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
10389656|NCT00654940|11532262|FG000|STARTED|Period 2||12
10389657|NCT00654940|11532263|FG001|STARTED|Period 2||11
10389658|NCT00654940|11532262|FG000|COMPLETED|Period 2||12
10389659|NCT00654940|11532263|FG001|COMPLETED|Period 2||11
10389660|NCT00654940|11532262|FG000|NOT COMPLETED|Period 2||0
10389661|NCT00654940|11532263|FG001|NOT COMPLETED|Period 2||0
10389662|NCT00654953|11532278|FG000|STARTED|Overall Study||36
10389663|NCT00654953|11532279|FG001|STARTED|Overall Study||36
10389664|NCT00654953|11532280|FG002|STARTED|Overall Study||30
10389665|NCT00654953|11532278|FG000|COMPLETED|Overall Study||6
10389666|NCT00654953|11532279|FG001|COMPLETED|Overall Study||8
10389667|NCT00654953|11532280|FG002|COMPLETED|Overall Study||8
10389668|NCT00654953|11532278|FG000|NOT COMPLETED|Overall Study||30
10389669|NCT00654953|11532279|FG001|NOT COMPLETED|Overall Study||28
10389670|NCT00654953|11532280|FG002|NOT COMPLETED|Overall Study||22
10389671|NCT00655083|11532290|FG000|STARTED|Overall Study||12
10389672|NCT00655083|11532291|FG001|STARTED|Overall Study||8
10389673|NCT00655083|11532290|FG000|COMPLETED|Overall Study||12
10389674|NCT00655083|11532291|FG001|COMPLETED|Overall Study||8
10389675|NCT00655083|11532290|FG000|NOT COMPLETED|Overall Study||0
10389676|NCT00655083|11532291|FG001|NOT COMPLETED|Overall Study||0
10389677|NCT00655356|11532299|FG000|STARTED|Overall Study||110
10389678|NCT00655356|11532300|FG001|STARTED|Overall Study||108
10389679|NCT00655356|11532299|FG000|COMPLETED|Overall Study||93
10389680|NCT00655356|11532300|FG001|COMPLETED|Overall Study||98
10389681|NCT00655356|11532299|FG000|NOT COMPLETED|Overall Study||17
10389682|NCT00655356|11532300|FG001|NOT COMPLETED|Overall Study||10
10389683|NCT00655473|11532308|FG000|STARTED|Overall Study||64
10389684|NCT00655473|11532309|FG001|STARTED|Overall Study||66
10389685|NCT00655473|11532308|FG000|COMPLETED|Overall Study||53
10389686|NCT00655473|11532309|FG001|COMPLETED|Overall Study||51
10389687|NCT00655473|11532308|FG000|NOT COMPLETED|Overall Study||11
10389688|NCT00655473|11532309|FG001|NOT COMPLETED|Overall Study||15
10542583|NCT01477710|11695637|FG000|NOT COMPLETED|Overall Study||0
10542584|NCT01477749|11695645|FG000|STARTED|Overall Study||47
10542585|NCT01477749|11695645|FG000|COMPLETED|Overall Study||43
10542586|NCT01477749|11695645|FG000|NOT COMPLETED|Overall Study||4
10542587|NCT01477762|11695653|FG000|STARTED|Overall Study||25
10542588|NCT01477762|11695654|FG001|STARTED|Overall Study||33
10542589|NCT01477762|11695655|FG002|STARTED|Overall Study||20
10542590|NCT01477762|11695656|FG003|STARTED|Overall Study||13
10389689|NCT00655486|11532315|FG000|STARTED|Overall Study||97
10389690|NCT00655486|11532315|FG000|COMPLETED|Overall Study||69
10389691|NCT00655486|11532315|FG000|NOT COMPLETED|Overall Study||28
10389692|NCT00655499|11532319|FG000|STARTED|Overall Study||69
10389693|NCT00655499|11532319|FG000|COMPLETED|Overall Study||65
10389694|NCT00655499|11532319|FG000|NOT COMPLETED|Overall Study||4
10389695|NCT00655538|11532326|FG000|STARTED|Overall Study||238
10389696|NCT00655538|11532327|FG001|STARTED|Overall Study||238
10389697|NCT00655538|11532326|FG000|COMPLETED|Overall Study||214
10389698|NCT00655538|11532327|FG001|COMPLETED|Overall Study||211
10389699|NCT00655538|11532326|FG000|NOT COMPLETED|Overall Study||24
10389700|NCT00655538|11532327|FG001|NOT COMPLETED|Overall Study||27
10389701|NCT00655551|11532336|FG000|STARTED|All Periods Combined||25
10389702|NCT00655551|11532337|FG001|STARTED|All Periods Combined||50
10389703|NCT00655551|11532338|FG002|STARTED|All Periods Combined||25
10389704|NCT00655551|11532336|FG000|COMPLETED|All Periods Combined||25
10389705|NCT00655551|11532337|FG001|COMPLETED|All Periods Combined||47
10389706|NCT00655551|11532338|FG002|COMPLETED|All Periods Combined||21
10389707|NCT00655551|11532336|FG000|NOT COMPLETED|All Periods Combined||0
10389708|NCT00655551|11532337|FG001|NOT COMPLETED|All Periods Combined||3
10389709|NCT00655551|11532338|FG002|NOT COMPLETED|All Periods Combined||4
10389710|NCT00655551|11532336|FG000|STARTED|Period 1 (up to 7 Days)||25
10389711|NCT00655551|11532337|FG001|STARTED|Period 1 (up to 7 Days)||0
10389712|NCT00655551|11532338|FG002|STARTED|Period 1 (up to 7 Days)||0
10389713|NCT00655551|11532336|FG000|COMPLETED|Period 1 (up to 7 Days)||25
10389714|NCT00655551|11532337|FG001|COMPLETED|Period 1 (up to 7 Days)||0
10389715|NCT00655551|11532338|FG002|COMPLETED|Period 1 (up to 7 Days)||0
10389716|NCT00655551|11532336|FG000|NOT COMPLETED|Period 1 (up to 7 Days)||0
10389717|NCT00655551|11532337|FG001|NOT COMPLETED|Period 1 (up to 7 Days)||0
10389718|NCT00655551|11532338|FG002|NOT COMPLETED|Period 1 (up to 7 Days)||0
10389719|NCT00655551|11532336|FG000|STARTED|Period 2 (up to 7 Days)||0
10389720|NCT00655551|11532337|FG001|STARTED|Period 2 (up to 7 Days)||25
10389721|NCT00655551|11532338|FG002|STARTED|Period 2 (up to 7 Days)||0
10389722|NCT00655551|11532336|FG000|COMPLETED|Period 2 (up to 7 Days)||0
10389723|NCT00655551|11532337|FG001|COMPLETED|Period 2 (up to 7 Days)||24
10389724|NCT00655551|11532338|FG002|COMPLETED|Period 2 (up to 7 Days)||0
10389725|NCT00655551|11532336|FG000|NOT COMPLETED|Period 2 (up to 7 Days)||0
10389726|NCT00655551|11532337|FG001|NOT COMPLETED|Period 2 (up to 7 Days)||1
10389727|NCT00655551|11532338|FG002|NOT COMPLETED|Period 2 (up to 7 Days)||0
10389728|NCT00655551|11532336|FG000|STARTED|Period 3 (up to 7 Days)||0
10389729|NCT00655551|11532337|FG001|STARTED|Period 3 (up to 7 Days)||0
10389730|NCT00655551|11532338|FG002|STARTED|Period 3 (up to 7 Days)||25
10389731|NCT00655551|11532336|FG000|COMPLETED|Period 3 (up to 7 Days)||0
10389732|NCT00655551|11532337|FG001|COMPLETED|Period 3 (up to 7 Days)||0
10542591|NCT01477762|11695653|FG000|COMPLETED|Overall Study||16
10542592|NCT01477762|11695654|FG001|COMPLETED|Overall Study||20
10542593|NCT01477762|11695655|FG002|COMPLETED|Overall Study||16
10542594|NCT01477762|11695656|FG003|COMPLETED|Overall Study||11
10658559|NCT02233946|11819757|FG001|STARTED|Baseline|Allocated to and received usual care|243
10812737|NCT03344562|11974886|FG001|STARTED|Overall Study||9
10812738|NCT03344562|11974885|FG000|COMPLETED|Overall Study||8
10542595|NCT01477762|11695653|FG000|NOT COMPLETED|Overall Study||9
10307277|NCT00104650|11440212|FG000|STARTED|Treatment Period (25 Weeks)||37
10307278|NCT00104650|11440213|FG001|STARTED|Treatment Period (25 Weeks)||36
10307279|NCT00104650|11440214|FG002|STARTED|Treatment Period (25 Weeks)||38
10307280|NCT00104650|11440212|FG000|Received Investigational Product|Treatment Period (25 Weeks)||35
10307281|NCT00104650|11440213|FG001|Received Investigational Product|Treatment Period (25 Weeks)||35
10307282|NCT00104650|11440214|FG002|Received Investigational Product|Treatment Period (25 Weeks)||38
10718459|NCT02703350|11882067|FG002|NOT COMPLETED|Period Five (Part A)||0
10718460|NCT02703350|11882068|FG003|NOT COMPLETED|Period Five (Part A)||0
10718461|NCT02703350|11882069|FG004|NOT COMPLETED|Period Five (Part A)||0
10307283|NCT00104650|11440212|FG000|COMPLETED|Treatment Period (25 Weeks)||25
10307284|NCT00104650|11440213|FG001|COMPLETED|Treatment Period (25 Weeks)||25
10307285|NCT00104650|11440214|FG002|COMPLETED|Treatment Period (25 Weeks)||28
10307286|NCT00104650|11440212|FG000|NOT COMPLETED|Treatment Period (25 Weeks)||12
10307287|NCT00104650|11440213|FG001|NOT COMPLETED|Treatment Period (25 Weeks)||11
10307288|NCT00104650|11440214|FG002|NOT COMPLETED|Treatment Period (25 Weeks)||10
10307289|NCT00104650|11440212|FG000|STARTED|Follow-up Period||25
10307290|NCT00104650|11440213|FG001|STARTED|Follow-up Period||25
10307291|NCT00104650|11440214|FG002|STARTED|Follow-up Period||28
10307292|NCT00104650|11440212|FG000|COMPLETED|Follow-up Period||14
10307293|NCT00104650|11440213|FG001|COMPLETED|Follow-up Period||12
10307294|NCT00104650|11440214|FG002|COMPLETED|Follow-up Period||18
10307295|NCT00104650|11440212|FG000|NOT COMPLETED|Follow-up Period||11
10307296|NCT00104650|11440213|FG001|NOT COMPLETED|Follow-up Period||13
10307297|NCT00104650|11440214|FG002|NOT COMPLETED|Follow-up Period||10
10307298|NCT00104858|11440222|FG000|STARTED|Overall Study||52
10307299|NCT00104858|11440222|FG000|COMPLETED|Overall Study||52
10307300|NCT00104858|11440222|FG000|NOT COMPLETED|Overall Study||0
10307301|NCT00104871|11440228|FG000|STARTED|Overall Study||22
10307302|NCT00104871|11440228|FG000|COMPLETED|Overall Study||21
10307303|NCT00104871|11440228|FG000|NOT COMPLETED|Overall Study||1
10307304|NCT00104884|11440232|FG000|STARTED|Overall Study||4
10307305|NCT00104884|11440232|FG000|COMPLETED|Overall Study||0
10307306|NCT00104884|11440232|FG000|NOT COMPLETED|Overall Study||4
10307307|NCT00105001|11440239|FG000|STARTED|Overall Study||70
10307308|NCT00105001|11440240|FG001|STARTED|Overall Study||71
10307309|NCT00105001|11440241|FG002|STARTED|Overall Study||69
10307310|NCT00105001|11440239|FG000|COMPLETED|Overall Study||70
10307311|NCT00105001|11440240|FG001|COMPLETED|Overall Study||71
10307312|NCT00105001|11440241|FG002|COMPLETED|Overall Study||69
10307313|NCT00105001|11440239|FG000|NOT COMPLETED|Overall Study||0
10307314|NCT00105001|11440240|FG001|NOT COMPLETED|Overall Study||0
10307315|NCT00105001|11440241|FG002|NOT COMPLETED|Overall Study||0
10307316|NCT00105027|11440255|FG000|STARTED|Overall Study||88
10307317|NCT00105027|11440256|FG001|STARTED|Overall Study||92
10307318|NCT00105027|11440257|FG002|STARTED|Overall Study||91
10307319|NCT00105027|11440258|FG003|STARTED|Overall Study||137
10307320|NCT00105027|11440259|FG004|STARTED|Overall Study||136
10307321|NCT00105027|11440260|FG005|STARTED|Overall Study||138
10307322|NCT00105027|11440255|FG000|COMPLETED|Overall Study||73
10307323|NCT00105027|11440256|FG001|COMPLETED|Overall Study||83
10307324|NCT00105027|11440257|FG002|COMPLETED|Overall Study||82
10307325|NCT00105027|11440258|FG003|COMPLETED|Overall Study||121
10307326|NCT00105027|11440259|FG004|COMPLETED|Overall Study||121
10307327|NCT00105027|11440260|FG005|COMPLETED|Overall Study||125
10307328|NCT00105027|11440255|FG000|NOT COMPLETED|Overall Study||15
10307329|NCT00105027|11440256|FG001|NOT COMPLETED|Overall Study||9
10307330|NCT00105027|11440257|FG002|NOT COMPLETED|Overall Study||9
10307331|NCT00105027|11440258|FG003|NOT COMPLETED|Overall Study||16
10307332|NCT00105027|11440259|FG004|NOT COMPLETED|Overall Study||15
10307333|NCT00105027|11440260|FG005|NOT COMPLETED|Overall Study||13
10307334|NCT00105066|11440276|FG000|STARTED|Overall Study||27
10307335|NCT00105066|11440277|FG001|STARTED|Overall Study||50
10307336|NCT00105066|11440276|FG000|COMPLETED|Overall Study||25
10307337|NCT00105066|11440277|FG001|COMPLETED|Overall Study||45
10307338|NCT00105066|11440276|FG000|NOT COMPLETED|Overall Study||2
10307339|NCT00105066|11440277|FG001|NOT COMPLETED|Overall Study||5
10307340|NCT00105079|11440285|FG000|STARTED|Overall Study||167
10307341|NCT00105079|11440286|FG001|STARTED|Overall Study||170
10307342|NCT00105079|11440285|FG000|Safety Population|Overall Study||163
10307343|NCT00105079|11440286|FG001|Safety Population|Overall Study||168
10307344|NCT00105079|11440285|FG000|COMPLETED|Overall Study||128
10307345|NCT00105079|11440286|FG001|COMPLETED|Overall Study||135
10307346|NCT00105079|11440285|FG000|NOT COMPLETED|Overall Study||39
10307347|NCT00105079|11440286|FG001|NOT COMPLETED|Overall Study||35
10307348|NCT00105157|11440296|FG000|STARTED|Double-Blind (DB)||44
10307349|NCT00105157|11440297|FG001|STARTED|Double-Blind (DB)||45
10307350|NCT00105157|11440298|FG002|STARTED|Double-Blind (DB)||45
10307351|NCT00105157|11440299|FG003|STARTED|Double-Blind (DB)||45
10307352|NCT00105157|11440296|FG000|Treated|Double-Blind (DB)||43
10718462|NCT02703350|11882070|FG005|NOT COMPLETED|Period Five (Part A)||0
10718463|NCT02703350|11882071|FG006|NOT COMPLETED|Period Five (Part A)||0
10718464|NCT02703350|11882072|FG007|NOT COMPLETED|Period Five (Part A)||0
10718465|NCT02703350|11882065|FG000|STARTED|Period Six (Part A)||5
10307353|NCT00105157|11440297|FG001|Treated|Double-Blind (DB)||45
10307354|NCT00105157|11440298|FG002|Treated|Double-Blind (DB)||45
10307355|NCT00105157|11440299|FG003|Treated|Double-Blind (DB)||45
10812739|NCT03344562|11974886|FG001|COMPLETED|Overall Study||9
10812740|NCT03344562|11974885|FG000|NOT COMPLETED|Overall Study||2
10812741|NCT03344562|11974886|FG001|NOT COMPLETED|Overall Study||0
10812742|NCT03342638|11974894|FG000|STARTED|Overall Study||34
10812743|NCT03342638|11974895|FG001|STARTED|Overall Study||32
10812744|NCT03342638|11974894|FG000|COMPLETED|Overall Study||33
10718466|NCT02703350|11882066|FG001|STARTED|Period Six (Part A)||5
10718467|NCT02703350|11882067|FG002|STARTED|Period Six (Part A)||5
10718468|NCT02703350|11882068|FG003|STARTED|Period Six (Part A)||5
10718469|NCT02703350|11882069|FG004|STARTED|Period Six (Part A)||5
10718470|NCT02703350|11882070|FG005|STARTED|Period Six (Part A)||5
10718471|NCT02703350|11882071|FG006|STARTED|Period Six (Part A)||0
10718472|NCT02703350|11882072|FG007|STARTED|Period Six (Part A)||0
10718473|NCT02703350|11882065|FG000|Received Study Drug|Period Six (Part A)||5
10718474|NCT02703350|11882066|FG001|Received Study Drug|Period Six (Part A)||5
10718475|NCT02703350|11882067|FG002|Received Study Drug|Period Six (Part A)||5
10718476|NCT02703350|11882068|FG003|Received Study Drug|Period Six (Part A)||5
10718477|NCT02703350|11882069|FG004|Received Study Drug|Period Six (Part A)||5
10718478|NCT02703350|11882070|FG005|Received Study Drug|Period Six (Part A)||5
10718479|NCT02703350|11882071|FG006|Received Study Drug|Period Six (Part A)||0
10718480|NCT02703350|11882072|FG007|Received Study Drug|Period Six (Part A)||0
10718481|NCT02703350|11882065|FG000|COMPLETED|Period Six (Part A)||5
10718482|NCT02703350|11882066|FG001|COMPLETED|Period Six (Part A)||5
10718483|NCT02703350|11882067|FG002|COMPLETED|Period Six (Part A)||5
10718484|NCT02703350|11882068|FG003|COMPLETED|Period Six (Part A)||5
10718485|NCT02703350|11882069|FG004|COMPLETED|Period Six (Part A)||5
10718486|NCT02703350|11882070|FG005|COMPLETED|Period Six (Part A)||5
10718487|NCT02703350|11882071|FG006|COMPLETED|Period Six (Part A)||0
10718488|NCT02703350|11882072|FG007|COMPLETED|Period Six (Part A)||0
10718489|NCT02703350|11882065|FG000|NOT COMPLETED|Period Six (Part A)||0
10718490|NCT02703350|11882066|FG001|NOT COMPLETED|Period Six (Part A)||0
10307356|NCT00105157|11440296|FG000|COMPLETED|Double-Blind (DB)||30
10307357|NCT00105157|11440297|FG001|COMPLETED|Double-Blind (DB)||31
10718491|NCT02703350|11882067|FG002|NOT COMPLETED|Period Six (Part A)||0
10307358|NCT00105157|11440298|FG002|COMPLETED|Double-Blind (DB)||33
10307359|NCT00105157|11440299|FG003|COMPLETED|Double-Blind (DB)||6
10307360|NCT00105157|11440296|FG000|NOT COMPLETED|Double-Blind (DB)||14
10307361|NCT00105157|11440297|FG001|NOT COMPLETED|Double-Blind (DB)||14
10307362|NCT00105157|11440298|FG002|NOT COMPLETED|Double-Blind (DB)||12
10307363|NCT00105157|11440299|FG003|NOT COMPLETED|Double-Blind (DB)||39
10307364|NCT00105157|11440296|FG000|STARTED|Open-Label Continuation of DB||30
10307365|NCT00105157|11440297|FG001|STARTED|Open-Label Continuation of DB||31
10307366|NCT00105157|11440298|FG002|STARTED|Open-Label Continuation of DB||33
10307367|NCT00105157|11440299|FG003|STARTED|Open-Label Continuation of DB||6
10307368|NCT00105157|11440296|FG000|COMPLETED|Open-Label Continuation of DB||23
10307369|NCT00105157|11440297|FG001|COMPLETED|Open-Label Continuation of DB||21
10307370|NCT00105157|11440298|FG002|COMPLETED|Open-Label Continuation of DB||24
10307371|NCT00105157|11440299|FG003|COMPLETED|Open-Label Continuation of DB||5
10307372|NCT00105157|11440296|FG000|NOT COMPLETED|Open-Label Continuation of DB||7
10307373|NCT00105157|11440297|FG001|NOT COMPLETED|Open-Label Continuation of DB||10
10307374|NCT00105157|11440298|FG002|NOT COMPLETED|Open-Label Continuation of DB||9
10307375|NCT00105157|11440299|FG003|NOT COMPLETED|Open-Label Continuation of DB||1
10307376|NCT00105157|11440296|FG000|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|11
10307377|NCT00105157|11440297|FG001|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|13
10389809|NCT00655980|11532451|FG001|STARTED|Overall Study||281
10307378|NCT00105157|11440298|FG002|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|11
10307379|NCT00105157|11440299|FG003|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|37
10307380|NCT00105157|11440296|FG000|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||2
10307381|NCT00105157|11440297|FG001|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||7
10307382|NCT00105157|11440298|FG002|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||5
10307383|NCT00105157|11440299|FG003|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||19
10307384|NCT00105157|11440296|FG000|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||9
10307385|NCT00105157|11440297|FG001|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||6
10542596|NCT01477762|11695654|FG001|NOT COMPLETED|Overall Study||13
10542597|NCT01477762|11695655|FG002|NOT COMPLETED|Overall Study||4
10542598|NCT01477762|11695656|FG003|NOT COMPLETED|Overall Study||2
10542599|NCT01477853|11695669|FG000|STARTED|Phase A||55
10542600|NCT01477853|11695670|FG001|STARTED|Phase A||56
10542601|NCT01477853|11695671|FG002|STARTED|Phase A||55
10542602|NCT01477853|11695669|FG000|COMPLETED|Phase A||12
10542603|NCT01477853|11695670|FG001|COMPLETED|Phase A||11
10542604|NCT01477853|11695671|FG002|COMPLETED|Phase A||11
10542605|NCT01477853|11695669|FG000|NOT COMPLETED|Phase A||43
10542606|NCT01477853|11695670|FG001|NOT COMPLETED|Phase A||45
10542607|NCT01477853|11695671|FG002|NOT COMPLETED|Phase A||44
10542608|NCT01477853|11695669|FG000|STARTED|Phase B||12
10542609|NCT01477853|11695670|FG001|STARTED|Phase B||11
10542610|NCT01477853|11695671|FG002|STARTED|Phase B||11
10542611|NCT01477853|11695669|FG000|COMPLETED|Phase B||0
10542612|NCT01477853|11695670|FG001|COMPLETED|Phase B||0
10542613|NCT01477853|11695671|FG002|COMPLETED|Phase B||0
10542614|NCT01477853|11695669|FG000|NOT COMPLETED|Phase B||12
10542615|NCT01477853|11695670|FG001|NOT COMPLETED|Phase B||11
10542616|NCT01477853|11695671|FG002|NOT COMPLETED|Phase B||11
10542617|NCT01477892|11695681|FG000|STARTED|Overall Study||7
10542618|NCT01477892|11695682|FG001|STARTED|Overall Study||7
10542619|NCT01477892|11695681|FG000|COMPLETED|Overall Study||7
10542620|NCT01477892|11695682|FG001|COMPLETED|Overall Study||5
10542621|NCT01477892|11695681|FG000|NOT COMPLETED|Overall Study||0
10542622|NCT01477892|11695682|FG001|NOT COMPLETED|Overall Study||2
10542623|NCT01478009|11695690|FG000|STARTED|Overall Study||50
10542624|NCT01478009|11695691|FG001|STARTED|Overall Study||50
10542625|NCT01478009|11695690|FG000|COMPLETED|Overall Study||49
10542626|NCT01478009|11695691|FG001|COMPLETED|Overall Study||49
10542627|NCT01478009|11695690|FG000|NOT COMPLETED|Overall Study||1
10542628|NCT01478009|11695691|FG001|NOT COMPLETED|Overall Study||1
10542629|NCT01478048|11695699|FG000|STARTED|Overall Study||77
10658560|NCT02233946|11819756|FG000|COMPLETED|Baseline|Completed baseline assessment|626
10542630|NCT01478048|11695700|FG001|STARTED|Overall Study||75
10542631|NCT01478048|11695699|FG000|Received Treatment|Overall Study|1 randomized to E-Bd but received Bd. Included in E-Bd group for efficacy and Bd group for safety|76
10542632|NCT01478048|11695700|FG001|Received Treatment|Overall Study|1 randomized to E-Bd but received Bd. Included in E-Bd group for efficacy and Bd group for safety|74
10542633|NCT01478048|11695699|FG000|COMPLETED|Overall Study||0
10718492|NCT02703350|11882068|FG003|NOT COMPLETED|Period Six (Part A)||0
10718493|NCT02703350|11882069|FG004|NOT COMPLETED|Period Six (Part A)||0
10389733|NCT00655551|11532338|FG002|COMPLETED|Period 3 (up to 7 Days)||21
10389734|NCT00655551|11532336|FG000|NOT COMPLETED|Period 3 (up to 7 Days)||0
10389735|NCT00655551|11532337|FG001|NOT COMPLETED|Period 3 (up to 7 Days)||0
10389736|NCT00655551|11532338|FG002|NOT COMPLETED|Period 3 (up to 7 Days)||4
10389737|NCT00655551|11532336|FG000|STARTED|Period 4 (up to 7 Days)||0
10389738|NCT00655551|11532337|FG001|STARTED|Period 4 (up to 7 Days)||25
10389739|NCT00655551|11532338|FG002|STARTED|Period 4 (up to 7 Days)||0
10389740|NCT00655551|11532336|FG000|COMPLETED|Period 4 (up to 7 Days)||0
10389741|NCT00655551|11532337|FG001|COMPLETED|Period 4 (up to 7 Days)||23
10389742|NCT00655551|11532338|FG002|COMPLETED|Period 4 (up to 7 Days)||0
10389743|NCT00655551|11532336|FG000|NOT COMPLETED|Period 4 (up to 7 Days)||0
10389744|NCT00655551|11532337|FG001|NOT COMPLETED|Period 4 (up to 7 Days)||2
10389745|NCT00655551|11532338|FG002|NOT COMPLETED|Period 4 (up to 7 Days)||0
10389746|NCT00655564|11532346|FG000|STARTED|Overall Study||15
10389747|NCT00655564|11532346|FG000|COMPLETED|Overall Study||12
10389748|NCT00655564|11532346|FG000|NOT COMPLETED|Overall Study||3
10389749|NCT00655629|11532353|FG000|STARTED|Overall Study||172
10389750|NCT00655629|11532354|FG001|STARTED|Overall Study||167
10389751|NCT00655629|11532353|FG000|Participants Received Treatment|Overall Study|1 patient could not verify drug ingestion. (safety population)|171
10389752|NCT00655629|11532354|FG001|Participants Received Treatment|Overall Study|1 patient could not verify drug ingestion.(safety population)|166
10389753|NCT00655629|11532353|FG000|COMPLETED|Overall Study||151
10389754|NCT00655629|11532354|FG001|COMPLETED|Overall Study||144
10389755|NCT00655629|11532353|FG000|NOT COMPLETED|Overall Study||21
10389756|NCT00655629|11532354|FG001|NOT COMPLETED|Overall Study||23
10389757|NCT00655642|11532364|FG000|STARTED|Overall Study||42
10389758|NCT00655642|11532365|FG001|STARTED|Overall Study||43
10389759|NCT00655642|11532366|FG002|STARTED|Overall Study||45
10389760|NCT00655642|11532367|FG003|STARTED|Overall Study||41
10718494|NCT02703350|11882070|FG005|NOT COMPLETED|Period Six (Part A)||0
10389761|NCT00655642|11532364|FG000|COMPLETED|Overall Study|1 patient withdrawn by treating physician after consent|41
10389762|NCT00655642|11532365|FG001|COMPLETED|Overall Study|1 patient given drug orally rather than intravenous(iv);1 patient refused iv; 1 pt lost to follow-up|40
10389763|NCT00655642|11532366|FG002|COMPLETED|Overall Study|1 patient left the ED prior to receiving drug; 1 patient's nausea resolved prior to receiving drug|43
10542660|NCT01478347|11695725|FG000|STARTED|Visit 1-Visit 3 (Day 0-91) - Part I||18
10389764|NCT00655642|11532367|FG003|COMPLETED|Overall Study|1 patient's initial Visual analog scale (VAS)<40; 1 patient was withdrawn by treating physician|39
10389765|NCT00655642|11532364|FG000|NOT COMPLETED|Overall Study||1
10389766|NCT00655642|11532365|FG001|NOT COMPLETED|Overall Study||3
10389767|NCT00655642|11532366|FG002|NOT COMPLETED|Overall Study||2
10389768|NCT00655642|11532367|FG003|NOT COMPLETED|Overall Study||2
10389769|NCT00655668|11532377|FG000|STARTED|Overall Study|Planned enrollment: 80 participants|54
10389770|NCT00655668|11532377|FG000|COMPLETED|Overall Study|Participants dosed up to 24 months, disease progression or unacceptable adverse events developed.|0
10389771|NCT00655668|11532377|FG000|NOT COMPLETED|Overall Study||54
10389772|NCT00655707|11532381|FG000|STARTED|Overall Study||5
10389773|NCT00655707|11532381|FG000|COMPLETED|Overall Study||5
10389774|NCT00655707|11532381|FG000|NOT COMPLETED|Overall Study||0
10389775|NCT00655733|11532388|FG000|STARTED|Overall Study||51
10389776|NCT00655733|11532389|FG001|STARTED|Overall Study||50
10718495|NCT02703350|11882071|FG006|NOT COMPLETED|Period Six (Part A)||0
10718496|NCT02703350|11882072|FG007|NOT COMPLETED|Period Six (Part A)||0
10718497|NCT02703350|11882065|FG000|STARTED|Part B||0
10718498|NCT02703350|11882066|FG001|STARTED|Part B||0
10718499|NCT02703350|11882067|FG002|STARTED|Part B||0
10718500|NCT02703350|11882068|FG003|STARTED|Part B||0
10718501|NCT02703350|11882069|FG004|STARTED|Part B||0
10718502|NCT02703350|11882070|FG005|STARTED|Part B||0
10718503|NCT02703350|11882071|FG006|STARTED|Part B||15
10718504|NCT02703350|11882072|FG007|STARTED|Part B||15
10718505|NCT02703350|11882065|FG000|Received Study Drug|Part B||0
10718506|NCT02703350|11882066|FG001|Received Study Drug|Part B||0
10718507|NCT02703350|11882067|FG002|Received Study Drug|Part B||0
10718508|NCT02703350|11882068|FG003|Received Study Drug|Part B||0
10718509|NCT02703350|11882069|FG004|Received Study Drug|Part B||0
10718510|NCT02703350|11882070|FG005|Received Study Drug|Part B||0
10718511|NCT02703350|11882071|FG006|Received Study Drug|Part B||15
10718512|NCT02703350|11882072|FG007|Received Study Drug|Part B||15
10718513|NCT02703350|11882065|FG000|COMPLETED|Part B||0
10812745|NCT03342638|11974895|FG001|COMPLETED|Overall Study||31
10812746|NCT03342638|11974894|FG000|NOT COMPLETED|Overall Study||1
10812747|NCT03342638|11974895|FG001|NOT COMPLETED|Overall Study||1
10812748|NCT03342157|11974903|FG000|STARTED|Overall Study||1
10812749|NCT03342157|11974904|FG001|STARTED|Overall Study||1
10812750|NCT03342157|11974903|FG000|COMPLETED|Overall Study||1
10718514|NCT02703350|11882066|FG001|COMPLETED|Part B||0
10718515|NCT02703350|11882067|FG002|COMPLETED|Part B||0
10718516|NCT02703350|11882068|FG003|COMPLETED|Part B||0
10718517|NCT02703350|11882069|FG004|COMPLETED|Part B||0
10718518|NCT02703350|11882070|FG005|COMPLETED|Part B||0
10718519|NCT02703350|11882071|FG006|COMPLETED|Part B||15
10307386|NCT00105157|11440298|FG002|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||6
10389777|NCT00655733|11532388|FG000|COMPLETED|Overall Study||44
10389778|NCT00655733|11532389|FG001|COMPLETED|Overall Study||42
10389779|NCT00655733|11532388|FG000|NOT COMPLETED|Overall Study||7
10389780|NCT00655733|11532389|FG001|NOT COMPLETED|Overall Study||8
10389781|NCT00655746|11532397|FG000|STARTED|Overall Study||14
10389782|NCT00655746|11532397|FG000|COMPLETED|Overall Study||13
10389783|NCT00655746|11532397|FG000|NOT COMPLETED|Overall Study||1
10389784|NCT00655811|11532405|FG000|STARTED|Overall Study||40
10389785|NCT00655811|11532405|FG000|COMPLETED|Overall Study||40
10389786|NCT00655811|11532405|FG000|NOT COMPLETED|Overall Study||0
10389787|NCT00655850|11532415|FG000|STARTED|Overall Study||39
10389788|NCT00655850|11532415|FG000|COMPLETED|Overall Study||36
10389789|NCT00655850|11532415|FG000|NOT COMPLETED|Overall Study||3
10389790|NCT00655863|11532424|FG000|STARTED|Overall Study||24
10389791|NCT00655863|11532425|FG001|STARTED|Overall Study||25
10389792|NCT00655863|11532426|FG002|STARTED|Overall Study||22
10389793|NCT00655863|11532424|FG000|COMPLETED|Overall Study||24
10389794|NCT00655863|11532425|FG001|COMPLETED|Overall Study||25
10542634|NCT01478048|11695700|FG001|COMPLETED|Overall Study||0
10542635|NCT01478048|11695699|FG000|NOT COMPLETED|Overall Study||77
10542636|NCT01478048|11695700|FG001|NOT COMPLETED|Overall Study||75
10542637|NCT01478087|11695706|FG000|STARTED|Overall Study||3
10542638|NCT01478087|11695706|FG000|COMPLETED|Overall Study||2
10542639|NCT01478087|11695706|FG000|NOT COMPLETED|Overall Study||1
10542640|NCT01478256|11695712|FG000|STARTED|Overall Study||15
10542641|NCT01478256|11695713|FG001|STARTED|Overall Study||15
10542642|NCT01478256|11695712|FG000|COMPLETED|Overall Study||15
10542643|NCT01478256|11695713|FG001|COMPLETED|Overall Study||15
10542644|NCT01478256|11695712|FG000|NOT COMPLETED|Overall Study||0
10542645|NCT01478256|11695713|FG001|NOT COMPLETED|Overall Study||0
10542646|NCT01478321|11695721|FG000|STARTED|Concurrent Therapy (5 Weeks)||54
10542647|NCT01478321|11695721|FG000|COMPLETED|Concurrent Therapy (5 Weeks)||38
10542648|NCT01478321|11695721|FG000|NOT COMPLETED|Concurrent Therapy (5 Weeks)||16
10542649|NCT01478321|11695721|FG000|STARTED|Started Adjuvant Therapy||38
10542650|NCT01478321|11695721|FG000|Completed First Cycle|Started Adjuvant Therapy||37
10542651|NCT01478321|11695721|FG000|COMPLETED|Started Adjuvant Therapy||37
10542652|NCT01478321|11695721|FG000|NOT COMPLETED|Started Adjuvant Therapy||1
10542653|NCT01478321|11695721|FG000|STARTED|Adjuvant Therapy Until PD or Toxicity||37
10542654|NCT01478321|11695721|FG000|Went on to Cycle 2 +|Adjuvant Therapy Until PD or Toxicity||27
10542655|NCT01478321|11695721|FG000|COMPLETED|Adjuvant Therapy Until PD or Toxicity||27
10542656|NCT01478321|11695721|FG000|NOT COMPLETED|Adjuvant Therapy Until PD or Toxicity||10
10542657|NCT01478321|11695721|FG000|STARTED|Follow-up Until Death or 12.31.18 Occurs||54
10542658|NCT01478321|11695721|FG000|COMPLETED|Follow-up Until Death or 12.31.18 Occurs||54
10542659|NCT01478321|11695721|FG000|NOT COMPLETED|Follow-up Until Death or 12.31.18 Occurs||0
10542661|NCT01478347|11695725|FG000|COMPLETED|Visit 1-Visit 3 (Day 0-91) - Part I||17
10542662|NCT01478347|11695725|FG000|NOT COMPLETED|Visit 1-Visit 3 (Day 0-91) - Part I||1
10542663|NCT01478347|11695725|FG000|STARTED|Visit 4-Visit 7 (Day 151-331) - Part II||12
10542664|NCT01478347|11695725|FG000|COMPLETED|Visit 4-Visit 7 (Day 151-331) - Part II||4
10542665|NCT01478347|11695725|FG000|NOT COMPLETED|Visit 4-Visit 7 (Day 151-331) - Part II||8
10542666|NCT01478360|11695731|FG000|STARTED|Overall Study||31
10542667|NCT01478360|11695732|FG001|STARTED|Overall Study||15
10542668|NCT01478360|11695731|FG000|PD (Pharmacodynamic) Analysis Set|Overall Study||31
10389795|NCT00655863|11532426|FG002|COMPLETED|Overall Study||21
10389796|NCT00655863|11532424|FG000|NOT COMPLETED|Overall Study||0
10389797|NCT00655863|11532425|FG001|NOT COMPLETED|Overall Study||0
10389798|NCT00655863|11532426|FG002|NOT COMPLETED|Overall Study||1
10389799|NCT00655889|11532434|FG000|STARTED|Overall Study||13
10389800|NCT00655889|11532434|FG000|COMPLETED|Overall Study||11
10389801|NCT00655889|11532434|FG000|NOT COMPLETED|Overall Study||2
10389802|NCT00655928|11532440|FG000|STARTED|Overall Study||26
10389803|NCT00655928|11532441|FG001|STARTED|Overall Study||26
10307387|NCT00105157|11440299|FG003|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||18
10307388|NCT00105183|11440310|FG000|STARTED|Overall Study|Randomized|82
10307389|NCT00105183|11440311|FG001|STARTED|Overall Study|Randomized|79
10307390|NCT00105183|11440312|FG002|STARTED|Overall Study|Randomized|62
10307391|NCT00105183|11440310|FG000|COMPLETED|Overall Study|Completed at least 12 months follow up|60
10307392|NCT00105183|11440311|FG001|COMPLETED|Overall Study|Completed at least 12 months follow up|60
10307393|NCT00105183|11440312|FG002|COMPLETED|Overall Study|Completed at least 12 months follow up|39
10307394|NCT00105183|11440310|FG000|NOT COMPLETED|Overall Study||22
10307395|NCT00105183|11440311|FG001|NOT COMPLETED|Overall Study||19
10307396|NCT00105183|11440312|FG002|NOT COMPLETED|Overall Study||23
10307397|NCT00105196|11440322|FG000|STARTED|Overall Study||177
10307398|NCT00105196|11440323|FG001|STARTED|Overall Study||172
10307399|NCT00105196|11440322|FG000|COMPLETED|Overall Study||147
10307400|NCT00105196|11440323|FG001|COMPLETED|Overall Study||149
10307401|NCT00105196|11440322|FG000|NOT COMPLETED|Overall Study||30
10307402|NCT00105196|11440323|FG001|NOT COMPLETED|Overall Study||23
10307403|NCT00105235|11440329|FG000|STARTED|Overall Study||27
10307404|NCT00105235|11440329|FG000|COMPLETED|Overall Study||20
10307405|NCT00105235|11440329|FG000|NOT COMPLETED|Overall Study||7
10307406|NCT00105443|11440339|FG000|STARTED|Double-Blind Treatment||242
10307407|NCT00105443|11440340|FG001|STARTED|Double-Blind Treatment||57
10307408|NCT00105443|11440341|FG002|STARTED|Double-Blind Treatment||256
10307409|NCT00105443|11440342|FG003|STARTED|Double-Blind Treatment||47
10307410|NCT00105443|11440339|FG000|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG1 and RG3 (RG = Reporting Group for Safety Data)|240
10307411|NCT00105443|11440340|FG001|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG1 and RG3|57
10307412|NCT00105443|11440341|FG002|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG2 and RG4|255
10307413|NCT00105443|11440342|FG003|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG2 and RG4 as well as RG5|47
10307414|NCT00105443|11440339|FG000|COMPLETED|Double-Blind Treatment|228 participants directly switched to the Follow-up (FU) phase only|228
10307415|NCT00105443|11440340|FG001|COMPLETED|Double-Blind Treatment|47 participants continued with Sorafenib Open Label (OL); 10 first to FU prior to also switch to OL|57
10307416|NCT00105443|11440341|FG002|COMPLETED|Double-Blind Treatment|245 participants directly switched to the Follow-up (FU) phase|245
10307417|NCT00105443|11440342|FG003|COMPLETED|Double-Blind Treatment|36 participants switched to Sorafenib Open Label (OL); 11 first to FU prior to also switch to OL|47
10307418|NCT00105443|11440339|FG000|NOT COMPLETED|Double-Blind Treatment||14
10307419|NCT00105443|11440340|FG001|NOT COMPLETED|Double-Blind Treatment||0
10307420|NCT00105443|11440341|FG002|NOT COMPLETED|Double-Blind Treatment||11
10307421|NCT00105443|11440342|FG003|NOT COMPLETED|Double-Blind Treatment||0
10307422|NCT00105443|11440339|FG000|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 228 participants directly switched to Follow-up (FU)|228
10307423|NCT00105443|11440340|FG001|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 47 participants directly switched to Open Label (OL) Sorafenib treatment|57
10307424|NCT00105443|11440341|FG002|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 245 participants directly switched to Follow-up (FU)|245
10307425|NCT00105443|11440342|FG003|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 36 participants directly switched to Open Label (OL) Sorafenib treatment|47
10307426|NCT00105443|11440339|FG000|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar|"In parallel to Open Label treatment only phase"|228
10307427|NCT00105443|11440340|FG001|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar||0
10307428|NCT00105443|11440341|FG002|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar|"In parallel to Open Label treatment only phase"|245
10307429|NCT00105443|11440342|FG003|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar||0
10307430|NCT00105443|11440339|FG000|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar||0
10307431|NCT00105443|11440340|FG001|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar|"In parallel to Follow-up only phase; participants received Sorafenib 400 mg bid"|47
10307432|NCT00105443|11440341|FG002|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar||0
10315346|NCT00177216|11449189|FG002|COMPLETED|Overall Study||19
10315347|NCT00177216|11449187|FG000|NOT COMPLETED|Overall Study||6
10389804|NCT00655928|11532440|FG000|COMPLETED|Overall Study||23
10389805|NCT00655928|11532441|FG001|COMPLETED|Overall Study||24
10389806|NCT00655928|11532440|FG000|NOT COMPLETED|Overall Study||3
10389807|NCT00655928|11532441|FG001|NOT COMPLETED|Overall Study||2
10389808|NCT00655980|11532450|FG000|STARTED|Overall Study||276
10389810|NCT00655980|11532452|FG002|STARTED|Overall Study||130
10389811|NCT00655980|11532450|FG000|COMPLETED|Overall Study||250
10389812|NCT00655980|11532451|FG001|COMPLETED|Overall Study||250
10389813|NCT00655980|11532452|FG002|COMPLETED|Overall Study||125
10389814|NCT00655980|11532450|FG000|NOT COMPLETED|Overall Study||26
10389815|NCT00655980|11532451|FG001|NOT COMPLETED|Overall Study||31
10389816|NCT00655980|11532452|FG002|NOT COMPLETED|Overall Study||5
10389817|NCT00656019|11532467|FG000|STARTED|Overall Study||29
10389818|NCT00656019|11532468|FG001|STARTED|Overall Study||19
10389819|NCT00656019|11532469|FG002|STARTED|Overall Study||11
10389820|NCT00656019|11532470|FG003|STARTED|Overall Study||4
10389821|NCT00656019|11532467|FG000|COMPLETED|Overall Study||15
10718520|NCT02703350|11882072|FG007|COMPLETED|Part B||15
10718521|NCT02703350|11882065|FG000|NOT COMPLETED|Part B||0
10718522|NCT02703350|11882066|FG001|NOT COMPLETED|Part B||0
10718523|NCT02703350|11882067|FG002|NOT COMPLETED|Part B||0
10718524|NCT02703350|11882068|FG003|NOT COMPLETED|Part B||0
10718525|NCT02703350|11882069|FG004|NOT COMPLETED|Part B||0
10718526|NCT02703350|11882070|FG005|NOT COMPLETED|Part B||0
10718527|NCT02703350|11882071|FG006|NOT COMPLETED|Part B||0
10718528|NCT02703350|11882072|FG007|NOT COMPLETED|Part B||0
10718529|NCT02703454|11882092|FG000|STARTED|Overall Study||24
10718530|NCT02703454|11882093|FG001|STARTED|Overall Study||27
10718531|NCT02703454|11882092|FG000|Treated|Overall Study||23
10718532|NCT02703454|11882093|FG001|Treated|Overall Study||24
10718533|NCT02703454|11882092|FG000|COMPLETED|Overall Study||13
10718534|NCT02703454|11882093|FG001|COMPLETED|Overall Study||11
10718535|NCT02703454|11882092|FG000|NOT COMPLETED|Overall Study||11
10718536|NCT02703454|11882093|FG001|NOT COMPLETED|Overall Study||16
10718537|NCT02703467|11882102|FG000|STARTED|Overall Study||20
10718538|NCT02703467|11882103|FG001|STARTED|Overall Study||5
10718539|NCT02703467|11882104|FG002|STARTED|Overall Study||45
10718540|NCT02703467|11882102|FG000|COMPLETED|Overall Study||20
10718541|NCT02703467|11882103|FG001|COMPLETED|Overall Study||5
10718542|NCT02703467|11882104|FG002|COMPLETED|Overall Study||45
10718543|NCT02703467|11882102|FG000|NOT COMPLETED|Overall Study||0
10718544|NCT02703467|11882103|FG001|NOT COMPLETED|Overall Study||0
10718545|NCT02703467|11882104|FG002|NOT COMPLETED|Overall Study||0
10718546|NCT02703532|11882120|FG000|STARTED|Overall Study||21
10718547|NCT02703532|11882121|FG001|STARTED|Overall Study||11
10718548|NCT02703532|11882122|FG002|STARTED|Overall Study||21
10718549|NCT02703532|11882123|FG003|STARTED|Overall Study||11
10542669|NCT01478360|11695732|FG001|PD (Pharmacodynamic) Analysis Set|Overall Study||15
10542670|NCT01478360|11695731|FG000|PK (Pharmacokinetics) Analysis Set|Overall Study|Serum samples were collected during the study and analyzed only for the AIN457 group|31
10718550|NCT02703532|11882120|FG000|COMPLETED|Overall Study||19
10718551|NCT02703532|11882121|FG001|COMPLETED|Overall Study||10
10718552|NCT02703532|11882122|FG002|COMPLETED|Overall Study||19
10718553|NCT02703532|11882123|FG003|COMPLETED|Overall Study||10
10718554|NCT02703532|11882120|FG000|NOT COMPLETED|Overall Study||2
10718555|NCT02703532|11882121|FG001|NOT COMPLETED|Overall Study||1
10718556|NCT02703532|11882122|FG002|NOT COMPLETED|Overall Study||2
10718557|NCT02703532|11882123|FG003|NOT COMPLETED|Overall Study||1
10718558|NCT02703636|11882133|FG000|STARTED|Overall Study||118
10718559|NCT02703636|11882133|FG000|COMPLETED|Overall Study||102
10718560|NCT02703636|11882133|FG000|NOT COMPLETED|Overall Study||16
10718561|NCT02703779|11882139|FG000|STARTED|Overall Study||51
10718562|NCT02703779|11882140|FG001|STARTED|Overall Study||50
10718563|NCT02703779|11882139|FG000|COMPLETED|Overall Study||51
10718564|NCT02703779|11882140|FG001|COMPLETED|Overall Study||50
10718565|NCT02703779|11882139|FG000|NOT COMPLETED|Overall Study||0
10718566|NCT02703779|11882140|FG001|NOT COMPLETED|Overall Study||0
10718567|NCT02703909|11882150|FG000|STARTED|Overall Study||36
10718568|NCT02703909|11882151|FG001|STARTED|Overall Study||37
10718569|NCT02703909|11882152|FG002|STARTED|Overall Study||36
10718570|NCT02703909|11882153|FG003|STARTED|Overall Study||35
10718571|NCT02703909|11882150|FG000|COMPLETED|Overall Study||36
10718572|NCT02703909|11882151|FG001|COMPLETED|Overall Study||37
10718573|NCT02703909|11882152|FG002|COMPLETED|Overall Study||36
10542671|NCT01478360|11695732|FG001|PK (Pharmacokinetics) Analysis Set|Overall Study||0
10307433|NCT00105443|11440342|FG003|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar|"In parallel to Follow-up only phase; participants received Sorafenib 400 mg bid"|36
10307434|NCT00105443|11440339|FG000|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||0
10307435|NCT00105443|11440340|FG001|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||10
10307436|NCT00105443|11440341|FG002|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||0
10307437|NCT00105443|11440342|FG003|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||11
10307438|NCT00105443|11440339|FG000|COMPLETED|Follow-up and/or Open Label Nexavar||0
10307439|NCT00105443|11440340|FG001|COMPLETED|Follow-up and/or Open Label Nexavar|57 participants in total (47 + 10) received Open Label Sorafenib treatment (Subjects at Risk)|0
10307440|NCT00105443|11440341|FG002|COMPLETED|Follow-up and/or Open Label Nexavar||0
10307441|NCT00105443|11440342|FG003|COMPLETED|Follow-up and/or Open Label Nexavar|47 participants in total (36 + 11) received Open Label Sorafenib treatment (Subjects at Risk)|0
10307442|NCT00105443|11440339|FG000|NOT COMPLETED|Follow-up and/or Open Label Nexavar||228
10307443|NCT00105443|11440340|FG001|NOT COMPLETED|Follow-up and/or Open Label Nexavar||57
10307444|NCT00105443|11440341|FG002|NOT COMPLETED|Follow-up and/or Open Label Nexavar||245
10307445|NCT00105443|11440342|FG003|NOT COMPLETED|Follow-up and/or Open Label Nexavar||47
10307446|NCT00105469|11440353|FG000|STARTED|Overall Study||365
10307447|NCT00105469|11440354|FG001|STARTED|Overall Study||378
10542672|NCT01478360|11695731|FG000|COMPLETED|Overall Study||29
10718574|NCT02703909|11882153|FG003|COMPLETED|Overall Study||35
10718575|NCT02703909|11882150|FG000|NOT COMPLETED|Overall Study||0
10718576|NCT02703909|11882151|FG001|NOT COMPLETED|Overall Study||0
10718577|NCT02703909|11882152|FG002|NOT COMPLETED|Overall Study||0
10718578|NCT02703909|11882153|FG003|NOT COMPLETED|Overall Study||0
10718582|NCT02703987|11882171|FG000|STARTED|Visit 3 Intervention (1 Day)||14
10718583|NCT02703987|11882172|FG001|STARTED|Visit 3 Intervention (1 Day)||14
10718584|NCT02703987|11882171|FG000|COMPLETED|Visit 3 Intervention (1 Day)||13
10718585|NCT02703987|11882172|FG001|COMPLETED|Visit 3 Intervention (1 Day)||11
10718586|NCT02703987|11882171|FG000|NOT COMPLETED|Visit 3 Intervention (1 Day)||1
10718587|NCT02703987|11882172|FG001|NOT COMPLETED|Visit 3 Intervention (1 Day)||3
10718588|NCT02703987|11882171|FG000|STARTED|Washout (Minimum 5 Days)||13
10718589|NCT02703987|11882172|FG001|STARTED|Washout (Minimum 5 Days)||11
10718590|NCT02703987|11882171|FG000|COMPLETED|Washout (Minimum 5 Days)||13
10718591|NCT02703987|11882172|FG001|COMPLETED|Washout (Minimum 5 Days)||11
10389822|NCT00656019|11532468|FG001|COMPLETED|Overall Study||18
10389823|NCT00656019|11532469|FG002|COMPLETED|Overall Study||11
10389824|NCT00656019|11532470|FG003|COMPLETED|Overall Study||4
10389825|NCT00656019|11532467|FG000|NOT COMPLETED|Overall Study||14
10389826|NCT00656019|11532468|FG001|NOT COMPLETED|Overall Study||1
10389827|NCT00656019|11532469|FG002|NOT COMPLETED|Overall Study||0
10389828|NCT00656019|11532470|FG003|NOT COMPLETED|Overall Study||0
10389829|NCT00656058|11532480|FG000|STARTED|Overall Study||25
10389830|NCT00656058|11532480|FG000|COMPLETED|Overall Study||19
10389831|NCT00656058|11532480|FG000|NOT COMPLETED|Overall Study||6
10389832|NCT00656084|11532484|FG000|STARTED|Overall Study||16
10389833|NCT00656084|11532484|FG000|COMPLETED|Overall Study||9
10389834|NCT00656084|11532484|FG000|NOT COMPLETED|Overall Study||7
10389835|NCT00656136|11532490|FG000|STARTED|Overall Study|Randomised patients.|195
10389836|NCT00656136|11532491|FG001|STARTED|Overall Study|Randomised patients.|390
10389837|NCT00656136|11532490|FG000|COMPLETED|Overall Study||0
10389838|NCT00656136|11532491|FG001|COMPLETED|Overall Study||0
10389839|NCT00656136|11532490|FG000|NOT COMPLETED|Overall Study||195
10389840|NCT00656136|11532491|FG001|NOT COMPLETED|Overall Study||390
10389841|NCT00656175|11532499|FG000|STARTED|Overall Study||18
10389842|NCT00656175|11532500|FG001|STARTED|Overall Study||21
10389843|NCT00656175|11532499|FG000|COMPLETED|Overall Study||17
10389844|NCT00656175|11532500|FG001|COMPLETED|Overall Study||20
10389845|NCT00656175|11532499|FG000|NOT COMPLETED|Overall Study||1
10389846|NCT00656175|11532500|FG001|NOT COMPLETED|Overall Study||1
10389847|NCT00656201|11532508|FG000|STARTED|Overall Study||235
10389848|NCT00656201|11532509|FG001|STARTED|Overall Study||233
10389849|NCT00656201|11532508|FG000|COMPLETED|Overall Study||206
10389850|NCT00656201|11532509|FG001|COMPLETED|Overall Study||201
10389851|NCT00656201|11532508|FG000|NOT COMPLETED|Overall Study||29
10389852|NCT00656201|11532509|FG001|NOT COMPLETED|Overall Study||32
10389853|NCT00656292|11532517|FG000|STARTED|Overall Study||32
10389854|NCT00656292|11532518|FG001|STARTED|Overall Study||29
10389855|NCT00656292|11532517|FG000|COMPLETED|Overall Study||29
10389856|NCT00656292|11532518|FG001|COMPLETED|Overall Study||24
10389857|NCT00656292|11532517|FG000|NOT COMPLETED|Overall Study||3
10389858|NCT00656292|11532518|FG001|NOT COMPLETED|Overall Study||5
10389859|NCT00656305|11532526|FG000|STARTED|Overall Study||87
10389860|NCT00656305|11532527|FG001|STARTED|Overall Study||28
10389861|NCT00656305|11532526|FG000|COMPLETED|Overall Study||65
10389862|NCT00656305|11532527|FG001|COMPLETED|Overall Study||21
10389863|NCT00656305|11532526|FG000|NOT COMPLETED|Overall Study||22
10389864|NCT00656305|11532527|FG001|NOT COMPLETED|Overall Study||7
10389865|NCT00656370|11532533|FG000|STARTED|Overall Study|25 subjects were assessed for eligibility and signed an Informed Consent Form.|25
10389866|NCT00656370|11532533|FG000|COMPLETED|Overall Study|15 subjects were randomized and completed stage 1 (received both NS and LR).|15
10389867|NCT00656370|11532533|FG000|NOT COMPLETED|Overall Study||10
10389868|NCT00656448|11532541|FG000|STARTED|Overall Study||25
10389869|NCT00656448|11532542|FG001|STARTED|Overall Study||25
10389870|NCT00656448|11532541|FG000|COMPLETED|Overall Study||25
10389871|NCT00656448|11532542|FG001|COMPLETED|Overall Study||25
10389872|NCT00656448|11532541|FG000|NOT COMPLETED|Overall Study||0
10389873|NCT00656448|11532542|FG001|NOT COMPLETED|Overall Study||0
10389874|NCT00656474|11532549|FG000|STARTED|Overall Study||12
10389875|NCT00656474|11532549|FG000|COMPLETED|Overall Study||11
10389876|NCT00656474|11532549|FG000|NOT COMPLETED|Overall Study||1
10389877|NCT00656487|11532557|FG000|STARTED|Overall Study||23
10389878|NCT00656487|11532558|FG001|STARTED|Overall Study||23
10389879|NCT00656487|11532559|FG002|STARTED|Overall Study||20
10389880|NCT00656487|11532557|FG000|COMPLETED|Overall Study||21
10389881|NCT00656487|11532558|FG001|COMPLETED|Overall Study||19
10389882|NCT00656487|11532559|FG002|COMPLETED|Overall Study||20
10389883|NCT00656487|11532557|FG000|NOT COMPLETED|Overall Study||2
10389884|NCT00656487|11532558|FG001|NOT COMPLETED|Overall Study||4
10389885|NCT00656487|11532559|FG002|NOT COMPLETED|Overall Study||0
10389886|NCT00656513|11532570|FG000|STARTED|Overall Study||48
10389887|NCT00656513|11532571|FG001|STARTED|Overall Study||73
10389888|NCT00656513|11532572|FG002|STARTED|Overall Study||75
10389889|NCT00656513|11532570|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|44
10389890|NCT00656513|11532571|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|43
10389891|NCT00656513|11532572|FG002|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|53
10389892|NCT00656513|11532570|FG000|NOT COMPLETED|Overall Study||4
10389893|NCT00656513|11532571|FG001|NOT COMPLETED|Overall Study||30
10389894|NCT00656513|11532572|FG002|NOT COMPLETED|Overall Study||22
10389895|NCT00656617|11532580|FG000|STARTED|Overall Study||106
10389896|NCT00656617|11532580|FG000|Run-in Induction Phase|Overall Study|Initial run-in: Vorinostat induction dose 500 mg orally three times daily for 3 days.|3
10389897|NCT00656617|11532580|FG000|Induction Phase|Overall Study|Induction phase following determination of safe combination Vorinostat with Idarubicin.|103
10389898|NCT00656617|11532580|FG000|COMPLETED|Overall Study||99
10389899|NCT00656617|11532580|FG000|NOT COMPLETED|Overall Study||7
10389900|NCT00656630|11532588|FG000|STARTED|Overall Study||22
10389901|NCT00656630|11532589|FG001|STARTED|Overall Study||27
10389902|NCT00656630|11532590|FG002|STARTED|Overall Study||19
10389903|NCT00656630|11532588|FG000|COMPLETED|Overall Study||20
10389904|NCT00656630|11532589|FG001|COMPLETED|Overall Study||25
10542673|NCT01478360|11695732|FG001|COMPLETED|Overall Study||12
10542674|NCT01478360|11695731|FG000|NOT COMPLETED|Overall Study||2
10542675|NCT01478360|11695732|FG001|NOT COMPLETED|Overall Study||3
10812751|NCT03342157|11974904|FG001|COMPLETED|Overall Study||1
10812752|NCT03342157|11974903|FG000|NOT COMPLETED|Overall Study||0
10812753|NCT03342157|11974904|FG001|NOT COMPLETED|Overall Study||0
10812754|NCT03339401|11974912|FG000|STARTED|Overall Study||20
10307448|NCT00105469|11440353|FG000|COMPLETED|Overall Study||343
10307449|NCT00105469|11440354|FG001|COMPLETED|Overall Study||367
10307450|NCT00105469|11440353|FG000|NOT COMPLETED|Overall Study||22
10307451|NCT00105469|11440354|FG001|NOT COMPLETED|Overall Study||11
10307452|NCT00105482|11440362|FG000|STARTED|Overall Study||87
10307453|NCT00105482|11440363|FG001|STARTED|Overall Study||85
10307454|NCT00105482|11440362|FG000|COMPLETED|Overall Study||28
10307455|NCT00105482|11440363|FG001|COMPLETED|Overall Study||30
10389905|NCT00656630|11532590|FG002|COMPLETED|Overall Study||17
10389906|NCT00656630|11532588|FG000|NOT COMPLETED|Overall Study||2
10389907|NCT00656630|11532589|FG001|NOT COMPLETED|Overall Study||2
10389908|NCT00656630|11532590|FG002|NOT COMPLETED|Overall Study||2
10389909|NCT00656656|11532598|FG000|STARTED|Overall Study||23
10389910|NCT00656656|11532598|FG000|COMPLETED|Overall Study||23
10389911|NCT00656656|11532598|FG000|NOT COMPLETED|Overall Study||0
10389912|NCT00656669|11532602|FG000|STARTED|Single Agent Sunitinib (Cycle 1)||23
10389913|NCT00656669|11532602|FG000|COMPLETED|Single Agent Sunitinib (Cycle 1)||23
10389914|NCT00656669|11532602|FG000|NOT COMPLETED|Single Agent Sunitinib (Cycle 1)||0
10389915|NCT00656669|11532602|FG000|STARTED|Paclitaxel/Sunitinib (Cycles 2-5)||23
10389916|NCT00656669|11532602|FG000|COMPLETED|Paclitaxel/Sunitinib (Cycles 2-5)||17
10389917|NCT00656669|11532602|FG000|NOT COMPLETED|Paclitaxel/Sunitinib (Cycles 2-5)||6
10389918|NCT00656669|11532602|FG000|STARTED|AC (Cycles 6-9)||17
10389919|NCT00656669|11532602|FG000|COMPLETED|AC (Cycles 6-9)||15
10389920|NCT00656669|11532602|FG000|NOT COMPLETED|AC (Cycles 6-9)||2
10389921|NCT00656799|11532611|FG000|STARTED|Overall Study||6
10389922|NCT00656799|11532611|FG000|COMPLETED|Overall Study||4
10389923|NCT00656799|11532611|FG000|NOT COMPLETED|Overall Study||2
10389924|NCT00656851|11532617|FG000|STARTED|Overall Study||12
10389925|NCT00656851|11532618|FG001|STARTED|Overall Study||12
10389926|NCT00656851|11532617|FG000|COMPLETED|Overall Study||12
10389927|NCT00656851|11532618|FG001|COMPLETED|Overall Study||8
10389928|NCT00656851|11532617|FG000|NOT COMPLETED|Overall Study||0
10389929|NCT00656851|11532618|FG001|NOT COMPLETED|Overall Study||4
10389930|NCT00656968|11532626|FG000|STARTED|Overall Study||115
10389931|NCT00656968|11532627|FG001|STARTED|Overall Study||117
10389932|NCT00656968|11532626|FG000|COMPLETED|Overall Study||115
10389933|NCT00656968|11532627|FG001|COMPLETED|Overall Study||117
10389934|NCT00656968|11532626|FG000|NOT COMPLETED|Overall Study||0
10389935|NCT00656968|11532627|FG001|NOT COMPLETED|Overall Study||0
10389936|NCT00657020|11532633|FG000|STARTED|PERIOD 1||11
10389937|NCT00657020|11532634|FG001|STARTED|PERIOD 1||12
10389938|NCT00657020|11532633|FG000|COMPLETED|PERIOD 1||11
10389939|NCT00657020|11532634|FG001|COMPLETED|PERIOD 1||11
10389940|NCT00657020|11532633|FG000|NOT COMPLETED|PERIOD 1||0
10389941|NCT00657020|11532634|FG001|NOT COMPLETED|PERIOD 1||1
10389942|NCT00657020|11532633|FG000|STARTED|PERIOD 2||11
10389943|NCT00657020|11532634|FG001|STARTED|PERIOD 2||11
10389944|NCT00657020|11532633|FG000|COMPLETED|PERIOD 2||11
10389945|NCT00657020|11532634|FG001|COMPLETED|PERIOD 2||11
10389946|NCT00657020|11532633|FG000|NOT COMPLETED|PERIOD 2||0
10389947|NCT00657020|11532634|FG001|NOT COMPLETED|PERIOD 2||0
10389948|NCT00657046|11532649|FG000|STARTED|Overall Study||30
10389949|NCT00657046|11532650|FG001|STARTED|Overall Study||32
10389950|NCT00657046|11532651|FG002|STARTED|Overall Study||23
10389951|NCT00657046|11532649|FG000|Had at Least 1 Post Baseline Visit|Overall Study||30
10389952|NCT00657046|11532650|FG001|Had at Least 1 Post Baseline Visit|Overall Study||31
10389953|NCT00657046|11532651|FG002|Had at Least 1 Post Baseline Visit|Overall Study||23
10542676|NCT01478373|11695738|FG000|STARTED|Treatment Phase||39
10542677|NCT01478373|11695738|FG000|COMPLETED|Treatment Phase||38
10542678|NCT01478373|11695738|FG000|NOT COMPLETED|Treatment Phase||1
10542679|NCT01478373|11695738|FG000|STARTED|Survival Phase||38
10542680|NCT01478373|11695738|FG000|COMPLETED|Survival Phase||0
10542681|NCT01478373|11695738|FG000|NOT COMPLETED|Survival Phase||38
10389954|NCT00657046|11532649|FG000|Had Visits up to Visit 18|Overall Study||28
10389955|NCT00657046|11532650|FG001|Had Visits up to Visit 18|Overall Study||30
10389956|NCT00657046|11532651|FG002|Had Visits up to Visit 18|Overall Study||23
10389957|NCT00657046|11532649|FG000|COMPLETED|Overall Study||26
10389958|NCT00657046|11532650|FG001|COMPLETED|Overall Study||29
10389959|NCT00657046|11532651|FG002|COMPLETED|Overall Study||21
10389960|NCT00657046|11532649|FG000|NOT COMPLETED|Overall Study||4
10389961|NCT00657046|11532650|FG001|NOT COMPLETED|Overall Study||3
10389962|NCT00657046|11532651|FG002|NOT COMPLETED|Overall Study||2
10389963|NCT00657150|11532661|FG000|STARTED|Overall Study||1010
10389964|NCT00657150|11532662|FG001|STARTED|Overall Study||1003
10389965|NCT00657150|11532661|FG000|COMPLETED|Overall Study||895
10389966|NCT00657150|11532662|FG001|COMPLETED|Overall Study||910
10389967|NCT00657150|11532661|FG000|NOT COMPLETED|Overall Study||115
10389968|NCT00657150|11532662|FG001|NOT COMPLETED|Overall Study||93
10389969|NCT00657150|11532661|FG000|STARTED|Treatment||1010
10389970|NCT00657150|11532662|FG001|STARTED|Treatment||1003
10389971|NCT00657150|11532661|FG000|COMPLETED|Treatment||903
10389972|NCT00657150|11532662|FG001|COMPLETED|Treatment||906
10389973|NCT00657150|11532661|FG000|NOT COMPLETED|Treatment||107
10389974|NCT00657150|11532662|FG001|NOT COMPLETED|Treatment||97
10428478|NCT00858442|11574533|FG000|STARTED|From Surgery to Start Compression;||21
10428479|NCT00858442|11574534|FG001|STARTED|From Surgery to Start Compression;||23
10428480|NCT00858442|11574533|FG000|COMPLETED|From Surgery to Start Compression;||21
10428481|NCT00858442|11574534|FG001|COMPLETED|From Surgery to Start Compression;||23
10428482|NCT00858442|11574533|FG000|NOT COMPLETED|From Surgery to Start Compression;||0
10428483|NCT00858442|11574534|FG001|NOT COMPLETED|From Surgery to Start Compression;||0
10428484|NCT00858442|11574533|FG000|STARTED|Compression:Start to Finish||21
10428485|NCT00858442|11574534|FG001|STARTED|Compression:Start to Finish||23
10428486|NCT00858442|11574533|FG000|COMPLETED|Compression:Start to Finish||20
10428487|NCT00858442|11574534|FG001|COMPLETED|Compression:Start to Finish||20
10428488|NCT00858442|11574533|FG000|NOT COMPLETED|Compression:Start to Finish||1
10428489|NCT00858442|11574534|FG001|NOT COMPLETED|Compression:Start to Finish||3
10428490|NCT00858468|11574543|FG000|STARTED|Overall Study|1 enrolled participant was not vaccinated and removed from analysis|201
10428491|NCT00858468|11574544|FG001|STARTED|Overall Study||192
10428492|NCT00858468|11574543|FG000|COMPLETED|Overall Study||201
10428493|NCT00858468|11574544|FG001|COMPLETED|Overall Study||192
10428494|NCT00858468|11574543|FG000|NOT COMPLETED|Overall Study||0
10428495|NCT00858468|11574544|FG001|NOT COMPLETED|Overall Study||0
10428496|NCT00858494|11574550|FG000|STARTED|Overall Study||49
10428497|NCT00858494|11574550|FG000|COMPLETED|Overall Study|2 participants dropped out before giving study medication. Symptoms resolved without a dose in 2.|45
10428498|NCT00858494|11574550|FG000|NOT COMPLETED|Overall Study||4
10428499|NCT00858507|11574556|FG000|STARTED|Overall Study||105
10428500|NCT00858507|11574557|FG001|STARTED|Overall Study||116
10428501|NCT00858507|11574556|FG000|COMPLETED|Overall Study||83
10428502|NCT00858507|11574557|FG001|COMPLETED|Overall Study||101
10428503|NCT00858507|11574556|FG000|NOT COMPLETED|Overall Study||22
10428504|NCT00858507|11574557|FG001|NOT COMPLETED|Overall Study||15
10428505|NCT00858637|11574565|FG000|STARTED|Active Comparison Phase||127
10428506|NCT00858637|11574566|FG001|STARTED|Active Comparison Phase||0
10428507|NCT00858637|11574567|FG002|STARTED|Active Comparison Phase||0
10428508|NCT00858637|11574568|FG003|STARTED|Active Comparison Phase||133
10428509|NCT00858637|11574569|FG004|STARTED|Active Comparison Phase||0
10428510|NCT00858637|11574570|FG005|STARTED|Active Comparison Phase||0
10428511|NCT00858637|11574565|FG000|COMPLETED|Active Comparison Phase||103
10428512|NCT00858637|11574566|FG001|COMPLETED|Active Comparison Phase||0
10428513|NCT00858637|11574567|FG002|COMPLETED|Active Comparison Phase||0
10542682|NCT01478581|11695746|FG000|STARTED|Overall Study||13
10542683|NCT01478581|11695747|FG001|STARTED|Overall Study||18
10542684|NCT01478581|11695748|FG002|STARTED|Overall Study||18
10542685|NCT01478581|11695749|FG003|STARTED|Overall Study|Simon 2-stage design - cohort 4 expansion per stage 1 data (≥3 Clinical Benefit Responders observed|43
10542686|NCT01478581|11695746|FG000|COMPLETED|Overall Study||13
10542687|NCT01478581|11695747|FG001|COMPLETED|Overall Study||18
10542688|NCT01478581|11695748|FG002|COMPLETED|Overall Study||18
10542689|NCT01478581|11695749|FG003|COMPLETED|Overall Study||43
10812755|NCT03339401|11974913|FG001|STARTED|Overall Study||9
10812756|NCT03339401|11974912|FG000|COMPLETED|Overall Study||11
10389975|NCT00657267|11532668|FG000|STARTED|Overall Study||58
10389976|NCT00657267|11532668|FG000|COMPLETED|Overall Study||4
10389977|NCT00657267|11532668|FG000|NOT COMPLETED|Overall Study||54
10389978|NCT00657280|11532674|FG000|STARTED|Overall Study||16
10389979|NCT00657280|11532674|FG000|COMPLETED|Overall Study||16
10389980|NCT00657280|11532674|FG000|NOT COMPLETED|Overall Study||0
10389981|NCT00657358|11532678|FG000|STARTED|Overall Study||22
10389982|NCT00657358|11532678|FG000|COMPLETED|Overall Study||16
10389983|NCT00657358|11532678|FG000|NOT COMPLETED|Overall Study||6
10389984|NCT00657371|11532683|FG000|STARTED|Overall Study||288
10389985|NCT00657371|11532683|FG000|COMPLETED|Overall Study||249
10389986|NCT00657371|11532683|FG000|NOT COMPLETED|Overall Study||39
10389987|NCT00657540|11532689|FG000|STARTED|Overall Study||29
10542690|NCT01478581|11695746|FG000|NOT COMPLETED|Overall Study||0
10718592|NCT02703987|11882171|FG000|NOT COMPLETED|Washout (Minimum 5 Days)||0
10307456|NCT00105482|11440362|FG000|NOT COMPLETED|Overall Study||59
10307457|NCT00105482|11440363|FG001|NOT COMPLETED|Overall Study||55
10307458|NCT00105508|11440371|FG000|STARTED|Overall Study||253
10307459|NCT00105508|11440372|FG001|STARTED|Overall Study||253
10307460|NCT00105508|11440371|FG000|COMPLETED|Overall Study||213
10307461|NCT00105508|11440372|FG001|COMPLETED|Overall Study||217
10307462|NCT00105508|11440371|FG000|NOT COMPLETED|Overall Study||40
10307463|NCT00105508|11440372|FG001|NOT COMPLETED|Overall Study||36
10307464|NCT00105521|11440382|FG000|STARTED|Overall Study||98
10307465|NCT00105521|11440383|FG001|STARTED|Overall Study||101
10307466|NCT00105521|11440384|FG002|STARTED|Overall Study||97
10307467|NCT00105521|11440385|FG003|STARTED|Overall Study||102
10307468|NCT00105521|11440382|FG000|COMPLETED|Overall Study||83
10307469|NCT00105521|11440383|FG001|COMPLETED|Overall Study||90
10812757|NCT03339401|11974913|FG001|COMPLETED|Overall Study||5
10812758|NCT03339401|11974912|FG000|NOT COMPLETED|Overall Study||9
10812759|NCT03339401|11974913|FG001|NOT COMPLETED|Overall Study||4
10812760|NCT03339245|11974921|FG000|STARTED|Overall Study||6
10307470|NCT00105521|11440384|FG002|COMPLETED|Overall Study||80
10307471|NCT00105521|11440385|FG003|COMPLETED|Overall Study||85
10307472|NCT00105521|11440382|FG000|NOT COMPLETED|Overall Study||15
10307473|NCT00105521|11440383|FG001|NOT COMPLETED|Overall Study||11
10307474|NCT00105521|11440384|FG002|NOT COMPLETED|Overall Study||17
10307475|NCT00105521|11440385|FG003|NOT COMPLETED|Overall Study||17
10307476|NCT00105534|11440397|FG000|STARTED|Overall Study||335
10307477|NCT00105534|11440398|FG001|STARTED|Overall Study||350
10307478|NCT00105534|11440397|FG000|COMPLETED|Overall Study||313
10307479|NCT00105534|11440398|FG001|COMPLETED|Overall Study||317
10307480|NCT00105534|11440397|FG000|NOT COMPLETED|Overall Study||22
10307481|NCT00105534|11440398|FG001|NOT COMPLETED|Overall Study||33
10307482|NCT00105586|11440406|FG000|STARTED|Overall Study||92
10307483|NCT00105586|11440407|FG001|STARTED|Overall Study||85
10307484|NCT00105586|11440406|FG000|COMPLETED|Overall Study||75
10307485|NCT00105586|11440407|FG001|COMPLETED|Overall Study||69
10307486|NCT00105586|11440406|FG000|NOT COMPLETED|Overall Study||17
10307487|NCT00105586|11440407|FG001|NOT COMPLETED|Overall Study||16
10307488|NCT00105989|11440415|FG000|STARTED|Acute - Open Label: Week 0-10||514
10307489|NCT00105989|11440416|FG001|STARTED|Acute - Open Label: Week 0-10||0
10307490|NCT00105989|11440415|FG000|COMPLETED|Acute - Open Label: Week 0-10||413
10307491|NCT00105989|11440416|FG001|COMPLETED|Acute - Open Label: Week 0-10||0
10307492|NCT00105989|11440415|FG000|NOT COMPLETED|Acute - Open Label: Week 0-10||101
10307493|NCT00105989|11440416|FG001|NOT COMPLETED|Acute - Open Label: Week 0-10||0
10307494|NCT00105989|11440415|FG000|STARTED|Continuation - Open Label:Week 10-34||413
10307495|NCT00105989|11440416|FG001|STARTED|Continuation - Open Label:Week 10-34||0
10307496|NCT00105989|11440415|FG000|COMPLETED|Continuation - Open Label:Week 10-34||288
10307497|NCT00105989|11440416|FG001|COMPLETED|Continuation - Open Label:Week 10-34||0
10307498|NCT00105989|11440415|FG000|NOT COMPLETED|Continuation - Open Label:Week 10-34||125
10307499|NCT00105989|11440416|FG001|NOT COMPLETED|Continuation - Open Label:Week 10-34||0
10307500|NCT00105989|11440415|FG000|STARTED|Maintenance - Double-Blind:Week 34-86||146
10307501|NCT00105989|11440416|FG001|STARTED|Maintenance - Double-Blind:Week 34-86||142
10307502|NCT00105989|11440415|FG000|COMPLETED|Maintenance - Double-Blind:Week 34-86||96
10307503|NCT00105989|11440416|FG001|COMPLETED|Maintenance - Double-Blind:Week 34-86||73
10307504|NCT00105989|11440415|FG000|NOT COMPLETED|Maintenance - Double-Blind:Week 34-86||50
10307505|NCT00105989|11440416|FG001|NOT COMPLETED|Maintenance - Double-Blind:Week 34-86||69
10307506|NCT00106002|11440432|FG000|STARTED|Overall Study||37
10307507|NCT00106002|11440432|FG000|COMPLETED|Overall Study|Completed means that the patient was evaluable for response.|35
10307508|NCT00106002|11440432|FG000|NOT COMPLETED|Overall Study||2
10307509|NCT00106028|11440438|FG000|STARTED|Overall Study|ITT Population: Patients Randomized and Received at least 1 Dose of Study Drug|49
10307510|NCT00106028|11440439|FG001|STARTED|Overall Study|ITT Population: Patients Randomized and Received at least 1 Dose of Study Drug|94
10307511|NCT00106028|11440438|FG000|Month 12 Completed/Started Open Label|Overall Study||49
10307512|NCT00106028|11440439|FG001|Month 12 Completed/Started Open Label|Overall Study||87
10307513|NCT00106028|11440438|FG000|COMPLETED|Overall Study|Completed Month 36|43
10307514|NCT00106028|11440439|FG001|COMPLETED|Overall Study|Completed Month 36|82
10307515|NCT00106028|11440438|FG000|NOT COMPLETED|Overall Study||6
10307516|NCT00106028|11440439|FG001|NOT COMPLETED|Overall Study||12
10812761|NCT03339245|11974922|FG001|STARTED|Overall Study||7
10542691|NCT01478581|11695747|FG001|NOT COMPLETED|Overall Study||0
10542692|NCT01478581|11695748|FG002|NOT COMPLETED|Overall Study||0
10542693|NCT01478581|11695749|FG003|NOT COMPLETED|Overall Study||0
10542694|NCT01478594|11695765|FG000|STARTED|Overall Study||177
10542695|NCT01478594|11695766|FG001|STARTED|Overall Study||88
10542696|NCT01478594|11695765|FG000|Treated|Overall Study||177
10542697|NCT01478594|11695766|FG001|Treated|Overall Study||87
10542698|NCT01478594|11695765|FG000|COMPLETED|Overall Study|Participants still on study as of 28 February 2014|112
10542699|NCT01478594|11695766|FG001|COMPLETED|Overall Study|Participants still on study as of 28 February 2014|60
10542700|NCT01478594|11695765|FG000|NOT COMPLETED|Overall Study||65
10542701|NCT01478594|11695766|FG001|NOT COMPLETED|Overall Study||28
10542702|NCT01478620|11695825|FG000|STARTED|Overall Study||125
10542703|NCT01478620|11695825|FG000|COMPLETED|Overall Study||119
10542704|NCT01478620|11695825|FG000|NOT COMPLETED|Overall Study||6
10542705|NCT01478828|11695829|FG000|STARTED|Overall Study||2
10542706|NCT01478828|11695829|FG000|COMPLETED|Overall Study||1
10542707|NCT01478828|11695829|FG000|NOT COMPLETED|Overall Study||1
10542708|NCT01478854|11695834|FG000|STARTED|Overall Study||30
10542709|NCT01478854|11695834|FG000|COMPLETED|Overall Study||30
10542710|NCT01478854|11695834|FG000|NOT COMPLETED|Overall Study||0
10542711|NCT01478958|11695841|FG000|STARTED|Overall Study||67
10542712|NCT01478958|11695842|FG001|STARTED|Overall Study||66
10542713|NCT01478958|11695843|FG002|STARTED|Overall Study||69
10542714|NCT01478958|11695841|FG000|COMPLETED|Overall Study||65
10542715|NCT01478958|11695842|FG001|COMPLETED|Overall Study||64
10542716|NCT01478958|11695843|FG002|COMPLETED|Overall Study||66
10542717|NCT01478958|11695841|FG000|NOT COMPLETED|Overall Study||2
10542718|NCT01478958|11695842|FG001|NOT COMPLETED|Overall Study||2
10542719|NCT01478958|11695843|FG002|NOT COMPLETED|Overall Study||3
10542720|NCT01478971|11695851|FG000|STARTED|Standard of Care Period||184
10542721|NCT01478971|11695851|FG000|Received Treatment|Standard of Care Period||178
10542722|NCT01478971|11695851|FG000|COMPLETED|Standard of Care Period||159
10542723|NCT01478971|11695851|FG000|NOT COMPLETED|Standard of Care Period||25
10542724|NCT01478971|11695851|FG000|STARTED|Peginesatide Treatment Period|2 participants terminated the study before transitioning to peginesatide for unknown reasons|157
10542725|NCT01478971|11695851|FG000|COMPLETED|Peginesatide Treatment Period||143
10542726|NCT01478971|11695851|FG000|NOT COMPLETED|Peginesatide Treatment Period||14
10542727|NCT01479127|11695859|FG000|STARTED|Overall Study|started oral study drug (full safety sample)|8
10542728|NCT01479127|11695859|FG000|Started LCIG|Overall Study||6
10542729|NCT01479127|11695859|FG000|COMPLETED|Overall Study||5
10542730|NCT01479127|11695859|FG000|NOT COMPLETED|Overall Study||3
10542731|NCT01479270|11695869|FG000|STARTED|Overall Study||28
10812762|NCT03339245|11974921|FG000|COMPLETED|Overall Study|"1 withdrawn due to elevated glucose during pre-intervention testing~1 withdrawn for personal reason"|4
10812763|NCT03339245|11974922|FG001|COMPLETED|Overall Study|1 withdrawn due to elevated glucose on baseline testing|6
10812764|NCT03339245|11974921|FG000|NOT COMPLETED|Overall Study||2
10542732|NCT01479270|11695870|FG001|STARTED|Overall Study||28
10542733|NCT01479270|11695869|FG000|COMPLETED|Overall Study||28
10542734|NCT01479270|11695870|FG001|COMPLETED|Overall Study||28
10542735|NCT01479270|11695869|FG000|NOT COMPLETED|Overall Study||0
10542736|NCT01479270|11695870|FG001|NOT COMPLETED|Overall Study||0
10542737|NCT01479348|11695879|FG000|STARTED|Overall Study||5
10542738|NCT01479348|11695880|FG001|STARTED|Overall Study||0
10542739|NCT01479348|11695879|FG000|COMPLETED|Overall Study||5
10542740|NCT01479348|11695880|FG001|COMPLETED|Overall Study||0
10542741|NCT01479348|11695879|FG000|NOT COMPLETED|Overall Study||0
10542742|NCT01479348|11695880|FG001|NOT COMPLETED|Overall Study||0
10542743|NCT01479374|11695887|FG000|STARTED|Overall Study||66
10542744|NCT01479374|11695888|FG001|STARTED|Overall Study||68
10542745|NCT01479374|11695889|FG002|STARTED|Overall Study||68
10542746|NCT01479374|11695887|FG000|COMPLETED|Overall Study||63
10542747|NCT01479374|11695888|FG001|COMPLETED|Overall Study||60
10542748|NCT01479374|11695889|FG002|COMPLETED|Overall Study||63
10542749|NCT01479374|11695887|FG000|NOT COMPLETED|Overall Study||3
10542750|NCT01479374|11695888|FG001|NOT COMPLETED|Overall Study||8
10542751|NCT01479374|11695889|FG002|NOT COMPLETED|Overall Study||5
10542752|NCT01479426|11695899|FG000|STARTED|Overall Study||40
10718593|NCT02703987|11882172|FG001|NOT COMPLETED|Washout (Minimum 5 Days)||0
10718594|NCT02703987|11882171|FG000|STARTED|Visit 4 Intervention (1 Day)||13
10718595|NCT02703987|11882172|FG001|STARTED|Visit 4 Intervention (1 Day)||11
10718596|NCT02703987|11882171|FG000|COMPLETED|Visit 4 Intervention (1 Day)||12
10718597|NCT02703987|11882172|FG001|COMPLETED|Visit 4 Intervention (1 Day)||10
10718598|NCT02703987|11882171|FG000|NOT COMPLETED|Visit 4 Intervention (1 Day)||1
10718599|NCT02703987|11882172|FG001|NOT COMPLETED|Visit 4 Intervention (1 Day)||1
10718600|NCT02704091|11882180|FG000|STARTED|Overall Study||430
10718601|NCT02704091|11882181|FG001|STARTED|Overall Study||423
10718602|NCT02704091|11882180|FG000|COMPLETED|Overall Study||402
10718603|NCT02704091|11882181|FG001|COMPLETED|Overall Study||400
10389988|NCT00657540|11532690|FG001|STARTED|Overall Study||31
10389989|NCT00657540|11532689|FG000|COMPLETED|Overall Study|All subjects had a known treatment failure disposition at time of loss to follow-up.|28
10718604|NCT02704091|11882180|FG000|NOT COMPLETED|Overall Study||28
10812765|NCT03339245|11974922|FG001|NOT COMPLETED|Overall Study||1
10812766|NCT03333746|11974928|FG000|STARTED|Overall Study||1
10812767|NCT03333746|11974928|FG000|COMPLETED|Overall Study||0
10812768|NCT03333746|11974928|FG000|NOT COMPLETED|Overall Study||1
10812769|NCT03329404|11974934|FG000|STARTED|Overall Study||4
10812770|NCT03329404|11974935|FG001|STARTED|Overall Study||5
10812771|NCT03329404|11974934|FG000|COMPLETED|Overall Study||3
10812772|NCT03329404|11974935|FG001|COMPLETED|Overall Study||1
10389990|NCT00657540|11532690|FG001|COMPLETED|Overall Study|All subjects had a known treatment failure disposition at time of loss to follow-up.|27
10389991|NCT00657540|11532689|FG000|NOT COMPLETED|Overall Study||1
10389992|NCT00657540|11532690|FG001|NOT COMPLETED|Overall Study||4
10389993|NCT00657605|11532696|FG000|STARTED|Overall Study||3
10389994|NCT00657605|11532696|FG000|COMPLETED|Overall Study||3
10307517|NCT00106080|11440449|FG000|STARTED|Overall Study||194
10307518|NCT00106080|11440450|FG001|STARTED|Overall Study||182
10307519|NCT00106080|11440449|FG000|COMPLETED|Overall Study||151
10307520|NCT00106080|11440450|FG001|COMPLETED|Overall Study||155
10307521|NCT00106080|11440449|FG000|NOT COMPLETED|Overall Study||43
10307522|NCT00106080|11440450|FG001|NOT COMPLETED|Overall Study||27
10307523|NCT00106106|11440458|FG000|STARTED|Overall Study||26
10307524|NCT00106106|11440459|FG001|STARTED|Overall Study||23
10307525|NCT00106106|11440458|FG000|Completed Both MRS Scans|Overall Study||18
10307526|NCT00106106|11440459|FG001|Completed Both MRS Scans|Overall Study||15
10307527|NCT00106106|11440458|FG000|COMPLETED|Overall Study|Although 22 subjects completed all other assessments for the study, only 18 completed both MRS scans|22
10307528|NCT00106106|11440459|FG001|COMPLETED|Overall Study|Although 19 subjects completed all other assessments for the study, only 15 completed both MRS scans|19
10307529|NCT00106106|11440458|FG000|NOT COMPLETED|Overall Study||4
10307530|NCT00106106|11440459|FG001|NOT COMPLETED|Overall Study||4
10307531|NCT00106119|11440465|FG000|STARTED|First Intervention||7
10307532|NCT00106119|11440466|FG001|STARTED|First Intervention||7
10307533|NCT00106119|11440465|FG000|COMPLETED|First Intervention||7
10307534|NCT00106119|11440466|FG001|COMPLETED|First Intervention||7
10307535|NCT00106119|11440465|FG000|NOT COMPLETED|First Intervention||0
10307536|NCT00106119|11440466|FG001|NOT COMPLETED|First Intervention||0
10307537|NCT00106119|11440465|FG000|STARTED|Washout Period of 30 Days||7
10307538|NCT00106119|11440466|FG001|STARTED|Washout Period of 30 Days||7
10307539|NCT00106119|11440465|FG000|COMPLETED|Washout Period of 30 Days||7
10307540|NCT00106119|11440466|FG001|COMPLETED|Washout Period of 30 Days||7
10307541|NCT00106119|11440465|FG000|NOT COMPLETED|Washout Period of 30 Days||0
10307542|NCT00106119|11440466|FG001|NOT COMPLETED|Washout Period of 30 Days||0
10307543|NCT00106119|11440465|FG000|STARTED|Second Intervention||7
10307544|NCT00106119|11440466|FG001|STARTED|Second Intervention||7
10307545|NCT00106119|11440465|FG000|COMPLETED|Second Intervention||7
10307546|NCT00106119|11440466|FG001|COMPLETED|Second Intervention||7
10307547|NCT00106119|11440465|FG000|NOT COMPLETED|Second Intervention||0
10307548|NCT00106119|11440466|FG001|NOT COMPLETED|Second Intervention||0
10307549|NCT00106184|11440474|FG000|STARTED|Overall Study||96
10307550|NCT00106184|11440475|FG001|STARTED|Overall Study||104
10307551|NCT00106184|11440474|FG000|Treated|Overall Study|96 subjects were randomized.|93
10389995|NCT00657605|11532696|FG000|NOT COMPLETED|Overall Study||0
10307552|NCT00106184|11440475|FG001|Treated|Overall Study|104 subjects were randomized.|102
10307553|NCT00106184|11440474|FG000|COMPLETED|Overall Study||93
10307554|NCT00106184|11440475|FG001|COMPLETED|Overall Study||102
10307555|NCT00106184|11440474|FG000|NOT COMPLETED|Overall Study||3
10307556|NCT00106184|11440475|FG001|NOT COMPLETED|Overall Study||2
10307557|NCT00106249|11440485|FG000|STARTED|Overall Study||14
10307558|NCT00106249|11440486|FG001|STARTED|Overall Study||13
10389996|NCT00657618|11532700|FG000|STARTED|Overall Study||77
10389997|NCT00657618|11532700|FG000|COMPLETED|Overall Study||34
10389998|NCT00657618|11532700|FG000|NOT COMPLETED|Overall Study||43
10389999|NCT00657657|11532704|FG000|STARTED|Overall Study||29
10390000|NCT00657657|11532704|FG000|COMPLETED|Overall Study||29
10390001|NCT00657657|11532704|FG000|NOT COMPLETED|Overall Study||0
10390002|NCT00657709|11532713|FG000|STARTED|Overall Study||833
10390003|NCT00657709|11532714|FG001|STARTED|Overall Study||828
10390004|NCT00657709|11532715|FG002|STARTED|Overall Study||820
10390005|NCT00657709|11532716|FG003|STARTED|Overall Study||659
10390006|NCT00657709|11532717|FG004|STARTED|Overall Study||490
10390007|NCT00657709|11532713|FG000|COMPLETED|Overall Study||810
10390008|NCT00657709|11532714|FG001|COMPLETED|Overall Study||795
10390009|NCT00657709|11532715|FG002|COMPLETED|Overall Study||792
10390010|NCT00657709|11532716|FG003|COMPLETED|Overall Study||645
10390011|NCT00657709|11532717|FG004|COMPLETED|Overall Study||457
10390012|NCT00657709|11532713|FG000|NOT COMPLETED|Overall Study||23
10390013|NCT00657709|11532714|FG001|NOT COMPLETED|Overall Study||33
10390014|NCT00657709|11532715|FG002|NOT COMPLETED|Overall Study||28
10390015|NCT00657709|11532716|FG003|NOT COMPLETED|Overall Study||14
10390016|NCT00657709|11532717|FG004|NOT COMPLETED|Overall Study||33
10390017|NCT00657917|11532739|FG000|STARTED|Overall Study||1
10390018|NCT00657917|11532739|FG000|COMPLETED|Overall Study||1
10390019|NCT00657917|11532739|FG000|NOT COMPLETED|Overall Study||0
10390020|NCT00658021|11532746|FG000|STARTED|28-Week Treatment Period||42
10390021|NCT00658021|11532747|FG001|STARTED|28-Week Treatment Period||38
10390022|NCT00658021|11532748|FG002|STARTED|28-Week Treatment Period||42
10390023|NCT00658021|11532746|FG000|Received Treatment|28-Week Treatment Period||40
10390024|NCT00658021|11532747|FG001|Received Treatment|28-Week Treatment Period||38
10390025|NCT00658021|11532748|FG002|Received Treatment|28-Week Treatment Period||42
10390026|NCT00658021|11532746|FG000|COMPLETED|28-Week Treatment Period||31
10390027|NCT00658021|11532747|FG001|COMPLETED|28-Week Treatment Period||25
10390028|NCT00658021|11532748|FG002|COMPLETED|28-Week Treatment Period||25
10390029|NCT00658021|11532746|FG000|NOT COMPLETED|28-Week Treatment Period||11
10390030|NCT00658021|11532747|FG001|NOT COMPLETED|28-Week Treatment Period||13
10390031|NCT00658021|11532748|FG002|NOT COMPLETED|28-Week Treatment Period||17
10390032|NCT00658021|11532746|FG000|STARTED|Long-term Safety Follow-up Period|Entered safety follow-up period.|7
10390033|NCT00658021|11532747|FG001|STARTED|Long-term Safety Follow-up Period|Entered safety follow-up period.|5
10390034|NCT00658021|11532748|FG002|STARTED|Long-term Safety Follow-up Period|Entered safety follow-up period.|7
10390035|NCT00658021|11532746|FG000|COMPLETED|Long-term Safety Follow-up Period||7
10718605|NCT02704091|11882181|FG001|NOT COMPLETED|Overall Study||23
10718606|NCT02704104|11882187|FG000|STARTED|Overall Study||46
10718607|NCT02704104|11882187|FG000|COMPLETED|Overall Study||46
10718608|NCT02704104|11882187|FG000|NOT COMPLETED|Overall Study||0
10718609|NCT02704143|11882195|FG000|STARTED|Overall Study||63
10390036|NCT00658021|11532747|FG001|COMPLETED|Long-term Safety Follow-up Period||2
10390037|NCT00658021|11532748|FG002|COMPLETED|Long-term Safety Follow-up Period||7
10390038|NCT00658021|11532746|FG000|NOT COMPLETED|Long-term Safety Follow-up Period||0
10390039|NCT00658021|11532747|FG001|NOT COMPLETED|Long-term Safety Follow-up Period||3
10390040|NCT00658021|11532748|FG002|NOT COMPLETED|Long-term Safety Follow-up Period||0
10390041|NCT00658112|11532758|FG000|STARTED|Overall Study||20
10390042|NCT00658112|11532758|FG000|COMPLETED|Overall Study||11
10390043|NCT00658112|11532758|FG000|NOT COMPLETED|Overall Study||9
10390044|NCT00658138|11532762|FG000|STARTED|Overall Study||61
10390045|NCT00658138|11532762|FG000|COMPLETED|Overall Study||40
10390046|NCT00658138|11532762|FG000|NOT COMPLETED|Overall Study||21
10390047|NCT00658320|11532769|FG000|STARTED|Core Study: 12 Months||61
10390048|NCT00658320|11532770|FG001|STARTED|Core Study: 12 Months||61
10390049|NCT00658320|11532769|FG000|COMPLETED|Core Study: 12 Months||56
10390050|NCT00658320|11532770|FG001|COMPLETED|Core Study: 12 Months||58
10390051|NCT00658320|11532769|FG000|NOT COMPLETED|Core Study: 12 Months||5
10390052|NCT00658320|11532770|FG001|NOT COMPLETED|Core Study: 12 Months||3
10390053|NCT00658320|11532769|FG000|STARTED|Extension Study: Month 12 to Month 24||53
10390054|NCT00658320|11532770|FG001|STARTED|Extension Study: Month 12 to Month 24||57
10390055|NCT00658320|11532769|FG000|Extension ITT: Received Study Drug|Extension Study: Month 12 to Month 24||50
10390056|NCT00658320|11532770|FG001|Extension ITT: Received Study Drug|Extension Study: Month 12 to Month 24||50
10390057|NCT00658320|11532769|FG000|COMPLETED|Extension Study: Month 12 to Month 24||47
10390058|NCT00658320|11532770|FG001|COMPLETED|Extension Study: Month 12 to Month 24||50
10390059|NCT00658320|11532769|FG000|NOT COMPLETED|Extension Study: Month 12 to Month 24||6
10390060|NCT00658320|11532770|FG001|NOT COMPLETED|Extension Study: Month 12 to Month 24||7
10390061|NCT00658320|11532769|FG000|STARTED|Extension Study: After Month 24||44
10390062|NCT00658320|11532770|FG001|STARTED|Extension Study: After Month 24||0
10390063|NCT00658320|11532769|FG000|COMPLETED|Extension Study: After Month 24||42
10718610|NCT02704143|11882195|FG000|COMPLETED|Overall Study||53
10718611|NCT02704143|11882195|FG000|NOT COMPLETED|Overall Study||10
10718612|NCT02704689|11882199|FG000|STARTED|Overall Study||9
10307559|NCT00106249|11440485|FG000|COMPLETED|Overall Study||11
10307560|NCT00106249|11440486|FG001|COMPLETED|Overall Study||11
10307561|NCT00106249|11440485|FG000|NOT COMPLETED|Overall Study||3
10307562|NCT00106249|11440486|FG001|NOT COMPLETED|Overall Study||2
10307563|NCT00106353|11440494|FG000|STARTED|Part 1||4
10307564|NCT00106353|11440495|FG001|STARTED|Part 1||5
10307565|NCT00106353|11440496|FG002|STARTED|Part 1||3
10307566|NCT00106353|11440497|FG003|STARTED|Part 1||7
10307567|NCT00106353|11440498|FG004|STARTED|Part 1||0
10718613|NCT02704689|11882199|FG000|COMPLETED|Overall Study||6
10718614|NCT02704689|11882199|FG000|NOT COMPLETED|Overall Study||3
10307568|NCT00106353|11440499|FG005|STARTED|Part 1||0
10307569|NCT00106353|11440500|FG006|STARTED|Part 1||0
10307570|NCT00106353|11440494|FG000|COMPLETED|Part 1||0
10307571|NCT00106353|11440495|FG001|COMPLETED|Part 1||0
10307572|NCT00106353|11440496|FG002|COMPLETED|Part 1||0
10307573|NCT00106353|11440497|FG003|COMPLETED|Part 1||0
10307574|NCT00106353|11440498|FG004|COMPLETED|Part 1||0
10307575|NCT00106353|11440499|FG005|COMPLETED|Part 1||0
10307576|NCT00106353|11440500|FG006|COMPLETED|Part 1||0
10307577|NCT00106353|11440494|FG000|NOT COMPLETED|Part 1||4
10307578|NCT00106353|11440495|FG001|NOT COMPLETED|Part 1||5
10307579|NCT00106353|11440496|FG002|NOT COMPLETED|Part 1||3
10307580|NCT00106353|11440497|FG003|NOT COMPLETED|Part 1||7
10307581|NCT00106353|11440498|FG004|NOT COMPLETED|Part 1||0
10307582|NCT00106353|11440499|FG005|NOT COMPLETED|Part 1||0
10307583|NCT00106353|11440500|FG006|NOT COMPLETED|Part 1||0
10307584|NCT00106353|11440494|FG000|STARTED|Part 2||0
10307585|NCT00106353|11440495|FG001|STARTED|Part 2||0
10307586|NCT00106353|11440496|FG002|STARTED|Part 2||0
10307587|NCT00106353|11440497|FG003|STARTED|Part 2||0
10307588|NCT00106353|11440498|FG004|STARTED|Part 2||17
10307589|NCT00106353|11440499|FG005|STARTED|Part 2||19
10307590|NCT00106353|11440500|FG006|STARTED|Part 2||16
10307591|NCT00106353|11440494|FG000|COMPLETED|Part 2||0
10307592|NCT00106353|11440495|FG001|COMPLETED|Part 2||0
10307593|NCT00106353|11440496|FG002|COMPLETED|Part 2||0
10307594|NCT00106353|11440497|FG003|COMPLETED|Part 2||0
10307595|NCT00106353|11440498|FG004|COMPLETED|Part 2||1
10307596|NCT00106353|11440499|FG005|COMPLETED|Part 2||1
10307597|NCT00106353|11440500|FG006|COMPLETED|Part 2||0
10307598|NCT00106353|11440494|FG000|NOT COMPLETED|Part 2||0
10307599|NCT00106353|11440495|FG001|NOT COMPLETED|Part 2||0
10307600|NCT00106353|11440496|FG002|NOT COMPLETED|Part 2||0
10307601|NCT00106353|11440497|FG003|NOT COMPLETED|Part 2||0
10307602|NCT00106353|11440498|FG004|NOT COMPLETED|Part 2||16
10307603|NCT00106353|11440499|FG005|NOT COMPLETED|Part 2||18
10307604|NCT00106353|11440500|FG006|NOT COMPLETED|Part 2||16
10307605|NCT00106392|11440523|FG000|STARTED|Overall Study||62
10307606|NCT00106392|11440524|FG001|STARTED|Overall Study||69
10307607|NCT00106392|11440523|FG000|Baseline Participants|Overall Study|3 patients withdrew: 2 prior to surgery and study drug; 1 took study drug but did not have surgery|59
10307608|NCT00106392|11440524|FG001|Baseline Participants|Overall Study|4 patients withdrew: all prior to surgery and study drug|65
10307609|NCT00106392|11440523|FG000|Full Analysis Set (FAS)|Overall Study||53
10307610|NCT00106392|11440524|FG001|Full Analysis Set (FAS)|Overall Study||61
10307611|NCT00106392|11440523|FG000|COMPLETED|Overall Study||36
10307612|NCT00106392|11440524|FG001|COMPLETED|Overall Study||42
10307613|NCT00106392|11440523|FG000|NOT COMPLETED|Overall Study||26
10307614|NCT00106392|11440524|FG001|NOT COMPLETED|Overall Study||27
10307615|NCT00106431|11440530|FG000|STARTED|Overall Study||102
10307616|NCT00106431|11440530|FG000|COMPLETED|Overall Study|37 represents the number of patients who reached at least 6 months treatment|37
10307617|NCT00106431|11440530|FG000|NOT COMPLETED|Overall Study||65
10307618|NCT00106535|11440537|FG000|STARTED|2-year Placebo Controlled Period||394
10307619|NCT00106535|11440538|FG001|STARTED|2-year Placebo Controlled Period||401
10307620|NCT00106535|11440539|FG002|STARTED|2-year Placebo Controlled Period||401
10307621|NCT00106535|11440540|FG003|STARTED|2-year Placebo Controlled Period||0
10307622|NCT00106535|11440537|FG000|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||393
10307623|NCT00106535|11440538|FG001|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||399
10307624|NCT00106535|11440539|FG002|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||398
10307625|NCT00106535|11440540|FG003|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||0
10390064|NCT00658320|11532770|FG001|COMPLETED|Extension Study: After Month 24||0
10390065|NCT00658320|11532769|FG000|NOT COMPLETED|Extension Study: After Month 24||2
10718615|NCT02704702|11882209|FG000|STARTED|Overall Study||6
10307626|NCT00106535|11440537|FG000|Safety: Actual Treatment Received|2-year Placebo Controlled Period||392
10307627|NCT00106535|11440538|FG001|Safety: Actual Treatment Received|2-year Placebo Controlled Period||399
10307628|NCT00106535|11440539|FG002|Safety: Actual Treatment Received|2-year Placebo Controlled Period||399
10307629|NCT00106535|11440540|FG003|Safety: Actual Treatment Received|2-year Placebo Controlled Period||0
10307630|NCT00106535|11440537|FG000|Completed Week 24|2-year Placebo Controlled Period||356
10307631|NCT00106535|11440538|FG001|Completed Week 24|2-year Placebo Controlled Period||373
10307632|NCT00106535|11440539|FG002|Completed Week 24|2-year Placebo Controlled Period||366
10718616|NCT02704702|11882210|FG001|STARTED|Overall Study||6
10812773|NCT03329404|11974934|FG000|NOT COMPLETED|Overall Study||1
10812774|NCT03329404|11974935|FG001|NOT COMPLETED|Overall Study||4
10812775|NCT03326869|11974943|FG000|STARTED|Overall Study||1
10812776|NCT03326869|11974944|FG001|STARTED|Overall Study||1
10812777|NCT03326869|11974943|FG000|COMPLETED|Overall Study||0
10812778|NCT03326869|11974944|FG001|COMPLETED|Overall Study||0
10812779|NCT03326869|11974943|FG000|NOT COMPLETED|Overall Study||1
10718617|NCT02704702|11882211|FG002|STARTED|Overall Study||6
10718618|NCT02704702|11882212|FG003|STARTED|Overall Study||6
10718619|NCT02704702|11882213|FG004|STARTED|Overall Study||6
10390066|NCT00658320|11532770|FG001|NOT COMPLETED|Extension Study: After Month 24||0
10390067|NCT00658333|11532780|FG000|STARTED|Overall Study||15
10390068|NCT00658333|11532781|FG001|STARTED|Overall Study||15
10718620|NCT02704702|11882214|FG005|STARTED|Overall Study||6
10718621|NCT02704702|11882209|FG000|COMPLETED|Overall Study||5
10718622|NCT02704702|11882210|FG001|COMPLETED|Overall Study||6
10390069|NCT00658333|11532780|FG000|COMPLETED|Overall Study||13
10390070|NCT00658333|11532781|FG001|COMPLETED|Overall Study||14
10390071|NCT00658333|11532780|FG000|NOT COMPLETED|Overall Study||2
10390072|NCT00658333|11532781|FG001|NOT COMPLETED|Overall Study||1
10390073|NCT00658359|11532790|FG000|STARTED|Overall Study||64
10390074|NCT00658359|11532791|FG001|STARTED|Overall Study||60
10390075|NCT00658359|11532792|FG002|STARTED|Overall Study||54
10390076|NCT00658359|11532790|FG000|COMPLETED|Overall Study||36
10390077|NCT00658359|11532791|FG001|COMPLETED|Overall Study||15
10390078|NCT00658359|11532792|FG002|COMPLETED|Overall Study||8
10390079|NCT00658359|11532790|FG000|NOT COMPLETED|Overall Study||28
10390080|NCT00658359|11532791|FG001|NOT COMPLETED|Overall Study||45
10390081|NCT00658359|11532792|FG002|NOT COMPLETED|Overall Study||46
10390082|NCT00658385|11532802|FG000|STARTED|Overall Study||5
10390083|NCT00658385|11532802|FG000|COMPLETED|Overall Study||5
10390084|NCT00658385|11532802|FG000|NOT COMPLETED|Overall Study||0
10390085|NCT00658411|11532806|FG000|STARTED|Overall Study||5
10390086|NCT00658411|11532806|FG000|COMPLETED|Overall Study||5
10390087|NCT00658411|11532806|FG000|NOT COMPLETED|Overall Study||0
10390088|NCT00658515|11532816|FG000|STARTED|Overall Study||7938
10390089|NCT00658515|11532817|FG001|STARTED|Overall Study||7933
10390090|NCT00658515|11532816|FG000|COMPLETED|Overall Study||7626
10390091|NCT00658515|11532817|FG001|COMPLETED|Overall Study||7668
10390092|NCT00658515|11532816|FG000|NOT COMPLETED|Overall Study||312
10390093|NCT00658515|11532817|FG001|NOT COMPLETED|Overall Study||265
10390094|NCT00658528|11532825|FG000|STARTED|Overall Study|Treated|531
10390095|NCT00658528|11532826|FG001|STARTED|Overall Study|Treated|524
10390096|NCT00658528|11532825|FG000|COMPLETED|Overall Study||491
10390097|NCT00658528|11532826|FG001|COMPLETED|Overall Study||479
10718623|NCT02704702|11882211|FG002|COMPLETED|Overall Study||6
10718624|NCT02704702|11882212|FG003|COMPLETED|Overall Study||5
10390098|NCT00658528|11532825|FG000|NOT COMPLETED|Overall Study||40
10390099|NCT00658528|11532826|FG001|NOT COMPLETED|Overall Study||45
10390100|NCT00658541|11532832|FG000|STARTED|First Intervention||19
10390101|NCT00658541|11532833|FG001|STARTED|First Intervention||19
10390102|NCT00658541|11532832|FG000|COMPLETED|First Intervention||19
10390103|NCT00658541|11532833|FG001|COMPLETED|First Intervention||19
10390104|NCT00658541|11532832|FG000|NOT COMPLETED|First Intervention||0
10390105|NCT00658541|11532833|FG001|NOT COMPLETED|First Intervention||0
10718625|NCT02704702|11882213|FG004|COMPLETED|Overall Study||4
10718626|NCT02704702|11882214|FG005|COMPLETED|Overall Study||4
10718627|NCT02704702|11882209|FG000|NOT COMPLETED|Overall Study||1
10718628|NCT02704702|11882210|FG001|NOT COMPLETED|Overall Study||0
10718629|NCT02704702|11882211|FG002|NOT COMPLETED|Overall Study||0
10718630|NCT02704702|11882212|FG003|NOT COMPLETED|Overall Study||1
10718631|NCT02704702|11882213|FG004|NOT COMPLETED|Overall Study||2
10718632|NCT02704702|11882214|FG005|NOT COMPLETED|Overall Study||2
10812780|NCT03326869|11974944|FG001|NOT COMPLETED|Overall Study||1
10812781|NCT03325114|11974950|FG000|STARTED|Overall Study||1
10812782|NCT03325114|11974950|FG000|COMPLETED|Overall Study||0
10812783|NCT03325114|11974950|FG000|NOT COMPLETED|Overall Study||1
10812784|NCT03319407|11974954|FG000|STARTED|Overall Study||21
10812785|NCT03319407|11974954|FG000|COMPLETED|Overall Study||0
10812786|NCT03319407|11974954|FG000|NOT COMPLETED|Overall Study||21
10812787|NCT03316105|11974960|FG000|STARTED|Overall Study||9
10812788|NCT03316105|11974961|FG001|STARTED|Overall Study||7
10812789|NCT03316105|11974960|FG000|COMPLETED|Overall Study||9
10812790|NCT03316105|11974961|FG001|COMPLETED|Overall Study||7
10812791|NCT03316105|11974960|FG000|NOT COMPLETED|Overall Study||0
10812792|NCT03316105|11974961|FG001|NOT COMPLETED|Overall Study||0
10812793|NCT03305055|11974969|FG000|STARTED|Overall Study||2
10812794|NCT03305055|11974970|FG001|STARTED|Overall Study||2
10812795|NCT03305055|11974969|FG000|COMPLETED|Overall Study||1
10812796|NCT03305055|11974970|FG001|COMPLETED|Overall Study||0
10812797|NCT03305055|11974969|FG000|NOT COMPLETED|Overall Study||1
10812798|NCT03305055|11974970|FG001|NOT COMPLETED|Overall Study||2
10812799|NCT03303469|11974976|FG000|STARTED|Overall Study||3
10812800|NCT03303469|11974976|FG000|COMPLETED|Overall Study||1
10812801|NCT03303469|11974976|FG000|NOT COMPLETED|Overall Study||2
10812802|NCT03302247|11974980|FG000|STARTED|Overall Study||3
10812803|NCT03302247|11974980|FG000|COMPLETED|Overall Study||0
10812804|NCT03302247|11974980|FG000|NOT COMPLETED|Overall Study||3
10812805|NCT03300024|11974986|FG000|STARTED|Overall Study||4
10812806|NCT03300024|11974987|FG001|STARTED|Overall Study||6
10812807|NCT03300024|11974986|FG000|COMPLETED|Overall Study||0
10812808|NCT03300024|11974987|FG001|COMPLETED|Overall Study||0
10812809|NCT03300024|11974986|FG000|NOT COMPLETED|Overall Study||4
10812810|NCT03300024|11974987|FG001|NOT COMPLETED|Overall Study||6
10812811|NCT03283709|11974997|FG000|STARTED|Overall Study||0
10812812|NCT03283709|11974998|FG001|STARTED|Overall Study||1
10812813|NCT03283709|11974997|FG000|COMPLETED|Overall Study||0
10812814|NCT03283709|11974998|FG001|COMPLETED|Overall Study||0
10812815|NCT03283709|11974997|FG000|NOT COMPLETED|Overall Study||0
10812816|NCT03283709|11974998|FG001|NOT COMPLETED|Overall Study||1
10812817|NCT03277183|11975006|FG000|STARTED|Overall Study||3
10542753|NCT01479426|11695900|FG001|STARTED|Overall Study||40
10542754|NCT01479426|11695899|FG000|COMPLETED|Overall Study||36
10542755|NCT01479426|11695900|FG001|COMPLETED|Overall Study||37
10542756|NCT01479426|11695899|FG000|NOT COMPLETED|Overall Study||4
10542757|NCT01479426|11695900|FG001|NOT COMPLETED|Overall Study||3
10542758|NCT01479439|11695909|FG000|STARTED|Overall Study||15
10542759|NCT01479439|11695910|FG001|STARTED|Overall Study||13
10658561|NCT02233946|11819757|FG001|COMPLETED|Baseline|Completed baseline assessment|243
10812818|NCT03277183|11975007|FG001|STARTED|Overall Study||2
10812819|NCT03277183|11975006|FG000|COMPLETED|Overall Study||0
10812820|NCT03277183|11975007|FG001|COMPLETED|Overall Study||0
10812821|NCT03277183|11975006|FG000|NOT COMPLETED|Overall Study||3
10812822|NCT03277183|11975007|FG001|NOT COMPLETED|Overall Study||2
10812823|NCT03269968|11975015|FG000|STARTED|Overall Study||0
10812824|NCT03269968|11975016|FG001|STARTED|Overall Study||0
10812825|NCT03269968|11975015|FG000|COMPLETED|Overall Study||0
10812826|NCT03269968|11975016|FG001|COMPLETED|Overall Study||0
10812827|NCT03269968|11975015|FG000|NOT COMPLETED|Overall Study||0
10812828|NCT03269968|11975016|FG001|NOT COMPLETED|Overall Study||0
10542760|NCT01479439|11695911|FG002|STARTED|Overall Study||8
10542761|NCT01479439|11695909|FG000|COMPLETED|Overall Study||14
10307633|NCT00106535|11440540|FG003|Completed Week 24|2-year Placebo Controlled Period||0
10307634|NCT00106535|11440537|FG000|Completed Week 52|2-year Placebo Controlled Period||326
10307635|NCT00106535|11440538|FG001|Completed Week 52|2-year Placebo Controlled Period||342
10307636|NCT00106535|11440539|FG002|Completed Week 52|2-year Placebo Controlled Period||338
10307637|NCT00106535|11440540|FG003|Completed Week 52|2-year Placebo Controlled Period||0
10307638|NCT00106535|11440537|FG000|COMPLETED|2-year Placebo Controlled Period|Completed Week 104 (Year 2). 284 participants randomized to the Placebo arm entered the LTE period.|287
10390106|NCT00658541|11532832|FG000|STARTED|Washout Period of 7 Days||19
10390107|NCT00658541|11532833|FG001|STARTED|Washout Period of 7 Days||19
10390108|NCT00658541|11532832|FG000|COMPLETED|Washout Period of 7 Days||18
10390109|NCT00658541|11532833|FG001|COMPLETED|Washout Period of 7 Days||17
10390110|NCT00658541|11532832|FG000|NOT COMPLETED|Washout Period of 7 Days||1
10390111|NCT00658541|11532833|FG001|NOT COMPLETED|Washout Period of 7 Days||2
10390112|NCT00658541|11532832|FG000|STARTED|Second Intervention||18
10390113|NCT00658541|11532833|FG001|STARTED|Second Intervention||17
10390114|NCT00658541|11532832|FG000|COMPLETED|Second Intervention||18
10390115|NCT00658541|11532833|FG001|COMPLETED|Second Intervention||17
10390116|NCT00658541|11532832|FG000|NOT COMPLETED|Second Intervention||0
10390117|NCT00658541|11532833|FG001|NOT COMPLETED|Second Intervention||0
10390118|NCT00658567|11532842|FG000|STARTED|Overall Study||40
10390119|NCT00658567|11532843|FG001|STARTED|Overall Study||42
10390120|NCT00658567|11532844|FG002|STARTED|Overall Study||41
10390121|NCT00658567|11532842|FG000|COMPLETED|Overall Study||32
10390122|NCT00658567|11532843|FG001|COMPLETED|Overall Study||38
10390123|NCT00658567|11532844|FG002|COMPLETED|Overall Study||35
10390124|NCT00658567|11532842|FG000|NOT COMPLETED|Overall Study||8
10390125|NCT00658567|11532843|FG001|NOT COMPLETED|Overall Study||4
10390126|NCT00658567|11532844|FG002|NOT COMPLETED|Overall Study||6
10390127|NCT00658606|11532854|FG000|STARTED|Overall Study||49
10390128|NCT00658606|11532855|FG001|STARTED|Overall Study||49
10390129|NCT00658606|11532854|FG000|Completed Treatment|Overall Study||42
10390130|NCT00658606|11532855|FG001|Completed Treatment|Overall Study||44
10390131|NCT00658606|11532854|FG000|COMPLETED|Overall Study|Represents patients who completed follow-up|33
10390132|NCT00658606|11532855|FG001|COMPLETED|Overall Study|Represents patients who completed follow-up|26
10390133|NCT00658606|11532854|FG000|NOT COMPLETED|Overall Study||16
10390134|NCT00658606|11532855|FG001|NOT COMPLETED|Overall Study||23
10390135|NCT00658619|11532866|FG000|STARTED|Overall Study||3
10390136|NCT00658619|11532867|FG001|STARTED|Overall Study||3
10390137|NCT00658619|11532868|FG002|STARTED|Overall Study||41
10542762|NCT01479439|11695910|FG001|COMPLETED|Overall Study||12
10542763|NCT01479439|11695911|FG002|COMPLETED|Overall Study||6
10390138|NCT00658619|11532869|FG003|STARTED|Overall Study||49
10390139|NCT00658619|11532870|FG004|STARTED|Overall Study||23
10390140|NCT00658619|11532866|FG000|COMPLETED|Overall Study||3
10390141|NCT00658619|11532867|FG001|COMPLETED|Overall Study||2
10390142|NCT00658619|11532868|FG002|COMPLETED|Overall Study||31
10390143|NCT00658619|11532869|FG003|COMPLETED|Overall Study||37
10390144|NCT00658619|11532870|FG004|COMPLETED|Overall Study||21
10390145|NCT00658619|11532866|FG000|NOT COMPLETED|Overall Study||0
10390146|NCT00658619|11532867|FG001|NOT COMPLETED|Overall Study||1
10390147|NCT00658619|11532868|FG002|NOT COMPLETED|Overall Study||10
10390148|NCT00658619|11532869|FG003|NOT COMPLETED|Overall Study||12
10390149|NCT00658619|11532870|FG004|NOT COMPLETED|Overall Study||2
10390150|NCT00658632|11532881|FG000|STARTED|Overall Study|Treated|682
10390151|NCT00658632|11532882|FG001|STARTED|Overall Study|Treated|698
10390152|NCT00658632|11532881|FG000|COMPLETED|Overall Study||618
10390153|NCT00658632|11532882|FG001|COMPLETED|Overall Study||633
10390154|NCT00658632|11532881|FG000|NOT COMPLETED|Overall Study||64
10390155|NCT00658632|11532882|FG001|NOT COMPLETED|Overall Study||65
10390156|NCT00658658|11532893|FG000|STARTED|Overall Study||6
10390157|NCT00658658|11532894|FG001|STARTED|Overall Study||7
10390158|NCT00658658|11532895|FG002|STARTED|Overall Study||4
10390159|NCT00658658|11532896|FG003|STARTED|Overall Study||6
10390160|NCT00658658|11532897|FG004|STARTED|Overall Study||8
10390161|NCT00658658|11532893|FG000|COMPLETED|Overall Study||1
10390162|NCT00658658|11532894|FG001|COMPLETED|Overall Study||5
10390163|NCT00658658|11532895|FG002|COMPLETED|Overall Study||4
10390164|NCT00658658|11532896|FG003|COMPLETED|Overall Study||4
10390165|NCT00658658|11532897|FG004|COMPLETED|Overall Study||3
10390166|NCT00658658|11532893|FG000|NOT COMPLETED|Overall Study||5
10390167|NCT00658658|11532894|FG001|NOT COMPLETED|Overall Study||2
10390168|NCT00658658|11532895|FG002|NOT COMPLETED|Overall Study||0
10390169|NCT00658658|11532896|FG003|NOT COMPLETED|Overall Study||2
10390170|NCT00658658|11532897|FG004|NOT COMPLETED|Overall Study||5
10390171|NCT00658684|11532912|FG000|STARTED|Overall Study||152
10390172|NCT00658684|11532913|FG001|STARTED|Overall Study||99
10390173|NCT00658684|11532914|FG002|STARTED|Overall Study||25
10390174|NCT00658684|11532915|FG003|STARTED|Overall Study||28
10390175|NCT00658684|11532912|FG000|COMPLETED|Overall Study||133
10390176|NCT00658684|11532913|FG001|COMPLETED|Overall Study||84
10390177|NCT00658684|11532914|FG002|COMPLETED|Overall Study||22
10390178|NCT00658684|11532915|FG003|COMPLETED|Overall Study||27
10390179|NCT00658684|11532912|FG000|NOT COMPLETED|Overall Study||19
10390180|NCT00658684|11532913|FG001|NOT COMPLETED|Overall Study||15
10390181|NCT00658684|11532914|FG002|NOT COMPLETED|Overall Study||3
10390182|NCT00658684|11532915|FG003|NOT COMPLETED|Overall Study||1
10390183|NCT00658697|11532925|FG000|STARTED|Overall Study||41
10390184|NCT00658697|11532925|FG000|COMPLETED|Overall Study||41
10390185|NCT00658697|11532925|FG000|NOT COMPLETED|Overall Study||0
10390186|NCT00658723|11532933|FG000|STARTED|Overall Study||60
10390187|NCT00658723|11532934|FG001|STARTED|Overall Study||30
10390188|NCT00658723|11532935|FG002|STARTED|Overall Study||51
10390189|NCT00658723|11532933|FG000|COMPLETED|Overall Study||56
10390190|NCT00658723|11532934|FG001|COMPLETED|Overall Study||26
10390191|NCT00658723|11532935|FG002|COMPLETED|Overall Study||44
10390192|NCT00658723|11532933|FG000|NOT COMPLETED|Overall Study||4
10390193|NCT00658723|11532934|FG001|NOT COMPLETED|Overall Study||4
10390194|NCT00658723|11532935|FG002|NOT COMPLETED|Overall Study||7
10390195|NCT00658736|11532948|FG000|STARTED|Overall Study||19
10390196|NCT00658736|11532949|FG001|STARTED|Overall Study||21
10390197|NCT00658736|11532948|FG000|COMPLETED|Overall Study||13
10390198|NCT00658736|11532949|FG001|COMPLETED|Overall Study||19
10390199|NCT00658736|11532948|FG000|NOT COMPLETED|Overall Study||6
10390200|NCT00658736|11532949|FG001|NOT COMPLETED|Overall Study||2
10390201|NCT00658775|11532957|FG000|STARTED|Overall Study|Treated|537
10390202|NCT00658775|11532958|FG001|STARTED|Overall Study|Treated|528
10390203|NCT00658775|11532957|FG000|COMPLETED|Overall Study||495
10390204|NCT00658775|11532958|FG001|COMPLETED|Overall Study||485
10390205|NCT00658775|11532957|FG000|NOT COMPLETED|Overall Study||42
10390206|NCT00658775|11532958|FG001|NOT COMPLETED|Overall Study||43
10390210|NCT00658879|11532977|FG000|STARTED|Overall Study||251
10390211|NCT00658879|11532977|FG000|COMPLETED|Overall Study||250
10390212|NCT00658879|11532977|FG000|NOT COMPLETED|Overall Study||1
10390213|NCT00658996|11532981|FG000|STARTED|First Intervention||109
10390214|NCT00658996|11532982|FG001|STARTED|First Intervention||107
10390215|NCT00658996|11532981|FG000|COMPLETED|First Intervention||108
10390216|NCT00658996|11532982|FG001|COMPLETED|First Intervention||106
10390217|NCT00658996|11532981|FG000|NOT COMPLETED|First Intervention||1
10390218|NCT00658996|11532982|FG001|NOT COMPLETED|First Intervention||1
10390219|NCT00658996|11532981|FG000|STARTED|Crossover Period||108
10390220|NCT00658996|11532982|FG001|STARTED|Crossover Period||106
10390221|NCT00658996|11532981|FG000|COMPLETED|Crossover Period||106
10390222|NCT00658996|11532982|FG001|COMPLETED|Crossover Period||105
10390223|NCT00658996|11532981|FG000|NOT COMPLETED|Crossover Period||2
10542764|NCT01479439|11695909|FG000|NOT COMPLETED|Overall Study||1
10390224|NCT00658996|11532982|FG001|NOT COMPLETED|Crossover Period||1
10390225|NCT00658996|11532981|FG000|STARTED|Second Intervention||106
10390226|NCT00658996|11532982|FG001|STARTED|Second Intervention||105
10390227|NCT00658996|11532981|FG000|COMPLETED|Second Intervention||105
10390228|NCT00658996|11532982|FG001|COMPLETED|Second Intervention||104
10390229|NCT00658996|11532981|FG000|NOT COMPLETED|Second Intervention||1
10390230|NCT00658996|11532982|FG001|NOT COMPLETED|Second Intervention||1
10390231|NCT00659165|11532990|FG000|STARTED|Overall Study||5
10390232|NCT00659165|11532991|FG001|STARTED|Overall Study||5
10390233|NCT00659165|11532990|FG000|COMPLETED|Overall Study||5
10390234|NCT00659165|11532991|FG001|COMPLETED|Overall Study||5
10390235|NCT00659165|11532990|FG000|NOT COMPLETED|Overall Study||0
10390236|NCT00659165|11532991|FG001|NOT COMPLETED|Overall Study||0
10307639|NCT00106535|11440538|FG001|COMPLETED|2-year Placebo Controlled Period|Completed Week 104. 304 participants randomized to the TCZ 4 mg/kg arm entered the LTE period.|309
10390237|NCT00659230|11532999|FG000|STARTED|Overall Study|2 did not return post-randomization, 5 lost source documents, thus 7 excluded from results analysis|51
10390238|NCT00659230|11533000|FG001|STARTED|Overall Study|3 did not return post-randomization, 4 lost source documents, thus 7 excluded from results analysis|49
10390239|NCT00659230|11532999|FG000|COMPLETED|Overall Study||42
10390240|NCT00659230|11533000|FG001|COMPLETED|Overall Study||37
10390241|NCT00659230|11532999|FG000|NOT COMPLETED|Overall Study||9
10390242|NCT00659230|11533000|FG001|NOT COMPLETED|Overall Study||12
10390243|NCT00659269|11533008|FG000|STARTED|Overall Study||157
10390244|NCT00659269|11533009|FG001|STARTED|Overall Study||162
10390245|NCT00659269|11533008|FG000|Group 1 (Heavy Metals)|Overall Study||52
10390246|NCT00659269|11533009|FG001|Group 1 (Heavy Metals)|Overall Study||52
10390247|NCT00659269|11533008|FG000|Group 2 (Vinca Alkaloids)|Overall Study||12
10390248|NCT00659269|11533009|FG001|Group 2 (Vinca Alkaloids)|Overall Study||12
10390249|NCT00659269|11533008|FG000|Group 3 (Taxanes)|Overall Study||92
10390250|NCT00659269|11533009|FG001|Group 3 (Taxanes)|Overall Study||97
10390251|NCT00659269|11533008|FG000|COMPLETED|Overall Study||156
10390252|NCT00659269|11533009|FG001|COMPLETED|Overall Study||161
10390253|NCT00659269|11533008|FG000|NOT COMPLETED|Overall Study||1
10390254|NCT00659269|11533009|FG001|NOT COMPLETED|Overall Study||1
10390255|NCT00659295|11533026|FG000|STARTED|Overall Study||13529
10390256|NCT00659295|11533027|FG001|STARTED|Overall Study||37641
10390257|NCT00659295|11533026|FG000|COMPLETED|Overall Study||10821
10390258|NCT00659295|11533027|FG001|COMPLETED|Overall Study||32038
10390259|NCT00659295|11533026|FG000|NOT COMPLETED|Overall Study||2708
10390260|NCT00659295|11533027|FG001|NOT COMPLETED|Overall Study||5603
10390261|NCT00659334|11533040|FG000|STARTED|Overall Study||46
10390262|NCT00659334|11533041|FG001|STARTED|Overall Study||41
10390263|NCT00659334|11533042|FG002|STARTED|Overall Study||5
10390264|NCT00659334|11533043|FG003|STARTED|Overall Study||2
10390265|NCT00659334|11533044|FG004|STARTED|Overall Study||1
10390266|NCT00659334|11533045|FG005|STARTED|Overall Study||0
10390267|NCT00659334|11533046|FG006|STARTED|Overall Study||21
10390268|NCT00659334|11533040|FG000|COMPLETED|Overall Study|8 Screen failures|38
10307640|NCT00106535|11440539|FG002|COMPLETED|2-year Placebo Controlled Period|Completed Week 104. 306 participants randomized to the TCZ 8 mg/kg arm entered the LTE period.|310
10307641|NCT00106535|11440540|FG003|COMPLETED|2-year Placebo Controlled Period||0
10390269|NCT00659334|11533041|FG001|COMPLETED|Overall Study|5 Screen failures|36
10390270|NCT00659334|11533042|FG002|COMPLETED|Overall Study||5
10390271|NCT00659334|11533043|FG003|COMPLETED|Overall Study||2
10390272|NCT00659334|11533044|FG004|COMPLETED|Overall Study||1
10390273|NCT00659334|11533045|FG005|COMPLETED|Overall Study||0
10390274|NCT00659334|11533046|FG006|COMPLETED|Overall Study|1 screen failure|20
10307642|NCT00106535|11440537|FG000|NOT COMPLETED|2-year Placebo Controlled Period||107
10307643|NCT00106535|11440538|FG001|NOT COMPLETED|2-year Placebo Controlled Period||92
10307644|NCT00106535|11440539|FG002|NOT COMPLETED|2-year Placebo Controlled Period||91
10307645|NCT00106535|11440540|FG003|NOT COMPLETED|2-year Placebo Controlled Period||0
10390275|NCT00659334|11533040|FG000|NOT COMPLETED|Overall Study||8
10390276|NCT00659334|11533041|FG001|NOT COMPLETED|Overall Study||5
10390277|NCT00659334|11533042|FG002|NOT COMPLETED|Overall Study||0
10390278|NCT00659334|11533043|FG003|NOT COMPLETED|Overall Study||0
10390279|NCT00659334|11533044|FG004|NOT COMPLETED|Overall Study||0
10390280|NCT00659334|11533045|FG005|NOT COMPLETED|Overall Study||0
10390281|NCT00659334|11533046|FG006|NOT COMPLETED|Overall Study||1
10390282|NCT00659360|11533062|FG000|STARTED|Overall Study||17
10390283|NCT00659360|11533062|FG000|COMPLETED|Overall Study||17
10390284|NCT00659360|11533062|FG000|NOT COMPLETED|Overall Study||0
10390285|NCT00659373|11533070|FG000|STARTED|Overall Study||25
10390286|NCT00659373|11533071|FG001|STARTED|Overall Study||61
10390287|NCT00659373|11533070|FG000|COMPLETED|Overall Study||20
10390288|NCT00659373|11533071|FG001|COMPLETED|Overall Study||54
10390289|NCT00659373|11533070|FG000|NOT COMPLETED|Overall Study||5
10390290|NCT00659373|11533071|FG001|NOT COMPLETED|Overall Study||7
10390291|NCT00659425|11533087|FG000|STARTED|Overall Study||1
10390292|NCT00659425|11533088|FG001|STARTED|Overall Study||1
10390293|NCT00659425|11533089|FG002|STARTED|Overall Study||1
10390294|NCT00659425|11533090|FG003|STARTED|Overall Study||4
10390295|NCT00659425|11533091|FG004|STARTED|Overall Study||4
10390296|NCT00659425|11533092|FG005|STARTED|Overall Study||5
10390297|NCT00659425|11533093|FG006|STARTED|Overall Study||8
10390298|NCT00659425|11533094|FG007|STARTED|Overall Study||11
10390299|NCT00659425|11533095|FG008|STARTED|Overall Study||6
10390300|NCT00659425|11533096|FG009|STARTED|Overall Study||14
10390301|NCT00659425|11533087|FG000|COMPLETED|Overall Study||0
10390302|NCT00659425|11533088|FG001|COMPLETED|Overall Study||0
10390303|NCT00659425|11533089|FG002|COMPLETED|Overall Study||0
10390304|NCT00659425|11533090|FG003|COMPLETED|Overall Study||0
10390305|NCT00659425|11533091|FG004|COMPLETED|Overall Study||0
10390306|NCT00659425|11533092|FG005|COMPLETED|Overall Study||1
10390307|NCT00659425|11533093|FG006|COMPLETED|Overall Study||0
10390308|NCT00659425|11533094|FG007|COMPLETED|Overall Study||0
10390309|NCT00659425|11533095|FG008|COMPLETED|Overall Study||0
10390310|NCT00659425|11533096|FG009|COMPLETED|Overall Study||1
10390311|NCT00659425|11533087|FG000|NOT COMPLETED|Overall Study||1
10390312|NCT00659425|11533088|FG001|NOT COMPLETED|Overall Study||1
10390313|NCT00659425|11533089|FG002|NOT COMPLETED|Overall Study||1
10390314|NCT00659425|11533090|FG003|NOT COMPLETED|Overall Study||4
10390315|NCT00659425|11533091|FG004|NOT COMPLETED|Overall Study||4
10390316|NCT00659425|11533092|FG005|NOT COMPLETED|Overall Study||4
10390317|NCT00659425|11533093|FG006|NOT COMPLETED|Overall Study||8
10390318|NCT00659425|11533094|FG007|NOT COMPLETED|Overall Study||11
10718651|NCT02705352|11882261|FG000|STARTED|Overall Study||1
10718652|NCT02705352|11882262|FG001|STARTED|Overall Study||0
10718653|NCT02705352|11882261|FG000|COMPLETED|Overall Study||1
10718654|NCT02705352|11882262|FG001|COMPLETED|Overall Study||0
10390319|NCT00659425|11533095|FG008|NOT COMPLETED|Overall Study||6
10390320|NCT00659425|11533096|FG009|NOT COMPLETED|Overall Study||13
10390321|NCT00659438|11533133|FG000|STARTED|Overall Study||47
10718655|NCT02705352|11882261|FG000|NOT COMPLETED|Overall Study||0
10390322|NCT00659438|11533134|FG001|STARTED|Overall Study||48
10390323|NCT00659438|11533133|FG000|Assessable Set : Primary Analysis|Overall Study||44
10390324|NCT00659438|11533134|FG001|Assessable Set : Primary Analysis|Overall Study||45
10390325|NCT00659438|11533133|FG000|Secondary Analysis Set|Overall Study||47
10390326|NCT00659438|11533134|FG001|Secondary Analysis Set|Overall Study||48
10718656|NCT02705352|11882262|FG001|NOT COMPLETED|Overall Study||0
10718657|NCT02705365|11882270|FG000|STARTED|Overall Study||400
10718658|NCT02705365|11882271|FG001|STARTED|Overall Study||800
10718659|NCT02705365|11882270|FG000|COMPLETED|Overall Study||400
10390327|NCT00659438|11533133|FG000|Safety Analysis Set|Overall Study|One patient randomized to placebo was accounted in vandetanib group as he mistakenly received drug|48
10390328|NCT00659438|11533134|FG001|Safety Analysis Set|Overall Study||47
10390329|NCT00659438|11533133|FG000|COMPLETED|Overall Study||33
10390330|NCT00659438|11533134|FG001|COMPLETED|Overall Study||40
10390331|NCT00659438|11533133|FG000|NOT COMPLETED|Overall Study||14
10390332|NCT00659438|11533134|FG001|NOT COMPLETED|Overall Study||8
10390333|NCT00659490|11533143|FG000|STARTED|Overall Study||61
10390334|NCT00659490|11533144|FG001|STARTED|Overall Study||59
10390335|NCT00659490|11533145|FG002|STARTED|Overall Study||31
10390336|NCT00659490|11533143|FG000|COMPLETED|Overall Study||59
10390337|NCT00659490|11533144|FG001|COMPLETED|Overall Study||59
10390338|NCT00659490|11533145|FG002|COMPLETED|Overall Study||30
10390339|NCT00659490|11533143|FG000|NOT COMPLETED|Overall Study||2
10390340|NCT00659490|11533144|FG001|NOT COMPLETED|Overall Study||0
10390341|NCT00659490|11533145|FG002|NOT COMPLETED|Overall Study||1
10390342|NCT00659529|11533153|FG000|STARTED|Overall Study|There were 9 screen failures (subjects who did not meet inclusion/exclusion criteria)|36
10390343|NCT00659529|11533153|FG000|Received at Least One Dose of Study Drug|Overall Study|Received at least one dose of study drug|27
10390344|NCT00659529|11533153|FG000|COMPLETED|Overall Study|4 patients withdrew as a result of side effects. 3 subjects were withdrawn by the investigator.|20
10390345|NCT00659529|11533153|FG000|NOT COMPLETED|Overall Study||16
10390346|NCT00659581|11533157|FG000|STARTED|Overall Study||20994
10390347|NCT00659581|11533157|FG000|COMPLETED|Overall Study||12412
10718660|NCT02705365|11882271|FG001|COMPLETED|Overall Study||800
10390348|NCT00659581|11533157|FG000|NOT COMPLETED|Overall Study||8582
10390349|NCT00659607|11533161|FG000|STARTED|Overall Study||3932
10390350|NCT00659607|11533161|FG000|COMPLETED|Overall Study||3616
10390351|NCT00659607|11533161|FG000|NOT COMPLETED|Overall Study||316
10390352|NCT00659633|11533167|FG000|STARTED|Overall Study||10
10390353|NCT00659633|11533167|FG000|COMPLETED|Overall Study||10
10390354|NCT00659633|11533167|FG000|NOT COMPLETED|Overall Study||0
10390355|NCT00659724|11533171|FG000|STARTED|Weeks 1-2: Assessment of 180NR or 200NR||33
10390356|NCT00659724|11533171|FG000|COMPLETED|Weeks 1-2: Assessment of 180NR or 200NR||33
10390357|NCT00659724|11533171|FG000|NOT COMPLETED|Weeks 1-2: Assessment of 180NR or 200NR||0
10390358|NCT00659724|11533171|FG000|STARTED|Weeks 3-4: Assessment of HD-C4 Big||33
10718661|NCT02705365|11882270|FG000|NOT COMPLETED|Overall Study||0
10718662|NCT02705365|11882271|FG001|NOT COMPLETED|Overall Study||0
10542765|NCT01479439|11695910|FG001|NOT COMPLETED|Overall Study||1
10542766|NCT01479439|11695911|FG002|NOT COMPLETED|Overall Study||2
10542767|NCT01479465|11695926|FG000|STARTED|Overall Study||11
10542768|NCT01479465|11695927|FG001|STARTED|Overall Study||84
10542769|NCT01479465|11695928|FG002|STARTED|Overall Study||86
10718663|NCT02705586|11882277|FG000|STARTED|Overall Study||13
10542770|NCT01479465|11695929|FG003|STARTED|Overall Study||85
10542771|NCT01479465|11695926|FG000|COMPLETED|Overall Study||0
10542772|NCT01479465|11695927|FG001|COMPLETED|Overall Study||0
10542773|NCT01479465|11695928|FG002|COMPLETED|Overall Study||0
10812829|NCT03248141|11975024|FG000|STARTED|Overall Study||11
10812830|NCT03248141|11975025|FG001|STARTED|Overall Study|No enrollment occurred in this arm prior to study termination.|0
10812831|NCT03248141|11975024|FG000|COMPLETED|Overall Study|Participants who were present in the study till termination were considered as completed.|11
10812832|NCT03248141|11975025|FG001|COMPLETED|Overall Study||0
10812833|NCT03248141|11975024|FG000|NOT COMPLETED|Overall Study||0
10812834|NCT03248141|11975025|FG001|NOT COMPLETED|Overall Study||0
10812835|NCT03263806|11975033|FG000|STARTED|Overall Study||6
10718664|NCT02705586|11882277|FG000|COMPLETED|Overall Study||5
10718665|NCT02705586|11882277|FG000|NOT COMPLETED|Overall Study||8
10718666|NCT02705625|11882284|FG000|STARTED|Overall Study||82
10718667|NCT02705625|11882285|FG001|STARTED|Overall Study||82
10718668|NCT02705625|11882286|FG002|STARTED|Overall Study||80
10718669|NCT02705625|11882284|FG000|COMPLETED|Overall Study||74
10718670|NCT02705625|11882285|FG001|COMPLETED|Overall Study||72
10390359|NCT00659724|11533171|FG000|COMPLETED|Weeks 3-4: Assessment of HD-C4 Big||33
10390360|NCT00659724|11533171|FG000|NOT COMPLETED|Weeks 3-4: Assessment of HD-C4 Big||0
10390361|NCT00659737|11533179|FG000|STARTED|Overall Study||57
10390362|NCT00659737|11533180|FG001|STARTED|Overall Study||58
10390363|NCT00659737|11533179|FG000|COMPLETED|Overall Study||57
10390364|NCT00659737|11533180|FG001|COMPLETED|Overall Study||58
10390365|NCT00659737|11533179|FG000|NOT COMPLETED|Overall Study||0
10390366|NCT00659737|11533180|FG001|NOT COMPLETED|Overall Study||0
10390367|NCT00659789|11533188|FG000|STARTED|Overall Study||93
10390368|NCT00659789|11533189|FG001|STARTED|Overall Study||43
10390369|NCT00659789|11533188|FG000|COMPLETED|Overall Study||86
10390370|NCT00659789|11533189|FG001|COMPLETED|Overall Study||36
10390371|NCT00659789|11533188|FG000|NOT COMPLETED|Overall Study||7
10390372|NCT00659789|11533189|FG001|NOT COMPLETED|Overall Study||7
10390373|NCT00659802|11533198|FG000|STARTED|Overall Study||74
10390374|NCT00659802|11533199|FG001|STARTED|Overall Study|One patient was incorrectly randomized and was excluded from the efficacy analyses.|75
10390375|NCT00659802|11533200|FG002|STARTED|Overall Study||75
10390376|NCT00659802|11533198|FG000|COMPLETED|Overall Study||59
10718671|NCT02705625|11882286|FG002|COMPLETED|Overall Study||69
10542774|NCT01479465|11695929|FG003|COMPLETED|Overall Study||0
10718672|NCT02705625|11882284|FG000|NOT COMPLETED|Overall Study||8
10718673|NCT02705625|11882285|FG001|NOT COMPLETED|Overall Study||10
10390377|NCT00659802|11533199|FG001|COMPLETED|Overall Study||57
10390378|NCT00659802|11533200|FG002|COMPLETED|Overall Study||64
10390379|NCT00659802|11533198|FG000|NOT COMPLETED|Overall Study||15
10390380|NCT00659802|11533199|FG001|NOT COMPLETED|Overall Study||18
10390381|NCT00659802|11533200|FG002|NOT COMPLETED|Overall Study||11
10390382|NCT00659815|11533210|FG000|STARTED|Overall Study||157
10390383|NCT00659815|11533211|FG001|STARTED|Overall Study||151
10390384|NCT00659815|11533210|FG000|COMPLETED|Overall Study||153
10390385|NCT00659815|11533211|FG001|COMPLETED|Overall Study||147
10390386|NCT00659815|11533210|FG000|NOT COMPLETED|Overall Study||4
10390387|NCT00659815|11533211|FG001|NOT COMPLETED|Overall Study||4
10390388|NCT00659828|11533217|FG000|STARTED|Overall Study||1
10390389|NCT00659828|11533217|FG000|COMPLETED|Overall Study||1
10390390|NCT00659828|11533217|FG000|NOT COMPLETED|Overall Study||0
10390391|NCT00659880|11533221|FG000|STARTED|Overall Study||9
10390392|NCT00659880|11533221|FG000|6 Weeks|Overall Study||9
10390393|NCT00659880|11533221|FG000|6 Months|Overall Study||9
10390394|NCT00659880|11533221|FG000|12 Months|Overall Study||7
10390395|NCT00659880|11533221|FG000|24 Months|Overall Study||6
10390396|NCT00659880|11533221|FG000|COMPLETED|Overall Study|60 months|4
10390397|NCT00659880|11533221|FG000|NOT COMPLETED|Overall Study||5
10390398|NCT00659945|11533228|FG000|STARTED|Overall Study||75
10390399|NCT00659945|11533229|FG001|STARTED|Overall Study||75
10390400|NCT00659945|11533228|FG000|COMPLETED|Overall Study||75
10390401|NCT00659945|11533229|FG001|COMPLETED|Overall Study||75
10390402|NCT00659945|11533228|FG000|NOT COMPLETED|Overall Study||0
10390403|NCT00659945|11533229|FG001|NOT COMPLETED|Overall Study||0
10390404|NCT00659984|11533235|FG000|STARTED|Overall Study||15
10390405|NCT00659984|11533235|FG000|COMPLETED|Overall Study||14
10390406|NCT00659984|11533235|FG000|NOT COMPLETED|Overall Study||1
10390407|NCT00660010|11533245|FG000|STARTED|Overall Study||55
10718674|NCT02705625|11882286|FG002|NOT COMPLETED|Overall Study||11
10718675|NCT02705716|11882296|FG000|STARTED|Overall Study||72
10718676|NCT02705716|11882297|FG001|STARTED|Overall Study||70
10390408|NCT00660010|11533245|FG000|COMPLETED|Overall Study||46
10390409|NCT00660010|11533245|FG000|NOT COMPLETED|Overall Study||9
10390410|NCT00660023|11533249|FG000|STARTED|Overall Study||124
10390411|NCT00660023|11533249|FG000|Treated|Overall Study||114
10390412|NCT00660023|11533249|FG000|COMPLETED|Overall Study||95
10390413|NCT00660023|11533249|FG000|NOT COMPLETED|Overall Study||29
10390414|NCT00660049|11533253|FG000|STARTED|Overall Study||12
10390415|NCT00660049|11533253|FG000|COMPLETED|Overall Study||6
10390416|NCT00660049|11533253|FG000|NOT COMPLETED|Overall Study||6
10390417|NCT00660075|11533259|FG000|STARTED|First Intervention (Week 1 to Week 6)||18
10390418|NCT00660075|11533260|FG001|STARTED|First Intervention (Week 1 to Week 6)||18
10390419|NCT00660075|11533259|FG000|COMPLETED|First Intervention (Week 1 to Week 6)||18
10390420|NCT00660075|11533260|FG001|COMPLETED|First Intervention (Week 1 to Week 6)||18
10390421|NCT00660075|11533259|FG000|NOT COMPLETED|First Intervention (Week 1 to Week 6)||0
10390422|NCT00660075|11533260|FG001|NOT COMPLETED|First Intervention (Week 1 to Week 6)||0
10390423|NCT00660075|11533259|FG000|STARTED|Washout Period (Week 7 to Week 10)||18
10390424|NCT00660075|11533260|FG001|STARTED|Washout Period (Week 7 to Week 10)||18
10390425|NCT00660075|11533259|FG000|COMPLETED|Washout Period (Week 7 to Week 10)||18
10390426|NCT00660075|11533260|FG001|COMPLETED|Washout Period (Week 7 to Week 10)||18
10390427|NCT00660075|11533259|FG000|NOT COMPLETED|Washout Period (Week 7 to Week 10)||0
10390428|NCT00660075|11533260|FG001|NOT COMPLETED|Washout Period (Week 7 to Week 10)||0
10390429|NCT00660075|11533259|FG000|STARTED|Second Intervention (Week 11 to Week 16||18
10390430|NCT00660075|11533260|FG001|STARTED|Second Intervention (Week 11 to Week 16||18
10390431|NCT00660075|11533259|FG000|COMPLETED|Second Intervention (Week 11 to Week 16||18
10390432|NCT00660075|11533260|FG001|COMPLETED|Second Intervention (Week 11 to Week 16||18
10390433|NCT00660075|11533259|FG000|NOT COMPLETED|Second Intervention (Week 11 to Week 16||0
10390434|NCT00660075|11533260|FG001|NOT COMPLETED|Second Intervention (Week 11 to Week 16||0
10718677|NCT02705716|11882296|FG000|COMPLETED|Overall Study||68
10718678|NCT02705716|11882297|FG001|COMPLETED|Overall Study||68
10718679|NCT02705716|11882296|FG000|NOT COMPLETED|Overall Study||4
10390435|NCT00660179|11533269|FG000|STARTED|Overall Study||250
10390436|NCT00660179|11533270|FG001|STARTED|Overall Study||250
10390437|NCT00660179|11533271|FG002|STARTED|Overall Study||242
10390438|NCT00660179|11533269|FG000|COMPLETED|Overall Study||194
10390439|NCT00660179|11533270|FG001|COMPLETED|Overall Study||192
10390440|NCT00660179|11533271|FG002|COMPLETED|Overall Study||201
10390441|NCT00660179|11533269|FG000|NOT COMPLETED|Overall Study||56
10390442|NCT00660179|11533270|FG001|NOT COMPLETED|Overall Study||58
10390443|NCT00660179|11533271|FG002|NOT COMPLETED|Overall Study||41
10390444|NCT00660192|11533281|FG000|STARTED|Overall Study||12
10390445|NCT00660192|11533282|FG001|STARTED|Overall Study||13
10390446|NCT00660192|11533281|FG000|COMPLETED|Overall Study||10
10390447|NCT00660192|11533282|FG001|COMPLETED|Overall Study||10
10718680|NCT02705716|11882297|FG001|NOT COMPLETED|Overall Study||2
10718681|NCT02705807|11882303|FG000|STARTED|Overall Study||10
10812836|NCT03263806|11975034|FG001|STARTED|Overall Study||7
10307646|NCT00106535|11440537|FG000|STARTED|Long-term Extension Period (Year 3 to 5)||0
10307647|NCT00106535|11440538|FG001|STARTED|Long-term Extension Period (Year 3 to 5)||0
10307648|NCT00106535|11440539|FG002|STARTED|Long-term Extension Period (Year 3 to 5)||0
10307649|NCT00106535|11440540|FG003|STARTED|Long-term Extension Period (Year 3 to 5)|Entered the Long-term Extension.|894
10307650|NCT00106535|11440537|FG000|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
10307651|NCT00106535|11440538|FG001|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
10307652|NCT00106535|11440539|FG002|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
10307653|NCT00106535|11440540|FG003|COMPLETED|Long-term Extension Period (Year 3 to 5)|Completed the study.|704
10307654|NCT00106535|11440537|FG000|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
10307655|NCT00106535|11440538|FG001|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
10307656|NCT00106535|11440539|FG002|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
10307657|NCT00106535|11440540|FG003|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||190
10307658|NCT00106639|11440555|FG000|STARTED|Overall Study||20
10307659|NCT00106639|11440556|FG001|STARTED|Overall Study||20
10307660|NCT00106639|11440557|FG002|STARTED|Overall Study||21
10307661|NCT00106639|11440555|FG000|COMPLETED|Overall Study||17
10307662|NCT00106639|11440556|FG001|COMPLETED|Overall Study||13
10307663|NCT00106639|11440557|FG002|COMPLETED|Overall Study||19
10307664|NCT00106639|11440555|FG000|NOT COMPLETED|Overall Study||3
10307665|NCT00106639|11440556|FG001|NOT COMPLETED|Overall Study||7
10307666|NCT00106639|11440557|FG002|NOT COMPLETED|Overall Study||2
10307667|NCT00106704|11440568|FG000|STARTED|Overall Study||222
10307668|NCT00106704|11440569|FG001|STARTED|Overall Study||219
10307669|NCT00106704|11440568|FG000|COMPLETED|Overall Study||91
10307670|NCT00106704|11440569|FG001|COMPLETED|Overall Study||68
10307671|NCT00106704|11440568|FG000|NOT COMPLETED|Overall Study||131
10307672|NCT00106704|11440569|FG001|NOT COMPLETED|Overall Study||151
10307673|NCT00106938|11440577|FG000|STARTED|Overall Study||1089
10307674|NCT00106938|11440578|FG001|STARTED|Overall Study||364
10307675|NCT00106938|11440577|FG000|COMPLETED|Overall Study||913
10307676|NCT00106938|11440578|FG001|COMPLETED|Overall Study||293
10307677|NCT00106938|11440577|FG000|NOT COMPLETED|Overall Study||176
10307678|NCT00106938|11440578|FG001|NOT COMPLETED|Overall Study||71
10307679|NCT00106964|11440587|FG000|STARTED|Overall Study||118
10307680|NCT00106964|11440588|FG001|STARTED|Overall Study||126
10307681|NCT00106964|11440589|FG002|STARTED|Overall Study||127
10307682|NCT00106964|11440587|FG000|COMPLETED|Overall Study|The number of those those who completed the vaccine series was 105.|105
10307683|NCT00106964|11440588|FG001|COMPLETED|Overall Study|The number of those who completed the vaccine series was 111.|111
10307684|NCT00106964|11440589|FG002|COMPLETED|Overall Study|The number of those who completed the vaccine series was 120.|120
10307685|NCT00106964|11440587|FG000|NOT COMPLETED|Overall Study||13
10307686|NCT00106964|11440588|FG001|NOT COMPLETED|Overall Study||15
10307687|NCT00106964|11440589|FG002|NOT COMPLETED|Overall Study||7
10307688|NCT00107042|11440608|FG000|STARTED|Overall Study||60
10307689|NCT00107042|11440609|FG001|STARTED|Overall Study||63
10307690|NCT00107042|11440608|FG000|COMPLETED|Overall Study||38
10307691|NCT00107042|11440609|FG001|COMPLETED|Overall Study||47
10307692|NCT00107042|11440608|FG000|NOT COMPLETED|Overall Study||22
10307693|NCT00107042|11440609|FG001|NOT COMPLETED|Overall Study||16
10307694|NCT00107120|11440659|FG000|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|155
10307695|NCT00107120|11440660|FG001|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|157
10307696|NCT00107120|11440659|FG000|COMPLETED|Overall Study||126
10307697|NCT00107120|11440660|FG001|COMPLETED|Overall Study||133
10307698|NCT00107120|11440659|FG000|NOT COMPLETED|Overall Study||29
10307699|NCT00107120|11440660|FG001|NOT COMPLETED|Overall Study||24
10307700|NCT00107172|11440668|FG000|STARTED|Overall Study||114
10307701|NCT00107172|11440669|FG001|STARTED|Overall Study||108
10307702|NCT00107172|11440668|FG000|COMPLETED|Overall Study||109
10307703|NCT00107172|11440669|FG001|COMPLETED|Overall Study||103
10307704|NCT00107172|11440668|FG000|NOT COMPLETED|Overall Study||5
10307705|NCT00107172|11440669|FG001|NOT COMPLETED|Overall Study||5
10307709|NCT00107276|11440679|FG000|STARTED|Overall Study||112
10307710|NCT00107276|11440679|FG000|Eligible|Overall Study||96
10307711|NCT00107276|11440679|FG000|COMPLETED|Overall Study||40
10307712|NCT00107276|11440679|FG000|NOT COMPLETED|Overall Study||72
10718702|NCT02706327|11882331|FG001|COMPLETED|Overall Study||21
10812837|NCT03263806|11975033|FG000|COMPLETED|Overall Study|Study Terminated due to lack of enrollment|0
10812838|NCT03263806|11975034|FG001|COMPLETED|Overall Study|Study Terminated due to lack of enrollment|0
10812839|NCT03263806|11975033|FG000|NOT COMPLETED|Overall Study||6
10812840|NCT03263806|11975034|FG001|NOT COMPLETED|Overall Study||7
10812841|NCT03261531|11975040|FG000|STARTED|Overall Study||7
10812842|NCT03261531|11975040|FG000|COMPLETED|Overall Study||3
10812843|NCT03261531|11975040|FG000|NOT COMPLETED|Overall Study||4
10812844|NCT03219372|11975046|FG000|STARTED|Overall Study||1
10812845|NCT03219372|11975047|FG001|STARTED|Overall Study||0
10812846|NCT03219372|11975046|FG000|COMPLETED|Overall Study||0
10812847|NCT03219372|11975047|FG001|COMPLETED|Overall Study||0
10812848|NCT03219372|11975046|FG000|NOT COMPLETED|Overall Study||1
10812849|NCT03219372|11975047|FG001|NOT COMPLETED|Overall Study||0
10812850|NCT03217175|11975053|FG000|STARTED|Overall Study||4
10390448|NCT00660192|11533281|FG000|NOT COMPLETED|Overall Study||2
10390449|NCT00660192|11533282|FG001|NOT COMPLETED|Overall Study||3
10390450|NCT00660309|11533290|FG000|STARTED|Overall Study|Represents participants who received one dose of Captopril.|23
10390451|NCT00660309|11533291|FG001|STARTED|Overall Study|Represents participants who received one dose of Captopril.|22
10390452|NCT00660309|11533290|FG000|Treated With Aliskiren or Irbesartan|Overall Study||22
10390453|NCT00660309|11533291|FG001|Treated With Aliskiren or Irbesartan|Overall Study||21
10390454|NCT00660309|11533290|FG000|Pharmacodynamic Analysis Set|Overall Study||22
10390455|NCT00660309|11533291|FG001|Pharmacodynamic Analysis Set|Overall Study||20
10390456|NCT00660309|11533290|FG000|COMPLETED|Overall Study||21
10390457|NCT00660309|11533291|FG001|COMPLETED|Overall Study||19
10390458|NCT00660309|11533290|FG000|NOT COMPLETED|Overall Study||2
10390459|NCT00660309|11533291|FG001|NOT COMPLETED|Overall Study||3
10390460|NCT00660387|11533300|FG000|STARTED|Overall Study||37
10390461|NCT00660387|11533301|FG001|STARTED|Overall Study||34
10390462|NCT00660387|11533300|FG000|COMPLETED|Overall Study||35
10390463|NCT00660387|11533301|FG001|COMPLETED|Overall Study||31
10390464|NCT00660387|11533300|FG000|NOT COMPLETED|Overall Study||2
10390465|NCT00660387|11533301|FG001|NOT COMPLETED|Overall Study||3
10658562|NCT02233946|11819756|FG000|NOT COMPLETED|Baseline||2
10658563|NCT02233946|11819757|FG001|NOT COMPLETED|Baseline||0
10658564|NCT02233946|11819756|FG000|STARTED|Immediate Post-visit Questionnaire||626
10658565|NCT02233946|11819757|FG001|STARTED|Immediate Post-visit Questionnaire||243
10658566|NCT02233946|11819756|FG000|COMPLETED|Immediate Post-visit Questionnaire||624
10390466|NCT00660400|11533307|FG000|STARTED|Overall Study||25
10658567|NCT02233946|11819757|FG001|COMPLETED|Immediate Post-visit Questionnaire||243
10658568|NCT02233946|11819756|FG000|NOT COMPLETED|Immediate Post-visit Questionnaire||2
10658569|NCT02233946|11819757|FG001|NOT COMPLETED|Immediate Post-visit Questionnaire||0
10658570|NCT02233946|11819756|FG000|STARTED|3-months Follow-up||624
10390467|NCT00660400|11533307|FG000|COMPLETED|Overall Study||21
10390468|NCT00660400|11533307|FG000|NOT COMPLETED|Overall Study||4
10390469|NCT00660504|11533313|FG000|STARTED|Overall Study||149
10390470|NCT00660504|11533314|FG001|STARTED|Overall Study||151
10390471|NCT00660504|11533313|FG000|COMPLETED|Overall Study||149
10390472|NCT00660504|11533314|FG001|COMPLETED|Overall Study||150
10390473|NCT00660504|11533313|FG000|NOT COMPLETED|Overall Study||0
10390474|NCT00660504|11533314|FG001|NOT COMPLETED|Overall Study||1
10390475|NCT00660517|11533324|FG000|STARTED|Overall Study||153
10390476|NCT00660517|11533325|FG001|STARTED|Overall Study||152
10390477|NCT00660517|11533326|FG002|STARTED|Overall Study||151
10390478|NCT00660517|11533327|FG003|STARTED|Overall Study||151
10390479|NCT00660517|11533324|FG000|COMPLETED|Overall Study||145
10390480|NCT00660517|11533325|FG001|COMPLETED|Overall Study||144
10390481|NCT00660517|11533326|FG002|COMPLETED|Overall Study||144
10390482|NCT00660517|11533327|FG003|COMPLETED|Overall Study||144
10390483|NCT00660517|11533324|FG000|NOT COMPLETED|Overall Study||8
10718682|NCT02705807|11882303|FG000|COMPLETED|Overall Study||10
10718683|NCT02705807|11882303|FG000|NOT COMPLETED|Overall Study||0
10718684|NCT02706041|11882309|FG000|STARTED|Overall Study||18
10718685|NCT02706041|11882310|FG001|STARTED|Overall Study||21
10718686|NCT02706041|11882309|FG000|Received Allocated Intervention|Overall Study||18
10718687|NCT02706041|11882310|FG001|Received Allocated Intervention|Overall Study||18
10390484|NCT00660517|11533325|FG001|NOT COMPLETED|Overall Study||8
10718688|NCT02706041|11882309|FG000|COMPLETED|Overall Study||18
10718689|NCT02706041|11882310|FG001|COMPLETED|Overall Study||18
10718690|NCT02706041|11882309|FG000|NOT COMPLETED|Overall Study||0
10718691|NCT02706041|11882310|FG001|NOT COMPLETED|Overall Study||3
10718692|NCT02706249|11882318|FG000|STARTED|Overall Study||25
10718693|NCT02706249|11882319|FG001|STARTED|Overall Study||25
10718694|NCT02706249|11882318|FG000|COMPLETED|Overall Study||23
10718695|NCT02706249|11882319|FG001|COMPLETED|Overall Study||24
10390485|NCT00660517|11533326|FG002|NOT COMPLETED|Overall Study||7
10390486|NCT00660517|11533327|FG003|NOT COMPLETED|Overall Study||7
10390487|NCT00660530|11533338|FG000|STARTED|Overall Study||11
10390488|NCT00660530|11533338|FG000|COMPLETED|Overall Study||11
10390489|NCT00660530|11533338|FG000|NOT COMPLETED|Overall Study||0
10390490|NCT00660543|11533344|FG000|STARTED|Overall Study||14
10390491|NCT00660543|11533344|FG000|COMPLETED|Overall Study||14
10390492|NCT00660543|11533344|FG000|NOT COMPLETED|Overall Study||0
10718696|NCT02706249|11882318|FG000|NOT COMPLETED|Overall Study||2
10718697|NCT02706249|11882319|FG001|NOT COMPLETED|Overall Study||1
10718698|NCT02706327|11882330|FG000|STARTED|Overall Study||22
10718699|NCT02706327|11882331|FG001|STARTED|Overall Study||22
10718700|NCT02706327|11882332|FG002|STARTED|Overall Study||23
10718701|NCT02706327|11882330|FG000|COMPLETED|Overall Study||21
10718703|NCT02706327|11882332|FG002|COMPLETED|Overall Study||21
10718704|NCT02706327|11882330|FG000|NOT COMPLETED|Overall Study||1
10718705|NCT02706327|11882331|FG001|NOT COMPLETED|Overall Study||1
10718706|NCT02706327|11882332|FG002|NOT COMPLETED|Overall Study||2
10718707|NCT02706483|11882340|FG000|STARTED|Overall Study||2272
10718708|NCT02706483|11882340|FG000|COMPLETED|Overall Study||1842
10718709|NCT02706483|11882340|FG000|NOT COMPLETED|Overall Study||430
10718710|NCT02706717|11882346|FG000|STARTED|Overall Study||47
10718711|NCT02706717|11882347|FG001|STARTED|Overall Study|3 placebo participants never initiated study treatment.|46
10718712|NCT02706717|11882346|FG000|COMPLETED|Overall Study||46
10718713|NCT02706717|11882347|FG001|COMPLETED|Overall Study||35
10718714|NCT02706717|11882346|FG000|NOT COMPLETED|Overall Study||1
10718715|NCT02706717|11882347|FG001|NOT COMPLETED|Overall Study||11
10718716|NCT02706834|11882364|FG000|STARTED|Overall Study||3
10718717|NCT02706834|11882365|FG001|STARTED|Overall Study||3
10718718|NCT02706834|11882366|FG002|STARTED|Overall Study||3
10718719|NCT02706834|11882367|FG003|STARTED|Overall Study||3
10718720|NCT02706834|11882368|FG004|STARTED|Overall Study||3
10718721|NCT02706834|11882369|FG005|STARTED|Overall Study||3
10718722|NCT02706834|11882370|FG006|STARTED|Overall Study||3
10718723|NCT02706834|11882371|FG007|STARTED|Overall Study||3
10718724|NCT02706834|11882372|FG008|STARTED|Overall Study||4
10718725|NCT02706834|11882373|FG009|STARTED|Overall Study||4
10718726|NCT02706834|11882374|FG010|STARTED|Overall Study||4
10718727|NCT02706834|11882364|FG000|COMPLETED|Overall Study|Completed = completed study drug|1
10718728|NCT02706834|11882365|FG001|COMPLETED|Overall Study||2
10718729|NCT02706834|11882366|FG002|COMPLETED|Overall Study||2
10718730|NCT02706834|11882367|FG003|COMPLETED|Overall Study||3
10390493|NCT00660660|11533355|FG000|STARTED|Overall Study|Randomized|143
10390494|NCT00660660|11533356|FG001|STARTED|Overall Study|Randomized|133
10390495|NCT00660660|11533355|FG000|Met Criteria for MITT Population|Overall Study||137
10390496|NCT00660660|11533356|FG001|Met Criteria for MITT Population|Overall Study||125
10390497|NCT00660660|11533355|FG000|COMPLETED|Overall Study|Number of completed patients is based on randomized population (143) minus withdrawals (5).|138
10390498|NCT00660660|11533356|FG001|COMPLETED|Overall Study|Number of completed patients is based on randomized population (133) minus withdrawals (9).|124
10390499|NCT00660660|11533355|FG000|NOT COMPLETED|Overall Study||5
10390500|NCT00660660|11533356|FG001|NOT COMPLETED|Overall Study||9
10390501|NCT00660699|11533362|FG000|STARTED|Overall Study||50
10390502|NCT00660699|11533362|FG000|COMPLETED|Overall Study||48
10390503|NCT00660699|11533362|FG000|NOT COMPLETED|Overall Study||2
10390504|NCT00660790|11533366|FG000|STARTED|Baseline to 3 Months||97
10390505|NCT00660790|11533366|FG000|COMPLETED|Baseline to 3 Months||94
10390506|NCT00660790|11533366|FG000|NOT COMPLETED|Baseline to 3 Months||3
10390507|NCT00660790|11533366|FG000|STARTED|3 Months to 2 Years||94
10390508|NCT00660790|11533366|FG000|COMPLETED|3 Months to 2 Years||77
10390509|NCT00660790|11533366|FG000|NOT COMPLETED|3 Months to 2 Years||17
10390510|NCT00660816|11533372|FG000|STARTED|Overall Study||24
10390511|NCT00660816|11533373|FG001|STARTED|Overall Study||22
10390512|NCT00660816|11533372|FG000|COMPLETED|Overall Study||4
10390513|NCT00660816|11533373|FG001|COMPLETED|Overall Study||3
10390514|NCT00660816|11533372|FG000|NOT COMPLETED|Overall Study||20
10390515|NCT00660816|11533373|FG001|NOT COMPLETED|Overall Study||19
10390516|NCT00660829|11533381|FG000|STARTED|Overall Study|2 subjects were randomized in error|268
10390517|NCT00660829|11533382|FG001|STARTED|Overall Study|2 subjects were randomized in error|268
10390518|NCT00660829|11533381|FG000|COMPLETED|Overall Study||250
10390519|NCT00660829|11533382|FG001|COMPLETED|Overall Study||249
10390520|NCT00660829|11533381|FG000|NOT COMPLETED|Overall Study||18
10390521|NCT00660829|11533382|FG001|NOT COMPLETED|Overall Study||19
10390522|NCT00660907|11533390|FG000|STARTED|Overall Study|Of the 406 randomized participants only 400 were included in the full analysis set.|406
10390523|NCT00660907|11533391|FG001|STARTED|Overall Study|Of the 408 randomized participants only 401 were included in the full analysis set.|408
10390524|NCT00660907|11533390|FG000|COMPLETED|Overall Study||322
10390525|NCT00660907|11533391|FG001|COMPLETED|Overall Study||314
10390526|NCT00660907|11533390|FG000|NOT COMPLETED|Overall Study||84
10390527|NCT00660907|11533391|FG001|NOT COMPLETED|Overall Study||94
10390528|NCT00660985|11533399|FG000|STARTED|Overall Study||26
10390529|NCT00660985|11533400|FG001|STARTED|Overall Study||25
10390530|NCT00660985|11533399|FG000|COMPLETED|Overall Study||25
10390531|NCT00660985|11533400|FG001|COMPLETED|Overall Study||25
10390532|NCT00660985|11533399|FG000|NOT COMPLETED|Overall Study||1
10390533|NCT00660985|11533400|FG001|NOT COMPLETED|Overall Study||0
10390534|NCT00661037|11533408|FG000|STARTED|Overall Study||836
10390535|NCT00661037|11533409|FG001|STARTED|Overall Study||1284
10390536|NCT00661037|11533408|FG000|Witdrawn|Overall Study||47
10390537|NCT00661037|11533409|FG001|Witdrawn|Overall Study||68
10390538|NCT00661037|11533408|FG000|Deaths|Overall Study||108
10390539|NCT00661037|11533409|FG001|Deaths|Overall Study||188
10390540|NCT00661037|11533408|FG000|COMPLETED|Overall Study||682
10718731|NCT02706834|11882368|FG004|COMPLETED|Overall Study||2
10718732|NCT02706834|11882369|FG005|COMPLETED|Overall Study||3
10718733|NCT02706834|11882370|FG006|COMPLETED|Overall Study||3
10718734|NCT02706834|11882371|FG007|COMPLETED|Overall Study||3
10718735|NCT02706834|11882372|FG008|COMPLETED|Overall Study||4
10718736|NCT02706834|11882373|FG009|COMPLETED|Overall Study||3
10718737|NCT02706834|11882374|FG010|COMPLETED|Overall Study||3
10718738|NCT02706834|11882364|FG000|NOT COMPLETED|Overall Study||2
10718739|NCT02706834|11882365|FG001|NOT COMPLETED|Overall Study||1
10718740|NCT02706834|11882366|FG002|NOT COMPLETED|Overall Study||1
10718741|NCT02706834|11882367|FG003|NOT COMPLETED|Overall Study||0
10718742|NCT02706834|11882368|FG004|NOT COMPLETED|Overall Study||1
10718743|NCT02706834|11882369|FG005|NOT COMPLETED|Overall Study||0
10718744|NCT02706834|11882370|FG006|NOT COMPLETED|Overall Study||0
10718745|NCT02706834|11882371|FG007|NOT COMPLETED|Overall Study||0
10718746|NCT02706834|11882372|FG008|NOT COMPLETED|Overall Study||0
10718747|NCT02706834|11882373|FG009|NOT COMPLETED|Overall Study||1
10718748|NCT02706834|11882374|FG010|NOT COMPLETED|Overall Study||1
10390541|NCT00661037|11533409|FG001|COMPLETED|Overall Study||1027
10390542|NCT00661037|11533408|FG000|NOT COMPLETED|Overall Study||154
10390543|NCT00661037|11533409|FG001|NOT COMPLETED|Overall Study||257
10390544|NCT00661089|11533419|FG000|STARTED|Overall Study||10
10390545|NCT00661089|11533420|FG001|STARTED|Overall Study||11
10718773|NCT02706886|11882447|FG000|STARTED|Part A: SAD Period||8
10718774|NCT02706886|11882448|FG001|STARTED|Part A: SAD Period||6
10718775|NCT02706886|11882449|FG002|STARTED|Part A: SAD Period||6
10718776|NCT02706886|11882450|FG003|STARTED|Part A: SAD Period||6
10718777|NCT02706886|11882451|FG004|STARTED|Part A: SAD Period||6
10718778|NCT02706886|11882452|FG005|STARTED|Part A: SAD Period||0
10390546|NCT00661089|11533419|FG000|COMPLETED|Overall Study||10
10390547|NCT00661089|11533420|FG001|COMPLETED|Overall Study||9
10390548|NCT00661089|11533419|FG000|NOT COMPLETED|Overall Study||0
10390549|NCT00661089|11533420|FG001|NOT COMPLETED|Overall Study||2
10390550|NCT00661141|11533430|FG000|STARTED|Overall Study||8
10390551|NCT00661141|11533431|FG001|STARTED|Overall Study||8
10390552|NCT00661141|11533432|FG002|STARTED|Overall Study||4
10390553|NCT00661141|11533433|FG003|STARTED|Overall Study||4
10390554|NCT00661141|11533434|FG004|STARTED|Overall Study||4
10390555|NCT00661141|11533435|FG005|STARTED|Overall Study||4
10390556|NCT00661141|11533430|FG000|Administered 30 Minutes Prior to Ethanol|Overall Study||6
10718779|NCT02706886|11882453|FG006|STARTED|Part A: SAD Period||0
10718780|NCT02706886|11882454|FG007|STARTED|Part A: SAD Period||0
10718781|NCT02706886|11882455|FG008|STARTED|Part A: SAD Period||0
10718782|NCT02706886|11882447|FG000|COMPLETED|Part A: SAD Period||8
10390557|NCT00661141|11533431|FG001|Administered 30 Minutes Prior to Ethanol|Overall Study||6
10390558|NCT00661141|11533432|FG002|Administered 30 Minutes Prior to Ethanol|Overall Study||2
10390559|NCT00661141|11533433|FG003|Administered 30 Minutes Prior to Ethanol|Overall Study||2
10390560|NCT00661141|11533434|FG004|Administered 30 Minutes Prior to Ethanol|Overall Study||4
10390561|NCT00661141|11533435|FG005|Administered 30 Minutes Prior to Ethanol|Overall Study||4
10390562|NCT00661141|11533430|FG000|Administered 30 Minutes After Ethanol|Overall Study||2
10390563|NCT00661141|11533431|FG001|Administered 30 Minutes After Ethanol|Overall Study||2
10390564|NCT00661141|11533432|FG002|Administered 30 Minutes After Ethanol|Overall Study||2
10390565|NCT00661141|11533433|FG003|Administered 30 Minutes After Ethanol|Overall Study||2
10390566|NCT00661141|11533434|FG004|Administered 30 Minutes After Ethanol|Overall Study||0
10390567|NCT00661141|11533435|FG005|Administered 30 Minutes After Ethanol|Overall Study||0
10390568|NCT00661141|11533430|FG000|COMPLETED|Overall Study||8
10390569|NCT00661141|11533431|FG001|COMPLETED|Overall Study||8
10390570|NCT00661141|11533432|FG002|COMPLETED|Overall Study||4
10390571|NCT00661141|11533433|FG003|COMPLETED|Overall Study||4
10390572|NCT00661141|11533434|FG004|COMPLETED|Overall Study||4
10390573|NCT00661141|11533435|FG005|COMPLETED|Overall Study||4
10390574|NCT00661141|11533430|FG000|NOT COMPLETED|Overall Study||0
10390575|NCT00661141|11533431|FG001|NOT COMPLETED|Overall Study||0
10390576|NCT00661141|11533432|FG002|NOT COMPLETED|Overall Study||0
10718783|NCT02706886|11882448|FG001|COMPLETED|Part A: SAD Period||6
10390577|NCT00661141|11533433|FG003|NOT COMPLETED|Overall Study||0
10390578|NCT00661141|11533434|FG004|NOT COMPLETED|Overall Study||0
10390579|NCT00661141|11533435|FG005|NOT COMPLETED|Overall Study||0
10390580|NCT00661193|11533456|FG000|STARTED|Overall Study||33
10390581|NCT00661193|11533457|FG001|STARTED|Overall Study||26
10390582|NCT00661193|11533456|FG000|COMPLETED|Overall Study||0
10390583|NCT00661193|11533457|FG001|COMPLETED|Overall Study||0
10390584|NCT00661193|11533456|FG000|NOT COMPLETED|Overall Study||33
10390585|NCT00661193|11533457|FG001|NOT COMPLETED|Overall Study||26
10390586|NCT00661258|11533465|FG000|STARTED|Overall Study||34
10390587|NCT00661258|11533466|FG001|STARTED|Overall Study||34
10390588|NCT00661258|11533465|FG000|COMPLETED|Overall Study||31
10390589|NCT00661258|11533466|FG001|COMPLETED|Overall Study||33
10390590|NCT00661258|11533465|FG000|NOT COMPLETED|Overall Study||3
10390591|NCT00661258|11533466|FG001|NOT COMPLETED|Overall Study||1
10390592|NCT00661271|11533474|FG000|STARTED|Overall Study||48
10390593|NCT00661271|11533475|FG001|STARTED|Overall Study||45
10390594|NCT00661271|11533474|FG000|COMPLETED|Overall Study||20
10390595|NCT00661271|11533475|FG001|COMPLETED|Overall Study||20
10390596|NCT00661271|11533474|FG000|NOT COMPLETED|Overall Study||28
10390597|NCT00661271|11533475|FG001|NOT COMPLETED|Overall Study||25
10390598|NCT00661362|11533483|FG000|STARTED|Overall Study|Randomized and treated|283
10390599|NCT00661362|11533484|FG001|STARTED|Overall Study|Randomized and treated|287
10390600|NCT00661362|11533483|FG000|COMPLETED|Overall Study|Completed 24 Weeks of treatment|254
10390601|NCT00661362|11533484|FG001|COMPLETED|Overall Study|Completed 24 Weeks of treatment|247
10390602|NCT00661362|11533483|FG000|NOT COMPLETED|Overall Study||29
10390603|NCT00661362|11533484|FG001|NOT COMPLETED|Overall Study||40
10390604|NCT00661388|11533490|FG000|STARTED|Overall Study||75
10390605|NCT00661388|11533490|FG000|COMPLETED|Overall Study||51
10390606|NCT00661388|11533490|FG000|NOT COMPLETED|Overall Study||24
10390607|NCT00661427|11533496|FG000|STARTED|Overall Study||35
10390608|NCT00661427|11533497|FG001|STARTED|Overall Study||26
10390609|NCT00661427|11533496|FG000|COMPLETED|Overall Study||30
10390610|NCT00661427|11533497|FG001|COMPLETED|Overall Study||19
10390611|NCT00661427|11533496|FG000|NOT COMPLETED|Overall Study||5
10390612|NCT00661427|11533497|FG001|NOT COMPLETED|Overall Study||7
10390613|NCT00661453|11533503|FG000|STARTED|Overall Study||38
10390614|NCT00661453|11533503|FG000|COMPLETED|Overall Study||25
10390615|NCT00661453|11533503|FG000|NOT COMPLETED|Overall Study||13
10390616|NCT00661479|11533511|FG000|STARTED|Overall Study||12
10390617|NCT00661479|11533512|FG001|STARTED|Overall Study||3
10390618|NCT00661479|11533513|FG002|STARTED|Overall Study||3
10390619|NCT00661479|11533514|FG003|STARTED|Overall Study||3
10390620|NCT00661479|11533511|FG000|COMPLETED|Overall Study||12
10390621|NCT00661479|11533512|FG001|COMPLETED|Overall Study||3
10390622|NCT00661479|11533513|FG002|COMPLETED|Overall Study||3
10390623|NCT00661479|11533514|FG003|COMPLETED|Overall Study||3
10390624|NCT00661479|11533511|FG000|NOT COMPLETED|Overall Study||0
10390625|NCT00661479|11533512|FG001|NOT COMPLETED|Overall Study||0
10390626|NCT00661479|11533513|FG002|NOT COMPLETED|Overall Study||0
10390627|NCT00661479|11533514|FG003|NOT COMPLETED|Overall Study||0
10390628|NCT00661492|11533525|FG000|STARTED|Overall Study||75
10390629|NCT00661492|11533526|FG001|STARTED|Overall Study||40
10390630|NCT00661492|11533525|FG000|COMPLETED|Overall Study||7
10390631|NCT00661492|11533526|FG001|COMPLETED|Overall Study||11
10390632|NCT00661492|11533525|FG000|NOT COMPLETED|Overall Study||68
10390633|NCT00661492|11533526|FG001|NOT COMPLETED|Overall Study||29
10390634|NCT00661505|11533532|FG000|STARTED|Overall Study||132
10390635|NCT00661505|11533532|FG000|COMPLETED|Overall Study||102
10390636|NCT00661505|11533532|FG000|NOT COMPLETED|Overall Study||30
10390637|NCT00661531|11533537|FG000|STARTED|Overall Study||11
10390638|NCT00661531|11533537|FG000|COMPLETED|Overall Study||8
10390639|NCT00661531|11533537|FG000|NOT COMPLETED|Overall Study||3
10390640|NCT00661544|11533541|FG000|STARTED|Overall Study||48
10390641|NCT00661544|11533541|FG000|COMPLETED|Overall Study||48
10390642|NCT00661544|11533541|FG000|NOT COMPLETED|Overall Study||0
10390643|NCT00661557|11533547|FG000|STARTED|Overall Study||192
10390644|NCT00661557|11533548|FG001|STARTED|Overall Study||79
10390645|NCT00661557|11533547|FG000|COMPLETED|Overall Study||183
10390646|NCT00661557|11533548|FG001|COMPLETED|Overall Study||79
10390647|NCT00661557|11533547|FG000|NOT COMPLETED|Overall Study||9
10390648|NCT00661557|11533548|FG001|NOT COMPLETED|Overall Study||0
10390649|NCT00661570|11533554|FG000|STARTED|Overall Study||26
10390650|NCT00661570|11533554|FG000|COMPLETED|Overall Study||26
10390651|NCT00661570|11533554|FG000|NOT COMPLETED|Overall Study||0
10390652|NCT00661583|11533561|FG000|STARTED|Overall Study||10
10390653|NCT00661583|11533562|FG001|STARTED|Overall Study||10
10390654|NCT00661583|11533563|FG002|STARTED|Overall Study||10
10390655|NCT00661583|11533561|FG000|COMPLETED|Overall Study||10
10390656|NCT00661583|11533562|FG001|COMPLETED|Overall Study||10
10390657|NCT00661583|11533563|FG002|COMPLETED|Overall Study||10
10390658|NCT00661583|11533561|FG000|NOT COMPLETED|Overall Study||0
10390659|NCT00661583|11533562|FG001|NOT COMPLETED|Overall Study||0
10390660|NCT00661583|11533563|FG002|NOT COMPLETED|Overall Study||0
10390661|NCT00661609|11533571|FG000|STARTED|Overall Study|All dosed patients|41
10390662|NCT00661609|11533571|FG000|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
10390663|NCT00661609|11533571|FG000|NOT COMPLETED|Overall Study||41
10390664|NCT00661622|11533577|FG000|STARTED|Overall Study||26
10390665|NCT00661622|11533578|FG001|STARTED|Overall Study||27
10390666|NCT00661622|11533577|FG000|COMPLETED|Overall Study||25
10390667|NCT00661622|11533578|FG001|COMPLETED|Overall Study||27
10390668|NCT00661622|11533577|FG000|NOT COMPLETED|Overall Study||1
10390669|NCT00661622|11533578|FG001|NOT COMPLETED|Overall Study||0
10390670|NCT00661661|11533587|FG000|STARTED|Overall Study||382
10390671|NCT00661661|11533588|FG001|STARTED|Overall Study||105
10390672|NCT00661661|11533587|FG000|COMPLETED|Overall Study||242
10390673|NCT00661661|11533588|FG001|COMPLETED|Overall Study||66
10390674|NCT00661661|11533587|FG000|NOT COMPLETED|Overall Study||140
10390675|NCT00661661|11533588|FG001|NOT COMPLETED|Overall Study||39
10428514|NCT00858637|11574568|FG003|COMPLETED|Active Comparison Phase||115
10390676|NCT00661674|11533596|FG000|STARTED|Overall Study|Participants 1 & 10 were assigned to sequence 1|2
10390677|NCT00661674|11533597|FG001|STARTED|Overall Study|Participants 2 & 3 were assigned to sequence 2|2
10390678|NCT00661674|11533598|FG002|STARTED|Overall Study|Participants 4 & 7 were assigned to sequence 3|2
10390679|NCT00661674|11533599|FG003|STARTED|Overall Study|Participant 5 was assigned to sequence 4|1
10390680|NCT00661674|11533600|FG004|STARTED|Overall Study|Participants 6 & 8 were assigned to sequence 5|2
10390681|NCT00661674|11533601|FG005|STARTED|Overall Study|Participant 9 was assigned to sequence 6|1
10390682|NCT00661674|11533596|FG000|COMPLETED|Overall Study|Participants 1 & 10 completed sequence 1|2
10390683|NCT00661674|11533597|FG001|COMPLETED|Overall Study|Participants 2 & 3 completed sequence 2|2
10390684|NCT00661674|11533598|FG002|COMPLETED|Overall Study|Participants 4 & 7 completed sequence 3|2
10390685|NCT00661674|11533599|FG003|COMPLETED|Overall Study|Participant 5 completed sequence 4|1
10390686|NCT00661674|11533600|FG004|COMPLETED|Overall Study|Participants 6 & 8 completed sequence 5|2
10390687|NCT00661674|11533601|FG005|COMPLETED|Overall Study|Participant 9 completed sequence 6|1
10390688|NCT00661674|11533596|FG000|NOT COMPLETED|Overall Study||0
10390689|NCT00661674|11533597|FG001|NOT COMPLETED|Overall Study||0
10390690|NCT00661674|11533598|FG002|NOT COMPLETED|Overall Study||0
10390691|NCT00661674|11533599|FG003|NOT COMPLETED|Overall Study||0
10390692|NCT00661674|11533600|FG004|NOT COMPLETED|Overall Study||0
10390693|NCT00661674|11533601|FG005|NOT COMPLETED|Overall Study||0
10390694|NCT00661687|11533609|FG000|STARTED|Overall Study|Contralateral study design, numbers indicate number of subjects.|204
10390695|NCT00661687|11533609|FG000|COMPLETED|Overall Study|Number indicates number of subjects successfully completing study.|189
10390696|NCT00661687|11533609|FG000|NOT COMPLETED|Overall Study||15
10428515|NCT00858637|11574569|FG004|COMPLETED|Active Comparison Phase||0
10428516|NCT00858637|11574570|FG005|COMPLETED|Active Comparison Phase||0
10428517|NCT00858637|11574565|FG000|NOT COMPLETED|Active Comparison Phase||24
10428518|NCT00858637|11574566|FG001|NOT COMPLETED|Active Comparison Phase||0
10428519|NCT00858637|11574567|FG002|NOT COMPLETED|Active Comparison Phase||0
10428520|NCT00858637|11574568|FG003|NOT COMPLETED|Active Comparison Phase||18
10428521|NCT00858637|11574569|FG004|NOT COMPLETED|Active Comparison Phase||0
10428522|NCT00858637|11574570|FG005|NOT COMPLETED|Active Comparison Phase||0
10428523|NCT00858637|11574565|FG000|STARTED|Placebo-controlled Withdrawal Phase||0
10428524|NCT00858637|11574566|FG001|STARTED|Placebo-controlled Withdrawal Phase||49
10428525|NCT00858637|11574567|FG002|STARTED|Placebo-controlled Withdrawal Phase||54
10428526|NCT00858637|11574568|FG003|STARTED|Placebo-controlled Withdrawal Phase||0
10428527|NCT00858637|11574569|FG004|STARTED|Placebo-controlled Withdrawal Phase||56
10428528|NCT00858637|11574570|FG005|STARTED|Placebo-controlled Withdrawal Phase||59
10428529|NCT00858637|11574565|FG000|COMPLETED|Placebo-controlled Withdrawal Phase||0
10428530|NCT00858637|11574566|FG001|COMPLETED|Placebo-controlled Withdrawal Phase||49
10428531|NCT00858637|11574567|FG002|COMPLETED|Placebo-controlled Withdrawal Phase||53
10428532|NCT00858637|11574568|FG003|COMPLETED|Placebo-controlled Withdrawal Phase||0
10428533|NCT00858637|11574569|FG004|COMPLETED|Placebo-controlled Withdrawal Phase||55
10428534|NCT00858637|11574570|FG005|COMPLETED|Placebo-controlled Withdrawal Phase||58
10428535|NCT00858637|11574565|FG000|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
10428536|NCT00858637|11574566|FG001|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
10428537|NCT00858637|11574567|FG002|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
10428538|NCT00858637|11574568|FG003|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
10428539|NCT00858637|11574569|FG004|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
10428540|NCT00858637|11574570|FG005|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
10718784|NCT02706886|11882449|FG002|COMPLETED|Part A: SAD Period||6
10307713|NCT00107380|11440684|FG000|STARTED|Overall Study||86
10307714|NCT00107380|11440684|FG000|Eligible|Overall Study||84
10307715|NCT00107380|11440684|FG000|COMPLETED|Overall Study||56
10307716|NCT00107380|11440684|FG000|NOT COMPLETED|Overall Study||30
10307717|NCT00107536|11440689|FG000|STARTED|Overall Study||26
10307718|NCT00107536|11440689|FG000|COMPLETED|Overall Study||26
10307719|NCT00107536|11440689|FG000|NOT COMPLETED|Overall Study||0
10307720|NCT00107575|11440695|FG000|STARTED|Overall Study||119
10307721|NCT00107575|11440696|FG001|STARTED|Overall Study||117
10307722|NCT00107575|11440695|FG000|COMPLETED|Overall Study||108
10307723|NCT00107575|11440696|FG001|COMPLETED|Overall Study||107
10307724|NCT00107575|11440695|FG000|NOT COMPLETED|Overall Study||11
10307725|NCT00107575|11440696|FG001|NOT COMPLETED|Overall Study||10
10307726|NCT00107653|11440704|FG000|STARTED|Overall Study||269
10307727|NCT00107653|11440705|FG001|STARTED|Overall Study||300
10307728|NCT00107653|11440704|FG000|COMPLETED|Overall Study||190
10390697|NCT00661713|11533623|FG000|STARTED|Overall Study||128
10390698|NCT00661713|11533624|FG001|STARTED|Overall Study||247
10390699|NCT00661713|11533625|FG002|STARTED|Overall Study||128
10390700|NCT00661713|11533626|FG003|STARTED|Overall Study||247
10390701|NCT00661713|11533627|FG004|STARTED|Overall Study||127
10390702|NCT00661713|11533628|FG005|STARTED|Overall Study||253
10390703|NCT00661713|11533629|FG006|STARTED|Overall Study||373
10390704|NCT00661713|11533630|FG007|STARTED|Overall Study||128
10390705|NCT00661713|11533623|FG000|COMPLETED|Overall Study||112
10390706|NCT00661713|11533624|FG001|COMPLETED|Overall Study||208
10390707|NCT00661713|11533625|FG002|COMPLETED|Overall Study||111
10390708|NCT00661713|11533626|FG003|COMPLETED|Overall Study||219
10390709|NCT00661713|11533627|FG004|COMPLETED|Overall Study||107
10390710|NCT00661713|11533628|FG005|COMPLETED|Overall Study||216
10390711|NCT00661713|11533629|FG006|COMPLETED|Overall Study||309
10390712|NCT00661713|11533630|FG007|COMPLETED|Overall Study||117
10390713|NCT00661713|11533623|FG000|NOT COMPLETED|Overall Study||16
10390714|NCT00661713|11533624|FG001|NOT COMPLETED|Overall Study||39
10390715|NCT00661713|11533625|FG002|NOT COMPLETED|Overall Study||17
10390716|NCT00661713|11533626|FG003|NOT COMPLETED|Overall Study||28
10390717|NCT00661713|11533627|FG004|NOT COMPLETED|Overall Study||20
10390718|NCT00661713|11533628|FG005|NOT COMPLETED|Overall Study||37
10390719|NCT00661713|11533629|FG006|NOT COMPLETED|Overall Study||64
10718785|NCT02706886|11882450|FG003|COMPLETED|Part A: SAD Period||4
10718786|NCT02706886|11882451|FG004|COMPLETED|Part A: SAD Period||6
10390720|NCT00661713|11533630|FG007|NOT COMPLETED|Overall Study||11
10390721|NCT00661726|11533650|FG000|STARTED|Overall Study||6
10390722|NCT00661726|11533650|FG000|COMPLETED|Overall Study||5
10390723|NCT00661726|11533650|FG000|NOT COMPLETED|Overall Study||1
10390724|NCT00661778|11533654|FG000|STARTED|Overall Study||50
10390725|NCT00661778|11533654|FG000|COMPLETED|Overall Study||0
10390726|NCT00661778|11533654|FG000|NOT COMPLETED|Overall Study||50
10390727|NCT00661830|11533660|FG000|STARTED|Overall Study||49
10390728|NCT00661830|11533661|FG001|STARTED|Overall Study||48
10390729|NCT00661830|11533660|FG000|COMPLETED|Overall Study||9
10390730|NCT00661830|11533661|FG001|COMPLETED|Overall Study||6
10390731|NCT00661830|11533660|FG000|NOT COMPLETED|Overall Study||40
10390732|NCT00661830|11533661|FG001|NOT COMPLETED|Overall Study||42
10390733|NCT00661895|11533669|FG000|STARTED|Overall Study||49
10390734|NCT00661895|11533670|FG001|STARTED|Overall Study||50
10390735|NCT00661895|11533669|FG000|COMPLETED|Overall Study||49
10390736|NCT00661895|11533670|FG001|COMPLETED|Overall Study||50
10390737|NCT00661895|11533669|FG000|NOT COMPLETED|Overall Study||0
10390738|NCT00661895|11533670|FG001|NOT COMPLETED|Overall Study||0
10390739|NCT00661960|11533679|FG000|STARTED|Overall Study||5
10390740|NCT00661960|11533680|FG001|STARTED|Overall Study||10
10390741|NCT00661960|11533681|FG002|STARTED|Overall Study||10
10307729|NCT00107653|11440705|FG001|COMPLETED|Overall Study||224
10307730|NCT00107653|11440704|FG000|NOT COMPLETED|Overall Study||79
10307731|NCT00107653|11440705|FG001|NOT COMPLETED|Overall Study||76
10307732|NCT00107744|11440714|FG000|STARTED|Intervention 1 (8 Weeks)||117
10390742|NCT00661960|11533679|FG000|COMPLETED|Overall Study||5
10390743|NCT00661960|11533680|FG001|COMPLETED|Overall Study||7
10390744|NCT00661960|11533681|FG002|COMPLETED|Overall Study||9
10390745|NCT00661960|11533679|FG000|NOT COMPLETED|Overall Study||0
10718787|NCT02706886|11882452|FG005|COMPLETED|Part A: SAD Period||0
10812851|NCT03217175|11975054|FG001|STARTED|Overall Study||1
10812852|NCT03217175|11975053|FG000|COMPLETED|Overall Study||0
10812853|NCT03217175|11975054|FG001|COMPLETED|Overall Study||0
10390746|NCT00661960|11533680|FG001|NOT COMPLETED|Overall Study||3
10390747|NCT00661960|11533681|FG002|NOT COMPLETED|Overall Study||1
10390748|NCT00661999|11533692|FG000|STARTED|Overall Study||164
10390749|NCT00661999|11533693|FG001|STARTED|Overall Study||163
10390750|NCT00661999|11533694|FG002|STARTED|Overall Study||163
10390751|NCT00661999|11533692|FG000|COMPLETED|Overall Study||105
10390752|NCT00661999|11533693|FG001|COMPLETED|Overall Study||113
10390753|NCT00661999|11533694|FG002|COMPLETED|Overall Study||106
10390754|NCT00661999|11533692|FG000|NOT COMPLETED|Overall Study||59
10390755|NCT00661999|11533693|FG001|NOT COMPLETED|Overall Study||50
10390756|NCT00661999|11533694|FG002|NOT COMPLETED|Overall Study||57
10390757|NCT00662012|11533702|FG000|STARTED|Overall Study||414
10390758|NCT00662012|11533702|FG000|COMPLETED|Overall Study||327
10390759|NCT00662012|11533702|FG000|NOT COMPLETED|Overall Study||87
10390760|NCT00662025|11533706|FG000|STARTED|Overall Study|All 63 participants were included in Full Analysis Set population.|63
10390761|NCT00662025|11533706|FG000|COMPLETED|Overall Study||0
10390762|NCT00662025|11533706|FG000|NOT COMPLETED|Overall Study||63
10390763|NCT00662038|11533710|FG000|STARTED|Overall Study||1058
10390764|NCT00662038|11533710|FG000|COMPLETED|Overall Study||427
10390765|NCT00662038|11533710|FG000|NOT COMPLETED|Overall Study||631
10390766|NCT00662129|11533714|FG000|STARTED|Overall Study||50
10390767|NCT00662129|11533714|FG000|COMPLETED|Overall Study||47
10390768|NCT00662129|11533714|FG000|NOT COMPLETED|Overall Study||3
10390769|NCT00662155|11533722|FG000|STARTED|Overall Study||16
10390770|NCT00662155|11533723|FG001|STARTED|Overall Study||20
10390771|NCT00662155|11533724|FG002|STARTED|Overall Study||20
10390772|NCT00662155|11533725|FG003|STARTED|Overall Study||18
10390773|NCT00662155|11533722|FG000|COMPLETED|Overall Study||13
10390774|NCT00662155|11533723|FG001|COMPLETED|Overall Study||15
10390775|NCT00662155|11533724|FG002|COMPLETED|Overall Study||13
10390776|NCT00662155|11533725|FG003|COMPLETED|Overall Study||14
10390777|NCT00662155|11533722|FG000|NOT COMPLETED|Overall Study||3
10390778|NCT00662155|11533723|FG001|NOT COMPLETED|Overall Study||5
10390779|NCT00662155|11533724|FG002|NOT COMPLETED|Overall Study||7
10390780|NCT00662155|11533725|FG003|NOT COMPLETED|Overall Study||4
10390781|NCT00662207|11533735|FG000|STARTED|Overall Study||3
10390782|NCT00662207|11533735|FG000|COMPLETED|Overall Study||3
10390783|NCT00662207|11533735|FG000|NOT COMPLETED|Overall Study||0
10390784|NCT00662259|11533741|FG000|STARTED|Overall Study||21
10390785|NCT00662259|11533742|FG001|STARTED|Overall Study||11
10390786|NCT00662259|11533741|FG000|COMPLETED|Overall Study||19
10390787|NCT00662259|11533742|FG001|COMPLETED|Overall Study||11
10390788|NCT00662259|11533741|FG000|NOT COMPLETED|Overall Study||2
10390789|NCT00662259|11533742|FG001|NOT COMPLETED|Overall Study||0
10390790|NCT00662298|11533748|FG000|STARTED|Overall Study||5
10390791|NCT00662298|11533748|FG000|COMPLETED|Overall Study||5
10390792|NCT00662298|11533748|FG000|NOT COMPLETED|Overall Study||0
10390793|NCT00662311|11533755|FG000|STARTED|Overall Study||5
10390794|NCT00662311|11533756|FG001|STARTED|Overall Study||0
10390795|NCT00662311|11533757|FG002|STARTED|Overall Study||0
10390796|NCT00662311|11533755|FG000|COMPLETED|Overall Study||4
10390797|NCT00662311|11533756|FG001|COMPLETED|Overall Study||0
10390798|NCT00662311|11533757|FG002|COMPLETED|Overall Study||0
10390799|NCT00662311|11533755|FG000|NOT COMPLETED|Overall Study||1
10390800|NCT00662311|11533756|FG001|NOT COMPLETED|Overall Study||0
10390801|NCT00662311|11533757|FG002|NOT COMPLETED|Overall Study||0
10390802|NCT00662363|11533767|FG000|STARTED|Overall Study||32
10390803|NCT00662363|11533768|FG001|STARTED|Overall Study||32
10390804|NCT00662363|11533767|FG000|COMPLETED|Overall Study|1 subject withdrew before taking any study medication|21
10390805|NCT00662363|11533768|FG001|COMPLETED|Overall Study|one subject died before receiving any study med 2 subjects withdrew before taking any study med|22
10390806|NCT00662363|11533767|FG000|NOT COMPLETED|Overall Study||11
10390807|NCT00662363|11533768|FG001|NOT COMPLETED|Overall Study||10
10718788|NCT02706886|11882453|FG006|COMPLETED|Part A: SAD Period||0
10718789|NCT02706886|11882454|FG007|COMPLETED|Part A: SAD Period||0
10718790|NCT02706886|11882455|FG008|COMPLETED|Part A: SAD Period||0
10718791|NCT02706886|11882447|FG000|NOT COMPLETED|Part A: SAD Period||0
10718792|NCT02706886|11882448|FG001|NOT COMPLETED|Part A: SAD Period||0
10390808|NCT00662532|11533778|FG000|STARTED|Overall Study||22
10390809|NCT00662532|11533779|FG001|STARTED|Overall Study||22
10390810|NCT00662532|11533778|FG000|COMPLETED|Overall Study||22
10390811|NCT00662532|11533779|FG001|COMPLETED|Overall Study||20
10718793|NCT02706886|11882449|FG002|NOT COMPLETED|Part A: SAD Period||0
10390812|NCT00662532|11533778|FG000|NOT COMPLETED|Overall Study||0
10390813|NCT00662532|11533779|FG001|NOT COMPLETED|Overall Study||2
10390814|NCT00662545|11533787|FG000|STARTED|Overall Study||5
10390815|NCT00662545|11533788|FG001|STARTED|Overall Study||5
10390816|NCT00662545|11533787|FG000|COMPLETED|Overall Study||5
10390817|NCT00662545|11533788|FG001|COMPLETED|Overall Study||5
10390818|NCT00662545|11533787|FG000|NOT COMPLETED|Overall Study||0
10390819|NCT00662545|11533788|FG001|NOT COMPLETED|Overall Study||0
10390820|NCT00662558|11533796|FG000|STARTED|Overall Study||398
10390821|NCT00662558|11533797|FG001|STARTED|Overall Study||404
10307733|NCT00107744|11440715|FG001|STARTED|Intervention 1 (8 Weeks)||117
10307734|NCT00107744|11440716|FG002|STARTED|Intervention 1 (8 Weeks)||118
10307735|NCT00107744|11440714|FG000|COMPLETED|Intervention 1 (8 Weeks)||101
10307736|NCT00107744|11440715|FG001|COMPLETED|Intervention 1 (8 Weeks)||104
10307737|NCT00107744|11440716|FG002|COMPLETED|Intervention 1 (8 Weeks)||101
10307738|NCT00107744|11440714|FG000|NOT COMPLETED|Intervention 1 (8 Weeks)||16
10307739|NCT00107744|11440715|FG001|NOT COMPLETED|Intervention 1 (8 Weeks)||13
10307740|NCT00107744|11440716|FG002|NOT COMPLETED|Intervention 1 (8 Weeks)||17
10307741|NCT00107744|11440714|FG000|STARTED|Intervention 2 (8 Weeks)||101
10307742|NCT00107744|11440715|FG001|STARTED|Intervention 2 (8 Weeks)||104
10307743|NCT00107744|11440716|FG002|STARTED|Intervention 2 (8 Weeks)||101
10307744|NCT00107744|11440714|FG000|COMPLETED|Intervention 2 (8 Weeks)||93
10307745|NCT00107744|11440715|FG001|COMPLETED|Intervention 2 (8 Weeks)||92
10307746|NCT00107744|11440716|FG002|COMPLETED|Intervention 2 (8 Weeks)||88
10307747|NCT00107744|11440714|FG000|NOT COMPLETED|Intervention 2 (8 Weeks)||8
10307748|NCT00107744|11440715|FG001|NOT COMPLETED|Intervention 2 (8 Weeks)||12
10307749|NCT00107744|11440716|FG002|NOT COMPLETED|Intervention 2 (8 Weeks)||13
10307750|NCT00107744|11440714|FG000|STARTED|Intervention 3 (8 Weeks)||93
10307751|NCT00107744|11440715|FG001|STARTED|Intervention 3 (8 Weeks)||92
10307752|NCT00107744|11440716|FG002|STARTED|Intervention 3 (8 Weeks)||88
10307753|NCT00107744|11440714|FG000|COMPLETED|Intervention 3 (8 Weeks)||93
10307754|NCT00107744|11440715|FG001|COMPLETED|Intervention 3 (8 Weeks)||92
10307755|NCT00107744|11440716|FG002|COMPLETED|Intervention 3 (8 Weeks)||88
10307756|NCT00107744|11440714|FG000|NOT COMPLETED|Intervention 3 (8 Weeks)||0
10307757|NCT00107744|11440715|FG001|NOT COMPLETED|Intervention 3 (8 Weeks)||0
10307758|NCT00107744|11440716|FG002|NOT COMPLETED|Intervention 3 (8 Weeks)||0
10307759|NCT00107783|11440726|FG000|STARTED|Overall Study||20
10307760|NCT00107783|11440727|FG001|STARTED|Overall Study||20
10307761|NCT00107783|11440726|FG000|COMPLETED|Overall Study||17
10307762|NCT00107783|11440727|FG001|COMPLETED|Overall Study||16
10307763|NCT00107783|11440726|FG000|NOT COMPLETED|Overall Study||3
10307764|NCT00107783|11440727|FG001|NOT COMPLETED|Overall Study||4
10307765|NCT00107900|11440739|FG000|STARTED|Overall Study||85
10307766|NCT00107900|11440740|FG001|STARTED|Overall Study||75
10307767|NCT00107900|11440741|FG002|STARTED|Overall Study||129
10307768|NCT00107900|11440742|FG003|STARTED|Overall Study||99
10307769|NCT00107900|11440743|FG004|STARTED|Overall Study||115
10307770|NCT00107900|11440744|FG005|STARTED|Overall Study||103
10307771|NCT00107900|11440739|FG000|COMPLETED|Overall Study||75
10307772|NCT00107900|11440740|FG001|COMPLETED|Overall Study||72
10307773|NCT00107900|11440741|FG002|COMPLETED|Overall Study||104
10307774|NCT00107900|11440742|FG003|COMPLETED|Overall Study||87
10307775|NCT00107900|11440743|FG004|COMPLETED|Overall Study||94
10307776|NCT00107900|11440744|FG005|COMPLETED|Overall Study||94
10390822|NCT00662558|11533796|FG000|Received Treatment|Overall Study||396
10390823|NCT00662558|11533797|FG001|Received Treatment|Overall Study||396
10390824|NCT00662558|11533796|FG000|COMPLETED|Overall Study||342
10390825|NCT00662558|11533797|FG001|COMPLETED|Overall Study||294
10390826|NCT00662558|11533796|FG000|NOT COMPLETED|Overall Study||56
10390827|NCT00662558|11533797|FG001|NOT COMPLETED|Overall Study||110
10390828|NCT00662649|11533807|FG000|STARTED|Core Study (24 Months)||429
10390829|NCT00662649|11533808|FG001|STARTED|Core Study (24 Months)||425
10390830|NCT00662649|11533809|FG002|STARTED|Core Study (24 Months)||418
10390831|NCT00662649|11533810|FG003|STARTED|Core Study (24 Months)|This reporting group is used only in extension study.|0
10390832|NCT00662649|11533811|FG004|STARTED|Core Study (24 Months)|This reporting group is used only in extension study.|0
10718794|NCT02706886|11882450|FG003|NOT COMPLETED|Part A: SAD Period||2
10718795|NCT02706886|11882451|FG004|NOT COMPLETED|Part A: SAD Period||0
10718796|NCT02706886|11882452|FG005|NOT COMPLETED|Part A: SAD Period||0
10390833|NCT00662649|11533807|FG000|Intent to Treat (ITT)|Core Study (24 Months)||429
10542775|NCT01479465|11695926|FG000|NOT COMPLETED|Overall Study||11
10542776|NCT01479465|11695927|FG001|NOT COMPLETED|Overall Study||84
10718797|NCT02706886|11882453|FG006|NOT COMPLETED|Part A: SAD Period||0
10390834|NCT00662649|11533808|FG001|Intent to Treat (ITT)|Core Study (24 Months)||425
10390835|NCT00662649|11533809|FG002|Intent to Treat (ITT)|Core Study (24 Months)||418
10390836|NCT00662649|11533810|FG003|Intent to Treat (ITT)|Core Study (24 Months)||0
10390837|NCT00662649|11533811|FG004|Intent to Treat (ITT)|Core Study (24 Months)||0
10390838|NCT00662649|11533807|FG000|COMPLETED|Core Study (24 Months)||332
10390839|NCT00662649|11533808|FG001|COMPLETED|Core Study (24 Months)||369
10390840|NCT00662649|11533809|FG002|COMPLETED|Core Study (24 Months)||332
10390841|NCT00662649|11533810|FG003|COMPLETED|Core Study (24 Months)||0
10390842|NCT00662649|11533811|FG004|COMPLETED|Core Study (24 Months)||0
10390843|NCT00662649|11533807|FG000|NOT COMPLETED|Core Study (24 Months)||97
10390844|NCT00662649|11533808|FG001|NOT COMPLETED|Core Study (24 Months)||56
10390845|NCT00662649|11533809|FG002|NOT COMPLETED|Core Study (24 Months)||86
10390846|NCT00662649|11533810|FG003|NOT COMPLETED|Core Study (24 Months)||0
10390847|NCT00662649|11533811|FG004|NOT COMPLETED|Core Study (24 Months)||0
10390848|NCT00662649|11533807|FG000|STARTED|Extension Study (Month 24 to 60)||289
10390849|NCT00662649|11533808|FG001|STARTED|Extension Study (Month 24 to 60)||331
10390850|NCT00662649|11533809|FG002|STARTED|Extension Study (Month 24 to 60)|This reporting group is used only for core study|0
10390851|NCT00662649|11533810|FG003|STARTED|Extension Study (Month 24 to 60)||145
10390852|NCT00662649|11533811|FG004|STARTED|Extension Study (Month 24 to 60)||155
10390853|NCT00662649|11533807|FG000|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||287
10390854|NCT00662649|11533808|FG001|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||330
10390855|NCT00662649|11533809|FG002|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||0
10390856|NCT00662649|11533810|FG003|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||145
10390857|NCT00662649|11533811|FG004|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||154
10390858|NCT00662649|11533807|FG000|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||289
10390859|NCT00662649|11533808|FG001|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||331
10718798|NCT02706886|11882454|FG007|NOT COMPLETED|Part A: SAD Period||0
10718799|NCT02706886|11882455|FG008|NOT COMPLETED|Part A: SAD Period||0
10718800|NCT02706886|11882447|FG000|STARTED|Part B: MAD Study Days 1-85||0
10718801|NCT02706886|11882448|FG001|STARTED|Part B: MAD Study Days 1-85||0
10718802|NCT02706886|11882449|FG002|STARTED|Part B: MAD Study Days 1-85||0
10390860|NCT00662649|11533809|FG002|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||0
10390861|NCT00662649|11533810|FG003|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||145
10390862|NCT00662649|11533811|FG004|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||155
10390863|NCT00662649|11533807|FG000|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||276
10390864|NCT00662649|11533808|FG001|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||324
10390865|NCT00662649|11533809|FG002|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||0
10390866|NCT00662649|11533810|FG003|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||136
10390867|NCT00662649|11533811|FG004|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||152
10390868|NCT00662649|11533807|FG000|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||270
10390869|NCT00662649|11533808|FG001|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||311
10390870|NCT00662649|11533809|FG002|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||0
10390871|NCT00662649|11533810|FG003|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||130
10390872|NCT00662649|11533811|FG004|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||145
10390873|NCT00662649|11533807|FG000|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||254
10542777|NCT01479465|11695928|FG002|NOT COMPLETED|Overall Study||86
10307777|NCT00107900|11440739|FG000|NOT COMPLETED|Overall Study||10
10307778|NCT00107900|11440740|FG001|NOT COMPLETED|Overall Study||3
10307779|NCT00107900|11440741|FG002|NOT COMPLETED|Overall Study||25
10307780|NCT00107900|11440742|FG003|NOT COMPLETED|Overall Study||12
10307781|NCT00107900|11440743|FG004|NOT COMPLETED|Overall Study||21
10307782|NCT00107900|11440744|FG005|NOT COMPLETED|Overall Study||9
10307783|NCT00107952|11440760|FG000|STARTED|Overall Study||381
10307784|NCT00107952|11440761|FG001|STARTED|Overall Study||380
10307785|NCT00107952|11440760|FG000|COMPLETED|Overall Study||286
10307786|NCT00107952|11440761|FG001|COMPLETED|Overall Study||299
10307787|NCT00107952|11440760|FG000|NOT COMPLETED|Overall Study||95
10307788|NCT00107952|11440761|FG001|NOT COMPLETED|Overall Study||81
10307789|NCT00107978|11440769|FG000|STARTED|Overall Study||458
10307790|NCT00107978|11440770|FG001|STARTED|Overall Study||481
10307791|NCT00107978|11440769|FG000|COMPLETED|Overall Study||425
10307792|NCT00107978|11440770|FG001|COMPLETED|Overall Study||431
10307793|NCT00107978|11440769|FG000|NOT COMPLETED|Overall Study||33
10307794|NCT00107978|11440770|FG001|NOT COMPLETED|Overall Study||50
10307795|NCT00107991|11440776|FG000|STARTED|Eligibility Assessment||38
10307796|NCT00107991|11440776|FG000|COMPLETED|Eligibility Assessment||15
10307797|NCT00107991|11440776|FG000|NOT COMPLETED|Eligibility Assessment||23
10307798|NCT00107991|11440776|FG000|STARTED|12 Week Treatment Period||15
10307799|NCT00107991|11440776|FG000|COMPLETED|12 Week Treatment Period||10
10307800|NCT00107991|11440776|FG000|NOT COMPLETED|12 Week Treatment Period||5
10307801|NCT00107991|11440776|FG000|STARTED|18-Week Post Treatment Assessment||10
10307802|NCT00107991|11440776|FG000|COMPLETED|18-Week Post Treatment Assessment||8
10307803|NCT00107991|11440776|FG000|NOT COMPLETED|18-Week Post Treatment Assessment||2
10307804|NCT00108069|11440782|FG000|STARTED|Overall Study||30
10718803|NCT02706886|11882450|FG003|STARTED|Part B: MAD Study Days 1-85||0
10718804|NCT02706886|11882451|FG004|STARTED|Part B: MAD Study Days 1-85||0
10718805|NCT02706886|11882452|FG005|STARTED|Part B: MAD Study Days 1-85||3
10307805|NCT00108069|11440783|FG001|STARTED|Overall Study||13
10307806|NCT00108069|11440782|FG000|COMPLETED|Overall Study||0
10307807|NCT00108069|11440783|FG001|COMPLETED|Overall Study||0
10307808|NCT00108069|11440782|FG000|NOT COMPLETED|Overall Study||30
10307809|NCT00108069|11440783|FG001|NOT COMPLETED|Overall Study||13
10307810|NCT00108082|11440798|FG000|STARTED|Overall Study||91
10307811|NCT00108082|11440799|FG001|STARTED|Overall Study||100
10307812|NCT00108082|11440800|FG002|STARTED|Overall Study||96
10307813|NCT00108082|11440798|FG000|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|53
10307814|NCT00108082|11440799|FG001|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|68
10307815|NCT00108082|11440800|FG002|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|53
10307816|NCT00108082|11440798|FG000|NOT COMPLETED|Overall Study||38
10307817|NCT00108082|11440799|FG001|NOT COMPLETED|Overall Study||32
10307818|NCT00108082|11440800|FG002|NOT COMPLETED|Overall Study||43
10307819|NCT00108160|11440810|FG000|STARTED|Overall Study||83
10307820|NCT00108160|11440811|FG001|STARTED|Overall Study||63
10307821|NCT00108160|11440810|FG000|Completed Visit 0 (Baseline)|Overall Study|4 patients who signed consent and were randomized did not complete the initial visit to start drug|79
10307822|NCT00108160|11440811|FG001|Completed Visit 0 (Baseline)|Overall Study|3 patients who signed a consent and were randomized did not complete the initial visit to start drug|60
10307823|NCT00108160|11440810|FG000|Completed Visit 1 (2 Wks)|Overall Study||72
10307824|NCT00108160|11440811|FG001|Completed Visit 1 (2 Wks)|Overall Study||54
10307825|NCT00108160|11440810|FG000|Completed Visit 2 (3 mo)|Overall Study||54
10307826|NCT00108160|11440811|FG001|Completed Visit 2 (3 mo)|Overall Study||46
10307827|NCT00108160|11440810|FG000|Completed Visit 3 (6 mo)|Overall Study||44
10307828|NCT00108160|11440811|FG001|Completed Visit 3 (6 mo)|Overall Study||38
10307829|NCT00108160|11440810|FG000|Completed Visit 4 (9 mo)|Overall Study||38
10307830|NCT00108160|11440811|FG001|Completed Visit 4 (9 mo)|Overall Study||37
10307831|NCT00108160|11440810|FG000|Completed Visit 5 (12 mo)|Overall Study||37
10307832|NCT00108160|11440811|FG001|Completed Visit 5 (12 mo)|Overall Study||37
10307833|NCT00108160|11440810|FG000|Completed Visit 6 (15 mo)|Overall Study||36
10307834|NCT00108160|11440811|FG001|Completed Visit 6 (15 mo)|Overall Study||33
10307835|NCT00108160|11440810|FG000|Completed Visit 7 (18 mo)|Overall Study||34
10307836|NCT00108160|11440811|FG001|Completed Visit 7 (18 mo)|Overall Study||31
10307837|NCT00108160|11440810|FG000|COMPLETED|Overall Study|Patients who completed 18 months of mupirocin or developed new (recurrent) S. aureus infection.|44
10307838|NCT00108160|11440811|FG001|COMPLETED|Overall Study|Participants who completed 18 months of placebo or developed new (recurrent) S. aureus infection.|42
10307839|NCT00108160|11440810|FG000|NOT COMPLETED|Overall Study||39
10307840|NCT00108160|11440811|FG001|NOT COMPLETED|Overall Study||21
10307841|NCT00108277|11440822|FG000|STARTED|Overall Study||29
10307842|NCT00108277|11440823|FG001|STARTED|Overall Study||28
10307843|NCT00108277|11440824|FG002|STARTED|Overall Study||35
10307844|NCT00108277|11440822|FG000|COMPLETED|Overall Study||19
10718806|NCT02706886|11882453|FG006|STARTED|Part B: MAD Study Days 1-85||7
10718807|NCT02706886|11882454|FG007|STARTED|Part B: MAD Study Days 1-85||7
10718808|NCT02706886|11882455|FG008|STARTED|Part B: MAD Study Days 1-85||3
10718809|NCT02706886|11882447|FG000|COMPLETED|Part B: MAD Study Days 1-85||0
10718810|NCT02706886|11882448|FG001|COMPLETED|Part B: MAD Study Days 1-85||0
10718811|NCT02706886|11882449|FG002|COMPLETED|Part B: MAD Study Days 1-85||0
10718812|NCT02706886|11882450|FG003|COMPLETED|Part B: MAD Study Days 1-85||0
10718813|NCT02706886|11882451|FG004|COMPLETED|Part B: MAD Study Days 1-85||0
10718814|NCT02706886|11882452|FG005|COMPLETED|Part B: MAD Study Days 1-85||3
10390874|NCT00662649|11533808|FG001|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||301
10390875|NCT00662649|11533809|FG002|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||0
10390876|NCT00662649|11533810|FG003|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||120
10390877|NCT00662649|11533811|FG004|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||136
10390878|NCT00662649|11533807|FG000|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||125
10390879|NCT00662649|11533808|FG001|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||152
10390880|NCT00662649|11533809|FG002|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||0
10390881|NCT00662649|11533810|FG003|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||58
10390882|NCT00662649|11533811|FG004|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||67
10390883|NCT00662649|11533807|FG000|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||31
10390884|NCT00662649|11533808|FG001|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||32
10390885|NCT00662649|11533809|FG002|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||0
10390886|NCT00662649|11533810|FG003|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||11
10390887|NCT00662649|11533811|FG004|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||13
10390888|NCT00662649|11533807|FG000|COMPLETED|Extension Study (Month 24 to 60)|"completed refers to patients that completed extension study in different time points."|245
10390889|NCT00662649|11533808|FG001|COMPLETED|Extension Study (Month 24 to 60)||290
10390890|NCT00662649|11533809|FG002|COMPLETED|Extension Study (Month 24 to 60)||0
10390891|NCT00662649|11533810|FG003|COMPLETED|Extension Study (Month 24 to 60)||112
10390892|NCT00662649|11533811|FG004|COMPLETED|Extension Study (Month 24 to 60)||126
10390893|NCT00662649|11533807|FG000|NOT COMPLETED|Extension Study (Month 24 to 60)||44
10390894|NCT00662649|11533808|FG001|NOT COMPLETED|Extension Study (Month 24 to 60)||41
10390895|NCT00662649|11533809|FG002|NOT COMPLETED|Extension Study (Month 24 to 60)||0
10390896|NCT00662649|11533810|FG003|NOT COMPLETED|Extension Study (Month 24 to 60)||33
10390897|NCT00662649|11533811|FG004|NOT COMPLETED|Extension Study (Month 24 to 60)||29
10390898|NCT00662675|11533827|FG000|STARTED|Overall Study||20
10390899|NCT00662675|11533828|FG001|STARTED|Overall Study||20
10390900|NCT00662675|11533827|FG000|COMPLETED|Overall Study||20
10390901|NCT00662675|11533828|FG001|COMPLETED|Overall Study||20
10390902|NCT00662675|11533827|FG000|NOT COMPLETED|Overall Study||0
10390903|NCT00662675|11533828|FG001|NOT COMPLETED|Overall Study||0
10390904|NCT00662818|11533836|FG000|STARTED|Period 1 (6 Weeks)||84
10390905|NCT00662818|11533837|FG001|STARTED|Period 1 (6 Weeks)||81
10390906|NCT00662818|11533836|FG000|Treated|Period 1 (6 Weeks)||56
10390907|NCT00662818|11533837|FG001|Treated|Period 1 (6 Weeks)||58
10390908|NCT00662818|11533836|FG000|COMPLETED|Period 1 (6 Weeks)||56
10390909|NCT00662818|11533837|FG001|COMPLETED|Period 1 (6 Weeks)||58
10390910|NCT00662818|11533836|FG000|NOT COMPLETED|Period 1 (6 Weeks)||28
10390911|NCT00662818|11533837|FG001|NOT COMPLETED|Period 1 (6 Weeks)||23
10390912|NCT00662818|11533836|FG000|STARTED|Wash-Out (14 Days)||56
10307845|NCT00108277|11440823|FG001|COMPLETED|Overall Study||16
10307846|NCT00108277|11440824|FG002|COMPLETED|Overall Study||19
10307847|NCT00108277|11440822|FG000|NOT COMPLETED|Overall Study||10
10307848|NCT00108277|11440823|FG001|NOT COMPLETED|Overall Study||12
10307849|NCT00108277|11440824|FG002|NOT COMPLETED|Overall Study||16
10307850|NCT00108303|11440835|FG000|STARTED|Overall Study||179
10307851|NCT00108303|11440836|FG001|STARTED|Overall Study||179
10307852|NCT00108303|11440837|FG002|STARTED|Overall Study||180
10307853|NCT00108303|11440835|FG000|COMPLETED|Overall Study||179
10307854|NCT00108303|11440836|FG001|COMPLETED|Overall Study||179
10307855|NCT00108303|11440837|FG002|COMPLETED|Overall Study||180
10307856|NCT00108303|11440835|FG000|NOT COMPLETED|Overall Study||0
10307857|NCT00108303|11440836|FG001|NOT COMPLETED|Overall Study||0
10307858|NCT00108303|11440837|FG002|NOT COMPLETED|Overall Study||0
10307859|NCT00108355|11440851|FG000|STARTED|Overall Study|Two patients met inclusion criteria not randomized, one had peritonitis , other loculated ascites.|15
10307860|NCT00108355|11440852|FG001|STARTED|Overall Study|Two patients met inclusion criteria not randomized, one had peritonitis, other loculated ascites.|14
10307861|NCT00108355|11440851|FG000|COMPLETED|Overall Study||13
10307862|NCT00108355|11440852|FG001|COMPLETED|Overall Study||12
10307863|NCT00108355|11440851|FG000|NOT COMPLETED|Overall Study||2
10307864|NCT00108355|11440852|FG001|NOT COMPLETED|Overall Study||2
10307865|NCT00108485|11440860|FG000|STARTED|Overall Study||5
10307866|NCT00108485|11440861|FG001|STARTED|Overall Study||4
10307867|NCT00108485|11440860|FG000|COMPLETED|Overall Study||2
10307868|NCT00108485|11440861|FG001|COMPLETED|Overall Study||2
10307869|NCT00108485|11440860|FG000|NOT COMPLETED|Overall Study||3
10307870|NCT00108485|11440861|FG001|NOT COMPLETED|Overall Study||2
10307871|NCT00108524|11440869|FG000|STARTED|Overall Study||81
10307872|NCT00108524|11440870|FG001|STARTED|Overall Study||79
10307873|NCT00108524|11440869|FG000|COMPLETED|Overall Study||52
10307874|NCT00108524|11440870|FG001|COMPLETED|Overall Study||61
10307875|NCT00108524|11440869|FG000|NOT COMPLETED|Overall Study||29
10307876|NCT00108524|11440870|FG001|NOT COMPLETED|Overall Study||18
10307877|NCT00108550|11440878|FG000|STARTED|Overall Study||55
10307878|NCT00108550|11440879|FG001|STARTED|Overall Study||53
10307879|NCT00108550|11440878|FG000|COMPLETED|Overall Study||39
10307880|NCT00108550|11440879|FG001|COMPLETED|Overall Study||37
10307881|NCT00108550|11440878|FG000|NOT COMPLETED|Overall Study||16
10307882|NCT00108550|11440879|FG001|NOT COMPLETED|Overall Study||16
10307883|NCT00108628|11440887|FG000|STARTED|Overall Study||61
10307884|NCT00108628|11440888|FG001|STARTED|Overall Study||63
10307885|NCT00108628|11440887|FG000|Received One or More Sessions|Overall Study||53
10307886|NCT00108628|11440888|FG001|Received One or More Sessions|Overall Study||58
10307887|NCT00108628|11440887|FG000|Completed Treatment|Overall Study||42
10307888|NCT00108628|11440888|FG001|Completed Treatment|Overall Study||57
10307889|NCT00108628|11440887|FG000|COMPLETED|Overall Study||41
10307890|NCT00108628|11440888|FG001|COMPLETED|Overall Study||53
10307891|NCT00108628|11440887|FG000|NOT COMPLETED|Overall Study||20
10307892|NCT00108628|11440888|FG001|NOT COMPLETED|Overall Study||10
10307893|NCT00108732|11440894|FG000|STARTED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||50
10307894|NCT00108732|11440894|FG000|Eligible and Treated|Step 1 (Vaccinia/Fowlpox/GM-CSF)||40
10307895|NCT00108732|11440894|FG000|COMPLETED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||36
10307896|NCT00108732|11440894|FG000|NOT COMPLETED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||14
10307897|NCT00108732|11440894|FG000|STARTED|Step 2 (Androgen Ablation and Vaccine)||31
10390913|NCT00662818|11533837|FG001|STARTED|Wash-Out (14 Days)||58
10390914|NCT00662818|11533836|FG000|COMPLETED|Wash-Out (14 Days)||51
10390915|NCT00662818|11533837|FG001|COMPLETED|Wash-Out (14 Days)||53
10390916|NCT00662818|11533836|FG000|NOT COMPLETED|Wash-Out (14 Days)||5
10390917|NCT00662818|11533837|FG001|NOT COMPLETED|Wash-Out (14 Days)||5
10390918|NCT00662818|11533836|FG000|STARTED|Period 2 (6 Weeks)||51
10390919|NCT00662818|11533837|FG001|STARTED|Period 2 (6 Weeks)||53
10542778|NCT01479465|11695929|FG003|NOT COMPLETED|Overall Study||85
10542779|NCT01479478|11695941|FG000|STARTED|Overall Study||125
10542780|NCT01479478|11695942|FG001|STARTED|Overall Study||126
10542781|NCT01479478|11695941|FG000|COMPLETED|Overall Study||125
10542782|NCT01479478|11695942|FG001|COMPLETED|Overall Study||126
10542783|NCT01479478|11695941|FG000|NOT COMPLETED|Overall Study||0
10542784|NCT01479478|11695942|FG001|NOT COMPLETED|Overall Study||0
10542785|NCT01479517|11695951|FG000|STARTED|Overall Study||10
10542786|NCT01479517|11695952|FG001|STARTED|Overall Study||10
10542787|NCT01479517|11695953|FG002|STARTED|Overall Study||10
10542788|NCT01479517|11695951|FG000|COMPLETED|Overall Study||10
10542789|NCT01479517|11695952|FG001|COMPLETED|Overall Study||10
10542790|NCT01479517|11695953|FG002|COMPLETED|Overall Study||10
10542791|NCT01479517|11695951|FG000|NOT COMPLETED|Overall Study||0
10542792|NCT01479517|11695952|FG001|NOT COMPLETED|Overall Study||0
10542793|NCT01479517|11695953|FG002|NOT COMPLETED|Overall Study||0
10542794|NCT01479530|11695963|FG000|STARTED|Overall Study||158
10542795|NCT01479530|11695964|FG001|STARTED|Overall Study||163
10542796|NCT01479530|11695963|FG000|COMPLETED|Overall Study||148
10542797|NCT01479530|11695964|FG001|COMPLETED|Overall Study||151
10542798|NCT01479530|11695963|FG000|NOT COMPLETED|Overall Study||10
10658571|NCT02233946|11819757|FG001|STARTED|3-months Follow-up||243
10542799|NCT01479530|11695964|FG001|NOT COMPLETED|Overall Study||12
10542800|NCT01479543|11695975|FG000|STARTED|Overall Study||21
10542801|NCT01479543|11695976|FG001|STARTED|Overall Study||20
10542802|NCT01479543|11695977|FG002|STARTED|Overall Study||21
10542803|NCT01479543|11695978|FG003|STARTED|Overall Study||20
10542804|NCT01479543|11695979|FG004|STARTED|Overall Study||21
10542805|NCT01479543|11695975|FG000|COMPLETED|Overall Study||20
10542806|NCT01479543|11695976|FG001|COMPLETED|Overall Study||20
10542807|NCT01479543|11695977|FG002|COMPLETED|Overall Study||20
10542808|NCT01479543|11695978|FG003|COMPLETED|Overall Study||20
10542809|NCT01479543|11695979|FG004|COMPLETED|Overall Study||20
10542810|NCT01479543|11695975|FG000|NOT COMPLETED|Overall Study||1
10542811|NCT01479543|11695976|FG001|NOT COMPLETED|Overall Study||0
10542812|NCT01479543|11695977|FG002|NOT COMPLETED|Overall Study||1
10542813|NCT01479543|11695978|FG003|NOT COMPLETED|Overall Study||0
10542814|NCT01479543|11695979|FG004|NOT COMPLETED|Overall Study||1
10542815|NCT01479595|11695993|FG000|STARTED|Overall Study||44
10658572|NCT02233946|11819756|FG000|COMPLETED|3-months Follow-up||571
10812854|NCT03217175|11975053|FG000|NOT COMPLETED|Overall Study||4
10812855|NCT03217175|11975054|FG001|NOT COMPLETED|Overall Study||1
10812856|NCT03231397|11975064|FG000|STARTED|Overall Study||0
10812857|NCT03231397|11975065|FG001|STARTED|Overall Study||1
10812858|NCT03231397|11975066|FG002|STARTED|Overall Study||1
10812859|NCT03231397|11975067|FG003|STARTED|Overall Study||0
10390920|NCT00662818|11533836|FG000|COMPLETED|Period 2 (6 Weeks)||38
10390921|NCT00662818|11533837|FG001|COMPLETED|Period 2 (6 Weeks)||41
10390922|NCT00662818|11533836|FG000|NOT COMPLETED|Period 2 (6 Weeks)||13
10390923|NCT00662818|11533837|FG001|NOT COMPLETED|Period 2 (6 Weeks)||12
10390924|NCT00662831|11533847|FG000|STARTED|Overall Study||184
10390925|NCT00662831|11533848|FG001|STARTED|Overall Study||92
10390926|NCT00662831|11533847|FG000|COMPLETED|Overall Study||78
10390927|NCT00662831|11533848|FG001|COMPLETED|Overall Study||33
10390928|NCT00662831|11533847|FG000|NOT COMPLETED|Overall Study||106
10390929|NCT00662831|11533848|FG001|NOT COMPLETED|Overall Study||59
10390930|NCT00662857|11533854|FG000|STARTED|TI Dosing Period 1 (1 Day)||13
10390931|NCT00662857|11533855|FG001|STARTED|TI Dosing Period 1 (1 Day)||16
10390932|NCT00662857|11533854|FG000|COMPLETED|TI Dosing Period 1 (1 Day)||13
10390933|NCT00662857|11533855|FG001|COMPLETED|TI Dosing Period 1 (1 Day)||16
10390934|NCT00662857|11533854|FG000|NOT COMPLETED|TI Dosing Period 1 (1 Day)||0
10390935|NCT00662857|11533855|FG001|NOT COMPLETED|TI Dosing Period 1 (1 Day)||0
10390936|NCT00662857|11533854|FG000|STARTED|Washout 1 (3 - 14 Days)||13
10390937|NCT00662857|11533855|FG001|STARTED|Washout 1 (3 - 14 Days)||16
10390938|NCT00662857|11533854|FG000|COMPLETED|Washout 1 (3 - 14 Days)||13
10390939|NCT00662857|11533855|FG001|COMPLETED|Washout 1 (3 - 14 Days)||14
10390940|NCT00662857|11533854|FG000|NOT COMPLETED|Washout 1 (3 - 14 Days)||0
10542816|NCT01479595|11695994|FG001|STARTED|Overall Study||21
10542817|NCT01479595|11695993|FG000|PK Analysis Set|Overall Study||42
10542818|NCT01479595|11695994|FG001|PK Analysis Set|Overall Study||0
10390941|NCT00662857|11533855|FG001|NOT COMPLETED|Washout 1 (3 - 14 Days)||2
10307898|NCT00108732|11440894|FG000|COMPLETED|Step 2 (Androgen Ablation and Vaccine)||26
10307899|NCT00108732|11440894|FG000|NOT COMPLETED|Step 2 (Androgen Ablation and Vaccine)||5
10307900|NCT00108745|11440901|FG000|STARTED|Overall Study||387
10307901|NCT00108745|11440902|FG001|STARTED|Overall Study||384
10307902|NCT00108745|11440903|FG002|STARTED|Overall Study||386
10307903|NCT00108745|11440901|FG000|COMPLETED|Overall Study||353
10307904|NCT00108745|11440902|FG001|COMPLETED|Overall Study||349
10307905|NCT00108745|11440903|FG002|COMPLETED|Overall Study||349
10307906|NCT00108745|11440901|FG000|NOT COMPLETED|Overall Study||34
10307907|NCT00108745|11440902|FG001|NOT COMPLETED|Overall Study||35
10307908|NCT00108745|11440903|FG002|NOT COMPLETED|Overall Study||37
10307909|NCT00108862|11440913|FG000|STARTED|Overall Study||405
10307910|NCT00108862|11440914|FG001|STARTED|Overall Study|Three participants who were deemed clinically ineligible and taken off study were omitted.|401
10307911|NCT00108862|11440913|FG000|COMPLETED|Overall Study||337
10307912|NCT00108862|11440914|FG001|COMPLETED|Overall Study||339
10307913|NCT00108862|11440913|FG000|NOT COMPLETED|Overall Study||68
10307914|NCT00108862|11440914|FG001|NOT COMPLETED|Overall Study||62
10307915|NCT00108953|11440922|FG000|STARTED|Treatment Period|ITT population|47
10307916|NCT00108953|11440923|FG001|STARTED|Treatment Period|ITT population|49
10307917|NCT00108953|11440922|FG000|COMPLETED|Treatment Period|No patient under study medication anymore|47
10307918|NCT00108953|11440923|FG001|COMPLETED|Treatment Period|No patient under study medication anymore|49
10307919|NCT00108953|11440922|FG000|NOT COMPLETED|Treatment Period||0
10307920|NCT00108953|11440923|FG001|NOT COMPLETED|Treatment Period||0
10307921|NCT00108953|11440922|FG000|STARTED|Follow-up|40 out of 47 patients were followed after end of double blind treatment|40
10307922|NCT00108953|11440923|FG001|STARTED|Follow-up|45 out of 49 patients were followed after end of double blind treatment|45
10307923|NCT00108953|11440922|FG000|COMPLETED|Follow-up||11
10307924|NCT00108953|11440923|FG001|COMPLETED|Follow-up||12
10307925|NCT00108953|11440922|FG000|NOT COMPLETED|Follow-up||29
10307926|NCT00108953|11440923|FG001|NOT COMPLETED|Follow-up||33
10307927|NCT00109005|11440933|FG000|STARTED|Overall Study||8
10718815|NCT02706886|11882453|FG006|COMPLETED|Part B: MAD Study Days 1-85||7
10718816|NCT02706886|11882454|FG007|COMPLETED|Part B: MAD Study Days 1-85||7
10718817|NCT02706886|11882455|FG008|COMPLETED|Part B: MAD Study Days 1-85||3
10718818|NCT02706886|11882447|FG000|NOT COMPLETED|Part B: MAD Study Days 1-85||0
10718819|NCT02706886|11882448|FG001|NOT COMPLETED|Part B: MAD Study Days 1-85||0
10718820|NCT02706886|11882449|FG002|NOT COMPLETED|Part B: MAD Study Days 1-85||0
10718821|NCT02706886|11882450|FG003|NOT COMPLETED|Part B: MAD Study Days 1-85||0
10718822|NCT02706886|11882451|FG004|NOT COMPLETED|Part B: MAD Study Days 1-85||0
10718823|NCT02706886|11882452|FG005|NOT COMPLETED|Part B: MAD Study Days 1-85||0
10718824|NCT02706886|11882453|FG006|NOT COMPLETED|Part B: MAD Study Days 1-85||0
10718825|NCT02706886|11882454|FG007|NOT COMPLETED|Part B: MAD Study Days 1-85||0
10718826|NCT02706886|11882455|FG008|NOT COMPLETED|Part B: MAD Study Days 1-85||0
10718827|NCT02706886|11882447|FG000|STARTED|Part B: MAD Study Day 85-End of Study||0
10718828|NCT02706886|11882448|FG001|STARTED|Part B: MAD Study Day 85-End of Study||0
10718829|NCT02706886|11882449|FG002|STARTED|Part B: MAD Study Day 85-End of Study||0
10718830|NCT02706886|11882450|FG003|STARTED|Part B: MAD Study Day 85-End of Study||0
10718831|NCT02706886|11882451|FG004|STARTED|Part B: MAD Study Day 85-End of Study||0
10718832|NCT02706886|11882452|FG005|STARTED|Part B: MAD Study Day 85-End of Study||0
10718833|NCT02706886|11882453|FG006|STARTED|Part B: MAD Study Day 85-End of Study|One participant from the Part B: MAD: Placebo arm crossed over to this lumasiran arm.|8
10718834|NCT02706886|11882454|FG007|STARTED|Part B: MAD Study Day 85-End of Study|One participant from the Part B: MAD: Placebo arm crossed over to this lumasiran arm.|8
10718835|NCT02706886|11882455|FG008|STARTED|Part B: MAD Study Day 85-End of Study|One participant from the Part B: MAD: Placebo arm crossed over to this lumasiran arm.|4
10718836|NCT02706886|11882447|FG000|COMPLETED|Part B: MAD Study Day 85-End of Study||0
10718837|NCT02706886|11882448|FG001|COMPLETED|Part B: MAD Study Day 85-End of Study||0
10390942|NCT00662857|11533854|FG000|STARTED|TI Dosing Period 2 (1 Day)||13
10390943|NCT00662857|11533855|FG001|STARTED|TI Dosing Period 2 (1 Day)||14
10390944|NCT00662857|11533854|FG000|COMPLETED|TI Dosing Period 2 (1 Day)||13
10390945|NCT00662857|11533855|FG001|COMPLETED|TI Dosing Period 2 (1 Day)||14
10390946|NCT00662857|11533854|FG000|NOT COMPLETED|TI Dosing Period 2 (1 Day)||0
10390947|NCT00662857|11533855|FG001|NOT COMPLETED|TI Dosing Period 2 (1 Day)||0
10390948|NCT00662857|11533854|FG000|STARTED|Washout 2 (3 - 14 Days)||13
10390949|NCT00662857|11533855|FG001|STARTED|Washout 2 (3 - 14 Days)||14
10390950|NCT00662857|11533854|FG000|COMPLETED|Washout 2 (3 - 14 Days)||12
10390951|NCT00662857|11533855|FG001|COMPLETED|Washout 2 (3 - 14 Days)||14
10390952|NCT00662857|11533854|FG000|NOT COMPLETED|Washout 2 (3 - 14 Days)||1
10390953|NCT00662857|11533855|FG001|NOT COMPLETED|Washout 2 (3 - 14 Days)||0
10390954|NCT00662857|11533854|FG000|STARTED|Lispro Dosing Period (1 Day)||12
10542819|NCT01479595|11695993|FG000|Per Protocol Analysis Set|Overall Study||41
10542820|NCT01479595|11695994|FG001|Per Protocol Analysis Set|Overall Study||20
10542821|NCT01479595|11695993|FG000|COMPLETED|Overall Study||42
10542822|NCT01479595|11695994|FG001|COMPLETED|Overall Study||19
10812860|NCT03231397|11975064|FG000|COMPLETED|Overall Study||0
10812861|NCT03231397|11975065|FG001|COMPLETED|Overall Study||1
10812862|NCT03231397|11975066|FG002|COMPLETED|Overall Study||1
10812863|NCT03231397|11975067|FG003|COMPLETED|Overall Study||0
10812864|NCT03231397|11975064|FG000|NOT COMPLETED|Overall Study||0
10812865|NCT03231397|11975065|FG001|NOT COMPLETED|Overall Study||0
10812866|NCT03231397|11975066|FG002|NOT COMPLETED|Overall Study||0
10390955|NCT00662857|11533855|FG001|STARTED|Lispro Dosing Period (1 Day)||14
10390956|NCT00662857|11533854|FG000|COMPLETED|Lispro Dosing Period (1 Day)||12
10390957|NCT00662857|11533855|FG001|COMPLETED|Lispro Dosing Period (1 Day)||14
10390958|NCT00662857|11533854|FG000|NOT COMPLETED|Lispro Dosing Period (1 Day)||0
10390959|NCT00662857|11533855|FG001|NOT COMPLETED|Lispro Dosing Period (1 Day)||0
10390960|NCT00662909|11533867|FG000|STARTED|Overall Study||454
10390961|NCT00662909|11533868|FG001|STARTED|Overall Study||442
10390962|NCT00662909|11533869|FG002|STARTED|Overall Study||433
10390963|NCT00662909|11533867|FG000|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|453
10390964|NCT00662909|11533868|FG001|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|442
10390965|NCT00662909|11533869|FG002|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|433
10390966|NCT00662909|11533867|FG000|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|433
10390967|NCT00662909|11533868|FG001|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|425
10390968|NCT00662909|11533869|FG002|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|412
10428541|NCT00858689|11574580|FG000|STARTED|Overall Study||20
10428542|NCT00858689|11574580|FG000|COMPLETED|Overall Study||19
10428543|NCT00858689|11574580|FG000|NOT COMPLETED|Overall Study||1
10428544|NCT00858780|11574584|FG000|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||91
10718838|NCT02706886|11882449|FG002|COMPLETED|Part B: MAD Study Day 85-End of Study||0
10718839|NCT02706886|11882450|FG003|COMPLETED|Part B: MAD Study Day 85-End of Study||0
10718840|NCT02706886|11882451|FG004|COMPLETED|Part B: MAD Study Day 85-End of Study||0
10718841|NCT02706886|11882452|FG005|COMPLETED|Part B: MAD Study Day 85-End of Study||0
10718842|NCT02706886|11882453|FG006|COMPLETED|Part B: MAD Study Day 85-End of Study||8
10812867|NCT03231397|11975067|FG003|NOT COMPLETED|Overall Study||0
10812868|NCT03232892|11975077|FG000|STARTED|Overall Study||1
10812869|NCT03232892|11975077|FG000|COMPLETED|Overall Study||1
10812870|NCT03232892|11975077|FG000|NOT COMPLETED|Overall Study||0
10812871|NCT03223662|11975081|FG000|STARTED|Overall Study||2
10812872|NCT03223662|11975081|FG000|COMPLETED|Overall Study||0
10718843|NCT02706886|11882454|FG007|COMPLETED|Part B: MAD Study Day 85-End of Study||8
10718844|NCT02706886|11882455|FG008|COMPLETED|Part B: MAD Study Day 85-End of Study||4
10718845|NCT02706886|11882447|FG000|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
10718846|NCT02706886|11882448|FG001|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
10812873|NCT03223662|11975081|FG000|NOT COMPLETED|Overall Study||2
10718847|NCT02706886|11882449|FG002|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
10812874|NCT03212144|11975087|FG000|STARTED|First Sequence (4 Weeks)||2
10812875|NCT03212144|11975088|FG001|STARTED|First Sequence (4 Weeks)||1
10812876|NCT03212144|11975087|FG000|COMPLETED|First Sequence (4 Weeks)||1
10812877|NCT03212144|11975088|FG001|COMPLETED|First Sequence (4 Weeks)||1
10812878|NCT03212144|11975087|FG000|NOT COMPLETED|First Sequence (4 Weeks)||1
10812879|NCT03212144|11975088|FG001|NOT COMPLETED|First Sequence (4 Weeks)||0
10812880|NCT03212144|11975087|FG000|STARTED|Washout (4 Weeks)||1
10812881|NCT03212144|11975088|FG001|STARTED|Washout (4 Weeks)||1
10812882|NCT03212144|11975087|FG000|COMPLETED|Washout (4 Weeks)||1
10812883|NCT03212144|11975088|FG001|COMPLETED|Washout (4 Weeks)||1
10812884|NCT03212144|11975087|FG000|NOT COMPLETED|Washout (4 Weeks)||0
10812885|NCT03212144|11975088|FG001|NOT COMPLETED|Washout (4 Weeks)||0
10812886|NCT03212144|11975087|FG000|STARTED|Second Sequence (4 Weeks)||1
10812887|NCT03212144|11975088|FG001|STARTED|Second Sequence (4 Weeks)||1
10812888|NCT03212144|11975087|FG000|COMPLETED|Second Sequence (4 Weeks)||0
10812889|NCT03212144|11975088|FG001|COMPLETED|Second Sequence (4 Weeks)||0
10390969|NCT00662909|11533867|FG000|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|325
10390970|NCT00662909|11533868|FG001|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|312
10390971|NCT00662909|11533869|FG002|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|296
10390972|NCT00662909|11533867|FG000|COMPLETED|Overall Study||385
10390973|NCT00662909|11533868|FG001|COMPLETED|Overall Study||383
10390974|NCT00662909|11533869|FG002|COMPLETED|Overall Study||380
10390975|NCT00662909|11533867|FG000|NOT COMPLETED|Overall Study||69
10390976|NCT00662909|11533868|FG001|NOT COMPLETED|Overall Study||59
10390977|NCT00662909|11533869|FG002|NOT COMPLETED|Overall Study||53
10390978|NCT00663026|11533880|FG000|STARTED|Overall Study||19
10390979|NCT00663026|11533881|FG001|STARTED|Overall Study||29
10390980|NCT00663026|11533882|FG002|STARTED|Overall Study||31
10390981|NCT00663026|11533880|FG000|COMPLETED|Overall Study||17
10390982|NCT00663026|11533881|FG001|COMPLETED|Overall Study||23
10390983|NCT00663026|11533882|FG002|COMPLETED|Overall Study||27
10390984|NCT00663026|11533880|FG000|NOT COMPLETED|Overall Study||2
10390985|NCT00663026|11533881|FG001|NOT COMPLETED|Overall Study||6
10390986|NCT00663026|11533882|FG002|NOT COMPLETED|Overall Study||4
10390987|NCT00663039|11533892|FG000|STARTED|Overall Study||14
10542823|NCT01479595|11695993|FG000|NOT COMPLETED|Overall Study||2
10542824|NCT01479595|11695994|FG001|NOT COMPLETED|Overall Study||2
10542825|NCT01479621|11696006|FG000|STARTED|Pre-Assignment Period (Run-In Placebo)||909
10718848|NCT02706886|11882450|FG003|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
10718849|NCT02706886|11882451|FG004|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
10718850|NCT02706886|11882452|FG005|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
10718851|NCT02706886|11882453|FG006|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
10718852|NCT02706886|11882454|FG007|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
10718853|NCT02706886|11882455|FG008|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
10718854|NCT02706899|11882500|FG000|STARTED|Overall Study||13
10718855|NCT02706899|11882501|FG001|STARTED|Overall Study||6
10718856|NCT02706899|11882500|FG000|COMPLETED|Overall Study||0
10812890|NCT03212144|11975087|FG000|NOT COMPLETED|Second Sequence (4 Weeks)||1
10812891|NCT03212144|11975088|FG001|NOT COMPLETED|Second Sequence (4 Weeks)||1
10812892|NCT03218163|11975094|FG000|STARTED|Overall Study||0
10390988|NCT00663039|11533893|FG001|STARTED|Overall Study||13
10390989|NCT00663039|11533892|FG000|COMPLETED|Overall Study||10
10390990|NCT00663039|11533893|FG001|COMPLETED|Overall Study||9
10390991|NCT00663039|11533892|FG000|NOT COMPLETED|Overall Study||4
10390992|NCT00663039|11533893|FG001|NOT COMPLETED|Overall Study||4
10390993|NCT00663117|11533901|FG000|STARTED|Overall Study||20
10390994|NCT00663117|11533902|FG001|STARTED|Overall Study||20
10390995|NCT00663117|11533901|FG000|COMPLETED|Overall Study|One patient in placebo flared and was unblinded and crossed over to active drug|19
10390996|NCT00663117|11533902|FG001|COMPLETED|Overall Study||20
10390997|NCT00663117|11533901|FG000|NOT COMPLETED|Overall Study||1
10390998|NCT00663117|11533902|FG001|NOT COMPLETED|Overall Study||0
10390999|NCT00663169|11533916|FG000|STARTED|Overall Study||3
10391000|NCT00663169|11533917|FG001|STARTED|Overall Study||3
10391001|NCT00663169|11533916|FG000|COMPLETED|Overall Study||3
10391002|NCT00663169|11533917|FG001|COMPLETED|Overall Study||3
10391003|NCT00663169|11533916|FG000|NOT COMPLETED|Overall Study||0
10391004|NCT00663169|11533917|FG001|NOT COMPLETED|Overall Study||0
10391005|NCT00663208|11533930|FG000|STARTED|Treatment Period||4
10391006|NCT00663208|11533931|FG001|STARTED|Treatment Period||4
10391007|NCT00663208|11533932|FG002|STARTED|Treatment Period||4
10391008|NCT00663208|11533933|FG003|STARTED|Treatment Period||4
10391009|NCT00663208|11533934|FG004|STARTED|Treatment Period||4
10391010|NCT00663208|11533935|FG005|STARTED|Treatment Period||4
10391011|NCT00663208|11533936|FG006|STARTED|Treatment Period||6
10391012|NCT00663208|11533930|FG000|COMPLETED|Treatment Period||4
10391013|NCT00663208|11533931|FG001|COMPLETED|Treatment Period||3
10391014|NCT00663208|11533932|FG002|COMPLETED|Treatment Period||4
10391015|NCT00663208|11533933|FG003|COMPLETED|Treatment Period||4
10391016|NCT00663208|11533934|FG004|COMPLETED|Treatment Period||4
10391017|NCT00663208|11533935|FG005|COMPLETED|Treatment Period||4
10391018|NCT00663208|11533936|FG006|COMPLETED|Treatment Period||6
10391019|NCT00663208|11533930|FG000|NOT COMPLETED|Treatment Period||0
10391020|NCT00663208|11533931|FG001|NOT COMPLETED|Treatment Period||1
10391021|NCT00663208|11533932|FG002|NOT COMPLETED|Treatment Period||0
10391022|NCT00663208|11533933|FG003|NOT COMPLETED|Treatment Period||0
10307928|NCT00109005|11440934|FG001|STARTED|Overall Study||9
10307929|NCT00109005|11440933|FG000|COMPLETED|Overall Study||8
10307930|NCT00109005|11440934|FG001|COMPLETED|Overall Study||9
10307931|NCT00109005|11440933|FG000|NOT COMPLETED|Overall Study||0
10307932|NCT00109005|11440934|FG001|NOT COMPLETED|Overall Study||0
10307933|NCT00109031|11440945|FG000|STARTED|Overall Study||11
10307934|NCT00109031|11440946|FG001|STARTED|Overall Study||10
10307935|NCT00109031|11440947|FG002|STARTED|Overall Study||14
10307936|NCT00109031|11440948|FG003|STARTED|Overall Study||12
10307937|NCT00109031|11440945|FG000|COMPLETED|Overall Study||11
10307938|NCT00109031|11440946|FG001|COMPLETED|Overall Study||8
10307939|NCT00109031|11440947|FG002|COMPLETED|Overall Study||12
10307940|NCT00109031|11440948|FG003|COMPLETED|Overall Study||12
10307941|NCT00109031|11440945|FG000|NOT COMPLETED|Overall Study||0
10307942|NCT00109031|11440946|FG001|NOT COMPLETED|Overall Study||2
10307943|NCT00109031|11440947|FG002|NOT COMPLETED|Overall Study||2
10307944|NCT00109031|11440948|FG003|NOT COMPLETED|Overall Study||0
10307945|NCT00109343|11440961|FG000|STARTED|Overall Study||510
10307946|NCT00109343|11440962|FG001|STARTED|Overall Study||258
10307947|NCT00109343|11440963|FG002|STARTED|Overall Study||259
10307948|NCT00109343|11440961|FG000|Vaccinated at Visit 1|Overall Study||510
10307949|NCT00109343|11440962|FG001|Vaccinated at Visit 1|Overall Study||258
10307950|NCT00109343|11440963|FG002|Vaccinated at Visit 1|Overall Study||259
10307951|NCT00109343|11440961|FG000|Vaccinated at Visit 2|Overall Study|Per-protocol, subjects in Group 1 were not vaccinated at Visit 2|0
10391023|NCT00663208|11533934|FG004|NOT COMPLETED|Treatment Period||0
10391024|NCT00663208|11533935|FG005|NOT COMPLETED|Treatment Period||0
10391025|NCT00663208|11533936|FG006|NOT COMPLETED|Treatment Period||0
10391026|NCT00663208|11533930|FG000|STARTED|Follow-up Period||4
10391027|NCT00663208|11533931|FG001|STARTED|Follow-up Period||3
10391028|NCT00663208|11533932|FG002|STARTED|Follow-up Period||4
10391029|NCT00663208|11533933|FG003|STARTED|Follow-up Period||4
10542826|NCT01479621|11696007|FG001|STARTED|Pre-Assignment Period (Run-In Placebo)||0
10542827|NCT01479621|11696008|FG002|STARTED|Pre-Assignment Period (Run-In Placebo)||0
10542828|NCT01479621|11696009|FG003|STARTED|Pre-Assignment Period (Run-In Placebo)||0
10542829|NCT01479621|11696010|FG004|STARTED|Pre-Assignment Period (Run-In Placebo)||0
10542830|NCT01479621|11696011|FG005|STARTED|Pre-Assignment Period (Run-In Placebo)||0
10542831|NCT01479621|11696012|FG006|STARTED|Pre-Assignment Period (Run-In Placebo)||0
10542832|NCT01479621|11696006|FG000|COMPLETED|Pre-Assignment Period (Run-In Placebo)||622
10542833|NCT01479621|11696007|FG001|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
10542834|NCT01479621|11696008|FG002|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
10542835|NCT01479621|11696009|FG003|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
10542836|NCT01479621|11696010|FG004|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
10542837|NCT01479621|11696011|FG005|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
10542838|NCT01479621|11696012|FG006|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
10542839|NCT01479621|11696006|FG000|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||287
10542840|NCT01479621|11696007|FG001|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
10542841|NCT01479621|11696008|FG002|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
10542842|NCT01479621|11696009|FG003|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
10542843|NCT01479621|11696010|FG004|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
10542844|NCT01479621|11696011|FG005|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
10542845|NCT01479621|11696012|FG006|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
10542846|NCT01479621|11696006|FG000|STARTED|Treatment Period||0
10542847|NCT01479621|11696007|FG001|STARTED|Treatment Period||103
10542848|NCT01479621|11696008|FG002|STARTED|Treatment Period||104
10542849|NCT01479621|11696009|FG003|STARTED|Treatment Period||104
10542850|NCT01479621|11696010|FG004|STARTED|Treatment Period||103
10542851|NCT01479621|11696011|FG005|STARTED|Treatment Period||104
10542852|NCT01479621|11696012|FG006|STARTED|Treatment Period||104
10542853|NCT01479621|11696006|FG000|Safety Population|Treatment Period||0
10542854|NCT01479621|11696007|FG001|Safety Population|Treatment Period||103
10542855|NCT01479621|11696008|FG002|Safety Population|Treatment Period||104
10542856|NCT01479621|11696009|FG003|Safety Population|Treatment Period||104
10542857|NCT01479621|11696010|FG004|Safety Population|Treatment Period||103
10542858|NCT01479621|11696011|FG005|Safety Population|Treatment Period||104
10542859|NCT01479621|11696012|FG006|Safety Population|Treatment Period||104
10542860|NCT01479621|11696006|FG000|Full Analysis Set|Treatment Period||0
10658573|NCT02233946|11819757|FG001|COMPLETED|3-months Follow-up||214
10658574|NCT02233946|11819756|FG000|NOT COMPLETED|3-months Follow-up||53
10307952|NCT00109343|11440962|FG001|Vaccinated at Visit 2|Overall Study||246
10307953|NCT00109343|11440963|FG002|Vaccinated at Visit 2|Overall Study||246
10307954|NCT00109343|11440961|FG000|Vaccinated at Visit 4|Overall Study||466
10307955|NCT00109343|11440962|FG001|Vaccinated at Visit 4|Overall Study||235
10391030|NCT00663208|11533934|FG004|STARTED|Follow-up Period||4
10391031|NCT00663208|11533935|FG005|STARTED|Follow-up Period||4
10391032|NCT00663208|11533936|FG006|STARTED|Follow-up Period||6
10542861|NCT01479621|11696007|FG001|Full Analysis Set|Treatment Period||102
10542862|NCT01479621|11696008|FG002|Full Analysis Set|Treatment Period||101
10542863|NCT01479621|11696009|FG003|Full Analysis Set|Treatment Period||102
10542864|NCT01479621|11696010|FG004|Full Analysis Set|Treatment Period||102
10718857|NCT02706899|11882501|FG001|COMPLETED|Overall Study||0
10718858|NCT02706899|11882500|FG000|NOT COMPLETED|Overall Study||13
10718859|NCT02706899|11882501|FG001|NOT COMPLETED|Overall Study||6
10718860|NCT02706925|11882516|FG000|STARTED|Overall Study||16
10718861|NCT02706925|11882517|FG001|STARTED|Overall Study||6
10718862|NCT02706925|11882518|FG002|STARTED|Overall Study||6
10391033|NCT00663208|11533930|FG000|COMPLETED|Follow-up Period||1
10391034|NCT00663208|11533931|FG001|COMPLETED|Follow-up Period||3
10391035|NCT00663208|11533932|FG002|COMPLETED|Follow-up Period||1
10391036|NCT00663208|11533933|FG003|COMPLETED|Follow-up Period||2
10391037|NCT00663208|11533934|FG004|COMPLETED|Follow-up Period||4
10718863|NCT02706925|11882519|FG003|STARTED|Overall Study||6
10718864|NCT02706925|11882520|FG004|STARTED|Overall Study||6
10718865|NCT02706925|11882521|FG005|STARTED|Overall Study||5
10718866|NCT02706925|11882522|FG006|STARTED|Overall Study||6
10718867|NCT02706925|11882523|FG007|STARTED|Overall Study||6
10718868|NCT02706925|11882524|FG008|STARTED|Overall Study||6
10718869|NCT02706925|11882516|FG000|COMPLETED|Overall Study||16
10718870|NCT02706925|11882517|FG001|COMPLETED|Overall Study||6
10718871|NCT02706925|11882518|FG002|COMPLETED|Overall Study||6
10718872|NCT02706925|11882519|FG003|COMPLETED|Overall Study||6
10718873|NCT02706925|11882520|FG004|COMPLETED|Overall Study||6
10718874|NCT02706925|11882521|FG005|COMPLETED|Overall Study||5
10718875|NCT02706925|11882522|FG006|COMPLETED|Overall Study||6
10718876|NCT02706925|11882523|FG007|COMPLETED|Overall Study||6
10718877|NCT02706925|11882524|FG008|COMPLETED|Overall Study||6
10718878|NCT02706925|11882516|FG000|NOT COMPLETED|Overall Study||0
10718879|NCT02706925|11882517|FG001|NOT COMPLETED|Overall Study||0
10391038|NCT00663208|11533935|FG005|COMPLETED|Follow-up Period||4
10391039|NCT00663208|11533936|FG006|COMPLETED|Follow-up Period||5
10391040|NCT00663208|11533930|FG000|NOT COMPLETED|Follow-up Period||3
10391041|NCT00663208|11533931|FG001|NOT COMPLETED|Follow-up Period||0
10391042|NCT00663208|11533932|FG002|NOT COMPLETED|Follow-up Period||3
10391043|NCT00663208|11533933|FG003|NOT COMPLETED|Follow-up Period||2
10391044|NCT00663208|11533934|FG004|NOT COMPLETED|Follow-up Period||0
10391045|NCT00663208|11533935|FG005|NOT COMPLETED|Follow-up Period||0
10391046|NCT00663208|11533936|FG006|NOT COMPLETED|Follow-up Period||1
10391047|NCT00663234|11533954|FG000|STARTED|Overall Study||28
10391048|NCT00663234|11533954|FG000|Dose Increased to 20 mg at Week 8|Overall Study||10
10391049|NCT00663234|11533954|FG000|COMPLETED|Overall Study||27
10391050|NCT00663234|11533954|FG000|NOT COMPLETED|Overall Study||1
10391051|NCT00663260|11533965|FG000|STARTED|Overall Study||84
10391052|NCT00663260|11533966|FG001|STARTED|Overall Study||83
10391053|NCT00663260|11533967|FG002|STARTED|Overall Study||85
10391054|NCT00663260|11533965|FG000|COMPLETED|Overall Study||63
10391055|NCT00663260|11533966|FG001|COMPLETED|Overall Study||72
10391056|NCT00663260|11533967|FG002|COMPLETED|Overall Study||69
10391057|NCT00663260|11533965|FG000|NOT COMPLETED|Overall Study||21
10391058|NCT00663260|11533966|FG001|NOT COMPLETED|Overall Study||11
10391059|NCT00663260|11533967|FG002|NOT COMPLETED|Overall Study||16
10391060|NCT00663403|11533975|FG000|STARTED|Overall Study||8
10391061|NCT00663403|11533975|FG000|COMPLETED|Overall Study||8
10391062|NCT00663403|11533975|FG000|NOT COMPLETED|Overall Study||0
10391063|NCT00663702|11533981|FG000|STARTED|Overall Study||52
10718880|NCT02706925|11882518|FG002|NOT COMPLETED|Overall Study||0
10718881|NCT02706925|11882519|FG003|NOT COMPLETED|Overall Study||0
10718882|NCT02706925|11882520|FG004|NOT COMPLETED|Overall Study||0
10718883|NCT02706925|11882521|FG005|NOT COMPLETED|Overall Study||0
10718884|NCT02706925|11882522|FG006|NOT COMPLETED|Overall Study||0
10718885|NCT02706925|11882523|FG007|NOT COMPLETED|Overall Study||0
10718886|NCT02706925|11882524|FG008|NOT COMPLETED|Overall Study||0
10718887|NCT02706938|11882554|FG000|STARTED|First Period, 6 Weeks||32
10718888|NCT02706938|11882555|FG001|STARTED|First Period, 6 Weeks||33
10718889|NCT02706938|11882554|FG000|COMPLETED|First Period, 6 Weeks||21
10718890|NCT02706938|11882555|FG001|COMPLETED|First Period, 6 Weeks||31
10718891|NCT02706938|11882554|FG000|NOT COMPLETED|First Period, 6 Weeks||11
10391064|NCT00663702|11533982|FG001|STARTED|Overall Study||71
10391065|NCT00663702|11533981|FG000|COMPLETED|Overall Study||34
10391066|NCT00663702|11533982|FG001|COMPLETED|Overall Study||61
10391067|NCT00663702|11533981|FG000|NOT COMPLETED|Overall Study||18
10391068|NCT00663702|11533982|FG001|NOT COMPLETED|Overall Study||10
10307956|NCT00109343|11440963|FG002|Vaccinated at Visit 4|Overall Study||240
10542865|NCT01479621|11696011|FG005|Full Analysis Set|Treatment Period||102
10542866|NCT01479621|11696012|FG006|Full Analysis Set|Treatment Period||102
10542867|NCT01479621|11696006|FG000|COMPLETED|Treatment Period||0
10307957|NCT00109343|11440961|FG000|COMPLETED|Overall Study||446
10307958|NCT00109343|11440962|FG001|COMPLETED|Overall Study||221
10307959|NCT00109343|11440963|FG002|COMPLETED|Overall Study||229
10307960|NCT00109343|11440961|FG000|NOT COMPLETED|Overall Study||64
10307961|NCT00109343|11440962|FG001|NOT COMPLETED|Overall Study||37
10307962|NCT00109343|11440963|FG002|NOT COMPLETED|Overall Study||30
10307963|NCT00109473|11440973|FG000|STARTED|Baseline (0 Through 12 Weeks)|11 subjects allocated to Group A; one withdrew consent, only 10 receieved intervention.|10
10307964|NCT00109473|11440974|FG001|STARTED|Baseline (0 Through 12 Weeks)||10
10307965|NCT00109473|11440973|FG000|Analyzed|Baseline (0 Through 12 Weeks)||10
10307966|NCT00109473|11440974|FG001|Analyzed|Baseline (0 Through 12 Weeks)||10
10307967|NCT00109473|11440973|FG000|COMPLETED|Baseline (0 Through 12 Weeks)||10
10307968|NCT00109473|11440974|FG001|COMPLETED|Baseline (0 Through 12 Weeks)|One subject discontinued intervention because of active disease requiring imfliximab|9
10307969|NCT00109473|11440973|FG000|NOT COMPLETED|Baseline (0 Through 12 Weeks)||0
10307970|NCT00109473|11440974|FG001|NOT COMPLETED|Baseline (0 Through 12 Weeks)||1
10307971|NCT00109473|11440973|FG000|STARTED|Week 12 to Week 24||10
10307972|NCT00109473|11440974|FG001|STARTED|Week 12 to Week 24||9
10307973|NCT00109473|11440973|FG000|Analyzed|Week 12 to Week 24||9
10307974|NCT00109473|11440974|FG001|Analyzed|Week 12 to Week 24||9
10307975|NCT00109473|11440973|FG000|COMPLETED|Week 12 to Week 24|One subject withdrew consent|9
10307976|NCT00109473|11440974|FG001|COMPLETED|Week 12 to Week 24|one subject discontinued intervention due to active disease requiring surgery|9
10307977|NCT00109473|11440973|FG000|NOT COMPLETED|Week 12 to Week 24||1
10307978|NCT00109473|11440974|FG001|NOT COMPLETED|Week 12 to Week 24||0
10307979|NCT00109473|11440973|FG000|STARTED|52 Week Extension Phase||9
10307980|NCT00109473|11440974|FG001|STARTED|52 Week Extension Phase||8
10307981|NCT00109473|11440973|FG000|Analyzed|52 Week Extension Phase||9
10307982|NCT00109473|11440974|FG001|Analyzed|52 Week Extension Phase||8
10307983|NCT00109473|11440973|FG000|COMPLETED|52 Week Extension Phase|Extension phase ends when subjects discontinue intervention due to active disease or reaches week 64|5
10307984|NCT00109473|11440974|FG001|COMPLETED|52 Week Extension Phase|Extension phase ends when subjects discontinue intervention due to active disease or reaches week 64|3
10307985|NCT00109473|11440973|FG000|NOT COMPLETED|52 Week Extension Phase||4
10307986|NCT00109473|11440974|FG001|NOT COMPLETED|52 Week Extension Phase||5
10307987|NCT00109577|11440985|FG000|STARTED|Overall Study||20
10307988|NCT00109577|11440986|FG001|STARTED|Overall Study||20
10307989|NCT00109577|11440985|FG000|COMPLETED|Overall Study||17
10307990|NCT00109577|11440986|FG001|COMPLETED|Overall Study||17
10307991|NCT00109577|11440985|FG000|NOT COMPLETED|Overall Study||3
10718892|NCT02706938|11882555|FG001|NOT COMPLETED|First Period, 6 Weeks||2
10718893|NCT02706938|11882554|FG000|STARTED|Second Period, 6 Weeks||21
10718894|NCT02706938|11882555|FG001|STARTED|Second Period, 6 Weeks||31
10718895|NCT02706938|11882554|FG000|COMPLETED|Second Period, 6 Weeks|Only data from 20 patients were finally analyzed because of missing data.|21
10812893|NCT03218163|11975094|FG000|COMPLETED|Overall Study||0
10307992|NCT00109577|11440986|FG001|NOT COMPLETED|Overall Study||3
10307993|NCT00109590|11440995|FG000|STARTED|Overall Study||57
10307994|NCT00109590|11440996|FG001|STARTED|Overall Study||58
10307995|NCT00109590|11440997|FG002|STARTED|Overall Study||60
10307996|NCT00109590|11440995|FG000|RECEIVED TREATMENT|Overall Study||56
10307997|NCT00109590|11440996|FG001|RECEIVED TREATMENT|Overall Study||56
10307998|NCT00109590|11440997|FG002|RECEIVED TREATMENT|Overall Study||57
10307999|NCT00109590|11440995|FG000|COMPLETED|Overall Study||55
10308000|NCT00109590|11440996|FG001|COMPLETED|Overall Study||56
10308001|NCT00109590|11440997|FG002|COMPLETED|Overall Study||56
10308002|NCT00109590|11440995|FG000|NOT COMPLETED|Overall Study||2
10308003|NCT00109590|11440996|FG001|NOT COMPLETED|Overall Study||2
10308004|NCT00109590|11440997|FG002|NOT COMPLETED|Overall Study||4
10308005|NCT00109707|11441022|FG000|STARTED|Overall Study||321
10308006|NCT00109707|11441023|FG001|STARTED|Overall Study||137
10308007|NCT00109707|11441024|FG002|STARTED|Overall Study||49
10308008|NCT00109707|11441022|FG000|Entered Extension Study|Overall Study||106
10308009|NCT00109707|11441023|FG001|Entered Extension Study|Overall Study||15
10308010|NCT00109707|11441024|FG002|Entered Extension Study|Overall Study||15
10308011|NCT00109707|11441022|FG000|COMPLETED|Overall Study||67
10308012|NCT00109707|11441023|FG001|COMPLETED|Overall Study||8
10718896|NCT02706938|11882555|FG001|COMPLETED|Second Period, 6 Weeks|Only data from 19 patients were finally analyzed because of missing data.|21
10308013|NCT00109707|11441024|FG002|COMPLETED|Overall Study||8
10308014|NCT00109707|11441022|FG000|NOT COMPLETED|Overall Study||254
10308015|NCT00109707|11441023|FG001|NOT COMPLETED|Overall Study||129
10308016|NCT00109707|11441024|FG002|NOT COMPLETED|Overall Study||41
10308017|NCT00109733|11441038|FG000|STARTED|Overall Study||15
10308018|NCT00109733|11441039|FG001|STARTED|Overall Study||16
10308019|NCT00109733|11441038|FG000|COMPLETED|Overall Study||13
10308020|NCT00109733|11441039|FG001|COMPLETED|Overall Study||12
10542868|NCT01479621|11696007|FG001|COMPLETED|Treatment Period||79
10308021|NCT00109733|11441038|FG000|NOT COMPLETED|Overall Study||2
10308022|NCT00109733|11441039|FG001|NOT COMPLETED|Overall Study||4
10308023|NCT00109772|11441047|FG000|STARTED|Double-blind Treatment||90
10308024|NCT00109772|11441048|FG001|STARTED|Double-blind Treatment||94
10308025|NCT00109772|11441047|FG000|Safety and ITT Population|Double-blind Treatment|Safety: at least one dose of study drug ITT: treated and at least one post dose diary measurement|87
10308026|NCT00109772|11441048|FG001|Safety and ITT Population|Double-blind Treatment|Safety: at least one dose of study drug ITT: treated and at least one post dose diary measurement|93
10308027|NCT00109772|11441047|FG000|COMPLETED|Double-blind Treatment||68
10308028|NCT00109772|11441048|FG001|COMPLETED|Double-blind Treatment||79
10308029|NCT00109772|11441047|FG000|NOT COMPLETED|Double-blind Treatment||22
10308030|NCT00109772|11441048|FG001|NOT COMPLETED|Double-blind Treatment||15
10308031|NCT00109772|11441047|FG000|STARTED|Open-label Extension|Four double-blind participants did not continue into the open-label extension|64
10308032|NCT00109772|11441048|FG001|STARTED|Open-label Extension|One double-blind participant did not continue into the open-label extension|78
10308033|NCT00109772|11441047|FG000|COMPLETED|Open-label Extension|Participants who were active in extension period when the sponsor terminated the study.|19
10308034|NCT00109772|11441048|FG001|COMPLETED|Open-label Extension|Participants who were active in extension period when the sponsor terminated the study.|29
10308035|NCT00109772|11441047|FG000|NOT COMPLETED|Open-label Extension||45
10308036|NCT00109772|11441048|FG001|NOT COMPLETED|Open-label Extension||49
10308037|NCT00109837|11441054|FG000|STARTED|Overall Study||79
10308038|NCT00109837|11441054|FG000|Eligible|Overall Study||78
10308039|NCT00109837|11441054|FG000|Eligible and Ph-|Overall Study||61
10308040|NCT00109837|11441054|FG000|Eligible and Ph- and Treated|Overall Study||60
10308041|NCT00109837|11441054|FG000|COMPLETED|Overall Study||56
10308042|NCT00109837|11441054|FG000|NOT COMPLETED|Overall Study||23
10308043|NCT00109850|11441062|FG000|STARTED|Overall Study||22
10308044|NCT00109850|11441062|FG000|Eligible|Overall Study||21
10308045|NCT00109850|11441062|FG000|Eligible and Began Protocol Therapy|Overall Study||21
10308046|NCT00109850|11441062|FG000|COMPLETED|Overall Study||18
10308047|NCT00109850|11441062|FG000|NOT COMPLETED|Overall Study||4
10391069|NCT00663793|11533990|FG000|STARTED|Overall Study||8
10391070|NCT00663793|11533991|FG001|STARTED|Overall Study||8
10391071|NCT00663793|11533990|FG000|COMPLETED|Overall Study||8
10391072|NCT00663793|11533991|FG001|COMPLETED|Overall Study||8
10391073|NCT00663793|11533990|FG000|NOT COMPLETED|Overall Study||0
10391074|NCT00663793|11533991|FG001|NOT COMPLETED|Overall Study||0
10391075|NCT00663819|11533999|FG000|STARTED|Overall Study||123
10391076|NCT00663819|11534000|FG001|STARTED|Overall Study||135
10391077|NCT00663819|11533999|FG000|COMPLETED|Overall Study||123
10391078|NCT00663819|11534000|FG001|COMPLETED|Overall Study||135
10391079|NCT00663819|11533999|FG000|NOT COMPLETED|Overall Study||0
10391080|NCT00663819|11534000|FG001|NOT COMPLETED|Overall Study||0
10391081|NCT00663858|11534011|FG000|STARTED|Overall Study||212
10391082|NCT00663858|11534012|FG001|STARTED|Overall Study||106
10391083|NCT00663858|11534013|FG002|STARTED|Overall Study||102
10391084|NCT00663858|11534011|FG000|COMPLETED|Overall Study||178
10391085|NCT00663858|11534012|FG001|COMPLETED|Overall Study||96
10391086|NCT00663858|11534013|FG002|COMPLETED|Overall Study||82
10391087|NCT00663858|11534011|FG000|NOT COMPLETED|Overall Study||34
10391088|NCT00663858|11534012|FG001|NOT COMPLETED|Overall Study||10
10391089|NCT00663858|11534013|FG002|NOT COMPLETED|Overall Study||20
10391090|NCT00663871|11534023|FG000|STARTED|Overall Study||134
10391091|NCT00663871|11534024|FG001|STARTED|Overall Study||138
10391092|NCT00663871|11534023|FG000|COMPLETED|Overall Study||124
10391093|NCT00663871|11534024|FG001|COMPLETED|Overall Study||131
10391094|NCT00663871|11534023|FG000|NOT COMPLETED|Overall Study||10
10391095|NCT00663871|11534024|FG001|NOT COMPLETED|Overall Study||7
10391096|NCT00663923|11534032|FG000|STARTED|Overall Study||50
10391097|NCT00663923|11534032|FG000|COMPLETED|Overall Study||48
10391098|NCT00663923|11534032|FG000|NOT COMPLETED|Overall Study||2
10391099|NCT00663962|11534040|FG000|STARTED|Overall Study||7
10391100|NCT00663962|11534041|FG001|STARTED|Overall Study||8
10391101|NCT00663962|11534040|FG000|COMPLETED|Overall Study|1 patient excluded for somnolence and unblinded--in 300mg group|6
10391102|NCT00663962|11534041|FG001|COMPLETED|Overall Study||8
10391103|NCT00663962|11534040|FG000|NOT COMPLETED|Overall Study||1
10391104|NCT00663962|11534041|FG001|NOT COMPLETED|Overall Study||0
10308048|NCT00109876|11441066|FG000|STARTED|Overall Study||51
10308049|NCT00109876|11441066|FG000|COMPLETED|Overall Study||51
10308050|NCT00109876|11441066|FG000|NOT COMPLETED|Overall Study||0
10391105|NCT00664105|11534047|FG000|STARTED|Overall Study||63
10391106|NCT00664105|11534047|FG000|COMPLETED|Overall Study||39
10391107|NCT00664105|11534047|FG000|NOT COMPLETED|Overall Study||24
10718897|NCT02706938|11882554|FG000|NOT COMPLETED|Second Period, 6 Weeks||0
10718898|NCT02706938|11882555|FG001|NOT COMPLETED|Second Period, 6 Weeks||10
10658575|NCT02233946|11819757|FG001|NOT COMPLETED|3-months Follow-up||29
10658576|NCT02233946|11819756|FG000|STARTED|6-months Follow-up||571
10658577|NCT02233946|11819757|FG001|STARTED|6-months Follow-up||214
10658578|NCT02233946|11819756|FG000|COMPLETED|6-months Follow-up||550
10658579|NCT02233946|11819757|FG001|COMPLETED|6-months Follow-up||212
10658580|NCT02233946|11819756|FG000|NOT COMPLETED|6-months Follow-up||21
10658581|NCT02233946|11819757|FG001|NOT COMPLETED|6-months Follow-up||2
10658582|NCT02233946|11819756|FG000|STARTED|9-month Follow-up||550
10658583|NCT02233946|11819757|FG001|STARTED|9-month Follow-up||212
10658584|NCT02233946|11819756|FG000|COMPLETED|9-month Follow-up||530
10658585|NCT02233946|11819757|FG001|COMPLETED|9-month Follow-up||201
10658586|NCT02233946|11819756|FG000|NOT COMPLETED|9-month Follow-up||20
10658587|NCT02233946|11819757|FG001|NOT COMPLETED|9-month Follow-up||11
10718908|NCT02707146|11882577|FG000|STARTED|Overall Study||359
10812894|NCT03218163|11975094|FG000|NOT COMPLETED|Overall Study||0
10812895|NCT03172520|11975098|FG000|STARTED|Overall Study||10
10812896|NCT03172520|11975098|FG000|COMPLETED|Overall Study||0
10308051|NCT00109928|11441070|FG000|STARTED|Overall Study||34
10308052|NCT00109928|11441070|FG000|Eligible|Overall Study||33
10308053|NCT00109928|11441070|FG000|Eligible and Began Protocol Therapy|Overall Study||33
10308054|NCT00109928|11441070|FG000|COMPLETED|Overall Study||21
10308055|NCT00109928|11441070|FG000|NOT COMPLETED|Overall Study||13
10308056|NCT00109967|11441077|FG000|STARTED|Overall Study||50
10308057|NCT00109967|11441078|FG001|STARTED|Overall Study||21
10308058|NCT00109967|11441077|FG000|COMPLETED|Overall Study||30
10308059|NCT00109967|11441078|FG001|COMPLETED|Overall Study||15
10308060|NCT00109967|11441077|FG000|NOT COMPLETED|Overall Study||20
10308061|NCT00109967|11441078|FG001|NOT COMPLETED|Overall Study||6
10308062|NCT00110019|11441086|FG000|STARTED|Overall Study||410
10308063|NCT00110019|11441087|FG001|STARTED|Overall Study||413
10308064|NCT00110019|11441086|FG000|Eligible|Overall Study||395
10308065|NCT00110019|11441087|FG001|Eligible|Overall Study||398
10308066|NCT00110019|11441086|FG000|Treated|Overall Study||393
10308067|NCT00110019|11441087|FG001|Treated|Overall Study||397
10308068|NCT00110019|11441086|FG000|COMPLETED|Overall Study||4
10308069|NCT00110019|11441087|FG001|COMPLETED|Overall Study||0
10308070|NCT00110019|11441086|FG000|NOT COMPLETED|Overall Study||406
10308071|NCT00110019|11441087|FG001|NOT COMPLETED|Overall Study||413
10308072|NCT00110084|11441093|FG000|STARTED|Overall Study||50
10308073|NCT00110084|11441093|FG000|COMPLETED|Overall Study||22
10308074|NCT00110084|11441093|FG000|NOT COMPLETED|Overall Study||28
10308075|NCT00110136|11441097|FG000|STARTED|Overall Study||9
10308076|NCT00110136|11441097|FG000|COMPLETED|Overall Study||9
10308077|NCT00110136|11441097|FG000|NOT COMPLETED|Overall Study||0
10315348|NCT00177216|11449188|FG001|NOT COMPLETED|Overall Study||3
10315349|NCT00177216|11449189|FG002|NOT COMPLETED|Overall Study||1
10315350|NCT00177255|11449201|FG000|STARTED|Overall Study||39
10315351|NCT00177255|11449201|FG000|COMPLETED|Overall Study||39
10315352|NCT00177255|11449201|FG000|NOT COMPLETED|Overall Study||0
10315353|NCT00177294|11449207|FG000|STARTED|Overall Study||60
10315354|NCT00177294|11449208|FG001|STARTED|Overall Study||64
10391108|NCT00664209|11534052|FG000|STARTED|Motor Fluctuations Screen||13
10391109|NCT00664209|11534052|FG000|COMPLETED|Motor Fluctuations Screen||6
10391110|NCT00664209|11534052|FG000|NOT COMPLETED|Motor Fluctuations Screen||7
10391111|NCT00664209|11534052|FG000|STARTED|Study Treatment Period||6
10391112|NCT00664209|11534052|FG000|COMPLETED|Study Treatment Period||0
10391113|NCT00664209|11534052|FG000|NOT COMPLETED|Study Treatment Period||6
10391114|NCT00664326|11534057|FG000|STARTED|Overall Study||49
10391115|NCT00664326|11534057|FG000|COMPLETED|Overall Study|transitioned to rollover study|1
10391116|NCT00664326|11534057|FG000|NOT COMPLETED|Overall Study||48
10391117|NCT00664430|11534061|FG000|STARTED|Overall Study||13
10391118|NCT00664430|11534061|FG000|COMPLETED|Overall Study|Study terminated early due to low enrollment rate.|0
10391119|NCT00664430|11534061|FG000|NOT COMPLETED|Overall Study||13
10391120|NCT00664521|11534067|FG000|STARTED|Overall Study||18
10391121|NCT00664521|11534068|FG001|STARTED|Overall Study||9
10391122|NCT00664521|11534067|FG000|COMPLETED|Overall Study||12
10391123|NCT00664521|11534068|FG001|COMPLETED|Overall Study||8
10391124|NCT00664521|11534067|FG000|NOT COMPLETED|Overall Study||6
10391125|NCT00664521|11534068|FG001|NOT COMPLETED|Overall Study||1
10315355|NCT00177294|11449207|FG000|COMPLETED|Overall Study||53
10315356|NCT00177294|11449208|FG001|COMPLETED|Overall Study||59
10315357|NCT00177294|11449207|FG000|NOT COMPLETED|Overall Study||7
10315358|NCT00177294|11449208|FG001|NOT COMPLETED|Overall Study||5
10315359|NCT00177307|11449214|FG000|STARTED|Overall Study||40
10315360|NCT00177307|11449214|FG000|COMPLETED|Overall Study||39
10315361|NCT00177307|11449214|FG000|NOT COMPLETED|Overall Study||1
10315362|NCT00177671|11449220|FG000|STARTED|Overall Study||67
10315363|NCT00177671|11449221|FG001|STARTED|Overall Study||63
10315364|NCT00177671|11449220|FG000|Month 12|Overall Study||45
10315365|NCT00177671|11449221|FG001|Month 12|Overall Study||57
10315366|NCT00177671|11449220|FG000|Month 24|Overall Study||42
10315367|NCT00177671|11449221|FG001|Month 24|Overall Study||49
10315368|NCT00177671|11449220|FG000|COMPLETED|Overall Study||42
10315369|NCT00177671|11449221|FG001|COMPLETED|Overall Study||49
10315370|NCT00177671|11449220|FG000|NOT COMPLETED|Overall Study||25
10315371|NCT00177671|11449221|FG001|NOT COMPLETED|Overall Study||14
10315372|NCT00178126|11449229|FG000|STARTED|Overall Study||119
10315373|NCT00178126|11449230|FG001|STARTED|Overall Study||113
10315374|NCT00178126|11449229|FG000|COMPLETED|Overall Study||94
10315375|NCT00178126|11449230|FG001|COMPLETED|Overall Study||86
10315376|NCT00178126|11449229|FG000|NOT COMPLETED|Overall Study||25
10315377|NCT00178126|11449230|FG001|NOT COMPLETED|Overall Study||27
10315378|NCT00178178|11449240|FG000|STARTED|Overall Study||24
10315379|NCT00178178|11449241|FG001|STARTED|Overall Study||24
10315380|NCT00178178|11449242|FG002|STARTED|Overall Study||24
10391126|NCT00664534|11534076|FG000|STARTED|Overall Study||173
10391127|NCT00664534|11534077|FG001|STARTED|Overall Study||171
10391128|NCT00664534|11534076|FG000|COMPLETED|Overall Study||132
10391129|NCT00664534|11534077|FG001|COMPLETED|Overall Study||138
10391130|NCT00664534|11534076|FG000|NOT COMPLETED|Overall Study||41
10391131|NCT00664534|11534077|FG001|NOT COMPLETED|Overall Study||33
10391132|NCT00664560|11534086|FG000|STARTED|Overall Study|Safety Population|247
10391133|NCT00664560|11534087|FG001|STARTED|Overall Study|Safety Population|243
10391134|NCT00664560|11534088|FG002|STARTED|Overall Study|Safety Population|124
10391135|NCT00664560|11534086|FG000|COMPLETED|Overall Study||208
10391136|NCT00664560|11534087|FG001|COMPLETED|Overall Study||208
10391137|NCT00664560|11534088|FG002|COMPLETED|Overall Study||105
10391138|NCT00664560|11534086|FG000|NOT COMPLETED|Overall Study||39
10391139|NCT00664560|11534087|FG001|NOT COMPLETED|Overall Study||35
10391140|NCT00664560|11534088|FG002|NOT COMPLETED|Overall Study||19
10391141|NCT00664742|11534096|FG000|STARTED|Overall Study||607
10391142|NCT00664742|11534096|FG000|COMPLETED|Overall Study||481
10391143|NCT00664742|11534096|FG000|NOT COMPLETED|Overall Study||126
10391144|NCT00664755|11534102|FG000|STARTED|Overall Study||67
10391145|NCT00664755|11534103|FG001|STARTED|Overall Study||73
10391146|NCT00664755|11534102|FG000|COMPLETED|Overall Study||67
10391147|NCT00664755|11534103|FG001|COMPLETED|Overall Study||73
10391148|NCT00664755|11534102|FG000|NOT COMPLETED|Overall Study||0
10391149|NCT00664755|11534103|FG001|NOT COMPLETED|Overall Study||0
10391150|NCT00664859|11534112|FG000|STARTED|Overall Study||51
10391151|NCT00664859|11534113|FG001|STARTED|Overall Study||45
10391152|NCT00664859|11534114|FG002|STARTED|Overall Study||44
10391153|NCT00664859|11534112|FG000|COMPLETED|Overall Study||34
10391154|NCT00664859|11534113|FG001|COMPLETED|Overall Study||35
10391155|NCT00664859|11534114|FG002|COMPLETED|Overall Study||23
10391156|NCT00664859|11534112|FG000|NOT COMPLETED|Overall Study||17
10391157|NCT00664859|11534113|FG001|NOT COMPLETED|Overall Study||10
10391158|NCT00664859|11534114|FG002|NOT COMPLETED|Overall Study||21
10391159|NCT00665002|11534122|FG000|STARTED|Overall Study||16
10391160|NCT00665002|11534122|FG000|COMPLETED|Overall Study||4
10391161|NCT00665002|11534122|FG000|NOT COMPLETED|Overall Study||12
10391162|NCT00665132|11534126|FG000|STARTED|Overall Study||10
10391163|NCT00665132|11534126|FG000|COMPLETED|Overall Study||10
10718909|NCT02707146|11882578|FG001|STARTED|Overall Study||391
10718910|NCT02707146|11882577|FG000|COMPLETED|Overall Study||359
10718911|NCT02707146|11882578|FG001|COMPLETED|Overall Study||388
10718912|NCT02707146|11882577|FG000|NOT COMPLETED|Overall Study||0
10718913|NCT02707146|11882578|FG001|NOT COMPLETED|Overall Study||3
10718914|NCT02707172|11882584|FG000|STARTED|1st Set of Experiment||28
10718915|NCT02707172|11882584|FG000|COMPLETED|1st Set of Experiment||28
10718916|NCT02707172|11882584|FG000|NOT COMPLETED|1st Set of Experiment||0
10718917|NCT02707172|11882584|FG000|STARTED|Wash Out||28
10718918|NCT02707172|11882584|FG000|COMPLETED|Wash Out||28
10718919|NCT02707172|11882584|FG000|NOT COMPLETED|Wash Out||0
10718920|NCT02707172|11882584|FG000|STARTED|2nd Set of Experiment||28
10391164|NCT00665132|11534126|FG000|NOT COMPLETED|Overall Study||0
10391165|NCT00665353|11534130|FG000|STARTED|Study Step 1||19
10391166|NCT00665353|11534130|FG000|COMPLETED|Study Step 1||16
10391167|NCT00665353|11534130|FG000|NOT COMPLETED|Study Step 1||3
10391168|NCT00665353|11534130|FG000|STARTED|Study Step 2||16
10391169|NCT00665353|11534130|FG000|COMPLETED|Study Step 2||2
10391170|NCT00665353|11534130|FG000|NOT COMPLETED|Study Step 2||14
10391171|NCT00665366|11534136|FG000|STARTED|Overall Study|Participants randomized|189
10658588|NCT02233946|11819756|FG000|STARTED|12-month Follow-up||530
10718921|NCT02707172|11882584|FG000|COMPLETED|2nd Set of Experiment||28
10718922|NCT02707172|11882584|FG000|NOT COMPLETED|2nd Set of Experiment||0
10718923|NCT02707432|11882591|FG000|STARTED|Overall Study||72
10718924|NCT02707432|11882592|FG001|STARTED|Overall Study||71
10718925|NCT02707432|11882591|FG000|COMPLETED|Overall Study||57
10718926|NCT02707432|11882592|FG001|COMPLETED|Overall Study||51
10718927|NCT02707432|11882591|FG000|NOT COMPLETED|Overall Study||15
10718928|NCT02707432|11882592|FG001|NOT COMPLETED|Overall Study||20
10718929|NCT02707523|11882601|FG000|STARTED|Overall Study||16
10718930|NCT02707523|11882602|FG001|STARTED|Overall Study||16
10812897|NCT03172520|11975098|FG000|NOT COMPLETED|Overall Study||10
10812898|NCT03204539|11975104|FG000|STARTED|Overall Study||0
10812899|NCT03204539|11975105|FG001|STARTED|Overall Study||1
10812900|NCT03204539|11975104|FG000|COMPLETED|Overall Study||0
10812901|NCT03204539|11975105|FG001|COMPLETED|Overall Study||0
10812902|NCT03204539|11975104|FG000|NOT COMPLETED|Overall Study||0
10812903|NCT03204539|11975105|FG001|NOT COMPLETED|Overall Study||1
10812904|NCT03206216|11975113|FG000|STARTED|Overall Study||0
10812905|NCT03206216|11975114|FG001|STARTED|Overall Study||1
10812906|NCT03206216|11975113|FG000|COMPLETED|Overall Study||0
10812907|NCT03206216|11975114|FG001|COMPLETED|Overall Study||0
10812908|NCT03206216|11975113|FG000|NOT COMPLETED|Overall Study||0
10812909|NCT03206216|11975114|FG001|NOT COMPLETED|Overall Study||1
10812910|NCT03195660|11975120|FG000|STARTED|Overall Study||2
10812911|NCT03195660|11975120|FG000|COMPLETED|Overall Study||0
10812912|NCT03195660|11975120|FG000|NOT COMPLETED|Overall Study||2
10812913|NCT03195465|11975124|FG000|STARTED|Overall Study||0
10812914|NCT03195465|11975124|FG000|COMPLETED|Overall Study||0
10812915|NCT03195465|11975124|FG000|NOT COMPLETED|Overall Study||0
10812916|NCT03166618|11975130|FG000|STARTED|Overall Study||0
10812917|NCT03166618|11975131|FG001|STARTED|Overall Study||1
10718931|NCT02707523|11882603|FG002|STARTED|Overall Study||16
10718932|NCT02707523|11882601|FG000|COMPLETED|Overall Study||16
10718933|NCT02707523|11882602|FG001|COMPLETED|Overall Study||16
10718934|NCT02707523|11882603|FG002|COMPLETED|Overall Study||16
10718935|NCT02707523|11882601|FG000|NOT COMPLETED|Overall Study||0
10718936|NCT02707523|11882602|FG001|NOT COMPLETED|Overall Study||0
10718937|NCT02707523|11882603|FG002|NOT COMPLETED|Overall Study||0
10718938|NCT02707601|11882613|FG000|STARTED|Overall Study||76
10718939|NCT02707601|11882614|FG001|STARTED|Overall Study||74
10718940|NCT02707601|11882613|FG000|COMPLETED|Overall Study||72
10718941|NCT02707601|11882614|FG001|COMPLETED|Overall Study||70
10718942|NCT02707601|11882613|FG000|NOT COMPLETED|Overall Study||4
10718943|NCT02707601|11882614|FG001|NOT COMPLETED|Overall Study||4
10718944|NCT02707640|11882626|FG000|STARTED|Overall Study||61
10718945|NCT02707640|11882627|FG001|STARTED|Overall Study||62
10718946|NCT02707640|11882626|FG000|COMPLETED|Overall Study||52
10718947|NCT02707640|11882627|FG001|COMPLETED|Overall Study||55
10718948|NCT02707640|11882626|FG000|NOT COMPLETED|Overall Study||9
10718949|NCT02707640|11882627|FG001|NOT COMPLETED|Overall Study||7
10718950|NCT02707757|11882635|FG000|STARTED|Overall Study||88
10718951|NCT02707757|11882636|FG001|STARTED|Overall Study||96
10718952|NCT02707757|11882635|FG000|COMPLETED|Overall Study||76
10718953|NCT02707757|11882636|FG001|COMPLETED|Overall Study||84
10718954|NCT02707757|11882635|FG000|NOT COMPLETED|Overall Study||12
10718955|NCT02707757|11882636|FG001|NOT COMPLETED|Overall Study||12
10718956|NCT02707770|11882644|FG000|STARTED|Overall Study||10
10718957|NCT02707770|11882645|FG001|STARTED|Overall Study||10
10718958|NCT02707770|11882644|FG000|COMPLETED|Overall Study|One patient withdrew from the study following consent, initial assessment and randomisation|9
10718959|NCT02707770|11882645|FG001|COMPLETED|Overall Study||10
10812918|NCT03166618|11975130|FG000|COMPLETED|Overall Study||0
10812919|NCT03166618|11975131|FG001|COMPLETED|Overall Study||0
10812920|NCT03166618|11975130|FG000|NOT COMPLETED|Overall Study||0
10812921|NCT03166618|11975131|FG001|NOT COMPLETED|Overall Study||1
10391172|NCT00665366|11534137|FG001|STARTED|Overall Study|Participants randomized|181
10391173|NCT00665366|11534136|FG000|COMPLETED|Overall Study||131
10391174|NCT00665366|11534137|FG001|COMPLETED|Overall Study||122
10658589|NCT02233946|11819757|FG001|STARTED|12-month Follow-up||201
10658590|NCT02233946|11819756|FG000|COMPLETED|12-month Follow-up||502
10658591|NCT02233946|11819757|FG001|COMPLETED|12-month Follow-up||190
10658592|NCT02233946|11819756|FG000|NOT COMPLETED|12-month Follow-up||28
10658593|NCT02233946|11819757|FG001|NOT COMPLETED|12-month Follow-up||11
10658594|NCT02233985|11819765|FG000|STARTED|Overall Study||33
10658595|NCT02233985|11819766|FG001|STARTED|Overall Study||31
10658596|NCT02233985|11819765|FG000|COMPLETED|Overall Study||33
10658597|NCT02233985|11819766|FG001|COMPLETED|Overall Study||31
10658598|NCT02233985|11819765|FG000|NOT COMPLETED|Overall Study||0
10658599|NCT02233985|11819766|FG001|NOT COMPLETED|Overall Study||0
10658600|NCT02233998|11819777|FG000|STARTED|Overall Study||53
10658601|NCT02233998|11819778|FG001|STARTED|Overall Study||52
10391175|NCT00665366|11534136|FG000|NOT COMPLETED|Overall Study||58
10391176|NCT00665366|11534137|FG001|NOT COMPLETED|Overall Study||59
10391177|NCT00665392|11534143|FG000|STARTED|Overall Study||42
10391178|NCT00665392|11534143|FG000|COMPLETED|Overall Study||41
10391179|NCT00665392|11534143|FG000|NOT COMPLETED|Overall Study||1
10391180|NCT00665431|11534151|FG000|STARTED|Overall Study|Safety population|243
10391181|NCT00665431|11534152|FG001|STARTED|Overall Study|Safety population|245
10391182|NCT00665431|11534153|FG002|STARTED|Overall Study|Safety population|122
10391183|NCT00665431|11534151|FG000|COMPLETED|Overall Study||203
10391184|NCT00665431|11534152|FG001|COMPLETED|Overall Study||188
10391185|NCT00665431|11534153|FG002|COMPLETED|Overall Study||98
10391186|NCT00665431|11534151|FG000|NOT COMPLETED|Overall Study||40
10391187|NCT00665431|11534152|FG001|NOT COMPLETED|Overall Study||57
10391188|NCT00665431|11534153|FG002|NOT COMPLETED|Overall Study||24
10391189|NCT00665457|11534161|FG000|STARTED|Overall Study||3
10391190|NCT00665457|11534161|FG000|COMPLETED|Overall Study||3
10391191|NCT00665457|11534161|FG000|NOT COMPLETED|Overall Study||0
10391192|NCT00665470|11534167|FG000|STARTED|Overall Study||10
10391193|NCT00665470|11534168|FG001|STARTED|Overall Study||0
10391194|NCT00665470|11534167|FG000|COMPLETED|Overall Study||10
10391195|NCT00665470|11534168|FG001|COMPLETED|Overall Study||0
10391196|NCT00665470|11534167|FG000|NOT COMPLETED|Overall Study||0
10391197|NCT00665470|11534168|FG001|NOT COMPLETED|Overall Study||0
10391198|NCT00665561|11534176|FG000|STARTED|Overall Study||1316
10718960|NCT02707770|11882644|FG000|NOT COMPLETED|Overall Study||1
10718961|NCT02707770|11882645|FG001|NOT COMPLETED|Overall Study||0
10718962|NCT02707861|11882655|FG000|STARTED|Overall Study||41
10718963|NCT02707861|11882656|FG001|STARTED|Overall Study||38
10718964|NCT02707861|11882655|FG000|COMPLETED|Overall Study||0
10718965|NCT02707861|11882656|FG001|COMPLETED|Overall Study||0
10391199|NCT00665561|11534177|FG001|STARTED|Overall Study||1130
10391200|NCT00665561|11534176|FG000|COMPLETED|Overall Study||814
10391201|NCT00665561|11534177|FG001|COMPLETED|Overall Study||596
10391202|NCT00665561|11534176|FG000|NOT COMPLETED|Overall Study||502
10391203|NCT00665561|11534177|FG001|NOT COMPLETED|Overall Study||534
10391204|NCT00665626|11534185|FG000|STARTED|Overall Study|Participants randomized|73
10391205|NCT00665626|11534186|FG001|STARTED|Overall Study|Participants randomized|146
10391206|NCT00665626|11534185|FG000|COMPLETED|Overall Study|Participants completed the study|63
10391207|NCT00665626|11534186|FG001|COMPLETED|Overall Study|Participants completed the study|124
10391208|NCT00665626|11534185|FG000|NOT COMPLETED|Overall Study||10
10391209|NCT00665626|11534186|FG001|NOT COMPLETED|Overall Study||22
10391210|NCT00665652|11534192|FG000|STARTED|Overall Study||8
10391211|NCT00665652|11534192|FG000|COMPLETED|Overall Study||2
10391212|NCT00665652|11534192|FG000|NOT COMPLETED|Overall Study||6
10391213|NCT00665704|11534196|FG000|STARTED|Overall Study||9
10391214|NCT00665704|11534196|FG000|COMPLETED|Overall Study||9
10391215|NCT00665704|11534196|FG000|NOT COMPLETED|Overall Study||0
10391216|NCT00665847|11534200|FG000|STARTED|Overall Study||101
10391217|NCT00665847|11534200|FG000|COMPLETED|Overall Study||76
10391218|NCT00665847|11534200|FG000|NOT COMPLETED|Overall Study||25
10391219|NCT00665925|11534208|FG000|STARTED|Overall Study|Participants randomized|77
10391220|NCT00665925|11534209|FG001|STARTED|Overall Study|Participants randomized|76
10391221|NCT00665925|11534210|FG002|STARTED|Overall Study|Participants randomized|152
10391222|NCT00665925|11534211|FG003|STARTED|Overall Study|Participants randomized|152
10391223|NCT00665925|11534208|FG000|COMPLETED|Overall Study|Participants completed the study|62
10391224|NCT00665925|11534209|FG001|COMPLETED|Overall Study|Participants completed the study|59
10391225|NCT00665925|11534210|FG002|COMPLETED|Overall Study|Participants completed the study|126
10391226|NCT00665925|11534211|FG003|COMPLETED|Overall Study|Participants completed the study|131
10391227|NCT00665925|11534208|FG000|NOT COMPLETED|Overall Study||15
10391228|NCT00665925|11534209|FG001|NOT COMPLETED|Overall Study||17
10391229|NCT00665925|11534210|FG002|NOT COMPLETED|Overall Study||26
10391230|NCT00665925|11534211|FG003|NOT COMPLETED|Overall Study||21
10391231|NCT00666029|11534224|FG000|STARTED|Overall Study||20
10391232|NCT00666029|11534225|FG001|STARTED|Overall Study||20
10391233|NCT00666029|11534224|FG000|COMPLETED|Overall Study||19
10391234|NCT00666029|11534225|FG001|COMPLETED|Overall Study||20
10391235|NCT00666029|11534224|FG000|NOT COMPLETED|Overall Study||1
10391236|NCT00666029|11534225|FG001|NOT COMPLETED|Overall Study||0
10391237|NCT00666198|11534232|FG000|STARTED|Overall Study||3337
10391238|NCT00666198|11534232|FG000|COMPLETED|Overall Study||3304
10391239|NCT00666198|11534232|FG000|NOT COMPLETED|Overall Study||33
10391240|NCT00666211|11534238|FG000|STARTED|Overall Study||42
10391241|NCT00666211|11534239|FG001|STARTED|Overall Study||56
10718966|NCT02707861|11882655|FG000|NOT COMPLETED|Overall Study||41
10391242|NCT00666211|11534238|FG000|COMPLETED|Overall Study||22
10391243|NCT00666211|11534239|FG001|COMPLETED|Overall Study||18
10391244|NCT00666211|11534238|FG000|NOT COMPLETED|Overall Study||20
10391245|NCT00666211|11534239|FG001|NOT COMPLETED|Overall Study||38
10391246|NCT00666224|11534247|FG000|STARTED|Double-Blind||243
10391247|NCT00666224|11534248|FG001|STARTED|Double-Blind||238
10718967|NCT02707861|11882656|FG001|NOT COMPLETED|Overall Study||38
10718968|NCT02707952|11882666|FG000|STARTED|Overall Study||129
10391248|NCT00666224|11534247|FG000|COMPLETED|Double-Blind|78 completed 3 years treatment, 66 converted to CDMS, 54 switched to OL as per DMC|198
10718969|NCT02707952|11882667|FG001|STARTED|Overall Study||53
10718970|NCT02707952|11882668|FG002|STARTED|Overall Study||103
10308078|NCT00110149|11441102|FG000|STARTED|Overall Study|total number that signed consent to be screened.|12
10391249|NCT00666224|11534248|FG001|COMPLETED|Double-Blind|55 completed 3 years treatment, 109 converted to CDMS, 47 switched to OL as per DMC|211
10391250|NCT00666224|11534247|FG000|NOT COMPLETED|Double-Blind||45
10391251|NCT00666224|11534248|FG001|NOT COMPLETED|Double-Blind||27
10391252|NCT00666224|11534247|FG000|STARTED|Open-Label|454 participants took at least one dose of GA including 45 who didn't continue into the OL.|198
10391253|NCT00666224|11534248|FG001|STARTED|Open-Label||211
10391254|NCT00666224|11534247|FG000|COMPLETED|Open-Label||163
10391255|NCT00666224|11534248|FG001|COMPLETED|Open-Label||126
10391256|NCT00666224|11534247|FG000|NOT COMPLETED|Open-Label||35
10391257|NCT00666224|11534248|FG001|NOT COMPLETED|Open-Label||85
10391258|NCT00666263|11534255|FG000|STARTED|Study Part 1 (Stabilization Phase 1)||22
10391259|NCT00666263|11534256|FG001|STARTED|Study Part 1 (Stabilization Phase 1)||22
10391260|NCT00666263|11534255|FG000|COMPLETED|Study Part 1 (Stabilization Phase 1)||22
10391261|NCT00666263|11534256|FG001|COMPLETED|Study Part 1 (Stabilization Phase 1)||21
10391262|NCT00666263|11534255|FG000|NOT COMPLETED|Study Part 1 (Stabilization Phase 1)||0
10391263|NCT00666263|11534256|FG001|NOT COMPLETED|Study Part 1 (Stabilization Phase 1)||1
10391264|NCT00666263|11534255|FG000|STARTED|Study Part 2 (Cross-over Period 1)||22
10391265|NCT00666263|11534256|FG001|STARTED|Study Part 2 (Cross-over Period 1)||21
10391266|NCT00666263|11534255|FG000|COMPLETED|Study Part 2 (Cross-over Period 1)||22
10308079|NCT00110149|11441102|FG000|Received Treatment|Overall Study|total number of patient that passed screening and received treatment.|9
10308080|NCT00110149|11441102|FG000|COMPLETED|Overall Study||9
10308081|NCT00110149|11441102|FG000|NOT COMPLETED|Overall Study||3
10308082|NCT00110214|11441109|FG000|STARTED|Overall Study||526
10308083|NCT00110214|11441110|FG001|STARTED|Overall Study||524
10308084|NCT00110214|11441109|FG000|COMPLETED|Overall Study||17
10308085|NCT00110214|11441110|FG001|COMPLETED|Overall Study||21
10308086|NCT00110214|11441109|FG000|NOT COMPLETED|Overall Study||509
10308087|NCT00110214|11441110|FG001|NOT COMPLETED|Overall Study||503
10391267|NCT00666263|11534256|FG001|COMPLETED|Study Part 2 (Cross-over Period 1)||21
10391268|NCT00666263|11534255|FG000|NOT COMPLETED|Study Part 2 (Cross-over Period 1)||0
10718971|NCT02707952|11882669|FG003|STARTED|Overall Study||10
10718972|NCT02707952|11882666|FG000|Participants Who Received Study Drug|Overall Study||129
10718973|NCT02707952|11882667|FG001|Participants Who Received Study Drug|Overall Study||52
10718974|NCT02707952|11882668|FG002|Participants Who Received Study Drug|Overall Study||103
10718975|NCT02707952|11882669|FG003|Participants Who Received Study Drug|Overall Study||10
10718976|NCT02707952|11882666|FG000|COMPLETED|Overall Study||127
10718977|NCT02707952|11882667|FG001|COMPLETED|Overall Study||52
10718978|NCT02707952|11882668|FG002|COMPLETED|Overall Study||101
10308088|NCT00110266|11441116|FG000|STARTED|Overall Study||173
10308089|NCT00110266|11441116|FG000|COMPLETED|Overall Study||95
10308090|NCT00110266|11441116|FG000|NOT COMPLETED|Overall Study||78
10308091|NCT00110305|11441125|FG000|STARTED|Overall Study||279
10308092|NCT00110305|11441126|FG001|STARTED|Overall Study||89
10308093|NCT00110305|11441125|FG000|COMPLETED|Overall Study||165
10308094|NCT00110305|11441126|FG001|COMPLETED|Overall Study||57
10308095|NCT00110305|11441125|FG000|NOT COMPLETED|Overall Study||114
10308096|NCT00110305|11441126|FG001|NOT COMPLETED|Overall Study||32
10308097|NCT00110357|11441145|FG000|STARTED|Overall Study||27
10308098|NCT00110357|11441146|FG001|STARTED|Overall Study||19
10308099|NCT00110357|11441145|FG000|COMPLETED|Overall Study|Number Still on Study|0
10308100|NCT00110357|11441146|FG001|COMPLETED|Overall Study|Number Still on Study|0
10308101|NCT00110357|11441145|FG000|NOT COMPLETED|Overall Study||27
10308102|NCT00110357|11441146|FG001|NOT COMPLETED|Overall Study||19
10308103|NCT00110396|11441179|FG000|STARTED|Overall Study||260
10308104|NCT00110396|11441179|FG000|COMPLETED|Overall Study|260 participants included in the Safety Population.207 completed treatment. 224 completed the trial|224
10308105|NCT00110396|11441179|FG000|NOT COMPLETED|Overall Study||36
10308106|NCT00110461|11441186|FG000|STARTED|30-Week, Double-blind Treatment Phase||98
10308107|NCT00110461|11441187|FG001|STARTED|30-Week, Double-blind Treatment Phase||99
10308108|NCT00110461|11441188|FG002|STARTED|30-Week, Double-blind Treatment Phase||99
10308109|NCT00110461|11441186|FG000|COMPLETED|30-Week, Double-blind Treatment Phase||34
10308110|NCT00110461|11441187|FG001|COMPLETED|30-Week, Double-blind Treatment Phase||22
10308111|NCT00110461|11441188|FG002|COMPLETED|30-Week, Double-blind Treatment Phase||12
10308112|NCT00110461|11441186|FG000|NOT COMPLETED|30-Week, Double-blind Treatment Phase||64
10308113|NCT00110461|11441187|FG001|NOT COMPLETED|30-Week, Double-blind Treatment Phase||77
10542869|NCT01479621|11696008|FG002|COMPLETED|Treatment Period||83
10542870|NCT01479621|11696009|FG003|COMPLETED|Treatment Period||92
10308114|NCT00110461|11441188|FG002|NOT COMPLETED|30-Week, Double-blind Treatment Phase||87
10308115|NCT00110461|11441186|FG000|STARTED|Acute Phase||98
10308116|NCT00110461|11441187|FG001|STARTED|Acute Phase||99
10308117|NCT00110461|11441188|FG002|STARTED|Acute Phase||99
10308118|NCT00110461|11441186|FG000|COMPLETED|Acute Phase||84
10308119|NCT00110461|11441187|FG001|COMPLETED|Acute Phase||77
10308120|NCT00110461|11441188|FG002|COMPLETED|Acute Phase||76
10308121|NCT00110461|11441186|FG000|NOT COMPLETED|Acute Phase||14
10308122|NCT00110461|11441187|FG001|NOT COMPLETED|Acute Phase||22
10308123|NCT00110461|11441188|FG002|NOT COMPLETED|Acute Phase||23
10308124|NCT00110513|11441196|FG000|STARTED|Overall Study||18
10308125|NCT00110513|11441196|FG000|COMPLETED|Overall Study||18
10308126|NCT00110513|11441196|FG000|NOT COMPLETED|Overall Study||0
10308127|NCT00110617|11441202|FG000|STARTED|Overall Study||135
10308128|NCT00110617|11441203|FG001|STARTED|Overall Study|Full Analysis Set 1 does not include 9 participants who were excluded due to GCP violations.|68
10308129|NCT00110617|11441202|FG000|Safety Set 1; Received Study Drug|Overall Study||135
10308130|NCT00110617|11441203|FG001|Safety Set 1; Received Study Drug|Overall Study||56
10308131|NCT00110617|11441202|FG000|Full Analysis 2; Received ICL670|Overall Study||135
10308132|NCT00110617|11441203|FG001|Full Analysis 2; Received ICL670|Overall Study||53
10308133|NCT00110617|11441202|FG000|On Going at Week 24|Overall Study||126
10308134|NCT00110617|11441203|FG001|On Going at Week 24|Overall Study||53
10308135|NCT00110617|11441202|FG000|COMPLETED|Overall Study||96
10308136|NCT00110617|11441203|FG001|COMPLETED|Overall Study||39
10308137|NCT00110617|11441202|FG000|NOT COMPLETED|Overall Study||39
10308138|NCT00110617|11441203|FG001|NOT COMPLETED|Overall Study||29
10308139|NCT00110812|11441214|FG000|STARTED|Main Study||91
10542871|NCT01479621|11696010|FG004|COMPLETED|Treatment Period||82
10812922|NCT03169530|11975139|FG000|STARTED|Overall Study||15
10812923|NCT03169530|11975140|FG001|STARTED|Overall Study||17
10812924|NCT03169530|11975139|FG000|COMPLETED|Overall Study||0
10812925|NCT03169530|11975140|FG001|COMPLETED|Overall Study||0
10812926|NCT03169530|11975139|FG000|NOT COMPLETED|Overall Study||15
10812927|NCT03169530|11975140|FG001|NOT COMPLETED|Overall Study||17
10718979|NCT02707952|11882669|FG003|COMPLETED|Overall Study||10
10718980|NCT02707952|11882666|FG000|NOT COMPLETED|Overall Study||2
10718981|NCT02707952|11882667|FG001|NOT COMPLETED|Overall Study||1
10718982|NCT02707952|11882668|FG002|NOT COMPLETED|Overall Study||2
10812928|NCT03189433|11975148|FG000|STARTED|Overall Study||2
10812929|NCT03189433|11975149|FG001|STARTED|Overall Study||0
10812930|NCT03189433|11975148|FG000|COMPLETED|Overall Study||0
10812931|NCT03189433|11975149|FG001|COMPLETED|Overall Study||0
10812932|NCT03189433|11975148|FG000|NOT COMPLETED|Overall Study||2
10812933|NCT03189433|11975149|FG001|NOT COMPLETED|Overall Study||0
10812934|NCT03151226|11975155|FG000|STARTED|Overall Study||3
10812935|NCT03151226|11975155|FG000|COMPLETED|Overall Study||0
10812936|NCT03151226|11975155|FG000|NOT COMPLETED|Overall Study||3
10391269|NCT00666263|11534256|FG001|NOT COMPLETED|Study Part 2 (Cross-over Period 1)||0
10391270|NCT00666263|11534255|FG000|STARTED|Study Part 3 (Stabilization Phase 2)||22
10391271|NCT00666263|11534256|FG001|STARTED|Study Part 3 (Stabilization Phase 2)||21
10391272|NCT00666263|11534255|FG000|COMPLETED|Study Part 3 (Stabilization Phase 2)||22
10391273|NCT00666263|11534256|FG001|COMPLETED|Study Part 3 (Stabilization Phase 2)||21
10391274|NCT00666263|11534255|FG000|NOT COMPLETED|Study Part 3 (Stabilization Phase 2)||0
10391275|NCT00666263|11534256|FG001|NOT COMPLETED|Study Part 3 (Stabilization Phase 2)||0
10391276|NCT00666263|11534255|FG000|STARTED|Study Part 4 (Cross-over Period 2)||22
10391277|NCT00666263|11534256|FG001|STARTED|Study Part 4 (Cross-over Period 2)||21
10391278|NCT00666263|11534255|FG000|COMPLETED|Study Part 4 (Cross-over Period 2)||21
10391279|NCT00666263|11534256|FG001|COMPLETED|Study Part 4 (Cross-over Period 2)||21
10391280|NCT00666263|11534255|FG000|NOT COMPLETED|Study Part 4 (Cross-over Period 2)||1
10391281|NCT00666263|11534256|FG001|NOT COMPLETED|Study Part 4 (Cross-over Period 2)||0
10391282|NCT00666263|11534255|FG000|STARTED|Study Part 5 (Stabilization Phase 3)||21
10391283|NCT00666263|11534256|FG001|STARTED|Study Part 5 (Stabilization Phase 3)||21
10391284|NCT00666263|11534255|FG000|COMPLETED|Study Part 5 (Stabilization Phase 3)||21
10391285|NCT00666263|11534256|FG001|COMPLETED|Study Part 5 (Stabilization Phase 3)||20
10391286|NCT00666263|11534255|FG000|NOT COMPLETED|Study Part 5 (Stabilization Phase 3)||0
10391287|NCT00666263|11534256|FG001|NOT COMPLETED|Study Part 5 (Stabilization Phase 3)||1
10391288|NCT00666263|11534255|FG000|STARTED|End of Study Visit|End of Study Visit done on all 22 randomized regardless of participation in Study Parts|22
10391289|NCT00666263|11534256|FG001|STARTED|End of Study Visit|End of Study Visit done on all 22 randomized regardless of participation in Study Parts|22
10391290|NCT00666263|11534255|FG000|COMPLETED|End of Study Visit||22
10391291|NCT00666263|11534256|FG001|COMPLETED|End of Study Visit||22
10391292|NCT00666263|11534255|FG000|NOT COMPLETED|End of Study Visit||0
10391293|NCT00666263|11534256|FG001|NOT COMPLETED|End of Study Visit||0
10391294|NCT00666276|11534301|FG000|STARTED|Overall Study||1004
10718983|NCT02707952|11882669|FG003|NOT COMPLETED|Overall Study||0
10718984|NCT02707965|11882690|FG000|STARTED|Overall Study||3
10718985|NCT02707965|11882691|FG001|STARTED|Overall Study||2
10718986|NCT02707965|11882692|FG002|STARTED|Overall Study||4
10718987|NCT02707965|11882693|FG003|STARTED|Overall Study||0
10718988|NCT02707965|11882694|FG004|STARTED|Overall Study||2
10718989|NCT02707965|11882695|FG005|STARTED|Overall Study||1
10718990|NCT02707965|11882696|FG006|STARTED|Overall Study||0
10718991|NCT02707965|11882697|FG007|STARTED|Overall Study||3
10812937|NCT03165747|11975161|FG000|STARTED|Overall Study||0
10812938|NCT03165747|11975162|FG001|STARTED|Overall Study||0
10812939|NCT03165747|11975161|FG000|COMPLETED|Overall Study||0
10812940|NCT03165747|11975162|FG001|COMPLETED|Overall Study||0
10812941|NCT03165747|11975161|FG000|NOT COMPLETED|Overall Study||0
10812942|NCT03165747|11975162|FG001|NOT COMPLETED|Overall Study||0
10812943|NCT03168906|11975170|FG000|STARTED|Overall Study||6
10812944|NCT03168906|11975171|FG001|STARTED|Overall Study||6
10812945|NCT03168906|11975170|FG000|COMPLETED|Overall Study|Study discontinued due to futile nature of drug|0
10391295|NCT00666276|11534301|FG000|COMPLETED|Overall Study||970
10391296|NCT00666276|11534301|FG000|NOT COMPLETED|Overall Study||34
10391297|NCT00666328|11534324|FG000|STARTED|Overall Study|Safety population: participants dosed with study drug (primary population for Safety analyses)|35
10391357|NCT00666679|11534397|FG000|COMPLETED|Washout Period of 1 Week||62
10391298|NCT00666328|11534324|FG000|Modified Intent To Treat (mITT)|Overall Study|mITT population: participants dosed and in whom all inclusion and no exclusion criteria were met|33
10429861|NCT00866879|11576008|FG001|STARTED|Overall Study||185
10718992|NCT02707965|11882698|FG008|STARTED|Overall Study||1
10718993|NCT02707965|11882699|FG009|STARTED|Overall Study||0
10718994|NCT02707965|11882700|FG010|STARTED|Overall Study||1
10718995|NCT02707965|11882701|FG011|STARTED|Overall Study||0
10391299|NCT00666328|11534324|FG000|COMPLETED|Overall Study|30/35 completed the study within the Safety population; 28/33 completed within the mITT population.|30
10391300|NCT00666328|11534324|FG000|NOT COMPLETED|Overall Study||5
10391301|NCT00666406|11534330|FG000|STARTED|First PK Infusion||6
10391302|NCT00666406|11534331|FG001|STARTED|First PK Infusion||3
10391303|NCT00666406|11534330|FG000|COMPLETED|First PK Infusion||6
10391304|NCT00666406|11534331|FG001|COMPLETED|First PK Infusion||3
10391305|NCT00666406|11534330|FG000|NOT COMPLETED|First PK Infusion||0
10391306|NCT00666406|11534331|FG001|NOT COMPLETED|First PK Infusion||0
10391307|NCT00666406|11534330|FG000|STARTED|Second PK Infusion||6
10391308|NCT00666406|11534331|FG001|STARTED|Second PK Infusion||3
10391309|NCT00666406|11534330|FG000|COMPLETED|Second PK Infusion||6
10391310|NCT00666406|11534331|FG001|COMPLETED|Second PK Infusion||3
10391311|NCT00666406|11534330|FG000|NOT COMPLETED|Second PK Infusion||0
10391312|NCT00666406|11534331|FG001|NOT COMPLETED|Second PK Infusion||0
10391313|NCT00666458|11534338|FG000|STARTED|Overall Study|Randomized and treated|403
10391314|NCT00666458|11534339|FG001|STARTED|Overall Study|Randomized and treated|398
10391315|NCT00666458|11534338|FG000|COMPLETED|Overall Study|Completed 18 weeks of treatment|365
10391316|NCT00666458|11534339|FG001|COMPLETED|Overall Study|Completed 18 weeks of treatment|374
10391317|NCT00666458|11534338|FG000|NOT COMPLETED|Overall Study||38
10391318|NCT00666458|11534339|FG001|NOT COMPLETED|Overall Study||24
10391319|NCT00666536|11534347|FG000|STARTED|Overall Study||369
10391320|NCT00666536|11534348|FG001|STARTED|Overall Study||359
10391321|NCT00666536|11534347|FG000|COMPLETED|Overall Study||336
10391322|NCT00666536|11534348|FG001|COMPLETED|Overall Study||322
10391323|NCT00666536|11534347|FG000|NOT COMPLETED|Overall Study||33
10391324|NCT00666536|11534348|FG001|NOT COMPLETED|Overall Study||37
10391325|NCT00666562|11534357|FG000|STARTED|Overall Study||11
10391326|NCT00666562|11534358|FG001|STARTED|Overall Study||10
10391327|NCT00666562|11534359|FG002|STARTED|Overall Study||10
10391328|NCT00666562|11534357|FG000|COMPLETED|Overall Study||11
10391329|NCT00666562|11534358|FG001|COMPLETED|Overall Study||8
10391330|NCT00666562|11534359|FG002|COMPLETED|Overall Study||10
10718996|NCT02707965|11882702|FG012|STARTED|Overall Study||0
10718997|NCT02707965|11882703|FG013|STARTED|Overall Study||2
10391331|NCT00666562|11534357|FG000|NOT COMPLETED|Overall Study||0
10391332|NCT00666562|11534358|FG001|NOT COMPLETED|Overall Study||2
10718998|NCT02707965|11882704|FG014|STARTED|Overall Study||2
10308140|NCT00110812|11441215|FG001|STARTED|Main Study||89
10391333|NCT00666562|11534359|FG002|NOT COMPLETED|Overall Study||0
10391334|NCT00666588|11534378|FG000|STARTED|Overall Study||18
10391335|NCT00666588|11534379|FG001|STARTED|Overall Study||6
10391336|NCT00666588|11534380|FG002|STARTED|Overall Study||6
10391337|NCT00666588|11534381|FG003|STARTED|Overall Study||22
10391338|NCT00666588|11534378|FG000|COMPLETED|Overall Study||14
10391339|NCT00666588|11534379|FG001|COMPLETED|Overall Study||6
10391340|NCT00666588|11534380|FG002|COMPLETED|Overall Study||6
10391341|NCT00666588|11534381|FG003|COMPLETED|Overall Study||20
10308141|NCT00110812|11441216|FG002|STARTED|Main Study||87
10308142|NCT00110812|11441214|FG000|COMPLETED|Main Study||83
10308143|NCT00110812|11441215|FG001|COMPLETED|Main Study||78
10308144|NCT00110812|11441216|FG002|COMPLETED|Main Study||74
10308145|NCT00110812|11441214|FG000|NOT COMPLETED|Main Study||8
10308146|NCT00110812|11441215|FG001|NOT COMPLETED|Main Study||11
10308147|NCT00110812|11441216|FG002|NOT COMPLETED|Main Study||13
10308148|NCT00110812|11441214|FG000|STARTED|Extended Follow-up||80
10308149|NCT00110812|11441215|FG001|STARTED|Extended Follow-up||69
10308150|NCT00110812|11441216|FG002|STARTED|Extended Follow-up||73
10308151|NCT00110812|11441214|FG000|COMPLETED|Extended Follow-up||78
10308152|NCT00110812|11441215|FG001|COMPLETED|Extended Follow-up||65
10308153|NCT00110812|11441216|FG002|COMPLETED|Extended Follow-up||69
10308154|NCT00110812|11441214|FG000|NOT COMPLETED|Extended Follow-up||2
10308155|NCT00110812|11441215|FG001|NOT COMPLETED|Extended Follow-up||4
10308156|NCT00110812|11441216|FG002|NOT COMPLETED|Extended Follow-up||4
10308157|NCT00110890|11441231|FG000|STARTED|Overall Study||368
10308158|NCT00110890|11441232|FG001|STARTED|Overall Study||184
10308159|NCT00110890|11441231|FG000|End of Dose Optimization Phase|Overall Study|Weeks 1 to 16|316
10315381|NCT00178178|11449243|FG003|STARTED|Overall Study||24
10391342|NCT00666588|11534378|FG000|NOT COMPLETED|Overall Study||4
10391343|NCT00666588|11534379|FG001|NOT COMPLETED|Overall Study||0
10391344|NCT00666588|11534380|FG002|NOT COMPLETED|Overall Study||0
10391345|NCT00666588|11534381|FG003|NOT COMPLETED|Overall Study||2
10391346|NCT00666666|11534391|FG000|STARTED|Overall Study||55
10391347|NCT00666666|11534391|FG000|COMPLETED|Overall Study||55
10391348|NCT00666666|11534391|FG000|NOT COMPLETED|Overall Study||0
10391349|NCT00666679|11534397|FG000|STARTED|First Intervention||66
10391350|NCT00666679|11534398|FG001|STARTED|First Intervention||68
10391351|NCT00666679|11534397|FG000|COMPLETED|First Intervention||62
10391352|NCT00666679|11534398|FG001|COMPLETED|First Intervention||67
10391353|NCT00666679|11534397|FG000|NOT COMPLETED|First Intervention||4
10391354|NCT00666679|11534398|FG001|NOT COMPLETED|First Intervention||1
10391355|NCT00666679|11534397|FG000|STARTED|Washout Period of 1 Week||62
10391356|NCT00666679|11534398|FG001|STARTED|Washout Period of 1 Week||67
10391358|NCT00666679|11534398|FG001|COMPLETED|Washout Period of 1 Week||65
10391359|NCT00666679|11534397|FG000|NOT COMPLETED|Washout Period of 1 Week||0
10391360|NCT00666679|11534398|FG001|NOT COMPLETED|Washout Period of 1 Week||2
10718999|NCT02707965|11882705|FG015|STARTED|Overall Study||0
10719000|NCT02707965|11882690|FG000|COMPLETED|Overall Study||2
10812946|NCT03168906|11975171|FG001|COMPLETED|Overall Study|Study discontinued due to futile nature of drug|0
10812947|NCT03168906|11975170|FG000|NOT COMPLETED|Overall Study||6
10812948|NCT03168906|11975171|FG001|NOT COMPLETED|Overall Study||6
10812949|NCT03178201|11975178|FG000|STARTED|Overall Study||5
10812950|NCT03178201|11975178|FG000|COMPLETED|Overall Study||0
10812951|NCT03178201|11975178|FG000|NOT COMPLETED|Overall Study||5
10812952|NCT03172026|11975184|FG000|STARTED|Overall Study||2
10812953|NCT03172026|11975185|FG001|STARTED|Overall Study||0
10812954|NCT03172026|11975184|FG000|8 Week Assessment|Overall Study||0
10812955|NCT03172026|11975185|FG001|8 Week Assessment|Overall Study||0
10391361|NCT00666679|11534397|FG000|STARTED|Second Intervention||62
10391362|NCT00666679|11534398|FG001|STARTED|Second Intervention||65
10391363|NCT00666679|11534397|FG000|COMPLETED|Second Intervention||61
10391364|NCT00666679|11534398|FG001|COMPLETED|Second Intervention||64
10391365|NCT00666679|11534397|FG000|NOT COMPLETED|Second Intervention||1
10391366|NCT00666679|11534398|FG001|NOT COMPLETED|Second Intervention||1
10391367|NCT00666705|11534404|FG000|STARTED|Overall Study||18
10391368|NCT00666705|11534404|FG000|Raltegravir Alone (Days 1 - 3)|Overall Study|400 mg Raltegravir every 12 hours (AM dose on Day 3)|18
10391369|NCT00666705|11534404|FG000|Washout (Days 4 - 5)|Overall Study||18
10391370|NCT00666705|11534404|FG000|Maraviroc Alone (Days 6 - 11)|Overall Study|300 mg Maraviroc every 12 hours|18
10391371|NCT00666705|11534404|FG000|Raltegravir + Maraviroc (Days 12 - 14)|Overall Study|400 mg Raltegravir every 12 hours plus 300 mg Maraviroc every 12 hours (AM doses only on Day 14)|17
10391372|NCT00666705|11534404|FG000|COMPLETED|Overall Study||17
10391373|NCT00666705|11534404|FG000|NOT COMPLETED|Overall Study||1
10391374|NCT00666718|11534415|FG000|STARTED|Overall Study||187
10391375|NCT00666718|11534416|FG001|STARTED|Overall Study||187
10391376|NCT00666718|11534415|FG000|COMPLETED|Overall Study||175
10391377|NCT00666718|11534416|FG001|COMPLETED|Overall Study||169
10391378|NCT00666718|11534415|FG000|NOT COMPLETED|Overall Study||12
10391379|NCT00666718|11534416|FG001|NOT COMPLETED|Overall Study||18
10391380|NCT00666757|11534424|FG000|STARTED|Overall Study||372
10391381|NCT00666757|11534425|FG001|STARTED|Overall Study||378
10391382|NCT00666757|11534424|FG000|COMPLETED|Overall Study||272
10391383|NCT00666757|11534425|FG001|COMPLETED|Overall Study||281
10391384|NCT00666757|11534424|FG000|NOT COMPLETED|Overall Study||100
10391385|NCT00666757|11534425|FG001|NOT COMPLETED|Overall Study||97
10391386|NCT00666835|11534436|FG000|STARTED|Overall Study||314
10391387|NCT00666835|11534437|FG001|STARTED|Overall Study||164
10391388|NCT00666835|11534436|FG000|COMPLETED|Overall Study||261
10391389|NCT00666835|11534437|FG001|COMPLETED|Overall Study||142
10391390|NCT00666835|11534436|FG000|NOT COMPLETED|Overall Study||53
10719001|NCT02707965|11882691|FG001|COMPLETED|Overall Study||1
10719002|NCT02707965|11882692|FG002|COMPLETED|Overall Study||3
10719003|NCT02707965|11882693|FG003|COMPLETED|Overall Study||0
10391391|NCT00666835|11534437|FG001|NOT COMPLETED|Overall Study||22
10719004|NCT02707965|11882694|FG004|COMPLETED|Overall Study||2
10719005|NCT02707965|11882695|FG005|COMPLETED|Overall Study||1
10719006|NCT02707965|11882696|FG006|COMPLETED|Overall Study||0
10719007|NCT02707965|11882697|FG007|COMPLETED|Overall Study||0
10719008|NCT02707965|11882698|FG008|COMPLETED|Overall Study||1
10719009|NCT02707965|11882699|FG009|COMPLETED|Overall Study||0
10719010|NCT02707965|11882700|FG010|COMPLETED|Overall Study||1
10719011|NCT02707965|11882701|FG011|COMPLETED|Overall Study||0
10719012|NCT02707965|11882702|FG012|COMPLETED|Overall Study||0
10719013|NCT02707965|11882703|FG013|COMPLETED|Overall Study||2
10719014|NCT02707965|11882704|FG014|COMPLETED|Overall Study||0
10719015|NCT02707965|11882705|FG015|COMPLETED|Overall Study||0
10719016|NCT02707965|11882690|FG000|NOT COMPLETED|Overall Study||1
10719017|NCT02707965|11882691|FG001|NOT COMPLETED|Overall Study||1
10719018|NCT02707965|11882692|FG002|NOT COMPLETED|Overall Study||1
10719019|NCT02707965|11882693|FG003|NOT COMPLETED|Overall Study||0
10719020|NCT02707965|11882694|FG004|NOT COMPLETED|Overall Study||0
10719021|NCT02707965|11882695|FG005|NOT COMPLETED|Overall Study||0
10719022|NCT02707965|11882696|FG006|NOT COMPLETED|Overall Study||0
10719023|NCT02707965|11882697|FG007|NOT COMPLETED|Overall Study||3
10719024|NCT02707965|11882698|FG008|NOT COMPLETED|Overall Study||0
10719025|NCT02707965|11882699|FG009|NOT COMPLETED|Overall Study||0
10719026|NCT02707965|11882700|FG010|NOT COMPLETED|Overall Study||0
10719027|NCT02707965|11882701|FG011|NOT COMPLETED|Overall Study||0
10719028|NCT02707965|11882702|FG012|NOT COMPLETED|Overall Study||0
10719029|NCT02707965|11882703|FG013|NOT COMPLETED|Overall Study||0
10719030|NCT02707965|11882704|FG014|NOT COMPLETED|Overall Study||2
10719031|NCT02707965|11882705|FG015|NOT COMPLETED|Overall Study||0
10719032|NCT02707991|11882740|FG000|STARTED|Overall Study||33
10719033|NCT02707991|11882741|FG001|STARTED|Overall Study||35
10719034|NCT02707991|11882740|FG000|Day 60 Data Collectio|Overall Study||32
10719035|NCT02707991|11882741|FG001|Day 60 Data Collectio|Overall Study||34
10719036|NCT02707991|11882740|FG000|Month 6 Data Collection|Overall Study||32
10719037|NCT02707991|11882741|FG001|Month 6 Data Collection|Overall Study||34
10719038|NCT02707991|11882740|FG000|COMPLETED|Overall Study||32
10719039|NCT02707991|11882741|FG001|COMPLETED|Overall Study||34
10719040|NCT02707991|11882740|FG000|NOT COMPLETED|Overall Study||1
10719041|NCT02707991|11882741|FG001|NOT COMPLETED|Overall Study||1
10719042|NCT02708095|11882750|FG000|STARTED|Overall Study||105
10719043|NCT02708095|11882751|FG001|STARTED|Overall Study||105
10719044|NCT02708095|11882752|FG002|STARTED|Overall Study||104
10719045|NCT02708095|11882750|FG000|Received at Least 1 Dose of Study Drug|Overall Study||105
10719046|NCT02708095|11882751|FG001|Received at Least 1 Dose of Study Drug|Overall Study||105
10719047|NCT02708095|11882752|FG002|Received at Least 1 Dose of Study Drug|Overall Study||104
10719048|NCT02708095|11882750|FG000|COMPLETED|Overall Study||83
10308160|NCT00110890|11441232|FG001|End of Dose Optimization Phase|Overall Study|Weeks 1 to 16|170
10308161|NCT00110890|11441231|FG000|End of Efficacy Assessment Phase|Overall Study|Weeks 17 to 23|280
10308162|NCT00110890|11441232|FG001|End of Efficacy Assessment Phase|Overall Study|Weeks 17 to 23|150
10308163|NCT00110890|11441231|FG000|COMPLETED|Overall Study|Follow-up Phase|7
10308164|NCT00110890|11441232|FG001|COMPLETED|Overall Study|Follow-up Phase|5
10308165|NCT00110890|11441231|FG000|NOT COMPLETED|Overall Study||361
10308166|NCT00110890|11441232|FG001|NOT COMPLETED|Overall Study||179
10308167|NCT00110994|11441240|FG000|STARTED|Double-blind (DB) Treatment|ITT population|51
10308168|NCT00110994|11441241|FG001|STARTED|Double-blind (DB) Treatment|ITT population|50
10308169|NCT00110994|11441240|FG000|Received Treatment|Double-blind (DB) Treatment|Safety population|51
10308170|NCT00110994|11441241|FG001|Received Treatment|Double-blind (DB) Treatment|Safety population|50
10308171|NCT00110994|11441240|FG000|COMPLETED|Double-blind (DB) Treatment||9
10308172|NCT00110994|11441241|FG001|COMPLETED|Double-blind (DB) Treatment||3
10308173|NCT00110994|11441240|FG000|NOT COMPLETED|Double-blind (DB) Treatment||42
10308174|NCT00110994|11441241|FG001|NOT COMPLETED|Double-blind (DB) Treatment||47
10308175|NCT00110994|11441240|FG000|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|1
10308176|NCT00110994|11441241|FG001|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|2
10308177|NCT00110994|11441240|FG000|COMPLETED|Active Follow-up||0
10308178|NCT00110994|11441241|FG001|COMPLETED|Active Follow-up||0
10308179|NCT00110994|11441240|FG000|NOT COMPLETED|Active Follow-up||1
10308180|NCT00110994|11441241|FG001|NOT COMPLETED|Active Follow-up||2
10308181|NCT00110994|11441240|FG000|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|41
10308182|NCT00110994|11441241|FG001|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|47
10308183|NCT00110994|11441240|FG000|COMPLETED|Long Term Follow-up||22
10308184|NCT00110994|11441241|FG001|COMPLETED|Long Term Follow-up||30
10308185|NCT00110994|11441240|FG000|NOT COMPLETED|Long Term Follow-up||19
10308186|NCT00110994|11441241|FG001|NOT COMPLETED|Long Term Follow-up||17
10308187|NCT00111007|11441249|FG000|STARTED|Double-blind (DB) Treatment|ITT population|135
10308188|NCT00111007|11441250|FG001|STARTED|Double-blind (DB) Treatment|ITT population|135
10308189|NCT00111007|11441249|FG000|Received Treatment|Double-blind (DB) Treatment|Safety population|134
10308190|NCT00111007|11441250|FG001|Received Treatment|Double-blind (DB) Treatment|Safety population|134
10308191|NCT00111007|11441249|FG000|COMPLETED|Double-blind (DB) Treatment||27
10308192|NCT00111007|11441250|FG001|COMPLETED|Double-blind (DB) Treatment||24
10308193|NCT00111007|11441249|FG000|NOT COMPLETED|Double-blind (DB) Treatment||108
10308194|NCT00111007|11441250|FG001|NOT COMPLETED|Double-blind (DB) Treatment||111
10308195|NCT00111007|11441249|FG000|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|6
10542872|NCT01479621|11696011|FG005|COMPLETED|Treatment Period||63
10542873|NCT01479621|11696012|FG006|COMPLETED|Treatment Period||84
10542874|NCT01479621|11696006|FG000|NOT COMPLETED|Treatment Period||0
10542875|NCT01479621|11696007|FG001|NOT COMPLETED|Treatment Period||24
10542876|NCT01479621|11696008|FG002|NOT COMPLETED|Treatment Period||21
10542877|NCT01479621|11696009|FG003|NOT COMPLETED|Treatment Period||12
10542878|NCT01479621|11696010|FG004|NOT COMPLETED|Treatment Period||21
10542879|NCT01479621|11696011|FG005|NOT COMPLETED|Treatment Period||41
10542880|NCT01479621|11696012|FG006|NOT COMPLETED|Treatment Period||20
10542881|NCT01479725|11696028|FG000|STARTED|Overall Study||6
10542882|NCT01479725|11696029|FG001|STARTED|Overall Study||2
10542883|NCT01479725|11696028|FG000|COMPLETED|Overall Study||4
10542884|NCT01479725|11696029|FG001|COMPLETED|Overall Study||1
10542885|NCT01479725|11696028|FG000|NOT COMPLETED|Overall Study||2
10542886|NCT01479725|11696029|FG001|NOT COMPLETED|Overall Study||1
10542887|NCT01479764|11696037|FG000|STARTED|Randomized||76
10542888|NCT01479764|11696038|FG001|STARTED|Randomized||78
10542889|NCT01479764|11696037|FG000|COMPLETED|Randomized|2 randomized participants did not receive study drug|74
10542890|NCT01479764|11696038|FG001|COMPLETED|Randomized|1 randomized participant did not receive study drug|77
10542891|NCT01479764|11696037|FG000|NOT COMPLETED|Randomized||2
10542892|NCT01479764|11696038|FG001|NOT COMPLETED|Randomized||1
10542893|NCT01479764|11696037|FG000|STARTED|Treated||74
10542894|NCT01479764|11696038|FG001|STARTED|Treated||77
10542895|NCT01479764|11696037|FG000|COMPLETED|Treated||74
10542896|NCT01479764|11696038|FG001|COMPLETED|Treated||75
10542897|NCT01479764|11696037|FG000|NOT COMPLETED|Treated||0
10542898|NCT01479764|11696038|FG001|NOT COMPLETED|Treated||2
10658602|NCT02233998|11819779|FG002|STARTED|Overall Study||53
10658603|NCT02233998|11819777|FG000|COMPLETED|Overall Study||53
10658604|NCT02233998|11819778|FG001|COMPLETED|Overall Study||52
10658605|NCT02233998|11819779|FG002|COMPLETED|Overall Study||53
10658606|NCT02233998|11819777|FG000|NOT COMPLETED|Overall Study||0
10658607|NCT02233998|11819778|FG001|NOT COMPLETED|Overall Study||0
10658608|NCT02233998|11819779|FG002|NOT COMPLETED|Overall Study||0
10658609|NCT02234063|11819789|FG000|STARTED|Overall Study||1795
10658610|NCT02234063|11819790|FG001|STARTED|Overall Study||255
10658611|NCT02234063|11819789|FG000|COMPLETED|Overall Study||1540
10658612|NCT02234063|11819790|FG001|COMPLETED|Overall Study||212
10658613|NCT02234063|11819789|FG000|NOT COMPLETED|Overall Study||255
10658614|NCT02234063|11819790|FG001|NOT COMPLETED|Overall Study||43
10658615|NCT02234115|11819801|FG000|STARTED|Overall Study||137
10658616|NCT02234115|11819801|FG000|ITT|Overall Study||137
10658617|NCT02234115|11819801|FG000|PP|Overall Study||124
10542899|NCT01479777|11696044|FG000|STARTED|Overall Study||12
10542900|NCT01479777|11696044|FG000|COMPLETED|Overall Study||10
10542901|NCT01479777|11696044|FG000|NOT COMPLETED|Overall Study||2
10542902|NCT01479868|11696048|FG000|STARTED|Overall Study|Restricted to subject who received at least one dose of treatment (TMC435/RBV/PegIFN).|106
10542903|NCT01479868|11696048|FG000|COMPLETED|Overall Study||97
10542904|NCT01479868|11696048|FG000|NOT COMPLETED|Overall Study||9
10542905|NCT01479985|11696054|FG000|STARTED|Overall Study||167
10542906|NCT01479985|11696055|FG001|STARTED|Overall Study||86
10542907|NCT01479985|11696054|FG000|Baseline Survey|Overall Study||166
10542908|NCT01479985|11696055|FG001|Baseline Survey|Overall Study||85
10542909|NCT01479985|11696054|FG000|COMPLETED|Overall Study||161
10542910|NCT01479985|11696055|FG001|COMPLETED|Overall Study||80
10542911|NCT01479985|11696054|FG000|NOT COMPLETED|Overall Study||6
10542912|NCT01479985|11696055|FG001|NOT COMPLETED|Overall Study||6
10542913|NCT01480076|11696063|FG000|STARTED|Overall Study|enrolled and started run-in treatment|901
10542914|NCT01480076|11696063|FG000|Intent to Treat Population|Overall Study|Received ≥1 dose of study drug & provided ≥1 efficacy assessment at Baseline & the 3-month visit.|835
10542915|NCT01480076|11696063|FG000|COMPLETED|Overall Study||611
10542916|NCT01480076|11696063|FG000|NOT COMPLETED|Overall Study||290
10542917|NCT01480089|11696081|FG000|STARTED|Overall Study||25
10542918|NCT01480089|11696082|FG001|STARTED|Overall Study||30
10542919|NCT01480089|11696081|FG000|COMPLETED|Overall Study||25
10542920|NCT01480089|11696082|FG001|COMPLETED|Overall Study||30
10542921|NCT01480089|11696081|FG000|NOT COMPLETED|Overall Study||0
10542922|NCT01480089|11696082|FG001|NOT COMPLETED|Overall Study||0
10542923|NCT01480219|11696090|FG000|STARTED|Overall Study||325
10542924|NCT01480219|11696091|FG001|STARTED|Overall Study||142
10542925|NCT01480219|11696090|FG000|COMPLETED|Overall Study||325
10542926|NCT01480219|11696091|FG001|COMPLETED|Overall Study||142
10542927|NCT01480219|11696090|FG000|NOT COMPLETED|Overall Study||0
10542928|NCT01480219|11696091|FG001|NOT COMPLETED|Overall Study||0
10542929|NCT01480232|11696101|FG000|STARTED|Overall Study||40
10308196|NCT00111007|11441250|FG001|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|4
10308197|NCT00111007|11441249|FG000|COMPLETED|Active Follow-up||0
10308198|NCT00111007|11441250|FG001|COMPLETED|Active Follow-up||2
10308199|NCT00111007|11441249|FG000|NOT COMPLETED|Active Follow-up||6
10308200|NCT00111007|11441250|FG001|NOT COMPLETED|Active Follow-up||2
10308201|NCT00111007|11441249|FG000|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|101
10308202|NCT00111007|11441250|FG001|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|107
10308203|NCT00111007|11441249|FG000|COMPLETED|Long Term Follow-up||54
10308204|NCT00111007|11441250|FG001|COMPLETED|Long Term Follow-up||62
10308205|NCT00111007|11441249|FG000|NOT COMPLETED|Long Term Follow-up||47
10308206|NCT00111007|11441250|FG001|NOT COMPLETED|Long Term Follow-up||45
10308207|NCT00111228|11441259|FG000|STARTED|Overall Study||54
10391392|NCT00666848|11534447|FG000|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|8
10391393|NCT00666848|11534448|FG001|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|9
10391394|NCT00666848|11534449|FG002|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|7
10391395|NCT00666848|11534447|FG000|COMPLETED|Overall Study|finished Aim 2|8
10391396|NCT00666848|11534448|FG001|COMPLETED|Overall Study|finished Aim 1|9
10391397|NCT00666848|11534449|FG002|COMPLETED|Overall Study|finished Aim 3|7
10391398|NCT00666848|11534447|FG000|NOT COMPLETED|Overall Study||0
10542930|NCT01480232|11696102|FG001|STARTED|Overall Study||41
10542931|NCT01480232|11696103|FG002|STARTED|Overall Study||38
10542932|NCT01480232|11696104|FG003|STARTED|Overall Study||41
10542933|NCT01480232|11696101|FG000|COMPLETED|Overall Study||22
10391399|NCT00666848|11534448|FG001|NOT COMPLETED|Overall Study||0
10391400|NCT00666848|11534449|FG002|NOT COMPLETED|Overall Study||0
10391401|NCT00666926|11534457|FG000|STARTED|Overall Study||2
10391402|NCT00666926|11534458|FG001|STARTED|Overall Study||4
10391403|NCT00666926|11534459|FG002|STARTED|Overall Study||3
10391404|NCT00666926|11534460|FG003|STARTED|Overall Study||4
10391405|NCT00666926|11534461|FG004|STARTED|Overall Study||3
10391406|NCT00666926|11534462|FG005|STARTED|Overall Study||4
10391407|NCT00666926|11534463|FG006|STARTED|Overall Study||4
10391408|NCT00666926|11534464|FG007|STARTED|Overall Study||1
10391409|NCT00666926|11534465|FG008|STARTED|Overall Study||3
10391410|NCT00666926|11534466|FG009|STARTED|Overall Study||10
10391411|NCT00666926|11534467|FG010|STARTED|Overall Study||6
10391412|NCT00666926|11534468|FG011|STARTED|Overall Study||33
10391413|NCT00666926|11534469|FG012|STARTED|Overall Study||3
10391414|NCT00666926|11534470|FG013|STARTED|Overall Study||4
10391415|NCT00666926|11534471|FG014|STARTED|Overall Study||7
10391416|NCT00666926|11534472|FG015|STARTED|Overall Study||8
10391417|NCT00666926|11534457|FG000|COMPLETED|Overall Study||0
10391418|NCT00666926|11534458|FG001|COMPLETED|Overall Study||0
10391419|NCT00666926|11534459|FG002|COMPLETED|Overall Study||0
10391420|NCT00666926|11534460|FG003|COMPLETED|Overall Study||0
10391421|NCT00666926|11534461|FG004|COMPLETED|Overall Study||0
10391422|NCT00666926|11534462|FG005|COMPLETED|Overall Study||0
10391423|NCT00666926|11534463|FG006|COMPLETED|Overall Study||0
10391424|NCT00666926|11534464|FG007|COMPLETED|Overall Study||0
10391425|NCT00666926|11534465|FG008|COMPLETED|Overall Study||0
10391426|NCT00666926|11534466|FG009|COMPLETED|Overall Study||0
10391427|NCT00666926|11534467|FG010|COMPLETED|Overall Study||0
10391428|NCT00666926|11534468|FG011|COMPLETED|Overall Study||0
10391429|NCT00666926|11534469|FG012|COMPLETED|Overall Study||0
10391430|NCT00666926|11534470|FG013|COMPLETED|Overall Study||0
10391431|NCT00666926|11534471|FG014|COMPLETED|Overall Study||0
10391432|NCT00666926|11534472|FG015|COMPLETED|Overall Study||0
10391433|NCT00666926|11534457|FG000|NOT COMPLETED|Overall Study||2
10391434|NCT00666926|11534458|FG001|NOT COMPLETED|Overall Study||4
10391435|NCT00666926|11534459|FG002|NOT COMPLETED|Overall Study||3
10391436|NCT00666926|11534460|FG003|NOT COMPLETED|Overall Study||4
10391437|NCT00666926|11534461|FG004|NOT COMPLETED|Overall Study||3
10391438|NCT00666926|11534462|FG005|NOT COMPLETED|Overall Study||4
10391439|NCT00666926|11534463|FG006|NOT COMPLETED|Overall Study||4
10391440|NCT00666926|11534464|FG007|NOT COMPLETED|Overall Study||1
10391441|NCT00666926|11534465|FG008|NOT COMPLETED|Overall Study||3
10391442|NCT00666926|11534466|FG009|NOT COMPLETED|Overall Study||10
10391443|NCT00666926|11534467|FG010|NOT COMPLETED|Overall Study||6
10391444|NCT00666926|11534468|FG011|NOT COMPLETED|Overall Study||33
10391445|NCT00666926|11534469|FG012|NOT COMPLETED|Overall Study||3
10391446|NCT00666926|11534470|FG013|NOT COMPLETED|Overall Study||4
10391447|NCT00666926|11534471|FG014|NOT COMPLETED|Overall Study||7
10391448|NCT00666926|11534472|FG015|NOT COMPLETED|Overall Study||8
10391449|NCT00666965|11534527|FG000|STARTED|Overall Study||58
10391450|NCT00666965|11534528|FG001|STARTED|Overall Study||57
10391451|NCT00666965|11534529|FG002|STARTED|Overall Study||58
10391452|NCT00666965|11534530|FG003|STARTED|Overall Study||57
10391453|NCT00666965|11534527|FG000|COMPLETED|Overall Study||55
10391454|NCT00666965|11534528|FG001|COMPLETED|Overall Study||53
10391455|NCT00666965|11534529|FG002|COMPLETED|Overall Study||56
10391456|NCT00666965|11534530|FG003|COMPLETED|Overall Study||42
10391457|NCT00666965|11534527|FG000|NOT COMPLETED|Overall Study||3
10391458|NCT00666965|11534528|FG001|NOT COMPLETED|Overall Study||4
10391459|NCT00666965|11534529|FG002|NOT COMPLETED|Overall Study||2
10391460|NCT00666965|11534530|FG003|NOT COMPLETED|Overall Study||15
10391461|NCT00666978|11534542|FG000|STARTED|Overall Study||270
10391462|NCT00666978|11534543|FG001|STARTED|Overall Study||270
10391463|NCT00666978|11534542|FG000|COMPLETED|Overall Study||192
10391464|NCT00666978|11534543|FG001|COMPLETED|Overall Study||187
10391465|NCT00666978|11534542|FG000|NOT COMPLETED|Overall Study||78
10391466|NCT00666978|11534543|FG001|NOT COMPLETED|Overall Study||83
10391467|NCT00667004|11534553|FG000|STARTED|Overall Study||95
10391468|NCT00667004|11534554|FG001|STARTED|Overall Study||88
10391469|NCT00667004|11534553|FG000|COMPLETED|Overall Study||93
10391470|NCT00667004|11534554|FG001|COMPLETED|Overall Study||85
10391471|NCT00667004|11534553|FG000|NOT COMPLETED|Overall Study||2
10391472|NCT00667004|11534554|FG001|NOT COMPLETED|Overall Study||3
10391473|NCT00667095|11534562|FG000|STARTED|Overall Study||11
10391474|NCT00667095|11534563|FG001|STARTED|Overall Study||10
10391475|NCT00667095|11534562|FG000|COMPLETED|Overall Study||11
10391476|NCT00667095|11534563|FG001|COMPLETED|Overall Study||9
10391477|NCT00667095|11534562|FG000|NOT COMPLETED|Overall Study||0
10391478|NCT00667095|11534563|FG001|NOT COMPLETED|Overall Study||1
10391479|NCT00667186|11534571|FG000|STARTED|Overall Study||4692
10391480|NCT00667186|11534572|FG001|STARTED|Overall Study||4880
10391481|NCT00667186|11534571|FG000|COMPLETED|Overall Study||4692
10391482|NCT00667186|11534572|FG001|COMPLETED|Overall Study||4880
10391483|NCT00667186|11534571|FG000|NOT COMPLETED|Overall Study||0
10391484|NCT00667186|11534572|FG001|NOT COMPLETED|Overall Study||0
10391485|NCT00667225|11534580|FG000|STARTED|Overall Study||16
10391486|NCT00667225|11534581|FG001|STARTED|Overall Study||13
10391487|NCT00667225|11534580|FG000|COMPLETED|Overall Study||15
10391488|NCT00667225|11534581|FG001|COMPLETED|Overall Study||12
10719049|NCT02708095|11882751|FG001|COMPLETED|Overall Study||86
10719050|NCT02708095|11882752|FG002|COMPLETED|Overall Study||86
10391489|NCT00667225|11534580|FG000|NOT COMPLETED|Overall Study||1
10391490|NCT00667225|11534581|FG001|NOT COMPLETED|Overall Study||1
10391491|NCT00667277|11534587|FG000|STARTED|Overall Study||13
10308208|NCT00111228|11441260|FG001|STARTED|Overall Study||54
10308209|NCT00111228|11441261|FG002|STARTED|Overall Study||54
10308210|NCT00111228|11441259|FG000|COMPLETED|Overall Study||49
10308211|NCT00111228|11441260|FG001|COMPLETED|Overall Study||53
10308212|NCT00111228|11441261|FG002|COMPLETED|Overall Study||54
10308213|NCT00111228|11441259|FG000|NOT COMPLETED|Overall Study||5
10308214|NCT00111228|11441260|FG001|NOT COMPLETED|Overall Study||1
10308215|NCT00111228|11441261|FG002|NOT COMPLETED|Overall Study||0
10308216|NCT00111241|11441271|FG000|STARTED|Overall Study||45
10308217|NCT00111241|11441272|FG001|STARTED|Overall Study||70
10308218|NCT00111241|11441271|FG000|COMPLETED|Overall Study||30
10308219|NCT00111241|11441272|FG001|COMPLETED|Overall Study||62
10308220|NCT00111241|11441271|FG000|NOT COMPLETED|Overall Study||15
10308221|NCT00111241|11441272|FG001|NOT COMPLETED|Overall Study||8
10308222|NCT00111475|11441290|FG000|STARTED|Overall Study||4
10308223|NCT00111475|11441291|FG001|STARTED|Overall Study||4
10308224|NCT00111475|11441292|FG002|STARTED|Overall Study||4
10308225|NCT00111475|11441293|FG003|STARTED|Overall Study||4
10308226|NCT00111475|11441294|FG004|STARTED|Overall Study||4
10308227|NCT00111475|11441295|FG005|STARTED|Overall Study||4
10308228|NCT00111475|11441296|FG006|STARTED|Overall Study||4
10308229|NCT00111475|11441297|FG007|STARTED|Overall Study||8
10308230|NCT00111475|11441298|FG008|STARTED|Overall Study||8
10308231|NCT00111475|11441299|FG009|STARTED|Overall Study||1
10308232|NCT00111475|11441290|FG000|COMPLETED|Overall Study||4
10308233|NCT00111475|11441291|FG001|COMPLETED|Overall Study||4
10308234|NCT00111475|11441292|FG002|COMPLETED|Overall Study||4
10308235|NCT00111475|11441293|FG003|COMPLETED|Overall Study||4
10308236|NCT00111475|11441294|FG004|COMPLETED|Overall Study||4
10308237|NCT00111475|11441295|FG005|COMPLETED|Overall Study||3
10308238|NCT00111475|11441296|FG006|COMPLETED|Overall Study||4
10308239|NCT00111475|11441297|FG007|COMPLETED|Overall Study||8
10308240|NCT00111475|11441298|FG008|COMPLETED|Overall Study||8
10308241|NCT00111475|11441299|FG009|COMPLETED|Overall Study||1
10308242|NCT00111475|11441290|FG000|NOT COMPLETED|Overall Study||0
10308243|NCT00111475|11441291|FG001|NOT COMPLETED|Overall Study||0
10308244|NCT00111475|11441292|FG002|NOT COMPLETED|Overall Study||0
10308245|NCT00111475|11441293|FG003|NOT COMPLETED|Overall Study||0
10308246|NCT00111475|11441294|FG004|NOT COMPLETED|Overall Study||0
10308247|NCT00111475|11441295|FG005|NOT COMPLETED|Overall Study||1
10308248|NCT00111475|11441296|FG006|NOT COMPLETED|Overall Study||0
10308249|NCT00111475|11441297|FG007|NOT COMPLETED|Overall Study||0
10308250|NCT00111475|11441298|FG008|NOT COMPLETED|Overall Study||0
10308251|NCT00111475|11441299|FG009|NOT COMPLETED|Overall Study||0
10308252|NCT00111657|11441326|FG000|STARTED|Overall Study|37 consented. 30 initiated treatment. 29 completed at least 1 dose.|37
10308253|NCT00111657|11441326|FG000|COMPLETED|Overall Study|Completed all intended doses.|21
10308254|NCT00111657|11441326|FG000|NOT COMPLETED|Overall Study||16
10308255|NCT00111761|11441334|FG000|STARTED|Part 1|This treatment group was not initiated until Part 2|0
10308256|NCT00111761|11441335|FG001|STARTED|Part 1||19
10308257|NCT00111761|11441334|FG000|COMPLETED|Part 1||0
10308258|NCT00111761|11441335|FG001|COMPLETED|Part 1|Completed through safety followup|14
10308259|NCT00111761|11441334|FG000|NOT COMPLETED|Part 1||0
10308260|NCT00111761|11441335|FG001|NOT COMPLETED|Part 1||5
10308261|NCT00111761|11441334|FG000|STARTED|Part 2||24
10308262|NCT00111761|11441335|FG001|STARTED|Part 2|This treatment group was used in Part 1 only|0
10308263|NCT00111761|11441334|FG000|COMPLETED|Part 2||16
10308264|NCT00111761|11441335|FG001|COMPLETED|Part 2||0
10308265|NCT00111761|11441334|FG000|NOT COMPLETED|Part 2||8
10308266|NCT00111761|11441335|FG001|NOT COMPLETED|Part 2||0
10308267|NCT00111800|11441347|FG000|STARTED|Period 1: Main Phase (12 Weeks)||64
10308268|NCT00111800|11441348|FG001|STARTED|Period 1: Main Phase (12 Weeks)||61
10308269|NCT00111800|11441349|FG002|STARTED|Period 1: Main Phase (12 Weeks)||63
10308270|NCT00111800|11441350|FG003|STARTED|Period 1: Main Phase (12 Weeks)||66
10308271|NCT00111800|11441351|FG004|STARTED|Period 1: Main Phase (12 Weeks)||60
10308272|NCT00111800|11441352|FG005|STARTED|Period 1: Main Phase (12 Weeks)||61
10308273|NCT00111800|11441347|FG000|COMPLETED|Period 1: Main Phase (12 Weeks)||49
10308274|NCT00111800|11441348|FG001|COMPLETED|Period 1: Main Phase (12 Weeks)||47
10308275|NCT00111800|11441349|FG002|COMPLETED|Period 1: Main Phase (12 Weeks)||54
10308276|NCT00111800|11441350|FG003|COMPLETED|Period 1: Main Phase (12 Weeks)||60
10308277|NCT00111800|11441351|FG004|COMPLETED|Period 1: Main Phase (12 Weeks)||55
10308278|NCT00111800|11441352|FG005|COMPLETED|Period 1: Main Phase (12 Weeks)||56
10308279|NCT00111800|11441347|FG000|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||15
10308280|NCT00111800|11441348|FG001|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||14
10308281|NCT00111800|11441349|FG002|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||9
10308282|NCT00111800|11441350|FG003|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||6
10308283|NCT00111800|11441351|FG004|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||5
10719051|NCT02708095|11882750|FG000|NOT COMPLETED|Overall Study||22
10719052|NCT02708095|11882751|FG001|NOT COMPLETED|Overall Study||19
10391492|NCT00667277|11534587|FG000|COMPLETED|Overall Study||11
10391493|NCT00667277|11534587|FG000|NOT COMPLETED|Overall Study||2
10391494|NCT00667342|11534594|FG000|STARTED|Overall Study||31
10391495|NCT00667342|11534595|FG001|STARTED|Overall Study||0
10391496|NCT00667342|11534596|FG002|STARTED|Overall Study||12
10391497|NCT00667342|11534594|FG000|COMPLETED|Overall Study||17
10391498|NCT00667342|11534595|FG001|COMPLETED|Overall Study||0
10391499|NCT00667342|11534596|FG002|COMPLETED|Overall Study||3
10391500|NCT00667342|11534594|FG000|NOT COMPLETED|Overall Study||14
10391501|NCT00667342|11534595|FG001|NOT COMPLETED|Overall Study||0
10719053|NCT02708095|11882752|FG002|NOT COMPLETED|Overall Study||18
10719054|NCT02708121|11882764|FG000|STARTED|Overall Study||35
10391502|NCT00667342|11534596|FG002|NOT COMPLETED|Overall Study||9
10391503|NCT00667355|11534610|FG000|STARTED|Overall Study||41
10391504|NCT00667355|11534610|FG000|COMPLETED|Overall Study||30
10391505|NCT00667355|11534610|FG000|NOT COMPLETED|Overall Study||11
10391506|NCT00667368|11534616|FG000|STARTED|Overall Study||682
10391507|NCT00667368|11534617|FG001|STARTED|Overall Study||683
10391508|NCT00667368|11534616|FG000|COMPLETED|Overall Study||482
10391509|NCT00667368|11534617|FG001|COMPLETED|Overall Study||511
10391510|NCT00667368|11534616|FG000|NOT COMPLETED|Overall Study||200
10391511|NCT00667368|11534617|FG001|NOT COMPLETED|Overall Study||172
10391512|NCT00667381|11534625|FG000|STARTED|Overall Study||501
10391513|NCT00667381|11534626|FG001|STARTED|Overall Study||503
10391514|NCT00667381|11534625|FG000|COMPLETED|Overall Study||501
10391515|NCT00667381|11534626|FG001|COMPLETED|Overall Study||503
10391516|NCT00667381|11534625|FG000|NOT COMPLETED|Overall Study||0
10391517|NCT00667381|11534626|FG001|NOT COMPLETED|Overall Study||0
10391518|NCT00667394|11534634|FG000|STARTED|Overall Study||41
10391519|NCT00667394|11534635|FG001|STARTED|Overall Study||1
10308284|NCT00111800|11441352|FG005|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||5
10308285|NCT00111800|11441347|FG000|STARTED|Period 2: Extension Phase (12 Weeks)||48
10308286|NCT00111800|11441348|FG001|STARTED|Period 2: Extension Phase (12 Weeks)||47
10308287|NCT00111800|11441349|FG002|STARTED|Period 2: Extension Phase (12 Weeks)||54
10308288|NCT00111800|11441350|FG003|STARTED|Period 2: Extension Phase (12 Weeks)||59
10308289|NCT00111800|11441351|FG004|STARTED|Period 2: Extension Phase (12 Weeks)||55
10308290|NCT00111800|11441352|FG005|STARTED|Period 2: Extension Phase (12 Weeks)||55
10308291|NCT00111800|11441347|FG000|COMPLETED|Period 2: Extension Phase (12 Weeks)||46
10391520|NCT00667394|11534634|FG000|COMPLETED|Overall Study||37
10391521|NCT00667394|11534635|FG001|COMPLETED|Overall Study||1
10391522|NCT00667394|11534634|FG000|NOT COMPLETED|Overall Study||4
10719055|NCT02708121|11882765|FG001|STARTED|Overall Study||31
10719056|NCT02708121|11882764|FG000|Provided Acceptability Data|Overall Study||20
10719057|NCT02708121|11882765|FG001|Provided Acceptability Data|Overall Study|This condition did not participate in acceptability survey|0
10719058|NCT02708121|11882764|FG000|Treatment Program Use Data Available|Overall Study||34
10719059|NCT02708121|11882765|FG001|Treatment Program Use Data Available|Overall Study||24
10719060|NCT02708121|11882764|FG000|6 Month In-Person Follow Up Data|Overall Study||22
10719061|NCT02708121|11882765|FG001|6 Month In-Person Follow Up Data|Overall Study||19
10719062|NCT02708121|11882764|FG000|6 Month Weight Data Via EHR|Overall Study||14
10719063|NCT02708121|11882765|FG001|6 Month Weight Data Via EHR|Overall Study||13
10719064|NCT02708121|11882764|FG000|COMPLETED|Overall Study||34
10719065|NCT02708121|11882765|FG001|COMPLETED|Overall Study||26
10719066|NCT02708121|11882764|FG000|NOT COMPLETED|Overall Study||1
10719067|NCT02708121|11882765|FG001|NOT COMPLETED|Overall Study||5
10719068|NCT02708186|11882773|FG000|STARTED|Overall Study||16
10719069|NCT02708186|11882774|FG001|STARTED|Overall Study||18
10719070|NCT02708186|11882773|FG000|COMPLETED|Overall Study||14
10719071|NCT02708186|11882774|FG001|COMPLETED|Overall Study||16
10719072|NCT02708186|11882773|FG000|NOT COMPLETED|Overall Study||2
10719073|NCT02708186|11882774|FG001|NOT COMPLETED|Overall Study||2
10719074|NCT02708212|11882782|FG000|STARTED|Overall Study||60
10719075|NCT02708212|11882783|FG001|STARTED|Overall Study||60
10719076|NCT02708212|11882782|FG000|COMPLETED|Overall Study||60
10719077|NCT02708212|11882783|FG001|COMPLETED|Overall Study||60
10719078|NCT02708212|11882782|FG000|NOT COMPLETED|Overall Study||0
10719079|NCT02708212|11882783|FG001|NOT COMPLETED|Overall Study||0
10719080|NCT02708238|11882796|FG000|STARTED|Overall Study||60
10719081|NCT02708238|11882797|FG001|STARTED|Overall Study||60
10719082|NCT02708238|11882798|FG002|STARTED|Overall Study||60
10719083|NCT02708238|11882796|FG000|COMPLETED|Overall Study||60
10719084|NCT02708238|11882797|FG001|COMPLETED|Overall Study||59
10719085|NCT02708238|11882798|FG002|COMPLETED|Overall Study||57
10719086|NCT02708238|11882796|FG000|NOT COMPLETED|Overall Study||0
10719087|NCT02708238|11882797|FG001|NOT COMPLETED|Overall Study||1
10719088|NCT02708238|11882798|FG002|NOT COMPLETED|Overall Study||3
10719089|NCT02708277|11882808|FG000|STARTED|Overall Study||50
10308292|NCT00111800|11441348|FG001|COMPLETED|Period 2: Extension Phase (12 Weeks)||40
10308293|NCT00111800|11441349|FG002|COMPLETED|Period 2: Extension Phase (12 Weeks)||47
10308294|NCT00111800|11441350|FG003|COMPLETED|Period 2: Extension Phase (12 Weeks)||54
10308295|NCT00111800|11441351|FG004|COMPLETED|Period 2: Extension Phase (12 Weeks)||51
10308296|NCT00111800|11441352|FG005|COMPLETED|Period 2: Extension Phase (12 Weeks)||53
10308297|NCT00111800|11441347|FG000|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||2
10308298|NCT00111800|11441348|FG001|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||7
10308299|NCT00111800|11441349|FG002|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||7
10391523|NCT00667394|11534635|FG001|NOT COMPLETED|Overall Study||0
10391524|NCT00667420|11534641|FG000|STARTED|Overall Study||17
10391525|NCT00667420|11534641|FG000|Completion of Pre-operative EOX-P|Overall Study||15
10391526|NCT00667420|11534641|FG000|Completion of Surgery/Re-staging|Overall Study||11
10391527|NCT00667420|11534641|FG000|COMPLETED|Overall Study||7
10391528|NCT00667420|11534641|FG000|NOT COMPLETED|Overall Study||10
10391529|NCT00667446|11534648|FG000|STARTED|Treatment Period (36 Months)||34
10391530|NCT00667446|11534649|FG001|STARTED|Treatment Period (36 Months)||38
10391531|NCT00667446|11534648|FG000|COMPLETED|Treatment Period (36 Months)||11
10391532|NCT00667446|11534649|FG001|COMPLETED|Treatment Period (36 Months)||13
10391533|NCT00667446|11534648|FG000|NOT COMPLETED|Treatment Period (36 Months)||23
10391534|NCT00667446|11534649|FG001|NOT COMPLETED|Treatment Period (36 Months)||25
10391535|NCT00667446|11534648|FG000|STARTED|Safety Follow-up Period (12 Weeks)||28
10391536|NCT00667446|11534649|FG001|STARTED|Safety Follow-up Period (12 Weeks)||26
10391537|NCT00667446|11534648|FG000|COMPLETED|Safety Follow-up Period (12 Weeks)||28
10391538|NCT00667446|11534649|FG001|COMPLETED|Safety Follow-up Period (12 Weeks)||25
10391539|NCT00667446|11534648|FG000|NOT COMPLETED|Safety Follow-up Period (12 Weeks)||0
10391540|NCT00667446|11534649|FG001|NOT COMPLETED|Safety Follow-up Period (12 Weeks)||1
10391541|NCT00667459|11534657|FG000|STARTED|Overall Study||280
10391542|NCT00667459|11534658|FG001|STARTED|Overall Study||265
10391543|NCT00667459|11534657|FG000|COMPLETED|Overall Study||272
10391544|NCT00667459|11534658|FG001|COMPLETED|Overall Study||220
10391545|NCT00667459|11534657|FG000|NOT COMPLETED|Overall Study||8
10391546|NCT00667459|11534658|FG001|NOT COMPLETED|Overall Study||45
10428545|NCT00858780|11574585|FG001|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
10428546|NCT00858780|11574586|FG002|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
10428547|NCT00858780|11574587|FG003|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
10428548|NCT00858780|11574588|FG004|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
10428549|NCT00858780|11574584|FG000|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||73
10308300|NCT00111800|11441350|FG003|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||5
10308301|NCT00111800|11441351|FG004|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||4
10308302|NCT00111800|11441352|FG005|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||2
10308303|NCT00111813|11441375|FG000|STARTED|Overall Study||3
10428550|NCT00858780|11574585|FG001|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
10308304|NCT00111813|11441376|FG001|STARTED|Overall Study||3
10308305|NCT00111813|11441377|FG002|STARTED|Overall Study||10
10308306|NCT00111813|11441378|FG003|STARTED|Overall Study||6
10308307|NCT00111813|11441379|FG004|STARTED|Overall Study||6
10308308|NCT00111813|11441380|FG005|STARTED|Overall Study||6
10308309|NCT00111813|11441375|FG000|COMPLETED|Overall Study||0
10308310|NCT00111813|11441376|FG001|COMPLETED|Overall Study||0
10308311|NCT00111813|11441377|FG002|COMPLETED|Overall Study||0
10308312|NCT00111813|11441378|FG003|COMPLETED|Overall Study||1
10308313|NCT00111813|11441379|FG004|COMPLETED|Overall Study||0
10308314|NCT00111813|11441380|FG005|COMPLETED|Overall Study||0
10308315|NCT00111813|11441375|FG000|NOT COMPLETED|Overall Study||3
10391547|NCT00667511|11534664|FG000|STARTED|Intervention 1: Home DHD||58
10391548|NCT00667511|11534664|FG000|COMPLETED|Intervention 1: Home DHD||51
10391549|NCT00667511|11534664|FG000|NOT COMPLETED|Intervention 1: Home DHD||7
10391550|NCT00667511|11534664|FG000|STARTED|Training/Transition Period||51
10391551|NCT00667511|11534664|FG000|COMPLETED|Training/Transition Period||43
10391552|NCT00667511|11534664|FG000|NOT COMPLETED|Training/Transition Period||8
10391553|NCT00667511|11534664|FG000|STARTED|Intervention 2: Home NHD||43
10391554|NCT00667511|11534664|FG000|COMPLETED|Intervention 2: Home NHD||39
10391555|NCT00667511|11534664|FG000|NOT COMPLETED|Intervention 2: Home NHD||4
10391556|NCT00667563|11534670|FG000|STARTED|Overall Study||150
10391557|NCT00667563|11534670|FG000|COMPLETED|Overall Study||126
10391558|NCT00667563|11534670|FG000|NOT COMPLETED|Overall Study||24
10391559|NCT00667576|11534679|FG000|STARTED|Overall Study||30
10391560|NCT00667576|11534680|FG001|STARTED|Overall Study||31
10391561|NCT00667576|11534681|FG002|STARTED|Overall Study||31
10391562|NCT00667576|11534682|FG003|STARTED|Overall Study||31
10391563|NCT00667576|11534683|FG004|STARTED|Overall Study||30
10391564|NCT00667576|11534679|FG000|COMPLETED|Overall Study||28
10391565|NCT00667576|11534680|FG001|COMPLETED|Overall Study||30
10391566|NCT00667576|11534681|FG002|COMPLETED|Overall Study||29
10391567|NCT00667576|11534682|FG003|COMPLETED|Overall Study||27
10391568|NCT00667576|11534683|FG004|COMPLETED|Overall Study||29
10391569|NCT00667576|11534679|FG000|NOT COMPLETED|Overall Study||2
10391570|NCT00667576|11534680|FG001|NOT COMPLETED|Overall Study||1
10391571|NCT00667576|11534681|FG002|NOT COMPLETED|Overall Study||2
10391572|NCT00667576|11534682|FG003|NOT COMPLETED|Overall Study||4
10391573|NCT00667576|11534683|FG004|NOT COMPLETED|Overall Study||1
10391574|NCT00667589|11534699|FG000|STARTED|Overall Study||1
10391575|NCT00667589|11534700|FG001|STARTED|Overall Study||0
10391576|NCT00667589|11534701|FG002|STARTED|Overall Study||3
10391577|NCT00667589|11534702|FG003|STARTED|Overall Study||2
10391578|NCT00667589|11534699|FG000|COMPLETED|Overall Study||0
10391579|NCT00667589|11534700|FG001|COMPLETED|Overall Study||0
10391580|NCT00667589|11534701|FG002|COMPLETED|Overall Study||0
10391581|NCT00667589|11534702|FG003|COMPLETED|Overall Study||1
10391582|NCT00667589|11534699|FG000|NOT COMPLETED|Overall Study||1
10391583|NCT00667589|11534700|FG001|NOT COMPLETED|Overall Study||0
10391584|NCT00667589|11534701|FG002|NOT COMPLETED|Overall Study||3
10391585|NCT00667589|11534702|FG003|NOT COMPLETED|Overall Study||1
10391586|NCT00667602|11534715|FG000|STARTED|Overall Study||219
10391587|NCT00667602|11534716|FG001|STARTED|Overall Study||228
10391588|NCT00667602|11534717|FG002|STARTED|Overall Study||215
10391589|NCT00667602|11534715|FG000|COMPLETED|Overall Study||211
10391590|NCT00667602|11534716|FG001|COMPLETED|Overall Study||213
10391591|NCT00667602|11534717|FG002|COMPLETED|Overall Study||197
10719090|NCT02708277|11882809|FG001|STARTED|Overall Study||43
10719091|NCT02708277|11882808|FG000|COMPLETED|Overall Study||43
10719092|NCT02708277|11882809|FG001|COMPLETED|Overall Study||39
10719093|NCT02708277|11882808|FG000|NOT COMPLETED|Overall Study||7
10719094|NCT02708277|11882809|FG001|NOT COMPLETED|Overall Study||4
10719095|NCT02708290|11882817|FG000|STARTED|Overall Study||1009
10719096|NCT02708290|11882818|FG001|STARTED|Overall Study||1009
10719097|NCT02708290|11882817|FG000|COMPLETED|Overall Study||1009
10719098|NCT02708290|11882818|FG001|COMPLETED|Overall Study||1009
10542934|NCT01480232|11696102|FG001|COMPLETED|Overall Study||19
10542935|NCT01480232|11696103|FG002|COMPLETED|Overall Study||21
10542936|NCT01480232|11696104|FG003|COMPLETED|Overall Study||22
10542937|NCT01480232|11696101|FG000|NOT COMPLETED|Overall Study||18
10542938|NCT01480232|11696102|FG001|NOT COMPLETED|Overall Study||22
10542939|NCT01480232|11696103|FG002|NOT COMPLETED|Overall Study||17
10542940|NCT01480232|11696104|FG003|NOT COMPLETED|Overall Study||19
10542941|NCT01480258|11696116|FG000|STARTED|Infant Series||656
10542942|NCT01480258|11696117|FG001|STARTED|Infant Series||659
10542943|NCT01480258|11696116|FG000|Vaccinated|Infant Series||653
10542944|NCT01480258|11696117|FG001|Vaccinated|Infant Series||659
10542945|NCT01480258|11696116|FG000|COMPLETED|Infant Series||649
10542946|NCT01480258|11696117|FG001|COMPLETED|Infant Series||651
10542947|NCT01480258|11696116|FG000|NOT COMPLETED|Infant Series||7
10542948|NCT01480258|11696117|FG001|NOT COMPLETED|Infant Series||8
10542949|NCT01480258|11696116|FG000|STARTED|Interim Period||649
10812956|NCT03172026|11975184|FG000|6 Month Assessment|Overall Study||0
10812957|NCT03172026|11975185|FG001|6 Month Assessment|Overall Study||0
10812958|NCT03172026|11975184|FG000|COMPLETED|Overall Study||0
10812959|NCT03172026|11975185|FG001|COMPLETED|Overall Study||0
10812960|NCT03172026|11975184|FG000|NOT COMPLETED|Overall Study||2
10812961|NCT03172026|11975185|FG001|NOT COMPLETED|Overall Study||0
10719099|NCT02708290|11882817|FG000|NOT COMPLETED|Overall Study||0
10719100|NCT02708290|11882818|FG001|NOT COMPLETED|Overall Study||0
10719101|NCT02708355|11882827|FG000|STARTED|Overall Study||21
10719102|NCT02708355|11882828|FG001|STARTED|Overall Study||22
10812962|NCT03152526|11975194|FG000|STARTED|Overall Study|No participants were enrolled on this arm.|0
10542950|NCT01480258|11696117|FG001|STARTED|Interim Period||651
10542951|NCT01480258|11696116|FG000|COMPLETED|Interim Period||639
10542952|NCT01480258|11696117|FG001|COMPLETED|Interim Period||642
10719103|NCT02708355|11882829|FG002|STARTED|Overall Study||12
10719104|NCT02708355|11882827|FG000|COMPLETED|Overall Study||20
10719105|NCT02708355|11882828|FG001|COMPLETED|Overall Study||22
10719106|NCT02708355|11882829|FG002|COMPLETED|Overall Study||12
10719107|NCT02708355|11882827|FG000|NOT COMPLETED|Overall Study||1
10719108|NCT02708355|11882828|FG001|NOT COMPLETED|Overall Study||0
10719109|NCT02708355|11882829|FG002|NOT COMPLETED|Overall Study||0
10719110|NCT02708433|11882837|FG000|STARTED|First Intervention (Visit 1)||12
10719111|NCT02708433|11882838|FG001|STARTED|First Intervention (Visit 1)||11
10719112|NCT02708433|11882837|FG000|COMPLETED|First Intervention (Visit 1)||12
10719113|NCT02708433|11882838|FG001|COMPLETED|First Intervention (Visit 1)||11
10719114|NCT02708433|11882837|FG000|NOT COMPLETED|First Intervention (Visit 1)||0
10719115|NCT02708433|11882838|FG001|NOT COMPLETED|First Intervention (Visit 1)||0
10719116|NCT02708433|11882837|FG000|STARTED|Washout (at Least 1 Week)||12
10719117|NCT02708433|11882838|FG001|STARTED|Washout (at Least 1 Week)||11
10719118|NCT02708433|11882837|FG000|COMPLETED|Washout (at Least 1 Week)||12
10719119|NCT02708433|11882838|FG001|COMPLETED|Washout (at Least 1 Week)||11
10719120|NCT02708433|11882837|FG000|NOT COMPLETED|Washout (at Least 1 Week)||0
10719121|NCT02708433|11882838|FG001|NOT COMPLETED|Washout (at Least 1 Week)||0
10719122|NCT02708433|11882837|FG000|STARTED|Second Intervention (Visit 2)||12
10719123|NCT02708433|11882838|FG001|STARTED|Second Intervention (Visit 2)||11
10719124|NCT02708433|11882837|FG000|COMPLETED|Second Intervention (Visit 2)||12
10719125|NCT02708433|11882838|FG001|COMPLETED|Second Intervention (Visit 2)||11
10719126|NCT02708433|11882837|FG000|NOT COMPLETED|Second Intervention (Visit 2)||0
10719127|NCT02708433|11882838|FG001|NOT COMPLETED|Second Intervention (Visit 2)||0
10719128|NCT02708485|11882846|FG000|STARTED|Overall Study||3
10812963|NCT03152526|11975195|FG001|STARTED|Overall Study|One participant was enrolled on this arm.|1
10812964|NCT03152526|11975194|FG000|COMPLETED|Overall Study|No participants were enrolled on this arm.|0
10812965|NCT03152526|11975195|FG001|COMPLETED|Overall Study|The one participant enrolled on this arm withdrew from the study early.|0
10812966|NCT03152526|11975194|FG000|NOT COMPLETED|Overall Study||0
10812967|NCT03152526|11975195|FG001|NOT COMPLETED|Overall Study||1
10812968|NCT03161964|11975203|FG000|STARTED|Overall Study||1
10812969|NCT03161964|11975204|FG001|STARTED|Overall Study||1
10812970|NCT03161964|11975203|FG000|COMPLETED|Overall Study||1
10812971|NCT03161964|11975204|FG001|COMPLETED|Overall Study||0
10812972|NCT03161964|11975203|FG000|NOT COMPLETED|Overall Study||0
10812973|NCT03161964|11975204|FG001|NOT COMPLETED|Overall Study||1
10812974|NCT03150160|11975212|FG000|STARTED|Overall Study||0
10812975|NCT03150160|11975213|FG001|STARTED|Overall Study||1
10812976|NCT03150160|11975212|FG000|COMPLETED|Overall Study||0
10812977|NCT03150160|11975213|FG001|COMPLETED|Overall Study||1
10812978|NCT03150160|11975212|FG000|NOT COMPLETED|Overall Study||0
10812979|NCT03150160|11975213|FG001|NOT COMPLETED|Overall Study||0
10812980|NCT03137225|11975221|FG000|STARTED|First 4 Hour Measurement Period||1
10812981|NCT03137225|11975222|FG001|STARTED|First 4 Hour Measurement Period||0
10812982|NCT03137225|11975221|FG000|COMPLETED|First 4 Hour Measurement Period||1
10812983|NCT03137225|11975222|FG001|COMPLETED|First 4 Hour Measurement Period||0
10812984|NCT03137225|11975221|FG000|NOT COMPLETED|First 4 Hour Measurement Period||0
10812985|NCT03137225|11975222|FG001|NOT COMPLETED|First 4 Hour Measurement Period||0
10812986|NCT03137225|11975221|FG000|STARTED|Second 4 Hour Measurement Period||1
10812987|NCT03137225|11975222|FG001|STARTED|Second 4 Hour Measurement Period||0
10812988|NCT03137225|11975221|FG000|COMPLETED|Second 4 Hour Measurement Period||1
10812989|NCT03137225|11975222|FG001|COMPLETED|Second 4 Hour Measurement Period||0
10812990|NCT03137225|11975221|FG000|NOT COMPLETED|Second 4 Hour Measurement Period||0
10812991|NCT03137225|11975222|FG001|NOT COMPLETED|Second 4 Hour Measurement Period||0
10812992|NCT03123393|11975230|FG000|STARTED|Overall Study||24
10812993|NCT03123393|11975231|FG001|STARTED|Overall Study||25
10812994|NCT03123393|11975230|FG000|COMPLETED|Overall Study||3
10812995|NCT03123393|11975231|FG001|COMPLETED|Overall Study||2
10812996|NCT03123393|11975230|FG000|NOT COMPLETED|Overall Study||21
10812997|NCT03123393|11975231|FG001|NOT COMPLETED|Overall Study||23
10812998|NCT03123328|11975237|FG000|STARTED|Overall Study||380
10812999|NCT03123328|11975237|FG000|COMPLETED|Overall Study||351
10813000|NCT03123328|11975237|FG000|NOT COMPLETED|Overall Study||29
10813001|NCT03119662|11975243|FG000|STARTED|Overall Study||2
10813002|NCT03119662|11975244|FG001|STARTED|Overall Study||2
10813003|NCT03119662|11975243|FG000|COMPLETED|Overall Study||2
10813004|NCT03119662|11975244|FG001|COMPLETED|Overall Study||1
10813005|NCT03119662|11975243|FG000|NOT COMPLETED|Overall Study||0
10719129|NCT02708485|11882847|FG001|STARTED|Overall Study||12
10813006|NCT03119662|11975244|FG001|NOT COMPLETED|Overall Study||1
10813007|NCT03109418|11975252|FG000|STARTED|Overall Study||2
10813008|NCT03109418|11975253|FG001|STARTED|Overall Study||4
10813009|NCT03109418|11975252|FG000|COMPLETED|Overall Study||2
10719130|NCT02708485|11882846|FG000|COMPLETED|Overall Study||0
10719131|NCT02708485|11882847|FG001|COMPLETED|Overall Study||10
10719132|NCT02708485|11882846|FG000|NOT COMPLETED|Overall Study||3
10719133|NCT02708485|11882847|FG001|NOT COMPLETED|Overall Study||2
10719134|NCT02708498|11882861|FG000|STARTED|Overall Study||42
10813010|NCT03109418|11975253|FG001|COMPLETED|Overall Study||3
10813011|NCT03109418|11975252|FG000|NOT COMPLETED|Overall Study||0
10308316|NCT00111813|11441376|FG001|NOT COMPLETED|Overall Study||3
10308317|NCT00111813|11441377|FG002|NOT COMPLETED|Overall Study||10
10308318|NCT00111813|11441378|FG003|NOT COMPLETED|Overall Study||5
10308319|NCT00111813|11441379|FG004|NOT COMPLETED|Overall Study||6
10308320|NCT00111813|11441380|FG005|NOT COMPLETED|Overall Study||6
10308321|NCT00111839|11441398|FG000|STARTED|Overall Study||50
10308322|NCT00111839|11441399|FG001|STARTED|Overall Study||51
10308323|NCT00111839|11441400|FG002|STARTED|Overall Study||49
10308324|NCT00111839|11441398|FG000|Treated|Overall Study||50
10308325|NCT00111839|11441399|FG001|Treated|Overall Study||51
10308326|NCT00111839|11441400|FG002|Treated|Overall Study||47
10308327|NCT00111839|11441398|FG000|COMPLETED|Overall Study||2
10308328|NCT00111839|11441399|FG001|COMPLETED|Overall Study||5
10308329|NCT00111839|11441400|FG002|COMPLETED|Overall Study||0
10308330|NCT00111839|11441398|FG000|NOT COMPLETED|Overall Study||48
10308331|NCT00111839|11441399|FG001|NOT COMPLETED|Overall Study||46
10308332|NCT00111839|11441400|FG002|NOT COMPLETED|Overall Study||49
10308333|NCT00111917|11441410|FG000|STARTED|Overall Study||9
10308334|NCT00111917|11441411|FG001|STARTED|Overall Study||4
10308335|NCT00111917|11441410|FG000|COMPLETED|Overall Study||8
10308336|NCT00111917|11441411|FG001|COMPLETED|Overall Study||3
10308337|NCT00111917|11441410|FG000|NOT COMPLETED|Overall Study||1
10308338|NCT00111917|11441411|FG001|NOT COMPLETED|Overall Study||1
10308339|NCT00112047|11441423|FG000|STARTED|Randomized Phase|Intention to treat (ITT) population N=255 (2 participants had received prior antiretroviral therapy)|257
10308340|NCT00112047|11441424|FG001|STARTED|Randomized Phase|ITT analysis population|254
10308341|NCT00112047|11441423|FG000|COMPLETED|Randomized Phase||187
10308342|NCT00112047|11441424|FG001|COMPLETED|Randomized Phase||166
10308343|NCT00112047|11441423|FG000|NOT COMPLETED|Randomized Phase||70
10308344|NCT00112047|11441424|FG001|NOT COMPLETED|Randomized Phase||88
10308345|NCT00112047|11441423|FG000|STARTED|Atripla Phase|Number of participants who completed randomized phase and opted to roll over to Atripla at Week 144|160
10308346|NCT00112047|11441424|FG001|STARTED|Atripla Phase|Number of participants who completed randomized phase and opted to roll over to Atripla at Week 144|126
10308347|NCT00112047|11441423|FG000|COMPLETED|Atripla Phase||142
10308348|NCT00112047|11441424|FG001|COMPLETED|Atripla Phase||106
10308349|NCT00112047|11441423|FG000|NOT COMPLETED|Atripla Phase||18
10308350|NCT00112047|11441424|FG001|NOT COMPLETED|Atripla Phase||20
10308351|NCT00112112|11441437|FG000|STARTED|Overall Study||10
10308352|NCT00112112|11441438|FG001|STARTED|Overall Study||10
10308353|NCT00112112|11441437|FG000|COMPLETED|Overall Study||10
10308354|NCT00112112|11441438|FG001|COMPLETED|Overall Study||10
10308355|NCT00112112|11441437|FG000|NOT COMPLETED|Overall Study||0
10308356|NCT00112112|11441438|FG001|NOT COMPLETED|Overall Study||0
10308357|NCT00112125|11441446|FG000|STARTED|Overall Study||213
10308358|NCT00112125|11441447|FG001|STARTED|Overall Study||215
10308359|NCT00112125|11441446|FG000|COMPLETED|Overall Study||189
10308360|NCT00112125|11441447|FG001|COMPLETED|Overall Study||193
10308361|NCT00112125|11441446|FG000|NOT COMPLETED|Overall Study||24
10308362|NCT00112125|11441447|FG001|NOT COMPLETED|Overall Study||22
10308363|NCT00112151|11441459|FG000|STARTED|Overall Study||28
10308364|NCT00112151|11441460|FG001|STARTED|Overall Study||28
10308365|NCT00112151|11441461|FG002|STARTED|Overall Study||28
10308366|NCT00112151|11441462|FG003|STARTED|Overall Study||27
10391592|NCT00667602|11534715|FG000|NOT COMPLETED|Overall Study||8
10391593|NCT00667602|11534716|FG001|NOT COMPLETED|Overall Study||15
10391594|NCT00667602|11534717|FG002|NOT COMPLETED|Overall Study||18
10391595|NCT00667615|11534730|FG000|STARTED|Overall Study||30
10391596|NCT00667615|11534730|FG000|COMPLETED|Overall Study||30
10391597|NCT00667615|11534730|FG000|NOT COMPLETED|Overall Study||0
10391598|NCT00667693|11534736|FG000|STARTED|Overall Study||49
10391599|NCT00667693|11534737|FG001|STARTED|Overall Study||52
10391600|NCT00667693|11534736|FG000|COMPLETED|Overall Study||49
10391601|NCT00667693|11534737|FG001|COMPLETED|Overall Study||50
10391602|NCT00667693|11534736|FG000|NOT COMPLETED|Overall Study||0
10391603|NCT00667693|11534737|FG001|NOT COMPLETED|Overall Study||2
10391604|NCT00667719|11534743|FG000|STARTED|Overall Study||564
10391605|NCT00667719|11534743|FG000|COMPLETED|Overall Study||493
10391606|NCT00667719|11534743|FG000|NOT COMPLETED|Overall Study||71
10391607|NCT00667732|11534754|FG000|STARTED|Run -In (8 Weeks)||41
10391608|NCT00667732|11534755|FG001|STARTED|Run -In (8 Weeks)||0
10391609|NCT00667732|11534756|FG002|STARTED|Run -In (8 Weeks)||0
10429862|NCT00866879|11576007|FG000|COMPLETED|Overall Study||90
10719135|NCT02708498|11882862|FG001|STARTED|Overall Study||40
10719136|NCT02708498|11882863|FG002|STARTED|Overall Study||152
10719137|NCT02708498|11882864|FG003|STARTED|Overall Study||156
10719138|NCT02708498|11882865|FG004|STARTED|Overall Study||363
10719139|NCT02708498|11882866|FG005|STARTED|Overall Study||330
10658618|NCT02234115|11819801|FG000|PK Subgroup|Overall Study||31
10719140|NCT02708498|11882867|FG006|STARTED|Overall Study||20
10658619|NCT02234115|11819801|FG000|COMPLETED|Overall Study||122
10391610|NCT00667732|11534754|FG000|Participants Enrolled in Substudy|Run -In (8 Weeks)||20
10391611|NCT00667732|11534755|FG001|Participants Enrolled in Substudy|Run -In (8 Weeks)||0
10391612|NCT00667732|11534756|FG002|Participants Enrolled in Substudy|Run -In (8 Weeks)||0
10391613|NCT00667732|11534754|FG000|COMPLETED|Run -In (8 Weeks)||34
10391614|NCT00667732|11534755|FG001|COMPLETED|Run -In (8 Weeks)||0
10391615|NCT00667732|11534756|FG002|COMPLETED|Run -In (8 Weeks)||0
10391616|NCT00667732|11534754|FG000|NOT COMPLETED|Run -In (8 Weeks)||7
10391617|NCT00667732|11534755|FG001|NOT COMPLETED|Run -In (8 Weeks)||0
10719141|NCT02708498|11882868|FG007|STARTED|Overall Study||48
10719142|NCT02708498|11882861|FG000|COMPLETED|Overall Study||22
10391618|NCT00667732|11534756|FG002|NOT COMPLETED|Run -In (8 Weeks)||0
10391619|NCT00667732|11534754|FG000|STARTED|Randomization (24 Weeks)||0
10391620|NCT00667732|11534755|FG001|STARTED|Randomization (24 Weeks)||17
10391621|NCT00667732|11534756|FG002|STARTED|Randomization (24 Weeks)||17
10391622|NCT00667732|11534754|FG000|Participants Enrolled in Substudy|Randomization (24 Weeks)||0
10391623|NCT00667732|11534755|FG001|Participants Enrolled in Substudy|Randomization (24 Weeks)||11
10391624|NCT00667732|11534756|FG002|Participants Enrolled in Substudy|Randomization (24 Weeks)||9
10391625|NCT00667732|11534754|FG000|COMPLETED|Randomization (24 Weeks)||0
10391626|NCT00667732|11534755|FG001|COMPLETED|Randomization (24 Weeks)||16
10391627|NCT00667732|11534756|FG002|COMPLETED|Randomization (24 Weeks)||17
10391628|NCT00667732|11534754|FG000|NOT COMPLETED|Randomization (24 Weeks)||0
10391629|NCT00667732|11534755|FG001|NOT COMPLETED|Randomization (24 Weeks)||1
10391630|NCT00667732|11534756|FG002|NOT COMPLETED|Randomization (24 Weeks)||0
10391631|NCT00667732|11534754|FG000|STARTED|Extension (26 Weeks)||0
10391632|NCT00667732|11534755|FG001|STARTED|Extension (26 Weeks)||14
10391633|NCT00667732|11534756|FG002|STARTED|Extension (26 Weeks)||17
10391634|NCT00667732|11534754|FG000|COMPLETED|Extension (26 Weeks)||0
10391635|NCT00667732|11534755|FG001|COMPLETED|Extension (26 Weeks)||14
10391636|NCT00667732|11534756|FG002|COMPLETED|Extension (26 Weeks)||17
10391637|NCT00667732|11534754|FG000|NOT COMPLETED|Extension (26 Weeks)||0
10391638|NCT00667732|11534755|FG001|NOT COMPLETED|Extension (26 Weeks)||0
10391639|NCT00667732|11534756|FG002|NOT COMPLETED|Extension (26 Weeks)||0
10391640|NCT00667745|11534768|FG000|STARTED|Overall Study||141
10391641|NCT00667745|11534769|FG001|STARTED|Overall Study||142
10391642|NCT00667745|11534768|FG000|COMPLETED|Overall Study||116
10391643|NCT00667745|11534769|FG001|COMPLETED|Overall Study||121
10391644|NCT00667745|11534768|FG000|NOT COMPLETED|Overall Study||25
10391645|NCT00667745|11534769|FG001|NOT COMPLETED|Overall Study||21
10391646|NCT00667810|11534780|FG000|STARTED|Overall Study||269
10391647|NCT00667810|11534781|FG001|STARTED|Overall Study||264
10391648|NCT00667810|11534782|FG002|STARTED|Overall Study||346
10391649|NCT00667810|11534783|FG003|STARTED|Overall Study||11
10391650|NCT00667810|11534780|FG000|Treated|Overall Study||267
10391651|NCT00667810|11534781|FG001|Treated|Overall Study||263
10391652|NCT00667810|11534782|FG002|Treated|Overall Study||344
10391653|NCT00667810|11534783|FG003|Treated|Overall Study||11
10391654|NCT00667810|11534780|FG000|COMPLETED|Overall Study||102
10391655|NCT00667810|11534781|FG001|COMPLETED|Overall Study||94
10391656|NCT00667810|11534782|FG002|COMPLETED|Overall Study||124
10391657|NCT00667810|11534783|FG003|COMPLETED|Overall Study||9
10391658|NCT00667810|11534780|FG000|NOT COMPLETED|Overall Study||167
10391659|NCT00667810|11534781|FG001|NOT COMPLETED|Overall Study||170
10391660|NCT00667810|11534782|FG002|NOT COMPLETED|Overall Study||222
10391661|NCT00667810|11534783|FG003|NOT COMPLETED|Overall Study||2
10391662|NCT00667849|11534800|FG000|STARTED|Overall Study||250
10391663|NCT00667849|11534801|FG001|STARTED|Overall Study||251
10391664|NCT00667849|11534800|FG000|COMPLETED|Overall Study||142
10391665|NCT00667849|11534801|FG001|COMPLETED|Overall Study||130
10391666|NCT00667849|11534800|FG000|NOT COMPLETED|Overall Study||108
10391667|NCT00667849|11534801|FG001|NOT COMPLETED|Overall Study||121
10391668|NCT00667862|11534810|FG000|STARTED|Overall Study||35
10391669|NCT00667862|11534810|FG000|COMPLETED|Overall Study||0
10719143|NCT02708498|11882862|FG001|COMPLETED|Overall Study||21
10391670|NCT00667862|11534810|FG000|NOT COMPLETED|Overall Study||35
10391671|NCT00667875|11534817|FG000|STARTED|Overall Study|3 subjects had no data after randomization and were excluded from analysis|23
10391672|NCT00667875|11534818|FG001|STARTED|Overall Study||21
10391673|NCT00667875|11534819|FG002|STARTED|Overall Study|2 subjects had no data following randomization and were excluded from the analysis.|21
10391674|NCT00667875|11534817|FG000|Subjects Included in Analysisd|Overall Study||20
10391675|NCT00667875|11534818|FG001|Subjects Included in Analysisd|Overall Study||21
10719144|NCT02708498|11882863|FG002|COMPLETED|Overall Study||90
10719145|NCT02708498|11882864|FG003|COMPLETED|Overall Study||105
10542953|NCT01480258|11696116|FG000|NOT COMPLETED|Interim Period||10
10542954|NCT01480258|11696117|FG001|NOT COMPLETED|Interim Period||9
10542955|NCT01480258|11696116|FG000|STARTED|Toddler Dose||639
10542956|NCT01480258|11696117|FG001|STARTED|Toddler Dose||642
10308367|NCT00112151|11441463|FG004|STARTED|Overall Study||28
10308368|NCT00112151|11441464|FG005|STARTED|Overall Study||28
10308369|NCT00112151|11441459|FG000|COMPLETED|Overall Study||24
10308370|NCT00112151|11441460|FG001|COMPLETED|Overall Study||23
10308371|NCT00112151|11441461|FG002|COMPLETED|Overall Study||25
10308372|NCT00112151|11441462|FG003|COMPLETED|Overall Study||24
10308373|NCT00112151|11441463|FG004|COMPLETED|Overall Study||22
10308374|NCT00112151|11441464|FG005|COMPLETED|Overall Study||25
10308375|NCT00112151|11441459|FG000|NOT COMPLETED|Overall Study||4
10308376|NCT00112151|11441460|FG001|NOT COMPLETED|Overall Study||5
10308377|NCT00112151|11441461|FG002|NOT COMPLETED|Overall Study||3
10308378|NCT00112151|11441462|FG003|NOT COMPLETED|Overall Study||3
10308379|NCT00112151|11441463|FG004|NOT COMPLETED|Overall Study||6
10308380|NCT00112151|11441464|FG005|NOT COMPLETED|Overall Study||3
10308381|NCT00112242|11441480|FG000|STARTED|Overall Study||10
10308382|NCT00112242|11441481|FG001|STARTED|Overall Study||5
10308383|NCT00112242|11441482|FG002|STARTED|Overall Study||5
10308384|NCT00112242|11441483|FG003|STARTED|Overall Study||10
10308385|NCT00112242|11441484|FG004|STARTED|Overall Study|One patient received only 1 vaccine however this minimum dose allowed the safety evaluation|9
10308386|NCT00112242|11441480|FG000|Cycle 1 Completed|Overall Study||10
10308387|NCT00112242|11441481|FG001|Cycle 1 Completed|Overall Study||5
10308388|NCT00112242|11441482|FG002|Cycle 1 Completed|Overall Study||5
10308389|NCT00112242|11441483|FG003|Cycle 1 Completed|Overall Study||9
10308390|NCT00112242|11441484|FG004|Cycle 1 Completed|Overall Study||7
10308391|NCT00112242|11441480|FG000|Cycle 2 Completed|Overall Study||8
10308392|NCT00112242|11441481|FG001|Cycle 2 Completed|Overall Study||3
10308393|NCT00112242|11441482|FG002|Cycle 2 Completed|Overall Study||4
10308394|NCT00112242|11441483|FG003|Cycle 2 Completed|Overall Study||8
10308395|NCT00112242|11441484|FG004|Cycle 2 Completed|Overall Study||4
10308396|NCT00112242|11441480|FG000|Cycle 3 Completed|Overall Study||5
10308397|NCT00112242|11441481|FG001|Cycle 3 Completed|Overall Study||3
10308398|NCT00112242|11441482|FG002|Cycle 3 Completed|Overall Study||4
10308399|NCT00112242|11441483|FG003|Cycle 3 Completed|Overall Study||4
10308400|NCT00112242|11441484|FG004|Cycle 3 Completed|Overall Study||2
10542957|NCT01480258|11696116|FG000|COMPLETED|Toddler Dose||639
10542958|NCT01480258|11696117|FG001|COMPLETED|Toddler Dose||642
10308401|NCT00112242|11441480|FG000|COMPLETED|Overall Study||5
10308402|NCT00112242|11441481|FG001|COMPLETED|Overall Study||3
10308403|NCT00112242|11441482|FG002|COMPLETED|Overall Study||4
10308404|NCT00112242|11441483|FG003|COMPLETED|Overall Study||4
10308405|NCT00112242|11441484|FG004|COMPLETED|Overall Study||2
10308406|NCT00112242|11441480|FG000|NOT COMPLETED|Overall Study||5
10308407|NCT00112242|11441481|FG001|NOT COMPLETED|Overall Study||2
10308408|NCT00112242|11441482|FG002|NOT COMPLETED|Overall Study||1
10542959|NCT01480258|11696116|FG000|NOT COMPLETED|Toddler Dose||0
10391676|NCT00667875|11534819|FG002|Subjects Included in Analysisd|Overall Study||19
10391677|NCT00667875|11534817|FG000|COMPLETED|Overall Study|Subjects who dropped out during treatment are considered completed if they provide end of study data|13
10391678|NCT00667875|11534818|FG001|COMPLETED|Overall Study||10
10391679|NCT00667875|11534819|FG002|COMPLETED|Overall Study||8
10391680|NCT00667875|11534817|FG000|NOT COMPLETED|Overall Study||10
10391681|NCT00667875|11534818|FG001|NOT COMPLETED|Overall Study||11
10391682|NCT00667875|11534819|FG002|NOT COMPLETED|Overall Study||13
10391683|NCT00667888|11534835|FG000|STARTED|Overall Study||111
10391684|NCT00667888|11534836|FG001|STARTED|Overall Study||111
10391685|NCT00667888|11534835|FG000|COMPLETED|Overall Study||101
10391686|NCT00667888|11534836|FG001|COMPLETED|Overall Study||102
10391687|NCT00667888|11534835|FG000|NOT COMPLETED|Overall Study||10
10391688|NCT00667888|11534836|FG001|NOT COMPLETED|Overall Study||9
10391689|NCT00667992|11534844|FG000|STARTED|First Intervention 100 Mcg Twice Daily||49
10391690|NCT00667992|11534845|FG001|STARTED|First Intervention 100 Mcg Twice Daily||50
10391691|NCT00667992|11534844|FG000|COMPLETED|First Intervention 100 Mcg Twice Daily||44
10391692|NCT00667992|11534845|FG001|COMPLETED|First Intervention 100 Mcg Twice Daily||45
10391693|NCT00667992|11534844|FG000|NOT COMPLETED|First Intervention 100 Mcg Twice Daily||5
10391694|NCT00667992|11534845|FG001|NOT COMPLETED|First Intervention 100 Mcg Twice Daily||5
10391695|NCT00667992|11534844|FG000|STARTED|Second Intervention 400 Mcg Twice Daily||44
10391696|NCT00667992|11534845|FG001|STARTED|Second Intervention 400 Mcg Twice Daily||45
10391697|NCT00667992|11534844|FG000|COMPLETED|Second Intervention 400 Mcg Twice Daily||41
10391698|NCT00667992|11534845|FG001|COMPLETED|Second Intervention 400 Mcg Twice Daily||41
10391699|NCT00667992|11534844|FG000|NOT COMPLETED|Second Intervention 400 Mcg Twice Daily||3
10391700|NCT00667992|11534845|FG001|NOT COMPLETED|Second Intervention 400 Mcg Twice Daily||4
10391701|NCT00667992|11534844|FG000|STARTED|Wash-out||41
10391702|NCT00667992|11534845|FG001|STARTED|Wash-out||41
10391703|NCT00667992|11534844|FG000|COMPLETED|Wash-out||34
10391704|NCT00667992|11534845|FG001|COMPLETED|Wash-out||36
10391705|NCT00667992|11534844|FG000|NOT COMPLETED|Wash-out||7
10391706|NCT00667992|11534845|FG001|NOT COMPLETED|Wash-out||5
10391707|NCT00667992|11534844|FG000|STARTED|Third Intervention 100 Mcg Twice Daily||34
10391708|NCT00667992|11534845|FG001|STARTED|Third Intervention 100 Mcg Twice Daily||36
10391709|NCT00667992|11534844|FG000|COMPLETED|Third Intervention 100 Mcg Twice Daily||33
10391710|NCT00667992|11534845|FG001|COMPLETED|Third Intervention 100 Mcg Twice Daily||35
10391711|NCT00667992|11534844|FG000|NOT COMPLETED|Third Intervention 100 Mcg Twice Daily||1
10391712|NCT00667992|11534845|FG001|NOT COMPLETED|Third Intervention 100 Mcg Twice Daily||1
10391713|NCT00667992|11534844|FG000|STARTED|Forth Intervention 400 Mcg Twice Daily||33
10391714|NCT00667992|11534845|FG001|STARTED|Forth Intervention 400 Mcg Twice Daily||35
10391715|NCT00667992|11534844|FG000|COMPLETED|Forth Intervention 400 Mcg Twice Daily||33
10391716|NCT00667992|11534845|FG001|COMPLETED|Forth Intervention 400 Mcg Twice Daily||35
10391717|NCT00667992|11534844|FG000|NOT COMPLETED|Forth Intervention 400 Mcg Twice Daily||0
10391718|NCT00667992|11534845|FG001|NOT COMPLETED|Forth Intervention 400 Mcg Twice Daily||0
10391719|NCT00668148|11534861|FG000|STARTED|Overall Study||113
10391720|NCT00668148|11534861|FG000|Received at Least 1 Dose of Study Drug|Overall Study||111
10391721|NCT00668148|11534861|FG000|COMPLETED|Overall Study||103
10391722|NCT00668148|11534861|FG000|NOT COMPLETED|Overall Study||10
10391723|NCT00668200|11534876|FG000|STARTED|Overall Study||80
10391724|NCT00668200|11534876|FG000|Safety Population|Overall Study|1 patient was not included in the ITT patient was enrolled in error|81
10542960|NCT01480258|11696117|FG001|NOT COMPLETED|Toddler Dose||0
10542961|NCT01480284|11696125|FG000|STARTED|Overall Study||110
10542962|NCT01480284|11696126|FG001|STARTED|Overall Study||56
10542963|NCT01480284|11696125|FG000|COMPLETED|Overall Study||102
10542964|NCT01480284|11696126|FG001|COMPLETED|Overall Study||56
10542965|NCT01480284|11696125|FG000|NOT COMPLETED|Overall Study||8
10542966|NCT01480284|11696126|FG001|NOT COMPLETED|Overall Study||0
10542967|NCT01480297|11696132|FG000|STARTED|Overall Study||8
10542968|NCT01480297|11696132|FG000|COMPLETED|Overall Study||8
10542969|NCT01480297|11696132|FG000|NOT COMPLETED|Overall Study||0
10542970|NCT01480596|11696138|FG000|STARTED|Overall Study||22
10542971|NCT01480596|11696139|FG001|STARTED|Overall Study||18
10542972|NCT01480596|11696138|FG000|COMPLETED|Overall Study||17
10542973|NCT01480596|11696139|FG001|COMPLETED|Overall Study||16
10542974|NCT01480596|11696138|FG000|NOT COMPLETED|Overall Study||5
10542975|NCT01480596|11696139|FG001|NOT COMPLETED|Overall Study||2
10542976|NCT01480674|11696145|FG000|STARTED|Overall Study||160
10542977|NCT01480674|11696145|FG000|Safety Set|Overall Study||154
10542978|NCT01480674|11696145|FG000|Analysed Set|Overall Study||128
10542979|NCT01480674|11696145|FG000|COMPLETED|Overall Study||125
10542980|NCT01480674|11696145|FG000|NOT COMPLETED|Overall Study||35
10542981|NCT01480843|11696149|FG000|STARTED|Overall Study||65
10542982|NCT01480843|11696149|FG000|COMPLETED|Overall Study||60
10719146|NCT02708498|11882865|FG004|COMPLETED|Overall Study||167
10719147|NCT02708498|11882866|FG005|COMPLETED|Overall Study||198
10719148|NCT02708498|11882867|FG006|COMPLETED|Overall Study||20
10719149|NCT02708498|11882868|FG007|COMPLETED|Overall Study||48
10719150|NCT02708498|11882861|FG000|NOT COMPLETED|Overall Study||20
10719151|NCT02708498|11882862|FG001|NOT COMPLETED|Overall Study||19
10719152|NCT02708498|11882863|FG002|NOT COMPLETED|Overall Study||62
10719153|NCT02708498|11882864|FG003|NOT COMPLETED|Overall Study||51
10813012|NCT03109418|11975253|FG001|NOT COMPLETED|Overall Study||1
10813013|NCT03120676|11975259|FG000|STARTED|Overall Study||3
10813014|NCT03120676|11975259|FG000|COMPLETED|Overall Study||2
10813015|NCT03120676|11975259|FG000|NOT COMPLETED|Overall Study||1
10813016|NCT03109873|11975265|FG000|STARTED|Overall Study||5
10813017|NCT03109873|11975266|FG001|STARTED|Overall Study||4
10813018|NCT03109873|11975265|FG000|COMPLETED|Overall Study||5
10813019|NCT03109873|11975266|FG001|COMPLETED|Overall Study||4
10813020|NCT03109873|11975265|FG000|NOT COMPLETED|Overall Study||0
10813021|NCT03109873|11975266|FG001|NOT COMPLETED|Overall Study||0
10813022|NCT03100617|11975272|FG000|STARTED|Overall Study||6
10813023|NCT03100617|11975272|FG000|COMPLETED|Overall Study||6
10813024|NCT03100617|11975272|FG000|NOT COMPLETED|Overall Study||0
10813025|NCT03115853|11975276|FG000|STARTED|Overall Study||31
10813026|NCT03115853|11975276|FG000|COMPLETED|Overall Study||31
10308409|NCT00112242|11441483|FG003|NOT COMPLETED|Overall Study||6
10308410|NCT00112242|11441484|FG004|NOT COMPLETED|Overall Study||7
10308411|NCT00112294|11441506|FG000|STARTED|Overall Study|338 randomized and 325 treated.|325
10308412|NCT00112294|11441507|FG001|STARTED|Overall Study|338 randomized and 320 treated.|320
10308413|NCT00112294|11441506|FG000|Never Treated|Overall Study|Number by randomized group = 11, but 2 participants received C/T/C instead of T/C.|13
10308414|NCT00112294|11441507|FG001|Never Treated|Overall Study|Number by randomized group = 20, but 2 participants received C/T/C instead of T/C.|18
10308415|NCT00112294|11441506|FG000|COMPLETED|Overall Study|Off all study therapies.|320
10308416|NCT00112294|11441507|FG001|COMPLETED|Overall Study|Off all study therapies.|320
10308417|NCT00112294|11441506|FG000|NOT COMPLETED|Overall Study||5
10308418|NCT00112294|11441507|FG001|NOT COMPLETED|Overall Study||0
10308419|NCT00112359|11441515|FG000|STARTED|Overall Study||84
10308420|NCT00112359|11441516|FG001|STARTED|Overall Study||80
10308421|NCT00112359|11441515|FG000|COMPLETED|Overall Study||57
10308422|NCT00112359|11441516|FG001|COMPLETED|Overall Study||67
10308423|NCT00112359|11441515|FG000|NOT COMPLETED|Overall Study||27
10308424|NCT00112359|11441516|FG001|NOT COMPLETED|Overall Study||13
10308425|NCT00112385|11441524|FG000|STARTED|Overall Study||11
10308426|NCT00112385|11441525|FG001|STARTED|Overall Study||5
10308427|NCT00112385|11441524|FG000|COMPLETED|Overall Study||10
10813027|NCT03115853|11975276|FG000|NOT COMPLETED|Overall Study||0
10813028|NCT03113071|11975284|FG000|STARTED|Overall Study||1
10813029|NCT03113071|11975285|FG001|STARTED|Overall Study||0
10813030|NCT03113071|11975284|FG000|COMPLETED|Overall Study||0
10813031|NCT03113071|11975285|FG001|COMPLETED|Overall Study||0
10813032|NCT03113071|11975284|FG000|NOT COMPLETED|Overall Study||1
10813033|NCT03113071|11975285|FG001|NOT COMPLETED|Overall Study||0
10813034|NCT03110900|11975293|FG000|STARTED|Overall Study||1
10813035|NCT03110900|11975294|FG001|STARTED|Overall Study||1
10813036|NCT03110900|11975293|FG000|COMPLETED|Overall Study||0
10813037|NCT03110900|11975294|FG001|COMPLETED|Overall Study||0
10813038|NCT03110900|11975293|FG000|NOT COMPLETED|Overall Study||1
10391725|NCT00668200|11534876|FG000|Intent to Treat (ITT)|Overall Study||80
10391726|NCT00668200|11534876|FG000|COMPLETED|Overall Study||77
10391727|NCT00668200|11534876|FG000|NOT COMPLETED|Overall Study||3
10391728|NCT00668317|11534880|FG000|STARTED|Overall Study||5
10391729|NCT00668317|11534880|FG000|COMPLETED|Overall Study||3
10391730|NCT00668317|11534880|FG000|NOT COMPLETED|Overall Study||2
10391731|NCT00668382|11534884|FG000|STARTED|Overall Study|beginning of trial|11
10391732|NCT00668382|11534884|FG000|COMPLETED|Overall Study||11
10391733|NCT00668382|11534884|FG000|NOT COMPLETED|Overall Study||0
10391734|NCT00668395|11534891|FG000|STARTED|Overall Study||45
10391735|NCT00668395|11534892|FG001|STARTED|Overall Study||22
10391736|NCT00668395|11534893|FG002|STARTED|Overall Study||6
10391737|NCT00668395|11534891|FG000|COMPLETED|Overall Study||39
10391738|NCT00668395|11534892|FG001|COMPLETED|Overall Study||16
10391739|NCT00668395|11534893|FG002|COMPLETED|Overall Study||5
10391740|NCT00668395|11534891|FG000|NOT COMPLETED|Overall Study||6
10391741|NCT00668395|11534892|FG001|NOT COMPLETED|Overall Study||6
10391742|NCT00668395|11534893|FG002|NOT COMPLETED|Overall Study||1
10391743|NCT00668434|11534903|FG000|STARTED|Primary Outcome Time Point (3 Weeks)|Baseline|181
10391744|NCT00668434|11534904|FG001|STARTED|Primary Outcome Time Point (3 Weeks)|Baseline|88
10391745|NCT00668434|11534903|FG000|COMPLETED|Primary Outcome Time Point (3 Weeks)||179
10391746|NCT00668434|11534904|FG001|COMPLETED|Primary Outcome Time Point (3 Weeks)||88
10391747|NCT00668434|11534903|FG000|NOT COMPLETED|Primary Outcome Time Point (3 Weeks)||2
10391748|NCT00668434|11534904|FG001|NOT COMPLETED|Primary Outcome Time Point (3 Weeks)||0
10391749|NCT00668434|11534903|FG000|STARTED|Secondary Outcome Time Point (52 Weeks)|Baseline|179
10391750|NCT00668434|11534904|FG001|STARTED|Secondary Outcome Time Point (52 Weeks)|Baseline|88
10391751|NCT00668434|11534903|FG000|COMPLETED|Secondary Outcome Time Point (52 Weeks)||157
10391752|NCT00668434|11534904|FG001|COMPLETED|Secondary Outcome Time Point (52 Weeks)||77
10391753|NCT00668434|11534903|FG000|NOT COMPLETED|Secondary Outcome Time Point (52 Weeks)||22
10391754|NCT00668434|11534904|FG001|NOT COMPLETED|Secondary Outcome Time Point (52 Weeks)||11
10391755|NCT00668525|11534913|FG000|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|325
10391756|NCT00668525|11534914|FG001|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|332
10391757|NCT00668525|11534915|FG002|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|220
10391758|NCT00668525|11534913|FG000|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|248
10391759|NCT00668525|11534914|FG001|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|239
10391760|NCT00668525|11534915|FG002|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|167
10391761|NCT00668525|11534913|FG000|NOT COMPLETED|Overall Study||77
10391762|NCT00668525|11534914|FG001|NOT COMPLETED|Overall Study||93
10391763|NCT00668525|11534915|FG002|NOT COMPLETED|Overall Study||53
10391764|NCT00668564|11534923|FG000|STARTED|Overall Study||18
10391765|NCT00668564|11534923|FG000|COMPLETED|Overall Study||18
10391766|NCT00668564|11534923|FG000|NOT COMPLETED|Overall Study||0
10391767|NCT00668707|11534929|FG000|STARTED|Overall Study||356
10391768|NCT00668707|11534930|FG001|STARTED|Overall Study||353
10391769|NCT00668707|11534929|FG000|COMPLETED|Overall Study||157
10391770|NCT00668707|11534930|FG001|COMPLETED|Overall Study||173
10391771|NCT00668707|11534929|FG000|NOT COMPLETED|Overall Study||199
10391772|NCT00668707|11534930|FG001|NOT COMPLETED|Overall Study||180
10391773|NCT00668733|11534943|FG000|STARTED|Overall Study||89
10391774|NCT00668733|11534944|FG001|STARTED|Overall Study||90
10391775|NCT00668733|11534943|FG000|COMPLETED|Overall Study||87
10391776|NCT00668733|11534944|FG001|COMPLETED|Overall Study||83
10391777|NCT00668733|11534943|FG000|NOT COMPLETED|Overall Study||2
10813039|NCT03110900|11975294|FG001|NOT COMPLETED|Overall Study||1
10391778|NCT00668733|11534944|FG001|NOT COMPLETED|Overall Study||7
10391779|NCT00668746|11534952|FG000|STARTED|Overall Study||23
10391780|NCT00668746|11534953|FG001|STARTED|Overall Study||12
10391781|NCT00668746|11534952|FG000|COMPLETED|Overall Study||21
10391782|NCT00668746|11534953|FG001|COMPLETED|Overall Study||11
10391783|NCT00668746|11534952|FG000|NOT COMPLETED|Overall Study||2
10391784|NCT00668746|11534953|FG001|NOT COMPLETED|Overall Study||1
10391785|NCT00668811|11534969|FG000|STARTED|Overall Study||23
10391786|NCT00668811|11534969|FG000|COMPLETED|Overall Study||23
10391787|NCT00668811|11534969|FG000|NOT COMPLETED|Overall Study||0
10391788|NCT00668863|11534973|FG000|STARTED|Overall Study||71
10391789|NCT00668863|11534973|FG000|COMPLETED|Overall Study||0
10391790|NCT00668863|11534973|FG000|NOT COMPLETED|Overall Study||71
10391791|NCT00668902|11534980|FG000|STARTED|Overall Study||10
10391792|NCT00668902|11534981|FG001|STARTED|Overall Study||10
10391793|NCT00668902|11534982|FG002|STARTED|Overall Study||5
10391794|NCT00668902|11534980|FG000|COMPLETED|Overall Study||10
10391795|NCT00668902|11534981|FG001|COMPLETED|Overall Study||10
10391796|NCT00668902|11534982|FG002|COMPLETED|Overall Study||5
10391797|NCT00668902|11534980|FG000|NOT COMPLETED|Overall Study||0
10391798|NCT00668902|11534981|FG001|NOT COMPLETED|Overall Study||0
10391799|NCT00668902|11534982|FG002|NOT COMPLETED|Overall Study||0
10391800|NCT00669019|11534990|FG000|STARTED|Overall Study||23
10391801|NCT00669019|11534990|FG000|COMPLETED|Overall Study||23
10391802|NCT00669019|11534990|FG000|NOT COMPLETED|Overall Study||0
10391803|NCT00669032|11534996|FG000|STARTED|Overall Study||153
10391804|NCT00669032|11534997|FG001|STARTED|Overall Study||153
10391805|NCT00669032|11534996|FG000|COMPLETED|Overall Study||109
10391806|NCT00669032|11534997|FG001|COMPLETED|Overall Study||94
10391807|NCT00669032|11534996|FG000|NOT COMPLETED|Overall Study||44
10391808|NCT00669032|11534997|FG001|NOT COMPLETED|Overall Study||59
10391812|NCT00669110|11535011|FG000|STARTED|Overall Study||20
10391813|NCT00669110|11535012|FG001|STARTED|Overall Study||20
10391814|NCT00669110|11535011|FG000|COMPLETED|Overall Study||12
10391815|NCT00669110|11535012|FG001|COMPLETED|Overall Study||7
10391816|NCT00669110|11535011|FG000|NOT COMPLETED|Overall Study||8
10391817|NCT00669110|11535012|FG001|NOT COMPLETED|Overall Study||13
10391818|NCT00669162|11535018|FG000|STARTED|Overall Study||27
10391819|NCT00669162|11535018|FG000|COMPLETED|Overall Study||26
10391820|NCT00669162|11535018|FG000|NOT COMPLETED|Overall Study||1
10391821|NCT00669214|11535024|FG000|STARTED|Double-Blind Treatment Period (Week 12)||27
10391822|NCT00669214|11535025|FG001|STARTED|Double-Blind Treatment Period (Week 12)||62
10391823|NCT00669214|11535024|FG000|COMPLETED|Double-Blind Treatment Period (Week 12)||22
10391824|NCT00669214|11535025|FG001|COMPLETED|Double-Blind Treatment Period (Week 12)||55
10391825|NCT00669214|11535024|FG000|NOT COMPLETED|Double-Blind Treatment Period (Week 12)||5
10391826|NCT00669214|11535025|FG001|NOT COMPLETED|Double-Blind Treatment Period (Week 12)||7
10391827|NCT00669214|11535024|FG000|STARTED|Open-Label Treatment Period (Week 24)||22
10391828|NCT00669214|11535025|FG001|STARTED|Open-Label Treatment Period (Week 24)||55
10391829|NCT00669214|11535024|FG000|COMPLETED|Open-Label Treatment Period (Week 24)||18
10391830|NCT00669214|11535025|FG001|COMPLETED|Open-Label Treatment Period (Week 24)||46
10391831|NCT00669214|11535024|FG000|NOT COMPLETED|Open-Label Treatment Period (Week 24)||4
10391832|NCT00669214|11535025|FG001|NOT COMPLETED|Open-Label Treatment Period (Week 24)||9
10391833|NCT00669240|11535035|FG000|STARTED|Overall Study||567
10391834|NCT00669240|11535035|FG000|Assigned to Treatment|Overall Study||566
10391835|NCT00669240|11535035|FG000|Received Treatment|Overall Study||551
10391836|NCT00669240|11535035|FG000|COMPLETED|Overall Study||402
10391837|NCT00669240|11535035|FG000|NOT COMPLETED|Overall Study||165
10391838|NCT00669279|11535041|FG000|STARTED|Overall Study||22
10391839|NCT00669279|11535042|FG001|STARTED|Overall Study||19
10391840|NCT00669279|11535041|FG000|COMPLETED|Overall Study||22
10391841|NCT00669279|11535042|FG001|COMPLETED|Overall Study||19
10391842|NCT00669279|11535041|FG000|NOT COMPLETED|Overall Study||0
10391843|NCT00669279|11535042|FG001|NOT COMPLETED|Overall Study||0
10391844|NCT00669318|11535048|FG000|STARTED|Overall Study||41
10391845|NCT00669318|11535048|FG000|COMPLETED|Overall Study||39
10391846|NCT00669318|11535048|FG000|NOT COMPLETED|Overall Study||2
10391847|NCT00669331|11535054|FG000|STARTED|Randomisation to First Dose||244
10391848|NCT00669331|11535055|FG001|STARTED|Randomisation to First Dose||241
10391849|NCT00669331|11535054|FG000|COMPLETED|Randomisation to First Dose||233
10391850|NCT00669331|11535055|FG001|COMPLETED|Randomisation to First Dose||228
10391851|NCT00669331|11535054|FG000|NOT COMPLETED|Randomisation to First Dose||11
10391852|NCT00669331|11535055|FG001|NOT COMPLETED|Randomisation to First Dose||13
10391853|NCT00669331|11535054|FG000|STARTED|Blinded Treatment Period||233
10391854|NCT00669331|11535055|FG001|STARTED|Blinded Treatment Period||228
10391855|NCT00669331|11535054|FG000|COMPLETED|Blinded Treatment Period||191
10391856|NCT00669331|11535055|FG001|COMPLETED|Blinded Treatment Period||189
10391857|NCT00669331|11535054|FG000|NOT COMPLETED|Blinded Treatment Period||42
10391858|NCT00669331|11535055|FG001|NOT COMPLETED|Blinded Treatment Period||39
10391859|NCT00669383|11535065|FG000|STARTED|Overall Study||44
10391860|NCT00669383|11535066|FG001|STARTED|Overall Study||41
10391861|NCT00669383|11535065|FG000|COMPLETED|Overall Study||44
10391862|NCT00669383|11535066|FG001|COMPLETED|Overall Study||41
10391863|NCT00669383|11535065|FG000|NOT COMPLETED|Overall Study||0
10391864|NCT00669383|11535066|FG001|NOT COMPLETED|Overall Study||0
10391865|NCT00669396|11535074|FG000|STARTED|Overall Study||23
10391866|NCT00669396|11535075|FG001|STARTED|Overall Study||34
10391867|NCT00669396|11535074|FG000|COMPLETED|Overall Study||13
10391868|NCT00669396|11535075|FG001|COMPLETED|Overall Study||22
10391869|NCT00669396|11535074|FG000|NOT COMPLETED|Overall Study||10
10391870|NCT00669396|11535075|FG001|NOT COMPLETED|Overall Study||12
10391871|NCT00669409|11535087|FG000|STARTED|Part 1||6
10391872|NCT00669409|11535088|FG001|STARTED|Part 1||6
10391873|NCT00669409|11535089|FG002|STARTED|Part 1||6
10391874|NCT00669409|11535090|FG003|STARTED|Part 1||6
10391875|NCT00669409|11535091|FG004|STARTED|Part 1||6
10391876|NCT00669409|11535092|FG005|STARTED|Part 1||12
10391877|NCT00669409|11535093|FG006|STARTED|Part 1||0
10391878|NCT00669409|11535094|FG007|STARTED|Part 1||0
10391879|NCT00669409|11535095|FG008|STARTED|Part 1||0
10391880|NCT00669409|11535096|FG009|STARTED|Part 1||0
10391881|NCT00669409|11535097|FG010|STARTED|Part 1||0
10391882|NCT00669409|11535087|FG000|COMPLETED|Part 1||6
10391883|NCT00669409|11535088|FG001|COMPLETED|Part 1||6
10391884|NCT00669409|11535089|FG002|COMPLETED|Part 1||6
10391885|NCT00669409|11535090|FG003|COMPLETED|Part 1||6
10391886|NCT00669409|11535091|FG004|COMPLETED|Part 1||6
10391887|NCT00669409|11535092|FG005|COMPLETED|Part 1||12
10391888|NCT00669409|11535093|FG006|COMPLETED|Part 1||0
10391889|NCT00669409|11535094|FG007|COMPLETED|Part 1||0
10391890|NCT00669409|11535095|FG008|COMPLETED|Part 1||0
10391891|NCT00669409|11535096|FG009|COMPLETED|Part 1||0
10391892|NCT00669409|11535097|FG010|COMPLETED|Part 1||0
10391893|NCT00669409|11535087|FG000|NOT COMPLETED|Part 1||0
10391894|NCT00669409|11535088|FG001|NOT COMPLETED|Part 1||0
10391895|NCT00669409|11535089|FG002|NOT COMPLETED|Part 1||0
10391896|NCT00669409|11535090|FG003|NOT COMPLETED|Part 1||0
10391897|NCT00669409|11535091|FG004|NOT COMPLETED|Part 1||0
10391898|NCT00669409|11535092|FG005|NOT COMPLETED|Part 1||0
10391899|NCT00669409|11535093|FG006|NOT COMPLETED|Part 1||0
10391900|NCT00669409|11535094|FG007|NOT COMPLETED|Part 1||0
10391901|NCT00669409|11535095|FG008|NOT COMPLETED|Part 1||0
10391902|NCT00669409|11535096|FG009|NOT COMPLETED|Part 1||0
10391903|NCT00669409|11535097|FG010|NOT COMPLETED|Part 1||0
10391904|NCT00669409|11535087|FG000|STARTED|Part 2||0
10391905|NCT00669409|11535088|FG001|STARTED|Part 2||0
10391906|NCT00669409|11535089|FG002|STARTED|Part 2||0
10391907|NCT00669409|11535090|FG003|STARTED|Part 2||0
10391908|NCT00669409|11535091|FG004|STARTED|Part 2||0
10391909|NCT00669409|11535092|FG005|STARTED|Part 2||0
10391910|NCT00669409|11535093|FG006|STARTED|Part 2||9
10391911|NCT00669409|11535094|FG007|STARTED|Part 2||9
10391912|NCT00669409|11535095|FG008|STARTED|Part 2||9
10391913|NCT00669409|11535096|FG009|STARTED|Part 2||10
10391914|NCT00669409|11535097|FG010|STARTED|Part 2||4
10391915|NCT00669409|11535087|FG000|COMPLETED|Part 2||0
10391916|NCT00669409|11535088|FG001|COMPLETED|Part 2||0
10391917|NCT00669409|11535089|FG002|COMPLETED|Part 2||0
10391918|NCT00669409|11535090|FG003|COMPLETED|Part 2||0
10391919|NCT00669409|11535091|FG004|COMPLETED|Part 2||0
10391920|NCT00669409|11535092|FG005|COMPLETED|Part 2||0
10391921|NCT00669409|11535093|FG006|COMPLETED|Part 2||9
10719154|NCT02708498|11882865|FG004|NOT COMPLETED|Overall Study||196
10719155|NCT02708498|11882866|FG005|NOT COMPLETED|Overall Study||132
10719156|NCT02708498|11882867|FG006|NOT COMPLETED|Overall Study||0
10391922|NCT00669409|11535094|FG007|COMPLETED|Part 2||9
10391923|NCT00669409|11535095|FG008|COMPLETED|Part 2||9
10391924|NCT00669409|11535096|FG009|COMPLETED|Part 2||9
10391925|NCT00669409|11535097|FG010|COMPLETED|Part 2||4
10391926|NCT00669409|11535087|FG000|NOT COMPLETED|Part 2||0
10391927|NCT00669409|11535088|FG001|NOT COMPLETED|Part 2||0
10391928|NCT00669409|11535089|FG002|NOT COMPLETED|Part 2||0
10719157|NCT02708498|11882868|FG007|NOT COMPLETED|Overall Study||0
10391929|NCT00669409|11535090|FG003|NOT COMPLETED|Part 2||0
10391930|NCT00669409|11535091|FG004|NOT COMPLETED|Part 2||0
10391931|NCT00669409|11535092|FG005|NOT COMPLETED|Part 2||0
10391932|NCT00669409|11535093|FG006|NOT COMPLETED|Part 2||0
10391933|NCT00669409|11535094|FG007|NOT COMPLETED|Part 2||0
10391934|NCT00669409|11535095|FG008|NOT COMPLETED|Part 2||0
10391935|NCT00669409|11535096|FG009|NOT COMPLETED|Part 2||1
10391936|NCT00669409|11535097|FG010|NOT COMPLETED|Part 2||0
10391937|NCT00669539|11535126|FG000|STARTED|Overall Study||94
10391938|NCT00669539|11535127|FG001|STARTED|Overall Study||52
10391939|NCT00669539|11535126|FG000|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|86
10391940|NCT00669539|11535127|FG001|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|43
10391941|NCT00669539|11535126|FG000|NOT COMPLETED|Overall Study||8
10391942|NCT00669539|11535127|FG001|NOT COMPLETED|Overall Study||9
10391943|NCT00669552|11535133|FG000|STARTED|Overall Study||11
10391944|NCT00669552|11535133|FG000|COMPLETED|Overall Study||11
10391945|NCT00669552|11535133|FG000|NOT COMPLETED|Overall Study||0
10391946|NCT00669578|11535139|FG000|STARTED|Overall Study||12
10391947|NCT00669578|11535140|FG001|STARTED|Overall Study||65
10391948|NCT00669578|11535139|FG000|COMPLETED|Overall Study||12
10391949|NCT00669578|11535140|FG001|COMPLETED|Overall Study||65
10542983|NCT01480843|11696149|FG000|NOT COMPLETED|Overall Study||5
10542984|NCT01481116|11696156|FG000|STARTED|Overall Study||824
10542985|NCT01481116|11696157|FG001|STARTED|Overall Study||817
10542986|NCT01481116|11696158|FG002|STARTED|Overall Study||813
10542987|NCT01481116|11696156|FG000|Treated|Overall Study||822
10542988|NCT01481116|11696157|FG001|Treated|Overall Study||816
10542989|NCT01481116|11696158|FG002|Treated|Overall Study||813
10542990|NCT01481116|11696156|FG000|COMPLETED|Overall Study||0
10542991|NCT01481116|11696157|FG001|COMPLETED|Overall Study||0
10542992|NCT01481116|11696158|FG002|COMPLETED|Overall Study||0
10542993|NCT01481116|11696156|FG000|NOT COMPLETED|Overall Study||824
10542994|NCT01481116|11696157|FG001|NOT COMPLETED|Overall Study||817
10542995|NCT01481116|11696158|FG002|NOT COMPLETED|Overall Study||813
10542996|NCT01481129|11696166|FG000|STARTED|Overall Study||22
10542997|NCT01481129|11696166|FG000|COMPLETED|Overall Study||22
10542998|NCT01481129|11696166|FG000|NOT COMPLETED|Overall Study||0
10542999|NCT01481324|11696173|FG000|STARTED|Overall Study||21
10543000|NCT01481324|11696174|FG001|STARTED|Overall Study||24
10543001|NCT01481324|11696175|FG002|STARTED|Overall Study||22
10543002|NCT01481324|11696173|FG000|Month 1-Wear Rate Data|Overall Study||15
10543003|NCT01481324|11696174|FG001|Month 1-Wear Rate Data|Overall Study||16
10658620|NCT02234115|11819801|FG000|NOT COMPLETED|Overall Study||15
10658621|NCT02234128|11819808|FG000|STARTED|Overall Study||35
10658622|NCT02234128|11819809|FG001|STARTED|Overall Study||31
10658623|NCT02234128|11819810|FG002|STARTED|Overall Study||52
10658624|NCT02234128|11819808|FG000|COMPLETED|Overall Study||30
10658625|NCT02234128|11819809|FG001|COMPLETED|Overall Study||29
10658626|NCT02234128|11819810|FG002|COMPLETED|Overall Study||48
10658627|NCT02234128|11819808|FG000|NOT COMPLETED|Overall Study||5
10658628|NCT02234128|11819809|FG001|NOT COMPLETED|Overall Study||2
10658629|NCT02234128|11819810|FG002|NOT COMPLETED|Overall Study||4
10658630|NCT02234141|11819822|FG000|STARTED|Treatment Period (24 Weeks)||39
10658631|NCT02234141|11819823|FG001|STARTED|Treatment Period (24 Weeks)||38
10658632|NCT02234141|11819824|FG002|STARTED|Treatment Period (24 Weeks)||37
10658633|NCT02234141|11819825|FG003|STARTED|Treatment Period (24 Weeks)||37
10658634|NCT02234141|11819826|FG004|STARTED|Treatment Period (24 Weeks)||0
10658635|NCT02234141|11819827|FG005|STARTED|Treatment Period (24 Weeks)||0
10658636|NCT02234141|11819828|FG006|STARTED|Treatment Period (24 Weeks)||0
10658637|NCT02234141|11819822|FG000|COMPLETED|Treatment Period (24 Weeks)||35
10658638|NCT02234141|11819823|FG001|COMPLETED|Treatment Period (24 Weeks)||32
10658639|NCT02234141|11819824|FG002|COMPLETED|Treatment Period (24 Weeks)||35
10658640|NCT02234141|11819825|FG003|COMPLETED|Treatment Period (24 Weeks)||32
10658641|NCT02234141|11819826|FG004|COMPLETED|Treatment Period (24 Weeks)||0
10658642|NCT02234141|11819827|FG005|COMPLETED|Treatment Period (24 Weeks)||0
10658643|NCT02234141|11819828|FG006|COMPLETED|Treatment Period (24 Weeks)||0
10658644|NCT02234141|11819822|FG000|NOT COMPLETED|Treatment Period (24 Weeks)||4
10658645|NCT02234141|11819823|FG001|NOT COMPLETED|Treatment Period (24 Weeks)||6
10658646|NCT02234141|11819824|FG002|NOT COMPLETED|Treatment Period (24 Weeks)||2
10658647|NCT02234141|11819825|FG003|NOT COMPLETED|Treatment Period (24 Weeks)||5
10658648|NCT02234141|11819826|FG004|NOT COMPLETED|Treatment Period (24 Weeks)||0
10658649|NCT02234141|11819827|FG005|NOT COMPLETED|Treatment Period (24 Weeks)||0
10658650|NCT02234141|11819828|FG006|NOT COMPLETED|Treatment Period (24 Weeks)||0
10658651|NCT02234141|11819822|FG000|STARTED|Long-Term Treatment Period|2 participants who completed Period 1 did not continue into the Long-Term Treatment Phase.|33
10658652|NCT02234141|11819823|FG001|STARTED|Long-Term Treatment Period|1 participant who completed the Period 1 did not continue into the Long-Term Treatment Phase.|31
10658653|NCT02234141|11819824|FG002|STARTED|Long-Term Treatment Period|2 participants who completed Period 1 did not continue into the Long-Term Treatment Phase.|33
10658654|NCT02234141|11819825|FG003|STARTED|Long-Term Treatment Period|Participants were rerandomized to receive selonsertib during the Long-Term Treatment Phase.|0
10658655|NCT02234141|11819826|FG004|STARTED|Long-Term Treatment Period|The Placebo group was rerandomized to receive selonsertib during the Long-Term Treatment Phase.|10
10658656|NCT02234141|11819827|FG005|STARTED|Long-Term Treatment Period|The Placebo group was rerandomized to receive selonsertib during the Long-Term Treatment Phase.|12
10658657|NCT02234141|11819828|FG006|STARTED|Long-Term Treatment Period|The Placebo group was rerandomized to receive selonsertib during the Long-Term Treatment Phase.|10
10658658|NCT02234141|11819822|FG000|COMPLETED|Long-Term Treatment Period||0
10658659|NCT02234141|11819823|FG001|COMPLETED|Long-Term Treatment Period||0
10658660|NCT02234141|11819824|FG002|COMPLETED|Long-Term Treatment Period||0
10658661|NCT02234141|11819825|FG003|COMPLETED|Long-Term Treatment Period||0
10658662|NCT02234141|11819826|FG004|COMPLETED|Long-Term Treatment Period||0
10658663|NCT02234141|11819827|FG005|COMPLETED|Long-Term Treatment Period||0
10658664|NCT02234141|11819828|FG006|COMPLETED|Long-Term Treatment Period||0
10658665|NCT02234141|11819822|FG000|NOT COMPLETED|Long-Term Treatment Period||33
10658666|NCT02234141|11819823|FG001|NOT COMPLETED|Long-Term Treatment Period||31
10658667|NCT02234141|11819824|FG002|NOT COMPLETED|Long-Term Treatment Period||33
10658668|NCT02234141|11819825|FG003|NOT COMPLETED|Long-Term Treatment Period||0
10658669|NCT02234141|11819826|FG004|NOT COMPLETED|Long-Term Treatment Period||10
10658670|NCT02234141|11819827|FG005|NOT COMPLETED|Long-Term Treatment Period||12
10658671|NCT02234141|11819828|FG006|NOT COMPLETED|Long-Term Treatment Period||10
10658672|NCT02234180|11819839|FG000|STARTED|Overall Study||2
10658673|NCT02234180|11819840|FG001|STARTED|Overall Study||1
10658674|NCT02234180|11819839|FG000|COMPLETED|Overall Study||2
10543004|NCT01481324|11696175|FG002|Month 1-Wear Rate Data|Overall Study||8
10391950|NCT00669578|11535139|FG000|NOT COMPLETED|Overall Study||0
10391951|NCT00669578|11535140|FG001|NOT COMPLETED|Overall Study||0
10391952|NCT00669617|11535147|FG000|STARTED|Period 1||18
10391953|NCT00669617|11535148|FG001|STARTED|Period 1||17
10391954|NCT00669617|11535149|FG002|STARTED|Period 1||18
10391955|NCT00669617|11535150|FG003|STARTED|Period 1||18
10391956|NCT00669617|11535151|FG004|STARTED|Period 1||18
10391957|NCT00669617|11535147|FG000|COMPLETED|Period 1||18
10391958|NCT00669617|11535148|FG001|COMPLETED|Period 1||17
10391959|NCT00669617|11535149|FG002|COMPLETED|Period 1||17
10391960|NCT00669617|11535150|FG003|COMPLETED|Period 1||18
10391961|NCT00669617|11535151|FG004|COMPLETED|Period 1||17
10391962|NCT00669617|11535147|FG000|NOT COMPLETED|Period 1||0
10391963|NCT00669617|11535148|FG001|NOT COMPLETED|Period 1||0
10391964|NCT00669617|11535149|FG002|NOT COMPLETED|Period 1||1
10391965|NCT00669617|11535150|FG003|NOT COMPLETED|Period 1||0
10391966|NCT00669617|11535151|FG004|NOT COMPLETED|Period 1||1
10391967|NCT00669617|11535147|FG000|STARTED|Period 2||18
10391968|NCT00669617|11535148|FG001|STARTED|Period 2||17
10391969|NCT00669617|11535149|FG002|STARTED|Period 2||17
10391970|NCT00669617|11535150|FG003|STARTED|Period 2||18
10391971|NCT00669617|11535151|FG004|STARTED|Period 2||17
10391972|NCT00669617|11535147|FG000|COMPLETED|Period 2||18
10391973|NCT00669617|11535148|FG001|COMPLETED|Period 2||17
10391974|NCT00669617|11535149|FG002|COMPLETED|Period 2||17
10391975|NCT00669617|11535150|FG003|COMPLETED|Period 2||18
10391976|NCT00669617|11535151|FG004|COMPLETED|Period 2||17
10391977|NCT00669617|11535147|FG000|NOT COMPLETED|Period 2||0
10391978|NCT00669617|11535148|FG001|NOT COMPLETED|Period 2||0
10391979|NCT00669617|11535149|FG002|NOT COMPLETED|Period 2||0
10391980|NCT00669617|11535150|FG003|NOT COMPLETED|Period 2||0
10391981|NCT00669617|11535151|FG004|NOT COMPLETED|Period 2||0
10391982|NCT00669617|11535147|FG000|STARTED|Period 3||18
10391983|NCT00669617|11535148|FG001|STARTED|Period 3||17
10391984|NCT00669617|11535149|FG002|STARTED|Period 3||17
10391985|NCT00669617|11535150|FG003|STARTED|Period 3||18
10391986|NCT00669617|11535151|FG004|STARTED|Period 3||17
10391987|NCT00669617|11535147|FG000|COMPLETED|Period 3||17
10391988|NCT00669617|11535148|FG001|COMPLETED|Period 3||17
10391989|NCT00669617|11535149|FG002|COMPLETED|Period 3||17
10391990|NCT00669617|11535150|FG003|COMPLETED|Period 3||18
10391991|NCT00669617|11535151|FG004|COMPLETED|Period 3||17
10391992|NCT00669617|11535147|FG000|NOT COMPLETED|Period 3||1
10391993|NCT00669617|11535148|FG001|NOT COMPLETED|Period 3||0
10391994|NCT00669617|11535149|FG002|NOT COMPLETED|Period 3||0
10391995|NCT00669617|11535150|FG003|NOT COMPLETED|Period 3||0
10391996|NCT00669617|11535151|FG004|NOT COMPLETED|Period 3||0
10391997|NCT00669617|11535147|FG000|STARTED|Period 4||17
10391998|NCT00669617|11535148|FG001|STARTED|Period 4||17
10391999|NCT00669617|11535149|FG002|STARTED|Period 4||17
10392000|NCT00669617|11535150|FG003|STARTED|Period 4||18
10392001|NCT00669617|11535151|FG004|STARTED|Period 4||17
10392002|NCT00669617|11535147|FG000|COMPLETED|Period 4||17
10392003|NCT00669617|11535148|FG001|COMPLETED|Period 4||17
10392004|NCT00669617|11535149|FG002|COMPLETED|Period 4||17
10392005|NCT00669617|11535150|FG003|COMPLETED|Period 4||18
10392006|NCT00669617|11535151|FG004|COMPLETED|Period 4||17
10392007|NCT00669617|11535147|FG000|NOT COMPLETED|Period 4||0
10392008|NCT00669617|11535148|FG001|NOT COMPLETED|Period 4||0
10392009|NCT00669617|11535149|FG002|NOT COMPLETED|Period 4||0
10392010|NCT00669617|11535150|FG003|NOT COMPLETED|Period 4||0
10392011|NCT00669617|11535151|FG004|NOT COMPLETED|Period 4||0
10392012|NCT00669617|11535147|FG000|STARTED|Period 5||17
10392013|NCT00669617|11535148|FG001|STARTED|Period 5||17
10392014|NCT00669617|11535149|FG002|STARTED|Period 5||17
10392015|NCT00669617|11535150|FG003|STARTED|Period 5||18
10392016|NCT00669617|11535151|FG004|STARTED|Period 5||17
10392017|NCT00669617|11535147|FG000|COMPLETED|Period 5||17
10392018|NCT00669617|11535148|FG001|COMPLETED|Period 5||17
10392019|NCT00669617|11535149|FG002|COMPLETED|Period 5||17
10392020|NCT00669617|11535150|FG003|COMPLETED|Period 5||18
10392021|NCT00669617|11535151|FG004|COMPLETED|Period 5||17
10392022|NCT00669617|11535147|FG000|NOT COMPLETED|Period 5||0
10392023|NCT00669617|11535148|FG001|NOT COMPLETED|Period 5||0
10392024|NCT00669617|11535149|FG002|NOT COMPLETED|Period 5||0
10392025|NCT00669617|11535150|FG003|NOT COMPLETED|Period 5||0
10392026|NCT00669617|11535151|FG004|NOT COMPLETED|Period 5||0
10392027|NCT00669682|11535163|FG000|STARTED|Overall Study||9
10392028|NCT00669682|11535163|FG000|COMPLETED|Overall Study||9
10392029|NCT00669682|11535163|FG000|NOT COMPLETED|Overall Study||0
10392030|NCT00669864|11535168|FG000|STARTED|Overall Study||293
10392031|NCT00669864|11535168|FG000|COMPLETED|Overall Study||284
10392032|NCT00669864|11535168|FG000|NOT COMPLETED|Overall Study||9
10392033|NCT00669877|11535172|FG000|STARTED|Overall Study||56
10392034|NCT00669877|11535172|FG000|COMPLETED|Overall Study||52
10392035|NCT00669877|11535172|FG000|NOT COMPLETED|Overall Study||4
10392036|NCT00669903|11535180|FG000|STARTED|Overall Study||23
10392037|NCT00669903|11535181|FG001|STARTED|Overall Study||37
10392038|NCT00669903|11535182|FG002|STARTED|Overall Study||18
10392039|NCT00669903|11535183|FG003|STARTED|Overall Study||22
10392040|NCT00669903|11535180|FG000|Completed Treatment Period|Overall Study||23
10392041|NCT00669903|11535181|FG001|Completed Treatment Period|Overall Study||33
10392042|NCT00669903|11535182|FG002|Completed Treatment Period|Overall Study||13
10392043|NCT00669903|11535183|FG003|Completed Treatment Period|Overall Study||19
10392044|NCT00669903|11535180|FG000|COMPLETED|Overall Study||22
10392045|NCT00669903|11535181|FG001|COMPLETED|Overall Study||32
10392046|NCT00669903|11535182|FG002|COMPLETED|Overall Study||13
10392047|NCT00669903|11535183|FG003|COMPLETED|Overall Study||18
10392048|NCT00669903|11535180|FG000|NOT COMPLETED|Overall Study||1
10392049|NCT00669903|11535181|FG001|NOT COMPLETED|Overall Study||5
10392050|NCT00669903|11535182|FG002|NOT COMPLETED|Overall Study||5
10392051|NCT00669903|11535183|FG003|NOT COMPLETED|Overall Study||4
10392052|NCT00669916|11535195|FG000|STARTED|Overall Study||18
10392053|NCT00669916|11535196|FG001|STARTED|Overall Study||18
10392054|NCT00669916|11535195|FG000|COMPLETED|Overall Study||18
10392055|NCT00669916|11535196|FG001|COMPLETED|Overall Study||18
10392056|NCT00669916|11535195|FG000|NOT COMPLETED|Overall Study||0
10392057|NCT00669916|11535196|FG001|NOT COMPLETED|Overall Study||0
10392058|NCT00669942|11535214|FG000|STARTED|Part 1||6
10392059|NCT00669942|11535215|FG001|STARTED|Part 1||6
10392060|NCT00669942|11535216|FG002|STARTED|Part 1||6
10392061|NCT00669942|11535217|FG003|STARTED|Part 1||6
10392062|NCT00669942|11535218|FG004|STARTED|Part 1||8
10392063|NCT00669942|11535219|FG005|STARTED|Part 1||0
10392064|NCT00669942|11535220|FG006|STARTED|Part 1||0
10392065|NCT00669942|11535221|FG007|STARTED|Part 1||0
10392066|NCT00669942|11535222|FG008|STARTED|Part 1||0
10392067|NCT00669942|11535223|FG009|STARTED|Part 1||0
10392068|NCT00669942|11535224|FG010|STARTED|Part 1||0
10392069|NCT00669942|11535225|FG011|STARTED|Part 1||0
10392070|NCT00669942|11535214|FG000|COMPLETED|Part 1||6
10392071|NCT00669942|11535215|FG001|COMPLETED|Part 1||6
10392072|NCT00669942|11535216|FG002|COMPLETED|Part 1||6
10392073|NCT00669942|11535217|FG003|COMPLETED|Part 1||6
10392074|NCT00669942|11535218|FG004|COMPLETED|Part 1||8
10392075|NCT00669942|11535219|FG005|COMPLETED|Part 1||0
10392076|NCT00669942|11535220|FG006|COMPLETED|Part 1||0
10392077|NCT00669942|11535221|FG007|COMPLETED|Part 1||0
10392078|NCT00669942|11535222|FG008|COMPLETED|Part 1||0
10392079|NCT00669942|11535223|FG009|COMPLETED|Part 1||0
10392080|NCT00669942|11535224|FG010|COMPLETED|Part 1||0
10392081|NCT00669942|11535225|FG011|COMPLETED|Part 1||0
10392082|NCT00669942|11535214|FG000|NOT COMPLETED|Part 1||0
10392083|NCT00669942|11535215|FG001|NOT COMPLETED|Part 1||0
10392084|NCT00669942|11535216|FG002|NOT COMPLETED|Part 1||0
10392085|NCT00669942|11535217|FG003|NOT COMPLETED|Part 1||0
10392086|NCT00669942|11535218|FG004|NOT COMPLETED|Part 1||0
10392087|NCT00669942|11535219|FG005|NOT COMPLETED|Part 1||0
10392088|NCT00669942|11535220|FG006|NOT COMPLETED|Part 1||0
10392089|NCT00669942|11535221|FG007|NOT COMPLETED|Part 1||0
10392090|NCT00669942|11535222|FG008|NOT COMPLETED|Part 1||0
10392091|NCT00669942|11535223|FG009|NOT COMPLETED|Part 1||0
10392092|NCT00669942|11535224|FG010|NOT COMPLETED|Part 1||0
10392093|NCT00669942|11535225|FG011|NOT COMPLETED|Part 1||0
10392094|NCT00669942|11535214|FG000|STARTED|Parts 2 and 3||0
10392095|NCT00669942|11535215|FG001|STARTED|Parts 2 and 3||0
10392096|NCT00669942|11535216|FG002|STARTED|Parts 2 and 3||0
10392097|NCT00669942|11535217|FG003|STARTED|Parts 2 and 3||0
10392098|NCT00669942|11535218|FG004|STARTED|Parts 2 and 3||0
10392099|NCT00669942|11535219|FG005|STARTED|Parts 2 and 3||6
10392100|NCT00669942|11535220|FG006|STARTED|Parts 2 and 3||6
10392101|NCT00669942|11535221|FG007|STARTED|Parts 2 and 3||26
10392102|NCT00669942|11535222|FG008|STARTED|Parts 2 and 3||26
10392103|NCT00669942|11535223|FG009|STARTED|Parts 2 and 3||0
10392104|NCT00669942|11535224|FG010|STARTED|Parts 2 and 3||0
10392105|NCT00669942|11535225|FG011|STARTED|Parts 2 and 3||0
10392106|NCT00669942|11535214|FG000|COMPLETED|Parts 2 and 3||0
10392107|NCT00669942|11535215|FG001|COMPLETED|Parts 2 and 3||0
10392108|NCT00669942|11535216|FG002|COMPLETED|Parts 2 and 3||0
10392109|NCT00669942|11535217|FG003|COMPLETED|Parts 2 and 3||0
10392110|NCT00669942|11535218|FG004|COMPLETED|Parts 2 and 3||0
10392111|NCT00669942|11535219|FG005|COMPLETED|Parts 2 and 3||4
10392112|NCT00669942|11535220|FG006|COMPLETED|Parts 2 and 3||6
10392113|NCT00669942|11535221|FG007|COMPLETED|Parts 2 and 3||24
10392114|NCT00669942|11535222|FG008|COMPLETED|Parts 2 and 3||23
10392115|NCT00669942|11535223|FG009|COMPLETED|Parts 2 and 3||0
10392116|NCT00669942|11535224|FG010|COMPLETED|Parts 2 and 3||0
10392117|NCT00669942|11535225|FG011|COMPLETED|Parts 2 and 3||0
10392118|NCT00669942|11535214|FG000|NOT COMPLETED|Parts 2 and 3||0
10392119|NCT00669942|11535215|FG001|NOT COMPLETED|Parts 2 and 3||0
10392120|NCT00669942|11535216|FG002|NOT COMPLETED|Parts 2 and 3||0
10392121|NCT00669942|11535217|FG003|NOT COMPLETED|Parts 2 and 3||0
10392122|NCT00669942|11535218|FG004|NOT COMPLETED|Parts 2 and 3||0
10392123|NCT00669942|11535219|FG005|NOT COMPLETED|Parts 2 and 3||2
10392124|NCT00669942|11535220|FG006|NOT COMPLETED|Parts 2 and 3||0
10392125|NCT00669942|11535221|FG007|NOT COMPLETED|Parts 2 and 3||2
10392126|NCT00669942|11535222|FG008|NOT COMPLETED|Parts 2 and 3||3
10392127|NCT00669942|11535223|FG009|NOT COMPLETED|Parts 2 and 3||0
10392128|NCT00669942|11535224|FG010|NOT COMPLETED|Parts 2 and 3||0
10392129|NCT00669942|11535225|FG011|NOT COMPLETED|Parts 2 and 3||0
10392130|NCT00669942|11535214|FG000|STARTED|Healthy Volunteers||0
10392131|NCT00669942|11535215|FG001|STARTED|Healthy Volunteers||0
10392132|NCT00669942|11535216|FG002|STARTED|Healthy Volunteers||0
10392133|NCT00669942|11535217|FG003|STARTED|Healthy Volunteers||0
10392134|NCT00669942|11535218|FG004|STARTED|Healthy Volunteers||0
10392135|NCT00669942|11535219|FG005|STARTED|Healthy Volunteers||0
10392136|NCT00669942|11535220|FG006|STARTED|Healthy Volunteers||0
10392137|NCT00669942|11535221|FG007|STARTED|Healthy Volunteers||0
10392138|NCT00669942|11535222|FG008|STARTED|Healthy Volunteers||0
10392139|NCT00669942|11535223|FG009|STARTED|Healthy Volunteers||3
10392140|NCT00669942|11535224|FG010|STARTED|Healthy Volunteers||3
10392141|NCT00669942|11535225|FG011|STARTED|Healthy Volunteers||2
10392142|NCT00669942|11535214|FG000|COMPLETED|Healthy Volunteers||0
10392143|NCT00669942|11535215|FG001|COMPLETED|Healthy Volunteers||0
10392144|NCT00669942|11535216|FG002|COMPLETED|Healthy Volunteers||0
10392145|NCT00669942|11535217|FG003|COMPLETED|Healthy Volunteers||0
10392146|NCT00669942|11535218|FG004|COMPLETED|Healthy Volunteers||0
10392147|NCT00669942|11535219|FG005|COMPLETED|Healthy Volunteers||0
10392148|NCT00669942|11535220|FG006|COMPLETED|Healthy Volunteers||0
10392149|NCT00669942|11535221|FG007|COMPLETED|Healthy Volunteers||0
10392150|NCT00669942|11535222|FG008|COMPLETED|Healthy Volunteers||0
10392151|NCT00669942|11535223|FG009|COMPLETED|Healthy Volunteers||3
10392152|NCT00669942|11535224|FG010|COMPLETED|Healthy Volunteers||2
10392153|NCT00669942|11535225|FG011|COMPLETED|Healthy Volunteers||2
10392154|NCT00669942|11535214|FG000|NOT COMPLETED|Healthy Volunteers||0
10392155|NCT00669942|11535215|FG001|NOT COMPLETED|Healthy Volunteers||0
10392156|NCT00669942|11535216|FG002|NOT COMPLETED|Healthy Volunteers||0
10392157|NCT00669942|11535217|FG003|NOT COMPLETED|Healthy Volunteers||0
10392158|NCT00669942|11535218|FG004|NOT COMPLETED|Healthy Volunteers||0
10392159|NCT00669942|11535219|FG005|NOT COMPLETED|Healthy Volunteers||0
10392160|NCT00669942|11535220|FG006|NOT COMPLETED|Healthy Volunteers||0
10392161|NCT00669942|11535221|FG007|NOT COMPLETED|Healthy Volunteers||0
10392162|NCT00669942|11535222|FG008|NOT COMPLETED|Healthy Volunteers||0
10392163|NCT00669942|11535223|FG009|NOT COMPLETED|Healthy Volunteers||0
10392164|NCT00669942|11535224|FG010|NOT COMPLETED|Healthy Volunteers||1
10392165|NCT00669942|11535225|FG011|NOT COMPLETED|Healthy Volunteers||0
10392166|NCT00669955|11535250|FG000|STARTED|Overall Study|216 patients received study drug. 2 patients were dispensed study drug but did not take it|218
10392167|NCT00669955|11535251|FG001|STARTED|Overall Study||222
10392168|NCT00669955|11535250|FG000|COMPLETED|Overall Study||204
10392169|NCT00669955|11535251|FG001|COMPLETED|Overall Study||195
10392170|NCT00669955|11535250|FG000|NOT COMPLETED|Overall Study||14
10392171|NCT00669955|11535251|FG001|NOT COMPLETED|Overall Study||27
10392172|NCT00670007|11535257|FG000|STARTED|Overall Study||140
10392173|NCT00670007|11535257|FG000|COMPLETED|Overall Study||131
10392174|NCT00670007|11535257|FG000|NOT COMPLETED|Overall Study||9
10392175|NCT00670046|11535264|FG000|STARTED|Overall Study||7
10392176|NCT00670046|11535265|FG001|STARTED|Overall Study||8
10392177|NCT00670046|11535264|FG000|COMPLETED|Overall Study||6
10392178|NCT00670046|11535265|FG001|COMPLETED|Overall Study||6
10392179|NCT00670046|11535264|FG000|NOT COMPLETED|Overall Study||1
10392180|NCT00670046|11535265|FG001|NOT COMPLETED|Overall Study||2
10392181|NCT00670111|11535274|FG000|STARTED|Enrollment to One Month||5
10392182|NCT00670111|11535275|FG001|STARTED|Enrollment to One Month||8
10392183|NCT00670111|11535276|FG002|STARTED|Enrollment to One Month||19
10392184|NCT00670111|11535274|FG000|COMPLETED|Enrollment to One Month||4
10392185|NCT00670111|11535275|FG001|COMPLETED|Enrollment to One Month||8
10392186|NCT00670111|11535276|FG002|COMPLETED|Enrollment to One Month||0
10392187|NCT00670111|11535274|FG000|NOT COMPLETED|Enrollment to One Month||1
10392188|NCT00670111|11535275|FG001|NOT COMPLETED|Enrollment to One Month||0
10392189|NCT00670111|11535276|FG002|NOT COMPLETED|Enrollment to One Month||19
10392190|NCT00670111|11535274|FG000|STARTED|One Month Period A||4
10392191|NCT00670111|11535275|FG001|STARTED|One Month Period A||8
10392192|NCT00670111|11535276|FG002|STARTED|One Month Period A||0
10392193|NCT00670111|11535274|FG000|COMPLETED|One Month Period A||4
10392194|NCT00670111|11535275|FG001|COMPLETED|One Month Period A||8
10392195|NCT00670111|11535276|FG002|COMPLETED|One Month Period A||0
10392196|NCT00670111|11535274|FG000|NOT COMPLETED|One Month Period A||0
10392197|NCT00670111|11535275|FG001|NOT COMPLETED|One Month Period A||0
10392198|NCT00670111|11535276|FG002|NOT COMPLETED|One Month Period A||0
10392199|NCT00670111|11535274|FG000|STARTED|One Month Period B||4
10392200|NCT00670111|11535275|FG001|STARTED|One Month Period B||8
10392201|NCT00670111|11535276|FG002|STARTED|One Month Period B||0
10392202|NCT00670111|11535274|FG000|COMPLETED|One Month Period B|4 patients in this group completed the 1 month visit; 0 had data eligible for endpoint analysis.|4
10658675|NCT02234180|11819840|FG001|COMPLETED|Overall Study||1
10658676|NCT02234180|11819839|FG000|NOT COMPLETED|Overall Study||0
10658677|NCT02234180|11819840|FG001|NOT COMPLETED|Overall Study||0
10658678|NCT02234284|11819846|FG000|STARTED|Overall Study||100
10658679|NCT02234284|11819847|FG001|STARTED|Overall Study||92
10392203|NCT00670111|11535275|FG001|COMPLETED|One Month Period B|8 patients in this group completed the 1 month visit; 6 had data eligible for endpoint analysis.|8
10392204|NCT00670111|11535276|FG002|COMPLETED|One Month Period B||0
10392205|NCT00670111|11535274|FG000|NOT COMPLETED|One Month Period B||0
10392206|NCT00670111|11535275|FG001|NOT COMPLETED|One Month Period B||0
10392207|NCT00670111|11535276|FG002|NOT COMPLETED|One Month Period B||0
10392208|NCT00670111|11535274|FG000|STARTED|One Month to Six Months||4
10392209|NCT00670111|11535275|FG001|STARTED|One Month to Six Months||8
10392210|NCT00670111|11535276|FG002|STARTED|One Month to Six Months||0
10392211|NCT00670111|11535274|FG000|COMPLETED|One Month to Six Months|4 patients in this group completed the 1 month visit; 0 had data eligible for endpoint analysis.|4
10392212|NCT00670111|11535275|FG001|COMPLETED|One Month to Six Months|8 patients in this group completed the 1 month visit; 4 had data eligible for endpoint analysis.|8
10392213|NCT00670111|11535276|FG002|COMPLETED|One Month to Six Months||0
10392214|NCT00670111|11535274|FG000|NOT COMPLETED|One Month to Six Months||0
10392215|NCT00670111|11535275|FG001|NOT COMPLETED|One Month to Six Months||0
10392216|NCT00670111|11535276|FG002|NOT COMPLETED|One Month to Six Months||0
10392217|NCT00670111|11535274|FG000|STARTED|Six Months to Twelve Months||4
10658680|NCT02234284|11819846|FG000|COMPLETED|Overall Study||75
10658681|NCT02234284|11819847|FG001|COMPLETED|Overall Study||83
10658682|NCT02234284|11819846|FG000|NOT COMPLETED|Overall Study||25
10658683|NCT02234284|11819847|FG001|NOT COMPLETED|Overall Study||9
10392218|NCT00670111|11535275|FG001|STARTED|Six Months to Twelve Months||8
10392219|NCT00670111|11535276|FG002|STARTED|Six Months to Twelve Months||0
10392220|NCT00670111|11535274|FG000|COMPLETED|Six Months to Twelve Months||4
10392221|NCT00670111|11535275|FG001|COMPLETED|Six Months to Twelve Months||8
10392222|NCT00670111|11535276|FG002|COMPLETED|Six Months to Twelve Months||0
10392223|NCT00670111|11535274|FG000|NOT COMPLETED|Six Months to Twelve Months||0
10392224|NCT00670111|11535275|FG001|NOT COMPLETED|Six Months to Twelve Months||0
10392225|NCT00670111|11535276|FG002|NOT COMPLETED|Six Months to Twelve Months||0
10392226|NCT00670202|11535286|FG000|STARTED|Overall Study|Investigators blinded to study drug assignment due to early termination of study|2
10392227|NCT00670202|11535287|FG001|STARTED|Overall Study||0
10392228|NCT00670202|11535286|FG000|COMPLETED|Overall Study|Investigators blinded to study drug assignment due to early termination of study|2
10392229|NCT00670202|11535287|FG001|COMPLETED|Overall Study||0
10392230|NCT00670202|11535286|FG000|NOT COMPLETED|Overall Study||0
10392231|NCT00670202|11535287|FG001|NOT COMPLETED|Overall Study||0
10392232|NCT00670228|11535295|FG000|STARTED|Overall Study||18
10392233|NCT00670228|11535296|FG001|STARTED|Overall Study||15
10392234|NCT00670228|11535295|FG000|COMPLETED|Overall Study||13
10392235|NCT00670228|11535296|FG001|COMPLETED|Overall Study||12
10392236|NCT00670228|11535295|FG000|NOT COMPLETED|Overall Study||5
10392237|NCT00670228|11535296|FG001|NOT COMPLETED|Overall Study||3
10392238|NCT00670241|11535305|FG000|STARTED|Overall Study||183
10392239|NCT00670241|11535306|FG001|STARTED|Overall Study||184
10392240|NCT00670241|11535307|FG002|STARTED|Overall Study||91
10392241|NCT00670241|11535305|FG000|COMPLETED|Overall Study||171
10392242|NCT00670241|11535306|FG001|COMPLETED|Overall Study||163
10392243|NCT00670241|11535307|FG002|COMPLETED|Overall Study||64
10392244|NCT00670241|11535305|FG000|NOT COMPLETED|Overall Study||12
10392245|NCT00670241|11535306|FG001|NOT COMPLETED|Overall Study||21
10392246|NCT00670241|11535307|FG002|NOT COMPLETED|Overall Study||27
10392247|NCT00670267|11535315|FG000|STARTED|Overall Study||10
10392248|NCT00670267|11535315|FG000|COMPLETED|Overall Study||9
10392249|NCT00670267|11535315|FG000|NOT COMPLETED|Overall Study||1
10392250|NCT00670306|11535321|FG000|STARTED|Overall Study||528
10392251|NCT00670306|11535321|FG000|COMPLETED|Overall Study||473
10392252|NCT00670306|11535321|FG000|NOT COMPLETED|Overall Study||55
10392253|NCT00670449|11535329|FG000|STARTED|Overall Study||47
10392254|NCT00670449|11535330|FG001|STARTED|Overall Study||46
10392255|NCT00670449|11535331|FG002|STARTED|Overall Study||27
10392256|NCT00670449|11535332|FG003|STARTED|Overall Study||23
10392257|NCT00670449|11535329|FG000|Switched to 0.5mg (Open Label)|Overall Study||45
10392258|NCT00670449|11535330|FG001|Switched to 0.5mg (Open Label)|Overall Study|Following protocol amendment, study became open-label with all patients receiving FTY720 0.5 mg/day|41
10392259|NCT00670449|11535331|FG002|Switched to 0.5mg (Open Label)|Overall Study||23
10392260|NCT00670449|11535332|FG003|Switched to 0.5mg (Open Label)|Overall Study|Following protocol amendment, study became open-label with all patients receiving FTY720 0.5 mg/day|17
10392261|NCT00670449|11535329|FG000|COMPLETED|Overall Study||38
10392262|NCT00670449|11535330|FG001|COMPLETED|Overall Study||36
10392263|NCT00670449|11535331|FG002|COMPLETED|Overall Study||18
10392264|NCT00670449|11535332|FG003|COMPLETED|Overall Study||15
10392265|NCT00670449|11535329|FG000|NOT COMPLETED|Overall Study||9
10392266|NCT00670449|11535330|FG001|NOT COMPLETED|Overall Study||10
10392267|NCT00670449|11535331|FG002|NOT COMPLETED|Overall Study||9
10392268|NCT00670449|11535332|FG003|NOT COMPLETED|Overall Study||8
10392269|NCT00670462|11535343|FG000|STARTED|Overall Study||106
10392270|NCT00670462|11535344|FG001|STARTED|Overall Study||107
10392271|NCT00670462|11535343|FG000|COMPLETED|Overall Study||76
10392272|NCT00670462|11535344|FG001|COMPLETED|Overall Study||76
10392273|NCT00670462|11535343|FG000|NOT COMPLETED|Overall Study||30
10392274|NCT00670462|11535344|FG001|NOT COMPLETED|Overall Study||31
10392275|NCT00670488|11535362|FG000|STARTED|Overall Study||3
10392276|NCT00670488|11535363|FG001|STARTED|Overall Study||58
10392277|NCT00670488|11535364|FG002|STARTED|Overall Study||3
10392278|NCT00670488|11535365|FG003|STARTED|Overall Study||7
10392279|NCT00670488|11535366|FG004|STARTED|Overall Study||3
10392280|NCT00670488|11535367|FG005|STARTED|Overall Study||5
10392281|NCT00670488|11535368|FG006|STARTED|Overall Study||17
10392282|NCT00670488|11535369|FG007|STARTED|Overall Study||3
10392283|NCT00670488|11535370|FG008|STARTED|Overall Study||3
10392284|NCT00670488|11535371|FG009|STARTED|Overall Study||2
10392285|NCT00670488|11535362|FG000|COMPLETED|Overall Study||0
10392286|NCT00670488|11535363|FG001|COMPLETED|Overall Study||0
10392287|NCT00670488|11535364|FG002|COMPLETED|Overall Study||0
10392288|NCT00670488|11535365|FG003|COMPLETED|Overall Study||0
10392289|NCT00670488|11535366|FG004|COMPLETED|Overall Study||0
10392290|NCT00670488|11535367|FG005|COMPLETED|Overall Study||0
10392291|NCT00670488|11535368|FG006|COMPLETED|Overall Study||0
10392292|NCT00670488|11535369|FG007|COMPLETED|Overall Study||0
10392293|NCT00670488|11535370|FG008|COMPLETED|Overall Study||0
10392294|NCT00670488|11535371|FG009|COMPLETED|Overall Study||0
10392295|NCT00670488|11535362|FG000|NOT COMPLETED|Overall Study||3
10392296|NCT00670488|11535363|FG001|NOT COMPLETED|Overall Study||58
10392297|NCT00670488|11535364|FG002|NOT COMPLETED|Overall Study||3
10392298|NCT00670488|11535365|FG003|NOT COMPLETED|Overall Study||7
10392299|NCT00670488|11535366|FG004|NOT COMPLETED|Overall Study||3
10392300|NCT00670488|11535367|FG005|NOT COMPLETED|Overall Study||5
10392301|NCT00670488|11535368|FG006|NOT COMPLETED|Overall Study||17
10392302|NCT00670488|11535369|FG007|NOT COMPLETED|Overall Study||3
10392303|NCT00670488|11535370|FG008|NOT COMPLETED|Overall Study||3
10392304|NCT00670488|11535371|FG009|NOT COMPLETED|Overall Study||2
10392305|NCT00670540|11535393|FG000|STARTED|Overall Study||8256
10392306|NCT00670540|11535393|FG000|COMPLETED|Overall Study|total recruited for the follow up|4931
10392307|NCT00670540|11535393|FG000|NOT COMPLETED|Overall Study||3325
10392308|NCT00670709|11535399|FG000|STARTED|Overall Study||27
10392309|NCT00670709|11535400|FG001|STARTED|Overall Study||15
10392310|NCT00670709|11535399|FG000|COMPLETED|Overall Study||27
10392311|NCT00670709|11535400|FG001|COMPLETED|Overall Study||15
10392312|NCT00670709|11535399|FG000|NOT COMPLETED|Overall Study||0
10392313|NCT00670709|11535400|FG001|NOT COMPLETED|Overall Study||0
10392314|NCT00670748|11535410|FG000|STARTED|Overall Study||17
10392315|NCT00670748|11535411|FG001|STARTED|Overall Study||16
10392316|NCT00670748|11535412|FG002|STARTED|Overall Study||7
10392317|NCT00670748|11535413|FG003|STARTED|Overall Study||5
10392318|NCT00670748|11535410|FG000|COMPLETED|Overall Study||14
10392319|NCT00670748|11535411|FG001|COMPLETED|Overall Study||14
10392320|NCT00670748|11535412|FG002|COMPLETED|Overall Study||5
10392321|NCT00670748|11535413|FG003|COMPLETED|Overall Study||4
10392322|NCT00670748|11535410|FG000|NOT COMPLETED|Overall Study||3
10392323|NCT00670748|11535411|FG001|NOT COMPLETED|Overall Study||2
10392324|NCT00670748|11535412|FG002|NOT COMPLETED|Overall Study||2
10392325|NCT00670748|11535413|FG003|NOT COMPLETED|Overall Study||1
10392326|NCT00670774|11535423|FG000|STARTED|Overall Study||26
10392327|NCT00670774|11535423|FG000|COMPLETED|Overall Study||26
10392328|NCT00670774|11535423|FG000|NOT COMPLETED|Overall Study||0
10392329|NCT00670800|11535429|FG000|STARTED|Overall Study||7
10392330|NCT00670800|11535430|FG001|STARTED|Overall Study||7
10392331|NCT00670800|11535429|FG000|COMPLETED|Overall Study||7
10392332|NCT00670800|11535430|FG001|COMPLETED|Overall Study|Two controls were found to have insulin resistance and were excluded from analysis.|5
10392333|NCT00670800|11535429|FG000|NOT COMPLETED|Overall Study||0
10392334|NCT00670800|11535430|FG001|NOT COMPLETED|Overall Study||2
10392335|NCT00670930|11535440|FG000|STARTED|Overall Study|"Started indicates Randomized and Safety populaiton"|23
10392336|NCT00670930|11535441|FG001|STARTED|Overall Study||13
10392337|NCT00670930|11535440|FG000|Intent to Treat (ITT) Population|Overall Study||23
10392338|NCT00670930|11535441|FG001|Intent to Treat (ITT) Population|Overall Study||12
10392339|NCT00670930|11535440|FG000|COMPLETED|Overall Study||22
10392340|NCT00670930|11535441|FG001|COMPLETED|Overall Study||12
10392341|NCT00670930|11535440|FG000|NOT COMPLETED|Overall Study||1
10392342|NCT00670930|11535441|FG001|NOT COMPLETED|Overall Study||1
10392343|NCT00670956|11535447|FG000|STARTED|Overall Study||1
10392344|NCT00670956|11535447|FG000|COMPLETED|Overall Study||1
10392345|NCT00670956|11535447|FG000|NOT COMPLETED|Overall Study||0
10392346|NCT00670982|11535453|FG000|STARTED|Overall Study||22
10392347|NCT00670982|11535454|FG001|STARTED|Overall Study||7
10392348|NCT00670982|11535453|FG000|COMPLETED|Overall Study||22
10392349|NCT00670982|11535454|FG001|COMPLETED|Overall Study||7
10392350|NCT00670982|11535453|FG000|NOT COMPLETED|Overall Study||0
10392351|NCT00670982|11535454|FG001|NOT COMPLETED|Overall Study||0
10392352|NCT00671034|11535462|FG000|STARTED|Overall Study||69
10392353|NCT00671034|11535463|FG001|STARTED|Overall Study||42
10392354|NCT00671034|11535464|FG002|STARTED|Overall Study||55
10392355|NCT00671034|11535462|FG000|COMPLETED|Overall Study||30
10392356|NCT00671034|11535463|FG001|COMPLETED|Overall Study||22
10392357|NCT00671034|11535464|FG002|COMPLETED|Overall Study||31
10392358|NCT00671034|11535462|FG000|NOT COMPLETED|Overall Study||39
10392359|NCT00671034|11535463|FG001|NOT COMPLETED|Overall Study||20
10392360|NCT00671034|11535464|FG002|NOT COMPLETED|Overall Study||24
10392361|NCT00671060|11535475|FG000|STARTED|Overall Study||77
10392362|NCT00671060|11535476|FG001|STARTED|Overall Study||76
10392363|NCT00671060|11535475|FG000|COMPLETED|Overall Study|1 woman completed study but was excluded from analysis because gestational age <14 weeks.|76
10392364|NCT00671060|11535476|FG001|COMPLETED|Overall Study|1 woman was withdrawn from the study due to preeclampsia.|75
10719158|NCT02708524|11882888|FG000|STARTED|Overall Study||139
10392365|NCT00671060|11535475|FG000|NOT COMPLETED|Overall Study||1
10392366|NCT00671060|11535476|FG001|NOT COMPLETED|Overall Study||1
10392367|NCT00671177|11535484|FG000|STARTED|Overall Study||114
10392368|NCT00671177|11535485|FG001|STARTED|Overall Study||115
10392369|NCT00671177|11535484|FG000|COMPLETED|Overall Study||112
10392370|NCT00671177|11535485|FG001|COMPLETED|Overall Study||114
10392371|NCT00671177|11535484|FG000|NOT COMPLETED|Overall Study||2
10392372|NCT00671177|11535485|FG001|NOT COMPLETED|Overall Study||1
10392373|NCT00671437|11535491|FG000|STARTED|Overall Study||42
10392374|NCT00671437|11535491|FG000|COMPLETED|Overall Study||27
10392375|NCT00671437|11535491|FG000|NOT COMPLETED|Overall Study||15
10392376|NCT00671502|11535506|FG000|STARTED|Overall Study||281
10392377|NCT00671502|11535507|FG001|STARTED|Overall Study||280
10392378|NCT00671502|11535508|FG002|STARTED|Overall Study||279
10392379|NCT00671502|11535506|FG000|COMPLETED|Overall Study||242
10392380|NCT00671502|11535507|FG001|COMPLETED|Overall Study||241
10392381|NCT00671502|11535508|FG002|COMPLETED|Overall Study||252
10392382|NCT00671502|11535506|FG000|NOT COMPLETED|Overall Study||39
10392383|NCT00671502|11535507|FG001|NOT COMPLETED|Overall Study||39
10392384|NCT00671502|11535508|FG002|NOT COMPLETED|Overall Study||27
10392385|NCT00671515|11535516|FG000|STARTED|Phase 1||23
10392386|NCT00671515|11535516|FG000|COMPLETED|Phase 1||20
10392387|NCT00671515|11535516|FG000|NOT COMPLETED|Phase 1||3
10392388|NCT00671515|11535516|FG000|STARTED|Phase 2||13
10719159|NCT02708524|11882889|FG001|STARTED|Overall Study||136
10392389|NCT00671515|11535516|FG000|COMPLETED|Phase 2||9
10392390|NCT00671515|11535516|FG000|NOT COMPLETED|Phase 2||4
10392391|NCT00671554|11535520|FG000|STARTED|Overall Study||3
10392392|NCT00671554|11535520|FG000|COMPLETED|Overall Study||0
10392393|NCT00671554|11535520|FG000|NOT COMPLETED|Overall Study||3
10392394|NCT00671658|11535525|FG000|STARTED|Overall Study||220
10392395|NCT00671658|11535525|FG000|COMPLETED|Overall Study||215
10392396|NCT00671658|11535525|FG000|NOT COMPLETED|Overall Study||5
10392397|NCT00671671|11535531|FG000|STARTED|Overall Study||10
10392398|NCT00671671|11535532|FG001|STARTED|Overall Study||10
10392399|NCT00671671|11535531|FG000|COMPLETED|Overall Study||10
10392400|NCT00671671|11535532|FG001|COMPLETED|Overall Study||10
10392401|NCT00671671|11535531|FG000|NOT COMPLETED|Overall Study||0
10543005|NCT01481324|11696173|FG000|Month 2-Wear Rate Data|Overall Study||9
10543006|NCT01481324|11696174|FG001|Month 2-Wear Rate Data|Overall Study||13
10543007|NCT01481324|11696175|FG002|Month 2-Wear Rate Data|Overall Study||7
10543008|NCT01481324|11696173|FG000|Month 3-Wear Rate Data|Overall Study||7
10543009|NCT01481324|11696174|FG001|Month 3-Wear Rate Data|Overall Study||11
10543010|NCT01481324|11696175|FG002|Month 3-Wear Rate Data|Overall Study||6
10543011|NCT01481324|11696173|FG000|COMPLETED|Overall Study||21
10543012|NCT01481324|11696174|FG001|COMPLETED|Overall Study||22
10543013|NCT01481324|11696175|FG002|COMPLETED|Overall Study||20
10543014|NCT01481324|11696173|FG000|NOT COMPLETED|Overall Study||0
10543015|NCT01481324|11696174|FG001|NOT COMPLETED|Overall Study||2
10543016|NCT01481324|11696175|FG002|NOT COMPLETED|Overall Study||2
10543017|NCT01481376|11696183|FG000|STARTED|Overall Study||200
10658684|NCT02234362|11819857|FG000|STARTED|Overall Study||47
10658685|NCT02234362|11819857|FG000|Received at Least One Dose of Medication|Overall Study||27
10658686|NCT02234362|11819857|FG000|COMPLETED|Overall Study||21
10658687|NCT02234362|11819857|FG000|NOT COMPLETED|Overall Study||26
10658688|NCT02234427|11819861|FG000|STARTED|Overall Study||34
10658689|NCT02234427|11819861|FG000|COMPLETED|Overall Study|One individual withdrew after first visit|33
10658690|NCT02234427|11819861|FG000|NOT COMPLETED|Overall Study||1
10658691|NCT02234479|11819867|FG000|STARTED|Overall Study||16
10658692|NCT02234479|11819868|FG001|STARTED|Overall Study||18
10658693|NCT02234479|11819867|FG000|COMPLETED|Overall Study||15
10658694|NCT02234479|11819868|FG001|COMPLETED|Overall Study||15
10719160|NCT02708524|11882890|FG002|STARTED|Overall Study||137
10719161|NCT02708524|11882891|FG003|STARTED|Overall Study||136
10658695|NCT02234479|11819867|FG000|NOT COMPLETED|Overall Study||1
10658696|NCT02234479|11819868|FG001|NOT COMPLETED|Overall Study||3
10658697|NCT02234570|11819882|FG000|STARTED|Overall Study||8
10658698|NCT02234570|11819883|FG001|STARTED|Overall Study||8
10658699|NCT02234570|11819884|FG002|STARTED|Overall Study||8
10658700|NCT02234570|11819885|FG003|STARTED|Overall Study||8
10658701|NCT02234570|11819886|FG004|STARTED|Overall Study||8
10658702|NCT02234570|11819887|FG005|STARTED|Overall Study||8
10658703|NCT02234570|11819888|FG006|STARTED|Overall Study||8
10658704|NCT02234570|11819889|FG007|STARTED|Overall Study||14
10658705|NCT02234570|11819882|FG000|COMPLETED|Overall Study||8
10658706|NCT02234570|11819883|FG001|COMPLETED|Overall Study||8
10658707|NCT02234570|11819884|FG002|COMPLETED|Overall Study||8
10658708|NCT02234570|11819885|FG003|COMPLETED|Overall Study||8
10658709|NCT02234570|11819886|FG004|COMPLETED|Overall Study||8
10658710|NCT02234570|11819887|FG005|COMPLETED|Overall Study||8
10658711|NCT02234570|11819888|FG006|COMPLETED|Overall Study||8
10658712|NCT02234570|11819889|FG007|COMPLETED|Overall Study||14
10658713|NCT02234570|11819882|FG000|NOT COMPLETED|Overall Study||0
10658714|NCT02234570|11819883|FG001|NOT COMPLETED|Overall Study||0
10658715|NCT02234570|11819884|FG002|NOT COMPLETED|Overall Study||0
10658716|NCT02234570|11819885|FG003|NOT COMPLETED|Overall Study||0
10658717|NCT02234570|11819886|FG004|NOT COMPLETED|Overall Study||0
10658718|NCT02234570|11819887|FG005|NOT COMPLETED|Overall Study||0
10658719|NCT02234570|11819888|FG006|NOT COMPLETED|Overall Study||0
10658720|NCT02234570|11819889|FG007|NOT COMPLETED|Overall Study||0
10658721|NCT02234583|11819909|FG000|STARTED|Overall Study||847
10658722|NCT02234583|11819910|FG001|STARTED|Overall Study||1241
10658723|NCT02234583|11819909|FG000|COMPLETED|Overall Study||434
10658724|NCT02234583|11819910|FG001|COMPLETED|Overall Study||685
10658725|NCT02234583|11819909|FG000|NOT COMPLETED|Overall Study||413
10658726|NCT02234583|11819910|FG001|NOT COMPLETED|Overall Study||556
10658727|NCT02234596|11819922|FG000|STARTED|Overall Study||34
10658728|NCT02234596|11819922|FG000|COMPLETED|Overall Study||32
10658729|NCT02234596|11819922|FG000|NOT COMPLETED|Overall Study||2
10658730|NCT02234622|11819928|FG000|STARTED|Overall Study||108
10658731|NCT02234622|11819929|FG001|STARTED|Overall Study||104
10658732|NCT02234622|11819928|FG000|COMPLETED|Overall Study||65
10658733|NCT02234622|11819929|FG001|COMPLETED|Overall Study||68
10658734|NCT02234622|11819928|FG000|NOT COMPLETED|Overall Study||43
10658735|NCT02234622|11819929|FG001|NOT COMPLETED|Overall Study||36
10658736|NCT02234713|11819939|FG000|STARTED|Overall Study||31
10658737|NCT02234713|11819940|FG001|STARTED|Overall Study||32
10719162|NCT02708524|11882888|FG000|COMPLETED|Overall Study||135
10658738|NCT02234713|11819939|FG000|COMPLETED|Overall Study||25
10658739|NCT02234713|11819940|FG001|COMPLETED|Overall Study||27
10658740|NCT02234713|11819939|FG000|NOT COMPLETED|Overall Study||6
10658741|NCT02234713|11819940|FG001|NOT COMPLETED|Overall Study||5
10658742|NCT02234752|11819947|FG000|STARTED|Overall Study||3
10719163|NCT02708524|11882889|FG001|COMPLETED|Overall Study||130
10392402|NCT00671671|11535532|FG001|NOT COMPLETED|Overall Study||0
10658743|NCT02234752|11819947|FG000|COMPLETED|Overall Study||2
10658744|NCT02234752|11819947|FG000|NOT COMPLETED|Overall Study||1
10658745|NCT02235064|11819954|FG000|STARTED|Overall Study||1
10658746|NCT02235064|11819955|FG001|STARTED|Overall Study||1
10658747|NCT02235064|11819954|FG000|COMPLETED|Overall Study||1
10658748|NCT02235064|11819955|FG001|COMPLETED|Overall Study||1
10392403|NCT00671723|11535542|FG000|STARTED|Overall Study||11
10392404|NCT00671723|11535543|FG001|STARTED|Overall Study||11
10392405|NCT00671723|11535544|FG002|STARTED|Overall Study||11
10392406|NCT00671723|11535542|FG000|COMPLETED|Overall Study||11
10392407|NCT00671723|11535543|FG001|COMPLETED|Overall Study||11
10392408|NCT00671723|11535544|FG002|COMPLETED|Overall Study||11
10392409|NCT00671723|11535542|FG000|NOT COMPLETED|Overall Study||0
10392410|NCT00671723|11535543|FG001|NOT COMPLETED|Overall Study||0
10719164|NCT02708524|11882890|FG002|COMPLETED|Overall Study||134
10719165|NCT02708524|11882891|FG003|COMPLETED|Overall Study||136
10719166|NCT02708524|11882888|FG000|NOT COMPLETED|Overall Study||4
10719167|NCT02708524|11882889|FG001|NOT COMPLETED|Overall Study||6
10719168|NCT02708524|11882890|FG002|NOT COMPLETED|Overall Study||3
10719169|NCT02708524|11882891|FG003|NOT COMPLETED|Overall Study||0
10719170|NCT02708641|11882901|FG000|STARTED|Overall Study||12
10719171|NCT02708641|11882901|FG000|COMPLETED|Overall Study||12
10719172|NCT02708641|11882901|FG000|NOT COMPLETED|Overall Study||0
10719173|NCT02708745|11882909|FG000|STARTED|Overall Study||91
10719174|NCT02708745|11882910|FG001|STARTED|Overall Study||69
10719175|NCT02708745|11882911|FG002|STARTED|Overall Study||204
10719176|NCT02708745|11882912|FG003|STARTED|Overall Study||198
10719177|NCT02708745|11882909|FG000|COMPLETED|Overall Study||91
10719178|NCT02708745|11882910|FG001|COMPLETED|Overall Study||65
10719179|NCT02708745|11882911|FG002|COMPLETED|Overall Study||121
10719180|NCT02708745|11882912|FG003|COMPLETED|Overall Study||116
10719181|NCT02708745|11882909|FG000|NOT COMPLETED|Overall Study||0
10719182|NCT02708745|11882910|FG001|NOT COMPLETED|Overall Study||4
10719183|NCT02708745|11882911|FG002|NOT COMPLETED|Overall Study||83
10719184|NCT02708745|11882912|FG003|NOT COMPLETED|Overall Study||82
10392411|NCT00671723|11535544|FG002|NOT COMPLETED|Overall Study||0
10719185|NCT02708862|11882924|FG000|STARTED|Overall Study||26
10719186|NCT02708862|11882924|FG000|COMPLETED|Overall Study||26
10308428|NCT00112385|11441525|FG001|COMPLETED|Overall Study||4
10308429|NCT00112385|11441524|FG000|NOT COMPLETED|Overall Study||1
10308430|NCT00112385|11441525|FG001|NOT COMPLETED|Overall Study||1
10308431|NCT00112437|11441536|FG000|STARTED|Year 1 (12-Month Base Study)||83
10308432|NCT00112437|11441537|FG001|STARTED|Year 1 (12-Month Base Study)||82
10308433|NCT00112437|11441538|FG002|STARTED|Year 1 (12-Month Base Study)||77
10308434|NCT00112437|11441539|FG003|STARTED|Year 1 (12-Month Base Study)||79
10308435|NCT00112437|11441540|FG004|STARTED|Year 1 (12-Month Base Study)||78
10308436|NCT00112437|11441541|FG005|STARTED|Year 1 (12-Month Base Study)||0
10308437|NCT00112437|11441542|FG006|STARTED|Year 1 (12-Month Base Study)||0
10308438|NCT00112437|11441543|FG007|STARTED|Year 1 (12-Month Base Study)||0
10308439|NCT00112437|11441544|FG008|STARTED|Year 1 (12-Month Base Study)||0
10392415|NCT00671788|11535556|FG000|STARTED|Overall Study||35
10392416|NCT00671788|11535556|FG000|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|21
10392417|NCT00671788|11535556|FG000|NOT COMPLETED|Overall Study||14
10392418|NCT00671853|11535562|FG000|STARTED|Overall Study||46
10392419|NCT00671853|11535563|FG001|STARTED|Overall Study||45
10392420|NCT00671853|11535562|FG000|COMPLETED|Overall Study||26
10392421|NCT00671853|11535563|FG001|COMPLETED|Overall Study||18
10392422|NCT00671853|11535562|FG000|NOT COMPLETED|Overall Study||20
10392423|NCT00671853|11535563|FG001|NOT COMPLETED|Overall Study||27
10392424|NCT00671879|11535574|FG000|STARTED|Overall Study||281
10392425|NCT00671879|11535575|FG001|STARTED|Overall Study||279
10392426|NCT00671879|11535576|FG002|STARTED|Overall Study||280
10392427|NCT00671879|11535574|FG000|COMPLETED|Overall Study||281
10392428|NCT00671879|11535575|FG001|COMPLETED|Overall Study||275
10392429|NCT00671879|11535576|FG002|COMPLETED|Overall Study||274
10392430|NCT00671879|11535574|FG000|NOT COMPLETED|Overall Study||0
10392431|NCT00671879|11535575|FG001|NOT COMPLETED|Overall Study||4
10392432|NCT00671879|11535576|FG002|NOT COMPLETED|Overall Study||6
10392433|NCT00671918|11535585|FG000|STARTED|Overall Study||186
10392434|NCT00671918|11535585|FG000|COMPLETED|Overall Study||169
10392435|NCT00671918|11535585|FG000|NOT COMPLETED|Overall Study||17
10392436|NCT00671931|11535595|FG000|STARTED|Overall Study||9
10392437|NCT00671931|11535596|FG001|STARTED|Overall Study||8
10392438|NCT00671931|11535597|FG002|STARTED|Overall Study||9
10392439|NCT00671931|11535598|FG003|STARTED|Overall Study||10
10392440|NCT00671931|11535599|FG004|STARTED|Overall Study||8
10392441|NCT00671931|11535595|FG000|COMPLETED|Overall Study|Nueromonitoring equipment falure|8
10392442|NCT00671931|11535596|FG001|COMPLETED|Overall Study|All completed|8
10392443|NCT00671931|11535597|FG002|COMPLETED|Overall Study|all completed|9
10429863|NCT00866879|11576008|FG001|COMPLETED|Overall Study||185
10543018|NCT01481376|11696183|FG000|COMPLETED|Overall Study||169
10543019|NCT01481376|11696183|FG000|NOT COMPLETED|Overall Study||31
10543020|NCT01481545|11696189|FG000|STARTED|Overall Study||16
10543021|NCT01481545|11696190|FG001|STARTED|Overall Study||46
10658749|NCT02235064|11819954|FG000|NOT COMPLETED|Overall Study||0
10658750|NCT02235064|11819955|FG001|NOT COMPLETED|Overall Study||0
10658751|NCT02235077|11819965|FG000|STARTED|Overall Study||182
10308440|NCT00112437|11441545|FG009|STARTED|Year 1 (12-Month Base Study)||0
10308441|NCT00112437|11441546|FG010|STARTED|Year 1 (12-Month Base Study)||0
10308442|NCT00112437|11441547|FG011|STARTED|Year 1 (12-Month Base Study)||0
10308443|NCT00112437|11441548|FG012|STARTED|Year 1 (12-Month Base Study)||0
10308444|NCT00112437|11441549|FG013|STARTED|Year 1 (12-Month Base Study)||0
10308445|NCT00112437|11441550|FG014|STARTED|Year 1 (12-Month Base Study)||0
10308446|NCT00112437|11441551|FG015|STARTED|Year 1 (12-Month Base Study)||0
10308447|NCT00112437|11441552|FG016|STARTED|Year 1 (12-Month Base Study)||0
10308448|NCT00112437|11441553|FG017|STARTED|Year 1 (12-Month Base Study)||0
10308449|NCT00112437|11441554|FG018|STARTED|Year 1 (12-Month Base Study)||0
10308450|NCT00112437|11441555|FG019|STARTED|Year 1 (12-Month Base Study)||0
10308451|NCT00112437|11441556|FG020|STARTED|Year 1 (12-Month Base Study)||0
10308452|NCT00112437|11441557|FG021|STARTED|Year 1 (12-Month Base Study)||0
10308453|NCT00112437|11441558|FG022|STARTED|Year 1 (12-Month Base Study)||0
10308454|NCT00112437|11441559|FG023|STARTED|Year 1 (12-Month Base Study)||0
10308455|NCT00112437|11441560|FG024|STARTED|Year 1 (12-Month Base Study)||0
10308456|NCT00112437|11441561|FG025|STARTED|Year 1 (12-Month Base Study)||0
10308457|NCT00112437|11441536|FG000|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in completed total.|68
10308458|NCT00112437|11441537|FG001|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in completed total.|64
10308459|NCT00112437|11441538|FG002|COMPLETED|Year 1 (12-Month Base Study)||65
10308460|NCT00112437|11441539|FG003|COMPLETED|Year 1 (12-Month Base Study)||71
10308461|NCT00112437|11441540|FG004|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in the completed total.|66
10308462|NCT00112437|11441541|FG005|COMPLETED|Year 1 (12-Month Base Study)||0
10308463|NCT00112437|11441542|FG006|COMPLETED|Year 1 (12-Month Base Study)||0
10308464|NCT00112437|11441543|FG007|COMPLETED|Year 1 (12-Month Base Study)||0
10308465|NCT00112437|11441544|FG008|COMPLETED|Year 1 (12-Month Base Study)||0
10308466|NCT00112437|11441545|FG009|COMPLETED|Year 1 (12-Month Base Study)||0
10308467|NCT00112437|11441546|FG010|COMPLETED|Year 1 (12-Month Base Study)||0
10308468|NCT00112437|11441547|FG011|COMPLETED|Year 1 (12-Month Base Study)||0
10308469|NCT00112437|11441548|FG012|COMPLETED|Year 1 (12-Month Base Study)||0
10308470|NCT00112437|11441549|FG013|COMPLETED|Year 1 (12-Month Base Study)||0
10308471|NCT00112437|11441550|FG014|COMPLETED|Year 1 (12-Month Base Study)||0
10308472|NCT00112437|11441551|FG015|COMPLETED|Year 1 (12-Month Base Study)||0
10308473|NCT00112437|11441552|FG016|COMPLETED|Year 1 (12-Month Base Study)||0
10308474|NCT00112437|11441553|FG017|COMPLETED|Year 1 (12-Month Base Study)||0
10308475|NCT00112437|11441554|FG018|COMPLETED|Year 1 (12-Month Base Study)||0
10308476|NCT00112437|11441555|FG019|COMPLETED|Year 1 (12-Month Base Study)||0
10308477|NCT00112437|11441556|FG020|COMPLETED|Year 1 (12-Month Base Study)||0
10308478|NCT00112437|11441557|FG021|COMPLETED|Year 1 (12-Month Base Study)||0
10308479|NCT00112437|11441558|FG022|COMPLETED|Year 1 (12-Month Base Study)||0
10308480|NCT00112437|11441559|FG023|COMPLETED|Year 1 (12-Month Base Study)||0
10308481|NCT00112437|11441560|FG024|COMPLETED|Year 1 (12-Month Base Study)||0
10308482|NCT00112437|11441561|FG025|COMPLETED|Year 1 (12-Month Base Study)||0
10308483|NCT00112437|11441536|FG000|NOT COMPLETED|Year 1 (12-Month Base Study)||15
10308484|NCT00112437|11441537|FG001|NOT COMPLETED|Year 1 (12-Month Base Study)||18
10308485|NCT00112437|11441538|FG002|NOT COMPLETED|Year 1 (12-Month Base Study)||12
10308486|NCT00112437|11441539|FG003|NOT COMPLETED|Year 1 (12-Month Base Study)||8
10308487|NCT00112437|11441540|FG004|NOT COMPLETED|Year 1 (12-Month Base Study)||12
10308488|NCT00112437|11441541|FG005|NOT COMPLETED|Year 1 (12-Month Base Study)||0
10308489|NCT00112437|11441542|FG006|NOT COMPLETED|Year 1 (12-Month Base Study)||0
10308490|NCT00112437|11441543|FG007|NOT COMPLETED|Year 1 (12-Month Base Study)||0
10308491|NCT00112437|11441544|FG008|NOT COMPLETED|Year 1 (12-Month Base Study)||0
10308492|NCT00112437|11441545|FG009|NOT COMPLETED|Year 1 (12-Month Base Study)||0
10308493|NCT00112437|11441546|FG010|NOT COMPLETED|Year 1 (12-Month Base Study)||0
10308494|NCT00112437|11441547|FG011|NOT COMPLETED|Year 1 (12-Month Base Study)||0
10308495|NCT00112437|11441548|FG012|NOT COMPLETED|Year 1 (12-Month Base Study)||0
10308496|NCT00112437|11441549|FG013|NOT COMPLETED|Year 1 (12-Month Base Study)||0
10308497|NCT00112437|11441550|FG014|NOT COMPLETED|Year 1 (12-Month Base Study)||0
10308498|NCT00112437|11441551|FG015|NOT COMPLETED|Year 1 (12-Month Base Study)||0
10308499|NCT00112437|11441552|FG016|NOT COMPLETED|Year 1 (12-Month Base Study)||0
10308500|NCT00112437|11441553|FG017|NOT COMPLETED|Year 1 (12-Month Base Study)||0
10308501|NCT00112437|11441554|FG018|NOT COMPLETED|Year 1 (12-Month Base Study)||0
10308502|NCT00112437|11441555|FG019|NOT COMPLETED|Year 1 (12-Month Base Study)||0
10308503|NCT00112437|11441556|FG020|NOT COMPLETED|Year 1 (12-Month Base Study)||0
10308504|NCT00112437|11441557|FG021|NOT COMPLETED|Year 1 (12-Month Base Study)||0
10308505|NCT00112437|11441558|FG022|NOT COMPLETED|Year 1 (12-Month Base Study)||0
10308506|NCT00112437|11441559|FG023|NOT COMPLETED|Year 1 (12-Month Base Study)||0
10308507|NCT00112437|11441560|FG024|NOT COMPLETED|Year 1 (12-Month Base Study)||0
10308508|NCT00112437|11441561|FG025|NOT COMPLETED|Year 1 (12-Month Base Study)||0
10308509|NCT00112437|11441536|FG000|STARTED|Year 2 (12-Month Extension)||0
10308510|NCT00112437|11441537|FG001|STARTED|Year 2 (12-Month Extension)||0
10308511|NCT00112437|11441538|FG002|STARTED|Year 2 (12-Month Extension)||0
10308512|NCT00112437|11441539|FG003|STARTED|Year 2 (12-Month Extension)||0
10308513|NCT00112437|11441540|FG004|STARTED|Year 2 (12-Month Extension)||0
10308514|NCT00112437|11441541|FG005|STARTED|Year 2 (12-Month Extension)||63
10308515|NCT00112437|11441542|FG006|STARTED|Year 2 (12-Month Extension)||62
10308516|NCT00112437|11441543|FG007|STARTED|Year 2 (12-Month Extension)||63
10308517|NCT00112437|11441544|FG008|STARTED|Year 2 (12-Month Extension)||69
10308518|NCT00112437|11441545|FG009|STARTED|Year 2 (12-Month Extension)||63
10308519|NCT00112437|11441546|FG010|STARTED|Year 2 (12-Month Extension)||0
10308520|NCT00112437|11441547|FG011|STARTED|Year 2 (12-Month Extension)||0
10308521|NCT00112437|11441548|FG012|STARTED|Year 2 (12-Month Extension)||0
10308522|NCT00112437|11441549|FG013|STARTED|Year 2 (12-Month Extension)||0
10308523|NCT00112437|11441550|FG014|STARTED|Year 2 (12-Month Extension)||0
10308524|NCT00112437|11441551|FG015|STARTED|Year 2 (12-Month Extension)||0
10308525|NCT00112437|11441552|FG016|STARTED|Year 2 (12-Month Extension)||0
10308526|NCT00112437|11441553|FG017|STARTED|Year 2 (12-Month Extension)||0
10308527|NCT00112437|11441554|FG018|STARTED|Year 2 (12-Month Extension)||0
10308528|NCT00112437|11441555|FG019|STARTED|Year 2 (12-Month Extension)||0
10308529|NCT00112437|11441556|FG020|STARTED|Year 2 (12-Month Extension)||0
10308530|NCT00112437|11441557|FG021|STARTED|Year 2 (12-Month Extension)||0
10308531|NCT00112437|11441558|FG022|STARTED|Year 2 (12-Month Extension)||0
10308532|NCT00112437|11441559|FG023|STARTED|Year 2 (12-Month Extension)||0
10308533|NCT00112437|11441560|FG024|STARTED|Year 2 (12-Month Extension)||0
10308534|NCT00112437|11441561|FG025|STARTED|Year 2 (12-Month Extension)||0
10308535|NCT00112437|11441536|FG000|COMPLETED|Year 2 (12-Month Extension)||0
10308536|NCT00112437|11441537|FG001|COMPLETED|Year 2 (12-Month Extension)||0
10308537|NCT00112437|11441538|FG002|COMPLETED|Year 2 (12-Month Extension)||0
10308538|NCT00112437|11441539|FG003|COMPLETED|Year 2 (12-Month Extension)||0
10308539|NCT00112437|11441540|FG004|COMPLETED|Year 2 (12-Month Extension)||0
10308540|NCT00112437|11441541|FG005|COMPLETED|Year 2 (12-Month Extension)||60
10308541|NCT00112437|11441542|FG006|COMPLETED|Year 2 (12-Month Extension)||53
10308542|NCT00112437|11441543|FG007|COMPLETED|Year 2 (12-Month Extension)||55
10308543|NCT00112437|11441544|FG008|COMPLETED|Year 2 (12-Month Extension)||62
10308544|NCT00112437|11441545|FG009|COMPLETED|Year 2 (12-Month Extension)||50
10308545|NCT00112437|11441546|FG010|COMPLETED|Year 2 (12-Month Extension)||0
10308546|NCT00112437|11441547|FG011|COMPLETED|Year 2 (12-Month Extension)||0
10308547|NCT00112437|11441548|FG012|COMPLETED|Year 2 (12-Month Extension)||0
10308548|NCT00112437|11441549|FG013|COMPLETED|Year 2 (12-Month Extension)||0
10308549|NCT00112437|11441550|FG014|COMPLETED|Year 2 (12-Month Extension)||0
10308550|NCT00112437|11441551|FG015|COMPLETED|Year 2 (12-Month Extension)||0
10308551|NCT00112437|11441552|FG016|COMPLETED|Year 2 (12-Month Extension)||0
10308552|NCT00112437|11441553|FG017|COMPLETED|Year 2 (12-Month Extension)||0
10308553|NCT00112437|11441554|FG018|COMPLETED|Year 2 (12-Month Extension)||0
10308554|NCT00112437|11441555|FG019|COMPLETED|Year 2 (12-Month Extension)||0
10308555|NCT00112437|11441556|FG020|COMPLETED|Year 2 (12-Month Extension)||0
10308556|NCT00112437|11441557|FG021|COMPLETED|Year 2 (12-Month Extension)||0
10308557|NCT00112437|11441558|FG022|COMPLETED|Year 2 (12-Month Extension)||0
10308558|NCT00112437|11441559|FG023|COMPLETED|Year 2 (12-Month Extension)||0
10308559|NCT00112437|11441560|FG024|COMPLETED|Year 2 (12-Month Extension)||0
10308560|NCT00112437|11441561|FG025|COMPLETED|Year 2 (12-Month Extension)||0
10308561|NCT00112437|11441536|FG000|NOT COMPLETED|Year 2 (12-Month Extension)||0
10308562|NCT00112437|11441537|FG001|NOT COMPLETED|Year 2 (12-Month Extension)||0
10308563|NCT00112437|11441538|FG002|NOT COMPLETED|Year 2 (12-Month Extension)||0
10308564|NCT00112437|11441539|FG003|NOT COMPLETED|Year 2 (12-Month Extension)||0
10308565|NCT00112437|11441540|FG004|NOT COMPLETED|Year 2 (12-Month Extension)||0
10308566|NCT00112437|11441541|FG005|NOT COMPLETED|Year 2 (12-Month Extension)||3
10308567|NCT00112437|11441542|FG006|NOT COMPLETED|Year 2 (12-Month Extension)||9
10308568|NCT00112437|11441543|FG007|NOT COMPLETED|Year 2 (12-Month Extension)||8
10308569|NCT00112437|11441544|FG008|NOT COMPLETED|Year 2 (12-Month Extension)||7
10308570|NCT00112437|11441545|FG009|NOT COMPLETED|Year 2 (12-Month Extension)||13
10308571|NCT00112437|11441546|FG010|NOT COMPLETED|Year 2 (12-Month Extension)||0
10308572|NCT00112437|11441547|FG011|NOT COMPLETED|Year 2 (12-Month Extension)||0
10308573|NCT00112437|11441548|FG012|NOT COMPLETED|Year 2 (12-Month Extension)||0
10308574|NCT00112437|11441549|FG013|NOT COMPLETED|Year 2 (12-Month Extension)||0
10392444|NCT00671931|11535598|FG003|COMPLETED|Overall Study|Prepositioning - Neuromonitoring required|8
10392445|NCT00671931|11535599|FG004|COMPLETED|Overall Study|Low heart rate requiring treatment|7
10392446|NCT00671931|11535595|FG000|NOT COMPLETED|Overall Study||1
10392447|NCT00671931|11535596|FG001|NOT COMPLETED|Overall Study||0
10392448|NCT00671931|11535597|FG002|NOT COMPLETED|Overall Study||0
10392449|NCT00671931|11535598|FG003|NOT COMPLETED|Overall Study||2
10392450|NCT00671931|11535599|FG004|NOT COMPLETED|Overall Study||1
10392451|NCT00671970|11535613|FG000|STARTED|Overall Study||32
10392452|NCT00671970|11535614|FG001|STARTED|Overall Study||25
10392453|NCT00671970|11535613|FG000|COMPLETED|Overall Study||32
10392454|NCT00671970|11535614|FG001|COMPLETED|Overall Study||25
10392455|NCT00671970|11535613|FG000|NOT COMPLETED|Overall Study||0
10392456|NCT00671970|11535614|FG001|NOT COMPLETED|Overall Study||0
10392457|NCT00672100|11535635|FG000|STARTED|Overall Study||12
10392458|NCT00672100|11535636|FG001|STARTED|Overall Study||12
10392459|NCT00672100|11535637|FG002|STARTED|Overall Study||12
10392460|NCT00672100|11535635|FG000|PACU (Within 8 Hours)|Overall Study||12
10392461|NCT00672100|11535636|FG001|PACU (Within 8 Hours)|Overall Study||12
10392462|NCT00672100|11535637|FG002|PACU (Within 8 Hours)|Overall Study||12
10392463|NCT00672100|11535635|FG000|COMPLETED|Overall Study||12
10392464|NCT00672100|11535636|FG001|COMPLETED|Overall Study||12
10392465|NCT00672100|11535637|FG002|COMPLETED|Overall Study||12
10392466|NCT00672100|11535635|FG000|NOT COMPLETED|Overall Study||0
10392467|NCT00672100|11535636|FG001|NOT COMPLETED|Overall Study||0
10392468|NCT00672100|11535637|FG002|NOT COMPLETED|Overall Study||0
10392469|NCT00672139|11535651|FG000|STARTED|Overall Study|Three of 60 enrolled subjects did not receive study drug.|57
10543022|NCT01481545|11696189|FG000|COMPLETED|Overall Study||11
10543023|NCT01481545|11696190|FG001|COMPLETED|Overall Study||40
10543024|NCT01481545|11696189|FG000|NOT COMPLETED|Overall Study||5
10543025|NCT01481545|11696190|FG001|NOT COMPLETED|Overall Study||6
10543026|NCT01481558|11696200|FG000|STARTED|Overall Study||20
10543027|NCT01481558|11696201|FG001|STARTED|Overall Study||20
10543028|NCT01481558|11696200|FG000|COMPLETED|Overall Study||20
10543029|NCT01481558|11696201|FG001|COMPLETED|Overall Study||20
10543030|NCT01481558|11696200|FG000|NOT COMPLETED|Overall Study||0
10543031|NCT01481558|11696201|FG001|NOT COMPLETED|Overall Study||0
10543032|NCT01481740|11696209|FG000|STARTED|Overall Study||90
10543033|NCT01481740|11696210|FG001|STARTED|Overall Study||88
10543034|NCT01481740|11696209|FG000|COMPLETED|Overall Study||79
10543035|NCT01481740|11696210|FG001|COMPLETED|Overall Study||81
10543036|NCT01481740|11696209|FG000|NOT COMPLETED|Overall Study||11
10543037|NCT01481740|11696210|FG001|NOT COMPLETED|Overall Study||7
10543038|NCT01481779|11696218|FG000|STARTED|Overall Study||295
10658752|NCT02235077|11819966|FG001|STARTED|Overall Study||178
10658753|NCT02235077|11819965|FG000|COMPLETED|Overall Study||164
10658754|NCT02235077|11819966|FG001|COMPLETED|Overall Study||159
10658755|NCT02235077|11819965|FG000|NOT COMPLETED|Overall Study||18
10658756|NCT02235077|11819966|FG001|NOT COMPLETED|Overall Study||19
10392470|NCT00672139|11535652|FG001|STARTED|Overall Study|Four of 96 enrolled subjects did not receive study drug.|92
10392471|NCT00672139|11535651|FG000|COMPLETED|Overall Study||27
10392472|NCT00672139|11535652|FG001|COMPLETED|Overall Study||47
10392473|NCT00672139|11535651|FG000|NOT COMPLETED|Overall Study||30
10392474|NCT00672139|11535652|FG001|NOT COMPLETED|Overall Study||45
10392475|NCT00672204|11535658|FG000|STARTED|Overall Study||23
10392476|NCT00672204|11535658|FG000|COMPLETED|Overall Study||3
10392477|NCT00672204|11535658|FG000|NOT COMPLETED|Overall Study||20
10392478|NCT00672243|11535662|FG000|STARTED|Overall Study||32
10392479|NCT00672243|11535662|FG000|COMPLETED|Overall Study||32
10392480|NCT00672243|11535662|FG000|NOT COMPLETED|Overall Study||0
10392481|NCT00672256|11535667|FG000|STARTED|Overall Study|January 2007|62
10392482|NCT00672256|11535667|FG000|COMPLETED|Overall Study||18
10392483|NCT00672256|11535667|FG000|NOT COMPLETED|Overall Study||44
10392484|NCT00672438|11535673|FG000|STARTED|Infusion 1||119
10392485|NCT00672438|11535674|FG001|STARTED|Infusion 1||118
10658757|NCT02235285|11819972|FG000|STARTED|Overall Study||162
10392486|NCT00672438|11535673|FG000|COMPLETED|Infusion 1||119
10543039|NCT01481779|11696219|FG001|STARTED|Overall Study||160
10543040|NCT01481779|11696218|FG000|Received at Least 1 Dose of Study Drug|Overall Study||294
10543041|NCT01481779|11696219|FG001|Received at Least 1 Dose of Study Drug|Overall Study||159
10658758|NCT02235285|11819972|FG000|COMPLETED|Overall Study||149
10392487|NCT00672438|11535674|FG001|COMPLETED|Infusion 1||118
10392488|NCT00672438|11535673|FG000|NOT COMPLETED|Infusion 1||0
10658759|NCT02235285|11819972|FG000|NOT COMPLETED|Overall Study||13
10308575|NCT00112437|11441550|FG014|NOT COMPLETED|Year 2 (12-Month Extension)||0
10308576|NCT00112437|11441551|FG015|NOT COMPLETED|Year 2 (12-Month Extension)||0
10308577|NCT00112437|11441552|FG016|NOT COMPLETED|Year 2 (12-Month Extension)||0
10308578|NCT00112437|11441553|FG017|NOT COMPLETED|Year 2 (12-Month Extension)||0
10308579|NCT00112437|11441554|FG018|NOT COMPLETED|Year 2 (12-Month Extension)||0
10308580|NCT00112437|11441555|FG019|NOT COMPLETED|Year 2 (12-Month Extension)||0
10308581|NCT00112437|11441556|FG020|NOT COMPLETED|Year 2 (12-Month Extension)||0
10308582|NCT00112437|11441557|FG021|NOT COMPLETED|Year 2 (12-Month Extension)||0
10308583|NCT00112437|11441558|FG022|NOT COMPLETED|Year 2 (12-Month Extension)||0
10308584|NCT00112437|11441559|FG023|NOT COMPLETED|Year 2 (12-Month Extension)||0
10308585|NCT00112437|11441560|FG024|NOT COMPLETED|Year 2 (12-Month Extension)||0
10308586|NCT00112437|11441561|FG025|NOT COMPLETED|Year 2 (12-Month Extension)||0
10308587|NCT00112437|11441536|FG000|STARTED|Year 3 (12-Month Extension)||0
10308588|NCT00112437|11441537|FG001|STARTED|Year 3 (12-Month Extension)||0
10308589|NCT00112437|11441538|FG002|STARTED|Year 3 (12-Month Extension)||0
10308590|NCT00112437|11441539|FG003|STARTED|Year 3 (12-Month Extension)||0
10308591|NCT00112437|11441540|FG004|STARTED|Year 3 (12-Month Extension)||0
10308592|NCT00112437|11441541|FG005|STARTED|Year 3 (12-Month Extension)||0
10308593|NCT00112437|11441542|FG006|STARTED|Year 3 (12-Month Extension)||0
10308594|NCT00112437|11441543|FG007|STARTED|Year 3 (12-Month Extension)||0
10308595|NCT00112437|11441544|FG008|STARTED|Year 3 (12-Month Extension)||0
10308596|NCT00112437|11441545|FG009|STARTED|Year 3 (12-Month Extension)||0
10308597|NCT00112437|11441546|FG010|STARTED|Year 3 (12-Month Extension)||19
10308598|NCT00112437|11441547|FG011|STARTED|Year 3 (12-Month Extension)||22
10308599|NCT00112437|11441548|FG012|STARTED|Year 3 (12-Month Extension)||18
10308600|NCT00112437|11441549|FG013|STARTED|Year 3 (12-Month Extension)||17
10308601|NCT00112437|11441550|FG014|STARTED|Year 3 (12-Month Extension)||18
10308602|NCT00112437|11441551|FG015|STARTED|Year 3 (12-Month Extension)||17
10308603|NCT00112437|11441552|FG016|STARTED|Year 3 (12-Month Extension)||19
10308604|NCT00112437|11441553|FG017|STARTED|Year 3 (12-Month Extension)||21
10308605|NCT00112437|11441554|FG018|STARTED|Year 3 (12-Month Extension)||18
10308606|NCT00112437|11441555|FG019|STARTED|Year 3 (12-Month Extension)||20
10308607|NCT00112437|11441556|FG020|STARTED|Year 3 (12-Month Extension)||0
10308608|NCT00112437|11441557|FG021|STARTED|Year 3 (12-Month Extension)||0
10813040|NCT03078868|11975300|FG000|STARTED|Overall Study||3
10813041|NCT03078868|11975300|FG000|COMPLETED|Overall Study||0
10813042|NCT03078868|11975300|FG000|NOT COMPLETED|Overall Study||3
10308609|NCT00112437|11441558|FG022|STARTED|Year 3 (12-Month Extension)||0
10308610|NCT00112437|11441559|FG023|STARTED|Year 3 (12-Month Extension)||0
10308611|NCT00112437|11441560|FG024|STARTED|Year 3 (12-Month Extension)||0
10308612|NCT00112437|11441561|FG025|STARTED|Year 3 (12-Month Extension)||0
10308613|NCT00112437|11441536|FG000|COMPLETED|Year 3 (12-Month Extension)||0
10308614|NCT00112437|11441537|FG001|COMPLETED|Year 3 (12-Month Extension)||0
10308615|NCT00112437|11441538|FG002|COMPLETED|Year 3 (12-Month Extension)||0
10658760|NCT02235298|11819978|FG000|STARTED|Overall Study||50
10658761|NCT02235298|11819979|FG001|STARTED|Overall Study||50
10658762|NCT02235298|11819978|FG000|COMPLETED|Overall Study||42
10658763|NCT02235298|11819979|FG001|COMPLETED|Overall Study||42
10658764|NCT02235298|11819978|FG000|NOT COMPLETED|Overall Study||8
10658765|NCT02235298|11819979|FG001|NOT COMPLETED|Overall Study||8
10308616|NCT00112437|11441539|FG003|COMPLETED|Year 3 (12-Month Extension)||0
10392489|NCT00672438|11535674|FG001|NOT COMPLETED|Infusion 1||0
10392490|NCT00672438|11535673|FG000|STARTED|Washout||119
10392491|NCT00672438|11535674|FG001|STARTED|Washout||118
10392492|NCT00672438|11535673|FG000|COMPLETED|Washout||119
10658766|NCT02235311|11819987|FG000|STARTED|Overall Study||1
10813043|NCT03078270|11975306|FG000|STARTED|Overall Study||4
10813044|NCT03078270|11975307|FG001|STARTED|Overall Study||0
10392493|NCT00672438|11535674|FG001|COMPLETED|Washout||118
10392494|NCT00672438|11535673|FG000|NOT COMPLETED|Washout||0
10392495|NCT00672438|11535674|FG001|NOT COMPLETED|Washout||0
10392496|NCT00672438|11535673|FG000|STARTED|Infusion 2||119
10392497|NCT00672438|11535674|FG001|STARTED|Infusion 2||118
10392498|NCT00672438|11535673|FG000|COMPLETED|Infusion 2||119
10392499|NCT00672438|11535674|FG001|COMPLETED|Infusion 2||118
10392500|NCT00672438|11535673|FG000|NOT COMPLETED|Infusion 2||0
10392501|NCT00672438|11535674|FG001|NOT COMPLETED|Infusion 2||0
10392502|NCT00672451|11535682|FG000|STARTED|Overall Study||1
10392503|NCT00672451|11535683|FG001|STARTED|Overall Study||2
10392504|NCT00672451|11535682|FG000|COMPLETED|Overall Study||1
10392505|NCT00672451|11535683|FG001|COMPLETED|Overall Study||2
10392506|NCT00672451|11535682|FG000|NOT COMPLETED|Overall Study||0
10392507|NCT00672451|11535683|FG001|NOT COMPLETED|Overall Study||0
10392508|NCT00672477|11535691|FG000|STARTED|Overall Study|120 subjects were randomized to this group, but only 116 subjects received study drug.|116
10392509|NCT00672477|11535692|FG001|STARTED|Overall Study|117 subjects were randomized to this group, but only 114 subjects received study drug.|114
10428551|NCT00858780|11574586|FG002|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
10719187|NCT02708862|11882924|FG000|NOT COMPLETED|Overall Study||0
10719188|NCT02708966|11882933|FG000|STARTED|Overall Study||15
10719189|NCT02708966|11882934|FG001|STARTED|Overall Study||15
10392510|NCT00672477|11535691|FG000|COMPLETED|Overall Study|One subject had missing data as reason for study termination - not counted as early termination.|89
10392511|NCT00672477|11535692|FG001|COMPLETED|Overall Study||88
10392512|NCT00672477|11535691|FG000|NOT COMPLETED|Overall Study||27
10392513|NCT00672477|11535692|FG001|NOT COMPLETED|Overall Study||26
10392514|NCT00672490|11535700|FG000|STARTED|Overall Study||187
10392515|NCT00672490|11535701|FG001|STARTED|Overall Study||189
10392516|NCT00672490|11535700|FG000|COMPLETED|Overall Study||163
10392517|NCT00672490|11535701|FG001|COMPLETED|Overall Study||157
10392518|NCT00672490|11535700|FG000|NOT COMPLETED|Overall Study||24
10392519|NCT00672490|11535701|FG001|NOT COMPLETED|Overall Study||32
10392520|NCT00672555|11535707|FG000|STARTED|Overall Study||70
10392521|NCT00672555|11535707|FG000|COMPLETED|Overall Study|All patients were seen at 3 weeks in the outpatient clinic.|64
10392522|NCT00672555|11535707|FG000|NOT COMPLETED|Overall Study||6
10428552|NCT00858780|11574587|FG003|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
10428553|NCT00858780|11574588|FG004|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
10428554|NCT00858780|11574584|FG000|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||18
10428555|NCT00858780|11574585|FG001|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
10428556|NCT00858780|11574586|FG002|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
10428557|NCT00858780|11574587|FG003|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
10428558|NCT00858780|11574588|FG004|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
10428559|NCT00858780|11574584|FG000|STARTED|Double-Blind (Week 0 to Failure/Week 48)||0
10428560|NCT00858780|11574585|FG001|STARTED|Double-Blind (Week 0 to Failure/Week 48)||23
10428561|NCT00858780|11574586|FG002|STARTED|Double-Blind (Week 0 to Failure/Week 48)||27
10428562|NCT00858780|11574587|FG003|STARTED|Double-Blind (Week 0 to Failure/Week 48)||23
10428563|NCT00858780|11574588|FG004|STARTED|Double-Blind (Week 0 to Failure/Week 48)||0
10428564|NCT00858780|11574584|FG000|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
10428565|NCT00858780|11574585|FG001|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||21
10428566|NCT00858780|11574586|FG002|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||25
10428567|NCT00858780|11574587|FG003|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||22
10428568|NCT00858780|11574588|FG004|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
10428569|NCT00858780|11574584|FG000|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
10428570|NCT00858780|11574585|FG001|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||2
10428571|NCT00858780|11574586|FG002|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||2
10428572|NCT00858780|11574587|FG003|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||1
10428573|NCT00858780|11574588|FG004|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
10428574|NCT00858780|11574584|FG000|STARTED|OL Re-Treatment (Failure to Week 48)||0
10428575|NCT00858780|11574585|FG001|STARTED|OL Re-Treatment (Failure to Week 48)||0
10428576|NCT00858780|11574586|FG002|STARTED|OL Re-Treatment (Failure to Week 48)||0
10428577|NCT00858780|11574587|FG003|STARTED|OL Re-Treatment (Failure to Week 48)||0
10428578|NCT00858780|11574588|FG004|STARTED|OL Re-Treatment (Failure to Week 48)|43 participants showed treatment failure in Period 2 and entered in Period 3.|43
10428579|NCT00858780|11574584|FG000|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
10428580|NCT00858780|11574585|FG001|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
10428581|NCT00858780|11574586|FG002|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
10428582|NCT00858780|11574587|FG003|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
10428583|NCT00858780|11574588|FG004|COMPLETED|OL Re-Treatment (Failure to Week 48)||41
10428584|NCT00858780|11574584|FG000|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
10428585|NCT00858780|11574585|FG001|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
10428586|NCT00858780|11574586|FG002|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
10428587|NCT00858780|11574587|FG003|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
10428588|NCT00858780|11574588|FG004|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||2
10428589|NCT00858832|11574600|FG000|STARTED|Overall Study|study terminated early due to enrollment deficiencies|21
10428590|NCT00858832|11574601|FG001|STARTED|Overall Study||23
10428591|NCT00858832|11574600|FG000|COMPLETED|Overall Study||20
10428592|NCT00858832|11574601|FG001|COMPLETED|Overall Study||22
10428593|NCT00858832|11574600|FG000|NOT COMPLETED|Overall Study||1
10428594|NCT00858832|11574601|FG001|NOT COMPLETED|Overall Study||1
10428595|NCT00858845|11574609|FG000|STARTED|Overall Study||5
10428596|NCT00858845|11574610|FG001|STARTED|Overall Study||6
10543042|NCT01481779|11696218|FG000|COMPLETED|Overall Study||225
10719190|NCT02708966|11882933|FG000|COMPLETED|Overall Study||13
10719191|NCT02708966|11882934|FG001|COMPLETED|Overall Study||13
10392523|NCT00672594|11535711|FG000|STARTED|Overall Study||30
10392524|NCT00672594|11535711|FG000|COMPLETED|Overall Study||27
10392525|NCT00672594|11535711|FG000|NOT COMPLETED|Overall Study||3
10392526|NCT00672620|11535719|FG000|STARTED|Overall Study||153
10392527|NCT00672620|11535720|FG001|STARTED|Overall Study||153
10392528|NCT00672620|11535721|FG002|STARTED|Overall Study||153
10392529|NCT00672620|11535722|FG003|STARTED|Overall Study||152
10392530|NCT00672620|11535719|FG000|Treated|Overall Study||151
10392531|NCT00672620|11535720|FG001|Treated|Overall Study||149
10392532|NCT00672620|11535721|FG002|Treated|Overall Study||153
10392533|NCT00672620|11535722|FG003|Treated|Overall Study||150
10392534|NCT00672620|11535719|FG000|COMPLETED|Overall Study||120
10392535|NCT00672620|11535720|FG001|COMPLETED|Overall Study||99
10392536|NCT00672620|11535721|FG002|COMPLETED|Overall Study||122
10392537|NCT00672620|11535722|FG003|COMPLETED|Overall Study||110
10392538|NCT00672620|11535719|FG000|NOT COMPLETED|Overall Study||33
10392539|NCT00672620|11535720|FG001|NOT COMPLETED|Overall Study||54
10392540|NCT00672620|11535721|FG002|NOT COMPLETED|Overall Study||31
10392541|NCT00672620|11535722|FG003|NOT COMPLETED|Overall Study||42
10392542|NCT00672633|11535734|FG000|STARTED|Overall Study||12
10392543|NCT00672633|11535735|FG001|STARTED|Overall Study||13
10392544|NCT00672633|11535734|FG000|COMPLETED|Overall Study||12
10392545|NCT00672633|11535735|FG001|COMPLETED|Overall Study||12
10392546|NCT00672633|11535734|FG000|NOT COMPLETED|Overall Study||0
10392547|NCT00672633|11535735|FG001|NOT COMPLETED|Overall Study||1
10392548|NCT00672646|11535744|FG000|STARTED|Overall Study||40
10392549|NCT00672646|11535745|FG001|STARTED|Overall Study||23
10392550|NCT00672646|11535746|FG002|STARTED|Overall Study||40
10392551|NCT00672646|11535744|FG000|COMPLETED|Overall Study||40
10392552|NCT00672646|11535745|FG001|COMPLETED|Overall Study||22
10392553|NCT00672646|11535746|FG002|COMPLETED|Overall Study||37
10392554|NCT00672646|11535744|FG000|NOT COMPLETED|Overall Study||0
10392555|NCT00672646|11535745|FG001|NOT COMPLETED|Overall Study||1
10392556|NCT00672646|11535746|FG002|NOT COMPLETED|Overall Study||3
10392557|NCT00672737|11535754|FG000|STARTED|Overall Study||56
10392558|NCT00672737|11535754|FG000|COMPLETED|Overall Study||48
10392559|NCT00672737|11535754|FG000|NOT COMPLETED|Overall Study||8
10392560|NCT00672841|11535761|FG000|STARTED|Overall Study||17
10392561|NCT00672841|11535762|FG001|STARTED|Overall Study||47
10392562|NCT00672841|11535761|FG000|COMPLETED|Overall Study||16
10392563|NCT00672841|11535762|FG001|COMPLETED|Overall Study||32
10392564|NCT00672841|11535761|FG000|NOT COMPLETED|Overall Study||1
10392565|NCT00672841|11535762|FG001|NOT COMPLETED|Overall Study||15
10392566|NCT00672854|11535773|FG000|STARTED|Overall Study||49
10392567|NCT00672854|11535774|FG001|STARTED|Overall Study||51
10392568|NCT00672854|11535773|FG000|COMPLETED|Overall Study||49
10392569|NCT00672854|11535774|FG001|COMPLETED|Overall Study||51
10392570|NCT00672854|11535773|FG000|NOT COMPLETED|Overall Study||0
10392571|NCT00672854|11535774|FG001|NOT COMPLETED|Overall Study||0
10392572|NCT00672932|11535784|FG000|STARTED|Overall Study||9
10392573|NCT00672932|11535785|FG001|STARTED|Overall Study||9
10392630|NCT00673049|11535818|FG001|COMPLETED|Before Progression on Erlotinib||0
10392574|NCT00672932|11535784|FG000|Completed Initial 12-week Assignment|Overall Study||9
10392575|NCT00672932|11535785|FG001|Completed Initial 12-week Assignment|Overall Study||9
10392576|NCT00672932|11535784|FG000|Provided Analyzable Blood and CSF Sample|Overall Study|one subject was censored when pharmacological study showed no drug in plasma or CSF|8
10813045|NCT03078270|11975306|FG000|COMPLETED|Overall Study||0
10813046|NCT03078270|11975307|FG001|COMPLETED|Overall Study||0
10813047|NCT03078270|11975306|FG000|NOT COMPLETED|Overall Study||4
10813048|NCT03078270|11975307|FG001|NOT COMPLETED|Overall Study||0
10658767|NCT02235311|11819988|FG001|STARTED|Overall Study||2
10658768|NCT02235311|11819987|FG000|COMPLETED|Overall Study||1
10658769|NCT02235311|11819988|FG001|COMPLETED|Overall Study||0
10658770|NCT02235311|11819987|FG000|NOT COMPLETED|Overall Study||0
10658771|NCT02235311|11819988|FG001|NOT COMPLETED|Overall Study||2
10658772|NCT02235454|11819994|FG000|STARTED|Overall Study||57
10658773|NCT02235454|11819994|FG000|COMPLETED|Overall Study||55
10813049|NCT03065933|11975313|FG000|STARTED|Overall Study||5
10392577|NCT00672932|11535785|FG001|Provided Analyzable Blood and CSF Sample|Overall Study||9
10392578|NCT00672932|11535784|FG000|Rolled Over to Raltegravir|Overall Study||0
10392579|NCT00672932|11535785|FG001|Rolled Over to Raltegravir|Overall Study|6 subjects randomized to no drug later rolled over to receive raltegravir|6
10392580|NCT00672932|11535784|FG000|COMPLETED|Overall Study||9
10392581|NCT00672932|11535785|FG001|COMPLETED|Overall Study||9
10392582|NCT00672932|11535784|FG000|NOT COMPLETED|Overall Study||0
10392583|NCT00672932|11535785|FG001|NOT COMPLETED|Overall Study||0
10392584|NCT00672958|11535793|FG000|STARTED|Overall Study||300
10392585|NCT00672958|11535794|FG001|STARTED|Overall Study||300
10392586|NCT00672958|11535793|FG000|Safety Set|Overall Study|All randomized patients who received at least 1 dose of double-blind study drug.|298
10392587|NCT00672958|11535794|FG001|Safety Set|Overall Study|All randomized patients who received at least 1 dose of double-blind study drug.|299
10392588|NCT00672958|11535793|FG000|Full Analysis Set|Overall Study|All safety set patients who had at least 1 valid postbaseline primary efficacy assessment.|286
10392589|NCT00672958|11535794|FG001|Full Analysis Set|Overall Study|All safety set patients who had at least 1 valid postbaseline primary efficacy assessment.|292
10392590|NCT00672958|11535793|FG000|COMPLETED|Overall Study||236
10392591|NCT00672958|11535794|FG001|COMPLETED|Overall Study||244
10392592|NCT00672958|11535793|FG000|NOT COMPLETED|Overall Study||64
10392593|NCT00672958|11535794|FG001|NOT COMPLETED|Overall Study||56
10392594|NCT00672984|11535803|FG000|STARTED|First Intervention||31
10392595|NCT00672984|11535804|FG001|STARTED|First Intervention||25
10392596|NCT00672984|11535805|FG002|STARTED|First Intervention||27
10392597|NCT00672984|11535803|FG000|COMPLETED|First Intervention||22
10392598|NCT00672984|11535804|FG001|COMPLETED|First Intervention||23
10392599|NCT00672984|11535805|FG002|COMPLETED|First Intervention||25
10392600|NCT00672984|11535803|FG000|NOT COMPLETED|First Intervention||9
10392601|NCT00672984|11535804|FG001|NOT COMPLETED|First Intervention||2
10392602|NCT00672984|11535805|FG002|NOT COMPLETED|First Intervention||2
10392603|NCT00672984|11535803|FG000|STARTED|Second Intervention||22
10392604|NCT00672984|11535804|FG001|STARTED|Second Intervention||23
10392605|NCT00672984|11535805|FG002|STARTED|Second Intervention||25
10392606|NCT00672984|11535803|FG000|COMPLETED|Second Intervention||22
10392607|NCT00672984|11535804|FG001|COMPLETED|Second Intervention||17
10392608|NCT00672984|11535805|FG002|COMPLETED|Second Intervention||24
10392609|NCT00672984|11535803|FG000|NOT COMPLETED|Second Intervention||0
10392610|NCT00672984|11535804|FG001|NOT COMPLETED|Second Intervention||6
10392611|NCT00672984|11535805|FG002|NOT COMPLETED|Second Intervention||1
10392612|NCT00672984|11535803|FG000|STARTED|Third Intervention||22
10392613|NCT00672984|11535804|FG001|STARTED|Third Intervention||17
10392614|NCT00672984|11535805|FG002|STARTED|Third Intervention||24
10392615|NCT00672984|11535803|FG000|COMPLETED|Third Intervention||21
10392616|NCT00672984|11535804|FG001|COMPLETED|Third Intervention||17
10813050|NCT03065933|11975313|FG000|COMPLETED|Overall Study||0
10813051|NCT03065933|11975313|FG000|NOT COMPLETED|Overall Study||5
10719192|NCT02708966|11882933|FG000|NOT COMPLETED|Overall Study||2
10719193|NCT02708966|11882934|FG001|NOT COMPLETED|Overall Study||2
10719194|NCT02709005|11882942|FG000|STARTED|Overall Study||73
10719195|NCT02709005|11882943|FG001|STARTED|Overall Study||36
10719196|NCT02709005|11882942|FG000|COMPLETED|Overall Study||69
10719197|NCT02709005|11882943|FG001|COMPLETED|Overall Study||35
10719198|NCT02709005|11882942|FG000|NOT COMPLETED|Overall Study||4
10543043|NCT01481779|11696219|FG001|COMPLETED|Overall Study||132
10719199|NCT02709005|11882943|FG001|NOT COMPLETED|Overall Study||1
10719200|NCT02709018|11882951|FG000|STARTED|Overall Study||75
10543044|NCT01481779|11696218|FG000|NOT COMPLETED|Overall Study||70
10719201|NCT02709018|11882952|FG001|STARTED|Overall Study||74
10392617|NCT00672984|11535805|FG002|COMPLETED|Third Intervention||23
10392618|NCT00672984|11535803|FG000|NOT COMPLETED|Third Intervention||1
10392619|NCT00672984|11535804|FG001|NOT COMPLETED|Third Intervention||0
10392620|NCT00672984|11535805|FG002|NOT COMPLETED|Third Intervention||1
10392621|NCT00673049|11535817|FG000|STARTED|Before Progression on Erlotinib||292
10392622|NCT00673049|11535818|FG001|STARTED|Before Progression on Erlotinib||290
10392623|NCT00673049|11535819|FG002|STARTED|Before Progression on Erlotinib||1
10392624|NCT00673049|11535820|FG003|STARTED|Before Progression on Erlotinib|Participants treated with erlo alone who subsequently received figi upon disease progression.|0
10392625|NCT00673049|11535817|FG000|Treated|Before Progression on Erlotinib||289
10392626|NCT00673049|11535818|FG001|Treated|Before Progression on Erlotinib||289
10392627|NCT00673049|11535819|FG002|Treated|Before Progression on Erlotinib||1
10392628|NCT00673049|11535820|FG003|Treated|Before Progression on Erlotinib||0
10392629|NCT00673049|11535817|FG000|COMPLETED|Before Progression on Erlotinib||0
10392631|NCT00673049|11535819|FG002|COMPLETED|Before Progression on Erlotinib||0
10392632|NCT00673049|11535820|FG003|COMPLETED|Before Progression on Erlotinib||0
10392633|NCT00673049|11535817|FG000|NOT COMPLETED|Before Progression on Erlotinib||292
10392634|NCT00673049|11535818|FG001|NOT COMPLETED|Before Progression on Erlotinib||290
10392635|NCT00673049|11535819|FG002|NOT COMPLETED|Before Progression on Erlotinib||1
10392636|NCT00673049|11535820|FG003|NOT COMPLETED|Before Progression on Erlotinib||0
10392637|NCT00673049|11535817|FG000|STARTED|After Progression on Erlotinib||0
10392638|NCT00673049|11535818|FG001|STARTED|After Progression on Erlotinib||0
10392639|NCT00673049|11535819|FG002|STARTED|After Progression on Erlotinib||0
10392640|NCT00673049|11535820|FG003|STARTED|After Progression on Erlotinib||83
10392641|NCT00673049|11535817|FG000|COMPLETED|After Progression on Erlotinib||0
10392642|NCT00673049|11535818|FG001|COMPLETED|After Progression on Erlotinib||0
10392643|NCT00673049|11535819|FG002|COMPLETED|After Progression on Erlotinib||0
10392644|NCT00673049|11535820|FG003|COMPLETED|After Progression on Erlotinib||0
10392645|NCT00673049|11535817|FG000|NOT COMPLETED|After Progression on Erlotinib||0
10392646|NCT00673049|11535818|FG001|NOT COMPLETED|After Progression on Erlotinib||0
10392647|NCT00673049|11535819|FG002|NOT COMPLETED|After Progression on Erlotinib||0
10392648|NCT00673049|11535820|FG003|NOT COMPLETED|After Progression on Erlotinib||83
10392649|NCT00673075|11535830|FG000|STARTED|Overall Study||21
10392650|NCT00673075|11535831|FG001|STARTED|Overall Study||18
10392651|NCT00673075|11535830|FG000|COMPLETED|Overall Study||12
10392652|NCT00673075|11535831|FG001|COMPLETED|Overall Study||11
10392653|NCT00673075|11535830|FG000|NOT COMPLETED|Overall Study||9
10392654|NCT00673075|11535831|FG001|NOT COMPLETED|Overall Study||7
10392655|NCT00673114|11535839|FG000|STARTED|Overall Study||3
10392656|NCT00673114|11535839|FG000|COMPLETED|Overall Study||3
10392657|NCT00673114|11535839|FG000|NOT COMPLETED|Overall Study||0
10392658|NCT00673127|11535843|FG000|STARTED|Overall Study||57
10392659|NCT00673127|11535843|FG000|COMPLETED|Overall Study||57
10392660|NCT00673127|11535843|FG000|NOT COMPLETED|Overall Study||0
10392661|NCT00673153|11535848|FG000|STARTED|Overall Study||31
10392662|NCT00673153|11535848|FG000|COMPLETED|Overall Study||30
10392663|NCT00673153|11535848|FG000|NOT COMPLETED|Overall Study||1
10392664|NCT00673231|11535856|FG000|STARTED|Overall Study|Of the 197 randomized participants only 193 were included in the full analysis set|197
10392665|NCT00673231|11535857|FG001|STARTED|Overall Study|All 202 were included in the full analysis set|202
10392666|NCT00673231|11535858|FG002|STARTED|Overall Study|Of the 212 randomized participants only 211 were included in the full analysis set|212
10392667|NCT00673231|11535859|FG003|STARTED|Overall Study|Of the 196 randomized participants only 194 were included in the full analysis set|196
10392668|NCT00673231|11535856|FG000|COMPLETED|Overall Study||168
10392669|NCT00673231|11535857|FG001|COMPLETED|Overall Study||180
10392670|NCT00673231|11535858|FG002|COMPLETED|Overall Study||186
10392671|NCT00673231|11535859|FG003|COMPLETED|Overall Study||178
10392672|NCT00673231|11535856|FG000|NOT COMPLETED|Overall Study||29
10392673|NCT00673231|11535857|FG001|NOT COMPLETED|Overall Study||22
10392674|NCT00673231|11535858|FG002|NOT COMPLETED|Overall Study||26
10392675|NCT00673231|11535859|FG003|NOT COMPLETED|Overall Study||18
10392676|NCT00673244|11535871|FG000|STARTED|Overall Study||52
10392677|NCT00673244|11535872|FG001|STARTED|Overall Study||25
10392678|NCT00673244|11535871|FG000|COMPLETED|Overall Study||52
10392679|NCT00673244|11535872|FG001|COMPLETED|Overall Study||25
10392680|NCT00673244|11535871|FG000|NOT COMPLETED|Overall Study||0
10392681|NCT00673244|11535872|FG001|NOT COMPLETED|Overall Study||0
10392682|NCT00673257|11535878|FG000|STARTED|Overall Study||107
10392683|NCT00673257|11535878|FG000|COMPLETED|Overall Study||102
10392684|NCT00673257|11535878|FG000|NOT COMPLETED|Overall Study||5
10392685|NCT00673387|11535890|FG000|STARTED|Overall Study||75
10392686|NCT00673387|11535891|FG001|STARTED|Overall Study||77
10392687|NCT00673387|11535892|FG002|STARTED|Overall Study||72
10392688|NCT00673387|11535893|FG003|STARTED|Overall Study||75
10392689|NCT00673387|11535894|FG004|STARTED|Overall Study||78
10392690|NCT00673387|11535895|FG005|STARTED|Overall Study||78
10392691|NCT00673387|11535896|FG006|STARTED|Overall Study||78
10392692|NCT00673387|11535897|FG007|STARTED|Overall Study||75
10392693|NCT00673387|11535890|FG000|COMPLETED|Overall Study||46
10392694|NCT00673387|11535891|FG001|COMPLETED|Overall Study||54
10392695|NCT00673387|11535892|FG002|COMPLETED|Overall Study||41
10392696|NCT00673387|11535893|FG003|COMPLETED|Overall Study||49
10392697|NCT00673387|11535894|FG004|COMPLETED|Overall Study||48
10392698|NCT00673387|11535895|FG005|COMPLETED|Overall Study||44
10392699|NCT00673387|11535896|FG006|COMPLETED|Overall Study||48
10392700|NCT00673387|11535897|FG007|COMPLETED|Overall Study||40
10392701|NCT00673387|11535890|FG000|NOT COMPLETED|Overall Study||29
10392702|NCT00673387|11535891|FG001|NOT COMPLETED|Overall Study||23
10392703|NCT00673387|11535892|FG002|NOT COMPLETED|Overall Study||31
10392704|NCT00673387|11535893|FG003|NOT COMPLETED|Overall Study||26
10392705|NCT00673387|11535894|FG004|NOT COMPLETED|Overall Study||30
10392706|NCT00673387|11535895|FG005|NOT COMPLETED|Overall Study||34
10392707|NCT00673387|11535896|FG006|NOT COMPLETED|Overall Study||30
10392708|NCT00673387|11535897|FG007|NOT COMPLETED|Overall Study||35
10392709|NCT00673400|11535925|FG000|STARTED|Overall Study||52
10392710|NCT00673400|11535925|FG000|COMPLETED|Overall Study||52
10392711|NCT00673400|11535925|FG000|NOT COMPLETED|Overall Study||0
10392712|NCT00673439|11535935|FG000|STARTED|Overall Study||3
10392713|NCT00673439|11535935|FG000|COMPLETED|Overall Study||3
10392714|NCT00673439|11535935|FG000|NOT COMPLETED|Overall Study||0
10392715|NCT00673452|11535942|FG000|STARTED|Acute Double-Blind Phase||263
10392716|NCT00673452|11535943|FG001|STARTED|Acute Double-Blind Phase||267
10392717|NCT00673452|11535942|FG000|COMPLETED|Acute Double-Blind Phase||176
10392718|NCT00673452|11535943|FG001|COMPLETED|Acute Double-Blind Phase||187
10392719|NCT00673452|11535942|FG000|NOT COMPLETED|Acute Double-Blind Phase||87
10392720|NCT00673452|11535943|FG001|NOT COMPLETED|Acute Double-Blind Phase||80
10392721|NCT00673452|11535942|FG000|STARTED|Continuation Double-Blind Phase||176
10392722|NCT00673452|11535943|FG001|STARTED|Continuation Double-Blind Phase|Patients on placebo in acute phase received 60 mg duloxetine during the continuation phase.|187
10392723|NCT00673452|11535942|FG000|COMPLETED|Continuation Double-Blind Phase||151
10392724|NCT00673452|11535943|FG001|COMPLETED|Continuation Double-Blind Phase||153
10392725|NCT00673452|11535942|FG000|NOT COMPLETED|Continuation Double-Blind Phase||25
10392726|NCT00673452|11535943|FG001|NOT COMPLETED|Continuation Double-Blind Phase||34
10392727|NCT00673465|11535949|FG000|STARTED|Part 1/Period 1 (United States)||3
10392728|NCT00673465|11535950|FG001|STARTED|Part 1/Period 1 (United States)||3
10392729|NCT00673465|11535951|FG002|STARTED|Part 1/Period 1 (United States)||3
10813052|NCT03070002|11975317|FG000|STARTED|3 Cycles of Treatment||1
10813053|NCT03070002|11975317|FG000|COMPLETED|3 Cycles of Treatment||1
10813054|NCT03070002|11975317|FG000|NOT COMPLETED|3 Cycles of Treatment||0
10813055|NCT03070002|11975317|FG000|STARTED|Follow up for 2 Years||1
10813056|NCT03070002|11975317|FG000|COMPLETED|Follow up for 2 Years||0
10813057|NCT03070002|11975317|FG000|NOT COMPLETED|Follow up for 2 Years||1
10813058|NCT03058705|11975321|FG000|STARTED|Overall Study||10
10813059|NCT03058705|11975321|FG000|COMPLETED|Overall Study||6
10813060|NCT03058705|11975321|FG000|NOT COMPLETED|Overall Study||4
10813061|NCT03061279|11975327|FG000|STARTED|Overall Study||0
10813062|NCT03061279|11975328|FG001|STARTED|Overall Study||1
10392730|NCT00673465|11535952|FG003|STARTED|Part 1/Period 1 (United States)||3
10392731|NCT00673465|11535953|FG004|STARTED|Part 1/Period 1 (United States)||3
10392732|NCT00673465|11535954|FG005|STARTED|Part 1/Period 1 (United States)||2
10392733|NCT00673465|11535955|FG006|STARTED|Part 1/Period 1 (United States)||0
10392734|NCT00673465|11535956|FG007|STARTED|Part 1/Period 1 (United States)||0
10392735|NCT00673465|11535957|FG008|STARTED|Part 1/Period 1 (United States)||0
10392736|NCT00673465|11535958|FG009|STARTED|Part 1/Period 1 (United States)||0
10392737|NCT00673465|11535959|FG010|STARTED|Part 1/Period 1 (United States)||0
10392738|NCT00673465|11535960|FG011|STARTED|Part 1/Period 1 (United States)||0
10392739|NCT00673465|11535949|FG000|COMPLETED|Part 1/Period 1 (United States)||3
10392740|NCT00673465|11535950|FG001|COMPLETED|Part 1/Period 1 (United States)||3
10392741|NCT00673465|11535951|FG002|COMPLETED|Part 1/Period 1 (United States)||3
10392742|NCT00673465|11535952|FG003|COMPLETED|Part 1/Period 1 (United States)||3
10392743|NCT00673465|11535953|FG004|COMPLETED|Part 1/Period 1 (United States)||2
10392744|NCT00673465|11535954|FG005|COMPLETED|Part 1/Period 1 (United States)||1
10392745|NCT00673465|11535955|FG006|COMPLETED|Part 1/Period 1 (United States)||0
10392746|NCT00673465|11535956|FG007|COMPLETED|Part 1/Period 1 (United States)||0
10392747|NCT00673465|11535957|FG008|COMPLETED|Part 1/Period 1 (United States)||0
10392748|NCT00673465|11535958|FG009|COMPLETED|Part 1/Period 1 (United States)||0
10392749|NCT00673465|11535959|FG010|COMPLETED|Part 1/Period 1 (United States)||0
10392750|NCT00673465|11535960|FG011|COMPLETED|Part 1/Period 1 (United States)||0
10392751|NCT00673465|11535949|FG000|NOT COMPLETED|Part 1/Period 1 (United States)||0
10392752|NCT00673465|11535950|FG001|NOT COMPLETED|Part 1/Period 1 (United States)||0
10392753|NCT00673465|11535951|FG002|NOT COMPLETED|Part 1/Period 1 (United States)||0
10392754|NCT00673465|11535952|FG003|NOT COMPLETED|Part 1/Period 1 (United States)||0
10392755|NCT00673465|11535953|FG004|NOT COMPLETED|Part 1/Period 1 (United States)||1
10392756|NCT00673465|11535954|FG005|NOT COMPLETED|Part 1/Period 1 (United States)||1
10392757|NCT00673465|11535955|FG006|NOT COMPLETED|Part 1/Period 1 (United States)||0
10392758|NCT00673465|11535956|FG007|NOT COMPLETED|Part 1/Period 1 (United States)||0
10392759|NCT00673465|11535957|FG008|NOT COMPLETED|Part 1/Period 1 (United States)||0
10392760|NCT00673465|11535958|FG009|NOT COMPLETED|Part 1/Period 1 (United States)||0
10392761|NCT00673465|11535959|FG010|NOT COMPLETED|Part 1/Period 1 (United States)||0
10392762|NCT00673465|11535960|FG011|NOT COMPLETED|Part 1/Period 1 (United States)||0
10392763|NCT00673465|11535949|FG000|STARTED|Part 1/Period 2 (United States)||3
10392764|NCT00673465|11535950|FG001|STARTED|Part 1/Period 2 (United States)||3
10392765|NCT00673465|11535951|FG002|STARTED|Part 1/Period 2 (United States)||3
10392766|NCT00673465|11535952|FG003|STARTED|Part 1/Period 2 (United States)||3
10392767|NCT00673465|11535953|FG004|STARTED|Part 1/Period 2 (United States)||2
10392768|NCT00673465|11535954|FG005|STARTED|Part 1/Period 2 (United States)||1
10392769|NCT00673465|11535955|FG006|STARTED|Part 1/Period 2 (United States)||0
10392770|NCT00673465|11535956|FG007|STARTED|Part 1/Period 2 (United States)||0
10392771|NCT00673465|11535957|FG008|STARTED|Part 1/Period 2 (United States)||0
10392772|NCT00673465|11535958|FG009|STARTED|Part 1/Period 2 (United States)||0
10392773|NCT00673465|11535959|FG010|STARTED|Part 1/Period 2 (United States)||0
10392774|NCT00673465|11535960|FG011|STARTED|Part 1/Period 2 (United States)||0
10392775|NCT00673465|11535949|FG000|COMPLETED|Part 1/Period 2 (United States)||3
10392776|NCT00673465|11535950|FG001|COMPLETED|Part 1/Period 2 (United States)||3
10392777|NCT00673465|11535951|FG002|COMPLETED|Part 1/Period 2 (United States)||3
10392778|NCT00673465|11535952|FG003|COMPLETED|Part 1/Period 2 (United States)||3
10392779|NCT00673465|11535953|FG004|COMPLETED|Part 1/Period 2 (United States)||1
10392780|NCT00673465|11535954|FG005|COMPLETED|Part 1/Period 2 (United States)||1
10392781|NCT00673465|11535955|FG006|COMPLETED|Part 1/Period 2 (United States)||0
10813063|NCT03061279|11975327|FG000|COMPLETED|Overall Study||0
10813064|NCT03061279|11975328|FG001|COMPLETED|Overall Study||0
10813065|NCT03061279|11975327|FG000|NOT COMPLETED|Overall Study||0
10308617|NCT00112437|11441540|FG004|COMPLETED|Year 3 (12-Month Extension)||0
10308618|NCT00112437|11441541|FG005|COMPLETED|Year 3 (12-Month Extension)||0
10308619|NCT00112437|11441542|FG006|COMPLETED|Year 3 (12-Month Extension)||0
10308620|NCT00112437|11441543|FG007|COMPLETED|Year 3 (12-Month Extension)||0
10308621|NCT00112437|11441544|FG008|COMPLETED|Year 3 (12-Month Extension)||0
10308622|NCT00112437|11441545|FG009|COMPLETED|Year 3 (12-Month Extension)||0
10308623|NCT00112437|11441546|FG010|COMPLETED|Year 3 (12-Month Extension)||17
10308624|NCT00112437|11441547|FG011|COMPLETED|Year 3 (12-Month Extension)||17
10308625|NCT00112437|11441548|FG012|COMPLETED|Year 3 (12-Month Extension)||18
10308626|NCT00112437|11441549|FG013|COMPLETED|Year 3 (12-Month Extension)||16
10308627|NCT00112437|11441550|FG014|COMPLETED|Year 3 (12-Month Extension)||17
10392782|NCT00673465|11535956|FG007|COMPLETED|Part 1/Period 2 (United States)||0
10392783|NCT00673465|11535957|FG008|COMPLETED|Part 1/Period 2 (United States)||0
10392784|NCT00673465|11535958|FG009|COMPLETED|Part 1/Period 2 (United States)||0
10392785|NCT00673465|11535959|FG010|COMPLETED|Part 1/Period 2 (United States)||0
10392786|NCT00673465|11535960|FG011|COMPLETED|Part 1/Period 2 (United States)||0
10392787|NCT00673465|11535949|FG000|NOT COMPLETED|Part 1/Period 2 (United States)||0
10392788|NCT00673465|11535950|FG001|NOT COMPLETED|Part 1/Period 2 (United States)||0
10392789|NCT00673465|11535951|FG002|NOT COMPLETED|Part 1/Period 2 (United States)||0
10392790|NCT00673465|11535952|FG003|NOT COMPLETED|Part 1/Period 2 (United States)||0
10392791|NCT00673465|11535953|FG004|NOT COMPLETED|Part 1/Period 2 (United States)||1
10392792|NCT00673465|11535954|FG005|NOT COMPLETED|Part 1/Period 2 (United States)||0
10392793|NCT00673465|11535955|FG006|NOT COMPLETED|Part 1/Period 2 (United States)||0
10392794|NCT00673465|11535956|FG007|NOT COMPLETED|Part 1/Period 2 (United States)||0
10392795|NCT00673465|11535957|FG008|NOT COMPLETED|Part 1/Period 2 (United States)||0
10392796|NCT00673465|11535958|FG009|NOT COMPLETED|Part 1/Period 2 (United States)||0
10392797|NCT00673465|11535959|FG010|NOT COMPLETED|Part 1/Period 2 (United States)||0
10392798|NCT00673465|11535960|FG011|NOT COMPLETED|Part 1/Period 2 (United States)||0
10392799|NCT00673465|11535949|FG000|STARTED|Part 1/Period 3 (United States)||3
10392800|NCT00673465|11535950|FG001|STARTED|Part 1/Period 3 (United States)||3
10392801|NCT00673465|11535951|FG002|STARTED|Part 1/Period 3 (United States)||3
10392802|NCT00673465|11535952|FG003|STARTED|Part 1/Period 3 (United States)||3
10392803|NCT00673465|11535953|FG004|STARTED|Part 1/Period 3 (United States)||1
10543045|NCT01481779|11696219|FG001|NOT COMPLETED|Overall Study||28
10719202|NCT02709018|11882951|FG000|COMPLETED|Overall Study||59
10719203|NCT02709018|11882952|FG001|COMPLETED|Overall Study||58
10719204|NCT02709018|11882951|FG000|NOT COMPLETED|Overall Study||16
10719205|NCT02709018|11882952|FG001|NOT COMPLETED|Overall Study||16
10543046|NCT01481896|11696225|FG000|STARTED|Overall Study|The 126 participants includes 5 participants with bilateral hip replacements for a total of 131 THAs|126
10543047|NCT01481896|11696225|FG000|Min 4.75 yr Follow-up, Revised or Dead|Overall Study|114 participants with 119 THAs had at least 4.75 year follow-up or were known revised or deceased|114
10543048|NCT01481896|11696225|FG000|COMPLETED|Overall Study|The 114 participants includes 5 participants with bilateral hip replacements for a total of 119 THAs|114
10543049|NCT01481896|11696225|FG000|NOT COMPLETED|Overall Study||12
10543050|NCT01482065|11696241|FG000|STARTED|Overall Study||4
10543051|NCT01482065|11696242|FG001|STARTED|Overall Study||5
10543052|NCT01482065|11696241|FG000|COMPLETED|Overall Study||4
10543053|NCT01482065|11696242|FG001|COMPLETED|Overall Study||4
10543054|NCT01482065|11696241|FG000|NOT COMPLETED|Overall Study||0
10543055|NCT01482065|11696242|FG001|NOT COMPLETED|Overall Study||1
10543056|NCT01482091|11696250|FG000|STARTED|Overall Study||25
10543057|NCT01482091|11696251|FG001|STARTED|Overall Study||24
10658774|NCT02235454|11819994|FG000|NOT COMPLETED|Overall Study||2
10658775|NCT02235493|11819998|FG000|STARTED|Overall Study||6
10658776|NCT02235493|11819998|FG000|COMPLETED|Overall Study||6
10658777|NCT02235493|11819998|FG000|NOT COMPLETED|Overall Study||0
10658778|NCT02235831|11820002|FG000|STARTED|Period 1, First 5 Days of Wear||4
10658779|NCT02235831|11820003|FG001|STARTED|Period 1, First 5 Days of Wear||4
10658780|NCT02235831|11820004|FG002|STARTED|Period 1, First 5 Days of Wear||4
10658781|NCT02235831|11820005|FG003|STARTED|Period 1, First 5 Days of Wear||4
10658782|NCT02235831|11820006|FG004|STARTED|Period 1, First 5 Days of Wear||4
10658783|NCT02235831|11820007|FG005|STARTED|Period 1, First 5 Days of Wear||4
10658784|NCT02235831|11820002|FG000|COMPLETED|Period 1, First 5 Days of Wear||4
10658785|NCT02235831|11820003|FG001|COMPLETED|Period 1, First 5 Days of Wear||4
10658786|NCT02235831|11820004|FG002|COMPLETED|Period 1, First 5 Days of Wear||4
10658787|NCT02235831|11820005|FG003|COMPLETED|Period 1, First 5 Days of Wear||4
10658788|NCT02235831|11820006|FG004|COMPLETED|Period 1, First 5 Days of Wear||4
10658789|NCT02235831|11820007|FG005|COMPLETED|Period 1, First 5 Days of Wear||4
10719206|NCT02709096|11882962|FG000|STARTED|Overall Study||22
10719207|NCT02709096|11882963|FG001|STARTED|Overall Study||11
10308628|NCT00112437|11441551|FG015|COMPLETED|Year 3 (12-Month Extension)||13
10308629|NCT00112437|11441552|FG016|COMPLETED|Year 3 (12-Month Extension)||16
10308630|NCT00112437|11441553|FG017|COMPLETED|Year 3 (12-Month Extension)||20
10308631|NCT00112437|11441554|FG018|COMPLETED|Year 3 (12-Month Extension)||16
10308632|NCT00112437|11441555|FG019|COMPLETED|Year 3 (12-Month Extension)||19
10813066|NCT03061279|11975328|FG001|NOT COMPLETED|Overall Study||1
10813067|NCT03040323|11975336|FG000|STARTED|Overall Study|No information available regarding how many participants Started and Completed the study in each arm|0
10308633|NCT00112437|11441556|FG020|COMPLETED|Year 3 (12-Month Extension)||0
10308634|NCT00112437|11441557|FG021|COMPLETED|Year 3 (12-Month Extension)||0
10308635|NCT00112437|11441558|FG022|COMPLETED|Year 3 (12-Month Extension)||0
10308636|NCT00112437|11441559|FG023|COMPLETED|Year 3 (12-Month Extension)||0
10308637|NCT00112437|11441560|FG024|COMPLETED|Year 3 (12-Month Extension)||0
10308638|NCT00112437|11441561|FG025|COMPLETED|Year 3 (12-Month Extension)||0
10308639|NCT00112437|11441536|FG000|NOT COMPLETED|Year 3 (12-Month Extension)||0
10308640|NCT00112437|11441537|FG001|NOT COMPLETED|Year 3 (12-Month Extension)||0
10308641|NCT00112437|11441538|FG002|NOT COMPLETED|Year 3 (12-Month Extension)||0
10392804|NCT00673465|11535954|FG005|STARTED|Part 1/Period 3 (United States)||1
10392805|NCT00673465|11535955|FG006|STARTED|Part 1/Period 3 (United States)||0
10392806|NCT00673465|11535956|FG007|STARTED|Part 1/Period 3 (United States)||0
10392807|NCT00673465|11535957|FG008|STARTED|Part 1/Period 3 (United States)||0
10813068|NCT03040323|11975337|FG001|STARTED|Overall Study|No information available regarding how many participants Started and Completed the study in each arm|0
10813069|NCT03040323|11975336|FG000|COMPLETED|Overall Study||0
10813070|NCT03040323|11975337|FG001|COMPLETED|Overall Study||0
10392808|NCT00673465|11535958|FG009|STARTED|Part 1/Period 3 (United States)||0
10392809|NCT00673465|11535959|FG010|STARTED|Part 1/Period 3 (United States)||0
10392810|NCT00673465|11535960|FG011|STARTED|Part 1/Period 3 (United States)||0
10392811|NCT00673465|11535949|FG000|COMPLETED|Part 1/Period 3 (United States)||3
10392812|NCT00673465|11535950|FG001|COMPLETED|Part 1/Period 3 (United States)||3
10392813|NCT00673465|11535951|FG002|COMPLETED|Part 1/Period 3 (United States)||3
10392814|NCT00673465|11535952|FG003|COMPLETED|Part 1/Period 3 (United States)||3
10392815|NCT00673465|11535953|FG004|COMPLETED|Part 1/Period 3 (United States)||1
10392816|NCT00673465|11535954|FG005|COMPLETED|Part 1/Period 3 (United States)||1
10392817|NCT00673465|11535955|FG006|COMPLETED|Part 1/Period 3 (United States)||0
10392818|NCT00673465|11535956|FG007|COMPLETED|Part 1/Period 3 (United States)||0
10392819|NCT00673465|11535957|FG008|COMPLETED|Part 1/Period 3 (United States)||0
10392820|NCT00673465|11535958|FG009|COMPLETED|Part 1/Period 3 (United States)||0
10392821|NCT00673465|11535959|FG010|COMPLETED|Part 1/Period 3 (United States)||0
10392822|NCT00673465|11535960|FG011|COMPLETED|Part 1/Period 3 (United States)||0
10392823|NCT00673465|11535949|FG000|NOT COMPLETED|Part 1/Period 3 (United States)||0
10392824|NCT00673465|11535950|FG001|NOT COMPLETED|Part 1/Period 3 (United States)||0
10392825|NCT00673465|11535951|FG002|NOT COMPLETED|Part 1/Period 3 (United States)||0
10392826|NCT00673465|11535952|FG003|NOT COMPLETED|Part 1/Period 3 (United States)||0
10392827|NCT00673465|11535953|FG004|NOT COMPLETED|Part 1/Period 3 (United States)||0
10392828|NCT00673465|11535954|FG005|NOT COMPLETED|Part 1/Period 3 (United States)||0
10392829|NCT00673465|11535955|FG006|NOT COMPLETED|Part 1/Period 3 (United States)||0
10719208|NCT02709096|11882962|FG000|COMPLETED|Overall Study||21
10719209|NCT02709096|11882963|FG001|COMPLETED|Overall Study||10
10719210|NCT02709096|11882962|FG000|NOT COMPLETED|Overall Study||1
10719211|NCT02709096|11882963|FG001|NOT COMPLETED|Overall Study||1
10719212|NCT02709109|11882973|FG000|STARTED|Treatment Period 1 (28 Days)||49
10719213|NCT02709109|11882974|FG001|STARTED|Treatment Period 1 (28 Days)||47
10719214|NCT02709109|11882975|FG002|STARTED|Treatment Period 1 (28 Days)||22
10719215|NCT02709109|11882976|FG003|STARTED|Treatment Period 1 (28 Days)||24
10719216|NCT02709109|11882973|FG000|COMPLETED|Treatment Period 1 (28 Days)||45
10719217|NCT02709109|11882974|FG001|COMPLETED|Treatment Period 1 (28 Days)||42
10719218|NCT02709109|11882975|FG002|COMPLETED|Treatment Period 1 (28 Days)||21
10719219|NCT02709109|11882976|FG003|COMPLETED|Treatment Period 1 (28 Days)||24
10719220|NCT02709109|11882973|FG000|NOT COMPLETED|Treatment Period 1 (28 Days)||4
10392830|NCT00673465|11535956|FG007|NOT COMPLETED|Part 1/Period 3 (United States)||0
10392831|NCT00673465|11535957|FG008|NOT COMPLETED|Part 1/Period 3 (United States)||0
10392832|NCT00673465|11535958|FG009|NOT COMPLETED|Part 1/Period 3 (United States)||0
10392833|NCT00673465|11535959|FG010|NOT COMPLETED|Part 1/Period 3 (United States)||0
10392834|NCT00673465|11535960|FG011|NOT COMPLETED|Part 1/Period 3 (United States)||0
10392835|NCT00673465|11535949|FG000|STARTED|Part 2 (India)||0
10392836|NCT00673465|11535950|FG001|STARTED|Part 2 (India)||0
10392837|NCT00673465|11535951|FG002|STARTED|Part 2 (India)||0
10719221|NCT02709109|11882974|FG001|NOT COMPLETED|Treatment Period 1 (28 Days)||5
10719222|NCT02709109|11882975|FG002|NOT COMPLETED|Treatment Period 1 (28 Days)||1
10392838|NCT00673465|11535952|FG003|STARTED|Part 2 (India)||0
10392839|NCT00673465|11535953|FG004|STARTED|Part 2 (India)||0
10308642|NCT00112437|11441539|FG003|NOT COMPLETED|Year 3 (12-Month Extension)||0
10308643|NCT00112437|11441540|FG004|NOT COMPLETED|Year 3 (12-Month Extension)||0
10308644|NCT00112437|11441541|FG005|NOT COMPLETED|Year 3 (12-Month Extension)||0
10308645|NCT00112437|11441542|FG006|NOT COMPLETED|Year 3 (12-Month Extension)||0
10308646|NCT00112437|11441543|FG007|NOT COMPLETED|Year 3 (12-Month Extension)||0
10308647|NCT00112437|11441544|FG008|NOT COMPLETED|Year 3 (12-Month Extension)||0
10308648|NCT00112437|11441545|FG009|NOT COMPLETED|Year 3 (12-Month Extension)||0
10308649|NCT00112437|11441546|FG010|NOT COMPLETED|Year 3 (12-Month Extension)||2
10308650|NCT00112437|11441547|FG011|NOT COMPLETED|Year 3 (12-Month Extension)||5
10308651|NCT00112437|11441548|FG012|NOT COMPLETED|Year 3 (12-Month Extension)||0
10308652|NCT00112437|11441549|FG013|NOT COMPLETED|Year 3 (12-Month Extension)||1
10308653|NCT00112437|11441550|FG014|NOT COMPLETED|Year 3 (12-Month Extension)||1
10308654|NCT00112437|11441551|FG015|NOT COMPLETED|Year 3 (12-Month Extension)||4
10308655|NCT00112437|11441552|FG016|NOT COMPLETED|Year 3 (12-Month Extension)||3
10392840|NCT00673465|11535954|FG005|STARTED|Part 2 (India)||0
10308656|NCT00112437|11441553|FG017|NOT COMPLETED|Year 3 (12-Month Extension)||1
10308657|NCT00112437|11441554|FG018|NOT COMPLETED|Year 3 (12-Month Extension)||2
10308658|NCT00112437|11441555|FG019|NOT COMPLETED|Year 3 (12-Month Extension)||1
10308659|NCT00112437|11441556|FG020|NOT COMPLETED|Year 3 (12-Month Extension)||0
10308660|NCT00112437|11441557|FG021|NOT COMPLETED|Year 3 (12-Month Extension)||0
10308661|NCT00112437|11441558|FG022|NOT COMPLETED|Year 3 (12-Month Extension)||0
10308662|NCT00112437|11441559|FG023|NOT COMPLETED|Year 3 (12-Month Extension)||0
10308663|NCT00112437|11441560|FG024|NOT COMPLETED|Year 3 (12-Month Extension)||0
10308664|NCT00112437|11441561|FG025|NOT COMPLETED|Year 3 (12-Month Extension)||0
10308665|NCT00112437|11441536|FG000|STARTED|Years 4-5 (24-Month Extension)||0
10392841|NCT00673465|11535955|FG006|STARTED|Part 2 (India)||0
10392842|NCT00673465|11535956|FG007|STARTED|Part 2 (India)||0
10392843|NCT00673465|11535957|FG008|STARTED|Part 2 (India)||0
10392844|NCT00673465|11535958|FG009|STARTED|Part 2 (India)||0
10392845|NCT00673465|11535959|FG010|STARTED|Part 2 (India)||0
10392846|NCT00673465|11535960|FG011|STARTED|Part 2 (India)||0
10392847|NCT00673465|11535949|FG000|COMPLETED|Part 2 (India)||0
10392848|NCT00673465|11535950|FG001|COMPLETED|Part 2 (India)||0
10392849|NCT00673465|11535951|FG002|COMPLETED|Part 2 (India)||0
10392850|NCT00673465|11535952|FG003|COMPLETED|Part 2 (India)||0
10392851|NCT00673465|11535953|FG004|COMPLETED|Part 2 (India)||0
10392852|NCT00673465|11535954|FG005|COMPLETED|Part 2 (India)||0
10392853|NCT00673465|11535955|FG006|COMPLETED|Part 2 (India)||0
10392854|NCT00673465|11535956|FG007|COMPLETED|Part 2 (India)||0
10392855|NCT00673465|11535957|FG008|COMPLETED|Part 2 (India)||0
10392856|NCT00673465|11535958|FG009|COMPLETED|Part 2 (India)||0
10392857|NCT00673465|11535959|FG010|COMPLETED|Part 2 (India)||0
10392858|NCT00673465|11535960|FG011|COMPLETED|Part 2 (India)||0
10392859|NCT00673465|11535949|FG000|NOT COMPLETED|Part 2 (India)||0
10392860|NCT00673465|11535950|FG001|NOT COMPLETED|Part 2 (India)||0
10392861|NCT00673465|11535951|FG002|NOT COMPLETED|Part 2 (India)||0
10392862|NCT00673465|11535952|FG003|NOT COMPLETED|Part 2 (India)||0
10392863|NCT00673465|11535953|FG004|NOT COMPLETED|Part 2 (India)||0
10392864|NCT00673465|11535954|FG005|NOT COMPLETED|Part 2 (India)||0
10392865|NCT00673465|11535955|FG006|NOT COMPLETED|Part 2 (India)||0
10392866|NCT00673465|11535956|FG007|NOT COMPLETED|Part 2 (India)||0
10392867|NCT00673465|11535957|FG008|NOT COMPLETED|Part 2 (India)||0
10392868|NCT00673465|11535958|FG009|NOT COMPLETED|Part 2 (India)||0
10392869|NCT00673465|11535959|FG010|NOT COMPLETED|Part 2 (India)||0
10392870|NCT00673465|11535960|FG011|NOT COMPLETED|Part 2 (India)||0
10392871|NCT00673660|11535968|FG000|STARTED|Overall Study||375
10392872|NCT00673660|11535968|FG000|COMPLETED|Overall Study||268
10392873|NCT00673660|11535968|FG000|NOT COMPLETED|Overall Study||107
10392874|NCT00673673|11535977|FG000|STARTED|Overall Study||39
10392875|NCT00673673|11535977|FG000|COMPLETED|Overall Study||3
10392876|NCT00673673|11535977|FG000|NOT COMPLETED|Overall Study||36
10392877|NCT00673712|11535983|FG000|STARTED|Overall Study||321
10392878|NCT00673712|11535984|FG001|STARTED|Overall Study||326
10543058|NCT01482091|11696250|FG000|COMPLETED|Overall Study||25
10543059|NCT01482091|11696251|FG001|COMPLETED|Overall Study||24
10543060|NCT01482091|11696250|FG000|NOT COMPLETED|Overall Study||0
10543061|NCT01482091|11696251|FG001|NOT COMPLETED|Overall Study||0
10543062|NCT01482169|11696257|FG000|STARTED|Overall Study||48
10543063|NCT01482169|11696257|FG000|COMPLETED|Overall Study||46
10543064|NCT01482169|11696257|FG000|NOT COMPLETED|Overall Study||2
10543065|NCT01482221|11696267|FG000|STARTED|Overall Study||101
10543066|NCT01482221|11696268|FG001|STARTED|Overall Study||101
10543067|NCT01482221|11696269|FG002|STARTED|Overall Study||100
10543068|NCT01482221|11696267|FG000|COMPLETED|Overall Study||80
10543069|NCT01482221|11696268|FG001|COMPLETED|Overall Study||81
10543070|NCT01482221|11696269|FG002|COMPLETED|Overall Study||77
10543071|NCT01482221|11696267|FG000|NOT COMPLETED|Overall Study||21
10543072|NCT01482221|11696268|FG001|NOT COMPLETED|Overall Study||20
10543073|NCT01482221|11696269|FG002|NOT COMPLETED|Overall Study||23
10658790|NCT02235831|11820002|FG000|NOT COMPLETED|Period 1, First 5 Days of Wear||0
10658791|NCT02235831|11820003|FG001|NOT COMPLETED|Period 1, First 5 Days of Wear||0
10658792|NCT02235831|11820004|FG002|NOT COMPLETED|Period 1, First 5 Days of Wear||0
10658793|NCT02235831|11820005|FG003|NOT COMPLETED|Period 1, First 5 Days of Wear||0
10658794|NCT02235831|11820006|FG004|NOT COMPLETED|Period 1, First 5 Days of Wear||0
10658795|NCT02235831|11820007|FG005|NOT COMPLETED|Period 1, First 5 Days of Wear||0
10658796|NCT02235831|11820002|FG000|STARTED|Period 2, Second 5 Days of Wear||4
10658797|NCT02235831|11820003|FG001|STARTED|Period 2, Second 5 Days of Wear||4
10658798|NCT02235831|11820004|FG002|STARTED|Period 2, Second 5 Days of Wear||4
10658799|NCT02235831|11820005|FG003|STARTED|Period 2, Second 5 Days of Wear||4
10658800|NCT02235831|11820006|FG004|STARTED|Period 2, Second 5 Days of Wear||4
10658801|NCT02235831|11820007|FG005|STARTED|Period 2, Second 5 Days of Wear||4
10543074|NCT01482312|11696277|FG000|STARTED|Period 1, 90 Minutes of Wear||10
10543075|NCT01482312|11696278|FG001|STARTED|Period 1, 90 Minutes of Wear||9
10719223|NCT02709109|11882976|FG003|NOT COMPLETED|Treatment Period 1 (28 Days)||0
10719224|NCT02709109|11882973|FG000|STARTED|Washout Period (28 Days)||45
10719225|NCT02709109|11882974|FG001|STARTED|Washout Period (28 Days)||42
10719226|NCT02709109|11882975|FG002|STARTED|Washout Period (28 Days)||21
10308666|NCT00112437|11441537|FG001|STARTED|Years 4-5 (24-Month Extension)||0
10392879|NCT00673712|11535983|FG000|COMPLETED|Overall Study||321
10392880|NCT00673712|11535984|FG001|COMPLETED|Overall Study||326
10392881|NCT00673712|11535983|FG000|NOT COMPLETED|Overall Study||0
10392882|NCT00673712|11535984|FG001|NOT COMPLETED|Overall Study||0
10392883|NCT00673738|11535990|FG000|STARTED|Overall Study||27
10392884|NCT00673738|11535990|FG000|COMPLETED|Overall Study||27
10392885|NCT00673738|11535990|FG000|NOT COMPLETED|Overall Study||0
10392886|NCT00673764|11535994|FG000|STARTED|Overall Study||24
10392887|NCT00673764|11535995|FG001|STARTED|Overall Study||24
10392888|NCT00673764|11535994|FG000|COMPLETED|Overall Study||24
10392889|NCT00673764|11535995|FG001|COMPLETED|Overall Study||24
10392890|NCT00673764|11535994|FG000|NOT COMPLETED|Overall Study||0
10392891|NCT00673764|11535995|FG001|NOT COMPLETED|Overall Study||0
10392892|NCT00673790|11536004|FG000|STARTED|Overall Study||223
10392893|NCT00673790|11536005|FG001|STARTED|Overall Study||212
10392894|NCT00673790|11536006|FG002|STARTED|Overall Study||102
10392895|NCT00673790|11536004|FG000|COMPLETED|Overall Study||178
10392896|NCT00673790|11536005|FG001|COMPLETED|Overall Study||174
10392897|NCT00673790|11536006|FG002|COMPLETED|Overall Study||90
10392898|NCT00673790|11536004|FG000|NOT COMPLETED|Overall Study||45
10392899|NCT00673790|11536005|FG001|NOT COMPLETED|Overall Study||38
10392900|NCT00673790|11536006|FG002|NOT COMPLETED|Overall Study||12
10392901|NCT00673816|11536015|FG000|STARTED|Overall Study||2
10392902|NCT00673816|11536015|FG000|COMPLETED|Overall Study||0
10392903|NCT00673816|11536015|FG000|NOT COMPLETED|Overall Study||2
10392904|NCT00673855|11536020|FG000|STARTED|First Intervention||10
10392905|NCT00673855|11536021|FG001|STARTED|First Intervention||10
10392906|NCT00673855|11536020|FG000|COMPLETED|First Intervention||10
10392907|NCT00673855|11536021|FG001|COMPLETED|First Intervention||10
10392908|NCT00673855|11536020|FG000|NOT COMPLETED|First Intervention||0
10392909|NCT00673855|11536021|FG001|NOT COMPLETED|First Intervention||0
10392910|NCT00673855|11536020|FG000|STARTED|Second Intervention||10
10392911|NCT00673855|11536021|FG001|STARTED|Second Intervention||10
10392912|NCT00673855|11536020|FG000|COMPLETED|Second Intervention||10
10392913|NCT00673855|11536021|FG001|COMPLETED|Second Intervention||10
10392914|NCT00673855|11536020|FG000|NOT COMPLETED|Second Intervention||0
10392915|NCT00673855|11536021|FG001|NOT COMPLETED|Second Intervention||0
10392916|NCT00673881|11536027|FG000|STARTED|Overall Study||25
10392917|NCT00673881|11536027|FG000|COMPLETED|Overall Study||24
10392918|NCT00673881|11536027|FG000|NOT COMPLETED|Overall Study||1
10392919|NCT00673894|11536033|FG000|STARTED|First Intervention 4 Weeks||8
10392920|NCT00673894|11536034|FG001|STARTED|First Intervention 4 Weeks||7
10392921|NCT00673894|11536033|FG000|COMPLETED|First Intervention 4 Weeks||6
10392922|NCT00673894|11536034|FG001|COMPLETED|First Intervention 4 Weeks||7
10392923|NCT00673894|11536033|FG000|NOT COMPLETED|First Intervention 4 Weeks||2
10392924|NCT00673894|11536034|FG001|NOT COMPLETED|First Intervention 4 Weeks||0
10392925|NCT00673894|11536033|FG000|STARTED|Washout 4-6 Weeks||6
10392926|NCT00673894|11536034|FG001|STARTED|Washout 4-6 Weeks||7
10392927|NCT00673894|11536033|FG000|COMPLETED|Washout 4-6 Weeks||6
10392928|NCT00673894|11536034|FG001|COMPLETED|Washout 4-6 Weeks||7
10392929|NCT00673894|11536033|FG000|NOT COMPLETED|Washout 4-6 Weeks||0
10392930|NCT00673894|11536034|FG001|NOT COMPLETED|Washout 4-6 Weeks||0
10392931|NCT00673894|11536033|FG000|STARTED|Second Intervention 4 Weeks||6
10392932|NCT00673894|11536034|FG001|STARTED|Second Intervention 4 Weeks||7
10392933|NCT00673894|11536033|FG000|COMPLETED|Second Intervention 4 Weeks||6
10392934|NCT00673894|11536034|FG001|COMPLETED|Second Intervention 4 Weeks||7
10392935|NCT00673894|11536033|FG000|NOT COMPLETED|Second Intervention 4 Weeks||0
10392936|NCT00673894|11536034|FG001|NOT COMPLETED|Second Intervention 4 Weeks||0
10392937|NCT00673920|11536048|FG000|STARTED|Baseline up to Week 48||64
10719227|NCT02709109|11882976|FG003|STARTED|Washout Period (28 Days)||24
10719228|NCT02709109|11882973|FG000|COMPLETED|Washout Period (28 Days)||43
10719229|NCT02709109|11882974|FG001|COMPLETED|Washout Period (28 Days)||40
10719230|NCT02709109|11882975|FG002|COMPLETED|Washout Period (28 Days)||18
10719231|NCT02709109|11882976|FG003|COMPLETED|Washout Period (28 Days)||24
10719232|NCT02709109|11882973|FG000|NOT COMPLETED|Washout Period (28 Days)||2
10719233|NCT02709109|11882974|FG001|NOT COMPLETED|Washout Period (28 Days)||2
10719234|NCT02709109|11882975|FG002|NOT COMPLETED|Washout Period (28 Days)||3
10719235|NCT02709109|11882976|FG003|NOT COMPLETED|Washout Period (28 Days)||0
10719236|NCT02709109|11882973|FG000|STARTED|Treatment Period 2 (28 Days)||43
10719237|NCT02709109|11882974|FG001|STARTED|Treatment Period 2 (28 Days)||40
10719238|NCT02709109|11882975|FG002|STARTED|Treatment Period 2 (28 Days)||18
10392938|NCT00673920|11536049|FG001|STARTED|Baseline up to Week 48||117
10392939|NCT00673920|11536050|FG002|STARTED|Baseline up to Week 48||133
10392940|NCT00673920|11536051|FG003|STARTED|Baseline up to Week 48||0
10392941|NCT00673920|11536052|FG004|STARTED|Baseline up to Week 48||0
10392942|NCT00673920|11536053|FG005|STARTED|Baseline up to Week 48||0
10392943|NCT00673920|11536054|FG006|STARTED|Baseline up to Week 48||0
10392944|NCT00673920|11536055|FG007|STARTED|Baseline up to Week 48||0
10392945|NCT00673920|11536048|FG000|COMPLETED|Baseline up to Week 48||60
10392946|NCT00673920|11536049|FG001|COMPLETED|Baseline up to Week 48||114
10392947|NCT00673920|11536050|FG002|COMPLETED|Baseline up to Week 48||126
10392948|NCT00673920|11536051|FG003|COMPLETED|Baseline up to Week 48||0
10392949|NCT00673920|11536052|FG004|COMPLETED|Baseline up to Week 48||0
10392950|NCT00673920|11536053|FG005|COMPLETED|Baseline up to Week 48||0
10392951|NCT00673920|11536054|FG006|COMPLETED|Baseline up to Week 48||0
10392952|NCT00673920|11536055|FG007|COMPLETED|Baseline up to Week 48||0
10392953|NCT00673920|11536048|FG000|NOT COMPLETED|Baseline up to Week 48||4
10392954|NCT00673920|11536049|FG001|NOT COMPLETED|Baseline up to Week 48||3
10392955|NCT00673920|11536050|FG002|NOT COMPLETED|Baseline up to Week 48||7
10392956|NCT00673920|11536051|FG003|NOT COMPLETED|Baseline up to Week 48||0
10392957|NCT00673920|11536052|FG004|NOT COMPLETED|Baseline up to Week 48||0
10392958|NCT00673920|11536053|FG005|NOT COMPLETED|Baseline up to Week 48||0
10392959|NCT00673920|11536054|FG006|NOT COMPLETED|Baseline up to Week 48||0
10392960|NCT00673920|11536055|FG007|NOT COMPLETED|Baseline up to Week 48||0
10392961|NCT00673920|11536048|FG000|STARTED|Week 24 to Week 48||0
10392962|NCT00673920|11536049|FG001|STARTED|Week 24 to Week 48||0
10392963|NCT00673920|11536050|FG002|STARTED|Week 24 to Week 48||0
10392964|NCT00673920|11536051|FG003|STARTED|Week 24 to Week 48||61
10392965|NCT00673920|11536052|FG004|STARTED|Week 24 to Week 48||61
10392966|NCT00673920|11536053|FG005|STARTED|Week 24 to Week 48||109
10392967|NCT00673920|11536054|FG006|STARTED|Week 24 to Week 48||29
10392968|NCT00673920|11536055|FG007|STARTED|Week 24 to Week 48||28
10392969|NCT00673920|11536048|FG000|COMPLETED|Week 24 to Week 48||0
10392970|NCT00673920|11536049|FG001|COMPLETED|Week 24 to Week 48||0
10392971|NCT00673920|11536050|FG002|COMPLETED|Week 24 to Week 48||0
10392972|NCT00673920|11536051|FG003|COMPLETED|Week 24 to Week 48||60
10392973|NCT00673920|11536052|FG004|COMPLETED|Week 24 to Week 48||61
10392974|NCT00673920|11536053|FG005|COMPLETED|Week 24 to Week 48||106
10392975|NCT00673920|11536054|FG006|COMPLETED|Week 24 to Week 48||28
10392976|NCT00673920|11536055|FG007|COMPLETED|Week 24 to Week 48||28
10392977|NCT00673920|11536048|FG000|NOT COMPLETED|Week 24 to Week 48||0
10392978|NCT00673920|11536049|FG001|NOT COMPLETED|Week 24 to Week 48||0
10392979|NCT00673920|11536050|FG002|NOT COMPLETED|Week 24 to Week 48||0
10392980|NCT00673920|11536051|FG003|NOT COMPLETED|Week 24 to Week 48||1
10392981|NCT00673920|11536052|FG004|NOT COMPLETED|Week 24 to Week 48||0
10392982|NCT00673920|11536053|FG005|NOT COMPLETED|Week 24 to Week 48||3
10392983|NCT00673920|11536054|FG006|NOT COMPLETED|Week 24 to Week 48||1
10392984|NCT00673920|11536055|FG007|NOT COMPLETED|Week 24 to Week 48||0
10392985|NCT00673933|11536077|FG000|STARTED|Overall Study||20
10392986|NCT00673933|11536077|FG000|COMPLETED|Overall Study||17
10392987|NCT00673933|11536077|FG000|NOT COMPLETED|Overall Study||3
10392988|NCT00673959|11536083|FG000|STARTED|Overall Study||10
10392989|NCT00673959|11536084|FG001|STARTED|Overall Study||10
10392990|NCT00673959|11536083|FG000|COMPLETED|Overall Study||10
10392991|NCT00673959|11536084|FG001|COMPLETED|Overall Study||10
10392992|NCT00673959|11536083|FG000|NOT COMPLETED|Overall Study||0
10392993|NCT00673959|11536084|FG001|NOT COMPLETED|Overall Study||0
10392994|NCT00674115|11536090|FG000|STARTED|First Intervention||14
10392995|NCT00674115|11536091|FG001|STARTED|First Intervention||16
10392996|NCT00674115|11536092|FG002|STARTED|First Intervention||14
10392997|NCT00674115|11536093|FG003|STARTED|First Intervention||16
10392998|NCT00674115|11536090|FG000|COMPLETED|First Intervention||14
10813071|NCT03040323|11975336|FG000|NOT COMPLETED|Overall Study||0
10392999|NCT00674115|11536091|FG001|COMPLETED|First Intervention||16
10393000|NCT00674115|11536092|FG002|COMPLETED|First Intervention||14
10393001|NCT00674115|11536093|FG003|COMPLETED|First Intervention||16
10393002|NCT00674115|11536090|FG000|NOT COMPLETED|First Intervention||0
10393003|NCT00674115|11536091|FG001|NOT COMPLETED|First Intervention||0
10393004|NCT00674115|11536092|FG002|NOT COMPLETED|First Intervention||0
10393005|NCT00674115|11536093|FG003|NOT COMPLETED|First Intervention||0
10393006|NCT00674115|11536090|FG000|STARTED|Washout Period of 2 Weeks||14
10393007|NCT00674115|11536091|FG001|STARTED|Washout Period of 2 Weeks||16
10393008|NCT00674115|11536092|FG002|STARTED|Washout Period of 2 Weeks||14
10393009|NCT00674115|11536093|FG003|STARTED|Washout Period of 2 Weeks||16
10393010|NCT00674115|11536090|FG000|COMPLETED|Washout Period of 2 Weeks||14
10813072|NCT03040323|11975337|FG001|NOT COMPLETED|Overall Study||0
10393011|NCT00674115|11536091|FG001|COMPLETED|Washout Period of 2 Weeks||16
10393012|NCT00674115|11536092|FG002|COMPLETED|Washout Period of 2 Weeks||14
10393013|NCT00674115|11536093|FG003|COMPLETED|Washout Period of 2 Weeks||16
10393014|NCT00674115|11536090|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
10393015|NCT00674115|11536091|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
10393016|NCT00674115|11536092|FG002|NOT COMPLETED|Washout Period of 2 Weeks||0
10393017|NCT00674115|11536093|FG003|NOT COMPLETED|Washout Period of 2 Weeks||0
10393018|NCT00674115|11536090|FG000|STARTED|Second Intervention||14
10393019|NCT00674115|11536091|FG001|STARTED|Second Intervention||16
10393020|NCT00674115|11536092|FG002|STARTED|Second Intervention||14
10393021|NCT00674115|11536093|FG003|STARTED|Second Intervention||16
10393022|NCT00674115|11536090|FG000|COMPLETED|Second Intervention||14
10393023|NCT00674115|11536091|FG001|COMPLETED|Second Intervention||16
10393024|NCT00674115|11536092|FG002|COMPLETED|Second Intervention||14
10393025|NCT00674115|11536093|FG003|COMPLETED|Second Intervention||16
10393026|NCT00674115|11536090|FG000|NOT COMPLETED|Second Intervention||0
10393027|NCT00674115|11536091|FG001|NOT COMPLETED|Second Intervention||0
10393028|NCT00674115|11536092|FG002|NOT COMPLETED|Second Intervention||0
10393029|NCT00674115|11536093|FG003|NOT COMPLETED|Second Intervention||0
10393030|NCT00674115|11536090|FG000|STARTED|Washout Period of 2 Weeks||14
10393031|NCT00674115|11536091|FG001|STARTED|Washout Period of 2 Weeks||16
10393032|NCT00674115|11536092|FG002|STARTED|Washout Period of 2 Weeks||0
10393033|NCT00674115|11536093|FG003|STARTED|Washout Period of 2 Weeks||0
10393034|NCT00674115|11536090|FG000|COMPLETED|Washout Period of 2 Weeks||14
10393035|NCT00674115|11536091|FG001|COMPLETED|Washout Period of 2 Weeks||16
10393036|NCT00674115|11536092|FG002|COMPLETED|Washout Period of 2 Weeks||0
10393037|NCT00674115|11536093|FG003|COMPLETED|Washout Period of 2 Weeks||0
10393038|NCT00674115|11536090|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
10393039|NCT00674115|11536091|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
10393040|NCT00674115|11536092|FG002|NOT COMPLETED|Washout Period of 2 Weeks||0
10393041|NCT00674115|11536093|FG003|NOT COMPLETED|Washout Period of 2 Weeks||0
10393042|NCT00674115|11536090|FG000|STARTED|Third Intervention||14
10393043|NCT00674115|11536091|FG001|STARTED|Third Intervention||16
10393044|NCT00674115|11536092|FG002|STARTED|Third Intervention||0
10393045|NCT00674115|11536093|FG003|STARTED|Third Intervention||0
10393046|NCT00674115|11536090|FG000|COMPLETED|Third Intervention||14
10719239|NCT02709109|11882976|FG003|STARTED|Treatment Period 2 (28 Days)||24
10719240|NCT02709109|11882973|FG000|COMPLETED|Treatment Period 2 (28 Days)||41
10719241|NCT02709109|11882974|FG001|COMPLETED|Treatment Period 2 (28 Days)||36
10393047|NCT00674115|11536091|FG001|COMPLETED|Third Intervention||16
10393048|NCT00674115|11536092|FG002|COMPLETED|Third Intervention||0
10393049|NCT00674115|11536093|FG003|COMPLETED|Third Intervention||0
10393050|NCT00674115|11536090|FG000|NOT COMPLETED|Third Intervention||0
10393051|NCT00674115|11536091|FG001|NOT COMPLETED|Third Intervention||0
10393052|NCT00674115|11536092|FG002|NOT COMPLETED|Third Intervention||0
10393053|NCT00674115|11536093|FG003|NOT COMPLETED|Third Intervention||0
10393054|NCT00674128|11536104|FG000|STARTED|Overall Study||50
10393055|NCT00674128|11536105|FG001|STARTED|Overall Study||44
10393056|NCT00674128|11536104|FG000|COMPLETED|Overall Study||25
10393057|NCT00674128|11536105|FG001|COMPLETED|Overall Study||21
10393058|NCT00674128|11536104|FG000|NOT COMPLETED|Overall Study||25
10393059|NCT00674128|11536105|FG001|NOT COMPLETED|Overall Study||23
10393060|NCT00674154|11536113|FG000|STARTED|Overall Study||23
10393061|NCT00674154|11536114|FG001|STARTED|Overall Study||23
10393062|NCT00674154|11536113|FG000|COMPLETED|Overall Study||20
10393063|NCT00674154|11536114|FG001|COMPLETED|Overall Study||20
10393064|NCT00674154|11536113|FG000|NOT COMPLETED|Overall Study||3
10719242|NCT02709109|11882975|FG002|COMPLETED|Treatment Period 2 (28 Days)||15
10719243|NCT02709109|11882976|FG003|COMPLETED|Treatment Period 2 (28 Days)||24
10719244|NCT02709109|11882973|FG000|NOT COMPLETED|Treatment Period 2 (28 Days)||2
10719245|NCT02709109|11882974|FG001|NOT COMPLETED|Treatment Period 2 (28 Days)||4
10719246|NCT02709109|11882975|FG002|NOT COMPLETED|Treatment Period 2 (28 Days)||3
10719247|NCT02709109|11882976|FG003|NOT COMPLETED|Treatment Period 2 (28 Days)||0
10719248|NCT02709330|11882987|FG000|STARTED|Overall Study||50
10719249|NCT02709330|11882988|FG001|STARTED|Overall Study||10
10719250|NCT02709330|11882987|FG000|COMPLETED|Overall Study||37
10393065|NCT00674154|11536114|FG001|NOT COMPLETED|Overall Study||3
10393066|NCT00674206|11536120|FG000|STARTED|Overall Study||6
10393067|NCT00674206|11536120|FG000|COMPLETED|Overall Study||6
10393068|NCT00674206|11536120|FG000|NOT COMPLETED|Overall Study||0
10393069|NCT00674219|11536126|FG000|STARTED|Overall Study||10
10393070|NCT00674219|11536127|FG001|STARTED|Overall Study||7
10393071|NCT00674219|11536126|FG000|COMPLETED|Overall Study||10
10393072|NCT00674219|11536127|FG001|COMPLETED|Overall Study||7
10393073|NCT00674219|11536126|FG000|NOT COMPLETED|Overall Study||0
10393074|NCT00674219|11536127|FG001|NOT COMPLETED|Overall Study||0
10719251|NCT02709330|11882988|FG001|COMPLETED|Overall Study||10
10393075|NCT00674297|11536133|FG000|STARTED|Overall Study||18
10393076|NCT00674297|11536134|FG001|STARTED|Overall Study||7
10393077|NCT00674297|11536135|FG002|STARTED|Overall Study||9
10393078|NCT00674297|11536136|FG003|STARTED|Overall Study||7
10393079|NCT00674297|11536133|FG000|COMPLETED|Overall Study||8
10393080|NCT00674297|11536134|FG001|COMPLETED|Overall Study||7
10393081|NCT00674297|11536135|FG002|COMPLETED|Overall Study||5
10719252|NCT02709330|11882987|FG000|NOT COMPLETED|Overall Study||13
10719253|NCT02709330|11882988|FG001|NOT COMPLETED|Overall Study||0
10719254|NCT02709369|11882994|FG000|STARTED|Overall Study||300
10719255|NCT02709369|11882994|FG000|COMPLETED|Overall Study||273
10719256|NCT02709369|11882994|FG000|NOT COMPLETED|Overall Study||27
10719257|NCT02709486|11883001|FG000|STARTED|Overall Study||282
10719258|NCT02709486|11883002|FG001|STARTED|Overall Study||283
10719259|NCT02709486|11883003|FG002|STARTED|Overall Study||284
10719260|NCT02709486|11883001|FG000|COMPLETED|Overall Study||238
10719261|NCT02709486|11883002|FG001|COMPLETED|Overall Study||249
10308667|NCT00112437|11441538|FG002|STARTED|Years 4-5 (24-Month Extension)||0
10308668|NCT00112437|11441539|FG003|STARTED|Years 4-5 (24-Month Extension)||0
10308669|NCT00112437|11441540|FG004|STARTED|Years 4-5 (24-Month Extension)||0
10308670|NCT00112437|11441541|FG005|STARTED|Years 4-5 (24-Month Extension)||0
10308671|NCT00112437|11441542|FG006|STARTED|Years 4-5 (24-Month Extension)||0
10308672|NCT00112437|11441543|FG007|STARTED|Years 4-5 (24-Month Extension)||0
10308673|NCT00112437|11441544|FG008|STARTED|Years 4-5 (24-Month Extension)||0
10308674|NCT00112437|11441545|FG009|STARTED|Years 4-5 (24-Month Extension)||0
10308675|NCT00112437|11441546|FG010|STARTED|Years 4-5 (24-Month Extension)||0
10308676|NCT00112437|11441547|FG011|STARTED|Years 4-5 (24-Month Extension)||0
10393082|NCT00674297|11536136|FG003|COMPLETED|Overall Study||4
10393083|NCT00674297|11536133|FG000|NOT COMPLETED|Overall Study||10
10393084|NCT00674297|11536134|FG001|NOT COMPLETED|Overall Study||0
10393085|NCT00674297|11536135|FG002|NOT COMPLETED|Overall Study||4
10393086|NCT00674297|11536136|FG003|NOT COMPLETED|Overall Study||3
10393087|NCT00674323|11536146|FG000|STARTED|Overall Study||19
10393088|NCT00674323|11536147|FG001|STARTED|Overall Study||21
10393089|NCT00674323|11536148|FG002|STARTED|Overall Study||21
10393090|NCT00674323|11536146|FG000|COMPLETED|Overall Study||18
10393091|NCT00674323|11536147|FG001|COMPLETED|Overall Study||20
10393092|NCT00674323|11536148|FG002|COMPLETED|Overall Study||21
10393093|NCT00674323|11536146|FG000|NOT COMPLETED|Overall Study||1
10393094|NCT00674323|11536147|FG001|NOT COMPLETED|Overall Study||1
10393095|NCT00674323|11536148|FG002|NOT COMPLETED|Overall Study||0
10393096|NCT00674362|11536158|FG000|STARTED|Double Blind||96
10393097|NCT00674362|11536159|FG001|STARTED|Double Blind||98
10393098|NCT00674362|11536158|FG000|COMPLETED|Double Blind||84
10393099|NCT00674362|11536159|FG001|COMPLETED|Double Blind||80
10393100|NCT00674362|11536158|FG000|NOT COMPLETED|Double Blind||12
10393101|NCT00674362|11536159|FG001|NOT COMPLETED|Double Blind||18
10393102|NCT00674362|11536158|FG000|STARTED|Open Label||20
10393103|NCT00674362|11536159|FG001|STARTED|Open Label||7
10393104|NCT00674362|11536158|FG000|COMPLETED|Open Label||18
10393105|NCT00674362|11536159|FG001|COMPLETED|Open Label||7
10393106|NCT00674362|11536158|FG000|NOT COMPLETED|Open Label||2
10393107|NCT00674362|11536159|FG001|NOT COMPLETED|Open Label||0
10393108|NCT00674466|11536169|FG000|STARTED|Overall Study||30
10393109|NCT00674466|11536170|FG001|STARTED|Overall Study||30
10393110|NCT00674466|11536171|FG002|STARTED|Overall Study||30
10393111|NCT00674466|11536169|FG000|COMPLETED|Overall Study||23
10393112|NCT00674466|11536170|FG001|COMPLETED|Overall Study||22
10393113|NCT00674466|11536171|FG002|COMPLETED|Overall Study||21
10393114|NCT00674466|11536169|FG000|NOT COMPLETED|Overall Study||7
10393115|NCT00674466|11536170|FG001|NOT COMPLETED|Overall Study||8
10393116|NCT00674466|11536171|FG002|NOT COMPLETED|Overall Study||9
10393117|NCT00674479|11536179|FG000|STARTED|Overall Study||51
10393118|NCT00674479|11536179|FG000|COMPLETED|Overall Study||51
10393119|NCT00674479|11536179|FG000|NOT COMPLETED|Overall Study||0
10393120|NCT00674492|11536183|FG000|STARTED|Overall Study||21
10393121|NCT00674492|11536183|FG000|COMPLETED|Overall Study||21
10393122|NCT00674492|11536183|FG000|NOT COMPLETED|Overall Study||0
10393123|NCT00674570|11536190|FG000|STARTED|Overall Study||37
10393124|NCT00674570|11536191|FG001|STARTED|Overall Study||34
10393125|NCT00674570|11536192|FG002|STARTED|Overall Study||35
10393126|NCT00674570|11536190|FG000|COMPLETED|Overall Study||37
10393127|NCT00674570|11536191|FG001|COMPLETED|Overall Study||32
10393128|NCT00674570|11536192|FG002|COMPLETED|Overall Study||35
10393129|NCT00674570|11536190|FG000|NOT COMPLETED|Overall Study||0
10393130|NCT00674570|11536191|FG001|NOT COMPLETED|Overall Study||2
10393131|NCT00674570|11536192|FG002|NOT COMPLETED|Overall Study||0
10393132|NCT00674583|11536202|FG000|STARTED|Overall Study||311
10393133|NCT00674583|11536203|FG001|STARTED|Overall Study||103
10393134|NCT00674583|11536202|FG000|COMPLETED|Overall Study||311
10393135|NCT00674583|11536203|FG001|COMPLETED|Overall Study||103
10393136|NCT00674583|11536202|FG000|NOT COMPLETED|Overall Study||0
10393137|NCT00674583|11536203|FG001|NOT COMPLETED|Overall Study||0
10393138|NCT00674609|11536216|FG000|STARTED|Overall Study||60
10393139|NCT00674609|11536217|FG001|STARTED|Overall Study||58
10393140|NCT00674609|11536218|FG002|STARTED|Overall Study||59
10393141|NCT00674609|11536216|FG000|COMPLETED|Overall Study||48
10393142|NCT00674609|11536217|FG001|COMPLETED|Overall Study||45
10393143|NCT00674609|11536218|FG002|COMPLETED|Overall Study||51
10393144|NCT00674609|11536216|FG000|NOT COMPLETED|Overall Study||12
10393145|NCT00674609|11536217|FG001|NOT COMPLETED|Overall Study||13
10308677|NCT00112437|11441548|FG012|STARTED|Years 4-5 (24-Month Extension)||0
10308678|NCT00112437|11441549|FG013|STARTED|Years 4-5 (24-Month Extension)||0
10308679|NCT00112437|11441550|FG014|STARTED|Years 4-5 (24-Month Extension)||0
10308680|NCT00112437|11441551|FG015|STARTED|Years 4-5 (24-Month Extension)||0
10308681|NCT00112437|11441552|FG016|STARTED|Years 4-5 (24-Month Extension)||0
10308682|NCT00112437|11441553|FG017|STARTED|Years 4-5 (24-Month Extension)||0
10308683|NCT00112437|11441554|FG018|STARTED|Years 4-5 (24-Month Extension)||0
10308684|NCT00112437|11441555|FG019|STARTED|Years 4-5 (24-Month Extension)||0
10308685|NCT00112437|11441556|FG020|STARTED|Years 4-5 (24-Month Extension)||41
10308686|NCT00112437|11441557|FG021|STARTED|Years 4-5 (24-Month Extension)||100
10308687|NCT00112437|11441558|FG022|STARTED|Years 4-5 (24-Month Extension)||0
10308688|NCT00112437|11441559|FG023|STARTED|Years 4-5 (24-Month Extension)||0
10308689|NCT00112437|11441560|FG024|STARTED|Years 4-5 (24-Month Extension)||0
10308690|NCT00112437|11441561|FG025|STARTED|Years 4-5 (24-Month Extension)||0
10308691|NCT00112437|11441536|FG000|COMPLETED|Years 4-5 (24-Month Extension)||0
10308692|NCT00112437|11441537|FG001|COMPLETED|Years 4-5 (24-Month Extension)||0
10308693|NCT00112437|11441538|FG002|COMPLETED|Years 4-5 (24-Month Extension)||0
10308694|NCT00112437|11441539|FG003|COMPLETED|Years 4-5 (24-Month Extension)||0
10308695|NCT00112437|11441540|FG004|COMPLETED|Years 4-5 (24-Month Extension)||0
10308696|NCT00112437|11441541|FG005|COMPLETED|Years 4-5 (24-Month Extension)||0
10308697|NCT00112437|11441542|FG006|COMPLETED|Years 4-5 (24-Month Extension)||0
10308698|NCT00112437|11441543|FG007|COMPLETED|Years 4-5 (24-Month Extension)||0
10308699|NCT00112437|11441544|FG008|COMPLETED|Years 4-5 (24-Month Extension)||0
10308700|NCT00112437|11441545|FG009|COMPLETED|Years 4-5 (24-Month Extension)||0
10308701|NCT00112437|11441546|FG010|COMPLETED|Years 4-5 (24-Month Extension)||0
10308702|NCT00112437|11441547|FG011|COMPLETED|Years 4-5 (24-Month Extension)||0
10308703|NCT00112437|11441548|FG012|COMPLETED|Years 4-5 (24-Month Extension)||0
10308704|NCT00112437|11441549|FG013|COMPLETED|Years 4-5 (24-Month Extension)||0
10308705|NCT00112437|11441550|FG014|COMPLETED|Years 4-5 (24-Month Extension)||0
10308706|NCT00112437|11441551|FG015|COMPLETED|Years 4-5 (24-Month Extension)||0
10308707|NCT00112437|11441552|FG016|COMPLETED|Years 4-5 (24-Month Extension)||0
10308708|NCT00112437|11441553|FG017|COMPLETED|Years 4-5 (24-Month Extension)||0
10308709|NCT00112437|11441554|FG018|COMPLETED|Years 4-5 (24-Month Extension)||0
10308710|NCT00112437|11441555|FG019|COMPLETED|Years 4-5 (24-Month Extension)||0
10308711|NCT00112437|11441556|FG020|COMPLETED|Years 4-5 (24-Month Extension)||37
10308712|NCT00112437|11441557|FG021|COMPLETED|Years 4-5 (24-Month Extension)||92
10308713|NCT00112437|11441558|FG022|COMPLETED|Years 4-5 (24-Month Extension)||0
10308714|NCT00112437|11441559|FG023|COMPLETED|Years 4-5 (24-Month Extension)||0
10308715|NCT00112437|11441560|FG024|COMPLETED|Years 4-5 (24-Month Extension)||0
10308716|NCT00112437|11441561|FG025|COMPLETED|Years 4-5 (24-Month Extension)||0
10308717|NCT00112437|11441536|FG000|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
10308718|NCT00112437|11441537|FG001|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
10308719|NCT00112437|11441538|FG002|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
10308720|NCT00112437|11441539|FG003|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
10308721|NCT00112437|11441540|FG004|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
10308722|NCT00112437|11441541|FG005|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
10308723|NCT00112437|11441542|FG006|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
10308724|NCT00112437|11441543|FG007|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
10308725|NCT00112437|11441544|FG008|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
10308726|NCT00112437|11441545|FG009|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
10308727|NCT00112437|11441546|FG010|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
10308728|NCT00112437|11441547|FG011|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
10308729|NCT00112437|11441548|FG012|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
10308730|NCT00112437|11441549|FG013|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
10719262|NCT02709486|11883003|FG002|COMPLETED|Overall Study||239
10719263|NCT02709486|11883001|FG000|NOT COMPLETED|Overall Study||44
10719264|NCT02709486|11883002|FG001|NOT COMPLETED|Overall Study||34
10719265|NCT02709486|11883003|FG002|NOT COMPLETED|Overall Study||45
10393146|NCT00674609|11536218|FG002|NOT COMPLETED|Overall Study||8
10393147|NCT00674622|11536229|FG000|STARTED|Overall Study||22
10393148|NCT00674622|11536230|FG001|STARTED|Overall Study||22
10393149|NCT00674622|11536231|FG002|STARTED|Overall Study||22
10393150|NCT00674622|11536229|FG000|COMPLETED|Overall Study||21
10393151|NCT00674622|11536230|FG001|COMPLETED|Overall Study||18
10393152|NCT00674622|11536231|FG002|COMPLETED|Overall Study||22
10719266|NCT02709538|11883014|FG000|STARTED|Overall Study||400
10719267|NCT02709538|11883015|FG001|STARTED|Overall Study||100
10719268|NCT02709538|11883016|FG002|STARTED|Overall Study||101
10719269|NCT02709538|11883014|FG000|COMPLETED|Overall Study||287
10393153|NCT00674622|11536229|FG000|NOT COMPLETED|Overall Study||1
10719270|NCT02709538|11883015|FG001|COMPLETED|Overall Study||72
10308731|NCT00112437|11441550|FG014|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
10308732|NCT00112437|11441551|FG015|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
10308733|NCT00112437|11441552|FG016|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
10308734|NCT00112437|11441553|FG017|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
10308735|NCT00112437|11441554|FG018|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
10308736|NCT00112437|11441555|FG019|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
10308737|NCT00112437|11441556|FG020|NOT COMPLETED|Years 4-5 (24-Month Extension)||4
10308738|NCT00112437|11441557|FG021|NOT COMPLETED|Years 4-5 (24-Month Extension)||8
10308739|NCT00112437|11441558|FG022|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
10308740|NCT00112437|11441559|FG023|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
10308741|NCT00112437|11441560|FG024|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
10308742|NCT00112437|11441561|FG025|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
10308743|NCT00112437|11441536|FG000|STARTED|Years 6-10 (60-Month Extension)||0
10308744|NCT00112437|11441537|FG001|STARTED|Years 6-10 (60-Month Extension)||0
10308745|NCT00112437|11441538|FG002|STARTED|Years 6-10 (60-Month Extension)||0
10308746|NCT00112437|11441539|FG003|STARTED|Years 6-10 (60-Month Extension)||0
10308747|NCT00112437|11441540|FG004|STARTED|Years 6-10 (60-Month Extension)||0
10308748|NCT00112437|11441541|FG005|STARTED|Years 6-10 (60-Month Extension)||0
10308749|NCT00112437|11441542|FG006|STARTED|Years 6-10 (60-Month Extension)||0
10308750|NCT00112437|11441543|FG007|STARTED|Years 6-10 (60-Month Extension)||0
10308751|NCT00112437|11441544|FG008|STARTED|Years 6-10 (60-Month Extension)||0
10308752|NCT00112437|11441545|FG009|STARTED|Years 6-10 (60-Month Extension)||0
10308753|NCT00112437|11441546|FG010|STARTED|Years 6-10 (60-Month Extension)||0
10308754|NCT00112437|11441547|FG011|STARTED|Years 6-10 (60-Month Extension)||0
10308755|NCT00112437|11441548|FG012|STARTED|Years 6-10 (60-Month Extension)||0
10308756|NCT00112437|11441549|FG013|STARTED|Years 6-10 (60-Month Extension)||0
10308757|NCT00112437|11441550|FG014|STARTED|Years 6-10 (60-Month Extension)||0
10308758|NCT00112437|11441551|FG015|STARTED|Years 6-10 (60-Month Extension)||0
10308759|NCT00112437|11441552|FG016|STARTED|Years 6-10 (60-Month Extension)||0
10308760|NCT00112437|11441553|FG017|STARTED|Years 6-10 (60-Month Extension)||0
10308761|NCT00112437|11441554|FG018|STARTED|Years 6-10 (60-Month Extension)||0
10308762|NCT00112437|11441555|FG019|STARTED|Years 6-10 (60-Month Extension)||0
10308763|NCT00112437|11441556|FG020|STARTED|Years 6-10 (60-Month Extension)||0
10308764|NCT00112437|11441557|FG021|STARTED|Years 6-10 (60-Month Extension)||0
10308765|NCT00112437|11441558|FG022|STARTED|Years 6-10 (60-Month Extension)||28
10308766|NCT00112437|11441559|FG023|STARTED|Years 6-10 (60-Month Extension)||34
10308767|NCT00112437|11441560|FG024|STARTED|Years 6-10 (60-Month Extension)||23
10308768|NCT00112437|11441561|FG025|STARTED|Years 6-10 (60-Month Extension)||32
10308769|NCT00112437|11441536|FG000|COMPLETED|Years 6-10 (60-Month Extension)||0
10308770|NCT00112437|11441537|FG001|COMPLETED|Years 6-10 (60-Month Extension)||0
10719271|NCT02709538|11883016|FG002|COMPLETED|Overall Study||81
10719272|NCT02709538|11883014|FG000|NOT COMPLETED|Overall Study||113
10719273|NCT02709538|11883015|FG001|NOT COMPLETED|Overall Study||28
10719274|NCT02709538|11883016|FG002|NOT COMPLETED|Overall Study||20
10719275|NCT02709577|11883026|FG000|STARTED|Overall Study||12
10308771|NCT00112437|11441538|FG002|COMPLETED|Years 6-10 (60-Month Extension)||0
10308772|NCT00112437|11441539|FG003|COMPLETED|Years 6-10 (60-Month Extension)||0
10308773|NCT00112437|11441540|FG004|COMPLETED|Years 6-10 (60-Month Extension)||0
10308774|NCT00112437|11441541|FG005|COMPLETED|Years 6-10 (60-Month Extension)||0
10393154|NCT00674622|11536230|FG001|NOT COMPLETED|Overall Study||4
10308775|NCT00112437|11441542|FG006|COMPLETED|Years 6-10 (60-Month Extension)||0
10308776|NCT00112437|11441543|FG007|COMPLETED|Years 6-10 (60-Month Extension)||0
10308777|NCT00112437|11441544|FG008|COMPLETED|Years 6-10 (60-Month Extension)||0
10719276|NCT02709577|11883027|FG001|STARTED|Overall Study||13
10308778|NCT00112437|11441545|FG009|COMPLETED|Years 6-10 (60-Month Extension)||0
10308779|NCT00112437|11441546|FG010|COMPLETED|Years 6-10 (60-Month Extension)||0
10308780|NCT00112437|11441547|FG011|COMPLETED|Years 6-10 (60-Month Extension)||0
10308781|NCT00112437|11441548|FG012|COMPLETED|Years 6-10 (60-Month Extension)||0
10719277|NCT02709577|11883028|FG002|STARTED|Overall Study||6
10393155|NCT00674622|11536231|FG002|NOT COMPLETED|Overall Study||0
10393156|NCT00674661|11536241|FG000|STARTED|Overall Study||67
10393157|NCT00674661|11536242|FG001|STARTED|Overall Study||63
10393158|NCT00674661|11536241|FG000|COMPLETED|Overall Study||56
10393159|NCT00674661|11536242|FG001|COMPLETED|Overall Study||48
10393160|NCT00674661|11536241|FG000|NOT COMPLETED|Overall Study||11
10393161|NCT00674661|11536242|FG001|NOT COMPLETED|Overall Study||15
10393162|NCT00674700|11536251|FG000|STARTED|Year 1||170
10393163|NCT00674700|11536252|FG001|STARTED|Year 1||169
10393164|NCT00674700|11536253|FG002|STARTED|Year 1||170
10393165|NCT00674700|11536251|FG000|COMPLETED|Year 1||139
10393166|NCT00674700|11536252|FG001|COMPLETED|Year 1||135
10393167|NCT00674700|11536253|FG002|COMPLETED|Year 1||153
10393168|NCT00674700|11536251|FG000|NOT COMPLETED|Year 1||31
10393169|NCT00674700|11536252|FG001|NOT COMPLETED|Year 1||34
10393170|NCT00674700|11536253|FG002|NOT COMPLETED|Year 1||17
10393171|NCT00674700|11536251|FG000|STARTED|Year 2 Follow-up Without Treatment||139
10393172|NCT00674700|11536252|FG001|STARTED|Year 2 Follow-up Without Treatment||135
10393173|NCT00674700|11536253|FG002|STARTED|Year 2 Follow-up Without Treatment||153
10393174|NCT00674700|11536251|FG000|COMPLETED|Year 2 Follow-up Without Treatment||133
10393175|NCT00674700|11536252|FG001|COMPLETED|Year 2 Follow-up Without Treatment||123
10393176|NCT00674700|11536253|FG002|COMPLETED|Year 2 Follow-up Without Treatment||141
10393177|NCT00674700|11536251|FG000|NOT COMPLETED|Year 2 Follow-up Without Treatment||6
10393178|NCT00674700|11536252|FG001|NOT COMPLETED|Year 2 Follow-up Without Treatment||12
10393179|NCT00674700|11536253|FG002|NOT COMPLETED|Year 2 Follow-up Without Treatment||12
10543076|NCT01482312|11696279|FG002|STARTED|Period 1, 90 Minutes of Wear||10
10543077|NCT01482312|11696277|FG000|COMPLETED|Period 1, 90 Minutes of Wear||9
10543078|NCT01482312|11696278|FG001|COMPLETED|Period 1, 90 Minutes of Wear||9
10543079|NCT01482312|11696279|FG002|COMPLETED|Period 1, 90 Minutes of Wear||10
10543080|NCT01482312|11696277|FG000|NOT COMPLETED|Period 1, 90 Minutes of Wear||1
10543081|NCT01482312|11696278|FG001|NOT COMPLETED|Period 1, 90 Minutes of Wear||0
10543082|NCT01482312|11696279|FG002|NOT COMPLETED|Period 1, 90 Minutes of Wear||0
10543083|NCT01482312|11696277|FG000|STARTED|Period 2, 90 Minutes of Wear||9
10543084|NCT01482312|11696278|FG001|STARTED|Period 2, 90 Minutes of Wear||9
10543085|NCT01482312|11696279|FG002|STARTED|Period 2, 90 Minutes of Wear|One participant discontinued between Period 1 and Period 2|9
10543086|NCT01482312|11696277|FG000|COMPLETED|Period 2, 90 Minutes of Wear||8
10543087|NCT01482312|11696278|FG001|COMPLETED|Period 2, 90 Minutes of Wear||9
10543088|NCT01482312|11696279|FG002|COMPLETED|Period 2, 90 Minutes of Wear||9
10543089|NCT01482312|11696277|FG000|NOT COMPLETED|Period 2, 90 Minutes of Wear||1
10543090|NCT01482312|11696278|FG001|NOT COMPLETED|Period 2, 90 Minutes of Wear||0
10543091|NCT01482312|11696279|FG002|NOT COMPLETED|Period 2, 90 Minutes of Wear||0
10543092|NCT01482312|11696277|FG000|STARTED|Period 3, 90 Minutes of Wear||8
10543093|NCT01482312|11696278|FG001|STARTED|Period 3, 90 Minutes of Wear||9
10543094|NCT01482312|11696279|FG002|STARTED|Period 3, 90 Minutes of Wear||9
10543095|NCT01482312|11696277|FG000|COMPLETED|Period 3, 90 Minutes of Wear||8
10543096|NCT01482312|11696278|FG001|COMPLETED|Period 3, 90 Minutes of Wear||9
10543097|NCT01482312|11696279|FG002|COMPLETED|Period 3, 90 Minutes of Wear||9
10393180|NCT00674739|11536264|FG000|STARTED|Overall Study||178
10393181|NCT00674739|11536265|FG001|STARTED|Overall Study||195
10393182|NCT00674739|11536266|FG002|STARTED|Overall Study||97
10393183|NCT00674739|11536264|FG000|COMPLETED|Overall Study||121
10393184|NCT00674739|11536265|FG001|COMPLETED|Overall Study||136
10393185|NCT00674739|11536266|FG002|COMPLETED|Overall Study||65
10393186|NCT00674739|11536264|FG000|NOT COMPLETED|Overall Study||57
10393187|NCT00674739|11536265|FG001|NOT COMPLETED|Overall Study||59
10393188|NCT00674739|11536266|FG002|NOT COMPLETED|Overall Study||32
10393189|NCT00674765|11536276|FG000|STARTED|Overall Study||81
10393190|NCT00674765|11536277|FG001|STARTED|Overall Study||75
10393191|NCT00674765|11536276|FG000|COMPLETED|Overall Study||45
10393192|NCT00674765|11536277|FG001|COMPLETED|Overall Study||46
10393193|NCT00674765|11536276|FG000|NOT COMPLETED|Overall Study||36
10393194|NCT00674765|11536277|FG001|NOT COMPLETED|Overall Study||29
10393195|NCT00674817|11536283|FG000|STARTED|Period 1||44
10393196|NCT00674817|11536283|FG000|COMPLETED|Period 1||41
10393197|NCT00674817|11536283|FG000|NOT COMPLETED|Period 1||3
10719278|NCT02709577|11883029|FG003|STARTED|Overall Study||5
10719279|NCT02709577|11883026|FG000|COMPLETED|Overall Study||10
10719280|NCT02709577|11883027|FG001|COMPLETED|Overall Study||8
10393198|NCT00674817|11536283|FG000|STARTED|Period 2||41
10393199|NCT00674817|11536283|FG000|COMPLETED|Period 2||41
10393200|NCT00674817|11536283|FG000|NOT COMPLETED|Period 2||0
10393201|NCT00674817|11536283|FG000|STARTED|Period 3||41
10393202|NCT00674817|11536283|FG000|COMPLETED|Period 3||39
10393203|NCT00674817|11536283|FG000|NOT COMPLETED|Period 3||2
10393204|NCT00674817|11536283|FG000|STARTED|Period 4||39
10393205|NCT00674817|11536283|FG000|COMPLETED|Period 4||38
10393206|NCT00674817|11536283|FG000|NOT COMPLETED|Period 4||1
10393207|NCT00674817|11536283|FG000|STARTED|Period 5||38
10393208|NCT00674817|11536283|FG000|COMPLETED|Period 5||38
10393209|NCT00674817|11536283|FG000|NOT COMPLETED|Period 5||0
10393210|NCT00674817|11536283|FG000|STARTED|Period 6||38
10393211|NCT00674817|11536283|FG000|COMPLETED|Period 6||38
10393212|NCT00674817|11536283|FG000|NOT COMPLETED|Period 6||0
10393213|NCT00674973|11536299|FG000|STARTED|Overall Study||103
10393214|NCT00674973|11536300|FG001|STARTED|Overall Study||104
10393215|NCT00674973|11536299|FG000|Switch to Open-Label Erlotinib|Overall Study|Participants with PD were given opportunity to switch.|57
10393216|NCT00674973|11536300|FG001|Switch to Open-Label Erlotinib|Overall Study||0
10393217|NCT00674973|11536299|FG000|COMPLETED|Overall Study|Completed double-blind treatment.|3
10393218|NCT00674973|11536300|FG001|COMPLETED|Overall Study|Completed double-blind treatment.|2
10393219|NCT00674973|11536299|FG000|NOT COMPLETED|Overall Study||100
10393220|NCT00674973|11536300|FG001|NOT COMPLETED|Overall Study||102
10393221|NCT00674986|11536308|FG000|STARTED|Overall Study||230
10393222|NCT00674986|11536309|FG001|STARTED|Overall Study||269
10393223|NCT00674986|11536308|FG000|Intent to Treat Population|Overall Study||227
10393224|NCT00674986|11536309|FG001|Intent to Treat Population|Overall Study||256
10393225|NCT00674986|11536308|FG000|COMPLETED|Overall Study||187
10393226|NCT00674986|11536309|FG001|COMPLETED|Overall Study||188
10393227|NCT00674986|11536308|FG000|NOT COMPLETED|Overall Study||43
10393228|NCT00674986|11536309|FG001|NOT COMPLETED|Overall Study||81
10393229|NCT00675025|11536318|FG000|STARTED|Overall Study||54
10393230|NCT00675025|11536319|FG001|STARTED|Overall Study||63
10393231|NCT00675025|11536318|FG000|COMPLETED|Overall Study||0
10393232|NCT00675025|11536319|FG001|COMPLETED|Overall Study||0
10393233|NCT00675025|11536318|FG000|NOT COMPLETED|Overall Study||54
10393234|NCT00675025|11536319|FG001|NOT COMPLETED|Overall Study||63
10393235|NCT00675103|11536325|FG000|STARTED|Overall Study||7
10393236|NCT00675103|11536325|FG000|COMPLETED|Overall Study||4
10393237|NCT00675103|11536325|FG000|NOT COMPLETED|Overall Study||3
10393238|NCT00675259|11536329|FG000|STARTED|Overall Study||33
10393239|NCT00675259|11536329|FG000|COMPLETED|Overall Study||19
10719281|NCT02709577|11883028|FG002|COMPLETED|Overall Study||4
10719282|NCT02709577|11883029|FG003|COMPLETED|Overall Study||5
10719283|NCT02709577|11883026|FG000|NOT COMPLETED|Overall Study||2
10719284|NCT02709577|11883027|FG001|NOT COMPLETED|Overall Study||5
10719285|NCT02709577|11883028|FG002|NOT COMPLETED|Overall Study||2
10719286|NCT02709577|11883029|FG003|NOT COMPLETED|Overall Study||0
10719287|NCT02709694|11883040|FG000|STARTED|Overall Study||33
10813073|NCT03053518|11975343|FG000|STARTED|Overall Study||22
10813074|NCT03053518|11975343|FG000|COMPLETED|Overall Study||12
10393240|NCT00675259|11536329|FG000|NOT COMPLETED|Overall Study||14
10543098|NCT01482312|11696277|FG000|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
10719288|NCT02709694|11883040|FG000|Any Back Pain|Overall Study||19
10813075|NCT03053518|11975343|FG000|NOT COMPLETED|Overall Study||10
10813076|NCT03050398|11975347|FG000|STARTED|Overall Study||8
10393241|NCT00675415|11536339|FG000|STARTED|Overall Study||132
10393242|NCT00675415|11536340|FG001|STARTED|Overall Study||131
10393243|NCT00675415|11536339|FG000|COMPLETED|Overall Study||124
10393244|NCT00675415|11536340|FG001|COMPLETED|Overall Study||123
10393245|NCT00675415|11536339|FG000|NOT COMPLETED|Overall Study||8
10393246|NCT00675415|11536340|FG001|NOT COMPLETED|Overall Study||8
10393247|NCT00675428|11536348|FG000|STARTED|Overall Study||3
10393248|NCT00675428|11536349|FG001|STARTED|Overall Study||3
10393249|NCT00675428|11536348|FG000|COMPLETED|Overall Study||0
10393250|NCT00675428|11536349|FG001|COMPLETED|Overall Study||0
10393251|NCT00675428|11536348|FG000|NOT COMPLETED|Overall Study||3
10393252|NCT00675428|11536349|FG001|NOT COMPLETED|Overall Study||3
10393253|NCT00675441|11536355|FG000|STARTED|Overall Study||5
10393254|NCT00675441|11536355|FG000|COMPLETED|Overall Study||2
10393255|NCT00675441|11536355|FG000|NOT COMPLETED|Overall Study||3
10393256|NCT00675506|11536361|FG000|STARTED|Overall Study||31
10393257|NCT00675506|11536362|FG001|STARTED|Overall Study||29
10393258|NCT00675506|11536361|FG000|Received Intervention|Overall Study|Two subjects did not start treatment: 1) disclosed cancer history, 2) declined participation.|29
10393259|NCT00675506|11536362|FG001|Received Intervention|Overall Study||29
10393260|NCT00675506|11536361|FG000|COMPLETED|Overall Study||19
10393261|NCT00675506|11536362|FG001|COMPLETED|Overall Study||17
10393262|NCT00675506|11536361|FG000|NOT COMPLETED|Overall Study||12
10393263|NCT00675506|11536362|FG001|NOT COMPLETED|Overall Study||12
10393264|NCT00675558|11536372|FG000|STARTED|Surgery||10
10393265|NCT00675558|11536373|FG001|STARTED|Surgery||10
10393266|NCT00675558|11536374|FG002|STARTED|Surgery||30
10393267|NCT00675558|11536372|FG000|COMPLETED|Surgery||10
10393268|NCT00675558|11536373|FG001|COMPLETED|Surgery||10
10393269|NCT00675558|11536374|FG002|COMPLETED|Surgery||30
10393270|NCT00675558|11536372|FG000|NOT COMPLETED|Surgery||0
10393271|NCT00675558|11536373|FG001|NOT COMPLETED|Surgery||0
10393272|NCT00675558|11536374|FG002|NOT COMPLETED|Surgery||0
10393273|NCT00675558|11536372|FG000|STARTED|Second Operation|No medical reason, and no study-related reason for non-obese pts to have a second procedure.|0
10393274|NCT00675558|11536373|FG001|STARTED|Second Operation|No medical reason, and none for the goals of the study, for MO pts to have a second procedure .|0
10393275|NCT00675558|11536374|FG002|STARTED|Second Operation|As predicted, only 10 SMO patients medically required a second operation, and thus met study goals.|10
10393276|NCT00675558|11536372|FG000|COMPLETED|Second Operation||0
10393277|NCT00675558|11536373|FG001|COMPLETED|Second Operation||0
10393278|NCT00675558|11536374|FG002|COMPLETED|Second Operation||10
10393279|NCT00675558|11536372|FG000|NOT COMPLETED|Second Operation||0
10393280|NCT00675558|11536373|FG001|NOT COMPLETED|Second Operation||0
10393281|NCT00675558|11536374|FG002|NOT COMPLETED|Second Operation||0
10393282|NCT00675584|11536384|FG000|STARTED|Overall Study||139
10393283|NCT00675584|11536385|FG001|STARTED|Overall Study||139
10393284|NCT00675584|11536384|FG000|COMPLETED|Overall Study||100
10393285|NCT00675584|11536385|FG001|COMPLETED|Overall Study||113
10393286|NCT00675584|11536384|FG000|NOT COMPLETED|Overall Study||39
10393287|NCT00675584|11536385|FG001|NOT COMPLETED|Overall Study||26
10393288|NCT00675597|11536391|FG000|STARTED|Overall Study||26
10393289|NCT00675597|11536391|FG000|COMPLETED|Overall Study||23
10393290|NCT00675597|11536391|FG000|NOT COMPLETED|Overall Study||3
10393291|NCT00675766|11536399|FG000|STARTED|Overall Study||106
10393292|NCT00675766|11536400|FG001|STARTED|Overall Study||30
10393293|NCT00675766|11536401|FG002|STARTED|Overall Study||50
10393294|NCT00675766|11536402|FG003|STARTED|Overall Study||37
10393295|NCT00675766|11536399|FG000|Year 2|Overall Study||105
10393296|NCT00675766|11536400|FG001|Year 2|Overall Study||28
10393297|NCT00675766|11536401|FG002|Year 2|Overall Study||34
10393298|NCT00675766|11536402|FG003|Year 2|Overall Study||20
10393299|NCT00675766|11536399|FG000|Year 3|Overall Study||100
10393300|NCT00675766|11536400|FG001|Year 3|Overall Study||25
10393301|NCT00675766|11536401|FG002|Year 3|Overall Study||29
10393302|NCT00675766|11536402|FG003|Year 3|Overall Study||11
10393303|NCT00675766|11536399|FG000|COMPLETED|Overall Study||100
10393304|NCT00675766|11536400|FG001|COMPLETED|Overall Study||25
10393305|NCT00675766|11536401|FG002|COMPLETED|Overall Study||29
10393306|NCT00675766|11536402|FG003|COMPLETED|Overall Study||11
10393307|NCT00675766|11536399|FG000|NOT COMPLETED|Overall Study||6
10393308|NCT00675766|11536400|FG001|NOT COMPLETED|Overall Study||5
10393309|NCT00675766|11536401|FG002|NOT COMPLETED|Overall Study||21
10393310|NCT00675766|11536402|FG003|NOT COMPLETED|Overall Study||26
10393311|NCT00675792|11536414|FG000|STARTED|Overall Study||51
10393312|NCT00675792|11536415|FG001|STARTED|Overall Study||49
10393313|NCT00675792|11536414|FG000|COMPLETED|Overall Study||51
10393314|NCT00675792|11536415|FG001|COMPLETED|Overall Study||49
10719289|NCT02709694|11883040|FG000|No Back Pain|Overall Study||14
10719290|NCT02709694|11883040|FG000|MRI Showing Presence of Sacroiliitis|Overall Study||4
10719291|NCT02709694|11883040|FG000|MRI Not Showing Sacroiliitis|Overall Study||29
10719292|NCT02709694|11883040|FG000|Classified as Having Inflammatory Back Pain by the ASAS Criteria|Overall Study||6
10719293|NCT02709694|11883040|FG000|Not Classified as Having Inflammatory Back Pain by the ASAS Criteria|Overall Study||25
10719294|NCT02709694|11883040|FG000|Having Bone Marrow Edema Seen in MRI|Overall Study||33
10719295|NCT02709694|11883040|FG000|Having Erosion (a Structural Lesion) Seen in MRI|Overall Study||33
10719296|NCT02709694|11883040|FG000|Having Fat Metaplasia Seen in MRI|Overall Study||33
10719297|NCT02709694|11883040|FG000|Having Backfill (Type of Structural Lesion) Seen in MRI|Overall Study||33
10719298|NCT02709694|11883040|FG000|Having Ankylosis Seen in MRI|Overall Study||33
10719299|NCT02709694|11883040|FG000|COMPLETED|Overall Study||33
10719300|NCT02709694|11883040|FG000|NOT COMPLETED|Overall Study||0
10719301|NCT02709746|11883059|FG000|STARTED|Phase A (Single-blind Treatment Period)||784
10719302|NCT02709746|11883060|FG001|STARTED|Phase A (Single-blind Treatment Period)||0
10813077|NCT03050398|11975347|FG000|COMPLETED|Overall Study||0
10813078|NCT03050398|11975347|FG000|NOT COMPLETED|Overall Study||8
10813079|NCT03042780|11975351|FG000|STARTED|Overall Study||2
10813080|NCT03042780|11975351|FG000|COMPLETED|Overall Study||2
10813081|NCT03042780|11975351|FG000|NOT COMPLETED|Overall Study||0
10813082|NCT03053960|11975355|FG000|STARTED|Overall Study||8
10813083|NCT03053960|11975355|FG000|COMPLETED|Overall Study||8
10813084|NCT03053960|11975355|FG000|NOT COMPLETED|Overall Study||0
10813085|NCT03036735|11975359|FG000|STARTED|Overall Study||10
10813086|NCT03036735|11975359|FG000|COMPLETED|Overall Study||0
10813087|NCT03036735|11975359|FG000|NOT COMPLETED|Overall Study||10
10813088|NCT03029832|11975365|FG000|STARTED|Overall Study||4
10813089|NCT03029832|11975366|FG001|STARTED|Overall Study||1
10813090|NCT03029832|11975365|FG000|COMPLETED|Overall Study||0
10813091|NCT03029832|11975366|FG001|COMPLETED|Overall Study||0
10813092|NCT03029832|11975365|FG000|NOT COMPLETED|Overall Study||4
10813093|NCT03029832|11975366|FG001|NOT COMPLETED|Overall Study||1
10813094|NCT03020446|11975372|FG000|STARTED|Overall Study||3
10813095|NCT03020446|11975372|FG000|COMPLETED|Overall Study||0
10813096|NCT03020446|11975372|FG000|NOT COMPLETED|Overall Study||3
10813097|NCT03031340|11975378|FG000|STARTED|Overall Study||2
10813098|NCT03031340|11975379|FG001|STARTED|Overall Study||1
10813099|NCT03031340|11975378|FG000|COMPLETED|Overall Study||0
10813100|NCT03031340|11975379|FG001|COMPLETED|Overall Study||0
10813101|NCT03031340|11975378|FG000|NOT COMPLETED|Overall Study||2
10813102|NCT03031340|11975379|FG001|NOT COMPLETED|Overall Study||1
10813103|NCT03017040|11975385|FG000|STARTED|Overall Study|Participants enroll one wrist into each group,thus, one participant flows into both groups.|1
10813104|NCT03017040|11975386|FG001|STARTED|Overall Study|Participants enroll one wrist into each group,thus, one participant flows into both groups.|1
10813105|NCT03017040|11975385|FG000|COMPLETED|Overall Study||0
10813106|NCT03017040|11975386|FG001|COMPLETED|Overall Study||0
10813107|NCT03017040|11975385|FG000|NOT COMPLETED|Overall Study||1
10813108|NCT03017040|11975386|FG001|NOT COMPLETED|Overall Study||1
10813109|NCT03007719|11975394|FG000|STARTED|Overall Study||0
10813110|NCT03007719|11975395|FG001|STARTED|Overall Study||4
10813111|NCT03007719|11975394|FG000|COMPLETED|Overall Study||0
10393315|NCT00675792|11536414|FG000|NOT COMPLETED|Overall Study||0
10393316|NCT00675792|11536415|FG001|NOT COMPLETED|Overall Study||0
10393317|NCT00675909|11536424|FG000|STARTED|Overall Study||60
10393318|NCT00675909|11536425|FG001|STARTED|Overall Study||60
10393319|NCT00675909|11536426|FG002|STARTED|Overall Study||60
10393320|NCT00675909|11536424|FG000|COMPLETED|Overall Study||60
10393321|NCT00675909|11536425|FG001|COMPLETED|Overall Study||60
10393322|NCT00675909|11536426|FG002|COMPLETED|Overall Study||60
10393323|NCT00675909|11536424|FG000|NOT COMPLETED|Overall Study||0
10393324|NCT00675909|11536425|FG001|NOT COMPLETED|Overall Study||0
10393325|NCT00675909|11536426|FG002|NOT COMPLETED|Overall Study||0
10393326|NCT00675922|11536434|FG000|STARTED|Overall Study||98
10393327|NCT00675922|11536434|FG000|COMPLETED|Overall Study||98
10393328|NCT00675922|11536434|FG000|NOT COMPLETED|Overall Study||0
10428597|NCT00858845|11574609|FG000|COMPLETED|Overall Study||5
10813112|NCT03007719|11975395|FG001|COMPLETED|Overall Study||4
10428598|NCT00858845|11574610|FG001|COMPLETED|Overall Study||5
10428599|NCT00858845|11574609|FG000|NOT COMPLETED|Overall Study||0
10428600|NCT00858845|11574610|FG001|NOT COMPLETED|Overall Study||1
10428601|NCT00858858|11574616|FG000|STARTED|Overall Study||60
10428602|NCT00858858|11574616|FG000|COMPLETED|Overall Study||42
10428603|NCT00858858|11574616|FG000|NOT COMPLETED|Overall Study||18
10428604|NCT00858962|11574620|FG000|STARTED|Overall Study||12
10428605|NCT00858962|11574620|FG000|COMPLETED|Overall Study||12
10428606|NCT00858962|11574620|FG000|NOT COMPLETED|Overall Study||0
10428607|NCT00858988|11574626|FG000|STARTED|Randomized and Allocation||74
10428608|NCT00858988|11574627|FG001|STARTED|Randomized and Allocation||73
10428609|NCT00858988|11574626|FG000|COMPLETED|Randomized and Allocation||74
10428610|NCT00858988|11574627|FG001|COMPLETED|Randomized and Allocation||73
10428611|NCT00858988|11574626|FG000|NOT COMPLETED|Randomized and Allocation||0
10428612|NCT00858988|11574627|FG001|NOT COMPLETED|Randomized and Allocation||0
10428613|NCT00858988|11574626|FG000|STARTED|Analysis||74
10428614|NCT00858988|11574627|FG001|STARTED|Analysis||73
10428615|NCT00858988|11574626|FG000|COMPLETED|Analysis||72
10428616|NCT00858988|11574627|FG001|COMPLETED|Analysis||72
10428617|NCT00858988|11574626|FG000|NOT COMPLETED|Analysis||2
10428618|NCT00858988|11574627|FG001|NOT COMPLETED|Analysis||1
10428619|NCT00859014|11574633|FG000|STARTED|Overall Study||25
10813113|NCT03007719|11975394|FG000|NOT COMPLETED|Overall Study||0
10308782|NCT00112437|11441549|FG013|COMPLETED|Years 6-10 (60-Month Extension)||0
10308783|NCT00112437|11441550|FG014|COMPLETED|Years 6-10 (60-Month Extension)||0
10308784|NCT00112437|11441551|FG015|COMPLETED|Years 6-10 (60-Month Extension)||0
10308785|NCT00112437|11441552|FG016|COMPLETED|Years 6-10 (60-Month Extension)||0
10308786|NCT00112437|11441553|FG017|COMPLETED|Years 6-10 (60-Month Extension)||0
10308787|NCT00112437|11441554|FG018|COMPLETED|Years 6-10 (60-Month Extension)||0
10308788|NCT00112437|11441555|FG019|COMPLETED|Years 6-10 (60-Month Extension)||0
10308789|NCT00112437|11441556|FG020|COMPLETED|Years 6-10 (60-Month Extension)||0
10308790|NCT00112437|11441557|FG021|COMPLETED|Years 6-10 (60-Month Extension)||0
10308791|NCT00112437|11441558|FG022|COMPLETED|Years 6-10 (60-Month Extension)||23
10393329|NCT00675948|11536441|FG000|STARTED|Overall Study||39
10393330|NCT00675948|11536442|FG001|STARTED|Overall Study||4
10393331|NCT00675948|11536441|FG000|COMPLETED|Overall Study||0
10393332|NCT00675948|11536442|FG001|COMPLETED|Overall Study||1
10393333|NCT00675948|11536441|FG000|NOT COMPLETED|Overall Study||39
10393334|NCT00675948|11536442|FG001|NOT COMPLETED|Overall Study||3
10393335|NCT00675987|11536451|FG000|STARTED|Overall Study||26
10393336|NCT00675987|11536452|FG001|STARTED|Overall Study||27
10393337|NCT00675987|11536451|FG000|COMPLETED|Overall Study||26
10393338|NCT00675987|11536452|FG001|COMPLETED|Overall Study||27
10393339|NCT00675987|11536451|FG000|NOT COMPLETED|Overall Study||0
10719303|NCT02709746|11883061|FG002|STARTED|Phase A (Single-blind Treatment Period)||0
10719304|NCT02709746|11883062|FG003|STARTED|Phase A (Single-blind Treatment Period)||0
10719305|NCT02709746|11883063|FG004|STARTED|Phase A (Single-blind Treatment Period)||0
10719306|NCT02709746|11883059|FG000|COMPLETED|Phase A (Single-blind Treatment Period)||616
10719307|NCT02709746|11883060|FG001|COMPLETED|Phase A (Single-blind Treatment Period)||0
10719308|NCT02709746|11883061|FG002|COMPLETED|Phase A (Single-blind Treatment Period)||0
10719309|NCT02709746|11883062|FG003|COMPLETED|Phase A (Single-blind Treatment Period)||0
10719310|NCT02709746|11883063|FG004|COMPLETED|Phase A (Single-blind Treatment Period)||0
10719311|NCT02709746|11883059|FG000|NOT COMPLETED|Phase A (Single-blind Treatment Period)||168
10719312|NCT02709746|11883060|FG001|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0
10719313|NCT02709746|11883061|FG002|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0
10719314|NCT02709746|11883062|FG003|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0
10719315|NCT02709746|11883063|FG004|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0
10719316|NCT02709746|11883059|FG000|STARTED|Phase B (Double-blind Treatment Period)||0
10719317|NCT02709746|11883060|FG001|STARTED|Phase B (Double-blind Treatment Period)||147
10719318|NCT02709746|11883061|FG002|STARTED|Phase B (Double-blind Treatment Period)||162
10719319|NCT02709746|11883062|FG003|STARTED|Phase B (Double-blind Treatment Period)||153
10719320|NCT02709746|11883063|FG004|STARTED|Phase B (Double-blind Treatment Period)||154
10719321|NCT02709746|11883059|FG000|COMPLETED|Phase B (Double-blind Treatment Period)||0
10719322|NCT02709746|11883060|FG001|COMPLETED|Phase B (Double-blind Treatment Period)||126
10719323|NCT02709746|11883061|FG002|COMPLETED|Phase B (Double-blind Treatment Period)||140
10719324|NCT02709746|11883062|FG003|COMPLETED|Phase B (Double-blind Treatment Period)||138
10719325|NCT02709746|11883063|FG004|COMPLETED|Phase B (Double-blind Treatment Period)||138
10719326|NCT02709746|11883059|FG000|NOT COMPLETED|Phase B (Double-blind Treatment Period)||0
10393340|NCT00675987|11536452|FG001|NOT COMPLETED|Overall Study||0
10393341|NCT00676013|11536460|FG000|STARTED|Overall Study||158
10308792|NCT00112437|11441559|FG023|COMPLETED|Years 6-10 (60-Month Extension)||22
10308793|NCT00112437|11441560|FG024|COMPLETED|Years 6-10 (60-Month Extension)||22
10308794|NCT00112437|11441561|FG025|COMPLETED|Years 6-10 (60-Month Extension)||27
10393342|NCT00676013|11536460|FG000|COMPLETED|Overall Study||157
10393343|NCT00676013|11536460|FG000|NOT COMPLETED|Overall Study||1
10393344|NCT00676052|11536473|FG000|STARTED|Overall Study||96
10393345|NCT00676052|11536474|FG001|STARTED|Overall Study||95
10393346|NCT00676052|11536475|FG002|STARTED|Overall Study||96
10393347|NCT00676052|11536476|FG003|STARTED|Overall Study||97
10719327|NCT02709746|11883060|FG001|NOT COMPLETED|Phase B (Double-blind Treatment Period)||21
10308795|NCT00112437|11441536|FG000|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
10393348|NCT00676052|11536477|FG004|STARTED|Overall Study||95
10393349|NCT00676052|11536478|FG005|STARTED|Overall Study||97
10393350|NCT00676052|11536473|FG000|COMPLETED|Overall Study||87
10393351|NCT00676052|11536474|FG001|COMPLETED|Overall Study||88
10393352|NCT00676052|11536475|FG002|COMPLETED|Overall Study||90
10393353|NCT00676052|11536476|FG003|COMPLETED|Overall Study||92
10393354|NCT00676052|11536477|FG004|COMPLETED|Overall Study||89
10393355|NCT00676052|11536478|FG005|COMPLETED|Overall Study||91
10393356|NCT00676052|11536473|FG000|NOT COMPLETED|Overall Study||9
10393357|NCT00676052|11536474|FG001|NOT COMPLETED|Overall Study||7
10393358|NCT00676052|11536475|FG002|NOT COMPLETED|Overall Study||6
10393359|NCT00676052|11536476|FG003|NOT COMPLETED|Overall Study||5
10393360|NCT00676052|11536477|FG004|NOT COMPLETED|Overall Study||6
10393361|NCT00676052|11536478|FG005|NOT COMPLETED|Overall Study||6
10393362|NCT00676065|11536495|FG000|STARTED|Overall Study||16534
10393363|NCT00676065|11536496|FG001|STARTED|Overall Study||15428
10393364|NCT00676065|11536497|FG002|STARTED|Overall Study||26341
10393365|NCT00676065|11536495|FG000|COMPLETED|Overall Study||16534
10393366|NCT00676065|11536496|FG001|COMPLETED|Overall Study||15428
10393367|NCT00676065|11536497|FG002|COMPLETED|Overall Study||26341
10543099|NCT01482312|11696278|FG001|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
10543100|NCT01482312|11696279|FG002|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
10543101|NCT01482351|11696289|FG000|STARTED|Overall Study||68
10543102|NCT01482351|11696289|FG000|6 Months|Overall Study|14 dropped out|54
10543103|NCT01482351|11696289|FG000|12 Months|Overall Study||54
10543104|NCT01482351|11696289|FG000|COMPLETED|Overall Study||54
10543105|NCT01482351|11696289|FG000|NOT COMPLETED|Overall Study||14
10543106|NCT01482429|11696299|FG000|STARTED|Care Usual||0
10543107|NCT01482429|11696300|FG001|STARTED|Care Usual||269
10543108|NCT01482429|11696299|FG000|COMPLETED|Care Usual||0
10543109|NCT01482429|11696300|FG001|COMPLETED|Care Usual||96
10543110|NCT01482429|11696299|FG000|NOT COMPLETED|Care Usual||0
10543111|NCT01482429|11696300|FG001|NOT COMPLETED|Care Usual||173
10543112|NCT01482429|11696299|FG000|STARTED|Protocol||414
10543113|NCT01482429|11696300|FG001|STARTED|Protocol||0
10543114|NCT01482429|11696299|FG000|COMPLETED|Protocol||139
10543115|NCT01482429|11696300|FG001|COMPLETED|Protocol||0
10543116|NCT01482429|11696299|FG000|NOT COMPLETED|Protocol||275
10719328|NCT02709746|11883061|FG002|NOT COMPLETED|Phase B (Double-blind Treatment Period)||22
10308796|NCT00112437|11441537|FG001|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
10393368|NCT00676065|11536495|FG000|NOT COMPLETED|Overall Study||0
10393369|NCT00676065|11536496|FG001|NOT COMPLETED|Overall Study||0
10393370|NCT00676065|11536497|FG002|NOT COMPLETED|Overall Study||0
10393371|NCT00676091|11536507|FG000|STARTED|Infant Series||177
10393372|NCT00676091|11536508|FG001|STARTED|Infant Series||177
10393373|NCT00676091|11536507|FG000|Vaccinated Dose 1|Infant Series||163
10393374|NCT00676091|11536508|FG001|Vaccinated Dose 1|Infant Series||162
10393375|NCT00676091|11536507|FG000|Vaccinated Dose 2|Infant Series||159
10543117|NCT01482429|11696300|FG001|NOT COMPLETED|Protocol||0
10543118|NCT01482715|11696319|FG000|STARTED|Overall Study||6
10543119|NCT01482715|11696320|FG001|STARTED|Overall Study||3
10308797|NCT00112437|11441538|FG002|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
10308798|NCT00112437|11441539|FG003|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
10308799|NCT00112437|11441540|FG004|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
10308800|NCT00112437|11441541|FG005|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
10308801|NCT00112437|11441542|FG006|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
10308802|NCT00112437|11441543|FG007|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
10308803|NCT00112437|11441544|FG008|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
10308804|NCT00112437|11441545|FG009|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
10308805|NCT00112437|11441546|FG010|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
10308806|NCT00112437|11441547|FG011|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
10308807|NCT00112437|11441548|FG012|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
10308808|NCT00112437|11441549|FG013|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
10308809|NCT00112437|11441550|FG014|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
10308810|NCT00112437|11441551|FG015|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
10308811|NCT00112437|11441552|FG016|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
10719329|NCT02709746|11883062|FG003|NOT COMPLETED|Phase B (Double-blind Treatment Period)||15
10719330|NCT02709746|11883063|FG004|NOT COMPLETED|Phase B (Double-blind Treatment Period)||16
10719331|NCT02709785|11883078|FG000|STARTED|Overall Study||24
10719332|NCT02709785|11883079|FG001|STARTED|Overall Study||28
10719333|NCT02709785|11883080|FG002|STARTED|Overall Study||28
10308812|NCT00112437|11441553|FG017|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
10308813|NCT00112437|11441554|FG018|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
10308814|NCT00112437|11441555|FG019|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
10308815|NCT00112437|11441556|FG020|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
10308816|NCT00112437|11441557|FG021|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
10308817|NCT00112437|11441558|FG022|NOT COMPLETED|Years 6-10 (60-Month Extension)||5
10308818|NCT00112437|11441559|FG023|NOT COMPLETED|Years 6-10 (60-Month Extension)||12
10308819|NCT00112437|11441560|FG024|NOT COMPLETED|Years 6-10 (60-Month Extension)||1
10308820|NCT00112437|11441561|FG025|NOT COMPLETED|Years 6-10 (60-Month Extension)||5
10308821|NCT00112463|11441615|FG000|STARTED|Overall Study||40
10308822|NCT00112463|11441615|FG000|COMPLETED|Overall Study||1
10308823|NCT00112463|11441615|FG000|NOT COMPLETED|Overall Study||39
10308824|NCT00112489|11441620|FG000|STARTED|Overall Study|All patients enrolled on study|55
10308825|NCT00112489|11441620|FG000|COMPLETED|Overall Study|Completed regimen due to progression|15
10308826|NCT00112489|11441620|FG000|NOT COMPLETED|Overall Study||40
10308827|NCT00112502|11441638|FG000|STARTED|Overall Study||22
10308828|NCT00112502|11441639|FG001|STARTED|Overall Study||22
10308829|NCT00112502|11441640|FG002|STARTED|Overall Study||22
10308830|NCT00112502|11441641|FG003|STARTED|Overall Study||22
10308831|NCT00112502|11441642|FG004|STARTED|Overall Study||23
10308832|NCT00112502|11441643|FG005|STARTED|Overall Study||22
10308833|NCT00112502|11441644|FG006|STARTED|Overall Study||23
10308834|NCT00112502|11441645|FG007|STARTED|Overall Study||22
10308835|NCT00112502|11441638|FG000|COMPLETED|Overall Study||22
10308836|NCT00112502|11441639|FG001|COMPLETED|Overall Study||21
10308837|NCT00112502|11441640|FG002|COMPLETED|Overall Study||21
10308838|NCT00112502|11441641|FG003|COMPLETED|Overall Study||18
10308839|NCT00112502|11441642|FG004|COMPLETED|Overall Study||21
10308840|NCT00112502|11441643|FG005|COMPLETED|Overall Study||17
10393376|NCT00676091|11536508|FG001|Vaccinated Dose 2|Infant Series||162
10393377|NCT00676091|11536507|FG000|Vaccinated Dose 3|Infant Series||158
10393378|NCT00676091|11536508|FG001|Vaccinated Dose 3|Infant Series||161
10393379|NCT00676091|11536507|FG000|COMPLETED|Infant Series||157
10393380|NCT00676091|11536508|FG001|COMPLETED|Infant Series||159
10393381|NCT00676091|11536507|FG000|NOT COMPLETED|Infant Series||20
10393382|NCT00676091|11536508|FG001|NOT COMPLETED|Infant Series||18
10393383|NCT00676091|11536507|FG000|STARTED|After Infant Series||157
10393384|NCT00676091|11536508|FG001|STARTED|After Infant Series||159
10393385|NCT00676091|11536507|FG000|COMPLETED|After Infant Series||156
10393386|NCT00676091|11536508|FG001|COMPLETED|After Infant Series||156
10393387|NCT00676091|11536507|FG000|NOT COMPLETED|After Infant Series||1
10393388|NCT00676091|11536508|FG001|NOT COMPLETED|After Infant Series||3
10393389|NCT00676091|11536507|FG000|STARTED|Toddler Dose||156
10393390|NCT00676091|11536508|FG001|STARTED|Toddler Dose||156
10393391|NCT00676091|11536507|FG000|COMPLETED|Toddler Dose||153
10393392|NCT00676091|11536508|FG001|COMPLETED|Toddler Dose||156
10393393|NCT00676091|11536507|FG000|NOT COMPLETED|Toddler Dose||3
10393394|NCT00676091|11536508|FG001|NOT COMPLETED|Toddler Dose||0
10393395|NCT00676130|11536520|FG000|STARTED|Overall Study||76
10393396|NCT00676130|11536521|FG001|STARTED|Overall Study||77
10393397|NCT00676130|11536520|FG000|COMPLETED|Overall Study||73
10719334|NCT02709785|11883078|FG000|3 Weeks|Overall Study||23
10719335|NCT02709785|11883079|FG001|3 Weeks|Overall Study||27
10393398|NCT00676130|11536521|FG001|COMPLETED|Overall Study||73
10393399|NCT00676130|11536520|FG000|NOT COMPLETED|Overall Study||3
10719336|NCT02709785|11883080|FG002|3 Weeks|Overall Study||27
10308841|NCT00112502|11441644|FG006|COMPLETED|Overall Study||20
10308842|NCT00112502|11441645|FG007|COMPLETED|Overall Study||15
10308843|NCT00112502|11441638|FG000|NOT COMPLETED|Overall Study||0
10308844|NCT00112502|11441639|FG001|NOT COMPLETED|Overall Study||1
10308845|NCT00112502|11441640|FG002|NOT COMPLETED|Overall Study||1
10308846|NCT00112502|11441641|FG003|NOT COMPLETED|Overall Study||4
10308847|NCT00112502|11441642|FG004|NOT COMPLETED|Overall Study||2
10308848|NCT00112502|11441643|FG005|NOT COMPLETED|Overall Study||5
10308849|NCT00112502|11441644|FG006|NOT COMPLETED|Overall Study||3
10308850|NCT00112502|11441645|FG007|NOT COMPLETED|Overall Study||7
10308851|NCT00112580|11441675|FG000|STARTED|Overall Study||8
10308852|NCT00112580|11441676|FG001|STARTED|Overall Study||19
10308853|NCT00112580|11441675|FG000|COMPLETED|Overall Study||0
10308854|NCT00112580|11441676|FG001|COMPLETED|Overall Study||0
10308855|NCT00112580|11441675|FG000|NOT COMPLETED|Overall Study||8
10308856|NCT00112580|11441676|FG001|NOT COMPLETED|Overall Study||19
10308857|NCT00112593|11441681|FG000|STARTED|Overall Study||5
10393400|NCT00676130|11536521|FG001|NOT COMPLETED|Overall Study||4
10393401|NCT00676143|11536529|FG000|STARTED|Overall Study||441
10393402|NCT00676143|11536530|FG001|STARTED|Overall Study||658
10393403|NCT00676143|11536529|FG000|Treated|Overall Study||439
10393404|NCT00676143|11536530|FG001|Treated|Overall Study||654
10393405|NCT00676143|11536529|FG000|COMPLETED|Overall Study||285
10393406|NCT00676143|11536530|FG001|COMPLETED|Overall Study||398
10393407|NCT00676143|11536529|FG000|NOT COMPLETED|Overall Study||156
10393408|NCT00676143|11536530|FG001|NOT COMPLETED|Overall Study||260
10393409|NCT00676182|11536539|FG000|STARTED|Overall Study||75
10393410|NCT00676182|11536539|FG000|COMPLETED|Overall Study||75
10393411|NCT00676182|11536539|FG000|NOT COMPLETED|Overall Study||0
10393412|NCT00676195|11536549|FG000|STARTED|Overall Study||24
10393413|NCT00676195|11536549|FG000|COMPLETED|Overall Study||21
10393414|NCT00676195|11536549|FG000|NOT COMPLETED|Overall Study||3
10393415|NCT00676208|11536556|FG000|STARTED|Overall Study||14
10393416|NCT00676208|11536557|FG001|STARTED|Overall Study||19
10393417|NCT00676208|11536556|FG000|COMPLETED|Overall Study||12
10393418|NCT00676208|11536557|FG001|COMPLETED|Overall Study||13
10393419|NCT00676208|11536556|FG000|NOT COMPLETED|Overall Study||2
10393420|NCT00676208|11536557|FG001|NOT COMPLETED|Overall Study||6
10393421|NCT00676338|11536569|FG000|STARTED|Overall Study||248
10393422|NCT00676338|11536570|FG001|STARTED|Overall Study||246
10393423|NCT00676338|11536571|FG002|STARTED|Overall Study||163
10393424|NCT00676338|11536572|FG003|STARTED|Overall Study||163
10393425|NCT00676338|11536569|FG000|COMPLETED|Overall Study||210
10393426|NCT00676338|11536570|FG001|COMPLETED|Overall Study||213
10393427|NCT00676338|11536571|FG002|COMPLETED|Overall Study||133
10393428|NCT00676338|11536572|FG003|COMPLETED|Overall Study||140
10393429|NCT00676338|11536569|FG000|NOT COMPLETED|Overall Study||38
10393430|NCT00676338|11536570|FG001|NOT COMPLETED|Overall Study||33
10393431|NCT00676338|11536571|FG002|NOT COMPLETED|Overall Study||30
10393432|NCT00676338|11536572|FG003|NOT COMPLETED|Overall Study||23
10393433|NCT00676364|11536584|FG000|STARTED|Overall Study||57
10393434|NCT00676364|11536585|FG001|STARTED|Overall Study||57
10393435|NCT00676364|11536584|FG000|COMPLETED|Overall Study||57
10393436|NCT00676364|11536585|FG001|COMPLETED|Overall Study||57
10393437|NCT00676364|11536584|FG000|NOT COMPLETED|Overall Study||0
10393438|NCT00676364|11536585|FG001|NOT COMPLETED|Overall Study||0
10393439|NCT00676403|11536599|FG000|STARTED|Overall Study||23
10393440|NCT00676403|11536600|FG001|STARTED|Overall Study||22
10393441|NCT00676403|11536601|FG002|STARTED|Overall Study||23
10393442|NCT00676403|11536602|FG003|STARTED|Overall Study||22
10393443|NCT00676403|11536603|FG004|STARTED|Overall Study||24
10393444|NCT00676403|11536604|FG005|STARTED|Overall Study||23
10393445|NCT00676403|11536599|FG000|COMPLETED|Overall Study||21
10393446|NCT00676403|11536600|FG001|COMPLETED|Overall Study||20
10393447|NCT00676403|11536601|FG002|COMPLETED|Overall Study||22
10393448|NCT00676403|11536602|FG003|COMPLETED|Overall Study||17
10393449|NCT00676403|11536603|FG004|COMPLETED|Overall Study||23
10393450|NCT00676403|11536604|FG005|COMPLETED|Overall Study||18
10393451|NCT00676403|11536599|FG000|NOT COMPLETED|Overall Study||2
10393452|NCT00676403|11536600|FG001|NOT COMPLETED|Overall Study||2
10393453|NCT00676403|11536601|FG002|NOT COMPLETED|Overall Study||1
10308858|NCT00112593|11441681|FG000|COMPLETED|Overall Study||5
10308859|NCT00112593|11441681|FG000|NOT COMPLETED|Overall Study||0
10308860|NCT00112671|11441685|FG000|STARTED|Overall Study||17
10308861|NCT00112671|11441685|FG000|COMPLETED|Overall Study||17
10308862|NCT00112671|11441685|FG000|NOT COMPLETED|Overall Study||0
10308863|NCT00112723|11441689|FG000|STARTED|Overall Study||13
10393454|NCT00676403|11536602|FG003|NOT COMPLETED|Overall Study||5
10393455|NCT00676403|11536603|FG004|NOT COMPLETED|Overall Study||1
10393456|NCT00676403|11536604|FG005|NOT COMPLETED|Overall Study||5
10393457|NCT00676520|11536624|FG000|STARTED|Overall Study||8040
10393458|NCT00676520|11536624|FG000|COMPLETED|Overall Study||7309
10393459|NCT00676520|11536624|FG000|NOT COMPLETED|Overall Study||731
10719337|NCT02709785|11883078|FG000|6 Weeks|Overall Study||23
10719338|NCT02709785|11883079|FG001|6 Weeks|Overall Study||26
10719339|NCT02709785|11883080|FG002|6 Weeks|Overall Study||27
10719340|NCT02709785|11883078|FG000|COMPLETED|Overall Study||23
10719341|NCT02709785|11883079|FG001|COMPLETED|Overall Study||26
10393460|NCT00676572|11536635|FG000|STARTED|Overall Study||6
10393461|NCT00676572|11536636|FG001|STARTED|Overall Study||6
10393462|NCT00676572|11536635|FG000|COMPLETED|Overall Study||6
10393463|NCT00676572|11536636|FG001|COMPLETED|Overall Study||6
10393464|NCT00676572|11536635|FG000|NOT COMPLETED|Overall Study||0
10393465|NCT00676572|11536636|FG001|NOT COMPLETED|Overall Study||0
10393466|NCT00676585|11536644|FG000|STARTED|Overall Study||25
10393467|NCT00676585|11536645|FG001|STARTED|Overall Study||25
10393468|NCT00676585|11536644|FG000|COMPLETED|Overall Study||25
10393469|NCT00676585|11536645|FG001|COMPLETED|Overall Study||25
10393470|NCT00676585|11536644|FG000|NOT COMPLETED|Overall Study||0
10393471|NCT00676585|11536645|FG001|NOT COMPLETED|Overall Study||0
10393472|NCT00676650|11536653|FG000|STARTED|Overall Study||584
10393473|NCT00676650|11536654|FG001|STARTED|Overall Study||289
10393474|NCT00676650|11536653|FG000|Treated|Overall Study||581
10393475|NCT00676650|11536654|FG001|Treated|Overall Study||285
10393476|NCT00676650|11536653|FG000|COMPLETED|Overall Study||0
10393477|NCT00676650|11536654|FG001|COMPLETED|Overall Study||0
10393478|NCT00676650|11536653|FG000|NOT COMPLETED|Overall Study||584
10393479|NCT00676650|11536654|FG001|NOT COMPLETED|Overall Study||289
10393480|NCT00676676|11536660|FG000|STARTED|Overall Study||9
10393481|NCT00676676|11536660|FG000|COMPLETED|Overall Study||9
10393482|NCT00676676|11536660|FG000|NOT COMPLETED|Overall Study||0
10393483|NCT00676689|11536664|FG000|STARTED|Overall Study||81
10543120|NCT01482715|11696321|FG002|STARTED|Overall Study||4
10719342|NCT02709785|11883080|FG002|COMPLETED|Overall Study||27
10393484|NCT00676689|11536664|FG000|Procedure|Overall Study|Two enrolled patients did not meet eligibility criteria and did not undergo the study procedure.|79
10393485|NCT00676689|11536664|FG000|30 Day Follow-up|Overall Study||78
10393486|NCT00676689|11536664|FG000|1 Year Follow-up|Overall Study||64
10813114|NCT03007719|11975395|FG001|NOT COMPLETED|Overall Study||0
10813115|NCT03010423|11975401|FG000|STARTED|Overall Study||8
10813116|NCT03010423|11975401|FG000|COMPLETED|Overall Study||0
10813117|NCT03010423|11975401|FG000|NOT COMPLETED|Overall Study||8
10813118|NCT02985801|11975407|FG000|STARTED|Overall Study||8
10813119|NCT02985801|11975408|FG001|STARTED|Overall Study||8
10393487|NCT00676689|11536664|FG000|COMPLETED|Overall Study||20
10393488|NCT00676689|11536664|FG000|NOT COMPLETED|Overall Study||61
10393489|NCT00676780|11536668|FG000|STARTED|Overall Study||33
10393490|NCT00676780|11536668|FG000|COMPLETED|Overall Study||26
10393491|NCT00676780|11536668|FG000|NOT COMPLETED|Overall Study||7
10393492|NCT00676793|11536674|FG000|STARTED|Overall Study||32
10719343|NCT02709785|11883078|FG000|NOT COMPLETED|Overall Study||1
10719344|NCT02709785|11883079|FG001|NOT COMPLETED|Overall Study||2
10719345|NCT02709785|11883080|FG002|NOT COMPLETED|Overall Study||1
10393493|NCT00676793|11536674|FG000|COMPLETED|Overall Study||19
10393494|NCT00676793|11536674|FG000|NOT COMPLETED|Overall Study||13
10393495|NCT00676806|11536681|FG000|STARTED|Overall Study||3
10393496|NCT00676806|11536682|FG001|STARTED|Overall Study||3
10393497|NCT00676806|11536681|FG000|COMPLETED|Overall Study||3
10393498|NCT00676806|11536682|FG001|COMPLETED|Overall Study||3
10393499|NCT00676806|11536681|FG000|NOT COMPLETED|Overall Study||0
10393500|NCT00676806|11536682|FG001|NOT COMPLETED|Overall Study||0
10393501|NCT00676897|11536694|FG000|STARTED|Overall Study||8
10393502|NCT00676897|11536695|FG001|STARTED|Overall Study||10
10393503|NCT00676897|11536694|FG000|COMPLETED|Overall Study||8
10393504|NCT00676897|11536695|FG001|COMPLETED|Overall Study||10
10393505|NCT00676897|11536694|FG000|NOT COMPLETED|Overall Study||0
10393506|NCT00676897|11536695|FG001|NOT COMPLETED|Overall Study||0
10393507|NCT00677014|11536704|FG000|STARTED|Overall Study||325
10393508|NCT00677014|11536705|FG001|STARTED|Overall Study||323
10393509|NCT00677014|11536706|FG002|STARTED|Overall Study||332
10393510|NCT00677014|11536704|FG000|COMPLETED|Overall Study||281
10393511|NCT00677014|11536705|FG001|COMPLETED|Overall Study||282
10719346|NCT02709889|11883096|FG000|STARTED|Overall Study||43
10393512|NCT00677014|11536706|FG002|COMPLETED|Overall Study||283
10393513|NCT00677014|11536704|FG000|NOT COMPLETED|Overall Study||44
10393514|NCT00677014|11536705|FG001|NOT COMPLETED|Overall Study||41
10393515|NCT00677014|11536706|FG002|NOT COMPLETED|Overall Study||49
10393516|NCT00677040|11536714|FG000|STARTED|Overall Study||20
10393517|NCT00677040|11536714|FG000|COMPLETED|Overall Study||20
10393518|NCT00677040|11536714|FG000|NOT COMPLETED|Overall Study||0
10393519|NCT00677092|11536719|FG000|STARTED|Overall Study||12
10393520|NCT00677092|11536719|FG000|Received Study Treatment|Overall Study||11
10393521|NCT00677092|11536719|FG000|COMPLETED|Overall Study||6
10393522|NCT00677092|11536719|FG000|NOT COMPLETED|Overall Study||6
10393523|NCT00677235|11536726|FG000|STARTED|Overall Study||138
10393524|NCT00677235|11536727|FG001|STARTED|Overall Study||132
10393525|NCT00677235|11536726|FG000|COMPLETED|Overall Study||97
10393526|NCT00677235|11536727|FG001|COMPLETED|Overall Study||94
10393527|NCT00677235|11536726|FG000|NOT COMPLETED|Overall Study||41
10393528|NCT00677235|11536727|FG001|NOT COMPLETED|Overall Study||38
10428620|NCT00859014|11574633|FG000|COMPLETED|Overall Study||20
10428621|NCT00859014|11574633|FG000|NOT COMPLETED|Overall Study||5
10428622|NCT00859027|11574639|FG000|STARTED|Overall Study||25
10428623|NCT00859027|11574640|FG001|STARTED|Overall Study||25
10428624|NCT00859027|11574639|FG000|COMPLETED|Overall Study||20
10428625|NCT00859027|11574640|FG001|COMPLETED|Overall Study||20
10428626|NCT00859027|11574639|FG000|NOT COMPLETED|Overall Study||5
10428627|NCT00859027|11574640|FG001|NOT COMPLETED|Overall Study||5
10428628|NCT00859040|11574648|FG000|STARTED|Overall Study||18
10428629|NCT00859040|11574649|FG001|STARTED|Overall Study||16
10428630|NCT00859040|11574648|FG000|COMPLETED|Overall Study||18
10428631|NCT00859040|11574649|FG001|COMPLETED|Overall Study||16
10428632|NCT00859040|11574648|FG000|NOT COMPLETED|Overall Study||0
10428633|NCT00859040|11574649|FG001|NOT COMPLETED|Overall Study||0
10428634|NCT00859053|11574659|FG000|STARTED|Overall Study||6
10428635|NCT00859053|11574660|FG001|STARTED|Overall Study||6
10428636|NCT00859053|11574661|FG002|STARTED|Overall Study||6
10428637|NCT00859053|11574662|FG003|STARTED|Overall Study||12
10428638|NCT00859053|11574659|FG000|COMPLETED|Overall Study||6
10428639|NCT00859053|11574660|FG001|COMPLETED|Overall Study||6
10428640|NCT00859053|11574661|FG002|COMPLETED|Overall Study||6
10428641|NCT00859053|11574662|FG003|COMPLETED|Overall Study||12
10428642|NCT00859053|11574659|FG000|NOT COMPLETED|Overall Study||0
10428643|NCT00859053|11574660|FG001|NOT COMPLETED|Overall Study||0
10428644|NCT00859053|11574661|FG002|NOT COMPLETED|Overall Study||0
10428645|NCT00859053|11574662|FG003|NOT COMPLETED|Overall Study||0
10428646|NCT00859131|11574674|FG000|STARTED|Overall Study||102
10428647|NCT00859131|11574675|FG001|STARTED|Overall Study||98
10428648|NCT00859131|11574674|FG000|COMPLETED|Overall Study||102
10428649|NCT00859131|11574675|FG001|COMPLETED|Overall Study||98
10428650|NCT00859131|11574674|FG000|NOT COMPLETED|Overall Study||0
10428651|NCT00859131|11574675|FG001|NOT COMPLETED|Overall Study||0
10428652|NCT00859222|11574684|FG000|STARTED|Overall Study||3
10428653|NCT00859222|11574685|FG001|STARTED|Overall Study||3
10428654|NCT00859222|11574686|FG002|STARTED|Overall Study||6
10428655|NCT00859222|11574687|FG003|STARTED|Overall Study||24
10428656|NCT00859222|11574688|FG004|STARTED|Overall Study||15
10428657|NCT00859222|11574684|FG000|COMPLETED|Overall Study||0
10428658|NCT00859222|11574685|FG001|COMPLETED|Overall Study||0
10428659|NCT00859222|11574686|FG002|COMPLETED|Overall Study||0
10428660|NCT00859222|11574687|FG003|COMPLETED|Overall Study||0
10428661|NCT00859222|11574688|FG004|COMPLETED|Overall Study||0
10428662|NCT00859222|11574684|FG000|NOT COMPLETED|Overall Study||3
10428663|NCT00859222|11574685|FG001|NOT COMPLETED|Overall Study||3
10428664|NCT00859222|11574686|FG002|NOT COMPLETED|Overall Study||6
10428665|NCT00859222|11574687|FG003|NOT COMPLETED|Overall Study||24
10428666|NCT00859222|11574688|FG004|NOT COMPLETED|Overall Study||15
10428667|NCT00859313|11574703|FG000|STARTED|Overall Study||30
10428668|NCT00859313|11574703|FG000|COMPLETED|Overall Study||26
10428669|NCT00859313|11574703|FG000|NOT COMPLETED|Overall Study||4
10428670|NCT00859339|11574707|FG000|STARTED|Overall Study||9
10428671|NCT00859339|11574707|FG000|COMPLETED|Overall Study||9
10428672|NCT00859339|11574707|FG000|NOT COMPLETED|Overall Study||0
10428673|NCT00859456|11574711|FG000|STARTED|Overall Study||9
10428674|NCT00859456|11574711|FG000|COMPLETED|Overall Study||1
10428675|NCT00859456|11574711|FG000|NOT COMPLETED|Overall Study||8
10428676|NCT00859469|11574715|FG000|STARTED|Overall Study||29
10428677|NCT00859469|11574715|FG000|6 Cycles|Overall Study||16
10428678|NCT00859469|11574715|FG000|COMPLETED|Overall Study||1
10428679|NCT00859469|11574715|FG000|NOT COMPLETED|Overall Study||28
10428680|NCT00859495|11574719|FG000|STARTED|Overall Study||9
10308864|NCT00112723|11441690|FG001|STARTED|Overall Study||19
10308865|NCT00112723|11441691|FG002|STARTED|Overall Study||14
10308866|NCT00112723|11441689|FG000|Patients Evaluable for Toxicity|Overall Study||11
10308867|NCT00112723|11441690|FG001|Patients Evaluable for Toxicity|Overall Study||12
10308868|NCT00112723|11441691|FG002|Patients Evaluable for Toxicity|Overall Study||12
10308869|NCT00112723|11441689|FG000|COMPLETED|Overall Study||11
10308870|NCT00112723|11441690|FG001|COMPLETED|Overall Study||12
10308871|NCT00112723|11441691|FG002|COMPLETED|Overall Study||12
10308872|NCT00112723|11441689|FG000|NOT COMPLETED|Overall Study||2
10308873|NCT00112723|11441690|FG001|NOT COMPLETED|Overall Study||7
10308874|NCT00112723|11441691|FG002|NOT COMPLETED|Overall Study||2
10308875|NCT00112736|11441715|FG000|STARTED|Overall Study||22
10308876|NCT00112736|11441716|FG001|STARTED|Overall Study||47
10308877|NCT00112736|11441715|FG000|COMPLETED|Overall Study|12 of Phase I pts treated at MTD and hence considered part of the Phase II analysis|21
10308878|NCT00112736|11441716|FG001|COMPLETED|Overall Study|12 additional pts from phase 1 study were used in analysis for Phase 2 as they were treated at MTD|47
10308879|NCT00112736|11441715|FG000|NOT COMPLETED|Overall Study||1
10308880|NCT00112736|11441716|FG001|NOT COMPLETED|Overall Study||0
10308881|NCT00112827|11441733|FG000|STARTED|Overall Study||3
10308882|NCT00112827|11441734|FG001|STARTED|Overall Study||4
10308883|NCT00112827|11441735|FG002|STARTED|Overall Study||4
10308884|NCT00112827|11441736|FG003|STARTED|Overall Study||36
10308885|NCT00112827|11441737|FG004|STARTED|Overall Study||7
10308886|NCT00112827|11441733|FG000|COMPLETED|Overall Study||3
10308887|NCT00112827|11441734|FG001|COMPLETED|Overall Study||4
10308888|NCT00112827|11441735|FG002|COMPLETED|Overall Study||4
10308889|NCT00112827|11441736|FG003|COMPLETED|Overall Study||36
10308890|NCT00112827|11441737|FG004|COMPLETED|Overall Study||7
10308891|NCT00112827|11441733|FG000|NOT COMPLETED|Overall Study||0
10308892|NCT00112827|11441734|FG001|NOT COMPLETED|Overall Study||0
10308893|NCT00112827|11441735|FG002|NOT COMPLETED|Overall Study||0
10308894|NCT00112827|11441736|FG003|NOT COMPLETED|Overall Study||0
10719347|NCT02709889|11883097|FG001|STARTED|Overall Study||57
10308895|NCT00112827|11441737|FG004|NOT COMPLETED|Overall Study||0
10308896|NCT00112866|11441752|FG000|STARTED|Overall Study||15
10308897|NCT00112866|11441753|FG001|STARTED|Overall Study||15
10308898|NCT00112866|11441752|FG000|COMPLETED|Overall Study||13
10308899|NCT00112866|11441753|FG001|COMPLETED|Overall Study||13
10308900|NCT00112866|11441752|FG000|NOT COMPLETED|Overall Study||2
10308901|NCT00112866|11441753|FG001|NOT COMPLETED|Overall Study||2
10308902|NCT00112905|11441767|FG000|STARTED|Overall Study||27
10308903|NCT00112905|11441767|FG000|Eligible and Treated|Overall Study||22
10308904|NCT00112905|11441767|FG000|COMPLETED|Overall Study||15
10308905|NCT00112905|11441767|FG000|NOT COMPLETED|Overall Study||12
10308906|NCT00112918|11441774|FG000|STARTED|Overall Study||1151
10308907|NCT00112918|11441775|FG001|STARTED|Overall Study||1155
10719348|NCT02709889|11883098|FG002|STARTED|Overall Study||12
10308908|NCT00112918|11441776|FG002|STARTED|Overall Study||1145
10308909|NCT00112918|11441774|FG000|Received Treatment|Overall Study||1126
10308910|NCT00112918|11441775|FG001|Received Treatment|Overall Study|Includes two patients from FOLFOX4 who received Bv and were assigned to FOLFOX4+Bv safety analysis|1145
10308911|NCT00112918|11441776|FG002|Received Treatment|Overall Study||1135
10308912|NCT00112918|11441774|FG000|Stage III Disease Population|Overall Study||955
10308913|NCT00112918|11441775|FG001|Stage III Disease Population|Overall Study||960
10308914|NCT00112918|11441776|FG002|Stage III Disease Population|Overall Study||952
10308915|NCT00112918|11441774|FG000|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|854
10308916|NCT00112918|11441775|FG001|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|810
10315382|NCT00178178|11449240|FG000|COMPLETED|Overall Study||24
10393529|NCT00677352|11536735|FG000|STARTED|Treatment Phase|All 157 subjects were treated with Sertraline.|157
10393530|NCT00677352|11536736|FG001|STARTED|Treatment Phase|2 subjects were not teated, therefore 162 subjects were treated with paroxetine.|164
10393531|NCT00677352|11536735|FG000|COMPLETED|Treatment Phase||132
10393532|NCT00677352|11536736|FG001|COMPLETED|Treatment Phase||122
10393533|NCT00677352|11536735|FG000|NOT COMPLETED|Treatment Phase||25
10393534|NCT00677352|11536736|FG001|NOT COMPLETED|Treatment Phase||42
10393535|NCT00677352|11536735|FG000|STARTED|Tapering Phase||132
10393536|NCT00677352|11536736|FG001|STARTED|Tapering Phase||122
10393537|NCT00677352|11536735|FG000|COMPLETED|Tapering Phase||126
10393538|NCT00677352|11536736|FG001|COMPLETED|Tapering Phase||112
10393539|NCT00677352|11536735|FG000|NOT COMPLETED|Tapering Phase||6
10393540|NCT00677352|11536736|FG001|NOT COMPLETED|Tapering Phase||10
10393541|NCT00677365|11536746|FG000|STARTED|Overall Study||37
10393542|NCT00677365|11536747|FG001|STARTED|Overall Study||38
10393543|NCT00677365|11536748|FG002|STARTED|Overall Study||37
10393544|NCT00677365|11536749|FG003|STARTED|Overall Study||39
10393545|NCT00677365|11536746|FG000|COMPLETED|Overall Study||35
10393546|NCT00677365|11536747|FG001|COMPLETED|Overall Study||37
10393547|NCT00677365|11536748|FG002|COMPLETED|Overall Study||35
10393548|NCT00677365|11536749|FG003|COMPLETED|Overall Study||36
10393549|NCT00677365|11536746|FG000|NOT COMPLETED|Overall Study||2
10393550|NCT00677365|11536747|FG001|NOT COMPLETED|Overall Study||1
10393551|NCT00677365|11536748|FG002|NOT COMPLETED|Overall Study||2
10393552|NCT00677365|11536749|FG003|NOT COMPLETED|Overall Study||3
10393553|NCT00677534|11536759|FG000|STARTED|Washout (Weeks 1-4)||10
10393554|NCT00677534|11536759|FG000|COMPLETED|Washout (Weeks 1-4)||7
10393555|NCT00677534|11536759|FG000|NOT COMPLETED|Washout (Weeks 1-4)||3
10393556|NCT00677534|11536759|FG000|STARTED|Cholecalciferol (Weeks 5-12)||7
10393557|NCT00677534|11536759|FG000|COMPLETED|Cholecalciferol (Weeks 5-12)||7
10393558|NCT00677534|11536759|FG000|NOT COMPLETED|Cholecalciferol (Weeks 5-12)||0
10393559|NCT00677534|11536759|FG000|STARTED|After Paricalcitol Restart (Weeks 13-14)||7
10393560|NCT00677534|11536759|FG000|COMPLETED|After Paricalcitol Restart (Weeks 13-14)||7
10393561|NCT00677534|11536759|FG000|NOT COMPLETED|After Paricalcitol Restart (Weeks 13-14)||0
10393562|NCT00677690|11536765|FG000|STARTED|Overall Study||42
10393563|NCT00677690|11536766|FG001|STARTED|Overall Study||41
10393564|NCT00677690|11536765|FG000|COMPLETED|Overall Study||42
10393565|NCT00677690|11536766|FG001|COMPLETED|Overall Study||41
10393566|NCT00677690|11536765|FG000|NOT COMPLETED|Overall Study||0
10393567|NCT00677690|11536766|FG001|NOT COMPLETED|Overall Study||0
10719349|NCT02709889|11883099|FG003|STARTED|Overall Study||88
10719350|NCT02709889|11883096|FG000|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||3
10719351|NCT02709889|11883097|FG001|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||4
10719352|NCT02709889|11883098|FG002|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||2
10719353|NCT02709889|11883099|FG003|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||4
10393568|NCT00677807|11536775|FG000|STARTED|Overall Study||144
10393569|NCT00677807|11536776|FG001|STARTED|Overall Study||146
10719354|NCT02709889|11883096|FG000|Neuroendocrine Prostate Cancer|Overall Study||4
10719355|NCT02709889|11883097|FG001|Neuroendocrine Prostate Cancer|Overall Study||7
10393570|NCT00677807|11536777|FG002|STARTED|Overall Study||125
10393571|NCT00677807|11536775|FG000|Safety/ITT: Received Study Drug|Overall Study||144
10393572|NCT00677807|11536776|FG001|Safety/ITT: Received Study Drug|Overall Study||146
10393573|NCT00677807|11536777|FG002|Safety/ITT: Received Study Drug|Overall Study|One patient did not take study medication.|124
10393574|NCT00677807|11536775|FG000|COMPLETED|Overall Study||126
10393575|NCT00677807|11536776|FG001|COMPLETED|Overall Study||135
10393576|NCT00677807|11536777|FG002|COMPLETED|Overall Study||105
10393577|NCT00677807|11536775|FG000|NOT COMPLETED|Overall Study||18
10393578|NCT00677807|11536776|FG001|NOT COMPLETED|Overall Study||11
10393579|NCT00677807|11536777|FG002|NOT COMPLETED|Overall Study||20
10393580|NCT00677820|11536787|FG000|STARTED|Overall Study||240
10393581|NCT00677820|11536788|FG001|STARTED|Overall Study||60
10393582|NCT00677820|11536787|FG000|COMPLETED|Overall Study||239
10393583|NCT00677820|11536788|FG001|COMPLETED|Overall Study||60
10393584|NCT00677820|11536787|FG000|NOT COMPLETED|Overall Study||1
10393585|NCT00677820|11536788|FG001|NOT COMPLETED|Overall Study||0
10393586|NCT00677833|11536798|FG000|STARTED|Overall Study||55
10393587|NCT00677833|11536799|FG001|STARTED|Overall Study||51
10393588|NCT00677833|11536800|FG002|STARTED|Overall Study||124
10393589|NCT00677833|11536801|FG003|STARTED|Overall Study||131
10393590|NCT00677833|11536798|FG000|COMPLETED|Overall Study||51
10393591|NCT00677833|11536799|FG001|COMPLETED|Overall Study||51
10393592|NCT00677833|11536800|FG002|COMPLETED|Overall Study||122
10393593|NCT00677833|11536801|FG003|COMPLETED|Overall Study||128
10393594|NCT00677833|11536798|FG000|NOT COMPLETED|Overall Study||4
10393595|NCT00677833|11536799|FG001|NOT COMPLETED|Overall Study||0
10393596|NCT00677833|11536800|FG002|NOT COMPLETED|Overall Study||2
10393597|NCT00677833|11536801|FG003|NOT COMPLETED|Overall Study||3
10719356|NCT02709889|11883098|FG002|Neuroendocrine Prostate Cancer|Overall Study||3
10719357|NCT02709889|11883099|FG003|Neuroendocrine Prostate Cancer|Overall Study||7
10393598|NCT00677898|11536811|FG000|STARTED|Overall Study||119
10393599|NCT00677898|11536812|FG001|STARTED|Overall Study||120
10393600|NCT00677898|11536811|FG000|COMPLETED|Overall Study||99
10393601|NCT00677898|11536812|FG001|COMPLETED|Overall Study||102
10393602|NCT00677898|11536811|FG000|NOT COMPLETED|Overall Study||20
10393603|NCT00677898|11536812|FG001|NOT COMPLETED|Overall Study||18
10393604|NCT00677924|11536820|FG000|STARTED|Overall Study||3
10393605|NCT00677924|11536821|FG001|STARTED|Overall Study||6
10393606|NCT00677924|11536820|FG000|COMPLETED|Overall Study||3
10719358|NCT02709889|11883096|FG000|Gastroenteropancreatic NEC|Overall Study||6
10393607|NCT00677924|11536821|FG001|COMPLETED|Overall Study||6
10393608|NCT00677924|11536820|FG000|NOT COMPLETED|Overall Study||0
10393609|NCT00677924|11536821|FG001|NOT COMPLETED|Overall Study||0
10393610|NCT00678015|11536827|FG000|STARTED|Overall Study||12
10393611|NCT00678015|11536827|FG000|COMPLETED|Overall Study||12
10393612|NCT00678015|11536827|FG000|NOT COMPLETED|Overall Study||0
10393613|NCT00678080|11536833|FG000|STARTED|Overall Study||11
10393614|NCT00678080|11536834|FG001|STARTED|Overall Study||14
10393615|NCT00678080|11536833|FG000|COMPLETED|Overall Study||8
10393616|NCT00678080|11536834|FG001|COMPLETED|Overall Study||13
10393617|NCT00678080|11536833|FG000|NOT COMPLETED|Overall Study||3
10393618|NCT00678080|11536834|FG001|NOT COMPLETED|Overall Study||1
10393619|NCT00678210|11536844|FG000|STARTED|Overall Study||49
10393620|NCT00678210|11536845|FG001|STARTED|Overall Study||49
10393621|NCT00678210|11536846|FG002|STARTED|Overall Study||49
10393622|NCT00678210|11536847|FG003|STARTED|Overall Study||50
10393623|NCT00678210|11536844|FG000|COMPLETED|Overall Study||38
10719359|NCT02709889|11883097|FG001|Gastroenteropancreatic NEC|Overall Study||5
10813120|NCT02985801|11975407|FG000|COMPLETED|Overall Study||8
10813121|NCT02985801|11975408|FG001|COMPLETED|Overall Study||8
10813122|NCT02985801|11975407|FG000|NOT COMPLETED|Overall Study||0
10393624|NCT00678210|11536845|FG001|COMPLETED|Overall Study||38
10393625|NCT00678210|11536846|FG002|COMPLETED|Overall Study||43
10393626|NCT00678210|11536847|FG003|COMPLETED|Overall Study||30
10393627|NCT00678210|11536844|FG000|NOT COMPLETED|Overall Study||11
10393628|NCT00678210|11536845|FG001|NOT COMPLETED|Overall Study||11
10393629|NCT00678210|11536846|FG002|NOT COMPLETED|Overall Study||6
10393630|NCT00678210|11536847|FG003|NOT COMPLETED|Overall Study||20
10393631|NCT00678249|11536860|FG000|STARTED|Overall Study||97
10393632|NCT00678249|11536861|FG001|STARTED|Overall Study||93
10393633|NCT00678249|11536862|FG002|STARTED|Overall Study||37
10393634|NCT00678249|11536860|FG000|COMPLETED|Overall Study||97
10393635|NCT00678249|11536861|FG001|COMPLETED|Overall Study||93
10393636|NCT00678249|11536862|FG002|COMPLETED|Overall Study||37
10393637|NCT00678249|11536860|FG000|NOT COMPLETED|Overall Study||0
10393638|NCT00678249|11536861|FG001|NOT COMPLETED|Overall Study||0
10393639|NCT00678249|11536862|FG002|NOT COMPLETED|Overall Study||0
10393640|NCT00678301|11536872|FG000|STARTED|Overall Study||239
10393641|NCT00678301|11536873|FG001|STARTED|Overall Study||118
10393642|NCT00678301|11536872|FG000|COMPLETED|Overall Study||231
10393643|NCT00678301|11536873|FG001|COMPLETED|Overall Study||116
10393644|NCT00678301|11536872|FG000|NOT COMPLETED|Overall Study||8
10393645|NCT00678301|11536873|FG001|NOT COMPLETED|Overall Study||2
10393646|NCT00678379|11536882|FG000|STARTED|Overall Study||40
10393647|NCT00678379|11536883|FG001|STARTED|Overall Study||40
10393648|NCT00678379|11536884|FG002|STARTED|Overall Study||40
10719360|NCT02709889|11883098|FG002|Gastroenteropancreatic NEC|Overall Study||2
10719361|NCT02709889|11883099|FG003|Gastroenteropancreatic NEC|Overall Study||23
10719362|NCT02709889|11883096|FG000|Other NEC|Overall Study||11
10719363|NCT02709889|11883097|FG001|Other NEC|Overall Study||12
10719364|NCT02709889|11883098|FG002|Other NEC|Overall Study||1
10393649|NCT00678379|11536882|FG000|COMPLETED|Overall Study||34
10393650|NCT00678379|11536883|FG001|COMPLETED|Overall Study||37
10393651|NCT00678379|11536884|FG002|COMPLETED|Overall Study||36
10393652|NCT00678379|11536882|FG000|NOT COMPLETED|Overall Study||6
10393653|NCT00678379|11536883|FG001|NOT COMPLETED|Overall Study||3
10393654|NCT00678379|11536884|FG002|NOT COMPLETED|Overall Study||4
10393655|NCT00678392|11536894|FG000|STARTED|Overall Study||361
10393656|NCT00678392|11536895|FG001|STARTED|Overall Study||362
10393657|NCT00678392|11536894|FG000|Treated|Overall Study||359
10393658|NCT00678392|11536895|FG001|Treated|Overall Study||355
10393659|NCT00678392|11536894|FG000|COMPLETED|Overall Study||0
10393660|NCT00678392|11536895|FG001|COMPLETED|Overall Study||0
10393661|NCT00678392|11536894|FG000|NOT COMPLETED|Overall Study||361
10393662|NCT00678392|11536895|FG001|NOT COMPLETED|Overall Study||362
10393663|NCT00678418|11536903|FG000|STARTED|Part A (Double Blind)||126
10393664|NCT00678418|11536904|FG001|STARTED|Part A (Double Blind)||124
10393665|NCT00678418|11536903|FG000|COMPLETED|Part A (Double Blind)||67
10393666|NCT00678418|11536904|FG001|COMPLETED|Part A (Double Blind)||47
10393667|NCT00678418|11536903|FG000|NOT COMPLETED|Part A (Double Blind)||59
10393668|NCT00678418|11536904|FG001|NOT COMPLETED|Part A (Double Blind)||77
10393669|NCT00678418|11536903|FG000|STARTED|Part B (Open Label)|All participants who received placebo in Part A were switched to open-label VIVITROL in Part B.|114
10393670|NCT00678418|11536904|FG001|STARTED|Part B (Open Label)||0
10393671|NCT00678418|11536903|FG000|COMPLETED|Part B (Open Label)||71
10393672|NCT00678418|11536904|FG001|COMPLETED|Part B (Open Label)||0
10393673|NCT00678418|11536903|FG000|NOT COMPLETED|Part B (Open Label)||43
10393674|NCT00678418|11536904|FG001|NOT COMPLETED|Part B (Open Label)||0
10393675|NCT00678444|11536912|FG000|STARTED|Overall Study||100
10393676|NCT00678444|11536913|FG001|STARTED|Overall Study||99
10393677|NCT00678444|11536912|FG000|COMPLETED|Overall Study||100
10393678|NCT00678444|11536913|FG001|COMPLETED|Overall Study||99
10393679|NCT00678444|11536912|FG000|NOT COMPLETED|Overall Study||0
10393680|NCT00678444|11536913|FG001|NOT COMPLETED|Overall Study||0
10393681|NCT00678470|11536919|FG000|STARTED|Overall Study||18
10393682|NCT00678470|11536919|FG000|COMPLETED|Overall Study||14
10393683|NCT00678470|11536919|FG000|NOT COMPLETED|Overall Study||4
10719365|NCT02709889|11883099|FG003|Other NEC|Overall Study||7
10719366|NCT02709889|11883096|FG000|Malignant Melanoma|Overall Study||3
10813123|NCT02985801|11975408|FG001|NOT COMPLETED|Overall Study||0
10813124|NCT02991430|11975417|FG000|STARTED|Treatment Period 1||14
10813125|NCT02991430|11975418|FG001|STARTED|Treatment Period 1||15
10813126|NCT02991430|11975419|FG002|STARTED|Treatment Period 1||16
10813127|NCT02991430|11975417|FG000|COMPLETED|Treatment Period 1||13
10813128|NCT02991430|11975418|FG001|COMPLETED|Treatment Period 1||11
10813129|NCT02991430|11975419|FG002|COMPLETED|Treatment Period 1||14
10813130|NCT02991430|11975417|FG000|NOT COMPLETED|Treatment Period 1||1
10813131|NCT02991430|11975418|FG001|NOT COMPLETED|Treatment Period 1||4
10813132|NCT02991430|11975419|FG002|NOT COMPLETED|Treatment Period 1||2
10813133|NCT02991430|11975417|FG000|STARTED|Treatment Period 2||13
10813134|NCT02991430|11975418|FG001|STARTED|Treatment Period 2||11
10393684|NCT00678496|11536925|FG000|STARTED|Overall Study||12
10393685|NCT00678496|11536926|FG001|STARTED|Overall Study||12
10393686|NCT00678496|11536925|FG000|Completed 8 Weeks Follow-up|Overall Study||9
10393687|NCT00678496|11536926|FG001|Completed 8 Weeks Follow-up|Overall Study||12
10393688|NCT00678496|11536925|FG000|COMPLETED|Overall Study||10
10393689|NCT00678496|11536926|FG001|COMPLETED|Overall Study||8
10393690|NCT00678496|11536925|FG000|NOT COMPLETED|Overall Study||2
10393691|NCT00678496|11536926|FG001|NOT COMPLETED|Overall Study||4
10813135|NCT02991430|11975419|FG002|STARTED|Treatment Period 2||14
10308917|NCT00112918|11441776|FG002|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|846
10308918|NCT00112918|11441774|FG000|NOT COMPLETED|Overall Study||297
10308919|NCT00112918|11441775|FG001|NOT COMPLETED|Overall Study||345
10308920|NCT00112918|11441776|FG002|NOT COMPLETED|Overall Study||299
10308921|NCT00112957|11441784|FG000|STARTED|Overall Study||23
10308922|NCT00112957|11441784|FG000|COMPLETED|Overall Study||4
10308923|NCT00112957|11441784|FG000|NOT COMPLETED|Overall Study||19
10308924|NCT00113022|11441790|FG000|STARTED|Overall Study||5
10308925|NCT00113022|11441791|FG001|STARTED|Overall Study||4
10308926|NCT00113022|11441790|FG000|COMPLETED|Overall Study||2
10308927|NCT00113022|11441791|FG001|COMPLETED|Overall Study||2
10308928|NCT00113022|11441790|FG000|NOT COMPLETED|Overall Study||3
10308929|NCT00113022|11441791|FG001|NOT COMPLETED|Overall Study||2
10308930|NCT00113087|11441799|FG000|STARTED|Overall Study||115
10308931|NCT00113087|11441800|FG001|STARTED|Overall Study||115
10308932|NCT00113087|11441799|FG000|COMPLETED|Overall Study||91
10308933|NCT00113087|11441800|FG001|COMPLETED|Overall Study||94
10308934|NCT00113087|11441799|FG000|NOT COMPLETED|Overall Study||24
10308935|NCT00113087|11441800|FG001|NOT COMPLETED|Overall Study||21
10308936|NCT00113217|11441806|FG000|STARTED|Overall Study||50
10308937|NCT00113217|11441806|FG000|COMPLETED|Overall Study||50
10308938|NCT00113217|11441806|FG000|NOT COMPLETED|Overall Study||0
10308939|NCT00113230|11441810|FG000|STARTED|Overall Study||25
10308940|NCT00113230|11441810|FG000|COMPLETED|Overall Study||25
10308941|NCT00113230|11441810|FG000|NOT COMPLETED|Overall Study||0
10308942|NCT00113269|11441818|FG000|STARTED|Overall Study||76
10308943|NCT00113269|11441819|FG001|STARTED|Overall Study||70
10308944|NCT00113269|11441820|FG002|STARTED|Overall Study||175
10308945|NCT00113269|11441821|FG003|STARTED|Overall Study||180
10308946|NCT00113269|11441818|FG000|Received Treatment|Overall Study||70
10308947|NCT00113269|11441819|FG001|Received Treatment|Overall Study||69
10308948|NCT00113269|11441820|FG002|Received Treatment|Overall Study||164
10308949|NCT00113269|11441821|FG003|Received Treatment|Overall Study||171
10308950|NCT00113269|11441818|FG000|COMPLETED|Overall Study||51
10308951|NCT00113269|11441819|FG001|COMPLETED|Overall Study||48
10308952|NCT00113269|11441820|FG002|COMPLETED|Overall Study||134
10308953|NCT00113269|11441821|FG003|COMPLETED|Overall Study||140
10308954|NCT00113269|11441818|FG000|NOT COMPLETED|Overall Study||25
10308955|NCT00113269|11441819|FG001|NOT COMPLETED|Overall Study||22
10308956|NCT00113269|11441820|FG002|NOT COMPLETED|Overall Study||41
10308957|NCT00113269|11441821|FG003|NOT COMPLETED|Overall Study||40
10308958|NCT00113295|11441833|FG000|STARTED|Overall Study||11
10308959|NCT00113295|11441834|FG001|STARTED|Overall Study||11
10308960|NCT00113295|11441833|FG000|COMPLETED|Overall Study||6
10308961|NCT00113295|11441834|FG001|COMPLETED|Overall Study||10
10308962|NCT00113295|11441833|FG000|NOT COMPLETED|Overall Study||5
10308963|NCT00113295|11441834|FG001|NOT COMPLETED|Overall Study||1
10308964|NCT00113321|11441842|FG000|STARTED|Overall Study||16
10308965|NCT00113321|11441842|FG000|COMPLETED|Overall Study||16
10308966|NCT00113321|11441842|FG000|NOT COMPLETED|Overall Study||0
10308967|NCT00113334|11441846|FG000|STARTED|Overall Study||6
10308968|NCT00113334|11441846|FG000|COMPLETED|Overall Study||6
10308969|NCT00113334|11441846|FG000|NOT COMPLETED|Overall Study||0
10308970|NCT00113360|11441850|FG000|STARTED|Overall Study|67 participants were enrolled for screening.|67
10308971|NCT00113360|11441850|FG000|COMPLETED|Overall Study||60
10308972|NCT00113360|11441850|FG000|NOT COMPLETED|Overall Study||7
10308973|NCT00113373|11441854|FG000|STARTED|Overall Study||28
10308974|NCT00113373|11441854|FG000|COMPLETED|Overall Study|Eligible and treated patients.|25
10308975|NCT00113373|11441854|FG000|NOT COMPLETED|Overall Study||3
10308976|NCT00113425|11441863|FG000|STARTED|Overall Study||44
10308977|NCT00113425|11441863|FG000|COMPLETED|Overall Study||29
10308978|NCT00113425|11441863|FG000|NOT COMPLETED|Overall Study||15
10308979|NCT00113490|11441870|FG000|STARTED|Overall Study||66
10308980|NCT00113490|11441871|FG001|STARTED|Overall Study||70
10308981|NCT00113490|11441870|FG000|COMPLETED|Overall Study||64
10308982|NCT00113490|11441871|FG001|COMPLETED|Overall Study||67
10308983|NCT00113490|11441870|FG000|NOT COMPLETED|Overall Study||2
10308984|NCT00113490|11441871|FG001|NOT COMPLETED|Overall Study||3
10308985|NCT00113516|11441877|FG000|STARTED|Part 1||84
10308986|NCT00113516|11441878|FG001|STARTED|Part 1||0
10308987|NCT00113516|11441877|FG000|COMPLETED|Part 1|66 subjects continued into Part 2 of the study.|0
10308988|NCT00113516|11441878|FG001|COMPLETED|Part 1||0
10813136|NCT02991430|11975417|FG000|COMPLETED|Treatment Period 2||7
10813137|NCT02991430|11975418|FG001|COMPLETED|Treatment Period 2||8
10813138|NCT02991430|11975419|FG002|COMPLETED|Treatment Period 2||10
10813139|NCT02991430|11975417|FG000|NOT COMPLETED|Treatment Period 2||6
10813140|NCT02991430|11975418|FG001|NOT COMPLETED|Treatment Period 2||3
10813141|NCT02991430|11975419|FG002|NOT COMPLETED|Treatment Period 2||4
10813142|NCT02991430|11975417|FG000|STARTED|Post-treatment Observation Period||7
10813143|NCT02991430|11975418|FG001|STARTED|Post-treatment Observation Period||8
10393692|NCT00678535|11536936|FG000|STARTED|Overall Study|ITT population|455
10393693|NCT00678535|11536937|FG001|STARTED|Overall Study|ITT population|449
10393694|NCT00678535|11536936|FG000|COMPLETED|Overall Study|subjects who died before or at 31 March 2012|362
10393695|NCT00678535|11536937|FG001|COMPLETED|Overall Study|subjects who died before or at 31 March 2012|351
10813144|NCT02991430|11975419|FG002|STARTED|Post-treatment Observation Period||10
10813145|NCT02991430|11975417|FG000|COMPLETED|Post-treatment Observation Period||4
10813146|NCT02991430|11975418|FG001|COMPLETED|Post-treatment Observation Period||2
10813147|NCT02991430|11975419|FG002|COMPLETED|Post-treatment Observation Period||5
10813148|NCT02991430|11975417|FG000|NOT COMPLETED|Post-treatment Observation Period||3
10813149|NCT02991430|11975418|FG001|NOT COMPLETED|Post-treatment Observation Period||6
10813150|NCT02991430|11975419|FG002|NOT COMPLETED|Post-treatment Observation Period||5
10813151|NCT02995967|11975429|FG000|STARTED|Overall Study||1
10813152|NCT02995967|11975430|FG001|STARTED|Overall Study||2
10813153|NCT02995967|11975429|FG000|COMPLETED|Overall Study||1
10813154|NCT02995967|11975430|FG001|COMPLETED|Overall Study||2
10813155|NCT02995967|11975429|FG000|NOT COMPLETED|Overall Study||0
10813156|NCT02995967|11975430|FG001|NOT COMPLETED|Overall Study||0
10813157|NCT02994251|11975437|FG000|STARTED|Overall Study||0
10813158|NCT02994251|11975437|FG000|COMPLETED|Overall Study||0
10813159|NCT02994251|11975437|FG000|NOT COMPLETED|Overall Study||0
10813160|NCT02978885|11975443|FG000|STARTED|Overall Study||0
10813161|NCT02978885|11975444|FG001|STARTED|Overall Study||1
10813162|NCT02978885|11975443|FG000|COMPLETED|Overall Study||0
10813163|NCT02978885|11975444|FG001|COMPLETED|Overall Study||1
10813164|NCT02978885|11975443|FG000|NOT COMPLETED|Overall Study||0
10813165|NCT02978885|11975444|FG001|NOT COMPLETED|Overall Study||0
10813166|NCT02978833|11975452|FG000|STARTED|Overall Study||1
10813167|NCT02978833|11975453|FG001|STARTED|Overall Study||1
10813168|NCT02978833|11975452|FG000|COMPLETED|Overall Study||0
10813169|NCT02978833|11975453|FG001|COMPLETED|Overall Study||0
10813170|NCT02978833|11975452|FG000|NOT COMPLETED|Overall Study||1
10393696|NCT00678535|11536936|FG000|NOT COMPLETED|Overall Study||93
10393697|NCT00678535|11536937|FG001|NOT COMPLETED|Overall Study||98
10393698|NCT00678561|11536951|FG000|STARTED|Overall Study||6
10393699|NCT00678561|11536952|FG001|STARTED|Overall Study||6
10393700|NCT00678561|11536953|FG002|STARTED|Overall Study||8
10393701|NCT00678561|11536954|FG003|STARTED|Overall Study||4
10393702|NCT00678561|11536955|FG004|STARTED|Overall Study||17
10393703|NCT00678561|11536956|FG005|STARTED|Overall Study||17
10393704|NCT00678561|11536957|FG006|STARTED|Overall Study||15
10393705|NCT00678561|11536958|FG007|STARTED|Overall Study||8
10393706|NCT00678561|11536951|FG000|COMPLETED|Overall Study||6
10393707|NCT00678561|11536952|FG001|COMPLETED|Overall Study||5
10393708|NCT00678561|11536953|FG002|COMPLETED|Overall Study||7
10393709|NCT00678561|11536954|FG003|COMPLETED|Overall Study||4
10393710|NCT00678561|11536955|FG004|COMPLETED|Overall Study||15
10393711|NCT00678561|11536956|FG005|COMPLETED|Overall Study||16
10543121|NCT01482715|11696322|FG003|STARTED|Overall Study||9
10543122|NCT01482715|11696323|FG004|STARTED|Overall Study||4
10393712|NCT00678561|11536957|FG006|COMPLETED|Overall Study||15
10393713|NCT00678561|11536958|FG007|COMPLETED|Overall Study||7
10393714|NCT00678561|11536951|FG000|NOT COMPLETED|Overall Study||0
10393715|NCT00678561|11536952|FG001|NOT COMPLETED|Overall Study||1
10393716|NCT00678561|11536953|FG002|NOT COMPLETED|Overall Study||1
10393717|NCT00678561|11536954|FG003|NOT COMPLETED|Overall Study||0
10813171|NCT02978833|11975453|FG001|NOT COMPLETED|Overall Study||1
10813172|NCT02971839|11975465|FG000|STARTED|Overall Study||2
10543123|NCT01482715|11696324|FG005|STARTED|Overall Study||3
10543124|NCT01482715|11696325|FG006|STARTED|Overall Study||8
10719367|NCT02709889|11883097|FG001|Malignant Melanoma|Overall Study||6
10719368|NCT02709889|11883098|FG002|Malignant Melanoma|Overall Study||0
10543125|NCT01482715|11696326|FG007|STARTED|Overall Study||9
10543126|NCT01482715|11696327|FG008|STARTED|Overall Study||7
10719369|NCT02709889|11883099|FG003|Malignant Melanoma|Overall Study||11
10719370|NCT02709889|11883096|FG000|Medullary Thyroid Cancer|Overall Study||3
10719371|NCT02709889|11883097|FG001|Medullary Thyroid Cancer|Overall Study||3
10719372|NCT02709889|11883098|FG002|Medullary Thyroid Cancer|Overall Study||0
10719373|NCT02709889|11883099|FG003|Medullary Thyroid Cancer|Overall Study||7
10719374|NCT02709889|11883096|FG000|Glioblastoma|Overall Study||4
10719375|NCT02709889|11883097|FG001|Glioblastoma|Overall Study||4
10393718|NCT00678561|11536955|FG004|NOT COMPLETED|Overall Study||2
10393719|NCT00678561|11536956|FG005|NOT COMPLETED|Overall Study||1
10393720|NCT00678561|11536957|FG006|NOT COMPLETED|Overall Study||0
10393721|NCT00678561|11536958|FG007|NOT COMPLETED|Overall Study||1
10393722|NCT00678587|11536985|FG000|STARTED|Overall Study||147
10719376|NCT02709889|11883098|FG002|Glioblastoma|Overall Study||1
10719377|NCT02709889|11883099|FG003|Glioblastoma|Overall Study||14
10719378|NCT02709889|11883096|FG000|Other Solid Tumors|Overall Study||9
10719379|NCT02709889|11883097|FG001|Other Solid Tumors|Overall Study||16
10719380|NCT02709889|11883098|FG002|Other Solid Tumors|Overall Study||3
10719381|NCT02709889|11883099|FG003|Other Solid Tumors|Overall Study||15
10719382|NCT02709889|11883096|FG000|COMPLETED|Overall Study||0
10719383|NCT02709889|11883097|FG001|COMPLETED|Overall Study||0
10719384|NCT02709889|11883098|FG002|COMPLETED|Overall Study||0
10719385|NCT02709889|11883099|FG003|COMPLETED|Overall Study||0
10719386|NCT02709889|11883096|FG000|NOT COMPLETED|Overall Study||43
10719387|NCT02709889|11883097|FG001|NOT COMPLETED|Overall Study||57
10719388|NCT02709889|11883098|FG002|NOT COMPLETED|Overall Study||12
10719389|NCT02709889|11883099|FG003|NOT COMPLETED|Overall Study||88
10719390|NCT02710045|11883147|FG000|STARTED|Overall Study||106
10719391|NCT02710045|11883148|FG001|STARTED|Overall Study||115
10393723|NCT00678587|11536986|FG001|STARTED|Overall Study||145
10393724|NCT00678587|11536985|FG000|COMPLETED|Overall Study||127
10393725|NCT00678587|11536986|FG001|COMPLETED|Overall Study||127
10393726|NCT00678587|11536985|FG000|NOT COMPLETED|Overall Study||20
10393727|NCT00678587|11536986|FG001|NOT COMPLETED|Overall Study||18
10393728|NCT00678639|11536995|FG000|STARTED|Overall Study||53
10393729|NCT00678639|11536996|FG001|STARTED|Overall Study||57
10543127|NCT01482715|11696328|FG009|STARTED|Overall Study||3
10393730|NCT00678639|11536995|FG000|Hospital Discharge|Overall Study||53
10393731|NCT00678639|11536996|FG001|Hospital Discharge|Overall Study||57
10393732|NCT00678639|11536995|FG000|COMPLETED|Overall Study||51
10393733|NCT00678639|11536996|FG001|COMPLETED|Overall Study||57
10393734|NCT00678639|11536995|FG000|NOT COMPLETED|Overall Study||2
10393735|NCT00678639|11536996|FG001|NOT COMPLETED|Overall Study||0
10393736|NCT00678652|11537007|FG000|STARTED|Overall Study||9
10393737|NCT00678652|11537008|FG001|STARTED|Overall Study||9
10393738|NCT00678652|11537009|FG002|STARTED|Overall Study||9
10393739|NCT00678652|11537010|FG003|STARTED|Overall Study||9
10393740|NCT00678652|11537007|FG000|COMPLETED|Overall Study||6
10393741|NCT00678652|11537008|FG001|COMPLETED|Overall Study||9
10719392|NCT02710045|11883149|FG002|STARTED|Overall Study||81
10719393|NCT02710045|11883147|FG000|COMPLETED|Overall Study||95
10719394|NCT02710045|11883148|FG001|COMPLETED|Overall Study||98
10719395|NCT02710045|11883149|FG002|COMPLETED|Overall Study||68
10393742|NCT00678652|11537009|FG002|COMPLETED|Overall Study||8
10393743|NCT00678652|11537010|FG003|COMPLETED|Overall Study||9
10393744|NCT00678652|11537007|FG000|NOT COMPLETED|Overall Study||3
10393745|NCT00678652|11537008|FG001|NOT COMPLETED|Overall Study||0
10393746|NCT00678652|11537009|FG002|NOT COMPLETED|Overall Study||1
10393747|NCT00678652|11537010|FG003|NOT COMPLETED|Overall Study||0
10393748|NCT00678691|11537022|FG000|STARTED|Overall Study||27
10393749|NCT00678691|11537023|FG001|STARTED|Overall Study||28
10393750|NCT00678691|11537022|FG000|COMPLETED|Overall Study||21
10393751|NCT00678691|11537023|FG001|COMPLETED|Overall Study||24
10393752|NCT00678691|11537022|FG000|NOT COMPLETED|Overall Study||6
10393753|NCT00678691|11537023|FG001|NOT COMPLETED|Overall Study||4
10393754|NCT00678795|11537031|FG000|STARTED|Overall Study||67
10393755|NCT00678795|11537032|FG001|STARTED|Overall Study||68
10393756|NCT00678795|11537031|FG000|COMPLETED|Overall Study||56
10393757|NCT00678795|11537032|FG001|COMPLETED|Overall Study||62
10393758|NCT00678795|11537031|FG000|NOT COMPLETED|Overall Study||11
10393759|NCT00678795|11537032|FG001|NOT COMPLETED|Overall Study||6
10393760|NCT00678834|11537041|FG000|STARTED|Overall Study||40
10393761|NCT00678834|11537042|FG001|STARTED|Overall Study||15
10393762|NCT00678834|11537043|FG002|STARTED|Overall Study||25
10393763|NCT00678834|11537041|FG000|COMPLETED|Overall Study||24
10393764|NCT00678834|11537042|FG001|COMPLETED|Overall Study||15
10393765|NCT00678834|11537043|FG002|COMPLETED|Overall Study||16
10393766|NCT00678834|11537041|FG000|NOT COMPLETED|Overall Study||16
10393767|NCT00678834|11537042|FG001|NOT COMPLETED|Overall Study||0
10393768|NCT00678834|11537043|FG002|NOT COMPLETED|Overall Study||9
10393769|NCT00678886|11537063|FG000|STARTED|Overall Study||10
10393770|NCT00678886|11537064|FG001|STARTED|Overall Study||19
10393771|NCT00678886|11537065|FG002|STARTED|Overall Study||81
10393772|NCT00678886|11537066|FG003|STARTED|Overall Study||162
10393773|NCT00678886|11537063|FG000|COMPLETED|Overall Study||10
10393774|NCT00678886|11537064|FG001|COMPLETED|Overall Study||19
10393775|NCT00678886|11537065|FG002|COMPLETED|Overall Study||72
10393776|NCT00678886|11537066|FG003|COMPLETED|Overall Study||153
10393777|NCT00678886|11537063|FG000|NOT COMPLETED|Overall Study||0
10393778|NCT00678886|11537064|FG001|NOT COMPLETED|Overall Study||0
10393779|NCT00678886|11537065|FG002|NOT COMPLETED|Overall Study||9
10393780|NCT00678886|11537066|FG003|NOT COMPLETED|Overall Study||9
10393781|NCT00678899|11537075|FG000|STARTED|Overall Study||50
10393782|NCT00678899|11537075|FG000|COMPLETED|Overall Study||49
10393783|NCT00678899|11537075|FG000|NOT COMPLETED|Overall Study||1
10393784|NCT00679029|11537080|FG000|STARTED|Overall Study||15
10393785|NCT00679029|11537080|FG000|COMPLETED|Overall Study||10
10393786|NCT00679029|11537080|FG000|NOT COMPLETED|Overall Study||5
10393796|NCT00679055|11537090|FG000|STARTED|Overall Study||8
10393797|NCT00679055|11537091|FG001|STARTED|Overall Study||6
10393798|NCT00679055|11537090|FG000|COMPLETED|Overall Study||6
10393799|NCT00679055|11537091|FG001|COMPLETED|Overall Study||1
10393800|NCT00679055|11537090|FG000|NOT COMPLETED|Overall Study||2
10393801|NCT00679055|11537091|FG001|NOT COMPLETED|Overall Study||5
10428681|NCT00859495|11574719|FG000|COMPLETED|Overall Study||9
10393802|NCT00679081|11537097|FG000|STARTED|Overall Study|Study design was within-subject control.|15
10393803|NCT00679081|11537097|FG000|COMPLETED|Overall Study||14
10658802|NCT02235831|11820002|FG000|COMPLETED|Period 2, Second 5 Days of Wear||4
10658803|NCT02235831|11820003|FG001|COMPLETED|Period 2, Second 5 Days of Wear||4
10813173|NCT02971839|11975466|FG001|STARTED|Overall Study||2
10308989|NCT00113516|11441877|FG000|NOT COMPLETED|Part 1||84
10308990|NCT00113516|11441878|FG001|NOT COMPLETED|Part 1||0
10308991|NCT00113516|11441877|FG000|STARTED|Part 2||0
10308992|NCT00113516|11441878|FG001|STARTED|Part 2||66
10308993|NCT00113516|11441877|FG000|COMPLETED|Part 2||0
10308994|NCT00113516|11441878|FG001|COMPLETED|Part 2||0
10308995|NCT00113516|11441877|FG000|NOT COMPLETED|Part 2||0
10308996|NCT00113516|11441878|FG001|NOT COMPLETED|Part 2||66
10308997|NCT00113529|11441884|FG000|STARTED|Overall Study|Phase 2 included 4 subjects from Phase 1 and 31 from Phase 2, for a total of 35 subjects.|35
10308998|NCT00113529|11441884|FG000|COMPLETED|Overall Study|Subject discontinued from the study and continued treatment on commercially available sunitinib.|1
10308999|NCT00113529|11441884|FG000|NOT COMPLETED|Overall Study||34
10309000|NCT00113555|11441888|FG000|STARTED|Overall Study||221
10309001|NCT00113555|11441888|FG000|TREATED|Overall Study|1 Additional Patient was treated on a compassionate use basis.|162
10309002|NCT00113555|11441888|FG000|COMPLETED|Overall Study|All treated patients were considered in the Intent to Treat analysis.|142
10309003|NCT00113555|11441888|FG000|NOT COMPLETED|Overall Study||79
10309004|NCT00113568|11441893|FG000|STARTED|Overall Study||784
10309005|NCT00113568|11441893|FG000|Intent to Treat Population|Overall Study||723
10309006|NCT00113568|11441893|FG000|COMPLETED|Overall Study||239
10309007|NCT00113568|11441893|FG000|NOT COMPLETED|Overall Study||545
10309008|NCT00113607|11441899|FG000|STARTED|Overall Study|Number of randomized participants|335
10309009|NCT00113607|11441900|FG001|STARTED|Overall Study|Number of randomized participants|337
10309010|NCT00113607|11441899|FG000|COMPLETED|Overall Study||0
10309011|NCT00113607|11441900|FG001|COMPLETED|Overall Study||0
10309012|NCT00113607|11441899|FG000|NOT COMPLETED|Overall Study||335
10309013|NCT00113607|11441900|FG001|NOT COMPLETED|Overall Study||337
10719396|NCT02710045|11883147|FG000|NOT COMPLETED|Overall Study||11
10719397|NCT02710045|11883148|FG001|NOT COMPLETED|Overall Study||17
10719398|NCT02710045|11883149|FG002|NOT COMPLETED|Overall Study||13
10719399|NCT02710071|11883159|FG000|STARTED|Placebo (2 Weeks).||21
10719400|NCT02710071|11883160|FG001|STARTED|Placebo (2 Weeks).||20
10719401|NCT02710071|11883159|FG000|COMPLETED|Placebo (2 Weeks).||21
10309022|NCT00113841|11441919|FG000|STARTED|Overall Study||16
10309023|NCT00113841|11441920|FG001|STARTED|Overall Study||17
10309024|NCT00113841|11441919|FG000|COMPLETED|Overall Study||15
10309025|NCT00113841|11441920|FG001|COMPLETED|Overall Study||15
10309026|NCT00113841|11441919|FG000|NOT COMPLETED|Overall Study||1
10309027|NCT00113841|11441920|FG001|NOT COMPLETED|Overall Study||2
10309028|NCT00113880|11441929|FG000|STARTED|Overall Study||63061
10309029|NCT00113880|11441930|FG001|STARTED|Overall Study||71949
10309030|NCT00113880|11441931|FG002|STARTED|Overall Study||62492
10309031|NCT00113880|11441929|FG000|COMPLETED|Overall Study||63061
10309032|NCT00113880|11441930|FG001|COMPLETED|Overall Study||71949
10309033|NCT00113880|11441931|FG002|COMPLETED|Overall Study||62492
10309034|NCT00113880|11441929|FG000|NOT COMPLETED|Overall Study||0
10309035|NCT00113880|11441930|FG001|NOT COMPLETED|Overall Study||0
10309036|NCT00113880|11441931|FG002|NOT COMPLETED|Overall Study||0
10309037|NCT00114114|11441952|FG000|STARTED|Overall Study||26
10309038|NCT00114114|11441953|FG001|STARTED|Overall Study||25
10309039|NCT00114114|11441954|FG002|STARTED|Overall Study||31
10309040|NCT00114114|11441955|FG003|STARTED|Overall Study||35
10309041|NCT00114114|11441956|FG004|STARTED|Overall Study||29
10309042|NCT00114114|11441957|FG005|STARTED|Overall Study||31
10309043|NCT00114114|11441952|FG000|COMPLETED|Overall Study||21
10309044|NCT00114114|11441953|FG001|COMPLETED|Overall Study||24
10309045|NCT00114114|11441954|FG002|COMPLETED|Overall Study||30
10309046|NCT00114114|11441955|FG003|COMPLETED|Overall Study||31
10309047|NCT00114114|11441956|FG004|COMPLETED|Overall Study||27
10309048|NCT00114114|11441957|FG005|COMPLETED|Overall Study||30
10309049|NCT00114114|11441952|FG000|NOT COMPLETED|Overall Study||5
10309050|NCT00114114|11441953|FG001|NOT COMPLETED|Overall Study||1
10309051|NCT00114114|11441954|FG002|NOT COMPLETED|Overall Study||1
10309052|NCT00114114|11441955|FG003|NOT COMPLETED|Overall Study||4
10309053|NCT00114114|11441956|FG004|NOT COMPLETED|Overall Study||2
10393804|NCT00679081|11537097|FG000|NOT COMPLETED|Overall Study||1
10719402|NCT02710071|11883160|FG001|COMPLETED|Placebo (2 Weeks).||20
10719403|NCT02710071|11883159|FG000|NOT COMPLETED|Placebo (2 Weeks).||0
10309054|NCT00114114|11441957|FG005|NOT COMPLETED|Overall Study||1
10309055|NCT00114127|11441975|FG000|STARTED|Overall Study||13
10309056|NCT00114127|11441976|FG001|STARTED|Overall Study||15
10309057|NCT00114127|11441975|FG000|COMPLETED|Overall Study||9
10309058|NCT00114127|11441976|FG001|COMPLETED|Overall Study||11
10309059|NCT00114127|11441975|FG000|NOT COMPLETED|Overall Study||4
10309060|NCT00114127|11441976|FG001|NOT COMPLETED|Overall Study||4
10309061|NCT00114166|11441984|FG000|STARTED|Overall Study||15
10309062|NCT00114166|11441985|FG001|STARTED|Overall Study||66
10309063|NCT00114166|11441984|FG000|COMPLETED|Overall Study||15
10393805|NCT00679172|11537110|FG000|STARTED|Overall Study||37
10719404|NCT02710071|11883160|FG001|NOT COMPLETED|Placebo (2 Weeks).||0
10719405|NCT02710071|11883159|FG000|STARTED|First Intervention (6 Weeks).||21
10719406|NCT02710071|11883160|FG001|STARTED|First Intervention (6 Weeks).||20
10719407|NCT02710071|11883159|FG000|COMPLETED|First Intervention (6 Weeks).||18
10719408|NCT02710071|11883160|FG001|COMPLETED|First Intervention (6 Weeks).||16
10393806|NCT00679172|11537111|FG001|STARTED|Overall Study||38
10393807|NCT00679172|11537112|FG002|STARTED|Overall Study||36
10393808|NCT00679172|11537113|FG003|STARTED|Overall Study||39
10393809|NCT00679172|11537114|FG004|STARTED|Overall Study||37
10393810|NCT00679172|11537110|FG000|COMPLETED|Overall Study||36
10393811|NCT00679172|11537111|FG001|COMPLETED|Overall Study||37
10393812|NCT00679172|11537112|FG002|COMPLETED|Overall Study||35
10393813|NCT00679172|11537113|FG003|COMPLETED|Overall Study||38
10393814|NCT00679172|11537114|FG004|COMPLETED|Overall Study||37
10393815|NCT00679172|11537110|FG000|NOT COMPLETED|Overall Study||1
10393816|NCT00679172|11537111|FG001|NOT COMPLETED|Overall Study||1
10393817|NCT00679172|11537112|FG002|NOT COMPLETED|Overall Study||1
10393818|NCT00679172|11537113|FG003|NOT COMPLETED|Overall Study||1
10393819|NCT00679172|11537114|FG004|NOT COMPLETED|Overall Study||0
10393820|NCT00679211|11537129|FG000|STARTED|Overall Study||110
10393821|NCT00679211|11537129|FG000|COMPLETED|Overall Study||0
10393822|NCT00679211|11537129|FG000|NOT COMPLETED|Overall Study||110
10393823|NCT00679263|11537138|FG000|STARTED|Visit 3/Dose 2||10
10393824|NCT00679263|11537139|FG001|STARTED|Visit 3/Dose 2||11
10393825|NCT00679263|11537140|FG002|STARTED|Visit 3/Dose 2||11
10393826|NCT00679263|11537138|FG000|COMPLETED|Visit 3/Dose 2||9
10393827|NCT00679263|11537139|FG001|COMPLETED|Visit 3/Dose 2||6
10393828|NCT00679263|11537140|FG002|COMPLETED|Visit 3/Dose 2||11
10393829|NCT00679263|11537138|FG000|NOT COMPLETED|Visit 3/Dose 2||1
10393830|NCT00679263|11537139|FG001|NOT COMPLETED|Visit 3/Dose 2||5
10393831|NCT00679263|11537140|FG002|NOT COMPLETED|Visit 3/Dose 2||0
10393832|NCT00679263|11537138|FG000|STARTED|Visit 2/Dose 1||11
10719409|NCT02710071|11883159|FG000|NOT COMPLETED|First Intervention (6 Weeks).||3
10719410|NCT02710071|11883160|FG001|NOT COMPLETED|First Intervention (6 Weeks).||4
10719411|NCT02710071|11883159|FG000|STARTED|Second Intervention (6 Weeks).||18
10393833|NCT00679263|11537139|FG001|STARTED|Visit 2/Dose 1||6
10393834|NCT00679263|11537140|FG002|STARTED|Visit 2/Dose 1||11
10393835|NCT00679263|11537138|FG000|COMPLETED|Visit 2/Dose 1||9
10393836|NCT00679263|11537139|FG001|COMPLETED|Visit 2/Dose 1||5
10393837|NCT00679263|11537140|FG002|COMPLETED|Visit 2/Dose 1||11
10393838|NCT00679263|11537138|FG000|NOT COMPLETED|Visit 2/Dose 1||2
10393839|NCT00679263|11537139|FG001|NOT COMPLETED|Visit 2/Dose 1||1
10393840|NCT00679263|11537140|FG002|NOT COMPLETED|Visit 2/Dose 1||0
10393841|NCT00679289|11537151|FG000|STARTED|Overall Study||6
10393842|NCT00679289|11537152|FG001|STARTED|Overall Study||6
10393843|NCT00679289|11537153|FG002|STARTED|Overall Study||24
10393844|NCT00679289|11537151|FG000|COMPLETED|Overall Study||1
10393845|NCT00679289|11537152|FG001|COMPLETED|Overall Study||0
10393846|NCT00679289|11537153|FG002|COMPLETED|Overall Study||1
10393847|NCT00679289|11537151|FG000|NOT COMPLETED|Overall Study||5
10393848|NCT00679289|11537152|FG001|NOT COMPLETED|Overall Study||6
10393849|NCT00679289|11537153|FG002|NOT COMPLETED|Overall Study||23
10393850|NCT00679302|11537165|FG000|STARTED|Overall Study||84
10393851|NCT00679302|11537166|FG001|STARTED|Overall Study||77
10393852|NCT00679302|11537165|FG000|COMPLETED|Overall Study||76
10393853|NCT00679302|11537166|FG001|COMPLETED|Overall Study||73
10393854|NCT00679302|11537165|FG000|NOT COMPLETED|Overall Study||8
10393855|NCT00679302|11537166|FG001|NOT COMPLETED|Overall Study||4
10393856|NCT00679341|11537174|FG000|STARTED|Overall Study||67
10393857|NCT00679341|11537175|FG001|STARTED|Overall Study||70
10393858|NCT00679341|11537174|FG000|COMPLETED|Overall Study||14
10393859|NCT00679341|11537175|FG001|COMPLETED|Overall Study||19
10393860|NCT00679341|11537174|FG000|NOT COMPLETED|Overall Study||53
10393861|NCT00679341|11537175|FG001|NOT COMPLETED|Overall Study||51
10393862|NCT00679354|11537182|FG000|STARTED|Overall Study||30
10393863|NCT00679354|11537182|FG000|COMPLETED|Overall Study||0
10393864|NCT00679354|11537182|FG000|NOT COMPLETED|Overall Study||30
10393865|NCT00679367|11537187|FG000|STARTED|Overall Study||16
10393866|NCT00679367|11537187|FG000|COMPLETED|Overall Study||4
10393867|NCT00679367|11537187|FG000|NOT COMPLETED|Overall Study||12
10393868|NCT00679380|11537196|FG000|STARTED|Overall Study||109
10393869|NCT00679380|11537197|FG001|STARTED|Overall Study||109
10393870|NCT00679380|11537198|FG002|STARTED|Overall Study||103
10393871|NCT00679380|11537199|FG003|STARTED|Overall Study||89
10393872|NCT00679380|11537196|FG000|COMPLETED|Overall Study||67
10393873|NCT00679380|11537197|FG001|COMPLETED|Overall Study||76
10393874|NCT00679380|11537198|FG002|COMPLETED|Overall Study||68
10393875|NCT00679380|11537199|FG003|COMPLETED|Overall Study||61
10393876|NCT00679380|11537196|FG000|NOT COMPLETED|Overall Study||42
10393877|NCT00679380|11537197|FG001|NOT COMPLETED|Overall Study||33
10393878|NCT00679380|11537198|FG002|NOT COMPLETED|Overall Study||35
10393879|NCT00679380|11537199|FG003|NOT COMPLETED|Overall Study||28
10393880|NCT00679432|11537213|FG000|STARTED|Overall Study||126
10393881|NCT00679432|11537214|FG001|STARTED|Overall Study||127
10393882|NCT00679432|11537215|FG002|STARTED|Overall Study||129
10393883|NCT00679432|11537216|FG003|STARTED|Overall Study||127
10393884|NCT00679432|11537213|FG000|COMPLETED|Overall Study||89
10393885|NCT00679432|11537214|FG001|COMPLETED|Overall Study||89
10393886|NCT00679432|11537215|FG002|COMPLETED|Overall Study||76
10393887|NCT00679432|11537216|FG003|COMPLETED|Overall Study||95
10393888|NCT00679432|11537213|FG000|NOT COMPLETED|Overall Study||37
10393889|NCT00679432|11537214|FG001|NOT COMPLETED|Overall Study||38
10393890|NCT00679432|11537215|FG002|NOT COMPLETED|Overall Study||53
10393891|NCT00679432|11537216|FG003|NOT COMPLETED|Overall Study||32
10393892|NCT00679549|11537228|FG000|STARTED|Overall Study||75
10393893|NCT00679549|11537229|FG001|STARTED|Overall Study||75
10393894|NCT00679549|11537228|FG000|COMPLETED|Overall Study||69
10393895|NCT00679549|11537229|FG001|COMPLETED|Overall Study|4 dropouts in the control arm; 5 missing echocardiograms in the control arm|66
10393896|NCT00679549|11537228|FG000|NOT COMPLETED|Overall Study||6
10393897|NCT00679549|11537229|FG001|NOT COMPLETED|Overall Study||9
10393898|NCT00679627|11537237|FG000|STARTED|Overall Study||1021
10393899|NCT00679627|11537238|FG001|STARTED|Overall Study||1024
10393900|NCT00679627|11537237|FG000|COMPLETED|Overall Study||322
10393901|NCT00679627|11537238|FG001|COMPLETED|Overall Study||339
10393902|NCT00679627|11537237|FG000|NOT COMPLETED|Overall Study||699
10393903|NCT00679627|11537238|FG001|NOT COMPLETED|Overall Study||685
10393904|NCT00679913|11537246|FG000|STARTED|Overall Study||101
10393905|NCT00679913|11537247|FG001|STARTED|Overall Study||99
10393906|NCT00679913|11537246|FG000|COMPLETED|Overall Study||83
10393907|NCT00679913|11537247|FG001|COMPLETED|Overall Study||86
10393908|NCT00679913|11537246|FG000|NOT COMPLETED|Overall Study||18
10393909|NCT00679913|11537247|FG001|NOT COMPLETED|Overall Study||13
10393910|NCT00679939|11537256|FG000|STARTED|52-Week Double-Blind (DB) Period||114
10393911|NCT00679939|11537257|FG001|STARTED|52-Week Double-Blind (DB) Period||112
10393912|NCT00679939|11537256|FG000|COMPLETED|52-Week Double-Blind (DB) Period||77
10393913|NCT00679939|11537257|FG001|COMPLETED|52-Week Double-Blind (DB) Period||85
10393914|NCT00679939|11537256|FG000|NOT COMPLETED|52-Week Double-Blind (DB) Period||37
10393915|NCT00679939|11537257|FG001|NOT COMPLETED|52-Week Double-Blind (DB) Period||27
10393916|NCT00679939|11537256|FG000|STARTED|24-Week Open-Label (OL) Period|One participant who completed the DB Period did not receive the OL dose of MET.|76
10393917|NCT00679939|11537257|FG001|STARTED|24-Week Open-Label (OL) Period|One participant who completed the DB Period did not receive the OL dose of MET.|84
10393918|NCT00679939|11537256|FG000|COMPLETED|24-Week Open-Label (OL) Period||69
10393919|NCT00679939|11537257|FG001|COMPLETED|24-Week Open-Label (OL) Period||80
10393920|NCT00679939|11537256|FG000|NOT COMPLETED|24-Week Open-Label (OL) Period||7
10393921|NCT00679939|11537257|FG001|NOT COMPLETED|24-Week Open-Label (OL) Period||4
10393922|NCT00679952|11537269|FG000|STARTED|Overall Study||86
10393923|NCT00679952|11537270|FG001|STARTED|Overall Study||82
10393924|NCT00679952|11537269|FG000|COMPLETED|Overall Study||86
10393925|NCT00679952|11537270|FG001|COMPLETED|Overall Study||82
10393926|NCT00679952|11537269|FG000|NOT COMPLETED|Overall Study||0
10393927|NCT00679952|11537270|FG001|NOT COMPLETED|Overall Study||0
10393928|NCT00680017|11537278|FG000|STARTED|Overall Study||140
10393929|NCT00680017|11537279|FG001|STARTED|Overall Study||140
10393930|NCT00680017|11537278|FG000|COMPLETED|Overall Study||123
10393931|NCT00680017|11537279|FG001|COMPLETED|Overall Study||128
10393932|NCT00680017|11537278|FG000|NOT COMPLETED|Overall Study||17
10393933|NCT00680017|11537279|FG001|NOT COMPLETED|Overall Study||12
10393934|NCT00680043|11537288|FG000|STARTED|Overall Study||39
10393935|NCT00680043|11537289|FG001|STARTED|Overall Study||37
10393936|NCT00680043|11537290|FG002|STARTED|Overall Study||38
10309064|NCT00114166|11441985|FG001|COMPLETED|Overall Study||65
10309065|NCT00114166|11441984|FG000|NOT COMPLETED|Overall Study||0
10309066|NCT00114166|11441985|FG001|NOT COMPLETED|Overall Study||1
10309067|NCT00114218|11441993|FG000|STARTED|Overall Study||28
10309068|NCT00114218|11441993|FG000|COMPLETED|Overall Study||24
10309069|NCT00114218|11441993|FG000|NOT COMPLETED|Overall Study||4
10309070|NCT00114231|11441999|FG000|STARTED|Overall Study||62
10309071|NCT00114231|11442000|FG001|STARTED|Overall Study||28
10309072|NCT00114231|11441999|FG000|COMPLETED|Overall Study||53
10309073|NCT00114231|11442000|FG001|COMPLETED|Overall Study||26
10309074|NCT00114231|11441999|FG000|NOT COMPLETED|Overall Study||9
10309075|NCT00114231|11442000|FG001|NOT COMPLETED|Overall Study||2
10309076|NCT00114244|11442007|FG000|STARTED|Overall Study||15
10309077|NCT00114244|11442008|FG001|STARTED|Overall Study||37
10309078|NCT00114244|11442007|FG000|COMPLETED|Overall Study||13
10309079|NCT00114244|11442008|FG001|COMPLETED|Overall Study||30
10309080|NCT00114244|11442007|FG000|NOT COMPLETED|Overall Study||2
10309081|NCT00114244|11442008|FG001|NOT COMPLETED|Overall Study||7
10309082|NCT00114504|11442016|FG000|STARTED|Overall Study||21
10309083|NCT00114504|11442017|FG001|STARTED|Overall Study||22
10309084|NCT00114504|11442016|FG000|COMPLETED|Overall Study||21
10309085|NCT00114504|11442017|FG001|COMPLETED|Overall Study||22
10309086|NCT00114504|11442016|FG000|NOT COMPLETED|Overall Study||0
10309087|NCT00114504|11442017|FG001|NOT COMPLETED|Overall Study||0
10309088|NCT00114517|11442031|FG000|STARTED|Overall Study||137
10309089|NCT00114517|11442032|FG001|STARTED|Overall Study||134
10309090|NCT00114517|11442033|FG002|STARTED|Overall Study||186
10309091|NCT00114517|11442034|FG003|STARTED|Overall Study||186
10309092|NCT00114517|11442031|FG000|COMPLETED|Overall Study||125
10309093|NCT00114517|11442032|FG001|COMPLETED|Overall Study||123
10309094|NCT00114517|11442033|FG002|COMPLETED|Overall Study||172
10309095|NCT00114517|11442034|FG003|COMPLETED|Overall Study||176
10309096|NCT00114517|11442031|FG000|NOT COMPLETED|Overall Study||12
10309097|NCT00114517|11442032|FG001|NOT COMPLETED|Overall Study||11
10309098|NCT00114517|11442033|FG002|NOT COMPLETED|Overall Study||14
10309099|NCT00114517|11442034|FG003|NOT COMPLETED|Overall Study||10
10309100|NCT00114530|11442042|FG000|STARTED|Overall Study||36
10309101|NCT00114530|11442043|FG001|STARTED|Overall Study||39
10309102|NCT00114530|11442042|FG000|COMPLETED|Overall Study|Completed 72 mo, 54 mo after failure, or at least 54 mo at study end (last patient's 54 mo visit)|27
10309103|NCT00114530|11442043|FG001|COMPLETED|Overall Study|Completed 72 mo, 54 mo after failure, or at least 54 mo at study end (last patient's 54 mo visit)|19
10309104|NCT00114530|11442042|FG000|NOT COMPLETED|Overall Study||9
10309105|NCT00114530|11442043|FG001|NOT COMPLETED|Overall Study||20
10309106|NCT00114634|11442053|FG000|STARTED|Overall Study||13
10309107|NCT00114634|11442053|FG000|COMPLETED|Overall Study|Assessment forms lost by one failure to complete and return forms by two|10
10309108|NCT00114634|11442053|FG000|NOT COMPLETED|Overall Study||3
10309109|NCT00114738|11442059|FG000|STARTED|Bortezomib Then Bortezomib + Induction||53
10309110|NCT00114738|11442060|FG001|STARTED|Bortezomib Then Bortezomib + Induction||0
10309111|NCT00114738|11442061|FG002|STARTED|Bortezomib Then Bortezomib + Induction||0
10309112|NCT00114738|11442059|FG000|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||47
10309113|NCT00114738|11442060|FG001|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
10309114|NCT00114738|11442061|FG002|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
10309115|NCT00114738|11442059|FG000|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||6
10309116|NCT00114738|11442060|FG001|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
10309117|NCT00114738|11442061|FG002|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
10309118|NCT00114738|11442059|FG000|COMPLETED|Bortezomib Then Bortezomib + Induction||51
10309119|NCT00114738|11442060|FG001|COMPLETED|Bortezomib Then Bortezomib + Induction||0
10309120|NCT00114738|11442061|FG002|COMPLETED|Bortezomib Then Bortezomib + Induction||0
10309121|NCT00114738|11442059|FG000|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||2
10309122|NCT00114738|11442060|FG001|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||0
10309123|NCT00114738|11442061|FG002|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||0
10309124|NCT00114738|11442059|FG000|STARTED|Screening for Randomization||51
10309125|NCT00114738|11442060|FG001|STARTED|Screening for Randomization||0
10309126|NCT00114738|11442061|FG002|STARTED|Screening for Randomization||0
10309127|NCT00114738|11442059|FG000|COMPLETED|Screening for Randomization||30
10309128|NCT00114738|11442060|FG001|COMPLETED|Screening for Randomization||0
10309129|NCT00114738|11442061|FG002|COMPLETED|Screening for Randomization||0
10309130|NCT00114738|11442059|FG000|NOT COMPLETED|Screening for Randomization||21
10309131|NCT00114738|11442060|FG001|NOT COMPLETED|Screening for Randomization||0
10309132|NCT00114738|11442061|FG002|NOT COMPLETED|Screening for Randomization||0
10309133|NCT00114738|11442059|FG000|STARTED|Randomization||0
10309134|NCT00114738|11442060|FG001|STARTED|Randomization||14
10309135|NCT00114738|11442061|FG002|STARTED|Randomization||16
10309136|NCT00114738|11442059|FG000|COMPLETED|Randomization||0
10309137|NCT00114738|11442060|FG001|COMPLETED|Randomization||14
10309138|NCT00114738|11442061|FG002|COMPLETED|Randomization||16
10309139|NCT00114738|11442059|FG000|NOT COMPLETED|Randomization||0
10309140|NCT00114738|11442060|FG001|NOT COMPLETED|Randomization||0
10309141|NCT00114738|11442061|FG002|NOT COMPLETED|Randomization||0
10309142|NCT00114777|11442071|FG000|STARTED|Randomization to Month 36||184
10309143|NCT00114777|11442072|FG001|STARTED|Randomization to Month 36||175
10309144|NCT00114777|11442073|FG002|STARTED|Randomization to Month 36||184
10309145|NCT00114777|11442071|FG000|COMPLETED|Randomization to Month 36||109
10393937|NCT00680043|11537288|FG000|COMPLETED|Overall Study||37
10393938|NCT00680043|11537289|FG001|COMPLETED|Overall Study||36
10393939|NCT00680043|11537290|FG002|COMPLETED|Overall Study||34
10393940|NCT00680043|11537288|FG000|NOT COMPLETED|Overall Study||2
10393941|NCT00680043|11537289|FG001|NOT COMPLETED|Overall Study||1
10393942|NCT00680043|11537290|FG002|NOT COMPLETED|Overall Study||4
10393943|NCT00680056|11537300|FG000|STARTED|First Intervention||16
10393944|NCT00680056|11537301|FG001|STARTED|First Intervention||17
10393945|NCT00680056|11537300|FG000|COMPLETED|First Intervention||15
10393946|NCT00680056|11537301|FG001|COMPLETED|First Intervention||15
10393947|NCT00680056|11537300|FG000|NOT COMPLETED|First Intervention||1
10393948|NCT00680056|11537301|FG001|NOT COMPLETED|First Intervention||2
10393949|NCT00680056|11537300|FG000|STARTED|Washout Period of One Week||15
10393950|NCT00680056|11537301|FG001|STARTED|Washout Period of One Week||15
10393951|NCT00680056|11537300|FG000|COMPLETED|Washout Period of One Week||15
10393952|NCT00680056|11537301|FG001|COMPLETED|Washout Period of One Week||15
10393953|NCT00680056|11537300|FG000|NOT COMPLETED|Washout Period of One Week||0
10393954|NCT00680056|11537301|FG001|NOT COMPLETED|Washout Period of One Week||0
10393955|NCT00680056|11537300|FG000|STARTED|Second Intervention||15
10393956|NCT00680056|11537301|FG001|STARTED|Second Intervention||15
10393957|NCT00680056|11537300|FG000|COMPLETED|Second Intervention||12
10393958|NCT00680056|11537301|FG001|COMPLETED|Second Intervention||14
10393959|NCT00680056|11537300|FG000|NOT COMPLETED|Second Intervention||3
10393960|NCT00680056|11537301|FG001|NOT COMPLETED|Second Intervention||1
10393961|NCT00680121|11537310|FG000|STARTED|Overall Study||60
10393962|NCT00680121|11537311|FG001|STARTED|Overall Study||60
10393963|NCT00680121|11537310|FG000|COMPLETED|Overall Study||33
10393964|NCT00680121|11537311|FG001|COMPLETED|Overall Study||37
10393965|NCT00680121|11537310|FG000|NOT COMPLETED|Overall Study||27
10393966|NCT00680121|11537311|FG001|NOT COMPLETED|Overall Study||23
10393967|NCT00680186|11537319|FG000|STARTED|Overall Study|Started treatment.|1280
10393968|NCT00680186|11537320|FG001|STARTED|Overall Study|Started treatment.|1288
10393969|NCT00680186|11537319|FG000|COMPLETED|Overall Study|Completed planned observation time.|1155
10393970|NCT00680186|11537320|FG001|COMPLETED|Overall Study|Completed planned observation time.|1172
10393971|NCT00680186|11537319|FG000|NOT COMPLETED|Overall Study||125
10393972|NCT00680186|11537320|FG001|NOT COMPLETED|Overall Study||116
10393973|NCT00680225|11537326|FG000|STARTED|Overall Study||10
10393974|NCT00680225|11537326|FG000|COMPLETED|Overall Study||8
10393975|NCT00680225|11537326|FG000|NOT COMPLETED|Overall Study||2
10393976|NCT00680368|11537330|FG000|STARTED|Overall Study||112
10393977|NCT00680368|11537330|FG000|COMPLETED|Overall Study|15 residents excluded because their attending physician was not participating in the study|97
10393978|NCT00680368|11537330|FG000|NOT COMPLETED|Overall Study||15
10393979|NCT00680407|11537339|FG000|STARTED|Overall Study||26
10393980|NCT00680407|11537340|FG001|STARTED|Overall Study||27
10393981|NCT00680407|11537341|FG002|STARTED|Overall Study||25
10393982|NCT00680407|11537339|FG000|COMPLETED|Overall Study||18
10393983|NCT00680407|11537340|FG001|COMPLETED|Overall Study||22
10393984|NCT00680407|11537341|FG002|COMPLETED|Overall Study||22
10393985|NCT00680407|11537339|FG000|NOT COMPLETED|Overall Study||8
10393986|NCT00680407|11537340|FG001|NOT COMPLETED|Overall Study||5
10393987|NCT00680407|11537341|FG002|NOT COMPLETED|Overall Study||3
10393988|NCT00680459|11537351|FG000|STARTED|Overall Study||7
10393989|NCT00680459|11537352|FG001|STARTED|Overall Study||6
10393990|NCT00680459|11537351|FG000|COMPLETED|Overall Study||7
10393991|NCT00680459|11537352|FG001|COMPLETED|Overall Study||6
10393992|NCT00680459|11537351|FG000|NOT COMPLETED|Overall Study||0
10543128|NCT01482715|11696329|FG010|STARTED|Overall Study||42
10543129|NCT01482715|11696330|FG011|STARTED|Overall Study||12
10543130|NCT01482715|11696331|FG012|STARTED|Overall Study||26
10543131|NCT01482715|11696319|FG000|COMPLETED|Overall Study||6
10543132|NCT01482715|11696320|FG001|COMPLETED|Overall Study||3
10543133|NCT01482715|11696321|FG002|COMPLETED|Overall Study||4
10543134|NCT01482715|11696322|FG003|COMPLETED|Overall Study||9
10393993|NCT00680459|11537352|FG001|NOT COMPLETED|Overall Study||0
10393994|NCT00680524|11537358|FG000|STARTED|Overall Study||20
10393995|NCT00680524|11537358|FG000|COMPLETED|Overall Study||17
10393996|NCT00680524|11537358|FG000|NOT COMPLETED|Overall Study||3
10393997|NCT00680628|11537364|FG000|STARTED|Overall Study||43
10393998|NCT00680628|11537365|FG001|STARTED|Overall Study||40
10393999|NCT00680628|11537364|FG000|COMPLETED|Overall Study||43
10394000|NCT00680628|11537365|FG001|COMPLETED|Overall Study||40
10394001|NCT00680628|11537364|FG000|NOT COMPLETED|Overall Study||0
10394002|NCT00680628|11537365|FG001|NOT COMPLETED|Overall Study||0
10394003|NCT00680706|11537373|FG000|STARTED|Overall Study||70
10394004|NCT00680706|11537374|FG001|STARTED|Overall Study||60
10394005|NCT00680706|11537373|FG000|COMPLETED|Overall Study||63
10394006|NCT00680706|11537374|FG001|COMPLETED|Overall Study||55
10543135|NCT01482715|11696323|FG004|COMPLETED|Overall Study||4
10309146|NCT00114777|11442072|FG001|COMPLETED|Randomization to Month 36||114
10309147|NCT00114777|11442073|FG002|COMPLETED|Randomization to Month 36||100
10309148|NCT00114777|11442071|FG000|NOT COMPLETED|Randomization to Month 36||75
10309149|NCT00114777|11442072|FG001|NOT COMPLETED|Randomization to Month 36||61
10309150|NCT00114777|11442073|FG002|NOT COMPLETED|Randomization to Month 36||84
10309151|NCT00114777|11442071|FG000|STARTED|Long-Term Extension to Month 84||104
10309152|NCT00114777|11442072|FG001|STARTED|Long-Term Extension to Month 84||113
10309153|NCT00114777|11442073|FG002|STARTED|Long-Term Extension to Month 84||87
10309154|NCT00114777|11442071|FG000|COMPLETED|Long-Term Extension to Month 84||74
10309155|NCT00114777|11442072|FG001|COMPLETED|Long-Term Extension to Month 84||84
10309156|NCT00114777|11442073|FG002|COMPLETED|Long-Term Extension to Month 84||57
10309157|NCT00114777|11442071|FG000|NOT COMPLETED|Long-Term Extension to Month 84||30
10309158|NCT00114777|11442072|FG001|NOT COMPLETED|Long-Term Extension to Month 84||29
10309159|NCT00114777|11442073|FG002|NOT COMPLETED|Long-Term Extension to Month 84||30
10309160|NCT00114959|11442082|FG000|STARTED|Overall Study||15
10309161|NCT00114959|11442082|FG000|COMPLETED|Overall Study|protocol definition of completed study is having received >= 4 cycles of treatment|7
10309162|NCT00114959|11442082|FG000|NOT COMPLETED|Overall Study||8
10309163|NCT00114972|11442088|FG000|STARTED|Overall Study||897
10309164|NCT00114972|11442089|FG001|STARTED|Overall Study||903
10309165|NCT00114972|11442088|FG000|COMPLETED|Overall Study||849
10309166|NCT00114972|11442089|FG001|COMPLETED|Overall Study||891
10309167|NCT00114972|11442088|FG000|NOT COMPLETED|Overall Study||48
10309168|NCT00114972|11442089|FG001|NOT COMPLETED|Overall Study||12
10309169|NCT00115037|11442097|FG000|STARTED|Phase1||152
10309170|NCT00115037|11442098|FG001|STARTED|Phase1||150
10309171|NCT00115037|11442099|FG002|STARTED|Phase1||0
10309172|NCT00115037|11442100|FG003|STARTED|Phase1||0
10309173|NCT00115037|11442101|FG004|STARTED|Phase1||0
10309174|NCT00115037|11442102|FG005|STARTED|Phase1||0
10309175|NCT00115037|11442097|FG000|COMPLETED|Phase1||127
10309176|NCT00115037|11442098|FG001|COMPLETED|Phase1||123
10309177|NCT00115037|11442099|FG002|COMPLETED|Phase1||0
10309178|NCT00115037|11442100|FG003|COMPLETED|Phase1||0
10309179|NCT00115037|11442101|FG004|COMPLETED|Phase1||0
10309180|NCT00115037|11442102|FG005|COMPLETED|Phase1||0
10309181|NCT00115037|11442097|FG000|NOT COMPLETED|Phase1||25
10309182|NCT00115037|11442098|FG001|NOT COMPLETED|Phase1||27
10309183|NCT00115037|11442099|FG002|NOT COMPLETED|Phase1||0
10309184|NCT00115037|11442100|FG003|NOT COMPLETED|Phase1||0
10309185|NCT00115037|11442101|FG004|NOT COMPLETED|Phase1||0
10309186|NCT00115037|11442102|FG005|NOT COMPLETED|Phase1||0
10309187|NCT00115037|11442097|FG000|STARTED|Phase2||0
10309188|NCT00115037|11442098|FG001|STARTED|Phase2||0
10309189|NCT00115037|11442099|FG002|STARTED|Phase2||91
10309190|NCT00115037|11442100|FG003|STARTED|Phase2||92
10309191|NCT00115037|11442101|FG004|STARTED|Phase2||34
10309192|NCT00115037|11442102|FG005|STARTED|Phase2||33
10309193|NCT00115037|11442097|FG000|COMPLETED|Phase2||0
10309194|NCT00115037|11442098|FG001|COMPLETED|Phase2||0
10309195|NCT00115037|11442099|FG002|COMPLETED|Phase2||76
10309196|NCT00115037|11442100|FG003|COMPLETED|Phase2||77
10309197|NCT00115037|11442101|FG004|COMPLETED|Phase2||28
10309198|NCT00115037|11442102|FG005|COMPLETED|Phase2||21
10309199|NCT00115037|11442097|FG000|NOT COMPLETED|Phase2||0
10309200|NCT00115037|11442098|FG001|NOT COMPLETED|Phase2||0
10309201|NCT00115037|11442099|FG002|NOT COMPLETED|Phase2||15
10309202|NCT00115037|11442100|FG003|NOT COMPLETED|Phase2||15
10309203|NCT00115037|11442101|FG004|NOT COMPLETED|Phase2||6
10394007|NCT00680706|11537373|FG000|NOT COMPLETED|Overall Study||7
10394008|NCT00680706|11537374|FG001|NOT COMPLETED|Overall Study||5
10394009|NCT00680745|11537384|FG000|STARTED|Overall Study|Safety Analysis Set|154
10394010|NCT00680745|11537385|FG001|STARTED|Overall Study|Safety Analysis Set|145
10394011|NCT00680745|11537386|FG002|STARTED|Overall Study|Safety Analysis Set|151
10394012|NCT00680745|11537387|FG003|STARTED|Overall Study|Safety Analysis Set|146
10394013|NCT00680745|11537384|FG000|COMPLETED|Overall Study||140
10394014|NCT00680745|11537385|FG001|COMPLETED|Overall Study||132
10394015|NCT00680745|11537386|FG002|COMPLETED|Overall Study||141
10394016|NCT00680745|11537387|FG003|COMPLETED|Overall Study||133
10394017|NCT00680745|11537384|FG000|NOT COMPLETED|Overall Study||14
10394018|NCT00680745|11537385|FG001|NOT COMPLETED|Overall Study||13
10394019|NCT00680745|11537386|FG002|NOT COMPLETED|Overall Study||10
10394020|NCT00680745|11537387|FG003|NOT COMPLETED|Overall Study||13
10394021|NCT00680771|11537400|FG000|STARTED|Overall Study||15
10394022|NCT00680771|11537401|FG001|STARTED|Overall Study||13
10394023|NCT00680771|11537400|FG000|COMPLETED|Overall Study||9
10394024|NCT00680771|11537401|FG001|COMPLETED|Overall Study||11
10394025|NCT00680771|11537400|FG000|NOT COMPLETED|Overall Study||6
10394026|NCT00680771|11537401|FG001|NOT COMPLETED|Overall Study||2
10394027|NCT00680797|11537411|FG000|STARTED|Overall Study||9
10394028|NCT00680797|11537412|FG001|STARTED|Overall Study||8
10394029|NCT00680797|11537413|FG002|STARTED|Overall Study||8
10394030|NCT00680797|11537414|FG003|STARTED|Overall Study||8
10394031|NCT00680797|11537411|FG000|COMPLETED|Overall Study||9
10394032|NCT00680797|11537412|FG001|COMPLETED|Overall Study||8
10394033|NCT00680797|11537413|FG002|COMPLETED|Overall Study||8
10394034|NCT00680797|11537414|FG003|COMPLETED|Overall Study||8
10394035|NCT00680797|11537411|FG000|NOT COMPLETED|Overall Study||0
10394036|NCT00680797|11537412|FG001|NOT COMPLETED|Overall Study||0
10394037|NCT00680797|11537413|FG002|NOT COMPLETED|Overall Study||0
10394038|NCT00680797|11537414|FG003|NOT COMPLETED|Overall Study||0
10394039|NCT00680823|11537427|FG000|STARTED|Overall Study||50
10394040|NCT00680823|11537428|FG001|STARTED|Overall Study||50
10394041|NCT00680823|11537429|FG002|STARTED|Overall Study||50
10394042|NCT00680823|11537427|FG000|COMPLETED|Overall Study||50
10394043|NCT00680823|11537428|FG001|COMPLETED|Overall Study||50
10394044|NCT00680823|11537429|FG002|COMPLETED|Overall Study||50
10394045|NCT00680823|11537427|FG000|NOT COMPLETED|Overall Study||0
10394046|NCT00680823|11537428|FG001|NOT COMPLETED|Overall Study||0
10394047|NCT00680823|11537429|FG002|NOT COMPLETED|Overall Study||0
10394048|NCT00680836|11537439|FG000|STARTED|Overall Study||27
10394049|NCT00680836|11537440|FG001|STARTED|Overall Study||27
10394050|NCT00680836|11537439|FG000|COMPLETED|Overall Study||19
10394051|NCT00680836|11537440|FG001|COMPLETED|Overall Study||25
10394052|NCT00680836|11537439|FG000|NOT COMPLETED|Overall Study||8
10394053|NCT00680836|11537440|FG001|NOT COMPLETED|Overall Study||2
10394054|NCT00680862|11537447|FG000|STARTED|Overall Study||25
10394055|NCT00680862|11537447|FG000|COMPLETED|Overall Study||25
10394056|NCT00680862|11537447|FG000|NOT COMPLETED|Overall Study||0
10394057|NCT00680914|11537453|FG000|STARTED|Overall Study||374
10394058|NCT00680914|11537454|FG001|STARTED|Overall Study||129
10719412|NCT02710071|11883160|FG001|STARTED|Second Intervention (6 Weeks).||16
10719413|NCT02710071|11883159|FG000|COMPLETED|Second Intervention (6 Weeks).||17
10719414|NCT02710071|11883160|FG001|COMPLETED|Second Intervention (6 Weeks).||14
10719415|NCT02710071|11883159|FG000|NOT COMPLETED|Second Intervention (6 Weeks).||1
10719416|NCT02710071|11883160|FG001|NOT COMPLETED|Second Intervention (6 Weeks).||2
10719417|NCT02710136|11883169|FG000|STARTED|Study Enrollment||10
10719418|NCT02710136|11883170|FG001|STARTED|Study Enrollment||25
10719419|NCT02710136|11883169|FG000|COMPLETED|Study Enrollment||10
10719420|NCT02710136|11883170|FG001|COMPLETED|Study Enrollment||25
10719421|NCT02710136|11883169|FG000|NOT COMPLETED|Study Enrollment||0
10719422|NCT02710136|11883170|FG001|NOT COMPLETED|Study Enrollment||0
10719423|NCT02710136|11883169|FG000|STARTED|Phase 1a[Refer to Arm/Group Description]||10
10719424|NCT02710136|11883170|FG001|STARTED|Phase 1a[Refer to Arm/Group Description]||0
10394059|NCT00680914|11537453|FG000|COMPLETED|Overall Study||364
10394060|NCT00680914|11537454|FG001|COMPLETED|Overall Study||125
10394061|NCT00680914|11537453|FG000|NOT COMPLETED|Overall Study||10
10394062|NCT00680914|11537454|FG001|NOT COMPLETED|Overall Study||4
10394063|NCT00680953|11537463|FG000|STARTED|Overall Study||500
10394064|NCT00680953|11537464|FG001|STARTED|Overall Study||511
10394065|NCT00680953|11537465|FG002|STARTED|Overall Study||251
10394066|NCT00680953|11537463|FG000|COMPLETED|Overall Study||414
10394067|NCT00680953|11537464|FG001|COMPLETED|Overall Study||416
10394068|NCT00680953|11537465|FG002|COMPLETED|Overall Study||204
10394069|NCT00680953|11537463|FG000|NOT COMPLETED|Overall Study||86
10394070|NCT00680953|11537464|FG001|NOT COMPLETED|Overall Study||95
10394071|NCT00680953|11537465|FG002|NOT COMPLETED|Overall Study||47
10394087|NCT00681031|11537487|FG000|STARTED|Overall Study||96
10394088|NCT00681031|11537487|FG000|COMPLETED|Overall Study||96
10394089|NCT00681031|11537487|FG000|NOT COMPLETED|Overall Study||0
10719425|NCT02710136|11883169|FG000|COMPLETED|Phase 1a[Refer to Arm/Group Description]||9
10394090|NCT00681083|11537491|FG000|STARTED|Night 1|26 participants were initially consented (this is the total for the study).|13
10394091|NCT00681083|11537492|FG001|STARTED|Night 1|26 participants were initially consented (this is the total for the study).|13
10394092|NCT00681083|11537491|FG000|COMPLETED|Night 1|20 in total completed study. 10 randomized to arm 1 and arm 2 then crossed over to other arm.|10
10394093|NCT00681083|11537492|FG001|COMPLETED|Night 1|20 in total completed study. 10 randomized to arm 1 and arm 2 then crossed over to other arm.|10
10394094|NCT00681083|11537491|FG000|NOT COMPLETED|Night 1||3
10394095|NCT00681083|11537492|FG001|NOT COMPLETED|Night 1||3
10394096|NCT00681083|11537491|FG000|STARTED|Night 2 (Crossover of Night 1)||10
10394097|NCT00681083|11537492|FG001|STARTED|Night 2 (Crossover of Night 1)||10
10394098|NCT00681083|11537491|FG000|COMPLETED|Night 2 (Crossover of Night 1)||10
10394099|NCT00681083|11537492|FG001|COMPLETED|Night 2 (Crossover of Night 1)||10
10394100|NCT00681083|11537491|FG000|NOT COMPLETED|Night 2 (Crossover of Night 1)||0
10394101|NCT00681083|11537492|FG001|NOT COMPLETED|Night 2 (Crossover of Night 1)||0
10394102|NCT00681109|11537501|FG000|STARTED|Overall Study||30
10394103|NCT00681109|11537502|FG001|STARTED|Overall Study||30
10394104|NCT00681109|11537503|FG002|STARTED|Overall Study||15
10394105|NCT00681109|11537501|FG000|COMPLETED|Overall Study||28
10394106|NCT00681109|11537502|FG001|COMPLETED|Overall Study||24
10394107|NCT00681109|11537503|FG002|COMPLETED|Overall Study||15
10394108|NCT00681109|11537501|FG000|NOT COMPLETED|Overall Study||2
10394109|NCT00681109|11537502|FG001|NOT COMPLETED|Overall Study||6
10394110|NCT00681109|11537503|FG002|NOT COMPLETED|Overall Study||0
10394111|NCT00681187|11537516|FG000|STARTED|Overall Study||11
10394112|NCT00681187|11537517|FG001|STARTED|Overall Study||15
10394113|NCT00681187|11537516|FG000|COMPLETED|Overall Study||10
10394114|NCT00681187|11537517|FG001|COMPLETED|Overall Study||13
10394115|NCT00681187|11537516|FG000|NOT COMPLETED|Overall Study||1
10394116|NCT00681187|11537517|FG001|NOT COMPLETED|Overall Study||2
10394117|NCT00681265|11537536|FG000|STARTED|Overall Study||16
10394118|NCT00681265|11537536|FG000|COMPLETED|Overall Study||16
10394119|NCT00681265|11537536|FG000|NOT COMPLETED|Overall Study||0
10394120|NCT00681291|11537544|FG000|STARTED|Overall Study||88
10394121|NCT00681291|11537545|FG001|STARTED|Overall Study||84
10394122|NCT00681291|11537544|FG000|COMPLETED|Overall Study||75
10394123|NCT00681291|11537545|FG001|COMPLETED|Overall Study||57
10394124|NCT00681291|11537544|FG000|NOT COMPLETED|Overall Study||13
10394125|NCT00681291|11537545|FG001|NOT COMPLETED|Overall Study||27
10394126|NCT00681473|11537551|FG000|STARTED|Overall Study|20 patients with WHO Grade 2 Glioma were enrolled.|20
10394127|NCT00681473|11537551|FG000|COMPLETED|Overall Study|All 20 patients completed RT and tolerated treatment well.|20
10394128|NCT00681473|11537551|FG000|NOT COMPLETED|Overall Study||0
10394129|NCT00681538|11537557|FG000|STARTED|Phase A- 4 Weeks Single Blind||572
10394130|NCT00681538|11537558|FG001|STARTED|Phase A- 4 Weeks Single Blind||0
10394131|NCT00681538|11537557|FG000|COMPLETED|Phase A- 4 Weeks Single Blind||538
10719426|NCT02710136|11883170|FG001|COMPLETED|Phase 1a[Refer to Arm/Group Description]||0
10719427|NCT02710136|11883169|FG000|NOT COMPLETED|Phase 1a[Refer to Arm/Group Description]||1
10719428|NCT02710136|11883170|FG001|NOT COMPLETED|Phase 1a[Refer to Arm/Group Description]||0
10719429|NCT02710136|11883169|FG000|STARTED|Phase 1b[Refer to Arm/Group Description]||4
10719430|NCT02710136|11883170|FG001|STARTED|Phase 1b[Refer to Arm/Group Description]||0
10719431|NCT02710136|11883169|FG000|COMPLETED|Phase 1b[Refer to Arm/Group Description]||4
10719432|NCT02710136|11883170|FG001|COMPLETED|Phase 1b[Refer to Arm/Group Description]||0
10719433|NCT02710136|11883169|FG000|NOT COMPLETED|Phase 1b[Refer to Arm/Group Description]||0
10719434|NCT02710136|11883170|FG001|NOT COMPLETED|Phase 1b[Refer to Arm/Group Description]||0
10719435|NCT02710136|11883169|FG000|STARTED|Phase 2 [Refer to Arm/Group Description]||0
10719436|NCT02710136|11883170|FG001|STARTED|Phase 2 [Refer to Arm/Group Description]||25
10719437|NCT02710136|11883169|FG000|COMPLETED|Phase 2 [Refer to Arm/Group Description]||0
10719438|NCT02710136|11883170|FG001|COMPLETED|Phase 2 [Refer to Arm/Group Description]||25
10719439|NCT02710136|11883169|FG000|NOT COMPLETED|Phase 2 [Refer to Arm/Group Description]||0
10719440|NCT02710136|11883170|FG001|NOT COMPLETED|Phase 2 [Refer to Arm/Group Description]||0
10719441|NCT02710214|11883179|FG000|STARTED|Overall Study||12
10719442|NCT02710214|11883180|FG001|STARTED|Overall Study||12
10719443|NCT02710214|11883179|FG000|COMPLETED|Overall Study||11
10719444|NCT02710214|11883180|FG001|COMPLETED|Overall Study||10
10719445|NCT02710214|11883179|FG000|NOT COMPLETED|Overall Study||1
10719446|NCT02710214|11883180|FG001|NOT COMPLETED|Overall Study||2
10719447|NCT02710240|11883186|FG000|STARTED|Overall Study||336
10719448|NCT02710240|11883186|FG000|COMPLETED|Overall Study||336
10719449|NCT02710240|11883186|FG000|NOT COMPLETED|Overall Study||0
10719450|NCT02710292|11883190|FG000|STARTED|Period 1, First 10 Days of Wear||47
10719451|NCT02710292|11883191|FG001|STARTED|Period 1, First 10 Days of Wear||52
10719452|NCT02710292|11883190|FG000|COMPLETED|Period 1, First 10 Days of Wear||46
10719453|NCT02710292|11883191|FG001|COMPLETED|Period 1, First 10 Days of Wear||49
10719454|NCT02710292|11883190|FG000|NOT COMPLETED|Period 1, First 10 Days of Wear||1
10719455|NCT02710292|11883191|FG001|NOT COMPLETED|Period 1, First 10 Days of Wear||3
10719456|NCT02710292|11883190|FG000|STARTED|Period 2, Second 10 Days of Wear||46
10719457|NCT02710292|11883191|FG001|STARTED|Period 2, Second 10 Days of Wear||49
10719458|NCT02710292|11883190|FG000|COMPLETED|Period 2, Second 10 Days of Wear||46
10719459|NCT02710292|11883191|FG001|COMPLETED|Period 2, Second 10 Days of Wear||49
10719460|NCT02710292|11883190|FG000|NOT COMPLETED|Period 2, Second 10 Days of Wear||0
10719461|NCT02710292|11883191|FG001|NOT COMPLETED|Period 2, Second 10 Days of Wear||0
10719462|NCT02710422|11883200|FG000|STARTED|Overall Study||12
10719463|NCT02710422|11883201|FG001|STARTED|Overall Study||12
10719464|NCT02710422|11883200|FG000|3 Month Visit|Overall Study||9
10719465|NCT02710422|11883201|FG001|3 Month Visit|Overall Study||11
10719466|NCT02710422|11883200|FG000|6 Month Visit|Overall Study||7
10719467|NCT02710422|11883201|FG001|6 Month Visit|Overall Study||8
10719468|NCT02710422|11883200|FG000|9 Month Visit|Overall Study||5
10719469|NCT02710422|11883201|FG001|9 Month Visit|Overall Study||5
10719470|NCT02710422|11883200|FG000|12 Month Visit|Overall Study||3
10719471|NCT02710422|11883201|FG001|12 Month Visit|Overall Study||3
10719472|NCT02710422|11883200|FG000|COMPLETED|Overall Study||3
10719473|NCT02710422|11883201|FG001|COMPLETED|Overall Study||3
10719474|NCT02710422|11883200|FG000|NOT COMPLETED|Overall Study||9
10719475|NCT02710422|11883201|FG001|NOT COMPLETED|Overall Study||9
10719476|NCT02710526|11883212|FG000|STARTED|Treatment Phase||28
10719477|NCT02710526|11883213|FG001|STARTED|Treatment Phase||20
10719478|NCT02710526|11883214|FG002|STARTED|Treatment Phase||18
10719479|NCT02710526|11883212|FG000|COMPLETED|Treatment Phase||22
10719480|NCT02710526|11883213|FG001|COMPLETED|Treatment Phase||16
10719481|NCT02710526|11883214|FG002|COMPLETED|Treatment Phase||12
10719482|NCT02710526|11883212|FG000|NOT COMPLETED|Treatment Phase||6
10719483|NCT02710526|11883213|FG001|NOT COMPLETED|Treatment Phase||4
10719484|NCT02710526|11883214|FG002|NOT COMPLETED|Treatment Phase||6
10719485|NCT02710526|11883212|FG000|STARTED|Safety Extension||15
10719486|NCT02710526|11883213|FG001|STARTED|Safety Extension||12
10719487|NCT02710526|11883214|FG002|STARTED|Safety Extension||0
10719488|NCT02710526|11883212|FG000|COMPLETED|Safety Extension||14
10719489|NCT02710526|11883213|FG001|COMPLETED|Safety Extension||12
10719490|NCT02710526|11883214|FG002|COMPLETED|Safety Extension||0
10719491|NCT02710526|11883212|FG000|NOT COMPLETED|Safety Extension||1
10719492|NCT02710526|11883213|FG001|NOT COMPLETED|Safety Extension||0
10719493|NCT02710526|11883214|FG002|NOT COMPLETED|Safety Extension||0
10719494|NCT02710591|11883236|FG000|STARTED|Overall Study||5
10719495|NCT02710591|11883237|FG001|STARTED|Overall Study||5
10719496|NCT02710591|11883238|FG002|STARTED|Overall Study||5
10719497|NCT02710591|11883239|FG003|STARTED|Overall Study||5
10719498|NCT02710591|11883236|FG000|COMPLETED|Overall Study||5
10719499|NCT02710591|11883237|FG001|COMPLETED|Overall Study||5
10719500|NCT02710591|11883238|FG002|COMPLETED|Overall Study||5
10719501|NCT02710591|11883239|FG003|COMPLETED|Overall Study||5
10719502|NCT02710591|11883236|FG000|NOT COMPLETED|Overall Study||0
10719503|NCT02710591|11883237|FG001|NOT COMPLETED|Overall Study||0
10719504|NCT02710591|11883238|FG002|NOT COMPLETED|Overall Study||0
10719505|NCT02710591|11883239|FG003|NOT COMPLETED|Overall Study||0
10309204|NCT00115037|11442102|FG005|NOT COMPLETED|Phase2||12
10309205|NCT00115063|11442118|FG000|STARTED|Overall Study||200
10309206|NCT00115063|11442119|FG001|STARTED|Overall Study||190
10309207|NCT00115063|11442118|FG000|COMPLETED|Overall Study||101
10309208|NCT00115063|11442119|FG001|COMPLETED|Overall Study||86
10309209|NCT00115063|11442118|FG000|NOT COMPLETED|Overall Study||99
10309210|NCT00115063|11442119|FG001|NOT COMPLETED|Overall Study||104
10309211|NCT00115076|11442125|FG000|STARTED|Overall Study||30
10309212|NCT00115076|11442125|FG000|COMPLETED|Overall Study||30
10309213|NCT00115076|11442125|FG000|NOT COMPLETED|Overall Study||0
10309214|NCT00115297|11442131|FG000|STARTED|Overall Study||30
10309215|NCT00115297|11442132|FG001|STARTED|Overall Study||32
10309216|NCT00115297|11442131|FG000|COMPLETED|Overall Study||30
10309217|NCT00115297|11442132|FG001|COMPLETED|Overall Study||32
10309218|NCT00115297|11442131|FG000|NOT COMPLETED|Overall Study||0
10309219|NCT00115297|11442132|FG001|NOT COMPLETED|Overall Study||0
10309220|NCT00115336|11442143|FG000|STARTED|Overall Study||6
10309221|NCT00115336|11442144|FG001|STARTED|Overall Study||4
10309222|NCT00115336|11442143|FG000|COMPLETED|Overall Study||6
10309223|NCT00115336|11442144|FG001|COMPLETED|Overall Study||3
10309224|NCT00115336|11442143|FG000|NOT COMPLETED|Overall Study||0
10309225|NCT00115336|11442144|FG001|NOT COMPLETED|Overall Study||1
10309226|NCT00115349|11442154|FG000|STARTED|Overall Study|Target was 43 subjects in this arm.|11
10309227|NCT00115349|11442155|FG001|STARTED|Overall Study|Target was 43 subjects in this arm.|9
10309228|NCT00115349|11442154|FG000|COMPLETED|Overall Study|Study closed due to low enrollment.|0
10309229|NCT00115349|11442155|FG001|COMPLETED|Overall Study|study closed due to low enrollment.|0
10309230|NCT00115349|11442154|FG000|NOT COMPLETED|Overall Study||11
10309231|NCT00115349|11442155|FG001|NOT COMPLETED|Overall Study||9
10309232|NCT00115739|11442161|FG000|STARTED|Overall Study||11
10309233|NCT00115739|11442161|FG000|COMPLETED|Overall Study||8
10309234|NCT00115739|11442161|FG000|NOT COMPLETED|Overall Study||3
10309235|NCT00115765|11442171|FG000|STARTED|Overall Study||115
10719506|NCT02710630|11883254|FG000|STARTED|Period 1||7
10719507|NCT02710630|11883255|FG001|STARTED|Period 1||7
10719508|NCT02710630|11883256|FG002|STARTED|Period 1||7
10719509|NCT02710630|11883257|FG003|STARTED|Period 1||7
10813174|NCT02971839|11975467|FG002|STARTED|Overall Study||2
10813175|NCT02971839|11975468|FG003|STARTED|Overall Study||2
10309236|NCT00115765|11442172|FG001|STARTED|Overall Study||413
10309237|NCT00115765|11442173|FG002|STARTED|Overall Study||410
10309238|NCT00115765|11442174|FG003|STARTED|Overall Study||115
10813176|NCT02971839|11975469|FG004|STARTED|Overall Study||3
10309239|NCT00115765|11442171|FG000|COMPLETED|Overall Study|Participants who were on study at closure or died|80
10309240|NCT00115765|11442172|FG001|COMPLETED|Overall Study|Participants who were on study at closure or died|313
10309241|NCT00115765|11442173|FG002|COMPLETED|Overall Study|Participants who were on study at closure or died|289
10309242|NCT00115765|11442174|FG003|COMPLETED|Overall Study|Participants who were on study at closure or died|84
10813177|NCT02971839|11975465|FG000|COMPLETED|Overall Study||2
10309243|NCT00115765|11442171|FG000|NOT COMPLETED|Overall Study||35
10309244|NCT00115765|11442172|FG001|NOT COMPLETED|Overall Study||100
10309245|NCT00115765|11442173|FG002|NOT COMPLETED|Overall Study||121
10309246|NCT00115765|11442174|FG003|NOT COMPLETED|Overall Study||31
10309247|NCT00115778|11442182|FG000|STARTED|Overall Study||6
10309248|NCT00115778|11442183|FG001|STARTED|Overall Study||5
10719510|NCT02710630|11883258|FG004|STARTED|Period 1||7
10309249|NCT00115778|11442182|FG000|COMPLETED|Overall Study||6
10309250|NCT00115778|11442183|FG001|COMPLETED|Overall Study||4
10309251|NCT00115778|11442182|FG000|NOT COMPLETED|Overall Study||0
10309252|NCT00115778|11442183|FG001|NOT COMPLETED|Overall Study||1
10719511|NCT02710630|11883254|FG000|COMPLETED|Period 1||7
10719512|NCT02710630|11883255|FG001|COMPLETED|Period 1||7
10719513|NCT02710630|11883256|FG002|COMPLETED|Period 1||7
10813178|NCT02971839|11975466|FG001|COMPLETED|Overall Study||2
10309253|NCT00115804|11442189|FG000|STARTED|Overall Study||6
10394132|NCT00681538|11537558|FG001|COMPLETED|Phase A- 4 Weeks Single Blind||0
10394133|NCT00681538|11537557|FG000|NOT COMPLETED|Phase A- 4 Weeks Single Blind||34
10394134|NCT00681538|11537558|FG001|NOT COMPLETED|Phase A- 4 Weeks Single Blind||0
10394135|NCT00681538|11537557|FG000|STARTED|Phase B- Responders;12 Week Double-blind||124
10394136|NCT00681538|11537558|FG001|STARTED|Phase B- Responders;12 Week Double-blind||117
10394137|NCT00681538|11537557|FG000|COMPLETED|Phase B- Responders;12 Week Double-blind||109
10394138|NCT00681538|11537558|FG001|COMPLETED|Phase B- Responders;12 Week Double-blind||115
10394139|NCT00681538|11537557|FG000|NOT COMPLETED|Phase B- Responders;12 Week Double-blind||15
10394140|NCT00681538|11537558|FG001|NOT COMPLETED|Phase B- Responders;12 Week Double-blind||2
10394141|NCT00681564|11537566|FG000|STARTED|Overall Study||47
10394142|NCT00681564|11537567|FG001|STARTED|Overall Study||55
10394143|NCT00681564|11537566|FG000|COMPLETED|Overall Study||41
10394144|NCT00681564|11537567|FG001|COMPLETED|Overall Study||47
10394145|NCT00681564|11537566|FG000|NOT COMPLETED|Overall Study||6
10394146|NCT00681564|11537567|FG001|NOT COMPLETED|Overall Study||8
10394147|NCT00681590|11537575|FG000|STARTED|Overall Study||34
10394148|NCT00681590|11537576|FG001|STARTED|Overall Study||71
10394149|NCT00681590|11537575|FG000|COMPLETED|Overall Study||32
10719514|NCT02710630|11883257|FG003|COMPLETED|Period 1||7
10719515|NCT02710630|11883258|FG004|COMPLETED|Period 1||7
10719516|NCT02710630|11883254|FG000|NOT COMPLETED|Period 1||0
10719517|NCT02710630|11883255|FG001|NOT COMPLETED|Period 1||0
10719518|NCT02710630|11883256|FG002|NOT COMPLETED|Period 1||0
10719519|NCT02710630|11883257|FG003|NOT COMPLETED|Period 1||0
10719520|NCT02710630|11883258|FG004|NOT COMPLETED|Period 1||0
10719521|NCT02710630|11883254|FG000|STARTED|Period 2||7
10719522|NCT02710630|11883255|FG001|STARTED|Period 2||7
10719523|NCT02710630|11883256|FG002|STARTED|Period 2||7
10719524|NCT02710630|11883257|FG003|STARTED|Period 2||7
10719525|NCT02710630|11883258|FG004|STARTED|Period 2||7
10719526|NCT02710630|11883254|FG000|Not Treated|Period 2||1
10719527|NCT02710630|11883255|FG001|Not Treated|Period 2||0
10719528|NCT02710630|11883256|FG002|Not Treated|Period 2||0
10719529|NCT02710630|11883257|FG003|Not Treated|Period 2||0
10719530|NCT02710630|11883258|FG004|Not Treated|Period 2||0
10719531|NCT02710630|11883254|FG000|COMPLETED|Period 2||7
10719532|NCT02710630|11883255|FG001|COMPLETED|Period 2||7
10719533|NCT02710630|11883256|FG002|COMPLETED|Period 2||7
10719534|NCT02710630|11883257|FG003|COMPLETED|Period 2||7
10719535|NCT02710630|11883258|FG004|COMPLETED|Period 2||7
10719536|NCT02710630|11883254|FG000|NOT COMPLETED|Period 2||0
10719537|NCT02710630|11883255|FG001|NOT COMPLETED|Period 2||0
10719538|NCT02710630|11883256|FG002|NOT COMPLETED|Period 2||0
10394150|NCT00681590|11537576|FG001|COMPLETED|Overall Study||59
10394151|NCT00681590|11537575|FG000|NOT COMPLETED|Overall Study||2
10394152|NCT00681590|11537576|FG001|NOT COMPLETED|Overall Study||12
10394153|NCT00681668|11537582|FG000|STARTED|Overall Study||5
10394154|NCT00681668|11537582|FG000|COMPLETED|Overall Study||3
10394155|NCT00681668|11537582|FG000|NOT COMPLETED|Overall Study||2
10394156|NCT00681811|11537588|FG000|STARTED|Overall Study||6
10394157|NCT00681811|11537589|FG001|STARTED|Overall Study||5
10394158|NCT00681811|11537588|FG000|COMPLETED|Overall Study||3
10394159|NCT00681811|11537589|FG001|COMPLETED|Overall Study||1
10394160|NCT00681811|11537588|FG000|NOT COMPLETED|Overall Study||3
10394161|NCT00681811|11537589|FG001|NOT COMPLETED|Overall Study||4
10394162|NCT00681824|11537609|FG000|STARTED|Overall Study||28
10394163|NCT00681824|11537610|FG001|STARTED|Overall Study||13
10394164|NCT00681824|11537611|FG002|STARTED|Overall Study||34
10394165|NCT00681824|11537609|FG000|COMPLETED|Overall Study||27
10394166|NCT00681824|11537610|FG001|COMPLETED|Overall Study||12
10394167|NCT00681824|11537611|FG002|COMPLETED|Overall Study||33
10394168|NCT00681824|11537609|FG000|NOT COMPLETED|Overall Study||1
10394169|NCT00681824|11537610|FG001|NOT COMPLETED|Overall Study||1
10394170|NCT00681824|11537611|FG002|NOT COMPLETED|Overall Study||1
10394171|NCT00681863|11537619|FG000|STARTED|Overall Study||45
10719539|NCT02710630|11883257|FG003|NOT COMPLETED|Period 2||0
10719540|NCT02710630|11883258|FG004|NOT COMPLETED|Period 2||0
10719541|NCT02710630|11883254|FG000|STARTED|Period 3||7
10719542|NCT02710630|11883255|FG001|STARTED|Period 3||7
10719543|NCT02710630|11883256|FG002|STARTED|Period 3||7
10719544|NCT02710630|11883257|FG003|STARTED|Period 3||7
10394172|NCT00681863|11537619|FG000|COMPLETED|Overall Study||22
10394173|NCT00681863|11537619|FG000|NOT COMPLETED|Overall Study||23
10394174|NCT00681889|11537623|FG000|STARTED|Overall Study||9
10394175|NCT00681889|11537623|FG000|COMPLETED|Overall Study||9
10394176|NCT00681889|11537623|FG000|NOT COMPLETED|Overall Study||0
10394177|NCT00682357|11537630|FG000|STARTED|Overall Study||10
10394178|NCT00682357|11537631|FG001|STARTED|Overall Study||10
10394179|NCT00682357|11537632|FG002|STARTED|Overall Study||5
10394180|NCT00682357|11537630|FG000|COMPLETED|Overall Study||10
10719545|NCT02710630|11883258|FG004|STARTED|Period 3||7
10719546|NCT02710630|11883254|FG000|COMPLETED|Period 3||7
10719547|NCT02710630|11883255|FG001|COMPLETED|Period 3||7
10543136|NCT01482715|11696324|FG005|COMPLETED|Overall Study||3
10543137|NCT01482715|11696325|FG006|COMPLETED|Overall Study||8
10543138|NCT01482715|11696326|FG007|COMPLETED|Overall Study||9
10543139|NCT01482715|11696327|FG008|COMPLETED|Overall Study||7
10543140|NCT01482715|11696328|FG009|COMPLETED|Overall Study||3
10543141|NCT01482715|11696329|FG010|COMPLETED|Overall Study||42
10543142|NCT01482715|11696330|FG011|COMPLETED|Overall Study||12
10543143|NCT01482715|11696331|FG012|COMPLETED|Overall Study||26
10543144|NCT01482715|11696319|FG000|NOT COMPLETED|Overall Study||0
10543145|NCT01482715|11696320|FG001|NOT COMPLETED|Overall Study||0
10543146|NCT01482715|11696321|FG002|NOT COMPLETED|Overall Study||0
10543147|NCT01482715|11696322|FG003|NOT COMPLETED|Overall Study||0
10543148|NCT01482715|11696323|FG004|NOT COMPLETED|Overall Study||0
10543149|NCT01482715|11696324|FG005|NOT COMPLETED|Overall Study||0
10394181|NCT00682357|11537631|FG001|COMPLETED|Overall Study||10
10394182|NCT00682357|11537632|FG002|COMPLETED|Overall Study||5
10309254|NCT00115804|11442189|FG000|COMPLETED|Overall Study||4
10309255|NCT00115804|11442189|FG000|NOT COMPLETED|Overall Study||2
10309256|NCT00115869|11442197|FG000|STARTED|Overall Study||4211
10309257|NCT00115869|11442198|FG001|STARTED|Overall Study||4177
10309258|NCT00115869|11442197|FG000|Completed Data Collection at 12th Grade|Overall Study||3876
10309259|NCT00115869|11442198|FG001|Completed Data Collection at 12th Grade|Overall Study||3847
10309260|NCT00115869|11442197|FG000|COMPLETED|Overall Study||3894
10309261|NCT00115869|11442198|FG001|COMPLETED|Overall Study|Follow-up at two years post high school.|3881
10309262|NCT00115869|11442197|FG000|NOT COMPLETED|Overall Study||317
10309263|NCT00115869|11442198|FG001|NOT COMPLETED|Overall Study||296
10309264|NCT00115934|11442208|FG000|STARTED|Overall Study|279 randomized to MBTS, but 3 did not have a Norwood surgery; one was withdrawn-with limited data.|279
10309265|NCT00115934|11442209|FG001|STARTED|Overall Study|276 randomized to RVPAS, but 2 did not have a Norwood surgery and were excluded from analyses.|276
10309266|NCT00115934|11442208|FG000|COMPLETED|Overall Study||275
10309267|NCT00115934|11442209|FG001|COMPLETED|Overall Study||274
10309268|NCT00115934|11442208|FG000|NOT COMPLETED|Overall Study||4
10309269|NCT00115934|11442209|FG001|NOT COMPLETED|Overall Study||2
10309270|NCT00116168|11442219|FG000|STARTED|Overall Study||6
10309271|NCT00116168|11442220|FG001|STARTED|Overall Study||11
10309272|NCT00116168|11442221|FG002|STARTED|Overall Study||6
10309273|NCT00116168|11442222|FG003|STARTED|Overall Study||6
10309274|NCT00116168|11442219|FG000|COMPLETED|Overall Study||0
10719548|NCT02710630|11883256|FG002|COMPLETED|Period 3||7
10719549|NCT02710630|11883257|FG003|COMPLETED|Period 3||7
10719550|NCT02710630|11883258|FG004|COMPLETED|Period 3||7
10719551|NCT02710630|11883254|FG000|NOT COMPLETED|Period 3||0
10719552|NCT02710630|11883255|FG001|NOT COMPLETED|Period 3||0
10719553|NCT02710630|11883256|FG002|NOT COMPLETED|Period 3||0
10719554|NCT02710630|11883257|FG003|NOT COMPLETED|Period 3||0
10309275|NCT00116168|11442220|FG001|COMPLETED|Overall Study||6
10309276|NCT00116168|11442221|FG002|COMPLETED|Overall Study||6
10309277|NCT00116168|11442222|FG003|COMPLETED|Overall Study||6
10309278|NCT00116168|11442219|FG000|NOT COMPLETED|Overall Study||6
10309279|NCT00116168|11442220|FG001|NOT COMPLETED|Overall Study||5
10309280|NCT00116168|11442221|FG002|NOT COMPLETED|Overall Study||0
10719555|NCT02710630|11883258|FG004|NOT COMPLETED|Period 3||0
10719556|NCT02710630|11883254|FG000|STARTED|Period 4||7
10719557|NCT02710630|11883255|FG001|STARTED|Period 4||7
10719558|NCT02710630|11883256|FG002|STARTED|Period 4||7
10719559|NCT02710630|11883257|FG003|STARTED|Period 4||7
10309281|NCT00116168|11442222|FG003|NOT COMPLETED|Overall Study||0
10813179|NCT02971839|11975467|FG002|COMPLETED|Overall Study||2
10813180|NCT02971839|11975468|FG003|COMPLETED|Overall Study||2
10813181|NCT02971839|11975469|FG004|COMPLETED|Overall Study||3
10813182|NCT02971839|11975465|FG000|NOT COMPLETED|Overall Study||0
10813183|NCT02971839|11975466|FG001|NOT COMPLETED|Overall Study||0
10813184|NCT02971839|11975467|FG002|NOT COMPLETED|Overall Study||0
10813185|NCT02971839|11975468|FG003|NOT COMPLETED|Overall Study||0
10813186|NCT02971839|11975469|FG004|NOT COMPLETED|Overall Study||0
10813187|NCT02985840|11975483|FG000|STARTED|Overall Study||64
10813188|NCT02985840|11975484|FG001|STARTED|Overall Study||63
10813189|NCT02985840|11975483|FG000|COMPLETED|Overall Study||64
10394183|NCT00682357|11537630|FG000|NOT COMPLETED|Overall Study||0
10394184|NCT00682357|11537631|FG001|NOT COMPLETED|Overall Study||0
10394185|NCT00682357|11537632|FG002|NOT COMPLETED|Overall Study||0
10394186|NCT00682435|11537640|FG000|STARTED|Overall Study||230
10394187|NCT00682435|11537640|FG000|Ensured Enrolled Only Once|Overall Study||228
10543150|NCT01482715|11696325|FG006|NOT COMPLETED|Overall Study||0
10543151|NCT01482715|11696326|FG007|NOT COMPLETED|Overall Study||0
10394188|NCT00682435|11537640|FG000|Sufficient Data to Carry Out Analysis|Overall Study||223
10658804|NCT02235831|11820004|FG002|COMPLETED|Period 2, Second 5 Days of Wear||4
10658805|NCT02235831|11820005|FG003|COMPLETED|Period 2, Second 5 Days of Wear||4
10309282|NCT00116207|11442234|FG000|STARTED|Overall Study||22
10309283|NCT00116207|11442235|FG001|STARTED|Overall Study||22
10309284|NCT00116207|11442234|FG000|COMPLETED|Overall Study||13
10309285|NCT00116207|11442235|FG001|COMPLETED|Overall Study||18
10309286|NCT00116207|11442234|FG000|NOT COMPLETED|Overall Study||9
10309287|NCT00116207|11442235|FG001|NOT COMPLETED|Overall Study||4
10309288|NCT00116272|11442243|FG000|STARTED|Overall Study||370
10309289|NCT00116272|11442244|FG001|STARTED|Overall Study||164
10309290|NCT00116272|11442243|FG000|COMPLETED|Overall Study|Indicates participants with a known outcome of pregnancy|359
10309291|NCT00116272|11442244|FG001|COMPLETED|Overall Study|Indicates participants with a known outcome of pregnancy|158
10309292|NCT00116272|11442243|FG000|NOT COMPLETED|Overall Study||11
10309293|NCT00116272|11442244|FG001|NOT COMPLETED|Overall Study||6
10309294|NCT00116337|11442252|FG000|STARTED|Overall Study||17
10309295|NCT00116337|11442252|FG000|COMPLETED|Overall Study||17
10309296|NCT00116337|11442252|FG000|NOT COMPLETED|Overall Study||0
10309297|NCT00116428|11442265|FG000|STARTED|Overall Study||106
10309298|NCT00116428|11442266|FG001|STARTED|Overall Study||61
10309299|NCT00116428|11442265|FG000|Underwent Study Ablation Procedure|Overall Study||103
10309300|NCT00116428|11442266|FG001|Underwent Study Ablation Procedure|Overall Study||36
10309301|NCT00116428|11442265|FG000|COMPLETED|Overall Study||103
10309302|NCT00116428|11442266|FG001|COMPLETED|Overall Study||56
10309303|NCT00116428|11442265|FG000|NOT COMPLETED|Overall Study||3
10309304|NCT00116428|11442266|FG001|NOT COMPLETED|Overall Study||5
10309305|NCT00116558|11442278|FG000|STARTED|Overall Study||80
10309306|NCT00116558|11442279|FG001|STARTED|Overall Study||26
10309307|NCT00116558|11442280|FG002|STARTED|Overall Study||47
10309308|NCT00116558|11442278|FG000|COMPLETED|Overall Study||49
10309309|NCT00116558|11442279|FG001|COMPLETED|Overall Study||11
10394189|NCT00682435|11537640|FG000|COMPLETED|Overall Study||223
10394190|NCT00682435|11537640|FG000|NOT COMPLETED|Overall Study||7
10394191|NCT00682448|11537646|FG000|STARTED|Overall Study||12
10394192|NCT00682448|11537647|FG001|STARTED|Overall Study||13
10394193|NCT00682448|11537646|FG000|COMPLETED|Overall Study||7
10394194|NCT00682448|11537647|FG001|COMPLETED|Overall Study||7
10394195|NCT00682448|11537646|FG000|NOT COMPLETED|Overall Study||5
10394196|NCT00682448|11537647|FG001|NOT COMPLETED|Overall Study||6
10394197|NCT00682539|11537656|FG000|STARTED|Bevacizumab vs Triamcinolone||18
10394198|NCT00682539|11537657|FG001|STARTED|Bevacizumab vs Triamcinolone||16
10309310|NCT00116558|11442280|FG002|COMPLETED|Overall Study||14
10309311|NCT00116558|11442278|FG000|NOT COMPLETED|Overall Study||31
10309312|NCT00116558|11442279|FG001|NOT COMPLETED|Overall Study||15
10394199|NCT00682539|11537658|FG002|STARTED|Bevacizumab vs Triamcinolone||0
10394200|NCT00682539|11537656|FG000|COMPLETED|Bevacizumab vs Triamcinolone||15
10394201|NCT00682539|11537657|FG001|COMPLETED|Bevacizumab vs Triamcinolone||15
10394202|NCT00682539|11537658|FG002|COMPLETED|Bevacizumab vs Triamcinolone||0
10394203|NCT00682539|11537656|FG000|NOT COMPLETED|Bevacizumab vs Triamcinolone||3
10394204|NCT00682539|11537657|FG001|NOT COMPLETED|Bevacizumab vs Triamcinolone||1
10394205|NCT00682539|11537658|FG002|NOT COMPLETED|Bevacizumab vs Triamcinolone||0
10394206|NCT00682539|11537656|FG000|STARTED|Ranibizumab vs Triamcinolone|Two independent periods.|0
10394207|NCT00682539|11537657|FG001|STARTED|Ranibizumab vs Triamcinolone|None of the patients of the 1st period was included in the second period.|18
10394208|NCT00682539|11537658|FG002|STARTED|Ranibizumab vs Triamcinolone|Both periods recruited independently following the same criteria.|18
10394209|NCT00682539|11537656|FG000|COMPLETED|Ranibizumab vs Triamcinolone||0
10394210|NCT00682539|11537657|FG001|COMPLETED|Ranibizumab vs Triamcinolone||15
10394211|NCT00682539|11537658|FG002|COMPLETED|Ranibizumab vs Triamcinolone||10
10394212|NCT00682539|11537656|FG000|NOT COMPLETED|Ranibizumab vs Triamcinolone||0
10394213|NCT00682539|11537657|FG001|NOT COMPLETED|Ranibizumab vs Triamcinolone||3
10394214|NCT00682539|11537658|FG002|NOT COMPLETED|Ranibizumab vs Triamcinolone||8
10394215|NCT00682565|11537669|FG000|STARTED|Overall Study||31
10394216|NCT00682565|11537670|FG001|STARTED|Overall Study||35
10394217|NCT00682565|11537671|FG002|STARTED|Overall Study||29
10394218|NCT00682565|11537669|FG000|COMPLETED|Overall Study||30
10543152|NCT01482715|11696327|FG008|NOT COMPLETED|Overall Study||0
10543153|NCT01482715|11696328|FG009|NOT COMPLETED|Overall Study||0
10543154|NCT01482715|11696329|FG010|NOT COMPLETED|Overall Study||0
10543155|NCT01482715|11696330|FG011|NOT COMPLETED|Overall Study||0
10543156|NCT01482715|11696331|FG012|NOT COMPLETED|Overall Study||0
10543157|NCT01482767|11696374|FG000|STARTED|Overall Study||135
10543158|NCT01482767|11696375|FG001|STARTED|Overall Study||127
10543159|NCT01482767|11696374|FG000|COMPLETED|Overall Study||81
10543160|NCT01482767|11696375|FG001|COMPLETED|Overall Study||78
10543161|NCT01482767|11696374|FG000|NOT COMPLETED|Overall Study||54
10394219|NCT00682565|11537670|FG001|COMPLETED|Overall Study||32
10394220|NCT00682565|11537671|FG002|COMPLETED|Overall Study||29
10394221|NCT00682565|11537669|FG000|NOT COMPLETED|Overall Study||1
10394222|NCT00682565|11537670|FG001|NOT COMPLETED|Overall Study||3
10394223|NCT00682565|11537671|FG002|NOT COMPLETED|Overall Study||0
10394224|NCT00682461|11537682|FG000|STARTED|Overall Study||100
10394225|NCT00682461|11537683|FG001|STARTED|Overall Study||100
10394226|NCT00682461|11537682|FG000|COMPLETED|Overall Study||75
10394227|NCT00682461|11537683|FG001|COMPLETED|Overall Study||69
10394228|NCT00682461|11537682|FG000|NOT COMPLETED|Overall Study||25
10394229|NCT00682461|11537683|FG001|NOT COMPLETED|Overall Study||31
10394230|NCT00682617|11537692|FG000|STARTED|Overall Study||13
10394231|NCT00682617|11537693|FG001|STARTED|Overall Study||28
10394232|NCT00682617|11537692|FG000|COMPLETED|Overall Study||10
10394233|NCT00682617|11537693|FG001|COMPLETED|Overall Study||21
10394234|NCT00682617|11537692|FG000|NOT COMPLETED|Overall Study||3
10394235|NCT00682617|11537693|FG001|NOT COMPLETED|Overall Study||7
10394236|NCT00682643|11537701|FG000|STARTED|Overall Study||182
10394237|NCT00682643|11537702|FG001|STARTED|Overall Study||368
10394238|NCT00682643|11537701|FG000|COMPLETED|Overall Study||104
10394239|NCT00682643|11537702|FG001|COMPLETED|Overall Study||199
10543162|NCT01482767|11696375|FG001|NOT COMPLETED|Overall Study||49
10543163|NCT01482819|11696381|FG000|STARTED|Overall Study||21
10543164|NCT01482819|11696381|FG000|COMPLETED|Overall Study||19
10543165|NCT01482819|11696381|FG000|NOT COMPLETED|Overall Study||2
10394240|NCT00682643|11537701|FG000|NOT COMPLETED|Overall Study||78
10394241|NCT00682643|11537702|FG001|NOT COMPLETED|Overall Study||169
10394242|NCT00682734|11537712|FG000|STARTED|Emergency Department Portion||113
10719560|NCT02710630|11883258|FG004|STARTED|Period 4||7
10719561|NCT02710630|11883254|FG000|COMPLETED|Period 4||7
10719562|NCT02710630|11883255|FG001|COMPLETED|Period 4||7
10719563|NCT02710630|11883256|FG002|COMPLETED|Period 4||7
10719564|NCT02710630|11883257|FG003|COMPLETED|Period 4||7
10394243|NCT00682734|11537713|FG001|STARTED|Emergency Department Portion||118
10394244|NCT00682734|11537714|FG002|STARTED|Emergency Department Portion||118
10394245|NCT00682734|11537712|FG000|COMPLETED|Emergency Department Portion||113
10394246|NCT00682734|11537713|FG001|COMPLETED|Emergency Department Portion||117
10394247|NCT00682734|11537714|FG002|COMPLETED|Emergency Department Portion||117
10394248|NCT00682734|11537712|FG000|NOT COMPLETED|Emergency Department Portion||0
10394249|NCT00682734|11537713|FG001|NOT COMPLETED|Emergency Department Portion||1
10394250|NCT00682734|11537714|FG002|NOT COMPLETED|Emergency Department Portion||1
10394251|NCT00682734|11537712|FG000|STARTED|48 Hour Follow-up||113
10394252|NCT00682734|11537713|FG001|STARTED|48 Hour Follow-up||117
10394253|NCT00682734|11537714|FG002|STARTED|48 Hour Follow-up||117
10394254|NCT00682734|11537712|FG000|COMPLETED|48 Hour Follow-up||107
10394255|NCT00682734|11537713|FG001|COMPLETED|48 Hour Follow-up||111
10394256|NCT00682734|11537714|FG002|COMPLETED|48 Hour Follow-up||106
10394257|NCT00682734|11537712|FG000|NOT COMPLETED|48 Hour Follow-up||6
10394258|NCT00682734|11537713|FG001|NOT COMPLETED|48 Hour Follow-up||6
10394259|NCT00682734|11537714|FG002|NOT COMPLETED|48 Hour Follow-up||11
10394260|NCT00682786|11537724|FG000|STARTED|Overall Study||98
10543166|NCT01482884|11696391|FG000|STARTED|Overall Study|One participant did not receive study treatment|56
10543167|NCT01482884|11696392|FG001|STARTED|Overall Study||55
10543168|NCT01482884|11696391|FG000|COMPLETED|Overall Study||43
10543169|NCT01482884|11696392|FG001|COMPLETED|Overall Study||37
10543170|NCT01482884|11696391|FG000|NOT COMPLETED|Overall Study||13
10543171|NCT01482884|11696392|FG001|NOT COMPLETED|Overall Study||18
10543172|NCT01482910|11696400|FG000|STARTED|Overall Study||228
10543173|NCT01482910|11696401|FG001|STARTED|Overall Study||76
10543174|NCT01482910|11696400|FG000|Completed Week 28|Overall Study||216
10543175|NCT01482910|11696401|FG001|Completed Week 28|Overall Study||71
10543176|NCT01482910|11696400|FG000|COMPLETED|Overall Study||213
10543177|NCT01482910|11696401|FG001|COMPLETED|Overall Study||67
10543178|NCT01482910|11696400|FG000|NOT COMPLETED|Overall Study||15
10543179|NCT01482910|11696401|FG001|NOT COMPLETED|Overall Study||9
10543180|NCT01482962|11696411|FG000|STARTED|Overall Study||138
10543181|NCT01482962|11696412|FG001|STARTED|Overall Study||133
10543182|NCT01482962|11696411|FG000|Safety Population: Received Study Drug|Overall Study||137
10543183|NCT01482962|11696412|FG001|Safety Population: Received Study Drug|Overall Study||127
10543184|NCT01482962|11696411|FG000|COMPLETED|Overall Study||0
10543185|NCT01482962|11696412|FG001|COMPLETED|Overall Study||0
10543186|NCT01482962|11696411|FG000|NOT COMPLETED|Overall Study||138
10543187|NCT01482962|11696412|FG001|NOT COMPLETED|Overall Study||133
10543188|NCT01483118|11696422|FG000|STARTED|Overall Study||23
10543189|NCT01483118|11696423|FG001|STARTED|Overall Study||22
10543190|NCT01483118|11696422|FG000|Completed 3 Months|Overall Study||15
10543191|NCT01483118|11696423|FG001|Completed 3 Months|Overall Study||11
10543192|NCT01483118|11696422|FG000|COMPLETED|Overall Study||11
10543193|NCT01483118|11696423|FG001|COMPLETED|Overall Study||6
10543194|NCT01483118|11696422|FG000|NOT COMPLETED|Overall Study||12
10543195|NCT01483118|11696423|FG001|NOT COMPLETED|Overall Study||16
10543196|NCT01483144|11696434|FG000|STARTED|Overall Study||56
10719565|NCT02710630|11883258|FG004|COMPLETED|Period 4||7
10394261|NCT00682786|11537725|FG001|STARTED|Overall Study||37
10394262|NCT00682786|11537724|FG000|COMPLETED|Overall Study||96
10394263|NCT00682786|11537725|FG001|COMPLETED|Overall Study||34
10394264|NCT00682786|11537724|FG000|NOT COMPLETED|Overall Study||2
10543197|NCT01483144|11696435|FG001|STARTED|Overall Study||57
10543198|NCT01483144|11696436|FG002|STARTED|Overall Study||58
10543199|NCT01483144|11696434|FG000|COMPLETED|Overall Study||41
10543200|NCT01483144|11696435|FG001|COMPLETED|Overall Study||44
10543201|NCT01483144|11696436|FG002|COMPLETED|Overall Study||43
10543202|NCT01483144|11696434|FG000|NOT COMPLETED|Overall Study||15
10543203|NCT01483144|11696435|FG001|NOT COMPLETED|Overall Study||13
10719566|NCT02710630|11883254|FG000|NOT COMPLETED|Period 4||0
10719567|NCT02710630|11883255|FG001|NOT COMPLETED|Period 4||0
10719568|NCT02710630|11883256|FG002|NOT COMPLETED|Period 4||0
10719569|NCT02710630|11883257|FG003|NOT COMPLETED|Period 4||0
10719570|NCT02710630|11883258|FG004|NOT COMPLETED|Period 4||0
10719571|NCT02710630|11883254|FG000|STARTED|Period 5||7
10719572|NCT02710630|11883255|FG001|STARTED|Period 5||7
10719573|NCT02710630|11883256|FG002|STARTED|Period 5||7
10719574|NCT02710630|11883257|FG003|STARTED|Period 5||7
10719575|NCT02710630|11883258|FG004|STARTED|Period 5||7
10719576|NCT02710630|11883254|FG000|COMPLETED|Period 5||7
10719577|NCT02710630|11883255|FG001|COMPLETED|Period 5||7
10719578|NCT02710630|11883256|FG002|COMPLETED|Period 5||7
10309313|NCT00116558|11442280|FG002|NOT COMPLETED|Overall Study||33
10309314|NCT00116584|11442289|FG000|STARTED|Overall Study||36
10309315|NCT00116584|11442290|FG001|STARTED|Overall Study||36
10309316|NCT00116584|11442289|FG000|COMPLETED|Overall Study||34
10309317|NCT00116584|11442290|FG001|COMPLETED|Overall Study||35
10309318|NCT00116584|11442289|FG000|NOT COMPLETED|Overall Study||2
10309319|NCT00116584|11442290|FG001|NOT COMPLETED|Overall Study||1
10309320|NCT00116649|11442296|FG000|STARTED|Overall Study|586 screened (34 not eligible) 552 enrolled 551 study population (1 subject not treated)|551
10309321|NCT00116649|11442296|FG000|COMPLETED|Overall Study||396
10309322|NCT00116649|11442296|FG000|NOT COMPLETED|Overall Study||155
10309323|NCT00116688|11442302|FG000|STARTED|Overall Study||292
10309324|NCT00116688|11442303|FG001|STARTED|Overall Study||21
10309325|NCT00116688|11442302|FG000|Received Study Medication|Overall Study||291
10309326|NCT00116688|11442303|FG001|Received Study Medication|Overall Study||20
10309327|NCT00116688|11442302|FG000|COMPLETED|Overall Study||200
10309328|NCT00116688|11442303|FG001|COMPLETED|Overall Study||17
10309329|NCT00116688|11442302|FG000|NOT COMPLETED|Overall Study||92
10309330|NCT00116688|11442303|FG001|NOT COMPLETED|Overall Study||4
10309331|NCT00116753|11442312|FG000|STARTED|Overall Study|Randomised.|153
10309332|NCT00116753|11442313|FG001|STARTED|Overall Study||155
10309333|NCT00116753|11442314|FG002|STARTED|Overall Study||152
10309334|NCT00116753|11442312|FG000|ITT Population|Overall Study||150
10309335|NCT00116753|11442313|FG001|ITT Population|Overall Study||150
10309336|NCT00116753|11442314|FG002|ITT Population|Overall Study||147
10309337|NCT00116753|11442312|FG000|COMPLETED|Overall Study||121
10309338|NCT00116753|11442313|FG001|COMPLETED|Overall Study||125
10309339|NCT00116753|11442314|FG002|COMPLETED|Overall Study||128
10309340|NCT00116753|11442312|FG000|NOT COMPLETED|Overall Study||32
10309341|NCT00116753|11442313|FG001|NOT COMPLETED|Overall Study||30
10309342|NCT00116753|11442314|FG002|NOT COMPLETED|Overall Study||24
10315383|NCT00178178|11449241|FG001|COMPLETED|Overall Study||24
10315384|NCT00178178|11449242|FG002|COMPLETED|Overall Study||24
10315385|NCT00178178|11449243|FG003|COMPLETED|Overall Study||24
10315386|NCT00178178|11449240|FG000|NOT COMPLETED|Overall Study||0
10315387|NCT00178178|11449241|FG001|NOT COMPLETED|Overall Study||0
10315388|NCT00178178|11449242|FG002|NOT COMPLETED|Overall Study||0
10315389|NCT00178178|11449243|FG003|NOT COMPLETED|Overall Study||0
10315390|NCT00178191|11449256|FG000|STARTED|Overall Study||11
10315391|NCT00178191|11449257|FG001|STARTED|Overall Study||10
10315392|NCT00178191|11449258|FG002|STARTED|Overall Study||7
10315393|NCT00178191|11449256|FG000|COMPLETED|Overall Study||11
10315394|NCT00178191|11449257|FG001|COMPLETED|Overall Study||10
10315395|NCT00178191|11449258|FG002|COMPLETED|Overall Study||7
10315396|NCT00178191|11449256|FG000|NOT COMPLETED|Overall Study||0
10315397|NCT00178191|11449257|FG001|NOT COMPLETED|Overall Study||0
10315398|NCT00178191|11449258|FG002|NOT COMPLETED|Overall Study||0
10315399|NCT00178256|11449266|FG000|STARTED|Overall Study||10
10315400|NCT00178256|11449267|FG001|STARTED|Overall Study||7
10315401|NCT00178256|11449268|FG002|STARTED|Overall Study||6
10315402|NCT00178256|11449269|FG003|STARTED|Overall Study||18
10315403|NCT00178256|11449266|FG000|COMPLETED|Overall Study||6
10315404|NCT00178256|11449267|FG001|COMPLETED|Overall Study||6
10315405|NCT00178256|11449268|FG002|COMPLETED|Overall Study||6
10315406|NCT00178256|11449269|FG003|COMPLETED|Overall Study||16
10315407|NCT00178256|11449266|FG000|NOT COMPLETED|Overall Study||4
10315408|NCT00178256|11449267|FG001|NOT COMPLETED|Overall Study||1
10315409|NCT00178256|11449268|FG002|NOT COMPLETED|Overall Study||0
10315410|NCT00178256|11449269|FG003|NOT COMPLETED|Overall Study||2
10315411|NCT00178399|11449276|FG000|STARTED|Overall Study||128
10315412|NCT00178399|11449276|FG000|COMPLETED|Overall Study||115
10315413|NCT00178399|11449276|FG000|NOT COMPLETED|Overall Study||13
10315414|NCT00178464|11449281|FG000|STARTED|Overall Study||11
10658806|NCT02235831|11820006|FG004|COMPLETED|Period 2, Second 5 Days of Wear||4
10658807|NCT02235831|11820007|FG005|COMPLETED|Period 2, Second 5 Days of Wear||4
10658808|NCT02235831|11820002|FG000|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
10658809|NCT02235831|11820003|FG001|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
10658810|NCT02235831|11820004|FG002|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
10658811|NCT02235831|11820005|FG003|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
10658812|NCT02235831|11820006|FG004|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
10658813|NCT02235831|11820007|FG005|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
10658814|NCT02235831|11820002|FG000|STARTED|Period 3, Third 5 Days of Wear||4
10658815|NCT02235831|11820003|FG001|STARTED|Period 3, Third 5 Days of Wear||4
10719579|NCT02710630|11883257|FG003|COMPLETED|Period 5||7
10719580|NCT02710630|11883258|FG004|COMPLETED|Period 5||7
10719581|NCT02710630|11883254|FG000|NOT COMPLETED|Period 5||0
10315415|NCT00178464|11449281|FG000|COMPLETED|Overall Study||9
10315416|NCT00178464|11449281|FG000|NOT COMPLETED|Overall Study||2
10315417|NCT00178503|11449285|FG000|STARTED|MPH Trial: Placebo||24
10315418|NCT00178503|11449285|FG000|COMPLETED|MPH Trial: Placebo||24
10658816|NCT02235831|11820004|FG002|STARTED|Period 3, Third 5 Days of Wear||4
10658817|NCT02235831|11820005|FG003|STARTED|Period 3, Third 5 Days of Wear||4
10719582|NCT02710630|11883255|FG001|NOT COMPLETED|Period 5||0
10719583|NCT02710630|11883256|FG002|NOT COMPLETED|Period 5||0
10394265|NCT00682786|11537725|FG001|NOT COMPLETED|Overall Study||3
10394266|NCT00682838|11537741|FG000|STARTED|Overall Study||65
10394267|NCT00682838|11537742|FG001|STARTED|Overall Study||67
10394268|NCT00682838|11537743|FG002|STARTED|Overall Study||75
10394269|NCT00682838|11537744|FG003|STARTED|Overall Study||73
10394270|NCT00682838|11537741|FG000|COMPLETED|Overall Study||65
10394271|NCT00682838|11537742|FG001|COMPLETED|Overall Study||67
10394272|NCT00682838|11537743|FG002|COMPLETED|Overall Study||75
10394273|NCT00682838|11537744|FG003|COMPLETED|Overall Study||73
10394274|NCT00682838|11537741|FG000|NOT COMPLETED|Overall Study||0
10394275|NCT00682838|11537742|FG001|NOT COMPLETED|Overall Study||0
10394276|NCT00682838|11537743|FG002|NOT COMPLETED|Overall Study||0
10394277|NCT00682838|11537744|FG003|NOT COMPLETED|Overall Study||0
10394278|NCT00682851|11537756|FG000|STARTED|Overall Study||251
10394279|NCT00682851|11537757|FG001|STARTED|Overall Study||268
10394280|NCT00682851|11537756|FG000|COMPLETED|Overall Study||251
10394281|NCT00682851|11537757|FG001|COMPLETED|Overall Study||268
10394282|NCT00682851|11537756|FG000|NOT COMPLETED|Overall Study||0
10394283|NCT00682851|11537757|FG001|NOT COMPLETED|Overall Study||0
10394284|NCT00682890|11537765|FG000|STARTED|Overall Study||12
10394285|NCT00682890|11537766|FG001|STARTED|Overall Study||11
10394286|NCT00682890|11537765|FG000|COMPLETED|Overall Study||10
10394287|NCT00682890|11537766|FG001|COMPLETED|Overall Study||9
10394288|NCT00682890|11537765|FG000|NOT COMPLETED|Overall Study||2
10394289|NCT00682890|11537766|FG001|NOT COMPLETED|Overall Study||2
10394290|NCT00682929|11537775|FG000|STARTED|Overall Study||13
10394291|NCT00682929|11537776|FG001|STARTED|Overall Study||14
10394292|NCT00682929|11537777|FG002|STARTED|Overall Study||14
10394293|NCT00682929|11537775|FG000|COMPLETED|Overall Study||7
10394294|NCT00682929|11537776|FG001|COMPLETED|Overall Study||9
10394295|NCT00682929|11537777|FG002|COMPLETED|Overall Study||12
10394296|NCT00682929|11537775|FG000|NOT COMPLETED|Overall Study||6
10394297|NCT00682929|11537776|FG001|NOT COMPLETED|Overall Study||5
10394298|NCT00682929|11537777|FG002|NOT COMPLETED|Overall Study||2
10394299|NCT00683020|11537787|FG000|STARTED|Overall Study||182
10394300|NCT00683020|11537788|FG001|STARTED|Overall Study||180
10394301|NCT00683020|11537787|FG000|COMPLETED|Overall Study||127
10394302|NCT00683020|11537788|FG001|COMPLETED|Overall Study||125
10394303|NCT00683020|11537787|FG000|NOT COMPLETED|Overall Study||55
10394304|NCT00683020|11537788|FG001|NOT COMPLETED|Overall Study||55
10428682|NCT00859495|11574719|FG000|NOT COMPLETED|Overall Study||0
10428683|NCT00859508|11574725|FG000|STARTED|Overall Study||68
10428684|NCT00859508|11574726|FG001|STARTED|Overall Study||37
10428685|NCT00859508|11574725|FG000|COMPLETED|Overall Study||62
10428686|NCT00859508|11574726|FG001|COMPLETED|Overall Study||37
10428687|NCT00859508|11574725|FG000|NOT COMPLETED|Overall Study||6
10428688|NCT00859508|11574726|FG001|NOT COMPLETED|Overall Study||0
10428689|NCT00859547|11574732|FG000|STARTED|Overall Study||30
10428690|NCT00859547|11574732|FG000|COMPLETED|Overall Study||28
10428691|NCT00859547|11574732|FG000|NOT COMPLETED|Overall Study||2
10428692|NCT00859573|11574738|FG000|STARTED|Overall Study||6
10428693|NCT00859573|11574739|FG001|STARTED|Overall Study||3
10428694|NCT00859573|11574738|FG000|COMPLETED|Overall Study||1
10428695|NCT00859573|11574739|FG001|COMPLETED|Overall Study||1
10428696|NCT00859573|11574738|FG000|NOT COMPLETED|Overall Study||5
10428697|NCT00859573|11574739|FG001|NOT COMPLETED|Overall Study||2
10428698|NCT00859586|11574745|FG000|STARTED|Overall Study||8
10428699|NCT00859586|11574745|FG000|COMPLETED|Overall Study||4
10428700|NCT00859586|11574745|FG000|NOT COMPLETED|Overall Study||4
10543204|NCT01483144|11696436|FG002|NOT COMPLETED|Overall Study||15
10543205|NCT01483183|11696454|FG000|STARTED|Overall Study||4
10543206|NCT01483183|11696455|FG001|STARTED|Overall Study||1
10543207|NCT01483183|11696456|FG002|STARTED|Overall Study||5
10543208|NCT01483183|11696457|FG003|STARTED|Overall Study||3
10543209|NCT01483183|11696458|FG004|STARTED|Overall Study||4
10543210|NCT01483183|11696459|FG005|STARTED|Overall Study||4
10543211|NCT01483183|11696460|FG006|STARTED|Overall Study||6
10543212|NCT01483183|11696461|FG007|STARTED|Overall Study||4
10543213|NCT01483183|11696462|FG008|STARTED|Overall Study||4
10543214|NCT01483183|11696463|FG009|STARTED|Overall Study||5
10543215|NCT01483183|11696454|FG000|COMPLETED|Overall Study||4
10543216|NCT01483183|11696455|FG001|COMPLETED|Overall Study||1
10543217|NCT01483183|11696456|FG002|COMPLETED|Overall Study||5
10543218|NCT01483183|11696457|FG003|COMPLETED|Overall Study||3
10543219|NCT01483183|11696458|FG004|COMPLETED|Overall Study||4
10543220|NCT01483183|11696459|FG005|COMPLETED|Overall Study||4
10543221|NCT01483183|11696460|FG006|COMPLETED|Overall Study||4
10543222|NCT01483183|11696461|FG007|COMPLETED|Overall Study||4
10543223|NCT01483183|11696462|FG008|COMPLETED|Overall Study||4
10543224|NCT01483183|11696463|FG009|COMPLETED|Overall Study||4
10543225|NCT01483183|11696454|FG000|NOT COMPLETED|Overall Study||0
10394305|NCT00683046|11537794|FG000|STARTED|Overall Study||204
10394306|NCT00683046|11537794|FG000|COMPLETED|Overall Study||204
10394307|NCT00683046|11537794|FG000|NOT COMPLETED|Overall Study||0
10658818|NCT02235831|11820006|FG004|STARTED|Period 3, Third 5 Days of Wear||4
10394308|NCT00683085|11537798|FG000|STARTED|Overall Study||2
10394309|NCT00683085|11537798|FG000|COMPLETED|Overall Study||2
10543226|NCT01483183|11696455|FG001|NOT COMPLETED|Overall Study||0
10543227|NCT01483183|11696456|FG002|NOT COMPLETED|Overall Study||0
10543228|NCT01483183|11696457|FG003|NOT COMPLETED|Overall Study||0
10543229|NCT01483183|11696458|FG004|NOT COMPLETED|Overall Study||0
10543230|NCT01483183|11696459|FG005|NOT COMPLETED|Overall Study||0
10394310|NCT00683085|11537798|FG000|NOT COMPLETED|Overall Study||0
10394311|NCT00683163|11537804|FG000|STARTED|Overall Study||22
10394312|NCT00683163|11537805|FG001|STARTED|Overall Study||22
10394313|NCT00683163|11537804|FG000|COMPLETED|Overall Study||22
10394314|NCT00683163|11537805|FG001|COMPLETED|Overall Study||22
10394315|NCT00683163|11537804|FG000|NOT COMPLETED|Overall Study||0
10394316|NCT00683163|11537805|FG001|NOT COMPLETED|Overall Study||0
10394317|NCT00683293|11537813|FG000|STARTED|Overall Study||50
10394318|NCT00683293|11537814|FG001|STARTED|Overall Study||50
10394319|NCT00683293|11537813|FG000|COMPLETED|Overall Study||48
10394320|NCT00683293|11537814|FG001|COMPLETED|Overall Study||47
10394321|NCT00683293|11537813|FG000|NOT COMPLETED|Overall Study||2
10394322|NCT00683293|11537814|FG001|NOT COMPLETED|Overall Study||3
10394323|NCT00683332|11537820|FG000|STARTED|Overall Study||621
10394324|NCT00683332|11537820|FG000|COMPLETED|Overall Study||621
10394325|NCT00683332|11537820|FG000|NOT COMPLETED|Overall Study||0
10394326|NCT00683384|11537824|FG000|STARTED|Overall Study||93
10394327|NCT00683384|11537824|FG000|COMPLETED|Overall Study||91
10394328|NCT00683384|11537824|FG000|NOT COMPLETED|Overall Study||2
10394329|NCT00683410|11537828|FG000|STARTED|Overall Study||3366
10394330|NCT00683410|11537828|FG000|Vaccinated Dose 1|Overall Study||3240
10394331|NCT00683410|11537828|FG000|Vaccinated Dose 2|Overall Study||1623
10394332|NCT00683410|11537828|FG000|Vaccinated Dose 3|Overall Study||817
10394333|NCT00683410|11537828|FG000|Vaccinated Dose 4|Overall Study||175
10394334|NCT00683410|11537828|FG000|COMPLETED|Overall Study||3366
10543231|NCT01483183|11696460|FG006|NOT COMPLETED|Overall Study||2
10543232|NCT01483183|11696461|FG007|NOT COMPLETED|Overall Study||0
10543233|NCT01483183|11696462|FG008|NOT COMPLETED|Overall Study||0
10543234|NCT01483183|11696463|FG009|NOT COMPLETED|Overall Study||1
10543235|NCT01483352|11696491|FG000|STARTED|Overall Study||12
10543236|NCT01483352|11696491|FG000|COMPLETED|Overall Study||12
10394335|NCT00683410|11537828|FG000|NOT COMPLETED|Overall Study||0
10394336|NCT00683449|11537837|FG000|STARTED|Overall Study||5
10394337|NCT00683449|11537838|FG001|STARTED|Overall Study||13
10394338|NCT00683449|11537839|FG002|STARTED|Overall Study||3
10394339|NCT00683449|11537840|FG003|STARTED|Overall Study||6
10394340|NCT00683449|11537841|FG004|STARTED|Overall Study||2
10394341|NCT00683449|11537837|FG000|COMPLETED|Overall Study||5
10394342|NCT00683449|11537838|FG001|COMPLETED|Overall Study||12
10394343|NCT00683449|11537839|FG002|COMPLETED|Overall Study||3
10309343|NCT00116779|11442324|FG000|STARTED|Overall Study|Randomized and treated; Intent-to-treat population|63
10309344|NCT00116779|11442325|FG001|STARTED|Overall Study|Randomized and treated; intent-to-treat population|64
10309345|NCT00116779|11442324|FG000|COMPLETED|Overall Study||42
10309346|NCT00116779|11442325|FG001|COMPLETED|Overall Study||45
10309347|NCT00116779|11442324|FG000|NOT COMPLETED|Overall Study||21
10309348|NCT00116779|11442325|FG001|NOT COMPLETED|Overall Study||19
10309349|NCT00116805|11442333|FG000|STARTED|Double-blind Period Through Week 48||176
10309350|NCT00116805|11442334|FG001|STARTED|Double-blind Period Through Week 48||90
10309351|NCT00116805|11442333|FG000|COMPLETED|Double-blind Period Through Week 48||165
10309352|NCT00116805|11442334|FG001|COMPLETED|Double-blind Period Through Week 48||85
10309353|NCT00116805|11442333|FG000|NOT COMPLETED|Double-blind Period Through Week 48||11
10309354|NCT00116805|11442334|FG001|NOT COMPLETED|Double-blind Period Through Week 48||5
10309355|NCT00116805|11442333|FG000|STARTED|Open-label Period Weeks 49 - 96|11 participants completed 48 weeks but did not continue on study.|154
10309356|NCT00116805|11442334|FG001|STARTED|Open-label Period Weeks 49 - 96|1 participant completed 48 weeks but did not continue on study.|84
10309357|NCT00116805|11442333|FG000|COMPLETED|Open-label Period Weeks 49 - 96||144
10309358|NCT00116805|11442334|FG001|COMPLETED|Open-label Period Weeks 49 - 96||83
10309359|NCT00116805|11442333|FG000|NOT COMPLETED|Open-label Period Weeks 49 - 96||10
10309360|NCT00116805|11442334|FG001|NOT COMPLETED|Open-label Period Weeks 49 - 96||1
10309361|NCT00116805|11442333|FG000|STARTED|Open-label Period Weeks 97 - 144||144
10309362|NCT00116805|11442334|FG001|STARTED|Open-label Period Weeks 97 - 144||83
10309363|NCT00116805|11442333|FG000|COMPLETED|Open-label Period Weeks 97 - 144||133
10309364|NCT00116805|11442334|FG001|COMPLETED|Open-label Period Weeks 97 - 144||74
10309365|NCT00116805|11442333|FG000|NOT COMPLETED|Open-label Period Weeks 97 - 144||11
10309366|NCT00116805|11442334|FG001|NOT COMPLETED|Open-label Period Weeks 97 - 144||9
10309367|NCT00116805|11442333|FG000|STARTED|Open-label Period Weeks 145 - 192||133
10309368|NCT00116805|11442334|FG001|STARTED|Open-label Period Weeks 145 - 192||74
10309369|NCT00116805|11442333|FG000|COMPLETED|Open-label Period Weeks 145 - 192||123
10543237|NCT01483352|11696491|FG000|NOT COMPLETED|Overall Study||0
10309370|NCT00116805|11442334|FG001|COMPLETED|Open-label Period Weeks 145 - 192||68
10309371|NCT00116805|11442333|FG000|NOT COMPLETED|Open-label Period Weeks 145 - 192||10
10309372|NCT00116805|11442334|FG001|NOT COMPLETED|Open-label Period Weeks 145 - 192||6
10309373|NCT00116805|11442333|FG000|STARTED|Open-label Period Weeks 193 - 240||123
10309374|NCT00116805|11442334|FG001|STARTED|Open-label Period Weeks 193 - 240||68
10309375|NCT00116805|11442333|FG000|COMPLETED|Open-label Period Weeks 193 - 240||110
10309376|NCT00116805|11442334|FG001|COMPLETED|Open-label Period Weeks 193 - 240||64
10309377|NCT00116805|11442333|FG000|NOT COMPLETED|Open-label Period Weeks 193 - 240||13
10309378|NCT00116805|11442334|FG001|NOT COMPLETED|Open-label Period Weeks 193 - 240||4
10309379|NCT00116805|11442333|FG000|STARTED|Open-label Period Weeks 241 - 288||110
10309380|NCT00116805|11442334|FG001|STARTED|Open-label Period Weeks 241 - 288||64
10309381|NCT00116805|11442333|FG000|COMPLETED|Open-label Period Weeks 241 - 288||104
10309382|NCT00116805|11442334|FG001|COMPLETED|Open-label Period Weeks 241 - 288||64
10309383|NCT00116805|11442333|FG000|NOT COMPLETED|Open-label Period Weeks 241 - 288||6
10309384|NCT00116805|11442334|FG001|NOT COMPLETED|Open-label Period Weeks 241 - 288||0
10309385|NCT00116805|11442333|FG000|STARTED|Open-label Period Weeks 289 - 336||104
10309386|NCT00116805|11442334|FG001|STARTED|Open-label Period Weeks 289 - 336||64
10315419|NCT00178503|11449285|FG000|NOT COMPLETED|MPH Trial: Placebo||0
10315420|NCT00178503|11449285|FG000|STARTED|MPH Trial: Low Dose||24
10315421|NCT00178503|11449285|FG000|COMPLETED|MPH Trial: Low Dose||24
10315422|NCT00178503|11449285|FG000|NOT COMPLETED|MPH Trial: Low Dose||0
10315423|NCT00178503|11449285|FG000|STARTED|MPH Trial: Med Dose||24
10315424|NCT00178503|11449285|FG000|COMPLETED|MPH Trial: Med Dose||24
10315425|NCT00178503|11449285|FG000|NOT COMPLETED|MPH Trial: Med Dose||0
10315426|NCT00178503|11449285|FG000|STARTED|MPH Trial: High Dose||24
10315427|NCT00178503|11449285|FG000|COMPLETED|MPH Trial: High Dose||24
10315428|NCT00178503|11449285|FG000|NOT COMPLETED|MPH Trial: High Dose||0
10315429|NCT00178633|11449300|FG000|STARTED|Overall Study||43
10315430|NCT00178633|11449300|FG000|COMPLETED|Overall Study||37
10315431|NCT00178633|11449300|FG000|NOT COMPLETED|Overall Study||6
10315432|NCT00178646|11449308|FG000|STARTED|Overall Study||12
10315433|NCT00178646|11449309|FG001|STARTED|Overall Study||9
10315434|NCT00178646|11449310|FG002|STARTED|Overall Study||11
10315435|NCT00178646|11449308|FG000|COMPLETED|Overall Study||12
10315436|NCT00178646|11449309|FG001|COMPLETED|Overall Study||8
10315437|NCT00178646|11449310|FG002|COMPLETED|Overall Study||10
10315438|NCT00178646|11449308|FG000|NOT COMPLETED|Overall Study||0
10315439|NCT00178646|11449309|FG001|NOT COMPLETED|Overall Study||1
10315440|NCT00178646|11449310|FG002|NOT COMPLETED|Overall Study||1
10315441|NCT00178685|11449324|FG000|STARTED|Overall Study||172
10315442|NCT00178685|11449325|FG001|STARTED|Overall Study||324
10315443|NCT00178685|11449326|FG002|STARTED|Overall Study||324
10315444|NCT00178685|11449324|FG000|COMPLETED|Overall Study||61
10315445|NCT00178685|11449325|FG001|COMPLETED|Overall Study||120
10315446|NCT00178685|11449326|FG002|COMPLETED|Overall Study||128
10315447|NCT00178685|11449324|FG000|NOT COMPLETED|Overall Study||111
10315448|NCT00178685|11449325|FG001|NOT COMPLETED|Overall Study||204
10315449|NCT00178685|11449326|FG002|NOT COMPLETED|Overall Study||196
10315450|NCT00178711|11449336|FG000|STARTED|Overall Study||52
10315451|NCT00178711|11449337|FG001|STARTED|Overall Study||45
10315452|NCT00178711|11449336|FG000|COMPLETED|Overall Study||52
10315453|NCT00178711|11449337|FG001|COMPLETED|Overall Study||45
10315454|NCT00178711|11449336|FG000|NOT COMPLETED|Overall Study||0
10315455|NCT00178711|11449337|FG001|NOT COMPLETED|Overall Study||0
10315456|NCT00178841|11449345|FG000|STARTED|Overall Study||4
10315457|NCT00178841|11449345|FG000|COMPLETED|Overall Study||4
10315458|NCT00178841|11449345|FG000|NOT COMPLETED|Overall Study||0
10315459|NCT00178919|11449352|FG000|STARTED|Overall Study||19
10315460|NCT00178919|11449353|FG001|STARTED|Overall Study||93
10315461|NCT00178919|11449352|FG000|COMPLETED|Overall Study||19
10315462|NCT00178919|11449353|FG001|COMPLETED|Overall Study||68
10315463|NCT00178919|11449352|FG000|NOT COMPLETED|Overall Study||0
10315464|NCT00178919|11449353|FG001|NOT COMPLETED|Overall Study||25
10315465|NCT00179010|11449361|FG000|STARTED|Overall Study||6
10315466|NCT00179010|11449362|FG001|STARTED|Overall Study||7
10315467|NCT00179010|11449361|FG000|COMPLETED|Overall Study||5
10315468|NCT00179010|11449362|FG001|COMPLETED|Overall Study||5
10315469|NCT00179010|11449361|FG000|NOT COMPLETED|Overall Study||1
10315470|NCT00179010|11449362|FG001|NOT COMPLETED|Overall Study||2
10315471|NCT00179309|11449371|FG000|STARTED|Treatment||25
10315472|NCT00179309|11449372|FG001|STARTED|Treatment||23
10315473|NCT00179309|11449371|FG000|COMPLETED|Treatment||21
10315474|NCT00179309|11449372|FG001|COMPLETED|Treatment||18
10658819|NCT02235831|11820007|FG005|STARTED|Period 3, Third 5 Days of Wear||4
10658820|NCT02235831|11820002|FG000|COMPLETED|Period 3, Third 5 Days of Wear||4
10719584|NCT02710630|11883257|FG003|NOT COMPLETED|Period 5||0
10719585|NCT02710630|11883258|FG004|NOT COMPLETED|Period 5||0
10719586|NCT02710630|11883254|FG000|STARTED|Period 6||7
10719587|NCT02710630|11883255|FG001|STARTED|Period 6||7
10719588|NCT02710630|11883256|FG002|STARTED|Period 6||7
10658821|NCT02235831|11820003|FG001|COMPLETED|Period 3, Third 5 Days of Wear||4
10658822|NCT02235831|11820004|FG002|COMPLETED|Period 3, Third 5 Days of Wear||4
10658823|NCT02235831|11820005|FG003|COMPLETED|Period 3, Third 5 Days of Wear||4
10658824|NCT02235831|11820006|FG004|COMPLETED|Period 3, Third 5 Days of Wear||4
10658825|NCT02235831|11820007|FG005|COMPLETED|Period 3, Third 5 Days of Wear||4
10658826|NCT02235831|11820002|FG000|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
10658827|NCT02235831|11820003|FG001|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
10658828|NCT02235831|11820004|FG002|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
10658829|NCT02235831|11820005|FG003|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
10658830|NCT02235831|11820006|FG004|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
10658831|NCT02235831|11820007|FG005|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
10658832|NCT02235870|11820016|FG000|STARTED|Overall Study||198
10658833|NCT02235870|11820017|FG001|STARTED|Overall Study||189
10719589|NCT02710630|11883257|FG003|STARTED|Period 6||7
10719590|NCT02710630|11883258|FG004|STARTED|Period 6||7
10719591|NCT02710630|11883254|FG000|COMPLETED|Period 6||7
10719592|NCT02710630|11883255|FG001|COMPLETED|Period 6||7
10719593|NCT02710630|11883256|FG002|COMPLETED|Period 6||7
10719594|NCT02710630|11883257|FG003|COMPLETED|Period 6||7
10719595|NCT02710630|11883258|FG004|COMPLETED|Period 6||7
10719596|NCT02710630|11883254|FG000|NOT COMPLETED|Period 6||0
10719597|NCT02710630|11883255|FG001|NOT COMPLETED|Period 6||0
10719598|NCT02710630|11883256|FG002|NOT COMPLETED|Period 6||0
10719599|NCT02710630|11883257|FG003|NOT COMPLETED|Period 6||0
10719600|NCT02710630|11883258|FG004|NOT COMPLETED|Period 6||0
10719601|NCT02710890|11883274|FG000|STARTED|Overall Study||48
10719602|NCT02710890|11883275|FG001|STARTED|Overall Study||55
10719603|NCT02710890|11883274|FG000|COMPLETED|Overall Study||48
10719604|NCT02710890|11883275|FG001|COMPLETED|Overall Study||55
10719605|NCT02710890|11883274|FG000|NOT COMPLETED|Overall Study||0
10719606|NCT02710890|11883275|FG001|NOT COMPLETED|Overall Study||0
10719607|NCT02710981|11883281|FG000|STARTED|6th Ovulation Induction Cycle (5 Days)||42
10719608|NCT02710981|11883282|FG001|STARTED|6th Ovulation Induction Cycle (5 Days)||0
10719609|NCT02710981|11883281|FG000|COMPLETED|6th Ovulation Induction Cycle (5 Days)||41
10719610|NCT02710981|11883282|FG001|COMPLETED|6th Ovulation Induction Cycle (5 Days)||0
10719611|NCT02710981|11883281|FG000|NOT COMPLETED|6th Ovulation Induction Cycle (5 Days)||1
10719612|NCT02710981|11883282|FG001|NOT COMPLETED|6th Ovulation Induction Cycle (5 Days)||0
10719613|NCT02710981|11883281|FG000|STARTED|7th Ovulation Induction Cycle (5 Days)||0
10719614|NCT02710981|11883282|FG001|STARTED|7th Ovulation Induction Cycle (5 Days)||41
10719615|NCT02710981|11883281|FG000|COMPLETED|7th Ovulation Induction Cycle (5 Days)||0
10719616|NCT02710981|11883282|FG001|COMPLETED|7th Ovulation Induction Cycle (5 Days)||36
10719617|NCT02710981|11883281|FG000|NOT COMPLETED|7th Ovulation Induction Cycle (5 Days)||0
10719618|NCT02710981|11883282|FG001|NOT COMPLETED|7th Ovulation Induction Cycle (5 Days)||5
10719619|NCT02711306|11883292|FG000|STARTED|Overall Study||18
10719620|NCT02711306|11883293|FG001|STARTED|Overall Study||18
10719621|NCT02711306|11883292|FG000|COMPLETED|Overall Study||16
10719622|NCT02711306|11883293|FG001|COMPLETED|Overall Study||16
10719623|NCT02711306|11883292|FG000|NOT COMPLETED|Overall Study||2
10719624|NCT02711306|11883293|FG001|NOT COMPLETED|Overall Study||2
10719625|NCT02711345|11883309|FG000|STARTED|Overall Study||2
10719626|NCT02711345|11883310|FG001|STARTED|Overall Study||3
10719627|NCT02711345|11883311|FG002|STARTED|Overall Study||6
10719628|NCT02711345|11883312|FG003|STARTED|Overall Study||4
10719629|NCT02711345|11883313|FG004|STARTED|Overall Study||8
10719630|NCT02711345|11883314|FG005|STARTED|Overall Study||6
10719631|NCT02711345|11883315|FG006|STARTED|Overall Study||12
10719632|NCT02711345|11883316|FG007|STARTED|Overall Study||6
10719633|NCT02711345|11883317|FG008|STARTED|Overall Study||6
10719634|NCT02711345|11883318|FG009|STARTED|Overall Study||12
10719635|NCT02711345|11883309|FG000|COMPLETED|Overall Study||0
10719636|NCT02711345|11883310|FG001|COMPLETED|Overall Study||0
10719637|NCT02711345|11883311|FG002|COMPLETED|Overall Study||0
10719638|NCT02711345|11883312|FG003|COMPLETED|Overall Study||0
10719639|NCT02711345|11883313|FG004|COMPLETED|Overall Study||0
10719640|NCT02711345|11883314|FG005|COMPLETED|Overall Study||0
10394344|NCT00683449|11537840|FG003|COMPLETED|Overall Study||6
10394345|NCT00683449|11537841|FG004|COMPLETED|Overall Study||2
10394346|NCT00683449|11537837|FG000|NOT COMPLETED|Overall Study||0
10719641|NCT02711345|11883315|FG006|COMPLETED|Overall Study||0
10719642|NCT02711345|11883316|FG007|COMPLETED|Overall Study||0
10719643|NCT02711345|11883317|FG008|COMPLETED|Overall Study||0
10719644|NCT02711345|11883318|FG009|COMPLETED|Overall Study||0
10719645|NCT02711345|11883309|FG000|NOT COMPLETED|Overall Study||2
10719646|NCT02711345|11883310|FG001|NOT COMPLETED|Overall Study||3
10719647|NCT02711345|11883311|FG002|NOT COMPLETED|Overall Study||6
10394347|NCT00683449|11537838|FG001|NOT COMPLETED|Overall Study||1
10719648|NCT02711345|11883312|FG003|NOT COMPLETED|Overall Study||4
10719649|NCT02711345|11883313|FG004|NOT COMPLETED|Overall Study||8
10719650|NCT02711345|11883314|FG005|NOT COMPLETED|Overall Study||6
10719651|NCT02711345|11883315|FG006|NOT COMPLETED|Overall Study||12
10719652|NCT02711345|11883316|FG007|NOT COMPLETED|Overall Study||6
10309387|NCT00116805|11442333|FG000|COMPLETED|Open-label Period Weeks 289 - 336||98
10309388|NCT00116805|11442334|FG001|COMPLETED|Open-label Period Weeks 289 - 336||57
10309389|NCT00116805|11442333|FG000|NOT COMPLETED|Open-label Period Weeks 289 - 336||6
10543238|NCT01483378|11696495|FG000|STARTED|Overall Study||100
10543239|NCT01483378|11696496|FG001|STARTED|Overall Study||66
10658834|NCT02235870|11820016|FG000|Completed Phase I (Week 24)|Overall Study||182
10309390|NCT00116805|11442334|FG001|NOT COMPLETED|Open-label Period Weeks 289 - 336||7
10309391|NCT00116805|11442333|FG000|STARTED|Open-label Period Weeks 337 - 384||98
10309392|NCT00116805|11442334|FG001|STARTED|Open-label Period Weeks 337 - 384||57
10309393|NCT00116805|11442333|FG000|COMPLETED|Open-label Period Weeks 337 - 384||90
10309394|NCT00116805|11442334|FG001|COMPLETED|Open-label Period Weeks 337 - 384||56
10309395|NCT00116805|11442333|FG000|NOT COMPLETED|Open-label Period Weeks 337 - 384||8
10309396|NCT00116805|11442334|FG001|NOT COMPLETED|Open-label Period Weeks 337 - 384||1
10309397|NCT00116805|11442333|FG000|STARTED|Open-label Period Weeks 385 - 432|31 participants completed 384 weeks but did not continue on study.|59
10309398|NCT00116805|11442334|FG001|STARTED|Open-label Period Weeks 385 - 432|26 participants completed 384 weeks but did not continue on study.|30
10309399|NCT00116805|11442333|FG000|COMPLETED|Open-label Period Weeks 385 - 432||57
10309400|NCT00116805|11442334|FG001|COMPLETED|Open-label Period Weeks 385 - 432||30
10309401|NCT00116805|11442333|FG000|NOT COMPLETED|Open-label Period Weeks 385 - 432||2
10309402|NCT00116805|11442334|FG001|NOT COMPLETED|Open-label Period Weeks 385 - 432||0
10309403|NCT00116805|11442333|FG000|STARTED|Open-label Period Weeks 433 - 480||57
10309404|NCT00116805|11442334|FG001|STARTED|Open-label Period Weeks 433 - 480|1 participant completed 432 weeks but did not continue on study.|29
10309405|NCT00116805|11442333|FG000|COMPLETED|Open-label Period Weeks 433 - 480||53
10309406|NCT00116805|11442334|FG001|COMPLETED|Open-label Period Weeks 433 - 480||29
10309407|NCT00116805|11442333|FG000|NOT COMPLETED|Open-label Period Weeks 433 - 480||4
10309408|NCT00116805|11442334|FG001|NOT COMPLETED|Open-label Period Weeks 433 - 480||0
10309409|NCT00116831|11442351|FG000|STARTED|Overall Study||337
10309410|NCT00116831|11442352|FG001|STARTED|Overall Study||331
10309411|NCT00116831|11442351|FG000|COMPLETED|Overall Study||264
10309412|NCT00116831|11442352|FG001|COMPLETED|Overall Study||259
10309413|NCT00116831|11442351|FG000|NOT COMPLETED|Overall Study||73
10309414|NCT00116831|11442352|FG001|NOT COMPLETED|Overall Study||72
10309415|NCT00116844|11442360|FG000|STARTED|Period 1: Treatment Period 1 (60 Days)||35
10309416|NCT00116844|11442361|FG001|STARTED|Period 1: Treatment Period 1 (60 Days)||36
10309417|NCT00116844|11442360|FG000|COMPLETED|Period 1: Treatment Period 1 (60 Days)||28
10309418|NCT00116844|11442361|FG001|COMPLETED|Period 1: Treatment Period 1 (60 Days)||33
10309419|NCT00116844|11442360|FG000|NOT COMPLETED|Period 1: Treatment Period 1 (60 Days)||7
10309420|NCT00116844|11442361|FG001|NOT COMPLETED|Period 1: Treatment Period 1 (60 Days)||3
10309421|NCT00116844|11442360|FG000|STARTED|Period 2: Washout Period (7 Days)||28
10309422|NCT00116844|11442361|FG001|STARTED|Period 2: Washout Period (7 Days)||33
10309423|NCT00116844|11442360|FG000|COMPLETED|Period 2: Washout Period (7 Days)||28
10309424|NCT00116844|11442361|FG001|COMPLETED|Period 2: Washout Period (7 Days)||33
10309425|NCT00116844|11442360|FG000|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
10309426|NCT00116844|11442361|FG001|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
10309427|NCT00116844|11442360|FG000|STARTED|Period 1: Treatment Period 2 (60 Days)||28
10309428|NCT00116844|11442361|FG001|STARTED|Period 1: Treatment Period 2 (60 Days)||33
10309429|NCT00116844|11442360|FG000|COMPLETED|Period 1: Treatment Period 2 (60 Days)||24
10309430|NCT00116844|11442361|FG001|COMPLETED|Period 1: Treatment Period 2 (60 Days)||28
10309431|NCT00116844|11442360|FG000|NOT COMPLETED|Period 1: Treatment Period 2 (60 Days)||4
10309432|NCT00116844|11442361|FG001|NOT COMPLETED|Period 1: Treatment Period 2 (60 Days)||5
10309433|NCT00116857|11442369|FG000|STARTED|Overall Study||62
10309434|NCT00116857|11442370|FG001|STARTED|Overall Study||60
10309435|NCT00116857|11442369|FG000|COMPLETED|Overall Study||59
10309436|NCT00116857|11442370|FG001|COMPLETED|Overall Study||56
10309437|NCT00116857|11442369|FG000|NOT COMPLETED|Overall Study||3
10309438|NCT00116857|11442370|FG001|NOT COMPLETED|Overall Study||4
10309439|NCT00117143|11442380|FG000|STARTED|Overall Study||4
10309440|NCT00117143|11442381|FG001|STARTED|Overall Study||4
10309441|NCT00117143|11442382|FG002|STARTED|Overall Study||7
10309442|NCT00117143|11442383|FG003|STARTED|Overall Study||1
10309443|NCT00117143|11442380|FG000|Received First Dose|Overall Study||4
10309444|NCT00117143|11442381|FG001|Received First Dose|Overall Study||4
10309445|NCT00117143|11442382|FG002|Received First Dose|Overall Study||7
10309446|NCT00117143|11442383|FG003|Received First Dose|Overall Study||1
10309447|NCT00117143|11442380|FG000|Received Second Dose|Overall Study||4
10309448|NCT00117143|11442381|FG001|Received Second Dose|Overall Study||4
10309449|NCT00117143|11442382|FG002|Received Second Dose|Overall Study||6
10309450|NCT00117143|11442383|FG003|Received Second Dose|Overall Study||0
10309451|NCT00117143|11442380|FG000|COMPLETED|Overall Study||4
10309452|NCT00117143|11442381|FG001|COMPLETED|Overall Study||4
10309453|NCT00117143|11442382|FG002|COMPLETED|Overall Study||7
10309454|NCT00117143|11442383|FG003|COMPLETED|Overall Study||1
10543240|NCT01483378|11696495|FG000|COMPLETED|Overall Study||100
10543241|NCT01483378|11696496|FG001|COMPLETED|Overall Study||66
10543242|NCT01483378|11696495|FG000|NOT COMPLETED|Overall Study||0
10813190|NCT02985840|11975484|FG001|COMPLETED|Overall Study||63
10813191|NCT02985840|11975483|FG000|NOT COMPLETED|Overall Study||0
10813192|NCT02985840|11975484|FG001|NOT COMPLETED|Overall Study||0
10813193|NCT02966223|11975490|FG000|STARTED|Overall Study||20
10813194|NCT02966223|11975490|FG000|COMPLETED|Overall Study||5
10813195|NCT02966223|11975490|FG000|NOT COMPLETED|Overall Study||15
10813196|NCT02965846|11975497|FG000|STARTED|Overall Study||5
10813197|NCT02965846|11975498|FG001|STARTED|Overall Study||5
10813198|NCT02965846|11975499|FG002|STARTED|Overall Study||33
10813199|NCT02965846|11975497|FG000|COMPLETED|Overall Study||0
10543243|NCT01483378|11696496|FG001|NOT COMPLETED|Overall Study||0
10543244|NCT01483560|11696504|FG000|STARTED|Overall Study||219
10394348|NCT00683449|11537839|FG002|NOT COMPLETED|Overall Study||0
10394349|NCT00683449|11537840|FG003|NOT COMPLETED|Overall Study||0
10543245|NCT01483560|11696505|FG001|STARTED|Overall Study||209
10543246|NCT01483560|11696504|FG000|COMPLETED|Overall Study||193
10543247|NCT01483560|11696505|FG001|COMPLETED|Overall Study||194
10543248|NCT01483560|11696504|FG000|NOT COMPLETED|Overall Study||26
10543249|NCT01483560|11696505|FG001|NOT COMPLETED|Overall Study||15
10543250|NCT01483599|11696518|FG000|STARTED|Controlled Period (CP) (up to Week 16)||42
10543251|NCT01483599|11696519|FG001|STARTED|Controlled Period (CP) (up to Week 16)||41
10543252|NCT01483599|11696520|FG002|STARTED|Controlled Period (CP) (up to Week 16)||41
10543253|NCT01483599|11696521|FG003|STARTED|Controlled Period (CP) (up to Week 16)||42
10543254|NCT01483599|11696522|FG004|STARTED|Controlled Period (CP) (up to Week 16)||42
10543255|NCT01483599|11696523|FG005|STARTED|Controlled Period (CP) (up to Week 16)||42
10543256|NCT01483599|11696524|FG006|STARTED|Controlled Period (CP) (up to Week 16)||43
10543257|NCT01483599|11696525|FG007|STARTED|Controlled Period (CP) (up to Week 16)||0
10543258|NCT01483599|11696526|FG008|STARTED|Controlled Period (CP) (up to Week 16)||0
10543259|NCT01483599|11696527|FG009|STARTED|Controlled Period (CP) (up to Week 16)||0
10543260|NCT01483599|11696528|FG010|STARTED|Controlled Period (CP) (up to Week 16)||0
10543261|NCT01483599|11696529|FG011|STARTED|Controlled Period (CP) (up to Week 16)||0
10543262|NCT01483599|11696530|FG012|STARTED|Controlled Period (CP) (up to Week 16)||0
10543263|NCT01483599|11696531|FG013|STARTED|Controlled Period (CP) (up to Week 16)||0
10543264|NCT01483599|11696518|FG000|Treated|Controlled Period (CP) (up to Week 16)||42
10543265|NCT01483599|11696519|FG001|Treated|Controlled Period (CP) (up to Week 16)||41
10543266|NCT01483599|11696520|FG002|Treated|Controlled Period (CP) (up to Week 16)||41
10543267|NCT01483599|11696521|FG003|Treated|Controlled Period (CP) (up to Week 16)||42
10543268|NCT01483599|11696522|FG004|Treated|Controlled Period (CP) (up to Week 16)||42
10543269|NCT01483599|11696523|FG005|Treated|Controlled Period (CP) (up to Week 16)||41
10543270|NCT01483599|11696524|FG006|Treated|Controlled Period (CP) (up to Week 16)||43
10543271|NCT01483599|11696525|FG007|Treated|Controlled Period (CP) (up to Week 16)||0
10394350|NCT00683449|11537841|FG004|NOT COMPLETED|Overall Study||0
10394351|NCT00683475|11537860|FG000|STARTED|Overall Study||69
10394352|NCT00683475|11537861|FG001|STARTED|Overall Study||69
10394353|NCT00683475|11537860|FG000|Received Any Quantity of Study Drug|Overall Study||66
10394354|NCT00683475|11537861|FG001|Received Any Quantity of Study Drug|Overall Study||66
10394355|NCT00683475|11537860|FG000|COMPLETED|Overall Study||65
10394356|NCT00683475|11537861|FG001|COMPLETED|Overall Study||66
10394357|NCT00683475|11537860|FG000|NOT COMPLETED|Overall Study||4
10394358|NCT00683475|11537861|FG001|NOT COMPLETED|Overall Study||3
10394359|NCT00683592|11537870|FG000|STARTED|Overall Study||240
10394360|NCT00683592|11537871|FG001|STARTED|Overall Study||241
10394361|NCT00683592|11537870|FG000|Intent to Treat Population|Overall Study||231
10394362|NCT00683592|11537871|FG001|Intent to Treat Population|Overall Study||232
10394363|NCT00683592|11537870|FG000|Safety Population|Overall Study||235
10394364|NCT00683592|11537871|FG001|Safety Population|Overall Study||233
10394365|NCT00683592|11537870|FG000|COMPLETED|Overall Study||193
10394366|NCT00683592|11537871|FG001|COMPLETED|Overall Study||195
10394367|NCT00683592|11537870|FG000|NOT COMPLETED|Overall Study||47
10394368|NCT00683592|11537871|FG001|NOT COMPLETED|Overall Study||46
10394369|NCT00683618|11537880|FG000|STARTED|Randomised Treatment Period||145
10394370|NCT00683618|11537881|FG001|STARTED|Randomised Treatment Period||145
10394371|NCT00683618|11537882|FG002|STARTED|Randomised Treatment Period||146
10394372|NCT00683618|11537880|FG000|COMPLETED|Randomised Treatment Period||139
10394373|NCT00683618|11537881|FG001|COMPLETED|Randomised Treatment Period||143
10394374|NCT00683618|11537882|FG002|COMPLETED|Randomised Treatment Period||140
10394375|NCT00683618|11537880|FG000|NOT COMPLETED|Randomised Treatment Period||6
10394376|NCT00683618|11537881|FG001|NOT COMPLETED|Randomised Treatment Period||2
10394377|NCT00683618|11537882|FG002|NOT COMPLETED|Randomised Treatment Period||6
10394378|NCT00683618|11537880|FG000|STARTED|Extension Treatment Period||36
10394379|NCT00683618|11537881|FG001|STARTED|Extension Treatment Period||23
10394380|NCT00683618|11537882|FG002|STARTED|Extension Treatment Period||0
10394381|NCT00683618|11537880|FG000|COMPLETED|Extension Treatment Period||33
10394382|NCT00683618|11537881|FG001|COMPLETED|Extension Treatment Period||23
10394383|NCT00683618|11537882|FG002|COMPLETED|Extension Treatment Period||0
10394384|NCT00683618|11537880|FG000|NOT COMPLETED|Extension Treatment Period||3
10394385|NCT00683618|11537881|FG001|NOT COMPLETED|Extension Treatment Period||0
10394386|NCT00683618|11537882|FG002|NOT COMPLETED|Extension Treatment Period||0
10394387|NCT00683644|11537894|FG000|STARTED|Overall Study||58
10309455|NCT00117143|11442380|FG000|NOT COMPLETED|Overall Study||0
10309456|NCT00117143|11442381|FG001|NOT COMPLETED|Overall Study||0
10309457|NCT00117143|11442382|FG002|NOT COMPLETED|Overall Study||0
10309458|NCT00117143|11442383|FG003|NOT COMPLETED|Overall Study||0
10309459|NCT00117156|11442393|FG000|STARTED|Overall Study||26
10309460|NCT00117156|11442393|FG000|COMPLETED|Overall Study||15
10309461|NCT00117156|11442393|FG000|NOT COMPLETED|Overall Study||11
10309462|NCT00117286|11442399|FG000|STARTED|Overall Study|Safety analysis set|30
10309463|NCT00117286|11442400|FG001|STARTED|Overall Study||27
10309464|NCT00117286|11442399|FG000|Switched to Higher Dose|Overall Study|A protocol amendment changed the dosage to 160 mg (40 mg/mL)|17
10309465|NCT00117286|11442400|FG001|Switched to Higher Dose|Overall Study||17
10309466|NCT00117286|11442399|FG000|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study|2
10309467|NCT00117286|11442400|FG001|COMPLETED|Overall Study||6
10309468|NCT00117286|11442399|FG000|NOT COMPLETED|Overall Study||28
10309469|NCT00117286|11442400|FG001|NOT COMPLETED|Overall Study||21
10309470|NCT00117312|11442410|FG000|STARTED|Overall Study||10
10309471|NCT00117312|11442411|FG001|STARTED|Overall Study||24
10309472|NCT00117312|11442412|FG002|STARTED|Overall Study||24
10309473|NCT00117312|11442413|FG003|STARTED|Overall Study||24
10309474|NCT00117312|11442410|FG000|Started FE200486 CS06A|Overall Study||1
10309475|NCT00117312|11442411|FG001|Started FE200486 CS06A|Overall Study||11
10309476|NCT00117312|11442412|FG002|Started FE200486 CS06A|Overall Study||16
10309477|NCT00117312|11442413|FG003|Started FE200486 CS06A|Overall Study||9
10309478|NCT00117312|11442410|FG000|COMPLETED|Overall Study||0
10309479|NCT00117312|11442411|FG001|COMPLETED|Overall Study|Defined as those patients ongoing when the extension study was terminated|4
10309480|NCT00117312|11442412|FG002|COMPLETED|Overall Study||0
10309481|NCT00117312|11442413|FG003|COMPLETED|Overall Study||3
10309482|NCT00117312|11442410|FG000|NOT COMPLETED|Overall Study||10
10309483|NCT00117312|11442411|FG001|NOT COMPLETED|Overall Study||20
10394388|NCT00683644|11537895|FG001|STARTED|Overall Study||58
10394389|NCT00683644|11537894|FG000|COMPLETED|Overall Study||45
10394390|NCT00683644|11537895|FG001|COMPLETED|Overall Study||44
10394391|NCT00683644|11537894|FG000|NOT COMPLETED|Overall Study||13
10394392|NCT00683644|11537895|FG001|NOT COMPLETED|Overall Study||14
10394393|NCT00683657|11537907|FG000|STARTED|Overall Study||46
10394394|NCT00683657|11537908|FG001|STARTED|Overall Study||47
10394395|NCT00683657|11537907|FG000|Randomized Subjects Data Set|Overall Study|Randomized subjects who took at least 1 dose of double-blind study medication.|46
10394396|NCT00683657|11537908|FG001|Randomized Subjects Data Set|Overall Study|Randomized subjects who took at least 1 dose of double-blind study medication.|47
10394397|NCT00683657|11537907|FG000|COMPLETED|Overall Study||45
10394398|NCT00683657|11537908|FG001|COMPLETED|Overall Study||46
10394399|NCT00683657|11537907|FG000|NOT COMPLETED|Overall Study||1
10394400|NCT00683657|11537908|FG001|NOT COMPLETED|Overall Study||1
10394401|NCT00683696|11537916|FG000|STARTED|Overall Study||404
10394402|NCT00683696|11537917|FG001|STARTED|Overall Study||405
10394403|NCT00683696|11537916|FG000|COMPLETED|Overall Study||0
10394404|NCT00683696|11537917|FG001|COMPLETED|Overall Study||0
10394405|NCT00683696|11537916|FG000|NOT COMPLETED|Overall Study||404
10394406|NCT00683696|11537917|FG001|NOT COMPLETED|Overall Study||405
10394407|NCT00683774|11537926|FG000|STARTED|Overall Study||11
10394408|NCT00683774|11537927|FG001|STARTED|Overall Study||10
10394409|NCT00683774|11537926|FG000|COMPLETED|Overall Study||8
10394410|NCT00683774|11537927|FG001|COMPLETED|Overall Study||9
10394411|NCT00683774|11537926|FG000|NOT COMPLETED|Overall Study||3
10394412|NCT00683774|11537927|FG001|NOT COMPLETED|Overall Study||1
10394413|NCT00683800|11537935|FG000|STARTED|Overall Study||1101
10394414|NCT00683800|11537936|FG001|STARTED|Overall Study||1085
10394415|NCT00683800|11537935|FG000|Treated|Overall Study||1066
10394416|NCT00683800|11537936|FG001|Treated|Overall Study||1052
10394417|NCT00683800|11537935|FG000|COMPLETED|Overall Study||669
10394418|NCT00683800|11537936|FG001|COMPLETED|Overall Study||719
10394419|NCT00683800|11537935|FG000|NOT COMPLETED|Overall Study||432
10394420|NCT00683800|11537936|FG001|NOT COMPLETED|Overall Study||366
10394421|NCT00683826|11537945|FG000|STARTED|Overall Study||8
10394422|NCT00683826|11537945|FG000|0g Leucine|Overall Study||8
10394423|NCT00683826|11537945|FG000|8g Leucine|Overall Study||8
10394424|NCT00683826|11537945|FG000|4g Leucine|Overall Study||7
10394425|NCT00683826|11537945|FG000|COMPLETED|Overall Study||7
10394426|NCT00683826|11537945|FG000|NOT COMPLETED|Overall Study||1
10394427|NCT00683852|11537955|FG000|STARTED|30-Day Phase 1 Period||56
10394428|NCT00683852|11537956|FG001|STARTED|30-Day Phase 1 Period||84
10394429|NCT00683852|11537957|FG002|STARTED|30-Day Phase 1 Period||85
10394430|NCT00683852|11537955|FG000|COMPLETED|30-Day Phase 1 Period||54
10394431|NCT00683852|11537956|FG001|COMPLETED|30-Day Phase 1 Period||83
10394432|NCT00683852|11537957|FG002|COMPLETED|30-Day Phase 1 Period||84
10394433|NCT00683852|11537955|FG000|NOT COMPLETED|30-Day Phase 1 Period||2
10394434|NCT00683852|11537956|FG001|NOT COMPLETED|30-Day Phase 1 Period||1
10394435|NCT00683852|11537957|FG002|NOT COMPLETED|30-Day Phase 1 Period||1
10394436|NCT00683852|11537955|FG000|STARTED|30-Day Phase 2 Period||54
10394437|NCT00683852|11537956|FG001|STARTED|30-Day Phase 2 Period||83
10394438|NCT00683852|11537957|FG002|STARTED|30-Day Phase 2 Period||84
10394439|NCT00683852|11537955|FG000|COMPLETED|30-Day Phase 2 Period||48
10394440|NCT00683852|11537956|FG001|COMPLETED|30-Day Phase 2 Period||78
10394441|NCT00683852|11537957|FG002|COMPLETED|30-Day Phase 2 Period||75
10394442|NCT00683852|11537955|FG000|NOT COMPLETED|30-Day Phase 2 Period||6
10394443|NCT00683852|11537956|FG001|NOT COMPLETED|30-Day Phase 2 Period||5
10394444|NCT00683852|11537957|FG002|NOT COMPLETED|30-Day Phase 2 Period||9
10394445|NCT00683878|11537975|FG000|STARTED|Overall Study||139
10394446|NCT00683878|11537976|FG001|STARTED|Overall Study||141
10394447|NCT00683878|11537977|FG002|STARTED|Overall Study||140
10394448|NCT00683878|11537975|FG000|COMPLETED|Overall Study||116
10394449|NCT00683878|11537976|FG001|COMPLETED|Overall Study||125
10394450|NCT00683878|11537977|FG002|COMPLETED|Overall Study||126
10394451|NCT00683878|11537975|FG000|NOT COMPLETED|Overall Study||23
10394452|NCT00683878|11537976|FG001|NOT COMPLETED|Overall Study||16
10394453|NCT00683878|11537977|FG002|NOT COMPLETED|Overall Study||14
10394454|NCT00683904|11537987|FG000|STARTED|Dose Level 1||6
10394455|NCT00683904|11537988|FG001|STARTED|Dose Level 1||0
10394456|NCT00683904|11537987|FG000|COMPLETED|Dose Level 1||3
10394457|NCT00683904|11537988|FG001|COMPLETED|Dose Level 1||0
10394458|NCT00683904|11537987|FG000|NOT COMPLETED|Dose Level 1||3
10394459|NCT00683904|11537988|FG001|NOT COMPLETED|Dose Level 1||0
10394460|NCT00683904|11537987|FG000|STARTED|Dose Level 2||0
10394461|NCT00683904|11537988|FG001|STARTED|Dose Level 2||6
10394462|NCT00683904|11537987|FG000|COMPLETED|Dose Level 2||0
10394463|NCT00683904|11537988|FG001|COMPLETED|Dose Level 2||4
10543272|NCT01483599|11696526|FG008|Treated|Controlled Period (CP) (up to Week 16)||0
10543273|NCT01483599|11696527|FG009|Treated|Controlled Period (CP) (up to Week 16)||0
10543274|NCT01483599|11696528|FG010|Treated|Controlled Period (CP) (up to Week 16)||0
10543275|NCT01483599|11696529|FG011|Treated|Controlled Period (CP) (up to Week 16)||0
10394464|NCT00683904|11537987|FG000|NOT COMPLETED|Dose Level 2||0
10394465|NCT00683904|11537988|FG001|NOT COMPLETED|Dose Level 2||2
10394466|NCT00683930|11538003|FG000|STARTED|Overall Study|One subject not included: no study drug dispensed.|36
10394467|NCT00683930|11538004|FG001|STARTED|Overall Study|One subject not included: no study drug dispensed.|21
10394468|NCT00683930|11538005|FG002|STARTED|Overall Study||37
10394469|NCT00683930|11538003|FG000|COMPLETED|Overall Study||29
10394470|NCT00683930|11538004|FG001|COMPLETED|Overall Study||18
10394471|NCT00683930|11538005|FG002|COMPLETED|Overall Study||28
10394472|NCT00683930|11538003|FG000|NOT COMPLETED|Overall Study||7
10394473|NCT00683930|11538004|FG001|NOT COMPLETED|Overall Study||3
10394474|NCT00683930|11538005|FG002|NOT COMPLETED|Overall Study||9
10394475|NCT00684021|11538018|FG000|STARTED|Overall Study||43
10394476|NCT00684021|11538019|FG001|STARTED|Overall Study||24
10394477|NCT00684021|11538020|FG002|STARTED|Overall Study||36
10394478|NCT00684021|11538021|FG003|STARTED|Overall Study||17
10394479|NCT00684021|11538018|FG000|COMPLETED|Overall Study||41
10394480|NCT00684021|11538019|FG001|COMPLETED|Overall Study||22
10394481|NCT00684021|11538020|FG002|COMPLETED|Overall Study||34
10394482|NCT00684021|11538021|FG003|COMPLETED|Overall Study||15
10394483|NCT00684021|11538018|FG000|NOT COMPLETED|Overall Study||2
10394484|NCT00684021|11538019|FG001|NOT COMPLETED|Overall Study||2
10394485|NCT00684021|11538020|FG002|NOT COMPLETED|Overall Study||2
10394486|NCT00684021|11538021|FG003|NOT COMPLETED|Overall Study||2
10394487|NCT00684047|11538034|FG000|STARTED|Overall Study||72
10394488|NCT00684047|11538035|FG001|STARTED|Overall Study||110
10394489|NCT00684047|11538036|FG002|STARTED|Overall Study||57
10394490|NCT00684047|11538034|FG000|COMPLETED|Overall Study||59
10394491|NCT00684047|11538035|FG001|COMPLETED|Overall Study||94
10394492|NCT00684047|11538036|FG002|COMPLETED|Overall Study||52
10394493|NCT00684047|11538034|FG000|NOT COMPLETED|Overall Study||13
10394494|NCT00684047|11538035|FG001|NOT COMPLETED|Overall Study||16
10394495|NCT00684047|11538036|FG002|NOT COMPLETED|Overall Study||5
10394496|NCT00684060|11538046|FG000|STARTED|Overall Study||58
10394497|NCT00684060|11538047|FG001|STARTED|Overall Study||29
10394498|NCT00684060|11538046|FG000|COMPLETED|Overall Study||55
10394499|NCT00684060|11538047|FG001|COMPLETED|Overall Study||26
10394500|NCT00684060|11538046|FG000|NOT COMPLETED|Overall Study||3
10394501|NCT00684060|11538047|FG001|NOT COMPLETED|Overall Study||3
10394502|NCT00684073|11538053|FG000|STARTED|Selection||60
10394503|NCT00684073|11538053|FG000|COMPLETED|Selection|number of subjects who had a Day 1 visit|53
10394504|NCT00684073|11538053|FG000|NOT COMPLETED|Selection||7
10394505|NCT00684073|11538053|FG000|STARTED|Treatment (Days 1 Through 5)|number of subjects who had a Day 1 visit|53
10394506|NCT00684073|11538053|FG000|COMPLETED|Treatment (Days 1 Through 5)|number of subjects who had a Day 5 visit (and therefore completed study)|52
10394507|NCT00684073|11538053|FG000|NOT COMPLETED|Treatment (Days 1 Through 5)||1
10394508|NCT00684138|11538063|FG000|STARTED|Overall Study||141
10394509|NCT00684138|11538064|FG001|STARTED|Overall Study||139
10394510|NCT00684138|11538063|FG000|COMPLETED|Overall Study||138
10394511|NCT00684138|11538064|FG001|COMPLETED|Overall Study||131
10394512|NCT00684138|11538063|FG000|NOT COMPLETED|Overall Study||3
10394513|NCT00684138|11538064|FG001|NOT COMPLETED|Overall Study||8
10394514|NCT00684177|11538074|FG000|STARTED|Overall Study||343
10394515|NCT00684177|11538075|FG001|STARTED|Overall Study||164
10394516|NCT00684177|11538074|FG000|COMPLETED|Overall Study||322
10394517|NCT00684177|11538075|FG001|COMPLETED|Overall Study||141
10394518|NCT00684177|11538074|FG000|NOT COMPLETED|Overall Study||21
10394519|NCT00684177|11538075|FG001|NOT COMPLETED|Overall Study||23
10394520|NCT00684203|11538087|FG000|STARTED|Overall Study||40
10394521|NCT00684203|11538088|FG001|STARTED|Overall Study||31
10394522|NCT00684203|11538089|FG002|STARTED|Overall Study||21
10394523|NCT00684203|11538090|FG003|STARTED|Overall Study||6
10394524|NCT00684203|11538091|FG004|STARTED|Overall Study||17
10394525|NCT00684203|11538092|FG005|STARTED|Overall Study||2
10394526|NCT00684203|11538087|FG000|COMPLETED|Overall Study||31
10394527|NCT00684203|11538088|FG001|COMPLETED|Overall Study||23
10394528|NCT00684203|11538089|FG002|COMPLETED|Overall Study||12
10394529|NCT00684203|11538090|FG003|COMPLETED|Overall Study||6
10394530|NCT00684203|11538091|FG004|COMPLETED|Overall Study||17
10394531|NCT00684203|11538092|FG005|COMPLETED|Overall Study||2
10394532|NCT00684203|11538087|FG000|NOT COMPLETED|Overall Study||9
10394533|NCT00684203|11538088|FG001|NOT COMPLETED|Overall Study||8
10394534|NCT00684203|11538089|FG002|NOT COMPLETED|Overall Study||9
10394535|NCT00684203|11538090|FG003|NOT COMPLETED|Overall Study||0
10394536|NCT00684203|11538091|FG004|NOT COMPLETED|Overall Study||0
10394537|NCT00684203|11538092|FG005|NOT COMPLETED|Overall Study||0
10394538|NCT00684242|11538113|FG000|STARTED|Overall Study||3
10394539|NCT00684242|11538113|FG000|COMPLETED|Overall Study||3
10394540|NCT00684242|11538113|FG000|NOT COMPLETED|Overall Study||0
10394541|NCT00684307|11538122|FG000|STARTED|Overall Study|Patients who received treatment|164
10394542|NCT00684307|11538123|FG001|STARTED|Overall Study||151
10394543|NCT00684307|11538124|FG002|STARTED|Overall Study||156
10394544|NCT00684307|11538125|FG003|STARTED|Overall Study||160
10394545|NCT00684307|11538126|FG004|STARTED|Overall Study||318
10394546|NCT00684307|11538122|FG000|On Treatment Period Started|Overall Study||164
10394547|NCT00684307|11538123|FG001|On Treatment Period Started|Overall Study||151
10394548|NCT00684307|11538124|FG002|On Treatment Period Started|Overall Study||156
10394549|NCT00684307|11538125|FG003|On Treatment Period Started|Overall Study||160
10394550|NCT00684307|11538126|FG004|On Treatment Period Started|Overall Study||318
10394551|NCT00684307|11538122|FG000|On Treatment Period Completed|Overall Study|Patients who completed treatment|140
10394552|NCT00684307|11538123|FG001|On Treatment Period Completed|Overall Study||129
10394553|NCT00684307|11538124|FG002|On Treatment Period Completed|Overall Study||128
10394554|NCT00684307|11538125|FG003|On Treatment Period Completed|Overall Study||128
10394555|NCT00684307|11538126|FG004|On Treatment Period Completed|Overall Study||293
10394556|NCT00684307|11538122|FG000|COMPLETED|Overall Study||140
10394557|NCT00684307|11538123|FG001|COMPLETED|Overall Study||129
10394558|NCT00684307|11538124|FG002|COMPLETED|Overall Study||128
10394559|NCT00684307|11538125|FG003|COMPLETED|Overall Study||128
10394560|NCT00684307|11538126|FG004|COMPLETED|Overall Study||293
10394561|NCT00684307|11538122|FG000|NOT COMPLETED|Overall Study||24
10394562|NCT00684307|11538123|FG001|NOT COMPLETED|Overall Study||22
10394563|NCT00684307|11538124|FG002|NOT COMPLETED|Overall Study||28
10394564|NCT00684307|11538125|FG003|NOT COMPLETED|Overall Study||32
10394565|NCT00684307|11538126|FG004|NOT COMPLETED|Overall Study||25
10394566|NCT00684320|11538140|FG000|STARTED|Overall Study||26
10394567|NCT00684320|11538141|FG001|STARTED|Overall Study||22
10394568|NCT00684320|11538140|FG000|COMPLETED|Overall Study||22
10394569|NCT00684320|11538141|FG001|COMPLETED|Overall Study||22
10394570|NCT00684320|11538140|FG000|NOT COMPLETED|Overall Study||4
10394571|NCT00684320|11538141|FG001|NOT COMPLETED|Overall Study||0
10394572|NCT00684411|11538147|FG000|STARTED|Overall Study||12
10394573|NCT00684411|11538147|FG000|Disease Evaluable|Overall Study||11
10394574|NCT00684411|11538147|FG000|COMPLETED|Overall Study||0
10394575|NCT00684411|11538147|FG000|NOT COMPLETED|Overall Study||12
10394576|NCT00684424|11538151|FG000|STARTED|Overall Study||199
10394577|NCT00684424|11538151|FG000|COMPLETED|Overall Study||194
10719653|NCT02711345|11883317|FG008|NOT COMPLETED|Overall Study||6
10719654|NCT02711345|11883318|FG009|NOT COMPLETED|Overall Study||12
10719655|NCT02711553|11883349|FG000|STARTED|Overall Study||106
10719656|NCT02711553|11883350|FG001|STARTED|Overall Study||52
10719657|NCT02711553|11883351|FG002|STARTED|Overall Study||102
10719658|NCT02711553|11883352|FG003|STARTED|Overall Study||49
10719659|NCT02711553|11883349|FG000|Received at Least 1 Dose of Study Drug|Overall Study||104
10394578|NCT00684424|11538151|FG000|NOT COMPLETED|Overall Study||5
10394579|NCT00684515|11538159|FG000|STARTED|Overall Study||33
10719660|NCT02711553|11883350|FG001|Received at Least 1 Dose of Study Drug|Overall Study||52
10719661|NCT02711553|11883351|FG002|Received at Least 1 Dose of Study Drug|Overall Study||102
10719662|NCT02711553|11883352|FG003|Received at Least 1 Dose of Study Drug|Overall Study||48
10394580|NCT00684515|11538160|FG001|STARTED|Overall Study||29
10394581|NCT00684515|11538161|FG002|STARTED|Overall Study||28
10394582|NCT00684515|11538159|FG000|COMPLETED|Overall Study||29
10394583|NCT00684515|11538160|FG001|COMPLETED|Overall Study||26
10394584|NCT00684515|11538161|FG002|COMPLETED|Overall Study||27
10394585|NCT00684515|11538159|FG000|NOT COMPLETED|Overall Study||4
10719663|NCT02711553|11883349|FG000|COMPLETED|Overall Study||100
10719664|NCT02711553|11883350|FG001|COMPLETED|Overall Study||47
10543276|NCT01483599|11696530|FG012|Treated|Controlled Period (CP) (up to Week 16)||0
10719665|NCT02711553|11883351|FG002|COMPLETED|Overall Study||92
10719666|NCT02711553|11883352|FG003|COMPLETED|Overall Study||45
10719667|NCT02711553|11883349|FG000|NOT COMPLETED|Overall Study||6
10719668|NCT02711553|11883350|FG001|NOT COMPLETED|Overall Study||5
10719669|NCT02711553|11883351|FG002|NOT COMPLETED|Overall Study||10
10719670|NCT02711553|11883352|FG003|NOT COMPLETED|Overall Study||4
10719671|NCT02711800|11883364|FG000|STARTED|Overall Study||9
10719672|NCT02711800|11883364|FG000|COMPLETED|Overall Study||7
10719673|NCT02711800|11883364|FG000|NOT COMPLETED|Overall Study||2
10719674|NCT02711839|11883370|FG000|STARTED|Overall Study||20
10719675|NCT02711839|11883371|FG001|STARTED|Overall Study||34
10719676|NCT02711839|11883370|FG000|COMPLETED|Overall Study||16
10719677|NCT02711839|11883371|FG001|COMPLETED|Overall Study||24
10719678|NCT02711839|11883370|FG000|NOT COMPLETED|Overall Study||4
10813200|NCT02965846|11975498|FG001|COMPLETED|Overall Study||0
10813201|NCT02965846|11975499|FG002|COMPLETED|Overall Study||0
10813202|NCT02965846|11975497|FG000|NOT COMPLETED|Overall Study||5
10813203|NCT02965846|11975498|FG001|NOT COMPLETED|Overall Study||5
10813204|NCT02965846|11975499|FG002|NOT COMPLETED|Overall Study||33
10813205|NCT02974803|11975505|FG000|STARTED|Overall Study||6
10813206|NCT02974803|11975505|FG000|COMPLETED|Overall Study||6
10813207|NCT02974803|11975505|FG000|NOT COMPLETED|Overall Study||0
10813208|NCT02974686|11975511|FG000|STARTED|Overall Study||0
10813209|NCT02974686|11975512|FG001|STARTED|Overall Study||0
10813210|NCT02974686|11975511|FG000|COMPLETED|Overall Study||0
10813211|NCT02974686|11975512|FG001|COMPLETED|Overall Study||0
10813212|NCT02974686|11975511|FG000|NOT COMPLETED|Overall Study||0
10813213|NCT02974686|11975512|FG001|NOT COMPLETED|Overall Study||0
10813214|NCT02956005|11975520|FG000|STARTED|Overall Study||18
10813215|NCT02956005|11975520|FG000|COMPLETED|Overall Study||2
10813216|NCT02956005|11975520|FG000|NOT COMPLETED|Overall Study||16
10813217|NCT02966184|11975526|FG000|STARTED|Overall Study||0
10813218|NCT02966184|11975527|FG001|STARTED|Overall Study||8
10813219|NCT02966184|11975526|FG000|COMPLETED|Overall Study||0
10813220|NCT02966184|11975527|FG001|COMPLETED|Overall Study||0
10813221|NCT02966184|11975526|FG000|NOT COMPLETED|Overall Study||0
10813222|NCT02966184|11975527|FG001|NOT COMPLETED|Overall Study||8
10813223|NCT02940223|11975535|FG000|STARTED|Overall Study||2
10813224|NCT02940223|11975536|FG001|STARTED|Overall Study||0
10719679|NCT02711839|11883371|FG001|NOT COMPLETED|Overall Study||10
10719680|NCT02711956|11883392|FG000|STARTED|Overall Study||2
10719681|NCT02711956|11883393|FG001|STARTED|Overall Study||2
10719682|NCT02711956|11883394|FG002|STARTED|Overall Study||3
10719683|NCT02711956|11883395|FG003|STARTED|Overall Study||5
10719684|NCT02711956|11883396|FG004|STARTED|Overall Study||4
10719685|NCT02711956|11883397|FG005|STARTED|Overall Study||3
10813225|NCT02940223|11975535|FG000|COMPLETED|Overall Study||0
10813226|NCT02940223|11975536|FG001|COMPLETED|Overall Study||0
10813227|NCT02940223|11975535|FG000|NOT COMPLETED|Overall Study||2
10394586|NCT00684515|11538160|FG001|NOT COMPLETED|Overall Study||3
10394587|NCT00684515|11538161|FG002|NOT COMPLETED|Overall Study||1
10394588|NCT00684541|11538171|FG000|STARTED|Overall Study||23
10394589|NCT00684541|11538172|FG001|STARTED|Overall Study||26
10394590|NCT00684541|11538171|FG000|COMPLETED|Overall Study||20
10394591|NCT00684541|11538172|FG001|COMPLETED|Overall Study||23
10394592|NCT00684541|11538171|FG000|NOT COMPLETED|Overall Study||3
10394593|NCT00684541|11538172|FG001|NOT COMPLETED|Overall Study||3
10394594|NCT00684554|11538181|FG000|STARTED|Overall Study||10
10394595|NCT00684554|11538182|FG001|STARTED|Overall Study||10
10394596|NCT00684554|11538181|FG000|COMPLETED|Overall Study||10
10394597|NCT00684554|11538182|FG001|COMPLETED|Overall Study||10
10394598|NCT00684554|11538181|FG000|NOT COMPLETED|Overall Study||0
10394599|NCT00684554|11538182|FG001|NOT COMPLETED|Overall Study||0
10394600|NCT00684567|11538188|FG000|STARTED|Concomitant Radiotherapy Period||30
10394601|NCT00684567|11538188|FG000|COMPLETED|Concomitant Radiotherapy Period||28
10394602|NCT00684567|11538188|FG000|NOT COMPLETED|Concomitant Radiotherapy Period||2
10394603|NCT00684567|11538188|FG000|STARTED|Monotherapy Period|5 subjects completed radiotherapy combined therapy phase but did not proceed to monotherapy phase.|23
10394604|NCT00684567|11538188|FG000|COMPLETED|Monotherapy Period||9
10394605|NCT00684567|11538188|FG000|NOT COMPLETED|Monotherapy Period||14
10394606|NCT00684593|11538194|FG000|STARTED|Overall Study||21
10394607|NCT00684593|11538195|FG001|STARTED|Overall Study||10
10394608|NCT00684593|11538194|FG000|COMPLETED|Overall Study||21
10394609|NCT00684593|11538195|FG001|COMPLETED|Overall Study||8
10394610|NCT00684593|11538194|FG000|NOT COMPLETED|Overall Study||0
10394611|NCT00684593|11538195|FG001|NOT COMPLETED|Overall Study||2
10394612|NCT00684645|11538201|FG000|STARTED|Overall Study||186
10394613|NCT00684645|11538201|FG000|COMPLETED|Overall Study||72
10394614|NCT00684645|11538201|FG000|NOT COMPLETED|Overall Study||114
10394615|NCT00684671|11538208|FG000|STARTED|Overall Study||172
10394616|NCT00684671|11538209|FG001|STARTED|Overall Study||170
10394617|NCT00684671|11538210|FG002|STARTED|Overall Study||164
10394618|NCT00684671|11538208|FG000|COMPLETED|Overall Study||169
10394619|NCT00684671|11538209|FG001|COMPLETED|Overall Study||170
10394620|NCT00684671|11538210|FG002|COMPLETED|Overall Study||164
10394621|NCT00684671|11538208|FG000|NOT COMPLETED|Overall Study||3
10394622|NCT00684671|11538209|FG001|NOT COMPLETED|Overall Study||0
10394623|NCT00684671|11538210|FG002|NOT COMPLETED|Overall Study||0
10394624|NCT00684723|11538218|FG000|STARTED|First Intervention||27
10394625|NCT00684723|11538219|FG001|STARTED|First Intervention||27
10394626|NCT00684723|11538218|FG000|COMPLETED|First Intervention||27
10543277|NCT01483599|11696531|FG013|Treated|Controlled Period (CP) (up to Week 16)||0
10543278|NCT01483599|11696518|FG000|COMPLETED|Controlled Period (CP) (up to Week 16)||39
10543279|NCT01483599|11696519|FG001|COMPLETED|Controlled Period (CP) (up to Week 16)||38
10543280|NCT01483599|11696520|FG002|COMPLETED|Controlled Period (CP) (up to Week 16)||41
10719686|NCT02711956|11883398|FG006|STARTED|Overall Study||4
10719687|NCT02711956|11883399|FG007|STARTED|Overall Study||4
10719688|NCT02711956|11883400|FG008|STARTED|Overall Study||4
10719689|NCT02711956|11883401|FG009|STARTED|Overall Study||3
10719690|NCT02711956|11883402|FG010|STARTED|Overall Study||1
10719691|NCT02711956|11883403|FG011|STARTED|Overall Study||9
10719692|NCT02711956|11883404|FG012|STARTED|Overall Study||17
10719693|NCT02711956|11883405|FG013|STARTED|Overall Study||6
10719694|NCT02711956|11883406|FG014|STARTED|Overall Study||8
10719695|NCT02711956|11883392|FG000|COMPLETED|Overall Study||0
10719696|NCT02711956|11883393|FG001|COMPLETED|Overall Study||0
10719697|NCT02711956|11883394|FG002|COMPLETED|Overall Study||1
10813228|NCT02940223|11975536|FG001|NOT COMPLETED|Overall Study||0
10543281|NCT01483599|11696521|FG003|COMPLETED|Controlled Period (CP) (up to Week 16)||39
10543282|NCT01483599|11696522|FG004|COMPLETED|Controlled Period (CP) (up to Week 16)||40
10543283|NCT01483599|11696523|FG005|COMPLETED|Controlled Period (CP) (up to Week 16)||38
10543284|NCT01483599|11696524|FG006|COMPLETED|Controlled Period (CP) (up to Week 16)||39
10543285|NCT01483599|11696525|FG007|COMPLETED|Controlled Period (CP) (up to Week 16)||0
10543286|NCT01483599|11696526|FG008|COMPLETED|Controlled Period (CP) (up to Week 16)||0
10719698|NCT02711956|11883395|FG003|COMPLETED|Overall Study||2
10719699|NCT02711956|11883396|FG004|COMPLETED|Overall Study||0
10719700|NCT02711956|11883397|FG005|COMPLETED|Overall Study||1
10394627|NCT00684723|11538219|FG001|COMPLETED|First Intervention||27
10394628|NCT00684723|11538218|FG000|NOT COMPLETED|First Intervention||0
10394629|NCT00684723|11538219|FG001|NOT COMPLETED|First Intervention||0
10394630|NCT00684723|11538218|FG000|STARTED|Washout Period of 7 Days||27
10719701|NCT02711956|11883398|FG006|COMPLETED|Overall Study||0
10719702|NCT02711956|11883399|FG007|COMPLETED|Overall Study||2
10719703|NCT02711956|11883400|FG008|COMPLETED|Overall Study||0
10719704|NCT02711956|11883401|FG009|COMPLETED|Overall Study||0
10719705|NCT02711956|11883402|FG010|COMPLETED|Overall Study||0
10719706|NCT02711956|11883403|FG011|COMPLETED|Overall Study||0
10719707|NCT02711956|11883404|FG012|COMPLETED|Overall Study||1
10719708|NCT02711956|11883405|FG013|COMPLETED|Overall Study||1
10719709|NCT02711956|11883406|FG014|COMPLETED|Overall Study||0
10719710|NCT02711956|11883392|FG000|NOT COMPLETED|Overall Study||2
10719711|NCT02711956|11883393|FG001|NOT COMPLETED|Overall Study||2
10719712|NCT02711956|11883394|FG002|NOT COMPLETED|Overall Study||2
10719713|NCT02711956|11883395|FG003|NOT COMPLETED|Overall Study||3
10719714|NCT02711956|11883396|FG004|NOT COMPLETED|Overall Study||4
10719715|NCT02711956|11883397|FG005|NOT COMPLETED|Overall Study||2
10719716|NCT02711956|11883398|FG006|NOT COMPLETED|Overall Study||4
10719717|NCT02711956|11883399|FG007|NOT COMPLETED|Overall Study||2
10719718|NCT02711956|11883400|FG008|NOT COMPLETED|Overall Study||4
10719719|NCT02711956|11883401|FG009|NOT COMPLETED|Overall Study||3
10394631|NCT00684723|11538219|FG001|STARTED|Washout Period of 7 Days||27
10394632|NCT00684723|11538218|FG000|COMPLETED|Washout Period of 7 Days||27
10394633|NCT00684723|11538219|FG001|COMPLETED|Washout Period of 7 Days||27
10394634|NCT00684723|11538218|FG000|NOT COMPLETED|Washout Period of 7 Days||0
10394635|NCT00684723|11538219|FG001|NOT COMPLETED|Washout Period of 7 Days||0
10394636|NCT00684723|11538218|FG000|STARTED|Second Intervention||27
10394637|NCT00684723|11538219|FG001|STARTED|Second Intervention||27
10394638|NCT00684723|11538218|FG000|COMPLETED|Second Intervention||27
10719720|NCT02711956|11883402|FG010|NOT COMPLETED|Overall Study||1
10719721|NCT02711956|11883403|FG011|NOT COMPLETED|Overall Study||9
10719722|NCT02711956|11883404|FG012|NOT COMPLETED|Overall Study||16
10719723|NCT02711956|11883405|FG013|NOT COMPLETED|Overall Study||5
10719724|NCT02711956|11883406|FG014|NOT COMPLETED|Overall Study||8
10719725|NCT02711995|11883447|FG000|STARTED|First Intervention (30 Days)||8
10719726|NCT02711995|11883447|FG000|COMPLETED|First Intervention (30 Days)||8
10719727|NCT02711995|11883447|FG000|NOT COMPLETED|First Intervention (30 Days)||0
10394639|NCT00684723|11538219|FG001|COMPLETED|Second Intervention||27
10394640|NCT00684723|11538218|FG000|NOT COMPLETED|Second Intervention||0
10394641|NCT00684723|11538219|FG001|NOT COMPLETED|Second Intervention||0
10394642|NCT00684749|11538225|FG000|STARTED|Overall Study||142
10394643|NCT00684749|11538225|FG000|COMPLETED|Overall Study||142
10394644|NCT00684749|11538225|FG000|NOT COMPLETED|Overall Study||0
10394645|NCT00684762|11538229|FG000|STARTED|First Intervention||16
10394646|NCT00684762|11538230|FG001|STARTED|First Intervention||16
10394647|NCT00684762|11538229|FG000|COMPLETED|First Intervention||16
10394648|NCT00684762|11538230|FG001|COMPLETED|First Intervention||16
10394649|NCT00684762|11538229|FG000|NOT COMPLETED|First Intervention||0
10394650|NCT00684762|11538230|FG001|NOT COMPLETED|First Intervention||0
10394651|NCT00684762|11538229|FG000|STARTED|Washout Period of 7 Days||16
10394652|NCT00684762|11538230|FG001|STARTED|Washout Period of 7 Days||16
10394653|NCT00684762|11538229|FG000|COMPLETED|Washout Period of 7 Days||14
10394654|NCT00684762|11538230|FG001|COMPLETED|Washout Period of 7 Days||14
10719728|NCT02711995|11883447|FG000|STARTED|Washout (90 Days)||8
10719729|NCT02711995|11883447|FG000|COMPLETED|Washout (90 Days)||7
10719730|NCT02711995|11883447|FG000|NOT COMPLETED|Washout (90 Days)||1
10719731|NCT02711995|11883447|FG000|STARTED|Second Intervention (30 Days)||7
10719732|NCT02711995|11883447|FG000|COMPLETED|Second Intervention (30 Days)||7
10719733|NCT02711995|11883447|FG000|NOT COMPLETED|Second Intervention (30 Days)||0
10719734|NCT02712008|11883456|FG000|STARTED|Baseline (Day 1) up to Week 12||50
10719735|NCT02712008|11883457|FG001|STARTED|Baseline (Day 1) up to Week 12||100
10719736|NCT02712008|11883458|FG002|STARTED|Baseline (Day 1) up to Week 12||152
10719737|NCT02712008|11883459|FG003|STARTED|Baseline (Day 1) up to Week 12||0
10719738|NCT02712008|11883460|FG004|STARTED|Baseline (Day 1) up to Week 12||0
10719739|NCT02712008|11883461|FG005|STARTED|Baseline (Day 1) up to Week 12||0
10719740|NCT02712008|11883462|FG006|STARTED|Baseline (Day 1) up to Week 12||0
10719741|NCT02712008|11883463|FG007|STARTED|Baseline (Day 1) up to Week 12||0
10719742|NCT02712008|11883456|FG000|COMPLETED|Baseline (Day 1) up to Week 12||46
10719743|NCT02712008|11883457|FG001|COMPLETED|Baseline (Day 1) up to Week 12||97
10719744|NCT02712008|11883458|FG002|COMPLETED|Baseline (Day 1) up to Week 12||148
10813229|NCT02954159|11975544|FG000|STARTED|Overall Study||2
10813230|NCT02954159|11975545|FG001|STARTED|Overall Study||2
10394655|NCT00684762|11538229|FG000|NOT COMPLETED|Washout Period of 7 Days||2
10394656|NCT00684762|11538230|FG001|NOT COMPLETED|Washout Period of 7 Days||2
10394657|NCT00684762|11538229|FG000|STARTED|Second Intervention||14
10394658|NCT00684762|11538230|FG001|STARTED|Second Intervention||14
10394659|NCT00684762|11538229|FG000|COMPLETED|Second Intervention||14
10394660|NCT00684762|11538230|FG001|COMPLETED|Second Intervention||14
10394661|NCT00684762|11538229|FG000|NOT COMPLETED|Second Intervention||0
10394662|NCT00684762|11538230|FG001|NOT COMPLETED|Second Intervention||0
10394663|NCT00684775|11538238|FG000|STARTED|Overall Study||19
10394664|NCT00684775|11538239|FG001|STARTED|Overall Study||19
10394665|NCT00684775|11538238|FG000|COMPLETED|Overall Study||19
10394666|NCT00684775|11538239|FG001|COMPLETED|Overall Study||19
10394667|NCT00684775|11538238|FG000|NOT COMPLETED|Overall Study||0
10394668|NCT00684775|11538239|FG001|NOT COMPLETED|Overall Study||0
10394669|NCT00684788|11538255|FG000|STARTED|Overall Study||17
10394670|NCT00684788|11538256|FG001|STARTED|Overall Study||18
10394671|NCT00684788|11538255|FG000|COMPLETED|Overall Study||17
10394672|NCT00684788|11538256|FG001|COMPLETED|Overall Study||18
10394673|NCT00684788|11538255|FG000|NOT COMPLETED|Overall Study||0
10394674|NCT00684788|11538256|FG001|NOT COMPLETED|Overall Study||0
10394675|NCT00684814|11538268|FG000|STARTED|First Intervention||19
10394676|NCT00684814|11538269|FG001|STARTED|First Intervention||19
10394677|NCT00684814|11538268|FG000|COMPLETED|First Intervention||19
10394678|NCT00684814|11538269|FG001|COMPLETED|First Intervention||19
10394679|NCT00684814|11538268|FG000|NOT COMPLETED|First Intervention||0
10394680|NCT00684814|11538269|FG001|NOT COMPLETED|First Intervention||0
10394681|NCT00684814|11538268|FG000|STARTED|Washout Period of 7 Days||19
10394682|NCT00684814|11538269|FG001|STARTED|Washout Period of 7 Days||19
10394683|NCT00684814|11538268|FG000|COMPLETED|Washout Period of 7 Days||17
10394684|NCT00684814|11538269|FG001|COMPLETED|Washout Period of 7 Days||15
10394685|NCT00684814|11538268|FG000|NOT COMPLETED|Washout Period of 7 Days||2
10394686|NCT00684814|11538269|FG001|NOT COMPLETED|Washout Period of 7 Days||4
10394687|NCT00684814|11538268|FG000|STARTED|Second Intervention||17
10394688|NCT00684814|11538269|FG001|STARTED|Second Intervention||15
10394689|NCT00684814|11538268|FG000|COMPLETED|Second Intervention||16
10394690|NCT00684814|11538269|FG001|COMPLETED|Second Intervention||15
10394691|NCT00684814|11538268|FG000|NOT COMPLETED|Second Intervention||1
10394692|NCT00684814|11538269|FG001|NOT COMPLETED|Second Intervention||0
10394693|NCT00684983|11538277|FG000|STARTED|Overall Study||19
10394694|NCT00684983|11538278|FG001|STARTED|Overall Study||45
10394695|NCT00684983|11538277|FG000|COMPLETED|Overall Study||19
10394696|NCT00684983|11538278|FG001|COMPLETED|Overall Study|One major violation patient in Arm B is included in the primary analysis per protocol.|45
10394697|NCT00684983|11538277|FG000|NOT COMPLETED|Overall Study||0
10394698|NCT00684983|11538278|FG001|NOT COMPLETED|Overall Study||0
10394699|NCT00684996|11538286|FG000|STARTED|Overall Study||5
10394700|NCT00684996|11538286|FG000|Eligible|Overall Study||5
10394701|NCT00684996|11538286|FG000|COMPLETED|Overall Study||0
10394702|NCT00684996|11538286|FG000|NOT COMPLETED|Overall Study||5
10394703|NCT00685035|11538293|FG000|STARTED|Period 1: First Intervention: 30 Minutes||9
10394704|NCT00685035|11538294|FG001|STARTED|Period 1: First Intervention: 30 Minutes||8
10394705|NCT00685035|11538293|FG000|COMPLETED|Period 1: First Intervention: 30 Minutes||8
10394706|NCT00685035|11538294|FG001|COMPLETED|Period 1: First Intervention: 30 Minutes||8
10394707|NCT00685035|11538293|FG000|NOT COMPLETED|Period 1: First Intervention: 30 Minutes||1
10394708|NCT00685035|11538294|FG001|NOT COMPLETED|Period 1: First Intervention: 30 Minutes||0
10394709|NCT00685035|11538293|FG000|STARTED|Period 2: 2-day Washout||8
10394710|NCT00685035|11538294|FG001|STARTED|Period 2: 2-day Washout||8
10394711|NCT00685035|11538293|FG000|COMPLETED|Period 2: 2-day Washout||8
10394712|NCT00685035|11538294|FG001|COMPLETED|Period 2: 2-day Washout||8
10394713|NCT00685035|11538293|FG000|NOT COMPLETED|Period 2: 2-day Washout||0
10394714|NCT00685035|11538294|FG001|NOT COMPLETED|Period 2: 2-day Washout||0
10394715|NCT00685035|11538293|FG000|STARTED|Period 3: 2nd Intervention||8
10394716|NCT00685035|11538294|FG001|STARTED|Period 3: 2nd Intervention||8
10394717|NCT00685035|11538293|FG000|COMPLETED|Period 3: 2nd Intervention||8
10394718|NCT00685035|11538294|FG001|COMPLETED|Period 3: 2nd Intervention||8
10394719|NCT00685035|11538293|FG000|NOT COMPLETED|Period 3: 2nd Intervention||0
10394720|NCT00685035|11538294|FG001|NOT COMPLETED|Period 3: 2nd Intervention||0
10394721|NCT00685139|11538318|FG000|STARTED|First Intervention||17
10394722|NCT00685139|11538319|FG001|STARTED|First Intervention||17
10394723|NCT00685139|11538318|FG000|COMPLETED|First Intervention||17
10394724|NCT00685139|11538319|FG001|COMPLETED|First Intervention||17
10394725|NCT00685139|11538318|FG000|NOT COMPLETED|First Intervention||0
10394726|NCT00685139|11538319|FG001|NOT COMPLETED|First Intervention||0
10394727|NCT00685139|11538318|FG000|STARTED|Washout Period of 28 Days||17
10394728|NCT00685139|11538319|FG001|STARTED|Washout Period of 28 Days||17
10394729|NCT00685139|11538318|FG000|COMPLETED|Washout Period of 28 Days||17
10394730|NCT00685139|11538319|FG001|COMPLETED|Washout Period of 28 Days||17
10394731|NCT00685139|11538318|FG000|NOT COMPLETED|Washout Period of 28 Days||0
10394732|NCT00685139|11538319|FG001|NOT COMPLETED|Washout Period of 28 Days||0
10394733|NCT00685139|11538318|FG000|STARTED|Second Intervention||17
10394734|NCT00685139|11538319|FG001|STARTED|Second Intervention||17
10394735|NCT00685139|11538318|FG000|COMPLETED|Second Intervention||17
10394736|NCT00685139|11538319|FG001|COMPLETED|Second Intervention||17
10394737|NCT00685139|11538318|FG000|NOT COMPLETED|Second Intervention||0
10394738|NCT00685139|11538319|FG001|NOT COMPLETED|Second Intervention||0
10394739|NCT00685165|11538325|FG000|STARTED|First Intervention||11
10394740|NCT00685165|11538326|FG001|STARTED|First Intervention||11
10394741|NCT00685165|11538325|FG000|COMPLETED|First Intervention||11
10394742|NCT00685165|11538326|FG001|COMPLETED|First Intervention||11
10394743|NCT00685165|11538325|FG000|NOT COMPLETED|First Intervention||0
10394744|NCT00685165|11538326|FG001|NOT COMPLETED|First Intervention||0
10394745|NCT00685165|11538325|FG000|STARTED|Washout Period of 14 Days||11
10394746|NCT00685165|11538326|FG001|STARTED|Washout Period of 14 Days||11
10394747|NCT00685165|11538325|FG000|COMPLETED|Washout Period of 14 Days|adverse event- possible upper respiratory infection|10
10394748|NCT00685165|11538326|FG001|COMPLETED|Washout Period of 14 Days||11
10394749|NCT00685165|11538325|FG000|NOT COMPLETED|Washout Period of 14 Days||1
10394750|NCT00685165|11538326|FG001|NOT COMPLETED|Washout Period of 14 Days||0
10394751|NCT00685165|11538325|FG000|STARTED|Second Intervention||10
10394752|NCT00685165|11538326|FG001|STARTED|Second Intervention||11
10394753|NCT00685165|11538325|FG000|COMPLETED|Second Intervention||10
10394754|NCT00685165|11538326|FG001|COMPLETED|Second Intervention||11
10394755|NCT00685165|11538325|FG000|NOT COMPLETED|Second Intervention||0
10394756|NCT00685165|11538326|FG001|NOT COMPLETED|Second Intervention||0
10394757|NCT00685178|11538336|FG000|STARTED|Overall Study||40
10394758|NCT00685178|11538337|FG001|STARTED|Overall Study||45
10394759|NCT00685178|11538338|FG002|STARTED|Overall Study||39
10394760|NCT00685178|11538339|FG003|STARTED|Overall Study||47
10394761|NCT00685178|11538336|FG000|COMPLETED|Overall Study||27
10394762|NCT00685178|11538337|FG001|COMPLETED|Overall Study||26
10394763|NCT00685178|11538338|FG002|COMPLETED|Overall Study||27
10394764|NCT00685178|11538339|FG003|COMPLETED|Overall Study||33
10394765|NCT00685178|11538336|FG000|NOT COMPLETED|Overall Study||13
10394766|NCT00685178|11538337|FG001|NOT COMPLETED|Overall Study||19
10394767|NCT00685178|11538338|FG002|NOT COMPLETED|Overall Study||12
10394768|NCT00685178|11538339|FG003|NOT COMPLETED|Overall Study||14
10394769|NCT00685295|11538351|FG000|STARTED|Overall Study||30
10394770|NCT00685295|11538352|FG001|STARTED|Overall Study||30
10394771|NCT00685295|11538351|FG000|COMPLETED|Overall Study||30
10394772|NCT00685295|11538352|FG001|COMPLETED|Overall Study||30
10394773|NCT00685295|11538351|FG000|NOT COMPLETED|Overall Study||0
10394774|NCT00685295|11538352|FG001|NOT COMPLETED|Overall Study||0
10394775|NCT00685334|11538362|FG000|STARTED|Overall Study||12
10394776|NCT00685334|11538363|FG001|STARTED|Overall Study||10
10394777|NCT00685334|11538362|FG000|COMPLETED|Overall Study||2
10394778|NCT00685334|11538363|FG001|COMPLETED|Overall Study||3
10394779|NCT00685334|11538362|FG000|NOT COMPLETED|Overall Study||10
10394780|NCT00685334|11538363|FG001|NOT COMPLETED|Overall Study||7
10394781|NCT00685373|11538369|FG000|STARTED|Overall Study||166
10394782|NCT00685373|11538369|FG000|COMPLETED|Overall Study||151
10394783|NCT00685373|11538369|FG000|NOT COMPLETED|Overall Study||15
10394784|NCT00685399|11538380|FG000|STARTED|Treatment Period 1||16
10394785|NCT00685399|11538381|FG001|STARTED|Treatment Period 1||0
10394786|NCT00685399|11538382|FG002|STARTED|Treatment Period 1||0
10394787|NCT00685399|11538383|FG003|STARTED|Treatment Period 1||0
10394788|NCT00685399|11538384|FG004|STARTED|Treatment Period 1||0
10394789|NCT00685399|11538385|FG005|STARTED|Treatment Period 1||0
10394790|NCT00685399|11538386|FG006|STARTED|Treatment Period 1||0
10394791|NCT00685399|11538387|FG007|STARTED|Treatment Period 1||0
10394792|NCT00685399|11538380|FG000|COMPLETED|Treatment Period 1||10
10394793|NCT00685399|11538381|FG001|COMPLETED|Treatment Period 1||0
10394794|NCT00685399|11538382|FG002|COMPLETED|Treatment Period 1||0
10394795|NCT00685399|11538383|FG003|COMPLETED|Treatment Period 1||0
10394796|NCT00685399|11538384|FG004|COMPLETED|Treatment Period 1||0
10394797|NCT00685399|11538385|FG005|COMPLETED|Treatment Period 1||0
10394798|NCT00685399|11538386|FG006|COMPLETED|Treatment Period 1||0
10394799|NCT00685399|11538387|FG007|COMPLETED|Treatment Period 1||0
10394800|NCT00685399|11538380|FG000|NOT COMPLETED|Treatment Period 1||6
10394801|NCT00685399|11538381|FG001|NOT COMPLETED|Treatment Period 1||0
10543287|NCT01483599|11696527|FG009|COMPLETED|Controlled Period (CP) (up to Week 16)||0
10543288|NCT01483599|11696528|FG010|COMPLETED|Controlled Period (CP) (up to Week 16)||0
10543289|NCT01483599|11696529|FG011|COMPLETED|Controlled Period (CP) (up to Week 16)||0
10543290|NCT01483599|11696530|FG012|COMPLETED|Controlled Period (CP) (up to Week 16)||0
10543291|NCT01483599|11696531|FG013|COMPLETED|Controlled Period (CP) (up to Week 16)||0
10543292|NCT01483599|11696518|FG000|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
10543293|NCT01483599|11696519|FG001|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
10543294|NCT01483599|11696520|FG002|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
10394802|NCT00685399|11538382|FG002|NOT COMPLETED|Treatment Period 1||0
10394803|NCT00685399|11538383|FG003|NOT COMPLETED|Treatment Period 1||0
10394804|NCT00685399|11538384|FG004|NOT COMPLETED|Treatment Period 1||0
10394805|NCT00685399|11538385|FG005|NOT COMPLETED|Treatment Period 1||0
10394806|NCT00685399|11538386|FG006|NOT COMPLETED|Treatment Period 1||0
10394807|NCT00685399|11538387|FG007|NOT COMPLETED|Treatment Period 1||0
10394808|NCT00685399|11538380|FG000|STARTED|Treatment Period 2||0
10394809|NCT00685399|11538381|FG001|STARTED|Treatment Period 2||14
10394810|NCT00685399|11538382|FG002|STARTED|Treatment Period 2||5
10394811|NCT00685399|11538383|FG003|STARTED|Treatment Period 2|in extension period only|0
10394812|NCT00685399|11538384|FG004|STARTED|Treatment Period 2||4
10394813|NCT00685399|11538385|FG005|STARTED|Treatment Period 2||12
10394814|NCT00685399|11538386|FG006|STARTED|Treatment Period 2||13
10394815|NCT00685399|11538387|FG007|STARTED|Treatment Period 2||12
10394816|NCT00685399|11538380|FG000|COMPLETED|Treatment Period 2||0
10394817|NCT00685399|11538381|FG001|COMPLETED|Treatment Period 2||2
10394818|NCT00685399|11538382|FG002|COMPLETED|Treatment Period 2||2
10394819|NCT00685399|11538383|FG003|COMPLETED|Treatment Period 2|in extension period only|0
10394820|NCT00685399|11538384|FG004|COMPLETED|Treatment Period 2||4
10394821|NCT00685399|11538385|FG005|COMPLETED|Treatment Period 2||10
10394822|NCT00685399|11538386|FG006|COMPLETED|Treatment Period 2||13
10394823|NCT00685399|11538387|FG007|COMPLETED|Treatment Period 2||10
10394824|NCT00685399|11538380|FG000|NOT COMPLETED|Treatment Period 2||0
10394825|NCT00685399|11538381|FG001|NOT COMPLETED|Treatment Period 2||12
10394826|NCT00685399|11538382|FG002|NOT COMPLETED|Treatment Period 2||3
10394827|NCT00685399|11538383|FG003|NOT COMPLETED|Treatment Period 2||0
10394828|NCT00685399|11538384|FG004|NOT COMPLETED|Treatment Period 2||0
10394829|NCT00685399|11538385|FG005|NOT COMPLETED|Treatment Period 2||2
10394830|NCT00685399|11538386|FG006|NOT COMPLETED|Treatment Period 2||0
10394831|NCT00685399|11538387|FG007|NOT COMPLETED|Treatment Period 2||2
10394832|NCT00685399|11538380|FG000|STARTED|Extension||0
10394833|NCT00685399|11538381|FG001|STARTED|Extension||0
10394834|NCT00685399|11538382|FG002|STARTED|Extension||0
10394835|NCT00685399|11538383|FG003|STARTED|Extension||28
10394836|NCT00685399|11538384|FG004|STARTED|Extension||0
10394837|NCT00685399|11538385|FG005|STARTED|Extension||0
10394838|NCT00685399|11538386|FG006|STARTED|Extension||0
10394839|NCT00685399|11538387|FG007|STARTED|Extension||0
10394840|NCT00685399|11538380|FG000|COMPLETED|Extension||0
10394841|NCT00685399|11538381|FG001|COMPLETED|Extension||0
10394842|NCT00685399|11538382|FG002|COMPLETED|Extension||0
10394843|NCT00685399|11538383|FG003|COMPLETED|Extension||21
10394844|NCT00685399|11538384|FG004|COMPLETED|Extension||0
10394845|NCT00685399|11538385|FG005|COMPLETED|Extension||0
10394846|NCT00685399|11538386|FG006|COMPLETED|Extension||0
10394847|NCT00685399|11538387|FG007|COMPLETED|Extension||0
10394848|NCT00685399|11538380|FG000|NOT COMPLETED|Extension||0
10394849|NCT00685399|11538381|FG001|NOT COMPLETED|Extension||0
10394850|NCT00685399|11538382|FG002|NOT COMPLETED|Extension||0
10394851|NCT00685399|11538383|FG003|NOT COMPLETED|Extension||7
10394852|NCT00685399|11538384|FG004|NOT COMPLETED|Extension||0
10394853|NCT00685399|11538385|FG005|NOT COMPLETED|Extension||0
10394854|NCT00685399|11538386|FG006|NOT COMPLETED|Extension||0
10394855|NCT00685399|11538387|FG007|NOT COMPLETED|Extension||0
10394856|NCT00685477|11538414|FG000|STARTED|Overall Study||10
10394857|NCT00685477|11538415|FG001|STARTED|Overall Study||10
10394858|NCT00685477|11538416|FG002|STARTED|Overall Study||10
10394859|NCT00685477|11538417|FG003|STARTED|Overall Study||10
10394860|NCT00685477|11538418|FG004|STARTED|Overall Study||10
10394861|NCT00685477|11538419|FG005|STARTED|Overall Study||10
10394862|NCT00685477|11538414|FG000|COMPLETED|Overall Study||10
10394863|NCT00685477|11538415|FG001|COMPLETED|Overall Study||10
10394864|NCT00685477|11538416|FG002|COMPLETED|Overall Study||10
10658835|NCT02235870|11820017|FG001|Completed Phase I (Week 24)|Overall Study||179
10658836|NCT02235870|11820016|FG000|Crossover (Week 24)|Overall Study||170
10658837|NCT02235870|11820017|FG001|Crossover (Week 24)|Overall Study||138
10719745|NCT02712008|11883459|FG003|COMPLETED|Baseline (Day 1) up to Week 12||0
10719746|NCT02712008|11883460|FG004|COMPLETED|Baseline (Day 1) up to Week 12||0
10719747|NCT02712008|11883461|FG005|COMPLETED|Baseline (Day 1) up to Week 12||0
10394865|NCT00685477|11538417|FG003|COMPLETED|Overall Study||10
10394866|NCT00685477|11538418|FG004|COMPLETED|Overall Study||10
10394867|NCT00685477|11538419|FG005|COMPLETED|Overall Study||10
10394868|NCT00685477|11538414|FG000|NOT COMPLETED|Overall Study||0
10394869|NCT00685477|11538415|FG001|NOT COMPLETED|Overall Study||0
10394870|NCT00685477|11538416|FG002|NOT COMPLETED|Overall Study||0
10719748|NCT02712008|11883462|FG006|COMPLETED|Baseline (Day 1) up to Week 12||0
10719749|NCT02712008|11883463|FG007|COMPLETED|Baseline (Day 1) up to Week 12||0
10719750|NCT02712008|11883456|FG000|NOT COMPLETED|Baseline (Day 1) up to Week 12||4
10719751|NCT02712008|11883457|FG001|NOT COMPLETED|Baseline (Day 1) up to Week 12||3
10719752|NCT02712008|11883458|FG002|NOT COMPLETED|Baseline (Day 1) up to Week 12||4
10719753|NCT02712008|11883459|FG003|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
10394871|NCT00685477|11538417|FG003|NOT COMPLETED|Overall Study||0
10394872|NCT00685477|11538418|FG004|NOT COMPLETED|Overall Study||0
10394873|NCT00685477|11538419|FG005|NOT COMPLETED|Overall Study||0
10394874|NCT00685516|11538431|FG000|STARTED|Overall Study||42
10394875|NCT00685516|11538432|FG001|STARTED|Overall Study||38
10658838|NCT02235870|11820016|FG000|COMPLETED|Overall Study||160
10658839|NCT02235870|11820017|FG001|COMPLETED|Overall Study||128
10658840|NCT02235870|11820016|FG000|NOT COMPLETED|Overall Study||38
10658841|NCT02235870|11820017|FG001|NOT COMPLETED|Overall Study||61
10658842|NCT02235987|11820024|FG000|STARTED|Overall Study||20
10658843|NCT02235987|11820024|FG000|Received Octreotide|Overall Study||20
10658844|NCT02235987|11820024|FG000|Received 100 µg DG3173|Overall Study||20
10658845|NCT02235987|11820024|FG000|Received 300 µg DG3173|Overall Study||20
10394876|NCT00685516|11538433|FG002|STARTED|Overall Study||33
10394877|NCT00685516|11538431|FG000|COMPLETED|Overall Study||34
10394878|NCT00685516|11538432|FG001|COMPLETED|Overall Study||33
10394879|NCT00685516|11538433|FG002|COMPLETED|Overall Study||26
10394880|NCT00685516|11538431|FG000|NOT COMPLETED|Overall Study||8
10394881|NCT00685516|11538432|FG001|NOT COMPLETED|Overall Study||5
10394882|NCT00685516|11538433|FG002|NOT COMPLETED|Overall Study||7
10394883|NCT00685659|11538447|FG000|STARTED|Overall Study||108
10394884|NCT00685659|11538448|FG001|STARTED|Overall Study||106
10719754|NCT02712008|11883460|FG004|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
10309484|NCT00117312|11442412|FG002|NOT COMPLETED|Overall Study||24
10309485|NCT00117312|11442413|FG003|NOT COMPLETED|Overall Study||21
10309486|NCT00117325|11442425|FG000|STARTED|Overall Study||173
10309487|NCT00117325|11442426|FG001|STARTED|Overall Study||179
10309488|NCT00117325|11442425|FG000|COMPLETED|Overall Study||160
10309489|NCT00117325|11442426|FG001|COMPLETED|Overall Study||167
10309490|NCT00117325|11442425|FG000|NOT COMPLETED|Overall Study||13
10309491|NCT00117325|11442426|FG001|NOT COMPLETED|Overall Study||12
10309492|NCT00117507|11442433|FG000|STARTED|Overall Study||24
10309493|NCT00117507|11442433|FG000|COMPLETED|Overall Study||9
10309494|NCT00117507|11442433|FG000|NOT COMPLETED|Overall Study||15
10309495|NCT00117559|11442440|FG000|STARTED|Overall Study||9
10309496|NCT00117559|11442441|FG001|STARTED|Overall Study||10
10309497|NCT00117559|11442440|FG000|COMPLETED|Overall Study||8
10309498|NCT00117559|11442441|FG001|COMPLETED|Overall Study||9
10309499|NCT00117559|11442440|FG000|NOT COMPLETED|Overall Study||1
10309500|NCT00117559|11442441|FG001|NOT COMPLETED|Overall Study||1
10309501|NCT00117572|11442449|FG000|STARTED|Overall Study||144
10309502|NCT00117572|11442450|FG001|STARTED|Overall Study||141
10309503|NCT00117572|11442449|FG000|COMPLETED|Overall Study||138
10309504|NCT00117572|11442450|FG001|COMPLETED|Overall Study||135
10309505|NCT00117572|11442449|FG000|NOT COMPLETED|Overall Study||6
10309506|NCT00117572|11442450|FG001|NOT COMPLETED|Overall Study||6
10309507|NCT00117585|11442456|FG000|STARTED|Overall Study||341
10309508|NCT00117585|11442456|FG000|COMPLETED|Overall Study||341
10309509|NCT00117585|11442456|FG000|NOT COMPLETED|Overall Study||0
10309510|NCT00117598|11442463|FG000|STARTED|Prior to Treatment Cross Over||57
10309511|NCT00117598|11442464|FG001|STARTED|Prior to Treatment Cross Over||56
10309512|NCT00117598|11442465|FG002|STARTED|Prior to Treatment Cross Over||56
10309513|NCT00117598|11442466|FG003|STARTED|Prior to Treatment Cross Over||0
10309514|NCT00117598|11442467|FG004|STARTED|Prior to Treatment Cross Over||0
10309515|NCT00117598|11442463|FG000|COMPLETED|Prior to Treatment Cross Over||0
10394885|NCT00685659|11538449|FG002|STARTED|Overall Study||107
10394886|NCT00685659|11538447|FG000|COMPLETED|Overall Study||77
10394887|NCT00685659|11538448|FG001|COMPLETED|Overall Study||81
10394888|NCT00685659|11538449|FG002|COMPLETED|Overall Study||92
10394889|NCT00685659|11538447|FG000|NOT COMPLETED|Overall Study||31
10394890|NCT00685659|11538448|FG001|NOT COMPLETED|Overall Study||25
10394891|NCT00685659|11538449|FG002|NOT COMPLETED|Overall Study||15
10394892|NCT00685685|11538457|FG000|STARTED|First Intervention||27
10394893|NCT00685685|11538458|FG001|STARTED|First Intervention||27
10394894|NCT00685685|11538457|FG000|COMPLETED|First Intervention||27
10394895|NCT00685685|11538458|FG001|COMPLETED|First Intervention||27
10394896|NCT00685685|11538457|FG000|NOT COMPLETED|First Intervention||0
10394897|NCT00685685|11538458|FG001|NOT COMPLETED|First Intervention||0
10394898|NCT00685685|11538457|FG000|STARTED|Washout Period of 7 Days||27
10394899|NCT00685685|11538458|FG001|STARTED|Washout Period of 7 Days||27
10394900|NCT00685685|11538457|FG000|COMPLETED|Washout Period of 7 Days||25
10394901|NCT00685685|11538458|FG001|COMPLETED|Washout Period of 7 Days||26
10394902|NCT00685685|11538457|FG000|NOT COMPLETED|Washout Period of 7 Days||2
10394903|NCT00685685|11538458|FG001|NOT COMPLETED|Washout Period of 7 Days||1
10394904|NCT00685685|11538457|FG000|STARTED|Second Intervention||25
10394905|NCT00685685|11538458|FG001|STARTED|Second Intervention||26
10394906|NCT00685685|11538457|FG000|COMPLETED|Second Intervention||25
10394907|NCT00685685|11538458|FG001|COMPLETED|Second Intervention||26
10394908|NCT00685685|11538457|FG000|NOT COMPLETED|Second Intervention||0
10394909|NCT00685685|11538458|FG001|NOT COMPLETED|Second Intervention||0
10394910|NCT00685698|11538464|FG000|STARTED|Overall Study||38
10394911|NCT00685698|11538464|FG000|COMPLETED|Overall Study||25
10394912|NCT00685698|11538464|FG000|NOT COMPLETED|Overall Study||13
10394913|NCT00685750|11538487|FG000|STARTED|Overall Study||17
10394914|NCT00685750|11538488|FG001|STARTED|Overall Study||3
10394915|NCT00685750|11538489|FG002|STARTED|Overall Study||21
10394916|NCT00685750|11538490|FG003|STARTED|Overall Study||2
10394917|NCT00685750|11538491|FG004|STARTED|Overall Study||15
10394918|NCT00685750|11538492|FG005|STARTED|Overall Study||20
10394919|NCT00685750|11538493|FG006|STARTED|Overall Study||10
10394920|NCT00685750|11538487|FG000|COMPLETED|Overall Study||17
10394921|NCT00685750|11538488|FG001|COMPLETED|Overall Study||3
10394922|NCT00685750|11538489|FG002|COMPLETED|Overall Study||19
10394923|NCT00685750|11538490|FG003|COMPLETED|Overall Study||2
10394924|NCT00685750|11538491|FG004|COMPLETED|Overall Study||15
10394925|NCT00685750|11538492|FG005|COMPLETED|Overall Study||20
10394926|NCT00685750|11538493|FG006|COMPLETED|Overall Study||9
10394927|NCT00685750|11538487|FG000|NOT COMPLETED|Overall Study||0
10394928|NCT00685750|11538488|FG001|NOT COMPLETED|Overall Study||0
10394929|NCT00685750|11538489|FG002|NOT COMPLETED|Overall Study||2
10394930|NCT00685750|11538490|FG003|NOT COMPLETED|Overall Study||0
10394931|NCT00685750|11538491|FG004|NOT COMPLETED|Overall Study||0
10394932|NCT00685750|11538492|FG005|NOT COMPLETED|Overall Study||0
10394933|NCT00685750|11538493|FG006|NOT COMPLETED|Overall Study||1
10394934|NCT00685763|11538513|FG000|STARTED|Overall Study||13
10394935|NCT00685763|11538513|FG000|COMPLETED|Overall Study||11
10394936|NCT00685763|11538513|FG000|NOT COMPLETED|Overall Study||2
10394937|NCT00685802|11538517|FG000|STARTED|First Intervention||16
10394938|NCT00685802|11538518|FG001|STARTED|First Intervention||16
10394939|NCT00685802|11538517|FG000|COMPLETED|First Intervention||16
10394940|NCT00685802|11538518|FG001|COMPLETED|First Intervention||16
10394941|NCT00685802|11538517|FG000|NOT COMPLETED|First Intervention||0
10394942|NCT00685802|11538518|FG001|NOT COMPLETED|First Intervention||0
10394943|NCT00685802|11538517|FG000|STARTED|Washout Period of 7 Days||16
10394944|NCT00685802|11538518|FG001|STARTED|Washout Period of 7 Days||16
10394945|NCT00685802|11538517|FG000|COMPLETED|Washout Period of 7 Days||14
10394946|NCT00685802|11538518|FG001|COMPLETED|Washout Period of 7 Days||15
10394947|NCT00685802|11538517|FG000|NOT COMPLETED|Washout Period of 7 Days||2
10394948|NCT00685802|11538518|FG001|NOT COMPLETED|Washout Period of 7 Days||1
10394949|NCT00685802|11538517|FG000|STARTED|Second Intervention||14
10394950|NCT00685802|11538518|FG001|STARTED|Second Intervention||15
10394951|NCT00685802|11538517|FG000|COMPLETED|Second Intervention||14
10394952|NCT00685802|11538518|FG001|COMPLETED|Second Intervention||15
10394953|NCT00685802|11538517|FG000|NOT COMPLETED|Second Intervention||0
10394954|NCT00685802|11538518|FG001|NOT COMPLETED|Second Intervention||0
10394955|NCT00685932|11538526|FG000|STARTED|Overall Study||76
10394956|NCT00685932|11538527|FG001|STARTED|Overall Study||78
10394957|NCT00685932|11538526|FG000|COMPLETED|Overall Study||55
10394958|NCT00685932|11538527|FG001|COMPLETED|Overall Study||58
10394959|NCT00685932|11538526|FG000|NOT COMPLETED|Overall Study||21
10719755|NCT02712008|11883461|FG005|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
10394960|NCT00685932|11538527|FG001|NOT COMPLETED|Overall Study||20
10394961|NCT00685945|11538533|FG000|STARTED|Control (Bradykinin Infusion)|A total of 24 subjects received an infusion of bradykinin|24
10394962|NCT00685945|11538533|FG000|COMPLETED|Control (Bradykinin Infusion)||24
10394963|NCT00685945|11538533|FG000|NOT COMPLETED|Control (Bradykinin Infusion)||0
10394964|NCT00685945|11538533|FG000|STARTED|L-NMMA + Bradykinin||24
10719756|NCT02712008|11883462|FG006|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
10394965|NCT00685945|11538533|FG000|COMPLETED|L-NMMA + Bradykinin||23
10394966|NCT00685945|11538533|FG000|NOT COMPLETED|L-NMMA + Bradykinin||1
10394967|NCT00685945|11538533|FG000|STARTED|Isosorbide + L-NMMA + Bradykinin||11
10394968|NCT00685945|11538533|FG000|COMPLETED|Isosorbide + L-NMMA + Bradykinin||11
10394969|NCT00685945|11538533|FG000|NOT COMPLETED|Isosorbide + L-NMMA + Bradykinin||0
10394970|NCT00685945|11538533|FG000|STARTED|Sildenafil + L-NMMA + Bradykinin||12
10394971|NCT00685945|11538533|FG000|COMPLETED|Sildenafil + L-NMMA + Bradykinin||12
10394972|NCT00685945|11538533|FG000|NOT COMPLETED|Sildenafil + L-NMMA + Bradykinin||0
10394973|NCT00686075|11538553|FG000|STARTED|Overall Study||79
10394974|NCT00686075|11538554|FG001|STARTED|Overall Study||81
10394975|NCT00686075|11538555|FG002|STARTED|Overall Study||80
10309516|NCT00117598|11442464|FG001|COMPLETED|Prior to Treatment Cross Over||3
10309517|NCT00117598|11442465|FG002|COMPLETED|Prior to Treatment Cross Over||4
10309518|NCT00117598|11442466|FG003|COMPLETED|Prior to Treatment Cross Over||0
10309519|NCT00117598|11442467|FG004|COMPLETED|Prior to Treatment Cross Over||0
10309520|NCT00117598|11442463|FG000|NOT COMPLETED|Prior to Treatment Cross Over||57
10309521|NCT00117598|11442464|FG001|NOT COMPLETED|Prior to Treatment Cross Over||53
10309522|NCT00117598|11442465|FG002|NOT COMPLETED|Prior to Treatment Cross Over||52
10309523|NCT00117598|11442466|FG003|NOT COMPLETED|Prior to Treatment Cross Over||0
10309524|NCT00117598|11442467|FG004|NOT COMPLETED|Prior to Treatment Cross Over||0
10309525|NCT00117598|11442463|FG000|STARTED|After Treament Cross Over||0
10309526|NCT00117598|11442464|FG001|STARTED|After Treament Cross Over||0
10309527|NCT00117598|11442465|FG002|STARTED|After Treament Cross Over||0
10309528|NCT00117598|11442466|FG003|STARTED|After Treament Cross Over||3
10309529|NCT00117598|11442467|FG004|STARTED|After Treament Cross Over||4
10309530|NCT00117598|11442463|FG000|COMPLETED|After Treament Cross Over||0
10309531|NCT00117598|11442464|FG001|COMPLETED|After Treament Cross Over||0
10309532|NCT00117598|11442465|FG002|COMPLETED|After Treament Cross Over||0
10309533|NCT00117598|11442466|FG003|COMPLETED|After Treament Cross Over||0
10309534|NCT00117598|11442467|FG004|COMPLETED|After Treament Cross Over||0
10309535|NCT00117598|11442463|FG000|NOT COMPLETED|After Treament Cross Over||0
10309536|NCT00117598|11442464|FG001|NOT COMPLETED|After Treament Cross Over||0
10309537|NCT00117598|11442465|FG002|NOT COMPLETED|After Treament Cross Over||0
10309538|NCT00117598|11442466|FG003|NOT COMPLETED|After Treament Cross Over||3
10309539|NCT00117598|11442467|FG004|NOT COMPLETED|After Treament Cross Over||4
10309540|NCT00117637|11442479|FG000|STARTED|First Intervention (Period 1)||97
10309541|NCT00117637|11442480|FG001|STARTED|First Intervention (Period 1)||92
10309542|NCT00117637|11442479|FG000|Subjects Received Treatment|First Intervention (Period 1)||97
10309543|NCT00117637|11442480|FG001|Subjects Received Treatment|First Intervention (Period 1)||90
10309544|NCT00117637|11442479|FG000|COMPLETED|First Intervention (Period 1)||79
10309545|NCT00117637|11442480|FG001|COMPLETED|First Intervention (Period 1)||67
10309546|NCT00117637|11442479|FG000|NOT COMPLETED|First Intervention (Period 1)||18
10309547|NCT00117637|11442480|FG001|NOT COMPLETED|First Intervention (Period 1)||25
10309548|NCT00117637|11442479|FG000|STARTED|Second Intervention (Period 2)|Not all patients who completed Period 1 (first progression) enter into Period 2|49
10309549|NCT00117637|11442480|FG001|STARTED|Second Intervention (Period 2)|Not all patients who completed Period 1 (first progression) enter into Period 2|61
10309550|NCT00117637|11442479|FG000|Subjects Received Treatment|Second Intervention (Period 2)||49
10309551|NCT00117637|11442480|FG001|Subjects Received Treatment|Second Intervention (Period 2)||61
10309552|NCT00117637|11442479|FG000|COMPLETED|Second Intervention (Period 2)||39
10719757|NCT02712008|11883463|FG007|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
10719758|NCT02712008|11883456|FG000|STARTED|From Week 12 up to Week 36|Out of 46 participants that completed Week 12, 45 re-randomized for treatment from Week 12 to 36|45
10719759|NCT02712008|11883457|FG001|STARTED|From Week 12 up to Week 36|Out of 97 participants that completed Week 12, 96 re-randomized to REGN910-3 (6:2mg) Q8 and Q12|0
10719760|NCT02712008|11883458|FG002|STARTED|From Week 12 up to Week 36|Out of 148 that completed Week 12,143 re-randomized to Aflibercept 2mg Q8, Q12, REGN910-3 (6:2mg) Q8|0
10719761|NCT02712008|11883459|FG003|STARTED|From Week 12 up to Week 36|Out of 96 that were re-randomized, 44 re-randomized from REGN910-3(6:2 mg)Q4 to REGN910-3(6:2 mg)Q8|44
10719762|NCT02712008|11883460|FG004|STARTED|From Week 12 up to Week 36|Out of 96 that were re-randomized, 52 re-randomized from REGN910-3(6:2 mg)Q4 to REGN910-3(6:2 mg)Q12|52
10719763|NCT02712008|11883461|FG005|STARTED|From Week 12 up to Week 36|Out of 143 that were re-randomized, 46 re-randomized from Aflibercept 2mg Q4 to Aflibercept 2mg Q8|46
10309553|NCT00117637|11442480|FG001|COMPLETED|Second Intervention (Period 2)||39
10309554|NCT00117637|11442479|FG000|NOT COMPLETED|Second Intervention (Period 2)||10
10309555|NCT00117637|11442480|FG001|NOT COMPLETED|Second Intervention (Period 2)||22
10309556|NCT00117676|11442495|FG000|STARTED|Double-blind Period Through Week 48||254
10309557|NCT00117676|11442496|FG001|STARTED|Double-blind Period Through Week 48||128
10719764|NCT02712008|11883462|FG006|STARTED|From Week 12 up to Week 36|Out of 143 that were re-randomized, 48 re-randomized from Aflibercept 2mg Q4 to Aflibercept 2mg Q12|48
10719765|NCT02712008|11883463|FG007|STARTED|From Week 12 up to Week 36|Out of 143 that were re-randomized, 49 re-randomized from Aflibercept 2mg Q4 to REGN910-3 (6:2mg) Q8|49
10719766|NCT02712008|11883456|FG000|COMPLETED|From Week 12 up to Week 36||44
10719767|NCT02712008|11883457|FG001|COMPLETED|From Week 12 up to Week 36||0
10719768|NCT02712008|11883458|FG002|COMPLETED|From Week 12 up to Week 36||0
10719769|NCT02712008|11883459|FG003|COMPLETED|From Week 12 up to Week 36||42
10719770|NCT02712008|11883460|FG004|COMPLETED|From Week 12 up to Week 36||50
10719771|NCT02712008|11883461|FG005|COMPLETED|From Week 12 up to Week 36||46
10719772|NCT02712008|11883462|FG006|COMPLETED|From Week 12 up to Week 36||43
10719773|NCT02712008|11883463|FG007|COMPLETED|From Week 12 up to Week 36||45
10719774|NCT02712008|11883456|FG000|NOT COMPLETED|From Week 12 up to Week 36||1
10719775|NCT02712008|11883457|FG001|NOT COMPLETED|From Week 12 up to Week 36||0
10719776|NCT02712008|11883458|FG002|NOT COMPLETED|From Week 12 up to Week 36||0
10719777|NCT02712008|11883459|FG003|NOT COMPLETED|From Week 12 up to Week 36||2
10719778|NCT02712008|11883460|FG004|NOT COMPLETED|From Week 12 up to Week 36||2
10719779|NCT02712008|11883461|FG005|NOT COMPLETED|From Week 12 up to Week 36||0
10719780|NCT02712008|11883462|FG006|NOT COMPLETED|From Week 12 up to Week 36||5
10719781|NCT02712008|11883463|FG007|NOT COMPLETED|From Week 12 up to Week 36||4
10719782|NCT02712047|11883477|FG000|STARTED|Treatment Period 1 (35 Days)||14
10719783|NCT02712047|11883478|FG001|STARTED|Treatment Period 1 (35 Days)||13
10719784|NCT02712047|11883477|FG000|COMPLETED|Treatment Period 1 (35 Days)||14
10719785|NCT02712047|11883478|FG001|COMPLETED|Treatment Period 1 (35 Days)||13
10719786|NCT02712047|11883477|FG000|NOT COMPLETED|Treatment Period 1 (35 Days)||0
10719787|NCT02712047|11883478|FG001|NOT COMPLETED|Treatment Period 1 (35 Days)||0
10719788|NCT02712047|11883477|FG000|STARTED|Washout Period (21 Days)||14
10719789|NCT02712047|11883478|FG001|STARTED|Washout Period (21 Days)||13
10719790|NCT02712047|11883477|FG000|COMPLETED|Washout Period (21 Days)||14
10719791|NCT02712047|11883478|FG001|COMPLETED|Washout Period (21 Days)||13
10719792|NCT02712047|11883477|FG000|NOT COMPLETED|Washout Period (21 Days)||0
10719793|NCT02712047|11883478|FG001|NOT COMPLETED|Washout Period (21 Days)||0
10719794|NCT02712047|11883477|FG000|STARTED|Treatment Period 2 (35 Days)||14
10719795|NCT02712047|11883478|FG001|STARTED|Treatment Period 2 (35 Days)||13
10719796|NCT02712047|11883477|FG000|COMPLETED|Treatment Period 2 (35 Days)||14
10719797|NCT02712047|11883478|FG001|COMPLETED|Treatment Period 2 (35 Days)||13
10719798|NCT02712047|11883477|FG000|NOT COMPLETED|Treatment Period 2 (35 Days)||0
10719799|NCT02712047|11883478|FG001|NOT COMPLETED|Treatment Period 2 (35 Days)||0
10719800|NCT02712099|11883486|FG000|STARTED|Overall Study||30
10719801|NCT02712099|11883487|FG001|STARTED|Overall Study||20
10719802|NCT02712099|11883486|FG000|COMPLETED|Overall Study||30
10719803|NCT02712099|11883487|FG001|COMPLETED|Overall Study||20
10719804|NCT02712099|11883486|FG000|NOT COMPLETED|Overall Study||0
10719805|NCT02712099|11883487|FG001|NOT COMPLETED|Overall Study||0
10719806|NCT02712320|11883493|FG000|STARTED|Overall Study||30
10719807|NCT02712320|11883493|FG000|COMPLETED|Overall Study||25
10719808|NCT02712320|11883493|FG000|NOT COMPLETED|Overall Study||5
10719809|NCT02712333|11883499|FG000|STARTED|First Period||34
10719810|NCT02712333|11883500|FG001|STARTED|First Period||26
10719811|NCT02712333|11883499|FG000|COMPLETED|First Period||31
10719812|NCT02712333|11883500|FG001|COMPLETED|First Period||24
10719813|NCT02712333|11883499|FG000|NOT COMPLETED|First Period||3
10719814|NCT02712333|11883500|FG001|NOT COMPLETED|First Period||2
10719815|NCT02712333|11883499|FG000|STARTED|Second Period||31
10719816|NCT02712333|11883500|FG001|STARTED|Second Period||24
10719817|NCT02712333|11883499|FG000|COMPLETED|Second Period||31
10719818|NCT02712333|11883500|FG001|COMPLETED|Second Period||24
10719819|NCT02712333|11883499|FG000|NOT COMPLETED|Second Period||0
10719820|NCT02712333|11883500|FG001|NOT COMPLETED|Second Period||0
10719821|NCT02712359|11883515|FG000|STARTED|Epoch 001: Persistence at Year 8||300
10719822|NCT02712359|11883516|FG001|STARTED|Epoch 001: Persistence at Year 8||300
10719823|NCT02712359|11883517|FG002|STARTED|Epoch 001: Persistence at Year 8||0
10719824|NCT02712359|11883518|FG003|STARTED|Epoch 001: Persistence at Year 8||0
10719825|NCT02712359|11883515|FG000|COMPLETED|Epoch 001: Persistence at Year 8||300
10719826|NCT02712359|11883516|FG001|COMPLETED|Epoch 001: Persistence at Year 8||300
10719827|NCT02712359|11883517|FG002|COMPLETED|Epoch 001: Persistence at Year 8||0
10719828|NCT02712359|11883518|FG003|COMPLETED|Epoch 001: Persistence at Year 8||0
10719829|NCT02712359|11883515|FG000|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
10813231|NCT02954159|11975544|FG000|COMPLETED|Overall Study||1
10813232|NCT02954159|11975545|FG001|COMPLETED|Overall Study||1
10813233|NCT02954159|11975544|FG000|NOT COMPLETED|Overall Study||1
10813234|NCT02954159|11975545|FG001|NOT COMPLETED|Overall Study||1
10813235|NCT02954952|11975554|FG000|STARTED|Overall Study||36
10813236|NCT02954952|11975555|FG001|STARTED|Overall Study||5
10813237|NCT02954952|11975556|FG002|STARTED|Overall Study||3
10394976|NCT00686075|11538556|FG003|STARTED|Overall Study||80
10394977|NCT00686075|11538557|FG004|STARTED|Overall Study||40
10394978|NCT00686075|11538558|FG005|STARTED|Overall Study||40
10719830|NCT02712359|11883516|FG001|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
10813238|NCT02954952|11975554|FG000|COMPLETED|Overall Study||35
10813239|NCT02954952|11975555|FG001|COMPLETED|Overall Study||4
10394979|NCT00686075|11538559|FG006|STARTED|Overall Study||82
10719831|NCT02712359|11883517|FG002|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
10813240|NCT02954952|11975556|FG002|COMPLETED|Overall Study||3
10813241|NCT02954952|11975554|FG000|NOT COMPLETED|Overall Study||1
10813242|NCT02954952|11975555|FG001|NOT COMPLETED|Overall Study||1
10813243|NCT02954952|11975556|FG002|NOT COMPLETED|Overall Study||0
10813244|NCT02950896|11975564|FG000|STARTED|Overall Study||4
10813245|NCT02950896|11975564|FG000|COMPLETED|Overall Study||4
10813246|NCT02950896|11975564|FG000|NOT COMPLETED|Overall Study||0
10813247|NCT02947022|11975568|FG000|STARTED|Overall Study||1
10813248|NCT02947022|11975568|FG000|COMPLETED|Overall Study||0
10813249|NCT02947022|11975568|FG000|NOT COMPLETED|Overall Study||1
10813250|NCT02936999|11975575|FG000|STARTED|Overall Study||8
10719832|NCT02712359|11883518|FG003|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
10719833|NCT02712359|11883515|FG000|STARTED|Epoch 002: Persistence at Year 10||0
10719834|NCT02712359|11883516|FG001|STARTED|Epoch 002: Persistence at Year 10||0
10719835|NCT02712359|11883517|FG002|STARTED|Epoch 002: Persistence at Year 10||299
10719836|NCT02712359|11883518|FG003|STARTED|Epoch 002: Persistence at Year 10||300
10719837|NCT02712359|11883515|FG000|COMPLETED|Epoch 002: Persistence at Year 10||0
10719838|NCT02712359|11883516|FG001|COMPLETED|Epoch 002: Persistence at Year 10||0
10719839|NCT02712359|11883517|FG002|COMPLETED|Epoch 002: Persistence at Year 10||299
10719840|NCT02712359|11883518|FG003|COMPLETED|Epoch 002: Persistence at Year 10||300
10719841|NCT02712359|11883515|FG000|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
10719842|NCT02712359|11883516|FG001|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
10719843|NCT02712359|11883517|FG002|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
10719844|NCT02712359|11883518|FG003|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
10719845|NCT02712398|11883528|FG000|STARTED|Overall Study||120
10719846|NCT02712398|11883528|FG000|COMPLETED|Overall Study||83
10719847|NCT02712398|11883528|FG000|NOT COMPLETED|Overall Study||37
10719848|NCT02712424|11883534|FG000|STARTED|Overall Study||315
10719849|NCT02712424|11883535|FG001|STARTED|Overall Study||310
10719850|NCT02712424|11883534|FG000|COMPLETED|Overall Study||281
10719851|NCT02712424|11883535|FG001|COMPLETED|Overall Study||278
10719852|NCT02712424|11883534|FG000|NOT COMPLETED|Overall Study||34
10719853|NCT02712424|11883535|FG001|NOT COMPLETED|Overall Study||32
10719854|NCT02712554|11883543|FG000|STARTED|Part A: Dose Selection Phase||12
10719855|NCT02712554|11883544|FG001|STARTED|Part A: Dose Selection Phase||0
10719856|NCT02712554|11883543|FG000|COMPLETED|Part A: Dose Selection Phase||12
10719857|NCT02712554|11883544|FG001|COMPLETED|Part A: Dose Selection Phase|Subjects who participated in Dose Selection Phase were not eligible to participate in Part B.|0
10719858|NCT02712554|11883543|FG000|NOT COMPLETED|Part A: Dose Selection Phase||0
10719859|NCT02712554|11883544|FG001|NOT COMPLETED|Part A: Dose Selection Phase||0
10719860|NCT02712554|11883543|FG000|STARTED|Part B: Qualification Phase||0
10719861|NCT02712554|11883544|FG001|STARTED|Part B: Qualification Phase||61
10719862|NCT02712554|11883543|FG000|COMPLETED|Part B: Qualification Phase||0
10719863|NCT02712554|11883544|FG001|COMPLETED|Part B: Qualification Phase||40
10719864|NCT02712554|11883543|FG000|NOT COMPLETED|Part B: Qualification Phase||0
10719865|NCT02712554|11883544|FG001|NOT COMPLETED|Part B: Qualification Phase||21
10719866|NCT02712554|11883543|FG000|STARTED|Part B: Treatment Phase||0
10719867|NCT02712554|11883544|FG001|STARTED|Part B: Treatment Phase||40
10719868|NCT02712554|11883543|FG000|COMPLETED|Part B: Treatment Phase||0
10719869|NCT02712554|11883544|FG001|COMPLETED|Part B: Treatment Phase||37
10719870|NCT02712554|11883543|FG000|NOT COMPLETED|Part B: Treatment Phase||0
10719871|NCT02712554|11883544|FG001|NOT COMPLETED|Part B: Treatment Phase||3
10719872|NCT02712788|11883569|FG000|STARTED|Overall Study||2
10719873|NCT02712788|11883570|FG001|STARTED|Overall Study||2
10719874|NCT02712788|11883569|FG000|COMPLETED|Overall Study||0
10719875|NCT02712788|11883570|FG001|COMPLETED|Overall Study||2
10719876|NCT02712788|11883569|FG000|NOT COMPLETED|Overall Study||2
10719877|NCT02712788|11883570|FG001|NOT COMPLETED|Overall Study||0
10719878|NCT02712983|11883585|FG000|STARTED|Treatment Phase||14
10719879|NCT02712983|11883586|FG001|STARTED|Treatment Phase||13
10719880|NCT02712983|11883587|FG002|STARTED|Treatment Phase||7
10719881|NCT02712983|11883588|FG003|STARTED|Treatment Phase||15
10719882|NCT02712983|11883589|FG004|STARTED|Treatment Phase||14
10719883|NCT02712983|11883590|FG005|STARTED|Treatment Phase||7
10719884|NCT02712983|11883591|FG006|STARTED|Treatment Phase||15
10719885|NCT02712983|11883592|FG007|STARTED|Treatment Phase||15
10719886|NCT02712983|11883593|FG008|STARTED|Treatment Phase||7
10719887|NCT02712983|11883585|FG000|Pharmacokinetic Analysis Set|Treatment Phase||14
10719888|NCT02712983|11883586|FG001|Pharmacokinetic Analysis Set|Treatment Phase||13
10719889|NCT02712983|11883587|FG002|Pharmacokinetic Analysis Set|Treatment Phase||0
10719890|NCT02712983|11883588|FG003|Pharmacokinetic Analysis Set|Treatment Phase||15
10813251|NCT02936999|11975575|FG000|COMPLETED|Overall Study||8
10813252|NCT02936999|11975575|FG000|NOT COMPLETED|Overall Study||0
10813253|NCT02950480|11975583|FG000|STARTED|Overall Study||2
10813254|NCT02950480|11975584|FG001|STARTED|Overall Study||2
10719891|NCT02712983|11883589|FG004|Pharmacokinetic Analysis Set|Treatment Phase||14
10719892|NCT02712983|11883590|FG005|Pharmacokinetic Analysis Set|Treatment Phase||0
10719893|NCT02712983|11883591|FG006|Pharmacokinetic Analysis Set|Treatment Phase||15
10719894|NCT02712983|11883592|FG007|Pharmacokinetic Analysis Set|Treatment Phase||14
10719895|NCT02712983|11883593|FG008|Pharmacokinetic Analysis Set|Treatment Phase||0
10719896|NCT02712983|11883585|FG000|COMPLETED|Treatment Phase||9
10813255|NCT02950480|11975583|FG000|COMPLETED|Overall Study||1
10813256|NCT02950480|11975584|FG001|COMPLETED|Overall Study||2
10719897|NCT02712983|11883586|FG001|COMPLETED|Treatment Phase||12
10719898|NCT02712983|11883587|FG002|COMPLETED|Treatment Phase||6
10719899|NCT02712983|11883588|FG003|COMPLETED|Treatment Phase||7
10719900|NCT02712983|11883589|FG004|COMPLETED|Treatment Phase||10
10719901|NCT02712983|11883590|FG005|COMPLETED|Treatment Phase||7
10813257|NCT02950480|11975583|FG000|NOT COMPLETED|Overall Study||1
10813258|NCT02950480|11975584|FG001|NOT COMPLETED|Overall Study||0
10813259|NCT02949947|11975592|FG000|STARTED|Overall Study||1
10813260|NCT02949947|11975593|FG001|STARTED|Overall Study||2
10813261|NCT02949947|11975592|FG000|COMPLETED|Overall Study||0
10719902|NCT02712983|11883591|FG006|COMPLETED|Treatment Phase||6
10719903|NCT02712983|11883592|FG007|COMPLETED|Treatment Phase||6
10719904|NCT02712983|11883593|FG008|COMPLETED|Treatment Phase||5
10719905|NCT02712983|11883585|FG000|NOT COMPLETED|Treatment Phase||5
10719906|NCT02712983|11883586|FG001|NOT COMPLETED|Treatment Phase||1
10719907|NCT02712983|11883587|FG002|NOT COMPLETED|Treatment Phase||1
10719908|NCT02712983|11883588|FG003|NOT COMPLETED|Treatment Phase||8
10719909|NCT02712983|11883589|FG004|NOT COMPLETED|Treatment Phase||4
10719910|NCT02712983|11883590|FG005|NOT COMPLETED|Treatment Phase||0
10719911|NCT02712983|11883591|FG006|NOT COMPLETED|Treatment Phase||9
10719912|NCT02712983|11883592|FG007|NOT COMPLETED|Treatment Phase||9
10719913|NCT02712983|11883593|FG008|NOT COMPLETED|Treatment Phase||2
10813262|NCT02949947|11975593|FG001|COMPLETED|Overall Study||1
10813263|NCT02949947|11975592|FG000|NOT COMPLETED|Overall Study||1
10813264|NCT02949947|11975593|FG001|NOT COMPLETED|Overall Study||1
10813265|NCT02947100|11975599|FG000|STARTED|Overall Study||4
10813266|NCT02947100|11975599|FG000|COMPLETED|Overall Study||0
10813267|NCT02947100|11975599|FG000|NOT COMPLETED|Overall Study||4
10813268|NCT02936206|11975605|FG000|STARTED|Overall Study||0
10813269|NCT02936206|11975606|FG001|STARTED|Overall Study||2
10813270|NCT02936206|11975605|FG000|COMPLETED|Overall Study||0
10813271|NCT02936206|11975606|FG001|COMPLETED|Overall Study||2
10813272|NCT02936206|11975605|FG000|NOT COMPLETED|Overall Study||0
10813273|NCT02936206|11975606|FG001|NOT COMPLETED|Overall Study||0
10813274|NCT02934932|11975612|FG000|STARTED|Overall Study||9
10813275|NCT02934932|11975612|FG000|COMPLETED|Overall Study||6
10813276|NCT02934932|11975612|FG000|NOT COMPLETED|Overall Study||3
10813277|NCT02908516|11975620|FG000|STARTED|Overall Study||3
10813278|NCT02908516|11975621|FG001|STARTED|Overall Study||3
10309558|NCT00117676|11442495|FG000|COMPLETED|Double-blind Period Through Week 48||244
10309559|NCT00117676|11442496|FG001|COMPLETED|Double-blind Period Through Week 48||121
10309560|NCT00117676|11442495|FG000|NOT COMPLETED|Double-blind Period Through Week 48||10
10309561|NCT00117676|11442496|FG001|NOT COMPLETED|Double-blind Period Through Week 48||7
10309562|NCT00117676|11442495|FG000|STARTED|Open-label Period: Weeks 49 - 96|9 participants completed 48 weeks but did not continue on study.|235
10309563|NCT00117676|11442496|FG001|STARTED|Open-label Period: Weeks 49 - 96|9 participants completed 48 weeks but did not continue on study.|112
10309564|NCT00117676|11442495|FG000|COMPLETED|Open-label Period: Weeks 49 - 96||225
10309565|NCT00117676|11442496|FG001|COMPLETED|Open-label Period: Weeks 49 - 96||110
10309566|NCT00117676|11442495|FG000|NOT COMPLETED|Open-label Period: Weeks 49 - 96||10
10309567|NCT00117676|11442496|FG001|NOT COMPLETED|Open-label Period: Weeks 49 - 96||2
10309568|NCT00117676|11442495|FG000|STARTED|Open-label Period: Weeks 97 - 144||225
10309569|NCT00117676|11442496|FG001|STARTED|Open-label Period: Weeks 97 - 144||110
10309570|NCT00117676|11442495|FG000|COMPLETED|Open-label Period: Weeks 97 - 144||219
10309571|NCT00117676|11442496|FG001|COMPLETED|Open-label Period: Weeks 97 - 144||109
10394980|NCT00686075|11538560|FG007|STARTED|Overall Study||78
10394981|NCT00686075|11538561|FG008|STARTED|Overall Study||81
10394982|NCT00686075|11538562|FG009|STARTED|Overall Study||79
10394983|NCT00686075|11538553|FG000|Treated|Overall Study||78
10719914|NCT02712983|11883585|FG000|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|0
10719915|NCT02712983|11883586|FG001|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|1
10813279|NCT02908516|11975620|FG000|COMPLETED|Overall Study||0
10813280|NCT02908516|11975621|FG001|COMPLETED|Overall Study||0
10309572|NCT00117676|11442495|FG000|NOT COMPLETED|Open-label Period: Weeks 97 - 144||6
10813281|NCT02908516|11975620|FG000|NOT COMPLETED|Overall Study||3
10813282|NCT02908516|11975621|FG001|NOT COMPLETED|Overall Study||3
10309573|NCT00117676|11442496|FG001|NOT COMPLETED|Open-label Period: Weeks 97 - 144||1
10309574|NCT00117676|11442495|FG000|STARTED|Open-label Period: Weeks 145 - 192||219
10309575|NCT00117676|11442496|FG001|STARTED|Open-label Period: Weeks 145 - 192||109
10309576|NCT00117676|11442495|FG000|COMPLETED|Open-label Period: Weeks 145 - 192||209
10309577|NCT00117676|11442496|FG001|COMPLETED|Open-label Period: Weeks 145 - 192||106
10309578|NCT00117676|11442495|FG000|NOT COMPLETED|Open-label Period: Weeks 145 - 192||10
10309579|NCT00117676|11442496|FG001|NOT COMPLETED|Open-label Period: Weeks 145 - 192||3
10309580|NCT00117676|11442495|FG000|STARTED|Open-label Period: Weeks 193 - 240||209
10309581|NCT00117676|11442496|FG001|STARTED|Open-label Period: Weeks 193 - 240||106
10309582|NCT00117676|11442495|FG000|COMPLETED|Open-label Period: Weeks 193 - 240||202
10309583|NCT00117676|11442496|FG001|COMPLETED|Open-label Period: Weeks 193 - 240||103
10309584|NCT00117676|11442495|FG000|NOT COMPLETED|Open-label Period: Weeks 193 - 240||7
10309585|NCT00117676|11442496|FG001|NOT COMPLETED|Open-label Period: Weeks 193 - 240||3
10309586|NCT00117676|11442495|FG000|STARTED|Open-label Period: Weeks 241 - 288||202
10309587|NCT00117676|11442496|FG001|STARTED|Open-label Period: Weeks 241 - 288||103
10309588|NCT00117676|11442495|FG000|COMPLETED|Open-label Period: Weeks 241 - 288||192
10309589|NCT00117676|11442496|FG001|COMPLETED|Open-label Period: Weeks 241 - 288||100
10309590|NCT00117676|11442495|FG000|NOT COMPLETED|Open-label Period: Weeks 241 - 288||10
10309591|NCT00117676|11442496|FG001|NOT COMPLETED|Open-label Period: Weeks 241 - 288||3
10309592|NCT00117676|11442495|FG000|STARTED|Open-label Period: Weeks 289 - 336||192
10309593|NCT00117676|11442496|FG001|STARTED|Open-label Period: Weeks 289 - 336||100
10309594|NCT00117676|11442495|FG000|COMPLETED|Open-label Period: Weeks 289 - 336||183
10309595|NCT00117676|11442496|FG001|COMPLETED|Open-label Period: Weeks 289 - 336||93
10309596|NCT00117676|11442495|FG000|NOT COMPLETED|Open-label Period: Weeks 289 - 336||9
10309597|NCT00117676|11442496|FG001|NOT COMPLETED|Open-label Period: Weeks 289 - 336||7
10309598|NCT00117676|11442495|FG000|STARTED|Open-label Period: Weeks 337 - 384||183
10543295|NCT01483599|11696521|FG003|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
10543296|NCT01483599|11696522|FG004|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||2
10309599|NCT00117676|11442496|FG001|STARTED|Open-label Period: Weeks 337 - 384||93
10309600|NCT00117676|11442495|FG000|COMPLETED|Open-label Period: Weeks 337 - 384||176
10309601|NCT00117676|11442496|FG001|COMPLETED|Open-label Period: Weeks 337 - 384||90
10309602|NCT00117676|11442495|FG000|NOT COMPLETED|Open-label Period: Weeks 337 - 384||7
10309603|NCT00117676|11442496|FG001|NOT COMPLETED|Open-label Period: Weeks 337 - 384||3
10309604|NCT00117676|11442495|FG000|STARTED|Open-label Period: Weeks 385 - 432|94 participants completed 384 weeks but did not continue on study.|82
10309605|NCT00117676|11442496|FG001|STARTED|Open-label Period: Weeks 385 - 432|44 participants completed 384 weeks but did not continue on study.|46
10309606|NCT00117676|11442495|FG000|COMPLETED|Open-label Period: Weeks 385 - 432||82
10309607|NCT00117676|11442496|FG001|COMPLETED|Open-label Period: Weeks 385 - 432||44
10309608|NCT00117676|11442495|FG000|NOT COMPLETED|Open-label Period: Weeks 385 - 432||0
10309609|NCT00117676|11442496|FG001|NOT COMPLETED|Open-label Period: Weeks 385 - 432||2
10309610|NCT00117676|11442495|FG000|STARTED|Open-label Period: Weeks 433 - 480||82
10309611|NCT00117676|11442496|FG001|STARTED|Open-label Period: Weeks 433 - 480|1 participant completed 432 weeks but did not continue on study.|43
10309612|NCT00117676|11442495|FG000|COMPLETED|Open-label Period: Weeks 433 - 480||80
10309613|NCT00117676|11442496|FG001|COMPLETED|Open-label Period: Weeks 433 - 480||41
10309614|NCT00117676|11442495|FG000|NOT COMPLETED|Open-label Period: Weeks 433 - 480||2
10309615|NCT00117676|11442496|FG001|NOT COMPLETED|Open-label Period: Weeks 433 - 480||2
10309616|NCT00117715|11442507|FG000|STARTED|Overall Study||121
10309617|NCT00117715|11442507|FG000|1 Year|Overall Study||88
10309618|NCT00117715|11442507|FG000|1.5 Year|Overall Study||85
10309619|NCT00117715|11442507|FG000|2 Year|Overall Study||76
10309620|NCT00117715|11442507|FG000|2.5 Year|Overall Study||70
10309621|NCT00117715|11442507|FG000|3 Year|Overall Study||61
10309622|NCT00117715|11442507|FG000|3.5 Year|Overall Study||60
10309623|NCT00117715|11442507|FG000|4 Year|Overall Study||58
10309624|NCT00117715|11442507|FG000|4.5 Year|Overall Study||55
10309625|NCT00117715|11442507|FG000|5 Year|Overall Study||49
10394984|NCT00686075|11538554|FG001|Treated|Overall Study||79
10394985|NCT00686075|11538555|FG002|Treated|Overall Study||80
10394986|NCT00686075|11538556|FG003|Treated|Overall Study||80
10394987|NCT00686075|11538557|FG004|Treated|Overall Study||40
10394988|NCT00686075|11538558|FG005|Treated|Overall Study||40
10394989|NCT00686075|11538559|FG006|Treated|Overall Study||82
10394990|NCT00686075|11538560|FG007|Treated|Overall Study||77
10394991|NCT00686075|11538561|FG008|Treated|Overall Study||80
10394992|NCT00686075|11538562|FG009|Treated|Overall Study||78
10394993|NCT00686075|11538553|FG000|COMPLETED|Overall Study||71
10394994|NCT00686075|11538554|FG001|COMPLETED|Overall Study||71
10394995|NCT00686075|11538555|FG002|COMPLETED|Overall Study||74
10394996|NCT00686075|11538556|FG003|COMPLETED|Overall Study||71
10394997|NCT00686075|11538557|FG004|COMPLETED|Overall Study||36
10394998|NCT00686075|11538558|FG005|COMPLETED|Overall Study||37
10394999|NCT00686075|11538559|FG006|COMPLETED|Overall Study||82
10395000|NCT00686075|11538560|FG007|COMPLETED|Overall Study||76
10395001|NCT00686075|11538561|FG008|COMPLETED|Overall Study||75
10395002|NCT00686075|11538562|FG009|COMPLETED|Overall Study||69
10395003|NCT00686075|11538553|FG000|NOT COMPLETED|Overall Study||8
10395004|NCT00686075|11538554|FG001|NOT COMPLETED|Overall Study||10
10395005|NCT00686075|11538555|FG002|NOT COMPLETED|Overall Study||6
10395006|NCT00686075|11538556|FG003|NOT COMPLETED|Overall Study||9
10395007|NCT00686075|11538557|FG004|NOT COMPLETED|Overall Study||4
10395008|NCT00686075|11538558|FG005|NOT COMPLETED|Overall Study||3
10395009|NCT00686075|11538559|FG006|NOT COMPLETED|Overall Study||0
10395010|NCT00686075|11538560|FG007|NOT COMPLETED|Overall Study||2
10395011|NCT00686075|11538561|FG008|NOT COMPLETED|Overall Study||6
10395012|NCT00686075|11538562|FG009|NOT COMPLETED|Overall Study||10
10395013|NCT00686127|11538586|FG000|STARTED|Overall Study||14
10395014|NCT00686127|11538587|FG001|STARTED|Overall Study||7
10395015|NCT00686127|11538586|FG000|COMPLETED|Overall Study|Patients withdrew from the study because they did not like wearing the patch.|0
10395016|NCT00686127|11538587|FG001|COMPLETED|Overall Study||1
10395017|NCT00686127|11538586|FG000|NOT COMPLETED|Overall Study||14
10395018|NCT00686127|11538587|FG001|NOT COMPLETED|Overall Study||6
10395019|NCT00686166|11538593|FG000|STARTED|Overall Study||83
10395020|NCT00686166|11538593|FG000|Eligible|Overall Study||78
10309626|NCT00117715|11442507|FG000|COMPLETED|Overall Study||49
10309627|NCT00117715|11442507|FG000|NOT COMPLETED|Overall Study||72
10309628|NCT00117793|11442511|FG000|STARTED|Overall Study||17
10719916|NCT02712983|11883587|FG002|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|0
10719917|NCT02712983|11883588|FG003|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|1
10719918|NCT02712983|11883589|FG004|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|2
10719919|NCT02712983|11883590|FG005|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|1
10309629|NCT00117793|11442511|FG000|COMPLETED|Overall Study||5
10309630|NCT00117793|11442511|FG000|NOT COMPLETED|Overall Study||12
10309631|NCT00117806|11442518|FG000|STARTED|Overall Study||81
10309632|NCT00117806|11442519|FG001|STARTED|Overall Study||76
10309633|NCT00117806|11442518|FG000|COMPLETED|Overall Study||43
10309634|NCT00117806|11442519|FG001|COMPLETED|Overall Study||60
10309635|NCT00117806|11442518|FG000|NOT COMPLETED|Overall Study||38
10395021|NCT00686166|11538593|FG000|Eligible and Began Protocol Therapy|Overall Study||74
10395022|NCT00686166|11538593|FG000|COMPLETED|Overall Study||63
10395023|NCT00686166|11538593|FG000|NOT COMPLETED|Overall Study||20
10395024|NCT00686205|11538604|FG000|STARTED|Overall Study||21606
10395025|NCT00686205|11538605|FG001|STARTED|Overall Study||2505
10395026|NCT00686205|11538604|FG000|COMPLETED|Overall Study||15599
10395027|NCT00686205|11538605|FG001|COMPLETED|Overall Study||1524
10395028|NCT00686205|11538604|FG000|NOT COMPLETED|Overall Study||6007
10395029|NCT00686205|11538605|FG001|NOT COMPLETED|Overall Study||981
10395030|NCT00686231|11538611|FG000|STARTED|Dose Test - Visit 1||12
10395031|NCT00686231|11538612|FG001|STARTED|Dose Test - Visit 1||7
10395032|NCT00686231|11538613|FG002|STARTED|Dose Test - Visit 1||0
10395033|NCT00686231|11538614|FG003|STARTED|Dose Test - Visit 1||0
10395034|NCT00686231|11538611|FG000|COMPLETED|Dose Test - Visit 1||12
10395035|NCT00686231|11538612|FG001|COMPLETED|Dose Test - Visit 1||7
10395036|NCT00686231|11538613|FG002|COMPLETED|Dose Test - Visit 1||0
10395037|NCT00686231|11538614|FG003|COMPLETED|Dose Test - Visit 1||0
10395038|NCT00686231|11538611|FG000|NOT COMPLETED|Dose Test - Visit 1||0
10395039|NCT00686231|11538612|FG001|NOT COMPLETED|Dose Test - Visit 1||0
10395040|NCT00686231|11538613|FG002|NOT COMPLETED|Dose Test - Visit 1||0
10395041|NCT00686231|11538614|FG003|NOT COMPLETED|Dose Test - Visit 1||0
10395042|NCT00686231|11538611|FG000|STARTED|Combination Test - Visit 2||0
10395043|NCT00686231|11538612|FG001|STARTED|Combination Test - Visit 2||0
10395044|NCT00686231|11538613|FG002|STARTED|Combination Test - Visit 2||10
10395045|NCT00686231|11538614|FG003|STARTED|Combination Test - Visit 2||9
10395046|NCT00686231|11538611|FG000|COMPLETED|Combination Test - Visit 2||0
10395047|NCT00686231|11538612|FG001|COMPLETED|Combination Test - Visit 2||0
10395048|NCT00686231|11538613|FG002|COMPLETED|Combination Test - Visit 2||10
10395049|NCT00686231|11538614|FG003|COMPLETED|Combination Test - Visit 2||9
10395050|NCT00686231|11538611|FG000|NOT COMPLETED|Combination Test - Visit 2||0
10395051|NCT00686231|11538612|FG001|NOT COMPLETED|Combination Test - Visit 2||0
10395052|NCT00686231|11538613|FG002|NOT COMPLETED|Combination Test - Visit 2||0
10395053|NCT00686231|11538614|FG003|NOT COMPLETED|Combination Test - Visit 2||0
10395054|NCT00686257|11538626|FG000|STARTED|Overall Study||29
10395055|NCT00686257|11538627|FG001|STARTED|Overall Study||31
10395056|NCT00686257|11538626|FG000|COMPLETED|Overall Study||29
10395057|NCT00686257|11538627|FG001|COMPLETED|Overall Study||31
10395058|NCT00686257|11538626|FG000|NOT COMPLETED|Overall Study||0
10395059|NCT00686257|11538627|FG001|NOT COMPLETED|Overall Study||0
10395060|NCT00686335|11538635|FG000|STARTED|Run-in Period||12
10395061|NCT00686335|11538635|FG000|COMPLETED|Run-in Period||7
10395062|NCT00686335|11538635|FG000|NOT COMPLETED|Run-in Period||5
10395063|NCT00686335|11538635|FG000|STARTED|Treatment Period||7
10395064|NCT00686335|11538635|FG000|COMPLETED|Treatment Period||7
10395065|NCT00686335|11538635|FG000|NOT COMPLETED|Treatment Period||0
10395066|NCT00686517|11538644|FG000|STARTED|Treatment||44
10395067|NCT00686517|11538645|FG001|STARTED|Treatment||43
10395068|NCT00686517|11538646|FG002|STARTED|Treatment||43
10395069|NCT00686517|11538644|FG000|Completed Final Treatment Visit|Treatment|Included 6 that discontinued the treatment before completion,but performed the Final Treatment Visit|44
10395070|NCT00686517|11538645|FG001|Completed Final Treatment Visit|Treatment|Included 3 that discontinued the treatment before completion,but performed the Final Treatment Visit|43
10395071|NCT00686517|11538646|FG002|Completed Final Treatment Visit|Treatment|Included 1 that discontinued the treatment before completion,but performed the Final Treatment Visit|43
10395072|NCT00686517|11538644|FG000|COMPLETED|Treatment||38
10395073|NCT00686517|11538645|FG001|COMPLETED|Treatment||40
10395074|NCT00686517|11538646|FG002|COMPLETED|Treatment||42
10395075|NCT00686517|11538644|FG000|NOT COMPLETED|Treatment||6
10395076|NCT00686517|11538645|FG001|NOT COMPLETED|Treatment||3
10395077|NCT00686517|11538646|FG002|NOT COMPLETED|Treatment||1
10395078|NCT00686517|11538644|FG000|STARTED|Follow-up||37
10395079|NCT00686517|11538645|FG001|STARTED|Follow-up||38
10395080|NCT00686517|11538646|FG002|STARTED|Follow-up||39
10395081|NCT00686517|11538644|FG000|COMPLETED|Follow-up||29
10395082|NCT00686517|11538645|FG001|COMPLETED|Follow-up||28
10395083|NCT00686517|11538646|FG002|COMPLETED|Follow-up||29
10395084|NCT00686517|11538644|FG000|NOT COMPLETED|Follow-up||8
10309636|NCT00117806|11442519|FG001|NOT COMPLETED|Overall Study||16
10309637|NCT00117845|11442528|FG000|STARTED|Overall Study||17
10309638|NCT00117845|11442528|FG000|COMPLETED|Overall Study||16
10309639|NCT00117845|11442528|FG000|NOT COMPLETED|Overall Study||1
10309640|NCT00117949|11442536|FG000|STARTED|Overall Study|Dose level terminated prematurely due to inadequate testosterone response|10
10309641|NCT00117949|11442537|FG001|STARTED|Overall Study||24
10309642|NCT00117949|11442538|FG002|STARTED|Overall Study||24
10309643|NCT00117949|11442539|FG003|STARTED|Overall Study||24
10309644|NCT00117949|11442536|FG000|COMPLETED|Overall Study||0
10309645|NCT00117949|11442537|FG001|COMPLETED|Overall Study||0
10309646|NCT00117949|11442538|FG002|COMPLETED|Overall Study||0
10309647|NCT00117949|11442539|FG003|COMPLETED|Overall Study||0
10309648|NCT00117949|11442536|FG000|NOT COMPLETED|Overall Study||10
10309649|NCT00117949|11442537|FG001|NOT COMPLETED|Overall Study||24
10309650|NCT00117949|11442538|FG002|NOT COMPLETED|Overall Study||24
10309651|NCT00117949|11442539|FG003|NOT COMPLETED|Overall Study||24
10309652|NCT00117962|11442551|FG000|STARTED|Overall Study||48
10309653|NCT00117962|11442552|FG001|STARTED|Overall Study||53
10309654|NCT00117962|11442551|FG000|COMPLETED|Overall Study||26
10309655|NCT00117962|11442552|FG001|COMPLETED|Overall Study||28
10309656|NCT00117962|11442551|FG000|NOT COMPLETED|Overall Study||22
10309657|NCT00117962|11442552|FG001|NOT COMPLETED|Overall Study||25
10395085|NCT00686517|11538645|FG001|NOT COMPLETED|Follow-up||10
10395086|NCT00686517|11538646|FG002|NOT COMPLETED|Follow-up||10
10395087|NCT00686543|11538658|FG000|STARTED|Overall Study||14
10395088|NCT00686543|11538659|FG001|STARTED|Overall Study||21
10395089|NCT00686543|11538660|FG002|STARTED|Overall Study||20
10395090|NCT00686543|11538661|FG003|STARTED|Overall Study||20
10395091|NCT00686543|11538658|FG000|COMPLETED|Overall Study||0
10395092|NCT00686543|11538659|FG001|COMPLETED|Overall Study||20
10395093|NCT00686543|11538660|FG002|COMPLETED|Overall Study||15
10395094|NCT00686543|11538661|FG003|COMPLETED|Overall Study||17
10395095|NCT00686543|11538658|FG000|NOT COMPLETED|Overall Study||14
10395096|NCT00686543|11538659|FG001|NOT COMPLETED|Overall Study||1
10395097|NCT00686543|11538660|FG002|NOT COMPLETED|Overall Study||5
10395098|NCT00686543|11538661|FG003|NOT COMPLETED|Overall Study||3
10395099|NCT00686582|11538674|FG000|STARTED|Overall Study||92
10395100|NCT00686582|11538675|FG001|STARTED|Overall Study||91
10395101|NCT00686582|11538676|FG002|STARTED|Overall Study||121
10395102|NCT00686582|11538674|FG000|Booster Vaccination|Overall Study||75
10395103|NCT00686582|11538675|FG001|Booster Vaccination|Overall Study||77
10395104|NCT00686582|11538676|FG002|Booster Vaccination|Overall Study||0
10395105|NCT00686582|11538674|FG000|COMPLETED|Overall Study||74
10395106|NCT00686582|11538675|FG001|COMPLETED|Overall Study||77
10395107|NCT00686582|11538676|FG002|COMPLETED|Overall Study||121
10395108|NCT00686582|11538674|FG000|NOT COMPLETED|Overall Study||18
10395109|NCT00686582|11538675|FG001|NOT COMPLETED|Overall Study||14
10395110|NCT00686582|11538676|FG002|NOT COMPLETED|Overall Study||0
10395111|NCT00686595|11538682|FG000|STARTED|Overall Study||38
10395112|NCT00686595|11538682|FG000|COMPLETED|Overall Study||31
10395113|NCT00686595|11538682|FG000|NOT COMPLETED|Overall Study||7
10395114|NCT00686634|11538686|FG000|STARTED|Overall Study||108
10395115|NCT00686634|11538686|FG000|COMPLETED|Overall Study||102
10395116|NCT00686634|11538686|FG000|NOT COMPLETED|Overall Study||6
10395117|NCT00686647|11538691|FG000|STARTED|Overall Study||93
10395118|NCT00686647|11538691|FG000|COMPLETED|Overall Study||91
10395119|NCT00686647|11538691|FG000|NOT COMPLETED|Overall Study||2
10395120|NCT00686686|11538696|FG000|STARTED|Overall Study||23
10395121|NCT00686686|11538696|FG000|COMPLETED|Overall Study||17
10395122|NCT00686686|11538696|FG000|NOT COMPLETED|Overall Study||6
10395123|NCT00686699|11538702|FG000|STARTED|Treatment Period 1||4
10395124|NCT00686699|11538703|FG001|STARTED|Treatment Period 1||7
10395125|NCT00686699|11538702|FG000|COMPLETED|Treatment Period 1||4
10395126|NCT00686699|11538703|FG001|COMPLETED|Treatment Period 1||5
10395127|NCT00686699|11538702|FG000|NOT COMPLETED|Treatment Period 1||0
10395128|NCT00686699|11538703|FG001|NOT COMPLETED|Treatment Period 1||2
10395129|NCT00686699|11538702|FG000|STARTED|Treatment Period 2||4
10395130|NCT00686699|11538703|FG001|STARTED|Treatment Period 2||5
10395131|NCT00686699|11538702|FG000|COMPLETED|Treatment Period 2||4
10395132|NCT00686699|11538703|FG001|COMPLETED|Treatment Period 2||5
10395133|NCT00686699|11538702|FG000|NOT COMPLETED|Treatment Period 2||0
10395134|NCT00686699|11538703|FG001|NOT COMPLETED|Treatment Period 2||0
10395135|NCT00686712|11538712|FG000|STARTED|Overall Study||30
10395136|NCT00686712|11538713|FG001|STARTED|Overall Study||25
10395137|NCT00686712|11538714|FG002|STARTED|Overall Study||30
10395138|NCT00686712|11538712|FG000|COMPLETED|Overall Study||20
10395139|NCT00686712|11538713|FG001|COMPLETED|Overall Study||14
10395140|NCT00686712|11538714|FG002|COMPLETED|Overall Study||17
10395141|NCT00686712|11538712|FG000|NOT COMPLETED|Overall Study||10
10309658|NCT00117988|11442558|FG000|STARTED|Overall Study||22
10309659|NCT00117988|11442558|FG000|COMPLETED|Overall Study||18
10309660|NCT00117988|11442558|FG000|NOT COMPLETED|Overall Study||4
10309661|NCT00118040|11442565|FG000|STARTED|Overall Study||20
10395142|NCT00686712|11538713|FG001|NOT COMPLETED|Overall Study||11
10395143|NCT00686712|11538714|FG002|NOT COMPLETED|Overall Study||13
10395144|NCT00686725|11538727|FG000|STARTED|Overall Study||47
10395145|NCT00686725|11538728|FG001|STARTED|Overall Study||52
10395146|NCT00686725|11538727|FG000|COMPLETED|Overall Study|Completers were defined as those who completed the established treatment.|1
10309662|NCT00118040|11442566|FG001|STARTED|Overall Study||20
10428701|NCT00859638|11574751|FG000|STARTED|Overall Study||65
10309663|NCT00118040|11442567|FG002|STARTED|Overall Study||20
10309664|NCT00118040|11442565|FG000|COMPLETED|Overall Study||19
10309665|NCT00118040|11442566|FG001|COMPLETED|Overall Study||18
10309666|NCT00118040|11442567|FG002|COMPLETED|Overall Study||14
10309667|NCT00118040|11442565|FG000|NOT COMPLETED|Overall Study||1
10309668|NCT00118040|11442566|FG001|NOT COMPLETED|Overall Study||2
10309669|NCT00118040|11442567|FG002|NOT COMPLETED|Overall Study||6
10309670|NCT00118092|11442580|FG000|STARTED|Overall Study||17
10309671|NCT00118092|11442580|FG000|COMPLETED|Overall Study||15
10309672|NCT00118092|11442580|FG000|NOT COMPLETED|Overall Study||2
10309673|NCT00118131|11442585|FG000|STARTED|Overall Study||49
10309674|NCT00118131|11442585|FG000|COMPLETED|Overall Study||49
10309675|NCT00118131|11442585|FG000|NOT COMPLETED|Overall Study||0
10309676|NCT00118144|11442589|FG000|STARTED|Overall Study||42
10309677|NCT00118144|11442589|FG000|COMPLETED|Overall Study||41
10309678|NCT00118144|11442589|FG000|NOT COMPLETED|Overall Study||1
10309679|NCT00118157|11442594|FG000|STARTED|Overall Study||19
10309680|NCT00118157|11442594|FG000|COMPLETED|Overall Study||7
10309681|NCT00118157|11442594|FG000|NOT COMPLETED|Overall Study||12
10309682|NCT00118209|11442601|FG000|STARTED|Overall Study||262
10309683|NCT00118209|11442602|FG001|STARTED|Overall Study||262
10309684|NCT00118209|11442601|FG000|Evaluable for Primary Endpoint|Overall Study||250
10309685|NCT00118209|11442602|FG001|Evaluable for Primary Endpoint|Overall Study||241
10309686|NCT00118209|11442601|FG000|Evaluable for Safety Analysis|Overall Study||243
10309687|NCT00118209|11442602|FG001|Evaluable for Safety Analysis|Overall Study||237
10309688|NCT00118209|11442601|FG000|COMPLETED|Overall Study||250
10309689|NCT00118209|11442602|FG001|COMPLETED|Overall Study||241
10309690|NCT00118209|11442601|FG000|NOT COMPLETED|Overall Study||12
10309691|NCT00118209|11442602|FG001|NOT COMPLETED|Overall Study||21
10309692|NCT00118248|11442610|FG000|STARTED|Overall Study||17
10309693|NCT00118248|11442611|FG001|STARTED|Overall Study||24
10309694|NCT00118248|11442610|FG000|COMPLETED|Overall Study||17
10395147|NCT00686725|11538728|FG001|COMPLETED|Overall Study|Completers were defined as those who completed the established treatment.|10
10395148|NCT00686725|11538727|FG000|NOT COMPLETED|Overall Study||46
10395149|NCT00686725|11538728|FG001|NOT COMPLETED|Overall Study||42
10395150|NCT00686777|11538734|FG000|STARTED|Overall Study||75
10395151|NCT00686777|11538734|FG000|Completed 24 Weeks of Treatment|Overall Study||69
10395152|NCT00686777|11538734|FG000|Completed 48 Weeks of Treatment|Overall Study||65
10395153|NCT00686777|11538734|FG000|Included in Follow-up (All Treated)|Overall Study||75
10395154|NCT00686777|11538734|FG000|Completed 24 Weeks of Follow-up|Overall Study||70
10395155|NCT00686777|11538734|FG000|COMPLETED|Overall Study|Of 10 noncompleters, 6 had AEs including 4 meeting protocol prespecified AE discontinuance criteria.|65
10395156|NCT00686777|11538734|FG000|NOT COMPLETED|Overall Study||10
10395157|NCT00686790|11538738|FG000|STARTED|Overall Study||48
10395158|NCT00686790|11538738|FG000|COMPLETED|Overall Study||32
10395159|NCT00686790|11538738|FG000|NOT COMPLETED|Overall Study||16
10395160|NCT00686803|11538745|FG000|STARTED|Overall Study||6
10395161|NCT00686803|11538746|FG001|STARTED|Overall Study||12
10395162|NCT00686803|11538747|FG002|STARTED|Overall Study||3
10395163|NCT00686803|11538745|FG000|COMPLETED|Overall Study||6
10395164|NCT00686803|11538746|FG001|COMPLETED|Overall Study||12
10395165|NCT00686803|11538747|FG002|COMPLETED|Overall Study||3
10395166|NCT00686803|11538745|FG000|NOT COMPLETED|Overall Study||0
10395167|NCT00686803|11538746|FG001|NOT COMPLETED|Overall Study||0
10395168|NCT00686803|11538747|FG002|NOT COMPLETED|Overall Study||0
10395169|NCT00686829|11538755|FG000|STARTED|Overall Study||79
10395170|NCT00686829|11538755|FG000|COMPLETED|Overall Study||0
10395171|NCT00686829|11538755|FG000|NOT COMPLETED|Overall Study||79
10395172|NCT00686842|11538759|FG000|STARTED|Overall Study||17
10395173|NCT00686842|11538759|FG000|COMPLETED|Overall Study||17
10395174|NCT00686842|11538759|FG000|NOT COMPLETED|Overall Study||0
10395175|NCT00686855|11538765|FG000|STARTED|Overall Study||28
10395176|NCT00686855|11538766|FG001|STARTED|Overall Study||18
10395177|NCT00686855|11538765|FG000|COMPLETED|Overall Study||27
10395178|NCT00686855|11538766|FG001|COMPLETED|Overall Study||17
10395179|NCT00686855|11538765|FG000|NOT COMPLETED|Overall Study||1
10395180|NCT00686855|11538766|FG001|NOT COMPLETED|Overall Study||1
10395181|NCT00686881|11538774|FG000|STARTED|Overall Study|After randomization, 2 participants withdrew consent and did not receive study drug.|127
10395182|NCT00686881|11538775|FG001|STARTED|Overall Study|After randomization, 6 participants withdrew consent and did not receive study drug.|134
10395183|NCT00686881|11538774|FG000|COMPLETED|Overall Study||45
10395184|NCT00686881|11538775|FG001|COMPLETED|Overall Study||53
10395185|NCT00686881|11538774|FG000|NOT COMPLETED|Overall Study||82
10395186|NCT00686881|11538775|FG001|NOT COMPLETED|Overall Study||81
10395187|NCT00686894|11538783|FG000|STARTED|Overall Study||7
10395188|NCT00686894|11538783|FG000|COMPLETED|Overall Study||1
10543297|NCT01483599|11696523|FG005|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||4
10395189|NCT00686894|11538783|FG000|NOT COMPLETED|Overall Study||6
10543298|NCT01483599|11696524|FG006|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||4
10309695|NCT00118248|11442611|FG001|COMPLETED|Overall Study||24
10309696|NCT00118248|11442610|FG000|NOT COMPLETED|Overall Study||0
10309697|NCT00118248|11442611|FG001|NOT COMPLETED|Overall Study||0
10309698|NCT00118274|11442620|FG000|STARTED|Overall Study||41
10309699|NCT00118274|11442621|FG001|STARTED|Overall Study||43
10309700|NCT00118274|11442622|FG002|STARTED|Overall Study||42
10309701|NCT00118274|11442623|FG003|STARTED|Overall Study||44
10309702|NCT00118274|11442620|FG000|COMPLETED|Overall Study||21
10309703|NCT00118274|11442621|FG001|COMPLETED|Overall Study||21
10309704|NCT00118274|11442622|FG002|COMPLETED|Overall Study||25
10309705|NCT00118274|11442623|FG003|COMPLETED|Overall Study||29
10309706|NCT00118274|11442620|FG000|NOT COMPLETED|Overall Study||20
10309707|NCT00118274|11442621|FG001|NOT COMPLETED|Overall Study||22
10309708|NCT00118274|11442622|FG002|NOT COMPLETED|Overall Study||17
10309709|NCT00118274|11442623|FG003|NOT COMPLETED|Overall Study||15
10309710|NCT00118287|11442633|FG000|STARTED|Overall Study||32
10309711|NCT00118287|11442633|FG000|COMPLETED|Overall Study||30
10309712|NCT00118287|11442633|FG000|NOT COMPLETED|Overall Study||2
10309713|NCT00118352|11442640|FG000|STARTED|Overall Study||12
10309714|NCT00118352|11442641|FG001|STARTED|Overall Study||0
10309715|NCT00118352|11442642|FG002|STARTED|Overall Study||0
10309716|NCT00118352|11442640|FG000|COMPLETED|Overall Study||12
10309717|NCT00118352|11442641|FG001|COMPLETED|Overall Study||0
10309718|NCT00118352|11442642|FG002|COMPLETED|Overall Study||0
10309719|NCT00118352|11442640|FG000|NOT COMPLETED|Overall Study||0
10309720|NCT00118352|11442641|FG001|NOT COMPLETED|Overall Study||0
10309721|NCT00118352|11442642|FG002|NOT COMPLETED|Overall Study||0
10309722|NCT00118365|11442652|FG000|STARTED|Overall Study||191
10309723|NCT00118365|11442653|FG001|STARTED|Overall Study||184
10309724|NCT00118365|11442652|FG000|COMPLETED|Overall Study||132
10309725|NCT00118365|11442653|FG001|COMPLETED|Overall Study||124
10309726|NCT00118365|11442652|FG000|NOT COMPLETED|Overall Study||59
10309727|NCT00118365|11442653|FG001|NOT COMPLETED|Overall Study||60
10309728|NCT00118378|11442691|FG000|STARTED|Overall Study||62
10309729|NCT00118378|11442692|FG001|STARTED|Overall Study||53
10719920|NCT02712983|11883591|FG006|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|2
10719921|NCT02712983|11883592|FG007|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|3
10719922|NCT02712983|11883593|FG008|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|0
10719923|NCT02712983|11883585|FG000|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
10719924|NCT02712983|11883586|FG001|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
10719925|NCT02712983|11883587|FG002|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
10719926|NCT02712983|11883588|FG003|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
10719927|NCT02712983|11883589|FG004|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
10395190|NCT00686920|11538789|FG000|STARTED|Overall Study||252
10395191|NCT00686920|11538790|FG001|STARTED|Overall Study||70
10395192|NCT00686920|11538789|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||252
10395193|NCT00686920|11538790|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||70
10719928|NCT02712983|11883590|FG005|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
10719929|NCT02712983|11883591|FG006|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
10719930|NCT02712983|11883592|FG007|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
10719931|NCT02712983|11883593|FG008|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
10395194|NCT00686920|11538789|FG000|COMPLETED|Overall Study||120
10395195|NCT00686920|11538790|FG001|COMPLETED|Overall Study||34
10395196|NCT00686920|11538789|FG000|NOT COMPLETED|Overall Study||132
10395197|NCT00686920|11538790|FG001|NOT COMPLETED|Overall Study||36
10395198|NCT00686959|11538798|FG000|STARTED|Overall Study||301
10395199|NCT00686959|11538799|FG001|STARTED|Overall Study||297
10395200|NCT00686959|11538798|FG000|Received at Least One Dose of Study Drug|Overall Study||283
10395201|NCT00686959|11538799|FG001|Received at Least One Dose of Study Drug|Overall Study||272
10395202|NCT00686959|11538798|FG000|Entered Consolidation Phase|Overall Study||229
10395203|NCT00686959|11538799|FG001|Entered Consolidation Phase|Overall Study||202
10395204|NCT00686959|11538798|FG000|COMPLETED|Overall Study|Study completion includes death due to any cause|177
10395205|NCT00686959|11538799|FG001|COMPLETED|Overall Study|Study completion includes death due to any cause.|180
10395206|NCT00686959|11538798|FG000|NOT COMPLETED|Overall Study||124
10309730|NCT00118378|11442691|FG000|COMPLETED|Overall Study||60
10309731|NCT00118378|11442692|FG001|COMPLETED|Overall Study||45
10309732|NCT00118378|11442691|FG000|NOT COMPLETED|Overall Study||2
10309733|NCT00118378|11442692|FG001|NOT COMPLETED|Overall Study||8
10309734|NCT00118404|11442703|FG000|STARTED|Overall Study||86
10309735|NCT00118404|11442704|FG001|STARTED|Overall Study||86
10309736|NCT00118404|11442705|FG002|STARTED|Overall Study||69
10309737|NCT00118404|11442703|FG000|COMPLETED|Overall Study||62
10309738|NCT00118404|11442704|FG001|COMPLETED|Overall Study||70
10309739|NCT00118404|11442705|FG002|COMPLETED|Overall Study||49
10309740|NCT00118404|11442703|FG000|NOT COMPLETED|Overall Study||24
10309741|NCT00118404|11442704|FG001|NOT COMPLETED|Overall Study||16
10309742|NCT00118404|11442705|FG002|NOT COMPLETED|Overall Study||20
10309743|NCT00118417|11442713|FG000|STARTED|Phase I (Weeks 0 to 6)||39
10309744|NCT00118417|11442714|FG001|STARTED|Phase I (Weeks 0 to 6)|In Phase 1, all participants received open label SSRI - no second treatment arm.|0
10309745|NCT00118417|11442713|FG000|COMPLETED|Phase I (Weeks 0 to 6)||21
10309746|NCT00118417|11442714|FG001|COMPLETED|Phase I (Weeks 0 to 6)||0
10309747|NCT00118417|11442713|FG000|NOT COMPLETED|Phase I (Weeks 0 to 6)||18
10309748|NCT00118417|11442714|FG001|NOT COMPLETED|Phase I (Weeks 0 to 6)||0
10309749|NCT00118417|11442713|FG000|STARTED|Phase II (Weeks 6 to 12)|Three new participants on Phase 1 endpoint doses of SSRIs entered at Phase 2.|11
10309750|NCT00118417|11442714|FG001|STARTED|Phase II (Weeks 6 to 12)||13
10309751|NCT00118417|11442713|FG000|COMPLETED|Phase II (Weeks 6 to 12)||9
10309752|NCT00118417|11442714|FG001|COMPLETED|Phase II (Weeks 6 to 12)||10
10309753|NCT00118417|11442713|FG000|NOT COMPLETED|Phase II (Weeks 6 to 12)||2
10309754|NCT00118417|11442714|FG001|NOT COMPLETED|Phase II (Weeks 6 to 12)||3
10309755|NCT00118417|11442713|FG000|STARTED|Phase III (Weeks 12 to 24)||9
10309756|NCT00118417|11442714|FG001|STARTED|Phase III (Weeks 12 to 24)||10
10309757|NCT00118417|11442713|FG000|COMPLETED|Phase III (Weeks 12 to 24)||8
10395207|NCT00686959|11538799|FG001|NOT COMPLETED|Overall Study||117
10395208|NCT00686998|11538808|FG000|STARTED|Overall Study|Randomized & received study medication|43
10395209|NCT00686998|11538809|FG001|STARTED|Overall Study|Randomized & received study medication|41
10395210|NCT00686998|11538810|FG002|STARTED|Overall Study|Randomized & received study medication|22
10395211|NCT00686998|11538808|FG000|Randomized|Overall Study||43
10395212|NCT00686998|11538809|FG001|Randomized|Overall Study||41
10395213|NCT00686998|11538810|FG002|Randomized|Overall Study||22
10395214|NCT00686998|11538808|FG000|Received Treatment|Overall Study||43
10395215|NCT00686998|11538809|FG001|Received Treatment|Overall Study||41
10395216|NCT00686998|11538810|FG002|Received Treatment|Overall Study||22
10395217|NCT00686998|11538808|FG000|Eligible for Efficacy Analysis|Overall Study||42
10395218|NCT00686998|11538809|FG001|Eligible for Efficacy Analysis|Overall Study||39
10395219|NCT00686998|11538810|FG002|Eligible for Efficacy Analysis|Overall Study||21
10395220|NCT00686998|11538808|FG000|Completed Scheduled Treatment|Overall Study||30
10395221|NCT00686998|11538809|FG001|Completed Scheduled Treatment|Overall Study||33
10395222|NCT00686998|11538810|FG002|Completed Scheduled Treatment|Overall Study||18
10395223|NCT00686998|11538808|FG000|COMPLETED|Overall Study||30
10395224|NCT00686998|11538809|FG001|COMPLETED|Overall Study||33
10395225|NCT00686998|11538810|FG002|COMPLETED|Overall Study||18
10395226|NCT00686998|11538808|FG000|NOT COMPLETED|Overall Study||13
10395227|NCT00686998|11538809|FG001|NOT COMPLETED|Overall Study||8
10395228|NCT00686998|11538810|FG002|NOT COMPLETED|Overall Study||4
10395229|NCT00687076|11538820|FG000|STARTED|Overall Study||51
10395230|NCT00687076|11538821|FG001|STARTED|Overall Study||51
10395231|NCT00687076|11538820|FG000|COMPLETED|Overall Study||19
10395232|NCT00687076|11538821|FG001|COMPLETED|Overall Study||21
10395233|NCT00687076|11538820|FG000|NOT COMPLETED|Overall Study||32
10395234|NCT00687076|11538821|FG001|NOT COMPLETED|Overall Study||30
10395235|NCT00687102|11538829|FG000|STARTED|Overall Study||733
10813283|NCT02923830|11975629|FG000|STARTED|Overall Study||13
10813284|NCT02923830|11975630|FG001|STARTED|Overall Study||15
10813285|NCT02923830|11975629|FG000|COMPLETED|Overall Study|Study terminated|0
10813286|NCT02923830|11975630|FG001|COMPLETED|Overall Study|Study terminated|0
10813287|NCT02923830|11975629|FG000|NOT COMPLETED|Overall Study||13
10813288|NCT02923830|11975630|FG001|NOT COMPLETED|Overall Study||15
10813289|NCT02920450|11975636|FG000|STARTED|Overall Study||3
10813290|NCT02920450|11975637|FG001|STARTED|Overall Study||0
10813291|NCT02920450|11975638|FG002|STARTED|Overall Study||0
10813292|NCT02920450|11975639|FG003|STARTED|Overall Study||0
10813293|NCT02920450|11975636|FG000|COMPLETED|Overall Study||1
10813294|NCT02920450|11975637|FG001|COMPLETED|Overall Study||0
10813295|NCT02920450|11975638|FG002|COMPLETED|Overall Study||0
10813296|NCT02920450|11975639|FG003|COMPLETED|Overall Study||0
10813297|NCT02920450|11975636|FG000|NOT COMPLETED|Overall Study||2
10813298|NCT02920450|11975637|FG001|NOT COMPLETED|Overall Study||0
10813299|NCT02920450|11975638|FG002|NOT COMPLETED|Overall Study||0
10719932|NCT02712983|11883585|FG000|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
10719933|NCT02712983|11883586|FG001|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||1
10719934|NCT02712983|11883587|FG002|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
10719935|NCT02712983|11883588|FG003|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||1
10719936|NCT02712983|11883589|FG004|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||2
10719937|NCT02712983|11883590|FG005|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||1
10719938|NCT02712983|11883591|FG006|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||2
10719939|NCT02712983|11883592|FG007|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||3
10719940|NCT02712983|11883593|FG008|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
10719941|NCT02712996|11883615|FG000|STARTED|First Intervention (Study Days 1-42)||8
10719942|NCT02712996|11883616|FG001|STARTED|First Intervention (Study Days 1-42)||9
10719943|NCT02712996|11883615|FG000|COMPLETED|First Intervention (Study Days 1-42)||8
10719944|NCT02712996|11883616|FG001|COMPLETED|First Intervention (Study Days 1-42)||9
10719945|NCT02712996|11883615|FG000|NOT COMPLETED|First Intervention (Study Days 1-42)||0
10719946|NCT02712996|11883616|FG001|NOT COMPLETED|First Intervention (Study Days 1-42)||0
10719947|NCT02712996|11883615|FG000|STARTED|Second Intervention (Study Days 43-84)||8
10719948|NCT02712996|11883616|FG001|STARTED|Second Intervention (Study Days 43-84)||9
10543299|NCT01483599|11696525|FG007|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
10543300|NCT01483599|11696526|FG008|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
10543301|NCT01483599|11696527|FG009|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
10543302|NCT01483599|11696528|FG010|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
10543303|NCT01483599|11696529|FG011|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
10543304|NCT01483599|11696530|FG012|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
10719949|NCT02712996|11883615|FG000|COMPLETED|Second Intervention (Study Days 43-84)||8
10309758|NCT00118417|11442714|FG001|COMPLETED|Phase III (Weeks 12 to 24)||9
10309759|NCT00118417|11442713|FG000|NOT COMPLETED|Phase III (Weeks 12 to 24)||1
10309760|NCT00118417|11442714|FG001|NOT COMPLETED|Phase III (Weeks 12 to 24)||1
10309761|NCT00118430|11442727|FG000|STARTED|Overall Study||123
10309762|NCT00118430|11442728|FG001|STARTED|Overall Study||127
10309763|NCT00118430|11442729|FG002|STARTED|Overall Study||250
10309764|NCT00118430|11442727|FG000|COMPLETED|Overall Study|123 included in primary analysis due to repeated measures and interim 1,3 and 6 month assessments|102
10309765|NCT00118430|11442728|FG001|COMPLETED|Overall Study|127 included in primary analysis due to repeated measures and interim 1,3 and 6 month assessments|103
10309766|NCT00118430|11442729|FG002|COMPLETED|Overall Study||222
10309767|NCT00118430|11442727|FG000|NOT COMPLETED|Overall Study||21
10309768|NCT00118430|11442728|FG001|NOT COMPLETED|Overall Study||24
10395236|NCT00687102|11538830|FG001|STARTED|Overall Study||765
10395237|NCT00687102|11538829|FG000|COMPLETED|Overall Study||733
10395238|NCT00687102|11538830|FG001|COMPLETED|Overall Study||765
10395239|NCT00687102|11538829|FG000|NOT COMPLETED|Overall Study||0
10395240|NCT00687102|11538830|FG001|NOT COMPLETED|Overall Study||0
10395241|NCT00687167|11538836|FG000|STARTED|First Intervention||17
10395242|NCT00687167|11538837|FG001|STARTED|First Intervention||17
10395243|NCT00687167|11538836|FG000|COMPLETED|First Intervention||17
10719950|NCT02712996|11883616|FG001|COMPLETED|Second Intervention (Study Days 43-84)||8
10719951|NCT02712996|11883615|FG000|NOT COMPLETED|Second Intervention (Study Days 43-84)||0
10719952|NCT02712996|11883616|FG001|NOT COMPLETED|Second Intervention (Study Days 43-84)||1
10719953|NCT02713178|11883627|FG000|STARTED|Overall Study||76
10719954|NCT02713178|11883628|FG001|STARTED|Overall Study||77
10719955|NCT02713178|11883629|FG002|STARTED|Overall Study||79
10719956|NCT02713178|11883627|FG000|COMPLETED|Overall Study||75
10719957|NCT02713178|11883628|FG001|COMPLETED|Overall Study||73
10719958|NCT02713178|11883629|FG002|COMPLETED|Overall Study||74
10719959|NCT02713178|11883627|FG000|NOT COMPLETED|Overall Study||1
10719960|NCT02713178|11883628|FG001|NOT COMPLETED|Overall Study||4
10813300|NCT02920450|11975639|FG003|NOT COMPLETED|Overall Study||0
10813301|NCT02920177|11975648|FG000|STARTED|Overall Study||2
10813302|NCT02920177|11975649|FG001|STARTED|Overall Study||2
10813303|NCT02920177|11975648|FG000|COMPLETED|Overall Study||0
10813304|NCT02920177|11975649|FG001|COMPLETED|Overall Study||0
10813305|NCT02920177|11975648|FG000|NOT COMPLETED|Overall Study||2
10813306|NCT02920177|11975649|FG001|NOT COMPLETED|Overall Study||2
10813307|NCT02926638|11975657|FG000|STARTED|Overall Study||4
10813308|NCT02926638|11975658|FG001|STARTED|Overall Study||5
10813309|NCT02926638|11975657|FG000|Eligible|Overall Study||3
10813310|NCT02926638|11975658|FG001|Eligible|Overall Study||5
10813311|NCT02926638|11975657|FG000|COMPLETED|Overall Study||0
10813312|NCT02926638|11975658|FG001|COMPLETED|Overall Study||0
10309769|NCT00118430|11442729|FG002|NOT COMPLETED|Overall Study||28
10813313|NCT02926638|11975657|FG000|NOT COMPLETED|Overall Study||4
10309770|NCT00118482|11442738|FG000|STARTED|Overall Study|3 patients signed the consent but did not take the study medication.|105
10309771|NCT00118482|11442739|FG001|STARTED|Overall Study||105
10309772|NCT00118482|11442738|FG000|COMPLETED|Overall Study|210 in the Intention To Treat analysis|75
10309773|NCT00118482|11442739|FG001|COMPLETED|Overall Study||76
10309774|NCT00118482|11442738|FG000|NOT COMPLETED|Overall Study||30
10309775|NCT00118482|11442739|FG001|NOT COMPLETED|Overall Study||29
10309776|NCT00118534|11442747|FG000|STARTED|Overall Study||472
10395244|NCT00687167|11538837|FG001|COMPLETED|First Intervention||17
10395245|NCT00687167|11538836|FG000|NOT COMPLETED|First Intervention||0
10813314|NCT02926638|11975658|FG001|NOT COMPLETED|Overall Study||5
10813315|NCT02920242|11975667|FG000|STARTED|Overall Study||13
10813316|NCT02920242|11975668|FG001|STARTED|Overall Study||11
10813317|NCT02920242|11975669|FG002|STARTED|Overall Study||4
10813318|NCT02920242|11975667|FG000|Safety Set|Overall Study||12
10813319|NCT02920242|11975668|FG001|Safety Set|Overall Study||11
10813320|NCT02920242|11975669|FG002|Safety Set|Overall Study||4
10813321|NCT02920242|11975667|FG000|COMPLETED|Overall Study||11
10309777|NCT00118534|11442748|FG001|STARTED|Overall Study||471
10309778|NCT00118534|11442747|FG000|COMPLETED|Overall Study||472
10309779|NCT00118534|11442748|FG001|COMPLETED|Overall Study||471
10309780|NCT00118534|11442747|FG000|NOT COMPLETED|Overall Study||0
10309781|NCT00118534|11442748|FG001|NOT COMPLETED|Overall Study||0
10309782|NCT00118703|11442757|FG000|STARTED|Overall Study||173
10309783|NCT00118703|11442758|FG001|STARTED|Overall Study||174
10309784|NCT00118703|11442757|FG000|COMPLETED|Overall Study||168
10309785|NCT00118703|11442758|FG001|COMPLETED|Overall Study||165
10395246|NCT00687167|11538837|FG001|NOT COMPLETED|First Intervention||0
10395247|NCT00687167|11538836|FG000|STARTED|Washout Period of 28 Days||17
10395248|NCT00687167|11538837|FG001|STARTED|Washout Period of 28 Days||17
10395249|NCT00687167|11538836|FG000|COMPLETED|Washout Period of 28 Days||17
10395250|NCT00687167|11538837|FG001|COMPLETED|Washout Period of 28 Days||17
10395251|NCT00687167|11538836|FG000|NOT COMPLETED|Washout Period of 28 Days||0
10395252|NCT00687167|11538837|FG001|NOT COMPLETED|Washout Period of 28 Days||0
10395253|NCT00687167|11538836|FG000|STARTED|Second Intervention||17
10395254|NCT00687167|11538837|FG001|STARTED|Second Intervention||17
10395255|NCT00687167|11538836|FG000|COMPLETED|Second Intervention||17
10813322|NCT02920242|11975668|FG001|COMPLETED|Overall Study||11
10309786|NCT00118703|11442757|FG000|NOT COMPLETED|Overall Study||5
10309787|NCT00118703|11442758|FG001|NOT COMPLETED|Overall Study||9
10309788|NCT00118716|11442766|FG000|STARTED|Overall Study||124
10309789|NCT00118716|11442767|FG001|STARTED|Overall Study||124
10309790|NCT00118716|11442766|FG000|COMPLETED|Overall Study||111
10309791|NCT00118716|11442767|FG001|COMPLETED|Overall Study||102
10309792|NCT00118716|11442766|FG000|NOT COMPLETED|Overall Study||13
10309793|NCT00118716|11442767|FG001|NOT COMPLETED|Overall Study||22
10309794|NCT00118742|11442775|FG000|STARTED|Overall Study||145
10309795|NCT00118742|11442776|FG001|STARTED|Overall Study||148
10309796|NCT00118742|11442775|FG000|COMPLETED|Overall Study||96
10309797|NCT00118742|11442776|FG001|COMPLETED|Overall Study||82
10309798|NCT00118742|11442775|FG000|NOT COMPLETED|Overall Study||49
10309799|NCT00118742|11442776|FG001|NOT COMPLETED|Overall Study||66
10309800|NCT00118755|11442784|FG000|STARTED|Overall Study||217
10309801|NCT00118755|11442785|FG001|STARTED|Overall Study||218
10309802|NCT00118755|11442784|FG000|Safety Population|Overall Study||208
10395256|NCT00687167|11538837|FG001|COMPLETED|Second Intervention||17
10395257|NCT00687167|11538836|FG000|NOT COMPLETED|Second Intervention||0
10395258|NCT00687167|11538837|FG001|NOT COMPLETED|Second Intervention||0
10395259|NCT00687193|11538849|FG000|STARTED|Overall Study||53
10395260|NCT00687193|11538850|FG001|STARTED|Overall Study||53
10395261|NCT00687193|11538851|FG002|STARTED|Overall Study||52
10395262|NCT00687193|11538852|FG003|STARTED|Overall Study||53
10395263|NCT00687193|11538853|FG004|STARTED|Overall Study||54
10395264|NCT00687193|11538854|FG005|STARTED|Overall Study|One participant withdrew after randomization but prior to treatment.|52
10395265|NCT00687193|11538849|FG000|COMPLETED|Overall Study||51
10395266|NCT00687193|11538850|FG001|COMPLETED|Overall Study||49
10395267|NCT00687193|11538851|FG002|COMPLETED|Overall Study||50
10395268|NCT00687193|11538852|FG003|COMPLETED|Overall Study||49
10395269|NCT00687193|11538853|FG004|COMPLETED|Overall Study||52
10395270|NCT00687193|11538854|FG005|COMPLETED|Overall Study||48
10395271|NCT00687193|11538849|FG000|NOT COMPLETED|Overall Study||2
10395272|NCT00687193|11538850|FG001|NOT COMPLETED|Overall Study||4
10395273|NCT00687193|11538851|FG002|NOT COMPLETED|Overall Study||2
10395274|NCT00687193|11538852|FG003|NOT COMPLETED|Overall Study||4
10395275|NCT00687193|11538853|FG004|NOT COMPLETED|Overall Study||2
10395276|NCT00687193|11538854|FG005|NOT COMPLETED|Overall Study||4
10395277|NCT00687219|11538871|FG000|STARTED|Overall Study||102
10395278|NCT00687219|11538871|FG000|COMPLETED|Overall Study||51
10395279|NCT00687219|11538871|FG000|NOT COMPLETED|Overall Study||51
10395280|NCT00687271|11538879|FG000|STARTED|Overall Study||94
10395281|NCT00687271|11538880|FG001|STARTED|Overall Study||96
10395282|NCT00687271|11538881|FG002|STARTED|Overall Study||96
10395283|NCT00687271|11538882|FG003|STARTED|Overall Study||48
10395284|NCT00687271|11538879|FG000|Treated|Overall Study||94
10395285|NCT00687271|11538880|FG001|Treated|Overall Study||95
10395286|NCT00687271|11538881|FG002|Treated|Overall Study||96
10395287|NCT00687271|11538882|FG003|Treated|Overall Study||48
10395288|NCT00687271|11538879|FG000|COMPLETED|Overall Study||91
10395289|NCT00687271|11538880|FG001|COMPLETED|Overall Study||90
10395290|NCT00687271|11538881|FG002|COMPLETED|Overall Study||91
10395291|NCT00687271|11538882|FG003|COMPLETED|Overall Study||48
10395292|NCT00687271|11538879|FG000|NOT COMPLETED|Overall Study||3
10395293|NCT00687271|11538880|FG001|NOT COMPLETED|Overall Study||6
10395294|NCT00687271|11538881|FG002|NOT COMPLETED|Overall Study||5
10395295|NCT00687271|11538882|FG003|NOT COMPLETED|Overall Study||0
10428702|NCT00859638|11574752|FG001|STARTED|Overall Study||59
10428703|NCT00859638|11574751|FG000|COMPLETED|Overall Study||55
10719961|NCT02713178|11883629|FG002|NOT COMPLETED|Overall Study||5
10719962|NCT02713204|11883640|FG000|STARTED|Baseline (Day 1) up to Week 12||60
10719963|NCT02713204|11883641|FG001|STARTED|Baseline (Day 1) up to Week 12||122
10719964|NCT02713204|11883642|FG002|STARTED|Baseline (Day 1) up to Week 12||183
10719965|NCT02713204|11883643|FG003|STARTED|Baseline (Day 1) up to Week 12||0
10719966|NCT02713204|11883644|FG004|STARTED|Baseline (Day 1) up to Week 12||0
10428704|NCT00859638|11574752|FG001|COMPLETED|Overall Study||55
10428705|NCT00859638|11574751|FG000|NOT COMPLETED|Overall Study||10
10428706|NCT00859638|11574752|FG001|NOT COMPLETED|Overall Study||4
10428707|NCT00859651|11574760|FG000|STARTED|Overall Study||18
10719967|NCT02713204|11883645|FG005|STARTED|Baseline (Day 1) up to Week 12||0
10719968|NCT02713204|11883646|FG006|STARTED|Baseline (Day 1) up to Week 12||0
10428708|NCT00859651|11574761|FG001|STARTED|Overall Study||22
10428709|NCT00859651|11574760|FG000|COMPLETED|Overall Study||18
10428710|NCT00859651|11574761|FG001|COMPLETED|Overall Study||22
10428711|NCT00859651|11574760|FG000|NOT COMPLETED|Overall Study||0
10428712|NCT00859651|11574761|FG001|NOT COMPLETED|Overall Study||0
10428713|NCT00859833|11574767|FG000|STARTED|Overall Study||30
10428714|NCT00859833|11574767|FG000|COMPLETED|Overall Study||30
10428715|NCT00859833|11574767|FG000|NOT COMPLETED|Overall Study||0
10429864|NCT00866879|11576007|FG000|NOT COMPLETED|Overall Study||0
10429865|NCT00866879|11576008|FG001|NOT COMPLETED|Overall Study||0
10429866|NCT00866905|11576014|FG000|STARTED|Overall Study||168
10429867|NCT00866905|11576014|FG000|COMPLETED|Overall Study||135
10429868|NCT00866905|11576014|FG000|NOT COMPLETED|Overall Study||33
10429912|NCT00867100|11576058|FG008|STARTED|Overall Study||6
10719969|NCT02713204|11883647|FG007|STARTED|Baseline (Day 1) up to Week 12||0
10395296|NCT00687297|11538894|FG000|STARTED|Randomization||80
10395297|NCT00687297|11538895|FG001|STARTED|Randomization||82
10395298|NCT00687297|11538894|FG000|COMPLETED|Randomization||77
10395299|NCT00687297|11538895|FG001|COMPLETED|Randomization||81
10395300|NCT00687297|11538894|FG000|NOT COMPLETED|Randomization||3
10395301|NCT00687297|11538895|FG001|NOT COMPLETED|Randomization||1
10395302|NCT00687297|11538894|FG000|STARTED|Induction||77
10395303|NCT00687297|11538895|FG001|STARTED|Induction||81
10395304|NCT00687297|11538894|FG000|COMPLETED|Induction||32
10395305|NCT00687297|11538895|FG001|COMPLETED|Induction||26
10395306|NCT00687297|11538894|FG000|NOT COMPLETED|Induction||45
10395307|NCT00687297|11538895|FG001|NOT COMPLETED|Induction||55
10395308|NCT00687297|11538894|FG000|STARTED|Maintenance||32
10395309|NCT00687297|11538895|FG001|STARTED|Maintenance||26
10395310|NCT00687297|11538894|FG000|COMPLETED|Maintenance||29
10395311|NCT00687297|11538895|FG001|COMPLETED|Maintenance||25
10395312|NCT00687297|11538894|FG000|NOT COMPLETED|Maintenance||3
10395313|NCT00687297|11538895|FG001|NOT COMPLETED|Maintenance||1
10395314|NCT00687323|11538903|FG000|STARTED|Overall Study|Number of screened participants|195
10395315|NCT00687323|11538903|FG000|Received Treatment|Overall Study||47
10395316|NCT00687323|11538903|FG000|COMPLETED|Overall Study|Number of participants alive at one year|15
10395317|NCT00687323|11538903|FG000|NOT COMPLETED|Overall Study||180
10395318|NCT00687362|11538907|FG000|STARTED|Overall Study||22
10395319|NCT00687362|11538907|FG000|COMPLETED|Overall Study|Completed protocol at Week 24|19
10395320|NCT00687362|11538907|FG000|NOT COMPLETED|Overall Study||3
10395321|NCT00687401|11538911|FG000|STARTED|Overall Study|215 participants enrolled in the study, of which 56 failed screening and did not receive study drug.|159
10395322|NCT00687401|11538911|FG000|COMPLETED|Overall Study||129
10395323|NCT00687401|11538911|FG000|NOT COMPLETED|Overall Study||30
10395324|NCT00687440|11538916|FG000|STARTED|Overall Study|Number of screened participants|27
10395325|NCT00687440|11538916|FG000|COMPLETED|Overall Study||15
10395326|NCT00687440|11538916|FG000|NOT COMPLETED|Overall Study||12
10395327|NCT00687453|11538922|FG000|STARTED|Overall Study||11
10395328|NCT00687453|11538923|FG001|STARTED|Overall Study||13
10395329|NCT00687453|11538922|FG000|COMPLETED|Overall Study||8
10395330|NCT00687453|11538923|FG001|COMPLETED|Overall Study||7
10395331|NCT00687453|11538922|FG000|NOT COMPLETED|Overall Study||3
10395332|NCT00687453|11538923|FG001|NOT COMPLETED|Overall Study||6
10395333|NCT00687544|11538929|FG000|STARTED|Overall Study||11
10395334|NCT00687544|11538929|FG000|COMPLETED|Overall Study||0
10395335|NCT00687544|11538929|FG000|NOT COMPLETED|Overall Study||11
10395336|NCT00687609|11538933|FG000|STARTED|Overall Study||7
10395337|NCT00687609|11538933|FG000|COMPLETED|Overall Study||4
10395338|NCT00687609|11538933|FG000|NOT COMPLETED|Overall Study||3
10395339|NCT00687674|11538937|FG000|STARTED|Overall Study||13
10395340|NCT00687674|11538937|FG000|COMPLETED|Overall Study||11
10395341|NCT00687674|11538937|FG000|NOT COMPLETED|Overall Study||2
10395342|NCT00687713|11538943|FG000|STARTED|Overall Study||100
10395343|NCT00687713|11538944|FG001|STARTED|Overall Study||104
10395344|NCT00687713|11538943|FG000|COMPLETED|Overall Study||68
10719970|NCT02713204|11883640|FG000|COMPLETED|Baseline (Day 1) up to Week 12||59
10719971|NCT02713204|11883641|FG001|COMPLETED|Baseline (Day 1) up to Week 12||121
10719972|NCT02713204|11883642|FG002|COMPLETED|Baseline (Day 1) up to Week 12||181
10719973|NCT02713204|11883643|FG003|COMPLETED|Baseline (Day 1) up to Week 12||0
10813323|NCT02920242|11975669|FG002|COMPLETED|Overall Study||3
10813324|NCT02920242|11975667|FG000|NOT COMPLETED|Overall Study||2
10395345|NCT00687713|11538944|FG001|COMPLETED|Overall Study||64
10719974|NCT02713204|11883644|FG004|COMPLETED|Baseline (Day 1) up to Week 12||0
10719975|NCT02713204|11883645|FG005|COMPLETED|Baseline (Day 1) up to Week 12||0
10309803|NCT00118755|11442785|FG001|Safety Population|Overall Study||211
10309804|NCT00118755|11442784|FG000|COMPLETED|Overall Study||7
10309805|NCT00118755|11442785|FG001|COMPLETED|Overall Study||3
10309806|NCT00118755|11442784|FG000|NOT COMPLETED|Overall Study||210
10309807|NCT00118755|11442785|FG001|NOT COMPLETED|Overall Study||215
10309808|NCT00118898|11442795|FG000|STARTED|Overall Study||464
10309809|NCT00118898|11442796|FG001|STARTED|Overall Study||465
10309810|NCT00118898|11442797|FG002|STARTED|Overall Study||465
10309811|NCT00118898|11442798|FG003|STARTED|Overall Study||463
10309812|NCT00118898|11442795|FG000|Initiated Treatment|Overall Study||461
10309813|NCT00118898|11442796|FG001|Initiated Treatment|Overall Study||461
10309814|NCT00118898|11442797|FG002|Initiated Treatment|Overall Study||464
10309815|NCT00118898|11442798|FG003|Initiated Treatment|Overall Study||462
10309816|NCT00118898|11442795|FG000|COMPLETED|Overall Study||343
10309817|NCT00118898|11442796|FG001|COMPLETED|Overall Study||324
10309818|NCT00118898|11442797|FG002|COMPLETED|Overall Study||342
10309819|NCT00118898|11442798|FG003|COMPLETED|Overall Study||322
10309820|NCT00118898|11442795|FG000|NOT COMPLETED|Overall Study||121
10309821|NCT00118898|11442796|FG001|NOT COMPLETED|Overall Study||141
10309822|NCT00118898|11442797|FG002|NOT COMPLETED|Overall Study||123
10309823|NCT00118898|11442798|FG003|NOT COMPLETED|Overall Study||141
10309824|NCT00118911|11442810|FG000|STARTED|Overall Study||43
10309825|NCT00118911|11442811|FG001|STARTED|Overall Study||43
10309826|NCT00118911|11442810|FG000|Received Intervention as Assigned|Overall Study||41
10309827|NCT00118911|11442811|FG001|Received Intervention as Assigned|Overall Study||38
10309828|NCT00118911|11442810|FG000|Completed Post-Treatment Assessment|Overall Study||41
10309829|NCT00118911|11442811|FG001|Completed Post-Treatment Assessment|Overall Study||37
10309830|NCT00118911|11442810|FG000|6 Month Follow-up|Overall Study||37
10309831|NCT00118911|11442811|FG001|6 Month Follow-up|Overall Study||30
10309832|NCT00118911|11442810|FG000|12 Month Follow-up|Overall Study|1 participant did not complete the 6 month follow-up but did complete the 12 month follow-up|38
10309833|NCT00118911|11442811|FG001|12 Month Follow-up|Overall Study|2 participants did not complete the 6 month follow-up but did complete the 12 month follow-up|32
10309834|NCT00118911|11442810|FG000|COMPLETED|Overall Study||41
10309835|NCT00118911|11442811|FG001|COMPLETED|Overall Study||38
10309836|NCT00118911|11442810|FG000|NOT COMPLETED|Overall Study||2
10309837|NCT00118911|11442811|FG001|NOT COMPLETED|Overall Study||5
10309838|NCT00119015|11442819|FG000|STARTED|Open-Label Phase (2 Weeks)||102
10309839|NCT00119015|11442820|FG001|STARTED|Open-Label Phase (2 Weeks)||0
10309840|NCT00119015|11442821|FG002|STARTED|Open-Label Phase (2 Weeks)||0
10309841|NCT00119015|11442819|FG000|COMPLETED|Open-Label Phase (2 Weeks)||54
10309842|NCT00119015|11442820|FG001|COMPLETED|Open-Label Phase (2 Weeks)||0
10309843|NCT00119015|11442821|FG002|COMPLETED|Open-Label Phase (2 Weeks)||0
10309844|NCT00119015|11442819|FG000|NOT COMPLETED|Open-Label Phase (2 Weeks)||48
10309845|NCT00119015|11442820|FG001|NOT COMPLETED|Open-Label Phase (2 Weeks)||0
10309846|NCT00119015|11442821|FG002|NOT COMPLETED|Open-Label Phase (2 Weeks)||0
10309847|NCT00119015|11442819|FG000|STARTED|Double-Blind, Randomized Phase (2 Weeks)||0
10309848|NCT00119015|11442820|FG001|STARTED|Double-Blind, Randomized Phase (2 Weeks)|Baseline Analysis Population|28
10309849|NCT00119015|11442821|FG002|STARTED|Double-Blind, Randomized Phase (2 Weeks)|Baseline Analysis Population|26
10309850|NCT00119015|11442819|FG000|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
10309851|NCT00119015|11442820|FG001|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||28
10309852|NCT00119015|11442821|FG002|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||26
10309853|NCT00119015|11442819|FG000|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
10309854|NCT00119015|11442820|FG001|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
10543305|NCT01483599|11696531|FG013|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
10543306|NCT01483599|11696518|FG000|STARTED|After Controlled Period(Week 16-Week 40)||0
10543307|NCT01483599|11696519|FG001|STARTED|After Controlled Period(Week 16-Week 40)||0
10543308|NCT01483599|11696520|FG002|STARTED|After Controlled Period(Week 16-Week 40)||0
10543309|NCT01483599|11696521|FG003|STARTED|After Controlled Period(Week 16-Week 40)||0
10543310|NCT01483599|11696522|FG004|STARTED|After Controlled Period(Week 16-Week 40)||0
10543311|NCT01483599|11696523|FG005|STARTED|After Controlled Period(Week 16-Week 40)||0
10543312|NCT01483599|11696524|FG006|STARTED|After Controlled Period(Week 16-Week 40)||0
10543313|NCT01483599|11696525|FG007|STARTED|After Controlled Period(Week 16-Week 40)||39
10543314|NCT01483599|11696526|FG008|STARTED|After Controlled Period(Week 16-Week 40)||38
10543315|NCT01483599|11696527|FG009|STARTED|After Controlled Period(Week 16-Week 40)||41
10543316|NCT01483599|11696528|FG010|STARTED|After Controlled Period(Week 16-Week 40)||39
10543317|NCT01483599|11696529|FG011|STARTED|After Controlled Period(Week 16-Week 40)||40
10543318|NCT01483599|11696530|FG012|STARTED|After Controlled Period(Week 16-Week 40)||38
10543319|NCT01483599|11696531|FG013|STARTED|After Controlled Period(Week 16-Week 40)||39
10543320|NCT01483599|11696518|FG000|COMPLETED|After Controlled Period(Week 16-Week 40)||0
10543321|NCT01483599|11696519|FG001|COMPLETED|After Controlled Period(Week 16-Week 40)||0
10543322|NCT01483599|11696520|FG002|COMPLETED|After Controlled Period(Week 16-Week 40)||0
10543323|NCT01483599|11696521|FG003|COMPLETED|After Controlled Period(Week 16-Week 40)||0
10543324|NCT01483599|11696522|FG004|COMPLETED|After Controlled Period(Week 16-Week 40)||0
10543325|NCT01483599|11696523|FG005|COMPLETED|After Controlled Period(Week 16-Week 40)||0
10543326|NCT01483599|11696524|FG006|COMPLETED|After Controlled Period(Week 16-Week 40)||0
10543327|NCT01483599|11696525|FG007|COMPLETED|After Controlled Period(Week 16-Week 40)||37
10658846|NCT02235987|11820024|FG000|Received 900 µg DG3173|Overall Study||19
10658847|NCT02235987|11820024|FG000|Received 1800 µg DG3173|Overall Study||19
10658848|NCT02235987|11820024|FG000|COMPLETED|Overall Study||19
10658849|NCT02235987|11820024|FG000|NOT COMPLETED|Overall Study||1
10658850|NCT02236130|11820039|FG000|STARTED|Overall Study||22
10658851|NCT02236130|11820040|FG001|STARTED|Overall Study||27
10658852|NCT02236130|11820039|FG000|COMPLETED|Overall Study||15
10658853|NCT02236130|11820040|FG001|COMPLETED|Overall Study||15
10658854|NCT02236130|11820039|FG000|NOT COMPLETED|Overall Study||7
10658855|NCT02236130|11820040|FG001|NOT COMPLETED|Overall Study||12
10658856|NCT02236338|11820048|FG000|STARTED|Overall Study||100
10658857|NCT02236338|11820049|FG001|STARTED|Overall Study||100
10658858|NCT02236338|11820048|FG000|COMPLETED|Overall Study||100
10658859|NCT02236338|11820049|FG001|COMPLETED|Overall Study||100
10658860|NCT02236338|11820048|FG000|NOT COMPLETED|Overall Study||0
10658861|NCT02236338|11820049|FG001|NOT COMPLETED|Overall Study||0
10658862|NCT02236520|11820059|FG000|STARTED|Overall Study||16
10658863|NCT02236520|11820060|FG001|STARTED|Overall Study||13
10658864|NCT02236520|11820061|FG002|STARTED|Overall Study||15
10658865|NCT02236520|11820062|FG003|STARTED|Overall Study||15
10658866|NCT02236520|11820059|FG000|COMPLETED|Overall Study||14
10658867|NCT02236520|11820060|FG001|COMPLETED|Overall Study||8
10658868|NCT02236520|11820061|FG002|COMPLETED|Overall Study||15
10658869|NCT02236520|11820062|FG003|COMPLETED|Overall Study||14
10658870|NCT02236520|11820059|FG000|NOT COMPLETED|Overall Study||2
10658871|NCT02236520|11820060|FG001|NOT COMPLETED|Overall Study||5
10658872|NCT02236520|11820061|FG002|NOT COMPLETED|Overall Study||0
10658873|NCT02236520|11820062|FG003|NOT COMPLETED|Overall Study||1
10658874|NCT02236559|11820074|FG000|STARTED|Overall Study||112
10658875|NCT02236559|11820075|FG001|STARTED|Overall Study||116
10658876|NCT02236559|11820074|FG000|COMPLETED|Overall Study||100
10658877|NCT02236559|11820075|FG001|COMPLETED|Overall Study||104
10658878|NCT02236559|11820074|FG000|NOT COMPLETED|Overall Study||12
10658879|NCT02236559|11820075|FG001|NOT COMPLETED|Overall Study||12
10658880|NCT02236598|11820083|FG000|STARTED|Overall Study||15
10658881|NCT02236598|11820084|FG001|STARTED|Overall Study||14
10395346|NCT00687713|11538943|FG000|NOT COMPLETED|Overall Study||32
10395347|NCT00687713|11538944|FG001|NOT COMPLETED|Overall Study||40
10395348|NCT00687739|11538956|FG000|STARTED|Overall Study||25
10395349|NCT00687739|11538957|FG001|STARTED|Overall Study||15
10395350|NCT00687739|11538958|FG002|STARTED|Overall Study||25
10395351|NCT00687739|11538959|FG003|STARTED|Overall Study||14
10395352|NCT00687739|11538956|FG000|COMPLETED|Overall Study||23
10395353|NCT00687739|11538957|FG001|COMPLETED|Overall Study||12
10395354|NCT00687739|11538958|FG002|COMPLETED|Overall Study||23
10395355|NCT00687739|11538959|FG003|COMPLETED|Overall Study||12
10395356|NCT00687739|11538956|FG000|NOT COMPLETED|Overall Study||2
10395357|NCT00687739|11538957|FG001|NOT COMPLETED|Overall Study||3
10395358|NCT00687739|11538958|FG002|NOT COMPLETED|Overall Study||2
10395359|NCT00687739|11538959|FG003|NOT COMPLETED|Overall Study||2
10395360|NCT00687804|11538974|FG000|STARTED|Core Study||116
10395361|NCT00687804|11538975|FG001|STARTED|Core Study||118
10543328|NCT01483599|11696526|FG008|COMPLETED|After Controlled Period(Week 16-Week 40)||29
10543329|NCT01483599|11696527|FG009|COMPLETED|After Controlled Period(Week 16-Week 40)||37
10543330|NCT01483599|11696528|FG010|COMPLETED|After Controlled Period(Week 16-Week 40)||37
10543331|NCT01483599|11696529|FG011|COMPLETED|After Controlled Period(Week 16-Week 40)||39
10543332|NCT01483599|11696530|FG012|COMPLETED|After Controlled Period(Week 16-Week 40)||35
10543333|NCT01483599|11696531|FG013|COMPLETED|After Controlled Period(Week 16-Week 40)||32
10543334|NCT01483599|11696518|FG000|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
10719976|NCT02713204|11883646|FG006|COMPLETED|Baseline (Day 1) up to Week 12||0
10719977|NCT02713204|11883647|FG007|COMPLETED|Baseline (Day 1) up to Week 12||0
10719978|NCT02713204|11883640|FG000|NOT COMPLETED|Baseline (Day 1) up to Week 12||1
10719979|NCT02713204|11883641|FG001|NOT COMPLETED|Baseline (Day 1) up to Week 12||1
10719980|NCT02713204|11883642|FG002|NOT COMPLETED|Baseline (Day 1) up to Week 12||2
10395362|NCT00687804|11538976|FG002|STARTED|Core Study||111
10395363|NCT00687804|11538974|FG000|COMPLETED|Core Study||102
10395364|NCT00687804|11538975|FG001|COMPLETED|Core Study||103
10395365|NCT00687804|11538976|FG002|COMPLETED|Core Study||98
10395366|NCT00687804|11538974|FG000|NOT COMPLETED|Core Study||14
10395367|NCT00687804|11538975|FG001|NOT COMPLETED|Core Study||15
10395368|NCT00687804|11538976|FG002|NOT COMPLETED|Core Study||13
10395369|NCT00687804|11538974|FG000|STARTED|Open-Label Extension Study||83
10395370|NCT00687804|11538975|FG001|STARTED|Open-Label Extension Study||83
10395371|NCT00687804|11538976|FG002|STARTED|Open-Label Extension Study||74
10395372|NCT00687804|11538974|FG000|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||16
10395373|NCT00687804|11538975|FG001|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||21
10395374|NCT00687804|11538976|FG002|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||15
10395375|NCT00687804|11538974|FG000|COMPLETED|Open-Label Extension Study||73
10395376|NCT00687804|11538975|FG001|COMPLETED|Open-Label Extension Study||72
10395377|NCT00687804|11538976|FG002|COMPLETED|Open-Label Extension Study||63
10395378|NCT00687804|11538974|FG000|NOT COMPLETED|Open-Label Extension Study||10
10395379|NCT00687804|11538975|FG001|NOT COMPLETED|Open-Label Extension Study||11
10395380|NCT00687804|11538976|FG002|NOT COMPLETED|Open-Label Extension Study||11
10395381|NCT00687830|11538992|FG000|STARTED|Overall Study||68
10395382|NCT00687830|11538993|FG001|STARTED|Overall Study||68
10395383|NCT00687830|11538992|FG000|COMPLETED|Overall Study||68
10395384|NCT00687830|11538993|FG001|COMPLETED|Overall Study||68
10395385|NCT00687830|11538992|FG000|NOT COMPLETED|Overall Study||0
10395386|NCT00687830|11538993|FG001|NOT COMPLETED|Overall Study||0
10395387|NCT00687856|11538999|FG000|STARTED|Overall Study||211
10395388|NCT00687856|11538999|FG000|COMPLETED|Overall Study||211
10395389|NCT00687856|11538999|FG000|NOT COMPLETED|Overall Study||0
10395390|NCT00687908|11539005|FG000|STARTED|Overall Study||123
10395391|NCT00687908|11539006|FG001|STARTED|Overall Study||120
10395392|NCT00687908|11539005|FG000|COMPLETED|Overall Study||105
10395393|NCT00687908|11539006|FG001|COMPLETED|Overall Study||78
10395394|NCT00687908|11539005|FG000|NOT COMPLETED|Overall Study||18
10395395|NCT00687908|11539006|FG001|NOT COMPLETED|Overall Study||42
10395396|NCT00687973|11539014|FG000|STARTED|Overall Study||193
10395397|NCT00687973|11539015|FG001|STARTED|Overall Study||200
10395398|NCT00687973|11539014|FG000|COMPLETED|Overall Study||169
10395399|NCT00687973|11539015|FG001|COMPLETED|Overall Study||162
10395400|NCT00687973|11539014|FG000|NOT COMPLETED|Overall Study||24
10395401|NCT00687973|11539015|FG001|NOT COMPLETED|Overall Study||38
10395402|NCT00688064|11539024|FG000|STARTED|Overall Study||232
10719981|NCT02713204|11883643|FG003|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
10719982|NCT02713204|11883644|FG004|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
10719983|NCT02713204|11883645|FG005|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
10395403|NCT00688064|11539025|FG001|STARTED|Overall Study||227
10395404|NCT00688064|11539024|FG000|COMPLETED|Overall Study||211
10395405|NCT00688064|11539025|FG001|COMPLETED|Overall Study||201
10395406|NCT00688064|11539024|FG000|NOT COMPLETED|Overall Study||21
10395407|NCT00688064|11539025|FG001|NOT COMPLETED|Overall Study||26
10395408|NCT00688103|11539033|FG000|STARTED|Overall Study||74
10395409|NCT00688103|11539034|FG001|STARTED|Overall Study||77
10395410|NCT00688103|11539033|FG000|Actually Treated|Overall Study||71
10395411|NCT00688103|11539034|FG001|Actually Treated|Overall Study||76
10395412|NCT00688103|11539033|FG000|COMPLETED|Overall Study||44
10395413|NCT00688103|11539034|FG001|COMPLETED|Overall Study||64
10719984|NCT02713204|11883646|FG006|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
10309855|NCT00119015|11442821|FG002|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
10309856|NCT00119041|11442830|FG000|STARTED|Overall Study||199
10309857|NCT00119041|11442831|FG001|STARTED|Overall Study||83
10309858|NCT00119041|11442832|FG002|STARTED|Overall Study||22
10309859|NCT00119041|11442830|FG000|COMPLETED|Overall Study||199
10309860|NCT00119041|11442831|FG001|COMPLETED|Overall Study||83
10309861|NCT00119041|11442832|FG002|COMPLETED|Overall Study||22
10309862|NCT00119041|11442830|FG000|NOT COMPLETED|Overall Study||0
10309863|NCT00119041|11442831|FG001|NOT COMPLETED|Overall Study||0
10309864|NCT00119041|11442832|FG002|NOT COMPLETED|Overall Study||0
10309865|NCT00119106|11442843|FG000|STARTED|Overall Study||1204
10309866|NCT00119106|11442844|FG001|STARTED|Overall Study|2 participants later found to be HIV infected at baseline. Therefore 1207 in mITT analysis|1209
10309867|NCT00119106|11442843|FG000|COMPLETED|Overall Study||1025
10395414|NCT00688103|11539033|FG000|NOT COMPLETED|Overall Study||30
10395415|NCT00688103|11539034|FG001|NOT COMPLETED|Overall Study||13
10395416|NCT00688155|11539046|FG000|STARTED|Overall Study||18
10395417|NCT00688155|11539047|FG001|STARTED|Overall Study||18
10395418|NCT00688155|11539048|FG002|STARTED|Overall Study||19
10395419|NCT00688155|11539049|FG003|STARTED|Overall Study||18
10395420|NCT00688155|11539046|FG000|COMPLETED|Overall Study||16
10395421|NCT00688155|11539047|FG001|COMPLETED|Overall Study||16
10395422|NCT00688155|11539048|FG002|COMPLETED|Overall Study||18
10395423|NCT00688155|11539049|FG003|COMPLETED|Overall Study||17
10395424|NCT00688155|11539046|FG000|NOT COMPLETED|Overall Study||2
10395425|NCT00688155|11539047|FG001|NOT COMPLETED|Overall Study||2
10395426|NCT00688155|11539048|FG002|NOT COMPLETED|Overall Study||1
10395427|NCT00688155|11539049|FG003|NOT COMPLETED|Overall Study||1
10395428|NCT00688181|11539059|FG000|STARTED|Overall Study||36
10395429|NCT00688181|11539059|FG000|COMPLETED|Overall Study||13
10395430|NCT00688181|11539059|FG000|NOT COMPLETED|Overall Study||23
10395431|NCT00688259|11539067|FG000|STARTED|Overall Study||44
10395432|NCT00688259|11539068|FG001|STARTED|Overall Study||44
10395433|NCT00688259|11539067|FG000|End to Active Treatment,|Overall Study||37
10395434|NCT00688259|11539068|FG001|End to Active Treatment,|Overall Study||37
10395435|NCT00688259|11539067|FG000|COMPLETED|Overall Study||37
10395436|NCT00688259|11539068|FG001|COMPLETED|Overall Study||36
10395437|NCT00688259|11539067|FG000|NOT COMPLETED|Overall Study||7
10395438|NCT00688259|11539068|FG001|NOT COMPLETED|Overall Study||8
10395439|NCT00688324|11539074|FG000|STARTED|Overall Study||36
10395440|NCT00688324|11539074|FG000|COMPLETED|Overall Study||28
10395441|NCT00688324|11539074|FG000|NOT COMPLETED|Overall Study||8
10395442|NCT00688467|11539081|FG000|STARTED|Treatment Period 1||9
10395443|NCT00688467|11539082|FG001|STARTED|Treatment Period 1||10
10395444|NCT00688467|11539081|FG000|COMPLETED|Treatment Period 1||7
10395445|NCT00688467|11539082|FG001|COMPLETED|Treatment Period 1||8
10395446|NCT00688467|11539081|FG000|NOT COMPLETED|Treatment Period 1||2
10395447|NCT00688467|11539082|FG001|NOT COMPLETED|Treatment Period 1||2
10395448|NCT00688467|11539081|FG000|STARTED|Treatment Period 2||7
10395449|NCT00688467|11539082|FG001|STARTED|Treatment Period 2||8
10395450|NCT00688467|11539081|FG000|COMPLETED|Treatment Period 2||7
10395451|NCT00688467|11539082|FG001|COMPLETED|Treatment Period 2||6
10395452|NCT00688467|11539081|FG000|NOT COMPLETED|Treatment Period 2||0
10395453|NCT00688467|11539082|FG001|NOT COMPLETED|Treatment Period 2||2
10395454|NCT00688519|11539090|FG000|STARTED|Overall Study||223
10395455|NCT00688519|11539091|FG001|STARTED|Overall Study||113
10395456|NCT00688519|11539090|FG000|COMPLETED|Overall Study||204
10658882|NCT02236598|11820083|FG000|COMPLETED|Overall Study||15
10658883|NCT02236598|11820084|FG001|COMPLETED|Overall Study||12
10658884|NCT02236598|11820083|FG000|NOT COMPLETED|Overall Study||0
10658885|NCT02236598|11820084|FG001|NOT COMPLETED|Overall Study||2
10658886|NCT02236611|11820092|FG000|STARTED|Overall Study||516
10658887|NCT02236611|11820093|FG001|STARTED|Overall Study||518
10658888|NCT02236611|11820092|FG000|COMPLETED|Overall Study||490
10658889|NCT02236611|11820093|FG001|COMPLETED|Overall Study||484
10309868|NCT00119106|11442844|FG001|COMPLETED|Overall Study||1031
10309869|NCT00119106|11442843|FG000|NOT COMPLETED|Overall Study||179
10309870|NCT00119106|11442844|FG001|NOT COMPLETED|Overall Study||178
10309871|NCT00119158|11442860|FG000|STARTED|Active Treatment|patients are self controls|45
10309872|NCT00119158|11442861|FG001|STARTED|Active Treatment||45
10309873|NCT00119158|11442860|FG000|COMPLETED|Active Treatment||45
10309874|NCT00119158|11442861|FG001|COMPLETED|Active Treatment||45
10309875|NCT00119158|11442860|FG000|NOT COMPLETED|Active Treatment||0
10309876|NCT00119158|11442861|FG001|NOT COMPLETED|Active Treatment||0
10309877|NCT00119158|11442860|FG000|STARTED|Placebo Treatment||45
10395457|NCT00688519|11539091|FG001|COMPLETED|Overall Study||98
10395458|NCT00688519|11539090|FG000|NOT COMPLETED|Overall Study||19
10395459|NCT00688519|11539091|FG001|NOT COMPLETED|Overall Study||15
10395460|NCT00688545|11539099|FG000|STARTED|Overall Study||55
10395461|NCT00688545|11539100|FG001|STARTED|Overall Study||219
10395462|NCT00688545|11539099|FG000|Switched Treatment at Least Once|Overall Study||6
10395463|NCT00688545|11539100|FG001|Switched Treatment at Least Once|Overall Study||13
10395464|NCT00688545|11539099|FG000|COMPLETED|Overall Study||50
10395465|NCT00688545|11539100|FG001|COMPLETED|Overall Study||204
10395466|NCT00688545|11539099|FG000|NOT COMPLETED|Overall Study||5
10395467|NCT00688545|11539100|FG001|NOT COMPLETED|Overall Study||15
10658890|NCT02236611|11820092|FG000|NOT COMPLETED|Overall Study||26
10658891|NCT02236611|11820093|FG001|NOT COMPLETED|Overall Study||34
10658892|NCT02236767|11820099|FG000|STARTED|Overall Study||1
10395468|NCT00688597|11539111|FG000|STARTED|Overall Study||3
10395469|NCT00688597|11539112|FG001|STARTED|Overall Study||0
10395470|NCT00688597|11539113|FG002|STARTED|Overall Study||0
10395471|NCT00688597|11539111|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
10395472|NCT00688597|11539112|FG001|Received at Least 1 Dose of Study Drug|Overall Study||0
10395473|NCT00688597|11539113|FG002|Received at Least 1 Dose of Study Drug|Overall Study||0
10395474|NCT00688597|11539111|FG000|COMPLETED|Overall Study||0
10395475|NCT00688597|11539112|FG001|COMPLETED|Overall Study||0
10309878|NCT00119158|11442861|FG001|STARTED|Placebo Treatment||45
10309879|NCT00119158|11442860|FG000|COMPLETED|Placebo Treatment||45
10309880|NCT00119158|11442861|FG001|COMPLETED|Placebo Treatment||45
10309881|NCT00119158|11442860|FG000|NOT COMPLETED|Placebo Treatment||0
10309882|NCT00119158|11442861|FG001|NOT COMPLETED|Placebo Treatment||0
10309883|NCT00119262|11442869|FG000|STARTED|Overall Study||104
10309884|NCT00119262|11442870|FG001|STARTED|Overall Study||122
10309885|NCT00119262|11442869|FG000|Eligible|Overall Study||103
10309886|NCT00119262|11442870|FG001|Eligible|Overall Study||120
10309887|NCT00119262|11442869|FG000|Treated|Overall Study||103
10309888|NCT00119262|11442870|FG001|Treated|Overall Study||120
10309889|NCT00119262|11442869|FG000|Eligible and Treated|Overall Study||102
10309890|NCT00119262|11442870|FG001|Eligible and Treated|Overall Study||119
10309891|NCT00119262|11442869|FG000|COMPLETED|Overall Study||58
10309892|NCT00119262|11442870|FG001|COMPLETED|Overall Study||64
10309893|NCT00119262|11442869|FG000|NOT COMPLETED|Overall Study||46
10309894|NCT00119262|11442870|FG001|NOT COMPLETED|Overall Study||58
10309895|NCT00119379|11442878|FG000|STARTED|Overall Study||26
10309896|NCT00119379|11442879|FG001|STARTED|Overall Study||24
10309897|NCT00119379|11442878|FG000|COMPLETED|Overall Study||22
10309898|NCT00119379|11442879|FG001|COMPLETED|Overall Study||23
10309899|NCT00119379|11442878|FG000|NOT COMPLETED|Overall Study||4
10309900|NCT00119379|11442879|FG001|NOT COMPLETED|Overall Study||1
10309901|NCT00119392|11442885|FG000|STARTED|Overall Study||45
10309902|NCT00119392|11442885|FG000|COMPLETED|Overall Study||40
10309903|NCT00119392|11442885|FG000|NOT COMPLETED|Overall Study||5
10309904|NCT00119405|11442889|FG000|STARTED|Overall Study||18
10309905|NCT00119405|11442889|FG000|COMPLETED|Overall Study||17
10309906|NCT00119405|11442889|FG000|NOT COMPLETED|Overall Study||1
10309907|NCT00119678|11442895|FG000|STARTED|Double-blind Treatment Period||122
10309908|NCT00119678|11442896|FG001|STARTED|Double-blind Treatment Period||61
10309909|NCT00119678|11442895|FG000|RANDOMIZED AND TREATED|Double-blind Treatment Period||121
10309910|NCT00119678|11442896|FG001|RANDOMIZED AND TREATED|Double-blind Treatment Period||59
10309911|NCT00119678|11442895|FG000|RANDOMIZED,TREATED, AND ANALYZED|Double-blind Treatment Period||118
10309912|NCT00119678|11442896|FG001|RANDOMIZED,TREATED, AND ANALYZED|Double-blind Treatment Period||57
10309913|NCT00119678|11442895|FG000|COMPLETED|Double-blind Treatment Period||81
10309914|NCT00119678|11442896|FG001|COMPLETED|Double-blind Treatment Period||35
10309915|NCT00119678|11442895|FG000|NOT COMPLETED|Double-blind Treatment Period||41
10309916|NCT00119678|11442896|FG001|NOT COMPLETED|Double-blind Treatment Period||26
10309917|NCT00119678|11442895|FG000|STARTED|Open-label Treatment Period|Number of participants treated|110
10309918|NCT00119678|11442896|FG001|STARTED|Open-label Treatment Period||0
10309919|NCT00119678|11442895|FG000|COMPLETED|Open-label Treatment Period||0
10309920|NCT00119678|11442896|FG001|COMPLETED|Open-label Treatment Period||0
10309921|NCT00119678|11442895|FG000|NOT COMPLETED|Open-label Treatment Period||110
10309922|NCT00119678|11442896|FG001|NOT COMPLETED|Open-label Treatment Period||0
10309923|NCT00120250|11442904|FG000|STARTED|Overall Study||13
10309924|NCT00120250|11442905|FG001|STARTED|Overall Study||14
10309925|NCT00120250|11442904|FG000|COMPLETED|Overall Study||12
10309926|NCT00120250|11442905|FG001|COMPLETED|Overall Study||12
10309927|NCT00120250|11442904|FG000|NOT COMPLETED|Overall Study||1
10395476|NCT00688597|11539113|FG002|COMPLETED|Overall Study||0
10309928|NCT00120250|11442905|FG001|NOT COMPLETED|Overall Study||2
10309929|NCT00120289|11442914|FG000|STARTED|Overall Study||1718
10309930|NCT00120289|11442915|FG001|STARTED|Overall Study||1696
10309931|NCT00120289|11442914|FG000|COMPLETED|Overall Study||1597
10395477|NCT00688597|11539111|FG000|NOT COMPLETED|Overall Study||3
10395478|NCT00688597|11539112|FG001|NOT COMPLETED|Overall Study||0
10395479|NCT00688597|11539113|FG002|NOT COMPLETED|Overall Study||0
10395480|NCT00688623|11539121|FG000|STARTED|Overall Study|Intent to treat (ITT)|73
10395481|NCT00688623|11539121|FG000|Safety Analysis Set|Overall Study|received at least one dose of study drug and had at least one post-baseline safety assessment|73
10395482|NCT00688623|11539121|FG000|Per Protocol (PP)|Overall Study|no major protocol deviation and 50% of planned dose of 8 weeks or d/c due to disease progression|60
10395483|NCT00688623|11539121|FG000|COMPLETED|Overall Study||18
10395484|NCT00688623|11539121|FG000|NOT COMPLETED|Overall Study||55
10395485|NCT00688636|11539127|FG000|STARTED|Overall Study||11
10395486|NCT00688636|11539128|FG001|STARTED|Overall Study||13
10395487|NCT00688636|11539127|FG000|COMPLETED|Overall Study||9
10395488|NCT00688636|11539128|FG001|COMPLETED|Overall Study||12
10395489|NCT00688636|11539127|FG000|NOT COMPLETED|Overall Study||2
10395490|NCT00688636|11539128|FG001|NOT COMPLETED|Overall Study||1
10395491|NCT00688662|11539136|FG000|STARTED|Overall Study||141
10395492|NCT00688662|11539137|FG001|STARTED|Overall Study||73
10395493|NCT00688662|11539136|FG000|COMPLETED|Overall Study||118
10395494|NCT00688662|11539137|FG001|COMPLETED|Overall Study||55
10395495|NCT00688662|11539136|FG000|NOT COMPLETED|Overall Study||23
10395496|NCT00688662|11539137|FG001|NOT COMPLETED|Overall Study||18
10395497|NCT00688688|11539147|FG000|STARTED|Overall Study||815
10395498|NCT00688688|11539148|FG001|STARTED|Overall Study||824
10395499|NCT00688688|11539149|FG002|STARTED|Overall Study||813
10395500|NCT00688688|11539147|FG000|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|812
10395501|NCT00688688|11539148|FG001|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|820
10395502|NCT00688688|11539149|FG002|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|812
10395503|NCT00688688|11539147|FG000|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|789
10395504|NCT00688688|11539148|FG001|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|802
10395505|NCT00688688|11539149|FG002|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|791
10395506|NCT00688688|11539147|FG000|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|479
10395507|NCT00688688|11539148|FG001|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|483
10395508|NCT00688688|11539149|FG002|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|488
10395509|NCT00688688|11539147|FG000|COMPLETED|Overall Study||629
10395510|NCT00688688|11539148|FG001|COMPLETED|Overall Study||645
10395511|NCT00688688|11539149|FG002|COMPLETED|Overall Study||621
10395512|NCT00688688|11539147|FG000|NOT COMPLETED|Overall Study||186
10395513|NCT00688688|11539148|FG001|NOT COMPLETED|Overall Study||179
10395514|NCT00688688|11539149|FG002|NOT COMPLETED|Overall Study||192
10395515|NCT00688701|11539160|FG000|STARTED|Overall Study|Randomized|61
10395516|NCT00688701|11539161|FG001|STARTED|Overall Study||61
10395517|NCT00688701|11539162|FG002|STARTED|Overall Study||120
10395518|NCT00688701|11539163|FG003|STARTED|Overall Study||119
10395519|NCT00688701|11539160|FG000|Treated/Safety Population|Overall Study|All patients who received at least 1 dose, regardless of amount of treatment administered.|61
10395520|NCT00688701|11539161|FG001|Treated/Safety Population|Overall Study||61
10395521|NCT00688701|11539162|FG002|Treated/Safety Population|Overall Study||120
10395522|NCT00688701|11539163|FG003|Treated/Safety Population|Overall Study||119
10395523|NCT00688701|11539160|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|61
10395524|NCT00688701|11539161|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||60
10395525|NCT00688701|11539162|FG002|Modified Intent-to-Treat(mITT)Population|Overall Study||120
10395526|NCT00688701|11539163|FG003|Modified Intent-to-Treat(mITT)Population|Overall Study||118
10428716|NCT00859898|11574775|FG000|STARTED|Overall Study||211
10309932|NCT00120289|11442915|FG001|COMPLETED|Overall Study||1587
10309933|NCT00120289|11442914|FG000|NOT COMPLETED|Overall Study||121
10309934|NCT00120289|11442915|FG001|NOT COMPLETED|Overall Study||109
10309935|NCT00120406|11442923|FG000|STARTED|Overall Study||236
10309936|NCT00120406|11442924|FG001|STARTED|Overall Study||238
10309937|NCT00120406|11442923|FG000|COMPLETED|Overall Study||217
10395527|NCT00688701|11539160|FG000|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal test was performed.|27
10309938|NCT00120406|11442924|FG001|COMPLETED|Overall Study||222
10309939|NCT00120406|11442923|FG000|NOT COMPLETED|Overall Study||19
10309940|NCT00120406|11442924|FG001|NOT COMPLETED|Overall Study||16
10309941|NCT00120523|11442932|FG000|STARTED|Treatment Period||1205
10309942|NCT00120523|11442933|FG001|STARTED|Treatment Period||1213
10309943|NCT00120523|11442932|FG000|COMPLETED|Treatment Period||836
10309944|NCT00120523|11442933|FG001|COMPLETED|Treatment Period||874
10309945|NCT00120523|11442932|FG000|NOT COMPLETED|Treatment Period||369
10309946|NCT00120523|11442933|FG001|NOT COMPLETED|Treatment Period||339
10309947|NCT00120523|11442932|FG000|STARTED|Follow-Up Period|Patients discontinued due to lost to follow-up or who withdrew consent were not part of this period.|120
10309948|NCT00120523|11442933|FG001|STARTED|Follow-Up Period|Patients discontinued due to lost to follow-up or who withdrew consent were not part of this period.|70
10309949|NCT00120523|11442932|FG000|COMPLETED|Follow-Up Period||90
10309950|NCT00120523|11442933|FG001|COMPLETED|Follow-Up Period||46
10309951|NCT00120523|11442932|FG000|NOT COMPLETED|Follow-Up Period||30
10309952|NCT00120523|11442933|FG001|NOT COMPLETED|Follow-Up Period||24
10309953|NCT00120627|11442942|FG000|STARTED|Overall Study|This is the number who enrolled and was randomly assigned to receive the Mantram Repetition Program.|71
10309954|NCT00120627|11442943|FG001|STARTED|Overall Study|This was the number that enrolled and was randomly assigned to receive the control condition.|75
10309955|NCT00120627|11442942|FG000|Began Interventions|Overall Study|Two people dropped due to scheduling conflict and illness.|69
10309956|NCT00120627|11442943|FG001|Began Interventions|Overall Study|Two people dropped due to scheduling conflict and an unknown reason.|73
10309957|NCT00120627|11442942|FG000|Did Not Complete Post-tx Assessments|Overall Study|One person had a scheduling conflict and two people were incarcerated.|3
10309958|NCT00120627|11442943|FG001|Did Not Complete Post-tx Assessments|Overall Study|Three people dropped out but no reason given.|3
10309959|NCT00120627|11442942|FG000|COMPLETED|Overall Study||66
10309960|NCT00120627|11442943|FG001|COMPLETED|Overall Study|Three people refused the post-assessments CAPS interview only.|70
10309961|NCT00120627|11442942|FG000|NOT COMPLETED|Overall Study||5
10309962|NCT00120627|11442943|FG001|NOT COMPLETED|Overall Study||5
10309963|NCT00120874|11442960|FG000|STARTED|Overall Study||10
10309964|NCT00120874|11442961|FG001|STARTED|Overall Study||10
10309965|NCT00120874|11442960|FG000|Completed Study; Started Extension Study|Overall Study||10
10309966|NCT00120874|11442961|FG001|Completed Study; Started Extension Study|Overall Study||10
10309967|NCT00120874|11442960|FG000|COMPLETED|Overall Study||10
10309968|NCT00120874|11442961|FG001|COMPLETED|Overall Study||9
10309969|NCT00120874|11442960|FG000|NOT COMPLETED|Overall Study||0
10309970|NCT00120874|11442961|FG001|NOT COMPLETED|Overall Study||1
10309971|NCT00121134|11442971|FG000|STARTED|Overall Study||40
10309972|NCT00121134|11442972|FG001|STARTED|Overall Study||41
10309973|NCT00121134|11442973|FG002|STARTED|Overall Study||41
10309974|NCT00121134|11442974|FG003|STARTED|Overall Study||40
10309975|NCT00121134|11442971|FG000|COMPLETED|Overall Study||24
10309976|NCT00121134|11442972|FG001|COMPLETED|Overall Study||26
10309977|NCT00121134|11442973|FG002|COMPLETED|Overall Study||20
10309978|NCT00121134|11442974|FG003|COMPLETED|Overall Study||31
10309979|NCT00121134|11442971|FG000|NOT COMPLETED|Overall Study||16
10309980|NCT00121134|11442972|FG001|NOT COMPLETED|Overall Study||15
10309981|NCT00121134|11442973|FG002|NOT COMPLETED|Overall Study||21
10309982|NCT00121134|11442974|FG003|NOT COMPLETED|Overall Study||9
10309983|NCT00121173|11442987|FG000|STARTED|Overall Study||4
10309984|NCT00121173|11442988|FG001|STARTED|Overall Study||3
10309985|NCT00121173|11442989|FG002|STARTED|Overall Study||9
10309986|NCT00121173|11442987|FG000|COMPLETED|Overall Study||3
10309987|NCT00121173|11442988|FG001|COMPLETED|Overall Study||3
10309988|NCT00121173|11442989|FG002|COMPLETED|Overall Study||9
10309989|NCT00121173|11442987|FG000|NOT COMPLETED|Overall Study||1
10309990|NCT00121173|11442988|FG001|NOT COMPLETED|Overall Study||0
10309991|NCT00121173|11442989|FG002|NOT COMPLETED|Overall Study||0
10309992|NCT00121186|11443000|FG000|STARTED|Overall Study||1
10309993|NCT00121186|11443000|FG000|COMPLETED|Overall Study||1
10309994|NCT00121186|11443000|FG000|NOT COMPLETED|Overall Study||0
10309995|NCT00121199|11443004|FG000|STARTED|Overall Study||73
10309996|NCT00121199|11443004|FG000|Eligible|Overall Study||64
10309997|NCT00121199|11443004|FG000|Eligible and Began Protocol Therapy|Overall Study||64
10309998|NCT00121199|11443004|FG000|COMPLETED|Overall Study||45
10309999|NCT00121199|11443004|FG000|NOT COMPLETED|Overall Study||28
10310000|NCT00121225|11443008|FG000|STARTED|Overall Study||32
10395528|NCT00688701|11539161|FG001|Subgroup for Standardized Meal Test|Overall Study||35
10395529|NCT00688701|11539162|FG002|Subgroup for Standardized Meal Test|Overall Study||60
10310001|NCT00121225|11443008|FG000|COMPLETED|Overall Study||32
10310002|NCT00121225|11443008|FG000|NOT COMPLETED|Overall Study||0
10310003|NCT00121238|11443013|FG000|STARTED|Overall Study||16
10395530|NCT00688701|11539163|FG003|Subgroup for Standardized Meal Test|Overall Study||65
10395531|NCT00688701|11539160|FG000|COMPLETED|Overall Study||57
10395532|NCT00688701|11539161|FG001|COMPLETED|Overall Study||56
10395533|NCT00688701|11539162|FG002|COMPLETED|Overall Study||110
10395534|NCT00688701|11539163|FG003|COMPLETED|Overall Study||108
10395535|NCT00688701|11539160|FG000|NOT COMPLETED|Overall Study||4
10395536|NCT00688701|11539161|FG001|NOT COMPLETED|Overall Study||5
10395537|NCT00688701|11539162|FG002|NOT COMPLETED|Overall Study||10
10395538|NCT00688701|11539163|FG003|NOT COMPLETED|Overall Study||11
10395539|NCT00688740|11539176|FG000|STARTED|Overall Study||745
10395540|NCT00688740|11539177|FG001|STARTED|Overall Study||746
10395541|NCT00688740|11539176|FG000|COMPLETED|Overall Study||679
10395542|NCT00688740|11539177|FG001|COMPLETED|Overall Study||711
10395543|NCT00688740|11539176|FG000|NOT COMPLETED|Overall Study||66
10395544|NCT00688740|11539177|FG001|NOT COMPLETED|Overall Study||35
10395545|NCT00688753|11539183|FG000|STARTED|Overall Study||92
10395546|NCT00688753|11539183|FG000|COMPLETED|Overall Study||0
10395547|NCT00688753|11539183|FG000|NOT COMPLETED|Overall Study||92
10543335|NCT01483599|11696519|FG001|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
10543336|NCT01483599|11696520|FG002|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
10543337|NCT01483599|11696521|FG003|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
10543338|NCT01483599|11696522|FG004|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
10543339|NCT01483599|11696523|FG005|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
10543340|NCT01483599|11696524|FG006|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
10543341|NCT01483599|11696525|FG007|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||2
10543342|NCT01483599|11696526|FG008|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||9
10543343|NCT01483599|11696527|FG009|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||4
10543344|NCT01483599|11696528|FG010|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||2
10543345|NCT01483599|11696529|FG011|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||1
10543346|NCT01483599|11696530|FG012|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||3
10543347|NCT01483599|11696531|FG013|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||7
10543348|NCT01483625|11696562|FG000|STARTED|Overall Study||72
10543349|NCT01483625|11696563|FG001|STARTED|Overall Study||68
10543350|NCT01483625|11696562|FG000|COMPLETED|Overall Study||68
10543351|NCT01483625|11696563|FG001|COMPLETED|Overall Study||66
10543352|NCT01483625|11696562|FG000|NOT COMPLETED|Overall Study||4
10543353|NCT01483625|11696563|FG001|NOT COMPLETED|Overall Study||2
10543354|NCT01483651|11696569|FG000|STARTED|Overall Study||1
10543355|NCT01483651|11696570|FG001|STARTED|Overall Study||3
10543356|NCT01483651|11696571|FG002|STARTED|Overall Study||2
10543357|NCT01483651|11696572|FG003|STARTED|Overall Study||1
10543358|NCT01483651|11696573|FG004|STARTED|Overall Study||2
10543359|NCT01483651|11696574|FG005|STARTED|Overall Study||2
10543360|NCT01483651|11696569|FG000|COMPLETED|Overall Study||1
10543361|NCT01483651|11696570|FG001|COMPLETED|Overall Study||2
10543362|NCT01483651|11696571|FG002|COMPLETED|Overall Study||1
10543363|NCT01483651|11696572|FG003|COMPLETED|Overall Study||1
10543364|NCT01483651|11696573|FG004|COMPLETED|Overall Study||2
10543365|NCT01483651|11696574|FG005|COMPLETED|Overall Study||1
10543366|NCT01483651|11696569|FG000|NOT COMPLETED|Overall Study||0
10395548|NCT00688844|11539187|FG000|STARTED|Overall Study||58
10395549|NCT00688844|11539187|FG000|COMPLETED|Overall Study||48
10395550|NCT00688844|11539187|FG000|NOT COMPLETED|Overall Study||10
10395551|NCT00688870|11539193|FG000|STARTED|Infant Series||84
10395552|NCT00688870|11539194|FG001|STARTED|Infant Series||84
10543367|NCT01483651|11696570|FG001|NOT COMPLETED|Overall Study||1
10543368|NCT01483651|11696571|FG002|NOT COMPLETED|Overall Study||1
10543369|NCT01483651|11696572|FG003|NOT COMPLETED|Overall Study||0
10543370|NCT01483651|11696573|FG004|NOT COMPLETED|Overall Study||0
10543371|NCT01483651|11696574|FG005|NOT COMPLETED|Overall Study||1
10395553|NCT00688870|11539193|FG000|Vaccinated Dose 1|Infant Series||83
10310004|NCT00121238|11443013|FG000|COMPLETED|Overall Study|2 were later deemed ineligible (PSA rise), censored from efficacy but included for toxicity analysis|13
10310005|NCT00121238|11443013|FG000|NOT COMPLETED|Overall Study||3
10310006|NCT00121251|11443017|FG000|STARTED|Overall Study||17
10310007|NCT00121251|11443017|FG000|COMPLETED|Overall Study||17
10310008|NCT00121251|11443017|FG000|NOT COMPLETED|Overall Study||0
10310009|NCT00121641|11443025|FG000|STARTED|24-week Short-term Treatment Period||102
10310010|NCT00121641|11443026|FG001|STARTED|24-week Short-term Treatment Period||106
10310011|NCT00121641|11443027|FG002|STARTED|24-week Short-term Treatment Period||98
10310012|NCT00121641|11443028|FG003|STARTED|24-week Short-term Treatment Period||95
10310013|NCT00121641|11443029|FG004|STARTED|24-week Short-term Treatment Period||66
10310014|NCT00121641|11443025|FG000|COMPLETED|24-week Short-term Treatment Period||73
10310015|NCT00121641|11443026|FG001|COMPLETED|24-week Short-term Treatment Period||68
10310016|NCT00121641|11443027|FG002|COMPLETED|24-week Short-term Treatment Period||69
10310017|NCT00121641|11443028|FG003|COMPLETED|24-week Short-term Treatment Period||55
10310018|NCT00121641|11443029|FG004|COMPLETED|24-week Short-term Treatment Period||25
10310019|NCT00121641|11443025|FG000|NOT COMPLETED|24-week Short-term Treatment Period||29
10310020|NCT00121641|11443026|FG001|NOT COMPLETED|24-week Short-term Treatment Period||38
10310021|NCT00121641|11443027|FG002|NOT COMPLETED|24-week Short-term Treatment Period||29
10310022|NCT00121641|11443028|FG003|NOT COMPLETED|24-week Short-term Treatment Period||40
10310023|NCT00121641|11443029|FG004|NOT COMPLETED|24-week Short-term Treatment Period||41
10310024|NCT00121641|11443025|FG000|STARTED|48-month Short Term + Long Term Period||102
10310025|NCT00121641|11443026|FG001|STARTED|48-month Short Term + Long Term Period||106
10310026|NCT00121641|11443027|FG002|STARTED|48-month Short Term + Long Term Period||98
10310027|NCT00121641|11443028|FG003|STARTED|48-month Short Term + Long Term Period||95
10310028|NCT00121641|11443029|FG004|STARTED|48-month Short Term + Long Term Period||66
10310029|NCT00121641|11443025|FG000|COMPLETED|48-month Short Term + Long Term Period||23
10310030|NCT00121641|11443026|FG001|COMPLETED|48-month Short Term + Long Term Period||24
10310031|NCT00121641|11443027|FG002|COMPLETED|48-month Short Term + Long Term Period||28
10310032|NCT00121641|11443028|FG003|COMPLETED|48-month Short Term + Long Term Period||24
10310033|NCT00121641|11443029|FG004|COMPLETED|48-month Short Term + Long Term Period||8
10310034|NCT00121641|11443025|FG000|NOT COMPLETED|48-month Short Term + Long Term Period||79
10310035|NCT00121641|11443026|FG001|NOT COMPLETED|48-month Short Term + Long Term Period||82
10310036|NCT00121641|11443027|FG002|NOT COMPLETED|48-month Short Term + Long Term Period||70
10310037|NCT00121641|11443028|FG003|NOT COMPLETED|48-month Short Term + Long Term Period||71
10310038|NCT00121641|11443029|FG004|NOT COMPLETED|48-month Short Term + Long Term Period||58
10310039|NCT00121667|11443047|FG000|STARTED|Short Term (ST) Period||192
10310040|NCT00121667|11443048|FG001|STARTED|Short Term (ST) Period||191
10310041|NCT00121667|11443049|FG002|STARTED|Short Term (ST) Period||181
10310042|NCT00121667|11443050|FG003|STARTED|Short Term (ST) Period||179
10310043|NCT00121667|11443047|FG000|COMPLETED|Short Term (ST) Period||148
10310044|NCT00121667|11443048|FG001|COMPLETED|Short Term (ST) Period||143
10310045|NCT00121667|11443049|FG002|COMPLETED|Short Term (ST) Period||140
10310046|NCT00121667|11443050|FG003|COMPLETED|Short Term (ST) Period||112
10310047|NCT00121667|11443047|FG000|NOT COMPLETED|Short Term (ST) Period||44
10310048|NCT00121667|11443048|FG001|NOT COMPLETED|Short Term (ST) Period||48
10310049|NCT00121667|11443049|FG002|NOT COMPLETED|Short Term (ST) Period||41
10310050|NCT00121667|11443050|FG003|NOT COMPLETED|Short Term (ST) Period||67
10310051|NCT00121667|11443047|FG000|STARTED|Short Term (ST) + Long Term (LT) Period||192
10310052|NCT00121667|11443048|FG001|STARTED|Short Term (ST) + Long Term (LT) Period||191
10310053|NCT00121667|11443049|FG002|STARTED|Short Term (ST) + Long Term (LT) Period||181
10543372|NCT01483690|11696584|FG000|STARTED|Overall Study||5
10543373|NCT01483690|11696585|FG001|STARTED|Overall Study||18
10310054|NCT00121667|11443050|FG003|STARTED|Short Term (ST) + Long Term (LT) Period||179
10310055|NCT00121667|11443047|FG000|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||14
10310056|NCT00121667|11443048|FG001|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||18
10310057|NCT00121667|11443049|FG002|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||23
10310058|NCT00121667|11443050|FG003|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||7
10310059|NCT00121667|11443047|FG000|COMPLETED|Short Term (ST) + Long Term (LT) Period||64
10310060|NCT00121667|11443048|FG001|COMPLETED|Short Term (ST) + Long Term (LT) Period||58
10310061|NCT00121667|11443049|FG002|COMPLETED|Short Term (ST) + Long Term (LT) Period||68
10310062|NCT00121667|11443050|FG003|COMPLETED|Short Term (ST) + Long Term (LT) Period||39
10310063|NCT00121667|11443047|FG000|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||128
10543374|NCT01483690|11696584|FG000|COMPLETED|Overall Study||3
10543375|NCT01483690|11696585|FG001|COMPLETED|Overall Study||13
10395554|NCT00688870|11539194|FG001|Vaccinated Dose 1|Infant Series||84
10395555|NCT00688870|11539193|FG000|Vaccinated Dose 2|Infant Series||80
10395556|NCT00688870|11539194|FG001|Vaccinated Dose 2|Infant Series||84
10395557|NCT00688870|11539193|FG000|Vaccinated Dose 3|Infant Series||80
10395558|NCT00688870|11539194|FG001|Vaccinated Dose 3|Infant Series||84
10395559|NCT00688870|11539193|FG000|COMPLETED|Infant Series||80
10395560|NCT00688870|11539194|FG001|COMPLETED|Infant Series||84
10395561|NCT00688870|11539193|FG000|NOT COMPLETED|Infant Series||4
10395562|NCT00688870|11539194|FG001|NOT COMPLETED|Infant Series||0
10395563|NCT00688870|11539193|FG000|STARTED|After Infant Series||80
10395564|NCT00688870|11539194|FG001|STARTED|After Infant Series||84
10395565|NCT00688870|11539193|FG000|COMPLETED|After Infant Series||80
10395566|NCT00688870|11539194|FG001|COMPLETED|After Infant Series||84
10395567|NCT00688870|11539193|FG000|NOT COMPLETED|After Infant Series||0
10395568|NCT00688870|11539194|FG001|NOT COMPLETED|After Infant Series||0
10395569|NCT00688870|11539193|FG000|STARTED|Toddler Dose||80
10395570|NCT00688870|11539194|FG001|STARTED|Toddler Dose||84
10395571|NCT00688870|11539193|FG000|COMPLETED|Toddler Dose||80
10395572|NCT00688870|11539194|FG001|COMPLETED|Toddler Dose||84
10395573|NCT00688870|11539193|FG000|NOT COMPLETED|Toddler Dose||0
10395574|NCT00688870|11539194|FG001|NOT COMPLETED|Toddler Dose||0
10395575|NCT00688909|11539204|FG000|STARTED|Overall Study||261
10395576|NCT00688909|11539204|FG000|COMPLETED|Overall Study||228
10395577|NCT00688909|11539204|FG000|NOT COMPLETED|Overall Study||33
10395578|NCT00689026|11539211|FG000|STARTED|Overall Study||30
10395579|NCT00689026|11539212|FG001|STARTED|Overall Study||30
10395580|NCT00689026|11539211|FG000|COMPLETED|Overall Study||17
10395581|NCT00689026|11539212|FG001|COMPLETED|Overall Study||24
10395582|NCT00689026|11539211|FG000|NOT COMPLETED|Overall Study||13
10395583|NCT00689026|11539212|FG001|NOT COMPLETED|Overall Study||6
10395584|NCT00689078|11539222|FG000|STARTED|Overall Study||9
10395585|NCT00689078|11539223|FG001|STARTED|Overall Study||9
10395586|NCT00689078|11539224|FG002|STARTED|Overall Study||9
10395587|NCT00689078|11539225|FG003|STARTED|Overall Study||9
10395588|NCT00689078|11539222|FG000|Intent to Treat|Overall Study||9
10719985|NCT02713204|11883647|FG007|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
10719986|NCT02713204|11883640|FG000|STARTED|From Week 12 up to Week 36||58
10719987|NCT02713204|11883641|FG001|STARTED|From Week 12 up to Week 36||0
10719988|NCT02713204|11883642|FG002|STARTED|From Week 12 up to Week 36||0
10719989|NCT02713204|11883643|FG003|STARTED|From Week 12 up to Week 36||57
10719990|NCT02713204|11883644|FG004|STARTED|From Week 12 up to Week 36||62
10719991|NCT02713204|11883645|FG005|STARTED|From Week 12 up to Week 36||60
10719992|NCT02713204|11883646|FG006|STARTED|From Week 12 up to Week 36||62
10719993|NCT02713204|11883647|FG007|STARTED|From Week 12 up to Week 36||58
10719994|NCT02713204|11883640|FG000|COMPLETED|From Week 12 up to Week 36||57
10719995|NCT02713204|11883641|FG001|COMPLETED|From Week 12 up to Week 36||0
10719996|NCT02713204|11883642|FG002|COMPLETED|From Week 12 up to Week 36||0
10719997|NCT02713204|11883643|FG003|COMPLETED|From Week 12 up to Week 36||53
10719998|NCT02713204|11883644|FG004|COMPLETED|From Week 12 up to Week 36||60
10395589|NCT00689078|11539223|FG001|Intent to Treat|Overall Study||7
10395590|NCT00689078|11539224|FG002|Intent to Treat|Overall Study||8
10395591|NCT00689078|11539225|FG003|Intent to Treat|Overall Study||8
10395592|NCT00689078|11539222|FG000|COMPLETED|Overall Study||9
10395593|NCT00689078|11539223|FG001|COMPLETED|Overall Study||7
10395594|NCT00689078|11539224|FG002|COMPLETED|Overall Study||8
10395595|NCT00689078|11539225|FG003|COMPLETED|Overall Study||8
10395596|NCT00689078|11539222|FG000|NOT COMPLETED|Overall Study||0
10395597|NCT00689078|11539223|FG001|NOT COMPLETED|Overall Study||2
10395598|NCT00689078|11539224|FG002|NOT COMPLETED|Overall Study||1
10395599|NCT00689078|11539225|FG003|NOT COMPLETED|Overall Study||1
10395600|NCT00689091|11539237|FG000|STARTED|Overall Study||10831
10395601|NCT00689091|11539238|FG001|STARTED|Overall Study||10770
10395602|NCT00689091|11539237|FG000|COMPLETED|Overall Study||9460
10395603|NCT00689091|11539238|FG001|COMPLETED|Overall Study||9376
10395604|NCT00689091|11539237|FG000|NOT COMPLETED|Overall Study||1371
10395605|NCT00689091|11539238|FG001|NOT COMPLETED|Overall Study||1394
10395606|NCT00689104|11539252|FG000|STARTED|Overall Study||497
10395607|NCT00689104|11539253|FG001|STARTED|Overall Study||497
10395608|NCT00689104|11539254|FG002|STARTED|Overall Study||498
10395609|NCT00689104|11539255|FG003|STARTED|Overall Study||495
10395610|NCT00689104|11539252|FG000|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|494
10428717|NCT00859898|11574776|FG001|STARTED|Overall Study||219
10395611|NCT00689104|11539253|FG001|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|493
10543376|NCT01483690|11696584|FG000|NOT COMPLETED|Overall Study||2
10543377|NCT01483690|11696585|FG001|NOT COMPLETED|Overall Study||5
10543378|NCT01483807|11696591|FG000|STARTED|First Treatment Phase (7 Weeks)||10
10543379|NCT01483807|11696592|FG001|STARTED|First Treatment Phase (7 Weeks)||10
10543380|NCT01483807|11696591|FG000|COMPLETED|First Treatment Phase (7 Weeks)||10
10543381|NCT01483807|11696592|FG001|COMPLETED|First Treatment Phase (7 Weeks)||10
10543382|NCT01483807|11696591|FG000|NOT COMPLETED|First Treatment Phase (7 Weeks)||0
10543383|NCT01483807|11696592|FG001|NOT COMPLETED|First Treatment Phase (7 Weeks)||0
10543384|NCT01483807|11696591|FG000|STARTED|Washout (2 Weeks)||10
10543385|NCT01483807|11696592|FG001|STARTED|Washout (2 Weeks)||10
10543386|NCT01483807|11696591|FG000|COMPLETED|Washout (2 Weeks)||10
10543387|NCT01483807|11696592|FG001|COMPLETED|Washout (2 Weeks)||10
10543388|NCT01483807|11696591|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10543389|NCT01483807|11696592|FG001|NOT COMPLETED|Washout (2 Weeks)||0
10543390|NCT01483807|11696591|FG000|STARTED|Second Treatment Phase (7 Weeks)||10
10543391|NCT01483807|11696592|FG001|STARTED|Second Treatment Phase (7 Weeks)||10
10543392|NCT01483807|11696591|FG000|COMPLETED|Second Treatment Phase (7 Weeks)||10
10543393|NCT01483807|11696592|FG001|COMPLETED|Second Treatment Phase (7 Weeks)||10
10543394|NCT01483807|11696591|FG000|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0
10543395|NCT01483807|11696592|FG001|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0
10543396|NCT01483924|11696605|FG000|STARTED|Overall Study||12
10543397|NCT01483924|11696606|FG001|STARTED|Overall Study||12
10543398|NCT01483924|11696607|FG002|STARTED|Overall Study||12
10543399|NCT01483924|11696608|FG003|STARTED|Overall Study||12
10543400|NCT01483924|11696609|FG004|STARTED|Overall Study||12
10543401|NCT01483924|11696605|FG000|COMPLETED|Overall Study||10
10543402|NCT01483924|11696606|FG001|COMPLETED|Overall Study||12
10543403|NCT01483924|11696607|FG002|COMPLETED|Overall Study||11
10543404|NCT01483924|11696608|FG003|COMPLETED|Overall Study||8
10543405|NCT01483924|11696609|FG004|COMPLETED|Overall Study||10
10543406|NCT01483924|11696605|FG000|NOT COMPLETED|Overall Study||2
10543407|NCT01483924|11696606|FG001|NOT COMPLETED|Overall Study||0
10543408|NCT01483924|11696607|FG002|NOT COMPLETED|Overall Study||1
10543409|NCT01483924|11696608|FG003|NOT COMPLETED|Overall Study||4
10543410|NCT01483924|11696609|FG004|NOT COMPLETED|Overall Study||2
10543411|NCT01483937|11696632|FG000|STARTED|Overall Study||15
10543412|NCT01483937|11696633|FG001|STARTED|Overall Study||17
10543413|NCT01483937|11696632|FG000|COMPLETED|Overall Study||11
10543414|NCT01483937|11696633|FG001|COMPLETED|Overall Study||14
10543415|NCT01483937|11696632|FG000|NOT COMPLETED|Overall Study||4
10395612|NCT00689104|11539254|FG002|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|496
10395613|NCT00689104|11539255|FG003|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|495
10395614|NCT00689104|11539252|FG000|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|480
10395615|NCT00689104|11539253|FG001|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|473
10395616|NCT00689104|11539254|FG002|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|478
10395617|NCT00689104|11539255|FG003|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|475
10395618|NCT00689104|11539252|FG000|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|291
10395619|NCT00689104|11539253|FG001|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|293
10395620|NCT00689104|11539254|FG002|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|281
10395621|NCT00689104|11539255|FG003|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|300
10395622|NCT00689104|11539252|FG000|COMPLETED|Overall Study||453
10395623|NCT00689104|11539253|FG001|COMPLETED|Overall Study||440
10543416|NCT01483937|11696633|FG001|NOT COMPLETED|Overall Study||3
10543417|NCT01483963|11696647|FG000|STARTED|Overall Study||10
10543418|NCT01483963|11696648|FG001|STARTED|Overall Study||10
10543419|NCT01483963|11696649|FG002|STARTED|Overall Study||10
10543420|NCT01483963|11696650|FG003|STARTED|Overall Study||10
10543421|NCT01483963|11696651|FG004|STARTED|Overall Study||10
10543422|NCT01483963|11696647|FG000|COMPLETED|Overall Study||10
10543423|NCT01483963|11696648|FG001|COMPLETED|Overall Study||10
10543424|NCT01483963|11696649|FG002|COMPLETED|Overall Study||10
10543425|NCT01483963|11696650|FG003|COMPLETED|Overall Study||10
10543426|NCT01483963|11696651|FG004|COMPLETED|Overall Study||10
10543427|NCT01483963|11696647|FG000|NOT COMPLETED|Overall Study||0
10543428|NCT01483963|11696648|FG001|NOT COMPLETED|Overall Study||0
10543429|NCT01483963|11696649|FG002|NOT COMPLETED|Overall Study||0
10395624|NCT00689104|11539254|FG002|COMPLETED|Overall Study||453
10395625|NCT00689104|11539255|FG003|COMPLETED|Overall Study||445
10719999|NCT02713204|11883645|FG005|COMPLETED|From Week 12 up to Week 36||59
10720000|NCT02713204|11883646|FG006|COMPLETED|From Week 12 up to Week 36||60
10720001|NCT02713204|11883647|FG007|COMPLETED|From Week 12 up to Week 36||54
10395626|NCT00689104|11539252|FG000|NOT COMPLETED|Overall Study||44
10395627|NCT00689104|11539253|FG001|NOT COMPLETED|Overall Study||57
10395628|NCT00689104|11539254|FG002|NOT COMPLETED|Overall Study||45
10395629|NCT00689104|11539255|FG003|NOT COMPLETED|Overall Study||50
10395630|NCT00689117|11539269|FG000|STARTED|Overall Study||476
10395631|NCT00689117|11539270|FG001|STARTED|Overall Study||467
10395632|NCT00689117|11539271|FG002|STARTED|Overall Study||464
10395633|NCT00689117|11539272|FG003|STARTED|Overall Study||242
10395634|NCT00689117|11539269|FG000|COMPLETED|Overall Study||414
10395635|NCT00689117|11539270|FG001|COMPLETED|Overall Study||416
10395636|NCT00689117|11539271|FG002|COMPLETED|Overall Study||405
10395637|NCT00689117|11539272|FG003|COMPLETED|Overall Study||211
10395638|NCT00689117|11539269|FG000|NOT COMPLETED|Overall Study||62
10395639|NCT00689117|11539270|FG001|NOT COMPLETED|Overall Study||51
10395640|NCT00689117|11539271|FG002|NOT COMPLETED|Overall Study||59
10395641|NCT00689117|11539272|FG003|NOT COMPLETED|Overall Study||31
10395642|NCT00689221|11539284|FG000|STARTED|Overall Study||272
10395643|NCT00689221|11539285|FG001|STARTED|Overall Study||273
10395644|NCT00689221|11539284|FG000|COMPLETED|Overall Study||233
10395645|NCT00689221|11539285|FG001|COMPLETED|Overall Study||237
10395646|NCT00689221|11539284|FG000|NOT COMPLETED|Overall Study||39
10395647|NCT00689221|11539285|FG001|NOT COMPLETED|Overall Study||36
10395648|NCT00689260|11539293|FG000|STARTED|Overall Study||21
10395649|NCT00689260|11539294|FG001|STARTED|Overall Study||21
10395650|NCT00689260|11539293|FG000|COMPLETED|Overall Study||19
10395651|NCT00689260|11539294|FG001|COMPLETED|Overall Study||21
10395652|NCT00689260|11539293|FG000|NOT COMPLETED|Overall Study||2
10395653|NCT00689260|11539294|FG001|NOT COMPLETED|Overall Study||0
10395654|NCT00689273|11539305|FG000|STARTED|Overall Study||79
10395655|NCT00689273|11539306|FG001|STARTED|Overall Study||78
10395656|NCT00689273|11539305|FG000|Treated|Overall Study||78
10395657|NCT00689273|11539306|FG001|Treated|Overall Study||78
10395658|NCT00689273|11539305|FG000|COMPLETED|Overall Study||66
10395659|NCT00689273|11539306|FG001|COMPLETED|Overall Study||73
10395660|NCT00689273|11539305|FG000|NOT COMPLETED|Overall Study||13
10395661|NCT00689273|11539306|FG001|NOT COMPLETED|Overall Study||5
10395662|NCT00689299|11539315|FG000|STARTED|Overall Study||58
10395663|NCT00689299|11539316|FG001|STARTED|Overall Study||57
10395664|NCT00689299|11539317|FG002|STARTED|Overall Study||54
10395665|NCT00689299|11539315|FG000|COMPLETED|Overall Study||51
10395666|NCT00689299|11539316|FG001|COMPLETED|Overall Study||54
10395667|NCT00689299|11539317|FG002|COMPLETED|Overall Study||49
10395668|NCT00689299|11539315|FG000|NOT COMPLETED|Overall Study||7
10395669|NCT00689299|11539316|FG001|NOT COMPLETED|Overall Study||3
10395670|NCT00689299|11539317|FG002|NOT COMPLETED|Overall Study||5
10395671|NCT00689338|11539325|FG000|STARTED|Overall Study||216
10395672|NCT00689338|11539325|FG000|COMPLETED|Overall Study||73
10395673|NCT00689338|11539325|FG000|NOT COMPLETED|Overall Study||143
10395674|NCT00689351|11539331|FG000|STARTED|Infant Series of Dosing||91
10395675|NCT00689351|11539332|FG001|STARTED|Infant Series of Dosing||89
10395676|NCT00689351|11539331|FG000|Vaccinated Dose 1|Infant Series of Dosing||88
10395677|NCT00689351|11539332|FG001|Vaccinated Dose 1|Infant Series of Dosing||89
10395678|NCT00689351|11539331|FG000|Vaccinated Dose 2|Infant Series of Dosing||86
10395679|NCT00689351|11539332|FG001|Vaccinated Dose 2|Infant Series of Dosing||88
10395680|NCT00689351|11539331|FG000|Vaccinated Dose 3|Infant Series of Dosing||85
10395681|NCT00689351|11539332|FG001|Vaccinated Dose 3|Infant Series of Dosing||88
10395682|NCT00689351|11539331|FG000|COMPLETED|Infant Series of Dosing||85
10395683|NCT00689351|11539332|FG001|COMPLETED|Infant Series of Dosing||88
10395684|NCT00689351|11539331|FG000|NOT COMPLETED|Infant Series of Dosing||6
10395685|NCT00689351|11539332|FG001|NOT COMPLETED|Infant Series of Dosing||1
10395686|NCT00689351|11539331|FG000|STARTED|After Infant Series||85
10395687|NCT00689351|11539332|FG001|STARTED|After Infant Series||88
10395688|NCT00689351|11539331|FG000|COMPLETED|After Infant Series||84
10395689|NCT00689351|11539332|FG001|COMPLETED|After Infant Series||88
10395690|NCT00689351|11539331|FG000|NOT COMPLETED|After Infant Series||1
10395691|NCT00689351|11539332|FG001|NOT COMPLETED|After Infant Series||0
10395692|NCT00689351|11539331|FG000|STARTED|Toddler Dose||84
10395693|NCT00689351|11539332|FG001|STARTED|Toddler Dose||88
10720002|NCT02713204|11883640|FG000|NOT COMPLETED|From Week 12 up to Week 36||1
10720003|NCT02713204|11883641|FG001|NOT COMPLETED|From Week 12 up to Week 36||0
10720004|NCT02713204|11883642|FG002|NOT COMPLETED|From Week 12 up to Week 36||0
10720005|NCT02713204|11883643|FG003|NOT COMPLETED|From Week 12 up to Week 36||4
10720006|NCT02713204|11883644|FG004|NOT COMPLETED|From Week 12 up to Week 36||2
10720007|NCT02713204|11883645|FG005|NOT COMPLETED|From Week 12 up to Week 36||1
10395694|NCT00689351|11539331|FG000|COMPLETED|Toddler Dose||84
10310064|NCT00121667|11443048|FG001|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||133
10310065|NCT00121667|11443049|FG002|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||113
10310066|NCT00121667|11443050|FG003|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||140
10310067|NCT00121719|11443072|FG000|STARTED|Dose Escalation (4 Weeks)||4
10310068|NCT00121719|11443073|FG001|STARTED|Dose Escalation (4 Weeks)||4
10310069|NCT00121719|11443074|FG002|STARTED|Dose Escalation (4 Weeks)||4
10310070|NCT00121719|11443075|FG003|STARTED|Dose Escalation (4 Weeks)||3
10310071|NCT00121719|11443076|FG004|STARTED|Dose Escalation (4 Weeks)||3
10310072|NCT00121719|11443077|FG005|STARTED|Dose Escalation (4 Weeks)||3
10310073|NCT00121719|11443078|FG006|STARTED|Dose Escalation (4 Weeks)||12
10310074|NCT00121719|11443079|FG007|STARTED|Dose Escalation (4 Weeks)||9
10310075|NCT00121719|11443080|FG008|STARTED|Dose Escalation (4 Weeks)||6
10310076|NCT00121719|11443081|FG009|STARTED|Dose Escalation (4 Weeks)||3
10310077|NCT00121719|11443082|FG010|STARTED|Dose Escalation (4 Weeks)||0
10310078|NCT00121719|11443083|FG011|STARTED|Dose Escalation (4 Weeks)||0
10310079|NCT00121719|11443084|FG012|STARTED|Dose Escalation (4 Weeks)||24
10310080|NCT00121719|11443085|FG013|STARTED|Dose Escalation (4 Weeks)||7
10310081|NCT00121719|11443072|FG000|COMPLETED|Dose Escalation (4 Weeks)||4
10310082|NCT00121719|11443073|FG001|COMPLETED|Dose Escalation (4 Weeks)||4
10310083|NCT00121719|11443074|FG002|COMPLETED|Dose Escalation (4 Weeks)||4
10720008|NCT02713204|11883646|FG006|NOT COMPLETED|From Week 12 up to Week 36||2
10720009|NCT02713204|11883647|FG007|NOT COMPLETED|From Week 12 up to Week 36||4
10720010|NCT02713230|11883667|FG000|STARTED|Overall Study||69
10720011|NCT02713230|11883668|FG001|STARTED|Overall Study||15
10720012|NCT02713230|11883669|FG002|STARTED|Overall Study||71
10310084|NCT00121719|11443075|FG003|COMPLETED|Dose Escalation (4 Weeks)||3
10310085|NCT00121719|11443076|FG004|COMPLETED|Dose Escalation (4 Weeks)||3
10310086|NCT00121719|11443077|FG005|COMPLETED|Dose Escalation (4 Weeks)||3
10310087|NCT00121719|11443078|FG006|COMPLETED|Dose Escalation (4 Weeks)||12
10310088|NCT00121719|11443079|FG007|COMPLETED|Dose Escalation (4 Weeks)||9
10310089|NCT00121719|11443080|FG008|COMPLETED|Dose Escalation (4 Weeks)||6
10310090|NCT00121719|11443081|FG009|COMPLETED|Dose Escalation (4 Weeks)||3
10310091|NCT00121719|11443082|FG010|COMPLETED|Dose Escalation (4 Weeks)||0
10310092|NCT00121719|11443083|FG011|COMPLETED|Dose Escalation (4 Weeks)||0
10310093|NCT00121719|11443084|FG012|COMPLETED|Dose Escalation (4 Weeks)||24
10310094|NCT00121719|11443085|FG013|COMPLETED|Dose Escalation (4 Weeks)||7
10720013|NCT02713230|11883667|FG000|COMPLETED|Overall Study||68
10310095|NCT00121719|11443072|FG000|NOT COMPLETED|Dose Escalation (4 Weeks)||0
10720014|NCT02713230|11883668|FG001|COMPLETED|Overall Study||15
10720015|NCT02713230|11883669|FG002|COMPLETED|Overall Study||71
10720016|NCT02713230|11883667|FG000|NOT COMPLETED|Overall Study||1
10720017|NCT02713230|11883668|FG001|NOT COMPLETED|Overall Study||0
10720018|NCT02713230|11883669|FG002|NOT COMPLETED|Overall Study||0
10720019|NCT02713243|11883678|FG000|STARTED|Overall Study||10
10720020|NCT02713243|11883679|FG001|STARTED|Overall Study||10
10720021|NCT02713243|11883678|FG000|PD Analysis Set|Overall Study||9
10720022|NCT02713243|11883679|FG001|PD Analysis Set|Overall Study||10
10720023|NCT02713243|11883678|FG000|PK Analysis Set|Overall Study||8
10395695|NCT00689351|11539332|FG001|COMPLETED|Toddler Dose||88
10395696|NCT00689351|11539331|FG000|NOT COMPLETED|Toddler Dose||0
10395697|NCT00689351|11539332|FG001|NOT COMPLETED|Toddler Dose||0
10395698|NCT00689390|11539344|FG000|STARTED|Overall Study||1907
10395699|NCT00689390|11539345|FG001|STARTED|Overall Study||47
10395700|NCT00689390|11539344|FG000|COMPLETED|Overall Study||1481
10395701|NCT00689390|11539345|FG001|COMPLETED|Overall Study||37
10395702|NCT00689390|11539344|FG000|NOT COMPLETED|Overall Study||426
10395703|NCT00689390|11539345|FG001|NOT COMPLETED|Overall Study||10
10395704|NCT00689481|11539358|FG000|STARTED|Overall Study||214
10395705|NCT00689481|11539359|FG001|STARTED|Overall Study||109
10395706|NCT00689481|11539358|FG000|COMPLETED|Overall Study||190
10395707|NCT00689481|11539359|FG001|COMPLETED|Overall Study||95
10395708|NCT00689481|11539358|FG000|NOT COMPLETED|Overall Study||24
10395709|NCT00689481|11539359|FG001|NOT COMPLETED|Overall Study||14
10395710|NCT00689572|11539367|FG000|STARTED|Overall Study||53
10395711|NCT00689572|11539368|FG001|STARTED|Overall Study||55
10395712|NCT00689572|11539367|FG000|COMPLETED|Overall Study||39
10395713|NCT00689572|11539368|FG001|COMPLETED|Overall Study||34
10395714|NCT00689572|11539367|FG000|NOT COMPLETED|Overall Study||14
10395715|NCT00689572|11539368|FG001|NOT COMPLETED|Overall Study||21
10395716|NCT00689611|11539376|FG000|STARTED|Overall Study||200
10395717|NCT00689611|11539377|FG001|STARTED|Overall Study||192
10395718|NCT00689611|11539376|FG000|COMPLETED|Overall Study||159
10395719|NCT00689611|11539377|FG001|COMPLETED|Overall Study||146
10395720|NCT00689611|11539376|FG000|NOT COMPLETED|Overall Study||41
10395721|NCT00689611|11539377|FG001|NOT COMPLETED|Overall Study||46
10395722|NCT00689728|11539386|FG000|STARTED|Double-Blind Treatment||35
10395723|NCT00689728|11539387|FG001|STARTED|Double-Blind Treatment||30
10395724|NCT00689728|11539388|FG002|STARTED|Double-Blind Treatment||35
10395725|NCT00689728|11539386|FG000|COMPLETED|Double-Blind Treatment||31
10395726|NCT00689728|11539387|FG001|COMPLETED|Double-Blind Treatment||26
10395727|NCT00689728|11539388|FG002|COMPLETED|Double-Blind Treatment||30
10395728|NCT00689728|11539386|FG000|NOT COMPLETED|Double-Blind Treatment||4
10395729|NCT00689728|11539387|FG001|NOT COMPLETED|Double-Blind Treatment||4
10395730|NCT00689728|11539388|FG002|NOT COMPLETED|Double-Blind Treatment||5
10395731|NCT00689728|11539386|FG000|STARTED|Rescue||31
10395732|NCT00689728|11539387|FG001|STARTED|Rescue||26
10395733|NCT00689728|11539388|FG002|STARTED|Rescue||30
10395734|NCT00689728|11539386|FG000|COMPLETED|Rescue||30
10395735|NCT00689728|11539387|FG001|COMPLETED|Rescue||24
10395736|NCT00689728|11539388|FG002|COMPLETED|Rescue||29
10395737|NCT00689728|11539386|FG000|NOT COMPLETED|Rescue||1
10395738|NCT00689728|11539387|FG001|NOT COMPLETED|Rescue||2
10395739|NCT00689728|11539388|FG002|NOT COMPLETED|Rescue||1
10395740|NCT00689728|11539386|FG000|STARTED|Optional Follow-Up|21 participants who completed the rescue period did not enter the optional follow-up period.|9
10395761|NCT00689871|11539441|FG000|STARTED|Overall Study|908 Implants|455
10395741|NCT00689728|11539387|FG001|STARTED|Optional Follow-Up|13 participants who completed the rescue period did not enter the optional follow-up period.|11
10395742|NCT00689728|11539388|FG002|STARTED|Optional Follow-Up|19 participants who completed the rescue period did not enter the optional follow-up period.|10
10395743|NCT00689728|11539386|FG000|COMPLETED|Optional Follow-Up||6
10395744|NCT00689728|11539387|FG001|COMPLETED|Optional Follow-Up||5
10395745|NCT00689728|11539388|FG002|COMPLETED|Optional Follow-Up||4
10395746|NCT00689728|11539386|FG000|NOT COMPLETED|Optional Follow-Up||3
10395747|NCT00689728|11539387|FG001|NOT COMPLETED|Optional Follow-Up||6
10395748|NCT00689728|11539388|FG002|NOT COMPLETED|Optional Follow-Up||6
10395749|NCT00689793|11539419|FG000|STARTED|Overall Study||78
10543430|NCT01483963|11696650|FG003|NOT COMPLETED|Overall Study||0
10543431|NCT01483963|11696651|FG004|NOT COMPLETED|Overall Study||0
10543432|NCT01484028|11696664|FG000|STARTED|Period 1||66
10543433|NCT01484028|11696665|FG001|STARTED|Period 1||70
10543434|NCT01484028|11696666|FG002|STARTED|Period 1||64
10543435|NCT01484028|11696667|FG003|STARTED|Period 1||67
10543436|NCT01484028|11696664|FG000|COMPLETED|Period 1||66
10658893|NCT02236767|11820099|FG000|COMPLETED|Overall Study||1
10658894|NCT02236767|11820099|FG000|NOT COMPLETED|Overall Study||0
10658895|NCT02236988|11820107|FG000|STARTED|Overall Study||16
10658896|NCT02236988|11820108|FG001|STARTED|Overall Study||16
10658897|NCT02236988|11820109|FG002|STARTED|Overall Study||18
10658898|NCT02236988|11820110|FG003|STARTED|Overall Study||30
10543437|NCT01484028|11696665|FG001|COMPLETED|Period 1||67
10543438|NCT01484028|11696666|FG002|COMPLETED|Period 1||64
10543439|NCT01484028|11696667|FG003|COMPLETED|Period 1||66
10543440|NCT01484028|11696664|FG000|NOT COMPLETED|Period 1||0
10658899|NCT02236988|11820107|FG000|COMPLETED|Overall Study||16
10658900|NCT02236988|11820108|FG001|COMPLETED|Overall Study||16
10310096|NCT00121719|11443073|FG001|NOT COMPLETED|Dose Escalation (4 Weeks)||0
10310097|NCT00121719|11443074|FG002|NOT COMPLETED|Dose Escalation (4 Weeks)||0
10310098|NCT00121719|11443075|FG003|NOT COMPLETED|Dose Escalation (4 Weeks)||0
10310099|NCT00121719|11443076|FG004|NOT COMPLETED|Dose Escalation (4 Weeks)||0
10310100|NCT00121719|11443077|FG005|NOT COMPLETED|Dose Escalation (4 Weeks)||0
10310101|NCT00121719|11443078|FG006|NOT COMPLETED|Dose Escalation (4 Weeks)||0
10310102|NCT00121719|11443079|FG007|NOT COMPLETED|Dose Escalation (4 Weeks)||0
10310103|NCT00121719|11443080|FG008|NOT COMPLETED|Dose Escalation (4 Weeks)||0
10310104|NCT00121719|11443081|FG009|NOT COMPLETED|Dose Escalation (4 Weeks)||0
10310105|NCT00121719|11443082|FG010|NOT COMPLETED|Dose Escalation (4 Weeks)||0
10310106|NCT00121719|11443083|FG011|NOT COMPLETED|Dose Escalation (4 Weeks)||0
10310107|NCT00121719|11443084|FG012|NOT COMPLETED|Dose Escalation (4 Weeks)||0
10720024|NCT02713243|11883679|FG001|PK Analysis Set|Overall Study||9
10720025|NCT02713243|11883678|FG000|COMPLETED|Overall Study||9
10720026|NCT02713243|11883679|FG001|COMPLETED|Overall Study||8
10720027|NCT02713243|11883678|FG000|NOT COMPLETED|Overall Study||1
10720028|NCT02713243|11883679|FG001|NOT COMPLETED|Overall Study||2
10310108|NCT00121719|11443085|FG013|NOT COMPLETED|Dose Escalation (4 Weeks)||0
10310109|NCT00121719|11443072|FG000|STARTED|Food-Effect Pilot Study (4 Weeks)||0
10310110|NCT00121719|11443073|FG001|STARTED|Food-Effect Pilot Study (4 Weeks)||0
10310111|NCT00121719|11443074|FG002|STARTED|Food-Effect Pilot Study (4 Weeks)||0
10310112|NCT00121719|11443075|FG003|STARTED|Food-Effect Pilot Study (4 Weeks)||0
10310113|NCT00121719|11443076|FG004|STARTED|Food-Effect Pilot Study (4 Weeks)||0
10310114|NCT00121719|11443077|FG005|STARTED|Food-Effect Pilot Study (4 Weeks)||0
10310115|NCT00121719|11443078|FG006|STARTED|Food-Effect Pilot Study (4 Weeks)||0
10310116|NCT00121719|11443079|FG007|STARTED|Food-Effect Pilot Study (4 Weeks)||0
10310117|NCT00121719|11443080|FG008|STARTED|Food-Effect Pilot Study (4 Weeks)||0
10310118|NCT00121719|11443081|FG009|STARTED|Food-Effect Pilot Study (4 Weeks)||0
10310119|NCT00121719|11443082|FG010|STARTED|Food-Effect Pilot Study (4 Weeks)||6
10310120|NCT00121719|11443083|FG011|STARTED|Food-Effect Pilot Study (4 Weeks)||5
10310121|NCT00121719|11443084|FG012|STARTED|Food-Effect Pilot Study (4 Weeks)||0
10310122|NCT00121719|11443085|FG013|STARTED|Food-Effect Pilot Study (4 Weeks)||0
10310123|NCT00121719|11443072|FG000|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10310124|NCT00121719|11443073|FG001|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10310125|NCT00121719|11443074|FG002|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10310126|NCT00121719|11443075|FG003|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10310127|NCT00121719|11443076|FG004|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10310128|NCT00121719|11443077|FG005|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10310129|NCT00121719|11443078|FG006|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10310130|NCT00121719|11443079|FG007|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10310131|NCT00121719|11443080|FG008|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10310132|NCT00121719|11443081|FG009|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10310133|NCT00121719|11443082|FG010|COMPLETED|Food-Effect Pilot Study (4 Weeks)||6
10310134|NCT00121719|11443083|FG011|COMPLETED|Food-Effect Pilot Study (4 Weeks)||5
10720029|NCT02713256|11883685|FG000|STARTED|Overall Study||15
10720030|NCT02713256|11883685|FG000|COMPLETED|Overall Study||15
10395750|NCT00689793|11539420|FG001|STARTED|Overall Study||76
10395751|NCT00689793|11539419|FG000|COMPLETED|Overall Study||74
10395752|NCT00689793|11539420|FG001|COMPLETED|Overall Study||71
10395753|NCT00689793|11539419|FG000|NOT COMPLETED|Overall Study||4
10395754|NCT00689793|11539420|FG001|NOT COMPLETED|Overall Study||5
10395755|NCT00689819|11539430|FG000|STARTED|Overall Study||65
10395756|NCT00689819|11539431|FG001|STARTED|Overall Study||58
10395757|NCT00689819|11539430|FG000|COMPLETED|Overall Study||45
10395758|NCT00689819|11539431|FG001|COMPLETED|Overall Study||43
10395759|NCT00689819|11539430|FG000|NOT COMPLETED|Overall Study||20
10395760|NCT00689819|11539431|FG001|NOT COMPLETED|Overall Study||15
10395762|NCT00689871|11539442|FG001|STARTED|Overall Study|127 Implants|98
10395763|NCT00689871|11539443|FG002|STARTED|Overall Study|288 Implants|147
10395764|NCT00689871|11539444|FG003|STARTED|Overall Study|25 Implants|15
10395765|NCT00689871|11539441|FG000|COMPLETED|Overall Study|35 Patients discontinued|280
10395766|NCT00689871|11539442|FG001|COMPLETED|Overall Study|35 Patients discontinued|46
10395767|NCT00689871|11539443|FG002|COMPLETED|Overall Study|28 Patients discontinued|74
10395768|NCT00689871|11539444|FG003|COMPLETED|Overall Study|4 Patients discontinued|8
10395769|NCT00689871|11539441|FG000|NOT COMPLETED|Overall Study||175
10395770|NCT00689871|11539442|FG001|NOT COMPLETED|Overall Study||52
10395771|NCT00689871|11539443|FG002|NOT COMPLETED|Overall Study||73
10395772|NCT00689871|11539444|FG003|NOT COMPLETED|Overall Study||7
10395773|NCT00689936|11539457|FG000|STARTED|Active Treatment Phase||535
10395774|NCT00689936|11539458|FG001|STARTED|Active Treatment Phase||541
10395775|NCT00689936|11539459|FG002|STARTED|Active Treatment Phase||547
10395776|NCT00689936|11539457|FG000|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|532
10395777|NCT00689936|11539458|FG001|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|540
10395778|NCT00689936|11539459|FG002|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|541
10395779|NCT00689936|11539457|FG000|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|3
10395780|NCT00689936|11539458|FG001|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|1
10395781|NCT00689936|11539459|FG002|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|6
10720031|NCT02713256|11883685|FG000|NOT COMPLETED|Overall Study||0
10720032|NCT02713425|11883689|FG000|STARTED|Overall Study||20
10720033|NCT02713425|11883689|FG000|COMPLETED|Overall Study||20
10720034|NCT02713425|11883689|FG000|NOT COMPLETED|Overall Study||0
10395782|NCT00689936|11539457|FG000|COMPLETED|Active Treatment Phase||0
10395783|NCT00689936|11539458|FG001|COMPLETED|Active Treatment Phase||0
10395784|NCT00689936|11539459|FG002|COMPLETED|Active Treatment Phase||0
10395785|NCT00689936|11539457|FG000|NOT COMPLETED|Active Treatment Phase||535
10395786|NCT00689936|11539458|FG001|NOT COMPLETED|Active Treatment Phase||541
10395787|NCT00689936|11539459|FG002|NOT COMPLETED|Active Treatment Phase||547
10395788|NCT00689936|11539457|FG000|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who discontinued treatment for reasons other than progressive disease.|87
10395789|NCT00689936|11539458|FG001|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who completed 18 cycles (Rd18) and did not experience progressive disease.|300
10395790|NCT00689936|11539459|FG002|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who completed 12 cycles MPT and did not experience progressive disease.|273
10395791|NCT00689936|11539457|FG000|COMPLETED|Progression Free Survival-PFS-Follow-Up||87
10395792|NCT00689936|11539458|FG001|COMPLETED|Progression Free Survival-PFS-Follow-Up||300
10395793|NCT00689936|11539459|FG002|COMPLETED|Progression Free Survival-PFS-Follow-Up||273
10395794|NCT00689936|11539457|FG000|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
10395795|NCT00689936|11539458|FG001|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
10395796|NCT00689936|11539459|FG002|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
10395797|NCT00689936|11539457|FG000|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|382
10395798|NCT00689936|11539458|FG001|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|463
10395799|NCT00689936|11539459|FG002|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|459
10395800|NCT00689936|11539457|FG000|COMPLETED|Long-Term Follow Up Phase||255
10395801|NCT00689936|11539458|FG001|COMPLETED|Long-Term Follow Up Phase||275
10395802|NCT00689936|11539459|FG002|COMPLETED|Long-Term Follow Up Phase||315
10395803|NCT00689936|11539457|FG000|NOT COMPLETED|Long-Term Follow Up Phase||127
10395804|NCT00689936|11539458|FG001|NOT COMPLETED|Long-Term Follow Up Phase||188
10395805|NCT00689936|11539459|FG002|NOT COMPLETED|Long-Term Follow Up Phase||144
10395806|NCT00690040|11539469|FG000|STARTED|Overall Study||145
10395807|NCT00690040|11539470|FG001|STARTED|Overall Study||148
10395808|NCT00690040|11539469|FG000|COMPLETED|Overall Study||145
10395809|NCT00690040|11539470|FG001|COMPLETED|Overall Study||148
10395810|NCT00690040|11539469|FG000|NOT COMPLETED|Overall Study||0
10395811|NCT00690040|11539470|FG001|NOT COMPLETED|Overall Study||0
10395812|NCT00690235|11539478|FG000|STARTED|Overall Study||17
10395813|NCT00690235|11539479|FG001|STARTED|Overall Study||16
10395814|NCT00690235|11539478|FG000|COMPLETED|Overall Study||12
10395815|NCT00690235|11539479|FG001|COMPLETED|Overall Study||12
10395816|NCT00690235|11539478|FG000|NOT COMPLETED|Overall Study||5
10395817|NCT00690235|11539479|FG001|NOT COMPLETED|Overall Study||4
10395818|NCT00690274|11539487|FG000|STARTED|Overall Study||29
10395819|NCT00690274|11539488|FG001|STARTED|Overall Study||23
10395820|NCT00690274|11539487|FG000|COMPLETED|Overall Study||23
10395821|NCT00690274|11539488|FG001|COMPLETED|Overall Study||15
10395822|NCT00690274|11539487|FG000|NOT COMPLETED|Overall Study||6
10543441|NCT01484028|11696665|FG001|NOT COMPLETED|Period 1||3
10543442|NCT01484028|11696666|FG002|NOT COMPLETED|Period 1||0
10543443|NCT01484028|11696667|FG003|NOT COMPLETED|Period 1||1
10543444|NCT01484028|11696664|FG000|STARTED|Period 2||66
10543445|NCT01484028|11696665|FG001|STARTED|Period 2||67
10543446|NCT01484028|11696666|FG002|STARTED|Period 2||64
10543447|NCT01484028|11696667|FG003|STARTED|Period 2||66
10543448|NCT01484028|11696664|FG000|COMPLETED|Period 2||66
10543449|NCT01484028|11696665|FG001|COMPLETED|Period 2||67
10543450|NCT01484028|11696666|FG002|COMPLETED|Period 2||64
10543451|NCT01484028|11696667|FG003|COMPLETED|Period 2||66
10543452|NCT01484028|11696664|FG000|NOT COMPLETED|Period 2||0
10720035|NCT02713490|11883695|FG000|STARTED|Overall Study||71
10720036|NCT02713490|11883696|FG001|STARTED|Overall Study||69
10720037|NCT02713490|11883695|FG000|COMPLETED|Overall Study||68
10543453|NCT01484028|11696665|FG001|NOT COMPLETED|Period 2||0
10720038|NCT02713490|11883696|FG001|COMPLETED|Overall Study||67
10720039|NCT02713490|11883695|FG000|NOT COMPLETED|Overall Study||3
10720040|NCT02713490|11883696|FG001|NOT COMPLETED|Overall Study||2
10543454|NCT01484028|11696666|FG002|NOT COMPLETED|Period 2||0
10543455|NCT01484028|11696667|FG003|NOT COMPLETED|Period 2||0
10395823|NCT00690274|11539488|FG001|NOT COMPLETED|Overall Study||8
10395824|NCT00690339|11539498|FG000|STARTED|Overall Study||492
10395825|NCT00690339|11539499|FG001|STARTED|Overall Study||225
10395826|NCT00690339|11539500|FG002|STARTED|Overall Study||156
10395827|NCT00690339|11539501|FG003|STARTED|Overall Study||68
10395828|NCT00690339|11539498|FG000|COMPLETED|Overall Study||375
10395829|NCT00690339|11539499|FG001|COMPLETED|Overall Study||144
10395830|NCT00690339|11539500|FG002|COMPLETED|Overall Study||99
10395831|NCT00690339|11539501|FG003|COMPLETED|Overall Study||43
10395832|NCT00690339|11539498|FG000|NOT COMPLETED|Overall Study||117
10395833|NCT00690339|11539499|FG001|NOT COMPLETED|Overall Study||81
10395834|NCT00690339|11539500|FG002|NOT COMPLETED|Overall Study||57
10395835|NCT00690339|11539501|FG003|NOT COMPLETED|Overall Study||25
10395836|NCT00690378|11539513|FG000|STARTED|Overall Study|Randomized|69
10395837|NCT00690378|11539514|FG001|STARTED|Overall Study|Randomized|68
10395838|NCT00690378|11539513|FG000|Treated|Overall Study||68
10395839|NCT00690378|11539514|FG001|Treated|Overall Study||67
10395840|NCT00690378|11539513|FG000|COMPLETED|Overall Study|Up to Late follow up (LFU) visit|49
10395841|NCT00690378|11539514|FG001|COMPLETED|Overall Study|Up to LFU visit|54
10395842|NCT00690378|11539513|FG000|NOT COMPLETED|Overall Study||20
10395843|NCT00690378|11539514|FG001|NOT COMPLETED|Overall Study||14
10395844|NCT00690430|11539522|FG000|STARTED|Core Phase|"Started indicates Full Analysis Set (FAS) and Safety Set."|53
10395845|NCT00690430|11539523|FG001|STARTED|Core Phase||57
10395846|NCT00690430|11539524|FG002|STARTED|Core Phase|This arm belongs to Extension Phase.|0
10395847|NCT00690430|11539522|FG000|COMPLETED|Core Phase||35
10395848|NCT00690430|11539523|FG001|COMPLETED|Core Phase||34
10395849|NCT00690430|11539524|FG002|COMPLETED|Core Phase||0
10395850|NCT00690430|11539522|FG000|NOT COMPLETED|Core Phase||18
10395851|NCT00690430|11539523|FG001|NOT COMPLETED|Core Phase||23
10395852|NCT00690430|11539524|FG002|NOT COMPLETED|Core Phase||0
10428718|NCT00859898|11574777|FG002|STARTED|Overall Study||208
10543456|NCT01484041|11696675|FG000|STARTED|Overall Study||12
10543457|NCT01484041|11696675|FG000|COMPLETED|Overall Study||12
10310135|NCT00121719|11443084|FG012|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10310136|NCT00121719|11443085|FG013|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10310137|NCT00121719|11443072|FG000|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10310138|NCT00121719|11443073|FG001|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10310139|NCT00121719|11443074|FG002|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10310140|NCT00121719|11443075|FG003|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10310141|NCT00121719|11443076|FG004|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10310142|NCT00121719|11443077|FG005|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10310143|NCT00121719|11443078|FG006|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10310144|NCT00121719|11443079|FG007|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10310145|NCT00121719|11443080|FG008|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10310146|NCT00121719|11443081|FG009|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10310147|NCT00121719|11443082|FG010|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10310148|NCT00121719|11443083|FG011|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10310149|NCT00121719|11443084|FG012|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10310150|NCT00121719|11443085|FG013|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10310151|NCT00121810|11443129|FG000|STARTED|Overall Study||151
10310152|NCT00121810|11443130|FG001|STARTED|Overall Study||154
10310153|NCT00121810|11443129|FG000|Safety Population|Overall Study||148
10310154|NCT00121810|11443130|FG001|Safety Population|Overall Study||153
10310155|NCT00121810|11443129|FG000|Intent-to-Treat (ITT) Population|Overall Study||148
10310156|NCT00121810|11443130|FG001|Intent-to-Treat (ITT) Population|Overall Study||151
10310157|NCT00121810|11443129|FG000|COMPLETED|Overall Study||121
10310158|NCT00121810|11443130|FG001|COMPLETED|Overall Study||115
10310159|NCT00121810|11443129|FG000|NOT COMPLETED|Overall Study||30
10310160|NCT00121810|11443130|FG001|NOT COMPLETED|Overall Study||39
10310161|NCT00121836|11443136|FG000|STARTED|Overall Study||109
10310162|NCT00121836|11443136|FG000|COMPLETED|Overall Study||54
10310163|NCT00121836|11443136|FG000|NOT COMPLETED|Overall Study||55
10310164|NCT00121992|11443143|FG000|STARTED|Overall Study||521
10310165|NCT00121992|11443144|FG001|STARTED|Overall Study||539
10310166|NCT00121992|11443143|FG000|Hormone-receptor Positive and HER2 Positive Status Subjects|Overall Study||28
10310167|NCT00121992|11443144|FG001|Hormone-receptor Positive and HER2 Positive Status Subjects|Overall Study||30
10310168|NCT00121992|11443143|FG000|Hormone-receptor Negative and HER2 Positive Status Subjects|Overall Study||24
10310169|NCT00121992|11443144|FG001|Hormone-receptor Negative and HER2 Positive Status Subjects|Overall Study||22
10310170|NCT00121992|11443143|FG000|Hormone-receptor Positive and HER2 Negative Status Subjects|Overall Study||209
10310171|NCT00121992|11443144|FG001|Hormone-receptor Positive and HER2 Negative Status Subjects|Overall Study||220
10310172|NCT00121992|11443143|FG000|Hormone-receptor Negative and HER2 Negative Status Subjects|Overall Study||92
10310173|NCT00121992|11443144|FG001|Hormone-receptor Negative and HER2 Negative Status Subjects|Overall Study||103
10310174|NCT00121992|11443143|FG000|COMPLETED|Overall Study||519
10310175|NCT00121992|11443144|FG001|COMPLETED|Overall Study||528
10310176|NCT00121992|11443143|FG000|NOT COMPLETED|Overall Study||2
10310177|NCT00121992|11443144|FG001|NOT COMPLETED|Overall Study||11
10310178|NCT00122109|11443152|FG000|STARTED|Overall Study|ITT|61
10310179|NCT00122109|11443153|FG001|STARTED|Overall Study|ITT|64
10310180|NCT00122109|11443152|FG000|COMPLETED|Overall Study||55
10310181|NCT00122109|11443153|FG001|COMPLETED|Overall Study||57
10310182|NCT00122109|11443152|FG000|NOT COMPLETED|Overall Study||6
10310183|NCT00122109|11443153|FG001|NOT COMPLETED|Overall Study||7
10310184|NCT00122135|11443164|FG000|STARTED|Overall Study||60
10310185|NCT00122135|11443165|FG001|STARTED|Overall Study||60
10310186|NCT00122135|11443164|FG000|COMPLETED|Overall Study||57
10310187|NCT00122135|11443165|FG001|COMPLETED|Overall Study||60
10310188|NCT00122135|11443164|FG000|NOT COMPLETED|Overall Study||3
10310189|NCT00122135|11443165|FG001|NOT COMPLETED|Overall Study||0
10310190|NCT00122187|11443173|FG000|STARTED|Overall Study||4
10310191|NCT00122187|11443174|FG001|STARTED|Overall Study||4
10310192|NCT00122187|11443173|FG000|Matched by Colonoscopy Volume|Overall Study||4
10310193|NCT00122187|11443174|FG001|Matched by Colonoscopy Volume|Overall Study||4
10310194|NCT00122187|11443173|FG000|Randomized to Intervention or Usual Care|Overall Study||4
10310195|NCT00122187|11443174|FG001|Randomized to Intervention or Usual Care|Overall Study||4
10310196|NCT00122187|11443173|FG000|Intervention Implemented|Overall Study||3
10310197|NCT00122187|11443174|FG001|Intervention Implemented|Overall Study||4
10310198|NCT00122187|11443173|FG000|Post-intervention Data Collection|Overall Study||2
10310199|NCT00122187|11443174|FG001|Post-intervention Data Collection|Overall Study||2
10310200|NCT00122187|11443173|FG000|COMPLETED|Overall Study||2
10310201|NCT00122187|11443174|FG001|COMPLETED|Overall Study||2
10310202|NCT00122187|11443173|FG000|NOT COMPLETED|Overall Study||2
10395853|NCT00690430|11539522|FG000|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|20
10395854|NCT00690430|11539523|FG001|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|6
10395855|NCT00690430|11539524|FG002|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|15
10395856|NCT00690430|11539522|FG000|COMPLETED|Extension Phase||2
10395857|NCT00690430|11539523|FG001|COMPLETED|Extension Phase||1
10395858|NCT00690430|11539524|FG002|COMPLETED|Extension Phase||2
10395859|NCT00690430|11539522|FG000|NOT COMPLETED|Extension Phase||18
10395860|NCT00690430|11539523|FG001|NOT COMPLETED|Extension Phase||5
10395861|NCT00690430|11539524|FG002|NOT COMPLETED|Extension Phase||13
10395862|NCT00690443|11539535|FG000|STARTED|Overall Study||23
10395863|NCT00690443|11539536|FG001|STARTED|Overall Study||21
10395864|NCT00690443|11539535|FG000|COMPLETED|Overall Study||22
10395865|NCT00690443|11539536|FG001|COMPLETED|Overall Study||19
10395866|NCT00690443|11539535|FG000|NOT COMPLETED|Overall Study||1
10395867|NCT00690443|11539536|FG001|NOT COMPLETED|Overall Study||2
10395868|NCT00690482|11539544|FG000|STARTED|Overall Study||61
10395869|NCT00690482|11539545|FG001|STARTED|Overall Study||57
10395870|NCT00690482|11539544|FG000|COMPLETED|Overall Study||57
10395871|NCT00690482|11539545|FG001|COMPLETED|Overall Study||54
10395872|NCT00690482|11539544|FG000|NOT COMPLETED|Overall Study||4
10395873|NCT00690482|11539545|FG001|NOT COMPLETED|Overall Study||3
10395874|NCT00690495|11539553|FG000|STARTED|Overall Study||50
10395875|NCT00690495|11539554|FG001|STARTED|Overall Study||50
10395876|NCT00690495|11539553|FG000|Primary Endpoint|Overall Study||50
10395877|NCT00690495|11539554|FG001|Primary Endpoint|Overall Study||50
10395878|NCT00690495|11539553|FG000|COMPLETED|Overall Study||50
10395879|NCT00690495|11539554|FG001|COMPLETED|Overall Study||50
10395880|NCT00690495|11539553|FG000|NOT COMPLETED|Overall Study||0
10395881|NCT00690495|11539554|FG001|NOT COMPLETED|Overall Study||0
10395882|NCT00690573|11539560|FG000|STARTED|Overall Study||25
10395883|NCT00690573|11539560|FG000|COMPLETED|Overall Study||16
10395884|NCT00690573|11539560|FG000|NOT COMPLETED|Overall Study||9
10395885|NCT00690612|11539564|FG000|STARTED|Overall Study||35
10395886|NCT00690612|11539564|FG000|COMPLETED|Overall Study||32
10395887|NCT00690612|11539564|FG000|NOT COMPLETED|Overall Study||3
10395888|NCT00690755|11539575|FG000|STARTED|Overall Study||30
10395889|NCT00690755|11539576|FG001|STARTED|Overall Study||0
10395890|NCT00690755|11539577|FG002|STARTED|Overall Study||97
10395891|NCT00690755|11539578|FG003|STARTED|Overall Study||20
10395892|NCT00690755|11539579|FG004|STARTED|Overall Study||0
10395893|NCT00690755|11539580|FG005|STARTED|Overall Study||10
10395894|NCT00690755|11539581|FG006|STARTED|Overall Study||0
10395895|NCT00690755|11539575|FG000|COMPLETED|Overall Study|Patient recruitment ended on 12/31/2010|28
10395896|NCT00690755|11539576|FG001|COMPLETED|Overall Study||0
10395897|NCT00690755|11539577|FG002|COMPLETED|Overall Study||51
10395898|NCT00690755|11539578|FG003|COMPLETED|Overall Study||15
10395899|NCT00690755|11539579|FG004|COMPLETED|Overall Study||0
10395900|NCT00690755|11539580|FG005|COMPLETED|Overall Study||6
10395901|NCT00690755|11539581|FG006|COMPLETED|Overall Study||0
10720041|NCT02713529|11883709|FG000|STARTED|Overall Study||8
10720042|NCT02713529|11883710|FG001|STARTED|Overall Study||7
10720043|NCT02713529|11883711|FG002|STARTED|Overall Study||42
10720044|NCT02713529|11883712|FG003|STARTED|Overall Study||31
10395902|NCT00690755|11539575|FG000|NOT COMPLETED|Overall Study||2
10720045|NCT02713529|11883713|FG004|STARTED|Overall Study||4
10720046|NCT02713529|11883714|FG005|STARTED|Overall Study||19
10720047|NCT02713529|11883715|FG006|STARTED|Overall Study||6
10720048|NCT02713529|11883709|FG000|COMPLETED|Overall Study||1
10310203|NCT00122187|11443174|FG001|NOT COMPLETED|Overall Study||2
10310204|NCT00122278|11443184|FG000|STARTED|Overall Study||106
10310205|NCT00122278|11443185|FG001|STARTED|Overall Study||99
10310206|NCT00122278|11443184|FG000|COMPLETED|Overall Study||104
10310207|NCT00122278|11443185|FG001|COMPLETED|Overall Study||99
10310208|NCT00122278|11443184|FG000|NOT COMPLETED|Overall Study||2
10310209|NCT00122278|11443185|FG001|NOT COMPLETED|Overall Study||0
10310210|NCT00122317|11443191|FG000|STARTED|Overall Study||187
10310211|NCT00122317|11443191|FG000|COMPLETED|Overall Study||176
10310212|NCT00122317|11443191|FG000|NOT COMPLETED|Overall Study||11
10310213|NCT00122369|11443198|FG000|STARTED|Overall Study||76
10310214|NCT00122369|11443199|FG001|STARTED|Overall Study||82
10310215|NCT00122369|11443200|FG002|STARTED|Overall Study||78
10310216|NCT00122369|11443198|FG000|COMPLETED|Overall Study||76
10310217|NCT00122369|11443199|FG001|COMPLETED|Overall Study||82
10310218|NCT00122369|11443200|FG002|COMPLETED|Overall Study||78
10310219|NCT00122369|11443198|FG000|NOT COMPLETED|Overall Study||0
10310220|NCT00122369|11443199|FG001|NOT COMPLETED|Overall Study||0
10310221|NCT00122369|11443200|FG002|NOT COMPLETED|Overall Study||0
10310222|NCT00122382|11443213|FG000|STARTED|Double-Blind Study|participants randomized|256
10310223|NCT00122382|11443214|FG001|STARTED|Double-Blind Study|participants randomized|255
10310224|NCT00122382|11443215|FG002|STARTED|Double-Blind Study||0
10310225|NCT00122382|11443213|FG000|Treated|Double-Blind Study||256
10310226|NCT00122382|11443214|FG001|Treated|Double-Blind Study||253
10310227|NCT00122382|11443215|FG002|Treated|Double-Blind Study||0
10395903|NCT00690755|11539576|FG001|NOT COMPLETED|Overall Study||0
10395904|NCT00690755|11539577|FG002|NOT COMPLETED|Overall Study||46
10395905|NCT00690755|11539578|FG003|NOT COMPLETED|Overall Study||5
10543458|NCT01484041|11696675|FG000|NOT COMPLETED|Overall Study||0
10543459|NCT01484054|11696679|FG000|STARTED|Period 1||50
10543460|NCT01484054|11696680|FG001|STARTED|Period 1||50
10543461|NCT01484054|11696679|FG000|COMPLETED|Period 1||50
10720049|NCT02713529|11883710|FG001|COMPLETED|Overall Study||3
10720050|NCT02713529|11883711|FG002|COMPLETED|Overall Study||11
10395906|NCT00690755|11539579|FG004|NOT COMPLETED|Overall Study||0
10395907|NCT00690755|11539580|FG005|NOT COMPLETED|Overall Study||4
10395908|NCT00690755|11539581|FG006|NOT COMPLETED|Overall Study||0
10395909|NCT00690794|11539599|FG000|STARTED|Overall Study||363
10395910|NCT00690794|11539600|FG001|STARTED|Overall Study||363
10395911|NCT00690794|11539599|FG000|COMPLETED|Overall Study||342
10395912|NCT00690794|11539600|FG001|COMPLETED|Overall Study||328
10395913|NCT00690794|11539599|FG000|NOT COMPLETED|Overall Study||21
10395914|NCT00690794|11539600|FG001|NOT COMPLETED|Overall Study||35
10395915|NCT00690820|11539608|FG000|STARTED|Period 1||8
10395916|NCT00690820|11539609|FG001|STARTED|Period 1||9
10395917|NCT00690820|11539608|FG000|COMPLETED|Period 1||8
10395918|NCT00690820|11539609|FG001|COMPLETED|Period 1||8
10395919|NCT00690820|11539608|FG000|NOT COMPLETED|Period 1||0
10395920|NCT00690820|11539609|FG001|NOT COMPLETED|Period 1||1
10395921|NCT00690820|11539608|FG000|STARTED|Period 2||8
10395922|NCT00690820|11539609|FG001|STARTED|Period 2||8
10395923|NCT00690820|11539608|FG000|COMPLETED|Period 2||8
10395924|NCT00690820|11539609|FG001|COMPLETED|Period 2||8
10395925|NCT00690820|11539608|FG000|NOT COMPLETED|Period 2||0
10395926|NCT00690820|11539609|FG001|NOT COMPLETED|Period 2||0
10395927|NCT00690833|11539615|FG000|STARTED|Overall Study||41
10395928|NCT00690833|11539615|FG000|COMPLETED|Overall Study||39
10395929|NCT00690833|11539615|FG000|NOT COMPLETED|Overall Study||2
10395930|NCT00690898|11539619|FG000|STARTED|SCREENING|Total of patients screened for the study.|108
10395931|NCT00690898|11539619|FG000|COMPLETED|SCREENING|Number of patients included in the study.|90
10395932|NCT00690898|11539619|FG000|NOT COMPLETED|SCREENING||18
10395933|NCT00690898|11539619|FG000|STARTED|TREATMENT|Total number of patients treated.|90
10720051|NCT02713529|11883712|FG003|COMPLETED|Overall Study||2
10720052|NCT02713529|11883713|FG004|COMPLETED|Overall Study||1
10395934|NCT00690898|11539619|FG000|COMPLETED|TREATMENT||64
10395935|NCT00690898|11539619|FG000|NOT COMPLETED|TREATMENT||26
10395936|NCT00690924|11539623|FG000|STARTED|Overall Study||16
10395937|NCT00690924|11539623|FG000|COMPLETED|Overall Study||16
10543462|NCT01484054|11696680|FG001|COMPLETED|Period 1||49
10720053|NCT02713529|11883714|FG005|COMPLETED|Overall Study||5
10310228|NCT00122382|11443213|FG000|COMPLETED|Double-Blind Study||232
10395938|NCT00690924|11539623|FG000|NOT COMPLETED|Overall Study||0
10543463|NCT01484054|11696679|FG000|NOT COMPLETED|Period 1||0
10543464|NCT01484054|11696680|FG001|NOT COMPLETED|Period 1||1
10310229|NCT00122382|11443214|FG001|COMPLETED|Double-Blind Study||227
10310230|NCT00122382|11443215|FG002|COMPLETED|Double-Blind Study||0
10310231|NCT00122382|11443213|FG000|NOT COMPLETED|Double-Blind Study||24
10310232|NCT00122382|11443214|FG001|NOT COMPLETED|Double-Blind Study||28
10310233|NCT00122382|11443215|FG002|NOT COMPLETED|Double-Blind Study||0
10310234|NCT00122382|11443213|FG000|STARTED|Open-Label Study||0
10310235|NCT00122382|11443214|FG001|STARTED|Open-Label Study||0
10310236|NCT00122382|11443215|FG002|STARTED|Open-Label Study||459
10310237|NCT00122382|11443213|FG000|COMPLETED|Open-Label Study||0
10310238|NCT00122382|11443214|FG001|COMPLETED|Open-Label Study||0
10310239|NCT00122382|11443215|FG002|COMPLETED|Open-Label Study||433
10310240|NCT00122382|11443213|FG000|NOT COMPLETED|Open-Label Study||0
10310241|NCT00122382|11443214|FG001|NOT COMPLETED|Open-Label Study||0
10310242|NCT00122382|11443215|FG002|NOT COMPLETED|Open-Label Study||26
10310243|NCT00122447|11443237|FG000|STARTED|Overall Study||18
10310244|NCT00122447|11443238|FG001|STARTED|Overall Study||18
10543465|NCT01484054|11696679|FG000|STARTED|Period 2||50
10543466|NCT01484054|11696680|FG001|STARTED|Period 2||49
10543467|NCT01484054|11696679|FG000|COMPLETED|Period 2||50
10543468|NCT01484054|11696680|FG001|COMPLETED|Period 2||49
10543469|NCT01484054|11696679|FG000|NOT COMPLETED|Period 2||0
10543470|NCT01484054|11696680|FG001|NOT COMPLETED|Period 2||0
10543471|NCT01484132|11696687|FG000|STARTED|Overall Study||113
10543472|NCT01484132|11696687|FG000|Pre-treatment Urine Sample|Overall Study|Urine samples were collected twice pre-treatment. 101 subjects completed at least one urine sample.|101
10543473|NCT01484132|11696687|FG000|COMPLETED|Overall Study|91 subjects had at least one pre-treatment and at least one post-treatment urine sample.|91
10543474|NCT01484132|11696687|FG000|NOT COMPLETED|Overall Study||22
10543475|NCT01484197|11696691|FG000|STARTED|Treatment Period 1||9
10543476|NCT01484197|11696692|FG001|STARTED|Treatment Period 1||9
10543477|NCT01484197|11696693|FG002|STARTED|Treatment Period 1||9
10543478|NCT01484197|11696694|FG003|STARTED|Treatment Period 1||9
10543479|NCT01484197|11696691|FG000|COMPLETED|Treatment Period 1||8
10543480|NCT01484197|11696692|FG001|COMPLETED|Treatment Period 1||9
10543481|NCT01484197|11696693|FG002|COMPLETED|Treatment Period 1||9
10543482|NCT01484197|11696694|FG003|COMPLETED|Treatment Period 1||9
10543483|NCT01484197|11696691|FG000|NOT COMPLETED|Treatment Period 1||1
10543484|NCT01484197|11696692|FG001|NOT COMPLETED|Treatment Period 1||0
10543485|NCT01484197|11696693|FG002|NOT COMPLETED|Treatment Period 1||0
10543486|NCT01484197|11696694|FG003|NOT COMPLETED|Treatment Period 1||0
10543487|NCT01484197|11696691|FG000|STARTED|Treatment Period 2|1 patient completed Period 1 but did not enter Period 2 due to a Protocol deviation.|7
10543488|NCT01484197|11696692|FG001|STARTED|Treatment Period 2|1 patient completed Period 1 but did not enter Period 2 due to an Adverse event (AE).|8
10543489|NCT01484197|11696693|FG002|STARTED|Treatment Period 2||9
10543490|NCT01484197|11696694|FG003|STARTED|Treatment Period 2||9
10543491|NCT01484197|11696691|FG000|COMPLETED|Treatment Period 2||7
10543492|NCT01484197|11696692|FG001|COMPLETED|Treatment Period 2||8
10543493|NCT01484197|11696693|FG002|COMPLETED|Treatment Period 2||9
10543494|NCT01484197|11696694|FG003|COMPLETED|Treatment Period 2||8
10658901|NCT02236988|11820109|FG002|COMPLETED|Overall Study||18
10658902|NCT02236988|11820110|FG003|COMPLETED|Overall Study||27
10658903|NCT02236988|11820107|FG000|NOT COMPLETED|Overall Study||0
10658904|NCT02236988|11820108|FG001|NOT COMPLETED|Overall Study||0
10658905|NCT02236988|11820109|FG002|NOT COMPLETED|Overall Study||0
10658906|NCT02236988|11820110|FG003|NOT COMPLETED|Overall Study||3
10658907|NCT02237001|11820161|FG000|STARTED|Overall Study||30
10658908|NCT02237001|11820161|FG000|6 Month Follow-up|Overall Study||27
10658909|NCT02237001|11820161|FG000|12 Month Follow-up|Overall Study||21
10658910|NCT02237001|11820161|FG000|24 Month Follow-up|Overall Study||19
10658911|NCT02237001|11820161|FG000|COMPLETED|Overall Study||19
10658912|NCT02237001|11820161|FG000|NOT COMPLETED|Overall Study||11
10658913|NCT02237092|11820165|FG000|STARTED|Overall Study||196
10658914|NCT02237092|11820165|FG000|COMPLETED|Overall Study||196
10658915|NCT02237092|11820165|FG000|NOT COMPLETED|Overall Study||0
10658916|NCT02237118|11820182|FG000|STARTED|Overall Study||60
10658917|NCT02237118|11820183|FG001|STARTED|Overall Study||63
10658918|NCT02237118|11820182|FG000|COMPLETED|Overall Study||59
10658919|NCT02237118|11820183|FG001|COMPLETED|Overall Study||62
10658920|NCT02237118|11820182|FG000|NOT COMPLETED|Overall Study||1
10658921|NCT02237118|11820183|FG001|NOT COMPLETED|Overall Study||1
10658922|NCT02237157|11820197|FG000|STARTED|Gemcitabine, Local Delivery (Dose 1)||20
10658923|NCT02237157|11820198|FG001|STARTED|Gemcitabine, Local Delivery (Dose 1)||0
10658924|NCT02237157|11820199|FG002|STARTED|Gemcitabine, Local Delivery (Dose 1)||0
10658925|NCT02237157|11820200|FG003|STARTED|Gemcitabine, Local Delivery (Dose 1)||0
10658926|NCT02237157|11820197|FG000|COMPLETED|Gemcitabine, Local Delivery (Dose 1)||16
10658927|NCT02237157|11820198|FG001|COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0
10658928|NCT02237157|11820199|FG002|COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0
10658929|NCT02237157|11820200|FG003|COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0
10658930|NCT02237157|11820197|FG000|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 1)||4
10658931|NCT02237157|11820198|FG001|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0
10658932|NCT02237157|11820199|FG002|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0
10658933|NCT02237157|11820200|FG003|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0
10658934|NCT02237157|11820197|FG000|STARTED|Gemcitabine, Local Delivery (Dose 2)||0
10658935|NCT02237157|11820198|FG001|STARTED|Gemcitabine, Local Delivery (Dose 2)||15
10658936|NCT02237157|11820199|FG002|STARTED|Gemcitabine, Local Delivery (Dose 2)||0
10658937|NCT02237157|11820200|FG003|STARTED|Gemcitabine, Local Delivery (Dose 2)||0
10658938|NCT02237157|11820197|FG000|COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
10658939|NCT02237157|11820198|FG001|COMPLETED|Gemcitabine, Local Delivery (Dose 2)||15
10658940|NCT02237157|11820199|FG002|COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
10658941|NCT02237157|11820200|FG003|COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
10658942|NCT02237157|11820197|FG000|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
10658943|NCT02237157|11820198|FG001|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
10543495|NCT01484197|11696691|FG000|NOT COMPLETED|Treatment Period 2||0
10543496|NCT01484197|11696692|FG001|NOT COMPLETED|Treatment Period 2||0
10543497|NCT01484197|11696693|FG002|NOT COMPLETED|Treatment Period 2||0
10543498|NCT01484197|11696694|FG003|NOT COMPLETED|Treatment Period 2||1
10543499|NCT01484197|11696691|FG000|STARTED|Treatment Period 3||7
10543500|NCT01484197|11696692|FG001|STARTED|Treatment Period 3||8
10543501|NCT01484197|11696693|FG002|STARTED|Treatment Period 3||9
10543502|NCT01484197|11696694|FG003|STARTED|Treatment Period 3||8
10543503|NCT01484197|11696691|FG000|COMPLETED|Treatment Period 3||7
10543504|NCT01484197|11696692|FG001|COMPLETED|Treatment Period 3||8
10543505|NCT01484197|11696693|FG002|COMPLETED|Treatment Period 3||9
10543506|NCT01484197|11696694|FG003|COMPLETED|Treatment Period 3||8
10543507|NCT01484197|11696691|FG000|NOT COMPLETED|Treatment Period 3||0
10543508|NCT01484197|11696692|FG001|NOT COMPLETED|Treatment Period 3||0
10543509|NCT01484197|11696693|FG002|NOT COMPLETED|Treatment Period 3||0
10543510|NCT01484197|11696694|FG003|NOT COMPLETED|Treatment Period 3||0
10543511|NCT01484197|11696691|FG000|STARTED|Treatment Period 4||7
10543512|NCT01484197|11696692|FG001|STARTED|Treatment Period 4||8
10543513|NCT01484197|11696693|FG002|STARTED|Treatment Period 4||9
10543514|NCT01484197|11696694|FG003|STARTED|Treatment Period 4|2 patients completed Period 3 but did not enter Period 4 due to a Protocol deviation and an AE.|6
10543515|NCT01484197|11696691|FG000|COMPLETED|Treatment Period 4||7
10310245|NCT00122447|11443239|FG002|STARTED|Overall Study||17
10310246|NCT00122447|11443240|FG003|STARTED|Overall Study||17
10310247|NCT00122447|11443237|FG000|COMPLETED|Overall Study||17
10310248|NCT00122447|11443238|FG001|COMPLETED|Overall Study||13
10310249|NCT00122447|11443239|FG002|COMPLETED|Overall Study||16
10310250|NCT00122447|11443240|FG003|COMPLETED|Overall Study||14
10310251|NCT00122447|11443237|FG000|NOT COMPLETED|Overall Study||1
10310252|NCT00122447|11443238|FG001|NOT COMPLETED|Overall Study||5
10310253|NCT00122447|11443239|FG002|NOT COMPLETED|Overall Study||1
10310254|NCT00122447|11443240|FG003|NOT COMPLETED|Overall Study||3
10310255|NCT00122460|11443256|FG000|STARTED|Overall Study|Intention To Treat population, treatment group as randomized|222
10310256|NCT00122460|11443257|FG001|STARTED|Overall Study|Intention To Treat population, treatment group as randomized|220
10310257|NCT00122460|11443256|FG000|COMPLETED|Overall Study||215
10310258|NCT00122460|11443257|FG001|COMPLETED|Overall Study||219
10310259|NCT00122460|11443256|FG000|NOT COMPLETED|Overall Study||7
10310260|NCT00122460|11443257|FG001|NOT COMPLETED|Overall Study||1
10310261|NCT00122681|11443265|FG000|STARTED|Overall Study||9325
10310262|NCT00122681|11443266|FG001|STARTED|Overall Study||9319
10310263|NCT00122681|11443265|FG000|COMPLETED|Overall Study||7811
10310264|NCT00122681|11443266|FG001|COMPLETED|Overall Study||7798
10310265|NCT00122681|11443265|FG000|NOT COMPLETED|Overall Study||1514
10310266|NCT00122681|11443266|FG001|NOT COMPLETED|Overall Study||1521
10310267|NCT00122954|11443282|FG000|STARTED|Overall Study||18
10310268|NCT00122954|11443283|FG001|STARTED|Overall Study||21
10310269|NCT00122954|11443282|FG000|COMPLETED|Overall Study||16
10310270|NCT00122954|11443283|FG001|COMPLETED|Overall Study||18
10310271|NCT00122954|11443282|FG000|NOT COMPLETED|Overall Study||2
10310272|NCT00122954|11443283|FG001|NOT COMPLETED|Overall Study||3
10310273|NCT00122980|11443291|FG000|STARTED|Overall Study|Randomized sample: 67; Intent-to-treat sample: 67|67
10310274|NCT00122980|11443292|FG001|STARTED|Overall Study|Randomized sample: 67; Intent-to-treat sample: 66|66
10310275|NCT00122980|11443291|FG000|COMPLETED|Overall Study|Study terminated early|24
10310276|NCT00122980|11443292|FG001|COMPLETED|Overall Study|Study terminated early|26
10310277|NCT00122980|11443291|FG000|NOT COMPLETED|Overall Study||43
10310278|NCT00122980|11443292|FG001|NOT COMPLETED|Overall Study||40
10310279|NCT00123110|11443301|FG000|STARTED|Overall Study||12
10310280|NCT00123110|11443302|FG001|STARTED|Overall Study||12
10310281|NCT00123110|11443303|FG002|STARTED|Overall Study||11
10310282|NCT00123110|11443301|FG000|COMPLETED|Overall Study||12
10310283|NCT00123110|11443302|FG001|COMPLETED|Overall Study||12
10310284|NCT00123110|11443303|FG002|COMPLETED|Overall Study||11
10310285|NCT00123110|11443301|FG000|NOT COMPLETED|Overall Study||0
10310286|NCT00123110|11443302|FG001|NOT COMPLETED|Overall Study||0
10310287|NCT00123110|11443303|FG002|NOT COMPLETED|Overall Study||0
10310288|NCT00123123|11443314|FG000|STARTED|Overall Study||59
10310289|NCT00123123|11443315|FG001|STARTED|Overall Study||58
10310290|NCT00123123|11443316|FG002|STARTED|Overall Study||58
10310291|NCT00123123|11443314|FG000|COMPLETED|Overall Study||59
10310292|NCT00123123|11443315|FG001|COMPLETED|Overall Study||58
10310293|NCT00123123|11443316|FG002|COMPLETED|Overall Study||58
10543516|NCT01484197|11696692|FG001|COMPLETED|Treatment Period 4||8
10543517|NCT01484197|11696693|FG002|COMPLETED|Treatment Period 4||9
10543518|NCT01484197|11696694|FG003|COMPLETED|Treatment Period 4||6
10543519|NCT01484197|11696691|FG000|NOT COMPLETED|Treatment Period 4||0
10543520|NCT01484197|11696692|FG001|NOT COMPLETED|Treatment Period 4||0
10310294|NCT00123123|11443314|FG000|NOT COMPLETED|Overall Study||0
10310295|NCT00123123|11443315|FG001|NOT COMPLETED|Overall Study||0
10310296|NCT00123123|11443316|FG002|NOT COMPLETED|Overall Study||0
10310297|NCT00123162|11443326|FG000|STARTED|Overall Study||13
10310298|NCT00123162|11443327|FG001|STARTED|Overall Study||12
10310299|NCT00123162|11443326|FG000|COMPLETED|Overall Study||13
10310300|NCT00123162|11443327|FG001|COMPLETED|Overall Study||12
10310301|NCT00123162|11443326|FG000|NOT COMPLETED|Overall Study||0
10310302|NCT00123162|11443327|FG001|NOT COMPLETED|Overall Study||0
10310303|NCT00123409|11443335|FG000|STARTED|Overall Study||72
10310304|NCT00123409|11443336|FG001|STARTED|Overall Study||74
10310305|NCT00123409|11443335|FG000|COMPLETED|Overall Study||68
10310306|NCT00123409|11443336|FG001|COMPLETED|Overall Study||71
10720054|NCT02713529|11883715|FG006|COMPLETED|Overall Study||2
10720055|NCT02713529|11883709|FG000|NOT COMPLETED|Overall Study||7
10720056|NCT02713529|11883710|FG001|NOT COMPLETED|Overall Study||4
10720057|NCT02713529|11883711|FG002|NOT COMPLETED|Overall Study||31
10720058|NCT02713529|11883712|FG003|NOT COMPLETED|Overall Study||29
10395939|NCT00691002|11539631|FG000|STARTED|8-week, Double-blind, 4-arm||353
10395940|NCT00691002|11539632|FG001|STARTED|8-week, Double-blind, 4-arm||342
10395941|NCT00691002|11539633|FG002|STARTED|8-week, Double-blind, 4-arm||363
10395942|NCT00691002|11539634|FG003|STARTED|8-week, Double-blind, 4-arm||181
10395943|NCT00691002|11539635|FG004|STARTED|8-week, Double-blind, 4-arm||0
10395944|NCT00691002|11539631|FG000|COMPLETED|8-week, Double-blind, 4-arm||325
10395945|NCT00691002|11539632|FG001|COMPLETED|8-week, Double-blind, 4-arm||308
10395946|NCT00691002|11539633|FG002|COMPLETED|8-week, Double-blind, 4-arm||340
10395947|NCT00691002|11539634|FG003|COMPLETED|8-week, Double-blind, 4-arm||169
10395948|NCT00691002|11539635|FG004|COMPLETED|8-week, Double-blind, 4-arm||0
10543521|NCT01484197|11696693|FG002|NOT COMPLETED|Treatment Period 4||0
10543522|NCT01484197|11696694|FG003|NOT COMPLETED|Treatment Period 4||0
10543523|NCT01484275|11696706|FG000|STARTED|Overall Study||43
10543524|NCT01484275|11696707|FG001|STARTED|Overall Study||42
10543525|NCT01484275|11696706|FG000|COMPLETED|Overall Study||0
10543526|NCT01484275|11696707|FG001|COMPLETED|Overall Study||0
10543527|NCT01484275|11696706|FG000|NOT COMPLETED|Overall Study||43
10543528|NCT01484275|11696707|FG001|NOT COMPLETED|Overall Study||42
10543529|NCT01484288|11696713|FG000|STARTED|Overall Study||11
10543530|NCT01484288|11696713|FG000|COMPLETED|Overall Study||11
10543531|NCT01484288|11696713|FG000|NOT COMPLETED|Overall Study||0
10548224|NCT01518244|11702041|FG000|STARTED|Overall Study||50
10548225|NCT01518244|11702041|FG000|COMPLETED|Overall Study||47
10548226|NCT01518244|11702041|FG000|NOT COMPLETED|Overall Study||3
10548227|NCT01518257|11702047|FG000|STARTED|Overall Study||61
10548228|NCT01518257|11702048|FG001|STARTED|Overall Study||60
10548229|NCT01518257|11702047|FG000|COMPLETED|Overall Study||59
10548230|NCT01518257|11702048|FG001|COMPLETED|Overall Study||60
10548231|NCT01518257|11702047|FG000|NOT COMPLETED|Overall Study||2
10548232|NCT01518257|11702048|FG001|NOT COMPLETED|Overall Study||0
10548233|NCT01518270|11702054|FG000|STARTED|Overall Study||179
10548234|NCT01518270|11702054|FG000|COMPLETED|Overall Study||179
10548235|NCT01518270|11702054|FG000|NOT COMPLETED|Overall Study||0
10548236|NCT01518309|11702058|FG000|STARTED|Overall Study||39
10548237|NCT01518309|11702058|FG000|COMPLETED|Overall Study||0
10548238|NCT01518309|11702058|FG000|NOT COMPLETED|Overall Study||39
10548239|NCT01518322|11702062|FG000|STARTED|Overall Study||235
10548240|NCT01518322|11702062|FG000|COMPLETED|Overall Study||222
10548241|NCT01518322|11702062|FG000|NOT COMPLETED|Overall Study||13
10548242|NCT01518374|11702071|FG000|STARTED|Overall Study||1768
10548243|NCT01518374|11702071|FG000|COMPLETED|Overall Study||1761
10548244|NCT01518374|11702071|FG000|NOT COMPLETED|Overall Study||7
10548245|NCT01518530|11702075|FG000|STARTED|Active Treatment Period||10
10548246|NCT01518530|11702075|FG000|COMPLETED|Active Treatment Period||9
10548247|NCT01518530|11702075|FG000|NOT COMPLETED|Active Treatment Period||1
10548248|NCT01518530|11702075|FG000|STARTED|Post-Treatment Follow-up||9
10548249|NCT01518530|11702075|FG000|COMPLETED|Post-Treatment Follow-up||9
10548250|NCT01518530|11702075|FG000|NOT COMPLETED|Post-Treatment Follow-up||0
10548251|NCT01518699|11702085|FG000|STARTED|Period 1||10
10548252|NCT01518699|11702086|FG001|STARTED|Period 1||9
10548253|NCT01518699|11702087|FG002|STARTED|Period 1||9
10548254|NCT01518699|11702088|FG003|STARTED|Period 1||10
10548255|NCT01518699|11702089|FG004|STARTED|Period 1||10
10548256|NCT01518699|11702090|FG005|STARTED|Period 1||9
10310307|NCT00123409|11443335|FG000|NOT COMPLETED|Overall Study||4
10310308|NCT00123409|11443336|FG001|NOT COMPLETED|Overall Study||3
10310309|NCT00123422|11443347|FG000|STARTED|Overall Study||35
10310310|NCT00123422|11443348|FG001|STARTED|Overall Study||33
10310311|NCT00123422|11443349|FG002|STARTED|Overall Study||35
10310312|NCT00123422|11443347|FG000|8-week Testing|Overall Study||32
10310313|NCT00123422|11443348|FG001|8-week Testing|Overall Study||30
10310314|NCT00123422|11443349|FG002|8-week Testing|Overall Study||27
10310315|NCT00123422|11443347|FG000|COMPLETED|Overall Study||31
10310316|NCT00123422|11443348|FG001|COMPLETED|Overall Study||27
10310317|NCT00123422|11443349|FG002|COMPLETED|Overall Study||25
10310318|NCT00123422|11443347|FG000|NOT COMPLETED|Overall Study||4
10310319|NCT00123422|11443348|FG001|NOT COMPLETED|Overall Study||6
10310320|NCT00123422|11443349|FG002|NOT COMPLETED|Overall Study||10
10310321|NCT00123474|11443361|FG000|STARTED|Randomized to Treatment||167
10310322|NCT00123474|11443362|FG001|STARTED|Randomized to Treatment||167
10310323|NCT00123474|11443363|FG002|STARTED|Randomized to Treatment||168
10310324|NCT00123474|11443364|FG003|STARTED|Randomized to Treatment||168
10310325|NCT00123474|11443361|FG000|COMPLETED|Randomized to Treatment||166
10310326|NCT00123474|11443362|FG001|COMPLETED|Randomized to Treatment||163
10310327|NCT00123474|11443363|FG002|COMPLETED|Randomized to Treatment||166
10310328|NCT00123474|11443364|FG003|COMPLETED|Randomized to Treatment||167
10310329|NCT00123474|11443361|FG000|NOT COMPLETED|Randomized to Treatment||1
10310330|NCT00123474|11443362|FG001|NOT COMPLETED|Randomized to Treatment||4
10310331|NCT00123474|11443363|FG002|NOT COMPLETED|Randomized to Treatment||2
10310332|NCT00123474|11443364|FG003|NOT COMPLETED|Randomized to Treatment||1
10310333|NCT00123474|11443361|FG000|STARTED|As Treated at Study Closure|Randomized to 50 mg BID but received 100 mg QD.|165
10310334|NCT00123474|11443362|FG001|STARTED|As Treated at Study Closure||163
10310335|NCT00123474|11443363|FG002|STARTED|As Treated at Study Closure||167
10310336|NCT00123474|11443364|FG003|STARTED|As Treated at Study Closure||167
10310337|NCT00123474|11443361|FG000|COMPLETED|As Treated at Study Closure||0
10310338|NCT00123474|11443362|FG001|COMPLETED|As Treated at Study Closure||0
10310339|NCT00123474|11443363|FG002|COMPLETED|As Treated at Study Closure|Randomized to 100 mg QD but received 50 mg BID.|0
10310340|NCT00123474|11443364|FG003|COMPLETED|As Treated at Study Closure||0
10310341|NCT00123474|11443361|FG000|NOT COMPLETED|As Treated at Study Closure||165
10310342|NCT00123474|11443362|FG001|NOT COMPLETED|As Treated at Study Closure||163
10310343|NCT00123474|11443363|FG002|NOT COMPLETED|As Treated at Study Closure||167
10310344|NCT00123474|11443364|FG003|NOT COMPLETED|As Treated at Study Closure||167
10310345|NCT00123487|11443397|FG000|STARTED|Randomized||306
10310346|NCT00123487|11443398|FG001|STARTED|Randomized||305
10310347|NCT00123487|11443397|FG000|COMPLETED|Randomized||305
10310348|NCT00123487|11443398|FG001|COMPLETED|Randomized||304
10310349|NCT00123487|11443397|FG000|NOT COMPLETED|Randomized||1
10310350|NCT00123487|11443398|FG001|NOT COMPLETED|Randomized||1
10310351|NCT00123487|11443397|FG000|STARTED|Treated With Study Drug|1 participant randomized to QD but received BID in error. 304 represents actual QD treatment.|304
10310352|NCT00123487|11443398|FG001|STARTED|Treated With Study Drug|1 participant randomized to QD but received BID in error. 305 represents actual BID treatment.|305
10310353|NCT00123487|11443397|FG000|COMPLETED|Treated With Study Drug||0
10310354|NCT00123487|11443398|FG001|COMPLETED|Treated With Study Drug||0
10310355|NCT00123487|11443397|FG000|NOT COMPLETED|Treated With Study Drug||304
10310356|NCT00123487|11443398|FG001|NOT COMPLETED|Treated With Study Drug||305
10310357|NCT00123604|11443407|FG000|STARTED|Overall Study||19
10310358|NCT00123604|11443408|FG001|STARTED|Overall Study||17
10310359|NCT00123604|11443407|FG000|COMPLETED|Overall Study||18
10310360|NCT00123604|11443408|FG001|COMPLETED|Overall Study||16
10310361|NCT00123604|11443407|FG000|NOT COMPLETED|Overall Study||1
10310362|NCT00123604|11443408|FG001|NOT COMPLETED|Overall Study||1
10310363|NCT00123630|11443416|FG000|STARTED|Overall Study||15
10395949|NCT00691002|11539631|FG000|NOT COMPLETED|8-week, Double-blind, 4-arm||28
10310364|NCT00123630|11443417|FG001|STARTED|Overall Study||15
10310365|NCT00123630|11443416|FG000|COMPLETED|Overall Study||15
10310366|NCT00123630|11443417|FG001|COMPLETED|Overall Study||15
10310367|NCT00123630|11443416|FG000|NOT COMPLETED|Overall Study||0
10310368|NCT00123630|11443417|FG001|NOT COMPLETED|Overall Study||0
10310369|NCT00123643|11443425|FG000|STARTED|Overall Study||20
10310370|NCT00123643|11443426|FG001|STARTED|Overall Study||16
10310371|NCT00123643|11443425|FG000|COMPLETED|Overall Study||20
10310372|NCT00123643|11443426|FG001|COMPLETED|Overall Study||16
10310373|NCT00123643|11443425|FG000|NOT COMPLETED|Overall Study||0
10310374|NCT00123643|11443426|FG001|NOT COMPLETED|Overall Study||0
10310375|NCT00123682|11443436|FG000|STARTED|Overall Study||1069
10310376|NCT00123682|11443437|FG001|STARTED|Overall Study||934
10310377|NCT00123682|11443438|FG002|STARTED|Overall Study||592
10310378|NCT00123682|11443439|FG003|STARTED|Overall Study||525
10310379|NCT00123682|11443436|FG000|COMPLETED|Overall Study||749
10310380|NCT00123682|11443437|FG001|COMPLETED|Overall Study||731
10310381|NCT00123682|11443438|FG002|COMPLETED|Overall Study||438
10310382|NCT00123682|11443439|FG003|COMPLETED|Overall Study||430
10310383|NCT00123682|11443436|FG000|NOT COMPLETED|Overall Study||320
10310384|NCT00123682|11443437|FG001|NOT COMPLETED|Overall Study||203
10310385|NCT00123682|11443438|FG002|NOT COMPLETED|Overall Study||154
10395950|NCT00691002|11539632|FG001|NOT COMPLETED|8-week, Double-blind, 4-arm||34
10395951|NCT00691002|11539633|FG002|NOT COMPLETED|8-week, Double-blind, 4-arm||23
10395952|NCT00691002|11539634|FG003|NOT COMPLETED|8-week, Double-blind, 4-arm||12
10395953|NCT00691002|11539635|FG004|NOT COMPLETED|8-week, Double-blind, 4-arm||0
10395954|NCT00691002|11539631|FG000|STARTED|52-week, Open-label, Single Arm||454
10720059|NCT02713529|11883713|FG004|NOT COMPLETED|Overall Study||3
10720060|NCT02713529|11883714|FG005|NOT COMPLETED|Overall Study||14
10720061|NCT02713529|11883715|FG006|NOT COMPLETED|Overall Study||4
10720062|NCT02713542|11883737|FG000|STARTED|Overall Study||60
10720063|NCT02713542|11883738|FG001|STARTED|Overall Study||30
10395955|NCT00691002|11539632|FG001|STARTED|52-week, Open-label, Single Arm||0
10395956|NCT00691002|11539633|FG002|STARTED|52-week, Open-label, Single Arm||0
10395957|NCT00691002|11539634|FG003|STARTED|52-week, Open-label, Single Arm||0
10395958|NCT00691002|11539635|FG004|STARTED|52-week, Open-label, Single Arm||0
10395959|NCT00691002|11539631|FG000|COMPLETED|52-week, Open-label, Single Arm||403
10395960|NCT00691002|11539632|FG001|COMPLETED|52-week, Open-label, Single Arm||0
10395961|NCT00691002|11539633|FG002|COMPLETED|52-week, Open-label, Single Arm||0
10395962|NCT00691002|11539634|FG003|COMPLETED|52-week, Open-label, Single Arm||0
10395963|NCT00691002|11539635|FG004|COMPLETED|52-week, Open-label, Single Arm||0
10395964|NCT00691002|11539631|FG000|NOT COMPLETED|52-week, Open-label, Single Arm||51
10395965|NCT00691002|11539632|FG001|NOT COMPLETED|52-week, Open-label, Single Arm||0
10395966|NCT00691002|11539633|FG002|NOT COMPLETED|52-week, Open-label, Single Arm||0
10395967|NCT00691002|11539634|FG003|NOT COMPLETED|52-week, Open-label, Single Arm||0
10395968|NCT00691002|11539635|FG004|NOT COMPLETED|52-week, Open-label, Single Arm||0
10395969|NCT00691015|11539646|FG000|STARTED|Overall Study||48
10395970|NCT00691015|11539646|FG000|COMPLETED|Overall Study||47
10395971|NCT00691015|11539646|FG000|NOT COMPLETED|Overall Study||1
10395972|NCT00691028|11539653|FG000|STARTED|Open-label Period||0
10395973|NCT00691028|11539654|FG001|STARTED|Open-label Period||0
10395974|NCT00691028|11539655|FG002|STARTED|Open-label Period||0
10395975|NCT00691028|11539656|FG003|STARTED|Open-label Period||327
10395976|NCT00691028|11539653|FG000|COMPLETED|Open-label Period||0
10395977|NCT00691028|11539654|FG001|COMPLETED|Open-label Period||0
10395978|NCT00691028|11539655|FG002|COMPLETED|Open-label Period||0
10395979|NCT00691028|11539656|FG003|COMPLETED|Open-label Period||307
10395980|NCT00691028|11539653|FG000|NOT COMPLETED|Open-label Period||0
10395981|NCT00691028|11539654|FG001|NOT COMPLETED|Open-label Period||0
10395982|NCT00691028|11539655|FG002|NOT COMPLETED|Open-label Period||0
10395983|NCT00691028|11539656|FG003|NOT COMPLETED|Open-label Period||20
10395984|NCT00691028|11539653|FG000|STARTED|Double-blind Period||99
10395985|NCT00691028|11539654|FG001|STARTED|Double-blind Period||104
10395986|NCT00691028|11539655|FG002|STARTED|Double-blind Period||104
10395987|NCT00691028|11539656|FG003|STARTED|Double-blind Period||0
10720064|NCT02713542|11883737|FG000|COMPLETED|Overall Study||42
10720065|NCT02713542|11883738|FG001|COMPLETED|Overall Study||24
10720066|NCT02713542|11883737|FG000|NOT COMPLETED|Overall Study||18
10720067|NCT02713542|11883738|FG001|NOT COMPLETED|Overall Study||6
10720068|NCT02713594|11883746|FG000|STARTED|Overall Study||952
10720069|NCT02713594|11883747|FG001|STARTED|Overall Study||948
10720070|NCT02713594|11883746|FG000|COMPLETED|Overall Study||562
10720071|NCT02713594|11883747|FG001|COMPLETED|Overall Study||552
10310386|NCT00123682|11443439|FG003|NOT COMPLETED|Overall Study||95
10310387|NCT00123734|11443453|FG000|STARTED|Overall Study||82
10310388|NCT00123734|11443453|FG000|COMPLETED|Overall Study||74
10310389|NCT00123734|11443453|FG000|NOT COMPLETED|Overall Study||8
10310390|NCT00123955|11443462|FG000|STARTED|Overall Study||42
10310391|NCT00123955|11443463|FG001|STARTED|Overall Study||38
10310392|NCT00123955|11443462|FG000|COMPLETED|Overall Study||37
10310393|NCT00123955|11443463|FG001|COMPLETED|Overall Study||34
10310394|NCT00123955|11443462|FG000|NOT COMPLETED|Overall Study||5
10310395|NCT00123955|11443463|FG001|NOT COMPLETED|Overall Study||4
10315475|NCT00179309|11449371|FG000|NOT COMPLETED|Treatment||4
10315476|NCT00179309|11449372|FG001|NOT COMPLETED|Treatment||5
10720072|NCT02713594|11883746|FG000|NOT COMPLETED|Overall Study||390
10315477|NCT00179309|11449371|FG000|STARTED|Crossover||0
10315478|NCT00179309|11449372|FG001|STARTED|Crossover|Crossover was allowed so that patients randomized to B could receive the vaccine upon progression.|3
10315479|NCT00179309|11449371|FG000|COMPLETED|Crossover||0
10315480|NCT00179309|11449372|FG001|COMPLETED|Crossover||3
10315481|NCT00179309|11449371|FG000|NOT COMPLETED|Crossover||0
10315482|NCT00179309|11449372|FG001|NOT COMPLETED|Crossover||0
10315483|NCT00179413|11449380|FG000|STARTED|Overall Study||282
10315484|NCT00179413|11449381|FG001|STARTED|Overall Study||267
10315485|NCT00179413|11449380|FG000|COMPLETED|Overall Study||157
10315486|NCT00179413|11449381|FG001|COMPLETED|Overall Study||152
10315487|NCT00179413|11449380|FG000|NOT COMPLETED|Overall Study||125
10315488|NCT00179413|11449381|FG001|NOT COMPLETED|Overall Study||115
10315489|NCT00179478|11449389|FG000|STARTED|Overall Study||81
10315490|NCT00179478|11449390|FG001|STARTED|Overall Study||74
10315491|NCT00179478|11449389|FG000|COMPLETED|Overall Study||68
10315492|NCT00179478|11449390|FG001|COMPLETED|Overall Study||59
10315493|NCT00179478|11449389|FG000|NOT COMPLETED|Overall Study||13
10315494|NCT00179478|11449390|FG001|NOT COMPLETED|Overall Study||15
10315495|NCT00179517|11449397|FG000|STARTED|Overall Study||20
10315496|NCT00179517|11449398|FG001|STARTED|Overall Study||20
10315497|NCT00179517|11449397|FG000|COMPLETED|Overall Study||18
10315498|NCT00179517|11449398|FG001|COMPLETED|Overall Study||19
10395988|NCT00691028|11539653|FG000|COMPLETED|Double-blind Period||86
10395989|NCT00691028|11539654|FG001|COMPLETED|Double-blind Period||91
10395990|NCT00691028|11539655|FG002|COMPLETED|Double-blind Period||95
10395991|NCT00691028|11539656|FG003|COMPLETED|Double-blind Period||0
10395992|NCT00691028|11539653|FG000|NOT COMPLETED|Double-blind Period||13
10395993|NCT00691028|11539654|FG001|NOT COMPLETED|Double-blind Period||13
10395994|NCT00691028|11539655|FG002|NOT COMPLETED|Double-blind Period||9
10395995|NCT00691028|11539656|FG003|NOT COMPLETED|Double-blind Period||0
10395996|NCT00691054|11539668|FG000|STARTED|Overall Study||20
10395997|NCT00691054|11539668|FG000|COMPLETED|Overall Study||19
10395998|NCT00691054|11539668|FG000|NOT COMPLETED|Overall Study||1
10395999|NCT00691093|11539674|FG000|STARTED|Overall Study||823
10396000|NCT00691093|11539674|FG000|COMPLETED|Overall Study||816
10396001|NCT00691093|11539674|FG000|NOT COMPLETED|Overall Study||7
10396002|NCT00691132|11539685|FG000|STARTED|Overall Study||53
10396003|NCT00691132|11539686|FG001|STARTED|Overall Study|107 total randomized. Approximately 1/2 per arm.|54
10396004|NCT00691132|11539685|FG000|COMPLETED|Overall Study||41
10396005|NCT00691132|11539686|FG001|COMPLETED|Overall Study|45 completed, but 4 excluded b/c urinary measures indicated they did not smoke study cigarettes.|41
10396006|NCT00691132|11539685|FG000|NOT COMPLETED|Overall Study||12
10396007|NCT00691132|11539686|FG001|NOT COMPLETED|Overall Study||13
10396008|NCT00691197|11539704|FG000|STARTED|Overall Study||166
10396009|NCT00691197|11539705|FG001|STARTED|Overall Study||80
10396010|NCT00691197|11539704|FG000|COMPLETED|Overall Study||155
10396011|NCT00691197|11539705|FG001|COMPLETED|Overall Study||75
10396012|NCT00691197|11539704|FG000|NOT COMPLETED|Overall Study||11
10396013|NCT00691197|11539705|FG001|NOT COMPLETED|Overall Study||5
10396014|NCT00691210|11539719|FG000|STARTED|Overall Study||3
10396015|NCT00691210|11539720|FG001|STARTED|Overall Study||5
10396016|NCT00691210|11539721|FG002|STARTED|Overall Study||3
10543532|NCT01484340|11696719|FG000|STARTED|Overall Study||281
10543533|NCT01484340|11696720|FG001|STARTED|Overall Study||279
10543534|NCT01484340|11696719|FG000|COMPLETED|Overall Study||281
10543535|NCT01484340|11696720|FG001|COMPLETED|Overall Study||279
10543536|NCT01484340|11696719|FG000|NOT COMPLETED|Overall Study||0
10543537|NCT01484340|11696720|FG001|NOT COMPLETED|Overall Study||0
10543538|NCT01484431|11696729|FG000|STARTED|Period 1: Low Dose||6
10543539|NCT01484431|11696730|FG001|STARTED|Period 1: Low Dose||7
10543540|NCT01484431|11696731|FG002|STARTED|Period 1: Low Dose||6
10543541|NCT01484431|11696729|FG000|Received 2 mg|Period 1: Low Dose||1
10543542|NCT01484431|11696730|FG001|Received 2 mg|Period 1: Low Dose||0
10543543|NCT01484431|11696731|FG002|Received 2 mg|Period 1: Low Dose||0
10543544|NCT01484431|11696729|FG000|Received 4 mg|Period 1: Low Dose||5
10543545|NCT01484431|11696730|FG001|Received 4 mg|Period 1: Low Dose||0
10543546|NCT01484431|11696731|FG002|Received 4 mg|Period 1: Low Dose||0
10543547|NCT01484431|11696729|FG000|Received 5 mg|Period 1: Low Dose||0
10658944|NCT02237157|11820199|FG002|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
10658945|NCT02237157|11820200|FG003|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
10720073|NCT02713594|11883747|FG001|NOT COMPLETED|Overall Study||396
10396017|NCT00691210|11539722|FG003|STARTED|Overall Study||9
10396018|NCT00691210|11539723|FG004|STARTED|Overall Study||5
10396019|NCT00691210|11539724|FG005|STARTED|Overall Study||7
10396020|NCT00691210|11539725|FG006|STARTED|Overall Study||6
10396021|NCT00691210|11539726|FG007|STARTED|Overall Study||0
10396022|NCT00691210|11539719|FG000|COMPLETED|Overall Study||3
10396023|NCT00691210|11539720|FG001|COMPLETED|Overall Study||5
10396024|NCT00691210|11539721|FG002|COMPLETED|Overall Study||3
10396025|NCT00691210|11539722|FG003|COMPLETED|Overall Study||6
10396026|NCT00691210|11539723|FG004|COMPLETED|Overall Study||5
10396027|NCT00691210|11539724|FG005|COMPLETED|Overall Study||6
10396028|NCT00691210|11539725|FG006|COMPLETED|Overall Study||6
10396029|NCT00691210|11539726|FG007|COMPLETED|Overall Study||0
10396030|NCT00691210|11539719|FG000|NOT COMPLETED|Overall Study||0
10396031|NCT00691210|11539720|FG001|NOT COMPLETED|Overall Study||0
10396032|NCT00691210|11539721|FG002|NOT COMPLETED|Overall Study||0
10396033|NCT00691210|11539722|FG003|NOT COMPLETED|Overall Study||3
10396034|NCT00691210|11539723|FG004|NOT COMPLETED|Overall Study||0
10543548|NCT01484431|11696730|FG001|Received 5 mg|Period 1: Low Dose||7
10543549|NCT01484431|11696731|FG002|Received 5 mg|Period 1: Low Dose||0
10543550|NCT01484431|11696729|FG000|Received 10 mg|Period 1: Low Dose||0
10543551|NCT01484431|11696730|FG001|Received 10 mg|Period 1: Low Dose||0
10543552|NCT01484431|11696731|FG002|Received 10 mg|Period 1: Low Dose||6
10658946|NCT02237157|11820197|FG000|STARTED|Gemcitabine, Local Delivery (Dose 3)||0
10396035|NCT00691210|11539724|FG005|NOT COMPLETED|Overall Study||1
10396036|NCT00691210|11539725|FG006|NOT COMPLETED|Overall Study||0
10396037|NCT00691210|11539726|FG007|NOT COMPLETED|Overall Study||0
10396038|NCT00691301|11539744|FG000|STARTED|Overall Study||55
10396039|NCT00691301|11539744|FG000|COMPLETED|Overall Study||1
10396040|NCT00691301|11539744|FG000|NOT COMPLETED|Overall Study||54
10396041|NCT00691327|11539756|FG000|STARTED|Overall Study||45055
10396042|NCT00691327|11539757|FG001|STARTED|Overall Study||39274
10396043|NCT00691327|11539756|FG000|COMPLETED|Overall Study||42214
10396044|NCT00691327|11539757|FG001|COMPLETED|Overall Study||36766
10396045|NCT00691327|11539756|FG000|NOT COMPLETED|Overall Study||2841
10396046|NCT00691327|11539757|FG001|NOT COMPLETED|Overall Study||2508
10396047|NCT00691483|11539765|FG000|STARTED|Overall Study||493
10396048|NCT00691483|11539766|FG001|STARTED|Overall Study||166
10396049|NCT00691483|11539765|FG000|Received Treatment|Overall Study||486
10396050|NCT00691483|11539766|FG001|Received Treatment|Overall Study||165
10396051|NCT00691483|11539765|FG000|COMPLETED|Overall Study|Completed refers to completion of the study.|425
10396052|NCT00691483|11539766|FG001|COMPLETED|Overall Study||141
10396053|NCT00691483|11539765|FG000|NOT COMPLETED|Overall Study||68
10396054|NCT00691483|11539766|FG001|NOT COMPLETED|Overall Study||25
10396055|NCT00691600|11539774|FG000|STARTED|Overall Study||12
10396056|NCT00691600|11539775|FG001|STARTED|Overall Study||11
10396057|NCT00691600|11539774|FG000|COMPLETED|Overall Study||12
10396058|NCT00691600|11539775|FG001|COMPLETED|Overall Study||11
10396059|NCT00691600|11539774|FG000|NOT COMPLETED|Overall Study||0
10396060|NCT00691600|11539775|FG001|NOT COMPLETED|Overall Study||0
10396061|NCT00691665|11539783|FG000|STARTED|Overall Study||65
10396062|NCT00691665|11539784|FG001|STARTED|Overall Study||65
10396063|NCT00691665|11539783|FG000|COMPLETED|Overall Study||65
10396064|NCT00691665|11539784|FG001|COMPLETED|Overall Study||65
10396065|NCT00691665|11539783|FG000|NOT COMPLETED|Overall Study||0
10396066|NCT00691665|11539784|FG001|NOT COMPLETED|Overall Study||0
10396067|NCT00691704|11539790|FG000|STARTED|Induction Therapy||18
10396068|NCT00691704|11539790|FG000|COMPLETED|Induction Therapy||16
10396069|NCT00691704|11539790|FG000|NOT COMPLETED|Induction Therapy||2
10396070|NCT00691704|11539790|FG000|STARTED|Two Years of Maintenance Therapy||16
10396071|NCT00691704|11539790|FG000|COMPLETED|Two Years of Maintenance Therapy||3
10396072|NCT00691704|11539790|FG000|NOT COMPLETED|Two Years of Maintenance Therapy||13
10396073|NCT00691808|11539797|FG000|STARTED|Overall Study||35
10396074|NCT00691808|11539798|FG001|STARTED|Overall Study||36
10396075|NCT00691808|11539799|FG002|STARTED|Overall Study||32
10396076|NCT00691808|11539797|FG000|COMPLETED|Overall Study||35
10396077|NCT00691808|11539798|FG001|COMPLETED|Overall Study||35
10396078|NCT00691808|11539799|FG002|COMPLETED|Overall Study||32
10396079|NCT00691808|11539797|FG000|NOT COMPLETED|Overall Study||0
10396080|NCT00691808|11539798|FG001|NOT COMPLETED|Overall Study||1
10396081|NCT00691808|11539799|FG002|NOT COMPLETED|Overall Study||0
10396082|NCT00691938|11539814|FG000|STARTED|Overall Study||5
10396083|NCT00691938|11539815|FG001|STARTED|Overall Study||3
10396084|NCT00691938|11539816|FG002|STARTED|Overall Study||6
10396085|NCT00691938|11539817|FG003|STARTED|Overall Study||8
10396086|NCT00691938|11539818|FG004|STARTED|Overall Study||10
10396087|NCT00691938|11539819|FG005|STARTED|Overall Study||6
10396088|NCT00691938|11539820|FG006|STARTED|Overall Study||14
10396089|NCT00691938|11539814|FG000|COMPLETED|Overall Study||4
10396090|NCT00691938|11539815|FG001|COMPLETED|Overall Study||3
10396091|NCT00691938|11539816|FG002|COMPLETED|Overall Study||6
10396092|NCT00691938|11539817|FG003|COMPLETED|Overall Study||8
10396093|NCT00691938|11539818|FG004|COMPLETED|Overall Study||10
10396094|NCT00691938|11539819|FG005|COMPLETED|Overall Study||6
10396095|NCT00691938|11539820|FG006|COMPLETED|Overall Study||14
10396096|NCT00691938|11539814|FG000|NOT COMPLETED|Overall Study||1
10396097|NCT00691938|11539815|FG001|NOT COMPLETED|Overall Study||0
10396098|NCT00691938|11539816|FG002|NOT COMPLETED|Overall Study||0
10396099|NCT00691938|11539817|FG003|NOT COMPLETED|Overall Study||0
10396100|NCT00691938|11539818|FG004|NOT COMPLETED|Overall Study||0
10396101|NCT00691938|11539819|FG005|NOT COMPLETED|Overall Study||0
10396102|NCT00691938|11539820|FG006|NOT COMPLETED|Overall Study||0
10396103|NCT00692185|11539833|FG000|STARTED|Overall Study||11
10396104|NCT00692185|11539834|FG001|STARTED|Overall Study||12
10396105|NCT00692185|11539833|FG000|COMPLETED|Overall Study||8
10396106|NCT00692185|11539834|FG001|COMPLETED|Overall Study||9
10396107|NCT00692185|11539833|FG000|NOT COMPLETED|Overall Study||3
10396108|NCT00692185|11539834|FG001|NOT COMPLETED|Overall Study||3
10396109|NCT00692198|11539844|FG000|STARTED|Overall Study||368
10396110|NCT00692198|11539845|FG001|STARTED|Overall Study||370
10396111|NCT00692198|11539844|FG000|COMPLETED|Overall Study||368
10396112|NCT00692198|11539845|FG001|COMPLETED|Overall Study||370
10396113|NCT00692198|11539844|FG000|NOT COMPLETED|Overall Study||0
10396114|NCT00692198|11539845|FG001|NOT COMPLETED|Overall Study||0
10396115|NCT00692211|11539854|FG000|STARTED|Overall Study||202
10396116|NCT00692211|11539855|FG001|STARTED|Overall Study||202
10310396|NCT00124020|11443471|FG000|STARTED|Overall Study||377
10310397|NCT00124020|11443472|FG001|STARTED|Overall Study||380
10310398|NCT00124020|11443471|FG000|COMPLETED|Overall Study||289
10310399|NCT00124020|11443472|FG001|COMPLETED|Overall Study||289
10310400|NCT00124020|11443471|FG000|NOT COMPLETED|Overall Study||88
10310401|NCT00124020|11443472|FG001|NOT COMPLETED|Overall Study||91
10310402|NCT00124072|11443482|FG000|STARTED|Overall Study||3017
10310403|NCT00124072|11443483|FG001|STARTED|Overall Study||3016
10310404|NCT00124072|11443484|FG002|STARTED|Overall Study||3016
10310405|NCT00124072|11443485|FG003|STARTED|Overall Study||3015
10310406|NCT00124072|11443482|FG000|COMPLETED|Overall Study||2503
10310407|NCT00124072|11443483|FG001|COMPLETED|Overall Study||2504
10310408|NCT00124072|11443484|FG002|COMPLETED|Overall Study||2524
10310409|NCT00124072|11443485|FG003|COMPLETED|Overall Study||2515
10310410|NCT00124072|11443482|FG000|NOT COMPLETED|Overall Study||514
10310411|NCT00124072|11443483|FG001|NOT COMPLETED|Overall Study||512
10310412|NCT00124072|11443484|FG002|NOT COMPLETED|Overall Study||492
10310413|NCT00124072|11443485|FG003|NOT COMPLETED|Overall Study||500
10310414|NCT00124176|11443497|FG000|STARTED|Overall Study||40
10310415|NCT00124176|11443498|FG001|STARTED|Overall Study||41
10310416|NCT00124176|11443497|FG000|Received Study Drug|Overall Study|3 never started on drug due to improvement but were kept in the study by intention to treat.|37
10310417|NCT00124176|11443498|FG001|Received Study Drug|Overall Study||41
10310418|NCT00124176|11443497|FG000|COMPLETED|Overall Study||40
10310419|NCT00124176|11443498|FG001|COMPLETED|Overall Study||41
10310420|NCT00124176|11443497|FG000|NOT COMPLETED|Overall Study||0
10310421|NCT00124176|11443498|FG001|NOT COMPLETED|Overall Study||0
10310422|NCT00124449|11443506|FG000|STARTED|6-month Double-Blind Treatment Period||28
10310423|NCT00124449|11443507|FG001|STARTED|6-month Double-Blind Treatment Period||28
10310424|NCT00124449|11443506|FG000|COMPLETED|6-month Double-Blind Treatment Period||22
10310425|NCT00124449|11443507|FG001|COMPLETED|6-month Double-Blind Treatment Period||17
10310426|NCT00124449|11443506|FG000|NOT COMPLETED|6-month Double-Blind Treatment Period||6
10310427|NCT00124449|11443507|FG001|NOT COMPLETED|6-month Double-Blind Treatment Period||11
10310428|NCT00124449|11443506|FG000|STARTED|18-Month Untreated Observation Period||22
10310429|NCT00124449|11443507|FG001|STARTED|18-Month Untreated Observation Period||17
10310430|NCT00124449|11443506|FG000|Completed Year 1 of Study|18-Month Untreated Observation Period||14
10310431|NCT00124449|11443507|FG001|Completed Year 1 of Study|18-Month Untreated Observation Period||9
10310432|NCT00124449|11443506|FG000|COMPLETED|18-Month Untreated Observation Period||7
10310433|NCT00124449|11443507|FG001|COMPLETED|18-Month Untreated Observation Period||4
10310434|NCT00124449|11443506|FG000|NOT COMPLETED|18-Month Untreated Observation Period||15
10310435|NCT00124449|11443507|FG001|NOT COMPLETED|18-Month Untreated Observation Period||13
10310436|NCT00124462|11443516|FG000|STARTED|Overall Study||40
10310437|NCT00124462|11443517|FG001|STARTED|Overall Study||40
10396117|NCT00692211|11539854|FG000|COMPLETED|Overall Study||202
10396118|NCT00692211|11539855|FG001|COMPLETED|Overall Study||202
10658947|NCT02237157|11820198|FG001|STARTED|Gemcitabine, Local Delivery (Dose 3)||0
10658948|NCT02237157|11820199|FG002|STARTED|Gemcitabine, Local Delivery (Dose 3)||11
10658949|NCT02237157|11820200|FG003|STARTED|Gemcitabine, Local Delivery (Dose 3)||0
10658950|NCT02237157|11820197|FG000|COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
10658951|NCT02237157|11820198|FG001|COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
10720074|NCT02713659|11883757|FG000|STARTED|Baseline||60
10396119|NCT00692211|11539854|FG000|NOT COMPLETED|Overall Study||0
10396120|NCT00692211|11539855|FG001|NOT COMPLETED|Overall Study||0
10658952|NCT02237157|11820199|FG002|COMPLETED|Gemcitabine, Local Delivery (Dose 3)||11
10658953|NCT02237157|11820200|FG003|COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
10658954|NCT02237157|11820197|FG000|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
10658955|NCT02237157|11820198|FG001|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
10720075|NCT02713659|11883758|FG001|STARTED|Baseline||60
10720076|NCT02713659|11883757|FG000|COMPLETED|Baseline||60
10720077|NCT02713659|11883758|FG001|COMPLETED|Baseline||60
10720078|NCT02713659|11883757|FG000|NOT COMPLETED|Baseline||0
10720079|NCT02713659|11883758|FG001|NOT COMPLETED|Baseline||0
10720080|NCT02713659|11883757|FG000|STARTED|6 Month Study Visit||60
10720081|NCT02713659|11883758|FG001|STARTED|6 Month Study Visit||60
10720082|NCT02713659|11883757|FG000|COMPLETED|6 Month Study Visit||53
10720083|NCT02713659|11883758|FG001|COMPLETED|6 Month Study Visit||47
10720084|NCT02713659|11883757|FG000|NOT COMPLETED|6 Month Study Visit||7
10720085|NCT02713659|11883758|FG001|NOT COMPLETED|6 Month Study Visit||13
10720086|NCT02713659|11883757|FG000|STARTED|12 Month Study Visit||57
10720087|NCT02713659|11883758|FG001|STARTED|12 Month Study Visit||55
10720088|NCT02713659|11883757|FG000|COMPLETED|12 Month Study Visit||54
10720089|NCT02713659|11883758|FG001|COMPLETED|12 Month Study Visit||52
10720090|NCT02713659|11883757|FG000|NOT COMPLETED|12 Month Study Visit||3
10720091|NCT02713659|11883758|FG001|NOT COMPLETED|12 Month Study Visit||3
10720092|NCT02713659|11883757|FG000|STARTED|18 Month Study Visit||58
10720093|NCT02713659|11883758|FG001|STARTED|18 Month Study Visit||53
10720094|NCT02713659|11883757|FG000|COMPLETED|18 Month Study Visit||50
10720095|NCT02713659|11883758|FG001|COMPLETED|18 Month Study Visit||50
10720096|NCT02713659|11883757|FG000|NOT COMPLETED|18 Month Study Visit||8
10720097|NCT02713659|11883758|FG001|NOT COMPLETED|18 Month Study Visit||3
10720098|NCT02713659|11883757|FG000|STARTED|24 Month Study Visit||57
10720099|NCT02713659|11883758|FG001|STARTED|24 Month Study Visit||52
10720100|NCT02713659|11883757|FG000|COMPLETED|24 Month Study Visit||49
10720101|NCT02713659|11883758|FG001|COMPLETED|24 Month Study Visit||44
10396121|NCT00692237|11539863|FG000|STARTED|Overall Study||30
10396122|NCT00692237|11539864|FG001|STARTED|Overall Study||29
10396123|NCT00692237|11539863|FG000|COMPLETED|Overall Study||29
10396124|NCT00692237|11539864|FG001|COMPLETED|Overall Study||25
10396125|NCT00692237|11539863|FG000|NOT COMPLETED|Overall Study||1
10396126|NCT00692237|11539864|FG001|NOT COMPLETED|Overall Study||4
10396127|NCT00692276|11539872|FG000|STARTED|Randomized Population||190
10396128|NCT00692276|11539873|FG001|STARTED|Randomized Population||201
10396129|NCT00692276|11539872|FG000|COMPLETED|Randomized Population||190
10396130|NCT00692276|11539873|FG001|COMPLETED|Randomized Population||201
10396131|NCT00692276|11539872|FG000|NOT COMPLETED|Randomized Population||0
10396132|NCT00692276|11539873|FG001|NOT COMPLETED|Randomized Population||0
10396133|NCT00692276|11539872|FG000|STARTED|Completed 24 Months||190
10396134|NCT00692276|11539873|FG001|STARTED|Completed 24 Months||201
10396135|NCT00692276|11539872|FG000|COMPLETED|Completed 24 Months||183
10396136|NCT00692276|11539873|FG001|COMPLETED|Completed 24 Months||187
10396137|NCT00692276|11539872|FG000|NOT COMPLETED|Completed 24 Months||7
10396138|NCT00692276|11539873|FG001|NOT COMPLETED|Completed 24 Months||14
10396139|NCT00692341|11539882|FG000|STARTED|Overall Study||8
10396140|NCT00692341|11539883|FG001|STARTED|Overall Study||8
10396141|NCT00692341|11539884|FG002|STARTED|Overall Study||8
10396142|NCT00692341|11539882|FG000|COMPLETED|Overall Study||8
10396143|NCT00692341|11539883|FG001|COMPLETED|Overall Study||8
10396144|NCT00692341|11539884|FG002|COMPLETED|Overall Study||8
10396145|NCT00692341|11539882|FG000|NOT COMPLETED|Overall Study||0
10396146|NCT00692341|11539883|FG001|NOT COMPLETED|Overall Study||0
10396147|NCT00692341|11539884|FG002|NOT COMPLETED|Overall Study||0
10396148|NCT00692406|11539892|FG000|STARTED|Overall Study|Initially this group was assigned to quit smoking before the second scan.|80
10396149|NCT00692406|11539892|FG000|COMPLETED|Overall Study|This group quit smoking before their second scan.|23
10396150|NCT00692406|11539892|FG000|NOT COMPLETED|Overall Study||57
10396151|NCT00692419|11539898|FG000|STARTED|Overall Study||100
10396152|NCT00692419|11539899|FG001|STARTED|Overall Study||120
10396153|NCT00692419|11539898|FG000|COMPLETED|Overall Study||84
10396154|NCT00692419|11539899|FG001|COMPLETED|Overall Study||102
10396155|NCT00692419|11539898|FG000|NOT COMPLETED|Overall Study||16
10396156|NCT00692419|11539899|FG001|NOT COMPLETED|Overall Study||18
10396157|NCT00692692|11539909|FG000|STARTED|Overall Study||20
10396158|NCT00692692|11539910|FG001|STARTED|Overall Study||16
10396159|NCT00692692|11539909|FG000|COMPLETED|Overall Study||20
10396160|NCT00692692|11539910|FG001|COMPLETED|Overall Study||16
10396161|NCT00692692|11539909|FG000|NOT COMPLETED|Overall Study||0
10396162|NCT00692692|11539910|FG001|NOT COMPLETED|Overall Study||0
10396163|NCT00692770|11539918|FG000|STARTED|Overall Study||556
10396164|NCT00692770|11539919|FG001|STARTED|Overall Study||558
10396165|NCT00692770|11539918|FG000|Participants Received Treatment|Overall Study||553
10396166|NCT00692770|11539919|FG001|Participants Received Treatment|Overall Study||554
10396167|NCT00692770|11539918|FG000|COMPLETED|Overall Study||0
10396168|NCT00692770|11539919|FG001|COMPLETED|Overall Study||0
10396169|NCT00692770|11539918|FG000|NOT COMPLETED|Overall Study||556
10396170|NCT00692770|11539919|FG001|NOT COMPLETED|Overall Study||558
10396171|NCT00692978|11539933|FG000|STARTED|FP From Active 250 ug MDI Inhaler||15
10396172|NCT00692978|11539934|FG001|STARTED|FP From Active 250 ug MDI Inhaler||15
10396173|NCT00692978|11539933|FG000|COMPLETED|FP From Active 250 ug MDI Inhaler||15
10396174|NCT00692978|11539934|FG001|COMPLETED|FP From Active 250 ug MDI Inhaler||15
10396175|NCT00692978|11539933|FG000|NOT COMPLETED|FP From Active 250 ug MDI Inhaler||0
10396176|NCT00692978|11539934|FG001|NOT COMPLETED|FP From Active 250 ug MDI Inhaler||0
10396177|NCT00692978|11539933|FG000|STARTED|FP1.5 Microns Size With MDI Inhaler||15
10396178|NCT00692978|11539934|FG001|STARTED|FP1.5 Microns Size With MDI Inhaler||15
10396179|NCT00692978|11539933|FG000|COMPLETED|FP1.5 Microns Size With MDI Inhaler||15
10396180|NCT00692978|11539934|FG001|COMPLETED|FP1.5 Microns Size With MDI Inhaler||15
10396181|NCT00692978|11539933|FG000|NOT COMPLETED|FP1.5 Microns Size With MDI Inhaler||0
10396182|NCT00692978|11539934|FG001|NOT COMPLETED|FP1.5 Microns Size With MDI Inhaler||0
10396183|NCT00692978|11539933|FG000|STARTED|FP 3 Microns Size With MDI Inhaler||15
10396184|NCT00692978|11539934|FG001|STARTED|FP 3 Microns Size With MDI Inhaler||15
10396185|NCT00692978|11539933|FG000|COMPLETED|FP 3 Microns Size With MDI Inhaler||15
10720102|NCT02713659|11883757|FG000|NOT COMPLETED|24 Month Study Visit||8
10720103|NCT02713659|11883758|FG001|NOT COMPLETED|24 Month Study Visit||8
10720104|NCT02713698|11883767|FG000|STARTED|Overall Study||20
10720105|NCT02713698|11883768|FG001|STARTED|Overall Study||20
10720106|NCT02713698|11883769|FG002|STARTED|Overall Study||20
10720107|NCT02713698|11883767|FG000|COMPLETED|Overall Study||20
10720108|NCT02713698|11883768|FG001|COMPLETED|Overall Study||20
10720109|NCT02713698|11883769|FG002|COMPLETED|Overall Study||20
10720110|NCT02713698|11883767|FG000|NOT COMPLETED|Overall Study||0
10310438|NCT00124462|11443516|FG000|COMPLETED|Overall Study||29
10310439|NCT00124462|11443517|FG001|COMPLETED|Overall Study||27
10310440|NCT00124462|11443516|FG000|NOT COMPLETED|Overall Study||11
10310441|NCT00124462|11443517|FG001|NOT COMPLETED|Overall Study||13
10310442|NCT00124514|11443528|FG000|STARTED|Overall Study||6
10310443|NCT00124514|11443529|FG001|STARTED|Overall Study||9
10310444|NCT00124514|11443530|FG002|STARTED|Overall Study||8
10310445|NCT00124514|11443531|FG003|STARTED|Overall Study||6
10310446|NCT00124514|11443532|FG004|STARTED|Overall Study||2
10310447|NCT00124514|11443528|FG000|COMPLETED|Overall Study||2
10310448|NCT00124514|11443529|FG001|COMPLETED|Overall Study||7
10310449|NCT00124514|11443530|FG002|COMPLETED|Overall Study||7
10310450|NCT00124514|11443531|FG003|COMPLETED|Overall Study||5
10310451|NCT00124514|11443532|FG004|COMPLETED|Overall Study||1
10310452|NCT00124514|11443528|FG000|NOT COMPLETED|Overall Study||4
10310453|NCT00124514|11443529|FG001|NOT COMPLETED|Overall Study||2
10310454|NCT00124514|11443530|FG002|NOT COMPLETED|Overall Study||1
10310455|NCT00124514|11443531|FG003|NOT COMPLETED|Overall Study||1
10310456|NCT00124514|11443532|FG004|NOT COMPLETED|Overall Study||1
10310457|NCT00124579|11443539|FG000|STARTED|Induction||7
10310458|NCT00124579|11443539|FG000|COMPLETED|Induction||2
10310459|NCT00124579|11443539|FG000|NOT COMPLETED|Induction||5
10310460|NCT00124579|11443539|FG000|STARTED|Maintenance||2
10310461|NCT00124579|11443539|FG000|COMPLETED|Maintenance||0
10310462|NCT00124579|11443539|FG000|NOT COMPLETED|Maintenance||2
10310463|NCT00124618|11443544|FG000|STARTED|Overall Study||58
10310464|NCT00124618|11443544|FG000|COMPLETED|Overall Study||57
10310465|NCT00124618|11443544|FG000|NOT COMPLETED|Overall Study||1
10310466|NCT00124657|11443551|FG000|STARTED|Overall Study||18
10310467|NCT00124657|11443552|FG001|STARTED|Overall Study||5
10310468|NCT00124657|11443553|FG002|STARTED|Overall Study||39
10310469|NCT00124657|11443551|FG000|COMPLETED|Overall Study||2
10310470|NCT00124657|11443552|FG001|COMPLETED|Overall Study||0
10310471|NCT00124657|11443553|FG002|COMPLETED|Overall Study||7
10310472|NCT00124657|11443551|FG000|NOT COMPLETED|Overall Study||16
10396186|NCT00692978|11539934|FG001|COMPLETED|FP 3 Microns Size With MDI Inhaler||15
10396187|NCT00692978|11539933|FG000|NOT COMPLETED|FP 3 Microns Size With MDI Inhaler||0
10396188|NCT00692978|11539934|FG001|NOT COMPLETED|FP 3 Microns Size With MDI Inhaler||0
10396189|NCT00692978|11539933|FG000|STARTED|FP 6 Microns Size With MDI Inhaler||15
10396190|NCT00692978|11539934|FG001|STARTED|FP 6 Microns Size With MDI Inhaler||15
10396191|NCT00692978|11539933|FG000|COMPLETED|FP 6 Microns Size With MDI Inhaler||15
10396192|NCT00692978|11539934|FG001|COMPLETED|FP 6 Microns Size With MDI Inhaler||15
10396193|NCT00692978|11539933|FG000|NOT COMPLETED|FP 6 Microns Size With MDI Inhaler||0
10396194|NCT00692978|11539934|FG001|NOT COMPLETED|FP 6 Microns Size With MDI Inhaler||0
10428719|NCT00859898|11574775|FG000|COMPLETED|Overall Study||183
10428720|NCT00859898|11574776|FG001|COMPLETED|Overall Study||188
10428721|NCT00859898|11574777|FG002|COMPLETED|Overall Study||181
10428722|NCT00859898|11574775|FG000|NOT COMPLETED|Overall Study||28
10428723|NCT00859898|11574776|FG001|NOT COMPLETED|Overall Study||31
10428724|NCT00859898|11574777|FG002|NOT COMPLETED|Overall Study||27
10428725|NCT00859937|11574788|FG000|STARTED|Overall Study||41
10428726|NCT00859937|11574789|FG001|STARTED|Overall Study||14
10428727|NCT00859937|11574788|FG000|COMPLETED|Overall Study||40
10428728|NCT00859937|11574789|FG001|COMPLETED|Overall Study||14
10428729|NCT00859937|11574788|FG000|NOT COMPLETED|Overall Study||1
10428730|NCT00859937|11574789|FG001|NOT COMPLETED|Overall Study||0
10428731|NCT00859950|11574797|FG000|STARTED|Overall Study||49
10428732|NCT00859950|11574798|FG001|STARTED|Overall Study||21
10428733|NCT00859950|11574797|FG000|COMPLETED|Overall Study||49
10428734|NCT00859950|11574798|FG001|COMPLETED|Overall Study||21
10428735|NCT00859950|11574797|FG000|NOT COMPLETED|Overall Study||0
10428736|NCT00859950|11574798|FG001|NOT COMPLETED|Overall Study||0
10428737|NCT00859976|11574806|FG000|STARTED|Overall Study||82
10428738|NCT00859976|11574807|FG001|STARTED|Overall Study||85
10428739|NCT00859976|11574806|FG000|COMPLETED|Overall Study||66
10428740|NCT00859976|11574807|FG001|COMPLETED|Overall Study||67
10428741|NCT00859976|11574806|FG000|NOT COMPLETED|Overall Study||16
10428742|NCT00859976|11574807|FG001|NOT COMPLETED|Overall Study||18
10428743|NCT00860015|11574813|FG000|STARTED|Overall Study||12
10428744|NCT00860015|11574813|FG000|COMPLETED|Overall Study||12
10428745|NCT00860015|11574813|FG000|NOT COMPLETED|Overall Study||0
10428746|NCT00860028|11574819|FG000|STARTED|Placebo Controlled Pretreatment Period||15
10428747|NCT00860028|11574820|FG001|STARTED|Placebo Controlled Pretreatment Period||15
10428748|NCT00860028|11574819|FG000|COMPLETED|Placebo Controlled Pretreatment Period||13
10428749|NCT00860028|11574820|FG001|COMPLETED|Placebo Controlled Pretreatment Period||14
10428750|NCT00860028|11574819|FG000|NOT COMPLETED|Placebo Controlled Pretreatment Period||2
10428751|NCT00860028|11574820|FG001|NOT COMPLETED|Placebo Controlled Pretreatment Period||1
10428752|NCT00860028|11574819|FG000|STARTED|Smoking Cessation Phase||13
10428753|NCT00860028|11574820|FG001|STARTED|Smoking Cessation Phase||14
10428754|NCT00860028|11574819|FG000|COMPLETED|Smoking Cessation Phase||13
10428755|NCT00860028|11574820|FG001|COMPLETED|Smoking Cessation Phase||12
10428756|NCT00860028|11574819|FG000|NOT COMPLETED|Smoking Cessation Phase||0
10396195|NCT00693160|11539954|FG000|STARTED|Overall Study||14
10396196|NCT00693160|11539955|FG001|STARTED|Overall Study||16
10396197|NCT00693160|11539954|FG000|COMPLETED|Overall Study||14
10396198|NCT00693160|11539955|FG001|COMPLETED|Overall Study||16
10396199|NCT00693160|11539954|FG000|NOT COMPLETED|Overall Study||0
10396200|NCT00693160|11539955|FG001|NOT COMPLETED|Overall Study||0
10310473|NCT00124657|11443552|FG001|NOT COMPLETED|Overall Study||5
10310474|NCT00124657|11443553|FG002|NOT COMPLETED|Overall Study||32
10310475|NCT00124709|11443576|FG000|STARTED|Overall Study||546
10310476|NCT00124709|11443577|FG001|STARTED|Overall Study||545
10310477|NCT00124709|11443576|FG000|Patients Who Received Study Medication|Overall Study||543
10310478|NCT00124709|11443577|FG001|Patients Who Received Study Medication|Overall Study||544
10310479|NCT00124709|11443576|FG000|COMPLETED|Overall Study|232 Participants entered the OL phase of the study.|291
10310480|NCT00124709|11443577|FG001|COMPLETED|Overall Study|232 Participants entered the OL phase of the study.|273
10310481|NCT00124709|11443576|FG000|NOT COMPLETED|Overall Study||255
10310482|NCT00124709|11443577|FG001|NOT COMPLETED|Overall Study||272
10310483|NCT00124735|11443593|FG000|STARTED|Overall Study||5
10310484|NCT00124735|11443594|FG001|STARTED|Overall Study||8
10310485|NCT00124735|11443595|FG002|STARTED|Overall Study||18
10310486|NCT00124735|11443596|FG003|STARTED|Overall Study||21
10310487|NCT00124735|11443597|FG004|STARTED|Overall Study||19
10310488|NCT00124735|11443598|FG005|STARTED|Overall Study||7
10310489|NCT00124735|11443599|FG006|STARTED|Overall Study||6
10310490|NCT00124735|11443600|FG007|STARTED|Overall Study||20
10310491|NCT00124735|11443601|FG008|STARTED|Overall Study||25
10310492|NCT00124735|11443602|FG009|STARTED|Overall Study||20
10310493|NCT00124735|11443593|FG000|COMPLETED|Overall Study||4
10310494|NCT00124735|11443594|FG001|COMPLETED|Overall Study||6
10310495|NCT00124735|11443595|FG002|COMPLETED|Overall Study||18
10310496|NCT00124735|11443596|FG003|COMPLETED|Overall Study||18
10310497|NCT00124735|11443597|FG004|COMPLETED|Overall Study||17
10310498|NCT00124735|11443598|FG005|COMPLETED|Overall Study||5
10310499|NCT00124735|11443599|FG006|COMPLETED|Overall Study||6
10310500|NCT00124735|11443600|FG007|COMPLETED|Overall Study||19
10310501|NCT00124735|11443601|FG008|COMPLETED|Overall Study||22
10310502|NCT00124735|11443602|FG009|COMPLETED|Overall Study||18
10310503|NCT00124735|11443593|FG000|NOT COMPLETED|Overall Study||1
10310504|NCT00124735|11443594|FG001|NOT COMPLETED|Overall Study||2
10310505|NCT00124735|11443595|FG002|NOT COMPLETED|Overall Study||0
10310506|NCT00124735|11443596|FG003|NOT COMPLETED|Overall Study||3
10310507|NCT00124735|11443597|FG004|NOT COMPLETED|Overall Study||2
10543553|NCT01484431|11696729|FG000|COMPLETED|Period 1: Low Dose||6
10543554|NCT01484431|11696730|FG001|COMPLETED|Period 1: Low Dose||7
10543555|NCT01484431|11696731|FG002|COMPLETED|Period 1: Low Dose||6
10720111|NCT02713698|11883768|FG001|NOT COMPLETED|Overall Study||0
10720112|NCT02713698|11883769|FG002|NOT COMPLETED|Overall Study||0
10720113|NCT02713711|11883777|FG000|STARTED|Overall Study||9
10543556|NCT01484431|11696729|FG000|NOT COMPLETED|Period 1: Low Dose||0
10543557|NCT01484431|11696730|FG001|NOT COMPLETED|Period 1: Low Dose||0
10543558|NCT01484431|11696731|FG002|NOT COMPLETED|Period 1: Low Dose||0
10543559|NCT01484431|11696729|FG000|STARTED|Period 1: High Dose||6
10543560|NCT01484431|11696730|FG001|STARTED|Period 1: High Dose||7
10310508|NCT00124735|11443598|FG005|NOT COMPLETED|Overall Study||2
10310509|NCT00124735|11443599|FG006|NOT COMPLETED|Overall Study||0
10310510|NCT00124735|11443600|FG007|NOT COMPLETED|Overall Study||1
10310511|NCT00124735|11443601|FG008|NOT COMPLETED|Overall Study||3
10310512|NCT00124735|11443602|FG009|NOT COMPLETED|Overall Study||2
10310513|NCT00124748|11443618|FG000|STARTED|Overall Study||157
10310514|NCT00124748|11443619|FG001|STARTED|Overall Study||319
10310515|NCT00124748|11443618|FG000|Safety Population|Overall Study||157
10310516|NCT00124748|11443619|FG001|Safety Population|Overall Study||316
10310517|NCT00124748|11443618|FG000|COMPLETED|Overall Study||14
10310518|NCT00124748|11443619|FG001|COMPLETED|Overall Study||35
10310519|NCT00124748|11443618|FG000|NOT COMPLETED|Overall Study||143
10310520|NCT00124748|11443619|FG001|NOT COMPLETED|Overall Study||284
10310521|NCT00124917|11443625|FG000|STARTED|Overall Study||6
10310522|NCT00124917|11443625|FG000|COMPLETED|Overall Study||3
10310523|NCT00124917|11443625|FG000|NOT COMPLETED|Overall Study||3
10310524|NCT00124943|11443634|FG000|STARTED|Phase I||3
10396201|NCT00693225|11539963|FG000|STARTED|Overall Study||43
10310525|NCT00124943|11443635|FG001|STARTED|Phase I||3
10310526|NCT00124943|11443636|FG002|STARTED|Phase I||3
10310527|NCT00124943|11443637|FG003|STARTED|Phase I||3
10310528|NCT00124943|11443634|FG000|COMPLETED|Phase I||3
10310529|NCT00124943|11443635|FG001|COMPLETED|Phase I||3
10720114|NCT02713711|11883778|FG001|STARTED|Overall Study||6
10720115|NCT02713711|11883779|FG002|STARTED|Overall Study||6
10720116|NCT02713711|11883780|FG003|STARTED|Overall Study||10
10720117|NCT02713711|11883777|FG000|COMPLETED|Overall Study||9
10720118|NCT02713711|11883778|FG001|COMPLETED|Overall Study||6
10720119|NCT02713711|11883779|FG002|COMPLETED|Overall Study||6
10720120|NCT02713711|11883780|FG003|COMPLETED|Overall Study||10
10720121|NCT02713711|11883777|FG000|NOT COMPLETED|Overall Study||0
10396202|NCT00693225|11539964|FG001|STARTED|Overall Study||48
10396203|NCT00693225|11539963|FG000|COMPLETED|Overall Study||41
10396204|NCT00693225|11539964|FG001|COMPLETED|Overall Study||43
10396205|NCT00693225|11539963|FG000|NOT COMPLETED|Overall Study||2
10396206|NCT00693225|11539964|FG001|NOT COMPLETED|Overall Study||5
10396207|NCT00693303|11539970|FG000|STARTED|Overall Study||21
10396208|NCT00693303|11539970|FG000|COMPLETED|Overall Study||21
10396209|NCT00693303|11539970|FG000|NOT COMPLETED|Overall Study||0
10396210|NCT00693420|11539976|FG000|STARTED|Overall Study||137
10396211|NCT00693420|11539977|FG001|STARTED|Overall Study||141
10396212|NCT00693420|11539976|FG000|COMPLETED|Overall Study||131
10396213|NCT00693420|11539977|FG001|COMPLETED|Overall Study||126
10396214|NCT00693420|11539976|FG000|NOT COMPLETED|Overall Study||6
10396215|NCT00693420|11539977|FG001|NOT COMPLETED|Overall Study||15
10396216|NCT00693472|11539987|FG000|STARTED|Part 1||19
10396217|NCT00693472|11539988|FG001|STARTED|Part 1||13
10396218|NCT00693472|11539989|FG002|STARTED|Part 1||0
10396219|NCT00693472|11539990|FG003|STARTED|Part 1||0
10396220|NCT00693472|11539987|FG000|COMPLETED|Part 1||13
10396221|NCT00693472|11539988|FG001|COMPLETED|Part 1||9
10396222|NCT00693472|11539989|FG002|COMPLETED|Part 1||0
10396223|NCT00693472|11539990|FG003|COMPLETED|Part 1||0
10396224|NCT00693472|11539987|FG000|NOT COMPLETED|Part 1||6
10720122|NCT02713711|11883778|FG001|NOT COMPLETED|Overall Study||0
10720123|NCT02713711|11883779|FG002|NOT COMPLETED|Overall Study||0
10396225|NCT00693472|11539988|FG001|NOT COMPLETED|Part 1||4
10396226|NCT00693472|11539989|FG002|NOT COMPLETED|Part 1||0
10720124|NCT02713711|11883780|FG003|NOT COMPLETED|Overall Study||0
10720125|NCT02713789|11883796|FG000|STARTED|Overall Study||8
10720126|NCT02713789|11883797|FG001|STARTED|Overall Study||10
10720127|NCT02713789|11883798|FG002|STARTED|Overall Study||8
10720128|NCT02713789|11883796|FG000|COMPLETED|Overall Study||8
10310530|NCT00124943|11443636|FG002|COMPLETED|Phase I||3
10310531|NCT00124943|11443637|FG003|COMPLETED|Phase I||3
10310532|NCT00124943|11443634|FG000|NOT COMPLETED|Phase I||0
10310533|NCT00124943|11443635|FG001|NOT COMPLETED|Phase I||0
10310534|NCT00124943|11443636|FG002|NOT COMPLETED|Phase I||0
10310535|NCT00124943|11443637|FG003|NOT COMPLETED|Phase I||0
10310536|NCT00124943|11443634|FG000|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|3
10310537|NCT00124943|11443635|FG001|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|51
10310538|NCT00124943|11443636|FG002|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|3
10310539|NCT00124943|11443637|FG003|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|55
10310540|NCT00124943|11443634|FG000|COMPLETED|Phase II||3
10310541|NCT00124943|11443635|FG001|COMPLETED|Phase II||49
10310542|NCT00124943|11443636|FG002|COMPLETED|Phase II||3
10310543|NCT00124943|11443637|FG003|COMPLETED|Phase II||50
10310544|NCT00124943|11443634|FG000|NOT COMPLETED|Phase II||0
10310545|NCT00124943|11443635|FG001|NOT COMPLETED|Phase II||2
10310546|NCT00124943|11443636|FG002|NOT COMPLETED|Phase II||0
10310547|NCT00124943|11443637|FG003|NOT COMPLETED|Phase II||5
10310548|NCT00124982|11443649|FG000|STARTED|Short-term Period||449
10310549|NCT00124982|11443650|FG001|STARTED|Short-term Period||597
10310550|NCT00124982|11443651|FG002|STARTED|Short-term Period||0
10310551|NCT00124982|11443649|FG000|COMPLETED|Short-term Period||377
10310552|NCT00124982|11443650|FG001|COMPLETED|Short-term Period||483
10310553|NCT00124982|11443651|FG002|COMPLETED|Short-term Period||0
10310554|NCT00124982|11443649|FG000|NOT COMPLETED|Short-term Period||72
10720129|NCT02713789|11883797|FG001|COMPLETED|Overall Study||9
10720130|NCT02713789|11883798|FG002|COMPLETED|Overall Study||7
10720131|NCT02713789|11883796|FG000|NOT COMPLETED|Overall Study||0
10310555|NCT00124982|11443650|FG001|NOT COMPLETED|Short-term Period||114
10310556|NCT00124982|11443651|FG002|NOT COMPLETED|Short-term Period||0
10310557|NCT00124982|11443649|FG000|STARTED|Long-term Period||0
10310558|NCT00124982|11443650|FG001|STARTED|Long-term Period||0
10310559|NCT00124982|11443651|FG002|STARTED|Long-term Period|A large number did not continue due to a rollover from study drug to commercially available drug.|530
10310560|NCT00124982|11443649|FG000|COMPLETED|Long-term Period||0
10310561|NCT00124982|11443650|FG001|COMPLETED|Long-term Period||0
10310562|NCT00124982|11443651|FG002|COMPLETED|Long-term Period||441
10310563|NCT00124982|11443649|FG000|NOT COMPLETED|Long-term Period||0
10310564|NCT00124982|11443650|FG001|NOT COMPLETED|Long-term Period||0
10310565|NCT00124982|11443651|FG002|NOT COMPLETED|Long-term Period||89
10315499|NCT00179517|11449397|FG000|NOT COMPLETED|Overall Study||2
10315500|NCT00179517|11449398|FG001|NOT COMPLETED|Overall Study||1
10315501|NCT00179621|11449407|FG000|STARTED|Double-Blind Period||67
10315502|NCT00179621|11449408|FG001|STARTED|Double-Blind Period||69
10396227|NCT00693472|11539990|FG003|NOT COMPLETED|Part 1||0
10396228|NCT00693472|11539987|FG000|STARTED|Part 2||0
10396229|NCT00693472|11539988|FG001|STARTED|Part 2||0
10396230|NCT00693472|11539989|FG002|STARTED|Part 2||8
10396231|NCT00693472|11539990|FG003|STARTED|Part 2||6
10396232|NCT00693472|11539987|FG000|COMPLETED|Part 2||0
10396233|NCT00693472|11539988|FG001|COMPLETED|Part 2||0
10396234|NCT00693472|11539989|FG002|COMPLETED|Part 2||6
10396235|NCT00693472|11539990|FG003|COMPLETED|Part 2||4
10396236|NCT00693472|11539987|FG000|NOT COMPLETED|Part 2||0
10396237|NCT00693472|11539988|FG001|NOT COMPLETED|Part 2||0
10396238|NCT00693472|11539989|FG002|NOT COMPLETED|Part 2||2
10396239|NCT00693472|11539990|FG003|NOT COMPLETED|Part 2||2
10396240|NCT00693485|11540003|FG000|STARTED|Overall Study||25
10396241|NCT00693485|11540004|FG001|STARTED|Overall Study||21
10396242|NCT00693485|11540005|FG002|STARTED|Overall Study||24
10396243|NCT00693485|11540003|FG000|COMPLETED|Overall Study||25
10396244|NCT00693485|11540004|FG001|COMPLETED|Overall Study||19
10396245|NCT00693485|11540005|FG002|COMPLETED|Overall Study||24
10396246|NCT00693485|11540003|FG000|NOT COMPLETED|Overall Study||0
10396247|NCT00693485|11540004|FG001|NOT COMPLETED|Overall Study||2
10396248|NCT00693485|11540005|FG002|NOT COMPLETED|Overall Study||0
10396249|NCT00693498|11540015|FG000|STARTED|Overall Study||81
10396250|NCT00693498|11540016|FG001|STARTED|Overall Study||81
10396251|NCT00693498|11540015|FG000|COMPLETED|Overall Study||81
10396252|NCT00693498|11540016|FG001|COMPLETED|Overall Study||81
10396253|NCT00693498|11540015|FG000|NOT COMPLETED|Overall Study||0
10396254|NCT00693498|11540016|FG001|NOT COMPLETED|Overall Study||0
10396255|NCT00693654|11540024|FG000|STARTED|Overall Study||14
10396256|NCT00693654|11540025|FG001|STARTED|Overall Study||14
10396257|NCT00693654|11540024|FG000|COMPLETED|Overall Study||14
10396258|NCT00693654|11540025|FG001|COMPLETED|Overall Study||14
10396259|NCT00693654|11540024|FG000|NOT COMPLETED|Overall Study||0
10396260|NCT00693654|11540025|FG001|NOT COMPLETED|Overall Study||0
10396261|NCT00693693|11540035|FG000|STARTED|Overall Study||7
10396262|NCT00693693|11540036|FG001|STARTED|Overall Study||9
10396263|NCT00693693|11540037|FG002|STARTED|Overall Study||9
10396264|NCT00693693|11540035|FG000|COMPLETED|Overall Study||6
10396265|NCT00693693|11540036|FG001|COMPLETED|Overall Study||8
10396266|NCT00693693|11540037|FG002|COMPLETED|Overall Study||7
10396267|NCT00693693|11540035|FG000|NOT COMPLETED|Overall Study||1
10396268|NCT00693693|11540036|FG001|NOT COMPLETED|Overall Study||1
10396269|NCT00693693|11540037|FG002|NOT COMPLETED|Overall Study||2
10396270|NCT00693706|11540047|FG000|STARTED|Overall Study||101
10396271|NCT00693706|11540048|FG001|STARTED|Overall Study||99
10396272|NCT00693706|11540047|FG000|COMPLETED|Overall Study||101
10396273|NCT00693706|11540048|FG001|COMPLETED|Overall Study||98
10396274|NCT00693706|11540047|FG000|NOT COMPLETED|Overall Study||0
10310566|NCT00125034|11443662|FG000|STARTED|Overall Study|Randomized & treated. 1 subject was not randomized correctly and was excluded in the ITT population.|170
10310567|NCT00125034|11443663|FG001|STARTED|Overall Study|Randomized & treated|168
10310568|NCT00125034|11443662|FG000|COMPLETED|Overall Study||170
10310569|NCT00125034|11443663|FG001|COMPLETED|Overall Study||168
10310570|NCT00125034|11443662|FG000|NOT COMPLETED|Overall Study||0
10310571|NCT00125034|11443663|FG001|NOT COMPLETED|Overall Study||0
10310572|NCT00125138|11443673|FG000|STARTED|Overall Study||15
10310573|NCT00125138|11443674|FG001|STARTED|Overall Study|One subject requested withdrawal prior to treatment; data for the subject are excluded from results.|20
10310574|NCT00125138|11443675|FG002|STARTED|Overall Study||25
10310575|NCT00125138|11443676|FG003|STARTED|Overall Study||30
10310576|NCT00125138|11443673|FG000|COMPLETED|Overall Study||12
10310577|NCT00125138|11443674|FG001|COMPLETED|Overall Study||17
10310578|NCT00125138|11443675|FG002|COMPLETED|Overall Study||21
10310579|NCT00125138|11443676|FG003|COMPLETED|Overall Study||25
10310580|NCT00125138|11443673|FG000|NOT COMPLETED|Overall Study||3
10310581|NCT00125138|11443674|FG001|NOT COMPLETED|Overall Study||3
10310582|NCT00125138|11443675|FG002|NOT COMPLETED|Overall Study||4
10310583|NCT00125138|11443676|FG003|NOT COMPLETED|Overall Study||5
10310584|NCT00125164|11443690|FG000|STARTED|Overall Study||25
10310585|NCT00125164|11443691|FG001|STARTED|Overall Study||16
10310586|NCT00125164|11443692|FG002|STARTED|Overall Study||44
10310587|NCT00125164|11443693|FG003|STARTED|Overall Study||51
10310588|NCT00125164|11443690|FG000|COMPLETED|Overall Study||23
10310589|NCT00125164|11443691|FG001|COMPLETED|Overall Study||16
10310590|NCT00125164|11443692|FG002|COMPLETED|Overall Study||40
10310591|NCT00125164|11443693|FG003|COMPLETED|Overall Study||45
10310592|NCT00125164|11443690|FG000|NOT COMPLETED|Overall Study||2
10310593|NCT00125164|11443691|FG001|NOT COMPLETED|Overall Study||0
10310594|NCT00125164|11443692|FG002|NOT COMPLETED|Overall Study||4
10310595|NCT00125164|11443693|FG003|NOT COMPLETED|Overall Study||6
10310596|NCT00125190|11443703|FG000|STARTED|Overall Study||45
10310597|NCT00125190|11443703|FG000|Completed 34 Weeks of Study|Overall Study||43
10310598|NCT00125190|11443703|FG000|COMPLETED|Overall Study||30
10310599|NCT00125190|11443703|FG000|NOT COMPLETED|Overall Study||15
10310600|NCT00125242|11443710|FG000|STARTED|Overall Study||94
10310601|NCT00125242|11443711|FG001|STARTED|Overall Study||16
10310602|NCT00125242|11443710|FG000|COMPLETED|Overall Study||87
10310603|NCT00125242|11443711|FG001|COMPLETED|Overall Study||14
10310604|NCT00125242|11443710|FG000|NOT COMPLETED|Overall Study||7
10310605|NCT00125242|11443711|FG001|NOT COMPLETED|Overall Study||2
10310606|NCT00125359|11443716|FG000|STARTED|Overall Study||42
10310607|NCT00125359|11443716|FG000|COMPLETED|Overall Study||19
10310608|NCT00125359|11443716|FG000|NOT COMPLETED|Overall Study||23
10310609|NCT00125372|11443720|FG000|STARTED|Overall Study||12
10310610|NCT00125372|11443720|FG000|COMPLETED|Overall Study||10
10310611|NCT00125372|11443720|FG000|NOT COMPLETED|Overall Study||2
10310612|NCT00125515|11443727|FG000|STARTED|Overall Study||27
10310613|NCT00125515|11443728|FG001|STARTED|Overall Study||27
10310614|NCT00125515|11443729|FG002|STARTED|Overall Study||27
10310615|NCT00125515|11443727|FG000|COMPLETED|Overall Study||7
10310616|NCT00125515|11443728|FG001|COMPLETED|Overall Study||7
10310617|NCT00125515|11443729|FG002|COMPLETED|Overall Study||6
10310618|NCT00125515|11443727|FG000|NOT COMPLETED|Overall Study||20
10310619|NCT00125515|11443728|FG001|NOT COMPLETED|Overall Study||20
10310620|NCT00125515|11443729|FG002|NOT COMPLETED|Overall Study||21
10310621|NCT00125528|11443739|FG000|STARTED|Overall Study||20
10310622|NCT00125528|11443740|FG001|STARTED|Overall Study||21
10310623|NCT00125528|11443739|FG000|COMPLETED|Overall Study||18
10310624|NCT00125528|11443740|FG001|COMPLETED|Overall Study||20
10310625|NCT00125528|11443739|FG000|NOT COMPLETED|Overall Study||2
10310626|NCT00125528|11443740|FG001|NOT COMPLETED|Overall Study||1
10310627|NCT00125593|11443748|FG000|STARTED|Overall Study||4650
10310628|NCT00125593|11443749|FG001|STARTED|Overall Study||4620
10310629|NCT00125593|11443748|FG000|COMPLETED|Overall Study||4549
10310630|NCT00125593|11443749|FG001|COMPLETED|Overall Study||4517
10310631|NCT00125593|11443748|FG000|NOT COMPLETED|Overall Study||101
10310632|NCT00125593|11443749|FG001|NOT COMPLETED|Overall Study||103
10310633|NCT00125619|11443757|FG000|STARTED|Overall Study||8
10310634|NCT00125619|11443758|FG001|STARTED|Overall Study||8
10310635|NCT00125619|11443757|FG000|COMPLETED|Overall Study||8
10310636|NCT00125619|11443758|FG001|COMPLETED|Overall Study||8
10310637|NCT00125619|11443757|FG000|NOT COMPLETED|Overall Study||0
10310638|NCT00125619|11443758|FG001|NOT COMPLETED|Overall Study||0
10310639|NCT00125658|11443767|FG000|STARTED|Overall Study||8
10310640|NCT00125658|11443768|FG001|STARTED|Overall Study||6
10310641|NCT00125658|11443767|FG000|COMPLETED|Overall Study||8
10310642|NCT00125658|11443768|FG001|COMPLETED|Overall Study||6
10310643|NCT00125658|11443767|FG000|NOT COMPLETED|Overall Study||0
10310644|NCT00125658|11443768|FG001|NOT COMPLETED|Overall Study||0
10310645|NCT00125762|11443776|FG000|STARTED|Overall Study||907
10310646|NCT00125762|11443776|FG000|COMPLETED|Overall Study||748
10310647|NCT00125762|11443776|FG000|NOT COMPLETED|Overall Study||159
10310648|NCT00125788|11443782|FG000|STARTED|Overall Study||37
10720132|NCT02713789|11883797|FG001|NOT COMPLETED|Overall Study||1
10720133|NCT02713789|11883798|FG002|NOT COMPLETED|Overall Study||1
10720134|NCT02713828|11883808|FG000|STARTED|Overall Study||13
10813325|NCT02920242|11975668|FG001|NOT COMPLETED|Overall Study||0
10813326|NCT02920242|11975669|FG002|NOT COMPLETED|Overall Study||1
10813327|NCT02900781|11975679|FG000|STARTED|Overall Study||4
10813328|NCT02900781|11975680|FG001|STARTED|Overall Study||5
10720135|NCT02713828|11883809|FG001|STARTED|Overall Study||0
10720136|NCT02713828|11883808|FG000|COMPLETED|Overall Study||8
10720137|NCT02713828|11883809|FG001|COMPLETED|Overall Study||0
10720138|NCT02713828|11883808|FG000|NOT COMPLETED|Overall Study||5
10813329|NCT02900781|11975679|FG000|COMPLETED|Overall Study||0
10813330|NCT02900781|11975680|FG001|COMPLETED|Overall Study||0
10813331|NCT02900781|11975679|FG000|NOT COMPLETED|Overall Study||4
10813332|NCT02900781|11975680|FG001|NOT COMPLETED|Overall Study||5
10813333|NCT02892500|11975688|FG000|STARTED|Overall Study||0
10813334|NCT02892500|11975689|FG001|STARTED|Overall Study||0
10813335|NCT02892500|11975688|FG000|COMPLETED|Overall Study||0
10813336|NCT02892500|11975689|FG001|COMPLETED|Overall Study||0
10813337|NCT02892500|11975688|FG000|NOT COMPLETED|Overall Study||0
10813338|NCT02892500|11975689|FG001|NOT COMPLETED|Overall Study||0
10813339|NCT02904356|11975695|FG000|STARTED|Overall Study||2
10813340|NCT02904356|11975695|FG000|COMPLETED|Overall Study||2
10813341|NCT02904356|11975695|FG000|NOT COMPLETED|Overall Study||0
10813342|NCT02899728|11975701|FG000|STARTED|Overall Study|0|5
10813343|NCT02899728|11975702|FG001|STARTED|Overall Study||3
10813344|NCT02899728|11975701|FG000|COMPLETED|Overall Study||4
10396275|NCT00693706|11540048|FG001|NOT COMPLETED|Overall Study||1
10396276|NCT00693719|11540054|FG000|STARTED|Overall Study||31
10396277|NCT00693719|11540054|FG000|COMPLETED|Overall Study||31
10396278|NCT00693719|11540054|FG000|NOT COMPLETED|Overall Study||0
10396279|NCT00693784|11540058|FG000|STARTED|Overall Study||15
10396280|NCT00693784|11540058|FG000|26-Week Primary Endpoint|Overall Study||15
10396281|NCT00693784|11540058|FG000|52-week Extended Follow-up|Overall Study||13
10396282|NCT00693784|11540058|FG000|104-week Extended Follow-up|Overall Study||11
10396283|NCT00693784|11540058|FG000|COMPLETED|Overall Study||11
10396284|NCT00693784|11540058|FG000|NOT COMPLETED|Overall Study||4
10396285|NCT00693992|11540064|FG000|STARTED|Overall Study||106
10396286|NCT00693992|11540065|FG001|STARTED|Overall Study||104
10396287|NCT00693992|11540064|FG000|COMPLETED|Overall Study||106
10396288|NCT00693992|11540065|FG001|COMPLETED|Overall Study||104
10396289|NCT00693992|11540064|FG000|NOT COMPLETED|Overall Study||0
10396290|NCT00693992|11540065|FG001|NOT COMPLETED|Overall Study||0
10396291|NCT00694018|11540073|FG000|STARTED|Overall Study||118
10543561|NCT01484431|11696731|FG002|STARTED|Period 1: High Dose||6
10543562|NCT01484431|11696729|FG000|Received 8 mg|Period 1: High Dose||1
10543563|NCT01484431|11696730|FG001|Received 8 mg|Period 1: High Dose||0
10720139|NCT02713828|11883809|FG001|NOT COMPLETED|Overall Study||0
10720140|NCT02714153|11883814|FG000|STARTED|Overall Study||23
10720141|NCT02714153|11883814|FG000|COMPLETED|Overall Study||22
10396292|NCT00694018|11540074|FG001|STARTED|Overall Study||111
10396293|NCT00694018|11540073|FG000|6 Months|Overall Study||106
10396294|NCT00694018|11540074|FG001|6 Months|Overall Study||101
10396295|NCT00694018|11540073|FG000|COMPLETED|Overall Study||105
10396296|NCT00694018|11540074|FG001|COMPLETED|Overall Study||102
10720142|NCT02714153|11883814|FG000|NOT COMPLETED|Overall Study||1
10813345|NCT02899728|11975702|FG001|COMPLETED|Overall Study||2
10813346|NCT02899728|11975701|FG000|NOT COMPLETED|Overall Study||1
10813347|NCT02899728|11975702|FG001|NOT COMPLETED|Overall Study||1
10396297|NCT00694018|11540073|FG000|NOT COMPLETED|Overall Study||13
10543564|NCT01484431|11696731|FG002|Received 8 mg|Period 1: High Dose||0
10543565|NCT01484431|11696729|FG000|Received 10 mg|Period 1: High Dose||1
10543566|NCT01484431|11696730|FG001|Received 10 mg|Period 1: High Dose||1
10396298|NCT00694018|11540074|FG001|NOT COMPLETED|Overall Study||9
10396299|NCT00694070|11540080|FG000|STARTED|Overall Study||51
10396300|NCT00694070|11540080|FG000|COMPLETED|Overall Study||51
10720143|NCT02714283|11883820|FG000|STARTED|Overall Study||83589
10813348|NCT02875067|11975708|FG000|STARTED|Overall Study||6
10813349|NCT02875067|11975708|FG000|COMPLETED|Overall Study||0
10813350|NCT02875067|11975708|FG000|NOT COMPLETED|Overall Study||6
10813351|NCT02877732|11975714|FG000|STARTED|Overall Study||6
10813352|NCT02877732|11975715|FG001|STARTED|Overall Study||6
10813353|NCT02877732|11975714|FG000|COMPLETED|Overall Study||0
10310649|NCT00125788|11443783|FG001|STARTED|Overall Study||33
10310650|NCT00125788|11443782|FG000|COMPLETED|Overall Study||33
10310651|NCT00125788|11443783|FG001|COMPLETED|Overall Study||29
10310652|NCT00125788|11443782|FG000|NOT COMPLETED|Overall Study||4
10310653|NCT00125788|11443783|FG001|NOT COMPLETED|Overall Study||4
10310654|NCT00125853|11443789|FG000|STARTED|Wash-out (4 Weeks)||27
10310655|NCT00125853|11443790|FG001|STARTED|Wash-out (4 Weeks)||27
10310656|NCT00125853|11443789|FG000|COMPLETED|Wash-out (4 Weeks)||27
10310657|NCT00125853|11443790|FG001|COMPLETED|Wash-out (4 Weeks)||27
10310658|NCT00125853|11443789|FG000|NOT COMPLETED|Wash-out (4 Weeks)||0
10310659|NCT00125853|11443790|FG001|NOT COMPLETED|Wash-out (4 Weeks)||0
10310660|NCT00125853|11443789|FG000|STARTED|First Intervention (8 Weeks)||27
10310661|NCT00125853|11443790|FG001|STARTED|First Intervention (8 Weeks)||27
10310662|NCT00125853|11443789|FG000|COMPLETED|First Intervention (8 Weeks)||27
10310663|NCT00125853|11443790|FG001|COMPLETED|First Intervention (8 Weeks)||27
10720144|NCT02714283|11883821|FG001|STARTED|Overall Study||6500
10813368|NCT02860169|11975723|FG000|Healthy Participants|Part C||6
10310664|NCT00125853|11443789|FG000|NOT COMPLETED|First Intervention (8 Weeks)||0
10310665|NCT00125853|11443790|FG001|NOT COMPLETED|First Intervention (8 Weeks)||0
10720145|NCT02714283|11883820|FG000|COMPLETED|Overall Study||83589
10310666|NCT00125853|11443789|FG000|STARTED|Wash-out (4 Weeks)||27
10310667|NCT00125853|11443790|FG001|STARTED|Wash-out (4 Weeks)||27
10310668|NCT00125853|11443789|FG000|COMPLETED|Wash-out (4 Weeks)||24
10543567|NCT01484431|11696731|FG002|Received 10 mg|Period 1: High Dose||0
10543568|NCT01484431|11696729|FG000|Received 15 mg|Period 1: High Dose||1
10543569|NCT01484431|11696730|FG001|Received 15 mg|Period 1: High Dose||1
10543570|NCT01484431|11696731|FG002|Received 15 mg|Period 1: High Dose||0
10543571|NCT01484431|11696729|FG000|Received 20 mg|Period 1: High Dose||3
10543572|NCT01484431|11696730|FG001|Received 20 mg|Period 1: High Dose||5
10543573|NCT01484431|11696731|FG002|Received 20 mg|Period 1: High Dose||1
10543574|NCT01484431|11696729|FG000|Received 40 mg|Period 1: High Dose||0
10543575|NCT01484431|11696730|FG001|Received 40 mg|Period 1: High Dose||0
10543576|NCT01484431|11696731|FG002|Received 40 mg|Period 1: High Dose||5
10543577|NCT01484431|11696729|FG000|COMPLETED|Period 1: High Dose||6
10658956|NCT02237157|11820199|FG002|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
10658957|NCT02237157|11820200|FG003|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
10658958|NCT02237157|11820197|FG000|STARTED|Gemcitabine, Local Delivery (Dose 4)||0
10658959|NCT02237157|11820198|FG001|STARTED|Gemcitabine, Local Delivery (Dose 4)||0
10658960|NCT02237157|11820199|FG002|STARTED|Gemcitabine, Local Delivery (Dose 4)||0
10658961|NCT02237157|11820200|FG003|STARTED|Gemcitabine, Local Delivery (Dose 4)||8
10658962|NCT02237157|11820197|FG000|COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
10658963|NCT02237157|11820198|FG001|COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
10658964|NCT02237157|11820199|FG002|COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
10658965|NCT02237157|11820200|FG003|COMPLETED|Gemcitabine, Local Delivery (Dose 4)||8
10658966|NCT02237157|11820197|FG000|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
10658967|NCT02237157|11820198|FG001|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
10658968|NCT02237157|11820199|FG002|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
10658969|NCT02237157|11820200|FG003|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
10658970|NCT02237196|11820211|FG000|STARTED|Overall Study||32
10658971|NCT02237196|11820212|FG001|STARTED|Overall Study||31
10658972|NCT02237196|11820213|FG002|STARTED|Overall Study||30
10658973|NCT02237196|11820214|FG003|STARTED|Overall Study||28
10658974|NCT02237196|11820211|FG000|COMPLETED|Overall Study||24
10658975|NCT02237196|11820212|FG001|COMPLETED|Overall Study||25
10658976|NCT02237196|11820213|FG002|COMPLETED|Overall Study||20
10658977|NCT02237196|11820214|FG003|COMPLETED|Overall Study||17
10658978|NCT02237196|11820211|FG000|NOT COMPLETED|Overall Study||8
10658979|NCT02237196|11820212|FG001|NOT COMPLETED|Overall Study||6
10658980|NCT02237196|11820213|FG002|NOT COMPLETED|Overall Study||10
10658981|NCT02237196|11820214|FG003|NOT COMPLETED|Overall Study||11
10658982|NCT02237417|11820227|FG000|STARTED|Overall Study||16
10658983|NCT02237417|11820228|FG001|STARTED|Overall Study||15
10658984|NCT02237417|11820229|FG002|STARTED|Overall Study||16
10658985|NCT02237417|11820227|FG000|COMPLETED|Overall Study||16
10658986|NCT02237417|11820228|FG001|COMPLETED|Overall Study||9
10658987|NCT02237417|11820229|FG002|COMPLETED|Overall Study||7
10658988|NCT02237417|11820227|FG000|NOT COMPLETED|Overall Study||0
10658989|NCT02237417|11820228|FG001|NOT COMPLETED|Overall Study||6
10658990|NCT02237417|11820229|FG002|NOT COMPLETED|Overall Study||9
10658991|NCT02237898|11820239|FG000|STARTED|Overall Study||12
10658992|NCT02237898|11820240|FG001|STARTED|Overall Study||14
10658993|NCT02237898|11820239|FG000|Completed 12 Weeks of CM|Overall Study||7
10658994|NCT02237898|11820240|FG001|Completed 12 Weeks of CM|Overall Study||2
10658995|NCT02237898|11820239|FG000|Completed 3 Month Follow-up|Overall Study||6
10658996|NCT02237898|11820240|FG001|Completed 3 Month Follow-up|Overall Study||6
10658997|NCT02237898|11820239|FG000|Completed 9 Month Follow-up|Overall Study||6
10658998|NCT02237898|11820240|FG001|Completed 9 Month Follow-up|Overall Study||7
10658999|NCT02237898|11820239|FG000|Completed 15 Month Follow-up|Overall Study||8
10310669|NCT00125853|11443790|FG001|COMPLETED|Wash-out (4 Weeks)||20
10310670|NCT00125853|11443789|FG000|NOT COMPLETED|Wash-out (4 Weeks)||3
10310671|NCT00125853|11443790|FG001|NOT COMPLETED|Wash-out (4 Weeks)||7
10310672|NCT00125853|11443789|FG000|STARTED|Second Intervention (8 Weeks)||24
10310673|NCT00125853|11443790|FG001|STARTED|Second Intervention (8 Weeks)||20
10310674|NCT00125853|11443789|FG000|COMPLETED|Second Intervention (8 Weeks)||24
10310675|NCT00125853|11443790|FG001|COMPLETED|Second Intervention (8 Weeks)||20
10310676|NCT00125853|11443789|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||0
10310677|NCT00125853|11443790|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0
10310678|NCT00125931|11443796|FG000|STARTED|Overall Study||10
10813354|NCT02877732|11975715|FG001|COMPLETED|Overall Study||0
10813355|NCT02877732|11975714|FG000|NOT COMPLETED|Overall Study||6
10813356|NCT02877732|11975715|FG001|NOT COMPLETED|Overall Study||6
10813357|NCT02860169|11975723|FG000|STARTED|Part A||46
10813358|NCT02860169|11975723|FG000|Healthy Participants|Part A||46
10813359|NCT02860169|11975723|FG000|Participants With Cold and Flu|Part A||0
10813360|NCT02860169|11975723|FG000|COMPLETED|Part A||35
10813361|NCT02860169|11975723|FG000|NOT COMPLETED|Part A||11
10813362|NCT02860169|11975723|FG000|STARTED|Part B||20
10813363|NCT02860169|11975723|FG000|Healthy Participants|Part B||10
10813364|NCT02860169|11975723|FG000|Participants With Cold and Flu|Part B||10
10813365|NCT02860169|11975723|FG000|COMPLETED|Part B||9
10813366|NCT02860169|11975723|FG000|NOT COMPLETED|Part B||11
10813367|NCT02860169|11975723|FG000|STARTED|Part C||48
10396301|NCT00694070|11540080|FG000|NOT COMPLETED|Overall Study||0
10396302|NCT00694096|11540084|FG000|STARTED|Overall Study||25
10813369|NCT02860169|11975723|FG000|Participants With Cold and Flu|Part C||42
10813370|NCT02860169|11975723|FG000|COMPLETED|Part C||47
10813371|NCT02860169|11975723|FG000|NOT COMPLETED|Part C||1
10813372|NCT02865395|11975732|FG000|STARTED|Overall Study||6
10813373|NCT02865395|11975733|FG001|STARTED|Overall Study||10
10813374|NCT02865395|11975734|FG002|STARTED|Overall Study||7
10310679|NCT00125931|11443796|FG000|COMPLETED|Overall Study||10
10310680|NCT00125931|11443796|FG000|NOT COMPLETED|Overall Study||0
10310681|NCT00125957|11443802|FG000|STARTED|First Intervention (3 Weeks)||15
10310682|NCT00125957|11443803|FG001|STARTED|First Intervention (3 Weeks)||17
10310683|NCT00125957|11443802|FG000|COMPLETED|First Intervention (3 Weeks)||15
10310684|NCT00125957|11443803|FG001|COMPLETED|First Intervention (3 Weeks)||17
10310685|NCT00125957|11443802|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0
10720146|NCT02714283|11883821|FG001|COMPLETED|Overall Study||6500
10720147|NCT02714283|11883820|FG000|NOT COMPLETED|Overall Study||0
10720148|NCT02714283|11883821|FG001|NOT COMPLETED|Overall Study||0
10720149|NCT02714400|11883831|FG000|STARTED|First Intervention (1 Day)||12
10720150|NCT02714400|11883832|FG001|STARTED|First Intervention (1 Day)||8
10720151|NCT02714400|11883831|FG000|COMPLETED|First Intervention (1 Day)||12
10310686|NCT00125957|11443803|FG001|NOT COMPLETED|First Intervention (3 Weeks)||0
10310687|NCT00125957|11443802|FG000|STARTED|Second Intervention (3 Weeks)||15
10310688|NCT00125957|11443803|FG001|STARTED|Second Intervention (3 Weeks)||17
10310689|NCT00125957|11443802|FG000|COMPLETED|Second Intervention (3 Weeks)||15
10310690|NCT00125957|11443803|FG001|COMPLETED|Second Intervention (3 Weeks)||17
10310691|NCT00125957|11443802|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
10310692|NCT00125957|11443803|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
10310693|NCT00126113|11443811|FG000|STARTED|Overall Study||37
10310694|NCT00126113|11443812|FG001|STARTED|Overall Study||37
10310695|NCT00126113|11443811|FG000|COMPLETED|Overall Study||34
10310696|NCT00126113|11443812|FG001|COMPLETED|Overall Study||35
10310697|NCT00126113|11443811|FG000|NOT COMPLETED|Overall Study||3
10310698|NCT00126113|11443812|FG001|NOT COMPLETED|Overall Study||2
10310699|NCT00126126|11443820|FG000|STARTED|Overall Study||9
10310700|NCT00126126|11443821|FG001|STARTED|Overall Study||9
10310701|NCT00126126|11443820|FG000|COMPLETED|Overall Study||9
10310702|NCT00126126|11443821|FG001|COMPLETED|Overall Study||7
10310703|NCT00126126|11443820|FG000|NOT COMPLETED|Overall Study||0
10310704|NCT00126126|11443821|FG001|NOT COMPLETED|Overall Study||2
10310705|NCT00126191|11443829|FG000|STARTED|Overall Study||2
10310706|NCT00126191|11443830|FG001|STARTED|Overall Study||8
10310707|NCT00126191|11443829|FG000|COMPLETED|Overall Study||2
10310708|NCT00126191|11443830|FG001|COMPLETED|Overall Study|1 pt off study during cycle 1 due to toxicity|6
10310709|NCT00126191|11443829|FG000|NOT COMPLETED|Overall Study||0
10310710|NCT00126191|11443830|FG001|NOT COMPLETED|Overall Study||2
10310711|NCT00126425|11443838|FG000|STARTED|Overall Study||539
10310712|NCT00126425|11443839|FG001|STARTED|Overall Study||48
10310713|NCT00126425|11443838|FG000|COMPLETED|Overall Study||498
10310714|NCT00126425|11443839|FG001|COMPLETED|Overall Study||37
10310715|NCT00126425|11443838|FG000|NOT COMPLETED|Overall Study||41
10310716|NCT00126425|11443839|FG001|NOT COMPLETED|Overall Study||11
10310717|NCT00126438|11443847|FG000|STARTED|Overall Study||453
10310718|NCT00126438|11443848|FG001|STARTED|Overall Study||62
10720152|NCT02714400|11883832|FG001|COMPLETED|First Intervention (1 Day)||8
10720153|NCT02714400|11883831|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10720154|NCT02714400|11883832|FG001|NOT COMPLETED|First Intervention (1 Day)||0
10720155|NCT02714400|11883831|FG000|STARTED|Washout (>4 Days)||12
10720156|NCT02714400|11883832|FG001|STARTED|Washout (>4 Days)||8
10720157|NCT02714400|11883831|FG000|COMPLETED|Washout (>4 Days)||12
10720158|NCT02714400|11883832|FG001|COMPLETED|Washout (>4 Days)||8
10720159|NCT02714400|11883831|FG000|NOT COMPLETED|Washout (>4 Days)||0
10720160|NCT02714400|11883832|FG001|NOT COMPLETED|Washout (>4 Days)||0
10310719|NCT00126438|11443847|FG000|COMPLETED|Overall Study||419
10310720|NCT00126438|11443848|FG001|COMPLETED|Overall Study||52
10310721|NCT00126438|11443847|FG000|NOT COMPLETED|Overall Study||34
10396303|NCT00694096|11540084|FG000|COMPLETED|Overall Study||20
10396304|NCT00694096|11540084|FG000|NOT COMPLETED|Overall Study||5
10396305|NCT00694109|11540088|FG000|STARTED|Overall Study|This does not include 2 patients from phase 2 trial with very different treatment experience.|142
10396306|NCT00694109|11540088|FG000|Treated|Overall Study||141
10396307|NCT00694109|11540088|FG000|Consented 2 Years Additional Treatment|Overall Study||42
10396308|NCT00694109|11540088|FG000|Completed Consented Length of Treatment|Overall Study||60
10396309|NCT00694109|11540088|FG000|COMPLETED|Overall Study||25
10396310|NCT00694109|11540088|FG000|NOT COMPLETED|Overall Study||117
10396311|NCT00694122|11540093|FG000|STARTED|First Intervention (3-4 Weeks)|Started Lantus then on NPH.|20
10396312|NCT00694122|11540094|FG001|STARTED|First Intervention (3-4 Weeks)|Started on NPH then on Lantus.|7
10396313|NCT00694122|11540093|FG000|COMPLETED|First Intervention (3-4 Weeks)||10
10396314|NCT00694122|11540094|FG001|COMPLETED|First Intervention (3-4 Weeks)||5
10396315|NCT00694122|11540093|FG000|NOT COMPLETED|First Intervention (3-4 Weeks)||10
10396316|NCT00694122|11540094|FG001|NOT COMPLETED|First Intervention (3-4 Weeks)||2
10720161|NCT02714400|11883831|FG000|STARTED|Second Intervention (1 Day)||12
10720162|NCT02714400|11883832|FG001|STARTED|Second Intervention (1 Day)||8
10310722|NCT00126438|11443848|FG001|NOT COMPLETED|Overall Study||10
10310723|NCT00126490|11443854|FG000|STARTED|Overall Study||19
10310724|NCT00126490|11443854|FG000|COMPLETED|Overall Study||18
10310725|NCT00126490|11443854|FG000|NOT COMPLETED|Overall Study||1
10310726|NCT00126503|11443860|FG000|STARTED|Overall Study||48
10813375|NCT02865395|11975732|FG000|COMPLETED|Overall Study|Data Not Collected|0
10310727|NCT00126503|11443861|FG001|STARTED|Overall Study||21
10396317|NCT00694122|11540093|FG000|STARTED|Washout (1 Day)||10
10396318|NCT00694122|11540094|FG001|STARTED|Washout (1 Day)||5
10396319|NCT00694122|11540093|FG000|COMPLETED|Washout (1 Day)||10
10396320|NCT00694122|11540094|FG001|COMPLETED|Washout (1 Day)||5
10396321|NCT00694122|11540093|FG000|NOT COMPLETED|Washout (1 Day)||0
10396322|NCT00694122|11540094|FG001|NOT COMPLETED|Washout (1 Day)||0
10396323|NCT00694122|11540093|FG000|STARTED|Second Intervention (3-4 Weeks)||10
10396324|NCT00694122|11540094|FG001|STARTED|Second Intervention (3-4 Weeks)||5
10396325|NCT00694122|11540093|FG000|COMPLETED|Second Intervention (3-4 Weeks)||10
10396326|NCT00694122|11540094|FG001|COMPLETED|Second Intervention (3-4 Weeks)||5
10396327|NCT00694122|11540093|FG000|NOT COMPLETED|Second Intervention (3-4 Weeks)||0
10720163|NCT02714400|11883831|FG000|COMPLETED|Second Intervention (1 Day)||12
10720164|NCT02714400|11883832|FG001|COMPLETED|Second Intervention (1 Day)||8
10720165|NCT02714400|11883831|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10720166|NCT02714400|11883832|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10720167|NCT02714426|11883840|FG000|STARTED|Overall Study||21
10720168|NCT02714426|11883841|FG001|STARTED|Overall Study||21
10720169|NCT02714426|11883840|FG000|COMPLETED|Overall Study||19
10720170|NCT02714426|11883841|FG001|COMPLETED|Overall Study||19
10720171|NCT02714426|11883840|FG000|NOT COMPLETED|Overall Study||2
10720172|NCT02714426|11883841|FG001|NOT COMPLETED|Overall Study||2
10720173|NCT02714504|11883849|FG000|STARTED|Overall Study||61
10720174|NCT02714504|11883850|FG001|STARTED|Overall Study||178
10396328|NCT00694122|11540094|FG001|NOT COMPLETED|Second Intervention (3-4 Weeks)||0
10396329|NCT00694161|11540105|FG000|STARTED|Part 1 (up to Week 6)||35
10396330|NCT00694161|11540105|FG000|COMPLETED|Part 1 (up to Week 6)||35
10396331|NCT00694161|11540105|FG000|NOT COMPLETED|Part 1 (up to Week 6)||0
10396332|NCT00694161|11540105|FG000|STARTED|Part 2 (After Week 6 up to Month 12)||35
10396333|NCT00694161|11540105|FG000|COMPLETED|Part 2 (After Week 6 up to Month 12)||32
10396334|NCT00694161|11540105|FG000|NOT COMPLETED|Part 2 (After Week 6 up to Month 12)||3
10396335|NCT00694304|11540109|FG000|STARTED|Overall Study||535
10396336|NCT00694304|11540109|FG000|COMPLETED|Overall Study||328
10396337|NCT00694304|11540109|FG000|NOT COMPLETED|Overall Study||207
10396338|NCT00694356|11540116|FG000|STARTED|Overall Study||3
10396339|NCT00694356|11540117|FG001|STARTED|Overall Study||6
10396340|NCT00694356|11540118|FG002|STARTED|Overall Study||6
10396341|NCT00694356|11540116|FG000|COMPLETED|Overall Study||0
10396342|NCT00694356|11540117|FG001|COMPLETED|Overall Study||0
10396343|NCT00694356|11540118|FG002|COMPLETED|Overall Study||0
10396344|NCT00694356|11540116|FG000|NOT COMPLETED|Overall Study||3
10396345|NCT00694356|11540117|FG001|NOT COMPLETED|Overall Study||6
10396346|NCT00694356|11540118|FG002|NOT COMPLETED|Overall Study||6
10396347|NCT00694473|11540126|FG000|STARTED|Overall Study|Aug 2008|76
10396348|NCT00694473|11540126|FG000|COMPLETED|Overall Study|Dec 2010|69
10396349|NCT00694473|11540126|FG000|NOT COMPLETED|Overall Study||7
10396350|NCT00694551|11540133|FG000|STARTED|Overall Study||10
10396351|NCT00694551|11540134|FG001|STARTED|Overall Study||10
10396352|NCT00694551|11540135|FG002|STARTED|Overall Study||9
10396353|NCT00694551|11540133|FG000|COMPLETED|Overall Study||9
10396354|NCT00694551|11540134|FG001|COMPLETED|Overall Study||10
10396355|NCT00694551|11540135|FG002|COMPLETED|Overall Study||8
10396356|NCT00694551|11540133|FG000|NOT COMPLETED|Overall Study||1
10396357|NCT00694551|11540134|FG001|NOT COMPLETED|Overall Study||0
10396358|NCT00694551|11540135|FG002|NOT COMPLETED|Overall Study||1
10396359|NCT00694564|11540144|FG000|STARTED|Overall Study||8
10396360|NCT00694564|11540144|FG000|COMPLETED|Overall Study||6
10396361|NCT00694564|11540144|FG000|NOT COMPLETED|Overall Study||2
10396362|NCT00694603|11540148|FG000|STARTED|Overall Study||18
10396363|NCT00694603|11540148|FG000|COMPLETED|Overall Study||18
10396364|NCT00694603|11540148|FG000|NOT COMPLETED|Overall Study||0
10396365|NCT00694707|11540157|FG000|STARTED|Overall Study||151
10396366|NCT00694707|11540158|FG001|STARTED|Overall Study||145
10396367|NCT00694707|11540159|FG002|STARTED|Overall Study||147
10720175|NCT02714504|11883849|FG000|COMPLETED|Overall Study||61
10720176|NCT02714504|11883850|FG001|COMPLETED|Overall Study||178
10720177|NCT02714504|11883849|FG000|NOT COMPLETED|Overall Study||0
10720178|NCT02714504|11883850|FG001|NOT COMPLETED|Overall Study||0
10396368|NCT00694707|11540160|FG003|STARTED|Overall Study||148
10396369|NCT00694707|11540161|FG004|STARTED|Overall Study||141
10396370|NCT00694707|11540157|FG000|COMPLETED|Overall Study||79
10396371|NCT00694707|11540158|FG001|COMPLETED|Overall Study||90
10396372|NCT00694707|11540159|FG002|COMPLETED|Overall Study||96
10720179|NCT02714569|11883867|FG000|STARTED|Part A First Intervention||3
10813376|NCT02865395|11975733|FG001|COMPLETED|Overall Study|Data Not Collected|0
10813377|NCT02865395|11975734|FG002|COMPLETED|Overall Study|Data Not Collected|0
10813378|NCT02865395|11975732|FG000|NOT COMPLETED|Overall Study||6
10813379|NCT02865395|11975733|FG001|NOT COMPLETED|Overall Study||10
10813380|NCT02865395|11975734|FG002|NOT COMPLETED|Overall Study||7
10813381|NCT02868892|11975742|FG000|STARTED|Overall Study||6
10310728|NCT00126503|11443860|FG000|COMPLETED|Overall Study||1
10310729|NCT00126503|11443861|FG001|COMPLETED|Overall Study||0
10310730|NCT00126503|11443860|FG000|NOT COMPLETED|Overall Study||47
10310731|NCT00126503|11443861|FG001|NOT COMPLETED|Overall Study||21
10310732|NCT00126555|11443871|FG000|STARTED|Overall Study||23
10310733|NCT00126555|11443871|FG000|Stratum 1- Resectable|Overall Study|1 participant did not participate|18
10310734|NCT00126555|11443871|FG000|Stratum 2- Unresectable|Overall Study||4
10310735|NCT00126555|11443871|FG000|COMPLETED|Overall Study||17
10310736|NCT00126555|11443871|FG000|NOT COMPLETED|Overall Study||6
10310737|NCT00126568|11443887|FG000|STARTED|Overall Study||20
10310738|NCT00126568|11443887|FG000|COMPLETED|Overall Study|Disease progression at beginning of study, not evaluable|18
10310739|NCT00126568|11443887|FG000|NOT COMPLETED|Overall Study||2
10310740|NCT00126581|11443894|FG000|STARTED|Overall Study||81
10310741|NCT00126581|11443895|FG001|STARTED|Overall Study||100
10310742|NCT00126581|11443894|FG000|COMPLETED|Overall Study||68
10310743|NCT00126581|11443895|FG001|COMPLETED|Overall Study||80
10310744|NCT00126581|11443894|FG000|NOT COMPLETED|Overall Study||13
10310745|NCT00126581|11443895|FG001|NOT COMPLETED|Overall Study||20
10310746|NCT00126594|11443905|FG000|STARTED|Overall Study||40
10310747|NCT00126594|11443906|FG001|STARTED|Overall Study||40
10310748|NCT00126594|11443905|FG000|COMPLETED|Overall Study||1
10310749|NCT00126594|11443906|FG001|COMPLETED|Overall Study||3
10310750|NCT00126594|11443905|FG000|NOT COMPLETED|Overall Study||39
10310751|NCT00126594|11443906|FG001|NOT COMPLETED|Overall Study||37
10310752|NCT00126737|11443917|FG000|STARTED|Overall Study||28
10310753|NCT00126737|11443918|FG001|STARTED|Overall Study||27
10310754|NCT00126737|11443919|FG002|STARTED|Overall Study||30
10310755|NCT00126737|11443920|FG003|STARTED|Overall Study||25
10310756|NCT00126737|11443917|FG000|COMPLETED|Overall Study||22
10310757|NCT00126737|11443918|FG001|COMPLETED|Overall Study||24
10310758|NCT00126737|11443919|FG002|COMPLETED|Overall Study||24
10310759|NCT00126737|11443920|FG003|COMPLETED|Overall Study||18
10310760|NCT00126737|11443917|FG000|NOT COMPLETED|Overall Study||6
10543578|NCT01484431|11696730|FG001|COMPLETED|Period 1: High Dose||6
10543579|NCT01484431|11696731|FG002|COMPLETED|Period 1: High Dose||6
10543580|NCT01484431|11696729|FG000|NOT COMPLETED|Period 1: High Dose||0
10543581|NCT01484431|11696730|FG001|NOT COMPLETED|Period 1: High Dose||1
10543582|NCT01484431|11696731|FG002|NOT COMPLETED|Period 1: High Dose||0
10543583|NCT01484431|11696729|FG000|STARTED|Period 2||6
10543584|NCT01484431|11696730|FG001|STARTED|Period 2||6
10543585|NCT01484431|11696731|FG002|STARTED|Period 2||6
10543586|NCT01484431|11696729|FG000|Received 7 mg|Period 2||1
10543587|NCT01484431|11696730|FG001|Received 7 mg|Period 2||0
10543588|NCT01484431|11696731|FG002|Received 7 mg|Period 2||0
10543589|NCT01484431|11696729|FG000|Received 7.5 mg|Period 2||0
10310761|NCT00126737|11443918|FG001|NOT COMPLETED|Overall Study||3
10310762|NCT00126737|11443919|FG002|NOT COMPLETED|Overall Study||6
10310763|NCT00126737|11443920|FG003|NOT COMPLETED|Overall Study||7
10310764|NCT00126750|11443935|FG000|STARTED|Overall Study|Number of providers from 84 clinics|385
10310765|NCT00126750|11443936|FG001|STARTED|Overall Study|Number of providers from 84 clinics|462
10310766|NCT00126750|11443935|FG000|COMPLETED|Overall Study|Total providers at participating clinic locations were given the option to 'enroll'.|205
10315503|NCT00179621|11449409|FG002|STARTED|Double-Blind Period||69
10720180|NCT02714569|11883868|FG001|STARTED|Part A First Intervention||3
10720181|NCT02714569|11883869|FG002|STARTED|Part A First Intervention||3
10720182|NCT02714569|11883870|FG003|STARTED|Part A First Intervention||3
10396373|NCT00694707|11540160|FG003|COMPLETED|Overall Study||98
10396374|NCT00694707|11540161|FG004|COMPLETED|Overall Study||101
10396375|NCT00694707|11540157|FG000|NOT COMPLETED|Overall Study||72
10396376|NCT00694707|11540158|FG001|NOT COMPLETED|Overall Study||55
10396377|NCT00694707|11540159|FG002|NOT COMPLETED|Overall Study||51
10396378|NCT00694707|11540160|FG003|NOT COMPLETED|Overall Study||50
10396379|NCT00694707|11540161|FG004|NOT COMPLETED|Overall Study||40
10396380|NCT00695019|11540176|FG000|STARTED|Overall Study||59
10396381|NCT00695019|11540177|FG001|STARTED|Overall Study||53
10396382|NCT00695019|11540178|FG002|STARTED|Overall Study||57
10396383|NCT00695019|11540176|FG000|COMPLETED|Overall Study||46
10396384|NCT00695019|11540177|FG001|COMPLETED|Overall Study||39
10396385|NCT00695019|11540178|FG002|COMPLETED|Overall Study||47
10396386|NCT00695019|11540176|FG000|NOT COMPLETED|Overall Study||13
10396387|NCT00695019|11540177|FG001|NOT COMPLETED|Overall Study||14
10396388|NCT00695019|11540178|FG002|NOT COMPLETED|Overall Study||10
10396389|NCT00695097|11540188|FG000|STARTED|Overall Study||10
10396390|NCT00695097|11540189|FG001|STARTED|Overall Study||5
10396391|NCT00695097|11540188|FG000|COMPLETED|Overall Study||9
10396392|NCT00695097|11540189|FG001|COMPLETED|Overall Study||5
10396393|NCT00695097|11540188|FG000|NOT COMPLETED|Overall Study||1
10396394|NCT00695097|11540189|FG001|NOT COMPLETED|Overall Study||0
10396395|NCT00695110|11540195|FG000|STARTED|Treatment Period 1||29
10396396|NCT00695110|11540195|FG000|COMPLETED|Treatment Period 1||26
10396397|NCT00695110|11540195|FG000|NOT COMPLETED|Treatment Period 1||3
10396398|NCT00695110|11540195|FG000|STARTED|Treatment Period 2||26
10396399|NCT00695110|11540195|FG000|COMPLETED|Treatment Period 2||26
10396400|NCT00695110|11540195|FG000|NOT COMPLETED|Treatment Period 2||0
10396401|NCT00695110|11540195|FG000|STARTED|Treatment Period 3||26
10396402|NCT00695110|11540195|FG000|COMPLETED|Treatment Period 3||25
10396403|NCT00695110|11540195|FG000|NOT COMPLETED|Treatment Period 3||1
10396404|NCT00695110|11540195|FG000|STARTED|Treatment Period 4||25
10396405|NCT00695110|11540195|FG000|COMPLETED|Treatment Period 4||24
10396406|NCT00695110|11540195|FG000|NOT COMPLETED|Treatment Period 4||1
10396407|NCT00695136|11540202|FG000|STARTED|Overall Study|7|7
10396408|NCT00695136|11540202|FG000|COMPLETED|Overall Study||5
10396409|NCT00695136|11540202|FG000|NOT COMPLETED|Overall Study||2
10396410|NCT00695188|11540208|FG000|STARTED|Overall Study||10
10396411|NCT00695188|11540209|FG001|STARTED|Overall Study||9
10396412|NCT00695188|11540208|FG000|COMPLETED|Overall Study||10
10396413|NCT00695188|11540209|FG001|COMPLETED|Overall Study||9
10396414|NCT00695188|11540208|FG000|NOT COMPLETED|Overall Study||0
10396415|NCT00695188|11540209|FG001|NOT COMPLETED|Overall Study||0
10396416|NCT00695253|11540215|FG000|STARTED|Overall Study|75 patients were screened and a total of 49 were enrolled in the study.|49
10396417|NCT00695253|11540215|FG000|COMPLETED|Overall Study|Eighteen (18) completed the study up to the 5 year followup.|18
10396418|NCT00695253|11540215|FG000|NOT COMPLETED|Overall Study||31
10396419|NCT00695292|11540220|FG000|STARTED|Overall Study||37
10396420|NCT00695292|11540220|FG000|COMPLETED|Overall Study||37
10396421|NCT00695292|11540220|FG000|NOT COMPLETED|Overall Study||0
10396422|NCT00695318|11540226|FG000|STARTED|Overall Study||10
10396423|NCT00695318|11540227|FG001|STARTED|Overall Study||7
10396424|NCT00695318|11540226|FG000|COMPLETED|Overall Study||5
10396425|NCT00695318|11540227|FG001|COMPLETED|Overall Study||6
10396426|NCT00695318|11540226|FG000|NOT COMPLETED|Overall Study||5
10720183|NCT02714569|11883871|FG004|STARTED|Part A First Intervention||3
10396427|NCT00695318|11540227|FG001|NOT COMPLETED|Overall Study||1
10396428|NCT00695396|11540241|FG000|STARTED|Overall Study||8
10396429|NCT00695396|11540242|FG001|STARTED|Overall Study||8
10396430|NCT00695396|11540243|FG002|STARTED|Overall Study||9
10396431|NCT00695396|11540241|FG000|COMPLETED|Overall Study||1
10396432|NCT00695396|11540242|FG001|COMPLETED|Overall Study||0
10396433|NCT00695396|11540243|FG002|COMPLETED|Overall Study||1
10396434|NCT00695396|11540241|FG000|NOT COMPLETED|Overall Study||7
10396435|NCT00695396|11540242|FG001|NOT COMPLETED|Overall Study||8
10396436|NCT00695396|11540243|FG002|NOT COMPLETED|Overall Study||8
10720184|NCT02714569|11883872|FG005|STARTED|Part A First Intervention||3
10396437|NCT00695409|11540251|FG000|STARTED|Overall Study||122
10396438|NCT00695409|11540251|FG000|COMPLETED|Overall Study||122
10396439|NCT00695409|11540251|FG000|NOT COMPLETED|Overall Study||0
10396440|NCT00695435|11540256|FG000|STARTED|Overall Study||7
10396441|NCT00695435|11540257|FG001|STARTED|Overall Study||7
10396442|NCT00695435|11540258|FG002|STARTED|Overall Study||7
10396443|NCT00695435|11540256|FG000|COMPLETED|Overall Study||7
10396444|NCT00695435|11540257|FG001|COMPLETED|Overall Study||7
10396445|NCT00695435|11540258|FG002|COMPLETED|Overall Study||7
10396446|NCT00695435|11540256|FG000|NOT COMPLETED|Overall Study||0
10396447|NCT00695435|11540257|FG001|NOT COMPLETED|Overall Study||0
10396448|NCT00695435|11540258|FG002|NOT COMPLETED|Overall Study||0
10396449|NCT00695500|11540268|FG000|STARTED|Overall Study||24
10396450|NCT00695500|11540269|FG001|STARTED|Overall Study||22
10396451|NCT00695500|11540268|FG000|COMPLETED|Overall Study||21
10396452|NCT00695500|11540269|FG001|COMPLETED|Overall Study||17
10396453|NCT00695500|11540268|FG000|NOT COMPLETED|Overall Study||3
10396454|NCT00695500|11540269|FG001|NOT COMPLETED|Overall Study||5
10396455|NCT00695565|11540277|FG000|STARTED|Overall Study||90
10396456|NCT00695565|11540278|FG001|STARTED|Overall Study||90
10396457|NCT00695565|11540277|FG000|COMPLETED|Overall Study||77
10396458|NCT00695565|11540278|FG001|COMPLETED|Overall Study||81
10396459|NCT00695565|11540277|FG000|NOT COMPLETED|Overall Study||13
10396460|NCT00695565|11540278|FG001|NOT COMPLETED|Overall Study||9
10396461|NCT00695578|11540286|FG000|STARTED|Overall Study||10
10396462|NCT00695578|11540287|FG001|STARTED|Overall Study||10
10396463|NCT00695578|11540286|FG000|COMPLETED|Overall Study||10
10396464|NCT00695578|11540287|FG001|COMPLETED|Overall Study||10
10396465|NCT00695578|11540286|FG000|NOT COMPLETED|Overall Study||0
10396466|NCT00695578|11540287|FG001|NOT COMPLETED|Overall Study||0
10396467|NCT00695669|11540297|FG000|STARTED|Overall Study||78
10396468|NCT00695669|11540298|FG001|STARTED|Overall Study||78
10396469|NCT00695669|11540299|FG002|STARTED|Overall Study||78
10396470|NCT00695669|11540300|FG003|STARTED|Overall Study||78
10720185|NCT02714569|11883873|FG006|STARTED|Part A First Intervention||0
10720186|NCT02714569|11883874|FG007|STARTED|Part A First Intervention||0
10720187|NCT02714569|11883875|FG008|STARTED|Part A First Intervention||0
10720188|NCT02714569|11883876|FG009|STARTED|Part A First Intervention||0
10396471|NCT00695669|11540297|FG000|COMPLETED|Overall Study||74
10396472|NCT00695669|11540298|FG001|COMPLETED|Overall Study||74
10396473|NCT00695669|11540299|FG002|COMPLETED|Overall Study||75
10396474|NCT00695669|11540300|FG003|COMPLETED|Overall Study||74
10396475|NCT00695669|11540297|FG000|NOT COMPLETED|Overall Study||4
10396476|NCT00695669|11540298|FG001|NOT COMPLETED|Overall Study||4
10396477|NCT00695669|11540299|FG002|NOT COMPLETED|Overall Study||3
10396478|NCT00695669|11540300|FG003|NOT COMPLETED|Overall Study||4
10396479|NCT00695786|11540317|FG000|STARTED|Overall Study||2
10396480|NCT00695786|11540318|FG001|STARTED|Overall Study||79
10396481|NCT00695786|11540319|FG002|STARTED|Overall Study||31
10396482|NCT00695786|11540320|FG003|STARTED|Overall Study||44
10396483|NCT00695786|11540317|FG000|COMPLETED|Overall Study||1
10396484|NCT00695786|11540318|FG001|COMPLETED|Overall Study||67
10396485|NCT00695786|11540319|FG002|COMPLETED|Overall Study||23
10396486|NCT00695786|11540320|FG003|COMPLETED|Overall Study||36
10396487|NCT00695786|11540317|FG000|NOT COMPLETED|Overall Study||1
10396488|NCT00695786|11540318|FG001|NOT COMPLETED|Overall Study||12
10396489|NCT00695786|11540319|FG002|NOT COMPLETED|Overall Study||8
10396490|NCT00695786|11540320|FG003|NOT COMPLETED|Overall Study||8
10396491|NCT00695864|11540330|FG000|STARTED|Placebo||14
10396492|NCT00695864|11540330|FG000|COMPLETED|Placebo||9
10396493|NCT00695864|11540330|FG000|NOT COMPLETED|Placebo||5
10396494|NCT00695864|11540330|FG000|STARTED|Ondansetron||14
10396495|NCT00695864|11540330|FG000|COMPLETED|Ondansetron||9
10396496|NCT00695864|11540330|FG000|NOT COMPLETED|Ondansetron||5
10396497|NCT00695903|11540338|FG000|STARTED|Had End of Therapy (EOT) Assessment||19
10396498|NCT00695903|11540339|FG001|STARTED|Had End of Therapy (EOT) Assessment||19
10396499|NCT00695903|11540338|FG000|Met Continuation Criteria|Had End of Therapy (EOT) Assessment||9
10396500|NCT00695903|11540339|FG001|Met Continuation Criteria|Had End of Therapy (EOT) Assessment||6
10396501|NCT00695903|11540338|FG000|COMPLETED|Had End of Therapy (EOT) Assessment||7
10543590|NCT01484431|11696730|FG001|Received 7.5 mg|Period 2||2
10543591|NCT01484431|11696731|FG002|Received 7.5 mg|Period 2||0
10543592|NCT01484431|11696729|FG000|Received 8 mg|Period 2||1
10720189|NCT02714569|11883877|FG010|STARTED|Part A First Intervention||0
10720190|NCT02714569|11883867|FG000|Received at Least One Dose of Study Drug|Part A First Intervention||3
10720191|NCT02714569|11883868|FG001|Received at Least One Dose of Study Drug|Part A First Intervention||3
10396502|NCT00695903|11540339|FG001|COMPLETED|Had End of Therapy (EOT) Assessment||4
10396503|NCT00695903|11540338|FG000|NOT COMPLETED|Had End of Therapy (EOT) Assessment||12
10396504|NCT00695903|11540339|FG001|NOT COMPLETED|Had End of Therapy (EOT) Assessment||15
10543593|NCT01484431|11696730|FG001|Received 8 mg|Period 2||0
10396505|NCT00695903|11540338|FG000|STARTED|Had Test of Cure (TOC) Assessment||7
10396506|NCT00695903|11540339|FG001|STARTED|Had Test of Cure (TOC) Assessment||4
10396507|NCT00695903|11540338|FG000|COMPLETED|Had Test of Cure (TOC) Assessment||5
10543594|NCT01484431|11696731|FG002|Received 8 mg|Period 2||0
10396508|NCT00695903|11540339|FG001|COMPLETED|Had Test of Cure (TOC) Assessment||3
10310767|NCT00126750|11443936|FG001|COMPLETED|Overall Study|Total providers at clinic locations were given the option to 'enroll'.|196
10310768|NCT00126750|11443935|FG000|NOT COMPLETED|Overall Study||180
10310769|NCT00126750|11443936|FG001|NOT COMPLETED|Overall Study||266
10310770|NCT00127036|11443944|FG000|STARTED|Overall Study||34
10310771|NCT00127036|11443945|FG001|STARTED|Overall Study||31
10310772|NCT00127036|11443944|FG000|COMPLETED|Overall Study|26 Participants were evaluable.|26
10310773|NCT00127036|11443945|FG001|COMPLETED|Overall Study|20 Participants were evaluable.|20
10310774|NCT00127036|11443944|FG000|NOT COMPLETED|Overall Study||8
10310775|NCT00127036|11443945|FG001|NOT COMPLETED|Overall Study||11
10310776|NCT00127062|11443953|FG000|STARTED|First intervention_Oxford Street||31
10310777|NCT00127062|11443954|FG001|STARTED|First intervention_Oxford Street||29
10310778|NCT00127062|11443953|FG000|COMPLETED|First intervention_Oxford Street||31
10310779|NCT00127062|11443954|FG001|COMPLETED|First intervention_Oxford Street||29
10310780|NCT00127062|11443953|FG000|NOT COMPLETED|First intervention_Oxford Street||0
10720192|NCT02714569|11883869|FG002|Received at Least One Dose of Study Drug|Part A First Intervention||3
10720193|NCT02714569|11883870|FG003|Received at Least One Dose of Study Drug|Part A First Intervention||3
10720194|NCT02714569|11883871|FG004|Received at Least One Dose of Study Drug|Part A First Intervention||3
10720195|NCT02714569|11883872|FG005|Received at Least One Dose of Study Drug|Part A First Intervention||3
10720196|NCT02714569|11883873|FG006|Received at Least One Dose of Study Drug|Part A First Intervention||0
10720197|NCT02714569|11883874|FG007|Received at Least One Dose of Study Drug|Part A First Intervention||0
10720198|NCT02714569|11883875|FG008|Received at Least One Dose of Study Drug|Part A First Intervention||0
10813382|NCT02868892|11975742|FG000|COMPLETED|Overall Study||0
10813383|NCT02868892|11975742|FG000|NOT COMPLETED|Overall Study||6
10813384|NCT02865083|11975748|FG000|STARTED|Overall Study||3
10813385|NCT02865083|11975749|FG001|STARTED|Overall Study||1
10813386|NCT02865083|11975748|FG000|COMPLETED|Overall Study||0
10813387|NCT02865083|11975749|FG001|COMPLETED|Overall Study||0
10813388|NCT02865083|11975748|FG000|NOT COMPLETED|Overall Study||3
10813389|NCT02865083|11975749|FG001|NOT COMPLETED|Overall Study||1
10813390|NCT02865122|11975758|FG000|STARTED|Overall Study||1
10813391|NCT02865122|11975759|FG001|STARTED|Overall Study||1
10813392|NCT02865122|11975760|FG002|STARTED|Overall Study||0
10813393|NCT02865122|11975758|FG000|COMPLETED|Overall Study||0
10813394|NCT02865122|11975759|FG001|COMPLETED|Overall Study||1
10813395|NCT02865122|11975760|FG002|COMPLETED|Overall Study||0
10813396|NCT02865122|11975758|FG000|NOT COMPLETED|Overall Study||1
10813397|NCT02865122|11975759|FG001|NOT COMPLETED|Overall Study||0
10813398|NCT02865122|11975760|FG002|NOT COMPLETED|Overall Study||0
10813399|NCT02865915|11975770|FG000|STARTED|Overall Study||25
10813400|NCT02865915|11975771|FG001|STARTED|Overall Study||30
10813401|NCT02865915|11975770|FG000|COMPLETED|Overall Study|Study terminated prior to completion by any subject|0
10813402|NCT02865915|11975771|FG001|COMPLETED|Overall Study|Study terminated prior to completion by any subject|0
10813403|NCT02865915|11975770|FG000|NOT COMPLETED|Overall Study||25
10813404|NCT02865915|11975771|FG001|NOT COMPLETED|Overall Study||30
10813405|NCT02855411|11975777|FG000|STARTED|Overall Study||35
10813406|NCT02855411|11975777|FG000|Assigned to Study Treatment|Overall Study||0
10813407|NCT02855411|11975777|FG000|COMPLETED|Overall Study||0
10813408|NCT02855411|11975777|FG000|NOT COMPLETED|Overall Study||35
10813409|NCT02828124|11975785|FG000|STARTED|Overall Study||1
10813410|NCT02828124|11975786|FG001|STARTED|Overall Study||2
10813411|NCT02828124|11975787|FG002|STARTED|Overall Study||1
10813412|NCT02828124|11975788|FG003|STARTED|Overall Study||6
10813413|NCT02828124|11975785|FG000|COMPLETED|Overall Study||0
10813414|NCT02828124|11975786|FG001|COMPLETED|Overall Study||0
10813415|NCT02828124|11975787|FG002|COMPLETED|Overall Study||0
10813416|NCT02828124|11975788|FG003|COMPLETED|Overall Study||0
10813417|NCT02828124|11975785|FG000|NOT COMPLETED|Overall Study||1
10813418|NCT02828124|11975786|FG001|NOT COMPLETED|Overall Study||2
10813419|NCT02828124|11975787|FG002|NOT COMPLETED|Overall Study||1
10813420|NCT02828124|11975788|FG003|NOT COMPLETED|Overall Study||6
10396509|NCT00695903|11540338|FG000|NOT COMPLETED|Had Test of Cure (TOC) Assessment||2
10396510|NCT00695903|11540339|FG001|NOT COMPLETED|Had Test of Cure (TOC) Assessment||1
10396511|NCT00695955|11540345|FG000|STARTED|Cohort 1||362
10396512|NCT00695955|11540345|FG000|COMPLETED|Cohort 1||260
10396513|NCT00695955|11540345|FG000|NOT COMPLETED|Cohort 1||102
10396514|NCT00695955|11540345|FG000|STARTED|Cohort 2||307
10396515|NCT00695955|11540345|FG000|COMPLETED|Cohort 2||203
10396516|NCT00695955|11540345|FG000|NOT COMPLETED|Cohort 2||104
10396517|NCT00696020|11540355|FG000|STARTED|Overall Study||90
10396518|NCT00696020|11540356|FG001|STARTED|Overall Study||89
10396519|NCT00696020|11540357|FG002|STARTED|Overall Study||93
10396520|NCT00696020|11540358|FG003|STARTED|Overall Study||88
10396521|NCT00696020|11540355|FG000|COMPLETED|Overall Study||86
10396522|NCT00696020|11540356|FG001|COMPLETED|Overall Study||87
10396523|NCT00696020|11540357|FG002|COMPLETED|Overall Study||90
10396524|NCT00696020|11540358|FG003|COMPLETED|Overall Study||84
10396525|NCT00696020|11540355|FG000|NOT COMPLETED|Overall Study||4
10396526|NCT00696020|11540356|FG001|NOT COMPLETED|Overall Study||2
10396527|NCT00696020|11540357|FG002|NOT COMPLETED|Overall Study||3
10396528|NCT00696020|11540358|FG003|NOT COMPLETED|Overall Study||4
10396529|NCT00696072|11540372|FG000|STARTED|Overall Study||57
10396530|NCT00696072|11540373|FG001|STARTED|Overall Study||63
10396531|NCT00696072|11540372|FG000|COMPLETED|Overall Study||0
10396532|NCT00696072|11540373|FG001|COMPLETED|Overall Study||0
10396533|NCT00696072|11540372|FG000|NOT COMPLETED|Overall Study||57
10396534|NCT00696072|11540373|FG001|NOT COMPLETED|Overall Study||63
10396535|NCT00696137|11540380|FG000|STARTED|Overall Study||5
10396536|NCT00696137|11540380|FG000|COMPLETED|Overall Study||3
10396537|NCT00696137|11540380|FG000|NOT COMPLETED|Overall Study||2
10396538|NCT00696241|11540389|FG000|STARTED|Overall Study||283
10396539|NCT00696241|11540390|FG001|STARTED|Overall Study||283
10396540|NCT00696241|11540391|FG002|STARTED|Overall Study||285
10396541|NCT00696241|11540392|FG003|STARTED|Overall Study||282
10396542|NCT00696241|11540393|FG004|STARTED|Overall Study||142
10396543|NCT00696241|11540389|FG000|COMPLETED|Overall Study||259
10396544|NCT00696241|11540390|FG001|COMPLETED|Overall Study||261
10396545|NCT00696241|11540391|FG002|COMPLETED|Overall Study||261
10396546|NCT00696241|11540392|FG003|COMPLETED|Overall Study||268
10396547|NCT00696241|11540393|FG004|COMPLETED|Overall Study||130
10396548|NCT00696241|11540389|FG000|NOT COMPLETED|Overall Study||24
10396549|NCT00696241|11540390|FG001|NOT COMPLETED|Overall Study||22
10396550|NCT00696241|11540391|FG002|NOT COMPLETED|Overall Study||24
10396551|NCT00696241|11540392|FG003|NOT COMPLETED|Overall Study||14
10396552|NCT00696241|11540393|FG004|NOT COMPLETED|Overall Study||12
10396553|NCT00696293|11540405|FG000|STARTED|Overall Study||30
10396554|NCT00696293|11540405|FG000|COMPLETED|Overall Study||28
10396555|NCT00696293|11540405|FG000|NOT COMPLETED|Overall Study||2
10396556|NCT00696384|11540410|FG000|STARTED|Open Label Phase||418
10396557|NCT00696384|11540411|FG001|STARTED|Open Label Phase||0
10396558|NCT00696384|11540412|FG002|STARTED|Open Label Phase||0
10396559|NCT00696384|11540410|FG000|COMPLETED|Open Label Phase||299
10396560|NCT00696384|11540411|FG001|COMPLETED|Open Label Phase||0
10396561|NCT00696384|11540412|FG002|COMPLETED|Open Label Phase||0
10396562|NCT00696384|11540410|FG000|NOT COMPLETED|Open Label Phase||119
10396563|NCT00696384|11540411|FG001|NOT COMPLETED|Open Label Phase||0
10396564|NCT00696384|11540412|FG002|NOT COMPLETED|Open Label Phase||0
10396565|NCT00696384|11540410|FG000|STARTED|Double Blind Phase||0
10396566|NCT00696384|11540411|FG001|STARTED|Double Blind Phase||148
10396567|NCT00696384|11540412|FG002|STARTED|Double Blind Phase||151
10396568|NCT00696384|11540410|FG000|COMPLETED|Double Blind Phase||0
10396569|NCT00696384|11540411|FG001|COMPLETED|Double Blind Phase||137
10396570|NCT00696384|11540412|FG002|COMPLETED|Double Blind Phase||145
10396571|NCT00696384|11540410|FG000|NOT COMPLETED|Double Blind Phase||0
10396572|NCT00696384|11540411|FG001|NOT COMPLETED|Double Blind Phase||11
10396573|NCT00696384|11540412|FG002|NOT COMPLETED|Double Blind Phase||6
10396574|NCT00696410|11540423|FG000|STARTED|Overall Study||38
10396575|NCT00696410|11540424|FG001|STARTED|Overall Study||10
10396576|NCT00696410|11540423|FG000|COMPLETED|Overall Study||25
10396577|NCT00696410|11540424|FG001|COMPLETED|Overall Study||10
10396578|NCT00696410|11540423|FG000|NOT COMPLETED|Overall Study||13
10396579|NCT00696410|11540424|FG001|NOT COMPLETED|Overall Study||0
10396580|NCT00696423|11540437|FG000|STARTED|Overall Study||244
10396581|NCT00696423|11540438|FG001|STARTED|Overall Study||223
10396582|NCT00696423|11540437|FG000|COMPLETED|Overall Study||244
10396583|NCT00696423|11540438|FG001|COMPLETED|Overall Study||218
10396584|NCT00696423|11540437|FG000|NOT COMPLETED|Overall Study||0
10396585|NCT00696423|11540438|FG001|NOT COMPLETED|Overall Study||5
10396586|NCT00696436|11540449|FG000|STARTED|Overall Study|Randomized participants only.|280
10428757|NCT00860028|11574820|FG001|NOT COMPLETED|Smoking Cessation Phase||2
10720199|NCT02714569|11883876|FG009|Received at Least One Dose of Study Drug|Part A First Intervention||0
10396587|NCT00696436|11540450|FG001|STARTED|Overall Study|Randomized participants only. One participant treated but not randomized and is not included.|285
10396588|NCT00696436|11540451|FG002|STARTED|Overall Study|Randomized participants only.|282
10396589|NCT00696436|11540452|FG003|STARTED|Overall Study|Randomized participants only.|290
10396590|NCT00696436|11540453|FG004|STARTED|Overall Study|Randomized participants only.|154
10396591|NCT00696436|11540449|FG000|COMPLETED|Overall Study||257
10396592|NCT00696436|11540450|FG001|COMPLETED|Overall Study||255
10396593|NCT00696436|11540451|FG002|COMPLETED|Overall Study||254
10396594|NCT00696436|11540452|FG003|COMPLETED|Overall Study||268
10396595|NCT00696436|11540453|FG004|COMPLETED|Overall Study||141
10396596|NCT00696436|11540449|FG000|NOT COMPLETED|Overall Study||23
10396597|NCT00696436|11540450|FG001|NOT COMPLETED|Overall Study||30
10396598|NCT00696436|11540451|FG002|NOT COMPLETED|Overall Study||28
10396599|NCT00696436|11540452|FG003|NOT COMPLETED|Overall Study||22
10396600|NCT00696436|11540453|FG004|NOT COMPLETED|Overall Study||13
10396601|NCT00696449|11540469|FG000|STARTED|Overall Study||15
10396602|NCT00696449|11540470|FG001|STARTED|Overall Study||15
10396603|NCT00696449|11540471|FG002|STARTED|Overall Study||15
10396604|NCT00696449|11540472|FG003|STARTED|Overall Study||16
10396605|NCT00696449|11540469|FG000|COMPLETED|Overall Study||12
10396606|NCT00696449|11540470|FG001|COMPLETED|Overall Study||9
10396607|NCT00696449|11540471|FG002|COMPLETED|Overall Study||14
10396608|NCT00696449|11540472|FG003|COMPLETED|Overall Study||13
10396609|NCT00696449|11540469|FG000|NOT COMPLETED|Overall Study||3
10396610|NCT00696449|11540470|FG001|NOT COMPLETED|Overall Study||6
10396611|NCT00696449|11540471|FG002|NOT COMPLETED|Overall Study||1
10396612|NCT00696449|11540472|FG003|NOT COMPLETED|Overall Study||3
10396613|NCT00696488|11540482|FG000|STARTED|Overall Study||20
10396614|NCT00696488|11540482|FG000|COMPLETED|Overall Study||20
10396615|NCT00696488|11540482|FG000|NOT COMPLETED|Overall Study||0
10396616|NCT00696618|11540489|FG000|STARTED|Overall Study||3
10396617|NCT00696618|11540490|FG001|STARTED|Overall Study||3
10396618|NCT00696618|11540491|FG002|STARTED|Overall Study||3
10396619|NCT00696618|11540489|FG000|COMPLETED|Overall Study||3
10396620|NCT00696618|11540490|FG001|COMPLETED|Overall Study||3
10396621|NCT00696618|11540491|FG002|COMPLETED|Overall Study||3
10396622|NCT00696618|11540489|FG000|NOT COMPLETED|Overall Study||0
10396623|NCT00696618|11540490|FG001|NOT COMPLETED|Overall Study||0
10396624|NCT00696618|11540491|FG002|NOT COMPLETED|Overall Study||0
10396625|NCT00696657|11540508|FG000|STARTED|Overall Study||46
10543595|NCT01484431|11696729|FG000|Received 10 mg|Period 2||0
10543596|NCT01484431|11696730|FG001|Received 10 mg|Period 2||1
10543597|NCT01484431|11696731|FG002|Received 10 mg|Period 2||0
10543598|NCT01484431|11696729|FG000|Received 15 mg|Period 2||1
10543599|NCT01484431|11696730|FG001|Received 15 mg|Period 2||2
10543600|NCT01484431|11696731|FG002|Received 15 mg|Period 2||1
10543601|NCT01484431|11696729|FG000|Received 20 mg|Period 2||3
10543602|NCT01484431|11696730|FG001|Received 20 mg|Period 2||1
10543603|NCT01484431|11696731|FG002|Received 20 mg|Period 2||4
10543604|NCT01484431|11696729|FG000|Received 40 mg|Period 2||0
10543605|NCT01484431|11696730|FG001|Received 40 mg|Period 2||0
10543606|NCT01484431|11696731|FG002|Received 40 mg|Period 2||1
10543607|NCT01484431|11696729|FG000|COMPLETED|Period 2||5
10543608|NCT01484431|11696730|FG001|COMPLETED|Period 2||5
10720200|NCT02714569|11883877|FG010|Received at Least One Dose of Study Drug|Part A First Intervention||0
10543609|NCT01484431|11696731|FG002|COMPLETED|Period 2||4
10543610|NCT01484431|11696729|FG000|NOT COMPLETED|Period 2||1
10543611|NCT01484431|11696730|FG001|NOT COMPLETED|Period 2||1
10543612|NCT01484431|11696731|FG002|NOT COMPLETED|Period 2||2
10543613|NCT01484496|11696746|FG000|STARTED|Period 1||280
10543614|NCT01484496|11696747|FG001|STARTED|Period 1||556
10543615|NCT01484496|11696748|FG002|STARTED|Period 1||0
10543616|NCT01484496|11696749|FG003|STARTED|Period 1||0
10543617|NCT01484496|11696746|FG000|COMPLETED|Period 1||214
10396626|NCT00696657|11540509|FG001|STARTED|Overall Study||47
10543618|NCT01484496|11696747|FG001|COMPLETED|Period 1||463
10543619|NCT01484496|11696748|FG002|COMPLETED|Period 1||0
10543620|NCT01484496|11696749|FG003|COMPLETED|Period 1||0
10310781|NCT00127062|11443954|FG001|NOT COMPLETED|First intervention_Oxford Street||0
10310782|NCT00127062|11443953|FG000|STARTED|Second intervention_Hyde Park||31
10310783|NCT00127062|11443954|FG001|STARTED|Second intervention_Hyde Park||29
10310784|NCT00127062|11443953|FG000|COMPLETED|Second intervention_Hyde Park||31
10310785|NCT00127062|11443954|FG001|COMPLETED|Second intervention_Hyde Park||29
10310786|NCT00127062|11443953|FG000|NOT COMPLETED|Second intervention_Hyde Park||0
10310787|NCT00127062|11443954|FG001|NOT COMPLETED|Second intervention_Hyde Park||0
10310788|NCT00127101|11443970|FG000|STARTED|Base Protocol||3
10310789|NCT00127101|11443971|FG001|STARTED|Base Protocol||5
10310790|NCT00127101|11443972|FG002|STARTED|Base Protocol||3
10310791|NCT00127101|11443973|FG003|STARTED|Base Protocol||3
10310792|NCT00127101|11443974|FG004|STARTED|Base Protocol||5
10310793|NCT00127101|11443975|FG005|STARTED|Base Protocol||4
10310794|NCT00127101|11443970|FG000|COMPLETED|Base Protocol||1
10310795|NCT00127101|11443971|FG001|COMPLETED|Base Protocol||1
10310796|NCT00127101|11443972|FG002|COMPLETED|Base Protocol||1
10310797|NCT00127101|11443973|FG003|COMPLETED|Base Protocol||3
10310798|NCT00127101|11443974|FG004|COMPLETED|Base Protocol||3
10310799|NCT00127101|11443975|FG005|COMPLETED|Base Protocol||3
10310800|NCT00127101|11443970|FG000|NOT COMPLETED|Base Protocol||2
10310801|NCT00127101|11443971|FG001|NOT COMPLETED|Base Protocol||4
10310802|NCT00127101|11443972|FG002|NOT COMPLETED|Base Protocol||2
10310803|NCT00127101|11443973|FG003|NOT COMPLETED|Base Protocol||0
10310804|NCT00127101|11443974|FG004|NOT COMPLETED|Base Protocol||2
10310805|NCT00127101|11443975|FG005|NOT COMPLETED|Base Protocol||1
10310806|NCT00127101|11443970|FG000|STARTED|Continuation Phase||0
10310807|NCT00127101|11443971|FG001|STARTED|Continuation Phase||0
10310808|NCT00127101|11443972|FG002|STARTED|Continuation Phase||1
10310809|NCT00127101|11443973|FG003|STARTED|Continuation Phase|No patients from the 2b Cohort entered into the extension phase|0
10310810|NCT00127101|11443974|FG004|STARTED|Continuation Phase||3
10310811|NCT00127101|11443975|FG005|STARTED|Continuation Phase||3
10310812|NCT00127101|11443970|FG000|COMPLETED|Continuation Phase||0
10310813|NCT00127101|11443971|FG001|COMPLETED|Continuation Phase||0
10310814|NCT00127101|11443972|FG002|COMPLETED|Continuation Phase||0
10310815|NCT00127101|11443973|FG003|COMPLETED|Continuation Phase||0
10310816|NCT00127101|11443974|FG004|COMPLETED|Continuation Phase||0
10720201|NCT02714569|11883867|FG000|COMPLETED|Part A First Intervention||3
10720202|NCT02714569|11883868|FG001|COMPLETED|Part A First Intervention||3
10720203|NCT02714569|11883869|FG002|COMPLETED|Part A First Intervention||3
10720204|NCT02714569|11883870|FG003|COMPLETED|Part A First Intervention||3
10720205|NCT02714569|11883871|FG004|COMPLETED|Part A First Intervention||3
10720206|NCT02714569|11883872|FG005|COMPLETED|Part A First Intervention||3
10720207|NCT02714569|11883873|FG006|COMPLETED|Part A First Intervention||0
10720208|NCT02714569|11883874|FG007|COMPLETED|Part A First Intervention||0
10720209|NCT02714569|11883875|FG008|COMPLETED|Part A First Intervention||0
10396627|NCT00696657|11540510|FG002|STARTED|Overall Study||44
10396628|NCT00696657|11540511|FG003|STARTED|Overall Study||49
10396629|NCT00696657|11540512|FG004|STARTED|Overall Study||44
10396630|NCT00696657|11540513|FG005|STARTED|Overall Study||45
10396631|NCT00696657|11540514|FG006|STARTED|Overall Study||45
10396632|NCT00696657|11540515|FG007|STARTED|Overall Study||45
10396633|NCT00696657|11540516|FG008|STARTED|Overall Study||50
10396634|NCT00696657|11540508|FG000|EXPOSED|Overall Study||46
10396635|NCT00696657|11540509|FG001|EXPOSED|Overall Study||47
10396636|NCT00696657|11540510|FG002|EXPOSED|Overall Study||43
10396637|NCT00696657|11540511|FG003|EXPOSED|Overall Study||48
10396638|NCT00696657|11540512|FG004|EXPOSED|Overall Study||44
10396639|NCT00696657|11540513|FG005|EXPOSED|Overall Study||43
10396640|NCT00696657|11540514|FG006|EXPOSED|Overall Study||45
10396641|NCT00696657|11540515|FG007|EXPOSED|Overall Study||45
10396642|NCT00696657|11540516|FG008|EXPOSED|Overall Study||50
10396643|NCT00696657|11540508|FG000|COMPLETED|Overall Study||45
10396644|NCT00696657|11540509|FG001|COMPLETED|Overall Study||42
10396645|NCT00696657|11540510|FG002|COMPLETED|Overall Study||36
10396646|NCT00696657|11540511|FG003|COMPLETED|Overall Study||38
10396647|NCT00696657|11540512|FG004|COMPLETED|Overall Study||34
10396648|NCT00696657|11540513|FG005|COMPLETED|Overall Study||33
10396649|NCT00696657|11540514|FG006|COMPLETED|Overall Study||30
10396650|NCT00696657|11540515|FG007|COMPLETED|Overall Study||42
10396651|NCT00696657|11540516|FG008|COMPLETED|Overall Study||41
10396652|NCT00696657|11540508|FG000|NOT COMPLETED|Overall Study||1
10396653|NCT00696657|11540509|FG001|NOT COMPLETED|Overall Study||5
10396654|NCT00696657|11540510|FG002|NOT COMPLETED|Overall Study||8
10396655|NCT00696657|11540511|FG003|NOT COMPLETED|Overall Study||11
10396656|NCT00696657|11540512|FG004|NOT COMPLETED|Overall Study||10
10396657|NCT00696657|11540513|FG005|NOT COMPLETED|Overall Study||12
10396658|NCT00696657|11540514|FG006|NOT COMPLETED|Overall Study||15
10396659|NCT00696657|11540515|FG007|NOT COMPLETED|Overall Study||3
10396660|NCT00696657|11540516|FG008|NOT COMPLETED|Overall Study||9
10396661|NCT00696696|11540536|FG000|STARTED|Overall Study||44
10396662|NCT00696696|11540536|FG000|COMPLETED|Overall Study|number of patients off treatment due to progression of disease only|26
10396663|NCT00696696|11540536|FG000|NOT COMPLETED|Overall Study||18
10396664|NCT00696709|11540545|FG000|STARTED|Overall Study||65
10396665|NCT00696709|11540546|FG001|STARTED|Overall Study||63
10396666|NCT00696709|11540547|FG002|STARTED|Overall Study||33
10396667|NCT00696709|11540548|FG003|STARTED|Overall Study||64
10396668|NCT00696709|11540549|FG004|STARTED|Overall Study||65
10396669|NCT00696709|11540545|FG000|Vaccination 1 (Day 1)|Overall Study||65
10396670|NCT00696709|11540546|FG001|Vaccination 1 (Day 1)|Overall Study||63
10396671|NCT00696709|11540547|FG002|Vaccination 1 (Day 1)|Overall Study||32
10396672|NCT00696709|11540548|FG003|Vaccination 1 (Day 1)|Overall Study||64
10396673|NCT00696709|11540549|FG004|Vaccination 1 (Day 1)|Overall Study||65
10396674|NCT00696709|11540545|FG000|Vaccination 2 (~Day 30)|Overall Study||64
10396675|NCT00696709|11540546|FG001|Vaccination 2 (~Day 30)|Overall Study||60
10396676|NCT00696709|11540547|FG002|Vaccination 2 (~Day 30)|Overall Study||32
10543621|NCT01484496|11696746|FG000|NOT COMPLETED|Period 1||66
10396677|NCT00696709|11540548|FG003|Vaccination 2 (~Day 30)|Overall Study||61
10396678|NCT00696709|11540549|FG004|Vaccination 2 (~Day 30)|Overall Study||64
10396679|NCT00696709|11540545|FG000|Vaccination 3 (~Day 60)|Overall Study||64
10396680|NCT00696709|11540546|FG001|Vaccination 3 (~Day 60)|Overall Study||60
10396681|NCT00696709|11540547|FG002|Vaccination 3 (~Day 60)|Overall Study||32
10396682|NCT00696709|11540548|FG003|Vaccination 3 (~Day 60)|Overall Study||59
10396683|NCT00696709|11540549|FG004|Vaccination 3 (~Day 60)|Overall Study||63
10396684|NCT00696709|11540545|FG000|Vaccination 4 (~Day 90)|Overall Study||62
10396685|NCT00696709|11540546|FG001|Vaccination 4 (~Day 90)|Overall Study||60
10396686|NCT00696709|11540547|FG002|Vaccination 4 (~Day 90)|Overall Study||32
10396687|NCT00696709|11540548|FG003|Vaccination 4 (~Day 90)|Overall Study||59
10396688|NCT00696709|11540549|FG004|Vaccination 4 (~Day 90)|Overall Study||63
10396689|NCT00696709|11540545|FG000|COMPLETED|Overall Study||62
10396690|NCT00696709|11540546|FG001|COMPLETED|Overall Study||60
10396691|NCT00696709|11540547|FG002|COMPLETED|Overall Study||32
10396692|NCT00696709|11540548|FG003|COMPLETED|Overall Study||59
10543622|NCT01484496|11696747|FG001|NOT COMPLETED|Period 1||93
10813421|NCT02826551|11975800|FG000|STARTED|Overall Study||11
10813422|NCT02826551|11975801|FG001|STARTED|Overall Study||12
10813423|NCT02826551|11975800|FG000|COMPLETED|Overall Study||11
10813424|NCT02826551|11975801|FG001|COMPLETED|Overall Study||12
10813425|NCT02826551|11975800|FG000|NOT COMPLETED|Overall Study||0
10813426|NCT02826551|11975801|FG001|NOT COMPLETED|Overall Study||0
10720210|NCT02714569|11883876|FG009|COMPLETED|Part A First Intervention||0
10720211|NCT02714569|11883877|FG010|COMPLETED|Part A First Intervention||0
10813427|NCT02825043|11975807|FG000|STARTED|Overall Study||6
10813428|NCT02825043|11975807|FG000|COMPLETED|Overall Study||2
10310817|NCT00127101|11443975|FG005|COMPLETED|Continuation Phase||0
10310818|NCT00127101|11443970|FG000|NOT COMPLETED|Continuation Phase||0
10310819|NCT00127101|11443971|FG001|NOT COMPLETED|Continuation Phase||0
10310820|NCT00127101|11443972|FG002|NOT COMPLETED|Continuation Phase||1
10310821|NCT00127101|11443973|FG003|NOT COMPLETED|Continuation Phase||0
10310822|NCT00127101|11443974|FG004|NOT COMPLETED|Continuation Phase||3
10310823|NCT00127101|11443975|FG005|NOT COMPLETED|Continuation Phase||3
10310824|NCT00127166|11443991|FG000|STARTED|Period I||78
10310825|NCT00127166|11443992|FG001|STARTED|Period I||76
10310826|NCT00127166|11443991|FG000|COMPLETED|Period I||75
10310827|NCT00127166|11443992|FG001|COMPLETED|Period I||74
10310828|NCT00127166|11443991|FG000|NOT COMPLETED|Period I||3
10310829|NCT00127166|11443992|FG001|NOT COMPLETED|Period I||2
10396693|NCT00696709|11540549|FG004|COMPLETED|Overall Study||62
10396694|NCT00696709|11540545|FG000|NOT COMPLETED|Overall Study||3
10396695|NCT00696709|11540546|FG001|NOT COMPLETED|Overall Study||3
10396696|NCT00696709|11540547|FG002|NOT COMPLETED|Overall Study||1
10396697|NCT00696709|11540548|FG003|NOT COMPLETED|Overall Study||5
10396698|NCT00696709|11540549|FG004|NOT COMPLETED|Overall Study||3
10396699|NCT00696761|11540569|FG000|STARTED|Overall Study||61
10396700|NCT00696761|11540570|FG001|STARTED|Overall Study||76
10396701|NCT00696761|11540571|FG002|STARTED|Overall Study||41
10396702|NCT00696761|11540572|FG003|STARTED|Overall Study||54
10396703|NCT00696761|11540569|FG000|COMPLETED|Overall Study||41
10396704|NCT00696761|11540570|FG001|COMPLETED|Overall Study||50
10396705|NCT00696761|11540571|FG002|COMPLETED|Overall Study||30
10396706|NCT00696761|11540572|FG003|COMPLETED|Overall Study||44
10396707|NCT00696761|11540569|FG000|NOT COMPLETED|Overall Study||20
10396708|NCT00696761|11540570|FG001|NOT COMPLETED|Overall Study||26
10396709|NCT00696761|11540571|FG002|NOT COMPLETED|Overall Study||11
10396710|NCT00696761|11540572|FG003|NOT COMPLETED|Overall Study||10
10396711|NCT00696774|11540593|FG000|STARTED|Period II||115
10396712|NCT00696774|11540594|FG001|STARTED|Period II||91
10396713|NCT00696774|11540595|FG002|STARTED|Period II|1 participant did not receive study drug and was not included in the safety analyses.|36
10396714|NCT00696774|11540593|FG000|COMPLETED|Period II||115
10396715|NCT00696774|11540594|FG001|COMPLETED|Period II||91
10396716|NCT00696774|11540595|FG002|COMPLETED|Period II||0
10396717|NCT00696774|11540593|FG000|NOT COMPLETED|Period II||0
10396718|NCT00696774|11540594|FG001|NOT COMPLETED|Period II||0
10396719|NCT00696774|11540595|FG002|NOT COMPLETED|Period II||36
10659000|NCT02237898|11820240|FG001|Completed 15 Month Follow-up|Overall Study||8
10659001|NCT02237898|11820239|FG000|COMPLETED|Overall Study||5
10659002|NCT02237898|11820240|FG001|COMPLETED|Overall Study||2
10659003|NCT02237898|11820239|FG000|NOT COMPLETED|Overall Study||7
10659004|NCT02237898|11820240|FG001|NOT COMPLETED|Overall Study||12
10396720|NCT00696774|11540593|FG000|STARTED|Period III|115 reported at Week 4; 113 started Period 3 (1 lost to follow-up and 1 protocol violation).|113
10396721|NCT00696774|11540594|FG001|STARTED|Period III|91 reported at Week 4; 88 start Period 3 (1 adverse event, 1 protocol violation, 1 lack of efficacy)|88
10396722|NCT00696774|11540595|FG002|STARTED|Period III||0
10396723|NCT00696774|11540593|FG000|COMPLETED|Period III||106
10396724|NCT00696774|11540594|FG001|COMPLETED|Period III|82 participants were reported at Week 8; 81 completed Week 8 as 1 participant decided to withdraw.|81
10396725|NCT00696774|11540595|FG002|COMPLETED|Period III||0
10396726|NCT00696774|11540593|FG000|NOT COMPLETED|Period III||7
10396727|NCT00696774|11540594|FG001|NOT COMPLETED|Period III||7
10396728|NCT00696774|11540595|FG002|NOT COMPLETED|Period III||0
10396729|NCT00696787|11540606|FG000|STARTED|Overall Study||40
10396730|NCT00696787|11540607|FG001|STARTED|Overall Study||42
10396731|NCT00696787|11540608|FG002|STARTED|Overall Study||43
10396732|NCT00696787|11540606|FG000|COMPLETED|Overall Study||25
10396733|NCT00696787|11540607|FG001|COMPLETED|Overall Study||22
10396734|NCT00696787|11540608|FG002|COMPLETED|Overall Study||17
10396735|NCT00696787|11540606|FG000|NOT COMPLETED|Overall Study||15
10396736|NCT00696787|11540607|FG001|NOT COMPLETED|Overall Study||20
10396737|NCT00696787|11540608|FG002|NOT COMPLETED|Overall Study||26
10396738|NCT00697073|11540616|FG000|STARTED|Overall Study||68
10396739|NCT00697073|11540616|FG000|COMPLETED|Overall Study||59
10396740|NCT00697073|11540616|FG000|NOT COMPLETED|Overall Study||9
10396741|NCT00697112|11540620|FG000|STARTED|Overall Study||53
10396742|NCT00697112|11540620|FG000|Met the Inclusion Criteria|Overall Study||52
10396743|NCT00697112|11540620|FG000|COMPLETED|Overall Study||43
10396744|NCT00697112|11540620|FG000|NOT COMPLETED|Overall Study||10
10396745|NCT00697190|11540624|FG000|STARTED|First Intervention||19
10396746|NCT00697190|11540625|FG001|STARTED|First Intervention||20
10396747|NCT00697190|11540624|FG000|COMPLETED|First Intervention||19
10396748|NCT00697190|11540625|FG001|COMPLETED|First Intervention||20
10396749|NCT00697190|11540624|FG000|NOT COMPLETED|First Intervention||0
10396750|NCT00697190|11540625|FG001|NOT COMPLETED|First Intervention||0
10396751|NCT00697190|11540624|FG000|STARTED|Second Intervention|one subject moved away between the first period and second period.|18
10396752|NCT00697190|11540625|FG001|STARTED|Second Intervention||20
10396753|NCT00697190|11540624|FG000|COMPLETED|Second Intervention||18
10396754|NCT00697190|11540625|FG001|COMPLETED|Second Intervention||20
10396755|NCT00697190|11540624|FG000|NOT COMPLETED|Second Intervention||0
10396756|NCT00697190|11540625|FG001|NOT COMPLETED|Second Intervention||0
10396757|NCT00697203|11540639|FG000|STARTED|Overall Study||76
10396758|NCT00697203|11540640|FG001|STARTED|Overall Study||68
10396759|NCT00697203|11540641|FG002|STARTED|Overall Study||74
10396760|NCT00697203|11540642|FG003|STARTED|Overall Study||74
10396761|NCT00697203|11540639|FG000|COMPLETED|Overall Study||67
10396762|NCT00697203|11540640|FG001|COMPLETED|Overall Study||62
10396763|NCT00697203|11540641|FG002|COMPLETED|Overall Study||66
10396764|NCT00697203|11540642|FG003|COMPLETED|Overall Study||67
10396765|NCT00697203|11540639|FG000|NOT COMPLETED|Overall Study||9
10396766|NCT00697203|11540640|FG001|NOT COMPLETED|Overall Study||6
10396767|NCT00697203|11540641|FG002|NOT COMPLETED|Overall Study||8
10396768|NCT00697203|11540642|FG003|NOT COMPLETED|Overall Study||7
10396769|NCT00697346|11540655|FG000|STARTED|Overall Study||28
10659005|NCT02237911|11820251|FG000|STARTED|Overall Study||96
10659006|NCT02237911|11820252|FG001|STARTED|Overall Study||96
10813429|NCT02825043|11975807|FG000|NOT COMPLETED|Overall Study||4
10813430|NCT02819804|11975811|FG000|STARTED|Complete Cycle 1 (28 Days)||1
10813431|NCT02819804|11975811|FG000|COMPLETED|Complete Cycle 1 (28 Days)||0
10813432|NCT02819804|11975811|FG000|NOT COMPLETED|Complete Cycle 1 (28 Days)||1
10813433|NCT02819804|11975811|FG000|STARTED|Start Cycle 2 and Beyond||0
10813434|NCT02819804|11975811|FG000|COMPLETED|Start Cycle 2 and Beyond||0
10813435|NCT02819804|11975811|FG000|NOT COMPLETED|Start Cycle 2 and Beyond||0
10813436|NCT02819804|11975811|FG000|STARTED|Follow-up for 1 Year||1
10813437|NCT02819804|11975811|FG000|COMPLETED|Follow-up for 1 Year||1
10813438|NCT02819804|11975811|FG000|NOT COMPLETED|Follow-up for 1 Year||0
10813439|NCT02809118|11975818|FG000|STARTED|Overall Study||18
10813440|NCT02809118|11975819|FG001|STARTED|Overall Study||19
10813441|NCT02809118|11975820|FG002|STARTED|Overall Study||19
10813442|NCT02809118|11975818|FG000|COMPLETED|Overall Study||18
10813443|NCT02809118|11975819|FG001|COMPLETED|Overall Study||18
10813444|NCT02809118|11975820|FG002|COMPLETED|Overall Study||18
10813445|NCT02809118|11975818|FG000|NOT COMPLETED|Overall Study||0
10396770|NCT00697346|11540656|FG001|STARTED|Overall Study||28
10396771|NCT00697346|11540657|FG002|STARTED|Overall Study||2
10396772|NCT00697346|11540655|FG000|COMPLETED|Overall Study|Completed = participants who completed study treatment.|0
10396773|NCT00697346|11540656|FG001|COMPLETED|Overall Study|2 participants were ongoing as of primary completion date 27 Dec 2011 and have now completed.|2
10396774|NCT00697346|11540657|FG002|COMPLETED|Overall Study|1 participant was ongoing as of primary completion date 27 Dec 2011 and has now completed.|1
10396775|NCT00697346|11540655|FG000|NOT COMPLETED|Overall Study||28
10396776|NCT00697346|11540656|FG001|NOT COMPLETED|Overall Study||26
10396777|NCT00697346|11540657|FG002|NOT COMPLETED|Overall Study||1
10396778|NCT00697463|11540684|FG000|STARTED|Overall Study||22
10396779|NCT00697463|11540684|FG000|COMPLETED|Overall Study||21
10396780|NCT00697463|11540684|FG000|NOT COMPLETED|Overall Study||1
10396781|NCT00697515|11540688|FG000|STARTED|Dose Optimization Period||142
10396782|NCT00697515|11540689|FG001|STARTED|Dose Optimization Period||0
10396783|NCT00697515|11540688|FG000|COMPLETED|Dose Optimization Period||127
10396784|NCT00697515|11540689|FG001|COMPLETED|Dose Optimization Period||0
10396785|NCT00697515|11540688|FG000|NOT COMPLETED|Dose Optimization Period||15
10543623|NCT01484496|11696748|FG002|NOT COMPLETED|Period 1||0
10543624|NCT01484496|11696749|FG003|NOT COMPLETED|Period 1||0
10543625|NCT01484496|11696746|FG000|STARTED|Period 2||0
10310830|NCT00127166|11443991|FG000|STARTED|Washout Period||75
10310831|NCT00127166|11443992|FG001|STARTED|Washout Period||74
10310832|NCT00127166|11443991|FG000|COMPLETED|Washout Period||75
10310833|NCT00127166|11443992|FG001|COMPLETED|Washout Period||73
10310834|NCT00127166|11443991|FG000|NOT COMPLETED|Washout Period||0
10310835|NCT00127166|11443992|FG001|NOT COMPLETED|Washout Period||1
10310836|NCT00127166|11443991|FG000|STARTED|Period II||75
10310837|NCT00127166|11443992|FG001|STARTED|Period II||73
10310838|NCT00127166|11443991|FG000|COMPLETED|Period II||72
10310839|NCT00127166|11443992|FG001|COMPLETED|Period II||73
10310840|NCT00127166|11443991|FG000|NOT COMPLETED|Period II||3
10310841|NCT00127166|11443992|FG001|NOT COMPLETED|Period II||0
10310842|NCT00127192|11444003|FG000|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|80
10310843|NCT00127192|11444004|FG001|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|72
10310844|NCT00127192|11444005|FG002|STARTED|Overall Study|Study enrolled as per the target of N=70|70
10310845|NCT00127192|11444006|FG003|STARTED|Overall Study|Study enrolled slightly less than the target of N=70|68
10310846|NCT00127192|11444007|FG004|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|73
10310847|NCT00127192|11444003|FG000|COMPLETED|Overall Study||77
10310848|NCT00127192|11444004|FG001|COMPLETED|Overall Study||71
10310849|NCT00127192|11444005|FG002|COMPLETED|Overall Study||68
10310850|NCT00127192|11444006|FG003|COMPLETED|Overall Study||67
10310851|NCT00127192|11444007|FG004|COMPLETED|Overall Study||68
10310852|NCT00127192|11444003|FG000|NOT COMPLETED|Overall Study||3
10310853|NCT00127192|11444004|FG001|NOT COMPLETED|Overall Study||1
10310854|NCT00127192|11444005|FG002|NOT COMPLETED|Overall Study||2
10310855|NCT00127192|11444006|FG003|NOT COMPLETED|Overall Study||1
10310856|NCT00127192|11444007|FG004|NOT COMPLETED|Overall Study||5
10310857|NCT00127205|11444022|FG000|STARTED|Overall Study||2262
10310858|NCT00127205|11444023|FG001|STARTED|Overall Study||2268
10310859|NCT00127205|11444024|FG002|STARTED|Overall Study||1567
10310860|NCT00127205|11444022|FG000|COMPLETED|Overall Study||1433
10310861|NCT00127205|11444023|FG001|COMPLETED|Overall Study||1295
10310862|NCT00127205|11444024|FG002|COMPLETED|Overall Study||955
10310863|NCT00127205|11444022|FG000|NOT COMPLETED|Overall Study||829
10310864|NCT00127205|11444023|FG001|NOT COMPLETED|Overall Study||973
10310865|NCT00127205|11444024|FG002|NOT COMPLETED|Overall Study||612
10310866|NCT00127218|11444036|FG000|STARTED|Overall Study||72
10310867|NCT00127218|11444037|FG001|STARTED|Overall Study||73
10310868|NCT00127218|11444036|FG000|COMPLETED|Overall Study||59
10310869|NCT00127218|11444037|FG001|COMPLETED|Overall Study||58
10310870|NCT00127218|11444036|FG000|NOT COMPLETED|Overall Study||13
10310871|NCT00127218|11444037|FG001|NOT COMPLETED|Overall Study||15
10310872|NCT00127231|11444047|FG000|STARTED|Overall Study||74
10310873|NCT00127231|11444048|FG001|STARTED|Overall Study||74
10396786|NCT00697515|11540689|FG001|NOT COMPLETED|Dose Optimization Period||0
10396787|NCT00697515|11540688|FG000|STARTED|First Intervention (Crossover Period)||63
10396788|NCT00697515|11540689|FG001|STARTED|First Intervention (Crossover Period)||64
10396789|NCT00697515|11540688|FG000|COMPLETED|First Intervention (Crossover Period)||53
10396790|NCT00697515|11540689|FG001|COMPLETED|First Intervention (Crossover Period)||52
10396791|NCT00697515|11540688|FG000|NOT COMPLETED|First Intervention (Crossover Period)||10
10396792|NCT00697515|11540689|FG001|NOT COMPLETED|First Intervention (Crossover Period)||12
10396793|NCT00697515|11540688|FG000|STARTED|Second Intervention (Crossover Period)||53
10396794|NCT00697515|11540689|FG001|STARTED|Second Intervention (Crossover Period)||52
10396795|NCT00697515|11540688|FG000|COMPLETED|Second Intervention (Crossover Period)||52
10396796|NCT00697515|11540689|FG001|COMPLETED|Second Intervention (Crossover Period)||51
10396797|NCT00697515|11540688|FG000|NOT COMPLETED|Second Intervention (Crossover Period)||1
10396798|NCT00697515|11540689|FG001|NOT COMPLETED|Second Intervention (Crossover Period)||1
10396799|NCT00697541|11540697|FG000|STARTED|Overall Study||10
10396800|NCT00697541|11540698|FG001|STARTED|Overall Study||10
10396801|NCT00697541|11540697|FG000|COMPLETED|Overall Study||8
10396802|NCT00697541|11540698|FG001|COMPLETED|Overall Study||9
10396803|NCT00697541|11540697|FG000|NOT COMPLETED|Overall Study||2
10396804|NCT00697541|11540698|FG001|NOT COMPLETED|Overall Study||1
10396805|NCT00697593|11540705|FG000|STARTED|Overall Study||70
10396806|NCT00697593|11540705|FG000|COMPLETED|Overall Study||51
10396807|NCT00697593|11540705|FG000|NOT COMPLETED|Overall Study||19
10396808|NCT00697619|11540711|FG000|STARTED|Overall Study||30
10396809|NCT00697619|11540712|FG001|STARTED|Overall Study||30
10396810|NCT00697619|11540711|FG000|COMPLETED|Overall Study||24
10396811|NCT00697619|11540712|FG001|COMPLETED|Overall Study||22
10396812|NCT00697619|11540711|FG000|NOT COMPLETED|Overall Study||6
10396813|NCT00697619|11540712|FG001|NOT COMPLETED|Overall Study||8
10396814|NCT00697697|11540720|FG000|STARTED|Overall Study||94
10396815|NCT00697697|11540721|FG001|STARTED|Overall Study||98
10396816|NCT00697697|11540720|FG000|COMPLETED|Overall Study||45
10396817|NCT00697697|11540721|FG001|COMPLETED|Overall Study||44
10396818|NCT00697697|11540720|FG000|NOT COMPLETED|Overall Study||49
10396819|NCT00697697|11540721|FG001|NOT COMPLETED|Overall Study||54
10396820|NCT00697788|11540727|FG000|STARTED|Dexmedetomidine Bolus 1 mcg/kg||8
10396821|NCT00697788|11540728|FG001|STARTED|Dexmedetomidine Bolus 1 mcg/kg|One participant did not begin infusion due to hypotension (mean pressure <50)|0
10396822|NCT00697788|11540729|FG002|STARTED|Dexmedetomidine Bolus 1 mcg/kg|2 participants did not begin the ascending (1.0 mcg/kg/hr) due to MAP<50|0
10396823|NCT00697788|11540730|FG003|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
10396824|NCT00697788|11540731|FG004|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
10396825|NCT00697788|11540732|FG005|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
10396826|NCT00697788|11540733|FG006|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
10396827|NCT00697788|11540734|FG007|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
10396828|NCT00697788|11540727|FG000|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||8
10396829|NCT00697788|11540728|FG001|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
10396830|NCT00697788|11540729|FG002|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
10396831|NCT00697788|11540730|FG003|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
10396832|NCT00697788|11540731|FG004|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
10396833|NCT00697788|11540732|FG005|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
10396834|NCT00697788|11540733|FG006|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
10396835|NCT00697788|11540734|FG007|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
10396836|NCT00697788|11540727|FG000|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
10396837|NCT00697788|11540728|FG001|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
10396838|NCT00697788|11540729|FG002|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
10396839|NCT00697788|11540730|FG003|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
10396840|NCT00697788|11540731|FG004|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
10396841|NCT00697788|11540732|FG005|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
10396842|NCT00697788|11540733|FG006|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
10396843|NCT00697788|11540734|FG007|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
10396844|NCT00697788|11540727|FG000|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
10396845|NCT00697788|11540728|FG001|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion|1 participant did not begin infusion due to hypotension (MAP<50)|7
10396846|NCT00697788|11540729|FG002|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
10720212|NCT02714569|11883867|FG000|NOT COMPLETED|Part A First Intervention||0
10396847|NCT00697788|11540730|FG003|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
10396848|NCT00697788|11540731|FG004|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
10396849|NCT00697788|11540732|FG005|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
10396850|NCT00697788|11540733|FG006|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
10396851|NCT00697788|11540734|FG007|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
10396852|NCT00697788|11540727|FG000|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
10396853|NCT00697788|11540728|FG001|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||5
10396854|NCT00697788|11540729|FG002|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
10396855|NCT00697788|11540730|FG003|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
10396856|NCT00697788|11540731|FG004|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
10396857|NCT00697788|11540732|FG005|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
10396858|NCT00697788|11540733|FG006|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
10396859|NCT00697788|11540734|FG007|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
10396860|NCT00697788|11540727|FG000|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
10396861|NCT00697788|11540728|FG001|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||2
10396862|NCT00697788|11540729|FG002|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
10396863|NCT00697788|11540730|FG003|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
10396864|NCT00697788|11540731|FG004|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
10396865|NCT00697788|11540732|FG005|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
10396866|NCT00697788|11540733|FG006|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
10396867|NCT00697788|11540734|FG007|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
10720213|NCT02714569|11883868|FG001|NOT COMPLETED|Part A First Intervention||0
10720214|NCT02714569|11883869|FG002|NOT COMPLETED|Part A First Intervention||0
10720215|NCT02714569|11883870|FG003|NOT COMPLETED|Part A First Intervention||0
10396868|NCT00697788|11540727|FG000|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
10396869|NCT00697788|11540728|FG001|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
10396870|NCT00697788|11540729|FG002|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion|2 participants did not begin this infusion due to hypotension (MAP<50)|3
10396871|NCT00697788|11540730|FG003|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
10396872|NCT00697788|11540731|FG004|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
10396873|NCT00697788|11540732|FG005|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
10396874|NCT00697788|11540733|FG006|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
10396875|NCT00697788|11540734|FG007|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
10396876|NCT00697788|11540727|FG000|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
10396877|NCT00697788|11540728|FG001|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
10396878|NCT00697788|11540729|FG002|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||3
10396879|NCT00697788|11540730|FG003|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
10396880|NCT00697788|11540731|FG004|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
10396881|NCT00697788|11540732|FG005|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
10396882|NCT00697788|11540733|FG006|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
10396883|NCT00697788|11540734|FG007|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
10396884|NCT00697788|11540727|FG000|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
10396885|NCT00697788|11540728|FG001|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
10396886|NCT00697788|11540729|FG002|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
10396887|NCT00697788|11540730|FG003|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
10396888|NCT00697788|11540731|FG004|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
10396889|NCT00697788|11540732|FG005|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
10396890|NCT00697788|11540733|FG006|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
10396891|NCT00697788|11540734|FG007|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
10396892|NCT00697788|11540727|FG000|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
10396893|NCT00697788|11540728|FG001|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
10396894|NCT00697788|11540729|FG002|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
10720216|NCT02714569|11883871|FG004|NOT COMPLETED|Part A First Intervention||0
10396895|NCT00697788|11540730|FG003|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||3
10396896|NCT00697788|11540731|FG004|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
10396897|NCT00697788|11540732|FG005|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
10310874|NCT00127231|11444047|FG000|COMPLETED|Overall Study||68
10310875|NCT00127231|11444048|FG001|COMPLETED|Overall Study||68
10310876|NCT00127231|11444047|FG000|NOT COMPLETED|Overall Study||6
10310877|NCT00127231|11444048|FG001|NOT COMPLETED|Overall Study||6
10310878|NCT00127413|11444058|FG000|STARTED|Overall Study||12
10310879|NCT00127413|11444059|FG001|STARTED|Overall Study||10
10310880|NCT00127413|11444060|FG002|STARTED|Overall Study||13
10310881|NCT00127413|11444061|FG003|STARTED|Overall Study||7
10310882|NCT00127413|11444058|FG000|COMPLETED|Overall Study||6
10310883|NCT00127413|11444059|FG001|COMPLETED|Overall Study||6
10310884|NCT00127413|11444060|FG002|COMPLETED|Overall Study||5
10310885|NCT00127413|11444061|FG003|COMPLETED|Overall Study||5
10310886|NCT00127413|11444058|FG000|NOT COMPLETED|Overall Study||6
10310887|NCT00127413|11444059|FG001|NOT COMPLETED|Overall Study||4
10310888|NCT00127413|11444060|FG002|NOT COMPLETED|Overall Study||8
10310889|NCT00127413|11444061|FG003|NOT COMPLETED|Overall Study||2
10310890|NCT00127439|11444073|FG000|STARTED|Overall Study||9
10310891|NCT00127439|11444074|FG001|STARTED|Overall Study||10
10310892|NCT00127439|11444073|FG000|COMPLETED|Overall Study||9
10310893|NCT00127439|11444074|FG001|COMPLETED|Overall Study||10
10310894|NCT00127439|11444073|FG000|NOT COMPLETED|Overall Study||0
10310895|NCT00127439|11444074|FG001|NOT COMPLETED|Overall Study||0
10310896|NCT00127530|11444085|FG000|STARTED|Overall Study||72
10310897|NCT00127530|11444086|FG001|STARTED|Overall Study||228
10310898|NCT00127530|11444085|FG000|COMPLETED|Overall Study||71
10310899|NCT00127530|11444086|FG001|COMPLETED|Overall Study||207
10310900|NCT00127530|11444085|FG000|NOT COMPLETED|Overall Study||1
10310901|NCT00127530|11444086|FG001|NOT COMPLETED|Overall Study||21
10310902|NCT00127608|11444092|FG000|STARTED|Overall Study||36
10310903|NCT00127608|11444092|FG000|COMPLETED|Overall Study||35
10310904|NCT00127608|11444092|FG000|NOT COMPLETED|Overall Study||1
10310905|NCT00127660|11444100|FG000|STARTED|Overall Study||153
10310906|NCT00127660|11444101|FG001|STARTED|Overall Study||154
10310907|NCT00127660|11444102|FG002|STARTED|Overall Study||148
10310908|NCT00127660|11444103|FG003|STARTED|Overall Study||150
10310909|NCT00127660|11444100|FG000|COMPLETED|Overall Study||150
10310910|NCT00127660|11444101|FG001|COMPLETED|Overall Study||151
10310911|NCT00127660|11444102|FG002|COMPLETED|Overall Study||143
10310912|NCT00127660|11444103|FG003|COMPLETED|Overall Study||150
10310913|NCT00127660|11444100|FG000|NOT COMPLETED|Overall Study||3
10310914|NCT00127660|11444101|FG001|NOT COMPLETED|Overall Study||3
10310915|NCT00127660|11444102|FG002|NOT COMPLETED|Overall Study||5
10310916|NCT00127660|11444103|FG003|NOT COMPLETED|Overall Study||0
10310917|NCT00127712|11444115|FG000|STARTED|Overall Study||65
10310918|NCT00127712|11444116|FG001|STARTED|Overall Study||65
10310919|NCT00127712|11444115|FG000|COMPLETED|Overall Study||60
10310920|NCT00127712|11444116|FG001|COMPLETED|Overall Study||65
10310921|NCT00127712|11444115|FG000|NOT COMPLETED|Overall Study||5
10310922|NCT00127712|11444116|FG001|NOT COMPLETED|Overall Study||0
10310923|NCT00127790|11444126|FG000|STARTED|Pre-Treatment|7 enrolled subjects were withdrawn prior to randomization; 21 of 28 enrolled were randomized.|6
10310924|NCT00127790|11444127|FG001|STARTED|Pre-Treatment||5
10310925|NCT00127790|11444128|FG002|STARTED|Pre-Treatment||6
10310926|NCT00127790|11444129|FG003|STARTED|Pre-Treatment||4
10310927|NCT00127790|11444126|FG000|COMPLETED|Pre-Treatment||6
10310928|NCT00127790|11444127|FG001|COMPLETED|Pre-Treatment||5
10310929|NCT00127790|11444128|FG002|COMPLETED|Pre-Treatment||6
10310930|NCT00127790|11444129|FG003|COMPLETED|Pre-Treatment||4
10310931|NCT00127790|11444126|FG000|NOT COMPLETED|Pre-Treatment||0
10396898|NCT00697788|11540733|FG006|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
10396899|NCT00697788|11540734|FG007|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
10396900|NCT00697788|11540727|FG000|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
10396901|NCT00697788|11540728|FG001|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
10396902|NCT00697788|11540729|FG002|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
10396903|NCT00697788|11540730|FG003|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||3
10396904|NCT00697788|11540731|FG004|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
10396905|NCT00697788|11540732|FG005|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
10396906|NCT00697788|11540733|FG006|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
10310932|NCT00127790|11444127|FG001|NOT COMPLETED|Pre-Treatment||0
10310933|NCT00127790|11444128|FG002|NOT COMPLETED|Pre-Treatment||0
10310934|NCT00127790|11444129|FG003|NOT COMPLETED|Pre-Treatment||0
10396907|NCT00697788|11540734|FG007|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
10396908|NCT00697788|11540727|FG000|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
10396909|NCT00697788|11540728|FG001|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
10396910|NCT00697788|11540729|FG002|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
10396911|NCT00697788|11540730|FG003|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
10310935|NCT00127790|11444126|FG000|STARTED|Post-Treatment||6
10310936|NCT00127790|11444127|FG001|STARTED|Post-Treatment||5
10310937|NCT00127790|11444128|FG002|STARTED|Post-Treatment||6
10310938|NCT00127790|11444129|FG003|STARTED|Post-Treatment||4
10310939|NCT00127790|11444126|FG000|COMPLETED|Post-Treatment||6
10310940|NCT00127790|11444127|FG001|COMPLETED|Post-Treatment||5
10310941|NCT00127790|11444128|FG002|COMPLETED|Post-Treatment||6
10310942|NCT00127790|11444129|FG003|COMPLETED|Post-Treatment||4
10310943|NCT00127790|11444126|FG000|NOT COMPLETED|Post-Treatment||0
10310944|NCT00127790|11444127|FG001|NOT COMPLETED|Post-Treatment||0
10396912|NCT00697788|11540731|FG004|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
10396913|NCT00697788|11540732|FG005|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
10396914|NCT00697788|11540733|FG006|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
10396915|NCT00697788|11540734|FG007|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
10396916|NCT00697788|11540727|FG000|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
10396917|NCT00697788|11540728|FG001|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
10396918|NCT00697788|11540729|FG002|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
10396919|NCT00697788|11540730|FG003|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
10396920|NCT00697788|11540731|FG004|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||3
10543626|NCT01484496|11696747|FG001|STARTED|Period 2||0
10543627|NCT01484496|11696748|FG002|STARTED|Period 2||206
10543628|NCT01484496|11696749|FG003|STARTED|Period 2||456
10543629|NCT01484496|11696746|FG000|COMPLETED|Period 2||0
10543630|NCT01484496|11696747|FG001|COMPLETED|Period 2||0
10543631|NCT01484496|11696748|FG002|COMPLETED|Period 2||191
10543632|NCT01484496|11696749|FG003|COMPLETED|Period 2||434
10543633|NCT01484496|11696746|FG000|NOT COMPLETED|Period 2||0
10543634|NCT01484496|11696747|FG001|NOT COMPLETED|Period 2||0
10543635|NCT01484496|11696748|FG002|NOT COMPLETED|Period 2||15
10543636|NCT01484496|11696749|FG003|NOT COMPLETED|Period 2||22
10543637|NCT01484561|11696759|FG000|STARTED|Overall Study||97
10543638|NCT01484561|11696760|FG001|STARTED|Overall Study||51
10543639|NCT01484561|11696759|FG000|COMPLETED|Overall Study||88
10543640|NCT01484561|11696760|FG001|COMPLETED|Overall Study||45
10543641|NCT01484561|11696759|FG000|NOT COMPLETED|Overall Study||9
10543642|NCT01484561|11696760|FG001|NOT COMPLETED|Overall Study||6
10543643|NCT01484626|11696766|FG000|STARTED|Overall Study||3
10720217|NCT02714569|11883872|FG005|NOT COMPLETED|Part A First Intervention||0
10720218|NCT02714569|11883873|FG006|NOT COMPLETED|Part A First Intervention||0
10720219|NCT02714569|11883874|FG007|NOT COMPLETED|Part A First Intervention||0
10543644|NCT01484626|11696766|FG000|COMPLETED|Overall Study||3
10543645|NCT01484626|11696766|FG000|NOT COMPLETED|Overall Study||0
10543646|NCT01484652|11696772|FG000|STARTED|Overall Study||166
10543647|NCT01484652|11696773|FG001|STARTED|Overall Study||163
10543648|NCT01484652|11696772|FG000|COMPLETED|Overall Study||151
10720220|NCT02714569|11883875|FG008|NOT COMPLETED|Part A First Intervention||0
10396921|NCT00697788|11540732|FG005|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
10543649|NCT01484652|11696773|FG001|COMPLETED|Overall Study||142
10543650|NCT01484652|11696772|FG000|NOT COMPLETED|Overall Study||15
10543651|NCT01484652|11696773|FG001|NOT COMPLETED|Overall Study||21
10543652|NCT01484834|11696783|FG000|STARTED|Overall Study||65
10543653|NCT01484834|11696784|FG001|STARTED|Overall Study||62
10310945|NCT00127790|11444128|FG002|NOT COMPLETED|Post-Treatment||0
10310946|NCT00127790|11444129|FG003|NOT COMPLETED|Post-Treatment||0
10720221|NCT02714569|11883876|FG009|NOT COMPLETED|Part A First Intervention||0
10720222|NCT02714569|11883877|FG010|NOT COMPLETED|Part A First Intervention||0
10720223|NCT02714569|11883867|FG000|STARTED|Part A Second Intervention||3
10720224|NCT02714569|11883868|FG001|STARTED|Part A Second Intervention||3
10720225|NCT02714569|11883869|FG002|STARTED|Part A Second Intervention||3
10720226|NCT02714569|11883870|FG003|STARTED|Part A Second Intervention||3
10720227|NCT02714569|11883871|FG004|STARTED|Part A Second Intervention||3
10720228|NCT02714569|11883872|FG005|STARTED|Part A Second Intervention||3
10720229|NCT02714569|11883873|FG006|STARTED|Part A Second Intervention||0
10720230|NCT02714569|11883874|FG007|STARTED|Part A Second Intervention||0
10720231|NCT02714569|11883875|FG008|STARTED|Part A Second Intervention||0
10720232|NCT02714569|11883876|FG009|STARTED|Part A Second Intervention||0
10720233|NCT02714569|11883877|FG010|STARTED|Part A Second Intervention||0
10720234|NCT02714569|11883867|FG000|Received at Least One Dose of Study Drug|Part A Second Intervention||3
10720235|NCT02714569|11883868|FG001|Received at Least One Dose of Study Drug|Part A Second Intervention||2
10720236|NCT02714569|11883869|FG002|Received at Least One Dose of Study Drug|Part A Second Intervention||3
10720237|NCT02714569|11883870|FG003|Received at Least One Dose of Study Drug|Part A Second Intervention||3
10720238|NCT02714569|11883871|FG004|Received at Least One Dose of Study Drug|Part A Second Intervention||3
10720239|NCT02714569|11883872|FG005|Received at Least One Dose of Study Drug|Part A Second Intervention||3
10720240|NCT02714569|11883873|FG006|Received at Least One Dose of Study Drug|Part A Second Intervention||0
10720241|NCT02714569|11883874|FG007|Received at Least One Dose of Study Drug|Part A Second Intervention||0
10720242|NCT02714569|11883875|FG008|Received at Least One Dose of Study Drug|Part A Second Intervention||0
10720243|NCT02714569|11883876|FG009|Received at Least One Dose of Study Drug|Part A Second Intervention||0
10720244|NCT02714569|11883877|FG010|Received at Least One Dose of Study Drug|Part A Second Intervention||0
10720245|NCT02714569|11883867|FG000|COMPLETED|Part A Second Intervention||3
10720246|NCT02714569|11883868|FG001|COMPLETED|Part A Second Intervention||2
10720247|NCT02714569|11883869|FG002|COMPLETED|Part A Second Intervention||3
10720248|NCT02714569|11883870|FG003|COMPLETED|Part A Second Intervention||3
10720249|NCT02714569|11883871|FG004|COMPLETED|Part A Second Intervention||3
10720250|NCT02714569|11883872|FG005|COMPLETED|Part A Second Intervention||3
10720251|NCT02714569|11883873|FG006|COMPLETED|Part A Second Intervention||0
10720252|NCT02714569|11883874|FG007|COMPLETED|Part A Second Intervention||0
10720253|NCT02714569|11883875|FG008|COMPLETED|Part A Second Intervention||0
10720254|NCT02714569|11883876|FG009|COMPLETED|Part A Second Intervention||0
10720255|NCT02714569|11883877|FG010|COMPLETED|Part A Second Intervention||0
10720256|NCT02714569|11883867|FG000|NOT COMPLETED|Part A Second Intervention||0
10720257|NCT02714569|11883868|FG001|NOT COMPLETED|Part A Second Intervention||1
10720258|NCT02714569|11883869|FG002|NOT COMPLETED|Part A Second Intervention||0
10720259|NCT02714569|11883870|FG003|NOT COMPLETED|Part A Second Intervention||0
10720260|NCT02714569|11883871|FG004|NOT COMPLETED|Part A Second Intervention||0
10720261|NCT02714569|11883872|FG005|NOT COMPLETED|Part A Second Intervention||0
10720262|NCT02714569|11883873|FG006|NOT COMPLETED|Part A Second Intervention||0
10720263|NCT02714569|11883874|FG007|NOT COMPLETED|Part A Second Intervention||0
10720264|NCT02714569|11883875|FG008|NOT COMPLETED|Part A Second Intervention||0
10720265|NCT02714569|11883876|FG009|NOT COMPLETED|Part A Second Intervention||0
10720266|NCT02714569|11883877|FG010|NOT COMPLETED|Part A Second Intervention||0
10720267|NCT02714569|11883867|FG000|STARTED|Part A Third Intervention||3
10720268|NCT02714569|11883868|FG001|STARTED|Part A Third Intervention||2
10720269|NCT02714569|11883869|FG002|STARTED|Part A Third Intervention||3
10720270|NCT02714569|11883870|FG003|STARTED|Part A Third Intervention||3
10310947|NCT00127803|11444143|FG000|STARTED|Overall Study||13
10310948|NCT00127803|11444144|FG001|STARTED|Overall Study||13
10310949|NCT00127803|11444145|FG002|STARTED|Overall Study||12
10310950|NCT00127803|11444146|FG003|STARTED|Overall Study||12
10310951|NCT00127803|11444143|FG000|COMPLETED|Overall Study||10
10310952|NCT00127803|11444144|FG001|COMPLETED|Overall Study||13
10720271|NCT02714569|11883871|FG004|STARTED|Part A Third Intervention||3
10720272|NCT02714569|11883872|FG005|STARTED|Part A Third Intervention||3
10720273|NCT02714569|11883873|FG006|STARTED|Part A Third Intervention||0
10720274|NCT02714569|11883874|FG007|STARTED|Part A Third Intervention||0
10720275|NCT02714569|11883875|FG008|STARTED|Part A Third Intervention||0
10720276|NCT02714569|11883876|FG009|STARTED|Part A Third Intervention||0
10720277|NCT02714569|11883877|FG010|STARTED|Part A Third Intervention||0
10720278|NCT02714569|11883867|FG000|Received at Least One Dose of Study Drug|Part A Third Intervention||3
10720279|NCT02714569|11883868|FG001|Received at Least One Dose of Study Drug|Part A Third Intervention||2
10720280|NCT02714569|11883869|FG002|Received at Least One Dose of Study Drug|Part A Third Intervention||2
10720281|NCT02714569|11883870|FG003|Received at Least One Dose of Study Drug|Part A Third Intervention||2
10720282|NCT02714569|11883871|FG004|Received at Least One Dose of Study Drug|Part A Third Intervention||3
10720283|NCT02714569|11883872|FG005|Received at Least One Dose of Study Drug|Part A Third Intervention||3
10720284|NCT02714569|11883873|FG006|Received at Least One Dose of Study Drug|Part A Third Intervention||0
10720285|NCT02714569|11883874|FG007|Received at Least One Dose of Study Drug|Part A Third Intervention||0
10720286|NCT02714569|11883875|FG008|Received at Least One Dose of Study Drug|Part A Third Intervention||0
10720287|NCT02714569|11883876|FG009|Received at Least One Dose of Study Drug|Part A Third Intervention||0
10720288|NCT02714569|11883877|FG010|Received at Least One Dose of Study Drug|Part A Third Intervention||0
10720289|NCT02714569|11883867|FG000|COMPLETED|Part A Third Intervention||3
10720290|NCT02714569|11883868|FG001|COMPLETED|Part A Third Intervention||2
10720291|NCT02714569|11883869|FG002|COMPLETED|Part A Third Intervention||2
10720292|NCT02714569|11883870|FG003|COMPLETED|Part A Third Intervention||2
10720293|NCT02714569|11883871|FG004|COMPLETED|Part A Third Intervention||3
10720294|NCT02714569|11883872|FG005|COMPLETED|Part A Third Intervention||3
10720295|NCT02714569|11883873|FG006|COMPLETED|Part A Third Intervention||0
10720296|NCT02714569|11883874|FG007|COMPLETED|Part A Third Intervention||0
10720297|NCT02714569|11883875|FG008|COMPLETED|Part A Third Intervention||0
10720298|NCT02714569|11883876|FG009|COMPLETED|Part A Third Intervention||0
10720299|NCT02714569|11883877|FG010|COMPLETED|Part A Third Intervention||0
10720300|NCT02714569|11883867|FG000|NOT COMPLETED|Part A Third Intervention||0
10720301|NCT02714569|11883868|FG001|NOT COMPLETED|Part A Third Intervention||0
10720302|NCT02714569|11883869|FG002|NOT COMPLETED|Part A Third Intervention||1
10720303|NCT02714569|11883870|FG003|NOT COMPLETED|Part A Third Intervention||1
10720304|NCT02714569|11883871|FG004|NOT COMPLETED|Part A Third Intervention||0
10720305|NCT02714569|11883872|FG005|NOT COMPLETED|Part A Third Intervention||0
10720306|NCT02714569|11883873|FG006|NOT COMPLETED|Part A Third Intervention||0
10720307|NCT02714569|11883874|FG007|NOT COMPLETED|Part A Third Intervention||0
10720308|NCT02714569|11883875|FG008|NOT COMPLETED|Part A Third Intervention||0
10720309|NCT02714569|11883876|FG009|NOT COMPLETED|Part A Third Intervention||0
10720310|NCT02714569|11883877|FG010|NOT COMPLETED|Part A Third Intervention||0
10720311|NCT02714569|11883867|FG000|STARTED|Part A Fourth Intervention|An additional participant replaced a discontinued participant.|4
10720312|NCT02714569|11883868|FG001|STARTED|Part A Fourth Intervention||2
10720313|NCT02714569|11883869|FG002|STARTED|Part A Fourth Intervention|An additional participant replaced a discontinued participant.|3
10720314|NCT02714569|11883870|FG003|STARTED|Part A Fourth Intervention||2
10720315|NCT02714569|11883871|FG004|STARTED|Part A Fourth Intervention||3
10720316|NCT02714569|11883872|FG005|STARTED|Part A Fourth Intervention||3
10720317|NCT02714569|11883873|FG006|STARTED|Part A Fourth Intervention||0
10720318|NCT02714569|11883874|FG007|STARTED|Part A Fourth Intervention||0
10720319|NCT02714569|11883875|FG008|STARTED|Part A Fourth Intervention||0
10720320|NCT02714569|11883876|FG009|STARTED|Part A Fourth Intervention||0
10720321|NCT02714569|11883877|FG010|STARTED|Part A Fourth Intervention||0
10720322|NCT02714569|11883867|FG000|Received at Least One Dose of Study Drug|Part A Fourth Intervention||3
10720323|NCT02714569|11883868|FG001|Received at Least One Dose of Study Drug|Part A Fourth Intervention||2
10720324|NCT02714569|11883869|FG002|Received at Least One Dose of Study Drug|Part A Fourth Intervention||3
10720325|NCT02714569|11883870|FG003|Received at Least One Dose of Study Drug|Part A Fourth Intervention||2
10720326|NCT02714569|11883871|FG004|Received at Least One Dose of Study Drug|Part A Fourth Intervention||3
10720327|NCT02714569|11883872|FG005|Received at Least One Dose of Study Drug|Part A Fourth Intervention||2
10720328|NCT02714569|11883873|FG006|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0
10720329|NCT02714569|11883874|FG007|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0
10720330|NCT02714569|11883875|FG008|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0
10720331|NCT02714569|11883876|FG009|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0
10720332|NCT02714569|11883877|FG010|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0
10720333|NCT02714569|11883867|FG000|COMPLETED|Part A Fourth Intervention||3
10720334|NCT02714569|11883868|FG001|COMPLETED|Part A Fourth Intervention||2
10720335|NCT02714569|11883869|FG002|COMPLETED|Part A Fourth Intervention||3
10720336|NCT02714569|11883870|FG003|COMPLETED|Part A Fourth Intervention||2
10720337|NCT02714569|11883871|FG004|COMPLETED|Part A Fourth Intervention||3
10720338|NCT02714569|11883872|FG005|COMPLETED|Part A Fourth Intervention||2
10720339|NCT02714569|11883873|FG006|COMPLETED|Part A Fourth Intervention||0
10720340|NCT02714569|11883874|FG007|COMPLETED|Part A Fourth Intervention||0
10720341|NCT02714569|11883875|FG008|COMPLETED|Part A Fourth Intervention||0
10720342|NCT02714569|11883876|FG009|COMPLETED|Part A Fourth Intervention||0
10720343|NCT02714569|11883877|FG010|COMPLETED|Part A Fourth Intervention||0
10720344|NCT02714569|11883867|FG000|NOT COMPLETED|Part A Fourth Intervention||1
10720345|NCT02714569|11883868|FG001|NOT COMPLETED|Part A Fourth Intervention||0
10720346|NCT02714569|11883869|FG002|NOT COMPLETED|Part A Fourth Intervention||0
10720347|NCT02714569|11883870|FG003|NOT COMPLETED|Part A Fourth Intervention||0
10720348|NCT02714569|11883871|FG004|NOT COMPLETED|Part A Fourth Intervention||0
10720349|NCT02714569|11883872|FG005|NOT COMPLETED|Part A Fourth Intervention||1
10720350|NCT02714569|11883873|FG006|NOT COMPLETED|Part A Fourth Intervention||0
10720351|NCT02714569|11883874|FG007|NOT COMPLETED|Part A Fourth Intervention||0
10720352|NCT02714569|11883875|FG008|NOT COMPLETED|Part A Fourth Intervention||0
10720353|NCT02714569|11883876|FG009|NOT COMPLETED|Part A Fourth Intervention||0
10720354|NCT02714569|11883877|FG010|NOT COMPLETED|Part A Fourth Intervention||0
10720355|NCT02714569|11883867|FG000|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0
10720356|NCT02714569|11883868|FG001|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0
10720357|NCT02714569|11883869|FG002|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0
10720358|NCT02714569|11883870|FG003|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0
10720359|NCT02714569|11883871|FG004|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0
10720360|NCT02714569|11883872|FG005|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0
10720361|NCT02714569|11883873|FG006|STARTED|Part B (Overall)|Part B participants randomized to receive 5 mg of LY3202328 + atorvastatin/simvastatin.|8
10720362|NCT02714569|11883874|FG007|STARTED|Part B (Overall)|Part B participants randomized to receive 20 mg of LY3202328 + atorvastatin/simvastatin.|8
10720363|NCT02714569|11883875|FG008|STARTED|Part B (Overall)|Part B participants randomized to receive 100 mg of LY3202328 + atorvastatin/simvastatin.|8
10720364|NCT02714569|11883876|FG009|STARTED|Part B (Overall)|Part B participants randomized to receive 300 mg of LY3202328 + atorvastatin/simvastatin.|8
10813448|NCT02818946|11975828|FG000|STARTED|Overall Study||30
10720365|NCT02714569|11883877|FG010|STARTED|Part B (Overall)|Part B participants randomized to receive placebo instead of LY3202328 + atorvastatin/simvastatin.|8
10720366|NCT02714569|11883867|FG000|COMPLETED|Part B (Overall)||0
10720367|NCT02714569|11883868|FG001|COMPLETED|Part B (Overall)||0
10720368|NCT02714569|11883869|FG002|COMPLETED|Part B (Overall)||0
10720369|NCT02714569|11883870|FG003|COMPLETED|Part B (Overall)||0
10720370|NCT02714569|11883871|FG004|COMPLETED|Part B (Overall)||0
10720371|NCT02714569|11883872|FG005|COMPLETED|Part B (Overall)||0
10720372|NCT02714569|11883873|FG006|COMPLETED|Part B (Overall)||7
10720373|NCT02714569|11883874|FG007|COMPLETED|Part B (Overall)||7
10720374|NCT02714569|11883875|FG008|COMPLETED|Part B (Overall)||8
10720375|NCT02714569|11883876|FG009|COMPLETED|Part B (Overall)||6
10720376|NCT02714569|11883877|FG010|COMPLETED|Part B (Overall)||8
10720377|NCT02714569|11883867|FG000|NOT COMPLETED|Part B (Overall)||0
10720378|NCT02714569|11883868|FG001|NOT COMPLETED|Part B (Overall)||0
10720379|NCT02714569|11883869|FG002|NOT COMPLETED|Part B (Overall)||0
10720380|NCT02714569|11883870|FG003|NOT COMPLETED|Part B (Overall)||0
10720381|NCT02714569|11883871|FG004|NOT COMPLETED|Part B (Overall)||0
10720382|NCT02714569|11883872|FG005|NOT COMPLETED|Part B (Overall)||0
10720383|NCT02714569|11883873|FG006|NOT COMPLETED|Part B (Overall)||1
10720384|NCT02714569|11883874|FG007|NOT COMPLETED|Part B (Overall)||1
10720385|NCT02714569|11883875|FG008|NOT COMPLETED|Part B (Overall)||0
10720386|NCT02714569|11883876|FG009|NOT COMPLETED|Part B (Overall)||2
10720387|NCT02714569|11883877|FG010|NOT COMPLETED|Part B (Overall)||0
10720388|NCT02714595|11883939|FG000|STARTED|Overall Study||101
10720389|NCT02714595|11883940|FG001|STARTED|Overall Study||51
10720390|NCT02714595|11883939|FG000|Received Treatment|Overall Study||101
10720391|NCT02714595|11883940|FG001|Received Treatment|Overall Study||49
10777319|NCT03339206|11939289|FG000|STARTED|Overall Study||262
10777320|NCT03339206|11939290|FG001|STARTED|Overall Study||263
10777321|NCT03339206|11939291|FG002|STARTED|Overall Study||264
10777322|NCT03339206|11939289|FG000|COMPLETED|Overall Study||262
10777323|NCT03339206|11939290|FG001|COMPLETED|Overall Study||263
10777324|NCT03339206|11939291|FG002|COMPLETED|Overall Study||264
10777325|NCT03339206|11939289|FG000|NOT COMPLETED|Overall Study||0
10777326|NCT03339206|11939290|FG001|NOT COMPLETED|Overall Study||0
10777327|NCT03339206|11939291|FG002|NOT COMPLETED|Overall Study||0
10777328|NCT03339219|11939299|FG000|STARTED|Overall Study||35
10777329|NCT03339219|11939299|FG000|COMPLETED|Overall Study||0
10777330|NCT03339219|11939299|FG000|NOT COMPLETED|Overall Study||35
10777331|NCT03339297|11939305|FG000|STARTED|Overall Study||79
10777332|NCT03339297|11939306|FG001|STARTED|Overall Study||73
10777333|NCT03339297|11939305|FG000|COMPLETED|Overall Study||56
10777334|NCT03339297|11939306|FG001|COMPLETED|Overall Study||59
10777335|NCT03339297|11939305|FG000|NOT COMPLETED|Overall Study||23
10777336|NCT03339297|11939306|FG001|NOT COMPLETED|Overall Study||14
10777337|NCT03339453|11939314|FG000|STARTED|First Visit of Glucagon Treatment||35
10777338|NCT03339453|11939315|FG001|STARTED|First Visit of Glucagon Treatment||35
10777339|NCT03339453|11939314|FG000|Received at Least 1 Dose of Study Drug|First Visit of Glucagon Treatment||35
10777340|NCT03339453|11939315|FG001|Received at Least 1 Dose of Study Drug|First Visit of Glucagon Treatment||35
10777341|NCT03339453|11939314|FG000|COMPLETED|First Visit of Glucagon Treatment||35
10777342|NCT03339453|11939315|FG001|COMPLETED|First Visit of Glucagon Treatment||34
10777343|NCT03339453|11939314|FG000|NOT COMPLETED|First Visit of Glucagon Treatment||0
10777344|NCT03339453|11939315|FG001|NOT COMPLETED|First Visit of Glucagon Treatment||1
10777345|NCT03339453|11939314|FG000|STARTED|Second Visit for Alternate Glucagon||35
10720392|NCT02714595|11883939|FG000|Carbapenem-resistant Microbiological Intent-to-treat|Overall Study||80
10720393|NCT02714595|11883940|FG001|Carbapenem-resistant Microbiological Intent-to-treat|Overall Study||38
10720394|NCT02714595|11883939|FG000|COMPLETED|Overall Study||69
10720395|NCT02714595|11883940|FG001|COMPLETED|Overall Study||38
10720396|NCT02714595|11883939|FG000|NOT COMPLETED|Overall Study||32
10720397|NCT02714595|11883940|FG001|NOT COMPLETED|Overall Study||13
10720398|NCT02714868|11883966|FG000|STARTED|Overall Study||47
10720399|NCT02714868|11883967|FG001|STARTED|Overall Study||35
10720400|NCT02714868|11883966|FG000|COMPLETED|Overall Study||42
10720401|NCT02714868|11883967|FG001|COMPLETED|Overall Study||35
10720402|NCT02714868|11883966|FG000|NOT COMPLETED|Overall Study||5
10720403|NCT02714868|11883967|FG001|NOT COMPLETED|Overall Study||0
10720404|NCT02715076|11883980|FG000|STARTED|Overall Study||48
10720405|NCT02715076|11883981|FG001|STARTED|Overall Study||50
10720406|NCT02715076|11883982|FG002|STARTED|Overall Study||49
10720407|NCT02715076|11883983|FG003|STARTED|Overall Study||50
10720408|NCT02715076|11883984|FG004|STARTED|Overall Study||47
10720409|NCT02715076|11883985|FG005|STARTED|Overall Study||48
10720410|NCT02715076|11883980|FG000|COMPLETED|Overall Study||48
10720411|NCT02715076|11883981|FG001|COMPLETED|Overall Study||50
10720412|NCT02715076|11883982|FG002|COMPLETED|Overall Study||49
10720413|NCT02715076|11883983|FG003|COMPLETED|Overall Study||50
10720414|NCT02715076|11883984|FG004|COMPLETED|Overall Study||47
10720415|NCT02715076|11883985|FG005|COMPLETED|Overall Study||48
10720416|NCT02715076|11883980|FG000|NOT COMPLETED|Overall Study||0
10720417|NCT02715076|11883981|FG001|NOT COMPLETED|Overall Study||0
10720418|NCT02715076|11883982|FG002|NOT COMPLETED|Overall Study||0
10720419|NCT02715076|11883983|FG003|NOT COMPLETED|Overall Study||0
10720420|NCT02715076|11883984|FG004|NOT COMPLETED|Overall Study||0
10813446|NCT02809118|11975819|FG001|NOT COMPLETED|Overall Study||1
10813447|NCT02809118|11975820|FG002|NOT COMPLETED|Overall Study||1
10813449|NCT02818946|11975828|FG000|COMPLETED|Overall Study||30
10813450|NCT02818946|11975828|FG000|NOT COMPLETED|Overall Study||0
10813451|NCT02819908|11975834|FG000|STARTED|Overall Study||12
10813452|NCT02819908|11975835|FG001|STARTED|Overall Study||13
10813453|NCT02819908|11975834|FG000|COMPLETED|Overall Study||12
10813454|NCT02819908|11975835|FG001|COMPLETED|Overall Study||13
10813455|NCT02819908|11975834|FG000|NOT COMPLETED|Overall Study||0
10813456|NCT02819908|11975835|FG001|NOT COMPLETED|Overall Study||0
10813457|NCT02808390|11975846|FG000|STARTED|Overall Study||4
10813458|NCT02808390|11975847|FG001|STARTED|Overall Study||8
10813459|NCT02808390|11975848|FG002|STARTED|Overall Study||7
10813460|NCT02808390|11975846|FG000|COMPLETED|Overall Study||2
10813461|NCT02808390|11975847|FG001|COMPLETED|Overall Study||2
10813462|NCT02808390|11975848|FG002|COMPLETED|Overall Study||4
10813463|NCT02808390|11975846|FG000|NOT COMPLETED|Overall Study||2
10813464|NCT02808390|11975847|FG001|NOT COMPLETED|Overall Study||6
10813465|NCT02808390|11975848|FG002|NOT COMPLETED|Overall Study||3
10813466|NCT02806960|11975856|FG000|STARTED|Period 1||3
10813467|NCT02806960|11975857|FG001|STARTED|Period 1||3
10813468|NCT02806960|11975858|FG002|STARTED|Period 1||3
10813469|NCT02806960|11975859|FG003|STARTED|Period 1||3
10813470|NCT02806960|11975856|FG000|COMPLETED|Period 1||0
10813471|NCT02806960|11975857|FG001|COMPLETED|Period 1||0
10813472|NCT02806960|11975858|FG002|COMPLETED|Period 1||0
10813473|NCT02806960|11975859|FG003|COMPLETED|Period 1||0
10813474|NCT02806960|11975856|FG000|NOT COMPLETED|Period 1||3
10813475|NCT02806960|11975857|FG001|NOT COMPLETED|Period 1||3
10813476|NCT02806960|11975858|FG002|NOT COMPLETED|Period 1||3
10813477|NCT02806960|11975859|FG003|NOT COMPLETED|Period 1||3
10813478|NCT02806960|11975856|FG000|STARTED|Period 2||0
10813479|NCT02806960|11975857|FG001|STARTED|Period 2||0
10813480|NCT02806960|11975858|FG002|STARTED|Period 2||0
10813481|NCT02806960|11975859|FG003|STARTED|Period 2||0
10813482|NCT02806960|11975856|FG000|COMPLETED|Period 2||0
10813483|NCT02806960|11975857|FG001|COMPLETED|Period 2||0
10813484|NCT02806960|11975858|FG002|COMPLETED|Period 2||0
10813485|NCT02806960|11975859|FG003|COMPLETED|Period 2||0
10813486|NCT02806960|11975856|FG000|NOT COMPLETED|Period 2||0
10813487|NCT02806960|11975857|FG001|NOT COMPLETED|Period 2||0
10813488|NCT02806960|11975858|FG002|NOT COMPLETED|Period 2||0
10720421|NCT02715076|11883985|FG005|NOT COMPLETED|Overall Study||0
10720422|NCT02715258|11884001|FG000|STARTED|Overall Study||140
10720423|NCT02715258|11884002|FG001|STARTED|Overall Study||70
10720424|NCT02715258|11884001|FG000|Intent to Treat/Safety Analysis|Overall Study||138
10720425|NCT02715258|11884002|FG001|Intent to Treat/Safety Analysis|Overall Study||69
10720426|NCT02715258|11884001|FG000|COMPLETED|Overall Study||124
10720427|NCT02715258|11884002|FG001|COMPLETED|Overall Study||64
10720428|NCT02715258|11884001|FG000|NOT COMPLETED|Overall Study||16
10720429|NCT02715258|11884002|FG001|NOT COMPLETED|Overall Study||6
10720430|NCT02715700|11884008|FG000|STARTED|Overall Study||14
10720431|NCT02715700|11884008|FG000|COMPLETED|Overall Study||14
10813489|NCT02806960|11975859|FG003|NOT COMPLETED|Period 2||0
10813490|NCT02806960|11975856|FG000|STARTED|Period 3||0
10813491|NCT02806960|11975857|FG001|STARTED|Period 3||0
10813492|NCT02806960|11975858|FG002|STARTED|Period 3||0
10813493|NCT02806960|11975859|FG003|STARTED|Period 3||0
10813494|NCT02806960|11975856|FG000|COMPLETED|Period 3||0
10813495|NCT02806960|11975857|FG001|COMPLETED|Period 3||0
10813496|NCT02806960|11975858|FG002|COMPLETED|Period 3||0
10813497|NCT02806960|11975859|FG003|COMPLETED|Period 3||0
10813498|NCT02806960|11975856|FG000|NOT COMPLETED|Period 3||0
10813499|NCT02806960|11975857|FG001|NOT COMPLETED|Period 3||0
10720432|NCT02715700|11884008|FG000|NOT COMPLETED|Overall Study||0
10720433|NCT02715726|11884018|FG000|STARTED|Overall Study|Randomized|208
10720434|NCT02715726|11884019|FG001|STARTED|Overall Study|Randomized|407
10720435|NCT02715726|11884018|FG000|Treated|Overall Study||207
10720436|NCT02715726|11884019|FG001|Treated|Overall Study||405
10720437|NCT02715726|11884018|FG000|Safety Population|Overall Study||206
10720438|NCT02715726|11884019|FG001|Safety Population|Overall Study||406
10720439|NCT02715726|11884018|FG000|COMPLETED|Overall Study||190
10720440|NCT02715726|11884019|FG001|COMPLETED|Overall Study||380
10720441|NCT02715726|11884018|FG000|NOT COMPLETED|Overall Study||18
10720442|NCT02715726|11884019|FG001|NOT COMPLETED|Overall Study||27
10720443|NCT02715804|11884027|FG000|STARTED|Overall Study||327
10720444|NCT02715804|11884028|FG001|STARTED|Overall Study||165
10720445|NCT02715804|11884027|FG000|Received at Least 1 Dose of Study Drug|Overall Study||323
10720446|NCT02715804|11884028|FG001|Received at Least 1 Dose of Study Drug|Overall Study||158
10720447|NCT02715804|11884027|FG000|Safety Population|Overall Study|3 participants randomized to AG but received PAG|325
10720448|NCT02715804|11884028|FG001|Safety Population|Overall Study|1 participant randomized to PAG but received AG|156
10720449|NCT02715804|11884027|FG000|COMPLETED|Overall Study||98
10720450|NCT02715804|11884028|FG001|COMPLETED|Overall Study||52
10813500|NCT02806960|11975858|FG002|NOT COMPLETED|Period 3||0
10813501|NCT02806960|11975859|FG003|NOT COMPLETED|Period 3||0
10813502|NCT02806960|11975856|FG000|STARTED|Period 4||0
10813503|NCT02806960|11975857|FG001|STARTED|Period 4||0
10813504|NCT02806960|11975858|FG002|STARTED|Period 4||0
10813505|NCT02806960|11975859|FG003|STARTED|Period 4||0
10813506|NCT02806960|11975856|FG000|COMPLETED|Period 4||0
10813507|NCT02806960|11975857|FG001|COMPLETED|Period 4||0
10813508|NCT02806960|11975858|FG002|COMPLETED|Period 4||0
10813509|NCT02806960|11975859|FG003|COMPLETED|Period 4||0
10813510|NCT02806960|11975856|FG000|NOT COMPLETED|Period 4||0
10813511|NCT02806960|11975857|FG001|NOT COMPLETED|Period 4||0
10813512|NCT02806960|11975858|FG002|NOT COMPLETED|Period 4||0
10813513|NCT02806960|11975859|FG003|NOT COMPLETED|Period 4||0
10813514|NCT02815397|11975869|FG000|STARTED|Overall Study||2
10813515|NCT02815397|11975869|FG000|COMPLETED|Overall Study||0
10813516|NCT02815397|11975869|FG000|NOT COMPLETED|Overall Study||2
10813517|NCT02802592|11975873|FG000|STARTED|Overall Study||4
10813518|NCT02802592|11975873|FG000|COMPLETED|Overall Study||0
10813519|NCT02802592|11975873|FG000|NOT COMPLETED|Overall Study||4
10813520|NCT02774148|11975880|FG000|STARTED|Overall Study||0
10813521|NCT02774148|11975881|FG001|STARTED|Overall Study||0
10813522|NCT02774148|11975880|FG000|COMPLETED|Overall Study||0
10813523|NCT02774148|11975881|FG001|COMPLETED|Overall Study||0
10813524|NCT02774148|11975880|FG000|NOT COMPLETED|Overall Study||0
10813525|NCT02774148|11975881|FG001|NOT COMPLETED|Overall Study||0
10813526|NCT02773576|11975889|FG000|STARTED|Overall Study||0
10813527|NCT02773576|11975890|FG001|STARTED|Overall Study||0
10813528|NCT02773576|11975889|FG000|COMPLETED|Overall Study||0
10813529|NCT02773576|11975890|FG001|COMPLETED|Overall Study||0
10813530|NCT02773576|11975889|FG000|NOT COMPLETED|Overall Study||0
10813531|NCT02773576|11975890|FG001|NOT COMPLETED|Overall Study||0
10396922|NCT00697788|11540733|FG006|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
10720451|NCT02715804|11884027|FG000|NOT COMPLETED|Overall Study||229
10720452|NCT02715804|11884028|FG001|NOT COMPLETED|Overall Study||113
10720453|NCT02716194|11884037|FG000|STARTED|Period 1 - ADVATE||11
10720454|NCT02716194|11884038|FG001|STARTED|Period 1 - ADVATE||16
10720455|NCT02716194|11884039|FG002|STARTED|Period 1 - ADVATE||13
10396923|NCT00697788|11540734|FG007|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
10720456|NCT02716194|11884037|FG000|COMPLETED|Period 1 - ADVATE||10
10813532|NCT02730793|11975898|FG000|STARTED|Overall Study||2
10813533|NCT02730793|11975899|FG001|STARTED|Overall Study||3
10813534|NCT02730793|11975898|FG000|COMPLETED|Overall Study||2
10813535|NCT02730793|11975899|FG001|COMPLETED|Overall Study||1
10813536|NCT02730793|11975898|FG000|NOT COMPLETED|Overall Study||0
10813537|NCT02730793|11975899|FG001|NOT COMPLETED|Overall Study||2
10813538|NCT02744352|11975907|FG000|STARTED|Overall Study||4
10720457|NCT02716194|11884038|FG001|COMPLETED|Period 1 - ADVATE||15
10720458|NCT02716194|11884039|FG002|COMPLETED|Period 1 - ADVATE||13
10720459|NCT02716194|11884037|FG000|NOT COMPLETED|Period 1 - ADVATE||1
10720460|NCT02716194|11884038|FG001|NOT COMPLETED|Period 1 - ADVATE||1
10720461|NCT02716194|11884039|FG002|NOT COMPLETED|Period 1 - ADVATE||0
10720462|NCT02716194|11884037|FG000|STARTED|Period 2 - BAX 826||10
10720463|NCT02716194|11884038|FG001|STARTED|Period 2 - BAX 826||15
10720464|NCT02716194|11884039|FG002|STARTED|Period 2 - BAX 826||13
10720465|NCT02716194|11884037|FG000|COMPLETED|Period 2 - BAX 826||10
10720466|NCT02716194|11884038|FG001|COMPLETED|Period 2 - BAX 826||15
10720467|NCT02716194|11884039|FG002|COMPLETED|Period 2 - BAX 826||13
10720468|NCT02716194|11884037|FG000|NOT COMPLETED|Period 2 - BAX 826||0
10720469|NCT02716194|11884038|FG001|NOT COMPLETED|Period 2 - BAX 826||0
10720470|NCT02716194|11884039|FG002|NOT COMPLETED|Period 2 - BAX 826||0
10720471|NCT02716298|11884060|FG000|STARTED|First Intervention (1 Month)||25
10720472|NCT02716298|11884061|FG001|STARTED|First Intervention (1 Month)||24
10720473|NCT02716298|11884060|FG000|COMPLETED|First Intervention (1 Month)||24
10720474|NCT02716298|11884061|FG001|COMPLETED|First Intervention (1 Month)||23
10720475|NCT02716298|11884060|FG000|NOT COMPLETED|First Intervention (1 Month)||1
10720476|NCT02716298|11884061|FG001|NOT COMPLETED|First Intervention (1 Month)||1
10720477|NCT02716298|11884060|FG000|STARTED|Second Intervention (1 Month)||24
10720478|NCT02716298|11884061|FG001|STARTED|Second Intervention (1 Month)||23
10720479|NCT02716298|11884060|FG000|COMPLETED|Second Intervention (1 Month)||24
10720480|NCT02716298|11884061|FG001|COMPLETED|Second Intervention (1 Month)||23
10720481|NCT02716298|11884060|FG000|NOT COMPLETED|Second Intervention (1 Month)||0
10720482|NCT02716298|11884061|FG001|NOT COMPLETED|Second Intervention (1 Month)||0
10720483|NCT02716324|11884074|FG000|STARTED|Overall Study||149
10720484|NCT02716324|11884075|FG001|STARTED|Overall Study||154
10720485|NCT02716324|11884074|FG000|COMPLETED|Overall Study||130
10720486|NCT02716324|11884075|FG001|COMPLETED|Overall Study||143
10720487|NCT02716324|11884074|FG000|NOT COMPLETED|Overall Study||19
10720488|NCT02716324|11884075|FG001|NOT COMPLETED|Overall Study||11
10720489|NCT02716506|11884081|FG000|STARTED|Overall Study||3515
10720490|NCT02716506|11884081|FG000|6 Months|Overall Study|Patients that completed the questionnaires six months after the operation.|2528
10720491|NCT02716506|11884081|FG000|2 Years|Overall Study|Patients that completed the questionnaires two years after the operation.|2351
10720492|NCT02716506|11884081|FG000|COMPLETED|Overall Study||2351
10720493|NCT02716506|11884081|FG000|NOT COMPLETED|Overall Study||1164
10720494|NCT02716584|11884087|FG000|STARTED|Overall Study||35
10720495|NCT02716584|11884088|FG001|STARTED|Overall Study||18
10720496|NCT02716584|11884087|FG000|COMPLETED|Overall Study||27
10720497|NCT02716584|11884088|FG001|COMPLETED|Overall Study||13
10720498|NCT02716584|11884087|FG000|NOT COMPLETED|Overall Study||8
10720499|NCT02716584|11884088|FG001|NOT COMPLETED|Overall Study||5
10720500|NCT02716714|11884096|FG000|STARTED|Overall Study||67
10720501|NCT02716714|11884097|FG001|STARTED|Overall Study||10
10720502|NCT02716714|11884096|FG000|COMPLETED|Overall Study||55
10720503|NCT02716714|11884097|FG001|COMPLETED|Overall Study||8
10720504|NCT02716714|11884096|FG000|NOT COMPLETED|Overall Study||12
10720505|NCT02716714|11884097|FG001|NOT COMPLETED|Overall Study||2
10720506|NCT02716727|11884109|FG000|STARTED|Overall Study||7
10720507|NCT02716727|11884110|FG001|STARTED|Overall Study||9
10720508|NCT02716727|11884109|FG000|COMPLETED|Overall Study||7
10720509|NCT02716727|11884110|FG001|COMPLETED|Overall Study||9
10720510|NCT02716727|11884109|FG000|NOT COMPLETED|Overall Study||0
10720511|NCT02716727|11884110|FG001|NOT COMPLETED|Overall Study||0
10720512|NCT02716779|11884119|FG000|STARTED|Monotherapy||14
10720513|NCT02716779|11884120|FG001|STARTED|Monotherapy||26
10720514|NCT02716779|11884121|FG002|STARTED|Monotherapy||27
10720515|NCT02716779|11884119|FG000|COMPLETED|Monotherapy||14
10720516|NCT02716779|11884120|FG001|COMPLETED|Monotherapy||25
10720517|NCT02716779|11884121|FG002|COMPLETED|Monotherapy||26
10720518|NCT02716779|11884119|FG000|NOT COMPLETED|Monotherapy||0
10720519|NCT02716779|11884120|FG001|NOT COMPLETED|Monotherapy||1
10720520|NCT02716779|11884121|FG002|NOT COMPLETED|Monotherapy||1
10720521|NCT02716779|11884119|FG000|STARTED|Combination Therapy||14
10720522|NCT02716779|11884120|FG001|STARTED|Combination Therapy||25
10720523|NCT02716779|11884121|FG002|STARTED|Combination Therapy||26
10720524|NCT02716779|11884119|FG000|COMPLETED|Combination Therapy||14
10720525|NCT02716779|11884120|FG001|COMPLETED|Combination Therapy||23
10720526|NCT02716779|11884121|FG002|COMPLETED|Combination Therapy||25
10720527|NCT02716779|11884119|FG000|NOT COMPLETED|Combination Therapy||0
10720528|NCT02716779|11884120|FG001|NOT COMPLETED|Combination Therapy||2
10720529|NCT02716779|11884121|FG002|NOT COMPLETED|Combination Therapy||1
10720530|NCT02716805|11884135|FG000|STARTED|Overall Study||6
10720531|NCT02716805|11884136|FG001|STARTED|Overall Study||0
10720532|NCT02716805|11884137|FG002|STARTED|Overall Study||0
10720533|NCT02716805|11884138|FG003|STARTED|Overall Study||0
10720534|NCT02716805|11884135|FG000|COMPLETED|Overall Study||4
10720535|NCT02716805|11884136|FG001|COMPLETED|Overall Study||0
10720536|NCT02716805|11884137|FG002|COMPLETED|Overall Study||0
10720537|NCT02716805|11884138|FG003|COMPLETED|Overall Study||0
10720538|NCT02716805|11884135|FG000|NOT COMPLETED|Overall Study||2
10720539|NCT02716805|11884136|FG001|NOT COMPLETED|Overall Study||0
10720540|NCT02716805|11884137|FG002|NOT COMPLETED|Overall Study||0
10720541|NCT02716805|11884138|FG003|NOT COMPLETED|Overall Study||0
10720542|NCT02716818|11884144|FG000|STARTED|Overall Study||61
10720543|NCT02716818|11884145|FG001|STARTED|Overall Study||61
10720544|NCT02716818|11884144|FG000|COMPLETED|Overall Study||58
10720545|NCT02716818|11884145|FG001|COMPLETED|Overall Study||59
10720546|NCT02716818|11884144|FG000|NOT COMPLETED|Overall Study||3
10720547|NCT02716818|11884145|FG001|NOT COMPLETED|Overall Study||2
10720548|NCT02716896|11884175|FG000|STARTED|Overall Study||1
10720549|NCT02716896|11884176|FG001|STARTED|Overall Study||1
10720550|NCT02716896|11884175|FG000|COMPLETED|Overall Study||1
10720551|NCT02716896|11884176|FG001|COMPLETED|Overall Study||0
10720552|NCT02716896|11884175|FG000|NOT COMPLETED|Overall Study||0
10720553|NCT02716896|11884176|FG001|NOT COMPLETED|Overall Study||1
10720554|NCT02716987|11884188|FG000|STARTED|Overall Study||4
10720555|NCT02716987|11884189|FG001|STARTED|Overall Study||2
10720556|NCT02716987|11884190|FG002|STARTED|Overall Study||5
10720557|NCT02716987|11884191|FG003|STARTED|Overall Study||2
10720558|NCT02716987|11884192|FG004|STARTED|Overall Study||6
10310953|NCT00127803|11444145|FG002|COMPLETED|Overall Study||12
10310954|NCT00127803|11444146|FG003|COMPLETED|Overall Study||11
10310955|NCT00127803|11444143|FG000|NOT COMPLETED|Overall Study||3
10310956|NCT00127803|11444144|FG001|NOT COMPLETED|Overall Study||0
10396924|NCT00697788|11540727|FG000|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
10396925|NCT00697788|11540728|FG001|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
10396926|NCT00697788|11540729|FG002|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
10396927|NCT00697788|11540730|FG003|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
10396928|NCT00697788|11540731|FG004|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||2
10396929|NCT00697788|11540732|FG005|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
10396930|NCT00697788|11540733|FG006|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
10396931|NCT00697788|11540734|FG007|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
10659007|NCT02237911|11820253|FG002|STARTED|Overall Study||48
10310957|NCT00127803|11444145|FG002|NOT COMPLETED|Overall Study||0
10310958|NCT00127803|11444146|FG003|NOT COMPLETED|Overall Study||1
10310959|NCT00127842|11444156|FG000|STARTED|Overall Study||110
10310960|NCT00127842|11444156|FG000|COMPLETED|Overall Study||71
10310961|NCT00127842|11444156|FG000|NOT COMPLETED|Overall Study||39
10310962|NCT00127855|11444165|FG000|STARTED|Primary Vaccination Course||82
10659008|NCT02237911|11820251|FG000|3 Months|Overall Study||90
10659009|NCT02237911|11820252|FG001|3 Months|Overall Study||87
10659010|NCT02237911|11820253|FG002|3 Months|Overall Study||44
10659011|NCT02237911|11820251|FG000|6 Months|Overall Study||89
10659012|NCT02237911|11820252|FG001|6 Months|Overall Study||88
10659013|NCT02237911|11820253|FG002|6 Months|Overall Study||45
10659014|NCT02237911|11820251|FG000|COMPLETED|Overall Study||89
10659015|NCT02237911|11820252|FG001|COMPLETED|Overall Study||88
10659016|NCT02237911|11820253|FG002|COMPLETED|Overall Study||45
10659017|NCT02237911|11820251|FG000|NOT COMPLETED|Overall Study||7
10659018|NCT02237911|11820252|FG001|NOT COMPLETED|Overall Study||8
10659019|NCT02237911|11820253|FG002|NOT COMPLETED|Overall Study||3
10659020|NCT02237950|11820263|FG000|STARTED|Overall Study||295
10720559|NCT02716987|11884193|FG005|STARTED|Overall Study||1
10720560|NCT02716987|11884188|FG000|COMPLETED|Overall Study||4
10720561|NCT02716987|11884189|FG001|COMPLETED|Overall Study||2
10720562|NCT02716987|11884190|FG002|COMPLETED|Overall Study||4
10720563|NCT02716987|11884191|FG003|COMPLETED|Overall Study||2
10720564|NCT02716987|11884192|FG004|COMPLETED|Overall Study||5
10720565|NCT02716987|11884193|FG005|COMPLETED|Overall Study||0
10720566|NCT02716987|11884188|FG000|NOT COMPLETED|Overall Study||0
10720567|NCT02716987|11884189|FG001|NOT COMPLETED|Overall Study||0
10720568|NCT02716987|11884190|FG002|NOT COMPLETED|Overall Study||1
10720569|NCT02716987|11884191|FG003|NOT COMPLETED|Overall Study||0
10720570|NCT02716987|11884192|FG004|NOT COMPLETED|Overall Study||1
10720571|NCT02716987|11884193|FG005|NOT COMPLETED|Overall Study||1
10720572|NCT02717195|11884222|FG000|STARTED|Prospective Confirmation (PC) Period||711
10720573|NCT02717195|11884223|FG001|STARTED|Prospective Confirmation (PC) Period||387
10720574|NCT02717195|11884224|FG002|STARTED|Prospective Confirmation (PC) Period||0
10720575|NCT02717195|11884225|FG003|STARTED|Prospective Confirmation (PC) Period||0
10720576|NCT02717195|11884226|FG004|STARTED|Prospective Confirmation (PC) Period||0
10720577|NCT02717195|11884222|FG000|COMPLETED|Prospective Confirmation (PC) Period||421
10720578|NCT02717195|11884223|FG001|COMPLETED|Prospective Confirmation (PC) Period||276
10720579|NCT02717195|11884224|FG002|COMPLETED|Prospective Confirmation (PC) Period||0
10720580|NCT02717195|11884225|FG003|COMPLETED|Prospective Confirmation (PC) Period||0
10720581|NCT02717195|11884226|FG004|COMPLETED|Prospective Confirmation (PC) Period||0
10720582|NCT02717195|11884222|FG000|NOT COMPLETED|Prospective Confirmation (PC) Period||290
10720583|NCT02717195|11884223|FG001|NOT COMPLETED|Prospective Confirmation (PC) Period||111
10720584|NCT02717195|11884224|FG002|NOT COMPLETED|Prospective Confirmation (PC) Period||0
10720585|NCT02717195|11884225|FG003|NOT COMPLETED|Prospective Confirmation (PC) Period||0
10720586|NCT02717195|11884226|FG004|NOT COMPLETED|Prospective Confirmation (PC) Period||0
10720587|NCT02717195|11884222|FG000|STARTED|Double-blind Treatment (DBT) Period||0
10720588|NCT02717195|11884223|FG001|STARTED|Double-blind Treatment (DBT) Period||0
10720589|NCT02717195|11884224|FG002|STARTED|Double-blind Treatment (DBT) Period||235
10720590|NCT02717195|11884225|FG003|STARTED|Double-blind Treatment (DBT) Period||232
10720591|NCT02717195|11884226|FG004|STARTED|Double-blind Treatment (DBT) Period||230
10720592|NCT02717195|11884222|FG000|COMPLETED|Double-blind Treatment (DBT) Period||0
10720593|NCT02717195|11884223|FG001|COMPLETED|Double-blind Treatment (DBT) Period||0
10720594|NCT02717195|11884224|FG002|COMPLETED|Double-blind Treatment (DBT) Period||198
10720595|NCT02717195|11884225|FG003|COMPLETED|Double-blind Treatment (DBT) Period||188
10720596|NCT02717195|11884226|FG004|COMPLETED|Double-blind Treatment (DBT) Period||200
10720597|NCT02717195|11884222|FG000|NOT COMPLETED|Double-blind Treatment (DBT) Period||0
10720598|NCT02717195|11884223|FG001|NOT COMPLETED|Double-blind Treatment (DBT) Period||0
10720599|NCT02717195|11884224|FG002|NOT COMPLETED|Double-blind Treatment (DBT) Period||37
10720600|NCT02717195|11884225|FG003|NOT COMPLETED|Double-blind Treatment (DBT) Period||44
10720601|NCT02717195|11884226|FG004|NOT COMPLETED|Double-blind Treatment (DBT) Period||30
10720602|NCT02717273|11884241|FG000|STARTED|Overall Study||52
10720603|NCT02717273|11884242|FG001|STARTED|Overall Study||50
10720604|NCT02717273|11884241|FG000|COMPLETED|Overall Study||49
10720605|NCT02717273|11884242|FG001|COMPLETED|Overall Study||48
10720606|NCT02717273|11884241|FG000|NOT COMPLETED|Overall Study||3
10720607|NCT02717273|11884242|FG001|NOT COMPLETED|Overall Study||2
10720608|NCT02717494|11884251|FG000|STARTED|First Intervention (Step 1)||115
10720609|NCT02717494|11884252|FG001|STARTED|First Intervention (Step 1)||115
10720610|NCT02717494|11884253|FG002|STARTED|First Intervention (Step 1)||116
10720611|NCT02717494|11884251|FG000|Were Randomized to Step 2A (PPV-23)|First Intervention (Step 1)||0
10720612|NCT02717494|11884252|FG001|Were Randomized to Step 2A (PPV-23)|First Intervention (Step 1)||0
10720613|NCT02717494|11884253|FG002|Were Randomized to Step 2A (PPV-23)|First Intervention (Step 1)||53
10720614|NCT02717494|11884251|FG000|Were Randomized to Step 2B (PCV-10)|First Intervention (Step 1)||0
10720615|NCT02717494|11884252|FG001|Were Randomized to Step 2B (PCV-10)|First Intervention (Step 1)||0
10720616|NCT02717494|11884253|FG002|Were Randomized to Step 2B (PCV-10)|First Intervention (Step 1)||53
10720617|NCT02717494|11884251|FG000|Were Enrolled in Step 3 (PCV-10)|First Intervention (Step 1)||0
10720618|NCT02717494|11884252|FG001|Were Enrolled in Step 3 (PCV-10)|First Intervention (Step 1)||0
10720619|NCT02717494|11884253|FG002|Were Enrolled in Step 3 (PCV-10)|First Intervention (Step 1)||4
10720620|NCT02717494|11884251|FG000|COMPLETED|First Intervention (Step 1)||109
10720621|NCT02717494|11884252|FG001|COMPLETED|First Intervention (Step 1)||108
10720622|NCT02717494|11884253|FG002|COMPLETED|First Intervention (Step 1)||111
10720623|NCT02717494|11884251|FG000|NOT COMPLETED|First Intervention (Step 1)||6
10720624|NCT02717494|11884252|FG001|NOT COMPLETED|First Intervention (Step 1)||7
10720625|NCT02717494|11884253|FG002|NOT COMPLETED|First Intervention (Step 1)||5
10813539|NCT02744352|11975908|FG001|STARTED|Overall Study||4
10813540|NCT02744352|11975907|FG000|COMPLETED|Overall Study||4
10813541|NCT02744352|11975908|FG001|COMPLETED|Overall Study||4
10813542|NCT02744352|11975907|FG000|NOT COMPLETED|Overall Study||0
10813543|NCT02744352|11975908|FG001|NOT COMPLETED|Overall Study||0
10813544|NCT02760602|11975916|FG000|STARTED|Overall Study||13
10813545|NCT02760602|11975917|FG001|STARTED|Overall Study||13
10813546|NCT02760602|11975916|FG000|COMPLETED|Overall Study||0
10813547|NCT02760602|11975917|FG001|COMPLETED|Overall Study||0
10813548|NCT02760602|11975916|FG000|NOT COMPLETED|Overall Study||13
10813549|NCT02760602|11975917|FG001|NOT COMPLETED|Overall Study||13
10813550|NCT02757521|11975925|FG000|STARTED|Overall Study||1
10813551|NCT02757521|11975926|FG001|STARTED|Overall Study||0
10813552|NCT02757521|11975925|FG000|COMPLETED|Overall Study||0
10813553|NCT02757521|11975926|FG001|COMPLETED|Overall Study||0
10813554|NCT02757521|11975925|FG000|NOT COMPLETED|Overall Study||1
10813555|NCT02757521|11975926|FG001|NOT COMPLETED|Overall Study||0
10813556|NCT02758132|11975934|FG000|STARTED|Overall Study||0
10813557|NCT02758132|11975935|FG001|STARTED|Overall Study||1
10396932|NCT00697788|11540727|FG000|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
10396933|NCT00697788|11540728|FG001|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
10396934|NCT00697788|11540729|FG002|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
10396935|NCT00697788|11540730|FG003|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
10396936|NCT00697788|11540731|FG004|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||1
10396937|NCT00697788|11540732|FG005|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
10396938|NCT00697788|11540733|FG006|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
10396939|NCT00697788|11540734|FG007|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
10396940|NCT00697788|11540727|FG000|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
10396941|NCT00697788|11540728|FG001|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
10396942|NCT00697788|11540729|FG002|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
10396943|NCT00697788|11540730|FG003|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
10396944|NCT00697788|11540731|FG004|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
10396945|NCT00697788|11540732|FG005|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||2
10396946|NCT00697788|11540733|FG006|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
10396947|NCT00697788|11540734|FG007|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
10396948|NCT00697788|11540727|FG000|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
10396949|NCT00697788|11540728|FG001|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
10396950|NCT00697788|11540729|FG002|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
10396951|NCT00697788|11540730|FG003|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
10396952|NCT00697788|11540731|FG004|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
10396953|NCT00697788|11540732|FG005|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||2
10396954|NCT00697788|11540733|FG006|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
10396955|NCT00697788|11540734|FG007|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
10396956|NCT00697788|11540727|FG000|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
10396957|NCT00697788|11540728|FG001|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
10396958|NCT00697788|11540729|FG002|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
10396959|NCT00697788|11540730|FG003|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
10396960|NCT00697788|11540731|FG004|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
10396961|NCT00697788|11540732|FG005|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
10396962|NCT00697788|11540733|FG006|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
10396963|NCT00697788|11540734|FG007|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
10396964|NCT00697788|11540727|FG000|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
10396965|NCT00697788|11540728|FG001|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
10396966|NCT00697788|11540729|FG002|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
10396967|NCT00697788|11540730|FG003|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
10396968|NCT00697788|11540731|FG004|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
10396969|NCT00697788|11540732|FG005|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
10396970|NCT00697788|11540733|FG006|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||2
10396971|NCT00697788|11540734|FG007|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
10396972|NCT00697788|11540727|FG000|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
10396973|NCT00697788|11540728|FG001|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
10396974|NCT00697788|11540729|FG002|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
10396975|NCT00697788|11540730|FG003|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
10396976|NCT00697788|11540731|FG004|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
10396977|NCT00697788|11540732|FG005|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
10396978|NCT00697788|11540733|FG006|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||2
10396979|NCT00697788|11540734|FG007|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
10396980|NCT00697788|11540727|FG000|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
10396981|NCT00697788|11540728|FG001|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
10396982|NCT00697788|11540729|FG002|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
10396983|NCT00697788|11540730|FG003|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
10396984|NCT00697788|11540731|FG004|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
10396985|NCT00697788|11540732|FG005|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
10396986|NCT00697788|11540733|FG006|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
10396987|NCT00697788|11540734|FG007|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
10396988|NCT00697788|11540727|FG000|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
10396989|NCT00697788|11540728|FG001|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
10396990|NCT00697788|11540729|FG002|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
10396991|NCT00697788|11540730|FG003|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
10396992|NCT00697788|11540731|FG004|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
10396993|NCT00697788|11540732|FG005|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
10396994|NCT00697788|11540733|FG006|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
10396995|NCT00697788|11540734|FG007|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||2
10396996|NCT00697788|11540727|FG000|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
10396997|NCT00697788|11540728|FG001|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
10396998|NCT00697788|11540729|FG002|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
10396999|NCT00697788|11540730|FG003|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
10397000|NCT00697788|11540731|FG004|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
10397001|NCT00697788|11540732|FG005|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
10397002|NCT00697788|11540733|FG006|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
10397003|NCT00697788|11540734|FG007|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||2
10397004|NCT00697788|11540727|FG000|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
10397005|NCT00697788|11540728|FG001|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
10397006|NCT00697788|11540729|FG002|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
10397007|NCT00697788|11540730|FG003|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
10397008|NCT00697788|11540731|FG004|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
10397009|NCT00697788|11540732|FG005|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
10397010|NCT00697788|11540733|FG006|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
10397011|NCT00697788|11540734|FG007|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
10397012|NCT00697801|11540764|FG000|STARTED|Overall Study||69
10397013|NCT00697801|11540765|FG001|STARTED|Overall Study||70
10397014|NCT00697801|11540766|FG002|STARTED|Overall Study||69
10397015|NCT00697801|11540764|FG000|COMPLETED|Overall Study||57
10397016|NCT00697801|11540765|FG001|COMPLETED|Overall Study||58
10397017|NCT00697801|11540766|FG002|COMPLETED|Overall Study||45
10397018|NCT00697801|11540764|FG000|NOT COMPLETED|Overall Study||12
10397019|NCT00697801|11540765|FG001|NOT COMPLETED|Overall Study||12
10397020|NCT00697801|11540766|FG002|NOT COMPLETED|Overall Study||24
10397021|NCT00697827|11540776|FG000|STARTED|Overall Study||28
10397022|NCT00697827|11540777|FG001|STARTED|Overall Study||16
10397023|NCT00697827|11540776|FG000|COMPLETED|Overall Study||26
10397024|NCT00697827|11540777|FG001|COMPLETED|Overall Study||15
10397025|NCT00697827|11540776|FG000|NOT COMPLETED|Overall Study||2
10397026|NCT00697827|11540777|FG001|NOT COMPLETED|Overall Study||1
10397027|NCT00698035|11540785|FG000|STARTED|Overall Study||39
10397028|NCT00698035|11540786|FG001|STARTED|Overall Study||36
10397029|NCT00698035|11540785|FG000|COMPLETED|Overall Study||35
10397030|NCT00698035|11540786|FG001|COMPLETED|Overall Study||34
10397031|NCT00698035|11540785|FG000|NOT COMPLETED|Overall Study||4
10397032|NCT00698035|11540786|FG001|NOT COMPLETED|Overall Study||2
10397033|NCT00698139|11540798|FG000|STARTED|Overall Study||1
10397034|NCT00698139|11540799|FG001|STARTED|Overall Study||1
10397035|NCT00698139|11540800|FG002|STARTED|Overall Study||1
10397036|NCT00698139|11540798|FG000|2nd Visit|Overall Study||1
10397037|NCT00698139|11540799|FG001|2nd Visit|Overall Study||1
10397038|NCT00698139|11540800|FG002|2nd Visit|Overall Study|1 subject in the Intervention Group did not have a 2nd visit (per design).|0
10397039|NCT00698139|11540798|FG000|COMPLETED|Overall Study||1
10397040|NCT00698139|11540799|FG001|COMPLETED|Overall Study||1
10397041|NCT00698139|11540800|FG002|COMPLETED|Overall Study||1
10397042|NCT00698139|11540798|FG000|NOT COMPLETED|Overall Study||0
10397043|NCT00698139|11540799|FG001|NOT COMPLETED|Overall Study||0
10397044|NCT00698139|11540800|FG002|NOT COMPLETED|Overall Study||0
10397045|NCT00698204|11540810|FG000|STARTED|Overall Study||20
10397046|NCT00698204|11540811|FG001|STARTED|Overall Study||20
10397047|NCT00698204|11540810|FG000|COMPLETED|Overall Study||19
10397048|NCT00698204|11540811|FG001|COMPLETED|Overall Study||20
10397049|NCT00698204|11540810|FG000|NOT COMPLETED|Overall Study||1
10397050|NCT00698204|11540811|FG001|NOT COMPLETED|Overall Study||0
10397051|NCT00698451|11540819|FG000|STARTED|Overall Study||54
10397052|NCT00698451|11540819|FG000|COMPLETED|Overall Study||15
10659021|NCT02237950|11820264|FG001|STARTED|Overall Study||291
10659022|NCT02237950|11820263|FG000|COMPLETED|Overall Study||247
10659023|NCT02237950|11820264|FG001|COMPLETED|Overall Study||243
10659024|NCT02237950|11820263|FG000|NOT COMPLETED|Overall Study||48
10659025|NCT02237950|11820264|FG001|NOT COMPLETED|Overall Study||48
10659026|NCT02237989|11820272|FG000|STARTED|Overall Study||19
10659027|NCT02237989|11820273|FG001|STARTED|Overall Study||20
10397053|NCT00698451|11540819|FG000|NOT COMPLETED|Overall Study||39
10397054|NCT00698516|11540823|FG000|STARTED|Overall Study||50
10397055|NCT00698516|11540823|FG000|COMPLETED|Overall Study||45
10397056|NCT00698516|11540823|FG000|NOT COMPLETED|Overall Study||5
10397057|NCT00698581|11540833|FG000|STARTED|Overall Study||68
10397058|NCT00698581|11540834|FG001|STARTED|Overall Study||20
10397059|NCT00698581|11540833|FG000|COMPLETED|Overall Study||23
10397060|NCT00698581|11540834|FG001|COMPLETED|Overall Study||8
10397061|NCT00698581|11540833|FG000|NOT COMPLETED|Overall Study||45
10397062|NCT00698581|11540834|FG001|NOT COMPLETED|Overall Study||12
10397063|NCT00698646|11540844|FG000|STARTED|Overall Study||128
10397064|NCT00698646|11540845|FG001|STARTED|Overall Study||128
10397065|NCT00698646|11540846|FG002|STARTED|Overall Study||128
10397066|NCT00698646|11540844|FG000|COMPLETED|Overall Study||92
10397067|NCT00698646|11540845|FG001|COMPLETED|Overall Study||97
10397068|NCT00698646|11540846|FG002|COMPLETED|Overall Study||99
10397069|NCT00698646|11540844|FG000|NOT COMPLETED|Overall Study||36
10397070|NCT00698646|11540845|FG001|NOT COMPLETED|Overall Study||31
10397071|NCT00698646|11540846|FG002|NOT COMPLETED|Overall Study||29
10397072|NCT00698685|11540854|FG000|STARTED|Overall Study||14
10397073|NCT00698685|11540854|FG000|COMPLETED|Overall Study||12
10397074|NCT00698685|11540854|FG000|NOT COMPLETED|Overall Study||2
10397075|NCT00698841|11540858|FG000|STARTED|Overall Study||51
10397076|NCT00698841|11540858|FG000|COMPLETED|Overall Study||33
10397077|NCT00698841|11540858|FG000|NOT COMPLETED|Overall Study||18
10397078|NCT00698867|11540862|FG000|STARTED|Overall Study||118
10397079|NCT00698867|11540862|FG000|Subjects With 1 Year Data|Overall Study||68
10397080|NCT00698867|11540862|FG000|Subjects With 2 Year Data|Overall Study||55
10397081|NCT00698867|11540862|FG000|Subjects With 3 Year Data|Overall Study||35
10397082|NCT00698867|11540862|FG000|Subjects With 4 Year Data|Overall Study||34
10397083|NCT00698867|11540862|FG000|COMPLETED|Overall Study||27
10543654|NCT01484834|11696785|FG002|STARTED|Overall Study||39
10543655|NCT01484834|11696786|FG003|STARTED|Overall Study||24
10543656|NCT01484834|11696783|FG000|COMPLETED|Overall Study||60
10543657|NCT01484834|11696784|FG001|COMPLETED|Overall Study||54
10543658|NCT01484834|11696785|FG002|COMPLETED|Overall Study||38
10543659|NCT01484834|11696786|FG003|COMPLETED|Overall Study||20
10543660|NCT01484834|11696783|FG000|NOT COMPLETED|Overall Study||5
10543661|NCT01484834|11696784|FG001|NOT COMPLETED|Overall Study||8
10543662|NCT01484834|11696785|FG002|NOT COMPLETED|Overall Study||1
10543663|NCT01484834|11696786|FG003|NOT COMPLETED|Overall Study||4
10543664|NCT01484873|11696796|FG000|STARTED|Overall Study||10
10543665|NCT01484873|11696796|FG000|COMPLETED|Overall Study||8
10543666|NCT01484873|11696796|FG000|NOT COMPLETED|Overall Study||2
10543667|NCT01484912|11696803|FG000|STARTED|Overall Study||39
10543668|NCT01484912|11696804|FG001|STARTED|Overall Study||40
10543669|NCT01484912|11696803|FG000|COMPLETED|Overall Study||38
10543670|NCT01484912|11696804|FG001|COMPLETED|Overall Study||39
10543671|NCT01484912|11696803|FG000|NOT COMPLETED|Overall Study||1
10543672|NCT01484912|11696804|FG001|NOT COMPLETED|Overall Study||1
10543673|NCT01484938|11696810|FG000|STARTED|Overall Study||175
10543674|NCT01484938|11696810|FG000|COMPLETED|Overall Study||171
10543675|NCT01484938|11696810|FG000|NOT COMPLETED|Overall Study||4
10543676|NCT01484951|11696814|FG000|STARTED|Overall Study||74
10543677|NCT01484951|11696814|FG000|COMPLETED|Overall Study||69
10543678|NCT01484951|11696814|FG000|NOT COMPLETED|Overall Study||5
10659028|NCT02237989|11820272|FG000|COMPLETED|Overall Study||19
10659029|NCT02237989|11820273|FG001|COMPLETED|Overall Study||20
10543679|NCT01484977|11696818|FG000|STARTED|Overall Study||120
10543680|NCT01484977|11696818|FG000|COMPLETED|Overall Study||93
10543681|NCT01484977|11696818|FG000|NOT COMPLETED|Overall Study||27
10543682|NCT01485055|11696822|FG000|STARTED|Overall Study||11
10659030|NCT02237989|11820272|FG000|NOT COMPLETED|Overall Study||0
10397084|NCT00698867|11540862|FG000|NOT COMPLETED|Overall Study||91
10543683|NCT01485055|11696822|FG000|COMPLETED|Overall Study||11
10543684|NCT01485055|11696822|FG000|NOT COMPLETED|Overall Study||0
10659031|NCT02237989|11820273|FG001|NOT COMPLETED|Overall Study||0
10659032|NCT02238028|11820279|FG000|STARTED|Overall Study||14
10543685|NCT01485094|11696829|FG000|STARTED|Overall Study||20
10543686|NCT01485094|11696830|FG001|STARTED|Overall Study||20
10543687|NCT01485094|11696831|FG002|STARTED|Overall Study||19
10543688|NCT01485094|11696829|FG000|COMPLETED|Overall Study||17
10543689|NCT01485094|11696830|FG001|COMPLETED|Overall Study||18
10543690|NCT01485094|11696831|FG002|COMPLETED|Overall Study||18
10543691|NCT01485094|11696829|FG000|NOT COMPLETED|Overall Study||3
10543692|NCT01485094|11696830|FG001|NOT COMPLETED|Overall Study||2
10543693|NCT01485094|11696831|FG002|NOT COMPLETED|Overall Study||1
10543694|NCT01485120|11696839|FG000|STARTED|Overall Study||34
10720626|NCT02717494|11884251|FG000|STARTED|Second Intervention (Step 2 or Step 3)|Only Step 1 placebo recipients were enrolled in Step 2.|0
10720627|NCT02717494|11884252|FG001|STARTED|Second Intervention (Step 2 or Step 3)|Only Step 1 placebo recipients were enrolled in Step 2.|0
10543695|NCT01485120|11696839|FG000|COMPLETED|Overall Study||32
10543696|NCT01485120|11696839|FG000|NOT COMPLETED|Overall Study||2
10659033|NCT02238028|11820280|FG001|STARTED|Overall Study||14
10659034|NCT02238028|11820279|FG000|COMPLETED|Overall Study||12
10659035|NCT02238028|11820280|FG001|COMPLETED|Overall Study||12
10659036|NCT02238028|11820279|FG000|NOT COMPLETED|Overall Study||2
10659037|NCT02238028|11820280|FG001|NOT COMPLETED|Overall Study||2
10659038|NCT02238067|11820291|FG000|STARTED|Overall Study||196
10659039|NCT02238067|11820291|FG000|COMPLETED|Overall Study||151
10659040|NCT02238067|11820291|FG000|NOT COMPLETED|Overall Study||45
10310963|NCT00127855|11444166|FG001|STARTED|Primary Vaccination Course||82
10310964|NCT00127855|11444167|FG002|STARTED|Primary Vaccination Course||80
10310965|NCT00127855|11444168|FG003|STARTED|Primary Vaccination Course||81
10310966|NCT00127855|11444169|FG004|STARTED|Primary Vaccination Course||82
10310967|NCT00127855|11444165|FG000|COMPLETED|Primary Vaccination Course||80
10310968|NCT00127855|11444166|FG001|COMPLETED|Primary Vaccination Course||81
10310969|NCT00127855|11444167|FG002|COMPLETED|Primary Vaccination Course||78
10310970|NCT00127855|11444168|FG003|COMPLETED|Primary Vaccination Course||81
10310971|NCT00127855|11444169|FG004|COMPLETED|Primary Vaccination Course||78
10310972|NCT00127855|11444165|FG000|NOT COMPLETED|Primary Vaccination Course||2
10310973|NCT00127855|11444166|FG001|NOT COMPLETED|Primary Vaccination Course||1
10310974|NCT00127855|11444167|FG002|NOT COMPLETED|Primary Vaccination Course||2
10310975|NCT00127855|11444168|FG003|NOT COMPLETED|Primary Vaccination Course||0
10310976|NCT00127855|11444169|FG004|NOT COMPLETED|Primary Vaccination Course||4
10310977|NCT00127855|11444165|FG000|STARTED|Polysaccharide Challenge Dose||80
10310978|NCT00127855|11444166|FG001|STARTED|Polysaccharide Challenge Dose||79
10310979|NCT00127855|11444167|FG002|STARTED|Polysaccharide Challenge Dose||77
10310980|NCT00127855|11444168|FG003|STARTED|Polysaccharide Challenge Dose||81
10310981|NCT00127855|11444169|FG004|STARTED|Polysaccharide Challenge Dose||77
10310982|NCT00127855|11444165|FG000|COMPLETED|Polysaccharide Challenge Dose||80
10310983|NCT00127855|11444166|FG001|COMPLETED|Polysaccharide Challenge Dose||79
10310984|NCT00127855|11444167|FG002|COMPLETED|Polysaccharide Challenge Dose||77
10310985|NCT00127855|11444168|FG003|COMPLETED|Polysaccharide Challenge Dose||81
10310986|NCT00127855|11444169|FG004|COMPLETED|Polysaccharide Challenge Dose||77
10310987|NCT00127855|11444165|FG000|NOT COMPLETED|Polysaccharide Challenge Dose||0
10310988|NCT00127855|11444166|FG001|NOT COMPLETED|Polysaccharide Challenge Dose||0
10310989|NCT00127855|11444167|FG002|NOT COMPLETED|Polysaccharide Challenge Dose||0
10310990|NCT00127855|11444168|FG003|NOT COMPLETED|Polysaccharide Challenge Dose||0
10310991|NCT00127855|11444169|FG004|NOT COMPLETED|Polysaccharide Challenge Dose||0
10310992|NCT00127933|11444183|FG000|STARTED|Overall Study||123
10310993|NCT00127933|11444184|FG001|STARTED|Overall Study||34
10310994|NCT00127933|11444183|FG000|Pathological Response|Overall Study||101
10310995|NCT00127933|11444184|FG001|Pathological Response|Overall Study||28
10310996|NCT00127933|11444183|FG000|Clinical Response|Overall Study||122
10310997|NCT00127933|11444184|FG001|Clinical Response|Overall Study||34
10310998|NCT00127933|11444183|FG000|Safety Population|Overall Study||122
10310999|NCT00127933|11444184|FG001|Safety Population|Overall Study||34
10311000|NCT00127933|11444183|FG000|Quality of Life Population|Overall Study||118
10311001|NCT00127933|11444184|FG001|Quality of Life Population|Overall Study||33
10311002|NCT00127933|11444183|FG000|Postoperative|Overall Study||98
10311003|NCT00127933|11444184|FG001|Postoperative|Overall Study||27
10311004|NCT00127933|11444183|FG000|COMPLETED|Overall Study||122
10311005|NCT00127933|11444184|FG001|COMPLETED|Overall Study||34
10311006|NCT00127933|11444183|FG000|NOT COMPLETED|Overall Study||1
10311007|NCT00127933|11444184|FG001|NOT COMPLETED|Overall Study||0
10311008|NCT00128102|11444192|FG000|STARTED|Overall Study||329
10311009|NCT00128102|11444193|FG001|STARTED|Overall Study||332
10311010|NCT00128102|11444192|FG000|Treated|Overall Study||329
10311011|NCT00128102|11444193|FG001|Treated|Overall Study||329
10311012|NCT00128102|11444192|FG000|COMPLETED|Overall Study||1
10311013|NCT00128102|11444193|FG001|COMPLETED|Overall Study||0
10311014|NCT00128102|11444192|FG000|NOT COMPLETED|Overall Study||328
10720628|NCT02717494|11884253|FG002|STARTED|Second Intervention (Step 2 or Step 3)|One participant who completed Step 1 did not enroll in Step 2.|110
10720629|NCT02717494|11884251|FG000|Completed Step 2A|Second Intervention (Step 2 or Step 3)||0
10720630|NCT02717494|11884252|FG001|Completed Step 2A|Second Intervention (Step 2 or Step 3)||0
10813558|NCT02758132|11975934|FG000|COMPLETED|Overall Study||0
10813559|NCT02758132|11975935|FG001|COMPLETED|Overall Study||0
10813560|NCT02758132|11975934|FG000|NOT COMPLETED|Overall Study||0
10813561|NCT02758132|11975935|FG001|NOT COMPLETED|Overall Study||1
10813562|NCT02757547|11975941|FG000|STARTED|Overall Study||2
10813563|NCT02757547|11975941|FG000|COMPLETED|Overall Study||2
10813564|NCT02757547|11975941|FG000|NOT COMPLETED|Overall Study||0
10813565|NCT02757053|11975948|FG000|STARTED|Overall Study||3
10813566|NCT02757053|11975949|FG001|STARTED|Overall Study||5
10813567|NCT02757053|11975948|FG000|COMPLETED|Overall Study||0
10813568|NCT02757053|11975949|FG001|COMPLETED|Overall Study||0
10813569|NCT02757053|11975948|FG000|NOT COMPLETED|Overall Study||3
10813570|NCT02757053|11975949|FG001|NOT COMPLETED|Overall Study||5
10813571|NCT02734940|11975957|FG000|STARTED|Overall Study||0
10813572|NCT02734940|11975958|FG001|STARTED|Overall Study||0
10813573|NCT02734940|11975957|FG000|COMPLETED|Overall Study||0
10720631|NCT02717494|11884253|FG002|Completed Step 2A|Second Intervention (Step 2 or Step 3)||52
10720632|NCT02717494|11884251|FG000|Completed Step 2B|Second Intervention (Step 2 or Step 3)||0
10720633|NCT02717494|11884252|FG001|Completed Step 2B|Second Intervention (Step 2 or Step 3)||0
10720634|NCT02717494|11884253|FG002|Completed Step 2B|Second Intervention (Step 2 or Step 3)||50
10720635|NCT02717494|11884251|FG000|Completed Step 3|Second Intervention (Step 2 or Step 3)||0
10720636|NCT02717494|11884252|FG001|Completed Step 3|Second Intervention (Step 2 or Step 3)||0
10720637|NCT02717494|11884253|FG002|Completed Step 3|Second Intervention (Step 2 or Step 3)||4
10720638|NCT02717494|11884251|FG000|COMPLETED|Second Intervention (Step 2 or Step 3)||0
10720639|NCT02717494|11884252|FG001|COMPLETED|Second Intervention (Step 2 or Step 3)||0
10720640|NCT02717494|11884253|FG002|COMPLETED|Second Intervention (Step 2 or Step 3)||106
10720641|NCT02717494|11884251|FG000|NOT COMPLETED|Second Intervention (Step 2 or Step 3)||0
10720642|NCT02717494|11884252|FG001|NOT COMPLETED|Second Intervention (Step 2 or Step 3)||0
10720643|NCT02717494|11884253|FG002|NOT COMPLETED|Second Intervention (Step 2 or Step 3)||4
10720644|NCT02717546|11884279|FG000|STARTED|Overall Study||32
10720645|NCT02717546|11884279|FG000|COMPLETED|Overall Study||20
10720646|NCT02717546|11884279|FG000|NOT COMPLETED|Overall Study||12
10720647|NCT02717754|11884289|FG000|STARTED|Overall Study||10
10813574|NCT02734940|11975958|FG001|COMPLETED|Overall Study||0
10813575|NCT02734940|11975957|FG000|NOT COMPLETED|Overall Study||0
10813576|NCT02734940|11975958|FG001|NOT COMPLETED|Overall Study||0
10813577|NCT02749617|11975964|FG000|STARTED|Overall Study||2
10813578|NCT02749617|11975964|FG000|COMPLETED|Overall Study||2
10813579|NCT02749617|11975964|FG000|NOT COMPLETED|Overall Study||0
10813580|NCT02749227|11975968|FG000|STARTED|Overall Study||4
10813581|NCT02749227|11975968|FG000|COMPLETED|Overall Study||4
10813582|NCT02749227|11975968|FG000|NOT COMPLETED|Overall Study||0
10813583|NCT02745210|11975974|FG000|STARTED|Overall Study||0
10813584|NCT02745210|11975975|FG001|STARTED|Overall Study||9
10813585|NCT02745210|11975974|FG000|COMPLETED|Overall Study||0
10813586|NCT02745210|11975975|FG001|COMPLETED|Overall Study||9
10813587|NCT02745210|11975974|FG000|NOT COMPLETED|Overall Study||0
10813588|NCT02745210|11975975|FG001|NOT COMPLETED|Overall Study||0
10813589|NCT02725671|11975979|FG000|STARTED|Overall Study||2
10813590|NCT02725671|11975979|FG000|COMPLETED|Overall Study||1
10813591|NCT02725671|11975979|FG000|NOT COMPLETED|Overall Study||1
10813592|NCT02746263|11975987|FG000|STARTED|Overall Study||0
10813593|NCT02746263|11975988|FG001|STARTED|Overall Study||1
10813594|NCT02746263|11975987|FG000|Per Protocol Analysis Set|Overall Study||0
10813595|NCT02746263|11975988|FG001|Per Protocol Analysis Set|Overall Study||0
10813596|NCT02746263|11975987|FG000|COMPLETED|Overall Study||0
10813597|NCT02746263|11975988|FG001|COMPLETED|Overall Study||1
10813598|NCT02746263|11975987|FG000|NOT COMPLETED|Overall Study||0
10813599|NCT02746263|11975988|FG001|NOT COMPLETED|Overall Study||0
10813600|NCT02721277|11975994|FG000|STARTED|Overall Study||2
10813601|NCT02721277|11975994|FG000|COMPLETED|Overall Study||2
10813602|NCT02721277|11975994|FG000|NOT COMPLETED|Overall Study||0
10813603|NCT02732327|11976000|FG000|STARTED|Overall Study||0
10813604|NCT02732327|11976001|FG001|STARTED|Overall Study||2
10813605|NCT02732327|11976000|FG000|COMPLETED|Overall Study||0
10813606|NCT02732327|11976001|FG001|COMPLETED|Overall Study||1
10813607|NCT02732327|11976000|FG000|NOT COMPLETED|Overall Study||0
10813608|NCT02732327|11976001|FG001|NOT COMPLETED|Overall Study||1
10813609|NCT02726399|11976007|FG000|STARTED|Overall Study||7
10813610|NCT02726399|11976007|FG000|COMPLETED|Overall Study||0
10813611|NCT02726399|11976007|FG000|NOT COMPLETED|Overall Study||7
10813612|NCT02720510|11976013|FG000|STARTED|Overall Study||3
10397085|NCT00698932|11540868|FG000|STARTED|Overall Study|Randomized and treated|284
10397086|NCT00698932|11540869|FG001|STARTED|Overall Study|Randomized and treated|284
10397087|NCT00698932|11540868|FG000|COMPLETED|Overall Study|Completed 24 Weeks of treatment|262
10397088|NCT00698932|11540869|FG001|COMPLETED|Overall Study|Completed 24 Weeks of treatment|248
10397089|NCT00698932|11540868|FG000|NOT COMPLETED|Overall Study||22
10397090|NCT00698932|11540869|FG001|NOT COMPLETED|Overall Study||36
10397091|NCT00698997|11540877|FG000|STARTED|Overall Study|1 enrollment|55
10397092|NCT00698997|11540878|FG001|STARTED|Overall Study|1 enrollment|63
10397093|NCT00698997|11540877|FG000|COMPLETED|Overall Study|45 - final participant assessment completed|45
10397094|NCT00698997|11540878|FG001|COMPLETED|Overall Study|36 - final assessment completed|36
10397095|NCT00698997|11540877|FG000|NOT COMPLETED|Overall Study||10
10397096|NCT00698997|11540878|FG001|NOT COMPLETED|Overall Study||27
10397097|NCT00699010|11540887|FG000|STARTED|Overall Study||15
10397098|NCT00699010|11540888|FG001|STARTED|Overall Study||15
10397099|NCT00699010|11540887|FG000|COMPLETED|Overall Study||15
10397100|NCT00699010|11540888|FG001|COMPLETED|Overall Study||15
10397101|NCT00699010|11540887|FG000|NOT COMPLETED|Overall Study||0
10397102|NCT00699010|11540888|FG001|NOT COMPLETED|Overall Study||0
10397103|NCT00699140|11540894|FG000|STARTED|Overall Study||18
10397104|NCT00699140|11540894|FG000|COMPLETED|Overall Study||18
10397105|NCT00699140|11540894|FG000|NOT COMPLETED|Overall Study||0
10397106|NCT00699153|11540904|FG000|STARTED|Overall Study|Intent to treat population|203
10397107|NCT00699153|11540905|FG001|STARTED|Overall Study|Intent to treat population|202
10397108|NCT00699153|11540904|FG000|COMPLETED|Overall Study||200
10397109|NCT00699153|11540905|FG001|COMPLETED|Overall Study||200
10397110|NCT00699153|11540904|FG000|NOT COMPLETED|Overall Study||3
10397111|NCT00699153|11540905|FG001|NOT COMPLETED|Overall Study||2
10397112|NCT00699192|11540914|FG000|STARTED|Overall Study||275
10397113|NCT00699192|11540915|FG001|STARTED|Overall Study||272
10397114|NCT00699192|11540916|FG002|STARTED|Overall Study||272
10397115|NCT00699192|11540914|FG000|COMPLETED|Overall Study||259
10397116|NCT00699192|11540915|FG001|COMPLETED|Overall Study||260
10397117|NCT00699192|11540916|FG002|COMPLETED|Overall Study||261
10397118|NCT00699192|11540914|FG000|NOT COMPLETED|Overall Study||16
10397119|NCT00699192|11540915|FG001|NOT COMPLETED|Overall Study||12
10397120|NCT00699192|11540916|FG002|NOT COMPLETED|Overall Study||11
10397121|NCT00699218|11540924|FG000|STARTED|Overall Study||15
10397122|NCT00699218|11540924|FG000|COMPLETED|Overall Study||15
10397123|NCT00699218|11540924|FG000|NOT COMPLETED|Overall Study||0
10397124|NCT00699283|11540930|FG000|STARTED|Overall Study||47
10397125|NCT00699283|11540931|FG001|STARTED|Overall Study||15
10397126|NCT00699283|11540930|FG000|COMPLETED|Overall Study||14
10397127|NCT00699283|11540931|FG001|COMPLETED|Overall Study||7
10397128|NCT00699283|11540930|FG000|NOT COMPLETED|Overall Study||33
10397129|NCT00699283|11540931|FG001|NOT COMPLETED|Overall Study||8
10397130|NCT00699335|11540936|FG000|STARTED|Overall Study||5308
10397131|NCT00699335|11540936|FG000|COMPLETED|Overall Study||5080
10397132|NCT00699335|11540936|FG000|NOT COMPLETED|Overall Study||228
10397133|NCT00699348|11540943|FG000|STARTED|Overall Study||351
10397134|NCT00699348|11540943|FG000|COMPLETED|Overall Study||261
10397135|NCT00699348|11540943|FG000|NOT COMPLETED|Overall Study||90
10397136|NCT00699374|11540949|FG000|STARTED|Overall Study||530
10543697|NCT01485172|11696850|FG000|STARTED|Overall Study||40
10543698|NCT01485172|11696851|FG001|STARTED|Overall Study||13
10543699|NCT01485172|11696852|FG002|STARTED|Overall Study||41
10543700|NCT01485172|11696853|FG003|STARTED|Overall Study||40
10543701|NCT01485172|11696854|FG004|STARTED|Overall Study||39
10659041|NCT02238080|11820295|FG000|STARTED|Overall Study||197
10659042|NCT02238080|11820295|FG000|COMPLETED|Overall Study||172
10659043|NCT02238080|11820295|FG000|NOT COMPLETED|Overall Study||25
10659044|NCT02238379|11820301|FG000|STARTED|Overall Study||12
10543702|NCT01485172|11696855|FG005|STARTED|Overall Study||13
10543703|NCT01485172|11696850|FG000|COMPLETED|Overall Study||33
10543704|NCT01485172|11696851|FG001|COMPLETED|Overall Study||12
10543705|NCT01485172|11696852|FG002|COMPLETED|Overall Study||34
10543706|NCT01485172|11696853|FG003|COMPLETED|Overall Study||32
10659045|NCT02238379|11820302|FG001|STARTED|Overall Study||14
10659046|NCT02238379|11820301|FG000|COMPLETED|Overall Study||11
10659047|NCT02238379|11820302|FG001|COMPLETED|Overall Study||14
10397137|NCT00699374|11540950|FG001|STARTED|Overall Study||544
10397138|NCT00699374|11540949|FG000|Treated|Overall Study||526
10397139|NCT00699374|11540950|FG001|Treated|Overall Study||542
10397140|NCT00699374|11540949|FG000|COMPLETED|Overall Study||0
10397141|NCT00699374|11540950|FG001|COMPLETED|Overall Study||0
10397142|NCT00699374|11540949|FG000|NOT COMPLETED|Overall Study||530
10397143|NCT00699374|11540950|FG001|NOT COMPLETED|Overall Study||544
10397144|NCT00699400|11540959|FG000|STARTED|Overall Study||42
10397145|NCT00699400|11540960|FG001|STARTED|Overall Study||3
10397146|NCT00699400|11540961|FG002|STARTED|Overall Study||138
10397147|NCT00699400|11540962|FG003|STARTED|Overall Study||6
10397148|NCT00699400|11540963|FG004|STARTED|Overall Study||4
10397149|NCT00699400|11540964|FG005|STARTED|Overall Study||11
10397150|NCT00699400|11540959|FG000|COMPLETED|Overall Study||42
10397151|NCT00699400|11540960|FG001|COMPLETED|Overall Study||3
10397152|NCT00699400|11540961|FG002|COMPLETED|Overall Study||138
10397153|NCT00699400|11540962|FG003|COMPLETED|Overall Study||6
10397154|NCT00699400|11540963|FG004|COMPLETED|Overall Study||4
10397155|NCT00699400|11540964|FG005|COMPLETED|Overall Study||0
10397156|NCT00699400|11540959|FG000|NOT COMPLETED|Overall Study||0
10397157|NCT00699400|11540960|FG001|NOT COMPLETED|Overall Study||0
10397158|NCT00699400|11540961|FG002|NOT COMPLETED|Overall Study||0
10397159|NCT00699400|11540962|FG003|NOT COMPLETED|Overall Study||0
10397160|NCT00699400|11540963|FG004|NOT COMPLETED|Overall Study||0
10397161|NCT00699400|11540964|FG005|NOT COMPLETED|Overall Study||11
10397162|NCT00699491|11540978|FG000|STARTED|Overall Study||3
10397163|NCT00699491|11540979|FG001|STARTED|Overall Study||2
10397164|NCT00699491|11540980|FG002|STARTED|Overall Study||7
10397165|NCT00699491|11540981|FG003|STARTED|Overall Study||6
10397166|NCT00699491|11540982|FG004|STARTED|Overall Study||8
10397167|NCT00699491|11540983|FG005|STARTED|Overall Study||22
10397168|NCT00699491|11540978|FG000|COMPLETED|Overall Study||3
10397169|NCT00699491|11540979|FG001|COMPLETED|Overall Study||2
10720648|NCT02717754|11884290|FG001|STARTED|Overall Study||19
10720649|NCT02717754|11884291|FG002|STARTED|Overall Study||20
10397170|NCT00699491|11540980|FG002|COMPLETED|Overall Study||7
10397171|NCT00699491|11540981|FG003|COMPLETED|Overall Study||6
10397172|NCT00699491|11540982|FG004|COMPLETED|Overall Study||8
10397173|NCT00699491|11540983|FG005|COMPLETED|Overall Study||22
10397174|NCT00699491|11540978|FG000|NOT COMPLETED|Overall Study||0
10397175|NCT00699491|11540979|FG001|NOT COMPLETED|Overall Study||0
10397176|NCT00699491|11540980|FG002|NOT COMPLETED|Overall Study||0
10397177|NCT00699491|11540981|FG003|NOT COMPLETED|Overall Study||0
10397178|NCT00699491|11540982|FG004|NOT COMPLETED|Overall Study||0
10397179|NCT00699491|11540983|FG005|NOT COMPLETED|Overall Study||0
10428758|NCT00860067|11574831|FG000|STARTED|Overall Study||1200
10428759|NCT00860067|11574832|FG001|STARTED|Overall Study||299
10428760|NCT00860067|11574833|FG002|STARTED|Overall Study||301
10428761|NCT00860067|11574831|FG000|COMPLETED|Overall Study||1149
10428762|NCT00860067|11574832|FG001|COMPLETED|Overall Study||290
10428763|NCT00860067|11574833|FG002|COMPLETED|Overall Study||292
10428764|NCT00860067|11574831|FG000|NOT COMPLETED|Overall Study||51
10428765|NCT00860067|11574832|FG001|NOT COMPLETED|Overall Study||9
10428766|NCT00860067|11574833|FG002|NOT COMPLETED|Overall Study||9
10428767|NCT00860171|11574844|FG000|STARTED|Overall Study||16
10720650|NCT02717754|11884292|FG003|STARTED|Overall Study||10
10428768|NCT00860171|11574844|FG000|COMPLETED|Overall Study||16
10428769|NCT00860171|11574844|FG000|NOT COMPLETED|Overall Study||0
10428770|NCT00860262|11574851|FG000|STARTED|Overall Study||421
10428771|NCT00860262|11574852|FG001|STARTED|Overall Study||217
10720651|NCT02717754|11884293|FG004|STARTED|Overall Study||20
10397180|NCT00699556|11540997|FG000|STARTED|First Intervention (1 Day)||11
10397181|NCT00699556|11540998|FG001|STARTED|First Intervention (1 Day)||11
10397182|NCT00699556|11540997|FG000|COMPLETED|First Intervention (1 Day)||11
10397183|NCT00699556|11540998|FG001|COMPLETED|First Intervention (1 Day)||11
10397184|NCT00699556|11540997|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10397185|NCT00699556|11540998|FG001|NOT COMPLETED|First Intervention (1 Day)||0
10397186|NCT00699556|11540997|FG000|STARTED|Second Intervention (1 Day)||11
10397187|NCT00699556|11540998|FG001|STARTED|Second Intervention (1 Day)||11
10397188|NCT00699556|11540997|FG000|COMPLETED|Second Intervention (1 Day)||11
10397189|NCT00699556|11540998|FG001|COMPLETED|Second Intervention (1 Day)||11
10397190|NCT00699556|11540997|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10397191|NCT00699556|11540998|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10397192|NCT00699582|11541008|FG000|STARTED|Overall Study||138
10397193|NCT00699582|11541009|FG001|STARTED|Overall Study||130
10397194|NCT00699582|11541010|FG002|STARTED|Overall Study||121
10397195|NCT00699582|11541008|FG000|COMPLETED|Overall Study||120
10397196|NCT00699582|11541009|FG001|COMPLETED|Overall Study||108
10397197|NCT00699582|11541010|FG002|COMPLETED|Overall Study||93
10397198|NCT00699582|11541008|FG000|NOT COMPLETED|Overall Study||18
10397199|NCT00699582|11541009|FG001|NOT COMPLETED|Overall Study||22
10397200|NCT00699582|11541010|FG002|NOT COMPLETED|Overall Study||28
10397201|NCT00699608|11541018|FG000|STARTED|First Intervention||16
10397202|NCT00699608|11541019|FG001|STARTED|First Intervention||15
10397203|NCT00699608|11541020|FG002|STARTED|First Intervention||15
10397204|NCT00699608|11541021|FG003|STARTED|First Intervention||15
10397205|NCT00699608|11541022|FG004|STARTED|First Intervention||15
10397206|NCT00699608|11541023|FG005|STARTED|First Intervention||15
10397207|NCT00699608|11541018|FG000|COMPLETED|First Intervention||16
10397208|NCT00699608|11541019|FG001|COMPLETED|First Intervention||15
10397209|NCT00699608|11541020|FG002|COMPLETED|First Intervention||14
10397210|NCT00699608|11541021|FG003|COMPLETED|First Intervention||15
10397211|NCT00699608|11541022|FG004|COMPLETED|First Intervention||14
10720652|NCT02717754|11884294|FG005|STARTED|Overall Study||20
10720653|NCT02717754|11884289|FG000|COMPLETED|Overall Study||10
10720654|NCT02717754|11884290|FG001|COMPLETED|Overall Study||19
10397212|NCT00699608|11541023|FG005|COMPLETED|First Intervention||15
10397213|NCT00699608|11541018|FG000|NOT COMPLETED|First Intervention||0
10397214|NCT00699608|11541019|FG001|NOT COMPLETED|First Intervention||0
10397215|NCT00699608|11541020|FG002|NOT COMPLETED|First Intervention||1
10397216|NCT00699608|11541021|FG003|NOT COMPLETED|First Intervention||0
10397217|NCT00699608|11541022|FG004|NOT COMPLETED|First Intervention||1
10397218|NCT00699608|11541023|FG005|NOT COMPLETED|First Intervention||0
10397219|NCT00699608|11541018|FG000|STARTED|First 4-14 Day Washout Period||16
10397220|NCT00699608|11541019|FG001|STARTED|First 4-14 Day Washout Period||15
10397221|NCT00699608|11541020|FG002|STARTED|First 4-14 Day Washout Period||14
10397222|NCT00699608|11541021|FG003|STARTED|First 4-14 Day Washout Period||15
10397223|NCT00699608|11541022|FG004|STARTED|First 4-14 Day Washout Period||14
10397224|NCT00699608|11541023|FG005|STARTED|First 4-14 Day Washout Period||15
10397225|NCT00699608|11541018|FG000|COMPLETED|First 4-14 Day Washout Period||16
10397226|NCT00699608|11541019|FG001|COMPLETED|First 4-14 Day Washout Period||15
10397227|NCT00699608|11541020|FG002|COMPLETED|First 4-14 Day Washout Period||14
10397228|NCT00699608|11541021|FG003|COMPLETED|First 4-14 Day Washout Period||15
10397229|NCT00699608|11541022|FG004|COMPLETED|First 4-14 Day Washout Period||14
10397230|NCT00699608|11541023|FG005|COMPLETED|First 4-14 Day Washout Period||15
10397231|NCT00699608|11541018|FG000|NOT COMPLETED|First 4-14 Day Washout Period||0
10397232|NCT00699608|11541019|FG001|NOT COMPLETED|First 4-14 Day Washout Period||0
10397233|NCT00699608|11541020|FG002|NOT COMPLETED|First 4-14 Day Washout Period||0
10397234|NCT00699608|11541021|FG003|NOT COMPLETED|First 4-14 Day Washout Period||0
10397235|NCT00699608|11541022|FG004|NOT COMPLETED|First 4-14 Day Washout Period||0
10397236|NCT00699608|11541023|FG005|NOT COMPLETED|First 4-14 Day Washout Period||0
10397237|NCT00699608|11541018|FG000|STARTED|Second Intervention||16
10397238|NCT00699608|11541019|FG001|STARTED|Second Intervention||15
10720655|NCT02717754|11884291|FG002|COMPLETED|Overall Study||20
10720656|NCT02717754|11884292|FG003|COMPLETED|Overall Study||0
10720657|NCT02717754|11884293|FG004|COMPLETED|Overall Study||0
10720658|NCT02717754|11884294|FG005|COMPLETED|Overall Study||0
10397239|NCT00699608|11541020|FG002|STARTED|Second Intervention||14
10397240|NCT00699608|11541021|FG003|STARTED|Second Intervention||15
10397241|NCT00699608|11541022|FG004|STARTED|Second Intervention||14
10397242|NCT00699608|11541023|FG005|STARTED|Second Intervention||15
10397243|NCT00699608|11541018|FG000|COMPLETED|Second Intervention||16
10720659|NCT02717754|11884289|FG000|NOT COMPLETED|Overall Study||0
10397244|NCT00699608|11541019|FG001|COMPLETED|Second Intervention||15
10397245|NCT00699608|11541020|FG002|COMPLETED|Second Intervention||13
10397246|NCT00699608|11541021|FG003|COMPLETED|Second Intervention||14
10397247|NCT00699608|11541022|FG004|COMPLETED|Second Intervention||14
10397248|NCT00699608|11541023|FG005|COMPLETED|Second Intervention||15
10397249|NCT00699608|11541018|FG000|NOT COMPLETED|Second Intervention||0
10397250|NCT00699608|11541019|FG001|NOT COMPLETED|Second Intervention||0
10397251|NCT00699608|11541020|FG002|NOT COMPLETED|Second Intervention||1
10397252|NCT00699608|11541021|FG003|NOT COMPLETED|Second Intervention||1
10397253|NCT00699608|11541022|FG004|NOT COMPLETED|Second Intervention||0
10397254|NCT00699608|11541023|FG005|NOT COMPLETED|Second Intervention||0
10397255|NCT00699608|11541018|FG000|STARTED|Second 4-14 Day Washout Period||16
10397256|NCT00699608|11541019|FG001|STARTED|Second 4-14 Day Washout Period||15
10397257|NCT00699608|11541020|FG002|STARTED|Second 4-14 Day Washout Period||13
10397258|NCT00699608|11541021|FG003|STARTED|Second 4-14 Day Washout Period||14
10397259|NCT00699608|11541022|FG004|STARTED|Second 4-14 Day Washout Period||14
10397260|NCT00699608|11541023|FG005|STARTED|Second 4-14 Day Washout Period||15
10397261|NCT00699608|11541018|FG000|COMPLETED|Second 4-14 Day Washout Period||16
10397262|NCT00699608|11541019|FG001|COMPLETED|Second 4-14 Day Washout Period||15
10397263|NCT00699608|11541020|FG002|COMPLETED|Second 4-14 Day Washout Period||13
10397264|NCT00699608|11541021|FG003|COMPLETED|Second 4-14 Day Washout Period||14
10397265|NCT00699608|11541022|FG004|COMPLETED|Second 4-14 Day Washout Period||14
10397266|NCT00699608|11541023|FG005|COMPLETED|Second 4-14 Day Washout Period||15
10397267|NCT00699608|11541018|FG000|NOT COMPLETED|Second 4-14 Day Washout Period||0
10397268|NCT00699608|11541019|FG001|NOT COMPLETED|Second 4-14 Day Washout Period||0
10397269|NCT00699608|11541020|FG002|NOT COMPLETED|Second 4-14 Day Washout Period||0
10397270|NCT00699608|11541021|FG003|NOT COMPLETED|Second 4-14 Day Washout Period||0
10397271|NCT00699608|11541022|FG004|NOT COMPLETED|Second 4-14 Day Washout Period||0
10397272|NCT00699608|11541023|FG005|NOT COMPLETED|Second 4-14 Day Washout Period||0
10397273|NCT00699608|11541018|FG000|STARTED|Third Intervention||16
10397274|NCT00699608|11541019|FG001|STARTED|Third Intervention||15
10397275|NCT00699608|11541020|FG002|STARTED|Third Intervention||13
10397276|NCT00699608|11541021|FG003|STARTED|Third Intervention||14
10397277|NCT00699608|11541022|FG004|STARTED|Third Intervention||14
10397278|NCT00699608|11541023|FG005|STARTED|Third Intervention||15
10397279|NCT00699608|11541018|FG000|COMPLETED|Third Intervention||16
10397280|NCT00699608|11541019|FG001|COMPLETED|Third Intervention||15
10397281|NCT00699608|11541020|FG002|COMPLETED|Third Intervention||13
10397282|NCT00699608|11541021|FG003|COMPLETED|Third Intervention||14
10311015|NCT00128102|11444193|FG001|NOT COMPLETED|Overall Study||332
10311016|NCT00128180|11444201|FG000|STARTED|Overall Study||32
10311017|NCT00128180|11444202|FG001|STARTED|Overall Study||34
10311018|NCT00128180|11444201|FG000|COMPLETED|Overall Study||32
10311019|NCT00128180|11444202|FG001|COMPLETED|Overall Study||34
10311020|NCT00128180|11444201|FG000|NOT COMPLETED|Overall Study||0
10311021|NCT00128180|11444202|FG001|NOT COMPLETED|Overall Study||0
10311022|NCT00128193|11444220|FG000|STARTED|Overall Study||5
10311023|NCT00128193|11444221|FG001|STARTED|Overall Study||5
10311024|NCT00128193|11444222|FG002|STARTED|Overall Study||45
10311025|NCT00128193|11444223|FG003|STARTED|Overall Study||45
10311026|NCT00128193|11444224|FG004|STARTED|Overall Study||20
10311027|NCT00128193|11444225|FG005|STARTED|Overall Study||20
10311028|NCT00128193|11444226|FG006|STARTED|Overall Study||20
10311029|NCT00128193|11444227|FG007|STARTED|Overall Study||20
10311030|NCT00128193|11444228|FG008|STARTED|Overall Study||20
10311031|NCT00128193|11444229|FG009|STARTED|Overall Study||20
10397283|NCT00699608|11541022|FG004|COMPLETED|Third Intervention||14
10397284|NCT00699608|11541023|FG005|COMPLETED|Third Intervention||15
10397285|NCT00699608|11541018|FG000|NOT COMPLETED|Third Intervention||0
10397286|NCT00699608|11541019|FG001|NOT COMPLETED|Third Intervention||0
10397287|NCT00699608|11541020|FG002|NOT COMPLETED|Third Intervention||0
10397288|NCT00699608|11541021|FG003|NOT COMPLETED|Third Intervention||0
10397289|NCT00699608|11541022|FG004|NOT COMPLETED|Third Intervention||0
10397290|NCT00699608|11541023|FG005|NOT COMPLETED|Third Intervention||0
10397291|NCT00699660|11541033|FG000|STARTED|Overall Study||190
10397292|NCT00699660|11541034|FG001|STARTED|Overall Study||216
10397293|NCT00699660|11541033|FG000|COMPLETED|Overall Study||176
10397294|NCT00699660|11541034|FG001|COMPLETED|Overall Study||208
10397295|NCT00699660|11541033|FG000|NOT COMPLETED|Overall Study||14
10397296|NCT00699660|11541034|FG001|NOT COMPLETED|Overall Study||8
10397297|NCT00699699|11541040|FG000|STARTED|Overall Study||1280
10397298|NCT00699699|11541040|FG000|COMPLETED|Overall Study||1223
10397299|NCT00699699|11541040|FG000|NOT COMPLETED|Overall Study||57
10397300|NCT00699751|11541046|FG000|STARTED|Period 1: Without/Before Drug Switch||614
10397301|NCT00699751|11541047|FG001|STARTED|Period 1: Without/Before Drug Switch||307
10397302|NCT00699751|11541046|FG000|Participants Received Treatment|Period 1: Without/Before Drug Switch||600
10397303|NCT00699751|11541047|FG001|Participants Received Treatment|Period 1: Without/Before Drug Switch||301
10397304|NCT00699751|11541046|FG000|Entered 3-Year Follow-up Period|Period 1: Without/Before Drug Switch|Participants were not required to complete all 6 injections to enter to 3-year follow-up period.|407
10397305|NCT00699751|11541047|FG001|Entered 3-Year Follow-up Period|Period 1: Without/Before Drug Switch|Participants were not required to complete all 6 injections to enter to 3-year follow-up period.|168
10397306|NCT00699751|11541046|FG000|Completed 3-Year Follow-up Period|Period 1: Without/Before Drug Switch||49
10397307|NCT00699751|11541047|FG001|Completed 3-Year Follow-up Period|Period 1: Without/Before Drug Switch||12
10397308|NCT00699751|11541046|FG000|COMPLETED|Period 1: Without/Before Drug Switch|Completed all 6 injections|389
10397309|NCT00699751|11541047|FG001|COMPLETED|Period 1: Without/Before Drug Switch|Completed all 6 injections|145
10397310|NCT00699751|11541046|FG000|NOT COMPLETED|Period 1: Without/Before Drug Switch||225
10397311|NCT00699751|11541047|FG001|NOT COMPLETED|Period 1: Without/Before Drug Switch||162
10397312|NCT00699751|11541046|FG000|STARTED|Period 2:Switched From Placebo to Xofigo||0
10397313|NCT00699751|11541047|FG001|STARTED|Period 2:Switched From Placebo to Xofigo|Participants in the placebo group switched to Xofigo treatment|26
10311032|NCT00128193|11444230|FG010|STARTED|Overall Study||20
10397314|NCT00699751|11541046|FG000|Participants Received Treatment|Period 2:Switched From Placebo to Xofigo||0
10397315|NCT00699751|11541047|FG001|Participants Received Treatment|Period 2:Switched From Placebo to Xofigo||24
10311033|NCT00128193|11444231|FG011|STARTED|Overall Study||20
10311034|NCT00128193|11444220|FG000|COMPLETED|Overall Study||5
10311035|NCT00128193|11444221|FG001|COMPLETED|Overall Study||5
10311036|NCT00128193|11444222|FG002|COMPLETED|Overall Study||42
10720660|NCT02717754|11884290|FG001|NOT COMPLETED|Overall Study||0
10720661|NCT02717754|11884291|FG002|NOT COMPLETED|Overall Study||0
10720662|NCT02717754|11884292|FG003|NOT COMPLETED|Overall Study||10
10720663|NCT02717754|11884293|FG004|NOT COMPLETED|Overall Study||20
10397316|NCT00699751|11541046|FG000|Entered 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
10397317|NCT00699751|11541047|FG001|Entered 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||15
10397318|NCT00699751|11541046|FG000|Completed 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
10397319|NCT00699751|11541047|FG001|Completed 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
10397320|NCT00699751|11541046|FG000|COMPLETED|Period 2:Switched From Placebo to Xofigo||0
10397321|NCT00699751|11541047|FG001|COMPLETED|Period 2:Switched From Placebo to Xofigo|Completed all 6 injections|17
10397322|NCT00699751|11541046|FG000|NOT COMPLETED|Period 2:Switched From Placebo to Xofigo||0
10397323|NCT00699751|11541047|FG001|NOT COMPLETED|Period 2:Switched From Placebo to Xofigo||9
10397324|NCT00699803|11541056|FG000|STARTED|Overall Study||32
10397325|NCT00699803|11541057|FG001|STARTED|Overall Study||32
10397326|NCT00699803|11541056|FG000|COMPLETED|Overall Study||30
10397327|NCT00699803|11541057|FG001|COMPLETED|Overall Study||26
10397328|NCT00699803|11541056|FG000|NOT COMPLETED|Overall Study||2
10397329|NCT00699803|11541057|FG001|NOT COMPLETED|Overall Study||6
10397330|NCT00699816|11541065|FG000|STARTED|Overall Study||115
10397331|NCT00699816|11541066|FG001|STARTED|Overall Study||115
10397332|NCT00699816|11541065|FG000|COMPLETED|Overall Study||114
10397333|NCT00699816|11541066|FG001|COMPLETED|Overall Study||112
10397334|NCT00699816|11541065|FG000|NOT COMPLETED|Overall Study||1
10720664|NCT02717754|11884294|FG005|NOT COMPLETED|Overall Study||20
10397335|NCT00699816|11541066|FG001|NOT COMPLETED|Overall Study||3
10397336|NCT00699907|11541075|FG000|STARTED|Overall Study||14
10397337|NCT00699907|11541076|FG001|STARTED|Overall Study||57
10397338|NCT00699907|11541077|FG002|STARTED|Overall Study||56
10397339|NCT00699907|11541075|FG000|COMPLETED|Overall Study||12
10397340|NCT00699907|11541076|FG001|COMPLETED|Overall Study||47
10397341|NCT00699907|11541077|FG002|COMPLETED|Overall Study||48
10397342|NCT00699907|11541075|FG000|NOT COMPLETED|Overall Study||2
10397343|NCT00699907|11541076|FG001|NOT COMPLETED|Overall Study||10
10397344|NCT00699907|11541077|FG002|NOT COMPLETED|Overall Study||8
10397345|NCT00699972|11541088|FG000|STARTED|Overall Study||122
10397346|NCT00699972|11541089|FG001|STARTED|Overall Study||133
10397347|NCT00699972|11541090|FG002|STARTED|Overall Study||135
10397348|NCT00699972|11541088|FG000|COMPLETED|Overall Study||106
10397349|NCT00699972|11541089|FG001|COMPLETED|Overall Study||114
10397350|NCT00699972|11541090|FG002|COMPLETED|Overall Study||100
10397351|NCT00699972|11541088|FG000|NOT COMPLETED|Overall Study||16
10397352|NCT00699972|11541089|FG001|NOT COMPLETED|Overall Study||19
10397353|NCT00699972|11541090|FG002|NOT COMPLETED|Overall Study||35
10397354|NCT00699998|11541102|FG000|STARTED|Overall Study||3620
10397355|NCT00699998|11541103|FG001|STARTED|Overall Study||1043
10397356|NCT00699998|11541104|FG002|STARTED|Overall Study||3623
10397357|NCT00699998|11541105|FG003|STARTED|Overall Study||1040
10397358|NCT00699998|11541102|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3590
10397359|NCT00699998|11541103|FG001|Received at Least 1 Dose of Study Drug|Overall Study||1033
10397360|NCT00699998|11541104|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3590
10397361|NCT00699998|11541105|FG003|Received at Least 1 Dose of Study Drug|Overall Study||1027
10397362|NCT00699998|11541102|FG000|COMPLETED|Overall Study||3421
10397363|NCT00699998|11541103|FG001|COMPLETED|Overall Study||957
10397364|NCT00699998|11541104|FG002|COMPLETED|Overall Study||3417
10397365|NCT00699998|11541105|FG003|COMPLETED|Overall Study||958
10397366|NCT00699998|11541102|FG000|NOT COMPLETED|Overall Study||199
10397367|NCT00699998|11541103|FG001|NOT COMPLETED|Overall Study||86
10397368|NCT00699998|11541104|FG002|NOT COMPLETED|Overall Study||206
10397369|NCT00699998|11541105|FG003|NOT COMPLETED|Overall Study||82
10397370|NCT00700011|11541122|FG000|STARTED|Overall Study||8
10397371|NCT00700011|11541123|FG001|STARTED|Overall Study||2
10397372|NCT00700011|11541122|FG000|COMPLETED|Overall Study||8
10397373|NCT00700011|11541123|FG001|COMPLETED|Overall Study||1
10397374|NCT00700011|11541122|FG000|NOT COMPLETED|Overall Study||0
10397375|NCT00700011|11541123|FG001|NOT COMPLETED|Overall Study||1
10397376|NCT00700063|11541137|FG000|STARTED|Overall Study||33
10397377|NCT00700063|11541138|FG001|STARTED|Overall Study||34
10397378|NCT00700063|11541139|FG002|STARTED|Overall Study||33
10397379|NCT00700063|11541140|FG003|STARTED|Overall Study||33
10397380|NCT00700063|11541141|FG004|STARTED|Overall Study||33
10397381|NCT00700063|11541142|FG005|STARTED|Overall Study||34
10397382|NCT00700063|11541143|FG006|STARTED|Overall Study||32
10397383|NCT00700063|11541144|FG007|STARTED|Overall Study||33
10397384|NCT00700063|11541137|FG000|COMPLETED|Overall Study||32
10397385|NCT00700063|11541138|FG001|COMPLETED|Overall Study||34
10397386|NCT00700063|11541139|FG002|COMPLETED|Overall Study||33
10397387|NCT00700063|11541140|FG003|COMPLETED|Overall Study||31
10397388|NCT00700063|11541141|FG004|COMPLETED|Overall Study||31
10397389|NCT00700063|11541142|FG005|COMPLETED|Overall Study||34
10397390|NCT00700063|11541143|FG006|COMPLETED|Overall Study||32
10397391|NCT00700063|11541144|FG007|COMPLETED|Overall Study||33
10397392|NCT00700063|11541137|FG000|NOT COMPLETED|Overall Study||1
10397393|NCT00700063|11541138|FG001|NOT COMPLETED|Overall Study||0
10397394|NCT00700063|11541139|FG002|NOT COMPLETED|Overall Study||0
10397395|NCT00700063|11541140|FG003|NOT COMPLETED|Overall Study||2
10397396|NCT00700063|11541141|FG004|NOT COMPLETED|Overall Study||2
10397397|NCT00700063|11541142|FG005|NOT COMPLETED|Overall Study||0
10397398|NCT00700063|11541143|FG006|NOT COMPLETED|Overall Study||0
10397399|NCT00700063|11541144|FG007|NOT COMPLETED|Overall Study||0
10397400|NCT00700102|11541164|FG000|STARTED|Overall Study||411
10397401|NCT00700102|11541165|FG001|STARTED|Overall Study||409
10397402|NCT00700102|11541164|FG000|Intention to Treat|Overall Study||410
10397403|NCT00700102|11541165|FG001|Intention to Treat|Overall Study||409
10397404|NCT00700102|11541164|FG000|Received at Least One Dose|Overall Study||407
10397405|NCT00700102|11541165|FG001|Received at Least One Dose|Overall Study||403
10397406|NCT00700102|11541164|FG000|COMPLETED|Overall Study||9
10397407|NCT00700102|11541165|FG001|COMPLETED|Overall Study||14
10311037|NCT00128193|11444223|FG003|COMPLETED|Overall Study||44
10311038|NCT00128193|11444224|FG004|COMPLETED|Overall Study||18
10311039|NCT00128193|11444225|FG005|COMPLETED|Overall Study||17
10311040|NCT00128193|11444226|FG006|COMPLETED|Overall Study||16
10311041|NCT00128193|11444227|FG007|COMPLETED|Overall Study||20
10311042|NCT00128193|11444228|FG008|COMPLETED|Overall Study||18
10311043|NCT00128193|11444229|FG009|COMPLETED|Overall Study||18
10311044|NCT00128193|11444230|FG010|COMPLETED|Overall Study||17
10311045|NCT00128193|11444231|FG011|COMPLETED|Overall Study||18
10311046|NCT00128193|11444220|FG000|NOT COMPLETED|Overall Study||0
10311047|NCT00128193|11444221|FG001|NOT COMPLETED|Overall Study||0
10311048|NCT00128193|11444222|FG002|NOT COMPLETED|Overall Study||3
10311049|NCT00128193|11444223|FG003|NOT COMPLETED|Overall Study||1
10311050|NCT00128193|11444224|FG004|NOT COMPLETED|Overall Study||2
10311051|NCT00128193|11444225|FG005|NOT COMPLETED|Overall Study||3
10311052|NCT00128193|11444226|FG006|NOT COMPLETED|Overall Study||4
10311053|NCT00128193|11444227|FG007|NOT COMPLETED|Overall Study||0
10311054|NCT00128193|11444228|FG008|NOT COMPLETED|Overall Study||2
10311055|NCT00128193|11444229|FG009|NOT COMPLETED|Overall Study||2
10720674|NCT02718131|11884319|FG000|STARTED|Overall Study||5
10720675|NCT02718131|11884320|FG001|STARTED|Overall Study||0
10720676|NCT02718131|11884319|FG000|Completed 12 Months|Overall Study||2
10720677|NCT02718131|11884320|FG001|Completed 12 Months|Overall Study||0
10397408|NCT00700102|11541164|FG000|NOT COMPLETED|Overall Study||402
10397409|NCT00700102|11541165|FG001|NOT COMPLETED|Overall Study||395
10720678|NCT02718131|11884319|FG000|COMPLETED|Overall Study||2
10397410|NCT00700115|11541173|FG000|STARTED|Overall Study||40
10397411|NCT00700115|11541174|FG001|STARTED|Overall Study||20
10397412|NCT00700115|11541173|FG000|COMPLETED|Overall Study||39
10397413|NCT00700115|11541174|FG001|COMPLETED|Overall Study||19
10397414|NCT00700115|11541173|FG000|NOT COMPLETED|Overall Study||1
10397415|NCT00700115|11541174|FG001|NOT COMPLETED|Overall Study||1
10397416|NCT00700141|11541180|FG000|STARTED|Overall Study||482
10397417|NCT00700141|11541180|FG000|COMPLETED|Overall Study||482
10397418|NCT00700141|11541180|FG000|NOT COMPLETED|Overall Study||0
10397419|NCT00700180|11541186|FG000|STARTED|Overall Study||154
10397420|NCT00700180|11541187|FG001|STARTED|Overall Study||149
10397421|NCT00700180|11541186|FG000|COMPLETED|Overall Study|Clinical cutoff date: July 11, 2011|0
10397422|NCT00700180|11541187|FG001|COMPLETED|Overall Study|Clinical cutoff date: July 11, 2011|0
10397423|NCT00700180|11541186|FG000|NOT COMPLETED|Overall Study||154
10397424|NCT00700180|11541187|FG001|NOT COMPLETED|Overall Study||149
10397425|NCT00700271|11541195|FG000|STARTED|Overall Study||278
10397426|NCT00700271|11541196|FG001|STARTED|Overall Study||268
10397427|NCT00700271|11541195|FG000|COMPLETED|Overall Study||264
10397428|NCT00700271|11541196|FG001|COMPLETED|Overall Study||256
10397429|NCT00700271|11541195|FG000|NOT COMPLETED|Overall Study||14
10397430|NCT00700271|11541196|FG001|NOT COMPLETED|Overall Study||12
10397431|NCT00700310|11541206|FG000|STARTED|Overall Study||187
10397432|NCT00700310|11541207|FG001|STARTED|Overall Study||180
10397433|NCT00700310|11541208|FG002|STARTED|Overall Study||174
10397434|NCT00700310|11541209|FG003|STARTED|Overall Study||171
10397435|NCT00700310|11541206|FG000|COMPLETED|Overall Study||166
10397436|NCT00700310|11541207|FG001|COMPLETED|Overall Study||154
10397437|NCT00700310|11541208|FG002|COMPLETED|Overall Study||158
10397438|NCT00700310|11541209|FG003|COMPLETED|Overall Study||145
10397439|NCT00700310|11541206|FG000|NOT COMPLETED|Overall Study||21
10397440|NCT00700310|11541207|FG001|NOT COMPLETED|Overall Study||26
10397441|NCT00700310|11541208|FG002|NOT COMPLETED|Overall Study||16
10397442|NCT00700310|11541209|FG003|NOT COMPLETED|Overall Study||26
10397443|NCT00700336|11541222|FG000|STARTED|Overall Study||40
10397444|NCT00700336|11541223|FG001|STARTED|Overall Study||23
10397445|NCT00700336|11541224|FG002|STARTED|Overall Study||6
10397446|NCT00700336|11541222|FG000|COMPLETED|Overall Study||40
10397447|NCT00700336|11541223|FG001|COMPLETED|Overall Study||23
10397448|NCT00700336|11541224|FG002|COMPLETED|Overall Study||6
10397449|NCT00700336|11541222|FG000|NOT COMPLETED|Overall Study||0
10397450|NCT00700336|11541223|FG001|NOT COMPLETED|Overall Study||0
10397451|NCT00700336|11541224|FG002|NOT COMPLETED|Overall Study||0
10397452|NCT00700375|11541233|FG000|STARTED|Overall Study||30
10397453|NCT00700375|11541234|FG001|STARTED|Overall Study||29
10397454|NCT00700375|11541233|FG000|2 Days After Creatinine Mesurement|Overall Study||30
10397455|NCT00700375|11541234|FG001|2 Days After Creatinine Mesurement|Overall Study||29
10397456|NCT00700375|11541233|FG000|COMPLETED|Overall Study||30
10397457|NCT00700375|11541234|FG001|COMPLETED|Overall Study||29
10397458|NCT00700375|11541233|FG000|NOT COMPLETED|Overall Study||0
10397459|NCT00700375|11541234|FG001|NOT COMPLETED|Overall Study||0
10397460|NCT00700401|11541240|FG000|STARTED|Overall Study||262
10397461|NCT00700401|11541240|FG000|COMPLETED|Overall Study||168
10397462|NCT00700401|11541240|FG000|NOT COMPLETED|Overall Study||94
10397463|NCT00700427|11541244|FG000|STARTED|Study Period 2 (Open-Label Acute Trx)||2017
10397464|NCT00700427|11541245|FG001|STARTED|Study Period 2 (Open-Label Acute Trx)||0
10397465|NCT00700427|11541246|FG002|STARTED|Study Period 2 (Open-Label Acute Trx)||0
10397466|NCT00700427|11541247|FG003|STARTED|Study Period 2 (Open-Label Acute Trx)||0
10397467|NCT00700427|11541248|FG004|STARTED|Study Period 2 (Open-Label Acute Trx)||0
10397468|NCT00700427|11541244|FG000|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||2011
10397469|NCT00700427|11541245|FG001|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
10397470|NCT00700427|11541246|FG002|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
10397471|NCT00700427|11541247|FG003|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
10397472|NCT00700427|11541248|FG004|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
10397473|NCT00700427|11541244|FG000|COMPLETED|Study Period 2 (Open-Label Acute Trx)|One participant was mistakenly recorded as completed. The reason for discontinuation is unknown.|1006
10397474|NCT00700427|11541245|FG001|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
10397475|NCT00700427|11541246|FG002|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
10397476|NCT00700427|11541247|FG003|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
10397477|NCT00700427|11541248|FG004|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
10397478|NCT00700427|11541244|FG000|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||1011
10397479|NCT00700427|11541245|FG001|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
10397480|NCT00700427|11541246|FG002|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
10397481|NCT00700427|11541247|FG003|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
10397482|NCT00700427|11541248|FG004|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
10397483|NCT00700427|11541244|FG000|STARTED|Study Period 3A (Blinded Maintenance)||0
10397484|NCT00700427|11541245|FG001|STARTED|Study Period 3A (Blinded Maintenance)||1005
10397485|NCT00700427|11541246|FG002|STARTED|Study Period 3A (Blinded Maintenance)||0
10397486|NCT00700427|11541247|FG003|STARTED|Study Period 3A (Blinded Maintenance)||0
10397487|NCT00700427|11541248|FG004|STARTED|Study Period 3A (Blinded Maintenance)||0
10397488|NCT00700427|11541244|FG000|COMPLETED|Study Period 3A (Blinded Maintenance)||0
10397489|NCT00700427|11541245|FG001|COMPLETED|Study Period 3A (Blinded Maintenance)||524
10397490|NCT00700427|11541246|FG002|COMPLETED|Study Period 3A (Blinded Maintenance)||0
10397491|NCT00700427|11541247|FG003|COMPLETED|Study Period 3A (Blinded Maintenance)||0
10397492|NCT00700427|11541248|FG004|COMPLETED|Study Period 3A (Blinded Maintenance)||0
10397493|NCT00700427|11541244|FG000|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
10397494|NCT00700427|11541245|FG001|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||481
10397495|NCT00700427|11541246|FG002|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
10397496|NCT00700427|11541247|FG003|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
10397497|NCT00700427|11541248|FG004|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
10543707|NCT01485172|11696854|FG004|COMPLETED|Overall Study||34
10543708|NCT01485172|11696855|FG005|COMPLETED|Overall Study||9
10543709|NCT01485172|11696850|FG000|NOT COMPLETED|Overall Study||7
10543710|NCT01485172|11696851|FG001|NOT COMPLETED|Overall Study||1
10543711|NCT01485172|11696852|FG002|NOT COMPLETED|Overall Study||7
10543712|NCT01485172|11696853|FG003|NOT COMPLETED|Overall Study||8
10659048|NCT02238379|11820301|FG000|NOT COMPLETED|Overall Study||1
10659049|NCT02238379|11820302|FG001|NOT COMPLETED|Overall Study||0
10659050|NCT02238483|11820310|FG000|STARTED|Overall Study||108
10311056|NCT00128193|11444230|FG010|NOT COMPLETED|Overall Study||3
10311057|NCT00128193|11444231|FG011|NOT COMPLETED|Overall Study||2
10311058|NCT00128206|11444313|FG000|STARTED|Overall Study||184
10311059|NCT00128206|11444314|FG001|STARTED|Overall Study||180
10311060|NCT00128206|11444313|FG000|COMPLETED|Overall Study||47
10311061|NCT00128206|11444314|FG001|COMPLETED|Overall Study||60
10311062|NCT00128206|11444313|FG000|NOT COMPLETED|Overall Study||137
10311063|NCT00128206|11444314|FG001|NOT COMPLETED|Overall Study||120
10311064|NCT00128219|11444322|FG000|STARTED|Overall Study||333
10311065|NCT00128219|11444323|FG001|STARTED|Overall Study||334
10311066|NCT00128219|11444322|FG000|COMPLETED|Overall Study||264
10311067|NCT00128219|11444323|FG001|COMPLETED|Overall Study||263
10311068|NCT00128219|11444322|FG000|NOT COMPLETED|Overall Study||69
10311069|NCT00128219|11444323|FG001|NOT COMPLETED|Overall Study||71
10311070|NCT00128401|11444331|FG000|STARTED|Overall Study||20
10311071|NCT00128401|11444332|FG001|STARTED|Overall Study||19
10311072|NCT00128401|11444331|FG000|COMPLETED|Overall Study||14
10311073|NCT00128401|11444332|FG001|COMPLETED|Overall Study||15
10311074|NCT00128401|11444331|FG000|NOT COMPLETED|Overall Study||6
10311075|NCT00128401|11444332|FG001|NOT COMPLETED|Overall Study||4
10311076|NCT00128492|11444341|FG000|STARTED|Overall Study||85
10311077|NCT00128492|11444342|FG001|STARTED|Overall Study||189
10311078|NCT00128492|11444341|FG000|COMPLETED|Overall Study||65
10311079|NCT00128492|11444342|FG001|COMPLETED|Overall Study||130
10311080|NCT00128492|11444341|FG000|NOT COMPLETED|Overall Study||20
10311081|NCT00128492|11444342|FG001|NOT COMPLETED|Overall Study||59
10311082|NCT00128661|11444350|FG000|STARTED|Overall Study||3727
10311083|NCT00128661|11444351|FG001|STARTED|Overall Study||3739
10311084|NCT00128661|11444350|FG000|COMPLETED|Overall Study||3453
10311085|NCT00128661|11444351|FG001|COMPLETED|Overall Study||3481
10311086|NCT00128661|11444350|FG000|NOT COMPLETED|Overall Study||274
10311087|NCT00128661|11444351|FG001|NOT COMPLETED|Overall Study||258
10311088|NCT00128713|11444360|FG000|STARTED|Overall Study||453
10311089|NCT00128713|11444361|FG001|STARTED|Overall Study||449
10311090|NCT00128713|11444362|FG002|STARTED|Overall Study||449
10311091|NCT00128713|11444360|FG000|COMPLETED|Overall Study||453
10311092|NCT00128713|11444361|FG001|COMPLETED|Overall Study||449
10311093|NCT00128713|11444362|FG002|COMPLETED|Overall Study||449
10311094|NCT00128713|11444360|FG000|NOT COMPLETED|Overall Study||0
10311095|NCT00128713|11444361|FG001|NOT COMPLETED|Overall Study||0
10311096|NCT00128713|11444362|FG002|NOT COMPLETED|Overall Study||0
10397498|NCT00700427|11541244|FG000|STARTED|Study Period 3B (Randomized Withdrawal)||0
10397499|NCT00700427|11541245|FG001|STARTED|Study Period 3B (Randomized Withdrawal)||0
10397500|NCT00700427|11541246|FG002|STARTED|Study Period 3B (Randomized Withdrawal)||266
10397501|NCT00700427|11541247|FG003|STARTED|Study Period 3B (Randomized Withdrawal)||258
10397502|NCT00700427|11541248|FG004|STARTED|Study Period 3B (Randomized Withdrawal)||0
10397503|NCT00700427|11541244|FG000|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
10659051|NCT02238483|11820311|FG001|STARTED|Overall Study||105
10659052|NCT02238483|11820310|FG000|COMPLETED|Overall Study||93
10659053|NCT02238483|11820311|FG001|COMPLETED|Overall Study||91
10659054|NCT02238483|11820310|FG000|NOT COMPLETED|Overall Study||15
10659055|NCT02238483|11820311|FG001|NOT COMPLETED|Overall Study||14
10659056|NCT02238626|11820321|FG000|STARTED|Overall Study||17
10659057|NCT02238626|11820322|FG001|STARTED|Overall Study||34
10659058|NCT02238626|11820323|FG002|STARTED|Overall Study||8
10659059|NCT02238626|11820324|FG003|STARTED|Overall Study||11
10659060|NCT02238626|11820321|FG000|COMPLETED|Overall Study||12
10659061|NCT02238626|11820322|FG001|COMPLETED|Overall Study||20
10659062|NCT02238626|11820323|FG002|COMPLETED|Overall Study||5
10659063|NCT02238626|11820324|FG003|COMPLETED|Overall Study||4
10659064|NCT02238626|11820321|FG000|NOT COMPLETED|Overall Study||5
10720679|NCT02718131|11884320|FG001|COMPLETED|Overall Study||0
10720680|NCT02718131|11884319|FG000|NOT COMPLETED|Overall Study||3
10720681|NCT02718131|11884320|FG001|NOT COMPLETED|Overall Study||0
10720682|NCT02718157|11884328|FG000|STARTED|Overall Study||771
10720683|NCT02718157|11884328|FG000|COMPLETED|Overall Study||609
10720684|NCT02718157|11884328|FG000|NOT COMPLETED|Overall Study||162
10311097|NCT00128830|11444370|FG000|STARTED|Overall Study||211
10311098|NCT00128830|11444370|FG000|COMPLETED|Overall Study||139
10311099|NCT00128830|11444370|FG000|NOT COMPLETED|Overall Study||72
10311100|NCT00128921|11444379|FG000|STARTED|Overall Study||10
10311101|NCT00128921|11444380|FG001|STARTED|Overall Study||8
10311102|NCT00128921|11444381|FG002|STARTED|Overall Study||0
10397504|NCT00700427|11541245|FG001|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
10659065|NCT02238626|11820322|FG001|NOT COMPLETED|Overall Study||14
10659066|NCT02238626|11820323|FG002|NOT COMPLETED|Overall Study||3
10720685|NCT02718248|11884332|FG000|STARTED|Overall Study||7
10659067|NCT02238626|11820324|FG003|NOT COMPLETED|Overall Study||7
10659068|NCT02238782|11820345|FG000|STARTED|Overall Study||12
10720686|NCT02718248|11884332|FG000|COMPLETED|Overall Study||7
10720687|NCT02718248|11884332|FG000|NOT COMPLETED|Overall Study||0
10720688|NCT02718326|11884339|FG000|STARTED|Overall Study||133
10720689|NCT02718326|11884340|FG001|STARTED|Overall Study||135
10720690|NCT02718326|11884341|FG002|STARTED|Overall Study||134
10720691|NCT02718326|11884339|FG000|Completed Week 52|Overall Study||109
10720692|NCT02718326|11884340|FG001|Completed Week 52|Overall Study||122
10720693|NCT02718326|11884341|FG002|Completed Week 52|Overall Study||124
10813613|NCT02720510|11976014|FG001|STARTED|Overall Study||3
10813614|NCT02720510|11976013|FG000|COMPLETED|Overall Study||0
10813615|NCT02720510|11976014|FG001|COMPLETED|Overall Study||0
10813616|NCT02720510|11976013|FG000|NOT COMPLETED|Overall Study||3
10813617|NCT02720510|11976014|FG001|NOT COMPLETED|Overall Study||3
10813618|NCT02715765|11976023|FG000|STARTED|Overall Study||3
10720694|NCT02718326|11884339|FG000|COMPLETED|Overall Study||97
10720695|NCT02718326|11884340|FG001|COMPLETED|Overall Study||111
10720696|NCT02718326|11884341|FG002|COMPLETED|Overall Study||112
10397505|NCT00700427|11541246|FG002|COMPLETED|Study Period 3B (Randomized Withdrawal)||184
10397506|NCT00700427|11541247|FG003|COMPLETED|Study Period 3B (Randomized Withdrawal)||165
10397507|NCT00700427|11541248|FG004|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
10397508|NCT00700427|11541244|FG000|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
10397509|NCT00700427|11541245|FG001|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
10397510|NCT00700427|11541246|FG002|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||82
10397511|NCT00700427|11541247|FG003|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||93
10720697|NCT02718326|11884339|FG000|NOT COMPLETED|Overall Study||36
10720698|NCT02718326|11884340|FG001|NOT COMPLETED|Overall Study||24
10720699|NCT02718326|11884341|FG002|NOT COMPLETED|Overall Study||22
10777346|NCT03339453|11939315|FG001|STARTED|Second Visit for Alternate Glucagon||34
10777347|NCT03339453|11939314|FG000|COMPLETED|Second Visit for Alternate Glucagon||35
10777348|NCT03339453|11939315|FG001|COMPLETED|Second Visit for Alternate Glucagon||34
10777349|NCT03339453|11939314|FG000|NOT COMPLETED|Second Visit for Alternate Glucagon||0
10777350|NCT03339453|11939315|FG001|NOT COMPLETED|Second Visit for Alternate Glucagon||0
10777351|NCT03339570|11939321|FG000|STARTED|Overall Study||20
10777352|NCT03339570|11939321|FG000|COMPLETED|Overall Study||16
10777353|NCT03339570|11939321|FG000|NOT COMPLETED|Overall Study||4
10397512|NCT00700427|11541248|FG004|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
10397513|NCT00700427|11541244|FG000|STARTED|Study Period 4 (Open-Label Extension)||0
10397514|NCT00700427|11541245|FG001|STARTED|Study Period 4 (Open-Label Extension)||0
10397515|NCT00700427|11541246|FG002|STARTED|Study Period 4 (Open-Label Extension)||0
10397516|NCT00700427|11541247|FG003|STARTED|Study Period 4 (Open-Label Extension)||0
10397517|NCT00700427|11541248|FG004|STARTED|Study Period 4 (Open-Label Extension)||180
10397518|NCT00700427|11541244|FG000|COMPLETED|Study Period 4 (Open-Label Extension)||0
10397519|NCT00700427|11541245|FG001|COMPLETED|Study Period 4 (Open-Label Extension)||0
10397520|NCT00700427|11541246|FG002|COMPLETED|Study Period 4 (Open-Label Extension)||0
10397521|NCT00700427|11541247|FG003|COMPLETED|Study Period 4 (Open-Label Extension)||0
10777354|NCT03339583|11939336|FG000|STARTED|First Intervention (14 Days)||19
10777355|NCT03339583|11939337|FG001|STARTED|First Intervention (14 Days)||23
10813619|NCT02715765|11976024|FG001|STARTED|Overall Study||0
10813620|NCT02715765|11976025|FG002|STARTED|Overall Study||0
10813621|NCT02715765|11976023|FG000|COMPLETED|Overall Study||0
10813622|NCT02715765|11976024|FG001|COMPLETED|Overall Study||0
10813623|NCT02715765|11976025|FG002|COMPLETED|Overall Study||0
10813624|NCT02715765|11976023|FG000|NOT COMPLETED|Overall Study||3
10397522|NCT00700427|11541248|FG004|COMPLETED|Study Period 4 (Open-Label Extension)||96
10397523|NCT00700427|11541244|FG000|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
10397524|NCT00700427|11541245|FG001|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
10397525|NCT00700427|11541246|FG002|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
10397526|NCT00700427|11541247|FG003|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
10659069|NCT02238782|11820345|FG000|Subjects Treated|Overall Study||12
10659070|NCT02238782|11820345|FG000|COMPLETED|Overall Study||12
10659071|NCT02238782|11820345|FG000|NOT COMPLETED|Overall Study||0
10659072|NCT02238847|11820351|FG000|STARTED|Overall Study||59
10659073|NCT02238847|11820352|FG001|STARTED|Overall Study||60
10659074|NCT02238847|11820351|FG000|COMPLETED|Overall Study||37
10659075|NCT02238847|11820352|FG001|COMPLETED|Overall Study||36
10397527|NCT00700427|11541248|FG004|NOT COMPLETED|Study Period 4 (Open-Label Extension)||84
10397528|NCT00700440|11541256|FG000|STARTED|Overall Study||100
10397529|NCT00700440|11541256|FG000|COMPLETED|Overall Study||100
10397530|NCT00700440|11541256|FG000|NOT COMPLETED|Overall Study||0
10397531|NCT00700570|11541262|FG000|STARTED|Overall Study||19
10397532|NCT00700570|11541263|FG001|STARTED|Overall Study||26
10659076|NCT02238847|11820351|FG000|NOT COMPLETED|Overall Study||22
10659077|NCT02238847|11820352|FG001|NOT COMPLETED|Overall Study||24
10659078|NCT02238925|11820358|FG000|STARTED|Overall Study||26
10311103|NCT00128921|11444379|FG000|Received Bortezomib|Overall Study||10
10311104|NCT00128921|11444380|FG001|Received Bortezomib|Overall Study||6
10311105|NCT00128921|11444381|FG002|Received Bortezomib|Overall Study||0
10311106|NCT00128921|11444379|FG000|COMPLETED|Overall Study||5
10311107|NCT00128921|11444380|FG001|COMPLETED|Overall Study||3
10311108|NCT00128921|11444381|FG002|COMPLETED|Overall Study||0
10311109|NCT00128921|11444379|FG000|NOT COMPLETED|Overall Study||5
10311110|NCT00128921|11444380|FG001|NOT COMPLETED|Overall Study||5
10311111|NCT00128921|11444381|FG002|NOT COMPLETED|Overall Study||0
10311112|NCT00129116|11444396|FG000|STARTED|Primary Phase||78
10311113|NCT00129116|11444397|FG001|STARTED|Primary Phase||77
10311114|NCT00129116|11444398|FG002|STARTED|Primary Phase||78
10311115|NCT00129116|11444399|FG003|STARTED|Primary Phase||78
10311116|NCT00129116|11444400|FG004|STARTED|Primary Phase||77
10311117|NCT00129116|11444396|FG000|COMPLETED|Primary Phase||76
10311118|NCT00129116|11444397|FG001|COMPLETED|Primary Phase||73
10311119|NCT00129116|11444398|FG002|COMPLETED|Primary Phase||77
10311120|NCT00129116|11444399|FG003|COMPLETED|Primary Phase||77
10311121|NCT00129116|11444400|FG004|COMPLETED|Primary Phase||76
10311122|NCT00129116|11444396|FG000|NOT COMPLETED|Primary Phase||2
10311123|NCT00129116|11444397|FG001|NOT COMPLETED|Primary Phase||4
10311124|NCT00129116|11444398|FG002|NOT COMPLETED|Primary Phase||1
10720700|NCT02718417|11884354|FG000|STARTED|Chemotherapy Phase (CP)||332
10720701|NCT02718417|11884355|FG001|STARTED|Chemotherapy Phase (CP)||331
10720702|NCT02718417|11884356|FG002|STARTED|Chemotherapy Phase (CP)||335
10720703|NCT02718417|11884354|FG000|Safety Population|Chemotherapy Phase (CP)||328
10720704|NCT02718417|11884355|FG001|Safety Population|Chemotherapy Phase (CP)||329
10720705|NCT02718417|11884356|FG002|Safety Population|Chemotherapy Phase (CP)||334
10720706|NCT02718417|11884354|FG000|COMPLETED|Chemotherapy Phase (CP)||280
10720707|NCT02718417|11884355|FG001|COMPLETED|Chemotherapy Phase (CP)||294
10720708|NCT02718417|11884356|FG002|COMPLETED|Chemotherapy Phase (CP)||289
10311125|NCT00129116|11444399|FG003|NOT COMPLETED|Primary Phase||1
10311126|NCT00129116|11444400|FG004|NOT COMPLETED|Primary Phase||1
10720709|NCT02718417|11884354|FG000|NOT COMPLETED|Chemotherapy Phase (CP)||52
10720710|NCT02718417|11884355|FG001|NOT COMPLETED|Chemotherapy Phase (CP)||37
10720711|NCT02718417|11884356|FG002|NOT COMPLETED|Chemotherapy Phase (CP)||46
10720712|NCT02718417|11884354|FG000|STARTED|Maintenance Phase (MP)|Included participants without evidence of disease progression at the end of Chemotherapy phase.|267
10720713|NCT02718417|11884355|FG001|STARTED|Maintenance Phase (MP)|Included participants without evidence of disease progression at the end of Chemotherapy phase.|288
10720714|NCT02718417|11884356|FG002|STARTED|Maintenance Phase (MP)|After completing CP, participants moved to observation phase. MP was not applicable for this arm.|0
10720715|NCT02718417|11884354|FG000|COMPLETED|Maintenance Phase (MP)||1
10720716|NCT02718417|11884355|FG001|COMPLETED|Maintenance Phase (MP)||1
10720717|NCT02718417|11884356|FG002|COMPLETED|Maintenance Phase (MP)||0
10720718|NCT02718417|11884354|FG000|NOT COMPLETED|Maintenance Phase (MP)||266
10720719|NCT02718417|11884355|FG001|NOT COMPLETED|Maintenance Phase (MP)||287
10720720|NCT02718417|11884356|FG002|NOT COMPLETED|Maintenance Phase (MP)||0
10720721|NCT02718417|11884354|FG000|STARTED|Observation Phase (OP)|After completing MP, participants moved to follow-up phase. OP was not applicable.|0
10720722|NCT02718417|11884355|FG001|STARTED|Observation Phase (OP)|After completing MP, participants moved to follow-up phase. OP was not applicable.|0
10311127|NCT00129116|11444396|FG000|STARTED|Booster Phase||47
10311128|NCT00129116|11444397|FG001|STARTED|Booster Phase||42
10311129|NCT00129116|11444398|FG002|STARTED|Booster Phase||44
10311130|NCT00129116|11444399|FG003|STARTED|Booster Phase||44
10311131|NCT00129116|11444400|FG004|STARTED|Booster Phase||44
10311132|NCT00129116|11444396|FG000|COMPLETED|Booster Phase||45
10311133|NCT00129116|11444397|FG001|COMPLETED|Booster Phase||42
10311134|NCT00129116|11444398|FG002|COMPLETED|Booster Phase||44
10311135|NCT00129116|11444399|FG003|COMPLETED|Booster Phase||44
10311136|NCT00129116|11444400|FG004|COMPLETED|Booster Phase||43
10311137|NCT00129116|11444396|FG000|NOT COMPLETED|Booster Phase||2
10720723|NCT02718417|11884356|FG002|STARTED|Observation Phase (OP)|Included participants without evidence of disease progression at the end of Chemotherapy phase.|284
10720724|NCT02718417|11884354|FG000|COMPLETED|Observation Phase (OP)||0
10720725|NCT02718417|11884355|FG001|COMPLETED|Observation Phase (OP)||0
10397533|NCT00700570|11541262|FG000|COMPLETED|Overall Study||8
10397534|NCT00700570|11541263|FG001|COMPLETED|Overall Study||0
10397535|NCT00700570|11541262|FG000|NOT COMPLETED|Overall Study||11
10397536|NCT00700570|11541263|FG001|NOT COMPLETED|Overall Study||26
10397537|NCT00700622|11541271|FG000|STARTED|Overall Study||65
10397538|NCT00700622|11541272|FG001|STARTED|Overall Study||65
10397539|NCT00700622|11541271|FG000|COMPLETED|Overall Study||52
10397540|NCT00700622|11541272|FG001|COMPLETED|Overall Study||60
10397541|NCT00700622|11541271|FG000|NOT COMPLETED|Overall Study||13
10397542|NCT00700622|11541272|FG001|NOT COMPLETED|Overall Study||5
10397543|NCT00700635|11541281|FG000|STARTED|Overall Study||111
10397544|NCT00700635|11541282|FG001|STARTED|Overall Study||111
10397545|NCT00700635|11541283|FG002|STARTED|Overall Study||111
10397546|NCT00700635|11541281|FG000|COMPLETED|Overall Study||100
10397547|NCT00700635|11541282|FG001|COMPLETED|Overall Study||103
10397548|NCT00700635|11541283|FG002|COMPLETED|Overall Study||110
10397549|NCT00700635|11541281|FG000|NOT COMPLETED|Overall Study||11
10397550|NCT00700635|11541282|FG001|NOT COMPLETED|Overall Study||8
10397551|NCT00700635|11541283|FG002|NOT COMPLETED|Overall Study||1
10397552|NCT00700713|11541294|FG000|STARTED|Overall Study||48
10397553|NCT00700713|11541295|FG001|STARTED|Overall Study||66
10397554|NCT00700713|11541296|FG002|STARTED|Overall Study||67
10397555|NCT00700713|11541294|FG000|COMPLETED|Overall Study||47
10397556|NCT00700713|11541295|FG001|COMPLETED|Overall Study||66
10397557|NCT00700713|11541296|FG002|COMPLETED|Overall Study||65
10397558|NCT00700713|11541294|FG000|NOT COMPLETED|Overall Study||1
10397559|NCT00700713|11541295|FG001|NOT COMPLETED|Overall Study||0
10397560|NCT00700713|11541296|FG002|NOT COMPLETED|Overall Study||2
10397561|NCT00700739|11541306|FG000|STARTED|Overall Study||22
10397562|NCT00700739|11541307|FG001|STARTED|Overall Study||16
10397563|NCT00700739|11541306|FG000|COMPLETED|Overall Study||18
10397564|NCT00700739|11541307|FG001|COMPLETED|Overall Study||12
10397565|NCT00700739|11541306|FG000|NOT COMPLETED|Overall Study||4
10397566|NCT00700739|11541307|FG001|NOT COMPLETED|Overall Study||4
10397567|NCT00700752|11541314|FG000|STARTED|First Intervention||20
10397568|NCT00700752|11541315|FG001|STARTED|First Intervention||20
10397569|NCT00700752|11541314|FG000|COMPLETED|First Intervention||20
10397570|NCT00700752|11541315|FG001|COMPLETED|First Intervention||18
10397571|NCT00700752|11541314|FG000|NOT COMPLETED|First Intervention||0
10397572|NCT00700752|11541315|FG001|NOT COMPLETED|First Intervention||2
10397573|NCT00700752|11541314|FG000|STARTED|Second Intervention||20
10397574|NCT00700752|11541315|FG001|STARTED|Second Intervention||18
10397575|NCT00700752|11541314|FG000|COMPLETED|Second Intervention||20
10397576|NCT00700752|11541315|FG001|COMPLETED|Second Intervention||18
10397577|NCT00700752|11541314|FG000|NOT COMPLETED|Second Intervention||0
10397578|NCT00700752|11541315|FG001|NOT COMPLETED|Second Intervention||0
10397579|NCT00700804|11541323|FG000|STARTED|Overall Study||17
10397580|NCT00700804|11541324|FG001|STARTED|Overall Study||17
10397581|NCT00700804|11541323|FG000|COMPLETED|Overall Study||14
10397582|NCT00700804|11541324|FG001|COMPLETED|Overall Study||13
10397583|NCT00700804|11541323|FG000|NOT COMPLETED|Overall Study||3
10397584|NCT00700804|11541324|FG001|NOT COMPLETED|Overall Study||4
10397585|NCT00700817|11541335|FG000|STARTED|Week 0-26 (Main Period)|Randomised|225
10397586|NCT00700817|11541336|FG001|STARTED|Week 0-26 (Main Period)|Randomised|221
10397587|NCT00700817|11541337|FG002|STARTED|Week 0-26 (Main Period)|Randomised|219
10397588|NCT00700817|11541338|FG003|STARTED|Week 0-26 (Main Period)||0
10397589|NCT00700817|11541339|FG004|STARTED|Week 0-26 (Main Period)||0
10397590|NCT00700817|11541335|FG000|Exposed|Week 0-26 (Main Period)|4 subjects withdrew before exposure to trial drug and were not included in Full Analysis Set (FAS)|221
10397591|NCT00700817|11541336|FG001|Exposed|Week 0-26 (Main Period)|3 subjects withdrew before exposure to trial drug and were not included in Full Analysis Set (FAS)|218
10720726|NCT02718417|11884356|FG002|COMPLETED|Observation Phase (OP)||2
10720727|NCT02718417|11884354|FG000|NOT COMPLETED|Observation Phase (OP)||0
10720728|NCT02718417|11884355|FG001|NOT COMPLETED|Observation Phase (OP)||0
10311138|NCT00129116|11444397|FG001|NOT COMPLETED|Booster Phase||0
10311139|NCT00129116|11444398|FG002|NOT COMPLETED|Booster Phase||0
10311140|NCT00129116|11444399|FG003|NOT COMPLETED|Booster Phase||0
10311141|NCT00129116|11444400|FG004|NOT COMPLETED|Booster Phase||1
10720729|NCT02718417|11884356|FG002|NOT COMPLETED|Observation Phase (OP)||282
10720730|NCT02718417|11884354|FG000|STARTED|Follow-up Phase|Participants not completing MP could also start this phase.|238
10777356|NCT03339583|11939336|FG000|COMPLETED|First Intervention (14 Days)||18
10311142|NCT00129129|11444415|FG000|STARTED|Primary Phase||287
10311143|NCT00129129|11444416|FG001|STARTED|Primary Phase||319
10311144|NCT00129129|11444417|FG002|STARTED|Primary Phase||150
10311145|NCT00129129|11444418|FG003|STARTED|Primary Phase||0
10311146|NCT00129129|11444419|FG004|STARTED|Primary Phase||0
10311147|NCT00129129|11444415|FG000|COMPLETED|Primary Phase||262
10311148|NCT00129129|11444416|FG001|COMPLETED|Primary Phase||294
10311149|NCT00129129|11444417|FG002|COMPLETED|Primary Phase||150
10311150|NCT00129129|11444418|FG003|COMPLETED|Primary Phase||0
10311151|NCT00129129|11444419|FG004|COMPLETED|Primary Phase||0
10311152|NCT00129129|11444415|FG000|NOT COMPLETED|Primary Phase||25
10311153|NCT00129129|11444416|FG001|NOT COMPLETED|Primary Phase||25
10311154|NCT00129129|11444417|FG002|NOT COMPLETED|Primary Phase||0
10311155|NCT00129129|11444418|FG003|NOT COMPLETED|Primary Phase||0
10311156|NCT00129129|11444419|FG004|NOT COMPLETED|Primary Phase||0
10311157|NCT00129129|11444415|FG000|STARTED|Fourth Dose Phase||236
10311158|NCT00129129|11444416|FG001|STARTED|Fourth Dose Phase||0
10311159|NCT00129129|11444417|FG002|STARTED|Fourth Dose Phase||0
10311160|NCT00129129|11444418|FG003|STARTED|Fourth Dose Phase||132
10311161|NCT00129129|11444419|FG004|STARTED|Fourth Dose Phase||130
10311162|NCT00129129|11444415|FG000|COMPLETED|Fourth Dose Phase||232
10311163|NCT00129129|11444416|FG001|COMPLETED|Fourth Dose Phase||0
10311164|NCT00129129|11444417|FG002|COMPLETED|Fourth Dose Phase||0
10311165|NCT00129129|11444418|FG003|COMPLETED|Fourth Dose Phase||128
10311166|NCT00129129|11444419|FG004|COMPLETED|Fourth Dose Phase||124
10311167|NCT00129129|11444415|FG000|NOT COMPLETED|Fourth Dose Phase||4
10311168|NCT00129129|11444416|FG001|NOT COMPLETED|Fourth Dose Phase||0
10311169|NCT00129129|11444417|FG002|NOT COMPLETED|Fourth Dose Phase||0
10311170|NCT00129129|11444418|FG003|NOT COMPLETED|Fourth Dose Phase||4
10311171|NCT00129129|11444419|FG004|NOT COMPLETED|Fourth Dose Phase||6
10311172|NCT00129220|11444442|FG000|STARTED|Study Period II||105
10311173|NCT00129220|11444443|FG001|STARTED|Study Period II||20
10311174|NCT00129220|11444444|FG002|STARTED|Study Period II||99
10311175|NCT00129220|11444442|FG000|Received at Least One Dose of Study Drug|Study Period II||104
10311176|NCT00129220|11444443|FG001|Received at Least One Dose of Study Drug|Study Period II||20
10311177|NCT00129220|11444444|FG002|Received at Least One Dose of Study Drug|Study Period II||97
10311178|NCT00129220|11444442|FG000|COMPLETED|Study Period II||72
10311179|NCT00129220|11444443|FG001|COMPLETED|Study Period II||8
10311180|NCT00129220|11444444|FG002|COMPLETED|Study Period II||52
10311181|NCT00129220|11444442|FG000|NOT COMPLETED|Study Period II||33
10311182|NCT00129220|11444443|FG001|NOT COMPLETED|Study Period II||12
10311183|NCT00129220|11444444|FG002|NOT COMPLETED|Study Period II||47
10311184|NCT00129220|11444442|FG000|STARTED|Study Period III||72
10311185|NCT00129220|11444443|FG001|STARTED|Study Period III||8
10311186|NCT00129220|11444444|FG002|STARTED|Study Period III||52
10311187|NCT00129220|11444442|FG000|COMPLETED|Study Period III||59
10311188|NCT00129220|11444443|FG001|COMPLETED|Study Period III||7
10311189|NCT00129220|11444444|FG002|COMPLETED|Study Period III||42
10311190|NCT00129220|11444442|FG000|NOT COMPLETED|Study Period III||13
10311191|NCT00129220|11444443|FG001|NOT COMPLETED|Study Period III||1
10311192|NCT00129220|11444444|FG002|NOT COMPLETED|Study Period III||10
10311193|NCT00129246|11444456|FG000|STARTED|Overall Study||20
10311194|NCT00129246|11444457|FG001|STARTED|Overall Study||20
10311195|NCT00129246|11444456|FG000|COMPLETED|Overall Study||20
10311196|NCT00129246|11444457|FG001|COMPLETED|Overall Study||20
10311197|NCT00129246|11444456|FG000|NOT COMPLETED|Overall Study||0
10311198|NCT00129246|11444457|FG001|NOT COMPLETED|Overall Study||0
10311199|NCT00129259|11444465|FG000|STARTED|Overall Study|Subjects not in the Intent-to-treat group did not have a baseline visit and are not included here|52
10311200|NCT00129259|11444466|FG001|STARTED|Overall Study|Subjects not in the Intent-to-treat group did not have a baseline visit and are not included here|25
10311201|NCT00129259|11444465|FG000|Received All or Part of Cycle 1|Overall Study||52
10311202|NCT00129259|11444466|FG001|Received All or Part of Cycle 1|Overall Study||0
10311203|NCT00129259|11444465|FG000|Received All or Part of Cycle 2|Overall Study||40
10311204|NCT00129259|11444466|FG001|Received All or Part of Cycle 2|Overall Study||0
10397592|NCT00700817|11541337|FG002|Exposed|Week 0-26 (Main Period)||219
10397593|NCT00700817|11541338|FG003|Exposed|Week 0-26 (Main Period)||0
10397594|NCT00700817|11541339|FG004|Exposed|Week 0-26 (Main Period)||0
10397595|NCT00700817|11541335|FG000|COMPLETED|Week 0-26 (Main Period)||169
10397596|NCT00700817|11541336|FG001|COMPLETED|Week 0-26 (Main Period)||191
10397597|NCT00700817|11541337|FG002|COMPLETED|Week 0-26 (Main Period)||194
10397598|NCT00700817|11541338|FG003|COMPLETED|Week 0-26 (Main Period)||0
10397599|NCT00700817|11541339|FG004|COMPLETED|Week 0-26 (Main Period)||0
10397600|NCT00700817|11541335|FG000|NOT COMPLETED|Week 0-26 (Main Period)||56
10397601|NCT00700817|11541336|FG001|NOT COMPLETED|Week 0-26 (Main Period)||30
10397602|NCT00700817|11541337|FG002|NOT COMPLETED|Week 0-26 (Main Period)||25
10397603|NCT00700817|11541338|FG003|NOT COMPLETED|Week 0-26 (Main Period)||0
10397604|NCT00700817|11541339|FG004|NOT COMPLETED|Week 0-26 (Main Period)||0
10397605|NCT00700817|11541335|FG000|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|155
10397606|NCT00700817|11541336|FG001|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|176
10397607|NCT00700817|11541337|FG002|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|166
10397608|NCT00700817|11541338|FG003|STARTED|Week 26-52 (Extension Period 1)||0
10397609|NCT00700817|11541339|FG004|STARTED|Week 26-52 (Extension Period 1)||0
10397610|NCT00700817|11541335|FG000|COMPLETED|Week 26-52 (Extension Period 1)||135
10397611|NCT00700817|11541336|FG001|COMPLETED|Week 26-52 (Extension Period 1)||150
10397612|NCT00700817|11541337|FG002|COMPLETED|Week 26-52 (Extension Period 1)||151
10397613|NCT00700817|11541338|FG003|COMPLETED|Week 26-52 (Extension Period 1)||0
10397614|NCT00700817|11541339|FG004|COMPLETED|Week 26-52 (Extension Period 1)||0
10397615|NCT00700817|11541335|FG000|NOT COMPLETED|Week 26-52 (Extension Period 1)||20
10397616|NCT00700817|11541336|FG001|NOT COMPLETED|Week 26-52 (Extension Period 1)||26
10397617|NCT00700817|11541337|FG002|NOT COMPLETED|Week 26-52 (Extension Period 1)||15
10397618|NCT00700817|11541338|FG003|NOT COMPLETED|Week 26-52 (Extension Period 1)||0
10397619|NCT00700817|11541339|FG004|NOT COMPLETED|Week 26-52 (Extension Period 1)||0
10397620|NCT00700817|11541335|FG000|STARTED|Week 52-78 (Extension Period 2)|Subject withdrew before entry to extension period 2|134
10397621|NCT00700817|11541336|FG001|STARTED|Week 52-78 (Extension Period 2)||150
10397622|NCT00700817|11541337|FG002|STARTED|Week 52-78 (Extension Period 2)|Re-randomised to lira 1.2 or 1.8 mg|0
10397623|NCT00700817|11541338|FG003|STARTED|Week 52-78 (Extension Period 2)|Re-randomised from sita treatment group. Some subjects withdrew before entry to extension period 2.|67
10397624|NCT00700817|11541339|FG004|STARTED|Week 52-78 (Extension Period 2)|Re-randomised from sita treatment group. Some subjects withdrew before entry to extension period 2.|68
10397625|NCT00700817|11541335|FG000|COMPLETED|Week 52-78 (Extension Period 2)||124
10397626|NCT00700817|11541336|FG001|COMPLETED|Week 52-78 (Extension Period 2)||135
10397627|NCT00700817|11541337|FG002|COMPLETED|Week 52-78 (Extension Period 2)||0
10397628|NCT00700817|11541338|FG003|COMPLETED|Week 52-78 (Extension Period 2)||59
10397629|NCT00700817|11541339|FG004|COMPLETED|Week 52-78 (Extension Period 2)||63
10397630|NCT00700817|11541335|FG000|NOT COMPLETED|Week 52-78 (Extension Period 2)||10
10397631|NCT00700817|11541336|FG001|NOT COMPLETED|Week 52-78 (Extension Period 2)||15
10397632|NCT00700817|11541337|FG002|NOT COMPLETED|Week 52-78 (Extension Period 2)||0
10397633|NCT00700817|11541338|FG003|NOT COMPLETED|Week 52-78 (Extension Period 2)||8
10397634|NCT00700817|11541339|FG004|NOT COMPLETED|Week 52-78 (Extension Period 2)||5
10397635|NCT00700973|11541351|FG000|STARTED|Overall Study||71
10397636|NCT00700973|11541352|FG001|STARTED|Overall Study||70
10397637|NCT00700973|11541351|FG000|COMPLETED|Overall Study||63
10397638|NCT00700973|11541352|FG001|COMPLETED|Overall Study||63
10397639|NCT00700973|11541351|FG000|NOT COMPLETED|Overall Study||8
10397640|NCT00700973|11541352|FG001|NOT COMPLETED|Overall Study||7
10397641|NCT00700999|11541360|FG000|STARTED|Overall Study||36
10397642|NCT00700999|11541361|FG001|STARTED|Overall Study||29
10397643|NCT00700999|11541360|FG000|First MRI Scan|Overall Study||29
10397644|NCT00700999|11541361|FG001|First MRI Scan|Overall Study||22
10397645|NCT00700999|11541360|FG000|Second MRI Scan|Overall Study||19
10397646|NCT00700999|11541361|FG001|Second MRI Scan|Overall Study||18
10397647|NCT00700999|11541360|FG000|COMPLETED|Overall Study||21
10397648|NCT00700999|11541361|FG001|COMPLETED|Overall Study||20
10397649|NCT00700999|11541360|FG000|NOT COMPLETED|Overall Study||15
10397650|NCT00700999|11541361|FG001|NOT COMPLETED|Overall Study||9
10397651|NCT00701038|11541369|FG000|STARTED|Overall Study||27
10397652|NCT00701038|11541370|FG001|STARTED|Overall Study||27
10397653|NCT00701038|11541369|FG000|COMPLETED|Overall Study||23
10397654|NCT00701038|11541370|FG001|COMPLETED|Overall Study||23
10397655|NCT00701038|11541369|FG000|NOT COMPLETED|Overall Study||4
10397656|NCT00701038|11541370|FG001|NOT COMPLETED|Overall Study||4
10397657|NCT00701051|11541378|FG000|STARTED|Screening|Arm assignment not known until baseline testing; both arms included in this number|90
10397658|NCT00701051|11541379|FG001|STARTED|Screening||0
10543713|NCT01485172|11696854|FG004|NOT COMPLETED|Overall Study||5
10543714|NCT01485172|11696855|FG005|NOT COMPLETED|Overall Study||4
10543715|NCT01485354|11696869|FG000|STARTED|Overall Study||17
10543716|NCT01485354|11696869|FG000|COMPLETED|Overall Study||12
10543717|NCT01485354|11696869|FG000|NOT COMPLETED|Overall Study||5
10543718|NCT01485380|11696873|FG000|STARTED|Overall Study||20
10543719|NCT01485380|11696873|FG000|COMPLETED|Overall Study||17
10543720|NCT01485380|11696873|FG000|NOT COMPLETED|Overall Study||3
10397659|NCT00701051|11541380|FG002|STARTED|Screening||0
10397660|NCT00701051|11541378|FG000|COMPLETED|Screening|Arm assignment not known until baseline testing; both arms included in this number|31
10397661|NCT00701051|11541379|FG001|COMPLETED|Screening||0
10397662|NCT00701051|11541380|FG002|COMPLETED|Screening||0
10543721|NCT01485393|11696877|FG000|STARTED|Overall Study||5
10720731|NCT02718417|11884355|FG001|STARTED|Follow-up Phase|Participants not completing MP could also start this phase.|263
10720732|NCT02718417|11884356|FG002|STARTED|Follow-up Phase|Participants not completing OP could also start this phase.|39
10720733|NCT02718417|11884354|FG000|COMPLETED|Follow-up Phase||103
10720734|NCT02718417|11884355|FG001|COMPLETED|Follow-up Phase||91
10720735|NCT02718417|11884356|FG002|COMPLETED|Follow-up Phase||20
10397663|NCT00701051|11541378|FG000|NOT COMPLETED|Screening||59
10397664|NCT00701051|11541379|FG001|NOT COMPLETED|Screening||0
10397665|NCT00701051|11541380|FG002|NOT COMPLETED|Screening||0
10397666|NCT00701051|11541378|FG000|STARTED|Exercise Intervention|Participants assigned to Normal or Impaired glucose tolerance arm after screening.|0
10397667|NCT00701051|11541379|FG001|STARTED|Exercise Intervention|Participants assigned to group after Period 1: Screening|19
10397668|NCT00701051|11541380|FG002|STARTED|Exercise Intervention|Participants assigned to group after Period 1: Screening|12
10397669|NCT00701051|11541378|FG000|COMPLETED|Exercise Intervention||0
10397670|NCT00701051|11541379|FG001|COMPLETED|Exercise Intervention||14
10397671|NCT00701051|11541380|FG002|COMPLETED|Exercise Intervention||9
10397672|NCT00701051|11541378|FG000|NOT COMPLETED|Exercise Intervention||0
10397673|NCT00701051|11541379|FG001|NOT COMPLETED|Exercise Intervention||5
10397674|NCT00701051|11541380|FG002|NOT COMPLETED|Exercise Intervention||3
10397675|NCT00701051|11541378|FG000|STARTED|Detraining Intervention (Optional)||0
10397676|NCT00701051|11541379|FG001|STARTED|Detraining Intervention (Optional)|Participation in this period was optional.|6
10397677|NCT00701051|11541380|FG002|STARTED|Detraining Intervention (Optional)|Participation in this period was optional.|6
10397678|NCT00701051|11541378|FG000|COMPLETED|Detraining Intervention (Optional)||0
10397679|NCT00701051|11541379|FG001|COMPLETED|Detraining Intervention (Optional)||6
10397680|NCT00701051|11541380|FG002|COMPLETED|Detraining Intervention (Optional)||6
10397681|NCT00701051|11541378|FG000|NOT COMPLETED|Detraining Intervention (Optional)||0
10397682|NCT00701051|11541379|FG001|NOT COMPLETED|Detraining Intervention (Optional)||0
10397683|NCT00701051|11541380|FG002|NOT COMPLETED|Detraining Intervention (Optional)||0
10397684|NCT00701064|11541388|FG000|STARTED|Overall Study||35
10397685|NCT00701064|11541389|FG001|STARTED|Overall Study||36
10397686|NCT00701064|11541388|FG000|COMPLETED|Overall Study||31
10720736|NCT02718417|11884354|FG000|NOT COMPLETED|Follow-up Phase||135
10720737|NCT02718417|11884355|FG001|NOT COMPLETED|Follow-up Phase||172
10720738|NCT02718417|11884356|FG002|NOT COMPLETED|Follow-up Phase||19
10397687|NCT00701064|11541389|FG001|COMPLETED|Overall Study||32
10397688|NCT00701064|11541388|FG000|NOT COMPLETED|Overall Study||4
10397689|NCT00701064|11541389|FG001|NOT COMPLETED|Overall Study||4
10397690|NCT00701090|11541397|FG000|STARTED|Overall Study||516
10397691|NCT00701090|11541398|FG001|STARTED|Overall Study||519
10397692|NCT00701090|11541397|FG000|COMPLETED|Overall Study||468
10720739|NCT02718417|11884354|FG000|STARTED|Long-term Follow-up Phase|Participants not completing follow-up phase could also start this phase.|139
10720740|NCT02718417|11884355|FG001|STARTED|Long-term Follow-up Phase|Participants not completing follow-up phase could also start this phase.|112
10397693|NCT00701090|11541398|FG001|COMPLETED|Overall Study||468
10397694|NCT00701090|11541397|FG000|NOT COMPLETED|Overall Study||48
10397695|NCT00701090|11541398|FG001|NOT COMPLETED|Overall Study||51
10397696|NCT00701103|11541415|FG000|STARTED|Overall Study||5
10397697|NCT00701103|11541416|FG001|STARTED|Overall Study||3
10397698|NCT00701103|11541417|FG002|STARTED|Overall Study||8
10397699|NCT00701103|11541418|FG003|STARTED|Overall Study||6
10397700|NCT00701103|11541419|FG004|STARTED|Overall Study||6
10397701|NCT00701103|11541420|FG005|STARTED|Overall Study||6
10397702|NCT00701103|11541421|FG006|STARTED|Overall Study||8
10397703|NCT00701103|11541422|FG007|STARTED|Overall Study||7
10397704|NCT00701103|11541423|FG008|STARTED|Overall Study||9
10397705|NCT00701103|11541424|FG009|STARTED|Overall Study||11
10397706|NCT00701103|11541425|FG010|STARTED|Overall Study||11
10397707|NCT00701103|11541415|FG000|COMPLETED|Overall Study||0
10397708|NCT00701103|11541416|FG001|COMPLETED|Overall Study||0
10397709|NCT00701103|11541417|FG002|COMPLETED|Overall Study||0
10397710|NCT00701103|11541418|FG003|COMPLETED|Overall Study||0
10397711|NCT00701103|11541419|FG004|COMPLETED|Overall Study||0
10397712|NCT00701103|11541420|FG005|COMPLETED|Overall Study||0
10397713|NCT00701103|11541421|FG006|COMPLETED|Overall Study||0
10397714|NCT00701103|11541422|FG007|COMPLETED|Overall Study||0
10397715|NCT00701103|11541423|FG008|COMPLETED|Overall Study||0
10397716|NCT00701103|11541424|FG009|COMPLETED|Overall Study||0
10397717|NCT00701103|11541425|FG010|COMPLETED|Overall Study||0
10397718|NCT00701103|11541415|FG000|NOT COMPLETED|Overall Study||5
10543722|NCT01485393|11696878|FG001|STARTED|Overall Study||5
10543723|NCT01485393|11696877|FG000|COMPLETED|Overall Study||5
10543724|NCT01485393|11696878|FG001|COMPLETED|Overall Study||5
10543725|NCT01485393|11696877|FG000|NOT COMPLETED|Overall Study||0
10397719|NCT00701103|11541416|FG001|NOT COMPLETED|Overall Study||3
10397720|NCT00701103|11541417|FG002|NOT COMPLETED|Overall Study||8
10397721|NCT00701103|11541418|FG003|NOT COMPLETED|Overall Study||6
10397722|NCT00701103|11541419|FG004|NOT COMPLETED|Overall Study||6
10397723|NCT00701103|11541420|FG005|NOT COMPLETED|Overall Study||6
10397724|NCT00701103|11541421|FG006|NOT COMPLETED|Overall Study||8
10397725|NCT00701103|11541422|FG007|NOT COMPLETED|Overall Study||7
10397726|NCT00701103|11541423|FG008|NOT COMPLETED|Overall Study||9
10397727|NCT00701103|11541424|FG009|NOT COMPLETED|Overall Study||11
10397728|NCT00701103|11541425|FG010|NOT COMPLETED|Overall Study||11
10397729|NCT00701129|11541453|FG000|STARTED|Overall Study||4
10397730|NCT00701129|11541453|FG000|Full Analysis Set (FAS)|Overall Study|All enrolled patients who signed informed consent, received at least 1 dose of alglucosidase alfa.|4
10397731|NCT00701129|11541453|FG000|COMPLETED|Overall Study||2
10397732|NCT00701129|11541453|FG000|NOT COMPLETED|Overall Study||2
10397733|NCT00701311|11541457|FG000|STARTED|Overall Study||17
10397734|NCT00701311|11541457|FG000|COMPLETED|Overall Study|Eight subjects did not complete full period of treatment but their data was included in analysis.|9
10397735|NCT00701311|11541457|FG000|NOT COMPLETED|Overall Study||8
10397736|NCT00701363|11541465|FG000|STARTED|Screening (Pre-assignment) Phase||128
10397737|NCT00701363|11541466|FG001|STARTED|Screening (Pre-assignment) Phase||0
10397738|NCT00701363|11541467|FG002|STARTED|Screening (Pre-assignment) Phase||0
10397739|NCT00701363|11541468|FG003|STARTED|Screening (Pre-assignment) Phase||0
10397740|NCT00701363|11541465|FG000|COMPLETED|Screening (Pre-assignment) Phase||124
10397741|NCT00701363|11541466|FG001|COMPLETED|Screening (Pre-assignment) Phase||0
10397742|NCT00701363|11541467|FG002|COMPLETED|Screening (Pre-assignment) Phase||0
10397743|NCT00701363|11541468|FG003|COMPLETED|Screening (Pre-assignment) Phase||0
10397744|NCT00701363|11541465|FG000|NOT COMPLETED|Screening (Pre-assignment) Phase||4
10397745|NCT00701363|11541466|FG001|NOT COMPLETED|Screening (Pre-assignment) Phase||0
10397746|NCT00701363|11541467|FG002|NOT COMPLETED|Screening (Pre-assignment) Phase||0
10397747|NCT00701363|11541468|FG003|NOT COMPLETED|Screening (Pre-assignment) Phase||0
10397748|NCT00701363|11541465|FG000|STARTED|Treatment Phase 1||124
10397749|NCT00701363|11541466|FG001|STARTED|Treatment Phase 1||0
10397750|NCT00701363|11541467|FG002|STARTED|Treatment Phase 1||0
10397751|NCT00701363|11541468|FG003|STARTED|Treatment Phase 1||0
10397752|NCT00701363|11541465|FG000|COMPLETED|Treatment Phase 1||109
10397753|NCT00701363|11541466|FG001|COMPLETED|Treatment Phase 1||0
10397754|NCT00701363|11541467|FG002|COMPLETED|Treatment Phase 1||0
10397755|NCT00701363|11541468|FG003|COMPLETED|Treatment Phase 1||0
10397756|NCT00701363|11541465|FG000|NOT COMPLETED|Treatment Phase 1||15
10397757|NCT00701363|11541466|FG001|NOT COMPLETED|Treatment Phase 1||0
10397758|NCT00701363|11541467|FG002|NOT COMPLETED|Treatment Phase 1||0
10397759|NCT00701363|11541468|FG003|NOT COMPLETED|Treatment Phase 1||0
10397760|NCT00701363|11541465|FG000|STARTED|Treatment Phase 2||0
10397761|NCT00701363|11541466|FG001|STARTED|Treatment Phase 2||13
10397762|NCT00701363|11541467|FG002|STARTED|Treatment Phase 2||70
10397763|NCT00701363|11541468|FG003|STARTED|Treatment Phase 2||26
10397764|NCT00701363|11541465|FG000|COMPLETED|Treatment Phase 2||0
10397765|NCT00701363|11541466|FG001|COMPLETED|Treatment Phase 2||13
10397766|NCT00701363|11541467|FG002|COMPLETED|Treatment Phase 2||68
10397767|NCT00701363|11541468|FG003|COMPLETED|Treatment Phase 2||26
10397768|NCT00701363|11541465|FG000|NOT COMPLETED|Treatment Phase 2||0
10397769|NCT00701363|11541466|FG001|NOT COMPLETED|Treatment Phase 2||0
10397770|NCT00701363|11541467|FG002|NOT COMPLETED|Treatment Phase 2||2
10397771|NCT00701363|11541468|FG003|NOT COMPLETED|Treatment Phase 2||0
10397772|NCT00701376|11541488|FG000|STARTED|Overall Study||106
10397773|NCT00701376|11541488|FG000|COMPLETED|Overall Study||105
10397774|NCT00701376|11541488|FG000|NOT COMPLETED|Overall Study||1
10397775|NCT00701389|11541493|FG000|STARTED|Period 1||6
10397776|NCT00701389|11541494|FG001|STARTED|Period 1||6
10397777|NCT00701389|11541495|FG002|STARTED|Period 1||6
10397778|NCT00701389|11541496|FG003|STARTED|Period 1||6
10397779|NCT00701389|11541493|FG000|COMPLETED|Period 1||6
10397780|NCT00701389|11541494|FG001|COMPLETED|Period 1||6
10397781|NCT00701389|11541495|FG002|COMPLETED|Period 1||6
10397782|NCT00701389|11541496|FG003|COMPLETED|Period 1||6
10397783|NCT00701389|11541493|FG000|NOT COMPLETED|Period 1||0
10397784|NCT00701389|11541494|FG001|NOT COMPLETED|Period 1||0
10397785|NCT00701389|11541495|FG002|NOT COMPLETED|Period 1||0
10397786|NCT00701389|11541496|FG003|NOT COMPLETED|Period 1||0
10397787|NCT00701389|11541493|FG000|STARTED|Period 2||6
10397788|NCT00701389|11541494|FG001|STARTED|Period 2||6
10397789|NCT00701389|11541495|FG002|STARTED|Period 2||6
10397790|NCT00701389|11541496|FG003|STARTED|Period 2||6
10397791|NCT00701389|11541493|FG000|COMPLETED|Period 2||6
10397792|NCT00701389|11541494|FG001|COMPLETED|Period 2||6
10397793|NCT00701389|11541495|FG002|COMPLETED|Period 2||6
10397794|NCT00701389|11541496|FG003|COMPLETED|Period 2||6
10397795|NCT00701389|11541493|FG000|NOT COMPLETED|Period 2||0
10397796|NCT00701389|11541494|FG001|NOT COMPLETED|Period 2||0
10311205|NCT00129259|11444465|FG000|COMPLETED|Overall Study||49
10311206|NCT00129259|11444466|FG001|COMPLETED|Overall Study||22
10311207|NCT00129259|11444465|FG000|NOT COMPLETED|Overall Study||3
10397797|NCT00701389|11541495|FG002|NOT COMPLETED|Period 2||0
10397798|NCT00701389|11541496|FG003|NOT COMPLETED|Period 2||0
10397799|NCT00701389|11541493|FG000|STARTED|Period 3||6
10397800|NCT00701389|11541494|FG001|STARTED|Period 3||6
10397801|NCT00701389|11541495|FG002|STARTED|Period 3||6
10397802|NCT00701389|11541496|FG003|STARTED|Period 3||6
10397803|NCT00701389|11541493|FG000|COMPLETED|Period 3||6
10397804|NCT00701389|11541494|FG001|COMPLETED|Period 3||6
10397805|NCT00701389|11541495|FG002|COMPLETED|Period 3||6
10397806|NCT00701389|11541496|FG003|COMPLETED|Period 3||6
10397807|NCT00701389|11541493|FG000|NOT COMPLETED|Period 3||0
10397808|NCT00701389|11541494|FG001|NOT COMPLETED|Period 3||0
10397809|NCT00701389|11541495|FG002|NOT COMPLETED|Period 3||0
10397810|NCT00701389|11541496|FG003|NOT COMPLETED|Period 3||0
10397811|NCT00701389|11541493|FG000|STARTED|Period 4||6
10397812|NCT00701389|11541494|FG001|STARTED|Period 4||6
10397813|NCT00701389|11541495|FG002|STARTED|Period 4||6
10397814|NCT00701389|11541496|FG003|STARTED|Period 4||6
10397815|NCT00701389|11541493|FG000|COMPLETED|Period 4||6
10397816|NCT00701389|11541494|FG001|COMPLETED|Period 4||6
10397817|NCT00701389|11541495|FG002|COMPLETED|Period 4||6
10397818|NCT00701389|11541496|FG003|COMPLETED|Period 4||6
10397819|NCT00701389|11541493|FG000|NOT COMPLETED|Period 4||0
10397820|NCT00701389|11541494|FG001|NOT COMPLETED|Period 4||0
10397821|NCT00701389|11541495|FG002|NOT COMPLETED|Period 4||0
10397822|NCT00701389|11541496|FG003|NOT COMPLETED|Period 4||0
10397823|NCT00701415|11541512|FG000|STARTED|Overall Study||16
10397824|NCT00701415|11541513|FG001|STARTED|Overall Study||15
10397825|NCT00701415|11541512|FG000|COMPLETED|Overall Study||15
10397826|NCT00701415|11541513|FG001|COMPLETED|Overall Study||14
10397827|NCT00701415|11541512|FG000|NOT COMPLETED|Overall Study||1
10397828|NCT00701415|11541513|FG001|NOT COMPLETED|Overall Study||1
10397829|NCT00701441|11541521|FG000|STARTED|Overall Study||9
10397830|NCT00701441|11541522|FG001|STARTED|Overall Study||16
10397831|NCT00701441|11541521|FG000|COMPLETED|Overall Study||9
10311208|NCT00129259|11444466|FG001|NOT COMPLETED|Overall Study||3
10311209|NCT00129272|11444474|FG000|STARTED|Overall Study||71
10311210|NCT00129272|11444475|FG001|STARTED|Overall Study||73
10311211|NCT00129272|11444474|FG000|COMPLETED|Overall Study||54
10311212|NCT00129272|11444475|FG001|COMPLETED|Overall Study||51
10311213|NCT00129272|11444474|FG000|NOT COMPLETED|Overall Study||17
10311214|NCT00129272|11444475|FG001|NOT COMPLETED|Overall Study||22
10311215|NCT00129285|11444484|FG000|STARTED|Overall Study||65
10311216|NCT00129285|11444485|FG001|STARTED|Overall Study||70
10311217|NCT00129285|11444486|FG002|STARTED|Overall Study||75
10311218|NCT00129285|11444484|FG000|COMPLETED|Overall Study||40
10311219|NCT00129285|11444485|FG001|COMPLETED|Overall Study||43
10311220|NCT00129285|11444486|FG002|COMPLETED|Overall Study||37
10311221|NCT00129285|11444484|FG000|NOT COMPLETED|Overall Study||25
10311222|NCT00129285|11444485|FG001|NOT COMPLETED|Overall Study||27
10311223|NCT00129285|11444486|FG002|NOT COMPLETED|Overall Study||38
10311224|NCT00129311|11444500|FG000|STARTED|Overall Study||51
10311225|NCT00129311|11444501|FG001|STARTED|Overall Study||50
10311226|NCT00129311|11444500|FG000|COMPLETED|Overall Study||39
10311227|NCT00129311|11444501|FG001|COMPLETED|Overall Study||31
10311228|NCT00129311|11444500|FG000|NOT COMPLETED|Overall Study||12
10397832|NCT00701441|11541522|FG001|COMPLETED|Overall Study||12
10397833|NCT00701441|11541521|FG000|NOT COMPLETED|Overall Study||0
10397834|NCT00701441|11541522|FG001|NOT COMPLETED|Overall Study||4
10397835|NCT00701558|11541532|FG000|STARTED|Overall Study||19
10397836|NCT00701558|11541532|FG000|COMPLETED|Overall Study||4
10397837|NCT00701558|11541532|FG000|NOT COMPLETED|Overall Study||15
10543726|NCT01485393|11696878|FG001|NOT COMPLETED|Overall Study||0
10543727|NCT01485536|11696885|FG000|STARTED|Overall Study||21
10543728|NCT01485536|11696885|FG000|COMPLETED|Overall Study||17
10543729|NCT01485536|11696885|FG000|NOT COMPLETED|Overall Study||4
10543730|NCT01485588|11696892|FG000|STARTED|Overall Study||6
10543731|NCT01485588|11696893|FG001|STARTED|Overall Study||6
10543732|NCT01485588|11696894|FG002|STARTED|Overall Study||6
10543733|NCT01485588|11696892|FG000|COMPLETED|Overall Study||6
10543734|NCT01485588|11696893|FG001|COMPLETED|Overall Study||6
10543735|NCT01485588|11696894|FG002|COMPLETED|Overall Study||6
10543736|NCT01485588|11696892|FG000|NOT COMPLETED|Overall Study||0
10543737|NCT01485588|11696893|FG001|NOT COMPLETED|Overall Study||0
10543738|NCT01485588|11696894|FG002|NOT COMPLETED|Overall Study||0
10397838|NCT00701636|11541538|FG000|STARTED|Overall Study||15
10397839|NCT00701636|11541539|FG001|STARTED|Overall Study||15
10397840|NCT00701636|11541538|FG000|COMPLETED|Overall Study||15
10397841|NCT00701636|11541539|FG001|COMPLETED|Overall Study||15
10397842|NCT00701636|11541538|FG000|NOT COMPLETED|Overall Study||0
10397843|NCT00701636|11541539|FG001|NOT COMPLETED|Overall Study||0
10397844|NCT00701662|11541544|FG000|STARTED|Overall Study||8
10397845|NCT00701662|11541544|FG000|COMPLETED|Overall Study||7
10397846|NCT00701662|11541544|FG000|NOT COMPLETED|Overall Study||1
10397847|NCT00701675|11541551|FG000|STARTED|Overall Study||14
10397848|NCT00701675|11541552|FG001|STARTED|Overall Study||14
10397849|NCT00701675|11541553|FG002|STARTED|Overall Study||14
10397850|NCT00701675|11541551|FG000|COMPLETED|Overall Study||10
10397851|NCT00701675|11541552|FG001|COMPLETED|Overall Study||6
10397852|NCT00701675|11541553|FG002|COMPLETED|Overall Study||7
10397853|NCT00701675|11541551|FG000|NOT COMPLETED|Overall Study||4
10397854|NCT00701675|11541552|FG001|NOT COMPLETED|Overall Study||8
10397855|NCT00701675|11541553|FG002|NOT COMPLETED|Overall Study||7
10397856|NCT00701701|11541563|FG000|STARTED|Overall Study||1
10397857|NCT00701701|11541564|FG001|STARTED|Overall Study||3
10397858|NCT00701701|11541563|FG000|COMPLETED|Overall Study||1
10397859|NCT00701701|11541564|FG001|COMPLETED|Overall Study||1
10397860|NCT00701701|11541563|FG000|NOT COMPLETED|Overall Study||0
10397861|NCT00701701|11541564|FG001|NOT COMPLETED|Overall Study||2
10397862|NCT00701714|11541573|FG000|STARTED|Treatment Period (up to 1 Year)||174
10397863|NCT00701714|11541574|FG001|STARTED|Treatment Period (up to 1 Year)||163
10397864|NCT00701714|11541573|FG000|COMPLETED|Treatment Period (up to 1 Year)||37
10397865|NCT00701714|11541574|FG001|COMPLETED|Treatment Period (up to 1 Year)||29
10397866|NCT00701714|11541573|FG000|NOT COMPLETED|Treatment Period (up to 1 Year)||137
10397867|NCT00701714|11541574|FG001|NOT COMPLETED|Treatment Period (up to 1 Year)||134
10397868|NCT00701714|11541573|FG000|STARTED|Safety Follow-up Period (6 Months)|Study terminated prematurely, all available randomized patients followed-up 6 months for safety|151
10397869|NCT00701714|11541574|FG001|STARTED|Safety Follow-up Period (6 Months)|Study terminated prematurely, all available randomized patients followed-up 6 months for safety|119
10397870|NCT00701714|11541573|FG000|COMPLETED|Safety Follow-up Period (6 Months)||144
10397871|NCT00701714|11541574|FG001|COMPLETED|Safety Follow-up Period (6 Months)||112
10397872|NCT00701714|11541573|FG000|NOT COMPLETED|Safety Follow-up Period (6 Months)||7
10397873|NCT00701714|11541574|FG001|NOT COMPLETED|Safety Follow-up Period (6 Months)||7
10397874|NCT00701727|11541584|FG000|STARTED|First Treatment Period||16
10397875|NCT00701727|11541585|FG001|STARTED|First Treatment Period||15
10397876|NCT00701727|11541584|FG000|COMPLETED|First Treatment Period||15
10397877|NCT00701727|11541585|FG001|COMPLETED|First Treatment Period||13
10397878|NCT00701727|11541584|FG000|NOT COMPLETED|First Treatment Period||1
10397879|NCT00701727|11541585|FG001|NOT COMPLETED|First Treatment Period||2
10397880|NCT00701727|11541584|FG000|STARTED|Second Treatment Period||15
10397881|NCT00701727|11541585|FG001|STARTED|Second Treatment Period||13
10397882|NCT00701727|11541584|FG000|COMPLETED|Second Treatment Period||13
10397883|NCT00701727|11541585|FG001|COMPLETED|Second Treatment Period||13
10397884|NCT00701727|11541584|FG000|NOT COMPLETED|Second Treatment Period||2
10397885|NCT00701727|11541585|FG001|NOT COMPLETED|Second Treatment Period||0
10397886|NCT00701779|11541591|FG000|STARTED|Overall Study||63
10397887|NCT00701779|11541591|FG000|3 Month|Overall Study||60
10397888|NCT00701779|11541591|FG000|6 Month|Overall Study||58
10397889|NCT00701779|11541591|FG000|9 Month|Overall Study||56
10397890|NCT00701779|11541591|FG000|12 Month|Overall Study||54
10311229|NCT00129311|11444501|FG001|NOT COMPLETED|Overall Study||19
10311230|NCT00129376|11444507|FG000|STARTED|Overall Study||63
10311231|NCT00129376|11444507|FG000|COMPLETED|Overall Study||61
10311232|NCT00129376|11444507|FG000|NOT COMPLETED|Overall Study||2
10311233|NCT00129389|11444513|FG000|STARTED|Overall Study||974
10311234|NCT00129389|11444514|FG001|STARTED|Overall Study||951
10311235|NCT00129389|11444513|FG000|COMPLETED|Overall Study|1 patient was crossed from arm A to B by error. 16 patients were crossed from arm B, to A by error.|941
10311236|NCT00129389|11444514|FG001|COMPLETED|Overall Study|16 patients were crossed from arm B to A by error. 1 patient was crossed from arm A to B by error.|811
10311237|NCT00129389|11444513|FG000|NOT COMPLETED|Overall Study||33
10311238|NCT00129389|11444514|FG001|NOT COMPLETED|Overall Study||140
10311239|NCT00129441|11444522|FG000|STARTED|Overall Study||9
10311240|NCT00129441|11444523|FG001|STARTED|Overall Study||6
10311241|NCT00129441|11444522|FG000|Baseline, Visit 1|Overall Study|Baseline # only includes those who completed 4-week trial (one L-830982 subject did not complete).|9
10311242|NCT00129441|11444523|FG001|Baseline, Visit 1|Overall Study||6
10311243|NCT00129441|11444522|FG000|Week 1, Visit 2|Overall Study||9
10311244|NCT00129441|11444523|FG001|Week 1, Visit 2|Overall Study||6
10311245|NCT00129441|11444522|FG000|Week 2, Visit 3|Overall Study||9
10311246|NCT00129441|11444523|FG001|Week 2, Visit 3|Overall Study||6
10311247|NCT00129441|11444522|FG000|Week 3, Visit 4|Overall Study||9
10311248|NCT00129441|11444523|FG001|Week 3, Visit 4|Overall Study||6
10311249|NCT00129441|11444522|FG000|Week 4, Visit 5|Overall Study||9
10311250|NCT00129441|11444523|FG001|Week 4, Visit 5|Overall Study||6
10311251|NCT00129441|11444522|FG000|Week 5, Visit 6|Overall Study||9
10311252|NCT00129441|11444523|FG001|Week 5, Visit 6|Overall Study||6
10311253|NCT00129441|11444522|FG000|Week 26, Visit 7|Overall Study||9
10311254|NCT00129441|11444523|FG001|Week 26, Visit 7|Overall Study||6
10311255|NCT00129441|11444522|FG000|Year 1, Visit 8|Overall Study||9
10311256|NCT00129441|11444523|FG001|Year 1, Visit 8|Overall Study||6
10311257|NCT00129441|11444522|FG000|COMPLETED|Overall Study||9
10311258|NCT00129441|11444523|FG001|COMPLETED|Overall Study||6
10311259|NCT00129441|11444522|FG000|NOT COMPLETED|Overall Study||0
10311260|NCT00129441|11444523|FG001|NOT COMPLETED|Overall Study||0
10311261|NCT00129467|11444531|FG000|STARTED|Received Intervention||15
10311262|NCT00129467|11444532|FG001|STARTED|Received Intervention||17
10311263|NCT00129467|11444531|FG000|COMPLETED|Received Intervention||9
10311264|NCT00129467|11444532|FG001|COMPLETED|Received Intervention||13
10311265|NCT00129467|11444531|FG000|NOT COMPLETED|Received Intervention||6
10311266|NCT00129467|11444532|FG001|NOT COMPLETED|Received Intervention||4
10311267|NCT00129467|11444531|FG000|STARTED|Open Label for SSRI+Methylphenidate Arm|Eligible if in methylphenidate arm & had 50% reduction in Montgomery-Asberg Depression Rating score|4
10311268|NCT00129467|11444532|FG001|STARTED|Open Label for SSRI+Methylphenidate Arm||0
10311269|NCT00129467|11444531|FG000|COMPLETED|Open Label for SSRI+Methylphenidate Arm||2
10311270|NCT00129467|11444532|FG001|COMPLETED|Open Label for SSRI+Methylphenidate Arm||0
10311271|NCT00129467|11444531|FG000|NOT COMPLETED|Open Label for SSRI+Methylphenidate Arm||2
10311272|NCT00129467|11444532|FG001|NOT COMPLETED|Open Label for SSRI+Methylphenidate Arm||0
10397891|NCT00701779|11541591|FG000|COMPLETED|Overall Study||54
10397892|NCT00701779|11541591|FG000|NOT COMPLETED|Overall Study||9
10397893|NCT00701805|11541599|FG000|STARTED|Overall Study||26
10397894|NCT00701805|11541600|FG001|STARTED|Overall Study||29
10397895|NCT00701805|11541601|FG002|STARTED|Overall Study||23
10397896|NCT00701805|11541602|FG003|STARTED|Overall Study||26
10397897|NCT00701805|11541599|FG000|COMPLETED|Overall Study||23
10397898|NCT00701805|11541600|FG001|COMPLETED|Overall Study||25
10397899|NCT00701805|11541601|FG002|COMPLETED|Overall Study||16
10397900|NCT00701805|11541602|FG003|COMPLETED|Overall Study||22
10397901|NCT00701805|11541599|FG000|NOT COMPLETED|Overall Study||3
10397902|NCT00701805|11541600|FG001|NOT COMPLETED|Overall Study||4
10311273|NCT00129480|11444540|FG000|STARTED|Overall Study||187
10311274|NCT00129480|11444541|FG001|STARTED|Overall Study||214
10311275|NCT00129480|11444540|FG000|COMPLETED|Overall Study||187
10311276|NCT00129480|11444541|FG001|COMPLETED|Overall Study||214
10397903|NCT00701805|11541601|FG002|NOT COMPLETED|Overall Study||7
10397904|NCT00701805|11541602|FG003|NOT COMPLETED|Overall Study||4
10397905|NCT00701896|11541614|FG000|STARTED|Overall Study|Includes those eligible but declined to participate|143
10311277|NCT00129480|11444540|FG000|NOT COMPLETED|Overall Study||0
10311278|NCT00129480|11444541|FG001|NOT COMPLETED|Overall Study||0
10311279|NCT00129545|11444550|FG000|STARTED|Overall Study||93
10311280|NCT00129545|11444551|FG001|STARTED|Overall Study|2:1 randomization WATCHMAN to warfarin|463
10311281|NCT00129545|11444552|FG002|STARTED|Overall Study||244
10311282|NCT00129545|11444550|FG000|COMPLETED|Overall Study||67
10311283|NCT00129545|11444551|FG001|COMPLETED|Overall Study||299
10311284|NCT00129545|11444552|FG002|COMPLETED|Overall Study||133
10311285|NCT00129545|11444550|FG000|NOT COMPLETED|Overall Study||26
10311286|NCT00129545|11444551|FG001|NOT COMPLETED|Overall Study||164
10311287|NCT00129545|11444552|FG002|NOT COMPLETED|Overall Study||111
10311288|NCT00129623|11444562|FG000|STARTED|Overall Study||83
10311289|NCT00129623|11444563|FG001|STARTED|Overall Study||77
10311290|NCT00129623|11444562|FG000|Intent-to-treat (ITT)/ Safety Population|Overall Study||83
10311291|NCT00129623|11444563|FG001|Intent-to-treat (ITT)/ Safety Population|Overall Study||77
10311292|NCT00129623|11444562|FG000|COMPLETED|Overall Study||73
10311293|NCT00129623|11444563|FG001|COMPLETED|Overall Study||65
10311294|NCT00129623|11444562|FG000|NOT COMPLETED|Overall Study||10
10311295|NCT00129623|11444563|FG001|NOT COMPLETED|Overall Study||12
10311296|NCT00129649|11444573|FG000|STARTED|Overall Study||258
10311297|NCT00129649|11444574|FG001|STARTED|Overall Study||246
10311298|NCT00129649|11444573|FG000|COMPLETED|Overall Study||182
10311299|NCT00129649|11444574|FG001|COMPLETED|Overall Study||181
10311300|NCT00129649|11444573|FG000|NOT COMPLETED|Overall Study||76
10311301|NCT00129649|11444574|FG001|NOT COMPLETED|Overall Study||65
10311302|NCT00129701|11444580|FG000|STARTED|Overall Study||104
10311303|NCT00129701|11444580|FG000|COMPLETED|Overall Study||71
10311304|NCT00129701|11444580|FG000|NOT COMPLETED|Overall Study||33
10311305|NCT00129727|11444587|FG000|STARTED|Overall Study||62
10311306|NCT00129727|11444587|FG000|COMPLETED|Overall Study||57
10311307|NCT00129727|11444587|FG000|NOT COMPLETED|Overall Study||5
10311308|NCT00129740|11444591|FG000|STARTED|Overall Study||148
10311309|NCT00129740|11444591|FG000|COMPLETED|Overall Study||148
10311310|NCT00129740|11444591|FG000|NOT COMPLETED|Overall Study||0
10311311|NCT00129766|11444597|FG000|STARTED|Overall Study||3306
10311312|NCT00129766|11444598|FG001|STARTED|Overall Study||3329
10311313|NCT00129766|11444597|FG000|COMPLETED|Overall Study||3246
10311314|NCT00129766|11444598|FG001|COMPLETED|Overall Study||3270
10311315|NCT00129766|11444597|FG000|NOT COMPLETED|Overall Study||60
10311316|NCT00129766|11444598|FG001|NOT COMPLETED|Overall Study||59
10311317|NCT00129935|11444607|FG000|STARTED|Overall Study||669
10311318|NCT00129935|11444608|FG001|STARTED|Overall Study||715
10311319|NCT00129935|11444607|FG000|COMPLETED|Overall Study|2 patients crossed from arm A to B by error, and 1 patient received other treatment by error.|633
10311320|NCT00129935|11444608|FG001|COMPLETED|Overall Study|1 patient crossed from arm B to A by error.|623
10311321|NCT00129935|11444607|FG000|NOT COMPLETED|Overall Study||36
10311322|NCT00129935|11444608|FG001|NOT COMPLETED|Overall Study||92
10311323|NCT00129961|11444616|FG000|STARTED|Overall Study||39
10311324|NCT00129961|11444617|FG001|STARTED|Overall Study||47
10311325|NCT00129961|11444616|FG000|COMPLETED|Overall Study||20
10311326|NCT00129961|11444617|FG001|COMPLETED|Overall Study||24
10311327|NCT00129961|11444616|FG000|NOT COMPLETED|Overall Study||19
10311328|NCT00129961|11444617|FG001|NOT COMPLETED|Overall Study||23
10311329|NCT00129987|11444625|FG000|STARTED|1st Educational Session||287
10311330|NCT00129987|11444626|FG001|STARTED|1st Educational Session||280
10311331|NCT00129987|11444625|FG000|COMPLETED|1st Educational Session||146
10311332|NCT00129987|11444626|FG001|COMPLETED|1st Educational Session||171
10311333|NCT00129987|11444625|FG000|NOT COMPLETED|1st Educational Session||141
10311334|NCT00129987|11444626|FG001|NOT COMPLETED|1st Educational Session||109
10311335|NCT00129987|11444625|FG000|STARTED|1 Year||146
10311336|NCT00129987|11444626|FG001|STARTED|1 Year||171
10311337|NCT00129987|11444625|FG000|COMPLETED|1 Year||114
10311338|NCT00129987|11444626|FG001|COMPLETED|1 Year||150
10311339|NCT00129987|11444625|FG000|NOT COMPLETED|1 Year||32
10311340|NCT00129987|11444626|FG001|NOT COMPLETED|1 Year||21
10311341|NCT00130039|11444634|FG000|STARTED|Overall Study||232
10311342|NCT00130039|11444635|FG001|STARTED|Overall Study||225
10311343|NCT00130039|11444634|FG000|COMPLETED|Overall Study|full analysis set|202
10311344|NCT00130039|11444635|FG001|COMPLETED|Overall Study|full analysis set|207
10311345|NCT00130039|11444634|FG000|NOT COMPLETED|Overall Study||30
10311346|NCT00130039|11444635|FG001|NOT COMPLETED|Overall Study||18
10311347|NCT00130117|11444643|FG000|STARTED|Overall Study||11
10720741|NCT02718417|11884356|FG002|STARTED|Long-term Follow-up Phase|Participants not completing follow-up could also start this phase.|135
10311348|NCT00130117|11444644|FG001|STARTED|Overall Study||9
10311349|NCT00130117|11444643|FG000|COMPLETED|Overall Study||7
10311350|NCT00130117|11444644|FG001|COMPLETED|Overall Study||6
10311351|NCT00130117|11444643|FG000|NOT COMPLETED|Overall Study||4
10311352|NCT00130117|11444644|FG001|NOT COMPLETED|Overall Study||3
10315504|NCT00179621|11449410|FG003|STARTED|Double-Blind Period||0
10315505|NCT00179621|11449407|FG000|COMPLETED|Double-Blind Period||3
10315506|NCT00179621|11449408|FG001|COMPLETED|Double-Blind Period||23
10315507|NCT00179621|11449409|FG002|COMPLETED|Double-Blind Period||39
10315508|NCT00179621|11449410|FG003|COMPLETED|Double-Blind Period||0
10315509|NCT00179621|11449407|FG000|NOT COMPLETED|Double-Blind Period||64
10397906|NCT00701896|11541615|FG001|STARTED|Overall Study|Includes those eligible but declined to participate|151
10397907|NCT00701896|11541614|FG000|COMPLETED|Overall Study||110
10397908|NCT00701896|11541615|FG001|COMPLETED|Overall Study||118
10397909|NCT00701896|11541614|FG000|NOT COMPLETED|Overall Study||33
10397910|NCT00701896|11541615|FG001|NOT COMPLETED|Overall Study||33
10397911|NCT00701935|11541623|FG000|STARTED|Overall Study||43
10397912|NCT00701935|11541624|FG001|STARTED|Overall Study||37
10397913|NCT00701935|11541623|FG000|COMPLETED|Overall Study||27
10397914|NCT00701935|11541624|FG001|COMPLETED|Overall Study||26
10397915|NCT00701935|11541623|FG000|NOT COMPLETED|Overall Study||16
10397916|NCT00701935|11541624|FG001|NOT COMPLETED|Overall Study||11
10397917|NCT00702052|11541630|FG000|STARTED|Overall Study||58
10397918|NCT00702052|11541630|FG000|COMPLETED|Overall Study||0
10397919|NCT00702052|11541630|FG000|NOT COMPLETED|Overall Study||58
10397920|NCT00702143|11541637|FG000|STARTED|Overall Study||45
10397921|NCT00702143|11541638|FG001|STARTED|Overall Study||60
10397922|NCT00702143|11541639|FG002|STARTED|Overall Study||79
10397923|NCT00702143|11541637|FG000|COMPLETED|Overall Study||45
10397924|NCT00702143|11541638|FG001|COMPLETED|Overall Study||60
10659079|NCT02238925|11820358|FG000|COMPLETED|Overall Study||1
10659080|NCT02238925|11820358|FG000|NOT COMPLETED|Overall Study||25
10659081|NCT02238977|11820364|FG000|STARTED|Overall Study||0
10659082|NCT02238977|11820365|FG001|STARTED|Overall Study||1
10659083|NCT02238977|11820364|FG000|COMPLETED|Overall Study||0
10659084|NCT02238977|11820365|FG001|COMPLETED|Overall Study||1
10659085|NCT02238977|11820364|FG000|NOT COMPLETED|Overall Study||0
10659086|NCT02238977|11820365|FG001|NOT COMPLETED|Overall Study||0
10659087|NCT02239094|11820371|FG000|STARTED|Overall Study||20
10659088|NCT02239094|11820371|FG000|COMPLETED|Overall Study||18
10659089|NCT02239094|11820371|FG000|NOT COMPLETED|Overall Study||2
10659090|NCT02239120|11820377|FG000|STARTED|Overall Study||2695
10659091|NCT02239120|11820378|FG001|STARTED|Overall Study||2695
10659092|NCT02239120|11820377|FG000|COMPLETED|Overall Study||2620
10659093|NCT02239120|11820378|FG001|COMPLETED|Overall Study||2623
10659094|NCT02239120|11820377|FG000|NOT COMPLETED|Overall Study||75
10659095|NCT02239120|11820378|FG001|NOT COMPLETED|Overall Study||72
10659096|NCT02239224|11820388|FG000|STARTED|Overall Study||3
10659097|NCT02239224|11820389|FG001|STARTED|Overall Study||6
10659098|NCT02239224|11820390|FG002|STARTED|Overall Study||6
10659099|NCT02239224|11820391|FG003|STARTED|Overall Study||5
10659100|NCT02239224|11820388|FG000|Received at Least One Dose of Study Drug|Overall Study||3
10659101|NCT02239224|11820389|FG001|Received at Least One Dose of Study Drug|Overall Study||6
10659102|NCT02239224|11820390|FG002|Received at Least One Dose of Study Drug|Overall Study||6
10659103|NCT02239224|11820391|FG003|Received at Least One Dose of Study Drug|Overall Study||5
10659104|NCT02239224|11820388|FG000|COMPLETED|Overall Study||3
10659105|NCT02239224|11820389|FG001|COMPLETED|Overall Study||6
10659106|NCT02239224|11820390|FG002|COMPLETED|Overall Study||3
10659107|NCT02239224|11820391|FG003|COMPLETED|Overall Study||4
10659108|NCT02239224|11820388|FG000|NOT COMPLETED|Overall Study||0
10659109|NCT02239224|11820389|FG001|NOT COMPLETED|Overall Study||0
10659110|NCT02239224|11820390|FG002|NOT COMPLETED|Overall Study||3
10397925|NCT00702143|11541639|FG002|COMPLETED|Overall Study||78
10397926|NCT00702143|11541637|FG000|NOT COMPLETED|Overall Study||0
10397927|NCT00702143|11541638|FG001|NOT COMPLETED|Overall Study||0
10397928|NCT00702143|11541639|FG002|NOT COMPLETED|Overall Study||1
10397929|NCT00702208|11541645|FG000|STARTED|Overall Study||198
10397930|NCT00702208|11541645|FG000|COMPLETED|Overall Study||167
10659111|NCT02239224|11820391|FG003|NOT COMPLETED|Overall Study||1
10659112|NCT02239263|11820401|FG000|STARTED|Overall Study||40
10659113|NCT02239263|11820401|FG000|COMPLETED|Overall Study||34
10659114|NCT02239263|11820401|FG000|NOT COMPLETED|Overall Study||6
10659115|NCT02239289|11820407|FG000|STARTED|Overall Study||21
10659116|NCT02239289|11820407|FG000|COMPLETED|Overall Study||21
10311353|NCT00130208|11444653|FG000|STARTED|Maintenance Period (26 Weeks)||524
10311354|NCT00130208|11444654|FG001|STARTED|Maintenance Period (26 Weeks)||532
10311355|NCT00130208|11444653|FG000|Valid Albumin Creatinine Ratio|Maintenance Period (26 Weeks)||492
10311356|NCT00130208|11444654|FG001|Valid Albumin Creatinine Ratio|Maintenance Period (26 Weeks)||494
10311357|NCT00130208|11444653|FG000|COMPLETED|Maintenance Period (26 Weeks)||500
10311358|NCT00130208|11444654|FG001|COMPLETED|Maintenance Period (26 Weeks)||502
10311359|NCT00130208|11444653|FG000|NOT COMPLETED|Maintenance Period (26 Weeks)||24
10311360|NCT00130208|11444654|FG001|NOT COMPLETED|Maintenance Period (26 Weeks)||30
10311361|NCT00130208|11444653|FG000|STARTED|Washout Period (8 Weeks)||500
10311362|NCT00130208|11444654|FG001|STARTED|Washout Period (8 Weeks)||502
10311363|NCT00130208|11444653|FG000|COMPLETED|Washout Period (8 Weeks)||494
10311364|NCT00130208|11444654|FG001|COMPLETED|Washout Period (8 Weeks)||490
10311365|NCT00130208|11444653|FG000|NOT COMPLETED|Washout Period (8 Weeks)||6
10311366|NCT00130208|11444654|FG001|NOT COMPLETED|Washout Period (8 Weeks)||12
10311367|NCT00130247|11444662|FG000|STARTED|Overall Study||196
10311368|NCT00130247|11444663|FG001|STARTED|Overall Study||198
10311369|NCT00130247|11444662|FG000|COMPLETED|Overall Study||194
10311370|NCT00130247|11444663|FG001|COMPLETED|Overall Study||194
10311371|NCT00130247|11444662|FG000|NOT COMPLETED|Overall Study||2
10311372|NCT00130247|11444663|FG001|NOT COMPLETED|Overall Study||4
10311373|NCT00130286|11444673|FG000|STARTED|Overall Study||22
10311374|NCT00130286|11444674|FG001|STARTED|Overall Study||19
10311375|NCT00130286|11444675|FG002|STARTED|Overall Study||17
10311376|NCT00130286|11444676|FG003|STARTED|Overall Study||19
10311377|NCT00130286|11444673|FG000|COMPLETED|Overall Study||22
10311378|NCT00130286|11444674|FG001|COMPLETED|Overall Study||16
10311379|NCT00130286|11444675|FG002|COMPLETED|Overall Study||13
10311380|NCT00130286|11444676|FG003|COMPLETED|Overall Study||17
10311381|NCT00130286|11444673|FG000|NOT COMPLETED|Overall Study||0
10311382|NCT00130286|11444674|FG001|NOT COMPLETED|Overall Study||3
10311383|NCT00130286|11444675|FG002|NOT COMPLETED|Overall Study||4
10311384|NCT00130286|11444676|FG003|NOT COMPLETED|Overall Study||2
10311385|NCT00130520|11444686|FG000|STARTED|Overall Study|85 women were screened for eligibility, 56 consented, 40 treated.|40
10311386|NCT00130520|11444686|FG000|Completion of at Least One Cycle|Overall Study||39
10311387|NCT00130520|11444686|FG000|COMPLETED|Overall Study||1
10311388|NCT00130520|11444686|FG000|NOT COMPLETED|Overall Study||39
10311389|NCT00130533|11444692|FG000|STARTED|Overall Study||448
10311390|NCT00130533|11444693|FG001|STARTED|Overall Study||428
10311391|NCT00130533|11444692|FG000|COMPLETED|Overall Study||337
10311392|NCT00130533|11444693|FG001|COMPLETED|Overall Study||398
10311393|NCT00130533|11444692|FG000|NOT COMPLETED|Overall Study||111
10311394|NCT00130533|11444693|FG001|NOT COMPLETED|Overall Study||30
10311395|NCT00130637|11444699|FG000|STARTED|Overall Study||6
10311396|NCT00130637|11444699|FG000|COMPLETED|Overall Study||3
10311397|NCT00130637|11444699|FG000|NOT COMPLETED|Overall Study||3
10311398|NCT00130689|11444703|FG000|STARTED|Overall Study||43
10311399|NCT00130689|11444703|FG000|Eligible|Overall Study||37
10311400|NCT00130689|11444703|FG000|Treated|Overall Study||35
10311401|NCT00130689|11444703|FG000|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
10311402|NCT00130689|11444703|FG000|NOT COMPLETED|Overall Study||43
10311403|NCT00130728|11444709|FG000|STARTED|Overall Study||319
10311404|NCT00130728|11444710|FG001|STARTED|Overall Study||317
10311405|NCT00130728|11444709|FG000|Received Study Drug (Safety Population)|Overall Study||313
10311406|NCT00130728|11444710|FG001|Received Study Drug (Safety Population)|Overall Study||313
10311407|NCT00130728|11444709|FG000|COMPLETED|Overall Study||57
10397931|NCT00702208|11541645|FG000|NOT COMPLETED|Overall Study||31
10397932|NCT00702221|11541652|FG000|STARTED|Overall Study||10
10397933|NCT00702221|11541653|FG001|STARTED|Overall Study||10
10659117|NCT02239289|11820407|FG000|NOT COMPLETED|Overall Study||0
10659118|NCT02239328|11820411|FG000|STARTED|Overall Study||182
10659119|NCT02239328|11820411|FG000|COMPLETED|Overall Study||174
10659120|NCT02239328|11820411|FG000|NOT COMPLETED|Overall Study||8
10659121|NCT02239380|11820415|FG000|STARTED|Overall Study||26
10659122|NCT02239380|11820415|FG000|COMPLETED|Overall Study||26
10659123|NCT02239380|11820415|FG000|NOT COMPLETED|Overall Study||0
10659124|NCT02239510|11820421|FG000|STARTED|Overall Study||5
10659125|NCT02239510|11820422|FG001|STARTED|Overall Study||4
10659126|NCT02239510|11820421|FG000|COMPLETED|Overall Study||3
10659127|NCT02239510|11820422|FG001|COMPLETED|Overall Study||3
10659128|NCT02239510|11820421|FG000|NOT COMPLETED|Overall Study||2
10659129|NCT02239510|11820422|FG001|NOT COMPLETED|Overall Study||1
10659130|NCT02239536|11820430|FG000|STARTED|Overall Study||190
10659131|NCT02239536|11820431|FG001|STARTED|Overall Study||172
10659132|NCT02239536|11820430|FG000|COMPLETED|Overall Study||167
10659133|NCT02239536|11820431|FG001|COMPLETED|Overall Study||155
10659134|NCT02239536|11820430|FG000|NOT COMPLETED|Overall Study||23
10659135|NCT02239536|11820431|FG001|NOT COMPLETED|Overall Study||17
10659136|NCT02239562|11820443|FG000|STARTED|Overall Study||6
10659137|NCT02239562|11820444|FG001|STARTED|Overall Study||6
10659138|NCT02239562|11820445|FG002|STARTED|Overall Study||6
10659139|NCT02239562|11820446|FG003|STARTED|Overall Study||6
10659140|NCT02239562|11820447|FG004|STARTED|Overall Study||6
10659141|NCT02239562|11820448|FG005|STARTED|Overall Study||6
10659142|NCT02239562|11820443|FG000|COMPLETED|Overall Study||6
10659143|NCT02239562|11820444|FG001|COMPLETED|Overall Study||6
10659144|NCT02239562|11820445|FG002|COMPLETED|Overall Study||6
10659145|NCT02239562|11820446|FG003|COMPLETED|Overall Study||6
10659146|NCT02239562|11820447|FG004|COMPLETED|Overall Study||6
10659147|NCT02239562|11820448|FG005|COMPLETED|Overall Study||6
10659148|NCT02239562|11820443|FG000|NOT COMPLETED|Overall Study||0
10659149|NCT02239562|11820444|FG001|NOT COMPLETED|Overall Study||0
10659150|NCT02239562|11820445|FG002|NOT COMPLETED|Overall Study||0
10659151|NCT02239562|11820446|FG003|NOT COMPLETED|Overall Study||0
10659152|NCT02239562|11820447|FG004|NOT COMPLETED|Overall Study||0
10659153|NCT02239562|11820448|FG005|NOT COMPLETED|Overall Study||0
10659154|NCT02239601|11820466|FG000|STARTED|Overall Study||29
10659155|NCT02239601|11820467|FG001|STARTED|Overall Study||32
10659156|NCT02239601|11820466|FG000|COMPLETED|Overall Study||22
10659157|NCT02239601|11820467|FG001|COMPLETED|Overall Study||26
10659158|NCT02239601|11820466|FG000|NOT COMPLETED|Overall Study||7
10659159|NCT02239601|11820467|FG001|NOT COMPLETED|Overall Study||6
10659160|NCT02239640|11820478|FG000|STARTED|Overall Study||984
10659161|NCT02239640|11820478|FG000|COMPLETED|Overall Study||767
10659162|NCT02239640|11820478|FG000|NOT COMPLETED|Overall Study||217
10659163|NCT02239679|11820491|FG000|STARTED|Overall Study||53
10659164|NCT02239679|11820492|FG001|STARTED|Overall Study||59
10659165|NCT02239679|11820493|FG002|STARTED|Overall Study||54
10659166|NCT02239679|11820491|FG000|COMPLETED|Overall Study||50
10659167|NCT02239679|11820492|FG001|COMPLETED|Overall Study||56
10659168|NCT02239679|11820493|FG002|COMPLETED|Overall Study||53
10659169|NCT02239679|11820491|FG000|NOT COMPLETED|Overall Study||3
10659170|NCT02239679|11820492|FG001|NOT COMPLETED|Overall Study||3
10659171|NCT02239679|11820493|FG002|NOT COMPLETED|Overall Study||1
10659172|NCT02239692|11820503|FG000|STARTED|Overall Study||73
10659173|NCT02239692|11820504|FG001|STARTED|Overall Study||131
10659174|NCT02239692|11820503|FG000|Intention-to-treat Analysis Set|Overall Study||73
10659175|NCT02239692|11820504|FG001|Intention-to-treat Analysis Set|Overall Study||131
10659176|NCT02239692|11820503|FG000|Per-protocol Analysis Set|Overall Study||66
10659177|NCT02239692|11820504|FG001|Per-protocol Analysis Set|Overall Study||120
10659178|NCT02239692|11820503|FG000|Safety Analysis Set|Overall Study||70
10659179|NCT02239692|11820504|FG001|Safety Analysis Set|Overall Study||125
10659180|NCT02239692|11820503|FG000|COMPLETED|Overall Study||67
10659181|NCT02239692|11820504|FG001|COMPLETED|Overall Study||118
10659182|NCT02239692|11820503|FG000|NOT COMPLETED|Overall Study||6
10659183|NCT02239692|11820504|FG001|NOT COMPLETED|Overall Study||13
10659184|NCT02239744|11820512|FG000|STARTED|Period 1||17
10659185|NCT02239744|11820513|FG001|STARTED|Period 1||18
10659186|NCT02239744|11820512|FG000|COMPLETED|Period 1||17
10659187|NCT02239744|11820513|FG001|COMPLETED|Period 1||18
10659188|NCT02239744|11820512|FG000|NOT COMPLETED|Period 1||0
10659189|NCT02239744|11820513|FG001|NOT COMPLETED|Period 1||0
10659190|NCT02239744|11820512|FG000|STARTED|Period 2||17
10659191|NCT02239744|11820513|FG001|STARTED|Period 2||18
10659192|NCT02239744|11820512|FG000|COMPLETED|Period 2||17
10311408|NCT00130728|11444710|FG001|COMPLETED|Overall Study||57
10311409|NCT00130728|11444709|FG000|NOT COMPLETED|Overall Study||262
10311410|NCT00130728|11444710|FG001|NOT COMPLETED|Overall Study||260
10311411|NCT00130780|11444718|FG000|STARTED|Overall Study||51
10813625|NCT02715765|11976024|FG001|NOT COMPLETED|Overall Study||0
10311412|NCT00130780|11444719|FG001|STARTED|Overall Study||20
10311413|NCT00130780|11444718|FG000|COMPLETED|Overall Study||51
10311414|NCT00130780|11444719|FG001|COMPLETED|Overall Study||20
10311415|NCT00130780|11444718|FG000|NOT COMPLETED|Overall Study||0
10311416|NCT00130780|11444719|FG001|NOT COMPLETED|Overall Study||0
10311417|NCT00130793|11444727|FG000|STARTED|Overall Study||183
10311418|NCT00130793|11444728|FG001|STARTED|Overall Study||185
10311419|NCT00130793|11444727|FG000|Vaccinated|Overall Study|One subject was allocated but not vaccinated.|182
10311420|NCT00130793|11444728|FG001|Vaccinated|Overall Study||185
10311421|NCT00130793|11444727|FG000|COMPLETED|Overall Study|Subject received vaccine, completed blood draws, returned vaccination report card (VRC) at Week 4|180
10311422|NCT00130793|11444728|FG001|COMPLETED|Overall Study|Subject received vaccine, completed blood draws, returned VRC at Week 4|181
10311423|NCT00130793|11444727|FG000|NOT COMPLETED|Overall Study||3
10311424|NCT00130793|11444728|FG001|NOT COMPLETED|Overall Study||4
10311425|NCT00130832|11444737|FG000|STARTED|Overall Study||372
10311426|NCT00130832|11444738|FG001|STARTED|Overall Study||363
10311427|NCT00130832|11444737|FG000|COMPLETED|Overall Study|Those who received all 3 doses of concomitant RotaTeq™/ OPV with blood draw ~42 days postdose 3|356
10311428|NCT00130832|11444738|FG001|COMPLETED|Overall Study|Those who received all 3 doses; last 2 blood draws ~42 days postdose 3 of RotaTeq™ and postdose OPV|346
10311429|NCT00130832|11444737|FG000|NOT COMPLETED|Overall Study||16
10311430|NCT00130832|11444738|FG001|NOT COMPLETED|Overall Study||17
10311431|NCT00130923|11444746|FG000|STARTED|Overall Study||49
10311432|NCT00130923|11444747|FG001|STARTED|Overall Study||46
10311433|NCT00130923|11444746|FG000|COMPLETED|Overall Study||36
10311434|NCT00130923|11444747|FG001|COMPLETED|Overall Study||32
10311435|NCT00130923|11444746|FG000|NOT COMPLETED|Overall Study||13
10311436|NCT00130923|11444747|FG001|NOT COMPLETED|Overall Study||14
10311437|NCT00131248|11444754|FG000|STARTED|Intervention 1 (3-day Course)||9
10311438|NCT00131248|11444755|FG001|STARTED|Intervention 1 (3-day Course)||9
10311439|NCT00131248|11444754|FG000|COMPLETED|Intervention 1 (3-day Course)||8
10311440|NCT00131248|11444755|FG001|COMPLETED|Intervention 1 (3-day Course)||9
10311441|NCT00131248|11444754|FG000|NOT COMPLETED|Intervention 1 (3-day Course)||1
10311442|NCT00131248|11444755|FG001|NOT COMPLETED|Intervention 1 (3-day Course)||0
10311443|NCT00131248|11444754|FG000|STARTED|Washout (24 Hour)||8
10311444|NCT00131248|11444755|FG001|STARTED|Washout (24 Hour)||9
10311445|NCT00131248|11444754|FG000|COMPLETED|Washout (24 Hour)||8
10311446|NCT00131248|11444755|FG001|COMPLETED|Washout (24 Hour)||9
10311447|NCT00131248|11444754|FG000|NOT COMPLETED|Washout (24 Hour)||0
10311448|NCT00131248|11444755|FG001|NOT COMPLETED|Washout (24 Hour)||0
10311449|NCT00131248|11444754|FG000|STARTED|Intervention 2 (7-day Course)||8
10311450|NCT00131248|11444755|FG001|STARTED|Intervention 2 (7-day Course)||9
10311451|NCT00131248|11444754|FG000|COMPLETED|Intervention 2 (7-day Course)||8
10311452|NCT00131248|11444755|FG001|COMPLETED|Intervention 2 (7-day Course)||9
10311453|NCT00131248|11444754|FG000|NOT COMPLETED|Intervention 2 (7-day Course)||0
10311454|NCT00131248|11444755|FG001|NOT COMPLETED|Intervention 2 (7-day Course)||0
10311455|NCT00131248|11444754|FG000|STARTED|Washout 2 (24 Hours)||8
10311456|NCT00131248|11444755|FG001|STARTED|Washout 2 (24 Hours)||9
10311457|NCT00131248|11444754|FG000|COMPLETED|Washout 2 (24 Hours)||8
10311458|NCT00131248|11444755|FG001|COMPLETED|Washout 2 (24 Hours)||9
10311459|NCT00131248|11444754|FG000|NOT COMPLETED|Washout 2 (24 Hours)||0
10311460|NCT00131248|11444755|FG001|NOT COMPLETED|Washout 2 (24 Hours)||0
10311461|NCT00131248|11444754|FG000|STARTED|Intervention 3 (4-day Course)||8
10397934|NCT00702221|11541652|FG000|COMPLETED|Overall Study||6
10397935|NCT00702221|11541653|FG001|COMPLETED|Overall Study||7
10397936|NCT00702221|11541652|FG000|NOT COMPLETED|Overall Study||4
10397937|NCT00702221|11541653|FG001|NOT COMPLETED|Overall Study||3
10397938|NCT00702299|11541659|FG000|STARTED|Overall Study||15
10397939|NCT00702299|11541659|FG000|COMPLETED|Overall Study||15
10397940|NCT00702299|11541659|FG000|NOT COMPLETED|Overall Study||0
10397941|NCT00702325|11541668|FG000|STARTED|Overall Study|Randomized|156
10397942|NCT00702325|11541669|FG001|STARTED|Overall Study|Randomized|155
10397943|NCT00702325|11541668|FG000|COMPLETED|Overall Study|Completed participants based on randomized population (156) minus discontinued participants (38).|118
10397944|NCT00702325|11541669|FG001|COMPLETED|Overall Study|Completed participants based on randomized population (155) minus discontinued participants (53).|102
10397945|NCT00702325|11541668|FG000|NOT COMPLETED|Overall Study||38
10397946|NCT00702325|11541669|FG001|NOT COMPLETED|Overall Study||53
10397947|NCT00702364|11541677|FG000|STARTED|Overall Study||26
10397948|NCT00702364|11541678|FG001|STARTED|Overall Study||29
10397949|NCT00702364|11541677|FG000|COMPLETED|Overall Study||24
10397950|NCT00702364|11541678|FG001|COMPLETED|Overall Study||25
10311462|NCT00131248|11444755|FG001|STARTED|Intervention 3 (4-day Course)||9
10311463|NCT00131248|11444754|FG000|COMPLETED|Intervention 3 (4-day Course)||8
10397951|NCT00702364|11541677|FG000|NOT COMPLETED|Overall Study||2
10397952|NCT00702364|11541678|FG001|NOT COMPLETED|Overall Study||4
10397953|NCT00702377|11541686|FG000|STARTED|Overall Study||53
10397954|NCT00702377|11541687|FG001|STARTED|Overall Study||56
10397955|NCT00702377|11541686|FG000|COMPLETED|Overall Study||52
10397956|NCT00702377|11541687|FG001|COMPLETED|Overall Study||53
10397957|NCT00702377|11541686|FG000|NOT COMPLETED|Overall Study||1
10397958|NCT00702377|11541687|FG001|NOT COMPLETED|Overall Study||3
10397959|NCT00702403|11541693|FG000|STARTED|From Consent to Engraftment|"57 agreed to participate and completed informed consent (= the 1st intention to treat population)"|57
10397960|NCT00702403|11541693|FG000|Ineligible for Study Drug|From Consent to Engraftment||17
10397961|NCT00702403|11541693|FG000|COMPLETED|From Consent to Engraftment|40 of 57 originally consented subjects remained eligible at engraftment (= the 2nd ITT population)|40
10397962|NCT00702403|11541693|FG000|NOT COMPLETED|From Consent to Engraftment||17
10397963|NCT00702403|11541693|FG000|STARTED|From Engraftment to Study Completion||40
10397964|NCT00702403|11541693|FG000|Patient Drop-outs|From Engraftment to Study Completion||27
10397965|NCT00702403|11541693|FG000|COMPLETED|From Engraftment to Study Completion||13
10397966|NCT00702403|11541693|FG000|NOT COMPLETED|From Engraftment to Study Completion||27
10397967|NCT00702468|11541702|FG000|STARTED|Overall Study||18
10813626|NCT02715765|11976025|FG002|NOT COMPLETED|Overall Study||0
10813627|NCT02717949|11976035|FG000|STARTED|Overall Study||0
10813628|NCT02717949|11976036|FG001|STARTED|Overall Study||0
10813629|NCT02717949|11976035|FG000|COMPLETED|Overall Study||0
10813630|NCT02717949|11976036|FG001|COMPLETED|Overall Study||0
10813631|NCT02717949|11976035|FG000|NOT COMPLETED|Overall Study||0
10813632|NCT02717949|11976036|FG001|NOT COMPLETED|Overall Study||0
10813633|NCT02717130|11976044|FG000|STARTED|Overall Study|Of the nine enrolled subjects, eight received study drug.|8
10311464|NCT00131248|11444755|FG001|COMPLETED|Intervention 3 (4-day Course)||9
10311465|NCT00131248|11444754|FG000|NOT COMPLETED|Intervention 3 (4-day Course)||0
10311466|NCT00131248|11444755|FG001|NOT COMPLETED|Intervention 3 (4-day Course)||0
10311467|NCT00131352|11444763|FG000|STARTED|Initial Treatment Period|Safety population|123
10720742|NCT02718417|11884354|FG000|COMPLETED|Long-term Follow-up Phase||0
10720743|NCT02718417|11884355|FG001|COMPLETED|Long-term Follow-up Phase||0
10720744|NCT02718417|11884356|FG002|COMPLETED|Long-term Follow-up Phase||0
10720745|NCT02718417|11884354|FG000|NOT COMPLETED|Long-term Follow-up Phase||139
10720746|NCT02718417|11884355|FG001|NOT COMPLETED|Long-term Follow-up Phase||112
10720747|NCT02718417|11884356|FG002|NOT COMPLETED|Long-term Follow-up Phase||135
10720748|NCT02718625|11884373|FG000|STARTED|Overall Study||1
10720749|NCT02718625|11884374|FG001|STARTED|Overall Study||2
10720750|NCT02718625|11884373|FG000|COMPLETED|Overall Study||1
10720751|NCT02718625|11884374|FG001|COMPLETED|Overall Study||0
10720752|NCT02718625|11884373|FG000|NOT COMPLETED|Overall Study||0
10720753|NCT02718625|11884374|FG001|NOT COMPLETED|Overall Study||2
10720754|NCT02718898|11884382|FG000|STARTED|Blinded Treatment Period||74
10720755|NCT02718898|11884383|FG001|STARTED|Blinded Treatment Period||75
10720756|NCT02718898|11884384|FG002|STARTED|Blinded Treatment Period||0
10720757|NCT02718898|11884385|FG003|STARTED|Blinded Treatment Period||0
10720758|NCT02718898|11884386|FG004|STARTED|Blinded Treatment Period||0
10720759|NCT02718898|11884387|FG005|STARTED|Blinded Treatment Period||0
10720760|NCT02718898|11884388|FG006|STARTED|Blinded Treatment Period||0
10397968|NCT00702468|11541703|FG001|STARTED|Overall Study||18
10397969|NCT00702468|11541702|FG000|COMPLETED|Overall Study||15
10397970|NCT00702468|11541703|FG001|COMPLETED|Overall Study||2
10397971|NCT00702468|11541702|FG000|NOT COMPLETED|Overall Study||3
10397972|NCT00702468|11541703|FG001|NOT COMPLETED|Overall Study||16
10397973|NCT00702507|11541709|FG000|STARTED|Initial Treatment Phase||200
10397974|NCT00702507|11541709|FG000|COMPLETED|Initial Treatment Phase||159
10397975|NCT00702507|11541709|FG000|NOT COMPLETED|Initial Treatment Phase||41
10397976|NCT00702507|11541709|FG000|STARTED|Follow-up Phase||159
10397977|NCT00702507|11541709|FG000|COMPLETED|Follow-up Phase||132
10397978|NCT00702507|11541709|FG000|NOT COMPLETED|Follow-up Phase||27
10397979|NCT00702650|11541714|FG000|STARTED|Overall Study||155
10397980|NCT00702650|11541714|FG000|COMPLETED|Overall Study||135
10397981|NCT00702650|11541714|FG000|NOT COMPLETED|Overall Study||20
10397982|NCT00702689|11541718|FG000|STARTED|Overall Study||20
10397983|NCT00702689|11541718|FG000|COMPLETED|Overall Study||14
10397984|NCT00702689|11541718|FG000|NOT COMPLETED|Overall Study||6
10397985|NCT00702715|11541724|FG000|STARTED|Overall Study||35
10397986|NCT00702715|11541725|FG001|STARTED|Overall Study|One subject was enrolled but did not start study|33
10397987|NCT00702715|11541724|FG000|COMPLETED|Overall Study||34
10397988|NCT00702715|11541725|FG001|COMPLETED|Overall Study||33
10397989|NCT00702715|11541724|FG000|NOT COMPLETED|Overall Study||1
10397990|NCT00702715|11541725|FG001|NOT COMPLETED|Overall Study||0
10397991|NCT00702754|11541731|FG000|STARTED|MYOBLOC Treatment Session 1 (Time 0)||502
10397992|NCT00702754|11541731|FG000|COMPLETED|MYOBLOC Treatment Session 1 (Time 0)|Approximately 70% of subjects completed at least 2 years of treatment.|495
10397993|NCT00702754|11541731|FG000|NOT COMPLETED|MYOBLOC Treatment Session 1 (Time 0)||7
10397994|NCT00702754|11541731|FG000|STARTED|MYOBLOC Treatment Session 2 (App 12 Wks)||495
10397995|NCT00702754|11541731|FG000|COMPLETED|MYOBLOC Treatment Session 2 (App 12 Wks)||475
10397996|NCT00702754|11541731|FG000|NOT COMPLETED|MYOBLOC Treatment Session 2 (App 12 Wks)||20
10397997|NCT00702754|11541731|FG000|STARTED|MYOBLOC Treatment Session 3 (App 24 Wks)||475
10397998|NCT00702754|11541731|FG000|COMPLETED|MYOBLOC Treatment Session 3 (App 24 Wks)||450
10397999|NCT00702754|11541731|FG000|NOT COMPLETED|MYOBLOC Treatment Session 3 (App 24 Wks)||25
10398000|NCT00702754|11541731|FG000|STARTED|MYOBLOC Treatment Session 4 (App 36 Wks)||450
10398001|NCT00702754|11541731|FG000|COMPLETED|MYOBLOC Treatment Session 4 (App 36 Wks)||428
10398002|NCT00702754|11541731|FG000|NOT COMPLETED|MYOBLOC Treatment Session 4 (App 36 Wks)||22
10398003|NCT00702754|11541731|FG000|STARTED|MYOBLOC Treatment Session 5 (App 48 Wks)||428
10398004|NCT00702754|11541731|FG000|COMPLETED|MYOBLOC Treatment Session 5 (App 48 Wks)||396
10398005|NCT00702754|11541731|FG000|NOT COMPLETED|MYOBLOC Treatment Session 5 (App 48 Wks)||32
10398006|NCT00702754|11541731|FG000|STARTED|MYOBLOC Treatment Session 6 (App 60 Wks)||396
10398007|NCT00702754|11541731|FG000|COMPLETED|MYOBLOC Treatment Session 6 (App 60 Wks)||377
10398008|NCT00702754|11541731|FG000|NOT COMPLETED|MYOBLOC Treatment Session 6 (App 60 Wks)||19
10398009|NCT00702754|11541731|FG000|STARTED|MYOBLOC Treatment Session 7 (App 72 Wks)||377
10398010|NCT00702754|11541731|FG000|COMPLETED|MYOBLOC Treatment Session 7 (App 72 Wks)||353
10398011|NCT00702754|11541731|FG000|NOT COMPLETED|MYOBLOC Treatment Session 7 (App 72 Wks)||24
10398012|NCT00702754|11541731|FG000|STARTED|MYOBLOC Treatment Session 8 (App 84 Wks)||353
10398013|NCT00702754|11541731|FG000|COMPLETED|MYOBLOC Treatment Session 8 (App 84 Wks)||329
10398014|NCT00702754|11541731|FG000|NOT COMPLETED|MYOBLOC Treatment Session 8 (App 84 Wks)||24
10398015|NCT00702780|11541737|FG000|STARTED|Overall Study||37
10398016|NCT00702780|11541738|FG001|STARTED|Overall Study||37
10398017|NCT00702780|11541737|FG000|COMPLETED|Overall Study||28
10398018|NCT00702780|11541738|FG001|COMPLETED|Overall Study||29
10398019|NCT00702780|11541737|FG000|NOT COMPLETED|Overall Study||9
10398020|NCT00702780|11541738|FG001|NOT COMPLETED|Overall Study||8
10398021|NCT00702884|11541744|FG000|STARTED|Overall Study||25
10398022|NCT00702884|11541744|FG000|COMPLETED|Overall Study||25
10398023|NCT00702884|11541744|FG000|NOT COMPLETED|Overall Study||0
10398024|NCT00702923|11541751|FG000|STARTED|Overall Study||12
10398025|NCT00702923|11541751|FG000|COMPLETED|Overall Study||11
10398026|NCT00702923|11541751|FG000|NOT COMPLETED|Overall Study||1
10398027|NCT00702949|11541759|FG000|STARTED|Overall Study||63
10398028|NCT00702949|11541760|FG001|STARTED|Overall Study||66
10398029|NCT00702949|11541761|FG002|STARTED|Overall Study||62
10398030|NCT00702949|11541759|FG000|Evaluable for Primary Endpoint|Overall Study||56
10398031|NCT00702949|11541760|FG001|Evaluable for Primary Endpoint|Overall Study||56
10398032|NCT00702949|11541761|FG002|Evaluable for Primary Endpoint|Overall Study||51
10398033|NCT00702949|11541759|FG000|COMPLETED|Overall Study||58
10398034|NCT00702949|11541760|FG001|COMPLETED|Overall Study||57
10398035|NCT00702949|11541761|FG002|COMPLETED|Overall Study||54
10398036|NCT00702949|11541759|FG000|NOT COMPLETED|Overall Study||5
10398037|NCT00702949|11541760|FG001|NOT COMPLETED|Overall Study||9
10311468|NCT00131352|11444764|FG001|STARTED|Initial Treatment Period|Safety population|130
10311469|NCT00131352|11444763|FG000|Intent to Treat Population|Initial Treatment Period||124
10311470|NCT00131352|11444764|FG001|Intent to Treat Population|Initial Treatment Period||129
10311471|NCT00131352|11444763|FG000|COMPLETED|Initial Treatment Period||114
10311472|NCT00131352|11444764|FG001|COMPLETED|Initial Treatment Period||118
10398038|NCT00702949|11541761|FG002|NOT COMPLETED|Overall Study||8
10398039|NCT00703053|11541780|FG000|STARTED|Overall Study||27
10398040|NCT00703053|11541781|FG001|STARTED|Overall Study||26
10398041|NCT00703053|11541782|FG002|STARTED|Overall Study||51
10398042|NCT00703053|11541783|FG003|STARTED|Overall Study||49
10398043|NCT00703053|11541784|FG004|STARTED|Overall Study||51
10398044|NCT00703053|11541785|FG005|STARTED|Overall Study||49
10398045|NCT00703053|11541786|FG006|STARTED|Overall Study||52
10398046|NCT00703053|11541787|FG007|STARTED|Overall Study||97
10398047|NCT00703053|11541788|FG008|STARTED|Overall Study||103
10398048|NCT00703053|11541780|FG000|COMPLETED|Overall Study||26
10398049|NCT00703053|11541781|FG001|COMPLETED|Overall Study||24
10398050|NCT00703053|11541782|FG002|COMPLETED|Overall Study||48
10398051|NCT00703053|11541783|FG003|COMPLETED|Overall Study||46
10398052|NCT00703053|11541784|FG004|COMPLETED|Overall Study||50
10398053|NCT00703053|11541785|FG005|COMPLETED|Overall Study||43
10398054|NCT00703053|11541786|FG006|COMPLETED|Overall Study||45
10398055|NCT00703053|11541787|FG007|COMPLETED|Overall Study||91
10398056|NCT00703053|11541788|FG008|COMPLETED|Overall Study||102
10398057|NCT00703053|11541780|FG000|NOT COMPLETED|Overall Study||1
10398058|NCT00703053|11541781|FG001|NOT COMPLETED|Overall Study||2
10398059|NCT00703053|11541782|FG002|NOT COMPLETED|Overall Study||3
10398060|NCT00703053|11541783|FG003|NOT COMPLETED|Overall Study||3
10398061|NCT00703053|11541784|FG004|NOT COMPLETED|Overall Study||1
10398062|NCT00703053|11541785|FG005|NOT COMPLETED|Overall Study||6
10398063|NCT00703053|11541786|FG006|NOT COMPLETED|Overall Study||7
10398064|NCT00703053|11541787|FG007|NOT COMPLETED|Overall Study||6
10398065|NCT00703053|11541788|FG008|NOT COMPLETED|Overall Study||1
10398066|NCT00703118|11541813|FG000|STARTED|Overall Study||266
10398067|NCT00703118|11541814|FG001|STARTED|Overall Study||264
10398068|NCT00703118|11541815|FG002|STARTED|Overall Study||132
10398069|NCT00703118|11541813|FG000|COMPLETED|Overall Study||245
10398070|NCT00703118|11541814|FG001|COMPLETED|Overall Study||248
10398071|NCT00703118|11541815|FG002|COMPLETED|Overall Study||110
10398072|NCT00703118|11541813|FG000|NOT COMPLETED|Overall Study||21
10398073|NCT00703118|11541814|FG001|NOT COMPLETED|Overall Study||16
10398074|NCT00703118|11541815|FG002|NOT COMPLETED|Overall Study||22
10398075|NCT00703157|11541828|FG000|STARTED|Overall Study||26
10398076|NCT00703157|11541829|FG001|STARTED|Overall Study||26
10398077|NCT00703157|11541828|FG000|6 Months FU|Overall Study||25
10398078|NCT00703157|11541829|FG001|6 Months FU|Overall Study||25
10398079|NCT00703157|11541828|FG000|24 Months FU|Overall Study||22
10398080|NCT00703157|11541829|FG001|24 Months FU|Overall Study||24
10398081|NCT00703157|11541828|FG000|COMPLETED|Overall Study||22
10398082|NCT00703157|11541829|FG001|COMPLETED|Overall Study||24
10398083|NCT00703157|11541828|FG000|NOT COMPLETED|Overall Study||4
10398084|NCT00703157|11541829|FG001|NOT COMPLETED|Overall Study||2
10398085|NCT00703261|11541839|FG000|STARTED|Overall Study||42
10398086|NCT00703261|11541840|FG001|STARTED|Overall Study||41
10398087|NCT00703261|11541839|FG000|COMPLETED|Overall Study||36
10659193|NCT02239744|11820513|FG001|COMPLETED|Period 2||18
10659194|NCT02239744|11820512|FG000|NOT COMPLETED|Period 2||0
10659195|NCT02239744|11820513|FG001|NOT COMPLETED|Period 2||0
10659196|NCT02239770|11820526|FG000|STARTED|Part 1||4
10659197|NCT02239770|11820527|FG001|STARTED|Part 1||4
10659198|NCT02239770|11820528|FG002|STARTED|Part 1||4
10659199|NCT02239770|11820529|FG003|STARTED|Part 1||0
10311473|NCT00131352|11444763|FG000|NOT COMPLETED|Initial Treatment Period||9
10311474|NCT00131352|11444764|FG001|NOT COMPLETED|Initial Treatment Period||12
10311475|NCT00131352|11444763|FG000|STARTED|Repeat Treatment Period|Safety population: 77 Synvisc + 83 Saline Control participants from the Initial Treatment period.|160
10311476|NCT00131352|11444764|FG001|STARTED|Repeat Treatment Period||0
10311477|NCT00131352|11444763|FG000|COMPLETED|Repeat Treatment Period||158
10311478|NCT00131352|11444764|FG001|COMPLETED|Repeat Treatment Period||0
10311479|NCT00131352|11444763|FG000|NOT COMPLETED|Repeat Treatment Period||2
10311480|NCT00131352|11444764|FG001|NOT COMPLETED|Repeat Treatment Period||0
10311481|NCT00131365|11444772|FG000|STARTED|Overall Study|Only safety data was reported due to early closure of the study due to device obsolescence.|9
10311482|NCT00131365|11444772|FG000|COMPLETED|Overall Study||5
10398088|NCT00703261|11541840|FG001|COMPLETED|Overall Study||35
10398089|NCT00703261|11541839|FG000|NOT COMPLETED|Overall Study||6
10398090|NCT00703261|11541840|FG001|NOT COMPLETED|Overall Study||6
10398091|NCT00703391|11541849|FG000|STARTED|Overall Study||12
10398092|NCT00703391|11541850|FG001|STARTED|Overall Study||6
10398093|NCT00703391|11541849|FG000|COMPLETED|Overall Study||12
10398094|NCT00703391|11541850|FG001|COMPLETED|Overall Study||6
10398095|NCT00703391|11541849|FG000|NOT COMPLETED|Overall Study||0
10398096|NCT00703391|11541850|FG001|NOT COMPLETED|Overall Study||0
10398097|NCT00703508|11541856|FG000|STARTED|Overall Study||26
10398098|NCT00703508|11541856|FG000|COMPLETED|Overall Study||26
10398099|NCT00703508|11541856|FG000|NOT COMPLETED|Overall Study||0
10659200|NCT02239770|11820530|FG004|STARTED|Part 1||0
10659201|NCT02239770|11820531|FG005|STARTED|Part 1||0
10659202|NCT02239770|11820526|FG000|COMPLETED|Part 1||4
10659203|NCT02239770|11820527|FG001|COMPLETED|Part 1||4
10659204|NCT02239770|11820528|FG002|COMPLETED|Part 1||4
10659205|NCT02239770|11820529|FG003|COMPLETED|Part 1||0
10659206|NCT02239770|11820530|FG004|COMPLETED|Part 1||0
10659207|NCT02239770|11820531|FG005|COMPLETED|Part 1||0
10659208|NCT02239770|11820526|FG000|NOT COMPLETED|Part 1||0
10659209|NCT02239770|11820527|FG001|NOT COMPLETED|Part 1||0
10659210|NCT02239770|11820528|FG002|NOT COMPLETED|Part 1||0
10659211|NCT02239770|11820529|FG003|NOT COMPLETED|Part 1||0
10659212|NCT02239770|11820530|FG004|NOT COMPLETED|Part 1||0
10398100|NCT00703664|11541865|FG000|STARTED|Overall Study||22
10398101|NCT00703664|11541866|FG001|STARTED|Overall Study||4
10398102|NCT00703664|11541867|FG002|STARTED|Overall Study||39
10398103|NCT00703664|11541865|FG000|COMPLETED|Overall Study||22
10398104|NCT00703664|11541866|FG001|COMPLETED|Overall Study||4
10398105|NCT00703664|11541867|FG002|COMPLETED|Overall Study||39
10398106|NCT00703664|11541865|FG000|NOT COMPLETED|Overall Study||0
10398107|NCT00703664|11541866|FG001|NOT COMPLETED|Overall Study||0
10398108|NCT00703664|11541867|FG002|NOT COMPLETED|Overall Study||0
10398109|NCT00703677|11541875|FG000|STARTED|Overall Study||17
10398110|NCT00703677|11541875|FG000|COMPLETED|Overall Study||14
10398111|NCT00703677|11541875|FG000|NOT COMPLETED|Overall Study||3
10398112|NCT00703729|11541881|FG000|STARTED|Overall Study||25
10398113|NCT00703729|11541882|FG001|STARTED|Overall Study||24
10398114|NCT00703729|11541881|FG000|COMPLETED|Overall Study||25
10398115|NCT00703729|11541882|FG001|COMPLETED|Overall Study||21
10398116|NCT00703729|11541881|FG000|NOT COMPLETED|Overall Study||0
10398117|NCT00703729|11541882|FG001|NOT COMPLETED|Overall Study||3
10398118|NCT00703781|11541890|FG000|STARTED|Overall Study||63
10398119|NCT00703781|11541891|FG001|STARTED|Overall Study||63
10659213|NCT02239770|11820531|FG005|NOT COMPLETED|Part 1||0
10398120|NCT00703781|11541890|FG000|COMPLETED|Overall Study||61
10398121|NCT00703781|11541891|FG001|COMPLETED|Overall Study||61
10398122|NCT00703781|11541890|FG000|NOT COMPLETED|Overall Study||2
10398123|NCT00703781|11541891|FG001|NOT COMPLETED|Overall Study||2
10398124|NCT00703820|11541899|FG000|STARTED|Overall Study||133
10398125|NCT00703820|11541900|FG001|STARTED|Overall Study||129
10398126|NCT00703820|11541899|FG000|COMPLETED|Overall Study||98
10398127|NCT00703820|11541900|FG001|COMPLETED|Overall Study||95
10398128|NCT00703820|11541899|FG000|NOT COMPLETED|Overall Study||35
10398129|NCT00703820|11541900|FG001|NOT COMPLETED|Overall Study||34
10398130|NCT00703846|11541908|FG000|STARTED|Overall Study||500
10398131|NCT00703846|11541908|FG000|COMPLETED|Overall Study||363
10398132|NCT00703846|11541908|FG000|NOT COMPLETED|Overall Study||137
10398133|NCT00703911|11541912|FG000|STARTED|Overall Study||102
10398134|NCT00703911|11541912|FG000|COMPLETED|Overall Study||92
10398135|NCT00703911|11541912|FG000|NOT COMPLETED|Overall Study||10
10398136|NCT00703924|11541918|FG000|STARTED|Overall Study||50
10398137|NCT00703924|11541919|FG001|STARTED|Overall Study||42
10398138|NCT00703924|11541918|FG000|COMPLETED|Overall Study||49
10398139|NCT00703924|11541919|FG001|COMPLETED|Overall Study||41
10398140|NCT00703924|11541918|FG000|NOT COMPLETED|Overall Study||1
10398141|NCT00703924|11541919|FG001|NOT COMPLETED|Overall Study||1
10398142|NCT00703937|11541931|FG000|STARTED|Overall Study||343
10398143|NCT00703937|11541932|FG001|STARTED|Overall Study||360
10398144|NCT00703937|11541931|FG000|COMPLETED|Overall Study||278
10398145|NCT00703937|11541932|FG001|COMPLETED|Overall Study||267
10398146|NCT00703937|11541931|FG000|NOT COMPLETED|Overall Study||65
10398147|NCT00703937|11541932|FG001|NOT COMPLETED|Overall Study||93
10398148|NCT00703963|11541940|FG000|STARTED|Overall Study||100
10398149|NCT00703963|11541941|FG001|STARTED|Overall Study||100
10398150|NCT00703963|11541940|FG000|COMPLETED|Overall Study||93
10398151|NCT00703963|11541941|FG001|COMPLETED|Overall Study||86
10398152|NCT00703963|11541940|FG000|NOT COMPLETED|Overall Study||7
10398153|NCT00703963|11541941|FG001|NOT COMPLETED|Overall Study||14
10398154|NCT00703976|11541949|FG000|STARTED|Overall Study||37
10398155|NCT00703976|11541950|FG001|STARTED|Overall Study||41
10398156|NCT00703976|11541949|FG000|COMPLETED|Overall Study||37
10398157|NCT00703976|11541950|FG001|COMPLETED|Overall Study||41
10398158|NCT00703976|11541949|FG000|NOT COMPLETED|Overall Study||0
10398159|NCT00703976|11541950|FG001|NOT COMPLETED|Overall Study||0
10398160|NCT00704028|11541960|FG000|STARTED|Overall Study||82
10398161|NCT00704028|11541961|FG001|STARTED|Overall Study|A subject randomized to iron dextran never received study drug and was d/c due to subject request.|78
10398162|NCT00704028|11541960|FG000|COMPLETED|Overall Study||70
10398163|NCT00704028|11541961|FG001|COMPLETED|Overall Study||57
10398164|NCT00704028|11541960|FG000|NOT COMPLETED|Overall Study||12
10398165|NCT00704028|11541961|FG001|NOT COMPLETED|Overall Study||21
10398166|NCT00704132|11541969|FG000|STARTED|Overall Study||26
10398167|NCT00704132|11541970|FG001|STARTED|Overall Study||24
10398168|NCT00704132|11541969|FG000|COMPLETED|Overall Study||25
10398169|NCT00704132|11541970|FG001|COMPLETED|Overall Study||22
10398170|NCT00704132|11541969|FG000|NOT COMPLETED|Overall Study||1
10398171|NCT00704132|11541970|FG001|NOT COMPLETED|Overall Study||2
10398172|NCT00704171|11541978|FG000|STARTED|Overall Study||62
10398173|NCT00704171|11541979|FG001|STARTED|Overall Study||59
10398174|NCT00704171|11541978|FG000|COMPLETED|Overall Study|One subject withdrew consent prior to study completion. No reason given.|61
10398175|NCT00704171|11541979|FG001|COMPLETED|Overall Study|All control subjects completed the study.|59
10398176|NCT00704171|11541978|FG000|NOT COMPLETED|Overall Study||1
10398177|NCT00704171|11541979|FG001|NOT COMPLETED|Overall Study||0
10398178|NCT00704184|11541990|FG000|STARTED|Double-Blind Treatment||20
10398179|NCT00704184|11541991|FG001|STARTED|Double-Blind Treatment||18
10398180|NCT00704184|11541992|FG002|STARTED|Double-Blind Treatment||20
10398181|NCT00704184|11541993|FG003|STARTED|Double-Blind Treatment||18
10398182|NCT00704184|11541994|FG004|STARTED|Double-Blind Treatment||19
10398183|NCT00704184|11541990|FG000|Treated|Double-Blind Treatment|One participant was randomized to placebo but withdrew prior to receiving study medication.|19
10398184|NCT00704184|11541991|FG001|Treated|Double-Blind Treatment||18
10398185|NCT00704184|11541992|FG002|Treated|Double-Blind Treatment||20
10398186|NCT00704184|11541993|FG003|Treated|Double-Blind Treatment||18
10398187|NCT00704184|11541994|FG004|Treated|Double-Blind Treatment||19
10398188|NCT00704184|11541990|FG000|COMPLETED|Double-Blind Treatment||19
10398189|NCT00704184|11541991|FG001|COMPLETED|Double-Blind Treatment||18
10398190|NCT00704184|11541992|FG002|COMPLETED|Double-Blind Treatment||20
10398191|NCT00704184|11541993|FG003|COMPLETED|Double-Blind Treatment||18
10398192|NCT00704184|11541994|FG004|COMPLETED|Double-Blind Treatment||19
10398193|NCT00704184|11541990|FG000|NOT COMPLETED|Double-Blind Treatment||1
10398194|NCT00704184|11541991|FG001|NOT COMPLETED|Double-Blind Treatment||0
10720761|NCT02718898|11884382|FG000|COMPLETED|Blinded Treatment Period||65
10720762|NCT02718898|11884383|FG001|COMPLETED|Blinded Treatment Period||74
10720763|NCT02718898|11884384|FG002|COMPLETED|Blinded Treatment Period||0
10398195|NCT00704184|11541992|FG002|NOT COMPLETED|Double-Blind Treatment||0
10398196|NCT00704184|11541993|FG003|NOT COMPLETED|Double-Blind Treatment||0
10398197|NCT00704184|11541994|FG004|NOT COMPLETED|Double-Blind Treatment||0
10398198|NCT00704184|11541990|FG000|STARTED|Open-Label Treatment||19
10398199|NCT00704184|11541991|FG001|STARTED|Open-Label Treatment||18
10398200|NCT00704184|11541992|FG002|STARTED|Open-Label Treatment||20
10398201|NCT00704184|11541993|FG003|STARTED|Open-Label Treatment||18
10398202|NCT00704184|11541994|FG004|STARTED|Open-Label Treatment||19
10398203|NCT00704184|11541990|FG000|COMPLETED|Open-Label Treatment||18
10398204|NCT00704184|11541991|FG001|COMPLETED|Open-Label Treatment||16
10398205|NCT00704184|11541992|FG002|COMPLETED|Open-Label Treatment||16
10398206|NCT00704184|11541993|FG003|COMPLETED|Open-Label Treatment||13
10398207|NCT00704184|11541994|FG004|COMPLETED|Open-Label Treatment||16
10398208|NCT00704184|11541990|FG000|NOT COMPLETED|Open-Label Treatment||1
10398209|NCT00704184|11541991|FG001|NOT COMPLETED|Open-Label Treatment||2
10398210|NCT00704184|11541992|FG002|NOT COMPLETED|Open-Label Treatment||4
10398211|NCT00704184|11541993|FG003|NOT COMPLETED|Open-Label Treatment||5
10398212|NCT00704184|11541994|FG004|NOT COMPLETED|Open-Label Treatment||3
10398213|NCT00704262|11542006|FG000|STARTED|Overall Study||33
10398214|NCT00704262|11542006|FG000|COMPLETED|Overall Study||31
10398215|NCT00704262|11542006|FG000|NOT COMPLETED|Overall Study||2
10398216|NCT00704340|11542012|FG000|STARTED|Overall Study||120
10398217|NCT00704340|11542013|FG001|STARTED|Overall Study||117
10398218|NCT00704340|11542012|FG000|COMPLETED|Overall Study||118
10398219|NCT00704340|11542013|FG001|COMPLETED|Overall Study||115
10398220|NCT00704340|11542012|FG000|NOT COMPLETED|Overall Study||2
10398221|NCT00704340|11542013|FG001|NOT COMPLETED|Overall Study||2
10398222|NCT00704353|11542021|FG000|STARTED|Overall Study||366
10398223|NCT00704353|11542022|FG001|STARTED|Overall Study||369
10398224|NCT00704353|11542021|FG000|COMPLETED|Overall Study||268
10398225|NCT00704353|11542022|FG001|COMPLETED|Overall Study||255
10398226|NCT00704353|11542021|FG000|NOT COMPLETED|Overall Study||98
10398227|NCT00704353|11542022|FG001|NOT COMPLETED|Overall Study||114
10428772|NCT00860262|11574853|FG002|STARTED|Overall Study||220
10428773|NCT00860262|11574851|FG000|COMPLETED|Overall Study||401
10428774|NCT00860262|11574852|FG001|COMPLETED|Overall Study||195
10428775|NCT00860262|11574853|FG002|COMPLETED|Overall Study||202
10428776|NCT00860262|11574851|FG000|NOT COMPLETED|Overall Study||20
10428777|NCT00860262|11574852|FG001|NOT COMPLETED|Overall Study||22
10428778|NCT00860262|11574853|FG002|NOT COMPLETED|Overall Study||18
10428779|NCT00860314|11574865|FG000|STARTED|Overall Study||48
10428780|NCT00860314|11574866|FG001|STARTED|Overall Study||48
10428781|NCT00860314|11574865|FG000|COMPLETED|Overall Study||48
10428782|NCT00860314|11574866|FG001|COMPLETED|Overall Study||48
10428783|NCT00860314|11574865|FG000|NOT COMPLETED|Overall Study||0
10428784|NCT00860314|11574866|FG001|NOT COMPLETED|Overall Study||0
10428785|NCT00860379|11574875|FG000|STARTED|Overall Study||4
10428786|NCT00860379|11574876|FG001|STARTED|Overall Study||6
10428787|NCT00860379|11574877|FG002|STARTED|Overall Study||4
10428788|NCT00860379|11574875|FG000|COMPLETED|Overall Study||4
10428789|NCT00860379|11574876|FG001|COMPLETED|Overall Study||6
10428790|NCT00860379|11574877|FG002|COMPLETED|Overall Study||4
10428791|NCT00860379|11574875|FG000|NOT COMPLETED|Overall Study||0
10428792|NCT00860379|11574876|FG001|NOT COMPLETED|Overall Study||0
10428793|NCT00860379|11574877|FG002|NOT COMPLETED|Overall Study||0
10428794|NCT00860405|11574887|FG000|STARTED|Overall Study||31
10428795|NCT00860405|11574888|FG001|STARTED|Overall Study||30
10428796|NCT00860405|11574887|FG000|Completed Treatment|Overall Study||31
10428797|NCT00860405|11574888|FG001|Completed Treatment|Overall Study||29
10428798|NCT00860405|11574887|FG000|Day 28 Follow-up Performed|Overall Study||31
10428799|NCT00860405|11574888|FG001|Day 28 Follow-up Performed|Overall Study||29
10428800|NCT00860405|11574887|FG000|COMPLETED|Overall Study|completed overall study|26
10428801|NCT00860405|11574888|FG001|COMPLETED|Overall Study||26
10428802|NCT00860405|11574887|FG000|NOT COMPLETED|Overall Study||5
10428803|NCT00860405|11574888|FG001|NOT COMPLETED|Overall Study||4
10428804|NCT00860457|11574894|FG000|STARTED|Overall Study||22
10428805|NCT00860457|11574894|FG000|COMPLETED|Overall Study||11
10428806|NCT00860457|11574894|FG000|NOT COMPLETED|Overall Study||11
10428807|NCT00860470|11574900|FG000|STARTED|Overall Study||22162
10428808|NCT00860470|11574901|FG001|STARTED|Overall Study||22405
10428809|NCT00860470|11574900|FG000|COMPLETED|Overall Study||22114
10428810|NCT00860470|11574901|FG001|COMPLETED|Overall Study||22346
10428811|NCT00860470|11574900|FG000|NOT COMPLETED|Overall Study||48
10428812|NCT00860470|11574901|FG001|NOT COMPLETED|Overall Study||59
10428813|NCT00860535|11574907|FG000|STARTED|Overall Study||9
10428814|NCT00860535|11574907|FG000|DISCONTINUED|Overall Study|Participant did not meet inclusion criteria and did not complete the study.|1
10720764|NCT02718898|11884385|FG003|COMPLETED|Blinded Treatment Period||0
10720765|NCT02718898|11884386|FG004|COMPLETED|Blinded Treatment Period||0
10720766|NCT02718898|11884387|FG005|COMPLETED|Blinded Treatment Period||0
10720767|NCT02718898|11884388|FG006|COMPLETED|Blinded Treatment Period||0
10720768|NCT02718898|11884382|FG000|NOT COMPLETED|Blinded Treatment Period||9
10720769|NCT02718898|11884383|FG001|NOT COMPLETED|Blinded Treatment Period||1
10720770|NCT02718898|11884384|FG002|NOT COMPLETED|Blinded Treatment Period||0
10398228|NCT00704379|11542030|FG000|STARTED|Overall Study||46
10398229|NCT00704379|11542031|FG001|STARTED|Overall Study||48
10398230|NCT00704379|11542030|FG000|COMPLETED|Overall Study||39
10398231|NCT00704379|11542031|FG001|COMPLETED|Overall Study||41
10398232|NCT00704379|11542030|FG000|NOT COMPLETED|Overall Study||7
10398233|NCT00704379|11542031|FG001|NOT COMPLETED|Overall Study||7
10398234|NCT00704405|11542044|FG000|STARTED|Overall Study (NC Population)||42
10398235|NCT00704405|11542045|FG001|STARTED|Overall Study (NC Population)||44
10398236|NCT00704405|11542046|FG002|STARTED|Overall Study (NC Population)||41
10398237|NCT00704405|11542047|FG003|STARTED|Overall Study (NC Population)||42
10543779|NCT01485627|11696929|FG000|STARTED|Overall Study|139 patients and 105 caregivers|244
10543780|NCT01485627|11696930|FG001|STARTED|Overall Study|142 patients and 99 caregivers|241
10543781|NCT01485627|11696929|FG000|Allocated Caregivers: Total|Overall Study||105
10543782|NCT01485627|11696930|FG001|Allocated Caregivers: Total|Overall Study||99
10659214|NCT02239770|11820526|FG000|STARTED|Part 2||0
10659215|NCT02239770|11820527|FG001|STARTED|Part 2||0
10659216|NCT02239770|11820528|FG002|STARTED|Part 2||0
10659217|NCT02239770|11820529|FG003|STARTED|Part 2||4
10659218|NCT02239770|11820530|FG004|STARTED|Part 2||4
10659219|NCT02239770|11820531|FG005|STARTED|Part 2||4
10659220|NCT02239770|11820526|FG000|COMPLETED|Part 2||0
10659221|NCT02239770|11820527|FG001|COMPLETED|Part 2||0
10659222|NCT02239770|11820528|FG002|COMPLETED|Part 2||0
10659223|NCT02239770|11820529|FG003|COMPLETED|Part 2||4
10659224|NCT02239770|11820530|FG004|COMPLETED|Part 2||4
10659225|NCT02239770|11820531|FG005|COMPLETED|Part 2||4
10398238|NCT00704405|11542048|FG004|STARTED|Overall Study (NC Population)||42
10398239|NCT00704405|11542044|FG000|COMPLETED|Overall Study (NC Population)||37
10398240|NCT00704405|11542045|FG001|COMPLETED|Overall Study (NC Population)||40
10398241|NCT00704405|11542046|FG002|COMPLETED|Overall Study (NC Population)||38
10398242|NCT00704405|11542047|FG003|COMPLETED|Overall Study (NC Population)||38
10543783|NCT01485627|11696929|FG000|Bereaved Caregivers: Total|Overall Study||63
10543784|NCT01485627|11696930|FG001|Bereaved Caregivers: Total|Overall Study||64
10543785|NCT01485627|11696929|FG000|Bereaved Caregivers: 1 Month|Overall Study||51
10659226|NCT02239770|11820526|FG000|NOT COMPLETED|Part 2||0
10659227|NCT02239770|11820527|FG001|NOT COMPLETED|Part 2||0
10659228|NCT02239770|11820528|FG002|NOT COMPLETED|Part 2||0
10311483|NCT00131365|11444772|FG000|NOT COMPLETED|Overall Study||4
10311484|NCT00131378|11444781|FG000|STARTED|Overall Study||40
10311485|NCT00131378|11444782|FG001|STARTED|Overall Study||40
10311486|NCT00131378|11444783|FG002|STARTED|Overall Study||32
10311487|NCT00131378|11444784|FG003|STARTED|Overall Study||30
10311488|NCT00131378|11444781|FG000|COMPLETED|Overall Study||29
10311489|NCT00131378|11444782|FG001|COMPLETED|Overall Study||22
10311490|NCT00131378|11444783|FG002|COMPLETED|Overall Study||22
10311491|NCT00131378|11444784|FG003|COMPLETED|Overall Study||21
10311492|NCT00131378|11444781|FG000|NOT COMPLETED|Overall Study||11
10311493|NCT00131378|11444782|FG001|NOT COMPLETED|Overall Study||18
10311494|NCT00131378|11444783|FG002|NOT COMPLETED|Overall Study||10
10311495|NCT00131378|11444784|FG003|NOT COMPLETED|Overall Study||9
10311496|NCT00131456|11444798|FG000|STARTED|Overall Study||52
10311497|NCT00131456|11444799|FG001|STARTED|Overall Study||51
10311498|NCT00131456|11444798|FG000|COMPLETED|Overall Study||33
10311499|NCT00131456|11444799|FG001|COMPLETED|Overall Study||31
10311500|NCT00131456|11444798|FG000|NOT COMPLETED|Overall Study||19
10311501|NCT00131456|11444799|FG001|NOT COMPLETED|Overall Study||20
10311502|NCT00131469|11444807|FG000|STARTED|Overall Study||38
10311503|NCT00131469|11444808|FG001|STARTED|Overall Study||40
10311504|NCT00131469|11444807|FG000|COMPLETED|Overall Study||29
10311505|NCT00131469|11444808|FG001|COMPLETED|Overall Study||27
10311506|NCT00131469|11444807|FG000|NOT COMPLETED|Overall Study||9
10311507|NCT00131469|11444808|FG001|NOT COMPLETED|Overall Study||13
10311508|NCT00131508|11444816|FG000|STARTED|Overall Study||12
10311509|NCT00131508|11444817|FG001|STARTED|Overall Study||13
10311510|NCT00131508|11444816|FG000|COMPLETED|Overall Study||9
10311511|NCT00131508|11444817|FG001|COMPLETED|Overall Study||5
10311512|NCT00131508|11444816|FG000|NOT COMPLETED|Overall Study||3
10311513|NCT00131508|11444817|FG001|NOT COMPLETED|Overall Study||8
10311514|NCT00131573|11444825|FG000|STARTED|Overall Study||46
10311515|NCT00131573|11444826|FG001|STARTED|Overall Study||39
10311516|NCT00131573|11444825|FG000|COMPLETED|Overall Study||13
10311517|NCT00131573|11444826|FG001|COMPLETED|Overall Study||13
10311518|NCT00131573|11444825|FG000|NOT COMPLETED|Overall Study||33
10311519|NCT00131573|11444826|FG001|NOT COMPLETED|Overall Study||26
10311520|NCT00131664|11444836|FG000|STARTED|First Period (First 6 Months)||136
10311521|NCT00131664|11444837|FG001|STARTED|First Period (First 6 Months)||135
10311522|NCT00131664|11444838|FG002|STARTED|First Period (First 6 Months)||120
10311523|NCT00131664|11444839|FG003|STARTED|First Period (First 6 Months)||0
10311524|NCT00131664|11444840|FG004|STARTED|First Period (First 6 Months)||0
10311525|NCT00131664|11444841|FG005|STARTED|First Period (First 6 Months)||0
10311526|NCT00131664|11444836|FG000|COMPLETED|First Period (First 6 Months)||111
10398243|NCT00704405|11542048|FG004|COMPLETED|Overall Study (NC Population)||37
10398244|NCT00704405|11542044|FG000|NOT COMPLETED|Overall Study (NC Population)||5
10398245|NCT00704405|11542045|FG001|NOT COMPLETED|Overall Study (NC Population)||4
10398246|NCT00704405|11542046|FG002|NOT COMPLETED|Overall Study (NC Population)||3
10398247|NCT00704405|11542047|FG003|NOT COMPLETED|Overall Study (NC Population)||4
10398248|NCT00704405|11542048|FG004|NOT COMPLETED|Overall Study (NC Population)||5
10398249|NCT00704405|11542044|FG000|STARTED|Overall Study (C Population)||16
10398250|NCT00704405|11542045|FG001|STARTED|Overall Study (C Population)||14
10398251|NCT00704405|11542046|FG002|STARTED|Overall Study (C Population)||15
10398252|NCT00704405|11542047|FG003|STARTED|Overall Study (C Population)||15
10398253|NCT00704405|11542048|FG004|STARTED|Overall Study (C Population)||14
10398254|NCT00704405|11542044|FG000|COMPLETED|Overall Study (C Population)||15
10398255|NCT00704405|11542045|FG001|COMPLETED|Overall Study (C Population)||11
10398256|NCT00704405|11542046|FG002|COMPLETED|Overall Study (C Population)||14
10398257|NCT00704405|11542047|FG003|COMPLETED|Overall Study (C Population)||14
10398258|NCT00704405|11542048|FG004|COMPLETED|Overall Study (C Population)||14
10311527|NCT00131664|11444837|FG001|COMPLETED|First Period (First 6 Months)||117
10311528|NCT00131664|11444838|FG002|COMPLETED|First Period (First 6 Months)||104
10311529|NCT00131664|11444839|FG003|COMPLETED|First Period (First 6 Months)||0
10311530|NCT00131664|11444840|FG004|COMPLETED|First Period (First 6 Months)||0
10311531|NCT00131664|11444841|FG005|COMPLETED|First Period (First 6 Months)||0
10311532|NCT00131664|11444836|FG000|NOT COMPLETED|First Period (First 6 Months)||25
10311533|NCT00131664|11444837|FG001|NOT COMPLETED|First Period (First 6 Months)||18
10311534|NCT00131664|11444838|FG002|NOT COMPLETED|First Period (First 6 Months)||16
10398259|NCT00704405|11542044|FG000|NOT COMPLETED|Overall Study (C Population)||1
10398260|NCT00704405|11542045|FG001|NOT COMPLETED|Overall Study (C Population)||3
10398261|NCT00704405|11542046|FG002|NOT COMPLETED|Overall Study (C Population)||1
10398262|NCT00704405|11542047|FG003|NOT COMPLETED|Overall Study (C Population)||1
10398263|NCT00704405|11542048|FG004|NOT COMPLETED|Overall Study (C Population)||0
10398264|NCT00704418|11542068|FG000|STARTED|Overall Study||78
10398265|NCT00704418|11542069|FG001|STARTED|Overall Study||78
10398266|NCT00704418|11542068|FG000|COMPLETED|Overall Study||73
10398267|NCT00704418|11542069|FG001|COMPLETED|Overall Study||72
10398268|NCT00704418|11542068|FG000|NOT COMPLETED|Overall Study||5
10398269|NCT00704418|11542069|FG001|NOT COMPLETED|Overall Study||6
10398270|NCT00704522|11542077|FG000|STARTED|Overall Study||481
10398271|NCT00704522|11542078|FG001|STARTED|Overall Study||120
10398272|NCT00704522|11542077|FG000|COMPLETED|Overall Study||298
10398273|NCT00704522|11542078|FG001|COMPLETED|Overall Study||75
10398274|NCT00704522|11542077|FG000|NOT COMPLETED|Overall Study||183
10398275|NCT00704522|11542078|FG001|NOT COMPLETED|Overall Study||45
10398276|NCT00704717|11542083|FG000|STARTED|Overall Study||185
10398277|NCT00704717|11542083|FG000|COMPLETED|Overall Study||185
10398278|NCT00704717|11542083|FG000|NOT COMPLETED|Overall Study||0
10398279|NCT00704730|11542089|FG000|STARTED|Overall Study|Randomized|219
10398280|NCT00704730|11542090|FG001|STARTED|Overall Study|Randomized|111
10398281|NCT00704730|11542089|FG000|COMPLETED|Overall Study|Continuing treatment at data cutoff for primary analysis, but subsequently discontinued study|98
10398282|NCT00704730|11542090|FG001|COMPLETED|Overall Study|Continuing study treatment at the time of data cut-off.|15
10398283|NCT00704730|11542089|FG000|NOT COMPLETED|Overall Study||121
10398284|NCT00704730|11542090|FG001|NOT COMPLETED|Overall Study||96
10398285|NCT00704808|11542097|FG000|STARTED|Overall Study||180
10398286|NCT00704808|11542097|FG000|COMPLETED|Overall Study||49
10398287|NCT00704808|11542097|FG000|NOT COMPLETED|Overall Study||131
10398288|NCT00704847|11542103|FG000|STARTED|Overall Study||521
10398289|NCT00704847|11542104|FG001|STARTED|Overall Study||509
10398290|NCT00704847|11542103|FG000|COMPLETED|Overall Study||300
10398291|NCT00704847|11542104|FG001|COMPLETED|Overall Study||339
10398292|NCT00704847|11542103|FG000|NOT COMPLETED|Overall Study||221
10398293|NCT00704847|11542104|FG001|NOT COMPLETED|Overall Study||170
10398294|NCT00704912|11542113|FG000|STARTED|Overall Study||50
10398295|NCT00704912|11542114|FG001|STARTED|Overall Study||49
10398296|NCT00704912|11542115|FG002|STARTED|Overall Study||50
10398297|NCT00704912|11542113|FG000|COMPLETED|Overall Study||44
10398298|NCT00704912|11542114|FG001|COMPLETED|Overall Study||45
10398299|NCT00704912|11542115|FG002|COMPLETED|Overall Study||43
10398300|NCT00704912|11542113|FG000|NOT COMPLETED|Overall Study||6
10398301|NCT00704912|11542114|FG001|NOT COMPLETED|Overall Study||4
10398302|NCT00704912|11542115|FG002|NOT COMPLETED|Overall Study||7
10398303|NCT00704938|11542125|FG000|STARTED|Overall Study||2
10398304|NCT00704938|11542126|FG001|STARTED|Overall Study||1
10398305|NCT00704938|11542125|FG000|COMPLETED|Overall Study||2
10659229|NCT02239770|11820529|FG003|NOT COMPLETED|Part 2||0
10659230|NCT02239770|11820530|FG004|NOT COMPLETED|Part 2||0
10659231|NCT02239770|11820531|FG005|NOT COMPLETED|Part 2||0
10659232|NCT02239939|11820555|FG000|STARTED|Overall Study||20
10659233|NCT02239939|11820556|FG001|STARTED|Overall Study||17
10659234|NCT02239939|11820555|FG000|COMPLETED|Overall Study||18
10659235|NCT02239939|11820556|FG001|COMPLETED|Overall Study||15
10659236|NCT02239939|11820555|FG000|NOT COMPLETED|Overall Study||2
10659237|NCT02239939|11820556|FG001|NOT COMPLETED|Overall Study||2
10659238|NCT02239978|11820566|FG000|STARTED|Overall Study||30
10659239|NCT02239978|11820567|FG001|STARTED|Overall Study||12
10659240|NCT02239978|11820566|FG000|COMPLETED|Overall Study||28
10659241|NCT02239978|11820567|FG001|COMPLETED|Overall Study||12
10659242|NCT02239978|11820566|FG000|NOT COMPLETED|Overall Study||2
10659243|NCT02239978|11820567|FG001|NOT COMPLETED|Overall Study||0
10659244|NCT02240030|11820578|FG000|STARTED|Overall Study||113
10659245|NCT02240030|11820579|FG001|STARTED|Overall Study||114
10659246|NCT02240030|11820580|FG002|STARTED|Overall Study||112
10659247|NCT02240030|11820578|FG000|COMPLETED|Overall Study||96
10659248|NCT02240030|11820579|FG001|COMPLETED|Overall Study||97
10659249|NCT02240030|11820580|FG002|COMPLETED|Overall Study||97
10659250|NCT02240030|11820578|FG000|NOT COMPLETED|Overall Study||17
10659251|NCT02240030|11820579|FG001|NOT COMPLETED|Overall Study||17
10659252|NCT02240030|11820580|FG002|NOT COMPLETED|Overall Study||15
10720771|NCT02718898|11884385|FG003|NOT COMPLETED|Blinded Treatment Period||0
10720772|NCT02718898|11884386|FG004|NOT COMPLETED|Blinded Treatment Period||0
10720773|NCT02718898|11884387|FG005|NOT COMPLETED|Blinded Treatment Period||0
10720774|NCT02718898|11884388|FG006|NOT COMPLETED|Blinded Treatment Period||0
10720775|NCT02718898|11884382|FG000|STARTED|Open Label Treatment Period (OLTP)||0
10720776|NCT02718898|11884383|FG001|STARTED|Open Label Treatment Period (OLTP)||0
10720777|NCT02718898|11884384|FG002|STARTED|Open Label Treatment Period (OLTP)||65
10720778|NCT02718898|11884385|FG003|STARTED|Open Label Treatment Period (OLTP)||74
10398306|NCT00704938|11542126|FG001|COMPLETED|Overall Study||1
10398307|NCT00704938|11542125|FG000|NOT COMPLETED|Overall Study||0
10398308|NCT00704938|11542126|FG001|NOT COMPLETED|Overall Study||0
10398309|NCT00704964|11542132|FG000|STARTED|Overall Study|Number of participants who took at least one dose of study medication.|746
10398310|NCT00704964|11542132|FG000|COMPLETED|Overall Study|Number of participants who completed therapy as scheduled.|418
10398311|NCT00704964|11542132|FG000|NOT COMPLETED|Overall Study||328
10398312|NCT00705003|11542139|FG000|STARTED|Enrolled||71
10398313|NCT00705003|11542140|FG001|STARTED|Enrolled||37
10398314|NCT00705003|11542141|FG002|STARTED|Enrolled||34
10398315|NCT00705003|11542139|FG000|COMPLETED|Enrolled||67
10398316|NCT00705003|11542140|FG001|COMPLETED|Enrolled||34
10398317|NCT00705003|11542141|FG002|COMPLETED|Enrolled||33
10398318|NCT00705003|11542139|FG000|NOT COMPLETED|Enrolled||4
10398319|NCT00705003|11542140|FG001|NOT COMPLETED|Enrolled||3
10398320|NCT00705003|11542141|FG002|NOT COMPLETED|Enrolled||1
10398321|NCT00705003|11542139|FG000|STARTED|Treated||67
10398322|NCT00705003|11542140|FG001|STARTED|Treated||34
10398323|NCT00705003|11542141|FG002|STARTED|Treated||33
10398324|NCT00705003|11542139|FG000|COMPLETED|Treated||54
10398325|NCT00705003|11542140|FG001|COMPLETED|Treated||28
10398326|NCT00705003|11542141|FG002|COMPLETED|Treated||30
10398327|NCT00705003|11542139|FG000|NOT COMPLETED|Treated||13
10398328|NCT00705003|11542140|FG001|NOT COMPLETED|Treated||6
10720779|NCT02718898|11884386|FG004|STARTED|Open Label Treatment Period (OLTP)||0
10720780|NCT02718898|11884387|FG005|STARTED|Open Label Treatment Period (OLTP)||0
10720781|NCT02718898|11884388|FG006|STARTED|Open Label Treatment Period (OLTP)||0
10720782|NCT02718898|11884382|FG000|COMPLETED|Open Label Treatment Period (OLTP)||0
10398329|NCT00705003|11542141|FG002|NOT COMPLETED|Treated||3
10398330|NCT00705016|11542153|FG000|STARTED|Overall Study||62
10398331|NCT00705016|11542154|FG001|STARTED|Overall Study||60
10398332|NCT00705016|11542155|FG002|STARTED|Overall Study||62
10398333|NCT00705016|11542153|FG000|COMPLETED|Overall Study||2
10398334|NCT00705016|11542154|FG001|COMPLETED|Overall Study||2
10398335|NCT00705016|11542155|FG002|COMPLETED|Overall Study||4
10398336|NCT00705016|11542153|FG000|NOT COMPLETED|Overall Study||60
10398337|NCT00705016|11542154|FG001|NOT COMPLETED|Overall Study||58
10398338|NCT00705016|11542155|FG002|NOT COMPLETED|Overall Study||58
10398339|NCT00705107|11542163|FG000|STARTED|Overall Study||267
10398340|NCT00705107|11542163|FG000|COMPLETED|Overall Study||218
10398341|NCT00705107|11542163|FG000|NOT COMPLETED|Overall Study||49
10398342|NCT00705133|11542167|FG000|STARTED|Overall Study||15
10398343|NCT00705133|11542167|FG000|COMPLETED|Overall Study||15
10398344|NCT00705133|11542167|FG000|NOT COMPLETED|Overall Study||0
10398345|NCT00705146|11542173|FG000|STARTED|Overall Study||32
10398346|NCT00705146|11542174|FG001|STARTED|Overall Study||24
10398347|NCT00705146|11542173|FG000|COMPLETED|Overall Study||31
10398348|NCT00705146|11542174|FG001|COMPLETED|Overall Study||23
10398349|NCT00705146|11542173|FG000|NOT COMPLETED|Overall Study||1
10398350|NCT00705146|11542174|FG001|NOT COMPLETED|Overall Study||1
10398351|NCT00705159|11542184|FG000|STARTED|Overall Study||34
10398352|NCT00705159|11542185|FG001|STARTED|Overall Study||35
10398353|NCT00705159|11542186|FG002|STARTED|Overall Study||34
10398354|NCT00705159|11542187|FG003|STARTED|Overall Study||34
10398355|NCT00705159|11542184|FG000|COMPLETED|Overall Study||34
10398356|NCT00705159|11542185|FG001|COMPLETED|Overall Study||33
10398357|NCT00705159|11542186|FG002|COMPLETED|Overall Study||29
10398358|NCT00705159|11542187|FG003|COMPLETED|Overall Study||30
10659253|NCT02240108|11820592|FG000|STARTED|Overall Study||35
10398359|NCT00705159|11542184|FG000|NOT COMPLETED|Overall Study||0
10398360|NCT00705159|11542185|FG001|NOT COMPLETED|Overall Study||2
10398361|NCT00705159|11542186|FG002|NOT COMPLETED|Overall Study||5
10398362|NCT00705159|11542187|FG003|NOT COMPLETED|Overall Study||4
10398363|NCT00705224|11542197|FG000|STARTED|Overall Study||250
10398364|NCT00705224|11542197|FG000|COMPLETED|Overall Study||239
10398365|NCT00705224|11542197|FG000|NOT COMPLETED|Overall Study||11
10398366|NCT00705250|11542204|FG000|STARTED|Overall Study||36
10398367|NCT00705250|11542204|FG000|COMPLETED|Overall Study||34
10398368|NCT00705250|11542204|FG000|NOT COMPLETED|Overall Study||2
10398369|NCT00705263|11542208|FG000|STARTED|Overall Study|113 patients started the treatment; however, data were available for only 110 patients.|110
10398370|NCT00705263|11542208|FG000|COMPLETED|Overall Study||108
10659254|NCT02240108|11820593|FG001|STARTED|Overall Study||46
10659255|NCT02240108|11820592|FG000|Intent-to-treat (ITT) Population|Overall Study||35
10659256|NCT02240108|11820593|FG001|Intent-to-treat (ITT) Population|Overall Study||45
10659257|NCT02240108|11820592|FG000|COMPLETED|Overall Study||21
10659258|NCT02240108|11820593|FG001|COMPLETED|Overall Study||21
10659259|NCT02240108|11820592|FG000|NOT COMPLETED|Overall Study||14
10659260|NCT02240108|11820593|FG001|NOT COMPLETED|Overall Study||25
10659261|NCT02240121|11820601|FG000|STARTED|Overall Study||40
10720783|NCT02718898|11884383|FG001|COMPLETED|Open Label Treatment Period (OLTP)||0
10720784|NCT02718898|11884384|FG002|COMPLETED|Open Label Treatment Period (OLTP)||62
10720785|NCT02718898|11884385|FG003|COMPLETED|Open Label Treatment Period (OLTP)||64
10720786|NCT02718898|11884386|FG004|COMPLETED|Open Label Treatment Period (OLTP)||0
10720787|NCT02718898|11884387|FG005|COMPLETED|Open Label Treatment Period (OLTP)||0
10720788|NCT02718898|11884388|FG006|COMPLETED|Open Label Treatment Period (OLTP)||0
10398371|NCT00705263|11542208|FG000|NOT COMPLETED|Overall Study||2
10398372|NCT00705289|11542212|FG000|STARTED|Overall Study||728
10398373|NCT00705289|11542212|FG000|COMPLETED|Overall Study||597
10398374|NCT00705289|11542212|FG000|NOT COMPLETED|Overall Study||131
10398375|NCT00705341|11542235|FG000|STARTED|Phase 1:Control Challenge||126
10398376|NCT00705341|11542236|FG001|STARTED|Phase 1:Control Challenge||93
10398377|NCT00705341|11542237|FG002|STARTED|Phase 1:Control Challenge||0
10398378|NCT00705341|11542238|FG003|STARTED|Phase 1:Control Challenge||0
10398379|NCT00705341|11542235|FG000|COMPLETED|Phase 1:Control Challenge|If participants in this group met criteria, they were randomized into phase 2|126
10398380|NCT00705341|11542236|FG001|COMPLETED|Phase 1:Control Challenge|Nonasthmatic controls did not advance to phase 2 due to design of study|93
10398381|NCT00705341|11542237|FG002|COMPLETED|Phase 1:Control Challenge||0
10398382|NCT00705341|11542238|FG003|COMPLETED|Phase 1:Control Challenge||0
10398383|NCT00705341|11542235|FG000|NOT COMPLETED|Phase 1:Control Challenge||0
10398384|NCT00705341|11542236|FG001|NOT COMPLETED|Phase 1:Control Challenge||0
10398385|NCT00705341|11542237|FG002|NOT COMPLETED|Phase 1:Control Challenge||0
10398386|NCT00705341|11542238|FG003|NOT COMPLETED|Phase 1:Control Challenge||0
10398387|NCT00705341|11542235|FG000|STARTED|Phase 2: Trial||0
10398388|NCT00705341|11542236|FG001|STARTED|Phase 2: Trial||0
10398389|NCT00705341|11542237|FG002|STARTED|Phase 2: Trial|This group was randomized from asthmatic controls in phase 1 if they met criteria to be in phase 2|30
10398390|NCT00705341|11542238|FG003|STARTED|Phase 2: Trial|This group was randomized from asthmatic controls in phase 1 if they met criteria to be in phase 2|32
10398391|NCT00705341|11542235|FG000|COMPLETED|Phase 2: Trial||0
10398392|NCT00705341|11542236|FG001|COMPLETED|Phase 2: Trial||0
10398393|NCT00705341|11542237|FG002|COMPLETED|Phase 2: Trial||23
10398394|NCT00705341|11542238|FG003|COMPLETED|Phase 2: Trial||28
10398395|NCT00705341|11542235|FG000|NOT COMPLETED|Phase 2: Trial||0
10398396|NCT00705341|11542236|FG001|NOT COMPLETED|Phase 2: Trial||0
10398397|NCT00705341|11542237|FG002|NOT COMPLETED|Phase 2: Trial||7
10398398|NCT00705341|11542238|FG003|NOT COMPLETED|Phase 2: Trial||4
10398399|NCT00705367|11542248|FG000|STARTED|Short-term Period||6
10720789|NCT02718898|11884382|FG000|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
10720790|NCT02718898|11884383|FG001|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
10720791|NCT02718898|11884384|FG002|NOT COMPLETED|Open Label Treatment Period (OLTP)||3
10398400|NCT00705367|11542249|FG001|STARTED|Short-term Period||3
10398401|NCT00705367|11542248|FG000|COMPLETED|Short-term Period||6
10720792|NCT02718898|11884385|FG003|NOT COMPLETED|Open Label Treatment Period (OLTP)||10
10720793|NCT02718898|11884386|FG004|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
10720794|NCT02718898|11884387|FG005|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
10720795|NCT02718898|11884388|FG006|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
10720796|NCT02718898|11884382|FG000|STARTED|Post Treatment Follow-up Period||0
10720797|NCT02718898|11884383|FG001|STARTED|Post Treatment Follow-up Period||0
10720798|NCT02718898|11884384|FG002|STARTED|Post Treatment Follow-up Period||0
10720799|NCT02718898|11884385|FG003|STARTED|Post Treatment Follow-up Period||0
10720800|NCT02718898|11884386|FG004|STARTED|Post Treatment Follow-up Period|One participant who discontinued from placebo blinded treatment had entered post-treatment follow-up|1
10311535|NCT00131664|11444839|FG003|NOT COMPLETED|First Period (First 6 Months)||0
10311536|NCT00131664|11444840|FG004|NOT COMPLETED|First Period (First 6 Months)||0
10311537|NCT00131664|11444841|FG005|NOT COMPLETED|First Period (First 6 Months)||0
10311538|NCT00131664|11444836|FG000|STARTED|Second Period (Additional Drug Added)|21 had added Metformin at Month 6|90
10311539|NCT00131664|11444837|FG001|STARTED|Second Period (Additional Drug Added)|16 had added Amaryl at Month 6|101
10311540|NCT00131664|11444838|FG002|STARTED|Second Period (Additional Drug Added)|25 had added Amaryl at Month 6|79
10398402|NCT00705367|11542249|FG001|COMPLETED|Short-term Period||3
10398403|NCT00705367|11542248|FG000|NOT COMPLETED|Short-term Period||0
10398404|NCT00705367|11542249|FG001|NOT COMPLETED|Short-term Period||0
10398405|NCT00705367|11542248|FG000|STARTED|Long-term Extension Period||9
10398406|NCT00705367|11542249|FG001|STARTED|Long-term Extension Period||0
10398407|NCT00705367|11542248|FG000|COMPLETED|Long-term Extension Period||0
10398408|NCT00705367|11542249|FG001|COMPLETED|Long-term Extension Period||0
10398409|NCT00705367|11542248|FG000|NOT COMPLETED|Long-term Extension Period||9
10398410|NCT00705367|11542249|FG001|NOT COMPLETED|Long-term Extension Period||0
10398411|NCT00705406|11542259|FG000|STARTED|Overall Study||203
10398412|NCT00705406|11542260|FG001|STARTED|Overall Study||202
10398413|NCT00705406|11542259|FG000|COMPLETED|Overall Study||199
10398414|NCT00705406|11542260|FG001|COMPLETED|Overall Study||197
10398415|NCT00705406|11542259|FG000|NOT COMPLETED|Overall Study||4
10398416|NCT00705406|11542260|FG001|NOT COMPLETED|Overall Study||5
10398417|NCT00705432|11542273|FG000|STARTED|Treatment Period||311
10398418|NCT00705432|11542274|FG001|STARTED|Treatment Period||316
10398419|NCT00705432|11542275|FG002|STARTED|Treatment Period||311
10398420|NCT00705432|11542276|FG003|STARTED|Treatment Period||52
10398421|NCT00705432|11542277|FG004|STARTED|Treatment Period||52
10398422|NCT00705432|11542278|FG005|STARTED|Treatment Period||55
10398423|NCT00705432|11542273|FG000|STARTED BOCEPREVIR/PLACEBO|Treatment Period||297
10398424|NCT00705432|11542274|FG001|STARTED BOCEPREVIR/PLACEBO|Treatment Period||303
10398425|NCT00705432|11542275|FG002|STARTED BOCEPREVIR/PLACEBO|Treatment Period||299
10398426|NCT00705432|11542276|FG003|STARTED BOCEPREVIR/PLACEBO|Treatment Period||47
10398427|NCT00705432|11542277|FG004|STARTED BOCEPREVIR/PLACEBO|Treatment Period||47
10398428|NCT00705432|11542278|FG005|STARTED BOCEPREVIR/PLACEBO|Treatment Period||55
10398429|NCT00705432|11542273|FG000|COMPLETED|Treatment Period||148
10398430|NCT00705432|11542274|FG001|COMPLETED|Treatment Period||205
10398431|NCT00705432|11542275|FG002|COMPLETED|Treatment Period||190
10398432|NCT00705432|11542276|FG003|COMPLETED|Treatment Period||11
10398433|NCT00705432|11542277|FG004|COMPLETED|Treatment Period||24
10398434|NCT00705432|11542278|FG005|COMPLETED|Treatment Period||25
10398435|NCT00705432|11542273|FG000|NOT COMPLETED|Treatment Period||163
10398436|NCT00705432|11542274|FG001|NOT COMPLETED|Treatment Period||111
10398437|NCT00705432|11542275|FG002|NOT COMPLETED|Treatment Period||121
10398438|NCT00705432|11542276|FG003|NOT COMPLETED|Treatment Period||41
10398439|NCT00705432|11542277|FG004|NOT COMPLETED|Treatment Period||28
10398440|NCT00705432|11542278|FG005|NOT COMPLETED|Treatment Period||30
10398441|NCT00705432|11542273|FG000|STARTED|Follow-up Period (Upto Week 72)||278
10398442|NCT00705432|11542274|FG001|STARTED|Follow-up Period (Upto Week 72)||295
10398443|NCT00705432|11542275|FG002|STARTED|Follow-up Period (Upto Week 72)||291
10398444|NCT00705432|11542276|FG003|STARTED|Follow-up Period (Upto Week 72)||42
10398445|NCT00705432|11542277|FG004|STARTED|Follow-up Period (Upto Week 72)||44
10398446|NCT00705432|11542278|FG005|STARTED|Follow-up Period (Upto Week 72)||53
10398447|NCT00705432|11542273|FG000|COMPLETED|Follow-up Period (Upto Week 72)||207
10398448|NCT00705432|11542274|FG001|COMPLETED|Follow-up Period (Upto Week 72)||252
10398449|NCT00705432|11542275|FG002|COMPLETED|Follow-up Period (Upto Week 72)||266
10398450|NCT00705432|11542276|FG003|COMPLETED|Follow-up Period (Upto Week 72)||28
10398451|NCT00705432|11542277|FG004|COMPLETED|Follow-up Period (Upto Week 72)||38
10398452|NCT00705432|11542278|FG005|COMPLETED|Follow-up Period (Upto Week 72)||46
10398453|NCT00705432|11542273|FG000|NOT COMPLETED|Follow-up Period (Upto Week 72)||71
10398454|NCT00705432|11542274|FG001|NOT COMPLETED|Follow-up Period (Upto Week 72)||43
10398455|NCT00705432|11542275|FG002|NOT COMPLETED|Follow-up Period (Upto Week 72)||25
10398456|NCT00705432|11542276|FG003|NOT COMPLETED|Follow-up Period (Upto Week 72)||14
10398457|NCT00705432|11542277|FG004|NOT COMPLETED|Follow-up Period (Upto Week 72)||6
10398458|NCT00705432|11542278|FG005|NOT COMPLETED|Follow-up Period (Upto Week 72)||7
10398459|NCT00705484|11542291|FG000|STARTED|Overall Study|Number Enrolled|1059
10398460|NCT00705484|11542292|FG001|STARTED|Overall Study|Number Enrolled|1180
10398461|NCT00705484|11542291|FG000|Follow-up Period|Overall Study||1059
10398462|NCT00705484|11542292|FG001|Follow-up Period|Overall Study|Switched From Standard Therapy to Remicade|296
10398463|NCT00705484|11542291|FG000|COMPLETED|Overall Study||677
10311541|NCT00131664|11444839|FG003|STARTED|Second Period (Additional Drug Added)||21
10398464|NCT00705484|11542292|FG001|COMPLETED|Overall Study||772
10398465|NCT00705484|11542291|FG000|NOT COMPLETED|Overall Study||382
10398466|NCT00705484|11542292|FG001|NOT COMPLETED|Overall Study||408
10398467|NCT00705523|11542302|FG000|STARTED|Overall Study||19
10398468|NCT00705523|11542303|FG001|STARTED|Overall Study||21
10398469|NCT00705523|11542302|FG000|COMPLETED|Overall Study||17
10398470|NCT00705523|11542303|FG001|COMPLETED|Overall Study||18
10398471|NCT00705523|11542302|FG000|NOT COMPLETED|Overall Study||2
10398472|NCT00705523|11542303|FG001|NOT COMPLETED|Overall Study||3
10398473|NCT00705536|11542311|FG000|STARTED|Start Period 1||6
10398474|NCT00705536|11542312|FG001|STARTED|Start Period 1||6
10398475|NCT00705536|11542313|FG002|STARTED|Start Period 1||7
10398476|NCT00705536|11542314|FG003|STARTED|Start Period 1||7
10398477|NCT00705536|11542311|FG000|Received at Least 1 Dose of Study Drug|Start Period 1||6
10398478|NCT00705536|11542312|FG001|Received at Least 1 Dose of Study Drug|Start Period 1||6
10398479|NCT00705536|11542313|FG002|Received at Least 1 Dose of Study Drug|Start Period 1||7
10398480|NCT00705536|11542314|FG003|Received at Least 1 Dose of Study Drug|Start Period 1||7
10398481|NCT00705536|11542311|FG000|COMPLETED|Start Period 1||6
10398482|NCT00705536|11542312|FG001|COMPLETED|Start Period 1||6
10398483|NCT00705536|11542313|FG002|COMPLETED|Start Period 1||7
10398484|NCT00705536|11542314|FG003|COMPLETED|Start Period 1||6
10398485|NCT00705536|11542311|FG000|NOT COMPLETED|Start Period 1||0
10398486|NCT00705536|11542312|FG001|NOT COMPLETED|Start Period 1||0
10398487|NCT00705536|11542313|FG002|NOT COMPLETED|Start Period 1||0
10398488|NCT00705536|11542314|FG003|NOT COMPLETED|Start Period 1||1
10398489|NCT00705536|11542311|FG000|STARTED|Washout Period of at Least 6 Days||6
10398490|NCT00705536|11542312|FG001|STARTED|Washout Period of at Least 6 Days||6
10398491|NCT00705536|11542313|FG002|STARTED|Washout Period of at Least 6 Days||7
10398492|NCT00705536|11542314|FG003|STARTED|Washout Period of at Least 6 Days||6
10398493|NCT00705536|11542311|FG000|COMPLETED|Washout Period of at Least 6 Days||6
10398494|NCT00705536|11542312|FG001|COMPLETED|Washout Period of at Least 6 Days||6
10398495|NCT00705536|11542313|FG002|COMPLETED|Washout Period of at Least 6 Days||7
10398496|NCT00705536|11542314|FG003|COMPLETED|Washout Period of at Least 6 Days||6
10398497|NCT00705536|11542311|FG000|NOT COMPLETED|Washout Period of at Least 6 Days||0
10398498|NCT00705536|11542312|FG001|NOT COMPLETED|Washout Period of at Least 6 Days||0
10398499|NCT00705536|11542313|FG002|NOT COMPLETED|Washout Period of at Least 6 Days||0
10398500|NCT00705536|11542314|FG003|NOT COMPLETED|Washout Period of at Least 6 Days||0
10398501|NCT00705536|11542311|FG000|STARTED|Start Period 2||6
10398502|NCT00705536|11542312|FG001|STARTED|Start Period 2||6
10398503|NCT00705536|11542313|FG002|STARTED|Start Period 2||7
10398504|NCT00705536|11542314|FG003|STARTED|Start Period 2||6
10398505|NCT00705536|11542311|FG000|COMPLETED|Start Period 2||6
10398506|NCT00705536|11542312|FG001|COMPLETED|Start Period 2||6
10398507|NCT00705536|11542313|FG002|COMPLETED|Start Period 2||7
10398508|NCT00705536|11542314|FG003|COMPLETED|Start Period 2||6
10398509|NCT00705536|11542311|FG000|NOT COMPLETED|Start Period 2||0
10398510|NCT00705536|11542312|FG001|NOT COMPLETED|Start Period 2||0
10398511|NCT00705536|11542313|FG002|NOT COMPLETED|Start Period 2||0
10398512|NCT00705536|11542314|FG003|NOT COMPLETED|Start Period 2||0
10398513|NCT00705536|11542311|FG000|STARTED|Completed Study||6
10398514|NCT00705536|11542312|FG001|STARTED|Completed Study||6
10398515|NCT00705536|11542313|FG002|STARTED|Completed Study||7
10398516|NCT00705536|11542314|FG003|STARTED|Completed Study||6
10398517|NCT00705536|11542311|FG000|COMPLETED|Completed Study||6
10398518|NCT00705536|11542312|FG001|COMPLETED|Completed Study||6
10398519|NCT00705536|11542313|FG002|COMPLETED|Completed Study||7
10720801|NCT02718898|11884387|FG005|STARTED|Post Treatment Follow-up Period||78
10720802|NCT02718898|11884388|FG006|STARTED|Post Treatment Follow-up Period||49
10720803|NCT02718898|11884382|FG000|COMPLETED|Post Treatment Follow-up Period||0
10720804|NCT02718898|11884383|FG001|COMPLETED|Post Treatment Follow-up Period||0
10720805|NCT02718898|11884384|FG002|COMPLETED|Post Treatment Follow-up Period||0
10720806|NCT02718898|11884385|FG003|COMPLETED|Post Treatment Follow-up Period||0
10720807|NCT02718898|11884386|FG004|COMPLETED|Post Treatment Follow-up Period||0
10720808|NCT02718898|11884387|FG005|COMPLETED|Post Treatment Follow-up Period||67
10398520|NCT00705536|11542314|FG003|COMPLETED|Completed Study||6
10398521|NCT00705536|11542311|FG000|NOT COMPLETED|Completed Study||0
10398522|NCT00705536|11542312|FG001|NOT COMPLETED|Completed Study||0
10398523|NCT00705536|11542313|FG002|NOT COMPLETED|Completed Study||0
10398524|NCT00705536|11542314|FG003|NOT COMPLETED|Completed Study||0
10720809|NCT02718898|11884388|FG006|COMPLETED|Post Treatment Follow-up Period||44
10720810|NCT02718898|11884382|FG000|NOT COMPLETED|Post Treatment Follow-up Period||0
10398525|NCT00705575|11542335|FG000|STARTED|Overall Study||349
10398526|NCT00705575|11542336|FG001|STARTED|Overall Study||339
10311542|NCT00131664|11444840|FG004|STARTED|Second Period (Additional Drug Added)||16
10311543|NCT00131664|11444841|FG005|STARTED|Second Period (Additional Drug Added)||25
10311544|NCT00131664|11444836|FG000|COMPLETED|Second Period (Additional Drug Added)||81
10311545|NCT00131664|11444837|FG001|COMPLETED|Second Period (Additional Drug Added)||97
10311546|NCT00131664|11444838|FG002|COMPLETED|Second Period (Additional Drug Added)||76
10311547|NCT00131664|11444839|FG003|COMPLETED|Second Period (Additional Drug Added)||19
10311548|NCT00131664|11444840|FG004|COMPLETED|Second Period (Additional Drug Added)||15
10311549|NCT00131664|11444841|FG005|COMPLETED|Second Period (Additional Drug Added)||22
10311550|NCT00131664|11444836|FG000|NOT COMPLETED|Second Period (Additional Drug Added)||9
10311551|NCT00131664|11444837|FG001|NOT COMPLETED|Second Period (Additional Drug Added)||4
10311552|NCT00131664|11444838|FG002|NOT COMPLETED|Second Period (Additional Drug Added)||3
10311553|NCT00131664|11444839|FG003|NOT COMPLETED|Second Period (Additional Drug Added)||2
10311554|NCT00131664|11444840|FG004|NOT COMPLETED|Second Period (Additional Drug Added)||1
10311555|NCT00131664|11444841|FG005|NOT COMPLETED|Second Period (Additional Drug Added)||3
10311556|NCT00131677|11444854|FG000|STARTED|Overall Study|201 randomized to active drug; 101 to start immediately and 100 after a 9 month delay.|201
10311557|NCT00131677|11444855|FG001|STARTED|Overall Study|199 randomized to placebo; 99 to start immediately and 100 after a 9 month delay.|199
10311558|NCT00131677|11444854|FG000|COMPLETED|Overall Study||171
10311559|NCT00131677|11444855|FG001|COMPLETED|Overall Study||160
10311560|NCT00131677|11444854|FG000|NOT COMPLETED|Overall Study||30
10311561|NCT00131677|11444855|FG001|NOT COMPLETED|Overall Study||39
10311562|NCT00131885|11444870|FG000|STARTED|Time 1: First Intervention||9
10311563|NCT00131885|11444871|FG001|STARTED|Time 1: First Intervention||9
10311564|NCT00131885|11444872|FG002|STARTED|Time 1: First Intervention||9
10311565|NCT00131885|11444873|FG003|STARTED|Time 1: First Intervention||9
10311566|NCT00131885|11444870|FG000|COMPLETED|Time 1: First Intervention||9
10311567|NCT00131885|11444871|FG001|COMPLETED|Time 1: First Intervention||9
10311568|NCT00131885|11444872|FG002|COMPLETED|Time 1: First Intervention||9
10311569|NCT00131885|11444873|FG003|COMPLETED|Time 1: First Intervention||9
10311570|NCT00131885|11444870|FG000|NOT COMPLETED|Time 1: First Intervention||0
10311571|NCT00131885|11444871|FG001|NOT COMPLETED|Time 1: First Intervention||0
10311572|NCT00131885|11444872|FG002|NOT COMPLETED|Time 1: First Intervention||0
10311573|NCT00131885|11444873|FG003|NOT COMPLETED|Time 1: First Intervention||0
10311574|NCT00131885|11444870|FG000|STARTED|Time 2: Second Intervention||9
10311575|NCT00131885|11444871|FG001|STARTED|Time 2: Second Intervention||9
10311576|NCT00131885|11444872|FG002|STARTED|Time 2: Second Intervention||9
10311577|NCT00131885|11444873|FG003|STARTED|Time 2: Second Intervention||9
10311578|NCT00131885|11444870|FG000|COMPLETED|Time 2: Second Intervention||9
10311579|NCT00131885|11444871|FG001|COMPLETED|Time 2: Second Intervention||9
10311580|NCT00131885|11444872|FG002|COMPLETED|Time 2: Second Intervention||9
10311581|NCT00131885|11444873|FG003|COMPLETED|Time 2: Second Intervention||9
10311582|NCT00131885|11444870|FG000|NOT COMPLETED|Time 2: Second Intervention||0
10311583|NCT00131885|11444871|FG001|NOT COMPLETED|Time 2: Second Intervention||0
10311584|NCT00131885|11444872|FG002|NOT COMPLETED|Time 2: Second Intervention||0
10311585|NCT00131885|11444873|FG003|NOT COMPLETED|Time 2: Second Intervention||0
10311586|NCT00131911|11444885|FG000|STARTED|Overall Study||51
10311587|NCT00131911|11444886|FG001|STARTED|Overall Study||42
10311588|NCT00131911|11444885|FG000|COMPLETED|Overall Study||50
10311589|NCT00131911|11444886|FG001|COMPLETED|Overall Study||42
10311590|NCT00131911|11444885|FG000|NOT COMPLETED|Overall Study||1
10311591|NCT00131911|11444886|FG001|NOT COMPLETED|Overall Study||0
10311592|NCT00131937|11444891|FG000|STARTED|Overall Study||14
10311593|NCT00131937|11444891|FG000|COMPLETED|Overall Study||0
10311594|NCT00131937|11444891|FG000|NOT COMPLETED|Overall Study||14
10311595|NCT00132002|11444895|FG000|STARTED|Overall Study||14
10311596|NCT00132002|11444895|FG000|COMPLETED|Overall Study||14
10311597|NCT00132002|11444895|FG000|NOT COMPLETED|Overall Study||0
10311598|NCT00132028|11444899|FG000|STARTED|Overall Study||27
10311599|NCT00132028|11444899|FG000|Eligible|Overall Study||25
10311600|NCT00132028|11444899|FG000|Eligible and Began Protocol Therapy|Overall Study||25
10311601|NCT00132028|11444899|FG000|COMPLETED|Overall Study|"Since there was no maximum number of cycles, patients could not complete treatment."|0
10311602|NCT00132028|11444899|FG000|NOT COMPLETED|Overall Study||27
10311603|NCT00132041|11444903|FG000|STARTED|Baseline||51
10311604|NCT00132041|11444903|FG000|Eligible|Baseline||45
10311605|NCT00132041|11444903|FG000|COMPLETED|Baseline||45
10311606|NCT00132041|11444903|FG000|NOT COMPLETED|Baseline||6
10311607|NCT00132041|11444903|FG000|STARTED|3 Months Post Ablation||45
10311608|NCT00132041|11444903|FG000|COMPLETED|3 Months Post Ablation||42
10311609|NCT00132041|11444903|FG000|NOT COMPLETED|3 Months Post Ablation||3
10311610|NCT00132041|11444903|FG000|STARTED|6 Months Post Ablation||42
10311611|NCT00132041|11444903|FG000|COMPLETED|6 Months Post Ablation||32
10398527|NCT00705575|11542335|FG000|COMPLETED|Overall Study||326
10398528|NCT00705575|11542336|FG001|COMPLETED|Overall Study||293
10398529|NCT00705575|11542335|FG000|NOT COMPLETED|Overall Study||23
10720811|NCT02718898|11884383|FG001|NOT COMPLETED|Post Treatment Follow-up Period||0
10720812|NCT02718898|11884384|FG002|NOT COMPLETED|Post Treatment Follow-up Period||0
10720813|NCT02718898|11884385|FG003|NOT COMPLETED|Post Treatment Follow-up Period||0
10720814|NCT02718898|11884386|FG004|NOT COMPLETED|Post Treatment Follow-up Period||1
10720815|NCT02718898|11884387|FG005|NOT COMPLETED|Post Treatment Follow-up Period||11
10720816|NCT02718898|11884388|FG006|NOT COMPLETED|Post Treatment Follow-up Period||5
10720817|NCT02718963|11884403|FG000|STARTED|Overall Study||10
10720818|NCT02718963|11884404|FG001|STARTED|Overall Study||10
10720819|NCT02718963|11884403|FG000|COMPLETED|Overall Study||9
10720820|NCT02718963|11884404|FG001|COMPLETED|Overall Study||9
10720821|NCT02718963|11884403|FG000|NOT COMPLETED|Overall Study||1
10311612|NCT00132041|11444903|FG000|NOT COMPLETED|6 Months Post Ablation||10
10311613|NCT00132041|11444903|FG000|STARTED|9 Months Post Ablation||32
10311614|NCT00132041|11444903|FG000|COMPLETED|9 Months Post Ablation||30
10311615|NCT00132041|11444903|FG000|NOT COMPLETED|9 Months Post Ablation||2
10311616|NCT00132041|11444903|FG000|STARTED|12 Months Post Ablation||30
10311617|NCT00132041|11444903|FG000|COMPLETED|12 Months Post Ablation||26
10311618|NCT00132041|11444903|FG000|NOT COMPLETED|12 Months Post Ablation||4
10311619|NCT00132041|11444903|FG000|STARTED|15 Months Post Ablation||26
10311620|NCT00132041|11444903|FG000|COMPLETED|15 Months Post Ablation||18
10311621|NCT00132041|11444903|FG000|NOT COMPLETED|15 Months Post Ablation||8
10311622|NCT00132041|11444903|FG000|STARTED|18 Months Post Ablation||18
10311623|NCT00132041|11444903|FG000|COMPLETED|18 Months Post Ablation||12
10311624|NCT00132041|11444903|FG000|NOT COMPLETED|18 Months Post Ablation||6
10311625|NCT00132132|11444915|FG000|STARTED|Overall Study||15
10311626|NCT00132132|11444916|FG001|STARTED|Overall Study||15
10311627|NCT00132132|11444915|FG000|COMPLETED|Overall Study||8
10311628|NCT00132132|11444916|FG001|COMPLETED|Overall Study||13
10311629|NCT00132132|11444915|FG000|NOT COMPLETED|Overall Study||7
10311630|NCT00132132|11444916|FG001|NOT COMPLETED|Overall Study||2
10311631|NCT00132301|11444924|FG000|STARTED|Overall Study||141
10311632|NCT00132301|11444925|FG001|STARTED|Overall Study||157
10311633|NCT00132301|11444924|FG000|COMPLETED|Overall Study||121
10311634|NCT00132301|11444925|FG001|COMPLETED|Overall Study||144
10311635|NCT00132301|11444924|FG000|NOT COMPLETED|Overall Study||20
10311636|NCT00132301|11444925|FG001|NOT COMPLETED|Overall Study||13
10311637|NCT00132314|11444933|FG000|STARTED|Overall Study||190
10311638|NCT00132314|11444934|FG001|STARTED|Overall Study||192
10311639|NCT00132314|11444933|FG000|Received Treatment|Overall Study||188
10311640|NCT00132314|11444934|FG001|Received Treatment|Overall Study||185
10311641|NCT00132314|11444933|FG000|Completed Baseline Visit, Provided SSN|Overall Study|This is the ITT cohort|187
10311642|NCT00132314|11444934|FG001|Completed Baseline Visit, Provided SSN|Overall Study|This is the ITT cohort.|182
10311643|NCT00132314|11444933|FG000|COMPLETED|Overall Study||117
10311644|NCT00132314|11444934|FG001|COMPLETED|Overall Study||120
10311645|NCT00132314|11444933|FG000|NOT COMPLETED|Overall Study||73
10311646|NCT00132314|11444934|FG001|NOT COMPLETED|Overall Study||72
10311647|NCT00132496|11444942|FG000|STARTED|Overall Study||54
10311648|NCT00132496|11444943|FG001|STARTED|Overall Study||57
10311649|NCT00132496|11444942|FG000|COMPLETED|Overall Study||52
10311650|NCT00132496|11444943|FG001|COMPLETED|Overall Study||55
10311651|NCT00132496|11444942|FG000|NOT COMPLETED|Overall Study||2
10311652|NCT00132496|11444943|FG001|NOT COMPLETED|Overall Study||2
10311653|NCT00132678|11444951|FG000|STARTED|Period II (Open-Label Oral Risperidone)||0
10311654|NCT00132678|11444952|FG001|STARTED|Period II (Open-Label Oral Risperidone)||0
10311655|NCT00132678|11444953|FG002|STARTED|Period II (Open-Label Oral Risperidone)||440
10311656|NCT00132678|11444951|FG000|COMPLETED|Period II (Open-Label Oral Risperidone)||0
10311657|NCT00132678|11444952|FG001|COMPLETED|Period II (Open-Label Oral Risperidone)||0
10311658|NCT00132678|11444953|FG002|COMPLETED|Period II (Open-Label Oral Risperidone)||382
10311659|NCT00132678|11444951|FG000|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||0
10311660|NCT00132678|11444952|FG001|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||0
10311661|NCT00132678|11444953|FG002|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||58
10311662|NCT00132678|11444951|FG000|STARTED|Period III (Open-Label Stabilization)||501
10311663|NCT00132678|11444952|FG001|STARTED|Period III (Open-Label Stabilization)||0
10311664|NCT00132678|11444953|FG002|STARTED|Period III (Open-Label Stabilization)||0
10311665|NCT00132678|11444951|FG000|COMPLETED|Period III (Open-Label Stabilization)||303
10311666|NCT00132678|11444952|FG001|COMPLETED|Period III (Open-Label Stabilization)||0
10311667|NCT00132678|11444953|FG002|COMPLETED|Period III (Open-Label Stabilization)||0
10311668|NCT00132678|11444951|FG000|NOT COMPLETED|Period III (Open-Label Stabilization)||198
10311669|NCT00132678|11444952|FG001|NOT COMPLETED|Period III (Open-Label Stabilization)||0
10311670|NCT00132678|11444953|FG002|NOT COMPLETED|Period III (Open-Label Stabilization)||0
10311671|NCT00132678|11444951|FG000|STARTED|Period IV (Double-Blind Treatment)||154
10311672|NCT00132678|11444952|FG001|STARTED|Period IV (Double-Blind Treatment)||149
10311673|NCT00132678|11444953|FG002|STARTED|Period IV (Double-Blind Treatment)||0
10311674|NCT00132678|11444951|FG000|COMPLETED|Period IV (Double-Blind Treatment)||117
10311675|NCT00132678|11444952|FG001|COMPLETED|Period IV (Double-Blind Treatment)||109
10311676|NCT00132678|11444953|FG002|COMPLETED|Period IV (Double-Blind Treatment)||0
10311677|NCT00132678|11444951|FG000|NOT COMPLETED|Period IV (Double-Blind Treatment)||37
10311678|NCT00132678|11444952|FG001|NOT COMPLETED|Period IV (Double-Blind Treatment)||40
10311679|NCT00132678|11444953|FG002|NOT COMPLETED|Period IV (Double-Blind Treatment)||0
10311680|NCT00132691|11444963|FG000|STARTED|Overall Study|129 participants were assigned to implant; 122 received implant|129
10311681|NCT00132691|11444964|FG001|STARTED|Overall Study|126 participants were assigned to systemic treatment; 121 received systemic therapy|126
10311682|NCT00132691|11444963|FG000|COMPLETED|Overall Study|118 participants completed the 2-year anniversary visit|118
10311683|NCT00132691|11444964|FG001|COMPLETED|Overall Study|114 participants completed the 2-year anniversary visit|114
10311684|NCT00132691|11444963|FG000|NOT COMPLETED|Overall Study||11
10311685|NCT00132691|11444964|FG001|NOT COMPLETED|Overall Study||12
10311686|NCT00132730|11444979|FG000|STARTED|Period I - Placebo Run-in (Base)||150
10311687|NCT00132730|11444980|FG001|STARTED|Period I - Placebo Run-in (Base)||148
10311688|NCT00132730|11444981|FG002|STARTED|Period I - Placebo Run-in (Base)||153
10311689|NCT00132730|11444982|FG003|STARTED|Period I - Placebo Run-in (Base)||153
10311690|NCT00132730|11444983|FG004|STARTED|Period I - Placebo Run-in (Base)||0
10311691|NCT00132730|11444984|FG005|STARTED|Period I - Placebo Run-in (Base)||0
10311692|NCT00132730|11444979|FG000|COMPLETED|Period I - Placebo Run-in (Base)||150
10311693|NCT00132730|11444980|FG001|COMPLETED|Period I - Placebo Run-in (Base)||148
10311694|NCT00132730|11444981|FG002|COMPLETED|Period I - Placebo Run-in (Base)||153
10311695|NCT00132730|11444982|FG003|COMPLETED|Period I - Placebo Run-in (Base)||153
10311696|NCT00132730|11444983|FG004|COMPLETED|Period I - Placebo Run-in (Base)||0
10311697|NCT00132730|11444984|FG005|COMPLETED|Period I - Placebo Run-in (Base)||0
10311698|NCT00132730|11444979|FG000|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
10311699|NCT00132730|11444980|FG001|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
10311700|NCT00132730|11444981|FG002|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
10720822|NCT02718963|11884404|FG001|NOT COMPLETED|Overall Study||1
10720823|NCT02719028|11884414|FG000|STARTED|Overall Study||30
10720824|NCT02719028|11884415|FG001|STARTED|Overall Study||30
10720825|NCT02719028|11884416|FG002|STARTED|Overall Study||30
10311701|NCT00132730|11444982|FG003|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
10311702|NCT00132730|11444983|FG004|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
10311703|NCT00132730|11444984|FG005|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
10311704|NCT00132730|11444979|FG000|STARTED|Period II - 12-week Treatment (Base)||150
10311705|NCT00132730|11444980|FG001|STARTED|Period II - 12-week Treatment (Base)||148
10311706|NCT00132730|11444981|FG002|STARTED|Period II - 12-week Treatment (Base)||153
10311707|NCT00132730|11444982|FG003|STARTED|Period II - 12-week Treatment (Base)||153
10311708|NCT00132730|11444983|FG004|STARTED|Period II - 12-week Treatment (Base)||0
10720826|NCT02719028|11884417|FG003|STARTED|Overall Study||30
10720827|NCT02719028|11884414|FG000|COMPLETED|Overall Study||28
10398530|NCT00705575|11542336|FG001|NOT COMPLETED|Overall Study||46
10398531|NCT00705614|11542344|FG000|STARTED|Initial Intervention||1541
10398532|NCT00705614|11542345|FG001|STARTED|Initial Intervention||1121
10398533|NCT00705614|11542344|FG000|COMPLETED|Initial Intervention||1023
10398534|NCT00705614|11542345|FG001|COMPLETED|Initial Intervention||800
10398535|NCT00705614|11542344|FG000|NOT COMPLETED|Initial Intervention||518
10398536|NCT00705614|11542345|FG001|NOT COMPLETED|Initial Intervention||321
10398537|NCT00705614|11542344|FG000|STARTED|Switch to Remicade||0
10398538|NCT00705614|11542345|FG001|STARTED|Switch to Remicade||298
10398539|NCT00705614|11542344|FG000|COMPLETED|Switch to Remicade||0
10398540|NCT00705614|11542345|FG001|COMPLETED|Switch to Remicade||249
10398541|NCT00705614|11542344|FG000|NOT COMPLETED|Switch to Remicade||0
10398542|NCT00705614|11542345|FG001|NOT COMPLETED|Switch to Remicade||49
10398543|NCT00705653|11542353|FG000|STARTED|Overall Study||46
10398544|NCT00705653|11542353|FG000|COMPLETED|Overall Study||46
10398545|NCT00705653|11542353|FG000|NOT COMPLETED|Overall Study||0
10398546|NCT00705666|11542357|FG000|STARTED|Overall Study||789
10398547|NCT00705666|11542357|FG000|COMPLETED|Overall Study||450
10398548|NCT00705666|11542357|FG000|NOT COMPLETED|Overall Study||339
10398549|NCT00705679|11542366|FG000|STARTED|Overall Study||1007
10398550|NCT00705679|11542367|FG001|STARTED|Overall Study||1003
10398551|NCT00705679|11542368|FG002|STARTED|Overall Study||1009
10398552|NCT00705679|11542369|FG003|STARTED|Overall Study||1007
10398553|NCT00705679|11542370|FG004|STARTED|Overall Study||1003
10398554|NCT00705679|11542366|FG000|COMPLETED|Overall Study||942
10398555|NCT00705679|11542367|FG001|COMPLETED|Overall Study||864
10398556|NCT00705679|11542368|FG002|COMPLETED|Overall Study||894
10398557|NCT00705679|11542369|FG003|COMPLETED|Overall Study||927
10398558|NCT00705679|11542370|FG004|COMPLETED|Overall Study||934
10398559|NCT00705679|11542366|FG000|NOT COMPLETED|Overall Study||65
10398560|NCT00705679|11542367|FG001|NOT COMPLETED|Overall Study||139
10398561|NCT00705679|11542368|FG002|NOT COMPLETED|Overall Study||115
10398562|NCT00705679|11542369|FG003|NOT COMPLETED|Overall Study||80
10398563|NCT00705679|11542370|FG004|NOT COMPLETED|Overall Study||69
10398564|NCT00705718|11542389|FG000|STARTED|Overall Study||44
10398565|NCT00705718|11542390|FG001|STARTED|Overall Study||150
10398566|NCT00705718|11542389|FG000|1 Month Follow up|Overall Study|1 Death|43
10398567|NCT00705718|11542390|FG001|1 Month Follow up|Overall Study|1 Subject Missed Visit|149
10398568|NCT00705718|11542389|FG000|6 Month Follow up|Overall Study|3 Deaths|40
10659262|NCT02240121|11820602|FG001|STARTED|Overall Study||40
10659263|NCT02240121|11820601|FG000|COMPLETED|Overall Study||22
10659264|NCT02240121|11820602|FG001|COMPLETED|Overall Study||20
10659265|NCT02240121|11820601|FG000|NOT COMPLETED|Overall Study||18
10659266|NCT02240121|11820602|FG001|NOT COMPLETED|Overall Study||20
10659267|NCT02240186|11820608|FG000|STARTED|Overall Study||50
10659268|NCT02240186|11820608|FG000|COMPLETED|Overall Study||23
10659269|NCT02240186|11820608|FG000|NOT COMPLETED|Overall Study||27
10659270|NCT02240329|11820615|FG000|STARTED|Overall Study||4
10659271|NCT02240329|11820615|FG000|Determination of Urge to Cough|Overall Study||4
10659272|NCT02240329|11820615|FG000|COMPLETED|Overall Study||4
10659273|NCT02240329|11820615|FG000|NOT COMPLETED|Overall Study||0
10659274|NCT02240368|11820622|FG000|STARTED|Overall Study||9
10659275|NCT02240368|11820623|FG001|STARTED|Overall Study||22
10659276|NCT02240368|11820624|FG002|STARTED|Overall Study||19
10659277|NCT02240368|11820622|FG000|COMPLETED|Overall Study||8
10659278|NCT02240368|11820623|FG001|COMPLETED|Overall Study||22
10720828|NCT02719028|11884415|FG001|COMPLETED|Overall Study||28
10720829|NCT02719028|11884416|FG002|COMPLETED|Overall Study||24
10720830|NCT02719028|11884417|FG003|COMPLETED|Overall Study||20
10398569|NCT00705718|11542390|FG001|6 Month Follow up|Overall Study|2 Deaths, 5 Subjects Missed Visit|143
10398570|NCT00705718|11542389|FG000|12 Month Follow up|Overall Study|2 Deaths|37
10398571|NCT00705718|11542390|FG001|12 Month Follow up|Overall Study|4 Deaths, 12 Subjects Not due for next visit, 4 Subjects Missed Visit|128
10398572|NCT00705718|11542389|FG000|COMPLETED|Overall Study||37
10398573|NCT00705718|11542390|FG001|COMPLETED|Overall Study||128
10398574|NCT00705718|11542389|FG000|NOT COMPLETED|Overall Study||7
10398575|NCT00705718|11542390|FG001|NOT COMPLETED|Overall Study||22
10398576|NCT00705757|11542399|FG000|STARTED|Overall Study||32
10398577|NCT00705757|11542400|FG001|STARTED|Overall Study||29
10659279|NCT02240368|11820624|FG002|COMPLETED|Overall Study||18
10659280|NCT02240368|11820622|FG000|NOT COMPLETED|Overall Study||1
10659281|NCT02240368|11820623|FG001|NOT COMPLETED|Overall Study||0
10720831|NCT02719028|11884414|FG000|NOT COMPLETED|Overall Study||2
10720832|NCT02719028|11884415|FG001|NOT COMPLETED|Overall Study||2
10720833|NCT02719028|11884416|FG002|NOT COMPLETED|Overall Study||6
10720834|NCT02719028|11884417|FG003|NOT COMPLETED|Overall Study||10
10311709|NCT00132730|11444984|FG005|STARTED|Period II - 12-week Treatment (Base)||0
10311710|NCT00132730|11444979|FG000|COMPLETED|Period II - 12-week Treatment (Base)||127
10311711|NCT00132730|11444980|FG001|COMPLETED|Period II - 12-week Treatment (Base)||133
10311712|NCT00132730|11444981|FG002|COMPLETED|Period II - 12-week Treatment (Base)||135
10311713|NCT00132730|11444982|FG003|COMPLETED|Period II - 12-week Treatment (Base)||131
10311714|NCT00132730|11444983|FG004|COMPLETED|Period II - 12-week Treatment (Base)||0
10311715|NCT00132730|11444984|FG005|COMPLETED|Period II - 12-week Treatment (Base)||0
10311716|NCT00132730|11444979|FG000|NOT COMPLETED|Period II - 12-week Treatment (Base)||23
10311717|NCT00132730|11444980|FG001|NOT COMPLETED|Period II - 12-week Treatment (Base)||15
10311718|NCT00132730|11444981|FG002|NOT COMPLETED|Period II - 12-week Treatment (Base)||18
10311719|NCT00132730|11444982|FG003|NOT COMPLETED|Period II - 12-week Treatment (Base)||22
10311720|NCT00132730|11444983|FG004|NOT COMPLETED|Period II - 12-week Treatment (Base)||0
10311721|NCT00132730|11444984|FG005|NOT COMPLETED|Period II - 12-week Treatment (Base)||0
10311722|NCT00132730|11444979|FG000|STARTED|Period III - Blinded Extension (EXT1)||0
10311723|NCT00132730|11444980|FG001|STARTED|Period III - Blinded Extension (EXT1)||0
10311724|NCT00132730|11444981|FG002|STARTED|Period III - Blinded Extension (EXT1)|Includes all MK-0873 participants from Period II. Not all eligible participants entered EXT1|317
10311725|NCT00132730|11444982|FG003|STARTED|Period III - Blinded Extension (EXT1)|Not all eligible participants entered EXT1|107
10311726|NCT00132730|11444983|FG004|STARTED|Period III - Blinded Extension (EXT1)||0
10311727|NCT00132730|11444984|FG005|STARTED|Period III - Blinded Extension (EXT1)||0
10311728|NCT00132730|11444979|FG000|COMPLETED|Period III - Blinded Extension (EXT1)||0
10311729|NCT00132730|11444980|FG001|COMPLETED|Period III - Blinded Extension (EXT1)||0
10311730|NCT00132730|11444981|FG002|COMPLETED|Period III - Blinded Extension (EXT1)||235
10311731|NCT00132730|11444982|FG003|COMPLETED|Period III - Blinded Extension (EXT1)||82
10311732|NCT00132730|11444983|FG004|COMPLETED|Period III - Blinded Extension (EXT1)||0
10311733|NCT00132730|11444984|FG005|COMPLETED|Period III - Blinded Extension (EXT1)||0
10311734|NCT00132730|11444979|FG000|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
10311735|NCT00132730|11444980|FG001|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
10311736|NCT00132730|11444981|FG002|NOT COMPLETED|Period III - Blinded Extension (EXT1)||82
10311737|NCT00132730|11444982|FG003|NOT COMPLETED|Period III - Blinded Extension (EXT1)||25
10311738|NCT00132730|11444983|FG004|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
10311739|NCT00132730|11444984|FG005|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
10311740|NCT00132730|11444979|FG000|STARTED|Period IV - Open-label Extension (EXT2)||0
10311741|NCT00132730|11444980|FG001|STARTED|Period IV - Open-label Extension (EXT2)||0
10311742|NCT00132730|11444981|FG002|STARTED|Period IV - Open-label Extension (EXT2)||0
10311743|NCT00132730|11444982|FG003|STARTED|Period IV - Open-label Extension (EXT2)||0
10311744|NCT00132730|11444983|FG004|STARTED|Period IV - Open-label Extension (EXT2)|Includes participants from Period III. Not all eligible participants entered EXT2|187
10311745|NCT00132730|11444984|FG005|STARTED|Period IV - Open-label Extension (EXT2)|Includes paricipants from Period III. Not all eligible participants entered EXT2|71
10311746|NCT00132730|11444979|FG000|COMPLETED|Period IV - Open-label Extension (EXT2)||0
10311747|NCT00132730|11444980|FG001|COMPLETED|Period IV - Open-label Extension (EXT2)||0
10311748|NCT00132730|11444981|FG002|COMPLETED|Period IV - Open-label Extension (EXT2)||0
10311749|NCT00132730|11444982|FG003|COMPLETED|Period IV - Open-label Extension (EXT2)||0
10659282|NCT02240368|11820624|FG002|NOT COMPLETED|Overall Study||1
10659283|NCT02240589|11820634|FG000|STARTED|Overall Study||5
10659284|NCT02240589|11820635|FG001|STARTED|Overall Study||6
10659285|NCT02240589|11820634|FG000|COMPLETED|Overall Study||3
10659286|NCT02240589|11820635|FG001|COMPLETED|Overall Study||4
10659287|NCT02240589|11820634|FG000|NOT COMPLETED|Overall Study||2
10659288|NCT02240589|11820635|FG001|NOT COMPLETED|Overall Study||2
10659289|NCT02240628|11820643|FG000|STARTED|Overall Study||38
10659290|NCT02240628|11820644|FG001|STARTED|Overall Study||38
10659291|NCT02240628|11820643|FG000|COMPLETED|Overall Study||32
10659292|NCT02240628|11820644|FG001|COMPLETED|Overall Study||33
10659293|NCT02240628|11820643|FG000|NOT COMPLETED|Overall Study||6
10720835|NCT02719158|11884430|FG000|STARTED|Overall Study||38
10720836|NCT02719158|11884431|FG001|STARTED|Overall Study||38
10720837|NCT02719158|11884432|FG002|STARTED|Overall Study||19
10720838|NCT02719158|11884430|FG000|COMPLETED|Overall Study||38
10720839|NCT02719158|11884431|FG001|COMPLETED|Overall Study||38
10720840|NCT02719158|11884432|FG002|COMPLETED|Overall Study||18
10720841|NCT02719158|11884430|FG000|NOT COMPLETED|Overall Study||0
10720842|NCT02719158|11884431|FG001|NOT COMPLETED|Overall Study||0
10720843|NCT02719158|11884432|FG002|NOT COMPLETED|Overall Study||1
10398578|NCT00705757|11542401|FG002|STARTED|Overall Study||28
10398579|NCT00705757|11542399|FG000|COMPLETED|Overall Study||19
10398580|NCT00705757|11542400|FG001|COMPLETED|Overall Study||21
10398581|NCT00705757|11542401|FG002|COMPLETED|Overall Study||17
10398582|NCT00705757|11542399|FG000|NOT COMPLETED|Overall Study||13
10398583|NCT00705757|11542400|FG001|NOT COMPLETED|Overall Study||8
10398584|NCT00705757|11542401|FG002|NOT COMPLETED|Overall Study||11
10398585|NCT00705783|11542411|FG000|STARTED|Conversion Phase||633
10398586|NCT00705783|11542412|FG001|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
10398587|NCT00705783|11542413|FG002|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
10398588|NCT00705783|11542411|FG000|Received Study Medication|Conversion Phase||632
10398589|NCT00705783|11542412|FG001|Received Study Medication|Conversion Phase||0
10398590|NCT00705783|11542413|FG002|Received Study Medication|Conversion Phase||0
10398591|NCT00705783|11542411|FG000|COMPLETED|Conversion Phase||500
10398592|NCT00705783|11542412|FG001|COMPLETED|Conversion Phase||0
10398593|NCT00705783|11542413|FG002|COMPLETED|Conversion Phase||0
10398594|NCT00705783|11542411|FG000|NOT COMPLETED|Conversion Phase||133
10398595|NCT00705783|11542412|FG001|NOT COMPLETED|Conversion Phase||0
10398596|NCT00705783|11542413|FG002|NOT COMPLETED|Conversion Phase||0
10398597|NCT00705783|11542411|FG000|STARTED|Oral Stabilization Phase|210 of the 710 patients who started this phase enrolled in this study directly into this phase.|710
10720844|NCT02719171|11884445|FG000|STARTED|Overall Study||42
10813634|NCT02717130|11976044|FG000|COMPLETED|Overall Study||1
10813635|NCT02717130|11976044|FG000|NOT COMPLETED|Overall Study||7
10813636|NCT02685202|11976048|FG000|STARTED|Overall Study||9
10813637|NCT02685202|11976048|FG000|COMPLETED|Overall Study||0
10813638|NCT02685202|11976048|FG000|NOT COMPLETED|Overall Study||9
10813639|NCT02709083|11976052|FG000|STARTED|Overall Study||7
10398598|NCT00705783|11542412|FG001|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
10398599|NCT00705783|11542413|FG002|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
10398600|NCT00705783|11542411|FG000|Received Study Medication|Oral Stabilization Phase||709
10398601|NCT00705783|11542412|FG001|Received Study Medication|Oral Stabilization Phase||0
10398602|NCT00705783|11542413|FG002|Received Study Medication|Oral Stabilization Phase||0
10398603|NCT00705783|11542411|FG000|COMPLETED|Oral Stabilization Phase||576
10398604|NCT00705783|11542412|FG001|COMPLETED|Oral Stabilization Phase||0
10398605|NCT00705783|11542413|FG002|COMPLETED|Oral Stabilization Phase||0
10398606|NCT00705783|11542411|FG000|NOT COMPLETED|Oral Stabilization Phase||134
10398607|NCT00705783|11542412|FG001|NOT COMPLETED|Oral Stabilization Phase||0
10398608|NCT00705783|11542413|FG002|NOT COMPLETED|Oral Stabilization Phase||0
10398609|NCT00705783|11542411|FG000|STARTED|Depot Stabilization Phase||576
10398610|NCT00705783|11542412|FG001|STARTED|Depot Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
10398611|NCT00705783|11542413|FG002|STARTED|Depot Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
10398612|NCT00705783|11542411|FG000|COMPLETED|Depot Stabilization Phase||403
10398613|NCT00705783|11542412|FG001|COMPLETED|Depot Stabilization Phase||0
10398614|NCT00705783|11542413|FG002|COMPLETED|Depot Stabilization Phase||0
10398615|NCT00705783|11542411|FG000|NOT COMPLETED|Depot Stabilization Phase||173
10398616|NCT00705783|11542412|FG001|NOT COMPLETED|Depot Stabilization Phase||0
10398617|NCT00705783|11542413|FG002|NOT COMPLETED|Depot Stabilization Phase||0
10398618|NCT00705783|11542411|FG000|STARTED|Depot Maintenance Phase|Patients were randomized into the aripiprazole and placebo depot groups in this phase of the study.|0
10398619|NCT00705783|11542412|FG001|STARTED|Depot Maintenance Phase||269
10398620|NCT00705783|11542413|FG002|STARTED|Depot Maintenance Phase||134
10398621|NCT00705783|11542411|FG000|COMPLETED|Depot Maintenance Phase||0
10398622|NCT00705783|11542412|FG001|COMPLETED|Depot Maintenance Phase||23
10398623|NCT00705783|11542413|FG002|COMPLETED|Depot Maintenance Phase||3
10398624|NCT00705783|11542411|FG000|NOT COMPLETED|Depot Maintenance Phase||0
10398625|NCT00705783|11542412|FG001|NOT COMPLETED|Depot Maintenance Phase||246
10398626|NCT00705783|11542413|FG002|NOT COMPLETED|Depot Maintenance Phase||131
10398627|NCT00705874|11542429|FG000|STARTED|Overall Study||12
10398628|NCT00705874|11542430|FG001|STARTED|Overall Study||9
10398629|NCT00705874|11542431|FG002|STARTED|Overall Study||34
10398630|NCT00705874|11542432|FG003|STARTED|Overall Study||34
10398631|NCT00705874|11542433|FG004|STARTED|Overall Study||48
10398632|NCT00705874|11542434|FG005|STARTED|Overall Study||32
10398633|NCT00705874|11542435|FG006|STARTED|Overall Study||3
10398634|NCT00705874|11542429|FG000|COMPLETED|Overall Study||10
10398635|NCT00705874|11542430|FG001|COMPLETED|Overall Study||8
10398636|NCT00705874|11542431|FG002|COMPLETED|Overall Study||32
10398637|NCT00705874|11542432|FG003|COMPLETED|Overall Study||33
10398638|NCT00705874|11542433|FG004|COMPLETED|Overall Study||36
10398639|NCT00705874|11542434|FG005|COMPLETED|Overall Study||28
10398640|NCT00705874|11542435|FG006|COMPLETED|Overall Study||3
10398641|NCT00705874|11542429|FG000|NOT COMPLETED|Overall Study||2
10398642|NCT00705874|11542430|FG001|NOT COMPLETED|Overall Study||1
10398643|NCT00705874|11542431|FG002|NOT COMPLETED|Overall Study||2
10398644|NCT00705874|11542432|FG003|NOT COMPLETED|Overall Study||1
10398645|NCT00705874|11542433|FG004|NOT COMPLETED|Overall Study||12
10398646|NCT00705874|11542434|FG005|NOT COMPLETED|Overall Study||4
10398647|NCT00705874|11542435|FG006|NOT COMPLETED|Overall Study||0
10398648|NCT00705939|11542454|FG000|STARTED|Overall Study||12
10398649|NCT00705939|11542455|FG001|STARTED|Overall Study||14
10398650|NCT00705939|11542456|FG002|STARTED|Overall Study|1 subject enrolled but not treated in this protocol.|18
10720845|NCT02719171|11884446|FG001|STARTED|Overall Study||42
10720846|NCT02719171|11884447|FG002|STARTED|Overall Study||42
10720847|NCT02719171|11884448|FG003|STARTED|Overall Study||39
10398651|NCT00705939|11542454|FG000|COMPLETED|Overall Study||12
10398652|NCT00705939|11542455|FG001|COMPLETED|Overall Study||12
10398653|NCT00705939|11542456|FG002|COMPLETED|Overall Study||14
10398654|NCT00705939|11542454|FG000|NOT COMPLETED|Overall Study||0
10720848|NCT02719171|11884449|FG004|STARTED|Overall Study||20
10720849|NCT02719171|11884445|FG000|COMPLETED|Overall Study||41
10720850|NCT02719171|11884446|FG001|COMPLETED|Overall Study||38
10398655|NCT00705939|11542455|FG001|NOT COMPLETED|Overall Study||2
10398656|NCT00705939|11542456|FG002|NOT COMPLETED|Overall Study||4
10398657|NCT00706004|11542465|FG000|STARTED|Overall Study||9
10398658|NCT00706004|11542465|FG000|COMPLETED|Overall Study||7
10398659|NCT00706004|11542465|FG000|NOT COMPLETED|Overall Study||2
10398660|NCT00706030|11542474|FG000|STARTED|Overall Study||6
10398661|NCT00706030|11542475|FG001|STARTED|Overall Study||6
10398662|NCT00706030|11542476|FG002|STARTED|Overall Study||64
10398663|NCT00706030|11542477|FG003|STARTED|Overall Study||16
10398664|NCT00706030|11542474|FG000|Treated|Overall Study||6
10398665|NCT00706030|11542475|FG001|Treated|Overall Study||6
10398666|NCT00706030|11542476|FG002|Treated|Overall Study||64
10398667|NCT00706030|11542477|FG003|Treated|Overall Study||15
10398668|NCT00706030|11542474|FG000|COMPLETED|Overall Study||0
10398669|NCT00706030|11542475|FG001|COMPLETED|Overall Study||0
10398670|NCT00706030|11542476|FG002|COMPLETED|Overall Study||4
10398671|NCT00706030|11542477|FG003|COMPLETED|Overall Study||0
10398672|NCT00706030|11542474|FG000|NOT COMPLETED|Overall Study||6
10398673|NCT00706030|11542475|FG001|NOT COMPLETED|Overall Study||6
10398674|NCT00706030|11542476|FG002|NOT COMPLETED|Overall Study||60
10398675|NCT00706030|11542477|FG003|NOT COMPLETED|Overall Study||16
10398676|NCT00706095|11542491|FG000|STARTED|Overall Study||6
10398677|NCT00706095|11542492|FG001|STARTED|Overall Study||7
10398678|NCT00706095|11542493|FG002|STARTED|Overall Study||5
10398679|NCT00706095|11542491|FG000|COMPLETED|Overall Study||0
10398680|NCT00706095|11542492|FG001|COMPLETED|Overall Study||0
10398681|NCT00706095|11542493|FG002|COMPLETED|Overall Study||0
10398682|NCT00706095|11542491|FG000|NOT COMPLETED|Overall Study||6
10398683|NCT00706095|11542492|FG001|NOT COMPLETED|Overall Study||7
10398684|NCT00706095|11542493|FG002|NOT COMPLETED|Overall Study||5
10398685|NCT00706121|11542505|FG000|STARTED|Overall Study||2039
10398686|NCT00706121|11542506|FG001|STARTED|Overall Study||2096
10398687|NCT00706121|11542507|FG002|STARTED|Overall Study||2030
10398688|NCT00706121|11542508|FG003|STARTED|Overall Study||1929
10398689|NCT00706121|11542505|FG000|COMPLETED|Overall Study||1643
10398690|NCT00706121|11542506|FG001|COMPLETED|Overall Study||1700
10398691|NCT00706121|11542507|FG002|COMPLETED|Overall Study||1626
10398692|NCT00706121|11542508|FG003|COMPLETED|Overall Study||1577
10398693|NCT00706121|11542505|FG000|NOT COMPLETED|Overall Study||396
10398694|NCT00706121|11542506|FG001|NOT COMPLETED|Overall Study||396
10398695|NCT00706121|11542507|FG002|NOT COMPLETED|Overall Study||404
10398696|NCT00706121|11542508|FG003|NOT COMPLETED|Overall Study||352
10398697|NCT00706134|11542530|FG000|STARTED|Overall Study||189
10398698|NCT00706134|11542531|FG001|STARTED|Overall Study||192
10398699|NCT00706134|11542532|FG002|STARTED|Overall Study||189
10398700|NCT00706134|11542533|FG003|STARTED|Overall Study||186
10720851|NCT02719171|11884447|FG002|COMPLETED|Overall Study||39
10398701|NCT00706134|11542530|FG000|Entered Double-blind Period|Overall Study||187
10398702|NCT00706134|11542531|FG001|Entered Double-blind Period|Overall Study||192
10398703|NCT00706134|11542532|FG002|Entered Double-blind Period|Overall Study||189
10398704|NCT00706134|11542533|FG003|Entered Double-blind Period|Overall Study||186
10398705|NCT00706134|11542530|FG000|COMPLETED|Overall Study||169
10398706|NCT00706134|11542531|FG001|COMPLETED|Overall Study||173
10398707|NCT00706134|11542532|FG002|COMPLETED|Overall Study||183
10398708|NCT00706134|11542533|FG003|COMPLETED|Overall Study||175
10398709|NCT00706134|11542530|FG000|NOT COMPLETED|Overall Study||20
10398710|NCT00706134|11542531|FG001|NOT COMPLETED|Overall Study||19
10398711|NCT00706134|11542532|FG002|NOT COMPLETED|Overall Study||6
10398712|NCT00706134|11542533|FG003|NOT COMPLETED|Overall Study||11
10398713|NCT00706238|11542543|FG000|STARTED|Overall Study||5
10720852|NCT02719171|11884448|FG003|COMPLETED|Overall Study||37
10720853|NCT02719171|11884449|FG004|COMPLETED|Overall Study||18
10398714|NCT00706238|11542543|FG000|COMPLETED|Overall Study||0
10398715|NCT00706238|11542543|FG000|NOT COMPLETED|Overall Study||5
10398716|NCT00706264|11542549|FG000|STARTED|Overall Study||193
10398717|NCT00706264|11542550|FG001|STARTED|Overall Study||192
10398718|NCT00706264|11542549|FG000|COMPLETED|Overall Study||190
10398719|NCT00706264|11542550|FG001|COMPLETED|Overall Study||190
10398720|NCT00706264|11542549|FG000|NOT COMPLETED|Overall Study||3
10398721|NCT00706264|11542550|FG001|NOT COMPLETED|Overall Study||2
10398722|NCT00706342|11542558|FG000|STARTED|Overall Study||18
10398723|NCT00706342|11542558|FG000|COMPLETED|Overall Study||0
10398724|NCT00706342|11542558|FG000|NOT COMPLETED|Overall Study||18
10398725|NCT00706355|11542566|FG000|STARTED|Period 1: PF-04217903 50 mg||3
10398726|NCT00706355|11542567|FG001|STARTED|Period 1: PF-04217903 50 mg||0
10398727|NCT00706355|11542568|FG002|STARTED|Period 1: PF-04217903 50 mg||0
10398728|NCT00706355|11542569|FG003|STARTED|Period 1: PF-04217903 50 mg||0
10398729|NCT00706355|11542566|FG000|COMPLETED|Period 1: PF-04217903 50 mg||0
10659294|NCT02240628|11820644|FG001|NOT COMPLETED|Overall Study||5
10659295|NCT02240654|11820655|FG000|STARTED|Overall Study||1706
10659296|NCT02240654|11820656|FG001|STARTED|Overall Study||2813
10659297|NCT02240654|11820657|FG002|STARTED|Overall Study||28619
10659298|NCT02240654|11820658|FG003|STARTED|Overall Study||2150
10659299|NCT02240654|11820659|FG004|STARTED|Overall Study||1285
10659300|NCT02240654|11820655|FG000|COMPLETED|Overall Study||1706
10659301|NCT02240654|11820656|FG001|COMPLETED|Overall Study||2813
10659302|NCT02240654|11820657|FG002|COMPLETED|Overall Study||28619
10659303|NCT02240654|11820658|FG003|COMPLETED|Overall Study||2150
10659304|NCT02240654|11820659|FG004|COMPLETED|Overall Study||1285
10720854|NCT02719171|11884445|FG000|NOT COMPLETED|Overall Study||1
10720855|NCT02719171|11884446|FG001|NOT COMPLETED|Overall Study||4
10720856|NCT02719171|11884447|FG002|NOT COMPLETED|Overall Study||3
10720857|NCT02719171|11884448|FG003|NOT COMPLETED|Overall Study||2
10720858|NCT02719171|11884449|FG004|NOT COMPLETED|Overall Study||2
10720859|NCT02719353|11884464|FG000|STARTED|First Intervention||7
10720860|NCT02719353|11884465|FG001|STARTED|First Intervention||7
10720861|NCT02719353|11884464|FG000|COMPLETED|First Intervention||7
10720862|NCT02719353|11884465|FG001|COMPLETED|First Intervention||6
10720863|NCT02719353|11884464|FG000|NOT COMPLETED|First Intervention||0
10720864|NCT02719353|11884465|FG001|NOT COMPLETED|First Intervention||1
10720865|NCT02719353|11884464|FG000|STARTED|Second Intervention||7
10720866|NCT02719353|11884465|FG001|STARTED|Second Intervention||6
10720867|NCT02719353|11884464|FG000|COMPLETED|Second Intervention||7
10720868|NCT02719353|11884465|FG001|COMPLETED|Second Intervention||6
10720869|NCT02719353|11884464|FG000|NOT COMPLETED|Second Intervention||0
10720870|NCT02719353|11884465|FG001|NOT COMPLETED|Second Intervention||0
10720871|NCT02719366|11884472|FG000|STARTED|First Intervention||6
10720872|NCT02719366|11884473|FG001|STARTED|First Intervention||6
10720873|NCT02719366|11884472|FG000|COMPLETED|First Intervention||6
10720874|NCT02719366|11884473|FG001|COMPLETED|First Intervention||6
10398730|NCT00706355|11542567|FG001|COMPLETED|Period 1: PF-04217903 50 mg||0
10398731|NCT00706355|11542568|FG002|COMPLETED|Period 1: PF-04217903 50 mg||0
10398732|NCT00706355|11542569|FG003|COMPLETED|Period 1: PF-04217903 50 mg||0
10398733|NCT00706355|11542566|FG000|NOT COMPLETED|Period 1: PF-04217903 50 mg||3
10398734|NCT00706355|11542567|FG001|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
10720875|NCT02719366|11884472|FG000|NOT COMPLETED|First Intervention||0
10720876|NCT02719366|11884473|FG001|NOT COMPLETED|First Intervention||0
10398735|NCT00706355|11542568|FG002|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
10659305|NCT02240654|11820655|FG000|NOT COMPLETED|Overall Study||0
10659306|NCT02240654|11820656|FG001|NOT COMPLETED|Overall Study||0
10659307|NCT02240654|11820657|FG002|NOT COMPLETED|Overall Study||0
10720877|NCT02719366|11884472|FG000|STARTED|Second Intervention||6
10720878|NCT02719366|11884473|FG001|STARTED|Second Intervention||6
10720879|NCT02719366|11884472|FG000|COMPLETED|Second Intervention||6
10720880|NCT02719366|11884473|FG001|COMPLETED|Second Intervention||6
10311750|NCT00132730|11444983|FG004|COMPLETED|Period IV - Open-label Extension (EXT2)||8
10311751|NCT00132730|11444984|FG005|COMPLETED|Period IV - Open-label Extension (EXT2)||3
10311752|NCT00132730|11444979|FG000|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
10311753|NCT00132730|11444980|FG001|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
10311754|NCT00132730|11444981|FG002|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
10311755|NCT00132730|11444982|FG003|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
10311756|NCT00132730|11444983|FG004|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||179
10659308|NCT02240654|11820658|FG003|NOT COMPLETED|Overall Study||0
10659309|NCT02240654|11820659|FG004|NOT COMPLETED|Overall Study||0
10659310|NCT02240667|11820673|FG000|STARTED|Overall Study||771
10659311|NCT02240667|11820674|FG001|STARTED|Overall Study||650
10659312|NCT02240667|11820673|FG000|COMPLETED|Overall Study||771
10311757|NCT00132730|11444984|FG005|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||68
10311758|NCT00132730|11444979|FG000|STARTED|Period V - Open-label Extension (EXT2)||0
10311759|NCT00132730|11444980|FG001|STARTED|Period V - Open-label Extension (EXT2)||0
10311760|NCT00132730|11444981|FG002|STARTED|Period V - Open-label Extension (EXT2)||0
10311761|NCT00132730|11444982|FG003|STARTED|Period V - Open-label Extension (EXT2)||0
10311762|NCT00132730|11444983|FG004|STARTED|Period V - Open-label Extension (EXT2)|Not all participants who completed Period IV entered Period V|7
10311763|NCT00132730|11444984|FG005|STARTED|Period V - Open-label Extension (EXT2)|Not all participants who completed Period IV entered Period V|2
10311764|NCT00132730|11444979|FG000|COMPLETED|Period V - Open-label Extension (EXT2)||0
10311765|NCT00132730|11444980|FG001|COMPLETED|Period V - Open-label Extension (EXT2)||0
10311766|NCT00132730|11444981|FG002|COMPLETED|Period V - Open-label Extension (EXT2)||0
10311767|NCT00132730|11444982|FG003|COMPLETED|Period V - Open-label Extension (EXT2)||0
10311768|NCT00132730|11444983|FG004|COMPLETED|Period V - Open-label Extension (EXT2)||0
10311769|NCT00132730|11444984|FG005|COMPLETED|Period V - Open-label Extension (EXT2)||0
10311770|NCT00132730|11444979|FG000|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
10311771|NCT00132730|11444980|FG001|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
10311772|NCT00132730|11444981|FG002|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
10311773|NCT00132730|11444982|FG003|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
10311774|NCT00132730|11444983|FG004|NOT COMPLETED|Period V - Open-label Extension (EXT2)||7
10311775|NCT00132730|11444984|FG005|NOT COMPLETED|Period V - Open-label Extension (EXT2)||2
10311776|NCT00132769|11445000|FG000|STARTED|Overall Study||53
10311777|NCT00132769|11445001|FG001|STARTED|Overall Study||53
10311778|NCT00132769|11445000|FG000|COMPLETED|Overall Study||42
10311779|NCT00132769|11445001|FG001|COMPLETED|Overall Study||42
10311780|NCT00132769|11445000|FG000|NOT COMPLETED|Overall Study||11
10659313|NCT02240667|11820674|FG001|COMPLETED|Overall Study||650
10398736|NCT00706355|11542569|FG003|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
10398737|NCT00706355|11542566|FG000|STARTED|Period 2: PF-04217903 100 mg||0
10398738|NCT00706355|11542567|FG001|STARTED|Period 2: PF-04217903 100 mg||7
10398739|NCT00706355|11542568|FG002|STARTED|Period 2: PF-04217903 100 mg||0
10398740|NCT00706355|11542569|FG003|STARTED|Period 2: PF-04217903 100 mg||0
10398741|NCT00706355|11542566|FG000|COMPLETED|Period 2: PF-04217903 100 mg||0
10398742|NCT00706355|11542567|FG001|COMPLETED|Period 2: PF-04217903 100 mg||0
10398743|NCT00706355|11542568|FG002|COMPLETED|Period 2: PF-04217903 100 mg||0
10398744|NCT00706355|11542569|FG003|COMPLETED|Period 2: PF-04217903 100 mg||0
10398745|NCT00706355|11542566|FG000|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
10398746|NCT00706355|11542567|FG001|NOT COMPLETED|Period 2: PF-04217903 100 mg||7
10398747|NCT00706355|11542568|FG002|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
10398748|NCT00706355|11542569|FG003|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
10398749|NCT00706355|11542566|FG000|STARTED|Period 3: PF-04217903 200 mg||0
10398750|NCT00706355|11542567|FG001|STARTED|Period 3: PF-04217903 200 mg||0
10398751|NCT00706355|11542568|FG002|STARTED|Period 3: PF-04217903 200 mg||2
10398752|NCT00706355|11542569|FG003|STARTED|Period 3: PF-04217903 200 mg||0
10398753|NCT00706355|11542566|FG000|COMPLETED|Period 3: PF-04217903 200 mg||0
10398754|NCT00706355|11542567|FG001|COMPLETED|Period 3: PF-04217903 200 mg||0
10398755|NCT00706355|11542568|FG002|COMPLETED|Period 3: PF-04217903 200 mg||0
10398756|NCT00706355|11542569|FG003|COMPLETED|Period 3: PF-04217903 200 mg||0
10398757|NCT00706355|11542566|FG000|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
10398758|NCT00706355|11542567|FG001|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
10398759|NCT00706355|11542568|FG002|NOT COMPLETED|Period 3: PF-04217903 200 mg||2
10398760|NCT00706355|11542569|FG003|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
10398761|NCT00706355|11542566|FG000|STARTED|Period 4: PF-04217903 150 mg||0
10398762|NCT00706355|11542567|FG001|STARTED|Period 4: PF-04217903 150 mg||0
10398763|NCT00706355|11542568|FG002|STARTED|Period 4: PF-04217903 150 mg||0
10398764|NCT00706355|11542569|FG003|STARTED|Period 4: PF-04217903 150 mg||4
10398765|NCT00706355|11542566|FG000|COMPLETED|Period 4: PF-04217903 150 mg||0
10398766|NCT00706355|11542567|FG001|COMPLETED|Period 4: PF-04217903 150 mg||0
10398767|NCT00706355|11542568|FG002|COMPLETED|Period 4: PF-04217903 150 mg||0
10398768|NCT00706355|11542569|FG003|COMPLETED|Period 4: PF-04217903 150 mg||0
10398769|NCT00706355|11542566|FG000|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
10398770|NCT00706355|11542567|FG001|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
10398771|NCT00706355|11542568|FG002|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
10398772|NCT00706355|11542569|FG003|NOT COMPLETED|Period 4: PF-04217903 150 mg||4
10398773|NCT00706381|11542585|FG000|STARTED|Overall Study||10
10398774|NCT00706381|11542586|FG001|STARTED|Overall Study||6
10398775|NCT00706381|11542587|FG002|STARTED|Overall Study||6
10398776|NCT00706381|11542588|FG003|STARTED|Overall Study||9
10398777|NCT00706381|11542585|FG000|Intervention 1 (1 Day)|Overall Study||10
10398778|NCT00706381|11542586|FG001|Intervention 1 (1 Day)|Overall Study||6
10398779|NCT00706381|11542587|FG002|Intervention 1 (1 Day)|Overall Study||6
10398780|NCT00706381|11542588|FG003|Intervention 1 (1 Day)|Overall Study||9
10398781|NCT00706381|11542585|FG000|Intervention 2 (1 Day)|Overall Study||10
10398782|NCT00706381|11542586|FG001|Intervention 2 (1 Day)|Overall Study||6
10398783|NCT00706381|11542587|FG002|Intervention 2 (1 Day)|Overall Study||6
10398784|NCT00706381|11542588|FG003|Intervention 2 (1 Day)|Overall Study||9
10398785|NCT00706381|11542585|FG000|Intervention 3 (1 Day)|Overall Study||10
10398786|NCT00706381|11542586|FG001|Intervention 3 (1 Day)|Overall Study||6
10398787|NCT00706381|11542587|FG002|Intervention 3 (1 Day)|Overall Study||6
10398788|NCT00706381|11542588|FG003|Intervention 3 (1 Day)|Overall Study||9
10398789|NCT00706381|11542585|FG000|Intervention 4 (1 Day)|Overall Study||10
10398790|NCT00706381|11542586|FG001|Intervention 4 (1 Day)|Overall Study||5
10398791|NCT00706381|11542587|FG002|Intervention 4 (1 Day)|Overall Study||6
10398792|NCT00706381|11542588|FG003|Intervention 4 (1 Day)|Overall Study||9
10398793|NCT00706381|11542585|FG000|Intervention 5 (1 Day)|Overall Study||10
10398794|NCT00706381|11542586|FG001|Intervention 5 (1 Day)|Overall Study||5
10398795|NCT00706381|11542587|FG002|Intervention 5 (1 Day)|Overall Study||5
10398796|NCT00706381|11542588|FG003|Intervention 5 (1 Day)|Overall Study||9
10398797|NCT00706381|11542585|FG000|COMPLETED|Overall Study||10
10398798|NCT00706381|11542586|FG001|COMPLETED|Overall Study||5
10398799|NCT00706381|11542587|FG002|COMPLETED|Overall Study||5
10398800|NCT00706381|11542588|FG003|COMPLETED|Overall Study||9
10398801|NCT00706381|11542585|FG000|NOT COMPLETED|Overall Study||0
10398802|NCT00706381|11542586|FG001|NOT COMPLETED|Overall Study||1
10398803|NCT00706381|11542587|FG002|NOT COMPLETED|Overall Study||1
10398804|NCT00706381|11542588|FG003|NOT COMPLETED|Overall Study||0
10398805|NCT00706394|11542601|FG000|STARTED|Overall Study||19
10398806|NCT00706394|11542601|FG000|COMPLETED|Overall Study||8
10398807|NCT00706394|11542601|FG000|NOT COMPLETED|Overall Study||11
10398808|NCT00706407|11542607|FG000|STARTED|Overall Study||42
10398809|NCT00706407|11542607|FG000|COMPLETED|Overall Study||33
10398810|NCT00706407|11542607|FG000|NOT COMPLETED|Overall Study||9
10398811|NCT00706433|11542618|FG000|STARTED|Overall Study||68
10398812|NCT00706433|11542619|FG001|STARTED|Overall Study||65
10398813|NCT00706433|11542620|FG002|STARTED|Overall Study||67
10398814|NCT00706433|11542621|FG003|STARTED|Overall Study||66
10398815|NCT00706433|11542618|FG000|COMPLETED|Overall Study||63
10398816|NCT00706433|11542619|FG001|COMPLETED|Overall Study||62
10398817|NCT00706433|11542620|FG002|COMPLETED|Overall Study||57
10398818|NCT00706433|11542621|FG003|COMPLETED|Overall Study||64
10398819|NCT00706433|11542618|FG000|NOT COMPLETED|Overall Study||5
10398820|NCT00706433|11542619|FG001|NOT COMPLETED|Overall Study||3
10398821|NCT00706433|11542620|FG002|NOT COMPLETED|Overall Study||10
10398822|NCT00706433|11542621|FG003|NOT COMPLETED|Overall Study||2
10398823|NCT00706446|11542637|FG000|STARTED|Overall Study||29
10398824|NCT00706446|11542638|FG001|STARTED|Overall Study||57
10398825|NCT00706446|11542639|FG002|STARTED|Overall Study||44
10398826|NCT00706446|11542640|FG003|STARTED|Overall Study||26
10398827|NCT00706446|11542641|FG004|STARTED|Overall Study||54
10398828|NCT00706446|11542642|FG005|STARTED|Overall Study||45
10398829|NCT00706446|11542637|FG000|COMPLETED|Overall Study||3
10398830|NCT00706446|11542638|FG001|COMPLETED|Overall Study||8
10398831|NCT00706446|11542639|FG002|COMPLETED|Overall Study||7
10398832|NCT00706446|11542640|FG003|COMPLETED|Overall Study||4
10398833|NCT00706446|11542641|FG004|COMPLETED|Overall Study||10
10659314|NCT02240667|11820673|FG000|NOT COMPLETED|Overall Study||0
10659315|NCT02240667|11820674|FG001|NOT COMPLETED|Overall Study||0
10659316|NCT02240680|11820682|FG000|STARTED|Overall Study (Up to 24 Weeks)||151
10659317|NCT02240680|11820683|FG001|STARTED|Overall Study (Up to 24 Weeks)||151
10659318|NCT02240680|11820684|FG002|STARTED|Overall Study (Up to 24 Weeks)||0
10659319|NCT02240680|11820685|FG003|STARTED|Overall Study (Up to 24 Weeks)||0
10659320|NCT02240680|11820682|FG000|COMPLETED|Overall Study (Up to 24 Weeks)||136
10659321|NCT02240680|11820683|FG001|COMPLETED|Overall Study (Up to 24 Weeks)||143
10659322|NCT02240680|11820684|FG002|COMPLETED|Overall Study (Up to 24 Weeks)||0
10659323|NCT02240680|11820685|FG003|COMPLETED|Overall Study (Up to 24 Weeks)||0
10659324|NCT02240680|11820682|FG000|NOT COMPLETED|Overall Study (Up to 24 Weeks)||15
10659325|NCT02240680|11820683|FG001|NOT COMPLETED|Overall Study (Up to 24 Weeks)||8
10659326|NCT02240680|11820684|FG002|NOT COMPLETED|Overall Study (Up to 24 Weeks)||0
10659327|NCT02240680|11820685|FG003|NOT COMPLETED|Overall Study (Up to 24 Weeks)||0
10659328|NCT02240680|11820682|FG000|STARTED|Japanese Patients (Up to 52 Weeks)||0
10398834|NCT00706446|11542642|FG005|COMPLETED|Overall Study||7
10398835|NCT00706446|11542637|FG000|NOT COMPLETED|Overall Study||26
10398836|NCT00706446|11542638|FG001|NOT COMPLETED|Overall Study||49
10398837|NCT00706446|11542639|FG002|NOT COMPLETED|Overall Study||37
10398838|NCT00706446|11542640|FG003|NOT COMPLETED|Overall Study||22
10398839|NCT00706446|11542641|FG004|NOT COMPLETED|Overall Study||44
10398840|NCT00706446|11542642|FG005|NOT COMPLETED|Overall Study||38
10398841|NCT00706485|11542656|FG000|STARTED|Overall Study||5
10398842|NCT00706485|11542656|FG000|COMPLETED|Overall Study||5
10398843|NCT00706485|11542656|FG000|NOT COMPLETED|Overall Study||0
10398844|NCT00706511|11542664|FG000|STARTED|Overall Study||10
10398845|NCT00706511|11542665|FG001|STARTED|Overall Study||4
10398846|NCT00706511|11542666|FG002|STARTED|Overall Study||3
10398847|NCT00706511|11542667|FG003|STARTED|Overall Study||10
10398848|NCT00706511|11542664|FG000|COMPLETED|Overall Study||9
10720881|NCT02719366|11884472|FG000|NOT COMPLETED|Second Intervention||0
10720882|NCT02719366|11884473|FG001|NOT COMPLETED|Second Intervention||0
10398849|NCT00706511|11542665|FG001|COMPLETED|Overall Study||4
10398850|NCT00706511|11542666|FG002|COMPLETED|Overall Study||3
10398851|NCT00706511|11542667|FG003|COMPLETED|Overall Study||10
10398852|NCT00706511|11542664|FG000|NOT COMPLETED|Overall Study||1
10398853|NCT00706511|11542665|FG001|NOT COMPLETED|Overall Study||0
10398854|NCT00706511|11542666|FG002|NOT COMPLETED|Overall Study||0
10398855|NCT00706511|11542667|FG003|NOT COMPLETED|Overall Study||0
10398856|NCT00706550|11542677|FG000|STARTED|Overall Study||43
10398857|NCT00706550|11542678|FG001|STARTED|Overall Study||64
10398858|NCT00706550|11542677|FG000|COMPLETED|Overall Study||36
10398859|NCT00706550|11542678|FG001|COMPLETED|Overall Study||36
10398860|NCT00706550|11542677|FG000|NOT COMPLETED|Overall Study||7
10398861|NCT00706550|11542678|FG001|NOT COMPLETED|Overall Study||28
10398862|NCT00706563|11542687|FG000|STARTED|Overall Study||61
10398863|NCT00706563|11542688|FG001|STARTED|Overall Study||59
10398864|NCT00706563|11542687|FG000|COMPLETED|Overall Study||61
10398865|NCT00706563|11542688|FG001|COMPLETED|Overall Study||59
10398866|NCT00706563|11542687|FG000|NOT COMPLETED|Overall Study||0
10398867|NCT00706563|11542688|FG001|NOT COMPLETED|Overall Study||0
10398868|NCT00706589|11542696|FG000|STARTED|Overall Study||32
10398869|NCT00706589|11542697|FG001|STARTED|Overall Study||29
10398870|NCT00706589|11542696|FG000|COMPLETED|Overall Study||29
10398871|NCT00706589|11542697|FG001|COMPLETED|Overall Study||25
10398872|NCT00706589|11542696|FG000|NOT COMPLETED|Overall Study||3
10398873|NCT00706589|11542697|FG001|NOT COMPLETED|Overall Study||4
10398874|NCT00706628|11542707|FG000|STARTED|Overall Study||47
10398875|NCT00706628|11542708|FG001|STARTED|Overall Study||21
10398876|NCT00706628|11542709|FG002|STARTED|Overall Study||16
10398877|NCT00706628|11542710|FG003|STARTED|Overall Study||3
10398878|NCT00706628|11542707|FG000|COMPLETED|Overall Study||0
10398879|NCT00706628|11542708|FG001|COMPLETED|Overall Study||0
10398880|NCT00706628|11542709|FG002|COMPLETED|Overall Study||0
10398881|NCT00706628|11542710|FG003|COMPLETED|Overall Study||0
10398882|NCT00706628|11542707|FG000|NOT COMPLETED|Overall Study||47
10398883|NCT00706628|11542708|FG001|NOT COMPLETED|Overall Study||21
10398884|NCT00706628|11542709|FG002|NOT COMPLETED|Overall Study||16
10398885|NCT00706628|11542710|FG003|NOT COMPLETED|Overall Study||3
10398886|NCT00706641|11542723|FG000|STARTED|Dasatinib Administration||25
10398887|NCT00706641|11542723|FG000|Toxicity Evaluation|Dasatinib Administration||24
10398888|NCT00706641|11542723|FG000|COMPLETED|Dasatinib Administration||23
10398889|NCT00706641|11542723|FG000|NOT COMPLETED|Dasatinib Administration||2
10398890|NCT00706641|11542723|FG000|STARTED|Radical Cystectomy||23
10398891|NCT00706641|11542723|FG000|COMPLETED|Radical Cystectomy||22
10398892|NCT00706641|11542723|FG000|NOT COMPLETED|Radical Cystectomy||1
10398893|NCT00706654|11542730|FG000|STARTED|Conversion Phase||709
10720883|NCT02719535|11884480|FG000|STARTED|Overall Study||59
10720884|NCT02719535|11884480|FG000|COMPLETED|Overall Study||37
10398894|NCT00706654|11542731|FG001|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
10398895|NCT00706654|11542732|FG002|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
10720885|NCT02719535|11884480|FG000|NOT COMPLETED|Overall Study||22
10720886|NCT02719639|11884484|FG000|STARTED|Overall Study||7443
10720887|NCT02719639|11884484|FG000|COMPLETED|Overall Study||7443
10813640|NCT02709083|11976052|FG000|COMPLETED|Overall Study||0
10813641|NCT02709083|11976052|FG000|NOT COMPLETED|Overall Study||7
10813642|NCT02693171|11976056|FG000|STARTED|Overall Study|At study termination, 13 subjects had enrolled, 12 subjects received at least 1 dose of study drug.|12
10813643|NCT02693171|11976056|FG000|COMPLETED|Overall Study||3
10813644|NCT02693171|11976056|FG000|NOT COMPLETED|Overall Study||9
10813645|NCT02696226|11976064|FG000|STARTED|Overall Study||1
10813646|NCT02696226|11976065|FG001|STARTED|Overall Study||0
10813647|NCT02696226|11976066|FG002|STARTED|Overall Study||2
10813648|NCT02696226|11976067|FG003|STARTED|Overall Study||0
10813649|NCT02696226|11976064|FG000|COMPLETED|Overall Study||0
10813650|NCT02696226|11976065|FG001|COMPLETED|Overall Study||0
10813651|NCT02696226|11976066|FG002|COMPLETED|Overall Study||0
10813652|NCT02696226|11976067|FG003|COMPLETED|Overall Study||0
10813653|NCT02696226|11976064|FG000|NOT COMPLETED|Overall Study||1
10813654|NCT02696226|11976065|FG001|NOT COMPLETED|Overall Study||0
10813655|NCT02696226|11976066|FG002|NOT COMPLETED|Overall Study||2
10398896|NCT00706654|11542733|FG003|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
10398897|NCT00706654|11542730|FG000|COMPLETED|Conversion Phase||614
10398898|NCT00706654|11542731|FG001|COMPLETED|Conversion Phase||0
10398899|NCT00706654|11542732|FG002|COMPLETED|Conversion Phase||0
10398900|NCT00706654|11542733|FG003|COMPLETED|Conversion Phase||0
10398901|NCT00706654|11542730|FG000|NOT COMPLETED|Conversion Phase||95
10398902|NCT00706654|11542731|FG001|NOT COMPLETED|Conversion Phase||0
10398903|NCT00706654|11542732|FG002|NOT COMPLETED|Conversion Phase||0
10398904|NCT00706654|11542733|FG003|NOT COMPLETED|Conversion Phase||0
10398905|NCT00706654|11542730|FG000|STARTED|Oral Stabilization Phase|228 of the 842 patients who started this phase enrolled directly into this phase of the study.|842
10398906|NCT00706654|11542731|FG001|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
10398907|NCT00706654|11542732|FG002|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
10398908|NCT00706654|11542733|FG003|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
10398909|NCT00706654|11542730|FG000|COMPLETED|Oral Stabilization Phase||662
10398910|NCT00706654|11542731|FG001|COMPLETED|Oral Stabilization Phase||0
10398911|NCT00706654|11542732|FG002|COMPLETED|Oral Stabilization Phase||0
10398912|NCT00706654|11542733|FG003|COMPLETED|Oral Stabilization Phase||0
10398913|NCT00706654|11542730|FG000|NOT COMPLETED|Oral Stabilization Phase||180
10398914|NCT00706654|11542731|FG001|NOT COMPLETED|Oral Stabilization Phase||0
10398915|NCT00706654|11542732|FG002|NOT COMPLETED|Oral Stabilization Phase||0
10398916|NCT00706654|11542733|FG003|NOT COMPLETED|Oral Stabilization Phase||0
10398917|NCT00706654|11542730|FG000|STARTED|Depot Maintenance Phase|Patients were randomized into the 3 aripiprazole treatment groups in this phase of the study.|0
10398918|NCT00706654|11542731|FG001|STARTED|Depot Maintenance Phase||265
10398919|NCT00706654|11542732|FG002|STARTED|Depot Maintenance Phase||266
10398920|NCT00706654|11542733|FG003|STARTED|Depot Maintenance Phase||131
10398921|NCT00706654|11542730|FG000|COMPLETED|Depot Maintenance Phase||0
10398922|NCT00706654|11542731|FG001|COMPLETED|Depot Maintenance Phase||196
10398923|NCT00706654|11542732|FG002|COMPLETED|Depot Maintenance Phase||178
10398924|NCT00706654|11542733|FG003|COMPLETED|Depot Maintenance Phase||61
10398925|NCT00706654|11542730|FG000|NOT COMPLETED|Depot Maintenance Phase||0
10398926|NCT00706654|11542731|FG001|NOT COMPLETED|Depot Maintenance Phase||69
10398927|NCT00706654|11542732|FG002|NOT COMPLETED|Depot Maintenance Phase||88
10398928|NCT00706654|11542733|FG003|NOT COMPLETED|Depot Maintenance Phase||70
10398929|NCT00706706|11542743|FG000|STARTED|Overall Study||105
10398930|NCT00706706|11542743|FG000|COMPLETED|Overall Study||0
10398931|NCT00706706|11542743|FG000|NOT COMPLETED|Overall Study||105
10398932|NCT00706719|11542750|FG000|STARTED|Overall Study||5
10398933|NCT00706719|11542751|FG001|STARTED|Overall Study||7
10398934|NCT00706719|11542752|FG002|STARTED|Overall Study||5
10398935|NCT00706719|11542750|FG000|COMPLETED|Overall Study||5
10398936|NCT00706719|11542751|FG001|COMPLETED|Overall Study||6
10398937|NCT00706719|11542752|FG002|COMPLETED|Overall Study||1
10398938|NCT00706719|11542750|FG000|NOT COMPLETED|Overall Study||0
10398939|NCT00706719|11542751|FG001|NOT COMPLETED|Overall Study||1
10398940|NCT00706719|11542752|FG002|NOT COMPLETED|Overall Study||4
10398941|NCT00706784|11542761|FG000|STARTED|Overall Study||3
10398942|NCT00706784|11542762|FG001|STARTED|Overall Study||3
10398943|NCT00706784|11542761|FG000|COMPLETED|Overall Study||3
10398944|NCT00706784|11542762|FG001|COMPLETED|Overall Study||3
10398945|NCT00706784|11542761|FG000|NOT COMPLETED|Overall Study||0
10720888|NCT02719639|11884484|FG000|NOT COMPLETED|Overall Study||0
10720889|NCT02719743|11884493|FG000|STARTED|Overall Study||38
10398946|NCT00706784|11542762|FG001|NOT COMPLETED|Overall Study||0
10398947|NCT00706810|11542768|FG000|STARTED|Overall Study||8
10720890|NCT02719743|11884494|FG001|STARTED|Overall Study||37
10813656|NCT02696226|11976067|FG003|NOT COMPLETED|Overall Study||0
10813657|NCT02693743|11976079|FG000|STARTED|Overall Study||1
10813658|NCT02693743|11976080|FG001|STARTED|Overall Study||0
10720891|NCT02719743|11884495|FG002|STARTED|Overall Study||38
10720892|NCT02719743|11884496|FG003|STARTED|Overall Study||37
10720893|NCT02719743|11884497|FG004|STARTED|Overall Study||35
10720894|NCT02719743|11884493|FG000|COMPLETED|Overall Study||37
10720895|NCT02719743|11884494|FG001|COMPLETED|Overall Study||34
10720896|NCT02719743|11884495|FG002|COMPLETED|Overall Study||38
10720897|NCT02719743|11884496|FG003|COMPLETED|Overall Study||36
10720898|NCT02719743|11884497|FG004|COMPLETED|Overall Study||33
10813659|NCT02693743|11976079|FG000|COMPLETED|Overall Study||0
10813660|NCT02693743|11976080|FG001|COMPLETED|Overall Study||0
10813661|NCT02693743|11976079|FG000|NOT COMPLETED|Overall Study||1
10813662|NCT02693743|11976080|FG001|NOT COMPLETED|Overall Study||0
10813663|NCT02706691|11976086|FG000|STARTED|Overall Study||1
10813664|NCT02706691|11976086|FG000|COMPLETED|Overall Study||0
10813665|NCT02706691|11976086|FG000|NOT COMPLETED|Overall Study||1
10813666|NCT02708849|11976093|FG000|STARTED|Overall Study||2
10813667|NCT02708849|11976094|FG001|STARTED|Overall Study||1
10813668|NCT02708849|11976093|FG000|COMPLETED|Overall Study||1
10813669|NCT02708849|11976094|FG001|COMPLETED|Overall Study||1
10813670|NCT02708849|11976093|FG000|NOT COMPLETED|Overall Study||1
10813671|NCT02708849|11976094|FG001|NOT COMPLETED|Overall Study||0
10813672|NCT02693717|11976100|FG000|STARTED|Overall Study||7
10813673|NCT02693717|11976100|FG000|COMPLETED|Overall Study||7
10813674|NCT02693717|11976100|FG000|NOT COMPLETED|Overall Study||0
10813675|NCT02694757|11976104|FG000|STARTED|Overall Study||3
10813676|NCT02694757|11976104|FG000|COMPLETED|Overall Study||0
10813677|NCT02694757|11976104|FG000|NOT COMPLETED|Overall Study||3
10813678|NCT02693002|11976110|FG000|STARTED|Overall Study||2
10813679|NCT02693002|11976111|FG001|STARTED|Overall Study||2
10813680|NCT02693002|11976110|FG000|COMPLETED|Overall Study||1
10398948|NCT00706810|11542768|FG000|COMPLETED|Overall Study||7
10398949|NCT00706810|11542768|FG000|NOT COMPLETED|Overall Study||1
10813681|NCT02693002|11976111|FG001|COMPLETED|Overall Study||2
10813682|NCT02693002|11976110|FG000|NOT COMPLETED|Overall Study||1
10813683|NCT02693002|11976111|FG001|NOT COMPLETED|Overall Study||0
10813684|NCT02689518|11976117|FG000|STARTED|Overall Study||49
10813685|NCT02689518|11976117|FG000|COMPLETED|Overall Study||46
10813686|NCT02689518|11976117|FG000|NOT COMPLETED|Overall Study||3
10813687|NCT02687165|11976121|FG000|STARTED|Overall Study||0
10813688|NCT02687165|11976122|FG001|STARTED|Overall Study||0
10813689|NCT02687165|11976121|FG000|COMPLETED|Overall Study||0
10813690|NCT02687165|11976122|FG001|COMPLETED|Overall Study||0
10813691|NCT02687165|11976121|FG000|NOT COMPLETED|Overall Study||0
10813692|NCT02687165|11976122|FG001|NOT COMPLETED|Overall Study||0
10813693|NCT02679560|11976130|FG000|STARTED|Overall Study||1
10813694|NCT02679560|11976131|FG001|STARTED|Overall Study||2
10813695|NCT02679560|11976130|FG000|COMPLETED|Overall Study||1
10813696|NCT02679560|11976131|FG001|COMPLETED|Overall Study||2
10813697|NCT02679560|11976130|FG000|NOT COMPLETED|Overall Study||0
10813698|NCT02679560|11976131|FG001|NOT COMPLETED|Overall Study||0
10813699|NCT02679066|11976139|FG000|STARTED|Overall Study||100
10813700|NCT02679066|11976140|FG001|STARTED|Overall Study||100
10813701|NCT02679066|11976139|FG000|COMPLETED|Overall Study||100
10813702|NCT02679066|11976140|FG001|COMPLETED|Overall Study||100
10813703|NCT02679066|11976139|FG000|NOT COMPLETED|Overall Study||0
10813704|NCT02679066|11976140|FG001|NOT COMPLETED|Overall Study||0
10813705|NCT02673684|11976148|FG000|STARTED|Overall Study||9
10813706|NCT02673684|11976149|FG001|STARTED|Overall Study||8
10813707|NCT02673684|11976148|FG000|COMPLETED|Overall Study||0
10398950|NCT00706823|11542775|FG000|STARTED|Overall Study||25
10398951|NCT00706823|11542776|FG001|STARTED|Overall Study||25
10398952|NCT00706823|11542775|FG000|COMPLETED|Overall Study||25
10720899|NCT02719743|11884493|FG000|NOT COMPLETED|Overall Study||1
10720900|NCT02719743|11884494|FG001|NOT COMPLETED|Overall Study||3
10720901|NCT02719743|11884495|FG002|NOT COMPLETED|Overall Study||0
10813708|NCT02673684|11976149|FG001|COMPLETED|Overall Study||0
10813709|NCT02673684|11976148|FG000|NOT COMPLETED|Overall Study||9
10813710|NCT02673684|11976149|FG001|NOT COMPLETED|Overall Study||8
10813711|NCT02674204|11976159|FG000|STARTED|Overall Study||1
10720902|NCT02719743|11884496|FG003|NOT COMPLETED|Overall Study||1
10720903|NCT02719743|11884497|FG004|NOT COMPLETED|Overall Study||2
10720904|NCT02719938|11884511|FG000|STARTED|Overall Study||30
10720905|NCT02719938|11884512|FG001|STARTED|Overall Study||32
10720906|NCT02719938|11884511|FG000|COMPLETED|Overall Study||26
10720907|NCT02719938|11884512|FG001|COMPLETED|Overall Study||31
10720908|NCT02719938|11884511|FG000|NOT COMPLETED|Overall Study||4
10720909|NCT02719938|11884512|FG001|NOT COMPLETED|Overall Study||1
10720910|NCT02720042|11884518|FG000|STARTED|Overall Study||84
10720911|NCT02720042|11884518|FG000|COMPLETED|Overall Study||69
10720912|NCT02720042|11884518|FG000|NOT COMPLETED|Overall Study||15
10720913|NCT02720081|11884524|FG000|STARTED|Overall Study||72
10720914|NCT02720081|11884525|FG001|STARTED|Overall Study||70
10720915|NCT02720081|11884524|FG000|Treated|Overall Study||70
10720916|NCT02720081|11884525|FG001|Treated|Overall Study||69
10720917|NCT02720081|11884524|FG000|COMPLETED|Overall Study||68
10720918|NCT02720081|11884525|FG001|COMPLETED|Overall Study||66
10720919|NCT02720081|11884524|FG000|NOT COMPLETED|Overall Study||4
10720920|NCT02720081|11884525|FG001|NOT COMPLETED|Overall Study||4
10720921|NCT02720107|11884531|FG000|STARTED|Overall Study||130
10311781|NCT00132769|11445001|FG001|NOT COMPLETED|Overall Study||11
10311782|NCT00132808|11445010|FG000|STARTED|Stratum I||77
10543786|NCT01485627|11696930|FG001|Bereaved Caregivers: 1 Month|Overall Study||51
10543787|NCT01485627|11696929|FG000|Bereaved Caregivers: 2 Month Completed|Overall Study||49
10543788|NCT01485627|11696930|FG001|Bereaved Caregivers: 2 Month Completed|Overall Study||52
10543789|NCT01485627|11696929|FG000|Bereaved Caregivers: 7 Month Completed|Overall Study||48
10543790|NCT01485627|11696930|FG001|Bereaved Caregivers: 7 Month Completed|Overall Study||49
10543791|NCT01485627|11696929|FG000|COMPLETED|Overall Study|130 patients and 48 caregivers|178
10543792|NCT01485627|11696930|FG001|COMPLETED|Overall Study|135 patients and 49 caregivers|184
10543793|NCT01485627|11696929|FG000|NOT COMPLETED|Overall Study||66
10543794|NCT01485627|11696930|FG001|NOT COMPLETED|Overall Study||57
10543795|NCT01485640|11696940|FG000|STARTED|Overall Study||162
10543796|NCT01485640|11696940|FG000|COMPLETED|Overall Study||40
10543797|NCT01485640|11696940|FG000|NOT COMPLETED|Overall Study||122
10543798|NCT01485770|11696946|FG000|STARTED|First Intervention (2 Weeks)||17
10543799|NCT01485770|11696947|FG001|STARTED|First Intervention (2 Weeks)||16
10543800|NCT01485770|11696946|FG000|COMPLETED|First Intervention (2 Weeks)||17
10543801|NCT01485770|11696947|FG001|COMPLETED|First Intervention (2 Weeks)||16
10543802|NCT01485770|11696946|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
10543803|NCT01485770|11696947|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
10543804|NCT01485770|11696946|FG000|STARTED|Second Intervention (2 Weeks)||17
10720922|NCT02720107|11884531|FG000|COMPLETED|Overall Study||130
10720923|NCT02720107|11884531|FG000|NOT COMPLETED|Overall Study||0
10720924|NCT02720198|11884537|FG000|STARTED|Overall Study||29
10720925|NCT02720198|11884538|FG001|STARTED|Overall Study||31
10311783|NCT00132808|11445011|FG001|STARTED|Stratum I||70
10311784|NCT00132808|11445012|FG002|STARTED|Stratum I||77
10311785|NCT00132808|11445010|FG000|COMPLETED|Stratum I||68
10311786|NCT00132808|11445011|FG001|COMPLETED|Stratum I||58
10311787|NCT00132808|11445012|FG002|COMPLETED|Stratum I||72
10311788|NCT00132808|11445010|FG000|NOT COMPLETED|Stratum I||9
10311789|NCT00132808|11445011|FG001|NOT COMPLETED|Stratum I||12
10311790|NCT00132808|11445012|FG002|NOT COMPLETED|Stratum I||5
10311791|NCT00132808|11445010|FG000|STARTED|Stratum II||121
10311792|NCT00132808|11445011|FG001|STARTED|Stratum II||111
10311793|NCT00132808|11445012|FG002|STARTED|Stratum II||125
10311794|NCT00132808|11445010|FG000|COMPLETED|Stratum II||113
10311795|NCT00132808|11445011|FG001|COMPLETED|Stratum II||96
10311796|NCT00132808|11445012|FG002|COMPLETED|Stratum II||116
10311797|NCT00132808|11445010|FG000|NOT COMPLETED|Stratum II||8
10311798|NCT00132808|11445011|FG001|NOT COMPLETED|Stratum II||15
10311799|NCT00132808|11445012|FG002|NOT COMPLETED|Stratum II||9
10311800|NCT00132873|11445020|FG000|STARTED|Overall Study||59
10311801|NCT00132873|11445020|FG000|COMPLETED|Overall Study||50
10543805|NCT01485770|11696947|FG001|STARTED|Second Intervention (2 Weeks)||16
10720926|NCT02720198|11884537|FG000|COMPLETED|Overall Study||29
10720927|NCT02720198|11884538|FG001|COMPLETED|Overall Study||30
10720928|NCT02720198|11884537|FG000|NOT COMPLETED|Overall Study||0
10720929|NCT02720198|11884538|FG001|NOT COMPLETED|Overall Study||1
10720930|NCT02720224|11884544|FG000|STARTED|Overall Study||6
10720931|NCT02720224|11884544|FG000|COMPLETED|Overall Study||6
10398953|NCT00706823|11542776|FG001|COMPLETED|Overall Study||25
10398954|NCT00706823|11542775|FG000|NOT COMPLETED|Overall Study||0
10398955|NCT00706823|11542776|FG001|NOT COMPLETED|Overall Study||0
10543806|NCT01485770|11696946|FG000|COMPLETED|Second Intervention (2 Weeks)||17
10543807|NCT01485770|11696947|FG001|COMPLETED|Second Intervention (2 Weeks)||16
10543808|NCT01485770|11696946|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
10543809|NCT01485770|11696947|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
10543810|NCT01485796|11696955|FG000|STARTED|Period 1: Epoch 1 (Ramp-up)||37
10543811|NCT01485796|11696955|FG000|Treated in Epoch 1|Period 1: Epoch 1 (Ramp-up)||37
10543812|NCT01485796|11696955|FG000|COMPLETED|Period 1: Epoch 1 (Ramp-up)||36
10543813|NCT01485796|11696955|FG000|NOT COMPLETED|Period 1: Epoch 1 (Ramp-up)||1
10543814|NCT01485796|11696955|FG000|STARTED|Period 2: Epoch 2||36
10543815|NCT01485796|11696955|FG000|Treated in Epoch 2|Period 2: Epoch 2||36
10543816|NCT01485796|11696955|FG000|COMPLETED|Period 2: Epoch 2||1
10543817|NCT01485796|11696955|FG000|NOT COMPLETED|Period 2: Epoch 2||35
10543818|NCT01485796|11696955|FG000|STARTED|Overall Trial (Incl. Safety Follow-up)||37
10543819|NCT01485796|11696955|FG000|Treated in Epoch 1 (Ramp-up)|Overall Trial (Incl. Safety Follow-up)||37
10543820|NCT01485796|11696955|FG000|Completed Epoch 1 (Ramp-up)|Overall Trial (Incl. Safety Follow-up)||36
10543821|NCT01485796|11696955|FG000|Started Epoch 2|Overall Trial (Incl. Safety Follow-up)||36
10543822|NCT01485796|11696955|FG000|Treated in Epoch 2|Overall Trial (Incl. Safety Follow-up)||36
10543823|NCT01485796|11696955|FG000|Completed Epoch 2|Overall Trial (Incl. Safety Follow-up)||1
10543824|NCT01485796|11696955|FG000|Switch to Safety Follow-up|Overall Trial (Incl. Safety Follow-up)||26
10543825|NCT01485796|11696955|FG000|Completed Safety Follow-up|Overall Trial (Incl. Safety Follow-up)||24
10543826|NCT01485796|11696955|FG000|COMPLETED|Overall Trial (Incl. Safety Follow-up)|1 subject who completed Epoch 2 + 24 subjects who completed the safety follow-up|25
10543827|NCT01485796|11696955|FG000|NOT COMPLETED|Overall Trial (Incl. Safety Follow-up)||12
10543828|NCT01485887|11696963|FG000|STARTED|Overall Study||50
10543829|NCT01485887|11696963|FG000|COMPLETED|Overall Study||38
10543830|NCT01485887|11696963|FG000|NOT COMPLETED|Overall Study||12
10543831|NCT01485991|11696969|FG000|STARTED|Overall Study||385
10543832|NCT01485991|11696970|FG001|STARTED|Overall Study||386
10543833|NCT01485991|11696969|FG000|Treated|Overall Study||379
10543834|NCT01485991|11696970|FG001|Treated|Overall Study||384
10543835|NCT01485991|11696969|FG000|COMPLETED|Overall Study||353
10543836|NCT01485991|11696970|FG001|COMPLETED|Overall Study||350
10543837|NCT01485991|11696969|FG000|NOT COMPLETED|Overall Study||32
10543838|NCT01485991|11696970|FG001|NOT COMPLETED|Overall Study||36
10543839|NCT01486043|11696976|FG000|STARTED|Overall Study||4
10398956|NCT00706836|11542782|FG000|STARTED|Overall Study||16
10398957|NCT00706836|11542782|FG000|COMPLETED|Overall Study||16
10543840|NCT01486043|11696976|FG000|COMPLETED|Overall Study|Study terminated due to insufficient recruitment|2
10543841|NCT01486043|11696976|FG000|NOT COMPLETED|Overall Study||2
10543842|NCT01486199|11696982|FG000|STARTED|Baseline Study Day||10
10543843|NCT01486199|11696983|FG001|STARTED|Baseline Study Day||10
10398958|NCT00706836|11542782|FG000|NOT COMPLETED|Overall Study||0
10398959|NCT00706849|11542792|FG000|STARTED|Treatment Period||41
10398960|NCT00706849|11542793|FG001|STARTED|Treatment Period||83
10398961|NCT00706849|11542792|FG000|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|41
10398962|NCT00706849|11542793|FG001|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement.|82
10398963|NCT00706849|11542792|FG000|COMPLETED|Treatment Period|38 patients entered the open-label extension study (301012-CS6; NCT00694109).|41
10398964|NCT00706849|11542793|FG001|COMPLETED|Treatment Period|55 patients entered the open-label extension study (301012-CS6; NCT00694109).|73
10398965|NCT00706849|11542792|FG000|NOT COMPLETED|Treatment Period||0
10398966|NCT00706849|11542793|FG001|NOT COMPLETED|Treatment Period||10
10398967|NCT00706849|11542792|FG000|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|3
10398968|NCT00706849|11542793|FG001|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|28
10398969|NCT00706849|11542792|FG000|COMPLETED|Follow-up Period||3
10398970|NCT00706849|11542793|FG001|COMPLETED|Follow-up Period||25
10398971|NCT00706849|11542792|FG000|NOT COMPLETED|Follow-up Period||0
10398972|NCT00706849|11542793|FG001|NOT COMPLETED|Follow-up Period||3
10398973|NCT00706901|11542802|FG000|STARTED|Overall Study||59
10398974|NCT00706901|11542803|FG001|STARTED|Overall Study||62
10398975|NCT00706901|11542804|FG002|STARTED|Overall Study||59
10398976|NCT00706901|11542802|FG000|COMPLETED|Overall Study||51
10398977|NCT00706901|11542803|FG001|COMPLETED|Overall Study||57
10398978|NCT00706901|11542804|FG002|COMPLETED|Overall Study||51
10398979|NCT00706901|11542802|FG000|NOT COMPLETED|Overall Study||8
10398980|NCT00706901|11542803|FG001|NOT COMPLETED|Overall Study||5
10398981|NCT00706901|11542804|FG002|NOT COMPLETED|Overall Study||8
10398982|NCT00706914|11542816|FG000|STARTED|Overall Study||63
10398983|NCT00706914|11542817|FG001|STARTED|Overall Study||62
10398984|NCT00706914|11542818|FG002|STARTED|Overall Study||31
10398985|NCT00706914|11542816|FG000|COMPLETED|Overall Study||57
10398986|NCT00706914|11542817|FG001|COMPLETED|Overall Study||58
10398987|NCT00706914|11542818|FG002|COMPLETED|Overall Study||30
10398988|NCT00706914|11542816|FG000|NOT COMPLETED|Overall Study||6
10398989|NCT00706914|11542817|FG001|NOT COMPLETED|Overall Study||4
10398990|NCT00706914|11542818|FG002|NOT COMPLETED|Overall Study||1
10398991|NCT00706966|11542826|FG000|STARTED|Overall Study||10
10398992|NCT00706966|11542826|FG000|COMPLETED|Overall Study||9
10398993|NCT00706966|11542826|FG000|NOT COMPLETED|Overall Study||1
10398994|NCT00706979|11542860|FG000|STARTED|Overall Study||426
10398995|NCT00706979|11542861|FG001|STARTED|Overall Study||423
10398996|NCT00706979|11542860|FG000|COMPLETED|Overall Study||426
10398997|NCT00706979|11542861|FG001|COMPLETED|Overall Study||423
10398998|NCT00706979|11542860|FG000|NOT COMPLETED|Overall Study||0
10398999|NCT00706979|11542861|FG001|NOT COMPLETED|Overall Study||0
10399000|NCT00706992|11542874|FG000|STARTED|Overall Study||8
10399001|NCT00706992|11542875|FG001|STARTED|Overall Study||8
10399002|NCT00706992|11542876|FG002|STARTED|Overall Study||9
10399003|NCT00706992|11542877|FG003|STARTED|Overall Study||8
10399004|NCT00706992|11542878|FG004|STARTED|Overall Study||6
10399005|NCT00706992|11542879|FG005|STARTED|Overall Study||5
10399006|NCT00706992|11542880|FG006|STARTED|Overall Study||6
10399007|NCT00706992|11542874|FG000|COMPLETED|Overall Study||3
10399008|NCT00706992|11542875|FG001|COMPLETED|Overall Study||3
10399009|NCT00706992|11542876|FG002|COMPLETED|Overall Study||3
10399010|NCT00706992|11542877|FG003|COMPLETED|Overall Study||6
10659329|NCT02240680|11820683|FG001|STARTED|Japanese Patients (Up to 52 Weeks)||0
10659330|NCT02240680|11820684|FG002|STARTED|Japanese Patients (Up to 52 Weeks)||50
10659331|NCT02240680|11820685|FG003|STARTED|Japanese Patients (Up to 52 Weeks)||52
10659332|NCT02240680|11820682|FG000|COMPLETED|Japanese Patients (Up to 52 Weeks)||0
10659333|NCT02240680|11820683|FG001|COMPLETED|Japanese Patients (Up to 52 Weeks)||0
10659334|NCT02240680|11820684|FG002|COMPLETED|Japanese Patients (Up to 52 Weeks)||42
10659335|NCT02240680|11820685|FG003|COMPLETED|Japanese Patients (Up to 52 Weeks)||45
10659336|NCT02240680|11820682|FG000|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||0
10659337|NCT02240680|11820683|FG001|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||0
10659338|NCT02240680|11820684|FG002|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||8
10659339|NCT02240680|11820685|FG003|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||7
10659340|NCT02240693|11820698|FG000|STARTED|Overall Study||22
10659341|NCT02240693|11820699|FG001|STARTED|Overall Study||21
10659342|NCT02240693|11820700|FG002|STARTED|Overall Study||21
10659343|NCT02240693|11820701|FG003|STARTED|Overall Study||21
10659344|NCT02240693|11820702|FG004|STARTED|Overall Study||43
10659345|NCT02240693|11820698|FG000|COMPLETED|Overall Study||22
10399011|NCT00706992|11542878|FG004|COMPLETED|Overall Study||2
10399012|NCT00706992|11542879|FG005|COMPLETED|Overall Study||3
10399013|NCT00706992|11542880|FG006|COMPLETED|Overall Study||3
10399014|NCT00706992|11542874|FG000|NOT COMPLETED|Overall Study||5
10399015|NCT00706992|11542875|FG001|NOT COMPLETED|Overall Study||5
10399016|NCT00706992|11542876|FG002|NOT COMPLETED|Overall Study||6
10720932|NCT02720224|11884544|FG000|NOT COMPLETED|Overall Study||0
10720933|NCT02720484|11884548|FG000|STARTED|Treatment on Study||10
10720934|NCT02720484|11884548|FG000|Reached 1st Response/2 Cycles|Treatment on Study||7
10720935|NCT02720484|11884548|FG000|Treated Cycle 3|Treatment on Study||4
10720936|NCT02720484|11884548|FG000|COMPLETED|Treatment on Study||4
10720937|NCT02720484|11884548|FG000|NOT COMPLETED|Treatment on Study||6
10720938|NCT02720484|11884548|FG000|STARTED|Follow Up for 2 Years|All patients that receive at least one treatment on study go into follow up.|7
10720939|NCT02720484|11884548|FG000|COMPLETED|Follow Up for 2 Years||1
10720940|NCT02720484|11884548|FG000|NOT COMPLETED|Follow Up for 2 Years||6
10720941|NCT02720536|11884552|FG000|STARTED|Overall Study||53
10311802|NCT00132873|11445020|FG000|NOT COMPLETED|Overall Study||9
10311803|NCT00132964|11445026|FG000|STARTED|Overall Study||54
10311804|NCT00132964|11445027|FG001|STARTED|Overall Study||57
10311805|NCT00132964|11445026|FG000|COMPLETED|Overall Study||50
10311806|NCT00132964|11445027|FG001|COMPLETED|Overall Study||54
10311807|NCT00132964|11445026|FG000|NOT COMPLETED|Overall Study||4
10311808|NCT00132964|11445027|FG001|NOT COMPLETED|Overall Study||3
10311809|NCT00133575|11445040|FG000|STARTED|Overall Study||10
10311810|NCT00133575|11445041|FG001|STARTED|Overall Study||10
10311811|NCT00133575|11445042|FG002|STARTED|Overall Study||10
10311812|NCT00133575|11445043|FG003|STARTED|Overall Study||10
10311813|NCT00133575|11445044|FG004|STARTED|Overall Study||10
10311814|NCT00133575|11445045|FG005|STARTED|Overall Study||10
10311815|NCT00133575|11445046|FG006|STARTED|Overall Study||12
10311816|NCT00133575|11445040|FG000|COMPLETED|Overall Study||10
10720942|NCT02720536|11884552|FG000|COMPLETED|Overall Study||34
10720943|NCT02720536|11884552|FG000|NOT COMPLETED|Overall Study||19
10720944|NCT02720627|11884562|FG000|STARTED|Overall Study||27
10720945|NCT02720627|11884562|FG000|COMPLETED|Overall Study||27
10311817|NCT00133575|11445041|FG001|COMPLETED|Overall Study||10
10311818|NCT00133575|11445042|FG002|COMPLETED|Overall Study||8
10311819|NCT00133575|11445043|FG003|COMPLETED|Overall Study||9
10311820|NCT00133575|11445044|FG004|COMPLETED|Overall Study||6
10311821|NCT00133575|11445045|FG005|COMPLETED|Overall Study||9
10311822|NCT00133575|11445046|FG006|COMPLETED|Overall Study||9
10311823|NCT00133575|11445040|FG000|NOT COMPLETED|Overall Study||0
10311824|NCT00133575|11445041|FG001|NOT COMPLETED|Overall Study||0
10399017|NCT00706992|11542877|FG003|NOT COMPLETED|Overall Study||2
10399018|NCT00706992|11542878|FG004|NOT COMPLETED|Overall Study||4
10399019|NCT00706992|11542879|FG005|NOT COMPLETED|Overall Study||2
10399020|NCT00706992|11542880|FG006|NOT COMPLETED|Overall Study||3
10399021|NCT00707031|11542899|FG000|STARTED|Overall Study|Randomized|320
10399022|NCT00707031|11542900|FG001|STARTED|Overall Study||319
10399023|NCT00707031|11542899|FG000|Treated/Safety Population|Overall Study|All patients who received at least 1 dose, regardless of amount of treatment administered.|318
10399024|NCT00707031|11542900|FG001|Treated/Safety Population|Overall Study||316
10399025|NCT00707031|11542899|FG000|Modified Intent-to-Treat Population|Overall Study|All patients who received at least 1 dose;had baseline;at least 1 post-baseline efficacy assessment.|315
10399026|NCT00707031|11542900|FG001|Modified Intent-to-Treat Population|Overall Study||315
10399027|NCT00707031|11542899|FG000|COMPLETED|Overall Study||216
10399028|NCT00707031|11542900|FG001|COMPLETED|Overall Study||220
10399029|NCT00707031|11542899|FG000|NOT COMPLETED|Overall Study||104
10399030|NCT00707031|11542900|FG001|NOT COMPLETED|Overall Study||99
10399031|NCT00707057|11542909|FG000|STARTED|Overall Study||169
10399032|NCT00707057|11542910|FG001|STARTED|Overall Study||87
10399033|NCT00707057|11542909|FG000|COMPLETED|Overall Study||161
10399034|NCT00707057|11542910|FG001|COMPLETED|Overall Study||83
10399035|NCT00707057|11542909|FG000|NOT COMPLETED|Overall Study||8
10720946|NCT02720627|11884562|FG000|NOT COMPLETED|Overall Study||0
10720947|NCT02720757|11884566|FG000|STARTED|Overall Study||132
10720948|NCT02720757|11884566|FG000|COMPLETED|Overall Study||114
10720949|NCT02720757|11884566|FG000|NOT COMPLETED|Overall Study||18
10720950|NCT02721017|11884572|FG000|STARTED|Hospital Stay|Intraoperative Application of Cryoanalgesia started on Date of Surgery (DOS).|10
10399036|NCT00707057|11542910|FG001|NOT COMPLETED|Overall Study||4
10399037|NCT00707174|11542918|FG000|STARTED|Overall Study||46
10399038|NCT00707174|11542919|FG001|STARTED|Overall Study||44
10399039|NCT00707174|11542918|FG000|COMPLETED|Overall Study||41
10399040|NCT00707174|11542919|FG001|COMPLETED|Overall Study||37
10659346|NCT02240693|11820699|FG001|COMPLETED|Overall Study||21
10659347|NCT02240693|11820700|FG002|COMPLETED|Overall Study||17
10720951|NCT02721017|11884573|FG001|STARTED|Hospital Stay|Thoracic Epidural placed on Date of Surgery (DOS).|10
10720952|NCT02721017|11884572|FG000|COMPLETED|Hospital Stay|Completed during the course of surgery.|10
10720953|NCT02721017|11884573|FG001|COMPLETED|Hospital Stay|Removal occurs prior to Hospital Discharge.|10
10720954|NCT02721017|11884572|FG000|NOT COMPLETED|Hospital Stay||0
10720955|NCT02721017|11884573|FG001|NOT COMPLETED|Hospital Stay||0
10720956|NCT02721017|11884572|FG000|STARTED|Participant Follow Up|Assessment of recovery at 2 weeks, 1 month, 3 month and 12 month intervals.|10
10720957|NCT02721017|11884573|FG001|STARTED|Participant Follow Up|Assessment of recovery at 2 weeks, 1 month, 3 month and 12 month intervals.|10
10720958|NCT02721017|11884572|FG000|COMPLETED|Participant Follow Up|12 months after Date of Surgery.|10
10399041|NCT00707174|11542918|FG000|NOT COMPLETED|Overall Study||5
10399042|NCT00707174|11542919|FG001|NOT COMPLETED|Overall Study||7
10399043|NCT00707239|11542928|FG000|STARTED|Overall Study||37
10399044|NCT00707239|11542929|FG001|STARTED|Overall Study||36
10399045|NCT00707239|11542930|FG002|STARTED|Overall Study||35
10659348|NCT02240693|11820701|FG003|COMPLETED|Overall Study||20
10659349|NCT02240693|11820702|FG004|COMPLETED|Overall Study||42
10659350|NCT02240693|11820698|FG000|NOT COMPLETED|Overall Study||0
10659351|NCT02240693|11820699|FG001|NOT COMPLETED|Overall Study||0
10659352|NCT02240693|11820700|FG002|NOT COMPLETED|Overall Study||4
10659353|NCT02240693|11820701|FG003|NOT COMPLETED|Overall Study||1
10659354|NCT02240693|11820702|FG004|NOT COMPLETED|Overall Study||1
10659355|NCT02240706|11820721|FG000|STARTED|Overall Study||3
10659356|NCT02240706|11820722|FG001|STARTED|Overall Study||3
10659357|NCT02240706|11820723|FG002|STARTED|Overall Study||6
10659358|NCT02240706|11820724|FG003|STARTED|Overall Study||4
10659359|NCT02240706|11820725|FG004|STARTED|Overall Study||11
10659360|NCT02240706|11820726|FG005|STARTED|Overall Study|No patients were enrolled in the Phase II part due to strategic reasons.|0
10659361|NCT02240706|11820727|FG006|STARTED|Overall Study|No patients were enrolled in the Phase II part due to strategic reasons.|0
10659362|NCT02240706|11820721|FG000|COMPLETED|Overall Study||0
10659363|NCT02240706|11820722|FG001|COMPLETED|Overall Study||0
10659364|NCT02240706|11820723|FG002|COMPLETED|Overall Study||0
10659365|NCT02240706|11820724|FG003|COMPLETED|Overall Study||0
10659366|NCT02240706|11820725|FG004|COMPLETED|Overall Study||0
10399046|NCT00707239|11542928|FG000|Treated|Overall Study||36
10399047|NCT00707239|11542929|FG001|Treated|Overall Study||35
10399048|NCT00707239|11542930|FG002|Treated|Overall Study||34
10399049|NCT00707239|11542928|FG000|COMPLETED|Overall Study||18
10399050|NCT00707239|11542929|FG001|COMPLETED|Overall Study||25
10399051|NCT00707239|11542930|FG002|COMPLETED|Overall Study||21
10399052|NCT00707239|11542928|FG000|NOT COMPLETED|Overall Study||19
10399053|NCT00707239|11542929|FG001|NOT COMPLETED|Overall Study||11
10399054|NCT00707239|11542930|FG002|NOT COMPLETED|Overall Study||14
10399055|NCT00707343|11542941|FG000|STARTED|Overall Study||15
10399056|NCT00707343|11542941|FG000|COMPLETED|Overall Study||15
10399057|NCT00707343|11542941|FG000|NOT COMPLETED|Overall Study||0
10399058|NCT00707447|11542947|FG000|STARTED|Overall Study||89
10399059|NCT00707447|11542948|FG001|STARTED|Overall Study||93
10399060|NCT00707447|11542947|FG000|COMPLETED|Overall Study||81
10399061|NCT00707447|11542948|FG001|COMPLETED|Overall Study||85
10399062|NCT00707447|11542947|FG000|NOT COMPLETED|Overall Study||8
10399063|NCT00707447|11542948|FG001|NOT COMPLETED|Overall Study||8
10399064|NCT00707486|11542954|FG000|STARTED|Overall Study||72
10399065|NCT00707486|11542954|FG000|COMPLETED|Overall Study||71
10399066|NCT00707486|11542954|FG000|NOT COMPLETED|Overall Study||1
10399067|NCT00707577|11542962|FG000|STARTED|Overall Study||174
10399068|NCT00707577|11542963|FG001|STARTED|Overall Study||156
10399069|NCT00707577|11542962|FG000|COMPLETED|Overall Study||120
10399070|NCT00707577|11542963|FG001|COMPLETED|Overall Study||118
10399071|NCT00707577|11542962|FG000|NOT COMPLETED|Overall Study||54
10399072|NCT00707577|11542963|FG001|NOT COMPLETED|Overall Study||38
10399073|NCT00707655|11542971|FG000|STARTED|Overall Study||3
10399074|NCT00707655|11542972|FG001|STARTED|Overall Study||5
10399075|NCT00707655|11542971|FG000|COMPLETED|Overall Study||3
10399076|NCT00707655|11542972|FG001|COMPLETED|Overall Study||3
10399077|NCT00707655|11542971|FG000|NOT COMPLETED|Overall Study||0
10399078|NCT00707655|11542972|FG001|NOT COMPLETED|Overall Study||2
10399079|NCT00707746|11542982|FG000|STARTED|Treatment Period||12
10399080|NCT00707746|11542983|FG001|STARTED|Treatment Period||22
10399081|NCT00707746|11542982|FG000|Full Analysis Set (FAS) and Safety Set|Treatment Period|FAS: Treated patients with a valid baseline & post-baseline LDL-C measurement|12
10399082|NCT00707746|11542983|FG001|Full Analysis Set (FAS) and Safety Set|Treatment Period|FAS: Treated patients with a valid baseline & post-baseline LDL-C measurement|21
10399083|NCT00707746|11542982|FG000|COMPLETED|Treatment Period||10
10399084|NCT00707746|11542983|FG001|COMPLETED|Treatment Period||17
10399085|NCT00707746|11542982|FG000|NOT COMPLETED|Treatment Period||2
10399086|NCT00707746|11542983|FG001|NOT COMPLETED|Treatment Period||5
10399087|NCT00707746|11542982|FG000|STARTED|Follow-up Period||12
10399088|NCT00707746|11542983|FG001|STARTED|Follow-up Period||21
10399089|NCT00707746|11542982|FG000|COMPLETED|Follow-up Period||12
10399090|NCT00707746|11542983|FG001|COMPLETED|Follow-up Period||21
10399091|NCT00707746|11542982|FG000|NOT COMPLETED|Follow-up Period||0
10399092|NCT00707746|11542983|FG001|NOT COMPLETED|Follow-up Period||0
10399093|NCT00707759|11542991|FG000|STARTED|Overall Study||14
10399094|NCT00707759|11542992|FG001|STARTED|Overall Study||14
10399095|NCT00707759|11542991|FG000|COMPLETED|Overall Study||12
10399096|NCT00707759|11542992|FG001|COMPLETED|Overall Study||12
10399097|NCT00707759|11542991|FG000|NOT COMPLETED|Overall Study||2
10399098|NCT00707759|11542992|FG001|NOT COMPLETED|Overall Study||2
10399099|NCT00707863|11543000|FG000|STARTED|Overall Study||6
10399100|NCT00707863|11543001|FG001|STARTED|Overall Study||11
10399101|NCT00707863|11543000|FG000|COMPLETED|Overall Study||6
10399102|NCT00707863|11543001|FG001|COMPLETED|Overall Study||8
10399103|NCT00707863|11543000|FG000|NOT COMPLETED|Overall Study||0
10399104|NCT00707863|11543001|FG001|NOT COMPLETED|Overall Study||3
10399105|NCT00707915|11543007|FG000|STARTED|Overall Study||30
10399106|NCT00707915|11543007|FG000|Effects of Discontinuing Benzodiazepine|Overall Study||30
10399107|NCT00707915|11543007|FG000|COMPLETED|Overall Study||30
10399108|NCT00707915|11543007|FG000|NOT COMPLETED|Overall Study||0
10399109|NCT00707954|11543016|FG000|STARTED|Overall Study||12
10399110|NCT00707954|11543017|FG001|STARTED|Overall Study||12
10399111|NCT00707954|11543018|FG002|STARTED|Overall Study||14
10399112|NCT00707954|11543019|FG003|STARTED|Overall Study||13
10399113|NCT00707954|11543020|FG004|STARTED|Overall Study||10
10399114|NCT00707954|11543016|FG000|COMPLETED|Overall Study||12
10399115|NCT00707954|11543017|FG001|COMPLETED|Overall Study||12
10399116|NCT00707954|11543018|FG002|COMPLETED|Overall Study||14
10399117|NCT00707954|11543019|FG003|COMPLETED|Overall Study||13
10399118|NCT00707954|11543020|FG004|COMPLETED|Overall Study||9
10399119|NCT00707954|11543016|FG000|NOT COMPLETED|Overall Study||0
10399120|NCT00707954|11543017|FG001|NOT COMPLETED|Overall Study||0
10399121|NCT00707954|11543018|FG002|NOT COMPLETED|Overall Study||0
10399122|NCT00707954|11543019|FG003|NOT COMPLETED|Overall Study||0
10399123|NCT00707954|11543020|FG004|NOT COMPLETED|Overall Study||1
10399124|NCT00707967|11543035|FG000|STARTED|Overall Study||22
10399125|NCT00707967|11543036|FG001|STARTED|Overall Study||8
10399126|NCT00707967|11543037|FG002|STARTED|Overall Study||7
10399127|NCT00707967|11543035|FG000|COMPLETED|Overall Study||22
10399128|NCT00707967|11543036|FG001|COMPLETED|Overall Study||8
10399129|NCT00707967|11543037|FG002|COMPLETED|Overall Study||7
10399130|NCT00707967|11543035|FG000|NOT COMPLETED|Overall Study||0
10399131|NCT00707967|11543036|FG001|NOT COMPLETED|Overall Study||0
10399132|NCT00707967|11543037|FG002|NOT COMPLETED|Overall Study||0
10399133|NCT00707980|11543045|FG000|STARTED|Overall Study||836
10399134|NCT00707980|11543045|FG000|Received Treatment|Overall Study||834
10399135|NCT00707980|11543045|FG000|COMPLETED|Overall Study||526
10399136|NCT00707980|11543045|FG000|NOT COMPLETED|Overall Study||310
10399137|NCT00707993|11543051|FG000|STARTED|Overall Study||222
10399138|NCT00707993|11543052|FG001|STARTED|Overall Study||219
10399139|NCT00707993|11543051|FG000|COMPLETED|Overall Study||133
10399140|NCT00707993|11543052|FG001|COMPLETED|Overall Study||125
10399141|NCT00707993|11543051|FG000|NOT COMPLETED|Overall Study||89
10399142|NCT00707993|11543052|FG001|NOT COMPLETED|Overall Study||94
10399143|NCT00708019|11543060|FG000|STARTED|Overall Study||92
10399144|NCT00708019|11543061|FG001|STARTED|Overall Study||93
10399145|NCT00708019|11543060|FG000|COMPLETED|Overall Study||77
10399146|NCT00708019|11543061|FG001|COMPLETED|Overall Study||78
10399147|NCT00708019|11543060|FG000|NOT COMPLETED|Overall Study||15
10399148|NCT00708019|11543061|FG001|NOT COMPLETED|Overall Study||15
10399149|NCT00708032|11543069|FG000|STARTED|Overall Study||36
10399150|NCT00708032|11543070|FG001|STARTED|Overall Study||38
10399151|NCT00708032|11543069|FG000|COMPLETED|Overall Study||26
10399152|NCT00708032|11543070|FG001|COMPLETED|Overall Study||22
10399153|NCT00708032|11543069|FG000|NOT COMPLETED|Overall Study||10
10399154|NCT00708032|11543070|FG001|NOT COMPLETED|Overall Study||16
10399155|NCT00708071|11543076|FG000|STARTED|Overall Study|Randomized and treated|45
10399156|NCT00708071|11543076|FG000|COMPLETED|Overall Study||45
10399157|NCT00708071|11543076|FG000|NOT COMPLETED|Overall Study||0
10399158|NCT00708097|11543110|FG000|STARTED|Period 1||11
10399159|NCT00708097|11543111|FG001|STARTED|Period 1||12
10399160|NCT00708097|11543112|FG002|STARTED|Period 1||12
10399161|NCT00708097|11543113|FG003|STARTED|Period 1||11
10399162|NCT00708097|11543114|FG004|STARTED|Period 1||11
10399163|NCT00708097|11543110|FG000|COMPLETED|Period 1||11
10399164|NCT00708097|11543111|FG001|COMPLETED|Period 1||11
10399165|NCT00708097|11543112|FG002|COMPLETED|Period 1||12
10399166|NCT00708097|11543113|FG003|COMPLETED|Period 1||9
10399167|NCT00708097|11543114|FG004|COMPLETED|Period 1||10
10399168|NCT00708097|11543110|FG000|NOT COMPLETED|Period 1||0
10399169|NCT00708097|11543111|FG001|NOT COMPLETED|Period 1||1
10399170|NCT00708097|11543112|FG002|NOT COMPLETED|Period 1||0
10399171|NCT00708097|11543113|FG003|NOT COMPLETED|Period 1||2
10399172|NCT00708097|11543114|FG004|NOT COMPLETED|Period 1||1
10399173|NCT00708097|11543110|FG000|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
10399174|NCT00708097|11543111|FG001|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|12
10399175|NCT00708097|11543112|FG002|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
10399176|NCT00708097|11543113|FG003|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|11
10399177|NCT00708097|11543114|FG004|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
10399178|NCT00708097|11543110|FG000|COMPLETED|Period 2||10
10399179|NCT00708097|11543111|FG001|COMPLETED|Period 2||11
10399180|NCT00708097|11543112|FG002|COMPLETED|Period 2||9
10399181|NCT00708097|11543113|FG003|COMPLETED|Period 2||10
10399182|NCT00708097|11543114|FG004|COMPLETED|Period 2||10
10399183|NCT00708097|11543110|FG000|NOT COMPLETED|Period 2||0
10399184|NCT00708097|11543111|FG001|NOT COMPLETED|Period 2||1
10399185|NCT00708097|11543112|FG002|NOT COMPLETED|Period 2||1
10543844|NCT01486199|11696982|FG000|COMPLETED|Baseline Study Day||10
10543845|NCT01486199|11696983|FG001|COMPLETED|Baseline Study Day||9
10543846|NCT01486199|11696982|FG000|NOT COMPLETED|Baseline Study Day||0
10543847|NCT01486199|11696983|FG001|NOT COMPLETED|Baseline Study Day||1
10543848|NCT01486199|11696982|FG000|STARTED|Two Year Period Between Study Days||10
10543849|NCT01486199|11696983|FG001|STARTED|Two Year Period Between Study Days||0
10720959|NCT02721017|11884573|FG001|COMPLETED|Participant Follow Up|12 months after Date of Surgery.|10
10720960|NCT02721017|11884572|FG000|NOT COMPLETED|Participant Follow Up||0
10720961|NCT02721017|11884573|FG001|NOT COMPLETED|Participant Follow Up||0
10399186|NCT00708097|11543113|FG003|NOT COMPLETED|Period 2||1
10399187|NCT00708097|11543114|FG004|NOT COMPLETED|Period 2||0
10399188|NCT00708097|11543110|FG000|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|9
10399189|NCT00708097|11543111|FG001|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|11
10399190|NCT00708097|11543112|FG002|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
10399191|NCT00708097|11543113|FG003|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
10399192|NCT00708097|11543114|FG004|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
10399193|NCT00708097|11543110|FG000|COMPLETED|Period 3||9
10399194|NCT00708097|11543111|FG001|COMPLETED|Period 3||11
10399195|NCT00708097|11543112|FG002|COMPLETED|Period 3||10
10720962|NCT02721147|11884584|FG000|STARTED|Overall Study||40
10720963|NCT02721147|11884585|FG001|STARTED|Overall Study||18
10399196|NCT00708097|11543113|FG003|COMPLETED|Period 3||10
10399197|NCT00708097|11543114|FG004|COMPLETED|Period 3||10
10399198|NCT00708097|11543110|FG000|NOT COMPLETED|Period 3||0
10399199|NCT00708097|11543111|FG001|NOT COMPLETED|Period 3||0
10399200|NCT00708097|11543112|FG002|NOT COMPLETED|Period 3||0
10399201|NCT00708097|11543113|FG003|NOT COMPLETED|Period 3||0
10399202|NCT00708097|11543114|FG004|NOT COMPLETED|Period 3||0
10399203|NCT00708097|11543110|FG000|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|12
10399204|NCT00708097|11543111|FG001|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|9
10399205|NCT00708097|11543112|FG002|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|10
10399206|NCT00708097|11543113|FG003|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|11
10399207|NCT00708097|11543114|FG004|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|8
10399208|NCT00708097|11543110|FG000|COMPLETED|Period 4||12
10399209|NCT00708097|11543111|FG001|COMPLETED|Period 4||9
10399210|NCT00708097|11543112|FG002|COMPLETED|Period 4||10
10399211|NCT00708097|11543113|FG003|COMPLETED|Period 4||11
10399212|NCT00708097|11543114|FG004|COMPLETED|Period 4||8
10399213|NCT00708097|11543110|FG000|NOT COMPLETED|Period 4||0
10399214|NCT00708097|11543111|FG001|NOT COMPLETED|Period 4||0
10399215|NCT00708097|11543112|FG002|NOT COMPLETED|Period 4||0
10399216|NCT00708097|11543113|FG003|NOT COMPLETED|Period 4||0
10399217|NCT00708097|11543114|FG004|NOT COMPLETED|Period 4||0
10399218|NCT00708097|11543110|FG000|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|8
10399219|NCT00708097|11543111|FG001|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|9
10399220|NCT00708097|11543112|FG002|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|11
10399221|NCT00708097|11543113|FG003|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|10
10399222|NCT00708097|11543114|FG004|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|12
10399223|NCT00708097|11543110|FG000|COMPLETED|Period 5||8
10399224|NCT00708097|11543111|FG001|COMPLETED|Period 5||9
10399225|NCT00708097|11543112|FG002|COMPLETED|Period 5||11
10399226|NCT00708097|11543113|FG003|COMPLETED|Period 5||10
10399227|NCT00708097|11543114|FG004|COMPLETED|Period 5||12
10399228|NCT00708097|11543110|FG000|NOT COMPLETED|Period 5||0
10399229|NCT00708097|11543111|FG001|NOT COMPLETED|Period 5||0
10399230|NCT00708097|11543112|FG002|NOT COMPLETED|Period 5||0
10399231|NCT00708097|11543113|FG003|NOT COMPLETED|Period 5||0
10720964|NCT02721147|11884586|FG002|STARTED|Overall Study||31
10720965|NCT02721147|11884584|FG000|COMPLETED|Overall Study||38
10311825|NCT00133575|11445042|FG002|NOT COMPLETED|Overall Study||2
10311826|NCT00133575|11445043|FG003|NOT COMPLETED|Overall Study||1
10311827|NCT00133575|11445044|FG004|NOT COMPLETED|Overall Study||4
10311828|NCT00133575|11445045|FG005|NOT COMPLETED|Overall Study||1
10311829|NCT00133575|11445046|FG006|NOT COMPLETED|Overall Study||3
10311830|NCT00133705|11445064|FG000|STARTED|Overall Study||22
10311831|NCT00133705|11445065|FG001|STARTED|Overall Study||20
10311832|NCT00133705|11445064|FG000|COMPLETED|Overall Study||20
10311833|NCT00133705|11445065|FG001|COMPLETED|Overall Study||17
10311834|NCT00133705|11445064|FG000|NOT COMPLETED|Overall Study||2
10311835|NCT00133705|11445065|FG001|NOT COMPLETED|Overall Study||3
10311836|NCT00133809|11445071|FG000|STARTED|Overall Study||8
10311837|NCT00133809|11445071|FG000|COMPLETED|Overall Study||8
10311838|NCT00133809|11445071|FG000|NOT COMPLETED|Overall Study||0
10311839|NCT00133952|11445077|FG000|STARTED|Overall Study||157
10311840|NCT00133952|11445078|FG001|STARTED|Overall Study||152
10311841|NCT00133952|11445077|FG000|Received at Least One Dose of Study Drug|Overall Study||153
10311842|NCT00133952|11445078|FG001|Received at Least One Dose of Study Drug|Overall Study||149
10311843|NCT00133952|11445077|FG000|COMPLETED|Overall Study||115
10311844|NCT00133952|11445078|FG001|COMPLETED|Overall Study||124
10311845|NCT00133952|11445077|FG000|NOT COMPLETED|Overall Study||42
10311846|NCT00133952|11445078|FG001|NOT COMPLETED|Overall Study||28
10311847|NCT00133978|11445088|FG000|STARTED|Overall Study||303
10311848|NCT00133978|11445089|FG001|STARTED|Overall Study||308
10311849|NCT00133978|11445090|FG002|STARTED|Overall Study||310
10311850|NCT00133978|11445091|FG003|STARTED|Overall Study||302
10311851|NCT00133978|11445088|FG000|COMPLETED|Overall Study||301
10311852|NCT00133978|11445089|FG001|COMPLETED|Overall Study||307
10311853|NCT00133978|11445090|FG002|COMPLETED|Overall Study||310
10311854|NCT00133978|11445091|FG003|COMPLETED|Overall Study||300
10311855|NCT00133978|11445088|FG000|NOT COMPLETED|Overall Study||2
10311856|NCT00133978|11445089|FG001|NOT COMPLETED|Overall Study||1
10311857|NCT00133978|11445090|FG002|NOT COMPLETED|Overall Study||0
10311858|NCT00133978|11445091|FG003|NOT COMPLETED|Overall Study||2
10311859|NCT00133991|11445105|FG000|STARTED|Overall Study||21
10311860|NCT00133991|11445105|FG000|COMPLETED|Overall Study||17
10311861|NCT00133991|11445105|FG000|NOT COMPLETED|Overall Study||4
10311862|NCT00134004|11445109|FG000|STARTED|Overall Study||210
10311863|NCT00134004|11445109|FG000|COMPLETED|Overall Study||210
10311864|NCT00134004|11445109|FG000|NOT COMPLETED|Overall Study||0
10311865|NCT00134017|11445113|FG000|STARTED|Overall Study||142
10311866|NCT00134017|11445113|FG000|COMPLETED|Overall Study||142
10311867|NCT00134017|11445113|FG000|NOT COMPLETED|Overall Study||0
10311868|NCT00134043|11445119|FG000|STARTED|Overall Study||16
10311869|NCT00134043|11445120|FG001|STARTED|Overall Study||3
10311870|NCT00134043|11445119|FG000|COMPLETED|Overall Study||16
10311871|NCT00134043|11445120|FG001|COMPLETED|Overall Study||3
10311872|NCT00134043|11445119|FG000|NOT COMPLETED|Overall Study||0
10311873|NCT00134043|11445120|FG001|NOT COMPLETED|Overall Study||0
10311874|NCT00134056|11445127|FG000|STARTED|Randomization||518
10311875|NCT00134056|11445128|FG001|STARTED|Randomization||520
10311876|NCT00134056|11445127|FG000|COMPLETED|Randomization||496
10311877|NCT00134056|11445128|FG001|COMPLETED|Randomization||500
10311878|NCT00134056|11445127|FG000|NOT COMPLETED|Randomization||22
10311879|NCT00134056|11445128|FG001|NOT COMPLETED|Randomization||20
10311880|NCT00134056|11445127|FG000|STARTED|Eligible for Protocol Assigned Treatment||496
10311881|NCT00134056|11445128|FG001|STARTED|Eligible for Protocol Assigned Treatment||500
10311882|NCT00134056|11445127|FG000|COMPLETED|Eligible for Protocol Assigned Treatment||169
10311883|NCT00134056|11445128|FG001|COMPLETED|Eligible for Protocol Assigned Treatment||185
10311884|NCT00134056|11445127|FG000|NOT COMPLETED|Eligible for Protocol Assigned Treatment||327
10311885|NCT00134056|11445128|FG001|NOT COMPLETED|Eligible for Protocol Assigned Treatment||315
10399232|NCT00708097|11543114|FG004|NOT COMPLETED|Period 5||0
10399233|NCT00708110|11543135|FG000|STARTED|Overall Study||7
10399234|NCT00708110|11543136|FG001|STARTED|Overall Study||9
10399235|NCT00708110|11543137|FG002|STARTED|Overall Study||9
10399236|NCT00708110|11543138|FG003|STARTED|Overall Study||10
10399237|NCT00708110|11543135|FG000|COMPLETED|Overall Study||7
10399238|NCT00708110|11543136|FG001|COMPLETED|Overall Study||9
10399239|NCT00708110|11543137|FG002|COMPLETED|Overall Study||9
10399240|NCT00708110|11543138|FG003|COMPLETED|Overall Study||10
10399241|NCT00708110|11543135|FG000|NOT COMPLETED|Overall Study||0
10399242|NCT00708110|11543136|FG001|NOT COMPLETED|Overall Study||0
10399243|NCT00708110|11543137|FG002|NOT COMPLETED|Overall Study||0
10399244|NCT00708110|11543138|FG003|NOT COMPLETED|Overall Study||0
10399245|NCT00708123|11543148|FG000|STARTED|Period 1||12
10399246|NCT00708123|11543149|FG001|STARTED|Period 1||12
10399247|NCT00708123|11543150|FG002|STARTED|Period 1||12
10399248|NCT00708123|11543151|FG003|STARTED|Period 1||12
10399249|NCT00708123|11543152|FG004|STARTED|Period 1||12
10399250|NCT00708123|11543148|FG000|COMPLETED|Period 1||12
10399251|NCT00708123|11543149|FG001|COMPLETED|Period 1||11
10399252|NCT00708123|11543150|FG002|COMPLETED|Period 1||11
10399253|NCT00708123|11543151|FG003|COMPLETED|Period 1||11
10311886|NCT00134082|11445137|FG000|STARTED|Overall Study||30
10311887|NCT00134082|11445137|FG000|COMPLETED|Overall Study||27
10311888|NCT00134082|11445137|FG000|NOT COMPLETED|Overall Study||3
10311889|NCT00134381|11445141|FG000|STARTED|Overall Study||1
10311890|NCT00134381|11445142|FG001|STARTED|Overall Study||2
10399254|NCT00708123|11543152|FG004|COMPLETED|Period 1||12
10399255|NCT00708123|11543148|FG000|NOT COMPLETED|Period 1||0
10399256|NCT00708123|11543149|FG001|NOT COMPLETED|Period 1||1
10720966|NCT02721147|11884585|FG001|COMPLETED|Overall Study||18
10720967|NCT02721147|11884586|FG002|COMPLETED|Overall Study||31
10720968|NCT02721147|11884584|FG000|NOT COMPLETED|Overall Study||2
10720969|NCT02721147|11884585|FG001|NOT COMPLETED|Overall Study||0
10311891|NCT00134381|11445143|FG002|STARTED|Overall Study||1
10311892|NCT00134381|11445144|FG003|STARTED|Overall Study||2
10311893|NCT00134381|11445145|FG004|STARTED|Overall Study||31
10311894|NCT00134381|11445146|FG005|STARTED|Overall Study||31
10311895|NCT00134381|11445141|FG000|COMPLETED|Overall Study||1
10311896|NCT00134381|11445142|FG001|COMPLETED|Overall Study||2
10311897|NCT00134381|11445143|FG002|COMPLETED|Overall Study||1
10311898|NCT00134381|11445144|FG003|COMPLETED|Overall Study||2
10311899|NCT00134381|11445145|FG004|COMPLETED|Overall Study||31
10311900|NCT00134381|11445146|FG005|COMPLETED|Overall Study||29
10399257|NCT00708123|11543150|FG002|NOT COMPLETED|Period 1||1
10399258|NCT00708123|11543151|FG003|NOT COMPLETED|Period 1||1
10399259|NCT00708123|11543152|FG004|NOT COMPLETED|Period 1||0
10399260|NCT00708123|11543148|FG000|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
10399261|NCT00708123|11543149|FG001|STARTED|Period 2|Due to crossover design,different set of participants received this treatment compared to Period 1|12
10399262|NCT00708123|11543150|FG002|STARTED|Period 2|Due to crossover design,different set of participants received this treatment compared to Period 1|12
10399263|NCT00708123|11543151|FG003|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
10721023|NCT02722239|11884656|FG000|First Intervention (1 Day)|Overall Study||20
10399264|NCT00708123|11543152|FG004|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
10399265|NCT00708123|11543148|FG000|COMPLETED|Period 2||10
10399266|NCT00708123|11543149|FG001|COMPLETED|Period 2||12
10399267|NCT00708123|11543150|FG002|COMPLETED|Period 2||12
10399268|NCT00708123|11543151|FG003|COMPLETED|Period 2||10
10399269|NCT00708123|11543152|FG004|COMPLETED|Period 2||11
10399270|NCT00708123|11543148|FG000|NOT COMPLETED|Period 2||1
10399271|NCT00708123|11543149|FG001|NOT COMPLETED|Period 2||0
10399272|NCT00708123|11543150|FG002|NOT COMPLETED|Period 2||0
10659367|NCT02240706|11820726|FG005|COMPLETED|Overall Study||0
10659368|NCT02240706|11820727|FG006|COMPLETED|Overall Study||0
10659369|NCT02240706|11820721|FG000|NOT COMPLETED|Overall Study||3
10659370|NCT02240706|11820722|FG001|NOT COMPLETED|Overall Study||3
10659371|NCT02240706|11820723|FG002|NOT COMPLETED|Overall Study||6
10720970|NCT02721147|11884586|FG002|NOT COMPLETED|Overall Study||0
10720971|NCT02721251|11884597|FG000|STARTED|Overall Study||14
10720972|NCT02721251|11884598|FG001|STARTED|Overall Study||16
10720973|NCT02721251|11884599|FG002|STARTED|Overall Study||17
10720974|NCT02721251|11884597|FG000|COMPLETED|Overall Study||4
10720975|NCT02721251|11884598|FG001|COMPLETED|Overall Study||7
10720976|NCT02721251|11884599|FG002|COMPLETED|Overall Study||6
10720977|NCT02721251|11884597|FG000|NOT COMPLETED|Overall Study||10
10720978|NCT02721251|11884598|FG001|NOT COMPLETED|Overall Study||9
10720979|NCT02721251|11884599|FG002|NOT COMPLETED|Overall Study||11
10720980|NCT02721355|11884610|FG000|STARTED|Overall Study||42
10720981|NCT02721355|11884611|FG001|STARTED|Overall Study||42
10720982|NCT02721355|11884610|FG000|COMPLETED|Overall Study||36
10720983|NCT02721355|11884611|FG001|COMPLETED|Overall Study||41
10720984|NCT02721355|11884610|FG000|NOT COMPLETED|Overall Study||6
10720985|NCT02721355|11884611|FG001|NOT COMPLETED|Overall Study||1
10720986|NCT02721641|11884617|FG000|STARTED|Overall Study||69
10720987|NCT02721641|11884617|FG000|COMPLETED|Overall Study|In this continued access study, all participants were considered to have completed per protocol.|69
10720988|NCT02721641|11884617|FG000|NOT COMPLETED|Overall Study||0
10720989|NCT02721875|11884623|FG000|STARTED|Overall Study||1
10720990|NCT02721875|11884624|FG001|STARTED|Overall Study||0
10720991|NCT02721875|11884623|FG000|COMPLETED|Overall Study||0
10720992|NCT02721875|11884624|FG001|COMPLETED|Overall Study||0
10720993|NCT02721875|11884623|FG000|NOT COMPLETED|Overall Study||1
10720994|NCT02721875|11884624|FG001|NOT COMPLETED|Overall Study||0
10720995|NCT02721966|11884633|FG000|STARTED|Overall Study||167
10720996|NCT02721966|11884634|FG001|STARTED|Overall Study||165
10720997|NCT02721966|11884635|FG002|STARTED|Overall Study||81
10720998|NCT02721966|11884636|FG003|STARTED|Overall Study||80
10720999|NCT02721966|11884637|FG004|STARTED|Overall Study||5
10399273|NCT00708123|11543151|FG003|NOT COMPLETED|Period 2||1
10399274|NCT00708123|11543152|FG004|NOT COMPLETED|Period 2||0
10399275|NCT00708123|11543148|FG000|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|12
10399276|NCT00708123|11543149|FG001|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|10
10399277|NCT00708123|11543150|FG002|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|11
10721000|NCT02721966|11884633|FG000|Completed Period 1 & Went to Period 2|Overall Study||162
10721001|NCT02721966|11884634|FG001|Completed Period 1 & Went to Period 2|Overall Study||153
10721002|NCT02721966|11884635|FG002|Completed Period 1 & Went to Period 2|Overall Study||81
10721003|NCT02721966|11884636|FG003|Completed Period 1 & Went to Period 2|Overall Study||80
10721004|NCT02721966|11884637|FG004|Completed Period 1 & Went to Period 2|Overall Study||0
10721005|NCT02721966|11884633|FG000|COMPLETED|Overall Study||138
10721006|NCT02721966|11884634|FG001|COMPLETED|Overall Study||142
10721007|NCT02721966|11884635|FG002|COMPLETED|Overall Study||72
10721008|NCT02721966|11884636|FG003|COMPLETED|Overall Study||73
10721009|NCT02721966|11884637|FG004|COMPLETED|Overall Study||0
10721010|NCT02721966|11884633|FG000|NOT COMPLETED|Overall Study||29
10721011|NCT02721966|11884634|FG001|NOT COMPLETED|Overall Study||23
10721012|NCT02721966|11884635|FG002|NOT COMPLETED|Overall Study||9
10721013|NCT02721966|11884636|FG003|NOT COMPLETED|Overall Study||7
10721014|NCT02721966|11884637|FG004|NOT COMPLETED|Overall Study||5
10777357|NCT03339583|11939337|FG001|COMPLETED|First Intervention (14 Days)||23
10777358|NCT03339583|11939336|FG000|NOT COMPLETED|First Intervention (14 Days)||1
10777359|NCT03339583|11939337|FG001|NOT COMPLETED|First Intervention (14 Days)||0
10777360|NCT03339583|11939336|FG000|STARTED|Washout (14 Days)||18
10777361|NCT03339583|11939337|FG001|STARTED|Washout (14 Days)||23
10777362|NCT03339583|11939336|FG000|COMPLETED|Washout (14 Days)||18
10777363|NCT03339583|11939337|FG001|COMPLETED|Washout (14 Days)||23
10777364|NCT03339583|11939336|FG000|NOT COMPLETED|Washout (14 Days)||0
10777365|NCT03339583|11939337|FG001|NOT COMPLETED|Washout (14 Days)||0
10777366|NCT03339583|11939336|FG000|STARTED|Second Intervention (14 Days)||18
10777367|NCT03339583|11939337|FG001|STARTED|Second Intervention (14 Days)||23
10777368|NCT03339583|11939336|FG000|COMPLETED|Second Intervention (14 Days)||18
10777369|NCT03339583|11939337|FG001|COMPLETED|Second Intervention (14 Days)||21
10721015|NCT02722044|11884645|FG000|STARTED|Overall Study||33
10721016|NCT02722044|11884645|FG000|COMPLETED|Overall Study||28
10721017|NCT02722044|11884645|FG000|NOT COMPLETED|Overall Study||5
10721018|NCT02722148|11884650|FG000|STARTED|Overall Study||24
10721019|NCT02722148|11884650|FG000|COMPLETED|Overall Study||19
10721020|NCT02722148|11884650|FG000|NOT COMPLETED|Overall Study||5
10721021|NCT02722239|11884656|FG000|STARTED|Overall Study||20
10721022|NCT02722239|11884657|FG001|STARTED|Overall Study||20
10721024|NCT02722239|11884657|FG001|First Intervention (1 Day)|Overall Study||20
10721025|NCT02722239|11884656|FG000|Washout (7 Days)|Overall Study||20
10721026|NCT02722239|11884657|FG001|Washout (7 Days)|Overall Study||20
10721027|NCT02722239|11884656|FG000|Second Intervention (1 Day)|Overall Study||20
10721028|NCT02722239|11884657|FG001|Second Intervention (1 Day)|Overall Study||20
10721029|NCT02722239|11884656|FG000|COMPLETED|Overall Study||20
10721030|NCT02722239|11884657|FG001|COMPLETED|Overall Study||20
10721031|NCT02722239|11884656|FG000|NOT COMPLETED|Overall Study||0
10721032|NCT02722239|11884657|FG001|NOT COMPLETED|Overall Study||0
10721033|NCT02722278|11884666|FG000|STARTED|Overall Study||166
10721034|NCT02722278|11884667|FG001|STARTED|Overall Study||56
10721035|NCT02722278|11884666|FG000|COMPLETED|Overall Study||154
10311901|NCT00134381|11445141|FG000|NOT COMPLETED|Overall Study||0
10311902|NCT00134381|11445142|FG001|NOT COMPLETED|Overall Study||0
10311903|NCT00134381|11445143|FG002|NOT COMPLETED|Overall Study||0
10311904|NCT00134381|11445144|FG003|NOT COMPLETED|Overall Study||0
10311905|NCT00134381|11445145|FG004|NOT COMPLETED|Overall Study||0
10311906|NCT00134381|11445146|FG005|NOT COMPLETED|Overall Study||2
10311907|NCT00134563|11445166|FG000|STARTED|Overall Study|Randomized|363
10311908|NCT00134563|11445167|FG001|STARTED|Overall Study|Randomized|366
10311909|NCT00134563|11445168|FG002|STARTED|Overall Study|Randomized|359
10311910|NCT00134563|11445166|FG000|Treated|Overall Study|Two participants received doses of Teriflunomide 7 mg, one participant doses of Teriflunomide 14 mg|363
10311911|NCT00134563|11445167|FG001|Treated|Overall Study||365
10311912|NCT00134563|11445168|FG002|Treated|Overall Study|one participant received doses of Teriflunomide 7 mg|358
10311913|NCT00134563|11445166|FG000|COMPLETED|Overall Study|completed treatment period|259
10311914|NCT00134563|11445167|FG001|COMPLETED|Overall Study|completed treatment period|274
10311915|NCT00134563|11445168|FG002|COMPLETED|Overall Study|completed treatment period|263
10311916|NCT00134563|11445166|FG000|NOT COMPLETED|Overall Study||104
10311917|NCT00134563|11445167|FG001|NOT COMPLETED|Overall Study||92
10311918|NCT00134563|11445168|FG002|NOT COMPLETED|Overall Study||96
10311919|NCT00134719|11445179|FG000|STARTED|Primary Vaccination Phase||661
10311920|NCT00134719|11445180|FG001|STARTED|Primary Vaccination Phase||221
10311921|NCT00134719|11445181|FG002|STARTED|Primary Vaccination Phase||221
10311922|NCT00134719|11445179|FG000|COMPLETED|Primary Vaccination Phase||647
10399278|NCT00708123|11543151|FG003|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|12
10428815|NCT00860535|11574907|FG000|COMPLETED|Overall Study||8
10721036|NCT02722278|11884667|FG001|COMPLETED|Overall Study||49
10721037|NCT02722278|11884666|FG000|NOT COMPLETED|Overall Study||12
10721038|NCT02722278|11884667|FG001|NOT COMPLETED|Overall Study||7
10721039|NCT02722304|11884680|FG000|STARTED|Overall Study||1
10721040|NCT02722304|11884681|FG001|STARTED|Overall Study||0
10311923|NCT00134719|11445180|FG001|COMPLETED|Primary Vaccination Phase||215
10311924|NCT00134719|11445181|FG002|COMPLETED|Primary Vaccination Phase||216
10311925|NCT00134719|11445179|FG000|NOT COMPLETED|Primary Vaccination Phase||14
10543850|NCT01486199|11696982|FG000|COMPLETED|Two Year Period Between Study Days||9
10543851|NCT01486199|11696983|FG001|COMPLETED|Two Year Period Between Study Days||0
10543852|NCT01486199|11696982|FG000|NOT COMPLETED|Two Year Period Between Study Days||1
10543853|NCT01486199|11696983|FG001|NOT COMPLETED|Two Year Period Between Study Days||0
10543854|NCT01486199|11696982|FG000|STARTED|Study Day at t= 2 Years||9
10543855|NCT01486199|11696983|FG001|STARTED|Study Day at t= 2 Years||0
10543856|NCT01486199|11696982|FG000|COMPLETED|Study Day at t= 2 Years||9
10543857|NCT01486199|11696983|FG001|COMPLETED|Study Day at t= 2 Years||0
10543858|NCT01486199|11696982|FG000|NOT COMPLETED|Study Day at t= 2 Years||0
10543859|NCT01486199|11696983|FG001|NOT COMPLETED|Study Day at t= 2 Years||0
10543860|NCT01486238|11696991|FG000|STARTED|Overall Study||23
10543861|NCT01486238|11696992|FG001|STARTED|Overall Study||49
10543862|NCT01486238|11696991|FG000|COMPLETED|Overall Study||21
10543863|NCT01486238|11696992|FG001|COMPLETED|Overall Study||43
10399279|NCT00708123|11543152|FG004|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|10
10399280|NCT00708123|11543148|FG000|COMPLETED|Period 3||12
10399281|NCT00708123|11543149|FG001|COMPLETED|Period 3||10
10399282|NCT00708123|11543150|FG002|COMPLETED|Period 3||10
10399283|NCT00708123|11543151|FG003|COMPLETED|Period 3||11
10399284|NCT00708123|11543152|FG004|COMPLETED|Period 3||10
10399285|NCT00708123|11543148|FG000|NOT COMPLETED|Period 3||0
10399286|NCT00708123|11543149|FG001|NOT COMPLETED|Period 3||0
10399287|NCT00708123|11543150|FG002|NOT COMPLETED|Period 3||1
10399288|NCT00708123|11543151|FG003|NOT COMPLETED|Period 3||1
10399289|NCT00708123|11543152|FG004|NOT COMPLETED|Period 3||0
10399290|NCT00708123|11543148|FG000|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
10399291|NCT00708123|11543149|FG001|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|12
10399292|NCT00708123|11543150|FG002|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
10399293|NCT00708123|11543151|FG003|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
10399294|NCT00708123|11543152|FG004|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|11
10399295|NCT00708123|11543148|FG000|COMPLETED|Period 4||10
10399296|NCT00708123|11543149|FG001|COMPLETED|Period 4||11
10399297|NCT00708123|11543150|FG002|COMPLETED|Period 4||10
10399298|NCT00708123|11543151|FG003|COMPLETED|Period 4||10
10399299|NCT00708123|11543152|FG004|COMPLETED|Period 4||11
10399300|NCT00708123|11543148|FG000|NOT COMPLETED|Period 4||0
10399301|NCT00708123|11543149|FG001|NOT COMPLETED|Period 4||1
10399302|NCT00708123|11543150|FG002|NOT COMPLETED|Period 4||0
10399303|NCT00708123|11543151|FG003|NOT COMPLETED|Period 4||0
10399304|NCT00708123|11543152|FG004|NOT COMPLETED|Period 4||0
10399305|NCT00708123|11543148|FG000|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
10399306|NCT00708123|11543149|FG001|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
10399307|NCT00708123|11543150|FG002|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|11
10399308|NCT00708123|11543151|FG003|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|11
10399309|NCT00708123|11543152|FG004|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
10399310|NCT00708123|11543148|FG000|COMPLETED|Period 5||10
10399311|NCT00708123|11543149|FG001|COMPLETED|Period 5||10
10399312|NCT00708123|11543150|FG002|COMPLETED|Period 5||11
10399313|NCT00708123|11543151|FG003|COMPLETED|Period 5||11
10399314|NCT00708123|11543152|FG004|COMPLETED|Period 5||10
10399315|NCT00708123|11543148|FG000|NOT COMPLETED|Period 5||0
10399316|NCT00708123|11543149|FG001|NOT COMPLETED|Period 5||0
10399317|NCT00708123|11543150|FG002|NOT COMPLETED|Period 5||0
10399318|NCT00708123|11543151|FG003|NOT COMPLETED|Period 5||0
10399319|NCT00708123|11543152|FG004|NOT COMPLETED|Period 5||0
10399320|NCT00708162|11543170|FG000|STARTED|Randomized Phase||361
10399321|NCT00708162|11543171|FG001|STARTED|Randomized Phase||363
10399322|NCT00708162|11543170|FG000|Randomized and Treated|Randomized Phase||354
10399323|NCT00708162|11543171|FG001|Randomized and Treated|Randomized Phase||358
10399324|NCT00708162|11543170|FG000|COMPLETED|Randomized Phase||205
10399325|NCT00708162|11543171|FG001|COMPLETED|Randomized Phase||209
10399326|NCT00708162|11543170|FG000|NOT COMPLETED|Randomized Phase||156
10399327|NCT00708162|11543171|FG001|NOT COMPLETED|Randomized Phase||154
10399328|NCT00708162|11543170|FG000|STARTED|Open-Label Phase|9 participants completing the Randomized Phase did not continue to the Open-Label Phase.|196
10543864|NCT01486238|11696991|FG000|NOT COMPLETED|Overall Study||2
10543865|NCT01486238|11696992|FG001|NOT COMPLETED|Overall Study||6
10543866|NCT01486316|11697001|FG000|STARTED|Overall Study|prior to study closure, 24 subjects were enrolled 7 subjects randomized to Control Arm|7
10659372|NCT02240706|11820724|FG003|NOT COMPLETED|Overall Study||4
10399329|NCT00708162|11543171|FG001|STARTED|Open-Label Phase|58 participants completing the Randomized Phase did not continue to the Open-Label Phase.|151
10399330|NCT00708162|11543170|FG000|COMPLETED|Open-Label Phase||152
10399331|NCT00708162|11543171|FG001|COMPLETED|Open-Label Phase||121
10399332|NCT00708162|11543170|FG000|NOT COMPLETED|Open-Label Phase||44
10399333|NCT00708162|11543171|FG001|NOT COMPLETED|Open-Label Phase||30
10399334|NCT00708175|11543180|FG000|STARTED|Overall Study||78
10399335|NCT00708175|11543181|FG001|STARTED|Overall Study||78
10399336|NCT00708175|11543180|FG000|COMPLETED|Overall Study||60
10399337|NCT00708175|11543181|FG001|COMPLETED|Overall Study||57
10399338|NCT00708175|11543180|FG000|NOT COMPLETED|Overall Study||18
10399339|NCT00708175|11543181|FG001|NOT COMPLETED|Overall Study||21
10399340|NCT00708201|11543189|FG000|STARTED|Overall Study||137
10399341|NCT00708201|11543190|FG001|STARTED|Overall Study||143
10399342|NCT00708201|11543189|FG000|Received at Least 1 Dose of Study Drug|Overall Study||130
10399343|NCT00708201|11543190|FG001|Received at Least 1 Dose of Study Drug|Overall Study||137
10399344|NCT00708201|11543189|FG000|COMPLETED|Overall Study||130
10399345|NCT00708201|11543190|FG001|COMPLETED|Overall Study||137
10399346|NCT00708201|11543189|FG000|NOT COMPLETED|Overall Study||7
10399347|NCT00708201|11543190|FG001|NOT COMPLETED|Overall Study||6
10659373|NCT02240706|11820725|FG004|NOT COMPLETED|Overall Study||11
10659374|NCT02240706|11820726|FG005|NOT COMPLETED|Overall Study||0
10659375|NCT02240706|11820727|FG006|NOT COMPLETED|Overall Study||0
10659376|NCT02240810|11820744|FG000|STARTED|Overall Study||1501
10659377|NCT02240810|11820745|FG001|STARTED|Overall Study|correct typo|2681
10721041|NCT02722304|11884682|FG002|STARTED|Overall Study||2
10399348|NCT00708214|11543199|FG000|STARTED|Overall Study||7
10399349|NCT00708214|11543200|FG001|STARTED|Overall Study||13
10399350|NCT00708214|11543201|FG002|STARTED|Overall Study||8
10399351|NCT00708214|11543199|FG000|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
10399352|NCT00708214|11543200|FG001|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
10399353|NCT00708214|11543201|FG002|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
10399354|NCT00708214|11543199|FG000|NOT COMPLETED|Overall Study||7
10399355|NCT00708214|11543200|FG001|NOT COMPLETED|Overall Study||13
10399356|NCT00708214|11543201|FG002|NOT COMPLETED|Overall Study||8
10399357|NCT00708227|11543218|FG000|STARTED|Overall Study||19
10399358|NCT00708227|11543219|FG001|STARTED|Overall Study||26
10399359|NCT00708227|11543220|FG002|STARTED|Overall Study||18
10399360|NCT00708227|11543221|FG003|STARTED|Overall Study||25
10399361|NCT00708227|11543218|FG000|COMPLETED|Overall Study||18
10399362|NCT00708227|11543219|FG001|COMPLETED|Overall Study||21
10399363|NCT00708227|11543220|FG002|COMPLETED|Overall Study||17
10399364|NCT00708227|11543221|FG003|COMPLETED|Overall Study||22
10399365|NCT00708227|11543218|FG000|NOT COMPLETED|Overall Study||1
10399366|NCT00708227|11543219|FG001|NOT COMPLETED|Overall Study||5
10399367|NCT00708227|11543220|FG002|NOT COMPLETED|Overall Study||1
10399368|NCT00708227|11543221|FG003|NOT COMPLETED|Overall Study||3
10428816|NCT00860535|11574907|FG000|NOT COMPLETED|Overall Study||1
10428817|NCT00860574|11574911|FG000|STARTED|Overall Study||96
10428818|NCT00860574|11574911|FG000|COMPLETED|Overall Study||93
10428819|NCT00860574|11574911|FG000|NOT COMPLETED|Overall Study||3
10428820|NCT00860743|11574921|FG000|STARTED|Overall Study||40
10428821|NCT00860743|11574922|FG001|STARTED|Overall Study||23
10428822|NCT00860743|11574921|FG000|COMPLETED|Overall Study||37
10428823|NCT00860743|11574922|FG001|COMPLETED|Overall Study||23
10428824|NCT00860743|11574921|FG000|NOT COMPLETED|Overall Study||3
10428825|NCT00860743|11574922|FG001|NOT COMPLETED|Overall Study||0
10428826|NCT00860795|11574930|FG000|STARTED|Overall Study||10
10428827|NCT00860795|11574931|FG001|STARTED|Overall Study||10
10428828|NCT00860795|11574930|FG000|Number to Complete Study Medication|Overall Study||9
10428829|NCT00860795|11574931|FG001|Number to Complete Study Medication|Overall Study||10
10428830|NCT00860795|11574930|FG000|COMPLETED|Overall Study|One participant discontinued study medication on day 5, but completed safety evaluations|10
10428831|NCT00860795|11574931|FG001|COMPLETED|Overall Study||10
10428832|NCT00860795|11574930|FG000|NOT COMPLETED|Overall Study||0
10428833|NCT00860795|11574931|FG001|NOT COMPLETED|Overall Study||0
10428834|NCT00860847|11574939|FG000|STARTED|Overall Study||32
10721042|NCT02722304|11884683|FG003|STARTED|Overall Study||2
10721043|NCT02722304|11884684|FG004|STARTED|Overall Study||2
10428835|NCT00860847|11574940|FG001|STARTED|Overall Study||33
10428836|NCT00860847|11574939|FG000|COMPLETED|Overall Study||28
10428837|NCT00860847|11574940|FG001|COMPLETED|Overall Study||28
10428838|NCT00860847|11574939|FG000|NOT COMPLETED|Overall Study||4
10428839|NCT00860847|11574940|FG001|NOT COMPLETED|Overall Study||5
10428840|NCT00860938|11574948|FG000|STARTED|Overall Study||45
10428841|NCT00860938|11574949|FG001|STARTED|Overall Study||45
10428842|NCT00860938|11574948|FG000|COMPLETED|Overall Study||31
10428843|NCT00860938|11574949|FG001|COMPLETED|Overall Study||37
10428844|NCT00860938|11574948|FG000|NOT COMPLETED|Overall Study||14
10428845|NCT00860938|11574949|FG001|NOT COMPLETED|Overall Study||8
10428846|NCT00860951|11574955|FG000|STARTED|Overall Study||29
10428847|NCT00860951|11574955|FG000|COMPLETED|Overall Study||22
10428848|NCT00860951|11574955|FG000|NOT COMPLETED|Overall Study||7
10428849|NCT00861146|11574963|FG000|STARTED|Overall Study||105
10428850|NCT00861146|11574964|FG001|STARTED|Overall Study||46
10428851|NCT00861146|11574963|FG000|Week 2 Assessment|Overall Study||97
10428852|NCT00861146|11574964|FG001|Week 2 Assessment|Overall Study||45
10428853|NCT00861146|11574963|FG000|Week 13 Assessment|Overall Study||85
10543867|NCT01486316|11697002|FG001|STARTED|Overall Study|prior to study closure, 24 subjects were enrolled with 10 being randomized to HFRS Guided Arm|10
10543868|NCT01486316|11697003|FG002|STARTED|Overall Study|Exited prior to implant|5
10543869|NCT01486316|11697004|FG003|STARTED|Overall Study|Exited prior to 6 month visit|2
10543870|NCT01486316|11697001|FG000|COMPLETED|Overall Study||3
10543871|NCT01486316|11697002|FG001|COMPLETED|Overall Study||7
10543872|NCT01486316|11697003|FG002|COMPLETED|Overall Study||0
10543873|NCT01486316|11697004|FG003|COMPLETED|Overall Study||0
10543874|NCT01486316|11697001|FG000|NOT COMPLETED|Overall Study||4
10543875|NCT01486316|11697002|FG001|NOT COMPLETED|Overall Study||3
10543876|NCT01486316|11697003|FG002|NOT COMPLETED|Overall Study||5
10543877|NCT01486316|11697004|FG003|NOT COMPLETED|Overall Study||2
10543878|NCT01486446|11697015|FG000|STARTED|Overall Study||7
10543879|NCT01486446|11697016|FG001|STARTED|Overall Study||1
10543880|NCT01486446|11697015|FG000|COMPLETED|Overall Study||6
10399369|NCT00708305|11543251|FG000|STARTED|Period 1||16
10399370|NCT00708305|11543252|FG001|STARTED|Period 1||16
10399371|NCT00708305|11543253|FG002|STARTED|Period 1||17
10399372|NCT00708305|11543254|FG003|STARTED|Period 1||16
10399373|NCT00708305|11543251|FG000|COMPLETED|Period 1||15
10399374|NCT00708305|11543252|FG001|COMPLETED|Period 1||16
10399375|NCT00708305|11543253|FG002|COMPLETED|Period 1||16
10399376|NCT00708305|11543254|FG003|COMPLETED|Period 1||14
10399377|NCT00708305|11543251|FG000|NOT COMPLETED|Period 1||1
10399378|NCT00708305|11543252|FG001|NOT COMPLETED|Period 1||0
10399379|NCT00708305|11543253|FG002|NOT COMPLETED|Period 1||1
10399380|NCT00708305|11543254|FG003|NOT COMPLETED|Period 1||2
10399381|NCT00708305|11543251|FG000|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
10399382|NCT00708305|11543252|FG001|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
10399383|NCT00708305|11543253|FG002|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|16
10399384|NCT00708305|11543254|FG003|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
10399385|NCT00708305|11543251|FG000|COMPLETED|Period 2||14
10399386|NCT00708305|11543252|FG001|COMPLETED|Period 2||13
10399387|NCT00708305|11543253|FG002|COMPLETED|Period 2||16
10399388|NCT00708305|11543254|FG003|COMPLETED|Period 2||14
10399389|NCT00708305|11543251|FG000|NOT COMPLETED|Period 2||1
10399390|NCT00708305|11543252|FG001|NOT COMPLETED|Period 2||2
10399391|NCT00708305|11543253|FG002|NOT COMPLETED|Period 2||0
10399392|NCT00708305|11543254|FG003|NOT COMPLETED|Period 2||1
10399393|NCT00708305|11543251|FG000|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|15
10399394|NCT00708305|11543252|FG001|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
10399395|NCT00708305|11543253|FG002|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
10399396|NCT00708305|11543254|FG003|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
10399397|NCT00708305|11543251|FG000|COMPLETED|Period 3||14
10399398|NCT00708305|11543252|FG001|COMPLETED|Period 3||12
10399399|NCT00708305|11543253|FG002|COMPLETED|Period 3||14
10399400|NCT00708305|11543254|FG003|COMPLETED|Period 3||14
10399401|NCT00708305|11543251|FG000|NOT COMPLETED|Period 3||1
10399402|NCT00708305|11543252|FG001|NOT COMPLETED|Period 3||2
10399403|NCT00708305|11543253|FG002|NOT COMPLETED|Period 3||0
10399404|NCT00708305|11543254|FG003|NOT COMPLETED|Period 3||0
10399405|NCT00708305|11543251|FG000|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|12
10399406|NCT00708305|11543252|FG001|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
10399407|NCT00708305|11543253|FG002|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
10399408|NCT00708305|11543254|FG003|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
10399409|NCT00708305|11543251|FG000|COMPLETED|Period 4||12
10399410|NCT00708305|11543252|FG001|COMPLETED|Period 4||14
10399411|NCT00708305|11543253|FG002|COMPLETED|Period 4||14
10399412|NCT00708305|11543254|FG003|COMPLETED|Period 4||14
10399413|NCT00708305|11543251|FG000|NOT COMPLETED|Period 4||0
10399414|NCT00708305|11543252|FG001|NOT COMPLETED|Period 4||0
10399415|NCT00708305|11543253|FG002|NOT COMPLETED|Period 4||0
10399416|NCT00708305|11543254|FG003|NOT COMPLETED|Period 4||0
10399417|NCT00708422|11543269|FG000|STARTED|Overall Study||116
10399418|NCT00708422|11543270|FG001|STARTED|Overall Study||115
10399419|NCT00708422|11543269|FG000|COMPLETED|Overall Study||112
10399420|NCT00708422|11543270|FG001|COMPLETED|Overall Study||114
10399421|NCT00708422|11543269|FG000|NOT COMPLETED|Overall Study||4
10399422|NCT00708422|11543270|FG001|NOT COMPLETED|Overall Study||1
10399423|NCT00708435|11543278|FG000|STARTED|Overall Study||107
10399424|NCT00708435|11543279|FG001|STARTED|Overall Study||109
10399425|NCT00708435|11543278|FG000|COMPLETED|Overall Study|These data are 'on-study' results collected up to the subject's Day 45 visit.|82
10543881|NCT01486446|11697016|FG001|COMPLETED|Overall Study||1
10543882|NCT01486446|11697015|FG000|NOT COMPLETED|Overall Study||1
10543883|NCT01486446|11697016|FG001|NOT COMPLETED|Overall Study||0
10543884|NCT01486615|11697026|FG000|STARTED|Overall Study||20
10543885|NCT01486615|11697027|FG001|STARTED|Overall Study||20
10543886|NCT01486615|11697028|FG002|STARTED|Overall Study||20
10543887|NCT01486615|11697029|FG003|STARTED|Overall Study||20
10659378|NCT02240810|11820744|FG000|COMPLETED|Overall Study||1441
10399426|NCT00708435|11543279|FG001|COMPLETED|Overall Study|These data are 'on-study' results collected up to the subject's Day 45 visit.|92
10399427|NCT00708435|11543278|FG000|NOT COMPLETED|Overall Study||25
10399428|NCT00708435|11543279|FG001|NOT COMPLETED|Overall Study||17
10399429|NCT00708461|11543289|FG000|STARTED|Overall Study||752
10399430|NCT00708461|11543290|FG001|STARTED|Overall Study||995
10399431|NCT00708461|11543289|FG000|COMPLETED|Overall Study||611
10399432|NCT00708461|11543290|FG001|COMPLETED|Overall Study||795
10399433|NCT00708461|11543289|FG000|NOT COMPLETED|Overall Study||141
10399434|NCT00708461|11543290|FG001|NOT COMPLETED|Overall Study||200
10399435|NCT00708500|11543299|FG000|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||80
10399436|NCT00708500|11543300|FG001|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
10399437|NCT00708500|11543301|FG002|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
10399438|NCT00708500|11543299|FG000|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||80
10399439|NCT00708500|11543300|FG001|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
10399440|NCT00708500|11543301|FG002|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||161
10399441|NCT00708500|11543299|FG000|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||78
10399442|NCT00708500|11543300|FG001|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||156
10399443|NCT00708500|11543301|FG002|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||160
10399444|NCT00708500|11543299|FG000|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||2
10399445|NCT00708500|11543300|FG001|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||6
10399446|NCT00708500|11543301|FG002|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||2
10399447|NCT00708500|11543299|FG000|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||78
10399448|NCT00708500|11543300|FG001|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||156
10399449|NCT00708500|11543301|FG002|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||160
10399450|NCT00708500|11543299|FG000|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||23
10399451|NCT00708500|11543300|FG001|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||104
10399452|NCT00708500|11543301|FG002|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||105
10399453|NCT00708500|11543299|FG000|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||55
10399454|NCT00708500|11543300|FG001|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||52
10399455|NCT00708500|11543301|FG002|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||55
10399456|NCT00708500|11543299|FG000|STARTED|FOLLOWUP||77
10399457|NCT00708500|11543300|FG001|STARTED|FOLLOWUP||151
10399458|NCT00708500|11543301|FG002|STARTED|FOLLOWUP||158
10399459|NCT00708500|11543299|FG000|COMPLETED|FOLLOWUP||37
10399460|NCT00708500|11543300|FG001|COMPLETED|FOLLOWUP||136
10399461|NCT00708500|11543301|FG002|COMPLETED|FOLLOWUP||143
10399462|NCT00708500|11543299|FG000|NOT COMPLETED|FOLLOWUP||40
10399463|NCT00708500|11543300|FG001|NOT COMPLETED|FOLLOWUP||15
10399464|NCT00708500|11543301|FG002|NOT COMPLETED|FOLLOWUP||15
10399465|NCT00708526|11543311|FG000|STARTED|Wake up After Anesthesia||11
10399466|NCT00708526|11543312|FG001|STARTED|Wake up After Anesthesia||11
10399467|NCT00708526|11543311|FG000|COMPLETED|Wake up After Anesthesia||11
10399468|NCT00708526|11543312|FG001|COMPLETED|Wake up After Anesthesia||11
10399469|NCT00708526|11543311|FG000|NOT COMPLETED|Wake up After Anesthesia||0
10399470|NCT00708526|11543312|FG001|NOT COMPLETED|Wake up After Anesthesia||0
10399471|NCT00708526|11543311|FG000|STARTED|Return of Cognitive Function||11
10399472|NCT00708526|11543312|FG001|STARTED|Return of Cognitive Function||11
10399473|NCT00708526|11543311|FG000|COMPLETED|Return of Cognitive Function||11
10399474|NCT00708526|11543312|FG001|COMPLETED|Return of Cognitive Function||11
10399475|NCT00708526|11543311|FG000|NOT COMPLETED|Return of Cognitive Function||0
10399476|NCT00708526|11543312|FG001|NOT COMPLETED|Return of Cognitive Function||0
10399477|NCT00708552|11543322|FG000|STARTED|Overall Study||145
10399478|NCT00708552|11543323|FG001|STARTED|Overall Study||145
10399479|NCT00708552|11543324|FG002|STARTED|Overall Study||133
10399480|NCT00708552|11543325|FG003|STARTED|Overall Study||151
10399481|NCT00708552|11543322|FG000|COMPLETED|Overall Study||118
10399482|NCT00708552|11543323|FG001|COMPLETED|Overall Study||127
10399483|NCT00708552|11543324|FG002|COMPLETED|Overall Study||118
10399484|NCT00708552|11543325|FG003|COMPLETED|Overall Study||130
10399485|NCT00708552|11543322|FG000|NOT COMPLETED|Overall Study||27
10399486|NCT00708552|11543323|FG001|NOT COMPLETED|Overall Study||18
10399487|NCT00708552|11543324|FG002|NOT COMPLETED|Overall Study||15
10399488|NCT00708552|11543325|FG003|NOT COMPLETED|Overall Study||21
10399489|NCT00708643|11543341|FG000|STARTED|Overall Study||40
10399490|NCT00708643|11543342|FG001|STARTED|Overall Study||40
10399491|NCT00708643|11543341|FG000|COMPLETED|Overall Study||40
10399492|NCT00708643|11543342|FG001|COMPLETED|Overall Study||39
10399493|NCT00708643|11543341|FG000|NOT COMPLETED|Overall Study||0
10399494|NCT00708643|11543342|FG001|NOT COMPLETED|Overall Study||1
10399495|NCT00708682|11543348|FG000|STARTED|Infant Series||225
10399496|NCT00708682|11543348|FG000|Vaccinated Dose 1|Infant Series||223
10399497|NCT00708682|11543348|FG000|Vaccinated Dose 2|Infant Series||214
10399498|NCT00708682|11543348|FG000|Vaccinated Dose 3|Infant Series||194
10399499|NCT00708682|11543348|FG000|COMPLETED|Infant Series||192
10399500|NCT00708682|11543348|FG000|NOT COMPLETED|Infant Series||33
10399501|NCT00708682|11543348|FG000|STARTED|After Infant Series||192
10399502|NCT00708682|11543348|FG000|COMPLETED|After Infant Series||191
10399503|NCT00708682|11543348|FG000|NOT COMPLETED|After Infant Series||1
10399504|NCT00708682|11543348|FG000|STARTED|Toddler Dose||191
10399505|NCT00708682|11543348|FG000|COMPLETED|Toddler Dose||183
10399506|NCT00708682|11543348|FG000|NOT COMPLETED|Toddler Dose||8
10399507|NCT00708708|11543354|FG000|STARTED|Overall Study||955
10399508|NCT00708708|11543354|FG000|COMPLETED|Overall Study|Included participants completed total observation period and participants with planned study end.|213
10543888|NCT01486615|11697026|FG000|COMPLETED|Overall Study||20
10543889|NCT01486615|11697027|FG001|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|19
10543890|NCT01486615|11697028|FG002|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|18
10543891|NCT01486615|11697029|FG003|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|18
10543892|NCT01486615|11697026|FG000|NOT COMPLETED|Overall Study||0
10543893|NCT01486615|11697027|FG001|NOT COMPLETED|Overall Study||1
10399509|NCT00708708|11543354|FG000|NOT COMPLETED|Overall Study||742
10399510|NCT00708721|11543361|FG000|STARTED|Overall Study||2
10399511|NCT00708721|11543362|FG001|STARTED|Overall Study||4
10399512|NCT00708721|11543363|FG002|STARTED|Overall Study||3
10399513|NCT00708721|11543364|FG003|STARTED|Overall Study||2
10399514|NCT00708721|11543361|FG000|COMPLETED|Overall Study||2
10399515|NCT00708721|11543362|FG001|COMPLETED|Overall Study||4
10399516|NCT00708721|11543363|FG002|COMPLETED|Overall Study||3
10399517|NCT00708721|11543364|FG003|COMPLETED|Overall Study||2
10399518|NCT00708721|11543361|FG000|NOT COMPLETED|Overall Study||0
10399519|NCT00708721|11543362|FG001|NOT COMPLETED|Overall Study||0
10399520|NCT00708721|11543363|FG002|NOT COMPLETED|Overall Study||0
10399521|NCT00708721|11543364|FG003|NOT COMPLETED|Overall Study||0
10399522|NCT00708851|11543375|FG000|STARTED|Overall Study||12
10399523|NCT00708851|11543375|FG000|COMPLETED|Overall Study||12
10399524|NCT00708851|11543375|FG000|NOT COMPLETED|Overall Study||0
10399525|NCT00708877|11543381|FG000|STARTED|Overall Study||5
10399526|NCT00708877|11543381|FG000|COMPLETED|Overall Study||5
10399527|NCT00708877|11543381|FG000|NOT COMPLETED|Overall Study||0
10399528|NCT00708942|11543390|FG000|STARTED|Overall Study||47
10399529|NCT00708942|11543391|FG001|STARTED|Overall Study||12
10399530|NCT00708942|11543392|FG002|STARTED|Overall Study||11
10399531|NCT00708942|11543393|FG003|STARTED|Overall Study||10
10399532|NCT00708942|11543394|FG004|STARTED|Overall Study||3
10399533|NCT00708942|11543390|FG000|COMPLETED|Overall Study||40
10399534|NCT00708942|11543391|FG001|COMPLETED|Overall Study||11
10399535|NCT00708942|11543392|FG002|COMPLETED|Overall Study||9
10399536|NCT00708942|11543393|FG003|COMPLETED|Overall Study||10
10399537|NCT00708942|11543394|FG004|COMPLETED|Overall Study||2
10399538|NCT00708942|11543390|FG000|NOT COMPLETED|Overall Study||7
10399539|NCT00708942|11543391|FG001|NOT COMPLETED|Overall Study||1
10399540|NCT00708942|11543392|FG002|NOT COMPLETED|Overall Study||2
10399541|NCT00708942|11543393|FG003|NOT COMPLETED|Overall Study||0
10399542|NCT00708942|11543394|FG004|NOT COMPLETED|Overall Study||1
10399543|NCT00709059|11543406|FG000|STARTED|Overall Study||538
10399544|NCT00709059|11543406|FG000|COMPLETED|Overall Study||444
10399545|NCT00709059|11543406|FG000|NOT COMPLETED|Overall Study||94
10399546|NCT00709098|11543413|FG000|STARTED|Double-blind Period||25
10399547|NCT00709098|11543414|FG001|STARTED|Double-blind Period||24
10399548|NCT00709098|11543415|FG002|STARTED|Double-blind Period||0
10399549|NCT00709098|11543413|FG000|COMPLETED|Double-blind Period||19
10399550|NCT00709098|11543414|FG001|COMPLETED|Double-blind Period||16
10399551|NCT00709098|11543415|FG002|COMPLETED|Double-blind Period||0
10399552|NCT00709098|11543413|FG000|NOT COMPLETED|Double-blind Period||6
10399553|NCT00709098|11543414|FG001|NOT COMPLETED|Double-blind Period||8
10399554|NCT00709098|11543415|FG002|NOT COMPLETED|Double-blind Period||0
10399555|NCT00709098|11543413|FG000|STARTED|Open-label Period||0
10399556|NCT00709098|11543414|FG001|STARTED|Open-label Period||0
10311983|NCT00135356|11445249|FG001|COMPLETED|Overall Study||60
10399557|NCT00709098|11543415|FG002|STARTED|Open-label Period|The open-label period was only made available to patients in US centers|32
10399558|NCT00709098|11543413|FG000|COMPLETED|Open-label Period||0
10399559|NCT00709098|11543414|FG001|COMPLETED|Open-label Period||0
10399560|NCT00709098|11543415|FG002|COMPLETED|Open-label Period||18
10399561|NCT00709098|11543413|FG000|NOT COMPLETED|Open-label Period||0
10543894|NCT01486615|11697028|FG002|NOT COMPLETED|Overall Study||2
10543895|NCT01486615|11697029|FG003|NOT COMPLETED|Overall Study||2
10543896|NCT01486758|11697041|FG000|STARTED|Overall Study||20
10543897|NCT01486758|11697042|FG001|STARTED|Overall Study||20
10543898|NCT01486758|11697041|FG000|COMPLETED|Overall Study||20
10543899|NCT01486758|11697042|FG001|COMPLETED|Overall Study||19
10399562|NCT00709098|11543414|FG001|NOT COMPLETED|Open-label Period||0
10399563|NCT00709098|11543415|FG002|NOT COMPLETED|Open-label Period||14
10399564|NCT00709111|11543424|FG000|STARTED|Overall Study||34
10399565|NCT00709111|11543424|FG000|Week 22/24|Overall Study||33
10399566|NCT00709111|11543424|FG000|COMPLETED|Overall Study||32
10399567|NCT00709111|11543424|FG000|NOT COMPLETED|Overall Study||2
10399568|NCT00709124|11543430|FG000|STARTED|Overall Study||16
10399569|NCT00709124|11543431|FG001|STARTED|Overall Study||18
10399570|NCT00709124|11543430|FG000|COMPLETED|Overall Study||12
10311926|NCT00134719|11445180|FG001|NOT COMPLETED|Primary Vaccination Phase||6
10311927|NCT00134719|11445181|FG002|NOT COMPLETED|Primary Vaccination Phase||5
10311928|NCT00134719|11445179|FG000|STARTED|Fourth Dose Vaccination Phase||625
10311929|NCT00134719|11445180|FG001|STARTED|Fourth Dose Vaccination Phase||206
10311930|NCT00134719|11445181|FG002|STARTED|Fourth Dose Vaccination Phase||204
10311931|NCT00134719|11445179|FG000|COMPLETED|Fourth Dose Vaccination Phase||623
10311932|NCT00134719|11445180|FG001|COMPLETED|Fourth Dose Vaccination Phase||203
10311933|NCT00134719|11445181|FG002|COMPLETED|Fourth Dose Vaccination Phase||203
10311934|NCT00134719|11445179|FG000|NOT COMPLETED|Fourth Dose Vaccination Phase||2
10311935|NCT00134719|11445180|FG001|NOT COMPLETED|Fourth Dose Vaccination Phase||3
10311936|NCT00134719|11445181|FG002|NOT COMPLETED|Fourth Dose Vaccination Phase||1
10311937|NCT00134784|11445193|FG000|STARTED|Overall Study||29
10311938|NCT00134784|11445194|FG001|STARTED|Overall Study||38
10311939|NCT00134784|11445195|FG002|STARTED|Overall Study||37
10311940|NCT00134784|11445196|FG003|STARTED|Overall Study||38
10311941|NCT00134784|11445193|FG000|COMPLETED|Overall Study||27
10311942|NCT00134784|11445194|FG001|COMPLETED|Overall Study||36
10311943|NCT00134784|11445195|FG002|COMPLETED|Overall Study||35
10311944|NCT00134784|11445196|FG003|COMPLETED|Overall Study||37
10311945|NCT00134784|11445193|FG000|NOT COMPLETED|Overall Study||2
10311946|NCT00134784|11445194|FG001|NOT COMPLETED|Overall Study||2
10311947|NCT00134784|11445195|FG002|NOT COMPLETED|Overall Study||2
10311948|NCT00134784|11445196|FG003|NOT COMPLETED|Overall Study||1
10311949|NCT00134901|11445205|FG000|STARTED|Overall Study||39
10311950|NCT00134901|11445206|FG001|STARTED|Overall Study||42
10311951|NCT00134901|11445205|FG000|COMPLETED|Overall Study||22
10311952|NCT00134901|11445206|FG001|COMPLETED|Overall Study||27
10721044|NCT02722304|11884680|FG000|Treated|Overall Study||1
10721045|NCT02722304|11884681|FG001|Treated|Overall Study||0
10721046|NCT02722304|11884682|FG002|Treated|Overall Study||1
10721047|NCT02722304|11884683|FG003|Treated|Overall Study||1
10721048|NCT02722304|11884684|FG004|Treated|Overall Study||2
10721049|NCT02722304|11884680|FG000|COMPLETED|Overall Study||0
10721050|NCT02722304|11884681|FG001|COMPLETED|Overall Study||0
10721051|NCT02722304|11884682|FG002|COMPLETED|Overall Study||0
10721052|NCT02722304|11884683|FG003|COMPLETED|Overall Study||0
10721053|NCT02722304|11884684|FG004|COMPLETED|Overall Study||0
10721054|NCT02722304|11884680|FG000|NOT COMPLETED|Overall Study||1
10311953|NCT00134901|11445205|FG000|NOT COMPLETED|Overall Study||17
10311954|NCT00134901|11445206|FG001|NOT COMPLETED|Overall Study||15
10311955|NCT00135226|11445218|FG000|STARTED|Overall Study||3870
10311956|NCT00135226|11445219|FG001|STARTED|Overall Study||3870
10311957|NCT00135226|11445220|FG002|STARTED|Overall Study||3870
10311958|NCT00135226|11445221|FG003|STARTED|Overall Study||3870
10311959|NCT00135226|11445218|FG000|COMPLETED|Overall Study||3836
10311960|NCT00135226|11445219|FG001|COMPLETED|Overall Study||3835
10311961|NCT00135226|11445220|FG002|COMPLETED|Overall Study||3836
10311962|NCT00135226|11445221|FG003|COMPLETED|Overall Study||3834
10311963|NCT00135226|11445218|FG000|NOT COMPLETED|Overall Study||34
10311964|NCT00135226|11445219|FG001|NOT COMPLETED|Overall Study||35
10311965|NCT00135226|11445220|FG002|NOT COMPLETED|Overall Study||34
10311966|NCT00135226|11445221|FG003|NOT COMPLETED|Overall Study||36
10311967|NCT00135330|11445236|FG000|STARTED|Overall Study||45
10311968|NCT00135330|11445237|FG001|STARTED|Overall Study||47
10311969|NCT00135330|11445238|FG002|STARTED|Overall Study||45
10311970|NCT00135330|11445236|FG000|COMPLETED|Overall Study||33
10311971|NCT00135330|11445237|FG001|COMPLETED|Overall Study||34
10311972|NCT00135330|11445238|FG002|COMPLETED|Overall Study||34
10311973|NCT00135330|11445236|FG000|NOT COMPLETED|Overall Study||12
10311974|NCT00135330|11445237|FG001|NOT COMPLETED|Overall Study||13
10311975|NCT00135330|11445238|FG002|NOT COMPLETED|Overall Study||11
10311976|NCT00135356|11445248|FG000|STARTED|Overall Study|Number randomized and treated|131
10311977|NCT00135356|11445249|FG001|STARTED|Overall Study|Number randomized and treated(1 randomized and never treated subject not included in this number.)|69
10311978|NCT00135356|11445248|FG000|Discontinued Prior to Week 96 Visit|Overall Study||16
10311979|NCT00135356|11445249|FG001|Discontinued Prior to Week 96 Visit|Overall Study||9
10311980|NCT00135356|11445248|FG000|Discontinued on or After Week 96 Visit|Overall Study||1
10311981|NCT00135356|11445249|FG001|Discontinued on or After Week 96 Visit|Overall Study||0
10311982|NCT00135356|11445248|FG000|COMPLETED|Overall Study||114
10311984|NCT00135356|11445248|FG000|NOT COMPLETED|Overall Study||17
10311985|NCT00135356|11445249|FG001|NOT COMPLETED|Overall Study||9
10311986|NCT00135512|11445255|FG000|STARTED|Overall Study||234
10311987|NCT00135512|11445255|FG000|COMPLETED|Overall Study||111
10311988|NCT00135512|11445255|FG000|NOT COMPLETED|Overall Study||123
10721055|NCT02722304|11884681|FG001|NOT COMPLETED|Overall Study||0
10721056|NCT02722304|11884682|FG002|NOT COMPLETED|Overall Study||2
10721057|NCT02722304|11884683|FG003|NOT COMPLETED|Overall Study||2
10721058|NCT02722304|11884684|FG004|NOT COMPLETED|Overall Study||2
10311989|NCT00135694|11445262|FG000|STARTED|Overall Study||180
10311990|NCT00135694|11445263|FG001|STARTED|Overall Study||77
10311991|NCT00135694|11445264|FG002|STARTED|Overall Study||18
10311992|NCT00135694|11445262|FG000|COMPLETED|Overall Study|Subjects were assessed as ineligible for random assignment and subsequently terminated per protocol.|0
10311993|NCT00135694|11445263|FG001|COMPLETED|Overall Study||56
10311994|NCT00135694|11445264|FG002|COMPLETED|Overall Study||11
10311995|NCT00135694|11445262|FG000|NOT COMPLETED|Overall Study||180
10721059|NCT02722330|11884698|FG000|STARTED|Overall Study||23
10399571|NCT00709124|11543431|FG001|COMPLETED|Overall Study||17
10399572|NCT00709124|11543430|FG000|NOT COMPLETED|Overall Study||4
10399573|NCT00709124|11543431|FG001|NOT COMPLETED|Overall Study||1
10399574|NCT00709202|11543443|FG000|STARTED|Overall Study||19
10399575|NCT00709202|11543444|FG001|STARTED|Overall Study||21
10399576|NCT00709202|11543443|FG000|COMPLETED|Overall Study||13
10399577|NCT00709202|11543444|FG001|COMPLETED|Overall Study||15
10399578|NCT00709202|11543443|FG000|NOT COMPLETED|Overall Study||6
10399579|NCT00709202|11543444|FG001|NOT COMPLETED|Overall Study||6
10399580|NCT00709228|11543451|FG000|STARTED|Overall Study||496
10399581|NCT00709228|11543451|FG000|COMPLETED|Overall Study|Number completed is defined as participants who completed the follow-up period.|164
10399582|NCT00709228|11543451|FG000|NOT COMPLETED|Overall Study||332
10399583|NCT00709306|11543459|FG000|STARTED|Overall Study||48
10399584|NCT00709306|11543460|FG001|STARTED|Overall Study||44
10399585|NCT00709306|11543461|FG002|STARTED|Overall Study||58
10399586|NCT00709306|11543462|FG003|STARTED|Overall Study||47
10399587|NCT00709306|11543459|FG000|COMPLETED|Overall Study||39
10399588|NCT00709306|11543460|FG001|COMPLETED|Overall Study||30
10399589|NCT00709306|11543461|FG002|COMPLETED|Overall Study||48
10399590|NCT00709306|11543462|FG003|COMPLETED|Overall Study||37
10399591|NCT00709306|11543459|FG000|NOT COMPLETED|Overall Study||9
10399592|NCT00709306|11543460|FG001|NOT COMPLETED|Overall Study||14
10399593|NCT00709306|11543461|FG002|NOT COMPLETED|Overall Study||10
10399594|NCT00709306|11543462|FG003|NOT COMPLETED|Overall Study||10
10399595|NCT00709319|11543472|FG000|STARTED|Overall Study||87
10399596|NCT00709319|11543472|FG000|COMPLETED|Overall Study||81
10399597|NCT00709319|11543472|FG000|NOT COMPLETED|Overall Study||6
10399598|NCT00709592|11543478|FG000|STARTED|Overall Study||19
10399599|NCT00709592|11543479|FG001|STARTED|Overall Study||23
10399600|NCT00709592|11543478|FG000|COMPLETED|Overall Study||19
10399601|NCT00709592|11543479|FG001|COMPLETED|Overall Study||22
10399602|NCT00709592|11543478|FG000|NOT COMPLETED|Overall Study||0
10399603|NCT00709592|11543479|FG001|NOT COMPLETED|Overall Study||1
10399604|NCT00709618|11543485|FG000|STARTED|Overall Study||44
10399605|NCT00709618|11543485|FG000|COMPLETED|Overall Study||14
10399606|NCT00709618|11543485|FG000|NOT COMPLETED|Overall Study||30
10399607|NCT00709696|11543491|FG000|STARTED|Overall Study||4
10399608|NCT00709696|11543492|FG001|STARTED|Overall Study||3
10399609|NCT00709696|11543491|FG000|COMPLETED|Overall Study||4
10399610|NCT00709696|11543492|FG001|COMPLETED|Overall Study||3
10399611|NCT00709696|11543491|FG000|NOT COMPLETED|Overall Study||0
10399612|NCT00709696|11543492|FG001|NOT COMPLETED|Overall Study||0
10399613|NCT00709722|11543498|FG000|STARTED|Overall Study||21
10399614|NCT00709722|11543498|FG000|COMPLETED|Overall Study||20
10399615|NCT00709722|11543498|FG000|NOT COMPLETED|Overall Study||1
10399616|NCT00709735|11543504|FG000|STARTED|Overall Study||11
10399617|NCT00709735|11543505|FG001|STARTED|Overall Study||12
10399618|NCT00709735|11543504|FG000|COMPLETED|Overall Study||8
10399619|NCT00709735|11543505|FG001|COMPLETED|Overall Study||10
10399620|NCT00709735|11543504|FG000|NOT COMPLETED|Overall Study||3
10399621|NCT00709735|11543505|FG001|NOT COMPLETED|Overall Study||2
10399622|NCT00709761|11543511|FG000|STARTED|Overall Study||60
10399623|NCT00709761|11543511|FG000|COMPLETED|Overall Study||33
10399624|NCT00709761|11543511|FG000|NOT COMPLETED|Overall Study||27
10399625|NCT00709826|11543517|FG000|STARTED|Overall Study||70
10399626|NCT00709826|11543518|FG001|STARTED|Overall Study||39
10399627|NCT00709826|11543517|FG000|COMPLETED|Overall Study||68
10659379|NCT02240810|11820745|FG001|COMPLETED|Overall Study||2621
10659380|NCT02240810|11820744|FG000|NOT COMPLETED|Overall Study||60
10659381|NCT02240810|11820745|FG001|NOT COMPLETED|Overall Study||60
10659382|NCT02241486|11820752|FG000|STARTED|Overall Study||2
10659383|NCT02241486|11820752|FG000|COMPLETED|Overall Study||2
10659384|NCT02241486|11820752|FG000|NOT COMPLETED|Overall Study||0
10659385|NCT02241512|11820758|FG000|STARTED|Overall Study||30
10659386|NCT02241512|11820759|FG001|STARTED|Overall Study||29
10659387|NCT02241512|11820758|FG000|COMPLETED|Overall Study||29
10813712|NCT02674204|11976160|FG001|STARTED|Overall Study||1
10813713|NCT02674204|11976159|FG000|COMPLETED|Overall Study||0
10813714|NCT02674204|11976160|FG001|COMPLETED|Overall Study||1
10399628|NCT00709826|11543518|FG001|COMPLETED|Overall Study||38
10659388|NCT02241512|11820759|FG001|COMPLETED|Overall Study||29
10659389|NCT02241512|11820758|FG000|NOT COMPLETED|Overall Study||1
10813715|NCT02674204|11976159|FG000|NOT COMPLETED|Overall Study||1
10813716|NCT02674204|11976160|FG001|NOT COMPLETED|Overall Study||0
10813717|NCT02665221|11976168|FG000|STARTED|Overall Study||15
10659390|NCT02241512|11820759|FG001|NOT COMPLETED|Overall Study||0
10659391|NCT02241655|11820767|FG000|STARTED|Overall Study||614
10659392|NCT02241655|11820768|FG001|STARTED|Overall Study||618
10813718|NCT02665221|11976169|FG001|STARTED|Overall Study||15
10813719|NCT02665221|11976168|FG000|COMPLETED|Overall Study||0
10399629|NCT00709826|11543517|FG000|NOT COMPLETED|Overall Study||2
10399630|NCT00709826|11543518|FG001|NOT COMPLETED|Overall Study||1
10399631|NCT00709852|11543524|FG000|STARTED|Period 1||228
10399632|NCT00709852|11543525|FG001|STARTED|Period 1||174
10399633|NCT00709852|11543524|FG000|COMPLETED|Period 1||220
10399634|NCT00709852|11543525|FG001|COMPLETED|Period 1||171
10399635|NCT00709852|11543524|FG000|NOT COMPLETED|Period 1||8
10399636|NCT00709852|11543525|FG001|NOT COMPLETED|Period 1||3
10399637|NCT00709852|11543524|FG000|STARTED|Period 2||220
10399638|NCT00709852|11543525|FG001|STARTED|Period 2||171
10399639|NCT00709852|11543524|FG000|COMPLETED|Period 2||211
10813720|NCT02665221|11976169|FG001|COMPLETED|Overall Study||0
10813721|NCT02665221|11976168|FG000|NOT COMPLETED|Overall Study||15
10399640|NCT00709852|11543525|FG001|COMPLETED|Period 2||169
10399641|NCT00709852|11543524|FG000|NOT COMPLETED|Period 2||9
10399642|NCT00709852|11543525|FG001|NOT COMPLETED|Period 2||2
10399643|NCT00709878|11543544|FG000|STARTED|Overall Study||8
10399644|NCT00709878|11543545|FG001|STARTED|Overall Study||8
10399645|NCT00709878|11543546|FG002|STARTED|Overall Study||8
10399646|NCT00709878|11543547|FG003|STARTED|Overall Study||8
10399647|NCT00709878|11543544|FG000|COMPLETED|Overall Study||8
10399648|NCT00709878|11543545|FG001|COMPLETED|Overall Study||8
10399649|NCT00709878|11543546|FG002|COMPLETED|Overall Study||8
10399650|NCT00709878|11543547|FG003|COMPLETED|Overall Study||8
10399651|NCT00709878|11543544|FG000|NOT COMPLETED|Overall Study||0
10399652|NCT00709878|11543545|FG001|NOT COMPLETED|Overall Study||0
10399653|NCT00709878|11543546|FG002|NOT COMPLETED|Overall Study||0
10399654|NCT00709878|11543547|FG003|NOT COMPLETED|Overall Study||0
10399655|NCT00709891|11543557|FG000|STARTED|Baseline, Cross-sectional Phase||47208
10399656|NCT00709891|11543557|FG000|COMPLETED|Baseline, Cross-sectional Phase||45758
10399657|NCT00709891|11543557|FG000|NOT COMPLETED|Baseline, Cross-sectional Phase||1450
10399658|NCT00709891|11543557|FG000|STARTED|Longitudinal Follow-up Phase|Only participants who met study criteria in the Baseline phase started the Follow-up phase.|10002
10399659|NCT00709891|11543557|FG000|COMPLETED|Longitudinal Follow-up Phase||5020
10399660|NCT00709891|11543557|FG000|NOT COMPLETED|Longitudinal Follow-up Phase||4982
10399661|NCT00709956|11543563|FG000|STARTED|Overall Study|Day 1 Single-blind placebo run-in|33
10399662|NCT00709956|11543564|FG001|STARTED|Overall Study|Day 1 Single-blind placebo run-in|37
10399663|NCT00709956|11543563|FG000|Double-blind Crossover-period|Overall Study|Days 2 and 3|31
10399664|NCT00709956|11543564|FG001|Double-blind Crossover-period|Overall Study|Days 2 and 3|33
10399665|NCT00709956|11543563|FG000|COMPLETED|Overall Study||30
10399666|NCT00709956|11543564|FG001|COMPLETED|Overall Study||33
10399667|NCT00709956|11543563|FG000|NOT COMPLETED|Overall Study||3
10399668|NCT00709956|11543564|FG001|NOT COMPLETED|Overall Study||4
10399669|NCT00709995|11543574|FG000|STARTED|Overall Study||11
10399670|NCT00709995|11543575|FG001|STARTED|Overall Study||6
10399671|NCT00709995|11543574|FG000|Progressive Disease|Overall Study||6
10399672|NCT00709995|11543575|FG001|Progressive Disease|Overall Study||1
10399673|NCT00709995|11543574|FG000|COMPLETED|Overall Study||6
10399674|NCT00709995|11543575|FG001|COMPLETED|Overall Study||1
10399675|NCT00709995|11543574|FG000|NOT COMPLETED|Overall Study||5
10399676|NCT00709995|11543575|FG001|NOT COMPLETED|Overall Study||5
10399677|NCT00710021|11543587|FG000|STARTED|Overall Study||19
10399678|NCT00710021|11543588|FG001|STARTED|Overall Study||19
10399679|NCT00710021|11543589|FG002|STARTED|Overall Study||19
10428854|NCT00861146|11574964|FG001|Week 13 Assessment|Overall Study||38
10399680|NCT00710021|11543587|FG000|Modified Intent-to-Treat (mITT)|Overall Study||19
10399681|NCT00710021|11543588|FG001|Modified Intent-to-Treat (mITT)|Overall Study|2 subjects who did not take study drug were excluded from mITT|17
10399682|NCT00710021|11543589|FG002|Modified Intent-to-Treat (mITT)|Overall Study|1 subject who did not take study drug was excluded from mITT|18
10399683|NCT00710021|11543587|FG000|COMPLETED|Overall Study||18
10399684|NCT00710021|11543588|FG001|COMPLETED|Overall Study||16
10399685|NCT00710021|11543589|FG002|COMPLETED|Overall Study||18
10399686|NCT00710021|11543587|FG000|NOT COMPLETED|Overall Study||1
10399687|NCT00710021|11543588|FG001|NOT COMPLETED|Overall Study||3
10399688|NCT00710021|11543589|FG002|NOT COMPLETED|Overall Study||1
10399689|NCT00710034|11543600|FG000|STARTED|Completed 6 Weeks of Treatment||195
10399690|NCT00710034|11543601|FG001|STARTED|Completed 6 Weeks of Treatment||196
10399691|NCT00710034|11543600|FG000|COMPLETED|Completed 6 Weeks of Treatment|Completed 6 weeks of treatment for primary outcome assessment: N=154|154
10399692|NCT00710034|11543601|FG001|COMPLETED|Completed 6 Weeks of Treatment|Completed 6 weeks of treatment for primary outcome assessment: N=149|149
10399693|NCT00710034|11543600|FG000|NOT COMPLETED|Completed 6 Weeks of Treatment||41
10399694|NCT00710034|11543601|FG001|NOT COMPLETED|Completed 6 Weeks of Treatment||47
10399695|NCT00710034|11543600|FG000|STARTED|Completed 12 Weeks of Treatment||154
10399696|NCT00710034|11543601|FG001|STARTED|Completed 12 Weeks of Treatment||149
10399697|NCT00710034|11543600|FG000|COMPLETED|Completed 12 Weeks of Treatment||141
10399698|NCT00710034|11543601|FG001|COMPLETED|Completed 12 Weeks of Treatment||138
10399699|NCT00710034|11543600|FG000|NOT COMPLETED|Completed 12 Weeks of Treatment||13
10399700|NCT00710034|11543601|FG001|NOT COMPLETED|Completed 12 Weeks of Treatment||11
10399701|NCT00710203|11543607|FG000|STARTED|Overall Study||10
10399702|NCT00710203|11543607|FG000|COMPLETED|Overall Study||10
10399703|NCT00710203|11543607|FG000|NOT COMPLETED|Overall Study||0
10399704|NCT00710385|11543617|FG000|STARTED|Overall Study|19 participants signed consent for the study 2 withdrew before any study procedures were initiated.|17
10399705|NCT00710385|11543617|FG000|COMPLETED|Overall Study||12
10399706|NCT00710385|11543617|FG000|NOT COMPLETED|Overall Study||5
10399707|NCT00710424|11543629|FG000|STARTED|Overall Study||149
10399708|NCT00710424|11543630|FG001|STARTED|Overall Study||148
10399709|NCT00710424|11543629|FG000|COMPLETED|Overall Study||105
10399710|NCT00710424|11543630|FG001|COMPLETED|Overall Study||125
10399711|NCT00710424|11543629|FG000|NOT COMPLETED|Overall Study||44
10399712|NCT00710424|11543630|FG001|NOT COMPLETED|Overall Study||23
10399713|NCT00710554|11543638|FG000|STARTED|Overall Study||128
10399714|NCT00710554|11543639|FG001|STARTED|Overall Study||118
10399715|NCT00710554|11543638|FG000|COMPLETED|Overall Study||79
10399716|NCT00710554|11543639|FG001|COMPLETED|Overall Study||94
10399717|NCT00710554|11543638|FG000|NOT COMPLETED|Overall Study||49
10399718|NCT00710554|11543639|FG001|NOT COMPLETED|Overall Study||24
10399719|NCT00710593|11543647|FG000|STARTED|Overall Study||69
10399720|NCT00710593|11543648|FG001|STARTED|Overall Study||30
10399721|NCT00710593|11543647|FG000|COMPLETED|Overall Study|54 completed study and vaccine. 6 did not receive all vaccine, but completed all study visits.|54
10399722|NCT00710593|11543648|FG001|COMPLETED|Overall Study|25 completed study and vaccine. 2 did not receive all vaccine, but completed all study visits.|25
10399723|NCT00710593|11543647|FG000|NOT COMPLETED|Overall Study||15
10399724|NCT00710593|11543648|FG001|NOT COMPLETED|Overall Study||5
10399725|NCT00710606|11543672|FG000|STARTED|Overall Study||20
10399726|NCT00710606|11543673|FG001|STARTED|Overall Study||20
10399727|NCT00710606|11543672|FG000|COMPLETED|Overall Study||20
10399728|NCT00710606|11543673|FG001|COMPLETED|Overall Study||18
10399729|NCT00710606|11543672|FG000|NOT COMPLETED|Overall Study||0
10399730|NCT00710606|11543673|FG001|NOT COMPLETED|Overall Study||2
10399731|NCT00710684|11543684|FG000|STARTED|Overall Study||225
10399732|NCT00710684|11543685|FG001|STARTED|Overall Study||221
10399733|NCT00710684|11543686|FG002|STARTED|Overall Study||236
10399734|NCT00710684|11543684|FG000|COMPLETED|Overall Study||151
10399735|NCT00710684|11543685|FG001|COMPLETED|Overall Study||147
10399736|NCT00710684|11543686|FG002|COMPLETED|Overall Study||172
10659393|NCT02241655|11820767|FG000|COMPLETED|Overall Study||614
10659394|NCT02241655|11820768|FG001|COMPLETED|Overall Study||618
10659395|NCT02241655|11820767|FG000|NOT COMPLETED|Overall Study||0
10659396|NCT02241655|11820768|FG001|NOT COMPLETED|Overall Study||0
10659397|NCT02241720|11820779|FG000|STARTED|Overall Study||5
10659398|NCT02241720|11820779|FG000|COMPLETED|Overall Study||1
10813722|NCT02665221|11976169|FG001|NOT COMPLETED|Overall Study||15
10813723|NCT02672033|11976175|FG000|STARTED|Overall Study||2
10813724|NCT02672033|11976175|FG000|COMPLETED|Overall Study||2
10813725|NCT02672033|11976175|FG000|NOT COMPLETED|Overall Study||0
10813726|NCT02671461|11976182|FG000|STARTED|Treatment||3
10813727|NCT02671461|11976183|FG001|STARTED|Treatment||5
10813728|NCT02671461|11976184|FG002|STARTED|Treatment||7
10813729|NCT02671461|11976182|FG000|COMPLETED|Treatment||1
10813730|NCT02671461|11976183|FG001|COMPLETED|Treatment||2
10813731|NCT02671461|11976184|FG002|COMPLETED|Treatment||2
10813732|NCT02671461|11976182|FG000|NOT COMPLETED|Treatment||2
10659399|NCT02241720|11820779|FG000|NOT COMPLETED|Overall Study||4
10659400|NCT02241733|11820785|FG000|STARTED|Overall Study||40
10659401|NCT02241733|11820786|FG001|STARTED|Overall Study||40
10659402|NCT02241733|11820785|FG000|COMPLETED|Overall Study||25
10399737|NCT00710684|11543684|FG000|NOT COMPLETED|Overall Study||74
10399738|NCT00710684|11543685|FG001|NOT COMPLETED|Overall Study||74
10399739|NCT00710684|11543686|FG002|NOT COMPLETED|Overall Study||64
10659403|NCT02241733|11820786|FG001|COMPLETED|Overall Study||30
10659404|NCT02241733|11820785|FG000|NOT COMPLETED|Overall Study||15
10813733|NCT02671461|11976183|FG001|NOT COMPLETED|Treatment||3
10311996|NCT00135694|11445263|FG001|NOT COMPLETED|Overall Study||21
10311997|NCT00135694|11445264|FG002|NOT COMPLETED|Overall Study||7
10311998|NCT00135707|11445274|FG000|STARTED|Overall Study||5088
10311999|NCT00135707|11445275|FG001|STARTED|Overall Study||5066
10312000|NCT00135707|11445274|FG000|COMPLETED|Overall Study||4993
10312001|NCT00135707|11445275|FG001|COMPLETED|Overall Study||4976
10312002|NCT00135707|11445274|FG000|NOT COMPLETED|Overall Study||95
10312003|NCT00135707|11445275|FG001|NOT COMPLETED|Overall Study||90
10312004|NCT00135798|11445288|FG000|STARTED|Overall Study||16
10312005|NCT00135798|11445289|FG001|STARTED|Overall Study||31
10312006|NCT00135798|11445290|FG002|STARTED|Overall Study||32
10312007|NCT00135798|11445288|FG000|COMPLETED|Overall Study||16
10312008|NCT00135798|11445289|FG001|COMPLETED|Overall Study||31
10312009|NCT00135798|11445290|FG002|COMPLETED|Overall Study||32
10312010|NCT00135798|11445288|FG000|NOT COMPLETED|Overall Study||0
10312011|NCT00135798|11445289|FG001|NOT COMPLETED|Overall Study||0
10312012|NCT00135798|11445290|FG002|NOT COMPLETED|Overall Study||0
10312013|NCT00136084|11445299|FG000|STARTED|Overall Study||109
10312014|NCT00136084|11445300|FG001|STARTED|Overall Study||114
10312015|NCT00136084|11445299|FG000|COMPLETED|Overall Study||61
10312016|NCT00136084|11445300|FG001|COMPLETED|Overall Study||72
10312017|NCT00136084|11445299|FG000|NOT COMPLETED|Overall Study||48
10312018|NCT00136084|11445300|FG001|NOT COMPLETED|Overall Study||42
10312019|NCT00136214|11445314|FG000|STARTED|Overall Study||15
10399740|NCT00710749|11543700|FG000|STARTED|Clinic Baseline Recording||30
10399741|NCT00710749|11543701|FG001|STARTED|Clinic Baseline Recording||30
10399742|NCT00710749|11543700|FG000|COMPLETED|Clinic Baseline Recording||30
10399743|NCT00710749|11543701|FG001|COMPLETED|Clinic Baseline Recording||30
10399744|NCT00710749|11543700|FG000|NOT COMPLETED|Clinic Baseline Recording||0
10399745|NCT00710749|11543701|FG001|NOT COMPLETED|Clinic Baseline Recording||0
10399746|NCT00710749|11543700|FG000|STARTED|First Intervention||30
10399747|NCT00710749|11543701|FG001|STARTED|First Intervention||30
10399748|NCT00710749|11543700|FG000|COMPLETED|First Intervention||29
10399749|NCT00710749|11543701|FG001|COMPLETED|First Intervention||30
10399750|NCT00710749|11543700|FG000|NOT COMPLETED|First Intervention||1
10399751|NCT00710749|11543701|FG001|NOT COMPLETED|First Intervention||0
10399752|NCT00710749|11543700|FG000|STARTED|Second Intervention||29
10399753|NCT00710749|11543701|FG001|STARTED|Second Intervention||30
10399754|NCT00710749|11543700|FG000|COMPLETED|Second Intervention||29
10399755|NCT00710749|11543701|FG001|COMPLETED|Second Intervention||30
10399756|NCT00710749|11543700|FG000|NOT COMPLETED|Second Intervention||0
10399757|NCT00710749|11543701|FG001|NOT COMPLETED|Second Intervention||0
10399758|NCT00710762|11543711|FG000|STARTED|Overall Study||44
10399759|NCT00710762|11543712|FG001|STARTED|Overall Study||40
10399760|NCT00710762|11543711|FG000|COMPLETED|Overall Study||5
10399761|NCT00710762|11543712|FG001|COMPLETED|Overall Study||0
10399762|NCT00710762|11543711|FG000|NOT COMPLETED|Overall Study||39
10399763|NCT00710762|11543712|FG001|NOT COMPLETED|Overall Study||40
10399764|NCT00710814|11543720|FG000|STARTED|Overall Study||15
10399765|NCT00710814|11543721|FG001|STARTED|Overall Study||16
10399766|NCT00710814|11543720|FG000|COMPLETED|Overall Study||14
10399767|NCT00710814|11543721|FG001|COMPLETED|Overall Study||13
10399768|NCT00710814|11543720|FG000|NOT COMPLETED|Overall Study||1
10399769|NCT00710814|11543721|FG001|NOT COMPLETED|Overall Study||3
10399770|NCT00710840|11543729|FG000|STARTED|Overall Study||22
10399771|NCT00710840|11543730|FG001|STARTED|Overall Study||22
10399772|NCT00710840|11543729|FG000|COMPLETED|Overall Study||22
10399773|NCT00710840|11543730|FG001|COMPLETED|Overall Study||19
10399774|NCT00710840|11543729|FG000|NOT COMPLETED|Overall Study||0
10399775|NCT00710840|11543730|FG001|NOT COMPLETED|Overall Study||3
10399776|NCT00710866|11543738|FG000|STARTED|Overall Study||133
10399777|NCT00710866|11543739|FG001|STARTED|Overall Study||134
10399778|NCT00710866|11543738|FG000|COMPLETED|Overall Study||124
10399779|NCT00710866|11543739|FG001|COMPLETED|Overall Study||128
10399780|NCT00710866|11543738|FG000|NOT COMPLETED|Overall Study||9
10399781|NCT00710866|11543739|FG001|NOT COMPLETED|Overall Study||6
10543900|NCT01486758|11697041|FG000|NOT COMPLETED|Overall Study||0
10543901|NCT01486758|11697042|FG001|NOT COMPLETED|Overall Study||1
10312020|NCT00136214|11445315|FG001|STARTED|Overall Study||7
10312021|NCT00136214|11445314|FG000|COMPLETED|Overall Study||15
10543902|NCT01486784|11697055|FG000|STARTED|Overall Study||3
10543903|NCT01486784|11697056|FG001|STARTED|Overall Study||7
10543904|NCT01486784|11697057|FG002|STARTED|Overall Study||6
10543905|NCT01486784|11697058|FG003|STARTED|Overall Study||1
10543906|NCT01486784|11697059|FG004|STARTED|Overall Study||5
10543907|NCT01486784|11697060|FG005|STARTED|Overall Study||5
10543908|NCT01486784|11697055|FG000|Completed Cycle 1|Overall Study||2
10543909|NCT01486784|11697056|FG001|Completed Cycle 1|Overall Study||6
10543910|NCT01486784|11697057|FG002|Completed Cycle 1|Overall Study||3
10543911|NCT01486784|11697058|FG003|Completed Cycle 1|Overall Study||1
10543912|NCT01486784|11697059|FG004|Completed Cycle 1|Overall Study||3
10312022|NCT00136214|11445315|FG001|COMPLETED|Overall Study||7
10312023|NCT00136214|11445314|FG000|NOT COMPLETED|Overall Study||0
10399782|NCT00710879|11543747|FG000|STARTED|Overall Study||60
10399783|NCT00710879|11543748|FG001|STARTED|Overall Study||117
10399784|NCT00710879|11543747|FG000|COMPLETED|Overall Study||58
10543913|NCT01486784|11697060|FG005|Completed Cycle 1|Overall Study||2
10543914|NCT01486784|11697055|FG000|Received Treatment|Overall Study||3
10543915|NCT01486784|11697056|FG001|Received Treatment|Overall Study||7
10543916|NCT01486784|11697057|FG002|Received Treatment|Overall Study||5
10399785|NCT00710879|11543748|FG001|COMPLETED|Overall Study||113
10399786|NCT00710879|11543747|FG000|NOT COMPLETED|Overall Study||2
10399787|NCT00710879|11543748|FG001|NOT COMPLETED|Overall Study||4
10399788|NCT00710905|11543754|FG000|STARTED|Overall Study||50
10399789|NCT00710905|11543754|FG000|COMPLETED|Overall Study||34
10399790|NCT00710905|11543754|FG000|NOT COMPLETED|Overall Study||16
10399791|NCT00710931|11543758|FG000|STARTED|Overall Study||34
10399792|NCT00710931|11543758|FG000|COMPLETED|Overall Study||29
10399793|NCT00710931|11543758|FG000|NOT COMPLETED|Overall Study||5
10399794|NCT00710944|11543765|FG000|STARTED|Overall Study||55
10399795|NCT00710944|11543766|FG001|STARTED|Overall Study||58
10399796|NCT00710944|11543767|FG002|STARTED|Overall Study||19
10399797|NCT00710944|11543765|FG000|COMPLETED|Overall Study||45
10399798|NCT00710944|11543766|FG001|COMPLETED|Overall Study||49
10399799|NCT00710944|11543767|FG002|COMPLETED|Overall Study||17
10399800|NCT00710944|11543765|FG000|NOT COMPLETED|Overall Study||10
10399801|NCT00710944|11543766|FG001|NOT COMPLETED|Overall Study||9
10399802|NCT00710944|11543767|FG002|NOT COMPLETED|Overall Study||2
10399803|NCT00710996|11543778|FG000|STARTED|Overall Study||17
10399804|NCT00710996|11543779|FG001|STARTED|Overall Study||20
10399805|NCT00710996|11543780|FG002|STARTED|Overall Study||21
10399806|NCT00710996|11543778|FG000|COMPLETED|Overall Study||16
10399807|NCT00710996|11543779|FG001|COMPLETED|Overall Study||16
10399808|NCT00710996|11543780|FG002|COMPLETED|Overall Study||21
10399809|NCT00710996|11543778|FG000|NOT COMPLETED|Overall Study||1
10399810|NCT00710996|11543779|FG001|NOT COMPLETED|Overall Study||4
10399811|NCT00710996|11543780|FG002|NOT COMPLETED|Overall Study||0
10399812|NCT00711009|11543790|FG000|STARTED|Overall Study||105
10399813|NCT00711009|11543791|FG001|STARTED|Overall Study||101
10399814|NCT00711009|11543790|FG000|COMPLETED|Overall Study||90
10399815|NCT00711009|11543791|FG001|COMPLETED|Overall Study||82
10399816|NCT00711009|11543790|FG000|NOT COMPLETED|Overall Study||15
10399817|NCT00711009|11543791|FG001|NOT COMPLETED|Overall Study||19
10399818|NCT00711022|11543797|FG000|STARTED|Overall Study||51
10399819|NCT00711022|11543797|FG000|COMPLETED|Overall Study||40
10399820|NCT00711022|11543797|FG000|NOT COMPLETED|Overall Study||11
10399821|NCT00711100|11543801|FG000|STARTED|Overall Study||104
10399822|NCT00711100|11543801|FG000|COMPLETED|Overall Study||91
10399823|NCT00711100|11543801|FG000|NOT COMPLETED|Overall Study||13
10399824|NCT00711113|11543817|FG000|STARTED|Overall Study||47
10399825|NCT00711113|11543817|FG000|COMPLETED|Overall Study||36
10399826|NCT00711113|11543817|FG000|NOT COMPLETED|Overall Study||11
10399827|NCT00711191|11543824|FG000|STARTED|Overall Study||3
10399828|NCT00711191|11543825|FG001|STARTED|Overall Study||6
10399829|NCT00711191|11543826|FG002|STARTED|Overall Study||13
10399830|NCT00711191|11543824|FG000|COMPLETED|Overall Study||0
10399831|NCT00711191|11543825|FG001|COMPLETED|Overall Study||1
10399832|NCT00711191|11543826|FG002|COMPLETED|Overall Study||1
10399833|NCT00711191|11543824|FG000|NOT COMPLETED|Overall Study||3
10399834|NCT00711191|11543825|FG001|NOT COMPLETED|Overall Study||5
10721060|NCT02722330|11884698|FG000|COMPLETED|Overall Study||23
10721061|NCT02722330|11884698|FG000|NOT COMPLETED|Overall Study||0
10721062|NCT02722408|11884702|FG000|STARTED|Overall Study||8
10721063|NCT02722408|11884702|FG000|COMPLETED|Overall Study||8
10721064|NCT02722408|11884702|FG000|NOT COMPLETED|Overall Study||0
10721065|NCT02722499|11884711|FG000|STARTED|Overall Study||20
10721066|NCT02722499|11884712|FG001|STARTED|Overall Study||20
10721067|NCT02722499|11884713|FG002|STARTED|Overall Study||20
10721068|NCT02722499|11884711|FG000|COMPLETED|Overall Study||18
10721069|NCT02722499|11884712|FG001|COMPLETED|Overall Study||20
10721070|NCT02722499|11884713|FG002|COMPLETED|Overall Study||19
10721071|NCT02722499|11884711|FG000|NOT COMPLETED|Overall Study||2
10721072|NCT02722499|11884712|FG001|NOT COMPLETED|Overall Study||0
10721073|NCT02722499|11884713|FG002|NOT COMPLETED|Overall Study||1
10813734|NCT02671461|11976184|FG002|NOT COMPLETED|Treatment||5
10813735|NCT02671461|11976182|FG000|STARTED|Follow-up||2
10813736|NCT02671461|11976183|FG001|STARTED|Follow-up||5
10813737|NCT02671461|11976184|FG002|STARTED|Follow-up||7
10813738|NCT02671461|11976182|FG000|COMPLETED|Follow-up||1
10813739|NCT02671461|11976183|FG001|COMPLETED|Follow-up||4
10399835|NCT00711191|11543826|FG002|NOT COMPLETED|Overall Study||12
10399836|NCT00711243|11543843|FG000|STARTED|Registed and Started Treatment||3
10399837|NCT00711243|11543844|FG001|STARTED|Registed and Started Treatment||3
10399838|NCT00711243|11543845|FG002|STARTED|Registed and Started Treatment||3
10399839|NCT00711243|11543846|FG003|STARTED|Registed and Started Treatment||3
10399840|NCT00711243|11543847|FG004|STARTED|Registed and Started Treatment||3
10399841|NCT00711243|11543848|FG005|STARTED|Registed and Started Treatment||44
10399842|NCT00711243|11543843|FG000|Registered to Study|Registed and Started Treatment||3
10399843|NCT00711243|11543844|FG001|Registered to Study|Registed and Started Treatment||3
10399844|NCT00711243|11543845|FG002|Registered to Study|Registed and Started Treatment||3
10399845|NCT00711243|11543846|FG003|Registered to Study|Registed and Started Treatment||3
10399846|NCT00711243|11543847|FG004|Registered to Study|Registed and Started Treatment||3
10399847|NCT00711243|11543848|FG005|Registered to Study|Registed and Started Treatment||44
10721074|NCT02722564|11884721|FG000|STARTED|Overall Study||55
10721075|NCT02722564|11884721|FG000|COMPLETED|Overall Study||55
10721076|NCT02722564|11884721|FG000|NOT COMPLETED|Overall Study||0
10721077|NCT02722577|11884725|FG000|STARTED|Overall Study||20
10813740|NCT02671461|11976184|FG002|COMPLETED|Follow-up||6
10399848|NCT00711243|11543843|FG000|Started Treatment|Registed and Started Treatment||3
10399849|NCT00711243|11543844|FG001|Started Treatment|Registed and Started Treatment||3
10813741|NCT02671461|11976182|FG000|NOT COMPLETED|Follow-up||1
10399850|NCT00711243|11543845|FG002|Started Treatment|Registed and Started Treatment||3
10399851|NCT00711243|11543846|FG003|Started Treatment|Registed and Started Treatment||3
10399852|NCT00711243|11543847|FG004|Started Treatment|Registed and Started Treatment||3
10399853|NCT00711243|11543848|FG005|Started Treatment|Registed and Started Treatment||43
10399854|NCT00711243|11543843|FG000|COMPLETED|Registed and Started Treatment||3
10399855|NCT00711243|11543844|FG001|COMPLETED|Registed and Started Treatment||3
10399856|NCT00711243|11543845|FG002|COMPLETED|Registed and Started Treatment||3
10399857|NCT00711243|11543846|FG003|COMPLETED|Registed and Started Treatment||3
10399858|NCT00711243|11543847|FG004|COMPLETED|Registed and Started Treatment||3
10399859|NCT00711243|11543848|FG005|COMPLETED|Registed and Started Treatment||43
10399860|NCT00711243|11543843|FG000|NOT COMPLETED|Registed and Started Treatment||0
10399861|NCT00711243|11543844|FG001|NOT COMPLETED|Registed and Started Treatment||0
10399862|NCT00711243|11543845|FG002|NOT COMPLETED|Registed and Started Treatment||0
10399863|NCT00711243|11543846|FG003|NOT COMPLETED|Registed and Started Treatment||0
10399864|NCT00711243|11543847|FG004|NOT COMPLETED|Registed and Started Treatment||0
10399865|NCT00711243|11543848|FG005|NOT COMPLETED|Registed and Started Treatment||1
10399866|NCT00711243|11543843|FG000|STARTED|Reached First Response/4 Cycles||3
10399867|NCT00711243|11543844|FG001|STARTED|Reached First Response/4 Cycles||3
10399868|NCT00711243|11543845|FG002|STARTED|Reached First Response/4 Cycles||3
10399869|NCT00711243|11543846|FG003|STARTED|Reached First Response/4 Cycles||3
10399870|NCT00711243|11543847|FG004|STARTED|Reached First Response/4 Cycles||3
10399871|NCT00711243|11543848|FG005|STARTED|Reached First Response/4 Cycles||43
10399872|NCT00711243|11543843|FG000|COMPLETED|Reached First Response/4 Cycles||3
10399873|NCT00711243|11543844|FG001|COMPLETED|Reached First Response/4 Cycles||3
10399874|NCT00711243|11543845|FG002|COMPLETED|Reached First Response/4 Cycles||3
10399875|NCT00711243|11543846|FG003|COMPLETED|Reached First Response/4 Cycles||2
10399876|NCT00711243|11543847|FG004|COMPLETED|Reached First Response/4 Cycles||3
10399877|NCT00711243|11543848|FG005|COMPLETED|Reached First Response/4 Cycles||41
10399878|NCT00711243|11543843|FG000|NOT COMPLETED|Reached First Response/4 Cycles||0
10399879|NCT00711243|11543844|FG001|NOT COMPLETED|Reached First Response/4 Cycles||0
10399880|NCT00711243|11543845|FG002|NOT COMPLETED|Reached First Response/4 Cycles||0
10399881|NCT00711243|11543846|FG003|NOT COMPLETED|Reached First Response/4 Cycles||1
10399882|NCT00711243|11543847|FG004|NOT COMPLETED|Reached First Response/4 Cycles||0
10399883|NCT00711243|11543848|FG005|NOT COMPLETED|Reached First Response/4 Cycles||2
10399884|NCT00711243|11543843|FG000|STARTED|Treated Cycle 5 After First Response||3
10399885|NCT00711243|11543844|FG001|STARTED|Treated Cycle 5 After First Response||3
10399886|NCT00711243|11543845|FG002|STARTED|Treated Cycle 5 After First Response||3
10399887|NCT00711243|11543846|FG003|STARTED|Treated Cycle 5 After First Response||2
10399888|NCT00711243|11543847|FG004|STARTED|Treated Cycle 5 After First Response||3
10399889|NCT00711243|11543848|FG005|STARTED|Treated Cycle 5 After First Response||41
10399890|NCT00711243|11543843|FG000|COMPLETED|Treated Cycle 5 After First Response||2
10399891|NCT00711243|11543844|FG001|COMPLETED|Treated Cycle 5 After First Response||1
10399892|NCT00711243|11543845|FG002|COMPLETED|Treated Cycle 5 After First Response||3
10399893|NCT00711243|11543846|FG003|COMPLETED|Treated Cycle 5 After First Response||2
10399894|NCT00711243|11543847|FG004|COMPLETED|Treated Cycle 5 After First Response||2
10399895|NCT00711243|11543848|FG005|COMPLETED|Treated Cycle 5 After First Response||37
10399896|NCT00711243|11543843|FG000|NOT COMPLETED|Treated Cycle 5 After First Response||1
10399897|NCT00711243|11543844|FG001|NOT COMPLETED|Treated Cycle 5 After First Response||2
10399898|NCT00711243|11543845|FG002|NOT COMPLETED|Treated Cycle 5 After First Response||0
10399899|NCT00711243|11543846|FG003|NOT COMPLETED|Treated Cycle 5 After First Response||0
10399900|NCT00711243|11543847|FG004|NOT COMPLETED|Treated Cycle 5 After First Response||1
10399901|NCT00711243|11543848|FG005|NOT COMPLETED|Treated Cycle 5 After First Response||4
10399902|NCT00711243|11543843|FG000|STARTED|Follow up Every 3 Months Until Death||3
10399903|NCT00711243|11543844|FG001|STARTED|Follow up Every 3 Months Until Death||3
10399904|NCT00711243|11543845|FG002|STARTED|Follow up Every 3 Months Until Death||3
10399905|NCT00711243|11543846|FG003|STARTED|Follow up Every 3 Months Until Death||3
10399906|NCT00711243|11543847|FG004|STARTED|Follow up Every 3 Months Until Death||3
10399907|NCT00711243|11543848|FG005|STARTED|Follow up Every 3 Months Until Death|4 patients died whilst on study and 1 patient did not get treated on study|39
10399908|NCT00711243|11543843|FG000|COMPLETED|Follow up Every 3 Months Until Death||3
10399909|NCT00711243|11543844|FG001|COMPLETED|Follow up Every 3 Months Until Death||3
10659405|NCT02241733|11820786|FG001|NOT COMPLETED|Overall Study||10
10659406|NCT02241785|11820792|FG000|STARTED|Overall Study||47
10659407|NCT02241785|11820792|FG000|COMPLETED|Overall Study||0
10659408|NCT02241785|11820792|FG000|NOT COMPLETED|Overall Study||47
10659409|NCT02241889|11820796|FG000|STARTED|Overall Study||4
10659410|NCT02241889|11820797|FG001|STARTED|Overall Study||4
10659411|NCT02241889|11820798|FG002|STARTED|Overall Study||3
10813742|NCT02671461|11976183|FG001|NOT COMPLETED|Follow-up||1
10399910|NCT00711243|11543845|FG002|COMPLETED|Follow up Every 3 Months Until Death||3
10399911|NCT00711243|11543846|FG003|COMPLETED|Follow up Every 3 Months Until Death||3
10399912|NCT00711243|11543847|FG004|COMPLETED|Follow up Every 3 Months Until Death||3
10399913|NCT00711243|11543848|FG005|COMPLETED|Follow up Every 3 Months Until Death||37
10399914|NCT00711243|11543843|FG000|NOT COMPLETED|Follow up Every 3 Months Until Death||0
10399915|NCT00711243|11543844|FG001|NOT COMPLETED|Follow up Every 3 Months Until Death||0
10428855|NCT00861146|11574963|FG000|COMPLETED|Overall Study||85
10659412|NCT02241889|11820799|FG003|STARTED|Overall Study||3
10659413|NCT02241889|11820800|FG004|STARTED|Overall Study||5
10399916|NCT00711243|11543845|FG002|NOT COMPLETED|Follow up Every 3 Months Until Death||0
10399917|NCT00711243|11543846|FG003|NOT COMPLETED|Follow up Every 3 Months Until Death||0
10399918|NCT00711243|11543847|FG004|NOT COMPLETED|Follow up Every 3 Months Until Death||0
10399919|NCT00711243|11543848|FG005|NOT COMPLETED|Follow up Every 3 Months Until Death||2
10399920|NCT00711347|11543866|FG000|STARTED|Overall Study||14
10399921|NCT00711347|11543867|FG001|STARTED|Overall Study||14
10399922|NCT00711347|11543866|FG000|COMPLETED|Overall Study||14
10399923|NCT00711347|11543867|FG001|COMPLETED|Overall Study||14
10399924|NCT00711347|11543866|FG000|NOT COMPLETED|Overall Study||0
10399925|NCT00711347|11543867|FG001|NOT COMPLETED|Overall Study||0
10399926|NCT00711412|11543873|FG000|STARTED|Induction Treatment||44
10399927|NCT00711412|11543873|FG000|Registered to Study|Induction Treatment||44
10399928|NCT00711412|11543873|FG000|Started Induction Treatment|Induction Treatment||43
10399929|NCT00711412|11543873|FG000|COMPLETED|Induction Treatment||40
10399930|NCT00711412|11543873|FG000|NOT COMPLETED|Induction Treatment||4
10399931|NCT00711412|11543873|FG000|STARTED|Evaluated for Combination Treatment||40
10399932|NCT00711412|11543873|FG000|COMPLETED|Evaluated for Combination Treatment||34
10399933|NCT00711412|11543873|FG000|NOT COMPLETED|Evaluated for Combination Treatment||6
10399934|NCT00711412|11543873|FG000|STARTED|Combination Treatment||34
10399935|NCT00711412|11543873|FG000|COMPLETED|Combination Treatment||33
10399936|NCT00711412|11543873|FG000|NOT COMPLETED|Combination Treatment||1
10399937|NCT00711412|11543873|FG000|STARTED|Evaluation for Response and Surgery|1 patient only completed 2 cycles of therapy was evaluated and eligible for surgical resection.|34
10399938|NCT00711412|11543873|FG000|COMPLETED|Evaluation for Response and Surgery||28
10399939|NCT00711412|11543873|FG000|NOT COMPLETED|Evaluation for Response and Surgery||6
10399940|NCT00711412|11543873|FG000|STARTED|Survival Follow up Until Death|All patients that received treatment went into follow up period.|38
10399941|NCT00711412|11543873|FG000|COMPLETED|Survival Follow up Until Death||26
10399942|NCT00711412|11543873|FG000|NOT COMPLETED|Survival Follow up Until Death||12
10399943|NCT00711425|11543878|FG000|STARTED|Overall Study|Implant placement in 45 patients. Implant loading (baseline) in 44 patients.|45
10399944|NCT00711425|11543878|FG000|COMPLETED|Overall Study||41
10399945|NCT00711425|11543878|FG000|NOT COMPLETED|Overall Study||4
10399946|NCT00711464|11543882|FG000|STARTED|Overall Study||29
10399947|NCT00711464|11543882|FG000|COMPLETED|Overall Study||29
10399948|NCT00711464|11543882|FG000|NOT COMPLETED|Overall Study||0
10399949|NCT00711477|11543894|FG000|STARTED|Overall Study||23
10399950|NCT00711477|11543895|FG001|STARTED|Overall Study||23
10399951|NCT00711477|11543894|FG000|COMPLETED|Overall Study||20
10399952|NCT00711477|11543895|FG001|COMPLETED|Overall Study||20
10399953|NCT00711477|11543894|FG000|NOT COMPLETED|Overall Study||3
10399954|NCT00711477|11543895|FG001|NOT COMPLETED|Overall Study||3
10399955|NCT00711490|11543903|FG000|STARTED|Overall Study||5
10399956|NCT00711490|11543903|FG000|COMPLETED|Overall Study||5
10399957|NCT00711490|11543903|FG000|NOT COMPLETED|Overall Study||0
10399958|NCT00711516|11543910|FG000|STARTED|Overall Study||21
10399959|NCT00711516|11543911|FG001|STARTED|Overall Study||19
10399960|NCT00711516|11543910|FG000|COMPLETED|Overall Study||20
10399961|NCT00711516|11543911|FG001|COMPLETED|Overall Study||16
10399962|NCT00711516|11543910|FG000|NOT COMPLETED|Overall Study||1
10399963|NCT00711516|11543911|FG001|NOT COMPLETED|Overall Study||3
10659414|NCT02241889|11820801|FG005|STARTED|Overall Study||4
10659415|NCT02241889|11820796|FG000|COMPLETED|Overall Study||4
10659416|NCT02241889|11820797|FG001|COMPLETED|Overall Study||4
10659417|NCT02241889|11820798|FG002|COMPLETED|Overall Study||2
10399964|NCT00711529|11543919|FG000|STARTED|Overall Study||13
10399965|NCT00711529|11543920|FG001|STARTED|Overall Study||14
10399966|NCT00711529|11543919|FG000|COMPLETED|Overall Study|2 women lost their hot flash diary, so only 7 patients were evaluable for primary endpoint.|9
10399967|NCT00711529|11543920|FG001|COMPLETED|Overall Study||8
10399968|NCT00711529|11543919|FG000|NOT COMPLETED|Overall Study||4
10659418|NCT02241889|11820799|FG003|COMPLETED|Overall Study||3
10399969|NCT00711529|11543920|FG001|NOT COMPLETED|Overall Study||6
10659419|NCT02241889|11820800|FG004|COMPLETED|Overall Study||5
10399970|NCT00711594|11543930|FG000|STARTED|Overall Study||3
10399971|NCT00711594|11543931|FG001|STARTED|Overall Study||3
10399972|NCT00711594|11543932|FG002|STARTED|Overall Study||6
10399973|NCT00711594|11543933|FG003|STARTED|Overall Study||62
10399974|NCT00711594|11543930|FG000|COMPLETED|Overall Study||0
10399975|NCT00711594|11543931|FG001|COMPLETED|Overall Study||0
10399976|NCT00711594|11543932|FG002|COMPLETED|Overall Study||0
10399977|NCT00711594|11543933|FG003|COMPLETED|Overall Study||0
10399978|NCT00711594|11543930|FG000|NOT COMPLETED|Overall Study||3
10399979|NCT00711594|11543931|FG001|NOT COMPLETED|Overall Study||3
10399980|NCT00711594|11543932|FG002|NOT COMPLETED|Overall Study||6
10399981|NCT00711594|11543933|FG003|NOT COMPLETED|Overall Study||62
10399982|NCT00711646|11543947|FG000|STARTED|Overall Study||124
10399983|NCT00711646|11543948|FG001|STARTED|Overall Study||65
10399984|NCT00711646|11543947|FG000|COMPLETED|Overall Study||112
10399985|NCT00711646|11543948|FG001|COMPLETED|Overall Study||62
10399986|NCT00711646|11543947|FG000|NOT COMPLETED|Overall Study||12
10399987|NCT00711646|11543948|FG001|NOT COMPLETED|Overall Study||3
10399988|NCT00711711|11543956|FG000|STARTED|Overall Study||30
10399989|NCT00711711|11543957|FG001|STARTED|Overall Study||30
10399990|NCT00711711|11543956|FG000|Second Postsurgical Day|Overall Study||30
10399991|NCT00711711|11543957|FG001|Second Postsurgical Day|Overall Study||30
10399992|NCT00711711|11543956|FG000|Seventh Postsurgical Day|Overall Study||29
10399993|NCT00711711|11543957|FG001|Seventh Postsurgical Day|Overall Study||27
10399994|NCT00711711|11543956|FG000|COMPLETED|Overall Study||29
10312024|NCT00136214|11445315|FG001|NOT COMPLETED|Overall Study||0
10721078|NCT02722577|11884725|FG000|COMPLETED|Overall Study||20
10312025|NCT00136318|11445325|FG000|STARTED|Overall Study|Took first dose of study medication|90
10312026|NCT00136318|11445326|FG001|STARTED|Overall Study|Took first dose of study medication|91
10312027|NCT00136318|11445325|FG000|COMPLETED|Overall Study|reached end-point of antiviral treatment|83
10312028|NCT00136318|11445326|FG001|COMPLETED|Overall Study||84
10312029|NCT00136318|11445325|FG000|NOT COMPLETED|Overall Study||7
10312030|NCT00136318|11445326|FG001|NOT COMPLETED|Overall Study||7
10312031|NCT00136357|11445335|FG000|STARTED|Overall Study||41
10312032|NCT00136357|11445336|FG001|STARTED|Overall Study||41
10312033|NCT00136357|11445335|FG000|COMPLETED|Overall Study||38
10312034|NCT00136357|11445336|FG001|COMPLETED|Overall Study||39
10312035|NCT00136357|11445335|FG000|NOT COMPLETED|Overall Study||3
10312036|NCT00136357|11445336|FG001|NOT COMPLETED|Overall Study||2
10312037|NCT00136604|11445347|FG000|STARTED|Overall Study||249
10312038|NCT00136604|11445348|FG001|STARTED|Overall Study||123
10312039|NCT00136604|11445349|FG002|STARTED|Overall Study||79
10312040|NCT00136604|11445350|FG003|STARTED|Overall Study||41
10312041|NCT00136604|11445351|FG004|STARTED|Overall Study||125
10312042|NCT00136604|11445347|FG000|COMPLETED|Overall Study||248
10312043|NCT00136604|11445348|FG001|COMPLETED|Overall Study||122
10312044|NCT00136604|11445349|FG002|COMPLETED|Overall Study||79
10312045|NCT00136604|11445350|FG003|COMPLETED|Overall Study||41
10312046|NCT00136604|11445351|FG004|COMPLETED|Overall Study||124
10312047|NCT00136604|11445347|FG000|NOT COMPLETED|Overall Study||1
10312048|NCT00136604|11445348|FG001|NOT COMPLETED|Overall Study||1
10312049|NCT00136604|11445349|FG002|NOT COMPLETED|Overall Study||0
10312050|NCT00136604|11445350|FG003|NOT COMPLETED|Overall Study||0
10312051|NCT00136604|11445351|FG004|NOT COMPLETED|Overall Study||1
10312058|NCT00136760|11445380|FG000|STARTED|Overall Study||12
10312059|NCT00136760|11445381|FG001|STARTED|Overall Study||16
10312060|NCT00136760|11445382|FG002|STARTED|Overall Study||11
10312061|NCT00136760|11445383|FG003|STARTED|Overall Study||13
10312062|NCT00136760|11445380|FG000|COMPLETED|Overall Study||12
10312063|NCT00136760|11445381|FG001|COMPLETED|Overall Study||16
10312064|NCT00136760|11445382|FG002|COMPLETED|Overall Study||11
10312065|NCT00136760|11445383|FG003|COMPLETED|Overall Study||13
10312066|NCT00136760|11445380|FG000|NOT COMPLETED|Overall Study||0
10312067|NCT00136760|11445381|FG001|NOT COMPLETED|Overall Study||0
10312068|NCT00136760|11445382|FG002|NOT COMPLETED|Overall Study||0
10312069|NCT00136760|11445383|FG003|NOT COMPLETED|Overall Study||0
10312070|NCT00136812|11445395|FG000|STARTED|Overall Study||111
10312071|NCT00136812|11445396|FG001|STARTED|Overall Study||113
10312072|NCT00136812|11445395|FG000|COMPLETED|Overall Study||111
10312073|NCT00136812|11445396|FG001|COMPLETED|Overall Study||113
10312074|NCT00136812|11445395|FG000|NOT COMPLETED|Overall Study||0
10312075|NCT00136812|11445396|FG001|NOT COMPLETED|Overall Study||0
10312076|NCT00136838|11445402|FG000|STARTED|First Intervention ( 5 Days)||6
10312077|NCT00136838|11445403|FG001|STARTED|First Intervention ( 5 Days)||6
10312078|NCT00136838|11445402|FG000|COMPLETED|First Intervention ( 5 Days)||6
10312079|NCT00136838|11445403|FG001|COMPLETED|First Intervention ( 5 Days)||6
10312080|NCT00136838|11445402|FG000|NOT COMPLETED|First Intervention ( 5 Days)||0
10312081|NCT00136838|11445403|FG001|NOT COMPLETED|First Intervention ( 5 Days)||0
10312082|NCT00136838|11445402|FG000|STARTED|Second Intervention ( 5 Days)||6
10399995|NCT00711711|11543957|FG001|COMPLETED|Overall Study||24
10399996|NCT00711711|11543956|FG000|NOT COMPLETED|Overall Study||1
10399997|NCT00711711|11543957|FG001|NOT COMPLETED|Overall Study||6
10399998|NCT00711802|11543973|FG000|STARTED|Overall Study||75
10399999|NCT00711802|11543974|FG001|STARTED|Overall Study||38
10400000|NCT00711802|11543975|FG002|STARTED|Overall Study||75
10400001|NCT00711802|11543976|FG003|STARTED|Overall Study||38
10400002|NCT00711802|11543977|FG004|STARTED|Overall Study||83
10400003|NCT00711802|11543978|FG005|STARTED|Overall Study||42
10400004|NCT00711802|11543979|FG006|STARTED|Overall Study||30
10400005|NCT00711802|11543980|FG007|STARTED|Overall Study||15
10400006|NCT00711802|11543973|FG000|Received at Least 1 Dose of Study Drug|Overall Study||73
10400007|NCT00711802|11543974|FG001|Received at Least 1 Dose of Study Drug|Overall Study||37
10400008|NCT00711802|11543975|FG002|Received at Least 1 Dose of Study Drug|Overall Study||73
10400009|NCT00711802|11543976|FG003|Received at Least 1 Dose of Study Drug|Overall Study||38
10400010|NCT00711802|11543977|FG004|Received at Least 1 Dose of Study Drug|Overall Study||81
10400011|NCT00711802|11543978|FG005|Received at Least 1 Dose of Study Drug|Overall Study||42
10400012|NCT00711802|11543979|FG006|Received at Least 1 Dose of Study Drug|Overall Study||30
10312083|NCT00136838|11445403|FG001|STARTED|Second Intervention ( 5 Days)||6
10721079|NCT02722577|11884725|FG000|NOT COMPLETED|Overall Study||0
10721080|NCT02722837|11884729|FG000|STARTED|Overall Study||119
10312084|NCT00136838|11445402|FG000|COMPLETED|Second Intervention ( 5 Days)||6
10312085|NCT00136838|11445403|FG001|COMPLETED|Second Intervention ( 5 Days)||6
10312086|NCT00136838|11445402|FG000|NOT COMPLETED|Second Intervention ( 5 Days)||0
10312087|NCT00136838|11445403|FG001|NOT COMPLETED|Second Intervention ( 5 Days)||0
10312088|NCT00136916|11445413|FG000|STARTED|Overall Study||319
10312089|NCT00136916|11445414|FG001|STARTED|Overall Study||316
10312090|NCT00136916|11445413|FG000|Received Treatment|Overall Study||316
10813743|NCT02671461|11976184|FG002|NOT COMPLETED|Follow-up||1
10813744|NCT02671136|11976194|FG000|STARTED|Overall Study||3
10813745|NCT02671136|11976195|FG001|STARTED|Overall Study||0
10813746|NCT02671136|11976194|FG000|COMPLETED|Overall Study||3
10813747|NCT02671136|11976195|FG001|COMPLETED|Overall Study||0
10400013|NCT00711802|11543980|FG007|Received at Least 1 Dose of Study Drug|Overall Study||15
10400014|NCT00711802|11543973|FG000|COMPLETED|Overall Study||73
10400015|NCT00711802|11543974|FG001|COMPLETED|Overall Study||32
10400016|NCT00711802|11543975|FG002|COMPLETED|Overall Study||69
10400017|NCT00711802|11543976|FG003|COMPLETED|Overall Study||35
10400018|NCT00711802|11543977|FG004|COMPLETED|Overall Study||69
10400019|NCT00711802|11543978|FG005|COMPLETED|Overall Study||34
10400020|NCT00711802|11543979|FG006|COMPLETED|Overall Study||25
10400021|NCT00711802|11543980|FG007|COMPLETED|Overall Study||13
10400022|NCT00711802|11543973|FG000|NOT COMPLETED|Overall Study||2
10400023|NCT00711802|11543974|FG001|NOT COMPLETED|Overall Study||6
10400024|NCT00711802|11543975|FG002|NOT COMPLETED|Overall Study||6
10400025|NCT00711802|11543976|FG003|NOT COMPLETED|Overall Study||3
10400026|NCT00711802|11543977|FG004|NOT COMPLETED|Overall Study||14
10400027|NCT00711802|11543978|FG005|NOT COMPLETED|Overall Study||8
10400028|NCT00711802|11543979|FG006|NOT COMPLETED|Overall Study||5
10400029|NCT00711802|11543980|FG007|NOT COMPLETED|Overall Study||2
10400030|NCT00711828|11544001|FG000|STARTED|Overall Study||21
10400031|NCT00711828|11544001|FG000|COMPLETED|Overall Study||21
10659420|NCT02241889|11820801|FG005|COMPLETED|Overall Study||3
10659421|NCT02241889|11820796|FG000|NOT COMPLETED|Overall Study||0
10659422|NCT02241889|11820797|FG001|NOT COMPLETED|Overall Study||0
10659423|NCT02241889|11820798|FG002|NOT COMPLETED|Overall Study||1
10659424|NCT02241889|11820799|FG003|NOT COMPLETED|Overall Study||0
10659425|NCT02241889|11820800|FG004|NOT COMPLETED|Overall Study||0
10659426|NCT02241889|11820801|FG005|NOT COMPLETED|Overall Study||1
10813748|NCT02671136|11976194|FG000|NOT COMPLETED|Overall Study||0
10813749|NCT02671136|11976195|FG001|NOT COMPLETED|Overall Study||0
10813750|NCT02663752|11976201|FG000|STARTED|Overall Study||1
10813751|NCT02663752|11976201|FG000|COMPLETED|Overall Study||1
10813752|NCT02663752|11976201|FG000|NOT COMPLETED|Overall Study||0
10813753|NCT02658357|11976207|FG000|STARTED|Overall Study||0
10813754|NCT02658357|11976208|FG001|STARTED|Overall Study||0
10813755|NCT02658357|11976207|FG000|COMPLETED|Overall Study||0
10813756|NCT02658357|11976208|FG001|COMPLETED|Overall Study||0
10813757|NCT02658357|11976207|FG000|NOT COMPLETED|Overall Study||0
10813758|NCT02658357|11976208|FG001|NOT COMPLETED|Overall Study||0
10813759|NCT02665988|11976216|FG000|STARTED|Overall Study||2
10659439|NCT02242019|11820826|FG000|STARTED|Overall Study||109
10659440|NCT02242019|11820826|FG000|COMPLETED|Overall Study||109
10659441|NCT02242019|11820826|FG000|NOT COMPLETED|Overall Study||0
10659442|NCT02242045|11820830|FG000|STARTED|Overall Study||6
10659443|NCT02242045|11820830|FG000|COMPLETED|Overall Study||0
10659444|NCT02242045|11820830|FG000|NOT COMPLETED|Overall Study||6
10659445|NCT02242201|11820837|FG000|STARTED|Overall Study||55
10659446|NCT02242201|11820838|FG001|STARTED|Overall Study||55
10659447|NCT02242201|11820839|FG002|STARTED|Overall Study||55
10659448|NCT02242201|11820837|FG000|COMPLETED|Overall Study||51
10659449|NCT02242201|11820838|FG001|COMPLETED|Overall Study||54
10659450|NCT02242201|11820839|FG002|COMPLETED|Overall Study||54
10813760|NCT02665988|11976217|FG001|STARTED|Overall Study||2
10813761|NCT02665988|11976216|FG000|COMPLETED|Overall Study||2
10813762|NCT02665988|11976217|FG001|COMPLETED|Overall Study||2
10813763|NCT02665988|11976216|FG000|NOT COMPLETED|Overall Study||0
10659451|NCT02242201|11820837|FG000|NOT COMPLETED|Overall Study||4
10813764|NCT02665988|11976217|FG001|NOT COMPLETED|Overall Study||0
10813765|NCT02660528|11976223|FG000|STARTED|Overall Study||0
10813766|NCT02660528|11976223|FG000|COMPLETED|Overall Study||0
10400032|NCT00711828|11544001|FG000|NOT COMPLETED|Overall Study||0
10400033|NCT00711867|11544007|FG000|STARTED|Overall Study||30
10400034|NCT00711867|11544008|FG001|STARTED|Overall Study||25
10659452|NCT02242201|11820838|FG001|NOT COMPLETED|Overall Study||1
10659453|NCT02242201|11820839|FG002|NOT COMPLETED|Overall Study||1
10659454|NCT02242305|11820849|FG000|STARTED|Overall Study||151
10813767|NCT02660528|11976223|FG000|NOT COMPLETED|Overall Study||0
10813768|NCT02658877|11976229|FG000|STARTED|Overall Study||3
10813769|NCT02658877|11976230|FG001|STARTED|Overall Study||0
10813770|NCT02658877|11976229|FG000|COMPLETED|Overall Study||3
10813771|NCT02658877|11976230|FG001|COMPLETED|Overall Study||0
10813772|NCT02658877|11976229|FG000|NOT COMPLETED|Overall Study||0
10813773|NCT02658877|11976230|FG001|NOT COMPLETED|Overall Study||0
10813774|NCT02654782|11976238|FG000|STARTED|Overall Study||5
10813775|NCT02654782|11976239|FG001|STARTED|Overall Study||5
10813776|NCT02654782|11976238|FG000|COMPLETED|Overall Study||5
10813777|NCT02654782|11976239|FG001|COMPLETED|Overall Study||5
10813778|NCT02654782|11976238|FG000|NOT COMPLETED|Overall Study||0
10813779|NCT02654782|11976239|FG001|NOT COMPLETED|Overall Study||0
10813780|NCT02656199|11976245|FG000|STARTED|Overall Study|0 analyzed.PI left the institution.Effort to contact PI unsuccessful.No study data available|0
10813781|NCT02656199|11976245|FG000|COMPLETED|Overall Study|0 analyzed.PI left the institution.Effort to contact PI unsuccessful.No study data available|0
10813782|NCT02656199|11976245|FG000|NOT COMPLETED|Overall Study||0
10813783|NCT02654639|11976249|FG000|STARTED|Overall Study||4
10813784|NCT02654639|11976249|FG000|COMPLETED|Overall Study||4
10813785|NCT02654639|11976249|FG000|NOT COMPLETED|Overall Study||0
10400035|NCT00711867|11544007|FG000|COMPLETED|Overall Study|2 received additional warming. 3 missing primary measure.|25
10400036|NCT00711867|11544008|FG001|COMPLETED|Overall Study|3 received additional warming. 1 missing primary measure.|21
10400037|NCT00711867|11544007|FG000|NOT COMPLETED|Overall Study||5
10400038|NCT00711867|11544008|FG001|NOT COMPLETED|Overall Study||4
10400039|NCT00711880|11544016|FG000|STARTED|Overall Study||63
10400040|NCT00711880|11544017|FG001|STARTED|Overall Study||62
10400041|NCT00711880|11544016|FG000|COMPLETED|Overall Study||50
10400042|NCT00711880|11544017|FG001|COMPLETED|Overall Study||55
10543917|NCT01486784|11697058|FG003|Received Treatment|Overall Study||1
10813786|NCT02653495|11976255|FG000|STARTED|Overall Study||15
10813787|NCT02653495|11976256|FG001|STARTED|Overall Study||2
10813788|NCT02653495|11976255|FG000|COMPLETED|Overall Study||3
10813789|NCT02653495|11976256|FG001|COMPLETED|Overall Study||2
10813790|NCT02653495|11976255|FG000|NOT COMPLETED|Overall Study||12
10813791|NCT02653495|11976256|FG001|NOT COMPLETED|Overall Study||0
10813792|NCT02640573|11976262|FG000|STARTED|Overall Study||1
10813793|NCT02640573|11976262|FG000|COMPLETED|Overall Study||0
10813794|NCT02640573|11976262|FG000|NOT COMPLETED|Overall Study||1
10813795|NCT02639390|11976268|FG000|STARTED|Overall Study||0
10813796|NCT02639390|11976269|FG001|STARTED|Overall Study||5
10813797|NCT02639390|11976268|FG000|COMPLETED|Overall Study||0
10813798|NCT02639390|11976269|FG001|COMPLETED|Overall Study||3
10813799|NCT02639390|11976268|FG000|NOT COMPLETED|Overall Study||0
10813800|NCT02639390|11976269|FG001|NOT COMPLETED|Overall Study||2
10813801|NCT02634606|11976275|FG000|STARTED|Overall Study||13
10813802|NCT02634606|11976275|FG000|COMPLETED|Overall Study||0
10813803|NCT02634606|11976275|FG000|NOT COMPLETED|Overall Study||13
10813804|NCT02634827|11976283|FG000|STARTED|Overall Study||1
10813805|NCT02634827|11976283|FG000|COMPLETED|Overall Study||1
10813806|NCT02634827|11976283|FG000|NOT COMPLETED|Overall Study||0
10813807|NCT02636283|11976289|FG000|STARTED|Overall Study||3
10813808|NCT02636283|11976290|FG001|STARTED|Overall Study||3
10813809|NCT02636283|11976289|FG000|COMPLETED|Overall Study||1
10813810|NCT02636283|11976290|FG001|COMPLETED|Overall Study||0
10813811|NCT02636283|11976289|FG000|NOT COMPLETED|Overall Study||2
10813812|NCT02636283|11976290|FG001|NOT COMPLETED|Overall Study||3
10813813|NCT02638129|11976298|FG000|STARTED|Overall Study||28
10813814|NCT02638129|11976299|FG001|STARTED|Overall Study||30
10813815|NCT02638129|11976298|FG000|COMPLETED|Overall Study||0
10813816|NCT02638129|11976299|FG001|COMPLETED|Overall Study||0
10813817|NCT02638129|11976298|FG000|NOT COMPLETED|Overall Study||28
10813818|NCT02638129|11976299|FG001|NOT COMPLETED|Overall Study||30
10813819|NCT02615990|11976307|FG000|STARTED|Overall Study||1
10813820|NCT02615990|11976308|FG001|STARTED|Overall Study||1
10813821|NCT02615990|11976307|FG000|COMPLETED|Overall Study||0
10813822|NCT02615990|11976308|FG001|COMPLETED|Overall Study||0
10813823|NCT02615990|11976307|FG000|NOT COMPLETED|Overall Study||1
10813824|NCT02615990|11976308|FG001|NOT COMPLETED|Overall Study||1
10813825|NCT02640677|11976314|FG000|STARTED|Overall Study||2
10813826|NCT02640677|11976314|FG000|COMPLETED|Overall Study||0
10813827|NCT02640677|11976314|FG000|NOT COMPLETED|Overall Study||2
10813828|NCT02633540|11976318|FG000|STARTED|Overall Study||2
10813829|NCT02633540|11976318|FG000|COMPLETED|Overall Study||2
10813830|NCT02633540|11976318|FG000|NOT COMPLETED|Overall Study||0
10813831|NCT02623959|11976324|FG000|STARTED|Overall Study||0
10813832|NCT02623959|11976325|FG001|STARTED|Overall Study||1
10813833|NCT02623959|11976324|FG000|COMPLETED|Overall Study||0
10813834|NCT02623959|11976325|FG001|COMPLETED|Overall Study|due to progression|0
10813835|NCT02623959|11976324|FG000|NOT COMPLETED|Overall Study||0
10813836|NCT02623959|11976325|FG001|NOT COMPLETED|Overall Study||1
10813837|NCT02631148|11976335|FG000|STARTED|Overall Study||12
10813838|NCT02631148|11976336|FG001|STARTED|Overall Study||0
10813839|NCT02631148|11976335|FG000|COMPLETED|Overall Study||2
10813840|NCT02631148|11976336|FG001|COMPLETED|Overall Study||0
10813841|NCT02631148|11976335|FG000|NOT COMPLETED|Overall Study||10
10813842|NCT02631148|11976336|FG001|NOT COMPLETED|Overall Study||0
10813843|NCT02630472|11976344|FG000|STARTED|Overall Study||10
10813844|NCT02630472|11976345|FG001|STARTED|Overall Study||0
10813845|NCT02630472|11976344|FG000|COMPLETED|Overall Study||0
10813846|NCT02630472|11976345|FG001|COMPLETED|Overall Study||0
10813847|NCT02630472|11976344|FG000|NOT COMPLETED|Overall Study||10
10813848|NCT02630472|11976345|FG001|NOT COMPLETED|Overall Study||0
10813849|NCT02626520|11976354|FG000|STARTED|Overall Study||1
10813850|NCT02626520|11976355|FG001|STARTED|Overall Study||10
10813851|NCT02626520|11976354|FG000|COMPLETED|Overall Study||0
10813852|NCT02626520|11976355|FG001|COMPLETED|Overall Study||0
10813853|NCT02626520|11976354|FG000|NOT COMPLETED|Overall Study||1
10813854|NCT02626520|11976355|FG001|NOT COMPLETED|Overall Study||10
10813855|NCT02614898|11976363|FG000|STARTED|Overall Study||15
10813856|NCT02614898|11976364|FG001|STARTED|Overall Study||52
10813857|NCT02614898|11976363|FG000|Safety Population|Overall Study||15
10813858|NCT02614898|11976364|FG001|Safety Population|Overall Study||52
10813859|NCT02614898|11976363|FG000|COMPLETED|Overall Study||0
10813860|NCT02614898|11976364|FG001|COMPLETED|Overall Study||1
10813861|NCT02614898|11976363|FG000|NOT COMPLETED|Overall Study||15
10813862|NCT02614898|11976364|FG001|NOT COMPLETED|Overall Study||51
10813863|NCT02622828|11976371|FG000|STARTED|Overall Study||4
10813864|NCT02622828|11976371|FG000|COMPLETED|Overall Study||1
10721081|NCT02722837|11884729|FG000|COMPLETED|Overall Study||119
10721082|NCT02722837|11884729|FG000|NOT COMPLETED|Overall Study||0
10721083|NCT02722863|11884733|FG000|STARTED|Overall Study||908
10659455|NCT02242305|11820850|FG001|STARTED|Overall Study||151
10659456|NCT02242305|11820849|FG000|COMPLETED|Overall Study||145
10659457|NCT02242305|11820850|FG001|COMPLETED|Overall Study||141
10659458|NCT02242305|11820849|FG000|NOT COMPLETED|Overall Study||6
10659459|NCT02242305|11820850|FG001|NOT COMPLETED|Overall Study||10
10659460|NCT02242487|11820858|FG000|STARTED|Overall Study||161
10659461|NCT02242487|11820859|FG001|STARTED|Overall Study||164
10659462|NCT02242487|11820858|FG000|COMPLETED|Overall Study||99
10659463|NCT02242487|11820859|FG001|COMPLETED|Overall Study||117
10659464|NCT02242487|11820858|FG000|NOT COMPLETED|Overall Study||62
10721084|NCT02722863|11884733|FG000|COMPLETED|Overall Study||908
10312091|NCT00136916|11445414|FG001|Received Treatment|Overall Study||311
10312092|NCT00136916|11445413|FG000|COMPLETED|Overall Study|At study termination, active subjects completed end-of-study assessment and 3-month follow-up visit|194
10312093|NCT00136916|11445414|FG001|COMPLETED|Overall Study|At study termination, active subjects completed end-of-study assessment and 3-month follow-up visit|212
10312094|NCT00136916|11445413|FG000|NOT COMPLETED|Overall Study||125
10312095|NCT00136916|11445414|FG001|NOT COMPLETED|Overall Study||104
10312096|NCT00136955|11445422|FG000|STARTED|Overall Study||41
10312097|NCT00136955|11445422|FG000|COMPLETED|Overall Study||18
10312098|NCT00136955|11445422|FG000|NOT COMPLETED|Overall Study||23
10312099|NCT00137046|11445428|FG000|STARTED|Overall Study|One subject was randomized to inhaled insulin but never received treatment.|291
10312100|NCT00137046|11445429|FG001|STARTED|Overall Study|One subject was randomized to subcutaneous insulin but never received treatment.|291
10312101|NCT00137046|11445428|FG000|Received Study Treatment|Overall Study||290
10312102|NCT00137046|11445429|FG001|Received Study Treatment|Overall Study||290
10312103|NCT00137046|11445428|FG000|COMPLETED|Overall Study|Completed subjects were those subjects who did not discontinue while on active drug.|192
10312104|NCT00137046|11445429|FG001|COMPLETED|Overall Study||198
10312105|NCT00137046|11445428|FG000|NOT COMPLETED|Overall Study||99
10312106|NCT00137046|11445429|FG001|NOT COMPLETED|Overall Study||93
10312107|NCT00137111|11445443|FG000|STARTED|Window Therapy||0
10312108|NCT00137111|11445444|FG001|STARTED|Window Therapy||176
10312109|NCT00137111|11445445|FG002|STARTED|Window Therapy||180
10312110|NCT00137111|11445446|FG003|STARTED|Window Therapy||142
10312111|NCT00137111|11445443|FG000|COMPLETED|Window Therapy||0
10312112|NCT00137111|11445444|FG001|COMPLETED|Window Therapy||176
10312113|NCT00137111|11445445|FG002|COMPLETED|Window Therapy||180
10312114|NCT00137111|11445446|FG003|COMPLETED|Window Therapy||142
10312115|NCT00137111|11445443|FG000|NOT COMPLETED|Window Therapy||0
10312116|NCT00137111|11445444|FG001|NOT COMPLETED|Window Therapy||0
10312117|NCT00137111|11445445|FG002|NOT COMPLETED|Window Therapy||0
10312118|NCT00137111|11445446|FG003|NOT COMPLETED|Window Therapy||0
10312119|NCT00137111|11445443|FG000|STARTED|Total Therapy||498
10312120|NCT00137111|11445444|FG001|STARTED|Total Therapy||0
10312121|NCT00137111|11445445|FG002|STARTED|Total Therapy||0
10312122|NCT00137111|11445446|FG003|STARTED|Total Therapy||0
10312123|NCT00137111|11445443|FG000|COMPLETED|Total Therapy||458
10312124|NCT00137111|11445444|FG001|COMPLETED|Total Therapy||0
10312125|NCT00137111|11445445|FG002|COMPLETED|Total Therapy||0
10312126|NCT00137111|11445446|FG003|COMPLETED|Total Therapy||0
10312127|NCT00137111|11445443|FG000|NOT COMPLETED|Total Therapy||40
10312128|NCT00137111|11445444|FG001|NOT COMPLETED|Total Therapy||0
10312129|NCT00137111|11445445|FG002|NOT COMPLETED|Total Therapy||0
10312130|NCT00137111|11445446|FG003|NOT COMPLETED|Total Therapy||0
10400043|NCT00711880|11544016|FG000|NOT COMPLETED|Overall Study||13
10400044|NCT00711880|11544017|FG001|NOT COMPLETED|Overall Study||7
10400045|NCT00711958|11544025|FG000|STARTED|Overall Study||74
10400046|NCT00711958|11544026|FG001|STARTED|Overall Study||40
10400047|NCT00711958|11544025|FG000|COMPLETED|Overall Study||41
10400048|NCT00711958|11544026|FG001|COMPLETED|Overall Study||17
10400049|NCT00711958|11544025|FG000|NOT COMPLETED|Overall Study||33
10400050|NCT00711958|11544026|FG001|NOT COMPLETED|Overall Study||23
10400051|NCT00711971|11544035|FG000|STARTED|Overall Study||42
10400052|NCT00711971|11544036|FG001|STARTED|Overall Study||42
10400053|NCT00711971|11544037|FG002|STARTED|Overall Study||42
10400054|NCT00711971|11544035|FG000|COMPLETED|Overall Study||39
10400055|NCT00711971|11544036|FG001|COMPLETED|Overall Study||38
10400056|NCT00711971|11544037|FG002|COMPLETED|Overall Study||41
10400057|NCT00711971|11544035|FG000|NOT COMPLETED|Overall Study||3
10400058|NCT00711971|11544036|FG001|NOT COMPLETED|Overall Study||4
10400059|NCT00711971|11544037|FG002|NOT COMPLETED|Overall Study||1
10400060|NCT00711997|11544051|FG000|STARTED|Overall Study||3
10400061|NCT00711997|11544052|FG001|STARTED|Overall Study||6
10312131|NCT00137267|11445455|FG000|STARTED|Overall Study||55
10400062|NCT00711997|11544051|FG000|COMPLETED|Overall Study||3
10400063|NCT00711997|11544052|FG001|COMPLETED|Overall Study||6
10400064|NCT00711997|11544051|FG000|NOT COMPLETED|Overall Study||0
10312132|NCT00137267|11445456|FG001|STARTED|Overall Study||47
10312133|NCT00137267|11445455|FG000|COMPLETED|Overall Study||40
10312134|NCT00137267|11445456|FG001|COMPLETED|Overall Study||26
10312135|NCT00137267|11445455|FG000|NOT COMPLETED|Overall Study||15
10312136|NCT00137267|11445456|FG001|NOT COMPLETED|Overall Study||21
10400065|NCT00711997|11544052|FG001|NOT COMPLETED|Overall Study||0
10400066|NCT00712010|11544060|FG000|STARTED|1st Protein Testing (1 Day)|1 subject withdrew his consent form before to starting the 1st intervention|24
10721085|NCT02722863|11884733|FG000|NOT COMPLETED|Overall Study||0
10721086|NCT02722928|11884740|FG000|STARTED|Overall Study||49
10721087|NCT02722928|11884741|FG001|STARTED|Overall Study||51
10813865|NCT02622828|11976371|FG000|NOT COMPLETED|Overall Study||3
10813866|NCT02624739|11976377|FG000|STARTED|Overall Study||0
10813867|NCT02624739|11976378|FG001|STARTED|Overall Study||0
10813868|NCT02624739|11976377|FG000|COMPLETED|Overall Study||0
10813869|NCT02624739|11976378|FG001|COMPLETED|Overall Study||0
10813870|NCT02624739|11976377|FG000|NOT COMPLETED|Overall Study||0
10813871|NCT02624739|11976378|FG001|NOT COMPLETED|Overall Study||0
10813872|NCT02608905|11976386|FG000|STARTED|Overall Study||7
10813873|NCT02608905|11976387|FG001|STARTED|Overall Study||10
10813874|NCT02608905|11976386|FG000|COMPLETED|Overall Study||5
10813875|NCT02608905|11976387|FG001|COMPLETED|Overall Study||10
10813876|NCT02608905|11976386|FG000|NOT COMPLETED|Overall Study||2
10400067|NCT00712010|11544060|FG000|COMPLETED|1st Protein Testing (1 Day)||24
10400068|NCT00712010|11544060|FG000|NOT COMPLETED|1st Protein Testing (1 Day)||0
10400069|NCT00712010|11544060|FG000|STARTED|Washout (7 Days)||24
10400070|NCT00712010|11544060|FG000|COMPLETED|Washout (7 Days)||24
10400071|NCT00712010|11544060|FG000|NOT COMPLETED|Washout (7 Days)||0
10400072|NCT00712010|11544060|FG000|STARTED|2nd Protein Testing (1 Day)||24
10400073|NCT00712010|11544060|FG000|COMPLETED|2nd Protein Testing (1 Day)||24
10400074|NCT00712010|11544060|FG000|NOT COMPLETED|2nd Protein Testing (1 Day)||0
10400075|NCT00712010|11544060|FG000|STARTED|Washout (7 Days)||24
10400076|NCT00712010|11544060|FG000|COMPLETED|Washout (7 Days)||24
10721088|NCT02722928|11884740|FG000|COMPLETED|Overall Study||39
10721089|NCT02722928|11884741|FG001|COMPLETED|Overall Study||31
10721090|NCT02722928|11884740|FG000|NOT COMPLETED|Overall Study||10
10721091|NCT02722928|11884741|FG001|NOT COMPLETED|Overall Study||20
10813877|NCT02608905|11976387|FG001|NOT COMPLETED|Overall Study||0
10400077|NCT00712010|11544060|FG000|NOT COMPLETED|Washout (7 Days)||0
10400078|NCT00712010|11544060|FG000|STARTED|3rd Protein Testing (1 Day)||24
10400079|NCT00712010|11544060|FG000|COMPLETED|3rd Protein Testing (1 Day)||24
10400080|NCT00712010|11544060|FG000|NOT COMPLETED|3rd Protein Testing (1 Day)||0
10400081|NCT00712010|11544060|FG000|STARTED|Washout (7 Days)||24
10400082|NCT00712010|11544060|FG000|COMPLETED|Washout (7 Days)||24
10400083|NCT00712010|11544060|FG000|NOT COMPLETED|Washout (7 Days)||0
10400084|NCT00712010|11544060|FG000|STARTED|4th Protein Testing (1 Day)||24
10400085|NCT00712010|11544060|FG000|COMPLETED|4th Protein Testing (1 Day)||24
10400086|NCT00712010|11544060|FG000|NOT COMPLETED|4th Protein Testing (1 Day)||0
10400087|NCT00712010|11544060|FG000|STARTED|Washout (7 Days)||24
10400088|NCT00712010|11544060|FG000|COMPLETED|Washout (7 Days)||23
10400089|NCT00712010|11544060|FG000|NOT COMPLETED|Washout (7 Days)||1
10400090|NCT00712010|11544060|FG000|STARTED|5th Protein Testing (1 Day)||23
10400091|NCT00712010|11544060|FG000|COMPLETED|5th Protein Testing (1 Day)||23
10400092|NCT00712010|11544060|FG000|NOT COMPLETED|5th Protein Testing (1 Day)||0
10400093|NCT00712010|11544060|FG000|STARTED|Washout (7 Days)||23
10400094|NCT00712010|11544060|FG000|COMPLETED|Washout (7 Days)||23
10400095|NCT00712010|11544060|FG000|NOT COMPLETED|Washout (7 Days)||0
10721092|NCT02722967|11884754|FG000|STARTED|Overall Study||22
10721093|NCT02722967|11884755|FG001|STARTED|Overall Study||12
10721094|NCT02722967|11884756|FG002|STARTED|Overall Study||15
10813878|NCT02619812|11976397|FG000|STARTED|Overall Study||0
10813879|NCT02619812|11976398|FG001|STARTED|Overall Study||0
10813880|NCT02619812|11976399|FG002|STARTED|Overall Study||1
10400096|NCT00712010|11544060|FG000|STARTED|6th Protein Testing (1 Day)||23
10400097|NCT00712010|11544060|FG000|COMPLETED|6th Protein Testing (1 Day)||23
10721095|NCT02722967|11884754|FG000|COMPLETED|Overall Study||17
10721096|NCT02722967|11884755|FG001|COMPLETED|Overall Study||10
10721097|NCT02722967|11884756|FG002|COMPLETED|Overall Study||11
10721098|NCT02722967|11884754|FG000|NOT COMPLETED|Overall Study||5
10721099|NCT02722967|11884755|FG001|NOT COMPLETED|Overall Study||2
10721100|NCT02722967|11884756|FG002|NOT COMPLETED|Overall Study||4
10721101|NCT02723006|11884767|FG000|STARTED|Overall Study||1
10721102|NCT02723006|11884768|FG001|STARTED|Overall Study||9
10721103|NCT02723006|11884769|FG002|STARTED|Overall Study||12
10721104|NCT02723006|11884767|FG000|COMPLETED|Overall Study||0
10721105|NCT02723006|11884768|FG001|COMPLETED|Overall Study||2
10721106|NCT02723006|11884769|FG002|COMPLETED|Overall Study||5
10721107|NCT02723006|11884767|FG000|NOT COMPLETED|Overall Study||1
10721108|NCT02723006|11884768|FG001|NOT COMPLETED|Overall Study||7
10721109|NCT02723006|11884769|FG002|NOT COMPLETED|Overall Study||7
10721110|NCT02723084|11884779|FG000|STARTED|Overall Study||90
10721111|NCT02723084|11884780|FG001|STARTED|Overall Study||46
10721112|NCT02723084|11884779|FG000|COMPLETED|Overall Study||86
10721113|NCT02723084|11884780|FG001|COMPLETED|Overall Study||45
10721114|NCT02723084|11884779|FG000|NOT COMPLETED|Overall Study||4
10721115|NCT02723084|11884780|FG001|NOT COMPLETED|Overall Study||1
10721116|NCT02723175|11884788|FG000|STARTED|Overall Study||8
10813881|NCT02619812|11976400|FG003|STARTED|Overall Study||2
10813882|NCT02619812|11976397|FG000|COMPLETED|Overall Study||0
10813883|NCT02619812|11976398|FG001|COMPLETED|Overall Study||0
10813884|NCT02619812|11976399|FG002|COMPLETED|Overall Study||0
10813885|NCT02619812|11976400|FG003|COMPLETED|Overall Study||0
10813886|NCT02619812|11976397|FG000|NOT COMPLETED|Overall Study||0
10813887|NCT02619812|11976398|FG001|NOT COMPLETED|Overall Study||0
10813888|NCT02619812|11976399|FG002|NOT COMPLETED|Overall Study||1
10813889|NCT02619812|11976400|FG003|NOT COMPLETED|Overall Study||2
10813890|NCT02612285|11976410|FG000|STARTED|Overall Study||1
10813891|NCT02612285|11976410|FG000|COMPLETED|Overall Study|Subject did not complete Cycle 1; no data points recorded|0
10813892|NCT02612285|11976410|FG000|NOT COMPLETED|Overall Study||1
10813893|NCT02614586|11976414|FG000|STARTED|Overall Study||11
10813894|NCT02614586|11976414|FG000|COMPLETED|Overall Study||11
10813895|NCT02614586|11976414|FG000|NOT COMPLETED|Overall Study||0
10813896|NCT02606279|11976420|FG000|STARTED|Overall Study||0
10813897|NCT02606279|11976421|FG001|STARTED|Overall Study||1
10813898|NCT02606279|11976420|FG000|COMPLETED|Overall Study||0
10813899|NCT02606279|11976421|FG001|COMPLETED|Overall Study||0
10813900|NCT02606279|11976420|FG000|NOT COMPLETED|Overall Study||0
10813901|NCT02606279|11976421|FG001|NOT COMPLETED|Overall Study||1
10813902|NCT02605824|11976429|FG000|STARTED|Overall Study||1
10813903|NCT02605824|11976430|FG001|STARTED|Overall Study||0
10813904|NCT02605824|11976429|FG000|COMPLETED|Overall Study||0
10813905|NCT02605824|11976430|FG001|COMPLETED|Overall Study||0
10813906|NCT02605824|11976429|FG000|NOT COMPLETED|Overall Study||1
10813907|NCT02605824|11976430|FG001|NOT COMPLETED|Overall Study||0
10813908|NCT02598622|11976438|FG000|STARTED|Overall Study||8
10813909|NCT02598622|11976439|FG001|STARTED|Overall Study|Study terminated prior to randomization phase. No enrollment in this arm.|0
10813910|NCT02598622|11976438|FG000|COMPLETED|Overall Study||2
10813911|NCT02598622|11976439|FG001|COMPLETED|Overall Study||0
10813912|NCT02598622|11976438|FG000|NOT COMPLETED|Overall Study||6
10813913|NCT02598622|11976439|FG001|NOT COMPLETED|Overall Study||0
10813914|NCT02589145|11976448|FG000|STARTED|Overall Study||4
10813915|NCT02589145|11976449|FG001|STARTED|Overall Study||2
10813916|NCT02589145|11976450|FG002|STARTED|Overall Study||2
10813917|NCT02589145|11976448|FG000|COMPLETED|Overall Study||4
10813918|NCT02589145|11976449|FG001|COMPLETED|Overall Study||2
10813919|NCT02589145|11976450|FG002|COMPLETED|Overall Study||2
10813920|NCT02589145|11976448|FG000|NOT COMPLETED|Overall Study||0
10721117|NCT02723175|11884789|FG001|STARTED|Overall Study||7
10721118|NCT02723175|11884788|FG000|COMPLETED|Overall Study||4
10721119|NCT02723175|11884789|FG001|COMPLETED|Overall Study||4
10721120|NCT02723175|11884788|FG000|NOT COMPLETED|Overall Study||4
10721121|NCT02723175|11884789|FG001|NOT COMPLETED|Overall Study||3
10721122|NCT02723188|11884798|FG000|STARTED|Overall Study||15
10721123|NCT02723188|11884799|FG001|STARTED|Overall Study||15
10721124|NCT02723188|11884800|FG002|STARTED|Overall Study||15
10813921|NCT02589145|11976449|FG001|NOT COMPLETED|Overall Study||0
10813922|NCT02589145|11976450|FG002|NOT COMPLETED|Overall Study||0
10813923|NCT02590068|11976460|FG000|STARTED|Overall Study||0
10813924|NCT02590068|11976461|FG001|STARTED|Overall Study||14
10813925|NCT02590068|11976460|FG000|COMPLETED|Overall Study||0
10813926|NCT02590068|11976461|FG001|COMPLETED|Overall Study||14
10813927|NCT02590068|11976460|FG000|NOT COMPLETED|Overall Study||0
10813928|NCT02590068|11976461|FG001|NOT COMPLETED|Overall Study||0
10813929|NCT02593682|11976469|FG000|STARTED|Overall Study||0
10813930|NCT02593682|11976470|FG001|STARTED|Overall Study||0
10813931|NCT02593682|11976469|FG000|COMPLETED|Overall Study||0
10813932|NCT02593682|11976470|FG001|COMPLETED|Overall Study||0
10813933|NCT02593682|11976469|FG000|NOT COMPLETED|Overall Study||0
10813934|NCT02593682|11976470|FG001|NOT COMPLETED|Overall Study||0
10813935|NCT02587650|11976476|FG000|STARTED|Overall Study||0
10312137|NCT00137280|11445464|FG000|STARTED|Overall Study||389
10312138|NCT00137280|11445465|FG001|STARTED|Overall Study||412
10312139|NCT00137280|11445464|FG000|COMPLETED|Overall Study||305
10312140|NCT00137280|11445465|FG001|COMPLETED|Overall Study||357
10312141|NCT00137280|11445464|FG000|NOT COMPLETED|Overall Study||84
10312142|NCT00137280|11445465|FG001|NOT COMPLETED|Overall Study||55
10312143|NCT00137423|11445473|FG000|STARTED|Overall Study||54
10312144|NCT00137423|11445474|FG001|STARTED|Overall Study||53
10312145|NCT00137423|11445473|FG000|COMPLETED|Overall Study||15
10312146|NCT00137423|11445474|FG001|COMPLETED|Overall Study||9
10312147|NCT00137423|11445473|FG000|NOT COMPLETED|Overall Study||39
10312148|NCT00137423|11445474|FG001|NOT COMPLETED|Overall Study||44
10312149|NCT00137436|11445484|FG000|STARTED|Overall Study|Phase 2 did not include 38 participants from Phase 1.|55
10312150|NCT00137436|11445484|FG000|COMPLETED|Overall Study||12
10312151|NCT00137436|11445484|FG000|NOT COMPLETED|Overall Study||43
10312152|NCT00137449|11445490|FG000|STARTED|Overall Study||30
10400098|NCT00712010|11544060|FG000|NOT COMPLETED|6th Protein Testing (1 Day)||0
10400099|NCT00712010|11544060|FG000|STARTED|Washout (7 Days)||23
10400100|NCT00712010|11544060|FG000|COMPLETED|Washout (7 Days)||23
10400101|NCT00712010|11544060|FG000|NOT COMPLETED|Washout (7 Days)||0
10400102|NCT00712010|11544060|FG000|STARTED|7th and Last Protein Testing (1 Day)||23
10400103|NCT00712010|11544060|FG000|COMPLETED|7th and Last Protein Testing (1 Day)||23
10400104|NCT00712010|11544060|FG000|NOT COMPLETED|7th and Last Protein Testing (1 Day)||0
10400105|NCT00712075|11544079|FG000|STARTED|Overall Study||22
10400106|NCT00712075|11544080|FG001|STARTED|Overall Study||30
10400107|NCT00712075|11544081|FG002|STARTED|Overall Study||25
10400108|NCT00712075|11544079|FG000|COMPLETED|Overall Study||17
10400109|NCT00712075|11544080|FG001|COMPLETED|Overall Study||26
10400110|NCT00712075|11544081|FG002|COMPLETED|Overall Study||14
10400111|NCT00712075|11544079|FG000|NOT COMPLETED|Overall Study||5
10400112|NCT00712075|11544080|FG001|NOT COMPLETED|Overall Study||4
10400113|NCT00712075|11544081|FG002|NOT COMPLETED|Overall Study||11
10400114|NCT00712166|11544091|FG000|STARTED|Overall Study||81
10400115|NCT00712166|11544092|FG001|STARTED|Overall Study||76
10400116|NCT00712166|11544091|FG000|COMPLETED|Overall Study||81
10400117|NCT00712166|11544092|FG001|COMPLETED|Overall Study||75
10400118|NCT00712166|11544091|FG000|NOT COMPLETED|Overall Study||0
10400119|NCT00712166|11544092|FG001|NOT COMPLETED|Overall Study||1
10400120|NCT00712179|11544100|FG000|STARTED|Overall Study||49
10400121|NCT00712179|11544100|FG000|COMPLETED|Overall Study|Data from 4 subjects was excluded due to noise in recorded EMG signal, so 33 subjects were analysed.|37
10400122|NCT00712179|11544100|FG000|NOT COMPLETED|Overall Study||12
10400123|NCT00712244|11544108|FG000|STARTED|Overall Study||29
10400124|NCT00712244|11544109|FG001|STARTED|Overall Study||29
10400125|NCT00712244|11544110|FG002|STARTED|Overall Study||27
10400126|NCT00712244|11544111|FG003|STARTED|Overall Study||27
10400127|NCT00712244|11544108|FG000|COMPLETED|Overall Study||25
10400128|NCT00712244|11544109|FG001|COMPLETED|Overall Study||28
10400129|NCT00712244|11544110|FG002|COMPLETED|Overall Study||25
10400130|NCT00712244|11544111|FG003|COMPLETED|Overall Study||26
10400131|NCT00712244|11544108|FG000|NOT COMPLETED|Overall Study||4
10400132|NCT00712244|11544109|FG001|NOT COMPLETED|Overall Study||1
10400133|NCT00712244|11544110|FG002|NOT COMPLETED|Overall Study||2
10400134|NCT00712244|11544111|FG003|NOT COMPLETED|Overall Study||1
10400135|NCT00712270|11544124|FG000|STARTED|Overall Study||21
10400136|NCT00712270|11544124|FG000|COMPLETED|Overall Study||7
10400137|NCT00712270|11544124|FG000|NOT COMPLETED|Overall Study||14
10400138|NCT00712296|11544138|FG000|STARTED|Phase I ( 1 Week)||12
10400139|NCT00712296|11544139|FG001|STARTED|Phase I ( 1 Week)||8
10400140|NCT00712296|11544140|FG002|STARTED|Phase I ( 1 Week)||0
10400141|NCT00712296|11544141|FG003|STARTED|Phase I ( 1 Week)||0
10400142|NCT00712296|11544142|FG004|STARTED|Phase I ( 1 Week)||0
10400143|NCT00712296|11544138|FG000|COMPLETED|Phase I ( 1 Week)||12
10400144|NCT00712296|11544139|FG001|COMPLETED|Phase I ( 1 Week)||8
10400145|NCT00712296|11544140|FG002|COMPLETED|Phase I ( 1 Week)||0
10400146|NCT00712296|11544141|FG003|COMPLETED|Phase I ( 1 Week)||0
10400147|NCT00712296|11544142|FG004|COMPLETED|Phase I ( 1 Week)||0
10400148|NCT00712296|11544138|FG000|NOT COMPLETED|Phase I ( 1 Week)||0
10400149|NCT00712296|11544139|FG001|NOT COMPLETED|Phase I ( 1 Week)||0
10400150|NCT00712296|11544140|FG002|NOT COMPLETED|Phase I ( 1 Week)||0
10400151|NCT00712296|11544141|FG003|NOT COMPLETED|Phase I ( 1 Week)||0
10400152|NCT00712296|11544142|FG004|NOT COMPLETED|Phase I ( 1 Week)||0
10400153|NCT00712296|11544138|FG000|STARTED|Phase II (28 Weeks)||0
10400154|NCT00712296|11544139|FG001|STARTED|Phase II (28 Weeks)||0
10400155|NCT00712296|11544140|FG002|STARTED|Phase II (28 Weeks)||15
10400156|NCT00712296|11544141|FG003|STARTED|Phase II (28 Weeks)||16
10400157|NCT00712296|11544142|FG004|STARTED|Phase II (28 Weeks)||15
10400158|NCT00712296|11544138|FG000|COMPLETED|Phase II (28 Weeks)||0
10400159|NCT00712296|11544139|FG001|COMPLETED|Phase II (28 Weeks)||0
10400160|NCT00712296|11544140|FG002|COMPLETED|Phase II (28 Weeks)|ASHMI/Placebo was discontinued on 9/29/10.20 participants were re-randomized into the Phase II.|2
10400161|NCT00712296|11544141|FG003|COMPLETED|Phase II (28 Weeks)||1
10400162|NCT00712296|11544142|FG004|COMPLETED|Phase II (28 Weeks)||3
10400163|NCT00712296|11544138|FG000|NOT COMPLETED|Phase II (28 Weeks)||0
10400164|NCT00712296|11544139|FG001|NOT COMPLETED|Phase II (28 Weeks)||0
10400165|NCT00712296|11544140|FG002|NOT COMPLETED|Phase II (28 Weeks)||13
10400166|NCT00712296|11544141|FG003|NOT COMPLETED|Phase II (28 Weeks)||15
10400167|NCT00712296|11544142|FG004|NOT COMPLETED|Phase II (28 Weeks)||12
10400168|NCT00712335|11544178|FG000|STARTED|Overall Study||8
10400169|NCT00712335|11544179|FG001|STARTED|Overall Study||32
10400170|NCT00712335|11544180|FG002|STARTED|Overall Study||11
10400171|NCT00712335|11544181|FG003|STARTED|Overall Study||24
10400172|NCT00712335|11544182|FG004|STARTED|Overall Study||30
10400173|NCT00712335|11544178|FG000|COMPLETED|Overall Study||5
10400174|NCT00712335|11544179|FG001|COMPLETED|Overall Study||15
10400175|NCT00712335|11544180|FG002|COMPLETED|Overall Study||6
10400176|NCT00712335|11544181|FG003|COMPLETED|Overall Study||19
10400177|NCT00712335|11544182|FG004|COMPLETED|Overall Study||30
10400178|NCT00712335|11544178|FG000|NOT COMPLETED|Overall Study||3
10400179|NCT00712335|11544179|FG001|NOT COMPLETED|Overall Study||17
10400180|NCT00712335|11544180|FG002|NOT COMPLETED|Overall Study||5
10400181|NCT00712335|11544181|FG003|NOT COMPLETED|Overall Study||5
10400182|NCT00712335|11544182|FG004|NOT COMPLETED|Overall Study||0
10400183|NCT00712348|11544194|FG000|STARTED|Overall Study||31
10400184|NCT00712348|11544194|FG000|COMPLETED|Overall Study||30
10400185|NCT00712348|11544194|FG000|NOT COMPLETED|Overall Study||1
10400186|NCT00712530|11544201|FG000|STARTED|Overall Study||3
10400187|NCT00712530|11544202|FG001|STARTED|Overall Study||3
10400188|NCT00712530|11544203|FG002|STARTED|Overall Study|Screened 4 patients, but one failed to meet entry criteria due to a history of bleeding and diabetes|3
10400189|NCT00712530|11544201|FG000|COMPLETED|Overall Study||3
10400190|NCT00712530|11544202|FG001|COMPLETED|Overall Study||3
10400191|NCT00712530|11544203|FG002|COMPLETED|Overall Study||3
10400192|NCT00712530|11544201|FG000|NOT COMPLETED|Overall Study||0
10400193|NCT00712530|11544202|FG001|NOT COMPLETED|Overall Study||0
10400194|NCT00712530|11544203|FG002|NOT COMPLETED|Overall Study||0
10400195|NCT00712543|11544213|FG000|STARTED|Day 1-7||23
10400196|NCT00712543|11544214|FG001|STARTED|Day 1-7||27
10400197|NCT00712543|11544213|FG000|COMPLETED|Day 1-7||23
10659465|NCT02242487|11820859|FG001|NOT COMPLETED|Overall Study||47
10659466|NCT02242630|11820871|FG000|STARTED|Overall Study||15
10813936|NCT02587650|11976477|FG001|STARTED|Overall Study||0
10813937|NCT02587650|11976478|FG002|STARTED|Overall Study||1
10813938|NCT02587650|11976479|FG003|STARTED|Overall Study||0
10813939|NCT02587650|11976476|FG000|COMPLETED|Overall Study||0
10813940|NCT02587650|11976477|FG001|COMPLETED|Overall Study||0
10813941|NCT02587650|11976478|FG002|COMPLETED|Overall Study||1
10813942|NCT02587650|11976479|FG003|COMPLETED|Overall Study||0
10813943|NCT02587650|11976476|FG000|NOT COMPLETED|Overall Study||0
10813944|NCT02587650|11976477|FG001|NOT COMPLETED|Overall Study||0
10813945|NCT02587650|11976478|FG002|NOT COMPLETED|Overall Study||0
10400198|NCT00712543|11544214|FG001|COMPLETED|Day 1-7||27
10400199|NCT00712543|11544213|FG000|NOT COMPLETED|Day 1-7||0
10400200|NCT00712543|11544214|FG001|NOT COMPLETED|Day 1-7||0
10400201|NCT00712543|11544213|FG000|STARTED|Day 8-14||23
10400202|NCT00712543|11544214|FG001|STARTED|Day 8-14||27
10400203|NCT00712543|11544213|FG000|COMPLETED|Day 8-14||23
10400204|NCT00712543|11544214|FG001|COMPLETED|Day 8-14||25
10813946|NCT02587650|11976479|FG003|NOT COMPLETED|Overall Study||0
10813947|NCT02569957|11976485|FG000|STARTED|Overall Study||0
10400205|NCT00712543|11544213|FG000|NOT COMPLETED|Day 8-14||0
10400206|NCT00712543|11544214|FG001|NOT COMPLETED|Day 8-14||2
10400207|NCT00712673|11544223|FG000|STARTED|Overall Study|Randomized.|85
10400208|NCT00712673|11544224|FG001|STARTED|Overall Study||85
10400209|NCT00712673|11544225|FG002|STARTED|Overall Study||255
10400210|NCT00712673|11544226|FG003|STARTED|Overall Study||255
10400211|NCT00712673|11544223|FG000|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|85
10400212|NCT00712673|11544224|FG001|Safety Population|Overall Study||85
10400213|NCT00712673|11544225|FG002|Safety Population|Overall Study||255
10400214|NCT00712673|11544226|FG003|Safety Population|Overall Study||255
10400215|NCT00712673|11544223|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|85
10400216|NCT00712673|11544224|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||85
10400217|NCT00712673|11544225|FG002|Modified Intent-to-Treat(mITT)Population|Overall Study||255
10400218|NCT00712673|11544226|FG003|Modified Intent-to-Treat(mITT)Population|Overall Study||255
10400219|NCT00712673|11544223|FG000|Subgroup for Standardized Meal Test|Overall Study|Patients from morning injection arms where standardized meal test was performed.|85
10400220|NCT00712673|11544224|FG001|Subgroup for Standardized Meal Test|Overall Study||0
10400221|NCT00712673|11544225|FG002|Subgroup for Standardized Meal Test|Overall Study||255
10400222|NCT00712673|11544226|FG003|Subgroup for Standardized Meal Test|Overall Study||0
10400223|NCT00712673|11544223|FG000|COMPLETED|Overall Study||64
10400224|NCT00712673|11544224|FG001|COMPLETED|Overall Study||64
10400225|NCT00712673|11544225|FG002|COMPLETED|Overall Study||198
10400226|NCT00712673|11544226|FG003|COMPLETED|Overall Study||185
10400227|NCT00712673|11544223|FG000|NOT COMPLETED|Overall Study||21
10400228|NCT00712673|11544224|FG001|NOT COMPLETED|Overall Study||21
10400229|NCT00712673|11544225|FG002|NOT COMPLETED|Overall Study||57
10400230|NCT00712673|11544226|FG003|NOT COMPLETED|Overall Study||70
10400231|NCT00712712|11544245|FG000|STARTED|Overall Study||78
10400232|NCT00712712|11544245|FG000|COMPLETED|Overall Study||55
10400233|NCT00712712|11544245|FG000|NOT COMPLETED|Overall Study||23
10400234|NCT00712725|11544257|FG000|STARTED|Overall Study||169
10400235|NCT00712725|11544258|FG001|STARTED|Overall Study||39
10400236|NCT00712725|11544259|FG002|STARTED|Overall Study||57
10400237|NCT00712725|11544260|FG003|STARTED|Overall Study||84
10400238|NCT00712725|11544261|FG004|STARTED|Overall Study||86
10400239|NCT00712725|11544262|FG005|STARTED|Overall Study||84
10400240|NCT00712725|11544263|FG006|STARTED|Overall Study||83
10400241|NCT00712725|11544264|FG007|STARTED|Overall Study||74
10400242|NCT00712725|11544257|FG000|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|140
10400243|NCT00712725|11544258|FG001|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|33
10400244|NCT00712725|11544259|FG002|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|47
10400245|NCT00712725|11544260|FG003|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|67
10400246|NCT00712725|11544261|FG004|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|67
10400247|NCT00712725|11544262|FG005|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|68
10400248|NCT00712725|11544263|FG006|COMPLETED|Overall Study|One patient received study drug. The remaining patients discontinued prior to receiving study drug.|61
10400249|NCT00712725|11544264|FG007|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|63
10400250|NCT00712725|11544257|FG000|NOT COMPLETED|Overall Study||29
10400251|NCT00712725|11544258|FG001|NOT COMPLETED|Overall Study||6
10400252|NCT00712725|11544259|FG002|NOT COMPLETED|Overall Study||10
10400253|NCT00712725|11544260|FG003|NOT COMPLETED|Overall Study||17
10400254|NCT00712725|11544261|FG004|NOT COMPLETED|Overall Study||19
10400255|NCT00712725|11544262|FG005|NOT COMPLETED|Overall Study||16
10813948|NCT02569957|11976486|FG001|STARTED|Overall Study||1
10813949|NCT02569957|11976485|FG000|COMPLETED|Overall Study||0
10813950|NCT02569957|11976486|FG001|COMPLETED|Overall Study||0
10813951|NCT02569957|11976485|FG000|NOT COMPLETED|Overall Study||0
10813952|NCT02569957|11976486|FG001|NOT COMPLETED|Overall Study||1
10813953|NCT02568007|11976495|FG000|STARTED|Overall Study||2
10813954|NCT02568007|11976496|FG001|STARTED|Overall Study||2
10813955|NCT02568007|11976497|FG002|STARTED|Overall Study||0
10813956|NCT02568007|11976495|FG000|COMPLETED|Overall Study||2
10813957|NCT02568007|11976496|FG001|COMPLETED|Overall Study||2
10813958|NCT02568007|11976497|FG002|COMPLETED|Overall Study||0
10813959|NCT02568007|11976495|FG000|NOT COMPLETED|Overall Study||0
10312153|NCT00137449|11445491|FG001|STARTED|Overall Study||30
10312154|NCT00137449|11445490|FG000|COMPLETED|Overall Study||14
10312155|NCT00137449|11445491|FG001|COMPLETED|Overall Study||12
10312156|NCT00137449|11445490|FG000|NOT COMPLETED|Overall Study||16
10312157|NCT00137449|11445491|FG001|NOT COMPLETED|Overall Study||18
10312158|NCT00137631|11445500|FG000|STARTED|Overall Study||164
10312159|NCT00137631|11445501|FG001|STARTED|Overall Study||174
10400256|NCT00712725|11544263|FG006|NOT COMPLETED|Overall Study||22
10400257|NCT00712725|11544264|FG007|NOT COMPLETED|Overall Study||11
10400258|NCT00712920|11544285|FG000|STARTED|Overall Study||192
10400259|NCT00712920|11544286|FG001|STARTED|Overall Study|3 subjects were randomized in error|197
10400260|NCT00712920|11544287|FG002|STARTED|Overall Study||192
10400261|NCT00712920|11544285|FG000|COMPLETED|Overall Study||175
10400262|NCT00712920|11544286|FG001|COMPLETED|Overall Study||180
10400263|NCT00712920|11544287|FG002|COMPLETED|Overall Study||180
10400264|NCT00712920|11544285|FG000|NOT COMPLETED|Overall Study||17
10400265|NCT00712920|11544286|FG001|NOT COMPLETED|Overall Study||17
10400266|NCT00712920|11544287|FG002|NOT COMPLETED|Overall Study||12
10400267|NCT00712959|11544297|FG000|STARTED|Overall Study||361
10400268|NCT00712959|11544298|FG001|STARTED|Overall Study||407
10400269|NCT00712959|11544297|FG000|COMPLETED|Overall Study||342
10400270|NCT00712959|11544298|FG001|COMPLETED|Overall Study||404
10400271|NCT00712959|11544297|FG000|NOT COMPLETED|Overall Study||19
10400272|NCT00712959|11544298|FG001|NOT COMPLETED|Overall Study||3
10400273|NCT00712985|11544304|FG000|STARTED|Overall Study||18
10400274|NCT00712985|11544304|FG000|COMPLETED|Overall Study||13
10400275|NCT00712985|11544304|FG000|NOT COMPLETED|Overall Study||5
10400276|NCT00713219|11544308|FG000|STARTED|Overall Study||14
10400277|NCT00713219|11544308|FG000|COMPLETED|Overall Study||12
10400278|NCT00713219|11544308|FG000|NOT COMPLETED|Overall Study||2
10400279|NCT00713284|11544312|FG000|STARTED|Overall Study|29 participants were screened but only 13 eligible for conversion and continue in the study.|29
10400280|NCT00713284|11544312|FG000|COMPLETED|Overall Study||13
10400281|NCT00713284|11544312|FG000|NOT COMPLETED|Overall Study||16
10400282|NCT00713310|11544318|FG000|STARTED|Overall Study||41
10400283|NCT00713310|11544319|FG001|STARTED|Overall Study||42
10400284|NCT00713310|11544318|FG000|mITT Population|Overall Study||41
10400285|NCT00713310|11544319|FG001|mITT Population|Overall Study|1 subject randomized to high dose not dosed so not included in the mITT population.|41
10400286|NCT00713310|11544318|FG000|COMPLETED|Overall Study||36
10400287|NCT00713310|11544319|FG001|COMPLETED|Overall Study||36
10400288|NCT00713310|11544318|FG000|NOT COMPLETED|Overall Study||5
10400289|NCT00713310|11544319|FG001|NOT COMPLETED|Overall Study||6
10400290|NCT00713323|11544325|FG000|STARTED|Overall Study||380
10400291|NCT00713323|11544325|FG000|COMPLETED|Overall Study||234
10400292|NCT00713323|11544325|FG000|NOT COMPLETED|Overall Study||146
10400293|NCT00713349|11544329|FG000|STARTED|Overall Study||25
10400294|NCT00713349|11544329|FG000|COMPLETED|Overall Study||24
10312160|NCT00137631|11445500|FG000|Complete 3-month Follow-up|Overall Study||120
10312161|NCT00137631|11445501|FG001|Complete 3-month Follow-up|Overall Study||125
10312162|NCT00137631|11445500|FG000|Completed 6-month Follow-up|Overall Study|7 participants who were lost to follow-up at 3-months were retained at 6-months|127
10400295|NCT00713349|11544329|FG000|NOT COMPLETED|Overall Study||1
10400296|NCT00713427|11544335|FG000|STARTED|Overall Study||70
10400297|NCT00713427|11544335|FG000|COMPLETED|Overall Study||66
10400298|NCT00713427|11544335|FG000|NOT COMPLETED|Overall Study||4
10813960|NCT02568007|11976496|FG001|NOT COMPLETED|Overall Study||0
10813961|NCT02568007|11976497|FG002|NOT COMPLETED|Overall Study||0
10813962|NCT02575365|11976505|FG000|STARTED|Overall Study||4
10813963|NCT02575365|11976505|FG000|COMPLETED|Overall Study||0
10721125|NCT02723188|11884798|FG000|COMPLETED|Overall Study||14
10400299|NCT00713479|11544339|FG000|STARTED|First Medication Condition||6
10400300|NCT00713479|11544340|FG001|STARTED|First Medication Condition||6
10400301|NCT00713479|11544339|FG000|COMPLETED|First Medication Condition||2
10400302|NCT00713479|11544340|FG001|COMPLETED|First Medication Condition||6
10400303|NCT00713479|11544339|FG000|NOT COMPLETED|First Medication Condition||4
10400304|NCT00713479|11544340|FG001|NOT COMPLETED|First Medication Condition||0
10400305|NCT00713479|11544339|FG000|STARTED|Washout||2
10400306|NCT00713479|11544340|FG001|STARTED|Washout||6
10400307|NCT00713479|11544339|FG000|COMPLETED|Washout||2
10400308|NCT00713479|11544340|FG001|COMPLETED|Washout||6
10400309|NCT00713479|11544339|FG000|NOT COMPLETED|Washout||0
10400310|NCT00713479|11544340|FG001|NOT COMPLETED|Washout||0
10400311|NCT00713479|11544339|FG000|STARTED|Next Medication Condition||2
10400312|NCT00713479|11544340|FG001|STARTED|Next Medication Condition||6
10400313|NCT00713479|11544339|FG000|COMPLETED|Next Medication Condition||2
10400314|NCT00713479|11544340|FG001|COMPLETED|Next Medication Condition||6
10400315|NCT00713479|11544339|FG000|NOT COMPLETED|Next Medication Condition||0
10400316|NCT00713479|11544340|FG001|NOT COMPLETED|Next Medication Condition||0
10400317|NCT00713544|11544354|FG000|STARTED|Overall Study||52
10400318|NCT00713544|11544355|FG001|STARTED|Overall Study||52
10400319|NCT00713544|11544356|FG002|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|52
10400320|NCT00713544|11544357|FG003|STARTED|Overall Study||76
10400321|NCT00713544|11544358|FG004|STARTED|Overall Study||65
10400322|NCT00713544|11544359|FG005|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|76
10400323|NCT00713544|11544354|FG000|COMPLETED|Overall Study||45
10400324|NCT00713544|11544355|FG001|COMPLETED|Overall Study||46
10400325|NCT00713544|11544356|FG002|COMPLETED|Overall Study||41
10400326|NCT00713544|11544357|FG003|COMPLETED|Overall Study||66
10400327|NCT00713544|11544358|FG004|COMPLETED|Overall Study||57
10400328|NCT00713544|11544359|FG005|COMPLETED|Overall Study||67
10400329|NCT00713544|11544354|FG000|NOT COMPLETED|Overall Study||7
10400330|NCT00713544|11544355|FG001|NOT COMPLETED|Overall Study||6
10400331|NCT00713544|11544356|FG002|NOT COMPLETED|Overall Study||11
10400332|NCT00713544|11544357|FG003|NOT COMPLETED|Overall Study||10
10721126|NCT02723188|11884799|FG001|COMPLETED|Overall Study||15
10400333|NCT00713544|11544358|FG004|NOT COMPLETED|Overall Study||8
10400334|NCT00713544|11544359|FG005|NOT COMPLETED|Overall Study||9
10400335|NCT00713583|11544375|FG000|STARTED|Overall Study||45
10400336|NCT00713583|11544376|FG001|STARTED|Overall Study||40
10400337|NCT00713583|11544375|FG000|COMPLETED|Overall Study||45
10400338|NCT00713583|11544376|FG001|COMPLETED|Overall Study||40
10400339|NCT00713583|11544375|FG000|NOT COMPLETED|Overall Study||0
10400340|NCT00713583|11544376|FG001|NOT COMPLETED|Overall Study||0
10400341|NCT00713609|11544388|FG000|STARTED|Overall Study||106
10400342|NCT00713609|11544389|FG001|STARTED|Overall Study||105
10400343|NCT00713609|11544390|FG002|STARTED|Overall Study||107
10400344|NCT00713609|11544391|FG003|STARTED|Overall Study||108
10400345|NCT00713609|11544392|FG004|STARTED|Overall Study||106
10400346|NCT00713609|11544393|FG005|STARTED|Overall Study||55
10400347|NCT00713609|11544388|FG000|COMPLETED|Overall Study||85
10400348|NCT00713609|11544389|FG001|COMPLETED|Overall Study||90
10400349|NCT00713609|11544390|FG002|COMPLETED|Overall Study||92
10400350|NCT00713609|11544391|FG003|COMPLETED|Overall Study||99
10400351|NCT00713609|11544392|FG004|COMPLETED|Overall Study||87
10400352|NCT00713609|11544393|FG005|COMPLETED|Overall Study||47
10400353|NCT00713609|11544388|FG000|NOT COMPLETED|Overall Study||21
10400354|NCT00713609|11544389|FG001|NOT COMPLETED|Overall Study||15
10721127|NCT02723188|11884800|FG002|COMPLETED|Overall Study||15
10721128|NCT02723188|11884798|FG000|NOT COMPLETED|Overall Study||1
10659467|NCT02242630|11820872|FG001|STARTED|Overall Study||15
10659468|NCT02242630|11820873|FG002|STARTED|Overall Study||15
10659469|NCT02242630|11820874|FG003|STARTED|Overall Study||16
10659470|NCT02242630|11820871|FG000|COMPLETED|Overall Study||15
10659471|NCT02242630|11820872|FG001|COMPLETED|Overall Study||15
10659472|NCT02242630|11820873|FG002|COMPLETED|Overall Study||15
10659473|NCT02242630|11820874|FG003|COMPLETED|Overall Study||16
10659474|NCT02242630|11820871|FG000|NOT COMPLETED|Overall Study||0
10659475|NCT02242630|11820872|FG001|NOT COMPLETED|Overall Study||0
10659476|NCT02242630|11820873|FG002|NOT COMPLETED|Overall Study||0
10659477|NCT02242630|11820874|FG003|NOT COMPLETED|Overall Study||0
10659478|NCT02242643|11820886|FG000|STARTED|Overall Study||1207
10659479|NCT02242643|11820887|FG001|STARTED|Overall Study||1217
10659480|NCT02242643|11820886|FG000|COMPLETED|Overall Study||1132
10659481|NCT02242643|11820887|FG001|COMPLETED|Overall Study||1139
10659482|NCT02242643|11820886|FG000|NOT COMPLETED|Overall Study||75
10659483|NCT02242643|11820887|FG001|NOT COMPLETED|Overall Study||78
10659484|NCT02242903|11820902|FG000|STARTED|Overall Study||12
10813964|NCT02575365|11976505|FG000|NOT COMPLETED|Overall Study||4
10813965|NCT02549755|11976509|FG000|STARTED|Overall Study||1
10813966|NCT02549755|11976509|FG000|COMPLETED|Overall Study||0
10813967|NCT02549755|11976509|FG000|NOT COMPLETED|Overall Study||1
10813968|NCT02547129|11976515|FG000|STARTED|Overall Study||2
10813969|NCT02547129|11976516|FG001|STARTED|Overall Study||2
10813970|NCT02547129|11976515|FG000|COMPLETED|Overall Study||1
10813971|NCT02547129|11976516|FG001|COMPLETED|Overall Study||2
10813972|NCT02547129|11976515|FG000|NOT COMPLETED|Overall Study||1
10813973|NCT02547129|11976516|FG001|NOT COMPLETED|Overall Study||0
10813974|NCT02528097|11976524|FG000|STARTED|Overall Study||1
10659485|NCT02242903|11820903|FG001|STARTED|Overall Study||6
10659486|NCT02242903|11820904|FG002|STARTED|Overall Study||6
10659487|NCT02242903|11820905|FG003|STARTED|Overall Study||6
10659488|NCT02242903|11820906|FG004|STARTED|Overall Study||6
10659489|NCT02242903|11820907|FG005|STARTED|Overall Study||6
10813975|NCT02528097|11976525|FG001|STARTED|Overall Study||1
10813976|NCT02528097|11976524|FG000|COMPLETED|Overall Study||1
10813977|NCT02528097|11976525|FG001|COMPLETED|Overall Study||1
10315510|NCT00179621|11449408|FG001|NOT COMPLETED|Double-Blind Period||46
10315511|NCT00179621|11449409|FG002|NOT COMPLETED|Double-Blind Period||30
10315512|NCT00179621|11449410|FG003|NOT COMPLETED|Double-Blind Period||0
10315513|NCT00179621|11449407|FG000|STARTED|Open-Label Period||0
10315514|NCT00179621|11449408|FG001|STARTED|Open-Label Period|'Started' includes 23 participants who completed double-blind and 19 who discontinued double-blind.|42
10315515|NCT00179621|11449409|FG002|STARTED|Open-Label Period|'Started' includes 39 participants who completed double-blind and 8 who discontinued double-blind.|47
10315516|NCT00179621|11449410|FG003|STARTED|Open-Label Period|'Started' includes 1 participant who completed double-blind and 55 who discontinued double-blind.|56
10315517|NCT00179621|11449407|FG000|COMPLETED|Open-Label Period||0
10315518|NCT00179621|11449408|FG001|COMPLETED|Open-Label Period||14
10315519|NCT00179621|11449409|FG002|COMPLETED|Open-Label Period||19
10315520|NCT00179621|11449410|FG003|COMPLETED|Open-Label Period||13
10400355|NCT00713609|11544390|FG002|NOT COMPLETED|Overall Study||15
10400356|NCT00713609|11544391|FG003|NOT COMPLETED|Overall Study||9
10400357|NCT00713609|11544392|FG004|NOT COMPLETED|Overall Study||19
10400358|NCT00713609|11544393|FG005|NOT COMPLETED|Overall Study||8
10400359|NCT00713648|11544407|FG000|STARTED|Overall Study||41
10400360|NCT00713648|11544407|FG000|COMPLETED|Overall Study||33
10400361|NCT00713648|11544407|FG000|NOT COMPLETED|Overall Study||8
10400362|NCT00713661|11544415|FG000|STARTED|Overall Study||7
10400363|NCT00713661|11544416|FG001|STARTED|Overall Study||9
10400364|NCT00713661|11544417|FG002|STARTED|Overall Study||4
10400365|NCT00713661|11544418|FG003|STARTED|Overall Study||5
10400366|NCT00713661|11544415|FG000|COMPLETED|Overall Study||7
10400367|NCT00713661|11544416|FG001|COMPLETED|Overall Study||9
10400368|NCT00713661|11544417|FG002|COMPLETED|Overall Study||4
10400369|NCT00713661|11544418|FG003|COMPLETED|Overall Study||5
10400370|NCT00713661|11544415|FG000|NOT COMPLETED|Overall Study||0
10400371|NCT00713661|11544416|FG001|NOT COMPLETED|Overall Study||0
10400372|NCT00713661|11544417|FG002|NOT COMPLETED|Overall Study||0
10400373|NCT00713661|11544418|FG003|NOT COMPLETED|Overall Study||0
10400374|NCT00713700|11544428|FG000|STARTED|Overall Study||192
10400375|NCT00713700|11544428|FG000|COMPLETED|Overall Study||188
10400376|NCT00713700|11544428|FG000|NOT COMPLETED|Overall Study||4
10400377|NCT00713817|11544434|FG000|STARTED|Overall Study||10
10400378|NCT00713817|11544435|FG001|STARTED|Overall Study||9
10400379|NCT00713817|11544434|FG000|COMPLETED|Overall Study||10
10400380|NCT00713817|11544435|FG001|COMPLETED|Overall Study||9
10400381|NCT00713817|11544434|FG000|NOT COMPLETED|Overall Study||0
10400382|NCT00713817|11544435|FG001|NOT COMPLETED|Overall Study||0
10400383|NCT00713830|11544443|FG000|STARTED|Overall Study|Randomized.|286
10400384|NCT00713830|11544444|FG001|STARTED|Overall Study||573
10400385|NCT00713830|11544443|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|286
10400386|NCT00713830|11544444|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||570
10400387|NCT00713830|11544443|FG000|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|285
10400388|NCT00713830|11544444|FG001|Safety Population|Overall Study|1 patient randomized to placebo received Lixisenatide (at least one dose)|574
10400389|NCT00713830|11544443|FG000|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal challenge test was performed.|155
10400390|NCT00713830|11544444|FG001|Subgroup for Standardized Meal Test|Overall Study||313
10400391|NCT00713830|11544443|FG000|COMPLETED|Overall Study||204
10400392|NCT00713830|11544444|FG001|COMPLETED|Overall Study||396
10400393|NCT00713830|11544443|FG000|NOT COMPLETED|Overall Study||82
10721129|NCT02723188|11884799|FG001|NOT COMPLETED|Overall Study||0
10721130|NCT02723188|11884800|FG002|NOT COMPLETED|Overall Study||0
10721131|NCT02723201|11884811|FG000|STARTED|First Intervention Period||11
10721132|NCT02723201|11884812|FG001|STARTED|First Intervention Period||7
10721133|NCT02723201|11884813|FG002|STARTED|First Intervention Period||7
10400394|NCT00713830|11544444|FG001|NOT COMPLETED|Overall Study||177
10400395|NCT00714051|11544452|FG000|STARTED|Overall Study||27
10400396|NCT00714051|11544453|FG001|STARTED|Overall Study||28
10400397|NCT00714051|11544452|FG000|COMPLETED|Overall Study||26
10400398|NCT00714051|11544453|FG001|COMPLETED|Overall Study||27
10400399|NCT00714051|11544452|FG000|NOT COMPLETED|Overall Study||1
10400400|NCT00714051|11544453|FG001|NOT COMPLETED|Overall Study||1
10400401|NCT00714168|11544461|FG000|STARTED|Overall Study||165
10400402|NCT00714168|11544462|FG001|STARTED|Overall Study||198
10400403|NCT00714168|11544461|FG000|COMPLETED|Overall Study||121
10400404|NCT00714168|11544462|FG001|COMPLETED|Overall Study||139
10400405|NCT00714168|11544461|FG000|NOT COMPLETED|Overall Study||44
10400406|NCT00714168|11544462|FG001|NOT COMPLETED|Overall Study||59
10400407|NCT00714233|11544472|FG000|STARTED|Overall Study||10
10400408|NCT00714233|11544473|FG001|STARTED|Overall Study||11
10400409|NCT00714233|11544474|FG002|STARTED|Overall Study||11
10400410|NCT00714233|11544475|FG003|STARTED|Overall Study||10
10400411|NCT00714233|11544472|FG000|COMPLETED|Overall Study||6
10400412|NCT00714233|11544473|FG001|COMPLETED|Overall Study||10
10400413|NCT00714233|11544474|FG002|COMPLETED|Overall Study||10
10400414|NCT00714233|11544475|FG003|COMPLETED|Overall Study||6
10721134|NCT02723201|11884811|FG000|COMPLETED|First Intervention Period||11
10400415|NCT00714233|11544472|FG000|NOT COMPLETED|Overall Study||4
10400416|NCT00714233|11544473|FG001|NOT COMPLETED|Overall Study||1
10400417|NCT00714233|11544474|FG002|NOT COMPLETED|Overall Study||1
10400418|NCT00714233|11544475|FG003|NOT COMPLETED|Overall Study||4
10400419|NCT00714259|11544490|FG000|STARTED|Overall Study||5
10400420|NCT00714259|11544490|FG000|COMPLETED|Overall Study||3
10400421|NCT00714259|11544490|FG000|NOT COMPLETED|Overall Study||2
10400422|NCT00714272|11544496|FG000|STARTED|Overall Study||2
10400423|NCT00714272|11544497|FG001|STARTED|Overall Study||2
10400424|NCT00714272|11544496|FG000|COMPLETED|Overall Study||2
10400425|NCT00714272|11544497|FG001|COMPLETED|Overall Study||2
10400426|NCT00714272|11544496|FG000|NOT COMPLETED|Overall Study||0
10400427|NCT00714272|11544497|FG001|NOT COMPLETED|Overall Study||0
10400428|NCT00714285|11544507|FG000|STARTED|Overall Study||105
10400429|NCT00714285|11544508|FG001|STARTED|Overall Study||105
10400430|NCT00714285|11544509|FG002|STARTED|Overall Study||105
10400431|NCT00714285|11544510|FG003|STARTED|Overall Study||105
10400432|NCT00714285|11544507|FG000|COMPLETED|Overall Study|Completed upto Day 180|105
10400433|NCT00714285|11544508|FG001|COMPLETED|Overall Study|Completed upto Day 180|102
10400434|NCT00714285|11544509|FG002|COMPLETED|Overall Study|Completed upto Day 180|105
10400435|NCT00714285|11544510|FG003|COMPLETED|Overall Study|Completed upto Day 180|104
10400436|NCT00714285|11544507|FG000|NOT COMPLETED|Overall Study||0
10400437|NCT00714285|11544508|FG001|NOT COMPLETED|Overall Study||3
10400438|NCT00714285|11544509|FG002|NOT COMPLETED|Overall Study||0
10400439|NCT00714285|11544510|FG003|NOT COMPLETED|Overall Study||1
10400440|NCT00714311|11544524|FG000|STARTED|Overall Study||52
10400441|NCT00714311|11544525|FG001|STARTED|Overall Study||52
10400442|NCT00714311|11544524|FG000|COMPLETED|Overall Study||39
10400443|NCT00714311|11544525|FG001|COMPLETED|Overall Study||30
10400444|NCT00714311|11544524|FG000|NOT COMPLETED|Overall Study||13
10400445|NCT00714311|11544525|FG001|NOT COMPLETED|Overall Study||22
10400446|NCT00714389|11544531|FG000|STARTED|Overall Study||12
10400447|NCT00714389|11544531|FG000|COMPLETED|Overall Study||12
10400448|NCT00714389|11544531|FG000|NOT COMPLETED|Overall Study||0
10400449|NCT00714415|11544537|FG000|STARTED|Overall Study||25
10400450|NCT00714415|11544538|FG001|STARTED|Overall Study||55
10400451|NCT00714415|11544537|FG000|COMPLETED|Overall Study||23
10400452|NCT00714415|11544538|FG001|COMPLETED|Overall Study||55
10400453|NCT00714415|11544537|FG000|NOT COMPLETED|Overall Study||2
10400454|NCT00714415|11544538|FG001|NOT COMPLETED|Overall Study||0
10400455|NCT00714493|11544544|FG000|STARTED|Overall Study||203
10400456|NCT00714493|11544544|FG000|COMPLETED|Overall Study||154
10400457|NCT00714493|11544544|FG000|NOT COMPLETED|Overall Study||49
10400458|NCT00714571|11544554|FG000|STARTED|Stage 1||12
10400459|NCT00714571|11544555|FG001|STARTED|Stage 1|11 allocated to intervention, but 1 withdrew before the first intervention session|15
10400460|NCT00714571|11544556|FG002|STARTED|Stage 1||11
10400461|NCT00714571|11544557|FG003|STARTED|Stage 1||14
10400462|NCT00714571|11544558|FG004|STARTED|Stage 1||0
10400463|NCT00714571|11544559|FG005|STARTED|Stage 1||0
10813978|NCT02528097|11976524|FG000|NOT COMPLETED|Overall Study||0
10813979|NCT02528097|11976525|FG001|NOT COMPLETED|Overall Study||0
10813980|NCT02549716|11976533|FG000|STARTED|Overall Study||1
10813981|NCT02549716|11976534|FG001|STARTED|Overall Study||2
10813982|NCT02549716|11976533|FG000|COMPLETED|Overall Study||1
10813983|NCT02549716|11976534|FG001|COMPLETED|Overall Study||2
10813984|NCT02549716|11976533|FG000|NOT COMPLETED|Overall Study||0
10813985|NCT02549716|11976534|FG001|NOT COMPLETED|Overall Study||0
10813986|NCT02540434|11976542|FG000|STARTED|Overall Study||1
10813987|NCT02540434|11976543|FG001|STARTED|Overall Study||1
10813988|NCT02540434|11976542|FG000|COMPLETED|Overall Study||1
10813989|NCT02540434|11976543|FG001|COMPLETED|Overall Study||1
10813990|NCT02540434|11976542|FG000|NOT COMPLETED|Overall Study||0
10813991|NCT02540434|11976543|FG001|NOT COMPLETED|Overall Study||0
10400464|NCT00714571|11544554|FG000|COMPLETED|Stage 1|1 patient excluded who completed training but did not disclose ongoing chemotherapy for cancer|12
10400465|NCT00714571|11544555|FG001|COMPLETED|Stage 1||15
10400466|NCT00714571|11544556|FG002|COMPLETED|Stage 1||10
10400467|NCT00714571|11544557|FG003|COMPLETED|Stage 1||14
10400468|NCT00714571|11544558|FG004|COMPLETED|Stage 1||0
10400469|NCT00714571|11544559|FG005|COMPLETED|Stage 1||0
10400470|NCT00714571|11544554|FG000|NOT COMPLETED|Stage 1||0
10400471|NCT00714571|11544555|FG001|NOT COMPLETED|Stage 1||0
10400472|NCT00714571|11544556|FG002|NOT COMPLETED|Stage 1||1
10400473|NCT00714571|11544557|FG003|NOT COMPLETED|Stage 1||0
10400474|NCT00714571|11544558|FG004|NOT COMPLETED|Stage 1||0
10400475|NCT00714571|11544559|FG005|NOT COMPLETED|Stage 1||0
10400476|NCT00714571|11544554|FG000|STARTED|Stage 2||0
10400477|NCT00714571|11544555|FG001|STARTED|Stage 2||0
10400478|NCT00714571|11544556|FG002|STARTED|Stage 2||0
10400479|NCT00714571|11544557|FG003|STARTED|Stage 2||0
10400480|NCT00714571|11544558|FG004|STARTED|Stage 2||15
10400481|NCT00714571|11544559|FG005|STARTED|Stage 2||15
10400482|NCT00714571|11544554|FG000|COMPLETED|Stage 2||0
10400483|NCT00714571|11544555|FG001|COMPLETED|Stage 2||0
10400484|NCT00714571|11544556|FG002|COMPLETED|Stage 2||0
10400485|NCT00714571|11544557|FG003|COMPLETED|Stage 2||0
10400486|NCT00714571|11544558|FG004|COMPLETED|Stage 2||15
10400487|NCT00714571|11544559|FG005|COMPLETED|Stage 2||15
10400488|NCT00714571|11544554|FG000|NOT COMPLETED|Stage 2||0
10400489|NCT00714571|11544555|FG001|NOT COMPLETED|Stage 2||0
10400490|NCT00714571|11544556|FG002|NOT COMPLETED|Stage 2||0
10400491|NCT00714571|11544557|FG003|NOT COMPLETED|Stage 2||0
10400492|NCT00714571|11544558|FG004|NOT COMPLETED|Stage 2||0
10400493|NCT00714571|11544559|FG005|NOT COMPLETED|Stage 2||0
10400494|NCT00714688|11544576|FG000|STARTED|Overall Study||97
10312163|NCT00137631|11445501|FG001|Completed 6-month Follow-up|Overall Study|8 participants who were lost to follow-up at 3-months were retained at 6-months|133
10312164|NCT00137631|11445500|FG000|COMPLETED|Overall Study||127
10312165|NCT00137631|11445501|FG001|COMPLETED|Overall Study||133
10312166|NCT00137631|11445500|FG000|NOT COMPLETED|Overall Study||37
10312167|NCT00137631|11445501|FG001|NOT COMPLETED|Overall Study||41
10312168|NCT00137839|11445507|FG000|STARTED|Overall Study||84
10312169|NCT00137839|11445507|FG000|Treated|Overall Study||83
10721135|NCT02723201|11884812|FG001|COMPLETED|First Intervention Period||7
10721136|NCT02723201|11884813|FG002|COMPLETED|First Intervention Period||7
10721137|NCT02723201|11884811|FG000|NOT COMPLETED|First Intervention Period||0
10721138|NCT02723201|11884812|FG001|NOT COMPLETED|First Intervention Period||0
10721139|NCT02723201|11884813|FG002|NOT COMPLETED|First Intervention Period||0
10721140|NCT02723201|11884811|FG000|STARTED|Washout Period 1||11
10721141|NCT02723201|11884812|FG001|STARTED|Washout Period 1||7
10721142|NCT02723201|11884813|FG002|STARTED|Washout Period 1||7
10721143|NCT02723201|11884811|FG000|COMPLETED|Washout Period 1||11
10312170|NCT00137839|11445507|FG000|COMPLETED|Overall Study|Data on Reason Not Completed reflects Reason Off-Study|0
10312171|NCT00137839|11445507|FG000|NOT COMPLETED|Overall Study||84
10312172|NCT00137969|11445516|FG000|STARTED|Overall Study||174
10312173|NCT00137969|11445517|FG001|STARTED|Overall Study||88
10312174|NCT00137969|11445516|FG000|Received Study Drug|Overall Study||169
10312175|NCT00137969|11445517|FG001|Received Study Drug|Overall Study||88
10312176|NCT00137969|11445516|FG000|COMPLETED|Overall Study||107
10312177|NCT00137969|11445517|FG001|COMPLETED|Overall Study||67
10312178|NCT00137969|11445516|FG000|NOT COMPLETED|Overall Study||67
10312179|NCT00137969|11445517|FG001|NOT COMPLETED|Overall Study||21
10312180|NCT00138034|11445525|FG000|STARTED|Overall Study||26
10312181|NCT00138034|11445526|FG001|STARTED|Overall Study||23
10312182|NCT00138034|11445525|FG000|COMPLETED|Overall Study||23
10312183|NCT00138034|11445526|FG001|COMPLETED|Overall Study||20
10312184|NCT00138034|11445525|FG000|NOT COMPLETED|Overall Study||3
10400495|NCT00714688|11544577|FG001|STARTED|Overall Study||90
10400496|NCT00714688|11544578|FG002|STARTED|Overall Study||92
10312185|NCT00138034|11445526|FG001|NOT COMPLETED|Overall Study||3
10312186|NCT00138125|11445532|FG000|STARTED|Overall Study||2
10312187|NCT00138125|11445532|FG000|COMPLETED|Overall Study||2
10312188|NCT00138125|11445532|FG000|NOT COMPLETED|Overall Study||0
10312189|NCT00138203|11445537|FG000|STARTED|Overall Study||16
10400497|NCT00714688|11544576|FG000|COMPLETED|Overall Study||68
10312190|NCT00138203|11445537|FG000|COMPLETED|Overall Study||16
10312191|NCT00138203|11445537|FG000|NOT COMPLETED|Overall Study||0
10312192|NCT00138294|11445542|FG000|STARTED|Overall Study||29255
10312193|NCT00138294|11445542|FG000|COMPLETED|Overall Study||29255
10721144|NCT02723201|11884812|FG001|COMPLETED|Washout Period 1||7
10543918|NCT01486784|11697059|FG004|Received Treatment|Overall Study||3
10543919|NCT01486784|11697060|FG005|Received Treatment|Overall Study||2
10543920|NCT01486784|11697055|FG000|COMPLETED|Overall Study||3
10543921|NCT01486784|11697056|FG001|COMPLETED|Overall Study||7
10543922|NCT01486784|11697057|FG002|COMPLETED|Overall Study||5
10543923|NCT01486784|11697058|FG003|COMPLETED|Overall Study||1
10400498|NCT00714688|11544577|FG001|COMPLETED|Overall Study||55
10400499|NCT00714688|11544578|FG002|COMPLETED|Overall Study||55
10400500|NCT00714688|11544576|FG000|NOT COMPLETED|Overall Study||29
10400501|NCT00714688|11544577|FG001|NOT COMPLETED|Overall Study||35
10400502|NCT00714688|11544578|FG002|NOT COMPLETED|Overall Study||37
10400503|NCT00714714|11544586|FG000|STARTED|Overall Study||25
10400504|NCT00714714|11544586|FG000|COMPLETED|Overall Study||24
10400505|NCT00714714|11544586|FG000|NOT COMPLETED|Overall Study||1
10400506|NCT00714753|11544592|FG000|STARTED|Overall Study||5
10400507|NCT00714753|11544592|FG000|HDR Brachytherapy|Overall Study||5
10400508|NCT00714753|11544592|FG000|External Beam Radiotherapy (EBRT)|Overall Study||1
10400509|NCT00714753|11544592|FG000|COMPLETED|Overall Study||5
10400510|NCT00714753|11544592|FG000|NOT COMPLETED|Overall Study||0
10400511|NCT00714792|11544598|FG000|STARTED|Overall Study||10
10400512|NCT00714792|11544599|FG001|STARTED|Overall Study||8
10400513|NCT00714792|11544598|FG000|COMPLETED|Overall Study||10
10400514|NCT00714792|11544599|FG001|COMPLETED|Overall Study||8
10400515|NCT00714792|11544598|FG000|NOT COMPLETED|Overall Study||0
10400516|NCT00714792|11544599|FG001|NOT COMPLETED|Overall Study||0
10400517|NCT00714870|11544607|FG000|STARTED|Overall Study||49
10400518|NCT00714870|11544608|FG001|STARTED|Overall Study||27
10400519|NCT00714870|11544607|FG000|COMPLETED|Overall Study||22
10400520|NCT00714870|11544608|FG001|COMPLETED|Overall Study||22
10400521|NCT00714870|11544607|FG000|NOT COMPLETED|Overall Study||27
10400522|NCT00714870|11544608|FG001|NOT COMPLETED|Overall Study||5
10400523|NCT00715026|11544614|FG000|STARTED|Overall Study|30 unilateral subjects and 1 bilateral|31
10400524|NCT00715026|11544614|FG000|Subjects That Received Surgery|Overall Study|24 unilateral subjects and 1 bilateral|25
10400525|NCT00715026|11544614|FG000|COMPLETED|Overall Study|20 unilateral subjects and 1 bilateral|21
10400526|NCT00715026|11544614|FG000|NOT COMPLETED|Overall Study||10
10400527|NCT00715078|11544621|FG000|STARTED|Overall Study||41
10400528|NCT00715078|11544622|FG001|STARTED|Overall Study||40
10400529|NCT00715078|11544623|FG002|STARTED|Overall Study||41
10400530|NCT00715078|11544621|FG000|Received ≥ 1 Study Infusion|Overall Study||40
10659490|NCT02242903|11820908|FG006|STARTED|Overall Study||6
10659491|NCT02242903|11820902|FG000|Received at Least One Dose of Study Drug|Overall Study||12
10659492|NCT02242903|11820903|FG001|Received at Least One Dose of Study Drug|Overall Study||6
10659493|NCT02242903|11820904|FG002|Received at Least One Dose of Study Drug|Overall Study||6
10659494|NCT02242903|11820905|FG003|Received at Least One Dose of Study Drug|Overall Study||6
10659495|NCT02242903|11820906|FG004|Received at Least One Dose of Study Drug|Overall Study||6
10659496|NCT02242903|11820907|FG005|Received at Least One Dose of Study Drug|Overall Study||6
10659497|NCT02242903|11820908|FG006|Received at Least One Dose of Study Drug|Overall Study||6
10659498|NCT02242903|11820902|FG000|COMPLETED|Overall Study||11
10659499|NCT02242903|11820903|FG001|COMPLETED|Overall Study||6
10721145|NCT02723201|11884813|FG002|COMPLETED|Washout Period 1||7
10721146|NCT02723201|11884811|FG000|NOT COMPLETED|Washout Period 1||0
10721147|NCT02723201|11884812|FG001|NOT COMPLETED|Washout Period 1||0
10400531|NCT00715078|11544622|FG001|Received ≥ 1 Study Infusion|Overall Study||40
10400532|NCT00715078|11544623|FG002|Received ≥ 1 Study Infusion|Overall Study||39
10312194|NCT00138294|11445542|FG000|NOT COMPLETED|Overall Study||0
10312195|NCT00138424|11445552|FG000|STARTED|Overall Study||9
10312196|NCT00138424|11445553|FG001|STARTED|Overall Study||5
10312197|NCT00138424|11445554|FG002|STARTED|Overall Study||5
10312198|NCT00138424|11445555|FG003|STARTED|Overall Study||3
10400533|NCT00715078|11544621|FG000|Received ≥ 1 Leukapheresis|Overall Study||40
10400534|NCT00715078|11544622|FG001|Received ≥ 1 Leukapheresis|Overall Study||40
10400535|NCT00715078|11544623|FG002|Received ≥ 1 Leukapheresis|Overall Study||40
10400536|NCT00715078|11544621|FG000|COMPLETED|Overall Study||11
10400537|NCT00715078|11544622|FG001|COMPLETED|Overall Study||4
10400538|NCT00715078|11544623|FG002|COMPLETED|Overall Study||3
10400539|NCT00715078|11544621|FG000|NOT COMPLETED|Overall Study||30
10400540|NCT00715078|11544622|FG001|NOT COMPLETED|Overall Study||36
10400541|NCT00715078|11544623|FG002|NOT COMPLETED|Overall Study||38
10400542|NCT00715104|11544634|FG000|STARTED|Overall Study||18
10400543|NCT00715104|11544635|FG001|STARTED|Overall Study||16
10400544|NCT00715104|11544636|FG002|STARTED|Overall Study||8
10400545|NCT00715104|11544634|FG000|COMPLETED|Overall Study||18
10400546|NCT00715104|11544635|FG001|COMPLETED|Overall Study||16
10659500|NCT02242903|11820904|FG002|COMPLETED|Overall Study||6
10659501|NCT02242903|11820905|FG003|COMPLETED|Overall Study||6
10659502|NCT02242903|11820906|FG004|COMPLETED|Overall Study||6
10659503|NCT02242903|11820907|FG005|COMPLETED|Overall Study||6
10659504|NCT02242903|11820908|FG006|COMPLETED|Overall Study||6
10400547|NCT00715104|11544636|FG002|COMPLETED|Overall Study||8
10400548|NCT00715104|11544634|FG000|NOT COMPLETED|Overall Study||0
10400549|NCT00715104|11544635|FG001|NOT COMPLETED|Overall Study||0
10400550|NCT00715104|11544636|FG002|NOT COMPLETED|Overall Study||0
10400551|NCT00715117|11544680|FG000|STARTED|Overall Study||6
10400552|NCT00715117|11544681|FG001|STARTED|Overall Study||6
10400553|NCT00715117|11544680|FG000|Completion fo 8 Week Study|Overall Study||6
10400554|NCT00715117|11544681|FG001|Completion fo 8 Week Study|Overall Study||6
10400555|NCT00715117|11544680|FG000|COMPLETED|Overall Study||6
10400556|NCT00715117|11544681|FG001|COMPLETED|Overall Study|One subject flared and was rescued with steroids|5
10400557|NCT00715117|11544680|FG000|NOT COMPLETED|Overall Study||0
10400558|NCT00715117|11544681|FG001|NOT COMPLETED|Overall Study||1
10400559|NCT00715208|11544694|FG000|STARTED|Overall Study||7
10400560|NCT00715208|11544695|FG001|STARTED|Overall Study||48
10400561|NCT00715208|11544694|FG000|COMPLETED|Overall Study||6
10400562|NCT00715208|11544695|FG001|COMPLETED|Overall Study||39
10400563|NCT00715208|11544694|FG000|NOT COMPLETED|Overall Study||1
10400564|NCT00715208|11544695|FG001|NOT COMPLETED|Overall Study||9
10400565|NCT00715299|11544701|FG000|STARTED|Overall Study|A total of 38 participants were consented to the study, but only 36 made it to day one of testing.|36
10400566|NCT00715299|11544701|FG000|COMPLETED|Overall Study||30
10400567|NCT00715299|11544701|FG000|NOT COMPLETED|Overall Study||6
10400568|NCT00715390|11544705|FG000|STARTED|Overall Study|114,209 Anesthetic records were screened to identify 234 records.|234
10400569|NCT00715390|11544705|FG000|Eligible|Overall Study||234
10400570|NCT00715390|11544705|FG000|COMPLETED|Overall Study|These were broken down to different types of dysrhythymia.|234
10400571|NCT00715390|11544705|FG000|NOT COMPLETED|Overall Study||0
10400572|NCT00715403|11544716|FG000|STARTED|Overall Study||1
10400573|NCT00715403|11544717|FG001|STARTED|Overall Study||1
10400574|NCT00715403|11544718|FG002|STARTED|Overall Study||4
10400575|NCT00715403|11544719|FG003|STARTED|Overall Study||9
10400576|NCT00715403|11544720|FG004|STARTED|Overall Study||6
10400577|NCT00715403|11544721|FG005|STARTED|Overall Study||19
10400578|NCT00715403|11544722|FG006|STARTED|Overall Study||1
10400579|NCT00715403|11544716|FG000|COMPLETED|Overall Study||0
10400580|NCT00715403|11544717|FG001|COMPLETED|Overall Study||0
10400581|NCT00715403|11544718|FG002|COMPLETED|Overall Study||0
10400582|NCT00715403|11544719|FG003|COMPLETED|Overall Study||0
10400583|NCT00715403|11544720|FG004|COMPLETED|Overall Study||0
10400584|NCT00715403|11544721|FG005|COMPLETED|Overall Study||0
10400585|NCT00715403|11544722|FG006|COMPLETED|Overall Study||0
10400586|NCT00715403|11544716|FG000|NOT COMPLETED|Overall Study||1
10400587|NCT00715403|11544717|FG001|NOT COMPLETED|Overall Study||1
10400588|NCT00715403|11544718|FG002|NOT COMPLETED|Overall Study||4
10400589|NCT00715403|11544719|FG003|NOT COMPLETED|Overall Study||9
10400590|NCT00715403|11544720|FG004|NOT COMPLETED|Overall Study||6
10400591|NCT00715403|11544721|FG005|NOT COMPLETED|Overall Study||19
10400592|NCT00715403|11544722|FG006|NOT COMPLETED|Overall Study||1
10400593|NCT00715429|11544740|FG000|STARTED|Overall Study||7
10400594|NCT00715429|11544741|FG001|STARTED|Overall Study||7
10813995|NCT02533531|11976555|FG000|STARTED|Overall Study||1
10813996|NCT02533531|11976555|FG000|COMPLETED|Overall Study||0
10813997|NCT02533531|11976555|FG000|NOT COMPLETED|Overall Study||1
10813998|NCT02534038|11976561|FG000|STARTED|Period 1 (6 Weeks)||1
10813999|NCT02534038|11976562|FG001|STARTED|Period 1 (6 Weeks)||0
10814000|NCT02534038|11976561|FG000|COMPLETED|Period 1 (6 Weeks)||1
10814001|NCT02534038|11976562|FG001|COMPLETED|Period 1 (6 Weeks)||0
10814002|NCT02534038|11976561|FG000|NOT COMPLETED|Period 1 (6 Weeks)||0
10814003|NCT02534038|11976562|FG001|NOT COMPLETED|Period 1 (6 Weeks)||0
10814004|NCT02534038|11976561|FG000|STARTED|Period 2 (6 Weeks)||1
10400595|NCT00715429|11544740|FG000|COMPLETED|Overall Study||7
10400596|NCT00715429|11544741|FG001|COMPLETED|Overall Study||6
10400597|NCT00715429|11544740|FG000|NOT COMPLETED|Overall Study||0
10400598|NCT00715429|11544741|FG001|NOT COMPLETED|Overall Study||1
10400599|NCT00715520|11544750|FG000|STARTED|Overall Study||20
10400600|NCT00715520|11544751|FG001|STARTED|Overall Study||10
10814005|NCT02534038|11976562|FG001|STARTED|Period 2 (6 Weeks)||0
10814006|NCT02534038|11976561|FG000|COMPLETED|Period 2 (6 Weeks)||1
10400601|NCT00715520|11544752|FG002|STARTED|Overall Study||3
10400602|NCT00715520|11544750|FG000|COMPLETED|Overall Study||10
10659505|NCT02242903|11820902|FG000|NOT COMPLETED|Overall Study||1
10659506|NCT02242903|11820903|FG001|NOT COMPLETED|Overall Study||0
10659507|NCT02242903|11820904|FG002|NOT COMPLETED|Overall Study||0
10659508|NCT02242903|11820905|FG003|NOT COMPLETED|Overall Study||0
10659509|NCT02242903|11820906|FG004|NOT COMPLETED|Overall Study||0
10659510|NCT02242903|11820907|FG005|NOT COMPLETED|Overall Study||0
10400603|NCT00715520|11544751|FG001|COMPLETED|Overall Study||9
10400604|NCT00715520|11544752|FG002|COMPLETED|Overall Study||1
10400605|NCT00715520|11544750|FG000|NOT COMPLETED|Overall Study||10
10400606|NCT00715520|11544751|FG001|NOT COMPLETED|Overall Study||1
10400607|NCT00715520|11544752|FG002|NOT COMPLETED|Overall Study||2
10400608|NCT00715559|11544760|FG000|STARTED|Overall Study||3
10400609|NCT00715559|11544760|FG000|COMPLETED|Overall Study||2
10400610|NCT00715559|11544760|FG000|NOT COMPLETED|Overall Study||1
10400611|NCT00715624|11544766|FG000|STARTED|Overall Study|Randomized|167
10400612|NCT00715624|11544767|FG001|STARTED|Overall Study||329
10400613|NCT00715624|11544766|FG000|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|167
10400614|NCT00715624|11544767|FG001|Treated/Safety Population|Overall Study||328
10400615|NCT00715624|11544766|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|166
10400616|NCT00715624|11544767|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||327
10400617|NCT00715624|11544766|FG000|COMPLETED|Overall Study||115
10400618|NCT00715624|11544767|FG001|COMPLETED|Overall Study||213
10400619|NCT00715624|11544766|FG000|NOT COMPLETED|Overall Study||52
10400620|NCT00715624|11544767|FG001|NOT COMPLETED|Overall Study||116
10400621|NCT00715650|11544775|FG000|STARTED|Intervention||47
10659511|NCT02242903|11820908|FG006|NOT COMPLETED|Overall Study||0
10659512|NCT02242981|11820930|FG000|STARTED|Overall Study||6
10659513|NCT02242981|11820930|FG000|Received Study Drug|Overall Study||6
10659514|NCT02242981|11820930|FG000|COMPLETED|Overall Study||5
10659515|NCT02242981|11820930|FG000|NOT COMPLETED|Overall Study||1
10659516|NCT02242994|11820934|FG000|STARTED|Overall Study||5
10659517|NCT02242994|11820934|FG000|COMPLETED|Overall Study||5
10659518|NCT02242994|11820934|FG000|NOT COMPLETED|Overall Study||0
10721148|NCT02723201|11884813|FG002|NOT COMPLETED|Washout Period 1||0
10721149|NCT02723201|11884811|FG000|STARTED|Second Intervention Period||11
10721150|NCT02723201|11884812|FG001|STARTED|Second Intervention Period||7
10721151|NCT02723201|11884813|FG002|STARTED|Second Intervention Period||7
10721152|NCT02723201|11884811|FG000|COMPLETED|Second Intervention Period||9
10400622|NCT00715650|11544776|FG001|STARTED|Intervention||45
10721153|NCT02723201|11884812|FG001|COMPLETED|Second Intervention Period||7
10400623|NCT00715650|11544775|FG000|Received Any Session|Intervention||39
10400624|NCT00715650|11544776|FG001|Received Any Session|Intervention||38
10400625|NCT00715650|11544775|FG000|Attended ≥ 2 Sessions|Intervention||36
10400626|NCT00715650|11544776|FG001|Attended ≥ 2 Sessions|Intervention||33
10400627|NCT00715650|11544775|FG000|Attended ≥ 3 Sessions|Intervention||23
10400628|NCT00715650|11544776|FG001|Attended ≥ 3 Sessions|Intervention||17
10400629|NCT00715650|11544775|FG000|COMPLETED|Intervention||42
10400630|NCT00715650|11544776|FG001|COMPLETED|Intervention||42
10400631|NCT00715650|11544775|FG000|NOT COMPLETED|Intervention||5
10400632|NCT00715650|11544776|FG001|NOT COMPLETED|Intervention||3
10400633|NCT00715650|11544775|FG000|STARTED|Follow-up||42
10400634|NCT00715650|11544776|FG001|STARTED|Follow-up||42
10400635|NCT00715650|11544775|FG000|Completed Month 1 Follow-up|Follow-up||40
10400636|NCT00715650|11544776|FG001|Completed Month 1 Follow-up|Follow-up||38
10400637|NCT00715650|11544775|FG000|Completed Month 3 Follow-up|Follow-up||35
10400638|NCT00715650|11544776|FG001|Completed Month 3 Follow-up|Follow-up||40
10400639|NCT00715650|11544775|FG000|Completed Month 6 Follow-up|Follow-up||29
10400640|NCT00715650|11544776|FG001|Completed Month 6 Follow-up|Follow-up||37
10400641|NCT00715650|11544775|FG000|COMPLETED|Follow-up||29
10400642|NCT00715650|11544776|FG001|COMPLETED|Follow-up||37
10400643|NCT00715650|11544775|FG000|NOT COMPLETED|Follow-up||13
10400644|NCT00715650|11544776|FG001|NOT COMPLETED|Follow-up||5
10400685|NCT00715793|11544827|FG000|NOT COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
10400645|NCT00715676|11544785|FG000|STARTED|Overall Study|1 additional subject was enrolled in the placebo group but discontinued before taking any study drug|49
10400646|NCT00715676|11544786|FG001|STARTED|Overall Study||54
10400647|NCT00715676|11544787|FG002|STARTED|Overall Study||53
10400648|NCT00715676|11544785|FG000|COMPLETED|Overall Study||43
10400649|NCT00715676|11544786|FG001|COMPLETED|Overall Study||43
10400650|NCT00715676|11544787|FG002|COMPLETED|Overall Study||21
10400651|NCT00715676|11544785|FG000|NOT COMPLETED|Overall Study||6
10400652|NCT00715676|11544786|FG001|NOT COMPLETED|Overall Study||11
10400653|NCT00715676|11544787|FG002|NOT COMPLETED|Overall Study||32
10659519|NCT02243007|11820940|FG000|STARTED|Overall Study||4
10659520|NCT02243007|11820941|FG001|STARTED|Overall Study||3
10659521|NCT02243007|11820940|FG000|COMPLETED|Overall Study||4
10659522|NCT02243007|11820941|FG001|COMPLETED|Overall Study||3
10659523|NCT02243007|11820940|FG000|NOT COMPLETED|Overall Study||0
10659524|NCT02243007|11820941|FG001|NOT COMPLETED|Overall Study||0
10659525|NCT02243046|11820950|FG000|STARTED|Overall Study||55
10659526|NCT02243046|11820951|FG001|STARTED|Overall Study||54
10659527|NCT02243046|11820952|FG002|STARTED|Overall Study||53
10659528|NCT02243046|11820950|FG000|3 Month|Overall Study|1 subject didn't return for 3 month clinic visit|54
10659529|NCT02243046|11820951|FG001|3 Month|Overall Study|1 subject didn't return for 3 month clinic visit|53
10659530|NCT02243046|11820952|FG002|3 Month|Overall Study|2 subjects didn't return for 3 month clinic visit|51
10659531|NCT02243046|11820950|FG000|6 Month|Overall Study||54
10659532|NCT02243046|11820951|FG001|6 Month|Overall Study||53
10659533|NCT02243046|11820952|FG002|6 Month|Overall Study|2 subjects didn't return for 6 month clinic visit|49
10659534|NCT02243046|11820950|FG000|COMPLETED|Overall Study||54
10659535|NCT02243046|11820951|FG001|COMPLETED|Overall Study||53
10659536|NCT02243046|11820952|FG002|COMPLETED|Overall Study||49
10659537|NCT02243046|11820950|FG000|NOT COMPLETED|Overall Study||1
10659538|NCT02243046|11820951|FG001|NOT COMPLETED|Overall Study||1
10659539|NCT02243046|11820952|FG002|NOT COMPLETED|Overall Study||4
10659540|NCT02243176|11820962|FG000|STARTED|Overall Study|3 of the randomized subjects withdrew before taking any medication|244
10659541|NCT02243176|11820963|FG001|STARTED|Overall Study||244
10659542|NCT02243176|11820962|FG000|COMPLETED|Overall Study||230
10659543|NCT02243176|11820963|FG001|COMPLETED|Overall Study||229
10659544|NCT02243176|11820962|FG000|NOT COMPLETED|Overall Study||14
10659545|NCT02243176|11820963|FG001|NOT COMPLETED|Overall Study||15
10659546|NCT02243202|11820973|FG000|STARTED|Overall Study||82
10659547|NCT02243202|11820974|FG001|STARTED|Overall Study||85
10659548|NCT02243202|11820975|FG002|STARTED|Overall Study||84
10659549|NCT02243202|11820976|FG003|STARTED|Overall Study||84
10659550|NCT02243202|11820973|FG000|Treated|Overall Study||82
10659551|NCT02243202|11820974|FG001|Treated|Overall Study||85
10659552|NCT02243202|11820975|FG002|Treated|Overall Study||84
10659553|NCT02243202|11820976|FG003|Treated|Overall Study||83
10659554|NCT02243202|11820973|FG000|COMPLETED|Overall Study||57
10659555|NCT02243202|11820974|FG001|COMPLETED|Overall Study||60
10814007|NCT02534038|11976562|FG001|COMPLETED|Period 2 (6 Weeks)||0
10814008|NCT02534038|11976561|FG000|NOT COMPLETED|Period 2 (6 Weeks)||0
10814009|NCT02534038|11976562|FG001|NOT COMPLETED|Period 2 (6 Weeks)||0
10814010|NCT02520726|11976571|FG000|STARTED|Overall Study||3
10814011|NCT02520726|11976572|FG001|STARTED|Overall Study||2
10814012|NCT02520726|11976571|FG000|COMPLETED|Overall Study||0
10814013|NCT02520726|11976572|FG001|COMPLETED|Overall Study||0
10814014|NCT02520726|11976571|FG000|NOT COMPLETED|Overall Study||3
10814015|NCT02520726|11976572|FG001|NOT COMPLETED|Overall Study||2
10400654|NCT00715728|11544797|FG000|STARTED|Overall Study||14
10400655|NCT00715728|11544798|FG001|STARTED|Overall Study||14
10400656|NCT00715728|11544797|FG000|COMPLETED|Overall Study||14
10659556|NCT02243202|11820975|FG002|COMPLETED|Overall Study||53
10659557|NCT02243202|11820976|FG003|COMPLETED|Overall Study||61
10659558|NCT02243202|11820973|FG000|NOT COMPLETED|Overall Study||25
10400657|NCT00715728|11544798|FG001|COMPLETED|Overall Study||14
10400658|NCT00715728|11544797|FG000|NOT COMPLETED|Overall Study||0
10400659|NCT00715728|11544798|FG001|NOT COMPLETED|Overall Study||0
10400660|NCT00715741|11544810|FG000|STARTED|Overall Study||25
10400661|NCT00715741|11544811|FG001|STARTED|Overall Study||25
10400662|NCT00715741|11544812|FG002|STARTED|Overall Study||25
10400663|NCT00715741|11544813|FG003|STARTED|Overall Study||25
10400664|NCT00715741|11544810|FG000|COMPLETED|Overall Study||25
10400665|NCT00715741|11544811|FG001|COMPLETED|Overall Study||25
10400666|NCT00715741|11544812|FG002|COMPLETED|Overall Study||25
10400667|NCT00715741|11544813|FG003|COMPLETED|Overall Study||25
10400668|NCT00715741|11544810|FG000|NOT COMPLETED|Overall Study||0
10400669|NCT00715741|11544811|FG001|NOT COMPLETED|Overall Study||0
10400670|NCT00715741|11544812|FG002|NOT COMPLETED|Overall Study||0
10400671|NCT00715741|11544813|FG003|NOT COMPLETED|Overall Study||0
10400672|NCT00715754|11544823|FG000|STARTED|Overall Study||47
10400673|NCT00715754|11544823|FG000|COMPLETED|Overall Study||47
10400674|NCT00715754|11544823|FG000|NOT COMPLETED|Overall Study||0
10400675|NCT00715793|11544827|FG000|STARTED|Phase 1 RP2D DAC + TMZ||4
10400676|NCT00715793|11544828|FG001|STARTED|Phase 1 RP2D DAC + TMZ||6
10400677|NCT00715793|11544827|FG000|COMPLETED|Phase 1 RP2D DAC + TMZ||3
10400678|NCT00715793|11544828|FG001|COMPLETED|Phase 1 RP2D DAC + TMZ||6
10400679|NCT00715793|11544827|FG000|NOT COMPLETED|Phase 1 RP2D DAC + TMZ||1
10400680|NCT00715793|11544828|FG001|NOT COMPLETED|Phase 1 RP2D DAC + TMZ||0
10400681|NCT00715793|11544827|FG000|STARTED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
10400682|NCT00715793|11544828|FG001|STARTED|Phase 2 DAC (0.15 mg/kg) + TMZ||29
10400683|NCT00715793|11544827|FG000|COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
10400684|NCT00715793|11544828|FG001|COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||27
10721154|NCT02723201|11884813|FG002|COMPLETED|Second Intervention Period||7
10721155|NCT02723201|11884811|FG000|NOT COMPLETED|Second Intervention Period||2
10721156|NCT02723201|11884812|FG001|NOT COMPLETED|Second Intervention Period||0
10721157|NCT02723201|11884813|FG002|NOT COMPLETED|Second Intervention Period||0
10721158|NCT02723201|11884811|FG000|STARTED|Washout Period 2||9
10400686|NCT00715793|11544828|FG001|NOT COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||2
10400687|NCT00715884|11544837|FG000|STARTED|Overall Study||452
10400688|NCT00715884|11544838|FG001|STARTED|Overall Study||226
10400689|NCT00715884|11544837|FG000|COMPLETED|Overall Study||444
10400690|NCT00715884|11544838|FG001|COMPLETED|Overall Study||225
10400691|NCT00715884|11544837|FG000|NOT COMPLETED|Overall Study||8
10400692|NCT00715884|11544838|FG001|NOT COMPLETED|Overall Study||1
10400693|NCT00715910|11544848|FG000|STARTED|Year 1||433
10400694|NCT00715910|11544849|FG001|STARTED|Year 1||147
10400695|NCT00715910|11544850|FG002|STARTED|Year 1||68
10400696|NCT00715910|11544851|FG003|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
10400697|NCT00715910|11544852|FG004|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
10400698|NCT00715910|11544853|FG005|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
10400699|NCT00715910|11544848|FG000|COMPLETED|Year 1||433
10543924|NCT01486784|11697059|FG004|COMPLETED|Overall Study||3
10543925|NCT01486784|11697060|FG005|COMPLETED|Overall Study||2
10543926|NCT01486784|11697055|FG000|NOT COMPLETED|Overall Study||0
10543927|NCT01486784|11697056|FG001|NOT COMPLETED|Overall Study||0
10543928|NCT01486784|11697057|FG002|NOT COMPLETED|Overall Study||1
10543929|NCT01486784|11697058|FG003|NOT COMPLETED|Overall Study||0
10543930|NCT01486784|11697059|FG004|NOT COMPLETED|Overall Study||2
10543931|NCT01486784|11697060|FG005|NOT COMPLETED|Overall Study||3
10543932|NCT01486810|11697074|FG000|STARTED|Overall Study||17
10543933|NCT01486810|11697074|FG000|COMPLETED|Overall Study||9
10543934|NCT01486810|11697074|FG000|NOT COMPLETED|Overall Study||8
10543935|NCT01486927|11697078|FG000|STARTED|Overall Study||174
10659559|NCT02243202|11820974|FG001|NOT COMPLETED|Overall Study||25
10659560|NCT02243202|11820975|FG002|NOT COMPLETED|Overall Study||31
10659561|NCT02243202|11820976|FG003|NOT COMPLETED|Overall Study||23
10659562|NCT02243280|11820997|FG000|STARTED|Enrolled||40
10659563|NCT02243280|11820998|FG001|STARTED|Enrolled||39
10721159|NCT02723201|11884812|FG001|STARTED|Washout Period 2||0
10721160|NCT02723201|11884813|FG002|STARTED|Washout Period 2||0
10721161|NCT02723201|11884811|FG000|COMPLETED|Washout Period 2||9
10721162|NCT02723201|11884812|FG001|COMPLETED|Washout Period 2||0
10721163|NCT02723201|11884813|FG002|COMPLETED|Washout Period 2||0
10721164|NCT02723201|11884811|FG000|NOT COMPLETED|Washout Period 2||0
10721165|NCT02723201|11884812|FG001|NOT COMPLETED|Washout Period 2||0
10721166|NCT02723201|11884813|FG002|NOT COMPLETED|Washout Period 2||0
10814016|NCT02520297|11976578|FG000|STARTED|Overall Study||1
10814017|NCT02520297|11976578|FG000|COMPLETED|Overall Study||1
10814018|NCT02520297|11976578|FG000|NOT COMPLETED|Overall Study||0
10814019|NCT02519712|11976582|FG000|STARTED|Overall Study||4
10814020|NCT02519712|11976582|FG000|COMPLETED|Overall Study||0
10814021|NCT02519712|11976582|FG000|NOT COMPLETED|Overall Study||4
10814022|NCT02518750|11976586|FG000|STARTED|Overall Study||3
10814023|NCT02518750|11976586|FG000|COMPLETED|Overall Study||1
10814024|NCT02518750|11976586|FG000|NOT COMPLETED|Overall Study||2
10814025|NCT02516228|11976590|FG000|STARTED|Overall Study||6
10814026|NCT02516228|11976590|FG000|COMPLETED|Overall Study||3
10814027|NCT02516228|11976590|FG000|NOT COMPLETED|Overall Study||3
10814028|NCT02515851|11976596|FG000|STARTED|Overall Study||15
10814029|NCT02515851|11976597|FG001|STARTED|Overall Study||15
10814030|NCT02515851|11976596|FG000|COMPLETED|Overall Study||15
10400700|NCT00715910|11544849|FG001|COMPLETED|Year 1||147
10400701|NCT00715910|11544850|FG002|COMPLETED|Year 1||68
10428856|NCT00861146|11574964|FG001|COMPLETED|Overall Study||38
10428857|NCT00861146|11574963|FG000|NOT COMPLETED|Overall Study||20
10428858|NCT00861146|11574964|FG001|NOT COMPLETED|Overall Study||8
10428859|NCT00861198|11574970|FG000|STARTED|Overall Study||75
10428860|NCT00861198|11574970|FG000|COMPLETED|Overall Study||70
10428861|NCT00861198|11574970|FG000|NOT COMPLETED|Overall Study||5
10428862|NCT00861263|11574974|FG000|STARTED|Overall Study||193
10428863|NCT00861263|11574974|FG000|COMPLETED|Overall Study||193
10428864|NCT00861263|11574974|FG000|NOT COMPLETED|Overall Study||0
10543936|NCT01486927|11697078|FG000|COMPLETED|Overall Study||161
10543937|NCT01486927|11697078|FG000|NOT COMPLETED|Overall Study||13
10543938|NCT01486966|11697091|FG000|STARTED|Overall Study||29
10543939|NCT01486966|11697092|FG001|STARTED|Overall Study||29
10543940|NCT01486966|11697091|FG000|COMPLETED|Overall Study||29
10543941|NCT01486966|11697092|FG001|COMPLETED|Overall Study||27
10543942|NCT01486966|11697091|FG000|NOT COMPLETED|Overall Study||0
10543943|NCT01486966|11697092|FG001|NOT COMPLETED|Overall Study||2
10543944|NCT01487161|11697102|FG000|STARTED|Overall Study||58
10543945|NCT01487161|11697103|FG001|STARTED|Overall Study||59
10543946|NCT01487161|11697104|FG002|STARTED|Overall Study||60
10543947|NCT01487161|11697105|FG003|STARTED|Overall Study||52
10543948|NCT01487161|11697102|FG000|COMPLETED|Overall Study||56
10543949|NCT01487161|11697103|FG001|COMPLETED|Overall Study||57
10543950|NCT01487161|11697104|FG002|COMPLETED|Overall Study||59
10312199|NCT00138424|11445552|FG000|COMPLETED|Overall Study||9
10312200|NCT00138424|11445553|FG001|COMPLETED|Overall Study||4
10312201|NCT00138424|11445554|FG002|COMPLETED|Overall Study||5
10312202|NCT00138424|11445555|FG003|COMPLETED|Overall Study||3
10312203|NCT00138424|11445552|FG000|NOT COMPLETED|Overall Study||0
10312204|NCT00138424|11445553|FG001|NOT COMPLETED|Overall Study||1
10312205|NCT00138424|11445554|FG002|NOT COMPLETED|Overall Study||0
10312206|NCT00138424|11445555|FG003|NOT COMPLETED|Overall Study||0
10312207|NCT00138645|11445569|FG000|STARTED|Overall Study||30
10312208|NCT00138645|11445570|FG001|STARTED|Overall Study||30
10312209|NCT00138645|11445569|FG000|COMPLETED|Overall Study||24
10312210|NCT00138645|11445570|FG001|COMPLETED|Overall Study||23
10312211|NCT00138645|11445569|FG000|NOT COMPLETED|Overall Study||6
10312212|NCT00138645|11445570|FG001|NOT COMPLETED|Overall Study||7
10312213|NCT00138658|11445576|FG000|STARTED|Overall Study||81
10312214|NCT00138658|11445576|FG000|COMPLETED|Overall Study||20
10312215|NCT00138658|11445576|FG000|NOT COMPLETED|Overall Study||61
10312216|NCT00138671|11445584|FG000|STARTED|Overall Study||59
10312217|NCT00138671|11445585|FG001|STARTED|Overall Study||46
10312218|NCT00138671|11445584|FG000|COMPLETED|Overall Study||46
10312219|NCT00138671|11445585|FG001|COMPLETED|Overall Study||30
10312220|NCT00138671|11445584|FG000|NOT COMPLETED|Overall Study||13
10312221|NCT00138671|11445585|FG001|NOT COMPLETED|Overall Study||16
10312222|NCT00139399|11445595|FG000|STARTED|Overall Study||60
10312223|NCT00139399|11445596|FG001|STARTED|Overall Study||82
10312224|NCT00139399|11445595|FG000|COMPLETED|Overall Study||44
10312225|NCT00139399|11445596|FG001|COMPLETED|Overall Study||59
10312226|NCT00139399|11445595|FG000|NOT COMPLETED|Overall Study||16
10312227|NCT00139399|11445596|FG001|NOT COMPLETED|Overall Study||23
10312228|NCT00139477|11445604|FG000|STARTED|First Intervention -Baseline to 6Months||31
10312229|NCT00139477|11445605|FG001|STARTED|First Intervention -Baseline to 6Months||35
10312230|NCT00139477|11445604|FG000|COMPLETED|First Intervention -Baseline to 6Months||19
10312231|NCT00139477|11445605|FG001|COMPLETED|First Intervention -Baseline to 6Months||23
10312232|NCT00139477|11445604|FG000|NOT COMPLETED|First Intervention -Baseline to 6Months||12
10312233|NCT00139477|11445605|FG001|NOT COMPLETED|First Intervention -Baseline to 6Months||12
10312234|NCT00139477|11445604|FG000|STARTED|Second Intervention -6Months to 12Months||19
10312235|NCT00139477|11445605|FG001|STARTED|Second Intervention -6Months to 12Months||23
10400702|NCT00715910|11544851|FG003|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
10400703|NCT00715910|11544852|FG004|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
10400704|NCT00715910|11544853|FG005|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
10400705|NCT00715910|11544848|FG000|NOT COMPLETED|Year 1||0
10400706|NCT00715910|11544849|FG001|NOT COMPLETED|Year 1||0
10400707|NCT00715910|11544850|FG002|NOT COMPLETED|Year 1||0
10400708|NCT00715910|11544851|FG003|NOT COMPLETED|Year 1||0
10400709|NCT00715910|11544852|FG004|NOT COMPLETED|Year 1||0
10400710|NCT00715910|11544853|FG005|NOT COMPLETED|Year 1||0
10400711|NCT00715910|11544848|FG000|STARTED|Year 3||345
10400712|NCT00715910|11544849|FG001|STARTED|Year 3||86
10400713|NCT00715910|11544850|FG002|STARTED|Year 3||56
10400714|NCT00715910|11544851|FG003|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
10400715|NCT00715910|11544852|FG004|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
10400716|NCT00715910|11544853|FG005|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
10400717|NCT00715910|11544848|FG000|COMPLETED|Year 3||345
10400718|NCT00715910|11544849|FG001|COMPLETED|Year 3||86
10400719|NCT00715910|11544850|FG002|COMPLETED|Year 3||56
10400720|NCT00715910|11544851|FG003|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
10400721|NCT00715910|11544852|FG004|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
10400722|NCT00715910|11544853|FG005|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
10400723|NCT00715910|11544848|FG000|NOT COMPLETED|Year 3||0
10400724|NCT00715910|11544849|FG001|NOT COMPLETED|Year 3||0
10659564|NCT02243280|11820999|FG002|STARTED|Enrolled||0
10659565|NCT02243280|11821000|FG003|STARTED|Enrolled||0
10659566|NCT02243280|11821001|FG004|STARTED|Enrolled||0
10659567|NCT02243280|11821002|FG005|STARTED|Enrolled||27
10659568|NCT02243280|11821003|FG006|STARTED|Enrolled||0
10659569|NCT02243280|11821004|FG007|STARTED|Enrolled||0
10659570|NCT02243280|11821005|FG008|STARTED|Enrolled||34
10659571|NCT02243280|11821006|FG009|STARTED|Enrolled||0
10659572|NCT02243280|11821007|FG010|STARTED|Enrolled||34
10659573|NCT02243280|11820997|FG000|COMPLETED|Enrolled||40
10659574|NCT02243280|11820998|FG001|COMPLETED|Enrolled||39
10659575|NCT02243280|11820999|FG002|COMPLETED|Enrolled||0
10659576|NCT02243280|11821000|FG003|COMPLETED|Enrolled||0
10659577|NCT02243280|11821001|FG004|COMPLETED|Enrolled||0
10659578|NCT02243280|11821002|FG005|COMPLETED|Enrolled||27
10659579|NCT02243280|11821003|FG006|COMPLETED|Enrolled||0
10659580|NCT02243280|11821004|FG007|COMPLETED|Enrolled||0
10659581|NCT02243280|11821005|FG008|COMPLETED|Enrolled||34
10659582|NCT02243280|11821006|FG009|COMPLETED|Enrolled||0
10659583|NCT02243280|11821007|FG010|COMPLETED|Enrolled||34
10659584|NCT02243280|11820997|FG000|NOT COMPLETED|Enrolled||0
10659585|NCT02243280|11820998|FG001|NOT COMPLETED|Enrolled||0
10659586|NCT02243280|11820999|FG002|NOT COMPLETED|Enrolled||0
10659587|NCT02243280|11821000|FG003|NOT COMPLETED|Enrolled||0
10659588|NCT02243280|11821001|FG004|NOT COMPLETED|Enrolled||0
10659589|NCT02243280|11821002|FG005|NOT COMPLETED|Enrolled||0
10659590|NCT02243280|11821003|FG006|NOT COMPLETED|Enrolled||0
10659591|NCT02243280|11821004|FG007|NOT COMPLETED|Enrolled||0
10659592|NCT02243280|11821005|FG008|NOT COMPLETED|Enrolled||0
10659593|NCT02243280|11821006|FG009|NOT COMPLETED|Enrolled||0
10659594|NCT02243280|11821007|FG010|NOT COMPLETED|Enrolled||0
10659595|NCT02243280|11820997|FG000|STARTED|Treated|Two Arm I participants received ABT-493 doses of 200 mg instead of 300 mg and are included in Arm A|42
10659596|NCT02243280|11820998|FG001|STARTED|Treated||39
10659597|NCT02243280|11820999|FG002|STARTED|Treated||0
10659598|NCT02243280|11821000|FG003|STARTED|Treated||0
10659599|NCT02243280|11821001|FG004|STARTED|Treated||0
10659600|NCT02243280|11821002|FG005|STARTED|Treated||27
10659601|NCT02243280|11821003|FG006|STARTED|Treated||0
10659602|NCT02243280|11821004|FG007|STARTED|Treated||0
10659603|NCT02243280|11821005|FG008|STARTED|Treated|Two Arm I participants received ABT-493 doses of 200 mg instead of 300 mg and are included in Arm A|32
10659604|NCT02243280|11821006|FG009|STARTED|Treated||0
10659605|NCT02243280|11821007|FG010|STARTED|Treated||34
10659606|NCT02243280|11820997|FG000|Completed Treatment|Treated||42
10659607|NCT02243280|11820998|FG001|Completed Treatment|Treated||38
10659608|NCT02243280|11820999|FG002|Completed Treatment|Treated||0
10659609|NCT02243280|11821000|FG003|Completed Treatment|Treated||0
10814031|NCT02515851|11976597|FG001|COMPLETED|Overall Study||15
10814032|NCT02515851|11976596|FG000|NOT COMPLETED|Overall Study||0
10814033|NCT02515851|11976597|FG001|NOT COMPLETED|Overall Study||0
10814034|NCT02506985|11976605|FG000|STARTED|Overall Study||4
10814035|NCT02506985|11976606|FG001|STARTED|Overall Study||6
10814036|NCT02506985|11976605|FG000|COMPLETED|Overall Study||4
10814037|NCT02506985|11976606|FG001|COMPLETED|Overall Study||6
10814038|NCT02506985|11976605|FG000|NOT COMPLETED|Overall Study||0
10814039|NCT02506985|11976606|FG001|NOT COMPLETED|Overall Study||0
10400725|NCT00715910|11544850|FG002|NOT COMPLETED|Year 3||0
10400726|NCT00715910|11544851|FG003|NOT COMPLETED|Year 3||0
10659610|NCT02243280|11821001|FG004|Completed Treatment|Treated||0
10659611|NCT02243280|11821002|FG005|Completed Treatment|Treated||27
10659612|NCT02243280|11821003|FG006|Completed Treatment|Treated||0
10659613|NCT02243280|11821004|FG007|Completed Treatment|Treated||0
10659614|NCT02243280|11821005|FG008|Completed Treatment|Treated||32
10659615|NCT02243280|11821006|FG009|Completed Treatment|Treated||0
10659616|NCT02243280|11821007|FG010|Completed Treatment|Treated||33
10659617|NCT02243280|11820997|FG000|COMPLETED|Treated||41
10659618|NCT02243280|11820998|FG001|COMPLETED|Treated||39
10659619|NCT02243280|11820999|FG002|COMPLETED|Treated||0
10400727|NCT00715910|11544852|FG004|NOT COMPLETED|Year 3||0
10400728|NCT00715910|11544853|FG005|NOT COMPLETED|Year 3||0
10400729|NCT00715910|11544848|FG000|STARTED|Year 5||218
10400730|NCT00715910|11544849|FG001|STARTED|Year 5||56
10400731|NCT00715910|11544850|FG002|STARTED|Year 5||38
10400732|NCT00715910|11544851|FG003|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
10400733|NCT00715910|11544852|FG004|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
10400734|NCT00715910|11544853|FG005|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
10400735|NCT00715910|11544848|FG000|COMPLETED|Year 5||218
10400736|NCT00715910|11544849|FG001|COMPLETED|Year 5||56
10400737|NCT00715910|11544850|FG002|COMPLETED|Year 5||38
10400738|NCT00715910|11544851|FG003|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
10400739|NCT00715910|11544852|FG004|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
10400740|NCT00715910|11544853|FG005|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
10400741|NCT00715910|11544848|FG000|NOT COMPLETED|Year 5||0
10400742|NCT00715910|11544849|FG001|NOT COMPLETED|Year 5||0
10400743|NCT00715910|11544850|FG002|NOT COMPLETED|Year 5||0
10400744|NCT00715910|11544851|FG003|NOT COMPLETED|Year 5||0
10400745|NCT00715910|11544852|FG004|NOT COMPLETED|Year 5||0
10400746|NCT00715910|11544853|FG005|NOT COMPLETED|Year 5||0
10400747|NCT00715910|11544848|FG000|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
10400748|NCT00715910|11544849|FG001|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
10400749|NCT00715910|11544850|FG002|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
10400750|NCT00715910|11544851|FG003|STARTED|Booster and ESFU Phase||183
10400751|NCT00715910|11544852|FG004|STARTED|Booster and ESFU Phase||38
10400752|NCT00715910|11544853|FG005|STARTED|Booster and ESFU Phase||101
10400753|NCT00715910|11544848|FG000|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
10400754|NCT00715910|11544849|FG001|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
10400755|NCT00715910|11544850|FG002|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
10400756|NCT00715910|11544851|FG003|COMPLETED|Booster and ESFU Phase||172
10400757|NCT00715910|11544852|FG004|COMPLETED|Booster and ESFU Phase||36
10400758|NCT00715910|11544853|FG005|COMPLETED|Booster and ESFU Phase||88
10400759|NCT00715910|11544848|FG000|NOT COMPLETED|Booster and ESFU Phase||0
10400760|NCT00715910|11544849|FG001|NOT COMPLETED|Booster and ESFU Phase||0
10400761|NCT00715910|11544850|FG002|NOT COMPLETED|Booster and ESFU Phase||0
10400762|NCT00715910|11544851|FG003|NOT COMPLETED|Booster and ESFU Phase||11
10659620|NCT02243280|11821000|FG003|COMPLETED|Treated||0
10659621|NCT02243280|11821001|FG004|COMPLETED|Treated||0
10659622|NCT02243280|11821002|FG005|COMPLETED|Treated||27
10659623|NCT02243280|11821003|FG006|COMPLETED|Treated||0
10659624|NCT02243280|11821004|FG007|COMPLETED|Treated||0
10659625|NCT02243280|11821005|FG008|COMPLETED|Treated||31
10659626|NCT02243280|11821006|FG009|COMPLETED|Treated||0
10659627|NCT02243280|11821007|FG010|COMPLETED|Treated||31
10659628|NCT02243280|11820997|FG000|NOT COMPLETED|Treated||1
10659629|NCT02243280|11820998|FG001|NOT COMPLETED|Treated||0
10659630|NCT02243280|11820999|FG002|NOT COMPLETED|Treated||0
10659631|NCT02243280|11821000|FG003|NOT COMPLETED|Treated||0
10659632|NCT02243280|11821001|FG004|NOT COMPLETED|Treated||0
10659633|NCT02243280|11821002|FG005|NOT COMPLETED|Treated||0
10659634|NCT02243280|11821003|FG006|NOT COMPLETED|Treated||0
10659635|NCT02243280|11821004|FG007|NOT COMPLETED|Treated||0
10814040|NCT02514252|11976612|FG000|STARTED|Overall Study||6
10814041|NCT02514252|11976612|FG000|COMPLETED|Overall Study||6
10814042|NCT02514252|11976612|FG000|NOT COMPLETED|Overall Study||0
10814043|NCT02501759|11976616|FG000|STARTED|Overall Study||2
10814044|NCT02501759|11976616|FG000|COMPLETED|Overall Study||1
10814045|NCT02501759|11976616|FG000|NOT COMPLETED|Overall Study||1
10400763|NCT00715910|11544852|FG004|NOT COMPLETED|Booster and ESFU Phase||2
10400764|NCT00715910|11544853|FG005|NOT COMPLETED|Booster and ESFU Phase||13
10400765|NCT00715949|11544869|FG000|STARTED|Overall Study|4 dropped because could not finish first test|120
10400766|NCT00715949|11544869|FG000|COMPLETED|Overall Study|116 patients completed first test|116
10400767|NCT00715949|11544869|FG000|NOT COMPLETED|Overall Study||4
10400768|NCT00715962|11544875|FG000|STARTED|Overall Study||50
10400769|NCT00715962|11544876|FG001|STARTED|Overall Study||50
10400770|NCT00715962|11544875|FG000|COMPLETED|Overall Study||44
10400771|NCT00715962|11544876|FG001|COMPLETED|Overall Study||48
10400772|NCT00715962|11544875|FG000|NOT COMPLETED|Overall Study||6
10400773|NCT00715962|11544876|FG001|NOT COMPLETED|Overall Study||2
10400774|NCT00716079|11544885|FG000|STARTED|Overall Study||1403
10400775|NCT00716079|11544886|FG001|STARTED|Overall Study||1436
10400776|NCT00716079|11544885|FG000|COMPLETED|Overall Study||1394
10400777|NCT00716079|11544886|FG001|COMPLETED|Overall Study||1421
10400778|NCT00716079|11544885|FG000|NOT COMPLETED|Overall Study||9
10400779|NCT00716079|11544886|FG001|NOT COMPLETED|Overall Study||15
10400780|NCT00716092|11544895|FG000|STARTED|Overall Study||40
10400781|NCT00716092|11544896|FG001|STARTED|Overall Study||40
10400782|NCT00716092|11544897|FG002|STARTED|Overall Study||41
10400783|NCT00716092|11544895|FG000|COMPLETED|Overall Study||38
10400784|NCT00716092|11544896|FG001|COMPLETED|Overall Study||39
10400785|NCT00716092|11544897|FG002|COMPLETED|Overall Study||41
10400786|NCT00716092|11544895|FG000|NOT COMPLETED|Overall Study||2
10400787|NCT00716092|11544896|FG001|NOT COMPLETED|Overall Study||1
10400788|NCT00716092|11544897|FG002|NOT COMPLETED|Overall Study||0
10400789|NCT00716144|11544909|FG000|STARTED|Overall Study||41
10400790|NCT00716144|11544910|FG001|STARTED|Overall Study||45
10400791|NCT00716144|11544911|FG002|STARTED|Overall Study||45
10400792|NCT00716144|11544912|FG003|STARTED|Overall Study||45
10400793|NCT00716144|11544909|FG000|COMPLETED|Overall Study||32
10400794|NCT00716144|11544910|FG001|COMPLETED|Overall Study||38
10400795|NCT00716144|11544911|FG002|COMPLETED|Overall Study||33
10400796|NCT00716144|11544912|FG003|COMPLETED|Overall Study||33
10400797|NCT00716144|11544909|FG000|NOT COMPLETED|Overall Study||9
10400798|NCT00716144|11544910|FG001|NOT COMPLETED|Overall Study||7
10400799|NCT00716144|11544911|FG002|NOT COMPLETED|Overall Study||12
10659636|NCT02243280|11821005|FG008|NOT COMPLETED|Treated||1
10659637|NCT02243280|11821006|FG009|NOT COMPLETED|Treated||0
10659638|NCT02243280|11821007|FG010|NOT COMPLETED|Treated||3
10659639|NCT02243293|11821042|FG000|STARTED|Overall Study||25
10659640|NCT02243293|11821043|FG001|STARTED|Overall Study||24
10659641|NCT02243293|11821044|FG002|STARTED|Overall Study||25
10659642|NCT02243293|11821045|FG003|STARTED|Overall Study||30
10659643|NCT02243293|11821046|FG004|STARTED|Overall Study||31
10659644|NCT02243293|11821047|FG005|STARTED|Overall Study||31
10659645|NCT02243293|11821048|FG006|STARTED|Overall Study||30
10659646|NCT02243293|11821049|FG007|STARTED|Overall Study||0
10659647|NCT02243293|11821050|FG008|STARTED|Overall Study||0
10659648|NCT02243293|11821051|FG009|STARTED|Overall Study||55
10659649|NCT02243293|11821052|FG010|STARTED|Overall Study||0
10659650|NCT02243293|11821053|FG011|STARTED|Overall Study||53
10659651|NCT02243293|11821054|FG012|STARTED|Overall Study||0
10659652|NCT02243293|11821055|FG013|STARTED|Overall Study||0
10659653|NCT02243293|11821056|FG014|STARTED|Overall Study||28
10659654|NCT02243293|11821057|FG015|STARTED|Overall Study||27
10400800|NCT00716144|11544912|FG003|NOT COMPLETED|Overall Study||12
10400801|NCT00716274|11544925|FG000|STARTED|Study Period II (16-Weeks)||45
10400802|NCT00716274|11544926|FG001|STARTED|Study Period II (16-Weeks)||44
10400803|NCT00716274|11544927|FG002|STARTED|Study Period II (16-Weeks)||0
10400804|NCT00716274|11544928|FG003|STARTED|Study Period II (16-Weeks)||0
10400805|NCT00716274|11544929|FG004|STARTED|Study Period II (16-Weeks)||0
10400806|NCT00716274|11544930|FG005|STARTED|Study Period II (16-Weeks)||21
10400807|NCT00716274|11544925|FG000|COMPLETED|Study Period II (16-Weeks)||36
10400808|NCT00716274|11544926|FG001|COMPLETED|Study Period II (16-Weeks)||35
10400809|NCT00716274|11544927|FG002|COMPLETED|Study Period II (16-Weeks)||0
10400810|NCT00716274|11544928|FG003|COMPLETED|Study Period II (16-Weeks)||0
10400811|NCT00716274|11544929|FG004|COMPLETED|Study Period II (16-Weeks)||0
10400812|NCT00716274|11544930|FG005|COMPLETED|Study Period II (16-Weeks)||19
10400813|NCT00716274|11544925|FG000|NOT COMPLETED|Study Period II (16-Weeks)||9
10400814|NCT00716274|11544926|FG001|NOT COMPLETED|Study Period II (16-Weeks)||9
10400815|NCT00716274|11544927|FG002|NOT COMPLETED|Study Period II (16-Weeks)||0
10400816|NCT00716274|11544928|FG003|NOT COMPLETED|Study Period II (16-Weeks)||0
10400817|NCT00716274|11544929|FG004|NOT COMPLETED|Study Period II (16-Weeks)||0
10400818|NCT00716274|11544930|FG005|NOT COMPLETED|Study Period II (16-Weeks)||2
10400819|NCT00716274|11544925|FG000|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|0
10400820|NCT00716274|11544926|FG001|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|0
10400821|NCT00716274|11544927|FG002|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|18
10400822|NCT00716274|11544928|FG003|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|18
10400823|NCT00716274|11544929|FG004|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|35
10400824|NCT00716274|11544930|FG005|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|19
10400825|NCT00716274|11544925|FG000|COMPLETED|Study Period III (16-Weeks)||0
10400826|NCT00716274|11544926|FG001|COMPLETED|Study Period III (16-Weeks)||0
10400827|NCT00716274|11544927|FG002|COMPLETED|Study Period III (16-Weeks)||16
10400828|NCT00716274|11544928|FG003|COMPLETED|Study Period III (16-Weeks)||17
10400829|NCT00716274|11544929|FG004|COMPLETED|Study Period III (16-Weeks)||32
10400830|NCT00716274|11544930|FG005|COMPLETED|Study Period III (16-Weeks)||19
10400831|NCT00716274|11544925|FG000|NOT COMPLETED|Study Period III (16-Weeks)||0
10400832|NCT00716274|11544926|FG001|NOT COMPLETED|Study Period III (16-Weeks)||0
10400833|NCT00716274|11544927|FG002|NOT COMPLETED|Study Period III (16-Weeks)||2
10400834|NCT00716274|11544928|FG003|NOT COMPLETED|Study Period III (16-Weeks)||1
10400835|NCT00716274|11544929|FG004|NOT COMPLETED|Study Period III (16-Weeks)||3
10400836|NCT00716274|11544930|FG005|NOT COMPLETED|Study Period III (16-Weeks)||0
10400837|NCT00716417|11544957|FG000|STARTED|Overall Study||3
10400838|NCT00716417|11544958|FG001|STARTED|Overall Study||6
10400839|NCT00716417|11544959|FG002|STARTED|Overall Study||5
10400840|NCT00716417|11544960|FG003|STARTED|Overall Study||11
10400841|NCT00716417|11544961|FG004|STARTED|Overall Study||1
10400842|NCT00716417|11544962|FG005|STARTED|Overall Study||3
10400843|NCT00716417|11544963|FG006|STARTED|Overall Study||7
10400844|NCT00716417|11544964|FG007|STARTED|Overall Study||3
10400845|NCT00716417|11544965|FG008|STARTED|Overall Study||5
10400846|NCT00716417|11544966|FG009|STARTED|Overall Study||3
10400847|NCT00716417|11544957|FG000|COMPLETED|Overall Study||0
10400848|NCT00716417|11544958|FG001|COMPLETED|Overall Study||0
10400849|NCT00716417|11544959|FG002|COMPLETED|Overall Study||0
10400850|NCT00716417|11544960|FG003|COMPLETED|Overall Study||0
10400851|NCT00716417|11544961|FG004|COMPLETED|Overall Study||0
10400852|NCT00716417|11544962|FG005|COMPLETED|Overall Study||0
10400853|NCT00716417|11544963|FG006|COMPLETED|Overall Study||0
10400854|NCT00716417|11544964|FG007|COMPLETED|Overall Study||0
10400855|NCT00716417|11544965|FG008|COMPLETED|Overall Study||0
10400856|NCT00716417|11544966|FG009|COMPLETED|Overall Study||0
10400857|NCT00716417|11544957|FG000|NOT COMPLETED|Overall Study||3
10400858|NCT00716417|11544958|FG001|NOT COMPLETED|Overall Study||6
10400859|NCT00716417|11544959|FG002|NOT COMPLETED|Overall Study||5
10400860|NCT00716417|11544960|FG003|NOT COMPLETED|Overall Study||11
10400861|NCT00716417|11544961|FG004|NOT COMPLETED|Overall Study||1
10400862|NCT00716417|11544962|FG005|NOT COMPLETED|Overall Study||3
10400863|NCT00716417|11544963|FG006|NOT COMPLETED|Overall Study||7
10400864|NCT00716417|11544964|FG007|NOT COMPLETED|Overall Study||3
10312236|NCT00139477|11445604|FG000|COMPLETED|Second Intervention -6Months to 12Months||14
10312237|NCT00139477|11445605|FG001|COMPLETED|Second Intervention -6Months to 12Months||18
10312238|NCT00139477|11445604|FG000|NOT COMPLETED|Second Intervention -6Months to 12Months||5
10312239|NCT00139477|11445605|FG001|NOT COMPLETED|Second Intervention -6Months to 12Months||5
10312240|NCT00139659|11445615|FG000|STARTED|Overall Study|1 subject randomized was DC'd prior to receiving inhaled insulin but received subcutaneous insulin|146
10312241|NCT00139659|11445616|FG001|STARTED|Overall Study|1 subject randomized DC'd before receiving subcutaneous insulin and is not included in # of subjects|141
10312242|NCT00139659|11445615|FG000|COMPLETED|Overall Study||106
10312243|NCT00139659|11445616|FG001|COMPLETED|Overall Study||123
10312244|NCT00139659|11445615|FG000|NOT COMPLETED|Overall Study||40
10312245|NCT00139659|11445616|FG001|NOT COMPLETED|Overall Study||18
10312246|NCT00139737|11445626|FG000|STARTED|Overall Study||344
10312247|NCT00139737|11445626|FG000|Received Treatment|Overall Study||331
10312248|NCT00139737|11445626|FG000|COMPLETED|Overall Study||3
10312249|NCT00139737|11445626|FG000|NOT COMPLETED|Overall Study||341
10312250|NCT00139776|11445632|FG000|STARTED|Period I||1772
10312251|NCT00139776|11445633|FG001|STARTED|Period I||0
10312252|NCT00139776|11445634|FG002|STARTED|Period I||0
10312253|NCT00139776|11445635|FG003|STARTED|Period I||0
10312254|NCT00139776|11445632|FG000|COMPLETED|Period I||1197
10312255|NCT00139776|11445633|FG001|COMPLETED|Period I||0
10312256|NCT00139776|11445634|FG002|COMPLETED|Period I||0
10312257|NCT00139776|11445635|FG003|COMPLETED|Period I||0
10312258|NCT00139776|11445632|FG000|NOT COMPLETED|Period I||575
10721167|NCT02723201|11884811|FG000|STARTED|Third Intervention Period||9
10721168|NCT02723201|11884812|FG001|STARTED|Third Intervention Period||0
10721169|NCT02723201|11884813|FG002|STARTED|Third Intervention Period||0
10721170|NCT02723201|11884811|FG000|COMPLETED|Third Intervention Period||9
10312259|NCT00139776|11445633|FG001|NOT COMPLETED|Period I||0
10312260|NCT00139776|11445634|FG002|NOT COMPLETED|Period I||0
10312261|NCT00139776|11445635|FG003|NOT COMPLETED|Period I||0
10312262|NCT00139776|11445632|FG000|STARTED|Period II||0
10312263|NCT00139776|11445633|FG001|STARTED|Period II||1197
10312264|NCT00139776|11445634|FG002|STARTED|Period II||0
10312265|NCT00139776|11445635|FG003|STARTED|Period II||0
10312266|NCT00139776|11445632|FG000|COMPLETED|Period II||0
10312267|NCT00139776|11445633|FG001|COMPLETED|Period II||875
10312268|NCT00139776|11445634|FG002|COMPLETED|Period II||0
10312269|NCT00139776|11445635|FG003|COMPLETED|Period II||0
10312270|NCT00139776|11445632|FG000|NOT COMPLETED|Period II||0
10312271|NCT00139776|11445633|FG001|NOT COMPLETED|Period II||322
10721171|NCT02723201|11884812|FG001|COMPLETED|Third Intervention Period||0
10721172|NCT02723201|11884813|FG002|COMPLETED|Third Intervention Period||0
10312272|NCT00139776|11445634|FG002|NOT COMPLETED|Period II||0
10312273|NCT00139776|11445635|FG003|NOT COMPLETED|Period II||0
10312274|NCT00139776|11445632|FG000|STARTED|Period III||0
10312275|NCT00139776|11445633|FG001|STARTED|Period III||0
10312276|NCT00139776|11445634|FG002|STARTED|Period III|Randomized 440: 9 participants not treated|431
10312277|NCT00139776|11445635|FG003|STARTED|Period III|Randomized 435: 8 participants not treated|427
10312278|NCT00139776|11445632|FG000|COMPLETED|Period III||0
10312279|NCT00139776|11445633|FG001|COMPLETED|Period III||0
10312280|NCT00139776|11445634|FG002|COMPLETED|Period III||355
10312281|NCT00139776|11445635|FG003|COMPLETED|Period III||321
10312282|NCT00139776|11445632|FG000|NOT COMPLETED|Period III||0
10312283|NCT00139776|11445633|FG001|NOT COMPLETED|Period III||0
10312284|NCT00139776|11445634|FG002|NOT COMPLETED|Period III||76
10312285|NCT00139776|11445635|FG003|NOT COMPLETED|Period III||106
10312286|NCT00139997|11445644|FG000|STARTED|Overall Study||15
10312287|NCT00139997|11445645|FG001|STARTED|Overall Study||11
10312288|NCT00139997|11445644|FG000|COMPLETED|Overall Study||14
10312289|NCT00139997|11445645|FG001|COMPLETED|Overall Study||9
10400865|NCT00716417|11544965|FG008|NOT COMPLETED|Overall Study||5
10400866|NCT00716417|11544966|FG009|NOT COMPLETED|Overall Study||3
10400870|NCT00716456|11544998|FG000|STARTED|Overall Study||3
10400871|NCT00716456|11544999|FG001|STARTED|Overall Study||5
10400872|NCT00716456|11545000|FG002|STARTED|Overall Study||13
10400873|NCT00716456|11544998|FG000|COMPLETED|Overall Study||3
10400874|NCT00716456|11544999|FG001|COMPLETED|Overall Study||3
10400875|NCT00716456|11545000|FG002|COMPLETED|Overall Study||13
10400876|NCT00716456|11544998|FG000|NOT COMPLETED|Overall Study||0
10543951|NCT01487161|11697105|FG003|COMPLETED|Overall Study||50
10543952|NCT01487161|11697102|FG000|NOT COMPLETED|Overall Study||2
10543953|NCT01487161|11697103|FG001|NOT COMPLETED|Overall Study||2
10543954|NCT01487161|11697104|FG002|NOT COMPLETED|Overall Study||1
10543955|NCT01487161|11697105|FG003|NOT COMPLETED|Overall Study||2
10543956|NCT01487200|11697124|FG000|STARTED|Overall Study||5
10543957|NCT01487200|11697125|FG001|STARTED|Overall Study||7
10659655|NCT02243293|11821058|FG016|STARTED|Overall Study||40
10659656|NCT02243293|11821059|FG017|STARTED|Overall Study||22
10659657|NCT02243293|11821060|FG018|STARTED|Overall Study||22
10659658|NCT02243293|11821061|FG019|STARTED|Overall Study||48
10659659|NCT02243293|11821062|FG020|STARTED|Overall Study||145
10659660|NCT02243293|11821063|FG021|STARTED|Overall Study||58
10659661|NCT02243293|11821042|FG000|COMPLETED|Overall Study||23
10659662|NCT02243293|11821043|FG001|COMPLETED|Overall Study||23
10659663|NCT02243293|11821044|FG002|COMPLETED|Overall Study||24
10659664|NCT02243293|11821045|FG003|COMPLETED|Overall Study||29
10659665|NCT02243293|11821046|FG004|COMPLETED|Overall Study||30
10659666|NCT02243293|11821047|FG005|COMPLETED|Overall Study||31
10659667|NCT02243293|11821048|FG006|COMPLETED|Overall Study||27
10659668|NCT02243293|11821049|FG007|COMPLETED|Overall Study||0
10659669|NCT02243293|11821050|FG008|COMPLETED|Overall Study||0
10659670|NCT02243293|11821051|FG009|COMPLETED|Overall Study||53
10659671|NCT02243293|11821052|FG010|COMPLETED|Overall Study||0
10659672|NCT02243293|11821053|FG011|COMPLETED|Overall Study||50
10659673|NCT02243293|11821054|FG012|COMPLETED|Overall Study||0
10659674|NCT02243293|11821055|FG013|COMPLETED|Overall Study||0
10659675|NCT02243293|11821056|FG014|COMPLETED|Overall Study||27
10400877|NCT00716456|11544999|FG001|NOT COMPLETED|Overall Study||2
10543958|NCT01487200|11697126|FG002|STARTED|Overall Study||7
10543959|NCT01487200|11697127|FG003|STARTED|Overall Study||5
10659676|NCT02243293|11821057|FG015|COMPLETED|Overall Study||26
10659677|NCT02243293|11821058|FG016|COMPLETED|Overall Study||37
10659678|NCT02243293|11821059|FG017|COMPLETED|Overall Study||21
10400878|NCT00716456|11545000|FG002|NOT COMPLETED|Overall Study||0
10400879|NCT00716482|11545008|FG000|STARTED|Overall Study||1681
10400880|NCT00716482|11545008|FG000|COMPLETED|Overall Study||1562
10400881|NCT00716482|11545008|FG000|NOT COMPLETED|Overall Study||119
10400882|NCT00716586|11545018|FG000|STARTED|Overall Study||44
10400883|NCT00716586|11545018|FG000|COMPLETED|Overall Study||44
10400884|NCT00716586|11545018|FG000|NOT COMPLETED|Overall Study||0
10400885|NCT00716625|11545023|FG000|STARTED|Overall Study||1674
10400886|NCT00716625|11545023|FG000|COMPLETED|Overall Study||1673
10400887|NCT00716625|11545023|FG000|NOT COMPLETED|Overall Study||1
10400888|NCT00716742|11545044|FG000|STARTED|Baseline||364
10400889|NCT00716742|11545045|FG001|STARTED|Baseline||370
10400890|NCT00716742|11545046|FG002|STARTED|Baseline||365
10400891|NCT00716742|11545044|FG000|COMPLETED|Baseline||347
10400892|NCT00716742|11545045|FG001|COMPLETED|Baseline||356
10400893|NCT00716742|11545046|FG002|COMPLETED|Baseline||352
10400894|NCT00716742|11545044|FG000|NOT COMPLETED|Baseline||17
10400895|NCT00716742|11545045|FG001|NOT COMPLETED|Baseline||14
10400896|NCT00716742|11545046|FG002|NOT COMPLETED|Baseline||13
10400897|NCT00716742|11545044|FG000|STARTED|1 Year Follow-up||347
10400898|NCT00716742|11545045|FG001|STARTED|1 Year Follow-up||356
10400899|NCT00716742|11545046|FG002|STARTED|1 Year Follow-up||352
10400900|NCT00716742|11545044|FG000|COMPLETED|1 Year Follow-up||160
10400901|NCT00716742|11545045|FG001|COMPLETED|1 Year Follow-up||163
10400902|NCT00716742|11545046|FG002|COMPLETED|1 Year Follow-up||152
10400903|NCT00716742|11545044|FG000|NOT COMPLETED|1 Year Follow-up||187
10400904|NCT00716742|11545045|FG001|NOT COMPLETED|1 Year Follow-up||193
10400905|NCT00716742|11545046|FG002|NOT COMPLETED|1 Year Follow-up||200
10400906|NCT00716742|11545044|FG000|STARTED|2 Year Follow-up||160
10400907|NCT00716742|11545045|FG001|STARTED|2 Year Follow-up||163
10400908|NCT00716742|11545046|FG002|STARTED|2 Year Follow-up||152
10400909|NCT00716742|11545044|FG000|COMPLETED|2 Year Follow-up||56
10400910|NCT00716742|11545045|FG001|COMPLETED|2 Year Follow-up||67
10400911|NCT00716742|11545046|FG002|COMPLETED|2 Year Follow-up||50
10400912|NCT00716742|11545044|FG000|NOT COMPLETED|2 Year Follow-up||104
10400913|NCT00716742|11545045|FG001|NOT COMPLETED|2 Year Follow-up||96
10400914|NCT00716742|11545046|FG002|NOT COMPLETED|2 Year Follow-up||102
10400915|NCT00716742|11545044|FG000|STARTED|3 Year Follow-up||56
10400916|NCT00716742|11545045|FG001|STARTED|3 Year Follow-up||67
10400917|NCT00716742|11545046|FG002|STARTED|3 Year Follow-up||50
10312290|NCT00139997|11445644|FG000|NOT COMPLETED|Overall Study||1
10312291|NCT00139997|11445645|FG001|NOT COMPLETED|Overall Study||2
10312292|NCT00140140|11445654|FG000|STARTED|Overall Study||4
10312293|NCT00140140|11445655|FG001|STARTED|Overall Study||6
10312294|NCT00140140|11445656|FG002|STARTED|Overall Study||6
10312295|NCT00140140|11445654|FG000|COMPLETED|Overall Study|Progressive disease|2
10312296|NCT00140140|11445655|FG001|COMPLETED|Overall Study|Progressive disease|4
10312297|NCT00140140|11445656|FG002|COMPLETED|Overall Study|Progressive disease|4
10312298|NCT00140140|11445654|FG000|NOT COMPLETED|Overall Study||2
10312299|NCT00140140|11445655|FG001|NOT COMPLETED|Overall Study||2
10721173|NCT02723201|11884811|FG000|NOT COMPLETED|Third Intervention Period||0
10721174|NCT02723201|11884812|FG001|NOT COMPLETED|Third Intervention Period||0
10721175|NCT02723201|11884813|FG002|NOT COMPLETED|Third Intervention Period||0
10312300|NCT00140140|11445656|FG002|NOT COMPLETED|Overall Study||2
10312301|NCT00140205|11445666|FG000|STARTED|Overall Study||5
10312302|NCT00140205|11445667|FG001|STARTED|Overall Study||5
10312303|NCT00140205|11445668|FG002|STARTED|Overall Study||5
10312304|NCT00140205|11445666|FG000|COMPLETED|Overall Study||5
10312305|NCT00140205|11445667|FG001|COMPLETED|Overall Study||5
10312306|NCT00140205|11445668|FG002|COMPLETED|Overall Study||5
10312307|NCT00140205|11445666|FG000|NOT COMPLETED|Overall Study||0
10312308|NCT00140205|11445667|FG001|NOT COMPLETED|Overall Study||0
10312309|NCT00140205|11445668|FG002|NOT COMPLETED|Overall Study||0
10312310|NCT00140231|11445699|FG000|STARTED|Fed State 1 Day- day5||7
10312311|NCT00140231|11445700|FG001|STARTED|Fed State 1 Day- day5||6
10312312|NCT00140231|11445699|FG000|COMPLETED|Fed State 1 Day- day5||7
10312313|NCT00140231|11445700|FG001|COMPLETED|Fed State 1 Day- day5||6
10721176|NCT02723201|11884811|FG000|STARTED|Washout Period 3||9
10721177|NCT02723201|11884812|FG001|STARTED|Washout Period 3||0
10721178|NCT02723201|11884813|FG002|STARTED|Washout Period 3||0
10721179|NCT02723201|11884811|FG000|COMPLETED|Washout Period 3||9
10721180|NCT02723201|11884812|FG001|COMPLETED|Washout Period 3||0
10721181|NCT02723201|11884813|FG002|COMPLETED|Washout Period 3||0
10721182|NCT02723201|11884811|FG000|NOT COMPLETED|Washout Period 3||0
10721183|NCT02723201|11884812|FG001|NOT COMPLETED|Washout Period 3||0
10721184|NCT02723201|11884813|FG002|NOT COMPLETED|Washout Period 3||0
10721185|NCT02723201|11884811|FG000|STARTED|Fourth Intervention Period||9
10721186|NCT02723201|11884812|FG001|STARTED|Fourth Intervention Period||0
10721187|NCT02723201|11884813|FG002|STARTED|Fourth Intervention Period||0
10312314|NCT00140231|11445699|FG000|NOT COMPLETED|Fed State 1 Day- day5||0
10312315|NCT00140231|11445700|FG001|NOT COMPLETED|Fed State 1 Day- day5||0
10312316|NCT00140231|11445699|FG000|STARTED|Washout 8weeks||7
10312317|NCT00140231|11445700|FG001|STARTED|Washout 8weeks||6
10312318|NCT00140231|11445699|FG000|COMPLETED|Washout 8weeks||7
10312319|NCT00140231|11445700|FG001|COMPLETED|Washout 8weeks||6
10312320|NCT00140231|11445699|FG000|NOT COMPLETED|Washout 8weeks||0
10312321|NCT00140231|11445700|FG001|NOT COMPLETED|Washout 8weeks||0
10312322|NCT00140231|11445699|FG000|STARTED|First Fasting State 3 Days With Placebo||7
10312323|NCT00140231|11445700|FG001|STARTED|First Fasting State 3 Days With Placebo||6
10312324|NCT00140231|11445699|FG000|COMPLETED|First Fasting State 3 Days With Placebo||7
10400918|NCT00716742|11545044|FG000|COMPLETED|3 Year Follow-up||26
10400919|NCT00716742|11545045|FG001|COMPLETED|3 Year Follow-up||35
10400920|NCT00716742|11545046|FG002|COMPLETED|3 Year Follow-up||29
10400921|NCT00716742|11545044|FG000|NOT COMPLETED|3 Year Follow-up||30
10400922|NCT00716742|11545045|FG001|NOT COMPLETED|3 Year Follow-up||32
10400923|NCT00716742|11545046|FG002|NOT COMPLETED|3 Year Follow-up||21
10400924|NCT00716820|11545054|FG000|STARTED|Overall Study||472
10400925|NCT00716820|11545054|FG000|COMPLETED|Overall Study||472
10400926|NCT00716820|11545054|FG000|NOT COMPLETED|Overall Study||0
10400927|NCT00716859|11545081|FG000|STARTED|Overall Study||70
10400928|NCT00716859|11545082|FG001|STARTED|Overall Study||69
10400929|NCT00716859|11545081|FG000|Received Treatment|Overall Study||69
10400930|NCT00716859|11545082|FG001|Received Treatment|Overall Study||68
10400931|NCT00716859|11545081|FG000|COMPLETED|Overall Study||61
10400932|NCT00716859|11545082|FG001|COMPLETED|Overall Study||64
10400933|NCT00716859|11545081|FG000|NOT COMPLETED|Overall Study||9
10400934|NCT00716859|11545082|FG001|NOT COMPLETED|Overall Study||5
10400935|NCT00716963|11545088|FG000|STARTED|Overall Study||2
10400936|NCT00716963|11545089|FG001|STARTED|Overall Study||1
10400937|NCT00716963|11545090|FG002|STARTED|Overall Study||1
10400938|NCT00716963|11545091|FG003|STARTED|Overall Study||1
10400939|NCT00716963|11545092|FG004|STARTED|Overall Study||1
10400940|NCT00716963|11545093|FG005|STARTED|Overall Study||1
10400941|NCT00716963|11545088|FG000|COMPLETED|Overall Study||1
10400942|NCT00716963|11545089|FG001|COMPLETED|Overall Study||1
10400943|NCT00716963|11545090|FG002|COMPLETED|Overall Study||1
10400944|NCT00716963|11545091|FG003|COMPLETED|Overall Study||1
10400945|NCT00716963|11545092|FG004|COMPLETED|Overall Study||1
10400946|NCT00716963|11545093|FG005|COMPLETED|Overall Study||1
10400947|NCT00716963|11545088|FG000|NOT COMPLETED|Overall Study||1
10400948|NCT00716963|11545089|FG001|NOT COMPLETED|Overall Study||0
10400949|NCT00716963|11545090|FG002|NOT COMPLETED|Overall Study||0
10400950|NCT00716963|11545091|FG003|NOT COMPLETED|Overall Study||0
10400951|NCT00716963|11545092|FG004|NOT COMPLETED|Overall Study||0
10400952|NCT00716963|11545093|FG005|NOT COMPLETED|Overall Study||0
10400953|NCT00716976|11545103|FG000|STARTED|Overall Study||65
10659679|NCT02243293|11821060|FG018|COMPLETED|Overall Study||22
10659680|NCT02243293|11821061|FG019|COMPLETED|Overall Study||47
10659681|NCT02243293|11821062|FG020|COMPLETED|Overall Study||143
10659682|NCT02243293|11821063|FG021|COMPLETED|Overall Study||55
10400954|NCT00716976|11545104|FG001|STARTED|Overall Study||66
10659683|NCT02243293|11821042|FG000|NOT COMPLETED|Overall Study||2
10400955|NCT00716976|11545103|FG000|COMPLETED|Overall Study||45
10400956|NCT00716976|11545104|FG001|COMPLETED|Overall Study||57
10400957|NCT00716976|11545103|FG000|NOT COMPLETED|Overall Study||20
10400958|NCT00716976|11545104|FG001|NOT COMPLETED|Overall Study||9
10400959|NCT00717041|11545112|FG000|STARTED|Overall Study||1206
10400960|NCT00717041|11545112|FG000|COMPLETED|Overall Study||1206
10400961|NCT00717041|11545112|FG000|NOT COMPLETED|Overall Study||0
10400962|NCT00717054|11545120|FG000|STARTED|Overall Study||58
10400963|NCT00717054|11545121|FG001|STARTED|Overall Study||57
10400964|NCT00717054|11545120|FG000|COMPLETED|Overall Study||58
10400965|NCT00717054|11545121|FG001|COMPLETED|Overall Study||57
10400966|NCT00717054|11545120|FG000|NOT COMPLETED|Overall Study||0
10400967|NCT00717054|11545121|FG001|NOT COMPLETED|Overall Study||0
10400968|NCT00717067|11545133|FG000|STARTED|Part 1a: Normal/Mild/Moderate Group||6
10400969|NCT00717067|11545134|FG001|STARTED|Part 1a: Normal/Mild/Moderate Group||6
10400970|NCT00717067|11545135|FG002|STARTED|Part 1a: Normal/Mild/Moderate Group||6
10400971|NCT00717067|11545136|FG003|STARTED|Part 1a: Normal/Mild/Moderate Group||0
10400972|NCT00717067|11545137|FG004|STARTED|Part 1a: Normal/Mild/Moderate Group||0
10400973|NCT00717067|11545133|FG000|COMPLETED|Part 1a: Normal/Mild/Moderate Group||6
10400974|NCT00717067|11545134|FG001|COMPLETED|Part 1a: Normal/Mild/Moderate Group||6
10400975|NCT00717067|11545135|FG002|COMPLETED|Part 1a: Normal/Mild/Moderate Group||5
10400976|NCT00717067|11545136|FG003|COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
10400977|NCT00717067|11545137|FG004|COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
10400978|NCT00717067|11545133|FG000|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
10400979|NCT00717067|11545134|FG001|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
10400980|NCT00717067|11545135|FG002|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||1
10400981|NCT00717067|11545136|FG003|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
10400982|NCT00717067|11545137|FG004|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
10400983|NCT00717067|11545133|FG000|STARTED|Part 1b: Severe Renal Impairment||0
10400984|NCT00717067|11545134|FG001|STARTED|Part 1b: Severe Renal Impairment||0
10400985|NCT00717067|11545135|FG002|STARTED|Part 1b: Severe Renal Impairment||0
10400986|NCT00717067|11545136|FG003|STARTED|Part 1b: Severe Renal Impairment||6
10400987|NCT00717067|11545137|FG004|STARTED|Part 1b: Severe Renal Impairment||0
10400988|NCT00717067|11545133|FG000|COMPLETED|Part 1b: Severe Renal Impairment||0
10400989|NCT00717067|11545134|FG001|COMPLETED|Part 1b: Severe Renal Impairment||0
10400990|NCT00717067|11545135|FG002|COMPLETED|Part 1b: Severe Renal Impairment||0
10400991|NCT00717067|11545136|FG003|COMPLETED|Part 1b: Severe Renal Impairment||6
10400992|NCT00717067|11545137|FG004|COMPLETED|Part 1b: Severe Renal Impairment||0
10400993|NCT00717067|11545133|FG000|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
10400994|NCT00717067|11545134|FG001|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
10400995|NCT00717067|11545135|FG002|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
10400996|NCT00717067|11545136|FG003|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
10400997|NCT00717067|11545137|FG004|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
10400998|NCT00717067|11545133|FG000|STARTED|Part 2: End Stage Renal Disease||0
10400999|NCT00717067|11545134|FG001|STARTED|Part 2: End Stage Renal Disease||0
10401000|NCT00717067|11545135|FG002|STARTED|Part 2: End Stage Renal Disease||0
10401001|NCT00717067|11545136|FG003|STARTED|Part 2: End Stage Renal Disease||0
10401002|NCT00717067|11545137|FG004|STARTED|Part 2: End Stage Renal Disease||6
10401003|NCT00717067|11545133|FG000|COMPLETED|Part 2: End Stage Renal Disease||0
10401004|NCT00717067|11545134|FG001|COMPLETED|Part 2: End Stage Renal Disease||0
10401005|NCT00717067|11545135|FG002|COMPLETED|Part 2: End Stage Renal Disease||0
10401006|NCT00717067|11545136|FG003|COMPLETED|Part 2: End Stage Renal Disease||0
10401007|NCT00717067|11545137|FG004|COMPLETED|Part 2: End Stage Renal Disease||6
10401008|NCT00717067|11545133|FG000|NOT COMPLETED|Part 2: End Stage Renal Disease||0
10401009|NCT00717067|11545134|FG001|NOT COMPLETED|Part 2: End Stage Renal Disease||0
10401010|NCT00717067|11545135|FG002|NOT COMPLETED|Part 2: End Stage Renal Disease||0
10659684|NCT02243293|11821043|FG001|NOT COMPLETED|Overall Study||1
10659685|NCT02243293|11821044|FG002|NOT COMPLETED|Overall Study||1
10659686|NCT02243293|11821045|FG003|NOT COMPLETED|Overall Study||1
10659687|NCT02243293|11821046|FG004|NOT COMPLETED|Overall Study||1
10659688|NCT02243293|11821047|FG005|NOT COMPLETED|Overall Study||0
10659689|NCT02243293|11821048|FG006|NOT COMPLETED|Overall Study||3
10659690|NCT02243293|11821049|FG007|NOT COMPLETED|Overall Study||0
10659691|NCT02243293|11821050|FG008|NOT COMPLETED|Overall Study||0
10659692|NCT02243293|11821051|FG009|NOT COMPLETED|Overall Study||2
10659693|NCT02243293|11821052|FG010|NOT COMPLETED|Overall Study||0
10814046|NCT02487277|11976622|FG000|STARTED|Overall Study||3
10814047|NCT02487277|11976623|FG001|STARTED|Overall Study||0
10814048|NCT02487277|11976622|FG000|COMPLETED|Overall Study||3
10814049|NCT02487277|11976623|FG001|COMPLETED|Overall Study||0
10814050|NCT02487277|11976622|FG000|NOT COMPLETED|Overall Study||0
10814051|NCT02487277|11976623|FG001|NOT COMPLETED|Overall Study||0
10814052|NCT02506101|11976630|FG000|STARTED|Overall Study||2
10814053|NCT02506101|11976631|FG001|STARTED|Overall Study||0
10814054|NCT02506101|11976630|FG000|COMPLETED|Overall Study||0
10814055|NCT02506101|11976631|FG001|COMPLETED|Overall Study||0
10814056|NCT02506101|11976630|FG000|NOT COMPLETED|Overall Study||2
10814057|NCT02506101|11976631|FG001|NOT COMPLETED|Overall Study||0
10401011|NCT00717067|11545136|FG003|NOT COMPLETED|Part 2: End Stage Renal Disease||0
10401012|NCT00717067|11545137|FG004|NOT COMPLETED|Part 2: End Stage Renal Disease||0
10659694|NCT02243293|11821053|FG011|NOT COMPLETED|Overall Study||3
10659695|NCT02243293|11821054|FG012|NOT COMPLETED|Overall Study||0
10814058|NCT02499887|11976639|FG000|STARTED|Overall Study||3
10814059|NCT02499887|11976640|FG001|STARTED|Overall Study||3
10814060|NCT02499887|11976639|FG000|COMPLETED|Overall Study||3
10814061|NCT02499887|11976640|FG001|COMPLETED|Overall Study||3
10814062|NCT02499887|11976639|FG000|NOT COMPLETED|Overall Study||0
10814063|NCT02499887|11976640|FG001|NOT COMPLETED|Overall Study||0
10814064|NCT02504099|11976646|FG000|STARTED|Overall Study||3
10814065|NCT02504099|11976646|FG000|COMPLETED|Overall Study||3
10814066|NCT02504099|11976646|FG000|NOT COMPLETED|Overall Study||0
10312325|NCT00140231|11445700|FG001|COMPLETED|First Fasting State 3 Days With Placebo||6
10312326|NCT00140231|11445699|FG000|NOT COMPLETED|First Fasting State 3 Days With Placebo||0
10312327|NCT00140231|11445700|FG001|NOT COMPLETED|First Fasting State 3 Days With Placebo||0
10312328|NCT00140231|11445699|FG000|STARTED|Washout 8 Weeks||7
10312329|NCT00140231|11445700|FG001|STARTED|Washout 8 Weeks||6
10312330|NCT00140231|11445699|FG000|COMPLETED|Washout 8 Weeks||7
10312331|NCT00140231|11445700|FG001|COMPLETED|Washout 8 Weeks||6
10401013|NCT00717093|11545161|FG000|STARTED|Overall Study||214
10401014|NCT00717093|11545162|FG001|STARTED|Overall Study||218
10401015|NCT00717093|11545161|FG000|Received Treatment|Overall Study||213
10401016|NCT00717093|11545162|FG001|Received Treatment|Overall Study||218
10401017|NCT00717093|11545161|FG000|COMPLETED|Overall Study||170
10401018|NCT00717093|11545162|FG001|COMPLETED|Overall Study||170
10401019|NCT00717093|11545161|FG000|NOT COMPLETED|Overall Study||44
10401020|NCT00717093|11545162|FG001|NOT COMPLETED|Overall Study||48
10401021|NCT00717197|11545168|FG000|STARTED|Overall Study||30
10401022|NCT00717197|11545168|FG000|COMPLETED|Overall Study||23
10401023|NCT00717197|11545168|FG000|NOT COMPLETED|Overall Study||7
10401024|NCT00717236|11545174|FG000|STARTED|Double-Blind Period||851
10401025|NCT00717236|11545175|FG001|STARTED|Double-Blind Period||212
10401026|NCT00717236|11545174|FG000|COMPLETED|Double-Blind Period||771
10401027|NCT00717236|11545175|FG001|COMPLETED|Double-Blind Period||184
10659696|NCT02243293|11821055|FG013|NOT COMPLETED|Overall Study||0
10659697|NCT02243293|11821056|FG014|NOT COMPLETED|Overall Study||1
10659698|NCT02243293|11821057|FG015|NOT COMPLETED|Overall Study||1
10659699|NCT02243293|11821058|FG016|NOT COMPLETED|Overall Study||3
10659700|NCT02243293|11821059|FG017|NOT COMPLETED|Overall Study||1
10659701|NCT02243293|11821060|FG018|NOT COMPLETED|Overall Study||0
10659702|NCT02243293|11821061|FG019|NOT COMPLETED|Overall Study||1
10659703|NCT02243293|11821062|FG020|NOT COMPLETED|Overall Study||2
10659704|NCT02243293|11821063|FG021|NOT COMPLETED|Overall Study||3
10659705|NCT02243371|11821102|FG000|STARTED|Overall Study||51
10659706|NCT02243371|11821103|FG001|STARTED|Overall Study||42
10659707|NCT02243371|11821102|FG000|COMPLETED|Overall Study||14
10659708|NCT02243371|11821103|FG001|COMPLETED|Overall Study||10
10659709|NCT02243371|11821102|FG000|NOT COMPLETED|Overall Study||37
10659710|NCT02243371|11821103|FG001|NOT COMPLETED|Overall Study||32
10659711|NCT02243527|11821111|FG000|STARTED|Overall Study||12
10659712|NCT02243527|11821112|FG001|STARTED|Overall Study||13
10659713|NCT02243527|11821111|FG000|COMPLETED|Overall Study||12
10659714|NCT02243527|11821112|FG001|COMPLETED|Overall Study||13
10659715|NCT02243527|11821111|FG000|NOT COMPLETED|Overall Study||0
10659716|NCT02243527|11821112|FG001|NOT COMPLETED|Overall Study||0
10659717|NCT02243579|11821118|FG000|STARTED|Overall Study||24
10659718|NCT02243579|11821118|FG000|COMPLETED|Overall Study||4
10659719|NCT02243579|11821118|FG000|NOT COMPLETED|Overall Study||20
10659720|NCT02243696|11821122|FG000|STARTED|Overall Study||1694
10659721|NCT02243696|11821122|FG000|COMPLETED|Overall Study||0
10659722|NCT02243696|11821122|FG000|NOT COMPLETED|Overall Study||1694
10659723|NCT02243865|11821128|FG000|STARTED|Overall Study||44
10659724|NCT02243865|11821129|FG001|STARTED|Overall Study||43
10659725|NCT02243865|11821128|FG000|COMPLETED|Overall Study||40
10659726|NCT02243865|11821129|FG001|COMPLETED|Overall Study||38
10659727|NCT02243865|11821128|FG000|NOT COMPLETED|Overall Study||4
10659728|NCT02243865|11821129|FG001|NOT COMPLETED|Overall Study||5
10659729|NCT02243943|11821139|FG000|STARTED|Overall Study||50
10659730|NCT02243943|11821140|FG001|STARTED|Overall Study||50
10659731|NCT02243943|11821139|FG000|COMPLETED|Overall Study||50
10659732|NCT02243943|11821140|FG001|COMPLETED|Overall Study||50
10814067|NCT02500901|11976650|FG000|STARTED|Overall Study||2
10814068|NCT02500901|11976650|FG000|COMPLETED|Overall Study||0
10814069|NCT02500901|11976650|FG000|NOT COMPLETED|Overall Study||2
10814070|NCT02483533|11976656|FG000|STARTED|Overall Study||50
10814071|NCT02483533|11976657|FG001|STARTED|Overall Study||50
10814072|NCT02483533|11976656|FG000|COMPLETED|Overall Study||0
10814073|NCT02483533|11976657|FG001|COMPLETED|Overall Study||0
10814074|NCT02483533|11976656|FG000|NOT COMPLETED|Overall Study||50
10814075|NCT02483533|11976657|FG001|NOT COMPLETED|Overall Study||50
10401028|NCT00717236|11545174|FG000|NOT COMPLETED|Double-Blind Period||80
10401029|NCT00717236|11545175|FG001|NOT COMPLETED|Double-Blind Period||28
10401030|NCT00717236|11545174|FG000|STARTED|Open-Label Period||771
10401031|NCT00717236|11545175|FG001|STARTED|Open-Label Period||184
10401032|NCT00717236|11545174|FG000|COMPLETED|Open-Label Period||646
10401033|NCT00717236|11545175|FG001|COMPLETED|Open-Label Period||163
10401034|NCT00717236|11545174|FG000|NOT COMPLETED|Open-Label Period||125
10401035|NCT00717236|11545175|FG001|NOT COMPLETED|Open-Label Period||21
10401036|NCT00717249|11545185|FG000|STARTED|Overall Study||326
10401037|NCT00717249|11545186|FG001|STARTED|Overall Study||165
10401038|NCT00717249|11545185|FG000|COMPLETED|Overall Study||304
10401039|NCT00717249|11545186|FG001|COMPLETED|Overall Study||150
10401040|NCT00717249|11545185|FG000|NOT COMPLETED|Overall Study||22
10401041|NCT00717249|11545186|FG001|NOT COMPLETED|Overall Study||15
10401042|NCT00717288|11545195|FG000|STARTED|Overall Study||28
10401043|NCT00717288|11545196|FG001|STARTED|Overall Study||29
10401044|NCT00717288|11545197|FG002|STARTED|Overall Study||25
10401045|NCT00717288|11545195|FG000|COMPLETED|Overall Study||28
10401046|NCT00717288|11545196|FG001|COMPLETED|Overall Study||29
10401047|NCT00717288|11545197|FG002|COMPLETED|Overall Study||25
10659733|NCT02243943|11821139|FG000|NOT COMPLETED|Overall Study||0
10659734|NCT02243943|11821140|FG001|NOT COMPLETED|Overall Study||0
10659735|NCT02244424|11821148|FG000|STARTED|Overall Study|Teens were the participants who received the intervention. Data were collected on the infants.|102
10721188|NCT02723201|11884811|FG000|COMPLETED|Fourth Intervention Period||9
10721189|NCT02723201|11884812|FG001|COMPLETED|Fourth Intervention Period||0
10721190|NCT02723201|11884813|FG002|COMPLETED|Fourth Intervention Period||0
10721191|NCT02723201|11884811|FG000|NOT COMPLETED|Fourth Intervention Period||0
10721192|NCT02723201|11884812|FG001|NOT COMPLETED|Fourth Intervention Period||0
10721193|NCT02723201|11884813|FG002|NOT COMPLETED|Fourth Intervention Period||0
10401048|NCT00717288|11545195|FG000|NOT COMPLETED|Overall Study||0
10401049|NCT00717288|11545196|FG001|NOT COMPLETED|Overall Study||0
10401050|NCT00717288|11545197|FG002|NOT COMPLETED|Overall Study||0
10401051|NCT00717314|11545213|FG000|STARTED|Overall Study||43
10401052|NCT00717314|11545214|FG001|STARTED|Overall Study||44
10401053|NCT00717314|11545213|FG000|COMPLETED|Overall Study||37
10401054|NCT00717314|11545214|FG001|COMPLETED|Overall Study||34
10401055|NCT00717314|11545213|FG000|NOT COMPLETED|Overall Study||6
10401056|NCT00717314|11545214|FG001|NOT COMPLETED|Overall Study||10
10401057|NCT00717366|11545222|FG000|STARTED|Core Study Period (20 Weeks)||16
10401058|NCT00717366|11545223|FG001|STARTED|Core Study Period (20 Weeks)||48
10401059|NCT00717366|11545222|FG000|COMPLETED|Core Study Period (20 Weeks)||12
10401060|NCT00717366|11545223|FG001|COMPLETED|Core Study Period (20 Weeks)||35
10401061|NCT00717366|11545222|FG000|NOT COMPLETED|Core Study Period (20 Weeks)||4
10401062|NCT00717366|11545223|FG001|NOT COMPLETED|Core Study Period (20 Weeks)||13
10401063|NCT00717366|11545222|FG000|STARTED|Extension Period (52 Weeks)||9
10401064|NCT00717366|11545223|FG001|STARTED|Extension Period (52 Weeks)||28
10401065|NCT00717366|11545222|FG000|Received Visit/Week 21 Dose|Extension Period (52 Weeks)||8
10401066|NCT00717366|11545223|FG001|Received Visit/Week 21 Dose|Extension Period (52 Weeks)||28
10401067|NCT00717366|11545222|FG000|COMPLETED|Extension Period (52 Weeks)||5
10401068|NCT00717366|11545223|FG001|COMPLETED|Extension Period (52 Weeks)||12
10401069|NCT00717366|11545222|FG000|NOT COMPLETED|Extension Period (52 Weeks)||4
10401070|NCT00717366|11545223|FG001|NOT COMPLETED|Extension Period (52 Weeks)||16
10401071|NCT00717405|11545229|FG000|STARTED|Overall Study||52
10401072|NCT00717405|11545229|FG000|COMPLETED|Overall Study||52
10401073|NCT00717405|11545229|FG000|NOT COMPLETED|Overall Study||0
10401074|NCT00717418|11545237|FG000|STARTED|Baseline||180
10401075|NCT00717418|11545238|FG001|STARTED|Baseline||74
10401076|NCT00717418|11545239|FG002|STARTED|Baseline||508
10401077|NCT00717418|11545240|FG003|STARTED|Baseline||19
10401078|NCT00717418|11545237|FG000|COMPLETED|Baseline||180
10401079|NCT00717418|11545238|FG001|COMPLETED|Baseline||74
10401080|NCT00717418|11545239|FG002|COMPLETED|Baseline||508
10401081|NCT00717418|11545240|FG003|COMPLETED|Baseline||4
10401082|NCT00717418|11545237|FG000|NOT COMPLETED|Baseline||0
10401083|NCT00717418|11545238|FG001|NOT COMPLETED|Baseline||0
10401084|NCT00717418|11545239|FG002|NOT COMPLETED|Baseline||0
10401085|NCT00717418|11545240|FG003|NOT COMPLETED|Baseline||15
10401086|NCT00717418|11545237|FG000|STARTED|1-Year Follow-Up||180
10401087|NCT00717418|11545238|FG001|STARTED|1-Year Follow-Up||74
10401088|NCT00717418|11545239|FG002|STARTED|1-Year Follow-Up||508
10401089|NCT00717418|11545240|FG003|STARTED|1-Year Follow-Up||4
10401090|NCT00717418|11545237|FG000|COMPLETED|1-Year Follow-Up||33
10401091|NCT00717418|11545238|FG001|COMPLETED|1-Year Follow-Up||23
10401092|NCT00717418|11545239|FG002|COMPLETED|1-Year Follow-Up||74
10401093|NCT00717418|11545240|FG003|COMPLETED|1-Year Follow-Up||0
10401094|NCT00717418|11545237|FG000|NOT COMPLETED|1-Year Follow-Up||147
10401095|NCT00717418|11545238|FG001|NOT COMPLETED|1-Year Follow-Up||51
10401096|NCT00717418|11545239|FG002|NOT COMPLETED|1-Year Follow-Up||434
10401097|NCT00717418|11545240|FG003|NOT COMPLETED|1-Year Follow-Up||4
10401098|NCT00717522|11545244|FG000|STARTED|Overall Study||7
10401099|NCT00717522|11545244|FG000|COMPLETED|Overall Study||0
10401100|NCT00717522|11545244|FG000|NOT COMPLETED|Overall Study||7
10401101|NCT00717574|11545250|FG000|STARTED|Overall Study||16
10401102|NCT00717574|11545251|FG001|STARTED|Overall Study||16
10401103|NCT00717574|11545250|FG000|COMPLETED|Overall Study||14
10401104|NCT00717574|11545251|FG001|COMPLETED|Overall Study||14
10401105|NCT00717574|11545250|FG000|NOT COMPLETED|Overall Study||2
10401106|NCT00717574|11545251|FG001|NOT COMPLETED|Overall Study||2
10401107|NCT00717626|11545257|FG000|STARTED|Overall Study||14
10401108|NCT00717626|11545257|FG000|COMPLETED|Overall Study||14
10401109|NCT00717626|11545257|FG000|NOT COMPLETED|Overall Study||0
10401110|NCT00717756|11545261|FG000|STARTED|Overall Study||41
10401111|NCT00717756|11545261|FG000|COMPLETED|Overall Study||40
10401112|NCT00717756|11545261|FG000|NOT COMPLETED|Overall Study||1
10401113|NCT00717769|11545268|FG000|STARTED|Overall Study||120
10401114|NCT00717769|11545269|FG001|STARTED|Overall Study||120
10401115|NCT00717769|11545270|FG002|STARTED|Overall Study||30
10401116|NCT00717769|11545268|FG000|COMPLETED|Overall Study||104
10401117|NCT00717769|11545269|FG001|COMPLETED|Overall Study||102
10312332|NCT00140231|11445699|FG000|NOT COMPLETED|Washout 8 Weeks||0
10312333|NCT00140231|11445700|FG001|NOT COMPLETED|Washout 8 Weeks||0
10312334|NCT00140231|11445699|FG000|STARTED|Fasting State With Leptin and Crossover||7
10721194|NCT02723344|11884829|FG000|STARTED|Overall Study||15
10721195|NCT02723344|11884830|FG001|STARTED|Overall Study||16
10721196|NCT02723344|11884829|FG000|COMPLETED|Overall Study||15
10721197|NCT02723344|11884830|FG001|COMPLETED|Overall Study||12
10401118|NCT00717769|11545270|FG002|COMPLETED|Overall Study||19
10401119|NCT00717769|11545268|FG000|NOT COMPLETED|Overall Study||16
10401120|NCT00717769|11545269|FG001|NOT COMPLETED|Overall Study||18
10401121|NCT00717769|11545270|FG002|NOT COMPLETED|Overall Study||11
10721198|NCT02723344|11884829|FG000|NOT COMPLETED|Overall Study||0
10814076|NCT02496039|11976663|FG000|STARTED|Overall Study||5
10814077|NCT02496039|11976663|FG000|COMPLETED|Overall Study||1
10814078|NCT02496039|11976663|FG000|NOT COMPLETED|Overall Study||4
10814079|NCT02492295|11976667|FG000|STARTED|Overall Study||0
10814080|NCT02492295|11976667|FG000|COMPLETED|Overall Study||0
10814081|NCT02492295|11976667|FG000|NOT COMPLETED|Overall Study||0
10814082|NCT02494206|11976672|FG000|STARTED|Overall Study||9
10814083|NCT02494206|11976672|FG000|COMPLETED|Overall Study||7
10814084|NCT02494206|11976672|FG000|NOT COMPLETED|Overall Study||2
10814085|NCT02473445|11976676|FG000|STARTED|Overall Study||22
10814086|NCT02473445|11976676|FG000|COMPLETED|Overall Study||0
10814087|NCT02473445|11976676|FG000|NOT COMPLETED|Overall Study||22
10814088|NCT02491411|11976680|FG000|STARTED|Overall Study||4
10814089|NCT02491411|11976680|FG000|COMPLETED|Overall Study||0
10814090|NCT02491411|11976680|FG000|NOT COMPLETED|Overall Study||4
10814091|NCT02476994|11976686|FG000|STARTED|Overall Study||1
10814092|NCT02476994|11976687|FG001|STARTED|Overall Study||0
10814093|NCT02476994|11976686|FG000|COMPLETED|Overall Study||0
10814094|NCT02476994|11976687|FG001|COMPLETED|Overall Study||0
10814095|NCT02476994|11976686|FG000|NOT COMPLETED|Overall Study||1
10814096|NCT02476994|11976687|FG001|NOT COMPLETED|Overall Study||0
10814097|NCT02473523|11976693|FG000|STARTED|Overall Study||2
10814098|NCT02473523|11976693|FG000|COMPLETED|Overall Study||0
10814099|NCT02473523|11976693|FG000|NOT COMPLETED|Overall Study||2
10814100|NCT02468583|11976699|FG000|STARTED|Overall Study||3
10814101|NCT02468583|11976700|FG001|STARTED|Overall Study||3
10814102|NCT02468583|11976699|FG000|COMPLETED|Overall Study||3
10814103|NCT02468583|11976700|FG001|COMPLETED|Overall Study||3
10814104|NCT02468583|11976699|FG000|NOT COMPLETED|Overall Study||0
10814105|NCT02468583|11976700|FG001|NOT COMPLETED|Overall Study||0
10814106|NCT02450591|11976706|FG000|STARTED|Overall Study||4
10814107|NCT02450591|11976706|FG000|COMPLETED|Overall Study||4
10814108|NCT02450591|11976706|FG000|NOT COMPLETED|Overall Study||0
10814109|NCT02472639|11976712|FG000|STARTED|Overall Study||4
10814110|NCT02472639|11976713|FG001|STARTED|Overall Study||3
10814111|NCT02472639|11976712|FG000|COMPLETED|Overall Study||0
10814112|NCT02472639|11976713|FG001|COMPLETED|Overall Study||0
10814113|NCT02472639|11976712|FG000|NOT COMPLETED|Overall Study||4
10814114|NCT02472639|11976713|FG001|NOT COMPLETED|Overall Study||3
10814115|NCT02469415|11976719|FG000|STARTED|Overall Study||3
10814116|NCT02469415|11976719|FG000|COMPLETED|Overall Study||0
10814117|NCT02469415|11976719|FG000|NOT COMPLETED|Overall Study||3
10814118|NCT02461550|11976723|FG000|STARTED|Overall Study||2
10814119|NCT02461550|11976723|FG000|COMPLETED|Overall Study||2
10814120|NCT02461550|11976723|FG000|NOT COMPLETED|Overall Study||0
10814121|NCT02461355|11976727|FG000|STARTED|Overall Study||2
10814122|NCT02461355|11976727|FG000|COMPLETED|Overall Study||2
10814123|NCT02461355|11976727|FG000|NOT COMPLETED|Overall Study||0
10814124|NCT02452359|11976731|FG000|STARTED|Overall Study||54
10814125|NCT02452359|11976731|FG000|COMPLETED|Overall Study||33
10814126|NCT02452359|11976731|FG000|NOT COMPLETED|Overall Study||21
10814127|NCT02434146|11976735|FG000|STARTED|Overall Study||3
10814128|NCT02434146|11976735|FG000|COMPLETED|Overall Study||3
10814129|NCT02434146|11976735|FG000|NOT COMPLETED|Overall Study||0
10814130|NCT02452398|11976739|FG000|STARTED|Overall Study|Study was halted prematurely. No results analysis completed.|79
10814131|NCT02452398|11976739|FG000|COMPLETED|Overall Study|Study was halted prematurely. No results analysis completed.|38
10814132|NCT02452398|11976739|FG000|NOT COMPLETED|Overall Study||41
10814133|NCT02447887|11976743|FG000|STARTED|Overall Study||3
10814134|NCT02447887|11976743|FG000|COMPLETED|Overall Study||0
10814135|NCT02447887|11976743|FG000|NOT COMPLETED|Overall Study||3
10814136|NCT02431494|11976750|FG000|STARTED|Overall Study|The results cannot be evaluated because the sample size was so small. He had trouble recruiting|0
10814137|NCT02431494|11976751|FG001|STARTED|Overall Study|The results cannot be evaluated because the sample size was so small. He had trouble recruiting|0
10814138|NCT02431494|11976752|FG002|STARTED|Overall Study|The results cannot be evaluated because the sample size was so small. He had trouble recruiting|0
10814139|NCT02431494|11976750|FG000|COMPLETED|Overall Study||0
10814140|NCT02431494|11976751|FG001|COMPLETED|Overall Study||0
10814141|NCT02431494|11976752|FG002|COMPLETED|Overall Study||0
10814142|NCT02431494|11976750|FG000|NOT COMPLETED|Overall Study||0
10814143|NCT02431494|11976751|FG001|NOT COMPLETED|Overall Study||0
10814144|NCT02431494|11976752|FG002|NOT COMPLETED|Overall Study||0
10814145|NCT02439970|11976764|FG000|STARTED|Overall Study||2
10814146|NCT02439970|11976765|FG001|STARTED|Overall Study||3
10814147|NCT02439970|11976764|FG000|COMPLETED|Overall Study||0
10814148|NCT02439970|11976765|FG001|COMPLETED|Overall Study||0
10814149|NCT02439970|11976764|FG000|NOT COMPLETED|Overall Study||2
10814150|NCT02439970|11976765|FG001|NOT COMPLETED|Overall Study||3
10814151|NCT02439957|11976773|FG000|STARTED|Overall Study||3
10814152|NCT02439957|11976774|FG001|STARTED|Overall Study||3
10814153|NCT02439957|11976773|FG000|Blinded Treatment Period|Overall Study||1
10814154|NCT02439957|11976774|FG001|Blinded Treatment Period|Overall Study||2
10814155|NCT02439957|11976773|FG000|COMPLETED|Overall Study||0
10814156|NCT02439957|11976774|FG001|COMPLETED|Overall Study||0
10814157|NCT02439957|11976773|FG000|NOT COMPLETED|Overall Study||3
10814158|NCT02439957|11976774|FG001|NOT COMPLETED|Overall Study||3
10814159|NCT02441036|11976785|FG000|STARTED|Overall Study||3
10401122|NCT00717860|11545282|FG000|STARTED|Overall Study||61
10401123|NCT00717860|11545283|FG001|STARTED|Overall Study||60
10401124|NCT00717860|11545282|FG000|COMPLETED|Overall Study||34
10401125|NCT00717860|11545283|FG001|COMPLETED|Overall Study||32
10401126|NCT00717860|11545282|FG000|NOT COMPLETED|Overall Study||27
10401127|NCT00717860|11545283|FG001|NOT COMPLETED|Overall Study||28
10401128|NCT00717873|11545291|FG000|STARTED|Overall Study||46
10401129|NCT00717873|11545292|FG001|STARTED|Overall Study||59
10401130|NCT00717873|11545291|FG000|COMPLETED|Overall Study||46
10401131|NCT00717873|11545292|FG001|COMPLETED|Overall Study||59
10401132|NCT00717873|11545291|FG000|NOT COMPLETED|Overall Study||0
10401133|NCT00717873|11545292|FG001|NOT COMPLETED|Overall Study||0
10401134|NCT00717886|11545298|FG000|STARTED|Overall Study||13
10401135|NCT00717886|11545298|FG000|COMPLETED|Overall Study||9
10401136|NCT00717886|11545298|FG000|NOT COMPLETED|Overall Study||4
10814160|NCT02441036|11976786|FG001|STARTED|Overall Study||5
10814161|NCT02441036|11976787|FG002|STARTED|Overall Study||3
10814162|NCT02441036|11976788|FG003|STARTED|Overall Study||4
10814163|NCT02441036|11976789|FG004|STARTED|Overall Study||1
10814164|NCT02441036|11976785|FG000|Treated|Overall Study||3
10814165|NCT02441036|11976786|FG001|Treated|Overall Study||5
10814166|NCT02441036|11976787|FG002|Treated|Overall Study||3
10814167|NCT02441036|11976788|FG003|Treated|Overall Study||4
10814168|NCT02441036|11976789|FG004|Treated|Overall Study||1
10814169|NCT02441036|11976785|FG000|Tissue Resected|Overall Study||3
10814170|NCT02441036|11976786|FG001|Tissue Resected|Overall Study||4
10814171|NCT02441036|11976787|FG002|Tissue Resected|Overall Study||3
10814172|NCT02441036|11976788|FG003|Tissue Resected|Overall Study||3
10814173|NCT02441036|11976789|FG004|Tissue Resected|Overall Study||1
10814174|NCT02441036|11976785|FG000|COMPLETED|Overall Study||3
10814175|NCT02441036|11976786|FG001|COMPLETED|Overall Study||4
10814176|NCT02441036|11976787|FG002|COMPLETED|Overall Study||3
10814177|NCT02441036|11976788|FG003|COMPLETED|Overall Study||3
10814178|NCT02441036|11976789|FG004|COMPLETED|Overall Study||1
10814179|NCT02441036|11976785|FG000|NOT COMPLETED|Overall Study||0
10814180|NCT02441036|11976786|FG001|NOT COMPLETED|Overall Study||1
10814181|NCT02441036|11976787|FG002|NOT COMPLETED|Overall Study||0
10814182|NCT02441036|11976788|FG003|NOT COMPLETED|Overall Study||1
10814183|NCT02441036|11976789|FG004|NOT COMPLETED|Overall Study||0
10814184|NCT02436265|11976804|FG000|STARTED|Overall Study||3
10814185|NCT02436265|11976805|FG001|STARTED|Overall Study||4
10814186|NCT02436265|11976804|FG000|COMPLETED|Overall Study||3
10814187|NCT02436265|11976805|FG001|COMPLETED|Overall Study||4
10814188|NCT02436265|11976804|FG000|NOT COMPLETED|Overall Study||0
10814189|NCT02436265|11976805|FG001|NOT COMPLETED|Overall Study||0
10814190|NCT02429583|11976813|FG000|STARTED|Overall Study||1
10814191|NCT02429583|11976814|FG001|STARTED|Overall Study||23
10814192|NCT02429583|11976813|FG000|COMPLETED|Overall Study||1
10814193|NCT02429583|11976814|FG001|COMPLETED|Overall Study||3
10814194|NCT02429583|11976813|FG000|NOT COMPLETED|Overall Study||0
10814195|NCT02429583|11976814|FG001|NOT COMPLETED|Overall Study||20
10814196|NCT02417870|11976820|FG000|STARTED|Overall Study||2
10814197|NCT02417870|11976820|FG000|COMPLETED|Overall Study||0
10814198|NCT02417870|11976820|FG000|NOT COMPLETED|Overall Study||2
10814199|NCT02430532|11976826|FG000|STARTED|Overall Study||30
10814200|NCT02430532|11976827|FG001|STARTED|Overall Study||28
10814201|NCT02430532|11976826|FG000|COMPLETED|Overall Study||0
10814202|NCT02430532|11976827|FG001|COMPLETED|Overall Study||0
10814203|NCT02430532|11976826|FG000|NOT COMPLETED|Overall Study||30
10814204|NCT02430532|11976827|FG001|NOT COMPLETED|Overall Study||28
10814205|NCT02428231|11976837|FG000|STARTED|Overall Study||30
10814206|NCT02428231|11976838|FG001|STARTED|Overall Study||32
10814207|NCT02428231|11976837|FG000|COMPLETED|Overall Study||17
10814208|NCT02428231|11976838|FG001|COMPLETED|Overall Study||15
10814209|NCT02428231|11976837|FG000|NOT COMPLETED|Overall Study||13
10814210|NCT02428231|11976838|FG001|NOT COMPLETED|Overall Study||17
10814211|NCT02424565|11976844|FG000|STARTED|Period 1 (D0)||8
10814212|NCT02424565|11976845|FG001|STARTED|Period 1 (D0)||7
10814213|NCT02424565|11976844|FG000|COMPLETED|Period 1 (D0)||8
10814214|NCT02424565|11976845|FG001|COMPLETED|Period 1 (D0)||6
10814215|NCT02424565|11976844|FG000|NOT COMPLETED|Period 1 (D0)||0
10814216|NCT02424565|11976845|FG001|NOT COMPLETED|Period 1 (D0)||1
10401137|NCT00717912|11545302|FG000|STARTED|Overall Study||1
10401138|NCT00717912|11545303|FG001|STARTED|Overall Study||1
10401139|NCT00717912|11545304|FG002|STARTED|Overall Study||1
10401140|NCT00717912|11545305|FG003|STARTED|Overall Study||1
10814217|NCT02424565|11976844|FG000|STARTED|Washout Period||8
10814218|NCT02424565|11976845|FG001|STARTED|Washout Period||6
10814219|NCT02424565|11976844|FG000|COMPLETED|Washout Period||8
10814220|NCT02424565|11976845|FG001|COMPLETED|Washout Period||6
10814221|NCT02424565|11976844|FG000|NOT COMPLETED|Washout Period||0
10814222|NCT02424565|11976845|FG001|NOT COMPLETED|Washout Period||0
10814223|NCT02424565|11976844|FG000|STARTED|Period 2 (D3)||8
10814224|NCT02424565|11976845|FG001|STARTED|Period 2 (D3)||6
10814225|NCT02424565|11976844|FG000|COMPLETED|Period 2 (D3)||8
10814226|NCT02424565|11976845|FG001|COMPLETED|Period 2 (D3)||6
10814227|NCT02424565|11976844|FG000|NOT COMPLETED|Period 2 (D3)||0
10814228|NCT02424565|11976845|FG001|NOT COMPLETED|Period 2 (D3)||0
10814229|NCT02413047|11976851|FG000|STARTED|Overall Study||3
10814230|NCT02413047|11976851|FG000|Participants on Infliximab|Overall Study||2
10721199|NCT02723344|11884830|FG001|NOT COMPLETED|Overall Study||4
10401141|NCT00717912|11545306|FG004|STARTED|Overall Study||1
10401142|NCT00717912|11545307|FG005|STARTED|Overall Study||1
10401143|NCT00717912|11545302|FG000|COMPLETED|Overall Study||1
10401144|NCT00717912|11545303|FG001|COMPLETED|Overall Study||1
10401145|NCT00717912|11545304|FG002|COMPLETED|Overall Study||1
10401146|NCT00717912|11545305|FG003|COMPLETED|Overall Study||1
10401147|NCT00717912|11545306|FG004|COMPLETED|Overall Study||1
10401148|NCT00717912|11545307|FG005|COMPLETED|Overall Study||1
10401149|NCT00717912|11545302|FG000|NOT COMPLETED|Overall Study||0
10401150|NCT00717912|11545303|FG001|NOT COMPLETED|Overall Study||0
10401151|NCT00717912|11545304|FG002|NOT COMPLETED|Overall Study||0
10401152|NCT00717912|11545305|FG003|NOT COMPLETED|Overall Study||0
10401153|NCT00717912|11545306|FG004|NOT COMPLETED|Overall Study||0
10401154|NCT00717912|11545307|FG005|NOT COMPLETED|Overall Study||0
10401155|NCT00717977|11545316|FG000|STARTED|Overall Study||74
10401156|NCT00717977|11545316|FG000|COMPLETED|Overall Study||74
10401157|NCT00717977|11545316|FG000|NOT COMPLETED|Overall Study||0
10401158|NCT00718042|11545326|FG000|STARTED|ABBOTT PRISM Chagas Testing||16313
10401159|NCT00718042|11545327|FG001|STARTED|ABBOTT PRISM Chagas Testing||289
10401160|NCT00718042|11545328|FG002|STARTED|ABBOTT PRISM Chagas Testing||525
10401161|NCT00718042|11545329|FG003|STARTED|ABBOTT PRISM Chagas Testing||110
10401162|NCT00718042|11545330|FG004|STARTED|ABBOTT PRISM Chagas Testing||25549
10401163|NCT00718042|11545331|FG005|STARTED|ABBOTT PRISM Chagas Testing|Specimens not screened with PRISM Chagas assay per protocol.|0
10401164|NCT00718042|11545326|FG000|COMPLETED|ABBOTT PRISM Chagas Testing||16249
10401165|NCT00718042|11545327|FG001|COMPLETED|ABBOTT PRISM Chagas Testing||287
10401166|NCT00718042|11545328|FG002|COMPLETED|ABBOTT PRISM Chagas Testing||524
10401167|NCT00718042|11545329|FG003|COMPLETED|ABBOTT PRISM Chagas Testing||110
10721200|NCT02723591|11884838|FG000|STARTED|Overall Study||300
10401168|NCT00718042|11545330|FG004|COMPLETED|ABBOTT PRISM Chagas Testing||25511
10401169|NCT00718042|11545331|FG005|COMPLETED|ABBOTT PRISM Chagas Testing||0
10401170|NCT00718042|11545326|FG000|NOT COMPLETED|ABBOTT PRISM Chagas Testing||64
10401171|NCT00718042|11545327|FG001|NOT COMPLETED|ABBOTT PRISM Chagas Testing||2
10401172|NCT00718042|11545328|FG002|NOT COMPLETED|ABBOTT PRISM Chagas Testing||1
10401173|NCT00718042|11545329|FG003|NOT COMPLETED|ABBOTT PRISM Chagas Testing||0
10401174|NCT00718042|11545330|FG004|NOT COMPLETED|ABBOTT PRISM Chagas Testing||38
10401175|NCT00718042|11545331|FG005|NOT COMPLETED|ABBOTT PRISM Chagas Testing||0
10401176|NCT00718042|11545326|FG000|STARTED|ESA Chagas Testing|Only specimens repeatedly reactive by screening assay or PRISM grayzone tested with ESA Chagas|36
10401177|NCT00718042|11545327|FG001|STARTED|ESA Chagas Testing||287
10401178|NCT00718042|11545328|FG002|STARTED|ESA Chagas Testing||524
10401179|NCT00718042|11545329|FG003|STARTED|ESA Chagas Testing||110
10401180|NCT00718042|11545330|FG004|STARTED|ESA Chagas Testing|Only specimens repeatedly reactive by screening assay or PRISM grayzone tested with ESA Chagas|43
10401181|NCT00718042|11545331|FG005|STARTED|ESA Chagas Testing|Specimens only tested with ESA Chagas|330
10401182|NCT00718042|11545326|FG000|COMPLETED|ESA Chagas Testing||36
10401183|NCT00718042|11545327|FG001|COMPLETED|ESA Chagas Testing||287
10401184|NCT00718042|11545328|FG002|COMPLETED|ESA Chagas Testing||524
10401185|NCT00718042|11545329|FG003|COMPLETED|ESA Chagas Testing||110
10401186|NCT00718042|11545330|FG004|COMPLETED|ESA Chagas Testing||43
10401187|NCT00718042|11545331|FG005|COMPLETED|ESA Chagas Testing||330
10659736|NCT02244424|11821149|FG001|STARTED|Overall Study|Teen participants received the MIHP standard care. Data were collected on infants.|62
10659737|NCT02244424|11821148|FG000|Infants|Overall Study|Infants of participants included in the study for collection of demographic and weight data.|51
10659738|NCT02244424|11821149|FG001|Infants|Overall Study|Infants of participants included in the study for collection of demographic and weight data.|31
10659739|NCT02244424|11821148|FG000|Mothers|Overall Study||51
10659740|NCT02244424|11821149|FG001|Mothers|Overall Study||31
10659741|NCT02244424|11821148|FG000|COMPLETED|Overall Study|Data were collected on all of the infants of the teen moms (n = 41).|82
10659742|NCT02244424|11821149|FG001|COMPLETED|Overall Study|Data were collected on all of the infants of teen moms (n = 26).|52
10659743|NCT02244424|11821148|FG000|NOT COMPLETED|Overall Study||20
10659744|NCT02244424|11821149|FG001|NOT COMPLETED|Overall Study||10
10659745|NCT02244580|11821155|FG000|STARTED|Overall Study||1010
10659746|NCT02244580|11821155|FG000|COMPLETED|Overall Study|An RT-qPCR assay was performed from breast cancer tissues of 769 out of the 1010 patients.|769
10659747|NCT02244580|11821155|FG000|NOT COMPLETED|Overall Study||241
10659748|NCT02244619|11821165|FG000|STARTED|Overall Study||249
10659749|NCT02244619|11821166|FG001|STARTED|Overall Study||266
10659750|NCT02244619|11821165|FG000|COMPLETED|Overall Study||241
10721201|NCT02723591|11884839|FG001|STARTED|Overall Study||299
10721202|NCT02723591|11884838|FG000|COMPLETED|Overall Study||204
10721203|NCT02723591|11884839|FG001|COMPLETED|Overall Study||198
10721204|NCT02723591|11884838|FG000|NOT COMPLETED|Overall Study||96
10721205|NCT02723591|11884839|FG001|NOT COMPLETED|Overall Study||101
10721206|NCT02723630|11884851|FG000|STARTED|Intervention Period 1||10
10814231|NCT02413047|11976851|FG000|Participants on Adalimumab|Overall Study||1
10814232|NCT02413047|11976851|FG000|COMPLETED|Overall Study||3
10814233|NCT02413047|11976851|FG000|NOT COMPLETED|Overall Study||0
10814234|NCT02414698|11976857|FG000|STARTED|Overall Study||3
10814235|NCT02414698|11976858|FG001|STARTED|Overall Study||1
10814236|NCT02414698|11976857|FG000|COMPLETED|Overall Study||3
10814237|NCT02414698|11976858|FG001|COMPLETED|Overall Study||1
10814238|NCT02414698|11976857|FG000|NOT COMPLETED|Overall Study||0
10814239|NCT02414698|11976858|FG001|NOT COMPLETED|Overall Study||0
10814240|NCT02422303|11976866|FG000|STARTED|Overall Study||6
10814241|NCT02422303|11976867|FG001|STARTED|Overall Study||6
10814242|NCT02422303|11976866|FG000|COMPLETED|Overall Study||5
10814243|NCT02422303|11976867|FG001|COMPLETED|Overall Study||5
10814244|NCT02422303|11976866|FG000|NOT COMPLETED|Overall Study||1
10814245|NCT02422303|11976867|FG001|NOT COMPLETED|Overall Study||1
10814246|NCT02415166|11976877|FG000|STARTED|Overall Study||6
10814247|NCT02415166|11976878|FG001|STARTED|Overall Study||0
10814248|NCT02415166|11976879|FG002|STARTED|Overall Study||0
10814249|NCT02415166|11976880|FG003|STARTED|Overall Study||0
10814250|NCT02415166|11976877|FG000|COMPLETED|Overall Study||6
10814251|NCT02415166|11976878|FG001|COMPLETED|Overall Study||0
10814252|NCT02415166|11976879|FG002|COMPLETED|Overall Study||0
10814253|NCT02415166|11976880|FG003|COMPLETED|Overall Study||0
10814254|NCT02415166|11976877|FG000|NOT COMPLETED|Overall Study||0
10814255|NCT02415166|11976878|FG001|NOT COMPLETED|Overall Study||0
10814256|NCT02415166|11976879|FG002|NOT COMPLETED|Overall Study||0
10814257|NCT02415166|11976880|FG003|NOT COMPLETED|Overall Study||0
10814258|NCT02414152|11976890|FG000|STARTED|Overall Study||2
10814259|NCT02414152|11976890|FG000|COMPLETED|Overall Study|Both subjects completed 56 days of anakinra but did not complete all visits in observational period|0
10814260|NCT02414152|11976890|FG000|NOT COMPLETED|Overall Study||2
10814261|NCT02410551|11976894|FG000|STARTED|Overall Study||4
10814262|NCT02410551|11976894|FG000|COMPLETED|Overall Study||0
10814263|NCT02410551|11976894|FG000|NOT COMPLETED|Overall Study||4
10814264|NCT02411643|11976899|FG000|STARTED|Overall Study||2
10721207|NCT02723630|11884852|FG001|STARTED|Intervention Period 1||10
10721208|NCT02723630|11884853|FG002|STARTED|Intervention Period 1||10
10721209|NCT02723630|11884854|FG003|STARTED|Intervention Period 1||10
10814265|NCT02411643|11976899|FG000|COMPLETED|Overall Study||2
10814266|NCT02411643|11976899|FG000|NOT COMPLETED|Overall Study||0
10814267|NCT02410954|11976905|FG000|STARTED|Overall Study||14
10401188|NCT00718042|11545326|FG000|NOT COMPLETED|ESA Chagas Testing||0
10401189|NCT00718042|11545327|FG001|NOT COMPLETED|ESA Chagas Testing||0
10401190|NCT00718042|11545328|FG002|NOT COMPLETED|ESA Chagas Testing||0
10401191|NCT00718042|11545329|FG003|NOT COMPLETED|ESA Chagas Testing||0
10401192|NCT00718042|11545330|FG004|NOT COMPLETED|ESA Chagas Testing||0
10401193|NCT00718042|11545331|FG005|NOT COMPLETED|ESA Chagas Testing||0
10401194|NCT00718042|11545326|FG000|STARTED|Donor Follow-up||36
10401195|NCT00718042|11545327|FG001|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
10721210|NCT02723630|11884855|FG004|STARTED|Intervention Period 1||10
10721211|NCT02723630|11884856|FG005|STARTED|Intervention Period 1||10
10721212|NCT02723630|11884851|FG000|COMPLETED|Intervention Period 1||9
10401196|NCT00718042|11545328|FG002|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
10401197|NCT00718042|11545329|FG003|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
10401198|NCT00718042|11545330|FG004|STARTED|Donor Follow-up||43
10401199|NCT00718042|11545331|FG005|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
10401200|NCT00718042|11545326|FG000|COMPLETED|Donor Follow-up||23
10401201|NCT00718042|11545327|FG001|COMPLETED|Donor Follow-up||0
10401202|NCT00718042|11545328|FG002|COMPLETED|Donor Follow-up||0
10401203|NCT00718042|11545329|FG003|COMPLETED|Donor Follow-up||0
10401204|NCT00718042|11545330|FG004|COMPLETED|Donor Follow-up||24
10401205|NCT00718042|11545331|FG005|COMPLETED|Donor Follow-up||0
10401206|NCT00718042|11545326|FG000|NOT COMPLETED|Donor Follow-up||13
10401207|NCT00718042|11545327|FG001|NOT COMPLETED|Donor Follow-up||0
10401208|NCT00718042|11545328|FG002|NOT COMPLETED|Donor Follow-up||0
10401209|NCT00718042|11545329|FG003|NOT COMPLETED|Donor Follow-up||0
10401210|NCT00718042|11545330|FG004|NOT COMPLETED|Donor Follow-up||19
10401211|NCT00718042|11545331|FG005|NOT COMPLETED|Donor Follow-up||0
10401212|NCT00718081|11545346|FG000|STARTED|Overall Study||29
10401213|NCT00718081|11545347|FG001|STARTED|Overall Study||29
10401214|NCT00718081|11545348|FG002|STARTED|Overall Study||30
10401215|NCT00718081|11545346|FG000|COMPLETED|Overall Study||22
10401216|NCT00718081|11545347|FG001|COMPLETED|Overall Study||25
10401217|NCT00718081|11545348|FG002|COMPLETED|Overall Study||9
10401218|NCT00718081|11545346|FG000|NOT COMPLETED|Overall Study||7
10401219|NCT00718081|11545347|FG001|NOT COMPLETED|Overall Study||4
10401220|NCT00718081|11545348|FG002|NOT COMPLETED|Overall Study||21
10401221|NCT00718094|11545358|FG000|STARTED|Overall Study||15
10401222|NCT00718094|11545359|FG001|STARTED|Overall Study||5
10401223|NCT00718094|11545358|FG000|COMPLETED|Overall Study||15
10401224|NCT00718094|11545359|FG001|COMPLETED|Overall Study||5
10401225|NCT00718094|11545358|FG000|NOT COMPLETED|Overall Study||0
10401226|NCT00718094|11545359|FG001|NOT COMPLETED|Overall Study||0
10401227|NCT00718120|11545367|FG000|STARTED|Overall Study||55
10401228|NCT00718120|11545368|FG001|STARTED|Overall Study||55
10401229|NCT00718120|11545367|FG000|COMPLETED|Overall Study||55
10401230|NCT00718120|11545368|FG001|COMPLETED|Overall Study||55
10401231|NCT00718120|11545367|FG000|NOT COMPLETED|Overall Study||0
10401232|NCT00718120|11545368|FG001|NOT COMPLETED|Overall Study||0
10401233|NCT00718159|11545381|FG000|STARTED|Overall Study||3
10401234|NCT00718159|11545382|FG001|STARTED|Overall Study||3
10401235|NCT00718159|11545383|FG002|STARTED|Overall Study||3
10401236|NCT00718159|11545384|FG003|STARTED|Overall Study||4
10401237|NCT00718159|11545385|FG004|STARTED|Overall Study||8
10401238|NCT00718159|11545386|FG005|STARTED|Overall Study||1
10401239|NCT00718159|11545387|FG006|STARTED|Overall Study||1
10401240|NCT00718159|11545381|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
10401241|NCT00718159|11545382|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
10401242|NCT00718159|11545383|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
10401243|NCT00718159|11545384|FG003|Received at Least 1 Dose of Study Drug|Overall Study||4
10401244|NCT00718159|11545385|FG004|Received at Least 1 Dose of Study Drug|Overall Study||8
10401245|NCT00718159|11545386|FG005|Received at Least 1 Dose of Study Drug|Overall Study||1
10721213|NCT02723630|11884852|FG001|COMPLETED|Intervention Period 1||10
10721214|NCT02723630|11884853|FG002|COMPLETED|Intervention Period 1||10
10721215|NCT02723630|11884854|FG003|COMPLETED|Intervention Period 1||10
10721216|NCT02723630|11884855|FG004|COMPLETED|Intervention Period 1||10
10721217|NCT02723630|11884856|FG005|COMPLETED|Intervention Period 1||10
10721218|NCT02723630|11884851|FG000|NOT COMPLETED|Intervention Period 1||1
10721219|NCT02723630|11884852|FG001|NOT COMPLETED|Intervention Period 1||0
10721220|NCT02723630|11884853|FG002|NOT COMPLETED|Intervention Period 1||0
10721221|NCT02723630|11884854|FG003|NOT COMPLETED|Intervention Period 1||0
10721222|NCT02723630|11884855|FG004|NOT COMPLETED|Intervention Period 1||0
10401246|NCT00718159|11545387|FG006|Received at Least 1 Dose of Study Drug|Overall Study||1
10401247|NCT00718159|11545381|FG000|COMPLETED|Overall Study||0
10401248|NCT00718159|11545382|FG001|COMPLETED|Overall Study||0
10401249|NCT00718159|11545383|FG002|COMPLETED|Overall Study||0
10401250|NCT00718159|11545384|FG003|COMPLETED|Overall Study||0
10401251|NCT00718159|11545385|FG004|COMPLETED|Overall Study||0
10401252|NCT00718159|11545386|FG005|COMPLETED|Overall Study||0
10401253|NCT00718159|11545387|FG006|COMPLETED|Overall Study||0
10401254|NCT00718159|11545381|FG000|NOT COMPLETED|Overall Study||3
10401255|NCT00718159|11545382|FG001|NOT COMPLETED|Overall Study||3
10401256|NCT00718159|11545383|FG002|NOT COMPLETED|Overall Study||3
10401257|NCT00718159|11545384|FG003|NOT COMPLETED|Overall Study||4
10401258|NCT00718159|11545385|FG004|NOT COMPLETED|Overall Study||8
10401259|NCT00718159|11545386|FG005|NOT COMPLETED|Overall Study||1
10401260|NCT00718159|11545387|FG006|NOT COMPLETED|Overall Study||1
10401261|NCT00718237|11545405|FG000|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized into the study|381
10401262|NCT00718237|11545406|FG001|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized into the study|381
10401263|NCT00718237|11545405|FG000|Vaccinated at Visit 1|Overall Study||380
10401264|NCT00718237|11545406|FG001|Vaccinated at Visit 1|Overall Study||381
10401265|NCT00718237|11545405|FG000|Vaccinated at Visit 2|Overall Study||373
10401266|NCT00718237|11545406|FG001|Vaccinated at Visit 2|Overall Study||374
10401267|NCT00718237|11545405|FG000|Vaccinated at Visit 3|Overall Study||371
10401268|NCT00718237|11545406|FG001|Vaccinated at Visit 3|Overall Study||369
10401269|NCT00718237|11545405|FG000|COMPLETED|Overall Study|Subjects who continued follow-up until the last visit, regardless of number of vaccinations received|368
10401270|NCT00718237|11545406|FG001|COMPLETED|Overall Study|Subjects who continued follow-up until the last visit, regardless of number of vaccinations received|366
10401271|NCT00718237|11545405|FG000|NOT COMPLETED|Overall Study||13
10401272|NCT00718237|11545406|FG001|NOT COMPLETED|Overall Study||15
10401273|NCT00718302|11545416|FG000|STARTED|Overall Study||119
10401274|NCT00718302|11545417|FG001|STARTED|Overall Study||114
10401275|NCT00718302|11545416|FG000|COMPLETED|Overall Study||119
10401276|NCT00718302|11545417|FG001|COMPLETED|Overall Study||114
10401277|NCT00718302|11545416|FG000|NOT COMPLETED|Overall Study||0
10401278|NCT00718302|11545417|FG001|NOT COMPLETED|Overall Study||0
10401279|NCT00718315|11545428|FG000|STARTED|Overall Study||67
10401280|NCT00718315|11545429|FG001|STARTED|Overall Study||67
10401281|NCT00718315|11545430|FG002|STARTED|Overall Study||67
10401282|NCT00718315|11545428|FG000|COMPLETED|Overall Study||48
10401283|NCT00718315|11545429|FG001|COMPLETED|Overall Study||45
10401284|NCT00718315|11545430|FG002|COMPLETED|Overall Study||46
10401285|NCT00718315|11545428|FG000|NOT COMPLETED|Overall Study||19
10401286|NCT00718315|11545429|FG001|NOT COMPLETED|Overall Study||22
10401287|NCT00718315|11545430|FG002|NOT COMPLETED|Overall Study||21
10721223|NCT02723630|11884856|FG005|NOT COMPLETED|Intervention Period 1||0
10721224|NCT02723630|11884851|FG000|STARTED|Intervention Period 2||9
10401288|NCT00718328|11545440|FG000|STARTED|Overall Study||1
10401289|NCT00718328|11545441|FG001|STARTED|Overall Study||0
10401290|NCT00718328|11545440|FG000|COMPLETED|Overall Study|Prematurely terminated due to poor enrollment|0
10401291|NCT00718328|11545441|FG001|COMPLETED|Overall Study|Terminated due to poor enrollment|0
10401292|NCT00718328|11545440|FG000|NOT COMPLETED|Overall Study||1
10401293|NCT00718328|11545441|FG001|NOT COMPLETED|Overall Study||0
10401294|NCT00718419|11545449|FG000|STARTED|Overall Study||14
10401295|NCT00718419|11545450|FG001|STARTED|Overall Study||42
10401296|NCT00718419|11545449|FG000|Received at Least One Dose of Study Drug|Overall Study||14
10401297|NCT00718419|11545450|FG001|Received at Least One Dose of Study Drug|Overall Study||42
10401298|NCT00718419|11545449|FG000|COMPLETED|Overall Study|Participants who completed 8 cycles of treatment.|1
10401299|NCT00718419|11545450|FG001|COMPLETED|Overall Study|Participants who completed 8 cycles of treatment.|3
10401300|NCT00718419|11545449|FG000|NOT COMPLETED|Overall Study||13
10401301|NCT00718419|11545450|FG001|NOT COMPLETED|Overall Study||39
10401302|NCT00718510|11545458|FG000|STARTED|First Intervention (3 Weeks)||7
10401303|NCT00718510|11545459|FG001|STARTED|First Intervention (3 Weeks)||8
10401304|NCT00718510|11545458|FG000|Received Intervention|First Intervention (3 Weeks)||7
10401305|NCT00718510|11545459|FG001|Received Intervention|First Intervention (3 Weeks)||7
10401306|NCT00718510|11545458|FG000|COMPLETED|First Intervention (3 Weeks)||7
10401307|NCT00718510|11545459|FG001|COMPLETED|First Intervention (3 Weeks)||7
10401308|NCT00718510|11545458|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0
10401309|NCT00718510|11545459|FG001|NOT COMPLETED|First Intervention (3 Weeks)||1
10401310|NCT00718510|11545458|FG000|STARTED|Washout (5 Days)||7
10401311|NCT00718510|11545459|FG001|STARTED|Washout (5 Days)||7
10721225|NCT02723630|11884852|FG001|STARTED|Intervention Period 2||10
10721226|NCT02723630|11884853|FG002|STARTED|Intervention Period 2||10
10721227|NCT02723630|11884854|FG003|STARTED|Intervention Period 2||10
10401312|NCT00718510|11545458|FG000|COMPLETED|Washout (5 Days)||7
10401313|NCT00718510|11545459|FG001|COMPLETED|Washout (5 Days)||7
10401314|NCT00718510|11545458|FG000|NOT COMPLETED|Washout (5 Days)||0
10401315|NCT00718510|11545459|FG001|NOT COMPLETED|Washout (5 Days)||0
10401316|NCT00718510|11545458|FG000|STARTED|Second Intervention (3 Weeks)||7
10401317|NCT00718510|11545459|FG001|STARTED|Second Intervention (3 Weeks)||7
10401318|NCT00718510|11545458|FG000|COMPLETED|Second Intervention (3 Weeks)||6
10401319|NCT00718510|11545459|FG001|COMPLETED|Second Intervention (3 Weeks)||7
10401320|NCT00718510|11545458|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||1
10401321|NCT00718510|11545459|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
10401322|NCT00718523|11545467|FG000|STARTED|Overall Study||84
10401323|NCT00718523|11545468|FG001|STARTED|Overall Study||86
10401324|NCT00718523|11545467|FG000|COMPLETED|Overall Study||66
10401325|NCT00718523|11545468|FG001|COMPLETED|Overall Study||62
10401326|NCT00718523|11545467|FG000|NOT COMPLETED|Overall Study||18
10401327|NCT00718523|11545468|FG001|NOT COMPLETED|Overall Study||24
10401328|NCT00718549|11545474|FG000|STARTED|Induction Phase||128
10401329|NCT00718549|11545475|FG001|STARTED|Induction Phase||0
10721228|NCT02723630|11884855|FG004|STARTED|Intervention Period 2||10
10312335|NCT00140231|11445700|FG001|STARTED|Fasting State With Leptin and Crossover||6
10312336|NCT00140231|11445699|FG000|COMPLETED|Fasting State With Leptin and Crossover||7
10312337|NCT00140231|11445700|FG001|COMPLETED|Fasting State With Leptin and Crossover||6
10312338|NCT00140231|11445699|FG000|NOT COMPLETED|Fasting State With Leptin and Crossover||0
10312339|NCT00140231|11445700|FG001|NOT COMPLETED|Fasting State With Leptin and Crossover||0
10315521|NCT00179621|11449407|FG000|NOT COMPLETED|Open-Label Period||0
10659751|NCT02244619|11821166|FG001|COMPLETED|Overall Study||245
10659752|NCT02244619|11821165|FG000|NOT COMPLETED|Overall Study||8
10659753|NCT02244619|11821166|FG001|NOT COMPLETED|Overall Study||21
10659754|NCT02244840|11821172|FG000|STARTED|Overall Study||40
10659755|NCT02244840|11821172|FG000|COMPLETED|Overall Study||40
10659756|NCT02244840|11821172|FG000|NOT COMPLETED|Overall Study||0
10659757|NCT02244918|11821178|FG000|STARTED|Overall Study||185
10659758|NCT02244918|11821179|FG001|STARTED|Overall Study||93
10659759|NCT02244918|11821178|FG000|Week 12|Overall Study||160
10659760|NCT02244918|11821179|FG001|Week 12|Overall Study||83
10659761|NCT02244918|11821178|FG000|COMPLETED|Overall Study||185
10659762|NCT02244918|11821179|FG001|COMPLETED|Overall Study||93
10659763|NCT02244918|11821178|FG000|NOT COMPLETED|Overall Study||0
10659764|NCT02244918|11821179|FG001|NOT COMPLETED|Overall Study||0
10659765|NCT02244957|11821188|FG000|STARTED|Overall Study||7
10659766|NCT02244957|11821189|FG001|STARTED|Overall Study||16
10659767|NCT02244957|11821188|FG000|COMPLETED|Overall Study||6
10659768|NCT02244957|11821189|FG001|COMPLETED|Overall Study||16
10721229|NCT02723630|11884856|FG005|STARTED|Intervention Period 2||10
10721230|NCT02723630|11884851|FG000|COMPLETED|Intervention Period 2||9
10721231|NCT02723630|11884852|FG001|COMPLETED|Intervention Period 2||10
10721232|NCT02723630|11884853|FG002|COMPLETED|Intervention Period 2||10
10721233|NCT02723630|11884854|FG003|COMPLETED|Intervention Period 2||10
10721234|NCT02723630|11884855|FG004|COMPLETED|Intervention Period 2||10
10721235|NCT02723630|11884856|FG005|COMPLETED|Intervention Period 2||10
10721236|NCT02723630|11884851|FG000|NOT COMPLETED|Intervention Period 2||0
10315522|NCT00179621|11449408|FG001|NOT COMPLETED|Open-Label Period||28
10315523|NCT00179621|11449409|FG002|NOT COMPLETED|Open-Label Period||28
10315524|NCT00179621|11449410|FG003|NOT COMPLETED|Open-Label Period||43
10315525|NCT00179647|11449419|FG000|STARTED|Overall Study||1913
10315526|NCT00179647|11449419|FG000|COMPLETED|Overall Study|Subjects participated in study until they presented with reason for discontinuation.|0
10315527|NCT00179647|11449419|FG000|NOT COMPLETED|Overall Study||1913
10315528|NCT00179660|11449423|FG000|STARTED|Overall Study||50
10315529|NCT00179660|11449423|FG000|Received Study Drug|Overall Study||49
10315530|NCT00179660|11449423|FG000|Completed 12 Cycles of Treatment|Overall Study||12
10315531|NCT00179660|11449423|FG000|COMPLETED|Overall Study|Completed refers to participants ongoing in the study at the time of analysis.|0
10315532|NCT00179660|11449423|FG000|NOT COMPLETED|Overall Study||50
10315533|NCT00179673|11449427|FG000|STARTED|Overall Study||43
10315534|NCT00179673|11449427|FG000|Received Study Drug|Overall Study||43
10315535|NCT00179673|11449427|FG000|COMPLETED|Overall Study|Completed refers to participants ongoing in the study at the time of analysis.|0
10315536|NCT00179673|11449427|FG000|NOT COMPLETED|Overall Study||43
10315537|NCT00179777|11449433|FG000|STARTED|Overall Study||2613
10315538|NCT00179777|11449434|FG001|STARTED|Overall Study||2543
10315539|NCT00179777|11449433|FG000|COMPLETED|Overall Study||1081
10315540|NCT00179777|11449434|FG001|COMPLETED|Overall Study||1078
10315541|NCT00179777|11449433|FG000|NOT COMPLETED|Overall Study||1532
10315542|NCT00179777|11449434|FG001|NOT COMPLETED|Overall Study||1465
10315543|NCT00179959|11449444|FG000|STARTED|Overall Study||15
10315544|NCT00179959|11449445|FG001|STARTED|Overall Study||16
10315545|NCT00179959|11449444|FG000|COMPLETED|Overall Study||9
10315546|NCT00179959|11449445|FG001|COMPLETED|Overall Study||13
10315547|NCT00179959|11449444|FG000|NOT COMPLETED|Overall Study||6
10315548|NCT00179959|11449445|FG001|NOT COMPLETED|Overall Study||3
10315549|NCT00179998|11449453|FG000|STARTED|Initial Period - 6 Months||12
10315550|NCT00179998|11449454|FG001|STARTED|Initial Period - 6 Months||12
10315551|NCT00179998|11449453|FG000|COMPLETED|Initial Period - 6 Months||12
10315552|NCT00179998|11449454|FG001|COMPLETED|Initial Period - 6 Months||12
10315553|NCT00179998|11449453|FG000|NOT COMPLETED|Initial Period - 6 Months||0
10315554|NCT00179998|11449454|FG001|NOT COMPLETED|Initial Period - 6 Months||0
10315555|NCT00179998|11449453|FG000|STARTED|Crossover Period - 6 Months||12
10315556|NCT00179998|11449454|FG001|STARTED|Crossover Period - 6 Months||12
10315557|NCT00179998|11449453|FG000|COMPLETED|Crossover Period - 6 Months||12
10315558|NCT00179998|11449454|FG001|COMPLETED|Crossover Period - 6 Months||10
10401330|NCT00718549|11545476|FG002|STARTED|Induction Phase||0
10401331|NCT00718549|11545474|FG000|COMPLETED|Induction Phase||66
10401332|NCT00718549|11545475|FG001|COMPLETED|Induction Phase||0
10401333|NCT00718549|11545476|FG002|COMPLETED|Induction Phase||0
10401334|NCT00718549|11545474|FG000|NOT COMPLETED|Induction Phase||62
10401335|NCT00718549|11545475|FG001|NOT COMPLETED|Induction Phase||0
10401336|NCT00718549|11545476|FG002|NOT COMPLETED|Induction Phase||0
10401337|NCT00718549|11545474|FG000|STARTED|Maintenance/ Observation Phase||0
10401338|NCT00718549|11545475|FG001|STARTED|Maintenance/ Observation Phase||33
10401339|NCT00718549|11545476|FG002|STARTED|Maintenance/ Observation Phase||33
10401340|NCT00718549|11545474|FG000|COMPLETED|Maintenance/ Observation Phase||0
10401341|NCT00718549|11545475|FG001|COMPLETED|Maintenance/ Observation Phase||5
10401342|NCT00718549|11545476|FG002|COMPLETED|Maintenance/ Observation Phase||3
10401343|NCT00718549|11545474|FG000|NOT COMPLETED|Maintenance/ Observation Phase||0
10401344|NCT00718549|11545475|FG001|NOT COMPLETED|Maintenance/ Observation Phase||28
10401345|NCT00718549|11545476|FG002|NOT COMPLETED|Maintenance/ Observation Phase||30
10401346|NCT00718666|11545492|FG000|STARTED|Persistence Phase Year 1||118
10401347|NCT00718666|11545493|FG001|STARTED|Persistence Phase Year 1||130
10401348|NCT00718666|11545494|FG002|STARTED|Persistence Phase Year 1||0
10401349|NCT00718666|11545492|FG000|COMPLETED|Persistence Phase Year 1||118
10401350|NCT00718666|11545493|FG001|COMPLETED|Persistence Phase Year 1||130
10401351|NCT00718666|11545494|FG002|COMPLETED|Persistence Phase Year 1|Subjects enrolled to receive Nimenrix vaccine as primary vaccination only at Booster Phase-Year 5.|0
10401352|NCT00718666|11545492|FG000|NOT COMPLETED|Persistence Phase Year 1||0
10401353|NCT00718666|11545493|FG001|NOT COMPLETED|Persistence Phase Year 1||0
10401354|NCT00718666|11545494|FG002|NOT COMPLETED|Persistence Phase Year 1||0
10401355|NCT00718666|11545492|FG000|STARTED|Persistence Phase Year 3||98
10401356|NCT00718666|11545493|FG001|STARTED|Persistence Phase Year 3||104
10401357|NCT00718666|11545494|FG002|STARTED|Persistence Phase Year 3||0
10401358|NCT00718666|11545492|FG000|COMPLETED|Persistence Phase Year 3||98
10401359|NCT00718666|11545493|FG001|COMPLETED|Persistence Phase Year 3||104
10401360|NCT00718666|11545494|FG002|COMPLETED|Persistence Phase Year 3|Subjects enrolled to receive Nimenrix vaccine as primary vaccination only at Booster Phase-Year 5.|0
10401361|NCT00718666|11545492|FG000|NOT COMPLETED|Persistence Phase Year 3||0
10401362|NCT00718666|11545493|FG001|NOT COMPLETED|Persistence Phase Year 3||0
10401363|NCT00718666|11545494|FG002|NOT COMPLETED|Persistence Phase Year 3||0
10401364|NCT00718666|11545492|FG000|STARTED|Persistence Phase Year 5||70
10401365|NCT00718666|11545493|FG001|STARTED|Persistence Phase Year 5||82
10401366|NCT00718666|11545494|FG002|STARTED|Persistence Phase Year 5||0
10401367|NCT00718666|11545492|FG000|COMPLETED|Persistence Phase Year 5||70
10401368|NCT00718666|11545493|FG001|COMPLETED|Persistence Phase Year 5||82
10401369|NCT00718666|11545494|FG002|COMPLETED|Persistence Phase Year 5|Subjects enrolled to receive Nimenrix vaccine as primary vaccination only at Booster Phase-Year 5.|0
10401370|NCT00718666|11545492|FG000|NOT COMPLETED|Persistence Phase Year 5||0
10401371|NCT00718666|11545493|FG001|NOT COMPLETED|Persistence Phase Year 5||0
10401372|NCT00718666|11545494|FG002|NOT COMPLETED|Persistence Phase Year 5||0
10401373|NCT00718666|11545492|FG000|STARTED|Booster Phase Year 5||38
10401374|NCT00718666|11545493|FG001|STARTED|Booster Phase Year 5||46
10401375|NCT00718666|11545494|FG002|STARTED|Booster Phase Year 5||100
10401376|NCT00718666|11545492|FG000|COMPLETED|Booster Phase Year 5||36
10401377|NCT00718666|11545493|FG001|COMPLETED|Booster Phase Year 5||46
10401378|NCT00718666|11545494|FG002|COMPLETED|Booster Phase Year 5||94
10401379|NCT00718666|11545492|FG000|NOT COMPLETED|Booster Phase Year 5||2
10401380|NCT00718666|11545493|FG001|NOT COMPLETED|Booster Phase Year 5||0
10401381|NCT00718666|11545494|FG002|NOT COMPLETED|Booster Phase Year 5||6
10401382|NCT00718718|11545519|FG000|STARTED|Prior to Week 12||19
10401383|NCT00718718|11545520|FG001|STARTED|Prior to Week 12||0
10401384|NCT00718718|11545521|FG002|STARTED|Prior to Week 12||17
10401385|NCT00718718|11545522|FG003|STARTED|Prior to Week 12||0
10401386|NCT00718718|11545523|FG004|STARTED|Prior to Week 12||30
10401387|NCT00718718|11545524|FG005|STARTED|Prior to Week 12||0
10401388|NCT00718718|11545525|FG006|STARTED|Prior to Week 12||30
10401389|NCT00718718|11545526|FG007|STARTED|Prior to Week 12||30
10401390|NCT00718718|11545527|FG008|STARTED|Prior to Week 12||30
10401391|NCT00718718|11545528|FG009|STARTED|Prior to Week 12||31
10401392|NCT00718718|11545519|FG000|COMPLETED|Prior to Week 12||18
10401393|NCT00718718|11545520|FG001|COMPLETED|Prior to Week 12||0
10401394|NCT00718718|11545521|FG002|COMPLETED|Prior to Week 12||16
10401395|NCT00718718|11545522|FG003|COMPLETED|Prior to Week 12||0
10401396|NCT00718718|11545523|FG004|COMPLETED|Prior to Week 12||27
10401397|NCT00718718|11545524|FG005|COMPLETED|Prior to Week 12||0
10401398|NCT00718718|11545525|FG006|COMPLETED|Prior to Week 12||29
10401399|NCT00718718|11545526|FG007|COMPLETED|Prior to Week 12||28
10401400|NCT00718718|11545527|FG008|COMPLETED|Prior to Week 12||28
10814268|NCT02410954|11976906|FG001|STARTED|Overall Study||0
10814269|NCT02410954|11976905|FG000|COMPLETED|Overall Study||0
10814270|NCT02410954|11976906|FG001|COMPLETED|Overall Study||0
10814271|NCT02410954|11976905|FG000|NOT COMPLETED|Overall Study||14
10814272|NCT02410954|11976906|FG001|NOT COMPLETED|Overall Study||0
10814273|NCT02410577|11976912|FG000|STARTED|Overall Study||2
10814274|NCT02410577|11976912|FG000|COMPLETED|Overall Study||2
10814275|NCT02410577|11976912|FG000|NOT COMPLETED|Overall Study||0
10401401|NCT00718718|11545528|FG009|COMPLETED|Prior to Week 12||31
10401402|NCT00718718|11545519|FG000|NOT COMPLETED|Prior to Week 12||1
10401403|NCT00718718|11545520|FG001|NOT COMPLETED|Prior to Week 12||0
10401404|NCT00718718|11545521|FG002|NOT COMPLETED|Prior to Week 12||1
10401405|NCT00718718|11545522|FG003|NOT COMPLETED|Prior to Week 12||0
10401406|NCT00718718|11545523|FG004|NOT COMPLETED|Prior to Week 12||3
10401407|NCT00718718|11545524|FG005|NOT COMPLETED|Prior to Week 12||0
10401408|NCT00718718|11545525|FG006|NOT COMPLETED|Prior to Week 12||1
10401409|NCT00718718|11545526|FG007|NOT COMPLETED|Prior to Week 12||2
10401410|NCT00718718|11545527|FG008|NOT COMPLETED|Prior to Week 12||2
10401411|NCT00718718|11545528|FG009|NOT COMPLETED|Prior to Week 12||0
10401412|NCT00718718|11545519|FG000|STARTED|Week 12 to End of Study||0
10401413|NCT00718718|11545520|FG001|STARTED|Week 12 to End of Study||18
10401414|NCT00718718|11545521|FG002|STARTED|Week 12 to End of Study||0
10401415|NCT00718718|11545522|FG003|STARTED|Week 12 to End of Study||16
10401416|NCT00718718|11545523|FG004|STARTED|Week 12 to End of Study||0
10401417|NCT00718718|11545524|FG005|STARTED|Week 12 to End of Study||27
10401418|NCT00718718|11545525|FG006|STARTED|Week 12 to End of Study||29
10401419|NCT00718718|11545526|FG007|STARTED|Week 12 to End of Study||28
10401420|NCT00718718|11545527|FG008|STARTED|Week 12 to End of Study||28
10401421|NCT00718718|11545528|FG009|STARTED|Week 12 to End of Study||31
10401422|NCT00718718|11545519|FG000|Treated|Week 12 to End of Study||0
10401423|NCT00718718|11545520|FG001|Treated|Week 12 to End of Study||18
10401424|NCT00718718|11545521|FG002|Treated|Week 12 to End of Study||0
10401425|NCT00718718|11545522|FG003|Treated|Week 12 to End of Study||16
10401426|NCT00718718|11545523|FG004|Treated|Week 12 to End of Study||0
10401427|NCT00718718|11545524|FG005|Treated|Week 12 to End of Study||26
10401428|NCT00718718|11545525|FG006|Treated|Week 12 to End of Study||29
10401429|NCT00718718|11545526|FG007|Treated|Week 12 to End of Study||28
10401430|NCT00718718|11545527|FG008|Treated|Week 12 to End of Study||28
10401431|NCT00718718|11545528|FG009|Treated|Week 12 to End of Study||31
10401432|NCT00718718|11545519|FG000|COMPLETED|Week 12 to End of Study||0
10401433|NCT00718718|11545520|FG001|COMPLETED|Week 12 to End of Study||17
10401434|NCT00718718|11545521|FG002|COMPLETED|Week 12 to End of Study||0
10401435|NCT00718718|11545522|FG003|COMPLETED|Week 12 to End of Study||15
10401436|NCT00718718|11545523|FG004|COMPLETED|Week 12 to End of Study||0
10401437|NCT00718718|11545524|FG005|COMPLETED|Week 12 to End of Study||24
10401438|NCT00718718|11545525|FG006|COMPLETED|Week 12 to End of Study||27
10401439|NCT00718718|11545526|FG007|COMPLETED|Week 12 to End of Study||27
10401440|NCT00718718|11545527|FG008|COMPLETED|Week 12 to End of Study||27
10401441|NCT00718718|11545528|FG009|COMPLETED|Week 12 to End of Study||31
10401442|NCT00718718|11545519|FG000|NOT COMPLETED|Week 12 to End of Study||0
10401443|NCT00718718|11545520|FG001|NOT COMPLETED|Week 12 to End of Study||1
10401444|NCT00718718|11545521|FG002|NOT COMPLETED|Week 12 to End of Study||0
10401445|NCT00718718|11545522|FG003|NOT COMPLETED|Week 12 to End of Study||1
10401446|NCT00718718|11545523|FG004|NOT COMPLETED|Week 12 to End of Study||0
10401447|NCT00718718|11545524|FG005|NOT COMPLETED|Week 12 to End of Study||3
10401448|NCT00718718|11545525|FG006|NOT COMPLETED|Week 12 to End of Study||2
10401449|NCT00718718|11545526|FG007|NOT COMPLETED|Week 12 to End of Study||1
10401450|NCT00718718|11545527|FG008|NOT COMPLETED|Week 12 to End of Study||1
10401451|NCT00718718|11545528|FG009|NOT COMPLETED|Week 12 to End of Study||0
10401452|NCT00718770|11545554|FG000|STARTED|Overall Study||10
10401453|NCT00718770|11545554|FG000|COMPLETED|Overall Study||2
10401454|NCT00718770|11545554|FG000|NOT COMPLETED|Overall Study||8
10428865|NCT00861341|11574978|FG000|STARTED|Overall Study||40
10428866|NCT00861341|11574978|FG000|COMPLETED|Overall Study||38
10428867|NCT00861341|11574978|FG000|NOT COMPLETED|Overall Study||2
10428868|NCT00861380|11574989|FG000|STARTED|Overall Study||8427
10428869|NCT00861380|11574990|FG001|STARTED|Overall Study||9112
10428870|NCT00861380|11574991|FG002|STARTED|Overall Study||8872
10428871|NCT00861380|11574992|FG003|STARTED|Overall Study||3689
10428872|NCT00861380|11574993|FG004|STARTED|Overall Study||1812
10428873|NCT00861380|11574994|FG005|STARTED|Overall Study||6249
10428874|NCT00861380|11574995|FG006|STARTED|Overall Study||3020
10428875|NCT00861380|11574989|FG000|COMPLETED|Overall Study||0
10428876|NCT00861380|11574990|FG001|COMPLETED|Overall Study||0
10428877|NCT00861380|11574991|FG002|COMPLETED|Overall Study||0
10428878|NCT00861380|11574992|FG003|COMPLETED|Overall Study||0
10428879|NCT00861380|11574993|FG004|COMPLETED|Overall Study||0
10428880|NCT00861380|11574994|FG005|COMPLETED|Overall Study||0
10428881|NCT00861380|11574995|FG006|COMPLETED|Overall Study||0
10428882|NCT00861380|11574989|FG000|NOT COMPLETED|Overall Study||8427
10428883|NCT00861380|11574990|FG001|NOT COMPLETED|Overall Study||9112
10721237|NCT02723630|11884852|FG001|NOT COMPLETED|Intervention Period 2||0
10721238|NCT02723630|11884853|FG002|NOT COMPLETED|Intervention Period 2||0
10721239|NCT02723630|11884854|FG003|NOT COMPLETED|Intervention Period 2||0
10721240|NCT02723630|11884855|FG004|NOT COMPLETED|Intervention Period 2||0
10428884|NCT00861380|11574991|FG002|NOT COMPLETED|Overall Study||8872
10428885|NCT00861380|11574992|FG003|NOT COMPLETED|Overall Study||3689
10428886|NCT00861380|11574993|FG004|NOT COMPLETED|Overall Study||1812
10428887|NCT00861380|11574994|FG005|NOT COMPLETED|Overall Study||6249
10428888|NCT00861380|11574995|FG006|NOT COMPLETED|Overall Study||3020
10428889|NCT00861471|11575028|FG000|STARTED|Overall Study||12
10428890|NCT00861471|11575028|FG000|COMPLETED|Overall Study||3
10428891|NCT00861471|11575028|FG000|NOT COMPLETED|Overall Study||9
10721241|NCT02723630|11884856|FG005|NOT COMPLETED|Intervention Period 2||0
10721242|NCT02723630|11884851|FG000|STARTED|Intervention Period 3||9
10721243|NCT02723630|11884852|FG001|STARTED|Intervention Period 3||10
10721244|NCT02723630|11884853|FG002|STARTED|Intervention Period 3||10
10721245|NCT02723630|11884854|FG003|STARTED|Intervention Period 3||10
10721246|NCT02723630|11884855|FG004|STARTED|Intervention Period 3||10
10401455|NCT00718809|11545560|FG000|STARTED|Overall Study||12
10401456|NCT00718809|11545561|FG001|STARTED|Overall Study||9
10401457|NCT00718809|11545560|FG000|COMPLETED|Overall Study||0
10401458|NCT00718809|11545561|FG001|COMPLETED|Overall Study||0
10401459|NCT00718809|11545560|FG000|NOT COMPLETED|Overall Study||12
10401460|NCT00718809|11545561|FG001|NOT COMPLETED|Overall Study||9
10401461|NCT00718861|11545569|FG000|STARTED|Overall Study|"Started indicates Randomized and Intent-to Treat (ITT) population"|95
10401462|NCT00718861|11545570|FG001|STARTED|Overall Study||95
10401463|NCT00718861|11545569|FG000|Safety Set|Overall Study|3 patients randomized but never received study drug|92
10401464|NCT00718861|11545570|FG001|Safety Set|Overall Study||95
10401465|NCT00718861|11545569|FG000|Modified Intent to Treat|Overall Study|ITT patients with DXA total hip measure at extension 2 baseline and year 9|67
10401466|NCT00718861|11545570|FG001|Modified Intent to Treat|Overall Study|ITT patients with DXA total hip measure at extension 2 baseline and year 9|69
10401467|NCT00718861|11545569|FG000|COMPLETED|Overall Study||74
10401468|NCT00718861|11545570|FG001|COMPLETED|Overall Study||77
10401469|NCT00718861|11545569|FG000|NOT COMPLETED|Overall Study||21
10401470|NCT00718861|11545570|FG001|NOT COMPLETED|Overall Study||18
10401471|NCT00718887|11545578|FG000|STARTED|Overall Study|Participants who received treatment.|89
10659769|NCT02244957|11821188|FG000|NOT COMPLETED|Overall Study||1
10659770|NCT02244957|11821189|FG001|NOT COMPLETED|Overall Study||0
10659771|NCT02244996|11821199|FG000|STARTED|Overall Study||25
10659772|NCT02244996|11821200|FG001|STARTED|Overall Study||25
10659773|NCT02244996|11821199|FG000|COMPLETED|Overall Study||23
10659774|NCT02244996|11821200|FG001|COMPLETED|Overall Study||19
10659775|NCT02244996|11821199|FG000|NOT COMPLETED|Overall Study||2
10659776|NCT02244996|11821200|FG001|NOT COMPLETED|Overall Study||6
10659777|NCT02245217|11821206|FG000|STARTED|Overall Study||9
10659778|NCT02245217|11821206|FG000|COMPLETED|Overall Study||7
10659779|NCT02245217|11821206|FG000|NOT COMPLETED|Overall Study||2
10659780|NCT02245360|11821212|FG000|STARTED|Overall Study||53
10659781|NCT02245360|11821213|FG001|STARTED|Overall Study||54
10659782|NCT02245360|11821212|FG000|COMPLETED|Overall Study||48
10659783|NCT02245360|11821213|FG001|COMPLETED|Overall Study||52
10659784|NCT02245360|11821212|FG000|NOT COMPLETED|Overall Study||5
10659785|NCT02245360|11821213|FG001|NOT COMPLETED|Overall Study||2
10659786|NCT02245412|11821222|FG000|STARTED|Treatment Period||17
10721247|NCT02723630|11884856|FG005|STARTED|Intervention Period 3||10
10721248|NCT02723630|11884851|FG000|COMPLETED|Intervention Period 3||9
10721249|NCT02723630|11884852|FG001|COMPLETED|Intervention Period 3||9
10721250|NCT02723630|11884853|FG002|COMPLETED|Intervention Period 3||10
10721251|NCT02723630|11884854|FG003|COMPLETED|Intervention Period 3||10
10721252|NCT02723630|11884855|FG004|COMPLETED|Intervention Period 3||10
10721253|NCT02723630|11884856|FG005|COMPLETED|Intervention Period 3||10
10721254|NCT02723630|11884851|FG000|NOT COMPLETED|Intervention Period 3||0
10721255|NCT02723630|11884852|FG001|NOT COMPLETED|Intervention Period 3||1
10721256|NCT02723630|11884853|FG002|NOT COMPLETED|Intervention Period 3||0
10721257|NCT02723630|11884854|FG003|NOT COMPLETED|Intervention Period 3||0
10721258|NCT02723630|11884855|FG004|NOT COMPLETED|Intervention Period 3||0
10721259|NCT02723630|11884856|FG005|NOT COMPLETED|Intervention Period 3||0
10721260|NCT02723786|11884869|FG000|STARTED|Overall Study||7
10721261|NCT02723786|11884869|FG000|COMPLETED|Overall Study||6
10721262|NCT02723786|11884869|FG000|NOT COMPLETED|Overall Study||1
10721263|NCT02723916|11884875|FG000|STARTED|Overall Study||144
10721264|NCT02723916|11884876|FG001|STARTED|Overall Study||143
10721265|NCT02723916|11884875|FG000|COMPLETED|Overall Study||135
10721266|NCT02723916|11884876|FG001|COMPLETED|Overall Study||137
10721267|NCT02723916|11884875|FG000|NOT COMPLETED|Overall Study||9
10721268|NCT02723916|11884876|FG001|NOT COMPLETED|Overall Study||6
10401472|NCT00718887|11545579|FG001|STARTED|Overall Study|Participants who received treatment.|77
10401473|NCT00718887|11545578|FG000|COMPLETED|Overall Study|Continued in study after 48 weeks|84
10401474|NCT00718887|11545579|FG001|COMPLETED|Overall Study||68
10401475|NCT00718887|11545578|FG000|NOT COMPLETED|Overall Study||5
10401476|NCT00718887|11545579|FG001|NOT COMPLETED|Overall Study||9
10401477|NCT00719043|11545598|FG000|STARTED|Overall Study||120
10401478|NCT00719043|11545599|FG001|STARTED|Overall Study||121
10401479|NCT00719043|11545600|FG002|STARTED|Overall Study||119
10401480|NCT00719043|11545601|FG003|STARTED|Overall Study||119
10401481|NCT00719043|11545602|FG004|STARTED|Overall Study||122
10401482|NCT00719043|11545603|FG005|STARTED|Overall Study||120
10401483|NCT00719043|11545604|FG006|STARTED|Overall Study||120
10401484|NCT00719043|11545598|FG000|COMPLETED|Overall Study|Up to Day 909|88
10401485|NCT00719043|11545599|FG001|COMPLETED|Overall Study|Up to Day 909|96
10401486|NCT00719043|11545600|FG002|COMPLETED|Overall Study|Up to Day 909|99
10401487|NCT00719043|11545601|FG003|COMPLETED|Overall Study|Up to Day 909|96
10401488|NCT00719043|11545602|FG004|COMPLETED|Overall Study|Up to Day 909|95
10401489|NCT00719043|11545603|FG005|COMPLETED|Overall Study|Up to Day 909|86
10401490|NCT00719043|11545604|FG006|COMPLETED|Overall Study|Up to Day 909|92
10401491|NCT00719043|11545598|FG000|NOT COMPLETED|Overall Study||32
10401492|NCT00719043|11545599|FG001|NOT COMPLETED|Overall Study||25
10401493|NCT00719043|11545600|FG002|NOT COMPLETED|Overall Study||20
10401494|NCT00719043|11545601|FG003|NOT COMPLETED|Overall Study||23
10401495|NCT00719043|11545602|FG004|NOT COMPLETED|Overall Study||27
10401496|NCT00719043|11545603|FG005|NOT COMPLETED|Overall Study||34
10401497|NCT00719043|11545604|FG006|NOT COMPLETED|Overall Study||28
10401498|NCT00719134|11545632|FG000|STARTED|Overall Study||76
10401499|NCT00719134|11545632|FG000|COMPLETED|Overall Study||66
10401500|NCT00719134|11545632|FG000|NOT COMPLETED|Overall Study||10
10401501|NCT00719160|11545637|FG000|STARTED|Overall Study||6
10401502|NCT00719160|11545638|FG001|STARTED|Overall Study||6
10401503|NCT00719160|11545637|FG000|COMPLETED|Overall Study||6
10401504|NCT00719160|11545638|FG001|COMPLETED|Overall Study||6
10401505|NCT00719160|11545637|FG000|NOT COMPLETED|Overall Study||0
10401506|NCT00719160|11545638|FG001|NOT COMPLETED|Overall Study||0
10401507|NCT00719186|11545647|FG000|STARTED|Overall Study||376
10401508|NCT00719186|11545648|FG001|STARTED|Overall Study||374
10401509|NCT00719186|11545647|FG000|COMPLETED|Overall Study||376
10401510|NCT00719186|11545648|FG001|COMPLETED|Overall Study||374
10401511|NCT00719186|11545647|FG000|NOT COMPLETED|Overall Study||0
10401512|NCT00719186|11545648|FG001|NOT COMPLETED|Overall Study||0
10401513|NCT00719212|11545654|FG000|STARTED|Overall Study||61
10401514|NCT00719212|11545654|FG000|COMPLETED|Overall Study||17
10401515|NCT00719212|11545654|FG000|NOT COMPLETED|Overall Study||44
10401516|NCT00719264|11545660|FG000|STARTED|Overall Study||182
10401517|NCT00719264|11545661|FG001|STARTED|Overall Study||183
10401518|NCT00719264|11545660|FG000|Full Analysis Set|Overall Study||182
10401519|NCT00719264|11545661|FG001|Full Analysis Set|Overall Study||183
10401520|NCT00719264|11545660|FG000|Safety Set|Overall Study||180
10401521|NCT00719264|11545661|FG001|Safety Set|Overall Study||181
10401522|NCT00719264|11545660|FG000|COMPLETED|Overall Study||0
10401523|NCT00719264|11545661|FG001|COMPLETED|Overall Study||0
10401524|NCT00719264|11545660|FG000|NOT COMPLETED|Overall Study||182
10401525|NCT00719264|11545661|FG001|NOT COMPLETED|Overall Study||183
10401526|NCT00719329|11545670|FG000|STARTED|Overall Study||705
10401527|NCT00719329|11545671|FG001|STARTED|Overall Study||571
10401528|NCT00719329|11545672|FG002|STARTED|Overall Study||647
10401529|NCT00719329|11545670|FG000|Day 1 Swab|Overall Study||705
10401530|NCT00719329|11545671|FG001|Day 1 Swab|Overall Study||569
10401531|NCT00719329|11545672|FG002|Day 1 Swab|Overall Study||646
10401532|NCT00719329|11545670|FG000|Day 3 Swab|Overall Study||614
10401533|NCT00719329|11545671|FG001|Day 3 Swab|Overall Study||501
10401534|NCT00719329|11545672|FG002|Day 3 Swab|Overall Study||578
10401535|NCT00719329|11545670|FG000|Day 7 Swab|Overall Study||593
10401536|NCT00719329|11545671|FG001|Day 7 Swab|Overall Study||467
10401537|NCT00719329|11545672|FG002|Day 7 Swab|Overall Study||561
10401538|NCT00719329|11545670|FG000|COMPLETED|Overall Study||705
10401539|NCT00719329|11545671|FG001|COMPLETED|Overall Study||569
10401540|NCT00719329|11545672|FG002|COMPLETED|Overall Study||646
10401541|NCT00719329|11545670|FG000|NOT COMPLETED|Overall Study||0
10401542|NCT00719329|11545671|FG001|NOT COMPLETED|Overall Study||2
10401543|NCT00719329|11545672|FG002|NOT COMPLETED|Overall Study||1
10401544|NCT00719355|11545685|FG000|STARTED|Overall Study||51
10401545|NCT00719355|11545686|FG001|STARTED|Overall Study||52
10401546|NCT00719355|11545685|FG000|Completed 6 Weeks|Overall Study||49
10401547|NCT00719355|11545686|FG001|Completed 6 Weeks|Overall Study||48
10401548|NCT00719355|11545685|FG000|Completed 12 Weeks|Overall Study||43
10401549|NCT00719355|11545686|FG001|Completed 12 Weeks|Overall Study||46
10401550|NCT00719355|11545685|FG000|Completed 24 Weeks|Overall Study||34
10401551|NCT00719355|11545686|FG001|Completed 24 Weeks|Overall Study||43
10401552|NCT00719355|11545685|FG000|Completed 32 Weeks|Overall Study||33
10401553|NCT00719355|11545686|FG001|Completed 32 Weeks|Overall Study||39
10401554|NCT00719355|11545685|FG000|COMPLETED|Overall Study||33
10401555|NCT00719355|11545686|FG001|COMPLETED|Overall Study||39
10401556|NCT00719355|11545685|FG000|NOT COMPLETED|Overall Study||18
10401557|NCT00719355|11545686|FG001|NOT COMPLETED|Overall Study||13
10401558|NCT00719472|11545692|FG000|STARTED|Enrolled in Study||451
10401559|NCT00719472|11545692|FG000|COMPLETED|Enrolled in Study||425
10401560|NCT00719472|11545692|FG000|NOT COMPLETED|Enrolled in Study||26
10401561|NCT00719472|11545692|FG000|STARTED|Received Cycle 1 Treatment||425
10401562|NCT00719472|11545692|FG000|COMPLETED|Received Cycle 1 Treatment||372
10401563|NCT00719472|11545692|FG000|NOT COMPLETED|Received Cycle 1 Treatment||53
10401564|NCT00719472|11545692|FG000|STARTED|Received Cycle 2 Treatment||372
10401565|NCT00719472|11545692|FG000|COMPLETED|Received Cycle 2 Treatment||304
10401566|NCT00719472|11545692|FG000|NOT COMPLETED|Received Cycle 2 Treatment||68
10401567|NCT00719537|11545698|FG000|STARTED|Overall Study||2
10401568|NCT00719537|11545699|FG001|STARTED|Overall Study||1
10659787|NCT02245412|11821223|FG001|STARTED|Treatment Period||6
10659788|NCT02245412|11821224|FG002|STARTED|Treatment Period||2
10659789|NCT02245412|11821222|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||17
10721275|NCT02724020|11884896|FG000|STARTED|Overall Study||32
10721276|NCT02724020|11884897|FG001|STARTED|Overall Study||32
10721277|NCT02724020|11884898|FG002|STARTED|Overall Study||32
10721278|NCT02724020|11884896|FG000|Treated (Safety Analysis Set)|Overall Study||32
10814276|NCT02409355|11976918|FG000|STARTED|Overall Study||4
10814277|NCT02409355|11976919|FG001|STARTED|Overall Study||4
10814278|NCT02409355|11976918|FG000|COMPLETED|Overall Study||0
10814279|NCT02409355|11976919|FG001|COMPLETED|Overall Study||0
10814280|NCT02409355|11976918|FG000|NOT COMPLETED|Overall Study||4
10814281|NCT02409355|11976919|FG001|NOT COMPLETED|Overall Study||4
10814282|NCT02403154|11976929|FG000|STARTED|Overall Study||2
10814283|NCT02403154|11976930|FG001|STARTED|Overall Study||0
10814284|NCT02403154|11976931|FG002|STARTED|Overall Study||1
10814285|NCT02403154|11976932|FG003|STARTED|Overall Study||1
10814286|NCT02403154|11976929|FG000|COMPLETED|Overall Study||0
10814287|NCT02403154|11976930|FG001|COMPLETED|Overall Study||0
10814288|NCT02403154|11976931|FG002|COMPLETED|Overall Study||0
10814289|NCT02403154|11976932|FG003|COMPLETED|Overall Study||0
10814290|NCT02403154|11976929|FG000|NOT COMPLETED|Overall Study||2
10814291|NCT02403154|11976930|FG001|NOT COMPLETED|Overall Study||0
10814292|NCT02403154|11976931|FG002|NOT COMPLETED|Overall Study||1
10814293|NCT02403154|11976932|FG003|NOT COMPLETED|Overall Study||1
10814294|NCT02404545|11976944|FG000|STARTED|Overall Study||6
10814295|NCT02404545|11976945|FG001|STARTED|Overall Study||6
10814296|NCT02404545|11976944|FG000|COMPLETED|Overall Study||0
10814297|NCT02404545|11976945|FG001|COMPLETED|Overall Study||0
10814298|NCT02404545|11976944|FG000|NOT COMPLETED|Overall Study||6
10814299|NCT02404545|11976945|FG001|NOT COMPLETED|Overall Study||6
10814300|NCT02392377|11976954|FG000|STARTED|Overall Study||0
10814301|NCT02392377|11976955|FG001|STARTED|Overall Study||1
10814302|NCT02392377|11976954|FG000|COMPLETED|Overall Study||0
10814303|NCT02392377|11976955|FG001|COMPLETED|Overall Study||0
10814304|NCT02392377|11976954|FG000|NOT COMPLETED|Overall Study||0
10814305|NCT02392377|11976955|FG001|NOT COMPLETED|Overall Study||1
10814306|NCT02399111|11976967|FG000|STARTED|Overall Study||4
10814307|NCT02399111|11976968|FG001|STARTED|Overall Study||1
10814308|NCT02399111|11976969|FG002|STARTED|Overall Study||4
10814309|NCT02399111|11976970|FG003|STARTED|Overall Study||0
10814310|NCT02399111|11976967|FG000|COMPLETED|Overall Study||4
10814311|NCT02399111|11976968|FG001|COMPLETED|Overall Study||1
10814312|NCT02399111|11976969|FG002|COMPLETED|Overall Study||4
10814313|NCT02399111|11976970|FG003|COMPLETED|Overall Study||0
10814314|NCT02399111|11976967|FG000|NOT COMPLETED|Overall Study||0
10814315|NCT02399111|11976968|FG001|NOT COMPLETED|Overall Study||0
10814316|NCT02399111|11976969|FG002|NOT COMPLETED|Overall Study||0
10814317|NCT02399111|11976970|FG003|NOT COMPLETED|Overall Study||0
10659790|NCT02245412|11821223|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||6
10659791|NCT02245412|11821224|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||2
10721279|NCT02724020|11884897|FG001|Treated (Safety Analysis Set)|Overall Study||32
10721280|NCT02724020|11884898|FG002|Treated (Safety Analysis Set)|Overall Study||31
10721281|NCT02724020|11884896|FG000|COMPLETED|Overall Study||0
10721282|NCT02724020|11884897|FG001|COMPLETED|Overall Study||0
10721283|NCT02724020|11884898|FG002|COMPLETED|Overall Study||0
10721284|NCT02724020|11884896|FG000|NOT COMPLETED|Overall Study||32
10721285|NCT02724020|11884897|FG001|NOT COMPLETED|Overall Study||32
10721286|NCT02724020|11884898|FG002|NOT COMPLETED|Overall Study||32
10814318|NCT02402036|11976982|FG000|STARTED|Overall Study||10
10814319|NCT02402036|11976982|FG000|COMPLETED|Overall Study||10
10814320|NCT02402036|11976982|FG000|NOT COMPLETED|Overall Study||0
10814321|NCT02394665|11976989|FG000|STARTED|Overall Study||1
10659792|NCT02245412|11821222|FG000|Modified Full Analysis Set (mFAS)|Treatment Period||16
10659793|NCT02245412|11821223|FG001|Modified Full Analysis Set (mFAS)|Treatment Period||6
10659794|NCT02245412|11821224|FG002|Modified Full Analysis Set (mFAS)|Treatment Period||2
10814322|NCT02394665|11976990|FG001|STARTED|Overall Study||0
10401569|NCT00719537|11545698|FG000|COMPLETED|Overall Study||1
10401570|NCT00719537|11545699|FG001|COMPLETED|Overall Study||0
10659795|NCT02245412|11821222|FG000|COMPLETED|Treatment Period||12
10659796|NCT02245412|11821223|FG001|COMPLETED|Treatment Period||3
10659797|NCT02245412|11821224|FG002|COMPLETED|Treatment Period||2
10659798|NCT02245412|11821222|FG000|NOT COMPLETED|Treatment Period||5
10659799|NCT02245412|11821223|FG001|NOT COMPLETED|Treatment Period||3
10312340|NCT00140244|11445706|FG000|STARTED|Intervention 1||3
10401571|NCT00719537|11545698|FG000|NOT COMPLETED|Overall Study||1
10401572|NCT00719537|11545699|FG001|NOT COMPLETED|Overall Study||1
10401573|NCT00719563|11545707|FG000|STARTED|Overall Study||171
10401574|NCT00719563|11545708|FG001|STARTED|Overall Study||170
10401575|NCT00719563|11545707|FG000|COMPLETED|Overall Study||133
10401576|NCT00719563|11545708|FG001|COMPLETED|Overall Study||128
10401577|NCT00719563|11545707|FG000|NOT COMPLETED|Overall Study||38
10401578|NCT00719563|11545708|FG001|NOT COMPLETED|Overall Study||42
10401579|NCT00719576|11545717|FG000|STARTED|Overall Study||72
10401580|NCT00719576|11545718|FG001|STARTED|Overall Study||72
10401581|NCT00719576|11545717|FG000|COMPLETED|Overall Study||70
10401582|NCT00719576|11545718|FG001|COMPLETED|Overall Study||67
10401583|NCT00719576|11545717|FG000|NOT COMPLETED|Overall Study||2
10401584|NCT00719576|11545718|FG001|NOT COMPLETED|Overall Study||5
10401585|NCT00719615|11545729|FG000|STARTED|Overall Study||42
10401586|NCT00719615|11545730|FG001|STARTED|Overall Study||45
10401587|NCT00719615|11545731|FG002|STARTED|Overall Study||24
10401588|NCT00719615|11545729|FG000|COMPLETED|Overall Study||42
10401589|NCT00719615|11545730|FG001|COMPLETED|Overall Study||45
10401590|NCT00719615|11545731|FG002|COMPLETED|Overall Study||24
10401591|NCT00719615|11545729|FG000|NOT COMPLETED|Overall Study||0
10401592|NCT00719615|11545730|FG001|NOT COMPLETED|Overall Study||0
10401593|NCT00719615|11545731|FG002|NOT COMPLETED|Overall Study||0
10401594|NCT00719680|11545739|FG000|STARTED|Overall Study||21
10401595|NCT00719680|11545739|FG000|COMPLETED|Overall Study||16
10401596|NCT00719680|11545739|FG000|NOT COMPLETED|Overall Study||5
10401597|NCT00719706|11545745|FG000|STARTED|Overall Study||20
10401598|NCT00719706|11545746|FG001|STARTED|Overall Study||20
10401599|NCT00719706|11545745|FG000|COMPLETED|Overall Study||11
10401600|NCT00719706|11545746|FG001|COMPLETED|Overall Study||14
10401601|NCT00719706|11545745|FG000|NOT COMPLETED|Overall Study||9
10401602|NCT00719706|11545746|FG001|NOT COMPLETED|Overall Study||6
10401603|NCT00719732|11545752|FG000|STARTED|Overall Study||218
10401604|NCT00719732|11545752|FG000|COMPLETED|Overall Study||196
10401605|NCT00719732|11545752|FG000|NOT COMPLETED|Overall Study||22
10401606|NCT00719810|11545759|FG000|STARTED|Overall Study||49
10401607|NCT00719810|11545760|FG001|STARTED|Overall Study||51
10401608|NCT00719810|11545761|FG002|STARTED|Overall Study||50
10401609|NCT00719810|11545759|FG000|COMPLETED|Overall Study||46
10401610|NCT00719810|11545760|FG001|COMPLETED|Overall Study||47
10401611|NCT00719810|11545761|FG002|COMPLETED|Overall Study||42
10401612|NCT00719810|11545759|FG000|NOT COMPLETED|Overall Study||3
10401613|NCT00719810|11545760|FG001|NOT COMPLETED|Overall Study||4
10401614|NCT00719810|11545761|FG002|NOT COMPLETED|Overall Study||8
10401615|NCT00719849|11545771|FG000|STARTED|Overall Study||4
10401616|NCT00719849|11545772|FG001|STARTED|Overall Study||9
10401617|NCT00719849|11545771|FG000|COMPLETED|Overall Study||4
10401618|NCT00719849|11545772|FG001|COMPLETED|Overall Study||8
10401619|NCT00719849|11545771|FG000|NOT COMPLETED|Overall Study||0
10401620|NCT00719849|11545772|FG001|NOT COMPLETED|Overall Study||1
10401621|NCT00719862|11545780|FG000|STARTED|Overall Study||242
10401622|NCT00719862|11545781|FG001|STARTED|Overall Study|1 subject was randomized in error|239
10401623|NCT00719862|11545780|FG000|COMPLETED|Overall Study||234
10401624|NCT00719862|11545781|FG001|COMPLETED|Overall Study||233
10401625|NCT00719862|11545780|FG000|NOT COMPLETED|Overall Study||8
10401626|NCT00719862|11545781|FG001|NOT COMPLETED|Overall Study||6
10401627|NCT00719901|11545787|FG000|STARTED|Overall Study||11
10401628|NCT00719901|11545787|FG000|COMPLETED|Overall Study||0
10401629|NCT00719901|11545787|FG000|NOT COMPLETED|Overall Study||11
10401630|NCT00719953|11545791|FG000|STARTED|Overall Study||30
10401631|NCT00719953|11545791|FG000|COMPLETED|Overall Study||26
10401632|NCT00719953|11545791|FG000|NOT COMPLETED|Overall Study||4
10401633|NCT00720057|11545797|FG000|STARTED|Overall Study||153
10401634|NCT00720057|11545798|FG001|STARTED|Overall Study||159
10401635|NCT00720057|11545797|FG000|COMPLETED|Overall Study||152
10401636|NCT00720057|11545798|FG001|COMPLETED|Overall Study||156
10543960|NCT01487200|11697124|FG000|COMPLETED|Overall Study||5
10543961|NCT01487200|11697125|FG001|COMPLETED|Overall Study||6
10543962|NCT01487200|11697126|FG002|COMPLETED|Overall Study||7
10543963|NCT01487200|11697127|FG003|COMPLETED|Overall Study||5
10543964|NCT01487200|11697124|FG000|NOT COMPLETED|Overall Study||0
10543965|NCT01487200|11697125|FG001|NOT COMPLETED|Overall Study||1
10543966|NCT01487200|11697126|FG002|NOT COMPLETED|Overall Study||0
10543967|NCT01487200|11697127|FG003|NOT COMPLETED|Overall Study||0
10543968|NCT01487265|11697138|FG000|STARTED|Overall Study||37
10543969|NCT01487265|11697138|FG000|COMPLETED|Overall Study||0
10543970|NCT01487265|11697138|FG000|NOT COMPLETED|Overall Study||37
10543971|NCT01487525|11697144|FG000|STARTED|Overall Study||22
10543972|NCT01487525|11697145|FG001|STARTED|Overall Study||20
10543973|NCT01487525|11697144|FG000|COMPLETED|Overall Study||22
10543974|NCT01487525|11697145|FG001|COMPLETED|Overall Study||19
10543975|NCT01487525|11697144|FG000|NOT COMPLETED|Overall Study||0
10543976|NCT01487525|11697145|FG001|NOT COMPLETED|Overall Study||1
10543977|NCT01487577|11697151|FG000|STARTED|Overall Study||19
10543978|NCT01487577|11697151|FG000|COMPLETED|Overall Study|One participant became ineligible after signing consent, but before receiving protocol therapy.|18
10543979|NCT01487577|11697151|FG000|NOT COMPLETED|Overall Study||1
10543980|NCT01487668|11697157|FG000|STARTED|Overall Study||146
10543981|NCT01487668|11697158|FG001|STARTED|Overall Study||141
10543982|NCT01487668|11697157|FG000|COMPLETED|Overall Study||121
10543983|NCT01487668|11697158|FG001|COMPLETED|Overall Study||124
10543984|NCT01487668|11697157|FG000|NOT COMPLETED|Overall Study||25
10543985|NCT01487668|11697158|FG001|NOT COMPLETED|Overall Study||17
10543986|NCT01487863|11697168|FG000|STARTED|Overall Study||35
10543987|NCT01487863|11697169|FG001|STARTED|Overall Study||34
10543988|NCT01487863|11697168|FG000|Subjects Randomized (Efficacy Analysis)|Overall Study||35
10543989|NCT01487863|11697169|FG001|Subjects Randomized (Efficacy Analysis)|Overall Study||34
10543990|NCT01487863|11697168|FG000|Rcvd ≥1 Leukapheresis (Safety Analysis)|Overall Study||35
10543991|NCT01487863|11697169|FG001|Rcvd ≥1 Leukapheresis (Safety Analysis)|Overall Study||34
10543992|NCT01487863|11697168|FG000|COMPLETED|Overall Study||16
10543993|NCT01487863|11697169|FG001|COMPLETED|Overall Study||15
10543994|NCT01487863|11697168|FG000|NOT COMPLETED|Overall Study||19
10543995|NCT01487863|11697169|FG001|NOT COMPLETED|Overall Study||19
10543996|NCT01487954|11697177|FG000|STARTED|Overall Study||29
10543997|NCT01487954|11697178|FG001|STARTED|Overall Study||16
10543998|NCT01487954|11697177|FG000|Safety lead-in|Overall Study||10
10543999|NCT01487954|11697178|FG001|Safety lead-in|Overall Study|Only the first 10 patients in the alkaline group were analyzed, as that was the experimental group.|0
10544000|NCT01487954|11697177|FG000|COMPLETED|Overall Study||29
10544001|NCT01487954|11697178|FG001|COMPLETED|Overall Study||16
10544002|NCT01487954|11697177|FG000|NOT COMPLETED|Overall Study||0
10544003|NCT01487954|11697178|FG001|NOT COMPLETED|Overall Study||0
10544004|NCT01488019|11697186|FG000|STARTED|Overall Study||541
10544005|NCT01488019|11697187|FG001|STARTED|Overall Study||530
10544006|NCT01488019|11697186|FG000|COMPLETED|Overall Study||294
10544007|NCT01488019|11697187|FG001|COMPLETED|Overall Study||226
10544008|NCT01488019|11697186|FG000|NOT COMPLETED|Overall Study||247
10544009|NCT01488019|11697187|FG001|NOT COMPLETED|Overall Study||304
10544010|NCT01488071|11697197|FG000|STARTED|Overall Study|all-patients-treated set (APTS)|253
10544011|NCT01488071|11697198|FG001|STARTED|Overall Study|APTS|242
10544012|NCT01488071|11697197|FG000|COMPLETED|Overall Study||200
10544013|NCT01488071|11697198|FG001|COMPLETED|Overall Study||179
10544014|NCT01488071|11697197|FG000|NOT COMPLETED|Overall Study||53
10544015|NCT01488071|11697198|FG001|NOT COMPLETED|Overall Study||63
10544016|NCT01488097|11697204|FG000|STARTED|Overall Study||8
10544017|NCT01488097|11697204|FG000|Received Study Drug in Extension Study|Overall Study||8
10544018|NCT01488097|11697204|FG000|COMPLETED|Overall Study||7
10544019|NCT01488097|11697204|FG000|NOT COMPLETED|Overall Study||1
10544020|NCT01488188|11697210|FG000|STARTED|Overall Study||20
10401637|NCT00720057|11545797|FG000|NOT COMPLETED|Overall Study||1
10401638|NCT00720057|11545798|FG001|NOT COMPLETED|Overall Study||3
10401639|NCT00720096|11545806|FG000|STARTED|Overall Study||2
10721287|NCT02724033|11884909|FG000|STARTED|Overall Study||11
10721288|NCT02724033|11884910|FG001|STARTED|Overall Study||14
10312341|NCT00140244|11445707|FG001|STARTED|Intervention 1||4
10312342|NCT00140244|11445706|FG000|COMPLETED|Intervention 1||3
10312343|NCT00140244|11445707|FG001|COMPLETED|Intervention 1||4
10312344|NCT00140244|11445706|FG000|NOT COMPLETED|Intervention 1||0
10312345|NCT00140244|11445707|FG001|NOT COMPLETED|Intervention 1||0
10312346|NCT00140244|11445706|FG000|STARTED|Washout||3
10312347|NCT00140244|11445707|FG001|STARTED|Washout||4
10312348|NCT00140244|11445706|FG000|COMPLETED|Washout||3
10312349|NCT00140244|11445707|FG001|COMPLETED|Washout||4
10312350|NCT00140244|11445706|FG000|NOT COMPLETED|Washout||0
10312351|NCT00140244|11445707|FG001|NOT COMPLETED|Washout||0
10312352|NCT00140244|11445706|FG000|STARTED|Intervention 2||3
10312353|NCT00140244|11445707|FG001|STARTED|Intervention 2||4
10312354|NCT00140244|11445706|FG000|COMPLETED|Intervention 2||3
10312355|NCT00140244|11445707|FG001|COMPLETED|Intervention 2||2
10312356|NCT00140244|11445706|FG000|NOT COMPLETED|Intervention 2||0
10312357|NCT00140244|11445707|FG001|NOT COMPLETED|Intervention 2||2
10312358|NCT00140413|11445717|FG000|STARTED|Overall Study||13
10312359|NCT00140413|11445718|FG001|STARTED|Overall Study||7
10312360|NCT00140413|11445717|FG000|Received at Least One Dose of GH|Overall Study||13
10312361|NCT00140413|11445718|FG001|Received at Least One Dose of GH|Overall Study|Controls were crossed over to GH if they met criteria for growth deceleration during the study.|3
10312362|NCT00140413|11445717|FG000|COMPLETED|Overall Study||10
10312363|NCT00140413|11445718|FG001|COMPLETED|Overall Study|Crossed over subjects were treated as controls for purpose of intent to treat analysis.|7
10312364|NCT00140413|11445717|FG000|NOT COMPLETED|Overall Study||3
10312365|NCT00140413|11445718|FG001|NOT COMPLETED|Overall Study||0
10312366|NCT00140426|11445727|FG000|STARTED|Overall Study||22
10312367|NCT00140426|11445728|FG001|STARTED|Overall Study||19
10312368|NCT00140426|11445727|FG000|COMPLETED|Overall Study||22
10312369|NCT00140426|11445728|FG001|COMPLETED|Overall Study||16
10312370|NCT00140426|11445727|FG000|NOT COMPLETED|Overall Study||0
10312371|NCT00140426|11445728|FG001|NOT COMPLETED|Overall Study||3
10312372|NCT00140556|11445739|FG000|STARTED|Pre Radiation Period: Avastin / Tarceva||28
10312373|NCT00140556|11445739|FG000|COMPLETED|Pre Radiation Period: Avastin / Tarceva||28
10312374|NCT00140556|11445739|FG000|NOT COMPLETED|Pre Radiation Period: Avastin / Tarceva||0
10312375|NCT00140556|11445739|FG000|STARTED|Chemoradiotherapy Period||28
10312376|NCT00140556|11445739|FG000|COMPLETED|Chemoradiotherapy Period||28
10312377|NCT00140556|11445739|FG000|NOT COMPLETED|Chemoradiotherapy Period||0
10312378|NCT00140621|11445743|FG000|STARTED|Overall Study||6
10312379|NCT00140621|11445743|FG000|COMPLETED|Overall Study||6
10312380|NCT00140621|11445743|FG000|NOT COMPLETED|Overall Study||0
10312381|NCT00140842|11445749|FG000|STARTED|Overall Study||15
10312382|NCT00140842|11445750|FG001|STARTED|Overall Study||15
10312383|NCT00140842|11445749|FG000|COMPLETED|Overall Study||15
10312384|NCT00140842|11445750|FG001|COMPLETED|Overall Study||15
10312385|NCT00140842|11445749|FG000|NOT COMPLETED|Overall Study||0
10312386|NCT00140842|11445750|FG001|NOT COMPLETED|Overall Study||0
10312387|NCT00140855|11445756|FG000|STARTED|Overall Study||6
10312388|NCT00140855|11445756|FG000|COMPLETED|Overall Study||4
10312389|NCT00140855|11445756|FG000|NOT COMPLETED|Overall Study||2
10312390|NCT00141037|11445762|FG000|STARTED|Overall Study||60
10312391|NCT00141037|11445763|FG001|STARTED|Overall Study||70
10312392|NCT00141037|11445762|FG000|COMPLETED|Overall Study|16 subjects had reduced follow-up|50
10312393|NCT00141037|11445763|FG001|COMPLETED|Overall Study|8 subjects had reduced follow-up|52
10312394|NCT00141037|11445762|FG000|NOT COMPLETED|Overall Study||10
10312395|NCT00141037|11445763|FG001|NOT COMPLETED|Overall Study||18
10312396|NCT00141102|11445771|FG000|STARTED|Overall Study||2238
10312397|NCT00141102|11445772|FG001|STARTED|Overall Study||2246
10312398|NCT00141102|11445771|FG000|Received Treatment|Overall Study||2223
10312399|NCT00141102|11445772|FG001|Received Treatment|Overall Study||2237
10312400|NCT00141102|11445771|FG000|COMPLETED|Overall Study||1730
10312401|NCT00141102|11445772|FG001|COMPLETED|Overall Study||1621
10312402|NCT00141102|11445771|FG000|NOT COMPLETED|Overall Study||508
10312403|NCT00141102|11445772|FG001|NOT COMPLETED|Overall Study||625
10401640|NCT00720096|11545807|FG001|STARTED|Overall Study||2
10401641|NCT00720096|11545806|FG000|COMPLETED|Overall Study||2
10721289|NCT02724033|11884911|FG002|STARTED|Overall Study||12
10312404|NCT00141115|11445779|FG000|STARTED|Overall Study||3
10312405|NCT00141115|11445779|FG000|COMPLETED|Overall Study||2
10312406|NCT00141115|11445779|FG000|NOT COMPLETED|Overall Study||1
10312407|NCT00141219|11445786|FG000|STARTED|Overall Study||162
10312408|NCT00141219|11445787|FG001|STARTED|Overall Study||78
10312409|NCT00141219|11445786|FG000|COMPLETED|Overall Study||138
10312410|NCT00141219|11445787|FG001|COMPLETED|Overall Study||62
10401642|NCT00720096|11545807|FG001|COMPLETED|Overall Study||0
10401643|NCT00720096|11545806|FG000|NOT COMPLETED|Overall Study||0
10721290|NCT02724033|11884909|FG000|COMPLETED|Overall Study||11
10659800|NCT02245412|11821224|FG002|NOT COMPLETED|Treatment Period||0
10814323|NCT02394665|11976991|FG002|STARTED|Overall Study||0
10814324|NCT02394665|11976989|FG000|COMPLETED|Overall Study||0
10814325|NCT02394665|11976990|FG001|COMPLETED|Overall Study||0
10814326|NCT02394665|11976991|FG002|COMPLETED|Overall Study||0
10814327|NCT02394665|11976989|FG000|NOT COMPLETED|Overall Study||1
10814328|NCT02394665|11976990|FG001|NOT COMPLETED|Overall Study||0
10814329|NCT02394665|11976991|FG002|NOT COMPLETED|Overall Study||0
10814330|NCT02389712|11977001|FG000|STARTED|Overall Study||1
10312411|NCT00141219|11445786|FG000|NOT COMPLETED|Overall Study||24
10312412|NCT00141219|11445787|FG001|NOT COMPLETED|Overall Study||16
10312413|NCT00141271|11445796|FG000|STARTED|Overall Study||171
10312414|NCT00141271|11445797|FG001|STARTED|Overall Study||165
10312415|NCT00141271|11445798|FG002|STARTED|Overall Study||168
10312416|NCT00141271|11445796|FG000|COMPLETED|Overall Study||91
10312417|NCT00141271|11445797|FG001|COMPLETED|Overall Study||102
10312418|NCT00141271|11445798|FG002|COMPLETED|Overall Study||111
10312419|NCT00141271|11445796|FG000|NOT COMPLETED|Overall Study||80
10312420|NCT00141271|11445797|FG001|NOT COMPLETED|Overall Study||63
10312421|NCT00141271|11445798|FG002|NOT COMPLETED|Overall Study||57
10312422|NCT00141297|11445808|FG000|STARTED|Overall Study||3
10312423|NCT00141297|11445809|FG001|STARTED|Overall Study||3
10312424|NCT00141297|11445810|FG002|STARTED|Overall Study||7
10312425|NCT00141297|11445811|FG003|STARTED|Overall Study||3
10312426|NCT00141297|11445812|FG004|STARTED|Overall Study||22
10312427|NCT00141297|11445813|FG005|STARTED|Overall Study||3
10312428|NCT00141297|11445814|FG006|STARTED|Overall Study||3
10312429|NCT00141297|11445815|FG007|STARTED|Overall Study||4
10312430|NCT00141297|11445816|FG008|STARTED|Overall Study||20
10312431|NCT00141297|11445817|FG009|STARTED|Overall Study||6
10312432|NCT00141297|11445808|FG000|COMPLETED|Overall Study||0
10312433|NCT00141297|11445809|FG001|COMPLETED|Overall Study||0
10312434|NCT00141297|11445810|FG002|COMPLETED|Overall Study||0
10312435|NCT00141297|11445811|FG003|COMPLETED|Overall Study||0
10312436|NCT00141297|11445812|FG004|COMPLETED|Overall Study||0
10312437|NCT00141297|11445813|FG005|COMPLETED|Overall Study||0
10312438|NCT00141297|11445814|FG006|COMPLETED|Overall Study||0
10312439|NCT00141297|11445815|FG007|COMPLETED|Overall Study||0
10312440|NCT00141297|11445816|FG008|COMPLETED|Overall Study||0
10312441|NCT00141297|11445817|FG009|COMPLETED|Overall Study||0
10312442|NCT00141297|11445808|FG000|NOT COMPLETED|Overall Study||3
10312443|NCT00141297|11445809|FG001|NOT COMPLETED|Overall Study||3
10312444|NCT00141297|11445810|FG002|NOT COMPLETED|Overall Study||7
10312445|NCT00141297|11445811|FG003|NOT COMPLETED|Overall Study||3
10312446|NCT00141297|11445812|FG004|NOT COMPLETED|Overall Study||22
10312447|NCT00141297|11445813|FG005|NOT COMPLETED|Overall Study||3
10312448|NCT00141297|11445814|FG006|NOT COMPLETED|Overall Study||3
10401644|NCT00720096|11545807|FG001|NOT COMPLETED|Overall Study||2
10401645|NCT00720109|11545813|FG000|STARTED|Induction Period||63
10401646|NCT00720109|11545814|FG001|STARTED|Induction Period||0
10401647|NCT00720109|11545815|FG002|STARTED|Induction Period||0
10401648|NCT00720109|11545813|FG000|COMPLETED|Induction Period||57
10401649|NCT00720109|11545814|FG001|COMPLETED|Induction Period||0
10401650|NCT00720109|11545815|FG002|COMPLETED|Induction Period||0
10401651|NCT00720109|11545813|FG000|NOT COMPLETED|Induction Period||6
10401652|NCT00720109|11545814|FG001|NOT COMPLETED|Induction Period||0
10401653|NCT00720109|11545815|FG002|NOT COMPLETED|Induction Period||0
10312449|NCT00141297|11445815|FG007|NOT COMPLETED|Overall Study||4
10312450|NCT00141297|11445816|FG008|NOT COMPLETED|Overall Study||20
10312451|NCT00141297|11445817|FG009|NOT COMPLETED|Overall Study||6
10312452|NCT00141453|11445852|FG000|STARTED|Overall Study||288
10312453|NCT00141453|11445853|FG001|STARTED|Overall Study||289
10401654|NCT00720109|11545813|FG000|STARTED|Risk Stratification Period||0
10401655|NCT00720109|11545814|FG001|STARTED|Risk Stratification Period||48
10401656|NCT00720109|11545815|FG002|STARTED|Risk Stratification Period||9
10401657|NCT00720109|11545813|FG000|COMPLETED|Risk Stratification Period||0
10401658|NCT00720109|11545814|FG001|COMPLETED|Risk Stratification Period||33
10401659|NCT00720109|11545815|FG002|COMPLETED|Risk Stratification Period||1
10814331|NCT02389712|11977002|FG001|STARTED|Overall Study||1
10312454|NCT00141453|11445852|FG000|COMPLETED|Overall Study||282
10312455|NCT00141453|11445853|FG001|COMPLETED|Overall Study||284
10312456|NCT00141453|11445852|FG000|NOT COMPLETED|Overall Study||6
10312457|NCT00141453|11445853|FG001|NOT COMPLETED|Overall Study||5
10312458|NCT00141518|11445862|FG000|STARTED|Overall Study||37
10312459|NCT00141518|11445863|FG001|STARTED|Overall Study||22
10312460|NCT00141518|11445864|FG002|STARTED|Overall Study||18
10721291|NCT02724033|11884910|FG001|COMPLETED|Overall Study||14
10721292|NCT02724033|11884911|FG002|COMPLETED|Overall Study||12
10721293|NCT02724033|11884909|FG000|NOT COMPLETED|Overall Study||0
10721294|NCT02724033|11884910|FG001|NOT COMPLETED|Overall Study||0
10721295|NCT02724033|11884911|FG002|NOT COMPLETED|Overall Study||0
10721296|NCT02724111|11884921|FG000|STARTED|Overall Study||45
10401660|NCT00720109|11545813|FG000|NOT COMPLETED|Risk Stratification Period||0
10401661|NCT00720109|11545814|FG001|NOT COMPLETED|Risk Stratification Period||15
10401662|NCT00720109|11545815|FG002|NOT COMPLETED|Risk Stratification Period||8
10401663|NCT00720122|11545824|FG000|STARTED|Overall Study||28
10401664|NCT00720122|11545824|FG000|COMPLETED|Overall Study||19
10401665|NCT00720122|11545824|FG000|NOT COMPLETED|Overall Study||9
10401666|NCT00720213|11545828|FG000|STARTED|Screening Phase With Diagnostic PSG||44
10401667|NCT00720213|11545829|FG001|STARTED|Screening Phase With Diagnostic PSG||0
10401668|NCT00720213|11545830|FG002|STARTED|Screening Phase With Diagnostic PSG||0
10401669|NCT00720213|11545828|FG000|COMPLETED|Screening Phase With Diagnostic PSG||37
10401670|NCT00720213|11545829|FG001|COMPLETED|Screening Phase With Diagnostic PSG||0
10401671|NCT00720213|11545830|FG002|COMPLETED|Screening Phase With Diagnostic PSG||0
10401672|NCT00720213|11545828|FG000|NOT COMPLETED|Screening Phase With Diagnostic PSG||7
10401673|NCT00720213|11545829|FG001|NOT COMPLETED|Screening Phase With Diagnostic PSG||0
10401674|NCT00720213|11545830|FG002|NOT COMPLETED|Screening Phase With Diagnostic PSG||0
10401675|NCT00720213|11545828|FG000|STARTED|Treatment Period||0
10401676|NCT00720213|11545829|FG001|STARTED|Treatment Period||20
10401677|NCT00720213|11545830|FG002|STARTED|Treatment Period||17
10401678|NCT00720213|11545828|FG000|COMPLETED|Treatment Period||0
10401679|NCT00720213|11545829|FG001|COMPLETED|Treatment Period||20
10401680|NCT00720213|11545830|FG002|COMPLETED|Treatment Period||17
10401681|NCT00720213|11545828|FG000|NOT COMPLETED|Treatment Period||0
10401682|NCT00720213|11545829|FG001|NOT COMPLETED|Treatment Period||0
10401683|NCT00720213|11545830|FG002|NOT COMPLETED|Treatment Period||0
10401684|NCT00720226|11545840|FG000|STARTED|Overall Study||54
10401685|NCT00720226|11545841|FG001|STARTED|Overall Study||52
10401686|NCT00720226|11545840|FG000|COMPLETED|Overall Study|Participants not completing did not have 12 month CT scan|47
10401687|NCT00720226|11545841|FG001|COMPLETED|Overall Study|Participants not completing did not have 12 month CT scan|48
10401688|NCT00720226|11545840|FG000|NOT COMPLETED|Overall Study||7
10401689|NCT00720226|11545841|FG001|NOT COMPLETED|Overall Study||4
10401690|NCT00720278|11545850|FG000|STARTED|Overall Study|1 subject was randomized in error|178
10401691|NCT00720278|11545851|FG001|STARTED|Overall Study|1 subject was randomized in error|170
10401692|NCT00720278|11545852|FG002|STARTED|Overall Study|1 subject was randomized in error|178
10401693|NCT00720278|11545850|FG000|COMPLETED|Overall Study||171
10721297|NCT02724111|11884922|FG001|STARTED|Overall Study||45
10721298|NCT02724111|11884921|FG000|COMPLETED|Overall Study||43
10721299|NCT02724111|11884922|FG001|COMPLETED|Overall Study||40
10721300|NCT02724111|11884921|FG000|NOT COMPLETED|Overall Study||2
10721301|NCT02724111|11884922|FG001|NOT COMPLETED|Overall Study||5
10401694|NCT00720278|11545851|FG001|COMPLETED|Overall Study||166
10401695|NCT00720278|11545852|FG002|COMPLETED|Overall Study||172
10401696|NCT00720278|11545850|FG000|NOT COMPLETED|Overall Study||7
10401697|NCT00720278|11545851|FG001|NOT COMPLETED|Overall Study||4
10401698|NCT00720278|11545852|FG002|NOT COMPLETED|Overall Study||6
10401699|NCT00720330|11545863|FG000|STARTED|Overall Study||5
10401700|NCT00720330|11545864|FG001|STARTED|Overall Study||4
10401701|NCT00720330|11545865|FG002|STARTED|Overall Study||3
10721302|NCT02724423|11884928|FG000|STARTED|Overall Study||57
10721303|NCT02724423|11884928|FG000|COMPLETED|Overall Study||54
10721304|NCT02724423|11884928|FG000|NOT COMPLETED|Overall Study||3
10721305|NCT02724449|11884933|FG000|STARTED|Overall Study||16
10721306|NCT02724449|11884933|FG000|COMPLETED|Overall Study||16
10721307|NCT02724449|11884933|FG000|NOT COMPLETED|Overall Study||0
10721308|NCT02724462|11884939|FG000|STARTED|3 Month Follow-up Survey||1254
10721309|NCT02724462|11884940|FG001|STARTED|3 Month Follow-up Survey||1249
10721310|NCT02724462|11884939|FG000|COMPLETED|3 Month Follow-up Survey||1043
10721311|NCT02724462|11884940|FG001|COMPLETED|3 Month Follow-up Survey||1050
10721312|NCT02724462|11884939|FG000|NOT COMPLETED|3 Month Follow-up Survey||211
10721313|NCT02724462|11884940|FG001|NOT COMPLETED|3 Month Follow-up Survey||199
10721314|NCT02724462|11884939|FG000|STARTED|6 Month Follow-up Survey||1254
10721315|NCT02724462|11884940|FG001|STARTED|6 Month Follow-up Survey||1249
10721316|NCT02724462|11884939|FG000|COMPLETED|6 Month Follow-up Survey||1058
10721317|NCT02724462|11884940|FG001|COMPLETED|6 Month Follow-up Survey||1078
10721318|NCT02724462|11884939|FG000|NOT COMPLETED|6 Month Follow-up Survey||196
10721319|NCT02724462|11884940|FG001|NOT COMPLETED|6 Month Follow-up Survey||171
10721320|NCT02724462|11884939|FG000|STARTED|12 Month Follow-up Survey||1254
10721321|NCT02724462|11884940|FG001|STARTED|12 Month Follow-up Survey||1249
10721322|NCT02724462|11884939|FG000|COMPLETED|12 Month Follow-up Survey||1040
10721323|NCT02724462|11884940|FG001|COMPLETED|12 Month Follow-up Survey||1067
10721324|NCT02724462|11884939|FG000|NOT COMPLETED|12 Month Follow-up Survey||214
10721325|NCT02724462|11884940|FG001|NOT COMPLETED|12 Month Follow-up Survey||182
10721326|NCT02724592|11884948|FG000|STARTED|Overall Study||35
10721327|NCT02724592|11884949|FG001|STARTED|Overall Study||35
10544021|NCT01488188|11697211|FG001|STARTED|Overall Study||20
10544022|NCT01488188|11697210|FG000|COMPLETED|Overall Study||20
10721328|NCT02724592|11884948|FG000|COMPLETED|Overall Study||31
10721329|NCT02724592|11884949|FG001|COMPLETED|Overall Study||34
10721330|NCT02724592|11884948|FG000|NOT COMPLETED|Overall Study||4
10721331|NCT02724592|11884949|FG001|NOT COMPLETED|Overall Study||1
10721332|NCT02724644|11884957|FG000|STARTED|Overall Study||189
10721333|NCT02724644|11884958|FG001|STARTED|Overall Study||186
10721334|NCT02724644|11884957|FG000|COMPLETED|Overall Study||168
10721335|NCT02724644|11884958|FG001|COMPLETED|Overall Study||182
10721336|NCT02724644|11884957|FG000|NOT COMPLETED|Overall Study||21
10721337|NCT02724644|11884958|FG001|NOT COMPLETED|Overall Study||4
10721338|NCT02724787|11884964|FG000|STARTED|Overall Study||24
10721339|NCT02724787|11884964|FG000|COMPLETED|Overall Study|22 completed treatment. 20 participants returned for post-treatment assessment.|22
10721340|NCT02724787|11884964|FG000|NOT COMPLETED|Overall Study||2
10721341|NCT02724800|11884970|FG000|STARTED|Overall Study||32
10721342|NCT02724800|11884971|FG001|STARTED|Overall Study||31
10721343|NCT02724800|11884970|FG000|COMPLETED|Overall Study||15
10721344|NCT02724800|11884971|FG001|COMPLETED|Overall Study||22
10721345|NCT02724800|11884970|FG000|NOT COMPLETED|Overall Study||17
10721346|NCT02724800|11884971|FG001|NOT COMPLETED|Overall Study||9
10721347|NCT02724839|11884980|FG000|STARTED|Overall Study||13
10721348|NCT02724839|11884981|FG001|STARTED|Overall Study||12
10721349|NCT02724839|11884982|FG002|STARTED|Overall Study||11
10721350|NCT02724839|11884980|FG000|COMPLETED|Overall Study||12
10721351|NCT02724839|11884981|FG001|COMPLETED|Overall Study||8
10721352|NCT02724839|11884982|FG002|COMPLETED|Overall Study||6
10721353|NCT02724839|11884980|FG000|NOT COMPLETED|Overall Study||1
10721354|NCT02724839|11884981|FG001|NOT COMPLETED|Overall Study||4
10721355|NCT02724839|11884982|FG002|NOT COMPLETED|Overall Study||5
10721356|NCT02724956|11884999|FG000|STARTED|Overall Study||27
10721357|NCT02724956|11885000|FG001|STARTED|Overall Study||26
10721358|NCT02724956|11884999|FG000|COMPLETED|Overall Study||26
10721359|NCT02724956|11885000|FG001|COMPLETED|Overall Study||24
10721360|NCT02724956|11884999|FG000|NOT COMPLETED|Overall Study||1
10814332|NCT02389712|11977001|FG000|COMPLETED|Overall Study||1
10401702|NCT00720330|11545863|FG000|COMPLETED|Overall Study||5
10401703|NCT00720330|11545864|FG001|COMPLETED|Overall Study||4
10401704|NCT00720330|11545865|FG002|COMPLETED|Overall Study||3
10401705|NCT00720330|11545863|FG000|NOT COMPLETED|Overall Study||0
10721361|NCT02724956|11885000|FG001|NOT COMPLETED|Overall Study||2
10721362|NCT02725008|11885008|FG000|STARTED|Overall Study||46
10721363|NCT02725008|11885009|FG001|STARTED|Overall Study||51
10721364|NCT02725008|11885008|FG000|COMPLETED|Overall Study||37
10721365|NCT02725008|11885009|FG001|COMPLETED|Overall Study||39
10401706|NCT00720330|11545864|FG001|NOT COMPLETED|Overall Study||0
10401707|NCT00720330|11545865|FG002|NOT COMPLETED|Overall Study||0
10401708|NCT00720356|11545873|FG000|STARTED|Registration to Study||115
10401709|NCT00720356|11545873|FG000|Completed Registration Step 1|Registration to Study||115
10401710|NCT00720356|11545873|FG000|Completed Registration Step 2|Registration to Study||48
10401711|NCT00720356|11545873|FG000|COMPLETED|Registration to Study||48
10401712|NCT00720356|11545873|FG000|NOT COMPLETED|Registration to Study||67
10401713|NCT00720356|11545873|FG000|STARTED|Reached 1st Response/2 Cycles||48
10401714|NCT00720356|11545873|FG000|COMPLETED|Reached 1st Response/2 Cycles||46
10401715|NCT00720356|11545873|FG000|NOT COMPLETED|Reached 1st Response/2 Cycles||2
10401716|NCT00720356|11545873|FG000|STARTED|Went on to be Treated Cycle 3||46
10401717|NCT00720356|11545873|FG000|COMPLETED|Went on to be Treated Cycle 3||44
10401718|NCT00720356|11545873|FG000|NOT COMPLETED|Went on to be Treated Cycle 3||2
10401719|NCT00720356|11545873|FG000|STARTED|Follow up Until Death|All patients that are treated on study go into the follow up period|48
10401720|NCT00720356|11545873|FG000|COMPLETED|Follow up Until Death||43
10401721|NCT00720356|11545873|FG000|NOT COMPLETED|Follow up Until Death||5
10401722|NCT00720369|11545879|FG000|STARTED|Overall Study||11
10401723|NCT00720369|11545880|FG001|STARTED|Overall Study||8
10401724|NCT00720369|11545879|FG000|COMPLETED|Overall Study|one subject discontinued due to an adverse event.|10
10401725|NCT00720369|11545880|FG001|COMPLETED|Overall Study||8
10401726|NCT00720369|11545879|FG000|NOT COMPLETED|Overall Study||1
10401727|NCT00720369|11545880|FG001|NOT COMPLETED|Overall Study||0
10401728|NCT00720382|11545890|FG000|STARTED|Overall Study||466
10401729|NCT00720382|11545891|FG001|STARTED|Overall Study||237
10401730|NCT00720382|11545890|FG000|COMPLETED|Overall Study||290
10401731|NCT00720382|11545891|FG001|COMPLETED|Overall Study||178
10401732|NCT00720382|11545890|FG000|NOT COMPLETED|Overall Study||176
10401733|NCT00720382|11545891|FG001|NOT COMPLETED|Overall Study||59
10401734|NCT00720434|11545901|FG000|STARTED|Double-Blind Period (Week 1-4)||10
10401735|NCT00720434|11545902|FG001|STARTED|Double-Blind Period (Week 1-4)||9
10401736|NCT00720434|11545903|FG002|STARTED|Double-Blind Period (Week 1-4)||8
10401737|NCT00720434|11545904|FG003|STARTED|Double-Blind Period (Week 1-4)||8
10401738|NCT00720434|11545901|FG000|COMPLETED|Double-Blind Period (Week 1-4)||10
10401739|NCT00720434|11545902|FG001|COMPLETED|Double-Blind Period (Week 1-4)||8
10401740|NCT00720434|11545903|FG002|COMPLETED|Double-Blind Period (Week 1-4)||8
10401741|NCT00720434|11545904|FG003|COMPLETED|Double-Blind Period (Week 1-4)||8
10401742|NCT00720434|11545901|FG000|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
10401743|NCT00720434|11545902|FG001|NOT COMPLETED|Double-Blind Period (Week 1-4)||1
10401744|NCT00720434|11545903|FG002|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
10401745|NCT00720434|11545904|FG003|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
10401746|NCT00720434|11545901|FG000|STARTED|Open-Label Period (Week 5-72)||10
10401747|NCT00720434|11545902|FG001|STARTED|Open-Label Period (Week 5-72)||8
10401748|NCT00720434|11545903|FG002|STARTED|Open-Label Period (Week 5-72)||8
10401749|NCT00720434|11545904|FG003|STARTED|Open-Label Period (Week 5-72)||8
10401750|NCT00720434|11545901|FG000|COMPLETED|Open-Label Period (Week 5-72)||4
10401751|NCT00720434|11545902|FG001|COMPLETED|Open-Label Period (Week 5-72)||5
10401752|NCT00720434|11545903|FG002|COMPLETED|Open-Label Period (Week 5-72)||4
10401753|NCT00720434|11545904|FG003|COMPLETED|Open-Label Period (Week 5-72)||4
10401754|NCT00720434|11545901|FG000|NOT COMPLETED|Open-Label Period (Week 5-72)||6
10401755|NCT00720434|11545902|FG001|NOT COMPLETED|Open-Label Period (Week 5-72)||3
10401756|NCT00720434|11545903|FG002|NOT COMPLETED|Open-Label Period (Week 5-72)||4
10401757|NCT00720434|11545904|FG003|NOT COMPLETED|Open-Label Period (Week 5-72)||4
10401758|NCT00720473|11545916|FG000|STARTED|Overall Study||45
10401759|NCT00720473|11545917|FG001|STARTED|Overall Study||24
10401760|NCT00720473|11545916|FG000|COMPLETED|Overall Study||15
10401761|NCT00720473|11545917|FG001|COMPLETED|Overall Study||16
10401762|NCT00720473|11545916|FG000|NOT COMPLETED|Overall Study||30
10401763|NCT00720473|11545917|FG001|NOT COMPLETED|Overall Study||8
10401764|NCT00720499|11545924|FG000|STARTED|Treatment Period 1 (4 Weeks)||69
10401765|NCT00720499|11545925|FG001|STARTED|Treatment Period 1 (4 Weeks)||72
10401766|NCT00720499|11545924|FG000|COMPLETED|Treatment Period 1 (4 Weeks)||66
10401767|NCT00720499|11545925|FG001|COMPLETED|Treatment Period 1 (4 Weeks)||70
10401768|NCT00720499|11545924|FG000|NOT COMPLETED|Treatment Period 1 (4 Weeks)||3
10401769|NCT00720499|11545925|FG001|NOT COMPLETED|Treatment Period 1 (4 Weeks)||2
10401770|NCT00720499|11545924|FG000|STARTED|Washout Period (2 Weeks)||66
10401771|NCT00720499|11545925|FG001|STARTED|Washout Period (2 Weeks)||70
10401772|NCT00720499|11545924|FG000|COMPLETED|Washout Period (2 Weeks)||66
10401773|NCT00720499|11545925|FG001|COMPLETED|Washout Period (2 Weeks)||70
10401774|NCT00720499|11545924|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
10401775|NCT00720499|11545925|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0
10401776|NCT00720499|11545924|FG000|STARTED|Treatment Period 2 (4 Weeks)||66
10401777|NCT00720499|11545925|FG001|STARTED|Treatment Period 2 (4 Weeks)||70
10401778|NCT00720499|11545924|FG000|COMPLETED|Treatment Period 2 (4 Weeks)||64
10401779|NCT00720499|11545925|FG001|COMPLETED|Treatment Period 2 (4 Weeks)||67
10401780|NCT00720499|11545924|FG000|NOT COMPLETED|Treatment Period 2 (4 Weeks)||2
10401781|NCT00720499|11545925|FG001|NOT COMPLETED|Treatment Period 2 (4 Weeks)||3
10401782|NCT00720629|11545932|FG000|STARTED|Overall Study||8
10401783|NCT00720629|11545932|FG000|COMPLETED|Overall Study||8
10401784|NCT00720629|11545932|FG000|NOT COMPLETED|Overall Study||0
10401785|NCT00720759|11545942|FG000|STARTED|Overall Study||6
10401786|NCT00720759|11545943|FG001|STARTED|Overall Study||6
10401787|NCT00720759|11545944|FG002|STARTED|Overall Study||6
10401788|NCT00720759|11545945|FG003|STARTED|Overall Study||6
10401789|NCT00720759|11545942|FG000|COMPLETED|Overall Study||6
10401790|NCT00720759|11545943|FG001|COMPLETED|Overall Study||5
10401791|NCT00720759|11545944|FG002|COMPLETED|Overall Study||5
10401792|NCT00720759|11545945|FG003|COMPLETED|Overall Study||6
10401793|NCT00720759|11545942|FG000|NOT COMPLETED|Overall Study||0
10401794|NCT00720759|11545943|FG001|NOT COMPLETED|Overall Study||1
10401795|NCT00720759|11545944|FG002|NOT COMPLETED|Overall Study||1
10401796|NCT00720759|11545945|FG003|NOT COMPLETED|Overall Study||0
10401797|NCT00720798|11545955|FG000|STARTED|Overall Study||2067
10401798|NCT00720798|11545955|FG000|COMPLETED|Overall Study||1311
10401799|NCT00720798|11545955|FG000|NOT COMPLETED|Overall Study||756
10401800|NCT00720876|11545959|FG000|STARTED|Overall Study||30
10401801|NCT00720876|11545959|FG000|COMPLETED|Overall Study||28
10401802|NCT00720876|11545959|FG000|NOT COMPLETED|Overall Study||2
10401803|NCT00720941|11545965|FG000|STARTED|Overall Study||557
10401804|NCT00720941|11545966|FG001|STARTED|Overall Study||553
10401805|NCT00720941|11545965|FG000|Ongoing|Overall Study||34
10401806|NCT00720941|11545966|FG001|Ongoing|Overall Study||23
10401807|NCT00720941|11545965|FG000|COMPLETED|Overall Study||144
10401808|NCT00720941|11545966|FG001|COMPLETED|Overall Study||138
10401809|NCT00720941|11545965|FG000|NOT COMPLETED|Overall Study||413
10401810|NCT00720941|11545966|FG001|NOT COMPLETED|Overall Study||415
10401811|NCT00721110|11545976|FG000|STARTED|Overall Study||16
10401812|NCT00721110|11545977|FG001|STARTED|Overall Study||16
10401813|NCT00721110|11545978|FG002|STARTED|Overall Study||16
10401814|NCT00721110|11545979|FG003|STARTED|Overall Study||16
10401815|NCT00721110|11545976|FG000|COMPLETED|Overall Study||15
10401816|NCT00721110|11545977|FG001|COMPLETED|Overall Study||16
10401817|NCT00721110|11545978|FG002|COMPLETED|Overall Study||15
10401818|NCT00721110|11545979|FG003|COMPLETED|Overall Study||16
10401819|NCT00721110|11545976|FG000|NOT COMPLETED|Overall Study||1
10401820|NCT00721110|11545977|FG001|NOT COMPLETED|Overall Study||0
10401821|NCT00721110|11545978|FG002|NOT COMPLETED|Overall Study||1
10401822|NCT00721110|11545979|FG003|NOT COMPLETED|Overall Study||0
10401823|NCT00721123|11545989|FG000|STARTED|Overall Study||538
10401824|NCT00721123|11545989|FG000|COMPLETED|Overall Study||355
10401825|NCT00721123|11545989|FG000|NOT COMPLETED|Overall Study||183
10401826|NCT00721136|11546013|FG000|STARTED|Overall Study||42
10401827|NCT00721136|11546014|FG001|STARTED|Overall Study||42
10401828|NCT00721136|11546015|FG002|STARTED|Overall Study||8
10401829|NCT00721136|11546016|FG003|STARTED|Overall Study||8
10401830|NCT00721136|11546013|FG000|COMPLETED|Overall Study||42
10401831|NCT00721136|11546014|FG001|COMPLETED|Overall Study||42
10401832|NCT00721136|11546015|FG002|COMPLETED|Overall Study||8
10401833|NCT00721136|11546016|FG003|COMPLETED|Overall Study||8
10401834|NCT00721136|11546013|FG000|NOT COMPLETED|Overall Study||0
10401835|NCT00721136|11546014|FG001|NOT COMPLETED|Overall Study||0
10401836|NCT00721136|11546015|FG002|NOT COMPLETED|Overall Study||0
10401837|NCT00721136|11546016|FG003|NOT COMPLETED|Overall Study||0
10401838|NCT00721149|11546030|FG000|STARTED|Overall Study|Enrollment was stopped after 10 subjects entered the trial.|10
10401839|NCT00721149|11546030|FG000|COMPLETED|Overall Study||9
10401840|NCT00721149|11546030|FG000|NOT COMPLETED|Overall Study||1
10401841|NCT00721162|11546034|FG000|STARTED|Overall Study||60
10401842|NCT00721162|11546034|FG000|Received Any Amount of Study Drug|Overall Study||60
10401843|NCT00721162|11546034|FG000|COMPLETED|Overall Study||60
10401844|NCT00721162|11546034|FG000|NOT COMPLETED|Overall Study||0
10401845|NCT00721175|11546040|FG000|STARTED|Overall Study||54
10401846|NCT00721175|11546041|FG001|STARTED|Overall Study||54
10401847|NCT00721175|11546040|FG000|COMPLETED|Overall Study||54
10814333|NCT02389712|11977002|FG001|COMPLETED|Overall Study||1
10814334|NCT02389712|11977001|FG000|NOT COMPLETED|Overall Study||0
10814335|NCT02389712|11977002|FG001|NOT COMPLETED|Overall Study||0
10814336|NCT02390362|11977010|FG000|STARTED|Overall Study|1 subject enrolled in this arm. completed 2 doses of Rituximab.|1
10814337|NCT02390362|11977011|FG001|STARTED|Overall Study||2
10401848|NCT00721175|11546041|FG001|COMPLETED|Overall Study||54
10401849|NCT00721175|11546040|FG000|NOT COMPLETED|Overall Study||0
10401850|NCT00721175|11546041|FG001|NOT COMPLETED|Overall Study||0
10401851|NCT00721188|11546047|FG000|STARTED|Overall Study||11
10814338|NCT02390362|11977010|FG000|COMPLETED|Overall Study||1
10814339|NCT02390362|11977011|FG001|COMPLETED|Overall Study||1
10401852|NCT00721188|11546047|FG000|COMPLETED|Overall Study||11
10401853|NCT00721188|11546047|FG000|NOT COMPLETED|Overall Study||0
10401854|NCT00721214|11546051|FG000|STARTED|Overall Study||16
10401855|NCT00721214|11546051|FG000|COMPLETED|Overall Study||12
10401856|NCT00721214|11546051|FG000|NOT COMPLETED|Overall Study||4
10401857|NCT00721227|11546057|FG000|STARTED|Overall Study||9
10401858|NCT00721227|11546058|FG001|STARTED|Overall Study||6
10401859|NCT00721227|11546057|FG000|COMPLETED|Overall Study|3 subjects lost to follow up; 1 subject did not complete due to noncompliance of scheduled visits.|5
10401860|NCT00721227|11546058|FG001|COMPLETED|Overall Study||6
10401861|NCT00721227|11546057|FG000|NOT COMPLETED|Overall Study||4
10401862|NCT00721227|11546058|FG001|NOT COMPLETED|Overall Study||0
10401863|NCT00721253|11546066|FG000|STARTED|Overall Study||20
10401864|NCT00721253|11546067|FG001|STARTED|Overall Study||22
10401865|NCT00721253|11546068|FG002|STARTED|Overall Study|There were no subjects that were implanted with the Tecnis lens.|0
10401866|NCT00721253|11546066|FG000|COMPLETED|Overall Study||20
10401867|NCT00721253|11546067|FG001|COMPLETED|Overall Study||22
10401868|NCT00721253|11546068|FG002|COMPLETED|Overall Study||0
10401869|NCT00721253|11546066|FG000|NOT COMPLETED|Overall Study||0
10401870|NCT00721253|11546067|FG001|NOT COMPLETED|Overall Study||0
10401871|NCT00721253|11546068|FG002|NOT COMPLETED|Overall Study||0
10401872|NCT00721279|11546076|FG000|STARTED|Overall Study||452
10401873|NCT00721279|11546077|FG001|STARTED|Overall Study||97
10401874|NCT00721279|11546076|FG000|COMPLETED|Overall Study||416
10401875|NCT00721279|11546077|FG001|COMPLETED|Overall Study||73
10401876|NCT00721279|11546076|FG000|NOT COMPLETED|Overall Study||36
10401877|NCT00721279|11546077|FG001|NOT COMPLETED|Overall Study||24
10401878|NCT00721357|11546086|FG000|STARTED|Overall Study||15
10401879|NCT00721357|11546087|FG001|STARTED|Overall Study||15
10401880|NCT00721357|11546086|FG000|COMPLETED|Overall Study||15
10401881|NCT00721357|11546087|FG001|COMPLETED|Overall Study||15
10401882|NCT00721357|11546086|FG000|NOT COMPLETED|Overall Study||0
10401883|NCT00721357|11546087|FG001|NOT COMPLETED|Overall Study||0
10401884|NCT00721396|11546099|FG000|STARTED|Overall Study||627
10401885|NCT00721396|11546100|FG001|STARTED|Overall Study||628
10401886|NCT00721396|11546101|FG002|STARTED|Overall Study||318
10401887|NCT00721396|11546102|FG003|STARTED|Overall Study||312
10401888|NCT00721396|11546099|FG000|COMPLETED|Overall Study||597
10401889|NCT00721396|11546100|FG001|COMPLETED|Overall Study||592
10721366|NCT02725008|11885008|FG000|NOT COMPLETED|Overall Study||9
10721367|NCT02725008|11885009|FG001|NOT COMPLETED|Overall Study||12
10721368|NCT02725268|11885019|FG000|STARTED|Overall Study||90
10401890|NCT00721396|11546101|FG002|COMPLETED|Overall Study||308
10401891|NCT00721396|11546102|FG003|COMPLETED|Overall Study||302
10401892|NCT00721396|11546099|FG000|NOT COMPLETED|Overall Study||30
10401893|NCT00721396|11546100|FG001|NOT COMPLETED|Overall Study||36
10401894|NCT00721396|11546101|FG002|NOT COMPLETED|Overall Study||10
10401895|NCT00721396|11546102|FG003|NOT COMPLETED|Overall Study||10
10401896|NCT00721409|11546120|FG000|STARTED|Overall Study||12
10401897|NCT00721409|11546121|FG001|STARTED|Overall Study||84
10401898|NCT00721409|11546122|FG002|STARTED|Overall Study||81
10401899|NCT00721409|11546120|FG000|Treated|Overall Study||12
10401900|NCT00721409|11546121|FG001|Treated|Overall Study||83
10401901|NCT00721409|11546122|FG002|Treated|Overall Study||77
10401902|NCT00721409|11546120|FG000|COMPLETED|Overall Study||0
10401903|NCT00721409|11546121|FG001|COMPLETED|Overall Study||2
10401904|NCT00721409|11546122|FG002|COMPLETED|Overall Study||2
10401905|NCT00721409|11546120|FG000|NOT COMPLETED|Overall Study||12
10401906|NCT00721409|11546121|FG001|NOT COMPLETED|Overall Study||82
10401907|NCT00721409|11546122|FG002|NOT COMPLETED|Overall Study||79
10401908|NCT00721500|11546146|FG000|STARTED|Period One||6
10401909|NCT00721500|11546147|FG001|STARTED|Period One||7
10401910|NCT00721500|11546148|FG002|STARTED|Period One||6
10401911|NCT00721500|11546149|FG003|STARTED|Period One||6
10401912|NCT00721500|11546146|FG000|COMPLETED|Period One||6
10401913|NCT00721500|11546147|FG001|COMPLETED|Period One||7
10401914|NCT00721500|11546148|FG002|COMPLETED|Period One||6
10401915|NCT00721500|11546149|FG003|COMPLETED|Period One||6
10401916|NCT00721500|11546146|FG000|NOT COMPLETED|Period One||0
10401917|NCT00721500|11546147|FG001|NOT COMPLETED|Period One||0
10401918|NCT00721500|11546148|FG002|NOT COMPLETED|Period One||0
10401919|NCT00721500|11546149|FG003|NOT COMPLETED|Period One||0
10401920|NCT00721500|11546146|FG000|STARTED|Period Two||6
10401921|NCT00721500|11546147|FG001|STARTED|Period Two||7
10721369|NCT02725268|11885020|FG001|STARTED|Overall Study||90
10401922|NCT00721500|11546148|FG002|STARTED|Period Two||6
10401923|NCT00721500|11546149|FG003|STARTED|Period Two||6
10401924|NCT00721500|11546146|FG000|COMPLETED|Period Two||6
10401925|NCT00721500|11546147|FG001|COMPLETED|Period Two||7
10721370|NCT02725268|11885021|FG002|STARTED|Overall Study||41
10721371|NCT02725268|11885022|FG003|STARTED|Overall Study||20
10401926|NCT00721500|11546148|FG002|COMPLETED|Period Two||6
10401927|NCT00721500|11546149|FG003|COMPLETED|Period Two||6
10401928|NCT00721500|11546146|FG000|NOT COMPLETED|Period Two||0
10401929|NCT00721500|11546147|FG001|NOT COMPLETED|Period Two||0
10401930|NCT00721500|11546148|FG002|NOT COMPLETED|Period Two||0
10401931|NCT00721500|11546149|FG003|NOT COMPLETED|Period Two||0
10401932|NCT00721500|11546146|FG000|STARTED|Period Three||6
10401933|NCT00721500|11546147|FG001|STARTED|Period Three||7
10401934|NCT00721500|11546148|FG002|STARTED|Period Three||6
10401935|NCT00721500|11546149|FG003|STARTED|Period Three||6
10401936|NCT00721500|11546146|FG000|COMPLETED|Period Three||6
10401937|NCT00721500|11546147|FG001|COMPLETED|Period Three||7
10401938|NCT00721500|11546148|FG002|COMPLETED|Period Three||6
10401939|NCT00721500|11546149|FG003|COMPLETED|Period Three||6
10401940|NCT00721500|11546146|FG000|NOT COMPLETED|Period Three||0
10401941|NCT00721500|11546147|FG001|NOT COMPLETED|Period Three||0
10401942|NCT00721500|11546148|FG002|NOT COMPLETED|Period Three||0
10401943|NCT00721500|11546149|FG003|NOT COMPLETED|Period Three||0
10401944|NCT00721513|11546161|FG000|STARTED|Overall Study||20
10401945|NCT00721513|11546161|FG000|COMPLETED|Overall Study||20
10401946|NCT00721513|11546161|FG000|NOT COMPLETED|Overall Study||0
10401947|NCT00721539|11546165|FG000|STARTED|Overall Study||9
10401948|NCT00721539|11546165|FG000|COMPLETED|Overall Study||9
10401949|NCT00721539|11546165|FG000|NOT COMPLETED|Overall Study||0
10401950|NCT00721578|11546169|FG000|STARTED|Overall Study||12
10401951|NCT00721578|11546170|FG001|STARTED|Overall Study||11
10401952|NCT00721578|11546169|FG000|COMPLETED|Overall Study||10
10401953|NCT00721578|11546170|FG001|COMPLETED|Overall Study||9
10401954|NCT00721578|11546169|FG000|NOT COMPLETED|Overall Study||2
10401955|NCT00721578|11546170|FG001|NOT COMPLETED|Overall Study||2
10401956|NCT00721617|11546176|FG000|STARTED|0 Hour (Baseline) of Saline Infusion||12
10401957|NCT00721617|11546176|FG000|COMPLETED|0 Hour (Baseline) of Saline Infusion||12
10401958|NCT00721617|11546176|FG000|NOT COMPLETED|0 Hour (Baseline) of Saline Infusion||0
10401959|NCT00721617|11546176|FG000|STARTED|4 Hours Into Saline Infusion||12
10401960|NCT00721617|11546176|FG000|COMPLETED|4 Hours Into Saline Infusion||12
10401961|NCT00721617|11546176|FG000|NOT COMPLETED|4 Hours Into Saline Infusion||0
10401962|NCT00721617|11546176|FG000|STARTED|8 Hours Into Saline Infusion||12
10401963|NCT00721617|11546176|FG000|COMPLETED|8 Hours Into Saline Infusion||12
10401964|NCT00721617|11546176|FG000|NOT COMPLETED|8 Hours Into Saline Infusion||0
10401965|NCT00721617|11546176|FG000|STARTED|0 Hour (Baseline) of Intralipid Infusion||12
10401966|NCT00721617|11546176|FG000|COMPLETED|0 Hour (Baseline) of Intralipid Infusion||12
10401967|NCT00721617|11546176|FG000|NOT COMPLETED|0 Hour (Baseline) of Intralipid Infusion||0
10401968|NCT00721617|11546176|FG000|STARTED|4 Hours Into Intralipid Infusion||12
10401969|NCT00721617|11546176|FG000|COMPLETED|4 Hours Into Intralipid Infusion||12
10401970|NCT00721617|11546176|FG000|NOT COMPLETED|4 Hours Into Intralipid Infusion||0
10401971|NCT00721617|11546176|FG000|STARTED|8 Hours Into Intralipid Infusion||12
10401972|NCT00721617|11546176|FG000|COMPLETED|8 Hours Into Intralipid Infusion||12
10401973|NCT00721617|11546176|FG000|NOT COMPLETED|8 Hours Into Intralipid Infusion||0
10401974|NCT00721617|11546176|FG000|STARTED|0 Hour (Baseline) of Dextrose Infusion||12
10401975|NCT00721617|11546176|FG000|COMPLETED|0 Hour (Baseline) of Dextrose Infusion||12
10401976|NCT00721617|11546176|FG000|NOT COMPLETED|0 Hour (Baseline) of Dextrose Infusion||0
10401977|NCT00721617|11546176|FG000|STARTED|4 Hours Into Dextrose Infusion||12
10401978|NCT00721617|11546176|FG000|COMPLETED|4 Hours Into Dextrose Infusion||12
10401979|NCT00721617|11546176|FG000|NOT COMPLETED|4 Hours Into Dextrose Infusion||0
10401980|NCT00721617|11546176|FG000|STARTED|8 Hours Into Dextrose Infusion||12
10401981|NCT00721617|11546176|FG000|COMPLETED|8 Hours Into Dextrose Infusion||12
10401982|NCT00721617|11546176|FG000|NOT COMPLETED|8 Hours Into Dextrose Infusion||0
10401983|NCT00721617|11546176|FG000|STARTED|0 Hour (Baseline) of Intralipid/Dextrose||12
10401984|NCT00721617|11546176|FG000|COMPLETED|0 Hour (Baseline) of Intralipid/Dextrose||12
10401985|NCT00721617|11546176|FG000|NOT COMPLETED|0 Hour (Baseline) of Intralipid/Dextrose||0
10312461|NCT00141518|11445862|FG000|Safety Sample|Overall Study||36
10312462|NCT00141518|11445863|FG001|Safety Sample|Overall Study||22
10312463|NCT00141518|11445864|FG002|Safety Sample|Overall Study||18
10312464|NCT00141518|11445862|FG000|Full Analysis Sample|Overall Study||27
10312465|NCT00141518|11445863|FG001|Full Analysis Sample|Overall Study||22
10312466|NCT00141518|11445864|FG002|Full Analysis Sample|Overall Study||18
10312467|NCT00141518|11445862|FG000|COMPLETED|Overall Study||21
10312468|NCT00141518|11445863|FG001|COMPLETED|Overall Study||16
10312469|NCT00141518|11445864|FG002|COMPLETED|Overall Study||12
10312470|NCT00141518|11445862|FG000|NOT COMPLETED|Overall Study||16
10312471|NCT00141518|11445863|FG001|NOT COMPLETED|Overall Study||6
10312472|NCT00141518|11445864|FG002|NOT COMPLETED|Overall Study||6
10312473|NCT00141726|11445874|FG000|STARTED|Overall Study||34
10544023|NCT01488188|11697211|FG001|COMPLETED|Overall Study||20
10659801|NCT02245412|11821222|FG000|STARTED|Follow-Up Period|One participant who discontinued Study Drug in Treatment Period continued to Follow-Up Period.|13
10659802|NCT02245412|11821223|FG001|STARTED|Follow-Up Period|One participant who discontinued Study Drug in Treatment Period continued to Follow-Up Period.|4
10659803|NCT02245412|11821224|FG002|STARTED|Follow-Up Period||2
10659804|NCT02245412|11821222|FG000|COMPLETED|Follow-Up Period||8
10312474|NCT00141726|11445874|FG000|COMPLETED|Overall Study||31
10312475|NCT00141726|11445874|FG000|NOT COMPLETED|Overall Study||3
10544024|NCT01488188|11697210|FG000|NOT COMPLETED|Overall Study||0
10544025|NCT01488188|11697211|FG001|NOT COMPLETED|Overall Study||0
10544026|NCT01488279|11697219|FG000|STARTED|Overall Study||5
10544027|NCT01488279|11697220|FG001|STARTED|Overall Study||5
10544028|NCT01488279|11697219|FG000|COMPLETED|Overall Study||5
10544029|NCT01488279|11697220|FG001|COMPLETED|Overall Study||5
10544030|NCT01488279|11697219|FG000|NOT COMPLETED|Overall Study||0
10544031|NCT01488279|11697220|FG001|NOT COMPLETED|Overall Study||0
10544032|NCT01488318|11697229|FG000|STARTED|Overall Study||14
10544033|NCT01488318|11697229|FG000|COMPLETED|Overall Study||14
10544034|NCT01488318|11697229|FG000|NOT COMPLETED|Overall Study||0
10544035|NCT01488370|11697236|FG000|STARTED|Overall Study||22
10544036|NCT01488370|11697237|FG001|STARTED|Overall Study||23
10544037|NCT01488370|11697238|FG002|STARTED|Overall Study||20
10544038|NCT01488370|11697236|FG000|COMPLETED|Overall Study||22
10544039|NCT01488370|11697237|FG001|COMPLETED|Overall Study||22
10544040|NCT01488370|11697238|FG002|COMPLETED|Overall Study||19
10544041|NCT01488370|11697236|FG000|NOT COMPLETED|Overall Study||0
10544042|NCT01488370|11697237|FG001|NOT COMPLETED|Overall Study||1
10544043|NCT01488370|11697238|FG002|NOT COMPLETED|Overall Study||1
10544044|NCT01488409|11697248|FG000|STARTED|Overall Study||20
10544045|NCT01488409|11697249|FG001|STARTED|Overall Study||19
10544046|NCT01488409|11697248|FG000|COMPLETED|Overall Study||16
10544047|NCT01488409|11697249|FG001|COMPLETED|Overall Study||15
10544048|NCT01488409|11697248|FG000|NOT COMPLETED|Overall Study||4
10544049|NCT01488409|11697249|FG001|NOT COMPLETED|Overall Study||4
10544050|NCT01488448|11697257|FG000|STARTED|Overall Study||113
10544051|NCT01488448|11697258|FG001|STARTED|Overall Study||114
10544052|NCT01488448|11697257|FG000|COMPLETED|Overall Study||93
10544053|NCT01488448|11697258|FG001|COMPLETED|Overall Study||97
10544054|NCT01488448|11697257|FG000|NOT COMPLETED|Overall Study||20
10544055|NCT01488448|11697258|FG001|NOT COMPLETED|Overall Study||17
10544056|NCT01488487|11697266|FG000|STARTED|Overall Study||24
10544057|NCT01488487|11697266|FG000|Received Treatment|Overall Study||24
10544058|NCT01488487|11697266|FG000|COMPLETED|Overall Study||15
10544059|NCT01488487|11697266|FG000|NOT COMPLETED|Overall Study||9
10544060|NCT01488578|11697270|FG000|STARTED|Overall Study||11157
10544061|NCT01488578|11697270|FG000|COMPLETED|Overall Study||9321
10544062|NCT01488578|11697270|FG000|NOT COMPLETED|Overall Study||1836
10544063|NCT01488708|11697302|FG000|STARTED|Overall Study||940
10544064|NCT01488708|11697303|FG001|STARTED|Overall Study||578
10544065|NCT01488708|11697302|FG000|Received at Least 1 Dose of Study Drug|Overall Study||937
10544066|NCT01488708|11697303|FG001|Received at Least 1 Dose of Study Drug|Overall Study||578
10544067|NCT01488708|11697302|FG000|Participated in Follow Up|Overall Study||810
10544068|NCT01488708|11697303|FG001|Participated in Follow Up|Overall Study||526
10544069|NCT01488708|11697302|FG000|COMPLETED|Overall Study||0
10544070|NCT01488708|11697303|FG001|COMPLETED|Overall Study||0
10544071|NCT01488708|11697302|FG000|NOT COMPLETED|Overall Study||940
10544072|NCT01488708|11697303|FG001|NOT COMPLETED|Overall Study||578
10544073|NCT01488877|11697311|FG000|STARTED|Initial Randomization||1
10544074|NCT01488877|11697312|FG001|STARTED|Initial Randomization||5
10544075|NCT01488877|11697313|FG002|STARTED|Initial Randomization||0
10544076|NCT01488877|11697311|FG000|COMPLETED|Initial Randomization||1
10544077|NCT01488877|11697312|FG001|COMPLETED|Initial Randomization||5
10544078|NCT01488877|11697313|FG002|COMPLETED|Initial Randomization||0
10544079|NCT01488877|11697311|FG000|NOT COMPLETED|Initial Randomization||0
10544080|NCT01488877|11697312|FG001|NOT COMPLETED|Initial Randomization||0
10544081|NCT01488877|11697313|FG002|NOT COMPLETED|Initial Randomization||0
10544082|NCT01488877|11697311|FG000|STARTED|Re-randomization||0
10544083|NCT01488877|11697312|FG001|STARTED|Re-randomization||0
10544084|NCT01488877|11697313|FG002|STARTED|Re-randomization|Three participants were re-randomized from PF-03882845 3 mg arm.|3
10544085|NCT01488877|11697311|FG000|COMPLETED|Re-randomization||0
10544086|NCT01488877|11697312|FG001|COMPLETED|Re-randomization||0
10544087|NCT01488877|11697313|FG002|COMPLETED|Re-randomization||3
10544088|NCT01488877|11697311|FG000|NOT COMPLETED|Re-randomization||0
10544089|NCT01488877|11697312|FG001|NOT COMPLETED|Re-randomization||0
10544090|NCT01488877|11697313|FG002|NOT COMPLETED|Re-randomization||0
10544091|NCT01488994|11697322|FG000|STARTED|Overall Study||11
10544092|NCT01488994|11697323|FG001|STARTED|Overall Study||12
10544093|NCT01488994|11697322|FG000|COMPLETED|Overall Study||11
10544094|NCT01488994|11697323|FG001|COMPLETED|Overall Study||11
10544095|NCT01488994|11697322|FG000|NOT COMPLETED|Overall Study||0
10544096|NCT01488994|11697323|FG001|NOT COMPLETED|Overall Study||1
10315559|NCT00179998|11449453|FG000|NOT COMPLETED|Crossover Period - 6 Months||0
10315560|NCT00179998|11449454|FG001|NOT COMPLETED|Crossover Period - 6 Months||2
10315561|NCT00180271|11449466|FG000|STARTED|Overall Study||1089
10315562|NCT00180271|11449467|FG001|STARTED|Overall Study||731
10315563|NCT00180271|11449466|FG000|COMPLETED|Overall Study||1089
10315564|NCT00180271|11449467|FG001|COMPLETED|Overall Study||731
10315565|NCT00180271|11449466|FG000|NOT COMPLETED|Overall Study||0
10315566|NCT00180271|11449467|FG001|NOT COMPLETED|Overall Study||0
10315567|NCT00180297|11449477|FG000|STARTED|Overall Study||107
10315568|NCT00180297|11449478|FG001|STARTED|Overall Study||108
10315569|NCT00180297|11449477|FG000|COMPLETED|Overall Study||61
10315570|NCT00180297|11449478|FG001|COMPLETED|Overall Study||67
10315571|NCT00180297|11449477|FG000|NOT COMPLETED|Overall Study||46
10315572|NCT00180297|11449478|FG001|NOT COMPLETED|Overall Study||41
10315573|NCT00180323|11449484|FG000|STARTED|Overall Study||43
10312476|NCT00141739|11445878|FG000|STARTED|Overall Study|Number of evaluable patients|100
10312477|NCT00141739|11445878|FG000|COMPLETED|Overall Study||100
10312478|NCT00141739|11445878|FG000|NOT COMPLETED|Overall Study||0
10312479|NCT00141765|11445884|FG000|STARTED|Overall Study||25
10312480|NCT00141765|11445884|FG000|COMPLETED|Overall Study||25
10312481|NCT00141765|11445884|FG000|NOT COMPLETED|Overall Study||0
10312482|NCT00141778|11445891|FG000|STARTED|Randomization Prior to Study Med||152
10312483|NCT00141778|11445892|FG001|STARTED|Randomization Prior to Study Med||153
10312484|NCT00141778|11445893|FG002|STARTED|Randomization Prior to Study Med||153
10312485|NCT00141778|11445891|FG000|COMPLETED|Randomization Prior to Study Med||147
10312486|NCT00141778|11445892|FG001|COMPLETED|Randomization Prior to Study Med||151
10312487|NCT00141778|11445893|FG002|COMPLETED|Randomization Prior to Study Med||147
10312488|NCT00141778|11445891|FG000|NOT COMPLETED|Randomization Prior to Study Med||5
10312489|NCT00141778|11445892|FG001|NOT COMPLETED|Randomization Prior to Study Med||2
10312490|NCT00141778|11445893|FG002|NOT COMPLETED|Randomization Prior to Study Med||6
10312491|NCT00141778|11445891|FG000|STARTED|Started Study Medication||147
10312492|NCT00141778|11445892|FG001|STARTED|Started Study Medication||151
10312493|NCT00141778|11445893|FG002|STARTED|Started Study Medication||147
10312494|NCT00141778|11445891|FG000|COMPLETED|Started Study Medication||145
10312495|NCT00141778|11445892|FG001|COMPLETED|Started Study Medication||144
10312496|NCT00141778|11445893|FG002|COMPLETED|Started Study Medication||143
10312497|NCT00141778|11445891|FG000|NOT COMPLETED|Started Study Medication||2
10312498|NCT00141778|11445892|FG001|NOT COMPLETED|Started Study Medication||7
10312499|NCT00141778|11445893|FG002|NOT COMPLETED|Started Study Medication||4
10312500|NCT00141817|11445905|FG000|STARTED|Overall Study||7
10312501|NCT00141817|11445906|FG001|STARTED|Overall Study||10
10312502|NCT00141817|11445907|FG002|STARTED|Overall Study||11
10312503|NCT00141817|11445908|FG003|STARTED|Overall Study||13
10312504|NCT00141817|11445905|FG000|COMPLETED|Overall Study||6
10312505|NCT00141817|11445906|FG001|COMPLETED|Overall Study||10
10312506|NCT00141817|11445907|FG002|COMPLETED|Overall Study||10
10312507|NCT00141817|11445908|FG003|COMPLETED|Overall Study||13
10312508|NCT00141817|11445905|FG000|NOT COMPLETED|Overall Study||1
10312509|NCT00141817|11445906|FG001|NOT COMPLETED|Overall Study||0
10312510|NCT00141817|11445907|FG002|NOT COMPLETED|Overall Study||1
10312511|NCT00141817|11445908|FG003|NOT COMPLETED|Overall Study||0
10312512|NCT00141921|11445918|FG000|STARTED|Overall Study||182
10312513|NCT00141921|11445918|FG000|Received Treatment|Overall Study||181
10312514|NCT00141921|11445918|FG000|COMPLETED|Overall Study||41
10312515|NCT00141921|11445918|FG000|NOT COMPLETED|Overall Study||141
10312516|NCT00142116|11445922|FG000|STARTED|Overall Study||25
10312517|NCT00142116|11445922|FG000|COMPLETED|Overall Study||25
10312518|NCT00142116|11445922|FG000|NOT COMPLETED|Overall Study||0
10312519|NCT00142168|11445927|FG000|STARTED|Overall Study||16
10312520|NCT00142168|11445927|FG000|COMPLETED|Overall Study||16
10312521|NCT00142168|11445927|FG000|NOT COMPLETED|Overall Study||0
10312522|NCT00142298|11445941|FG000|STARTED|Overall Study||667
10312523|NCT00142298|11445942|FG001|STARTED|Overall Study||632
10312524|NCT00142298|11445943|FG002|STARTED|Overall Study||123
10312525|NCT00142298|11445944|FG003|STARTED|Overall Study||206
10312526|NCT00142298|11445945|FG004|STARTED|Overall Study||56
10312527|NCT00142298|11445946|FG005|STARTED|Overall Study||26
10312528|NCT00142298|11445947|FG006|STARTED|Overall Study||23
10312529|NCT00142298|11445948|FG007|STARTED|Overall Study||66
10312530|NCT00142298|11445949|FG008|STARTED|Overall Study||57
10312531|NCT00142298|11445950|FG009|STARTED|Overall Study||13
10312532|NCT00142298|11445941|FG000|Safety Population|Overall Study||655
10312533|NCT00142298|11445942|FG001|Safety Population|Overall Study||626
10312534|NCT00142298|11445943|FG002|Safety Population|Overall Study||122
10312535|NCT00142298|11445944|FG003|Safety Population|Overall Study||206
10312536|NCT00142298|11445945|FG004|Safety Population|Overall Study||50
10312537|NCT00142298|11445946|FG005|Safety Population|Overall Study||26
10312538|NCT00142298|11445947|FG006|Safety Population|Overall Study||23
10312539|NCT00142298|11445948|FG007|Safety Population|Overall Study||66
10312540|NCT00142298|11445949|FG008|Safety Population|Overall Study||57
10312541|NCT00142298|11445950|FG009|Safety Population|Overall Study||13
10401986|NCT00721617|11546176|FG000|STARTED|4 Hours Into Intralipid/Dextrose||12
10312542|NCT00142298|11445941|FG000|Per Protocol Population|Overall Study||635
10312543|NCT00142298|11445942|FG001|Per Protocol Population|Overall Study||606
10312544|NCT00142298|11445943|FG002|Per Protocol Population|Overall Study||120
10312545|NCT00142298|11445944|FG003|Per Protocol Population|Overall Study||202
10312546|NCT00142298|11445945|FG004|Per Protocol Population|Overall Study||50
10312547|NCT00142298|11445946|FG005|Per Protocol Population|Overall Study||25
10312548|NCT00142298|11445947|FG006|Per Protocol Population|Overall Study||19
10312549|NCT00142298|11445948|FG007|Per Protocol Population|Overall Study||64
10312550|NCT00142298|11445949|FG008|Per Protocol Population|Overall Study||56
10312551|NCT00142298|11445950|FG009|Per Protocol Population|Overall Study||13
10312552|NCT00142298|11445941|FG000|COMPLETED|Overall Study|Completed week 104/week 208.|507
10312553|NCT00142298|11445942|FG001|COMPLETED|Overall Study||456
10401987|NCT00721617|11546176|FG000|COMPLETED|4 Hours Into Intralipid/Dextrose||12
10401988|NCT00721617|11546176|FG000|NOT COMPLETED|4 Hours Into Intralipid/Dextrose||0
10401989|NCT00721617|11546176|FG000|STARTED|8 Hours Into Intralipid/Dextrose||12
10401990|NCT00721617|11546176|FG000|COMPLETED|8 Hours Into Intralipid/Dextrose||12
10401991|NCT00721617|11546176|FG000|NOT COMPLETED|8 Hours Into Intralipid/Dextrose||0
10401992|NCT00721630|11546181|FG000|STARTED|Overall Study||24
10401993|NCT00721630|11546181|FG000|COMPLETED|Overall Study||23
10401994|NCT00721630|11546181|FG000|NOT COMPLETED|Overall Study||1
10401995|NCT00721734|11546190|FG000|STARTED|Overall Study||12
10401996|NCT00721734|11546191|FG001|STARTED|Overall Study||12
10401997|NCT00721734|11546192|FG002|STARTED|Overall Study||10
10401998|NCT00721734|11546193|FG003|STARTED|Overall Study||8
10401999|NCT00721734|11546194|FG004|STARTED|Overall Study||8
10402000|NCT00721734|11546190|FG000|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|4
10402001|NCT00721734|11546191|FG001|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|0
10402002|NCT00721734|11546192|FG002|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
10402003|NCT00721734|11546193|FG003|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
10402004|NCT00721734|11546194|FG004|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
10402005|NCT00721734|11546190|FG000|NOT COMPLETED|Overall Study||8
10402006|NCT00721734|11546191|FG001|NOT COMPLETED|Overall Study||12
10402007|NCT00721734|11546192|FG002|NOT COMPLETED|Overall Study||8
10402008|NCT00721734|11546193|FG003|NOT COMPLETED|Overall Study||6
10402009|NCT00721734|11546194|FG004|NOT COMPLETED|Overall Study||6
10402010|NCT00721799|11546206|FG000|STARTED|Overall Study||33
10402011|NCT00721799|11546206|FG000|Recieved FLT PET Scan 1|Overall Study||26
10402012|NCT00721799|11546206|FG000|Received FLT PET Scan #2|Overall Study||25
10402013|NCT00721799|11546206|FG000|COMPLETED|Overall Study||25
10402014|NCT00721799|11546206|FG000|NOT COMPLETED|Overall Study||8
10402015|NCT00721955|11546213|FG000|STARTED|Overall Study||105
10402016|NCT00721955|11546214|FG001|STARTED|Overall Study||104
10402017|NCT00721955|11546215|FG002|STARTED|Overall Study||105
10402018|NCT00721955|11546213|FG000|COMPLETED|Overall Study||105
10402019|NCT00721955|11546214|FG001|COMPLETED|Overall Study||104
10402020|NCT00721955|11546215|FG002|COMPLETED|Overall Study||103
10402021|NCT00721955|11546213|FG000|NOT COMPLETED|Overall Study||0
10402022|NCT00721955|11546214|FG001|NOT COMPLETED|Overall Study||0
10402023|NCT00721955|11546215|FG002|NOT COMPLETED|Overall Study||2
10402024|NCT00721968|11546225|FG000|STARTED|Overall Study||27
10402025|NCT00721968|11546226|FG001|STARTED|Overall Study||17
10402026|NCT00721968|11546225|FG000|COMPLETED|Overall Study||25
10402027|NCT00721968|11546226|FG001|COMPLETED|Overall Study||17
10659805|NCT02245412|11821223|FG001|COMPLETED|Follow-Up Period||2
10659806|NCT02245412|11821224|FG002|COMPLETED|Follow-Up Period||0
10659807|NCT02245412|11821222|FG000|NOT COMPLETED|Follow-Up Period||5
10659808|NCT02245412|11821223|FG001|NOT COMPLETED|Follow-Up Period||2
10659809|NCT02245412|11821224|FG002|NOT COMPLETED|Follow-Up Period||2
10659810|NCT02245516|11821234|FG000|STARTED|Overall Study||9
10659811|NCT02245516|11821235|FG001|STARTED|Overall Study||7
10659812|NCT02245516|11821234|FG000|COMPLETED|Overall Study||9
10659813|NCT02245516|11821235|FG001|COMPLETED|Overall Study||4
10659814|NCT02245516|11821234|FG000|NOT COMPLETED|Overall Study||0
10659815|NCT02245516|11821235|FG001|NOT COMPLETED|Overall Study||3
10659816|NCT02245568|11821241|FG000|STARTED|Overall Study||913
10659817|NCT02245568|11821241|FG000|COMPLETED|Overall Study||60
10659818|NCT02245568|11821241|FG000|NOT COMPLETED|Overall Study||853
10659819|NCT02245620|11821247|FG000|STARTED|Overall Study||20
10659820|NCT02245620|11821248|FG001|STARTED|Overall Study||21
10659821|NCT02245620|11821247|FG000|COMPLETED|Overall Study||19
10659822|NCT02245620|11821248|FG001|COMPLETED|Overall Study||20
10659823|NCT02245620|11821247|FG000|NOT COMPLETED|Overall Study||1
10659824|NCT02245620|11821248|FG001|NOT COMPLETED|Overall Study||1
10659825|NCT02245737|11821257|FG000|STARTED|Overall Study||740
10659826|NCT02245737|11821258|FG001|STARTED|Overall Study||739
10659827|NCT02245737|11821259|FG002|STARTED|Overall Study||739
10659828|NCT02245737|11821257|FG000|Received at Least 1 Dose of Study Drug|Overall Study||738
10659829|NCT02245737|11821258|FG001|Received at Least 1 Dose of Study Drug|Overall Study||736
10659830|NCT02245737|11821259|FG002|Received at Least 1 Dose of Study Drug|Overall Study||735
10659831|NCT02245737|11821257|FG000|COMPLETED|Overall Study||187
10659832|NCT02245737|11821258|FG001|COMPLETED|Overall Study||184
10659833|NCT02245737|11821259|FG002|COMPLETED|Overall Study||168
10659834|NCT02245737|11821257|FG000|NOT COMPLETED|Overall Study||553
10659835|NCT02245737|11821258|FG001|NOT COMPLETED|Overall Study||555
10659836|NCT02245737|11821259|FG002|NOT COMPLETED|Overall Study||571
10659837|NCT02245815|11821271|FG000|STARTED|Overall Study||45
10659838|NCT02245815|11821272|FG001|STARTED|Overall Study||45
10659839|NCT02245815|11821271|FG000|COMPLETED|Overall Study||45
10659840|NCT02245815|11821272|FG001|COMPLETED|Overall Study||45
10659841|NCT02245815|11821271|FG000|NOT COMPLETED|Overall Study||0
10659842|NCT02245815|11821272|FG001|NOT COMPLETED|Overall Study||0
10659843|NCT02246010|11821282|FG000|STARTED|Overall Study||4
10659844|NCT02246010|11821283|FG001|STARTED|Overall Study||2
10659845|NCT02246010|11821282|FG000|COMPLETED|Overall Study||4
10659846|NCT02246010|11821283|FG001|COMPLETED|Overall Study||2
10659847|NCT02246010|11821282|FG000|NOT COMPLETED|Overall Study||0
10721372|NCT02725268|11885019|FG000|Started|Overall Study||90
10721373|NCT02725268|11885020|FG001|Started|Overall Study||90
10721374|NCT02725268|11885021|FG002|Started|Overall Study||41
10721375|NCT02725268|11885022|FG003|Started|Overall Study||20
10721376|NCT02725268|11885019|FG000|Completed|Overall Study||18
10721377|NCT02725268|11885020|FG001|Completed|Overall Study||20
10721378|NCT02725268|11885021|FG002|Completed|Overall Study||3
10721379|NCT02725268|11885022|FG003|Completed|Overall Study||2
10721380|NCT02725268|11885019|FG000|COMPLETED|Overall Study||18
10721381|NCT02725268|11885020|FG001|COMPLETED|Overall Study||20
10721382|NCT02725268|11885021|FG002|COMPLETED|Overall Study||3
10814340|NCT02390362|11977010|FG000|NOT COMPLETED|Overall Study||0
10814341|NCT02390362|11977011|FG001|NOT COMPLETED|Overall Study||1
10814342|NCT02388776|11977017|FG000|STARTED|Overall Study||2
10814343|NCT02388776|11977017|FG000|COMPLETED|Overall Study||0
10814344|NCT02388776|11977017|FG000|NOT COMPLETED|Overall Study||2
10814345|NCT02383433|11977022|FG000|STARTED|Overall Study||2
10814346|NCT02383433|11977022|FG000|COMPLETED|Overall Study||0
10814347|NCT02383433|11977022|FG000|NOT COMPLETED|Overall Study||2
10814348|NCT02382588|11977028|FG000|STARTED|Overall Study||4
10814349|NCT02382588|11977029|FG001|STARTED|Overall Study||4
10814350|NCT02382588|11977028|FG000|COMPLETED|Overall Study||4
10814351|NCT02382588|11977029|FG001|COMPLETED|Overall Study||4
10814352|NCT02382588|11977028|FG000|NOT COMPLETED|Overall Study||0
10814353|NCT02382588|11977029|FG001|NOT COMPLETED|Overall Study||0
10814354|NCT02381626|11977038|FG000|STARTED|Overall Study||17
10814355|NCT02381626|11977039|FG001|STARTED|Overall Study||16
10659848|NCT02246010|11821283|FG001|NOT COMPLETED|Overall Study||0
10659849|NCT02246062|11821293|FG000|STARTED|Overall Study||21
10659850|NCT02246062|11821294|FG001|STARTED|Overall Study||21
10659851|NCT02246062|11821295|FG002|STARTED|Overall Study||21
10659852|NCT02246062|11821296|FG003|STARTED|Overall Study||21
10659853|NCT02246062|11821293|FG000|COMPLETED|Overall Study||21
10659854|NCT02246062|11821294|FG001|COMPLETED|Overall Study||21
10659855|NCT02246062|11821295|FG002|COMPLETED|Overall Study||21
10659856|NCT02246062|11821296|FG003|COMPLETED|Overall Study||21
10659857|NCT02246062|11821293|FG000|NOT COMPLETED|Overall Study||0
10659858|NCT02246062|11821294|FG001|NOT COMPLETED|Overall Study||0
10721383|NCT02725268|11885022|FG003|COMPLETED|Overall Study||2
10721384|NCT02725268|11885019|FG000|NOT COMPLETED|Overall Study||72
10721385|NCT02725268|11885020|FG001|NOT COMPLETED|Overall Study||70
10814356|NCT02381626|11977040|FG002|STARTED|Overall Study||6
10402028|NCT00721968|11546225|FG000|NOT COMPLETED|Overall Study||2
10659859|NCT02246062|11821295|FG002|NOT COMPLETED|Overall Study||0
10659860|NCT02246062|11821296|FG003|NOT COMPLETED|Overall Study||0
10659861|NCT02246166|11821308|FG000|STARTED|Overall Study||26
10659862|NCT02246166|11821309|FG001|STARTED|Overall Study||27
10814357|NCT02381626|11977038|FG000|COMPLETED|Overall Study||17
10814358|NCT02381626|11977039|FG001|COMPLETED|Overall Study||16
10814359|NCT02381626|11977040|FG002|COMPLETED|Overall Study||6
10814360|NCT02381626|11977038|FG000|NOT COMPLETED|Overall Study||0
10814361|NCT02381626|11977039|FG001|NOT COMPLETED|Overall Study||0
10814362|NCT02381626|11977040|FG002|NOT COMPLETED|Overall Study||0
10814363|NCT02379390|11977050|FG000|STARTED|Overall Study||4
10814364|NCT02379390|11977051|FG001|STARTED|Overall Study||4
10814365|NCT02379390|11977050|FG000|COMPLETED|Overall Study||2
10814366|NCT02379390|11977051|FG001|COMPLETED|Overall Study||2
10814367|NCT02379390|11977050|FG000|NOT COMPLETED|Overall Study||2
10814368|NCT02379390|11977051|FG001|NOT COMPLETED|Overall Study||2
10814369|NCT02373865|11977062|FG000|STARTED|Overall Study||2
10814370|NCT02373865|11977063|FG001|STARTED|Overall Study||2
10814371|NCT02373865|11977062|FG000|COMPLETED|Overall Study||2
10814372|NCT02373865|11977063|FG001|COMPLETED|Overall Study||2
10814373|NCT02373865|11977062|FG000|NOT COMPLETED|Overall Study||0
10814374|NCT02373865|11977063|FG001|NOT COMPLETED|Overall Study||0
10814375|NCT02365688|11977069|FG000|STARTED|Overall Study|All subjects received a bolus of 500cc before first incision|18
10814376|NCT02365688|11977069|FG000|COMPLETED|Overall Study|All subjects consented to an change in standard infusion volume pre-incision|18
10814377|NCT02365688|11977069|FG000|NOT COMPLETED|Overall Study||0
10814378|NCT02361580|11977075|FG000|STARTED|Overall Study||6
10814379|NCT02361580|11977076|FG001|STARTED|Overall Study||3
10814380|NCT02361580|11977075|FG000|COMPLETED|Overall Study||0
10402029|NCT00721968|11546226|FG001|NOT COMPLETED|Overall Study||0
10402030|NCT00722007|11546232|FG000|STARTED|Overall Study||147
10721386|NCT02725268|11885021|FG002|NOT COMPLETED|Overall Study||38
10721387|NCT02725268|11885022|FG003|NOT COMPLETED|Overall Study||18
10402031|NCT00722007|11546232|FG000|COMPLETED|Overall Study||117
10402032|NCT00722007|11546232|FG000|NOT COMPLETED|Overall Study||30
10402033|NCT00722020|11546239|FG000|STARTED|Overall Study||19
10402034|NCT00722020|11546240|FG001|STARTED|Overall Study||24
10402035|NCT00722020|11546239|FG000|COMPLETED|Overall Study||19
10402036|NCT00722020|11546240|FG001|COMPLETED|Overall Study||24
10402037|NCT00722020|11546239|FG000|NOT COMPLETED|Overall Study||0
10402038|NCT00722020|11546240|FG001|NOT COMPLETED|Overall Study||0
10402039|NCT00722072|11546248|FG000|STARTED|Overall Study||12
10402040|NCT00722072|11546248|FG000|COMPLETED|Overall Study||9
10402041|NCT00722072|11546248|FG000|NOT COMPLETED|Overall Study||3
10402042|NCT00722111|11546254|FG000|STARTED|Overall Study||11
10402043|NCT00722111|11546255|FG001|STARTED|Overall Study||72
10402044|NCT00722111|11546254|FG000|COMPLETED|Overall Study||11
10402045|NCT00722111|11546255|FG001|COMPLETED|Overall Study||72
10402046|NCT00722111|11546254|FG000|NOT COMPLETED|Overall Study||0
10402047|NCT00722111|11546255|FG001|NOT COMPLETED|Overall Study||0
10402048|NCT00722124|11546264|FG000|STARTED|Overall Study||40
10402049|NCT00722124|11546265|FG001|STARTED|Overall Study||40
10402050|NCT00722124|11546266|FG002|STARTED|Overall Study||40
10402051|NCT00722124|11546264|FG000|COMPLETED|Overall Study||23
10402052|NCT00722124|11546265|FG001|COMPLETED|Overall Study||26
10402053|NCT00722124|11546266|FG002|COMPLETED|Overall Study||20
10402054|NCT00722124|11546264|FG000|NOT COMPLETED|Overall Study||17
10402055|NCT00722124|11546265|FG001|NOT COMPLETED|Overall Study||14
10402056|NCT00722124|11546266|FG002|NOT COMPLETED|Overall Study||20
10402057|NCT00722137|11546276|FG000|STARTED|Overall Study||244
10402058|NCT00722137|11546277|FG001|STARTED|Overall Study||243
10402059|NCT00722137|11546276|FG000|COMPLETED|Overall Study||199
10402060|NCT00722137|11546277|FG001|COMPLETED|Overall Study||195
10402061|NCT00722137|11546276|FG000|NOT COMPLETED|Overall Study||45
10402062|NCT00722137|11546277|FG001|NOT COMPLETED|Overall Study||48
10402063|NCT00722371|11546290|FG000|STARTED|Overall Study||231
10402064|NCT00722371|11546291|FG001|STARTED|Overall Study||230
10402065|NCT00722371|11546292|FG002|STARTED|Overall Study||233
10544097|NCT01489020|11697340|FG000|STARTED|Overall Study||12
10544098|NCT01489020|11697341|FG001|STARTED|Overall Study||4
10544099|NCT01489020|11697342|FG002|STARTED|Overall Study||12
10721388|NCT02725411|11885035|FG000|STARTED|Treatment Period (56 Weeks)||92
10402066|NCT00722371|11546293|FG003|STARTED|Overall Study||230
10402067|NCT00722371|11546294|FG004|STARTED|Overall Study||230
10402068|NCT00722371|11546295|FG005|STARTED|Overall Study||231
10402069|NCT00722371|11546296|FG006|STARTED|Overall Study||230
10402070|NCT00722371|11546290|FG000|COMPLETED|Overall Study||175
10402071|NCT00722371|11546291|FG001|COMPLETED|Overall Study||158
10402072|NCT00722371|11546292|FG002|COMPLETED|Overall Study||168
10402073|NCT00722371|11546293|FG003|COMPLETED|Overall Study||167
10814381|NCT02361580|11977076|FG001|COMPLETED|Overall Study||0
10814382|NCT02361580|11977075|FG000|NOT COMPLETED|Overall Study||6
10402074|NCT00722371|11546294|FG004|COMPLETED|Overall Study||182
10402075|NCT00722371|11546295|FG005|COMPLETED|Overall Study||178
10402076|NCT00722371|11546296|FG006|COMPLETED|Overall Study||179
10402077|NCT00722371|11546290|FG000|NOT COMPLETED|Overall Study||56
10402078|NCT00722371|11546291|FG001|NOT COMPLETED|Overall Study||72
10402079|NCT00722371|11546292|FG002|NOT COMPLETED|Overall Study||65
10402080|NCT00722371|11546293|FG003|NOT COMPLETED|Overall Study||63
10402081|NCT00722371|11546294|FG004|NOT COMPLETED|Overall Study||48
10402082|NCT00722371|11546295|FG005|NOT COMPLETED|Overall Study||53
10402083|NCT00722371|11546296|FG006|NOT COMPLETED|Overall Study||51
10402084|NCT00722423|11546314|FG000|STARTED|Overall Study||182
10402085|NCT00722423|11546315|FG001|STARTED|Overall Study||182
10402086|NCT00722423|11546314|FG000|COMPLETED|Overall Study||182
10402087|NCT00722423|11546315|FG001|COMPLETED|Overall Study||181
10402088|NCT00722423|11546314|FG000|NOT COMPLETED|Overall Study||0
10402089|NCT00722423|11546315|FG001|NOT COMPLETED|Overall Study||1
10402090|NCT00722436|11546325|FG000|STARTED|Overall Study||9
10402091|NCT00722436|11546326|FG001|STARTED|Overall Study||11
10402092|NCT00722436|11546325|FG000|COMPLETED|Overall Study||9
10402093|NCT00722436|11546326|FG001|COMPLETED|Overall Study||11
10312554|NCT00142298|11445943|FG002|COMPLETED|Overall Study||90
10312555|NCT00142298|11445944|FG003|COMPLETED|Overall Study||121
10312556|NCT00142298|11445945|FG004|COMPLETED|Overall Study||46
10312557|NCT00142298|11445946|FG005|COMPLETED|Overall Study||10
10312558|NCT00142298|11445947|FG006|COMPLETED|Overall Study||15
10312559|NCT00142298|11445948|FG007|COMPLETED|Overall Study||58
10312560|NCT00142298|11445949|FG008|COMPLETED|Overall Study||52
10312561|NCT00142298|11445950|FG009|COMPLETED|Overall Study||13
10312562|NCT00142298|11445941|FG000|NOT COMPLETED|Overall Study||160
10312563|NCT00142298|11445942|FG001|NOT COMPLETED|Overall Study||176
10312564|NCT00142298|11445943|FG002|NOT COMPLETED|Overall Study||33
10312565|NCT00142298|11445944|FG003|NOT COMPLETED|Overall Study||85
10312566|NCT00142298|11445945|FG004|NOT COMPLETED|Overall Study||10
10312567|NCT00142298|11445946|FG005|NOT COMPLETED|Overall Study||16
10312568|NCT00142298|11445947|FG006|NOT COMPLETED|Overall Study||8
10312569|NCT00142298|11445948|FG007|NOT COMPLETED|Overall Study||8
10312570|NCT00142298|11445949|FG008|NOT COMPLETED|Overall Study||5
10312571|NCT00142298|11445950|FG009|NOT COMPLETED|Overall Study||0
10312572|NCT00142415|11445978|FG000|STARTED|Overall Study||3
10312573|NCT00142415|11445979|FG001|STARTED|Overall Study||3
10312574|NCT00142415|11445980|FG002|STARTED|Overall Study||6
10312575|NCT00142415|11445981|FG003|STARTED|Overall Study||3
10312576|NCT00142415|11445982|FG004|STARTED|Overall Study||3
10312577|NCT00142415|11445983|FG005|STARTED|Overall Study||8
10312578|NCT00142415|11445978|FG000|COMPLETED|Overall Study||3
10312579|NCT00142415|11445979|FG001|COMPLETED|Overall Study||3
10312580|NCT00142415|11445980|FG002|COMPLETED|Overall Study||6
10312581|NCT00142415|11445981|FG003|COMPLETED|Overall Study||3
10312582|NCT00142415|11445982|FG004|COMPLETED|Overall Study||2
10312583|NCT00142415|11445983|FG005|COMPLETED|Overall Study||6
10312584|NCT00142415|11445978|FG000|NOT COMPLETED|Overall Study||0
10312585|NCT00142415|11445979|FG001|NOT COMPLETED|Overall Study||0
10312586|NCT00142415|11445980|FG002|NOT COMPLETED|Overall Study||0
10312587|NCT00142415|11445981|FG003|NOT COMPLETED|Overall Study||0
10312588|NCT00142415|11445982|FG004|NOT COMPLETED|Overall Study||1
10312589|NCT00142415|11445983|FG005|NOT COMPLETED|Overall Study||2
10312590|NCT00142454|11445999|FG000|STARTED|Overall Study||9
10312591|NCT00142454|11445999|FG000|COMPLETED|Overall Study||9
10312592|NCT00142454|11445999|FG000|NOT COMPLETED|Overall Study||0
10312593|NCT00142506|11446005|FG000|STARTED|Overall Study||184
10312594|NCT00142506|11446006|FG001|STARTED|Overall Study||106
10312595|NCT00142506|11446005|FG000|COMPLETED|Overall Study||112
10312596|NCT00142506|11446006|FG001|COMPLETED|Overall Study||77
10312597|NCT00142506|11446005|FG000|NOT COMPLETED|Overall Study||72
10312598|NCT00142506|11446006|FG001|NOT COMPLETED|Overall Study||29
10312599|NCT00142597|11446014|FG000|STARTED|Overall Study|N=10 underwent PET imaging|23
10312600|NCT00142597|11446015|FG001|STARTED|Overall Study|N=10 underwent PET imaging|23
10312601|NCT00142597|11446014|FG000|COMPLETED|Overall Study|N=10 completed PET imaging|20
10312602|NCT00142597|11446015|FG001|COMPLETED|Overall Study|N=10 completed PET imaging|22
10402094|NCT00722436|11546325|FG000|NOT COMPLETED|Overall Study||0
10402095|NCT00722436|11546326|FG001|NOT COMPLETED|Overall Study||0
10402096|NCT00722553|11546332|FG000|STARTED|Overall Study||30
10402097|NCT00722553|11546332|FG000|COMPLETED|Overall Study||30
10402098|NCT00722553|11546332|FG000|NOT COMPLETED|Overall Study||0
10402099|NCT00722566|11546340|FG000|STARTED|Overall Study|One patient randomized and not dosed|148
10402100|NCT00722566|11546341|FG001|STARTED|Overall Study||74
10402101|NCT00722566|11546340|FG000|COMPLETED|Overall Study|Completed 8 cycles|81
10402102|NCT00722566|11546341|FG001|COMPLETED|Overall Study|Completed 8 cycles|39
10402103|NCT00722566|11546340|FG000|NOT COMPLETED|Overall Study||67
10402104|NCT00722566|11546341|FG001|NOT COMPLETED|Overall Study||35
10402105|NCT00722722|11546352|FG000|STARTED|Overall Study||3
10402106|NCT00722722|11546353|FG001|STARTED|Overall Study||5
10402107|NCT00722722|11546354|FG002|STARTED|Overall Study||10
10402108|NCT00722722|11546352|FG000|COMPLETED|Overall Study||3
10402109|NCT00722722|11546353|FG001|COMPLETED|Overall Study||5
10402110|NCT00722722|11546354|FG002|COMPLETED|Overall Study||10
10402111|NCT00722722|11546352|FG000|NOT COMPLETED|Overall Study||0
10402112|NCT00722722|11546353|FG001|NOT COMPLETED|Overall Study||0
10402113|NCT00722722|11546354|FG002|NOT COMPLETED|Overall Study||0
10402114|NCT00722761|11546364|FG000|STARTED|Overall Study||16
10402115|NCT00722761|11546365|FG001|STARTED|Overall Study||14
10402116|NCT00722761|11546364|FG000|COMPLETED AT LEAST 1 FOLLOW-UP VISIT|Overall Study||15
10402117|NCT00722761|11546365|FG001|COMPLETED AT LEAST 1 FOLLOW-UP VISIT|Overall Study||10
10402118|NCT00722761|11546364|FG000|COMPLETED|Overall Study||10
10402119|NCT00722761|11546365|FG001|COMPLETED|Overall Study||8
10402120|NCT00722761|11546364|FG000|NOT COMPLETED|Overall Study||6
10402121|NCT00722761|11546365|FG001|NOT COMPLETED|Overall Study||6
10402122|NCT00722800|11546373|FG000|STARTED|Overall Study||2
10402123|NCT00722800|11546374|FG001|STARTED|Overall Study||2
10402124|NCT00722800|11546373|FG000|COMPLETED|Overall Study||0
10402125|NCT00722800|11546374|FG001|COMPLETED|Overall Study||2
10721389|NCT02725411|11885036|FG001|STARTED|Treatment Period (56 Weeks)||93
10721390|NCT02725411|11885037|FG002|STARTED|Treatment Period (56 Weeks)||92
10402126|NCT00722800|11546373|FG000|NOT COMPLETED|Overall Study||2
10402127|NCT00722800|11546374|FG001|NOT COMPLETED|Overall Study||0
10402128|NCT00722865|11546380|FG000|STARTED|Overall Study||25
10402129|NCT00722865|11546380|FG000|COMPLETED|Overall Study||23
10402130|NCT00722865|11546380|FG000|NOT COMPLETED|Overall Study||2
10402131|NCT00723008|11546386|FG000|STARTED|Enrollment||11
10402132|NCT00723008|11546387|FG001|STARTED|Enrollment||9
10402133|NCT00723008|11546386|FG000|COMPLETED|Enrollment||10
10402134|NCT00723008|11546387|FG001|COMPLETED|Enrollment||9
10402135|NCT00723008|11546386|FG000|NOT COMPLETED|Enrollment||1
10402136|NCT00723008|11546387|FG001|NOT COMPLETED|Enrollment||0
10402137|NCT00723008|11546386|FG000|STARTED|4-Week Double Blinded||10
10402138|NCT00723008|11546387|FG001|STARTED|4-Week Double Blinded||9
10402139|NCT00723008|11546386|FG000|COMPLETED|4-Week Double Blinded||5
10402140|NCT00723008|11546387|FG001|COMPLETED|4-Week Double Blinded||4
10402141|NCT00723008|11546386|FG000|NOT COMPLETED|4-Week Double Blinded||5
10402142|NCT00723008|11546387|FG001|NOT COMPLETED|4-Week Double Blinded||5
10402143|NCT00723008|11546386|FG000|STARTED|4-Week Unblinded Treatment||5
10402144|NCT00723008|11546387|FG001|STARTED|4-Week Unblinded Treatment||4
10402145|NCT00723008|11546386|FG000|COMPLETED|4-Week Unblinded Treatment||4
10402146|NCT00723008|11546387|FG001|COMPLETED|4-Week Unblinded Treatment||3
10402147|NCT00723008|11546386|FG000|NOT COMPLETED|4-Week Unblinded Treatment||1
10402148|NCT00723008|11546387|FG001|NOT COMPLETED|4-Week Unblinded Treatment||1
10402149|NCT00723021|11546401|FG000|STARTED|Intervention Period 1||3
10402150|NCT00723021|11546402|FG001|STARTED|Intervention Period 1||3
10402151|NCT00723021|11546403|FG002|STARTED|Intervention Period 1||3
10402152|NCT00723021|11546404|FG003|STARTED|Intervention Period 1||3
10402153|NCT00723021|11546405|FG004|STARTED|Intervention Period 1||3
10402154|NCT00723021|11546401|FG000|COMPLETED|Intervention Period 1||3
10402155|NCT00723021|11546402|FG001|COMPLETED|Intervention Period 1||3
10402156|NCT00723021|11546403|FG002|COMPLETED|Intervention Period 1||3
10402157|NCT00723021|11546404|FG003|COMPLETED|Intervention Period 1||3
10402158|NCT00723021|11546405|FG004|COMPLETED|Intervention Period 1||3
10402159|NCT00723021|11546401|FG000|NOT COMPLETED|Intervention Period 1||0
10402160|NCT00723021|11546402|FG001|NOT COMPLETED|Intervention Period 1||0
10402161|NCT00723021|11546403|FG002|NOT COMPLETED|Intervention Period 1||0
10402162|NCT00723021|11546404|FG003|NOT COMPLETED|Intervention Period 1||0
10402163|NCT00723021|11546405|FG004|NOT COMPLETED|Intervention Period 1||0
10402164|NCT00723021|11546401|FG000|STARTED|Intervention Period 2||3
10402165|NCT00723021|11546402|FG001|STARTED|Intervention Period 2||3
10402166|NCT00723021|11546403|FG002|STARTED|Intervention Period 2||3
10659863|NCT02246166|11821308|FG000|COMPLETED|Overall Study||25
10659864|NCT02246166|11821309|FG001|COMPLETED|Overall Study||27
10659865|NCT02246166|11821308|FG000|NOT COMPLETED|Overall Study||1
10659866|NCT02246166|11821309|FG001|NOT COMPLETED|Overall Study||0
10659867|NCT02246218|11821317|FG000|STARTED|Overall Study||10
10659868|NCT02246218|11821318|FG001|STARTED|Overall Study||16
10659869|NCT02246218|11821317|FG000|COMPLETED|Overall Study||6
10659870|NCT02246218|11821318|FG001|COMPLETED|Overall Study||10
10721391|NCT02725411|11885035|FG000|Treated|Treatment Period (56 Weeks)||92
10721392|NCT02725411|11885036|FG001|Treated|Treatment Period (56 Weeks)||93
10402167|NCT00723021|11546404|FG003|STARTED|Intervention Period 2||3
10402168|NCT00723021|11546405|FG004|STARTED|Intervention Period 2||3
10402169|NCT00723021|11546401|FG000|COMPLETED|Intervention Period 2||3
10402170|NCT00723021|11546402|FG001|COMPLETED|Intervention Period 2||3
10402171|NCT00723021|11546403|FG002|COMPLETED|Intervention Period 2||3
10402172|NCT00723021|11546404|FG003|COMPLETED|Intervention Period 2||3
10402173|NCT00723021|11546405|FG004|COMPLETED|Intervention Period 2||3
10402174|NCT00723021|11546401|FG000|NOT COMPLETED|Intervention Period 2||0
10402175|NCT00723021|11546402|FG001|NOT COMPLETED|Intervention Period 2||0
10402176|NCT00723021|11546403|FG002|NOT COMPLETED|Intervention Period 2||0
10402177|NCT00723021|11546404|FG003|NOT COMPLETED|Intervention Period 2||0
10402178|NCT00723021|11546405|FG004|NOT COMPLETED|Intervention Period 2||0
10402179|NCT00723021|11546401|FG000|STARTED|Intervention Period 3||3
10402180|NCT00723021|11546402|FG001|STARTED|Intervention Period 3||3
10402181|NCT00723021|11546403|FG002|STARTED|Intervention Period 3||3
10402182|NCT00723021|11546404|FG003|STARTED|Intervention Period 3||3
10402183|NCT00723021|11546405|FG004|STARTED|Intervention Period 3||3
10402184|NCT00723021|11546401|FG000|COMPLETED|Intervention Period 3||3
10402185|NCT00723021|11546402|FG001|COMPLETED|Intervention Period 3||3
10402186|NCT00723021|11546403|FG002|COMPLETED|Intervention Period 3||3
10402187|NCT00723021|11546404|FG003|COMPLETED|Intervention Period 3||3
10402188|NCT00723021|11546405|FG004|COMPLETED|Intervention Period 3||3
10402189|NCT00723021|11546401|FG000|NOT COMPLETED|Intervention Period 3||0
10402190|NCT00723021|11546402|FG001|NOT COMPLETED|Intervention Period 3||0
10402191|NCT00723021|11546403|FG002|NOT COMPLETED|Intervention Period 3||0
10402192|NCT00723021|11546404|FG003|NOT COMPLETED|Intervention Period 3||0
10402193|NCT00723021|11546405|FG004|NOT COMPLETED|Intervention Period 3||0
10402194|NCT00723021|11546401|FG000|STARTED|Intervention Period 4||3
10402195|NCT00723021|11546402|FG001|STARTED|Intervention Period 4||3
10402196|NCT00723021|11546403|FG002|STARTED|Intervention Period 4||3
10402197|NCT00723021|11546404|FG003|STARTED|Intervention Period 4||3
10402198|NCT00723021|11546405|FG004|STARTED|Intervention Period 4||3
10402199|NCT00723021|11546401|FG000|COMPLETED|Intervention Period 4||3
10402200|NCT00723021|11546402|FG001|COMPLETED|Intervention Period 4||3
10402201|NCT00723021|11546403|FG002|COMPLETED|Intervention Period 4||3
10402202|NCT00723021|11546404|FG003|COMPLETED|Intervention Period 4||3
10402203|NCT00723021|11546405|FG004|COMPLETED|Intervention Period 4||2
10814383|NCT02361580|11977076|FG001|NOT COMPLETED|Overall Study||3
10814384|NCT02369744|11977084|FG000|STARTED|Overall Study||0
10814385|NCT02369744|11977085|FG001|STARTED|Overall Study||0
10814386|NCT02369744|11977084|FG000|COMPLETED|Overall Study||0
10814387|NCT02369744|11977085|FG001|COMPLETED|Overall Study||0
10312603|NCT00142597|11446014|FG000|NOT COMPLETED|Overall Study||3
10312604|NCT00142597|11446015|FG001|NOT COMPLETED|Overall Study||1
10312605|NCT00142792|11446024|FG000|STARTED|Overall Study||39
10312606|NCT00142792|11446025|FG001|STARTED|Overall Study||41
10312607|NCT00142792|11446026|FG002|STARTED|Overall Study||42
10312608|NCT00142792|11446024|FG000|Completed Intervention|Overall Study||35
10312609|NCT00142792|11446025|FG001|Completed Intervention|Overall Study||37
10544100|NCT01489020|11697343|FG003|STARTED|Overall Study||4
10544101|NCT01489020|11697344|FG004|STARTED|Overall Study||12
10814388|NCT02369744|11977084|FG000|NOT COMPLETED|Overall Study||0
10814389|NCT02369744|11977085|FG001|NOT COMPLETED|Overall Study||0
10312610|NCT00142792|11446026|FG002|Completed Intervention|Overall Study||37
10312611|NCT00142792|11446024|FG000|COMPLETED|Overall Study||27
10312612|NCT00142792|11446025|FG001|COMPLETED|Overall Study||26
10312613|NCT00142792|11446026|FG002|COMPLETED|Overall Study||30
10312614|NCT00142792|11446024|FG000|NOT COMPLETED|Overall Study||12
10312615|NCT00142792|11446025|FG001|NOT COMPLETED|Overall Study||15
10312616|NCT00142792|11446026|FG002|NOT COMPLETED|Overall Study||12
10312617|NCT00142818|11446038|FG000|STARTED|Overall Study||45
10312618|NCT00142818|11446039|FG001|STARTED|Overall Study||40
10312619|NCT00142818|11446040|FG002|STARTED|Overall Study||37
10312620|NCT00142818|11446041|FG003|STARTED|Overall Study||42
10312621|NCT00142818|11446038|FG000|COMPLETED|Overall Study||28
10312622|NCT00142818|11446039|FG001|COMPLETED|Overall Study||19
10312623|NCT00142818|11446040|FG002|COMPLETED|Overall Study||24
10312624|NCT00142818|11446041|FG003|COMPLETED|Overall Study||20
10312625|NCT00142818|11446038|FG000|NOT COMPLETED|Overall Study||17
10312626|NCT00142818|11446039|FG001|NOT COMPLETED|Overall Study||21
10312627|NCT00142818|11446040|FG002|NOT COMPLETED|Overall Study||13
10312628|NCT00142818|11446041|FG003|NOT COMPLETED|Overall Study||22
10312629|NCT00142909|11446057|FG000|STARTED|Randomization||42
10312630|NCT00142909|11446058|FG001|STARTED|Randomization||44
10312631|NCT00142909|11446057|FG000|COMPLETED|Randomization||35
10312632|NCT00142909|11446058|FG001|COMPLETED|Randomization||34
10312633|NCT00142909|11446057|FG000|NOT COMPLETED|Randomization||7
10312634|NCT00142909|11446058|FG001|NOT COMPLETED|Randomization||10
10312635|NCT00142909|11446057|FG000|STARTED|Medications Begin||35
10312636|NCT00142909|11446058|FG001|STARTED|Medications Begin||34
10312637|NCT00142909|11446057|FG000|COMPLETED|Medications Begin||26
10312638|NCT00142909|11446058|FG001|COMPLETED|Medications Begin||31
10312639|NCT00142909|11446057|FG000|NOT COMPLETED|Medications Begin||9
10312640|NCT00142909|11446058|FG001|NOT COMPLETED|Medications Begin||3
10312641|NCT00142935|11446067|FG000|STARTED|Overall Study||29
10312642|NCT00142935|11446068|FG001|STARTED|Overall Study||28
10312643|NCT00142935|11446069|FG002|STARTED|Overall Study||30
10312644|NCT00142935|11446067|FG000|COMPLETED|Overall Study||26
10312645|NCT00142935|11446068|FG001|COMPLETED|Overall Study||20
10312646|NCT00142935|11446069|FG002|COMPLETED|Overall Study||23
10312647|NCT00142935|11446067|FG000|NOT COMPLETED|Overall Study||3
10312648|NCT00142935|11446068|FG001|NOT COMPLETED|Overall Study||8
10312649|NCT00142935|11446069|FG002|NOT COMPLETED|Overall Study||7
10312650|NCT00143247|11446081|FG000|STARTED|Overall Study|173=total subjects of current + 3 previous protocols|173
10312651|NCT00143247|11446081|FG000|COMPLETED|Overall Study||17
10312652|NCT00143247|11446081|FG000|NOT COMPLETED|Overall Study||156
10312653|NCT00143312|11446085|FG000|STARTED|Overall Study||45
10312654|NCT00143312|11446085|FG000|COMPLETED|Overall Study||29
10312655|NCT00143312|11446085|FG000|NOT COMPLETED|Overall Study||16
10312656|NCT00143390|11446091|FG000|STARTED|Overall Study||149
10312657|NCT00143390|11446092|FG001|STARTED|Overall Study||149
10312658|NCT00143390|11446091|FG000|COMPLETED|Overall Study||0
10659871|NCT02246218|11821317|FG000|NOT COMPLETED|Overall Study||4
10659872|NCT02246218|11821318|FG001|NOT COMPLETED|Overall Study||6
10659873|NCT02246309|11821326|FG000|STARTED|Overall Study|16 patients going through Time Lapse System and 15 through Standard Embryo Culture.|16
10659874|NCT02246309|11821327|FG001|STARTED|Overall Study||15
10659875|NCT02246309|11821326|FG000|COMPLETED|Overall Study||16
10659876|NCT02246309|11821327|FG001|COMPLETED|Overall Study||15
10721393|NCT02725411|11885037|FG002|Treated|Treatment Period (56 Weeks)||92
10402204|NCT00723021|11546401|FG000|NOT COMPLETED|Intervention Period 4||0
10402205|NCT00723021|11546402|FG001|NOT COMPLETED|Intervention Period 4||0
10402206|NCT00723021|11546403|FG002|NOT COMPLETED|Intervention Period 4||0
10402207|NCT00723021|11546404|FG003|NOT COMPLETED|Intervention Period 4||0
10402208|NCT00723021|11546405|FG004|NOT COMPLETED|Intervention Period 4||1
10402209|NCT00723021|11546401|FG000|STARTED|Intervention Period 5||3
10402210|NCT00723021|11546402|FG001|STARTED|Intervention Period 5||3
10402211|NCT00723021|11546403|FG002|STARTED|Intervention Period 5||3
10402212|NCT00723021|11546404|FG003|STARTED|Intervention Period 5||3
10402213|NCT00723021|11546405|FG004|STARTED|Intervention Period 5||2
10402214|NCT00723021|11546401|FG000|COMPLETED|Intervention Period 5||3
10402215|NCT00723021|11546402|FG001|COMPLETED|Intervention Period 5||3
10402216|NCT00723021|11546403|FG002|COMPLETED|Intervention Period 5||3
10402217|NCT00723021|11546404|FG003|COMPLETED|Intervention Period 5||3
10402218|NCT00723021|11546405|FG004|COMPLETED|Intervention Period 5||2
10402219|NCT00723021|11546401|FG000|NOT COMPLETED|Intervention Period 5||0
10402220|NCT00723021|11546402|FG001|NOT COMPLETED|Intervention Period 5||0
10402221|NCT00723021|11546403|FG002|NOT COMPLETED|Intervention Period 5||0
10402222|NCT00723021|11546404|FG003|NOT COMPLETED|Intervention Period 5||0
10402223|NCT00723021|11546405|FG004|NOT COMPLETED|Intervention Period 5||0
10402224|NCT00723073|11546426|FG000|STARTED|Overall Study||149
10402225|NCT00723073|11546427|FG001|STARTED|Overall Study||174
10402226|NCT00723073|11546426|FG000|COMPLETED|Overall Study||149
10402227|NCT00723073|11546427|FG001|COMPLETED|Overall Study||174
10402228|NCT00723073|11546426|FG000|NOT COMPLETED|Overall Study||0
10402229|NCT00723073|11546427|FG001|NOT COMPLETED|Overall Study||0
10402230|NCT00723099|11546433|FG000|STARTED|Overall Study||73
10402231|NCT00723099|11546433|FG000|COMPLETED|Overall Study||72
10402232|NCT00723099|11546433|FG000|NOT COMPLETED|Overall Study||1
10402233|NCT00723125|11546440|FG000|STARTED|Overall Study|33 pts Neo-adjuvant, 28 evaluable,DDAC: Of 28 pts,27 treated DDAC Avastin:Of 27,15 Avastin post-op|33
10402234|NCT00723125|11546441|FG001|STARTED|Overall Study|27 evaluable Neo-adjuvant Of 27 patients neo-adjuvant, 24 DDAC Of 24 DDAC, 21 Avastin post-op|27
10402235|NCT00723125|11546440|FG000|COMPLETED|Overall Study||15
10402236|NCT00723125|11546441|FG001|COMPLETED|Overall Study||21
10402237|NCT00723125|11546440|FG000|NOT COMPLETED|Overall Study||18
10402238|NCT00723125|11546441|FG001|NOT COMPLETED|Overall Study||6
10402239|NCT00723177|11546456|FG000|STARTED|Overall Study||15
10402240|NCT00723177|11546457|FG001|STARTED|Overall Study||14
10402241|NCT00723177|11546458|FG002|STARTED|Overall Study||15
10402242|NCT00723177|11546456|FG000|COMPLETED|Overall Study||10
10402243|NCT00723177|11546457|FG001|COMPLETED|Overall Study||10
10659877|NCT02246309|11821326|FG000|NOT COMPLETED|Overall Study||0
10659878|NCT02246309|11821327|FG001|NOT COMPLETED|Overall Study||0
10402244|NCT00723177|11546458|FG002|COMPLETED|Overall Study||10
10402245|NCT00723177|11546456|FG000|NOT COMPLETED|Overall Study||5
10402246|NCT00723177|11546457|FG001|NOT COMPLETED|Overall Study||4
10402247|NCT00723177|11546458|FG002|NOT COMPLETED|Overall Study||5
10402248|NCT00723190|11546466|FG000|STARTED|Overall Study|Study CLON-301 (168 participants) and Study CLON-302 (135 participants)|303
10402249|NCT00723190|11546466|FG000|SAFETY POPULATION|Overall Study||301
10402250|NCT00723190|11546466|FG000|COMPLETED|Overall Study|53 participants completed 6-month protocol and 108 participants completed 12-month protocol|161
10402251|NCT00723190|11546466|FG000|NOT COMPLETED|Overall Study||142
10402252|NCT00723203|11546470|FG000|STARTED|Overall Study||16
10402253|NCT00723203|11546470|FG000|COMPLETED|Overall Study||13
10402254|NCT00723203|11546470|FG000|NOT COMPLETED|Overall Study||3
10659879|NCT02246413|11821335|FG000|STARTED|12-months (Primary Outcome)||204
10659880|NCT02246413|11821336|FG001|STARTED|12-months (Primary Outcome)||205
10659881|NCT02246413|11821335|FG000|COMPLETED|12-months (Primary Outcome)||169
10659882|NCT02246413|11821336|FG001|COMPLETED|12-months (Primary Outcome)||175
10659883|NCT02246413|11821335|FG000|NOT COMPLETED|12-months (Primary Outcome)||35
10659884|NCT02246413|11821336|FG001|NOT COMPLETED|12-months (Primary Outcome)||30
10659885|NCT02246413|11821335|FG000|STARTED|24-months (Secondary Outcome)||204
10659886|NCT02246413|11821336|FG001|STARTED|24-months (Secondary Outcome)||205
10659887|NCT02246413|11821335|FG000|COMPLETED|24-months (Secondary Outcome)||153
10659888|NCT02246413|11821336|FG001|COMPLETED|24-months (Secondary Outcome)||173
10659889|NCT02246413|11821335|FG000|NOT COMPLETED|24-months (Secondary Outcome)||51
10659890|NCT02246413|11821336|FG001|NOT COMPLETED|24-months (Secondary Outcome)||32
10659891|NCT02246439|11821344|FG000|STARTED|Overall Study|6 participants that enrolled in the study did not receive allocated intervention.|192
10659892|NCT02246439|11821345|FG001|STARTED|Overall Study|3 participants that enrolled in the study did not receive allocated intervention.|129
10659893|NCT02246439|11821344|FG000|Randomized|Overall Study||198
10659894|NCT02246439|11821345|FG001|Randomized|Overall Study||132
10659895|NCT02246439|11821344|FG000|COMPLETED|Overall Study||180
10659896|NCT02246439|11821345|FG001|COMPLETED|Overall Study||118
10659897|NCT02246439|11821344|FG000|NOT COMPLETED|Overall Study||12
10659898|NCT02246439|11821345|FG001|NOT COMPLETED|Overall Study||11
10659899|NCT02246478|11821355|FG000|STARTED|Single-dose Phase||6
10659900|NCT02246478|11821356|FG001|STARTED|Single-dose Phase||5
10659901|NCT02246478|11821357|FG002|STARTED|Single-dose Phase||5
10659902|NCT02246478|11821358|FG003|STARTED|Single-dose Phase||5
10659903|NCT02246478|11821355|FG000|COMPLETED|Single-dose Phase||6
10659904|NCT02246478|11821356|FG001|COMPLETED|Single-dose Phase||5
10659905|NCT02246478|11821357|FG002|COMPLETED|Single-dose Phase||5
10659906|NCT02246478|11821358|FG003|COMPLETED|Single-dose Phase||5
10659907|NCT02246478|11821355|FG000|NOT COMPLETED|Single-dose Phase||0
10659908|NCT02246478|11821356|FG001|NOT COMPLETED|Single-dose Phase||0
10659909|NCT02246478|11821357|FG002|NOT COMPLETED|Single-dose Phase||0
10659910|NCT02246478|11821358|FG003|NOT COMPLETED|Single-dose Phase||0
10659911|NCT02246478|11821355|FG000|STARTED|Multiple-dose Phase||6
10659912|NCT02246478|11821356|FG001|STARTED|Multiple-dose Phase||5
10659913|NCT02246478|11821357|FG002|STARTED|Multiple-dose Phase||5
10659914|NCT02246478|11821358|FG003|STARTED|Multiple-dose Phase||5
10659915|NCT02246478|11821355|FG000|COMPLETED|Multiple-dose Phase||5
10402255|NCT00723229|11546476|FG000|STARTED|First Intervention||25
10402256|NCT00723229|11546477|FG001|STARTED|First Intervention||23
10402257|NCT00723229|11546476|FG000|COMPLETED|First Intervention||18
10402258|NCT00723229|11546477|FG001|COMPLETED|First Intervention||20
10402259|NCT00723229|11546476|FG000|NOT COMPLETED|First Intervention||7
10659916|NCT02246478|11821356|FG001|COMPLETED|Multiple-dose Phase||5
10659917|NCT02246478|11821357|FG002|COMPLETED|Multiple-dose Phase||5
10659918|NCT02246478|11821358|FG003|COMPLETED|Multiple-dose Phase||4
10659919|NCT02246478|11821355|FG000|NOT COMPLETED|Multiple-dose Phase||1
10659920|NCT02246478|11821356|FG001|NOT COMPLETED|Multiple-dose Phase||0
10659921|NCT02246478|11821357|FG002|NOT COMPLETED|Multiple-dose Phase||0
10402260|NCT00723229|11546477|FG001|NOT COMPLETED|First Intervention||3
10402261|NCT00723229|11546476|FG000|STARTED|Second Intervention||18
10402262|NCT00723229|11546477|FG001|STARTED|Second Intervention||20
10402263|NCT00723229|11546476|FG000|COMPLETED|Second Intervention||18
10402264|NCT00723229|11546477|FG001|COMPLETED|Second Intervention||20
10402265|NCT00723229|11546476|FG000|NOT COMPLETED|Second Intervention||0
10402266|NCT00723229|11546477|FG001|NOT COMPLETED|Second Intervention||0
10402267|NCT00723255|11546483|FG000|STARTED|Overall Study||53
10402268|NCT00723255|11546483|FG000|COMPLETED|Overall Study|Eligible and treated patients|49
10402269|NCT00723255|11546483|FG000|NOT COMPLETED|Overall Study||4
10402270|NCT00723294|11546499|FG000|STARTED|Overall Study||99
10402271|NCT00723294|11546499|FG000|COMPLETED|Overall Study||86
10402272|NCT00723294|11546499|FG000|NOT COMPLETED|Overall Study||13
10402273|NCT00723398|11546508|FG000|STARTED|Overall Study||53
10402274|NCT00723398|11546509|FG001|STARTED|Overall Study||53
10402275|NCT00723398|11546510|FG002|STARTED|Overall Study||53
10402276|NCT00723398|11546511|FG003|STARTED|Overall Study||54
10402277|NCT00723398|11546512|FG004|STARTED|Overall Study||53
10402278|NCT00723398|11546508|FG000|COMPLETED|Overall Study||47
10402279|NCT00723398|11546509|FG001|COMPLETED|Overall Study||38
10402280|NCT00723398|11546510|FG002|COMPLETED|Overall Study||36
10402281|NCT00723398|11546511|FG003|COMPLETED|Overall Study||49
10402282|NCT00723398|11546512|FG004|COMPLETED|Overall Study||44
10402283|NCT00723398|11546508|FG000|NOT COMPLETED|Overall Study||6
10402284|NCT00723398|11546509|FG001|NOT COMPLETED|Overall Study||15
10402285|NCT00723398|11546510|FG002|NOT COMPLETED|Overall Study||17
10402286|NCT00723398|11546511|FG003|NOT COMPLETED|Overall Study||5
10402287|NCT00723398|11546512|FG004|NOT COMPLETED|Overall Study||9
10402288|NCT00723450|11546526|FG000|STARTED|Open-Label Phase||298
10721394|NCT02725411|11885035|FG000|COMPLETED|Treatment Period (56 Weeks)||62
10721395|NCT02725411|11885036|FG001|COMPLETED|Treatment Period (56 Weeks)||43
10721396|NCT02725411|11885037|FG002|COMPLETED|Treatment Period (56 Weeks)||43
10721397|NCT02725411|11885035|FG000|NOT COMPLETED|Treatment Period (56 Weeks)||30
10721398|NCT02725411|11885036|FG001|NOT COMPLETED|Treatment Period (56 Weeks)||50
10721399|NCT02725411|11885037|FG002|NOT COMPLETED|Treatment Period (56 Weeks)||49
10721400|NCT02725411|11885035|FG000|STARTED|Follow-up Period (24 Weeks)|All participants on either completion or discontinuation of treatment, entered follow up period.|92
10721401|NCT02725411|11885036|FG001|STARTED|Follow-up Period (24 Weeks)|All participants on either completion or discontinuation of treatment, entered follow up period.|93
10721402|NCT02725411|11885037|FG002|STARTED|Follow-up Period (24 Weeks)|All participants on either completion or discontinuation of treatment, entered follow up period.|92
10721403|NCT02725411|11885035|FG000|COMPLETED|Follow-up Period (24 Weeks)||88
10312659|NCT00143390|11446092|FG001|COMPLETED|Overall Study||0
10312660|NCT00143390|11446091|FG000|NOT COMPLETED|Overall Study||149
10312661|NCT00143390|11446092|FG001|NOT COMPLETED|Overall Study||149
10312662|NCT00143403|11446100|FG000|STARTED|Overall Study||160
10312663|NCT00143403|11446101|FG001|STARTED|Overall Study||161
10312664|NCT00143403|11446100|FG000|Treated|Overall Study||153
10312665|NCT00143403|11446101|FG001|Treated|Overall Study||153
10312666|NCT00143403|11446100|FG000|COMPLETED|Overall Study|Received maximum number of cycles.|125
10312667|NCT00143403|11446101|FG001|COMPLETED|Overall Study|Received maximum number of cycles.|115
10312668|NCT00143403|11446100|FG000|NOT COMPLETED|Overall Study||35
10312669|NCT00143403|11446101|FG001|NOT COMPLETED|Overall Study||46
10312670|NCT00143455|11446111|FG000|STARTED|Cohort 1||39
10312671|NCT00143455|11446112|FG001|STARTED|Cohort 1||39
10312672|NCT00143455|11446113|FG002|STARTED|Cohort 1||0
10312673|NCT00143455|11446114|FG003|STARTED|Cohort 1||0
10312674|NCT00143455|11446111|FG000|Received Treatment|Cohort 1||39
10312675|NCT00143455|11446112|FG001|Received Treatment|Cohort 1||38
10312676|NCT00143455|11446113|FG002|Received Treatment|Cohort 1||0
10312677|NCT00143455|11446114|FG003|Received Treatment|Cohort 1||0
10312678|NCT00143455|11446111|FG000|COMPLETED|Cohort 1||25
10312679|NCT00143455|11446112|FG001|COMPLETED|Cohort 1||22
10312680|NCT00143455|11446113|FG002|COMPLETED|Cohort 1||0
10312681|NCT00143455|11446114|FG003|COMPLETED|Cohort 1||0
10312682|NCT00143455|11446111|FG000|NOT COMPLETED|Cohort 1||14
10312683|NCT00143455|11446112|FG001|NOT COMPLETED|Cohort 1||17
10312684|NCT00143455|11446113|FG002|NOT COMPLETED|Cohort 1||0
10312685|NCT00143455|11446114|FG003|NOT COMPLETED|Cohort 1||0
10312686|NCT00143455|11446111|FG000|STARTED|Cohort 2||0
10312687|NCT00143455|11446112|FG001|STARTED|Cohort 2||0
10312688|NCT00143455|11446113|FG002|STARTED|Cohort 2||203
10312689|NCT00143455|11446114|FG003|STARTED|Cohort 2||204
10312690|NCT00143455|11446111|FG000|Received Treatment|Cohort 2||0
10312691|NCT00143455|11446112|FG001|Received Treatment|Cohort 2||0
10312692|NCT00143455|11446113|FG002|Received Treatment|Cohort 2||202
10312693|NCT00143455|11446114|FG003|Received Treatment|Cohort 2||203
10312694|NCT00143455|11446111|FG000|COMPLETED|Cohort 2||0
10312695|NCT00143455|11446112|FG001|COMPLETED|Cohort 2||0
10312696|NCT00143455|11446113|FG002|COMPLETED|Cohort 2||97
10312697|NCT00143455|11446114|FG003|COMPLETED|Cohort 2||111
10312698|NCT00143455|11446111|FG000|NOT COMPLETED|Cohort 2||0
10312699|NCT00143455|11446112|FG001|NOT COMPLETED|Cohort 2||0
10402289|NCT00723450|11546527|FG001|STARTED|Open-Label Phase||0
10402290|NCT00723450|11546528|FG002|STARTED|Open-Label Phase||0
10402291|NCT00723450|11546526|FG000|COMPLETED|Open-Label Phase||173
10402292|NCT00723450|11546527|FG001|COMPLETED|Open-Label Phase||0
10402293|NCT00723450|11546528|FG002|COMPLETED|Open-Label Phase||0
10402294|NCT00723450|11546526|FG000|NOT COMPLETED|Open-Label Phase||125
10402295|NCT00723450|11546527|FG001|NOT COMPLETED|Open-Label Phase||0
10402296|NCT00723450|11546528|FG002|NOT COMPLETED|Open-Label Phase||0
10402297|NCT00723450|11546526|FG000|STARTED|Randomized Phase||0
10402298|NCT00723450|11546527|FG001|STARTED|Randomized Phase||86
10402299|NCT00723450|11546528|FG002|STARTED|Randomized Phase||87
10402300|NCT00723450|11546526|FG000|COMPLETED|Randomized Phase||0
10402301|NCT00723450|11546527|FG001|COMPLETED|Randomized Phase||21
10402302|NCT00723450|11546528|FG002|COMPLETED|Randomized Phase||20
10402303|NCT00723450|11546526|FG000|NOT COMPLETED|Randomized Phase||0
10402304|NCT00723450|11546527|FG001|NOT COMPLETED|Randomized Phase||65
10402305|NCT00723450|11546528|FG002|NOT COMPLETED|Randomized Phase||67
10402306|NCT00723489|11546541|FG000|STARTED|Overall Study||21
10402307|NCT00723489|11546542|FG001|STARTED|Overall Study||19
10402308|NCT00723489|11546543|FG002|STARTED|Overall Study||19
10402309|NCT00723489|11546544|FG003|STARTED|Overall Study||23
10402310|NCT00723489|11546541|FG000|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|20
10402311|NCT00723489|11546542|FG001|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|15
10402312|NCT00723489|11546543|FG002|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|19
10402313|NCT00723489|11546544|FG003|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|20
10402314|NCT00723489|11546541|FG000|NOT COMPLETED|Overall Study||1
10402315|NCT00723489|11546542|FG001|NOT COMPLETED|Overall Study||4
10402316|NCT00723489|11546543|FG002|NOT COMPLETED|Overall Study||0
10402317|NCT00723489|11546544|FG003|NOT COMPLETED|Overall Study||3
10402318|NCT00723528|11546557|FG000|STARTED|Period 1: Controlled Period (CP)||32
10402319|NCT00723528|11546558|FG001|STARTED|Period 1: Controlled Period (CP)||64
10402320|NCT00723528|11546559|FG002|STARTED|Period 1: Controlled Period (CP)||62
10402321|NCT00723528|11546560|FG003|STARTED|Period 1: Controlled Period (CP)||0
10402322|NCT00723528|11546561|FG004|STARTED|Period 1: Controlled Period (CP)||0
10402323|NCT00723528|11546562|FG005|STARTED|Period 1: Controlled Period (CP)||0
10402324|NCT00723528|11546563|FG006|STARTED|Period 1: Controlled Period (CP)||0
10659922|NCT02246478|11821358|FG003|NOT COMPLETED|Multiple-dose Phase||1
10659923|NCT02246582|11821375|FG000|STARTED|Overall Study||44
10659924|NCT02246582|11821376|FG001|STARTED|Overall Study||45
10659925|NCT02246582|11821375|FG000|COMPLETED|Overall Study||41
10659926|NCT02246582|11821376|FG001|COMPLETED|Overall Study||41
10659927|NCT02246582|11821375|FG000|NOT COMPLETED|Overall Study||3
10659928|NCT02246582|11821376|FG001|NOT COMPLETED|Overall Study||4
10659929|NCT02246608|11821382|FG000|STARTED|Overall Study||22
10659930|NCT02246608|11821383|FG001|STARTED|Overall Study||21
10659931|NCT02246608|11821382|FG000|COMPLETED|Overall Study||10
10659932|NCT02246608|11821383|FG001|COMPLETED|Overall Study||11
10659933|NCT02246608|11821382|FG000|NOT COMPLETED|Overall Study||12
10659934|NCT02246608|11821383|FG001|NOT COMPLETED|Overall Study||10
10659935|NCT02246647|11821391|FG000|STARTED|Overall Study||19
10659936|NCT02246647|11821392|FG001|STARTED|Overall Study||20
10659937|NCT02246647|11821391|FG000|COMPLETED|Overall Study||18
10659938|NCT02246647|11821392|FG001|COMPLETED|Overall Study||19
10659939|NCT02246647|11821391|FG000|NOT COMPLETED|Overall Study||1
10659940|NCT02246647|11821392|FG001|NOT COMPLETED|Overall Study||1
10659941|NCT02246660|11821415|FG000|STARTED|Overall Study||23
10659942|NCT02246660|11821416|FG001|STARTED|Overall Study||21
10659943|NCT02246660|11821417|FG002|STARTED|Overall Study||22
10659944|NCT02246660|11821415|FG000|COMPLETED|Overall Study||23
10659945|NCT02246660|11821416|FG001|COMPLETED|Overall Study||20
10659946|NCT02246660|11821417|FG002|COMPLETED|Overall Study||21
10659947|NCT02246660|11821415|FG000|NOT COMPLETED|Overall Study||0
10659948|NCT02246660|11821416|FG001|NOT COMPLETED|Overall Study||1
10659949|NCT02246660|11821417|FG002|NOT COMPLETED|Overall Study||1
10659950|NCT02246673|11821430|FG000|STARTED|Overall Study||14
10659951|NCT02246673|11821431|FG001|STARTED|Overall Study||12
10659952|NCT02246673|11821432|FG002|STARTED|Overall Study||12
10659953|NCT02246673|11821433|FG003|STARTED|Overall Study||14
10659954|NCT02246673|11821434|FG004|STARTED|Overall Study||12
10659955|NCT02246673|11821430|FG000|COMPLETED|Overall Study||13
10659956|NCT02246673|11821431|FG001|COMPLETED|Overall Study||12
10659957|NCT02246673|11821432|FG002|COMPLETED|Overall Study||12
10659958|NCT02246673|11821433|FG003|COMPLETED|Overall Study||12
10659959|NCT02246673|11821434|FG004|COMPLETED|Overall Study||11
10721404|NCT02725411|11885036|FG001|COMPLETED|Follow-up Period (24 Weeks)||82
10721405|NCT02725411|11885037|FG002|COMPLETED|Follow-up Period (24 Weeks)||87
10659960|NCT02246673|11821430|FG000|NOT COMPLETED|Overall Study||1
10659961|NCT02246673|11821431|FG001|NOT COMPLETED|Overall Study||0
10659962|NCT02246673|11821432|FG002|NOT COMPLETED|Overall Study||0
10659963|NCT02246673|11821433|FG003|NOT COMPLETED|Overall Study||2
10721406|NCT02725411|11885035|FG000|NOT COMPLETED|Follow-up Period (24 Weeks)||4
10721407|NCT02725411|11885036|FG001|NOT COMPLETED|Follow-up Period (24 Weeks)||11
10721408|NCT02725411|11885037|FG002|NOT COMPLETED|Follow-up Period (24 Weeks)||5
10659964|NCT02246673|11821434|FG004|NOT COMPLETED|Overall Study||1
10659965|NCT02246764|11821479|FG000|STARTED|Overall Study||34
10659966|NCT02246764|11821480|FG001|STARTED|Overall Study||36
10659967|NCT02246764|11821481|FG002|STARTED|Overall Study||23
10721409|NCT02725476|11885047|FG000|STARTED|Overall Study||15
10659968|NCT02246764|11821479|FG000|COMPLETED|Overall Study||16
10402325|NCT00723528|11546557|FG000|COMPLETED|Period 1: Controlled Period (CP)||28
10402326|NCT00723528|11546558|FG001|COMPLETED|Period 1: Controlled Period (CP)||64
10659972|NCT02246764|11821480|FG001|NOT COMPLETED|Overall Study||32
10402327|NCT00723528|11546559|FG002|COMPLETED|Period 1: Controlled Period (CP)||58
10402328|NCT00723528|11546560|FG003|COMPLETED|Period 1: Controlled Period (CP)||0
10402329|NCT00723528|11546561|FG004|COMPLETED|Period 1: Controlled Period (CP)||0
10402330|NCT00723528|11546562|FG005|COMPLETED|Period 1: Controlled Period (CP)||0
10402331|NCT00723528|11546563|FG006|COMPLETED|Period 1: Controlled Period (CP)||0
10402332|NCT00723528|11546557|FG000|NOT COMPLETED|Period 1: Controlled Period (CP)||4
10402333|NCT00723528|11546558|FG001|NOT COMPLETED|Period 1: Controlled Period (CP)||0
10402334|NCT00723528|11546559|FG002|NOT COMPLETED|Period 1: Controlled Period (CP)||4
10402335|NCT00723528|11546560|FG003|NOT COMPLETED|Period 1: Controlled Period (CP)||0
10402336|NCT00723528|11546561|FG004|NOT COMPLETED|Period 1: Controlled Period (CP)||0
10402337|NCT00723528|11546562|FG005|NOT COMPLETED|Period 1: Controlled Period (CP)||0
10402338|NCT00723528|11546563|FG006|NOT COMPLETED|Period 1: Controlled Period (CP)||0
10402339|NCT00723528|11546557|FG000|STARTED|Period 2: After Controlled Period||0
10402340|NCT00723528|11546558|FG001|STARTED|Period 2: After Controlled Period||0
10402341|NCT00723528|11546559|FG002|STARTED|Period 2: After Controlled Period||0
10402342|NCT00723528|11546560|FG003|STARTED|Period 2: After Controlled Period||15
10402343|NCT00723528|11546561|FG004|STARTED|Period 2: After Controlled Period||13
10402344|NCT00723528|11546562|FG005|STARTED|Period 2: After Controlled Period||64
10402345|NCT00723528|11546563|FG006|STARTED|Period 2: After Controlled Period||58
10402346|NCT00723528|11546557|FG000|COMPLETED|Period 2: After Controlled Period||0
10402347|NCT00723528|11546558|FG001|COMPLETED|Period 2: After Controlled Period||0
10402348|NCT00723528|11546559|FG002|COMPLETED|Period 2: After Controlled Period||0
10402349|NCT00723528|11546560|FG003|COMPLETED|Period 2: After Controlled Period||14
10402350|NCT00723528|11546561|FG004|COMPLETED|Period 2: After Controlled Period||11
10402351|NCT00723528|11546562|FG005|COMPLETED|Period 2: After Controlled Period||58
10402352|NCT00723528|11546563|FG006|COMPLETED|Period 2: After Controlled Period||54
10402353|NCT00723528|11546557|FG000|NOT COMPLETED|Period 2: After Controlled Period||0
10402354|NCT00723528|11546558|FG001|NOT COMPLETED|Period 2: After Controlled Period||0
10402355|NCT00723528|11546559|FG002|NOT COMPLETED|Period 2: After Controlled Period||0
10402356|NCT00723528|11546560|FG003|NOT COMPLETED|Period 2: After Controlled Period||1
10402357|NCT00723528|11546561|FG004|NOT COMPLETED|Period 2: After Controlled Period||2
10402358|NCT00723528|11546562|FG005|NOT COMPLETED|Period 2: After Controlled Period||6
10402359|NCT00723528|11546563|FG006|NOT COMPLETED|Period 2: After Controlled Period||4
10402360|NCT00723554|11546579|FG000|STARTED|Overall Study||63
10402361|NCT00723554|11546579|FG000|COMPLETED|Overall Study||34
10402362|NCT00723554|11546579|FG000|NOT COMPLETED|Overall Study||29
10402363|NCT00723580|11546585|FG000|STARTED|Overall Study|Study was extended with continued repeated measurements.|1
10402364|NCT00723580|11546585|FG000|Baseline Measurements|Overall Study|Actigraphic, Psychometric and Observational Baseline Data Collected.|1
10402365|NCT00723580|11546585|FG000|COMPLETED|Overall Study|Completion of repeated Measurements|1
10402366|NCT00723580|11546585|FG000|NOT COMPLETED|Overall Study||0
10402367|NCT00723606|11546591|FG000|STARTED|Overall Study||189
10402368|NCT00723606|11546592|FG001|STARTED|Overall Study||187
10402369|NCT00723606|11546591|FG000|COMPLETED|Overall Study||185
10402370|NCT00723606|11546592|FG001|COMPLETED|Overall Study||180
10402371|NCT00723606|11546591|FG000|NOT COMPLETED|Overall Study||4
10402372|NCT00723606|11546592|FG001|NOT COMPLETED|Overall Study||7
10428892|NCT00861601|11575035|FG000|STARTED|Overall Study||12
10428893|NCT00861601|11575036|FG001|STARTED|Overall Study||14
10428894|NCT00861601|11575037|FG002|STARTED|Overall Study||12
10428895|NCT00861601|11575035|FG000|COMPLETED|Overall Study||12
10428896|NCT00861601|11575036|FG001|COMPLETED|Overall Study||14
10428897|NCT00861601|11575037|FG002|COMPLETED|Overall Study||12
10428898|NCT00861601|11575035|FG000|NOT COMPLETED|Overall Study||0
10428899|NCT00861601|11575036|FG001|NOT COMPLETED|Overall Study||0
10428900|NCT00861601|11575037|FG002|NOT COMPLETED|Overall Study||0
10428901|NCT00861614|11575050|FG000|STARTED|Overall Study||393
10428902|NCT00861614|11575051|FG001|STARTED|Overall Study||396
10428903|NCT00861614|11575050|FG000|COMPLETED|Overall Study||22
10428904|NCT00861614|11575051|FG001|COMPLETED|Overall Study||28
10428905|NCT00861614|11575050|FG000|NOT COMPLETED|Overall Study||371
10428906|NCT00861614|11575051|FG001|NOT COMPLETED|Overall Study||368
10428907|NCT00861692|11575057|FG000|STARTED|Overall Study||20
10428908|NCT00861692|11575057|FG000|COMPLETED|Overall Study||14
10428909|NCT00861692|11575057|FG000|NOT COMPLETED|Overall Study||6
10428910|NCT00861744|11575065|FG000|STARTED|Overall Study||304
10428911|NCT00861744|11575066|FG001|STARTED|Overall Study||304
10428912|NCT00861744|11575067|FG002|STARTED|Overall Study||304
10428913|NCT00861744|11575068|FG003|STARTED|Overall Study||308
10428914|NCT00861744|11575065|FG000|COMPLETED|Overall Study||287
10428915|NCT00861744|11575066|FG001|COMPLETED|Overall Study||275
10428916|NCT00861744|11575067|FG002|COMPLETED|Overall Study||280
10428917|NCT00861744|11575068|FG003|COMPLETED|Overall Study||275
10428918|NCT00861744|11575065|FG000|NOT COMPLETED|Overall Study||17
10428919|NCT00861744|11575066|FG001|NOT COMPLETED|Overall Study||29
10428920|NCT00861744|11575067|FG002|NOT COMPLETED|Overall Study||24
10428921|NCT00861744|11575068|FG003|NOT COMPLETED|Overall Study||33
10428922|NCT00861757|11575082|FG000|STARTED|Overall Study||154
10428923|NCT00861757|11575083|FG001|STARTED|Overall Study||151
10428924|NCT00861757|11575084|FG002|STARTED|Overall Study||155
10428925|NCT00861757|11575085|FG003|STARTED|Overall Study||152
10428926|NCT00861757|11575082|FG000|COMPLETED|Overall Study||145
10659969|NCT02246764|11821480|FG001|COMPLETED|Overall Study||4
10659970|NCT02246764|11821481|FG002|COMPLETED|Overall Study||19
10659971|NCT02246764|11821479|FG000|NOT COMPLETED|Overall Study||18
10659973|NCT02246764|11821481|FG002|NOT COMPLETED|Overall Study||4
10659974|NCT02246777|11821489|FG000|STARTED|Overall Study||32
10659975|NCT02246777|11821489|FG000|COMPLETED|Overall Study||29
10659976|NCT02246777|11821489|FG000|NOT COMPLETED|Overall Study||3
10659977|NCT02246998|11821502|FG000|STARTED|Overall Study||18
10659978|NCT02246998|11821503|FG001|STARTED|Overall Study||18
10659979|NCT02246998|11821504|FG002|STARTED|Overall Study||18
10659980|NCT02246998|11821505|FG003|STARTED|Overall Study||18
10659981|NCT02246998|11821502|FG000|COMPLETED|Overall Study||16
10659982|NCT02246998|11821503|FG001|COMPLETED|Overall Study||15
10659983|NCT02246998|11821504|FG002|COMPLETED|Overall Study||15
10659984|NCT02246998|11821505|FG003|COMPLETED|Overall Study||16
10659985|NCT02246998|11821502|FG000|NOT COMPLETED|Overall Study||2
10659986|NCT02246998|11821503|FG001|NOT COMPLETED|Overall Study||3
10721410|NCT02725476|11885048|FG001|STARTED|Overall Study||5
10721411|NCT02725476|11885047|FG000|COMPLETED|Overall Study||12
10721412|NCT02725476|11885048|FG001|COMPLETED|Overall Study||4
10721413|NCT02725476|11885047|FG000|NOT COMPLETED|Overall Study||3
10428927|NCT00861757|11575083|FG001|COMPLETED|Overall Study||136
10428928|NCT00861757|11575084|FG002|COMPLETED|Overall Study||137
10428929|NCT00861757|11575085|FG003|COMPLETED|Overall Study||143
10428930|NCT00861757|11575082|FG000|NOT COMPLETED|Overall Study||9
10428931|NCT00861757|11575083|FG001|NOT COMPLETED|Overall Study||15
10428932|NCT00861757|11575084|FG002|NOT COMPLETED|Overall Study||18
10428933|NCT00861757|11575085|FG003|NOT COMPLETED|Overall Study||9
10428934|NCT00861913|11575099|FG000|STARTED|Overall Study||13
10659987|NCT02246998|11821504|FG002|NOT COMPLETED|Overall Study||3
10659988|NCT02246998|11821505|FG003|NOT COMPLETED|Overall Study||2
10659989|NCT02247011|11821520|FG000|STARTED|Overall Study||1100
10659990|NCT02247011|11821520|FG000|COMPLETED|Overall Study||975
10659991|NCT02247011|11821520|FG000|NOT COMPLETED|Overall Study||125
10721414|NCT02725476|11885048|FG001|NOT COMPLETED|Overall Study||1
10721415|NCT02725515|11885056|FG000|STARTED|Overall Study||53
10721416|NCT02725515|11885057|FG001|STARTED|Overall Study||52
10721417|NCT02725515|11885056|FG000|COMPLETED|Overall Study||28
10721418|NCT02725515|11885057|FG001|COMPLETED|Overall Study||17
10721419|NCT02725515|11885056|FG000|NOT COMPLETED|Overall Study||25
10721420|NCT02725515|11885057|FG001|NOT COMPLETED|Overall Study||35
10721421|NCT02725645|11885063|FG000|STARTED|Overall Study||14
10721422|NCT02725645|11885063|FG000|COMPLETED|Overall Study||14
10721423|NCT02725645|11885063|FG000|NOT COMPLETED|Overall Study||0
10721424|NCT02725710|11885069|FG000|STARTED|Overall Study||48
10721425|NCT02725710|11885070|FG001|STARTED|Overall Study||47
10721426|NCT02725710|11885069|FG000|COMPLETED|Overall Study||47
10721427|NCT02725710|11885070|FG001|COMPLETED|Overall Study||47
10721428|NCT02725710|11885069|FG000|NOT COMPLETED|Overall Study||1
10721429|NCT02725710|11885070|FG001|NOT COMPLETED|Overall Study||0
10402373|NCT00723632|11546598|FG000|STARTED|Overall Study||901
10402374|NCT00723632|11546598|FG000|COMPLETED|Overall Study|Completed initial exam form and >= 1 follow up visit form; end of treatment and SVR status recorded|698
10402375|NCT00723632|11546598|FG000|NOT COMPLETED|Overall Study||203
10402376|NCT00723645|11546602|FG000|STARTED|Visit 1 (≤4 Weeks Post-treatment)||258
10402377|NCT00723645|11546602|FG000|COMPLETED|Visit 1 (≤4 Weeks Post-treatment)||258
10402378|NCT00723645|11546602|FG000|NOT COMPLETED|Visit 1 (≤4 Weeks Post-treatment)||0
10402379|NCT00723645|11546602|FG000|STARTED|Visit 2 (Week 24 Post-treatment)|10 discontinued before Visit 2; 7 lost to follow-up and 3 were HCV RNA+ before Wk 24|248
10402380|NCT00723645|11546602|FG000|COMPLETED|Visit 2 (Week 24 Post-treatment)||248
10402381|NCT00723645|11546602|FG000|NOT COMPLETED|Visit 2 (Week 24 Post-treatment)||0
10402382|NCT00723645|11546602|FG000|STARTED|Visit 3 (Week 72 Post-treatment)|61 discontinued before V3; 26 lost to followup, 34 HCV RNA+ at Wk 24,1 death,1 HCV RNA not available|187
10402383|NCT00723645|11546602|FG000|COMPLETED|Visit 3 (Week 72 Post-treatment)||187
10402384|NCT00723645|11546602|FG000|NOT COMPLETED|Visit 3 (Week 72 Post-treatment)||0
10402385|NCT00723697|11546606|FG000|STARTED|Overall Study||1307
10402386|NCT00723697|11546606|FG000|COMPLETED|Overall Study||1289
10402387|NCT00723697|11546606|FG000|NOT COMPLETED|Overall Study||18
10402388|NCT00723710|11546613|FG000|STARTED|Overall Study||294
10402389|NCT00723710|11546613|FG000|COMPLETED|Overall Study||120
10402390|NCT00723710|11546613|FG000|NOT COMPLETED|Overall Study||174
10402391|NCT00723749|11546617|FG000|STARTED|Overall Study|384 patients were enrolled, 36 non-eligible datasets were excluded from analysis|345
10402392|NCT00723749|11546617|FG000|COMPLETED|Overall Study||182
10402393|NCT00723749|11546617|FG000|NOT COMPLETED|Overall Study||163
10402394|NCT00723788|11546621|FG000|STARTED|Overall Study||21
10402395|NCT00723788|11546621|FG000|COMPLETED|Overall Study||21
10402396|NCT00723788|11546621|FG000|NOT COMPLETED|Overall Study||0
10402397|NCT00723801|11546629|FG000|STARTED|Overall Study||20
10402398|NCT00723801|11546630|FG001|STARTED|Overall Study||20
10402399|NCT00723801|11546629|FG000|COMPLETED|Overall Study||17
10402400|NCT00723801|11546630|FG001|COMPLETED|Overall Study||17
10402401|NCT00723801|11546629|FG000|NOT COMPLETED|Overall Study||3
10402402|NCT00723801|11546630|FG001|NOT COMPLETED|Overall Study||3
10402403|NCT00723827|11546636|FG000|STARTED|Overall Study||682
10402404|NCT00723827|11546636|FG000|COMPLETED|Overall Study||682
10402405|NCT00723827|11546636|FG000|NOT COMPLETED|Overall Study||0
10402406|NCT00723840|11546640|FG000|STARTED|Overall Study||245
10402407|NCT00723840|11546640|FG000|COMPLETED|Overall Study||163
10402408|NCT00723840|11546640|FG000|NOT COMPLETED|Overall Study||82
10402409|NCT00723892|11546653|FG000|STARTED|Overall Study||313
10402410|NCT00723892|11546654|FG001|STARTED|Overall Study||255
10402411|NCT00723892|11546653|FG000|COMPLETED|Overall Study||206
10402412|NCT00723892|11546654|FG001|COMPLETED|Overall Study||168
10402413|NCT00723892|11546653|FG000|NOT COMPLETED|Overall Study||107
10402414|NCT00723892|11546654|FG001|NOT COMPLETED|Overall Study||87
10402415|NCT00723931|11546660|FG000|STARTED|Overall Study||1267
10402416|NCT00723931|11546660|FG000|COMPLETED|Overall Study||1267
10402417|NCT00723931|11546660|FG000|NOT COMPLETED|Overall Study||0
10402418|NCT00723957|11546666|FG000|STARTED|Overall Study|Randomized|98
10402419|NCT00723957|11546667|FG001|STARTED|Overall Study|Randomized|99
10402420|NCT00723957|11546666|FG000|COMPLETED|Overall Study|Completed 6 cycles of study drug (maximum per protocol)|47
10402421|NCT00723957|11546667|FG001|COMPLETED|Overall Study|Completed 6 cycles of study drug (maximum per protocol)|46
10402422|NCT00723957|11546666|FG000|NOT COMPLETED|Overall Study||51
10402423|NCT00723957|11546667|FG001|NOT COMPLETED|Overall Study||53
10402424|NCT00724009|11546673|FG000|STARTED|Overall Study||29
10402425|NCT00724009|11546673|FG000|COMPLETED|Overall Study|One patient underwent conditioning but died 1 day before stem cell infusion due to sepsis.|29
10402426|NCT00724009|11546673|FG000|NOT COMPLETED|Overall Study||0
10402427|NCT00724061|11546677|FG000|STARTED|Dose Escalation Phase||7
10402428|NCT00724061|11546677|FG000|COMPLETED|Dose Escalation Phase||2
10402429|NCT00724061|11546677|FG000|NOT COMPLETED|Dose Escalation Phase||5
10402430|NCT00724061|11546677|FG000|STARTED|Maintenance Therapy||2
10402431|NCT00724061|11546677|FG000|COMPLETED|Maintenance Therapy||2
10402432|NCT00724061|11546677|FG000|NOT COMPLETED|Maintenance Therapy||0
10402433|NCT00724126|11546683|FG000|STARTED|Overall Study||321
10402434|NCT00724126|11546684|FG001|STARTED|Overall Study||316
10402435|NCT00724126|11546683|FG000|COMPLETED|Overall Study||302
10402436|NCT00724126|11546684|FG001|COMPLETED|Overall Study||301
10402437|NCT00724126|11546683|FG000|NOT COMPLETED|Overall Study||19
10402438|NCT00724126|11546684|FG001|NOT COMPLETED|Overall Study||15
10402439|NCT00724152|11546695|FG000|STARTED|Two-arm Study Period||14
10402440|NCT00724152|11546696|FG001|STARTED|Two-arm Study Period||11
10402441|NCT00724152|11546697|FG002|STARTED|Two-arm Study Period|Standard Care arm was added later (Period 2)|0
10814390|NCT02379585|11977093|FG000|STARTED|Overall Study||3
10814391|NCT02379585|11977094|FG001|STARTED|Overall Study||5
10814392|NCT02379585|11977093|FG000|COMPLETED|Overall Study||0
10814393|NCT02379585|11977094|FG001|COMPLETED|Overall Study||0
10402442|NCT00724152|11546695|FG000|COMPLETED|Two-arm Study Period||11
10402443|NCT00724152|11546696|FG001|COMPLETED|Two-arm Study Period||9
10402444|NCT00724152|11546697|FG002|COMPLETED|Two-arm Study Period||0
10402445|NCT00724152|11546695|FG000|NOT COMPLETED|Two-arm Study Period||3
10402446|NCT00724152|11546696|FG001|NOT COMPLETED|Two-arm Study Period||2
10402447|NCT00724152|11546697|FG002|NOT COMPLETED|Two-arm Study Period||0
10402448|NCT00724152|11546695|FG000|STARTED|Three-arm Study Period (+Standard Care)||4
10402449|NCT00724152|11546696|FG001|STARTED|Three-arm Study Period (+Standard Care)||2
10814394|NCT02379585|11977093|FG000|NOT COMPLETED|Overall Study||3
10402450|NCT00724152|11546697|FG002|STARTED|Three-arm Study Period (+Standard Care)|3-group randomization began|2
10402451|NCT00724152|11546695|FG000|COMPLETED|Three-arm Study Period (+Standard Care)||3
10402452|NCT00724152|11546696|FG001|COMPLETED|Three-arm Study Period (+Standard Care)||0
10402453|NCT00724152|11546697|FG002|COMPLETED|Three-arm Study Period (+Standard Care)||1
10402454|NCT00724152|11546695|FG000|NOT COMPLETED|Three-arm Study Period (+Standard Care)||1
10402455|NCT00724152|11546696|FG001|NOT COMPLETED|Three-arm Study Period (+Standard Care)||2
10659992|NCT02247063|11821529|FG000|STARTED|Overall Study||12
10659993|NCT02247063|11821530|FG001|STARTED|Overall Study||12
10659994|NCT02247063|11821529|FG000|COMPLETED|Overall Study||12
10659995|NCT02247063|11821530|FG001|COMPLETED|Overall Study||12
10659996|NCT02247063|11821529|FG000|NOT COMPLETED|Overall Study||0
10659997|NCT02247063|11821530|FG001|NOT COMPLETED|Overall Study||0
10659998|NCT02247193|11821538|FG000|STARTED|Overall Study||15
10659999|NCT02247193|11821539|FG001|STARTED|Overall Study||15
10660000|NCT02247193|11821538|FG000|Number Who Underwent Cleft Lip Repair Surgery|Overall Study||15
10660001|NCT02247193|11821539|FG001|Number Who Underwent Cleft Lip Repair Surgery|Overall Study||15
10660002|NCT02247193|11821538|FG000|Number Who Received Botox or Placebo|Overall Study||15
10660003|NCT02247193|11821539|FG001|Number Who Received Botox or Placebo|Overall Study||15
10660004|NCT02247193|11821538|FG000|Number Who Completed the 6-month Follow up|Overall Study||15
10660005|NCT02247193|11821539|FG001|Number Who Completed the 6-month Follow up|Overall Study||15
10660006|NCT02247193|11821538|FG000|Number Who Completed the 12-month Follow up|Overall Study||15
10660007|NCT02247193|11821539|FG001|Number Who Completed the 12-month Follow up|Overall Study||15
10660008|NCT02247193|11821538|FG000|COMPLETED|Overall Study||15
10660009|NCT02247193|11821539|FG001|COMPLETED|Overall Study||15
10660010|NCT02247193|11821538|FG000|NOT COMPLETED|Overall Study||0
10660011|NCT02247193|11821539|FG001|NOT COMPLETED|Overall Study||0
10660012|NCT02247245|11821549|FG000|STARTED|Overall Study||13
10660013|NCT02247245|11821550|FG001|STARTED|Overall Study||13
10660014|NCT02247245|11821551|FG002|STARTED|Overall Study||7
10660015|NCT02247245|11821552|FG003|STARTED|Overall Study||7
10660016|NCT02247245|11821549|FG000|COMPLETED|Overall Study||13
10660017|NCT02247245|11821550|FG001|COMPLETED|Overall Study||13
10660018|NCT02247245|11821551|FG002|COMPLETED|Overall Study||7
10660019|NCT02247245|11821552|FG003|COMPLETED|Overall Study||7
10660020|NCT02247245|11821549|FG000|NOT COMPLETED|Overall Study||0
10660021|NCT02247245|11821550|FG001|NOT COMPLETED|Overall Study||0
10660022|NCT02247245|11821551|FG002|NOT COMPLETED|Overall Study||0
10660023|NCT02247245|11821552|FG003|NOT COMPLETED|Overall Study||0
10660024|NCT02247336|11821564|FG000|STARTED|Overall Study||252
10660025|NCT02247336|11821565|FG001|STARTED|Overall Study||253
10660026|NCT02247336|11821564|FG000|COMPLETED|Overall Study||252
10660027|NCT02247336|11821565|FG001|COMPLETED|Overall Study||253
10660028|NCT02247336|11821564|FG000|NOT COMPLETED|Overall Study||0
10660029|NCT02247336|11821565|FG001|NOT COMPLETED|Overall Study||0
10660030|NCT02247401|11821574|FG000|STARTED|Overall Study||100
10660031|NCT02247401|11821575|FG001|STARTED|Overall Study||31
10660032|NCT02247401|11821576|FG002|STARTED|Overall Study||29
10660033|NCT02247401|11821574|FG000|COMPLETED|Overall Study||94
10660034|NCT02247401|11821575|FG001|COMPLETED|Overall Study||29
10660035|NCT02247401|11821576|FG002|COMPLETED|Overall Study||27
10660036|NCT02247401|11821574|FG000|NOT COMPLETED|Overall Study||6
10660037|NCT02247401|11821575|FG001|NOT COMPLETED|Overall Study||2
10660038|NCT02247401|11821576|FG002|NOT COMPLETED|Overall Study||2
10660039|NCT02247440|11821585|FG000|STARTED|Overall Study||18
10660040|NCT02247440|11821585|FG000|COMPLETED|Overall Study||14
10660041|NCT02247440|11821585|FG000|NOT COMPLETED|Overall Study||4
10660042|NCT02247466|11821591|FG000|STARTED|Overall Study||19
10660043|NCT02247466|11821592|FG001|STARTED|Overall Study||18
10660044|NCT02247466|11821591|FG000|COMPLETED|Overall Study||19
10660045|NCT02247466|11821592|FG001|COMPLETED|Overall Study||15
10660046|NCT02247466|11821591|FG000|NOT COMPLETED|Overall Study||0
10660047|NCT02247466|11821592|FG001|NOT COMPLETED|Overall Study||3
10660048|NCT02247479|11821601|FG000|STARTED|Overall Study||305
10660049|NCT02247479|11821602|FG001|STARTED|Overall Study||298
10660050|NCT02247479|11821603|FG002|STARTED|Overall Study||303
10660051|NCT02247479|11821601|FG000|COMPLETED|Overall Study||163
10660052|NCT02247479|11821602|FG001|COMPLETED|Overall Study||160
10660053|NCT02247479|11821603|FG002|COMPLETED|Overall Study||165
10660054|NCT02247479|11821601|FG000|NOT COMPLETED|Overall Study||142
10660055|NCT02247479|11821602|FG001|NOT COMPLETED|Overall Study||138
10660056|NCT02247479|11821603|FG002|NOT COMPLETED|Overall Study||138
10660057|NCT02247531|11821614|FG000|STARTED|Overall Study||321
10814395|NCT02379585|11977094|FG001|NOT COMPLETED|Overall Study||5
10814396|NCT02370888|11977107|FG000|STARTED|Overall Study||9
10814397|NCT02370888|11977107|FG000|Proceed to Treatment|Overall Study||3
10814398|NCT02370888|11977107|FG000|COMPLETED|Overall Study||1
10814399|NCT02370888|11977107|FG000|NOT COMPLETED|Overall Study||8
10814400|NCT02367170|11977117|FG000|STARTED|Overall Study||1
10814401|NCT02367170|11977118|FG001|STARTED|Overall Study||0
10814402|NCT02367170|11977117|FG000|COMPLETED|Overall Study||1
10814403|NCT02367170|11977118|FG001|COMPLETED|Overall Study||0
10402456|NCT00724152|11546697|FG002|NOT COMPLETED|Three-arm Study Period (+Standard Care)||1
10402457|NCT00724243|11546707|FG000|STARTED|Overall Study||33
10402458|NCT00724243|11546707|FG000|COMPLETED|Overall Study||18
10402459|NCT00724243|11546707|FG000|NOT COMPLETED|Overall Study||15
10660058|NCT02247531|11821615|FG001|STARTED|Overall Study||330
10660059|NCT02247531|11821616|FG002|STARTED|Overall Study||324
10660060|NCT02247531|11821614|FG000|COMPLETED|Overall Study||215
10402460|NCT00724308|11546713|FG000|STARTED|Overall Study||270
10402461|NCT00724308|11546714|FG001|STARTED|Overall Study||307
10402462|NCT00724308|11546713|FG000|COMPLETED|Overall Study||190
10402463|NCT00724308|11546714|FG001|COMPLETED|Overall Study||210
10402464|NCT00724308|11546713|FG000|NOT COMPLETED|Overall Study||80
10402465|NCT00724308|11546714|FG001|NOT COMPLETED|Overall Study||97
10402466|NCT00724347|11546720|FG000|STARTED|Overall Study|Training was the final step in the program, once the outcome tests had been developed.|18
10402467|NCT00724347|11546720|FG000|Baseline Testing|Overall Study||18
10402468|NCT00724347|11546720|FG000|COMPLETED|Overall Study||16
10402469|NCT00724347|11546720|FG000|NOT COMPLETED|Overall Study||2
10402470|NCT00724373|11546724|FG000|STARTED|Overall Study||442
10402471|NCT00724373|11546724|FG000|COMPLETED|Overall Study||271
10402472|NCT00724373|11546724|FG000|NOT COMPLETED|Overall Study||171
10402473|NCT00724451|11546728|FG000|STARTED|Overall Study||1128
10402474|NCT00724451|11546728|FG000|Received Antiviral Treatment|Overall Study||500
10402475|NCT00724451|11546728|FG000|COMPLETED|Overall Study|Completed defined as participants who completed anti-viral treatment.|326
10402476|NCT00724451|11546728|FG000|NOT COMPLETED|Overall Study||802
10402477|NCT00724464|11546732|FG000|STARTED|Overall Study||332
10402478|NCT00724464|11546732|FG000|COMPLETED|Overall Study||309
10402479|NCT00724464|11546732|FG000|NOT COMPLETED|Overall Study||23
10402480|NCT00724503|11546739|FG000|STARTED|Overall Study||267
10402481|NCT00724503|11546740|FG001|STARTED|Overall Study||263
10402482|NCT00724503|11546739|FG000|COMPLETED|Overall Study||57
10402483|NCT00724503|11546740|FG001|COMPLETED|Overall Study||43
10402484|NCT00724503|11546739|FG000|NOT COMPLETED|Overall Study||210
10402485|NCT00724503|11546740|FG001|NOT COMPLETED|Overall Study||220
10402486|NCT00724568|11546748|FG000|STARTED|Overall Study||42
10402487|NCT00724568|11546749|FG001|STARTED|Overall Study||32
10402488|NCT00724568|11546748|FG000|COMPLETED|Overall Study||42
10402489|NCT00724568|11546749|FG001|COMPLETED|Overall Study||32
10402490|NCT00724568|11546748|FG000|NOT COMPLETED|Overall Study||0
10402491|NCT00724568|11546749|FG001|NOT COMPLETED|Overall Study||0
10402492|NCT00724594|11546757|FG000|STARTED|Overall Study||12
10402493|NCT00724594|11546758|FG001|STARTED|Overall Study||12
10402494|NCT00724594|11546759|FG002|STARTED|Overall Study||11
10402495|NCT00724594|11546760|FG003|STARTED|Overall Study||11
10402496|NCT00724594|11546757|FG000|COMPLETED|Overall Study||12
10402497|NCT00724594|11546758|FG001|COMPLETED|Overall Study||12
10402498|NCT00724594|11546759|FG002|COMPLETED|Overall Study||11
10402499|NCT00724594|11546760|FG003|COMPLETED|Overall Study||10
10544102|NCT01489020|11697345|FG005|STARTED|Overall Study||4
10544103|NCT01489020|11697340|FG000|COMPLETED|Overall Study||11
10544104|NCT01489020|11697341|FG001|COMPLETED|Overall Study||4
10544105|NCT01489020|11697342|FG002|COMPLETED|Overall Study||9
10544106|NCT01489020|11697343|FG003|COMPLETED|Overall Study||4
10544107|NCT01489020|11697344|FG004|COMPLETED|Overall Study||6
10544108|NCT01489020|11697345|FG005|COMPLETED|Overall Study||4
10544109|NCT01489020|11697340|FG000|NOT COMPLETED|Overall Study||1
10544110|NCT01489020|11697341|FG001|NOT COMPLETED|Overall Study||0
10544111|NCT01489020|11697342|FG002|NOT COMPLETED|Overall Study||3
10544112|NCT01489020|11697343|FG003|NOT COMPLETED|Overall Study||0
10544113|NCT01489020|11697344|FG004|NOT COMPLETED|Overall Study||6
10544114|NCT01489020|11697345|FG005|NOT COMPLETED|Overall Study||0
10544115|NCT01489111|11697365|FG000|STARTED|Overall Study||36
10544116|NCT01489111|11697365|FG000|COMPLETED|Overall Study||35
10544117|NCT01489111|11697365|FG000|NOT COMPLETED|Overall Study||1
10544118|NCT01489189|11697371|FG000|STARTED|Overall Study|Number of Eyes|191
10544119|NCT01489189|11697372|FG001|STARTED|Overall Study|Number of Eyes|203
10544120|NCT01489189|11697371|FG000|COMPLETED|Overall Study|Number of Eyes|160
10544121|NCT01489189|11697372|FG001|COMPLETED|Overall Study|Number of Eyes|168
10544122|NCT01489189|11697371|FG000|NOT COMPLETED|Overall Study||31
10544123|NCT01489189|11697372|FG001|NOT COMPLETED|Overall Study||35
10544124|NCT01489254|11697382|FG000|STARTED|Double-blind Part||355
10544125|NCT01489254|11697383|FG001|STARTED|Double-blind Part||357
10544126|NCT01489254|11697384|FG002|STARTED|Double-blind Part||84
10544127|NCT01489254|11697385|FG003|STARTED|Double-blind Part||0
10544128|NCT01489254|11697382|FG000|COMPLETED|Double-blind Part||330
10660061|NCT02247531|11821615|FG001|COMPLETED|Overall Study||205
10660062|NCT02247531|11821616|FG002|COMPLETED|Overall Study||214
10660063|NCT02247531|11821614|FG000|NOT COMPLETED|Overall Study||106
10660064|NCT02247531|11821615|FG001|NOT COMPLETED|Overall Study||125
10660065|NCT02247531|11821616|FG002|NOT COMPLETED|Overall Study||110
10660066|NCT02247739|11821624|FG000|STARTED|Overall Study||5
10660067|NCT02247739|11821625|FG001|STARTED|Overall Study||6
10660068|NCT02247739|11821626|FG002|STARTED|Overall Study||5
10660069|NCT02247739|11821627|FG003|STARTED|Overall Study||5
10660070|NCT02247739|11821628|FG004|STARTED|Overall Study||6
10660071|NCT02247739|11821629|FG005|STARTED|Overall Study||5
10660072|NCT02247739|11821624|FG000|COMPLETED|Overall Study||5
10814404|NCT02367170|11977117|FG000|NOT COMPLETED|Overall Study||0
10402500|NCT00724594|11546757|FG000|NOT COMPLETED|Overall Study||0
10402501|NCT00724594|11546758|FG001|NOT COMPLETED|Overall Study||0
10402502|NCT00724594|11546759|FG002|NOT COMPLETED|Overall Study||0
10402503|NCT00724594|11546760|FG003|NOT COMPLETED|Overall Study||1
10402504|NCT00724711|11546787|FG000|STARTED|Overall Study||155
10544129|NCT01489254|11697383|FG001|COMPLETED|Double-blind Part||324
10544130|NCT01489254|11697384|FG002|COMPLETED|Double-blind Part||81
10544131|NCT01489254|11697385|FG003|COMPLETED|Double-blind Part||0
10660073|NCT02247739|11821625|FG001|COMPLETED|Overall Study||3
10660074|NCT02247739|11821626|FG002|COMPLETED|Overall Study||4
10402505|NCT00724711|11546788|FG001|STARTED|Overall Study||156
10402506|NCT00724711|11546787|FG000|COMPLETED|Overall Study||138
10402507|NCT00724711|11546788|FG001|COMPLETED|Overall Study||139
10402508|NCT00724711|11546787|FG000|NOT COMPLETED|Overall Study||17
10402509|NCT00724711|11546788|FG001|NOT COMPLETED|Overall Study||17
10402510|NCT00724750|11546796|FG000|STARTED|Overall Study||45
10402511|NCT00724750|11546797|FG001|STARTED|Overall Study||42
10402512|NCT00724750|11546796|FG000|COMPLETED|Overall Study||45
10402513|NCT00724750|11546797|FG001|COMPLETED|Overall Study||42
10402514|NCT00724750|11546796|FG000|NOT COMPLETED|Overall Study||0
10402515|NCT00724750|11546797|FG001|NOT COMPLETED|Overall Study||0
10402516|NCT00724815|11546805|FG000|STARTED|Overall Study|subjects randomized|265
10402517|NCT00724815|11546806|FG001|STARTED|Overall Study|subjects randomized|265
10402518|NCT00724815|11546805|FG000|COMPLETED|Overall Study||222
10402519|NCT00724815|11546806|FG001|COMPLETED|Overall Study||226
10402520|NCT00724815|11546805|FG000|NOT COMPLETED|Overall Study||43
10402521|NCT00724815|11546806|FG001|NOT COMPLETED|Overall Study||39
10402522|NCT00724854|11546814|FG000|STARTED|Overall Study|Number enrolled was 1146. 64 participants were screen failures.|1010
10402523|NCT00724854|11546815|FG001|STARTED|Overall Study|Number enrolled was 1146. 64 participants were screen failures.|72
10402524|NCT00724854|11546814|FG000|COMPLETED|Overall Study||607
10402525|NCT00724854|11546815|FG001|COMPLETED|Overall Study||41
10402526|NCT00724854|11546814|FG000|NOT COMPLETED|Overall Study||403
10402527|NCT00724854|11546815|FG001|NOT COMPLETED|Overall Study||31
10402528|NCT00724867|11546822|FG000|STARTED|Overall Study||268
10402529|NCT00724867|11546822|FG000|COMPLETED|Overall Study||140
10402530|NCT00724867|11546822|FG000|NOT COMPLETED|Overall Study||128
10402531|NCT00724893|11546831|FG000|STARTED|Overall Study||1302
10402532|NCT00724893|11546832|FG001|STARTED|Overall Study||1128
10402533|NCT00724893|11546831|FG000|COMPLETED|Overall Study||938
10402534|NCT00724893|11546832|FG001|COMPLETED|Overall Study||670
10814405|NCT02367170|11977118|FG001|NOT COMPLETED|Overall Study||0
10814406|NCT02376933|11977124|FG000|STARTED|Overall Study||10
10402535|NCT00724893|11546831|FG000|NOT COMPLETED|Overall Study||364
10402536|NCT00724893|11546832|FG001|NOT COMPLETED|Overall Study||458
10402537|NCT00724932|11546855|FG000|STARTED|Overall Study||70
10402538|NCT00724932|11546856|FG001|STARTED|Overall Study||70
10402539|NCT00724932|11546855|FG000|COMPLETED|Overall Study||65
10402540|NCT00724932|11546856|FG001|COMPLETED|Overall Study||67
10402541|NCT00724932|11546855|FG000|NOT COMPLETED|Overall Study||5
10402542|NCT00724932|11546856|FG001|NOT COMPLETED|Overall Study||3
10402543|NCT00724945|11546864|FG000|STARTED|Period 1||58
10402544|NCT00724945|11546865|FG001|STARTED|Period 1||55
10402545|NCT00724945|11546864|FG000|COMPLETED|Period 1||55
10402546|NCT00724945|11546865|FG001|COMPLETED|Period 1||54
10402547|NCT00724945|11546864|FG000|NOT COMPLETED|Period 1||3
10402548|NCT00724945|11546865|FG001|NOT COMPLETED|Period 1||1
10402549|NCT00724945|11546864|FG000|STARTED|Period 2||55
10402550|NCT00724945|11546865|FG001|STARTED|Period 2||54
10402551|NCT00724945|11546864|FG000|COMPLETED|Period 2||51
10402552|NCT00724945|11546865|FG001|COMPLETED|Period 2||54
10402553|NCT00724945|11546864|FG000|NOT COMPLETED|Period 2||4
10402554|NCT00724945|11546865|FG001|NOT COMPLETED|Period 2||0
10402555|NCT00724958|11546871|FG000|STARTED|Overall Study||348
10402556|NCT00724958|11546871|FG000|COMPLETED|Overall Study||166
10402557|NCT00724958|11546871|FG000|NOT COMPLETED|Overall Study||182
10402558|NCT00724971|11546875|FG000|STARTED|Overall Study||10
10402559|NCT00724971|11546875|FG000|COMPLETED|Overall Study||4
10402560|NCT00724971|11546875|FG000|NOT COMPLETED|Overall Study||6
10402561|NCT00724984|11546885|FG000|STARTED|Overall Study||5
10402562|NCT00724984|11546886|FG001|STARTED|Overall Study||8
10402563|NCT00724984|11546887|FG002|STARTED|Overall Study||3
10402564|NCT00724984|11546888|FG003|STARTED|Overall Study||9
10402565|NCT00724984|11546889|FG004|STARTED|Overall Study||16
10402566|NCT00724984|11546890|FG005|STARTED|Overall Study||14
10402567|NCT00724984|11546885|FG000|COMPLETED|Overall Study||4
10402568|NCT00724984|11546886|FG001|COMPLETED|Overall Study||7
10402569|NCT00724984|11546887|FG002|COMPLETED|Overall Study||3
10402570|NCT00724984|11546888|FG003|COMPLETED|Overall Study||7
10402571|NCT00724984|11546889|FG004|COMPLETED|Overall Study||12
10660075|NCT02247739|11821627|FG003|COMPLETED|Overall Study||5
10402572|NCT00724984|11546890|FG005|COMPLETED|Overall Study||9
10402573|NCT00724984|11546885|FG000|NOT COMPLETED|Overall Study||1
10402574|NCT00724984|11546886|FG001|NOT COMPLETED|Overall Study||1
10402575|NCT00724984|11546887|FG002|NOT COMPLETED|Overall Study||0
10402576|NCT00724984|11546888|FG003|NOT COMPLETED|Overall Study||2
10402577|NCT00724984|11546889|FG004|NOT COMPLETED|Overall Study||4
10402578|NCT00724984|11546890|FG005|NOT COMPLETED|Overall Study||5
10402579|NCT00725010|11546904|FG000|STARTED|Overall Study|Only in 50 of 64 participants the documentation of therapy and follow-up was received and evaluated.|50
10660076|NCT02247739|11821628|FG004|COMPLETED|Overall Study||5
10402580|NCT00725010|11546904|FG000|COMPLETED|Overall Study||25
10402581|NCT00725010|11546904|FG000|NOT COMPLETED|Overall Study||25
10402582|NCT00725075|11546913|FG000|STARTED|Overall Study||72
10402583|NCT00725075|11546914|FG001|STARTED|Overall Study||73
10402584|NCT00725075|11546915|FG002|STARTED|Overall Study||70
10402585|NCT00725075|11546913|FG000|Treated|Overall Study||71
10402586|NCT00725075|11546914|FG001|Treated|Overall Study||73
10402587|NCT00725075|11546915|FG002|Treated|Overall Study||70
10402588|NCT00725075|11546913|FG000|COMPLETED|Overall Study||61
10402589|NCT00725075|11546914|FG001|COMPLETED|Overall Study||65
10402590|NCT00725075|11546915|FG002|COMPLETED|Overall Study||61
10660077|NCT02247739|11821629|FG005|COMPLETED|Overall Study||4
10402591|NCT00725075|11546913|FG000|NOT COMPLETED|Overall Study||11
10402592|NCT00725075|11546914|FG001|NOT COMPLETED|Overall Study||8
10402593|NCT00725075|11546915|FG002|NOT COMPLETED|Overall Study||9
10544132|NCT01489254|11697382|FG000|NOT COMPLETED|Double-blind Part||25
10544133|NCT01489254|11697383|FG001|NOT COMPLETED|Double-blind Part||33
10544134|NCT01489254|11697384|FG002|NOT COMPLETED|Double-blind Part||3
10544135|NCT01489254|11697385|FG003|NOT COMPLETED|Double-blind Part||0
10544136|NCT01489254|11697382|FG000|STARTED|Open-label Extension Part||0
10544137|NCT01489254|11697383|FG001|STARTED|Open-label Extension Part||0
10544138|NCT01489254|11697384|FG002|STARTED|Open-label Extension Part||0
10544139|NCT01489254|11697385|FG003|STARTED|Open-label Extension Part|735 completed the DB part, 729 were eligible to continue in the OL part, 1 opted not to continue|728
10544140|NCT01489254|11697382|FG000|COMPLETED|Open-label Extension Part||0
10544141|NCT01489254|11697383|FG001|COMPLETED|Open-label Extension Part||0
10544142|NCT01489254|11697384|FG002|COMPLETED|Open-label Extension Part||0
10544143|NCT01489254|11697385|FG003|COMPLETED|Open-label Extension Part||670
10544144|NCT01489254|11697382|FG000|NOT COMPLETED|Open-label Extension Part||0
10544145|NCT01489254|11697383|FG001|NOT COMPLETED|Open-label Extension Part||0
10544146|NCT01489254|11697384|FG002|NOT COMPLETED|Open-label Extension Part||0
10544147|NCT01489254|11697385|FG003|NOT COMPLETED|Open-label Extension Part||58
10544148|NCT01489358|11697397|FG000|STARTED|Overall Study||5
10544149|NCT01489358|11697398|FG001|STARTED|Overall Study||10
10544150|NCT01489358|11697399|FG002|STARTED|Overall Study||10
10544151|NCT01489358|11697397|FG000|COMPLETED|Overall Study||5
10544152|NCT01489358|11697398|FG001|COMPLETED|Overall Study||10
10544153|NCT01489358|11697399|FG002|COMPLETED|Overall Study||8
10544154|NCT01489358|11697397|FG000|NOT COMPLETED|Overall Study||0
10544155|NCT01489358|11697398|FG001|NOT COMPLETED|Overall Study||0
10544156|NCT01489358|11697399|FG002|NOT COMPLETED|Overall Study||2
10544157|NCT01489527|11697409|FG000|STARTED|Overall Study||205
10544158|NCT01489527|11697410|FG001|STARTED|Overall Study||201
10544159|NCT01489527|11697409|FG000|COMPLETED|Overall Study||183
10544160|NCT01489527|11697410|FG001|COMPLETED|Overall Study||175
10544161|NCT01489527|11697409|FG000|NOT COMPLETED|Overall Study||22
10544162|NCT01489527|11697410|FG001|NOT COMPLETED|Overall Study||26
10544163|NCT01489579|11697418|FG000|STARTED|Overall Study||56
10544164|NCT01489579|11697419|FG001|STARTED|Overall Study||64
10544165|NCT01489579|11697418|FG000|COMPLETED|Overall Study||47
10544166|NCT01489579|11697419|FG001|COMPLETED|Overall Study||57
10544167|NCT01489579|11697418|FG000|NOT COMPLETED|Overall Study||9
10544168|NCT01489579|11697419|FG001|NOT COMPLETED|Overall Study||7
10544169|NCT01489670|11697427|FG000|STARTED|Overall Study||387
10544170|NCT01489670|11697427|FG000|COMPLETED|Overall Study||334
10544171|NCT01489670|11697427|FG000|NOT COMPLETED|Overall Study||53
10544172|NCT01489826|11697440|FG000|STARTED|Overall Study||3
10544173|NCT01489826|11697441|FG001|STARTED|Overall Study||3
10544174|NCT01489826|11697442|FG002|STARTED|Overall Study||3
10544175|NCT01489826|11697443|FG003|STARTED|Overall Study||7
10544176|NCT01489826|11697444|FG004|STARTED|Overall Study||3
10544177|NCT01489826|11697445|FG005|STARTED|Overall Study||3
10544178|NCT01489826|11697446|FG006|STARTED|Overall Study||9
10544179|NCT01489826|11697447|FG007|STARTED|Overall Study||3
10544180|NCT01489826|11697448|FG008|STARTED|Overall Study||6
10544181|NCT01489826|11697440|FG000|COMPLETED|Overall Study||3
10544182|NCT01489826|11697441|FG001|COMPLETED|Overall Study||3
10544183|NCT01489826|11697442|FG002|COMPLETED|Overall Study||3
10544184|NCT01489826|11697443|FG003|COMPLETED|Overall Study||7
10544185|NCT01489826|11697444|FG004|COMPLETED|Overall Study||3
10544186|NCT01489826|11697445|FG005|COMPLETED|Overall Study||3
10544187|NCT01489826|11697446|FG006|COMPLETED|Overall Study||9
10544188|NCT01489826|11697447|FG007|COMPLETED|Overall Study||3
10544189|NCT01489826|11697448|FG008|COMPLETED|Overall Study||6
10544190|NCT01489826|11697440|FG000|NOT COMPLETED|Overall Study||0
10544191|NCT01489826|11697441|FG001|NOT COMPLETED|Overall Study||0
10544192|NCT01489826|11697442|FG002|NOT COMPLETED|Overall Study||0
10544193|NCT01489826|11697443|FG003|NOT COMPLETED|Overall Study||0
10544194|NCT01489826|11697444|FG004|NOT COMPLETED|Overall Study||0
10660078|NCT02247739|11821624|FG000|NOT COMPLETED|Overall Study||0
10660079|NCT02247739|11821625|FG001|NOT COMPLETED|Overall Study||3
10660080|NCT02247739|11821626|FG002|NOT COMPLETED|Overall Study||1
10660081|NCT02247739|11821627|FG003|NOT COMPLETED|Overall Study||0
10660082|NCT02247739|11821628|FG004|NOT COMPLETED|Overall Study||1
10660083|NCT02247739|11821629|FG005|NOT COMPLETED|Overall Study||1
10660084|NCT02247765|11821639|FG000|STARTED|Overall Study||18
10660085|NCT02247765|11821639|FG000|COMPLETED|Overall Study||18
10660086|NCT02247765|11821639|FG000|NOT COMPLETED|Overall Study||0
10660087|NCT02247804|11821646|FG000|STARTED|Treatment Period 1||198
10660088|NCT02247804|11821647|FG001|STARTED|Treatment Period 1||198
10660089|NCT02247804|11821648|FG002|STARTED|Treatment Period 1||198
10660090|NCT02247804|11821646|FG000|Received (Sham or Bimatoprost SR)|Treatment Period 1||193
10660091|NCT02247804|11821647|FG001|Received (Sham or Bimatoprost SR)|Treatment Period 1||197
10660092|NCT02247804|11821648|FG002|Received (Sham or Bimatoprost SR)|Treatment Period 1||197
10544195|NCT01489826|11697445|FG005|NOT COMPLETED|Overall Study||0
10544196|NCT01489826|11697446|FG006|NOT COMPLETED|Overall Study||0
10544197|NCT01489826|11697447|FG007|NOT COMPLETED|Overall Study||0
10544198|NCT01489826|11697448|FG008|NOT COMPLETED|Overall Study||0
10544199|NCT01489891|11697478|FG000|STARTED|Overall Study||60
10544200|NCT01489891|11697479|FG001|STARTED|Overall Study||60
10544201|NCT01489891|11697478|FG000|COMPLETED|Overall Study||59
10544202|NCT01489891|11697479|FG001|COMPLETED|Overall Study||60
10402594|NCT00725101|11546923|FG000|STARTED|Overall Study||1700
10402595|NCT00725101|11546923|FG000|COMPLETED|Overall Study||1205
10402596|NCT00725101|11546923|FG000|NOT COMPLETED|Overall Study||495
10402597|NCT00725153|11546927|FG000|STARTED|Period One, 10 Hours of Wear||27
10402598|NCT00725153|11546928|FG001|STARTED|Period One, 10 Hours of Wear||28
10402599|NCT00725153|11546927|FG000|COMPLETED|Period One, 10 Hours of Wear||27
10402600|NCT00725153|11546928|FG001|COMPLETED|Period One, 10 Hours of Wear||28
10402601|NCT00725153|11546927|FG000|NOT COMPLETED|Period One, 10 Hours of Wear||0
10402602|NCT00725153|11546928|FG001|NOT COMPLETED|Period One, 10 Hours of Wear||0
10660093|NCT02247804|11821646|FG000|COMPLETED|Treatment Period 1||176
10660094|NCT02247804|11821647|FG001|COMPLETED|Treatment Period 1||194
10660095|NCT02247804|11821648|FG002|COMPLETED|Treatment Period 1||190
10660096|NCT02247804|11821646|FG000|NOT COMPLETED|Treatment Period 1||22
10660097|NCT02247804|11821647|FG001|NOT COMPLETED|Treatment Period 1||4
10660098|NCT02247804|11821648|FG002|NOT COMPLETED|Treatment Period 1||8
10660099|NCT02247804|11821646|FG000|STARTED|Treatment Period 2||172
10660100|NCT02247804|11821647|FG001|STARTED|Treatment Period 2||191
10660101|NCT02247804|11821648|FG002|STARTED|Treatment Period 2||187
10660102|NCT02247804|11821646|FG000|COMPLETED|Treatment Period 2||164
10660103|NCT02247804|11821647|FG001|COMPLETED|Treatment Period 2||186
10660104|NCT02247804|11821648|FG002|COMPLETED|Treatment Period 2||179
10660105|NCT02247804|11821646|FG000|NOT COMPLETED|Treatment Period 2||8
10660106|NCT02247804|11821647|FG001|NOT COMPLETED|Treatment Period 2||5
10660107|NCT02247804|11821648|FG002|NOT COMPLETED|Treatment Period 2||8
10660108|NCT02247804|11821646|FG000|STARTED|Treatment Period 3||158
10660109|NCT02247804|11821647|FG001|STARTED|Treatment Period 3||183
10660110|NCT02247804|11821648|FG002|STARTED|Treatment Period 3||177
10660111|NCT02247804|11821646|FG000|COMPLETED|Treatment Period 3||147
10660112|NCT02247804|11821647|FG001|COMPLETED|Treatment Period 3||173
10660113|NCT02247804|11821648|FG002|COMPLETED|Treatment Period 3||167
10660114|NCT02247804|11821646|FG000|NOT COMPLETED|Treatment Period 3||11
10660115|NCT02247804|11821647|FG001|NOT COMPLETED|Treatment Period 3||10
10660116|NCT02247804|11821648|FG002|NOT COMPLETED|Treatment Period 3||10
10660117|NCT02247960|11821658|FG000|STARTED|Patient Consent and Randomization||85
10660118|NCT02247960|11821659|FG001|STARTED|Patient Consent and Randomization||90
10660119|NCT02247960|11821658|FG000|COMPLETED|Patient Consent and Randomization||83
10660120|NCT02247960|11821659|FG001|COMPLETED|Patient Consent and Randomization||84
10660121|NCT02247960|11821658|FG000|NOT COMPLETED|Patient Consent and Randomization||2
10660122|NCT02247960|11821659|FG001|NOT COMPLETED|Patient Consent and Randomization||6
10660123|NCT02247960|11821658|FG000|STARTED|Catheter Removed||83
10660124|NCT02247960|11821659|FG001|STARTED|Catheter Removed||84
10660125|NCT02247960|11821658|FG000|COMPLETED|Catheter Removed||76
10660126|NCT02247960|11821659|FG001|COMPLETED|Catheter Removed||74
10660127|NCT02247960|11821658|FG000|NOT COMPLETED|Catheter Removed||7
10660128|NCT02247960|11821659|FG001|NOT COMPLETED|Catheter Removed||10
10660129|NCT02248103|11821667|FG000|STARTED|Overall Study||10
10660130|NCT02248103|11821668|FG001|STARTED|Overall Study||10
10660131|NCT02248103|11821667|FG000|COMPLETED|Overall Study||10
10660132|NCT02248103|11821668|FG001|COMPLETED|Overall Study||10
10660133|NCT02248103|11821667|FG000|NOT COMPLETED|Overall Study||0
10660134|NCT02248103|11821668|FG001|NOT COMPLETED|Overall Study||0
10660135|NCT02248246|11821674|FG000|STARTED|Overall Study||40
10660136|NCT02248246|11821674|FG000|COMPLETED|Overall Study||40
10660137|NCT02248246|11821674|FG000|NOT COMPLETED|Overall Study||0
10660138|NCT02248285|11821680|FG000|STARTED|Overall Study||687
10660139|NCT02248285|11821681|FG001|STARTED|Overall Study||858
10660140|NCT02248285|11821680|FG000|COMPLETED|Overall Study||586
10660141|NCT02248285|11821681|FG001|COMPLETED|Overall Study||571
10721430|NCT02725788|11885078|FG000|STARTED|Overall Study||123
10721431|NCT02725788|11885079|FG001|STARTED|Overall Study||124
10721432|NCT02725788|11885078|FG000|COMPLETED|Overall Study||122
10721433|NCT02725788|11885079|FG001|COMPLETED|Overall Study||122
10721434|NCT02725788|11885078|FG000|NOT COMPLETED|Overall Study||1
10721435|NCT02725788|11885079|FG001|NOT COMPLETED|Overall Study||2
10721436|NCT02725801|11885087|FG000|STARTED|Overall Study||8
10721437|NCT02725801|11885088|FG001|STARTED|Overall Study||12
10721438|NCT02725801|11885087|FG000|COMPLETED|Overall Study||8
10721439|NCT02725801|11885088|FG001|COMPLETED|Overall Study||12
10721440|NCT02725801|11885087|FG000|NOT COMPLETED|Overall Study||0
10721441|NCT02725801|11885088|FG001|NOT COMPLETED|Overall Study||0
10721442|NCT02725866|11885094|FG000|STARTED|Overall Study||216
10721443|NCT02725866|11885094|FG000|COMPLETED|Overall Study||202
10721444|NCT02725866|11885094|FG000|NOT COMPLETED|Overall Study||14
10721445|NCT02726022|11885098|FG000|STARTED|Overall Study||114
10721446|NCT02726022|11885098|FG000|COMPLETED|Overall Study||78
10721447|NCT02726022|11885098|FG000|NOT COMPLETED|Overall Study||36
10402603|NCT00725153|11546927|FG000|STARTED|Period Two, 10 Hours of Wear||27
10660142|NCT02248285|11821680|FG000|NOT COMPLETED|Overall Study||101
10660143|NCT02248285|11821681|FG001|NOT COMPLETED|Overall Study||287
10660144|NCT02248480|11821689|FG000|STARTED|Overall Study||178
10660145|NCT02248480|11821690|FG001|STARTED|Overall Study||176
10660146|NCT02248480|11821689|FG000|Efficacy Population|Overall Study||177
10660147|NCT02248480|11821690|FG001|Efficacy Population|Overall Study||176
10721448|NCT02726074|11885102|FG000|STARTED|Overall Study||106
10721449|NCT02726074|11885102|FG000|Treated|Overall Study||102
10721450|NCT02726074|11885102|FG000|COMPLETED|Overall Study||80
10721451|NCT02726074|11885102|FG000|NOT COMPLETED|Overall Study||26
10721452|NCT02726113|11885108|FG000|STARTED|Total Enrollment||28
10721453|NCT02726113|11885109|FG001|STARTED|Total Enrollment||22
10402604|NCT00725153|11546928|FG001|STARTED|Period Two, 10 Hours of Wear||28
10402605|NCT00725153|11546927|FG000|COMPLETED|Period Two, 10 Hours of Wear||27
10402606|NCT00725153|11546928|FG001|COMPLETED|Period Two, 10 Hours of Wear||28
10402607|NCT00725153|11546927|FG000|NOT COMPLETED|Period Two, 10 Hours of Wear||0
10402608|NCT00725153|11546928|FG001|NOT COMPLETED|Period Two, 10 Hours of Wear||0
10402609|NCT00725205|11546934|FG000|STARTED|Overall Study||294
10402610|NCT00725205|11546934|FG000|COMPLETED|Overall Study||207
10402611|NCT00725205|11546934|FG000|NOT COMPLETED|Overall Study||87
10402612|NCT00725270|11546940|FG000|STARTED|Overall Study||5
10402613|NCT00725270|11546941|FG001|STARTED|Overall Study||7
10402614|NCT00725270|11546940|FG000|COMPLETED|Overall Study||5
10402615|NCT00725270|11546941|FG001|COMPLETED|Overall Study||7
10402616|NCT00725270|11546940|FG000|NOT COMPLETED|Overall Study||0
10402617|NCT00725270|11546941|FG001|NOT COMPLETED|Overall Study||0
10402618|NCT00725283|11546947|FG000|STARTED|Overall Study||34
10402619|NCT00725283|11546947|FG000|COMPLETED|Overall Study||10
10402620|NCT00725283|11546947|FG000|NOT COMPLETED|Overall Study||24
10402621|NCT00725296|11546951|FG000|STARTED|Overall Study|163 of the 178 enrolled participants received at least one dose of Infliximab.|163
10402622|NCT00725296|11546951|FG000|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive infusions.|101
10402623|NCT00725296|11546951|FG000|NOT COMPLETED|Overall Study||62
10402624|NCT00725322|11546958|FG000|STARTED|First Injection Visit||15
10402625|NCT00725322|11546959|FG001|STARTED|First Injection Visit||15
10402626|NCT00725322|11546958|FG000|COMPLETED|First Injection Visit||15
10402627|NCT00725322|11546959|FG001|COMPLETED|First Injection Visit||15
10402628|NCT00725322|11546958|FG000|NOT COMPLETED|First Injection Visit||0
10402629|NCT00725322|11546959|FG001|NOT COMPLETED|First Injection Visit||0
10402630|NCT00725322|11546958|FG000|STARTED|Washout (28 Days)||15
10402631|NCT00725322|11546959|FG001|STARTED|Washout (28 Days)||15
10402632|NCT00725322|11546958|FG000|COMPLETED|Washout (28 Days)||13
10402633|NCT00725322|11546959|FG001|COMPLETED|Washout (28 Days)||14
10402634|NCT00725322|11546958|FG000|NOT COMPLETED|Washout (28 Days)||2
10402635|NCT00725322|11546959|FG001|NOT COMPLETED|Washout (28 Days)||1
10402636|NCT00725322|11546958|FG000|STARTED|Second Injection Visit||13
10402637|NCT00725322|11546959|FG001|STARTED|Second Injection Visit||14
10402638|NCT00725322|11546958|FG000|COMPLETED|Second Injection Visit||13
10402639|NCT00725322|11546959|FG001|COMPLETED|Second Injection Visit||14
10402640|NCT00725322|11546958|FG000|NOT COMPLETED|Second Injection Visit||0
10402641|NCT00725322|11546959|FG001|NOT COMPLETED|Second Injection Visit||0
10402642|NCT00725361|11546965|FG000|STARTED|Overall Study||20
10402643|NCT00725361|11546965|FG000|COMPLETED|Overall Study||16
10402644|NCT00725361|11546965|FG000|NOT COMPLETED|Overall Study||4
10402645|NCT00725452|11546969|FG000|STARTED|Overall Study||26
10402646|NCT00725452|11546969|FG000|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Infliximab infusions.|15
10402647|NCT00725452|11546969|FG000|NOT COMPLETED|Overall Study||11
10402648|NCT00725504|11546973|FG000|STARTED|Overall Study||71
10402649|NCT00725504|11546973|FG000|COMPLETED|Overall Study||71
10402650|NCT00725504|11546973|FG000|NOT COMPLETED|Overall Study||0
10402651|NCT00725530|11546980|FG000|STARTED|First Intervention, 7 Days (+0/-1)||27
10402652|NCT00725530|11546981|FG001|STARTED|First Intervention, 7 Days (+0/-1)||27
10402653|NCT00725530|11546980|FG000|COMPLETED|First Intervention, 7 Days (+0/-1)||27
10402654|NCT00725530|11546981|FG001|COMPLETED|First Intervention, 7 Days (+0/-1)||27
10402655|NCT00725530|11546980|FG000|NOT COMPLETED|First Intervention, 7 Days (+0/-1)||0
10402656|NCT00725530|11546981|FG001|NOT COMPLETED|First Intervention, 7 Days (+0/-1)||0
10402657|NCT00725530|11546980|FG000|STARTED|Second Intervention, 7 Days (+0/-1)||27
10402658|NCT00725530|11546981|FG001|STARTED|Second Intervention, 7 Days (+0/-1)||27
10402659|NCT00725530|11546980|FG000|COMPLETED|Second Intervention, 7 Days (+0/-1)||27
10402660|NCT00725530|11546981|FG001|COMPLETED|Second Intervention, 7 Days (+0/-1)||27
10402661|NCT00725530|11546980|FG000|NOT COMPLETED|Second Intervention, 7 Days (+0/-1)||0
10402662|NCT00725530|11546981|FG001|NOT COMPLETED|Second Intervention, 7 Days (+0/-1)||0
10402663|NCT00725543|11546987|FG000|STARTED|Overall Study||358
10402664|NCT00725543|11546987|FG000|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Remicade infusions.|205
10402665|NCT00725543|11546987|FG000|NOT COMPLETED|Overall Study||153
10402666|NCT00725608|11546991|FG000|STARTED|Overall Study|339 patients enrolled, 32 non-eligible datasets excluded from final general and safety analysis|307
10402667|NCT00725608|11546991|FG000|COMPLETED|Overall Study|1 patient terminated treatment at day 368 and was counted as dropout|140
10402668|NCT00725608|11546991|FG000|NOT COMPLETED|Overall Study||167
10402669|NCT00725621|11546995|FG000|STARTED|Overall Study|Started was defined as the number of participants who received at least one infusion of Remicade.|516
10402670|NCT00725621|11546995|FG000|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Remicade infusions.|245
10402671|NCT00725621|11546995|FG000|NOT COMPLETED|Overall Study||271
10402672|NCT00725712|11547005|FG000|STARTED|Overall Study||48
10402673|NCT00725712|11547006|FG001|STARTED|Overall Study||26
10402674|NCT00725712|11547005|FG000|COMPLETED|Overall Study||0
10402675|NCT00725712|11547006|FG001|COMPLETED|Overall Study||0
10402676|NCT00725712|11547005|FG000|NOT COMPLETED|Overall Study||48
10402677|NCT00725712|11547006|FG001|NOT COMPLETED|Overall Study||26
10402678|NCT00725725|11547019|FG000|STARTED|Overall Study||14
10402679|NCT00725725|11547020|FG001|STARTED|Overall Study||15
10402680|NCT00725725|11547021|FG002|STARTED|Overall Study||17
10402681|NCT00725725|11547019|FG000|Treated|Overall Study||11
10402682|NCT00725725|11547020|FG001|Treated|Overall Study||15
10402683|NCT00725725|11547021|FG002|Treated|Overall Study||14
10402684|NCT00725725|11547019|FG000|COMPLETED|Overall Study||10
10402685|NCT00725725|11547020|FG001|COMPLETED|Overall Study||11
10402686|NCT00725725|11547021|FG002|COMPLETED|Overall Study||12
10402687|NCT00725725|11547019|FG000|NOT COMPLETED|Overall Study||4
10402688|NCT00725725|11547020|FG001|NOT COMPLETED|Overall Study||4
10402689|NCT00725725|11547021|FG002|NOT COMPLETED|Overall Study||5
10402690|NCT00725751|11547031|FG000|STARTED|Overall Study||90
10402691|NCT00725751|11547032|FG001|STARTED|Overall Study||258
10402692|NCT00725751|11547031|FG000|COMPLETED|Overall Study||56
10402693|NCT00725751|11547032|FG001|COMPLETED|Overall Study||150
10402694|NCT00725751|11547031|FG000|NOT COMPLETED|Overall Study||34
10402695|NCT00725751|11547032|FG001|NOT COMPLETED|Overall Study||108
10402696|NCT00725764|11547039|FG000|STARTED|Overall Study||14
10402697|NCT00725764|11547039|FG000|COMPLETED|Overall Study||0
10402698|NCT00725764|11547039|FG000|NOT COMPLETED|Overall Study||14
10402699|NCT00725842|11547044|FG000|STARTED|Overall Study||97
10402700|NCT00725842|11547044|FG000|Participants Eligible for Analysis|Overall Study||90
10402701|NCT00725842|11547044|FG000|COMPLETED|Overall Study||57
10402702|NCT00725842|11547044|FG000|NOT COMPLETED|Overall Study||40
10402703|NCT00725920|11547050|FG000|STARTED|Overall Study||17
10402704|NCT00725920|11547051|FG001|STARTED|Overall Study||18
10402705|NCT00725920|11547050|FG000|COMPLETED|Overall Study||14
10402706|NCT00725920|11547051|FG001|COMPLETED|Overall Study||12
10402707|NCT00725920|11547050|FG000|NOT COMPLETED|Overall Study||3
10402708|NCT00725920|11547051|FG001|NOT COMPLETED|Overall Study||6
10402709|NCT00725959|11547059|FG000|STARTED|Overall Study||942
10402710|NCT00725959|11547060|FG001|STARTED|Overall Study||636
10402711|NCT00725959|11547059|FG000|COMPLETED|Overall Study||653
10402712|NCT00725959|11547060|FG001|COMPLETED|Overall Study||439
10402713|NCT00725959|11547059|FG000|NOT COMPLETED|Overall Study||289
10402714|NCT00725959|11547060|FG001|NOT COMPLETED|Overall Study||197
10402715|NCT00726232|11547072|FG000|STARTED|Initial Phase (Dose-finding)|The starting dose selected for the PV expansion cohort was 10 mg bid hence the sample size is larger|19
10402716|NCT00726232|11547073|FG001|STARTED|Initial Phase (Dose-finding)||8
10402717|NCT00726232|11547074|FG002|STARTED|Initial Phase (Dose-finding)||7
10402718|NCT00726232|11547075|FG003|STARTED|Initial Phase (Dose-finding)||8
10402719|NCT00726232|11547076|FG004|STARTED|Initial Phase (Dose-finding)|The starting dose selected for the ET expansion cohort was 25 mg bid hence the sample size is larger|22
10402720|NCT00726232|11547077|FG005|STARTED|Initial Phase (Dose-finding)||9
10402721|NCT00726232|11547078|FG006|STARTED|Initial Phase (Dose-finding)||0
10402722|NCT00726232|11547079|FG007|STARTED|Initial Phase (Dose-finding)||0
10402723|NCT00726232|11547072|FG000|Safety Evaluable Participants|Initial Phase (Dose-finding)||19
10402724|NCT00726232|11547073|FG001|Safety Evaluable Participants|Initial Phase (Dose-finding)||8
10402725|NCT00726232|11547074|FG002|Safety Evaluable Participants|Initial Phase (Dose-finding)||7
10402726|NCT00726232|11547075|FG003|Safety Evaluable Participants|Initial Phase (Dose-finding)||8
10402727|NCT00726232|11547076|FG004|Safety Evaluable Participants|Initial Phase (Dose-finding)||22
10402728|NCT00726232|11547077|FG005|Safety Evaluable Participants|Initial Phase (Dose-finding)||9
10402729|NCT00726232|11547078|FG006|Safety Evaluable Participants|Initial Phase (Dose-finding)||0
10402730|NCT00726232|11547079|FG007|Safety Evaluable Participants|Initial Phase (Dose-finding)||0
10402731|NCT00726232|11547072|FG000|ITT Participants|Initial Phase (Dose-finding)||19
10402732|NCT00726232|11547073|FG001|ITT Participants|Initial Phase (Dose-finding)||8
10402733|NCT00726232|11547074|FG002|ITT Participants|Initial Phase (Dose-finding)||7
10402734|NCT00726232|11547075|FG003|ITT Participants|Initial Phase (Dose-finding)||8
10402735|NCT00726232|11547076|FG004|ITT Participants|Initial Phase (Dose-finding)||22
10402736|NCT00726232|11547077|FG005|ITT Participants|Initial Phase (Dose-finding)||9
10721454|NCT02726113|11885108|FG000|COMPLETED|Total Enrollment||24
10721455|NCT02726113|11885109|FG001|COMPLETED|Total Enrollment||19
10721456|NCT02726113|11885108|FG000|NOT COMPLETED|Total Enrollment||4
10721457|NCT02726113|11885109|FG001|NOT COMPLETED|Total Enrollment||3
10721458|NCT02726113|11885108|FG000|STARTED|Genomic Analysis||19
10721459|NCT02726113|11885109|FG001|STARTED|Genomic Analysis||14
10721460|NCT02726113|11885108|FG000|COMPLETED|Genomic Analysis||15
10721461|NCT02726113|11885109|FG001|COMPLETED|Genomic Analysis||12
10721462|NCT02726113|11885108|FG000|NOT COMPLETED|Genomic Analysis||4
10721463|NCT02726113|11885109|FG001|NOT COMPLETED|Genomic Analysis||2
10402737|NCT00726232|11547078|FG006|ITT Participants|Initial Phase (Dose-finding)||0
10402738|NCT00726232|11547079|FG007|ITT Participants|Initial Phase (Dose-finding)||0
10402739|NCT00726232|11547072|FG000|COMPLETED|Initial Phase (Dose-finding)||6
10402740|NCT00726232|11547073|FG001|COMPLETED|Initial Phase (Dose-finding)||2
10402741|NCT00726232|11547074|FG002|COMPLETED|Initial Phase (Dose-finding)||2
10402742|NCT00726232|11547075|FG003|COMPLETED|Initial Phase (Dose-finding)||0
10402743|NCT00726232|11547076|FG004|COMPLETED|Initial Phase (Dose-finding)||1
10402744|NCT00726232|11547077|FG005|COMPLETED|Initial Phase (Dose-finding)||0
10402745|NCT00726232|11547078|FG006|COMPLETED|Initial Phase (Dose-finding)||0
10402746|NCT00726232|11547079|FG007|COMPLETED|Initial Phase (Dose-finding)||0
10402747|NCT00726232|11547072|FG000|NOT COMPLETED|Initial Phase (Dose-finding)||13
10402748|NCT00726232|11547073|FG001|NOT COMPLETED|Initial Phase (Dose-finding)||6
10402749|NCT00726232|11547074|FG002|NOT COMPLETED|Initial Phase (Dose-finding)||5
10402750|NCT00726232|11547075|FG003|NOT COMPLETED|Initial Phase (Dose-finding)||8
10721464|NCT02726178|11885118|FG000|STARTED|Overall Study||28
10721465|NCT02726178|11885119|FG001|STARTED|Overall Study||28
10721466|NCT02726178|11885118|FG000|COMPLETED|Overall Study||28
10402751|NCT00726232|11547076|FG004|NOT COMPLETED|Initial Phase (Dose-finding)||21
10402752|NCT00726232|11547077|FG005|NOT COMPLETED|Initial Phase (Dose-finding)||9
10402753|NCT00726232|11547078|FG006|NOT COMPLETED|Initial Phase (Dose-finding)||0
10402754|NCT00726232|11547079|FG007|NOT COMPLETED|Initial Phase (Dose-finding)||0
10402755|NCT00726232|11547072|FG000|STARTED|Expansion Phase||0
10402756|NCT00726232|11547073|FG001|STARTED|Expansion Phase||0
10402757|NCT00726232|11547074|FG002|STARTED|Expansion Phase||0
10402758|NCT00726232|11547075|FG003|STARTED|Expansion Phase||0
10402759|NCT00726232|11547076|FG004|STARTED|Expansion Phase||0
10402760|NCT00726232|11547077|FG005|STARTED|Expansion Phase||0
10402761|NCT00726232|11547078|FG006|STARTED|Expansion Phase||34
10402762|NCT00726232|11547079|FG007|STARTED|Expansion Phase||39
10402763|NCT00726232|11547072|FG000|Safety Evaluable Participants|Expansion Phase||0
10660148|NCT02248480|11821689|FG000|COMPLETED|Overall Study||161
10660149|NCT02248480|11821690|FG001|COMPLETED|Overall Study||162
10660150|NCT02248480|11821689|FG000|NOT COMPLETED|Overall Study||17
10660151|NCT02248480|11821690|FG001|NOT COMPLETED|Overall Study||14
10660152|NCT02248558|11821699|FG000|STARTED|Overall Study||369
10660153|NCT02248558|11821700|FG001|STARTED|Overall Study||352
10660154|NCT02248558|11821699|FG000|COMPLETED|Overall Study||317
10660155|NCT02248558|11821700|FG001|COMPLETED|Overall Study||307
10660156|NCT02248558|11821699|FG000|NOT COMPLETED|Overall Study||52
10660157|NCT02248558|11821700|FG001|NOT COMPLETED|Overall Study||45
10660158|NCT02248636|11821710|FG000|STARTED|Overall Study||26
10660159|NCT02248636|11821711|FG001|STARTED|Overall Study||35
10660160|NCT02248636|11821710|FG000|COMPLETED|Overall Study||20
10660161|NCT02248636|11821711|FG001|COMPLETED|Overall Study||32
10660162|NCT02248636|11821710|FG000|NOT COMPLETED|Overall Study||6
10660163|NCT02248636|11821711|FG001|NOT COMPLETED|Overall Study||3
10660164|NCT02248649|11821719|FG000|STARTED|Overall Study||80
10660165|NCT02248649|11821720|FG001|STARTED|Overall Study||80
10660166|NCT02248649|11821719|FG000|COMPLETED|Overall Study||59
10660167|NCT02248649|11821720|FG001|COMPLETED|Overall Study||59
10660168|NCT02248649|11821719|FG000|NOT COMPLETED|Overall Study||21
10660169|NCT02248649|11821720|FG001|NOT COMPLETED|Overall Study||21
10660170|NCT02248662|11821728|FG000|STARTED|Overall Study||5320
10660171|NCT02248662|11821729|FG001|STARTED|Overall Study||33194
10660172|NCT02248662|11821728|FG000|COMPLETED|Overall Study||757
10660173|NCT02248662|11821729|FG001|COMPLETED|Overall Study||2679
10660174|NCT02248662|11821728|FG000|NOT COMPLETED|Overall Study||4563
10660175|NCT02248662|11821729|FG001|NOT COMPLETED|Overall Study||30515
10660176|NCT02248675|11821741|FG000|STARTED|Overall Study||26
10660177|NCT02248675|11821742|FG001|STARTED|Overall Study||28
10660178|NCT02248675|11821741|FG000|COMPLETED|Overall Study||23
10660179|NCT02248675|11821742|FG001|COMPLETED|Overall Study||27
10660180|NCT02248675|11821741|FG000|NOT COMPLETED|Overall Study||3
10660181|NCT02248675|11821742|FG001|NOT COMPLETED|Overall Study||1
10660182|NCT02248714|11821750|FG000|STARTED|Overall Study||66
10660183|NCT02248714|11821751|FG001|STARTED|Overall Study||65
10660184|NCT02248714|11821750|FG000|COMPLETED|Overall Study||62
10660185|NCT02248714|11821751|FG001|COMPLETED|Overall Study||61
10660186|NCT02248714|11821750|FG000|NOT COMPLETED|Overall Study||4
10660187|NCT02248714|11821751|FG001|NOT COMPLETED|Overall Study||4
10660188|NCT02248727|11821757|FG000|STARTED|Overall Study||30
10660189|NCT02248727|11821757|FG000|COMPLETED|Overall Study||30
10660190|NCT02248727|11821757|FG000|NOT COMPLETED|Overall Study||0
10660191|NCT02248766|11821764|FG000|STARTED|Overall Study||30
10660192|NCT02248766|11821764|FG000|COMPLETED|Overall Study||30
10660193|NCT02248766|11821764|FG000|NOT COMPLETED|Overall Study||0
10721467|NCT02726178|11885119|FG001|COMPLETED|Overall Study||28
10721468|NCT02726178|11885118|FG000|NOT COMPLETED|Overall Study||0
10721469|NCT02726178|11885119|FG001|NOT COMPLETED|Overall Study||0
10721470|NCT02726451|11885129|FG000|STARTED|Overall Study||10
10721471|NCT02726451|11885130|FG001|STARTED|Overall Study||10
10721472|NCT02726451|11885129|FG000|COMPLETED|Overall Study||10
10721473|NCT02726451|11885130|FG001|COMPLETED|Overall Study||10
10721474|NCT02726451|11885129|FG000|NOT COMPLETED|Overall Study||0
10721475|NCT02726451|11885130|FG001|NOT COMPLETED|Overall Study||0
10721482|NCT02726620|11885147|FG000|STARTED|Historic Cohort - Three Years||17463
10721483|NCT02726620|11885148|FG001|STARTED|Historic Cohort - Three Years||0
10402764|NCT00726232|11547073|FG001|Safety Evaluable Participants|Expansion Phase||0
10402765|NCT00726232|11547074|FG002|Safety Evaluable Participants|Expansion Phase||0
10721484|NCT02726620|11885147|FG000|MAP < 65 mmHg: Primary Analysis|Historic Cohort - Three Years||15624
10721485|NCT02726620|11885148|FG001|MAP < 65 mmHg: Primary Analysis|Historic Cohort - Three Years||0
10721486|NCT02726620|11885147|FG000|COMPLETED|Historic Cohort - Three Years||17463
10721487|NCT02726620|11885148|FG001|COMPLETED|Historic Cohort - Three Years||0
10721488|NCT02726620|11885147|FG000|NOT COMPLETED|Historic Cohort - Three Years||0
10402766|NCT00726232|11547075|FG003|Safety Evaluable Participants|Expansion Phase||0
10402767|NCT00726232|11547076|FG004|Safety Evaluable Participants|Expansion Phase||0
10721489|NCT02726620|11885148|FG001|NOT COMPLETED|Historic Cohort - Three Years||0
10721490|NCT02726620|11885147|FG000|STARTED|Month 1: Attending Randomization||0
10721491|NCT02726620|11885148|FG001|STARTED|Month 1: Attending Randomization||485
10779312|NCT03364309|11940868|FG009|COMPLETED|Post-Treatment Followup Period||0
10544203|NCT01489891|11697478|FG000|NOT COMPLETED|Overall Study||1
10544204|NCT01489891|11697479|FG001|NOT COMPLETED|Overall Study||0
10544205|NCT01489956|11697487|FG000|STARTED|Overall Study|Ten of the 13 participants were considered evaluable.|13
10544206|NCT01489956|11697488|FG001|STARTED|Overall Study|Nine of the 10 participants receiving Immucothel alone had a response, so Montanide was not used.|0
10544207|NCT01489956|11697489|FG002|STARTED|Overall Study|These 6 subjects had Immucothel alone since Montanide was not needed for the 10 participants dosed.|6
10544208|NCT01489956|11697487|FG000|COMPLETED|Overall Study||12
10544209|NCT01489956|11697488|FG001|COMPLETED|Overall Study||0
10544210|NCT01489956|11697489|FG002|COMPLETED|Overall Study||5
10402768|NCT00726232|11547077|FG005|Safety Evaluable Participants|Expansion Phase||0
10402769|NCT00726232|11547078|FG006|Safety Evaluable Participants|Expansion Phase||34
10402770|NCT00726232|11547079|FG007|Safety Evaluable Participants|Expansion Phase||39
10402771|NCT00726232|11547072|FG000|ITT Participants|Expansion Phase||0
10402772|NCT00726232|11547073|FG001|ITT Participants|Expansion Phase||0
10402773|NCT00726232|11547074|FG002|ITT Participants|Expansion Phase||0
10402774|NCT00726232|11547075|FG003|ITT Participants|Expansion Phase||0
10402775|NCT00726232|11547076|FG004|ITT Participants|Expansion Phase||0
10402776|NCT00726232|11547077|FG005|ITT Participants|Expansion Phase||0
10402777|NCT00726232|11547078|FG006|ITT Participants|Expansion Phase||34
10402778|NCT00726232|11547079|FG007|ITT Participants|Expansion Phase||39
10402779|NCT00726232|11547072|FG000|COMPLETED|Expansion Phase||0
10402780|NCT00726232|11547073|FG001|COMPLETED|Expansion Phase||0
10402781|NCT00726232|11547074|FG002|COMPLETED|Expansion Phase||0
10402782|NCT00726232|11547075|FG003|COMPLETED|Expansion Phase||0
10402783|NCT00726232|11547076|FG004|COMPLETED|Expansion Phase||0
10402784|NCT00726232|11547077|FG005|COMPLETED|Expansion Phase||0
10402785|NCT00726232|11547078|FG006|COMPLETED|Expansion Phase||10
10402786|NCT00726232|11547079|FG007|COMPLETED|Expansion Phase||1
10402787|NCT00726232|11547072|FG000|NOT COMPLETED|Expansion Phase||0
10402788|NCT00726232|11547073|FG001|NOT COMPLETED|Expansion Phase||0
10402789|NCT00726232|11547074|FG002|NOT COMPLETED|Expansion Phase||0
10402790|NCT00726232|11547075|FG003|NOT COMPLETED|Expansion Phase||0
10660194|NCT02248818|11821780|FG000|STARTED|Screening||0
10660195|NCT02248818|11821781|FG001|STARTED|Screening||0
10660196|NCT02248818|11821782|FG002|STARTED|Screening||0
10660197|NCT02248818|11821783|FG003|STARTED|Screening||0
10660198|NCT02248818|11821784|FG004|STARTED|Screening||0
10660199|NCT02248818|11821785|FG005|STARTED|Screening||0
10660200|NCT02248818|11821786|FG006|STARTED|Screening||0
10660201|NCT02248818|11821787|FG007|STARTED|Screening||0
10660202|NCT02248818|11821788|FG008|STARTED|Screening||155
10660203|NCT02248818|11821780|FG000|COMPLETED|Screening||0
10660204|NCT02248818|11821781|FG001|COMPLETED|Screening||0
10660205|NCT02248818|11821782|FG002|COMPLETED|Screening||0
10660206|NCT02248818|11821783|FG003|COMPLETED|Screening||0
10721492|NCT02726620|11885147|FG000|MAP < 65 mmHg: Primary Analysis|Month 1: Attending Randomization||0
10721493|NCT02726620|11885148|FG001|MAP < 65 mmHg: Primary Analysis|Month 1: Attending Randomization||432
10721494|NCT02726620|11885147|FG000|Correct IOH Notifications|Month 1: Attending Randomization||0
10402791|NCT00726232|11547076|FG004|NOT COMPLETED|Expansion Phase||0
10402792|NCT00726232|11547077|FG005|NOT COMPLETED|Expansion Phase||0
10402793|NCT00726232|11547078|FG006|NOT COMPLETED|Expansion Phase||24
10402794|NCT00726232|11547079|FG007|NOT COMPLETED|Expansion Phase||38
10402795|NCT00726323|11547100|FG000|STARTED|Overall Study||37
10402796|NCT00726323|11547101|FG001|STARTED|Overall Study||37
10402797|NCT00726323|11547100|FG000|COMPLETED|Overall Study||0
10402798|NCT00726323|11547101|FG001|COMPLETED|Overall Study||6
10402799|NCT00726323|11547100|FG000|NOT COMPLETED|Overall Study||37
10402800|NCT00726323|11547101|FG001|NOT COMPLETED|Overall Study||31
10402801|NCT00726375|11547107|FG000|STARTED|Overall Study||34
10402802|NCT00726375|11547107|FG000|COMPLETED|Overall Study||34
10402803|NCT00726375|11547107|FG000|NOT COMPLETED|Overall Study||0
10402804|NCT00726388|11547111|FG000|STARTED|Overall Study||1050
10402805|NCT00726388|11547111|FG000|Treated|Overall Study||971
10402806|NCT00726388|11547111|FG000|COMPLETED|Overall Study||943
10402807|NCT00726388|11547111|FG000|NOT COMPLETED|Overall Study||107
10402808|NCT00726414|11547115|FG000|STARTED|First Intervention||11
10402809|NCT00726414|11547116|FG001|STARTED|First Intervention||11
10402810|NCT00726414|11547115|FG000|COMPLETED|First Intervention||11
10402811|NCT00726414|11547116|FG001|COMPLETED|First Intervention||11
10402812|NCT00726414|11547115|FG000|NOT COMPLETED|First Intervention||0
10402813|NCT00726414|11547116|FG001|NOT COMPLETED|First Intervention||0
10402814|NCT00726414|11547115|FG000|STARTED|Washout Period of 7 Days||11
10402815|NCT00726414|11547116|FG001|STARTED|Washout Period of 7 Days||11
10402816|NCT00726414|11547115|FG000|COMPLETED|Washout Period of 7 Days||11
10544211|NCT01489956|11697487|FG000|NOT COMPLETED|Overall Study||1
10544212|NCT01489956|11697488|FG001|NOT COMPLETED|Overall Study||0
10544213|NCT01489956|11697489|FG002|NOT COMPLETED|Overall Study||1
10544214|NCT01489969|11697500|FG000|STARTED|Overall Study||45
10660207|NCT02248818|11821784|FG004|COMPLETED|Screening||0
10660208|NCT02248818|11821785|FG005|COMPLETED|Screening||0
10660209|NCT02248818|11821786|FG006|COMPLETED|Screening||0
10660210|NCT02248818|11821787|FG007|COMPLETED|Screening||0
10660211|NCT02248818|11821788|FG008|COMPLETED|Screening||48
10402817|NCT00726414|11547116|FG001|COMPLETED|Washout Period of 7 Days||11
10402818|NCT00726414|11547115|FG000|NOT COMPLETED|Washout Period of 7 Days||0
10402819|NCT00726414|11547116|FG001|NOT COMPLETED|Washout Period of 7 Days||0
10402820|NCT00726414|11547115|FG000|STARTED|Second Intervention||11
10660212|NCT02248818|11821780|FG000|NOT COMPLETED|Screening||0
10402821|NCT00726414|11547116|FG001|STARTED|Second Intervention||11
10402822|NCT00726414|11547115|FG000|COMPLETED|Second Intervention||11
10402823|NCT00726414|11547116|FG001|COMPLETED|Second Intervention||11
10402824|NCT00726414|11547115|FG000|NOT COMPLETED|Second Intervention||0
10402825|NCT00726414|11547116|FG001|NOT COMPLETED|Second Intervention||0
10402826|NCT00726453|11547124|FG000|STARTED|Primary Enrollment Group||1402
10402827|NCT00726453|11547125|FG001|STARTED|Primary Enrollment Group||0
10402828|NCT00726453|11547124|FG000|COMPLETED|Primary Enrollment Group||1371
10402829|NCT00726453|11547125|FG001|COMPLETED|Primary Enrollment Group||0
10402830|NCT00726453|11547124|FG000|NOT COMPLETED|Primary Enrollment Group||31
10402831|NCT00726453|11547125|FG001|NOT COMPLETED|Primary Enrollment Group||0
10402832|NCT00726453|11547124|FG000|STARTED|38 mm Length Group||0
10402833|NCT00726453|11547125|FG001|STARTED|38 mm Length Group||114
10402834|NCT00726453|11547124|FG000|COMPLETED|38 mm Length Group||0
10402835|NCT00726453|11547125|FG001|COMPLETED|38 mm Length Group|This sub-study completed the primary endpoint in March 2012 results not yet available.|111
10402836|NCT00726453|11547124|FG000|NOT COMPLETED|38 mm Length Group||0
10402837|NCT00726453|11547125|FG001|NOT COMPLETED|38 mm Length Group||3
10402838|NCT00726557|11547130|FG000|STARTED|Overall Study||246
10402839|NCT00726557|11547130|FG000|COMPLETED|Overall Study|Completed is defined as those who finished the follow-up period.|118
10402840|NCT00726557|11547130|FG000|NOT COMPLETED|Overall Study||128
10402841|NCT00726609|11547135|FG000|STARTED|Overall Study||214
10402842|NCT00726609|11547135|FG000|COMPLETED|Overall Study|For 26 participants in the Missing category, it is unknown if they completed the study.|116
10402843|NCT00726609|11547135|FG000|NOT COMPLETED|Overall Study||98
10402844|NCT00726622|11547141|FG000|STARTED|Overall Study||243
10402845|NCT00726622|11547142|FG001|STARTED|Overall Study||243
10402846|NCT00726622|11547141|FG000|COMPLETED|Overall Study||225
10402847|NCT00726622|11547142|FG001|COMPLETED|Overall Study||240
10402848|NCT00726622|11547141|FG000|NOT COMPLETED|Overall Study||18
10402849|NCT00726622|11547142|FG001|NOT COMPLETED|Overall Study||3
10402850|NCT00726661|11547150|FG000|STARTED|Overall Study||832
10402851|NCT00726661|11547151|FG001|STARTED|Overall Study||435
10402852|NCT00726661|11547150|FG000|COMPLETED|Overall Study||18
10402853|NCT00726661|11547151|FG001|COMPLETED|Overall Study||17
10402854|NCT00726661|11547150|FG000|NOT COMPLETED|Overall Study||814
10402855|NCT00726661|11547151|FG001|NOT COMPLETED|Overall Study||418
10402856|NCT00726713|11547160|FG000|STARTED|Overall Study||106
10402857|NCT00726713|11547161|FG001|STARTED|Overall Study||108
10402858|NCT00726713|11547160|FG000|COMPLETED|Overall Study||99
10402859|NCT00726713|11547161|FG001|COMPLETED|Overall Study||101
10402860|NCT00726713|11547160|FG000|NOT COMPLETED|Overall Study||7
10402861|NCT00726713|11547161|FG001|NOT COMPLETED|Overall Study||7
10402862|NCT00726739|11547170|FG000|STARTED|Overall Study||11
10402863|NCT00726739|11547171|FG001|STARTED|Overall Study||10
10660213|NCT02248818|11821781|FG001|NOT COMPLETED|Screening||0
10660214|NCT02248818|11821782|FG002|NOT COMPLETED|Screening||0
10660215|NCT02248818|11821783|FG003|NOT COMPLETED|Screening||0
10660216|NCT02248818|11821784|FG004|NOT COMPLETED|Screening||0
10660217|NCT02248818|11821785|FG005|NOT COMPLETED|Screening||0
10660218|NCT02248818|11821786|FG006|NOT COMPLETED|Screening||0
10660219|NCT02248818|11821787|FG007|NOT COMPLETED|Screening||0
10660220|NCT02248818|11821788|FG008|NOT COMPLETED|Screening||107
10660221|NCT02248818|11821780|FG000|STARTED|Randomised Study||6
10660222|NCT02248818|11821781|FG001|STARTED|Randomised Study||6
10660223|NCT02248818|11821782|FG002|STARTED|Randomised Study||6
10660224|NCT02248818|11821783|FG003|STARTED|Randomised Study||6
10660225|NCT02248818|11821784|FG004|STARTED|Randomised Study||6
10660226|NCT02248818|11821785|FG005|STARTED|Randomised Study||8
10660227|NCT02248818|11821786|FG006|STARTED|Randomised Study||6
10660228|NCT02248818|11821787|FG007|STARTED|Randomised Study||4
10660229|NCT02248818|11821788|FG008|STARTED|Randomised Study||0
10402864|NCT00726739|11547170|FG000|COMPLETED|Overall Study|1 patient failed during screening due to brain metastasis.|10
10402865|NCT00726739|11547171|FG001|COMPLETED|Overall Study||10
10402866|NCT00726739|11547170|FG000|NOT COMPLETED|Overall Study||1
10402867|NCT00726739|11547171|FG001|NOT COMPLETED|Overall Study||0
10402868|NCT00726752|11547178|FG000|STARTED|Overall Study||6
10402869|NCT00726752|11547178|FG000|COMPLETED|Overall Study||0
10402870|NCT00726752|11547178|FG000|NOT COMPLETED|Overall Study||6
10660230|NCT02248818|11821780|FG000|COMPLETED|Randomised Study||6
10660231|NCT02248818|11821781|FG001|COMPLETED|Randomised Study||6
10660232|NCT02248818|11821782|FG002|COMPLETED|Randomised Study||6
10660233|NCT02248818|11821783|FG003|COMPLETED|Randomised Study||6
10660234|NCT02248818|11821784|FG004|COMPLETED|Randomised Study||6
10660235|NCT02248818|11821785|FG005|COMPLETED|Randomised Study||0
10660236|NCT02248818|11821786|FG006|COMPLETED|Randomised Study||6
10660237|NCT02248818|11821787|FG007|COMPLETED|Randomised Study||4
10660238|NCT02248818|11821788|FG008|COMPLETED|Randomised Study||0
10660239|NCT02248818|11821780|FG000|NOT COMPLETED|Randomised Study||0
10660240|NCT02248818|11821781|FG001|NOT COMPLETED|Randomised Study||0
10660241|NCT02248818|11821782|FG002|NOT COMPLETED|Randomised Study||0
10660242|NCT02248818|11821783|FG003|NOT COMPLETED|Randomised Study||0
10721495|NCT02726620|11885148|FG001|Correct IOH Notifications|Month 1: Attending Randomization||313
10660243|NCT02248818|11821784|FG004|NOT COMPLETED|Randomised Study||0
10402871|NCT00726882|11547182|FG000|STARTED|Overall Study||35
10660244|NCT02248818|11821785|FG005|NOT COMPLETED|Randomised Study||8
10660245|NCT02248818|11821786|FG006|NOT COMPLETED|Randomised Study||0
10660246|NCT02248818|11821787|FG007|NOT COMPLETED|Randomised Study||0
10660247|NCT02248818|11821788|FG008|NOT COMPLETED|Randomised Study||0
10402872|NCT00726882|11547182|FG000|Received ABT-333 in Study M10-380|Overall Study|Participants who received ABT-333 (and not placebo) in previous study (NCT00851890/M10-380).|22
10402873|NCT00726882|11547182|FG000|Received ABT-333 in Study M10-351|Overall Study|Participants who received ABT-333 (and not placebo) in previous study (NCT00696904/M10-351).|6
10402874|NCT00726882|11547182|FG000|COMPLETED|Overall Study||13
10402875|NCT00726882|11547182|FG000|NOT COMPLETED|Overall Study||22
10402876|NCT00726895|11547188|FG000|STARTED|First Intervention||12
10402877|NCT00726895|11547189|FG001|STARTED|First Intervention||12
10402878|NCT00726895|11547188|FG000|COMPLETED|First Intervention||12
10402879|NCT00726895|11547189|FG001|COMPLETED|First Intervention||12
10402880|NCT00726895|11547188|FG000|NOT COMPLETED|First Intervention||0
10660248|NCT02248857|11821809|FG000|STARTED|Baseline||157
10660249|NCT02248857|11821810|FG001|STARTED|Baseline||168
10660250|NCT02248857|11821811|FG002|STARTED|Baseline||127
10660251|NCT02248857|11821809|FG000|COMPLETED|Baseline||157
10660252|NCT02248857|11821810|FG001|COMPLETED|Baseline||168
10660253|NCT02248857|11821811|FG002|COMPLETED|Baseline||127
10721496|NCT02726620|11885147|FG000|COMPLETED|Month 1: Attending Randomization||0
10721497|NCT02726620|11885148|FG001|COMPLETED|Month 1: Attending Randomization||485
10721498|NCT02726620|11885147|FG000|NOT COMPLETED|Month 1: Attending Randomization||0
10721499|NCT02726620|11885148|FG001|NOT COMPLETED|Month 1: Attending Randomization||0
10721500|NCT02726620|11885147|FG000|STARTED|Months 2-3: In-room Providers Randomized||0
10721501|NCT02726620|11885148|FG001|STARTED|Months 2-3: In-room Providers Randomized||1253
10721502|NCT02726620|11885147|FG000|MAP < 65 mmHg: Primary Analysis|Months 2-3: In-room Providers Randomized||0
10721503|NCT02726620|11885148|FG001|MAP < 65 mmHg: Primary Analysis|Months 2-3: In-room Providers Randomized||1103
10721504|NCT02726620|11885147|FG000|Correct IOH Notifications|Months 2-3: In-room Providers Randomized||0
10721505|NCT02726620|11885148|FG001|Correct IOH Notifications|Months 2-3: In-room Providers Randomized||825
10721506|NCT02726620|11885147|FG000|COMPLETED|Months 2-3: In-room Providers Randomized||0
10721507|NCT02726620|11885148|FG001|COMPLETED|Months 2-3: In-room Providers Randomized||1253
10721508|NCT02726620|11885147|FG000|NOT COMPLETED|Months 2-3: In-room Providers Randomized||0
10721509|NCT02726620|11885148|FG001|NOT COMPLETED|Months 2-3: In-room Providers Randomized||0
10721510|NCT02726620|11885147|FG000|STARTED|Through End of Study: All Interventions||0
10721511|NCT02726620|11885148|FG001|STARTED|Through End of Study: All Interventions||3234
10721512|NCT02726620|11885147|FG000|MAP < 65 mmHg: Primary Analysis|Through End of Study: All Interventions||0
10721513|NCT02726620|11885148|FG001|MAP < 65 mmHg: Primary Analysis|Through End of Study: All Interventions||2793
10721514|NCT02726620|11885147|FG000|Correct IOH Notifications|Through End of Study: All Interventions||0
10721515|NCT02726620|11885148|FG001|Correct IOH Notifications|Through End of Study: All Interventions||2072
10721516|NCT02726620|11885147|FG000|COMPLETED|Through End of Study: All Interventions||0
10721517|NCT02726620|11885148|FG001|COMPLETED|Through End of Study: All Interventions||3234
10721518|NCT02726620|11885147|FG000|NOT COMPLETED|Through End of Study: All Interventions||0
10721519|NCT02726620|11885148|FG001|NOT COMPLETED|Through End of Study: All Interventions||0
10721520|NCT02726789|11885154|FG000|STARTED|Overall Study||5
10721521|NCT02726789|11885154|FG000|COMPLETED|Overall Study||5
10721522|NCT02726789|11885154|FG000|NOT COMPLETED|Overall Study||0
10721523|NCT02726945|11885162|FG000|STARTED|Overall Study||13
10721524|NCT02726945|11885163|FG001|STARTED|Overall Study||13
10721525|NCT02726945|11885164|FG002|STARTED|Overall Study||13
10721526|NCT02726945|11885162|FG000|COMPLETED|Overall Study||13
10721527|NCT02726945|11885163|FG001|COMPLETED|Overall Study||12
10721528|NCT02726945|11885164|FG002|COMPLETED|Overall Study||12
10721529|NCT02726945|11885162|FG000|NOT COMPLETED|Overall Study||0
10721530|NCT02726945|11885163|FG001|NOT COMPLETED|Overall Study||1
10721531|NCT02726945|11885164|FG002|NOT COMPLETED|Overall Study||1
10721532|NCT02726971|11885174|FG000|STARTED|Overall Study||70
10721533|NCT02726971|11885175|FG001|STARTED|Overall Study||71
10721534|NCT02726971|11885174|FG000|COMPLETED|Overall Study||59
10721535|NCT02726971|11885175|FG001|COMPLETED|Overall Study||62
10721536|NCT02726971|11885174|FG000|NOT COMPLETED|Overall Study||11
10721537|NCT02726971|11885175|FG001|NOT COMPLETED|Overall Study||9
10721538|NCT02727192|11885183|FG000|STARTED|Overall Study||54
10721539|NCT02727192|11885184|FG001|STARTED|Overall Study||54
10721540|NCT02727192|11885185|FG002|STARTED|Overall Study||1
10721541|NCT02727192|11885183|FG000|COMPLETED|Overall Study||53
10721542|NCT02727192|11885184|FG001|COMPLETED|Overall Study||54
10721543|NCT02727192|11885185|FG002|COMPLETED|Overall Study||1
10721544|NCT02727192|11885183|FG000|NOT COMPLETED|Overall Study||1
10721545|NCT02727192|11885184|FG001|NOT COMPLETED|Overall Study||0
10721546|NCT02727192|11885185|FG002|NOT COMPLETED|Overall Study||0
10721547|NCT02727322|11885194|FG000|STARTED|Overall Study||77
10721548|NCT02727322|11885195|FG001|STARTED|Overall Study||77
10721549|NCT02727322|11885194|FG000|COMPLETED|Overall Study||75
10721550|NCT02727322|11885195|FG001|COMPLETED|Overall Study||76
10721551|NCT02727322|11885194|FG000|NOT COMPLETED|Overall Study||2
10721552|NCT02727322|11885195|FG001|NOT COMPLETED|Overall Study||1
10721553|NCT02727660|11885208|FG000|STARTED|Overall Study||619
10721554|NCT02727660|11885209|FG001|STARTED|Overall Study||617
10721555|NCT02727660|11885210|FG002|STARTED|Overall Study||607
10721556|NCT02727660|11885208|FG000|COMPLETED|Overall Study||503
10721557|NCT02727660|11885209|FG001|COMPLETED|Overall Study||501
10721558|NCT02727660|11885210|FG002|COMPLETED|Overall Study||442
10721559|NCT02727660|11885208|FG000|NOT COMPLETED|Overall Study||116
10402881|NCT00726895|11547189|FG001|NOT COMPLETED|First Intervention||0
10402882|NCT00726895|11547188|FG000|STARTED|Washout Period of 7 Days||12
10402883|NCT00726895|11547189|FG001|STARTED|Washout Period of 7 Days||12
10402884|NCT00726895|11547188|FG000|COMPLETED|Washout Period of 7 Days||12
10402885|NCT00726895|11547189|FG001|COMPLETED|Washout Period of 7 Days||11
10402886|NCT00726895|11547188|FG000|NOT COMPLETED|Washout Period of 7 Days||0
10402887|NCT00726895|11547189|FG001|NOT COMPLETED|Washout Period of 7 Days||1
10402888|NCT00726895|11547188|FG000|STARTED|Second Intervention||12
10402889|NCT00726895|11547189|FG001|STARTED|Second Intervention||11
10402890|NCT00726895|11547188|FG000|COMPLETED|Second Intervention||12
10402891|NCT00726895|11547189|FG001|COMPLETED|Second Intervention||11
10402892|NCT00726895|11547188|FG000|NOT COMPLETED|Second Intervention||0
10402893|NCT00726895|11547189|FG001|NOT COMPLETED|Second Intervention||0
10402894|NCT00726986|11547196|FG000|STARTED|Induction Phase||18
10402895|NCT00726986|11547196|FG000|Maintance|Induction Phase||3
10402896|NCT00726986|11547196|FG000|COMPLETED|Induction Phase||3
10402897|NCT00726986|11547196|FG000|NOT COMPLETED|Induction Phase||15
10402898|NCT00726986|11547196|FG000|STARTED|Maintenance Phase||3
10402899|NCT00726986|11547196|FG000|COMPLETED|Maintenance Phase||0
10402900|NCT00726986|11547196|FG000|NOT COMPLETED|Maintenance Phase||3
10402901|NCT00726999|11547202|FG000|STARTED|Overall Study||32
10402902|NCT00726999|11547203|FG001|STARTED|Overall Study||31
10402903|NCT00726999|11547202|FG000|COMPLETED|Overall Study||29
10402904|NCT00726999|11547203|FG001|COMPLETED|Overall Study||30
10402905|NCT00726999|11547202|FG000|NOT COMPLETED|Overall Study||3
10402906|NCT00726999|11547203|FG001|NOT COMPLETED|Overall Study||1
10402907|NCT00727025|11547211|FG000|STARTED|Overall Study||74
10402908|NCT00727025|11547211|FG000|COMPLETED|Overall Study||51
10402909|NCT00727025|11547211|FG000|NOT COMPLETED|Overall Study||23
10402910|NCT00727064|11547221|FG000|STARTED|Overall Study||7
10402911|NCT00727064|11547222|FG001|STARTED|Overall Study||7
10402912|NCT00727064|11547221|FG000|COMPLETED|Overall Study||7
10402913|NCT00727064|11547222|FG001|COMPLETED|Overall Study||7
10402914|NCT00727064|11547221|FG000|NOT COMPLETED|Overall Study||0
10402915|NCT00727064|11547222|FG001|NOT COMPLETED|Overall Study||0
10402916|NCT00727194|11547228|FG000|STARTED|Screening Period||7
10402917|NCT00727194|11547229|FG001|STARTED|Screening Period||7
10402918|NCT00727194|11547230|FG002|STARTED|Screening Period||16
10402919|NCT00727194|11547228|FG000|COMPLETED|Screening Period||7
10402920|NCT00727194|11547229|FG001|COMPLETED|Screening Period||7
10402921|NCT00727194|11547230|FG002|COMPLETED|Screening Period||0
10402922|NCT00727194|11547228|FG000|NOT COMPLETED|Screening Period||0
10402923|NCT00727194|11547229|FG001|NOT COMPLETED|Screening Period||0
10402924|NCT00727194|11547230|FG002|NOT COMPLETED|Screening Period||16
10402925|NCT00727194|11547228|FG000|STARTED|Treatment Period 1||7
10402926|NCT00727194|11547229|FG001|STARTED|Treatment Period 1||7
10402927|NCT00727194|11547230|FG002|STARTED|Treatment Period 1||0
10402928|NCT00727194|11547228|FG000|COMPLETED|Treatment Period 1||7
10402929|NCT00727194|11547229|FG001|COMPLETED|Treatment Period 1||7
10402930|NCT00727194|11547230|FG002|COMPLETED|Treatment Period 1||0
10402931|NCT00727194|11547228|FG000|NOT COMPLETED|Treatment Period 1||0
10402932|NCT00727194|11547229|FG001|NOT COMPLETED|Treatment Period 1||0
10402933|NCT00727194|11547230|FG002|NOT COMPLETED|Treatment Period 1||0
10402934|NCT00727194|11547228|FG000|STARTED|Washout Period||7
10402935|NCT00727194|11547229|FG001|STARTED|Washout Period||7
10402936|NCT00727194|11547230|FG002|STARTED|Washout Period||0
10402937|NCT00727194|11547228|FG000|COMPLETED|Washout Period||7
10402938|NCT00727194|11547229|FG001|COMPLETED|Washout Period||7
10402939|NCT00727194|11547230|FG002|COMPLETED|Washout Period||0
10402940|NCT00727194|11547228|FG000|NOT COMPLETED|Washout Period||0
10402941|NCT00727194|11547229|FG001|NOT COMPLETED|Washout Period||0
10402942|NCT00727194|11547230|FG002|NOT COMPLETED|Washout Period||0
10402943|NCT00727194|11547228|FG000|STARTED|Treatment Period 2|Sponsor terminated study early; 2 patients (total) exited study without starting Treatment Period 2.|6
10402944|NCT00727194|11547229|FG001|STARTED|Treatment Period 2|Sponsor terminated study early; 2 patients (total) exited study without starting Treatment Period 2.|6
10402945|NCT00727194|11547230|FG002|STARTED|Treatment Period 2||0
10402946|NCT00727194|11547228|FG000|COMPLETED|Treatment Period 2||6
10402947|NCT00727194|11547229|FG001|COMPLETED|Treatment Period 2||5
10402948|NCT00727194|11547230|FG002|COMPLETED|Treatment Period 2||0
10402949|NCT00727194|11547228|FG000|NOT COMPLETED|Treatment Period 2||0
10402950|NCT00727194|11547229|FG001|NOT COMPLETED|Treatment Period 2||1
10402951|NCT00727194|11547230|FG002|NOT COMPLETED|Treatment Period 2||0
10402952|NCT00727220|11547246|FG000|STARTED|Overall Study||21
10402953|NCT00727220|11547247|FG001|STARTED|Overall Study||21
10402954|NCT00727220|11547246|FG000|COMPLETED|Overall Study||20
10402955|NCT00727220|11547247|FG001|COMPLETED|Overall Study||17
10402956|NCT00727220|11547246|FG000|NOT COMPLETED|Overall Study||1
10402957|NCT00727220|11547247|FG001|NOT COMPLETED|Overall Study||4
10402958|NCT00727246|11547257|FG000|STARTED|Overall Study||3
10402959|NCT00727246|11547258|FG001|STARTED|Overall Study||3
10402960|NCT00727246|11547259|FG002|STARTED|Overall Study||8
10402961|NCT00727246|11547260|FG003|STARTED|Overall Study||5
10402962|NCT00727246|11547257|FG000|COMPLETED|Overall Study||3
10402963|NCT00727246|11547258|FG001|COMPLETED|Overall Study||2
10402964|NCT00727246|11547259|FG002|COMPLETED|Overall Study||7
10402965|NCT00727246|11547260|FG003|COMPLETED|Overall Study||3
10402966|NCT00727246|11547257|FG000|NOT COMPLETED|Overall Study||0
10402967|NCT00727246|11547258|FG001|NOT COMPLETED|Overall Study||1
10402968|NCT00727246|11547259|FG002|NOT COMPLETED|Overall Study||1
10402969|NCT00727246|11547260|FG003|NOT COMPLETED|Overall Study||2
10402970|NCT00727259|11547270|FG000|STARTED|Overall Study||1995
10402971|NCT00727259|11547270|FG000|COMPLETED|Overall Study||940
10402972|NCT00727259|11547270|FG000|NOT COMPLETED|Overall Study||1055
10660254|NCT02248857|11821809|FG000|NOT COMPLETED|Baseline||0
10660255|NCT02248857|11821810|FG001|NOT COMPLETED|Baseline||0
10660256|NCT02248857|11821811|FG002|NOT COMPLETED|Baseline||0
10660257|NCT02248857|11821809|FG000|STARTED|3 Month||157
10660258|NCT02248857|11821810|FG001|STARTED|3 Month||168
10660259|NCT02248857|11821811|FG002|STARTED|3 Month||127
10660260|NCT02248857|11821809|FG000|COMPLETED|3 Month||111
10660261|NCT02248857|11821810|FG001|COMPLETED|3 Month||134
10660262|NCT02248857|11821811|FG002|COMPLETED|3 Month||96
10660263|NCT02248857|11821809|FG000|NOT COMPLETED|3 Month||46
10660264|NCT02248857|11821810|FG001|NOT COMPLETED|3 Month||34
10660265|NCT02248857|11821811|FG002|NOT COMPLETED|3 Month||31
10660266|NCT02248857|11821809|FG000|STARTED|6 Month|157 baseline - 9 who withdrew = 148|148
10660267|NCT02248857|11821810|FG001|STARTED|6 Month|168 baseline - 3 who withdrew = 165|165
10660268|NCT02248857|11821811|FG002|STARTED|6 Month|127 baseline - 4 who withdrew = 123|123
10660269|NCT02248857|11821809|FG000|COMPLETED|6 Month||120
10660270|NCT02248857|11821810|FG001|COMPLETED|6 Month||136
10660271|NCT02248857|11821811|FG002|COMPLETED|6 Month||106
10660272|NCT02248857|11821809|FG000|NOT COMPLETED|6 Month||28
10660273|NCT02248857|11821810|FG001|NOT COMPLETED|6 Month||29
10660274|NCT02248857|11821811|FG002|NOT COMPLETED|6 Month||17
10660275|NCT02248922|11821821|FG000|STARTED|Overall Study||5
10660276|NCT02248922|11821822|FG001|STARTED|Overall Study||12
10660277|NCT02248922|11821821|FG000|COMPLETED|Overall Study||5
10660278|NCT02248922|11821822|FG001|COMPLETED|Overall Study||12
10660279|NCT02248922|11821821|FG000|NOT COMPLETED|Overall Study||0
10660280|NCT02248922|11821822|FG001|NOT COMPLETED|Overall Study||0
10660281|NCT02248961|11821829|FG000|STARTED|Overall Study||89
10660282|NCT02248961|11821830|FG001|STARTED|Overall Study||90
10660283|NCT02248961|11821829|FG000|COMPLETED|Overall Study||86
10660284|NCT02248961|11821830|FG001|COMPLETED|Overall Study||88
10660285|NCT02248961|11821829|FG000|NOT COMPLETED|Overall Study||3
10660286|NCT02248961|11821830|FG001|NOT COMPLETED|Overall Study||2
10660287|NCT02248974|11821838|FG000|STARTED|Baseline||47
10660288|NCT02248974|11821839|FG001|STARTED|Baseline||51
10660289|NCT02248974|11821838|FG000|COMPLETED|Baseline||47
10660290|NCT02248974|11821839|FG001|COMPLETED|Baseline||51
10660291|NCT02248974|11821838|FG000|NOT COMPLETED|Baseline||0
10660292|NCT02248974|11821839|FG001|NOT COMPLETED|Baseline||0
10660293|NCT02248974|11821838|FG000|STARTED|1-Day Follow-Up||47
10660294|NCT02248974|11821839|FG001|STARTED|1-Day Follow-Up|"No DA group did not receive 1-Day Follow-up survey."|0
10660295|NCT02248974|11821838|FG000|COMPLETED|1-Day Follow-Up||37
10660296|NCT02248974|11821839|FG001|COMPLETED|1-Day Follow-Up|"No DA group did not receive 1-Day Follow-up survey."|0
10660297|NCT02248974|11821838|FG000|NOT COMPLETED|1-Day Follow-Up||10
10660298|NCT02248974|11821839|FG001|NOT COMPLETED|1-Day Follow-Up||0
10660299|NCT02248974|11821838|FG000|STARTED|1-Week Follow-Up||37
10660300|NCT02248974|11821839|FG001|STARTED|1-Week Follow-Up||51
10660301|NCT02248974|11821838|FG000|COMPLETED|1-Week Follow-Up||29
10660302|NCT02248974|11821839|FG001|COMPLETED|1-Week Follow-Up||34
10660303|NCT02248974|11821838|FG000|NOT COMPLETED|1-Week Follow-Up||8
10660304|NCT02248974|11821839|FG001|NOT COMPLETED|1-Week Follow-Up||17
10660305|NCT02248974|11821838|FG000|STARTED|1-Month Follow-Up||29
10660306|NCT02248974|11821839|FG001|STARTED|1-Month Follow-Up||34
10660307|NCT02248974|11821838|FG000|COMPLETED|1-Month Follow-Up||27
10660308|NCT02248974|11821839|FG001|COMPLETED|1-Month Follow-Up||31
10660309|NCT02248974|11821838|FG000|NOT COMPLETED|1-Month Follow-Up||2
10721560|NCT02727660|11885209|FG001|NOT COMPLETED|Overall Study||116
10721561|NCT02727660|11885210|FG002|NOT COMPLETED|Overall Study||165
10721562|NCT02727751|11885218|FG000|STARTED|Overall Study||312
10721563|NCT02727751|11885218|FG000|COMPLETED|Overall Study||262
10721564|NCT02727751|11885218|FG000|NOT COMPLETED|Overall Study||50
10721565|NCT02727777|11885225|FG000|STARTED|Overall Study||4
10721566|NCT02727777|11885226|FG001|STARTED|Overall Study||0
10402973|NCT00727272|11547275|FG000|STARTED|Period I||9
10402974|NCT00727272|11547276|FG001|STARTED|Period I||9
10402975|NCT00727272|11547277|FG002|STARTED|Period I||9
10402976|NCT00727272|11547275|FG000|COMPLETED|Period I||9
10402977|NCT00727272|11547276|FG001|COMPLETED|Period I||9
10402978|NCT00727272|11547277|FG002|COMPLETED|Period I||9
10402979|NCT00727272|11547275|FG000|NOT COMPLETED|Period I||0
10660310|NCT02248974|11821839|FG001|NOT COMPLETED|1-Month Follow-Up||3
10660311|NCT02249052|11821845|FG000|STARTED|Overall Study||19
10660312|NCT02249052|11821845|FG000|COMPLETED|Overall Study||19
10660313|NCT02249052|11821845|FG000|NOT COMPLETED|Overall Study||0
10660318|NCT02249091|11821859|FG000|STARTED|Overall Study||27
10660319|NCT02249091|11821860|FG001|STARTED|Overall Study||15
10660320|NCT02249091|11821859|FG000|COMPLETED|Overall Study||7
10660321|NCT02249091|11821860|FG001|COMPLETED|Overall Study||2
10660322|NCT02249091|11821859|FG000|NOT COMPLETED|Overall Study||20
10660323|NCT02249091|11821860|FG001|NOT COMPLETED|Overall Study||13
10721567|NCT02727777|11885227|FG002|STARTED|Overall Study||0
10402980|NCT00727272|11547276|FG001|NOT COMPLETED|Period I||0
10402981|NCT00727272|11547277|FG002|NOT COMPLETED|Period I||0
10402982|NCT00727272|11547275|FG000|STARTED|Washout Period A||9
10402983|NCT00727272|11547276|FG001|STARTED|Washout Period A||9
10402984|NCT00727272|11547277|FG002|STARTED|Washout Period A||9
10402985|NCT00727272|11547275|FG000|COMPLETED|Washout Period A||9
10402986|NCT00727272|11547276|FG001|COMPLETED|Washout Period A||9
10402987|NCT00727272|11547277|FG002|COMPLETED|Washout Period A|positive pregnancy test - recorded as an adverse event|8
10402988|NCT00727272|11547275|FG000|NOT COMPLETED|Washout Period A||0
10402989|NCT00727272|11547276|FG001|NOT COMPLETED|Washout Period A||0
10402990|NCT00727272|11547277|FG002|NOT COMPLETED|Washout Period A||1
10402991|NCT00727272|11547275|FG000|STARTED|Period II||9
10402992|NCT00727272|11547276|FG001|STARTED|Period II||9
10402993|NCT00727272|11547277|FG002|STARTED|Period II||8
10402994|NCT00727272|11547275|FG000|COMPLETED|Period II||9
10402995|NCT00727272|11547276|FG001|COMPLETED|Period II||9
10402996|NCT00727272|11547277|FG002|COMPLETED|Period II||8
10660327|NCT02249143|11821872|FG000|STARTED|Overall Study||24
10660328|NCT02249143|11821873|FG001|STARTED|Overall Study|randomized|26
10660329|NCT02249143|11821872|FG000|COMPLETED|Overall Study|with technically acceptable pulmonary function tests in the neonatal intensive care unit|22
10660330|NCT02249143|11821873|FG001|COMPLETED|Overall Study|with technically acceptable pulmonary function tests in the neonatal intensive care unit|22
10660331|NCT02249143|11821872|FG000|NOT COMPLETED|Overall Study||2
10660332|NCT02249143|11821873|FG001|NOT COMPLETED|Overall Study||4
10660333|NCT02249182|11821884|FG000|STARTED|PK Lead-In Phase||10
10660334|NCT02249182|11821885|FG001|STARTED|PK Lead-In Phase||12
10660335|NCT02249182|11821886|FG002|STARTED|PK Lead-In Phase||0
10660336|NCT02249182|11821887|FG003|STARTED|PK Lead-In Phase||0
10660337|NCT02249182|11821888|FG004|STARTED|PK Lead-In Phase||17
10660338|NCT02249182|11821884|FG000|COMPLETED|PK Lead-In Phase||10
10660339|NCT02249182|11821885|FG001|COMPLETED|PK Lead-In Phase||12
10660340|NCT02249182|11821886|FG002|COMPLETED|PK Lead-In Phase||0
10660341|NCT02249182|11821887|FG003|COMPLETED|PK Lead-In Phase||0
10660342|NCT02249182|11821888|FG004|COMPLETED|PK Lead-In Phase||17
10660343|NCT02249182|11821884|FG000|NOT COMPLETED|PK Lead-In Phase||0
10660344|NCT02249182|11821885|FG001|NOT COMPLETED|PK Lead-In Phase||0
10660345|NCT02249182|11821886|FG002|NOT COMPLETED|PK Lead-In Phase||0
10660346|NCT02249182|11821887|FG003|NOT COMPLETED|PK Lead-In Phase||0
10660347|NCT02249182|11821888|FG004|NOT COMPLETED|PK Lead-In Phase||0
10660348|NCT02249182|11821884|FG000|STARTED|Treatment Phase|90 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|100
10660349|NCT02249182|11821885|FG001|STARTED|Treatment Phase|77 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|89
10660350|NCT02249182|11821886|FG002|STARTED|Treatment Phase|1 participant enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|1
10660351|NCT02249182|11821887|FG003|STARTED|Treatment Phase|2 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|2
10660352|NCT02249182|11821888|FG004|STARTED|Treatment Phase|17 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|34
10660353|NCT02249182|11821884|FG000|COMPLETED|Treatment Phase||96
10660354|NCT02249182|11821885|FG001|COMPLETED|Treatment Phase||89
10660355|NCT02249182|11821886|FG002|COMPLETED|Treatment Phase||1
10660356|NCT02249182|11821887|FG003|COMPLETED|Treatment Phase||2
10660357|NCT02249182|11821888|FG004|COMPLETED|Treatment Phase||34
10660358|NCT02249182|11821884|FG000|NOT COMPLETED|Treatment Phase||4
10660359|NCT02249182|11821885|FG001|NOT COMPLETED|Treatment Phase||0
10660360|NCT02249182|11821886|FG002|NOT COMPLETED|Treatment Phase||0
10660361|NCT02249182|11821887|FG003|NOT COMPLETED|Treatment Phase||0
10660362|NCT02249182|11821888|FG004|NOT COMPLETED|Treatment Phase||0
10660363|NCT02249585|11821916|FG000|STARTED|Overall Study||43
10660364|NCT02249585|11821917|FG001|STARTED|Overall Study||44
10660365|NCT02249585|11821918|FG002|STARTED|Overall Study||44
10660366|NCT02249585|11821916|FG000|COMPLETED|Overall Study||43
10660367|NCT02249585|11821917|FG001|COMPLETED|Overall Study||44
10660368|NCT02249585|11821918|FG002|COMPLETED|Overall Study||44
10660369|NCT02249585|11821916|FG000|NOT COMPLETED|Overall Study||0
10660370|NCT02249585|11821917|FG001|NOT COMPLETED|Overall Study||0
10660371|NCT02249585|11821918|FG002|NOT COMPLETED|Overall Study||0
10660372|NCT02249728|11821926|FG000|STARTED|Part One (4 Days)||6
10660373|NCT02249728|11821926|FG000|COMPLETED|Part One (4 Days)||6
10660374|NCT02249728|11821926|FG000|NOT COMPLETED|Part One (4 Days)||0
10660375|NCT02249728|11821926|FG000|STARTED|Part Two (up to 6 Days)||6
10660376|NCT02249728|11821926|FG000|COMPLETED|Part Two (up to 6 Days)||6
10660377|NCT02249728|11821926|FG000|NOT COMPLETED|Part Two (up to 6 Days)||0
10660378|NCT02249767|11821936|FG000|STARTED|Overall Study||230
10660379|NCT02249767|11821937|FG001|STARTED|Overall Study||229
10660380|NCT02249767|11821938|FG002|STARTED|Overall Study||115
10660381|NCT02249767|11821936|FG000|COMPLETED|Overall Study||222
10660382|NCT02249767|11821937|FG001|COMPLETED|Overall Study||220
10660383|NCT02249767|11821938|FG002|COMPLETED|Overall Study||107
10660384|NCT02249767|11821936|FG000|NOT COMPLETED|Overall Study||8
10660385|NCT02249767|11821937|FG001|NOT COMPLETED|Overall Study||9
10660386|NCT02249767|11821938|FG002|NOT COMPLETED|Overall Study||8
10402997|NCT00727272|11547275|FG000|NOT COMPLETED|Period II||0
10660387|NCT02249793|11821946|FG000|STARTED|Session 1, 48-hours Healthy Volunteers||6
10660388|NCT02249793|11821946|FG000|COMPLETED|Session 1, 48-hours Healthy Volunteers||6
10660389|NCT02249793|11821946|FG000|NOT COMPLETED|Session 1, 48-hours Healthy Volunteers||0
10660390|NCT02249793|11821946|FG000|STARTED|Session 2, 48-Hours Healthy Volunteers||6
10660391|NCT02249793|11821946|FG000|COMPLETED|Session 2, 48-Hours Healthy Volunteers||6
10721568|NCT02727777|11885225|FG000|COMPLETED|Overall Study||0
10721569|NCT02727777|11885226|FG001|COMPLETED|Overall Study||0
10402998|NCT00727272|11547276|FG001|NOT COMPLETED|Period II||0
10402999|NCT00727272|11547277|FG002|NOT COMPLETED|Period II||0
10403000|NCT00727272|11547275|FG000|STARTED|Washout Period B||9
10403001|NCT00727272|11547276|FG001|STARTED|Washout Period B||9
10403002|NCT00727272|11547277|FG002|STARTED|Washout Period B||8
10660392|NCT02249793|11821946|FG000|NOT COMPLETED|Session 2, 48-Hours Healthy Volunteers||0
10660393|NCT02249819|11821951|FG000|STARTED|Overall Study||8
10660394|NCT02249819|11821952|FG001|STARTED|Overall Study||7
10660395|NCT02249819|11821951|FG000|COMPLETED|Overall Study||8
10660396|NCT02249819|11821952|FG001|COMPLETED|Overall Study||7
10660397|NCT02249819|11821951|FG000|NOT COMPLETED|Overall Study||0
10660398|NCT02249819|11821952|FG001|NOT COMPLETED|Overall Study||0
10660399|NCT02249832|11821958|FG000|STARTED|Overall Study||55
10660400|NCT02249832|11821958|FG000|COMPLETED|Overall Study||42
10660401|NCT02249832|11821958|FG000|NOT COMPLETED|Overall Study||13
10660402|NCT02249949|11821967|FG000|STARTED|Overall Study||13
10660403|NCT02249949|11821967|FG000|COMPLETED|Overall Study||11
10660404|NCT02249949|11821967|FG000|NOT COMPLETED|Overall Study||2
10660405|NCT02250092|11821973|FG000|STARTED|Overall Study||10
10660406|NCT02250092|11821974|FG001|STARTED|Overall Study||10
10660407|NCT02250092|11821973|FG000|COMPLETED|Overall Study||10
10660408|NCT02250092|11821974|FG001|COMPLETED|Overall Study||10
10660409|NCT02250092|11821973|FG000|NOT COMPLETED|Overall Study||0
10660410|NCT02250092|11821974|FG001|NOT COMPLETED|Overall Study||0
10660411|NCT02250183|11821980|FG000|STARTED|Overall Study||21
10660412|NCT02250183|11821980|FG000|COMPLETED|Overall Study||13
10660413|NCT02250183|11821980|FG000|NOT COMPLETED|Overall Study||8
10660414|NCT02250274|11821989|FG000|STARTED|Overall Study||85
10660415|NCT02250274|11821990|FG001|STARTED|Overall Study||46
10660416|NCT02250274|11821989|FG000|COMPLETED|Overall Study||78
10660417|NCT02250274|11821990|FG001|COMPLETED|Overall Study||40
10660418|NCT02250274|11821989|FG000|NOT COMPLETED|Overall Study||7
10660419|NCT02250274|11821990|FG001|NOT COMPLETED|Overall Study||6
10660420|NCT02250417|11822002|FG000|STARTED|First Intervention (1 Night)||6
10721570|NCT02727777|11885227|FG002|COMPLETED|Overall Study||0
10721571|NCT02727777|11885225|FG000|NOT COMPLETED|Overall Study||4
10721572|NCT02727777|11885226|FG001|NOT COMPLETED|Overall Study||0
10721573|NCT02727777|11885227|FG002|NOT COMPLETED|Overall Study||0
10721574|NCT02727816|11885235|FG000|STARTED|Overall Study||35
10721575|NCT02727816|11885235|FG000|COMPLETED|Overall Study||35
10721576|NCT02727816|11885235|FG000|NOT COMPLETED|Overall Study||0
10721577|NCT02727842|11885255|FG000|STARTED|Overall Study||30
10721578|NCT02727842|11885255|FG000|COMPLETED|Overall Study||30
10721579|NCT02727842|11885255|FG000|NOT COMPLETED|Overall Study||0
10721580|NCT02727894|11885261|FG000|STARTED|Overall Study|March 2013|73
10721581|NCT02727894|11885262|FG001|STARTED|Overall Study|March 2013|192
10721582|NCT02727894|11885261|FG000|COMPLETED|Overall Study|September 2015|73
10721583|NCT02727894|11885262|FG001|COMPLETED|Overall Study|September 2015|192
10721584|NCT02727894|11885261|FG000|NOT COMPLETED|Overall Study||0
10721585|NCT02727894|11885262|FG001|NOT COMPLETED|Overall Study||0
10721586|NCT02728089|11885271|FG000|STARTED|Overall Study||115
10721587|NCT02728089|11885271|FG000|Treated|Overall Study||114
10721588|NCT02728089|11885271|FG000|COMPLETED|Overall Study||112
10721589|NCT02728089|11885271|FG000|NOT COMPLETED|Overall Study||3
10403003|NCT00727272|11547275|FG000|COMPLETED|Washout Period B||9
10403004|NCT00727272|11547276|FG001|COMPLETED|Washout Period B||9
10403005|NCT00727272|11547277|FG002|COMPLETED|Washout Period B|personal reasons|7
10403006|NCT00727272|11547275|FG000|NOT COMPLETED|Washout Period B||0
10403007|NCT00727272|11547276|FG001|NOT COMPLETED|Washout Period B||0
10403008|NCT00727272|11547277|FG002|NOT COMPLETED|Washout Period B||1
10403009|NCT00727272|11547275|FG000|STARTED|Period III||9
10403010|NCT00727272|11547276|FG001|STARTED|Period III||9
10403011|NCT00727272|11547277|FG002|STARTED|Period III||7
10403012|NCT00727272|11547275|FG000|COMPLETED|Period III||9
10403013|NCT00727272|11547276|FG001|COMPLETED|Period III||9
10403014|NCT00727272|11547277|FG002|COMPLETED|Period III||7
10403015|NCT00727272|11547275|FG000|NOT COMPLETED|Period III||0
10660421|NCT02250417|11822003|FG001|STARTED|First Intervention (1 Night)||6
10721599|NCT02728206|11885287|FG000|STARTED|Overall Study||9
10721600|NCT02728206|11885287|FG000|COMPLETED|Overall Study||8
10403016|NCT00727272|11547276|FG001|NOT COMPLETED|Period III||0
10403017|NCT00727272|11547277|FG002|NOT COMPLETED|Period III||0
10403018|NCT00727298|11547287|FG000|STARTED|Overall Study||4485
10660422|NCT02250417|11822002|FG000|COMPLETED|First Intervention (1 Night)||6
10660423|NCT02250417|11822003|FG001|COMPLETED|First Intervention (1 Night)||6
10660424|NCT02250417|11822002|FG000|NOT COMPLETED|First Intervention (1 Night)||0
10660425|NCT02250417|11822003|FG001|NOT COMPLETED|First Intervention (1 Night)||0
10660426|NCT02250417|11822002|FG000|STARTED|Second Intervention (1 Night)||6
10660427|NCT02250417|11822003|FG001|STARTED|Second Intervention (1 Night)||6
10721601|NCT02728206|11885287|FG000|NOT COMPLETED|Overall Study||1
10721602|NCT02728830|11885291|FG000|STARTED|Overall Study||39
10721603|NCT02728830|11885291|FG000|COMPLETED|Overall Study||15
10403019|NCT00727298|11547287|FG000|COMPLETED|Overall Study||3228
10403020|NCT00727298|11547287|FG000|NOT COMPLETED|Overall Study||1257
10403021|NCT00727311|11547291|FG000|STARTED|Overall Study||2302
10403022|NCT00727311|11547291|FG000|COMPLETED|Overall Study||1195
10403023|NCT00727311|11547291|FG000|NOT COMPLETED|Overall Study||1107
10403024|NCT00727337|11547299|FG000|STARTED|Overall Study||68
10403025|NCT00727337|11547300|FG001|STARTED|Overall Study||65
10403026|NCT00727337|11547301|FG002|STARTED|Overall Study||73
10403027|NCT00727337|11547302|FG003|STARTED|Overall Study||73
10403028|NCT00727337|11547299|FG000|COMPLETED|Overall Study||61
10403029|NCT00727337|11547300|FG001|COMPLETED|Overall Study||55
10403030|NCT00727337|11547301|FG002|COMPLETED|Overall Study||63
10403031|NCT00727337|11547302|FG003|COMPLETED|Overall Study||64
10403032|NCT00727337|11547299|FG000|NOT COMPLETED|Overall Study||7
10403033|NCT00727337|11547300|FG001|NOT COMPLETED|Overall Study||10
10721604|NCT02728830|11885291|FG000|NOT COMPLETED|Overall Study||24
10721605|NCT02728895|11885297|FG000|STARTED|Overall Study||3
10721606|NCT02728895|11885298|FG001|STARTED|Overall Study||21
10721607|NCT02728895|11885297|FG000|COMPLETED|Overall Study||2
10721608|NCT02728895|11885298|FG001|COMPLETED|Overall Study||16
10721609|NCT02728895|11885297|FG000|NOT COMPLETED|Overall Study||1
10721610|NCT02728895|11885298|FG001|NOT COMPLETED|Overall Study||5
10660428|NCT02250417|11822002|FG000|COMPLETED|Second Intervention (1 Night)||6
10660429|NCT02250417|11822003|FG001|COMPLETED|Second Intervention (1 Night)||6
10660430|NCT02250417|11822002|FG000|NOT COMPLETED|Second Intervention (1 Night)||0
10660431|NCT02250417|11822003|FG001|NOT COMPLETED|Second Intervention (1 Night)||0
10660432|NCT02250443|11822012|FG000|STARTED|Overall Study||10
10660433|NCT02250443|11822012|FG000|COMPLETED|Overall Study||0
10403034|NCT00727337|11547301|FG002|NOT COMPLETED|Overall Study||10
10403035|NCT00727337|11547302|FG003|NOT COMPLETED|Overall Study||9
10403036|NCT00727402|11547317|FG000|STARTED|Overall Study||205
10403037|NCT00727402|11547317|FG000|COMPLETED|Overall Study||89
10403038|NCT00727402|11547317|FG000|NOT COMPLETED|Overall Study||116
10403039|NCT00727415|11547321|FG000|STARTED|Phase I||9
10403040|NCT00727415|11547321|FG000|COMPLETED|Phase I||7
10403041|NCT00727415|11547321|FG000|NOT COMPLETED|Phase I||2
10403042|NCT00727415|11547321|FG000|STARTED|Phase II||33
10403043|NCT00727415|11547321|FG000|COMPLETED|Phase II||33
10403044|NCT00727415|11547321|FG000|NOT COMPLETED|Phase II||0
10403045|NCT00727441|11547328|FG000|STARTED|Overall Study||29
10403046|NCT00727441|11547329|FG001|STARTED|Overall Study||28
10403047|NCT00727441|11547330|FG002|STARTED|Overall Study||30
10403048|NCT00727441|11547328|FG000|COMPLETED|Overall Study||11
10403049|NCT00727441|11547329|FG001|COMPLETED|Overall Study||6
10403050|NCT00727441|11547330|FG002|COMPLETED|Overall Study||5
10403051|NCT00727441|11547328|FG000|NOT COMPLETED|Overall Study||18
10403052|NCT00727441|11547329|FG001|NOT COMPLETED|Overall Study||22
10403053|NCT00727441|11547330|FG002|NOT COMPLETED|Overall Study||25
10403054|NCT00727506|11547347|FG000|STARTED|Overall Study|Entered|6
10403055|NCT00727506|11547348|FG001|STARTED|Overall Study|Entered|8
10403056|NCT00727506|11547349|FG002|STARTED|Overall Study|Entered|18
10403057|NCT00727506|11547350|FG003|STARTED|Overall Study|Randomized|39
10403058|NCT00727506|11547351|FG004|STARTED|Overall Study|Randomized|41
10403059|NCT00727506|11547352|FG005|STARTED|Overall Study|Randomized|39
10403060|NCT00727506|11547347|FG000|COMPLETED|Overall Study||0
10403061|NCT00727506|11547348|FG001|COMPLETED|Overall Study||0
10403062|NCT00727506|11547349|FG002|COMPLETED|Overall Study||0
10403063|NCT00727506|11547350|FG003|COMPLETED|Overall Study||0
10403064|NCT00727506|11547351|FG004|COMPLETED|Overall Study||0
10403065|NCT00727506|11547352|FG005|COMPLETED|Overall Study||0
10403066|NCT00727506|11547347|FG000|NOT COMPLETED|Overall Study||6
10403067|NCT00727506|11547348|FG001|NOT COMPLETED|Overall Study||8
10403068|NCT00727506|11547349|FG002|NOT COMPLETED|Overall Study||18
10660434|NCT02250443|11822012|FG000|NOT COMPLETED|Overall Study||10
10660435|NCT02250521|11822016|FG000|STARTED|Overall Study||100
10660436|NCT02250521|11822016|FG000|COMPLETED|Overall Study||99
10777370|NCT03339583|11939336|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
10777371|NCT03339583|11939337|FG001|NOT COMPLETED|Second Intervention (14 Days)||2
10777372|NCT03339583|11939336|FG000|STARTED|Follow-up (14 Days)||18
10777373|NCT03339583|11939337|FG001|STARTED|Follow-up (14 Days)||21
10777374|NCT03339583|11939336|FG000|COMPLETED|Follow-up (14 Days)||12
10777375|NCT03339583|11939337|FG001|COMPLETED|Follow-up (14 Days)||18
10777376|NCT03339583|11939336|FG000|NOT COMPLETED|Follow-up (14 Days)||6
10777377|NCT03339583|11939337|FG001|NOT COMPLETED|Follow-up (14 Days)||3
10777378|NCT03339713|11939347|FG000|STARTED|Overall Study||90
10403069|NCT00727506|11547350|FG003|NOT COMPLETED|Overall Study||39
10403070|NCT00727506|11547351|FG004|NOT COMPLETED|Overall Study||41
10403071|NCT00727506|11547352|FG005|NOT COMPLETED|Overall Study||39
10660437|NCT02250521|11822016|FG000|NOT COMPLETED|Overall Study||1
10660438|NCT02250612|11822025|FG000|STARTED|Overall Study||37
10660439|NCT02250612|11822026|FG001|STARTED|Overall Study||40
10777379|NCT03339713|11939348|FG001|STARTED|Overall Study||90
10777380|NCT03339713|11939347|FG000|COMPLETED|Overall Study||86
10777381|NCT03339713|11939348|FG001|COMPLETED|Overall Study||88
10777382|NCT03339713|11939347|FG000|NOT COMPLETED|Overall Study||4
10777383|NCT03339713|11939348|FG001|NOT COMPLETED|Overall Study||2
10403072|NCT00727532|11547372|FG000|STARTED|Overall Study||9
10403073|NCT00727532|11547372|FG000|COMPLETED|Overall Study||7
10403074|NCT00727532|11547372|FG000|NOT COMPLETED|Overall Study||2
10544215|NCT01489969|11697501|FG001|STARTED|Overall Study||47
10544216|NCT01489969|11697502|FG002|STARTED|Overall Study||45
10544217|NCT01489969|11697500|FG000|COMPLETED|Overall Study||40
10544218|NCT01489969|11697501|FG001|COMPLETED|Overall Study||43
10544219|NCT01489969|11697502|FG002|COMPLETED|Overall Study||44
10544220|NCT01489969|11697500|FG000|NOT COMPLETED|Overall Study||5
10544221|NCT01489969|11697501|FG001|NOT COMPLETED|Overall Study||4
10544222|NCT01489969|11697502|FG002|NOT COMPLETED|Overall Study||1
10544223|NCT01490060|11697512|FG000|STARTED|Cycle 1||11
10544224|NCT01490060|11697513|FG001|STARTED|Cycle 1||13
10544225|NCT01490060|11697514|FG002|STARTED|Cycle 1||12
10544226|NCT01490060|11697515|FG003|STARTED|Cycle 1||11
10544227|NCT01490060|11697512|FG000|COMPLETED|Cycle 1||11
10544228|NCT01490060|11697513|FG001|COMPLETED|Cycle 1||12
10660440|NCT02250612|11822027|FG002|STARTED|Overall Study||37
10660441|NCT02250612|11822028|FG003|STARTED|Overall Study||33
10660442|NCT02250612|11822029|FG004|STARTED|Overall Study||37
10660443|NCT02250612|11822025|FG000|COMPLETED|Overall Study||36
10660444|NCT02250612|11822026|FG001|COMPLETED|Overall Study||38
10660445|NCT02250612|11822027|FG002|COMPLETED|Overall Study||35
10660446|NCT02250612|11822028|FG003|COMPLETED|Overall Study||33
10660447|NCT02250612|11822029|FG004|COMPLETED|Overall Study||36
10660448|NCT02250612|11822025|FG000|NOT COMPLETED|Overall Study||1
10660449|NCT02250612|11822026|FG001|NOT COMPLETED|Overall Study||2
10660450|NCT02250612|11822027|FG002|NOT COMPLETED|Overall Study||2
10660451|NCT02250612|11822028|FG003|NOT COMPLETED|Overall Study||0
10660452|NCT02250612|11822029|FG004|NOT COMPLETED|Overall Study||1
10660453|NCT02250651|11822051|FG000|STARTED|Treatment Period 1 (Day 1 to Week 15)||176
10660454|NCT02250651|11822052|FG001|STARTED|Treatment Period 1 (Day 1 to Week 15)||176
10660455|NCT02250651|11822053|FG002|STARTED|Treatment Period 1 (Day 1 to Week 15)||176
10660456|NCT02250651|11822051|FG000|Received Sham or Bimatoprost SR|Treatment Period 1 (Day 1 to Week 15)||176
10660457|NCT02250651|11822052|FG001|Received Sham or Bimatoprost SR|Treatment Period 1 (Day 1 to Week 15)||175
10660458|NCT02250651|11822053|FG002|Received Sham or Bimatoprost SR|Treatment Period 1 (Day 1 to Week 15)||173
10660459|NCT02250651|11822051|FG000|COMPLETED|Treatment Period 1 (Day 1 to Week 15)||172
10660460|NCT02250651|11822052|FG001|COMPLETED|Treatment Period 1 (Day 1 to Week 15)||170
10660461|NCT02250651|11822053|FG002|COMPLETED|Treatment Period 1 (Day 1 to Week 15)||165
10660462|NCT02250651|11822051|FG000|NOT COMPLETED|Treatment Period 1 (Day 1 to Week 15)||4
10660463|NCT02250651|11822052|FG001|NOT COMPLETED|Treatment Period 1 (Day 1 to Week 15)||6
10660464|NCT02250651|11822053|FG002|NOT COMPLETED|Treatment Period 1 (Day 1 to Week 15)||11
10660465|NCT02250651|11822051|FG000|STARTED|Treatment Period 2 (Week 16 to Week 31)||165
10660466|NCT02250651|11822052|FG001|STARTED|Treatment Period 2 (Week 16 to Week 31)||168
10660467|NCT02250651|11822053|FG002|STARTED|Treatment Period 2 (Week 16 to Week 31)||165
10660468|NCT02250651|11822051|FG000|COMPLETED|Treatment Period 2 (Week 16 to Week 31)||159
10660469|NCT02250651|11822052|FG001|COMPLETED|Treatment Period 2 (Week 16 to Week 31)||162
10660470|NCT02250651|11822053|FG002|COMPLETED|Treatment Period 2 (Week 16 to Week 31)||160
10660471|NCT02250651|11822051|FG000|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 31)||6
10660472|NCT02250651|11822052|FG001|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 31)||6
10660473|NCT02250651|11822053|FG002|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 31)||5
10660474|NCT02250651|11822051|FG000|STARTED|Treatment Period 3 (Week 32 to Week 52)||147
10660475|NCT02250651|11822052|FG001|STARTED|Treatment Period 3 (Week 32 to Week 52)||156
10660476|NCT02250651|11822053|FG002|STARTED|Treatment Period 3 (Week 32 to Week 52)||159
10660477|NCT02250651|11822051|FG000|COMPLETED|Treatment Period 3 (Week 32 to Week 52)||138
10660478|NCT02250651|11822052|FG001|COMPLETED|Treatment Period 3 (Week 32 to Week 52)||152
10660479|NCT02250651|11822053|FG002|COMPLETED|Treatment Period 3 (Week 32 to Week 52)||154
10660480|NCT02250651|11822051|FG000|NOT COMPLETED|Treatment Period 3 (Week 32 to Week 52)||9
10660481|NCT02250651|11822052|FG001|NOT COMPLETED|Treatment Period 3 (Week 32 to Week 52)||4
10660482|NCT02250651|11822053|FG002|NOT COMPLETED|Treatment Period 3 (Week 32 to Week 52)||5
10660483|NCT02250703|11822063|FG000|STARTED|Overall Study||38
10403075|NCT00727558|11547378|FG000|STARTED|Overall Study||127
10403076|NCT00727558|11547379|FG001|STARTED|Overall Study||121
10403077|NCT00727558|11547378|FG000|COMPLETED|Overall Study||125
10403078|NCT00727558|11547379|FG001|COMPLETED|Overall Study||118
10403079|NCT00727558|11547378|FG000|NOT COMPLETED|Overall Study||2
10403080|NCT00727558|11547379|FG001|NOT COMPLETED|Overall Study||3
10403081|NCT00727571|11547389|FG000|STARTED|Overall Study||232
10403082|NCT00727571|11547390|FG001|STARTED|Overall Study||228
10403083|NCT00727571|11547391|FG002|STARTED|Overall Study||165
10403084|NCT00727571|11547392|FG003|STARTED|Overall Study||169
10403085|NCT00727571|11547389|FG000|COMPLETED|Overall Study||231
10403086|NCT00727571|11547390|FG001|COMPLETED|Overall Study||173
10403087|NCT00727571|11547391|FG002|COMPLETED|Overall Study||135
10403088|NCT00727571|11547392|FG003|COMPLETED|Overall Study||163
10403089|NCT00727571|11547389|FG000|NOT COMPLETED|Overall Study||1
10403090|NCT00727571|11547390|FG001|NOT COMPLETED|Overall Study||55
10544229|NCT01490060|11697514|FG002|COMPLETED|Cycle 1||9
10544230|NCT01490060|11697515|FG003|COMPLETED|Cycle 1||8
10544231|NCT01490060|11697512|FG000|NOT COMPLETED|Cycle 1||0
10660484|NCT02250703|11822064|FG001|STARTED|Overall Study||37
10660485|NCT02250703|11822063|FG000|COMPLETED|Overall Study||37
10660486|NCT02250703|11822064|FG001|COMPLETED|Overall Study||36
10660487|NCT02250703|11822063|FG000|NOT COMPLETED|Overall Study||1
10660488|NCT02250703|11822064|FG001|NOT COMPLETED|Overall Study||1
10403091|NCT00727571|11547391|FG002|NOT COMPLETED|Overall Study||30
10403092|NCT00727571|11547392|FG003|NOT COMPLETED|Overall Study||6
10403093|NCT00727597|11547404|FG000|STARTED|Overall Study||51
10403094|NCT00727597|11547405|FG001|STARTED|Overall Study||50
10403095|NCT00727597|11547404|FG000|COMPLETED|Overall Study||51
10403096|NCT00727597|11547405|FG001|COMPLETED|Overall Study||50
10403097|NCT00727597|11547404|FG000|NOT COMPLETED|Overall Study||0
10403098|NCT00727597|11547405|FG001|NOT COMPLETED|Overall Study||0
10403099|NCT00727636|11547413|FG000|STARTED|Overall Study||37
10403100|NCT00727636|11547414|FG001|STARTED|Overall Study||15
10403101|NCT00727636|11547413|FG000|COMPLETED|Overall Study||33
10403102|NCT00727636|11547414|FG001|COMPLETED|Overall Study||15
10403103|NCT00727636|11547413|FG000|NOT COMPLETED|Overall Study||4
10403104|NCT00727636|11547414|FG001|NOT COMPLETED|Overall Study||0
10403105|NCT00727649|11547422|FG000|STARTED|First Intervention (4-weeks)||37
10403106|NCT00727649|11547423|FG001|STARTED|First Intervention (4-weeks)||43
10403107|NCT00727649|11547422|FG000|COMPLETED|First Intervention (4-weeks)||34
10403108|NCT00727649|11547423|FG001|COMPLETED|First Intervention (4-weeks)||40
10403109|NCT00727649|11547422|FG000|NOT COMPLETED|First Intervention (4-weeks)||3
10403110|NCT00727649|11547423|FG001|NOT COMPLETED|First Intervention (4-weeks)||3
10403111|NCT00727649|11547422|FG000|STARTED|Wash-out (2-weeks)||34
10403112|NCT00727649|11547423|FG001|STARTED|Wash-out (2-weeks)||40
10403113|NCT00727649|11547422|FG000|COMPLETED|Wash-out (2-weeks)||30
10403114|NCT00727649|11547423|FG001|COMPLETED|Wash-out (2-weeks)||37
10403115|NCT00727649|11547422|FG000|NOT COMPLETED|Wash-out (2-weeks)||4
10403116|NCT00727649|11547423|FG001|NOT COMPLETED|Wash-out (2-weeks)||3
10403117|NCT00727649|11547422|FG000|STARTED|Second Intervention (4-weeks)||30
10403118|NCT00727649|11547423|FG001|STARTED|Second Intervention (4-weeks)||37
10403119|NCT00727649|11547422|FG000|COMPLETED|Second Intervention (4-weeks)||29
10403120|NCT00727649|11547423|FG001|COMPLETED|Second Intervention (4-weeks)||34
10403121|NCT00727649|11547422|FG000|NOT COMPLETED|Second Intervention (4-weeks)||1
10403122|NCT00727649|11547423|FG001|NOT COMPLETED|Second Intervention (4-weeks)||3
10403123|NCT00727714|11547431|FG000|STARTED|Overall Study||95
10403124|NCT00727714|11547431|FG000|COMPLETED|Overall Study||93
10403125|NCT00727714|11547431|FG000|NOT COMPLETED|Overall Study||2
10403126|NCT00727740|11547437|FG000|STARTED|Overall Study||56
10403127|NCT00727740|11547438|FG001|STARTED|Overall Study||61
10403128|NCT00727740|11547437|FG000|COMPLETED|Overall Study||56
10403129|NCT00727740|11547438|FG001|COMPLETED|Overall Study||61
10403130|NCT00727740|11547437|FG000|NOT COMPLETED|Overall Study||0
10403131|NCT00727740|11547438|FG001|NOT COMPLETED|Overall Study||0
10403132|NCT00727844|11547446|FG000|STARTED|Initial Randomization|2 patients withdrawn before receiving any linezolid owing to baseline neuropathy|21
10403133|NCT00727844|11547447|FG001|STARTED|Initial Randomization||20
10403134|NCT00727844|11547448|FG002|STARTED|Initial Randomization||0
10403135|NCT00727844|11547449|FG003|STARTED|Initial Randomization||0
10403136|NCT00727844|11547446|FG000|Included in MITT Analysis|Initial Randomization||19
10403137|NCT00727844|11547447|FG001|Included in MITT Analysis|Initial Randomization||20
10660489|NCT02250807|11822070|FG000|STARTED|Overall Study||40
10660490|NCT02250807|11822070|FG000|COMPLETED|Overall Study||40
10660491|NCT02250807|11822070|FG000|NOT COMPLETED|Overall Study||0
10660492|NCT02251236|11822077|FG000|STARTED|Overall Study||9
10660493|NCT02251236|11822078|FG001|STARTED|Overall Study||5
10660494|NCT02251236|11822079|FG002|STARTED|Overall Study||0
10660495|NCT02251236|11822077|FG000|COMPLETED|Overall Study||9
10660496|NCT02251236|11822078|FG001|COMPLETED|Overall Study||5
10660497|NCT02251236|11822079|FG002|COMPLETED|Overall Study||0
10660498|NCT02251236|11822077|FG000|NOT COMPLETED|Overall Study||0
10660499|NCT02251236|11822078|FG001|NOT COMPLETED|Overall Study||0
10660500|NCT02251236|11822079|FG002|NOT COMPLETED|Overall Study||0
10660501|NCT02251275|11822092|FG000|STARTED|Overall Study||506
10660502|NCT02251275|11822093|FG001|STARTED|Overall Study||570
10660503|NCT02251275|11822094|FG002|STARTED|Overall Study||718
10660504|NCT02251275|11822095|FG003|STARTED|Overall Study|From trials 156-04-251 and 156-09-290|6
10660505|NCT02251275|11822096|FG004|STARTED|Overall Study|From trials 156-04-251 and 156-09-290|3
10660506|NCT02251275|11822092|FG000|Received at Least 1 Dose of Study Drug|Overall Study||505
10660507|NCT02251275|11822093|FG001|Received at Least 1 Dose of Study Drug|Overall Study||569
10660508|NCT02251275|11822094|FG002|Received at Least 1 Dose of Study Drug|Overall Study||717
10660509|NCT02251275|11822095|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
10660510|NCT02251275|11822096|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3
10660511|NCT02251275|11822092|FG000|COMPLETED|Overall Study||434
10660512|NCT02251275|11822093|FG001|COMPLETED|Overall Study||423
10660513|NCT02251275|11822094|FG002|COMPLETED|Overall Study||624
10403138|NCT00727844|11547448|FG002|Included in MITT Analysis|Initial Randomization||0
10403139|NCT00727844|11547449|FG003|Included in MITT Analysis|Initial Randomization||0
10403140|NCT00727844|11547446|FG000|COMPLETED|Initial Randomization||19
10403141|NCT00727844|11547447|FG001|COMPLETED|Initial Randomization||20
10403142|NCT00727844|11547448|FG002|COMPLETED|Initial Randomization||0
10660514|NCT02251275|11822095|FG003|COMPLETED|Overall Study||5
10660515|NCT02251275|11822096|FG004|COMPLETED|Overall Study||2
10660516|NCT02251275|11822092|FG000|NOT COMPLETED|Overall Study||72
10660517|NCT02251275|11822093|FG001|NOT COMPLETED|Overall Study||147
10660518|NCT02251275|11822094|FG002|NOT COMPLETED|Overall Study||94
10660519|NCT02251275|11822095|FG003|NOT COMPLETED|Overall Study||1
10660520|NCT02251275|11822096|FG004|NOT COMPLETED|Overall Study||1
10660521|NCT02251379|11822110|FG000|STARTED|Overall Study||77
10660522|NCT02251379|11822111|FG001|STARTED|Overall Study||78
10403143|NCT00727844|11547449|FG003|COMPLETED|Initial Randomization||0
10403144|NCT00727844|11547446|FG000|NOT COMPLETED|Initial Randomization||2
10403145|NCT00727844|11547447|FG001|NOT COMPLETED|Initial Randomization||0
10403146|NCT00727844|11547448|FG002|NOT COMPLETED|Initial Randomization||0
10403147|NCT00727844|11547449|FG003|NOT COMPLETED|Initial Randomization||0
10403148|NCT00727844|11547446|FG000|STARTED|Second Randomization||0
10403149|NCT00727844|11547447|FG001|STARTED|Second Randomization||0
10403150|NCT00727844|11547448|FG002|STARTED|Second Randomization|6 patients excluded before 2nd randomization: 2 had withdrawn and 4 already dose reduced due to AE|17
10403151|NCT00727844|11547449|FG003|STARTED|Second Randomization|6 patients excluded before 2nd randomization: 2 had withdrawn and 4 already dose reduced due to AE|16
10403152|NCT00727844|11547446|FG000|COMPLETED|Second Randomization||0
10403153|NCT00727844|11547447|FG001|COMPLETED|Second Randomization||0
10403154|NCT00727844|11547448|FG002|COMPLETED|Second Randomization||17
10403155|NCT00727844|11547449|FG003|COMPLETED|Second Randomization||16
10403156|NCT00727844|11547446|FG000|NOT COMPLETED|Second Randomization||0
10403157|NCT00727844|11547447|FG001|NOT COMPLETED|Second Randomization||0
10403158|NCT00727844|11547448|FG002|NOT COMPLETED|Second Randomization||0
10403159|NCT00727844|11547449|FG003|NOT COMPLETED|Second Randomization||0
10403160|NCT00727857|11547457|FG000|STARTED|Overall Study||201
10403161|NCT00727857|11547458|FG001|STARTED|Overall Study||189
10403162|NCT00727857|11547459|FG002|STARTED|Overall Study||210
10403163|NCT00727857|11547457|FG000|COMPLETED|Overall Study||157
10403164|NCT00727857|11547458|FG001|COMPLETED|Overall Study||125
10403165|NCT00727857|11547459|FG002|COMPLETED|Overall Study||142
10403166|NCT00727857|11547457|FG000|NOT COMPLETED|Overall Study||44
10403167|NCT00727857|11547458|FG001|NOT COMPLETED|Overall Study||64
10403168|NCT00727857|11547459|FG002|NOT COMPLETED|Overall Study||68
10428935|NCT00861913|11575099|FG000|COMPLETED|Overall Study||13
10428936|NCT00861913|11575099|FG000|NOT COMPLETED|Overall Study||0
10428937|NCT00862082|11575105|FG000|STARTED|Overall Study||8
10428938|NCT00862082|11575106|FG001|STARTED|Overall Study||6
10428939|NCT00862082|11575105|FG000|COMPLETED|Overall Study||3
10428940|NCT00862082|11575106|FG001|COMPLETED|Overall Study||5
10428941|NCT00862082|11575105|FG000|NOT COMPLETED|Overall Study||5
10428942|NCT00862082|11575106|FG001|NOT COMPLETED|Overall Study||1
10428943|NCT00862121|11575121|FG000|STARTED|Overall Study||8
10428944|NCT00862121|11575122|FG001|STARTED|Overall Study|Randomised, intent-to-treat (ITT)|12
10428945|NCT00862121|11575121|FG000|Full Analysis Set (FAS)|Overall Study|One participant had no evaluable post-baseline CDAI score.|7
10428946|NCT00862121|11575122|FG001|Full Analysis Set (FAS)|Overall Study|One participant randomised in error (no IMP taken).|11
10428947|NCT00862121|11575121|FG000|Safety Analysis Set|Overall Study|The participant with no evaluable post-baseline CDAI score was included in the Safety Analysis Set.|8
10428948|NCT00862121|11575122|FG001|Safety Analysis Set|Overall Study||11
10428949|NCT00862121|11575121|FG000|COMPLETED|Overall Study||7
10428950|NCT00862121|11575122|FG001|COMPLETED|Overall Study||4
10428951|NCT00862121|11575121|FG000|NOT COMPLETED|Overall Study||1
10428952|NCT00862121|11575122|FG001|NOT COMPLETED|Overall Study||8
10428953|NCT00862134|11575130|FG000|STARTED|Overall Study||19
10428954|NCT00862134|11575131|FG001|STARTED|Overall Study||23
10428955|NCT00862134|11575130|FG000|COMPLETED|Overall Study||8
10428956|NCT00862134|11575131|FG001|COMPLETED|Overall Study||11
10428957|NCT00862134|11575130|FG000|NOT COMPLETED|Overall Study||11
10428958|NCT00862134|11575131|FG001|NOT COMPLETED|Overall Study||12
10428959|NCT00862186|11575137|FG000|STARTED|Overall Study||15
10428960|NCT00862186|11575137|FG000|COMPLETED|Overall Study||15
10428961|NCT00862186|11575137|FG000|NOT COMPLETED|Overall Study||0
10428962|NCT00862277|11575145|FG000|STARTED|Overall Study||561
10428963|NCT00862277|11575146|FG001|STARTED|Overall Study||96
10428964|NCT00862277|11575147|FG002|STARTED|Overall Study||105
10428965|NCT00862277|11575145|FG000|COMPLETED|Overall Study||560
10428966|NCT00862277|11575146|FG001|COMPLETED|Overall Study||94
10428967|NCT00862277|11575147|FG002|COMPLETED|Overall Study||100
10428968|NCT00862277|11575145|FG000|NOT COMPLETED|Overall Study||1
10428969|NCT00862277|11575146|FG001|NOT COMPLETED|Overall Study||2
10428970|NCT00862277|11575147|FG002|NOT COMPLETED|Overall Study||5
10428971|NCT00862446|11575155|FG000|STARTED|Overall Study||48
10428972|NCT00862446|11575155|FG000|COMPLETED|Overall Study||48
10428973|NCT00862446|11575155|FG000|NOT COMPLETED|Overall Study||0
10428974|NCT00862459|11575162|FG000|STARTED|Overall Study||72
10428975|NCT00862459|11575163|FG001|STARTED|Overall Study||93
10428976|NCT00862459|11575164|FG002|STARTED|Overall Study||72
10428977|NCT00862459|11575162|FG000|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 67 received Gadobutrol and 70 received OptiMARK|70
10428978|NCT00862459|11575163|FG001|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 90 received Gadobutrol and 88 received OptiMARK|90
10428979|NCT00862459|11575164|FG002|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 68 received Gadobutrol and 69 received OptiMARK|69
10428980|NCT00862459|11575162|FG000|COMPLETED|Overall Study||66
10428981|NCT00862459|11575163|FG001|COMPLETED|Overall Study||85
10428982|NCT00862459|11575164|FG002|COMPLETED|Overall Study||66
10428983|NCT00862459|11575162|FG000|NOT COMPLETED|Overall Study||6
10428984|NCT00862459|11575163|FG001|NOT COMPLETED|Overall Study||8
10428985|NCT00862459|11575164|FG002|NOT COMPLETED|Overall Study||6
10428986|NCT00862537|11575173|FG000|STARTED|Overall Study||18
10428987|NCT00862537|11575173|FG000|COMPLETED|Overall Study||11
10428988|NCT00862537|11575173|FG000|NOT COMPLETED|Overall Study||7
10428989|NCT00862563|11575181|FG000|STARTED|Overall Study||19
10403169|NCT00727909|11547468|FG000|STARTED|Overall Study||65
10403170|NCT00727909|11547469|FG001|STARTED|Overall Study||72
10403171|NCT00727909|11547470|FG002|STARTED|Overall Study||67
10403172|NCT00727909|11547471|FG003|STARTED|Overall Study||75
10403173|NCT00727909|11547468|FG000|COMPLETED|Overall Study||60
10403174|NCT00727909|11547469|FG001|COMPLETED|Overall Study||61
10403175|NCT00727909|11547470|FG002|COMPLETED|Overall Study||58
10403176|NCT00727909|11547471|FG003|COMPLETED|Overall Study||70
10403177|NCT00727909|11547468|FG000|NOT COMPLETED|Overall Study||5
10403178|NCT00727909|11547469|FG001|NOT COMPLETED|Overall Study||11
10403179|NCT00727909|11547470|FG002|NOT COMPLETED|Overall Study||9
10403180|NCT00727909|11547471|FG003|NOT COMPLETED|Overall Study||5
10403181|NCT00727961|11547475|FG000|STARTED|Overall Study||58
10403182|NCT00727961|11547475|FG000|COMPLETED|Overall Study||21
10403183|NCT00727961|11547475|FG000|NOT COMPLETED|Overall Study||37
10403184|NCT00728130|11547479|FG000|STARTED|Overall Study||22
10403185|NCT00728130|11547479|FG000|COMPLETED|Overall Study||19
10403186|NCT00728130|11547479|FG000|NOT COMPLETED|Overall Study||3
10403187|NCT00728182|11547485|FG000|STARTED|Overall Study||92
10403188|NCT00728182|11547486|FG001|STARTED|Overall Study||93
10403189|NCT00728182|11547485|FG000|COMPLETED|Overall Study||89
10403190|NCT00728182|11547486|FG001|COMPLETED|Overall Study||90
10403191|NCT00728182|11547485|FG000|NOT COMPLETED|Overall Study||3
10403192|NCT00728182|11547486|FG001|NOT COMPLETED|Overall Study||3
10403193|NCT00728260|11547494|FG000|STARTED|Overall Study||1421
10403194|NCT00728260|11547494|FG000|COMPLETED|Overall Study||1421
10403195|NCT00728260|11547494|FG000|NOT COMPLETED|Overall Study||0
10403196|NCT00728468|11547498|FG000|STARTED|Overall Study||16
10403197|NCT00728468|11547498|FG000|Treated|Overall Study||15
10403198|NCT00728468|11547498|FG000|COMPLETED|Overall Study||0
10403199|NCT00728468|11547498|FG000|NOT COMPLETED|Overall Study||16
10403200|NCT00728481|11547504|FG000|STARTED|Overall Study||19
10403201|NCT00728481|11547505|FG001|STARTED|Overall Study||32
10403202|NCT00728481|11547504|FG000|COMPLETED|Overall Study||18
10403203|NCT00728481|11547505|FG001|COMPLETED|Overall Study||28
10403204|NCT00728481|11547504|FG000|NOT COMPLETED|Overall Study||1
10403205|NCT00728481|11547505|FG001|NOT COMPLETED|Overall Study||4
10403206|NCT00728494|11547513|FG000|STARTED|Overall Study||60
10403207|NCT00728494|11547514|FG001|STARTED|Overall Study||39
10403208|NCT00728494|11547513|FG000|COMPLETED|Overall Study||51
10403209|NCT00728494|11547514|FG001|COMPLETED|Overall Study||32
10403210|NCT00728494|11547513|FG000|NOT COMPLETED|Overall Study||9
10403211|NCT00728494|11547514|FG001|NOT COMPLETED|Overall Study||7
10403212|NCT00728507|11547522|FG000|STARTED|Overall Study||62
10403213|NCT00728507|11547523|FG001|STARTED|Overall Study||59
10403214|NCT00728507|11547522|FG000|COMPLETED|Overall Study||60
10403215|NCT00728507|11547523|FG001|COMPLETED|Overall Study||51
10403216|NCT00728507|11547522|FG000|NOT COMPLETED|Overall Study||2
10403217|NCT00728507|11547523|FG001|NOT COMPLETED|Overall Study||8
10403218|NCT00728689|11547531|FG000|STARTED|First Intervention (Days 1 - 3)||6
10403219|NCT00728689|11547532|FG001|STARTED|First Intervention (Days 1 - 3)||6
10403220|NCT00728689|11547531|FG000|COMPLETED|First Intervention (Days 1 - 3)||6
10403221|NCT00728689|11547532|FG001|COMPLETED|First Intervention (Days 1 - 3)||6
10403222|NCT00728689|11547531|FG000|NOT COMPLETED|First Intervention (Days 1 - 3)||0
10403223|NCT00728689|11547532|FG001|NOT COMPLETED|First Intervention (Days 1 - 3)||0
10403224|NCT00728689|11547531|FG000|STARTED|Washout Period (Days 4 - 10)||6
10403225|NCT00728689|11547532|FG001|STARTED|Washout Period (Days 4 - 10)||6
10403226|NCT00728689|11547531|FG000|COMPLETED|Washout Period (Days 4 - 10)|Death in family during the Washout period. Completed First Intervention period with ST-246 Form I.|5
10403227|NCT00728689|11547532|FG001|COMPLETED|Washout Period (Days 4 - 10)||6
10403228|NCT00728689|11547531|FG000|NOT COMPLETED|Washout Period (Days 4 - 10)||1
10403229|NCT00728689|11547532|FG001|NOT COMPLETED|Washout Period (Days 4 - 10)||0
10403230|NCT00728689|11547531|FG000|STARTED|Second Intervention (Days 11 - 13)||5
10403231|NCT00728689|11547532|FG001|STARTED|Second Intervention (Days 11 - 13)||6
10403232|NCT00728689|11547531|FG000|COMPLETED|Second Intervention (Days 11 - 13)||5
10403233|NCT00728689|11547532|FG001|COMPLETED|Second Intervention (Days 11 - 13)||6
10403234|NCT00728689|11547531|FG000|NOT COMPLETED|Second Intervention (Days 11 - 13)||0
10403235|NCT00728689|11547532|FG001|NOT COMPLETED|Second Intervention (Days 11 - 13)||0
10403236|NCT00728728|11547542|FG000|STARTED|Overall Study||42
10403237|NCT00728728|11547543|FG001|STARTED|Overall Study||46
10403238|NCT00728728|11547542|FG000|COMPLETED|Overall Study||38
10403239|NCT00728728|11547543|FG001|COMPLETED|Overall Study||34
10403240|NCT00728728|11547542|FG000|NOT COMPLETED|Overall Study||4
10660523|NCT02251379|11822110|FG000|COMPLETED|Overall Study||57
10403241|NCT00728728|11547543|FG001|NOT COMPLETED|Overall Study||12
10403242|NCT00728819|11547552|FG000|STARTED|Overall Study||171
10403243|NCT00728819|11547553|FG001|STARTED|Overall Study||168
10403244|NCT00728819|11547552|FG000|COMPLETED|Overall Study||135
10403245|NCT00728819|11547553|FG001|COMPLETED|Overall Study||139
10403246|NCT00728819|11547552|FG000|NOT COMPLETED|Overall Study||36
10403247|NCT00728819|11547553|FG001|NOT COMPLETED|Overall Study||29
10403248|NCT00728910|11547559|FG000|STARTED|Atorvastatin||25
10403249|NCT00728910|11547559|FG000|COMPLETED|Atorvastatin||22
10403250|NCT00728910|11547559|FG000|NOT COMPLETED|Atorvastatin||3
10403251|NCT00728910|11547559|FG000|STARTED|Atorvastatin+ABT335||22
10403252|NCT00728910|11547559|FG000|COMPLETED|Atorvastatin+ABT335||22
10403253|NCT00728910|11547559|FG000|NOT COMPLETED|Atorvastatin+ABT335||0
10403254|NCT00728910|11547559|FG000|STARTED|Atorvastatin+ABT335+ER Niacin||22
10403255|NCT00728910|11547559|FG000|COMPLETED|Atorvastatin+ABT335+ER Niacin||22
10403256|NCT00728910|11547559|FG000|NOT COMPLETED|Atorvastatin+ABT335+ER Niacin||0
10403257|NCT00728923|11547568|FG000|STARTED|Overall Study||9
10403258|NCT00728923|11547568|FG000|COMPLETED|Overall Study||9
10403259|NCT00728923|11547568|FG000|NOT COMPLETED|Overall Study||0
10403260|NCT00728936|11547579|FG000|STARTED|Overall Study||10
10403261|NCT00728936|11547580|FG001|STARTED|Overall Study||8
10403262|NCT00728936|11547581|FG002|STARTED|Overall Study||9
10403263|NCT00728936|11547582|FG003|STARTED|Overall Study||8
10403264|NCT00728936|11547583|FG004|STARTED|Overall Study||8
10403265|NCT00728936|11547584|FG005|STARTED|Overall Study||8
10403266|NCT00728936|11547585|FG006|STARTED|Overall Study||7
10403267|NCT00728936|11547579|FG000|COMPLETED|Overall Study||10
10403268|NCT00728936|11547580|FG001|COMPLETED|Overall Study||8
10403269|NCT00728936|11547581|FG002|COMPLETED|Overall Study||9
10403270|NCT00728936|11547582|FG003|COMPLETED|Overall Study||8
10403271|NCT00728936|11547583|FG004|COMPLETED|Overall Study||8
10403272|NCT00728936|11547584|FG005|COMPLETED|Overall Study||7
10403273|NCT00728936|11547585|FG006|COMPLETED|Overall Study||7
10403274|NCT00728936|11547579|FG000|NOT COMPLETED|Overall Study||0
10403275|NCT00728936|11547580|FG001|NOT COMPLETED|Overall Study||0
10403276|NCT00728936|11547581|FG002|NOT COMPLETED|Overall Study||0
10403277|NCT00728936|11547582|FG003|NOT COMPLETED|Overall Study||0
10660524|NCT02251379|11822111|FG001|COMPLETED|Overall Study||58
10660525|NCT02251379|11822110|FG000|NOT COMPLETED|Overall Study||20
10660526|NCT02251379|11822111|FG001|NOT COMPLETED|Overall Study||20
10660527|NCT02251496|11822119|FG000|STARTED|Overall Study||19
10660528|NCT02251496|11822120|FG001|STARTED|Overall Study||15
10660529|NCT02251496|11822119|FG000|COMPLETED|Overall Study||14
10660530|NCT02251496|11822120|FG001|COMPLETED|Overall Study||11
10660531|NCT02251496|11822119|FG000|NOT COMPLETED|Overall Study||5
10660532|NCT02251496|11822120|FG001|NOT COMPLETED|Overall Study||4
10660533|NCT02251561|11822126|FG000|STARTED|Overall Study||28
10660534|NCT02251561|11822126|FG000|COMPLETED|Overall Study||28
10660535|NCT02251561|11822126|FG000|NOT COMPLETED|Overall Study||0
10660536|NCT02251613|11822132|FG000|STARTED|Overall Study||50
10660537|NCT02251613|11822132|FG000|COMPLETED|Overall Study||50
10660538|NCT02251613|11822132|FG000|NOT COMPLETED|Overall Study||0
10660539|NCT02251652|11822138|FG000|STARTED|Overall Study||17
10660540|NCT02251652|11822138|FG000|COMPLETED|Overall Study||16
10660541|NCT02251652|11822138|FG000|NOT COMPLETED|Overall Study||1
10660542|NCT02251717|11822146|FG000|STARTED|Overall Study||57
10660543|NCT02251717|11822147|FG001|STARTED|Overall Study||57
10660544|NCT02251717|11822146|FG000|COMPLETED|Overall Study||56
10660545|NCT02251717|11822147|FG001|COMPLETED|Overall Study||56
10660546|NCT02251717|11822146|FG000|NOT COMPLETED|Overall Study||1
10660547|NCT02251717|11822147|FG001|NOT COMPLETED|Overall Study||1
10660548|NCT02251743|11822155|FG000|STARTED|Overall Study||85
10660549|NCT02251743|11822156|FG001|STARTED|Overall Study||59
10660550|NCT02251743|11822155|FG000|COMPLETED|Overall Study||84
10660551|NCT02251743|11822156|FG001|COMPLETED|Overall Study||58
10660552|NCT02251743|11822155|FG000|NOT COMPLETED|Overall Study||1
10660553|NCT02251743|11822156|FG001|NOT COMPLETED|Overall Study||1
10660554|NCT02251886|11822166|FG000|STARTED|Overall Study||48
10660555|NCT02251886|11822167|FG001|STARTED|Overall Study||54
10660556|NCT02251886|11822168|FG002|STARTED|Overall Study||44
10660557|NCT02251886|11822169|FG003|STARTED|Overall Study||54
10660558|NCT02251886|11822166|FG000|COMPLETED|Overall Study||48
10660559|NCT02251886|11822167|FG001|COMPLETED|Overall Study||54
10660560|NCT02251886|11822168|FG002|COMPLETED|Overall Study||44
10660561|NCT02251886|11822169|FG003|COMPLETED|Overall Study||54
10660562|NCT02251886|11822166|FG000|NOT COMPLETED|Overall Study||0
10660563|NCT02251886|11822167|FG001|NOT COMPLETED|Overall Study||0
10660564|NCT02251886|11822168|FG002|NOT COMPLETED|Overall Study||0
10660565|NCT02251886|11822169|FG003|NOT COMPLETED|Overall Study||0
10660566|NCT02251912|11822181|FG000|STARTED|Overall Study||12
10660567|NCT02251912|11822182|FG001|STARTED|Overall Study||10
10660568|NCT02251912|11822181|FG000|COMPLETED|Overall Study||10
10660569|NCT02251912|11822182|FG001|COMPLETED|Overall Study||5
10660570|NCT02251912|11822181|FG000|NOT COMPLETED|Overall Study||2
10660571|NCT02251912|11822182|FG001|NOT COMPLETED|Overall Study||5
10660572|NCT02251938|11822188|FG000|STARTED|Overall Study||60
10660573|NCT02251938|11822188|FG000|COMPLETED|Overall Study||43
10660574|NCT02251938|11822188|FG000|NOT COMPLETED|Overall Study||17
10660575|NCT02251990|11822194|FG000|STARTED|Period 1 (Double-blind [DB])||366
10660576|NCT02251990|11822195|FG001|STARTED|Period 1 (Double-blind [DB])||123
10660577|NCT02251990|11822194|FG000|Treated|Period 1 (Double-blind [DB])|Started Grazoprevir/Elbasvir|365
10660578|NCT02251990|11822195|FG001|Treated|Period 1 (Double-blind [DB])|Started Placebo|123
10660579|NCT02251990|11822194|FG000|COMPLETED|Period 1 (Double-blind [DB])|Completed 12 weeks of Grazoprevir/Elbasvir|358
10660580|NCT02251990|11822195|FG001|COMPLETED|Period 1 (Double-blind [DB])|Completed 12 weeks of Placebo|122
10660581|NCT02251990|11822194|FG000|NOT COMPLETED|Period 1 (Double-blind [DB])||8
10660582|NCT02251990|11822195|FG001|NOT COMPLETED|Period 1 (Double-blind [DB])||1
10660583|NCT02251990|11822194|FG000|STARTED|Period 2 (ITG Follow-up/DTG Open Label)|2 participants that did not complete Period 1 treatment were included in Follow-up.|360
10660584|NCT02251990|11822195|FG001|STARTED|Period 2 (ITG Follow-up/DTG Open Label)|1 participant completing Period 1 was not eligible for Period 2 and was not treated.|121
10403278|NCT00728936|11547583|FG004|NOT COMPLETED|Overall Study||0
10403279|NCT00728936|11547584|FG005|NOT COMPLETED|Overall Study||1
10403280|NCT00728936|11547585|FG006|NOT COMPLETED|Overall Study||0
10403281|NCT00728949|11547603|FG000|STARTED|Overall Study||62
10403282|NCT00728949|11547604|FG001|STARTED|Overall Study||31
10403283|NCT00728949|11547603|FG000|COMPLETED|Overall Study||51
10403284|NCT00728949|11547604|FG001|COMPLETED|Overall Study||27
10403285|NCT00728949|11547603|FG000|NOT COMPLETED|Overall Study||11
10403286|NCT00728949|11547604|FG001|NOT COMPLETED|Overall Study||4
10403287|NCT00728988|11547612|FG000|STARTED|Overall Study||247
10403288|NCT00728988|11547613|FG001|STARTED|Overall Study||252
10403289|NCT00728988|11547612|FG000|Treated|Overall Study||245
10403290|NCT00728988|11547613|FG001|Treated|Overall Study||250
10403291|NCT00728988|11547612|FG000|Full Analysis Set|Overall Study||163
10403292|NCT00728988|11547613|FG001|Full Analysis Set|Overall Study||172
10403293|NCT00728988|11547612|FG000|COMPLETED|Overall Study||154
10403294|NCT00728988|11547613|FG001|COMPLETED|Overall Study||164
10403295|NCT00728988|11547612|FG000|NOT COMPLETED|Overall Study||93
10403296|NCT00728988|11547613|FG001|NOT COMPLETED|Overall Study||88
10403297|NCT00729053|11547624|FG000|STARTED|Overall Study||23
10403298|NCT00729053|11547625|FG001|STARTED|Overall Study||23
10403299|NCT00729053|11547626|FG002|STARTED|Overall Study||23
10403300|NCT00729053|11547627|FG003|STARTED|Overall Study||23
10403301|NCT00729053|11547624|FG000|COMPLETED|Overall Study||23
10403302|NCT00729053|11547625|FG001|COMPLETED|Overall Study||23
10403303|NCT00729053|11547626|FG002|COMPLETED|Overall Study||23
10403304|NCT00729053|11547627|FG003|COMPLETED|Overall Study||23
10403305|NCT00729053|11547624|FG000|NOT COMPLETED|Overall Study||0
10403306|NCT00729053|11547625|FG001|NOT COMPLETED|Overall Study||0
10403307|NCT00729053|11547626|FG002|NOT COMPLETED|Overall Study||0
10403308|NCT00729053|11547627|FG003|NOT COMPLETED|Overall Study||0
10403309|NCT00729157|11547637|FG000|STARTED|Overall Study||41
10403310|NCT00729157|11547637|FG000|COMPLETED|Overall Study||40
10403311|NCT00729157|11547637|FG000|NOT COMPLETED|Overall Study||1
10403312|NCT00729183|11547643|FG000|STARTED|Overall Study||109
10403313|NCT00729183|11547644|FG001|STARTED|Overall Study||105
10403314|NCT00729183|11547643|FG000|COMPLETED|Overall Study|Completed 24 month visit|84
10403315|NCT00729183|11547644|FG001|COMPLETED|Overall Study|Completed 24 month visit|90
10403316|NCT00729183|11547643|FG000|NOT COMPLETED|Overall Study||25
10403317|NCT00729183|11547644|FG001|NOT COMPLETED|Overall Study||15
10403318|NCT00729248|11547650|FG000|STARTED|Overall Study||12
10403319|NCT00729248|11547650|FG000|COMPLETED|Overall Study||10
10403320|NCT00729248|11547650|FG000|NOT COMPLETED|Overall Study||2
10403321|NCT00729326|11547657|FG000|STARTED|Overall Study||41
10403322|NCT00729326|11547658|FG001|STARTED|Overall Study||42
10403323|NCT00729326|11547657|FG000|COMPLETED|Overall Study||31
10403324|NCT00729326|11547658|FG001|COMPLETED|Overall Study||33
10403325|NCT00729326|11547657|FG000|NOT COMPLETED|Overall Study||10
10403326|NCT00729326|11547658|FG001|NOT COMPLETED|Overall Study||9
10403327|NCT00729378|11547666|FG000|STARTED|Baseline||430
10403328|NCT00729378|11547667|FG001|STARTED|Baseline||309
10403329|NCT00729378|11547666|FG000|COMPLETED|Baseline||292
10403330|NCT00729378|11547667|FG001|COMPLETED|Baseline||217
10403331|NCT00729378|11547666|FG000|NOT COMPLETED|Baseline||138
10403332|NCT00729378|11547667|FG001|NOT COMPLETED|Baseline||92
10403333|NCT00729378|11547666|FG000|STARTED|12-months||292
10403334|NCT00729378|11547667|FG001|STARTED|12-months||217
10403335|NCT00729378|11547666|FG000|COMPLETED|12-months||192
10403336|NCT00729378|11547667|FG001|COMPLETED|12-months||152
10403337|NCT00729378|11547666|FG000|NOT COMPLETED|12-months||100
10403338|NCT00729378|11547667|FG001|NOT COMPLETED|12-months||65
10403339|NCT00729378|11547666|FG000|STARTED|24-months||192
10403340|NCT00729378|11547667|FG001|STARTED|24-months||152
10403341|NCT00729378|11547666|FG000|COMPLETED|24-months||120
10403342|NCT00729378|11547667|FG001|COMPLETED|24-months||101
10403343|NCT00729378|11547666|FG000|NOT COMPLETED|24-months||72
10403344|NCT00729378|11547667|FG001|NOT COMPLETED|24-months||51
10403345|NCT00729378|11547666|FG000|STARTED|36-months||120
10403346|NCT00729378|11547667|FG001|STARTED|36-months||101
10403347|NCT00729378|11547666|FG000|COMPLETED|36-months||105
10403348|NCT00729378|11547667|FG001|COMPLETED|36-months||95
10403349|NCT00729378|11547666|FG000|NOT COMPLETED|36-months||15
10403350|NCT00729378|11547667|FG001|NOT COMPLETED|36-months||6
10403351|NCT00729430|11547678|FG000|STARTED|Overall Study||180
10403352|NCT00729430|11547679|FG001|STARTED|Overall Study||178
10403353|NCT00729430|11547678|FG000|COMPLETED|Overall Study||133
10403354|NCT00729430|11547679|FG001|COMPLETED|Overall Study||128
10403355|NCT00729430|11547678|FG000|NOT COMPLETED|Overall Study||47
10403356|NCT00729430|11547679|FG001|NOT COMPLETED|Overall Study||50
10403357|NCT00729469|11547688|FG000|STARTED|Overall Study||456
10403358|NCT00729469|11547689|FG001|STARTED|Overall Study||463
10403359|NCT00729469|11547688|FG000|COMPLETED|Overall Study||403
10403360|NCT00729469|11547689|FG001|COMPLETED|Overall Study||416
10403361|NCT00729469|11547688|FG000|NOT COMPLETED|Overall Study||53
10403362|NCT00729469|11547689|FG001|NOT COMPLETED|Overall Study||47
10403363|NCT00729482|11547695|FG000|STARTED|Overall Study||54
10403364|NCT00729482|11547695|FG000|COMPLETED|Overall Study||54
10403365|NCT00729482|11547695|FG000|NOT COMPLETED|Overall Study||0
10403366|NCT00729521|11547702|FG000|STARTED|Overall Study|10 communities in Control with average annual population of 12,494 residents over 65 years old.|12494
10403367|NCT00729521|11547703|FG001|STARTED|Overall Study|Five communities with average annual population of 14,842 residents over 65 years old.|14842
10403368|NCT00729521|11547704|FG002|STARTED|Overall Study|5 communities in Facilitative System with average annual pop. of 7,701 residents over 65 years.|7701
10403369|NCT00729521|11547702|FG000|COMPLETED|Overall Study|Average annual population over 65 years old.|12494
10403370|NCT00729521|11547703|FG001|COMPLETED|Overall Study|Average annual population over 65 years old.|14842
10403371|NCT00729521|11547704|FG002|COMPLETED|Overall Study|Average annual population over 65 years old.|7701
10403372|NCT00729521|11547702|FG000|NOT COMPLETED|Overall Study||0
10403373|NCT00729521|11547703|FG001|NOT COMPLETED|Overall Study||0
10403374|NCT00729521|11547704|FG002|NOT COMPLETED|Overall Study||0
10403375|NCT00729586|11547714|FG000|STARTED|Overall Study||51
10403376|NCT00729586|11547715|FG001|STARTED|Overall Study||22
10403377|NCT00729586|11547714|FG000|COMPLETED|Overall Study|Eligible and treated patients|50
10403378|NCT00729586|11547715|FG001|COMPLETED|Overall Study|Eligible and treated patients|21
10403379|NCT00729586|11547714|FG000|NOT COMPLETED|Overall Study||1
10403380|NCT00729586|11547715|FG001|NOT COMPLETED|Overall Study||1
10403381|NCT00729612|11547722|FG000|STARTED|Overall Study||63
10403382|NCT00729612|11547722|FG000|Died Before Cycle 1|Overall Study||1
10403383|NCT00729612|11547722|FG000|Received Cycle 1|Overall Study||62
10403384|NCT00729612|11547722|FG000|Did Not Receive Cycle 2|Overall Study||7
10660585|NCT02251990|11822194|FG000|COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)|Completed 24 weeks of follow-up|360
10660586|NCT02251990|11822195|FG001|COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)|Completed 12 weeks of Grazoprevir/Elbasvir|118
10660587|NCT02251990|11822194|FG000|NOT COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)||0
10660588|NCT02251990|11822195|FG001|NOT COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)||3
10660589|NCT02251990|11822194|FG000|STARTED|Period 3 (DTG Follow-up)|The ITG completed the study with Period 2|0
10660590|NCT02251990|11822195|FG001|STARTED|Period 3 (DTG Follow-up)|3 participants that discontinued treatment in Period 2 were included in Follow-up.|121
10660591|NCT02251990|11822194|FG000|COMPLETED|Period 3 (DTG Follow-up)||0
10660592|NCT02251990|11822195|FG001|COMPLETED|Period 3 (DTG Follow-up)|Completed 24 weeks of follow-up|121
10660593|NCT02251990|11822194|FG000|NOT COMPLETED|Period 3 (DTG Follow-up)||0
10660594|NCT02251990|11822195|FG001|NOT COMPLETED|Period 3 (DTG Follow-up)||0
10660595|NCT02252016|11822204|FG000|STARTED|Overall Study||107
10660596|NCT02252016|11822205|FG001|STARTED|Overall Study||52
10660597|NCT02252016|11822204|FG000|COMPLETED|Overall Study|Completed = completed 24 weeks of follow-up|104
10660598|NCT02252016|11822205|FG001|COMPLETED|Overall Study|Completed = completed 24 weeks of follow-up|49
10660599|NCT02252016|11822204|FG000|NOT COMPLETED|Overall Study||3
10660600|NCT02252016|11822205|FG001|NOT COMPLETED|Overall Study||3
10660609|NCT02252068|11822223|FG000|STARTED|Overall Study||5
10660610|NCT02252068|11822224|FG001|STARTED|Overall Study||13
10660611|NCT02252068|11822225|FG002|STARTED|Overall Study||13
10660612|NCT02252068|11822223|FG000|COMPLETED|Overall Study||3
10660613|NCT02252068|11822224|FG001|COMPLETED|Overall Study||13
10660614|NCT02252068|11822225|FG002|COMPLETED|Overall Study||13
10660615|NCT02252068|11822223|FG000|NOT COMPLETED|Overall Study||2
10660616|NCT02252068|11822224|FG001|NOT COMPLETED|Overall Study||0
10660617|NCT02252068|11822225|FG002|NOT COMPLETED|Overall Study||0
10660618|NCT02252081|11822235|FG000|STARTED|Overall Study||30
10660619|NCT02252081|11822236|FG001|STARTED|Overall Study||30
10660620|NCT02252081|11822235|FG000|COMPLETED|Overall Study||24
10660621|NCT02252081|11822236|FG001|COMPLETED|Overall Study||26
10660622|NCT02252081|11822235|FG000|NOT COMPLETED|Overall Study||6
10660623|NCT02252081|11822236|FG001|NOT COMPLETED|Overall Study||4
10660624|NCT02252133|11822247|FG000|STARTED|Period 1||23
10660625|NCT02252133|11822248|FG001|STARTED|Period 1||24
10660626|NCT02252133|11822247|FG000|COMPLETED|Period 1||23
10660627|NCT02252133|11822248|FG001|COMPLETED|Period 1||24
10660628|NCT02252133|11822247|FG000|NOT COMPLETED|Period 1||0
10660629|NCT02252133|11822248|FG001|NOT COMPLETED|Period 1||0
10660630|NCT02252133|11822247|FG000|STARTED|Period 2||23
10660631|NCT02252133|11822248|FG001|STARTED|Period 2||24
10660632|NCT02252133|11822247|FG000|COMPLETED|Period 2||23
10660633|NCT02252133|11822248|FG001|COMPLETED|Period 2||24
10660634|NCT02252133|11822247|FG000|NOT COMPLETED|Period 2||0
10660635|NCT02252133|11822248|FG001|NOT COMPLETED|Period 2||0
10660636|NCT02252146|11822254|FG000|STARTED|Overall Study||6
10660637|NCT02252146|11822254|FG000|COMPLETED|Overall Study||0
10660638|NCT02252146|11822254|FG000|NOT COMPLETED|Overall Study||6
10660639|NCT02252211|11822260|FG000|STARTED|Overall Study||5
10660640|NCT02252211|11822261|FG001|STARTED|Overall Study||3
10660641|NCT02252211|11822262|FG002|STARTED|Overall Study||1
10660642|NCT02252211|11822260|FG000|Received Dose 1 (Day 1)|Overall Study||4
10660643|NCT02252211|11822261|FG001|Received Dose 1 (Day 1)|Overall Study||3
10660644|NCT02252211|11822262|FG002|Received Dose 1 (Day 1)|Overall Study||0
10660645|NCT02252211|11822260|FG000|Received Dose 2 (Day 8)|Overall Study||4
10660646|NCT02252211|11822261|FG001|Received Dose 2 (Day 8)|Overall Study||3
10403385|NCT00729612|11547722|FG000|Received Cycle 2|Overall Study||54
10660647|NCT02252211|11822262|FG002|Received Dose 2 (Day 8)|Overall Study||0
10660648|NCT02252211|11822260|FG000|Received Dose 3 (Day 22)|Overall Study||3
10660649|NCT02252211|11822261|FG001|Received Dose 3 (Day 22)|Overall Study||3
10660650|NCT02252211|11822262|FG002|Received Dose 3 (Day 22)|Overall Study||0
10660651|NCT02252211|11822260|FG000|Received Dose 4 (Day 36)|Overall Study||1
10403386|NCT00729612|11547722|FG000|Died After Cycle 2 Before Response Eval|Overall Study||1
10403387|NCT00729612|11547722|FG000|COMPLETED|Overall Study||53
10403388|NCT00729612|11547722|FG000|NOT COMPLETED|Overall Study||10
10403389|NCT00729677|11547726|FG000|STARTED|Overall Study||64
10403390|NCT00729677|11547726|FG000|COMPLETED|Overall Study||64
10403391|NCT00729677|11547726|FG000|NOT COMPLETED|Overall Study||0
10403392|NCT00729690|11547740|FG000|STARTED|Overall Study||16
10403393|NCT00729690|11547741|FG001|STARTED|Overall Study||16
10403394|NCT00729690|11547742|FG002|STARTED|Overall Study||16
10403395|NCT00729690|11547740|FG000|COMPLETED|Overall Study||16
10403396|NCT00729690|11547741|FG001|COMPLETED|Overall Study||14
10403397|NCT00729690|11547742|FG002|COMPLETED|Overall Study||14
10403398|NCT00729690|11547740|FG000|NOT COMPLETED|Overall Study||0
10403399|NCT00729690|11547741|FG001|NOT COMPLETED|Overall Study||2
10403400|NCT00729690|11547742|FG002|NOT COMPLETED|Overall Study||2
10403401|NCT00729781|11547750|FG000|STARTED|Original Study||45
10403402|NCT00729781|11547750|FG000|COMPLETED|Original Study||45
10403403|NCT00729781|11547750|FG000|NOT COMPLETED|Original Study||0
10403404|NCT00729781|11547750|FG000|STARTED|Long-term Follow-up Study|Enrollment in the long-term follow-up required contact and a new Informed Consent.|42
10403405|NCT00729781|11547750|FG000|COMPLETED|Long-term Follow-up Study|All subjects completed the original study, but 3 did not consent to enroll in the follow-up study.|42
10403406|NCT00729781|11547750|FG000|NOT COMPLETED|Long-term Follow-up Study||0
10403407|NCT00729807|11547754|FG000|STARTED|Overall Study||6
10403408|NCT00729807|11547754|FG000|COMPLETED|Overall Study||6
10403409|NCT00729807|11547754|FG000|NOT COMPLETED|Overall Study||0
10403410|NCT00729833|11547758|FG000|STARTED|Overall Study||20
10403411|NCT00729833|11547759|FG001|STARTED|Overall Study||7
10403412|NCT00729833|11547760|FG002|STARTED|Overall Study||12
10403413|NCT00729833|11547761|FG003|STARTED|Overall Study||6
10403414|NCT00729833|11547758|FG000|COMPLETED|Overall Study||0
10403415|NCT00729833|11547759|FG001|COMPLETED|Overall Study||0
10403416|NCT00729833|11547760|FG002|COMPLETED|Overall Study||0
10403417|NCT00729833|11547761|FG003|COMPLETED|Overall Study||0
10403418|NCT00729833|11547758|FG000|NOT COMPLETED|Overall Study||20
10403419|NCT00729833|11547759|FG001|NOT COMPLETED|Overall Study||7
10403420|NCT00729833|11547760|FG002|NOT COMPLETED|Overall Study||12
10403421|NCT00729833|11547761|FG003|NOT COMPLETED|Overall Study||6
10403422|NCT00729846|11547774|FG000|STARTED|Overall Study||11
10403423|NCT00729846|11547775|FG001|STARTED|Overall Study||11
10403424|NCT00729846|11547774|FG000|COMPLETED|Overall Study||11
10403425|NCT00729846|11547775|FG001|COMPLETED|Overall Study||11
10403426|NCT00729846|11547774|FG000|NOT COMPLETED|Overall Study||0
10403427|NCT00729846|11547775|FG001|NOT COMPLETED|Overall Study||0
10403428|NCT00729859|11547784|FG000|STARTED|Overall Study||8
10403429|NCT00729859|11547785|FG001|STARTED|Overall Study||8
10403430|NCT00729859|11547786|FG002|STARTED|Overall Study||8
10403431|NCT00729859|11547784|FG000|COMPLETED|Overall Study||8
10403432|NCT00729859|11547785|FG001|COMPLETED|Overall Study||6
10403433|NCT00729859|11547786|FG002|COMPLETED|Overall Study||8
10403434|NCT00729859|11547784|FG000|NOT COMPLETED|Overall Study||0
10403435|NCT00729859|11547785|FG001|NOT COMPLETED|Overall Study||2
10403436|NCT00729859|11547786|FG002|NOT COMPLETED|Overall Study||0
10403437|NCT00729924|11547802|FG000|STARTED|Overall Study||40
10403438|NCT00729924|11547802|FG000|COMPLETED|Overall Study||40
10403439|NCT00729924|11547802|FG000|NOT COMPLETED|Overall Study||0
10403440|NCT00729937|11547815|FG000|STARTED|Overall Study||629
10403441|NCT00729937|11547816|FG001|STARTED|Overall Study||636
10403442|NCT00729937|11547817|FG002|STARTED|Overall Study||251
10403443|NCT00729937|11547818|FG003|STARTED|Overall Study||249
10403444|NCT00729937|11547819|FG004|STARTED|Overall Study||249
10403445|NCT00729937|11547820|FG005|STARTED|Overall Study||251
10403446|NCT00729937|11547815|FG000|COMPLETED|Overall Study||555
10403447|NCT00729937|11547816|FG001|COMPLETED|Overall Study||548
10403448|NCT00729937|11547817|FG002|COMPLETED|Overall Study||222
10721617|NCT02729038|11885317|FG000|STARTED|Part 1 (Up to 44 Days)||8
10721618|NCT02729038|11885318|FG001|STARTED|Part 1 (Up to 44 Days)||8
10721619|NCT02729038|11885319|FG002|STARTED|Part 1 (Up to 44 Days)||8
10403449|NCT00729937|11547818|FG003|COMPLETED|Overall Study||215
10403450|NCT00729937|11547819|FG004|COMPLETED|Overall Study||221
10403451|NCT00729937|11547820|FG005|COMPLETED|Overall Study||214
10403452|NCT00729937|11547815|FG000|NOT COMPLETED|Overall Study||74
10403453|NCT00729937|11547816|FG001|NOT COMPLETED|Overall Study||88
10403454|NCT00729937|11547817|FG002|NOT COMPLETED|Overall Study||29
10403455|NCT00729937|11547818|FG003|NOT COMPLETED|Overall Study||34
10403456|NCT00729937|11547819|FG004|NOT COMPLETED|Overall Study||28
10403457|NCT00729937|11547820|FG005|NOT COMPLETED|Overall Study||37
10403458|NCT00730015|11547837|FG000|STARTED|Overall Study||217
10403459|NCT00730015|11547838|FG001|STARTED|Overall Study||217
10403460|NCT00730015|11547839|FG002|STARTED|Overall Study||209
10403461|NCT00730015|11547837|FG000|COMPLETED|Overall Study||186
10403462|NCT00730015|11547838|FG001|COMPLETED|Overall Study||177
10403463|NCT00730015|11547839|FG002|COMPLETED|Overall Study||177
10403464|NCT00730015|11547837|FG000|NOT COMPLETED|Overall Study||31
10403465|NCT00730015|11547838|FG001|NOT COMPLETED|Overall Study||40
10403466|NCT00730015|11547839|FG002|NOT COMPLETED|Overall Study||32
10403467|NCT00730028|11547857|FG000|STARTED|Overall Study||264
10403468|NCT00730028|11547858|FG001|STARTED|Overall Study||260
10403469|NCT00730028|11547859|FG002|STARTED|Overall Study||266
10403470|NCT00730028|11547860|FG003|STARTED|Overall Study||263
10403471|NCT00730028|11547861|FG004|STARTED|Overall Study||257
10403472|NCT00730028|11547857|FG000|COMPLETED|Overall Study||204
10403473|NCT00730028|11547858|FG001|COMPLETED|Overall Study||194
10403474|NCT00730028|11547859|FG002|COMPLETED|Overall Study||221
10403475|NCT00730028|11547860|FG003|COMPLETED|Overall Study||207
10403476|NCT00730028|11547861|FG004|COMPLETED|Overall Study||175
10403477|NCT00730028|11547857|FG000|NOT COMPLETED|Overall Study||60
10403478|NCT00730028|11547858|FG001|NOT COMPLETED|Overall Study||66
10403479|NCT00730028|11547859|FG002|NOT COMPLETED|Overall Study||45
10403480|NCT00730028|11547860|FG003|NOT COMPLETED|Overall Study||56
10403481|NCT00730028|11547861|FG004|NOT COMPLETED|Overall Study||82
10403482|NCT00730041|11547875|FG000|STARTED|Overall Study|4/26 (15.4%) female, 22/26 (84.6%) male|26
10403483|NCT00730041|11547876|FG001|STARTED|Overall Study|4/25 (16.0%) female, 21/25 (84.0%) male|25
10403484|NCT00730041|11547875|FG000|COMPLETED|Overall Study||26
10403485|NCT00730041|11547876|FG001|COMPLETED|Overall Study|One subject did not return for the final PSG or final visit, and one missed only the final visit.|23
10403486|NCT00730041|11547875|FG000|NOT COMPLETED|Overall Study||0
10403487|NCT00730041|11547876|FG001|NOT COMPLETED|Overall Study||2
10403488|NCT00730158|11547884|FG000|STARTED|Overall Study||17
10403489|NCT00730158|11547885|FG001|STARTED|Overall Study||16
10403490|NCT00730158|11547884|FG000|COMPLETED|Overall Study||16
10403491|NCT00730158|11547885|FG001|COMPLETED|Overall Study||15
10403492|NCT00730158|11547884|FG000|NOT COMPLETED|Overall Study||1
10403493|NCT00730158|11547885|FG001|NOT COMPLETED|Overall Study||1
10403494|NCT00730171|11547895|FG000|STARTED|Overall Study||1725
10403495|NCT00730171|11547895|FG000|CC Safety Population|Overall Study||607
10403496|NCT00730171|11547895|FG000|IBS-C Safety Population|Overall Study||1119
10403497|NCT00730171|11547895|FG000|COMPLETED|Overall Study||954
10403498|NCT00730171|11547895|FG000|NOT COMPLETED|Overall Study||771
10403499|NCT00730236|11547903|FG000|STARTED|Overall Study||29
10403500|NCT00730236|11547903|FG000|COMPLETED|Overall Study||23
10403501|NCT00730236|11547903|FG000|NOT COMPLETED|Overall Study||6
10403502|NCT00730275|11547911|FG000|STARTED|Overall Study||9
10403503|NCT00730275|11547912|FG001|STARTED|Overall Study||9
10403504|NCT00730275|11547913|FG002|STARTED|Overall Study||8
10403505|NCT00730275|11547914|FG003|STARTED|Overall Study||9
10403506|NCT00730275|11547911|FG000|COMPLETED|Overall Study||9
10403507|NCT00730275|11547912|FG001|COMPLETED|Overall Study||9
10403508|NCT00730275|11547913|FG002|COMPLETED|Overall Study||8
10403509|NCT00730275|11547914|FG003|COMPLETED|Overall Study||8
10403510|NCT00730275|11547911|FG000|NOT COMPLETED|Overall Study||0
10403511|NCT00730275|11547912|FG001|NOT COMPLETED|Overall Study||0
10403512|NCT00730275|11547913|FG002|NOT COMPLETED|Overall Study||0
10403513|NCT00730275|11547914|FG003|NOT COMPLETED|Overall Study||1
10403514|NCT00730327|11547927|FG000|STARTED|Overall Study|Started is defined as subjects that began treatment.|125
10403515|NCT00730327|11547928|FG001|STARTED|Overall Study||130
10403516|NCT00730327|11547927|FG000|Completed Week 26|Overall Study|Week 26 was halfway through the study, at which point the BIB group had their balloon removed.|125
10403517|NCT00730327|11547928|FG001|Completed Week 26|Overall Study||99
10403518|NCT00730327|11547927|FG000|COMPLETED|Overall Study|Completed defined as subjects who completed the Week 52 follow-up visit.|98
10660652|NCT02252211|11822261|FG001|Received Dose 4 (Day 36)|Overall Study||1
10660653|NCT02252211|11822262|FG002|Received Dose 4 (Day 36)|Overall Study||0
10660654|NCT02252211|11822260|FG000|Received Further Doses (Through Dose 24)|Overall Study||1
10660655|NCT02252211|11822261|FG001|Received Further Doses (Through Dose 24)|Overall Study||0
10660656|NCT02252211|11822262|FG002|Received Further Doses (Through Dose 24)|Overall Study||0
10660657|NCT02252211|11822260|FG000|COMPLETED|Overall Study||0
10660658|NCT02252211|11822261|FG001|COMPLETED|Overall Study||0
10660659|NCT02252211|11822262|FG002|COMPLETED|Overall Study||0
10660660|NCT02252211|11822260|FG000|NOT COMPLETED|Overall Study||5
10660661|NCT02252211|11822261|FG001|NOT COMPLETED|Overall Study||3
10660662|NCT02252211|11822262|FG002|NOT COMPLETED|Overall Study||1
10660663|NCT02252354|11822271|FG000|STARTED|Overall Study||6
10660664|NCT02252354|11822272|FG001|STARTED|Overall Study||6
10660665|NCT02252354|11822271|FG000|COMPLETED|Overall Study||6
10660666|NCT02252354|11822272|FG001|COMPLETED|Overall Study||6
10660667|NCT02252354|11822271|FG000|NOT COMPLETED|Overall Study||0
10660668|NCT02252354|11822272|FG001|NOT COMPLETED|Overall Study||0
10660669|NCT02252406|11822280|FG000|STARTED|Starting Dose Ranolazine 500 mg BID||16
10660670|NCT02252406|11822281|FG001|STARTED|Starting Dose Ranolazine 500 mg BID||17
10660671|NCT02252406|11822280|FG000|COMPLETED|Starting Dose Ranolazine 500 mg BID||12
10660672|NCT02252406|11822281|FG001|COMPLETED|Starting Dose Ranolazine 500 mg BID||14
10660673|NCT02252406|11822280|FG000|NOT COMPLETED|Starting Dose Ranolazine 500 mg BID||4
10660674|NCT02252406|11822281|FG001|NOT COMPLETED|Starting Dose Ranolazine 500 mg BID||3
10660675|NCT02252406|11822280|FG000|STARTED|Titrated to Ranolazine 1000mg BID||12
10660676|NCT02252406|11822281|FG001|STARTED|Titrated to Ranolazine 1000mg BID||14
10660677|NCT02252406|11822280|FG000|COMPLETED|Titrated to Ranolazine 1000mg BID||9
10660678|NCT02252406|11822281|FG001|COMPLETED|Titrated to Ranolazine 1000mg BID||13
10660679|NCT02252406|11822280|FG000|NOT COMPLETED|Titrated to Ranolazine 1000mg BID||3
10660680|NCT02252406|11822281|FG001|NOT COMPLETED|Titrated to Ranolazine 1000mg BID||1
10660681|NCT02252445|11822289|FG000|STARTED|Overall Study||41
10403519|NCT00730327|11547928|FG001|COMPLETED|Overall Study||93
10403520|NCT00730327|11547927|FG000|NOT COMPLETED|Overall Study||27
10403521|NCT00730327|11547928|FG001|NOT COMPLETED|Overall Study||37
10403522|NCT00730353|11547934|FG000|STARTED|Overall Study||28
10403523|NCT00730353|11547934|FG000|COMPLETED|Overall Study||28
10403524|NCT00730353|11547934|FG000|NOT COMPLETED|Overall Study||0
10403525|NCT00730405|11547943|FG000|STARTED|Overall Study-Treatment Phase||116
10403526|NCT00730405|11547944|FG001|STARTED|Overall Study-Treatment Phase||117
10660682|NCT02252445|11822290|FG001|STARTED|Overall Study||41
10660683|NCT02252445|11822289|FG000|COMPLETED|Overall Study||41
10660684|NCT02252445|11822290|FG001|COMPLETED|Overall Study||41
10660685|NCT02252445|11822289|FG000|NOT COMPLETED|Overall Study||0
10403527|NCT00730405|11547945|FG002|STARTED|Overall Study-Treatment Phase||117
10403528|NCT00730405|11547946|FG003|STARTED|Overall Study-Treatment Phase||117
10403529|NCT00730405|11547947|FG004|STARTED|Overall Study-Treatment Phase||115
10403530|NCT00730405|11547943|FG000|COMPLETED|Overall Study-Treatment Phase||97
10403531|NCT00730405|11547944|FG001|COMPLETED|Overall Study-Treatment Phase||96
10403532|NCT00730405|11547945|FG002|COMPLETED|Overall Study-Treatment Phase||96
10403533|NCT00730405|11547946|FG003|COMPLETED|Overall Study-Treatment Phase||98
10403534|NCT00730405|11547947|FG004|COMPLETED|Overall Study-Treatment Phase||95
10403535|NCT00730405|11547943|FG000|NOT COMPLETED|Overall Study-Treatment Phase||19
10403536|NCT00730405|11547944|FG001|NOT COMPLETED|Overall Study-Treatment Phase||21
10403537|NCT00730405|11547945|FG002|NOT COMPLETED|Overall Study-Treatment Phase||21
10403538|NCT00730405|11547946|FG003|NOT COMPLETED|Overall Study-Treatment Phase||19
10403539|NCT00730405|11547947|FG004|NOT COMPLETED|Overall Study-Treatment Phase||20
10403540|NCT00730405|11547943|FG000|STARTED|Overall Study-follow-up Phase||116
10403541|NCT00730405|11547944|FG001|STARTED|Overall Study-follow-up Phase||117
10403542|NCT00730405|11547945|FG002|STARTED|Overall Study-follow-up Phase||117
10403543|NCT00730405|11547946|FG003|STARTED|Overall Study-follow-up Phase||117
10403544|NCT00730405|11547947|FG004|STARTED|Overall Study-follow-up Phase||115
10403545|NCT00730405|11547943|FG000|COMPLETED|Overall Study-follow-up Phase||95
10403546|NCT00730405|11547944|FG001|COMPLETED|Overall Study-follow-up Phase||96
10403547|NCT00730405|11547945|FG002|COMPLETED|Overall Study-follow-up Phase||94
10403548|NCT00730405|11547946|FG003|COMPLETED|Overall Study-follow-up Phase||100
10403549|NCT00730405|11547947|FG004|COMPLETED|Overall Study-follow-up Phase||93
10403550|NCT00730405|11547943|FG000|NOT COMPLETED|Overall Study-follow-up Phase||21
10403551|NCT00730405|11547944|FG001|NOT COMPLETED|Overall Study-follow-up Phase||21
10403552|NCT00730405|11547945|FG002|NOT COMPLETED|Overall Study-follow-up Phase||23
10403553|NCT00730405|11547946|FG003|NOT COMPLETED|Overall Study-follow-up Phase||17
10403554|NCT00730405|11547947|FG004|NOT COMPLETED|Overall Study-follow-up Phase||22
10403555|NCT00730483|11547961|FG000|STARTED|Overall Study||13
10403556|NCT00730483|11547961|FG000|1 Month After First DEB-TACE|Overall Study||13
10403557|NCT00730483|11547961|FG000|6 Months After First DEB-TACE|Overall Study||10
10403558|NCT00730483|11547961|FG000|COMPLETED|Overall Study||6
10403559|NCT00730483|11547961|FG000|NOT COMPLETED|Overall Study||7
10403560|NCT00730522|11547968|FG000|STARTED|Overall Study||28
10403561|NCT00730522|11547969|FG001|STARTED|Overall Study||27
10403562|NCT00730522|11547968|FG000|COMPLETED|Overall Study||28
10403563|NCT00730522|11547969|FG001|COMPLETED|Overall Study||27
10403564|NCT00730522|11547968|FG000|NOT COMPLETED|Overall Study||0
10403565|NCT00730522|11547969|FG001|NOT COMPLETED|Overall Study||0
10403566|NCT00730691|11547982|FG000|STARTED|Overall Study||157
10403567|NCT00730691|11547983|FG001|STARTED|Overall Study||156
10403568|NCT00730691|11547984|FG002|STARTED|Overall Study|One participant was randomized by error. Reason not completed is reported as Other.|156
10403569|NCT00730691|11547985|FG003|STARTED|Overall Study||156
10403570|NCT00730691|11547986|FG004|STARTED|Overall Study||156
10403571|NCT00730691|11547982|FG000|COMPLETED|Overall Study||121
10403572|NCT00730691|11547983|FG001|COMPLETED|Overall Study||120
10403573|NCT00730691|11547984|FG002|COMPLETED|Overall Study||117
10403574|NCT00730691|11547985|FG003|COMPLETED|Overall Study||111
10403575|NCT00730691|11547986|FG004|COMPLETED|Overall Study||106
10403576|NCT00730691|11547982|FG000|NOT COMPLETED|Overall Study||36
10403577|NCT00730691|11547983|FG001|NOT COMPLETED|Overall Study||36
10403578|NCT00730691|11547984|FG002|NOT COMPLETED|Overall Study||39
10403579|NCT00730691|11547985|FG003|NOT COMPLETED|Overall Study||45
10403580|NCT00730691|11547986|FG004|NOT COMPLETED|Overall Study||50
10403581|NCT00730730|11547998|FG000|STARTED|Overall Study||50
10403582|NCT00730730|11547998|FG000|COMPLETED|Overall Study||50
10403583|NCT00730730|11547998|FG000|NOT COMPLETED|Overall Study||0
10403584|NCT00730756|11548004|FG000|STARTED|Overall Study||49
10403585|NCT00730756|11548005|FG001|STARTED|Overall Study||53
10403586|NCT00730756|11548004|FG000|COMPLETED|Overall Study||45
10403587|NCT00730756|11548005|FG001|COMPLETED|Overall Study||48
10403588|NCT00730756|11548004|FG000|NOT COMPLETED|Overall Study||4
10403589|NCT00730756|11548005|FG001|NOT COMPLETED|Overall Study||5
10403590|NCT00730847|11548011|FG000|STARTED|Overall Study||596
10403591|NCT00730847|11548011|FG000|COMPLETED|Overall Study||465
10403592|NCT00730847|11548011|FG000|NOT COMPLETED|Overall Study||131
10403593|NCT00730912|11548018|FG000|STARTED|Overall Study||53
10403594|NCT00730912|11548019|FG001|STARTED|Overall Study||104
10403595|NCT00730912|11548020|FG002|STARTED|Overall Study||104
10403596|NCT00730912|11548018|FG000|COMPLETED|Overall Study||53
10403597|NCT00730912|11548019|FG001|COMPLETED|Overall Study||104
10403598|NCT00730912|11548020|FG002|COMPLETED|Overall Study||103
10403599|NCT00730912|11548018|FG000|NOT COMPLETED|Overall Study||0
10403600|NCT00730912|11548019|FG001|NOT COMPLETED|Overall Study||0
10403601|NCT00730912|11548020|FG002|NOT COMPLETED|Overall Study||1
10403602|NCT00730925|11548028|FG000|STARTED|Overall Study||41
10403603|NCT00730925|11548028|FG000|COMPLETED|Overall Study|On treatment at analysis cut-off date|0
10403604|NCT00730925|11548028|FG000|NOT COMPLETED|Overall Study||41
10403605|NCT00730964|11548032|FG000|STARTED|Overall Study||1039
10403606|NCT00730964|11548032|FG000|COMPLETED|Overall Study||1039
10403607|NCT00730964|11548032|FG000|NOT COMPLETED|Overall Study||0
10403608|NCT00731042|11548039|FG000|STARTED|First Intervention||16
10403609|NCT00731042|11548040|FG001|STARTED|First Intervention||17
10403610|NCT00731042|11548039|FG000|COMPLETED|First Intervention||16
10403611|NCT00731042|11548040|FG001|COMPLETED|First Intervention||17
10403612|NCT00731042|11548039|FG000|NOT COMPLETED|First Intervention||0
10403613|NCT00731042|11548040|FG001|NOT COMPLETED|First Intervention||0
10403614|NCT00731042|11548039|FG000|STARTED|Wash-out||16
10403615|NCT00731042|11548040|FG001|STARTED|Wash-out||17
10403616|NCT00731042|11548039|FG000|COMPLETED|Wash-out||16
10544232|NCT01490060|11697513|FG001|NOT COMPLETED|Cycle 1||1
10660686|NCT02252445|11822290|FG001|NOT COMPLETED|Overall Study||0
10660687|NCT02252536|11822298|FG000|STARTED|Overall Study||173
10660688|NCT02252536|11822299|FG001|STARTED|Overall Study||173
10660689|NCT02252536|11822298|FG000|COMPLETED|Overall Study||168
10660690|NCT02252536|11822299|FG001|COMPLETED|Overall Study||170
10660691|NCT02252536|11822298|FG000|NOT COMPLETED|Overall Study||5
10660692|NCT02252536|11822299|FG001|NOT COMPLETED|Overall Study||3
10660693|NCT02252562|11822307|FG000|STARTED|Overall Study||1620
10660694|NCT02252562|11822308|FG001|STARTED|Overall Study||1636
10660695|NCT02252562|11822307|FG000|COMPLETED|Overall Study||1620
10660696|NCT02252562|11822308|FG001|COMPLETED|Overall Study||1636
10660697|NCT02252562|11822307|FG000|NOT COMPLETED|Overall Study||0
10660698|NCT02252562|11822308|FG001|NOT COMPLETED|Overall Study||0
10660699|NCT02252588|11822317|FG000|STARTED|Overall Study||24
10660700|NCT02252588|11822318|FG001|STARTED|Overall Study||20
10660701|NCT02252588|11822317|FG000|COMPLETED|Overall Study||20
10660702|NCT02252588|11822318|FG001|COMPLETED|Overall Study||20
10660703|NCT02252588|11822317|FG000|NOT COMPLETED|Overall Study||4
10660704|NCT02252588|11822318|FG001|NOT COMPLETED|Overall Study||0
10660705|NCT02252666|11822324|FG000|STARTED|Overall Study||6
10660706|NCT02252666|11822324|FG000|COMPLETED|Overall Study||6
10660707|NCT02252666|11822324|FG000|NOT COMPLETED|Overall Study||0
10660708|NCT02252718|11822328|FG000|STARTED|Overall Study||100
10660709|NCT02252718|11822328|FG000|COMPLETED|Overall Study||100
10660710|NCT02252718|11822328|FG000|NOT COMPLETED|Overall Study||0
10660711|NCT02252744|11822332|FG000|STARTED|Overall Study||286
10660712|NCT02252744|11822332|FG000|COMPLETED|Overall Study||286
10660713|NCT02252744|11822332|FG000|NOT COMPLETED|Overall Study||0
10660714|NCT02252939|11822336|FG000|STARTED|Overall Study||62
10660715|NCT02252939|11822336|FG000|COMPLETED|Overall Study||59
10660716|NCT02252939|11822336|FG000|NOT COMPLETED|Overall Study||3
10660717|NCT02252965|11822347|FG000|STARTED|Overall Study||267
10660718|NCT02252965|11822348|FG001|STARTED|Overall Study||265
10660719|NCT02252965|11822347|FG000|Safety Population|Overall Study|Out of 261, 12 subjects intolerant to the Metformin IR switched to Metformin XR group.|261
10660720|NCT02252965|11822348|FG001|Safety Population|Overall Study||264
10660721|NCT02252965|11822347|FG000|COMPLETED|Overall Study||227
10660722|NCT02252965|11822348|FG001|COMPLETED|Overall Study||222
10403617|NCT00731042|11548040|FG001|COMPLETED|Wash-out||17
10403618|NCT00731042|11548039|FG000|NOT COMPLETED|Wash-out||0
10544233|NCT01490060|11697514|FG002|NOT COMPLETED|Cycle 1||3
10544234|NCT01490060|11697515|FG003|NOT COMPLETED|Cycle 1||3
10544235|NCT01490060|11697512|FG000|STARTED|Cycle 2||11
10544236|NCT01490060|11697513|FG001|STARTED|Cycle 2||12
10544237|NCT01490060|11697514|FG002|STARTED|Cycle 2||9
10544238|NCT01490060|11697515|FG003|STARTED|Cycle 2||8
10544239|NCT01490060|11697512|FG000|COMPLETED|Cycle 2||9
10544240|NCT01490060|11697513|FG001|COMPLETED|Cycle 2||11
10544241|NCT01490060|11697514|FG002|COMPLETED|Cycle 2||8
10544242|NCT01490060|11697515|FG003|COMPLETED|Cycle 2||8
10544243|NCT01490060|11697512|FG000|NOT COMPLETED|Cycle 2||2
10544244|NCT01490060|11697513|FG001|NOT COMPLETED|Cycle 2||1
10544245|NCT01490060|11697514|FG002|NOT COMPLETED|Cycle 2||1
10544246|NCT01490060|11697515|FG003|NOT COMPLETED|Cycle 2||0
10544247|NCT01490073|11697525|FG000|STARTED|Overall Study||12
10544248|NCT01490073|11697526|FG001|STARTED|Overall Study||12
10544249|NCT01490073|11697525|FG000|COMPLETED|Overall Study||12
10660723|NCT02252965|11822347|FG000|NOT COMPLETED|Overall Study||40
10403619|NCT00731042|11548040|FG001|NOT COMPLETED|Wash-out||0
10403620|NCT00731042|11548039|FG000|STARTED|Second Intervention||16
10403621|NCT00731042|11548040|FG001|STARTED|Second Intervention||17
10403622|NCT00731042|11548039|FG000|COMPLETED|Second Intervention||16
10403623|NCT00731042|11548040|FG001|COMPLETED|Second Intervention|2 subjects did not met inclusion criteria for Period 2 Visual scoring skin condition|15
10403624|NCT00731042|11548039|FG000|NOT COMPLETED|Second Intervention||0
10403625|NCT00731042|11548040|FG001|NOT COMPLETED|Second Intervention||2
10403626|NCT00731055|11548046|FG000|STARTED|Overall Study|This is a within-subjects study design.|16
10403627|NCT00731055|11548046|FG000|Received Placebo|Overall Study||16
10403628|NCT00731055|11548046|FG000|Received Varenicline 0.5 mg|Overall Study||16
10403629|NCT00731055|11548046|FG000|Received Varenicline 1.0 mg|Overall Study||16
10403630|NCT00731055|11548046|FG000|Received Varenicline 2.0 mg|Overall Study||16
10403631|NCT00731055|11548046|FG000|COMPLETED|Overall Study||16
10403632|NCT00731055|11548046|FG000|NOT COMPLETED|Overall Study||0
10403633|NCT00731094|11548055|FG000|STARTED|Overall Study||116
10403634|NCT00731094|11548056|FG001|STARTED|Overall Study||116
10403635|NCT00731094|11548055|FG000|Month 6|Overall Study||101
10403636|NCT00731094|11548056|FG001|Month 6|Overall Study||107
10403637|NCT00731094|11548055|FG000|COMPLETED|Overall Study||98
10403638|NCT00731094|11548056|FG001|COMPLETED|Overall Study||105
10403639|NCT00731094|11548055|FG000|NOT COMPLETED|Overall Study||18
10403640|NCT00731094|11548056|FG001|NOT COMPLETED|Overall Study||11
10403641|NCT00731120|11548065|FG000|STARTED|Overall Study||153
10403642|NCT00731120|11548066|FG001|STARTED|Overall Study||152
10403643|NCT00731120|11548067|FG002|STARTED|Overall Study||152
10403644|NCT00731120|11548065|FG000|Treated|Overall Study||153
10403645|NCT00731120|11548066|FG001|Treated|Overall Study||151
10403646|NCT00731120|11548067|FG002|Treated|Overall Study||152
10403647|NCT00731120|11548065|FG000|COMPLETED|Overall Study||111
10403648|NCT00731120|11548066|FG001|COMPLETED|Overall Study||109
10403649|NCT00731120|11548067|FG002|COMPLETED|Overall Study||116
10403650|NCT00731120|11548065|FG000|NOT COMPLETED|Overall Study||42
10403651|NCT00731120|11548066|FG001|NOT COMPLETED|Overall Study||43
10403652|NCT00731120|11548067|FG002|NOT COMPLETED|Overall Study||36
10403653|NCT00731133|11548075|FG000|STARTED|Overall Study||15
10403654|NCT00731133|11548075|FG000|COMPLETED|Overall Study||5
10403655|NCT00731133|11548075|FG000|NOT COMPLETED|Overall Study||10
10403656|NCT00731198|11548081|FG000|STARTED|Overall Study||325
10403657|NCT00731198|11548082|FG001|STARTED|Overall Study||325
10403658|NCT00731198|11548081|FG000|COMPLETED|Overall Study||319
10403659|NCT00731198|11548082|FG001|COMPLETED|Overall Study||319
10403660|NCT00731198|11548081|FG000|NOT COMPLETED|Overall Study||6
10403661|NCT00731198|11548082|FG001|NOT COMPLETED|Overall Study||6
10403662|NCT00731211|11548088|FG000|STARTED|Overall Study|2 patients ineligible (papillary histologic type-1 pt. Previous treatment with everolimus alone-1 pt|55
10403663|NCT00731211|11548088|FG000|COMPLETED|Overall Study||55
10721620|NCT02729038|11885320|FG003|STARTED|Part 1 (Up to 44 Days)||0
10721621|NCT02729038|11885317|FG000|COMPLETED|Part 1 (Up to 44 Days)||8
10721622|NCT02729038|11885318|FG001|COMPLETED|Part 1 (Up to 44 Days)||8
10403664|NCT00731211|11548088|FG000|NOT COMPLETED|Overall Study||0
10403665|NCT00731341|11548092|FG000|STARTED|Overall Study||3
10403666|NCT00731341|11548092|FG000|COMPLETED|Overall Study||3
10403667|NCT00731341|11548092|FG000|NOT COMPLETED|Overall Study||0
10403668|NCT00731484|11548096|FG000|STARTED|Overall Study||233
10403669|NCT00731484|11548096|FG000|COMPLETED|Overall Study||233
10403670|NCT00731484|11548096|FG000|NOT COMPLETED|Overall Study||0
10403671|NCT00731549|11548100|FG000|STARTED|Overall Study||1081
10403672|NCT00731549|11548100|FG000|COMPLETED|Overall Study||858
10403673|NCT00731549|11548100|FG000|NOT COMPLETED|Overall Study||223
10403674|NCT00731588|11548106|FG000|STARTED|Overall Study||9
10403675|NCT00731588|11548107|FG001|STARTED|Overall Study||95
10403676|NCT00731588|11548106|FG000|COMPLETED|Overall Study||9
10403677|NCT00731588|11548107|FG001|COMPLETED|Overall Study||53
10403678|NCT00731588|11548106|FG000|NOT COMPLETED|Overall Study||0
10403679|NCT00731588|11548107|FG001|NOT COMPLETED|Overall Study||42
10403680|NCT00731614|11548116|FG000|STARTED|Overall Study||23
10403681|NCT00731614|11548117|FG001|STARTED|Overall Study||31
10403682|NCT00731614|11548116|FG000|End of Treatment|Overall Study||16
10403683|NCT00731614|11548117|FG001|End of Treatment|Overall Study||24
10403684|NCT00731614|11548116|FG000|12 Weeks Posttreatment|Overall Study||18
10403685|NCT00731614|11548117|FG001|12 Weeks Posttreatment|Overall Study||23
10403686|NCT00731614|11548116|FG000|COMPLETED|Overall Study||16
10403687|NCT00731614|11548117|FG001|COMPLETED|Overall Study||18
10403688|NCT00731614|11548116|FG000|NOT COMPLETED|Overall Study||7
10403689|NCT00731614|11548117|FG001|NOT COMPLETED|Overall Study||13
10403690|NCT00731640|11548125|FG000|STARTED|Overall Study||20
10403691|NCT00731640|11548126|FG001|STARTED|Overall Study||32
10403692|NCT00731640|11548125|FG000|COMPLETED|Overall Study||20
10403693|NCT00731640|11548126|FG001|COMPLETED|Overall Study||32
10403694|NCT00731640|11548125|FG000|NOT COMPLETED|Overall Study||0
10403695|NCT00731640|11548126|FG001|NOT COMPLETED|Overall Study||0
10403696|NCT00731653|11548132|FG000|STARTED|Overall Study||81
10403697|NCT00731653|11548132|FG000|COMPLETED|Overall Study||72
10403698|NCT00731653|11548132|FG000|NOT COMPLETED|Overall Study||9
10721623|NCT02729038|11885319|FG002|COMPLETED|Part 1 (Up to 44 Days)||8
10403699|NCT00731666|11548136|FG000|STARTED|Overall Study||40
10403700|NCT00731666|11548136|FG000|COMPLETED|Overall Study||28
10403701|NCT00731666|11548136|FG000|NOT COMPLETED|Overall Study||12
10403702|NCT00731679|11548142|FG000|STARTED|Overall Study||314
10403703|NCT00731679|11548143|FG001|STARTED|Overall Study||309
10403704|NCT00731679|11548142|FG000|COMPLETED|Overall Study||292
10403705|NCT00731679|11548143|FG001|COMPLETED|Overall Study||283
10403706|NCT00731679|11548142|FG000|NOT COMPLETED|Overall Study||22
10403707|NCT00731679|11548143|FG001|NOT COMPLETED|Overall Study||26
10403708|NCT00731692|11548152|FG000|STARTED|Core Study (36 Months)||147
10403709|NCT00731692|11548153|FG001|STARTED|Core Study (36 Months)||336
10403710|NCT00731692|11548154|FG002|STARTED|Core Study (36 Months)||487
10403711|NCT00731692|11548152|FG000|Safety Set (SAF)|Core Study (36 Months)||0
10403712|NCT00731692|11548153|FG001|Safety Set (SAF)|Core Study (36 Months)||336
10403713|NCT00731692|11548154|FG002|Safety Set (SAF)|Core Study (36 Months)||487
10403714|NCT00731692|11548152|FG000|Full Analysis Set (FAS)|Core Study (36 Months)||0
10403715|NCT00731692|11548153|FG001|Full Analysis Set (FAS)|Core Study (36 Months)||336
10403716|NCT00731692|11548154|FG002|Full Analysis Set (FAS)|Core Study (36 Months)||487
10403717|NCT00731692|11548152|FG000|Pharmacokinetic Analysis Set|Core Study (36 Months)||102
10403718|NCT00731692|11548153|FG001|Pharmacokinetic Analysis Set|Core Study (36 Months)||249
10403719|NCT00731692|11548154|FG002|Pharmacokinetic Analysis Set|Core Study (36 Months)||0
10403720|NCT00731692|11548152|FG000|Post Protocol Amendment 5 Switch|Core Study (36 Months)||0
10660724|NCT02252965|11822348|FG001|NOT COMPLETED|Overall Study||43
10660725|NCT02253147|11822356|FG000|STARTED|Overall Study||118
10660726|NCT02253147|11822356|FG000|N Patients at W24 (Primary Outcome)|Overall Study||88
10660727|NCT02253147|11822356|FG000|N Patients at W36|Overall Study||86
10660728|NCT02253147|11822356|FG000|N Patients at W52|Overall Study||84
10660729|NCT02253147|11822356|FG000|COMPLETED|Overall Study||71
10660730|NCT02253147|11822356|FG000|NOT COMPLETED|Overall Study||47
10660731|NCT02253160|11822365|FG000|STARTED|Overall Study||1
10660732|NCT02253160|11822366|FG001|STARTED|Overall Study||12
10660733|NCT02253160|11822367|FG002|STARTED|Overall Study||10
10660734|NCT02253160|11822365|FG000|COMPLETED|Overall Study||1
10660735|NCT02253160|11822366|FG001|COMPLETED|Overall Study||12
10721624|NCT02729038|11885320|FG003|COMPLETED|Part 1 (Up to 44 Days)||0
10721625|NCT02729038|11885317|FG000|NOT COMPLETED|Part 1 (Up to 44 Days)||0
10721626|NCT02729038|11885318|FG001|NOT COMPLETED|Part 1 (Up to 44 Days)||0
10721627|NCT02729038|11885319|FG002|NOT COMPLETED|Part 1 (Up to 44 Days)||0
10721628|NCT02729038|11885320|FG003|NOT COMPLETED|Part 1 (Up to 44 Days)||0
10721629|NCT02729038|11885317|FG000|STARTED|Part 2 (Up to 50 Days)||0
10403721|NCT00731692|11548153|FG001|Post Protocol Amendment 5 Switch|Core Study (36 Months)|post protocol amendment 121 patients switch to 0.5 mg dose from 125mg dose|121
10660736|NCT02253160|11822367|FG002|COMPLETED|Overall Study||10
10660737|NCT02253160|11822365|FG000|NOT COMPLETED|Overall Study||0
10660738|NCT02253160|11822366|FG001|NOT COMPLETED|Overall Study||0
10660739|NCT02253160|11822367|FG002|NOT COMPLETED|Overall Study||0
10660740|NCT02253173|11822381|FG000|STARTED|Overall Study||191
10660741|NCT02253173|11822382|FG001|STARTED|Overall Study||191
10660742|NCT02253173|11822383|FG002|STARTED|Overall Study||190
10660743|NCT02253173|11822384|FG003|STARTED|Overall Study||192
10660744|NCT02253173|11822381|FG000|COMPLETED|Overall Study||175
10660745|NCT02253173|11822382|FG001|COMPLETED|Overall Study||174
10660746|NCT02253173|11822383|FG002|COMPLETED|Overall Study||177
10660747|NCT02253173|11822384|FG003|COMPLETED|Overall Study||178
10660748|NCT02253173|11822381|FG000|NOT COMPLETED|Overall Study||16
10660749|NCT02253173|11822382|FG001|NOT COMPLETED|Overall Study||17
10660750|NCT02253173|11822383|FG002|NOT COMPLETED|Overall Study||13
10660751|NCT02253173|11822384|FG003|NOT COMPLETED|Overall Study||14
10660752|NCT02253433|11822400|FG000|STARTED|Overall Study||130
10660753|NCT02253433|11822401|FG001|STARTED|Overall Study||134
10660754|NCT02253433|11822400|FG000|COMPLETED|Overall Study||114
10660755|NCT02253433|11822401|FG001|COMPLETED|Overall Study||79
10660756|NCT02253433|11822400|FG000|NOT COMPLETED|Overall Study||16
10660757|NCT02253433|11822401|FG001|NOT COMPLETED|Overall Study||55
10660758|NCT02253537|11822408|FG000|STARTED|Overall Study||15
10660759|NCT02253537|11822408|FG000|COMPLETED|Overall Study||15
10660760|NCT02253537|11822408|FG000|NOT COMPLETED|Overall Study||0
10660761|NCT02253654|11822414|FG000|STARTED|Overall Study||108
10660762|NCT02253654|11822415|FG001|STARTED|Overall Study||108
10660763|NCT02253654|11822414|FG000|Received Treatment|Overall Study||104
10660764|NCT02253654|11822415|FG001|Received Treatment|Overall Study||107
10660765|NCT02253654|11822414|FG000|COMPLETED|Overall Study||85
10660766|NCT02253654|11822415|FG001|COMPLETED|Overall Study||90
10660767|NCT02253654|11822414|FG000|NOT COMPLETED|Overall Study||23
10660768|NCT02253654|11822415|FG001|NOT COMPLETED|Overall Study||18
10660769|NCT02253992|11822424|FG000|STARTED|Overall Study||6
10660770|NCT02253992|11822425|FG001|STARTED|Overall Study||4
10660771|NCT02253992|11822426|FG002|STARTED|Overall Study||150
10660772|NCT02253992|11822424|FG000|COMPLETED|Overall Study||0
10660773|NCT02253992|11822425|FG001|COMPLETED|Overall Study||0
10660774|NCT02253992|11822426|FG002|COMPLETED|Overall Study||6
10660775|NCT02253992|11822424|FG000|NOT COMPLETED|Overall Study||6
10660776|NCT02253992|11822425|FG001|NOT COMPLETED|Overall Study||4
10660777|NCT02253992|11822426|FG002|NOT COMPLETED|Overall Study||144
10660778|NCT02254252|11822450|FG000|STARTED|Overall Study||27
10660779|NCT02254252|11822451|FG001|STARTED|Overall Study||27
10660780|NCT02254252|11822450|FG000|COMPLETED|Overall Study||24
10660781|NCT02254252|11822451|FG001|COMPLETED|Overall Study||25
10403722|NCT00731692|11548154|FG002|Post Protocol Amendment 5 Switch|Core Study (36 Months)||0
10403723|NCT00731692|11548152|FG000|COMPLETED|Core Study (36 Months)||79
10660782|NCT02254252|11822450|FG000|NOT COMPLETED|Overall Study||3
10660783|NCT02254252|11822451|FG001|NOT COMPLETED|Overall Study||2
10403724|NCT00731692|11548153|FG001|COMPLETED|Core Study (36 Months)||220
10403725|NCT00731692|11548154|FG002|COMPLETED|Core Study (36 Months)||317
10403726|NCT00731692|11548152|FG000|NOT COMPLETED|Core Study (36 Months)||68
10403727|NCT00731692|11548153|FG001|NOT COMPLETED|Core Study (36 Months)||116
10403728|NCT00731692|11548154|FG002|NOT COMPLETED|Core Study (36 Months)||170
10403729|NCT00731692|11548152|FG000|STARTED|Extension Phase||74
10403730|NCT00731692|11548153|FG001|STARTED|Extension Phase||196
10403731|NCT00731692|11548154|FG002|STARTED|Extension Phase||301
10403732|NCT00731692|11548152|FG000|COMPLETED|Extension Phase||0
10403733|NCT00731692|11548153|FG001|COMPLETED|Extension Phase||0
10403734|NCT00731692|11548154|FG002|COMPLETED|Extension Phase||0
10403735|NCT00731692|11548152|FG000|NOT COMPLETED|Extension Phase||74
10403736|NCT00731692|11548153|FG001|NOT COMPLETED|Extension Phase||196
10403737|NCT00731692|11548154|FG002|NOT COMPLETED|Extension Phase||301
10403738|NCT00731783|11548172|FG000|STARTED|One Month Follow-Up Visit||92
10403739|NCT00731783|11548173|FG001|STARTED|One Month Follow-Up Visit||91
10403740|NCT00731783|11548172|FG000|COMPLETED|One Month Follow-Up Visit||78
10403741|NCT00731783|11548173|FG001|COMPLETED|One Month Follow-Up Visit||69
10403742|NCT00731783|11548172|FG000|NOT COMPLETED|One Month Follow-Up Visit||14
10403743|NCT00731783|11548173|FG001|NOT COMPLETED|One Month Follow-Up Visit||22
10403744|NCT00731783|11548172|FG000|STARTED|Three Month Follow-Up Visit||79
10403745|NCT00731783|11548173|FG001|STARTED|Three Month Follow-Up Visit||73
10403746|NCT00731783|11548172|FG000|COMPLETED|Three Month Follow-Up Visit||72
10403747|NCT00731783|11548173|FG001|COMPLETED|Three Month Follow-Up Visit||57
10403748|NCT00731783|11548172|FG000|NOT COMPLETED|Three Month Follow-Up Visit||7
10403749|NCT00731783|11548173|FG001|NOT COMPLETED|Three Month Follow-Up Visit||16
10403750|NCT00731783|11548172|FG000|STARTED|Six Month Follow-Up Visit||77
10403751|NCT00731783|11548173|FG001|STARTED|Six Month Follow-Up Visit||67
10403752|NCT00731783|11548172|FG000|COMPLETED|Six Month Follow-Up Visit||71
10403753|NCT00731783|11548173|FG001|COMPLETED|Six Month Follow-Up Visit||64
10403754|NCT00731783|11548172|FG000|NOT COMPLETED|Six Month Follow-Up Visit||6
10403755|NCT00731783|11548173|FG001|NOT COMPLETED|Six Month Follow-Up Visit||3
10403756|NCT00731783|11548172|FG000|STARTED|12 Month Follow-Up Visit||74
10403757|NCT00731783|11548173|FG001|STARTED|12 Month Follow-Up Visit||65
10403758|NCT00731783|11548172|FG000|COMPLETED|12 Month Follow-Up Visit||68
10403759|NCT00731783|11548173|FG001|COMPLETED|12 Month Follow-Up Visit||58
10660793|NCT02254291|11822473|FG000|STARTED|Overall Study||103
10660794|NCT02254291|11822474|FG001|STARTED|Overall Study||102
10660795|NCT02254291|11822475|FG002|STARTED|Overall Study||103
10660796|NCT02254291|11822473|FG000|Exposed|Overall Study||103
10660797|NCT02254291|11822474|FG001|Exposed|Overall Study||102
10660798|NCT02254291|11822475|FG002|Exposed|Overall Study||103
10660799|NCT02254291|11822473|FG000|COMPLETED|Overall Study||103
10660800|NCT02254291|11822474|FG001|COMPLETED|Overall Study||99
10660801|NCT02254291|11822475|FG002|COMPLETED|Overall Study||101
10660802|NCT02254291|11822473|FG000|NOT COMPLETED|Overall Study||0
10660803|NCT02254291|11822474|FG001|NOT COMPLETED|Overall Study||3
10660804|NCT02254291|11822475|FG002|NOT COMPLETED|Overall Study||2
10660805|NCT02254304|11822485|FG000|STARTED|Overall Study||89
10660806|NCT02254304|11822486|FG001|STARTED|Overall Study||17
10660807|NCT02254304|11822485|FG000|COMPLETED|Overall Study||75
10660808|NCT02254304|11822486|FG001|COMPLETED|Overall Study||13
10660809|NCT02254304|11822485|FG000|NOT COMPLETED|Overall Study||14
10660810|NCT02254304|11822486|FG001|NOT COMPLETED|Overall Study||4
10660811|NCT02254408|11822496|FG000|STARTED|Overall Study||96
10660812|NCT02254408|11822497|FG001|STARTED|Overall Study||93
10660813|NCT02254408|11822496|FG000|COMPLETED|Overall Study||88
10660814|NCT02254408|11822497|FG001|COMPLETED|Overall Study||83
10660815|NCT02254408|11822496|FG000|NOT COMPLETED|Overall Study||8
10660816|NCT02254408|11822497|FG001|NOT COMPLETED|Overall Study||10
10660817|NCT02254421|11822505|FG000|STARTED|Overall Study||31
10660818|NCT02254421|11822506|FG001|STARTED|Overall Study||29
10660819|NCT02254421|11822505|FG000|COMPLETED|Overall Study||29
10403760|NCT00731783|11548172|FG000|NOT COMPLETED|12 Month Follow-Up Visit||6
10403761|NCT00731783|11548173|FG001|NOT COMPLETED|12 Month Follow-Up Visit||7
10660820|NCT02254421|11822506|FG001|COMPLETED|Overall Study||26
10660821|NCT02254421|11822505|FG000|NOT COMPLETED|Overall Study||2
10660822|NCT02254421|11822506|FG001|NOT COMPLETED|Overall Study||3
10660823|NCT02254460|11822512|FG000|STARTED|Overall Study||13
10660824|NCT02254460|11822513|FG001|STARTED|Overall Study||12
10660825|NCT02254460|11822512|FG000|COMPLETED|Overall Study||12
10403762|NCT00731822|11548181|FG000|STARTED|Overall Study||20
10403763|NCT00731822|11548182|FG001|STARTED|Overall Study||40
10403764|NCT00731822|11548181|FG000|COMPLETED|Overall Study||16
10403765|NCT00731822|11548182|FG001|COMPLETED|Overall Study||39
10403766|NCT00731822|11548181|FG000|NOT COMPLETED|Overall Study||4
10660826|NCT02254460|11822513|FG001|COMPLETED|Overall Study||12
10660827|NCT02254460|11822512|FG000|NOT COMPLETED|Overall Study||1
10660828|NCT02254460|11822513|FG001|NOT COMPLETED|Overall Study||0
10660829|NCT02254473|11822521|FG000|STARTED|Overall Study||9
10660830|NCT02254473|11822522|FG001|STARTED|Overall Study||3
10660831|NCT02254473|11822521|FG000|COMPLETED|Overall Study||7
10660832|NCT02254473|11822522|FG001|COMPLETED|Overall Study||2
10403767|NCT00731822|11548182|FG001|NOT COMPLETED|Overall Study||1
10403768|NCT00731874|11548190|FG000|STARTED|Overall Study||10
10403769|NCT00731874|11548191|FG001|STARTED|Overall Study||13
10660833|NCT02254473|11822521|FG000|NOT COMPLETED|Overall Study||2
10660834|NCT02254473|11822522|FG001|NOT COMPLETED|Overall Study||1
10660835|NCT02254486|11822530|FG000|STARTED|Overall Study||311
10721630|NCT02729038|11885318|FG001|STARTED|Part 2 (Up to 50 Days)||0
10721631|NCT02729038|11885319|FG002|STARTED|Part 2 (Up to 50 Days)||0
10721632|NCT02729038|11885320|FG003|STARTED|Part 2 (Up to 50 Days)||8
10721633|NCT02729038|11885317|FG000|COMPLETED|Part 2 (Up to 50 Days)||0
10721634|NCT02729038|11885318|FG001|COMPLETED|Part 2 (Up to 50 Days)||0
10721635|NCT02729038|11885319|FG002|COMPLETED|Part 2 (Up to 50 Days)||0
10721636|NCT02729038|11885320|FG003|COMPLETED|Part 2 (Up to 50 Days)||8
10721637|NCT02729038|11885317|FG000|NOT COMPLETED|Part 2 (Up to 50 Days)||0
10721638|NCT02729038|11885318|FG001|NOT COMPLETED|Part 2 (Up to 50 Days)||0
10721639|NCT02729038|11885319|FG002|NOT COMPLETED|Part 2 (Up to 50 Days)||0
10721640|NCT02729038|11885320|FG003|NOT COMPLETED|Part 2 (Up to 50 Days)||0
10721641|NCT02729051|11885339|FG000|STARTED|Overall Study||527
10721642|NCT02729051|11885340|FG001|STARTED|Overall Study||528
10721643|NCT02729051|11885339|FG000|COMPLETED|Overall Study||497
10721644|NCT02729051|11885340|FG001|COMPLETED|Overall Study||496
10721645|NCT02729051|11885339|FG000|NOT COMPLETED|Overall Study||30
10721646|NCT02729051|11885340|FG001|NOT COMPLETED|Overall Study||32
10721647|NCT02729194|11885346|FG000|STARTED|Overall Study||16
10721648|NCT02729194|11885346|FG000|COMPLETED|Overall Study||13
10721649|NCT02729194|11885346|FG000|NOT COMPLETED|Overall Study||3
10721650|NCT02729545|11885352|FG000|STARTED|Overall Study||30
10721651|NCT02729545|11885353|FG001|STARTED|Overall Study||30
10721652|NCT02729545|11885352|FG000|COMPLETED|Overall Study||27
10721653|NCT02729545|11885353|FG001|COMPLETED|Overall Study||25
10721654|NCT02729545|11885352|FG000|NOT COMPLETED|Overall Study||3
10721655|NCT02729545|11885353|FG001|NOT COMPLETED|Overall Study||5
10721656|NCT02729740|11885359|FG000|STARTED|Overall Study||995
10721657|NCT02729740|11885359|FG000|COMPLETED|Overall Study||864
10721658|NCT02729740|11885359|FG000|NOT COMPLETED|Overall Study||131
10721659|NCT02729831|11885367|FG000|STARTED|Baseline (Post Decision Aid, Pre-visit)||320
10721660|NCT02729831|11885368|FG001|STARTED|Baseline (Post Decision Aid, Pre-visit)||315
10721661|NCT02729831|11885369|FG002|STARTED|Baseline (Post Decision Aid, Pre-visit)||293
10721662|NCT02729831|11885370|FG003|STARTED|Baseline (Post Decision Aid, Pre-visit)||292
10721663|NCT02729831|11885367|FG000|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||282
10721664|NCT02729831|11885368|FG001|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||292
10721665|NCT02729831|11885369|FG002|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||275
10721666|NCT02729831|11885370|FG003|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||275
10721667|NCT02729831|11885367|FG000|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||38
10721668|NCT02729831|11885368|FG001|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||23
10721669|NCT02729831|11885369|FG002|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||18
10721670|NCT02729831|11885370|FG003|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||17
10721671|NCT02729831|11885367|FG000|STARTED|1 Week Post-visit||282
10721672|NCT02729831|11885368|FG001|STARTED|1 Week Post-visit||292
10721673|NCT02729831|11885369|FG002|STARTED|1 Week Post-visit||275
10721674|NCT02729831|11885370|FG003|STARTED|1 Week Post-visit||275
10721675|NCT02729831|11885367|FG000|COMPLETED|1 Week Post-visit||239
10721676|NCT02729831|11885368|FG001|COMPLETED|1 Week Post-visit||252
10721677|NCT02729831|11885369|FG002|COMPLETED|1 Week Post-visit||237
10721678|NCT02729831|11885370|FG003|COMPLETED|1 Week Post-visit||239
10721679|NCT02729831|11885367|FG000|NOT COMPLETED|1 Week Post-visit||43
10721680|NCT02729831|11885368|FG001|NOT COMPLETED|1 Week Post-visit||40
10721681|NCT02729831|11885369|FG002|NOT COMPLETED|1 Week Post-visit||38
10721682|NCT02729831|11885370|FG003|NOT COMPLETED|1 Week Post-visit||36
10721683|NCT02729831|11885367|FG000|STARTED|6 Month Follow-up||282
10721684|NCT02729831|11885368|FG001|STARTED|6 Month Follow-up||292
10721685|NCT02729831|11885369|FG002|STARTED|6 Month Follow-up||275
10721686|NCT02729831|11885370|FG003|STARTED|6 Month Follow-up||275
10721687|NCT02729831|11885367|FG000|COMPLETED|6 Month Follow-up||227
10721688|NCT02729831|11885368|FG001|COMPLETED|6 Month Follow-up||238
10721689|NCT02729831|11885369|FG002|COMPLETED|6 Month Follow-up||227
10721690|NCT02729831|11885370|FG003|COMPLETED|6 Month Follow-up||232
10721691|NCT02729831|11885367|FG000|NOT COMPLETED|6 Month Follow-up||55
10721692|NCT02729831|11885368|FG001|NOT COMPLETED|6 Month Follow-up||54
10721693|NCT02729831|11885369|FG002|NOT COMPLETED|6 Month Follow-up||48
10660836|NCT02254486|11822531|FG001|STARTED|Overall Study||310
10660837|NCT02254486|11822530|FG000|COMPLETED|Overall Study||261
10660838|NCT02254486|11822531|FG001|COMPLETED|Overall Study||255
10660839|NCT02254486|11822530|FG000|NOT COMPLETED|Overall Study||50
10660840|NCT02254486|11822531|FG001|NOT COMPLETED|Overall Study||55
10660841|NCT02254551|11822537|FG000|STARTED|Dose Escalation||7
10403770|NCT00731874|11548190|FG000|COMPLETED|Overall Study||10
10660842|NCT02254551|11822537|FG000|Cohort 1: LDE225 400mg|Dose Escalation|1 patient was found to be refractory to bortezomib and deemed ineligible.|7
10721694|NCT02729831|11885370|FG003|NOT COMPLETED|6 Month Follow-up||43
10721695|NCT02729896|11885383|FG000|STARTED|Overall Study||3
10721696|NCT02729896|11885384|FG001|STARTED|Overall Study||10
10721697|NCT02729896|11885385|FG002|STARTED|Overall Study||23
10721698|NCT02729896|11885383|FG000|COMPLETED|Overall Study||1
10721699|NCT02729896|11885384|FG001|COMPLETED|Overall Study||1
10721700|NCT02729896|11885385|FG002|COMPLETED|Overall Study||1
10721701|NCT02729896|11885383|FG000|NOT COMPLETED|Overall Study||2
10721702|NCT02729896|11885384|FG001|NOT COMPLETED|Overall Study||9
10403771|NCT00731874|11548191|FG001|COMPLETED|Overall Study||13
10403772|NCT00731874|11548190|FG000|NOT COMPLETED|Overall Study||0
10403773|NCT00731874|11548191|FG001|NOT COMPLETED|Overall Study||0
10403774|NCT00731939|11548197|FG000|STARTED|Overall Study||124
10403775|NCT00731939|11548197|FG000|COMPLETED|Overall Study||90
10403776|NCT00731939|11548197|FG000|NOT COMPLETED|Overall Study||34
10403777|NCT00732030|11548201|FG000|STARTED|Overall Study||26
10403778|NCT00732030|11548201|FG000|COMPLETED|Overall Study||24
10403779|NCT00732030|11548201|FG000|NOT COMPLETED|Overall Study||2
10403780|NCT00732069|11548205|FG000|STARTED|First Study Drug||3
10403781|NCT00732069|11548206|FG001|STARTED|First Study Drug||3
10403782|NCT00732069|11548207|FG002|STARTED|First Study Drug||3
10403783|NCT00732069|11548208|FG003|STARTED|First Study Drug||2
10403784|NCT00732069|11548209|FG004|STARTED|First Study Drug||3
10403785|NCT00732069|11548210|FG005|STARTED|First Study Drug||2
10403786|NCT00732069|11548205|FG000|COMPLETED|First Study Drug||3
10403787|NCT00732069|11548206|FG001|COMPLETED|First Study Drug||3
10403788|NCT00732069|11548207|FG002|COMPLETED|First Study Drug||3
10403789|NCT00732069|11548208|FG003|COMPLETED|First Study Drug||2
10403790|NCT00732069|11548209|FG004|COMPLETED|First Study Drug||3
10403791|NCT00732069|11548210|FG005|COMPLETED|First Study Drug||2
10403792|NCT00732069|11548205|FG000|NOT COMPLETED|First Study Drug||0
10403793|NCT00732069|11548206|FG001|NOT COMPLETED|First Study Drug||0
10403794|NCT00732069|11548207|FG002|NOT COMPLETED|First Study Drug||0
10403795|NCT00732069|11548208|FG003|NOT COMPLETED|First Study Drug||0
10403796|NCT00732069|11548209|FG004|NOT COMPLETED|First Study Drug||0
10403797|NCT00732069|11548210|FG005|NOT COMPLETED|First Study Drug||0
10403798|NCT00732069|11548205|FG000|STARTED|Washout After First Study Drug||3
10403799|NCT00732069|11548206|FG001|STARTED|Washout After First Study Drug||3
10403800|NCT00732069|11548207|FG002|STARTED|Washout After First Study Drug||3
10403801|NCT00732069|11548208|FG003|STARTED|Washout After First Study Drug||2
10403802|NCT00732069|11548209|FG004|STARTED|Washout After First Study Drug||3
10403803|NCT00732069|11548210|FG005|STARTED|Washout After First Study Drug||2
10403804|NCT00732069|11548205|FG000|COMPLETED|Washout After First Study Drug||2
10403805|NCT00732069|11548206|FG001|COMPLETED|Washout After First Study Drug||3
10403806|NCT00732069|11548207|FG002|COMPLETED|Washout After First Study Drug||3
10403807|NCT00732069|11548208|FG003|COMPLETED|Washout After First Study Drug||2
10403808|NCT00732069|11548209|FG004|COMPLETED|Washout After First Study Drug||3
10403809|NCT00732069|11548210|FG005|COMPLETED|Washout After First Study Drug||2
10403810|NCT00732069|11548205|FG000|NOT COMPLETED|Washout After First Study Drug||1
10403811|NCT00732069|11548206|FG001|NOT COMPLETED|Washout After First Study Drug||0
10403812|NCT00732069|11548207|FG002|NOT COMPLETED|Washout After First Study Drug||0
10403813|NCT00732069|11548208|FG003|NOT COMPLETED|Washout After First Study Drug||0
10403814|NCT00732069|11548209|FG004|NOT COMPLETED|Washout After First Study Drug||0
10403815|NCT00732069|11548210|FG005|NOT COMPLETED|Washout After First Study Drug||0
10403816|NCT00732069|11548205|FG000|STARTED|Second Study Drug||2
10403817|NCT00732069|11548206|FG001|STARTED|Second Study Drug||3
10403818|NCT00732069|11548207|FG002|STARTED|Second Study Drug||3
10403819|NCT00732069|11548208|FG003|STARTED|Second Study Drug||2
10403820|NCT00732069|11548209|FG004|STARTED|Second Study Drug||3
10403821|NCT00732069|11548210|FG005|STARTED|Second Study Drug||2
10403822|NCT00732069|11548205|FG000|COMPLETED|Second Study Drug||2
10403823|NCT00732069|11548206|FG001|COMPLETED|Second Study Drug||3
10403824|NCT00732069|11548207|FG002|COMPLETED|Second Study Drug||3
10403825|NCT00732069|11548208|FG003|COMPLETED|Second Study Drug||2
10403826|NCT00732069|11548209|FG004|COMPLETED|Second Study Drug||3
10403827|NCT00732069|11548210|FG005|COMPLETED|Second Study Drug||2
10403828|NCT00732069|11548205|FG000|NOT COMPLETED|Second Study Drug||0
10403829|NCT00732069|11548206|FG001|NOT COMPLETED|Second Study Drug||0
10403830|NCT00732069|11548207|FG002|NOT COMPLETED|Second Study Drug||0
10403831|NCT00732069|11548208|FG003|NOT COMPLETED|Second Study Drug||0
10403832|NCT00732069|11548209|FG004|NOT COMPLETED|Second Study Drug||0
10403833|NCT00732069|11548210|FG005|NOT COMPLETED|Second Study Drug||0
10403834|NCT00732069|11548205|FG000|STARTED|Washout After Second Study Drug||2
10403835|NCT00732069|11548206|FG001|STARTED|Washout After Second Study Drug||3
10403836|NCT00732069|11548207|FG002|STARTED|Washout After Second Study Drug||3
10403837|NCT00732069|11548208|FG003|STARTED|Washout After Second Study Drug||2
10403838|NCT00732069|11548209|FG004|STARTED|Washout After Second Study Drug||3
10403839|NCT00732069|11548210|FG005|STARTED|Washout After Second Study Drug||2
10403840|NCT00732069|11548205|FG000|COMPLETED|Washout After Second Study Drug||2
10403841|NCT00732069|11548206|FG001|COMPLETED|Washout After Second Study Drug||3
10403842|NCT00732069|11548207|FG002|COMPLETED|Washout After Second Study Drug||3
10403843|NCT00732069|11548208|FG003|COMPLETED|Washout After Second Study Drug||2
10403844|NCT00732069|11548209|FG004|COMPLETED|Washout After Second Study Drug||3
10403845|NCT00732069|11548210|FG005|COMPLETED|Washout After Second Study Drug||2
10403846|NCT00732069|11548205|FG000|NOT COMPLETED|Washout After Second Study Drug||0
10403847|NCT00732069|11548206|FG001|NOT COMPLETED|Washout After Second Study Drug||0
10403848|NCT00732069|11548207|FG002|NOT COMPLETED|Washout After Second Study Drug||0
10403849|NCT00732069|11548208|FG003|NOT COMPLETED|Washout After Second Study Drug||0
10403850|NCT00732069|11548209|FG004|NOT COMPLETED|Washout After Second Study Drug||0
10403851|NCT00732069|11548210|FG005|NOT COMPLETED|Washout After Second Study Drug||0
10403852|NCT00732069|11548205|FG000|STARTED|Third Study Drug||2
10403853|NCT00732069|11548206|FG001|STARTED|Third Study Drug||3
10403854|NCT00732069|11548207|FG002|STARTED|Third Study Drug||3
10403855|NCT00732069|11548208|FG003|STARTED|Third Study Drug||2
10403856|NCT00732069|11548209|FG004|STARTED|Third Study Drug||3
10403857|NCT00732069|11548210|FG005|STARTED|Third Study Drug||2
10403858|NCT00732069|11548205|FG000|COMPLETED|Third Study Drug||2
10403859|NCT00732069|11548206|FG001|COMPLETED|Third Study Drug||3
10403860|NCT00732069|11548207|FG002|COMPLETED|Third Study Drug||3
10403861|NCT00732069|11548208|FG003|COMPLETED|Third Study Drug||2
10403862|NCT00732069|11548209|FG004|COMPLETED|Third Study Drug||3
10403863|NCT00732069|11548210|FG005|COMPLETED|Third Study Drug||2
10403864|NCT00732069|11548205|FG000|NOT COMPLETED|Third Study Drug||0
10403865|NCT00732069|11548206|FG001|NOT COMPLETED|Third Study Drug||0
10403866|NCT00732069|11548207|FG002|NOT COMPLETED|Third Study Drug||0
10403867|NCT00732069|11548208|FG003|NOT COMPLETED|Third Study Drug||0
10403868|NCT00732069|11548209|FG004|NOT COMPLETED|Third Study Drug||0
10403869|NCT00732069|11548210|FG005|NOT COMPLETED|Third Study Drug||0
10403870|NCT00732160|11548222|FG000|STARTED|Overall Study||7
10403871|NCT00732160|11548223|FG001|STARTED|Overall Study||5
10403872|NCT00732160|11548224|FG002|STARTED|Overall Study||6
10403873|NCT00732160|11548225|FG003|STARTED|Overall Study||5
10403874|NCT00732160|11548222|FG000|HS Vehicle|Overall Study||7
10403875|NCT00732160|11548223|FG001|HS Vehicle|Overall Study||5
10403876|NCT00732160|11548224|FG002|HS Vehicle|Overall Study||3
10403877|NCT00732160|11548225|FG003|HS Vehicle|Overall Study||3
10403878|NCT00732160|11548222|FG000|HS Aldosterone|Overall Study||7
10721703|NCT02729896|11885385|FG002|NOT COMPLETED|Overall Study||22
10721704|NCT02729909|11885396|FG000|STARTED|Overall Study||105
10721705|NCT02729909|11885397|FG001|STARTED|Overall Study||106
10721706|NCT02729909|11885396|FG000|COMPLETED|Overall Study||104
10721707|NCT02729909|11885397|FG001|COMPLETED|Overall Study||101
10721708|NCT02729909|11885396|FG000|NOT COMPLETED|Overall Study||1
10721709|NCT02729909|11885397|FG001|NOT COMPLETED|Overall Study||5
10403879|NCT00732160|11548223|FG001|HS Aldosterone|Overall Study||5
10403880|NCT00732160|11548224|FG002|HS Aldosterone|Overall Study||3
10403881|NCT00732160|11548225|FG003|HS Aldosterone|Overall Study||3
10403882|NCT00732160|11548222|FG000|LS Vehicle|Overall Study||2
10403883|NCT00732160|11548223|FG001|LS Vehicle|Overall Study||1
10403884|NCT00732160|11548224|FG002|LS Vehicle|Overall Study||6
10403885|NCT00732160|11548225|FG003|LS Vehicle|Overall Study||5
10403886|NCT00732160|11548222|FG000|LS Aldosterone|Overall Study||2
10403887|NCT00732160|11548223|FG001|LS Aldosterone|Overall Study||1
10403888|NCT00732160|11548224|FG002|LS Aldosterone|Overall Study||6
10403889|NCT00732160|11548225|FG003|LS Aldosterone|Overall Study||5
10403890|NCT00732160|11548222|FG000|COMPLETED|Overall Study||2
10403891|NCT00732160|11548223|FG001|COMPLETED|Overall Study||1
10403892|NCT00732160|11548224|FG002|COMPLETED|Overall Study||3
10403893|NCT00732160|11548225|FG003|COMPLETED|Overall Study||3
10403894|NCT00732160|11548222|FG000|NOT COMPLETED|Overall Study||5
10403895|NCT00732160|11548223|FG001|NOT COMPLETED|Overall Study||4
10403896|NCT00732160|11548224|FG002|NOT COMPLETED|Overall Study||3
10403897|NCT00732160|11548225|FG003|NOT COMPLETED|Overall Study||2
10403898|NCT00732199|11548237|FG000|STARTED|Overall Study||50
10403899|NCT00732199|11548238|FG001|STARTED|Overall Study||42
10403900|NCT00732199|11548237|FG000|COMPLETED|Overall Study||16
10403901|NCT00732199|11548238|FG001|COMPLETED|Overall Study||16
10403902|NCT00732199|11548237|FG000|NOT COMPLETED|Overall Study||34
10403903|NCT00732199|11548238|FG001|NOT COMPLETED|Overall Study||26
10403904|NCT00732225|11548252|FG000|STARTED|Overall Study|76 eyes of 71 patients|71
10403905|NCT00732225|11548253|FG001|STARTED|Overall Study|41 eyes of 40 patients|40
10403906|NCT00732225|11548254|FG002|STARTED|Overall Study|26 eyes of 26 patients|26
10403907|NCT00732225|11548255|FG003|STARTED|Overall Study|33 eyes of 33 patients|33
10403908|NCT00732225|11548256|FG004|STARTED|Overall Study|55 eyes of 54 patients|54
10403909|NCT00732225|11548252|FG000|COMPLETED|Overall Study|64 eyes of 60 patients|60
10403910|NCT00732225|11548253|FG001|COMPLETED|Overall Study|33 eyes of 32 patients|32
10403911|NCT00732225|11548254|FG002|COMPLETED|Overall Study|23 eyes of 23 patients|23
10403912|NCT00732225|11548255|FG003|COMPLETED|Overall Study|29 eyes of 29 patients|29
10403913|NCT00732225|11548256|FG004|COMPLETED|Overall Study|48 eyes of 48 patients|48
10403914|NCT00732225|11548252|FG000|NOT COMPLETED|Overall Study||11
10403915|NCT00732225|11548253|FG001|NOT COMPLETED|Overall Study||8
10403916|NCT00732225|11548254|FG002|NOT COMPLETED|Overall Study||3
10403917|NCT00732225|11548255|FG003|NOT COMPLETED|Overall Study||4
10403918|NCT00732225|11548256|FG004|NOT COMPLETED|Overall Study||6
10403919|NCT00732238|11548270|FG000|STARTED|Overall Study||33
10814407|NCT02376933|11977124|FG000|COMPLETED|Overall Study||8
10814408|NCT02376933|11977124|FG000|NOT COMPLETED|Overall Study||2
10814409|NCT02365233|11977131|FG000|STARTED|Overall Study||1
10814410|NCT02365233|11977132|FG001|STARTED|Overall Study||2
10814411|NCT02365233|11977133|FG002|STARTED|Overall Study||2
10403920|NCT00732238|11548271|FG001|STARTED|Overall Study||28
10403921|NCT00732238|11548270|FG000|COMPLETED|Overall Study||28
10403922|NCT00732238|11548271|FG001|COMPLETED|Overall Study||27
10403923|NCT00732238|11548270|FG000|NOT COMPLETED|Overall Study||5
10403924|NCT00732238|11548271|FG001|NOT COMPLETED|Overall Study||1
10403925|NCT00732251|11548279|FG000|STARTED|Overall Study||8
10403926|NCT00732251|11548279|FG000|COMPLETED|Overall Study||1
10403927|NCT00732251|11548279|FG000|NOT COMPLETED|Overall Study||7
10403928|NCT00732303|11548283|FG000|STARTED|Overall Study||8
10403929|NCT00732303|11548283|FG000|COMPLETED|Overall Study||6
10403930|NCT00732303|11548283|FG000|NOT COMPLETED|Overall Study||2
10403931|NCT00732472|11548291|FG000|STARTED|Overall Study||9
10403949|NCT00732615|11548312|FG001|COMPLETED|Overall Study||79
10403932|NCT00732472|11548292|FG001|STARTED|Overall Study|One par. (counted as 2 on outputs) was randomized/dosed with UMEC 250 µg on 2 separate occasions.|10
10403933|NCT00732472|11548293|FG002|STARTED|Overall Study||10
10403934|NCT00732472|11548294|FG003|STARTED|Overall Study||9
10403935|NCT00732472|11548291|FG000|COMPLETED|Overall Study||9
10403936|NCT00732472|11548292|FG001|COMPLETED|Overall Study||7
10403937|NCT00732472|11548293|FG002|COMPLETED|Overall Study||9
10403938|NCT00732472|11548294|FG003|COMPLETED|Overall Study||6
10403939|NCT00732472|11548291|FG000|NOT COMPLETED|Overall Study||0
10403940|NCT00732472|11548292|FG001|NOT COMPLETED|Overall Study||3
10403941|NCT00732472|11548293|FG002|NOT COMPLETED|Overall Study||1
10660843|NCT02254551|11822537|FG000|Cohort 2: LDE225 600mg|Dose Escalation||0
10660844|NCT02254551|11822537|FG000|Cohort 3: LDE225 800mg|Dose Escalation||0
10660845|NCT02254551|11822537|FG000|COMPLETED|Dose Escalation|Due to toxicity and lack of efficacy, no other dose levels were examined.|4
10660846|NCT02254551|11822537|FG000|NOT COMPLETED|Dose Escalation||3
10660847|NCT02254551|11822537|FG000|STARTED|Expansion||0
10660848|NCT02254551|11822537|FG000|COMPLETED|Expansion||0
10660849|NCT02254551|11822537|FG000|NOT COMPLETED|Expansion||0
10660850|NCT02254551|11822537|FG000|STARTED|Maintenance||0
10660851|NCT02254551|11822537|FG000|COMPLETED|Maintenance||0
10660852|NCT02254551|11822537|FG000|NOT COMPLETED|Maintenance||0
10660853|NCT02254681|11822544|FG000|STARTED|Overall Study||6
10660854|NCT02254681|11822544|FG000|COMPLETED|Overall Study||0
10660855|NCT02254681|11822544|FG000|NOT COMPLETED|Overall Study||6
10660856|NCT02254772|11822549|FG000|STARTED|Overall Study||9
10660857|NCT02254772|11822549|FG000|COMPLETED|Overall Study||7
10660858|NCT02254772|11822549|FG000|NOT COMPLETED|Overall Study||2
10660859|NCT02255032|11822555|FG000|STARTED|Overall Study||17
10660860|NCT02255032|11822556|FG001|STARTED|Overall Study||5
10660861|NCT02255032|11822555|FG000|COMPLETED|Overall Study||17
10660862|NCT02255032|11822556|FG001|COMPLETED|Overall Study||5
10660863|NCT02255032|11822555|FG000|NOT COMPLETED|Overall Study||0
10660864|NCT02255032|11822556|FG001|NOT COMPLETED|Overall Study||0
10660865|NCT02255110|11822562|FG000|STARTED|Overall Study||6
10660866|NCT02255110|11822562|FG000|COMPLETED|Overall Study||6
10660867|NCT02255110|11822562|FG000|NOT COMPLETED|Overall Study||0
10660868|NCT02255149|11822566|FG000|STARTED|Overall Study||10
10660869|NCT02255149|11822566|FG000|COMPLETED|Overall Study||5
10660870|NCT02255149|11822566|FG000|NOT COMPLETED|Overall Study||5
10660871|NCT02255175|11822572|FG000|STARTED|Overall Study||33
10660872|NCT02255175|11822573|FG001|STARTED|Overall Study||31
10660873|NCT02255175|11822572|FG000|COMPLETED|Overall Study||16
10660874|NCT02255175|11822573|FG001|COMPLETED|Overall Study||19
10660875|NCT02255175|11822572|FG000|NOT COMPLETED|Overall Study||17
10660876|NCT02255175|11822573|FG001|NOT COMPLETED|Overall Study||12
10660877|NCT02255279|11822585|FG000|STARTED|Overall Study||144
10660878|NCT02255279|11822586|FG001|STARTED|Overall Study||143
10660879|NCT02255279|11822585|FG000|COMPLETED|Overall Study||139
10660880|NCT02255279|11822586|FG001|COMPLETED|Overall Study||134
10660881|NCT02255279|11822585|FG000|NOT COMPLETED|Overall Study||5
10660882|NCT02255279|11822586|FG001|NOT COMPLETED|Overall Study||9
10660883|NCT02255357|11822608|FG000|STARTED|Overall Study||11
10660884|NCT02255357|11822609|FG001|STARTED|Overall Study||15
10660885|NCT02255357|11822608|FG000|COMPLETED|Overall Study||4
10660886|NCT02255357|11822609|FG001|COMPLETED|Overall Study||5
10660887|NCT02255357|11822608|FG000|NOT COMPLETED|Overall Study||7
10660888|NCT02255357|11822609|FG001|NOT COMPLETED|Overall Study||10
10660889|NCT02255422|11822622|FG000|STARTED|Overall Study||13
10660890|NCT02255422|11822623|FG001|STARTED|Overall Study||6
10660891|NCT02255422|11822624|FG002|STARTED|Overall Study||6
10660892|NCT02255422|11822625|FG003|STARTED|Overall Study||6
10660893|NCT02255422|11822626|FG004|STARTED|Overall Study||6
10660894|NCT02255422|11822627|FG005|STARTED|Overall Study||6
10660895|NCT02255422|11822628|FG006|STARTED|Overall Study||10
10660896|NCT02255422|11822622|FG000|COMPLETED|Overall Study||13
10660897|NCT02255422|11822623|FG001|COMPLETED|Overall Study||6
10660898|NCT02255422|11822624|FG002|COMPLETED|Overall Study||5
10660899|NCT02255422|11822625|FG003|COMPLETED|Overall Study||6
10660900|NCT02255422|11822626|FG004|COMPLETED|Overall Study||6
10660901|NCT02255422|11822627|FG005|COMPLETED|Overall Study||6
10660902|NCT02255422|11822628|FG006|COMPLETED|Overall Study||8
10660903|NCT02255422|11822622|FG000|NOT COMPLETED|Overall Study||0
10403942|NCT00732472|11548294|FG003|NOT COMPLETED|Overall Study||3
10403943|NCT00732498|11548305|FG000|STARTED|Overall Study||28
10403944|NCT00732498|11548305|FG000|COMPLETED|Overall Study||22
10403945|NCT00732498|11548305|FG000|NOT COMPLETED|Overall Study||6
10660904|NCT02255422|11822623|FG001|NOT COMPLETED|Overall Study||0
10660905|NCT02255422|11822624|FG002|NOT COMPLETED|Overall Study||1
10660906|NCT02255422|11822625|FG003|NOT COMPLETED|Overall Study||0
10660907|NCT02255422|11822626|FG004|NOT COMPLETED|Overall Study||0
10660908|NCT02255422|11822627|FG005|NOT COMPLETED|Overall Study||0
10660909|NCT02255422|11822628|FG006|NOT COMPLETED|Overall Study||2
10660910|NCT02255461|11822649|FG000|STARTED|Overall Study||3
10660911|NCT02255461|11822650|FG001|STARTED|Overall Study||12
10660912|NCT02255461|11822651|FG002|STARTED|Overall Study||6
10660913|NCT02255461|11822652|FG003|STARTED|Overall Study||4
10660914|NCT02255461|11822653|FG004|STARTED|Overall Study||10
10660915|NCT02255461|11822649|FG000|COMPLETED|Overall Study||3
10660916|NCT02255461|11822650|FG001|COMPLETED|Overall Study||10
10660917|NCT02255461|11822651|FG002|COMPLETED|Overall Study||5
10403946|NCT00732615|11548311|FG000|STARTED|Overall Study||40
10403947|NCT00732615|11548312|FG001|STARTED|Overall Study||84
10403948|NCT00732615|11548311|FG000|COMPLETED|Overall Study||33
10403950|NCT00732615|11548311|FG000|NOT COMPLETED|Overall Study||7
10403951|NCT00732615|11548312|FG001|NOT COMPLETED|Overall Study||5
10403952|NCT00732641|11548321|FG000|STARTED|Overall Study||123
10403953|NCT00732641|11548322|FG001|STARTED|Overall Study||121
10403954|NCT00732641|11548321|FG000|COMPLETED|Overall Study||17
10403955|NCT00732641|11548322|FG001|COMPLETED|Overall Study||9
10403956|NCT00732641|11548321|FG000|NOT COMPLETED|Overall Study||106
10403957|NCT00732641|11548322|FG001|NOT COMPLETED|Overall Study||112
10403958|NCT00732654|11548331|FG000|STARTED|Overall Study||10
10403959|NCT00732654|11548332|FG001|STARTED|Overall Study||10
10403960|NCT00732654|11548333|FG002|STARTED|Overall Study||10
10403961|NCT00732654|11548331|FG000|COMPLETED|Overall Study||10
10403962|NCT00732654|11548332|FG001|COMPLETED|Overall Study||9
10403963|NCT00732654|11548333|FG002|COMPLETED|Overall Study||10
10403964|NCT00732654|11548331|FG000|NOT COMPLETED|Overall Study||0
10403965|NCT00732654|11548332|FG001|NOT COMPLETED|Overall Study||1
10403966|NCT00732654|11548333|FG002|NOT COMPLETED|Overall Study||0
10403967|NCT00732758|11548343|FG000|STARTED|Overall Study||78
10403968|NCT00732758|11548344|FG001|STARTED|Overall Study||79
10403969|NCT00732758|11548343|FG000|COMPLETED|Overall Study||70
10403970|NCT00732758|11548344|FG001|COMPLETED|Overall Study||63
10403971|NCT00732758|11548343|FG000|NOT COMPLETED|Overall Study||8
10403972|NCT00732758|11548344|FG001|NOT COMPLETED|Overall Study||16
10403973|NCT00732875|11548350|FG000|STARTED|Overall Study||92
10403974|NCT00732875|11548350|FG000|COMPLETED|Overall Study|These participants continued treatment until trial was completed by Sponsor.|57
10403975|NCT00732875|11548350|FG000|NOT COMPLETED|Overall Study||35
10403976|NCT00732901|11548356|FG000|STARTED|Overall Study||11
10403977|NCT00732901|11548357|FG001|STARTED|Overall Study||12
10403978|NCT00732901|11548356|FG000|COMPLETED|Overall Study||11
10403979|NCT00732901|11548357|FG001|COMPLETED|Overall Study||12
10403980|NCT00732901|11548356|FG000|NOT COMPLETED|Overall Study||0
10403981|NCT00732901|11548357|FG001|NOT COMPLETED|Overall Study||0
10403982|NCT00732940|11548365|FG000|STARTED|Overall Study||28
10403983|NCT00732940|11548366|FG001|STARTED|Overall Study||28
10403984|NCT00732940|11548365|FG000|COMPLETED|Overall Study||26
10403985|NCT00732940|11548366|FG001|COMPLETED|Overall Study||25
10403986|NCT00732940|11548365|FG000|NOT COMPLETED|Overall Study||2
10403987|NCT00732940|11548366|FG001|NOT COMPLETED|Overall Study||3
10403988|NCT00732992|11548374|FG000|STARTED|Overall Study||6
10403989|NCT00732992|11548375|FG001|STARTED|Overall Study||6
10403990|NCT00732992|11548374|FG000|COMPLETED|Overall Study||0
10403991|NCT00732992|11548375|FG001|COMPLETED|Overall Study||0
10403992|NCT00732992|11548374|FG000|NOT COMPLETED|Overall Study||6
10403993|NCT00732992|11548375|FG001|NOT COMPLETED|Overall Study||6
10403994|NCT00733096|11548385|FG000|STARTED|Overall Study||28
10403995|NCT00733096|11548386|FG001|STARTED|Overall Study||26
10403996|NCT00733096|11548387|FG002|STARTED|Overall Study||30
10403997|NCT00733096|11548385|FG000|COMPLETED|Overall Study||28
10403998|NCT00733096|11548386|FG001|COMPLETED|Overall Study||26
10403999|NCT00733096|11548387|FG002|COMPLETED|Overall Study||30
10404000|NCT00733096|11548385|FG000|NOT COMPLETED|Overall Study||0
10404001|NCT00733096|11548386|FG001|NOT COMPLETED|Overall Study||0
10404002|NCT00733096|11548387|FG002|NOT COMPLETED|Overall Study||0
10404003|NCT00733135|11548395|FG000|STARTED|Overall Study||133
10404004|NCT00733135|11548395|FG000|COMPLETED|Overall Study||131
10404005|NCT00733135|11548395|FG000|NOT COMPLETED|Overall Study||2
10404006|NCT00733226|11548403|FG000|STARTED|Overall Study||40
10404007|NCT00733226|11548404|FG001|STARTED|Overall Study||40
10404008|NCT00733226|11548403|FG000|COMPLETED|Overall Study||35
10404009|NCT00733226|11548404|FG001|COMPLETED|Overall Study||40
10404010|NCT00733226|11548403|FG000|NOT COMPLETED|Overall Study||5
10404011|NCT00733226|11548404|FG001|NOT COMPLETED|Overall Study||0
10404012|NCT00733278|11548410|FG000|STARTED|Overall Study||7
10404013|NCT00733278|11548410|FG000|COMPLETED|Overall Study||7
10404014|NCT00733278|11548410|FG000|NOT COMPLETED|Overall Study||0
10428990|NCT00862563|11575182|FG001|STARTED|Overall Study||21
10428991|NCT00862563|11575183|FG002|STARTED|Overall Study||21
10428992|NCT00862563|11575184|FG003|STARTED|Overall Study||24
10428993|NCT00862563|11575181|FG000|COMPLETED|Overall Study||15
10428994|NCT00862563|11575182|FG001|COMPLETED|Overall Study||17
10428995|NCT00862563|11575183|FG002|COMPLETED|Overall Study||15
10660918|NCT02255461|11822652|FG003|COMPLETED|Overall Study||4
10660919|NCT02255461|11822653|FG004|COMPLETED|Overall Study||8
10660920|NCT02255461|11822649|FG000|NOT COMPLETED|Overall Study||0
10660921|NCT02255461|11822650|FG001|NOT COMPLETED|Overall Study||2
10660922|NCT02255461|11822651|FG002|NOT COMPLETED|Overall Study||1
10660923|NCT02255461|11822652|FG003|NOT COMPLETED|Overall Study||0
10428996|NCT00862563|11575184|FG003|COMPLETED|Overall Study||19
10428997|NCT00862563|11575181|FG000|NOT COMPLETED|Overall Study||4
10428998|NCT00862563|11575182|FG001|NOT COMPLETED|Overall Study||4
10428999|NCT00862563|11575183|FG002|NOT COMPLETED|Overall Study||6
10429000|NCT00862563|11575184|FG003|NOT COMPLETED|Overall Study||5
10429001|NCT00862641|11575207|FG000|STARTED|Overall Study||177
10429002|NCT00862641|11575208|FG001|STARTED|Overall Study||360
10429003|NCT00862641|11575209|FG002|STARTED|Overall Study||152
10429004|NCT00862641|11575210|FG003|STARTED|Overall Study||320
10429913|NCT00867100|11576059|FG009|STARTED|Overall Study||6
10660924|NCT02255461|11822653|FG004|NOT COMPLETED|Overall Study||2
10660925|NCT02255474|11822673|FG000|STARTED|Overall Study||98
10404015|NCT00733291|11548417|FG000|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||13
10404016|NCT00733291|11548418|FG001|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
10404017|NCT00733291|11548419|FG002|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
10544250|NCT01490073|11697526|FG001|COMPLETED|Overall Study||12
10544251|NCT01490073|11697525|FG000|NOT COMPLETED|Overall Study||0
10544252|NCT01490073|11697526|FG001|NOT COMPLETED|Overall Study||0
10544253|NCT01490086|11697537|FG000|STARTED|Overall Study||58
10544254|NCT01490086|11697538|FG001|STARTED|Overall Study||59
10544255|NCT01490086|11697539|FG002|STARTED|Overall Study||58
10544256|NCT01490086|11697540|FG003|STARTED|Overall Study||20
10544257|NCT01490086|11697541|FG004|STARTED|Overall Study||39
10544258|NCT01490086|11697537|FG000|COMPLETED|Overall Study||50
10544259|NCT01490086|11697538|FG001|COMPLETED|Overall Study||44
10544260|NCT01490086|11697539|FG002|COMPLETED|Overall Study||51
10544261|NCT01490086|11697540|FG003|COMPLETED|Overall Study||13
10544262|NCT01490086|11697541|FG004|COMPLETED|Overall Study||28
10544263|NCT01490086|11697537|FG000|NOT COMPLETED|Overall Study||8
10544264|NCT01490086|11697538|FG001|NOT COMPLETED|Overall Study||15
10544265|NCT01490086|11697539|FG002|NOT COMPLETED|Overall Study||7
10544266|NCT01490086|11697540|FG003|NOT COMPLETED|Overall Study||7
10544267|NCT01490086|11697541|FG004|NOT COMPLETED|Overall Study||11
10544268|NCT01490125|11697553|FG000|STARTED|Period I||43
10544269|NCT01490125|11697554|FG001|STARTED|Period I||42
10544270|NCT01490125|11697555|FG002|STARTED|Period I||41
10544271|NCT01490125|11697556|FG003|STARTED|Period I||38
10544272|NCT01490125|11697557|FG004|STARTED|Period I||40
10544273|NCT01490125|11697558|FG005|STARTED|Period I||42
10544274|NCT01490125|11697553|FG000|COMPLETED|Period I||37
10544275|NCT01490125|11697554|FG001|COMPLETED|Period I||37
10544276|NCT01490125|11697555|FG002|COMPLETED|Period I||37
10544277|NCT01490125|11697556|FG003|COMPLETED|Period I||33
10544278|NCT01490125|11697557|FG004|COMPLETED|Period I||36
10544279|NCT01490125|11697558|FG005|COMPLETED|Period I||37
10544280|NCT01490125|11697553|FG000|NOT COMPLETED|Period I||6
10544281|NCT01490125|11697554|FG001|NOT COMPLETED|Period I||5
10544282|NCT01490125|11697555|FG002|NOT COMPLETED|Period I||4
10660926|NCT02255474|11822674|FG001|STARTED|Overall Study||98
10660927|NCT02255474|11822675|FG002|STARTED|Overall Study||98
10660928|NCT02255474|11822673|FG000|COMPLETED|Overall Study||96
10660929|NCT02255474|11822674|FG001|COMPLETED|Overall Study||96
10660930|NCT02255474|11822675|FG002|COMPLETED|Overall Study||95
10660931|NCT02255474|11822673|FG000|NOT COMPLETED|Overall Study||2
10660932|NCT02255474|11822674|FG001|NOT COMPLETED|Overall Study||2
10660933|NCT02255474|11822675|FG002|NOT COMPLETED|Overall Study||3
10660934|NCT02255500|11822686|FG000|STARTED|Overall Study||16
10660935|NCT02255500|11822687|FG001|STARTED|Overall Study||7
10660936|NCT02255500|11822686|FG000|COMPLETED|Overall Study||15
10660937|NCT02255500|11822687|FG001|COMPLETED|Overall Study||7
10660938|NCT02255500|11822686|FG000|NOT COMPLETED|Overall Study||1
10660939|NCT02255500|11822687|FG001|NOT COMPLETED|Overall Study||0
10660940|NCT02255513|11822695|FG000|STARTED|Open-label, Treatment Optimization||43
10660941|NCT02255513|11822696|FG001|STARTED|Open-label, Treatment Optimization||0
10660942|NCT02255513|11822695|FG000|COMPLETED|Open-label, Treatment Optimization||43
10660943|NCT02255513|11822696|FG001|COMPLETED|Open-label, Treatment Optimization||0
10660944|NCT02255513|11822695|FG000|NOT COMPLETED|Open-label, Treatment Optimization||0
10660945|NCT02255513|11822696|FG001|NOT COMPLETED|Open-label, Treatment Optimization||0
10660946|NCT02255513|11822695|FG000|STARTED|Double Blind, Placebo-controlled||22
10660947|NCT02255513|11822696|FG001|STARTED|Double Blind, Placebo-controlled||21
10660948|NCT02255513|11822695|FG000|COMPLETED|Double Blind, Placebo-controlled||22
10660949|NCT02255513|11822696|FG001|COMPLETED|Double Blind, Placebo-controlled||21
10660950|NCT02255513|11822695|FG000|NOT COMPLETED|Double Blind, Placebo-controlled||0
10660951|NCT02255513|11822696|FG001|NOT COMPLETED|Double Blind, Placebo-controlled||0
10660952|NCT02255552|11822704|FG000|STARTED|Overall Study||79
10660953|NCT02255552|11822705|FG001|STARTED|Overall Study||30
10660954|NCT02255552|11822704|FG000|COMPLETED|Overall Study||78
10660955|NCT02255552|11822705|FG001|COMPLETED|Overall Study||15
10660956|NCT02255552|11822704|FG000|NOT COMPLETED|Overall Study||1
10660957|NCT02255552|11822705|FG001|NOT COMPLETED|Overall Study||15
10660958|NCT02255565|11822714|FG000|STARTED|Overall Study||9
10660959|NCT02255565|11822715|FG001|STARTED|Overall Study||9
10660960|NCT02255565|11822716|FG002|STARTED|Overall Study||9
10660961|NCT02255565|11822714|FG000|COMPLETED|Overall Study||9
10660962|NCT02255565|11822715|FG001|COMPLETED|Overall Study||8
10660963|NCT02255565|11822716|FG002|COMPLETED|Overall Study||9
10660964|NCT02255565|11822714|FG000|NOT COMPLETED|Overall Study||0
10660965|NCT02255565|11822715|FG001|NOT COMPLETED|Overall Study||1
10544283|NCT01490125|11697556|FG003|NOT COMPLETED|Period I||5
10544284|NCT01490125|11697557|FG004|NOT COMPLETED|Period I||4
10544285|NCT01490125|11697558|FG005|NOT COMPLETED|Period I||5
10544286|NCT01490125|11697553|FG000|STARTED|Period II||37
10544287|NCT01490125|11697554|FG001|STARTED|Period II||37
10544288|NCT01490125|11697555|FG002|STARTED|Period II||37
10544289|NCT01490125|11697556|FG003|STARTED|Period II||33
10544290|NCT01490125|11697557|FG004|STARTED|Period II||36
10544291|NCT01490125|11697558|FG005|STARTED|Period II||37
10544292|NCT01490125|11697553|FG000|COMPLETED|Period II||34
10544293|NCT01490125|11697554|FG001|COMPLETED|Period II||33
10660966|NCT02255565|11822716|FG002|NOT COMPLETED|Overall Study||0
10660967|NCT02255604|11822760|FG000|STARTED|Overall Study||12
10660968|NCT02255604|11822761|FG001|STARTED|Overall Study||12
10660969|NCT02255604|11822762|FG002|STARTED|Overall Study||12
10660970|NCT02255604|11822760|FG000|COMPLETED|Overall Study||10
10404018|NCT00733291|11548420|FG003|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
10404019|NCT00733291|11548417|FG000|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||13
10404020|NCT00733291|11548418|FG001|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
10404021|NCT00733291|11548419|FG002|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
10404022|NCT00733291|11548420|FG003|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
10404023|NCT00733291|11548417|FG000|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
10404024|NCT00733291|11548418|FG001|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
10404025|NCT00733291|11548419|FG002|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
10660971|NCT02255604|11822761|FG001|COMPLETED|Overall Study||11
10660972|NCT02255604|11822762|FG002|COMPLETED|Overall Study||9
10660973|NCT02255604|11822760|FG000|NOT COMPLETED|Overall Study||2
10660974|NCT02255604|11822761|FG001|NOT COMPLETED|Overall Study||1
10660975|NCT02255604|11822762|FG002|NOT COMPLETED|Overall Study||3
10660976|NCT02255760|11822775|FG000|STARTED|Overall Study||14
10660977|NCT02255760|11822776|FG001|STARTED|Overall Study||3
10660978|NCT02255760|11822777|FG002|STARTED|Overall Study||15
10660979|NCT02255760|11822778|FG003|STARTED|Overall Study||15
10660980|NCT02255760|11822779|FG004|STARTED|Overall Study||9
10660981|NCT02255760|11822775|FG000|COMPLETED|Overall Study||14
10660982|NCT02255760|11822776|FG001|COMPLETED|Overall Study||2
10660983|NCT02255760|11822777|FG002|COMPLETED|Overall Study||15
10660984|NCT02255760|11822778|FG003|COMPLETED|Overall Study||15
10660985|NCT02255760|11822779|FG004|COMPLETED|Overall Study||9
10660986|NCT02255760|11822775|FG000|NOT COMPLETED|Overall Study||0
10660987|NCT02255760|11822776|FG001|NOT COMPLETED|Overall Study||1
10660988|NCT02255760|11822777|FG002|NOT COMPLETED|Overall Study||0
10660989|NCT02255760|11822778|FG003|NOT COMPLETED|Overall Study||0
10660990|NCT02255760|11822779|FG004|NOT COMPLETED|Overall Study||0
10660991|NCT02255981|11822795|FG000|STARTED|Overall Study|Both eyes of each patient were included except 2 that not were treatable|33
10660992|NCT02255981|11822795|FG000|COMPLETED|Overall Study|2 eyes of the final 29 subjects were excluded.|29
10660993|NCT02255981|11822795|FG000|NOT COMPLETED|Overall Study||4
10660994|NCT02256072|11822807|FG000|STARTED|Overall Study||194
10660995|NCT02256072|11822808|FG001|STARTED|Overall Study||191
10660996|NCT02256072|11822807|FG000|Completed 1 Month Follow-Up|Overall Study|Completed the 1-month follow-up|167
10660997|NCT02256072|11822808|FG001|Completed 1 Month Follow-Up|Overall Study||179
10660998|NCT02256072|11822807|FG000|COMPLETED|Overall Study|Completed the 3-month follow-up|152
10660999|NCT02256072|11822808|FG001|COMPLETED|Overall Study||162
10661000|NCT02256072|11822807|FG000|NOT COMPLETED|Overall Study||42
10661001|NCT02256072|11822808|FG001|NOT COMPLETED|Overall Study||29
10661002|NCT02256111|11822817|FG000|STARTED|Overall Study||13
10661003|NCT02256111|11822818|FG001|STARTED|Overall Study||13
10661004|NCT02256111|11822817|FG000|COMPLETED|Overall Study||13
10661005|NCT02256111|11822818|FG001|COMPLETED|Overall Study||13
10661006|NCT02256111|11822817|FG000|NOT COMPLETED|Overall Study||0
10661007|NCT02256111|11822818|FG001|NOT COMPLETED|Overall Study||0
10661008|NCT02256189|11822827|FG000|STARTED|Overall Study||15
10661009|NCT02256189|11822828|FG001|STARTED|Overall Study||13
10661010|NCT02256189|11822827|FG000|COMPLETED|Overall Study||15
10661011|NCT02256189|11822828|FG001|COMPLETED|Overall Study||13
10661012|NCT02256189|11822827|FG000|NOT COMPLETED|Overall Study||0
10661013|NCT02256189|11822828|FG001|NOT COMPLETED|Overall Study||0
10661014|NCT02256267|11822836|FG000|STARTED|Period 1 (Day 1; Day 2 to Day 9 Washout)||24
10721722|NCT02730195|11885420|FG000|STARTED|Overall Study||9
10721723|NCT02730195|11885420|FG000|COMPLETED|Overall Study||8
10721724|NCT02730195|11885420|FG000|NOT COMPLETED|Overall Study||1
10721725|NCT02730208|11885426|FG000|STARTED|Overall Study||20
10721726|NCT02730208|11885427|FG001|STARTED|Overall Study||21
10721727|NCT02730208|11885426|FG000|COMPLETED|Overall Study||20
10721728|NCT02730208|11885427|FG001|COMPLETED|Overall Study||20
10721729|NCT02730208|11885426|FG000|NOT COMPLETED|Overall Study||0
10721730|NCT02730208|11885427|FG001|NOT COMPLETED|Overall Study||1
10721731|NCT02730234|11885433|FG000|STARTED|Overall Study||60
10721732|NCT02730234|11885433|FG000|COMPLETED|Overall Study|8 Deaths|52
10721733|NCT02730234|11885433|FG000|NOT COMPLETED|Overall Study||8
10404026|NCT00733291|11548420|FG003|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
10404027|NCT00733291|11548417|FG000|STARTED|Washout Period, 3 Days (+/-1 Day)||13
10404028|NCT00733291|11548418|FG001|STARTED|Washout Period, 3 Days (+/-1 Day)||17
10661015|NCT02256267|11822836|FG000|Received at Least 1 Dose of LY2835219|Period 1 (Day 1; Day 2 to Day 9 Washout)||24
10661016|NCT02256267|11822836|FG000|COMPLETED|Period 1 (Day 1; Day 2 to Day 9 Washout)||23
10661017|NCT02256267|11822836|FG000|NOT COMPLETED|Period 1 (Day 1; Day 2 to Day 9 Washout)||1
10661018|NCT02256267|11822836|FG000|STARTED|Period 2 (Day 1 to Day 6)||23
10661019|NCT02256267|11822836|FG000|Received at Least 1 Dose of Rifampin|Period 2 (Day 1 to Day 6)||23
10661020|NCT02256267|11822836|FG000|COMPLETED|Period 2 (Day 1 to Day 6)||23
10661021|NCT02256267|11822836|FG000|NOT COMPLETED|Period 2 (Day 1 to Day 6)||0
10721734|NCT02730247|11885437|FG000|STARTED|Overall Study||7
10721735|NCT02730247|11885437|FG000|COMPLETED|Overall Study||7
10721736|NCT02730247|11885437|FG000|NOT COMPLETED|Overall Study||0
10721737|NCT02730260|11885443|FG000|STARTED|Overall Study||258
10721738|NCT02730260|11885444|FG001|STARTED|Overall Study||260
10404029|NCT00733291|11548419|FG002|STARTED|Washout Period, 3 Days (+/-1 Day)||17
10404030|NCT00733291|11548420|FG003|STARTED|Washout Period, 3 Days (+/-1 Day)||17
10404031|NCT00733291|11548417|FG000|COMPLETED|Washout Period, 3 Days (+/-1 Day)||12
10404032|NCT00733291|11548418|FG001|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
10404033|NCT00733291|11548419|FG002|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
10404034|NCT00733291|11548420|FG003|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
10404035|NCT00733291|11548417|FG000|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||1
10404036|NCT00733291|11548418|FG001|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
10404037|NCT00733291|11548419|FG002|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
10404038|NCT00733291|11548420|FG003|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
10404039|NCT00733291|11548417|FG000|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||12
10404040|NCT00733291|11548418|FG001|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
10404041|NCT00733291|11548419|FG002|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
10404042|NCT00733291|11548420|FG003|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
10404043|NCT00733291|11548417|FG000|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||12
10404044|NCT00733291|11548418|FG001|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
10404045|NCT00733291|11548419|FG002|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
10404046|NCT00733291|11548420|FG003|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
10404047|NCT00733291|11548417|FG000|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
10404048|NCT00733291|11548418|FG001|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
10404049|NCT00733291|11548419|FG002|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
10404050|NCT00733291|11548420|FG003|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
10404051|NCT00733304|11548434|FG000|STARTED|Overall Study||19
10404052|NCT00733304|11548435|FG001|STARTED|Overall Study||15
10404053|NCT00733304|11548436|FG002|STARTED|Overall Study||8
10404054|NCT00733304|11548434|FG000|COMPLETED|Overall Study||12
10404055|NCT00733304|11548435|FG001|COMPLETED|Overall Study||12
10404056|NCT00733304|11548436|FG002|COMPLETED|Overall Study||3
10404057|NCT00733304|11548434|FG000|NOT COMPLETED|Overall Study||7
10404058|NCT00733304|11548435|FG001|NOT COMPLETED|Overall Study||3
10404059|NCT00733304|11548436|FG002|NOT COMPLETED|Overall Study||5
10404060|NCT00733330|11548446|FG000|STARTED|Overall Study||32
10404061|NCT00733330|11548447|FG001|STARTED|Overall Study||52
10404062|NCT00733330|11548446|FG000|COMPLETED|Overall Study||30
10404063|NCT00733330|11548447|FG001|COMPLETED|Overall Study||48
10404064|NCT00733330|11548446|FG000|NOT COMPLETED|Overall Study||2
10404065|NCT00733330|11548447|FG001|NOT COMPLETED|Overall Study||4
10404066|NCT00733343|11548457|FG000|STARTED|Overall Study||666
10404067|NCT00733343|11548458|FG001|STARTED|Overall Study||659
10404068|NCT00733343|11548457|FG000|COMPLETED|Overall Study||583
10404069|NCT00733343|11548458|FG001|COMPLETED|Overall Study||578
10404070|NCT00733343|11548457|FG000|NOT COMPLETED|Overall Study||83
10721739|NCT02730260|11885443|FG000|COMPLETED|Overall Study||176
10721740|NCT02730260|11885444|FG001|COMPLETED|Overall Study||185
10721741|NCT02730260|11885443|FG000|NOT COMPLETED|Overall Study||82
10721742|NCT02730260|11885444|FG001|NOT COMPLETED|Overall Study||75
10721743|NCT02730351|11885450|FG000|STARTED|Treatment Period 1 (2 Weeks)||37
10721744|NCT02730351|11885451|FG001|STARTED|Treatment Period 1 (2 Weeks)||37
10721745|NCT02730351|11885450|FG000|COMPLETED|Treatment Period 1 (2 Weeks)||36
10721746|NCT02730351|11885451|FG001|COMPLETED|Treatment Period 1 (2 Weeks)||37
10721747|NCT02730351|11885450|FG000|NOT COMPLETED|Treatment Period 1 (2 Weeks)||1
10721748|NCT02730351|11885451|FG001|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
10721749|NCT02730351|11885450|FG000|STARTED|Wash-out Period (2 Weeks)||36
10721750|NCT02730351|11885451|FG001|STARTED|Wash-out Period (2 Weeks)||37
10721751|NCT02730351|11885450|FG000|COMPLETED|Wash-out Period (2 Weeks)||35
10721752|NCT02730351|11885451|FG001|COMPLETED|Wash-out Period (2 Weeks)||36
10721753|NCT02730351|11885450|FG000|NOT COMPLETED|Wash-out Period (2 Weeks)||1
10721754|NCT02730351|11885451|FG001|NOT COMPLETED|Wash-out Period (2 Weeks)||1
10721755|NCT02730351|11885450|FG000|STARTED|Treatment Period 2 (2 Weeks)||35
10814412|NCT02365233|11977131|FG000|COMPLETED|Overall Study||0
10814413|NCT02365233|11977132|FG001|COMPLETED|Overall Study||0
10814414|NCT02365233|11977133|FG002|COMPLETED|Overall Study||0
10814415|NCT02365233|11977131|FG000|NOT COMPLETED|Overall Study||1
10814416|NCT02365233|11977132|FG001|NOT COMPLETED|Overall Study||2
10814417|NCT02365233|11977133|FG002|NOT COMPLETED|Overall Study||2
10814418|NCT02347943|11977144|FG000|STARTED|Overall Study||140
10814419|NCT02347943|11977145|FG001|STARTED|Overall Study||67
10814420|NCT02347943|11977146|FG002|STARTED|Overall Study||45
10814421|NCT02347943|11977144|FG000|COMPLETED|Overall Study||0
10814422|NCT02347943|11977145|FG001|COMPLETED|Overall Study||0
10814423|NCT02347943|11977146|FG002|COMPLETED|Overall Study||0
10814424|NCT02347943|11977144|FG000|NOT COMPLETED|Overall Study||140
10404071|NCT00733343|11548458|FG001|NOT COMPLETED|Overall Study||81
10404072|NCT00733356|11548465|FG000|STARTED|Vyvanse Dose Titration||28
10404073|NCT00733356|11548465|FG000|COMPLETED|Vyvanse Dose Titration||26
10404074|NCT00733356|11548465|FG000|NOT COMPLETED|Vyvanse Dose Titration||2
10404075|NCT00733356|11548465|FG000|STARTED|Modified Lab School, Reading Evaluation||26
10721756|NCT02730351|11885451|FG001|STARTED|Treatment Period 2 (2 Weeks)||36
10721757|NCT02730351|11885450|FG000|COMPLETED|Treatment Period 2 (2 Weeks)||33
10721758|NCT02730351|11885451|FG001|COMPLETED|Treatment Period 2 (2 Weeks)||36
10721759|NCT02730351|11885450|FG000|NOT COMPLETED|Treatment Period 2 (2 Weeks)||2
10814425|NCT02347943|11977145|FG001|NOT COMPLETED|Overall Study||67
10814426|NCT02347943|11977146|FG002|NOT COMPLETED|Overall Study||45
10814427|NCT02365207|11977154|FG000|STARTED|Overall Study||6
10404076|NCT00733356|11548465|FG000|COMPLETED|Modified Lab School, Reading Evaluation||26
10404077|NCT00733356|11548465|FG000|NOT COMPLETED|Modified Lab School, Reading Evaluation||0
10404078|NCT00733369|11548471|FG000|STARTED|Overall Study||50
10404079|NCT00733369|11548472|FG001|STARTED|Overall Study||56
10404080|NCT00733369|11548471|FG000|COMPLETED|Overall Study||40
10404081|NCT00733369|11548472|FG001|COMPLETED|Overall Study||47
10404082|NCT00733369|11548471|FG000|NOT COMPLETED|Overall Study||10
10404083|NCT00733369|11548472|FG001|NOT COMPLETED|Overall Study||9
10404084|NCT00733408|11548478|FG000|STARTED|Overall Study||59
10404085|NCT00733408|11548478|FG000|COMPLETED|Overall Study||55
10404086|NCT00733408|11548478|FG000|NOT COMPLETED|Overall Study||4
10404087|NCT00733421|11548484|FG000|STARTED|Overall Study|November 2008|50
10404088|NCT00733421|11548485|FG001|STARTED|Overall Study|November 2008|50
10404089|NCT00733421|11548484|FG000|COMPLETED|Overall Study|All but one randomsied patient|49
10404090|NCT00733421|11548485|FG001|COMPLETED|Overall Study|All but one randomised patient|49
10404091|NCT00733421|11548484|FG000|NOT COMPLETED|Overall Study||1
10404092|NCT00733421|11548485|FG001|NOT COMPLETED|Overall Study||1
10404093|NCT00733499|11548493|FG000|STARTED|Pre-operative||102
10404094|NCT00733499|11548494|FG001|STARTED|Pre-operative|A death occurred prior to surgery which left a total of 102 participants|103
10404095|NCT00733499|11548493|FG000|COMPLETED|Pre-operative||102
10404096|NCT00733499|11548494|FG001|COMPLETED|Pre-operative||102
10404097|NCT00733499|11548493|FG000|NOT COMPLETED|Pre-operative||0
10404098|NCT00733499|11548494|FG001|NOT COMPLETED|Pre-operative||1
10404099|NCT00733499|11548493|FG000|STARTED|3 Months Follow-up||102
10404100|NCT00733499|11548494|FG001|STARTED|3 Months Follow-up||102
10404101|NCT00733499|11548493|FG000|COMPLETED|3 Months Follow-up||101
10404102|NCT00733499|11548494|FG001|COMPLETED|3 Months Follow-up||100
10404103|NCT00733499|11548493|FG000|NOT COMPLETED|3 Months Follow-up||1
10404104|NCT00733499|11548494|FG001|NOT COMPLETED|3 Months Follow-up||2
10404105|NCT00733499|11548493|FG000|STARTED|6 Months Follow-up||101
10404106|NCT00733499|11548494|FG001|STARTED|6 Months Follow-up||100
10404107|NCT00733499|11548493|FG000|COMPLETED|6 Months Follow-up||101
10404108|NCT00733499|11548494|FG001|COMPLETED|6 Months Follow-up||97
10404109|NCT00733499|11548493|FG000|NOT COMPLETED|6 Months Follow-up||0
10404110|NCT00733499|11548494|FG001|NOT COMPLETED|6 Months Follow-up||3
10404111|NCT00733499|11548493|FG000|STARTED|12 Months Follow-up||101
10404112|NCT00733499|11548494|FG001|STARTED|12 Months Follow-up||97
10404113|NCT00733499|11548493|FG000|COMPLETED|12 Months Follow-up||99
10404114|NCT00733499|11548494|FG001|COMPLETED|12 Months Follow-up||96
10404115|NCT00733499|11548493|FG000|NOT COMPLETED|12 Months Follow-up||2
10404116|NCT00733499|11548494|FG001|NOT COMPLETED|12 Months Follow-up||1
10404117|NCT00733499|11548493|FG000|STARTED|24 Months Follow-up||99
10404118|NCT00733499|11548494|FG001|STARTED|24 Months Follow-up||96
10404119|NCT00733499|11548493|FG000|COMPLETED|24 Months Follow-up||99
10404120|NCT00733499|11548494|FG001|COMPLETED|24 Months Follow-up||95
10404121|NCT00733499|11548493|FG000|NOT COMPLETED|24 Months Follow-up||0
10404122|NCT00733499|11548494|FG001|NOT COMPLETED|24 Months Follow-up||1
10404123|NCT00733499|11548493|FG000|STARTED|5 Year Followup||91
10404124|NCT00733499|11548494|FG001|STARTED|5 Year Followup||78
10404125|NCT00733499|11548493|FG000|COMPLETED|5 Year Followup||70
10404126|NCT00733499|11548494|FG001|COMPLETED|5 Year Followup||53
10404127|NCT00733499|11548493|FG000|NOT COMPLETED|5 Year Followup||21
10404128|NCT00733499|11548494|FG001|NOT COMPLETED|5 Year Followup||25
10404129|NCT00733499|11548493|FG000|STARTED|10 Year Followup||46
10404130|NCT00733499|11548494|FG001|STARTED|10 Year Followup||32
10404131|NCT00733499|11548493|FG000|COMPLETED|10 Year Followup||26
10404132|NCT00733499|11548494|FG001|COMPLETED|10 Year Followup||13
10404133|NCT00733499|11548493|FG000|NOT COMPLETED|10 Year Followup||20
10404134|NCT00733499|11548494|FG001|NOT COMPLETED|10 Year Followup||19
10404135|NCT00733512|11548500|FG000|STARTED|Overall Study||146
10404136|NCT00733512|11548500|FG000|COMPLETED|Overall Study||146
10404137|NCT00733512|11548500|FG000|NOT COMPLETED|Overall Study||0
10404138|NCT00733746|11548504|FG000|STARTED|Overall Study||119
10404139|NCT00733746|11548504|FG000|COMPLETED|Overall Study||114
10404140|NCT00733746|11548504|FG000|NOT COMPLETED|Overall Study||5
10404141|NCT00733824|11548513|FG000|STARTED|Phase I||10
10404142|NCT00733824|11548514|FG001|STARTED|Phase I||3
10404143|NCT00733824|11548515|FG002|STARTED|Phase I||6
10404144|NCT00733824|11548516|FG003|STARTED|Phase I||6
10404145|NCT00733824|11548517|FG004|STARTED|Phase I||0
10404146|NCT00733824|11548513|FG000|COMPLETED|Phase I||9
10404147|NCT00733824|11548514|FG001|COMPLETED|Phase I||3
10404148|NCT00733824|11548515|FG002|COMPLETED|Phase I||6
10404149|NCT00733824|11548516|FG003|COMPLETED|Phase I||6
10404150|NCT00733824|11548517|FG004|COMPLETED|Phase I||0
10404151|NCT00733824|11548513|FG000|NOT COMPLETED|Phase I||1
10404152|NCT00733824|11548514|FG001|NOT COMPLETED|Phase I||0
10404153|NCT00733824|11548515|FG002|NOT COMPLETED|Phase I||0
10404154|NCT00733824|11548516|FG003|NOT COMPLETED|Phase I||0
10404155|NCT00733824|11548517|FG004|NOT COMPLETED|Phase I||0
10404156|NCT00733824|11548513|FG000|STARTED|Phase II||0
10404157|NCT00733824|11548514|FG001|STARTED|Phase II||0
10404158|NCT00733824|11548515|FG002|STARTED|Phase II||0
10404159|NCT00733824|11548516|FG003|STARTED|Phase II||0
10404160|NCT00733824|11548517|FG004|STARTED|Phase II||36
10404161|NCT00733824|11548513|FG000|COMPLETED|Phase II||0
10404162|NCT00733824|11548514|FG001|COMPLETED|Phase II||0
10404163|NCT00733824|11548515|FG002|COMPLETED|Phase II||0
10404164|NCT00733824|11548516|FG003|COMPLETED|Phase II||0
10404165|NCT00733824|11548517|FG004|COMPLETED|Phase II||36
10404166|NCT00733824|11548513|FG000|NOT COMPLETED|Phase II||0
10404167|NCT00733824|11548514|FG001|NOT COMPLETED|Phase II||0
10404168|NCT00733824|11548515|FG002|NOT COMPLETED|Phase II||0
10404169|NCT00733824|11548516|FG003|NOT COMPLETED|Phase II||0
10404170|NCT00733824|11548517|FG004|NOT COMPLETED|Phase II||0
10404171|NCT00733902|11548535|FG000|STARTED|Overall Study||174
10404172|NCT00733902|11548536|FG001|STARTED|Overall Study||174
10661022|NCT02256267|11822836|FG000|STARTED|Period 2 (Day 7 to Day 14)||23
10661023|NCT02256267|11822836|FG000|Received LY2835219 + Rifampin|Period 2 (Day 7 to Day 14)||23
10661024|NCT02256267|11822836|FG000|COMPLETED|Period 2 (Day 7 to Day 14)||22
10661025|NCT02256267|11822836|FG000|NOT COMPLETED|Period 2 (Day 7 to Day 14)||1
10661026|NCT02256345|11822845|FG000|STARTED|Overall Study||9
10661027|NCT02256345|11822846|FG001|STARTED|Overall Study||3
10661028|NCT02256345|11822845|FG000|COMPLETED|Overall Study||9
10661029|NCT02256345|11822846|FG001|COMPLETED|Overall Study||3
10721760|NCT02730351|11885451|FG001|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
10721761|NCT02730377|11885459|FG000|STARTED|Overall Study||996
10721762|NCT02730377|11885460|FG001|STARTED|Overall Study||995
10721763|NCT02730377|11885459|FG000|Treated|Overall Study||980
10721764|NCT02730377|11885460|FG001|Treated|Overall Study||984
10721765|NCT02730377|11885459|FG000|Full Analysis Set (FAS)|Overall Study||996
10721766|NCT02730377|11885460|FG001|Full Analysis Set (FAS)|Overall Study||995
10721767|NCT02730377|11885459|FG000|Safety Analysis Set (SAS)|Overall Study||980
10721768|NCT02730377|11885460|FG001|Safety Analysis Set (SAS)|Overall Study||984
10721769|NCT02730377|11885459|FG000|COMPLETED|Overall Study||446
10721770|NCT02730377|11885460|FG001|COMPLETED|Overall Study||362
10721771|NCT02730377|11885459|FG000|NOT COMPLETED|Overall Study||550
10721772|NCT02730377|11885460|FG001|NOT COMPLETED|Overall Study||633
10721773|NCT02730403|11885466|FG000|STARTED|Overall Study||211
10721774|NCT02730403|11885466|FG000|COMPLETED|Overall Study||157
10721775|NCT02730403|11885466|FG000|NOT COMPLETED|Overall Study||54
10721776|NCT02730455|11885474|FG000|STARTED|Overall Study||94
10721777|NCT02730455|11885475|FG001|STARTED|Overall Study||91
10721778|NCT02730455|11885476|FG002|STARTED|Overall Study||92
10721779|NCT02730455|11885474|FG000|Safety Population|Overall Study||91
10721780|NCT02730455|11885475|FG001|Safety Population|Overall Study||90
10721781|NCT02730455|11885476|FG002|Safety Population|Overall Study||89
10721782|NCT02730455|11885474|FG000|Participants Dosed|Overall Study||91
10721783|NCT02730455|11885475|FG001|Participants Dosed|Overall Study||88
10721784|NCT02730455|11885476|FG002|Participants Dosed|Overall Study||91
10721785|NCT02730455|11885474|FG000|Who Received Total Volume of Study Drug|Overall Study||90
10721786|NCT02730455|11885475|FG001|Who Received Total Volume of Study Drug|Overall Study||88
10721787|NCT02730455|11885476|FG002|Who Received Total Volume of Study Drug|Overall Study||89
10721788|NCT02730455|11885474|FG000|COMPLETED|Overall Study||81
10721789|NCT02730455|11885475|FG001|COMPLETED|Overall Study||77
10721790|NCT02730455|11885476|FG002|COMPLETED|Overall Study||81
10721791|NCT02730455|11885474|FG000|NOT COMPLETED|Overall Study||13
10721792|NCT02730455|11885475|FG001|NOT COMPLETED|Overall Study||14
10721793|NCT02730455|11885476|FG002|NOT COMPLETED|Overall Study||11
10721794|NCT02730598|11885486|FG000|STARTED|Overall Study||14
10721795|NCT02730598|11885487|FG001|STARTED|Overall Study||14
10721796|NCT02730598|11885486|FG000|COMPLETED|Overall Study||10
10721797|NCT02730598|11885487|FG001|COMPLETED|Overall Study||10
10721798|NCT02730598|11885486|FG000|NOT COMPLETED|Overall Study||4
10721799|NCT02730598|11885487|FG001|NOT COMPLETED|Overall Study||4
10721800|NCT02730663|11885493|FG000|STARTED|Overall Study||36
10721801|NCT02730663|11885493|FG000|COMPLETED|Overall Study||35
10721802|NCT02730663|11885493|FG000|NOT COMPLETED|Overall Study||1
10721803|NCT02730728|11885500|FG000|STARTED|Overall Study||53
10721804|NCT02730728|11885501|FG001|STARTED|Overall Study||53
10721805|NCT02730728|11885502|FG002|STARTED|Overall Study||53
10721806|NCT02730728|11885500|FG000|COMPLETED|Overall Study||53
10721807|NCT02730728|11885501|FG001|COMPLETED|Overall Study||51
10721808|NCT02730728|11885502|FG002|COMPLETED|Overall Study||52
10721809|NCT02730728|11885500|FG000|NOT COMPLETED|Overall Study||0
10721810|NCT02730728|11885501|FG001|NOT COMPLETED|Overall Study||2
10721811|NCT02730728|11885502|FG002|NOT COMPLETED|Overall Study||1
10721812|NCT02730819|11885510|FG000|STARTED|Overall Study||19
10721813|NCT02730819|11885510|FG000|Follow-up Week 2|Overall Study||15
10721814|NCT02730819|11885510|FG000|Follow-up Week 4|Overall Study||16
10721815|NCT02730819|11885510|FG000|Follow-up Week 8|Overall Study||14
10404173|NCT00733902|11548537|FG002|STARTED|Overall Study||174
10404174|NCT00733902|11548538|FG003|STARTED|Overall Study||175
10404175|NCT00733902|11548535|FG000|Treated|Overall Study||172
10404176|NCT00733902|11548536|FG001|Treated|Overall Study||172
10404177|NCT00733902|11548537|FG002|Treated|Overall Study||172
10404178|NCT00733902|11548538|FG003|Treated|Overall Study||174
10721816|NCT02730819|11885510|FG000|Follow-up Week 12|Overall Study||11
10721817|NCT02730819|11885510|FG000|Follow-up Week 16|Overall Study||11
10721818|NCT02730819|11885510|FG000|Follow-up Week 20|Overall Study||10
10721819|NCT02730819|11885510|FG000|COMPLETED|Overall Study||10
10721820|NCT02730819|11885510|FG000|NOT COMPLETED|Overall Study||9
10721821|NCT02730871|11885516|FG000|STARTED|Overall Study||67
10721822|NCT02730871|11885517|FG001|STARTED|Overall Study||67
10721823|NCT02730871|11885516|FG000|Full Analysis Set (FAS)|Overall Study||67
10721824|NCT02730871|11885517|FG001|Full Analysis Set (FAS)|Overall Study||67
10721825|NCT02730871|11885516|FG000|Safety Analysis Set|Overall Study||67
10721826|NCT02730871|11885517|FG001|Safety Analysis Set|Overall Study||67
10721827|NCT02730871|11885516|FG000|COMPLETED|Overall Study||61
10404179|NCT00733902|11548535|FG000|COMPLETED|Overall Study||10
10404180|NCT00733902|11548536|FG001|COMPLETED|Overall Study||12
10661030|NCT02256345|11822845|FG000|NOT COMPLETED|Overall Study||0
10404181|NCT00733902|11548537|FG002|COMPLETED|Overall Study||13
10404182|NCT00733902|11548538|FG003|COMPLETED|Overall Study||11
10404183|NCT00733902|11548535|FG000|NOT COMPLETED|Overall Study||164
10404184|NCT00733902|11548536|FG001|NOT COMPLETED|Overall Study||162
10404185|NCT00733902|11548537|FG002|NOT COMPLETED|Overall Study||161
10404186|NCT00733902|11548538|FG003|NOT COMPLETED|Overall Study||164
10404193|NCT00733980|11548559|FG000|STARTED|Overall Study||74
10404194|NCT00733980|11548560|FG001|STARTED|Overall Study||76
10721828|NCT02730871|11885517|FG001|COMPLETED|Overall Study||67
10721829|NCT02730871|11885516|FG000|NOT COMPLETED|Overall Study||6
10814428|NCT02365207|11977154|FG000|COMPLETED|Overall Study||4
10404195|NCT00733980|11548559|FG000|COMPLETED|Overall Study||52
10404196|NCT00733980|11548560|FG001|COMPLETED|Overall Study||55
10404197|NCT00733980|11548559|FG000|NOT COMPLETED|Overall Study||22
10404198|NCT00733980|11548560|FG001|NOT COMPLETED|Overall Study||21
10404199|NCT00733993|11548569|FG000|STARTED|Overall Study||13
10404200|NCT00733993|11548570|FG001|STARTED|Overall Study||10
10404201|NCT00733993|11548569|FG000|COMPLETED|Overall Study||13
10404202|NCT00733993|11548570|FG001|COMPLETED|Overall Study||10
10404203|NCT00733993|11548569|FG000|NOT COMPLETED|Overall Study||0
10404204|NCT00733993|11548570|FG001|NOT COMPLETED|Overall Study||0
10404205|NCT00734032|11548585|FG000|STARTED|Overall Study||25
10661031|NCT02256345|11822846|FG001|NOT COMPLETED|Overall Study||0
10661032|NCT02256358|11822854|FG000|STARTED|Overall Study||34
10661033|NCT02256358|11822855|FG001|STARTED|Overall Study||34
10661034|NCT02256358|11822854|FG000|COMPLETED|Overall Study||34
10661035|NCT02256358|11822855|FG001|COMPLETED|Overall Study||33
10661036|NCT02256358|11822854|FG000|NOT COMPLETED|Overall Study||0
10661037|NCT02256358|11822855|FG001|NOT COMPLETED|Overall Study||1
10721830|NCT02730871|11885517|FG001|NOT COMPLETED|Overall Study||0
10721831|NCT02730884|11885523|FG000|STARTED|Overall Study||3
10721832|NCT02730884|11885523|FG000|COMPLETED|Overall Study||3
10721833|NCT02730884|11885523|FG000|NOT COMPLETED|Overall Study||0
10721834|NCT02730962|11885529|FG000|STARTED|Overall Study||7
10721835|NCT02730962|11885530|FG001|STARTED|Overall Study||5
10721836|NCT02730962|11885529|FG000|COMPLETED|Overall Study||7
10721837|NCT02730962|11885530|FG001|COMPLETED|Overall Study||5
10721838|NCT02730962|11885529|FG000|NOT COMPLETED|Overall Study||0
10721839|NCT02730962|11885530|FG001|NOT COMPLETED|Overall Study||0
10721840|NCT02730988|11885538|FG000|STARTED|Overall Study||47
10721841|NCT02730988|11885539|FG001|STARTED|Overall Study||49
10721842|NCT02730988|11885538|FG000|COMPLETED|Overall Study||43
10721843|NCT02730988|11885539|FG001|COMPLETED|Overall Study||39
10721844|NCT02730988|11885538|FG000|NOT COMPLETED|Overall Study||4
10721845|NCT02730988|11885539|FG001|NOT COMPLETED|Overall Study||10
10721846|NCT02731131|11885547|FG000|STARTED|Overall Study||6
10721847|NCT02731131|11885548|FG001|STARTED|Overall Study||6
10721848|NCT02731131|11885547|FG000|COMPLETED|Overall Study||6
10721849|NCT02731131|11885548|FG001|COMPLETED|Overall Study||4
10721850|NCT02731131|11885547|FG000|NOT COMPLETED|Overall Study||0
10721851|NCT02731131|11885548|FG001|NOT COMPLETED|Overall Study||2
10721852|NCT02731157|11885554|FG000|STARTED|First Standard RCE||4
10721853|NCT02731157|11885554|FG000|COMPLETED|First Standard RCE||4
10721854|NCT02731157|11885554|FG000|NOT COMPLETED|First Standard RCE||0
10721855|NCT02731157|11885554|FG000|STARTED|First Rejuvenated RCE||4
10721856|NCT02731157|11885554|FG000|COMPLETED|First Rejuvenated RCE||3
10721857|NCT02731157|11885554|FG000|NOT COMPLETED|First Rejuvenated RCE||1
10721858|NCT02731157|11885554|FG000|STARTED|Second Rejuvenated RCE||3
10721859|NCT02731157|11885554|FG000|COMPLETED|Second Rejuvenated RCE||3
10721860|NCT02731157|11885554|FG000|NOT COMPLETED|Second Rejuvenated RCE||0
10721861|NCT02731157|11885554|FG000|STARTED|Third Rejuvenated RCE||3
10721862|NCT02731157|11885554|FG000|COMPLETED|Third Rejuvenated RCE||3
10721863|NCT02731157|11885554|FG000|NOT COMPLETED|Third Rejuvenated RCE||0
10721864|NCT02731157|11885554|FG000|STARTED|Second Standard RCE||3
10721865|NCT02731157|11885554|FG000|COMPLETED|Second Standard RCE||3
10721866|NCT02731157|11885554|FG000|NOT COMPLETED|Second Standard RCE||0
10721867|NCT02731157|11885554|FG000|STARTED|Third Standard RCE||3
10721868|NCT02731157|11885554|FG000|COMPLETED|Third Standard RCE||3
10721869|NCT02731157|11885554|FG000|NOT COMPLETED|Third Standard RCE||0
10721870|NCT02731300|11885562|FG000|STARTED|Overall Study||15
10721871|NCT02731300|11885563|FG001|STARTED|Overall Study||7
10721872|NCT02731300|11885562|FG000|COMPLETED|Overall Study||15
10721873|NCT02731300|11885563|FG001|COMPLETED|Overall Study||7
10721874|NCT02731300|11885562|FG000|NOT COMPLETED|Overall Study||0
10721875|NCT02731300|11885563|FG001|NOT COMPLETED|Overall Study||0
10721876|NCT02731313|11885569|FG000|STARTED|Overall Study||367
10721877|NCT02731313|11885569|FG000|COMPLETED|Overall Study||367
10721878|NCT02731313|11885569|FG000|NOT COMPLETED|Overall Study||0
10721879|NCT02731469|11885584|FG000|STARTED|Overall Study||3
10721880|NCT02731469|11885585|FG001|STARTED|Overall Study||3
10721881|NCT02731469|11885586|FG002|STARTED|Overall Study||3
10721882|NCT02731469|11885587|FG003|STARTED|Overall Study||3
10721883|NCT02731469|11885588|FG004|STARTED|Overall Study||3
10404206|NCT00734032|11548586|FG001|STARTED|Overall Study||28
10404207|NCT00734032|11548587|FG002|STARTED|Overall Study||28
10404208|NCT00734032|11548588|FG003|STARTED|Overall Study||26
10404209|NCT00734032|11548585|FG000|COMPLETED|Overall Study||25
10404210|NCT00734032|11548586|FG001|COMPLETED|Overall Study||27
10404211|NCT00734032|11548587|FG002|COMPLETED|Overall Study||28
10404212|NCT00734032|11548588|FG003|COMPLETED|Overall Study||26
10404213|NCT00734032|11548585|FG000|NOT COMPLETED|Overall Study||0
10404214|NCT00734032|11548586|FG001|NOT COMPLETED|Overall Study||1
10404215|NCT00734032|11548587|FG002|NOT COMPLETED|Overall Study||0
10661038|NCT02256384|11822861|FG000|STARTED|Overall Study||76
10661039|NCT02256384|11822861|FG000|COMPLETED|Overall Study||62
10661040|NCT02256384|11822861|FG000|NOT COMPLETED|Overall Study||14
10661041|NCT02256436|11822871|FG000|STARTED|Overall Study||272
10661042|NCT02256436|11822872|FG001|STARTED|Overall Study||270
10661043|NCT02256436|11822871|FG000|Treated|Overall Study||255
10661044|NCT02256436|11822872|FG001|Treated|Overall Study||266
10661045|NCT02256436|11822871|FG000|Switched Over to Pembrolizumab|Overall Study||13
10661046|NCT02256436|11822872|FG001|Switched Over to Pembrolizumab|Overall Study||0
10661047|NCT02256436|11822871|FG000|COMPLETED|Overall Study||0
10661048|NCT02256436|11822872|FG001|COMPLETED|Overall Study||0
10661049|NCT02256436|11822871|FG000|NOT COMPLETED|Overall Study||272
10661050|NCT02256436|11822872|FG001|NOT COMPLETED|Overall Study||270
10661051|NCT02256488|11822883|FG000|STARTED|Overall Study||387
10661052|NCT02256488|11822884|FG001|STARTED|Overall Study||392
10661053|NCT02256488|11822885|FG002|STARTED|Overall Study||392
10661054|NCT02256488|11822886|FG003|STARTED|Overall Study||390
10661055|NCT02256488|11822883|FG000|COMPLETED|Overall Study||379
10661056|NCT02256488|11822884|FG001|COMPLETED|Overall Study||386
10661057|NCT02256488|11822885|FG002|COMPLETED|Overall Study||382
10661058|NCT02256488|11822886|FG003|COMPLETED|Overall Study||384
10661059|NCT02256488|11822883|FG000|NOT COMPLETED|Overall Study||8
10661060|NCT02256488|11822884|FG001|NOT COMPLETED|Overall Study||6
10661061|NCT02256488|11822885|FG002|NOT COMPLETED|Overall Study||10
10661062|NCT02256488|11822886|FG003|NOT COMPLETED|Overall Study||6
10661063|NCT02256540|11822897|FG000|STARTED|Overall Study||6
10661064|NCT02256540|11822898|FG001|STARTED|Overall Study||6
10661065|NCT02256540|11822899|FG002|STARTED|Overall Study||6
10721884|NCT02731469|11885589|FG005|STARTED|Overall Study||3
10721885|NCT02731469|11885590|FG006|STARTED|Overall Study||3
10721886|NCT02731469|11885591|FG007|STARTED|Overall Study||6
10661066|NCT02256540|11822897|FG000|COMPLETED|Overall Study||6
10661067|NCT02256540|11822898|FG001|COMPLETED|Overall Study||5
10661068|NCT02256540|11822899|FG002|COMPLETED|Overall Study||4
10661069|NCT02256540|11822897|FG000|NOT COMPLETED|Overall Study||0
10661070|NCT02256540|11822898|FG001|NOT COMPLETED|Overall Study||1
10661071|NCT02256540|11822899|FG002|NOT COMPLETED|Overall Study||2
10661072|NCT02256553|11822907|FG000|STARTED|Period I||102
10661073|NCT02256553|11822907|FG000|COMPLETED|Period I||96
10661074|NCT02256553|11822907|FG000|NOT COMPLETED|Period I||6
10661075|NCT02256553|11822907|FG000|STARTED|Period II||96
10661076|NCT02256553|11822907|FG000|COMPLETED|Period II||94
10661077|NCT02256553|11822907|FG000|NOT COMPLETED|Period II||2
10661078|NCT02256553|11822907|FG000|STARTED|Period III||94
10661079|NCT02256553|11822907|FG000|COMPLETED|Period III||91
10661080|NCT02256553|11822907|FG000|NOT COMPLETED|Period III||3
10661081|NCT02256839|11822915|FG000|STARTED|Overall Study||53
10661082|NCT02256839|11822916|FG001|STARTED|Overall Study||215
10661083|NCT02256839|11822915|FG000|COMPLETED|Overall Study||51
10721887|NCT02731469|11885592|FG008|STARTED|Overall Study||6
10404216|NCT00734032|11548588|FG003|NOT COMPLETED|Overall Study||0
10404217|NCT00734071|11548600|FG000|STARTED|Overall Study||152
10404218|NCT00734071|11548601|FG001|STARTED|Overall Study||152
10404219|NCT00734071|11548600|FG000|Treated|Overall Study||151
10404220|NCT00734071|11548601|FG001|Treated|Overall Study||148
10404221|NCT00734071|11548600|FG000|COMPLETED|Overall Study||114
10404222|NCT00734071|11548601|FG001|COMPLETED|Overall Study||125
10404223|NCT00734071|11548600|FG000|NOT COMPLETED|Overall Study||38
10404224|NCT00734071|11548601|FG001|NOT COMPLETED|Overall Study||27
10404225|NCT00734097|11548607|FG000|STARTED|Screening||337
10404226|NCT00734097|11548607|FG000|COMPLETED|Screening|20 participants were screening failure.|317
10404227|NCT00734097|11548607|FG000|NOT COMPLETED|Screening||20
10404228|NCT00734097|11548607|FG000|STARTED|Open Label|Full analysis performed in 311|317
10404229|NCT00734097|11548607|FG000|Safety Analysis|Open Label||317
10404230|NCT00734097|11548607|FG000|Full Analysis|Open Label||311
10404231|NCT00734097|11548607|FG000|Per Protocol|Open Label||301
10404232|NCT00734097|11548607|FG000|COMPLETED|Open Label|16 patients discontinued after randomization|301
10404233|NCT00734097|11548607|FG000|NOT COMPLETED|Open Label||16
10404234|NCT00734149|11548611|FG000|STARTED|Overall Study||45
10661084|NCT02256839|11822916|FG001|COMPLETED|Overall Study||212
10661085|NCT02256839|11822915|FG000|NOT COMPLETED|Overall Study||2
10661086|NCT02256839|11822916|FG001|NOT COMPLETED|Overall Study||3
10661087|NCT02256891|11822924|FG000|STARTED|Overall Study||55
10661088|NCT02256891|11822925|FG001|STARTED|Overall Study||42
10661089|NCT02256891|11822924|FG000|COMPLETED|Overall Study||43
10661090|NCT02256891|11822925|FG001|COMPLETED|Overall Study||29
10661091|NCT02256891|11822924|FG000|NOT COMPLETED|Overall Study||12
10404235|NCT00734149|11548611|FG000|COMPLETED|Overall Study||44
10404236|NCT00734149|11548611|FG000|NOT COMPLETED|Overall Study||1
10404237|NCT00734162|11548621|FG000|STARTED|Randomized Phase (Through Week 72)||10
10404238|NCT00734162|11548622|FG001|STARTED|Randomized Phase (Through Week 72)||42
10661092|NCT02256891|11822925|FG001|NOT COMPLETED|Overall Study||13
10661093|NCT02256917|11822933|FG000|STARTED|Pharmacokinetic (PK) Evaluation Phase||58
10661094|NCT02256917|11822933|FG000|COMPLETED|Pharmacokinetic (PK) Evaluation Phase||58
10721888|NCT02731469|11885593|FG009|STARTED|Overall Study||6
10404239|NCT00734162|11548623|FG002|STARTED|Randomized Phase (Through Week 72)||13
10404240|NCT00734162|11548624|FG003|STARTED|Randomized Phase (Through Week 72)||41
10404241|NCT00734162|11548621|FG000|COMPLETED|Randomized Phase (Through Week 72)||10
10404242|NCT00734162|11548622|FG001|COMPLETED|Randomized Phase (Through Week 72)||41
10404243|NCT00734162|11548623|FG002|COMPLETED|Randomized Phase (Through Week 72)||13
10404244|NCT00734162|11548624|FG003|COMPLETED|Randomized Phase (Through Week 72)||37
10404245|NCT00734162|11548621|FG000|NOT COMPLETED|Randomized Phase (Through Week 72)||0
10404246|NCT00734162|11548622|FG001|NOT COMPLETED|Randomized Phase (Through Week 72)||1
10404247|NCT00734162|11548623|FG002|NOT COMPLETED|Randomized Phase (Through Week 72)||0
10404248|NCT00734162|11548624|FG003|NOT COMPLETED|Randomized Phase (Through Week 72)||4
10404249|NCT00734162|11548621|FG000|STARTED|Open-Label Phase||10
10404250|NCT00734162|11548622|FG001|STARTED|Open-Label Phase||41
10404251|NCT00734162|11548623|FG002|STARTED|Open-Label Phase||13
10404252|NCT00734162|11548624|FG003|STARTED|Open-Label Phase|2 participants switched to open-label treatment before completing double-blind period (elevated ALT)|39
10404253|NCT00734162|11548621|FG000|COMPLETED|Open-Label Phase||7
10404254|NCT00734162|11548622|FG001|COMPLETED|Open-Label Phase||39
10404255|NCT00734162|11548623|FG002|COMPLETED|Open-Label Phase||12
10404256|NCT00734162|11548624|FG003|COMPLETED|Open-Label Phase||36
10404257|NCT00734162|11548621|FG000|NOT COMPLETED|Open-Label Phase||3
10404258|NCT00734162|11548622|FG001|NOT COMPLETED|Open-Label Phase||2
10404259|NCT00734162|11548623|FG002|NOT COMPLETED|Open-Label Phase||1
10404260|NCT00734162|11548624|FG003|NOT COMPLETED|Open-Label Phase||3
10404261|NCT00734214|11548640|FG000|STARTED|Overall Study||128
10404262|NCT00734214|11548641|FG001|STARTED|Overall Study||130
10404263|NCT00734214|11548640|FG000|COMPLETED|Overall Study||124
10404264|NCT00734214|11548641|FG001|COMPLETED|Overall Study||126
10404265|NCT00734214|11548640|FG000|NOT COMPLETED|Overall Study||4
10404266|NCT00734214|11548641|FG001|NOT COMPLETED|Overall Study||4
10404267|NCT00734305|11548649|FG000|STARTED|Overall Study||7
10404268|NCT00734305|11548650|FG001|STARTED|Overall Study||3
10404269|NCT00734305|11548651|FG002|STARTED|Overall Study||4
10404270|NCT00734305|11548652|FG003|STARTED|Overall Study||3
10404271|NCT00734305|11548653|FG004|STARTED|Overall Study||5
10404272|NCT00734305|11548654|FG005|STARTED|Overall Study||4
10404273|NCT00734305|11548655|FG006|STARTED|Overall Study||18
10404274|NCT00734305|11548649|FG000|COMPLETED|Overall Study|1 patient was enrolled but did not meet eligibility criteria at C1W1, and thus was never dosed|6
10404275|NCT00734305|11548650|FG001|COMPLETED|Overall Study||3
10404276|NCT00734305|11548651|FG002|COMPLETED|Overall Study||4
10404277|NCT00734305|11548652|FG003|COMPLETED|Overall Study||3
10404278|NCT00734305|11548653|FG004|COMPLETED|Overall Study||5
10404279|NCT00734305|11548654|FG005|COMPLETED|Overall Study||4
10404280|NCT00734305|11548655|FG006|COMPLETED|Overall Study||18
10404281|NCT00734305|11548649|FG000|NOT COMPLETED|Overall Study||1
10404282|NCT00734305|11548650|FG001|NOT COMPLETED|Overall Study||0
10404283|NCT00734305|11548651|FG002|NOT COMPLETED|Overall Study||0
10404284|NCT00734305|11548652|FG003|NOT COMPLETED|Overall Study||0
10404285|NCT00734305|11548653|FG004|NOT COMPLETED|Overall Study||0
10404286|NCT00734305|11548654|FG005|NOT COMPLETED|Overall Study||0
10404287|NCT00734305|11548655|FG006|NOT COMPLETED|Overall Study||0
10404288|NCT00734344|11548675|FG000|STARTED|Overall Study||9
10404289|NCT00734344|11548676|FG001|STARTED|Overall Study||9
10404290|NCT00734344|11548675|FG000|COMPLETED|Overall Study||9
10404291|NCT00734344|11548676|FG001|COMPLETED|Overall Study||9
10404292|NCT00734344|11548675|FG000|NOT COMPLETED|Overall Study||0
10404293|NCT00734344|11548676|FG001|NOT COMPLETED|Overall Study||0
10404294|NCT00734409|11548686|FG000|STARTED|Overall Study||155
10404295|NCT00734409|11548687|FG001|STARTED|Overall Study||145
10404296|NCT00734409|11548686|FG000|COMPLETED|Overall Study||155
10404297|NCT00734409|11548687|FG001|COMPLETED|Overall Study||145
10404298|NCT00734409|11548686|FG000|NOT COMPLETED|Overall Study||0
10404299|NCT00734409|11548687|FG001|NOT COMPLETED|Overall Study||0
10404300|NCT00734474|11548702|FG000|STARTED|Overall Study||15
10404301|NCT00734474|11548703|FG001|STARTED|Overall Study||30
10404302|NCT00734474|11548704|FG002|STARTED|Overall Study||304
10404303|NCT00734474|11548705|FG003|STARTED|Overall Study||10
10404304|NCT00734474|11548706|FG004|STARTED|Overall Study||302
10404305|NCT00734474|11548707|FG005|STARTED|Overall Study||25
10404306|NCT00734474|11548708|FG006|STARTED|Overall Study||24
10404307|NCT00734474|11548709|FG007|STARTED|Overall Study||315
10404308|NCT00734474|11548710|FG008|STARTED|Overall Study||177
10404309|NCT00734474|11548702|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
10404310|NCT00734474|11548703|FG001|Received at Least 1 Dose of Study Drug|Overall Study||30
10404311|NCT00734474|11548704|FG002|Received at Least 1 Dose of Study Drug|Overall Study||304
10404312|NCT00734474|11548705|FG003|Received at Least 1 Dose of Study Drug|Overall Study||10
10404313|NCT00734474|11548706|FG004|Received at Least 1 Dose of Study Drug|Overall Study||302
10404314|NCT00734474|11548707|FG005|Received at Least 1 Dose of Study Drug|Overall Study||25
10404315|NCT00734474|11548708|FG006|Received at Least 1 Dose of Study Drug|Overall Study||24
10404316|NCT00734474|11548709|FG007|Received at Least 1 Dose of Study Drug|Overall Study||315
10404317|NCT00734474|11548710|FG008|Received at Least 1 Dose of Study Drug|Overall Study||177
10404318|NCT00734474|11548702|FG000|Entered Study Before Dose Decision Point|Overall Study||15
10404319|NCT00734474|11548703|FG001|Entered Study Before Dose Decision Point|Overall Study||30
10404320|NCT00734474|11548704|FG002|Entered Study Before Dose Decision Point|Overall Study||25
10404321|NCT00734474|11548705|FG003|Entered Study Before Dose Decision Point|Overall Study||10
10404322|NCT00734474|11548706|FG004|Entered Study Before Dose Decision Point|Overall Study||21
10404323|NCT00734474|11548707|FG005|Entered Study Before Dose Decision Point|Overall Study||25
10404324|NCT00734474|11548708|FG006|Entered Study Before Dose Decision Point|Overall Study||24
10404325|NCT00734474|11548709|FG007|Entered Study Before Dose Decision Point|Overall Study||42
10404326|NCT00734474|11548710|FG008|Entered Study Before Dose Decision Point|Overall Study||38
10404327|NCT00734474|11548702|FG000|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|8
10404328|NCT00734474|11548703|FG001|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|25
10404329|NCT00734474|11548704|FG002|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (selected arm).|24
10404330|NCT00734474|11548705|FG003|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|8
10404331|NCT00734474|11548706|FG004|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (selected arm).|21
10404332|NCT00734474|11548707|FG005|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|21
10404333|NCT00734474|11548708|FG006|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|23
10404334|NCT00734474|11548709|FG007|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (comparator arm).|42
10429005|NCT00862641|11575207|FG000|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|176
10544294|NCT01490125|11697555|FG002|COMPLETED|Period II||34
10544295|NCT01490125|11697556|FG003|COMPLETED|Period II||30
10544296|NCT01490125|11697557|FG004|COMPLETED|Period II||32
10544297|NCT01490125|11697558|FG005|COMPLETED|Period II||35
10544298|NCT01490125|11697553|FG000|NOT COMPLETED|Period II||3
10544299|NCT01490125|11697554|FG001|NOT COMPLETED|Period II||4
10544300|NCT01490125|11697555|FG002|NOT COMPLETED|Period II||3
10544301|NCT01490125|11697556|FG003|NOT COMPLETED|Period II||3
10544302|NCT01490125|11697557|FG004|NOT COMPLETED|Period II||4
10661095|NCT02256917|11822933|FG000|NOT COMPLETED|Pharmacokinetic (PK) Evaluation Phase||0
10661096|NCT02256917|11822933|FG000|STARTED|Prophylactic Treatment Phase I||57
10661097|NCT02256917|11822933|FG000|COMPLETED|Prophylactic Treatment Phase I||56
10661098|NCT02256917|11822933|FG000|NOT COMPLETED|Prophylactic Treatment Phase I||1
10661099|NCT02256917|11822933|FG000|STARTED|Prophylactic Treatment Phase II||56
10661100|NCT02256917|11822933|FG000|COMPLETED|Prophylactic Treatment Phase II||52
10661101|NCT02256917|11822933|FG000|NOT COMPLETED|Prophylactic Treatment Phase II||4
10661102|NCT02256969|11822947|FG000|STARTED|Overall Study||15
10661103|NCT02256969|11822948|FG001|STARTED|Overall Study||15
10661104|NCT02256969|11822949|FG002|STARTED|Overall Study||15
10661105|NCT02256969|11822947|FG000|COMPLETED|Overall Study||13
10721889|NCT02731469|11885594|FG010|STARTED|Overall Study||6
10721890|NCT02731469|11885584|FG000|COMPLETED|Overall Study||3
10721891|NCT02731469|11885585|FG001|COMPLETED|Overall Study||3
10721892|NCT02731469|11885586|FG002|COMPLETED|Overall Study||3
10721893|NCT02731469|11885587|FG003|COMPLETED|Overall Study||3
10721894|NCT02731469|11885588|FG004|COMPLETED|Overall Study||3
10721895|NCT02731469|11885589|FG005|COMPLETED|Overall Study||3
10721896|NCT02731469|11885590|FG006|COMPLETED|Overall Study||3
10721897|NCT02731469|11885591|FG007|COMPLETED|Overall Study||6
10721898|NCT02731469|11885592|FG008|COMPLETED|Overall Study||6
10721899|NCT02731469|11885593|FG009|COMPLETED|Overall Study||6
10721900|NCT02731469|11885594|FG010|COMPLETED|Overall Study||6
10721901|NCT02731469|11885584|FG000|NOT COMPLETED|Overall Study||0
10721902|NCT02731469|11885585|FG001|NOT COMPLETED|Overall Study||0
10721903|NCT02731469|11885586|FG002|NOT COMPLETED|Overall Study||0
10721904|NCT02731469|11885587|FG003|NOT COMPLETED|Overall Study||0
10721905|NCT02731469|11885588|FG004|NOT COMPLETED|Overall Study||0
10721906|NCT02731469|11885589|FG005|NOT COMPLETED|Overall Study||0
10721907|NCT02731469|11885590|FG006|NOT COMPLETED|Overall Study||0
10721908|NCT02731469|11885591|FG007|NOT COMPLETED|Overall Study||0
10721909|NCT02731469|11885592|FG008|NOT COMPLETED|Overall Study||0
10721910|NCT02731469|11885593|FG009|NOT COMPLETED|Overall Study||0
10721911|NCT02731469|11885594|FG010|NOT COMPLETED|Overall Study||0
10721912|NCT02731638|11885620|FG000|STARTED|Overall Study||35
10721913|NCT02731638|11885621|FG001|STARTED|Overall Study||35
10721914|NCT02731638|11885620|FG000|COMPLETED|Overall Study||29
10721915|NCT02731638|11885621|FG001|COMPLETED|Overall Study||26
10721916|NCT02731638|11885620|FG000|NOT COMPLETED|Overall Study||6
10721917|NCT02731638|11885621|FG001|NOT COMPLETED|Overall Study||9
10721918|NCT02731690|11885627|FG000|STARTED|Overall Study||42
10721919|NCT02731690|11885627|FG000|COMPLETED|Overall Study||12
10721920|NCT02731690|11885627|FG000|NOT COMPLETED|Overall Study||30
10721921|NCT02731729|11885633|FG000|STARTED|Overall Study||10
10721922|NCT02731729|11885634|FG001|STARTED|Overall Study||10
10721923|NCT02731729|11885633|FG000|COMPLETED|Overall Study||1
10721924|NCT02731729|11885634|FG001|COMPLETED|Overall Study||2
10721925|NCT02731729|11885633|FG000|NOT COMPLETED|Overall Study||9
10721926|NCT02731729|11885634|FG001|NOT COMPLETED|Overall Study||8
10721927|NCT02731742|11885644|FG000|STARTED|Overall Study||3
10721928|NCT02731742|11885645|FG001|STARTED|Overall Study||3
10721929|NCT02731742|11885646|FG002|STARTED|Overall Study||6
10721930|NCT02731742|11885647|FG003|STARTED|Overall Study||2
10721931|NCT02731742|11885644|FG000|COMPLETED|Overall Study||0
10544303|NCT01490125|11697558|FG005|NOT COMPLETED|Period II||2
10544304|NCT01490125|11697553|FG000|STARTED|Period III||34
10544305|NCT01490125|11697554|FG001|STARTED|Period III||33
10544306|NCT01490125|11697555|FG002|STARTED|Period III||34
10404335|NCT00734474|11548710|FG008|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (comparator arm).|34
10404336|NCT00734474|11548702|FG000|Entered Study After Dose Decision Point|Overall Study||0
10404337|NCT00734474|11548703|FG001|Entered Study After Dose Decision Point|Overall Study||0
10404338|NCT00734474|11548704|FG002|Entered Study After Dose Decision Point|Overall Study||279
10404339|NCT00734474|11548705|FG003|Entered Study After Dose Decision Point|Overall Study||0
10404340|NCT00734474|11548706|FG004|Entered Study After Dose Decision Point|Overall Study||281
10404341|NCT00734474|11548707|FG005|Entered Study After Dose Decision Point|Overall Study||0
10404342|NCT00734474|11548708|FG006|Entered Study After Dose Decision Point|Overall Study||0
10404343|NCT00734474|11548709|FG007|Entered Study After Dose Decision Point|Overall Study||273
10404344|NCT00734474|11548710|FG008|Entered Study After Dose Decision Point|Overall Study||139
10404345|NCT00734474|11548702|FG000|Completed 26-Week Visit|Overall Study||0
10404346|NCT00734474|11548703|FG001|Completed 26-Week Visit|Overall Study||0
10404347|NCT00734474|11548704|FG002|Completed 26-Week Visit|Overall Study||258
10404348|NCT00734474|11548705|FG003|Completed 26-Week Visit|Overall Study||2
10404349|NCT00734474|11548706|FG004|Completed 26-Week Visit|Overall Study||268
10404350|NCT00734474|11548707|FG005|Completed 26-Week Visit|Overall Study||2
10404351|NCT00734474|11548708|FG006|Completed 26-Week Visit|Overall Study||2
10404352|NCT00734474|11548709|FG007|Completed 26-Week Visit|Overall Study||270
10404353|NCT00734474|11548710|FG008|Completed 26-Week Visit|Overall Study||124
10404354|NCT00734474|11548702|FG000|Completed 52-Week Visit|Overall Study||0
10404355|NCT00734474|11548703|FG001|Completed 52-Week Visit|Overall Study||0
10404356|NCT00734474|11548704|FG002|Completed 52-Week Visit|Overall Study||238
10404357|NCT00734474|11548705|FG003|Completed 52-Week Visit|Overall Study||0
10404358|NCT00734474|11548706|FG004|Completed 52-Week Visit|Overall Study||243
10404359|NCT00734474|11548707|FG005|Completed 52-Week Visit|Overall Study||0
10404360|NCT00734474|11548708|FG006|Completed 52-Week Visit|Overall Study||0
10404361|NCT00734474|11548709|FG007|Completed 52-Week Visit|Overall Study||238
10404362|NCT00734474|11548710|FG008|Completed 52-Week Visit|Overall Study||112
10404363|NCT00734474|11548702|FG000|COMPLETED|Overall Study||0
10404364|NCT00734474|11548703|FG001|COMPLETED|Overall Study||0
10404365|NCT00734474|11548704|FG002|COMPLETED|Overall Study||192
10404366|NCT00734474|11548705|FG003|COMPLETED|Overall Study||0
10404367|NCT00734474|11548706|FG004|COMPLETED|Overall Study||184
10404368|NCT00734474|11548707|FG005|COMPLETED|Overall Study||0
10404369|NCT00734474|11548708|FG006|COMPLETED|Overall Study||0
10404370|NCT00734474|11548709|FG007|COMPLETED|Overall Study||186
10404371|NCT00734474|11548710|FG008|COMPLETED|Overall Study||95
10404372|NCT00734474|11548702|FG000|NOT COMPLETED|Overall Study||15
10404373|NCT00734474|11548703|FG001|NOT COMPLETED|Overall Study||30
10404374|NCT00734474|11548704|FG002|NOT COMPLETED|Overall Study||112
10404375|NCT00734474|11548705|FG003|NOT COMPLETED|Overall Study||10
10404376|NCT00734474|11548706|FG004|NOT COMPLETED|Overall Study||118
10404377|NCT00734474|11548707|FG005|NOT COMPLETED|Overall Study||25
10404378|NCT00734474|11548708|FG006|NOT COMPLETED|Overall Study||24
10404379|NCT00734474|11548709|FG007|NOT COMPLETED|Overall Study||129
10661106|NCT02256969|11822948|FG001|COMPLETED|Overall Study||14
10661107|NCT02256969|11822949|FG002|COMPLETED|Overall Study||14
10661108|NCT02256969|11822947|FG000|NOT COMPLETED|Overall Study||2
10661109|NCT02256969|11822948|FG001|NOT COMPLETED|Overall Study||1
10661110|NCT02256969|11822949|FG002|NOT COMPLETED|Overall Study||1
10661111|NCT02256982|11822959|FG000|STARTED|Overall Study||1
10661112|NCT02256982|11822960|FG001|STARTED|Overall Study||2
10661113|NCT02256982|11822959|FG000|COMPLETED|Overall Study||1
10661114|NCT02256982|11822960|FG001|COMPLETED|Overall Study||1
10661115|NCT02256982|11822959|FG000|NOT COMPLETED|Overall Study||0
10661116|NCT02256982|11822960|FG001|NOT COMPLETED|Overall Study||1
10661117|NCT02257099|11822966|FG000|STARTED|Overall Study||20
10661118|NCT02257099|11822966|FG000|COMPLETED|Overall Study||20
10661119|NCT02257099|11822966|FG000|NOT COMPLETED|Overall Study||0
10661120|NCT02257177|11822983|FG000|STARTED|Overall Study||4
10661121|NCT02257177|11822984|FG001|STARTED|Overall Study||4
10661122|NCT02257177|11822985|FG002|STARTED|Overall Study||4
10661123|NCT02257177|11822986|FG003|STARTED|Overall Study||4
10661124|NCT02257177|11822987|FG004|STARTED|Overall Study||4
10661125|NCT02257177|11822988|FG005|STARTED|Overall Study||4
10661126|NCT02257177|11822989|FG006|STARTED|Overall Study||12
10721932|NCT02731742|11885645|FG001|COMPLETED|Overall Study||0
10721933|NCT02731742|11885646|FG002|COMPLETED|Overall Study||0
10721934|NCT02731742|11885647|FG003|COMPLETED|Overall Study||0
10721935|NCT02731742|11885644|FG000|NOT COMPLETED|Overall Study||3
10721936|NCT02731742|11885645|FG001|NOT COMPLETED|Overall Study||3
10721937|NCT02731742|11885646|FG002|NOT COMPLETED|Overall Study||6
10721938|NCT02731742|11885647|FG003|NOT COMPLETED|Overall Study||2
10721939|NCT02731755|11885657|FG000|STARTED|First Intervention||8
10721940|NCT02731755|11885658|FG001|STARTED|First Intervention||10
10721941|NCT02731755|11885657|FG000|COMPLETED|First Intervention||8
10721942|NCT02731755|11885658|FG001|COMPLETED|First Intervention||8
10661127|NCT02257177|11822990|FG007|STARTED|Overall Study||5
10721943|NCT02731755|11885657|FG000|NOT COMPLETED|First Intervention||0
10721944|NCT02731755|11885658|FG001|NOT COMPLETED|First Intervention||2
10721945|NCT02731755|11885657|FG000|STARTED|Second Intervention||8
10404380|NCT00734474|11548710|FG008|NOT COMPLETED|Overall Study||82
10404381|NCT00734500|11548736|FG000|STARTED|Overall Study||15
10404382|NCT00734500|11548736|FG000|COMPLETED|Overall Study||14
10404383|NCT00734500|11548736|FG000|NOT COMPLETED|Overall Study||1
10404384|NCT00734539|11548742|FG000|STARTED|Main Study||189
10404385|NCT00734539|11548743|FG001|STARTED|Main Study||173
10404386|NCT00734539|11548742|FG000|COMPLETED|Main Study|Number of subjects who participated through hospital discharge or study end|152
10404387|NCT00734539|11548743|FG001|COMPLETED|Main Study|Number of subjects who participated through hospital discharge or study end|138
10404388|NCT00734539|11548742|FG000|NOT COMPLETED|Main Study||37
10404389|NCT00734539|11548743|FG001|NOT COMPLETED|Main Study||35
10404390|NCT00734539|11548742|FG000|STARTED|Long Term Follow up||152
10404391|NCT00734539|11548743|FG001|STARTED|Long Term Follow up||138
10404392|NCT00734539|11548742|FG000|COMPLETED|Long Term Follow up|Number of participants who completed the 18-22 months follow-up|118
10404393|NCT00734539|11548743|FG001|COMPLETED|Long Term Follow up|Number of participants who completed the 18-22 months follow-up|107
10404394|NCT00734539|11548742|FG000|NOT COMPLETED|Long Term Follow up||34
10404395|NCT00734539|11548743|FG001|NOT COMPLETED|Long Term Follow up||31
10404396|NCT00734578|11548755|FG000|STARTED|Overall Study||154
10404397|NCT00734578|11548756|FG001|STARTED|Overall Study||153
10404398|NCT00734578|11548757|FG002|STARTED|Overall Study||154
10404399|NCT00734578|11548755|FG000|COMPLETED|Overall Study||121
10404400|NCT00734578|11548756|FG001|COMPLETED|Overall Study||128
10404401|NCT00734578|11548757|FG002|COMPLETED|Overall Study||129
10404402|NCT00734578|11548755|FG000|NOT COMPLETED|Overall Study||33
10404403|NCT00734578|11548756|FG001|NOT COMPLETED|Overall Study||25
10404404|NCT00734578|11548757|FG002|NOT COMPLETED|Overall Study||25
10404405|NCT00734591|11548767|FG000|STARTED|Retrospective Period||3875
10404406|NCT00734591|11548768|FG001|STARTED|Retrospective Period||3564
10404407|NCT00734591|11548767|FG000|COMPLETED|Retrospective Period||3875
10404408|NCT00734591|11548768|FG001|COMPLETED|Retrospective Period||3564
10404409|NCT00734591|11548767|FG000|NOT COMPLETED|Retrospective Period||0
10404410|NCT00734591|11548768|FG001|NOT COMPLETED|Retrospective Period||0
10404411|NCT00734591|11548767|FG000|STARTED|Screening for Prospective Period||3875
10404412|NCT00734591|11548768|FG001|STARTED|Screening for Prospective Period||3564
10404413|NCT00734591|11548767|FG000|COMPLETED|Screening for Prospective Period||1358
10404414|NCT00734591|11548768|FG001|COMPLETED|Screening for Prospective Period||1273
10404415|NCT00734591|11548767|FG000|NOT COMPLETED|Screening for Prospective Period||2517
10404416|NCT00734591|11548768|FG001|NOT COMPLETED|Screening for Prospective Period||2291
10404417|NCT00734591|11548767|FG000|STARTED|Prospective Period||1358
10404418|NCT00734591|11548768|FG001|STARTED|Prospective Period||1273
10404419|NCT00734591|11548767|FG000|COMPLETED|Prospective Period||1307
10404420|NCT00734591|11548768|FG001|COMPLETED|Prospective Period||1229
10404421|NCT00734591|11548767|FG000|NOT COMPLETED|Prospective Period||51
10404422|NCT00734591|11548768|FG001|NOT COMPLETED|Prospective Period||44
10404423|NCT00734604|11548780|FG000|STARTED|Overall Study||62
10404424|NCT00734604|11548781|FG001|STARTED|Overall Study||63
10404425|NCT00734604|11548782|FG002|STARTED|Overall Study||63
10404426|NCT00734604|11548783|FG003|STARTED|Overall Study||63
10404427|NCT00734604|11548784|FG004|STARTED|Overall Study||63
10404428|NCT00734604|11548785|FG005|STARTED|Overall Study||64
10404429|NCT00734604|11548780|FG000|COMPLETED|Overall Study||59
10404430|NCT00734604|11548781|FG001|COMPLETED|Overall Study||51
10404431|NCT00734604|11548782|FG002|COMPLETED|Overall Study||57
10404432|NCT00734604|11548783|FG003|COMPLETED|Overall Study||54
10404433|NCT00734604|11548784|FG004|COMPLETED|Overall Study||55
10404434|NCT00734604|11548785|FG005|COMPLETED|Overall Study||58
10404435|NCT00734604|11548780|FG000|NOT COMPLETED|Overall Study||3
10404436|NCT00734604|11548781|FG001|NOT COMPLETED|Overall Study||12
10404437|NCT00734604|11548782|FG002|NOT COMPLETED|Overall Study||6
10404438|NCT00734604|11548783|FG003|NOT COMPLETED|Overall Study||9
10404439|NCT00734604|11548784|FG004|NOT COMPLETED|Overall Study||8
10404440|NCT00734604|11548785|FG005|NOT COMPLETED|Overall Study||6
10404441|NCT00734617|11548798|FG000|STARTED|Overall Study||249
10404442|NCT00734617|11548799|FG001|STARTED|Overall Study||230
10404443|NCT00734617|11548798|FG000|COMPLETED|Overall Study||142
10404444|NCT00734617|11548799|FG001|COMPLETED|Overall Study||128
10404445|NCT00734617|11548798|FG000|NOT COMPLETED|Overall Study||107
10404446|NCT00734617|11548799|FG001|NOT COMPLETED|Overall Study||102
10404447|NCT00734630|11548807|FG000|STARTED|Overall Study||258
10404448|NCT00734630|11548808|FG001|STARTED|Overall Study||233
10404449|NCT00734630|11548807|FG000|COMPLETED|Overall Study||229
10404450|NCT00734630|11548808|FG001|COMPLETED|Overall Study||200
10404451|NCT00734630|11548807|FG000|NOT COMPLETED|Overall Study||29
10404452|NCT00734630|11548808|FG001|NOT COMPLETED|Overall Study||33
10404453|NCT00734656|11548814|FG000|STARTED|Lab Session 1||24
10404454|NCT00734656|11548815|FG001|STARTED|Lab Session 1||23
10404455|NCT00734656|11548816|FG002|STARTED|Lab Session 1||26
10404456|NCT00734656|11548817|FG003|STARTED|Lab Session 1||21
10404457|NCT00734656|11548814|FG000|COMPLETED|Lab Session 1||22
10404458|NCT00734656|11548815|FG001|COMPLETED|Lab Session 1||23
10404459|NCT00734656|11548816|FG002|COMPLETED|Lab Session 1||26
10404460|NCT00734656|11548817|FG003|COMPLETED|Lab Session 1||21
10404461|NCT00734656|11548814|FG000|NOT COMPLETED|Lab Session 1||2
10404462|NCT00734656|11548815|FG001|NOT COMPLETED|Lab Session 1||0
10404463|NCT00734656|11548816|FG002|NOT COMPLETED|Lab Session 1||0
10404464|NCT00734656|11548817|FG003|NOT COMPLETED|Lab Session 1||0
10404465|NCT00734656|11548814|FG000|STARTED|Washout 1||22
10404466|NCT00734656|11548815|FG001|STARTED|Washout 1||23
10404467|NCT00734656|11548816|FG002|STARTED|Washout 1||26
10404468|NCT00734656|11548817|FG003|STARTED|Washout 1||21
10404469|NCT00734656|11548814|FG000|COMPLETED|Washout 1||21
10404470|NCT00734656|11548815|FG001|COMPLETED|Washout 1||18
10404471|NCT00734656|11548816|FG002|COMPLETED|Washout 1||24
10404472|NCT00734656|11548817|FG003|COMPLETED|Washout 1||18
10404473|NCT00734656|11548814|FG000|NOT COMPLETED|Washout 1||1
10404474|NCT00734656|11548815|FG001|NOT COMPLETED|Washout 1||5
10404475|NCT00734656|11548816|FG002|NOT COMPLETED|Washout 1||2
10404476|NCT00734656|11548817|FG003|NOT COMPLETED|Washout 1||3
10661128|NCT02257177|11822991|FG008|STARTED|Overall Study||5
10661129|NCT02257177|11822992|FG009|STARTED|Overall Study||5
10661130|NCT02257177|11822993|FG010|STARTED|Overall Study||9
10661131|NCT02257177|11822983|FG000|COMPLETED|Overall Study||4
10661132|NCT02257177|11822984|FG001|COMPLETED|Overall Study||4
10661133|NCT02257177|11822985|FG002|COMPLETED|Overall Study||4
10661134|NCT02257177|11822986|FG003|COMPLETED|Overall Study||4
10661135|NCT02257177|11822987|FG004|COMPLETED|Overall Study||4
10661136|NCT02257177|11822988|FG005|COMPLETED|Overall Study||4
10721946|NCT02731755|11885658|FG001|STARTED|Second Intervention||8
10721947|NCT02731755|11885657|FG000|COMPLETED|Second Intervention||8
10721948|NCT02731755|11885658|FG001|COMPLETED|Second Intervention||8
10721949|NCT02731755|11885657|FG000|NOT COMPLETED|Second Intervention||0
10721950|NCT02731755|11885658|FG001|NOT COMPLETED|Second Intervention||0
10721951|NCT02731820|11885666|FG000|STARTED|Overall Study||20
10721952|NCT02731820|11885667|FG001|STARTED|Overall Study||20
10721953|NCT02731820|11885666|FG000|COMPLETED|Overall Study||17
10721954|NCT02731820|11885667|FG001|COMPLETED|Overall Study||18
10721955|NCT02731820|11885666|FG000|NOT COMPLETED|Overall Study||3
10721956|NCT02731820|11885667|FG001|NOT COMPLETED|Overall Study||2
10721957|NCT02731833|11885675|FG000|STARTED|Overall Study||111
10721958|NCT02731833|11885676|FG001|STARTED|Overall Study||111
10721959|NCT02731833|11885675|FG000|COMPLETED|Overall Study||111
10721960|NCT02731833|11885676|FG001|COMPLETED|Overall Study||111
10721961|NCT02731833|11885675|FG000|NOT COMPLETED|Overall Study||0
10721962|NCT02731833|11885676|FG001|NOT COMPLETED|Overall Study||0
10721963|NCT02732015|11885684|FG000|STARTED|Overall Study||9
10721964|NCT02732015|11885685|FG001|STARTED|Overall Study||27
10721965|NCT02732015|11885684|FG000|COMPLETED|Overall Study||9
10721966|NCT02732015|11885685|FG001|COMPLETED|Overall Study||26
10721967|NCT02732015|11885684|FG000|NOT COMPLETED|Overall Study||0
10721968|NCT02732015|11885685|FG001|NOT COMPLETED|Overall Study||1
10721969|NCT02732119|11885696|FG000|STARTED|Phase I||8
10721970|NCT02732119|11885697|FG001|STARTED|Phase I||10
10721971|NCT02732119|11885698|FG002|STARTED|Phase I||7
10721972|NCT02732119|11885699|FG003|STARTED|Phase I||0
10721973|NCT02732119|11885700|FG004|STARTED|Phase I||0
10721974|NCT02732119|11885696|FG000|COMPLETED|Phase I||0
10721975|NCT02732119|11885697|FG001|COMPLETED|Phase I||0
10721976|NCT02732119|11885698|FG002|COMPLETED|Phase I||0
10721977|NCT02732119|11885699|FG003|COMPLETED|Phase I||0
10721978|NCT02732119|11885700|FG004|COMPLETED|Phase I||0
10721979|NCT02732119|11885696|FG000|NOT COMPLETED|Phase I||8
10721980|NCT02732119|11885697|FG001|NOT COMPLETED|Phase I||10
10721981|NCT02732119|11885698|FG002|NOT COMPLETED|Phase I||7
10721982|NCT02732119|11885699|FG003|NOT COMPLETED|Phase I||0
10721983|NCT02732119|11885700|FG004|NOT COMPLETED|Phase I||0
10721984|NCT02732119|11885696|FG000|STARTED|Phase II||0
10721985|NCT02732119|11885697|FG001|STARTED|Phase II||0
10721986|NCT02732119|11885698|FG002|STARTED|Phase II||0
10721987|NCT02732119|11885699|FG003|STARTED|Phase II||46
10721988|NCT02732119|11885700|FG004|STARTED|Phase II||33
10721989|NCT02732119|11885696|FG000|Protocol Analysis Set|Phase II||0
10721990|NCT02732119|11885697|FG001|Protocol Analysis Set|Phase II||0
10721991|NCT02732119|11885698|FG002|Protocol Analysis Set|Phase II||0
10721992|NCT02732119|11885699|FG003|Protocol Analysis Set|Phase II||46
10721993|NCT02732119|11885700|FG004|Protocol Analysis Set|Phase II||32
10721994|NCT02732119|11885696|FG000|COMPLETED|Phase II||0
10721995|NCT02732119|11885697|FG001|COMPLETED|Phase II||0
10721996|NCT02732119|11885698|FG002|COMPLETED|Phase II||0
10721997|NCT02732119|11885699|FG003|COMPLETED|Phase II||0
10721998|NCT02732119|11885700|FG004|COMPLETED|Phase II||0
10721999|NCT02732119|11885696|FG000|NOT COMPLETED|Phase II||0
10722000|NCT02732119|11885697|FG001|NOT COMPLETED|Phase II||0
10722001|NCT02732119|11885698|FG002|NOT COMPLETED|Phase II||0
10722002|NCT02732119|11885699|FG003|NOT COMPLETED|Phase II||46
10722003|NCT02732119|11885700|FG004|NOT COMPLETED|Phase II||33
10722004|NCT02732145|11885716|FG000|STARTED|Overall Study||82
10429914|NCT00867100|11576060|FG010|STARTED|Overall Study||4
10722005|NCT02732145|11885717|FG001|STARTED|Overall Study||82
10722006|NCT02732145|11885718|FG002|STARTED|Overall Study||82
10722007|NCT02732145|11885719|FG003|STARTED|Overall Study||82
10722008|NCT02732145|11885716|FG000|COMPLETED|Overall Study||82
10661137|NCT02257177|11822989|FG006|COMPLETED|Overall Study||12
10661138|NCT02257177|11822990|FG007|COMPLETED|Overall Study||5
10722009|NCT02732145|11885717|FG001|COMPLETED|Overall Study||82
10722010|NCT02732145|11885718|FG002|COMPLETED|Overall Study||82
10722011|NCT02732145|11885719|FG003|COMPLETED|Overall Study||82
10722012|NCT02732145|11885716|FG000|NOT COMPLETED|Overall Study||0
10722013|NCT02732145|11885717|FG001|NOT COMPLETED|Overall Study||0
10722014|NCT02732145|11885718|FG002|NOT COMPLETED|Overall Study||0
10722015|NCT02732145|11885719|FG003|NOT COMPLETED|Overall Study||0
10722016|NCT02732210|11885751|FG000|STARTED|Overall Study||303
10722017|NCT02732210|11885752|FG001|STARTED|Overall Study||632
10722018|NCT02732210|11885751|FG000|COMPLETED|Overall Study||218
10722019|NCT02732210|11885752|FG001|COMPLETED|Overall Study||338
10722020|NCT02732210|11885751|FG000|NOT COMPLETED|Overall Study||85
10722021|NCT02732210|11885752|FG001|NOT COMPLETED|Overall Study||294
10722022|NCT02732366|11885760|FG000|STARTED|Overall Study||23
10722023|NCT02732366|11885761|FG001|STARTED|Overall Study||23
10722024|NCT02732366|11885760|FG000|Withdrawal by Participant|Overall Study||5
10404477|NCT00734656|11548814|FG000|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|19
10404478|NCT00734656|11548815|FG001|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|21
10404479|NCT00734656|11548816|FG002|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|21
10404480|NCT00734656|11548817|FG003|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|20
10404481|NCT00734656|11548814|FG000|COMPLETED|Lab Session 2||18
10404482|NCT00734656|11548815|FG001|COMPLETED|Lab Session 2||21
10404483|NCT00734656|11548816|FG002|COMPLETED|Lab Session 2||21
10404484|NCT00734656|11548817|FG003|COMPLETED|Lab Session 2||19
10404485|NCT00734656|11548814|FG000|NOT COMPLETED|Lab Session 2||1
10404486|NCT00734656|11548815|FG001|NOT COMPLETED|Lab Session 2||0
10404487|NCT00734656|11548816|FG002|NOT COMPLETED|Lab Session 2||0
10404488|NCT00734656|11548817|FG003|NOT COMPLETED|Lab Session 2||1
10404489|NCT00734656|11548814|FG000|STARTED|Washout 2||18
10404490|NCT00734656|11548815|FG001|STARTED|Washout 2||21
10404491|NCT00734656|11548816|FG002|STARTED|Washout 2||21
10404492|NCT00734656|11548817|FG003|STARTED|Washout 2||19
10404493|NCT00734656|11548814|FG000|COMPLETED|Washout 2||17
10404494|NCT00734656|11548815|FG001|COMPLETED|Washout 2||20
10404495|NCT00734656|11548816|FG002|COMPLETED|Washout 2||20
10404496|NCT00734656|11548817|FG003|COMPLETED|Washout 2||19
10404497|NCT00734656|11548814|FG000|NOT COMPLETED|Washout 2||1
10404498|NCT00734656|11548815|FG001|NOT COMPLETED|Washout 2||1
10404499|NCT00734656|11548816|FG002|NOT COMPLETED|Washout 2||1
10404500|NCT00734656|11548817|FG003|NOT COMPLETED|Washout 2||0
10404501|NCT00734656|11548814|FG000|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|18
10404502|NCT00734656|11548815|FG001|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|19
10404503|NCT00734656|11548816|FG002|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|20
10404504|NCT00734656|11548817|FG003|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|19
10404505|NCT00734656|11548814|FG000|COMPLETED|Lab Session 3||18
10404506|NCT00734656|11548815|FG001|COMPLETED|Lab Session 3||19
10404507|NCT00734656|11548816|FG002|COMPLETED|Lab Session 3||20
10404508|NCT00734656|11548817|FG003|COMPLETED|Lab Session 3||19
10404509|NCT00734656|11548814|FG000|NOT COMPLETED|Lab Session 3||0
10404510|NCT00734656|11548815|FG001|NOT COMPLETED|Lab Session 3||0
10404511|NCT00734656|11548816|FG002|NOT COMPLETED|Lab Session 3||0
10404512|NCT00734656|11548817|FG003|NOT COMPLETED|Lab Session 3||0
10404513|NCT00734656|11548814|FG000|STARTED|Washout 3||18
10404514|NCT00734656|11548815|FG001|STARTED|Washout 3||19
10404515|NCT00734656|11548816|FG002|STARTED|Washout 3||20
10404516|NCT00734656|11548817|FG003|STARTED|Washout 3||19
10404517|NCT00734656|11548814|FG000|COMPLETED|Washout 3||17
10404518|NCT00734656|11548815|FG001|COMPLETED|Washout 3||19
10404519|NCT00734656|11548816|FG002|COMPLETED|Washout 3||20
10404520|NCT00734656|11548817|FG003|COMPLETED|Washout 3||18
10404521|NCT00734656|11548814|FG000|NOT COMPLETED|Washout 3||1
10404522|NCT00734656|11548815|FG001|NOT COMPLETED|Washout 3||0
10404523|NCT00734656|11548816|FG002|NOT COMPLETED|Washout 3||0
10404524|NCT00734656|11548817|FG003|NOT COMPLETED|Washout 3||1
10404525|NCT00734656|11548814|FG000|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|20
10404526|NCT00734656|11548815|FG001|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|18
10404527|NCT00734656|11548816|FG002|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|16
10404528|NCT00734656|11548817|FG003|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|20
10404529|NCT00734656|11548814|FG000|COMPLETED|Lab Session 4||20
10404530|NCT00734656|11548815|FG001|COMPLETED|Lab Session 4||18
10404531|NCT00734656|11548816|FG002|COMPLETED|Lab Session 4||16
10404532|NCT00734656|11548817|FG003|COMPLETED|Lab Session 4||19
10404533|NCT00734656|11548814|FG000|NOT COMPLETED|Lab Session 4||0
10404534|NCT00734656|11548815|FG001|NOT COMPLETED|Lab Session 4||0
10404535|NCT00734656|11548816|FG002|NOT COMPLETED|Lab Session 4||0
10404536|NCT00734656|11548817|FG003|NOT COMPLETED|Lab Session 4||1
10404537|NCT00734734|11548827|FG000|STARTED|Overall Study||64
10404538|NCT00734734|11548827|FG000|COMPLETED|Overall Study||64
10404539|NCT00734734|11548827|FG000|NOT COMPLETED|Overall Study||0
10404540|NCT00734747|11548832|FG000|STARTED|SRS Procedure||72
10404541|NCT00734747|11548832|FG000|COMPLETED|SRS Procedure||69
10404542|NCT00734747|11548832|FG000|NOT COMPLETED|SRS Procedure||3
10404543|NCT00734747|11548832|FG000|STARTED|6 Month Follow-up||69
10404544|NCT00734747|11548832|FG000|COMPLETED|6 Month Follow-up||66
10404545|NCT00734747|11548832|FG000|NOT COMPLETED|6 Month Follow-up||3
10404546|NCT00734799|11548838|FG000|STARTED|Overall Study||9
10404547|NCT00734799|11548839|FG001|STARTED|Overall Study||13
10404548|NCT00734799|11548838|FG000|COMPLETED|Overall Study||9
10404549|NCT00734799|11548839|FG001|COMPLETED|Overall Study||9
10404550|NCT00734799|11548838|FG000|NOT COMPLETED|Overall Study||0
10404551|NCT00734799|11548839|FG001|NOT COMPLETED|Overall Study||4
10404552|NCT00734851|11548845|FG000|STARTED|Overall Study||34
10404553|NCT00734851|11548845|FG000|COMPLETED|Overall Study||13
10404554|NCT00734851|11548845|FG000|NOT COMPLETED|Overall Study||21
10404555|NCT00734903|11548851|FG000|STARTED|Overall Study||33
10404556|NCT00734903|11548852|FG001|STARTED|Overall Study||33
10404557|NCT00734903|11548851|FG000|Completed End of Treatment Assessment|Overall Study||21
10404558|NCT00734903|11548852|FG001|Completed End of Treatment Assessment|Overall Study||23
10404559|NCT00734903|11548851|FG000|Completed 3-month Followup|Overall Study||14
10404560|NCT00734903|11548852|FG001|Completed 3-month Followup|Overall Study||15
10404561|NCT00734903|11548851|FG000|COMPLETED|Overall Study||30
10404562|NCT00734903|11548852|FG001|COMPLETED|Overall Study||32
10404563|NCT00734903|11548851|FG000|NOT COMPLETED|Overall Study||3
10404564|NCT00734903|11548852|FG001|NOT COMPLETED|Overall Study||1
10404565|NCT00734929|11548860|FG000|STARTED|Overall Study||57
10404566|NCT00734929|11548861|FG001|STARTED|Overall Study||58
10404567|NCT00734929|11548860|FG000|COMPLETED|Overall Study||51
10404568|NCT00734929|11548861|FG001|COMPLETED|Overall Study||53
10404569|NCT00734929|11548860|FG000|NOT COMPLETED|Overall Study||6
10404570|NCT00734929|11548861|FG001|NOT COMPLETED|Overall Study||5
10404571|NCT00734968|11548871|FG000|STARTED|Overall Study||77
10404572|NCT00734968|11548872|FG001|STARTED|Overall Study||76
10404573|NCT00734968|11548871|FG000|COMPLETED|Overall Study||76
10404574|NCT00734968|11548872|FG001|COMPLETED|Overall Study||75
10404575|NCT00734968|11548871|FG000|NOT COMPLETED|Overall Study||1
10404576|NCT00734968|11548872|FG001|NOT COMPLETED|Overall Study||1
10404577|NCT00734994|11548878|FG000|STARTED|Overall Study||15
10404578|NCT00734994|11548878|FG000|COMPLETED|Overall Study||14
10404579|NCT00734994|11548878|FG000|NOT COMPLETED|Overall Study||1
10404580|NCT00735007|11548883|FG000|STARTED|Overall Study||106
10404581|NCT00735007|11548883|FG000|COMPLETED|Overall Study||101
10404582|NCT00735007|11548883|FG000|NOT COMPLETED|Overall Study||5
10404583|NCT00735072|11548889|FG000|STARTED|Overall Study||23
10404584|NCT00735072|11548890|FG001|STARTED|Overall Study||22
10404585|NCT00735072|11548889|FG000|COMPLETED|Overall Study||22
10404586|NCT00735072|11548890|FG001|COMPLETED|Overall Study||21
10404587|NCT00735072|11548889|FG000|NOT COMPLETED|Overall Study||1
10404588|NCT00735072|11548890|FG001|NOT COMPLETED|Overall Study||1
10404589|NCT00735306|11548898|FG000|STARTED|Overall Study||12
10404590|NCT00735306|11548898|FG000|COMPLETED|Overall Study||12
10404591|NCT00735306|11548898|FG000|NOT COMPLETED|Overall Study||0
10404592|NCT00735371|11548907|FG000|STARTED|Overall Study||78
10404593|NCT00735371|11548908|FG001|STARTED|Overall Study||79
10722025|NCT02732366|11885761|FG001|Withdrawal by Participant|Overall Study||2
10722026|NCT02732366|11885760|FG000|COMPLETED|Overall Study||18
10722027|NCT02732366|11885761|FG001|COMPLETED|Overall Study||21
10722028|NCT02732366|11885760|FG000|NOT COMPLETED|Overall Study||5
10722029|NCT02732366|11885761|FG001|NOT COMPLETED|Overall Study||2
10722030|NCT02732561|11885772|FG000|STARTED|Overall Study||5
10722031|NCT02732561|11885773|FG001|STARTED|Overall Study||5
10722032|NCT02732561|11885772|FG000|COMPLETED|Overall Study||3
10722033|NCT02732561|11885773|FG001|COMPLETED|Overall Study||4
10722034|NCT02732561|11885772|FG000|NOT COMPLETED|Overall Study||2
10722035|NCT02732561|11885773|FG001|NOT COMPLETED|Overall Study||1
10722036|NCT02732587|11885779|FG000|STARTED|Overall Study||5
10722037|NCT02732587|11885779|FG000|COMPLETED|Overall Study||5
10722038|NCT02732587|11885779|FG000|NOT COMPLETED|Overall Study||0
10722039|NCT02732600|11885785|FG000|STARTED|Overall Study||3525
10722040|NCT02732600|11885786|FG001|STARTED|Overall Study||2091
10722041|NCT02732600|11885785|FG000|Sub-set of Sites Newly Delivering PS Services|Overall Study||899
10722042|NCT02732600|11885786|FG001|Sub-set of Sites Newly Delivering PS Services|Overall Study||1484
10722043|NCT02732600|11885785|FG000|Veteran Baseline Veteran (Sub-set of 23 Sites)|Overall Study||118
10722044|NCT02732600|11885786|FG001|Veteran Baseline Veteran (Sub-set of 23 Sites)|Overall Study||145
10722045|NCT02732600|11885785|FG000|Veteran 6-months (Sub-set 23 Sites)|Overall Study||70
10722046|NCT02732600|11885786|FG001|Veteran 6-months (Sub-set 23 Sites)|Overall Study||84
10722047|NCT02732600|11885785|FG000|Veteran 1-year (Sub-set 23 Sites)|Overall Study||54
10722048|NCT02732600|11885786|FG001|Veteran 1-year (Sub-set 23 Sites)|Overall Study||71
10722049|NCT02732600|11885785|FG000|Peer Specialist Responses at 6-months (All 25 Sites)|Overall Study||12
10722050|NCT02732600|11885786|FG001|Peer Specialist Responses at 6-months (All 25 Sites)|Overall Study||14
10722051|NCT02732600|11885785|FG000|Peer Specialist Responses at 1-year (All 25 Sites)|Overall Study||5
10722052|NCT02732600|11885786|FG001|Peer Specialist Responses at 1-year (All 25 Sites)|Overall Study||12
10722053|NCT02732600|11885785|FG000|Supervisor Responses 6-months (All 25 Sites)|Overall Study||10
10722054|NCT02732600|11885786|FG001|Supervisor Responses 6-months (All 25 Sites)|Overall Study||21
10722055|NCT02732600|11885785|FG000|Supervisor 1-year (All 25 Sites)|Overall Study||6
10722056|NCT02732600|11885786|FG001|Supervisor 1-year (All 25 Sites)|Overall Study||10
10722057|NCT02732600|11885785|FG000|COMPLETED|Overall Study||100
10722058|NCT02732600|11885786|FG001|COMPLETED|Overall Study||113
10722059|NCT02732600|11885785|FG000|NOT COMPLETED|Overall Study||3425
10722060|NCT02732600|11885786|FG001|NOT COMPLETED|Overall Study||1978
10722061|NCT02732639|11885793|FG000|STARTED|Overall Study||31
10722062|NCT02732639|11885793|FG000|COMPLETED|Overall Study||30
10722063|NCT02732639|11885793|FG000|NOT COMPLETED|Overall Study||1
10722064|NCT02732847|11885799|FG000|STARTED|Overall Study||75
10722065|NCT02732847|11885800|FG001|STARTED|Overall Study||74
10722066|NCT02732847|11885799|FG000|COMPLETED|Overall Study||33
10404594|NCT00735371|11548909|FG002|STARTED|Overall Study||78
10404595|NCT00735371|11548910|FG003|STARTED|Overall Study||79
10404596|NCT00735371|11548907|FG000|COMPLETED|Overall Study||63
10722067|NCT02732847|11885800|FG001|COMPLETED|Overall Study||32
10404597|NCT00735371|11548908|FG001|COMPLETED|Overall Study||66
10404598|NCT00735371|11548909|FG002|COMPLETED|Overall Study||67
10404599|NCT00735371|11548910|FG003|COMPLETED|Overall Study||69
10722068|NCT02732847|11885799|FG000|NOT COMPLETED|Overall Study||42
10722069|NCT02732847|11885800|FG001|NOT COMPLETED|Overall Study||42
10404600|NCT00735371|11548907|FG000|NOT COMPLETED|Overall Study||15
10404601|NCT00735371|11548908|FG001|NOT COMPLETED|Overall Study||13
10722070|NCT02732899|11885808|FG000|STARTED|Overall Study||10
10722071|NCT02732899|11885809|FG001|STARTED|Overall Study||10
10722072|NCT02732899|11885808|FG000|COMPLETED|Overall Study||10
10722073|NCT02732899|11885809|FG001|COMPLETED|Overall Study||10
10722074|NCT02732899|11885808|FG000|NOT COMPLETED|Overall Study||0
10722075|NCT02732899|11885809|FG001|NOT COMPLETED|Overall Study||0
10722076|NCT02732912|11885817|FG000|STARTED|Overall Study||97
10722077|NCT02732912|11885818|FG001|STARTED|Overall Study||109
10722078|NCT02732912|11885817|FG000|COMPLETED|Overall Study||87
10722079|NCT02732912|11885818|FG001|COMPLETED|Overall Study||91
10722080|NCT02732912|11885817|FG000|NOT COMPLETED|Overall Study||10
10722081|NCT02732912|11885818|FG001|NOT COMPLETED|Overall Study||18
10722082|NCT02732938|11885826|FG000|STARTED|Overall Study||4
10722083|NCT02732938|11885827|FG001|STARTED|Overall Study||18
10722084|NCT02732938|11885828|FG002|STARTED|Overall Study||0
10722085|NCT02732938|11885826|FG000|Received Treatment|Overall Study||4
10722086|NCT02732938|11885827|FG001|Received Treatment|Overall Study||17
10722087|NCT02732938|11885828|FG002|Received Treatment|Overall Study||0
10722088|NCT02732938|11885826|FG000|COMPLETED|Overall Study||0
10722089|NCT02732938|11885827|FG001|COMPLETED|Overall Study||0
10722090|NCT02732938|11885828|FG002|COMPLETED|Overall Study||0
10722091|NCT02732938|11885826|FG000|NOT COMPLETED|Overall Study||4
10722092|NCT02732938|11885827|FG001|NOT COMPLETED|Overall Study||18
10722093|NCT02732938|11885828|FG002|NOT COMPLETED|Overall Study||0
10722094|NCT02732951|11885838|FG000|STARTED|Overall Study||53
10722095|NCT02732951|11885839|FG001|STARTED|Overall Study||52
10722096|NCT02732951|11885838|FG000|COMPLETED|Overall Study||48
10722097|NCT02732951|11885839|FG001|COMPLETED|Overall Study||46
10722098|NCT02732951|11885838|FG000|NOT COMPLETED|Overall Study||5
10722099|NCT02732951|11885839|FG001|NOT COMPLETED|Overall Study||6
10722100|NCT02733367|11885845|FG000|STARTED|Overall Study||18
10722101|NCT02733367|11885845|FG000|COMPLETED|Overall Study||12
10722102|NCT02733367|11885845|FG000|NOT COMPLETED|Overall Study||6
10722103|NCT02733588|11885850|FG000|STARTED|Overall Study||7
10722104|NCT02733588|11885850|FG000|COMPLETED|Overall Study||7
10722105|NCT02733588|11885850|FG000|NOT COMPLETED|Overall Study||0
10722106|NCT02733627|11885858|FG000|STARTED|Overall Study||9
10722107|NCT02733627|11885859|FG001|STARTED|Overall Study||9
10722108|NCT02733627|11885860|FG002|STARTED|Overall Study||9
10722109|NCT02733627|11885861|FG003|STARTED|Overall Study||9
10722110|NCT02733627|11885858|FG000|COMPLETED|Overall Study||9
10722111|NCT02733627|11885859|FG001|COMPLETED|Overall Study||8
10722112|NCT02733627|11885860|FG002|COMPLETED|Overall Study||7
10722113|NCT02733627|11885861|FG003|COMPLETED|Overall Study||9
10722114|NCT02733627|11885858|FG000|NOT COMPLETED|Overall Study||0
10722115|NCT02733627|11885859|FG001|NOT COMPLETED|Overall Study||1
10722116|NCT02733627|11885860|FG002|NOT COMPLETED|Overall Study||2
10722117|NCT02733627|11885861|FG003|NOT COMPLETED|Overall Study||0
10722118|NCT02733653|11885871|FG000|STARTED|Overall Study||50
10722119|NCT02733653|11885871|FG000|COMPLETED|Overall Study||49
10722120|NCT02733653|11885871|FG000|NOT COMPLETED|Overall Study||1
10722121|NCT02733757|11885879|FG000|STARTED|Overall Study||20
10722122|NCT02733757|11885880|FG001|STARTED|Overall Study||20
10722123|NCT02733757|11885881|FG002|STARTED|Overall Study||20
10722124|NCT02733757|11885882|FG003|STARTED|Overall Study||20
10722125|NCT02733757|11885879|FG000|COMPLETED|Overall Study||20
10722126|NCT02733757|11885880|FG001|COMPLETED|Overall Study||20
10722127|NCT02733757|11885881|FG002|COMPLETED|Overall Study||20
10722128|NCT02733757|11885882|FG003|COMPLETED|Overall Study||20
10722129|NCT02733757|11885879|FG000|NOT COMPLETED|Overall Study||0
10722130|NCT02733757|11885880|FG001|NOT COMPLETED|Overall Study||0
10722131|NCT02733757|11885881|FG002|NOT COMPLETED|Overall Study||0
10722132|NCT02733757|11885882|FG003|NOT COMPLETED|Overall Study||0
10722133|NCT02733991|11885894|FG000|STARTED|Overall Study||76
10722134|NCT02733991|11885895|FG001|STARTED|Overall Study||77
10722135|NCT02733991|11885894|FG000|COMPLETED|Overall Study||75
10722136|NCT02733991|11885895|FG001|COMPLETED|Overall Study||72
10722137|NCT02733991|11885894|FG000|NOT COMPLETED|Overall Study||1
10722138|NCT02733991|11885895|FG001|NOT COMPLETED|Overall Study||5
10722139|NCT02734056|11885903|FG000|STARTED|Overall Study||50
10722140|NCT02734056|11885904|FG001|STARTED|Overall Study||50
10722141|NCT02734056|11885903|FG000|COMPLETED|Overall Study||50
10722142|NCT02734056|11885904|FG001|COMPLETED|Overall Study||49
10722143|NCT02734056|11885903|FG000|NOT COMPLETED|Overall Study||0
10722144|NCT02734056|11885904|FG001|NOT COMPLETED|Overall Study||1
10722145|NCT02734147|11885912|FG000|STARTED|Overall Study||12
10722146|NCT02734147|11885913|FG001|STARTED|Overall Study||12
10722147|NCT02734147|11885912|FG000|COMPLETED|Overall Study||9
10722148|NCT02734147|11885913|FG001|COMPLETED|Overall Study||11
10722149|NCT02734147|11885912|FG000|NOT COMPLETED|Overall Study||3
10722150|NCT02734147|11885913|FG001|NOT COMPLETED|Overall Study||1
10722151|NCT02734212|11885921|FG000|STARTED|Overall Study||29
10722152|NCT02734212|11885922|FG001|STARTED|Overall Study||28
10722153|NCT02734212|11885921|FG000|COMPLETED|Overall Study||24
10722154|NCT02734212|11885922|FG001|COMPLETED|Overall Study||18
10722155|NCT02734212|11885921|FG000|NOT COMPLETED|Overall Study||5
10722156|NCT02734212|11885922|FG001|NOT COMPLETED|Overall Study||10
10722157|NCT02734238|11885931|FG000|STARTED|Overall Study||26
10722158|NCT02734238|11885932|FG001|STARTED|Overall Study||24
10722159|NCT02734238|11885931|FG000|COMPLETED|Overall Study||26
10722160|NCT02734238|11885932|FG001|COMPLETED|Overall Study||24
10722161|NCT02734238|11885931|FG000|NOT COMPLETED|Overall Study||0
10544307|NCT01490125|11697556|FG003|STARTED|Period III||30
10544308|NCT01490125|11697557|FG004|STARTED|Period III||32
10544309|NCT01490125|11697558|FG005|STARTED|Period III||35
10544310|NCT01490125|11697553|FG000|COMPLETED|Period III||31
10544311|NCT01490125|11697554|FG001|COMPLETED|Period III||32
10544312|NCT01490125|11697555|FG002|COMPLETED|Period III||34
10544313|NCT01490125|11697556|FG003|COMPLETED|Period III||28
10544314|NCT01490125|11697557|FG004|COMPLETED|Period III||31
10722162|NCT02734238|11885932|FG001|NOT COMPLETED|Overall Study||0
10722163|NCT02734355|11885940|FG000|STARTED|Overall Study||34
10722164|NCT02734355|11885941|FG001|STARTED|Overall Study||30
10722165|NCT02734355|11885940|FG000|COMPLETED|Overall Study||34
10722166|NCT02734355|11885941|FG001|COMPLETED|Overall Study||30
10722167|NCT02734355|11885940|FG000|NOT COMPLETED|Overall Study||0
10722168|NCT02734355|11885941|FG001|NOT COMPLETED|Overall Study||0
10722169|NCT02734498|11885950|FG000|STARTED|Overall Study||2
10722170|NCT02734498|11885951|FG001|STARTED|Overall Study||0
10722171|NCT02734498|11885952|FG002|STARTED|Overall Study||0
10722172|NCT02734498|11885950|FG000|COMPLETED|Overall Study||2
10722173|NCT02734498|11885951|FG001|COMPLETED|Overall Study||0
10722174|NCT02734498|11885952|FG002|COMPLETED|Overall Study||0
10722175|NCT02734498|11885950|FG000|NOT COMPLETED|Overall Study||0
10722176|NCT02734498|11885951|FG001|NOT COMPLETED|Overall Study||0
10722177|NCT02734498|11885952|FG002|NOT COMPLETED|Overall Study||0
10722178|NCT02734576|11885960|FG000|STARTED|Overall Study||10
10722179|NCT02734576|11885960|FG000|COMPLETED|Overall Study||10
10722180|NCT02734576|11885960|FG000|NOT COMPLETED|Overall Study||0
10312700|NCT00143455|11446113|FG002|NOT COMPLETED|Cohort 2||106
10312701|NCT00143455|11446114|FG003|NOT COMPLETED|Cohort 2||93
10312702|NCT00143507|11446128|FG000|STARTED|Overall Study||5479
10312703|NCT00143507|11446129|FG001|STARTED|Overall Study||5438
10312704|NCT00143507|11446128|FG000|COMPLETED|Overall Study||4792
10312705|NCT00143507|11446129|FG001|COMPLETED|Overall Study||4786
10312706|NCT00143507|11446128|FG000|NOT COMPLETED|Overall Study||687
10312707|NCT00143507|11446129|FG001|NOT COMPLETED|Overall Study||652
10312708|NCT00143598|11446137|FG000|STARTED|Overall Study||410
10312709|NCT00143598|11446138|FG001|STARTED|Overall Study||396
10312710|NCT00143598|11446137|FG000|COMPLETED|Overall Study||318
10312711|NCT00143598|11446138|FG001|COMPLETED|Overall Study||302
10312712|NCT00143598|11446137|FG000|NOT COMPLETED|Overall Study||92
10312713|NCT00143598|11446138|FG001|NOT COMPLETED|Overall Study||94
10312714|NCT00143819|11446146|FG000|STARTED|Overall Study||5
10312715|NCT00143819|11446147|FG001|STARTED|Overall Study||8
10312716|NCT00143819|11446146|FG000|COMPLETED|Overall Study||3
10312717|NCT00143819|11446147|FG001|COMPLETED|Overall Study||5
10312718|NCT00143819|11446146|FG000|NOT COMPLETED|Overall Study||2
10312719|NCT00143819|11446147|FG001|NOT COMPLETED|Overall Study||3
10312720|NCT00143845|11446157|FG000|STARTED|Overall Study||54
10312721|NCT00143845|11446157|FG000|COMPLETED|Overall Study||54
10312722|NCT00143845|11446157|FG000|NOT COMPLETED|Overall Study||0
10312723|NCT00144027|11446163|FG000|STARTED|Overall Study|participants who consented|39
10312724|NCT00144027|11446164|FG001|STARTED|Overall Study|participants who consented|36
10312725|NCT00144027|11446163|FG000|Completed Baseline Assessment|Overall Study||39
10312726|NCT00144027|11446164|FG001|Completed Baseline Assessment|Overall Study||29
10312727|NCT00144027|11446163|FG000|Completed 6 Month Assessment|Overall Study||37
10312728|NCT00144027|11446164|FG001|Completed 6 Month Assessment|Overall Study||24
10312729|NCT00144027|11446163|FG000|COMPLETED|Overall Study|participants who completed 12-month follow-up|36
10312730|NCT00144027|11446164|FG001|COMPLETED|Overall Study|participants who completed 12-month follow-up|25
10312731|NCT00144027|11446163|FG000|NOT COMPLETED|Overall Study||3
10312732|NCT00144027|11446164|FG001|NOT COMPLETED|Overall Study||11
10312733|NCT00144170|11446172|FG000|STARTED|Overall Study||438
10312734|NCT00144170|11446173|FG001|STARTED|Overall Study||428
10312735|NCT00144170|11446172|FG000|COMPLETED|Overall Study||86
10312736|NCT00144170|11446173|FG001|COMPLETED|Overall Study||32
10312737|NCT00144170|11446172|FG000|NOT COMPLETED|Overall Study||352
10312738|NCT00144170|11446173|FG001|NOT COMPLETED|Overall Study||396
10312739|NCT00144300|11446181|FG000|STARTED|Overall Study||121
10312740|NCT00144300|11446182|FG001|STARTED|Overall Study||125
10312741|NCT00144300|11446181|FG000|COMPLETED|Overall Study||92
10312742|NCT00144300|11446182|FG001|COMPLETED|Overall Study||97
10312743|NCT00144300|11446181|FG000|NOT COMPLETED|Overall Study||29
10312744|NCT00144300|11446182|FG001|NOT COMPLETED|Overall Study||28
10312745|NCT00144339|11446190|FG000|STARTED|Overall Study||3006
10312746|NCT00144339|11446191|FG001|STARTED|Overall Study||2986
10312747|NCT00144339|11446190|FG000|COMPLETED|Overall Study||1648
10312748|NCT00144339|11446191|FG001|COMPLETED|Overall Study||1887
10312749|NCT00144339|11446190|FG000|NOT COMPLETED|Overall Study||1358
10312750|NCT00144339|11446191|FG001|NOT COMPLETED|Overall Study||1099
10312751|NCT00144391|11446199|FG000|STARTED|Overall Study||11
10312752|NCT00144391|11446200|FG001|STARTED|Overall Study||9
10404602|NCT00735371|11548909|FG002|NOT COMPLETED|Overall Study||11
10404603|NCT00735371|11548910|FG003|NOT COMPLETED|Overall Study||10
10404604|NCT00735397|11548920|FG000|STARTED|Overall Study||1218
10404605|NCT00735397|11548920|FG000|COMPLETED|Overall Study||35
10404606|NCT00735397|11548920|FG000|NOT COMPLETED|Overall Study||1183
10404607|NCT00735436|11548927|FG000|STARTED|Overall Study||18
10404608|NCT00735436|11548927|FG000|COMPLETED|Overall Study||18
10404609|NCT00735436|11548927|FG000|NOT COMPLETED|Overall Study||0
10404610|NCT00735449|11548934|FG000|STARTED|Overall Study||102
10404611|NCT00735449|11548935|FG001|STARTED|Overall Study||102
10404612|NCT00735449|11548934|FG000|COMPLETED|Overall Study||95
10404613|NCT00735449|11548935|FG001|COMPLETED|Overall Study||96
10404614|NCT00735449|11548934|FG000|NOT COMPLETED|Overall Study||7
10404615|NCT00735449|11548935|FG001|NOT COMPLETED|Overall Study||6
10404616|NCT00735462|11548944|FG000|STARTED|Overall Study||202
10404617|NCT00735462|11548945|FG001|STARTED|Overall Study||204
10404618|NCT00735462|11548946|FG002|STARTED|Overall Study||105
10404619|NCT00735462|11548944|FG000|COMPLETED|Overall Study||139
10404620|NCT00735462|11548945|FG001|COMPLETED|Overall Study||149
10404621|NCT00735462|11548946|FG002|COMPLETED|Overall Study||77
10404622|NCT00735462|11548944|FG000|NOT COMPLETED|Overall Study||63
10404623|NCT00735462|11548945|FG001|NOT COMPLETED|Overall Study||55
10404624|NCT00735462|11548946|FG002|NOT COMPLETED|Overall Study||28
10404625|NCT00735475|11548956|FG000|STARTED|Overall Study||631
10404626|NCT00735475|11548957|FG001|STARTED|Overall Study||637
10404627|NCT00735475|11548956|FG000|COMPLETED|Overall Study||623
10404628|NCT00735475|11548957|FG001|COMPLETED|Overall Study||626
10404629|NCT00735475|11548956|FG000|NOT COMPLETED|Overall Study||8
10404630|NCT00735475|11548957|FG001|NOT COMPLETED|Overall Study||11
10404631|NCT00735618|11548963|FG000|STARTED|Overall Study||19
10404632|NCT00735618|11548963|FG000|COMPLETED|Overall Study||19
10404633|NCT00735618|11548963|FG000|NOT COMPLETED|Overall Study||0
10404634|NCT00735644|11548972|FG000|STARTED|Overall Study||303
10404635|NCT00735644|11548973|FG001|STARTED|Overall Study||300
10404636|NCT00735644|11548974|FG002|STARTED|Overall Study||296
10404637|NCT00735644|11548975|FG003|STARTED|Overall Study||199
10404638|NCT00735644|11548976|FG004|STARTED|Overall Study||102
10404639|NCT00735644|11548972|FG000|COMPLETED|Overall Study||303
10404640|NCT00735644|11548973|FG001|COMPLETED|Overall Study||298
10404641|NCT00735644|11548974|FG002|COMPLETED|Overall Study||295
10404642|NCT00735644|11548975|FG003|COMPLETED|Overall Study||198
10404643|NCT00735644|11548976|FG004|COMPLETED|Overall Study||102
10404644|NCT00735644|11548972|FG000|NOT COMPLETED|Overall Study||0
10404645|NCT00735644|11548973|FG001|NOT COMPLETED|Overall Study||2
10404646|NCT00735644|11548974|FG002|NOT COMPLETED|Overall Study||1
10404647|NCT00735644|11548975|FG003|NOT COMPLETED|Overall Study||1
10404648|NCT00735644|11548976|FG004|NOT COMPLETED|Overall Study||0
10404649|NCT00735670|11548997|FG000|STARTED|Overall Study||10
10404650|NCT00735670|11548998|FG001|STARTED|Overall Study||11
10404651|NCT00735670|11548997|FG000|COMPLETED|Overall Study||6
10404652|NCT00735670|11548998|FG001|COMPLETED|Overall Study||6
10404653|NCT00735670|11548997|FG000|NOT COMPLETED|Overall Study||4
10404654|NCT00735670|11548998|FG001|NOT COMPLETED|Overall Study||5
10404655|NCT00735696|11549004|FG000|STARTED|Overall Study||41
10404656|NCT00735696|11549004|FG000|Received Any Quantity of Study Drug|Overall Study||40
10404657|NCT00735696|11549004|FG000|COMPLETED|Overall Study||39
10404658|NCT00735696|11549004|FG000|NOT COMPLETED|Overall Study||2
10404659|NCT00735709|11549012|FG000|STARTED|Overall Study||140
10404660|NCT00735709|11549013|FG001|STARTED|Overall Study||140
10404661|NCT00735709|11549014|FG002|STARTED|Overall Study||140
10404662|NCT00735709|11549015|FG003|STARTED|Overall Study||140
10404663|NCT00735709|11549012|FG000|Treated|Overall Study||140
10404664|NCT00735709|11549013|FG001|Treated|Overall Study||140
10404665|NCT00735709|11549014|FG002|Treated|Overall Study||140
10404666|NCT00735709|11549015|FG003|Treated|Overall Study||139
10404667|NCT00735709|11549012|FG000|COMPLETED|Overall Study||127
10404668|NCT00735709|11549013|FG001|COMPLETED|Overall Study||127
10404669|NCT00735709|11549014|FG002|COMPLETED|Overall Study||129
10404670|NCT00735709|11549015|FG003|COMPLETED|Overall Study||122
10404671|NCT00735709|11549012|FG000|NOT COMPLETED|Overall Study||13
10404672|NCT00735709|11549013|FG001|NOT COMPLETED|Overall Study||13
10404673|NCT00735709|11549014|FG002|NOT COMPLETED|Overall Study||11
10404674|NCT00735709|11549015|FG003|NOT COMPLETED|Overall Study||18
10404675|NCT00735787|11549027|FG000|STARTED|Period 1||23
10404676|NCT00735787|11549028|FG001|STARTED|Period 1||49
10404677|NCT00735787|11549027|FG000|COMPLETED|Period 1|Per visit window, 18 completed; 17 completed per subject case report form.|17
10404678|NCT00735787|11549028|FG001|COMPLETED|Period 1||41
10404679|NCT00735787|11549027|FG000|NOT COMPLETED|Period 1||6
10404680|NCT00735787|11549028|FG001|NOT COMPLETED|Period 1||8
10404681|NCT00735787|11549027|FG000|STARTED|Period 2||18
10404682|NCT00735787|11549028|FG001|STARTED|Period 2||41
10404683|NCT00735787|11549027|FG000|COMPLETED|Period 2||13
10404684|NCT00735787|11549028|FG001|COMPLETED|Period 2||40
10404685|NCT00735787|11549027|FG000|NOT COMPLETED|Period 2||5
10404686|NCT00735787|11549028|FG001|NOT COMPLETED|Period 2||1
10404687|NCT00735826|11549034|FG000|STARTED|Overall Study||10
10404688|NCT00735826|11549034|FG000|COMPLETED|Overall Study||10
10404689|NCT00735826|11549034|FG000|NOT COMPLETED|Overall Study||0
10404690|NCT00735839|11549042|FG000|STARTED|Overall Study||30
10404691|NCT00735839|11549043|FG001|STARTED|Overall Study||10
10404692|NCT00735839|11549042|FG000|COMPLETED|Overall Study||30
10404693|NCT00735839|11549043|FG001|COMPLETED|Overall Study||10
10404694|NCT00735839|11549042|FG000|NOT COMPLETED|Overall Study||0
10404695|NCT00735839|11549043|FG001|NOT COMPLETED|Overall Study||0
10404696|NCT00735878|11549052|FG000|STARTED|Phase I- Dose Determination|13 subjects enrolled. One subject withdrew consent prior to receiving therapy & was replaced.|1
10404697|NCT00735878|11549053|FG001|STARTED|Phase I- Dose Determination||7
10404698|NCT00735878|11549054|FG002|STARTED|Phase I- Dose Determination||5
10404699|NCT00735878|11549052|FG000|COMPLETED|Phase I- Dose Determination|12 subjects received at least one cycle of treatment and were evaluable per the protocol.|1
10404700|NCT00735878|11549053|FG001|COMPLETED|Phase I- Dose Determination||7
10404701|NCT00735878|11549054|FG002|COMPLETED|Phase I- Dose Determination||4
10404702|NCT00735878|11549052|FG000|NOT COMPLETED|Phase I- Dose Determination||0
10404703|NCT00735878|11549053|FG001|NOT COMPLETED|Phase I- Dose Determination||0
10404704|NCT00735878|11549054|FG002|NOT COMPLETED|Phase I- Dose Determination||1
10404705|NCT00735878|11549052|FG000|STARTED|Phase II- Determined Dose||0
10404706|NCT00735878|11549053|FG001|STARTED|Phase II- Determined Dose||7
10404707|NCT00735878|11549054|FG002|STARTED|Phase II- Determined Dose||0
10404708|NCT00735878|11549052|FG000|COMPLETED|Phase II- Determined Dose|Seven subjects completed therapy within the Phase II portion of the trial.|0
10404709|NCT00735878|11549053|FG001|COMPLETED|Phase II- Determined Dose||7
10404710|NCT00735878|11549054|FG002|COMPLETED|Phase II- Determined Dose||0
10404711|NCT00735878|11549052|FG000|NOT COMPLETED|Phase II- Determined Dose||0
10404712|NCT00735878|11549053|FG001|NOT COMPLETED|Phase II- Determined Dose||0
10404713|NCT00735878|11549054|FG002|NOT COMPLETED|Phase II- Determined Dose||0
10404714|NCT00735904|11549065|FG000|STARTED|Overall Study||38
10404715|NCT00735904|11549065|FG000|COMPLETED|Overall Study||0
10404716|NCT00735904|11549065|FG000|NOT COMPLETED|Overall Study||38
10404717|NCT00735917|11549069|FG000|STARTED|Overall Study||19
10404718|NCT00735917|11549069|FG000|COMPLETED|Overall Study||19
10404719|NCT00735917|11549069|FG000|NOT COMPLETED|Overall Study||0
10404720|NCT00735943|11549073|FG000|STARTED|Overall Study||22
10404721|NCT00735943|11549073|FG000|COMPLETED|Overall Study||20
10404722|NCT00735943|11549073|FG000|NOT COMPLETED|Overall Study||2
10404723|NCT00735969|11549077|FG000|STARTED|Overall Study||21
10404724|NCT00735969|11549077|FG000|COMPLETED|Overall Study||21
10404725|NCT00735969|11549077|FG000|NOT COMPLETED|Overall Study||0
10404726|NCT00736034|11549081|FG000|STARTED|Overall Study||18
10404727|NCT00736034|11549081|FG000|COMPLETED|Overall Study||16
10404728|NCT00736034|11549081|FG000|NOT COMPLETED|Overall Study||2
10404729|NCT00736073|11549087|FG000|STARTED|Overall Study||34
10404730|NCT00736073|11549088|FG001|STARTED|Overall Study||39
10404731|NCT00736073|11549087|FG000|COMPLETED|Overall Study||34
10404732|NCT00736073|11549088|FG001|COMPLETED|Overall Study||39
10404733|NCT00736073|11549087|FG000|NOT COMPLETED|Overall Study||0
10404734|NCT00736073|11549088|FG001|NOT COMPLETED|Overall Study||0
10404735|NCT00736099|11549097|FG000|STARTED|Overall Study|Number who started treatment.|1532
10404736|NCT00736099|11549098|FG001|STARTED|Overall Study|Number who started treatment.|589
10404737|NCT00736099|11549097|FG000|COMPLETED|Overall Study|Number who completed treatment.|1349
10404738|NCT00736099|11549098|FG001|COMPLETED|Overall Study|Number who completed treatment.|531
10404739|NCT00736099|11549097|FG000|NOT COMPLETED|Overall Study||183
10404740|NCT00736099|11549098|FG001|NOT COMPLETED|Overall Study||58
10404741|NCT00736125|11549106|FG000|STARTED|Overall Study||10
10404742|NCT00736125|11549107|FG001|STARTED|Overall Study||10
10722181|NCT02734693|11885967|FG000|STARTED|Overall Study||56
10722182|NCT02734693|11885968|FG001|STARTED|Overall Study||56
10722183|NCT02734693|11885969|FG002|STARTED|Overall Study||20
10722184|NCT02734693|11885967|FG000|COMPLETED|Overall Study||50
10722185|NCT02734693|11885968|FG001|COMPLETED|Overall Study||53
10722186|NCT02734693|11885969|FG002|COMPLETED|Overall Study||17
10722187|NCT02734693|11885967|FG000|NOT COMPLETED|Overall Study||6
10722188|NCT02734693|11885968|FG001|NOT COMPLETED|Overall Study||3
10722189|NCT02734693|11885969|FG002|NOT COMPLETED|Overall Study||3
10722190|NCT02734810|11885979|FG000|STARTED|Overall Study||15
10722191|NCT02734810|11885980|FG001|STARTED|Overall Study||0
10722192|NCT02734810|11885979|FG000|COMPLETED|Overall Study||13
10722193|NCT02734810|11885980|FG001|COMPLETED|Overall Study||0
10722194|NCT02734810|11885979|FG000|NOT COMPLETED|Overall Study||2
10722195|NCT02734810|11885980|FG001|NOT COMPLETED|Overall Study||0
10722196|NCT02734849|11885989|FG000|STARTED|Overall Study|One patient was randomized but never received study treatment and excluded from all analysis sets.|16
10722197|NCT02734849|11885990|FG001|STARTED|Overall Study||14
10722198|NCT02734849|11885991|FG002|STARTED|Overall Study||10
10722199|NCT02734849|11885989|FG000|COMPLETED|Overall Study||12
10722200|NCT02734849|11885990|FG001|COMPLETED|Overall Study||14
10722201|NCT02734849|11885991|FG002|COMPLETED|Overall Study||9
10722202|NCT02734849|11885989|FG000|NOT COMPLETED|Overall Study||4
10722203|NCT02734849|11885990|FG001|NOT COMPLETED|Overall Study||0
10722204|NCT02734849|11885991|FG002|NOT COMPLETED|Overall Study||1
10722205|NCT02734862|11886002|FG000|STARTED|Part A||35
10722206|NCT02734862|11886003|FG001|STARTED|Part A||36
10722207|NCT02734862|11886004|FG002|STARTED|Part A||36
10722208|NCT02734862|11886002|FG000|COMPLETED|Part A||23
10722209|NCT02734862|11886003|FG001|COMPLETED|Part A||28
10722210|NCT02734862|11886004|FG002|COMPLETED|Part A||22
10722211|NCT02734862|11886002|FG000|NOT COMPLETED|Part A||12
10722212|NCT02734862|11886003|FG001|NOT COMPLETED|Part A||8
10722213|NCT02734862|11886004|FG002|NOT COMPLETED|Part A||14
10404743|NCT00736125|11549106|FG000|COMPLETED|Overall Study||9
10722214|NCT02734862|11886002|FG000|STARTED|Part B||46
10722215|NCT02734862|11886003|FG001|STARTED|Part B||21
10722216|NCT02734862|11886004|FG002|STARTED|Part B||33
10404744|NCT00736125|11549107|FG001|COMPLETED|Overall Study||8
10722217|NCT02734862|11886002|FG000|COMPLETED|Part B||33
10404745|NCT00736125|11549106|FG000|NOT COMPLETED|Overall Study||1
10404746|NCT00736125|11549107|FG001|NOT COMPLETED|Overall Study||2
10404747|NCT00736190|11549113|FG000|STARTED|Overall Study||90
10404748|NCT00736190|11549113|FG000|COMPLETED|Overall Study||87
10404749|NCT00736190|11549113|FG000|NOT COMPLETED|Overall Study||3
10404750|NCT00736229|11549120|FG000|STARTED|Overall Study|Actively Enrolled|40
10404751|NCT00736229|11549121|FG001|STARTED|Overall Study|Historic control|71
10404752|NCT00736229|11549122|FG002|STARTED|Overall Study|Historic Control|84
10404753|NCT00736229|11549120|FG000|COMPLETED|Overall Study|All patients received bolus and fixed infusion of study drug, thus completed the study|40
10404754|NCT00736229|11549121|FG001|COMPLETED|Overall Study||71
10404755|NCT00736229|11549122|FG002|COMPLETED|Overall Study||84
10404756|NCT00736229|11549120|FG000|NOT COMPLETED|Overall Study||0
10404757|NCT00736229|11549121|FG001|NOT COMPLETED|Overall Study||0
10404758|NCT00736229|11549122|FG002|NOT COMPLETED|Overall Study||0
10404759|NCT00736242|11549131|FG000|STARTED|Overall Study||232
10404760|NCT00736242|11549131|FG000|Participants in Safety Analysis Set|Overall Study||229
10404761|NCT00736242|11549131|FG000|COMPLETED|Overall Study||107
10404762|NCT00736242|11549131|FG000|NOT COMPLETED|Overall Study||125
10404763|NCT00736255|11549137|FG000|STARTED|Overall Study||17
10404764|NCT00736255|11549138|FG001|STARTED|Overall Study||15
10404765|NCT00736255|11549137|FG000|COMPLETED|Overall Study||14
10404766|NCT00736255|11549138|FG001|COMPLETED|Overall Study||14
10404767|NCT00736255|11549137|FG000|NOT COMPLETED|Overall Study||3
10404768|NCT00736255|11549138|FG001|NOT COMPLETED|Overall Study||1
10404769|NCT00736333|11549144|FG000|STARTED|Overall Study||167
10404770|NCT00736333|11549144|FG000|COMPLETED|Overall Study||56
10404771|NCT00736333|11549144|FG000|NOT COMPLETED|Overall Study||111
10404772|NCT00736450|11549148|FG000|STARTED|Overall Study||37
10404773|NCT00736450|11549148|FG000|COMPLETED|Overall Study||12
10404774|NCT00736450|11549148|FG000|NOT COMPLETED|Overall Study||25
10404775|NCT00736476|11549154|FG000|STARTED|Overall Study||36
10404776|NCT00736476|11549155|FG001|STARTED|Overall Study||27
10404777|NCT00736476|11549154|FG000|COMPLETED|Overall Study||35
10404778|NCT00736476|11549155|FG001|COMPLETED|Overall Study||27
10404779|NCT00736476|11549154|FG000|NOT COMPLETED|Overall Study||1
10404780|NCT00736476|11549155|FG001|NOT COMPLETED|Overall Study||0
10404781|NCT00736489|11549167|FG000|STARTED|Period 1|Cross-over study|6
10404782|NCT00736489|11549168|FG001|STARTED|Period 1||5
10404783|NCT00736489|11549169|FG002|STARTED|Period 1||6
10404784|NCT00736489|11549170|FG003|STARTED|Period 1||7
10404785|NCT00736489|11549171|FG004|STARTED|Period 1||7
10404786|NCT00736489|11549172|FG005|STARTED|Period 1||6
10404787|NCT00736489|11549167|FG000|COMPLETED|Period 1||5
10404788|NCT00736489|11549168|FG001|COMPLETED|Period 1||5
10404789|NCT00736489|11549169|FG002|COMPLETED|Period 1||6
10404790|NCT00736489|11549170|FG003|COMPLETED|Period 1||7
10404791|NCT00736489|11549171|FG004|COMPLETED|Period 1||7
10404792|NCT00736489|11549172|FG005|COMPLETED|Period 1||5
10404793|NCT00736489|11549167|FG000|NOT COMPLETED|Period 1||1
10404794|NCT00736489|11549168|FG001|NOT COMPLETED|Period 1||0
10404795|NCT00736489|11549169|FG002|NOT COMPLETED|Period 1||0
10404796|NCT00736489|11549170|FG003|NOT COMPLETED|Period 1||0
10404797|NCT00736489|11549171|FG004|NOT COMPLETED|Period 1||0
10404798|NCT00736489|11549172|FG005|NOT COMPLETED|Period 1||1
10404799|NCT00736489|11549167|FG000|STARTED|Period 2||5
10404800|NCT00736489|11549168|FG001|STARTED|Period 2||5
10404801|NCT00736489|11549169|FG002|STARTED|Period 2||6
10404802|NCT00736489|11549170|FG003|STARTED|Period 2||7
10404803|NCT00736489|11549171|FG004|STARTED|Period 2||7
10404804|NCT00736489|11549172|FG005|STARTED|Period 2||5
10404805|NCT00736489|11549167|FG000|COMPLETED|Period 2||5
10404806|NCT00736489|11549168|FG001|COMPLETED|Period 2||5
10404807|NCT00736489|11549169|FG002|COMPLETED|Period 2||6
10404808|NCT00736489|11549170|FG003|COMPLETED|Period 2||7
10404809|NCT00736489|11549171|FG004|COMPLETED|Period 2||7
10404810|NCT00736489|11549172|FG005|COMPLETED|Period 2||5
10404811|NCT00736489|11549167|FG000|NOT COMPLETED|Period 2||0
10404812|NCT00736489|11549168|FG001|NOT COMPLETED|Period 2||0
10404813|NCT00736489|11549169|FG002|NOT COMPLETED|Period 2||0
10404814|NCT00736489|11549170|FG003|NOT COMPLETED|Period 2||0
10404815|NCT00736489|11549171|FG004|NOT COMPLETED|Period 2||0
10404816|NCT00736489|11549172|FG005|NOT COMPLETED|Period 2||0
10404817|NCT00736489|11549167|FG000|STARTED|Period 3||5
10404818|NCT00736489|11549168|FG001|STARTED|Period 3||5
10404819|NCT00736489|11549169|FG002|STARTED|Period 3||6
10404820|NCT00736489|11549170|FG003|STARTED|Period 3||7
10404821|NCT00736489|11549171|FG004|STARTED|Period 3||7
10404822|NCT00736489|11549172|FG005|STARTED|Period 3||5
10404823|NCT00736489|11549167|FG000|COMPLETED|Period 3||5
10404824|NCT00736489|11549168|FG001|COMPLETED|Period 3||5
10404825|NCT00736489|11549169|FG002|COMPLETED|Period 3||6
10404826|NCT00736489|11549170|FG003|COMPLETED|Period 3||7
10404827|NCT00736489|11549171|FG004|COMPLETED|Period 3||7
10404828|NCT00736489|11549172|FG005|COMPLETED|Period 3||5
10404829|NCT00736489|11549167|FG000|NOT COMPLETED|Period 3||0
10404830|NCT00736489|11549168|FG001|NOT COMPLETED|Period 3||0
10404831|NCT00736489|11549169|FG002|NOT COMPLETED|Period 3||0
10404832|NCT00736489|11549170|FG003|NOT COMPLETED|Period 3||0
10404833|NCT00736489|11549171|FG004|NOT COMPLETED|Period 3||0
10404834|NCT00736489|11549172|FG005|NOT COMPLETED|Period 3||0
10404835|NCT00736489|11549167|FG000|STARTED|Period 4||5
10404836|NCT00736489|11549168|FG001|STARTED|Period 4||5
10404837|NCT00736489|11549169|FG002|STARTED|Period 4||6
10404838|NCT00736489|11549170|FG003|STARTED|Period 4||7
10404839|NCT00736489|11549171|FG004|STARTED|Period 4||7
10404840|NCT00736489|11549172|FG005|STARTED|Period 4||5
10404841|NCT00736489|11549167|FG000|COMPLETED|Period 4||5
10404842|NCT00736489|11549168|FG001|COMPLETED|Period 4||5
10404843|NCT00736489|11549169|FG002|COMPLETED|Period 4||6
10404844|NCT00736489|11549170|FG003|COMPLETED|Period 4||7
10404845|NCT00736489|11549171|FG004|COMPLETED|Period 4||7
10404846|NCT00736489|11549172|FG005|COMPLETED|Period 4||5
10404847|NCT00736489|11549167|FG000|NOT COMPLETED|Period 4||0
10404848|NCT00736489|11549168|FG001|NOT COMPLETED|Period 4||0
10404849|NCT00736489|11549169|FG002|NOT COMPLETED|Period 4||0
10404850|NCT00736489|11549170|FG003|NOT COMPLETED|Period 4||0
10404851|NCT00736489|11549171|FG004|NOT COMPLETED|Period 4||0
10404852|NCT00736489|11549172|FG005|NOT COMPLETED|Period 4||0
10404853|NCT00736489|11549167|FG000|STARTED|Period 5||5
10404854|NCT00736489|11549168|FG001|STARTED|Period 5||5
10404855|NCT00736489|11549169|FG002|STARTED|Period 5||6
10404856|NCT00736489|11549170|FG003|STARTED|Period 5||7
10404857|NCT00736489|11549171|FG004|STARTED|Period 5||7
10404858|NCT00736489|11549172|FG005|STARTED|Period 5||5
10404859|NCT00736489|11549167|FG000|COMPLETED|Period 5||5
10722218|NCT02734862|11886003|FG001|COMPLETED|Part B||14
10722219|NCT02734862|11886004|FG002|COMPLETED|Part B||28
10722220|NCT02734862|11886002|FG000|NOT COMPLETED|Part B||13
10722221|NCT02734862|11886003|FG001|NOT COMPLETED|Part B||7
10722222|NCT02734862|11886004|FG002|NOT COMPLETED|Part B||5
10722223|NCT02734953|11886013|FG000|STARTED|Overall Study||10
10722224|NCT02734953|11886013|FG000|COMPLETED|Overall Study||10
10722225|NCT02734953|11886013|FG000|NOT COMPLETED|Overall Study||0
10722226|NCT02734979|11886017|FG000|STARTED|Overall Study||1
10722227|NCT02734979|11886017|FG000|COMPLETED|Overall Study||1
10722228|NCT02734979|11886017|FG000|NOT COMPLETED|Overall Study||0
10722229|NCT02735096|11886029|FG000|STARTED|Overall Study||4
10722230|NCT02735096|11886029|FG000|COMPLETED|Overall Study||3
10722231|NCT02735096|11886029|FG000|NOT COMPLETED|Overall Study||1
10404860|NCT00736489|11549168|FG001|COMPLETED|Period 5||5
10404861|NCT00736489|11549169|FG002|COMPLETED|Period 5||6
10722232|NCT02735174|11886033|FG000|STARTED|Overall Study||21
10722233|NCT02735174|11886033|FG000|COMPLETED|Overall Study||21
10722234|NCT02735174|11886033|FG000|NOT COMPLETED|Overall Study||0
10722235|NCT02735187|11886039|FG000|STARTED|Overall Study||25
10722236|NCT02735187|11886040|FG001|STARTED|Overall Study||26
10722237|NCT02735187|11886039|FG000|COMPLETED|Overall Study||21
10722238|NCT02735187|11886040|FG001|COMPLETED|Overall Study||25
10722239|NCT02735187|11886039|FG000|NOT COMPLETED|Overall Study||4
10722240|NCT02735187|11886040|FG001|NOT COMPLETED|Overall Study||1
10722241|NCT02735200|11886054|FG000|STARTED|Overall Study||200
10722242|NCT02735200|11886055|FG001|STARTED|Overall Study||350
10722243|NCT02735200|11886054|FG000|COMPLETED|Overall Study||192
10722244|NCT02735200|11886055|FG001|COMPLETED|Overall Study||345
10722245|NCT02735200|11886054|FG000|NOT COMPLETED|Overall Study||8
10722246|NCT02735200|11886055|FG001|NOT COMPLETED|Overall Study||5
10722247|NCT02735382|11886065|FG000|STARTED|Overall Study||7481
10722248|NCT02735382|11886066|FG001|STARTED|Overall Study||7155
10722249|NCT02735382|11886067|FG002|STARTED|Overall Study||184
10722250|NCT02735382|11886068|FG003|STARTED|Overall Study||110
10722251|NCT02735382|11886065|FG000|COMPLETED|Overall Study||7481
10722252|NCT02735382|11886066|FG001|COMPLETED|Overall Study||7155
10722253|NCT02735382|11886067|FG002|COMPLETED|Overall Study||184
10722254|NCT02735382|11886068|FG003|COMPLETED|Overall Study||110
10722255|NCT02735382|11886065|FG000|NOT COMPLETED|Overall Study||0
10722256|NCT02735382|11886066|FG001|NOT COMPLETED|Overall Study||0
10722257|NCT02735382|11886067|FG002|NOT COMPLETED|Overall Study||0
10722258|NCT02735382|11886068|FG003|NOT COMPLETED|Overall Study||0
10722262|NCT02735551|11886088|FG000|STARTED|Overall Study||3
10722263|NCT02735551|11886089|FG001|STARTED|Overall Study||0
10722264|NCT02735551|11886090|FG002|STARTED|Overall Study||0
10722265|NCT02735551|11886088|FG000|COMPLETED|Overall Study||3
10722266|NCT02735551|11886089|FG001|COMPLETED|Overall Study||0
10722267|NCT02735551|11886090|FG002|COMPLETED|Overall Study||0
10722268|NCT02735551|11886088|FG000|NOT COMPLETED|Overall Study||0
10722269|NCT02735551|11886089|FG001|NOT COMPLETED|Overall Study||0
10404862|NCT00736489|11549170|FG003|COMPLETED|Period 5||7
10404863|NCT00736489|11549171|FG004|COMPLETED|Period 5||7
10722270|NCT02735551|11886090|FG002|NOT COMPLETED|Overall Study||0
10722271|NCT02735577|11886098|FG000|STARTED|Disulfiram Treatment||7
10722272|NCT02735577|11886098|FG000|COMPLETED|Disulfiram Treatment||6
10404864|NCT00736489|11549172|FG005|COMPLETED|Period 5||5
10722273|NCT02735577|11886098|FG000|NOT COMPLETED|Disulfiram Treatment||1
10722274|NCT02735577|11886098|FG000|STARTED|Optional 28 Days of Disulfiram Treatment||6
10722275|NCT02735577|11886098|FG000|COMPLETED|Optional 28 Days of Disulfiram Treatment||4
10722276|NCT02735577|11886098|FG000|NOT COMPLETED|Optional 28 Days of Disulfiram Treatment||2
10722277|NCT02735642|11886104|FG000|STARTED|Overall Study||1046
10404865|NCT00736489|11549167|FG000|NOT COMPLETED|Period 5||0
10404866|NCT00736489|11549168|FG001|NOT COMPLETED|Period 5||0
10404867|NCT00736489|11549169|FG002|NOT COMPLETED|Period 5||0
10722278|NCT02735642|11886105|FG001|STARTED|Overall Study||152
10404868|NCT00736489|11549170|FG003|NOT COMPLETED|Period 5||0
10404869|NCT00736489|11549171|FG004|NOT COMPLETED|Period 5||0
10404870|NCT00736489|11549172|FG005|NOT COMPLETED|Period 5||0
10404871|NCT00736489|11549167|FG000|STARTED|Period 6||5
10404872|NCT00736489|11549168|FG001|STARTED|Period 6||5
10404873|NCT00736489|11549169|FG002|STARTED|Period 6||6
10722279|NCT02735642|11886104|FG000|COMPLETED|Overall Study||1046
10404874|NCT00736489|11549170|FG003|STARTED|Period 6||7
10404875|NCT00736489|11549171|FG004|STARTED|Period 6||7
10404876|NCT00736489|11549172|FG005|STARTED|Period 6||5
10404877|NCT00736489|11549167|FG000|COMPLETED|Period 6||5
10404878|NCT00736489|11549168|FG001|COMPLETED|Period 6||5
10404879|NCT00736489|11549169|FG002|COMPLETED|Period 6||6
10404880|NCT00736489|11549170|FG003|COMPLETED|Period 6||7
10404881|NCT00736489|11549171|FG004|COMPLETED|Period 6||7
10404882|NCT00736489|11549172|FG005|COMPLETED|Period 6||5
10404883|NCT00736489|11549167|FG000|NOT COMPLETED|Period 6||0
10404884|NCT00736489|11549168|FG001|NOT COMPLETED|Period 6||0
10404885|NCT00736489|11549169|FG002|NOT COMPLETED|Period 6||0
10404886|NCT00736489|11549170|FG003|NOT COMPLETED|Period 6||0
10404887|NCT00736489|11549171|FG004|NOT COMPLETED|Period 6||0
10404888|NCT00736489|11549172|FG005|NOT COMPLETED|Period 6||0
10404889|NCT00736502|11549186|FG000|STARTED|Overall Study|Entered and treated.|278
10404890|NCT00736502|11549186|FG000|COMPLETED|Overall Study||213
10404891|NCT00736502|11549186|FG000|NOT COMPLETED|Overall Study||65
10404892|NCT00736580|11549192|FG000|STARTED|Overall Study||117
10404893|NCT00736580|11549193|FG001|STARTED|Overall Study||123
10404894|NCT00736580|11549192|FG000|COMPLETED|Overall Study||117
10404895|NCT00736580|11549193|FG001|COMPLETED|Overall Study||123
10404896|NCT00736580|11549192|FG000|NOT COMPLETED|Overall Study||0
10404897|NCT00736580|11549193|FG001|NOT COMPLETED|Overall Study||0
10404898|NCT00736632|11549202|FG000|STARTED|Overall Study||44
10404899|NCT00736632|11549203|FG001|STARTED|Overall Study||50
10404900|NCT00736632|11549204|FG002|STARTED|Overall Study||31
10404901|NCT00736632|11549202|FG000|COMPLETED|Overall Study||44
10404902|NCT00736632|11549203|FG001|COMPLETED|Overall Study||50
10404903|NCT00736632|11549204|FG002|COMPLETED|Overall Study||31
10404904|NCT00736632|11549202|FG000|NOT COMPLETED|Overall Study||0
10404905|NCT00736632|11549203|FG001|NOT COMPLETED|Overall Study||0
10404906|NCT00736632|11549204|FG002|NOT COMPLETED|Overall Study||0
10404907|NCT00736645|11549214|FG000|STARTED|Overall Study||13
10404908|NCT00736645|11549215|FG001|STARTED|Overall Study||15
10404909|NCT00736645|11549216|FG002|STARTED|Overall Study||14
10404910|NCT00736645|11549217|FG003|STARTED|Overall Study||13
10404911|NCT00736645|11549214|FG000|COMPLETED|Overall Study||13
10404912|NCT00736645|11549215|FG001|COMPLETED|Overall Study||13
10404913|NCT00736645|11549216|FG002|COMPLETED|Overall Study||14
10404914|NCT00736645|11549217|FG003|COMPLETED|Overall Study||13
10404915|NCT00736645|11549214|FG000|NOT COMPLETED|Overall Study||0
10404916|NCT00736645|11549215|FG001|NOT COMPLETED|Overall Study||2
10404917|NCT00736645|11549216|FG002|NOT COMPLETED|Overall Study||0
10404918|NCT00736645|11549217|FG003|NOT COMPLETED|Overall Study||0
10404919|NCT00736723|11549229|FG000|STARTED|Overall Study||30
10404920|NCT00736723|11549230|FG001|STARTED|Overall Study||21
10404921|NCT00736723|11549229|FG000|COMPLETED|Overall Study||26
10404922|NCT00736723|11549230|FG001|COMPLETED|Overall Study||18
10404923|NCT00736723|11549229|FG000|NOT COMPLETED|Overall Study||4
10404924|NCT00736723|11549230|FG001|NOT COMPLETED|Overall Study||3
10404925|NCT00736840|11549236|FG000|STARTED|Overall Study||414
10404926|NCT00736840|11549236|FG000|COMPLETED|Overall Study|9 subjects-no biopsy results, 2-no breath test, 2 no biopsy results and no complete breath test|401
10404927|NCT00736840|11549236|FG000|NOT COMPLETED|Overall Study||13
10404928|NCT00736853|11549240|FG000|STARTED|Open-Label Period||319
10404929|NCT00736853|11549241|FG001|STARTED|Open-Label Period||0
10404930|NCT00736853|11549242|FG002|STARTED|Open-Label Period||0
10404931|NCT00736853|11549240|FG000|Treated|Open-Label Period||277
10404932|NCT00736853|11549241|FG001|Treated|Open-Label Period||0
10404933|NCT00736853|11549242|FG002|Treated|Open-Label Period||0
10404934|NCT00736853|11549240|FG000|COMPLETED|Open-Label Period||187
10404935|NCT00736853|11549241|FG001|COMPLETED|Open-Label Period||0
10722280|NCT02735642|11886105|FG001|COMPLETED|Overall Study||152
10722281|NCT02735642|11886104|FG000|NOT COMPLETED|Overall Study||0
10722282|NCT02735642|11886105|FG001|NOT COMPLETED|Overall Study||0
10722283|NCT02735915|11886115|FG000|STARTED|Overall Study||70
10722284|NCT02735915|11886115|FG000|Vaccinated|Overall Study||62
10722285|NCT02735915|11886115|FG000|COMPLETED|Overall Study||59
10722286|NCT02735915|11886115|FG000|NOT COMPLETED|Overall Study||11
10722287|NCT02735980|11886124|FG000|STARTED|Overall Study||58
10722288|NCT02735980|11886125|FG001|STARTED|Overall Study||60
10722289|NCT02735980|11886126|FG002|STARTED|Overall Study||15
10722290|NCT02735980|11886124|FG000|Received at Least 1 Dose of Study Drug|Overall Study||56
10722291|NCT02735980|11886125|FG001|Received at Least 1 Dose of Study Drug|Overall Study||60
10722292|NCT02735980|11886126|FG002|Received at Least 1 Dose of Study Drug|Overall Study||15
10722293|NCT02735980|11886124|FG000|COMPLETED|Overall Study||48
10722294|NCT02735980|11886125|FG001|COMPLETED|Overall Study||49
10722295|NCT02735980|11886126|FG002|COMPLETED|Overall Study||14
10722296|NCT02735980|11886124|FG000|NOT COMPLETED|Overall Study||10
10722297|NCT02735980|11886125|FG001|NOT COMPLETED|Overall Study||11
10722298|NCT02735980|11886126|FG002|NOT COMPLETED|Overall Study||1
10722299|NCT02736175|11886141|FG000|STARTED|Overall Study||216
10404936|NCT00736853|11549242|FG002|COMPLETED|Open-Label Period||0
10404937|NCT00736853|11549240|FG000|NOT COMPLETED|Open-Label Period||132
10404938|NCT00736853|11549241|FG001|NOT COMPLETED|Open-Label Period||0
10404939|NCT00736853|11549242|FG002|NOT COMPLETED|Open-Label Period||0
10404940|NCT00736853|11549240|FG000|STARTED|Double-Blind Period||0
10404941|NCT00736853|11549241|FG001|STARTED|Double-Blind Period||94
10404942|NCT00736853|11549242|FG002|STARTED|Double-Blind Period||93
10404943|NCT00736853|11549240|FG000|COMPLETED|Double-Blind Period||0
10404944|NCT00736853|11549241|FG001|COMPLETED|Double-Blind Period||70
10404945|NCT00736853|11549242|FG002|COMPLETED|Double-Blind Period||45
10404946|NCT00736853|11549240|FG000|NOT COMPLETED|Double-Blind Period||0
10404947|NCT00736853|11549241|FG001|NOT COMPLETED|Double-Blind Period||24
10404948|NCT00736853|11549242|FG002|NOT COMPLETED|Double-Blind Period||48
10404949|NCT00736879|11549255|FG000|STARTED|Double Blind Treatment Period||68
10404950|NCT00736879|11549256|FG001|STARTED|Double Blind Treatment Period||72
10404951|NCT00736879|11549257|FG002|STARTED|Double Blind Treatment Period||74
10404952|NCT00736879|11549258|FG003|STARTED|Double Blind Treatment Period||68
10404953|NCT00736879|11549255|FG000|COMPLETED|Double Blind Treatment Period||65
10404954|NCT00736879|11549256|FG001|COMPLETED|Double Blind Treatment Period||68
10404955|NCT00736879|11549257|FG002|COMPLETED|Double Blind Treatment Period||67
10404956|NCT00736879|11549258|FG003|COMPLETED|Double Blind Treatment Period||63
10404957|NCT00736879|11549255|FG000|NOT COMPLETED|Double Blind Treatment Period||3
10404958|NCT00736879|11549256|FG001|NOT COMPLETED|Double Blind Treatment Period||4
10404959|NCT00736879|11549257|FG002|NOT COMPLETED|Double Blind Treatment Period||7
10404960|NCT00736879|11549258|FG003|NOT COMPLETED|Double Blind Treatment Period||5
10722340|NCT02736825|11886201|FG001|NOT COMPLETED|Overall Study||12
10722341|NCT02736890|11886210|FG000|STARTED|First 12 Weeks||5
10404961|NCT00736879|11549255|FG000|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|66
10404962|NCT00736879|11549256|FG001|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|70
10404963|NCT00736879|11549257|FG002|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|66
10404964|NCT00736879|11549258|FG003|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|62
10404965|NCT00736879|11549255|FG000|COMPLETED|Follow up Period - No Drug Treatment||65
10404966|NCT00736879|11549256|FG001|COMPLETED|Follow up Period - No Drug Treatment||67
10404967|NCT00736879|11549257|FG002|COMPLETED|Follow up Period - No Drug Treatment||66
10404968|NCT00736879|11549258|FG003|COMPLETED|Follow up Period - No Drug Treatment||62
10404969|NCT00736879|11549255|FG000|NOT COMPLETED|Follow up Period - No Drug Treatment||1
10404970|NCT00736879|11549256|FG001|NOT COMPLETED|Follow up Period - No Drug Treatment||3
10404971|NCT00736879|11549257|FG002|NOT COMPLETED|Follow up Period - No Drug Treatment||0
10404972|NCT00736879|11549258|FG003|NOT COMPLETED|Follow up Period - No Drug Treatment||0
10404973|NCT00736944|11549271|FG000|STARTED|Induction||30
10404974|NCT00736944|11549271|FG000|COMPLETED|Induction||29
10404975|NCT00736944|11549271|FG000|NOT COMPLETED|Induction||1
10404976|NCT00736944|11549271|FG000|STARTED|Definitive Treatment||29
10404977|NCT00736944|11549271|FG000|COMPLETED|Definitive Treatment||28
10404978|NCT00736944|11549271|FG000|NOT COMPLETED|Definitive Treatment||1
10404979|NCT00736957|11549278|FG000|STARTED|Overall Study||219
10404980|NCT00736957|11549278|FG000|Treated|Overall Study||190
10404981|NCT00736957|11549278|FG000|COMPLETED|Overall Study||97
10404982|NCT00736957|11549278|FG000|NOT COMPLETED|Overall Study||122
10404983|NCT00736996|11549285|FG000|STARTED|Overall Study||25
10404984|NCT00736996|11549286|FG001|STARTED|Overall Study||26
10404985|NCT00736996|11549287|FG002|STARTED|Overall Study||27
10404986|NCT00736996|11549285|FG000|COMPLETED|Overall Study||24
10404987|NCT00736996|11549286|FG001|COMPLETED|Overall Study||17
10404988|NCT00736996|11549287|FG002|COMPLETED|Overall Study||25
10404989|NCT00736996|11549285|FG000|NOT COMPLETED|Overall Study||1
10404990|NCT00736996|11549286|FG001|NOT COMPLETED|Overall Study||9
10404991|NCT00736996|11549287|FG002|NOT COMPLETED|Overall Study||2
10404992|NCT00737048|11549298|FG000|STARTED|Overall Study||132
10404993|NCT00737048|11549299|FG001|STARTED|Overall Study||66
10404994|NCT00737048|11549300|FG002|STARTED|Overall Study||130
10404995|NCT00737048|11549298|FG000|COMPLETED|Overall Study||129
10404996|NCT00737048|11549299|FG001|COMPLETED|Overall Study||60
10404997|NCT00737048|11549300|FG002|COMPLETED|Overall Study||126
10404998|NCT00737048|11549298|FG000|NOT COMPLETED|Overall Study||3
10722300|NCT02736175|11886142|FG001|STARTED|Overall Study||222
10722301|NCT02736175|11886141|FG000|COMPLETED|Overall Study||214
10722302|NCT02736175|11886142|FG001|COMPLETED|Overall Study||221
10722303|NCT02736175|11886141|FG000|NOT COMPLETED|Overall Study||2
10722304|NCT02736175|11886142|FG001|NOT COMPLETED|Overall Study||1
10722305|NCT02736188|11886148|FG000|STARTED|Overall Study||142
10722306|NCT02736188|11886148|FG000|COMPLETED|Overall Study||0
10722307|NCT02736188|11886148|FG000|NOT COMPLETED|Overall Study||142
10722308|NCT02736409|11886158|FG000|STARTED|Overall Study||23
10722309|NCT02736409|11886159|FG001|STARTED|Overall Study||25
10722310|NCT02736409|11886160|FG002|STARTED|Overall Study||106
10722311|NCT02736409|11886161|FG003|STARTED|Overall Study||65
10722312|NCT02736409|11886158|FG000|COMPLETED|Overall Study||19
10722313|NCT02736409|11886159|FG001|COMPLETED|Overall Study||22
10722314|NCT02736409|11886160|FG002|COMPLETED|Overall Study||80
10722315|NCT02736409|11886161|FG003|COMPLETED|Overall Study||53
10722316|NCT02736409|11886158|FG000|NOT COMPLETED|Overall Study||4
10722317|NCT02736409|11886159|FG001|NOT COMPLETED|Overall Study||3
10722318|NCT02736409|11886160|FG002|NOT COMPLETED|Overall Study||26
10722319|NCT02736409|11886161|FG003|NOT COMPLETED|Overall Study||12
10722320|NCT02736474|11886174|FG000|STARTED|Overall Study||11
10722321|NCT02736474|11886175|FG001|STARTED|Overall Study||11
10722322|NCT02736474|11886174|FG000|COMPLETED|Overall Study||11
10404999|NCT00737048|11549299|FG001|NOT COMPLETED|Overall Study||6
10405000|NCT00737048|11549300|FG002|NOT COMPLETED|Overall Study||4
10405001|NCT00737061|11549308|FG000|STARTED|Waiting Period||645
10722323|NCT02736474|11886175|FG001|COMPLETED|Overall Study||10
10722324|NCT02736474|11886174|FG000|NOT COMPLETED|Overall Study||0
10722325|NCT02736474|11886175|FG001|NOT COMPLETED|Overall Study||1
10405002|NCT00737061|11549308|FG000|COMPLETED|Waiting Period||570
10405003|NCT00737061|11549308|FG000|NOT COMPLETED|Waiting Period||75
10405004|NCT00737061|11549308|FG000|STARTED|1 Year Wearing Period||570
10405005|NCT00737061|11549308|FG000|COMPLETED|1 Year Wearing Period||553
10405006|NCT00737061|11549308|FG000|NOT COMPLETED|1 Year Wearing Period||17
10722326|NCT02736578|11886183|FG000|STARTED|Overall Study||6
10722327|NCT02736578|11886184|FG001|STARTED|Overall Study||2
10722328|NCT02736578|11886183|FG000|COMPLETED|Overall Study||5
10722329|NCT02736578|11886184|FG001|COMPLETED|Overall Study||2
10722330|NCT02736578|11886183|FG000|NOT COMPLETED|Overall Study||1
10722331|NCT02736578|11886184|FG001|NOT COMPLETED|Overall Study||0
10722332|NCT02736721|11886194|FG000|STARTED|Overall Study||41
10722333|NCT02736721|11886194|FG000|COMPLETED|Overall Study||25
10722334|NCT02736721|11886194|FG000|NOT COMPLETED|Overall Study||16
10722335|NCT02736825|11886200|FG000|STARTED|Overall Study||127
10722336|NCT02736825|11886201|FG001|STARTED|Overall Study||135
10722337|NCT02736825|11886200|FG000|COMPLETED|Overall Study||117
10722338|NCT02736825|11886201|FG001|COMPLETED|Overall Study||123
10722339|NCT02736825|11886200|FG000|NOT COMPLETED|Overall Study||10
10722342|NCT02736890|11886211|FG001|STARTED|First 12 Weeks||3
10722343|NCT02736890|11886210|FG000|COMPLETED|First 12 Weeks||5
10722344|NCT02736890|11886211|FG001|COMPLETED|First 12 Weeks||3
10722345|NCT02736890|11886210|FG000|NOT COMPLETED|First 12 Weeks||0
10722346|NCT02736890|11886211|FG001|NOT COMPLETED|First 12 Weeks||0
10722347|NCT02736890|11886210|FG000|STARTED|Crossover Next 12 Weeks||5
10722348|NCT02736890|11886211|FG001|STARTED|Crossover Next 12 Weeks||3
10722349|NCT02736890|11886210|FG000|COMPLETED|Crossover Next 12 Weeks||3
10722350|NCT02736890|11886211|FG001|COMPLETED|Crossover Next 12 Weeks||1
10722351|NCT02736890|11886210|FG000|NOT COMPLETED|Crossover Next 12 Weeks||2
10722352|NCT02736890|11886211|FG001|NOT COMPLETED|Crossover Next 12 Weeks||2
10722353|NCT02736955|11886220|FG000|STARTED|Overall Study||36
10722354|NCT02736955|11886221|FG001|STARTED|Overall Study||117
10722355|NCT02736955|11886222|FG002|STARTED|Overall Study||8
10722356|NCT02736955|11886220|FG000|COMPLETED|Overall Study||29
10722357|NCT02736955|11886221|FG001|COMPLETED|Overall Study||103
10722358|NCT02736955|11886222|FG002|COMPLETED|Overall Study||6
10722359|NCT02736955|11886220|FG000|NOT COMPLETED|Overall Study||7
10722360|NCT02736955|11886221|FG001|NOT COMPLETED|Overall Study||14
10722361|NCT02736955|11886222|FG002|NOT COMPLETED|Overall Study||2
10722362|NCT02737072|11886234|FG000|STARTED|Overall Study||3
10722363|NCT02737072|11886235|FG001|STARTED|Overall Study||3
10722364|NCT02737072|11886236|FG002|STARTED|Overall Study||3
10722365|NCT02737072|11886234|FG000|Received at Least One Dose of Drug|Overall Study||3
10722366|NCT02737072|11886235|FG001|Received at Least One Dose of Drug|Overall Study||3
10722367|NCT02737072|11886236|FG002|Received at Least One Dose of Drug|Overall Study||3
10722368|NCT02737072|11886234|FG000|COMPLETED|Overall Study||3
10722369|NCT02737072|11886235|FG001|COMPLETED|Overall Study||3
10722370|NCT02737072|11886236|FG002|COMPLETED|Overall Study||3
10722371|NCT02737072|11886234|FG000|NOT COMPLETED|Overall Study||0
10722372|NCT02737072|11886235|FG001|NOT COMPLETED|Overall Study||0
10722373|NCT02737072|11886236|FG002|NOT COMPLETED|Overall Study||0
10722374|NCT02737163|11886248|FG000|STARTED|Overall Study|114 encounter assessments were completed on 95 participants over 15 months|95
10722375|NCT02737163|11886248|FG000|COMPLETED|Overall Study||95
10722376|NCT02737163|11886248|FG000|NOT COMPLETED|Overall Study||0
10722377|NCT02737332|11886254|FG000|STARTED|Overall Study||29
10722378|NCT02737332|11886255|FG001|STARTED|Overall Study||24
10722379|NCT02737332|11886254|FG000|COMPLETED|Overall Study||28
10722380|NCT02737332|11886255|FG001|COMPLETED|Overall Study||23
10722381|NCT02737332|11886254|FG000|NOT COMPLETED|Overall Study||1
10722382|NCT02737332|11886255|FG001|NOT COMPLETED|Overall Study||1
10722383|NCT02737358|11886265|FG000|STARTED|Overall Study||55
10722384|NCT02737358|11886266|FG001|STARTED|Overall Study||59
10722385|NCT02737358|11886265|FG000|COMPLETED|Overall Study||46
10722386|NCT02737358|11886266|FG001|COMPLETED|Overall Study||44
10405007|NCT00737100|11549315|FG000|STARTED|Overall Study||168
10405008|NCT00737100|11549316|FG001|STARTED|Overall Study||166
10405009|NCT00737100|11549317|FG002|STARTED|Overall Study||176
10405010|NCT00737100|11549315|FG000|COMPLETED|Overall Study||161
10405011|NCT00737100|11549316|FG001|COMPLETED|Overall Study||159
10405012|NCT00737100|11549317|FG002|COMPLETED|Overall Study||169
10405013|NCT00737100|11549315|FG000|NOT COMPLETED|Overall Study||7
10405014|NCT00737100|11549316|FG001|NOT COMPLETED|Overall Study||7
10405015|NCT00737100|11549317|FG002|NOT COMPLETED|Overall Study||7
10405016|NCT00737178|11549329|FG000|STARTED|Overall Study||71
10405017|NCT00737178|11549330|FG001|STARTED|Overall Study||85
10405018|NCT00737178|11549329|FG000|COMPLETED|Overall Study||66
10405019|NCT00737178|11549330|FG001|COMPLETED|Overall Study||76
10405020|NCT00737178|11549329|FG000|NOT COMPLETED|Overall Study||5
10405021|NCT00737178|11549330|FG001|NOT COMPLETED|Overall Study||9
10722387|NCT02737358|11886265|FG000|NOT COMPLETED|Overall Study||9
10405022|NCT00737204|11549338|FG000|STARTED|Overall Study||36
10405023|NCT00737204|11549339|FG001|STARTED|Overall Study||34
10405024|NCT00737204|11549338|FG000|COMPLETED|Overall Study||36
10405025|NCT00737204|11549339|FG001|COMPLETED|Overall Study||28
10405026|NCT00737204|11549338|FG000|NOT COMPLETED|Overall Study||0
10722388|NCT02737358|11886266|FG001|NOT COMPLETED|Overall Study||15
10722389|NCT02737397|11886272|FG000|STARTED|Overall Study||13
10722390|NCT02737397|11886272|FG000|JMI-001|Overall Study||13
10722391|NCT02737397|11886272|FG000|SJP-304|Overall Study||12
10405027|NCT00737204|11549339|FG001|NOT COMPLETED|Overall Study||6
10405028|NCT00737243|11549345|FG000|STARTED|Overall Study||289
10405029|NCT00737243|11549345|FG000|Successful Assay Performed|Overall Study||252
10405030|NCT00737243|11549345|FG000|Insufficient Tissue for Assay, Withdrawn|Overall Study||37
10405031|NCT00737243|11549345|FG000|Treated|Overall Study||223
10405032|NCT00737243|11549345|FG000|Not Treated|Overall Study|16 pts no longer met eligibility criteria; 13 came off study due to physician or pt preference.|29
10405033|NCT00737243|11549345|FG000|Site Specific Therapy More Responsive|Overall Study||115
10405034|NCT00737243|11549345|FG000|Site Specific Therapy Less Responsive|Overall Study||79
10405035|NCT00737243|11549345|FG000|Empiric CUP Therapy|Overall Study||29
10405036|NCT00737243|11549345|FG000|COMPLETED|Overall Study||194
10405037|NCT00737243|11549345|FG000|NOT COMPLETED|Overall Study||95
10405038|NCT00737360|11549351|FG000|STARTED|Overall Study||27
10405039|NCT00737360|11549351|FG000|COMPLETED|Overall Study||27
10405040|NCT00737360|11549351|FG000|NOT COMPLETED|Overall Study||0
10405041|NCT00737438|11549355|FG000|STARTED|Overall Study||23
10405042|NCT00737438|11549355|FG000|COMPLETED|Overall Study||20
10405043|NCT00737438|11549355|FG000|NOT COMPLETED|Overall Study||3
10405044|NCT00737464|11549359|FG000|STARTED|Overall Study||132
10405045|NCT00737464|11549359|FG000|COMPLETED|Overall Study||114
10405046|NCT00737464|11549359|FG000|NOT COMPLETED|Overall Study||18
10405047|NCT00737477|11549363|FG000|STARTED|Overall Study||96
10405048|NCT00737477|11549363|FG000|COMPLETED|Overall Study||62
10405049|NCT00737477|11549363|FG000|NOT COMPLETED|Overall Study||34
10405050|NCT00737529|11549367|FG000|STARTED|Overall Study||134
10405051|NCT00737529|11549367|FG000|COMPLETED|Overall Study|Completed equals participants ongoing on treatment at the time of the data cut-off of 30 March 2017|1
10405052|NCT00737529|11549367|FG000|NOT COMPLETED|Overall Study||133
10405053|NCT00737568|11549373|FG000|STARTED|Treatment Period Through Week 240||141
10405054|NCT00737568|11549374|FG001|STARTED|Treatment Period Through Week 240||139
10405055|NCT00737568|11549373|FG000|COMPLETED|Treatment Period Through Week 240||121
10405056|NCT00737568|11549374|FG001|COMPLETED|Treatment Period Through Week 240||118
10405057|NCT00737568|11549373|FG000|NOT COMPLETED|Treatment Period Through Week 240||20
10405058|NCT00737568|11549374|FG001|NOT COMPLETED|Treatment Period Through Week 240||21
10405059|NCT00737568|11549373|FG000|STARTED|Treatment-Free Follow-up (TFFU) Period|1 participant not completing the 240 week treatment period enrolled in the TFFU period.|38
10405060|NCT00737568|11549374|FG001|STARTED|Treatment-Free Follow-up (TFFU) Period|4 participants not completing the 240 week treatment period enrolled in the TFFU period.|37
10405061|NCT00737568|11549373|FG000|COMPLETED|Treatment-Free Follow-up (TFFU) Period||12
10405062|NCT00737568|11549374|FG001|COMPLETED|Treatment-Free Follow-up (TFFU) Period||19
10405063|NCT00737568|11549373|FG000|NOT COMPLETED|Treatment-Free Follow-up (TFFU) Period||26
10405064|NCT00737568|11549374|FG001|NOT COMPLETED|Treatment-Free Follow-up (TFFU) Period||18
10405065|NCT00737633|11549382|FG000|STARTED|Overall Study||44
10405066|NCT00737633|11549383|FG001|STARTED|Overall Study||57
10405067|NCT00737633|11549382|FG000|COMPLETED|Overall Study||0
10405068|NCT00737633|11549383|FG001|COMPLETED|Overall Study||0
10405069|NCT00737633|11549382|FG000|NOT COMPLETED|Overall Study||44
10405070|NCT00737633|11549383|FG001|NOT COMPLETED|Overall Study||57
10429006|NCT00862641|11575208|FG001|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|356
10429007|NCT00862641|11575209|FG002|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|151
10429008|NCT00862641|11575210|FG003|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|316
10429009|NCT00862641|11575207|FG000|NOT COMPLETED|Overall Study||1
10429010|NCT00862641|11575208|FG001|NOT COMPLETED|Overall Study||4
10429011|NCT00862641|11575209|FG002|NOT COMPLETED|Overall Study||1
10429012|NCT00862641|11575210|FG003|NOT COMPLETED|Overall Study||4
10429013|NCT00862654|11575224|FG000|STARTED|Overall Study||82
10429014|NCT00862654|11575225|FG001|STARTED|Overall Study||82
10429015|NCT00862654|11575226|FG002|STARTED|Overall Study||82
10429016|NCT00862654|11575227|FG003|STARTED|Overall Study||80
10429017|NCT00862654|11575224|FG000|COMPLETED|Overall Study||76
10429018|NCT00862654|11575225|FG001|COMPLETED|Overall Study||74
10429019|NCT00862654|11575226|FG002|COMPLETED|Overall Study||76
10429020|NCT00862654|11575227|FG003|COMPLETED|Overall Study||74
10429021|NCT00862654|11575224|FG000|NOT COMPLETED|Overall Study||6
10429022|NCT00862654|11575225|FG001|NOT COMPLETED|Overall Study||8
10429023|NCT00862654|11575226|FG002|NOT COMPLETED|Overall Study||6
10429024|NCT00862654|11575227|FG003|NOT COMPLETED|Overall Study||6
10429025|NCT00862719|11575241|FG000|STARTED|Overall Study||17
10429026|NCT00862719|11575242|FG001|STARTED|Overall Study||7
10429027|NCT00862719|11575243|FG002|STARTED|Overall Study||4
10429028|NCT00862719|11575244|FG003|STARTED|Overall Study||1
10429029|NCT00862719|11575241|FG000|COMPLETED|Overall Study||7
10429030|NCT00862719|11575242|FG001|COMPLETED|Overall Study||1
10429031|NCT00862719|11575243|FG002|COMPLETED|Overall Study||0
10429032|NCT00862719|11575244|FG003|COMPLETED|Overall Study||0
10429033|NCT00862719|11575241|FG000|NOT COMPLETED|Overall Study||10
10429034|NCT00862719|11575242|FG001|NOT COMPLETED|Overall Study||6
10429035|NCT00862719|11575243|FG002|NOT COMPLETED|Overall Study||4
10429036|NCT00862719|11575244|FG003|NOT COMPLETED|Overall Study||1
10429037|NCT00862745|11575256|FG000|STARTED|Randomized Control Trial||322
10429038|NCT00862745|11575257|FG001|STARTED|Randomized Control Trial||323
10429039|NCT00862745|11575256|FG000|COMPLETED|Randomized Control Trial||284
10429040|NCT00862745|11575257|FG001|COMPLETED|Randomized Control Trial||284
10429041|NCT00862745|11575256|FG000|NOT COMPLETED|Randomized Control Trial||38
10429042|NCT00862745|11575257|FG001|NOT COMPLETED|Randomized Control Trial||39
10405071|NCT00737672|11549391|FG000|STARTED|Overall Study||145
10405072|NCT00737672|11549392|FG001|STARTED|Overall Study||148
10405073|NCT00737672|11549391|FG000|Exclusions Due to Protocol Deviations|Overall Study||14
10405074|NCT00737672|11549392|FG001|Exclusions Due to Protocol Deviations|Overall Study||10
10405075|NCT00737672|11549391|FG000|Per Protocol Population|Overall Study||131
10405076|NCT00737672|11549392|FG001|Per Protocol Population|Overall Study||138
10405077|NCT00737672|11549391|FG000|COMPLETED|Overall Study||65
10405078|NCT00737672|11549392|FG001|COMPLETED|Overall Study||65
10544315|NCT01490125|11697558|FG005|COMPLETED|Period III||35
10544316|NCT01490125|11697553|FG000|NOT COMPLETED|Period III||3
10544317|NCT01490125|11697554|FG001|NOT COMPLETED|Period III||1
10544318|NCT01490125|11697555|FG002|NOT COMPLETED|Period III||0
10544319|NCT01490125|11697556|FG003|NOT COMPLETED|Period III||2
10544320|NCT01490125|11697557|FG004|NOT COMPLETED|Period III||1
10544321|NCT01490125|11697558|FG005|NOT COMPLETED|Period III||0
10544322|NCT01490151|11697566|FG000|STARTED|Overall Study||22
10544323|NCT01490151|11697566|FG000|COMPLETED|Overall Study||22
10544324|NCT01490151|11697566|FG000|NOT COMPLETED|Overall Study||0
10544325|NCT01490294|11697576|FG000|STARTED|Overall Study||58
10544326|NCT01490294|11697577|FG001|STARTED|Overall Study||60
10722392|NCT02737397|11886272|FG000|SJP-223|Overall Study||13
10722393|NCT02737397|11886272|FG000|Placebo|Overall Study||13
10722394|NCT02737397|11886272|FG000|COMPLETED|Overall Study||13
10722395|NCT02737397|11886272|FG000|NOT COMPLETED|Overall Study||0
10722396|NCT02737501|11886284|FG000|STARTED|Randomized Phase||137
10722397|NCT02737501|11886285|FG001|STARTED|Randomized Phase||138
10722398|NCT02737501|11886286|FG002|STARTED|Randomized Phase||0
10722399|NCT02737501|11886284|FG000|Safety Analysis Set|Randomized Phase||136
10722400|NCT02737501|11886285|FG001|Safety Analysis Set|Randomized Phase||137
10722401|NCT02737501|11886286|FG002|Safety Analysis Set|Randomized Phase||0
10722402|NCT02737501|11886284|FG000|COMPLETED|Randomized Phase||20
10722403|NCT02737501|11886285|FG001|COMPLETED|Randomized Phase||84
10722404|NCT02737501|11886286|FG002|COMPLETED|Randomized Phase||0
10722405|NCT02737501|11886284|FG000|NOT COMPLETED|Randomized Phase||117
10722406|NCT02737501|11886285|FG001|NOT COMPLETED|Randomized Phase||54
10722407|NCT02737501|11886286|FG002|NOT COMPLETED|Randomized Phase||0
10722408|NCT02737501|11886284|FG000|STARTED|Crossover Phase||0
10722409|NCT02737501|11886285|FG001|STARTED|Crossover Phase||0
10722410|NCT02737501|11886286|FG002|STARTED|Crossover Phase||65
10722411|NCT02737501|11886284|FG000|COMPLETED|Crossover Phase||0
10722412|NCT02737501|11886285|FG001|COMPLETED|Crossover Phase||0
10722413|NCT02737501|11886286|FG002|COMPLETED|Crossover Phase||10
10722414|NCT02737501|11886284|FG000|NOT COMPLETED|Crossover Phase||0
10722415|NCT02737501|11886285|FG001|NOT COMPLETED|Crossover Phase||0
10722416|NCT02737501|11886286|FG002|NOT COMPLETED|Crossover Phase||55
10722417|NCT02737592|11886294|FG000|STARTED|Overall Study||34
10722418|NCT02737592|11886294|FG000|COMPLETED|Overall Study||33
10722419|NCT02737592|11886294|FG000|NOT COMPLETED|Overall Study||1
10722420|NCT02737618|11886298|FG000|STARTED|Overall Study||43
10722421|NCT02737618|11886298|FG000|COMPLETED|Overall Study||34
10722422|NCT02737618|11886298|FG000|NOT COMPLETED|Overall Study||9
10722423|NCT02737631|11886302|FG000|STARTED|Overall Study||222
10722424|NCT02737631|11886302|FG000|COMPLETED|Overall Study||222
10722425|NCT02737631|11886302|FG000|NOT COMPLETED|Overall Study||0
10777384|NCT03339726|11939359|FG000|STARTED|Overall Study||64
10777385|NCT03339726|11939360|FG001|STARTED|Overall Study||66
10777386|NCT03339726|11939361|FG002|STARTED|Overall Study||63
10777387|NCT03339726|11939359|FG000|COMPLETED|Overall Study||63
10777388|NCT03339726|11939360|FG001|COMPLETED|Overall Study||65
10777389|NCT03339726|11939361|FG002|COMPLETED|Overall Study||63
10777390|NCT03339726|11939359|FG000|NOT COMPLETED|Overall Study||1
10777391|NCT03339726|11939360|FG001|NOT COMPLETED|Overall Study||1
10777392|NCT03339726|11939361|FG002|NOT COMPLETED|Overall Study||0
10777393|NCT03339999|11939373|FG000|STARTED|Overall Study||7
10777394|NCT03339999|11939374|FG001|STARTED|Overall Study||6
10777395|NCT03339999|11939375|FG002|STARTED|Overall Study||6
10777396|NCT03339999|11939376|FG003|STARTED|Overall Study||5
10777397|NCT03339999|11939373|FG000|Modified Intent-to-Treat Population|Overall Study||7
10777398|NCT03339999|11939374|FG001|Modified Intent-to-Treat Population|Overall Study||6
10777399|NCT03339999|11939375|FG002|Modified Intent-to-Treat Population|Overall Study||5
10777400|NCT03339999|11939376|FG003|Modified Intent-to-Treat Population|Overall Study||4
10777401|NCT03339999|11939373|FG000|Safety Population: Received Treatment|Overall Study||7
10777402|NCT03339999|11939374|FG001|Safety Population: Received Treatment|Overall Study||6
10777403|NCT03339999|11939375|FG002|Safety Population: Received Treatment|Overall Study||6
10405079|NCT00737672|11549391|FG000|NOT COMPLETED|Overall Study||80
10405080|NCT00737672|11549392|FG001|NOT COMPLETED|Overall Study||83
10405081|NCT00737698|11549401|FG000|STARTED|Overall Study||23
10405082|NCT00737698|11549402|FG001|STARTED|Overall Study||42
10544327|NCT01490294|11697578|FG002|STARTED|Overall Study||59
10544328|NCT01490294|11697579|FG003|STARTED|Overall Study||55
10544329|NCT01490294|11697576|FG000|Participant Received Treatment|Overall Study||54
10777404|NCT03339999|11939376|FG003|Safety Population: Received Treatment|Overall Study||4
10777405|NCT03339999|11939373|FG000|COMPLETED|Overall Study||0
10777406|NCT03339999|11939374|FG001|COMPLETED|Overall Study||0
10777407|NCT03339999|11939375|FG002|COMPLETED|Overall Study||0
10777408|NCT03339999|11939376|FG003|COMPLETED|Overall Study||0
10777409|NCT03339999|11939373|FG000|NOT COMPLETED|Overall Study||7
10777410|NCT03339999|11939374|FG001|NOT COMPLETED|Overall Study||6
10777411|NCT03339999|11939375|FG002|NOT COMPLETED|Overall Study||6
10405083|NCT00737698|11549403|FG002|STARTED|Overall Study||21
10405084|NCT00737698|11549401|FG000|COMPLETED|Overall Study||17
10405085|NCT00737698|11549402|FG001|COMPLETED|Overall Study||37
10405086|NCT00737698|11549403|FG002|COMPLETED|Overall Study||17
10405087|NCT00737698|11549401|FG000|NOT COMPLETED|Overall Study||6
10405088|NCT00737698|11549402|FG001|NOT COMPLETED|Overall Study||5
10405089|NCT00737698|11549403|FG002|NOT COMPLETED|Overall Study||4
10405090|NCT00737711|11549411|FG000|STARTED|Overall Study||189
10405091|NCT00737711|11549411|FG000|COMPLETED|Overall Study||158
10405092|NCT00737711|11549411|FG000|NOT COMPLETED|Overall Study||31
10405093|NCT00737737|11549417|FG000|STARTED|Overall Study||2
10814429|NCT02365207|11977154|FG000|NOT COMPLETED|Overall Study||2
10814430|NCT02360111|11977158|FG000|STARTED|Overall Study||3
10814431|NCT02360111|11977158|FG000|COMPLETED|Overall Study||1
10814432|NCT02360111|11977158|FG000|NOT COMPLETED|Overall Study||2
10814433|NCT02353468|11977162|FG000|STARTED|Overall Study||3
10814434|NCT02353468|11977162|FG000|COMPLETED|Overall Study||0
10814435|NCT02353468|11977162|FG000|NOT COMPLETED|Overall Study||3
10544330|NCT01490294|11697577|FG001|Participant Received Treatment|Overall Study||60
10814436|NCT02360059|11977168|FG000|STARTED|Overall Study||1
10405094|NCT00737737|11549418|FG001|STARTED|Overall Study||2
10405095|NCT00737737|11549417|FG000|COMPLETED|Overall Study||2
10405096|NCT00737737|11549418|FG001|COMPLETED|Overall Study||2
10405097|NCT00737737|11549417|FG000|NOT COMPLETED|Overall Study||0
10405098|NCT00737737|11549418|FG001|NOT COMPLETED|Overall Study||0
10405099|NCT00737893|11549426|FG000|STARTED|Overall Study||29
10405100|NCT00737893|11549427|FG001|STARTED|Overall Study||27
10405101|NCT00737893|11549426|FG000|COMPLETED|Overall Study||29
10405102|NCT00737893|11549427|FG001|COMPLETED|Overall Study||27
10405103|NCT00737893|11549426|FG000|NOT COMPLETED|Overall Study||0
10405104|NCT00737893|11549427|FG001|NOT COMPLETED|Overall Study||0
10405105|NCT00738023|11549435|FG000|STARTED|Intralipid Infusion||19
10405106|NCT00738023|11549436|FG001|STARTED|Intralipid Infusion||13
10405107|NCT00738023|11549435|FG000|COMPLETED|Intralipid Infusion||19
10405108|NCT00738023|11549436|FG001|COMPLETED|Intralipid Infusion||13
10405109|NCT00738023|11549435|FG000|NOT COMPLETED|Intralipid Infusion||0
10405110|NCT00738023|11549436|FG001|NOT COMPLETED|Intralipid Infusion||0
10405111|NCT00738023|11549435|FG000|STARTED|Saline Infusion||19
10405112|NCT00738023|11549436|FG001|STARTED|Saline Infusion||0
10405113|NCT00738023|11549435|FG000|COMPLETED|Saline Infusion||19
10405114|NCT00738023|11549436|FG001|COMPLETED|Saline Infusion||0
10405115|NCT00738023|11549435|FG000|NOT COMPLETED|Saline Infusion||0
10405116|NCT00738023|11549436|FG001|NOT COMPLETED|Saline Infusion||0
10405117|NCT00738023|11549435|FG000|STARTED|Intralipid Infusion (Post 6 Wks of Drug)||19
10405118|NCT00738023|11549436|FG001|STARTED|Intralipid Infusion (Post 6 Wks of Drug)||0
10405119|NCT00738023|11549435|FG000|COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||19
10405120|NCT00738023|11549436|FG001|COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
10405121|NCT00738023|11549435|FG000|NOT COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
10405122|NCT00738023|11549436|FG001|NOT COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
10405123|NCT00738049|11549445|FG000|STARTED|1st Intervention(14 Days)||13
10405124|NCT00738049|11549446|FG001|STARTED|1st Intervention(14 Days)||7
10405125|NCT00738049|11549445|FG000|COMPLETED|1st Intervention(14 Days)||13
10405126|NCT00738049|11549446|FG001|COMPLETED|1st Intervention(14 Days)||7
10405127|NCT00738049|11549445|FG000|NOT COMPLETED|1st Intervention(14 Days)||0
10405128|NCT00738049|11549446|FG001|NOT COMPLETED|1st Intervention(14 Days)||0
10405129|NCT00738049|11549445|FG000|STARTED|2nd Intervention(14 Days)||13
10405130|NCT00738049|11549446|FG001|STARTED|2nd Intervention(14 Days)||7
10405131|NCT00738049|11549445|FG000|COMPLETED|2nd Intervention(14 Days)||13
10405132|NCT00738049|11549446|FG001|COMPLETED|2nd Intervention(14 Days)||7
10405133|NCT00738049|11549445|FG000|NOT COMPLETED|2nd Intervention(14 Days)||0
10405134|NCT00738049|11549446|FG001|NOT COMPLETED|2nd Intervention(14 Days)||0
10405135|NCT00738049|11549445|FG000|STARTED|Washout||13
10405136|NCT00738049|11549446|FG001|STARTED|Washout||7
10405137|NCT00738049|11549445|FG000|COMPLETED|Washout||13
10405138|NCT00738049|11549446|FG001|COMPLETED|Washout||7
10405139|NCT00738049|11549445|FG000|NOT COMPLETED|Washout||0
10405140|NCT00738049|11549446|FG001|NOT COMPLETED|Washout||0
10405141|NCT00738062|11549461|FG000|STARTED|Open Label Treatment||103
10405142|NCT00738062|11549462|FG001|STARTED|Open Label Treatment||0
10405143|NCT00738062|11549463|FG002|STARTED|Open Label Treatment||0
10405144|NCT00738062|11549461|FG000|COMPLETED|Open Label Treatment||75
10405145|NCT00738062|11549462|FG001|COMPLETED|Open Label Treatment||0
10814437|NCT02360059|11977169|FG001|STARTED|Overall Study||0
10405146|NCT00738062|11549463|FG002|COMPLETED|Open Label Treatment||0
10405147|NCT00738062|11549461|FG000|NOT COMPLETED|Open Label Treatment||28
10405148|NCT00738062|11549462|FG001|NOT COMPLETED|Open Label Treatment||0
10405149|NCT00738062|11549463|FG002|NOT COMPLETED|Open Label Treatment||0
10405150|NCT00738062|11549461|FG000|STARTED|2 Week Randomized Withdrawal|Patients completing the open label titration phase were randomized to either Droxidopa or Placebo|0
10405151|NCT00738062|11549462|FG001|STARTED|2 Week Randomized Withdrawal||38
10405152|NCT00738062|11549463|FG002|STARTED|2 Week Randomized Withdrawal||37
10405153|NCT00738062|11549461|FG000|COMPLETED|2 Week Randomized Withdrawal||0
10405154|NCT00738062|11549462|FG001|COMPLETED|2 Week Randomized Withdrawal||38
10405155|NCT00738062|11549463|FG002|COMPLETED|2 Week Randomized Withdrawal||37
10405156|NCT00738062|11549461|FG000|NOT COMPLETED|2 Week Randomized Withdrawal||0
10722426|NCT04865354|11886308|FG000|STARTED|First Wear Period (8 Days)||83
10722427|NCT04865354|11886309|FG001|STARTED|First Wear Period (8 Days)||84
10722428|NCT04865354|11886308|FG000|COMPLETED|First Wear Period (8 Days)||82
10722429|NCT04865354|11886309|FG001|COMPLETED|First Wear Period (8 Days)||83
10722430|NCT04865354|11886308|FG000|NOT COMPLETED|First Wear Period (8 Days)||1
10722431|NCT04865354|11886309|FG001|NOT COMPLETED|First Wear Period (8 Days)||1
10722432|NCT04865354|11886308|FG000|STARTED|Second Wear Period (8 Days)||82
10722433|NCT04865354|11886309|FG001|STARTED|Second Wear Period (8 Days)||83
10722434|NCT04865354|11886308|FG000|COMPLETED|Second Wear Period (8 Days)||81
10722435|NCT04865354|11886309|FG001|COMPLETED|Second Wear Period (8 Days)||83
10722436|NCT04865354|11886308|FG000|NOT COMPLETED|Second Wear Period (8 Days)||1
10722437|NCT04865354|11886309|FG001|NOT COMPLETED|Second Wear Period (8 Days)||0
10722438|NCT04658888|11886320|FG000|STARTED|Overall Study||333
10722439|NCT04658888|11886321|FG001|STARTED|Overall Study||631
10722440|NCT04658888|11886320|FG000|COMPLETED|Overall Study||333
10722441|NCT04658888|11886321|FG001|COMPLETED|Overall Study||631
10722442|NCT04658888|11886320|FG000|NOT COMPLETED|Overall Study||0
10722443|NCT04658888|11886321|FG001|NOT COMPLETED|Overall Study||0
10722475|NCT04097925|11886360|FG000|STARTED|Overall Study||30
10722476|NCT04097925|11886360|FG000|COMPLETED|Overall Study||29
10722477|NCT04097925|11886360|FG000|NOT COMPLETED|Overall Study||1
10722478|NCT04043312|11886366|FG000|STARTED|Overall Study||12
10722479|NCT04043312|11886367|FG001|STARTED|Overall Study||14
10722480|NCT04043312|11886366|FG000|COMPLETED|Overall Study||12
10722481|NCT04043312|11886367|FG001|COMPLETED|Overall Study||14
10722482|NCT04043312|11886366|FG000|NOT COMPLETED|Overall Study||0
10722483|NCT04043312|11886367|FG001|NOT COMPLETED|Overall Study||0
10722484|NCT04003987|11886375|FG000|STARTED|Overall Study||39
10722485|NCT04003987|11886376|FG001|STARTED|Overall Study||39
10722486|NCT04003987|11886375|FG000|COMPLETED|Overall Study||39
10722487|NCT04003987|11886376|FG001|COMPLETED|Overall Study||39
10722488|NCT04003987|11886375|FG000|NOT COMPLETED|Overall Study||0
10722489|NCT04003987|11886376|FG001|NOT COMPLETED|Overall Study||0
10722490|NCT03994120|11886384|FG000|STARTED|Overall Study||7
10722491|NCT03994120|11886385|FG001|STARTED|Overall Study||6
10722492|NCT03994120|11886384|FG000|COMPLETED|Overall Study||4
10722493|NCT03994120|11886385|FG001|COMPLETED|Overall Study||5
10722494|NCT03994120|11886384|FG000|NOT COMPLETED|Overall Study||3
10722495|NCT03994120|11886385|FG001|NOT COMPLETED|Overall Study||1
10722496|NCT03934216|11886393|FG000|STARTED|Randomization||88
10722497|NCT03934216|11886394|FG001|STARTED|Randomization||43
10722498|NCT03934216|11886393|FG000|COMPLETED|Randomization||87
10814438|NCT02360059|11977168|FG000|COMPLETED|Overall Study||1
10722499|NCT03934216|11886394|FG001|COMPLETED|Randomization||42
10722500|NCT03934216|11886393|FG000|NOT COMPLETED|Randomization||1
10814439|NCT02360059|11977169|FG001|COMPLETED|Overall Study||0
10405157|NCT00738062|11549462|FG001|NOT COMPLETED|2 Week Randomized Withdrawal||0
10405158|NCT00738062|11549463|FG002|NOT COMPLETED|2 Week Randomized Withdrawal||0
10405159|NCT00738062|11549461|FG000|STARTED|Open-Label Extension|One patient completed double blind randomization but did not enter the open label extension|74
10405160|NCT00738062|11549462|FG001|STARTED|Open-Label Extension||0
10405161|NCT00738062|11549463|FG002|STARTED|Open-Label Extension||0
10405162|NCT00738062|11549461|FG000|COMPLETED|Open-Label Extension||57
10405163|NCT00738062|11549462|FG001|COMPLETED|Open-Label Extension||0
10405164|NCT00738062|11549463|FG002|COMPLETED|Open-Label Extension||0
10405165|NCT00738062|11549461|FG000|NOT COMPLETED|Open-Label Extension||17
10405166|NCT00738062|11549462|FG001|NOT COMPLETED|Open-Label Extension||0
10405167|NCT00738062|11549463|FG002|NOT COMPLETED|Open-Label Extension||0
10405168|NCT00738101|11549472|FG000|STARTED|Overall Study||293
10405169|NCT00738101|11549472|FG000|COMPLETED|Overall Study|7 exclusions. 5 primary liver or unrelated disease, 1 died before Omegaven, 1 repeat enrollment|286
10405170|NCT00738101|11549472|FG000|NOT COMPLETED|Overall Study||7
10405171|NCT00738283|11549476|FG000|STARTED|Overall Study||17
10405172|NCT00738283|11549476|FG000|COMPLETED|Overall Study||13
10405173|NCT00738283|11549476|FG000|NOT COMPLETED|Overall Study||4
10405174|NCT00738361|11549480|FG000|STARTED|Overall Study||4
10405175|NCT00738361|11549480|FG000|COMPLETED|Overall Study||4
10405176|NCT00738361|11549480|FG000|NOT COMPLETED|Overall Study||0
10405177|NCT00738374|11549488|FG000|STARTED|Induction Treatment Phase||97
10405178|NCT00738374|11549489|FG001|STARTED|Induction Treatment Phase||0
10405179|NCT00738374|11549490|FG002|STARTED|Induction Treatment Phase|Participants were randomized at the end of the Induction Treatment Phase.|0
10405180|NCT00738374|11549491|FG003|STARTED|Induction Treatment Phase|Participants were randomized at the end of the Induction Treatment Phase.|0
10405181|NCT00738374|11549488|FG000|COMPLETED|Induction Treatment Phase||73
10544331|NCT01490294|11697578|FG002|Participant Received Treatment|Overall Study||58
10544332|NCT01490294|11697579|FG003|Participant Received Treatment|Overall Study||54
10544333|NCT01490294|11697576|FG000|COMPLETED|Overall Study||53
10544334|NCT01490294|11697577|FG001|COMPLETED|Overall Study||60
10544335|NCT01490294|11697578|FG002|COMPLETED|Overall Study||58
10722501|NCT03934216|11886394|FG001|NOT COMPLETED|Randomization||1
10722502|NCT03934216|11886393|FG000|STARTED|Treatment Period||87
10722503|NCT03934216|11886394|FG001|STARTED|Treatment Period||42
10405182|NCT00738374|11549489|FG001|COMPLETED|Induction Treatment Phase||0
10405183|NCT00738374|11549490|FG002|COMPLETED|Induction Treatment Phase||0
10405184|NCT00738374|11549491|FG003|COMPLETED|Induction Treatment Phase||0
10405185|NCT00738374|11549488|FG000|NOT COMPLETED|Induction Treatment Phase||24
10405186|NCT00738374|11549489|FG001|NOT COMPLETED|Induction Treatment Phase||0
10405187|NCT00738374|11549490|FG002|NOT COMPLETED|Induction Treatment Phase||0
10405188|NCT00738374|11549491|FG003|NOT COMPLETED|Induction Treatment Phase||0
10405189|NCT00738374|11549488|FG000|STARTED|Maintenance Treatment/Observation Phase|Participants were randomized to either maintenance therapy or observation at the end of induction.|0
10405190|NCT00738374|11549489|FG001|STARTED|Maintenance Treatment/Observation Phase||7
10405191|NCT00738374|11549490|FG002|STARTED|Maintenance Treatment/Observation Phase||34
10405192|NCT00738374|11549491|FG003|STARTED|Maintenance Treatment/Observation Phase||32
10405193|NCT00738374|11549488|FG000|COMPLETED|Maintenance Treatment/Observation Phase||0
10405194|NCT00738374|11549489|FG001|COMPLETED|Maintenance Treatment/Observation Phase||0
10405195|NCT00738374|11549490|FG002|COMPLETED|Maintenance Treatment/Observation Phase||27
10405196|NCT00738374|11549491|FG003|COMPLETED|Maintenance Treatment/Observation Phase||20
10405197|NCT00738374|11549488|FG000|NOT COMPLETED|Maintenance Treatment/Observation Phase||0
10405198|NCT00738374|11549489|FG001|NOT COMPLETED|Maintenance Treatment/Observation Phase||7
10405199|NCT00738374|11549490|FG002|NOT COMPLETED|Maintenance Treatment/Observation Phase||7
10405200|NCT00738374|11549491|FG003|NOT COMPLETED|Maintenance Treatment/Observation Phase||12
10405201|NCT00738400|11549502|FG000|STARTED|Overall Study||76
10544336|NCT01490294|11697579|FG003|COMPLETED|Overall Study||54
10544337|NCT01490294|11697576|FG000|NOT COMPLETED|Overall Study||5
10544338|NCT01490294|11697577|FG001|NOT COMPLETED|Overall Study||0
10544339|NCT01490294|11697578|FG002|NOT COMPLETED|Overall Study||1
10544340|NCT01490294|11697579|FG003|NOT COMPLETED|Overall Study||1
10544341|NCT01490359|11697591|FG000|STARTED|Overall Study||609
10544342|NCT01490359|11697592|FG001|STARTED|Overall Study||572
10544343|NCT01490359|11697591|FG000|Followed-up at 6 mo|Overall Study||558
10544344|NCT01490359|11697592|FG001|Followed-up at 6 mo|Overall Study||535
10544345|NCT01490359|11697591|FG000|Followed-up at 12 mo|Overall Study||569
10544346|NCT01490359|11697592|FG001|Followed-up at 12 mo|Overall Study||537
10544347|NCT01490359|11697591|FG000|COMPLETED|Overall Study||585
10544348|NCT01490359|11697592|FG001|COMPLETED|Overall Study||555
10544349|NCT01490359|11697591|FG000|NOT COMPLETED|Overall Study||24
10544350|NCT01490359|11697592|FG001|NOT COMPLETED|Overall Study||17
10544351|NCT01490450|11697603|FG000|STARTED|Period 1||41
10544352|NCT01490450|11697604|FG001|STARTED|Period 1||41
10544353|NCT01490450|11697605|FG002|STARTED|Period 1||42
10722504|NCT03934216|11886393|FG000|COMPLETED|Treatment Period||69
10722505|NCT03934216|11886394|FG001|COMPLETED|Treatment Period||35
10722506|NCT03934216|11886393|FG000|NOT COMPLETED|Treatment Period||18
10722507|NCT03934216|11886394|FG001|NOT COMPLETED|Treatment Period||7
10722508|NCT03907280|11886403|FG000|STARTED|Treatment Period 1 + Washout Period 1||4
10722509|NCT03907280|11886404|FG001|STARTED|Treatment Period 1 + Washout Period 1||4
10722510|NCT03907280|11886405|FG002|STARTED|Treatment Period 1 + Washout Period 1||4
10722511|NCT03907280|11886403|FG000|Treated With BI 1265162|Treatment Period 1 + Washout Period 1||4
10405202|NCT00738400|11549503|FG001|STARTED|Overall Study||74
10405203|NCT00738400|11549502|FG000|Received Treatment, Safety Population|Overall Study|One invalid participant (no evidence that this randomized participant took study medication).|75
10405204|NCT00738400|11549503|FG001|Received Treatment, Safety Population|Overall Study|Two invalid participants (no evidence that these randomized participants took study medication).|72
10405205|NCT00738400|11549502|FG000|ITT (Intent To Treatment) Population|Overall Study||75
10405206|NCT00738400|11549503|FG001|ITT (Intent To Treatment) Population|Overall Study|No post-baseline efficacy measurement in 2 participants|70
10405207|NCT00738400|11549502|FG000|COMPLETED|Overall Study||72
10405208|NCT00738400|11549503|FG001|COMPLETED|Overall Study||67
10405209|NCT00738400|11549502|FG000|NOT COMPLETED|Overall Study||4
10405210|NCT00738400|11549503|FG001|NOT COMPLETED|Overall Study||7
10405211|NCT00738426|11549511|FG000|STARTED|Overall Study||37
10405212|NCT00738426|11549512|FG001|STARTED|Overall Study||35
10405213|NCT00738426|11549511|FG000|COMPLETED|Overall Study||35
10405214|NCT00738426|11549512|FG001|COMPLETED|Overall Study||32
10405215|NCT00738426|11549511|FG000|NOT COMPLETED|Overall Study||2
10405216|NCT00738426|11549512|FG001|NOT COMPLETED|Overall Study||3
10405217|NCT00738530|11549520|FG000|STARTED|Overall Study||327
10405218|NCT00738530|11549521|FG001|STARTED|Overall Study||322
10405219|NCT00738530|11549520|FG000|Treated|Overall Study||325
10405220|NCT00738530|11549521|FG001|Treated|Overall Study||316
10405221|NCT00738530|11549520|FG000|COMPLETED|Overall Study||93
10405222|NCT00738530|11549521|FG001|COMPLETED|Overall Study||84
10405223|NCT00738530|11549520|FG000|NOT COMPLETED|Overall Study||234
10405224|NCT00738530|11549521|FG001|NOT COMPLETED|Overall Study||238
10405225|NCT00738543|11549527|FG000|STARTED|Povidone Iodine||48
10405226|NCT00738543|11549527|FG000|COMPLETED|Povidone Iodine||48
10405227|NCT00738543|11549527|FG000|NOT COMPLETED|Povidone Iodine||0
10405228|NCT00738543|11549527|FG000|STARTED|Sodium Hypochlorite||48
10405229|NCT00738543|11549527|FG000|COMPLETED|Sodium Hypochlorite||48
10405230|NCT00738543|11549527|FG000|NOT COMPLETED|Sodium Hypochlorite||0
10405231|NCT00738543|11549527|FG000|STARTED|Control||48
10722512|NCT03907280|11886404|FG001|Treated With BI 1265162|Treatment Period 1 + Washout Period 1||4
10722513|NCT03907280|11886405|FG002|Treated With BI 1265162|Treatment Period 1 + Washout Period 1||4
10722514|NCT03907280|11886403|FG000|COMPLETED|Treatment Period 1 + Washout Period 1||4
10722515|NCT03907280|11886404|FG001|COMPLETED|Treatment Period 1 + Washout Period 1||4
10722516|NCT03907280|11886405|FG002|COMPLETED|Treatment Period 1 + Washout Period 1||4
10722517|NCT03907280|11886403|FG000|NOT COMPLETED|Treatment Period 1 + Washout Period 1||0
10722518|NCT03907280|11886404|FG001|NOT COMPLETED|Treatment Period 1 + Washout Period 1||0
10722519|NCT03907280|11886405|FG002|NOT COMPLETED|Treatment Period 1 + Washout Period 1||0
10722520|NCT03907280|11886403|FG000|STARTED|Treatment Period 2 + Washout Period 2||4
10722521|NCT03907280|11886404|FG001|STARTED|Treatment Period 2 + Washout Period 2||4
10722522|NCT03907280|11886405|FG002|STARTED|Treatment Period 2 + Washout Period 2||4
10722523|NCT03907280|11886403|FG000|Treated With BI 1265162|Treatment Period 2 + Washout Period 2||4
10722524|NCT03907280|11886404|FG001|Treated With BI 1265162|Treatment Period 2 + Washout Period 2||4
10722525|NCT03907280|11886405|FG002|Treated With BI 1265162|Treatment Period 2 + Washout Period 2||4
10722526|NCT03907280|11886403|FG000|COMPLETED|Treatment Period 2 + Washout Period 2||4
10722527|NCT03907280|11886404|FG001|COMPLETED|Treatment Period 2 + Washout Period 2||4
10722528|NCT03907280|11886405|FG002|COMPLETED|Treatment Period 2 + Washout Period 2||4
10722587|NCT03689374|11886444|FG000|STARTED|Treatment Period (Week 0 to 52)||0
10722529|NCT03907280|11886403|FG000|NOT COMPLETED|Treatment Period 2 + Washout Period 2||0
10722530|NCT03907280|11886404|FG001|NOT COMPLETED|Treatment Period 2 + Washout Period 2||0
10722531|NCT03907280|11886405|FG002|NOT COMPLETED|Treatment Period 2 + Washout Period 2||0
10722532|NCT03907280|11886403|FG000|STARTED|Treatment Period 3 + Washout Period 3||4
10722533|NCT03907280|11886404|FG001|STARTED|Treatment Period 3 + Washout Period 3||4
10722534|NCT03907280|11886405|FG002|STARTED|Treatment Period 3 + Washout Period 3||4
10722535|NCT03907280|11886403|FG000|Treated With BI 1265162|Treatment Period 3 + Washout Period 3||4
10722536|NCT03907280|11886404|FG001|Treated With BI 1265162|Treatment Period 3 + Washout Period 3||3
10722537|NCT03907280|11886405|FG002|Treated With BI 1265162|Treatment Period 3 + Washout Period 3||4
10722538|NCT03907280|11886403|FG000|COMPLETED|Treatment Period 3 + Washout Period 3||4
10722539|NCT03907280|11886404|FG001|COMPLETED|Treatment Period 3 + Washout Period 3||3
10722540|NCT03907280|11886405|FG002|COMPLETED|Treatment Period 3 + Washout Period 3||4
10722541|NCT03907280|11886403|FG000|NOT COMPLETED|Treatment Period 3 + Washout Period 3||0
10722542|NCT03907280|11886404|FG001|NOT COMPLETED|Treatment Period 3 + Washout Period 3||1
10722543|NCT03907280|11886405|FG002|NOT COMPLETED|Treatment Period 3 + Washout Period 3||0
10722544|NCT03907280|11886403|FG000|STARTED|Treatment Period 4: Fixed Treatment T3||4
10722545|NCT03907280|11886404|FG001|STARTED|Treatment Period 4: Fixed Treatment T3||4
10722546|NCT03907280|11886405|FG002|STARTED|Treatment Period 4: Fixed Treatment T3||4
10722547|NCT03907280|11886403|FG000|Treated With BI 1265162|Treatment Period 4: Fixed Treatment T3||4
10722548|NCT03907280|11886404|FG001|Treated With BI 1265162|Treatment Period 4: Fixed Treatment T3||4
10722549|NCT03907280|11886405|FG002|Treated With BI 1265162|Treatment Period 4: Fixed Treatment T3||4
10722550|NCT03907280|11886403|FG000|COMPLETED|Treatment Period 4: Fixed Treatment T3||4
10722551|NCT03907280|11886404|FG001|COMPLETED|Treatment Period 4: Fixed Treatment T3||4
10722552|NCT03907280|11886405|FG002|COMPLETED|Treatment Period 4: Fixed Treatment T3||4
10722553|NCT03907280|11886403|FG000|NOT COMPLETED|Treatment Period 4: Fixed Treatment T3||0
10405232|NCT00738543|11549527|FG000|COMPLETED|Control||48
10405233|NCT00738543|11549527|FG000|NOT COMPLETED|Control||0
10405234|NCT00738673|11549533|FG000|STARTED|Overall Study||25
10405235|NCT00738673|11549534|FG001|STARTED|Overall Study||12
10405236|NCT00738673|11549533|FG000|Intent to Treat Population|Overall Study||24
10405237|NCT00738673|11549534|FG001|Intent to Treat Population|Overall Study||12
10405238|NCT00738673|11549533|FG000|COMPLETED|Overall Study||1
10405239|NCT00738673|11549534|FG001|COMPLETED|Overall Study||1
10405240|NCT00738673|11549533|FG000|NOT COMPLETED|Overall Study||24
10405241|NCT00738673|11549534|FG001|NOT COMPLETED|Overall Study||11
10405242|NCT00738699|11549542|FG000|STARTED|Overall Study||275
10405243|NCT00738699|11549543|FG001|STARTED|Overall Study||140
10405244|NCT00738699|11549542|FG000|Participants Not Treated|Overall Study||2
10405245|NCT00738699|11549543|FG001|Participants Not Treated|Overall Study||1
10405246|NCT00738699|11549542|FG000|Participants Treated|Overall Study||273
10405247|NCT00738699|11549543|FG001|Participants Treated|Overall Study||139
10405248|NCT00738699|11549542|FG000|COMPLETED|Overall Study||0
10405249|NCT00738699|11549543|FG001|COMPLETED|Overall Study||0
10405250|NCT00738699|11549542|FG000|NOT COMPLETED|Overall Study||275
10405251|NCT00738699|11549543|FG001|NOT COMPLETED|Overall Study||140
10405252|NCT00738881|11549551|FG000|STARTED|Overall Study||11
10405253|NCT00738881|11549552|FG001|STARTED|Overall Study||12
10405254|NCT00738881|11549551|FG000|COMPLETED|Overall Study||11
10405255|NCT00738881|11549552|FG001|COMPLETED|Overall Study||10
10405256|NCT00738881|11549551|FG000|NOT COMPLETED|Overall Study||0
10405257|NCT00738881|11549552|FG001|NOT COMPLETED|Overall Study||2
10405258|NCT00738894|11549560|FG000|STARTED|Overall Study||441
10405259|NCT00738894|11549561|FG001|STARTED|Overall Study||223
10405260|NCT00738894|11549560|FG000|COMPLETED|Overall Study||402
10405261|NCT00738894|11549561|FG001|COMPLETED|Overall Study||190
10405262|NCT00738894|11549560|FG000|NOT COMPLETED|Overall Study||39
10405263|NCT00738894|11549561|FG001|NOT COMPLETED|Overall Study||33
10405264|NCT00739102|11549567|FG000|STARTED|Overall Study||250
10405265|NCT00739102|11549567|FG000|COMPLETED|Overall Study|Completed 12-Month Follow-up|235
10405266|NCT00739102|11549567|FG000|NOT COMPLETED|Overall Study||15
10405267|NCT00739297|11549571|FG000|STARTED|First Intervention (Visit 3 to Visit 4)||17
10722554|NCT03907280|11886404|FG001|NOT COMPLETED|Treatment Period 4: Fixed Treatment T3||0
10722555|NCT03907280|11886405|FG002|NOT COMPLETED|Treatment Period 4: Fixed Treatment T3||0
10405268|NCT00739297|11549572|FG001|STARTED|First Intervention (Visit 3 to Visit 4)||11
10405269|NCT00739297|11549573|FG002|STARTED|First Intervention (Visit 3 to Visit 4)||6
10405270|NCT00739297|11549574|FG003|STARTED|First Intervention (Visit 3 to Visit 4)||19
10405271|NCT00739297|11549575|FG004|STARTED|First Intervention (Visit 3 to Visit 4)||6
10405272|NCT00739297|11549576|FG005|STARTED|First Intervention (Visit 3 to Visit 4)||9
10405273|NCT00739297|11549577|FG006|STARTED|First Intervention (Visit 3 to Visit 4)||68
10405274|NCT00739297|11549571|FG000|COMPLETED|First Intervention (Visit 3 to Visit 4)||17
10405275|NCT00739297|11549572|FG001|COMPLETED|First Intervention (Visit 3 to Visit 4)||11
10405276|NCT00739297|11549573|FG002|COMPLETED|First Intervention (Visit 3 to Visit 4)||6
10405277|NCT00739297|11549574|FG003|COMPLETED|First Intervention (Visit 3 to Visit 4)||19
10405278|NCT00739297|11549575|FG004|COMPLETED|First Intervention (Visit 3 to Visit 4)||6
10405279|NCT00739297|11549576|FG005|COMPLETED|First Intervention (Visit 3 to Visit 4)||9
10405280|NCT00739297|11549577|FG006|COMPLETED|First Intervention (Visit 3 to Visit 4)||68
10405281|NCT00739297|11549571|FG000|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
10405282|NCT00739297|11549572|FG001|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
10405283|NCT00739297|11549573|FG002|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
10405284|NCT00739297|11549574|FG003|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
10405285|NCT00739297|11549575|FG004|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
10405286|NCT00739297|11549576|FG005|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
10405287|NCT00739297|11549577|FG006|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
10405288|NCT00739297|11549571|FG000|STARTED|First Washout Period of 4-7 Days||17
10405289|NCT00739297|11549572|FG001|STARTED|First Washout Period of 4-7 Days||11
10405290|NCT00739297|11549573|FG002|STARTED|First Washout Period of 4-7 Days||6
10405291|NCT00739297|11549574|FG003|STARTED|First Washout Period of 4-7 Days||19
10405292|NCT00739297|11549575|FG004|STARTED|First Washout Period of 4-7 Days||6
10405293|NCT00739297|11549576|FG005|STARTED|First Washout Period of 4-7 Days||9
10405294|NCT00739297|11549577|FG006|STARTED|First Washout Period of 4-7 Days||68
10405295|NCT00739297|11549571|FG000|COMPLETED|First Washout Period of 4-7 Days||17
10405296|NCT00739297|11549572|FG001|COMPLETED|First Washout Period of 4-7 Days||11
10405297|NCT00739297|11549573|FG002|COMPLETED|First Washout Period of 4-7 Days||6
10405298|NCT00739297|11549574|FG003|COMPLETED|First Washout Period of 4-7 Days||17
10405299|NCT00739297|11549575|FG004|COMPLETED|First Washout Period of 4-7 Days||6
10405300|NCT00739297|11549576|FG005|COMPLETED|First Washout Period of 4-7 Days||9
10405301|NCT00739297|11549577|FG006|COMPLETED|First Washout Period of 4-7 Days||66
10405302|NCT00739297|11549571|FG000|NOT COMPLETED|First Washout Period of 4-7 Days||0
10405303|NCT00739297|11549572|FG001|NOT COMPLETED|First Washout Period of 4-7 Days||0
10405304|NCT00739297|11549573|FG002|NOT COMPLETED|First Washout Period of 4-7 Days||0
10405305|NCT00739297|11549574|FG003|NOT COMPLETED|First Washout Period of 4-7 Days||2
10405306|NCT00739297|11549575|FG004|NOT COMPLETED|First Washout Period of 4-7 Days||0
10405307|NCT00739297|11549576|FG005|NOT COMPLETED|First Washout Period of 4-7 Days||0
10405308|NCT00739297|11549577|FG006|NOT COMPLETED|First Washout Period of 4-7 Days||2
10405309|NCT00739297|11549571|FG000|STARTED|Second Intervention (Visit 5 to Visit 6)||18
10405310|NCT00739297|11549572|FG001|STARTED|Second Intervention (Visit 5 to Visit 6)||8
10405311|NCT00739297|11549573|FG002|STARTED|Second Intervention (Visit 5 to Visit 6)||10
10405312|NCT00739297|11549574|FG003|STARTED|Second Intervention (Visit 5 to Visit 6)||14
10405313|NCT00739297|11549575|FG004|STARTED|Second Intervention (Visit 5 to Visit 6)||6
10405314|NCT00739297|11549576|FG005|STARTED|Second Intervention (Visit 5 to Visit 6)||10
10405315|NCT00739297|11549577|FG006|STARTED|Second Intervention (Visit 5 to Visit 6)||66
10405316|NCT00739297|11549571|FG000|COMPLETED|Second Intervention (Visit 5 to Visit 6)||18
10405317|NCT00739297|11549572|FG001|COMPLETED|Second Intervention (Visit 5 to Visit 6)||8
10405318|NCT00739297|11549573|FG002|COMPLETED|Second Intervention (Visit 5 to Visit 6)||10
10405319|NCT00739297|11549574|FG003|COMPLETED|Second Intervention (Visit 5 to Visit 6)||14
10405320|NCT00739297|11549575|FG004|COMPLETED|Second Intervention (Visit 5 to Visit 6)||6
10405321|NCT00739297|11549576|FG005|COMPLETED|Second Intervention (Visit 5 to Visit 6)||10
10405322|NCT00739297|11549577|FG006|COMPLETED|Second Intervention (Visit 5 to Visit 6)||66
10405323|NCT00739297|11549571|FG000|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
10405324|NCT00739297|11549572|FG001|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
10405325|NCT00739297|11549573|FG002|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
10405326|NCT00739297|11549574|FG003|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
10405327|NCT00739297|11549575|FG004|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
10405328|NCT00739297|11549576|FG005|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
10405329|NCT00739297|11549577|FG006|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
10405330|NCT00739297|11549571|FG000|STARTED|Second Washout Period of 4-7 Days||18
10405331|NCT00739297|11549572|FG001|STARTED|Second Washout Period of 4-7 Days||8
10405332|NCT00739297|11549573|FG002|STARTED|Second Washout Period of 4-7 Days||10
10405333|NCT00739297|11549574|FG003|STARTED|Second Washout Period of 4-7 Days||14
10405334|NCT00739297|11549575|FG004|STARTED|Second Washout Period of 4-7 Days||6
10405335|NCT00739297|11549576|FG005|STARTED|Second Washout Period of 4-7 Days||10
10405336|NCT00739297|11549577|FG006|STARTED|Second Washout Period of 4-7 Days||66
10405337|NCT00739297|11549571|FG000|COMPLETED|Second Washout Period of 4-7 Days||18
10405338|NCT00739297|11549572|FG001|COMPLETED|Second Washout Period of 4-7 Days||8
10722564|NCT03745768|11886426|FG000|STARTED|Overall Study||10
10722565|NCT03745768|11886427|FG001|STARTED|Overall Study||9
10722566|NCT03745768|11886426|FG000|COMPLETED|Overall Study||8
10722567|NCT03745768|11886427|FG001|COMPLETED|Overall Study||9
10722568|NCT03745768|11886426|FG000|NOT COMPLETED|Overall Study||2
10722569|NCT03745768|11886427|FG001|NOT COMPLETED|Overall Study||0
10722570|NCT03694522|11886435|FG000|STARTED|Overall Study||77
10722571|NCT03694522|11886436|FG001|STARTED|Overall Study||78
10722572|NCT03694522|11886435|FG000|Received Any Study Treatment|Overall Study||76
10722573|NCT03694522|11886436|FG001|Received Any Study Treatment|Overall Study||77
10722574|NCT03694522|11886435|FG000|COMPLETED|Overall Study||0
10722575|NCT03694522|11886436|FG001|COMPLETED|Overall Study||0
10722576|NCT03694522|11886435|FG000|NOT COMPLETED|Overall Study||77
10722577|NCT03694522|11886436|FG001|NOT COMPLETED|Overall Study||78
10722578|NCT03689374|11886444|FG000|STARTED|Run-in Period (12 Weeks)||2274
10722579|NCT03689374|11886445|FG001|STARTED|Run-in Period (12 Weeks)||0
10722580|NCT03689374|11886446|FG002|STARTED|Run-in Period (12 Weeks)||0
10722581|NCT03689374|11886444|FG000|COMPLETED|Run-in Period (12 Weeks)||1748
10722582|NCT03689374|11886445|FG001|COMPLETED|Run-in Period (12 Weeks)||0
10722583|NCT03689374|11886446|FG002|COMPLETED|Run-in Period (12 Weeks)||0
10722584|NCT03689374|11886444|FG000|NOT COMPLETED|Run-in Period (12 Weeks)||526
10722585|NCT03689374|11886445|FG001|NOT COMPLETED|Run-in Period (12 Weeks)||0
10722586|NCT03689374|11886446|FG002|NOT COMPLETED|Run-in Period (12 Weeks)||0
10722588|NCT03689374|11886445|FG001|STARTED|Treatment Period (Week 0 to 52)||874
10722589|NCT03689374|11886446|FG002|STARTED|Treatment Period (Week 0 to 52)||874
10722590|NCT03689374|11886444|FG000|Treated|Treatment Period (Week 0 to 52)||0
10722591|NCT03689374|11886445|FG001|Treated|Treatment Period (Week 0 to 52)||874
10722592|NCT03689374|11886446|FG002|Treated|Treatment Period (Week 0 to 52)||864
10722593|NCT03689374|11886444|FG000|Full Analysis Set|Treatment Period (Week 0 to 52)||0
10722594|NCT03689374|11886445|FG001|Full Analysis Set|Treatment Period (Week 0 to 52)||874
10722595|NCT03689374|11886446|FG002|Full Analysis Set|Treatment Period (Week 0 to 52)||874
10722596|NCT03689374|11886444|FG000|Safety Analysis Set|Treatment Period (Week 0 to 52)||0
10722597|NCT03689374|11886445|FG001|Safety Analysis Set|Treatment Period (Week 0 to 52)||874
10722598|NCT03689374|11886446|FG002|Safety Analysis Set|Treatment Period (Week 0 to 52)||864
10722599|NCT03689374|11886444|FG000|COMPLETED|Treatment Period (Week 0 to 52)||0
10722600|NCT03689374|11886445|FG001|COMPLETED|Treatment Period (Week 0 to 52)||850
10722601|NCT03689374|11886446|FG002|COMPLETED|Treatment Period (Week 0 to 52)||831
10722602|NCT03689374|11886444|FG000|NOT COMPLETED|Treatment Period (Week 0 to 52)||0
10722603|NCT03689374|11886445|FG001|NOT COMPLETED|Treatment Period (Week 0 to 52)||24
10722604|NCT03689374|11886446|FG002|NOT COMPLETED|Treatment Period (Week 0 to 52)||43
10722605|NCT03639311|11886454|FG000|STARTED|Overall Study||90
10722606|NCT03639311|11886455|FG001|STARTED|Overall Study||7
10722607|NCT03639311|11886454|FG000|COMPLETED|Overall Study||0
10722608|NCT03639311|11886455|FG001|COMPLETED|Overall Study||7
10722609|NCT03639311|11886454|FG000|NOT COMPLETED|Overall Study||90
10405339|NCT00739297|11549573|FG002|COMPLETED|Second Washout Period of 4-7 Days||10
10405340|NCT00739297|11549574|FG003|COMPLETED|Second Washout Period of 4-7 Days||14
10405341|NCT00739297|11549575|FG004|COMPLETED|Second Washout Period of 4-7 Days||6
10405342|NCT00739297|11549576|FG005|COMPLETED|Second Washout Period of 4-7 Days||10
10405343|NCT00739297|11549577|FG006|COMPLETED|Second Washout Period of 4-7 Days||66
10405344|NCT00739297|11549571|FG000|NOT COMPLETED|Second Washout Period of 4-7 Days||0
10405345|NCT00739297|11549572|FG001|NOT COMPLETED|Second Washout Period of 4-7 Days||0
10405346|NCT00739297|11549573|FG002|NOT COMPLETED|Second Washout Period of 4-7 Days||0
10405347|NCT00739297|11549574|FG003|NOT COMPLETED|Second Washout Period of 4-7 Days||0
10405348|NCT00739297|11549575|FG004|NOT COMPLETED|Second Washout Period of 4-7 Days||0
10405349|NCT00739297|11549576|FG005|NOT COMPLETED|Second Washout Period of 4-7 Days||0
10405350|NCT00739297|11549577|FG006|NOT COMPLETED|Second Washout Period of 4-7 Days||0
10405351|NCT00739297|11549571|FG000|STARTED|Third Intervention (Visit 7 to Visit 8)||16
10405352|NCT00739297|11549572|FG001|STARTED|Third Intervention (Visit 7 to Visit 8)||12
10405353|NCT00739297|11549573|FG002|STARTED|Third Intervention (Visit 7 to Visit 8)||6
10405354|NCT00739297|11549574|FG003|STARTED|Third Intervention (Visit 7 to Visit 8)||18
10405355|NCT00739297|11549575|FG004|STARTED|Third Intervention (Visit 7 to Visit 8)||6
10405356|NCT00739297|11549576|FG005|STARTED|Third Intervention (Visit 7 to Visit 8)||8
10405357|NCT00739297|11549577|FG006|STARTED|Third Intervention (Visit 7 to Visit 8)||66
10405358|NCT00739297|11549571|FG000|COMPLETED|Third Intervention (Visit 7 to Visit 8)||16
10405359|NCT00739297|11549572|FG001|COMPLETED|Third Intervention (Visit 7 to Visit 8)||12
10405360|NCT00739297|11549573|FG002|COMPLETED|Third Intervention (Visit 7 to Visit 8)||6
10405361|NCT00739297|11549574|FG003|COMPLETED|Third Intervention (Visit 7 to Visit 8)||18
10405362|NCT00739297|11549575|FG004|COMPLETED|Third Intervention (Visit 7 to Visit 8)||6
10405363|NCT00739297|11549576|FG005|COMPLETED|Third Intervention (Visit 7 to Visit 8)||8
10405364|NCT00739297|11549577|FG006|COMPLETED|Third Intervention (Visit 7 to Visit 8)||66
10405365|NCT00739297|11549571|FG000|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
10405366|NCT00739297|11549572|FG001|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
10405367|NCT00739297|11549573|FG002|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
10405368|NCT00739297|11549574|FG003|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
10405369|NCT00739297|11549575|FG004|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
10405370|NCT00739297|11549576|FG005|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
10405371|NCT00739297|11549577|FG006|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
10405372|NCT00739297|11549571|FG000|STARTED|Third Washout Period of 4-7 Days||16
10405373|NCT00739297|11549572|FG001|STARTED|Third Washout Period of 4-7 Days||12
10405374|NCT00739297|11549573|FG002|STARTED|Third Washout Period of 4-7 Days||6
10405375|NCT00739297|11549574|FG003|STARTED|Third Washout Period of 4-7 Days||18
10405376|NCT00739297|11549575|FG004|STARTED|Third Washout Period of 4-7 Days||6
10405377|NCT00739297|11549576|FG005|STARTED|Third Washout Period of 4-7 Days||8
10405378|NCT00739297|11549577|FG006|STARTED|Third Washout Period of 4-7 Days||66
10405379|NCT00739297|11549571|FG000|COMPLETED|Third Washout Period of 4-7 Days||16
10405380|NCT00739297|11549572|FG001|COMPLETED|Third Washout Period of 4-7 Days||12
10405381|NCT00739297|11549573|FG002|COMPLETED|Third Washout Period of 4-7 Days||6
10405382|NCT00739297|11549574|FG003|COMPLETED|Third Washout Period of 4-7 Days||18
10405383|NCT00739297|11549575|FG004|COMPLETED|Third Washout Period of 4-7 Days||6
10405384|NCT00739297|11549576|FG005|COMPLETED|Third Washout Period of 4-7 Days||8
10405385|NCT00739297|11549577|FG006|COMPLETED|Third Washout Period of 4-7 Days||66
10405386|NCT00739297|11549571|FG000|NOT COMPLETED|Third Washout Period of 4-7 Days||0
10405387|NCT00739297|11549572|FG001|NOT COMPLETED|Third Washout Period of 4-7 Days||0
10405388|NCT00739297|11549573|FG002|NOT COMPLETED|Third Washout Period of 4-7 Days||0
10405389|NCT00739297|11549574|FG003|NOT COMPLETED|Third Washout Period of 4-7 Days||0
10405390|NCT00739297|11549575|FG004|NOT COMPLETED|Third Washout Period of 4-7 Days||0
10405391|NCT00739297|11549576|FG005|NOT COMPLETED|Third Washout Period of 4-7 Days||0
10405392|NCT00739297|11549577|FG006|NOT COMPLETED|Third Washout Period of 4-7 Days||0
10405393|NCT00739297|11549571|FG000|STARTED|Fourth Intervention(Visit 9 to Visit 10)||16
10405394|NCT00739297|11549572|FG001|STARTED|Fourth Intervention(Visit 9 to Visit 10)||11
10405395|NCT00739297|11549573|FG002|STARTED|Fourth Intervention(Visit 9 to Visit 10)||8
10405396|NCT00739297|11549574|FG003|STARTED|Fourth Intervention(Visit 9 to Visit 10)||15
10405397|NCT00739297|11549575|FG004|STARTED|Fourth Intervention(Visit 9 to Visit 10)||7
10405398|NCT00739297|11549576|FG005|STARTED|Fourth Intervention(Visit 9 to Visit 10)||9
10405399|NCT00739297|11549577|FG006|STARTED|Fourth Intervention(Visit 9 to Visit 10)||66
10405400|NCT00739297|11549571|FG000|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||16
10405401|NCT00739297|11549572|FG001|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||11
10405402|NCT00739297|11549573|FG002|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||8
10405403|NCT00739297|11549574|FG003|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||15
10405404|NCT00739297|11549575|FG004|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||7
10405405|NCT00739297|11549576|FG005|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||8
10405406|NCT00739297|11549577|FG006|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||65
10405407|NCT00739297|11549571|FG000|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
10405408|NCT00739297|11549572|FG001|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
10405409|NCT00739297|11549573|FG002|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
10405410|NCT00739297|11549574|FG003|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
10405411|NCT00739297|11549575|FG004|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
10429915|NCT00867100|11576061|FG011|STARTED|Overall Study||6
10405412|NCT00739297|11549576|FG005|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||1
10405413|NCT00739297|11549577|FG006|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||1
10405414|NCT00739310|11549593|FG000|STARTED|Overall Study||29
10405415|NCT00739310|11549593|FG000|COMPLETED|Overall Study||22
10405416|NCT00739310|11549593|FG000|NOT COMPLETED|Overall Study||7
10405417|NCT00739336|11549600|FG000|STARTED|Overall Study||21
10405418|NCT00739336|11549601|FG001|STARTED|Overall Study||24
10405419|NCT00739336|11549600|FG000|COMPLETED|Overall Study||17
10405420|NCT00739336|11549601|FG001|COMPLETED|Overall Study||24
10405421|NCT00739336|11549600|FG000|NOT COMPLETED|Overall Study||4
10405422|NCT00739336|11549601|FG001|NOT COMPLETED|Overall Study||0
10405423|NCT00739583|11549609|FG000|STARTED|Overall Study||10
10405424|NCT00739583|11549610|FG001|STARTED|Overall Study||10
10405425|NCT00739583|11549609|FG000|COMPLETED|Overall Study||10
10405426|NCT00739583|11549610|FG001|COMPLETED|Overall Study||10
10405427|NCT00739583|11549609|FG000|NOT COMPLETED|Overall Study||0
10405428|NCT00739583|11549610|FG001|NOT COMPLETED|Overall Study||0
10405429|NCT00739596|11549618|FG000|STARTED|Overall Study||166
10405430|NCT00739596|11549619|FG001|STARTED|Overall Study||166
10405431|NCT00739596|11549618|FG000|COMPLETED|Overall Study||141
10405432|NCT00739596|11549619|FG001|COMPLETED|Overall Study||149
10405433|NCT00739596|11549618|FG000|NOT COMPLETED|Overall Study||25
10405434|NCT00739596|11549619|FG001|NOT COMPLETED|Overall Study||17
10405435|NCT00739648|11549627|FG000|STARTED|Overall Study||108
10405436|NCT00739648|11549628|FG001|STARTED|Overall Study||214
10405437|NCT00739648|11549627|FG000|COMPLETED|Overall Study||82
10405438|NCT00739648|11549628|FG001|COMPLETED|Overall Study||161
10405439|NCT00739648|11549627|FG000|NOT COMPLETED|Overall Study||26
10405440|NCT00739648|11549628|FG001|NOT COMPLETED|Overall Study||53
10405441|NCT00739661|11549640|FG000|STARTED|Overall Study||52
10405442|NCT00739661|11549641|FG001|STARTED|Overall Study||52
10405443|NCT00739661|11549640|FG000|COMPLETED|Overall Study||6
10722610|NCT03639311|11886455|FG001|NOT COMPLETED|Overall Study||0
10722611|NCT03617926|11886466|FG000|STARTED|Overall Study||35
10722612|NCT03617926|11886467|FG001|STARTED|Overall Study||35
10722613|NCT03617926|11886466|FG000|COMPLETED|Overall Study||35
10722614|NCT03617926|11886467|FG001|COMPLETED|Overall Study||35
10722615|NCT03617926|11886466|FG000|NOT COMPLETED|Overall Study||0
10722616|NCT03617926|11886467|FG001|NOT COMPLETED|Overall Study||0
10722617|NCT03614663|11886480|FG000|STARTED|Overall Study||110
10722618|NCT03614663|11886481|FG001|STARTED|Overall Study||102
10722619|NCT03614663|11886480|FG000|COMPLETED|Overall Study||106
10722620|NCT03614663|11886481|FG001|COMPLETED|Overall Study||99
10722621|NCT03614663|11886480|FG000|NOT COMPLETED|Overall Study||4
10722622|NCT03614663|11886481|FG001|NOT COMPLETED|Overall Study||3
10722623|NCT03591874|11886491|FG000|STARTED|Overall Study||40
10722624|NCT03591874|11886492|FG001|STARTED|Overall Study||19
10722625|NCT03591874|11886491|FG000|Received at Least 1 Study Treatment|Overall Study||29
10722626|NCT03591874|11886492|FG001|Received at Least 1 Study Treatment|Overall Study||16
10722627|NCT03591874|11886491|FG000|COMPLETED|Overall Study||21
10722628|NCT03591874|11886492|FG001|COMPLETED|Overall Study||12
10722629|NCT03591874|11886491|FG000|NOT COMPLETED|Overall Study||19
10722630|NCT03591874|11886492|FG001|NOT COMPLETED|Overall Study||7
10405444|NCT00739661|11549641|FG001|COMPLETED|Overall Study||10
10405445|NCT00739661|11549640|FG000|NOT COMPLETED|Overall Study||46
10405446|NCT00739661|11549641|FG001|NOT COMPLETED|Overall Study||42
10405447|NCT00739752|11549653|FG000|STARTED|Overall Study||299
10405448|NCT00739752|11549654|FG001|STARTED|Overall Study||284
10405449|NCT00739752|11549655|FG002|STARTED|Overall Study||292
10405450|NCT00739752|11549656|FG003|STARTED|Overall Study||288
10405451|NCT00739752|11549657|FG004|STARTED|Overall Study||291
10722713|NCT03418727|11886543|FG000|STARTED|Overall Study||29
10722714|NCT03418727|11886544|FG001|STARTED|Overall Study||28
10722715|NCT03418727|11886545|FG002|STARTED|Overall Study||27
10722716|NCT03418727|11886543|FG000|Received at Least 1 Study Treatment|Overall Study||29
10722717|NCT03418727|11886544|FG001|Received at Least 1 Study Treatment|Overall Study||28
10722718|NCT03418727|11886545|FG002|Received at Least 1 Study Treatment|Overall Study||27
10722719|NCT03418727|11886543|FG000|COMPLETED|Overall Study||28
10722720|NCT03418727|11886544|FG001|COMPLETED|Overall Study||26
10722721|NCT03418727|11886545|FG002|COMPLETED|Overall Study||25
10722722|NCT03418727|11886543|FG000|NOT COMPLETED|Overall Study||1
10722723|NCT03418727|11886544|FG001|NOT COMPLETED|Overall Study||2
10722724|NCT03418727|11886545|FG002|NOT COMPLETED|Overall Study||2
10722725|NCT03410108|11886553|FG000|STARTED|Overall Study||104
10722726|NCT03410108|11886553|FG000|Safety Evaluation Lead-in Part|Overall Study||9
10722727|NCT03410108|11886553|FG000|Refractory Expansion Part: Main Cohort|Overall Study||47
10722728|NCT03410108|11886553|FG000|Refractory Expansion Part: Sub-Cohort|Overall Study||16
10722729|NCT03410108|11886553|FG000|Refractory Expansion Part|Overall Study||63
10722730|NCT03410108|11886553|FG000|All Refractory Participants|Overall Study||72
10722731|NCT03410108|11886553|FG000|TKI-Naive Expansion Cohort|Overall Study||32
10722732|NCT03410108|11886553|FG000|Completed|Overall Study||0
10722733|NCT03410108|11886553|FG000|COMPLETED|Overall Study||0
10722734|NCT03410108|11886553|FG000|NOT COMPLETED|Overall Study||104
10722735|NCT03242824|11886560|FG000|STARTED|Overall Study||20
10722736|NCT03242824|11886560|FG000|COMPLETED|Overall Study||20
10722737|NCT03242824|11886560|FG000|NOT COMPLETED|Overall Study||0
10722738|NCT03123185|11886578|FG000|STARTED|Overall Study||12
10722739|NCT03123185|11886579|FG001|STARTED|Overall Study||8
10814440|NCT02360059|11977168|FG000|NOT COMPLETED|Overall Study||0
10722740|NCT03123185|11886580|FG002|STARTED|Overall Study||6
10722741|NCT03123185|11886581|FG003|STARTED|Overall Study||5
10722742|NCT03123185|11886582|FG004|STARTED|Overall Study||6
10722743|NCT03123185|11886583|FG005|STARTED|Overall Study||6
10722744|NCT03123185|11886584|FG006|STARTED|Overall Study||6
10722745|NCT03123185|11886585|FG007|STARTED|Overall Study||6
10722746|NCT03123185|11886586|FG008|STARTED|Overall Study||6
10722747|NCT03123185|11886587|FG009|STARTED|Overall Study||6
10722748|NCT03123185|11886588|FG010|STARTED|Overall Study||6
10405452|NCT00739752|11549658|FG005|STARTED|Overall Study||293
10405453|NCT00739752|11549653|FG000|COMPLETED|Overall Study||299
10405454|NCT00739752|11549654|FG001|COMPLETED|Overall Study||284
10405455|NCT00739752|11549655|FG002|COMPLETED|Overall Study||292
10405456|NCT00739752|11549656|FG003|COMPLETED|Overall Study||288
10405457|NCT00739752|11549657|FG004|COMPLETED|Overall Study||291
10405458|NCT00739752|11549658|FG005|COMPLETED|Overall Study||293
10405459|NCT00739752|11549653|FG000|NOT COMPLETED|Overall Study||0
10405460|NCT00739752|11549654|FG001|NOT COMPLETED|Overall Study||0
10405461|NCT00739752|11549655|FG002|NOT COMPLETED|Overall Study||0
10405462|NCT00739752|11549656|FG003|NOT COMPLETED|Overall Study||0
10405463|NCT00739752|11549657|FG004|NOT COMPLETED|Overall Study||0
10405464|NCT00739752|11549658|FG005|NOT COMPLETED|Overall Study||0
10405465|NCT00739765|11549675|FG000|STARTED|Overall Study||40
10722749|NCT03123185|11886589|FG011|STARTED|Overall Study||6
10722750|NCT03123185|11886590|FG012|STARTED|Overall Study||6
10722751|NCT03123185|11886591|FG013|STARTED|Overall Study||6
10722752|NCT03123185|11886578|FG000|COMPLETED|Overall Study||12
10722753|NCT03123185|11886579|FG001|COMPLETED|Overall Study||8
10722754|NCT03123185|11886580|FG002|COMPLETED|Overall Study||6
10722755|NCT03123185|11886581|FG003|COMPLETED|Overall Study||5
10722756|NCT03123185|11886582|FG004|COMPLETED|Overall Study||6
10722757|NCT03123185|11886583|FG005|COMPLETED|Overall Study||6
10722758|NCT03123185|11886584|FG006|COMPLETED|Overall Study||6
10722759|NCT03123185|11886585|FG007|COMPLETED|Overall Study||6
10722760|NCT03123185|11886586|FG008|COMPLETED|Overall Study||6
10722761|NCT03123185|11886587|FG009|COMPLETED|Overall Study||6
10722762|NCT03123185|11886588|FG010|COMPLETED|Overall Study||6
10722763|NCT03123185|11886589|FG011|COMPLETED|Overall Study||6
10814441|NCT02360059|11977169|FG001|NOT COMPLETED|Overall Study||0
10405466|NCT00739765|11549676|FG001|STARTED|Overall Study||38
10405467|NCT00739765|11549677|FG002|STARTED|Overall Study||32
10722764|NCT03123185|11886590|FG012|COMPLETED|Overall Study||5
10722765|NCT03123185|11886591|FG013|COMPLETED|Overall Study||6
10722766|NCT03123185|11886578|FG000|NOT COMPLETED|Overall Study||0
10722767|NCT03123185|11886579|FG001|NOT COMPLETED|Overall Study||0
10722768|NCT03123185|11886580|FG002|NOT COMPLETED|Overall Study||0
10722769|NCT03123185|11886581|FG003|NOT COMPLETED|Overall Study||0
10722770|NCT03123185|11886582|FG004|NOT COMPLETED|Overall Study||0
10722771|NCT03123185|11886583|FG005|NOT COMPLETED|Overall Study||0
10722772|NCT03123185|11886584|FG006|NOT COMPLETED|Overall Study||0
10722773|NCT03123185|11886585|FG007|NOT COMPLETED|Overall Study||0
10722774|NCT03123185|11886586|FG008|NOT COMPLETED|Overall Study||0
10722775|NCT03123185|11886587|FG009|NOT COMPLETED|Overall Study||0
10722776|NCT03123185|11886588|FG010|NOT COMPLETED|Overall Study||0
10722777|NCT03123185|11886589|FG011|NOT COMPLETED|Overall Study||0
10722778|NCT03123185|11886590|FG012|NOT COMPLETED|Overall Study||1
10722779|NCT03123185|11886591|FG013|NOT COMPLETED|Overall Study||0
10722780|NCT03122509|11886641|FG000|STARTED|Overall Study||25
10722781|NCT03122509|11886642|FG001|STARTED|Overall Study||0
10722782|NCT03122509|11886641|FG000|COMPLETED|Overall Study||25
10722783|NCT03122509|11886642|FG001|COMPLETED|Overall Study||0
10722784|NCT03122509|11886641|FG000|NOT COMPLETED|Overall Study||0
10722785|NCT03122509|11886642|FG001|NOT COMPLETED|Overall Study||0
10722786|NCT03110133|11886649|FG000|STARTED|Week 8||106
10722787|NCT03110133|11886650|FG001|STARTED|Week 8||100
10722788|NCT03110133|11886649|FG000|COMPLETED|Week 8||101
10722789|NCT03110133|11886650|FG001|COMPLETED|Week 8||96
10722790|NCT03110133|11886649|FG000|NOT COMPLETED|Week 8||5
10722791|NCT03110133|11886650|FG001|NOT COMPLETED|Week 8||4
10722792|NCT03110133|11886649|FG000|STARTED|Week 24||101
10722793|NCT03110133|11886650|FG001|STARTED|Week 24||96
10722794|NCT03110133|11886649|FG000|COMPLETED|Week 24||99
10722795|NCT03110133|11886650|FG001|COMPLETED|Week 24||95
10722796|NCT03110133|11886649|FG000|NOT COMPLETED|Week 24||2
10722797|NCT03110133|11886650|FG001|NOT COMPLETED|Week 24||1
10722798|NCT03105128|11886659|FG000|STARTED|Period 1||373
10722799|NCT03105128|11886660|FG001|STARTED|Period 1||372
10722800|NCT03105128|11886661|FG002|STARTED|Period 1||186
10722801|NCT03105128|11886662|FG003|STARTED|Period 1||0
10722802|NCT03105128|11886663|FG004|STARTED|Period 1||0
10722803|NCT03105128|11886664|FG005|STARTED|Period 1||0
10722804|NCT03105128|11886665|FG006|STARTED|Period 1||0
10722805|NCT03105128|11886659|FG000|COMPLETED|Period 1||365
10405468|NCT00739765|11549675|FG000|COMPLETED|Overall Study||34
10405469|NCT00739765|11549676|FG001|COMPLETED|Overall Study||27
10722806|NCT03105128|11886660|FG001|COMPLETED|Period 1||366
10722807|NCT03105128|11886661|FG002|COMPLETED|Period 1||163
10722808|NCT03105128|11886662|FG003|COMPLETED|Period 1||0
10722809|NCT03105128|11886663|FG004|COMPLETED|Period 1||0
10722810|NCT03105128|11886664|FG005|COMPLETED|Period 1||0
10722811|NCT03105128|11886665|FG006|COMPLETED|Period 1||0
10722812|NCT03105128|11886659|FG000|NOT COMPLETED|Period 1||8
10722813|NCT03105128|11886660|FG001|NOT COMPLETED|Period 1||6
10722814|NCT03105128|11886661|FG002|NOT COMPLETED|Period 1||23
10405470|NCT00739765|11549677|FG002|COMPLETED|Overall Study||21
10722815|NCT03105128|11886662|FG003|NOT COMPLETED|Period 1||0
10722816|NCT03105128|11886663|FG004|NOT COMPLETED|Period 1||0
10722817|NCT03105128|11886664|FG005|NOT COMPLETED|Period 1||0
10722818|NCT03105128|11886665|FG006|NOT COMPLETED|Period 1||0
10722819|NCT03105128|11886659|FG000|STARTED|Period 2||0
10722820|NCT03105128|11886660|FG001|STARTED|Period 2||0
10722821|NCT03105128|11886661|FG002|STARTED|Period 2||0
10722822|NCT03105128|11886662|FG003|STARTED|Period 2||67
10405471|NCT00739765|11549675|FG000|NOT COMPLETED|Overall Study||6
10405472|NCT00739765|11549676|FG001|NOT COMPLETED|Overall Study||11
10405473|NCT00739765|11549677|FG002|NOT COMPLETED|Overall Study||11
10405474|NCT00739908|11549687|FG000|STARTED|Overall Study||142
10405475|NCT00739908|11549688|FG001|STARTED|Overall Study||143
10405476|NCT00739908|11549687|FG000|COMPLETED|Overall Study||117
10405477|NCT00739908|11549688|FG001|COMPLETED|Overall Study||118
10405478|NCT00739908|11549687|FG000|NOT COMPLETED|Overall Study||25
10405479|NCT00739908|11549688|FG001|NOT COMPLETED|Overall Study||25
10405480|NCT00739934|11549696|FG000|STARTED|Voriconazole IV||40
10405481|NCT00739934|11549696|FG000|COMPLETED|Voriconazole IV||34
10405482|NCT00739934|11549696|FG000|NOT COMPLETED|Voriconazole IV||6
10405483|NCT00739934|11549696|FG000|STARTED|Voriconazole Oral||34
10405484|NCT00739934|11549696|FG000|COMPLETED|Voriconazole Oral||31
10405485|NCT00739934|11549696|FG000|NOT COMPLETED|Voriconazole Oral||3
10405486|NCT00739960|11549705|FG000|STARTED|Overall Study||1
10405487|NCT00739960|11549705|FG000|COMPLETED|Overall Study||1
10405488|NCT00739960|11549705|FG000|NOT COMPLETED|Overall Study||0
10405489|NCT00739973|11549718|FG000|STARTED|Single-blind Period (2 to 4 Weeks)|In this period, participants were enrolled to only Placebo arm.|2694
10405490|NCT00739973|11549719|FG001|STARTED|Single-blind Period (2 to 4 Weeks)||0
10405491|NCT00739973|11549720|FG002|STARTED|Single-blind Period (2 to 4 Weeks)||0
10405492|NCT00739973|11549721|FG003|STARTED|Single-blind Period (2 to 4 Weeks)||0
10405493|NCT00739973|11549722|FG004|STARTED|Single-blind Period (2 to 4 Weeks)||0
10405494|NCT00739973|11549723|FG005|STARTED|Single-blind Period (2 to 4 Weeks)||0
10405495|NCT00739973|11549724|FG006|STARTED|Single-blind Period (2 to 4 Weeks)||0
10405496|NCT00739973|11549725|FG007|STARTED|Single-blind Period (2 to 4 Weeks)||0
10405497|NCT00739973|11549726|FG008|STARTED|Single-blind Period (2 to 4 Weeks)||0
10405498|NCT00739973|11549718|FG000|COMPLETED|Single-blind Period (2 to 4 Weeks)||1685
10405499|NCT00739973|11549719|FG001|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
10405500|NCT00739973|11549720|FG002|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
10405501|NCT00739973|11549721|FG003|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
10405502|NCT00739973|11549722|FG004|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
10405503|NCT00739973|11549723|FG005|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
10405504|NCT00739973|11549724|FG006|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
10405505|NCT00739973|11549725|FG007|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
10405506|NCT00739973|11549726|FG008|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
10405507|NCT00739973|11549718|FG000|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||1009
10405508|NCT00739973|11549719|FG001|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
10405509|NCT00739973|11549720|FG002|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
10405510|NCT00739973|11549721|FG003|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
10405511|NCT00739973|11549722|FG004|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
10405512|NCT00739973|11549723|FG005|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
10405513|NCT00739973|11549724|FG006|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
10405514|NCT00739973|11549725|FG007|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
10405515|NCT00739973|11549726|FG008|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
10405516|NCT00739973|11549718|FG000|STARTED|Double-blind:Randomized Period (8 Weeks)||198
10405517|NCT00739973|11549719|FG001|STARTED|Double-blind:Randomized Period (8 Weeks)|One pt. was mis-randomized, so discontinued from single-blind and was untreated in the double-blind.|195
10405518|NCT00739973|11549720|FG002|STARTED|Double-blind:Randomized Period (8 Weeks)||203
10405519|NCT00739973|11549721|FG003|STARTED|Double-blind:Randomized Period (8 Weeks)||185
10405520|NCT00739973|11549722|FG004|STARTED|Double-blind:Randomized Period (8 Weeks)||181
10405521|NCT00739973|11549723|FG005|STARTED|Double-blind:Randomized Period (8 Weeks)||181
10405522|NCT00739973|11549724|FG006|STARTED|Double-blind:Randomized Period (8 Weeks)|2 pts. were mis-randomized, so discontinued from single-blind and were untreated in double-blind.|183
10722823|NCT03105128|11886663|FG004|STARTED|Period 2||68
10722824|NCT03105128|11886664|FG005|STARTED|Period 2||67
10722825|NCT03105128|11886665|FG006|STARTED|Period 2||76
10722826|NCT03105128|11886659|FG000|COMPLETED|Period 2||0
10722827|NCT03105128|11886660|FG001|COMPLETED|Period 2||0
10722828|NCT03105128|11886661|FG002|COMPLETED|Period 2||0
10722829|NCT03105128|11886662|FG003|COMPLETED|Period 2||62
10722830|NCT03105128|11886663|FG004|COMPLETED|Period 2||65
10722831|NCT03105128|11886664|FG005|COMPLETED|Period 2||64
10722832|NCT03105128|11886665|FG006|COMPLETED|Period 2||74
10722833|NCT03105128|11886659|FG000|NOT COMPLETED|Period 2||0
10722834|NCT03105128|11886660|FG001|NOT COMPLETED|Period 2||0
10722835|NCT03105128|11886661|FG002|NOT COMPLETED|Period 2||0
10722836|NCT03105128|11886662|FG003|NOT COMPLETED|Period 2||5
10722837|NCT03105128|11886663|FG004|NOT COMPLETED|Period 2||3
10722838|NCT03105128|11886664|FG005|NOT COMPLETED|Period 2||3
10722839|NCT03105128|11886665|FG006|NOT COMPLETED|Period 2||2
10722845|NCT02952534|11886688|FG000|STARTED|Overall Study||172
10722846|NCT02952534|11886689|FG001|STARTED|Overall Study||59
10722847|NCT02952534|11886690|FG002|STARTED|Overall Study||14
10722848|NCT02952534|11886691|FG003|STARTED|Overall Study||7
10722849|NCT02952534|11886692|FG004|STARTED|Overall Study||25
10722850|NCT02952534|11886688|FG000|COMPLETED|Overall Study||172
10722851|NCT02952534|11886689|FG001|COMPLETED|Overall Study||59
10722852|NCT02952534|11886690|FG002|COMPLETED|Overall Study||14
10722853|NCT02952534|11886691|FG003|COMPLETED|Overall Study||7
10405523|NCT00739973|11549725|FG007|STARTED|Double-blind:Randomized Period (8 Weeks)||178
10405524|NCT00739973|11549726|FG008|STARTED|Double-blind:Randomized Period (8 Weeks)||184
10405525|NCT00739973|11549718|FG000|COMPLETED|Double-blind:Randomized Period (8 Weeks)||168
10405526|NCT00739973|11549719|FG001|COMPLETED|Double-blind:Randomized Period (8 Weeks)||175
10405527|NCT00739973|11549720|FG002|COMPLETED|Double-blind:Randomized Period (8 Weeks)||184
10405528|NCT00739973|11549721|FG003|COMPLETED|Double-blind:Randomized Period (8 Weeks)||173
10405529|NCT00739973|11549722|FG004|COMPLETED|Double-blind:Randomized Period (8 Weeks)||162
10405530|NCT00739973|11549723|FG005|COMPLETED|Double-blind:Randomized Period (8 Weeks)||169
10405531|NCT00739973|11549724|FG006|COMPLETED|Double-blind:Randomized Period (8 Weeks)||170
10405532|NCT00739973|11549725|FG007|COMPLETED|Double-blind:Randomized Period (8 Weeks)||168
10405533|NCT00739973|11549726|FG008|COMPLETED|Double-blind:Randomized Period (8 Weeks)||170
10405534|NCT00739973|11549718|FG000|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||30
10405535|NCT00739973|11549719|FG001|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||20
10405536|NCT00739973|11549720|FG002|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||19
10405537|NCT00739973|11549721|FG003|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||12
10405538|NCT00739973|11549722|FG004|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||19
10405539|NCT00739973|11549723|FG005|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||12
10405540|NCT00739973|11549724|FG006|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||13
10405541|NCT00739973|11549725|FG007|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||10
10405542|NCT00739973|11549726|FG008|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||14
10405543|NCT00739999|11549756|FG000|STARTED|Overall Study||15
10405544|NCT00739999|11549757|FG001|STARTED|Overall Study||24
10405545|NCT00739999|11549756|FG000|COMPLETED|Overall Study||15
10405546|NCT00739999|11549757|FG001|COMPLETED|Overall Study||24
10405547|NCT00739999|11549756|FG000|NOT COMPLETED|Overall Study||0
10405548|NCT00739999|11549757|FG001|NOT COMPLETED|Overall Study||0
10405549|NCT00740051|11549770|FG000|STARTED|Overall Study||76
10405550|NCT00740051|11549771|FG001|STARTED|Overall Study||151
10405551|NCT00740051|11549770|FG000|COMPLETED|Overall Study||58
10405552|NCT00740051|11549771|FG001|COMPLETED|Overall Study||119
10405553|NCT00740051|11549770|FG000|NOT COMPLETED|Overall Study||18
10405554|NCT00740051|11549771|FG001|NOT COMPLETED|Overall Study||32
10405555|NCT00740129|11549778|FG000|STARTED|Overall Study||6
10405556|NCT00740129|11549778|FG000|COMPLETED|Overall Study||6
10405557|NCT00740129|11549778|FG000|NOT COMPLETED|Overall Study||0
10405558|NCT00740207|11549785|FG000|STARTED|Overall Study||17
10405559|NCT00740207|11549786|FG001|STARTED|Overall Study||16
10405560|NCT00740207|11549785|FG000|COMPLETED|Overall Study||17
10405561|NCT00740207|11549786|FG001|COMPLETED|Overall Study||16
10405562|NCT00740207|11549785|FG000|NOT COMPLETED|Overall Study||0
10405563|NCT00740207|11549786|FG001|NOT COMPLETED|Overall Study||0
10405564|NCT00740220|11549796|FG000|STARTED|Overall Study||97
10405565|NCT00740220|11549796|FG000|COMPLETED|Overall Study||88
10405566|NCT00740220|11549796|FG000|NOT COMPLETED|Overall Study||9
10405567|NCT00740376|11549802|FG000|STARTED|Overall Study||22
10405568|NCT00740376|11549803|FG001|STARTED|Overall Study||15
10405569|NCT00740376|11549802|FG000|COMPLETED|Overall Study||19
10405570|NCT00740376|11549803|FG001|COMPLETED|Overall Study||12
10405571|NCT00740376|11549802|FG000|NOT COMPLETED|Overall Study||3
10405572|NCT00740376|11549803|FG001|NOT COMPLETED|Overall Study||3
10405573|NCT00740584|11549809|FG000|STARTED|Overall Study||12
10405574|NCT00740584|11549809|FG000|COMPLETED|Overall Study||11
10405575|NCT00740584|11549809|FG000|NOT COMPLETED|Overall Study||1
10405576|NCT00740636|11549816|FG000|STARTED|Overall Study||25
10405577|NCT00740636|11549817|FG001|STARTED|Overall Study||67
10405578|NCT00740636|11549816|FG000|COMPLETED|Overall Study||23
10405579|NCT00740636|11549817|FG001|COMPLETED|Overall Study||63
10405580|NCT00740636|11549816|FG000|NOT COMPLETED|Overall Study||2
10405581|NCT00740636|11549817|FG001|NOT COMPLETED|Overall Study||4
10405582|NCT00740714|11549826|FG000|STARTED|Overall Study|Randomized throughout the recruitment period|196
10405583|NCT00740714|11549827|FG001|STARTED|Overall Study|Randomized throughout the recruitment period|201
10405584|NCT00740714|11549828|FG002|STARTED|Overall Study|Randomized throughout the recruitment period|203
10405585|NCT00740714|11549826|FG000|Reaching Endpoint Before May 6, 2011|Overall Study||86
10405586|NCT00740714|11549827|FG001|Reaching Endpoint Before May 6, 2011|Overall Study||87
10405587|NCT00740714|11549828|FG002|Reaching Endpoint Before May 6, 2011|Overall Study||94
10405588|NCT00740714|11549826|FG000|Active Patients at Study Termination|Overall Study||24
10405589|NCT00740714|11549827|FG001|Active Patients at Study Termination|Overall Study||12
10405590|NCT00740714|11549828|FG002|Active Patients at Study Termination|Overall Study||33
10405591|NCT00740714|11549826|FG000|COMPLETED|Overall Study||179
10722854|NCT02952534|11886692|FG004|COMPLETED|Overall Study||25
10722855|NCT02952534|11886688|FG000|NOT COMPLETED|Overall Study||0
10722856|NCT02952534|11886689|FG001|NOT COMPLETED|Overall Study||0
10722857|NCT02952534|11886690|FG002|NOT COMPLETED|Overall Study||0
10722858|NCT02952534|11886691|FG003|NOT COMPLETED|Overall Study||0
10405592|NCT00740714|11549827|FG001|COMPLETED|Overall Study||182
10405593|NCT00740714|11549828|FG002|COMPLETED|Overall Study||174
10405594|NCT00740714|11549826|FG000|NOT COMPLETED|Overall Study||17
10405595|NCT00740714|11549827|FG001|NOT COMPLETED|Overall Study||19
10405596|NCT00740714|11549828|FG002|NOT COMPLETED|Overall Study||29
10405597|NCT00740779|11549839|FG000|STARTED|Overall Study||52
10405598|NCT00740779|11549840|FG001|STARTED|Overall Study||45
10722859|NCT02952534|11886692|FG004|NOT COMPLETED|Overall Study||0
10405599|NCT00740779|11549841|FG002|STARTED|Overall Study||54
10405600|NCT00740779|11549839|FG000|COMPLETED|Overall Study||43
10405601|NCT00740779|11549840|FG001|COMPLETED|Overall Study||31
10814442|NCT02350777|11977177|FG000|STARTED|Overall Study||2
10814443|NCT02350777|11977178|FG001|STARTED|Overall Study||2
10814444|NCT02350777|11977177|FG000|COMPLETED|Overall Study||2
10722860|NCT02949219|11886703|FG000|STARTED|Overall Study||41
10722861|NCT02949219|11886703|FG000|COMPLETED|Overall Study||40
10722862|NCT02949219|11886703|FG000|NOT COMPLETED|Overall Study||1
10722863|NCT02921763|11886707|FG000|STARTED|Overall Study||60
10722864|NCT02921763|11886707|FG000|COMPLETED|Overall Study||42
10722865|NCT02921763|11886707|FG000|NOT COMPLETED|Overall Study||18
10722866|NCT02876172|11886727|FG000|STARTED|Overall Study||6
10722867|NCT02876172|11886728|FG001|STARTED|Overall Study||6
10722868|NCT02876172|11886727|FG000|COMPLETED|Overall Study||6
10722869|NCT02876172|11886728|FG001|COMPLETED|Overall Study||6
10722870|NCT02876172|11886727|FG000|NOT COMPLETED|Overall Study||0
10722871|NCT02876172|11886728|FG001|NOT COMPLETED|Overall Study||0
10722876|NCT02836236|11886741|FG000|STARTED|Overall Study||105
10722877|NCT02836236|11886742|FG001|STARTED|Overall Study||50
10722878|NCT02836236|11886741|FG000|COMPLETED|Overall Study||0
10722879|NCT02836236|11886742|FG001|COMPLETED|Overall Study||0
10722880|NCT02836236|11886741|FG000|NOT COMPLETED|Overall Study||105
10722881|NCT02836236|11886742|FG001|NOT COMPLETED|Overall Study||50
10722897|NCT02811861|11886774|FG000|STARTED|Overall Study||357
10722898|NCT02811861|11886775|FG001|STARTED|Overall Study||355
10722899|NCT02811861|11886776|FG002|STARTED|Overall Study||357
10722900|NCT02811861|11886774|FG000|Treated|Overall Study||355
10722901|NCT02811861|11886775|FG001|Treated|Overall Study||352
10722902|NCT02811861|11886776|FG002|Treated|Overall Study||340
10722903|NCT02811861|11886774|FG000|COMPLETED|Overall Study||0
10722904|NCT02811861|11886775|FG001|COMPLETED|Overall Study||0
10722905|NCT02811861|11886776|FG002|COMPLETED|Overall Study||0
10722906|NCT02811861|11886774|FG000|NOT COMPLETED|Overall Study||357
10722907|NCT02811861|11886775|FG001|NOT COMPLETED|Overall Study||355
10722908|NCT02811861|11886776|FG002|NOT COMPLETED|Overall Study||357
10722909|NCT02759185|11886788|FG000|STARTED|Stage 1||20
10722910|NCT02759185|11886789|FG001|STARTED|Stage 1||20
10722911|NCT02759185|11886790|FG002|STARTED|Stage 1||20
10722912|NCT02759185|11886791|FG003|STARTED|Stage 1||20
10722913|NCT02759185|11886792|FG004|STARTED|Stage 1||0
10722914|NCT02759185|11886793|FG005|STARTED|Stage 1||0
10722915|NCT02759185|11886794|FG006|STARTED|Stage 1||0
10722916|NCT02759185|11886788|FG000|COMPLETED|Stage 1||19
10814445|NCT02350777|11977178|FG001|COMPLETED|Overall Study||2
10814446|NCT02350777|11977177|FG000|NOT COMPLETED|Overall Study||0
10814447|NCT02350777|11977178|FG001|NOT COMPLETED|Overall Study||0
10405602|NCT00740779|11549841|FG002|COMPLETED|Overall Study||41
10405603|NCT00740779|11549839|FG000|NOT COMPLETED|Overall Study||9
10405604|NCT00740779|11549840|FG001|NOT COMPLETED|Overall Study||14
10405605|NCT00740779|11549841|FG002|NOT COMPLETED|Overall Study||13
10405606|NCT00740792|11549853|FG000|STARTED|Overall Study||193
10405607|NCT00740792|11549854|FG001|STARTED|Overall Study||194
10405608|NCT00740792|11549855|FG002|STARTED|Overall Study||189
10405609|NCT00740792|11549856|FG003|STARTED|Overall Study||200
10722917|NCT02759185|11886789|FG001|COMPLETED|Stage 1||19
10722918|NCT02759185|11886790|FG002|COMPLETED|Stage 1||17
10722919|NCT02759185|11886791|FG003|COMPLETED|Stage 1||20
10722920|NCT02759185|11886792|FG004|COMPLETED|Stage 1||0
10722921|NCT02759185|11886793|FG005|COMPLETED|Stage 1||0
10722922|NCT02759185|11886794|FG006|COMPLETED|Stage 1||0
10722923|NCT02759185|11886788|FG000|NOT COMPLETED|Stage 1||1
10722924|NCT02759185|11886789|FG001|NOT COMPLETED|Stage 1||1
10722925|NCT02759185|11886790|FG002|NOT COMPLETED|Stage 1||3
10722926|NCT02759185|11886791|FG003|NOT COMPLETED|Stage 1||0
10722927|NCT02759185|11886792|FG004|NOT COMPLETED|Stage 1||0
10722928|NCT02759185|11886793|FG005|NOT COMPLETED|Stage 1||0
10722929|NCT02759185|11886794|FG006|NOT COMPLETED|Stage 1||0
10722930|NCT02759185|11886788|FG000|STARTED|Stage 2||0
10722931|NCT02759185|11886789|FG001|STARTED|Stage 2||0
10722932|NCT02759185|11886790|FG002|STARTED|Stage 2||0
10722933|NCT02759185|11886791|FG003|STARTED|Stage 2||0
10722934|NCT02759185|11886792|FG004|STARTED|Stage 2||29
10722935|NCT02759185|11886793|FG005|STARTED|Stage 2||27
10814448|NCT02345460|11977184|FG000|STARTED|Overall Study||1
10814449|NCT02345460|11977184|FG000|COMPLETED|Overall Study||1
10405610|NCT00740792|11549853|FG000|COMPLETED|Overall Study||183
10405611|NCT00740792|11549854|FG001|COMPLETED|Overall Study||186
10405612|NCT00740792|11549855|FG002|COMPLETED|Overall Study||180
10405613|NCT00740792|11549856|FG003|COMPLETED|Overall Study||190
10405614|NCT00740792|11549853|FG000|NOT COMPLETED|Overall Study||10
10405615|NCT00740792|11549854|FG001|NOT COMPLETED|Overall Study||8
10405616|NCT00740792|11549855|FG002|NOT COMPLETED|Overall Study||9
10405617|NCT00740792|11549856|FG003|NOT COMPLETED|Overall Study||10
10405618|NCT00740831|11549869|FG000|STARTED|Overall Study|Safety population|97
10405619|NCT00740831|11549870|FG001|STARTED|Overall Study|Safety population|103
10405620|NCT00740831|11549871|FG002|STARTED|Overall Study|Safety population|101
10405621|NCT00740831|11549869|FG000|COMPLETED|Overall Study|Patients who completed part A (visit 6)|93
10405622|NCT00740831|11549870|FG001|COMPLETED|Overall Study|Patients who completed part A (visit 6)|100
10405623|NCT00740831|11549871|FG002|COMPLETED|Overall Study|Patients who completed part A (visit 6)|95
10405624|NCT00740831|11549869|FG000|NOT COMPLETED|Overall Study||4
10722936|NCT02759185|11886794|FG006|STARTED|Stage 2||18
10722937|NCT02759185|11886788|FG000|COMPLETED|Stage 2||0
10722938|NCT02759185|11886789|FG001|COMPLETED|Stage 2||0
10722939|NCT02759185|11886790|FG002|COMPLETED|Stage 2||0
10722940|NCT02759185|11886791|FG003|COMPLETED|Stage 2||0
10722941|NCT02759185|11886792|FG004|COMPLETED|Stage 2||27
10722942|NCT02759185|11886793|FG005|COMPLETED|Stage 2||24
10722943|NCT02759185|11886794|FG006|COMPLETED|Stage 2||17
10722944|NCT02759185|11886788|FG000|NOT COMPLETED|Stage 2||0
10722945|NCT02759185|11886789|FG001|NOT COMPLETED|Stage 2||0
10722946|NCT02759185|11886790|FG002|NOT COMPLETED|Stage 2||0
10722947|NCT02759185|11886791|FG003|NOT COMPLETED|Stage 2||0
10722948|NCT02759185|11886792|FG004|NOT COMPLETED|Stage 2||2
10722949|NCT02759185|11886793|FG005|NOT COMPLETED|Stage 2||3
10722950|NCT02759185|11886794|FG006|NOT COMPLETED|Stage 2||1
10722951|NCT02629159|11886819|FG000|STARTED|Overall Study||651
10722952|NCT02629159|11886820|FG001|STARTED|Overall Study||327
10722953|NCT02629159|11886821|FG002|STARTED|Overall Study||651
10722954|NCT02629159|11886819|FG000|Received Assigned Study Drug|Overall Study||651
10722955|NCT02629159|11886820|FG001|Received Assigned Study Drug|Overall Study||327
10722956|NCT02629159|11886821|FG002|Received Assigned Study Drug|Overall Study|One participant received a placebo injection but no oral study drug before discontinuing the study|650
10722957|NCT02629159|11886819|FG000|Completed Week 14 on Study Drug|Overall Study||620
10722958|NCT02629159|11886820|FG001|Completed Week 14 on Study Drug|Overall Study||300
10722959|NCT02629159|11886821|FG002|Completed Week 14 on Study Drug|Overall Study||620
10722960|NCT02629159|11886819|FG000|Rescued at Week 14|Overall Study||231
10722961|NCT02629159|11886820|FG001|Rescued at Week 14|Overall Study||56
10722962|NCT02629159|11886821|FG002|Rescued at Week 14|Overall Study||78
10722963|NCT02629159|11886819|FG000|Rescued at Week 18|Overall Study|One participant rescued at week 18 did not receive any dose of upadacitinib|48
10722964|NCT02629159|11886820|FG001|Rescued at Week 18|Overall Study||14
10722965|NCT02629159|11886821|FG002|Rescued at Week 18|Overall Study||29
10722966|NCT02629159|11886819|FG000|Rescued at Week 22|Overall Study||26
10722967|NCT02629159|11886820|FG001|Rescued at Week 22|Overall Study||7
10722968|NCT02629159|11886821|FG002|Rescued at Week 22|Overall Study||18
10722969|NCT02629159|11886819|FG000|COMPLETED|Overall Study||595
10722970|NCT02629159|11886820|FG001|COMPLETED|Overall Study||288
10722971|NCT02629159|11886821|FG002|COMPLETED|Overall Study||600
10722972|NCT02629159|11886819|FG000|NOT COMPLETED|Overall Study||56
10722973|NCT02629159|11886820|FG001|NOT COMPLETED|Overall Study||39
10722974|NCT02629159|11886821|FG002|NOT COMPLETED|Overall Study||51
10722978|NCT02586025|11886838|FG000|STARTED|Neoadjuvant Treatment||219
10722979|NCT02586025|11886839|FG001|STARTED|Neoadjuvant Treatment||110
10722980|NCT02586025|11886838|FG000|Received at Least One Dose of Study Drug|Neoadjuvant Treatment||218
10722981|NCT02586025|11886839|FG001|Received at Least One Dose of Study Drug|Neoadjuvant Treatment||110
10722982|NCT02586025|11886838|FG000|Completed Neoadjuvant Treatment|Neoadjuvant Treatment||214
10722983|NCT02586025|11886839|FG001|Completed Neoadjuvant Treatment|Neoadjuvant Treatment||108
10722984|NCT02586025|11886838|FG000|Underwent Surgery|Neoadjuvant Treatment||210
10722985|NCT02586025|11886839|FG001|Underwent Surgery|Neoadjuvant Treatment||105
10722986|NCT02586025|11886838|FG000|COMPLETED|Neoadjuvant Treatment||208
10722987|NCT02586025|11886839|FG001|COMPLETED|Neoadjuvant Treatment||103
10722988|NCT02586025|11886838|FG000|NOT COMPLETED|Neoadjuvant Treatment||11
10722989|NCT02586025|11886839|FG001|NOT COMPLETED|Neoadjuvant Treatment||7
10814450|NCT02345460|11977184|FG000|NOT COMPLETED|Overall Study||0
10405625|NCT00740831|11549870|FG001|NOT COMPLETED|Overall Study||3
10405626|NCT00740831|11549871|FG002|NOT COMPLETED|Overall Study||6
10405627|NCT00740857|11549882|FG000|STARTED|Overall Study||33
10405628|NCT00740857|11549883|FG001|STARTED|Overall Study||88
10405629|NCT00740857|11549884|FG002|STARTED|Overall Study||90
10405630|NCT00740857|11549882|FG000|COMPLETED|Overall Study||32
10722990|NCT02586025|11886838|FG000|STARTED|Adjuvant Treatment||208
10722991|NCT02586025|11886839|FG001|STARTED|Adjuvant Treatment||103
10722992|NCT02586025|11886838|FG000|Started Adjuvant FEC Treatment|Adjuvant Treatment||208
10722993|NCT02586025|11886839|FG001|Started Adjuvant FEC Treatment|Adjuvant Treatment||103
10722994|NCT02586025|11886838|FG000|Started Adjuvant HER2 Treatment|Adjuvant Treatment||204
10722995|NCT02586025|11886839|FG001|Started Adjuvant HER2 Treatment|Adjuvant Treatment||99
10722996|NCT02586025|11886838|FG000|COMPLETED|Adjuvant Treatment||69
10722997|NCT02586025|11886839|FG001|COMPLETED|Adjuvant Treatment||34
10814451|NCT02346877|11977190|FG000|STARTED|Overall Study||19
10405631|NCT00740857|11549883|FG001|COMPLETED|Overall Study||88
10405632|NCT00740857|11549884|FG002|COMPLETED|Overall Study||90
10405633|NCT00740857|11549882|FG000|NOT COMPLETED|Overall Study||1
10405634|NCT00740857|11549883|FG001|NOT COMPLETED|Overall Study||0
10405635|NCT00740857|11549884|FG002|NOT COMPLETED|Overall Study||0
10405636|NCT00740870|11549892|FG000|STARTED|Overall Study||171
10405637|NCT00740870|11549892|FG000|COMPLETED|Overall Study||150
10405638|NCT00740870|11549892|FG000|NOT COMPLETED|Overall Study||21
10405639|NCT00741013|11549902|FG000|STARTED|Overall Study||7
10405640|NCT00741013|11549903|FG001|STARTED|Overall Study||8
10405641|NCT00741013|11549904|FG002|STARTED|Overall Study||7
10405642|NCT00741013|11549902|FG000|COMPLETED|Overall Study||6
10405643|NCT00741013|11549903|FG001|COMPLETED|Overall Study||6
10405644|NCT00741013|11549904|FG002|COMPLETED|Overall Study||6
10405645|NCT00741013|11549902|FG000|NOT COMPLETED|Overall Study||1
10405646|NCT00741013|11549903|FG001|NOT COMPLETED|Overall Study||2
10405647|NCT00741013|11549904|FG002|NOT COMPLETED|Overall Study||1
10405648|NCT00741026|11549912|FG000|STARTED|Overall Study||15
10405649|NCT00741026|11549912|FG000|COMPLETED|Overall Study||15
10405650|NCT00741026|11549912|FG000|NOT COMPLETED|Overall Study||0
10405651|NCT00741039|11549920|FG000|STARTED|Overall Study||102
10405652|NCT00741039|11549921|FG001|STARTED|Overall Study||25
10405653|NCT00741039|11549920|FG000|COMPLETED|Overall Study||100
10405654|NCT00741039|11549921|FG001|COMPLETED|Overall Study||25
10405655|NCT00741039|11549920|FG000|NOT COMPLETED|Overall Study||2
10405656|NCT00741039|11549921|FG001|NOT COMPLETED|Overall Study||0
10405657|NCT00741091|11549927|FG000|STARTED|Overall Study||1097
10405658|NCT00741091|11549927|FG000|COMPLETED|Overall Study||1040
10405659|NCT00741091|11549927|FG000|NOT COMPLETED|Overall Study||57
10405660|NCT00741104|11549931|FG000|STARTED|Overall Study||363
10405661|NCT00741104|11549931|FG000|COMPLETED|Overall Study||363
10405662|NCT00741104|11549931|FG000|NOT COMPLETED|Overall Study||0
10405663|NCT00741156|11549935|FG000|STARTED|Overall Study||12
10405664|NCT00741156|11549935|FG000|COMPLETED|Overall Study||12
10405665|NCT00741156|11549935|FG000|NOT COMPLETED|Overall Study||0
10405666|NCT00741260|11549957|FG000|STARTED|Overall Study||6
10405667|NCT00741260|11549958|FG001|STARTED|Overall Study||8
10405668|NCT00741260|11549959|FG002|STARTED|Overall Study||4
10405669|NCT00741260|11549960|FG003|STARTED|Overall Study||6
10405670|NCT00741260|11549961|FG004|STARTED|Overall Study||9
10405671|NCT00741260|11549962|FG005|STARTED|Overall Study||65
10405672|NCT00741260|11549963|FG006|STARTED|Overall Study||7
10722998|NCT02586025|11886838|FG000|NOT COMPLETED|Adjuvant Treatment||139
10722999|NCT02586025|11886839|FG001|NOT COMPLETED|Adjuvant Treatment||69
10405673|NCT00741260|11549957|FG000|COMPLETED|Overall Study||0
10405674|NCT00741260|11549958|FG001|COMPLETED|Overall Study||0
10405675|NCT00741260|11549959|FG002|COMPLETED|Overall Study||0
10405676|NCT00741260|11549960|FG003|COMPLETED|Overall Study||0
10405677|NCT00741260|11549961|FG004|COMPLETED|Overall Study||0
10405678|NCT00741260|11549962|FG005|COMPLETED|Overall Study||20
10405679|NCT00741260|11549963|FG006|COMPLETED|Overall Study||0
10405680|NCT00741260|11549957|FG000|NOT COMPLETED|Overall Study||6
10405681|NCT00741260|11549958|FG001|NOT COMPLETED|Overall Study||8
10405682|NCT00741260|11549959|FG002|NOT COMPLETED|Overall Study||4
10405683|NCT00741260|11549960|FG003|NOT COMPLETED|Overall Study||6
10405684|NCT00741260|11549961|FG004|NOT COMPLETED|Overall Study||9
10405685|NCT00741260|11549962|FG005|NOT COMPLETED|Overall Study||45
10405686|NCT00741260|11549963|FG006|NOT COMPLETED|Overall Study||7
10405687|NCT00741273|11549986|FG000|STARTED|Overall Study||8
10405688|NCT00741273|11549987|FG001|STARTED|Overall Study||8
10405689|NCT00741273|11549986|FG000|COMPLETED|Overall Study||8
10405690|NCT00741273|11549987|FG001|COMPLETED|Overall Study||8
10405691|NCT00741273|11549986|FG000|NOT COMPLETED|Overall Study||0
10405692|NCT00741273|11549987|FG001|NOT COMPLETED|Overall Study||0
10405693|NCT00741286|11549999|FG000|STARTED|Overall Study||103
10405694|NCT00741286|11550000|FG001|STARTED|Overall Study||100
10405695|NCT00741286|11549999|FG000|COMPLETED|Overall Study||83
10405696|NCT00741286|11550000|FG001|COMPLETED|Overall Study||81
10405697|NCT00741286|11549999|FG000|NOT COMPLETED|Overall Study||20
10405698|NCT00741286|11550000|FG001|NOT COMPLETED|Overall Study||19
10405699|NCT00741338|11550008|FG000|STARTED|Overall Study||3
10405700|NCT00741338|11550009|FG001|STARTED|Overall Study||3
10405701|NCT00741338|11550008|FG000|COMPLETED|Overall Study||3
10405702|NCT00741338|11550009|FG001|COMPLETED|Overall Study||2
10405703|NCT00741338|11550008|FG000|NOT COMPLETED|Overall Study||0
10405704|NCT00741338|11550009|FG001|NOT COMPLETED|Overall Study||1
10405705|NCT00741390|11550015|FG000|STARTED|Visit 1||62
10723000|NCT02586025|11886838|FG000|STARTED|Treatment-Free Follow-Up||59
10405706|NCT00741390|11550016|FG001|STARTED|Visit 1||63
10405707|NCT00741390|11550017|FG002|STARTED|Visit 1||62
10405708|NCT00741390|11550018|FG003|STARTED|Visit 1||63
10405709|NCT00741390|11550015|FG000|COMPLETED|Visit 1||60
10405710|NCT00741390|11550016|FG001|COMPLETED|Visit 1||63
10405711|NCT00741390|11550017|FG002|COMPLETED|Visit 1||55
10405712|NCT00741390|11550018|FG003|COMPLETED|Visit 1||62
10405713|NCT00741390|11550015|FG000|NOT COMPLETED|Visit 1||2
10405714|NCT00741390|11550016|FG001|NOT COMPLETED|Visit 1||0
10405715|NCT00741390|11550017|FG002|NOT COMPLETED|Visit 1||7
10405716|NCT00741390|11550018|FG003|NOT COMPLETED|Visit 1||1
10405717|NCT00741390|11550015|FG000|STARTED|Visit 2|1 subject lost to follow-up between Visit 1 and Visit 2.|59
10405718|NCT00741390|11550016|FG001|STARTED|Visit 2|2 subjects lost to follow-up between Visit 1 and Visit 2.|61
10405719|NCT00741390|11550017|FG002|STARTED|Visit 2||55
10405720|NCT00741390|11550018|FG003|STARTED|Visit 2|1 subject lost to follow-up between Visit 1 and Visit 2.|61
10405721|NCT00741390|11550015|FG000|COMPLETED|Visit 2||59
10405722|NCT00741390|11550016|FG001|COMPLETED|Visit 2||61
10405723|NCT00741390|11550017|FG002|COMPLETED|Visit 2||54
10405724|NCT00741390|11550018|FG003|COMPLETED|Visit 2||60
10405725|NCT00741390|11550015|FG000|NOT COMPLETED|Visit 2||0
10405726|NCT00741390|11550016|FG001|NOT COMPLETED|Visit 2||0
10405727|NCT00741390|11550017|FG002|NOT COMPLETED|Visit 2||1
10405728|NCT00741390|11550018|FG003|NOT COMPLETED|Visit 2||1
10405729|NCT00741455|11550037|FG000|STARTED|Overall Study||18
10405730|NCT00741455|11550037|FG000|COMPLETED|Overall Study||17
10405731|NCT00741455|11550037|FG000|NOT COMPLETED|Overall Study||1
10405732|NCT00741468|11550041|FG000|STARTED|Overall Study||18
10405733|NCT00741468|11550041|FG000|COMPLETED|Overall Study||18
10405734|NCT00741468|11550041|FG000|NOT COMPLETED|Overall Study||0
10405735|NCT00741598|11550051|FG000|STARTED|Overall Study||33
10405736|NCT00741598|11550052|FG001|STARTED|Overall Study||39
10405737|NCT00741598|11550051|FG000|COMPLETED|Overall Study||24
10405738|NCT00741598|11550052|FG001|COMPLETED|Overall Study||30
10405739|NCT00741598|11550051|FG000|NOT COMPLETED|Overall Study||9
10405740|NCT00741598|11550052|FG001|NOT COMPLETED|Overall Study||9
10405741|NCT00741611|11550062|FG000|STARTED|Overall Study||4
10405742|NCT00741611|11550063|FG001|STARTED|Overall Study||3
10405743|NCT00741611|11550064|FG002|STARTED|Overall Study||29
10405744|NCT00741611|11550062|FG000|COMPLETED|Overall Study||4
10405745|NCT00741611|11550063|FG001|COMPLETED|Overall Study||1
10405746|NCT00741611|11550064|FG002|COMPLETED|Overall Study||26
10405747|NCT00741611|11550062|FG000|NOT COMPLETED|Overall Study||0
10405748|NCT00741611|11550063|FG001|NOT COMPLETED|Overall Study||2
10405749|NCT00741611|11550064|FG002|NOT COMPLETED|Overall Study||3
10405750|NCT00741819|11550073|FG000|STARTED|Overall Study||73
10405751|NCT00741819|11550073|FG000|COMPLETED|Overall Study||65
10405752|NCT00741819|11550073|FG000|NOT COMPLETED|Overall Study||8
10405753|NCT00741858|11550081|FG000|STARTED|Overall Study||16
10405754|NCT00741858|11550082|FG001|STARTED|Overall Study||18
10405755|NCT00741858|11550081|FG000|COMPLETED|Overall Study||16
10405756|NCT00741858|11550082|FG001|COMPLETED|Overall Study||18
10405757|NCT00741858|11550081|FG000|NOT COMPLETED|Overall Study||0
10723001|NCT02586025|11886839|FG001|STARTED|Treatment-Free Follow-Up||38
10723002|NCT02586025|11886838|FG000|COMPLETED|Treatment-Free Follow-Up||3
10723003|NCT02586025|11886839|FG001|COMPLETED|Treatment-Free Follow-Up||3
10723004|NCT02586025|11886838|FG000|NOT COMPLETED|Treatment-Free Follow-Up||56
10723005|NCT02586025|11886839|FG001|NOT COMPLETED|Treatment-Free Follow-Up||35
10723021|NCT02569242|11886871|FG000|STARTED|Overall Study|Included in intention-to-treat analysis for overall survival and progression-free survival|210
10723022|NCT02569242|11886872|FG001|STARTED|Overall Study|Included in intention-to-treat analysis for overall survival and progression-free survival|209
10723023|NCT02569242|11886871|FG000|COMPLETED|Overall Study|Analysed for safety|209
10723024|NCT02569242|11886872|FG001|COMPLETED|Overall Study|Analysed for safety|208
10723025|NCT02569242|11886871|FG000|NOT COMPLETED|Overall Study||1
10723026|NCT02569242|11886872|FG001|NOT COMPLETED|Overall Study||1
10723027|NCT02524379|11886878|FG000|STARTED|Overall Study||3
10723028|NCT02524379|11886878|FG000|COMPLETED|Overall Study||2
10723029|NCT02524379|11886878|FG000|NOT COMPLETED|Overall Study||1
10405842|NCT00742391|11550209|FG001|STARTED|Overall Study||129
10405758|NCT00741858|11550082|FG001|NOT COMPLETED|Overall Study||0
10405759|NCT00741936|11550090|FG000|STARTED|Overall Study||60
10405760|NCT00741936|11550091|FG001|STARTED|Overall Study||60
10405761|NCT00741936|11550090|FG000|COMPLETED|Overall Study||51
10405762|NCT00741936|11550091|FG001|COMPLETED|Overall Study||52
10405763|NCT00741936|11550090|FG000|NOT COMPLETED|Overall Study||9
10405764|NCT00741936|11550091|FG001|NOT COMPLETED|Overall Study||8
10723042|NCT02445456|11886894|FG000|STARTED|Overall Study||13
10405765|NCT00742001|11550100|FG000|STARTED|Overall Study||4
10405766|NCT00742001|11550101|FG001|STARTED|Overall Study||4
10405767|NCT00742001|11550102|FG002|STARTED|Overall Study||4
10723043|NCT02445456|11886895|FG001|STARTED|Overall Study||2
10723044|NCT02445456|11886894|FG000|COMPLETED|Overall Study||13
10405768|NCT00742001|11550100|FG000|COMPLETED|Overall Study||4
10405769|NCT00742001|11550101|FG001|COMPLETED|Overall Study||4
10405770|NCT00742001|11550102|FG002|COMPLETED|Overall Study||3
10405771|NCT00742001|11550100|FG000|NOT COMPLETED|Overall Study||0
10405772|NCT00742001|11550101|FG001|NOT COMPLETED|Overall Study||0
10405773|NCT00742001|11550102|FG002|NOT COMPLETED|Overall Study||1
10405774|NCT00742027|11550113|FG000|STARTED|Overall Study||129
10405775|NCT00742027|11550113|FG000|COMPLETED|Overall Study||0
10405776|NCT00742027|11550113|FG000|NOT COMPLETED|Overall Study||129
10405777|NCT00742053|11550117|FG000|STARTED|Overall Study||7
10405778|NCT00742053|11550117|FG000|COMPLETED|Overall Study||7
10405779|NCT00742053|11550117|FG000|NOT COMPLETED|Overall Study||0
10405780|NCT00742079|11550123|FG000|STARTED|Overall Study||11
10405781|NCT00742079|11550124|FG001|STARTED|Overall Study||10
10405782|NCT00742079|11550123|FG000|Baseline/Week 1 (Received Dose 1)|Overall Study||11
10405783|NCT00742079|11550124|FG001|Baseline/Week 1 (Received Dose 1)|Overall Study||9
10405784|NCT00742079|11550123|FG000|Week 2 (Received Dose 2)|Overall Study||11
10405785|NCT00742079|11550124|FG001|Week 2 (Received Dose 2)|Overall Study||9
10405786|NCT00742079|11550123|FG000|COMPLETED|Overall Study||11
10405787|NCT00742079|11550124|FG001|COMPLETED|Overall Study||9
10405788|NCT00742079|11550123|FG000|NOT COMPLETED|Overall Study||0
10405789|NCT00742079|11550124|FG001|NOT COMPLETED|Overall Study||1
10405790|NCT00742170|11550132|FG000|STARTED|Overall Study||26
10405791|NCT00742170|11550133|FG001|STARTED|Overall Study||29
10405792|NCT00742170|11550132|FG000|COMPLETED|Overall Study||24
10405793|NCT00742170|11550133|FG001|COMPLETED|Overall Study||24
10405794|NCT00742170|11550132|FG000|NOT COMPLETED|Overall Study||2
10405795|NCT00742170|11550133|FG001|NOT COMPLETED|Overall Study||5
10405796|NCT00742183|11550141|FG000|STARTED|Overall Study|50 subjects randomised, one of them did not receive any treatment.|49
10405797|NCT00742183|11550142|FG001|STARTED|Overall Study||51
10405798|NCT00742183|11550141|FG000|COMPLETED|Overall Study||40
10405799|NCT00742183|11550142|FG001|COMPLETED|Overall Study||39
10405800|NCT00742183|11550141|FG000|NOT COMPLETED|Overall Study||9
10405801|NCT00742183|11550142|FG001|NOT COMPLETED|Overall Study||12
10405802|NCT00742209|11550153|FG000|STARTED|Overall Study||129
10405803|NCT00742209|11550154|FG001|STARTED|Overall Study||67
10405804|NCT00742209|11550155|FG002|STARTED|Overall Study||134
10405805|NCT00742209|11550156|FG003|STARTED|Overall Study||134
10405806|NCT00742209|11550157|FG004|STARTED|Overall Study||62
10405807|NCT00742209|11550153|FG000|COMPLETED|Overall Study||95
10405808|NCT00742209|11550154|FG001|COMPLETED|Overall Study||49
10405809|NCT00742209|11550155|FG002|COMPLETED|Overall Study||88
10405810|NCT00742209|11550156|FG003|COMPLETED|Overall Study||97
10405811|NCT00742209|11550157|FG004|COMPLETED|Overall Study||37
10405812|NCT00742209|11550153|FG000|NOT COMPLETED|Overall Study||34
10405813|NCT00742209|11550154|FG001|NOT COMPLETED|Overall Study||18
10405814|NCT00742209|11550155|FG002|NOT COMPLETED|Overall Study||46
10405815|NCT00742209|11550156|FG003|NOT COMPLETED|Overall Study||37
10405816|NCT00742209|11550157|FG004|NOT COMPLETED|Overall Study||25
10405817|NCT00742235|11550172|FG000|STARTED|Overall Study||32
10405818|NCT00742235|11550173|FG001|STARTED|Overall Study||67
10405819|NCT00742235|11550172|FG000|COMPLETED|Overall Study||32
10405820|NCT00742235|11550173|FG001|COMPLETED|Overall Study||36
10405821|NCT00742235|11550172|FG000|NOT COMPLETED|Overall Study||0
10405822|NCT00742235|11550173|FG001|NOT COMPLETED|Overall Study||31
10405823|NCT00742274|11550181|FG000|STARTED|Overall Study||30
10405824|NCT00742274|11550182|FG001|STARTED|Overall Study||31
10405825|NCT00742274|11550181|FG000|COMPLETED|Overall Study||27
10405826|NCT00742274|11550182|FG001|COMPLETED|Overall Study||28
10405827|NCT00742274|11550181|FG000|NOT COMPLETED|Overall Study||3
10405828|NCT00742274|11550182|FG001|NOT COMPLETED|Overall Study||3
10405829|NCT00742313|11550190|FG000|STARTED|Overall Study||25
10405830|NCT00742313|11550191|FG001|STARTED|Overall Study||19
10405831|NCT00742313|11550190|FG000|COMPLETED|Overall Study||24
10405832|NCT00742313|11550191|FG001|COMPLETED|Overall Study||19
10405833|NCT00742313|11550190|FG000|NOT COMPLETED|Overall Study||1
10405834|NCT00742313|11550191|FG001|NOT COMPLETED|Overall Study||0
10405835|NCT00742326|11550199|FG000|STARTED|Overall Study||6
10405836|NCT00742326|11550200|FG001|STARTED|Overall Study||7
10405837|NCT00742326|11550199|FG000|COMPLETED|Overall Study||6
10405838|NCT00742326|11550200|FG001|COMPLETED|Overall Study||6
10405839|NCT00742326|11550199|FG000|NOT COMPLETED|Overall Study||0
10405840|NCT00742326|11550200|FG001|NOT COMPLETED|Overall Study||1
10405841|NCT00742391|11550208|FG000|STARTED|Overall Study||126
10405843|NCT00742391|11550208|FG000|COMPLETED|Overall Study||122
10405844|NCT00742391|11550209|FG001|COMPLETED|Overall Study||128
10405845|NCT00742391|11550208|FG000|NOT COMPLETED|Overall Study||4
10405846|NCT00742391|11550209|FG001|NOT COMPLETED|Overall Study||1
10405847|NCT00742417|11550217|FG000|STARTED|Randomized||21
10405848|NCT00742417|11550218|FG001|STARTED|Randomized||21
10405849|NCT00742417|11550217|FG000|COMPLETED|Randomized||19
10405850|NCT00742417|11550218|FG001|COMPLETED|Randomized||20
10405851|NCT00742417|11550217|FG000|NOT COMPLETED|Randomized||2
10405852|NCT00742417|11550218|FG001|NOT COMPLETED|Randomized||1
10405853|NCT00742417|11550217|FG000|STARTED|Intensive Period||19
10405854|NCT00742417|11550218|FG001|STARTED|Intensive Period||20
10405855|NCT00742417|11550217|FG000|COMPLETED|Intensive Period|16 patients completed all the 6 plasma exchange with Albutein 5% during the Intensive Period|16
10405856|NCT00742417|11550218|FG001|COMPLETED|Intensive Period|19 control patients completed all the 6 plasma exchange during the Intensive Period|19
10405857|NCT00742417|11550217|FG000|NOT COMPLETED|Intensive Period||3
10405858|NCT00742417|11550218|FG001|NOT COMPLETED|Intensive Period||1
10405859|NCT00742417|11550217|FG000|STARTED|Maintenance I||16
10405860|NCT00742417|11550218|FG001|STARTED|Maintenance I||19
10405861|NCT00742417|11550217|FG000|COMPLETED|Maintenance I||16
10405862|NCT00742417|11550218|FG001|COMPLETED|Maintenance I||19
10405863|NCT00742417|11550217|FG000|NOT COMPLETED|Maintenance I||0
10405864|NCT00742417|11550218|FG001|NOT COMPLETED|Maintenance I||0
10405865|NCT00742417|11550217|FG000|STARTED|Maintenance II||16
10405866|NCT00742417|11550218|FG001|STARTED|Maintenance II||19
10405867|NCT00742417|11550217|FG000|COMPLETED|Maintenance II||16
10405868|NCT00742417|11550218|FG001|COMPLETED|Maintenance II||19
10405869|NCT00742417|11550217|FG000|NOT COMPLETED|Maintenance II||0
10405870|NCT00742417|11550218|FG001|NOT COMPLETED|Maintenance II||0
10405871|NCT00742469|11550228|FG000|STARTED|Overall Study||106
10405872|NCT00742469|11550229|FG001|STARTED|Overall Study||104
10405873|NCT00742469|11550228|FG000|COMPLETED|Overall Study||88
10405874|NCT00742469|11550229|FG001|COMPLETED|Overall Study||69
10405875|NCT00742469|11550228|FG000|NOT COMPLETED|Overall Study||18
10723045|NCT02445456|11886895|FG001|COMPLETED|Overall Study||2
10723046|NCT02445456|11886894|FG000|NOT COMPLETED|Overall Study||0
10723047|NCT02445456|11886895|FG001|NOT COMPLETED|Overall Study||0
10723051|NCT02427568|11886907|FG000|STARTED|Overall Study||5
10723052|NCT02427568|11886908|FG001|STARTED|Overall Study||13
10723053|NCT02427568|11886907|FG000|COMPLETED|Overall Study||5
10723054|NCT02427568|11886908|FG001|COMPLETED|Overall Study||13
10723055|NCT02427568|11886907|FG000|NOT COMPLETED|Overall Study||0
10723056|NCT02427568|11886908|FG001|NOT COMPLETED|Overall Study||0
10723077|NCT02340676|11886944|FG000|STARTED|Overall Study||25
10723078|NCT02340676|11886944|FG000|COMPLETED|Overall Study||25
10723079|NCT02340676|11886944|FG000|NOT COMPLETED|Overall Study||0
10723086|NCT02282345|11886959|FG000|STARTED|Overall Study||13
10723087|NCT02282345|11886960|FG001|STARTED|Overall Study||20
10723088|NCT02282345|11886959|FG000|COMPLETED|Overall Study||13
10723089|NCT02282345|11886960|FG001|COMPLETED|Overall Study||19
10723090|NCT02282345|11886959|FG000|NOT COMPLETED|Overall Study||0
10723091|NCT02282345|11886960|FG001|NOT COMPLETED|Overall Study||1
10814452|NCT02346877|11977191|FG001|STARTED|Overall Study||0
10814453|NCT02346877|11977190|FG000|COMPLETED|Overall Study||0
10405876|NCT00742469|11550229|FG001|NOT COMPLETED|Overall Study||35
10405877|NCT00742508|11550237|FG000|STARTED|8-Week Primary Evaluation Period||22
10405878|NCT00742508|11550238|FG001|STARTED|8-Week Primary Evaluation Period||19
10814454|NCT02346877|11977191|FG001|COMPLETED|Overall Study||0
10814455|NCT02346877|11977190|FG000|NOT COMPLETED|Overall Study||19
10814456|NCT02346877|11977191|FG001|NOT COMPLETED|Overall Study||0
10814457|NCT02351063|11977197|FG000|STARTED|Overall Study||1
10405934|NCT00742859|11550310|FG001|NOT COMPLETED|Overall Study||12
10814458|NCT02351063|11977197|FG000|COMPLETED|Overall Study|Study terminated. No study data collected.|1
10814459|NCT02351063|11977197|FG000|NOT COMPLETED|Overall Study||0
10814460|NCT02345772|11977201|FG000|STARTED|Overall Study||4
10814461|NCT02345772|11977201|FG000|COMPLETED|Overall Study||0
10814462|NCT02345772|11977201|FG000|NOT COMPLETED|Overall Study||4
10814463|NCT02340728|11977207|FG000|STARTED|Overall Study||13
10814464|NCT02340728|11977208|FG001|STARTED|Overall Study||11
10814465|NCT02340728|11977207|FG000|COMPLETED|Overall Study||13
10814466|NCT02340728|11977208|FG001|COMPLETED|Overall Study||11
10405879|NCT00742508|11550237|FG000|COMPLETED|8-Week Primary Evaluation Period||11
10405880|NCT00742508|11550238|FG001|COMPLETED|8-Week Primary Evaluation Period||8
10405881|NCT00742508|11550237|FG000|NOT COMPLETED|8-Week Primary Evaluation Period||11
10405882|NCT00742508|11550238|FG001|NOT COMPLETED|8-Week Primary Evaluation Period||11
10405883|NCT00742508|11550237|FG000|STARTED|4-Week Exploratory Evaluation Period||0
10405884|NCT00742508|11550238|FG001|STARTED|4-Week Exploratory Evaluation Period||8
10405885|NCT00742508|11550237|FG000|COMPLETED|4-Week Exploratory Evaluation Period||0
10405886|NCT00742508|11550238|FG001|COMPLETED|4-Week Exploratory Evaluation Period||7
10405887|NCT00742508|11550237|FG000|NOT COMPLETED|4-Week Exploratory Evaluation Period||0
10405888|NCT00742508|11550238|FG001|NOT COMPLETED|4-Week Exploratory Evaluation Period||1
10405889|NCT00742560|11550249|FG000|STARTED|Overall Study||3
10405890|NCT00742560|11550250|FG001|STARTED|Overall Study||3
10405891|NCT00742560|11550251|FG002|STARTED|Overall Study||22
10405892|NCT00742560|11550252|FG003|STARTED|Overall Study||36
10405893|NCT00742560|11550253|FG004|STARTED|Overall Study||37
10405894|NCT00742560|11550249|FG000|COMPLETED|Overall Study||0
10405895|NCT00742560|11550250|FG001|COMPLETED|Overall Study||0
10405896|NCT00742560|11550251|FG002|COMPLETED|Overall Study||0
10405897|NCT00742560|11550252|FG003|COMPLETED|Overall Study||0
10405898|NCT00742560|11550253|FG004|COMPLETED|Overall Study||0
10405899|NCT00742560|11550249|FG000|NOT COMPLETED|Overall Study||3
10405900|NCT00742560|11550250|FG001|NOT COMPLETED|Overall Study||3
10405901|NCT00742560|11550251|FG002|NOT COMPLETED|Overall Study||22
10405902|NCT00742560|11550252|FG003|NOT COMPLETED|Overall Study||36
10405903|NCT00742560|11550253|FG004|NOT COMPLETED|Overall Study||37
10405904|NCT00742573|11550286|FG000|STARTED|Overall Study||83
10405905|NCT00742573|11550287|FG001|STARTED|Overall Study||87
10405906|NCT00742573|11550286|FG000|Week 12|Overall Study||46
10405907|NCT00742573|11550287|FG001|Week 12|Overall Study||51
10405908|NCT00742573|11550286|FG000|Week 24|Overall Study||39
10405909|NCT00742573|11550287|FG001|Week 24|Overall Study||37
10405910|NCT00742573|11550286|FG000|Week 52|Overall Study||26
10405911|NCT00742573|11550287|FG001|Week 52|Overall Study||25
10405912|NCT00742573|11550286|FG000|COMPLETED|Overall Study||26
10405913|NCT00742573|11550287|FG001|COMPLETED|Overall Study||25
10405914|NCT00742573|11550286|FG000|NOT COMPLETED|Overall Study||57
10405915|NCT00742573|11550287|FG001|NOT COMPLETED|Overall Study||62
10405916|NCT00742625|11550293|FG000|STARTED|Remission Induction||95
10405917|NCT00742625|11550293|FG000|COMPLETED|Remission Induction||41
10405918|NCT00742625|11550293|FG000|NOT COMPLETED|Remission Induction||54
10405919|NCT00742625|11550293|FG000|STARTED|Consolidation||41
10405920|NCT00742625|11550293|FG000|COMPLETED|Consolidation||20
10405921|NCT00742625|11550293|FG000|NOT COMPLETED|Consolidation||21
10405922|NCT00742781|11550300|FG000|STARTED|Overall Study||21
10405923|NCT00742781|11550300|FG000|COMPLETED|Overall Study||18
10405924|NCT00742781|11550300|FG000|NOT COMPLETED|Overall Study||3
10405925|NCT00742859|11550309|FG000|STARTED|Overall Study||127
10405926|NCT00742859|11550310|FG001|STARTED|Overall Study||127
10405927|NCT00742859|11550311|FG002|STARTED|Overall Study||127
10405928|NCT00742859|11550312|FG003|STARTED|Overall Study||127
10405929|NCT00742859|11550309|FG000|COMPLETED|Overall Study||116
10405930|NCT00742859|11550310|FG001|COMPLETED|Overall Study||115
10405931|NCT00742859|11550311|FG002|COMPLETED|Overall Study||116
10405932|NCT00742859|11550312|FG003|COMPLETED|Overall Study||119
10814467|NCT02340728|11977207|FG000|NOT COMPLETED|Overall Study||0
10814468|NCT02340728|11977208|FG001|NOT COMPLETED|Overall Study||0
10723116|NCT02120469|11886991|FG000|STARTED|Overall Study||13
10723117|NCT02120469|11886992|FG001|STARTED|Overall Study||10
10723118|NCT02120469|11886993|FG002|STARTED|Overall Study||4
10723119|NCT02120469|11886991|FG000|COMPLETED|Overall Study||12
10723120|NCT02120469|11886992|FG001|COMPLETED|Overall Study||10
10723121|NCT02120469|11886993|FG002|COMPLETED|Overall Study||3
10723122|NCT02120469|11886991|FG000|NOT COMPLETED|Overall Study||1
10723123|NCT02120469|11886992|FG001|NOT COMPLETED|Overall Study||0
10723124|NCT02120469|11886993|FG002|NOT COMPLETED|Overall Study||1
10723125|NCT02109744|11887006|FG000|STARTED|Overall Study||26
10723126|NCT02109744|11887007|FG001|STARTED|Overall Study||1
10723127|NCT02109744|11887006|FG000|COMPLETED|Overall Study||24
10723128|NCT02109744|11887007|FG001|COMPLETED|Overall Study||0
10723129|NCT02109744|11887006|FG000|NOT COMPLETED|Overall Study||2
10723130|NCT02109744|11887007|FG001|NOT COMPLETED|Overall Study||1
10723131|NCT02008396|11887015|FG000|STARTED|Overall Study||4
10723132|NCT02008396|11887016|FG001|STARTED|Overall Study||8
10723133|NCT02008396|11887015|FG000|COMPLETED|Overall Study||4
10723134|NCT02008396|11887016|FG001|COMPLETED|Overall Study||7
10723135|NCT02008396|11887015|FG000|NOT COMPLETED|Overall Study||0
10723136|NCT02008396|11887016|FG001|NOT COMPLETED|Overall Study||1
10723137|NCT02000622|11887025|FG000|STARTED|Overall Study||205
10723138|NCT02000622|11887026|FG001|STARTED|Overall Study||97
10723139|NCT02000622|11887025|FG000|COMPLETED|Overall Study||36
10723140|NCT02000622|11887026|FG001|COMPLETED|Overall Study||17
10405933|NCT00742859|11550309|FG000|NOT COMPLETED|Overall Study||11
10405935|NCT00742859|11550311|FG002|NOT COMPLETED|Overall Study||11
10405936|NCT00742859|11550312|FG003|NOT COMPLETED|Overall Study||8
10405937|NCT00742872|11550324|FG000|STARTED|Overall Study||21
10405938|NCT00742872|11550325|FG001|STARTED|Overall Study||20
10405939|NCT00742872|11550324|FG000|COMPLETED|Overall Study||9
10405940|NCT00742872|11550325|FG001|COMPLETED|Overall Study||12
10405941|NCT00742872|11550324|FG000|NOT COMPLETED|Overall Study||12
10723141|NCT02000622|11887025|FG000|NOT COMPLETED|Overall Study||169
10405942|NCT00742872|11550325|FG001|NOT COMPLETED|Overall Study||8
10405943|NCT00742885|11550333|FG000|STARTED|Overall Study||50
10405944|NCT00742885|11550334|FG001|STARTED|Overall Study||50
10405945|NCT00742885|11550333|FG000|COMPLETED|Overall Study|to Day 182|49
10405946|NCT00742885|11550334|FG001|COMPLETED|Overall Study|to Day 182|50
10405947|NCT00742885|11550333|FG000|NOT COMPLETED|Overall Study||1
10405948|NCT00742885|11550334|FG001|NOT COMPLETED|Overall Study||0
10405949|NCT00742924|11550347|FG000|STARTED|Overall Study||6
10405950|NCT00742924|11550348|FG001|STARTED|Overall Study||6
10405951|NCT00742924|11550349|FG002|STARTED|Overall Study||6
10405952|NCT00742924|11550350|FG003|STARTED|Overall Study||6
10405953|NCT00742924|11550347|FG000|COMPLETED|Overall Study||1
10405954|NCT00742924|11550348|FG001|COMPLETED|Overall Study||4
10405955|NCT00742924|11550349|FG002|COMPLETED|Overall Study||2
10405956|NCT00742924|11550350|FG003|COMPLETED|Overall Study||0
10405957|NCT00742924|11550347|FG000|NOT COMPLETED|Overall Study||5
10405958|NCT00742924|11550348|FG001|NOT COMPLETED|Overall Study||2
10405959|NCT00742924|11550349|FG002|NOT COMPLETED|Overall Study||4
10405960|NCT00742924|11550350|FG003|NOT COMPLETED|Overall Study||6
10405961|NCT00742963|11550360|FG000|STARTED|Overall Study||101
10405962|NCT00742963|11550360|FG000|Completed All Treatment Cycles|Overall Study||68
10405963|NCT00742963|11550360|FG000|COMPLETED|Overall Study||68
10405964|NCT00742963|11550360|FG000|NOT COMPLETED|Overall Study||33
10405965|NCT00743093|11550366|FG000|STARTED|Base Study Period||224
10405966|NCT00743093|11550367|FG001|STARTED|Base Study Period||52
10405967|NCT00743093|11550366|FG000|COMPLETED|Base Study Period||205
10405968|NCT00743093|11550367|FG001|COMPLETED|Base Study Period||47
10405969|NCT00743093|11550366|FG000|NOT COMPLETED|Base Study Period||19
10405970|NCT00743093|11550367|FG001|NOT COMPLETED|Base Study Period||5
10405971|NCT00743093|11550366|FG000|STARTED|Extended Dosing Period|Subjects not meeting stopping criteria after base continued into the extended dosing.|51
10405972|NCT00743093|11550367|FG001|STARTED|Extended Dosing Period|Subjects not meeting stopping criteria after base continued into the extended dosing.|1
10405973|NCT00743093|11550366|FG000|COMPLETED|Extended Dosing Period||48
10405974|NCT00743093|11550367|FG001|COMPLETED|Extended Dosing Period||1
10405975|NCT00743093|11550366|FG000|NOT COMPLETED|Extended Dosing Period||3
10405976|NCT00743093|11550367|FG001|NOT COMPLETED|Extended Dosing Period||0
10405977|NCT00743106|11550375|FG000|STARTED|Overall Study||42
10405978|NCT00743106|11550376|FG001|STARTED|Overall Study||48
10405979|NCT00743106|11550375|FG000|COMPLETED|Overall Study||34
10405980|NCT00743106|11550376|FG001|COMPLETED|Overall Study||43
10405981|NCT00743106|11550375|FG000|NOT COMPLETED|Overall Study||8
10405982|NCT00743106|11550376|FG001|NOT COMPLETED|Overall Study||5
10405983|NCT00743119|11550382|FG000|STARTED|Overall Study||34
10405984|NCT00743119|11550382|FG000|COMPLETED|Overall Study||30
10405985|NCT00743119|11550382|FG000|NOT COMPLETED|Overall Study||4
10723142|NCT02000622|11887026|FG001|NOT COMPLETED|Overall Study||80
10723149|NCT01954966|11887047|FG000|STARTED|Overall Study||34
10723150|NCT01954966|11887048|FG001|STARTED|Overall Study||32
10723151|NCT01954966|11887047|FG000|Completed Week 1 of Intervention (Drug Assigned to Receive First)|Overall Study||30
10723152|NCT01954966|11887048|FG001|Completed Week 1 of Intervention (Drug Assigned to Receive First)|Overall Study||30
10723153|NCT01954966|11887047|FG000|Started Phase 2 After Washout Period (1-2 Week for Males, 1-3 Month for Females)|Overall Study||30
10723154|NCT01954966|11887048|FG001|Started Phase 2 After Washout Period (1-2 Week for Males, 1-3 Month for Females)|Overall Study||30
10723155|NCT01954966|11887047|FG000|Completed Week 2 of Intervention (Drug Assigned to Receive Second)|Overall Study||24
10723156|NCT01954966|11887048|FG001|Completed Week 2 of Intervention (Drug Assigned to Receive Second)|Overall Study||28
10723157|NCT01954966|11887047|FG000|COMPLETED|Overall Study||24
10723158|NCT01954966|11887048|FG001|COMPLETED|Overall Study||28
10723159|NCT01954966|11887047|FG000|NOT COMPLETED|Overall Study||10
10723160|NCT01954966|11887048|FG001|NOT COMPLETED|Overall Study||4
10723172|NCT01940341|11887070|FG000|STARTED|Double-Blind Phase||285
10723173|NCT01940341|11887071|FG001|STARTED|Double-Blind Phase||141
10723174|NCT01940341|11887070|FG000|COMPLETED|Double-Blind Phase||4
10723175|NCT01940341|11887071|FG001|COMPLETED|Double-Blind Phase||1
10405986|NCT00743145|11550394|FG000|STARTED|Overall Study||23
10405987|NCT00743145|11550394|FG000|COMPLETED|Overall Study||19
10405988|NCT00743145|11550394|FG000|NOT COMPLETED|Overall Study||4
10405989|NCT00743249|11550410|FG000|STARTED|Overall Study||30
10405990|NCT00743249|11550411|FG001|STARTED|Overall Study||30
10405991|NCT00743249|11550410|FG000|COMPLETED|Overall Study||28
10405992|NCT00743249|11550411|FG001|COMPLETED|Overall Study||24
10723176|NCT01940341|11887070|FG000|NOT COMPLETED|Double-Blind Phase||281
10405993|NCT00743249|11550410|FG000|NOT COMPLETED|Overall Study||2
10405994|NCT00743249|11550411|FG001|NOT COMPLETED|Overall Study||6
10405995|NCT00743262|11550417|FG000|STARTED|Overall Study||15
10405996|NCT00743262|11550417|FG000|COMPLETED|Overall Study||15
10405997|NCT00743262|11550417|FG000|NOT COMPLETED|Overall Study||0
10544354|NCT01490450|11697606|FG003|STARTED|Period 1||41
10544355|NCT01490450|11697603|FG000|COMPLETED|Period 1||38
10544356|NCT01490450|11697604|FG001|COMPLETED|Period 1||40
10544357|NCT01490450|11697605|FG002|COMPLETED|Period 1||38
10544358|NCT01490450|11697606|FG003|COMPLETED|Period 1||33
10544359|NCT01490450|11697603|FG000|NOT COMPLETED|Period 1||3
10544360|NCT01490450|11697604|FG001|NOT COMPLETED|Period 1||1
10544361|NCT01490450|11697605|FG002|NOT COMPLETED|Period 1||4
10544362|NCT01490450|11697606|FG003|NOT COMPLETED|Period 1||8
10544363|NCT01490450|11697603|FG000|STARTED|Period 2||38
10544364|NCT01490450|11697604|FG001|STARTED|Period 2||40
10544365|NCT01490450|11697605|FG002|STARTED|Period 2||37
10544366|NCT01490450|11697606|FG003|STARTED|Period 2||32
10544367|NCT01490450|11697603|FG000|COMPLETED|Period 2||36
10544368|NCT01490450|11697604|FG001|COMPLETED|Period 2||39
10544369|NCT01490450|11697605|FG002|COMPLETED|Period 2||37
10544370|NCT01490450|11697606|FG003|COMPLETED|Period 2||28
10544371|NCT01490450|11697603|FG000|NOT COMPLETED|Period 2||2
10544372|NCT01490450|11697604|FG001|NOT COMPLETED|Period 2||1
10544373|NCT01490450|11697605|FG002|NOT COMPLETED|Period 2||0
10544374|NCT01490450|11697606|FG003|NOT COMPLETED|Period 2||4
10544375|NCT01490580|11697621|FG000|STARTED|Overall Study||82
10544376|NCT01490580|11697622|FG001|STARTED|Overall Study||91
10544377|NCT01490580|11697621|FG000|COMPLETED|Overall Study||82
10544378|NCT01490580|11697622|FG001|COMPLETED|Overall Study||89
10544379|NCT01490580|11697621|FG000|NOT COMPLETED|Overall Study||0
10544380|NCT01490580|11697622|FG001|NOT COMPLETED|Overall Study||2
10544381|NCT01490632|11697637|FG000|STARTED|Part A: Initial Treatment Period||34
10544382|NCT01490632|11697638|FG001|STARTED|Part A: Initial Treatment Period||32
10544383|NCT01490632|11697639|FG002|STARTED|Part A: Initial Treatment Period||72
10544384|NCT01490632|11697640|FG003|STARTED|Part A: Initial Treatment Period||64
10544385|NCT01490632|11697641|FG004|STARTED|Part A: Initial Treatment Period||69
10544386|NCT01490632|11697642|FG005|STARTED|Part A: Initial Treatment Period||0
10544387|NCT01490632|11697643|FG006|STARTED|Part A: Initial Treatment Period||0
10544388|NCT01490632|11697644|FG007|STARTED|Part A: Initial Treatment Period||0
10544389|NCT01490632|11697645|FG008|STARTED|Part A: Initial Treatment Period||0
10544390|NCT01490632|11697646|FG009|STARTED|Part A: Initial Treatment Period||0
10544391|NCT01490632|11697647|FG010|STARTED|Part A: Initial Treatment Period||0
10544392|NCT01490632|11697648|FG011|STARTED|Part A: Initial Treatment Period||0
10544393|NCT01490632|11697649|FG012|STARTED|Part A: Initial Treatment Period||0
10544394|NCT01490632|11697650|FG013|STARTED|Part A: Initial Treatment Period||0
10544395|NCT01490632|11697651|FG014|STARTED|Part A: Initial Treatment Period||0
10544396|NCT01490632|11697652|FG015|STARTED|Part A: Initial Treatment Period||0
10544397|NCT01490632|11697653|FG016|STARTED|Part A: Initial Treatment Period||0
10544398|NCT01490632|11697654|FG017|STARTED|Part A: Initial Treatment Period||0
10544399|NCT01490632|11697655|FG018|STARTED|Part A: Initial Treatment Period||0
10544400|NCT01490632|11697656|FG019|STARTED|Part A: Initial Treatment Period||0
10544401|NCT01490632|11697637|FG000|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||34
10544402|NCT01490632|11697638|FG001|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||32
10544403|NCT01490632|11697639|FG002|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||72
10723177|NCT01940341|11887071|FG001|NOT COMPLETED|Double-Blind Phase||140
10723178|NCT01940341|11887070|FG000|STARTED|Open-label Extension Phase||4
10723179|NCT01940341|11887071|FG001|STARTED|Open-label Extension Phase||1
10723180|NCT01940341|11887070|FG000|COMPLETED|Open-label Extension Phase||0
10723181|NCT01940341|11887071|FG001|COMPLETED|Open-label Extension Phase||0
10723182|NCT01940341|11887070|FG000|NOT COMPLETED|Open-label Extension Phase||4
10723183|NCT01940341|11887071|FG001|NOT COMPLETED|Open-label Extension Phase||1
10723196|NCT01866657|11887099|FG000|STARTED|Overall Study||38
10723197|NCT01866657|11887100|FG001|STARTED|Overall Study||36
10723198|NCT01866657|11887099|FG000|COMPLETED|Overall Study||36
10723199|NCT01866657|11887100|FG001|COMPLETED|Overall Study||36
10723200|NCT01866657|11887099|FG000|NOT COMPLETED|Overall Study||2
10723201|NCT01866657|11887100|FG001|NOT COMPLETED|Overall Study||0
10544404|NCT01490632|11697640|FG003|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||64
10723258|NCT01222247|11887172|FG001|NOT COMPLETED|Overall Study||2
10544405|NCT01490632|11697641|FG004|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||69
10544406|NCT01490632|11697642|FG005|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
10544407|NCT01490632|11697643|FG006|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
10548257|NCT01518699|11702085|FG000|COMPLETED|Period 1||10
10405998|NCT00743275|11550423|FG000|STARTED|Overall Study||59
10405999|NCT00743275|11550424|FG001|STARTED|Overall Study||61
10406000|NCT00743275|11550423|FG000|COMPLETED|Overall Study||59
10406001|NCT00743275|11550424|FG001|COMPLETED|Overall Study||60
10406002|NCT00743275|11550423|FG000|NOT COMPLETED|Overall Study||0
10406003|NCT00743275|11550424|FG001|NOT COMPLETED|Overall Study||1
10406004|NCT00743288|11550430|FG000|STARTED|Overall Study||3
10406005|NCT00743288|11550431|FG001|STARTED|Overall Study||3
10406006|NCT00743288|11550432|FG002|STARTED|Overall Study||6
10406007|NCT00743288|11550433|FG003|STARTED|Overall Study||7
10406008|NCT00743288|11550434|FG004|STARTED|Overall Study||6
10406009|NCT00743288|11550435|FG005|STARTED|Overall Study||6
10406010|NCT00743288|11550436|FG006|STARTED|Overall Study|6 subjects were enrolled in phase 1 and 3 subjects were enrolled as part of the phase 2 expansion.|9
10406011|NCT00743288|11550430|FG000|COMPLETED|Overall Study||0
10406012|NCT00743288|11550431|FG001|COMPLETED|Overall Study||0
10406013|NCT00743288|11550432|FG002|COMPLETED|Overall Study||1
10406014|NCT00743288|11550433|FG003|COMPLETED|Overall Study||0
10406015|NCT00743288|11550434|FG004|COMPLETED|Overall Study||0
10406016|NCT00743288|11550435|FG005|COMPLETED|Overall Study||1
10406017|NCT00743288|11550436|FG006|COMPLETED|Overall Study||0
10406018|NCT00743288|11550430|FG000|NOT COMPLETED|Overall Study||3
10406019|NCT00743288|11550431|FG001|NOT COMPLETED|Overall Study||3
10406020|NCT00743288|11550432|FG002|NOT COMPLETED|Overall Study||5
10406021|NCT00743288|11550433|FG003|NOT COMPLETED|Overall Study||7
10406022|NCT00743288|11550434|FG004|NOT COMPLETED|Overall Study||6
10406023|NCT00743288|11550435|FG005|NOT COMPLETED|Overall Study||5
10406024|NCT00743288|11550436|FG006|NOT COMPLETED|Overall Study||9
10406025|NCT00743340|11550447|FG000|STARTED|Overall Study||50
10406026|NCT00743340|11550447|FG000|COMPLETED|Overall Study||9
10406027|NCT00743340|11550447|FG000|NOT COMPLETED|Overall Study||41
10406028|NCT00743366|11550451|FG000|STARTED|Intervention 1 (8 Days)||10
10406029|NCT00743366|11550452|FG001|STARTED|Intervention 1 (8 Days)||10
10406030|NCT00743366|11550451|FG000|COMPLETED|Intervention 1 (8 Days)|A total of 6 participants withdrew before completion of the final inpatient phase|7
10406031|NCT00743366|11550452|FG001|COMPLETED|Intervention 1 (8 Days)|A total of 6 participants withdrew before completion of the final inpatient phase|7
10406032|NCT00743366|11550451|FG000|NOT COMPLETED|Intervention 1 (8 Days)||3
10406033|NCT00743366|11550452|FG001|NOT COMPLETED|Intervention 1 (8 Days)||3
10406034|NCT00743366|11550451|FG000|STARTED|Intervention 2 (8 Days)||7
10406035|NCT00743366|11550452|FG001|STARTED|Intervention 2 (8 Days)||7
10406036|NCT00743366|11550451|FG000|COMPLETED|Intervention 2 (8 Days)||7
10406037|NCT00743366|11550452|FG001|COMPLETED|Intervention 2 (8 Days)||7
10406038|NCT00743366|11550451|FG000|NOT COMPLETED|Intervention 2 (8 Days)||0
10406039|NCT00743366|11550452|FG001|NOT COMPLETED|Intervention 2 (8 Days)||0
10429043|NCT00862745|11575256|FG000|STARTED|Open-label Follow-up|19 participants elected not to enter the open-label portion of the study after completing the RCT.|268
10429044|NCT00862745|11575257|FG001|STARTED|Open-label Follow-up|10 participants elected not to enter the open-label portion of the study after completing the RCT.|274
10429045|NCT00862745|11575256|FG000|COMPLETED|Open-label Follow-up||229
10429046|NCT00862745|11575257|FG001|COMPLETED|Open-label Follow-up||225
10429047|NCT00862745|11575256|FG000|NOT COMPLETED|Open-label Follow-up||39
10429048|NCT00862745|11575257|FG001|NOT COMPLETED|Open-label Follow-up||49
10429049|NCT00862784|11575263|FG000|STARTED|Overall Study||48
10814469|NCT02353572|11977214|FG000|STARTED|Overall Study||3
10814470|NCT02353572|11977214|FG000|COMPLETED|Overall Study||0
10429050|NCT00862784|11575263|FG000|Received Any Amount of Study Drug|Overall Study||48
10429051|NCT00862784|11575263|FG000|COMPLETED|Overall Study||48
10429052|NCT00862784|11575263|FG000|NOT COMPLETED|Overall Study||0
10429053|NCT00862810|11575269|FG000|STARTED|Overall Study||33
10429054|NCT00862810|11575270|FG001|STARTED|Overall Study||39
10429055|NCT00862810|11575269|FG000|COMPLETED|Overall Study||29
10429056|NCT00862810|11575270|FG001|COMPLETED|Overall Study||35
10429057|NCT00862810|11575269|FG000|NOT COMPLETED|Overall Study||4
10429058|NCT00862810|11575270|FG001|NOT COMPLETED|Overall Study||4
10429059|NCT00862823|11575276|FG000|STARTED|First Intervention||6
10429060|NCT00862823|11575277|FG001|STARTED|First Intervention||10
10429061|NCT00862823|11575276|FG000|COMPLETED|First Intervention||5
10429062|NCT00862823|11575277|FG001|COMPLETED|First Intervention||9
10429063|NCT00862823|11575276|FG000|NOT COMPLETED|First Intervention||1
10429064|NCT00862823|11575277|FG001|NOT COMPLETED|First Intervention||1
10429065|NCT00862823|11575276|FG000|STARTED|Washout Period of 2 Weeks||5
10429066|NCT00862823|11575277|FG001|STARTED|Washout Period of 2 Weeks||9
10429067|NCT00862823|11575276|FG000|COMPLETED|Washout Period of 2 Weeks||5
10429068|NCT00862823|11575277|FG001|COMPLETED|Washout Period of 2 Weeks||9
10429069|NCT00862823|11575276|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
10429070|NCT00862823|11575277|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
10429071|NCT00862823|11575276|FG000|STARTED|Second Intervention||5
10429072|NCT00862823|11575277|FG001|STARTED|Second Intervention||9
10429073|NCT00862823|11575276|FG000|COMPLETED|Second Intervention||5
10429074|NCT00862823|11575277|FG001|COMPLETED|Second Intervention||9
10429075|NCT00862823|11575276|FG000|NOT COMPLETED|Second Intervention||0
10429076|NCT00862823|11575277|FG001|NOT COMPLETED|Second Intervention||0
10429077|NCT00862836|11575282|FG000|STARTED|Overall Study||15
10429078|NCT00862836|11575282|FG000|Evaluable for Safety/Toxicity|Overall Study|1 patient withdrew consent before first cycle|14
10429079|NCT00862836|11575282|FG000|Evaluable for Activity (Tumour Response)|Overall Study||10
10429080|NCT00862836|11575282|FG000|COMPLETED|Overall Study||14
10429081|NCT00862836|11575282|FG000|NOT COMPLETED|Overall Study||1
10406040|NCT00743431|11550458|FG000|STARTED|Overall Study||224
10406041|NCT00743431|11550458|FG000|COMPLETED|Overall Study||98
10406042|NCT00743431|11550458|FG000|NOT COMPLETED|Overall Study||126
10406043|NCT00743444|11550462|FG000|STARTED|First Intervention||14
10406044|NCT00743444|11550463|FG001|STARTED|First Intervention||13
10406045|NCT00743444|11550462|FG000|COMPLETED|First Intervention||14
10406046|NCT00743444|11550463|FG001|COMPLETED|First Intervention||12
10406047|NCT00743444|11550462|FG000|NOT COMPLETED|First Intervention||0
10406048|NCT00743444|11550463|FG001|NOT COMPLETED|First Intervention||1
10406049|NCT00743444|11550462|FG000|STARTED|Washout Period||14
10406050|NCT00743444|11550463|FG001|STARTED|Washout Period||12
10406051|NCT00743444|11550462|FG000|COMPLETED|Washout Period||14
10406052|NCT00743444|11550463|FG001|COMPLETED|Washout Period||11
10406053|NCT00743444|11550462|FG000|NOT COMPLETED|Washout Period||0
10406054|NCT00743444|11550463|FG001|NOT COMPLETED|Washout Period||1
10406055|NCT00743444|11550462|FG000|STARTED|Second Intervention||14
10406056|NCT00743444|11550463|FG001|STARTED|Second Intervention||11
10406057|NCT00743444|11550462|FG000|COMPLETED|Second Intervention||14
10406058|NCT00743444|11550463|FG001|COMPLETED|Second Intervention||11
10406059|NCT00743444|11550462|FG000|NOT COMPLETED|Second Intervention||0
10406060|NCT00743444|11550463|FG001|NOT COMPLETED|Second Intervention||0
10406061|NCT00743483|11550469|FG000|STARTED|Baseline Period||15
10406062|NCT00743483|11550469|FG000|COMPLETED|Baseline Period||14
10406063|NCT00743483|11550469|FG000|NOT COMPLETED|Baseline Period||1
10406064|NCT00743483|11550469|FG000|STARTED|Treatment Period||14
10406065|NCT00743483|11550469|FG000|COMPLETED|Treatment Period||13
10406066|NCT00743483|11550469|FG000|NOT COMPLETED|Treatment Period||1
10406067|NCT00743509|11550473|FG000|STARTED|Overall Study||49
10406068|NCT00743509|11550473|FG000|COMPLETED|Overall Study||47
10406069|NCT00743509|11550473|FG000|NOT COMPLETED|Overall Study||2
10406070|NCT00743574|11550477|FG000|STARTED|Overall Study||36
10723217|NCT01705977|11887121|FG000|STARTED|Overall Study||2002
10723218|NCT01705977|11887122|FG001|STARTED|Overall Study||2001
10723219|NCT01705977|11887121|FG000|COMPLETED|Overall Study||1729
10723220|NCT01705977|11887122|FG001|COMPLETED|Overall Study||1741
10723221|NCT01705977|11887121|FG000|NOT COMPLETED|Overall Study||273
10723222|NCT01705977|11887122|FG001|NOT COMPLETED|Overall Study||260
10723223|NCT01689740|11887131|FG000|STARTED|Overall Study||2
10723224|NCT01689740|11887132|FG001|STARTED|Overall Study||3
10723225|NCT01689740|11887133|FG002|STARTED|Overall Study||5
10723226|NCT01689740|11887131|FG000|COMPLETED|Overall Study||2
10723227|NCT01689740|11887132|FG001|COMPLETED|Overall Study||3
10723228|NCT01689740|11887133|FG002|COMPLETED|Overall Study||5
10723229|NCT01689740|11887131|FG000|NOT COMPLETED|Overall Study||0
10723230|NCT01689740|11887132|FG001|NOT COMPLETED|Overall Study||0
10723231|NCT01689740|11887133|FG002|NOT COMPLETED|Overall Study||0
10814471|NCT02353572|11977214|FG000|NOT COMPLETED|Overall Study||3
10814472|NCT02345369|11977220|FG000|STARTED|Overall Study||0
10814473|NCT02345369|11977221|FG001|STARTED|Overall Study||0
10814474|NCT02345369|11977220|FG000|COMPLETED|Overall Study||0
10814475|NCT02345369|11977221|FG001|COMPLETED|Overall Study||0
10814476|NCT02345369|11977220|FG000|NOT COMPLETED|Overall Study||0
10723241|NCT01366092|11887161|FG000|STARTED|Overall Study||35
10723242|NCT01366092|11887161|FG000|COMPLETED|Overall Study||31
10723243|NCT01366092|11887161|FG000|NOT COMPLETED|Overall Study||4
10723247|NCT01222247|11887171|FG000|STARTED|Overall Study||1429
10723248|NCT01222247|11887172|FG001|STARTED|Overall Study||1402
10723249|NCT01222247|11887171|FG000|Received 2 Doses|Overall Study||860
10723250|NCT01222247|11887172|FG001|Received 2 Doses|Overall Study||826
10723251|NCT01222247|11887171|FG000|Received 1 Dose|Overall Study||568
10723252|NCT01222247|11887172|FG001|Received 1 Dose|Overall Study||571
10723253|NCT01222247|11887171|FG000|Did Not Receive Assigned Medication|Overall Study||1
10723254|NCT01222247|11887172|FG001|Did Not Receive Assigned Medication|Overall Study||5
10723255|NCT01222247|11887171|FG000|COMPLETED|Overall Study||1427
10723256|NCT01222247|11887172|FG001|COMPLETED|Overall Study||1400
10723257|NCT01222247|11887171|FG000|NOT COMPLETED|Overall Study||2
10406071|NCT00743574|11550477|FG000|Dropped Out Before Eligibility Testing|Overall Study||13
10406072|NCT00743574|11550477|FG000|Further Exclusions|Overall Study||8
10723280|NCT01107626|11887215|FG000|STARTED|Step 1: Induction Therapy||642
10723281|NCT01107626|11887216|FG001|STARTED|Step 1: Induction Therapy||287
10723282|NCT01107626|11887217|FG002|STARTED|Step 1: Induction Therapy||294
10723283|NCT01107626|11887218|FG003|STARTED|Step 1: Induction Therapy||293
10723284|NCT01107626|11887215|FG000|COMPLETED|Step 1: Induction Therapy||65
10723285|NCT01107626|11887216|FG001|COMPLETED|Step 1: Induction Therapy||287
10723286|NCT01107626|11887217|FG002|COMPLETED|Step 1: Induction Therapy||294
10723287|NCT01107626|11887218|FG003|COMPLETED|Step 1: Induction Therapy||293
10723288|NCT01107626|11887215|FG000|NOT COMPLETED|Step 1: Induction Therapy||577
10723289|NCT01107626|11887216|FG001|NOT COMPLETED|Step 1: Induction Therapy||0
10723290|NCT01107626|11887217|FG002|NOT COMPLETED|Step 1: Induction Therapy||0
10723291|NCT01107626|11887218|FG003|NOT COMPLETED|Step 1: Induction Therapy||0
10723292|NCT01107626|11887215|FG000|STARTED|Step 2: Maintenance Therapy|Patients without complete/partial response or stable disease post induction phase weren't randomized|0
10723293|NCT01107626|11887216|FG001|STARTED|Step 2: Maintenance Therapy||287
10723294|NCT01107626|11887217|FG002|STARTED|Step 2: Maintenance Therapy||294
10723295|NCT01107626|11887218|FG003|STARTED|Step 2: Maintenance Therapy||293
10723296|NCT01107626|11887215|FG000|COMPLETED|Step 2: Maintenance Therapy|Patients without complete/partial response or stable disease post induction phase weren't randomized|0
10723297|NCT01107626|11887216|FG001|COMPLETED|Step 2: Maintenance Therapy||1
10723298|NCT01107626|11887217|FG002|COMPLETED|Step 2: Maintenance Therapy||0
10723299|NCT01107626|11887218|FG003|COMPLETED|Step 2: Maintenance Therapy||1
10723300|NCT01107626|11887215|FG000|NOT COMPLETED|Step 2: Maintenance Therapy||0
10723301|NCT01107626|11887216|FG001|NOT COMPLETED|Step 2: Maintenance Therapy||286
10723302|NCT01107626|11887217|FG002|NOT COMPLETED|Step 2: Maintenance Therapy||294
10723303|NCT01107626|11887218|FG003|NOT COMPLETED|Step 2: Maintenance Therapy||292
10723307|NCT00920387|11887233|FG000|STARTED|Stage 1||8
10723308|NCT00920387|11887234|FG001|STARTED|Stage 1||4
10723309|NCT00920387|11887235|FG002|STARTED|Stage 1||0
10723310|NCT00920387|11887233|FG000|COMPLETED|Stage 1||7
10723311|NCT00920387|11887234|FG001|COMPLETED|Stage 1||4
10723312|NCT00920387|11887235|FG002|COMPLETED|Stage 1||0
10723313|NCT00920387|11887233|FG000|NOT COMPLETED|Stage 1||1
10723314|NCT00920387|11887234|FG001|NOT COMPLETED|Stage 1||0
10723315|NCT00920387|11887235|FG002|NOT COMPLETED|Stage 1||0
10723316|NCT00920387|11887233|FG000|STARTED|Stage 2||0
10723317|NCT00920387|11887234|FG001|STARTED|Stage 2||0
10723318|NCT00920387|11887235|FG002|STARTED|Stage 2||3
10723319|NCT00920387|11887233|FG000|COMPLETED|Stage 2||0
10723320|NCT00920387|11887234|FG001|COMPLETED|Stage 2||0
10723321|NCT00920387|11887235|FG002|COMPLETED|Stage 2||3
10723322|NCT00920387|11887233|FG000|NOT COMPLETED|Stage 2||0
10723323|NCT00920387|11887234|FG001|NOT COMPLETED|Stage 2||0
10723324|NCT00920387|11887235|FG002|NOT COMPLETED|Stage 2||0
10406073|NCT00743574|11550477|FG000|Dropped Out After Initiating Trial|Overall Study||3
10406074|NCT00743574|11550477|FG000|COMPLETED|Overall Study||12
10406075|NCT00743574|11550477|FG000|NOT COMPLETED|Overall Study||24
10406076|NCT00743652|11550486|FG000|STARTED|Overall Study||151
10406077|NCT00743652|11550487|FG001|STARTED|Overall Study||51
10406078|NCT00743652|11550488|FG002|STARTED|Overall Study||25
10406079|NCT00743652|11550489|FG003|STARTED|Overall Study||67
10406080|NCT00743652|11550490|FG004|STARTED|Overall Study||79
10406081|NCT00743652|11550486|FG000|Vaccinated Dose 1|Overall Study||151
10406082|NCT00743652|11550487|FG001|Vaccinated Dose 1|Overall Study||51
10406083|NCT00743652|11550488|FG002|Vaccinated Dose 1|Overall Study||25
10406084|NCT00743652|11550489|FG003|Vaccinated Dose 1|Overall Study||66
10406085|NCT00743652|11550490|FG004|Vaccinated Dose 1|Overall Study||79
10406086|NCT00743652|11550486|FG000|Vaccinated Dose 2|Overall Study||112
10406087|NCT00743652|11550487|FG001|Vaccinated Dose 2|Overall Study||41
10406088|NCT00743652|11550488|FG002|Vaccinated Dose 2|Overall Study||0
10406089|NCT00743652|11550489|FG003|Vaccinated Dose 2|Overall Study||49
10406090|NCT00743652|11550490|FG004|Vaccinated Dose 2|Overall Study||0
10406091|NCT00743652|11550486|FG000|Vaccinated Dose 3|Overall Study||74
10406092|NCT00743652|11550487|FG001|Vaccinated Dose 3|Overall Study||0
10548258|NCT01518699|11702086|FG001|COMPLETED|Period 1||9
10406093|NCT00743652|11550488|FG002|Vaccinated Dose 3|Overall Study||0
10406094|NCT00743652|11550489|FG003|Vaccinated Dose 3|Overall Study||0
10406095|NCT00743652|11550490|FG004|Vaccinated Dose 3|Overall Study||0
10406096|NCT00743652|11550486|FG000|Toddler Dose|Overall Study||15
10406097|NCT00743652|11550487|FG001|Toddler Dose|Overall Study||23
10406098|NCT00743652|11550488|FG002|Toddler Dose|Overall Study||16
10406099|NCT00743652|11550489|FG003|Toddler Dose|Overall Study||0
10406100|NCT00743652|11550490|FG004|Toddler Dose|Overall Study||0
10406101|NCT00743652|11550486|FG000|COMPLETED|Overall Study||141
10406102|NCT00743652|11550487|FG001|COMPLETED|Overall Study||48
10406103|NCT00743652|11550488|FG002|COMPLETED|Overall Study||23
10406104|NCT00743652|11550489|FG003|COMPLETED|Overall Study||63
10406105|NCT00743652|11550490|FG004|COMPLETED|Overall Study||79
10406106|NCT00743652|11550486|FG000|NOT COMPLETED|Overall Study||10
10406107|NCT00743652|11550487|FG001|NOT COMPLETED|Overall Study||3
10406108|NCT00743652|11550488|FG002|NOT COMPLETED|Overall Study||2
10406109|NCT00743652|11550489|FG003|NOT COMPLETED|Overall Study||4
10406110|NCT00743652|11550490|FG004|NOT COMPLETED|Overall Study||0
10406111|NCT00743717|11550508|FG000|STARTED|Overall Study||2
10406112|NCT00743717|11550509|FG001|STARTED|Overall Study||2
10406113|NCT00743717|11550508|FG000|COMPLETED|Overall Study||2
10406114|NCT00743717|11550509|FG001|COMPLETED|Overall Study||2
10406115|NCT00743717|11550508|FG000|NOT COMPLETED|Overall Study||0
10406116|NCT00743717|11550509|FG001|NOT COMPLETED|Overall Study||0
10406117|NCT00743730|11550518|FG000|STARTED|Overall Study||27
10406118|NCT00743730|11550519|FG001|STARTED|Overall Study||34
10406119|NCT00743730|11550520|FG002|STARTED|Overall Study||33
10406120|NCT00743730|11550518|FG000|COMPLETED|Overall Study||22
10406121|NCT00743730|11550519|FG001|COMPLETED|Overall Study||30
10406122|NCT00743730|11550520|FG002|COMPLETED|Overall Study||28
10406123|NCT00743730|11550518|FG000|NOT COMPLETED|Overall Study||5
10406124|NCT00743730|11550519|FG001|NOT COMPLETED|Overall Study||4
10406125|NCT00743730|11550520|FG002|NOT COMPLETED|Overall Study||5
10406126|NCT00744042|11550532|FG000|STARTED|Overall Study||11
10406127|NCT00744042|11550532|FG000|COMPLETED|Overall Study||10
10406128|NCT00744042|11550532|FG000|NOT COMPLETED|Overall Study||1
10406129|NCT00744055|11550544|FG000|STARTED|Overall Study||50
10406130|NCT00744055|11550545|FG001|STARTED|Overall Study||46
10406131|NCT00744055|11550544|FG000|COMPLETED|Overall Study||43
10406132|NCT00744055|11550545|FG001|COMPLETED|Overall Study||32
10406133|NCT00744055|11550544|FG000|NOT COMPLETED|Overall Study||7
10406134|NCT00744055|11550545|FG001|NOT COMPLETED|Overall Study||14
10406135|NCT00744211|11550554|FG000|STARTED|Baseline||10
10406136|NCT00744211|11550555|FG001|STARTED|Baseline||9
10406137|NCT00744211|11550556|FG002|STARTED|Baseline||10
10406138|NCT00744211|11550554|FG000|COMPLETED|Baseline||10
10406139|NCT00744211|11550555|FG001|COMPLETED|Baseline||9
10406140|NCT00744211|11550556|FG002|COMPLETED|Baseline||10
10406141|NCT00744211|11550554|FG000|NOT COMPLETED|Baseline||0
10406142|NCT00744211|11550555|FG001|NOT COMPLETED|Baseline||0
10406143|NCT00744211|11550556|FG002|NOT COMPLETED|Baseline||0
10406144|NCT00744211|11550554|FG000|STARTED|0.5 Hours After Cardiopulmonary Bypass||10
10406145|NCT00744211|11550555|FG001|STARTED|0.5 Hours After Cardiopulmonary Bypass||9
10406146|NCT00744211|11550556|FG002|STARTED|0.5 Hours After Cardiopulmonary Bypass||10
10406147|NCT00744211|11550554|FG000|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||10
10406148|NCT00744211|11550555|FG001|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||9
10406149|NCT00744211|11550556|FG002|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||10
10406150|NCT00744211|11550554|FG000|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
10406151|NCT00744211|11550555|FG001|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
10406152|NCT00744211|11550556|FG002|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
10406153|NCT00744211|11550554|FG000|STARTED|6 Hours After Cardiopulmonary Bypass||10
10406154|NCT00744211|11550555|FG001|STARTED|6 Hours After Cardiopulmonary Bypass||9
10406155|NCT00744211|11550556|FG002|STARTED|6 Hours After Cardiopulmonary Bypass||10
10406156|NCT00744211|11550554|FG000|COMPLETED|6 Hours After Cardiopulmonary Bypass||10
10406157|NCT00744211|11550555|FG001|COMPLETED|6 Hours After Cardiopulmonary Bypass||9
10406158|NCT00744211|11550556|FG002|COMPLETED|6 Hours After Cardiopulmonary Bypass||10
10406159|NCT00744211|11550554|FG000|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
10406160|NCT00744211|11550555|FG001|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
10406161|NCT00744211|11550556|FG002|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
10406162|NCT00744211|11550554|FG000|STARTED|12 Hours After Cardiopulmonary Bypass||10
10406163|NCT00744211|11550555|FG001|STARTED|12 Hours After Cardiopulmonary Bypass||9
10406164|NCT00744211|11550556|FG002|STARTED|12 Hours After Cardiopulmonary Bypass||10
10406165|NCT00744211|11550554|FG000|COMPLETED|12 Hours After Cardiopulmonary Bypass||10
10406166|NCT00744211|11550555|FG001|COMPLETED|12 Hours After Cardiopulmonary Bypass||9
10406167|NCT00744211|11550556|FG002|COMPLETED|12 Hours After Cardiopulmonary Bypass||10
10406168|NCT00744211|11550554|FG000|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
10406169|NCT00744211|11550555|FG001|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
10406170|NCT00744211|11550556|FG002|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
10406171|NCT00744211|11550554|FG000|STARTED|24 Hours After Cardiopulmonary Bypass||10
10406172|NCT00744211|11550555|FG001|STARTED|24 Hours After Cardiopulmonary Bypass||9
10406173|NCT00744211|11550556|FG002|STARTED|24 Hours After Cardiopulmonary Bypass||10
10406174|NCT00744211|11550554|FG000|COMPLETED|24 Hours After Cardiopulmonary Bypass||10
10406175|NCT00744211|11550555|FG001|COMPLETED|24 Hours After Cardiopulmonary Bypass||9
10406176|NCT00744211|11550556|FG002|COMPLETED|24 Hours After Cardiopulmonary Bypass||10
10406177|NCT00744211|11550554|FG000|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
10406178|NCT00744211|11550555|FG001|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
10406179|NCT00744211|11550556|FG002|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
10406180|NCT00744237|11550570|FG000|STARTED|Overall Study||83
10406181|NCT00744237|11550571|FG001|STARTED|Overall Study||73
10406182|NCT00744237|11550572|FG002|STARTED|Overall Study||74
10406183|NCT00744237|11550570|FG000|COMPLETED|Overall Study||56
10406184|NCT00744237|11550571|FG001|COMPLETED|Overall Study||46
10406185|NCT00744237|11550572|FG002|COMPLETED|Overall Study||59
10406186|NCT00744237|11550570|FG000|NOT COMPLETED|Overall Study||27
10406187|NCT00744237|11550571|FG001|NOT COMPLETED|Overall Study||27
10406188|NCT00744237|11550572|FG002|NOT COMPLETED|Overall Study||15
10406189|NCT00744263|11550582|FG000|STARTED|Overall Study||42240
10406190|NCT00744263|11550583|FG001|STARTED|Overall Study||42256
10406191|NCT00744263|11550582|FG000|COMPLETED|Overall Study||37004
10406192|NCT00744263|11550583|FG001|COMPLETED|Overall Study||36936
10406193|NCT00744263|11550582|FG000|NOT COMPLETED|Overall Study||5236
10406194|NCT00744263|11550583|FG001|NOT COMPLETED|Overall Study||5320
10814477|NCT02345369|11977221|FG001|NOT COMPLETED|Overall Study||0
10814478|NCT02343263|11977230|FG000|STARTED|Overall Study|Study closed due for administrative reasons|5
10406195|NCT00744328|11550594|FG000|STARTED|Overall Study||26
10406196|NCT00744328|11550595|FG001|STARTED|Overall Study||30
10406197|NCT00744328|11550596|FG002|STARTED|Overall Study||29
10406198|NCT00744328|11550594|FG000|COMPLETED|Overall Study||19
10406199|NCT00744328|11550595|FG001|COMPLETED|Overall Study||22
10406200|NCT00744328|11550596|FG002|COMPLETED|Overall Study||21
10406201|NCT00744328|11550594|FG000|NOT COMPLETED|Overall Study||7
10406202|NCT00744328|11550595|FG001|NOT COMPLETED|Overall Study||8
10406203|NCT00744328|11550596|FG002|NOT COMPLETED|Overall Study||8
10406204|NCT00744380|11550606|FG000|STARTED|Overall Study||12
10406205|NCT00744380|11550607|FG001|STARTED|Overall Study||11
10406206|NCT00744380|11550606|FG000|COMPLETED|Overall Study||12
10406207|NCT00744380|11550607|FG001|COMPLETED|Overall Study||11
10406208|NCT00744380|11550606|FG000|NOT COMPLETED|Overall Study||0
10406209|NCT00744380|11550607|FG001|NOT COMPLETED|Overall Study||0
10406210|NCT00744471|11550618|FG000|STARTED|Overall Study||156
10406211|NCT00744471|11550619|FG001|STARTED|Overall Study||156
10406212|NCT00744471|11550620|FG002|STARTED|Overall Study||158
10406213|NCT00744471|11550621|FG003|STARTED|Overall Study||157
10406214|NCT00744471|11550618|FG000|Treated|Overall Study||155
10406215|NCT00744471|11550619|FG001|Treated|Overall Study||155
10406216|NCT00744471|11550620|FG002|Treated|Overall Study||154
10406217|NCT00744471|11550621|FG003|Treated|Overall Study||157
10406218|NCT00744471|11550618|FG000|COMPLETED|Overall Study||13
10406219|NCT00744471|11550619|FG001|COMPLETED|Overall Study||11
10406220|NCT00744471|11550620|FG002|COMPLETED|Overall Study||6
10406221|NCT00744471|11550621|FG003|COMPLETED|Overall Study||9
10406222|NCT00744471|11550618|FG000|NOT COMPLETED|Overall Study||143
10406223|NCT00744471|11550619|FG001|NOT COMPLETED|Overall Study||145
10406224|NCT00744471|11550620|FG002|NOT COMPLETED|Overall Study||152
10406225|NCT00744471|11550621|FG003|NOT COMPLETED|Overall Study||148
10406226|NCT00744497|11550633|FG000|STARTED|Overall Study|Randomized|760
10406227|NCT00744497|11550634|FG001|STARTED|Overall Study|Randomized|762
10406228|NCT00744497|11550633|FG000|Received Treatment|Overall Study||757
10406229|NCT00744497|11550634|FG001|Received Treatment|Overall Study||761
10406230|NCT00744497|11550633|FG000|COMPLETED|Overall Study||0
10406231|NCT00744497|11550634|FG001|COMPLETED|Overall Study||0
10406232|NCT00744497|11550633|FG000|NOT COMPLETED|Overall Study||760
10406233|NCT00744497|11550634|FG001|NOT COMPLETED|Overall Study||762
10406234|NCT00744523|11550642|FG000|STARTED|Procedure||37
10406235|NCT00744523|11550643|FG001|STARTED|Procedure||225
10406236|NCT00744523|11550642|FG000|COMPLETED|Procedure||37
10406237|NCT00744523|11550643|FG001|COMPLETED|Procedure||225
10406238|NCT00744523|11550642|FG000|NOT COMPLETED|Procedure||0
10406239|NCT00744523|11550643|FG001|NOT COMPLETED|Procedure||0
10406240|NCT00744523|11550642|FG000|STARTED|30 Days After the Procedure||37
10406241|NCT00744523|11550643|FG001|STARTED|30 Days After the Procedure||225
10406242|NCT00744523|11550642|FG000|COMPLETED|30 Days After the Procedure||37
10406243|NCT00744523|11550643|FG001|COMPLETED|30 Days After the Procedure||220
10814479|NCT02343263|11977231|FG001|STARTED|Overall Study||3
10406244|NCT00744523|11550642|FG000|NOT COMPLETED|30 Days After the Procedure||0
10406245|NCT00744523|11550643|FG001|NOT COMPLETED|30 Days After the Procedure||5
10406246|NCT00744627|11550653|FG000|STARTED|Overall Study||151
10406247|NCT00744627|11550654|FG001|STARTED|Overall Study||150
10406248|NCT00744627|11550653|FG000|Treated|Overall Study||150
10406249|NCT00744627|11550654|FG001|Treated|Overall Study||150
10406250|NCT00744627|11550653|FG000|COMPLETED|Overall Study||126
10406251|NCT00744627|11550654|FG001|COMPLETED|Overall Study||128
10406252|NCT00744627|11550653|FG000|NOT COMPLETED|Overall Study||25
10406253|NCT00744627|11550654|FG001|NOT COMPLETED|Overall Study||22
10406254|NCT00744653|11550660|FG000|STARTED|Overall Study||17
10406255|NCT00744653|11550660|FG000|COMPLETED|Overall Study||1
10406256|NCT00744653|11550660|FG000|NOT COMPLETED|Overall Study||16
10406257|NCT00744692|11550665|FG000|STARTED|Overall Study||22
10406258|NCT00744692|11550665|FG000|COMPLETED|Overall Study||22
10406259|NCT00744692|11550665|FG000|NOT COMPLETED|Overall Study||0
10406260|NCT00744757|11550669|FG000|STARTED|Overall Study||37
10406261|NCT00744757|11550669|FG000|COMPLETED|Overall Study||16
10406262|NCT00744757|11550669|FG000|NOT COMPLETED|Overall Study||21
10406263|NCT00744796|11550673|FG000|STARTED|Pre-operative||21
10406264|NCT00744796|11550673|FG000|COMPLETED|Pre-operative||21
10406265|NCT00744796|11550673|FG000|NOT COMPLETED|Pre-operative||0
10406266|NCT00744796|11550673|FG000|STARTED|Post-Operative Day 1||21
10406267|NCT00744796|11550673|FG000|COMPLETED|Post-Operative Day 1||21
10406268|NCT00744796|11550673|FG000|NOT COMPLETED|Post-Operative Day 1||0
10406269|NCT00744796|11550673|FG000|STARTED|Post-Operative 3-6 Months||21
10406270|NCT00744796|11550673|FG000|COMPLETED|Post-Operative 3-6 Months||21
10406271|NCT00744796|11550673|FG000|NOT COMPLETED|Post-Operative 3-6 Months||0
10406272|NCT00744796|11550673|FG000|STARTED|Post-Operative 6-9 Months||21
10406273|NCT00744796|11550673|FG000|COMPLETED|Post-Operative 6-9 Months||9
10406274|NCT00744796|11550673|FG000|NOT COMPLETED|Post-Operative 6-9 Months||12
10406275|NCT00744848|11550679|FG000|STARTED|Overall Study||103
10406276|NCT00744848|11550680|FG001|STARTED|Overall Study||101
10406277|NCT00744848|11550679|FG000|COMPLETED|Overall Study||103
10406278|NCT00744848|11550680|FG001|COMPLETED|Overall Study||101
10406279|NCT00744848|11550679|FG000|NOT COMPLETED|Overall Study||0
10406280|NCT00744848|11550680|FG001|NOT COMPLETED|Overall Study||0
10406281|NCT00744861|11550690|FG000|STARTED|Feasibility Stage 1|Stage 1: Study phase to determine the feasibility of the study treatment and assessments|8
10406282|NCT00744861|11550691|FG001|STARTED|Feasibility Stage 1|Stage 1: Study phase to determine the feasibility of the study treatment and assessments|10
10406283|NCT00744861|11550692|FG002|STARTED|Feasibility Stage 1|No subjects enrolled in Stage 1/Feasibility study|0
10406284|NCT00744861|11550693|FG003|STARTED|Feasibility Stage 1|No subjects enrolled in Stage 1/Feasibility study|0
10406285|NCT00744861|11550690|FG000|COMPLETED|Feasibility Stage 1||7
10406286|NCT00744861|11550691|FG001|COMPLETED|Feasibility Stage 1||8
10406287|NCT00744861|11550692|FG002|COMPLETED|Feasibility Stage 1||0
10406288|NCT00744861|11550693|FG003|COMPLETED|Feasibility Stage 1||0
10406289|NCT00744861|11550690|FG000|NOT COMPLETED|Feasibility Stage 1||1
10406290|NCT00744861|11550691|FG001|NOT COMPLETED|Feasibility Stage 1||2
10406291|NCT00744861|11550692|FG002|NOT COMPLETED|Feasibility Stage 1||0
10406292|NCT00744861|11550693|FG003|NOT COMPLETED|Feasibility Stage 1||0
10406293|NCT00744861|11550690|FG000|STARTED|Pivotal Stage 2|No subjects enrolled in Stage 2 pivotal study phase|0
10406294|NCT00744861|11550691|FG001|STARTED|Pivotal Stage 2|No subjects enrolled in Stage 2 pivotal study phase|0
10406295|NCT00744861|11550692|FG002|STARTED|Pivotal Stage 2|Stage 2 pivotal study phase assessed safety and effectiveness of LIPUS treatment via Exospine device|154
10406296|NCT00744861|11550693|FG003|STARTED|Pivotal Stage 2|Stage 2 pivotal study phase assessed safety and effectiveness of LIPUS treatment via Exospine device|156
10406297|NCT00744861|11550690|FG000|COMPLETED|Pivotal Stage 2||0
10406298|NCT00744861|11550691|FG001|COMPLETED|Pivotal Stage 2||0
10406299|NCT00744861|11550692|FG002|COMPLETED|Pivotal Stage 2||52
10406300|NCT00744861|11550693|FG003|COMPLETED|Pivotal Stage 2||51
10406301|NCT00744861|11550690|FG000|NOT COMPLETED|Pivotal Stage 2||0
10406302|NCT00744861|11550691|FG001|NOT COMPLETED|Pivotal Stage 2||0
10406303|NCT00744861|11550692|FG002|NOT COMPLETED|Pivotal Stage 2||102
10406304|NCT00744861|11550693|FG003|NOT COMPLETED|Pivotal Stage 2||105
10406305|NCT00744874|11550701|FG000|STARTED|Overall Study||55
10406306|NCT00744874|11550701|FG000|COMPLETED|Overall Study||51
10406307|NCT00744874|11550701|FG000|NOT COMPLETED|Overall Study||4
10406308|NCT00744939|11550716|FG000|STARTED|Overall Study||168
10406309|NCT00744939|11550716|FG000|Treatment Received|Overall Study||141
10406310|NCT00744939|11550716|FG000|COMPLETED|Overall Study||77
10406311|NCT00744939|11550716|FG000|NOT COMPLETED|Overall Study||91
10406312|NCT00744965|11550730|FG000|STARTED|Overall Study||197
10406313|NCT00744965|11550731|FG001|STARTED|Overall Study||198
10406314|NCT00744965|11550730|FG000|COMPLETED|Overall Study||186
10406315|NCT00744965|11550731|FG001|COMPLETED|Overall Study||189
10406316|NCT00744965|11550730|FG000|NOT COMPLETED|Overall Study||11
10406317|NCT00744965|11550731|FG001|NOT COMPLETED|Overall Study||9
10406318|NCT00744978|11550739|FG000|STARTED|Period 1||32
10406319|NCT00744978|11550740|FG001|STARTED|Period 1||34
10406320|NCT00744978|11550739|FG000|Treated|Period 1||31
10406321|NCT00744978|11550740|FG001|Treated|Period 1||33
10406322|NCT00744978|11550739|FG000|COMPLETED|Period 1||26
10406323|NCT00744978|11550740|FG001|COMPLETED|Period 1||29
10406324|NCT00744978|11550739|FG000|NOT COMPLETED|Period 1||6
10406325|NCT00744978|11550740|FG001|NOT COMPLETED|Period 1||5
10406326|NCT00744978|11550739|FG000|STARTED|Placebo Washout||26
10406327|NCT00744978|11550740|FG001|STARTED|Placebo Washout||29
10406328|NCT00744978|11550739|FG000|COMPLETED|Placebo Washout||26
10406329|NCT00744978|11550740|FG001|COMPLETED|Placebo Washout||29
10406330|NCT00744978|11550739|FG000|NOT COMPLETED|Placebo Washout||0
10406331|NCT00744978|11550740|FG001|NOT COMPLETED|Placebo Washout||0
10406332|NCT00744978|11550739|FG000|STARTED|Period 2||26
10406333|NCT00744978|11550740|FG001|STARTED|Period 2||29
10406334|NCT00744978|11550739|FG000|COMPLETED|Period 2||26
10406335|NCT00744978|11550740|FG001|COMPLETED|Period 2||28
10406336|NCT00744978|11550739|FG000|NOT COMPLETED|Period 2||0
10406337|NCT00744978|11550740|FG001|NOT COMPLETED|Period 2||1
10406338|NCT00744991|11550746|FG000|STARTED|Overall Study||25
10406339|NCT00744991|11550746|FG000|Received at Least 1 Dose|Overall Study||25
10406340|NCT00744991|11550746|FG000|COMPLETED|Overall Study||0
10406341|NCT00744991|11550746|FG000|NOT COMPLETED|Overall Study||25
10406342|NCT00745095|11550759|FG000|STARTED|Overall Study||15
10406343|NCT00745095|11550760|FG001|STARTED|Overall Study||15
10406344|NCT00745095|11550761|FG002|STARTED|Overall Study||15
10406345|NCT00745095|11550762|FG003|STARTED|Overall Study||15
10406346|NCT00745095|11550763|FG004|STARTED|Overall Study||150
10406347|NCT00745095|11550764|FG005|STARTED|Overall Study||150
10406348|NCT00745095|11550759|FG000|COMPLETED|Overall Study||14
10406349|NCT00745095|11550760|FG001|COMPLETED|Overall Study||13
10406350|NCT00745095|11550761|FG002|COMPLETED|Overall Study||12
10406351|NCT00745095|11550762|FG003|COMPLETED|Overall Study||12
10406352|NCT00745095|11550763|FG004|COMPLETED|Overall Study||28
10406353|NCT00745095|11550764|FG005|COMPLETED|Overall Study||27
10406354|NCT00745095|11550759|FG000|NOT COMPLETED|Overall Study||1
10406355|NCT00745095|11550760|FG001|NOT COMPLETED|Overall Study||2
10406356|NCT00745095|11550761|FG002|NOT COMPLETED|Overall Study||3
10406357|NCT00745095|11550762|FG003|NOT COMPLETED|Overall Study||3
10406358|NCT00745095|11550763|FG004|NOT COMPLETED|Overall Study||122
10406359|NCT00745095|11550764|FG005|NOT COMPLETED|Overall Study||123
10406360|NCT00745121|11550783|FG000|STARTED|Overall Study||20
10406361|NCT00745121|11550784|FG001|STARTED|Overall Study||28
10406362|NCT00745121|11550783|FG000|COMPLETED|Overall Study||11
10406363|NCT00745121|11550784|FG001|COMPLETED|Overall Study||26
10544408|NCT01490632|11697644|FG007|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
10544409|NCT01490632|11697645|FG008|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
10544410|NCT01490632|11697646|FG009|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
10544411|NCT01490632|11697647|FG010|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
10723458|NCT00353938|11887294|FG000|STARTED|Stage 1||9
10723459|NCT00353938|11887295|FG001|STARTED|Stage 1||5
10723460|NCT00353938|11887296|FG002|STARTED|Stage 1||0
10723461|NCT00353938|11887297|FG003|STARTED|Stage 1||0
10723462|NCT00353938|11887294|FG000|COMPLETED|Stage 1||8
10723463|NCT00353938|11887295|FG001|COMPLETED|Stage 1||5
10723464|NCT00353938|11887296|FG002|COMPLETED|Stage 1||0
10723465|NCT00353938|11887297|FG003|COMPLETED|Stage 1||0
10723466|NCT00353938|11887294|FG000|NOT COMPLETED|Stage 1||1
10723467|NCT00353938|11887295|FG001|NOT COMPLETED|Stage 1||0
10723468|NCT00353938|11887296|FG002|NOT COMPLETED|Stage 1||0
10723469|NCT00353938|11887297|FG003|NOT COMPLETED|Stage 1||0
10723470|NCT00353938|11887294|FG000|STARTED|Stage 2||0
10723471|NCT00353938|11887295|FG001|STARTED|Stage 2||0
10723472|NCT00353938|11887296|FG002|STARTED|Stage 2||4
10723473|NCT00353938|11887297|FG003|STARTED|Stage 2||0
10723474|NCT00353938|11887294|FG000|COMPLETED|Stage 2||0
10723475|NCT00353938|11887295|FG001|COMPLETED|Stage 2||0
10723476|NCT00353938|11887296|FG002|COMPLETED|Stage 2||4
10723477|NCT00353938|11887297|FG003|COMPLETED|Stage 2||0
10723478|NCT00353938|11887294|FG000|NOT COMPLETED|Stage 2||0
10723479|NCT00353938|11887295|FG001|NOT COMPLETED|Stage 2||0
10723480|NCT00353938|11887296|FG002|NOT COMPLETED|Stage 2||0
10723481|NCT00353938|11887297|FG003|NOT COMPLETED|Stage 2||0
10723482|NCT00353938|11887294|FG000|STARTED|Stage 3||0
10723483|NCT00353938|11887295|FG001|STARTED|Stage 3||0
10723484|NCT00353938|11887296|FG002|STARTED|Stage 3||0
10723485|NCT00353938|11887297|FG003|STARTED|Stage 3||3
10723486|NCT00353938|11887294|FG000|COMPLETED|Stage 3||0
10406364|NCT00745121|11550783|FG000|NOT COMPLETED|Overall Study||9
10406365|NCT00745121|11550784|FG001|NOT COMPLETED|Overall Study||2
10723487|NCT00353938|11887295|FG001|COMPLETED|Stage 3||0
10723488|NCT00353938|11887296|FG002|COMPLETED|Stage 3||0
10723489|NCT00353938|11887297|FG003|COMPLETED|Stage 3||3
10723490|NCT00353938|11887294|FG000|NOT COMPLETED|Stage 3||0
10723491|NCT00353938|11887295|FG001|NOT COMPLETED|Stage 3||0
10406366|NCT00745251|11550792|FG000|STARTED|Overall Study||23
10406367|NCT00745251|11550793|FG001|STARTED|Overall Study||22
10406368|NCT00745251|11550792|FG000|COMPLETED|Overall Study||21
10723492|NCT00353938|11887296|FG002|NOT COMPLETED|Stage 3||0
10723493|NCT00353938|11887297|FG003|NOT COMPLETED|Stage 3||0
10406369|NCT00745251|11550793|FG001|COMPLETED|Overall Study||19
10406370|NCT00745251|11550792|FG000|NOT COMPLETED|Overall Study||2
10406371|NCT00745251|11550793|FG001|NOT COMPLETED|Overall Study||3
10406372|NCT00745290|11550801|FG000|STARTED|Overall Study||123
10406373|NCT00745290|11550802|FG001|STARTED|Overall Study||122
10406374|NCT00745290|11550801|FG000|COMPLETED|Overall Study||123
10406375|NCT00745290|11550802|FG001|COMPLETED|Overall Study||122
10406376|NCT00745290|11550801|FG000|NOT COMPLETED|Overall Study||0
10406377|NCT00745290|11550802|FG001|NOT COMPLETED|Overall Study||0
10406378|NCT00745368|11550808|FG000|STARTED|Overall Study|Of the 28 subjects who enrolled, 19 participated in a study visit|19
10406379|NCT00745368|11550808|FG000|COMPLETED|Overall Study|3 male subjects were unable to provide a sample and are not included in the results|16
10406380|NCT00745368|11550808|FG000|NOT COMPLETED|Overall Study||3
10406381|NCT00745420|11550812|FG000|STARTED|Overall Study||30
10406382|NCT00745420|11550812|FG000|COMPLETED|Overall Study||29
10406383|NCT00745420|11550812|FG000|NOT COMPLETED|Overall Study||1
10406384|NCT00745498|11550819|FG000|STARTED|Overall Study||41
10406385|NCT00745498|11550820|FG001|STARTED|Overall Study||43
10406386|NCT00745498|11550821|FG002|STARTED|Overall Study||42
10406387|NCT00745498|11550819|FG000|COMPLETED|Overall Study||36
10406388|NCT00745498|11550820|FG001|COMPLETED|Overall Study||37
10406389|NCT00745498|11550821|FG002|COMPLETED|Overall Study||34
10406390|NCT00745498|11550819|FG000|NOT COMPLETED|Overall Study||5
10406391|NCT00745498|11550820|FG001|NOT COMPLETED|Overall Study||6
10406392|NCT00745498|11550821|FG002|NOT COMPLETED|Overall Study||8
10406393|NCT00745615|11550833|FG000|STARTED|Double-Blind Extension (36 Weeks)||80
10406394|NCT00745615|11550834|FG001|STARTED|Double-Blind Extension (36 Weeks)||94
10406395|NCT00745615|11550835|FG002|STARTED|Double-Blind Extension (36 Weeks)||39
10723494|NCT00090064|11887307|FG000|STARTED|Overall Study||15
10723495|NCT00090064|11887308|FG001|STARTED|Overall Study||8
10723496|NCT00090064|11887307|FG000|COMPLETED|Overall Study||12
10723497|NCT00090064|11887308|FG001|COMPLETED|Overall Study||8
10723498|NCT00090064|11887307|FG000|NOT COMPLETED|Overall Study||3
10723499|NCT00090064|11887308|FG001|NOT COMPLETED|Overall Study||0
10777412|NCT03339999|11939376|FG003|NOT COMPLETED|Overall Study||5
10777413|NCT03340025|11939391|FG000|STARTED|Overall Study||11
10777414|NCT03340025|11939392|FG001|STARTED|Overall Study||9
10777415|NCT03340025|11939391|FG000|COMPLETED|Overall Study||9
10777416|NCT03340025|11939392|FG001|COMPLETED|Overall Study||7
10777417|NCT03340025|11939391|FG000|NOT COMPLETED|Overall Study||2
10777418|NCT03340025|11939392|FG001|NOT COMPLETED|Overall Study||2
10777419|NCT03340337|11939398|FG000|STARTED|Overall Study||30
10777420|NCT03340337|11939398|FG000|Received Neo-Russian|Overall Study||30
10777421|NCT03340337|11939398|FG000|Received Aussie|Overall Study||30
10777422|NCT03340337|11939398|FG000|Received RBS|Overall Study||30
10777423|NCT03340337|11939398|FG000|COMPLETED|Overall Study||30
10406396|NCT00745615|11550836|FG003|STARTED|Double-Blind Extension (36 Weeks)||44
10406397|NCT00745615|11550837|FG004|STARTED|Double-Blind Extension (36 Weeks)||0
10406398|NCT00745615|11550838|FG005|STARTED|Double-Blind Extension (36 Weeks)||0
10406399|NCT00745615|11550833|FG000|COMPLETED|Double-Blind Extension (36 Weeks)||75
10777424|NCT03340337|11939398|FG000|NOT COMPLETED|Overall Study||0
10777425|NCT03340350|11939413|FG000|STARTED|Overall Study||10
10777426|NCT03340350|11939413|FG000|COMPLETED|Overall Study||4
10777427|NCT03340350|11939413|FG000|NOT COMPLETED|Overall Study||6
10777428|NCT03340415|11939420|FG000|STARTED|Overall Study||29
10777429|NCT03340415|11939421|FG001|STARTED|Overall Study||24
10777430|NCT03340415|11939420|FG000|COMPLETED|Overall Study||29
10777431|NCT03340415|11939421|FG001|COMPLETED|Overall Study||21
10777432|NCT03340415|11939420|FG000|NOT COMPLETED|Overall Study||0
10777433|NCT03340415|11939421|FG001|NOT COMPLETED|Overall Study||3
10777434|NCT03340428|11939431|FG000|STARTED|Overall Study||117
10777435|NCT03340428|11939432|FG001|STARTED|Overall Study||59
10777436|NCT03340428|11939431|FG000|COMPLETED|Overall Study||116
10777437|NCT03340428|11939432|FG001|COMPLETED|Overall Study||59
10777438|NCT03340428|11939431|FG000|NOT COMPLETED|Overall Study||1
10777439|NCT03340428|11939432|FG001|NOT COMPLETED|Overall Study||0
10777440|NCT03340610|11939438|FG000|STARTED|Overall Study||30
10777441|NCT03340610|11939438|FG000|COMPLETED|Overall Study||27
10777442|NCT03340610|11939438|FG000|NOT COMPLETED|Overall Study||3
10777443|NCT03340805|11939444|FG000|STARTED|Overall Study||24
10777444|NCT03340805|11939445|FG001|STARTED|Overall Study||26
10777445|NCT03340805|11939444|FG000|COMPLETED|Overall Study|1 subject withdrew early from study fluid administration but stayed in trial for outcome assessment|24
10777446|NCT03340805|11939445|FG001|COMPLETED|Overall Study||26
10777447|NCT03340805|11939444|FG000|NOT COMPLETED|Overall Study||0
10777448|NCT03340805|11939445|FG001|NOT COMPLETED|Overall Study||0
10777449|NCT03340883|11939453|FG000|STARTED|Overall Study||4
10777450|NCT03340883|11939454|FG001|STARTED|Overall Study||3
10777451|NCT03340883|11939455|FG002|STARTED|Overall Study||4
10777452|NCT03340883|11939456|FG003|STARTED|Overall Study||4
10777453|NCT03340883|11939457|FG004|STARTED|Overall Study||3
10777454|NCT03340883|11939458|FG005|STARTED|Overall Study||3
10777455|NCT03340883|11939453|FG000|COMPLETED|Overall Study||4
10777456|NCT03340883|11939454|FG001|COMPLETED|Overall Study||3
10777457|NCT03340883|11939455|FG002|COMPLETED|Overall Study||4
10777458|NCT03340883|11939456|FG003|COMPLETED|Overall Study||4
10777459|NCT03340883|11939457|FG004|COMPLETED|Overall Study||3
10777460|NCT03340883|11939458|FG005|COMPLETED|Overall Study||3
10777461|NCT03340883|11939453|FG000|NOT COMPLETED|Overall Study||0
10777462|NCT03340883|11939454|FG001|NOT COMPLETED|Overall Study||0
10406400|NCT00745615|11550834|FG001|COMPLETED|Double-Blind Extension (36 Weeks)||87
10406401|NCT00745615|11550835|FG002|COMPLETED|Double-Blind Extension (36 Weeks)||38
10406402|NCT00745615|11550836|FG003|COMPLETED|Double-Blind Extension (36 Weeks)||39
10406403|NCT00745615|11550837|FG004|COMPLETED|Double-Blind Extension (36 Weeks)||0
10406404|NCT00745615|11550838|FG005|COMPLETED|Double-Blind Extension (36 Weeks)||0
10723500|NCT05028426|11887320|FG000|STARTED|Overall Study||214
10723501|NCT05028426|11887321|FG001|STARTED|Overall Study||132
10723502|NCT05028426|11887322|FG002|STARTED|Overall Study||109
10723503|NCT05028426|11887320|FG000|COMPLETED|Overall Study||214
10723504|NCT05028426|11887321|FG001|COMPLETED|Overall Study||132
10723505|NCT05028426|11887322|FG002|COMPLETED|Overall Study||109
10723506|NCT05028426|11887320|FG000|NOT COMPLETED|Overall Study||0
10723507|NCT05028426|11887321|FG001|NOT COMPLETED|Overall Study||0
10723508|NCT05028426|11887322|FG002|NOT COMPLETED|Overall Study||0
10723509|NCT04526574|11887332|FG000|STARTED|Overall Study||898
10723510|NCT04526574|11887333|FG001|STARTED|Overall Study||898
10723511|NCT04526574|11887332|FG000|Vaccination 1|Overall Study||895
10723512|NCT04526574|11887333|FG001|Vaccination 1|Overall Study||896
10723513|NCT04526574|11887332|FG000|Vaccination 2|Overall Study||874
10723514|NCT04526574|11887333|FG001|Vaccination 2|Overall Study||878
10723515|NCT04526574|11887332|FG000|COMPLETED|Overall Study||862
10723516|NCT04526574|11887333|FG001|COMPLETED|Overall Study||865
10723517|NCT04526574|11887332|FG000|NOT COMPLETED|Overall Study||36
10723518|NCT04526574|11887333|FG001|NOT COMPLETED|Overall Study||33
10723519|NCT04522206|11887343|FG000|STARTED|Overall Study||44
10723520|NCT04522206|11887343|FG000|COMPLETED|Overall Study||44
10723521|NCT04522206|11887343|FG000|NOT COMPLETED|Overall Study||0
10723522|NCT04345367|11887349|FG000|STARTED|Overall Study||362
10723523|NCT04345367|11887350|FG001|STARTED|Overall Study||365
10723524|NCT04345367|11887349|FG000|COMPLETED|Overall Study||327
10723525|NCT04345367|11887350|FG001|COMPLETED|Overall Study||334
10723526|NCT04345367|11887349|FG000|NOT COMPLETED|Overall Study||35
10723527|NCT04345367|11887350|FG001|NOT COMPLETED|Overall Study||31
10723534|NCT04109599|11887377|FG000|STARTED|Overall Study||3
10723535|NCT04109599|11887378|FG001|STARTED|Overall Study||4
10723536|NCT04109599|11887379|FG002|STARTED|Overall Study||4
10723537|NCT04109599|11887380|FG003|STARTED|Overall Study||4
10723538|NCT04109599|11887381|FG004|STARTED|Overall Study||4
10723539|NCT04109599|11887382|FG005|STARTED|Overall Study||4
10723540|NCT04109599|11887383|FG006|STARTED|Overall Study||4
10723541|NCT04109599|11887384|FG007|STARTED|Overall Study||3
10723542|NCT04109599|11887385|FG008|STARTED|Overall Study||3
10723543|NCT04109599|11887377|FG000|COMPLETED|Overall Study||3
10723544|NCT04109599|11887378|FG001|COMPLETED|Overall Study||4
10814480|NCT02343263|11977232|FG002|STARTED|Overall Study||1
10814481|NCT02343263|11977230|FG000|COMPLETED|Overall Study|Study closed due for administrative reasons|0
10814482|NCT02343263|11977231|FG001|COMPLETED|Overall Study||0
10814483|NCT02343263|11977232|FG002|COMPLETED|Overall Study||0
10814484|NCT02343263|11977230|FG000|NOT COMPLETED|Overall Study||5
10723545|NCT04109599|11887379|FG002|COMPLETED|Overall Study||4
10723546|NCT04109599|11887380|FG003|COMPLETED|Overall Study||4
10723547|NCT04109599|11887381|FG004|COMPLETED|Overall Study||4
10723548|NCT04109599|11887382|FG005|COMPLETED|Overall Study||4
10723549|NCT04109599|11887383|FG006|COMPLETED|Overall Study||4
10723550|NCT04109599|11887384|FG007|COMPLETED|Overall Study||3
10723551|NCT04109599|11887385|FG008|COMPLETED|Overall Study||3
10723552|NCT04109599|11887377|FG000|NOT COMPLETED|Overall Study||0
10723553|NCT04109599|11887378|FG001|NOT COMPLETED|Overall Study||0
10723554|NCT04109599|11887379|FG002|NOT COMPLETED|Overall Study||0
10723555|NCT04109599|11887380|FG003|NOT COMPLETED|Overall Study||0
10723556|NCT04109599|11887381|FG004|NOT COMPLETED|Overall Study||0
10723557|NCT04109599|11887382|FG005|NOT COMPLETED|Overall Study||0
10723558|NCT04109599|11887383|FG006|NOT COMPLETED|Overall Study||0
10723559|NCT04109599|11887384|FG007|NOT COMPLETED|Overall Study||0
10723560|NCT04109599|11887385|FG008|NOT COMPLETED|Overall Study||0
10723567|NCT04048382|11887417|FG000|STARTED|3-Month Follow Up||28
10723568|NCT04048382|11887418|FG001|STARTED|3-Month Follow Up||29
10723569|NCT04048382|11887417|FG000|COMPLETED|3-Month Follow Up||26
10723570|NCT04048382|11887418|FG001|COMPLETED|3-Month Follow Up||28
10723571|NCT04048382|11887417|FG000|NOT COMPLETED|3-Month Follow Up||2
10723572|NCT04048382|11887418|FG001|NOT COMPLETED|3-Month Follow Up||1
10723573|NCT04048382|11887417|FG000|STARTED|6-Month Follow up||28
10723574|NCT04048382|11887418|FG001|STARTED|6-Month Follow up||28
10723575|NCT04048382|11887417|FG000|COMPLETED|6-Month Follow up||26
10723576|NCT04048382|11887418|FG001|COMPLETED|6-Month Follow up||28
10723577|NCT04048382|11887417|FG000|NOT COMPLETED|6-Month Follow up||2
10723578|NCT04048382|11887418|FG001|NOT COMPLETED|6-Month Follow up||0
10723579|NCT03928821|11887428|FG000|STARTED|Overall Study||6
10723580|NCT03928821|11887429|FG001|STARTED|Overall Study||6
10723581|NCT03928821|11887430|FG002|STARTED|Overall Study||6
10723582|NCT03928821|11887431|FG003|STARTED|Overall Study||9
10723583|NCT03928821|11887428|FG000|COMPLETED|Overall Study||6
10723584|NCT03928821|11887429|FG001|COMPLETED|Overall Study||3
10723585|NCT03928821|11887430|FG002|COMPLETED|Overall Study||3
10723586|NCT03928821|11887431|FG003|COMPLETED|Overall Study||8
10723587|NCT03928821|11887428|FG000|NOT COMPLETED|Overall Study||0
10723588|NCT03928821|11887429|FG001|NOT COMPLETED|Overall Study||3
10723589|NCT03928821|11887430|FG002|NOT COMPLETED|Overall Study||3
10723590|NCT03928821|11887431|FG003|NOT COMPLETED|Overall Study||1
10723591|NCT03856996|11887443|FG000|STARTED|Overall Study||15
10723592|NCT03856996|11887444|FG001|STARTED|Overall Study||15
10723593|NCT03856996|11887443|FG000|COMPLETED|Overall Study||12
10723594|NCT03856996|11887444|FG001|COMPLETED|Overall Study||13
10723595|NCT03856996|11887443|FG000|NOT COMPLETED|Overall Study||3
10723596|NCT03856996|11887444|FG001|NOT COMPLETED|Overall Study||2
10814485|NCT02343263|11977231|FG001|NOT COMPLETED|Overall Study||3
10406405|NCT00745615|11550833|FG000|NOT COMPLETED|Double-Blind Extension (36 Weeks)||5
10723621|NCT03770689|11887470|FG000|STARTED|Overall Study||1
10723622|NCT03770689|11887471|FG001|STARTED|Overall Study||6
10723623|NCT03770689|11887472|FG002|STARTED|Overall Study||6
10723624|NCT03770689|11887473|FG003|STARTED|Overall Study||6
10723625|NCT03770689|11887470|FG000|Pharmacokinetic Analysis Set|Overall Study|Number of participants analyzed in 50 mg group for PK outcome is different than PK analysis set. Because 1 participant from peposertib 100 mg took peposertib 50 mg from Fraction Day (FD) 1 through FD 10. PK results for this participant was summarized by actual dose received (50 mg) whereas non-PK results are summarized by planned dose (100 mg). Number of participants analyzed for 50 mg dose level in PK outputs that is 2 was therefore higher than non-PK outputs that is 1.|1
10723626|NCT03770689|11887471|FG001|Pharmacokinetic Analysis Set|Overall Study|Number of participants analyzed in 100 mg group for PK outcome is different than PK analysis set. Because 1 participant from peposertib 100 mg took peposertib 50 mg from Fraction Day (FD) 1 through FD 10. PK results for this participant was summarized by actual dose received (50 mg) whereas non-PK results are summarized by planned dose (100 mg). Number of participants analyzed for 100 mg dose level in PK outputs that is 5 was therefore lesser than non-PK outputs that is 6.|6
10723627|NCT03770689|11887472|FG002|Pharmacokinetic Analysis Set|Overall Study||6
10723628|NCT03770689|11887473|FG003|Pharmacokinetic Analysis Set|Overall Study||6
10723629|NCT03770689|11887470|FG000|Full Analysis Set (FAS)|Overall Study||1
10723630|NCT03770689|11887471|FG001|Full Analysis Set (FAS)|Overall Study||6
10723631|NCT03770689|11887472|FG002|Full Analysis Set (FAS)|Overall Study||6
10723632|NCT03770689|11887473|FG003|Full Analysis Set (FAS)|Overall Study||6
10723633|NCT03770689|11887470|FG000|Safety Analysis Set (SAF)|Overall Study||1
10723634|NCT03770689|11887471|FG001|Safety Analysis Set (SAF)|Overall Study||6
10723635|NCT03770689|11887472|FG002|Safety Analysis Set (SAF)|Overall Study||6
10723636|NCT03770689|11887473|FG003|Safety Analysis Set (SAF)|Overall Study||6
10723637|NCT03770689|11887470|FG000|COMPLETED|Overall Study||1
10723638|NCT03770689|11887471|FG001|COMPLETED|Overall Study||6
10723639|NCT03770689|11887472|FG002|COMPLETED|Overall Study||6
10723640|NCT03770689|11887473|FG003|COMPLETED|Overall Study||6
10723641|NCT03770689|11887470|FG000|NOT COMPLETED|Overall Study||0
10723642|NCT03770689|11887471|FG001|NOT COMPLETED|Overall Study||0
10723643|NCT03770689|11887472|FG002|NOT COMPLETED|Overall Study||0
10723644|NCT03770689|11887473|FG003|NOT COMPLETED|Overall Study||0
10814486|NCT02343263|11977232|FG002|NOT COMPLETED|Overall Study||1
10406406|NCT00745615|11550834|FG001|NOT COMPLETED|Double-Blind Extension (36 Weeks)||7
10406407|NCT00745615|11550835|FG002|NOT COMPLETED|Double-Blind Extension (36 Weeks)||1
10406408|NCT00745615|11550836|FG003|NOT COMPLETED|Double-Blind Extension (36 Weeks)||5
10406409|NCT00745615|11550837|FG004|NOT COMPLETED|Double-Blind Extension (36 Weeks)||0
10406410|NCT00745615|11550838|FG005|NOT COMPLETED|Double-Blind Extension (36 Weeks)||0
10406411|NCT00745615|11550833|FG000|STARTED|Open-Label (up to Approx 10.5 Years)||0
10406412|NCT00745615|11550834|FG001|STARTED|Open-Label (up to Approx 10.5 Years)||0
10406413|NCT00745615|11550835|FG002|STARTED|Open-Label (up to Approx 10.5 Years)||0
10429082|NCT00862849|11575286|FG000|STARTED|Intervention 1||3
10406414|NCT00745615|11550836|FG003|STARTED|Open-Label (up to Approx 10.5 Years)||0
10406415|NCT00745615|11550837|FG004|STARTED|Open-Label (up to Approx 10.5 Years)||96
10723680|NCT03402607|11887519|FG000|STARTED|Overall Study||6
10723681|NCT03402607|11887520|FG001|STARTED|Overall Study||6
10723682|NCT03402607|11887519|FG000|COMPLETED|Overall Study||6
10723683|NCT03402607|11887520|FG001|COMPLETED|Overall Study||6
10723684|NCT03402607|11887519|FG000|NOT COMPLETED|Overall Study||0
10723685|NCT03402607|11887520|FG001|NOT COMPLETED|Overall Study||0
10723686|NCT03374891|11887528|FG000|STARTED|Overall Study||346
10723687|NCT03374891|11887529|FG001|STARTED|Overall Study||444
10723688|NCT03374891|11887528|FG000|COMPLETED|Overall Study||323
10723689|NCT03374891|11887529|FG001|COMPLETED|Overall Study||437
10723690|NCT03374891|11887528|FG000|NOT COMPLETED|Overall Study||23
10723691|NCT03374891|11887529|FG001|NOT COMPLETED|Overall Study||7
10723724|NCT03282123|11887583|FG000|STARTED|Overall Study||38
10723725|NCT03282123|11887583|FG000|COMPLETED|Overall Study||33
10723726|NCT03282123|11887583|FG000|NOT COMPLETED|Overall Study||5
10723727|NCT03199391|11887588|FG000|STARTED|Overall Study||71
10723728|NCT03199391|11887588|FG000|COMPLETED|Overall Study||55
10723729|NCT03199391|11887588|FG000|NOT COMPLETED|Overall Study||16
10406416|NCT00745615|11550838|FG005|STARTED|Open-Label (up to Approx 10.5 Years)||113
10406417|NCT00745615|11550833|FG000|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
10406418|NCT00745615|11550834|FG001|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
10406419|NCT00745615|11550835|FG002|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
10406420|NCT00745615|11550836|FG003|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
10723734|NCT03122886|11887598|FG000|STARTED|Overall Study||10
10723735|NCT03122886|11887599|FG001|STARTED|Overall Study||9
10723736|NCT03122886|11887598|FG000|COMPLETED|Overall Study||9
10723737|NCT03122886|11887599|FG001|COMPLETED|Overall Study||7
10723738|NCT03122886|11887598|FG000|NOT COMPLETED|Overall Study||1
10723739|NCT03122886|11887599|FG001|NOT COMPLETED|Overall Study||2
10723740|NCT03042611|11887607|FG000|STARTED|Core Phase||308
10723741|NCT03042611|11887608|FG001|STARTED|Core Phase||152
10723742|NCT03042611|11887609|FG002|STARTED|Core Phase||0
10723743|NCT03042611|11887610|FG003|STARTED|Core Phase||0
10723744|NCT03042611|11887607|FG000|Received at Least 1 Dose of Study Drug|Core Phase||307
10723745|NCT03042611|11887608|FG001|Received at Least 1 Dose of Study Drug|Core Phase||151
10406421|NCT00745615|11550837|FG004|COMPLETED|Open-Label (up to Approx 10.5 Years)||5
10406422|NCT00745615|11550838|FG005|COMPLETED|Open-Label (up to Approx 10.5 Years)||5
10406423|NCT00745615|11550833|FG000|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
10406424|NCT00745615|11550834|FG001|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
10406425|NCT00745615|11550835|FG002|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
10406426|NCT00745615|11550836|FG003|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
10406427|NCT00745615|11550837|FG004|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||91
10406428|NCT00745615|11550838|FG005|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||108
10723746|NCT03042611|11887609|FG002|Received at Least 1 Dose of Study Drug|Core Phase||0
10723747|NCT03042611|11887610|FG003|Received at Least 1 Dose of Study Drug|Core Phase||0
10723748|NCT03042611|11887607|FG000|COMPLETED|Core Phase||52
10723749|NCT03042611|11887608|FG001|COMPLETED|Core Phase||28
10723750|NCT03042611|11887609|FG002|COMPLETED|Core Phase||0
10723751|NCT03042611|11887610|FG003|COMPLETED|Core Phase||0
10723752|NCT03042611|11887607|FG000|NOT COMPLETED|Core Phase||256
10723753|NCT03042611|11887608|FG001|NOT COMPLETED|Core Phase||124
10723754|NCT03042611|11887609|FG002|NOT COMPLETED|Core Phase||0
10723755|NCT03042611|11887610|FG003|NOT COMPLETED|Core Phase||0
10723756|NCT03042611|11887607|FG000|STARTED|Extension Phase||0
10723757|NCT03042611|11887608|FG001|STARTED|Extension Phase||0
10723758|NCT03042611|11887609|FG002|STARTED|Extension Phase||52
10723759|NCT03042611|11887610|FG003|STARTED|Extension Phase||28
10723760|NCT03042611|11887607|FG000|COMPLETED|Extension Phase||0
10723761|NCT03042611|11887608|FG001|COMPLETED|Extension Phase||0
10723762|NCT03042611|11887609|FG002|COMPLETED|Extension Phase||0
10723763|NCT03042611|11887610|FG003|COMPLETED|Extension Phase||0
10723764|NCT03042611|11887607|FG000|NOT COMPLETED|Extension Phase||0
10723765|NCT03042611|11887608|FG001|NOT COMPLETED|Extension Phase||0
10723766|NCT03042611|11887609|FG002|NOT COMPLETED|Extension Phase||52
10723767|NCT03042611|11887610|FG003|NOT COMPLETED|Extension Phase||28
10723768|NCT03041181|11887618|FG000|STARTED|Overall Study||1
10723769|NCT03041181|11887619|FG001|STARTED|Overall Study||2
10723770|NCT03041181|11887618|FG000|COMPLETED|Overall Study||0
10723771|NCT03041181|11887619|FG001|COMPLETED|Overall Study||0
10723772|NCT03041181|11887618|FG000|NOT COMPLETED|Overall Study||1
10723773|NCT03041181|11887619|FG001|NOT COMPLETED|Overall Study||2
10723774|NCT03017742|11887625|FG000|STARTED|Overall Study||813
10723775|NCT03017742|11887625|FG000|COMPLETED|Overall Study||740
10723776|NCT03017742|11887625|FG000|NOT COMPLETED|Overall Study||73
10723780|NCT02941926|11887633|FG000|STARTED|Overall Study||3246
10723781|NCT02941926|11887633|FG000|Canadian Sub-study|Overall Study||88
10723782|NCT02941926|11887633|FG000|COMPLETED|Overall Study||1301
10723783|NCT02941926|11887633|FG000|NOT COMPLETED|Overall Study||1945
10723784|NCT02879448|11887641|FG000|STARTED|Overall Study||934
10723785|NCT02879448|11887642|FG001|STARTED|Overall Study||944
10723786|NCT02879448|11887641|FG000|COMPLETED|Overall Study||796
10723787|NCT02879448|11887642|FG001|COMPLETED|Overall Study||742
10723788|NCT02879448|11887641|FG000|NOT COMPLETED|Overall Study||138
10723789|NCT02879448|11887642|FG001|NOT COMPLETED|Overall Study||202
10723790|NCT02739347|11887650|FG000|STARTED|Overall Study||5
10723791|NCT02739347|11887651|FG001|STARTED|Overall Study||7
10723792|NCT02739347|11887650|FG000|COMPLETED|Overall Study||2
10723793|NCT02739347|11887651|FG001|COMPLETED|Overall Study||4
10723794|NCT02739347|11887650|FG000|NOT COMPLETED|Overall Study||3
10723795|NCT02739347|11887651|FG001|NOT COMPLETED|Overall Study||3
10406429|NCT00745823|11550852|FG000|STARTED|Overall Study||386
10406430|NCT00745823|11550853|FG001|STARTED|Overall Study||389
10406431|NCT00745823|11550852|FG000|TREATED Week 0 - 96|Overall Study||382
10406432|NCT00745823|11550853|FG001|TREATED Week 0 - 96|Overall Study||388
10406433|NCT00745823|11550852|FG000|COMPLETED|Overall Study||1
10406434|NCT00745823|11550853|FG001|COMPLETED|Overall Study||3
10406435|NCT00745823|11550852|FG000|NOT COMPLETED|Overall Study||385
10406436|NCT00745823|11550853|FG001|NOT COMPLETED|Overall Study||386
10723808|NCT02582749|11887668|FG000|STARTED|Overall Study||5
10723809|NCT02582749|11887669|FG001|STARTED|Overall Study||11
10723810|NCT02582749|11887668|FG000|COMPLETED|Overall Study||0
10723811|NCT02582749|11887669|FG001|COMPLETED|Overall Study||0
10723812|NCT02582749|11887668|FG000|NOT COMPLETED|Overall Study||5
10723813|NCT02582749|11887669|FG001|NOT COMPLETED|Overall Study||11
10406437|NCT00745849|11550861|FG000|STARTED|First Intervention||21
10406438|NCT00745849|11550862|FG001|STARTED|First Intervention||22
10406439|NCT00745849|11550861|FG000|COMPLETED|First Intervention||20
10406440|NCT00745849|11550862|FG001|COMPLETED|First Intervention||20
10406441|NCT00745849|11550861|FG000|NOT COMPLETED|First Intervention||1
10406442|NCT00745849|11550862|FG001|NOT COMPLETED|First Intervention||2
10406443|NCT00745849|11550861|FG000|STARTED|Washout Period||20
10406444|NCT00745849|11550862|FG001|STARTED|Washout Period||20
10406445|NCT00745849|11550861|FG000|COMPLETED|Washout Period||20
10406446|NCT00745849|11550862|FG001|COMPLETED|Washout Period||20
10406447|NCT00745849|11550861|FG000|NOT COMPLETED|Washout Period||0
10406448|NCT00745849|11550862|FG001|NOT COMPLETED|Washout Period||0
10406449|NCT00745849|11550861|FG000|STARTED|Second Intervention||20
10406450|NCT00745849|11550862|FG001|STARTED|Second Intervention||20
10406451|NCT00745849|11550861|FG000|COMPLETED|Second Intervention||18
10406452|NCT00745849|11550862|FG001|COMPLETED|Second Intervention||19
10406453|NCT00745849|11550861|FG000|NOT COMPLETED|Second Intervention||2
10406454|NCT00745849|11550862|FG001|NOT COMPLETED|Second Intervention||1
10406455|NCT00745875|11550870|FG000|STARTED|Overall Study|Started - Number of patients randomised|36
10406456|NCT00745875|11550871|FG001|STARTED|Overall Study|Started - Number of patients randomised|30
10406457|NCT00745875|11550870|FG000|COMPLETED|Overall Study|Completed - Number of patients discontinued study treatment at data cut-off (17th January 2010)|32
10406458|NCT00745875|11550871|FG001|COMPLETED|Overall Study|Completed - Number of patients discontinued study treatment at data cut-off (17th January 2010)|26
10406459|NCT00745875|11550870|FG000|NOT COMPLETED|Overall Study||4
10406460|NCT00745875|11550871|FG001|NOT COMPLETED|Overall Study||4
10406461|NCT00745901|11550879|FG000|STARTED|Overall Study|Number of Patients Randomized|178
10406462|NCT00745901|11550880|FG001|STARTED|Overall Study|Number of Patients Randomized|177
10406463|NCT00745901|11550879|FG000|COMPLETED|Overall Study||154
10406464|NCT00745901|11550880|FG001|COMPLETED|Overall Study||156
10406465|NCT00745901|11550879|FG000|NOT COMPLETED|Overall Study||24
10406466|NCT00745901|11550880|FG001|NOT COMPLETED|Overall Study||21
10406467|NCT00745940|11550888|FG000|STARTED|Overall Study||57
10406468|NCT00745940|11550889|FG001|STARTED|Overall Study||48
10406469|NCT00745940|11550888|FG000|COMPLETED|Overall Study||38
10406470|NCT00745940|11550889|FG001|COMPLETED|Overall Study||38
10406471|NCT00745940|11550888|FG000|NOT COMPLETED|Overall Study||19
10406472|NCT00745940|11550889|FG001|NOT COMPLETED|Overall Study||10
10406473|NCT00746096|11550897|FG000|STARTED|Overall Study||58
10406474|NCT00746096|11550898|FG001|STARTED|Overall Study||57
10406475|NCT00746096|11550897|FG000|COMPLETED|Overall Study||48
10406476|NCT00746096|11550898|FG001|COMPLETED|Overall Study||54
10406477|NCT00746096|11550897|FG000|NOT COMPLETED|Overall Study||10
10406478|NCT00746096|11550898|FG001|NOT COMPLETED|Overall Study||3
10406479|NCT00746122|11550906|FG000|STARTED|Overall Study||297
10406480|NCT00746122|11550907|FG001|STARTED|Overall Study|After 600 recruitment target 13 more patients were randomised before sites could be closed down.|316
10406481|NCT00746122|11550906|FG000|COMPLETED|Overall Study||297
10406482|NCT00746122|11550907|FG001|COMPLETED|Overall Study||316
10406483|NCT00746122|11550906|FG000|NOT COMPLETED|Overall Study||0
10406484|NCT00746122|11550907|FG001|NOT COMPLETED|Overall Study||0
10406485|NCT00746187|11550915|FG000|STARTED|Overall Study||18
10406486|NCT00746187|11550916|FG001|STARTED|Overall Study||18
10406487|NCT00746187|11550915|FG000|COMPLETED|Overall Study||15
10406488|NCT00746187|11550916|FG001|COMPLETED|Overall Study||16
10406489|NCT00746187|11550915|FG000|NOT COMPLETED|Overall Study||3
10406490|NCT00746187|11550916|FG001|NOT COMPLETED|Overall Study||2
10406491|NCT00746252|11550924|FG000|STARTED|Overall Study||1
10406492|NCT00746252|11550925|FG001|STARTED|Overall Study||2
10406493|NCT00746252|11550924|FG000|COMPLETED|Overall Study||0
10406494|NCT00746252|11550925|FG001|COMPLETED|Overall Study||0
10406495|NCT00746252|11550924|FG000|NOT COMPLETED|Overall Study||1
10406496|NCT00746252|11550925|FG001|NOT COMPLETED|Overall Study||2
10406497|NCT00746330|11550935|FG000|STARTED|Period 1||7
10406498|NCT00746330|11550936|FG001|STARTED|Period 1||9
10406499|NCT00746330|11550937|FG002|STARTED|Period 1||9
10406500|NCT00746330|11550938|FG003|STARTED|Period 1||7
10406501|NCT00746330|11550935|FG000|COMPLETED|Period 1||7
10406502|NCT00746330|11550936|FG001|COMPLETED|Period 1||9
10406503|NCT00746330|11550937|FG002|COMPLETED|Period 1||8
10406504|NCT00746330|11550938|FG003|COMPLETED|Period 1||7
10406505|NCT00746330|11550935|FG000|NOT COMPLETED|Period 1||0
10406506|NCT00746330|11550936|FG001|NOT COMPLETED|Period 1||0
10406507|NCT00746330|11550937|FG002|NOT COMPLETED|Period 1||1
10406508|NCT00746330|11550938|FG003|NOT COMPLETED|Period 1||0
10406509|NCT00746330|11550935|FG000|STARTED|Period 2||7
10406510|NCT00746330|11550936|FG001|STARTED|Period 2||9
10406511|NCT00746330|11550937|FG002|STARTED|Period 2||8
10406512|NCT00746330|11550938|FG003|STARTED|Period 2||7
10406513|NCT00746330|11550935|FG000|COMPLETED|Period 2||7
10544412|NCT01490632|11697648|FG011|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
10544413|NCT01490632|11697649|FG012|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
10406514|NCT00746330|11550936|FG001|COMPLETED|Period 2||9
10406515|NCT00746330|11550937|FG002|COMPLETED|Period 2||8
10406516|NCT00746330|11550938|FG003|COMPLETED|Period 2||7
10406517|NCT00746330|11550935|FG000|NOT COMPLETED|Period 2||0
10406518|NCT00746330|11550936|FG001|NOT COMPLETED|Period 2||0
10406519|NCT00746330|11550937|FG002|NOT COMPLETED|Period 2||0
10406520|NCT00746330|11550938|FG003|NOT COMPLETED|Period 2||0
10406521|NCT00746330|11550935|FG000|STARTED|Period 3||7
10406522|NCT00746330|11550936|FG001|STARTED|Period 3||9
10406523|NCT00746330|11550937|FG002|STARTED|Period 3||8
10406524|NCT00746330|11550938|FG003|STARTED|Period 3||7
10406525|NCT00746330|11550935|FG000|COMPLETED|Period 3||7
10406526|NCT00746330|11550936|FG001|COMPLETED|Period 3||9
10723820|NCT02535247|11887686|FG000|STARTED|Overall Study||17
10723821|NCT02535247|11887687|FG001|STARTED|Overall Study||0
10723822|NCT02535247|11887686|FG000|COMPLETED|Overall Study||13
10723823|NCT02535247|11887687|FG001|COMPLETED|Overall Study||0
10723824|NCT02535247|11887686|FG000|NOT COMPLETED|Overall Study||4
10723825|NCT02535247|11887687|FG001|NOT COMPLETED|Overall Study||0
10723826|NCT02499952|11887693|FG000|STARTED|Overall Study||12
10723827|NCT02499952|11887693|FG000|COMPLETED|Overall Study||2
10723828|NCT02499952|11887693|FG000|NOT COMPLETED|Overall Study||10
10723847|NCT02450331|11887724|FG000|STARTED|Overall Study||403
10723848|NCT02450331|11887725|FG001|STARTED|Overall Study||406
10723849|NCT02450331|11887724|FG000|COMPLETED|Overall Study||0
10723850|NCT02450331|11887725|FG001|COMPLETED|Overall Study||0
10723851|NCT02450331|11887724|FG000|NOT COMPLETED|Overall Study||403
10723852|NCT02450331|11887725|FG001|NOT COMPLETED|Overall Study||406
10723861|NCT02028221|11887743|FG000|STARTED|Overall Study||75
10723862|NCT02028221|11887744|FG001|STARTED|Overall Study||76
10723863|NCT02028221|11887743|FG000|COMPLETED|Overall Study||62
10723864|NCT02028221|11887744|FG001|COMPLETED|Overall Study||56
10723865|NCT02028221|11887743|FG000|NOT COMPLETED|Overall Study||13
10723866|NCT02028221|11887744|FG001|NOT COMPLETED|Overall Study||20
10723867|NCT01984346|11887752|FG000|STARTED|Overall Study|Date of full approval was 8/22/13. Date of first treated patient was 01/08/14|115
10723868|NCT01984346|11887753|FG001|STARTED|Overall Study||55
10723869|NCT01984346|11887752|FG000|Treated|Overall Study||102
10723870|NCT01984346|11887753|FG001|Treated|Overall Study||51
10723871|NCT01984346|11887752|FG000|COMPLETED|Overall Study||98
10723872|NCT01984346|11887753|FG001|COMPLETED|Overall Study||50
10723873|NCT01984346|11887752|FG000|NOT COMPLETED|Overall Study||17
10723874|NCT01984346|11887753|FG001|NOT COMPLETED|Overall Study||5
10723875|NCT01963780|11887759|FG000|STARTED|Overall Study|Patients received lung transplant|79
10723876|NCT01963780|11887759|FG000|COMPLETED|Overall Study||72
10723877|NCT01963780|11887759|FG000|NOT COMPLETED|Overall Study||7
10723878|NCT01958593|11887765|FG000|STARTED|Overall Study||2
10723879|NCT01958593|11887766|FG001|STARTED|Overall Study||4
10723880|NCT01958593|11887765|FG000|COMPLETED|Overall Study||2
10723881|NCT01958593|11887766|FG001|COMPLETED|Overall Study||4
10406527|NCT00746330|11550937|FG002|COMPLETED|Period 3||8
10406528|NCT00746330|11550938|FG003|COMPLETED|Period 3||7
10406529|NCT00746330|11550935|FG000|NOT COMPLETED|Period 3||0
10406530|NCT00746330|11550936|FG001|NOT COMPLETED|Period 3||0
10406531|NCT00746330|11550937|FG002|NOT COMPLETED|Period 3||0
10406532|NCT00746330|11550938|FG003|NOT COMPLETED|Period 3||0
10406533|NCT00746330|11550935|FG000|STARTED|Period 4||7
10406534|NCT00746330|11550936|FG001|STARTED|Period 4||9
10406535|NCT00746330|11550937|FG002|STARTED|Period 4||8
10723882|NCT01958593|11887765|FG000|NOT COMPLETED|Overall Study||0
10723883|NCT01958593|11887766|FG001|NOT COMPLETED|Overall Study||0
10723884|NCT01793610|11887776|FG000|STARTED|Overall Study||6
10723885|NCT01793610|11887777|FG001|STARTED|Overall Study||9
10723886|NCT01793610|11887778|FG002|STARTED|Overall Study||13
10723887|NCT01793610|11887776|FG000|COMPLETED|Overall Study||5
10406536|NCT00746330|11550938|FG003|STARTED|Period 4||7
10406537|NCT00746330|11550935|FG000|COMPLETED|Period 4||7
10723888|NCT01793610|11887777|FG001|COMPLETED|Overall Study||9
10723889|NCT01793610|11887778|FG002|COMPLETED|Overall Study||12
10723890|NCT01793610|11887776|FG000|NOT COMPLETED|Overall Study||1
10723891|NCT01793610|11887777|FG001|NOT COMPLETED|Overall Study||0
10723892|NCT01793610|11887778|FG002|NOT COMPLETED|Overall Study||1
10723893|NCT01780545|11887792|FG000|STARTED|Overall Study||99
10723894|NCT01780545|11887793|FG001|STARTED|Overall Study||101
10723895|NCT01780545|11887792|FG000|COMPLETED|Overall Study||95
10406538|NCT00746330|11550936|FG001|COMPLETED|Period 4||9
10406539|NCT00746330|11550937|FG002|COMPLETED|Period 4||8
10406540|NCT00746330|11550938|FG003|COMPLETED|Period 4||7
10406541|NCT00746330|11550935|FG000|NOT COMPLETED|Period 4||0
10406542|NCT00746330|11550936|FG001|NOT COMPLETED|Period 4||0
10406543|NCT00746330|11550937|FG002|NOT COMPLETED|Period 4||0
10406544|NCT00746330|11550938|FG003|NOT COMPLETED|Period 4||0
10406545|NCT00746356|11550949|FG000|STARTED|Overall Study||81
10406546|NCT00746356|11550950|FG001|STARTED|Overall Study||47
10406547|NCT00746356|11550949|FG000|COMPLETED|Overall Study||70
10406548|NCT00746356|11550950|FG001|COMPLETED|Overall Study||40
10406549|NCT00746356|11550949|FG000|NOT COMPLETED|Overall Study||11
10406550|NCT00746356|11550950|FG001|NOT COMPLETED|Overall Study||7
10406551|NCT00746395|11550960|FG000|STARTED|Overall Study||20
10406552|NCT00746395|11550961|FG001|STARTED|Overall Study||20
10406553|NCT00746395|11550960|FG000|COMPLETED|Overall Study||20
10406554|NCT00746395|11550961|FG001|COMPLETED|Overall Study||20
10406555|NCT00746395|11550960|FG000|NOT COMPLETED|Overall Study||0
10406556|NCT00746395|11550961|FG001|NOT COMPLETED|Overall Study||0
10406557|NCT00746421|11550969|FG000|STARTED|Overall Study||12
10406558|NCT00746421|11550970|FG001|STARTED|Overall Study||11
10406559|NCT00746421|11550969|FG000|COMPLETED|Overall Study||5
10406560|NCT00746421|11550970|FG001|COMPLETED|Overall Study||9
10406561|NCT00746421|11550969|FG000|NOT COMPLETED|Overall Study||7
10406562|NCT00746421|11550970|FG001|NOT COMPLETED|Overall Study||2
10406563|NCT00746512|11550980|FG000|STARTED|Overall Study||8
10406564|NCT00746512|11550981|FG001|STARTED|Overall Study||10
10406565|NCT00746512|11550982|FG002|STARTED|Overall Study||18
10406566|NCT00746512|11550983|FG003|STARTED|Overall Study||9
10406567|NCT00746512|11550980|FG000|COMPLETED|Overall Study||8
10406568|NCT00746512|11550981|FG001|COMPLETED|Overall Study||10
10406569|NCT00746512|11550982|FG002|COMPLETED|Overall Study||18
10406570|NCT00746512|11550983|FG003|COMPLETED|Overall Study||9
10406571|NCT00746512|11550980|FG000|NOT COMPLETED|Overall Study||0
10406572|NCT00746512|11550981|FG001|NOT COMPLETED|Overall Study||0
10406573|NCT00746512|11550982|FG002|NOT COMPLETED|Overall Study||0
10406574|NCT00746512|11550983|FG003|NOT COMPLETED|Overall Study||0
10406575|NCT00746551|11550995|FG000|STARTED|At Gestational Age of 36 Weeks||40
10406576|NCT00746551|11550996|FG001|STARTED|At Gestational Age of 36 Weeks||40
10406577|NCT00746551|11550995|FG000|COMPLETED|At Gestational Age of 36 Weeks||38
10406578|NCT00746551|11550996|FG001|COMPLETED|At Gestational Age of 36 Weeks||36
10406579|NCT00746551|11550995|FG000|NOT COMPLETED|At Gestational Age of 36 Weeks||2
10406580|NCT00746551|11550996|FG001|NOT COMPLETED|At Gestational Age of 36 Weeks||4
10406581|NCT00746551|11550995|FG000|STARTED|At Delivery (GA of 39 Weeks)||40
10406582|NCT00746551|11550996|FG001|STARTED|At Delivery (GA of 39 Weeks)||40
10406583|NCT00746551|11550995|FG000|COMPLETED|At Delivery (GA of 39 Weeks)||25
10406584|NCT00746551|11550996|FG001|COMPLETED|At Delivery (GA of 39 Weeks)||25
10406585|NCT00746551|11550995|FG000|NOT COMPLETED|At Delivery (GA of 39 Weeks)||15
10406586|NCT00746551|11550996|FG001|NOT COMPLETED|At Delivery (GA of 39 Weeks)||15
10406587|NCT00746564|11551002|FG000|STARTED|Overall Study||75
10406588|NCT00746564|11551002|FG000|COMPLETED|Overall Study||73
10406589|NCT00746564|11551002|FG000|NOT COMPLETED|Overall Study||2
10406590|NCT00746668|11551008|FG000|STARTED|Overall Study||6
10406591|NCT00746668|11551009|FG001|STARTED|Overall Study||5
10406592|NCT00746668|11551010|FG002|STARTED|Overall Study||5
10406593|NCT00746668|11551011|FG003|STARTED|Overall Study||5
10723896|NCT01780545|11887793|FG001|COMPLETED|Overall Study||99
10723897|NCT01780545|11887792|FG000|NOT COMPLETED|Overall Study||4
10723898|NCT01780545|11887793|FG001|NOT COMPLETED|Overall Study||2
10406594|NCT00746668|11551012|FG004|STARTED|Overall Study||5
10406595|NCT00746668|11551013|FG005|STARTED|Overall Study||5
10406596|NCT00746668|11551014|FG006|STARTED|Overall Study||5
10406597|NCT00746668|11551008|FG000|COMPLETED|Overall Study||6
10406598|NCT00746668|11551009|FG001|COMPLETED|Overall Study||5
10406599|NCT00746668|11551010|FG002|COMPLETED|Overall Study||5
10406600|NCT00746668|11551011|FG003|COMPLETED|Overall Study||5
10406601|NCT00746668|11551012|FG004|COMPLETED|Overall Study||5
10406602|NCT00746668|11551013|FG005|COMPLETED|Overall Study||5
10406603|NCT00746668|11551014|FG006|COMPLETED|Overall Study||5
10406604|NCT00746668|11551008|FG000|NOT COMPLETED|Overall Study||0
10406605|NCT00746668|11551009|FG001|NOT COMPLETED|Overall Study||0
10406606|NCT00746668|11551010|FG002|NOT COMPLETED|Overall Study||0
10312753|NCT00144391|11446199|FG000|COMPLETED|Overall Study||11
10312754|NCT00144391|11446200|FG001|COMPLETED|Overall Study||9
10312755|NCT00144391|11446199|FG000|NOT COMPLETED|Overall Study||0
10312756|NCT00144391|11446200|FG001|NOT COMPLETED|Overall Study||0
10312757|NCT00144781|11446210|FG000|STARTED|Overall Study||8
10312758|NCT00144781|11446211|FG001|STARTED|Overall Study||9
10312759|NCT00144781|11446212|FG002|STARTED|Overall Study||8
10312760|NCT00144781|11446213|FG003|STARTED|Overall Study||9
10312761|NCT00144781|11446210|FG000|COMPLETED|Overall Study||8
10312762|NCT00144781|11446211|FG001|COMPLETED|Overall Study||7
10312763|NCT00144781|11446212|FG002|COMPLETED|Overall Study||8
10312764|NCT00144781|11446213|FG003|COMPLETED|Overall Study||9
10312765|NCT00144781|11446210|FG000|NOT COMPLETED|Overall Study||0
10312766|NCT00144781|11446211|FG001|NOT COMPLETED|Overall Study||2
10406607|NCT00746668|11551011|FG003|NOT COMPLETED|Overall Study||0
10406608|NCT00746668|11551012|FG004|NOT COMPLETED|Overall Study||0
10406609|NCT00746668|11551013|FG005|NOT COMPLETED|Overall Study||0
10406610|NCT00746668|11551014|FG006|NOT COMPLETED|Overall Study||0
10406611|NCT00746694|11551027|FG000|STARTED|Overall Study||154
10406612|NCT00746694|11551027|FG000|COMPLETED|Overall Study||154
10406613|NCT00746694|11551027|FG000|NOT COMPLETED|Overall Study||0
10406614|NCT00746733|11551031|FG000|STARTED|First Intervention||12
10406615|NCT00746733|11551032|FG001|STARTED|First Intervention||12
10406616|NCT00746733|11551031|FG000|COMPLETED|First Intervention||12
10406617|NCT00746733|11551032|FG001|COMPLETED|First Intervention||12
10406618|NCT00746733|11551031|FG000|NOT COMPLETED|First Intervention||0
10406619|NCT00746733|11551032|FG001|NOT COMPLETED|First Intervention||0
10406620|NCT00746733|11551031|FG000|STARTED|Second Intervention||12
10406621|NCT00746733|11551032|FG001|STARTED|Second Intervention||12
10406622|NCT00746733|11551031|FG000|COMPLETED|Second Intervention||11
10406623|NCT00746733|11551032|FG001|COMPLETED|Second Intervention||12
10406624|NCT00746733|11551031|FG000|NOT COMPLETED|Second Intervention||1
10406625|NCT00746733|11551032|FG001|NOT COMPLETED|Second Intervention||0
10406626|NCT00746733|11551031|FG000|STARTED|Third Intervention||11
10406627|NCT00746733|11551032|FG001|STARTED|Third Intervention||12
10406628|NCT00746733|11551031|FG000|COMPLETED|Third Intervention||10
10406629|NCT00746733|11551032|FG001|COMPLETED|Third Intervention||11
10406630|NCT00746733|11551031|FG000|NOT COMPLETED|Third Intervention||1
10406631|NCT00746733|11551032|FG001|NOT COMPLETED|Third Intervention||1
10406632|NCT00746733|11551031|FG000|STARTED|Fourth Intervention||10
10406633|NCT00746733|11551032|FG001|STARTED|Fourth Intervention||11
10406634|NCT00746733|11551031|FG000|COMPLETED|Fourth Intervention||10
10406635|NCT00746733|11551032|FG001|COMPLETED|Fourth Intervention||11
10406636|NCT00746733|11551031|FG000|NOT COMPLETED|Fourth Intervention||0
10406637|NCT00746733|11551032|FG001|NOT COMPLETED|Fourth Intervention||0
10406638|NCT00746785|11551048|FG000|STARTED|Overall Study||43
10406639|NCT00746785|11551049|FG001|STARTED|Overall Study||46
10406640|NCT00746785|11551050|FG002|STARTED|Overall Study||40
10406641|NCT00746785|11551048|FG000|COMPLETED|Overall Study||14
10406642|NCT00746785|11551049|FG001|COMPLETED|Overall Study||21
10406643|NCT00746785|11551050|FG002|COMPLETED|Overall Study||13
10406644|NCT00746785|11551048|FG000|NOT COMPLETED|Overall Study||29
10406645|NCT00746785|11551049|FG001|NOT COMPLETED|Overall Study||25
10406646|NCT00746785|11551050|FG002|NOT COMPLETED|Overall Study||27
10406647|NCT00746798|11551062|FG000|STARTED|Overall Study||122
10406648|NCT00746798|11551063|FG001|STARTED|Overall Study||124
10406649|NCT00746798|11551064|FG002|STARTED|Overall Study||113
10406650|NCT00746798|11551065|FG003|STARTED|Overall Study||120
10406651|NCT00746798|11551062|FG000|COMPLETED|Overall Study||121
10406652|NCT00746798|11551063|FG001|COMPLETED|Overall Study||122
10406653|NCT00746798|11551064|FG002|COMPLETED|Overall Study||110
10406654|NCT00746798|11551065|FG003|COMPLETED|Overall Study||120
10406655|NCT00746798|11551062|FG000|NOT COMPLETED|Overall Study||1
10406656|NCT00746798|11551063|FG001|NOT COMPLETED|Overall Study||2
10406657|NCT00746798|11551064|FG002|NOT COMPLETED|Overall Study||3
10406658|NCT00746798|11551065|FG003|NOT COMPLETED|Overall Study||0
10406659|NCT00746863|11551077|FG000|STARTED|Overall Study||21
10406660|NCT00746863|11551078|FG001|STARTED|Overall Study||21
10406661|NCT00746863|11551077|FG000|COMPLETED|Overall Study||21
10406662|NCT00746863|11551078|FG001|COMPLETED|Overall Study||21
10406663|NCT00746863|11551077|FG000|NOT COMPLETED|Overall Study||0
10406664|NCT00746863|11551078|FG001|NOT COMPLETED|Overall Study||0
10406665|NCT00746889|11551086|FG000|STARTED|Overall Study||40
10406666|NCT00746889|11551087|FG001|STARTED|Overall Study||39
10406667|NCT00746889|11551086|FG000|COMPLETED|Overall Study||36
10406668|NCT00746889|11551087|FG001|COMPLETED|Overall Study||35
10406669|NCT00746889|11551086|FG000|NOT COMPLETED|Overall Study||4
10406670|NCT00746889|11551087|FG001|NOT COMPLETED|Overall Study||4
10406671|NCT00746941|11551099|FG000|STARTED|Overall Study||7
10406672|NCT00746941|11551100|FG001|STARTED|Overall Study||5
10406673|NCT00746941|11551101|FG002|STARTED|Overall Study||5
10406674|NCT00746941|11551102|FG003|STARTED|Overall Study||20
10406675|NCT00746941|11551099|FG000|COMPLETED|Overall Study||0
10406676|NCT00746941|11551100|FG001|COMPLETED|Overall Study||1
10406677|NCT00746941|11551101|FG002|COMPLETED|Overall Study||3
10406678|NCT00746941|11551102|FG003|COMPLETED|Overall Study||7
10406679|NCT00746941|11551099|FG000|NOT COMPLETED|Overall Study||7
10406680|NCT00746941|11551100|FG001|NOT COMPLETED|Overall Study||4
10406681|NCT00746941|11551101|FG002|NOT COMPLETED|Overall Study||2
10406682|NCT00746941|11551102|FG003|NOT COMPLETED|Overall Study||13
10406683|NCT00746954|11551111|FG000|STARTED|Overall Study||3
10406684|NCT00746954|11551112|FG001|STARTED|Overall Study||3
10406685|NCT00746954|11551113|FG002|STARTED|Overall Study||2
10406686|NCT00746954|11551111|FG000|COMPLETED|Overall Study||3
10548259|NCT01518699|11702087|FG002|COMPLETED|Period 1||9
10406687|NCT00746954|11551112|FG001|COMPLETED|Overall Study||3
10406688|NCT00746954|11551113|FG002|COMPLETED|Overall Study||2
10406689|NCT00746954|11551111|FG000|NOT COMPLETED|Overall Study||0
10406690|NCT00746954|11551112|FG001|NOT COMPLETED|Overall Study||0
10406691|NCT00746954|11551113|FG002|NOT COMPLETED|Overall Study||0
10406692|NCT00747006|11551122|FG000|STARTED|Overall Study||7
10406693|NCT00747006|11551123|FG001|STARTED|Overall Study||8
10406694|NCT00747006|11551124|FG002|STARTED|Overall Study||3
10406695|NCT00747006|11551122|FG000|COMPLETED|Overall Study||4
10406696|NCT00747006|11551123|FG001|COMPLETED|Overall Study||7
10406697|NCT00747006|11551124|FG002|COMPLETED|Overall Study||2
10406698|NCT00747006|11551122|FG000|NOT COMPLETED|Overall Study||3
10406699|NCT00747006|11551123|FG001|NOT COMPLETED|Overall Study||1
10406700|NCT00747006|11551124|FG002|NOT COMPLETED|Overall Study||1
10406701|NCT00747149|11551137|FG000|STARTED|Overall Study||154
10406702|NCT00747149|11551138|FG001|STARTED|Overall Study||444
10406703|NCT00747149|11551137|FG000|COMPLETED|Overall Study||153
10406704|NCT00747149|11551138|FG001|COMPLETED|Overall Study||401
10406705|NCT00747149|11551137|FG000|NOT COMPLETED|Overall Study||1
10406706|NCT00747149|11551138|FG001|NOT COMPLETED|Overall Study||43
10406707|NCT00747214|11551152|FG000|STARTED|Overall Study||27
10406708|NCT00747214|11551153|FG001|STARTED|Overall Study||32
10406709|NCT00747214|11551152|FG000|COMPLETED|Overall Study||19
10406710|NCT00747214|11551153|FG001|COMPLETED|Overall Study||29
10406711|NCT00747214|11551152|FG000|NOT COMPLETED|Overall Study||8
10406712|NCT00747214|11551153|FG001|NOT COMPLETED|Overall Study||3
10406713|NCT00747227|11551161|FG000|STARTED|Overall Study||126
10406714|NCT00747227|11551162|FG001|STARTED|Overall Study||124
10406715|NCT00747227|11551161|FG000|COMPLETED|Overall Study||120
10406716|NCT00747227|11551162|FG001|COMPLETED|Overall Study||120
10406717|NCT00747227|11551161|FG000|NOT COMPLETED|Overall Study||6
10406718|NCT00747227|11551162|FG001|NOT COMPLETED|Overall Study||4
10406719|NCT00747344|11551170|FG000|STARTED|Controlled Period||60
10406720|NCT00747344|11551171|FG001|STARTED|Controlled Period||61
10406721|NCT00747344|11551172|FG002|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
10406722|NCT00747344|11551173|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
10406723|NCT00747344|11551170|FG000|COMPLETED|Controlled Period||55
10406724|NCT00747344|11551171|FG001|COMPLETED|Controlled Period||57
10406725|NCT00747344|11551172|FG002|COMPLETED|Controlled Period||0
10406726|NCT00747344|11551173|FG003|COMPLETED|Controlled Period||0
10406727|NCT00747344|11551170|FG000|NOT COMPLETED|Controlled Period||5
10406728|NCT00747344|11551171|FG001|NOT COMPLETED|Controlled Period||4
10406729|NCT00747344|11551172|FG002|NOT COMPLETED|Controlled Period||0
10406730|NCT00747344|11551173|FG003|NOT COMPLETED|Controlled Period||0
10406731|NCT00747344|11551170|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
10406732|NCT00747344|11551171|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
10406733|NCT00747344|11551172|FG002|STARTED|After Controlled Period||55
10406734|NCT00747344|11551173|FG003|STARTED|After Controlled Period|2 participants discontinued in CP, had follow-up, and are among frequent and serious adverse events.|57
10406735|NCT00747344|11551170|FG000|COMPLETED|After Controlled Period||0
10406736|NCT00747344|11551171|FG001|COMPLETED|After Controlled Period||0
10406737|NCT00747344|11551172|FG002|COMPLETED|After Controlled Period||55
10406738|NCT00747344|11551173|FG003|COMPLETED|After Controlled Period||56
10406739|NCT00747344|11551170|FG000|NOT COMPLETED|After Controlled Period||0
10406740|NCT00747344|11551171|FG001|NOT COMPLETED|After Controlled Period||0
10406741|NCT00747344|11551172|FG002|NOT COMPLETED|After Controlled Period||0
10406742|NCT00747344|11551173|FG003|NOT COMPLETED|After Controlled Period||1
10406743|NCT00747435|11551181|FG000|STARTED|Overall Study||73
10406744|NCT00747435|11551181|FG000|COMPLETED|Overall Study||67
10406745|NCT00747435|11551181|FG000|NOT COMPLETED|Overall Study||6
10406746|NCT00747474|11551185|FG000|STARTED|Cohort 1 (1.5 mg/m^2) Period||3
10406747|NCT00747474|11551186|FG001|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
10406748|NCT00747474|11551187|FG002|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
10406749|NCT00747474|11551188|FG003|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
10406750|NCT00747474|11551189|FG004|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
10406751|NCT00747474|11551190|FG005|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
10406752|NCT00747474|11551191|FG006|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
10406753|NCT00747474|11551192|FG007|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
10406754|NCT00747474|11551193|FG008|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
10406755|NCT00747474|11551194|FG009|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
10406756|NCT00747474|11551195|FG010|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
10406757|NCT00747474|11551196|FG011|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
10406758|NCT00747474|11551185|FG000|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||3
10723907|NCT01732107|11887811|FG000|STARTED|Overall Study||13
10723908|NCT01732107|11887811|FG000|COMPLETED|Overall Study||0
10723909|NCT01732107|11887811|FG000|NOT COMPLETED|Overall Study||13
10312767|NCT00144781|11446212|FG002|NOT COMPLETED|Overall Study||0
10312768|NCT00144781|11446213|FG003|NOT COMPLETED|Overall Study||0
10312769|NCT00144963|11446223|FG000|STARTED|Overall Study||36
10312770|NCT00144963|11446223|FG000|COMPLETED|Overall Study||36
10312771|NCT00144963|11446223|FG000|NOT COMPLETED|Overall Study||0
10312772|NCT00145041|11446227|FG000|STARTED|Overall Study||7
10312773|NCT00145041|11446227|FG000|COMPLETED|Overall Study||7
10312774|NCT00145041|11446227|FG000|NOT COMPLETED|Overall Study||0
10312775|NCT00145119|11446231|FG000|STARTED|Overall Study||312
10312776|NCT00145119|11446231|FG000|COMPLETED|Overall Study||267
10312777|NCT00145119|11446231|FG000|NOT COMPLETED|Overall Study||45
10312778|NCT00145145|11446235|FG000|STARTED|Overall Study||1
10406759|NCT00747474|11551186|FG001|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
10406760|NCT00747474|11551187|FG002|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
10406761|NCT00747474|11551188|FG003|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
10406762|NCT00747474|11551189|FG004|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
10406763|NCT00747474|11551190|FG005|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
10406764|NCT00747474|11551191|FG006|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
10406765|NCT00747474|11551192|FG007|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
10406766|NCT00747474|11551193|FG008|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
10406767|NCT00747474|11551194|FG009|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
10406768|NCT00747474|11551195|FG010|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
10406769|NCT00747474|11551196|FG011|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
10406770|NCT00747474|11551185|FG000|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
10406771|NCT00747474|11551186|FG001|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
10406772|NCT00747474|11551187|FG002|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
10406773|NCT00747474|11551188|FG003|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
10406774|NCT00747474|11551189|FG004|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
10406775|NCT00747474|11551190|FG005|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
10406776|NCT00747474|11551191|FG006|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
10406777|NCT00747474|11551192|FG007|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
10406778|NCT00747474|11551193|FG008|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
10406779|NCT00747474|11551194|FG009|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
10406780|NCT00747474|11551195|FG010|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
10406781|NCT00747474|11551196|FG011|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
10544414|NCT01490632|11697650|FG013|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
10544415|NCT01490632|11697651|FG014|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
10544416|NCT01490632|11697652|FG015|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
10544417|NCT01490632|11697653|FG016|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
10544418|NCT01490632|11697654|FG017|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
10544419|NCT01490632|11697655|FG018|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
10723910|NCT01681433|11887817|FG000|STARTED|Overall Study||36
10723911|NCT01681433|11887818|FG001|STARTED|Overall Study||36
10723912|NCT01681433|11887817|FG000|COMPLETED|Overall Study||4
10723913|NCT01681433|11887818|FG001|COMPLETED|Overall Study||3
10723914|NCT01681433|11887817|FG000|NOT COMPLETED|Overall Study||32
10723915|NCT01681433|11887818|FG001|NOT COMPLETED|Overall Study||33
10544420|NCT01490632|11697656|FG019|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
10544421|NCT01490632|11697637|FG000|COMPLETED|Part A: Initial Treatment Period||27
10544422|NCT01490632|11697638|FG001|COMPLETED|Part A: Initial Treatment Period||28
10544423|NCT01490632|11697639|FG002|COMPLETED|Part A: Initial Treatment Period||67
10544424|NCT01490632|11697640|FG003|COMPLETED|Part A: Initial Treatment Period||55
10544425|NCT01490632|11697641|FG004|COMPLETED|Part A: Initial Treatment Period|Includes participants who completed Part A, but discontinued per protocol using Part A PASI score.|52
10544426|NCT01490632|11697642|FG005|COMPLETED|Part A: Initial Treatment Period||0
10544427|NCT01490632|11697643|FG006|COMPLETED|Part A: Initial Treatment Period||0
10544428|NCT01490632|11697644|FG007|COMPLETED|Part A: Initial Treatment Period||0
10544429|NCT01490632|11697645|FG008|COMPLETED|Part A: Initial Treatment Period||0
10544430|NCT01490632|11697646|FG009|COMPLETED|Part A: Initial Treatment Period||0
10544431|NCT01490632|11697647|FG010|COMPLETED|Part A: Initial Treatment Period||0
10544432|NCT01490632|11697648|FG011|COMPLETED|Part A: Initial Treatment Period||0
10544433|NCT01490632|11697649|FG012|COMPLETED|Part A: Initial Treatment Period||0
10544434|NCT01490632|11697650|FG013|COMPLETED|Part A: Initial Treatment Period||0
10544435|NCT01490632|11697651|FG014|COMPLETED|Part A: Initial Treatment Period||0
10544436|NCT01490632|11697652|FG015|COMPLETED|Part A: Initial Treatment Period||0
10544437|NCT01490632|11697653|FG016|COMPLETED|Part A: Initial Treatment Period||0
10544438|NCT01490632|11697654|FG017|COMPLETED|Part A: Initial Treatment Period||0
10544439|NCT01490632|11697655|FG018|COMPLETED|Part A: Initial Treatment Period||0
10544440|NCT01490632|11697656|FG019|COMPLETED|Part A: Initial Treatment Period||0
10544441|NCT01490632|11697637|FG000|NOT COMPLETED|Part A: Initial Treatment Period||7
10544442|NCT01490632|11697638|FG001|NOT COMPLETED|Part A: Initial Treatment Period||4
10544443|NCT01490632|11697639|FG002|NOT COMPLETED|Part A: Initial Treatment Period||5
10544444|NCT01490632|11697640|FG003|NOT COMPLETED|Part A: Initial Treatment Period||9
10544445|NCT01490632|11697641|FG004|NOT COMPLETED|Part A: Initial Treatment Period||17
10544446|NCT01490632|11697642|FG005|NOT COMPLETED|Part A: Initial Treatment Period||0
10723925|NCT01630434|11887840|FG000|STARTED|Overall Study||151
10723926|NCT01630434|11887841|FG001|STARTED|Overall Study||169
10723927|NCT01630434|11887840|FG000|Safety Population|Overall Study||150
10723928|NCT01630434|11887841|FG001|Safety Population|Overall Study||169
10723929|NCT01630434|11887840|FG000|Per Protocol Population|Overall Study||141
10406782|NCT00747474|11551185|FG000|STARTED|Cohort 2 (3 mg/m^2) Period||0
10406783|NCT00747474|11551186|FG001|STARTED|Cohort 2 (3 mg/m^2) Period||4
10723930|NCT01630434|11887841|FG001|Per Protocol Population|Overall Study||165
10723931|NCT01630434|11887840|FG000|COMPLETED|Overall Study||121
10723932|NCT01630434|11887841|FG001|COMPLETED|Overall Study||139
10723933|NCT01630434|11887840|FG000|NOT COMPLETED|Overall Study||30
10723934|NCT01630434|11887841|FG001|NOT COMPLETED|Overall Study||30
10406784|NCT00747474|11551187|FG002|STARTED|Cohort 2 (3 mg/m^2) Period||0
10406785|NCT00747474|11551188|FG003|STARTED|Cohort 2 (3 mg/m^2) Period||0
10406786|NCT00747474|11551189|FG004|STARTED|Cohort 2 (3 mg/m^2) Period||0
10406787|NCT00747474|11551190|FG005|STARTED|Cohort 2 (3 mg/m^2) Period||0
10406788|NCT00747474|11551191|FG006|STARTED|Cohort 2 (3 mg/m^2) Period||0
10406789|NCT00747474|11551192|FG007|STARTED|Cohort 2 (3 mg/m^2) Period||0
10544447|NCT01490632|11697643|FG006|NOT COMPLETED|Part A: Initial Treatment Period||0
10544448|NCT01490632|11697644|FG007|NOT COMPLETED|Part A: Initial Treatment Period||0
10544449|NCT01490632|11697645|FG008|NOT COMPLETED|Part A: Initial Treatment Period||0
10544450|NCT01490632|11697646|FG009|NOT COMPLETED|Part A: Initial Treatment Period||0
10544451|NCT01490632|11697647|FG010|NOT COMPLETED|Part A: Initial Treatment Period||0
10723962|NCT01524991|11887893|FG000|STARTED|Overall Study||36
10723963|NCT01524991|11887893|FG000|COMPLETED|Overall Study||2
10723964|NCT01524991|11887893|FG000|NOT COMPLETED|Overall Study||34
10723965|NCT01452854|11887897|FG000|STARTED|Overall Study||2
10723966|NCT01452854|11887897|FG000|COMPLETED|Overall Study||2
10814487|NCT02343159|11977247|FG000|STARTED|Overall Study||27
10814488|NCT02343159|11977248|FG001|STARTED|Overall Study||27
10814489|NCT02343159|11977249|FG002|STARTED|Overall Study||30
10814490|NCT02343159|11977247|FG000|COMPLETED|Overall Study||1
10814491|NCT02343159|11977248|FG001|COMPLETED|Overall Study||1
10814492|NCT02343159|11977249|FG002|COMPLETED|Overall Study||0
10814493|NCT02343159|11977247|FG000|NOT COMPLETED|Overall Study||26
10814494|NCT02343159|11977248|FG001|NOT COMPLETED|Overall Study||26
10814495|NCT02343159|11977249|FG002|NOT COMPLETED|Overall Study||30
10814496|NCT02341495|11977258|FG000|STARTED|Overall Study||4
10814497|NCT02341495|11977258|FG000|COMPLETED|Overall Study||4
10814498|NCT02341495|11977258|FG000|NOT COMPLETED|Overall Study||0
10814499|NCT02336425|11977266|FG000|STARTED|Overall Study||2
10814500|NCT02336425|11977267|FG001|STARTED|Overall Study||2
10814501|NCT02336425|11977268|FG002|STARTED|Overall Study||3
10814502|NCT02336425|11977269|FG003|STARTED|Overall Study||3
10814503|NCT02336425|11977266|FG000|COMPLETED|Overall Study||0
10814504|NCT02336425|11977267|FG001|COMPLETED|Overall Study||0
10814505|NCT02336425|11977268|FG002|COMPLETED|Overall Study||0
10814506|NCT02336425|11977269|FG003|COMPLETED|Overall Study||0
10814507|NCT02336425|11977266|FG000|NOT COMPLETED|Overall Study||2
10814508|NCT02336425|11977267|FG001|NOT COMPLETED|Overall Study||2
10814509|NCT02336425|11977268|FG002|NOT COMPLETED|Overall Study||3
10814510|NCT02336425|11977269|FG003|NOT COMPLETED|Overall Study||3
10814511|NCT02336763|11977279|FG000|STARTED|Overall Study||2
10814512|NCT02336763|11977279|FG000|COMPLETED|Overall Study||2
10814513|NCT02336763|11977279|FG000|NOT COMPLETED|Overall Study||0
10814514|NCT02320825|11977285|FG000|STARTED|Overall Study||8
10814515|NCT02320825|11977286|FG001|STARTED|Overall Study||8
10814516|NCT02320825|11977285|FG000|COMPLETED|Overall Study||8
10406790|NCT00747474|11551193|FG008|STARTED|Cohort 2 (3 mg/m^2) Period||0
10406791|NCT00747474|11551194|FG009|STARTED|Cohort 2 (3 mg/m^2) Period||0
10723967|NCT01452854|11887897|FG000|NOT COMPLETED|Overall Study||0
10723968|NCT01211405|11887904|FG000|STARTED|Overall Study||7
10723969|NCT01211405|11887905|FG001|STARTED|Overall Study||7
10723970|NCT01211405|11887906|FG002|STARTED|Overall Study||12
10814517|NCT02320825|11977286|FG001|COMPLETED|Overall Study||8
10814518|NCT02320825|11977285|FG000|NOT COMPLETED|Overall Study||0
10406792|NCT00747474|11551195|FG010|STARTED|Cohort 2 (3 mg/m^2) Period||0
10406793|NCT00747474|11551196|FG011|STARTED|Cohort 2 (3 mg/m^2) Period||0
10406794|NCT00747474|11551185|FG000|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
10406795|NCT00747474|11551186|FG001|COMPLETED|Cohort 2 (3 mg/m^2) Period||4
10406796|NCT00747474|11551187|FG002|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
10406797|NCT00747474|11551188|FG003|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
10406798|NCT00747474|11551189|FG004|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
10406799|NCT00747474|11551190|FG005|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
10406800|NCT00747474|11551191|FG006|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
10406801|NCT00747474|11551192|FG007|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
10406802|NCT00747474|11551193|FG008|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
10406803|NCT00747474|11551194|FG009|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
10406804|NCT00747474|11551195|FG010|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
10406805|NCT00747474|11551196|FG011|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
10406806|NCT00747474|11551185|FG000|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
10406807|NCT00747474|11551186|FG001|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
10406808|NCT00747474|11551187|FG002|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
10406809|NCT00747474|11551188|FG003|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
10406810|NCT00747474|11551189|FG004|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
10406811|NCT00747474|11551190|FG005|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
10406812|NCT00747474|11551191|FG006|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
10406813|NCT00747474|11551192|FG007|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
10406814|NCT00747474|11551193|FG008|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
10406815|NCT00747474|11551194|FG009|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
10406816|NCT00747474|11551195|FG010|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
10406817|NCT00747474|11551196|FG011|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
10406818|NCT00747474|11551185|FG000|STARTED|Cohort 3 (6 mg/m^2) Period||0
10406819|NCT00747474|11551186|FG001|STARTED|Cohort 3 (6 mg/m^2) Period||0
10406820|NCT00747474|11551187|FG002|STARTED|Cohort 3 (6 mg/m^2) Period||3
10406821|NCT00747474|11551188|FG003|STARTED|Cohort 3 (6 mg/m^2) Period||0
10406822|NCT00747474|11551189|FG004|STARTED|Cohort 3 (6 mg/m^2) Period||0
10406823|NCT00747474|11551190|FG005|STARTED|Cohort 3 (6 mg/m^2) Period||0
10406824|NCT00747474|11551191|FG006|STARTED|Cohort 3 (6 mg/m^2) Period||0
10406825|NCT00747474|11551192|FG007|STARTED|Cohort 3 (6 mg/m^2) Period||0
10406826|NCT00747474|11551193|FG008|STARTED|Cohort 3 (6 mg/m^2) Period||0
10406827|NCT00747474|11551194|FG009|STARTED|Cohort 3 (6 mg/m^2) Period||0
10406828|NCT00747474|11551195|FG010|STARTED|Cohort 3 (6 mg/m^2) Period||0
10406829|NCT00747474|11551196|FG011|STARTED|Cohort 3 (6 mg/m^2) Period||0
10406830|NCT00747474|11551185|FG000|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
10406831|NCT00747474|11551186|FG001|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
10406832|NCT00747474|11551187|FG002|COMPLETED|Cohort 3 (6 mg/m^2) Period||3
10406833|NCT00747474|11551188|FG003|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
10406834|NCT00747474|11551189|FG004|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
10406835|NCT00747474|11551190|FG005|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
10406836|NCT00747474|11551191|FG006|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
10406837|NCT00747474|11551192|FG007|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
10406838|NCT00747474|11551193|FG008|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
10406839|NCT00747474|11551194|FG009|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
10406840|NCT00747474|11551195|FG010|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
10406841|NCT00747474|11551196|FG011|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
10406842|NCT00747474|11551185|FG000|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
10406843|NCT00747474|11551186|FG001|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
10406844|NCT00747474|11551187|FG002|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
10406845|NCT00747474|11551188|FG003|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
10406846|NCT00747474|11551189|FG004|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
10406847|NCT00747474|11551190|FG005|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
10406848|NCT00747474|11551191|FG006|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
10406849|NCT00747474|11551192|FG007|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
10406850|NCT00747474|11551193|FG008|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
10406851|NCT00747474|11551194|FG009|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
10406852|NCT00747474|11551195|FG010|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
10406853|NCT00747474|11551196|FG011|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
10406854|NCT00747474|11551185|FG000|STARTED|Cohort 4 (9 mg/m^2) Period||0
10406855|NCT00747474|11551186|FG001|STARTED|Cohort 4 (9 mg/m^2) Period||0
10406856|NCT00747474|11551187|FG002|STARTED|Cohort 4 (9 mg/m^2) Period||0
10406857|NCT00747474|11551188|FG003|STARTED|Cohort 4 (9 mg/m^2) Period||4
10406858|NCT00747474|11551189|FG004|STARTED|Cohort 4 (9 mg/m^2) Period||0
10406859|NCT00747474|11551190|FG005|STARTED|Cohort 4 (9 mg/m^2) Period||0
10406860|NCT00747474|11551191|FG006|STARTED|Cohort 4 (9 mg/m^2) Period||0
10406861|NCT00747474|11551192|FG007|STARTED|Cohort 4 (9 mg/m^2) Period||0
10406862|NCT00747474|11551193|FG008|STARTED|Cohort 4 (9 mg/m^2) Period||0
10406863|NCT00747474|11551194|FG009|STARTED|Cohort 4 (9 mg/m^2) Period||0
10406864|NCT00747474|11551195|FG010|STARTED|Cohort 4 (9 mg/m^2) Period||0
10406865|NCT00747474|11551196|FG011|STARTED|Cohort 4 (9 mg/m^2) Period||0
10406866|NCT00747474|11551185|FG000|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
10406867|NCT00747474|11551186|FG001|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
10406868|NCT00747474|11551187|FG002|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
10406869|NCT00747474|11551188|FG003|COMPLETED|Cohort 4 (9 mg/m^2) Period||4
10406870|NCT00747474|11551189|FG004|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
10406871|NCT00747474|11551190|FG005|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
10406872|NCT00747474|11551191|FG006|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
10406873|NCT00747474|11551192|FG007|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
10406874|NCT00747474|11551193|FG008|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
10406875|NCT00747474|11551194|FG009|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
10406876|NCT00747474|11551195|FG010|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
10406877|NCT00747474|11551196|FG011|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
10406878|NCT00747474|11551185|FG000|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
10723971|NCT01211405|11887904|FG000|Completed Primary Endpoint|Overall Study||7
10723972|NCT01211405|11887905|FG001|Completed Primary Endpoint|Overall Study||7
10723973|NCT01211405|11887906|FG002|Completed Primary Endpoint|Overall Study||12
10723974|NCT01211405|11887904|FG000|Completed Three Open-Label Sessions, Secondary, and End of Stage 2 Assessment|Overall Study||6
10723975|NCT01211405|11887905|FG001|Completed Three Open-Label Sessions, Secondary, and End of Stage 2 Assessment|Overall Study||6
10723976|NCT01211405|11887906|FG002|Completed Three Open-Label Sessions, Secondary, and End of Stage 2 Assessment|Overall Study||12
10723977|NCT01211405|11887904|FG000|COMPLETED|Overall Study||6
10723978|NCT01211405|11887905|FG001|COMPLETED|Overall Study||7
10723979|NCT01211405|11887906|FG002|COMPLETED|Overall Study||11
10723980|NCT01211405|11887904|FG000|NOT COMPLETED|Overall Study||1
10723981|NCT01211405|11887905|FG001|NOT COMPLETED|Overall Study||0
10723982|NCT01211405|11887906|FG002|NOT COMPLETED|Overall Study||1
10723983|NCT01085084|11887917|FG000|STARTED|Overall Study||26
10723984|NCT01085084|11887918|FG001|STARTED|Overall Study||28
10723985|NCT01085084|11887919|FG002|STARTED|Overall Study||28
10723986|NCT01085084|11887917|FG000|Received at Least 1 Dose of Study Drug|Overall Study||26
10723987|NCT01085084|11887918|FG001|Received at Least 1 Dose of Study Drug|Overall Study||28
10723988|NCT01085084|11887919|FG002|Received at Least 1 Dose of Study Drug|Overall Study||28
10723989|NCT01085084|11887917|FG000|Safety Analysis Set|Overall Study||25
10723990|NCT01085084|11887918|FG001|Safety Analysis Set|Overall Study|1 participant was assigned to placebo but received laquinimod 0.5 mg by mistake.|29
10723991|NCT01085084|11887919|FG002|Safety Analysis Set|Overall Study||28
10406879|NCT00747474|11551186|FG001|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
10406880|NCT00747474|11551187|FG002|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
10723992|NCT01085084|11887917|FG000|COMPLETED|Overall Study||19
10723993|NCT01085084|11887918|FG001|COMPLETED|Overall Study||23
10723994|NCT01085084|11887919|FG002|COMPLETED|Overall Study||19
10723995|NCT01085084|11887917|FG000|NOT COMPLETED|Overall Study||7
10723996|NCT01085084|11887918|FG001|NOT COMPLETED|Overall Study||5
10723997|NCT01085084|11887919|FG002|NOT COMPLETED|Overall Study||9
10723998|NCT01084252|11887941|FG000|STARTED|Phase 1 (120 Weeks)||16
10723999|NCT01084252|11887942|FG001|STARTED|Phase 1 (120 Weeks)||6
10724000|NCT01084252|11887943|FG002|STARTED|Phase 1 (120 Weeks)||3
10724001|NCT01084252|11887944|FG003|STARTED|Phase 1 (120 Weeks)||26
10724002|NCT01084252|11887945|FG004|STARTED|Phase 1 (120 Weeks)||18
10724003|NCT01084252|11887946|FG005|STARTED|Phase 1 (120 Weeks)||6
10724004|NCT01084252|11887947|FG006|STARTED|Phase 1 (120 Weeks)||7
10724005|NCT01084252|11887948|FG007|STARTED|Phase 1 (120 Weeks)||7
10724006|NCT01084252|11887949|FG008|STARTED|Phase 1 (120 Weeks)||0
10724007|NCT01084252|11887950|FG009|STARTED|Phase 1 (120 Weeks)||0
10724008|NCT01084252|11887951|FG010|STARTED|Phase 1 (120 Weeks)||0
10724009|NCT01084252|11887952|FG011|STARTED|Phase 1 (120 Weeks)||0
10724010|NCT01084252|11887953|FG012|STARTED|Phase 1 (120 Weeks)||0
10724011|NCT01084252|11887954|FG013|STARTED|Phase 1 (120 Weeks)||0
10724012|NCT01084252|11887941|FG000|All Treated (AT) Population|Phase 1 (120 Weeks)||16
10724013|NCT01084252|11887942|FG001|All Treated (AT) Population|Phase 1 (120 Weeks)||6
10724014|NCT01084252|11887943|FG002|All Treated (AT) Population|Phase 1 (120 Weeks)||3
10724015|NCT01084252|11887944|FG003|All Treated (AT) Population|Phase 1 (120 Weeks)||26
10724016|NCT01084252|11887945|FG004|All Treated (AT) Population|Phase 1 (120 Weeks)||18
10724017|NCT01084252|11887946|FG005|All Treated (AT) Population|Phase 1 (120 Weeks)||6
10724018|NCT01084252|11887947|FG006|All Treated (AT) Population|Phase 1 (120 Weeks)||7
10724019|NCT01084252|11887948|FG007|All Treated (AT) Population|Phase 1 (120 Weeks)||7
10724020|NCT01084252|11887949|FG008|All Treated (AT) Population|Phase 1 (120 Weeks)||0
10724021|NCT01084252|11887950|FG009|All Treated (AT) Population|Phase 1 (120 Weeks)||0
10724022|NCT01084252|11887951|FG010|All Treated (AT) Population|Phase 1 (120 Weeks)||0
10724023|NCT01084252|11887952|FG011|All Treated (AT) Population|Phase 1 (120 Weeks)||0
10724024|NCT01084252|11887953|FG012|All Treated (AT) Population|Phase 1 (120 Weeks)||0
10724025|NCT01084252|11887954|FG013|All Treated (AT) Population|Phase 1 (120 Weeks)||0
10724026|NCT01084252|11887941|FG000|COMPLETED|Phase 1 (120 Weeks)||0
10724027|NCT01084252|11887942|FG001|COMPLETED|Phase 1 (120 Weeks)||0
10724028|NCT01084252|11887943|FG002|COMPLETED|Phase 1 (120 Weeks)||0
10724029|NCT01084252|11887944|FG003|COMPLETED|Phase 1 (120 Weeks)||0
10724030|NCT01084252|11887945|FG004|COMPLETED|Phase 1 (120 Weeks)||0
10724031|NCT01084252|11887946|FG005|COMPLETED|Phase 1 (120 Weeks)||0
10724032|NCT01084252|11887947|FG006|COMPLETED|Phase 1 (120 Weeks)||0
10724033|NCT01084252|11887948|FG007|COMPLETED|Phase 1 (120 Weeks)||0
10406881|NCT00747474|11551188|FG003|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
10406882|NCT00747474|11551189|FG004|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
10724034|NCT01084252|11887949|FG008|COMPLETED|Phase 1 (120 Weeks)||0
10724035|NCT01084252|11887950|FG009|COMPLETED|Phase 1 (120 Weeks)||0
10724036|NCT01084252|11887951|FG010|COMPLETED|Phase 1 (120 Weeks)||0
10724037|NCT01084252|11887952|FG011|COMPLETED|Phase 1 (120 Weeks)||0
10724038|NCT01084252|11887953|FG012|COMPLETED|Phase 1 (120 Weeks)||0
10724039|NCT01084252|11887954|FG013|COMPLETED|Phase 1 (120 Weeks)||0
10724040|NCT01084252|11887941|FG000|NOT COMPLETED|Phase 1 (120 Weeks)||16
10724041|NCT01084252|11887942|FG001|NOT COMPLETED|Phase 1 (120 Weeks)||6
10406883|NCT00747474|11551190|FG005|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
10406884|NCT00747474|11551191|FG006|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
10406885|NCT00747474|11551192|FG007|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
10406886|NCT00747474|11551193|FG008|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
10406887|NCT00747474|11551194|FG009|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
10406888|NCT00747474|11551195|FG010|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
10406889|NCT00747474|11551196|FG011|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
10406890|NCT00747474|11551185|FG000|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
10406891|NCT00747474|11551186|FG001|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
10406892|NCT00747474|11551187|FG002|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
10406893|NCT00747474|11551188|FG003|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
10406894|NCT00747474|11551189|FG004|STARTED|Cohort 5 (13.5 mg/m^2) Period||4
10406895|NCT00747474|11551190|FG005|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
10406896|NCT00747474|11551191|FG006|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
10406897|NCT00747474|11551192|FG007|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
10406898|NCT00747474|11551193|FG008|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
10406899|NCT00747474|11551194|FG009|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
10406900|NCT00747474|11551195|FG010|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
10406901|NCT00747474|11551196|FG011|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
10406902|NCT00747474|11551185|FG000|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
10406903|NCT00747474|11551186|FG001|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
10406904|NCT00747474|11551187|FG002|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
10406905|NCT00747474|11551188|FG003|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
10406906|NCT00747474|11551189|FG004|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||4
10406907|NCT00747474|11551190|FG005|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
10406908|NCT00747474|11551191|FG006|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
10406909|NCT00747474|11551192|FG007|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
10406910|NCT00747474|11551193|FG008|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
10406911|NCT00747474|11551194|FG009|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
10406912|NCT00747474|11551195|FG010|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
10406913|NCT00747474|11551196|FG011|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
10406914|NCT00747474|11551185|FG000|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
10406915|NCT00747474|11551186|FG001|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
10406916|NCT00747474|11551187|FG002|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
10406917|NCT00747474|11551188|FG003|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
10406918|NCT00747474|11551189|FG004|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
10406919|NCT00747474|11551190|FG005|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
10406920|NCT00747474|11551191|FG006|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
10406921|NCT00747474|11551192|FG007|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
10406922|NCT00747474|11551193|FG008|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
10406923|NCT00747474|11551194|FG009|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
10406924|NCT00747474|11551195|FG010|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
10406925|NCT00747474|11551196|FG011|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
10406926|NCT00747474|11551185|FG000|STARTED|Cohort 6 (20 mg/m^2) Period||0
10406927|NCT00747474|11551186|FG001|STARTED|Cohort 6 (20 mg/m^2) Period||0
10406928|NCT00747474|11551187|FG002|STARTED|Cohort 6 (20 mg/m^2) Period||0
10406929|NCT00747474|11551188|FG003|STARTED|Cohort 6 (20 mg/m^2) Period||0
10406930|NCT00747474|11551189|FG004|STARTED|Cohort 6 (20 mg/m^2) Period||0
10406931|NCT00747474|11551190|FG005|STARTED|Cohort 6 (20 mg/m^2) Period||4
10406932|NCT00747474|11551191|FG006|STARTED|Cohort 6 (20 mg/m^2) Period||0
10724042|NCT01084252|11887943|FG002|NOT COMPLETED|Phase 1 (120 Weeks)||3
10724043|NCT01084252|11887944|FG003|NOT COMPLETED|Phase 1 (120 Weeks)||26
10724044|NCT01084252|11887945|FG004|NOT COMPLETED|Phase 1 (120 Weeks)||18
10724045|NCT01084252|11887946|FG005|NOT COMPLETED|Phase 1 (120 Weeks)||6
10724046|NCT01084252|11887947|FG006|NOT COMPLETED|Phase 1 (120 Weeks)||7
10724047|NCT01084252|11887948|FG007|NOT COMPLETED|Phase 1 (120 Weeks)||7
10724048|NCT01084252|11887949|FG008|NOT COMPLETED|Phase 1 (120 Weeks)||0
10724049|NCT01084252|11887950|FG009|NOT COMPLETED|Phase 1 (120 Weeks)||0
10724050|NCT01084252|11887951|FG010|NOT COMPLETED|Phase 1 (120 Weeks)||0
10724051|NCT01084252|11887952|FG011|NOT COMPLETED|Phase 1 (120 Weeks)||0
10724052|NCT01084252|11887953|FG012|NOT COMPLETED|Phase 1 (120 Weeks)||0
10724053|NCT01084252|11887954|FG013|NOT COMPLETED|Phase 1 (120 Weeks)||0
10724054|NCT01084252|11887941|FG000|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10724055|NCT01084252|11887942|FG001|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10724056|NCT01084252|11887943|FG002|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10724057|NCT01084252|11887944|FG003|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10724058|NCT01084252|11887945|FG004|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10724059|NCT01084252|11887946|FG005|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10724060|NCT01084252|11887947|FG006|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10724061|NCT01084252|11887948|FG007|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10406933|NCT00747474|11551192|FG007|STARTED|Cohort 6 (20 mg/m^2) Period||0
10406934|NCT00747474|11551193|FG008|STARTED|Cohort 6 (20 mg/m^2) Period||0
10406935|NCT00747474|11551194|FG009|STARTED|Cohort 6 (20 mg/m^2) Period||0
10544452|NCT01490632|11697648|FG011|NOT COMPLETED|Part A: Initial Treatment Period||0
10724062|NCT01084252|11887949|FG008|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|23
10724063|NCT01084252|11887950|FG009|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|24
10406936|NCT00747474|11551195|FG010|STARTED|Cohort 6 (20 mg/m^2) Period||0
10406937|NCT00747474|11551196|FG011|STARTED|Cohort 6 (20 mg/m^2) Period||0
10406938|NCT00747474|11551185|FG000|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
10406939|NCT00747474|11551186|FG001|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
10406940|NCT00747474|11551187|FG002|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
10406941|NCT00747474|11551188|FG003|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
10406942|NCT00747474|11551189|FG004|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
10406943|NCT00747474|11551190|FG005|COMPLETED|Cohort 6 (20 mg/m^2) Period||4
10406944|NCT00747474|11551191|FG006|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
10406945|NCT00747474|11551192|FG007|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
10406946|NCT00747474|11551193|FG008|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
10724103|NCT01084252|11887948|FG007|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10724064|NCT01084252|11887951|FG010|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|25
10724065|NCT01084252|11887952|FG011|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|25
10724066|NCT01084252|11887953|FG012|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10724067|NCT01084252|11887954|FG013|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10724068|NCT01084252|11887941|FG000|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10724069|NCT01084252|11887942|FG001|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10724070|NCT01084252|11887943|FG002|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10724071|NCT01084252|11887944|FG003|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10724072|NCT01084252|11887945|FG004|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10724073|NCT01084252|11887946|FG005|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10724074|NCT01084252|11887947|FG006|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10724075|NCT01084252|11887948|FG007|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10724076|NCT01084252|11887949|FG008|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||23
10724077|NCT01084252|11887950|FG009|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||24
10724078|NCT01084252|11887951|FG010|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25
10724079|NCT01084252|11887952|FG011|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25
10724080|NCT01084252|11887953|FG012|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10724081|NCT01084252|11887954|FG013|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10724082|NCT01084252|11887941|FG000|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10724083|NCT01084252|11887942|FG001|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10724084|NCT01084252|11887943|FG002|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10724085|NCT01084252|11887944|FG003|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10724086|NCT01084252|11887945|FG004|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10724087|NCT01084252|11887946|FG005|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10724088|NCT01084252|11887947|FG006|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10724089|NCT01084252|11887948|FG007|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10724090|NCT01084252|11887949|FG008|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10724091|NCT01084252|11887950|FG009|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10724092|NCT01084252|11887951|FG010|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10724093|NCT01084252|11887952|FG011|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10724094|NCT01084252|11887953|FG012|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10724095|NCT01084252|11887954|FG013|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10724096|NCT01084252|11887941|FG000|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10724097|NCT01084252|11887942|FG001|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10724098|NCT01084252|11887943|FG002|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10724099|NCT01084252|11887944|FG003|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10724100|NCT01084252|11887945|FG004|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10406947|NCT00747474|11551194|FG009|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
10406948|NCT00747474|11551195|FG010|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
10406949|NCT00747474|11551196|FG011|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
10406950|NCT00747474|11551185|FG000|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
10406951|NCT00747474|11551186|FG001|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
10406952|NCT00747474|11551187|FG002|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
10406953|NCT00747474|11551188|FG003|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
10406954|NCT00747474|11551189|FG004|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
10406955|NCT00747474|11551190|FG005|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
10406956|NCT00747474|11551191|FG006|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
10406957|NCT00747474|11551192|FG007|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
10406958|NCT00747474|11551193|FG008|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
10406959|NCT00747474|11551194|FG009|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
10406960|NCT00747474|11551195|FG010|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
10406961|NCT00747474|11551196|FG011|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
10406962|NCT00747474|11551185|FG000|STARTED|Cohort 7 (30 mg/m^2) Period||0
10406963|NCT00747474|11551186|FG001|STARTED|Cohort 7 (30 mg/m^2) Period||0
10406964|NCT00747474|11551187|FG002|STARTED|Cohort 7 (30 mg/m^2) Period||0
10406965|NCT00747474|11551188|FG003|STARTED|Cohort 7 (30 mg/m^2) Period||0
10406966|NCT00747474|11551189|FG004|STARTED|Cohort 7 (30 mg/m^2) Period||0
10406967|NCT00747474|11551190|FG005|STARTED|Cohort 7 (30 mg/m^2) Period||0
10406968|NCT00747474|11551191|FG006|STARTED|Cohort 7 (30 mg/m^2) Period||4
10406969|NCT00747474|11551192|FG007|STARTED|Cohort 7 (30 mg/m^2) Period||0
10406970|NCT00747474|11551193|FG008|STARTED|Cohort 7 (30 mg/m^2) Period||0
10406971|NCT00747474|11551194|FG009|STARTED|Cohort 7 (30 mg/m^2) Period||0
10406972|NCT00747474|11551195|FG010|STARTED|Cohort 7 (30 mg/m^2) Period||0
10406973|NCT00747474|11551196|FG011|STARTED|Cohort 7 (30 mg/m^2) Period||0
10406974|NCT00747474|11551185|FG000|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
10406975|NCT00747474|11551186|FG001|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
10406976|NCT00747474|11551187|FG002|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
10406977|NCT00747474|11551188|FG003|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
10406978|NCT00747474|11551189|FG004|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
10406979|NCT00747474|11551190|FG005|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
10406980|NCT00747474|11551191|FG006|COMPLETED|Cohort 7 (30 mg/m^2) Period||4
10406981|NCT00747474|11551192|FG007|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
10724101|NCT01084252|11887946|FG005|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10724102|NCT01084252|11887947|FG006|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10724104|NCT01084252|11887949|FG008|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||23
10724105|NCT01084252|11887950|FG009|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||24
10724106|NCT01084252|11887951|FG010|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25
10724107|NCT01084252|11887952|FG011|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25
10724108|NCT01084252|11887953|FG012|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10724109|NCT01084252|11887954|FG013|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
10724110|NCT01084252|11887941|FG000|STARTED|Phase 2 Stage 2 (97 Weeks)||0
10724111|NCT01084252|11887942|FG001|STARTED|Phase 2 Stage 2 (97 Weeks)||0
10724112|NCT01084252|11887943|FG002|STARTED|Phase 2 Stage 2 (97 Weeks)||0
10724113|NCT01084252|11887944|FG003|STARTED|Phase 2 Stage 2 (97 Weeks)||0
10724114|NCT01084252|11887945|FG004|STARTED|Phase 2 Stage 2 (97 Weeks)||0
10724115|NCT01084252|11887946|FG005|STARTED|Phase 2 Stage 2 (97 Weeks)||0
10724116|NCT01084252|11887947|FG006|STARTED|Phase 2 Stage 2 (97 Weeks)||0
10724117|NCT01084252|11887948|FG007|STARTED|Phase 2 Stage 2 (97 Weeks)||0
10724118|NCT01084252|11887949|FG008|STARTED|Phase 2 Stage 2 (97 Weeks)||0
10724119|NCT01084252|11887950|FG009|STARTED|Phase 2 Stage 2 (97 Weeks)||0
10724120|NCT01084252|11887951|FG010|STARTED|Phase 2 Stage 2 (97 Weeks)||0
10724121|NCT01084252|11887952|FG011|STARTED|Phase 2 Stage 2 (97 Weeks)||0
10724122|NCT01084252|11887953|FG012|STARTED|Phase 2 Stage 2 (97 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|110
10724123|NCT01084252|11887954|FG013|STARTED|Phase 2 Stage 2 (97 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|55
10724124|NCT01084252|11887941|FG000|AT Population|Phase 2 Stage 2 (97 Weeks)||0
10724125|NCT01084252|11887942|FG001|AT Population|Phase 2 Stage 2 (97 Weeks)||0
10724126|NCT01084252|11887943|FG002|AT Population|Phase 2 Stage 2 (97 Weeks)||0
10724127|NCT01084252|11887944|FG003|AT Population|Phase 2 Stage 2 (97 Weeks)||0
10724128|NCT01084252|11887945|FG004|AT Population|Phase 2 Stage 2 (97 Weeks)||0
10724129|NCT01084252|11887946|FG005|AT Population|Phase 2 Stage 2 (97 Weeks)||0
10724130|NCT01084252|11887947|FG006|AT Population|Phase 2 Stage 2 (97 Weeks)||0
10724131|NCT01084252|11887948|FG007|AT Population|Phase 2 Stage 2 (97 Weeks)||0
10724132|NCT01084252|11887949|FG008|AT Population|Phase 2 Stage 2 (97 Weeks)||0
10724133|NCT01084252|11887950|FG009|AT Population|Phase 2 Stage 2 (97 Weeks)||0
10724134|NCT01084252|11887951|FG010|AT Population|Phase 2 Stage 2 (97 Weeks)||0
10724135|NCT01084252|11887952|FG011|AT Population|Phase 2 Stage 2 (97 Weeks)||0
10724136|NCT01084252|11887953|FG012|AT Population|Phase 2 Stage 2 (97 Weeks)||109
10724137|NCT01084252|11887954|FG013|AT Population|Phase 2 Stage 2 (97 Weeks)||55
10724138|NCT01084252|11887941|FG000|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10724139|NCT01084252|11887942|FG001|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10724140|NCT01084252|11887943|FG002|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10724141|NCT01084252|11887944|FG003|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10724142|NCT01084252|11887945|FG004|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10724143|NCT01084252|11887946|FG005|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10724144|NCT01084252|11887947|FG006|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10724145|NCT01084252|11887948|FG007|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10724146|NCT01084252|11887949|FG008|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10724147|NCT01084252|11887950|FG009|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10724148|NCT01084252|11887951|FG010|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10724149|NCT01084252|11887952|FG011|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10724150|NCT01084252|11887953|FG012|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10724151|NCT01084252|11887954|FG013|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10724152|NCT01084252|11887941|FG000|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10724153|NCT01084252|11887942|FG001|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10724154|NCT01084252|11887943|FG002|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10724155|NCT01084252|11887944|FG003|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10724156|NCT01084252|11887945|FG004|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10724157|NCT01084252|11887946|FG005|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10724158|NCT01084252|11887947|FG006|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10724159|NCT01084252|11887948|FG007|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10724160|NCT01084252|11887949|FG008|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10724161|NCT01084252|11887950|FG009|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10724162|NCT01084252|11887951|FG010|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10724163|NCT01084252|11887952|FG011|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
10724164|NCT01084252|11887953|FG012|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||110
10724165|NCT01084252|11887954|FG013|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||55
10724166|NCT01034631|11888021|FG000|STARTED|Phase I||15
10724167|NCT01034631|11888022|FG001|STARTED|Phase I|No Phase II Participants were enrolled during this time period|0
10724168|NCT01034631|11888023|FG002|STARTED|Phase I|No Phase II Participants were enrolled during this time period|0
10724169|NCT01034631|11888021|FG000|COMPLETED|Phase I||12
10406982|NCT00747474|11551193|FG008|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
10406983|NCT00747474|11551194|FG009|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
10406984|NCT00747474|11551195|FG010|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
10406985|NCT00747474|11551196|FG011|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
10406986|NCT00747474|11551185|FG000|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
10406987|NCT00747474|11551186|FG001|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
10406988|NCT00747474|11551187|FG002|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
10406989|NCT00747474|11551188|FG003|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
10406990|NCT00747474|11551189|FG004|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
10406991|NCT00747474|11551190|FG005|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
10406992|NCT00747474|11551191|FG006|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
10406993|NCT00747474|11551192|FG007|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
10406994|NCT00747474|11551193|FG008|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
10406995|NCT00747474|11551194|FG009|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
10406996|NCT00747474|11551195|FG010|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
10406997|NCT00747474|11551196|FG011|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
10406998|NCT00747474|11551185|FG000|STARTED|Cohort 8 (40 mg/m^2) Period||0
10406999|NCT00747474|11551186|FG001|STARTED|Cohort 8 (40 mg/m^2) Period||0
10407000|NCT00747474|11551187|FG002|STARTED|Cohort 8 (40 mg/m^2) Period||0
10407001|NCT00747474|11551188|FG003|STARTED|Cohort 8 (40 mg/m^2) Period||0
10407002|NCT00747474|11551189|FG004|STARTED|Cohort 8 (40 mg/m^2) Period||0
10407003|NCT00747474|11551190|FG005|STARTED|Cohort 8 (40 mg/m^2) Period||0
10407004|NCT00747474|11551191|FG006|STARTED|Cohort 8 (40 mg/m^2) Period||0
10407005|NCT00747474|11551192|FG007|STARTED|Cohort 8 (40 mg/m^2) Period||6
10407006|NCT00747474|11551193|FG008|STARTED|Cohort 8 (40 mg/m^2) Period||0
10407007|NCT00747474|11551194|FG009|STARTED|Cohort 8 (40 mg/m^2) Period||0
10407008|NCT00747474|11551195|FG010|STARTED|Cohort 8 (40 mg/m^2) Period||0
10407009|NCT00747474|11551196|FG011|STARTED|Cohort 8 (40 mg/m^2) Period||0
10407010|NCT00747474|11551185|FG000|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
10407011|NCT00747474|11551186|FG001|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
10407012|NCT00747474|11551187|FG002|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
10407013|NCT00747474|11551188|FG003|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
10407014|NCT00747474|11551189|FG004|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
10407015|NCT00747474|11551190|FG005|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
10407016|NCT00747474|11551191|FG006|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
10407017|NCT00747474|11551192|FG007|COMPLETED|Cohort 8 (40 mg/m^2) Period||5
10407018|NCT00747474|11551193|FG008|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
10407019|NCT00747474|11551194|FG009|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
10407020|NCT00747474|11551195|FG010|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
10407021|NCT00747474|11551196|FG011|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
10407022|NCT00747474|11551185|FG000|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
10407023|NCT00747474|11551186|FG001|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
10407024|NCT00747474|11551187|FG002|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
10407025|NCT00747474|11551188|FG003|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
10407026|NCT00747474|11551189|FG004|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
10407027|NCT00747474|11551190|FG005|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
10407028|NCT00747474|11551191|FG006|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
10407029|NCT00747474|11551192|FG007|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||1
10407030|NCT00747474|11551193|FG008|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
10407031|NCT00747474|11551194|FG009|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
10407032|NCT00747474|11551195|FG010|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
10407033|NCT00747474|11551196|FG011|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
10407034|NCT00747474|11551185|FG000|STARTED|Cohort 9 (35 mg/m^2) Period||0
10407035|NCT00747474|11551186|FG001|STARTED|Cohort 9 (35 mg/m^2) Period||0
10407036|NCT00747474|11551187|FG002|STARTED|Cohort 9 (35 mg/m^2) Period||0
10407037|NCT00747474|11551188|FG003|STARTED|Cohort 9 (35 mg/m^2) Period||0
10407038|NCT00747474|11551189|FG004|STARTED|Cohort 9 (35 mg/m^2) Period||0
10407039|NCT00747474|11551190|FG005|STARTED|Cohort 9 (35 mg/m^2) Period||0
10407040|NCT00747474|11551191|FG006|STARTED|Cohort 9 (35 mg/m^2) Period||0
10407041|NCT00747474|11551192|FG007|STARTED|Cohort 9 (35 mg/m^2) Period||0
10407042|NCT00747474|11551193|FG008|STARTED|Cohort 9 (35 mg/m^2) Period||4
10407043|NCT00747474|11551194|FG009|STARTED|Cohort 9 (35 mg/m^2) Period||0
10407044|NCT00747474|11551195|FG010|STARTED|Cohort 9 (35 mg/m^2) Period||0
10407045|NCT00747474|11551196|FG011|STARTED|Cohort 9 (35 mg/m^2) Period||0
10407046|NCT00747474|11551185|FG000|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
10407047|NCT00747474|11551186|FG001|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
10407048|NCT00747474|11551187|FG002|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
10407049|NCT00747474|11551188|FG003|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
10407050|NCT00747474|11551189|FG004|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
10407051|NCT00747474|11551190|FG005|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
10407052|NCT00747474|11551191|FG006|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
10407053|NCT00747474|11551192|FG007|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
10407054|NCT00747474|11551193|FG008|COMPLETED|Cohort 9 (35 mg/m^2) Period||4
10407055|NCT00747474|11551194|FG009|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
10407056|NCT00747474|11551195|FG010|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
10724170|NCT01034631|11888022|FG001|COMPLETED|Phase I||0
10724171|NCT01034631|11888023|FG002|COMPLETED|Phase I||0
10724172|NCT01034631|11888021|FG000|NOT COMPLETED|Phase I||3
10407057|NCT00747474|11551196|FG011|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
10407058|NCT00747474|11551185|FG000|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
10407059|NCT00747474|11551186|FG001|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
10407060|NCT00747474|11551187|FG002|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
10407061|NCT00747474|11551188|FG003|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
10407062|NCT00747474|11551189|FG004|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
10407063|NCT00747474|11551190|FG005|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
10407064|NCT00747474|11551191|FG006|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
10407065|NCT00747474|11551192|FG007|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
10407066|NCT00747474|11551193|FG008|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
10407067|NCT00747474|11551194|FG009|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
10407068|NCT00747474|11551195|FG010|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
10407069|NCT00747474|11551196|FG011|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
10407070|NCT00747474|11551185|FG000|STARTED|Cohort 10 (40 mg/m^2) Period||0
10407071|NCT00747474|11551186|FG001|STARTED|Cohort 10 (40 mg/m^2) Period||0
10407072|NCT00747474|11551187|FG002|STARTED|Cohort 10 (40 mg/m^2) Period||0
10407073|NCT00747474|11551188|FG003|STARTED|Cohort 10 (40 mg/m^2) Period||0
10407074|NCT00747474|11551189|FG004|STARTED|Cohort 10 (40 mg/m^2) Period||0
10407075|NCT00747474|11551190|FG005|STARTED|Cohort 10 (40 mg/m^2) Period||0
10407076|NCT00747474|11551191|FG006|STARTED|Cohort 10 (40 mg/m^2) Period||0
10407077|NCT00747474|11551192|FG007|STARTED|Cohort 10 (40 mg/m^2) Period||0
10407078|NCT00747474|11551193|FG008|STARTED|Cohort 10 (40 mg/m^2) Period||0
10407079|NCT00747474|11551194|FG009|STARTED|Cohort 10 (40 mg/m^2) Period||7
10407080|NCT00747474|11551195|FG010|STARTED|Cohort 10 (40 mg/m^2) Period||0
10407081|NCT00747474|11551196|FG011|STARTED|Cohort 10 (40 mg/m^2) Period||0
10407082|NCT00747474|11551185|FG000|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
10407083|NCT00747474|11551186|FG001|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
10407084|NCT00747474|11551187|FG002|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
10407085|NCT00747474|11551188|FG003|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
10407086|NCT00747474|11551189|FG004|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
10407087|NCT00747474|11551190|FG005|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
10407088|NCT00747474|11551191|FG006|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
10407089|NCT00747474|11551192|FG007|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
10407090|NCT00747474|11551193|FG008|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
10407091|NCT00747474|11551194|FG009|COMPLETED|Cohort 10 (40 mg/m^2) Period||7
10407092|NCT00747474|11551195|FG010|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
10407093|NCT00747474|11551196|FG011|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
10407094|NCT00747474|11551185|FG000|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
10407095|NCT00747474|11551186|FG001|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
10407096|NCT00747474|11551187|FG002|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
10407097|NCT00747474|11551188|FG003|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
10724173|NCT01034631|11888022|FG001|NOT COMPLETED|Phase I||0
10724174|NCT01034631|11888023|FG002|NOT COMPLETED|Phase I||0
10724175|NCT01034631|11888021|FG000|STARTED|Phase II|No Phase I Participants were enrolled during this time period.|0
10724176|NCT01034631|11888022|FG001|STARTED|Phase II||70
10724177|NCT01034631|11888023|FG002|STARTED|Phase II||69
10724178|NCT01034631|11888021|FG000|COMPLETED|Phase II||0
10814519|NCT02320825|11977286|FG001|NOT COMPLETED|Overall Study||0
10814520|NCT02319005|11977294|FG000|STARTED|Overall Study||140
10814521|NCT02319005|11977295|FG001|STARTED|Overall Study||66
10814522|NCT02319005|11977294|FG000|COMPLETED|Overall Study||92
10814523|NCT02319005|11977295|FG001|COMPLETED|Overall Study||51
10814524|NCT02319005|11977294|FG000|NOT COMPLETED|Overall Study||48
10814525|NCT02319005|11977295|FG001|NOT COMPLETED|Overall Study||15
10814526|NCT02318901|11977304|FG000|STARTED|Overall Study||5
10814527|NCT02318901|11977305|FG001|STARTED|Overall Study||1
10724179|NCT01034631|11888022|FG001|COMPLETED|Phase II||69
10724180|NCT01034631|11888023|FG002|COMPLETED|Phase II||67
10724181|NCT01034631|11888021|FG000|NOT COMPLETED|Phase II||0
10724182|NCT01034631|11888022|FG001|NOT COMPLETED|Phase II||1
10724183|NCT01034631|11888023|FG002|NOT COMPLETED|Phase II||2
10724184|NCT00402298|11888035|FG000|STARTED|Overall Study||3
10724185|NCT00402298|11888036|FG001|STARTED|Overall Study||2
10724186|NCT00402298|11888035|FG000|COMPLETED|Overall Study||2
10724187|NCT00402298|11888036|FG001|COMPLETED|Overall Study||2
10724188|NCT00402298|11888035|FG000|NOT COMPLETED|Overall Study||1
10724189|NCT00402298|11888036|FG001|NOT COMPLETED|Overall Study||0
10724190|NCT00212134|11888044|FG000|STARTED|Phase 1 (to Age 1 Year)||57
10724191|NCT00212134|11888045|FG001|STARTED|Phase 1 (to Age 1 Year)||57
10724192|NCT00212134|11888044|FG000|Complete First Endpoint at 1 Year|Phase 1 (to Age 1 Year)||57
10724193|NCT00212134|11888045|FG001|Complete First Endpoint at 1 Year|Phase 1 (to Age 1 Year)||57
10724194|NCT00212134|11888044|FG000|COMPLETED|Phase 1 (to Age 1 Year)|Age 1 data collection visit|57
10724195|NCT00212134|11888045|FG001|COMPLETED|Phase 1 (to Age 1 Year)|Age 1 data collection visit|57
10724196|NCT00212134|11888044|FG000|NOT COMPLETED|Phase 1 (to Age 1 Year)||0
10724197|NCT00212134|11888045|FG001|NOT COMPLETED|Phase 1 (to Age 1 Year)||0
10724198|NCT00212134|11888044|FG000|STARTED|Phase 2 (Age 1 Year to Age 5 Years)|Visual acuity assessment at Age 4.5 Years and final visit at Age 5 Years.|57
10724199|NCT00212134|11888045|FG001|STARTED|Phase 2 (Age 1 Year to Age 5 Years)|Visual acuity assessment at Age 4.5 Years and final visit at Age 5 Years.|57
10814528|NCT02318901|11977306|FG002|STARTED|Overall Study||10
10814529|NCT02318901|11977304|FG000|COMPLETED|Overall Study||0
10724200|NCT00212134|11888044|FG000|COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||57
10724201|NCT00212134|11888045|FG001|COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)|Patient lost to follow-up.|56
10724202|NCT00212134|11888044|FG000|NOT COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||0
10724203|NCT00212134|11888045|FG001|NOT COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||1
10814530|NCT02318901|11977305|FG001|COMPLETED|Overall Study||0
10407098|NCT00747474|11551189|FG004|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
10407099|NCT00747474|11551190|FG005|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
10407100|NCT00747474|11551191|FG006|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
10407101|NCT00747474|11551192|FG007|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
10407102|NCT00747474|11551193|FG008|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
10407103|NCT00747474|11551194|FG009|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
10407104|NCT00747474|11551195|FG010|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
10407105|NCT00747474|11551196|FG011|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
10407106|NCT00747474|11551185|FG000|STARTED|Cohort 11 (50 mg/m^2) Period||0
10407107|NCT00747474|11551186|FG001|STARTED|Cohort 11 (50 mg/m^2) Period||0
10407108|NCT00747474|11551187|FG002|STARTED|Cohort 11 (50 mg/m^2) Period||0
10407109|NCT00747474|11551188|FG003|STARTED|Cohort 11 (50 mg/m^2) Period||0
10407110|NCT00747474|11551189|FG004|STARTED|Cohort 11 (50 mg/m^2) Period||0
10407111|NCT00747474|11551190|FG005|STARTED|Cohort 11 (50 mg/m^2) Period||0
10407112|NCT00747474|11551191|FG006|STARTED|Cohort 11 (50 mg/m^2) Period||0
10407113|NCT00747474|11551192|FG007|STARTED|Cohort 11 (50 mg/m^2) Period||0
10407114|NCT00747474|11551193|FG008|STARTED|Cohort 11 (50 mg/m^2) Period||0
10407115|NCT00747474|11551194|FG009|STARTED|Cohort 11 (50 mg/m^2) Period||0
10407116|NCT00747474|11551195|FG010|STARTED|Cohort 11 (50 mg/m^2) Period||5
10407117|NCT00747474|11551196|FG011|STARTED|Cohort 11 (50 mg/m^2) Period||0
10407118|NCT00747474|11551185|FG000|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
10407119|NCT00747474|11551186|FG001|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
10407120|NCT00747474|11551187|FG002|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
10407121|NCT00747474|11551188|FG003|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
10407122|NCT00747474|11551189|FG004|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
10407123|NCT00747474|11551190|FG005|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
10407124|NCT00747474|11551191|FG006|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
10407125|NCT00747474|11551192|FG007|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
10407126|NCT00747474|11551193|FG008|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
10407127|NCT00747474|11551194|FG009|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
10407128|NCT00747474|11551195|FG010|COMPLETED|Cohort 11 (50 mg/m^2) Period||5
10407129|NCT00747474|11551196|FG011|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
10407130|NCT00747474|11551185|FG000|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
10407131|NCT00747474|11551186|FG001|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
10407132|NCT00747474|11551187|FG002|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
10407133|NCT00747474|11551188|FG003|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
10407134|NCT00747474|11551189|FG004|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
10407135|NCT00747474|11551190|FG005|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
10407136|NCT00747474|11551191|FG006|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
10407137|NCT00747474|11551192|FG007|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
10407138|NCT00747474|11551193|FG008|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
10407139|NCT00747474|11551194|FG009|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
10407140|NCT00747474|11551195|FG010|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
10407141|NCT00747474|11551196|FG011|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
10407142|NCT00747474|11551185|FG000|STARTED|Cohort 12 (60 mg/m^2) Period||0
10407143|NCT00747474|11551186|FG001|STARTED|Cohort 12 (60 mg/m^2) Period||0
10407144|NCT00747474|11551187|FG002|STARTED|Cohort 12 (60 mg/m^2) Period||0
10724204|NCT00212134|11888044|FG000|STARTED|Phase 3 (Age 10 Years)||57
10724205|NCT00212134|11888045|FG001|STARTED|Phase 3 (Age 10 Years)||56
10724206|NCT00212134|11888044|FG000|COMPLETED|Phase 3 (Age 10 Years)||55
10814531|NCT02318901|11977306|FG002|COMPLETED|Overall Study||0
10724207|NCT00212134|11888045|FG001|COMPLETED|Phase 3 (Age 10 Years)||55
10724208|NCT00212134|11888044|FG000|NOT COMPLETED|Phase 3 (Age 10 Years)||2
10724209|NCT00212134|11888045|FG001|NOT COMPLETED|Phase 3 (Age 10 Years)||1
10777463|NCT03340883|11939455|FG002|NOT COMPLETED|Overall Study||0
10777464|NCT03340883|11939456|FG003|NOT COMPLETED|Overall Study||0
10777465|NCT03340883|11939457|FG004|NOT COMPLETED|Overall Study||0
10777466|NCT03340883|11939458|FG005|NOT COMPLETED|Overall Study||0
10777467|NCT03340961|11939476|FG000|STARTED|Overall Study||53
10777468|NCT03340961|11939477|FG001|STARTED|Overall Study||50
10777469|NCT03340961|11939478|FG002|STARTED|Overall Study||49
10777470|NCT03340961|11939479|FG003|STARTED|Overall Study||53
10777471|NCT03340961|11939476|FG000|COMPLETED|Overall Study||47
10777472|NCT03340961|11939477|FG001|COMPLETED|Overall Study||38
10777473|NCT03340961|11939478|FG002|COMPLETED|Overall Study||40
10777474|NCT03340961|11939479|FG003|COMPLETED|Overall Study||35
10777475|NCT03340961|11939476|FG000|NOT COMPLETED|Overall Study||6
10777476|NCT03340961|11939477|FG001|NOT COMPLETED|Overall Study||12
10777477|NCT03340961|11939478|FG002|NOT COMPLETED|Overall Study||9
10777478|NCT03340961|11939479|FG003|NOT COMPLETED|Overall Study||18
10777479|NCT03341273|11939491|FG000|STARTED|Overall Study||249
10777480|NCT03341273|11939492|FG001|STARTED|Overall Study||250
10777481|NCT03341273|11939491|FG000|COMPLETED|Overall Study||229
10777482|NCT03341273|11939492|FG001|COMPLETED|Overall Study||238
10777483|NCT03341273|11939491|FG000|NOT COMPLETED|Overall Study||20
10407145|NCT00747474|11551188|FG003|STARTED|Cohort 12 (60 mg/m^2) Period||0
10407146|NCT00747474|11551189|FG004|STARTED|Cohort 12 (60 mg/m^2) Period||0
10407147|NCT00747474|11551190|FG005|STARTED|Cohort 12 (60 mg/m^2) Period||0
10777484|NCT03341273|11939492|FG001|NOT COMPLETED|Overall Study||12
10777485|NCT03341299|11939498|FG000|STARTED|Period 1||9
10777486|NCT03341299|11939499|FG001|STARTED|Period 1||9
10777487|NCT03341299|11939500|FG002|STARTED|Period 1||9
10777488|NCT03341299|11939501|FG003|STARTED|Period 1||9
10407148|NCT00747474|11551191|FG006|STARTED|Cohort 12 (60 mg/m^2) Period||0
10407149|NCT00747474|11551192|FG007|STARTED|Cohort 12 (60 mg/m^2) Period||0
10407150|NCT00747474|11551193|FG008|STARTED|Cohort 12 (60 mg/m^2) Period||0
10407151|NCT00747474|11551194|FG009|STARTED|Cohort 12 (60 mg/m^2) Period||0
10407152|NCT00747474|11551195|FG010|STARTED|Cohort 12 (60 mg/m^2) Period||0
10407153|NCT00747474|11551196|FG011|STARTED|Cohort 12 (60 mg/m^2) Period||6
10407154|NCT00747474|11551185|FG000|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
10407155|NCT00747474|11551186|FG001|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
10724210|NCT04336995|11888055|FG000|STARTED|Overall Study||14
10724211|NCT04336995|11888055|FG000|COMPLETED|Overall Study||14
10724212|NCT04336995|11888055|FG000|NOT COMPLETED|Overall Study||0
10724213|NCT04320745|11888059|FG000|STARTED|Overall Study||168
10724214|NCT04320745|11888059|FG000|COMPLETED|Overall Study||121
10724215|NCT04320745|11888059|FG000|NOT COMPLETED|Overall Study||47
10814532|NCT02318901|11977304|FG000|NOT COMPLETED|Overall Study||5
10814533|NCT02318901|11977305|FG001|NOT COMPLETED|Overall Study||1
10814534|NCT02318901|11977306|FG002|NOT COMPLETED|Overall Study||10
10814535|NCT02317276|11977314|FG000|STARTED|Overall Study||11
10814536|NCT02317276|11977314|FG000|COMPLETED|Overall Study||5
10814537|NCT02317276|11977314|FG000|NOT COMPLETED|Overall Study||6
10814538|NCT02307188|11977318|FG000|STARTED|Overall Study||5
10814539|NCT02307188|11977318|FG000|COMPLETED|Overall Study|Four of 5 patients did not meet required criteria to complete the study after they were enrolled.|1
10814540|NCT02307188|11977318|FG000|NOT COMPLETED|Overall Study||4
10814541|NCT02308475|11977322|FG000|STARTED|Overall Study||2
10814542|NCT02308475|11977322|FG000|COMPLETED|Overall Study||2
10814543|NCT02308475|11977322|FG000|NOT COMPLETED|Overall Study||0
10724228|NCT04077424|11888077|FG000|STARTED|Overall Study||2
10724229|NCT04077424|11888078|FG001|STARTED|Overall Study||2
10724230|NCT04077424|11888079|FG002|STARTED|Overall Study||6
10724231|NCT04077424|11888077|FG000|COMPLETED|Overall Study||2
10724232|NCT04077424|11888078|FG001|COMPLETED|Overall Study||2
10814544|NCT02308735|11977330|FG000|STARTED|Overall Study||2
10814545|NCT02308735|11977331|FG001|STARTED|Overall Study||0
10814546|NCT02308735|11977332|FG002|STARTED|Overall Study||0
10814547|NCT02308735|11977333|FG003|STARTED|Overall Study||2
10814548|NCT02308735|11977330|FG000|COMPLETED|Overall Study||0
10814549|NCT02308735|11977331|FG001|COMPLETED|Overall Study||0
10814550|NCT02308735|11977332|FG002|COMPLETED|Overall Study||0
10814551|NCT02308735|11977333|FG003|COMPLETED|Overall Study||0
10814552|NCT02308735|11977330|FG000|NOT COMPLETED|Overall Study||2
10814553|NCT02308735|11977331|FG001|NOT COMPLETED|Overall Study||0
10814554|NCT02308735|11977332|FG002|NOT COMPLETED|Overall Study||0
10814555|NCT02308735|11977333|FG003|NOT COMPLETED|Overall Study||2
10814556|NCT02299206|11977343|FG000|STARTED|Overall Study||4
10814557|NCT02299206|11977343|FG000|COMPLETED|Overall Study||2
10814558|NCT02299206|11977343|FG000|NOT COMPLETED|Overall Study||2
10814559|NCT02302859|11977349|FG000|STARTED|Overall Study||2
10814560|NCT02302859|11977350|FG001|STARTED|Overall Study||6
10814561|NCT02302859|11977349|FG000|COMPLETED|Overall Study||1
10814562|NCT02302859|11977350|FG001|COMPLETED|Overall Study||4
10814563|NCT02302859|11977349|FG000|NOT COMPLETED|Overall Study||1
10407156|NCT00747474|11551187|FG002|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
10814564|NCT02302859|11977350|FG001|NOT COMPLETED|Overall Study||2
10407157|NCT00747474|11551188|FG003|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
10724233|NCT04077424|11888079|FG002|COMPLETED|Overall Study||6
10724234|NCT04077424|11888077|FG000|NOT COMPLETED|Overall Study||0
10724235|NCT04077424|11888078|FG001|NOT COMPLETED|Overall Study||0
10724236|NCT04077424|11888079|FG002|NOT COMPLETED|Overall Study||0
10724237|NCT04016779|11888089|FG000|STARTED|Overall Study||184
10724238|NCT04016779|11888090|FG001|STARTED|Overall Study||190
10724239|NCT04016779|11888089|FG000|Treated|Overall Study||183
10724240|NCT04016779|11888090|FG001|Treated|Overall Study||189
10407158|NCT00747474|11551189|FG004|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
10407159|NCT00747474|11551190|FG005|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
10407160|NCT00747474|11551191|FG006|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
10724241|NCT04016779|11888089|FG000|COMPLETED|Overall Study||140
10724242|NCT04016779|11888090|FG001|COMPLETED|Overall Study||127
10724243|NCT04016779|11888089|FG000|NOT COMPLETED|Overall Study||44
10724244|NCT04016779|11888090|FG001|NOT COMPLETED|Overall Study||63
10724245|NCT04000165|11888098|FG000|STARTED|Overall Study||17
10724246|NCT04000165|11888098|FG000|Completed Study at 50 mg Dose|Overall Study||7
10724247|NCT04000165|11888098|FG000|Escalated to 100 mg|Overall Study||10
10724248|NCT04000165|11888098|FG000|COMPLETED|Overall Study||15
10724249|NCT04000165|11888098|FG000|NOT COMPLETED|Overall Study||2
10724250|NCT03952650|11888109|FG000|STARTED|Overall Study||4
10724251|NCT03952650|11888110|FG001|STARTED|Overall Study||90
10724252|NCT03952650|11888111|FG002|STARTED|Overall Study||4
10724253|NCT03952650|11888112|FG003|STARTED|Overall Study||60
10724254|NCT03952650|11888113|FG004|STARTED|Overall Study||4
10724255|NCT03952650|11888114|FG005|STARTED|Overall Study||54
10724256|NCT03952650|11888115|FG006|STARTED|Overall Study||36
10724257|NCT03952650|11888109|FG000|COMPLETED|Overall Study||4
10724258|NCT03952650|11888110|FG001|COMPLETED|Overall Study||83
10724259|NCT03952650|11888111|FG002|COMPLETED|Overall Study||4
10724260|NCT03952650|11888112|FG003|COMPLETED|Overall Study||53
10724261|NCT03952650|11888113|FG004|COMPLETED|Overall Study||4
10724262|NCT03952650|11888114|FG005|COMPLETED|Overall Study||47
10724263|NCT03952650|11888115|FG006|COMPLETED|Overall Study||32
10724264|NCT03952650|11888109|FG000|NOT COMPLETED|Overall Study||0
10724265|NCT03952650|11888110|FG001|NOT COMPLETED|Overall Study||7
10724266|NCT03952650|11888111|FG002|NOT COMPLETED|Overall Study||0
10724267|NCT03952650|11888112|FG003|NOT COMPLETED|Overall Study||7
10724268|NCT03952650|11888113|FG004|NOT COMPLETED|Overall Study||0
10724269|NCT03952650|11888114|FG005|NOT COMPLETED|Overall Study||7
10724270|NCT03952650|11888115|FG006|NOT COMPLETED|Overall Study||4
10724271|NCT03794089|11888133|FG000|STARTED|Overall Study||17
10724272|NCT03794089|11888134|FG001|STARTED|Overall Study||18
10724273|NCT03794089|11888133|FG000|Completed 4-week Assessment|Overall Study||16
10724274|NCT03794089|11888134|FG001|Completed 4-week Assessment|Overall Study||18
10724275|NCT03794089|11888133|FG000|Completed 8-week Assessment|Overall Study||14
10724276|NCT03794089|11888134|FG001|Completed 8-week Assessment|Overall Study||18
10724277|NCT03794089|11888133|FG000|Completed 12-week Assessment|Overall Study||13
10724278|NCT03794089|11888134|FG001|Completed 12-week Assessment|Overall Study||17
10724279|NCT03794089|11888133|FG000|COMPLETED|Overall Study||11
10724280|NCT03794089|11888134|FG001|COMPLETED|Overall Study||17
10724281|NCT03794089|11888133|FG000|NOT COMPLETED|Overall Study||6
10724282|NCT03794089|11888134|FG001|NOT COMPLETED|Overall Study||1
10724283|NCT03745716|11888142|FG000|STARTED|Overall Study||78
10724284|NCT03745716|11888143|FG001|STARTED|Overall Study||76
10724285|NCT03745716|11888142|FG000|COMPLETED|Overall Study||75
10724286|NCT03745716|11888143|FG001|COMPLETED|Overall Study||74
10724287|NCT03745716|11888142|FG000|NOT COMPLETED|Overall Study||3
10724288|NCT03745716|11888143|FG001|NOT COMPLETED|Overall Study||2
10724289|NCT03713021|11888149|FG000|STARTED|Overall Study||27
10724290|NCT03713021|11888149|FG000|COMPLETED|Overall Study||12
10724291|NCT03713021|11888149|FG000|NOT COMPLETED|Overall Study||15
10724298|NCT03631407|11888164|FG000|STARTED|Overall Study||21
10724299|NCT03631407|11888165|FG001|STARTED|Overall Study||20
10724300|NCT03631407|11888164|FG000|Treated|Overall Study||20
10724301|NCT03631407|11888165|FG001|Treated|Overall Study||20
10724302|NCT03631407|11888164|FG000|COMPLETED|Overall Study||1
10724303|NCT03631407|11888165|FG001|COMPLETED|Overall Study||0
10724304|NCT03631407|11888164|FG000|NOT COMPLETED|Overall Study||20
10724305|NCT03631407|11888165|FG001|NOT COMPLETED|Overall Study||20
10724306|NCT03531827|11888171|FG000|STARTED|Overall Study||4
10724307|NCT03531827|11888172|FG001|STARTED|Overall Study||0
10724308|NCT03531827|11888171|FG000|COMPLETED|Overall Study||1
10724309|NCT03531827|11888172|FG001|COMPLETED|Overall Study||0
10724310|NCT03531827|11888171|FG000|NOT COMPLETED|Overall Study||3
10724311|NCT03531827|11888172|FG001|NOT COMPLETED|Overall Study||0
10724312|NCT03452033|11888181|FG000|STARTED|Overall Study||21
10724313|NCT03452033|11888182|FG001|STARTED|Overall Study||22
10724314|NCT03452033|11888183|FG002|STARTED|Overall Study||22
10724315|NCT03452033|11888184|FG003|STARTED|Overall Study||22
10724316|NCT03452033|11888181|FG000|COMPLETED|Overall Study||21
10724317|NCT03452033|11888182|FG001|COMPLETED|Overall Study||22
10724318|NCT03452033|11888183|FG002|COMPLETED|Overall Study||22
10724319|NCT03452033|11888184|FG003|COMPLETED|Overall Study||22
10724320|NCT03452033|11888181|FG000|NOT COMPLETED|Overall Study||0
10724321|NCT03452033|11888182|FG001|NOT COMPLETED|Overall Study||0
10724322|NCT03452033|11888183|FG002|NOT COMPLETED|Overall Study||0
10724323|NCT03452033|11888184|FG003|NOT COMPLETED|Overall Study||0
10724324|NCT03395340|11888197|FG000|STARTED|Overall Study||1
10407161|NCT00747474|11551192|FG007|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
10724325|NCT03395340|11888197|FG000|COMPLETED|Overall Study||1
10724326|NCT03395340|11888197|FG000|NOT COMPLETED|Overall Study||0
10724327|NCT03380000|11888203|FG000|STARTED|First Intervention (1day)||8
10724328|NCT03380000|11888204|FG001|STARTED|First Intervention (1day)||8
10407162|NCT00747474|11551193|FG008|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
10407163|NCT00747474|11551194|FG009|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
10407164|NCT00747474|11551195|FG010|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
10407165|NCT00747474|11551196|FG011|COMPLETED|Cohort 12 (60 mg/m^2) Period||6
10407166|NCT00747474|11551185|FG000|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
10407167|NCT00747474|11551186|FG001|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
10407168|NCT00747474|11551187|FG002|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
10407169|NCT00747474|11551188|FG003|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
10407170|NCT00747474|11551189|FG004|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
10407171|NCT00747474|11551190|FG005|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
10407172|NCT00747474|11551191|FG006|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
10407173|NCT00747474|11551192|FG007|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
10724329|NCT03380000|11888203|FG000|COMPLETED|First Intervention (1day)||8
10724330|NCT03380000|11888204|FG001|COMPLETED|First Intervention (1day)||8
10724331|NCT03380000|11888203|FG000|NOT COMPLETED|First Intervention (1day)||0
10724332|NCT03380000|11888204|FG001|NOT COMPLETED|First Intervention (1day)||0
10724333|NCT03380000|11888203|FG000|STARTED|Washout (>7days)||8
10724334|NCT03380000|11888204|FG001|STARTED|Washout (>7days)||8
10724335|NCT03380000|11888203|FG000|COMPLETED|Washout (>7days)||8
10724336|NCT03380000|11888204|FG001|COMPLETED|Washout (>7days)||8
10724337|NCT03380000|11888203|FG000|NOT COMPLETED|Washout (>7days)||0
10724338|NCT03380000|11888204|FG001|NOT COMPLETED|Washout (>7days)||0
10724339|NCT03380000|11888203|FG000|STARTED|Second Intervention (1day)||8
10724340|NCT03380000|11888204|FG001|STARTED|Second Intervention (1day)||8
10724341|NCT03380000|11888203|FG000|COMPLETED|Second Intervention (1day)||8
10724342|NCT03380000|11888204|FG001|COMPLETED|Second Intervention (1day)||8
10724343|NCT03380000|11888203|FG000|NOT COMPLETED|Second Intervention (1day)||0
10724344|NCT03380000|11888204|FG001|NOT COMPLETED|Second Intervention (1day)||0
10724345|NCT03368664|11888210|FG000|STARTED|Phase1: Prior DMT:Month -4 to Month 0||16
10724346|NCT03368664|11888210|FG000|COMPLETED|Phase1: Prior DMT:Month -4 to Month 0||12
10724347|NCT03368664|11888210|FG000|NOT COMPLETED|Phase1: Prior DMT:Month -4 to Month 0||4
10724348|NCT03368664|11888210|FG000|STARTED|Phase2:AlemtuzumabTreatment:Month 0 to 8|Out of 12 participants who had completed Phase 1, one participant did not enter Phase 2.|11
10724349|NCT03368664|11888210|FG000|Treated|Phase2:AlemtuzumabTreatment:Month 0 to 8||11
10724350|NCT03368664|11888210|FG000|COMPLETED|Phase2:AlemtuzumabTreatment:Month 0 to 8||11
10724351|NCT03368664|11888210|FG000|NOT COMPLETED|Phase2:AlemtuzumabTreatment:Month 0 to 8||0
10724380|NCT03070600|11888256|FG000|STARTED|Overall Study||2250
10724381|NCT03070600|11888257|FG001|STARTED|Overall Study||2197
10724382|NCT03070600|11888256|FG000|COMPLETED|Overall Study||2156
10724383|NCT03070600|11888257|FG001|COMPLETED|Overall Study||2032
10724384|NCT03070600|11888256|FG000|NOT COMPLETED|Overall Study||94
10724385|NCT03070600|11888257|FG001|NOT COMPLETED|Overall Study||165
10724386|NCT02998671|11888274|FG000|STARTED|Period 1||21
10724387|NCT02998671|11888275|FG001|STARTED|Period 1||13
10724388|NCT02998671|11888276|FG002|STARTED|Period 1||6
10724389|NCT02998671|11888277|FG003|STARTED|Period 1||8
10724390|NCT02998671|11888278|FG004|STARTED|Period 1||4
10724391|NCT02998671|11888274|FG000|COMPLETED|Period 1||17
10407174|NCT00747474|11551193|FG008|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
10407175|NCT00747474|11551194|FG009|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
10407176|NCT00747474|11551195|FG010|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
10407177|NCT00747474|11551196|FG011|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
10407178|NCT00747552|11551201|FG000|STARTED|Overall Study|This number does not include the 2 who were enrolled but had no data collected on them.|30
10407179|NCT00747552|11551201|FG000|COMPLETED|Overall Study||30
10407180|NCT00747552|11551201|FG000|NOT COMPLETED|Overall Study||0
10407181|NCT00747565|11551207|FG000|STARTED|Overall Study|125 multifocal subjects in original study plus 222 multifocal subjects in the expansion study.|347
10407182|NCT00747565|11551208|FG001|STARTED|Overall Study||123
10407183|NCT00747565|11551207|FG000|COMPLETED|Overall Study|118 multifocal subjects in the original study plus 215 multifocal subejcts in the expansion study.|333
10407184|NCT00747565|11551208|FG001|COMPLETED|Overall Study||116
10407185|NCT00747565|11551207|FG000|NOT COMPLETED|Overall Study||14
10407186|NCT00747565|11551208|FG001|NOT COMPLETED|Overall Study||7
10407187|NCT00747617|11551216|FG000|STARTED|Overall Study||13
10407188|NCT00747617|11551217|FG001|STARTED|Overall Study||12
10407189|NCT00747617|11551216|FG000|COMPLETED|Overall Study||10
10407190|NCT00747617|11551217|FG001|COMPLETED|Overall Study||11
10407191|NCT00747617|11551216|FG000|NOT COMPLETED|Overall Study||3
10407192|NCT00747617|11551217|FG001|NOT COMPLETED|Overall Study||1
10407193|NCT00747643|11551225|FG000|STARTED|Overall Study||82
10407194|NCT00747643|11551226|FG001|STARTED|Overall Study||81
10407195|NCT00747643|11551225|FG000|COMPLETED|Overall Study||46
10407196|NCT00747643|11551226|FG001|COMPLETED|Overall Study||54
10407197|NCT00747643|11551225|FG000|NOT COMPLETED|Overall Study||36
10407198|NCT00747643|11551226|FG001|NOT COMPLETED|Overall Study||27
10407199|NCT00747747|11551235|FG000|STARTED|Overall Study||14
10407200|NCT00747747|11551236|FG001|STARTED|Overall Study||14
10407201|NCT00747747|11551237|FG002|STARTED|Overall Study||21
10407202|NCT00747747|11551235|FG000|COMPLETED|Overall Study|13 with acute episode + 1 with recurrent episode|14
10407203|NCT00747747|11551236|FG001|COMPLETED|Overall Study|11 with acute episode + 3 with recurrent episode|14
10407204|NCT00747747|11551237|FG002|COMPLETED|Overall Study|17 with acute episode + 4 with recurrent episode|21
10407205|NCT00747747|11551235|FG000|NOT COMPLETED|Overall Study||0
10407206|NCT00747747|11551236|FG001|NOT COMPLETED|Overall Study||0
10407207|NCT00747747|11551237|FG002|NOT COMPLETED|Overall Study||0
10407208|NCT00747812|11551247|FG000|STARTED|Overall Study||5
10407209|NCT00747812|11551248|FG001|STARTED|Overall Study|4 subjects were randomized to the Control Group; 1 was not implanted due to early enrollment closure|3
10407210|NCT00747812|11551247|FG000|COMPLETED|Overall Study||0
10407211|NCT00747812|11551248|FG001|COMPLETED|Overall Study||0
10407212|NCT00747812|11551247|FG000|NOT COMPLETED|Overall Study||5
10407213|NCT00747812|11551248|FG001|NOT COMPLETED|Overall Study||3
10407214|NCT00748033|11551256|FG000|STARTED|Overall Study||12
10407215|NCT00748033|11551257|FG001|STARTED|Overall Study||13
10407216|NCT00748033|11551256|FG000|COMPLETED|Overall Study||12
10407217|NCT00748033|11551257|FG001|COMPLETED|Overall Study|One subject participated only in 2 arms due to an adverse event.|12
10407218|NCT00748033|11551256|FG000|NOT COMPLETED|Overall Study||0
10407219|NCT00748033|11551257|FG001|NOT COMPLETED|Overall Study||1
10407220|NCT00748072|11551273|FG000|STARTED|Overall Study||82
10407221|NCT00748072|11551274|FG001|STARTED|Overall Study||80
10407222|NCT00748072|11551273|FG000|COMPLETED|Overall Study||82
10407223|NCT00748072|11551274|FG001|COMPLETED|Overall Study||80
10407224|NCT00748072|11551273|FG000|NOT COMPLETED|Overall Study||0
10407225|NCT00748072|11551274|FG001|NOT COMPLETED|Overall Study||0
10407226|NCT00748098|11551280|FG000|STARTED|First Treatment Intervention Period||69
10407227|NCT00748098|11551281|FG001|STARTED|First Treatment Intervention Period||67
10407228|NCT00748098|11551280|FG000|COMPLETED|First Treatment Intervention Period||64
10407229|NCT00748098|11551281|FG001|COMPLETED|First Treatment Intervention Period||66
10407230|NCT00748098|11551280|FG000|NOT COMPLETED|First Treatment Intervention Period||5
10407231|NCT00748098|11551281|FG001|NOT COMPLETED|First Treatment Intervention Period||1
10724392|NCT02998671|11888275|FG001|COMPLETED|Period 1||10
10724393|NCT02998671|11888276|FG002|COMPLETED|Period 1||6
10724394|NCT02998671|11888277|FG003|COMPLETED|Period 1||8
10724395|NCT02998671|11888278|FG004|COMPLETED|Period 1||0
10724396|NCT02998671|11888274|FG000|NOT COMPLETED|Period 1||4
10407232|NCT00748098|11551280|FG000|STARTED|First Taper Period||64
10407233|NCT00748098|11551281|FG001|STARTED|First Taper Period||66
10407234|NCT00748098|11551280|FG000|COMPLETED|First Taper Period||61
10407235|NCT00748098|11551281|FG001|COMPLETED|First Taper Period||65
10407236|NCT00748098|11551280|FG000|NOT COMPLETED|First Taper Period||3
10407237|NCT00748098|11551281|FG001|NOT COMPLETED|First Taper Period||1
10407238|NCT00748098|11551280|FG000|STARTED|1-Week Washout Period||61
10407239|NCT00748098|11551281|FG001|STARTED|1-Week Washout Period||65
10724397|NCT02998671|11888275|FG001|NOT COMPLETED|Period 1||3
10724398|NCT02998671|11888276|FG002|NOT COMPLETED|Period 1||0
10724399|NCT02998671|11888277|FG003|NOT COMPLETED|Period 1||0
10724400|NCT02998671|11888278|FG004|NOT COMPLETED|Period 1||4
10724401|NCT02998671|11888274|FG000|STARTED|Period 2||17
10724402|NCT02998671|11888275|FG001|STARTED|Period 2||10
10724403|NCT02998671|11888276|FG002|STARTED|Period 2||6
10724404|NCT02998671|11888277|FG003|STARTED|Period 2||8
10407240|NCT00748098|11551280|FG000|COMPLETED|1-Week Washout Period||59
10407241|NCT00748098|11551281|FG001|COMPLETED|1-Week Washout Period||64
10724405|NCT02998671|11888278|FG004|STARTED|Period 2||0
10724406|NCT02998671|11888274|FG000|COMPLETED|Period 2||14
10724407|NCT02998671|11888275|FG001|COMPLETED|Period 2||3
10407242|NCT00748098|11551280|FG000|NOT COMPLETED|1-Week Washout Period||2
10407243|NCT00748098|11551281|FG001|NOT COMPLETED|1-Week Washout Period||1
10407244|NCT00748098|11551280|FG000|STARTED|Second Treatment Intervention Period||59
10407245|NCT00748098|11551281|FG001|STARTED|Second Treatment Intervention Period||64
10407246|NCT00748098|11551280|FG000|COMPLETED|Second Treatment Intervention Period||53
10407247|NCT00748098|11551281|FG001|COMPLETED|Second Treatment Intervention Period||61
10407248|NCT00748098|11551280|FG000|NOT COMPLETED|Second Treatment Intervention Period||6
10407249|NCT00748098|11551281|FG001|NOT COMPLETED|Second Treatment Intervention Period||3
10407250|NCT00748098|11551280|FG000|STARTED|Second Taper Period||53
10407251|NCT00748098|11551281|FG001|STARTED|Second Taper Period||61
10407252|NCT00748098|11551280|FG000|COMPLETED|Second Taper Period||53
10407253|NCT00748098|11551281|FG001|COMPLETED|Second Taper Period||61
10407254|NCT00748098|11551280|FG000|NOT COMPLETED|Second Taper Period||0
10407255|NCT00748098|11551281|FG001|NOT COMPLETED|Second Taper Period||0
10407256|NCT00748189|11551290|FG000|STARTED|Overall Study||226
10407257|NCT00748189|11551291|FG001|STARTED|Overall Study||221
10407258|NCT00748189|11551290|FG000|COMPLETED|Overall Study||10
10407259|NCT00748189|11551291|FG001|COMPLETED|Overall Study||9
10407260|NCT00748189|11551290|FG000|NOT COMPLETED|Overall Study||216
10407261|NCT00748189|11551291|FG001|NOT COMPLETED|Overall Study||212
10407262|NCT00748215|11551304|FG000|STARTED|Overall Study||50
10407263|NCT00748215|11551305|FG001|STARTED|Overall Study||50
10407264|NCT00748215|11551304|FG000|Open Label CASAD After Initial 6 Weeks Intervention|Overall Study||22
10407265|NCT00748215|11551305|FG001|Open Label CASAD After Initial 6 Weeks Intervention|Overall Study||17
10407266|NCT00748215|11551304|FG000|COMPLETED|Overall Study||41
10407267|NCT00748215|11551305|FG001|COMPLETED|Overall Study||32
10407268|NCT00748215|11551304|FG000|NOT COMPLETED|Overall Study||9
10407269|NCT00748215|11551305|FG001|NOT COMPLETED|Overall Study||18
10407270|NCT00748241|11551311|FG000|STARTED|Overall Study||19
10407271|NCT00748241|11551311|FG000|COMPLETED|Overall Study||11
10407272|NCT00748241|11551311|FG000|NOT COMPLETED|Overall Study||8
10407273|NCT00748410|11551317|FG000|STARTED|Overall Study||1
10407274|NCT00748410|11551318|FG001|STARTED|Overall Study||2
10407275|NCT00748410|11551317|FG000|COMPLETED|Overall Study||1
10407276|NCT00748410|11551318|FG001|COMPLETED|Overall Study||2
10407277|NCT00748410|11551317|FG000|NOT COMPLETED|Overall Study||0
10407278|NCT00748410|11551318|FG001|NOT COMPLETED|Overall Study||0
10407279|NCT00748540|11551324|FG000|STARTED|Overall Study||50
10407280|NCT00748540|11551324|FG000|COMPLETED|Overall Study||49
10407281|NCT00748540|11551324|FG000|NOT COMPLETED|Overall Study||1
10407282|NCT00748553|11551330|FG000|STARTED|Overall Study||16
10407283|NCT00748553|11551331|FG001|STARTED|Overall Study||14
10407284|NCT00748553|11551330|FG000|COMPLETED|Overall Study||13
10407285|NCT00748553|11551331|FG001|COMPLETED|Overall Study||13
10407286|NCT00748553|11551330|FG000|NOT COMPLETED|Overall Study||3
10407287|NCT00748553|11551331|FG001|NOT COMPLETED|Overall Study||1
10407288|NCT00748566|11551336|FG000|STARTED|Overall Study||172
10407289|NCT00748566|11551336|FG000|COMPLETED|Overall Study||60
10407290|NCT00748566|11551336|FG000|NOT COMPLETED|Overall Study||112
10407291|NCT00748657|11551340|FG000|STARTED|Overall Study||36
10407292|NCT00748657|11551340|FG000|COMPLETED|Overall Study||36
10407293|NCT00748657|11551340|FG000|NOT COMPLETED|Overall Study||0
10407294|NCT00748709|11551350|FG000|STARTED|Overall Study|Treated|20
10407295|NCT00748709|11551350|FG000|COMPLETED|Overall Study||0
10407296|NCT00748709|11551350|FG000|NOT COMPLETED|Overall Study||20
10407341|NCT00749190|11551422|FG005|STARTED|Overall Study||70
10407297|NCT00748826|11551354|FG000|STARTED|Overall Study|Of 576 total enrolled, 68 out of scope participants were not used for analyses|508
10407298|NCT00748826|11551354|FG000|COMPLETED|Overall Study||207
10407299|NCT00748826|11551354|FG000|NOT COMPLETED|Overall Study||301
10407300|NCT00748865|11551358|FG000|STARTED|Overall Study||10
10407301|NCT00748865|11551359|FG001|STARTED|Overall Study||10
10407302|NCT00748865|11551358|FG000|COMPLETED|Overall Study||10
10407303|NCT00748865|11551359|FG001|COMPLETED|Overall Study||10
10407304|NCT00748865|11551358|FG000|NOT COMPLETED|Overall Study||0
10407305|NCT00748865|11551359|FG001|NOT COMPLETED|Overall Study||0
10407306|NCT00748956|11551368|FG000|STARTED|Overall Study||0
10724408|NCT02998671|11888276|FG002|COMPLETED|Period 2||5
10407307|NCT00748956|11551369|FG001|STARTED|Overall Study||5
10407308|NCT00748956|11551370|FG002|STARTED|Overall Study||5
10407309|NCT00748956|11551368|FG000|COMPLETED|Overall Study||0
10407310|NCT00748956|11551369|FG001|COMPLETED|Overall Study||5
10407311|NCT00748956|11551370|FG002|COMPLETED|Overall Study||5
10407312|NCT00748956|11551368|FG000|NOT COMPLETED|Overall Study||0
10407313|NCT00748956|11551369|FG001|NOT COMPLETED|Overall Study||0
10407314|NCT00748956|11551370|FG002|NOT COMPLETED|Overall Study||0
10407315|NCT00748969|11551380|FG000|STARTED|Overall Study|Subject withdrew from study due to worsening sleep apnea|1
10407316|NCT00748969|11551381|FG001|STARTED|Overall Study|Subject withdrew from study due to randomization to no treatment|1
10407317|NCT00748969|11551380|FG000|COMPLETED|Overall Study||0
10407318|NCT00748969|11551381|FG001|COMPLETED|Overall Study||0
10407319|NCT00748969|11551380|FG000|NOT COMPLETED|Overall Study||1
10407320|NCT00748969|11551381|FG001|NOT COMPLETED|Overall Study||1
10407321|NCT00748982|11551389|FG000|STARTED|Overall Study||12
10724409|NCT02998671|11888277|FG003|COMPLETED|Period 2||4
10407322|NCT00748982|11551390|FG001|STARTED|Overall Study||4
10407323|NCT00748982|11551389|FG000|COMPLETED|Overall Study||12
10407324|NCT00748982|11551390|FG001|COMPLETED|Overall Study||4
10407325|NCT00748982|11551389|FG000|NOT COMPLETED|Overall Study||0
10407326|NCT00748982|11551390|FG001|NOT COMPLETED|Overall Study||0
10407327|NCT00749073|11551396|FG000|STARTED|Overall Study||10
10407328|NCT00749073|11551396|FG000|COMPLETED|Overall Study||10
10407329|NCT00749073|11551396|FG000|NOT COMPLETED|Overall Study||0
10407330|NCT00749125|11551403|FG000|STARTED|Overall Study||47
10407331|NCT00749125|11551404|FG001|STARTED|Overall Study||52
10407332|NCT00749125|11551403|FG000|COMPLETED|Overall Study||36
10724410|NCT02998671|11888278|FG004|COMPLETED|Period 2||0
10724411|NCT02998671|11888274|FG000|NOT COMPLETED|Period 2||3
10724412|NCT02998671|11888275|FG001|NOT COMPLETED|Period 2||7
10724413|NCT02998671|11888276|FG002|NOT COMPLETED|Period 2||1
10724414|NCT02998671|11888277|FG003|NOT COMPLETED|Period 2||4
10724415|NCT02998671|11888278|FG004|NOT COMPLETED|Period 2||0
10724431|NCT02860039|11888315|FG000|STARTED|Overall Study||85
10724432|NCT02860039|11888316|FG001|STARTED|Overall Study||85
10724433|NCT02860039|11888315|FG000|Visit 1|Overall Study||85
10724434|NCT02860039|11888316|FG001|Visit 1|Overall Study||85
10724435|NCT02860039|11888315|FG000|Visit 2|Overall Study||84
10724436|NCT02860039|11888316|FG001|Visit 2|Overall Study||83
10724437|NCT02860039|11888315|FG000|Visit 3|Overall Study||78
10724438|NCT02860039|11888316|FG001|Visit 3|Overall Study||83
10724439|NCT02860039|11888315|FG000|Visit 4|Overall Study||74
10724440|NCT02860039|11888316|FG001|Visit 4|Overall Study||81
10724441|NCT02860039|11888315|FG000|Visit 1 Repeat|Overall Study||32
10724442|NCT02860039|11888316|FG001|Visit 1 Repeat|Overall Study||34
10724443|NCT02860039|11888315|FG000|Visit 2 Repeat|Overall Study||31
10724444|NCT02860039|11888316|FG001|Visit 2 Repeat|Overall Study||34
10724445|NCT02860039|11888315|FG000|Visit 3 Repeat|Overall Study||30
10724446|NCT02860039|11888316|FG001|Visit 3 Repeat|Overall Study||34
10724447|NCT02860039|11888315|FG000|Visit 4 Repeat|Overall Study||26
10724448|NCT02860039|11888316|FG001|Visit 4 Repeat|Overall Study||22
10724449|NCT02860039|11888315|FG000|COMPLETED|Overall Study||74
10724450|NCT02860039|11888316|FG001|COMPLETED|Overall Study||81
10724451|NCT02860039|11888315|FG000|NOT COMPLETED|Overall Study||11
10724452|NCT02860039|11888316|FG001|NOT COMPLETED|Overall Study||4
10724453|NCT02833805|11888322|FG000|STARTED|Overall Study||21
10407333|NCT00749125|11551404|FG001|COMPLETED|Overall Study||34
10407334|NCT00749125|11551403|FG000|NOT COMPLETED|Overall Study||11
10407335|NCT00749125|11551404|FG001|NOT COMPLETED|Overall Study||18
10407336|NCT00749190|11551417|FG000|STARTED|Overall Study||71
10407337|NCT00749190|11551418|FG001|STARTED|Overall Study||71
10407338|NCT00749190|11551419|FG002|STARTED|Overall Study||71
10407339|NCT00749190|11551420|FG003|STARTED|Overall Study||71
10407340|NCT00749190|11551421|FG004|STARTED|Overall Study||70
10407342|NCT00749190|11551423|FG006|STARTED|Overall Study||71
10407343|NCT00749190|11551417|FG000|COMPLETED|Overall Study||66
10407344|NCT00749190|11551418|FG001|COMPLETED|Overall Study||66
10407345|NCT00749190|11551419|FG002|COMPLETED|Overall Study||70
10407346|NCT00749190|11551420|FG003|COMPLETED|Overall Study||66
10407347|NCT00749190|11551421|FG004|COMPLETED|Overall Study||70
10407348|NCT00749190|11551422|FG005|COMPLETED|Overall Study||65
10407349|NCT00749190|11551423|FG006|COMPLETED|Overall Study||70
10407350|NCT00749190|11551417|FG000|NOT COMPLETED|Overall Study||5
10407351|NCT00749190|11551418|FG001|NOT COMPLETED|Overall Study||5
10407352|NCT00749190|11551419|FG002|NOT COMPLETED|Overall Study||1
10407353|NCT00749190|11551420|FG003|NOT COMPLETED|Overall Study||5
10407354|NCT00749190|11551421|FG004|NOT COMPLETED|Overall Study||0
10407355|NCT00749190|11551422|FG005|NOT COMPLETED|Overall Study||5
10407356|NCT00749190|11551423|FG006|NOT COMPLETED|Overall Study||1
10407357|NCT00749203|11551446|FG000|STARTED|First Infusion Day 1||22
10407358|NCT00749203|11551447|FG001|STARTED|First Infusion Day 1||19
10407359|NCT00749203|11551446|FG000|COMPLETED|First Infusion Day 1||22
10407360|NCT00749203|11551447|FG001|COMPLETED|First Infusion Day 1||19
10407361|NCT00749203|11551446|FG000|NOT COMPLETED|First Infusion Day 1||0
10407362|NCT00749203|11551447|FG001|NOT COMPLETED|First Infusion Day 1||0
10407363|NCT00749203|11551446|FG000|STARTED|no Infusion at Week 1||22
10407364|NCT00749203|11551447|FG001|STARTED|no Infusion at Week 1||19
10724454|NCT02833805|11888322|FG000|COMPLETED|Overall Study||21
10724455|NCT02833805|11888322|FG000|NOT COMPLETED|Overall Study||0
10407365|NCT00749203|11551446|FG000|COMPLETED|no Infusion at Week 1||22
10407366|NCT00749203|11551447|FG001|COMPLETED|no Infusion at Week 1||15
10407367|NCT00749203|11551446|FG000|NOT COMPLETED|no Infusion at Week 1||0
10724456|NCT02499146|11888326|FG000|STARTED|Overall Study||26
10724457|NCT02499146|11888326|FG000|COMPLETED|Overall Study||0
10407368|NCT00749203|11551447|FG001|NOT COMPLETED|no Infusion at Week 1||4
10407369|NCT00749203|11551446|FG000|STARTED|Second Infusion at 2 Weeks|N=6 completed the study at 2 wks due to CAPS scores < 50, precluding 2nd infusion.|16
10407370|NCT00749203|11551447|FG001|STARTED|Second Infusion at 2 Weeks||15
10407371|NCT00749203|11551446|FG000|COMPLETED|Second Infusion at 2 Weeks||16
10407372|NCT00749203|11551447|FG001|COMPLETED|Second Infusion at 2 Weeks||13
10407373|NCT00749203|11551446|FG000|NOT COMPLETED|Second Infusion at 2 Weeks||0
10407374|NCT00749203|11551447|FG001|NOT COMPLETED|Second Infusion at 2 Weeks||2
10407375|NCT00749268|11551457|FG000|STARTED|Overall Study||106
10407376|NCT00749268|11551458|FG001|STARTED|Overall Study||110
10407377|NCT00749268|11551457|FG000|COMPLETED|Overall Study||72
10407378|NCT00749268|11551458|FG001|COMPLETED|Overall Study||74
10407379|NCT00749268|11551457|FG000|NOT COMPLETED|Overall Study||34
10407380|NCT00749268|11551458|FG001|NOT COMPLETED|Overall Study||36
10407381|NCT00749398|11551468|FG000|STARTED|Overall Study|Nine participants were excluded because they did not fulfill the inclusion criteria.|124
10724458|NCT02499146|11888326|FG000|NOT COMPLETED|Overall Study||26
10407382|NCT00749398|11551468|FG000|COMPLETED|Overall Study||71
10407383|NCT00749398|11551468|FG000|NOT COMPLETED|Overall Study||53
10407384|NCT00749411|11551474|FG000|STARTED|Overall Study||21
10407385|NCT00749411|11551475|FG001|STARTED|Overall Study||40
10407386|NCT00749411|11551474|FG000|COMPLETED|Overall Study||20
10407387|NCT00749411|11551475|FG001|COMPLETED|Overall Study||35
10407388|NCT00749411|11551474|FG000|NOT COMPLETED|Overall Study||1
10407389|NCT00749411|11551475|FG001|NOT COMPLETED|Overall Study||5
10429083|NCT00862849|11575287|FG001|STARTED|Intervention 1||5
10429084|NCT00862849|11575288|FG002|STARTED|Intervention 1||3
10429085|NCT00862849|11575289|FG003|STARTED|Intervention 1||4
10429086|NCT00862849|11575290|FG004|STARTED|Intervention 1||4
10429087|NCT00862849|11575291|FG005|STARTED|Intervention 1||3
10429088|NCT00862849|11575286|FG000|Received at Least One Dose of Study Drug|Intervention 1||3
10429089|NCT00862849|11575287|FG001|Received at Least One Dose of Study Drug|Intervention 1||5
10429090|NCT00862849|11575288|FG002|Received at Least One Dose of Study Drug|Intervention 1||3
10429091|NCT00862849|11575289|FG003|Received at Least One Dose of Study Drug|Intervention 1||4
10429092|NCT00862849|11575290|FG004|Received at Least One Dose of Study Drug|Intervention 1||4
10429093|NCT00862849|11575291|FG005|Received at Least One Dose of Study Drug|Intervention 1||3
10429094|NCT00862849|11575286|FG000|COMPLETED|Intervention 1||3
10429095|NCT00862849|11575287|FG001|COMPLETED|Intervention 1||5
10429096|NCT00862849|11575288|FG002|COMPLETED|Intervention 1||3
10429097|NCT00862849|11575289|FG003|COMPLETED|Intervention 1||4
10429098|NCT00862849|11575290|FG004|COMPLETED|Intervention 1||4
10429099|NCT00862849|11575291|FG005|COMPLETED|Intervention 1||3
10429100|NCT00862849|11575286|FG000|NOT COMPLETED|Intervention 1||0
10429101|NCT00862849|11575287|FG001|NOT COMPLETED|Intervention 1||0
10429102|NCT00862849|11575288|FG002|NOT COMPLETED|Intervention 1||0
10429103|NCT00862849|11575289|FG003|NOT COMPLETED|Intervention 1||0
10429104|NCT00862849|11575290|FG004|NOT COMPLETED|Intervention 1||0
10429105|NCT00862849|11575291|FG005|NOT COMPLETED|Intervention 1||0
10429106|NCT00862849|11575286|FG000|STARTED|Washout 1 (3 to 14 Days)||3
10429107|NCT00862849|11575287|FG001|STARTED|Washout 1 (3 to 14 Days)||5
10429108|NCT00862849|11575288|FG002|STARTED|Washout 1 (3 to 14 Days)||3
10429109|NCT00862849|11575289|FG003|STARTED|Washout 1 (3 to 14 Days)||4
10429110|NCT00862849|11575290|FG004|STARTED|Washout 1 (3 to 14 Days)||4
10429111|NCT00862849|11575291|FG005|STARTED|Washout 1 (3 to 14 Days)||3
10429112|NCT00862849|11575286|FG000|COMPLETED|Washout 1 (3 to 14 Days)||3
10429113|NCT00862849|11575287|FG001|COMPLETED|Washout 1 (3 to 14 Days)||4
10429114|NCT00862849|11575288|FG002|COMPLETED|Washout 1 (3 to 14 Days)||3
10429115|NCT00862849|11575289|FG003|COMPLETED|Washout 1 (3 to 14 Days)||4
10429116|NCT00862849|11575290|FG004|COMPLETED|Washout 1 (3 to 14 Days)||4
10429117|NCT00862849|11575291|FG005|COMPLETED|Washout 1 (3 to 14 Days)||3
10429118|NCT00862849|11575286|FG000|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
10429119|NCT00862849|11575287|FG001|NOT COMPLETED|Washout 1 (3 to 14 Days)||1
10429120|NCT00862849|11575288|FG002|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
10429121|NCT00862849|11575289|FG003|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
10429122|NCT00862849|11575290|FG004|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
10429123|NCT00862849|11575291|FG005|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
10429124|NCT00862849|11575286|FG000|STARTED|Intervention 2||3
10429125|NCT00862849|11575287|FG001|STARTED|Intervention 2||4
10429126|NCT00862849|11575288|FG002|STARTED|Intervention 2||3
10429127|NCT00862849|11575289|FG003|STARTED|Intervention 2||4
10724459|NCT02499120|11888332|FG000|STARTED|Overall Study||65
10724460|NCT02499120|11888333|FG001|STARTED|Overall Study||60
10724461|NCT02499120|11888332|FG000|Received Treatment|Overall Study||64
10724462|NCT02499120|11888333|FG001|Received Treatment|Overall Study||60
10724463|NCT02499120|11888332|FG000|COMPLETED|Overall Study||0
10724464|NCT02499120|11888333|FG001|COMPLETED|Overall Study||0
10724465|NCT02499120|11888332|FG000|NOT COMPLETED|Overall Study||65
10724466|NCT02499120|11888333|FG001|NOT COMPLETED|Overall Study||60
10429128|NCT00862849|11575290|FG004|STARTED|Intervention 2||4
10429129|NCT00862849|11575291|FG005|STARTED|Intervention 2||3
10429130|NCT00862849|11575286|FG000|COMPLETED|Intervention 2||3
10429131|NCT00862849|11575287|FG001|COMPLETED|Intervention 2||4
10429132|NCT00862849|11575288|FG002|COMPLETED|Intervention 2||3
10429133|NCT00862849|11575289|FG003|COMPLETED|Intervention 2||4
10724467|NCT02425306|11888343|FG000|STARTED|Overall Study||3
10724468|NCT02425306|11888344|FG001|STARTED|Overall Study||7
10724469|NCT02425306|11888345|FG002|STARTED|Overall Study||6
10724470|NCT02425306|11888346|FG003|STARTED|Overall Study||32
10429134|NCT00862849|11575290|FG004|COMPLETED|Intervention 2||4
10429135|NCT00862849|11575291|FG005|COMPLETED|Intervention 2||3
10407390|NCT00749463|11551484|FG000|STARTED|Overall Study||86
10407391|NCT00749463|11551485|FG001|STARTED|Overall Study||64
10407392|NCT00749463|11551486|FG002|STARTED|Overall Study||150
10407393|NCT00749463|11551484|FG000|COMPLETED|Overall Study||85
10407394|NCT00749463|11551485|FG001|COMPLETED|Overall Study||60
10407395|NCT00749463|11551486|FG002|COMPLETED|Overall Study||149
10407396|NCT00749463|11551484|FG000|NOT COMPLETED|Overall Study||1
10407397|NCT00749463|11551485|FG001|NOT COMPLETED|Overall Study||4
10407398|NCT00749463|11551486|FG002|NOT COMPLETED|Overall Study||1
10407399|NCT00749515|11551496|FG000|STARTED|Overall Study||10
10407400|NCT00749515|11551497|FG001|STARTED|Overall Study||5
10407401|NCT00749515|11551496|FG000|COMPLETED|Overall Study||10
10407402|NCT00749515|11551497|FG001|COMPLETED|Overall Study||5
10407403|NCT00749515|11551496|FG000|NOT COMPLETED|Overall Study||0
10407404|NCT00749515|11551497|FG001|NOT COMPLETED|Overall Study||0
10544453|NCT01490632|11697649|FG012|NOT COMPLETED|Part A: Initial Treatment Period||0
10544454|NCT01490632|11697650|FG013|NOT COMPLETED|Part A: Initial Treatment Period||0
10544455|NCT01490632|11697651|FG014|NOT COMPLETED|Part A: Initial Treatment Period||0
10544456|NCT01490632|11697652|FG015|NOT COMPLETED|Part A: Initial Treatment Period||0
10544457|NCT01490632|11697653|FG016|NOT COMPLETED|Part A: Initial Treatment Period||0
10544458|NCT01490632|11697654|FG017|NOT COMPLETED|Part A: Initial Treatment Period||0
10544459|NCT01490632|11697655|FG018|NOT COMPLETED|Part A: Initial Treatment Period||0
10544460|NCT01490632|11697656|FG019|NOT COMPLETED|Part A: Initial Treatment Period||0
10544461|NCT01490632|11697637|FG000|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
10544462|NCT01490632|11697638|FG001|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
10544463|NCT01490632|11697639|FG002|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
10544464|NCT01490632|11697640|FG003|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
10544465|NCT01490632|11697641|FG004|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
10544466|NCT01490632|11697642|FG005|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥75 remained on 2 mg or 4 mg.|29
10544467|NCT01490632|11697643|FG006|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 8 mg or 10 mg with a PASI ≥75 remained on 8 mg or 10 mg.|64
10544468|NCT01490632|11697644|FG007|STARTED|Part B: Extension or Step-Up Period|Placebo participants in Part A with a PASI <75 were re-randomized to 8 mg or 10 mg.|19
10544469|NCT01490632|11697645|FG008|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥50 to <75 remained on 2 mg or 4 mg.|16
10544470|NCT01490632|11697646|FG009|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI <50 were re-randomized to 8 mg or 10 mg.|50
10544471|NCT01490632|11697647|FG010|STARTED|Part B: Extension or Step-Up Period|Part A 10 mg non-responders were discontinued from the study.|43
10544472|NCT01490632|11697648|FG011|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to Placebo remained on Placebo.|8
10544473|NCT01490632|11697649|FG012|STARTED|Part B: Extension or Step-Up Period||0
10544474|NCT01490632|11697650|FG013|STARTED|Part B: Extension or Step-Up Period||0
10544475|NCT01490632|11697651|FG014|STARTED|Part B: Extension or Step-Up Period||0
10544476|NCT01490632|11697652|FG015|STARTED|Part B: Extension or Step-Up Period||0
10544477|NCT01490632|11697653|FG016|STARTED|Part B: Extension or Step-Up Period||0
10544478|NCT01490632|11697654|FG017|STARTED|Part B: Extension or Step-Up Period||0
10544479|NCT01490632|11697655|FG018|STARTED|Part B: Extension or Step-Up Period||0
10544480|NCT01490632|11697656|FG019|STARTED|Part B: Extension or Step-Up Period||0
10544481|NCT01490632|11697637|FG000|COMPLETED|Part B: Extension or Step-Up Period||0
10544482|NCT01490632|11697638|FG001|COMPLETED|Part B: Extension or Step-Up Period||0
10544483|NCT01490632|11697639|FG002|COMPLETED|Part B: Extension or Step-Up Period||0
10544484|NCT01490632|11697640|FG003|COMPLETED|Part B: Extension or Step-Up Period||0
10544485|NCT01490632|11697641|FG004|COMPLETED|Part B: Extension or Step-Up Period||0
10544486|NCT01490632|11697642|FG005|COMPLETED|Part B: Extension or Step-Up Period||25
10544487|NCT01490632|11697643|FG006|COMPLETED|Part B: Extension or Step-Up Period||51
10544488|NCT01490632|11697644|FG007|COMPLETED|Part B: Extension or Step-Up Period||13
10544489|NCT01490632|11697645|FG008|COMPLETED|Part B: Extension or Step-Up Period||6
10544490|NCT01490632|11697646|FG009|COMPLETED|Part B: Extension or Step-Up Period||25
10544491|NCT01490632|11697647|FG010|COMPLETED|Part B: Extension or Step-Up Period||22
10544492|NCT01490632|11697648|FG011|COMPLETED|Part B: Extension or Step-Up Period||0
10544493|NCT01490632|11697649|FG012|COMPLETED|Part B: Extension or Step-Up Period||0
10544494|NCT01490632|11697650|FG013|COMPLETED|Part B: Extension or Step-Up Period||0
10544495|NCT01490632|11697651|FG014|COMPLETED|Part B: Extension or Step-Up Period||0
10544496|NCT01490632|11697652|FG015|COMPLETED|Part B: Extension or Step-Up Period||0
10544497|NCT01490632|11697653|FG016|COMPLETED|Part B: Extension or Step-Up Period||0
10544498|NCT01490632|11697654|FG017|COMPLETED|Part B: Extension or Step-Up Period||0
10544499|NCT01490632|11697655|FG018|COMPLETED|Part B: Extension or Step-Up Period||0
10544500|NCT01490632|11697656|FG019|COMPLETED|Part B: Extension or Step-Up Period||0
10814565|NCT02299934|11977356|FG000|STARTED|Overall Study||13
10814566|NCT02299934|11977356|FG000|COMPLETED|Overall Study||0
10407405|NCT00749580|11551505|FG000|STARTED|Overall Study|September 2008|21
10407406|NCT00749580|11551506|FG001|STARTED|Overall Study||25
10407407|NCT00749580|11551505|FG000|COMPLETED|Overall Study|December 2010|17
10407408|NCT00749580|11551506|FG001|COMPLETED|Overall Study||16
10407409|NCT00749580|11551505|FG000|NOT COMPLETED|Overall Study||4
10407410|NCT00749580|11551506|FG001|NOT COMPLETED|Overall Study||9
10407411|NCT00749606|11551514|FG000|STARTED|Year 1||129
10407412|NCT00749606|11551515|FG001|STARTED|Year 1||128
10407413|NCT00749606|11551514|FG000|COMPLETED|Year 1||74
10407414|NCT00749606|11551515|FG001|COMPLETED|Year 1||80
10407415|NCT00749606|11551514|FG000|NOT COMPLETED|Year 1||55
10407416|NCT00749606|11551515|FG001|NOT COMPLETED|Year 1||48
10407417|NCT00749606|11551514|FG000|STARTED|Year 2||74
10407418|NCT00749606|11551515|FG001|STARTED|Year 2||80
10407419|NCT00749606|11551514|FG000|COMPLETED|Year 2||63
10407420|NCT00749606|11551515|FG001|COMPLETED|Year 2||72
10407421|NCT00749606|11551514|FG000|NOT COMPLETED|Year 2||11
10724471|NCT02425306|11888343|FG000|COMPLETED|Overall Study||3
10724472|NCT02425306|11888344|FG001|COMPLETED|Overall Study||6
10724473|NCT02425306|11888345|FG002|COMPLETED|Overall Study||5
10724474|NCT02425306|11888346|FG003|COMPLETED|Overall Study||18
10724475|NCT02425306|11888343|FG000|NOT COMPLETED|Overall Study||0
10724476|NCT02425306|11888344|FG001|NOT COMPLETED|Overall Study||1
10724477|NCT02425306|11888345|FG002|NOT COMPLETED|Overall Study||1
10724478|NCT02425306|11888346|FG003|NOT COMPLETED|Overall Study||14
10724479|NCT02366403|11888358|FG000|STARTED|Overall Study||41
10724480|NCT02366403|11888359|FG001|STARTED|Overall Study||44
10724481|NCT02366403|11888358|FG000|COMPLETED|Overall Study||30
10724482|NCT02366403|11888359|FG001|COMPLETED|Overall Study||29
10724483|NCT02366403|11888358|FG000|NOT COMPLETED|Overall Study||11
10724484|NCT02366403|11888359|FG001|NOT COMPLETED|Overall Study||15
10724485|NCT02340221|11888367|FG000|STARTED|Overall Study||214
10724486|NCT02340221|11888368|FG001|STARTED|Overall Study||417
10724487|NCT02340221|11888367|FG000|COMPLETED|Overall Study||0
10724488|NCT02340221|11888368|FG001|COMPLETED|Overall Study||0
10724489|NCT02340221|11888367|FG000|NOT COMPLETED|Overall Study||214
10724490|NCT02340221|11888368|FG001|NOT COMPLETED|Overall Study||417
10724491|NCT02332915|11888377|FG000|STARTED|Overall Study||18
10724492|NCT02332915|11888378|FG001|STARTED|Overall Study||18
10724493|NCT02332915|11888377|FG000|COMPLETED|Overall Study||12
10724494|NCT02332915|11888378|FG001|COMPLETED|Overall Study||12
10724495|NCT02332915|11888377|FG000|NOT COMPLETED|Overall Study||6
10724496|NCT02332915|11888378|FG001|NOT COMPLETED|Overall Study||6
10724497|NCT02327195|11888391|FG000|STARTED|Overall Study||27
10724498|NCT02327195|11888392|FG001|STARTED|Overall Study||27
10724499|NCT02327195|11888391|FG000|COMPLETED|Overall Study||27
10724500|NCT02327195|11888392|FG001|COMPLETED|Overall Study||27
10724501|NCT02327195|11888391|FG000|NOT COMPLETED|Overall Study||0
10724502|NCT02327195|11888392|FG001|NOT COMPLETED|Overall Study||0
10724503|NCT02288247|11888398|FG000|STARTED|Period 1: OL Treatment (Max: 315 Weeks)||688
10724504|NCT02288247|11888399|FG001|STARTED|Period 1: OL Treatment (Max: 315 Weeks)||0
10724505|NCT02288247|11888398|FG000|Treated|Period 1: OL Treatment (Max: 315 Weeks)||687
10724506|NCT02288247|11888399|FG001|Treated|Period 1: OL Treatment (Max: 315 Weeks)||0
10724507|NCT02288247|11888398|FG000|COMPLETED|Period 1: OL Treatment (Max: 315 Weeks)||41
10724508|NCT02288247|11888399|FG001|COMPLETED|Period 1: OL Treatment (Max: 315 Weeks)||0
10724509|NCT02288247|11888398|FG000|NOT COMPLETED|Period 1: OL Treatment (Max: 315 Weeks)||647
10724510|NCT02288247|11888399|FG001|NOT COMPLETED|Period 1: OL Treatment (Max: 315 Weeks)||0
10724511|NCT02288247|11888398|FG000|STARTED|Period 2: DB Treatment (Max: 180 Weeks)|137 participants from period 1 were randomized to period 2.|137
10724512|NCT02288247|11888399|FG001|STARTED|Period 2: DB Treatment (Max: 180 Weeks)|136 participants from period 1 were randomized to period 2.|136
10724513|NCT02288247|11888398|FG000|Treated|Period 2: DB Treatment (Max: 180 Weeks)||136
10724514|NCT02288247|11888399|FG001|Treated|Period 2: DB Treatment (Max: 180 Weeks)||135
10724515|NCT02288247|11888398|FG000|COMPLETED|Period 2: DB Treatment (Max: 180 Weeks)||1
10724516|NCT02288247|11888399|FG001|COMPLETED|Period 2: DB Treatment (Max: 180 Weeks)||1
10724517|NCT02288247|11888398|FG000|NOT COMPLETED|Period 2: DB Treatment (Max: 180 Weeks)||136
10724518|NCT02288247|11888399|FG001|NOT COMPLETED|Period 2: DB Treatment (Max: 180 Weeks)||135
10407422|NCT00749606|11551515|FG001|NOT COMPLETED|Year 2||8
10724537|NCT02177175|11888419|FG000|STARTED|Overall Study||5
10407423|NCT00749606|11551514|FG000|STARTED|Year 3 (Observation)||63
10407424|NCT00749606|11551515|FG001|STARTED|Year 3 (Observation)||72
10407425|NCT00749606|11551514|FG000|COMPLETED|Year 3 (Observation)||63
10407426|NCT00749606|11551515|FG001|COMPLETED|Year 3 (Observation)||69
10407427|NCT00749606|11551514|FG000|NOT COMPLETED|Year 3 (Observation)||0
10724538|NCT02177175|11888420|FG001|STARTED|Overall Study||6
10724539|NCT02177175|11888419|FG000|COMPLETED|Overall Study||4
10724540|NCT02177175|11888420|FG001|COMPLETED|Overall Study||6
10407428|NCT00749606|11551515|FG001|NOT COMPLETED|Year 3 (Observation)||3
10407429|NCT00749671|11551525|FG000|STARTED|Overall Study||11
10407430|NCT00749671|11551526|FG001|STARTED|Overall Study||9
10407431|NCT00749671|11551525|FG000|COMPLETED|Overall Study||11
10407432|NCT00749671|11551526|FG001|COMPLETED|Overall Study||9
10407433|NCT00749671|11551525|FG000|NOT COMPLETED|Overall Study||0
10407434|NCT00749671|11551526|FG001|NOT COMPLETED|Overall Study||0
10407435|NCT00749684|11551534|FG000|STARTED|Overall Study||138
10407436|NCT00749684|11551534|FG000|COMPLETED|Overall Study||56
10407437|NCT00749684|11551534|FG000|NOT COMPLETED|Overall Study||82
10407438|NCT00749749|11551540|FG000|STARTED|Overall Study||14
10407439|NCT00749749|11551541|FG001|STARTED|Overall Study||13
10407440|NCT00749749|11551540|FG000|COMPLETED|Overall Study||14
10407441|NCT00749749|11551541|FG001|COMPLETED|Overall Study||13
10407442|NCT00749749|11551540|FG000|NOT COMPLETED|Overall Study||0
10407443|NCT00749749|11551541|FG001|NOT COMPLETED|Overall Study||0
10407444|NCT00749775|11551547|FG000|STARTED|Overall Study||3317
10407445|NCT00749775|11551547|FG000|COMPLETED|Overall Study||3210
10407446|NCT00749775|11551547|FG000|NOT COMPLETED|Overall Study||107
10407447|NCT00749879|11551561|FG000|STARTED|Overall Study||12
10407448|NCT00749879|11551561|FG000|COMPLETED|Overall Study||12
10407449|NCT00749879|11551561|FG000|NOT COMPLETED|Overall Study||0
10407450|NCT00749892|11551573|FG000|STARTED|Overall Study||34
10407451|NCT00749892|11551573|FG000|COMPLETED|Overall Study||31
10407452|NCT00749892|11551573|FG000|NOT COMPLETED|Overall Study||3
10407453|NCT00749931|11551579|FG000|STARTED|Overall Study||298
10407454|NCT00749931|11551580|FG001|STARTED|Overall Study||298
10407455|NCT00749931|11551581|FG002|STARTED|Overall Study||68
10407456|NCT00749931|11551579|FG000|COMPLETED|Overall Study||298
10407457|NCT00749931|11551580|FG001|COMPLETED|Overall Study||298
10407458|NCT00749931|11551581|FG002|COMPLETED|Overall Study||68
10407459|NCT00749931|11551579|FG000|NOT COMPLETED|Overall Study||0
10407460|NCT00749931|11551580|FG001|NOT COMPLETED|Overall Study||0
10407461|NCT00749931|11551581|FG002|NOT COMPLETED|Overall Study||0
10407462|NCT00749944|11551590|FG000|STARTED|Overall Study||55
10407463|NCT00749944|11551591|FG001|STARTED|Overall Study||55
10407464|NCT00749944|11551590|FG000|COMPLETED|Overall Study||50
10407465|NCT00749944|11551591|FG001|COMPLETED|Overall Study||54
10407466|NCT00749944|11551590|FG000|NOT COMPLETED|Overall Study||5
10407467|NCT00749944|11551591|FG001|NOT COMPLETED|Overall Study||1
10407468|NCT00749957|11551599|FG000|STARTED|Overall Study||6
10407469|NCT00749957|11551600|FG001|STARTED|Overall Study||6
10407470|NCT00749957|11551599|FG000|COMPLETED|Overall Study||6
10407471|NCT00749957|11551600|FG001|COMPLETED|Overall Study||6
10407472|NCT00749957|11551599|FG000|NOT COMPLETED|Overall Study||0
10407473|NCT00749957|11551600|FG001|NOT COMPLETED|Overall Study||0
10407474|NCT00749996|11551610|FG000|STARTED|Overall Study|4 pts were removed due to compliance issue. 2 pts were randomized but not treated (non-eligible)|75
10407475|NCT00749996|11551611|FG001|STARTED|Overall Study|5 pts were removed due to compliance issue. 1 pt was randomized but not treated (Non-eligible)|71
10407476|NCT00749996|11551610|FG000|6 Weeks Follow-up|Overall Study|Withdrawn (n=1). Visit not done (n=2)|72
10407477|NCT00749996|11551611|FG001|6 Weeks Follow-up|Overall Study|Withdrawn (n=2). Visit not done (n=2)|67
10407478|NCT00749996|11551610|FG000|3 Months Follow-up|Overall Study|Visit not done (n=2)|72
10407479|NCT00749996|11551611|FG001|3 Months Follow-up|Overall Study|Visit not done (n=1)|68
10407480|NCT00749996|11551610|FG000|6 Months Follow-up|Overall Study|Visit not done (n=3)|71
10407481|NCT00749996|11551611|FG001|6 Months Follow-up|Overall Study|Withdrawn (n=3). Visit not done (n=3)|63
10407482|NCT00749996|11551610|FG000|12 Months Follow-up|Overall Study|Withdrawn(n=4). Visit not done (n=2)|68
10407483|NCT00749996|11551611|FG001|12 Months Follow-up|Overall Study|Withdrawn (n=1). Visit not done (n=4). Lost to follow-up (n=1)|60
10407484|NCT00749996|11551610|FG000|24 Months Follow up|Overall Study|Withdrawn (n=5) Accidental death (n=1) Lost to follow up (n=7)|57
10407485|NCT00749996|11551611|FG001|24 Months Follow up|Overall Study|Withdrawn (n=3). Lost to follow-up (n=3)|58
10407486|NCT00749996|11551610|FG000|COMPLETED|Overall Study||57
10407487|NCT00749996|11551611|FG001|COMPLETED|Overall Study||58
10407488|NCT00749996|11551610|FG000|NOT COMPLETED|Overall Study||18
10407489|NCT00749996|11551611|FG001|NOT COMPLETED|Overall Study||13
10407490|NCT00750061|11551619|FG000|STARTED|Overall Study||20
10407491|NCT00750061|11551620|FG001|STARTED|Overall Study||20
10407492|NCT00750061|11551619|FG000|COMPLETED|Overall Study||18
10407493|NCT00750061|11551620|FG001|COMPLETED|Overall Study||18
10407494|NCT00750061|11551619|FG000|NOT COMPLETED|Overall Study||2
10407495|NCT00750061|11551620|FG001|NOT COMPLETED|Overall Study||2
10407496|NCT00750139|11551630|FG000|STARTED|Overall Study||234
10407497|NCT00750139|11551631|FG001|STARTED|Overall Study||118
10407498|NCT00750139|11551632|FG002|STARTED|Overall Study||236
10407499|NCT00750139|11551633|FG003|STARTED|Overall Study||119
10407500|NCT00750139|11551630|FG000|COMPLETED|Overall Study||145
10407501|NCT00750139|11551631|FG001|COMPLETED|Overall Study||59
10407502|NCT00750139|11551632|FG002|COMPLETED|Overall Study||135
10407503|NCT00750139|11551633|FG003|COMPLETED|Overall Study||73
10407504|NCT00750139|11551630|FG000|NOT COMPLETED|Overall Study||89
10407505|NCT00750139|11551631|FG001|NOT COMPLETED|Overall Study||59
10407506|NCT00750139|11551632|FG002|NOT COMPLETED|Overall Study||101
10407507|NCT00750139|11551633|FG003|NOT COMPLETED|Overall Study||46
10407508|NCT00750152|11551647|FG000|STARTED|Overall Study||166
10407509|NCT00750152|11551648|FG001|STARTED|Overall Study||168
10407510|NCT00750152|11551647|FG000|COMPLETED|Overall Study||144
10407511|NCT00750152|11551648|FG001|COMPLETED|Overall Study||141
10407512|NCT00750152|11551647|FG000|NOT COMPLETED|Overall Study||22
10407513|NCT00750152|11551648|FG001|NOT COMPLETED|Overall Study||27
10407514|NCT00750165|11551654|FG000|STARTED|Overall Study||32
10407515|NCT00750165|11551654|FG000|COMPLETED|Overall Study||21
10407516|NCT00750165|11551654|FG000|NOT COMPLETED|Overall Study||11
10407517|NCT00750191|11551660|FG000|STARTED|Overall Study||27
10407518|NCT00750191|11551661|FG001|STARTED|Overall Study||30
10407519|NCT00750191|11551660|FG000|COMPLETED|Overall Study||22
10407520|NCT00750191|11551661|FG001|COMPLETED|Overall Study||20
10407521|NCT00750191|11551660|FG000|NOT COMPLETED|Overall Study||5
10407522|NCT00750191|11551661|FG001|NOT COMPLETED|Overall Study||10
10407523|NCT00750282|11551671|FG000|STARTED|Overall Study||69
10407524|NCT00750282|11551672|FG001|STARTED|Overall Study||82
10407525|NCT00750282|11551673|FG002|STARTED|Overall Study||126
10544501|NCT01490632|11697637|FG000|NOT COMPLETED|Part B: Extension or Step-Up Period||0
10544502|NCT01490632|11697638|FG001|NOT COMPLETED|Part B: Extension or Step-Up Period||0
10544503|NCT01490632|11697639|FG002|NOT COMPLETED|Part B: Extension or Step-Up Period||0
10544504|NCT01490632|11697640|FG003|NOT COMPLETED|Part B: Extension or Step-Up Period||0
10544505|NCT01490632|11697641|FG004|NOT COMPLETED|Part B: Extension or Step-Up Period||0
10544506|NCT01490632|11697642|FG005|NOT COMPLETED|Part B: Extension or Step-Up Period||4
10544507|NCT01490632|11697643|FG006|NOT COMPLETED|Part B: Extension or Step-Up Period||13
10544508|NCT01490632|11697644|FG007|NOT COMPLETED|Part B: Extension or Step-Up Period||6
10544509|NCT01490632|11697645|FG008|NOT COMPLETED|Part B: Extension or Step-Up Period||10
10544510|NCT01490632|11697646|FG009|NOT COMPLETED|Part B: Extension or Step-Up Period||25
10544511|NCT01490632|11697647|FG010|NOT COMPLETED|Part B: Extension or Step-Up Period||21
10544512|NCT01490632|11697648|FG011|NOT COMPLETED|Part B: Extension or Step-Up Period||8
10544513|NCT01490632|11697649|FG012|NOT COMPLETED|Part B: Extension or Step-Up Period||0
10544514|NCT01490632|11697650|FG013|NOT COMPLETED|Part B: Extension or Step-Up Period||0
10544515|NCT01490632|11697651|FG014|NOT COMPLETED|Part B: Extension or Step-Up Period||0
10544516|NCT01490632|11697652|FG015|NOT COMPLETED|Part B: Extension or Step-Up Period||0
10544517|NCT01490632|11697653|FG016|NOT COMPLETED|Part B: Extension or Step-Up Period||0
10544518|NCT01490632|11697654|FG017|NOT COMPLETED|Part B: Extension or Step-Up Period||0
10544519|NCT01490632|11697655|FG018|NOT COMPLETED|Part B: Extension or Step-Up Period||0
10544520|NCT01490632|11697656|FG019|NOT COMPLETED|Part B: Extension or Step-Up Period||0
10544521|NCT01490632|11697637|FG000|STARTED|Part C: Washout or Step-Down Period||0
10544522|NCT01490632|11697638|FG001|STARTED|Part C: Washout or Step-Down Period||0
10544523|NCT01490632|11697639|FG002|STARTED|Part C: Washout or Step-Down Period||0
10724541|NCT02177175|11888419|FG000|NOT COMPLETED|Overall Study||1
10724542|NCT02177175|11888420|FG001|NOT COMPLETED|Overall Study||0
10724546|NCT02049138|11888437|FG000|STARTED|Overall Study||306
10724547|NCT02049138|11888438|FG001|STARTED|Overall Study||149
10724548|NCT02049138|11888439|FG002|STARTED|Overall Study||38
10724549|NCT02049138|11888437|FG000|Enrolled in Vaccine Sub-study|Overall Study||76
10724550|NCT02049138|11888438|FG001|Enrolled in Vaccine Sub-study|Overall Study||24
10724551|NCT02049138|11888439|FG002|Enrolled in Vaccine Sub-study|Overall Study||11
10724552|NCT02049138|11888437|FG000|COMPLETED|Overall Study||142
10724553|NCT02049138|11888438|FG001|COMPLETED|Overall Study||51
10724554|NCT02049138|11888439|FG002|COMPLETED|Overall Study||30
10724555|NCT02049138|11888437|FG000|NOT COMPLETED|Overall Study||164
10724556|NCT02049138|11888438|FG001|NOT COMPLETED|Overall Study||98
10724557|NCT02049138|11888439|FG002|NOT COMPLETED|Overall Study||8
10724558|NCT01721772|11888452|FG000|STARTED|Pre-Treatment||210
10724559|NCT01721772|11888453|FG001|STARTED|Pre-Treatment||208
10724560|NCT01721772|11888452|FG000|COMPLETED|Pre-Treatment||206
10724561|NCT01721772|11888453|FG001|COMPLETED|Pre-Treatment||205
10724562|NCT01721772|11888452|FG000|NOT COMPLETED|Pre-Treatment||4
10724563|NCT01721772|11888453|FG001|NOT COMPLETED|Pre-Treatment||3
10724564|NCT01721772|11888452|FG000|STARTED|Treatment||206
10724565|NCT01721772|11888453|FG001|STARTED|Treatment||205
10724566|NCT01721772|11888452|FG000|COMPLETED|Treatment||0
10724567|NCT01721772|11888453|FG001|COMPLETED|Treatment||0
10724568|NCT01721772|11888452|FG000|NOT COMPLETED|Treatment||206
10724569|NCT01721772|11888453|FG001|NOT COMPLETED|Treatment||205
10724570|NCT01412333|11888461|FG000|STARTED|Overall Study||418
10724571|NCT01412333|11888462|FG001|STARTED|Overall Study||417
10724572|NCT01412333|11888461|FG000|COMPLETED|Overall Study||320
10724573|NCT01412333|11888462|FG001|COMPLETED|Overall Study||360
10724574|NCT01412333|11888461|FG000|NOT COMPLETED|Overall Study||98
10724575|NCT01412333|11888462|FG001|NOT COMPLETED|Overall Study||57
10724576|NCT01306331|11888471|FG000|STARTED|Overall Study||1659
10724577|NCT01306331|11888472|FG001|STARTED|Overall Study||1665
10724578|NCT01306331|11888471|FG000|COMPLETED|Overall Study||758
10544524|NCT01490632|11697640|FG003|STARTED|Part C: Washout or Step-Down Period||0
10724579|NCT01306331|11888472|FG001|COMPLETED|Overall Study||788
10724580|NCT01306331|11888471|FG000|NOT COMPLETED|Overall Study||901
10724581|NCT01306331|11888472|FG001|NOT COMPLETED|Overall Study||877
10724582|NCT01247324|11888480|FG000|STARTED|Overall Study||411
10407526|NCT00750282|11551674|FG003|STARTED|Overall Study||148
10548260|NCT01518699|11702088|FG003|COMPLETED|Period 1||10
10724583|NCT01247324|11888481|FG001|STARTED|Overall Study||410
10724584|NCT01247324|11888480|FG000|COMPLETED|Overall Study||340
10724585|NCT01247324|11888481|FG001|COMPLETED|Overall Study||366
10724586|NCT01247324|11888480|FG000|NOT COMPLETED|Overall Study||71
10724587|NCT01247324|11888481|FG001|NOT COMPLETED|Overall Study||44
10724588|NCT01194570|11888490|FG000|STARTED|Overall Study||244
10407527|NCT00750282|11551671|FG000|COMPLETED|Overall Study||69
10407528|NCT00750282|11551672|FG001|COMPLETED|Overall Study||81
10407529|NCT00750282|11551673|FG002|COMPLETED|Overall Study||125
10407530|NCT00750282|11551674|FG003|COMPLETED|Overall Study||147
10407531|NCT00750282|11551671|FG000|NOT COMPLETED|Overall Study||0
10407532|NCT00750282|11551672|FG001|NOT COMPLETED|Overall Study||1
10407533|NCT00750282|11551673|FG002|NOT COMPLETED|Overall Study||1
10407534|NCT00750282|11551674|FG003|NOT COMPLETED|Overall Study||1
10407535|NCT00750308|11551698|FG000|STARTED|First Treatment|One female withdrew due to muscle pain|2
10407536|NCT00750308|11551699|FG001|STARTED|First Treatment||3
10407537|NCT00750308|11551700|FG002|STARTED|First Treatment||2
10407538|NCT00750308|11551701|FG003|STARTED|First Treatment||2
10407539|NCT00750308|11551702|FG004|STARTED|First Treatment||2
10407540|NCT00750308|11551703|FG005|STARTED|First Treatment||3
10407541|NCT00750308|11551704|FG006|STARTED|First Treatment||2
10407542|NCT00750308|11551705|FG007|STARTED|First Treatment||3
10407543|NCT00750308|11551706|FG008|STARTED|First Treatment||2
10407544|NCT00750308|11551707|FG009|STARTED|First Treatment||2
10407545|NCT00750308|11551708|FG010|STARTED|First Treatment||2
10407546|NCT00750308|11551709|FG011|STARTED|First Treatment||2
10407547|NCT00750308|11551698|FG000|COMPLETED|First Treatment||2
10407548|NCT00750308|11551699|FG001|COMPLETED|First Treatment||2
10407549|NCT00750308|11551700|FG002|COMPLETED|First Treatment||2
10407550|NCT00750308|11551701|FG003|COMPLETED|First Treatment||1
10407551|NCT00750308|11551702|FG004|COMPLETED|First Treatment||2
10407552|NCT00750308|11551703|FG005|COMPLETED|First Treatment||3
10407553|NCT00750308|11551704|FG006|COMPLETED|First Treatment||2
10407554|NCT00750308|11551705|FG007|COMPLETED|First Treatment||2
10407555|NCT00750308|11551706|FG008|COMPLETED|First Treatment||2
10407556|NCT00750308|11551707|FG009|COMPLETED|First Treatment||2
10407557|NCT00750308|11551708|FG010|COMPLETED|First Treatment||1
10407558|NCT00750308|11551709|FG011|COMPLETED|First Treatment||1
10407559|NCT00750308|11551698|FG000|NOT COMPLETED|First Treatment||0
10407560|NCT00750308|11551699|FG001|NOT COMPLETED|First Treatment||1
10407561|NCT00750308|11551700|FG002|NOT COMPLETED|First Treatment||0
10407562|NCT00750308|11551701|FG003|NOT COMPLETED|First Treatment||1
10407563|NCT00750308|11551702|FG004|NOT COMPLETED|First Treatment||0
10407564|NCT00750308|11551703|FG005|NOT COMPLETED|First Treatment||0
10407565|NCT00750308|11551704|FG006|NOT COMPLETED|First Treatment||0
10407566|NCT00750308|11551705|FG007|NOT COMPLETED|First Treatment||1
10407567|NCT00750308|11551706|FG008|NOT COMPLETED|First Treatment||0
10407568|NCT00750308|11551707|FG009|NOT COMPLETED|First Treatment||0
10407569|NCT00750308|11551708|FG010|NOT COMPLETED|First Treatment||1
10407570|NCT00750308|11551709|FG011|NOT COMPLETED|First Treatment||1
10407571|NCT00750308|11551698|FG000|STARTED|Washout||2
10407572|NCT00750308|11551699|FG001|STARTED|Washout||2
10407573|NCT00750308|11551700|FG002|STARTED|Washout||2
10407574|NCT00750308|11551701|FG003|STARTED|Washout||1
10407575|NCT00750308|11551702|FG004|STARTED|Washout||2
10407576|NCT00750308|11551703|FG005|STARTED|Washout||3
10407577|NCT00750308|11551704|FG006|STARTED|Washout||2
10407578|NCT00750308|11551705|FG007|STARTED|Washout||2
10407579|NCT00750308|11551706|FG008|STARTED|Washout||2
10407580|NCT00750308|11551707|FG009|STARTED|Washout||2
10407581|NCT00750308|11551708|FG010|STARTED|Washout||1
10407582|NCT00750308|11551709|FG011|STARTED|Washout||1
10407583|NCT00750308|11551698|FG000|COMPLETED|Washout||2
10407584|NCT00750308|11551699|FG001|COMPLETED|Washout||2
10407585|NCT00750308|11551700|FG002|COMPLETED|Washout||2
10407586|NCT00750308|11551701|FG003|COMPLETED|Washout||1
10407587|NCT00750308|11551702|FG004|COMPLETED|Washout||2
10407588|NCT00750308|11551703|FG005|COMPLETED|Washout||3
10407589|NCT00750308|11551704|FG006|COMPLETED|Washout||2
10724589|NCT01194570|11888491|FG001|STARTED|Overall Study||488
10724590|NCT01194570|11888490|FG000|COMPLETED|Overall Study|"Reason for discontinuation were provided for Core Treatment Completion."|0
10724591|NCT01194570|11888491|FG001|COMPLETED|Overall Study||0
10724592|NCT01194570|11888490|FG000|NOT COMPLETED|Overall Study||244
10724593|NCT01194570|11888491|FG001|NOT COMPLETED|Overall Study||488
10724594|NCT01190930|11888499|FG000|STARTED|Induction||9298
10724595|NCT01190930|11888500|FG001|STARTED|Induction||52
10724596|NCT01190930|11888501|FG002|STARTED|Induction||0
10724597|NCT01190930|11888502|FG003|STARTED|Induction||0
10724598|NCT01190930|11888503|FG004|STARTED|Induction||0
10724599|NCT01190930|11888504|FG005|STARTED|Induction||0
10724600|NCT01190930|11888505|FG006|STARTED|Induction||0
10724601|NCT01190930|11888506|FG007|STARTED|Induction||0
10407590|NCT00750308|11551705|FG007|COMPLETED|Washout||2
10407591|NCT00750308|11551706|FG008|COMPLETED|Washout||2
10407592|NCT00750308|11551707|FG009|COMPLETED|Washout||2
10407593|NCT00750308|11551708|FG010|COMPLETED|Washout||1
10407594|NCT00750308|11551709|FG011|COMPLETED|Washout||1
10407595|NCT00750308|11551698|FG000|NOT COMPLETED|Washout||0
10407596|NCT00750308|11551699|FG001|NOT COMPLETED|Washout||0
10407597|NCT00750308|11551700|FG002|NOT COMPLETED|Washout||0
10407598|NCT00750308|11551701|FG003|NOT COMPLETED|Washout||0
10407599|NCT00750308|11551702|FG004|NOT COMPLETED|Washout||0
10724602|NCT01190930|11888507|FG008|STARTED|Induction||0
10724603|NCT01190930|11888508|FG009|STARTED|Induction||0
10724604|NCT01190930|11888499|FG000|COMPLETED|Induction||3949
10407600|NCT00750308|11551703|FG005|NOT COMPLETED|Washout||0
10407601|NCT00750308|11551704|FG006|NOT COMPLETED|Washout||0
10407602|NCT00750308|11551705|FG007|NOT COMPLETED|Washout||0
10407603|NCT00750308|11551706|FG008|NOT COMPLETED|Washout||0
10407604|NCT00750308|11551707|FG009|NOT COMPLETED|Washout||0
10407605|NCT00750308|11551708|FG010|NOT COMPLETED|Washout||0
10407606|NCT00750308|11551709|FG011|NOT COMPLETED|Washout||0
10407607|NCT00750308|11551698|FG000|STARTED|Second Treatment||2
10407608|NCT00750308|11551699|FG001|STARTED|Second Treatment||2
10407609|NCT00750308|11551700|FG002|STARTED|Second Treatment||2
10407610|NCT00750308|11551701|FG003|STARTED|Second Treatment||1
10407611|NCT00750308|11551702|FG004|STARTED|Second Treatment||2
10407612|NCT00750308|11551703|FG005|STARTED|Second Treatment||3
10407613|NCT00750308|11551704|FG006|STARTED|Second Treatment||2
10407614|NCT00750308|11551705|FG007|STARTED|Second Treatment||2
10407615|NCT00750308|11551706|FG008|STARTED|Second Treatment||2
10407616|NCT00750308|11551707|FG009|STARTED|Second Treatment||2
10407617|NCT00750308|11551708|FG010|STARTED|Second Treatment||1
10407618|NCT00750308|11551709|FG011|STARTED|Second Treatment||1
10407619|NCT00750308|11551698|FG000|COMPLETED|Second Treatment||2
10407620|NCT00750308|11551699|FG001|COMPLETED|Second Treatment||2
10407621|NCT00750308|11551700|FG002|COMPLETED|Second Treatment||2
10407622|NCT00750308|11551701|FG003|COMPLETED|Second Treatment||1
10407623|NCT00750308|11551702|FG004|COMPLETED|Second Treatment||1
10407624|NCT00750308|11551703|FG005|COMPLETED|Second Treatment||2
10407625|NCT00750308|11551704|FG006|COMPLETED|Second Treatment||2
10407626|NCT00750308|11551705|FG007|COMPLETED|Second Treatment||2
10407627|NCT00750308|11551706|FG008|COMPLETED|Second Treatment||1
10407628|NCT00750308|11551707|FG009|COMPLETED|Second Treatment||2
10407629|NCT00750308|11551708|FG010|COMPLETED|Second Treatment||1
10407630|NCT00750308|11551709|FG011|COMPLETED|Second Treatment||1
10407631|NCT00750308|11551698|FG000|NOT COMPLETED|Second Treatment||0
10407632|NCT00750308|11551699|FG001|NOT COMPLETED|Second Treatment||0
10407633|NCT00750308|11551700|FG002|NOT COMPLETED|Second Treatment||0
10407634|NCT00750308|11551701|FG003|NOT COMPLETED|Second Treatment||0
10407635|NCT00750308|11551702|FG004|NOT COMPLETED|Second Treatment||1
10407636|NCT00750308|11551703|FG005|NOT COMPLETED|Second Treatment||1
10407637|NCT00750308|11551704|FG006|NOT COMPLETED|Second Treatment||0
10407638|NCT00750308|11551705|FG007|NOT COMPLETED|Second Treatment||0
10407639|NCT00750308|11551706|FG008|NOT COMPLETED|Second Treatment||1
10407640|NCT00750308|11551707|FG009|NOT COMPLETED|Second Treatment||0
10407641|NCT00750308|11551708|FG010|NOT COMPLETED|Second Treatment||0
10407642|NCT00750308|11551709|FG011|NOT COMPLETED|Second Treatment||0
10407643|NCT00750308|11551698|FG000|STARTED|Washout||2
10407644|NCT00750308|11551699|FG001|STARTED|Washout||2
10407645|NCT00750308|11551700|FG002|STARTED|Washout||2
10407646|NCT00750308|11551701|FG003|STARTED|Washout||1
10407647|NCT00750308|11551702|FG004|STARTED|Washout||1
10407648|NCT00750308|11551703|FG005|STARTED|Washout||2
10407649|NCT00750308|11551704|FG006|STARTED|Washout||2
10407650|NCT00750308|11551705|FG007|STARTED|Washout||2
10407651|NCT00750308|11551706|FG008|STARTED|Washout||1
10407652|NCT00750308|11551707|FG009|STARTED|Washout||2
10407653|NCT00750308|11551708|FG010|STARTED|Washout||1
10407654|NCT00750308|11551709|FG011|STARTED|Washout||1
10407655|NCT00750308|11551698|FG000|COMPLETED|Washout||2
10407656|NCT00750308|11551699|FG001|COMPLETED|Washout||2
10407657|NCT00750308|11551700|FG002|COMPLETED|Washout||2
10407658|NCT00750308|11551701|FG003|COMPLETED|Washout||1
10407659|NCT00750308|11551702|FG004|COMPLETED|Washout||1
10407660|NCT00750308|11551703|FG005|COMPLETED|Washout||2
10407661|NCT00750308|11551704|FG006|COMPLETED|Washout||2
10407662|NCT00750308|11551705|FG007|COMPLETED|Washout||2
10407663|NCT00750308|11551706|FG008|COMPLETED|Washout||1
10407664|NCT00750308|11551707|FG009|COMPLETED|Washout||2
10407665|NCT00750308|11551708|FG010|COMPLETED|Washout||1
10407666|NCT00750308|11551709|FG011|COMPLETED|Washout||1
10407667|NCT00750308|11551698|FG000|NOT COMPLETED|Washout||0
10407668|NCT00750308|11551699|FG001|NOT COMPLETED|Washout||0
10407669|NCT00750308|11551700|FG002|NOT COMPLETED|Washout||0
10407670|NCT00750308|11551701|FG003|NOT COMPLETED|Washout||0
10407671|NCT00750308|11551702|FG004|NOT COMPLETED|Washout||0
10407672|NCT00750308|11551703|FG005|NOT COMPLETED|Washout||0
10407673|NCT00750308|11551704|FG006|NOT COMPLETED|Washout||0
10407674|NCT00750308|11551705|FG007|NOT COMPLETED|Washout||0
10407675|NCT00750308|11551706|FG008|NOT COMPLETED|Washout||0
10407676|NCT00750308|11551707|FG009|NOT COMPLETED|Washout||0
10407677|NCT00750308|11551708|FG010|NOT COMPLETED|Washout||0
10407678|NCT00750308|11551709|FG011|NOT COMPLETED|Washout||0
10407679|NCT00750308|11551698|FG000|STARTED|Third Treatment||2
10407680|NCT00750308|11551699|FG001|STARTED|Third Treatment||2
10407681|NCT00750308|11551700|FG002|STARTED|Third Treatment||2
10407682|NCT00750308|11551701|FG003|STARTED|Third Treatment||1
10407683|NCT00750308|11551702|FG004|STARTED|Third Treatment||1
10407684|NCT00750308|11551703|FG005|STARTED|Third Treatment||2
10407685|NCT00750308|11551704|FG006|STARTED|Third Treatment||2
10407686|NCT00750308|11551705|FG007|STARTED|Third Treatment||2
10407687|NCT00750308|11551706|FG008|STARTED|Third Treatment||1
10407688|NCT00750308|11551707|FG009|STARTED|Third Treatment||2
10407689|NCT00750308|11551708|FG010|STARTED|Third Treatment||1
10407690|NCT00750308|11551709|FG011|STARTED|Third Treatment||1
10407691|NCT00750308|11551698|FG000|COMPLETED|Third Treatment||2
10407692|NCT00750308|11551699|FG001|COMPLETED|Third Treatment||1
10407693|NCT00750308|11551700|FG002|COMPLETED|Third Treatment||2
10407694|NCT00750308|11551701|FG003|COMPLETED|Third Treatment||1
10407695|NCT00750308|11551702|FG004|COMPLETED|Third Treatment||1
10407696|NCT00750308|11551703|FG005|COMPLETED|Third Treatment||2
10407697|NCT00750308|11551704|FG006|COMPLETED|Third Treatment||2
10407698|NCT00750308|11551705|FG007|COMPLETED|Third Treatment||2
10407699|NCT00750308|11551706|FG008|COMPLETED|Third Treatment||1
10407700|NCT00750308|11551707|FG009|COMPLETED|Third Treatment||2
10407701|NCT00750308|11551708|FG010|COMPLETED|Third Treatment||1
10407702|NCT00750308|11551709|FG011|COMPLETED|Third Treatment||1
10407703|NCT00750308|11551698|FG000|NOT COMPLETED|Third Treatment||0
10407704|NCT00750308|11551699|FG001|NOT COMPLETED|Third Treatment||1
10407705|NCT00750308|11551700|FG002|NOT COMPLETED|Third Treatment||0
10407706|NCT00750308|11551701|FG003|NOT COMPLETED|Third Treatment||0
10407707|NCT00750308|11551702|FG004|NOT COMPLETED|Third Treatment||0
10407708|NCT00750308|11551703|FG005|NOT COMPLETED|Third Treatment||0
10407709|NCT00750308|11551704|FG006|NOT COMPLETED|Third Treatment||0
10407710|NCT00750308|11551705|FG007|NOT COMPLETED|Third Treatment||0
10407711|NCT00750308|11551706|FG008|NOT COMPLETED|Third Treatment||0
10407712|NCT00750308|11551707|FG009|NOT COMPLETED|Third Treatment||0
10407713|NCT00750308|11551708|FG010|NOT COMPLETED|Third Treatment||0
10407714|NCT00750308|11551709|FG011|NOT COMPLETED|Third Treatment||0
10407715|NCT00750308|11551698|FG000|STARTED|Washout||2
10407716|NCT00750308|11551699|FG001|STARTED|Washout||1
10407717|NCT00750308|11551700|FG002|STARTED|Washout||2
10407718|NCT00750308|11551701|FG003|STARTED|Washout||1
10407719|NCT00750308|11551702|FG004|STARTED|Washout||1
10407720|NCT00750308|11551703|FG005|STARTED|Washout||2
10407721|NCT00750308|11551704|FG006|STARTED|Washout||2
10407722|NCT00750308|11551705|FG007|STARTED|Washout||2
10407723|NCT00750308|11551706|FG008|STARTED|Washout||1
10407724|NCT00750308|11551707|FG009|STARTED|Washout||2
10407725|NCT00750308|11551708|FG010|STARTED|Washout||1
10407726|NCT00750308|11551709|FG011|STARTED|Washout||1
10407727|NCT00750308|11551698|FG000|COMPLETED|Washout||2
10407728|NCT00750308|11551699|FG001|COMPLETED|Washout||1
10407729|NCT00750308|11551700|FG002|COMPLETED|Washout||2
10407730|NCT00750308|11551701|FG003|COMPLETED|Washout||1
10407731|NCT00750308|11551702|FG004|COMPLETED|Washout||1
10407732|NCT00750308|11551703|FG005|COMPLETED|Washout||2
10407733|NCT00750308|11551704|FG006|COMPLETED|Washout||2
10407734|NCT00750308|11551705|FG007|COMPLETED|Washout||2
10407735|NCT00750308|11551706|FG008|COMPLETED|Washout||1
10407736|NCT00750308|11551707|FG009|COMPLETED|Washout||2
10407737|NCT00750308|11551708|FG010|COMPLETED|Washout||1
10407738|NCT00750308|11551709|FG011|COMPLETED|Washout||1
10407739|NCT00750308|11551698|FG000|NOT COMPLETED|Washout||0
10407740|NCT00750308|11551699|FG001|NOT COMPLETED|Washout||0
10407741|NCT00750308|11551700|FG002|NOT COMPLETED|Washout||0
10407742|NCT00750308|11551701|FG003|NOT COMPLETED|Washout||0
10407743|NCT00750308|11551702|FG004|NOT COMPLETED|Washout||0
10407744|NCT00750308|11551703|FG005|NOT COMPLETED|Washout||0
10407745|NCT00750308|11551704|FG006|NOT COMPLETED|Washout||0
10407746|NCT00750308|11551705|FG007|NOT COMPLETED|Washout||0
10407747|NCT00750308|11551706|FG008|NOT COMPLETED|Washout||0
10724605|NCT01190930|11888500|FG001|COMPLETED|Induction||43
10724606|NCT01190930|11888501|FG002|COMPLETED|Induction||0
10724607|NCT01190930|11888502|FG003|COMPLETED|Induction||0
10724608|NCT01190930|11888503|FG004|COMPLETED|Induction||0
10724609|NCT01190930|11888504|FG005|COMPLETED|Induction||0
10724610|NCT01190930|11888505|FG006|COMPLETED|Induction||0
10724611|NCT01190930|11888506|FG007|COMPLETED|Induction||0
10724612|NCT01190930|11888507|FG008|COMPLETED|Induction||0
10724613|NCT01190930|11888508|FG009|COMPLETED|Induction||0
10724614|NCT01190930|11888499|FG000|NOT COMPLETED|Induction||5349
10724615|NCT01190930|11888500|FG001|NOT COMPLETED|Induction||9
10724616|NCT01190930|11888501|FG002|NOT COMPLETED|Induction||0
10724617|NCT01190930|11888502|FG003|NOT COMPLETED|Induction||0
10724618|NCT01190930|11888503|FG004|NOT COMPLETED|Induction||0
10724619|NCT01190930|11888504|FG005|NOT COMPLETED|Induction||0
10724620|NCT01190930|11888505|FG006|NOT COMPLETED|Induction||0
10724621|NCT01190930|11888506|FG007|NOT COMPLETED|Induction||0
10724622|NCT01190930|11888507|FG008|NOT COMPLETED|Induction||0
10724623|NCT01190930|11888508|FG009|NOT COMPLETED|Induction||0
10724624|NCT01190930|11888499|FG000|STARTED|Post Induction Pre-Maintenance||0
10724625|NCT01190930|11888500|FG001|STARTED|Post Induction Pre-Maintenance||43
10724626|NCT01190930|11888501|FG002|STARTED|Post Induction Pre-Maintenance||3122
10724627|NCT01190930|11888502|FG003|STARTED|Post Induction Pre-Maintenance||224
10724628|NCT01190930|11888503|FG004|STARTED|Post Induction Pre-Maintenance||301
10724629|NCT01190930|11888504|FG005|STARTED|Post Induction Pre-Maintenance||302
10724630|NCT01190930|11888505|FG006|STARTED|Post Induction Pre-Maintenance||0
10724631|NCT01190930|11888506|FG007|STARTED|Post Induction Pre-Maintenance||0
10724632|NCT01190930|11888507|FG008|STARTED|Post Induction Pre-Maintenance||0
10724633|NCT01190930|11888508|FG009|STARTED|Post Induction Pre-Maintenance||0
10724634|NCT01190930|11888499|FG000|COMPLETED|Post Induction Pre-Maintenance||0
10724635|NCT01190930|11888500|FG001|COMPLETED|Post Induction Pre-Maintenance||37
10724636|NCT01190930|11888501|FG002|COMPLETED|Post Induction Pre-Maintenance||2364
10724637|NCT01190930|11888502|FG003|COMPLETED|Post Induction Pre-Maintenance||207
10407748|NCT00750308|11551707|FG009|NOT COMPLETED|Washout||0
10407749|NCT00750308|11551708|FG010|NOT COMPLETED|Washout||0
10724638|NCT01190930|11888503|FG004|COMPLETED|Post Induction Pre-Maintenance||296
10724639|NCT01190930|11888504|FG005|COMPLETED|Post Induction Pre-Maintenance||296
10724640|NCT01190930|11888505|FG006|COMPLETED|Post Induction Pre-Maintenance||0
10724641|NCT01190930|11888506|FG007|COMPLETED|Post Induction Pre-Maintenance||0
10724642|NCT01190930|11888507|FG008|COMPLETED|Post Induction Pre-Maintenance||0
10724643|NCT01190930|11888508|FG009|COMPLETED|Post Induction Pre-Maintenance||0
10724644|NCT01190930|11888499|FG000|NOT COMPLETED|Post Induction Pre-Maintenance||0
10407750|NCT00750308|11551709|FG011|NOT COMPLETED|Washout||0
10407751|NCT00750308|11551698|FG000|STARTED|Fourth Treatment||2
10407752|NCT00750308|11551699|FG001|STARTED|Fourth Treatment||1
10407753|NCT00750308|11551700|FG002|STARTED|Fourth Treatment||2
10407754|NCT00750308|11551701|FG003|STARTED|Fourth Treatment||1
10407755|NCT00750308|11551702|FG004|STARTED|Fourth Treatment||1
10407756|NCT00750308|11551703|FG005|STARTED|Fourth Treatment||2
10407757|NCT00750308|11551704|FG006|STARTED|Fourth Treatment||2
10407758|NCT00750308|11551705|FG007|STARTED|Fourth Treatment||2
10407759|NCT00750308|11551706|FG008|STARTED|Fourth Treatment||1
10407760|NCT00750308|11551707|FG009|STARTED|Fourth Treatment||2
10407761|NCT00750308|11551708|FG010|STARTED|Fourth Treatment||1
10407762|NCT00750308|11551709|FG011|STARTED|Fourth Treatment||1
10407763|NCT00750308|11551698|FG000|COMPLETED|Fourth Treatment||2
10407764|NCT00750308|11551699|FG001|COMPLETED|Fourth Treatment||1
10407765|NCT00750308|11551700|FG002|COMPLETED|Fourth Treatment||2
10407766|NCT00750308|11551701|FG003|COMPLETED|Fourth Treatment||1
10407767|NCT00750308|11551702|FG004|COMPLETED|Fourth Treatment||1
10407768|NCT00750308|11551703|FG005|COMPLETED|Fourth Treatment||2
10407769|NCT00750308|11551704|FG006|COMPLETED|Fourth Treatment||2
10407770|NCT00750308|11551705|FG007|COMPLETED|Fourth Treatment||2
10407771|NCT00750308|11551706|FG008|COMPLETED|Fourth Treatment||1
10407772|NCT00750308|11551707|FG009|COMPLETED|Fourth Treatment||2
10724645|NCT01190930|11888500|FG001|NOT COMPLETED|Post Induction Pre-Maintenance||6
10724646|NCT01190930|11888501|FG002|NOT COMPLETED|Post Induction Pre-Maintenance||758
10724647|NCT01190930|11888502|FG003|NOT COMPLETED|Post Induction Pre-Maintenance||17
10724648|NCT01190930|11888503|FG004|NOT COMPLETED|Post Induction Pre-Maintenance||5
10724649|NCT01190930|11888504|FG005|NOT COMPLETED|Post Induction Pre-Maintenance||6
10724650|NCT01190930|11888505|FG006|NOT COMPLETED|Post Induction Pre-Maintenance||0
10724651|NCT01190930|11888506|FG007|NOT COMPLETED|Post Induction Pre-Maintenance||0
10724652|NCT01190930|11888507|FG008|NOT COMPLETED|Post Induction Pre-Maintenance||0
10724653|NCT01190930|11888508|FG009|NOT COMPLETED|Post Induction Pre-Maintenance||0
10724654|NCT01190930|11888499|FG000|STARTED|Maintenance||0
10724655|NCT01190930|11888500|FG001|STARTED|Maintenance||37
10724656|NCT01190930|11888501|FG002|STARTED|Maintenance||0
10724657|NCT01190930|11888502|FG003|STARTED|Maintenance||207
10724658|NCT01190930|11888503|FG004|STARTED|Maintenance||296
10724659|NCT01190930|11888504|FG005|STARTED|Maintenance||296
10724660|NCT01190930|11888505|FG006|STARTED|Maintenance||600
10724661|NCT01190930|11888506|FG007|STARTED|Maintenance||586
10724662|NCT01190930|11888507|FG008|STARTED|Maintenance||586
10724663|NCT01190930|11888508|FG009|STARTED|Maintenance||592
10724664|NCT01190930|11888499|FG000|COMPLETED|Maintenance||0
10724665|NCT01190930|11888500|FG001|COMPLETED|Maintenance||27
10724666|NCT01190930|11888501|FG002|COMPLETED|Maintenance||0
10724667|NCT01190930|11888502|FG003|COMPLETED|Maintenance||167
10724668|NCT01190930|11888503|FG004|COMPLETED|Maintenance||287
10724669|NCT01190930|11888504|FG005|COMPLETED|Maintenance||284
10724670|NCT01190930|11888505|FG006|COMPLETED|Maintenance||574
10724671|NCT01190930|11888506|FG007|COMPLETED|Maintenance||540
10724672|NCT01190930|11888507|FG008|COMPLETED|Maintenance||540
10724673|NCT01190930|11888508|FG009|COMPLETED|Maintenance||555
10724674|NCT01190930|11888499|FG000|NOT COMPLETED|Maintenance||0
10724675|NCT01190930|11888500|FG001|NOT COMPLETED|Maintenance||10
10724676|NCT01190930|11888501|FG002|NOT COMPLETED|Maintenance||0
10724677|NCT01190930|11888502|FG003|NOT COMPLETED|Maintenance||40
10724678|NCT01190930|11888503|FG004|NOT COMPLETED|Maintenance||9
10724679|NCT01190930|11888504|FG005|NOT COMPLETED|Maintenance||12
10724680|NCT01190930|11888505|FG006|NOT COMPLETED|Maintenance||26
10724681|NCT01190930|11888506|FG007|NOT COMPLETED|Maintenance||46
10724682|NCT01190930|11888507|FG008|NOT COMPLETED|Maintenance||46
10724683|NCT01190930|11888508|FG009|NOT COMPLETED|Maintenance||37
10724684|NCT01190306|11888534|FG000|STARTED|Overall Study||61
10724685|NCT01190306|11888535|FG001|STARTED|Overall Study||66
10724686|NCT01190306|11888534|FG000|COMPLETED|Overall Study||61
10724687|NCT01190306|11888535|FG001|COMPLETED|Overall Study||66
10724688|NCT01190306|11888534|FG000|NOT COMPLETED|Overall Study||0
10724689|NCT01190306|11888535|FG001|NOT COMPLETED|Overall Study||0
10724690|NCT00779324|11888543|FG000|STARTED|Overall Study||82
10724691|NCT00779324|11888544|FG001|STARTED|Overall Study||86
10724692|NCT00779324|11888543|FG000|Completed 28-day Mid-point|Overall Study||80
10724693|NCT00779324|11888544|FG001|Completed 28-day Mid-point|Overall Study||81
10724694|NCT00779324|11888543|FG000|COMPLETED|Overall Study||75
10724695|NCT00779324|11888544|FG001|COMPLETED|Overall Study||82
10724696|NCT00779324|11888543|FG000|NOT COMPLETED|Overall Study||7
10724697|NCT00779324|11888544|FG001|NOT COMPLETED|Overall Study||4
10724698|NCT00554788|11888553|FG000|STARTED|Overall Study||21
10724699|NCT00554788|11888554|FG001|STARTED|Overall Study||18
10724700|NCT00554788|11888555|FG002|STARTED|Overall Study||21
10724701|NCT00554788|11888553|FG000|COMPLETED|Overall Study||14
10724702|NCT00554788|11888554|FG001|COMPLETED|Overall Study||12
10724703|NCT00554788|11888555|FG002|COMPLETED|Overall Study||7
10724704|NCT00554788|11888553|FG000|NOT COMPLETED|Overall Study||7
10724705|NCT00554788|11888554|FG001|NOT COMPLETED|Overall Study||6
10724706|NCT00554788|11888555|FG002|NOT COMPLETED|Overall Study||14
10407773|NCT00750308|11551708|FG010|COMPLETED|Fourth Treatment||1
10407774|NCT00750308|11551709|FG011|COMPLETED|Fourth Treatment||1
10724707|NCT00553800|11888564|FG000|STARTED|Overall Study||32
10724708|NCT00553800|11888564|FG000|COMPLETED|Overall Study||32
10724709|NCT00553800|11888564|FG000|NOT COMPLETED|Overall Study||0
10724710|NCT00336024|11888570|FG000|STARTED|Overall Study||46
10724711|NCT00336024|11888571|FG001|STARTED|Overall Study||45
10724712|NCT00336024|11888570|FG000|COMPLETED|Overall Study||26
10724713|NCT00336024|11888571|FG001|COMPLETED|Overall Study||26
10724714|NCT00336024|11888570|FG000|NOT COMPLETED|Overall Study||20
10724715|NCT00336024|11888571|FG001|NOT COMPLETED|Overall Study||19
10724716|NCT00274937|11888577|FG000|STARTED|Overall Study||111
10724717|NCT00274937|11888577|FG000|COMPLETED|Overall Study||91
10724718|NCT00274937|11888577|FG000|NOT COMPLETED|Overall Study||20
10777489|NCT03341299|11939498|FG000|COMPLETED|Period 1||9
10312779|NCT00145145|11446235|FG000|COMPLETED|Overall Study||1
10312780|NCT00145145|11446235|FG000|NOT COMPLETED|Overall Study||0
10312781|NCT00145249|11446242|FG000|STARTED|Overall Study|47 subjects randomized; 45 subjects treated|47
10312782|NCT00145249|11446243|FG001|STARTED|Overall Study|48 subjects randomized; 47 subjects treated-2 subjects randomized to AmphoB rec'd AmphoB+Fluc400|48
10312783|NCT00145249|11446244|FG002|STARTED|Overall Study|48 subjects randomized; 49 treated-3 subjects randomized to AmphoB+Fluc400 rec'd AmphoB+Fluc800|48
10312784|NCT00145249|11446242|FG000|COMPLETED|Overall Study||36
10312785|NCT00145249|11446243|FG001|COMPLETED|Overall Study||33
10312786|NCT00145249|11446244|FG002|COMPLETED|Overall Study||31
10312787|NCT00145249|11446242|FG000|NOT COMPLETED|Overall Study||11
10312788|NCT00145249|11446243|FG001|NOT COMPLETED|Overall Study||15
10312789|NCT00145249|11446244|FG002|NOT COMPLETED|Overall Study||17
10312790|NCT00145327|11446255|FG000|STARTED|Overall Study|Group Z6 and Group Z3P3 have randomized participants.|616
10312791|NCT00145327|11446256|FG001|STARTED|Overall Study||617
10312792|NCT00145327|11446257|FG002|STARTED|Overall Study|Group P3Z3 have non-randomized participants|1223
10312793|NCT00145327|11446255|FG000|COMPLETED|Overall Study||474
10312794|NCT00145327|11446256|FG001|COMPLETED|Overall Study||493
10312795|NCT00145327|11446257|FG002|COMPLETED|Overall Study||975
10312796|NCT00145327|11446255|FG000|NOT COMPLETED|Overall Study||142
10312797|NCT00145327|11446256|FG001|NOT COMPLETED|Overall Study||124
10312798|NCT00145327|11446257|FG002|NOT COMPLETED|Overall Study||248
10312799|NCT00145418|11446265|FG000|STARTED|Overall Study||15
10312800|NCT00145418|11446265|FG000|COMPLETED|Overall Study||15
10312801|NCT00145418|11446265|FG000|NOT COMPLETED|Overall Study||0
10312802|NCT00145574|11446272|FG000|STARTED|Double Blind||65
10312803|NCT00145574|11446273|FG001|STARTED|Double Blind||65
10312804|NCT00145574|11446274|FG002|STARTED|Double Blind||64
10312805|NCT00145574|11446272|FG000|COMPLETED|Double Blind||64
10312806|NCT00145574|11446273|FG001|COMPLETED|Double Blind||60
10312807|NCT00145574|11446274|FG002|COMPLETED|Double Blind||62
10312808|NCT00145574|11446272|FG000|NOT COMPLETED|Double Blind||1
10312809|NCT00145574|11446273|FG001|NOT COMPLETED|Double Blind||5
10312810|NCT00145574|11446274|FG002|NOT COMPLETED|Double Blind||2
10312811|NCT00145574|11446272|FG000|STARTED|Open Label Long-term Extension||0
10312812|NCT00145574|11446273|FG001|STARTED|Open Label Long-term Extension||0
10312813|NCT00145574|11446274|FG002|STARTED|Open Label Long-term Extension|2 participants discontinued after completing double-blind but before starting open label.|184
10312814|NCT00145574|11446272|FG000|COMPLETED|Open Label Long-term Extension||0
10312815|NCT00145574|11446273|FG001|COMPLETED|Open Label Long-term Extension||0
10312816|NCT00145574|11446274|FG002|COMPLETED|Open Label Long-term Extension||173
10312817|NCT00145574|11446272|FG000|NOT COMPLETED|Open Label Long-term Extension||0
10312818|NCT00145574|11446273|FG001|NOT COMPLETED|Open Label Long-term Extension||0
10312819|NCT00145574|11446274|FG002|NOT COMPLETED|Open Label Long-term Extension||11
10312820|NCT00145587|11446289|FG000|STARTED|Overall Study||5
10312821|NCT00145587|11446290|FG001|STARTED|Overall Study||1
10312822|NCT00145587|11446289|FG000|COMPLETED|Overall Study||5
10312823|NCT00145587|11446290|FG001|COMPLETED|Overall Study||1
10312824|NCT00145587|11446289|FG000|NOT COMPLETED|Overall Study||0
10312825|NCT00145587|11446290|FG001|NOT COMPLETED|Overall Study||0
10312826|NCT00145626|11446298|FG000|STARTED|Overall Study||19
10312827|NCT00145626|11446298|FG000|COMPLETED|Overall Study||14
10312828|NCT00145626|11446298|FG000|NOT COMPLETED|Overall Study||5
10312829|NCT00145977|11446320|FG000|STARTED|Overall Study||19
10312830|NCT00145977|11446321|FG001|STARTED|Overall Study||17
10312831|NCT00145977|11446320|FG000|COMPLETED|Overall Study||17
10312832|NCT00145977|11446321|FG001|COMPLETED|Overall Study||13
10312833|NCT00145977|11446320|FG000|NOT COMPLETED|Overall Study||2
10312834|NCT00145977|11446321|FG001|NOT COMPLETED|Overall Study||4
10312835|NCT00146172|11446335|FG000|STARTED|Overall Study||3
10312836|NCT00146172|11446336|FG001|STARTED|Overall Study||4
10312837|NCT00146172|11446337|FG002|STARTED|Overall Study||4
10312838|NCT00146172|11446338|FG003|STARTED|Overall Study||6
10312839|NCT00146172|11446339|FG004|STARTED|Overall Study||3
10312840|NCT00146172|11446340|FG005|STARTED|Overall Study||7
10312841|NCT00146172|11446341|FG006|STARTED|Overall Study||6
10312842|NCT00146172|11446342|FG007|STARTED|Overall Study||40
10312843|NCT00146172|11446335|FG000|Received Drug|Overall Study||3
10312844|NCT00146172|11446336|FG001|Received Drug|Overall Study||4
10312845|NCT00146172|11446337|FG002|Received Drug|Overall Study||4
10312846|NCT00146172|11446338|FG003|Received Drug|Overall Study||6
10312847|NCT00146172|11446339|FG004|Received Drug|Overall Study||3
10407775|NCT00750308|11551698|FG000|NOT COMPLETED|Fourth Treatment||0
10407776|NCT00750308|11551699|FG001|NOT COMPLETED|Fourth Treatment||0
10407777|NCT00750308|11551700|FG002|NOT COMPLETED|Fourth Treatment||0
10407778|NCT00750308|11551701|FG003|NOT COMPLETED|Fourth Treatment||0
10407779|NCT00750308|11551702|FG004|NOT COMPLETED|Fourth Treatment||0
10407780|NCT00750308|11551703|FG005|NOT COMPLETED|Fourth Treatment||0
10407781|NCT00750308|11551704|FG006|NOT COMPLETED|Fourth Treatment||0
10407782|NCT00750308|11551705|FG007|NOT COMPLETED|Fourth Treatment||0
10407783|NCT00750308|11551706|FG008|NOT COMPLETED|Fourth Treatment||0
10407784|NCT00750308|11551707|FG009|NOT COMPLETED|Fourth Treatment||0
10407785|NCT00750308|11551708|FG010|NOT COMPLETED|Fourth Treatment||0
10407786|NCT00750308|11551709|FG011|NOT COMPLETED|Fourth Treatment||0
10407787|NCT00750360|11551729|FG000|STARTED|Overall Study|"Seven subjects enrolled in this group were not vaccinated and as such not included as STARTED."|294
10407788|NCT00750360|11551730|FG001|STARTED|Overall Study|"One subject enrolled in this group was not vaccinated and as such not included as STARTED."|1
10407789|NCT00750360|11551731|FG002|STARTED|Overall Study||384
10407790|NCT00750360|11551732|FG003|STARTED|Overall Study||79
10407791|NCT00750360|11551733|FG004|STARTED|Overall Study||46
10312848|NCT00146172|11446340|FG005|Received Drug|Overall Study||7
10312849|NCT00146172|11446341|FG006|Received Drug|Overall Study||6
10312850|NCT00146172|11446342|FG007|Received Drug|Overall Study||39
10312851|NCT00146172|11446335|FG000|COMPLETED|Overall Study||0
10312852|NCT00146172|11446336|FG001|COMPLETED|Overall Study||0
10407792|NCT00750360|11551734|FG005|STARTED|Overall Study||71
10407793|NCT00750360|11551729|FG000|COMPLETED|Overall Study||294
10407794|NCT00750360|11551730|FG001|COMPLETED|Overall Study||1
10407795|NCT00750360|11551731|FG002|COMPLETED|Overall Study||384
10407796|NCT00750360|11551732|FG003|COMPLETED|Overall Study||79
10407797|NCT00750360|11551733|FG004|COMPLETED|Overall Study||46
10407798|NCT00750360|11551734|FG005|COMPLETED|Overall Study||71
10407799|NCT00750360|11551729|FG000|NOT COMPLETED|Overall Study||0
10407800|NCT00750360|11551730|FG001|NOT COMPLETED|Overall Study||0
10407801|NCT00750360|11551731|FG002|NOT COMPLETED|Overall Study||0
10407802|NCT00750360|11551732|FG003|NOT COMPLETED|Overall Study||0
10407803|NCT00750360|11551733|FG004|NOT COMPLETED|Overall Study||0
10407804|NCT00750360|11551734|FG005|NOT COMPLETED|Overall Study||0
10407805|NCT00750373|11551756|FG000|STARTED|Overall Study||39
10407806|NCT00750373|11551757|FG001|STARTED|Overall Study||37
10724719|NCT02737722|11888585|FG000|STARTED|Overall Study||8
10724720|NCT02737722|11888586|FG001|STARTED|Overall Study||8
10724721|NCT02737722|11888587|FG002|STARTED|Overall Study||8
10724722|NCT02737722|11888588|FG003|STARTED|Overall Study||6
10724723|NCT02737722|11888585|FG000|COMPLETED|Overall Study||8
10724724|NCT02737722|11888586|FG001|COMPLETED|Overall Study||8
10724725|NCT02737722|11888587|FG002|COMPLETED|Overall Study||7
10724726|NCT02737722|11888588|FG003|COMPLETED|Overall Study||6
10724727|NCT02737722|11888585|FG000|NOT COMPLETED|Overall Study||0
10724728|NCT02737722|11888586|FG001|NOT COMPLETED|Overall Study||0
10724729|NCT02737722|11888587|FG002|NOT COMPLETED|Overall Study||1
10724730|NCT02737722|11888588|FG003|NOT COMPLETED|Overall Study||0
10724731|NCT02737826|11888598|FG000|STARTED|Phase I - Buprenorphine Initiation||27
10724732|NCT02737826|11888599|FG001|STARTED|Phase I - Buprenorphine Initiation||0
10724733|NCT02737826|11888600|FG002|STARTED|Phase I - Buprenorphine Initiation||0
10724734|NCT02737826|11888598|FG000|COMPLETED|Phase I - Buprenorphine Initiation||27
10724735|NCT02737826|11888599|FG001|COMPLETED|Phase I - Buprenorphine Initiation||0
10724736|NCT02737826|11888600|FG002|COMPLETED|Phase I - Buprenorphine Initiation||0
10724737|NCT02737826|11888598|FG000|NOT COMPLETED|Phase I - Buprenorphine Initiation||0
10724738|NCT02737826|11888599|FG001|NOT COMPLETED|Phase I - Buprenorphine Initiation||0
10724739|NCT02737826|11888600|FG002|NOT COMPLETED|Phase I - Buprenorphine Initiation||0
10724740|NCT02737826|11888598|FG000|STARTED|Phase II - Randomization + Taper||0
10724741|NCT02737826|11888599|FG001|STARTED|Phase II - Randomization + Taper||13
10724742|NCT02737826|11888600|FG002|STARTED|Phase II - Randomization + Taper||14
10312853|NCT00146172|11446337|FG002|COMPLETED|Overall Study||0
10312854|NCT00146172|11446338|FG003|COMPLETED|Overall Study||0
10312855|NCT00146172|11446339|FG004|COMPLETED|Overall Study||0
10312856|NCT00146172|11446340|FG005|COMPLETED|Overall Study||0
10407807|NCT00750373|11551756|FG000|COMPLETED|Overall Study||39
10407808|NCT00750373|11551757|FG001|COMPLETED|Overall Study||37
10407809|NCT00750373|11551756|FG000|NOT COMPLETED|Overall Study||0
10407810|NCT00750373|11551757|FG001|NOT COMPLETED|Overall Study||0
10407811|NCT00750438|11551765|FG000|STARTED|Overall Study||31
10724743|NCT02737826|11888598|FG000|COMPLETED|Phase II - Randomization + Taper||0
10724744|NCT02737826|11888599|FG001|COMPLETED|Phase II - Randomization + Taper||1
10724745|NCT02737826|11888600|FG002|COMPLETED|Phase II - Randomization + Taper||0
10724746|NCT02737826|11888598|FG000|NOT COMPLETED|Phase II - Randomization + Taper||0
10724747|NCT02737826|11888599|FG001|NOT COMPLETED|Phase II - Randomization + Taper||12
10724748|NCT02737826|11888600|FG002|NOT COMPLETED|Phase II - Randomization + Taper||14
10312857|NCT00146172|11446341|FG006|COMPLETED|Overall Study||0
10312858|NCT00146172|11446342|FG007|COMPLETED|Overall Study||0
10312859|NCT00146172|11446335|FG000|NOT COMPLETED|Overall Study||3
10407812|NCT00750438|11551766|FG001|STARTED|Overall Study||29
10407813|NCT00750438|11551765|FG000|COMPLETED|Overall Study||24
10407814|NCT00750438|11551766|FG001|COMPLETED|Overall Study||25
10407815|NCT00750438|11551765|FG000|NOT COMPLETED|Overall Study||7
10407816|NCT00750438|11551766|FG001|NOT COMPLETED|Overall Study||4
10407817|NCT00750737|11551774|FG000|STARTED|Overall Study||24
10407818|NCT00750737|11551775|FG001|STARTED|Overall Study||22
10407819|NCT00750737|11551774|FG000|COMPLETED|Overall Study||21
10407820|NCT00750737|11551775|FG001|COMPLETED|Overall Study||19
10407821|NCT00750737|11551774|FG000|NOT COMPLETED|Overall Study||3
10407822|NCT00750737|11551775|FG001|NOT COMPLETED|Overall Study||3
10407823|NCT00750815|11551783|FG000|STARTED|Overall Study||12
10407824|NCT00750815|11551784|FG001|STARTED|Overall Study||46
10407825|NCT00750815|11551783|FG000|COMPLETED|Overall Study||12
10407826|NCT00750815|11551784|FG001|COMPLETED|Overall Study||46
10407827|NCT00750815|11551783|FG000|NOT COMPLETED|Overall Study||0
10407828|NCT00750815|11551784|FG001|NOT COMPLETED|Overall Study||0
10407829|NCT00750867|11551794|FG000|STARTED|Overall Study||9
10407830|NCT00750867|11551794|FG000|COMPLETED|Overall Study||7
10407831|NCT00750867|11551794|FG000|NOT COMPLETED|Overall Study||2
10407832|NCT00750880|11551798|FG000|STARTED|Overall Study||1681
10407833|NCT00750880|11551798|FG000|COMPLETED|Overall Study||1466
10407834|NCT00750880|11551798|FG000|NOT COMPLETED|Overall Study||215
10407835|NCT00750893|11551803|FG000|STARTED|Overall Study||3111
10407836|NCT00750893|11551803|FG000|COMPLETED|Overall Study||2569
10407837|NCT00750893|11551803|FG000|NOT COMPLETED|Overall Study||542
10407838|NCT00750919|11551807|FG000|STARTED|Overall Study||184
10407839|NCT00750919|11551807|FG000|COMPLETED|Overall Study||126
10407840|NCT00750919|11551807|FG000|NOT COMPLETED|Overall Study||58
10407841|NCT00751023|11551813|FG000|STARTED|Overall Study||20
10407842|NCT00751023|11551814|FG001|STARTED|Overall Study||20
10407843|NCT00751023|11551813|FG000|COMPLETED|Overall Study||9
10407844|NCT00751023|11551814|FG001|COMPLETED|Overall Study||13
10407845|NCT00751023|11551813|FG000|NOT COMPLETED|Overall Study||11
10407846|NCT00751023|11551814|FG001|NOT COMPLETED|Overall Study||7
10407847|NCT00751036|11551822|FG000|STARTED|Overall Study|Started = Treated|48
10407848|NCT00751036|11551823|FG001|STARTED|Overall Study|Started = Treated|46
10407849|NCT00751036|11551822|FG000|COMPLETED|Overall Study|Reason Not Completed = Reason for End of Treatment|0
10407850|NCT00751036|11551823|FG001|COMPLETED|Overall Study|Reason Not Completed = Reason for End of Treatment|0
10407851|NCT00751036|11551822|FG000|NOT COMPLETED|Overall Study||48
10407852|NCT00751036|11551823|FG001|NOT COMPLETED|Overall Study||46
10407853|NCT00751101|11551831|FG000|STARTED|Overall Study||12
10407854|NCT00751101|11551832|FG001|STARTED|Overall Study||12
10407855|NCT00751101|11551831|FG000|Started Capecitabine|Overall Study||11
10407856|NCT00751101|11551832|FG001|Started Capecitabine|Overall Study||11
10407857|NCT00751101|11551831|FG000|COMPLETED|Overall Study||10
10407858|NCT00751101|11551832|FG001|COMPLETED|Overall Study||7
10407859|NCT00751101|11551831|FG000|NOT COMPLETED|Overall Study||2
10407860|NCT00751101|11551832|FG001|NOT COMPLETED|Overall Study||5
10407861|NCT00751114|11551844|FG000|STARTED|Overall Study|randomized|250
10407862|NCT00751114|11551845|FG001|STARTED|Overall Study||265
10407863|NCT00751114|11551844|FG000|TREATED = Safety Population|Overall Study|safety population: randomized patients who received at least one dose of investigational product|237
10407864|NCT00751114|11551845|FG001|TREATED = Safety Population|Overall Study||264
10407865|NCT00751114|11551844|FG000|mITT Population|Overall Study|modified Intent-To-Treat population: treated patients with at least 1 on-treatment efficacy measure|227
10407866|NCT00751114|11551845|FG001|mITT Population|Overall Study||253
10407867|NCT00751114|11551844|FG000|COMPLETED|Overall Study||212
10407868|NCT00751114|11551845|FG001|COMPLETED|Overall Study||233
10407869|NCT00751114|11551844|FG000|NOT COMPLETED|Overall Study||38
10407870|NCT00751114|11551845|FG001|NOT COMPLETED|Overall Study||32
10407871|NCT00751140|11551851|FG000|STARTED|Overall Study||20
10407872|NCT00751140|11551851|FG000|COMPLETED|Overall Study||19
10407873|NCT00751140|11551851|FG000|NOT COMPLETED|Overall Study||1
10407874|NCT00751179|11551861|FG000|STARTED|Overall Study|10 of 76 randomized were not treated with sugammadex; 4 of these 10 received rocuronium only|76
10407875|NCT00751179|11551862|FG001|STARTED|Overall Study|5 of 85 randomized were not treated with succinylcholine|85
10407876|NCT00751179|11551861|FG000|COMPLETED|Overall Study||62
10407877|NCT00751179|11551862|FG001|COMPLETED|Overall Study||70
10407878|NCT00751179|11551861|FG000|NOT COMPLETED|Overall Study||14
10407879|NCT00751179|11551862|FG001|NOT COMPLETED|Overall Study||15
10407880|NCT00751296|11551869|FG000|STARTED|Overall Study|The start date of the study was 25 August 2006.|27
10407881|NCT00751296|11551869|FG000|COMPLETED|Overall Study||25
10407882|NCT00751296|11551869|FG000|NOT COMPLETED|Overall Study||2
10407883|NCT00751348|11551875|FG000|STARTED|Overall Study||313
10407884|NCT00751348|11551876|FG001|STARTED|Overall Study||161
10407885|NCT00751348|11551875|FG000|COMPLETED|Overall Study||307
10407886|NCT00751348|11551876|FG001|COMPLETED|Overall Study||159
10407887|NCT00751348|11551875|FG000|NOT COMPLETED|Overall Study||6
10407888|NCT00751348|11551876|FG001|NOT COMPLETED|Overall Study||2
10407889|NCT00751400|11551882|FG000|STARTED|Overall Study||497
10407890|NCT00751400|11551882|FG000|Subjects Provided Drug|Overall Study||497
10407891|NCT00751400|11551882|FG000|Subjects Consumed Drug|Overall Study||485
10407892|NCT00751400|11551882|FG000|Subjects Provided Detailed Use Data|Overall Study||467
10407893|NCT00751400|11551882|FG000|COMPLETED|Overall Study||487
10407894|NCT00751400|11551882|FG000|NOT COMPLETED|Overall Study||10
10407895|NCT00751530|11551888|FG000|STARTED|Overall Study||332
10407896|NCT00751530|11551889|FG001|STARTED|Overall Study||110
10407897|NCT00751530|11551888|FG000|COMPLETED|Overall Study||332
10724749|NCT02737852|11888609|FG000|STARTED|Overall Study||32
10724750|NCT02737852|11888609|FG000|COMPLETED|Overall Study||30
10724751|NCT02737852|11888609|FG000|NOT COMPLETED|Overall Study||2
10724752|NCT02737891|11888615|FG000|STARTED|Overall Study||30
10724753|NCT02737891|11888616|FG001|STARTED|Overall Study||30
10724754|NCT02737891|11888615|FG000|COMPLETED|Overall Study||30
10724755|NCT02737891|11888616|FG001|COMPLETED|Overall Study||28
10724756|NCT02737891|11888615|FG000|NOT COMPLETED|Overall Study||0
10724757|NCT02737891|11888616|FG001|NOT COMPLETED|Overall Study||2
10724758|NCT02737917|11888624|FG000|STARTED|Overall Study||103
10724759|NCT02737917|11888625|FG001|STARTED|Overall Study||103
10724760|NCT02737917|11888624|FG000|COMPLETED|Overall Study||100
10814567|NCT02299934|11977356|FG000|NOT COMPLETED|Overall Study||13
10814568|NCT02297230|11977364|FG000|STARTED|Overall Study||11
10814569|NCT02297230|11977365|FG001|STARTED|Overall Study||11
10814570|NCT02297230|11977366|FG002|STARTED|Overall Study||11
10724761|NCT02737917|11888625|FG001|COMPLETED|Overall Study||100
10724762|NCT02737917|11888624|FG000|NOT COMPLETED|Overall Study||3
10724763|NCT02737917|11888625|FG001|NOT COMPLETED|Overall Study||3
10724764|NCT02737930|11888633|FG000|STARTED|Overall Study||5
10724765|NCT02737930|11888634|FG001|STARTED|Overall Study||7
10724766|NCT02737930|11888633|FG000|COMPLETED|Overall Study||5
10724767|NCT02737930|11888634|FG001|COMPLETED|Overall Study||6
10724768|NCT02737930|11888633|FG000|NOT COMPLETED|Overall Study||0
10724769|NCT02737930|11888634|FG001|NOT COMPLETED|Overall Study||1
10724770|NCT02738008|11888643|FG000|STARTED|Overall Study||1
10724771|NCT02738008|11888644|FG001|STARTED|Overall Study||6
10724772|NCT02738008|11888645|FG002|STARTED|Overall Study||5
10724773|NCT02738008|11888643|FG000|COMPLETED|Overall Study||0
10724774|NCT02738008|11888644|FG001|COMPLETED|Overall Study||0
10724775|NCT02738008|11888645|FG002|COMPLETED|Overall Study||0
10724776|NCT02738008|11888643|FG000|NOT COMPLETED|Overall Study||1
10724777|NCT02738008|11888644|FG001|NOT COMPLETED|Overall Study||6
10724778|NCT02738008|11888645|FG002|NOT COMPLETED|Overall Study||5
10724779|NCT02738086|11888655|FG000|STARTED|Overall Study||16
10724780|NCT02738086|11888656|FG001|STARTED|Overall Study||15
10724781|NCT02738086|11888655|FG000|COMPLETED|Overall Study||14
10724782|NCT02738086|11888656|FG001|COMPLETED|Overall Study||13
10724783|NCT02738086|11888655|FG000|NOT COMPLETED|Overall Study||2
10724784|NCT02738086|11888656|FG001|NOT COMPLETED|Overall Study||2
10724785|NCT02738138|11888667|FG000|STARTED|Overall Study||137
10724786|NCT02738138|11888668|FG001|STARTED|Overall Study||16
10724787|NCT02738138|11888667|FG000|COMPLETED|Overall Study||134
10724788|NCT02738138|11888668|FG001|COMPLETED|Overall Study||15
10724789|NCT02738138|11888667|FG000|NOT COMPLETED|Overall Study||3
10724790|NCT02738138|11888668|FG001|NOT COMPLETED|Overall Study||1
10724791|NCT02738151|11888675|FG000|STARTED|Overall Study||466
10724792|NCT02738151|11888676|FG001|STARTED|Overall Study||463
10724793|NCT02738151|11888675|FG000|Treated|Overall Study||462
10724794|NCT02738151|11888676|FG001|Treated|Overall Study||462
10724795|NCT02738151|11888675|FG000|COMPLETED|Overall Study||443
10724796|NCT02738151|11888676|FG001|COMPLETED|Overall Study||432
10724797|NCT02738151|11888675|FG000|NOT COMPLETED|Overall Study||23
10724798|NCT02738151|11888676|FG001|NOT COMPLETED|Overall Study||31
10724799|NCT02738203|11888684|FG000|STARTED|Overall Study||110
10724800|NCT02738203|11888685|FG001|STARTED|Overall Study||110
10724801|NCT02738203|11888684|FG000|COMPLETED|Overall Study||108
10724802|NCT02738203|11888685|FG001|COMPLETED|Overall Study||107
10724803|NCT02738203|11888684|FG000|NOT COMPLETED|Overall Study||2
10724804|NCT02738203|11888685|FG001|NOT COMPLETED|Overall Study||3
10724805|NCT02738333|11888694|FG000|STARTED|Overall Study||106
10724806|NCT02738333|11888695|FG001|STARTED|Overall Study||108
10724807|NCT02738333|11888696|FG002|STARTED|Overall Study||25
10724808|NCT02738333|11888694|FG000|COMPLETED|Overall Study||104
10724809|NCT02738333|11888695|FG001|COMPLETED|Overall Study||108
10724810|NCT02738333|11888696|FG002|COMPLETED|Overall Study||25
10724811|NCT02738333|11888694|FG000|NOT COMPLETED|Overall Study||2
10724812|NCT02738333|11888695|FG001|NOT COMPLETED|Overall Study||0
10724813|NCT02738333|11888696|FG002|NOT COMPLETED|Overall Study||0
10724814|NCT02738450|11888708|FG000|STARTED|Overall Study||6
10724815|NCT02738450|11888709|FG001|STARTED|Overall Study||6
10724816|NCT02738450|11888710|FG002|STARTED|Overall Study||4
10724817|NCT02738450|11888708|FG000|COMPLETED|Overall Study||6
10724818|NCT02738450|11888709|FG001|COMPLETED|Overall Study||4
10724819|NCT02738450|11888710|FG002|COMPLETED|Overall Study||4
10724820|NCT02738450|11888708|FG000|NOT COMPLETED|Overall Study||0
10724821|NCT02738450|11888709|FG001|NOT COMPLETED|Overall Study||2
10724822|NCT02738450|11888710|FG002|NOT COMPLETED|Overall Study||0
10724823|NCT02738580|11888721|FG000|STARTED|Overall Study|56 patients were assigned to this arms.|56
10724824|NCT02738580|11888722|FG001|STARTED|Overall Study||56
10724825|NCT02738580|11888721|FG000|COMPLETED|Overall Study|"3 cycles cancelled due to por response to stimullation.~1 cycle cancelled due to SAE."|52
10724826|NCT02738580|11888722|FG001|COMPLETED|Overall Study|"2 cycles cancelled due to por response to stimullation~1 patient withdrawal~1 excluded"|52
10724827|NCT02738580|11888721|FG000|NOT COMPLETED|Overall Study||4
10724828|NCT02738580|11888722|FG001|NOT COMPLETED|Overall Study||4
10814571|NCT02297230|11977367|FG003|STARTED|Overall Study||11
10724829|NCT02738775|11888734|FG000|STARTED|Overall Study||8
10724830|NCT02738775|11888735|FG001|STARTED|Overall Study||8
10724831|NCT02738775|11888736|FG002|STARTED|Overall Study||8
10724832|NCT02738775|11888737|FG003|STARTED|Overall Study||9
10724833|NCT02738775|11888738|FG004|STARTED|Overall Study||8
10724834|NCT02738775|11888739|FG005|STARTED|Overall Study||8
10407898|NCT00751530|11551889|FG001|COMPLETED|Overall Study||110
10407899|NCT00751530|11551888|FG000|NOT COMPLETED|Overall Study||0
10407900|NCT00751530|11551889|FG001|NOT COMPLETED|Overall Study||0
10407901|NCT00751621|11551895|FG000|STARTED|Overall Study||40
10407902|NCT00751621|11551895|FG000|COMPLETED|Overall Study||36
10407903|NCT00751621|11551895|FG000|NOT COMPLETED|Overall Study||4
10407904|NCT00751634|11551901|FG000|STARTED|Overall Study||20
10407905|NCT00751634|11551901|FG000|COMPLETED|Overall Study||20
10407906|NCT00751634|11551901|FG000|NOT COMPLETED|Overall Study||0
10407907|NCT00751777|11551908|FG000|STARTED|Overall Study||81
10407908|NCT00751777|11551909|FG001|STARTED|Overall Study||39
10407909|NCT00751777|11551908|FG000|COMPLETED|Overall Study|Day 380: study completion for LT group|70
10407910|NCT00751777|11551909|FG001|COMPLETED|Overall Study|Day 194: study completion for placebo group|36
10407911|NCT00751777|11551908|FG000|NOT COMPLETED|Overall Study||11
10407912|NCT00751777|11551909|FG001|NOT COMPLETED|Overall Study||3
10407913|NCT00751790|11551915|FG000|STARTED|Overall Study||120
10407914|NCT00751790|11551915|FG000|COMPLETED|Overall Study||115
10407915|NCT00751790|11551915|FG000|NOT COMPLETED|Overall Study||5
10407916|NCT00751881|11551922|FG000|STARTED|Core Treatment Period|Randomized|389
10407917|NCT00751881|11551923|FG001|STARTED|Core Treatment Period|Randomized|408
10407918|NCT00751881|11551924|FG002|STARTED|Core Treatment Period|Randomized|372
10407919|NCT00751881|11551922|FG000|Treated|Core Treatment Period|1 participant received teriflunomide 7 mg and 2 participants teriflunomide 14 mg (at least 1 dose)|388
10407920|NCT00751881|11551923|FG001|Treated|Core Treatment Period|1 participant received placebo (at least 1 dose)|407
10407921|NCT00751881|11551924|FG002|Treated|Core Treatment Period|1 participant received teriflunomide 7 mg and 1 participant placebo (at least 1 dose)|370
10407922|NCT00751881|11551922|FG000|COMPLETED|Core Treatment Period||263
10407923|NCT00751881|11551923|FG001|COMPLETED|Core Treatment Period||273
10407924|NCT00751881|11551924|FG002|COMPLETED|Core Treatment Period||244
10407925|NCT00751881|11551922|FG000|NOT COMPLETED|Core Treatment Period||126
10407926|NCT00751881|11551923|FG001|NOT COMPLETED|Core Treatment Period||135
10407927|NCT00751881|11551924|FG002|NOT COMPLETED|Core Treatment Period||128
10407928|NCT00751881|11551922|FG000|STARTED|Extension Study Period|10 participants completed core treatment period but did not enter in extension treatment period.|253
10407929|NCT00751881|11551923|FG001|STARTED|Extension Study Period|8 participants completed core treatment period but did not enter in extension treatment period.|265
10407930|NCT00751881|11551924|FG002|STARTED|Extension Study Period|11 participants completed core treatment period but did not enter in extension treatment period.|233
10407931|NCT00751881|11551922|FG000|COMPLETED|Extension Study Period||188
10407932|NCT00751881|11551923|FG001|COMPLETED|Extension Study Period||194
10407933|NCT00751881|11551924|FG002|COMPLETED|Extension Study Period||167
10407934|NCT00751881|11551922|FG000|NOT COMPLETED|Extension Study Period||65
10407935|NCT00751881|11551923|FG001|NOT COMPLETED|Extension Study Period||71
10407936|NCT00751881|11551924|FG002|NOT COMPLETED|Extension Study Period||66
10407937|NCT00751972|11551940|FG000|STARTED|Overall Study||140
10407938|NCT00751972|11551941|FG001|STARTED|Overall Study||499
10407939|NCT00751972|11551940|FG000|COMPLETED|Overall Study||140
10407940|NCT00751972|11551941|FG001|COMPLETED|Overall Study||499
10724835|NCT02738775|11888734|FG000|Initially Treated With Placebo|Overall Study||0
10724836|NCT02738775|11888735|FG001|Initially Treated With Placebo|Overall Study||0
10724837|NCT02738775|11888736|FG002|Initially Treated With Placebo|Overall Study||0
10724838|NCT02738775|11888737|FG003|Initially Treated With Placebo|Overall Study||1
10724839|NCT02738775|11888738|FG004|Initially Treated With Placebo|Overall Study||0
10724840|NCT02738775|11888739|FG005|Initially Treated With Placebo|Overall Study||0
10724841|NCT02738775|11888734|FG000|COMPLETED|Overall Study||8
10724842|NCT02738775|11888735|FG001|COMPLETED|Overall Study||6
10724843|NCT02738775|11888736|FG002|COMPLETED|Overall Study||8
10724844|NCT02738775|11888737|FG003|COMPLETED|Overall Study||8
10724845|NCT02738775|11888738|FG004|COMPLETED|Overall Study||8
10724846|NCT02738775|11888739|FG005|COMPLETED|Overall Study||7
10724847|NCT02738775|11888734|FG000|NOT COMPLETED|Overall Study||0
10724848|NCT02738775|11888735|FG001|NOT COMPLETED|Overall Study||2
10724849|NCT02738775|11888736|FG002|NOT COMPLETED|Overall Study||0
10724850|NCT02738775|11888737|FG003|NOT COMPLETED|Overall Study||1
10724851|NCT02738775|11888738|FG004|NOT COMPLETED|Overall Study||0
10724852|NCT02738775|11888739|FG005|NOT COMPLETED|Overall Study||1
10724853|NCT02738801|11888759|FG000|STARTED|Overall Study||6
10724854|NCT02738801|11888760|FG001|STARTED|Overall Study||17
10724855|NCT02738801|11888759|FG000|COMPLETED|Overall Study||5
10724856|NCT02738801|11888760|FG001|COMPLETED|Overall Study||15
10724857|NCT02738801|11888759|FG000|NOT COMPLETED|Overall Study||1
10724858|NCT02738801|11888760|FG001|NOT COMPLETED|Overall Study||2
10724859|NCT02738840|11888767|FG000|STARTED|Overall Study||56
10724860|NCT02738840|11888767|FG000|COMPLETED|Overall Study||48
10724861|NCT02738840|11888767|FG000|NOT COMPLETED|Overall Study||8
10724862|NCT02738879|11888773|FG000|STARTED|Overall Study||374
10724863|NCT02738879|11888774|FG001|STARTED|Overall Study||372
10724864|NCT02738879|11888773|FG000|Treated|Overall Study||373
10724865|NCT02738879|11888774|FG001|Treated|Overall Study||370
10724866|NCT02738879|11888773|FG000|COMPLETED|Overall Study||361
10407941|NCT00751972|11551940|FG000|NOT COMPLETED|Overall Study||0
10407942|NCT00751972|11551941|FG001|NOT COMPLETED|Overall Study||0
10407943|NCT00751998|11551946|FG000|STARTED|Overall Study||297
10407944|NCT00751998|11551946|FG000|COMPLETED|Overall Study||277
10407945|NCT00751998|11551946|FG000|NOT COMPLETED|Overall Study||20
10724867|NCT02738879|11888774|FG001|COMPLETED|Overall Study||347
10724868|NCT02738879|11888773|FG000|NOT COMPLETED|Overall Study||13
10407946|NCT00752089|11551950|FG000|STARTED|Overall Study||20
10724869|NCT02738879|11888774|FG001|NOT COMPLETED|Overall Study||25
10724870|NCT02739100|11888780|FG000|STARTED|Overall Study||13
10724871|NCT02739100|11888780|FG000|Triferic 2 Micromolar Via Hemodialysate|Overall Study||13
10724872|NCT02739100|11888780|FG000|Triferic 6.6 mg IV Predialyzer|Overall Study||13
10724873|NCT02739100|11888780|FG000|Triferic 6.6. mg IV Post-dialyzer|Overall Study||13
10724874|NCT02739100|11888780|FG000|COMPLETED|Overall Study||13
10724875|NCT02739100|11888780|FG000|NOT COMPLETED|Overall Study||0
10724876|NCT02739269|11888790|FG000|STARTED|Overall Study||100
10724877|NCT02739269|11888791|FG001|STARTED|Overall Study||100
10724878|NCT02739269|11888790|FG000|COMPLETED|Overall Study||93
10724879|NCT02739269|11888791|FG001|COMPLETED|Overall Study||96
10724880|NCT02739269|11888790|FG000|NOT COMPLETED|Overall Study||7
10724881|NCT02739269|11888791|FG001|NOT COMPLETED|Overall Study||4
10724882|NCT02739321|11888799|FG000|STARTED|Overall Study||23
10724883|NCT02739321|11888800|FG001|STARTED|Overall Study||22
10724884|NCT02739321|11888799|FG000|COMPLETED|Overall Study||20
10724885|NCT02739321|11888800|FG001|COMPLETED|Overall Study||18
10724886|NCT02739321|11888799|FG000|NOT COMPLETED|Overall Study||3
10724887|NCT02739321|11888800|FG001|NOT COMPLETED|Overall Study||4
10724888|NCT02739360|11888815|FG000|STARTED|Overall Study||3
10724889|NCT02739360|11888815|FG000|COMPLETED|Overall Study||0
10724890|NCT02739360|11888815|FG000|NOT COMPLETED|Overall Study||3
10724891|NCT02739594|11888821|FG000|STARTED|Overall Study||46
10724892|NCT02739594|11888822|FG001|STARTED|Overall Study||43
10724893|NCT02739594|11888821|FG000|Completed at Week 44|Overall Study||11
10724894|NCT02739594|11888822|FG001|Completed at Week 44|Overall Study||5
10724895|NCT02739594|11888821|FG000|Completed at Week 96|Overall Study||10
10724896|NCT02739594|11888822|FG001|Completed at Week 96|Overall Study||10
10724897|NCT02739594|11888821|FG000|COMPLETED|Overall Study|Includes all participants who reached the protocol-defined end of study (either Week 44 or 96).|21
10724898|NCT02739594|11888822|FG001|COMPLETED|Overall Study|Includes all participants who reached the protocol-defined end of study (either Week 44 or 96).|15
10724899|NCT02739594|11888821|FG000|NOT COMPLETED|Overall Study||25
10724900|NCT02739594|11888822|FG001|NOT COMPLETED|Overall Study||28
10724901|NCT02739698|11888831|FG000|STARTED|Overall Study||22
10724902|NCT02739698|11888832|FG001|STARTED|Overall Study||21
10724903|NCT02739698|11888831|FG000|COMPLETED|Overall Study||16
10724904|NCT02739698|11888832|FG001|COMPLETED|Overall Study||16
10724905|NCT02739698|11888831|FG000|NOT COMPLETED|Overall Study||6
10724906|NCT02739698|11888832|FG001|NOT COMPLETED|Overall Study||5
10724907|NCT02739789|11888840|FG000|STARTED|First fMRI Scan||9
10724908|NCT02739789|11888841|FG001|STARTED|First fMRI Scan||10
10724909|NCT02739789|11888840|FG000|COMPLETED|First fMRI Scan||9
10724910|NCT02739789|11888841|FG001|COMPLETED|First fMRI Scan||10
10724911|NCT02739789|11888840|FG000|NOT COMPLETED|First fMRI Scan||0
10724912|NCT02739789|11888841|FG001|NOT COMPLETED|First fMRI Scan||0
10724913|NCT02739789|11888840|FG000|STARTED|~1 Week Waiting Period||9
10724914|NCT02739789|11888841|FG001|STARTED|~1 Week Waiting Period||10
10724915|NCT02739789|11888840|FG000|COMPLETED|~1 Week Waiting Period||9
10724916|NCT02739789|11888841|FG001|COMPLETED|~1 Week Waiting Period||7
10724917|NCT02739789|11888840|FG000|NOT COMPLETED|~1 Week Waiting Period||0
10724918|NCT02739789|11888841|FG001|NOT COMPLETED|~1 Week Waiting Period||3
10724919|NCT02739789|11888840|FG000|STARTED|Second fMRI Scan||9
10724920|NCT02739789|11888841|FG001|STARTED|Second fMRI Scan||7
10724921|NCT02739789|11888840|FG000|COMPLETED|Second fMRI Scan||9
10724922|NCT02739789|11888841|FG001|COMPLETED|Second fMRI Scan||7
10724923|NCT02739789|11888840|FG000|NOT COMPLETED|Second fMRI Scan||0
10724924|NCT02739789|11888841|FG001|NOT COMPLETED|Second fMRI Scan||0
10724925|NCT02739828|11888847|FG000|STARTED|Overall Study||24
10724926|NCT02739828|11888847|FG000|COMPLETED|Overall Study||19
10724927|NCT02739828|11888847|FG000|NOT COMPLETED|Overall Study||5
10724928|NCT02739984|11888853|FG000|STARTED|Overall Study||143
10724929|NCT02739984|11888854|FG001|STARTED|Overall Study||281
10724930|NCT02739984|11888853|FG000|Received Study Drug|Overall Study||141
10724931|NCT02739984|11888854|FG001|Received Study Drug|Overall Study||280
10724932|NCT02739984|11888853|FG000|COMPLETED|Overall Study||138
10724933|NCT02739984|11888854|FG001|COMPLETED|Overall Study||279
10724934|NCT02739984|11888853|FG000|NOT COMPLETED|Overall Study||5
10724935|NCT02739984|11888854|FG001|NOT COMPLETED|Overall Study||2
10724936|NCT02739997|11888860|FG000|STARTED|Overall Study||100
10724937|NCT02739997|11888860|FG000|COMPLETED|Overall Study||98
10724938|NCT02739997|11888860|FG000|NOT COMPLETED|Overall Study||2
10724939|NCT02740049|11888864|FG000|STARTED|Overall Study||9
10724940|NCT02740049|11888864|FG000|COMPLETED|Overall Study||8
10724941|NCT02740049|11888864|FG000|NOT COMPLETED|Overall Study||1
10407947|NCT00752089|11551950|FG000|Received NaF/ KNO3/ 2% Isopentane|Overall Study||19
10407948|NCT00752089|11551950|FG000|Received NaF/KNO3/ 0% Isopentane|Overall Study||17
10724942|NCT02740114|11888870|FG000|STARTED|Overall Study||54
10724943|NCT02740114|11888871|FG001|STARTED|Overall Study||48
10724944|NCT02740114|11888870|FG000|COMPLETED|Overall Study||54
10724945|NCT02740114|11888871|FG001|COMPLETED|Overall Study||48
10724946|NCT02740114|11888870|FG000|NOT COMPLETED|Overall Study||0
10724947|NCT02740114|11888871|FG001|NOT COMPLETED|Overall Study||0
10724948|NCT02740153|11888879|FG000|STARTED|Overall Study||101
10724949|NCT02740153|11888880|FG001|STARTED|Overall Study||86
10724950|NCT02740153|11888879|FG000|COMPLETED|Overall Study||101
10724951|NCT02740153|11888880|FG001|COMPLETED|Overall Study||86
10724952|NCT02740153|11888879|FG000|NOT COMPLETED|Overall Study||0
10724953|NCT02740153|11888880|FG001|NOT COMPLETED|Overall Study||0
10407949|NCT00752089|11551950|FG000|Received NaF|Overall Study||18
10407950|NCT00752089|11551950|FG000|Received Placebo|Overall Study||18
10407951|NCT00752089|11551950|FG000|COMPLETED|Overall Study||14
10407952|NCT00752089|11551950|FG000|NOT COMPLETED|Overall Study||6
10407953|NCT00752102|11551963|FG000|STARTED|Overall Study||22
10407954|NCT00752102|11551964|FG001|STARTED|Overall Study||22
10407955|NCT00752102|11551963|FG000|COMPLETED|Overall Study||19
10407956|NCT00752102|11551964|FG001|COMPLETED|Overall Study||21
10407957|NCT00752102|11551963|FG000|NOT COMPLETED|Overall Study||3
10407958|NCT00752102|11551964|FG001|NOT COMPLETED|Overall Study||1
10407959|NCT00752128|11551970|FG000|STARTED|Overall Study||2349
10407960|NCT00752128|11551970|FG000|COMPLETED|Overall Study||2345
10407961|NCT00752128|11551970|FG000|NOT COMPLETED|Overall Study||4
10407962|NCT00752206|11551977|FG000|STARTED|Overall Study||19
10407963|NCT00752206|11551978|FG001|STARTED|Overall Study||19
10407964|NCT00752206|11551977|FG000|COMPLETED|Overall Study||10
10407965|NCT00752206|11551978|FG001|COMPLETED|Overall Study||8
10407966|NCT00752206|11551977|FG000|NOT COMPLETED|Overall Study||9
10407967|NCT00752206|11551978|FG001|NOT COMPLETED|Overall Study||11
10407968|NCT00752219|11551986|FG000|STARTED|Overall Study||102
10407969|NCT00752219|11551987|FG001|STARTED|Overall Study||102
10407970|NCT00752219|11551986|FG000|Treated|Overall Study||101
10407971|NCT00752219|11551987|FG001|Treated|Overall Study||102
10407972|NCT00752219|11551986|FG000|COMPLETED|Overall Study||91
10407973|NCT00752219|11551987|FG001|COMPLETED|Overall Study||96
10407974|NCT00752219|11551986|FG000|NOT COMPLETED|Overall Study||11
10407975|NCT00752219|11551987|FG001|NOT COMPLETED|Overall Study||6
10407976|NCT00752232|11552000|FG000|STARTED|Overall Study||6
10407977|NCT00752232|11552001|FG001|STARTED|Overall Study||6
10407978|NCT00752232|11552002|FG002|STARTED|Overall Study||6
10407979|NCT00752232|11552003|FG003|STARTED|Overall Study||6
10407980|NCT00752232|11552004|FG004|STARTED|Overall Study||6
10407981|NCT00752232|11552005|FG005|STARTED|Overall Study||6
10407982|NCT00752232|11552006|FG006|STARTED|Overall Study||4
10407983|NCT00752232|11552000|FG000|COMPLETED|Overall Study||4
10407984|NCT00752232|11552001|FG001|COMPLETED|Overall Study||6
10407985|NCT00752232|11552002|FG002|COMPLETED|Overall Study||5
10407986|NCT00752232|11552003|FG003|COMPLETED|Overall Study||5
10407987|NCT00752232|11552004|FG004|COMPLETED|Overall Study||3
10407988|NCT00752232|11552005|FG005|COMPLETED|Overall Study||5
10407989|NCT00752232|11552006|FG006|COMPLETED|Overall Study||4
10407990|NCT00752232|11552000|FG000|NOT COMPLETED|Overall Study||2
10407991|NCT00752232|11552001|FG001|NOT COMPLETED|Overall Study||0
10407992|NCT00752232|11552002|FG002|NOT COMPLETED|Overall Study||1
10407993|NCT00752232|11552003|FG003|NOT COMPLETED|Overall Study||1
10407994|NCT00752232|11552004|FG004|NOT COMPLETED|Overall Study||3
10407995|NCT00752232|11552005|FG005|NOT COMPLETED|Overall Study||1
10407996|NCT00752232|11552006|FG006|NOT COMPLETED|Overall Study||0
10407997|NCT00752557|11552026|FG000|STARTED|Overall Study||17
10407998|NCT00752557|11552027|FG001|STARTED|Overall Study||16
10407999|NCT00752557|11552028|FG002|STARTED|Overall Study||17
10408000|NCT00752557|11552026|FG000|COMPLETED|Overall Study||12
10408001|NCT00752557|11552027|FG001|COMPLETED|Overall Study||11
10408002|NCT00752557|11552028|FG002|COMPLETED|Overall Study||11
10408003|NCT00752557|11552026|FG000|NOT COMPLETED|Overall Study||5
10724954|NCT02740413|11888888|FG000|STARTED|Overall Study||86
10724955|NCT02740413|11888888|FG000|COMPLETED|Overall Study||86
10724956|NCT02740413|11888888|FG000|NOT COMPLETED|Overall Study||0
10724957|NCT02740478|11888896|FG000|STARTED|Overall Study|Volunteers recruited until quantity 20 completed the study|21
10777490|NCT03341299|11939499|FG001|COMPLETED|Period 1||9
10408004|NCT00752557|11552027|FG001|NOT COMPLETED|Overall Study||5
10408005|NCT00752557|11552028|FG002|NOT COMPLETED|Overall Study||6
10408006|NCT00752609|11552040|FG000|STARTED|Overall Study||53
10408007|NCT00752609|11552041|FG001|STARTED|Overall Study||49
10408008|NCT00752609|11552040|FG000|Full Analysis Set|Overall Study|One patient withdrew consent before receiving any study medication.|52
10408009|NCT00752609|11552041|FG001|Full Analysis Set|Overall Study||49
10408010|NCT00752609|11552040|FG000|COMPLETED|Overall Study||44
10408011|NCT00752609|11552041|FG001|COMPLETED|Overall Study||47
10408012|NCT00752609|11552040|FG000|NOT COMPLETED|Overall Study||9
10408013|NCT00752609|11552041|FG001|NOT COMPLETED|Overall Study||2
10408014|NCT00752622|11552050|FG000|STARTED|Induction Phase|The ELIG population comprised of 98 participants|100
10408015|NCT00752622|11552050|FG000|COMPLETED|Induction Phase||65
10408016|NCT00752622|11552050|FG000|NOT COMPLETED|Induction Phase||35
10408017|NCT00752622|11552050|FG000|STARTED|Observational Phase||65
10408018|NCT00752622|11552050|FG000|COMPLETED|Observational Phase|14 completed without loss of response 8 had loss of response & randomized into interventional phase|22
10408019|NCT00752622|11552050|FG000|NOT COMPLETED|Observational Phase||43
10408020|NCT00752622|11552050|FG000|STARTED|Interventional Phase|5 participants randomized into increased dose group and 3 randomized into shortened interval group|8
10408021|NCT00752622|11552050|FG000|COMPLETED|Interventional Phase|8 participants received at least 1 infusion of interventional treatment, but none completed trial|0
10408022|NCT00752622|11552050|FG000|NOT COMPLETED|Interventional Phase||8
10408023|NCT00752726|11552057|FG000|STARTED|Overall Study||65
10408024|NCT00752726|11552058|FG001|STARTED|Overall Study||66
10408025|NCT00752726|11552057|FG000|Safety Population|Overall Study|2 participants were never dosed with the study medication.|63
10777491|NCT03341299|11939500|FG002|COMPLETED|Period 1||9
10408026|NCT00752726|11552058|FG001|Safety Population|Overall Study|2 participants were never dosed with the study medication.|64
10408027|NCT00752726|11552057|FG000|Intention to Treat (ITT) Population|Overall Study|ITT population had atleast 1 post treatment efficacy measurement.|62
10408028|NCT00752726|11552058|FG001|Intention to Treat (ITT) Population|Overall Study|ITT population had atleast 1 post treatment efficacy measurement.|61
10408029|NCT00752726|11552057|FG000|COMPLETED|Overall Study||54
10408030|NCT00752726|11552058|FG001|COMPLETED|Overall Study||53
10408031|NCT00752726|11552057|FG000|NOT COMPLETED|Overall Study||11
10408032|NCT00752726|11552058|FG001|NOT COMPLETED|Overall Study||13
10408033|NCT00752791|11552064|FG000|STARTED|Overall Study||59
10408034|NCT00752791|11552064|FG000|COMPLETED|Overall Study||43
10408035|NCT00752791|11552064|FG000|NOT COMPLETED|Overall Study||16
10408036|NCT00752856|11552070|FG000|STARTED|Overall Study||26
10408037|NCT00752856|11552071|FG001|STARTED|Overall Study||25
10408038|NCT00752856|11552070|FG000|COMPLETED|Overall Study||26
10408039|NCT00752856|11552071|FG001|COMPLETED|Overall Study||24
10408040|NCT00752856|11552070|FG000|NOT COMPLETED|Overall Study||0
10408041|NCT00752856|11552071|FG001|NOT COMPLETED|Overall Study||1
10408042|NCT00752895|11552079|FG000|STARTED|Overall Study||147
10408043|NCT00752895|11552080|FG001|STARTED|Overall Study||146
10408044|NCT00752895|11552079|FG000|COMPLETED|Overall Study||139
10408045|NCT00752895|11552080|FG001|COMPLETED|Overall Study||143
10408046|NCT00752895|11552079|FG000|NOT COMPLETED|Overall Study||8
10408047|NCT00752895|11552080|FG001|NOT COMPLETED|Overall Study||3
10408048|NCT00752908|11552088|FG000|STARTED|Overall Study||14
10408049|NCT00752908|11552089|FG001|STARTED|Overall Study||13
10408050|NCT00752908|11552088|FG000|COMPLETED|Overall Study||14
10408051|NCT00752908|11552089|FG001|COMPLETED|Overall Study||13
10408052|NCT00752908|11552088|FG000|NOT COMPLETED|Overall Study||0
10408053|NCT00752908|11552089|FG001|NOT COMPLETED|Overall Study||0
10408054|NCT00752973|11552095|FG000|STARTED|Overall Study||12
10408055|NCT00752973|11552095|FG000|COMPLETED|Overall Study||12
10408056|NCT00752973|11552095|FG000|NOT COMPLETED|Overall Study||0
10408057|NCT00753012|11552103|FG000|STARTED|Overall Study||15
10408058|NCT00753012|11552104|FG001|STARTED|Overall Study||9
10408059|NCT00753012|11552103|FG000|COMPLETED|Overall Study||7
10408060|NCT00753012|11552104|FG001|COMPLETED|Overall Study||8
10408061|NCT00753012|11552103|FG000|NOT COMPLETED|Overall Study||8
10408062|NCT00753012|11552104|FG001|NOT COMPLETED|Overall Study||1
10408063|NCT00753142|11552114|FG000|STARTED|Overall Study||8
10408064|NCT00753142|11552115|FG001|STARTED|Overall Study||7
10408065|NCT00753142|11552116|FG002|STARTED|Overall Study||13
10408066|NCT00753142|11552114|FG000|COMPLETED|Overall Study||8
10408067|NCT00753142|11552115|FG001|COMPLETED|Overall Study||7
10408068|NCT00753142|11552116|FG002|COMPLETED|Overall Study||13
10408069|NCT00753142|11552114|FG000|NOT COMPLETED|Overall Study||0
10408070|NCT00753142|11552115|FG001|NOT COMPLETED|Overall Study||0
10408071|NCT00753142|11552116|FG002|NOT COMPLETED|Overall Study||0
10408072|NCT00753220|11552124|FG000|STARTED|Overall Study||7
10408073|NCT00753220|11552124|FG000|COMPLETED|Overall Study||2
10408074|NCT00753220|11552124|FG000|NOT COMPLETED|Overall Study||5
10408075|NCT00753272|11552130|FG000|STARTED|Overall Study||21893
10408076|NCT00753272|11552131|FG001|STARTED|Overall Study||21802
10408077|NCT00753272|11552130|FG000|COMPLETED|Overall Study||16911
10408078|NCT00753272|11552131|FG001|COMPLETED|Overall Study||16895
10408079|NCT00753272|11552130|FG000|NOT COMPLETED|Overall Study||4982
10408080|NCT00753272|11552131|FG001|NOT COMPLETED|Overall Study||4907
10408081|NCT00753298|11552142|FG000|STARTED|Overall Study||97
10408082|NCT00753298|11552143|FG001|STARTED|Overall Study||98
10408083|NCT00753298|11552142|FG000|COMPLETED|Overall Study||89
10408084|NCT00753298|11552143|FG001|COMPLETED|Overall Study||94
10408085|NCT00753298|11552142|FG000|NOT COMPLETED|Overall Study||8
10724958|NCT02740478|11888896|FG000|COMPLETED|Overall Study|One volunteer was very high BMI and uncomfortable lying still during the recordings: test stopped.|20
10724959|NCT02740478|11888896|FG000|NOT COMPLETED|Overall Study||1
10724960|NCT02740504|11888900|FG000|STARTED|Overall Study||20
10724961|NCT02740504|11888900|FG000|COMPLETED|Overall Study||20
10724962|NCT02740504|11888900|FG000|NOT COMPLETED|Overall Study||0
10724963|NCT02740517|11888907|FG000|STARTED|Overall Study||19
10724964|NCT02740517|11888908|FG001|STARTED|Overall Study||11
10724965|NCT02740517|11888909|FG002|STARTED|Overall Study||18
10724966|NCT02740517|11888907|FG000|COMPLETED|Overall Study||19
10724967|NCT02740517|11888908|FG001|COMPLETED|Overall Study||11
10724968|NCT02740517|11888909|FG002|COMPLETED|Overall Study||18
10724969|NCT02740517|11888907|FG000|NOT COMPLETED|Overall Study||0
10724970|NCT02740517|11888908|FG001|NOT COMPLETED|Overall Study||0
10724971|NCT02740517|11888909|FG002|NOT COMPLETED|Overall Study||0
10724972|NCT02740543|11888919|FG000|STARTED|Overall Study||9
10724973|NCT02740543|11888920|FG001|STARTED|Overall Study||9
10724974|NCT02740543|11888919|FG000|COMPLETED|Overall Study||9
10408086|NCT00753298|11552143|FG001|NOT COMPLETED|Overall Study||4
10408087|NCT00753337|11552149|FG000|STARTED|Overall Study||123
10724975|NCT02740543|11888920|FG001|COMPLETED|Overall Study||9
10724976|NCT02740543|11888919|FG000|NOT COMPLETED|Overall Study||0
10724977|NCT02740543|11888920|FG001|NOT COMPLETED|Overall Study||0
10724978|NCT02740582|11888928|FG000|STARTED|First Intervention||29
10724979|NCT02740582|11888929|FG001|STARTED|First Intervention||33
10724980|NCT02740582|11888928|FG000|COMPLETED|First Intervention||24
10724981|NCT02740582|11888929|FG001|COMPLETED|First Intervention||31
10724982|NCT02740582|11888928|FG000|NOT COMPLETED|First Intervention||5
10408088|NCT00753337|11552149|FG000|COMPLETED|Overall Study||123
10408089|NCT00753337|11552149|FG000|NOT COMPLETED|Overall Study||0
10408090|NCT00753363|11552156|FG000|STARTED|Overall Study||59
10408091|NCT00753363|11552157|FG001|STARTED|Overall Study||60
10408092|NCT00753363|11552156|FG000|COMPLETED|Overall Study||19
10408093|NCT00753363|11552157|FG001|COMPLETED|Overall Study||21
10408094|NCT00753363|11552156|FG000|NOT COMPLETED|Overall Study||40
10408095|NCT00753363|11552157|FG001|NOT COMPLETED|Overall Study||39
10408096|NCT00753415|11552168|FG000|STARTED|Part A||3
10408097|NCT00753415|11552169|FG001|STARTED|Part A||3
10408098|NCT00753415|11552170|FG002|STARTED|Part A||10
10408099|NCT00753415|11552171|FG003|STARTED|Part A||11
10408100|NCT00753415|11552172|FG004|STARTED|Part A||10
10408101|NCT00753415|11552173|FG005|STARTED|Part A||0
10408102|NCT00753415|11552174|FG006|STARTED|Part A||0
10408103|NCT00753415|11552175|FG007|STARTED|Part A||0
10408104|NCT00753415|11552176|FG008|STARTED|Part A||0
10408105|NCT00753415|11552177|FG009|STARTED|Part A||0
10408106|NCT00753415|11552168|FG000|COMPLETED|Part A||2
10724983|NCT02740582|11888929|FG001|NOT COMPLETED|First Intervention||2
10724984|NCT02740582|11888928|FG000|STARTED|Washout||24
10724985|NCT02740582|11888929|FG001|STARTED|Washout||31
10724986|NCT02740582|11888928|FG000|COMPLETED|Washout||24
10724987|NCT02740582|11888929|FG001|COMPLETED|Washout||31
10724988|NCT02740582|11888928|FG000|NOT COMPLETED|Washout||0
10724989|NCT02740582|11888929|FG001|NOT COMPLETED|Washout||0
10724990|NCT02740582|11888928|FG000|STARTED|Second Intervention||24
10724991|NCT02740582|11888929|FG001|STARTED|Second Intervention||31
10724992|NCT02740582|11888928|FG000|COMPLETED|Second Intervention||23
10724993|NCT02740582|11888929|FG001|COMPLETED|Second Intervention||28
10724994|NCT02740582|11888928|FG000|NOT COMPLETED|Second Intervention||1
10724995|NCT02740582|11888929|FG001|NOT COMPLETED|Second Intervention||3
10724996|NCT02740660|11888937|FG000|STARTED|Overall Study||6
10724997|NCT02740660|11888938|FG001|STARTED|Overall Study||6
10724998|NCT02740660|11888937|FG000|COMPLETED|Overall Study||6
10724999|NCT02740660|11888938|FG001|COMPLETED|Overall Study||6
10725000|NCT02740660|11888937|FG000|NOT COMPLETED|Overall Study||0
10725001|NCT02740660|11888938|FG001|NOT COMPLETED|Overall Study||0
10725002|NCT02740920|11888944|FG000|STARTED|Overall Study||9
10725003|NCT02740920|11888944|FG000|COMPLETED|Overall Study||9
10725004|NCT02740920|11888944|FG000|NOT COMPLETED|Overall Study||0
10725005|NCT02741076|11888952|FG000|STARTED|Overall Study||13
10725006|NCT02741076|11888953|FG001|STARTED|Overall Study||12
10725007|NCT02741076|11888954|FG002|STARTED|Overall Study||3
10725008|NCT02741076|11888955|FG003|STARTED|Overall Study||4
10725009|NCT02741076|11888952|FG000|COMPLETED|Overall Study||10
10725010|NCT02741076|11888953|FG001|COMPLETED|Overall Study||7
10725011|NCT02741076|11888954|FG002|COMPLETED|Overall Study||1
10725012|NCT02741076|11888955|FG003|COMPLETED|Overall Study||2
10725013|NCT02741076|11888952|FG000|NOT COMPLETED|Overall Study||3
10725014|NCT02741076|11888953|FG001|NOT COMPLETED|Overall Study||5
10725015|NCT02741076|11888954|FG002|NOT COMPLETED|Overall Study||2
10725016|NCT02741076|11888955|FG003|NOT COMPLETED|Overall Study||2
10725017|NCT02741284|11888968|FG000|STARTED|Overall Study||57
10725018|NCT02741284|11888969|FG001|STARTED|Overall Study||57
10725019|NCT02741284|11888968|FG000|COMPLETED|Overall Study||51
10725020|NCT02741284|11888969|FG001|COMPLETED|Overall Study||48
10725021|NCT02741284|11888968|FG000|NOT COMPLETED|Overall Study||6
10725022|NCT02741284|11888969|FG001|NOT COMPLETED|Overall Study||9
10725023|NCT02741297|11888977|FG000|STARTED|Overall Study||73
10725024|NCT02741297|11888977|FG000|COMPLETED|Overall Study||59
10725025|NCT02741297|11888977|FG000|NOT COMPLETED|Overall Study||14
10725026|NCT02741310|11888983|FG000|STARTED|Overall Study||12
10725027|NCT02741310|11888984|FG001|STARTED|Overall Study||22
10725028|NCT02741310|11888983|FG000|COMPLETED|Overall Study||10
10725029|NCT02741310|11888984|FG001|COMPLETED|Overall Study||20
10725030|NCT02741310|11888983|FG000|NOT COMPLETED|Overall Study||2
10725031|NCT02741310|11888984|FG001|NOT COMPLETED|Overall Study||2
10725032|NCT02741518|11889000|FG000|STARTED|Overall Study||11
10725033|NCT02741518|11889001|FG001|STARTED|Overall Study||11
10725034|NCT02741518|11889000|FG000|COMPLETED|Overall Study||10
10725035|NCT02741518|11889001|FG001|COMPLETED|Overall Study||10
10725036|NCT02741518|11889000|FG000|NOT COMPLETED|Overall Study||1
10725037|NCT02741518|11889001|FG001|NOT COMPLETED|Overall Study||1
10725038|NCT02741596|11889009|FG000|STARTED|Overall Study||109
10725039|NCT02741596|11889010|FG001|STARTED|Overall Study||103
10725040|NCT02741596|11889009|FG000|COMPLETED|Overall Study||31
10725041|NCT02741596|11889010|FG001|COMPLETED|Overall Study||25
10725042|NCT02741596|11889009|FG000|NOT COMPLETED|Overall Study||78
10408107|NCT00753415|11552169|FG001|COMPLETED|Part A||3
10408108|NCT00753415|11552170|FG002|COMPLETED|Part A||8
10725043|NCT02741596|11889010|FG001|NOT COMPLETED|Overall Study||78
10725044|NCT02741635|11889016|FG000|STARTED|Overall Study||15
10725045|NCT02741635|11889016|FG000|COMPLETED|Overall Study||14
10725046|NCT02741635|11889016|FG000|NOT COMPLETED|Overall Study||1
10725047|NCT02741687|11889023|FG000|STARTED|Overall Study||36
10725048|NCT02741687|11889024|FG001|STARTED|Overall Study||44
10725049|NCT02741687|11889023|FG000|COMPLETED|Overall Study||36
10725050|NCT02741687|11889024|FG001|COMPLETED|Overall Study||44
10725051|NCT02741687|11889023|FG000|NOT COMPLETED|Overall Study||0
10725052|NCT02741687|11889024|FG001|NOT COMPLETED|Overall Study||0
10725053|NCT02741713|11889032|FG000|STARTED|Overall Study||20
10408109|NCT00753415|11552171|FG003|COMPLETED|Part A||9
10408110|NCT00753415|11552172|FG004|COMPLETED|Part A||10
10408111|NCT00753415|11552173|FG005|COMPLETED|Part A||0
10408112|NCT00753415|11552174|FG006|COMPLETED|Part A||0
10408113|NCT00753415|11552175|FG007|COMPLETED|Part A||0
10725054|NCT02741713|11889033|FG001|STARTED|Overall Study||20
10725055|NCT02741713|11889032|FG000|COMPLETED|Overall Study||18
10725056|NCT02741713|11889033|FG001|COMPLETED|Overall Study||19
10725057|NCT02741713|11889032|FG000|NOT COMPLETED|Overall Study||2
10725058|NCT02741713|11889033|FG001|NOT COMPLETED|Overall Study||1
10408114|NCT00753415|11552176|FG008|COMPLETED|Part A||0
10408115|NCT00753415|11552177|FG009|COMPLETED|Part A||0
10408116|NCT00753415|11552168|FG000|NOT COMPLETED|Part A||1
10408117|NCT00753415|11552169|FG001|NOT COMPLETED|Part A||0
10408118|NCT00753415|11552170|FG002|NOT COMPLETED|Part A||2
10408119|NCT00753415|11552171|FG003|NOT COMPLETED|Part A||2
10408120|NCT00753415|11552172|FG004|NOT COMPLETED|Part A||0
10408121|NCT00753415|11552173|FG005|NOT COMPLETED|Part A||0
10408122|NCT00753415|11552174|FG006|NOT COMPLETED|Part A||0
10408123|NCT00753415|11552175|FG007|NOT COMPLETED|Part A||0
10408124|NCT00753415|11552176|FG008|NOT COMPLETED|Part A||0
10408125|NCT00753415|11552177|FG009|NOT COMPLETED|Part A||0
10408126|NCT00753415|11552168|FG000|STARTED|Part B||0
10408127|NCT00753415|11552169|FG001|STARTED|Part B||0
10408128|NCT00753415|11552170|FG002|STARTED|Part B||0
10408129|NCT00753415|11552171|FG003|STARTED|Part B||0
10408130|NCT00753415|11552172|FG004|STARTED|Part B||0
10408131|NCT00753415|11552173|FG005|STARTED|Part B|Of 2 eligible participants who completed Part A, 1 chose to enter Part B|1
10408132|NCT00753415|11552174|FG006|STARTED|Part B|Of 3 eligible participants who completed Part A, 2 chose to enter Part B|2
10408133|NCT00753415|11552175|FG007|STARTED|Part B|Of 8 eligible participants who completed Part A, 7 chose to enter Part B|7
10408134|NCT00753415|11552176|FG008|STARTED|Part B|9 participants who completed Part A were eligible and enrolled in Part B|9
10408135|NCT00753415|11552177|FG009|STARTED|Part B|Of 10 eligible participants who completed Part A, 9 chose to enter Part B|9
10408136|NCT00753415|11552168|FG000|COMPLETED|Part B||0
10408137|NCT00753415|11552169|FG001|COMPLETED|Part B||0
10408138|NCT00753415|11552170|FG002|COMPLETED|Part B||0
10408139|NCT00753415|11552171|FG003|COMPLETED|Part B||0
10408140|NCT00753415|11552172|FG004|COMPLETED|Part B||0
10408141|NCT00753415|11552173|FG005|COMPLETED|Part B||1
10408142|NCT00753415|11552174|FG006|COMPLETED|Part B||2
10408143|NCT00753415|11552175|FG007|COMPLETED|Part B||6
10408144|NCT00753415|11552176|FG008|COMPLETED|Part B||6
10408145|NCT00753415|11552177|FG009|COMPLETED|Part B||8
10408146|NCT00753415|11552168|FG000|NOT COMPLETED|Part B||0
10408147|NCT00753415|11552169|FG001|NOT COMPLETED|Part B||0
10408148|NCT00753415|11552170|FG002|NOT COMPLETED|Part B||0
10408149|NCT00753415|11552171|FG003|NOT COMPLETED|Part B||0
10408150|NCT00753415|11552172|FG004|NOT COMPLETED|Part B||0
10725059|NCT02742077|11889040|FG000|STARTED|Overall Study||20
10725060|NCT02742077|11889040|FG000|COMPLETED|Overall Study||20
10725061|NCT02742077|11889040|FG000|NOT COMPLETED|Overall Study||0
10725062|NCT02742103|11889046|FG000|STARTED|Overall Study||55
10725063|NCT02742103|11889047|FG001|STARTED|Overall Study||28
10725064|NCT02742103|11889046|FG000|COMPLETED|Overall Study||46
10725065|NCT02742103|11889047|FG001|COMPLETED|Overall Study||23
10725066|NCT02742103|11889046|FG000|NOT COMPLETED|Overall Study||9
10725067|NCT02742103|11889047|FG001|NOT COMPLETED|Overall Study||5
10725068|NCT02742129|11889055|FG000|STARTED|Phase 1||53
10725069|NCT02742129|11889056|FG001|STARTED|Phase 1||52
10725070|NCT02742129|11889055|FG000|COMPLETED|Phase 1||51
10725071|NCT02742129|11889056|FG001|COMPLETED|Phase 1||50
10725072|NCT02742129|11889055|FG000|NOT COMPLETED|Phase 1||2
10725073|NCT02742129|11889056|FG001|NOT COMPLETED|Phase 1||2
10725074|NCT02742129|11889055|FG000|STARTED|Phase 2||51
10725075|NCT02742129|11889056|FG001|STARTED|Phase 2||50
10725076|NCT02742129|11889055|FG000|COMPLETED|Phase 2||50
10725077|NCT02742129|11889056|FG001|COMPLETED|Phase 2||48
10725078|NCT02742129|11889055|FG000|NOT COMPLETED|Phase 2||1
10725079|NCT02742129|11889056|FG001|NOT COMPLETED|Phase 2||2
10725080|NCT02742441|11889067|FG000|STARTED|Overall Study||205
10725081|NCT02742441|11889068|FG001|STARTED|Overall Study||204
10725082|NCT02742441|11889067|FG000|COMPLETED|Overall Study||199
10725083|NCT02742441|11889068|FG001|COMPLETED|Overall Study||196
10725084|NCT02742441|11889067|FG000|NOT COMPLETED|Overall Study||6
10725085|NCT02742441|11889068|FG001|NOT COMPLETED|Overall Study||8
10725086|NCT02742519|11889076|FG000|STARTED|Part 1 Treatment Period 1 (8 Weeks)||8
10725087|NCT02742519|11889077|FG001|STARTED|Part 1 Treatment Period 1 (8 Weeks)||6
10725088|NCT02742519|11889078|FG002|STARTED|Part 1 Treatment Period 1 (8 Weeks)||0
10725089|NCT02742519|11889076|FG000|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||8
10725090|NCT02742519|11889077|FG001|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||6
10725091|NCT02742519|11889078|FG002|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
10725092|NCT02742519|11889076|FG000|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
10725093|NCT02742519|11889077|FG001|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
10725094|NCT02742519|11889078|FG002|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
10725095|NCT02742519|11889076|FG000|STARTED|Part 1 Treatment Period 2 (8 Weeks)||8
10725096|NCT02742519|11889077|FG001|STARTED|Part 1 Treatment Period 2 (8 Weeks)||6
10725097|NCT02742519|11889078|FG002|STARTED|Part 1 Treatment Period 2 (8 Weeks)||0
10725098|NCT02742519|11889076|FG000|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||7
10725099|NCT02742519|11889077|FG001|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||5
10725100|NCT02742519|11889078|FG002|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||0
10725101|NCT02742519|11889076|FG000|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||1
10725102|NCT02742519|11889077|FG001|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||1
10725103|NCT02742519|11889078|FG002|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||0
10725104|NCT02742519|11889076|FG000|STARTED|Part 2 Open Label Period (32 Weeks)||0
10408151|NCT00753415|11552173|FG005|NOT COMPLETED|Part B||0
10408152|NCT00753415|11552174|FG006|NOT COMPLETED|Part B||0
10408153|NCT00753415|11552175|FG007|NOT COMPLETED|Part B||1
10725105|NCT02742519|11889077|FG001|STARTED|Part 2 Open Label Period (32 Weeks)||0
10777492|NCT03341299|11939501|FG003|COMPLETED|Period 1||9
10777493|NCT03341299|11939498|FG000|NOT COMPLETED|Period 1||0
10408154|NCT00753415|11552176|FG008|NOT COMPLETED|Part B||3
10408155|NCT00753415|11552177|FG009|NOT COMPLETED|Part B||1
10408156|NCT00753454|11552201|FG000|STARTED|Overall Study||168
10408157|NCT00753454|11552201|FG000|COMPLETED|Overall Study||154
10408158|NCT00753454|11552201|FG000|NOT COMPLETED|Overall Study||14
10408159|NCT00753506|11552207|FG000|STARTED|Overall Study||33
10408160|NCT00753506|11552208|FG001|STARTED|Overall Study||33
10408161|NCT00753506|11552207|FG000|COMPLETED|Overall Study||26
10408162|NCT00753506|11552208|FG001|COMPLETED|Overall Study||31
10408163|NCT00753506|11552207|FG000|NOT COMPLETED|Overall Study||7
10408164|NCT00753506|11552208|FG001|NOT COMPLETED|Overall Study||2
10725106|NCT02742519|11889078|FG002|STARTED|Part 2 Open Label Period (32 Weeks)|Of 12 participants who completed DB period, only 10 entered OL period & 2 opted for commercial drug.|10
10725107|NCT02742519|11889076|FG000|COMPLETED|Part 2 Open Label Period (32 Weeks)||0
10725108|NCT02742519|11889077|FG001|COMPLETED|Part 2 Open Label Period (32 Weeks)||0
10725109|NCT02742519|11889078|FG002|COMPLETED|Part 2 Open Label Period (32 Weeks)||0
10725110|NCT02742519|11889076|FG000|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||0
10725111|NCT02742519|11889077|FG001|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||0
10725112|NCT02742519|11889078|FG002|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||10
10725113|NCT02742532|11889088|FG000|STARTED|Overall Study||31
10725114|NCT02742532|11889089|FG001|STARTED|Overall Study||32
10725115|NCT02742532|11889088|FG000|COMPLETED|Overall Study||28
10725116|NCT02742532|11889089|FG001|COMPLETED|Overall Study||31
10725117|NCT02742532|11889088|FG000|NOT COMPLETED|Overall Study||3
10725118|NCT02742532|11889089|FG001|NOT COMPLETED|Overall Study||1
10725119|NCT02742649|11889098|FG000|STARTED|Pre-Randomization Washout Period||55
10725120|NCT02742649|11889099|FG001|STARTED|Pre-Randomization Washout Period||0
10725121|NCT02742649|11889100|FG002|STARTED|Pre-Randomization Washout Period||0
10725122|NCT02742649|11889101|FG003|STARTED|Pre-Randomization Washout Period||0
10725123|NCT02742649|11889102|FG004|STARTED|Pre-Randomization Washout Period||0
10725124|NCT02742649|11889098|FG000|COMPLETED|Pre-Randomization Washout Period||50
10725125|NCT02742649|11889099|FG001|COMPLETED|Pre-Randomization Washout Period||0
10725126|NCT02742649|11889100|FG002|COMPLETED|Pre-Randomization Washout Period||0
10725127|NCT02742649|11889101|FG003|COMPLETED|Pre-Randomization Washout Period||0
10725128|NCT02742649|11889102|FG004|COMPLETED|Pre-Randomization Washout Period||0
10725129|NCT02742649|11889098|FG000|NOT COMPLETED|Pre-Randomization Washout Period||5
10725130|NCT02742649|11889099|FG001|NOT COMPLETED|Pre-Randomization Washout Period||0
10725131|NCT02742649|11889100|FG002|NOT COMPLETED|Pre-Randomization Washout Period||0
10725132|NCT02742649|11889101|FG003|NOT COMPLETED|Pre-Randomization Washout Period||0
10725133|NCT02742649|11889102|FG004|NOT COMPLETED|Pre-Randomization Washout Period||0
10725134|NCT02742649|11889098|FG000|STARTED|Double-Blind Treatment Period||0
10725135|NCT02742649|11889099|FG001|STARTED|Double-Blind Treatment Period||17
10725136|NCT02742649|11889100|FG002|STARTED|Double-Blind Treatment Period||17
10725137|NCT02742649|11889101|FG003|STARTED|Double-Blind Treatment Period||16
10725138|NCT02742649|11889102|FG004|STARTED|Double-Blind Treatment Period||0
10725139|NCT02742649|11889098|FG000|COMPLETED|Double-Blind Treatment Period||0
10725140|NCT02742649|11889099|FG001|COMPLETED|Double-Blind Treatment Period||16
10725141|NCT02742649|11889100|FG002|COMPLETED|Double-Blind Treatment Period||17
10725142|NCT02742649|11889101|FG003|COMPLETED|Double-Blind Treatment Period||16
10725143|NCT02742649|11889102|FG004|COMPLETED|Double-Blind Treatment Period||0
10725144|NCT02742649|11889098|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
10725145|NCT02742649|11889099|FG001|NOT COMPLETED|Double-Blind Treatment Period||1
10725146|NCT02742649|11889100|FG002|NOT COMPLETED|Double-Blind Treatment Period||0
10725147|NCT02742649|11889101|FG003|NOT COMPLETED|Double-Blind Treatment Period||0
10725148|NCT02742649|11889102|FG004|NOT COMPLETED|Double-Blind Treatment Period||0
10725149|NCT02742649|11889098|FG000|STARTED|Open-Label Period||0
10725150|NCT02742649|11889099|FG001|STARTED|Open-Label Period||0
10725151|NCT02742649|11889100|FG002|STARTED|Open-Label Period||0
10725152|NCT02742649|11889101|FG003|STARTED|Open-Label Period||0
10725153|NCT02742649|11889102|FG004|STARTED|Open-Label Period||49
10725154|NCT02742649|11889098|FG000|COMPLETED|Open-Label Period||0
10725155|NCT02742649|11889099|FG001|COMPLETED|Open-Label Period||0
10725156|NCT02742649|11889100|FG002|COMPLETED|Open-Label Period||0
10725157|NCT02742649|11889101|FG003|COMPLETED|Open-Label Period||0
10725158|NCT02742649|11889102|FG004|COMPLETED|Open-Label Period||48
10725159|NCT02742649|11889098|FG000|NOT COMPLETED|Open-Label Period||0
10725160|NCT02742649|11889099|FG001|NOT COMPLETED|Open-Label Period||0
10544525|NCT01490632|11697641|FG004|STARTED|Part C: Washout or Step-Down Period|One participant completed Part B but discontinued without receiving a Part C treatment assignment.|0
10544526|NCT01490632|11697642|FG005|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥75 remained on 2 mg or 4 mg.|0
10544527|NCT01490632|11697643|FG006|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 8 mg or 10 mg with a PASI ≥75 remained on 8 mg or 10 mg.|0
10544528|NCT01490632|11697644|FG007|STARTED|Part C: Washout or Step-Down Period|Placebo participants in Part A with a PASI <75 were re-randomized to 8 mg or 10 mg.|0
10725161|NCT02742649|11889100|FG002|NOT COMPLETED|Open-Label Period||0
10725162|NCT02742649|11889101|FG003|NOT COMPLETED|Open-Label Period||0
10408165|NCT00753519|11552216|FG000|STARTED|Overall Study||13
10408166|NCT00753519|11552217|FG001|STARTED|Overall Study||15
10725163|NCT02742649|11889102|FG004|NOT COMPLETED|Open-Label Period||1
10725164|NCT02742766|11889132|FG000|STARTED|Part 1 (Up to 8 Days)||20
10408167|NCT00753519|11552216|FG000|COMPLETED|Overall Study||13
10408168|NCT00753519|11552217|FG001|COMPLETED|Overall Study||13
10408169|NCT00753519|11552216|FG000|NOT COMPLETED|Overall Study||0
10408170|NCT00753519|11552217|FG001|NOT COMPLETED|Overall Study||2
10408171|NCT00753623|11552227|FG000|STARTED|Phase I (14 Days)||11
10408172|NCT00753623|11552228|FG001|STARTED|Phase I (14 Days)||12
10408173|NCT00753623|11552227|FG000|COMPLETED|Phase I (14 Days)||9
10408174|NCT00753623|11552228|FG001|COMPLETED|Phase I (14 Days)||8
10408175|NCT00753623|11552227|FG000|NOT COMPLETED|Phase I (14 Days)||2
10408176|NCT00753623|11552228|FG001|NOT COMPLETED|Phase I (14 Days)||4
10408177|NCT00753623|11552227|FG000|STARTED|Washout (7 Days)||9
10408178|NCT00753623|11552228|FG001|STARTED|Washout (7 Days)||8
10408179|NCT00753623|11552227|FG000|COMPLETED|Washout (7 Days)||8
10408180|NCT00753623|11552228|FG001|COMPLETED|Washout (7 Days)||8
10408181|NCT00753623|11552227|FG000|NOT COMPLETED|Washout (7 Days)||1
10408182|NCT00753623|11552228|FG001|NOT COMPLETED|Washout (7 Days)||0
10408183|NCT00753623|11552227|FG000|STARTED|Phase II (14 Days)||8
10408184|NCT00753623|11552228|FG001|STARTED|Phase II (14 Days)||8
10408185|NCT00753623|11552227|FG000|COMPLETED|Phase II (14 Days)||8
10408186|NCT00753623|11552228|FG001|COMPLETED|Phase II (14 Days)||7
10408187|NCT00753623|11552227|FG000|NOT COMPLETED|Phase II (14 Days)||0
10408188|NCT00753623|11552228|FG001|NOT COMPLETED|Phase II (14 Days)||1
10408189|NCT00753636|11552234|FG000|STARTED|Overall Study||31
10408190|NCT00753636|11552234|FG000|COMPLETED|Overall Study||25
10408191|NCT00753636|11552234|FG000|NOT COMPLETED|Overall Study||6
10408192|NCT00753649|11552240|FG000|STARTED|Overall Study||112
10408193|NCT00753649|11552241|FG001|STARTED|Overall Study||112
10408194|NCT00753649|11552240|FG000|COMPLETED|Overall Study||105
10408195|NCT00753649|11552241|FG001|COMPLETED|Overall Study||112
10408196|NCT00753649|11552240|FG000|NOT COMPLETED|Overall Study||7
10408197|NCT00753649|11552241|FG001|NOT COMPLETED|Overall Study||0
10408198|NCT00753675|11552250|FG000|STARTED|Overall Study||59
10408199|NCT00753675|11552251|FG001|STARTED|Overall Study||59
10408200|NCT00753675|11552252|FG002|STARTED|Overall Study||56
10408201|NCT00753675|11552250|FG000|COMPLETED|Overall Study||0
10408202|NCT00753675|11552251|FG001|COMPLETED|Overall Study||0
10544529|NCT01490632|11697645|FG008|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥50 to <75 remained on 2 mg or 4 mg.|0
10544530|NCT01490632|11697646|FG009|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI <50 were re-randomized to 8 mg or 10 mg.|0
10544531|NCT01490632|11697647|FG010|STARTED|Part C: Washout or Step-Down Period|Part A 10 mg non-responders were discontinued from the study.|0
10544532|NCT01490632|11697648|FG011|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to Placebo remained on Placebo.|0
10725165|NCT02742766|11889133|FG001|STARTED|Part 1 (Up to 8 Days)||6
10725166|NCT02742766|11889134|FG002|STARTED|Part 1 (Up to 8 Days)||6
10725167|NCT02742766|11889135|FG003|STARTED|Part 1 (Up to 8 Days)||6
10725168|NCT02742766|11889136|FG004|STARTED|Part 1 (Up to 8 Days)||6
10725169|NCT02742766|11889137|FG005|STARTED|Part 1 (Up to 8 Days)||6
10725170|NCT02742766|11889138|FG006|STARTED|Part 1 (Up to 8 Days)||6
10725171|NCT02742766|11889139|FG007|STARTED|Part 1 (Up to 8 Days)||6
10725172|NCT02742766|11889140|FG008|STARTED|Part 1 (Up to 8 Days)||6
10725173|NCT02742766|11889141|FG009|STARTED|Part 1 (Up to 8 Days)||0
10725174|NCT02742766|11889142|FG010|STARTED|Part 1 (Up to 8 Days)||6
10725175|NCT02742766|11889143|FG011|STARTED|Part 1 (Up to 8 Days)||6
10725176|NCT02742766|11889144|FG012|STARTED|Part 1 (Up to 8 Days)||0
10725177|NCT02742766|11889145|FG013|STARTED|Part 1 (Up to 8 Days)||0
10725178|NCT02742766|11889146|FG014|STARTED|Part 1 (Up to 8 Days)||0
10725179|NCT02742766|11889147|FG015|STARTED|Part 1 (Up to 8 Days)||0
10725180|NCT02742766|11889148|FG016|STARTED|Part 1 (Up to 8 Days)||0
10725181|NCT02742766|11889149|FG017|STARTED|Part 1 (Up to 8 Days)||0
10725182|NCT02742766|11889150|FG018|STARTED|Part 1 (Up to 8 Days)||0
10725183|NCT02742766|11889132|FG000|COMPLETED|Part 1 (Up to 8 Days)||20
10725184|NCT02742766|11889133|FG001|COMPLETED|Part 1 (Up to 8 Days)||6
10725185|NCT02742766|11889134|FG002|COMPLETED|Part 1 (Up to 8 Days)||6
10725186|NCT02742766|11889135|FG003|COMPLETED|Part 1 (Up to 8 Days)||6
10725187|NCT02742766|11889136|FG004|COMPLETED|Part 1 (Up to 8 Days)||6
10725188|NCT02742766|11889137|FG005|COMPLETED|Part 1 (Up to 8 Days)||6
10725189|NCT02742766|11889138|FG006|COMPLETED|Part 1 (Up to 8 Days)||6
10725190|NCT02742766|11889139|FG007|COMPLETED|Part 1 (Up to 8 Days)||6
10725191|NCT02742766|11889140|FG008|COMPLETED|Part 1 (Up to 8 Days)||6
10725192|NCT02742766|11889141|FG009|COMPLETED|Part 1 (Up to 8 Days)||0
10725193|NCT02742766|11889142|FG010|COMPLETED|Part 1 (Up to 8 Days)||6
10725194|NCT02742766|11889143|FG011|COMPLETED|Part 1 (Up to 8 Days)||6
10725195|NCT02742766|11889144|FG012|COMPLETED|Part 1 (Up to 8 Days)||0
10725196|NCT02742766|11889145|FG013|COMPLETED|Part 1 (Up to 8 Days)||0
10725197|NCT02742766|11889146|FG014|COMPLETED|Part 1 (Up to 8 Days)||0
10725198|NCT02742766|11889147|FG015|COMPLETED|Part 1 (Up to 8 Days)||0
10725199|NCT02742766|11889148|FG016|COMPLETED|Part 1 (Up to 8 Days)||0
10725200|NCT02742766|11889149|FG017|COMPLETED|Part 1 (Up to 8 Days)||0
10725201|NCT02742766|11889150|FG018|COMPLETED|Part 1 (Up to 8 Days)||0
10725202|NCT02742766|11889132|FG000|NOT COMPLETED|Part 1 (Up to 8 Days)||0
10725203|NCT02742766|11889133|FG001|NOT COMPLETED|Part 1 (Up to 8 Days)||0
10725204|NCT02742766|11889134|FG002|NOT COMPLETED|Part 1 (Up to 8 Days)||0
10725205|NCT02742766|11889135|FG003|NOT COMPLETED|Part 1 (Up to 8 Days)||0
10725206|NCT02742766|11889136|FG004|NOT COMPLETED|Part 1 (Up to 8 Days)||0
10725207|NCT02742766|11889137|FG005|NOT COMPLETED|Part 1 (Up to 8 Days)||0
10725208|NCT02742766|11889138|FG006|NOT COMPLETED|Part 1 (Up to 8 Days)||0
10408203|NCT00753675|11552252|FG002|COMPLETED|Overall Study||0
10408204|NCT00753675|11552250|FG000|NOT COMPLETED|Overall Study||59
10408205|NCT00753675|11552251|FG001|NOT COMPLETED|Overall Study||59
10725209|NCT02742766|11889139|FG007|NOT COMPLETED|Part 1 (Up to 8 Days)||0
10725210|NCT02742766|11889140|FG008|NOT COMPLETED|Part 1 (Up to 8 Days)||0
10725211|NCT02742766|11889141|FG009|NOT COMPLETED|Part 1 (Up to 8 Days)||0
10725212|NCT02742766|11889142|FG010|NOT COMPLETED|Part 1 (Up to 8 Days)||0
10725213|NCT02742766|11889143|FG011|NOT COMPLETED|Part 1 (Up to 8 Days)||0
10725214|NCT02742766|11889144|FG012|NOT COMPLETED|Part 1 (Up to 8 Days)||0
10725215|NCT02742766|11889145|FG013|NOT COMPLETED|Part 1 (Up to 8 Days)||0
10725216|NCT02742766|11889146|FG014|NOT COMPLETED|Part 1 (Up to 8 Days)||0
10725217|NCT02742766|11889147|FG015|NOT COMPLETED|Part 1 (Up to 8 Days)||0
10725218|NCT02742766|11889148|FG016|NOT COMPLETED|Part 1 (Up to 8 Days)||0
10725219|NCT02742766|11889149|FG017|NOT COMPLETED|Part 1 (Up to 8 Days)||0
10725220|NCT02742766|11889150|FG018|NOT COMPLETED|Part 1 (Up to 8 Days)||0
10725221|NCT02742766|11889132|FG000|STARTED|Part 2 (Up to 22 Days)||0
10725222|NCT02742766|11889133|FG001|STARTED|Part 2 (Up to 22 Days)||0
10725223|NCT02742766|11889134|FG002|STARTED|Part 2 (Up to 22 Days)||0
10725224|NCT02742766|11889135|FG003|STARTED|Part 2 (Up to 22 Days)||0
10725225|NCT02742766|11889136|FG004|STARTED|Part 2 (Up to 22 Days)||0
10725226|NCT02742766|11889137|FG005|STARTED|Part 2 (Up to 22 Days)||0
10725227|NCT02742766|11889138|FG006|STARTED|Part 2 (Up to 22 Days)||0
10725228|NCT02742766|11889139|FG007|STARTED|Part 2 (Up to 22 Days)||0
10725229|NCT02742766|11889140|FG008|STARTED|Part 2 (Up to 22 Days)||0
10725230|NCT02742766|11889141|FG009|STARTED|Part 2 (Up to 22 Days)||0
10725231|NCT02742766|11889142|FG010|STARTED|Part 2 (Up to 22 Days)||0
10725232|NCT02742766|11889143|FG011|STARTED|Part 2 (Up to 22 Days)||0
10725233|NCT02742766|11889144|FG012|STARTED|Part 2 (Up to 22 Days)||6
10725234|NCT02742766|11889145|FG013|STARTED|Part 2 (Up to 22 Days)||6
10725235|NCT02742766|11889146|FG014|STARTED|Part 2 (Up to 22 Days)||6
10725236|NCT02742766|11889147|FG015|STARTED|Part 2 (Up to 22 Days)||6
10725237|NCT02742766|11889148|FG016|STARTED|Part 2 (Up to 22 Days)||0
10725238|NCT02742766|11889149|FG017|STARTED|Part 2 (Up to 22 Days)||0
10725239|NCT02742766|11889150|FG018|STARTED|Part 2 (Up to 22 Days)||0
10725240|NCT02742766|11889132|FG000|COMPLETED|Part 2 (Up to 22 Days)||0
10725241|NCT02742766|11889133|FG001|COMPLETED|Part 2 (Up to 22 Days)||0
10725242|NCT02742766|11889134|FG002|COMPLETED|Part 2 (Up to 22 Days)||0
10725243|NCT02742766|11889135|FG003|COMPLETED|Part 2 (Up to 22 Days)||0
10725244|NCT02742766|11889136|FG004|COMPLETED|Part 2 (Up to 22 Days)||0
10725245|NCT02742766|11889137|FG005|COMPLETED|Part 2 (Up to 22 Days)||0
10725246|NCT02742766|11889138|FG006|COMPLETED|Part 2 (Up to 22 Days)||0
10725247|NCT02742766|11889139|FG007|COMPLETED|Part 2 (Up to 22 Days)||0
10725248|NCT02742766|11889140|FG008|COMPLETED|Part 2 (Up to 22 Days)||0
10725249|NCT02742766|11889141|FG009|COMPLETED|Part 2 (Up to 22 Days)||0
10725250|NCT02742766|11889142|FG010|COMPLETED|Part 2 (Up to 22 Days)||0
10725251|NCT02742766|11889143|FG011|COMPLETED|Part 2 (Up to 22 Days)||0
10725252|NCT02742766|11889144|FG012|COMPLETED|Part 2 (Up to 22 Days)||4
10725253|NCT02742766|11889145|FG013|COMPLETED|Part 2 (Up to 22 Days)||0
10725254|NCT02742766|11889146|FG014|COMPLETED|Part 2 (Up to 22 Days)||6
10725255|NCT02742766|11889147|FG015|COMPLETED|Part 2 (Up to 22 Days)|Day 4 study medication interrupted due to an AE and eventually withdrew from study on Day 5.|5
10725256|NCT02742766|11889148|FG016|COMPLETED|Part 2 (Up to 22 Days)||0
10725257|NCT02742766|11889149|FG017|COMPLETED|Part 2 (Up to 22 Days)||0
10725258|NCT02742766|11889150|FG018|COMPLETED|Part 2 (Up to 22 Days)||0
10725259|NCT02742766|11889132|FG000|NOT COMPLETED|Part 2 (Up to 22 Days)||0
10725260|NCT02742766|11889133|FG001|NOT COMPLETED|Part 2 (Up to 22 Days)||0
10725261|NCT02742766|11889134|FG002|NOT COMPLETED|Part 2 (Up to 22 Days)||0
10725262|NCT02742766|11889135|FG003|NOT COMPLETED|Part 2 (Up to 22 Days)||0
10725263|NCT02742766|11889136|FG004|NOT COMPLETED|Part 2 (Up to 22 Days)||0
10725264|NCT02742766|11889137|FG005|NOT COMPLETED|Part 2 (Up to 22 Days)||0
10725265|NCT02742766|11889138|FG006|NOT COMPLETED|Part 2 (Up to 22 Days)||0
10725266|NCT02742766|11889139|FG007|NOT COMPLETED|Part 2 (Up to 22 Days)||0
10725267|NCT02742766|11889140|FG008|NOT COMPLETED|Part 2 (Up to 22 Days)||0
10725268|NCT02742766|11889141|FG009|NOT COMPLETED|Part 2 (Up to 22 Days)||0
10725269|NCT02742766|11889142|FG010|NOT COMPLETED|Part 2 (Up to 22 Days)||0
10725270|NCT02742766|11889143|FG011|NOT COMPLETED|Part 2 (Up to 22 Days)||0
10725271|NCT02742766|11889144|FG012|NOT COMPLETED|Part 2 (Up to 22 Days)||2
10725272|NCT02742766|11889145|FG013|NOT COMPLETED|Part 2 (Up to 22 Days)||6
10725273|NCT02742766|11889146|FG014|NOT COMPLETED|Part 2 (Up to 22 Days)||0
10725274|NCT02742766|11889147|FG015|NOT COMPLETED|Part 2 (Up to 22 Days)||1
10725275|NCT02742766|11889148|FG016|NOT COMPLETED|Part 2 (Up to 22 Days)||0
10725276|NCT02742766|11889149|FG017|NOT COMPLETED|Part 2 (Up to 22 Days)||0
10725277|NCT02742766|11889150|FG018|NOT COMPLETED|Part 2 (Up to 22 Days)||0
10725278|NCT02742766|11889132|FG000|STARTED|Part 3 (Up to 36 Days)||0
10725279|NCT02742766|11889133|FG001|STARTED|Part 3 (Up to 36 Days)||0
10725280|NCT02742766|11889134|FG002|STARTED|Part 3 (Up to 36 Days)||0
10725281|NCT02742766|11889135|FG003|STARTED|Part 3 (Up to 36 Days)||0
10725282|NCT02742766|11889136|FG004|STARTED|Part 3 (Up to 36 Days)||0
10725283|NCT02742766|11889137|FG005|STARTED|Part 3 (Up to 36 Days)||0
10725284|NCT02742766|11889138|FG006|STARTED|Part 3 (Up to 36 Days)||0
10725285|NCT02742766|11889139|FG007|STARTED|Part 3 (Up to 36 Days)||0
10725286|NCT02742766|11889140|FG008|STARTED|Part 3 (Up to 36 Days)||0
10725287|NCT02742766|11889141|FG009|STARTED|Part 3 (Up to 36 Days)||0
10725288|NCT02742766|11889142|FG010|STARTED|Part 3 (Up to 36 Days)||0
10725289|NCT02742766|11889143|FG011|STARTED|Part 3 (Up to 36 Days)||0
10725290|NCT02742766|11889144|FG012|STARTED|Part 3 (Up to 36 Days)||0
10725291|NCT02742766|11889145|FG013|STARTED|Part 3 (Up to 36 Days)||0
10725292|NCT02742766|11889146|FG014|STARTED|Part 3 (Up to 36 Days)||0
10725293|NCT02742766|11889147|FG015|STARTED|Part 3 (Up to 36 Days)||0
10725294|NCT02742766|11889148|FG016|STARTED|Part 3 (Up to 36 Days)||0
10725295|NCT02742766|11889149|FG017|STARTED|Part 3 (Up to 36 Days)||0
10725296|NCT02742766|11889150|FG018|STARTED|Part 3 (Up to 36 Days)||0
10725297|NCT02742766|11889132|FG000|COMPLETED|Part 3 (Up to 36 Days)||0
10725298|NCT02742766|11889133|FG001|COMPLETED|Part 3 (Up to 36 Days)||0
10725299|NCT02742766|11889134|FG002|COMPLETED|Part 3 (Up to 36 Days)||0
10725300|NCT02742766|11889135|FG003|COMPLETED|Part 3 (Up to 36 Days)||0
10725301|NCT02742766|11889136|FG004|COMPLETED|Part 3 (Up to 36 Days)||0
10725302|NCT02742766|11889137|FG005|COMPLETED|Part 3 (Up to 36 Days)||0
10725303|NCT02742766|11889138|FG006|COMPLETED|Part 3 (Up to 36 Days)||0
10725304|NCT02742766|11889139|FG007|COMPLETED|Part 3 (Up to 36 Days)||0
10725305|NCT02742766|11889140|FG008|COMPLETED|Part 3 (Up to 36 Days)||0
10725306|NCT02742766|11889141|FG009|COMPLETED|Part 3 (Up to 36 Days)||0
10725307|NCT02742766|11889142|FG010|COMPLETED|Part 3 (Up to 36 Days)||0
10725308|NCT02742766|11889143|FG011|COMPLETED|Part 3 (Up to 36 Days)||0
10725309|NCT02742766|11889144|FG012|COMPLETED|Part 3 (Up to 36 Days)||0
10725310|NCT02742766|11889145|FG013|COMPLETED|Part 3 (Up to 36 Days)||0
10725311|NCT02742766|11889146|FG014|COMPLETED|Part 3 (Up to 36 Days)||0
10725312|NCT02742766|11889147|FG015|COMPLETED|Part 3 (Up to 36 Days)||0
10725313|NCT02742766|11889148|FG016|COMPLETED|Part 3 (Up to 36 Days)||0
10725314|NCT02742766|11889149|FG017|COMPLETED|Part 3 (Up to 36 Days)||0
10725315|NCT02742766|11889150|FG018|COMPLETED|Part 3 (Up to 36 Days)||0
10725316|NCT02742766|11889132|FG000|NOT COMPLETED|Part 3 (Up to 36 Days)||0
10725317|NCT02742766|11889133|FG001|NOT COMPLETED|Part 3 (Up to 36 Days)||0
10725318|NCT02742766|11889134|FG002|NOT COMPLETED|Part 3 (Up to 36 Days)||0
10725319|NCT02742766|11889135|FG003|NOT COMPLETED|Part 3 (Up to 36 Days)||0
10725320|NCT02742766|11889136|FG004|NOT COMPLETED|Part 3 (Up to 36 Days)||0
10725321|NCT02742766|11889137|FG005|NOT COMPLETED|Part 3 (Up to 36 Days)||0
10725322|NCT02742766|11889138|FG006|NOT COMPLETED|Part 3 (Up to 36 Days)||0
10725323|NCT02742766|11889139|FG007|NOT COMPLETED|Part 3 (Up to 36 Days)||0
10725324|NCT02742766|11889140|FG008|NOT COMPLETED|Part 3 (Up to 36 Days)||0
10725325|NCT02742766|11889141|FG009|NOT COMPLETED|Part 3 (Up to 36 Days)||0
10725326|NCT02742766|11889142|FG010|NOT COMPLETED|Part 3 (Up to 36 Days)||0
10725327|NCT02742766|11889143|FG011|NOT COMPLETED|Part 3 (Up to 36 Days)||0
10725328|NCT02742766|11889144|FG012|NOT COMPLETED|Part 3 (Up to 36 Days)||0
10725329|NCT02742766|11889145|FG013|NOT COMPLETED|Part 3 (Up to 36 Days)||0
10725330|NCT02742766|11889146|FG014|NOT COMPLETED|Part 3 (Up to 36 Days)||0
10725331|NCT02742766|11889147|FG015|NOT COMPLETED|Part 3 (Up to 36 Days)||0
10725332|NCT02742766|11889148|FG016|NOT COMPLETED|Part 3 (Up to 36 Days)||0
10725333|NCT02742766|11889149|FG017|NOT COMPLETED|Part 3 (Up to 36 Days)||0
10725334|NCT02742766|11889150|FG018|NOT COMPLETED|Part 3 (Up to 36 Days)||0
10725335|NCT02742818|11889212|FG000|STARTED|Overall Study||25
10725336|NCT02742818|11889213|FG001|STARTED|Overall Study||25
10725337|NCT02742818|11889212|FG000|COMPLETED|Overall Study||25
10725338|NCT02742818|11889213|FG001|COMPLETED|Overall Study||23
10725339|NCT02742818|11889212|FG000|NOT COMPLETED|Overall Study||0
10725340|NCT02742818|11889213|FG001|NOT COMPLETED|Overall Study||2
10725341|NCT02742987|11889223|FG000|STARTED|Overall Study||21
10725342|NCT02742987|11889224|FG001|STARTED|Overall Study||21
10725343|NCT02742987|11889223|FG000|COMPLETED|Overall Study||21
10725344|NCT02742987|11889224|FG001|COMPLETED|Overall Study||21
10725345|NCT02742987|11889223|FG000|NOT COMPLETED|Overall Study||0
10725346|NCT02742987|11889224|FG001|NOT COMPLETED|Overall Study||0
10725347|NCT02743078|11889230|FG000|STARTED|Overall Study||3
10725348|NCT02743078|11889230|FG000|Eligible Populaton|Overall Study||3
10725349|NCT02743078|11889230|FG000|Eligible With Six-month Follow-up Data|Overall Study||3
10725350|NCT02743078|11889230|FG000|COMPLETED|Overall Study||3
10725351|NCT02743078|11889230|FG000|NOT COMPLETED|Overall Study||0
10725352|NCT02743117|11889236|FG000|STARTED|Overall Study||60
10725353|NCT02743117|11889237|FG001|STARTED|Overall Study||241
10725354|NCT02743117|11889236|FG000|Treated|Overall Study||59
10725355|NCT02743117|11889237|FG001|Treated|Overall Study||241
10725356|NCT02743117|11889236|FG000|COMPLETED|Overall Study||59
10725357|NCT02743117|11889237|FG001|COMPLETED|Overall Study||240
10725358|NCT02743117|11889236|FG000|NOT COMPLETED|Overall Study||1
10725359|NCT02743117|11889237|FG001|NOT COMPLETED|Overall Study||1
10725360|NCT02743221|11889245|FG000|STARTED|Overall Study||77
10725361|NCT02743221|11889246|FG001|STARTED|Overall Study||77
10725362|NCT02743221|11889245|FG000|COMPLETED|Overall Study||21
10725363|NCT02743221|11889246|FG001|COMPLETED|Overall Study||17
10725364|NCT02743221|11889245|FG000|NOT COMPLETED|Overall Study||56
10725365|NCT02743221|11889246|FG001|NOT COMPLETED|Overall Study||60
10725366|NCT02743312|11889254|FG000|STARTED|Overall Study||3
10725367|NCT02743312|11889255|FG001|STARTED|Overall Study||2
10725368|NCT02743312|11889254|FG000|COMPLETED|Overall Study||3
10725369|NCT02743312|11889255|FG001|COMPLETED|Overall Study||2
10725370|NCT02743312|11889254|FG000|NOT COMPLETED|Overall Study||0
10725371|NCT02743312|11889255|FG001|NOT COMPLETED|Overall Study||0
10725372|NCT02743377|11889272|FG000|STARTED|Overall Study||9
10725373|NCT02743377|11889273|FG001|STARTED|Overall Study||6
10725374|NCT02743377|11889272|FG000|Brain PET With 11C Rolipram|Overall Study||8
10725375|NCT02743377|11889273|FG001|Brain PET With 11C Rolipram|Overall Study||3
10725376|NCT02743377|11889272|FG000|Whole Body PET Baseline With 11C Rolipra|Overall Study||5
10725377|NCT02743377|11889273|FG001|Whole Body PET Baseline With 11C Rolipra|Overall Study||4
10725378|NCT02743377|11889272|FG000|Whole Body PET Baseline & Blocked|Overall Study||0
10725379|NCT02743377|11889273|FG001|Whole Body PET Baseline & Blocked|Overall Study||2
10725380|NCT02743377|11889272|FG000|COMPLETED|Overall Study||7
10725381|NCT02743377|11889273|FG001|COMPLETED|Overall Study||6
10725382|NCT02743377|11889272|FG000|NOT COMPLETED|Overall Study||2
10725383|NCT02743377|11889273|FG001|NOT COMPLETED|Overall Study||0
10725384|NCT02743442|11889280|FG000|STARTED|Overall Study||8
10725385|NCT02743442|11889280|FG000|COMPLETED|Overall Study||8
10725386|NCT02743442|11889280|FG000|NOT COMPLETED|Overall Study||0
10725387|NCT02743520|11889284|FG000|STARTED|Overall Study||86
10725388|NCT02743520|11889284|FG000|COMPLETED|Overall Study||85
10725389|NCT02743520|11889284|FG000|NOT COMPLETED|Overall Study||1
10814572|NCT02297230|11977364|FG000|COMPLETED|Overall Study||11
10814573|NCT02297230|11977365|FG001|COMPLETED|Overall Study||11
10814574|NCT02297230|11977366|FG002|COMPLETED|Overall Study||11
10814575|NCT02297230|11977367|FG003|COMPLETED|Overall Study||11
10408206|NCT00753675|11552252|FG002|NOT COMPLETED|Overall Study||56
10408207|NCT00753688|11552262|FG000|STARTED|Overall Study||123
10725390|NCT02743702|11889290|FG000|STARTED|Overall Study||11
10725391|NCT02743702|11889291|FG001|STARTED|Overall Study||10
10725392|NCT02743702|11889290|FG000|COMPLETED|Overall Study||11
10725393|NCT02743702|11889291|FG001|COMPLETED|Overall Study||10
10725394|NCT02743702|11889290|FG000|NOT COMPLETED|Overall Study||0
10725395|NCT02743702|11889291|FG001|NOT COMPLETED|Overall Study||0
10725396|NCT02743780|11889302|FG000|STARTED|Part 1 (3 Days)||6
10725397|NCT02743780|11889303|FG001|STARTED|Part 1 (3 Days)||6
10725398|NCT02743780|11889304|FG002|STARTED|Part 1 (3 Days)||6
10725399|NCT02743780|11889305|FG003|STARTED|Part 1 (3 Days)||6
10725400|NCT02743780|11889306|FG004|STARTED|Part 1 (3 Days)||8
10725401|NCT02743780|11889302|FG000|COMPLETED|Part 1 (3 Days)||6
10725402|NCT02743780|11889303|FG001|COMPLETED|Part 1 (3 Days)||6
10725403|NCT02743780|11889304|FG002|COMPLETED|Part 1 (3 Days)||6
10725404|NCT02743780|11889305|FG003|COMPLETED|Part 1 (3 Days)||6
10725405|NCT02743780|11889306|FG004|COMPLETED|Part 1 (3 Days)||8
10725406|NCT02743780|11889302|FG000|NOT COMPLETED|Part 1 (3 Days)||0
10725407|NCT02743780|11889303|FG001|NOT COMPLETED|Part 1 (3 Days)||0
10725408|NCT02743780|11889304|FG002|NOT COMPLETED|Part 1 (3 Days)||0
10725409|NCT02743780|11889305|FG003|NOT COMPLETED|Part 1 (3 Days)||0
10725410|NCT02743780|11889306|FG004|NOT COMPLETED|Part 1 (3 Days)||0
10725411|NCT02743780|11889302|FG000|STARTED|Part 2 (8 Days)||0
10725412|NCT02743780|11889303|FG001|STARTED|Part 2 (8 Days)||6
10725413|NCT02743780|11889304|FG002|STARTED|Part 2 (8 Days)||6
10725414|NCT02743780|11889305|FG003|STARTED|Part 2 (8 Days)||0
10725415|NCT02743780|11889306|FG004|STARTED|Part 2 (8 Days)||4
10725416|NCT02743780|11889302|FG000|COMPLETED|Part 2 (8 Days)||0
10725417|NCT02743780|11889303|FG001|COMPLETED|Part 2 (8 Days)||6
10725418|NCT02743780|11889304|FG002|COMPLETED|Part 2 (8 Days)||6
10725419|NCT02743780|11889305|FG003|COMPLETED|Part 2 (8 Days)||0
10408208|NCT00753688|11552263|FG001|STARTED|Overall Study||246
10408209|NCT00753688|11552262|FG000|Ongoing - in Follow-up|Overall Study||15
10408210|NCT00753688|11552263|FG001|Ongoing - in Follow-up|Overall Study||31
10408211|NCT00753688|11552262|FG000|COMPLETED|Overall Study||0
10725420|NCT02743780|11889306|FG004|COMPLETED|Part 2 (8 Days)||4
10725421|NCT02743780|11889302|FG000|NOT COMPLETED|Part 2 (8 Days)||0
10725422|NCT02743780|11889303|FG001|NOT COMPLETED|Part 2 (8 Days)||0
10725423|NCT02743780|11889304|FG002|NOT COMPLETED|Part 2 (8 Days)||0
10725424|NCT02743780|11889305|FG003|NOT COMPLETED|Part 2 (8 Days)||0
10725425|NCT02743780|11889306|FG004|NOT COMPLETED|Part 2 (8 Days)||0
10725426|NCT02743780|11889302|FG000|STARTED|Part 3 (7 Days)||0
10725427|NCT02743780|11889303|FG001|STARTED|Part 3 (7 Days)||0
10725428|NCT02743780|11889304|FG002|STARTED|Part 3 (7 Days)||25
10725429|NCT02743780|11889305|FG003|STARTED|Part 3 (7 Days)||0
10725430|NCT02743780|11889306|FG004|STARTED|Part 3 (7 Days)||25
10725431|NCT02743780|11889302|FG000|COMPLETED|Part 3 (7 Days)||0
10725432|NCT02743780|11889303|FG001|COMPLETED|Part 3 (7 Days)||0
10725433|NCT02743780|11889304|FG002|COMPLETED|Part 3 (7 Days)||24
10725434|NCT02743780|11889305|FG003|COMPLETED|Part 3 (7 Days)||0
10725435|NCT02743780|11889306|FG004|COMPLETED|Part 3 (7 Days)||25
10725436|NCT02743780|11889302|FG000|NOT COMPLETED|Part 3 (7 Days)||0
10725437|NCT02743780|11889303|FG001|NOT COMPLETED|Part 3 (7 Days)||0
10725438|NCT02743780|11889304|FG002|NOT COMPLETED|Part 3 (7 Days)||1
10725439|NCT02743780|11889305|FG003|NOT COMPLETED|Part 3 (7 Days)||0
10725440|NCT02743780|11889306|FG004|NOT COMPLETED|Part 3 (7 Days)||0
10725441|NCT02743793|11889328|FG000|STARTED|Overall Study||5
10725442|NCT02743793|11889329|FG001|STARTED|Overall Study||36
10725443|NCT02743793|11889328|FG000|COMPLETED|Overall Study||0
10725444|NCT02743793|11889329|FG001|COMPLETED|Overall Study||0
10725445|NCT02743793|11889328|FG000|NOT COMPLETED|Overall Study||5
10725446|NCT02743793|11889329|FG001|NOT COMPLETED|Overall Study||36
10725447|NCT02743936|11889336|FG000|STARTED|Overall Study||32
10725448|NCT02743936|11889337|FG001|STARTED|Overall Study||32
10725449|NCT02743936|11889336|FG000|COMPLETED|Overall Study||32
10725450|NCT02743936|11889337|FG001|COMPLETED|Overall Study||32
10725451|NCT02743936|11889336|FG000|NOT COMPLETED|Overall Study||0
10725452|NCT02743936|11889337|FG001|NOT COMPLETED|Overall Study||0
10725453|NCT02743949|11889346|FG000|STARTED|Overall Study||86
10725454|NCT02743949|11889347|FG001|STARTED|Overall Study||85
10725455|NCT02743949|11889348|FG002|STARTED|Overall Study||85
10408212|NCT00753688|11552263|FG001|COMPLETED|Overall Study||0
10725456|NCT02743949|11889346|FG000|COMPLETED|Overall Study||82
10725457|NCT02743949|11889347|FG001|COMPLETED|Overall Study||84
10725458|NCT02743949|11889348|FG002|COMPLETED|Overall Study||82
10725459|NCT02743949|11889346|FG000|NOT COMPLETED|Overall Study||4
10725460|NCT02743949|11889347|FG001|NOT COMPLETED|Overall Study||1
10725461|NCT02743949|11889348|FG002|NOT COMPLETED|Overall Study||3
10725462|NCT02743962|11889358|FG000|STARTED|Overall Study||5
10725463|NCT02743962|11889359|FG001|STARTED|Overall Study||5
10725464|NCT02743962|11889358|FG000|COMPLETED|Overall Study||4
10725465|NCT02743962|11889359|FG001|COMPLETED|Overall Study||5
10725466|NCT02743962|11889358|FG000|NOT COMPLETED|Overall Study||1
10725467|NCT02743962|11889359|FG001|NOT COMPLETED|Overall Study||0
10725468|NCT02744066|11889370|FG000|STARTED|Overall Study||25
10725469|NCT02744066|11889371|FG001|STARTED|Overall Study||30
10408213|NCT00753688|11552262|FG000|NOT COMPLETED|Overall Study||123
10408214|NCT00753688|11552263|FG001|NOT COMPLETED|Overall Study||246
10408215|NCT00753714|11552271|FG000|STARTED|Overall Study||61
10725470|NCT02744066|11889370|FG000|COMPLETED|Overall Study||25
10725471|NCT02744066|11889371|FG001|COMPLETED|Overall Study||25
10725472|NCT02744066|11889370|FG000|NOT COMPLETED|Overall Study||0
10725473|NCT02744066|11889371|FG001|NOT COMPLETED|Overall Study||5
10725474|NCT02744391|11889379|FG000|STARTED|Overall Study||47
10725475|NCT02744391|11889379|FG000|COMPLETED|Overall Study||33
10725476|NCT02744391|11889379|FG000|NOT COMPLETED|Overall Study||14
10725477|NCT02744534|11889383|FG000|STARTED|Overall Study||21
10725478|NCT02744534|11889383|FG000|COMPLETED|Overall Study||21
10725479|NCT02744534|11889383|FG000|NOT COMPLETED|Overall Study||0
10725480|NCT02744755|11889391|FG000|STARTED|Study Period 1||177
10725481|NCT02744755|11889392|FG001|STARTED|Study Period 1||176
10725482|NCT02744755|11889391|FG000|COMPLETED|Study Period 1||163
10725483|NCT02744755|11889392|FG001|COMPLETED|Study Period 1||168
10725484|NCT02744755|11889391|FG000|NOT COMPLETED|Study Period 1||14
10725485|NCT02744755|11889392|FG001|NOT COMPLETED|Study Period 1||8
10725486|NCT02744755|11889391|FG000|STARTED|Study Period 2||159
10725487|NCT02744755|11889392|FG001|STARTED|Study Period 2||166
10725488|NCT02744755|11889391|FG000|COMPLETED|Study Period 2||145
10725489|NCT02744755|11889392|FG001|COMPLETED|Study Period 2||158
10725490|NCT02744755|11889391|FG000|NOT COMPLETED|Study Period 2||14
10725491|NCT02744755|11889392|FG001|NOT COMPLETED|Study Period 2||8
10725492|NCT02744846|11889402|FG000|STARTED|5 Year Outcome Assessment||681739
10725493|NCT02744846|11889402|FG000|Excluded Ineligible Patients|5 Year Outcome Assessment|Includes lost to follow-up and patients that had not reached age 4 years by end of study period|319189
10725494|NCT02744846|11889402|FG000|COMPLETED|5 Year Outcome Assessment|Number of patients that meet eligibility criteria|362550
10725495|NCT02744846|11889402|FG000|NOT COMPLETED|5 Year Outcome Assessment||319189
10725496|NCT02744846|11889402|FG000|STARTED|10 Year Outcome Assessment||362550
10725497|NCT02744846|11889402|FG000|Exclude Ineligible Patients|10 Year Outcome Assessment|Loss to follow-up, patients not yet 9 years, or systems that only had data from 2009 to 2016 or less|305820
10725498|NCT02744846|11889402|FG000|COMPLETED|10 Year Outcome Assessment||56730
10725499|NCT02744846|11889402|FG000|NOT COMPLETED|10 Year Outcome Assessment||305820
10725500|NCT02744898|11889410|FG000|STARTED|Overall Study||23
10725501|NCT02744898|11889410|FG000|COMPLETED|Overall Study||19
10725502|NCT02744898|11889410|FG000|NOT COMPLETED|Overall Study||4
10725503|NCT02745080|11889416|FG000|STARTED|Overall Study||426
10725504|NCT02745080|11889417|FG001|STARTED|Overall Study||427
10725505|NCT02745080|11889416|FG000|COMPLETED|Overall Study||371
10725506|NCT02745080|11889417|FG001|COMPLETED|Overall Study||338
10725507|NCT02745080|11889416|FG000|NOT COMPLETED|Overall Study||55
10725508|NCT02745080|11889417|FG001|NOT COMPLETED|Overall Study||89
10725509|NCT02745119|11889428|FG000|STARTED|Overall Study||145
10725510|NCT02745119|11889429|FG001|STARTED|Overall Study||274
10725511|NCT02745119|11889430|FG002|STARTED|Overall Study||146
10725512|NCT02745119|11889431|FG003|STARTED|Overall Study||277
10725513|NCT02745119|11889428|FG000|COMPLETED|Overall Study||0
10725514|NCT02745119|11889429|FG001|COMPLETED|Overall Study||0
10725515|NCT02745119|11889430|FG002|COMPLETED|Overall Study||0
10725516|NCT02745119|11889431|FG003|COMPLETED|Overall Study||0
10725517|NCT02745119|11889428|FG000|NOT COMPLETED|Overall Study||145
10725518|NCT02745119|11889429|FG001|NOT COMPLETED|Overall Study||274
10725519|NCT02745119|11889430|FG002|NOT COMPLETED|Overall Study||146
10725520|NCT02745119|11889431|FG003|NOT COMPLETED|Overall Study||277
10725521|NCT02745145|11889446|FG000|STARTED|Overall Study||10
10725522|NCT02745145|11889447|FG001|STARTED|Overall Study||5
10725523|NCT02745145|11889448|FG002|STARTED|Overall Study||9
10725524|NCT02745145|11889446|FG000|COMPLETED|Overall Study||0
10725525|NCT02745145|11889447|FG001|COMPLETED|Overall Study||0
10725526|NCT02745145|11889448|FG002|COMPLETED|Overall Study||0
10725527|NCT02745145|11889446|FG000|NOT COMPLETED|Overall Study||10
10725528|NCT02745145|11889447|FG001|NOT COMPLETED|Overall Study||5
10725529|NCT02745145|11889448|FG002|NOT COMPLETED|Overall Study||9
10725530|NCT02745353|11889458|FG000|STARTED|First Intervention (2 Weeks)||4
10408216|NCT00753714|11552272|FG001|STARTED|Overall Study||63
10725531|NCT02745353|11889459|FG001|STARTED|First Intervention (2 Weeks)||3
10725532|NCT02745353|11889458|FG000|COMPLETED|First Intervention (2 Weeks)||1
10725533|NCT02745353|11889459|FG001|COMPLETED|First Intervention (2 Weeks)||1
10725534|NCT02745353|11889458|FG000|NOT COMPLETED|First Intervention (2 Weeks)||3
10725535|NCT02745353|11889459|FG001|NOT COMPLETED|First Intervention (2 Weeks)||2
10725536|NCT02745353|11889458|FG000|STARTED|Washout (3 Days)||1
10725537|NCT02745353|11889459|FG001|STARTED|Washout (3 Days)||1
10725538|NCT02745353|11889458|FG000|COMPLETED|Washout (3 Days)||1
10725539|NCT02745353|11889459|FG001|COMPLETED|Washout (3 Days)||1
10725540|NCT02745353|11889458|FG000|NOT COMPLETED|Washout (3 Days)||0
10725541|NCT02745353|11889459|FG001|NOT COMPLETED|Washout (3 Days)||0
10725542|NCT02745353|11889458|FG000|STARTED|Second Intervention (2 Weeks)||1
10725543|NCT02745353|11889459|FG001|STARTED|Second Intervention (2 Weeks)||1
10725544|NCT02745353|11889458|FG000|COMPLETED|Second Intervention (2 Weeks)||1
10725545|NCT02745353|11889459|FG001|COMPLETED|Second Intervention (2 Weeks)||0
10725546|NCT02745353|11889458|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
10725547|NCT02745353|11889459|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||1
10725548|NCT02745392|11889469|FG000|STARTED|Overall Study||91
10725549|NCT02745392|11889470|FG001|STARTED|Overall Study||90
10725550|NCT02745392|11889471|FG002|STARTED|Overall Study||92
10725551|NCT02745392|11889472|FG003|STARTED|Overall Study||92
10725552|NCT02745392|11889469|FG000|COMPLETED|Overall Study||91
10725553|NCT02745392|11889470|FG001|COMPLETED|Overall Study||89
10725554|NCT02745392|11889471|FG002|COMPLETED|Overall Study||92
10725555|NCT02745392|11889472|FG003|COMPLETED|Overall Study||92
10725556|NCT02745392|11889469|FG000|NOT COMPLETED|Overall Study||0
10725557|NCT02745392|11889470|FG001|NOT COMPLETED|Overall Study||1
10725558|NCT02745392|11889471|FG002|NOT COMPLETED|Overall Study||0
10725559|NCT02745392|11889472|FG003|NOT COMPLETED|Overall Study||0
10725560|NCT02745626|11889485|FG000|STARTED|Overall Study||24
10725561|NCT02745626|11889486|FG001|STARTED|Overall Study||22
10725562|NCT02745626|11889487|FG002|STARTED|Overall Study||22
10725563|NCT02745626|11889485|FG000|COMPLETED|Overall Study||21
10725564|NCT02745626|11889486|FG001|COMPLETED|Overall Study||16
10725565|NCT02745626|11889487|FG002|COMPLETED|Overall Study||19
10725566|NCT02745626|11889485|FG000|NOT COMPLETED|Overall Study||3
10725567|NCT02745626|11889486|FG001|NOT COMPLETED|Overall Study||6
10725568|NCT02745626|11889487|FG002|NOT COMPLETED|Overall Study||3
10725569|NCT02746107|11889495|FG000|STARTED|Overall Study||968
10725570|NCT02746107|11889495|FG000|2 Diagrams DA|Overall Study||482
10725571|NCT02746107|11889495|FG000|1 Diagram DA|Overall Study||486
10725572|NCT02746107|11889495|FG000|1year Risk Estimate|Overall Study||483
10725573|NCT02746107|11889495|FG000|5year Risk Estimate|Overall Study||485
10725574|NCT02746107|11889495|FG000|Target=Patient|Overall Study||486
10725575|NCT02746107|11889495|FG000|Target=Physician|Overall Study||482
10725576|NCT02746107|11889495|FG000|CHA2DS2-VASC Score = 1|Overall Study||195
10725577|NCT02746107|11889495|FG000|CHA2DS2-VASC Score = 2|Overall Study||189
10725578|NCT02746107|11889495|FG000|CHA2DS2-VASC Score = 3|Overall Study||195
10725579|NCT02746107|11889495|FG000|CHA2DS2-VASC Score = 4|Overall Study||197
10725580|NCT02746107|11889495|FG000|CHA2DS2-VASC Score = 5|Overall Study||192
10725581|NCT02746107|11889495|FG000|COMPLETED|Overall Study||968
10725582|NCT02746107|11889495|FG000|NOT COMPLETED|Overall Study||0
10725583|NCT02746406|11889510|FG000|STARTED|Overall Study||5
10725584|NCT02746406|11889510|FG000|COMPLETED|Overall Study||5
10725585|NCT02746406|11889510|FG000|NOT COMPLETED|Overall Study||0
10725586|NCT02746575|11889514|FG000|STARTED|Overall Study||70
10725587|NCT02746575|11889514|FG000|COMPLETED|Overall Study||20
10725588|NCT02746575|11889514|FG000|NOT COMPLETED|Overall Study||50
10725589|NCT02746627|11889521|FG000|STARTED|Overall Study||60
10725590|NCT02746627|11889522|FG001|STARTED|Overall Study||30
10725591|NCT02746627|11889523|FG002|STARTED|Overall Study||30
10725592|NCT02746627|11889521|FG000|COMPLETED|Overall Study||59
10725593|NCT02746627|11889522|FG001|COMPLETED|Overall Study||29
10725594|NCT02746627|11889523|FG002|COMPLETED|Overall Study||29
10725595|NCT02746627|11889521|FG000|NOT COMPLETED|Overall Study||1
10725596|NCT02746627|11889522|FG001|NOT COMPLETED|Overall Study||1
10725597|NCT02746627|11889523|FG002|NOT COMPLETED|Overall Study||1
10725598|NCT02746679|11889533|FG000|STARTED|Overall Study||80
10725599|NCT02746679|11889534|FG001|STARTED|Overall Study||81
10725600|NCT02746679|11889533|FG000|COMPLETED|Overall Study||76
10725601|NCT02746679|11889534|FG001|COMPLETED|Overall Study||75
10725602|NCT02746679|11889533|FG000|NOT COMPLETED|Overall Study||4
10725603|NCT02746679|11889534|FG001|NOT COMPLETED|Overall Study||6
10725604|NCT02746705|11889542|FG000|STARTED|Overall Study||17
10725605|NCT02746705|11889543|FG001|STARTED|Overall Study||14
10725606|NCT02746705|11889542|FG000|COMPLETED|Overall Study||15
10725607|NCT02746705|11889543|FG001|COMPLETED|Overall Study||12
10725608|NCT02746705|11889542|FG000|NOT COMPLETED|Overall Study||2
10725609|NCT02746705|11889543|FG001|NOT COMPLETED|Overall Study||2
10725610|NCT02746874|11889551|FG000|STARTED|Overall Study||35
10725611|NCT02746874|11889552|FG001|STARTED|Overall Study||35
10725612|NCT02746874|11889551|FG000|COMPLETED|Overall Study||35
10725613|NCT02746874|11889552|FG001|COMPLETED|Overall Study||32
10725614|NCT02746874|11889551|FG000|NOT COMPLETED|Overall Study||0
10725615|NCT02746874|11889552|FG001|NOT COMPLETED|Overall Study||3
10725616|NCT02746991|11889560|FG000|STARTED|Overall Study||52
10725617|NCT02746991|11889561|FG001|STARTED|Overall Study||101
10725618|NCT02746991|11889560|FG000|COMPLETED|Overall Study||24
10725619|NCT02746991|11889561|FG001|COMPLETED|Overall Study||67
10725620|NCT02746991|11889560|FG000|NOT COMPLETED|Overall Study||28
10725621|NCT02746991|11889561|FG001|NOT COMPLETED|Overall Study||34
10725642|NCT02747108|11889593|FG000|STARTED|Overall Study||253
10725643|NCT02747108|11889594|FG001|STARTED|Overall Study||62
10725644|NCT02747108|11889593|FG000|COMPLETED|Overall Study||248
10725645|NCT02747108|11889594|FG001|COMPLETED|Overall Study||60
10725646|NCT02747108|11889593|FG000|NOT COMPLETED|Overall Study||5
10725647|NCT02747108|11889594|FG001|NOT COMPLETED|Overall Study||2
10725648|NCT02747186|11889607|FG000|STARTED|First Intervention||12
10725649|NCT02747186|11889608|FG001|STARTED|First Intervention||12
10725650|NCT02747186|11889607|FG000|COMPLETED|First Intervention||12
10725651|NCT02747186|11889608|FG001|COMPLETED|First Intervention||12
10725652|NCT02747186|11889607|FG000|NOT COMPLETED|First Intervention||0
10725653|NCT02747186|11889608|FG001|NOT COMPLETED|First Intervention||0
10725654|NCT02747186|11889607|FG000|STARTED|Washout (1 Week)||12
10725655|NCT02747186|11889608|FG001|STARTED|Washout (1 Week)||12
10725656|NCT02747186|11889607|FG000|COMPLETED|Washout (1 Week)||12
10725657|NCT02747186|11889608|FG001|COMPLETED|Washout (1 Week)||12
10725658|NCT02747186|11889607|FG000|NOT COMPLETED|Washout (1 Week)||0
10725659|NCT02747186|11889608|FG001|NOT COMPLETED|Washout (1 Week)||0
10725660|NCT02747186|11889607|FG000|STARTED|Second Intervention||12
10725661|NCT02747186|11889608|FG001|STARTED|Second Intervention||12
10725662|NCT02747186|11889607|FG000|COMPLETED|Second Intervention||12
10725663|NCT02747186|11889608|FG001|COMPLETED|Second Intervention||12
10725664|NCT02747186|11889607|FG000|NOT COMPLETED|Second Intervention||0
10725665|NCT02747186|11889608|FG001|NOT COMPLETED|Second Intervention||0
10725666|NCT02747238|11889616|FG000|STARTED|Overall Study||12
10725667|NCT02747238|11889617|FG001|STARTED|Overall Study||20
10725668|NCT02747238|11889616|FG000|COMPLETED|Overall Study||9
10725669|NCT02747238|11889617|FG001|COMPLETED|Overall Study||14
10725670|NCT02747238|11889616|FG000|NOT COMPLETED|Overall Study||3
10725671|NCT02747238|11889617|FG001|NOT COMPLETED|Overall Study||6
10725672|NCT02747420|11889625|FG000|STARTED|Overall Study||18
10725673|NCT02747420|11889626|FG001|STARTED|Overall Study||22
10725674|NCT02747420|11889625|FG000|COMPLETED|Overall Study||11
10725675|NCT02747420|11889626|FG001|COMPLETED|Overall Study||18
10725676|NCT02747420|11889625|FG000|NOT COMPLETED|Overall Study||7
10725677|NCT02747420|11889626|FG001|NOT COMPLETED|Overall Study||4
10725678|NCT02747615|11889634|FG000|STARTED|Overall Study||30
10725679|NCT02747615|11889635|FG001|STARTED|Overall Study||30
10725680|NCT02747615|11889634|FG000|COMPLETED|Overall Study||30
10725681|NCT02747615|11889635|FG001|COMPLETED|Overall Study||30
10725682|NCT02747615|11889634|FG000|NOT COMPLETED|Overall Study||0
10725683|NCT02747615|11889635|FG001|NOT COMPLETED|Overall Study||0
10725684|NCT02747628|11889644|FG000|STARTED|Overall Study||20
10725685|NCT02747628|11889645|FG001|STARTED|Overall Study||20
10725686|NCT02747628|11889646|FG002|STARTED|Overall Study||20
10725687|NCT02747628|11889644|FG000|COMPLETED|Overall Study||20
10725688|NCT02747628|11889645|FG001|COMPLETED|Overall Study||20
10725689|NCT02747628|11889646|FG002|COMPLETED|Overall Study||20
10725690|NCT02747628|11889644|FG000|NOT COMPLETED|Overall Study||0
10725691|NCT02747628|11889645|FG001|NOT COMPLETED|Overall Study||0
10725692|NCT02747628|11889646|FG002|NOT COMPLETED|Overall Study||0
10725693|NCT02747875|11889656|FG000|STARTED|Overall Study||12
10725694|NCT02747875|11889657|FG001|STARTED|Overall Study||14
10725695|NCT02747875|11889656|FG000|COMPLETED|Overall Study||11
10725696|NCT02747875|11889657|FG001|COMPLETED|Overall Study||13
10725697|NCT02747875|11889656|FG000|NOT COMPLETED|Overall Study||1
10725698|NCT02747875|11889657|FG001|NOT COMPLETED|Overall Study||1
10777494|NCT03341299|11939499|FG001|NOT COMPLETED|Period 1||0
10777495|NCT03341299|11939500|FG002|NOT COMPLETED|Period 1||0
10777496|NCT03341299|11939501|FG003|NOT COMPLETED|Period 1||0
10777497|NCT03341299|11939498|FG000|STARTED|Washout (A Minimum of 21 Hours)||9
10777498|NCT03341299|11939499|FG001|STARTED|Washout (A Minimum of 21 Hours)||9
10777499|NCT03341299|11939500|FG002|STARTED|Washout (A Minimum of 21 Hours)||9
10777500|NCT03341299|11939501|FG003|STARTED|Washout (A Minimum of 21 Hours)||9
10777501|NCT03341299|11939498|FG000|COMPLETED|Washout (A Minimum of 21 Hours)||9
10777502|NCT03341299|11939499|FG001|COMPLETED|Washout (A Minimum of 21 Hours)||9
10777503|NCT03341299|11939500|FG002|COMPLETED|Washout (A Minimum of 21 Hours)||8
10777504|NCT03341299|11939501|FG003|COMPLETED|Washout (A Minimum of 21 Hours)||9
10777505|NCT03341299|11939498|FG000|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
10777506|NCT03341299|11939499|FG001|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
10777507|NCT03341299|11939500|FG002|NOT COMPLETED|Washout (A Minimum of 21 Hours)||1
10777508|NCT03341299|11939501|FG003|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
10777509|NCT03341299|11939498|FG000|STARTED|Period 2||9
10777510|NCT03341299|11939499|FG001|STARTED|Period 2||9
10777511|NCT03341299|11939500|FG002|STARTED|Period 2||8
10777512|NCT03341299|11939501|FG003|STARTED|Period 2||9
10777513|NCT03341299|11939498|FG000|COMPLETED|Period 2||9
10777514|NCT03341299|11939499|FG001|COMPLETED|Period 2||9
10777515|NCT03341299|11939500|FG002|COMPLETED|Period 2||8
10777516|NCT03341299|11939501|FG003|COMPLETED|Period 2||9
10777517|NCT03341299|11939498|FG000|NOT COMPLETED|Period 2||0
10777518|NCT03341299|11939499|FG001|NOT COMPLETED|Period 2||0
10725707|NCT02748070|11889674|FG000|STARTED|Overall Study||41
10725708|NCT02748070|11889675|FG001|STARTED|Overall Study||40
10725709|NCT02748070|11889674|FG000|Randomized and Treated|Overall Study||40
10725710|NCT02748070|11889675|FG001|Randomized and Treated|Overall Study||40
10725711|NCT02748070|11889674|FG000|COMPLETED|Overall Study||33
10725712|NCT02748070|11889675|FG001|COMPLETED|Overall Study||39
10725713|NCT02748070|11889674|FG000|NOT COMPLETED|Overall Study||8
10725714|NCT02748070|11889675|FG001|NOT COMPLETED|Overall Study||1
10725715|NCT02748096|11889683|FG000|STARTED|Overall Study||23
10725716|NCT02748096|11889684|FG001|STARTED|Overall Study||22
10725717|NCT02748096|11889683|FG000|COMPLETED|Overall Study||23
10725718|NCT02748096|11889684|FG001|COMPLETED|Overall Study||22
10725719|NCT02748096|11889683|FG000|NOT COMPLETED|Overall Study||0
10814576|NCT02297230|11977364|FG000|NOT COMPLETED|Overall Study||0
10814577|NCT02297230|11977365|FG001|NOT COMPLETED|Overall Study||0
10814578|NCT02297230|11977366|FG002|NOT COMPLETED|Overall Study||0
10725720|NCT02748096|11889684|FG001|NOT COMPLETED|Overall Study||0
10725721|NCT02748213|11889692|FG000|STARTED|Overall Study||113
10725722|NCT02748213|11889693|FG001|STARTED|Overall Study||112
10725723|NCT02748213|11889692|FG000|Treated|Overall Study||112
10725724|NCT02748213|11889693|FG001|Treated|Overall Study||110
10725725|NCT02748213|11889692|FG000|COMPLETED|Overall Study|"*The reason Refused Treatment also includes those who did not cooperate or withdrew consent."|0
10725726|NCT02748213|11889693|FG001|COMPLETED|Overall Study||0
10725727|NCT02748213|11889692|FG000|NOT COMPLETED|Overall Study||113
10725728|NCT02748213|11889693|FG001|NOT COMPLETED|Overall Study||112
10725729|NCT02748317|11889699|FG000|STARTED|Overall Study||96
10725730|NCT02748317|11889699|FG000|COMPLETED|Overall Study||73
10725731|NCT02748317|11889699|FG000|NOT COMPLETED|Overall Study||23
10725732|NCT02748356|11889703|FG000|STARTED|Overall Study||7
10725733|NCT02748356|11889703|FG000|COMPLETED|Overall Study||6
10725734|NCT02748356|11889703|FG000|NOT COMPLETED|Overall Study||1
10725735|NCT02748512|11889709|FG000|STARTED|Overall Study||14
10725736|NCT02748512|11889710|FG001|STARTED|Overall Study||12
10725737|NCT02748512|11889709|FG000|COMPLETED|Overall Study||13
10725738|NCT02748512|11889710|FG001|COMPLETED|Overall Study||11
10725739|NCT02748512|11889709|FG000|NOT COMPLETED|Overall Study||1
10725740|NCT02748512|11889710|FG001|NOT COMPLETED|Overall Study||1
10725741|NCT02748525|11889716|FG000|STARTED|Overall Study||50
10725742|NCT02748525|11889716|FG000|Completed Study Intervention|Overall Study||50
10725743|NCT02748525|11889716|FG000|COMPLETED|Overall Study|Completed 6 months follow up|39
10725744|NCT02748525|11889716|FG000|NOT COMPLETED|Overall Study||11
10725745|NCT02748694|11889735|FG000|STARTED|Overall Study||10
10725746|NCT02748694|11889736|FG001|STARTED|Overall Study||6
10725747|NCT02748694|11889737|FG002|STARTED|Overall Study||6
10725748|NCT02748694|11889738|FG003|STARTED|Overall Study||6
10725749|NCT02748694|11889739|FG004|STARTED|Overall Study||6
10725750|NCT02748694|11889740|FG005|STARTED|Overall Study||6
10725751|NCT02748694|11889741|FG006|STARTED|Overall Study||8
10725752|NCT02748694|11889742|FG007|STARTED|Overall Study||6
10725753|NCT02748694|11889743|FG008|STARTED|Overall Study||6
10725754|NCT02748694|11889744|FG009|STARTED|Overall Study||6
10725755|NCT02748694|11889745|FG010|STARTED|Overall Study||6
10725756|NCT02748694|11889746|FG011|STARTED|Overall Study||9
10725757|NCT02748694|11889747|FG012|STARTED|Overall Study||9
10725758|NCT02748694|11889748|FG013|STARTED|Overall Study||8
10725759|NCT02748694|11889749|FG014|STARTED|Overall Study||16
10725760|NCT02748694|11889735|FG000|COMPLETED|Overall Study||10
10725761|NCT02748694|11889736|FG001|COMPLETED|Overall Study||6
10725762|NCT02748694|11889737|FG002|COMPLETED|Overall Study||6
10725763|NCT02748694|11889738|FG003|COMPLETED|Overall Study||6
10725764|NCT02748694|11889739|FG004|COMPLETED|Overall Study||6
10725765|NCT02748694|11889740|FG005|COMPLETED|Overall Study||6
10725766|NCT02748694|11889741|FG006|COMPLETED|Overall Study||8
10725767|NCT02748694|11889742|FG007|COMPLETED|Overall Study||6
10725768|NCT02748694|11889743|FG008|COMPLETED|Overall Study||6
10725769|NCT02748694|11889744|FG009|COMPLETED|Overall Study||6
10725770|NCT02748694|11889745|FG010|COMPLETED|Overall Study||6
10725771|NCT02748694|11889746|FG011|COMPLETED|Overall Study||9
10814579|NCT02297230|11977367|FG003|NOT COMPLETED|Overall Study||0
10814580|NCT02294981|11977383|FG000|STARTED|Overall Study||4
10814581|NCT02294981|11977383|FG000|COMPLETED|Overall Study||3
10725772|NCT02748694|11889747|FG012|COMPLETED|Overall Study||9
10725773|NCT02748694|11889748|FG013|COMPLETED|Overall Study||8
10725774|NCT02748694|11889749|FG014|COMPLETED|Overall Study||14
10725775|NCT02748694|11889735|FG000|NOT COMPLETED|Overall Study||0
10725776|NCT02748694|11889736|FG001|NOT COMPLETED|Overall Study||0
10725777|NCT02748694|11889737|FG002|NOT COMPLETED|Overall Study||0
10725778|NCT02748694|11889738|FG003|NOT COMPLETED|Overall Study||0
10725779|NCT02748694|11889739|FG004|NOT COMPLETED|Overall Study||0
10725780|NCT02748694|11889740|FG005|NOT COMPLETED|Overall Study||0
10725781|NCT02748694|11889741|FG006|NOT COMPLETED|Overall Study||0
10725782|NCT02748694|11889742|FG007|NOT COMPLETED|Overall Study||0
10725783|NCT02748694|11889743|FG008|NOT COMPLETED|Overall Study||0
10814582|NCT02294981|11977383|FG000|NOT COMPLETED|Overall Study||1
10725784|NCT02748694|11889744|FG009|NOT COMPLETED|Overall Study||0
10725785|NCT02748694|11889745|FG010|NOT COMPLETED|Overall Study||0
10725786|NCT02748694|11889746|FG011|NOT COMPLETED|Overall Study||0
10725787|NCT02748694|11889747|FG012|NOT COMPLETED|Overall Study||0
10725788|NCT02748694|11889748|FG013|NOT COMPLETED|Overall Study||0
10725789|NCT02748694|11889749|FG014|NOT COMPLETED|Overall Study||2
10725790|NCT02748785|11889809|FG000|STARTED|Visit 1- Visit 2||69
10725791|NCT02748785|11889810|FG001|STARTED|Visit 1- Visit 2||68
10725792|NCT02748785|11889811|FG002|STARTED|Visit 1- Visit 2||71
10725793|NCT02748785|11889812|FG003|STARTED|Visit 1- Visit 2||69
10725794|NCT02748785|11889809|FG000|COMPLETED|Visit 1- Visit 2||59
10725795|NCT02748785|11889810|FG001|COMPLETED|Visit 1- Visit 2||49
10725796|NCT02748785|11889811|FG002|COMPLETED|Visit 1- Visit 2||57
10725797|NCT02748785|11889812|FG003|COMPLETED|Visit 1- Visit 2||63
10725798|NCT02748785|11889809|FG000|NOT COMPLETED|Visit 1- Visit 2||10
10725799|NCT02748785|11889810|FG001|NOT COMPLETED|Visit 1- Visit 2||19
10725800|NCT02748785|11889811|FG002|NOT COMPLETED|Visit 1- Visit 2||14
10725801|NCT02748785|11889812|FG003|NOT COMPLETED|Visit 1- Visit 2||6
10725802|NCT02748785|11889809|FG000|STARTED|Visit 2-Visit 3||59
10725803|NCT02748785|11889810|FG001|STARTED|Visit 2-Visit 3||49
10408217|NCT00753714|11552271|FG000|COMPLETED|Overall Study||1
10408218|NCT00753714|11552272|FG001|COMPLETED|Overall Study||1
10408219|NCT00753714|11552271|FG000|NOT COMPLETED|Overall Study||60
10408220|NCT00753714|11552272|FG001|NOT COMPLETED|Overall Study||62
10408221|NCT00753766|11552283|FG000|STARTED|Overall Study||1
10408222|NCT00753766|11552284|FG001|STARTED|Overall Study||0
10408223|NCT00753766|11552283|FG000|COMPLETED|Overall Study||0
10408224|NCT00753766|11552284|FG001|COMPLETED|Overall Study||0
10408225|NCT00753766|11552283|FG000|NOT COMPLETED|Overall Study||1
10408226|NCT00753766|11552284|FG001|NOT COMPLETED|Overall Study||0
10408227|NCT00753896|11552291|FG000|STARTED|Overall Study||134
10408228|NCT00753896|11552291|FG000|COMPLETED|Overall Study||118
10408229|NCT00753896|11552291|FG000|NOT COMPLETED|Overall Study||16
10408230|NCT00753922|11552299|FG000|STARTED|Overall Study||552
10408231|NCT00753922|11552300|FG001|STARTED|Overall Study||251
10408232|NCT00753922|11552301|FG002|STARTED|Overall Study||145
10408233|NCT00753922|11552302|FG003|STARTED|Overall Study||60
10725804|NCT02748785|11889811|FG002|STARTED|Visit 2-Visit 3||57
10725805|NCT02748785|11889812|FG003|STARTED|Visit 2-Visit 3||63
10725806|NCT02748785|11889809|FG000|COMPLETED|Visit 2-Visit 3||54
10725807|NCT02748785|11889810|FG001|COMPLETED|Visit 2-Visit 3||44
10725808|NCT02748785|11889811|FG002|COMPLETED|Visit 2-Visit 3||49
10725809|NCT02748785|11889812|FG003|COMPLETED|Visit 2-Visit 3||52
10725810|NCT02748785|11889809|FG000|NOT COMPLETED|Visit 2-Visit 3||5
10725811|NCT02748785|11889810|FG001|NOT COMPLETED|Visit 2-Visit 3||5
10725812|NCT02748785|11889811|FG002|NOT COMPLETED|Visit 2-Visit 3||8
10725813|NCT02748785|11889812|FG003|NOT COMPLETED|Visit 2-Visit 3||11
10725814|NCT02748785|11889809|FG000|STARTED|Visit 3- Visit 4||54
10725815|NCT02748785|11889810|FG001|STARTED|Visit 3- Visit 4||44
10725816|NCT02748785|11889811|FG002|STARTED|Visit 3- Visit 4||49
10725817|NCT02748785|11889812|FG003|STARTED|Visit 3- Visit 4||52
10725818|NCT02748785|11889809|FG000|COMPLETED|Visit 3- Visit 4||53
10725819|NCT02748785|11889810|FG001|COMPLETED|Visit 3- Visit 4||43
10725820|NCT02748785|11889811|FG002|COMPLETED|Visit 3- Visit 4||47
10725821|NCT02748785|11889812|FG003|COMPLETED|Visit 3- Visit 4||50
10725822|NCT02748785|11889809|FG000|NOT COMPLETED|Visit 3- Visit 4||1
10725823|NCT02748785|11889810|FG001|NOT COMPLETED|Visit 3- Visit 4||1
10725824|NCT02748785|11889811|FG002|NOT COMPLETED|Visit 3- Visit 4||2
10725825|NCT02748785|11889812|FG003|NOT COMPLETED|Visit 3- Visit 4||2
10725826|NCT02748863|11889825|FG000|STARTED|Treatment Period 1||72
10725827|NCT02748863|11889826|FG001|STARTED|Treatment Period 1||71
10725828|NCT02748863|11889827|FG002|STARTED|Treatment Period 1||71
10725829|NCT02748863|11889828|FG003|STARTED|Treatment Period 1|Not applicable for this period|0
10725830|NCT02748863|11889829|FG004|STARTED|Treatment Period 1|Not applicable for this period|0
10725831|NCT02748863|11889825|FG000|COMPLETED|Treatment Period 1||72
10725832|NCT02748863|11889826|FG001|COMPLETED|Treatment Period 1||69
10725833|NCT02748863|11889827|FG002|COMPLETED|Treatment Period 1||69
10725834|NCT02748863|11889828|FG003|COMPLETED|Treatment Period 1||0
10725835|NCT02748863|11889829|FG004|COMPLETED|Treatment Period 1||0
10725836|NCT02748863|11889825|FG000|NOT COMPLETED|Treatment Period 1||0
10725837|NCT02748863|11889826|FG001|NOT COMPLETED|Treatment Period 1||2
10725838|NCT02748863|11889827|FG002|NOT COMPLETED|Treatment Period 1||2
10725839|NCT02748863|11889828|FG003|NOT COMPLETED|Treatment Period 1||0
10725840|NCT02748863|11889829|FG004|NOT COMPLETED|Treatment Period 1||0
10725841|NCT02748863|11889825|FG000|STARTED|Treatment Period 2||72
10725842|NCT02748863|11889826|FG001|STARTED|Treatment Period 2||69
10725843|NCT02748863|11889827|FG002|STARTED|Treatment Period 2||0
10725844|NCT02748863|11889828|FG003|STARTED|Treatment Period 2||34
10725845|NCT02748863|11889829|FG004|STARTED|Treatment Period 2||34
10725846|NCT02748863|11889825|FG000|COMPLETED|Treatment Period 2||67
10725847|NCT02748863|11889826|FG001|COMPLETED|Treatment Period 2||66
10408234|NCT00753922|11552299|FG000|COMPLETED|Overall Study||306
10408235|NCT00753922|11552300|FG001|COMPLETED|Overall Study||157
10408236|NCT00753922|11552301|FG002|COMPLETED|Overall Study||82
10408237|NCT00753922|11552302|FG003|COMPLETED|Overall Study||37
10408238|NCT00753922|11552299|FG000|NOT COMPLETED|Overall Study||246
10408239|NCT00753922|11552300|FG001|NOT COMPLETED|Overall Study||94
10408240|NCT00753922|11552301|FG002|NOT COMPLETED|Overall Study||63
10725848|NCT02748863|11889827|FG002|COMPLETED|Treatment Period 2||0
10725849|NCT02748863|11889828|FG003|COMPLETED|Treatment Period 2||32
10408241|NCT00753922|11552302|FG003|NOT COMPLETED|Overall Study||23
10408242|NCT00753935|11552314|FG000|STARTED|Overall Study||45
10408243|NCT00753935|11552315|FG001|STARTED|Overall Study||47
10408244|NCT00753935|11552314|FG000|COMPLETED|Overall Study||45
10408245|NCT00753935|11552315|FG001|COMPLETED|Overall Study||47
10408246|NCT00753935|11552314|FG000|NOT COMPLETED|Overall Study||0
10408247|NCT00753935|11552315|FG001|NOT COMPLETED|Overall Study||0
10408248|NCT00753948|11552324|FG000|STARTED|Overall Study||9
10408249|NCT00753948|11552325|FG001|STARTED|Overall Study||7
10408250|NCT00753948|11552326|FG002|STARTED|Overall Study||7
10408251|NCT00753948|11552324|FG000|COMPLETED|Overall Study||9
10408252|NCT00753948|11552325|FG001|COMPLETED|Overall Study||7
10408253|NCT00753948|11552326|FG002|COMPLETED|Overall Study||7
10408254|NCT00753948|11552324|FG000|NOT COMPLETED|Overall Study||0
10408255|NCT00753948|11552325|FG001|NOT COMPLETED|Overall Study||0
10408256|NCT00753948|11552326|FG002|NOT COMPLETED|Overall Study||0
10408257|NCT00754065|11552336|FG000|STARTED|Overall Study||203
10408258|NCT00754065|11552337|FG001|STARTED|Overall Study||206
10408259|NCT00754065|11552336|FG000|Participants Received Treatment|Overall Study||191
10408260|NCT00754065|11552337|FG001|Participants Received Treatment|Overall Study||204
10408261|NCT00754065|11552336|FG000|Cycle 6|Overall Study||141
10408262|NCT00754065|11552337|FG001|Cycle 6|Overall Study||153
10408263|NCT00754065|11552336|FG000|COMPLETED|Overall Study||122
10408264|NCT00754065|11552337|FG001|COMPLETED|Overall Study||126
10408265|NCT00754065|11552336|FG000|NOT COMPLETED|Overall Study||81
10408266|NCT00754065|11552337|FG001|NOT COMPLETED|Overall Study||80
10408267|NCT00754130|11552349|FG000|STARTED|Period 1 (5 Days)||2
10408268|NCT00754130|11552350|FG001|STARTED|Period 1 (5 Days)||2
10408269|NCT00754130|11552351|FG002|STARTED|Period 1 (5 Days)||4
10408270|NCT00754130|11552352|FG003|STARTED|Period 1 (5 Days)||2
10408271|NCT00754130|11552353|FG004|STARTED|Period 1 (5 Days)||2
10408272|NCT00754130|11552354|FG005|STARTED|Period 1 (5 Days)|One participant received MK-0941 10 mg in both Periods 1 and 2.|4
10408273|NCT00754130|11552349|FG000|COMPLETED|Period 1 (5 Days)||2
10408274|NCT00754130|11552350|FG001|COMPLETED|Period 1 (5 Days)||2
10408275|NCT00754130|11552351|FG002|COMPLETED|Period 1 (5 Days)||4
10408276|NCT00754130|11552352|FG003|COMPLETED|Period 1 (5 Days)||2
10408277|NCT00754130|11552353|FG004|COMPLETED|Period 1 (5 Days)||2
10408278|NCT00754130|11552354|FG005|COMPLETED|Period 1 (5 Days)||4
10408279|NCT00754130|11552349|FG000|NOT COMPLETED|Period 1 (5 Days)||0
10408280|NCT00754130|11552350|FG001|NOT COMPLETED|Period 1 (5 Days)||0
10408281|NCT00754130|11552351|FG002|NOT COMPLETED|Period 1 (5 Days)||0
10725850|NCT02748863|11889829|FG004|COMPLETED|Treatment Period 2||33
10725851|NCT02748863|11889825|FG000|NOT COMPLETED|Treatment Period 2||5
10725852|NCT02748863|11889826|FG001|NOT COMPLETED|Treatment Period 2||3
10725853|NCT02748863|11889827|FG002|NOT COMPLETED|Treatment Period 2||0
10725854|NCT02748863|11889828|FG003|NOT COMPLETED|Treatment Period 2||2
10725855|NCT02748863|11889829|FG004|NOT COMPLETED|Treatment Period 2||1
10725856|NCT02748889|11889846|FG000|STARTED|Overall Study||0
10725857|NCT02748889|11889847|FG001|STARTED|Overall Study||1
10725858|NCT02748889|11889846|FG000|COMPLETED|Overall Study||0
10725859|NCT02748889|11889847|FG001|COMPLETED|Overall Study||1
10408282|NCT00754130|11552352|FG003|NOT COMPLETED|Period 1 (5 Days)||0
10408283|NCT00754130|11552353|FG004|NOT COMPLETED|Period 1 (5 Days)||0
10408284|NCT00754130|11552354|FG005|NOT COMPLETED|Period 1 (5 Days)||0
10408285|NCT00754130|11552349|FG000|STARTED|Washout Period (>=8 Days)||2
10408286|NCT00754130|11552350|FG001|STARTED|Washout Period (>=8 Days)||2
10408287|NCT00754130|11552351|FG002|STARTED|Washout Period (>=8 Days)||4
10408288|NCT00754130|11552352|FG003|STARTED|Washout Period (>=8 Days)||2
10408289|NCT00754130|11552353|FG004|STARTED|Washout Period (>=8 Days)||2
10408290|NCT00754130|11552354|FG005|STARTED|Washout Period (>=8 Days)||4
10408291|NCT00754130|11552349|FG000|COMPLETED|Washout Period (>=8 Days)||2
10408292|NCT00754130|11552350|FG001|COMPLETED|Washout Period (>=8 Days)||2
10408293|NCT00754130|11552351|FG002|COMPLETED|Washout Period (>=8 Days)||4
10408294|NCT00754130|11552352|FG003|COMPLETED|Washout Period (>=8 Days)||2
10408295|NCT00754130|11552353|FG004|COMPLETED|Washout Period (>=8 Days)||2
10408296|NCT00754130|11552354|FG005|COMPLETED|Washout Period (>=8 Days)||4
10408297|NCT00754130|11552349|FG000|NOT COMPLETED|Washout Period (>=8 Days)||0
10725860|NCT02748889|11889846|FG000|NOT COMPLETED|Overall Study||0
10408298|NCT00754130|11552350|FG001|NOT COMPLETED|Washout Period (>=8 Days)||0
10408299|NCT00754130|11552351|FG002|NOT COMPLETED|Washout Period (>=8 Days)||0
10408300|NCT00754130|11552352|FG003|NOT COMPLETED|Washout Period (>=8 Days)||0
10408301|NCT00754130|11552353|FG004|NOT COMPLETED|Washout Period (>=8 Days)||0
10408302|NCT00754130|11552354|FG005|NOT COMPLETED|Washout Period (>=8 Days)||0
10408303|NCT00754130|11552349|FG000|STARTED|Period 2 (5 Days)|One participant received MK-0941 15 mg starting with Dose 2 on Day 2.|2
10408304|NCT00754130|11552350|FG001|STARTED|Period 2 (5 Days)||2
10408305|NCT00754130|11552351|FG002|STARTED|Period 2 (5 Days)||4
10408306|NCT00754130|11552352|FG003|STARTED|Period 2 (5 Days)||2
10408307|NCT00754130|11552353|FG004|STARTED|Period 2 (5 Days)||2
10408308|NCT00754130|11552354|FG005|STARTED|Period 2 (5 Days)|One participant received MK-0941 35 mg starting with Dose 3 on Day 3.|4
10408309|NCT00754130|11552349|FG000|COMPLETED|Period 2 (5 Days)||2
10408310|NCT00754130|11552350|FG001|COMPLETED|Period 2 (5 Days)||2
10408311|NCT00754130|11552351|FG002|COMPLETED|Period 2 (5 Days)||4
10725861|NCT02748889|11889847|FG001|NOT COMPLETED|Overall Study||0
10408312|NCT00754130|11552352|FG003|COMPLETED|Period 2 (5 Days)||2
10408313|NCT00754130|11552353|FG004|COMPLETED|Period 2 (5 Days)||2
10408314|NCT00754130|11552354|FG005|COMPLETED|Period 2 (5 Days)||4
10408315|NCT00754130|11552349|FG000|NOT COMPLETED|Period 2 (5 Days)||0
10408316|NCT00754130|11552350|FG001|NOT COMPLETED|Period 2 (5 Days)||0
10408317|NCT00754130|11552351|FG002|NOT COMPLETED|Period 2 (5 Days)||0
10408318|NCT00754130|11552352|FG003|NOT COMPLETED|Period 2 (5 Days)||0
10408319|NCT00754130|11552353|FG004|NOT COMPLETED|Period 2 (5 Days)||0
10408320|NCT00754130|11552354|FG005|NOT COMPLETED|Period 2 (5 Days)||0
10725862|NCT02748928|11889851|FG000|STARTED|Overall Study||62
10725863|NCT02748928|11889851|FG000|COMPLETED|Overall Study||62
10725864|NCT02748928|11889851|FG000|NOT COMPLETED|Overall Study||0
10725865|NCT02749201|11889856|FG000|STARTED|Overall Study||10
10725866|NCT02749201|11889856|FG000|COMPLETED|Overall Study||10
10725867|NCT02749201|11889856|FG000|NOT COMPLETED|Overall Study||0
10725868|NCT02749370|11889860|FG000|STARTED|Overall Study||80
10725869|NCT02749370|11889860|FG000|COMPLETED|Overall Study||66
10725870|NCT02749370|11889860|FG000|NOT COMPLETED|Overall Study||14
10725871|NCT02749721|11889864|FG000|STARTED|Screening||31
10725872|NCT02749721|11889864|FG000|COMPLETED|Screening||25
10725873|NCT02749721|11889864|FG000|NOT COMPLETED|Screening||6
10725874|NCT02749721|11889864|FG000|STARTED|8-week Open-Label Treatment Phase||25
10725875|NCT02749721|11889864|FG000|COMPLETED|8-week Open-Label Treatment Phase||22
10725876|NCT02749721|11889864|FG000|NOT COMPLETED|8-week Open-Label Treatment Phase||3
10725877|NCT02749799|11889870|FG000|STARTED|Overall Study||45
10725878|NCT02749799|11889870|FG000|COMPLETED|Overall Study||37
10725879|NCT02749799|11889870|FG000|NOT COMPLETED|Overall Study||8
10725880|NCT02749903|11889874|FG000|STARTED|Overall Study||46
10725881|NCT02749903|11889874|FG000|COMPLETED|Overall Study||46
10725882|NCT02749903|11889874|FG000|NOT COMPLETED|Overall Study||0
10725883|NCT02750267|11889880|FG000|STARTED|Overall Study||6
10725884|NCT02750267|11889881|FG001|STARTED|Overall Study||6
10725885|NCT02750267|11889880|FG000|COMPLETED|Overall Study||6
10725886|NCT02750267|11889881|FG001|COMPLETED|Overall Study||6
10725887|NCT02750267|11889880|FG000|NOT COMPLETED|Overall Study||0
10725888|NCT02750267|11889881|FG001|NOT COMPLETED|Overall Study||0
10725889|NCT02750306|11889891|FG000|STARTED|Overall Study||142
10725890|NCT02750306|11889892|FG001|STARTED|Overall Study||143
10725891|NCT02750306|11889891|FG000|COMPLETED|Overall Study||136
10725892|NCT02750306|11889892|FG001|COMPLETED|Overall Study||141
10725893|NCT02750306|11889891|FG000|NOT COMPLETED|Overall Study||6
10725894|NCT02750306|11889892|FG001|NOT COMPLETED|Overall Study||2
10725895|NCT02750332|11889898|FG000|STARTED|Treatment Period 1||10
10725896|NCT02750332|11889899|FG001|STARTED|Treatment Period 1||10
10725897|NCT02750332|11889898|FG000|COMPLETED|Treatment Period 1||10
10725898|NCT02750332|11889899|FG001|COMPLETED|Treatment Period 1||9
10725899|NCT02750332|11889898|FG000|NOT COMPLETED|Treatment Period 1||0
10725900|NCT02750332|11889899|FG001|NOT COMPLETED|Treatment Period 1||1
10725901|NCT02750332|11889898|FG000|STARTED|Treatment Period 2||10
10725902|NCT02750332|11889899|FG001|STARTED|Treatment Period 2||9
10725903|NCT02750332|11889898|FG000|COMPLETED|Treatment Period 2||10
10725904|NCT02750332|11889899|FG001|COMPLETED|Treatment Period 2||9
10725905|NCT02750332|11889898|FG000|NOT COMPLETED|Treatment Period 2||0
10725906|NCT02750332|11889899|FG001|NOT COMPLETED|Treatment Period 2||0
10725907|NCT02750345|11889905|FG000|STARTED|Intervention 1||4
10725908|NCT02750345|11889906|FG001|STARTED|Intervention 1||4
10725909|NCT02750345|11889907|FG002|STARTED|Intervention 1||4
10725910|NCT02750345|11889908|FG003|STARTED|Intervention 1||4
10725911|NCT02750345|11889909|FG004|STARTED|Intervention 1||4
10725912|NCT02750345|11889910|FG005|STARTED|Intervention 1||4
10725913|NCT02750345|11889905|FG000|COMPLETED|Intervention 1||4
10725914|NCT02750345|11889906|FG001|COMPLETED|Intervention 1||4
10725915|NCT02750345|11889907|FG002|COMPLETED|Intervention 1||4
10725916|NCT02750345|11889908|FG003|COMPLETED|Intervention 1||4
10725917|NCT02750345|11889909|FG004|COMPLETED|Intervention 1||3
10725918|NCT02750345|11889910|FG005|COMPLETED|Intervention 1||4
10725919|NCT02750345|11889905|FG000|NOT COMPLETED|Intervention 1||0
10725920|NCT02750345|11889906|FG001|NOT COMPLETED|Intervention 1||0
10725921|NCT02750345|11889907|FG002|NOT COMPLETED|Intervention 1||0
10725922|NCT02750345|11889908|FG003|NOT COMPLETED|Intervention 1||0
10725923|NCT02750345|11889909|FG004|NOT COMPLETED|Intervention 1||1
10725924|NCT02750345|11889910|FG005|NOT COMPLETED|Intervention 1||0
10408321|NCT00754156|11552372|FG000|STARTED|Overall Study||8
10408322|NCT00754156|11552373|FG001|STARTED|Overall Study||6
10408323|NCT00754156|11552372|FG000|COMPLETED|Overall Study||8
10408324|NCT00754156|11552373|FG001|COMPLETED|Overall Study||6
10408325|NCT00754156|11552372|FG000|NOT COMPLETED|Overall Study||0
10725925|NCT02750345|11889905|FG000|STARTED|Intervention 2||4
10725926|NCT02750345|11889906|FG001|STARTED|Intervention 2||4
10725927|NCT02750345|11889907|FG002|STARTED|Intervention 2||4
10725928|NCT02750345|11889908|FG003|STARTED|Intervention 2||4
10725929|NCT02750345|11889909|FG004|STARTED|Intervention 2||3
10725930|NCT02750345|11889910|FG005|STARTED|Intervention 2||4
10725931|NCT02750345|11889905|FG000|COMPLETED|Intervention 2||4
10725932|NCT02750345|11889906|FG001|COMPLETED|Intervention 2||4
10725933|NCT02750345|11889907|FG002|COMPLETED|Intervention 2||4
10725934|NCT02750345|11889908|FG003|COMPLETED|Intervention 2||4
10725935|NCT02750345|11889909|FG004|COMPLETED|Intervention 2||3
10725936|NCT02750345|11889910|FG005|COMPLETED|Intervention 2||4
10725937|NCT02750345|11889905|FG000|NOT COMPLETED|Intervention 2||0
10725938|NCT02750345|11889906|FG001|NOT COMPLETED|Intervention 2||0
10725939|NCT02750345|11889907|FG002|NOT COMPLETED|Intervention 2||0
10725940|NCT02750345|11889908|FG003|NOT COMPLETED|Intervention 2||0
10725941|NCT02750345|11889909|FG004|NOT COMPLETED|Intervention 2||0
10725942|NCT02750345|11889910|FG005|NOT COMPLETED|Intervention 2||0
10725943|NCT02750345|11889905|FG000|STARTED|Intervention 3||4
10408326|NCT00754156|11552373|FG001|NOT COMPLETED|Overall Study||0
10408327|NCT00754208|11552385|FG000|STARTED|Overall Study||7
10408328|NCT00754208|11552385|FG000|COMPLETED|Overall Study||7
10408329|NCT00754208|11552385|FG000|NOT COMPLETED|Overall Study||0
10408330|NCT00754234|11552390|FG000|STARTED|Overall Study|7 Menus were consumed in randomized order|16
10408331|NCT00754234|11552390|FG000|COMPLETED|Overall Study|2 participants did not receive the Day 1,4,5,6 menu and 1 did not receive the Day 2 menu|13
10408332|NCT00754234|11552390|FG000|NOT COMPLETED|Overall Study||3
10408333|NCT00754247|11552397|FG000|STARTED|Overall Study||10
10408334|NCT00754247|11552398|FG001|STARTED|Overall Study||10
10408335|NCT00754247|11552399|FG002|STARTED|Overall Study||10
10408336|NCT00754247|11552397|FG000|COMPLETED|Overall Study||5
10408337|NCT00754247|11552398|FG001|COMPLETED|Overall Study||5
10408338|NCT00754247|11552399|FG002|COMPLETED|Overall Study||5
10408339|NCT00754247|11552397|FG000|NOT COMPLETED|Overall Study||5
10408340|NCT00754247|11552398|FG001|NOT COMPLETED|Overall Study||5
10408341|NCT00754247|11552399|FG002|NOT COMPLETED|Overall Study||5
10408342|NCT00754325|11552409|FG000|STARTED|Initial Treatment||50
10408343|NCT00754325|11552410|FG001|STARTED|Initial Treatment||49
10408344|NCT00754325|11552409|FG000|COMPLETED|Initial Treatment||0
10408345|NCT00754325|11552410|FG001|COMPLETED|Initial Treatment||0
10408346|NCT00754325|11552409|FG000|NOT COMPLETED|Initial Treatment||50
10408347|NCT00754325|11552410|FG001|NOT COMPLETED|Initial Treatment||49
10408348|NCT00754325|11552409|FG000|STARTED|Progression and Cross-over|Arm 1 participants with dasatinib-related toxicity stop dasatinib, continue fulvestrant (Arm 1b).|0
10408349|NCT00754325|11552410|FG001|STARTED|Progression and Cross-over|Progressive disease participants in Arm 2 could add dasatinib (Arm 2b) at investigator discretion.|21
10408350|NCT00754325|11552409|FG000|COMPLETED|Progression and Cross-over||0
10408351|NCT00754325|11552410|FG001|COMPLETED|Progression and Cross-over||0
10408352|NCT00754325|11552409|FG000|NOT COMPLETED|Progression and Cross-over||0
10408353|NCT00754325|11552410|FG001|NOT COMPLETED|Progression and Cross-over||21
10408354|NCT00754338|11552421|FG000|STARTED|First Intervention for Phase1&Phase2||17
10408355|NCT00754338|11552422|FG001|STARTED|First Intervention for Phase1&Phase2||21
10408356|NCT00754338|11552423|FG002|STARTED|First Intervention for Phase1&Phase2||19
10408357|NCT00754338|11552424|FG003|STARTED|First Intervention for Phase1&Phase2||19
10408358|NCT00754338|11552421|FG000|COMPLETED|First Intervention for Phase1&Phase2||17
10408359|NCT00754338|11552422|FG001|COMPLETED|First Intervention for Phase1&Phase2||18
10725944|NCT02750345|11889906|FG001|STARTED|Intervention 3||4
10725945|NCT02750345|11889907|FG002|STARTED|Intervention 3||4
10725946|NCT02750345|11889908|FG003|STARTED|Intervention 3||4
10725947|NCT02750345|11889909|FG004|STARTED|Intervention 3||3
10725948|NCT02750345|11889910|FG005|STARTED|Intervention 3||4
10725949|NCT02750345|11889905|FG000|COMPLETED|Intervention 3||4
10725950|NCT02750345|11889906|FG001|COMPLETED|Intervention 3||4
10725951|NCT02750345|11889907|FG002|COMPLETED|Intervention 3||4
10725952|NCT02750345|11889908|FG003|COMPLETED|Intervention 3||4
10725953|NCT02750345|11889909|FG004|COMPLETED|Intervention 3||3
10725954|NCT02750345|11889910|FG005|COMPLETED|Intervention 3||4
10725955|NCT02750345|11889905|FG000|NOT COMPLETED|Intervention 3||0
10725956|NCT02750345|11889906|FG001|NOT COMPLETED|Intervention 3||0
10725957|NCT02750345|11889907|FG002|NOT COMPLETED|Intervention 3||0
10725958|NCT02750345|11889908|FG003|NOT COMPLETED|Intervention 3||0
10725959|NCT02750345|11889909|FG004|NOT COMPLETED|Intervention 3||0
10725960|NCT02750345|11889910|FG005|NOT COMPLETED|Intervention 3||0
10725961|NCT02750410|11889922|FG000|STARTED|Double-Blind Treatment Period||39
10725962|NCT02750410|11889923|FG001|STARTED|Double-Blind Treatment Period||120
10725963|NCT02750410|11889922|FG000|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||39
10725964|NCT02750410|11889923|FG001|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||120
10725965|NCT02750410|11889922|FG000|COMPLETED|Double-Blind Treatment Period||37
10725966|NCT02750410|11889923|FG001|COMPLETED|Double-Blind Treatment Period||117
10725967|NCT02750410|11889922|FG000|NOT COMPLETED|Double-Blind Treatment Period||2
10408360|NCT00754338|11552423|FG002|COMPLETED|First Intervention for Phase1&Phase2||16
10408361|NCT00754338|11552424|FG003|COMPLETED|First Intervention for Phase1&Phase2||19
10408362|NCT00754338|11552421|FG000|NOT COMPLETED|First Intervention for Phase1&Phase2||0
10408363|NCT00754338|11552422|FG001|NOT COMPLETED|First Intervention for Phase1&Phase2||3
10408364|NCT00754338|11552423|FG002|NOT COMPLETED|First Intervention for Phase1&Phase2||3
10408365|NCT00754338|11552424|FG003|NOT COMPLETED|First Intervention for Phase1&Phase2||0
10408366|NCT00754338|11552421|FG000|STARTED|Second Intervention for Phase1&Phase2||17
10408367|NCT00754338|11552422|FG001|STARTED|Second Intervention for Phase1&Phase2||18
10408368|NCT00754338|11552423|FG002|STARTED|Second Intervention for Phase1&Phase2||16
10548261|NCT01518699|11702089|FG004|COMPLETED|Period 1||10
10725968|NCT02750410|11889923|FG001|NOT COMPLETED|Double-Blind Treatment Period||3
10725969|NCT02750410|11889922|FG000|STARTED|Open-Label Extension Period||37
10725970|NCT02750410|11889923|FG001|STARTED|Open-Label Extension Period||117
10725971|NCT02750410|11889922|FG000|COMPLETED|Open-Label Extension Period||31
10725972|NCT02750410|11889923|FG001|COMPLETED|Open-Label Extension Period||111
10725973|NCT02750410|11889922|FG000|NOT COMPLETED|Open-Label Extension Period||6
10725974|NCT02750410|11889923|FG001|NOT COMPLETED|Open-Label Extension Period||6
10725975|NCT02750501|11889933|FG000|STARTED|Overall Study||44
10725976|NCT02750501|11889933|FG000|Enrolled|Overall Study||44
10725977|NCT02750501|11889933|FG000|Treated|Overall Study||39
10725978|NCT02750501|11889933|FG000|COMPLETED|Overall Study||36
10725979|NCT02750501|11889933|FG000|NOT COMPLETED|Overall Study||8
10725980|NCT02750514|11889946|FG000|STARTED|Track 1||40
10408369|NCT00754338|11552424|FG003|STARTED|Second Intervention for Phase1&Phase2||19
10408370|NCT00754338|11552421|FG000|COMPLETED|Second Intervention for Phase1&Phase2||17
10408371|NCT00754338|11552422|FG001|COMPLETED|Second Intervention for Phase1&Phase2||17
10408372|NCT00754338|11552423|FG002|COMPLETED|Second Intervention for Phase1&Phase2||16
10408373|NCT00754338|11552424|FG003|COMPLETED|Second Intervention for Phase1&Phase2||18
10408374|NCT00754338|11552421|FG000|NOT COMPLETED|Second Intervention for Phase1&Phase2||0
10408375|NCT00754338|11552422|FG001|NOT COMPLETED|Second Intervention for Phase1&Phase2||1
10408376|NCT00754338|11552423|FG002|NOT COMPLETED|Second Intervention for Phase1&Phase2||0
10408377|NCT00754338|11552424|FG003|NOT COMPLETED|Second Intervention for Phase1&Phase2||1
10408378|NCT00754377|11552438|FG000|STARTED|Overall Study||50
10408379|NCT00754377|11552439|FG001|STARTED|Overall Study||42
10408380|NCT00754377|11552438|FG000|COMPLETED|Overall Study||50
10408381|NCT00754377|11552439|FG001|COMPLETED|Overall Study||42
10408382|NCT00754377|11552438|FG000|NOT COMPLETED|Overall Study||0
10408383|NCT00754377|11552439|FG001|NOT COMPLETED|Overall Study||0
10408384|NCT00754390|11552447|FG000|STARTED|Ca/Phytate Test Meal 1 (Randomized)||17
10408385|NCT00754390|11552447|FG000|COMPLETED|Ca/Phytate Test Meal 1 (Randomized)||12
10408386|NCT00754390|11552447|FG000|NOT COMPLETED|Ca/Phytate Test Meal 1 (Randomized)||5
10408387|NCT00754390|11552447|FG000|STARTED|Ca/Phytate Test Meal 2 (Randomized)||12
10408388|NCT00754390|11552447|FG000|COMPLETED|Ca/Phytate Test Meal 2 (Randomized)||12
10408389|NCT00754390|11552447|FG000|NOT COMPLETED|Ca/Phytate Test Meal 2 (Randomized)||0
10408390|NCT00754390|11552447|FG000|STARTED|Ca/Phytate Test Meal 3 (Randomized)||12
10408391|NCT00754390|11552447|FG000|COMPLETED|Ca/Phytate Test Meal 3 (Randomized)||11
10408392|NCT00754390|11552447|FG000|NOT COMPLETED|Ca/Phytate Test Meal 3 (Randomized)||1
10408393|NCT00754390|11552447|FG000|STARTED|Ca/Phytate Test Meal 4 (Randomized)||11
10408394|NCT00754390|11552447|FG000|COMPLETED|Ca/Phytate Test Meal 4 (Randomized)||10
10408395|NCT00754390|11552447|FG000|NOT COMPLETED|Ca/Phytate Test Meal 4 (Randomized)||1
10408396|NCT00754442|11552456|FG000|STARTED|Overall Study|controls 11|11
10408397|NCT00754442|11552457|FG001|STARTED|Overall Study|patients 9|9
10408398|NCT00754442|11552456|FG000|COMPLETED|Overall Study||6
10725981|NCT02750514|11889947|FG001|STARTED|Track 1||4
10725982|NCT02750514|11889948|FG002|STARTED|Track 1||0
10725983|NCT02750514|11889949|FG003|STARTED|Track 1||3
10725984|NCT02750514|11889950|FG004|STARTED|Track 1||0
10725985|NCT02750514|11889946|FG000|COMPLETED|Track 1|3 participants were re-randomized to track 3 (2 part.) or track 5 (1 part.)|13
10725986|NCT02750514|11889947|FG001|COMPLETED|Track 1||2
10725987|NCT02750514|11889948|FG002|COMPLETED|Track 1||0
10725988|NCT02750514|11889949|FG003|COMPLETED|Track 1||1
10725989|NCT02750514|11889950|FG004|COMPLETED|Track 1||0
10725990|NCT02750514|11889946|FG000|NOT COMPLETED|Track 1||27
10725991|NCT02750514|11889947|FG001|NOT COMPLETED|Track 1||2
10725992|NCT02750514|11889948|FG002|NOT COMPLETED|Track 1||0
10725993|NCT02750514|11889949|FG003|NOT COMPLETED|Track 1||2
10725994|NCT02750514|11889950|FG004|NOT COMPLETED|Track 1||0
10725995|NCT02750514|11889946|FG000|STARTED|Track 2||9
10725996|NCT02750514|11889947|FG001|STARTED|Track 2||8
10725997|NCT02750514|11889948|FG002|STARTED|Track 2||2
10725998|NCT02750514|11889949|FG003|STARTED|Track 2||12
10725999|NCT02750514|11889950|FG004|STARTED|Track 2||0
10726000|NCT02750514|11889946|FG000|COMPLETED|Track 2|2 participants were re-randomized to track 3 (1 part.) or track 5 (1 part.)|3
10726001|NCT02750514|11889947|FG001|COMPLETED|Track 2||0
10726002|NCT02750514|11889948|FG002|COMPLETED|Track 2||0
10726003|NCT02750514|11889949|FG003|COMPLETED|Track 2|1 participant was re-randomized to track 5|5
10726004|NCT02750514|11889950|FG004|COMPLETED|Track 2||0
10726005|NCT02750514|11889946|FG000|NOT COMPLETED|Track 2||6
10726006|NCT02750514|11889947|FG001|NOT COMPLETED|Track 2||8
10726007|NCT02750514|11889948|FG002|NOT COMPLETED|Track 2||2
10726008|NCT02750514|11889949|FG003|NOT COMPLETED|Track 2||7
10726009|NCT02750514|11889950|FG004|NOT COMPLETED|Track 2||0
10726010|NCT02750514|11889946|FG000|STARTED|Track 3||0
10726011|NCT02750514|11889947|FG001|STARTED|Track 3|2 participants had prior treatment in track 1 (1 part.) or track 2 (1 part.)|41
10726012|NCT02750514|11889948|FG002|STARTED|Track 3|1 participant had prior treatment in track 3|16
10408399|NCT00754442|11552457|FG001|COMPLETED|Overall Study||6
10408400|NCT00754442|11552456|FG000|NOT COMPLETED|Overall Study||5
10408401|NCT00754442|11552457|FG001|NOT COMPLETED|Overall Study||3
10408402|NCT00754468|11552466|FG000|STARTED|Overall Study||4
10408403|NCT00754468|11552467|FG001|STARTED|Overall Study||3
10408404|NCT00754468|11552466|FG000|COMPLETED|Overall Study||4
10408405|NCT00754468|11552467|FG001|COMPLETED|Overall Study||3
10408406|NCT00754468|11552466|FG000|NOT COMPLETED|Overall Study||0
10408407|NCT00754468|11552467|FG001|NOT COMPLETED|Overall Study||0
10408408|NCT00754494|11552478|FG000|STARTED|Overall Study||15
10408409|NCT00754494|11552479|FG001|STARTED|Overall Study||15
10408410|NCT00754494|11552480|FG002|STARTED|Overall Study||15
10408411|NCT00754494|11552478|FG000|COMPLETED|Overall Study||13
10408412|NCT00754494|11552479|FG001|COMPLETED|Overall Study||15
10408413|NCT00754494|11552480|FG002|COMPLETED|Overall Study||14
10726013|NCT02750514|11889949|FG003|STARTED|Track 3|5 participants had prior treatment in track 1 (1 part.) or track 3 (4 part.)|18
10408414|NCT00754494|11552478|FG000|NOT COMPLETED|Overall Study||2
10726014|NCT02750514|11889950|FG004|STARTED|Track 3||0
10726015|NCT02750514|11889946|FG000|COMPLETED|Track 3||0
10726016|NCT02750514|11889947|FG001|COMPLETED|Track 3|6 participants were re-randomized to track 3 (5 part.) or to track 5 (1 part.)|5
10726017|NCT02750514|11889948|FG002|COMPLETED|Track 3||1
10726018|NCT02750514|11889949|FG003|COMPLETED|Track 3|1 participant was re-randomized to track 5|2
10726019|NCT02750514|11889950|FG004|COMPLETED|Track 3||0
10726020|NCT02750514|11889946|FG000|NOT COMPLETED|Track 3||0
10726021|NCT02750514|11889947|FG001|NOT COMPLETED|Track 3||36
10726022|NCT02750514|11889948|FG002|NOT COMPLETED|Track 3||15
10726023|NCT02750514|11889949|FG003|NOT COMPLETED|Track 3||16
10726024|NCT02750514|11889950|FG004|NOT COMPLETED|Track 3||0
10726025|NCT02750514|11889946|FG000|STARTED|Track 4||0
10726026|NCT02750514|11889947|FG001|STARTED|Track 4||53
10726027|NCT02750514|11889948|FG002|STARTED|Track 4||0
10726028|NCT02750514|11889949|FG003|STARTED|Track 4||60
10726029|NCT02750514|11889950|FG004|STARTED|Track 4||0
10726030|NCT02750514|11889946|FG000|COMPLETED|Track 4||0
10726031|NCT02750514|11889947|FG001|COMPLETED|Track 4|1 participant was re-randomized to track 5|2
10726032|NCT02750514|11889948|FG002|COMPLETED|Track 4||0
10726033|NCT02750514|11889949|FG003|COMPLETED|Track 4||18
10726034|NCT02750514|11889950|FG004|COMPLETED|Track 4||0
10726035|NCT02750514|11889946|FG000|NOT COMPLETED|Track 4||0
10726036|NCT02750514|11889947|FG001|NOT COMPLETED|Track 4||51
10726037|NCT02750514|11889948|FG002|NOT COMPLETED|Track 4||0
10726038|NCT02750514|11889949|FG003|NOT COMPLETED|Track 4||42
10726039|NCT02750514|11889950|FG004|NOT COMPLETED|Track 4||0
10726040|NCT02750514|11889946|FG000|STARTED|Track 5||0
10726041|NCT02750514|11889947|FG001|STARTED|Track 5||0
10726042|NCT02750514|11889948|FG002|STARTED|Track 5||0
10726043|NCT02750514|11889949|FG003|STARTED|Track 5||0
10726134|NCT02750761|11890002|FG005|NOT COMPLETED|Overall Study||0
10726044|NCT02750514|11889950|FG004|STARTED|Track 5|6 participants had prior treatment in track 1 (1 part.), 2 (2 part.), 3 (2 part.) or 4 (1 part.)|43
10726045|NCT02750514|11889946|FG000|COMPLETED|Track 5||0
10726046|NCT02750514|11889947|FG001|COMPLETED|Track 5||0
10726047|NCT02750514|11889948|FG002|COMPLETED|Track 5||0
10726048|NCT02750514|11889949|FG003|COMPLETED|Track 5||0
10726049|NCT02750514|11889950|FG004|COMPLETED|Track 5||0
10726050|NCT02750514|11889946|FG000|NOT COMPLETED|Track 5||0
10726051|NCT02750514|11889947|FG001|NOT COMPLETED|Track 5||0
10726052|NCT02750514|11889948|FG002|NOT COMPLETED|Track 5||0
10726053|NCT02750514|11889949|FG003|NOT COMPLETED|Track 5||0
10726054|NCT02750514|11889950|FG004|NOT COMPLETED|Track 5||43
10726055|NCT02750592|11889970|FG000|STARTED|Overall Study||30
10726056|NCT02750592|11889970|FG000|COMPLETED|Overall Study||25
10726057|NCT02750592|11889970|FG000|NOT COMPLETED|Overall Study||5
10726058|NCT02750618|11889974|FG000|STARTED|Overall Study||13
10726059|NCT02750618|11889974|FG000|Completed Week 40|Overall Study||13
10726060|NCT02750618|11889974|FG000|Completed Week 64|Overall Study||13
10726061|NCT02750618|11889974|FG000|COMPLETED|Overall Study||12
10726062|NCT02750618|11889974|FG000|NOT COMPLETED|Overall Study||1
10726063|NCT02750709|11889978|FG000|STARTED|Treatment Period 1||4
10726064|NCT02750709|11889979|FG001|STARTED|Treatment Period 1||4
10726065|NCT02750709|11889980|FG002|STARTED|Treatment Period 1||4
10726066|NCT02750709|11889981|FG003|STARTED|Treatment Period 1||4
10726067|NCT02750709|11889982|FG004|STARTED|Treatment Period 1||4
10726068|NCT02750709|11889983|FG005|STARTED|Treatment Period 1||4
10726069|NCT02750709|11889978|FG000|COMPLETED|Treatment Period 1||4
10726070|NCT02750709|11889979|FG001|COMPLETED|Treatment Period 1||4
10726071|NCT02750709|11889980|FG002|COMPLETED|Treatment Period 1||4
10726072|NCT02750709|11889981|FG003|COMPLETED|Treatment Period 1||4
10726073|NCT02750709|11889982|FG004|COMPLETED|Treatment Period 1||4
10726074|NCT02750709|11889983|FG005|COMPLETED|Treatment Period 1||3
10726075|NCT02750709|11889978|FG000|NOT COMPLETED|Treatment Period 1||0
10726076|NCT02750709|11889979|FG001|NOT COMPLETED|Treatment Period 1||0
10726077|NCT02750709|11889980|FG002|NOT COMPLETED|Treatment Period 1||0
10726078|NCT02750709|11889981|FG003|NOT COMPLETED|Treatment Period 1||0
10726079|NCT02750709|11889982|FG004|NOT COMPLETED|Treatment Period 1||0
10726080|NCT02750709|11889983|FG005|NOT COMPLETED|Treatment Period 1||1
10726081|NCT02750709|11889978|FG000|STARTED|Treatment Period 2||4
10726082|NCT02750709|11889979|FG001|STARTED|Treatment Period 2||4
10726083|NCT02750709|11889980|FG002|STARTED|Treatment Period 2||4
10726084|NCT02750709|11889981|FG003|STARTED|Treatment Period 2||4
10726085|NCT02750709|11889982|FG004|STARTED|Treatment Period 2||4
10726086|NCT02750709|11889983|FG005|STARTED|Treatment Period 2||3
10726087|NCT02750709|11889978|FG000|COMPLETED|Treatment Period 2||4
10726088|NCT02750709|11889979|FG001|COMPLETED|Treatment Period 2||4
10726089|NCT02750709|11889980|FG002|COMPLETED|Treatment Period 2||4
10726090|NCT02750709|11889981|FG003|COMPLETED|Treatment Period 2||4
10726091|NCT02750709|11889982|FG004|COMPLETED|Treatment Period 2||4
10726092|NCT02750709|11889983|FG005|COMPLETED|Treatment Period 2||3
10726093|NCT02750709|11889978|FG000|NOT COMPLETED|Treatment Period 2||0
10726094|NCT02750709|11889979|FG001|NOT COMPLETED|Treatment Period 2||0
10726095|NCT02750709|11889980|FG002|NOT COMPLETED|Treatment Period 2||0
10726096|NCT02750709|11889981|FG003|NOT COMPLETED|Treatment Period 2||0
10726097|NCT02750709|11889982|FG004|NOT COMPLETED|Treatment Period 2||0
10726098|NCT02750709|11889983|FG005|NOT COMPLETED|Treatment Period 2||0
10726099|NCT02750709|11889978|FG000|STARTED|Treatment Period 3||4
10726100|NCT02750709|11889979|FG001|STARTED|Treatment Period 3||4
10726101|NCT02750709|11889980|FG002|STARTED|Treatment Period 3||4
10726102|NCT02750709|11889981|FG003|STARTED|Treatment Period 3||4
10726103|NCT02750709|11889982|FG004|STARTED|Treatment Period 3||4
10726104|NCT02750709|11889983|FG005|STARTED|Treatment Period 3||3
10726105|NCT02750709|11889978|FG000|COMPLETED|Treatment Period 3||4
10726106|NCT02750709|11889979|FG001|COMPLETED|Treatment Period 3||4
10726107|NCT02750709|11889980|FG002|COMPLETED|Treatment Period 3||4
10726108|NCT02750709|11889981|FG003|COMPLETED|Treatment Period 3||4
10726109|NCT02750709|11889982|FG004|COMPLETED|Treatment Period 3||4
10726110|NCT02750709|11889983|FG005|COMPLETED|Treatment Period 3||3
10726111|NCT02750709|11889978|FG000|NOT COMPLETED|Treatment Period 3||0
10726112|NCT02750709|11889979|FG001|NOT COMPLETED|Treatment Period 3||0
10726113|NCT02750709|11889980|FG002|NOT COMPLETED|Treatment Period 3||0
10726114|NCT02750709|11889981|FG003|NOT COMPLETED|Treatment Period 3||0
10726115|NCT02750709|11889982|FG004|NOT COMPLETED|Treatment Period 3||0
10726116|NCT02750709|11889983|FG005|NOT COMPLETED|Treatment Period 3||0
10726117|NCT02750761|11889997|FG000|STARTED|Overall Study||5
10726118|NCT02750761|11889998|FG001|STARTED|Overall Study||5
10726119|NCT02750761|11889999|FG002|STARTED|Overall Study||5
10726120|NCT02750761|11890000|FG003|STARTED|Overall Study||5
10726121|NCT02750761|11890001|FG004|STARTED|Overall Study||6
10726122|NCT02750761|11890002|FG005|STARTED|Overall Study||6
10726123|NCT02750761|11889997|FG000|COMPLETED|Overall Study||5
10726124|NCT02750761|11889998|FG001|COMPLETED|Overall Study||5
10726125|NCT02750761|11889999|FG002|COMPLETED|Overall Study||4
10726126|NCT02750761|11890000|FG003|COMPLETED|Overall Study||5
10726127|NCT02750761|11890001|FG004|COMPLETED|Overall Study||6
10726128|NCT02750761|11890002|FG005|COMPLETED|Overall Study||6
10726129|NCT02750761|11889997|FG000|NOT COMPLETED|Overall Study||0
10726130|NCT02750761|11889998|FG001|NOT COMPLETED|Overall Study||0
10726131|NCT02750761|11889999|FG002|NOT COMPLETED|Overall Study||1
10726132|NCT02750761|11890000|FG003|NOT COMPLETED|Overall Study||0
10726133|NCT02750761|11890001|FG004|NOT COMPLETED|Overall Study||0
10726135|NCT02750800|11890026|FG000|STARTED|Overall Study||412
10726136|NCT02750800|11890026|FG000|COMPLETED|Overall Study||314
10726137|NCT02750800|11890026|FG000|NOT COMPLETED|Overall Study||98
10726138|NCT02750813|11890044|FG000|STARTED|Period 1, First 14 Days of Wear||125
10726139|NCT02750813|11890045|FG001|STARTED|Period 1, First 14 Days of Wear||121
10726140|NCT02750813|11890044|FG000|COMPLETED|Period 1, First 14 Days of Wear||124
10726141|NCT02750813|11890045|FG001|COMPLETED|Period 1, First 14 Days of Wear||120
10726142|NCT02750813|11890044|FG000|NOT COMPLETED|Period 1, First 14 Days of Wear||1
10726143|NCT02750813|11890045|FG001|NOT COMPLETED|Period 1, First 14 Days of Wear||1
10726144|NCT02750813|11890044|FG000|STARTED|Period 2, Second 14 Days of Wear||124
10726145|NCT02750813|11890045|FG001|STARTED|Period 2, Second 14 Days of Wear||120
10726146|NCT02750813|11890044|FG000|COMPLETED|Period 2, Second 14 Days of Wear||124
10726147|NCT02750813|11890045|FG001|COMPLETED|Period 2, Second 14 Days of Wear||120
10726148|NCT02750813|11890044|FG000|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
10726149|NCT02750813|11890045|FG001|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
10726150|NCT02750930|11890052|FG000|STARTED|Overall Study||8
10726151|NCT02750930|11890052|FG000|COMPLETED|Overall Study||0
10726152|NCT02750930|11890052|FG000|NOT COMPLETED|Overall Study||8
10726153|NCT02750943|11890058|FG000|STARTED|Overall Study||125
10726154|NCT02750943|11890059|FG001|STARTED|Overall Study||128
10726155|NCT02750943|11890058|FG000|COMPLETED|Overall Study||119
10726156|NCT02750943|11890059|FG001|COMPLETED|Overall Study||119
10726157|NCT02750943|11890058|FG000|NOT COMPLETED|Overall Study||6
10726158|NCT02750943|11890059|FG001|NOT COMPLETED|Overall Study||9
10726159|NCT02751320|11890065|FG000|STARTED|Overall Study||45
10726160|NCT02751320|11890065|FG000|Received Test Product 1|Overall Study||29
10726161|NCT02751320|11890065|FG000|Received Test Prodcut 2|Overall Study||28
10726162|NCT02751320|11890065|FG000|Received Test Prodcut 3|Overall Study||28
10726163|NCT02751320|11890065|FG000|Received Reference Product 1|Overall Study||29
10726164|NCT02751320|11890065|FG000|Received Reference Product 2|Overall Study||28
10726165|NCT02751320|11890065|FG000|Received Reference Product 3|Overall Study||28
10726166|NCT02751320|11890065|FG000|COMPLETED|Overall Study||42
10726167|NCT02751320|11890065|FG000|NOT COMPLETED|Overall Study||3
10726168|NCT02751359|11890090|FG000|STARTED|Overall Study||18
10726169|NCT02751359|11890090|FG000|COMPLETED|Overall Study||17
10726170|NCT02751359|11890090|FG000|NOT COMPLETED|Overall Study||1
10726171|NCT02751385|11890100|FG000|STARTED|Period 1||2
10726172|NCT02751385|11890101|FG001|STARTED|Period 1||0
10726173|NCT02751385|11890100|FG000|COMPLETED|Period 1||2
10726174|NCT02751385|11890101|FG001|COMPLETED|Period 1||0
10726175|NCT02751385|11890100|FG000|NOT COMPLETED|Period 1||0
10726176|NCT02751385|11890101|FG001|NOT COMPLETED|Period 1||0
10726177|NCT02751385|11890100|FG000|STARTED|Period 2||0
10726178|NCT02751385|11890101|FG001|STARTED|Period 2||2
10726179|NCT02751385|11890100|FG000|COMPLETED|Period 2||0
10726180|NCT02751385|11890101|FG001|COMPLETED|Period 2||2
10726181|NCT02751385|11890100|FG000|NOT COMPLETED|Period 2||0
10726182|NCT02751385|11890101|FG001|NOT COMPLETED|Period 2||0
10726183|NCT02751424|11890118|FG000|STARTED|Part 1||6
10726184|NCT02751424|11890119|FG001|STARTED|Part 1||6
10726185|NCT02751424|11890120|FG002|STARTED|Part 1||6
10726186|NCT02751424|11890121|FG003|STARTED|Part 1||6
10726187|NCT02751424|11890122|FG004|STARTED|Part 1||6
10726188|NCT02751424|11890123|FG005|STARTED|Part 1||6
10726189|NCT02751424|11890124|FG006|STARTED|Part 1||12
10726190|NCT02751424|11890125|FG007|STARTED|Part 1||0
10726191|NCT02751424|11890126|FG008|STARTED|Part 1||0
10726192|NCT02751424|11890118|FG000|COMPLETED|Part 1||6
10726193|NCT02751424|11890119|FG001|COMPLETED|Part 1||6
10726194|NCT02751424|11890120|FG002|COMPLETED|Part 1||6
10726195|NCT02751424|11890121|FG003|COMPLETED|Part 1||6
10726196|NCT02751424|11890122|FG004|COMPLETED|Part 1||6
10726197|NCT02751424|11890123|FG005|COMPLETED|Part 1||6
10726198|NCT02751424|11890124|FG006|COMPLETED|Part 1||12
10726199|NCT02751424|11890125|FG007|COMPLETED|Part 1||0
10726200|NCT02751424|11890126|FG008|COMPLETED|Part 1||0
10726201|NCT02751424|11890118|FG000|NOT COMPLETED|Part 1||0
10726202|NCT02751424|11890119|FG001|NOT COMPLETED|Part 1||0
10726203|NCT02751424|11890120|FG002|NOT COMPLETED|Part 1||0
10726204|NCT02751424|11890121|FG003|NOT COMPLETED|Part 1||0
10726205|NCT02751424|11890122|FG004|NOT COMPLETED|Part 1||0
10726206|NCT02751424|11890123|FG005|NOT COMPLETED|Part 1||0
10726207|NCT02751424|11890124|FG006|NOT COMPLETED|Part 1||0
10726208|NCT02751424|11890125|FG007|NOT COMPLETED|Part 1||0
10726209|NCT02751424|11890126|FG008|NOT COMPLETED|Part 1||0
10726210|NCT02751424|11890118|FG000|STARTED|Part 2||0
10726211|NCT02751424|11890119|FG001|STARTED|Part 2||0
10726212|NCT02751424|11890120|FG002|STARTED|Part 2||0
10726213|NCT02751424|11890121|FG003|STARTED|Part 2||0
10726214|NCT02751424|11890122|FG004|STARTED|Part 2||0
10726215|NCT02751424|11890123|FG005|STARTED|Part 2||0
10726216|NCT02751424|11890124|FG006|STARTED|Part 2||0
10726217|NCT02751424|11890125|FG007|STARTED|Part 2||11
10726218|NCT02751424|11890126|FG008|STARTED|Part 2||3
10726219|NCT02751424|11890118|FG000|COMPLETED|Part 2||0
10726220|NCT02751424|11890119|FG001|COMPLETED|Part 2||0
10726221|NCT02751424|11890120|FG002|COMPLETED|Part 2||0
10726222|NCT02751424|11890121|FG003|COMPLETED|Part 2||0
10726223|NCT02751424|11890122|FG004|COMPLETED|Part 2||0
10726224|NCT02751424|11890123|FG005|COMPLETED|Part 2||0
10726225|NCT02751424|11890124|FG006|COMPLETED|Part 2||0
10726226|NCT02751424|11890125|FG007|COMPLETED|Part 2||6
10726227|NCT02751424|11890126|FG008|COMPLETED|Part 2||3
10726228|NCT02751424|11890118|FG000|NOT COMPLETED|Part 2||0
10726229|NCT02751424|11890119|FG001|NOT COMPLETED|Part 2||0
10726230|NCT02751424|11890120|FG002|NOT COMPLETED|Part 2||0
10726231|NCT02751424|11890121|FG003|NOT COMPLETED|Part 2||0
10726232|NCT02751424|11890122|FG004|NOT COMPLETED|Part 2||0
10726233|NCT02751424|11890123|FG005|NOT COMPLETED|Part 2||0
10726234|NCT02751424|11890124|FG006|NOT COMPLETED|Part 2||0
10726235|NCT02751424|11890125|FG007|NOT COMPLETED|Part 2||5
10726236|NCT02751424|11890126|FG008|NOT COMPLETED|Part 2||0
10726237|NCT02751450|11890151|FG000|STARTED|Overall Study||117
10726238|NCT02751450|11890152|FG001|STARTED|Overall Study||116
10726239|NCT02751450|11890151|FG000|COMPLETED|Overall Study||116
10726240|NCT02751450|11890152|FG001|COMPLETED|Overall Study||116
10726241|NCT02751450|11890151|FG000|NOT COMPLETED|Overall Study||1
10726242|NCT02751450|11890152|FG001|NOT COMPLETED|Overall Study||0
10726243|NCT02751580|11890160|FG000|STARTED|Overall Study||37
10726244|NCT02751580|11890160|FG000|COMPLETED|Overall Study||31
10726245|NCT02751580|11890160|FG000|NOT COMPLETED|Overall Study||6
10726246|NCT02751827|11890167|FG000|STARTED|Overall Study||41
10726247|NCT02751827|11890168|FG001|STARTED|Overall Study||171
10726248|NCT02751827|11890169|FG002|STARTED|Overall Study||100
10726249|NCT02751827|11890167|FG000|COMPLETED|Overall Study||41
10726250|NCT02751827|11890168|FG001|COMPLETED|Overall Study||171
10726251|NCT02751827|11890169|FG002|COMPLETED|Overall Study||99
10726252|NCT02751827|11890167|FG000|NOT COMPLETED|Overall Study||0
10726253|NCT02751827|11890168|FG001|NOT COMPLETED|Overall Study||0
10726254|NCT02751827|11890169|FG002|NOT COMPLETED|Overall Study||1
10726255|NCT02751879|11890179|FG000|STARTED|Overall Study||157
10726256|NCT02751879|11890180|FG001|STARTED|Overall Study||71
10726257|NCT02751879|11890179|FG000|On Treatment at Study Completion|Overall Study||81
10726258|NCT02751879|11890180|FG001|On Treatment at Study Completion|Overall Study||41
10726259|NCT02751879|11890179|FG000|COMPLETED|Overall Study||157
10726260|NCT02751879|11890180|FG001|COMPLETED|Overall Study||71
10726261|NCT02751879|11890179|FG000|NOT COMPLETED|Overall Study||0
10726262|NCT02751879|11890180|FG001|NOT COMPLETED|Overall Study||0
10726263|NCT02751931|11890191|FG000|STARTED|Overall Study||56
10726264|NCT02751931|11890192|FG001|STARTED|Overall Study||35
10726265|NCT02751931|11890191|FG000|Treated|Overall Study||55
10726266|NCT02751931|11890192|FG001|Treated|Overall Study||31
10726267|NCT02751931|11890191|FG000|COMPLETED|Overall Study||43
10726268|NCT02751931|11890192|FG001|COMPLETED|Overall Study||27
10726269|NCT02751931|11890191|FG000|NOT COMPLETED|Overall Study||13
10726270|NCT02751931|11890192|FG001|NOT COMPLETED|Overall Study||8
10726271|NCT02751983|11890206|FG000|STARTED|Baseline and Randomization||35
10726272|NCT02751983|11890207|FG001|STARTED|Baseline and Randomization||35
10726273|NCT02751983|11890206|FG000|COMPLETED|Baseline and Randomization||35
10726274|NCT02751983|11890207|FG001|COMPLETED|Baseline and Randomization||35
10726275|NCT02751983|11890206|FG000|NOT COMPLETED|Baseline and Randomization||0
10726276|NCT02751983|11890207|FG001|NOT COMPLETED|Baseline and Randomization||0
10726277|NCT02751983|11890206|FG000|STARTED|Treatment||35
10726278|NCT02751983|11890207|FG001|STARTED|Treatment||35
10726279|NCT02751983|11890206|FG000|COMPLETED|Treatment||31
10726280|NCT02751983|11890207|FG001|COMPLETED|Treatment||35
10726281|NCT02751983|11890206|FG000|NOT COMPLETED|Treatment||4
10726282|NCT02751983|11890207|FG001|NOT COMPLETED|Treatment||0
10726283|NCT02751983|11890206|FG000|STARTED|Post-Treatment Assessment||35
10726284|NCT02751983|11890207|FG001|STARTED|Post-Treatment Assessment||0
10726285|NCT02751983|11890206|FG000|COMPLETED|Post-Treatment Assessment||30
10726286|NCT02751983|11890207|FG001|COMPLETED|Post-Treatment Assessment||0
10814583|NCT02284906|11977390|FG000|STARTED|Overall Study||3
10814584|NCT02284906|11977391|FG001|STARTED|Overall Study||18
10726287|NCT02751983|11890206|FG000|NOT COMPLETED|Post-Treatment Assessment||5
10726288|NCT02751983|11890207|FG001|NOT COMPLETED|Post-Treatment Assessment||0
10726289|NCT02751983|11890206|FG000|STARTED|One-Month Follow-Up Assessments||35
10726290|NCT02751983|11890207|FG001|STARTED|One-Month Follow-Up Assessments||35
10726291|NCT02751983|11890206|FG000|COMPLETED|One-Month Follow-Up Assessments||21
10726292|NCT02751983|11890207|FG001|COMPLETED|One-Month Follow-Up Assessments||23
10726293|NCT02751983|11890206|FG000|NOT COMPLETED|One-Month Follow-Up Assessments||14
10726294|NCT02751983|11890207|FG001|NOT COMPLETED|One-Month Follow-Up Assessments||12
10726295|NCT02751983|11890206|FG000|STARTED|Three-Month Follow-Up Assessments||35
10726296|NCT02751983|11890207|FG001|STARTED|Three-Month Follow-Up Assessments||35
10726297|NCT02751983|11890206|FG000|COMPLETED|Three-Month Follow-Up Assessments||23
10726298|NCT02751983|11890207|FG001|COMPLETED|Three-Month Follow-Up Assessments||19
10726299|NCT02751983|11890206|FG000|NOT COMPLETED|Three-Month Follow-Up Assessments||12
10726300|NCT02751983|11890207|FG001|NOT COMPLETED|Three-Month Follow-Up Assessments||16
10726301|NCT02752048|11890216|FG000|STARTED|Overall Study||11
10726302|NCT02752048|11890217|FG001|STARTED|Overall Study||12
10726303|NCT02752048|11890218|FG002|STARTED|Overall Study||13
10726304|NCT02752048|11890216|FG000|COMPLETED|Overall Study||11
10726305|NCT02752048|11890217|FG001|COMPLETED|Overall Study||12
10726306|NCT02752048|11890218|FG002|COMPLETED|Overall Study||10
10726307|NCT02752048|11890216|FG000|NOT COMPLETED|Overall Study||0
10726308|NCT02752048|11890217|FG001|NOT COMPLETED|Overall Study||0
10726309|NCT02752048|11890218|FG002|NOT COMPLETED|Overall Study||3
10726310|NCT02752074|11890228|FG000|STARTED|Overall Study||354
10726311|NCT02752074|11890229|FG001|STARTED|Overall Study||352
10726312|NCT02752074|11890228|FG000|Treated|Overall Study||353
10726313|NCT02752074|11890229|FG001|Treated|Overall Study||352
10726314|NCT02752074|11890228|FG000|COMPLETED|Overall Study||198
10726315|NCT02752074|11890229|FG001|COMPLETED|Overall Study||209
10726316|NCT02752074|11890228|FG000|NOT COMPLETED|Overall Study||156
10726317|NCT02752074|11890229|FG001|NOT COMPLETED|Overall Study||143
10726318|NCT02752087|11890235|FG000|STARTED|Study Period 1||12
10726319|NCT02752087|11890236|FG001|STARTED|Study Period 1||12
10726320|NCT02752087|11890235|FG000|Received Study Drug|Study Period 1||12
10726321|NCT02752087|11890236|FG001|Received Study Drug|Study Period 1||12
10726322|NCT02752087|11890235|FG000|COMPLETED|Study Period 1||12
10726323|NCT02752087|11890236|FG001|COMPLETED|Study Period 1||12
10726324|NCT02752087|11890235|FG000|NOT COMPLETED|Study Period 1||0
10726325|NCT02752087|11890236|FG001|NOT COMPLETED|Study Period 1||0
10726326|NCT02752087|11890235|FG000|STARTED|Washout||12
10726327|NCT02752087|11890236|FG001|STARTED|Washout||12
10726328|NCT02752087|11890235|FG000|COMPLETED|Washout||11
10726329|NCT02752087|11890236|FG001|COMPLETED|Washout||12
10726330|NCT02752087|11890235|FG000|NOT COMPLETED|Washout||1
10726331|NCT02752087|11890236|FG001|NOT COMPLETED|Washout||0
10726332|NCT02752087|11890235|FG000|STARTED|Study Period 2||11
10726333|NCT02752087|11890236|FG001|STARTED|Study Period 2||12
10726334|NCT02752087|11890235|FG000|Received Study Drug|Study Period 2||11
10726335|NCT02752087|11890236|FG001|Received Study Drug|Study Period 2||12
10726336|NCT02752087|11890235|FG000|COMPLETED|Study Period 2||11
10726337|NCT02752087|11890236|FG001|COMPLETED|Study Period 2||12
10726338|NCT02752087|11890235|FG000|NOT COMPLETED|Study Period 2||0
10726339|NCT02752087|11890236|FG001|NOT COMPLETED|Study Period 2||0
10726340|NCT02752087|11890235|FG000|STARTED|Washout||11
10726341|NCT02752087|11890236|FG001|STARTED|Washout||12
10726342|NCT02752087|11890235|FG000|COMPLETED|Washout||11
10726343|NCT02752087|11890236|FG001|COMPLETED|Washout||12
10726344|NCT02752087|11890235|FG000|NOT COMPLETED|Washout||0
10726345|NCT02752087|11890236|FG001|NOT COMPLETED|Washout||0
10726346|NCT02752087|11890235|FG000|STARTED|Study Period 3||11
10726347|NCT02752087|11890236|FG001|STARTED|Study Period 3||12
10726348|NCT02752087|11890235|FG000|Received Study Drug|Study Period 3||11
10726349|NCT02752087|11890236|FG001|Received Study Drug|Study Period 3||12
10726350|NCT02752087|11890235|FG000|COMPLETED|Study Period 3||11
10726351|NCT02752087|11890236|FG001|COMPLETED|Study Period 3||12
10726352|NCT02752087|11890235|FG000|NOT COMPLETED|Study Period 3||0
10726353|NCT02752087|11890236|FG001|NOT COMPLETED|Study Period 3||0
10726354|NCT02752087|11890235|FG000|STARTED|Washout||11
10726355|NCT02752087|11890236|FG001|STARTED|Washout||12
10726356|NCT02752087|11890235|FG000|COMPLETED|Washout||11
10726357|NCT02752087|11890236|FG001|COMPLETED|Washout||12
10726358|NCT02752087|11890235|FG000|NOT COMPLETED|Washout||0
10726359|NCT02752087|11890236|FG001|NOT COMPLETED|Washout||0
10726360|NCT02752087|11890235|FG000|STARTED|Study Period 4||11
10726361|NCT02752087|11890236|FG001|STARTED|Study Period 4||12
10726362|NCT02752087|11890235|FG000|Received Study Drug|Study Period 4||11
10726363|NCT02752087|11890236|FG001|Received Study Drug|Study Period 4||12
10726364|NCT02752087|11890235|FG000|COMPLETED|Study Period 4||11
10726365|NCT02752087|11890236|FG001|COMPLETED|Study Period 4||12
10726366|NCT02752087|11890235|FG000|NOT COMPLETED|Study Period 4||0
10726367|NCT02752087|11890236|FG001|NOT COMPLETED|Study Period 4||0
10726368|NCT02752087|11890235|FG000|STARTED|Follow-up||11
10726369|NCT02752087|11890236|FG001|STARTED|Follow-up||12
10726370|NCT02752087|11890235|FG000|COMPLETED|Follow-up||11
10726371|NCT02752087|11890236|FG001|COMPLETED|Follow-up||12
10726372|NCT02752087|11890235|FG000|NOT COMPLETED|Follow-up||0
10726373|NCT02752087|11890236|FG001|NOT COMPLETED|Follow-up||0
10726374|NCT02752256|11890244|FG000|STARTED|Overall Study||35
10726375|NCT02752256|11890245|FG001|STARTED|Overall Study||41
10726376|NCT02752256|11890244|FG000|COMPLETED|Overall Study||35
10726377|NCT02752256|11890245|FG001|COMPLETED|Overall Study||41
10726378|NCT02752256|11890244|FG000|NOT COMPLETED|Overall Study||0
10726379|NCT02752256|11890245|FG001|NOT COMPLETED|Overall Study||0
10726380|NCT02752490|11890253|FG000|STARTED|Overall Study||409
10726381|NCT02752490|11890254|FG001|STARTED|Overall Study||435
10726382|NCT02752490|11890253|FG000|COMPLETED|Overall Study||409
10726383|NCT02752490|11890254|FG001|COMPLETED|Overall Study||435
10726384|NCT02752490|11890253|FG000|NOT COMPLETED|Overall Study||0
10726385|NCT02752490|11890254|FG001|NOT COMPLETED|Overall Study||0
10726386|NCT02752633|11890260|FG000|STARTED|Overall Study||9
10726387|NCT02752633|11890260|FG000|COMPLETED|Overall Study||8
10726388|NCT02752633|11890260|FG000|NOT COMPLETED|Overall Study||1
10726389|NCT02752776|11890267|FG000|STARTED|Overall Study||663
10726390|NCT02752776|11890268|FG001|STARTED|Overall Study||673
10726391|NCT02752776|11890269|FG002|STARTED|Overall Study||324
10726392|NCT02752776|11890267|FG000|COMPLETED|Overall Study||611
10726393|NCT02752776|11890268|FG001|COMPLETED|Overall Study||597
10726394|NCT02752776|11890269|FG002|COMPLETED|Overall Study||276
10726395|NCT02752776|11890267|FG000|NOT COMPLETED|Overall Study||52
10726396|NCT02752776|11890268|FG001|NOT COMPLETED|Overall Study||76
10726397|NCT02752776|11890269|FG002|NOT COMPLETED|Overall Study||48
10726398|NCT02752802|11890281|FG000|STARTED|Overall Study||48
10726399|NCT02752802|11890282|FG001|STARTED|Overall Study||48
10726400|NCT02752802|11890281|FG000|COMPLETED|Overall Study||47
10726401|NCT02752802|11890282|FG001|COMPLETED|Overall Study||48
10726402|NCT02752802|11890281|FG000|NOT COMPLETED|Overall Study||1
10726403|NCT02752802|11890282|FG001|NOT COMPLETED|Overall Study||0
10726404|NCT02752880|11890292|FG000|STARTED|Overall Study||23
10726405|NCT02752880|11890293|FG001|STARTED|Overall Study||23
10726406|NCT02752880|11890292|FG000|COMPLETED|Overall Study||21
10726407|NCT02752880|11890293|FG001|COMPLETED|Overall Study||20
10726408|NCT02752880|11890292|FG000|NOT COMPLETED|Overall Study||2
10726409|NCT02752880|11890293|FG001|NOT COMPLETED|Overall Study||3
10726410|NCT02752958|11890300|FG000|STARTED|Overall Study||75
10726411|NCT02752958|11890300|FG000|COMPLETED|Overall Study||66
10726412|NCT02752958|11890300|FG000|NOT COMPLETED|Overall Study||9
10726413|NCT02753075|11890309|FG000|STARTED|Overall Study||79
10726414|NCT02753075|11890310|FG001|STARTED|Overall Study||80
10726415|NCT02753075|11890311|FG002|STARTED|Overall Study||81
10726416|NCT02753075|11890309|FG000|COMPLETED|Overall Study||71
10726417|NCT02753075|11890310|FG001|COMPLETED|Overall Study||77
10726418|NCT02753075|11890311|FG002|COMPLETED|Overall Study||78
10726419|NCT02753075|11890309|FG000|NOT COMPLETED|Overall Study||8
10726420|NCT02753075|11890310|FG001|NOT COMPLETED|Overall Study||3
10726421|NCT02753075|11890311|FG002|NOT COMPLETED|Overall Study||3
10726422|NCT02753400|11890322|FG000|STARTED|Overall Study||12
10726423|NCT02753400|11890323|FG001|STARTED|Overall Study||12
10726424|NCT02753400|11890322|FG000|COMPLETED|Overall Study||7
10726425|NCT02753400|11890323|FG001|COMPLETED|Overall Study||11
10726426|NCT02753400|11890322|FG000|NOT COMPLETED|Overall Study||5
10726427|NCT02753400|11890323|FG001|NOT COMPLETED|Overall Study||1
10726428|NCT02753413|11890331|FG000|STARTED|Overall Study||49
10726429|NCT02753413|11890332|FG001|STARTED|Overall Study||51
10726430|NCT02753413|11890331|FG000|COMPLETED|Overall Study||49
10726431|NCT02753413|11890332|FG001|COMPLETED|Overall Study||51
10726432|NCT02753413|11890331|FG000|NOT COMPLETED|Overall Study||0
10726433|NCT02753413|11890332|FG001|NOT COMPLETED|Overall Study||0
10726434|NCT02753595|11890340|FG000|STARTED|Overall Study||5
10726435|NCT02753595|11890341|FG001|STARTED|Overall Study||9
10726436|NCT02753595|11890340|FG000|COMPLETED|Overall Study||3
10726437|NCT02753595|11890341|FG001|COMPLETED|Overall Study||7
10726438|NCT02753595|11890340|FG000|NOT COMPLETED|Overall Study||2
10726439|NCT02753595|11890341|FG001|NOT COMPLETED|Overall Study||2
10726440|NCT02753699|11890349|FG000|STARTED|Overall Study||164
10726441|NCT02753699|11890350|FG001|STARTED|Overall Study||397
10726442|NCT02753699|11890351|FG002|STARTED|Overall Study||162
10726443|NCT02753699|11890349|FG000|COMPLETED|Overall Study||150
10726444|NCT02753699|11890350|FG001|COMPLETED|Overall Study||354
10726445|NCT02753699|11890351|FG002|COMPLETED|Overall Study||139
10726446|NCT02753699|11890349|FG000|NOT COMPLETED|Overall Study||14
10726447|NCT02753699|11890350|FG001|NOT COMPLETED|Overall Study||43
10726448|NCT02753699|11890351|FG002|NOT COMPLETED|Overall Study||23
10726449|NCT02753816|11890364|FG000|STARTED|Overall Study||7
10726450|NCT02753816|11890365|FG001|STARTED|Overall Study||11
10726451|NCT02753816|11890366|FG002|STARTED|Overall Study||7
10726452|NCT02753816|11890364|FG000|Tranexamic Acid|Overall Study||7
10726453|NCT02753816|11890365|FG001|Tranexamic Acid|Overall Study||0
10726454|NCT02753816|11890366|FG002|Tranexamic Acid|Overall Study||7
10726455|NCT02753816|11890364|FG000|Placebo|Overall Study||0
10726456|NCT02753816|11890365|FG001|Placebo|Overall Study||11
10726457|NCT02753816|11890366|FG002|Placebo|Overall Study||7
10726458|NCT02753816|11890364|FG000|COMPLETED|Overall Study||7
10726459|NCT02753816|11890365|FG001|COMPLETED|Overall Study||10
10726460|NCT02753816|11890366|FG002|COMPLETED|Overall Study||7
10726461|NCT02753816|11890364|FG000|NOT COMPLETED|Overall Study||0
10726462|NCT02753816|11890365|FG001|NOT COMPLETED|Overall Study||1
10726463|NCT02753816|11890366|FG002|NOT COMPLETED|Overall Study||0
10726464|NCT02753842|11890378|FG000|STARTED|First Follow-Up (Set of Condoms)||85
10726465|NCT02753842|11890379|FG001|STARTED|First Follow-Up (Set of Condoms)||84
10726466|NCT02753842|11890380|FG002|STARTED|First Follow-Up (Set of Condoms)||85
10726467|NCT02753842|11890381|FG003|STARTED|First Follow-Up (Set of Condoms)||83
10726468|NCT02753842|11890382|FG004|STARTED|First Follow-Up (Set of Condoms)||83
10726469|NCT02753842|11890383|FG005|STARTED|First Follow-Up (Set of Condoms)||84
10726470|NCT02753842|11890378|FG000|COMPLETED|First Follow-Up (Set of Condoms)||75
10726471|NCT02753842|11890379|FG001|COMPLETED|First Follow-Up (Set of Condoms)||76
10726472|NCT02753842|11890380|FG002|COMPLETED|First Follow-Up (Set of Condoms)||76
10726473|NCT02753842|11890381|FG003|COMPLETED|First Follow-Up (Set of Condoms)||81
10726474|NCT02753842|11890382|FG004|COMPLETED|First Follow-Up (Set of Condoms)||76
10726475|NCT02753842|11890383|FG005|COMPLETED|First Follow-Up (Set of Condoms)||79
10726476|NCT02753842|11890378|FG000|NOT COMPLETED|First Follow-Up (Set of Condoms)||10
10726477|NCT02753842|11890379|FG001|NOT COMPLETED|First Follow-Up (Set of Condoms)||8
10726478|NCT02753842|11890380|FG002|NOT COMPLETED|First Follow-Up (Set of Condoms)||9
10726479|NCT02753842|11890381|FG003|NOT COMPLETED|First Follow-Up (Set of Condoms)||2
10726480|NCT02753842|11890382|FG004|NOT COMPLETED|First Follow-Up (Set of Condoms)||7
10726481|NCT02753842|11890383|FG005|NOT COMPLETED|First Follow-Up (Set of Condoms)||5
10726482|NCT02753842|11890378|FG000|STARTED|Second Follow-Up (Set of Condoms)||75
10726483|NCT02753842|11890379|FG001|STARTED|Second Follow-Up (Set of Condoms)||76
10726484|NCT02753842|11890380|FG002|STARTED|Second Follow-Up (Set of Condoms)||76
10726485|NCT02753842|11890381|FG003|STARTED|Second Follow-Up (Set of Condoms)||81
10726486|NCT02753842|11890382|FG004|STARTED|Second Follow-Up (Set of Condoms)||76
10726487|NCT02753842|11890383|FG005|STARTED|Second Follow-Up (Set of Condoms)||79
10726488|NCT02753842|11890378|FG000|COMPLETED|Second Follow-Up (Set of Condoms)||71
10726489|NCT02753842|11890379|FG001|COMPLETED|Second Follow-Up (Set of Condoms)||71
10814585|NCT02284906|11977392|FG002|STARTED|Overall Study||19
10814586|NCT02284906|11977390|FG000|COMPLETED|Overall Study||0
10814587|NCT02284906|11977391|FG001|COMPLETED|Overall Study||0
10814588|NCT02284906|11977392|FG002|COMPLETED|Overall Study||0
10814589|NCT02284906|11977390|FG000|NOT COMPLETED|Overall Study||3
10814590|NCT02284906|11977391|FG001|NOT COMPLETED|Overall Study||18
10814591|NCT02284906|11977392|FG002|NOT COMPLETED|Overall Study||19
10726490|NCT02753842|11890380|FG002|COMPLETED|Second Follow-Up (Set of Condoms)||71
10726491|NCT02753842|11890381|FG003|COMPLETED|Second Follow-Up (Set of Condoms)||76
10726492|NCT02753842|11890382|FG004|COMPLETED|Second Follow-Up (Set of Condoms)||75
10726493|NCT02753842|11890383|FG005|COMPLETED|Second Follow-Up (Set of Condoms)||72
10726494|NCT02753842|11890378|FG000|NOT COMPLETED|Second Follow-Up (Set of Condoms)||4
10726495|NCT02753842|11890379|FG001|NOT COMPLETED|Second Follow-Up (Set of Condoms)||5
10726496|NCT02753842|11890380|FG002|NOT COMPLETED|Second Follow-Up (Set of Condoms)||5
10726497|NCT02753842|11890381|FG003|NOT COMPLETED|Second Follow-Up (Set of Condoms)||5
10726498|NCT02753842|11890382|FG004|NOT COMPLETED|Second Follow-Up (Set of Condoms)||1
10726499|NCT02753842|11890383|FG005|NOT COMPLETED|Second Follow-Up (Set of Condoms)||7
10726500|NCT02753842|11890378|FG000|STARTED|Third Follow-Up (Set of Condoms)||71
10726501|NCT02753842|11890379|FG001|STARTED|Third Follow-Up (Set of Condoms)||71
10726502|NCT02753842|11890380|FG002|STARTED|Third Follow-Up (Set of Condoms)||71
10726503|NCT02753842|11890381|FG003|STARTED|Third Follow-Up (Set of Condoms)||76
10726504|NCT02753842|11890382|FG004|STARTED|Third Follow-Up (Set of Condoms)||75
10726505|NCT02753842|11890383|FG005|STARTED|Third Follow-Up (Set of Condoms)||72
10726506|NCT02753842|11890378|FG000|COMPLETED|Third Follow-Up (Set of Condoms)||65
10726507|NCT02753842|11890379|FG001|COMPLETED|Third Follow-Up (Set of Condoms)||66
10726508|NCT02753842|11890380|FG002|COMPLETED|Third Follow-Up (Set of Condoms)||68
10726509|NCT02753842|11890381|FG003|COMPLETED|Third Follow-Up (Set of Condoms)||70
10726510|NCT02753842|11890382|FG004|COMPLETED|Third Follow-Up (Set of Condoms)||71
10726511|NCT02753842|11890383|FG005|COMPLETED|Third Follow-Up (Set of Condoms)||69
10726512|NCT02753842|11890378|FG000|NOT COMPLETED|Third Follow-Up (Set of Condoms)||6
10726513|NCT02753842|11890379|FG001|NOT COMPLETED|Third Follow-Up (Set of Condoms)||5
10726514|NCT02753842|11890380|FG002|NOT COMPLETED|Third Follow-Up (Set of Condoms)||3
10726515|NCT02753842|11890381|FG003|NOT COMPLETED|Third Follow-Up (Set of Condoms)||6
10726516|NCT02753842|11890382|FG004|NOT COMPLETED|Third Follow-Up (Set of Condoms)||4
10726517|NCT02753842|11890383|FG005|NOT COMPLETED|Third Follow-Up (Set of Condoms)||3
10726518|NCT02753881|11890400|FG000|STARTED|Overall Study||10
10726519|NCT02753881|11890401|FG001|STARTED|Overall Study||10
10726520|NCT02753881|11890402|FG002|STARTED|Overall Study||10
10726521|NCT02753881|11890400|FG000|COMPLETED|Overall Study||10
10726522|NCT02753881|11890401|FG001|COMPLETED|Overall Study||10
10726523|NCT02753881|11890402|FG002|COMPLETED|Overall Study||10
10726524|NCT02753881|11890400|FG000|NOT COMPLETED|Overall Study||0
10726525|NCT02753881|11890401|FG001|NOT COMPLETED|Overall Study||0
10726526|NCT02753881|11890402|FG002|NOT COMPLETED|Overall Study||0
10726527|NCT02753920|11890412|FG000|STARTED|Overall Study||87
10726528|NCT02753920|11890413|FG001|STARTED|Overall Study||86
10726529|NCT02753920|11890412|FG000|COMPLETED|Overall Study||87
10726530|NCT02753920|11890413|FG001|COMPLETED|Overall Study||86
10726531|NCT02753920|11890412|FG000|NOT COMPLETED|Overall Study||0
10726532|NCT02753920|11890413|FG001|NOT COMPLETED|Overall Study||0
10726533|NCT02753946|11890425|FG000|STARTED|Overall Study||233
10726534|NCT02753946|11890426|FG001|STARTED|Overall Study||231
10726535|NCT02753946|11890425|FG000|COMPLETED|Overall Study||219
10726536|NCT02753946|11890426|FG001|COMPLETED|Overall Study||222
10726537|NCT02753946|11890425|FG000|NOT COMPLETED|Overall Study||14
10726538|NCT02753946|11890426|FG001|NOT COMPLETED|Overall Study||9
10726539|NCT02754310|11890434|FG000|STARTED|Overall Study||42
10726540|NCT02754310|11890435|FG001|STARTED|Overall Study||43
10726541|NCT02754310|11890434|FG000|COMPLETED|Overall Study||42
10726542|NCT02754310|11890435|FG001|COMPLETED|Overall Study||43
10726543|NCT02754310|11890434|FG000|NOT COMPLETED|Overall Study||0
10726544|NCT02754310|11890435|FG001|NOT COMPLETED|Overall Study||0
10814592|NCT02287025|11977402|FG000|STARTED|Overall Study||12
10726545|NCT02754427|11890443|FG000|STARTED|Overall Study||21
10726546|NCT02754427|11890444|FG001|STARTED|Overall Study||20
10726547|NCT02754427|11890443|FG000|COMPLETED|Overall Study||21
10726548|NCT02754427|11890444|FG001|COMPLETED|Overall Study||19
10726549|NCT02754427|11890443|FG000|NOT COMPLETED|Overall Study||0
10726550|NCT02754427|11890444|FG001|NOT COMPLETED|Overall Study||1
10814593|NCT02287025|11977403|FG001|STARTED|Overall Study||11
10814594|NCT02287025|11977402|FG000|COMPLETED|Overall Study||2
10814595|NCT02287025|11977403|FG001|COMPLETED|Overall Study||2
10814596|NCT02287025|11977402|FG000|NOT COMPLETED|Overall Study||10
10814597|NCT02287025|11977403|FG001|NOT COMPLETED|Overall Study||9
10726551|NCT02754440|11890454|FG000|STARTED|Overall Study||99
10726552|NCT02754440|11890455|FG001|STARTED|Overall Study||101
10726553|NCT02754440|11890456|FG002|STARTED|Overall Study||100
10726554|NCT02754440|11890457|FG003|STARTED|Overall Study||35
10726555|NCT02754440|11890454|FG000|COMPLETED|Overall Study||93
10726556|NCT02754440|11890455|FG001|COMPLETED|Overall Study||93
10726557|NCT02754440|11890456|FG002|COMPLETED|Overall Study||93
10726558|NCT02754440|11890457|FG003|COMPLETED|Overall Study||0
10726559|NCT02754440|11890454|FG000|NOT COMPLETED|Overall Study||6
10726560|NCT02754440|11890455|FG001|NOT COMPLETED|Overall Study||8
10726561|NCT02754440|11890456|FG002|NOT COMPLETED|Overall Study||7
10726562|NCT02754440|11890457|FG003|NOT COMPLETED|Overall Study||35
10726563|NCT02754492|11890470|FG000|STARTED|Overall Study||97
10726564|NCT02754492|11890471|FG001|STARTED|Overall Study||95
10726565|NCT02754492|11890472|FG002|STARTED|Overall Study||95
10726566|NCT02754492|11890473|FG003|STARTED|Overall Study||23
10726567|NCT02754492|11890470|FG000|COMPLETED|Overall Study||93
10726568|NCT02754492|11890471|FG001|COMPLETED|Overall Study||93
10726569|NCT02754492|11890472|FG002|COMPLETED|Overall Study||93
10726570|NCT02754492|11890473|FG003|COMPLETED|Overall Study||0
10726571|NCT02754492|11890470|FG000|NOT COMPLETED|Overall Study||4
10726572|NCT02754492|11890471|FG001|NOT COMPLETED|Overall Study||2
10726573|NCT02754492|11890472|FG002|NOT COMPLETED|Overall Study||2
10726574|NCT02754492|11890473|FG003|NOT COMPLETED|Overall Study||23
10726575|NCT02754518|11890482|FG000|STARTED|Overall Study||40
10726576|NCT02754518|11890482|FG000|COMPLETED|Overall Study||40
10726577|NCT02754518|11890482|FG000|NOT COMPLETED|Overall Study||0
10726578|NCT02754570|11890486|FG000|STARTED|Overall Study||27
10726579|NCT02754570|11890486|FG000|Visits 1 and 2 (PGA Only)|Overall Study||27
10726580|NCT02754570|11890486|FG000|Visit 3 (PGA + Pilocarpine)|Overall Study||27
10726581|NCT02754570|11890486|FG000|COMPLETED|Overall Study||27
10726582|NCT02754570|11890486|FG000|NOT COMPLETED|Overall Study||0
10726583|NCT02754661|11890494|FG000|STARTED|Overall Study||160
10726584|NCT02754661|11890495|FG001|STARTED|Overall Study||160
10726585|NCT02754661|11890494|FG000|COMPLETED|Overall Study||145
10726586|NCT02754661|11890495|FG001|COMPLETED|Overall Study||141
10726587|NCT02754661|11890494|FG000|NOT COMPLETED|Overall Study||15
10726588|NCT02754661|11890495|FG001|NOT COMPLETED|Overall Study||19
10726589|NCT02754674|11890505|FG000|STARTED|Overall Study||34
10726590|NCT02754674|11890506|FG001|STARTED|Overall Study||33
10726591|NCT02754674|11890505|FG000|COMPLETED|Overall Study||28
10726592|NCT02754674|11890506|FG001|COMPLETED|Overall Study||26
10726593|NCT02754674|11890505|FG000|NOT COMPLETED|Overall Study||6
10726594|NCT02754674|11890506|FG001|NOT COMPLETED|Overall Study||7
10726595|NCT02755090|11890514|FG000|STARTED|Overall Study||19
10726596|NCT02755090|11890515|FG001|STARTED|Overall Study||20
10726597|NCT02755090|11890514|FG000|COMPLETED|Overall Study||18
10726598|NCT02755090|11890515|FG001|COMPLETED|Overall Study||20
10726599|NCT02755090|11890514|FG000|NOT COMPLETED|Overall Study||1
10726600|NCT02755090|11890515|FG001|NOT COMPLETED|Overall Study||0
10726601|NCT02755116|11890523|FG000|STARTED|Overall Study||74
10726602|NCT02755116|11890524|FG001|STARTED|Overall Study||70
10726603|NCT02755116|11890523|FG000|COMPLETED|Overall Study||71
10726604|NCT02755116|11890524|FG001|COMPLETED|Overall Study||69
10726605|NCT02755116|11890523|FG000|NOT COMPLETED|Overall Study||3
10726606|NCT02755116|11890524|FG001|NOT COMPLETED|Overall Study||1
10726607|NCT02755129|11890530|FG000|STARTED|Overall Study||15
10726608|NCT02755129|11890530|FG000|COMPLETED|Overall Study||15
10726609|NCT02755129|11890530|FG000|NOT COMPLETED|Overall Study||0
10726610|NCT02755285|11890537|FG000|STARTED|Overall Study||20
10726611|NCT02755285|11890537|FG000|COMPLETED|Overall Study||20
10726612|NCT02755285|11890537|FG000|NOT COMPLETED|Overall Study||0
10726613|NCT02755649|11890544|FG000|STARTED|Overall Study||108
10726614|NCT02755649|11890545|FG001|STARTED|Overall Study||107
10726615|NCT02755649|11890546|FG002|STARTED|Overall Study||110
10726616|NCT02755649|11890544|FG000|Completed Treatment (Week 16)|Overall Study||107
10726617|NCT02755649|11890545|FG001|Completed Treatment (Week 16)|Overall Study||106
10726618|NCT02755649|11890546|FG002|Completed Treatment (Week 16)|Overall Study||109
10726619|NCT02755649|11890544|FG000|Completed Study (Week 28)|Overall Study||7
10726620|NCT02755649|11890545|FG001|Completed Study (Week 28)|Overall Study||8
10726621|NCT02755649|11890546|FG002|Completed Study (Week 28)|Overall Study||8
10726622|NCT02755649|11890544|FG000|COMPLETED|Overall Study||7
10726623|NCT02755649|11890545|FG001|COMPLETED|Overall Study||8
10726624|NCT02755649|11890546|FG002|COMPLETED|Overall Study||8
10726625|NCT02755649|11890544|FG000|NOT COMPLETED|Overall Study||101
10726626|NCT02755649|11890545|FG001|NOT COMPLETED|Overall Study||99
10726627|NCT02755649|11890546|FG002|NOT COMPLETED|Overall Study||102
10726628|NCT02755805|11890556|FG000|STARTED|Overall Study||15
10726629|NCT02755805|11890557|FG001|STARTED|Overall Study||15
10726630|NCT02755805|11890556|FG000|COMPLETED|Overall Study||13
10726631|NCT02755805|11890557|FG001|COMPLETED|Overall Study||11
10726632|NCT02755805|11890556|FG000|NOT COMPLETED|Overall Study||2
10726633|NCT02755805|11890557|FG001|NOT COMPLETED|Overall Study||4
10726634|NCT02755818|11890567|FG000|STARTED|Overall Study||30
10726635|NCT02755818|11890568|FG001|STARTED|Overall Study||2
10726636|NCT02755818|11890569|FG002|STARTED|Overall Study||2
10726637|NCT02755818|11890570|FG003|STARTED|Overall Study||17
10726638|NCT02755818|11890567|FG000|COMPLETED|Overall Study||30
10726639|NCT02755818|11890568|FG001|COMPLETED|Overall Study||2
10726640|NCT02755818|11890569|FG002|COMPLETED|Overall Study||1
10726641|NCT02755818|11890570|FG003|COMPLETED|Overall Study||14
10726642|NCT02755818|11890567|FG000|NOT COMPLETED|Overall Study||0
10726643|NCT02755818|11890568|FG001|NOT COMPLETED|Overall Study||0
10726644|NCT02755818|11890569|FG002|NOT COMPLETED|Overall Study||1
10726645|NCT02755818|11890570|FG003|NOT COMPLETED|Overall Study||3
10726646|NCT02755831|11890584|FG000|STARTED|Overall Study||100
10726647|NCT02755831|11890585|FG001|STARTED|Overall Study||93
10726648|NCT02755831|11890584|FG000|COMPLETED|Overall Study||97
10726649|NCT02755831|11890585|FG001|COMPLETED|Overall Study||90
10726650|NCT02755831|11890584|FG000|NOT COMPLETED|Overall Study||3
10726651|NCT02755831|11890585|FG001|NOT COMPLETED|Overall Study||3
10726652|NCT02755935|11890591|FG000|STARTED|Overall Study||24
10726653|NCT02755935|11890591|FG000|COMPLETED|Overall Study||22
10726654|NCT02755935|11890591|FG000|NOT COMPLETED|Overall Study||2
10726655|NCT02756078|11890595|FG000|STARTED|Period 1||85
10726656|NCT02756078|11890596|FG001|STARTED|Period 1||86
10726657|NCT02756078|11890595|FG000|COMPLETED|Period 1||76
10726658|NCT02756078|11890596|FG001|COMPLETED|Period 1||64
10726659|NCT02756078|11890595|FG000|NOT COMPLETED|Period 1||9
10726660|NCT02756078|11890596|FG001|NOT COMPLETED|Period 1||22
10726661|NCT02756078|11890595|FG000|STARTED|Period 2||76
10726662|NCT02756078|11890596|FG001|STARTED|Period 2||64
10726663|NCT02756078|11890595|FG000|COMPLETED|Period 2||70
10726664|NCT02756078|11890596|FG001|COMPLETED|Period 2||57
10726665|NCT02756078|11890595|FG000|NOT COMPLETED|Period 2||6
10726666|NCT02756078|11890596|FG001|NOT COMPLETED|Period 2||7
10726667|NCT02756182|11890602|FG000|STARTED|Overall Study||25
10726668|NCT02756182|11890602|FG000|COMPLETED|Overall Study||21
10726669|NCT02756182|11890602|FG000|NOT COMPLETED|Overall Study||4
10726670|NCT02756338|11890608|FG000|STARTED|Overall Study||77
10726671|NCT02756338|11890608|FG000|COMPLETED|Overall Study||72
10726672|NCT02756338|11890608|FG000|NOT COMPLETED|Overall Study||5
10726673|NCT02756351|11890614|FG000|STARTED|Overall Study||24
10726674|NCT02756351|11890615|FG001|STARTED|Overall Study||24
10726675|NCT02756351|11890614|FG000|COMPLETED|Overall Study||24
10726676|NCT02756351|11890615|FG001|COMPLETED|Overall Study||24
10726677|NCT02756351|11890614|FG000|NOT COMPLETED|Overall Study||0
10726678|NCT02756351|11890615|FG001|NOT COMPLETED|Overall Study||0
10726679|NCT02756364|11890624|FG000|STARTED|Overall Study||46
10726680|NCT02756364|11890625|FG001|STARTED|Overall Study||47
10726681|NCT02756364|11890626|FG002|STARTED|Overall Study||48
10726682|NCT02756364|11890624|FG000|Treated Participants|Overall Study||46
10726683|NCT02756364|11890625|FG001|Treated Participants|Overall Study||47
10726684|NCT02756364|11890626|FG002|Treated Participants|Overall Study||47
10726685|NCT02756364|11890624|FG000|COMPLETED|Overall Study||0
10726686|NCT02756364|11890625|FG001|COMPLETED|Overall Study||0
10726687|NCT02756364|11890626|FG002|COMPLETED|Overall Study||0
10726688|NCT02756364|11890624|FG000|NOT COMPLETED|Overall Study||46
10726689|NCT02756364|11890625|FG001|NOT COMPLETED|Overall Study||47
10726690|NCT02756364|11890626|FG002|NOT COMPLETED|Overall Study||48
10726691|NCT02756572|11890634|FG000|STARTED|Overall Study||30
10726692|NCT02756572|11890634|FG000|COMPLETED|Overall Study||30
10726693|NCT02756572|11890634|FG000|NOT COMPLETED|Overall Study||0
10726694|NCT02756624|11890645|FG000|STARTED|Overall Study||343
10726695|NCT02756624|11890646|FG001|STARTED|Overall Study||173
10726696|NCT02756624|11890645|FG000|COMPLETED|Overall Study||327
10726697|NCT02756624|11890646|FG001|COMPLETED|Overall Study||166
10726698|NCT02756624|11890645|FG000|NOT COMPLETED|Overall Study||16
10726699|NCT02756624|11890646|FG001|NOT COMPLETED|Overall Study||7
10726700|NCT02756637|11890654|FG000|STARTED|Overall Study||317
10726701|NCT02756637|11890655|FG001|STARTED|Overall Study||317
10726702|NCT02756637|11890654|FG000|Eligible for SWOG 8710|Overall Study||307
10726703|NCT02756637|11890655|FG001|Eligible for SWOG 8710|Overall Study||307
10726704|NCT02756637|11890654|FG000|Had NLR Value|Overall Study||263
10726705|NCT02756637|11890655|FG001|Had NLR Value|Overall Study||263
10726706|NCT02756637|11890654|FG000|Completed Curative Treatment|Overall Study||230
10726707|NCT02756637|11890655|FG001|Completed Curative Treatment|Overall Study||0
10726708|NCT02756637|11890654|FG000|COMPLETED|Overall Study||230
10726709|NCT02756637|11890655|FG001|COMPLETED|Overall Study||263
10726710|NCT02756637|11890654|FG000|NOT COMPLETED|Overall Study||87
10726711|NCT02756637|11890655|FG001|NOT COMPLETED|Overall Study||54
10726712|NCT02756650|11890661|FG000|STARTED|Overall Study||8
10726713|NCT02756650|11890661|FG000|COMPLETED|Overall Study||6
10726714|NCT02756650|11890661|FG000|NOT COMPLETED|Overall Study||2
10726715|NCT02756689|11890667|FG000|STARTED|Overall Study||64
10726716|NCT02756689|11890668|FG001|STARTED|Overall Study||65
10726717|NCT02756689|11890667|FG000|COMPLETED|Overall Study||64
10726718|NCT02756689|11890668|FG001|COMPLETED|Overall Study||65
10726719|NCT02756689|11890667|FG000|NOT COMPLETED|Overall Study||0
10726720|NCT02756689|11890668|FG001|NOT COMPLETED|Overall Study||0
10726721|NCT02756819|11890708|FG000|STARTED|Overall Study||1945
10726722|NCT02756819|11890708|FG000|Per-protocol Set (PPS)|Overall Study|Participants who were enrolled, received Edarbi® therapy and did not have major protocol deviations.|1724
10726723|NCT02756819|11890708|FG000|Safety Analysis Set (SAS)|Overall Study|Participants who received at least one dose of Edarbi® therapy and had any follow-up data.|1934
10726724|NCT02756819|11890708|FG000|COMPLETED|Overall Study||1893
10726725|NCT02756819|11890708|FG000|NOT COMPLETED|Overall Study||52
10726726|NCT02756832|11890712|FG000|STARTED|Overall Study||1409
10726727|NCT02756832|11890712|FG000|Received Therapy|Overall Study||1393
10726728|NCT02756832|11890712|FG000|Included in Efficacy and Safety Analysis|Overall Study||1399
10726729|NCT02756832|11890712|FG000|COMPLETED|Overall Study||1356
10726730|NCT02756832|11890712|FG000|NOT COMPLETED|Overall Study||53
10726731|NCT02756910|11890716|FG000|STARTED|Overall Study||80
10726732|NCT02756910|11890716|FG000|COMPLETED|Overall Study||80
10726733|NCT02756910|11890716|FG000|NOT COMPLETED|Overall Study||0
10726734|NCT02756949|11890722|FG000|STARTED|Overall Study||181
10726735|NCT02756949|11890723|FG001|STARTED|Overall Study||172
10726736|NCT02756949|11890722|FG000|COMPLETED|Overall Study||181
10726737|NCT02756949|11890723|FG001|COMPLETED|Overall Study||164
10726738|NCT02756949|11890722|FG000|NOT COMPLETED|Overall Study||0
10726739|NCT02756949|11890723|FG001|NOT COMPLETED|Overall Study||8
10726740|NCT02757092|11890731|FG000|STARTED|Overall Study|Random assignment was to encode subjects from opaque envelopes and sealed, on the day of discharge|18
10726741|NCT02757092|11890732|FG001|STARTED|Overall Study|Random assignment was to encode subjects from opaque envelopes and sealed, on the day of discharge|18
10726742|NCT02757092|11890731|FG000|COMPLETED|Overall Study|All subjects completed the study|18
10726743|NCT02757092|11890732|FG001|COMPLETED|Overall Study|All subjects completed the study|18
10726744|NCT02757092|11890731|FG000|NOT COMPLETED|Overall Study||0
10726745|NCT02757092|11890732|FG001|NOT COMPLETED|Overall Study||0
10726746|NCT02757105|11890798|FG000|STARTED|Overall Study||75
10726747|NCT02757105|11890799|FG001|STARTED|Overall Study||52
10726748|NCT02757105|11890798|FG000|Treated|Overall Study||75
10726749|NCT02757105|11890799|FG001|Treated|Overall Study||51
10726750|NCT02757105|11890798|FG000|COMPLETED|Overall Study||63
10726751|NCT02757105|11890799|FG001|COMPLETED|Overall Study||41
10726752|NCT02757105|11890798|FG000|NOT COMPLETED|Overall Study||12
10726753|NCT02757105|11890799|FG001|NOT COMPLETED|Overall Study||11
10726754|NCT02757326|11890809|FG000|STARTED|Overall Study||3
10726755|NCT02757326|11890810|FG001|STARTED|Overall Study||4
10726756|NCT02757326|11890811|FG002|STARTED|Overall Study||6
10726757|NCT02757326|11890809|FG000|COMPLETED|Overall Study||3
10726758|NCT02757326|11890810|FG001|COMPLETED|Overall Study||4
10726759|NCT02757326|11890811|FG002|COMPLETED|Overall Study||6
10726760|NCT02757326|11890809|FG000|NOT COMPLETED|Overall Study||0
10726761|NCT02757326|11890810|FG001|NOT COMPLETED|Overall Study||0
10726762|NCT02757326|11890811|FG002|NOT COMPLETED|Overall Study||0
10726763|NCT02757352|11890826|FG000|STARTED|Double-Blind Period (Week 0 - Week 16)||105
10726764|NCT02757352|11890827|FG001|STARTED|Double-Blind Period (Week 0 - Week 16)||96
10726765|NCT02757352|11890828|FG002|STARTED|Double-Blind Period (Week 0 - Week 16)||102
10726766|NCT02757352|11890829|FG003|STARTED|Double-Blind Period (Week 0 - Week 16)||0
10726767|NCT02757352|11890830|FG004|STARTED|Double-Blind Period (Week 0 - Week 16)||0
10726768|NCT02757352|11890831|FG005|STARTED|Double-Blind Period (Week 0 - Week 16)||0
10726769|NCT02757352|11890832|FG006|STARTED|Double-Blind Period (Week 0 - Week 16)||0
10726770|NCT02757352|11890833|FG007|STARTED|Double-Blind Period (Week 0 - Week 16)||0
10726771|NCT02757352|11890834|FG008|STARTED|Double-Blind Period (Week 0 - Week 16)||0
10726772|NCT02757352|11890835|FG009|STARTED|Double-Blind Period (Week 0 - Week 16)||0
10726773|NCT02757352|11890826|FG000|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||104
10726774|NCT02757352|11890827|FG001|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||96
10726775|NCT02757352|11890828|FG002|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||102
10726776|NCT02757352|11890829|FG003|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
10726777|NCT02757352|11890830|FG004|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
10726778|NCT02757352|11890831|FG005|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
10726779|NCT02757352|11890832|FG006|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
10726780|NCT02757352|11890833|FG007|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
10726781|NCT02757352|11890834|FG008|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
10726782|NCT02757352|11890835|FG009|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
10726783|NCT02757352|11890826|FG000|COMPLETED|Double-Blind Period (Week 0 - Week 16)||97
10726784|NCT02757352|11890827|FG001|COMPLETED|Double-Blind Period (Week 0 - Week 16)||95
10726785|NCT02757352|11890828|FG002|COMPLETED|Double-Blind Period (Week 0 - Week 16)||98
10726786|NCT02757352|11890829|FG003|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
10726787|NCT02757352|11890830|FG004|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
10726788|NCT02757352|11890831|FG005|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
10726789|NCT02757352|11890832|FG006|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
10726790|NCT02757352|11890833|FG007|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
10726791|NCT02757352|11890834|FG008|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
10726792|NCT02757352|11890835|FG009|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
10726793|NCT02757352|11890826|FG000|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||8
10726794|NCT02757352|11890827|FG001|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||1
10726795|NCT02757352|11890828|FG002|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||4
10726796|NCT02757352|11890829|FG003|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
10726797|NCT02757352|11890830|FG004|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
10726798|NCT02757352|11890831|FG005|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
10726799|NCT02757352|11890832|FG006|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
10726800|NCT02757352|11890833|FG007|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
10726801|NCT02757352|11890834|FG008|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
10726802|NCT02757352|11890835|FG009|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
10726803|NCT02757352|11890826|FG000|STARTED|Double-Blind Period (Week 16 - Week 52)||97
10726804|NCT02757352|11890827|FG001|STARTED|Double-Blind Period (Week 16 - Week 52)||95
10726805|NCT02757352|11890828|FG002|STARTED|Double-Blind Period (Week 16 - Week 52)||98
10726806|NCT02757352|11890829|FG003|STARTED|Double-Blind Period (Week 16 - Week 52)||0
10726807|NCT02757352|11890830|FG004|STARTED|Double-Blind Period (Week 16 - Week 52)||0
10726808|NCT02757352|11890831|FG005|STARTED|Double-Blind Period (Week 16 - Week 52)||0
10726809|NCT02757352|11890832|FG006|STARTED|Double-Blind Period (Week 16 - Week 52)||0
10726810|NCT02757352|11890833|FG007|STARTED|Double-Blind Period (Week 16 - Week 52)||0
10726811|NCT02757352|11890834|FG008|STARTED|Double-Blind Period (Week 16 - Week 52)||0
10726812|NCT02757352|11890835|FG009|STARTED|Double-Blind Period (Week 16 - Week 52)||0
10726813|NCT02757352|11890826|FG000|COMPLETED|Double-Blind Period (Week 16 - Week 52)||34
10726814|NCT02757352|11890827|FG001|COMPLETED|Double-Blind Period (Week 16 - Week 52)||52
10726815|NCT02757352|11890828|FG002|COMPLETED|Double-Blind Period (Week 16 - Week 52)||52
10726816|NCT02757352|11890829|FG003|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
10726817|NCT02757352|11890830|FG004|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
10726818|NCT02757352|11890831|FG005|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
10726819|NCT02757352|11890832|FG006|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
10726820|NCT02757352|11890833|FG007|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
10726821|NCT02757352|11890834|FG008|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
10726822|NCT02757352|11890835|FG009|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
10726823|NCT02757352|11890826|FG000|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||63
10726824|NCT02757352|11890827|FG001|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||43
10726825|NCT02757352|11890828|FG002|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||46
10726826|NCT02757352|11890829|FG003|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
10726827|NCT02757352|11890830|FG004|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
10726828|NCT02757352|11890831|FG005|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
10726829|NCT02757352|11890832|FG006|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
10726830|NCT02757352|11890833|FG007|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
10726831|NCT02757352|11890834|FG008|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
10726832|NCT02757352|11890835|FG009|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
10726833|NCT02757352|11890826|FG000|STARTED|IR-Open Label Period (Week 16 - Week 52)|Participants continued with original assigned treatment without switching to open label ixeQ2W.|0
10726834|NCT02757352|11890827|FG001|STARTED|IR-Open Label Period (Week 16 - Week 52)|Participants continued with original assigned treatment without switching to open label ixeQ2W.|0
10726835|NCT02757352|11890828|FG002|STARTED|IR-Open Label Period (Week 16 - Week 52)|Participants continued with original assigned treatment without switching to open label ixeQ2W.|0
10726836|NCT02757352|11890829|FG003|STARTED|IR-Open Label Period (Week 16 - Week 52)|IR based on the investigator's opinion switched to ixekizumab open label 80 mg Q2W.|62
10726837|NCT02757352|11890830|FG004|STARTED|IR-Open Label Period (Week 16 - Week 52)|IR based on the investigator's opinion switched to ixekizumab open label 80 mg Q2W.|40
10726838|NCT02757352|11890831|FG005|STARTED|IR-Open Label Period (Week 16 - Week 52)|IR based on the investigator's opinion switched to ixekizumab open label 80 mg Q2W.|42
10726839|NCT02757352|11890832|FG006|STARTED|IR-Open Label Period (Week 16 - Week 52)||0
10726840|NCT02757352|11890833|FG007|STARTED|IR-Open Label Period (Week 16 - Week 52)||0
10726841|NCT02757352|11890834|FG008|STARTED|IR-Open Label Period (Week 16 - Week 52)||0
10726842|NCT02757352|11890835|FG009|STARTED|IR-Open Label Period (Week 16 - Week 52)||0
10726843|NCT02757352|11890826|FG000|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
10726844|NCT02757352|11890827|FG001|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
10726845|NCT02757352|11890828|FG002|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
10726846|NCT02757352|11890829|FG003|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||2
10726847|NCT02757352|11890830|FG004|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
10726848|NCT02757352|11890831|FG005|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||3
10726849|NCT02757352|11890832|FG006|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
10726850|NCT02757352|11890833|FG007|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
10726851|NCT02757352|11890834|FG008|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
10726852|NCT02757352|11890835|FG009|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
10726853|NCT02757352|11890826|FG000|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
10726854|NCT02757352|11890827|FG001|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
10726855|NCT02757352|11890828|FG002|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
10726856|NCT02757352|11890829|FG003|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||55
10726857|NCT02757352|11890830|FG004|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||37
10726858|NCT02757352|11890831|FG005|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||35
10726859|NCT02757352|11890832|FG006|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
10726860|NCT02757352|11890833|FG007|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
10726861|NCT02757352|11890834|FG008|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
10726862|NCT02757352|11890835|FG009|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
10726863|NCT02757352|11890826|FG000|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
10726864|NCT02757352|11890827|FG001|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
10726865|NCT02757352|11890828|FG002|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
10726866|NCT02757352|11890829|FG003|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||7
10726867|NCT02757352|11890830|FG004|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||3
10726868|NCT02757352|11890831|FG005|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||7
10726869|NCT02757352|11890832|FG006|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
10726870|NCT02757352|11890833|FG007|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
10726871|NCT02757352|11890834|FG008|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
10726872|NCT02757352|11890835|FG009|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
10726873|NCT02757352|11890826|FG000|STARTED|Follow-Up Period||0
10726874|NCT02757352|11890827|FG001|STARTED|Follow-Up Period||0
10726875|NCT02757352|11890828|FG002|STARTED|Follow-Up Period||0
10726876|NCT02757352|11890829|FG003|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|0
10726877|NCT02757352|11890830|FG004|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|0
10726878|NCT02757352|11890831|FG005|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|0
10726879|NCT02757352|11890832|FG006|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|3
10726880|NCT02757352|11890833|FG007|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|5
10726881|NCT02757352|11890834|FG008|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|28
10726882|NCT02757352|11890835|FG009|STARTED|Follow-Up Period||5
10726883|NCT02757352|11890826|FG000|COMPLETED|Follow-Up Period||0
10726884|NCT02757352|11890827|FG001|COMPLETED|Follow-Up Period||0
10726885|NCT02757352|11890828|FG002|COMPLETED|Follow-Up Period||0
10726886|NCT02757352|11890829|FG003|COMPLETED|Follow-Up Period||0
10726887|NCT02757352|11890830|FG004|COMPLETED|Follow-Up Period||0
10726888|NCT02757352|11890831|FG005|COMPLETED|Follow-Up Period||0
10726889|NCT02757352|11890832|FG006|COMPLETED|Follow-Up Period||2
10726890|NCT02757352|11890833|FG007|COMPLETED|Follow-Up Period||4
10726891|NCT02757352|11890834|FG008|COMPLETED|Follow-Up Period||18
10726892|NCT02757352|11890835|FG009|COMPLETED|Follow-Up Period||2
10726893|NCT02757352|11890826|FG000|NOT COMPLETED|Follow-Up Period||0
10726894|NCT02757352|11890827|FG001|NOT COMPLETED|Follow-Up Period||0
10726895|NCT02757352|11890828|FG002|NOT COMPLETED|Follow-Up Period||0
10726896|NCT02757352|11890829|FG003|NOT COMPLETED|Follow-Up Period||0
10726897|NCT02757352|11890830|FG004|NOT COMPLETED|Follow-Up Period||0
10726898|NCT02757352|11890831|FG005|NOT COMPLETED|Follow-Up Period||0
10726899|NCT02757352|11890832|FG006|NOT COMPLETED|Follow-Up Period||1
10726900|NCT02757352|11890833|FG007|NOT COMPLETED|Follow-Up Period||1
10726901|NCT02757352|11890834|FG008|NOT COMPLETED|Follow-Up Period||10
10726902|NCT02757352|11890835|FG009|NOT COMPLETED|Follow-Up Period||3
10726903|NCT02757430|11890866|FG000|STARTED|Overall Study||515
10726904|NCT02757430|11890866|FG000|Baseline Visits|Overall Study||503
10726905|NCT02757430|11890866|FG000|EP Mapping/Ablation Procedure|Overall Study||503
10726906|NCT02757430|11890866|FG000|COMPLETED|Overall Study|Subjects with pre-discharge visit were considered completed.|503
10726907|NCT02757430|11890866|FG000|NOT COMPLETED|Overall Study||12
10726908|NCT02757625|11890883|FG000|STARTED|Overall Study||14
10726909|NCT02757625|11890884|FG001|STARTED|Overall Study||18
10726910|NCT02757625|11890885|FG002|STARTED|Overall Study||19
10726911|NCT02757625|11890886|FG003|STARTED|Overall Study||12
10726912|NCT02757625|11890883|FG000|COMPLETED|Overall Study||14
10726913|NCT02757625|11890884|FG001|COMPLETED|Overall Study||18
10726914|NCT02757625|11890885|FG002|COMPLETED|Overall Study||17
10726915|NCT02757625|11890886|FG003|COMPLETED|Overall Study||12
10726916|NCT02757625|11890883|FG000|NOT COMPLETED|Overall Study||0
10726917|NCT02757625|11890884|FG001|NOT COMPLETED|Overall Study||0
10726918|NCT02757625|11890885|FG002|NOT COMPLETED|Overall Study||2
10726919|NCT02757625|11890886|FG003|NOT COMPLETED|Overall Study||0
10777519|NCT03341299|11939500|FG002|NOT COMPLETED|Period 2||0
10777520|NCT03341299|11939501|FG003|NOT COMPLETED|Period 2||0
10777521|NCT03341299|11939498|FG000|STARTED|Washout (A Minimum of 21 Hours)||9
10777522|NCT03341299|11939499|FG001|STARTED|Washout (A Minimum of 21 Hours)||9
10777523|NCT03341299|11939500|FG002|STARTED|Washout (A Minimum of 21 Hours)||8
10777524|NCT03341299|11939501|FG003|STARTED|Washout (A Minimum of 21 Hours)||9
10777525|NCT03341299|11939498|FG000|COMPLETED|Washout (A Minimum of 21 Hours)||9
10777526|NCT03341299|11939499|FG001|COMPLETED|Washout (A Minimum of 21 Hours)||9
10777527|NCT03341299|11939500|FG002|COMPLETED|Washout (A Minimum of 21 Hours)||8
10777528|NCT03341299|11939501|FG003|COMPLETED|Washout (A Minimum of 21 Hours)||9
10777529|NCT03341299|11939498|FG000|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
10777530|NCT03341299|11939499|FG001|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
10777531|NCT03341299|11939500|FG002|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
10777532|NCT03341299|11939501|FG003|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
10777533|NCT03341299|11939498|FG000|STARTED|Period 3||9
10777534|NCT03341299|11939499|FG001|STARTED|Period 3||9
10777535|NCT03341299|11939500|FG002|STARTED|Period 3||8
10777536|NCT03341299|11939501|FG003|STARTED|Period 3||9
10777537|NCT03341299|11939498|FG000|COMPLETED|Period 3||9
10777538|NCT03341299|11939499|FG001|COMPLETED|Period 3||9
10777539|NCT03341299|11939500|FG002|COMPLETED|Period 3||8
10777540|NCT03341299|11939501|FG003|COMPLETED|Period 3||9
10777541|NCT03341299|11939498|FG000|NOT COMPLETED|Period 3||0
10777542|NCT03341299|11939499|FG001|NOT COMPLETED|Period 3||0
10777543|NCT03341299|11939500|FG002|NOT COMPLETED|Period 3||0
10777544|NCT03341299|11939501|FG003|NOT COMPLETED|Period 3||0
10777545|NCT03341299|11939498|FG000|STARTED|Washout (A Minimum of 21 Hours)||9
10777546|NCT03341299|11939499|FG001|STARTED|Washout (A Minimum of 21 Hours)||9
10777547|NCT03341299|11939500|FG002|STARTED|Washout (A Minimum of 21 Hours)||8
10777548|NCT03341299|11939501|FG003|STARTED|Washout (A Minimum of 21 Hours)||9
10777549|NCT03341299|11939498|FG000|COMPLETED|Washout (A Minimum of 21 Hours)||9
10777550|NCT03341299|11939499|FG001|COMPLETED|Washout (A Minimum of 21 Hours)||9
10777551|NCT03341299|11939500|FG002|COMPLETED|Washout (A Minimum of 21 Hours)||8
10777552|NCT03341299|11939501|FG003|COMPLETED|Washout (A Minimum of 21 Hours)||9
10726920|NCT02757768|11890900|FG000|STARTED|Overall Study||356
10726921|NCT02757768|11890901|FG001|STARTED|Overall Study||359
10726922|NCT02757768|11890900|FG000|Treated|Overall Study||352
10726923|NCT02757768|11890901|FG001|Treated|Overall Study||354
10726924|NCT02757768|11890900|FG000|COMPLETED|Overall Study||323
10726925|NCT02757768|11890901|FG001|COMPLETED|Overall Study||331
10726926|NCT02757768|11890900|FG000|NOT COMPLETED|Overall Study||33
10726927|NCT02757768|11890901|FG001|NOT COMPLETED|Overall Study||28
10726928|NCT02757950|11890911|FG000|STARTED|Overall Study||1203
10726929|NCT02757950|11890912|FG001|STARTED|Overall Study||1259
10726930|NCT02757950|11890911|FG000|COMPLETED|Overall Study||1199
10726931|NCT02757950|11890912|FG001|COMPLETED|Overall Study||1248
10726932|NCT02757950|11890911|FG000|NOT COMPLETED|Overall Study||4
10726933|NCT02757950|11890912|FG001|NOT COMPLETED|Overall Study||11
10726934|NCT02757963|11890919|FG000|STARTED|Overall Study||1658
10726935|NCT02757963|11890919|FG000|COMPLETED|Overall Study||561
10726936|NCT02757963|11890919|FG000|NOT COMPLETED|Overall Study||1097
10726937|NCT02758119|11890936|FG000|STARTED|Overall Study||41
10726938|NCT02758119|11890937|FG001|STARTED|Overall Study||41
10726939|NCT02758119|11890936|FG000|COMPLETED|Overall Study||39
10726940|NCT02758119|11890937|FG001|COMPLETED|Overall Study||40
10544533|NCT01490632|11697649|FG012|STARTED|Part C: Washout or Step-Down Period|Responders receiving 2 or 4 mg were re-randomized to receive placebo.|15
10544534|NCT01490632|11697650|FG013|STARTED|Part C: Washout or Step-Down Period|Responders receiving 2 or 4 mg were re-randomized to receive half of the dose from Part B.|16
10544535|NCT01490632|11697651|FG014|STARTED|Part C: Washout or Step-Down Period|Responders receiving 8 or 10 mg were re-randomized to receive placebo.|55
10544536|NCT01490632|11697652|FG015|STARTED|Part C: Washout or Step-Down Period|Responders receiving 8 or 10 mg were re-randomized to receive 4 mg.|55
10544537|NCT01490632|11697653|FG016|STARTED|Part C: Washout or Step-Down Period||0
10544538|NCT01490632|11697654|FG017|STARTED|Part C: Washout or Step-Down Period||0
10544539|NCT01490632|11697655|FG018|STARTED|Part C: Washout or Step-Down Period||0
10544540|NCT01490632|11697656|FG019|STARTED|Part C: Washout or Step-Down Period||0
10544541|NCT01490632|11697637|FG000|COMPLETED|Part C: Washout or Step-Down Period||0
10544542|NCT01490632|11697638|FG001|COMPLETED|Part C: Washout or Step-Down Period||0
10544543|NCT01490632|11697639|FG002|COMPLETED|Part C: Washout or Step-Down Period||0
10544544|NCT01490632|11697640|FG003|COMPLETED|Part C: Washout or Step-Down Period||0
10544545|NCT01490632|11697641|FG004|COMPLETED|Part C: Washout or Step-Down Period||0
10544546|NCT01490632|11697642|FG005|COMPLETED|Part C: Washout or Step-Down Period||0
10548262|NCT01518699|11702090|FG005|COMPLETED|Period 1||9
10726941|NCT02758119|11890936|FG000|NOT COMPLETED|Overall Study||2
10726942|NCT02758119|11890937|FG001|NOT COMPLETED|Overall Study||1
10726943|NCT02758171|11890947|FG000|STARTED|Treatment Period 1||28
10726944|NCT02758171|11890948|FG001|STARTED|Treatment Period 1||28
10726945|NCT02758171|11890947|FG000|COMPLETED|Treatment Period 1||28
10726946|NCT02758171|11890948|FG001|COMPLETED|Treatment Period 1||28
10726947|NCT02758171|11890947|FG000|NOT COMPLETED|Treatment Period 1||0
10726948|NCT02758171|11890948|FG001|NOT COMPLETED|Treatment Period 1||0
10726949|NCT02758171|11890947|FG000|STARTED|Wash-out||28
10726950|NCT02758171|11890948|FG001|STARTED|Wash-out||28
10726951|NCT02758171|11890947|FG000|COMPLETED|Wash-out||26
10726952|NCT02758171|11890948|FG001|COMPLETED|Wash-out||28
10726953|NCT02758171|11890947|FG000|NOT COMPLETED|Wash-out||2
10726954|NCT02758171|11890948|FG001|NOT COMPLETED|Wash-out||0
10726955|NCT02758171|11890947|FG000|STARTED|Treatment Period 2||26
10726956|NCT02758171|11890948|FG001|STARTED|Treatment Period 2||28
10726957|NCT02758171|11890947|FG000|COMPLETED|Treatment Period 2||26
10726958|NCT02758171|11890948|FG001|COMPLETED|Treatment Period 2||28
10726959|NCT02758171|11890947|FG000|NOT COMPLETED|Treatment Period 2||0
10726960|NCT02758171|11890948|FG001|NOT COMPLETED|Treatment Period 2||0
10726961|NCT02758210|11890954|FG000|STARTED|Overall Study||20
10726962|NCT02758210|11890954|FG000|COMPLETED|Overall Study||20
10726963|NCT02758210|11890954|FG000|NOT COMPLETED|Overall Study||0
10726964|NCT02758301|11890960|FG000|STARTED|Overall Study||104
10726965|NCT02758301|11890961|FG001|STARTED|Overall Study||8
10726966|NCT02758301|11890960|FG000|COMPLETED|Overall Study||70
10726967|NCT02758301|11890961|FG001|COMPLETED|Overall Study||0
10726968|NCT02758301|11890960|FG000|NOT COMPLETED|Overall Study||34
10726969|NCT02758301|11890961|FG001|NOT COMPLETED|Overall Study||8
10726970|NCT02758613|11890971|FG000|STARTED|Treatment||8
10726971|NCT02758613|11890972|FG001|STARTED|Treatment||8
10726972|NCT02758613|11890973|FG002|STARTED|Treatment||9
10726973|NCT02758613|11890974|FG003|STARTED|Treatment||8
10726974|NCT02758613|11890971|FG000|Received at Least One Dose of Study Drug|Treatment||8
10726975|NCT02758613|11890972|FG001|Received at Least One Dose of Study Drug|Treatment||8
10726976|NCT02758613|11890973|FG002|Received at Least One Dose of Study Drug|Treatment||9
10726977|NCT02758613|11890974|FG003|Received at Least One Dose of Study Drug|Treatment||8
10726978|NCT02758613|11890971|FG000|COMPLETED|Treatment||6
10726979|NCT02758613|11890972|FG001|COMPLETED|Treatment||8
10726980|NCT02758613|11890973|FG002|COMPLETED|Treatment||8
10726981|NCT02758613|11890974|FG003|COMPLETED|Treatment||8
10726982|NCT02758613|11890971|FG000|NOT COMPLETED|Treatment||2
10726983|NCT02758613|11890972|FG001|NOT COMPLETED|Treatment||0
10726984|NCT02758613|11890973|FG002|NOT COMPLETED|Treatment||1
10726985|NCT02758613|11890974|FG003|NOT COMPLETED|Treatment||0
10726986|NCT02758613|11890971|FG000|STARTED|Follow-up||6
10726987|NCT02758613|11890972|FG001|STARTED|Follow-up||8
10726988|NCT02758613|11890973|FG002|STARTED|Follow-up||8
10726989|NCT02758613|11890974|FG003|STARTED|Follow-up||8
10726990|NCT02758613|11890971|FG000|COMPLETED|Follow-up||6
10726991|NCT02758613|11890972|FG001|COMPLETED|Follow-up||8
10726992|NCT02758613|11890973|FG002|COMPLETED|Follow-up||8
10726993|NCT02758613|11890974|FG003|COMPLETED|Follow-up||8
10726994|NCT02758613|11890971|FG000|NOT COMPLETED|Follow-up||0
10726995|NCT02758613|11890972|FG001|NOT COMPLETED|Follow-up||0
10726996|NCT02758613|11890973|FG002|NOT COMPLETED|Follow-up||0
10726997|NCT02758613|11890974|FG003|NOT COMPLETED|Follow-up||0
10726998|NCT02758899|11890989|FG000|STARTED|Overall Study||11
10726999|NCT02758899|11890990|FG001|STARTED|Overall Study||10
10727000|NCT02758899|11890989|FG000|COMPLETED|Overall Study||9
10727001|NCT02758899|11890990|FG001|COMPLETED|Overall Study||9
10727002|NCT02758899|11890989|FG000|NOT COMPLETED|Overall Study||2
10727003|NCT02758899|11890990|FG001|NOT COMPLETED|Overall Study||1
10727004|NCT02759016|11890998|FG000|STARTED|Overall Study||4
10727005|NCT02759016|11890999|FG001|STARTED|Overall Study||3
10727006|NCT02759016|11890998|FG000|Treated With BI 836826 and Ibrutinib|Overall Study||3
10727007|NCT02759016|11890999|FG001|Treated With BI 836826 and Ibrutinib|Overall Study||3
10727008|NCT02759016|11890998|FG000|COMPLETED|Overall Study||0
10727009|NCT02759016|11890999|FG001|COMPLETED|Overall Study||0
10727010|NCT02759016|11890998|FG000|NOT COMPLETED|Overall Study||4
10727011|NCT02759016|11890999|FG001|NOT COMPLETED|Overall Study||3
10727012|NCT02759055|11891008|FG000|STARTED|Overall Study||12702
10727013|NCT02759055|11891009|FG001|STARTED|Overall Study||8962
10727014|NCT02759055|11891008|FG000|COMPLETED|Overall Study||10775
10727015|NCT02759055|11891009|FG001|COMPLETED|Overall Study||7454
10727016|NCT02759055|11891008|FG000|NOT COMPLETED|Overall Study||1927
10727017|NCT02759055|11891009|FG001|NOT COMPLETED|Overall Study||1508
10727018|NCT02759120|11891017|FG000|STARTED|Overall Study||254
10727019|NCT02759120|11891018|FG001|STARTED|Overall Study||259
10727020|NCT02759120|11891017|FG000|COMPLETED|Overall Study||169
10727021|NCT02759120|11891018|FG001|COMPLETED|Overall Study||180
10727022|NCT02759120|11891017|FG000|NOT COMPLETED|Overall Study||85
10727023|NCT02759120|11891018|FG001|NOT COMPLETED|Overall Study||79
10727024|NCT02759146|11891030|FG000|STARTED|Week 1-4||57
10727025|NCT02759146|11891031|FG001|STARTED|Week 1-4||36
10727026|NCT02759146|11891032|FG002|STARTED|Week 1-4||33
10727027|NCT02759146|11891033|FG003|STARTED|Week 1-4|One control participant could continue without the other after baseline.|44
10727028|NCT02759146|11891034|FG004|STARTED|Week 1-4||49
10727029|NCT02759146|11891035|FG005|STARTED|Week 1-4||30
10727030|NCT02759146|11891036|FG006|STARTED|Week 1-4||27
10727031|NCT02759146|11891030|FG000|COMPLETED|Week 1-4||56
10727032|NCT02759146|11891031|FG001|COMPLETED|Week 1-4||34
10727033|NCT02759146|11891032|FG002|COMPLETED|Week 1-4||32
10727034|NCT02759146|11891033|FG003|COMPLETED|Week 1-4||44
10727035|NCT02759146|11891034|FG004|COMPLETED|Week 1-4||49
10727036|NCT02759146|11891035|FG005|COMPLETED|Week 1-4||29
10727037|NCT02759146|11891036|FG006|COMPLETED|Week 1-4||26
10727038|NCT02759146|11891030|FG000|NOT COMPLETED|Week 1-4||1
10727039|NCT02759146|11891031|FG001|NOT COMPLETED|Week 1-4||2
10727040|NCT02759146|11891032|FG002|NOT COMPLETED|Week 1-4||1
10727041|NCT02759146|11891033|FG003|NOT COMPLETED|Week 1-4||0
10727042|NCT02759146|11891034|FG004|NOT COMPLETED|Week 1-4||0
10727043|NCT02759146|11891035|FG005|NOT COMPLETED|Week 1-4||1
10727044|NCT02759146|11891036|FG006|NOT COMPLETED|Week 1-4||1
10727045|NCT02759146|11891030|FG000|STARTED|Week 5-8||56
10727046|NCT02759146|11891031|FG001|STARTED|Week 5-8||34
10727047|NCT02759146|11891032|FG002|STARTED|Week 5-8||32
10727048|NCT02759146|11891033|FG003|STARTED|Week 5-8||44
10727049|NCT02759146|11891034|FG004|STARTED|Week 5-8||49
10727050|NCT02759146|11891035|FG005|STARTED|Week 5-8||29
10727051|NCT02759146|11891036|FG006|STARTED|Week 5-8||26
10727052|NCT02759146|11891030|FG000|COMPLETED|Week 5-8||46
10727053|NCT02759146|11891031|FG001|COMPLETED|Week 5-8||29
10727054|NCT02759146|11891032|FG002|COMPLETED|Week 5-8||22
10727055|NCT02759146|11891033|FG003|COMPLETED|Week 5-8||37
10727056|NCT02759146|11891034|FG004|COMPLETED|Week 5-8||44
10727057|NCT02759146|11891035|FG005|COMPLETED|Week 5-8||23
10727058|NCT02759146|11891036|FG006|COMPLETED|Week 5-8||20
10727059|NCT02759146|11891030|FG000|NOT COMPLETED|Week 5-8||10
10727060|NCT02759146|11891031|FG001|NOT COMPLETED|Week 5-8||5
10727061|NCT02759146|11891032|FG002|NOT COMPLETED|Week 5-8||10
10727062|NCT02759146|11891033|FG003|NOT COMPLETED|Week 5-8||7
10727063|NCT02759146|11891034|FG004|NOT COMPLETED|Week 5-8||5
10727064|NCT02759146|11891035|FG005|NOT COMPLETED|Week 5-8||6
10727065|NCT02759146|11891036|FG006|NOT COMPLETED|Week 5-8||6
10727066|NCT02759315|11891057|FG000|STARTED|Overall Study||69
10727067|NCT02759315|11891058|FG001|STARTED|Overall Study||29
10727068|NCT02759315|11891059|FG002|STARTED|Overall Study||39
10727069|NCT02759315|11891060|FG003|STARTED|Overall Study||20
10727070|NCT02759315|11891061|FG004|STARTED|Overall Study||3
10727071|NCT02759315|11891057|FG000|COMPLETED|Overall Study||65
10727072|NCT02759315|11891058|FG001|COMPLETED|Overall Study||28
10727073|NCT02759315|11891059|FG002|COMPLETED|Overall Study||29
10727074|NCT02759315|11891060|FG003|COMPLETED|Overall Study||19
10727075|NCT02759315|11891061|FG004|COMPLETED|Overall Study||2
10727076|NCT02759315|11891057|FG000|NOT COMPLETED|Overall Study||4
10727077|NCT02759315|11891058|FG001|NOT COMPLETED|Overall Study||1
10727078|NCT02759315|11891059|FG002|NOT COMPLETED|Overall Study||10
10727079|NCT02759315|11891060|FG003|NOT COMPLETED|Overall Study||1
10727080|NCT02759315|11891061|FG004|NOT COMPLETED|Overall Study||1
10727081|NCT02759354|11891079|FG000|STARTED|Overall Study||192
10727082|NCT02759354|11891080|FG001|STARTED|Overall Study||190
10727083|NCT02759354|11891081|FG002|STARTED|Overall Study||181
10727084|NCT02759354|11891082|FG003|STARTED|Overall Study||191
10727085|NCT02759354|11891079|FG000|COMPLETED|Overall Study||192
10727086|NCT02759354|11891080|FG001|COMPLETED|Overall Study||190
10727087|NCT02759354|11891081|FG002|COMPLETED|Overall Study||181
10727088|NCT02759354|11891082|FG003|COMPLETED|Overall Study||191
10727089|NCT02759354|11891079|FG000|NOT COMPLETED|Overall Study||0
10727090|NCT02759354|11891080|FG001|NOT COMPLETED|Overall Study||0
10727091|NCT02759354|11891081|FG002|NOT COMPLETED|Overall Study||0
10727092|NCT02759354|11891082|FG003|NOT COMPLETED|Overall Study||0
10727093|NCT02759471|11891094|FG000|STARTED|Overall Study||54
10727094|NCT02759471|11891094|FG000|COMPLETED|Overall Study||52
10727095|NCT02759471|11891094|FG000|NOT COMPLETED|Overall Study||2
10727096|NCT02759562|11891102|FG000|STARTED|Double-Blind Treatment Period (8 Weeks)||3
10727097|NCT02759562|11891103|FG001|STARTED|Double-Blind Treatment Period (8 Weeks)||3
10727098|NCT02759562|11891102|FG000|COMPLETED|Double-Blind Treatment Period (8 Weeks)||3
10727099|NCT02759562|11891103|FG001|COMPLETED|Double-Blind Treatment Period (8 Weeks)||3
10727100|NCT02759562|11891102|FG000|NOT COMPLETED|Double-Blind Treatment Period (8 Weeks)||0
10727101|NCT02759562|11891103|FG001|NOT COMPLETED|Double-Blind Treatment Period (8 Weeks)||0
10727102|NCT02759562|11891102|FG000|STARTED|Open-Label Treatment Period||2
10727103|NCT02759562|11891103|FG001|STARTED|Open-Label Treatment Period||2
10727104|NCT02759562|11891102|FG000|COMPLETED|Open-Label Treatment Period||0
10727105|NCT02759562|11891103|FG001|COMPLETED|Open-Label Treatment Period||0
10727106|NCT02759562|11891102|FG000|NOT COMPLETED|Open-Label Treatment Period||2
10727107|NCT02759562|11891103|FG001|NOT COMPLETED|Open-Label Treatment Period||2
10727108|NCT02759575|11891110|FG000|STARTED|Overall Study||9
10727109|NCT02759575|11891110|FG000|COMPLETED|Overall Study||9
10727110|NCT02759575|11891110|FG000|NOT COMPLETED|Overall Study||0
10727111|NCT02759692|11891114|FG000|STARTED|Period 1||141
10727112|NCT02759692|11891115|FG001|STARTED|Period 1||142
10727113|NCT02759692|11891114|FG000|COMPLETED|Period 1||138
10727114|NCT02759692|11891115|FG001|COMPLETED|Period 1||140
10727115|NCT02759692|11891114|FG000|NOT COMPLETED|Period 1||3
10727116|NCT02759692|11891115|FG001|NOT COMPLETED|Period 1||2
10727117|NCT02759692|11891114|FG000|STARTED|Period 2||138
10727118|NCT02759692|11891115|FG001|STARTED|Period 2||140
10727119|NCT02759692|11891114|FG000|COMPLETED|Period 2||137
10727120|NCT02759692|11891115|FG001|COMPLETED|Period 2||139
10727121|NCT02759692|11891114|FG000|NOT COMPLETED|Period 2||1
10727122|NCT02759692|11891115|FG001|NOT COMPLETED|Period 2||1
10727123|NCT02759692|11891114|FG000|STARTED|Period 3||137
10727124|NCT02759692|11891115|FG001|STARTED|Period 3||139
10727125|NCT02759692|11891114|FG000|COMPLETED|Period 3||137
10727126|NCT02759692|11891115|FG001|COMPLETED|Period 3||139
10727127|NCT02759692|11891114|FG000|NOT COMPLETED|Period 3||0
10727128|NCT02759692|11891115|FG001|NOT COMPLETED|Period 3||0
10727129|NCT02759939|11891125|FG000|STARTED|Overall Study||1256
10727130|NCT02759939|11891126|FG001|STARTED|Overall Study||1143
10727131|NCT02759939|11891127|FG002|STARTED|Overall Study||1393
10727132|NCT02759939|11891128|FG003|STARTED|Overall Study||1246
10727133|NCT02759939|11891125|FG000|Analyzed at T1|Overall Study||1245
10727134|NCT02759939|11891126|FG001|Analyzed at T1|Overall Study||1141
10727135|NCT02759939|11891127|FG002|Analyzed at T1|Overall Study||1388
10727136|NCT02759939|11891128|FG003|Analyzed at T1|Overall Study||1244
10727137|NCT02759939|11891125|FG000|Eligible for T2 and T3|Overall Study||935
10727138|NCT02759939|11891126|FG001|Eligible for T2 and T3|Overall Study||962
10727139|NCT02759939|11891127|FG002|Eligible for T2 and T3|Overall Study||1022
10727140|NCT02759939|11891128|FG003|Eligible for T2 and T3|Overall Study||853
10727141|NCT02759939|11891125|FG000|Analyzed at T2 and/or T3|Overall Study||303
10727142|NCT02759939|11891126|FG001|Analyzed at T2 and/or T3|Overall Study||278
10727143|NCT02759939|11891127|FG002|Analyzed at T2 and/or T3|Overall Study||373
10727144|NCT02759939|11891128|FG003|Analyzed at T2 and/or T3|Overall Study||304
10727145|NCT02759939|11891125|FG000|Consented to T2 and T3|Overall Study||579
10727146|NCT02759939|11891126|FG001|Consented to T2 and T3|Overall Study||626
10727147|NCT02759939|11891127|FG002|Consented to T2 and T3|Overall Study||702
10727148|NCT02759939|11891128|FG003|Consented to T2 and T3|Overall Study||564
10727149|NCT02759939|11891125|FG000|COMPLETED|Overall Study||200
10727150|NCT02759939|11891126|FG001|COMPLETED|Overall Study||171
10727151|NCT02759939|11891127|FG002|COMPLETED|Overall Study||239
10727152|NCT02759939|11891128|FG003|COMPLETED|Overall Study||203
10727153|NCT02759939|11891125|FG000|NOT COMPLETED|Overall Study||1056
10727154|NCT02759939|11891126|FG001|NOT COMPLETED|Overall Study||972
10727155|NCT02759939|11891127|FG002|NOT COMPLETED|Overall Study||1154
10727156|NCT02759939|11891128|FG003|NOT COMPLETED|Overall Study||1043
10727157|NCT02760056|11891140|FG000|STARTED|Overall Study||10
10727158|NCT02760056|11891141|FG001|STARTED|Overall Study||5
10727159|NCT02760056|11891140|FG000|COMPLETED|Overall Study||10
10727160|NCT02760056|11891141|FG001|COMPLETED|Overall Study||5
10727161|NCT02760056|11891140|FG000|NOT COMPLETED|Overall Study||0
10727162|NCT02760056|11891141|FG001|NOT COMPLETED|Overall Study||0
10727163|NCT02760069|11891151|FG000|STARTED|Overall Study||40
10727164|NCT02760069|11891152|FG001|STARTED|Overall Study||41
10727165|NCT02760069|11891153|FG002|STARTED|Overall Study||41
10727166|NCT02760069|11891151|FG000|COMPLETED|Overall Study||40
10727167|NCT02760069|11891152|FG001|COMPLETED|Overall Study||40
10727168|NCT02760069|11891153|FG002|COMPLETED|Overall Study||40
10727169|NCT02760069|11891151|FG000|NOT COMPLETED|Overall Study||0
10727170|NCT02760069|11891152|FG001|NOT COMPLETED|Overall Study||1
10727171|NCT02760069|11891153|FG002|NOT COMPLETED|Overall Study||1
10727172|NCT02760264|11891165|FG000|STARTED|0.25 mg/kg/Day||12
10727173|NCT02760264|11891166|FG001|STARTED|0.25 mg/kg/Day||0
10727174|NCT02760264|11891167|FG002|STARTED|0.25 mg/kg/Day||0
10727175|NCT02760264|11891168|FG003|STARTED|0.25 mg/kg/Day||0
10727176|NCT02760264|11891165|FG000|COMPLETED|0.25 mg/kg/Day||12
10727177|NCT02760264|11891166|FG001|COMPLETED|0.25 mg/kg/Day||0
10727178|NCT02760264|11891167|FG002|COMPLETED|0.25 mg/kg/Day||0
10727179|NCT02760264|11891168|FG003|COMPLETED|0.25 mg/kg/Day||0
10727180|NCT02760264|11891165|FG000|NOT COMPLETED|0.25 mg/kg/Day||0
10727181|NCT02760264|11891166|FG001|NOT COMPLETED|0.25 mg/kg/Day||0
10727182|NCT02760264|11891167|FG002|NOT COMPLETED|0.25 mg/kg/Day||0
10727183|NCT02760264|11891168|FG003|NOT COMPLETED|0.25 mg/kg/Day||0
10727184|NCT02760264|11891165|FG000|STARTED|0.75 mg/kg/Day||0
10727185|NCT02760264|11891166|FG001|STARTED|0.75 mg/kg/Day||12
10727186|NCT02760264|11891167|FG002|STARTED|0.75 mg/kg/Day||0
10727187|NCT02760264|11891168|FG003|STARTED|0.75 mg/kg/Day||0
10727188|NCT02760264|11891165|FG000|COMPLETED|0.75 mg/kg/Day||0
10727189|NCT02760264|11891166|FG001|COMPLETED|0.75 mg/kg/Day||12
10727190|NCT02760264|11891167|FG002|COMPLETED|0.75 mg/kg/Day||0
10727191|NCT02760264|11891168|FG003|COMPLETED|0.75 mg/kg/Day||0
10727192|NCT02760264|11891165|FG000|NOT COMPLETED|0.75 mg/kg/Day||0
10727193|NCT02760264|11891166|FG001|NOT COMPLETED|0.75 mg/kg/Day||0
10727194|NCT02760264|11891167|FG002|NOT COMPLETED|0.75 mg/kg/Day||0
10727195|NCT02760264|11891168|FG003|NOT COMPLETED|0.75 mg/kg/Day||0
10727196|NCT02760264|11891165|FG000|STARTED|2.0 mg/kg/Day||0
10727197|NCT02760264|11891166|FG001|STARTED|2.0 mg/kg/Day||0
10727198|NCT02760264|11891167|FG002|STARTED|2.0 mg/kg/Day||12
10727199|NCT02760264|11891168|FG003|STARTED|2.0 mg/kg/Day||0
10727200|NCT02760264|11891165|FG000|COMPLETED|2.0 mg/kg/Day||0
10727201|NCT02760264|11891166|FG001|COMPLETED|2.0 mg/kg/Day||0
10727202|NCT02760264|11891167|FG002|COMPLETED|2.0 mg/kg/Day||12
10727203|NCT02760264|11891168|FG003|COMPLETED|2.0 mg/kg/Day||0
10727204|NCT02760264|11891165|FG000|NOT COMPLETED|2.0 mg/kg/Day||0
10727205|NCT02760264|11891166|FG001|NOT COMPLETED|2.0 mg/kg/Day||0
10727206|NCT02760264|11891167|FG002|NOT COMPLETED|2.0 mg/kg/Day||0
10727207|NCT02760264|11891168|FG003|NOT COMPLETED|2.0 mg/kg/Day||0
10727208|NCT02760264|11891165|FG000|STARTED|6.0 mg/kg/Day||0
10727209|NCT02760264|11891166|FG001|STARTED|6.0 mg/kg/Day||0
10727210|NCT02760264|11891167|FG002|STARTED|6.0 mg/kg/Day||0
10727211|NCT02760264|11891168|FG003|STARTED|6.0 mg/kg/Day||12
10727212|NCT02760264|11891165|FG000|COMPLETED|6.0 mg/kg/Day||0
10727213|NCT02760264|11891166|FG001|COMPLETED|6.0 mg/kg/Day||0
10727214|NCT02760264|11891167|FG002|COMPLETED|6.0 mg/kg/Day||0
10727215|NCT02760264|11891168|FG003|COMPLETED|6.0 mg/kg/Day||12
10727216|NCT02760264|11891165|FG000|NOT COMPLETED|6.0 mg/kg/Day||0
10727217|NCT02760264|11891166|FG001|NOT COMPLETED|6.0 mg/kg/Day||0
10727218|NCT02760264|11891167|FG002|NOT COMPLETED|6.0 mg/kg/Day||0
10727219|NCT02760264|11891168|FG003|NOT COMPLETED|6.0 mg/kg/Day||0
10727220|NCT02760277|11891183|FG000|STARTED|Vamorolone 0.25 mg/kg/Day||12
10727221|NCT02760277|11891184|FG001|STARTED|Vamorolone 0.25 mg/kg/Day||0
10727222|NCT02760277|11891185|FG002|STARTED|Vamorolone 0.25 mg/kg/Day||0
10727223|NCT02760277|11891186|FG003|STARTED|Vamorolone 0.25 mg/kg/Day||0
10727224|NCT02760277|11891183|FG000|COMPLETED|Vamorolone 0.25 mg/kg/Day||12
10727225|NCT02760277|11891184|FG001|COMPLETED|Vamorolone 0.25 mg/kg/Day||0
10727226|NCT02760277|11891185|FG002|COMPLETED|Vamorolone 0.25 mg/kg/Day||0
10727227|NCT02760277|11891186|FG003|COMPLETED|Vamorolone 0.25 mg/kg/Day||0
10727228|NCT02760277|11891183|FG000|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
10727229|NCT02760277|11891184|FG001|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
10727230|NCT02760277|11891185|FG002|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
10727231|NCT02760277|11891186|FG003|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
10727232|NCT02760277|11891183|FG000|STARTED|0.75 mg/kg/Day||0
10727233|NCT02760277|11891184|FG001|STARTED|0.75 mg/kg/Day||12
10727234|NCT02760277|11891185|FG002|STARTED|0.75 mg/kg/Day||0
10727235|NCT02760277|11891186|FG003|STARTED|0.75 mg/kg/Day||0
10727236|NCT02760277|11891183|FG000|COMPLETED|0.75 mg/kg/Day||0
10727237|NCT02760277|11891184|FG001|COMPLETED|0.75 mg/kg/Day||12
10727238|NCT02760277|11891185|FG002|COMPLETED|0.75 mg/kg/Day||0
10727239|NCT02760277|11891186|FG003|COMPLETED|0.75 mg/kg/Day||0
10727240|NCT02760277|11891183|FG000|NOT COMPLETED|0.75 mg/kg/Day||0
10727241|NCT02760277|11891184|FG001|NOT COMPLETED|0.75 mg/kg/Day||0
10727242|NCT02760277|11891185|FG002|NOT COMPLETED|0.75 mg/kg/Day||0
10727243|NCT02760277|11891186|FG003|NOT COMPLETED|0.75 mg/kg/Day||0
10727244|NCT02760277|11891183|FG000|STARTED|2.0 mg/kg/Day||0
10727245|NCT02760277|11891184|FG001|STARTED|2.0 mg/kg/Day||0
10727246|NCT02760277|11891185|FG002|STARTED|2.0 mg/kg/Day||12
10727247|NCT02760277|11891186|FG003|STARTED|2.0 mg/kg/Day||0
10727248|NCT02760277|11891183|FG000|COMPLETED|2.0 mg/kg/Day||0
10727249|NCT02760277|11891184|FG001|COMPLETED|2.0 mg/kg/Day||0
10727250|NCT02760277|11891185|FG002|COMPLETED|2.0 mg/kg/Day||12
10727251|NCT02760277|11891186|FG003|COMPLETED|2.0 mg/kg/Day||0
10727252|NCT02760277|11891183|FG000|NOT COMPLETED|2.0 mg/kg/Day||0
10727253|NCT02760277|11891184|FG001|NOT COMPLETED|2.0 mg/kg/Day||0
10727254|NCT02760277|11891185|FG002|NOT COMPLETED|2.0 mg/kg/Day||0
10727255|NCT02760277|11891186|FG003|NOT COMPLETED|2.0 mg/kg/Day||0
10727256|NCT02760277|11891183|FG000|STARTED|6.0 mg/kg/Day||0
10727257|NCT02760277|11891184|FG001|STARTED|6.0 mg/kg/Day||0
10727258|NCT02760277|11891185|FG002|STARTED|6.0 mg/kg/Day||0
10727259|NCT02760277|11891186|FG003|STARTED|6.0 mg/kg/Day||12
10727260|NCT02760277|11891183|FG000|COMPLETED|6.0 mg/kg/Day||0
10727261|NCT02760277|11891184|FG001|COMPLETED|6.0 mg/kg/Day||0
10727262|NCT02760277|11891185|FG002|COMPLETED|6.0 mg/kg/Day||0
10727263|NCT02760277|11891186|FG003|COMPLETED|6.0 mg/kg/Day||12
10727264|NCT02760277|11891183|FG000|NOT COMPLETED|6.0 mg/kg/Day||0
10727265|NCT02760277|11891184|FG001|NOT COMPLETED|6.0 mg/kg/Day||0
10727266|NCT02760277|11891185|FG002|NOT COMPLETED|6.0 mg/kg/Day||0
10727267|NCT02760277|11891186|FG003|NOT COMPLETED|6.0 mg/kg/Day||0
10727268|NCT02760368|11891199|FG000|STARTED|Overall Study||143
10727269|NCT02760368|11891200|FG001|STARTED|Overall Study||142
10727270|NCT02760368|11891201|FG002|STARTED|Overall Study||143
10727271|NCT02760368|11891199|FG000|COMPLETED|Overall Study||130
10727272|NCT02760368|11891200|FG001|COMPLETED|Overall Study||134
10727273|NCT02760368|11891201|FG002|COMPLETED|Overall Study||132
10727274|NCT02760368|11891199|FG000|NOT COMPLETED|Overall Study||13
10727275|NCT02760368|11891200|FG001|NOT COMPLETED|Overall Study||8
10727276|NCT02760368|11891201|FG002|NOT COMPLETED|Overall Study||11
10727277|NCT02760407|11891213|FG000|STARTED|Overall Study||479
10727278|NCT02760407|11891214|FG001|STARTED|Overall Study||464
10727279|NCT02760407|11891215|FG002|STARTED|Overall Study||462
10727280|NCT02760407|11891216|FG003|STARTED|Overall Study||243
10727281|NCT02760407|11891213|FG000|COMPLETED|Overall Study||443
10727282|NCT02760407|11891214|FG001|COMPLETED|Overall Study||421
10727283|NCT02760407|11891215|FG002|COMPLETED|Overall Study||412
10727284|NCT02760407|11891216|FG003|COMPLETED|Overall Study||207
10727285|NCT02760407|11891213|FG000|NOT COMPLETED|Overall Study||36
10727286|NCT02760407|11891214|FG001|NOT COMPLETED|Overall Study||43
10727287|NCT02760407|11891215|FG002|NOT COMPLETED|Overall Study||50
10727288|NCT02760407|11891216|FG003|NOT COMPLETED|Overall Study||36
10727289|NCT02760433|11891232|FG000|STARTED|Overall Study||161
10727290|NCT02760433|11891233|FG001|STARTED|Overall Study||138
10727291|NCT02760433|11891234|FG002|STARTED|Overall Study||26
10727292|NCT02760433|11891235|FG003|STARTED|Overall Study||32
10727293|NCT02760433|11891236|FG004|STARTED|Overall Study||11
10727294|NCT02760433|11891232|FG000|COMPLETED|Overall Study||134
10727295|NCT02760433|11891233|FG001|COMPLETED|Overall Study||128
10727296|NCT02760433|11891234|FG002|COMPLETED|Overall Study||25
10727297|NCT02760433|11891235|FG003|COMPLETED|Overall Study||30
10727298|NCT02760433|11891236|FG004|COMPLETED|Overall Study||1
10727299|NCT02760433|11891232|FG000|NOT COMPLETED|Overall Study||27
10727300|NCT02760433|11891233|FG001|NOT COMPLETED|Overall Study||10
10727301|NCT02760433|11891234|FG002|NOT COMPLETED|Overall Study||1
10727302|NCT02760433|11891235|FG003|NOT COMPLETED|Overall Study||2
10727303|NCT02760433|11891236|FG004|NOT COMPLETED|Overall Study||10
10727304|NCT02760654|11891255|FG000|STARTED|Overall Study||30
10727305|NCT02760654|11891256|FG001|STARTED|Overall Study||30
10727306|NCT02760654|11891255|FG000|COMPLETED|Overall Study||23
10727307|NCT02760654|11891256|FG001|COMPLETED|Overall Study||24
10727308|NCT02760654|11891255|FG000|NOT COMPLETED|Overall Study||7
10727309|NCT02760654|11891256|FG001|NOT COMPLETED|Overall Study||6
10727310|NCT02760810|11891262|FG000|STARTED|Overall Study||30
10727311|NCT02760810|11891262|FG000|COMPLETED|Overall Study||29
10727312|NCT02760810|11891262|FG000|NOT COMPLETED|Overall Study||1
10727313|NCT02760862|11891268|FG000|STARTED|Overall Study||25
10727314|NCT02760862|11891269|FG001|STARTED|Overall Study||25
10727315|NCT02760862|11891268|FG000|COMPLETED|Overall Study||25
10727316|NCT02760862|11891269|FG001|COMPLETED|Overall Study||25
10727317|NCT02760862|11891268|FG000|NOT COMPLETED|Overall Study||0
10727318|NCT02760862|11891269|FG001|NOT COMPLETED|Overall Study||0
10727319|NCT02760927|11891275|FG000|STARTED|Overall Study||4
10727320|NCT02760927|11891275|FG000|COMPLETED|Overall Study||3
10727321|NCT02760927|11891275|FG000|NOT COMPLETED|Overall Study||1
10727322|NCT02761252|11891282|FG000|STARTED|Overall Study||143
10727323|NCT02761252|11891283|FG001|STARTED|Overall Study||140
10727324|NCT02761252|11891284|FG002|STARTED|Overall Study||137
10727325|NCT02761252|11891282|FG000|COMPLETED|Overall Study||133
10727326|NCT02761252|11891283|FG001|COMPLETED|Overall Study||132
10727327|NCT02761252|11891284|FG002|COMPLETED|Overall Study||123
10727328|NCT02761252|11891282|FG000|NOT COMPLETED|Overall Study||10
10727329|NCT02761252|11891283|FG001|NOT COMPLETED|Overall Study||8
10727330|NCT02761252|11891284|FG002|NOT COMPLETED|Overall Study||14
10727331|NCT02761330|11891294|FG000|STARTED|Treatment Week 1||2
10727332|NCT02761330|11891295|FG001|STARTED|Treatment Week 1||3
10727333|NCT02761330|11891296|FG002|STARTED|Treatment Week 1||2
10727334|NCT02761330|11891297|FG003|STARTED|Treatment Week 1||3
10727335|NCT02761330|11891298|FG004|STARTED|Treatment Week 1||1
10727336|NCT02761330|11891299|FG005|STARTED|Treatment Week 1||3
10727337|NCT02761330|11891294|FG000|COMPLETED|Treatment Week 1||2
10727338|NCT02761330|11891295|FG001|COMPLETED|Treatment Week 1||3
10727339|NCT02761330|11891296|FG002|COMPLETED|Treatment Week 1||2
10727340|NCT02761330|11891297|FG003|COMPLETED|Treatment Week 1||2
10727341|NCT02761330|11891298|FG004|COMPLETED|Treatment Week 1||1
10727342|NCT02761330|11891299|FG005|COMPLETED|Treatment Week 1||2
10727343|NCT02761330|11891294|FG000|NOT COMPLETED|Treatment Week 1||0
10727344|NCT02761330|11891295|FG001|NOT COMPLETED|Treatment Week 1||0
10727345|NCT02761330|11891296|FG002|NOT COMPLETED|Treatment Week 1||0
10727346|NCT02761330|11891297|FG003|NOT COMPLETED|Treatment Week 1||1
10727347|NCT02761330|11891298|FG004|NOT COMPLETED|Treatment Week 1||0
10727348|NCT02761330|11891299|FG005|NOT COMPLETED|Treatment Week 1||1
10727349|NCT02761330|11891294|FG000|STARTED|Treatment Week 2||2
10727350|NCT02761330|11891295|FG001|STARTED|Treatment Week 2||3
10727351|NCT02761330|11891296|FG002|STARTED|Treatment Week 2||2
10727352|NCT02761330|11891297|FG003|STARTED|Treatment Week 2|1 pt. in this group completed Week 1, but did not begin Week 2 due to withdraw.|1
10727353|NCT02761330|11891298|FG004|STARTED|Treatment Week 2||1
10727354|NCT02761330|11891299|FG005|STARTED|Treatment Week 2|1 pt. in this group completed Week 1, but did not begin Week 2 due to cancellation of treatment.|1
10727355|NCT02761330|11891294|FG000|COMPLETED|Treatment Week 2||2
10727356|NCT02761330|11891295|FG001|COMPLETED|Treatment Week 2||3
10727357|NCT02761330|11891296|FG002|COMPLETED|Treatment Week 2||2
10727358|NCT02761330|11891297|FG003|COMPLETED|Treatment Week 2||1
10727359|NCT02761330|11891298|FG004|COMPLETED|Treatment Week 2||1
10727360|NCT02761330|11891299|FG005|COMPLETED|Treatment Week 2||1
10727361|NCT02761330|11891294|FG000|NOT COMPLETED|Treatment Week 2||0
10727362|NCT02761330|11891295|FG001|NOT COMPLETED|Treatment Week 2||0
10727363|NCT02761330|11891296|FG002|NOT COMPLETED|Treatment Week 2||0
10727364|NCT02761330|11891297|FG003|NOT COMPLETED|Treatment Week 2||0
10727365|NCT02761330|11891298|FG004|NOT COMPLETED|Treatment Week 2||0
10727366|NCT02761330|11891299|FG005|NOT COMPLETED|Treatment Week 2||0
10727367|NCT02761629|11891315|FG000|STARTED|Overall Study||90
10727368|NCT02761629|11891316|FG001|STARTED|Overall Study||90
10727369|NCT02761629|11891315|FG000|Treated|Overall Study||82
10727370|NCT02761629|11891316|FG001|Treated|Overall Study||86
10727371|NCT02761629|11891315|FG000|COMPLETED|Overall Study||63
10727372|NCT02761629|11891316|FG001|COMPLETED|Overall Study||58
10727373|NCT02761629|11891315|FG000|NOT COMPLETED|Overall Study||27
10727374|NCT02761629|11891316|FG001|NOT COMPLETED|Overall Study||32
10727375|NCT02761642|11891322|FG000|STARTED|Overall Study||200
10727376|NCT02761642|11891322|FG000|Treated|Overall Study||197
10727377|NCT02761642|11891322|FG000|COMPLETED|Overall Study||130
10727378|NCT02761642|11891322|FG000|NOT COMPLETED|Overall Study||70
10727379|NCT02761733|11891330|FG000|STARTED|Overall Study||60
10727380|NCT02761733|11891331|FG001|STARTED|Overall Study||60
10727381|NCT02761733|11891332|FG002|STARTED|Overall Study||60
10727382|NCT02761733|11891333|FG003|STARTED|Overall Study||60
10727383|NCT02761733|11891330|FG000|9/30/2014|Overall Study||53
10727384|NCT02761733|11891331|FG001|9/30/2014|Overall Study||56
10727385|NCT02761733|11891332|FG002|9/30/2014|Overall Study||48
10727386|NCT02761733|11891333|FG003|9/30/2014|Overall Study||55
10727387|NCT02761733|11891330|FG000|3/31/2015|Overall Study||48
10727388|NCT02761733|11891331|FG001|3/31/2015|Overall Study||47
10727389|NCT02761733|11891332|FG002|3/31/2015|Overall Study||43
10727390|NCT02761733|11891333|FG003|3/31/2015|Overall Study||50
10727391|NCT02761733|11891330|FG000|9/30/2015|Overall Study||40
10727392|NCT02761733|11891331|FG001|9/30/2015|Overall Study||44
10727393|NCT02761733|11891332|FG002|9/30/2015|Overall Study||33
10727394|NCT02761733|11891333|FG003|9/30/2015|Overall Study||50
10727395|NCT02761733|11891330|FG000|COMPLETED|Overall Study||30
10727396|NCT02761733|11891331|FG001|COMPLETED|Overall Study||39
10727397|NCT02761733|11891332|FG002|COMPLETED|Overall Study||33
10727398|NCT02761733|11891333|FG003|COMPLETED|Overall Study||45
10727399|NCT02761733|11891330|FG000|NOT COMPLETED|Overall Study||30
10727400|NCT02761733|11891331|FG001|NOT COMPLETED|Overall Study||21
10727401|NCT02761733|11891332|FG002|NOT COMPLETED|Overall Study||27
10727402|NCT02761733|11891333|FG003|NOT COMPLETED|Overall Study||15
10727403|NCT02761915|11891349|FG000|STARTED|Overall Study||4
10727404|NCT02761915|11891350|FG001|STARTED|Overall Study||1
10727405|NCT02761915|11891351|FG002|STARTED|Overall Study||1
10727406|NCT02761915|11891352|FG003|STARTED|Overall Study||3
10727407|NCT02761915|11891353|FG004|STARTED|Overall Study||3
10727408|NCT02761915|11891354|FG005|STARTED|Overall Study||5
10727409|NCT02761915|11891349|FG000|Underwent Leukapheresis|Overall Study||4
10727410|NCT02761915|11891350|FG001|Underwent Leukapheresis|Overall Study||1
10727411|NCT02761915|11891351|FG002|Underwent Leukapheresis|Overall Study||1
10727412|NCT02761915|11891352|FG003|Underwent Leukapheresis|Overall Study||3
10727413|NCT02761915|11891353|FG004|Underwent Leukapheresis|Overall Study||3
10727414|NCT02761915|11891354|FG005|Underwent Leukapheresis|Overall Study||5
10727415|NCT02761915|11891349|FG000|Received Investigational Medicinal Product|Overall Study||4
10727416|NCT02761915|11891350|FG001|Received Investigational Medicinal Product|Overall Study||1
10727417|NCT02761915|11891351|FG002|Received Investigational Medicinal Product|Overall Study||1
10727418|NCT02761915|11891352|FG003|Received Investigational Medicinal Product|Overall Study||3
10727419|NCT02761915|11891353|FG004|Received Investigational Medicinal Product|Overall Study||3
10727420|NCT02761915|11891354|FG005|Received Investigational Medicinal Product|Overall Study||0
10727421|NCT02761915|11891349|FG000|COMPLETED|Overall Study||0
10727422|NCT02761915|11891350|FG001|COMPLETED|Overall Study||0
10727423|NCT02761915|11891351|FG002|COMPLETED|Overall Study||0
10727424|NCT02761915|11891352|FG003|COMPLETED|Overall Study||0
10727425|NCT02761915|11891353|FG004|COMPLETED|Overall Study||0
10727426|NCT02761915|11891354|FG005|COMPLETED|Overall Study||0
10727427|NCT02761915|11891349|FG000|NOT COMPLETED|Overall Study||4
10727428|NCT02761915|11891350|FG001|NOT COMPLETED|Overall Study||1
10727429|NCT02761915|11891351|FG002|NOT COMPLETED|Overall Study||1
10727430|NCT02761915|11891352|FG003|NOT COMPLETED|Overall Study||3
10727431|NCT02761915|11891353|FG004|NOT COMPLETED|Overall Study||3
10727432|NCT02761915|11891354|FG005|NOT COMPLETED|Overall Study||5
10727433|NCT02761967|11891374|FG000|STARTED|Overall Study||70
10727434|NCT02761967|11891375|FG001|STARTED|Overall Study||70
10727435|NCT02761967|11891374|FG000|COMPLETED|Overall Study||65
10727436|NCT02761967|11891375|FG001|COMPLETED|Overall Study||64
10727437|NCT02761967|11891374|FG000|NOT COMPLETED|Overall Study||5
10727438|NCT02761967|11891375|FG001|NOT COMPLETED|Overall Study||6
10727439|NCT02761980|11891388|FG000|STARTED|Overall Study||29
10727440|NCT02761980|11891389|FG001|STARTED|Overall Study||87
10727441|NCT02761980|11891390|FG002|STARTED|Overall Study||87
10727442|NCT02761980|11891391|FG003|STARTED|Overall Study||87
10727443|NCT02761980|11891388|FG000|COMPLETED|Overall Study||25
10727444|NCT02761980|11891389|FG001|COMPLETED|Overall Study||80
10727445|NCT02761980|11891390|FG002|COMPLETED|Overall Study||81
10727446|NCT02761980|11891391|FG003|COMPLETED|Overall Study||81
10727447|NCT02761980|11891388|FG000|NOT COMPLETED|Overall Study||4
10727448|NCT02761980|11891389|FG001|NOT COMPLETED|Overall Study||7
10727449|NCT02761980|11891390|FG002|NOT COMPLETED|Overall Study||6
10727450|NCT02761980|11891391|FG003|NOT COMPLETED|Overall Study||6
10727451|NCT02761993|11891404|FG000|STARTED|Overall Study||52
10727452|NCT02761993|11891405|FG001|STARTED|Overall Study||49
10727453|NCT02761993|11891406|FG002|STARTED|Overall Study||50
10727454|NCT02761993|11891404|FG000|COMPLETED|Overall Study||50
10727455|NCT02761993|11891405|FG001|COMPLETED|Overall Study||43
10727456|NCT02761993|11891406|FG002|COMPLETED|Overall Study||46
10727457|NCT02761993|11891404|FG000|NOT COMPLETED|Overall Study||2
10727458|NCT02761993|11891405|FG001|NOT COMPLETED|Overall Study||6
10727459|NCT02761993|11891406|FG002|NOT COMPLETED|Overall Study||4
10727460|NCT02762071|11891416|FG000|STARTED|Overall Study||54
10727461|NCT02762071|11891417|FG001|STARTED|Overall Study||54
10727462|NCT02762071|11891416|FG000|COMPLETED|Overall Study||54
10727463|NCT02762071|11891417|FG001|COMPLETED|Overall Study||54
10727464|NCT02762071|11891416|FG000|NOT COMPLETED|Overall Study||0
10727465|NCT02762071|11891417|FG001|NOT COMPLETED|Overall Study||0
10727466|NCT02762084|11891427|FG000|STARTED|Overall Study||6
10727467|NCT02762084|11891428|FG001|STARTED|Overall Study||6
10727468|NCT02762084|11891429|FG002|STARTED|Overall Study||5
10727469|NCT02762084|11891427|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
10727470|NCT02762084|11891428|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
10727471|NCT02762084|11891429|FG002|Received at Least 1 Dose of Study Drug|Overall Study||5
10727472|NCT02762084|11891427|FG000|By Tumor Per Protocol Population (PP)|Overall Study||6
10727473|NCT02762084|11891428|FG001|By Tumor Per Protocol Population (PP)|Overall Study||6
10727474|NCT02762084|11891429|FG002|By Tumor Per Protocol Population (PP)|Overall Study||4
10727475|NCT02762084|11891427|FG000|COMPLETED|Overall Study||5
10727476|NCT02762084|11891428|FG001|COMPLETED|Overall Study||6
10727477|NCT02762084|11891429|FG002|COMPLETED|Overall Study||4
10727478|NCT02762084|11891427|FG000|NOT COMPLETED|Overall Study||1
10727479|NCT02762084|11891428|FG001|NOT COMPLETED|Overall Study||0
10727480|NCT02762084|11891429|FG002|NOT COMPLETED|Overall Study||1
10727481|NCT02762331|11891441|FG000|STARTED|Overall Study||4
10727482|NCT02762331|11891442|FG001|STARTED|Overall Study||2
10727483|NCT02762331|11891441|FG000|COMPLETED|Overall Study||4
10727484|NCT02762331|11891442|FG001|COMPLETED|Overall Study||2
10727485|NCT02762331|11891441|FG000|NOT COMPLETED|Overall Study||0
10727486|NCT02762331|11891442|FG001|NOT COMPLETED|Overall Study||0
10727487|NCT02762370|11891450|FG000|STARTED|Overall Study||18
10727488|NCT02762370|11891451|FG001|STARTED|Overall Study||15
10727489|NCT02762370|11891450|FG000|COMPLETED|Overall Study||17
10727490|NCT02762370|11891451|FG001|COMPLETED|Overall Study||15
10727491|NCT02762370|11891450|FG000|NOT COMPLETED|Overall Study||1
10727492|NCT02762370|11891451|FG001|NOT COMPLETED|Overall Study||0
10727493|NCT02762500|11891461|FG000|STARTED|Overall Study||62
10727494|NCT02762500|11891462|FG001|STARTED|Overall Study||62
10727495|NCT02762500|11891461|FG000|COMPLETED|Overall Study||60
10727496|NCT02762500|11891462|FG001|COMPLETED|Overall Study||59
10727497|NCT02762500|11891461|FG000|NOT COMPLETED|Overall Study||2
10727498|NCT02762500|11891462|FG001|NOT COMPLETED|Overall Study||3
10727499|NCT02762513|11891468|FG000|STARTED|Overall Study||28
10727500|NCT02762513|11891468|FG000|COMPLETED|Overall Study||28
10727501|NCT02762513|11891468|FG000|NOT COMPLETED|Overall Study||0
10727502|NCT02762565|11891472|FG000|STARTED|Overall Study||89
10727503|NCT02762565|11891472|FG000|COMPLETED|Overall Study||78
10727504|NCT02762565|11891472|FG000|NOT COMPLETED|Overall Study||11
10727505|NCT02762578|11891478|FG000|STARTED|Overall Study||361
10727506|NCT02762578|11891479|FG001|STARTED|Overall Study||182
10727507|NCT02762578|11891478|FG000|Exposed|Overall Study||360
10727508|NCT02762578|11891479|FG001|Exposed|Overall Study||181
10727509|NCT02762578|11891478|FG000|COMPLETED|Overall Study||346
10727510|NCT02762578|11891479|FG001|COMPLETED|Overall Study||172
10727511|NCT02762578|11891478|FG000|NOT COMPLETED|Overall Study||15
10727512|NCT02762578|11891479|FG001|NOT COMPLETED|Overall Study||10
10727513|NCT02762799|11891489|FG000|STARTED|Overall Study||18
10727514|NCT02762799|11891490|FG001|STARTED|Overall Study||18
10727515|NCT02762799|11891491|FG002|STARTED|Overall Study||12
10727516|NCT02762799|11891492|FG003|STARTED|Overall Study||12
10727517|NCT02762799|11891489|FG000|COMPLETED|Overall Study||18
10727518|NCT02762799|11891490|FG001|COMPLETED|Overall Study||18
10727519|NCT02762799|11891491|FG002|COMPLETED|Overall Study||11
10727520|NCT02762799|11891492|FG003|COMPLETED|Overall Study||12
10727521|NCT02762799|11891489|FG000|NOT COMPLETED|Overall Study||0
10727522|NCT02762799|11891490|FG001|NOT COMPLETED|Overall Study||0
10727523|NCT02762799|11891491|FG002|NOT COMPLETED|Overall Study||1
10727524|NCT02762799|11891492|FG003|NOT COMPLETED|Overall Study||0
10727525|NCT02762877|11891506|FG000|STARTED|Overall Study||121
10727526|NCT02762877|11891507|FG001|STARTED|Overall Study||19
10727527|NCT02762877|11891506|FG000|COMPLETED|Overall Study||121
10727528|NCT02762877|11891507|FG001|COMPLETED|Overall Study||19
10727529|NCT02762877|11891506|FG000|NOT COMPLETED|Overall Study||0
10727530|NCT02762877|11891507|FG001|NOT COMPLETED|Overall Study||0
10727531|NCT02762994|11891518|FG000|STARTED|Overall Study||31
10727532|NCT02762994|11891519|FG001|STARTED|Overall Study||31
10727533|NCT02762994|11891520|FG002|STARTED|Overall Study||30
10727534|NCT02762994|11891521|FG003|STARTED|Overall Study||28
10727535|NCT02762994|11891518|FG000|COMPLETED|Overall Study||30
10727536|NCT02762994|11891519|FG001|COMPLETED|Overall Study||30
10727537|NCT02762994|11891520|FG002|COMPLETED|Overall Study||28
10727538|NCT02762994|11891521|FG003|COMPLETED|Overall Study||26
10727539|NCT02762994|11891518|FG000|NOT COMPLETED|Overall Study||1
10727540|NCT02762994|11891519|FG001|NOT COMPLETED|Overall Study||1
10727541|NCT02762994|11891520|FG002|NOT COMPLETED|Overall Study||2
10727542|NCT02762994|11891521|FG003|NOT COMPLETED|Overall Study||2
10727543|NCT02763046|11891538|FG000|STARTED|Overall Study||71
10727544|NCT02763046|11891539|FG001|STARTED|Overall Study||70
10727545|NCT02763046|11891540|FG002|STARTED|Overall Study||70
10727546|NCT02763046|11891538|FG000|COMPLETED|Overall Study||62
10727547|NCT02763046|11891539|FG001|COMPLETED|Overall Study||65
10727548|NCT02763046|11891540|FG002|COMPLETED|Overall Study||62
10727549|NCT02763046|11891538|FG000|NOT COMPLETED|Overall Study||9
10727550|NCT02763046|11891539|FG001|NOT COMPLETED|Overall Study||5
10727551|NCT02763046|11891540|FG002|NOT COMPLETED|Overall Study||8
10727552|NCT02763124|11891554|FG000|STARTED|Overall Study||18
10727553|NCT02763124|11891554|FG000|COMPLETED|Overall Study||18
10727554|NCT02763124|11891554|FG000|NOT COMPLETED|Overall Study||0
10727555|NCT02763215|11891558|FG000|STARTED|Overall Study||64
10727556|NCT02763215|11891558|FG000|COMPLETED|Overall Study||57
10727557|NCT02763215|11891558|FG000|NOT COMPLETED|Overall Study||7
10727558|NCT02763254|11891562|FG000|STARTED|Overall Study||1
10727559|NCT02763254|11891562|FG000|COMPLETED|Overall Study||0
10727560|NCT02763254|11891562|FG000|NOT COMPLETED|Overall Study||1
10727798|NCT02763865|11891633|FG001|COMPLETED|Overall Study||5
10814598|NCT02282332|11977407|FG000|STARTED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0
10727573|NCT02763644|11891589|FG000|STARTED|Overall Study||3
10727574|NCT02763644|11891590|FG001|STARTED|Overall Study||4
10727575|NCT02763644|11891589|FG000|COMPLETED|Overall Study||0
10727576|NCT02763644|11891590|FG001|COMPLETED|Overall Study||2
10727577|NCT02763644|11891589|FG000|NOT COMPLETED|Overall Study||3
10727578|NCT02763644|11891590|FG001|NOT COMPLETED|Overall Study||2
10727579|NCT02763826|11891605|FG000|STARTED|Part 1 Dose Escalation, 1 mA||3
10727580|NCT02763826|11891606|FG001|STARTED|Part 1 Dose Escalation, 1 mA||0
10727581|NCT02763826|11891607|FG002|STARTED|Part 1 Dose Escalation, 1 mA||0
10727582|NCT02763826|11891608|FG003|STARTED|Part 1 Dose Escalation, 1 mA||0
10727583|NCT02763826|11891609|FG004|STARTED|Part 1 Dose Escalation, 1 mA||0
10727584|NCT02763826|11891610|FG005|STARTED|Part 1 Dose Escalation, 1 mA||0
10727585|NCT02763826|11891611|FG006|STARTED|Part 1 Dose Escalation, 1 mA||0
10727586|NCT02763826|11891612|FG007|STARTED|Part 1 Dose Escalation, 1 mA||0
10727587|NCT02763826|11891605|FG000|COMPLETED|Part 1 Dose Escalation, 1 mA||3
10727588|NCT02763826|11891606|FG001|COMPLETED|Part 1 Dose Escalation, 1 mA||0
10727589|NCT02763826|11891607|FG002|COMPLETED|Part 1 Dose Escalation, 1 mA||0
10727590|NCT02763826|11891608|FG003|COMPLETED|Part 1 Dose Escalation, 1 mA||0
10727591|NCT02763826|11891609|FG004|COMPLETED|Part 1 Dose Escalation, 1 mA||0
10727592|NCT02763826|11891610|FG005|COMPLETED|Part 1 Dose Escalation, 1 mA||0
10727593|NCT02763826|11891611|FG006|COMPLETED|Part 1 Dose Escalation, 1 mA||0
10727594|NCT02763826|11891612|FG007|COMPLETED|Part 1 Dose Escalation, 1 mA||0
10727595|NCT02763826|11891605|FG000|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
10727596|NCT02763826|11891606|FG001|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
10727597|NCT02763826|11891607|FG002|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
10727598|NCT02763826|11891608|FG003|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
10727599|NCT02763826|11891609|FG004|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
10727600|NCT02763826|11891610|FG005|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
10727601|NCT02763826|11891611|FG006|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
10727602|NCT02763826|11891612|FG007|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
10727603|NCT02763826|11891605|FG000|STARTED|Part 1 Dose Escalation, 2 mA||0
10727604|NCT02763826|11891606|FG001|STARTED|Part 1 Dose Escalation, 2 mA||3
10727605|NCT02763826|11891607|FG002|STARTED|Part 1 Dose Escalation, 2 mA||0
10727606|NCT02763826|11891608|FG003|STARTED|Part 1 Dose Escalation, 2 mA||0
10727607|NCT02763826|11891609|FG004|STARTED|Part 1 Dose Escalation, 2 mA||0
10727608|NCT02763826|11891610|FG005|STARTED|Part 1 Dose Escalation, 2 mA||0
10727609|NCT02763826|11891611|FG006|STARTED|Part 1 Dose Escalation, 2 mA||0
10727610|NCT02763826|11891612|FG007|STARTED|Part 1 Dose Escalation, 2 mA||0
10727611|NCT02763826|11891605|FG000|COMPLETED|Part 1 Dose Escalation, 2 mA||0
10727612|NCT02763826|11891606|FG001|COMPLETED|Part 1 Dose Escalation, 2 mA||3
10727613|NCT02763826|11891607|FG002|COMPLETED|Part 1 Dose Escalation, 2 mA||0
10727614|NCT02763826|11891608|FG003|COMPLETED|Part 1 Dose Escalation, 2 mA||0
10727615|NCT02763826|11891609|FG004|COMPLETED|Part 1 Dose Escalation, 2 mA||0
10727616|NCT02763826|11891610|FG005|COMPLETED|Part 1 Dose Escalation, 2 mA||0
10727617|NCT02763826|11891611|FG006|COMPLETED|Part 1 Dose Escalation, 2 mA||0
10727618|NCT02763826|11891612|FG007|COMPLETED|Part 1 Dose Escalation, 2 mA||0
10727619|NCT02763826|11891605|FG000|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
10727620|NCT02763826|11891606|FG001|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
10727621|NCT02763826|11891607|FG002|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
10727622|NCT02763826|11891608|FG003|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
10727623|NCT02763826|11891609|FG004|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
10727624|NCT02763826|11891610|FG005|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
10727625|NCT02763826|11891611|FG006|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
10727626|NCT02763826|11891612|FG007|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
10727627|NCT02763826|11891605|FG000|STARTED|Part 1 Dose Escalation, 2.5 mA||0
10727628|NCT02763826|11891606|FG001|STARTED|Part 1 Dose Escalation, 2.5 mA||0
10727629|NCT02763826|11891607|FG002|STARTED|Part 1 Dose Escalation, 2.5 mA||3
10727630|NCT02763826|11891608|FG003|STARTED|Part 1 Dose Escalation, 2.5 mA||0
10727631|NCT02763826|11891609|FG004|STARTED|Part 1 Dose Escalation, 2.5 mA||0
10727632|NCT02763826|11891610|FG005|STARTED|Part 1 Dose Escalation, 2.5 mA||0
10727633|NCT02763826|11891611|FG006|STARTED|Part 1 Dose Escalation, 2.5 mA||0
10727634|NCT02763826|11891612|FG007|STARTED|Part 1 Dose Escalation, 2.5 mA||0
10727635|NCT02763826|11891605|FG000|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
10727636|NCT02763826|11891606|FG001|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
10727637|NCT02763826|11891607|FG002|COMPLETED|Part 1 Dose Escalation, 2.5 mA||3
10727638|NCT02763826|11891608|FG003|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
10727639|NCT02763826|11891609|FG004|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
10727640|NCT02763826|11891610|FG005|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
10727641|NCT02763826|11891611|FG006|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
10727642|NCT02763826|11891612|FG007|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
10727643|NCT02763826|11891605|FG000|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
10727644|NCT02763826|11891606|FG001|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
10727645|NCT02763826|11891607|FG002|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
10727646|NCT02763826|11891608|FG003|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
10727647|NCT02763826|11891609|FG004|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
10727648|NCT02763826|11891610|FG005|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
10727649|NCT02763826|11891611|FG006|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
10727650|NCT02763826|11891612|FG007|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
10727651|NCT02763826|11891605|FG000|STARTED|Part 1 Dose Escalation, 3 mA||0
10727652|NCT02763826|11891606|FG001|STARTED|Part 1 Dose Escalation, 3 mA||0
10727653|NCT02763826|11891607|FG002|STARTED|Part 1 Dose Escalation, 3 mA||0
10727654|NCT02763826|11891608|FG003|STARTED|Part 1 Dose Escalation, 3 mA||3
10727655|NCT02763826|11891609|FG004|STARTED|Part 1 Dose Escalation, 3 mA||0
10727656|NCT02763826|11891610|FG005|STARTED|Part 1 Dose Escalation, 3 mA||0
10727657|NCT02763826|11891611|FG006|STARTED|Part 1 Dose Escalation, 3 mA||0
10727658|NCT02763826|11891612|FG007|STARTED|Part 1 Dose Escalation, 3 mA||0
10727659|NCT02763826|11891605|FG000|COMPLETED|Part 1 Dose Escalation, 3 mA||0
10727660|NCT02763826|11891606|FG001|COMPLETED|Part 1 Dose Escalation, 3 mA||0
10727661|NCT02763826|11891607|FG002|COMPLETED|Part 1 Dose Escalation, 3 mA||0
10727662|NCT02763826|11891608|FG003|COMPLETED|Part 1 Dose Escalation, 3 mA||3
10727663|NCT02763826|11891609|FG004|COMPLETED|Part 1 Dose Escalation, 3 mA||0
10727664|NCT02763826|11891610|FG005|COMPLETED|Part 1 Dose Escalation, 3 mA||0
10727665|NCT02763826|11891611|FG006|COMPLETED|Part 1 Dose Escalation, 3 mA||0
10727666|NCT02763826|11891612|FG007|COMPLETED|Part 1 Dose Escalation, 3 mA||0
10727667|NCT02763826|11891605|FG000|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
10727668|NCT02763826|11891606|FG001|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
10727669|NCT02763826|11891607|FG002|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
10727670|NCT02763826|11891608|FG003|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
10727671|NCT02763826|11891609|FG004|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
10727672|NCT02763826|11891610|FG005|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
10727673|NCT02763826|11891611|FG006|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
10727674|NCT02763826|11891612|FG007|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
10727675|NCT02763826|11891605|FG000|STARTED|Part 1 Dose Escalation, 3.5 mA||0
10727676|NCT02763826|11891606|FG001|STARTED|Part 1 Dose Escalation, 3.5 mA||0
10727677|NCT02763826|11891607|FG002|STARTED|Part 1 Dose Escalation, 3.5 mA||0
10727678|NCT02763826|11891608|FG003|STARTED|Part 1 Dose Escalation, 3.5 mA||0
10727679|NCT02763826|11891609|FG004|STARTED|Part 1 Dose Escalation, 3.5 mA||3
10727680|NCT02763826|11891610|FG005|STARTED|Part 1 Dose Escalation, 3.5 mA||0
10727681|NCT02763826|11891611|FG006|STARTED|Part 1 Dose Escalation, 3.5 mA||0
10727682|NCT02763826|11891612|FG007|STARTED|Part 1 Dose Escalation, 3.5 mA||0
10727683|NCT02763826|11891605|FG000|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
10727684|NCT02763826|11891606|FG001|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
10727685|NCT02763826|11891607|FG002|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
10727686|NCT02763826|11891608|FG003|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
10727687|NCT02763826|11891609|FG004|COMPLETED|Part 1 Dose Escalation, 3.5 mA||3
10727688|NCT02763826|11891610|FG005|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
10727689|NCT02763826|11891611|FG006|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
10727690|NCT02763826|11891612|FG007|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
10727691|NCT02763826|11891605|FG000|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
10727692|NCT02763826|11891606|FG001|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
10727693|NCT02763826|11891607|FG002|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
10727694|NCT02763826|11891608|FG003|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
10727695|NCT02763826|11891609|FG004|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
10727696|NCT02763826|11891610|FG005|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
10727697|NCT02763826|11891611|FG006|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
10727698|NCT02763826|11891612|FG007|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
10727699|NCT02763826|11891605|FG000|STARTED|Part 1 Dose Escalation, 4 mA||0
10727700|NCT02763826|11891606|FG001|STARTED|Part 1 Dose Escalation, 4 mA||0
10727701|NCT02763826|11891607|FG002|STARTED|Part 1 Dose Escalation, 4 mA||0
10727702|NCT02763826|11891608|FG003|STARTED|Part 1 Dose Escalation, 4 mA||0
10727703|NCT02763826|11891609|FG004|STARTED|Part 1 Dose Escalation, 4 mA||0
10727704|NCT02763826|11891610|FG005|STARTED|Part 1 Dose Escalation, 4 mA||3
10727705|NCT02763826|11891611|FG006|STARTED|Part 1 Dose Escalation, 4 mA||0
10727706|NCT02763826|11891612|FG007|STARTED|Part 1 Dose Escalation, 4 mA||0
10727707|NCT02763826|11891605|FG000|COMPLETED|Part 1 Dose Escalation, 4 mA||0
10727708|NCT02763826|11891606|FG001|COMPLETED|Part 1 Dose Escalation, 4 mA||0
10727709|NCT02763826|11891607|FG002|COMPLETED|Part 1 Dose Escalation, 4 mA||0
10727710|NCT02763826|11891608|FG003|COMPLETED|Part 1 Dose Escalation, 4 mA||0
10727711|NCT02763826|11891609|FG004|COMPLETED|Part 1 Dose Escalation, 4 mA||0
10727712|NCT02763826|11891610|FG005|COMPLETED|Part 1 Dose Escalation, 4 mA||3
10727713|NCT02763826|11891611|FG006|COMPLETED|Part 1 Dose Escalation, 4 mA||0
10727714|NCT02763826|11891612|FG007|COMPLETED|Part 1 Dose Escalation, 4 mA||0
10727715|NCT02763826|11891605|FG000|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
10727716|NCT02763826|11891606|FG001|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
10727717|NCT02763826|11891607|FG002|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
10727718|NCT02763826|11891608|FG003|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
10727719|NCT02763826|11891609|FG004|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
10727720|NCT02763826|11891610|FG005|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
10727721|NCT02763826|11891611|FG006|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
10727722|NCT02763826|11891612|FG007|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
10727723|NCT02763826|11891605|FG000|STARTED|Part 2 Montage Effect, 1st Intervention||0
10727724|NCT02763826|11891606|FG001|STARTED|Part 2 Montage Effect, 1st Intervention||0
10727725|NCT02763826|11891607|FG002|STARTED|Part 2 Montage Effect, 1st Intervention||0
10727726|NCT02763826|11891608|FG003|STARTED|Part 2 Montage Effect, 1st Intervention||0
10727727|NCT02763826|11891609|FG004|STARTED|Part 2 Montage Effect, 1st Intervention||0
10727728|NCT02763826|11891610|FG005|STARTED|Part 2 Montage Effect, 1st Intervention||6
10727729|NCT02763826|11891611|FG006|STARTED|Part 2 Montage Effect, 1st Intervention||6
10727730|NCT02763826|11891612|FG007|STARTED|Part 2 Montage Effect, 1st Intervention||7
10727731|NCT02763826|11891605|FG000|COMPLETED|Part 2 Montage Effect, 1st Intervention||0
10727732|NCT02763826|11891606|FG001|COMPLETED|Part 2 Montage Effect, 1st Intervention||0
10727733|NCT02763826|11891607|FG002|COMPLETED|Part 2 Montage Effect, 1st Intervention||0
10727734|NCT02763826|11891608|FG003|COMPLETED|Part 2 Montage Effect, 1st Intervention||0
10727735|NCT02763826|11891609|FG004|COMPLETED|Part 2 Montage Effect, 1st Intervention||0
10727736|NCT02763826|11891610|FG005|COMPLETED|Part 2 Montage Effect, 1st Intervention||6
10727737|NCT02763826|11891611|FG006|COMPLETED|Part 2 Montage Effect, 1st Intervention||6
10727738|NCT02763826|11891612|FG007|COMPLETED|Part 2 Montage Effect, 1st Intervention||7
10727739|NCT02763826|11891605|FG000|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
10727740|NCT02763826|11891606|FG001|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
10727741|NCT02763826|11891607|FG002|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
10727742|NCT02763826|11891608|FG003|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
10727743|NCT02763826|11891609|FG004|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
10727744|NCT02763826|11891610|FG005|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
10727745|NCT02763826|11891611|FG006|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
10727746|NCT02763826|11891612|FG007|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
10727747|NCT02763826|11891605|FG000|STARTED|Part 2 Montage Effect, 2nd Intervention||0
10727748|NCT02763826|11891606|FG001|STARTED|Part 2 Montage Effect, 2nd Intervention||0
10727749|NCT02763826|11891607|FG002|STARTED|Part 2 Montage Effect, 2nd Intervention||0
10727750|NCT02763826|11891608|FG003|STARTED|Part 2 Montage Effect, 2nd Intervention||0
10727751|NCT02763826|11891609|FG004|STARTED|Part 2 Montage Effect, 2nd Intervention||0
10727752|NCT02763826|11891610|FG005|STARTED|Part 2 Montage Effect, 2nd Intervention||6
10727753|NCT02763826|11891611|FG006|STARTED|Part 2 Montage Effect, 2nd Intervention||6
10727754|NCT02763826|11891612|FG007|STARTED|Part 2 Montage Effect, 2nd Intervention||6
10727755|NCT02763826|11891605|FG000|COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
10727756|NCT02763826|11891606|FG001|COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
10727757|NCT02763826|11891607|FG002|COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
10727758|NCT02763826|11891608|FG003|COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
10727759|NCT02763826|11891609|FG004|COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
10727760|NCT02763826|11891610|FG005|COMPLETED|Part 2 Montage Effect, 2nd Intervention||6
10727761|NCT02763826|11891611|FG006|COMPLETED|Part 2 Montage Effect, 2nd Intervention||6
10727762|NCT02763826|11891612|FG007|COMPLETED|Part 2 Montage Effect, 2nd Intervention||6
10727763|NCT02763826|11891605|FG000|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
10727764|NCT02763826|11891606|FG001|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
10727765|NCT02763826|11891607|FG002|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
10727766|NCT02763826|11891608|FG003|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
10727767|NCT02763826|11891609|FG004|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
10727768|NCT02763826|11891610|FG005|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
10727769|NCT02763826|11891611|FG006|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
10727770|NCT02763826|11891612|FG007|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
10779313|NCT03364309|11940869|FG010|COMPLETED|Post-Treatment Followup Period||0
10727771|NCT02763826|11891605|FG000|STARTED|Part 2 Montage Effect, 3rd Intervention||0
10727772|NCT02763826|11891606|FG001|STARTED|Part 2 Montage Effect, 3rd Intervention||0
10727773|NCT02763826|11891607|FG002|STARTED|Part 2 Montage Effect, 3rd Intervention||0
10727774|NCT02763826|11891608|FG003|STARTED|Part 2 Montage Effect, 3rd Intervention||0
10727775|NCT02763826|11891609|FG004|STARTED|Part 2 Montage Effect, 3rd Intervention||0
10727776|NCT02763826|11891610|FG005|STARTED|Part 2 Montage Effect, 3rd Intervention||6
10727777|NCT02763826|11891611|FG006|STARTED|Part 2 Montage Effect, 3rd Intervention||6
10727778|NCT02763826|11891612|FG007|STARTED|Part 2 Montage Effect, 3rd Intervention||6
10727779|NCT02763826|11891605|FG000|COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
10727780|NCT02763826|11891606|FG001|COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
10727781|NCT02763826|11891607|FG002|COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
10727782|NCT02763826|11891608|FG003|COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
10727783|NCT02763826|11891609|FG004|COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
10727784|NCT02763826|11891610|FG005|COMPLETED|Part 2 Montage Effect, 3rd Intervention||6
10727785|NCT02763826|11891611|FG006|COMPLETED|Part 2 Montage Effect, 3rd Intervention||6
10727786|NCT02763826|11891612|FG007|COMPLETED|Part 2 Montage Effect, 3rd Intervention||6
10727787|NCT02763826|11891605|FG000|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
10727788|NCT02763826|11891606|FG001|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
10727789|NCT02763826|11891607|FG002|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
10727790|NCT02763826|11891608|FG003|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
10727791|NCT02763826|11891609|FG004|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
10727792|NCT02763826|11891610|FG005|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
10727793|NCT02763826|11891611|FG006|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
10727794|NCT02763826|11891612|FG007|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
10727795|NCT02763865|11891632|FG000|STARTED|Overall Study||5
10727796|NCT02763865|11891633|FG001|STARTED|Overall Study||5
10727797|NCT02763865|11891632|FG000|COMPLETED|Overall Study||5
10727799|NCT02763865|11891632|FG000|NOT COMPLETED|Overall Study||0
10727800|NCT02763865|11891633|FG001|NOT COMPLETED|Overall Study||0
10727801|NCT02764151|11891645|FG000|STARTED|Overall Study||2
10727802|NCT02764151|11891646|FG001|STARTED|Overall Study||4
10727803|NCT02764151|11891647|FG002|STARTED|Overall Study||3
10727804|NCT02764151|11891648|FG003|STARTED|Overall Study||8
10727805|NCT02764151|11891645|FG000|COMPLETED|Overall Study||2
10727806|NCT02764151|11891646|FG001|COMPLETED|Overall Study||4
10727807|NCT02764151|11891647|FG002|COMPLETED|Overall Study||3
10727808|NCT02764151|11891648|FG003|COMPLETED|Overall Study||5
10727809|NCT02764151|11891645|FG000|NOT COMPLETED|Overall Study||0
10727810|NCT02764151|11891646|FG001|NOT COMPLETED|Overall Study||0
10727811|NCT02764151|11891647|FG002|NOT COMPLETED|Overall Study||0
10727812|NCT02764151|11891648|FG003|NOT COMPLETED|Overall Study||3
10727813|NCT02764164|11891658|FG000|STARTED|Overall Study||1
10727814|NCT02764164|11891658|FG000|COMPLETED|Overall Study|Duration flexible up to 12mo, ended early (funding), 2 week time point achieved|1
10727815|NCT02764164|11891658|FG000|NOT COMPLETED|Overall Study||0
10727816|NCT02764190|11891664|FG000|STARTED|Overall Study||167
10727817|NCT02764190|11891665|FG001|STARTED|Overall Study||135
10727818|NCT02764190|11891664|FG000|1 Day Follow-up|Overall Study||161
10727819|NCT02764190|11891665|FG001|1 Day Follow-up|Overall Study||131
10727820|NCT02764190|11891664|FG000|3 Month Follow-up|Overall Study||156
10727821|NCT02764190|11891665|FG001|3 Month Follow-up|Overall Study||128
10727822|NCT02764190|11891664|FG000|6 Month Follow-up|Overall Study||155
10727823|NCT02764190|11891665|FG001|6 Month Follow-up|Overall Study||128
10727824|NCT02764190|11891664|FG000|12 Month Follow-up|Overall Study||150
10727825|NCT02764190|11891665|FG001|12 Month Follow-up|Overall Study||122
10727826|NCT02764190|11891664|FG000|COMPLETED|Overall Study||150
10727827|NCT02764190|11891665|FG001|COMPLETED|Overall Study||122
10727828|NCT02764190|11891664|FG000|NOT COMPLETED|Overall Study||17
10727829|NCT02764190|11891665|FG001|NOT COMPLETED|Overall Study||13
10727830|NCT02764229|11891671|FG000|STARTED|Overall Study||112
10727831|NCT02764229|11891671|FG000|COMPLETED|Overall Study||10
10727832|NCT02764229|11891671|FG000|NOT COMPLETED|Overall Study||102
10727833|NCT02764320|11891677|FG000|STARTED|Overall Study||361
10727834|NCT02764320|11891678|FG001|STARTED|Overall Study||359
10727835|NCT02764320|11891677|FG000|COMPLETED|Overall Study||310
10727836|NCT02764320|11891678|FG001|COMPLETED|Overall Study||310
10727837|NCT02764320|11891677|FG000|NOT COMPLETED|Overall Study||51
10727838|NCT02764320|11891678|FG001|NOT COMPLETED|Overall Study||49
10727839|NCT02764333|11891684|FG000|STARTED|Overall Study||29
10727840|NCT02764333|11891684|FG000|COMPLETED|Overall Study||28
10727841|NCT02764333|11891684|FG000|NOT COMPLETED|Overall Study||1
10727842|NCT02764385|11891690|FG000|STARTED|Overall Study||9145
10727843|NCT02764385|11891691|FG001|STARTED|Overall Study||6641
10727844|NCT02764385|11891690|FG000|COMPLETED|Overall Study||9145
10727845|NCT02764385|11891691|FG001|COMPLETED|Overall Study||6641
10727846|NCT02764385|11891690|FG000|NOT COMPLETED|Overall Study||0
10727847|NCT02764385|11891691|FG001|NOT COMPLETED|Overall Study||0
10727848|NCT02764697|11891697|FG000|STARTED|Overall Study||5
10727849|NCT02764697|11891697|FG000|COMPLETED|Overall Study||2
10727850|NCT02764697|11891697|FG000|NOT COMPLETED|Overall Study||3
10727854|NCT02764775|11891705|FG000|STARTED|Overall Study|All 14 participants were assigned to the Headpod utilization group.|14
10727855|NCT02764775|11891705|FG000|COMPLETED|Overall Study||8
10727856|NCT02764775|11891705|FG000|NOT COMPLETED|Overall Study||6
10727857|NCT02764970|11891711|FG000|STARTED|Overall Study||65
10727858|NCT02764970|11891712|FG001|STARTED|Overall Study||47
10727859|NCT02764970|11891711|FG000|COMPLETED|Overall Study||65
10727860|NCT02764970|11891712|FG001|COMPLETED|Overall Study||47
10727861|NCT02764970|11891711|FG000|NOT COMPLETED|Overall Study||0
10727862|NCT02764970|11891712|FG001|NOT COMPLETED|Overall Study||0
10727863|NCT02765035|11891720|FG000|STARTED|First Intervention (90 Days)||5
10727864|NCT02765035|11891721|FG001|STARTED|First Intervention (90 Days)||8
10727865|NCT02765035|11891720|FG000|COMPLETED|First Intervention (90 Days)||4
10727866|NCT02765035|11891721|FG001|COMPLETED|First Intervention (90 Days)||7
10727867|NCT02765035|11891720|FG000|NOT COMPLETED|First Intervention (90 Days)||1
10727868|NCT02765035|11891721|FG001|NOT COMPLETED|First Intervention (90 Days)||1
10727869|NCT02765035|11891720|FG000|STARTED|Second Intervention (30 Days)||4
10727870|NCT02765035|11891721|FG001|STARTED|Second Intervention (30 Days)||7
10727871|NCT02765035|11891720|FG000|COMPLETED|Second Intervention (30 Days)||2
10727872|NCT02765035|11891721|FG001|COMPLETED|Second Intervention (30 Days)||5
10727873|NCT02765035|11891720|FG000|NOT COMPLETED|Second Intervention (30 Days)||2
10727874|NCT02765035|11891721|FG001|NOT COMPLETED|Second Intervention (30 Days)||2
10727875|NCT02765100|11891730|FG000|STARTED|Overall Study||9
10727876|NCT02765100|11891731|FG001|STARTED|Overall Study||12
10727877|NCT02765100|11891730|FG000|COMPLETED|Overall Study||8
10727878|NCT02765100|11891731|FG001|COMPLETED|Overall Study||10
10727879|NCT02765100|11891730|FG000|NOT COMPLETED|Overall Study||1
10727880|NCT02765100|11891731|FG001|NOT COMPLETED|Overall Study||2
10727881|NCT02765165|11891744|FG000|STARTED|Treatment Period||3
10727882|NCT02765165|11891745|FG001|STARTED|Treatment Period||4
10727883|NCT02765165|11891746|FG002|STARTED|Treatment Period||3
10727884|NCT02765165|11891747|FG003|STARTED|Treatment Period||3
10727885|NCT02765165|11891748|FG004|STARTED|Treatment Period||6
10727886|NCT02765165|11891749|FG005|STARTED|Treatment Period||3
10727887|NCT02765165|11891750|FG006|STARTED|Treatment Period||4
10727888|NCT02765165|11891744|FG000|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
10727889|NCT02765165|11891745|FG001|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
10727890|NCT02765165|11891746|FG002|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
10727891|NCT02765165|11891747|FG003|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
10727892|NCT02765165|11891748|FG004|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
10727893|NCT02765165|11891749|FG005|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
10727894|NCT02765165|11891750|FG006|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
10727895|NCT02765165|11891744|FG000|NOT COMPLETED|Treatment Period||3
10727896|NCT02765165|11891745|FG001|NOT COMPLETED|Treatment Period||4
10727897|NCT02765165|11891746|FG002|NOT COMPLETED|Treatment Period||3
10727898|NCT02765165|11891747|FG003|NOT COMPLETED|Treatment Period||3
10727899|NCT02765165|11891748|FG004|NOT COMPLETED|Treatment Period||6
10727900|NCT02765165|11891749|FG005|NOT COMPLETED|Treatment Period||3
10727901|NCT02765165|11891750|FG006|NOT COMPLETED|Treatment Period||4
10727902|NCT02765165|11891744|FG000|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|1
10727903|NCT02765165|11891745|FG001|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|3
10727904|NCT02765165|11891746|FG002|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|3
10727905|NCT02765165|11891747|FG003|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|3
10727906|NCT02765165|11891748|FG004|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|3
10727907|NCT02765165|11891749|FG005|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|3
10727908|NCT02765165|11891750|FG006|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|1
10727909|NCT02765165|11891744|FG000|COMPLETED|Post-treatment Follow-up|Open-ended follow-up|0
10727910|NCT02765165|11891745|FG001|COMPLETED|Post-treatment Follow-up||0
10727911|NCT02765165|11891746|FG002|COMPLETED|Post-treatment Follow-up||0
10727912|NCT02765165|11891747|FG003|COMPLETED|Post-treatment Follow-up||0
10727913|NCT02765165|11891748|FG004|COMPLETED|Post-treatment Follow-up|Open-ended follow-up|0
10727914|NCT02765165|11891749|FG005|COMPLETED|Post-treatment Follow-up||0
10727915|NCT02765165|11891750|FG006|COMPLETED|Post-treatment Follow-up||0
10727916|NCT02765165|11891744|FG000|NOT COMPLETED|Post-treatment Follow-up||1
10727917|NCT02765165|11891745|FG001|NOT COMPLETED|Post-treatment Follow-up||3
10727918|NCT02765165|11891746|FG002|NOT COMPLETED|Post-treatment Follow-up||3
10727919|NCT02765165|11891747|FG003|NOT COMPLETED|Post-treatment Follow-up||3
10727920|NCT02765165|11891748|FG004|NOT COMPLETED|Post-treatment Follow-up||3
10727921|NCT02765165|11891749|FG005|NOT COMPLETED|Post-treatment Follow-up||3
10727922|NCT02765165|11891750|FG006|NOT COMPLETED|Post-treatment Follow-up||1
10727923|NCT02765256|11891772|FG000|STARTED|Overall Study||4
10727924|NCT02765256|11891773|FG001|STARTED|Overall Study||4
10727925|NCT02765256|11891772|FG000|COMPLETED|Overall Study||4
10727926|NCT02765256|11891773|FG001|COMPLETED|Overall Study||4
10727927|NCT02765256|11891772|FG000|NOT COMPLETED|Overall Study||0
10727928|NCT02765256|11891773|FG001|NOT COMPLETED|Overall Study||0
10727929|NCT02765269|11891781|FG000|STARTED|Overall Study||25
10727930|NCT02765269|11891782|FG001|STARTED|Overall Study||21
10727931|NCT02765269|11891781|FG000|COMPLETED|Overall Study||25
10727932|NCT02765269|11891782|FG001|COMPLETED|Overall Study||21
10727933|NCT02765269|11891781|FG000|NOT COMPLETED|Overall Study||0
10727934|NCT02765269|11891782|FG001|NOT COMPLETED|Overall Study||0
10727935|NCT02765490|11891790|FG000|STARTED|Overall Study||183
10727936|NCT02765490|11891791|FG001|STARTED|Overall Study||182
10727937|NCT02765490|11891790|FG000|COMPLETED|Overall Study||182
10727938|NCT02765490|11891791|FG001|COMPLETED|Overall Study||179
10727939|NCT02765490|11891790|FG000|NOT COMPLETED|Overall Study||1
10727940|NCT02765490|11891791|FG001|NOT COMPLETED|Overall Study||3
10727941|NCT02766023|11891799|FG000|STARTED|Overall Study||152
10727942|NCT02766023|11891800|FG001|STARTED|Overall Study||76
10727943|NCT02766023|11891799|FG000|COMPLETED|Overall Study||122
10727944|NCT02766023|11891800|FG001|COMPLETED|Overall Study||59
10727945|NCT02766023|11891799|FG000|NOT COMPLETED|Overall Study||30
10727946|NCT02766023|11891800|FG001|NOT COMPLETED|Overall Study||17
10727947|NCT02766088|11891806|FG000|STARTED|Overall Study||850
10727948|NCT02766088|11891806|FG000|COMPLETED|Overall Study||344
10727949|NCT02766088|11891806|FG000|NOT COMPLETED|Overall Study||506
10727950|NCT02766244|11891810|FG000|STARTED|Overall Study||3
10727951|NCT02766244|11891810|FG000|COMPLETED|Overall Study||3
10727952|NCT02766244|11891810|FG000|NOT COMPLETED|Overall Study||0
10727953|NCT02766283|11891819|FG000|STARTED|Overall Study||843
10727954|NCT02766283|11891819|FG000|COMPLETED|Overall Study||816
10727955|NCT02766283|11891819|FG000|NOT COMPLETED|Overall Study||27
10727956|NCT02766374|11891829|FG000|STARTED|Overall Study||35
10727957|NCT02766374|11891830|FG001|STARTED|Overall Study||33
10727958|NCT02766374|11891829|FG000|COMPLETED|Overall Study||25
10727959|NCT02766374|11891830|FG001|COMPLETED|Overall Study||30
10727960|NCT02766374|11891829|FG000|NOT COMPLETED|Overall Study||10
10727961|NCT02766374|11891830|FG001|NOT COMPLETED|Overall Study||3
10727962|NCT02766400|11891838|FG000|STARTED|Overall Study||21
10727963|NCT02766400|11891839|FG001|STARTED|Overall Study||22
10727964|NCT02766400|11891838|FG000|COMPLETED|Overall Study||19
10727965|NCT02766400|11891839|FG001|COMPLETED|Overall Study||20
10727966|NCT02766400|11891838|FG000|NOT COMPLETED|Overall Study||2
10727967|NCT02766400|11891839|FG001|NOT COMPLETED|Overall Study||2
10727968|NCT02766517|11891848|FG000|STARTED|Overall Study||19
10727969|NCT02766517|11891849|FG001|STARTED|Overall Study||9
10727970|NCT02766517|11891850|FG002|STARTED|Overall Study||9
10727971|NCT02766517|11891848|FG000|COMPLETED|Overall Study||19
10727972|NCT02766517|11891849|FG001|COMPLETED|Overall Study||9
10727973|NCT02766517|11891850|FG002|COMPLETED|Overall Study||9
10727974|NCT02766517|11891848|FG000|NOT COMPLETED|Overall Study||0
10727975|NCT02766517|11891849|FG001|NOT COMPLETED|Overall Study||0
10727976|NCT02766517|11891850|FG002|NOT COMPLETED|Overall Study||0
10727977|NCT02766608|11891863|FG000|STARTED|Overall Study||655
10727978|NCT02766608|11891864|FG001|STARTED|Overall Study||637
10727979|NCT02766608|11891865|FG002|STARTED|Overall Study||644
10727980|NCT02766608|11891866|FG003|STARTED|Overall Study||206
10727981|NCT02766608|11891867|FG004|STARTED|Overall Study||219
10727982|NCT02766608|11891863|FG000|COMPLETED|Overall Study||576
10727983|NCT02766608|11891864|FG001|COMPLETED|Overall Study||567
10727984|NCT02766608|11891865|FG002|COMPLETED|Overall Study||554
10727985|NCT02766608|11891866|FG003|COMPLETED|Overall Study||169
10727986|NCT02766608|11891867|FG004|COMPLETED|Overall Study||190
10727987|NCT02766608|11891863|FG000|NOT COMPLETED|Overall Study||79
10727988|NCT02766608|11891864|FG001|NOT COMPLETED|Overall Study||70
10727989|NCT02766608|11891865|FG002|NOT COMPLETED|Overall Study||90
10727990|NCT02766608|11891866|FG003|NOT COMPLETED|Overall Study||37
10727991|NCT02766608|11891867|FG004|NOT COMPLETED|Overall Study||29
10727992|NCT02766673|11891882|FG000|STARTED|Overall Study||4
10727993|NCT02766673|11891883|FG001|STARTED|Overall Study||4
10727994|NCT02766673|11891884|FG002|STARTED|Overall Study||4
10727995|NCT02766673|11891885|FG003|STARTED|Overall Study||4
10727996|NCT02766673|11891886|FG004|STARTED|Overall Study||4
10727997|NCT02766673|11891887|FG005|STARTED|Overall Study||4
10727998|NCT02766673|11891882|FG000|COMPLETED|Overall Study||3
10727999|NCT02766673|11891883|FG001|COMPLETED|Overall Study||4
10728000|NCT02766673|11891884|FG002|COMPLETED|Overall Study||4
10728001|NCT02766673|11891885|FG003|COMPLETED|Overall Study||4
10728002|NCT02766673|11891886|FG004|COMPLETED|Overall Study||4
10728003|NCT02766673|11891887|FG005|COMPLETED|Overall Study||3
10728004|NCT02766673|11891882|FG000|NOT COMPLETED|Overall Study||1
10728005|NCT02766673|11891883|FG001|NOT COMPLETED|Overall Study||0
10728006|NCT02766673|11891884|FG002|NOT COMPLETED|Overall Study||0
10728007|NCT02766673|11891885|FG003|NOT COMPLETED|Overall Study||0
10728008|NCT02766673|11891886|FG004|NOT COMPLETED|Overall Study||0
10728009|NCT02766673|11891887|FG005|NOT COMPLETED|Overall Study||1
10728010|NCT02766777|11891895|FG000|STARTED|Overall Study||87
10728011|NCT02766777|11891895|FG000|Treated (Safety [SAF] Population)|Overall Study||87
10728012|NCT02766777|11891895|FG000|COMPLETED|Overall Study||53
10728013|NCT02766777|11891895|FG000|NOT COMPLETED|Overall Study||34
10728014|NCT02766907|11891901|FG000|STARTED|Overall Study||10
10728015|NCT02766907|11891902|FG001|STARTED|Overall Study||10
10728016|NCT02766907|11891901|FG000|COMPLETED|Overall Study||9
10728017|NCT02766907|11891902|FG001|COMPLETED|Overall Study||9
10728018|NCT02766907|11891901|FG000|NOT COMPLETED|Overall Study||1
10728019|NCT02766907|11891902|FG001|NOT COMPLETED|Overall Study||1
10728020|NCT02767011|11891910|FG000|STARTED|Overall Study||16
10728021|NCT02767011|11891911|FG001|STARTED|Overall Study||14
10728022|NCT02767011|11891910|FG000|COMPLETED|Overall Study||16
10728023|NCT02767011|11891911|FG001|COMPLETED|Overall Study||14
10728024|NCT02767011|11891910|FG000|NOT COMPLETED|Overall Study||0
10728025|NCT02767011|11891911|FG001|NOT COMPLETED|Overall Study||0
10728026|NCT02767128|11891917|FG000|STARTED|Overall Study||14
10728027|NCT02767128|11891917|FG000|Baseline|Overall Study||14
10728028|NCT02767128|11891917|FG000|Fer-In-Sol|Overall Study||14
10728029|NCT02767128|11891917|FG000|Shohl's + Fer-In-Sol|Overall Study||14
10728030|NCT02767128|11891917|FG000|Triferic|Overall Study||14
10728031|NCT02767128|11891917|FG000|Shohl's + Triferic After 10 Min|Overall Study||14
10728032|NCT02767128|11891917|FG000|Shohl's + Triferic Immediately|Overall Study||14
10728033|NCT02767128|11891917|FG000|COMPLETED|Overall Study||14
10728034|NCT02767128|11891917|FG000|NOT COMPLETED|Overall Study||0
10728035|NCT02767271|11891933|FG000|STARTED|Overall Study||15
10728036|NCT02767271|11891934|FG001|STARTED|Overall Study||15
10728037|NCT02767271|11891933|FG000|Safety Population|Overall Study||15
10728038|NCT02767271|11891934|FG001|Safety Population|Overall Study||15
10728039|NCT02767271|11891933|FG000|Pharmacokinetic Pedis (PKP) Population|Overall Study||15
10728040|NCT02767271|11891934|FG001|Pharmacokinetic Pedis (PKP) Population|Overall Study||0
10728041|NCT02767271|11891933|FG000|Pharmacokinetic Cruris (PKC) Population|Overall Study||0
10728042|NCT02767271|11891934|FG001|Pharmacokinetic Cruris (PKC) Population|Overall Study||15
10728043|NCT02767271|11891933|FG000|COMPLETED|Overall Study||15
10728044|NCT02767271|11891934|FG001|COMPLETED|Overall Study||15
10728045|NCT02767271|11891933|FG000|NOT COMPLETED|Overall Study||0
10728046|NCT02767271|11891934|FG001|NOT COMPLETED|Overall Study||0
10728047|NCT02767323|11891944|FG000|STARTED|Overall Study||83
10728048|NCT02767323|11891945|FG001|STARTED|Overall Study||42
10728049|NCT02767323|11891946|FG002|STARTED|Overall Study||58
10728050|NCT02767323|11891947|FG003|STARTED|Overall Study||1
10728051|NCT02767323|11891944|FG000|COMPLETED|Overall Study||49
10728052|NCT02767323|11891945|FG001|COMPLETED|Overall Study||17
10728053|NCT02767323|11891946|FG002|COMPLETED|Overall Study||28
10728054|NCT02767323|11891947|FG003|COMPLETED|Overall Study||1
10728055|NCT02767323|11891944|FG000|NOT COMPLETED|Overall Study||34
10728056|NCT02767323|11891945|FG001|NOT COMPLETED|Overall Study||25
10728057|NCT02767323|11891946|FG002|NOT COMPLETED|Overall Study||30
10728058|NCT02767323|11891947|FG003|NOT COMPLETED|Overall Study||0
10728059|NCT02767388|11891963|FG000|STARTED|Overall Study||15
10728060|NCT02767388|11891964|FG001|STARTED|Overall Study||15
10728061|NCT02767388|11891965|FG002|STARTED|Overall Study||15
10728062|NCT02767388|11891963|FG000|COMPLETED|Overall Study||8
10728063|NCT02767388|11891964|FG001|COMPLETED|Overall Study||10
10728064|NCT02767388|11891965|FG002|COMPLETED|Overall Study||12
10728065|NCT02767388|11891963|FG000|NOT COMPLETED|Overall Study||7
10728066|NCT02767388|11891964|FG001|NOT COMPLETED|Overall Study||5
10728067|NCT02767388|11891965|FG002|NOT COMPLETED|Overall Study||3
10728068|NCT02767427|11891975|FG000|STARTED|Overall Study||21
10728069|NCT02767427|11891976|FG001|STARTED|Overall Study||19
10728070|NCT02767427|11891975|FG000|COMPLETED|Overall Study||21
10728071|NCT02767427|11891976|FG001|COMPLETED|Overall Study||19
10728072|NCT02767427|11891975|FG000|NOT COMPLETED|Overall Study||0
10728073|NCT02767427|11891976|FG001|NOT COMPLETED|Overall Study||0
10728074|NCT02767492|11891984|FG000|STARTED|Overall Study||45
10728075|NCT02767492|11891985|FG001|STARTED|Overall Study||45
10728076|NCT02767492|11891984|FG000|COMPLETED|Overall Study||35
10728077|NCT02767492|11891985|FG001|COMPLETED|Overall Study||35
10728078|NCT02767492|11891984|FG000|NOT COMPLETED|Overall Study||10
10728079|NCT02767492|11891985|FG001|NOT COMPLETED|Overall Study||10
10728080|NCT02767609|11891991|FG000|STARTED|Overall Study||1
10728081|NCT02767609|11891991|FG000|COMPLETED|Overall Study||1
10728082|NCT02767609|11891991|FG000|NOT COMPLETED|Overall Study||0
10728083|NCT02767765|11891995|FG000|STARTED|Overall Study||61
10728084|NCT02767765|11891995|FG000|COMPLETED|Overall Study||50
10728085|NCT02767765|11891995|FG000|NOT COMPLETED|Overall Study||11
10728086|NCT02767843|11891999|FG000|STARTED|Overall Study||4
10408415|NCT00754494|11552479|FG001|NOT COMPLETED|Overall Study||0
10408416|NCT00754494|11552480|FG002|NOT COMPLETED|Overall Study||1
10408417|NCT00754546|11552488|FG000|STARTED|Overall Study||20
10408418|NCT00754546|11552488|FG000|COMPLETED|Overall Study||20
10408419|NCT00754546|11552488|FG000|NOT COMPLETED|Overall Study||0
10408420|NCT00754559|11552498|FG000|STARTED|Overall Study||286
10728087|NCT02767843|11891999|FG000|COMPLETED|Overall Study||4
10728088|NCT02767843|11891999|FG000|NOT COMPLETED|Overall Study||0
10728089|NCT02767869|11892007|FG000|STARTED|Overall Study||12
10728090|NCT02767869|11892008|FG001|STARTED|Overall Study||12
10728091|NCT02767869|11892007|FG000|COMPLETED|Overall Study||12
10728092|NCT02767869|11892008|FG001|COMPLETED|Overall Study||12
10728093|NCT02767869|11892007|FG000|NOT COMPLETED|Overall Study||0
10728094|NCT02767869|11892008|FG001|NOT COMPLETED|Overall Study||0
10728095|NCT02767934|11892014|FG000|STARTED|Overall Study||12
10728096|NCT02767934|11892014|FG000|COMPLETED|Overall Study||12
10728097|NCT02767934|11892014|FG000|NOT COMPLETED|Overall Study||0
10728098|NCT02767947|11892021|FG000|STARTED|Overall Study||60
10728099|NCT02767947|11892022|FG001|STARTED|Overall Study||15
10728100|NCT02767947|11892021|FG000|Safety Population|Overall Study||60
10728101|NCT02767947|11892022|FG001|Safety Population|Overall Study||15
10728102|NCT02767947|11892021|FG000|Pharmacokinetic (PK) Population|Overall Study||12
10728103|NCT02767947|11892022|FG001|Pharmacokinetic (PK) Population|Overall Study||3
10728104|NCT02767947|11892021|FG000|COMPLETED|Overall Study||60
10728105|NCT02767947|11892022|FG001|COMPLETED|Overall Study||15
10728106|NCT02767947|11892021|FG000|NOT COMPLETED|Overall Study||0
10728107|NCT02767947|11892022|FG001|NOT COMPLETED|Overall Study||0
10777553|NCT03341299|11939498|FG000|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
10777554|NCT03341299|11939499|FG001|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
10777555|NCT03341299|11939500|FG002|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
10777556|NCT03341299|11939501|FG003|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
10777557|NCT03341299|11939498|FG000|STARTED|Period 4||9
10777558|NCT03341299|11939499|FG001|STARTED|Period 4||9
10777559|NCT03341299|11939500|FG002|STARTED|Period 4||8
10777560|NCT03341299|11939501|FG003|STARTED|Period 4||9
10777561|NCT03341299|11939498|FG000|COMPLETED|Period 4||9
10777562|NCT03341299|11939499|FG001|COMPLETED|Period 4||9
10777563|NCT03341299|11939500|FG002|COMPLETED|Period 4||8
10777564|NCT03341299|11939501|FG003|COMPLETED|Period 4||9
10777565|NCT03341299|11939498|FG000|NOT COMPLETED|Period 4||0
10777566|NCT03341299|11939499|FG001|NOT COMPLETED|Period 4||0
10777567|NCT03341299|11939500|FG002|NOT COMPLETED|Period 4||0
10777568|NCT03341299|11939501|FG003|NOT COMPLETED|Period 4||0
10777569|NCT03341312|11939513|FG000|STARTED|Period 1||9
10777570|NCT03341312|11939514|FG001|STARTED|Period 1||10
10777571|NCT03341312|11939515|FG002|STARTED|Period 1||9
10777572|NCT03341312|11939516|FG003|STARTED|Period 1||8
10777573|NCT03341312|11939513|FG000|Received at Least One Dose of Study Drug|Period 1||9
10777574|NCT03341312|11939514|FG001|Received at Least One Dose of Study Drug|Period 1||10
10777575|NCT03341312|11939515|FG002|Received at Least One Dose of Study Drug|Period 1||9
10777576|NCT03341312|11939516|FG003|Received at Least One Dose of Study Drug|Period 1||8
10777577|NCT03341312|11939513|FG000|COMPLETED|Period 1||9
10777578|NCT03341312|11939514|FG001|COMPLETED|Period 1||9
10777579|NCT03341312|11939515|FG002|COMPLETED|Period 1||9
10777580|NCT03341312|11939516|FG003|COMPLETED|Period 1||8
10777581|NCT03341312|11939513|FG000|NOT COMPLETED|Period 1||0
10777582|NCT03341312|11939514|FG001|NOT COMPLETED|Period 1||1
10777583|NCT03341312|11939515|FG002|NOT COMPLETED|Period 1||0
10777584|NCT03341312|11939516|FG003|NOT COMPLETED|Period 1||0
10777585|NCT03341312|11939513|FG000|STARTED|Period 2||9
10777586|NCT03341312|11939514|FG001|STARTED|Period 2||9
10777587|NCT03341312|11939515|FG002|STARTED|Period 2||9
10777588|NCT03341312|11939516|FG003|STARTED|Period 2||8
10777589|NCT03341312|11939513|FG000|COMPLETED|Period 2||9
10777590|NCT03341312|11939514|FG001|COMPLETED|Period 2||9
10408421|NCT00754559|11552498|FG000|COMPLETED|Overall Study||239
10408422|NCT00754559|11552498|FG000|NOT COMPLETED|Overall Study||47
10408423|NCT00754572|11552505|FG000|STARTED|Overall Study||418
10408424|NCT00754572|11552505|FG000|COMPLETED|Overall Study||347
10544547|NCT01490632|11697643|FG006|COMPLETED|Part C: Washout or Step-Down Period||0
10544548|NCT01490632|11697644|FG007|COMPLETED|Part C: Washout or Step-Down Period||0
10544549|NCT01490632|11697645|FG008|COMPLETED|Part C: Washout or Step-Down Period||0
10777591|NCT03341312|11939515|FG002|COMPLETED|Period 2||9
10777592|NCT03341312|11939516|FG003|COMPLETED|Period 2||8
10777593|NCT03341312|11939513|FG000|NOT COMPLETED|Period 2||0
10777594|NCT03341312|11939514|FG001|NOT COMPLETED|Period 2||0
10777595|NCT03341312|11939515|FG002|NOT COMPLETED|Period 2||0
10777596|NCT03341312|11939516|FG003|NOT COMPLETED|Period 2||0
10777597|NCT03341312|11939513|FG000|STARTED|Period 3||9
10777598|NCT03341312|11939514|FG001|STARTED|Period 3||9
10777599|NCT03341312|11939515|FG002|STARTED|Period 3||9
10777600|NCT03341312|11939516|FG003|STARTED|Period 3||8
10777601|NCT03341312|11939513|FG000|COMPLETED|Period 3||9
10777602|NCT03341312|11939514|FG001|COMPLETED|Period 3||9
10777603|NCT03341312|11939515|FG002|COMPLETED|Period 3||9
10777604|NCT03341312|11939516|FG003|COMPLETED|Period 3||8
10777605|NCT03341312|11939513|FG000|NOT COMPLETED|Period 3||0
10777606|NCT03341312|11939514|FG001|NOT COMPLETED|Period 3||0
10777607|NCT03341312|11939515|FG002|NOT COMPLETED|Period 3||0
10777608|NCT03341312|11939516|FG003|NOT COMPLETED|Period 3||0
10777609|NCT03341312|11939513|FG000|STARTED|Period 4||9
10408425|NCT00754572|11552505|FG000|NOT COMPLETED|Overall Study||71
10429136|NCT00862849|11575286|FG000|NOT COMPLETED|Intervention 2||0
10429137|NCT00862849|11575287|FG001|NOT COMPLETED|Intervention 2||0
10429138|NCT00862849|11575288|FG002|NOT COMPLETED|Intervention 2||0
10429139|NCT00862849|11575289|FG003|NOT COMPLETED|Intervention 2||0
10429140|NCT00862849|11575290|FG004|NOT COMPLETED|Intervention 2||0
10429141|NCT00862849|11575291|FG005|NOT COMPLETED|Intervention 2||0
10429142|NCT00862849|11575286|FG000|STARTED|Washout 2 (3 to 14 Days)||3
10429143|NCT00862849|11575287|FG001|STARTED|Washout 2 (3 to 14 Days)||4
10777610|NCT03341312|11939514|FG001|STARTED|Period 4||9
10777611|NCT03341312|11939515|FG002|STARTED|Period 4||9
10777612|NCT03341312|11939516|FG003|STARTED|Period 4||8
10777613|NCT03341312|11939513|FG000|COMPLETED|Period 4||9
10777614|NCT03341312|11939514|FG001|COMPLETED|Period 4||9
10777615|NCT03341312|11939515|FG002|COMPLETED|Period 4||9
10777616|NCT03341312|11939516|FG003|COMPLETED|Period 4||8
10777617|NCT03341312|11939513|FG000|NOT COMPLETED|Period 4||0
10777618|NCT03341312|11939514|FG001|NOT COMPLETED|Period 4||0
10777619|NCT03341312|11939515|FG002|NOT COMPLETED|Period 4||0
10777620|NCT03341312|11939516|FG003|NOT COMPLETED|Period 4||0
10777621|NCT03341507|11939528|FG000|STARTED|Overall Study||64
10777622|NCT03341507|11939528|FG000|COMPLETED|Overall Study||30
10777623|NCT03341507|11939528|FG000|NOT COMPLETED|Overall Study||34
10728108|NCT02768103|11892028|FG000|STARTED|Overall Study||5
10728109|NCT02768103|11892028|FG000|COMPLETED|Overall Study||4
10728110|NCT02768103|11892028|FG000|NOT COMPLETED|Overall Study||1
10728111|NCT02768129|11892034|FG000|STARTED|Overall Study||11
10728112|NCT02768129|11892035|FG001|STARTED|Overall Study||10
10728113|NCT02768129|11892034|FG000|COMPLETED|Overall Study||11
10728114|NCT02768129|11892035|FG001|COMPLETED|Overall Study||10
10728115|NCT02768129|11892034|FG000|NOT COMPLETED|Overall Study||0
10728116|NCT02768129|11892035|FG001|NOT COMPLETED|Overall Study||0
10728117|NCT02768194|11892041|FG000|STARTED|Period 1||4
10728118|NCT02768194|11892042|FG001|STARTED|Period 1||4
10728119|NCT02768194|11892043|FG002|STARTED|Period 1||4
10728120|NCT02768194|11892044|FG003|STARTED|Period 1||4
10728121|NCT02768194|11892045|FG004|STARTED|Period 1||4
10728122|NCT02768194|11892046|FG005|STARTED|Period 1||4
10728123|NCT02768194|11892041|FG000|COMPLETED|Period 1||4
10728124|NCT02768194|11892042|FG001|COMPLETED|Period 1||4
10728125|NCT02768194|11892043|FG002|COMPLETED|Period 1||4
10728126|NCT02768194|11892044|FG003|COMPLETED|Period 1||3
10728127|NCT02768194|11892045|FG004|COMPLETED|Period 1||4
10728128|NCT02768194|11892046|FG005|COMPLETED|Period 1||4
10728129|NCT02768194|11892041|FG000|NOT COMPLETED|Period 1||0
10728130|NCT02768194|11892042|FG001|NOT COMPLETED|Period 1||0
10728131|NCT02768194|11892043|FG002|NOT COMPLETED|Period 1||0
10728132|NCT02768194|11892044|FG003|NOT COMPLETED|Period 1||1
10728133|NCT02768194|11892045|FG004|NOT COMPLETED|Period 1||0
10728134|NCT02768194|11892046|FG005|NOT COMPLETED|Period 1||0
10728135|NCT02768194|11892041|FG000|STARTED|Period 2||4
10728136|NCT02768194|11892042|FG001|STARTED|Period 2||4
10728137|NCT02768194|11892043|FG002|STARTED|Period 2||4
10728138|NCT02768194|11892044|FG003|STARTED|Period 2||3
10728139|NCT02768194|11892045|FG004|STARTED|Period 2||4
10728140|NCT02768194|11892046|FG005|STARTED|Period 2||4
10728141|NCT02768194|11892041|FG000|COMPLETED|Period 2||3
10728142|NCT02768194|11892042|FG001|COMPLETED|Period 2||4
10728143|NCT02768194|11892043|FG002|COMPLETED|Period 2||4
10728144|NCT02768194|11892044|FG003|COMPLETED|Period 2||3
10728145|NCT02768194|11892045|FG004|COMPLETED|Period 2||4
10728146|NCT02768194|11892046|FG005|COMPLETED|Period 2||4
10728147|NCT02768194|11892041|FG000|NOT COMPLETED|Period 2||1
10728148|NCT02768194|11892042|FG001|NOT COMPLETED|Period 2||0
10728149|NCT02768194|11892043|FG002|NOT COMPLETED|Period 2||0
10728150|NCT02768194|11892044|FG003|NOT COMPLETED|Period 2||0
10728151|NCT02768194|11892045|FG004|NOT COMPLETED|Period 2||0
10728152|NCT02768194|11892046|FG005|NOT COMPLETED|Period 2||0
10728153|NCT02768194|11892041|FG000|STARTED|Period 3||3
10728154|NCT02768194|11892042|FG001|STARTED|Period 3||4
10728155|NCT02768194|11892043|FG002|STARTED|Period 3||4
10728156|NCT02768194|11892044|FG003|STARTED|Period 3||3
10728157|NCT02768194|11892045|FG004|STARTED|Period 3||4
10728158|NCT02768194|11892046|FG005|STARTED|Period 3||4
10728159|NCT02768194|11892041|FG000|COMPLETED|Period 3||3
10728160|NCT02768194|11892042|FG001|COMPLETED|Period 3||3
10728161|NCT02768194|11892043|FG002|COMPLETED|Period 3||4
10728162|NCT02768194|11892044|FG003|COMPLETED|Period 3||3
10728163|NCT02768194|11892045|FG004|COMPLETED|Period 3||4
10728164|NCT02768194|11892046|FG005|COMPLETED|Period 3||4
10728165|NCT02768194|11892041|FG000|NOT COMPLETED|Period 3||0
10728166|NCT02768194|11892042|FG001|NOT COMPLETED|Period 3||1
10728167|NCT02768194|11892043|FG002|NOT COMPLETED|Period 3||0
10728168|NCT02768194|11892044|FG003|NOT COMPLETED|Period 3||0
10728169|NCT02768194|11892045|FG004|NOT COMPLETED|Period 3||0
10728170|NCT02768194|11892046|FG005|NOT COMPLETED|Period 3||0
10728171|NCT02768298|11892056|FG000|STARTED|Overall Study||103
10728172|NCT02768298|11892057|FG001|STARTED|Overall Study||98
10728173|NCT02768298|11892056|FG000|COMPLETED|Overall Study||99
10728174|NCT02768298|11892057|FG001|COMPLETED|Overall Study||91
10728175|NCT02768298|11892056|FG000|NOT COMPLETED|Overall Study||4
10728176|NCT02768298|11892057|FG001|NOT COMPLETED|Overall Study||7
10728177|NCT02768558|11892065|FG000|STARTED|Overall Study||3
10728178|NCT02768558|11892066|FG001|STARTED|Overall Study||5
10728179|NCT02768558|11892065|FG000|Eligible|Overall Study||3
10728180|NCT02768558|11892066|FG001|Eligible|Overall Study||5
10728181|NCT02768558|11892065|FG000|COMPLETED|Overall Study||3
10728182|NCT02768558|11892066|FG001|COMPLETED|Overall Study||5
10728183|NCT02768558|11892065|FG000|NOT COMPLETED|Overall Study||0
10728184|NCT02768558|11892066|FG001|NOT COMPLETED|Overall Study||0
10728185|NCT02768753|11892074|FG000|STARTED|Overall Study||30
10728186|NCT02768753|11892075|FG001|STARTED|Overall Study||30
10728187|NCT02768753|11892074|FG000|COMPLETED|Overall Study||30
10728188|NCT02768753|11892075|FG001|COMPLETED|Overall Study||30
10728189|NCT02768753|11892074|FG000|NOT COMPLETED|Overall Study||0
10728190|NCT02768753|11892075|FG001|NOT COMPLETED|Overall Study||0
10728194|NCT02769065|11892115|FG000|STARTED|Overall Study||17
10728195|NCT02769065|11892116|FG001|STARTED|Overall Study||6
10728196|NCT02769065|11892117|FG002|STARTED|Overall Study||6
10728197|NCT02769065|11892118|FG003|STARTED|Overall Study||6
10728198|NCT02769065|11892119|FG004|STARTED|Overall Study||6
10728199|NCT02769065|11892120|FG005|STARTED|Overall Study||6
10728200|NCT02769065|11892121|FG006|STARTED|Overall Study||7
10728201|NCT02769065|11892122|FG007|STARTED|Overall Study||6
10728202|NCT02769065|11892123|FG008|STARTED|Overall Study||6
10728203|NCT02769065|11892124|FG009|STARTED|Overall Study||6
10728204|NCT02769065|11892125|FG010|STARTED|Overall Study||6
10728205|NCT02769065|11892126|FG011|STARTED|Overall Study||6
10728206|NCT02769065|11892127|FG012|STARTED|Overall Study||6
10728207|NCT02769065|11892128|FG013|STARTED|Overall Study||6
10728208|NCT02769065|11892129|FG014|STARTED|Overall Study||6
10728209|NCT02769065|11892130|FG015|STARTED|Overall Study||3
10728210|NCT02769065|11892131|FG016|STARTED|Overall Study||5
10728211|NCT02769065|11892132|FG017|STARTED|Overall Study||5
10728212|NCT02769065|11892133|FG018|STARTED|Overall Study||5
10728213|NCT02769065|11892134|FG019|STARTED|Overall Study||0
10728214|NCT02769065|11892135|FG020|STARTED|Overall Study||4
10728215|NCT02769065|11892136|FG021|STARTED|Overall Study||4
10728216|NCT02769065|11892137|FG022|STARTED|Overall Study||4
10728217|NCT02769065|11892138|FG023|STARTED|Overall Study||6
10728218|NCT02769065|11892139|FG024|STARTED|Overall Study||6
10728219|NCT02769065|11892140|FG025|STARTED|Overall Study||9
10728220|NCT02769065|11892141|FG026|STARTED|Overall Study||9
10728221|NCT02769065|11892142|FG027|STARTED|Overall Study||5
10728222|NCT02769065|11892143|FG028|STARTED|Overall Study||6
10728223|NCT02769065|11892144|FG029|STARTED|Overall Study||6
10728224|NCT02769065|11892115|FG000|COMPLETED|Overall Study||16
10728225|NCT02769065|11892116|FG001|COMPLETED|Overall Study||6
10728226|NCT02769065|11892117|FG002|COMPLETED|Overall Study||6
10728227|NCT02769065|11892118|FG003|COMPLETED|Overall Study||6
10728228|NCT02769065|11892119|FG004|COMPLETED|Overall Study||6
10728229|NCT02769065|11892120|FG005|COMPLETED|Overall Study||6
10728230|NCT02769065|11892121|FG006|COMPLETED|Overall Study||6
10728231|NCT02769065|11892122|FG007|COMPLETED|Overall Study||6
10728232|NCT02769065|11892123|FG008|COMPLETED|Overall Study||6
10728233|NCT02769065|11892124|FG009|COMPLETED|Overall Study||6
10728234|NCT02769065|11892125|FG010|COMPLETED|Overall Study||5
10728235|NCT02769065|11892126|FG011|COMPLETED|Overall Study||6
10728236|NCT02769065|11892127|FG012|COMPLETED|Overall Study||6
10728237|NCT02769065|11892128|FG013|COMPLETED|Overall Study||6
10728238|NCT02769065|11892129|FG014|COMPLETED|Overall Study||6
10728239|NCT02769065|11892130|FG015|COMPLETED|Overall Study||3
10728240|NCT02769065|11892131|FG016|COMPLETED|Overall Study||5
10728241|NCT02769065|11892132|FG017|COMPLETED|Overall Study||5
10728242|NCT02769065|11892133|FG018|COMPLETED|Overall Study||5
10728243|NCT02769065|11892134|FG019|COMPLETED|Overall Study||0
10728244|NCT02769065|11892135|FG020|COMPLETED|Overall Study||4
10728245|NCT02769065|11892136|FG021|COMPLETED|Overall Study||4
10728246|NCT02769065|11892137|FG022|COMPLETED|Overall Study||4
10728247|NCT02769065|11892138|FG023|COMPLETED|Overall Study||6
10728248|NCT02769065|11892139|FG024|COMPLETED|Overall Study||6
10728249|NCT02769065|11892140|FG025|COMPLETED|Overall Study||9
10728250|NCT02769065|11892141|FG026|COMPLETED|Overall Study||9
10728251|NCT02769065|11892142|FG027|COMPLETED|Overall Study||5
10728252|NCT02769065|11892143|FG028|COMPLETED|Overall Study||6
10728253|NCT02769065|11892144|FG029|COMPLETED|Overall Study||6
10728254|NCT02769065|11892115|FG000|NOT COMPLETED|Overall Study||1
10728255|NCT02769065|11892116|FG001|NOT COMPLETED|Overall Study||0
10728256|NCT02769065|11892117|FG002|NOT COMPLETED|Overall Study||0
10728257|NCT02769065|11892118|FG003|NOT COMPLETED|Overall Study||0
10728258|NCT02769065|11892119|FG004|NOT COMPLETED|Overall Study||0
10728259|NCT02769065|11892120|FG005|NOT COMPLETED|Overall Study||0
10728260|NCT02769065|11892121|FG006|NOT COMPLETED|Overall Study||1
10728261|NCT02769065|11892122|FG007|NOT COMPLETED|Overall Study||0
10728262|NCT02769065|11892123|FG008|NOT COMPLETED|Overall Study||0
10728263|NCT02769065|11892124|FG009|NOT COMPLETED|Overall Study||0
10728264|NCT02769065|11892125|FG010|NOT COMPLETED|Overall Study||1
10728265|NCT02769065|11892126|FG011|NOT COMPLETED|Overall Study||0
10728266|NCT02769065|11892127|FG012|NOT COMPLETED|Overall Study||0
10728267|NCT02769065|11892128|FG013|NOT COMPLETED|Overall Study||0
10728268|NCT02769065|11892129|FG014|NOT COMPLETED|Overall Study||0
10728269|NCT02769065|11892130|FG015|NOT COMPLETED|Overall Study||0
10728270|NCT02769065|11892131|FG016|NOT COMPLETED|Overall Study||0
10728271|NCT02769065|11892132|FG017|NOT COMPLETED|Overall Study||0
10728272|NCT02769065|11892133|FG018|NOT COMPLETED|Overall Study||0
10728273|NCT02769065|11892134|FG019|NOT COMPLETED|Overall Study||0
10728274|NCT02769065|11892135|FG020|NOT COMPLETED|Overall Study||0
10728275|NCT02769065|11892136|FG021|NOT COMPLETED|Overall Study||0
10728276|NCT02769065|11892137|FG022|NOT COMPLETED|Overall Study||0
10728277|NCT02769065|11892138|FG023|NOT COMPLETED|Overall Study||0
10728278|NCT02769065|11892139|FG024|NOT COMPLETED|Overall Study||0
10728279|NCT02769065|11892140|FG025|NOT COMPLETED|Overall Study||0
10728280|NCT02769065|11892141|FG026|NOT COMPLETED|Overall Study||0
10728281|NCT02769065|11892142|FG027|NOT COMPLETED|Overall Study||0
10728282|NCT02769065|11892143|FG028|NOT COMPLETED|Overall Study||0
10728283|NCT02769065|11892144|FG029|NOT COMPLETED|Overall Study||0
10728284|NCT02769247|11892241|FG000|STARTED|Overall Study||40
10728285|NCT02769247|11892242|FG001|STARTED|Overall Study||40
10728286|NCT02769247|11892243|FG002|STARTED|Overall Study||40
10728287|NCT02769247|11892244|FG003|STARTED|Overall Study||40
10728288|NCT02769247|11892241|FG000|COMPLETED|Overall Study|unable to insert IUD in one patient; 1 pt decided against study participation after enrollment|38
10728289|NCT02769247|11892242|FG001|COMPLETED|Overall Study||40
10728290|NCT02769247|11892243|FG002|COMPLETED|Overall Study|1 took non-study med after enrollment/randomization, before IUD insertion (excluded from study)|39
10728291|NCT02769247|11892244|FG003|COMPLETED|Overall Study|1 patient decided against study participation after enrollment/randomization|39
10728292|NCT02769247|11892241|FG000|NOT COMPLETED|Overall Study||2
10728293|NCT02769247|11892242|FG001|NOT COMPLETED|Overall Study||0
10728294|NCT02769247|11892243|FG002|NOT COMPLETED|Overall Study||1
10728295|NCT02769247|11892244|FG003|NOT COMPLETED|Overall Study||1
10728296|NCT02769312|11892260|FG000|STARTED|Double-Blind (0-2 Weeks)||25
10728297|NCT02769312|11892261|FG001|STARTED|Double-Blind (0-2 Weeks)||25
10728298|NCT02769312|11892260|FG000|COMPLETED|Double-Blind (0-2 Weeks)||23
10728299|NCT02769312|11892261|FG001|COMPLETED|Double-Blind (0-2 Weeks)||24
10728300|NCT02769312|11892260|FG000|NOT COMPLETED|Double-Blind (0-2 Weeks)||2
10728301|NCT02769312|11892261|FG001|NOT COMPLETED|Double-Blind (0-2 Weeks)||1
10728302|NCT02769312|11892260|FG000|STARTED|Unblinded (Optional 2-4 Weeks)|2 participants chose not to continue with the unblinded period.|21
10728303|NCT02769312|11892261|FG001|STARTED|Unblinded (Optional 2-4 Weeks)||24
10728304|NCT02769312|11892260|FG000|COMPLETED|Unblinded (Optional 2-4 Weeks)||20
10728305|NCT02769312|11892261|FG001|COMPLETED|Unblinded (Optional 2-4 Weeks)||23
10728306|NCT02769312|11892260|FG000|NOT COMPLETED|Unblinded (Optional 2-4 Weeks)||1
10728307|NCT02769312|11892261|FG001|NOT COMPLETED|Unblinded (Optional 2-4 Weeks)||1
10728308|NCT02769312|11892260|FG000|STARTED|Follow-up||23
10728309|NCT02769312|11892261|FG001|STARTED|Follow-up||24
10728310|NCT02769312|11892260|FG000|COMPLETED|Follow-up||22
10728311|NCT02769312|11892261|FG001|COMPLETED|Follow-up||23
10728312|NCT02769312|11892260|FG000|NOT COMPLETED|Follow-up||1
10728313|NCT02769312|11892261|FG001|NOT COMPLETED|Follow-up||1
10728314|NCT02769351|11892268|FG000|STARTED|Overall Study|SP|46
10728315|NCT02769351|11892268|FG000|COMPLETED|Overall Study|SP|4
10728316|NCT02769351|11892268|FG000|NOT COMPLETED|Overall Study||42
10728317|NCT02769442|11892275|FG000|STARTED|Overall Study||309
10728318|NCT02769442|11892276|FG001|STARTED|Overall Study||291
10728319|NCT02769442|11892275|FG000|COMPLETED|Overall Study||309
10728320|NCT02769442|11892276|FG001|COMPLETED|Overall Study||291
10728321|NCT02769442|11892275|FG000|NOT COMPLETED|Overall Study||0
10728322|NCT02769442|11892276|FG001|NOT COMPLETED|Overall Study||0
10728323|NCT02769481|11892284|FG000|STARTED|Overall Study||213
10728324|NCT02769481|11892285|FG001|STARTED|Overall Study||213
10728325|NCT02769481|11892284|FG000|Study Complete at Week 60|Overall Study||193
10728326|NCT02769481|11892285|FG001|Study Complete at Week 60|Overall Study||192
10728327|NCT02769481|11892284|FG000|COMPLETED|Overall Study||180
10728328|NCT02769481|11892285|FG001|COMPLETED|Overall Study||177
10728329|NCT02769481|11892284|FG000|NOT COMPLETED|Overall Study||33
10728330|NCT02769481|11892285|FG001|NOT COMPLETED|Overall Study||36
10728331|NCT02769624|11892291|FG000|STARTED|Overall Study||7
10728332|NCT02769624|11892292|FG001|STARTED|Overall Study||8
10728333|NCT02769624|11892291|FG000|COMPLETED|Overall Study||7
10728334|NCT02769624|11892292|FG001|COMPLETED|Overall Study||7
10728335|NCT02769624|11892291|FG000|NOT COMPLETED|Overall Study||0
10728336|NCT02769624|11892292|FG001|NOT COMPLETED|Overall Study||1
10728337|NCT02769702|11892298|FG000|STARTED|Overall Study||2
10728338|NCT02769702|11892298|FG000|COMPLETED|Overall Study||2
10728339|NCT02769702|11892298|FG000|NOT COMPLETED|Overall Study||0
10728340|NCT02769858|11892302|FG000|STARTED|Overall Study||10
10728341|NCT02769858|11892302|FG000|COMPLETED|Overall Study||8
10728342|NCT02769858|11892302|FG000|NOT COMPLETED|Overall Study||2
10728343|NCT02770014|11892306|FG000|STARTED|Plasma Genotyping||43
10728344|NCT02770014|11892306|FG000|COMPLETED|Plasma Genotyping||43
10728345|NCT02770014|11892306|FG000|NOT COMPLETED|Plasma Genotyping||0
10728346|NCT02770014|11892306|FG000|STARTED|EGFR Exon 19 Pos, Treated With Erlotinib|A total of 11 participants were found to have an activating EGFR mutation (exon 19 del or L858R).|11
10728347|NCT02770014|11892306|FG000|COMPLETED|EGFR Exon 19 Pos, Treated With Erlotinib|Of the 11 participants that had an activating EGFR mutation, 6 started erlotinib treatment.|6
10728348|NCT02770014|11892306|FG000|NOT COMPLETED|EGFR Exon 19 Pos, Treated With Erlotinib||5
10728349|NCT02770170|11892315|FG000|STARTED|Overall Study||21
10728350|NCT02770170|11892316|FG001|STARTED|Overall Study||20
10728351|NCT02770170|11892317|FG002|STARTED|Overall Study||40
10728352|NCT02770170|11892318|FG003|STARTED|Overall Study||40
10728353|NCT02770170|11892315|FG000|COMPLETED|Overall Study||14
10728354|NCT02770170|11892316|FG001|COMPLETED|Overall Study||17
10728355|NCT02770170|11892317|FG002|COMPLETED|Overall Study||35
10728356|NCT02770170|11892318|FG003|COMPLETED|Overall Study||33
10728357|NCT02770170|11892315|FG000|NOT COMPLETED|Overall Study||7
10728358|NCT02770170|11892316|FG001|NOT COMPLETED|Overall Study||3
10728359|NCT02770170|11892317|FG002|NOT COMPLETED|Overall Study||5
10728360|NCT02770170|11892318|FG003|NOT COMPLETED|Overall Study||7
10728361|NCT02770248|11892330|FG000|STARTED|Overall Study||62
10728362|NCT02770248|11892331|FG001|STARTED|Overall Study||63
10728363|NCT02770248|11892330|FG000|COMPLETED|Overall Study||62
10728364|NCT02770248|11892331|FG001|COMPLETED|Overall Study||61
10728365|NCT02770248|11892330|FG000|NOT COMPLETED|Overall Study||0
10728366|NCT02770248|11892331|FG001|NOT COMPLETED|Overall Study||2
10728367|NCT02770287|11892337|FG000|STARTED|Overall Study||11
10728368|NCT02770287|11892337|FG000|COMPLETED|Overall Study||11
10728369|NCT02770287|11892337|FG000|NOT COMPLETED|Overall Study||0
10728370|NCT02770365|11892347|FG000|STARTED|Overall Study||277
10728371|NCT02770365|11892348|FG001|STARTED|Overall Study||279
10728372|NCT02770365|11892349|FG002|STARTED|Overall Study||139
10728373|NCT02770365|11892347|FG000|COMPLETED|Overall Study||272
10728374|NCT02770365|11892348|FG001|COMPLETED|Overall Study||275
10728375|NCT02770365|11892349|FG002|COMPLETED|Overall Study||139
10728376|NCT02770365|11892347|FG000|NOT COMPLETED|Overall Study||5
10728377|NCT02770365|11892348|FG001|NOT COMPLETED|Overall Study||4
10728378|NCT02770365|11892349|FG002|NOT COMPLETED|Overall Study||0
10728379|NCT02770521|11892359|FG000|STARTED|Period One||4
10728380|NCT02770521|11892360|FG001|STARTED|Period One||4
10728381|NCT02770521|11892361|FG002|STARTED|Period One||2
10728382|NCT02770521|11892362|FG003|STARTED|Period One||2
10728383|NCT02770521|11892363|FG004|STARTED|Period One||2
10728384|NCT02770521|11892364|FG005|STARTED|Period One||9
10728385|NCT02770521|11892359|FG000|Received Study Drug|Period One||4
10728386|NCT02770521|11892360|FG001|Received Study Drug|Period One||4
10728387|NCT02770521|11892361|FG002|Received Study Drug|Period One||2
10728388|NCT02770521|11892362|FG003|Received Study Drug|Period One||2
10728389|NCT02770521|11892363|FG004|Received Study Drug|Period One||2
10728390|NCT02770521|11892364|FG005|Received Study Drug|Period One||9
10728391|NCT02770521|11892359|FG000|COMPLETED|Period One||4
10728392|NCT02770521|11892360|FG001|COMPLETED|Period One||4
10728393|NCT02770521|11892361|FG002|COMPLETED|Period One||2
10728394|NCT02770521|11892362|FG003|COMPLETED|Period One||2
10728395|NCT02770521|11892363|FG004|COMPLETED|Period One||2
10728396|NCT02770521|11892364|FG005|COMPLETED|Period One||9
10728397|NCT02770521|11892359|FG000|NOT COMPLETED|Period One||0
10728398|NCT02770521|11892360|FG001|NOT COMPLETED|Period One||0
10728399|NCT02770521|11892361|FG002|NOT COMPLETED|Period One||0
10728400|NCT02770521|11892362|FG003|NOT COMPLETED|Period One||0
10728401|NCT02770521|11892363|FG004|NOT COMPLETED|Period One||0
10728402|NCT02770521|11892364|FG005|NOT COMPLETED|Period One||0
10728403|NCT02770521|11892359|FG000|STARTED|Period Two||4
10728404|NCT02770521|11892360|FG001|STARTED|Period Two||4
10728405|NCT02770521|11892361|FG002|STARTED|Period Two||2
10728406|NCT02770521|11892362|FG003|STARTED|Period Two||2
10728407|NCT02770521|11892363|FG004|STARTED|Period Two||2
10728408|NCT02770521|11892364|FG005|STARTED|Period Two||9
10728409|NCT02770521|11892359|FG000|Received Study Drug|Period Two||4
10728410|NCT02770521|11892360|FG001|Received Study Drug|Period Two||4
10728411|NCT02770521|11892361|FG002|Received Study Drug|Period Two||2
10728412|NCT02770521|11892362|FG003|Received Study Drug|Period Two||2
10728413|NCT02770521|11892363|FG004|Received Study Drug|Period Two||2
10728414|NCT02770521|11892364|FG005|Received Study Drug|Period Two||9
10728415|NCT02770521|11892359|FG000|COMPLETED|Period Two||4
10728416|NCT02770521|11892360|FG001|COMPLETED|Period Two||4
10728417|NCT02770521|11892361|FG002|COMPLETED|Period Two||2
10728418|NCT02770521|11892362|FG003|COMPLETED|Period Two||2
10728419|NCT02770521|11892363|FG004|COMPLETED|Period Two||2
10728420|NCT02770521|11892364|FG005|COMPLETED|Period Two||9
10728421|NCT02770521|11892359|FG000|NOT COMPLETED|Period Two||0
10728422|NCT02770521|11892360|FG001|NOT COMPLETED|Period Two||0
10728423|NCT02770521|11892361|FG002|NOT COMPLETED|Period Two||0
10728424|NCT02770521|11892362|FG003|NOT COMPLETED|Period Two||0
10728425|NCT02770521|11892363|FG004|NOT COMPLETED|Period Two||0
10728426|NCT02770521|11892364|FG005|NOT COMPLETED|Period Two||0
10728427|NCT02770521|11892359|FG000|STARTED|Period Three|Not applicable. Part A only had two periods.|0
10728428|NCT02770521|11892360|FG001|STARTED|Period Three|Not applicable. Part A only had two periods.|0
10728429|NCT02770521|11892361|FG002|STARTED|Period Three||2
10728430|NCT02770521|11892362|FG003|STARTED|Period Three||2
10728431|NCT02770521|11892363|FG004|STARTED|Period Three||2
10728432|NCT02770521|11892364|FG005|STARTED|Period Three||9
10728433|NCT02770521|11892359|FG000|Received Study Drug|Period Three||0
10728434|NCT02770521|11892360|FG001|Received Study Drug|Period Three||0
10728435|NCT02770521|11892361|FG002|Received Study Drug|Period Three||2
10728436|NCT02770521|11892362|FG003|Received Study Drug|Period Three||2
10728437|NCT02770521|11892363|FG004|Received Study Drug|Period Three||2
10728438|NCT02770521|11892364|FG005|Received Study Drug|Period Three||9
10728439|NCT02770521|11892359|FG000|COMPLETED|Period Three||0
10728440|NCT02770521|11892360|FG001|COMPLETED|Period Three||0
10728441|NCT02770521|11892361|FG002|COMPLETED|Period Three||2
10728442|NCT02770521|11892362|FG003|COMPLETED|Period Three||2
10728443|NCT02770521|11892363|FG004|COMPLETED|Period Three||2
10728444|NCT02770521|11892364|FG005|COMPLETED|Period Three||9
10728445|NCT02770521|11892359|FG000|NOT COMPLETED|Period Three||0
10728446|NCT02770521|11892360|FG001|NOT COMPLETED|Period Three||0
10728447|NCT02770521|11892361|FG002|NOT COMPLETED|Period Three||0
10728448|NCT02770521|11892362|FG003|NOT COMPLETED|Period Three||0
10728449|NCT02770521|11892363|FG004|NOT COMPLETED|Period Three||0
10728450|NCT02770521|11892364|FG005|NOT COMPLETED|Period Three||0
10728451|NCT02770547|11892384|FG000|STARTED|Overall Study||16
10728452|NCT02770547|11892385|FG001|STARTED|Overall Study||16
10728453|NCT02770547|11892384|FG000|COMPLETED|Overall Study||15
10728454|NCT02770547|11892385|FG001|COMPLETED|Overall Study||15
10728455|NCT02770547|11892384|FG000|NOT COMPLETED|Overall Study||1
10728456|NCT02770547|11892385|FG001|NOT COMPLETED|Overall Study||1
10728457|NCT02770612|11892391|FG000|STARTED|Overall Study||51
10728458|NCT02770612|11892391|FG000|COMPLETED|Overall Study||50
10728459|NCT02770612|11892391|FG000|NOT COMPLETED|Overall Study||1
10728460|NCT02770625|11892395|FG000|STARTED|Overall Study||8
10728461|NCT02770625|11892395|FG000|COMPLETED|Overall Study||8
10728462|NCT02770625|11892395|FG000|NOT COMPLETED|Overall Study||0
10728463|NCT02770820|11892399|FG000|STARTED|Overall Study||7
10728464|NCT02770820|11892399|FG000|COMPLETED|Overall Study||4
10728465|NCT02770820|11892399|FG000|NOT COMPLETED|Overall Study||3
10728466|NCT02770846|11892405|FG000|STARTED|Overall Study||25
10728467|NCT02770846|11892406|FG001|STARTED|Overall Study||25
10728468|NCT02770846|11892405|FG000|COMPLETED|Overall Study||25
10728469|NCT02770846|11892406|FG001|COMPLETED|Overall Study||25
10728470|NCT02770846|11892405|FG000|NOT COMPLETED|Overall Study||0
10728471|NCT02770846|11892406|FG001|NOT COMPLETED|Overall Study||0
10728472|NCT02771093|11892416|FG000|STARTED|Overall Study||13
10728473|NCT02771093|11892417|FG001|STARTED|Overall Study||14
10728474|NCT02771093|11892416|FG000|COMPLETED|Overall Study||13
10728475|NCT02771093|11892417|FG001|COMPLETED|Overall Study||14
10728476|NCT02771093|11892416|FG000|NOT COMPLETED|Overall Study||0
10728477|NCT02771093|11892417|FG001|NOT COMPLETED|Overall Study||0
10728478|NCT02771145|11892423|FG000|STARTED|Overall Study||90
10728479|NCT02771145|11892423|FG000|COMPLETED|Overall Study||86
10728480|NCT02771145|11892423|FG000|NOT COMPLETED|Overall Study||4
10728481|NCT02771210|11892445|FG000|STARTED|Period 1||102
10728482|NCT02771210|11892446|FG001|STARTED|Period 1||102
10728483|NCT02771210|11892445|FG000|COMPLETED|Period 1||91
10728484|NCT02771210|11892446|FG001|COMPLETED|Period 1||84
10728485|NCT02771210|11892445|FG000|NOT COMPLETED|Period 1||11
10728486|NCT02771210|11892446|FG001|NOT COMPLETED|Period 1||18
10728487|NCT02771210|11892445|FG000|STARTED|Period 2||91
10728488|NCT02771210|11892446|FG001|STARTED|Period 2||84
10728489|NCT02771210|11892445|FG000|COMPLETED|Period 2||89
10728490|NCT02771210|11892446|FG001|COMPLETED|Period 2||81
10728491|NCT02771210|11892445|FG000|NOT COMPLETED|Period 2||2
10728492|NCT02771210|11892446|FG001|NOT COMPLETED|Period 2||3
10728493|NCT02771340|11892455|FG000|STARTED|Overall Study||2
10728494|NCT02771340|11892456|FG001|STARTED|Overall Study||3
10728495|NCT02771340|11892457|FG002|STARTED|Overall Study||5
10728496|NCT02771340|11892455|FG000|COMPLETED|Overall Study||2
10728497|NCT02771340|11892456|FG001|COMPLETED|Overall Study||3
10728498|NCT02771340|11892457|FG002|COMPLETED|Overall Study||5
10728499|NCT02771340|11892455|FG000|NOT COMPLETED|Overall Study||0
10728500|NCT02771340|11892456|FG001|NOT COMPLETED|Overall Study||0
10728501|NCT02771340|11892457|FG002|NOT COMPLETED|Overall Study||0
10728502|NCT02771366|11892467|FG000|STARTED|Period 1||15
10728503|NCT02771366|11892468|FG001|STARTED|Period 1||15
10728504|NCT02771366|11892467|FG000|COMPLETED|Period 1||15
10728505|NCT02771366|11892468|FG001|COMPLETED|Period 1||13
10728506|NCT02771366|11892467|FG000|NOT COMPLETED|Period 1||0
10728507|NCT02771366|11892468|FG001|NOT COMPLETED|Period 1||2
10728508|NCT02771366|11892467|FG000|STARTED|Period 2 (Crossover)||15
10728509|NCT02771366|11892468|FG001|STARTED|Period 2 (Crossover)||13
10728510|NCT02771366|11892467|FG000|COMPLETED|Period 2 (Crossover)||13
10728511|NCT02771366|11892468|FG001|COMPLETED|Period 2 (Crossover)||13
10728512|NCT02771366|11892467|FG000|NOT COMPLETED|Period 2 (Crossover)||2
10728513|NCT02771366|11892468|FG001|NOT COMPLETED|Period 2 (Crossover)||0
10728514|NCT02771522|11892475|FG000|STARTED|Overall Study|119 teeth imaged with the Calcivis System from 30 patients|30
10728515|NCT02771522|11892475|FG000|COMPLETED|Overall Study|87 teeth imaged with the Calcivis System fro 22 patients|22
10728516|NCT02771522|11892475|FG000|NOT COMPLETED|Overall Study||8
10728517|NCT02771574|11892489|FG000|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||3
10728518|NCT02771574|11892490|FG001|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0
10728519|NCT02771574|11892491|FG002|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0
10728520|NCT02771574|11892492|FG003|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0
10728521|NCT02771574|11892493|FG004|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0
10728522|NCT02771574|11892489|FG000|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||3
10728523|NCT02771574|11892490|FG001|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
10728524|NCT02771574|11892491|FG002|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
10728525|NCT02771574|11892492|FG003|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
10728526|NCT02771574|11892493|FG004|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
10728527|NCT02771574|11892489|FG000|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
10728528|NCT02771574|11892490|FG001|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
10728529|NCT02771574|11892491|FG002|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
10728530|NCT02771574|11892492|FG003|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
10728531|NCT02771574|11892493|FG004|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
10728532|NCT02771574|11892489|FG000|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0
10728533|NCT02771574|11892490|FG001|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||5
10728534|NCT02771574|11892491|FG002|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0
10728535|NCT02771574|11892492|FG003|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0
10728536|NCT02771574|11892493|FG004|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0
10728537|NCT02771574|11892489|FG000|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
10728538|NCT02771574|11892490|FG001|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||5
10728539|NCT02771574|11892491|FG002|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
10728540|NCT02771574|11892492|FG003|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
10728541|NCT02771574|11892493|FG004|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
10728542|NCT02771574|11892489|FG000|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
10728543|NCT02771574|11892490|FG001|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
10728544|NCT02771574|11892491|FG002|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
10728545|NCT02771574|11892492|FG003|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
10728546|NCT02771574|11892493|FG004|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
10728547|NCT02771574|11892489|FG000|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0
10728548|NCT02771574|11892490|FG001|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0
10728549|NCT02771574|11892491|FG002|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||3
10728550|NCT02771574|11892492|FG003|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0
10728551|NCT02771574|11892493|FG004|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0
10728552|NCT02771574|11892489|FG000|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
10728553|NCT02771574|11892490|FG001|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
10728554|NCT02771574|11892491|FG002|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||3
10728555|NCT02771574|11892492|FG003|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
10728556|NCT02771574|11892493|FG004|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
10728557|NCT02771574|11892489|FG000|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
10728558|NCT02771574|11892490|FG001|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
10728559|NCT02771574|11892491|FG002|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
10728560|NCT02771574|11892492|FG003|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
10728561|NCT02771574|11892493|FG004|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
10728562|NCT02771574|11892489|FG000|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0
10728563|NCT02771574|11892490|FG001|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0
10728564|NCT02771574|11892491|FG002|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0
10728565|NCT02771574|11892492|FG003|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||3
10728566|NCT02771574|11892493|FG004|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0
10728567|NCT02771574|11892489|FG000|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
10728568|NCT02771574|11892490|FG001|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
10728569|NCT02771574|11892491|FG002|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
10728570|NCT02771574|11892492|FG003|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||3
10728571|NCT02771574|11892493|FG004|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
10728572|NCT02771574|11892489|FG000|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
10728573|NCT02771574|11892490|FG001|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
10728574|NCT02771574|11892491|FG002|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
10728575|NCT02771574|11892492|FG003|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
10728576|NCT02771574|11892493|FG004|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
10728577|NCT02771574|11892489|FG000|STARTED|Liq Avexitide (3 Days)||0
10728578|NCT02771574|11892490|FG001|STARTED|Liq Avexitide (3 Days)||0
10728579|NCT02771574|11892491|FG002|STARTED|Liq Avexitide (3 Days)||0
10728580|NCT02771574|11892492|FG003|STARTED|Liq Avexitide (3 Days)||0
10728581|NCT02771574|11892493|FG004|STARTED|Liq Avexitide (3 Days)||5
10728582|NCT02771574|11892489|FG000|COMPLETED|Liq Avexitide (3 Days)||0
10728583|NCT02771574|11892490|FG001|COMPLETED|Liq Avexitide (3 Days)||0
10728584|NCT02771574|11892491|FG002|COMPLETED|Liq Avexitide (3 Days)||0
10728585|NCT02771574|11892492|FG003|COMPLETED|Liq Avexitide (3 Days)||0
10728586|NCT02771574|11892493|FG004|COMPLETED|Liq Avexitide (3 Days)||5
10728587|NCT02771574|11892489|FG000|NOT COMPLETED|Liq Avexitide (3 Days)||0
10728588|NCT02771574|11892490|FG001|NOT COMPLETED|Liq Avexitide (3 Days)||0
10728589|NCT02771574|11892491|FG002|NOT COMPLETED|Liq Avexitide (3 Days)||0
10728590|NCT02771574|11892492|FG003|NOT COMPLETED|Liq Avexitide (3 Days)||0
10728591|NCT02771574|11892493|FG004|NOT COMPLETED|Liq Avexitide (3 Days)||0
10728592|NCT02772302|11892510|FG000|STARTED|Overall Study||10
10728593|NCT02772302|11892511|FG001|STARTED|Overall Study||10
10728594|NCT02772302|11892510|FG000|COMPLETED|Overall Study||10
10728595|NCT02772302|11892511|FG001|COMPLETED|Overall Study||10
10728596|NCT02772302|11892510|FG000|NOT COMPLETED|Overall Study||0
10728597|NCT02772302|11892511|FG001|NOT COMPLETED|Overall Study||0
10728598|NCT02772432|11892519|FG000|STARTED|Overall Study||31
10728599|NCT02772432|11892520|FG001|STARTED|Overall Study||22
10728600|NCT02772432|11892519|FG000|COMPLETED|Overall Study||19
10728601|NCT02772432|11892520|FG001|COMPLETED|Overall Study||21
10728602|NCT02772432|11892519|FG000|NOT COMPLETED|Overall Study||12
10728603|NCT02772432|11892520|FG001|NOT COMPLETED|Overall Study||1
10728604|NCT02772666|11892526|FG000|STARTED|O-Glas Then SFT||44
10728605|NCT02772666|11892526|FG000|COMPLETED|O-Glas Then SFT||44
10814599|NCT02282332|11977407|FG000|COMPLETED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0
10814600|NCT02282332|11977407|FG000|NOT COMPLETED|Overall Study||0
10814601|NCT02287636|11977411|FG000|STARTED|Overall Study||13
10814602|NCT02287636|11977411|FG000|COMPLETED|Overall Study||13
10814603|NCT02287636|11977411|FG000|NOT COMPLETED|Overall Study||0
10814604|NCT02276560|11977418|FG000|STARTED|Overall Study||1
10814605|NCT02276560|11977419|FG001|STARTED|Overall Study||0
10814606|NCT02276560|11977420|FG002|STARTED|Overall Study||0
10814607|NCT02276560|11977418|FG000|COMPLETED|Overall Study||0
10814608|NCT02276560|11977419|FG001|COMPLETED|Overall Study||0
10814609|NCT02276560|11977420|FG002|COMPLETED|Overall Study||0
10814610|NCT02276560|11977418|FG000|NOT COMPLETED|Overall Study||1
10814611|NCT02276560|11977419|FG001|NOT COMPLETED|Overall Study||0
10814612|NCT02276560|11977420|FG002|NOT COMPLETED|Overall Study||0
10814613|NCT02280252|11977428|FG000|STARTED|Overall Study||0
10814614|NCT02280252|11977428|FG000|COMPLETED|Overall Study||0
10814615|NCT02280252|11977428|FG000|NOT COMPLETED|Overall Study||0
10814616|NCT02284373|11977435|FG000|STARTED|Overall Study||5
10814617|NCT02284373|11977436|FG001|STARTED|Overall Study||5
10814618|NCT02284373|11977437|FG002|STARTED|Overall Study||29
10814619|NCT02284373|11977435|FG000|COMPLETED|Overall Study||5
10814620|NCT02284373|11977436|FG001|COMPLETED|Overall Study||2
10814621|NCT02284373|11977437|FG002|COMPLETED|Overall Study||29
10814622|NCT02284373|11977435|FG000|NOT COMPLETED|Overall Study||0
10814623|NCT02284373|11977436|FG001|NOT COMPLETED|Overall Study||3
10814624|NCT02284373|11977437|FG002|NOT COMPLETED|Overall Study||0
10814625|NCT02285270|11977445|FG000|STARTED|Overall Study||10
10814626|NCT02285270|11977445|FG000|COMPLETED|Overall Study||5
10814627|NCT02285270|11977445|FG000|NOT COMPLETED|Overall Study||5
10814628|NCT02275481|11977451|FG000|STARTED|Overall Study||32
10728606|NCT02772666|11892526|FG000|NOT COMPLETED|O-Glas Then SFT||0
10728607|NCT02772666|11892526|FG000|STARTED|SFT Then O-Glass||44
10728608|NCT02772666|11892526|FG000|COMPLETED|SFT Then O-Glass||44
10728609|NCT02772666|11892526|FG000|NOT COMPLETED|SFT Then O-Glass||0
10728610|NCT02772757|11892534|FG000|STARTED|Overall Study||22
10728611|NCT02772757|11892535|FG001|STARTED|Overall Study||24
10728612|NCT02772757|11892536|FG002|STARTED|Overall Study||26
10728613|NCT02772757|11892534|FG000|COMPLETED|Overall Study||21
10728614|NCT02772757|11892535|FG001|COMPLETED|Overall Study||21
10728615|NCT02772757|11892536|FG002|COMPLETED|Overall Study||21
10728616|NCT02772757|11892534|FG000|NOT COMPLETED|Overall Study||1
10728617|NCT02772757|11892535|FG001|NOT COMPLETED|Overall Study||3
10728618|NCT02772757|11892536|FG002|NOT COMPLETED|Overall Study||5
10728619|NCT02772783|11892545|FG000|STARTED|Experimental Condition 1, 1 Day||8
10728620|NCT02772783|11892546|FG001|STARTED|Experimental Condition 1, 1 Day||7
10728621|NCT02772783|11892545|FG000|COMPLETED|Experimental Condition 1, 1 Day||8
10728622|NCT02772783|11892546|FG001|COMPLETED|Experimental Condition 1, 1 Day||7
10728623|NCT02772783|11892545|FG000|NOT COMPLETED|Experimental Condition 1, 1 Day||0
10728624|NCT02772783|11892546|FG001|NOT COMPLETED|Experimental Condition 1, 1 Day||0
10728625|NCT02772783|11892545|FG000|STARTED|Wash-out, 1 Week||8
10728626|NCT02772783|11892546|FG001|STARTED|Wash-out, 1 Week||7
10728627|NCT02772783|11892545|FG000|COMPLETED|Wash-out, 1 Week||8
10728628|NCT02772783|11892546|FG001|COMPLETED|Wash-out, 1 Week||7
10728629|NCT02772783|11892545|FG000|NOT COMPLETED|Wash-out, 1 Week||0
10728630|NCT02772783|11892546|FG001|NOT COMPLETED|Wash-out, 1 Week||0
10728631|NCT02772783|11892545|FG000|STARTED|Comparison Condition, 1 Day||8
10728632|NCT02772783|11892546|FG001|STARTED|Comparison Condition, 1 Day||7
10728633|NCT02772783|11892545|FG000|COMPLETED|Comparison Condition, 1 Day||8
10728634|NCT02772783|11892546|FG001|COMPLETED|Comparison Condition, 1 Day||7
10728635|NCT02772783|11892545|FG000|NOT COMPLETED|Comparison Condition, 1 Day||0
10728636|NCT02772783|11892546|FG001|NOT COMPLETED|Comparison Condition, 1 Day||0
10728637|NCT02772783|11892545|FG000|STARTED|Wash-out, 1 Week||8
10728638|NCT02772783|11892546|FG001|STARTED|Wash-out, 1 Week||7
10728639|NCT02772783|11892545|FG000|COMPLETED|Wash-out, 1 Week||8
10728640|NCT02772783|11892546|FG001|COMPLETED|Wash-out, 1 Week||7
10728641|NCT02772783|11892545|FG000|NOT COMPLETED|Wash-out, 1 Week||0
10728642|NCT02772783|11892546|FG001|NOT COMPLETED|Wash-out, 1 Week||0
10728643|NCT02772783|11892545|FG000|STARTED|Experimental Condition 2, 1 Day||8
10728644|NCT02772783|11892546|FG001|STARTED|Experimental Condition 2, 1 Day||7
10728645|NCT02772783|11892545|FG000|COMPLETED|Experimental Condition 2, 1 Day||8
10728646|NCT02772783|11892546|FG001|COMPLETED|Experimental Condition 2, 1 Day||7
10728647|NCT02772783|11892545|FG000|NOT COMPLETED|Experimental Condition 2, 1 Day||0
10728648|NCT02772783|11892546|FG001|NOT COMPLETED|Experimental Condition 2, 1 Day||0
10728649|NCT02772809|11892554|FG000|STARTED|Overall Study||23
10728650|NCT02772809|11892554|FG000|COMPLETED|Overall Study||17
10728651|NCT02772809|11892554|FG000|NOT COMPLETED|Overall Study||6
10728652|NCT02772978|11892563|FG000|STARTED|Overall Study|First participant enrolled|10
10728653|NCT02772978|11892564|FG001|STARTED|Overall Study||9
10728654|NCT02772978|11892563|FG000|COMPLETED|Overall Study|Last participant enrolled|9
10728655|NCT02772978|11892564|FG001|COMPLETED|Overall Study||8
10728656|NCT02772978|11892563|FG000|NOT COMPLETED|Overall Study||1
10728657|NCT02772978|11892564|FG001|NOT COMPLETED|Overall Study||1
10728658|NCT02773368|11892571|FG000|STARTED|Overall Study||210
10728659|NCT02773368|11892572|FG001|STARTED|Overall Study||210
10728660|NCT02773368|11892571|FG000|Exposed|Overall Study||209
10728661|NCT02773368|11892572|FG001|Exposed|Overall Study||210
10728662|NCT02773368|11892571|FG000|COMPLETED|Overall Study||200
10728663|NCT02773368|11892572|FG001|COMPLETED|Overall Study||206
10728664|NCT02773368|11892571|FG000|NOT COMPLETED|Overall Study||10
10728665|NCT02773368|11892572|FG001|NOT COMPLETED|Overall Study||4
10728666|NCT02773446|11892584|FG000|STARTED|First Admission||7
10728667|NCT02773446|11892585|FG001|STARTED|First Admission||7
10728668|NCT02773446|11892586|FG002|STARTED|First Admission||7
10728669|NCT02773446|11892587|FG003|STARTED|First Admission||7
10728670|NCT02773446|11892588|FG004|STARTED|First Admission||0
10728671|NCT02773446|11892589|FG005|STARTED|First Admission||0
10728672|NCT02773446|11892584|FG000|COMPLETED|First Admission||6
10728673|NCT02773446|11892585|FG001|COMPLETED|First Admission||7
10728674|NCT02773446|11892586|FG002|COMPLETED|First Admission||7
10728675|NCT02773446|11892587|FG003|COMPLETED|First Admission||6
10728676|NCT02773446|11892588|FG004|COMPLETED|First Admission||0
10728677|NCT02773446|11892589|FG005|COMPLETED|First Admission||0
10728678|NCT02773446|11892584|FG000|NOT COMPLETED|First Admission||1
10728679|NCT02773446|11892585|FG001|NOT COMPLETED|First Admission||0
10728680|NCT02773446|11892586|FG002|NOT COMPLETED|First Admission||0
10728681|NCT02773446|11892587|FG003|NOT COMPLETED|First Admission||1
10728682|NCT02773446|11892588|FG004|NOT COMPLETED|First Admission||0
10728683|NCT02773446|11892589|FG005|NOT COMPLETED|First Admission||0
10728684|NCT02773446|11892584|FG000|STARTED|Second Admission||0
10728685|NCT02773446|11892585|FG001|STARTED|Second Admission||0
10728686|NCT02773446|11892586|FG002|STARTED|Second Admission||0
10728687|NCT02773446|11892587|FG003|STARTED|Second Admission||0
10728688|NCT02773446|11892588|FG004|STARTED|Second Admission||11
10728689|NCT02773446|11892589|FG005|STARTED|Second Admission||19
10728690|NCT02773446|11892584|FG000|COMPLETED|Second Admission||0
10728691|NCT02773446|11892585|FG001|COMPLETED|Second Admission||0
10728692|NCT02773446|11892586|FG002|COMPLETED|Second Admission||0
10728693|NCT02773446|11892587|FG003|COMPLETED|Second Admission||0
10728694|NCT02773446|11892588|FG004|COMPLETED|Second Admission||11
10728695|NCT02773446|11892589|FG005|COMPLETED|Second Admission||19
10728696|NCT02773446|11892584|FG000|NOT COMPLETED|Second Admission||0
10728697|NCT02773446|11892585|FG001|NOT COMPLETED|Second Admission||0
10728698|NCT02773446|11892586|FG002|NOT COMPLETED|Second Admission||0
10728699|NCT02773446|11892587|FG003|NOT COMPLETED|Second Admission||0
10728700|NCT02773446|11892588|FG004|NOT COMPLETED|Second Admission||0
10728701|NCT02773446|11892589|FG005|NOT COMPLETED|Second Admission||0
10728702|NCT02773537|11892609|FG000|STARTED|Overall Study||25
10728703|NCT02773537|11892610|FG001|STARTED|Overall Study||25
10728704|NCT02773537|11892611|FG002|STARTED|Overall Study||25
10728705|NCT02773537|11892609|FG000|COMPLETED|Overall Study||25
10728706|NCT02773537|11892610|FG001|COMPLETED|Overall Study||24
10728707|NCT02773537|11892611|FG002|COMPLETED|Overall Study||21
10728708|NCT02773537|11892609|FG000|NOT COMPLETED|Overall Study||0
10728709|NCT02773537|11892610|FG001|NOT COMPLETED|Overall Study||1
10728710|NCT02773537|11892611|FG002|NOT COMPLETED|Overall Study||4
10728711|NCT02773758|11892621|FG000|STARTED|Overall Study||71
10728712|NCT02773758|11892622|FG001|STARTED|Overall Study||70
10728713|NCT02773758|11892621|FG000|COMPLETED|Overall Study||71
10728714|NCT02773758|11892622|FG001|COMPLETED|Overall Study||70
10728715|NCT02773758|11892621|FG000|NOT COMPLETED|Overall Study||0
10728716|NCT02773758|11892622|FG001|NOT COMPLETED|Overall Study||0
10728717|NCT02773836|11892634|FG000|STARTED|Wave 1- Pre-TPD Implementation||1000
10728718|NCT02773836|11892635|FG001|STARTED|Wave 1- Pre-TPD Implementation||1003
10728719|NCT02773836|11892636|FG002|STARTED|Wave 1- Pre-TPD Implementation||1001
10728720|NCT02773836|11892637|FG003|STARTED|Wave 1- Pre-TPD Implementation||1001
10728721|NCT02773836|11892638|FG004|STARTED|Wave 1- Pre-TPD Implementation||1000
10728722|NCT02773836|11892639|FG005|STARTED|Wave 1- Pre-TPD Implementation||1006
10728723|NCT02773836|11892634|FG000|COMPLETED|Wave 1- Pre-TPD Implementation||1000
10728724|NCT02773836|11892635|FG001|COMPLETED|Wave 1- Pre-TPD Implementation||1003
10728725|NCT02773836|11892636|FG002|COMPLETED|Wave 1- Pre-TPD Implementation||1001
10728726|NCT02773836|11892637|FG003|COMPLETED|Wave 1- Pre-TPD Implementation||1001
10728727|NCT02773836|11892638|FG004|COMPLETED|Wave 1- Pre-TPD Implementation||1000
10728728|NCT02773836|11892639|FG005|COMPLETED|Wave 1- Pre-TPD Implementation||1006
10728729|NCT02773836|11892634|FG000|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
10728730|NCT02773836|11892635|FG001|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
10728731|NCT02773836|11892636|FG002|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
10728732|NCT02773836|11892637|FG003|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
10728733|NCT02773836|11892638|FG004|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
10728734|NCT02773836|11892639|FG005|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
10728735|NCT02773836|11892634|FG000|STARTED|Wave 2- Post-TPD Implementation||1010
10728736|NCT02773836|11892635|FG001|STARTED|Wave 2- Post-TPD Implementation||1013
10728737|NCT02773836|11892636|FG002|STARTED|Wave 2- Post-TPD Implementation||1003
10728738|NCT02773836|11892637|FG003|STARTED|Wave 2- Post-TPD Implementation||1010
10728739|NCT02773836|11892638|FG004|STARTED|Wave 2- Post-TPD Implementation||1002
10728740|NCT02773836|11892639|FG005|STARTED|Wave 2- Post-TPD Implementation||998
10728741|NCT02773836|11892634|FG000|COMPLETED|Wave 2- Post-TPD Implementation||1010
10728742|NCT02773836|11892635|FG001|COMPLETED|Wave 2- Post-TPD Implementation||1013
10728743|NCT02773836|11892636|FG002|COMPLETED|Wave 2- Post-TPD Implementation||1003
10728744|NCT02773836|11892637|FG003|COMPLETED|Wave 2- Post-TPD Implementation||1010
10728745|NCT02773836|11892638|FG004|COMPLETED|Wave 2- Post-TPD Implementation||1002
10728746|NCT02773836|11892639|FG005|COMPLETED|Wave 2- Post-TPD Implementation||998
10728747|NCT02773836|11892634|FG000|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
10408426|NCT00754624|11552509|FG000|STARTED|Overall Study||229
10408427|NCT00754624|11552509|FG000|COMPLETED|Overall Study||160
10408428|NCT00754624|11552509|FG000|NOT COMPLETED|Overall Study||69
10408429|NCT00754650|11552513|FG000|STARTED|Overall Study||2
10408430|NCT00754650|11552513|FG000|COMPLETED|Overall Study||0
10408431|NCT00754650|11552513|FG000|NOT COMPLETED|Overall Study||2
10728748|NCT02773836|11892635|FG001|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
10728749|NCT02773836|11892636|FG002|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
10728750|NCT02773836|11892637|FG003|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
10728751|NCT02773836|11892638|FG004|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
10728752|NCT02773836|11892639|FG005|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
10728753|NCT02774213|11892659|FG000|STARTED|Overall Study||74
10728754|NCT02774213|11892659|FG000|COMPLETED|Overall Study||55
10728755|NCT02774213|11892659|FG000|NOT COMPLETED|Overall Study||19
10728756|NCT02774226|11892665|FG000|STARTED|Overall Study||8
10728757|NCT02774226|11892666|FG001|STARTED|Overall Study||7
10728758|NCT02774226|11892665|FG000|COMPLETED|Overall Study||8
10728759|NCT02774226|11892666|FG001|COMPLETED|Overall Study||7
10728760|NCT02774226|11892665|FG000|NOT COMPLETED|Overall Study||0
10728761|NCT02774226|11892666|FG001|NOT COMPLETED|Overall Study||0
10728762|NCT02774278|11892672|FG000|STARTED|Overall Study||264
10728763|NCT02774278|11892672|FG000|Safety Analysis Population (SAP)|Overall Study|SAP: all participants who received at least 1 dose of trial medication and had a safety follow-up.|261
10728764|NCT02774278|11892672|FG000|COMPLETED|Overall Study||0
10728765|NCT02774278|11892672|FG000|NOT COMPLETED|Overall Study||264
10728766|NCT02774343|11892678|FG000|STARTED|Overall Study||15
10728767|NCT02774343|11892679|FG001|STARTED|Overall Study||15
10728768|NCT02774343|11892678|FG000|Received at Least One Capsule|Overall Study||12
10408432|NCT00754741|11552520|FG000|STARTED|Overall Study||567
10728769|NCT02774343|11892679|FG001|Received at Least One Capsule|Overall Study||14
10728770|NCT02774343|11892678|FG000|COMPLETED|Overall Study||9
10814629|NCT02275481|11977452|FG001|STARTED|Overall Study||34
10814630|NCT02275481|11977451|FG000|COMPLETED|Overall Study||23
10814631|NCT02275481|11977452|FG001|COMPLETED|Overall Study||31
10814632|NCT02275481|11977451|FG000|NOT COMPLETED|Overall Study||9
10814633|NCT02275481|11977452|FG001|NOT COMPLETED|Overall Study||3
10814634|NCT02266914|11977458|FG000|STARTED|Overall Study||9
10814635|NCT02266914|11977458|FG000|COMPLETED|Overall Study||0
10814636|NCT02266914|11977458|FG000|NOT COMPLETED|Overall Study||9
10814637|NCT02273752|11977462|FG000|STARTED|Overall Study||2
10814638|NCT02273752|11977462|FG000|COMPLETED|Overall Study||0
10814639|NCT02273752|11977462|FG000|NOT COMPLETED|Overall Study||2
10814640|NCT02270684|11977468|FG000|STARTED|Overall Study||1
10814641|NCT02270684|11977469|FG001|STARTED|Overall Study||3
10814642|NCT02270684|11977468|FG000|COMPLETED|Overall Study||0
10814643|NCT02270684|11977469|FG001|COMPLETED|Overall Study||0
10814644|NCT02270684|11977468|FG000|NOT COMPLETED|Overall Study||1
10814645|NCT02270684|11977469|FG001|NOT COMPLETED|Overall Study||3
10814646|NCT02262000|11977477|FG000|STARTED|Overall Study||3
10814647|NCT02262000|11977478|FG001|STARTED|Overall Study||0
10814648|NCT02262000|11977477|FG000|COMPLETED|Overall Study||3
10814649|NCT02262000|11977478|FG001|COMPLETED|Overall Study||0
10814650|NCT02262000|11977477|FG000|NOT COMPLETED|Overall Study||0
10814651|NCT02262000|11977478|FG001|NOT COMPLETED|Overall Study||0
10814652|NCT02271594|11977486|FG000|STARTED|Overall Study||19
10814653|NCT02271594|11977487|FG001|STARTED|Overall Study||12
10814654|NCT02271594|11977486|FG000|COMPLETED|Overall Study|Study closed down|0
10814655|NCT02271594|11977487|FG001|COMPLETED|Overall Study|Study closed down|0
10814656|NCT02271594|11977486|FG000|NOT COMPLETED|Overall Study||19
10814657|NCT02271594|11977487|FG001|NOT COMPLETED|Overall Study||12
10814658|NCT02263365|11977497|FG000|STARTED|Overall Study||22
10814659|NCT02263365|11977498|FG001|STARTED|Overall Study||18
10814660|NCT02263365|11977497|FG000|COMPLETED|Overall Study||0
10814661|NCT02263365|11977498|FG001|COMPLETED|Overall Study||0
10814662|NCT02263365|11977497|FG000|NOT COMPLETED|Overall Study||22
10814663|NCT02263365|11977498|FG001|NOT COMPLETED|Overall Study||18
10814664|NCT02266797|11977507|FG000|STARTED|Overall Study||1
10814665|NCT02266797|11977508|FG001|STARTED|Overall Study||3
10814666|NCT02266797|11977507|FG000|COMPLETED|Overall Study||1
10814667|NCT02266797|11977508|FG001|COMPLETED|Overall Study||2
10814668|NCT02266797|11977507|FG000|NOT COMPLETED|Overall Study||0
10814669|NCT02266797|11977508|FG001|NOT COMPLETED|Overall Study||1
10814670|NCT02249377|11977516|FG000|STARTED|Overall Study||25
10814671|NCT02249377|11977517|FG001|STARTED|Overall Study||25
10814672|NCT02249377|11977516|FG000|COMPLETED|Overall Study||0
10814673|NCT02249377|11977517|FG001|COMPLETED|Overall Study||1
10814674|NCT02249377|11977516|FG000|NOT COMPLETED|Overall Study||25
10814675|NCT02249377|11977517|FG001|NOT COMPLETED|Overall Study||24
10814676|NCT02253394|11977523|FG000|STARTED|Overall Study||0
10814677|NCT02253394|11977524|FG001|STARTED|Overall Study|Ambrisentan 5 or 10 mg QD + placebo (90 d) first, then washout (21 d), then +Spiro 50 mg QD (90 d).|2
10814678|NCT02253394|11977523|FG000|COMPLETED|Overall Study||0
10814679|NCT02253394|11977524|FG001|COMPLETED|Overall Study||2
10814680|NCT02253394|11977523|FG000|NOT COMPLETED|Overall Study||0
10814681|NCT02253394|11977524|FG001|NOT COMPLETED|Overall Study||0
10814682|NCT02241551|11977532|FG000|STARTED|Overall Study||1
10814683|NCT02241551|11977533|FG001|STARTED|Overall Study||0
10814684|NCT02241551|11977532|FG000|COMPLETED|Overall Study||0
10814685|NCT02241551|11977533|FG001|COMPLETED|Overall Study||0
10728771|NCT02774343|11892679|FG001|COMPLETED|Overall Study||12
10728772|NCT02774343|11892678|FG000|NOT COMPLETED|Overall Study||6
10728773|NCT02774343|11892679|FG001|NOT COMPLETED|Overall Study||3
10728774|NCT02774616|11892688|FG000|STARTED|Overall Study||95
10728775|NCT02774616|11892689|FG001|STARTED|Overall Study||167
10728776|NCT02774616|11892690|FG002|STARTED|Overall Study||16
10728777|NCT02774616|11892688|FG000|Died|Overall Study||6
10728778|NCT02774616|11892689|FG001|Died|Overall Study||3
10728779|NCT02774616|11892690|FG002|Died|Overall Study||1
10728780|NCT02774616|11892688|FG000|Withdrew Consent|Overall Study||3
10728781|NCT02774616|11892689|FG001|Withdrew Consent|Overall Study||3
10728782|NCT02774616|11892690|FG002|Withdrew Consent|Overall Study||0
10728783|NCT02774616|11892688|FG000|Lost to FU|Overall Study||2
10728784|NCT02774616|11892689|FG001|Lost to FU|Overall Study||0
10728785|NCT02774616|11892690|FG002|Lost to FU|Overall Study||0
10728786|NCT02774616|11892688|FG000|Device Explanted|Overall Study||2
10728787|NCT02774616|11892689|FG001|Device Explanted|Overall Study||1
10728788|NCT02774616|11892690|FG002|Device Explanted|Overall Study||1
10728789|NCT02774616|11892688|FG000|Other|Overall Study||2
10728790|NCT02774616|11892689|FG001|Other|Overall Study||4
10814686|NCT02241551|11977532|FG000|NOT COMPLETED|Overall Study||1
10814687|NCT02241551|11977533|FG001|NOT COMPLETED|Overall Study||0
10814688|NCT02246114|11977543|FG000|STARTED|Overall Study||1
10814689|NCT02246114|11977544|FG001|STARTED|Overall Study||0
10814690|NCT02246114|11977543|FG000|COMPLETED|Overall Study||0
10814691|NCT02246114|11977544|FG001|COMPLETED|Overall Study||0
10814692|NCT02246114|11977543|FG000|NOT COMPLETED|Overall Study||1
10814693|NCT02246114|11977544|FG001|NOT COMPLETED|Overall Study||0
10814694|NCT02232880|11977550|FG000|STARTED|Overall Study||1
10814695|NCT02232880|11977550|FG000|COMPLETED|Overall Study||0
10814696|NCT02232880|11977550|FG000|NOT COMPLETED|Overall Study||1
10814697|NCT02248740|11977556|FG000|STARTED|Overall Study||18
10728791|NCT02774616|11892690|FG002|Other|Overall Study||1
10728792|NCT02774616|11892688|FG000|COMPLETED|Overall Study||80
10728793|NCT02774616|11892689|FG001|COMPLETED|Overall Study||156
10728794|NCT02774616|11892690|FG002|COMPLETED|Overall Study||13
10728795|NCT02774616|11892688|FG000|NOT COMPLETED|Overall Study||15
10728796|NCT02774616|11892689|FG001|NOT COMPLETED|Overall Study||11
10728797|NCT02774616|11892690|FG002|NOT COMPLETED|Overall Study||3
10408433|NCT00754741|11552521|FG001|STARTED|Overall Study||569
10408434|NCT00754741|11552522|FG002|STARTED|Overall Study||556
10408435|NCT00754741|11552520|FG000|COMPLETED|Overall Study||510
10408436|NCT00754741|11552521|FG001|COMPLETED|Overall Study||500
10408437|NCT00754741|11552522|FG002|COMPLETED|Overall Study||502
10408438|NCT00754741|11552520|FG000|NOT COMPLETED|Overall Study||57
10408439|NCT00754741|11552521|FG001|NOT COMPLETED|Overall Study||69
10408440|NCT00754741|11552522|FG002|NOT COMPLETED|Overall Study||54
10408441|NCT00754832|11552530|FG000|STARTED|First 6 Weeks Intervention||26
10408442|NCT00754832|11552531|FG001|STARTED|First 6 Weeks Intervention||30
10408443|NCT00754832|11552530|FG000|COMPLETED|First 6 Weeks Intervention||18
10408444|NCT00754832|11552531|FG001|COMPLETED|First 6 Weeks Intervention||28
10408445|NCT00754832|11552530|FG000|NOT COMPLETED|First 6 Weeks Intervention||8
10408446|NCT00754832|11552531|FG001|NOT COMPLETED|First 6 Weeks Intervention||2
10408447|NCT00754832|11552530|FG000|STARTED|2 Weeks Washout||18
10408448|NCT00754832|11552531|FG001|STARTED|2 Weeks Washout||28
10728798|NCT02774681|11892700|FG000|STARTED|Treatment on Study||12
10728799|NCT02774681|11892700|FG000|Reached 1st Response/2 Cycles|Treatment on Study||10
10728800|NCT02774681|11892700|FG000|Went on to Start Cycle 3|Treatment on Study||5
10728801|NCT02774681|11892700|FG000|COMPLETED|Treatment on Study||5
10728802|NCT02774681|11892700|FG000|NOT COMPLETED|Treatment on Study||7
10728803|NCT02774681|11892700|FG000|STARTED|Follow-Up for 3 Years||12
10728804|NCT02774681|11892700|FG000|COMPLETED|Follow-Up for 3 Years||0
10728805|NCT02774681|11892700|FG000|NOT COMPLETED|Follow-Up for 3 Years||12
10728806|NCT02774798|11892707|FG000|STARTED|Overall Study||7
10728807|NCT02774798|11892708|FG001|STARTED|Overall Study||17
10728808|NCT02774798|11892709|FG002|STARTED|Overall Study||7
10728809|NCT02774798|11892707|FG000|COMPLETED|Overall Study||7
10728810|NCT02774798|11892708|FG001|COMPLETED|Overall Study||17
10728811|NCT02774798|11892709|FG002|COMPLETED|Overall Study||7
10728812|NCT02774798|11892707|FG000|NOT COMPLETED|Overall Study||0
10728813|NCT02774798|11892708|FG001|NOT COMPLETED|Overall Study||0
10728814|NCT02774798|11892709|FG002|NOT COMPLETED|Overall Study||0
10728815|NCT02774850|11892719|FG000|STARTED|Overall Study||610
10728816|NCT02774850|11892719|FG000|Induction I|Overall Study||585
10728817|NCT02774850|11892719|FG000|Early Discharge Eligible at Induction I|Overall Study|24 of these patients were managed as outpatients. 252 were managed as inpatients.|276
10728818|NCT02774850|11892719|FG000|Induction II|Overall Study||564
10728819|NCT02774850|11892719|FG000|Early Discharge Eligible at Induction II|Overall Study|114 of these patients were managed as outpatients. 379 were managed as inpatients.|493
10728820|NCT02774850|11892719|FG000|Intensification I|Overall Study||476
10728821|NCT02774850|11892719|FG000|Early Discharge Eligible at Int I|Overall Study|104 of these patients were managed as outpatients. 270 were managed as inpatients.|374
10728822|NCT02774850|11892719|FG000|Intensification II|Overall Study||342
10728901|NCT02776670|11892826|FG001|COMPLETED|Overall Study||108
10728823|NCT02774850|11892719|FG000|Early Discharge Eligible at Int II|Overall Study|56 of these patients were managed as outpatients. 229 were managed as inpatients.|285
10728824|NCT02774850|11892719|FG000|Intensification III|Overall Study||48
10728825|NCT02774850|11892719|FG000|Early Discharge Eligible at Int III|Overall Study|7 of these patients were managed as outpatients. 37 were managed as inpatients.|44
10728826|NCT02774850|11892719|FG000|COMPLETED|Overall Study||575
10728827|NCT02774850|11892719|FG000|NOT COMPLETED|Overall Study||35
10728828|NCT02774941|11892727|FG000|STARTED|Overall Study||110
10728829|NCT02774941|11892728|FG001|STARTED|Overall Study||110
10728830|NCT02774941|11892727|FG000|Subjects Excluded|Overall Study||1
10728831|NCT02774941|11892728|FG001|Subjects Excluded|Overall Study||2
10728832|NCT02774941|11892727|FG000|COMPLETED|Overall Study||109
10728833|NCT02774941|11892728|FG001|COMPLETED|Overall Study||108
10728834|NCT02774941|11892727|FG000|NOT COMPLETED|Overall Study||1
10728835|NCT02774941|11892728|FG001|NOT COMPLETED|Overall Study||2
10728836|NCT02775240|11892734|FG000|STARTED|Overall Study||18
10728837|NCT02775240|11892734|FG000|Started Treatment A|Overall Study||18
10728838|NCT02775240|11892734|FG000|Started Treatment B|Overall Study||17
10728839|NCT02775240|11892734|FG000|COMPLETED|Overall Study||17
10728840|NCT02775240|11892734|FG000|NOT COMPLETED|Overall Study||1
10728841|NCT02775344|11892743|FG000|STARTED|Overall Study||40
10728842|NCT02775344|11892744|FG001|STARTED|Overall Study||40
10728843|NCT02775344|11892743|FG000|COMPLETED|Overall Study||37
10728844|NCT02775344|11892744|FG001|COMPLETED|Overall Study||38
10728845|NCT02775344|11892743|FG000|NOT COMPLETED|Overall Study||3
10728846|NCT02775344|11892744|FG001|NOT COMPLETED|Overall Study||2
10728847|NCT02775617|11892752|FG000|STARTED|Overall Study|Participants are seen at via a survey of the community. 92.6% of the resident population|653
10728848|NCT02775617|11892753|FG001|STARTED|Overall Study|Participants are seen at via a survey of the community. 88.9% of the resident population|638
10728849|NCT02775617|11892752|FG000|COMPLETED|Overall Study|Participants are seen at via a survey of the community. 96.3% of the resident population|605
10777624|NCT03341533|11939534|FG000|STARTED|Overall Study||72
10777625|NCT03341533|11939535|FG001|STARTED|Overall Study||70
10408449|NCT00754832|11552530|FG000|COMPLETED|2 Weeks Washout||17
10408450|NCT00754832|11552531|FG001|COMPLETED|2 Weeks Washout||26
10408451|NCT00754832|11552530|FG000|NOT COMPLETED|2 Weeks Washout||1
10408452|NCT00754832|11552531|FG001|NOT COMPLETED|2 Weeks Washout||2
10408453|NCT00754832|11552530|FG000|STARTED|Second 6 Weeks Intervention||17
10728850|NCT02775617|11892753|FG001|COMPLETED|Overall Study|Participants are seen at via a survey of the community. 76.2% of the resident population|478
10728851|NCT02775617|11892752|FG000|NOT COMPLETED|Overall Study||48
10728852|NCT02775617|11892753|FG001|NOT COMPLETED|Overall Study||160
10728853|NCT02775864|11892763|FG000|STARTED|Overall Study||26014
10728854|NCT02775864|11892764|FG001|STARTED|Overall Study||31117
10728855|NCT02775864|11892765|FG002|STARTED|Overall Study||11941
10728856|NCT02775864|11892766|FG003|STARTED|Overall Study||12849
10728857|NCT02775864|11892763|FG000|COMPLETED|Overall Study||22772
10728858|NCT02775864|11892764|FG001|COMPLETED|Overall Study||26218
10728859|NCT02775864|11892765|FG002|COMPLETED|Overall Study||10081
10728860|NCT02775864|11892766|FG003|COMPLETED|Overall Study||10765
10728861|NCT02775864|11892763|FG000|NOT COMPLETED|Overall Study||3242
10728862|NCT02775864|11892764|FG001|NOT COMPLETED|Overall Study||4899
10728863|NCT02775864|11892765|FG002|NOT COMPLETED|Overall Study||1860
10728864|NCT02775864|11892766|FG003|NOT COMPLETED|Overall Study||2084
10728865|NCT02775916|11892779|FG000|STARTED|Overall Study||20
10728866|NCT02775916|11892780|FG001|STARTED|Overall Study||10
10728867|NCT02775916|11892779|FG000|COMPLETED|Overall Study||17
10728868|NCT02775916|11892780|FG001|COMPLETED|Overall Study||10
10728869|NCT02775916|11892779|FG000|NOT COMPLETED|Overall Study||3
10728870|NCT02775916|11892780|FG001|NOT COMPLETED|Overall Study||0
10728871|NCT02776033|11892789|FG000|STARTED|Overall Study||18
10728872|NCT02776033|11892790|FG001|STARTED|Overall Study||23
10728873|NCT02776033|11892791|FG002|STARTED|Overall Study||24
10728874|NCT02776033|11892789|FG000|COMPLETED|Overall Study||14
10728875|NCT02776033|11892790|FG001|COMPLETED|Overall Study||21
10728876|NCT02776033|11892791|FG002|COMPLETED|Overall Study||22
10728877|NCT02776033|11892789|FG000|NOT COMPLETED|Overall Study||4
10728878|NCT02776033|11892790|FG001|NOT COMPLETED|Overall Study||2
10728879|NCT02776033|11892791|FG002|NOT COMPLETED|Overall Study||2
10728880|NCT02776553|11892807|FG000|STARTED|Overall Study|One subject was eliminated for repeated hospitalizations.|9
10728881|NCT02776553|11892808|FG001|STARTED|Overall Study|Two subjects were eliminated for repeated hospitalizations.|8
10728882|NCT02776553|11892807|FG000|COMPLETED|Overall Study||6
10728883|NCT02776553|11892808|FG001|COMPLETED|Overall Study||5
10728884|NCT02776553|11892807|FG000|NOT COMPLETED|Overall Study||3
10728885|NCT02776553|11892808|FG001|NOT COMPLETED|Overall Study||3
10728886|NCT02776644|11892816|FG000|STARTED|Overall Study||1223
10728887|NCT02776644|11892817|FG001|STARTED|Overall Study||126
10728888|NCT02776644|11892816|FG000|COMPLETED|Overall Study||1223
10728889|NCT02776644|11892817|FG001|COMPLETED|Overall Study||126
10728890|NCT02776644|11892816|FG000|NOT COMPLETED|Overall Study||0
10728891|NCT02776644|11892817|FG001|NOT COMPLETED|Overall Study||0
10728892|NCT02776670|11892825|FG000|STARTED|Overall Study||117
10728893|NCT02776670|11892826|FG001|STARTED|Overall Study||114
10728894|NCT02776670|11892825|FG000|Full Analysis Set (FAS)|Overall Study||117
10728895|NCT02776670|11892826|FG001|Full Analysis Set (FAS)|Overall Study||114
10728896|NCT02776670|11892825|FG000|Per Protocol Analysis Set (PPS)|Overall Study||115
10728897|NCT02776670|11892826|FG001|Per Protocol Analysis Set (PPS)|Overall Study||113
10728898|NCT02776670|11892825|FG000|Safety Analysis Set|Overall Study||117
10728899|NCT02776670|11892826|FG001|Safety Analysis Set|Overall Study||114
10728900|NCT02776670|11892825|FG000|COMPLETED|Overall Study||117
10728902|NCT02776670|11892825|FG000|NOT COMPLETED|Overall Study||0
10728903|NCT02776670|11892826|FG001|NOT COMPLETED|Overall Study||6
10728904|NCT02776683|11892832|FG000|STARTED|Pre-switch Period|Assigned to trial medication or enrolled/treated|123
10728905|NCT02776683|11892833|FG001|STARTED|Pre-switch Period||0
10728906|NCT02776683|11892832|FG000|COMPLETED|Pre-switch Period|Entered into Switch Set|43
10728907|NCT02776683|11892833|FG001|COMPLETED|Pre-switch Period||0
10728908|NCT02776683|11892832|FG000|NOT COMPLETED|Pre-switch Period||80
10728909|NCT02776683|11892833|FG001|NOT COMPLETED|Pre-switch Period||0
10728910|NCT02776683|11892832|FG000|STARTED|Post-switch Period||0
10728911|NCT02776683|11892833|FG001|STARTED|Post-switch Period|Entered into Switch Set|43
10728912|NCT02776683|11892832|FG000|COMPLETED|Post-switch Period||0
10728913|NCT02776683|11892833|FG001|COMPLETED|Post-switch Period||0
10728914|NCT02776683|11892832|FG000|NOT COMPLETED|Post-switch Period||0
10728915|NCT02776683|11892833|FG001|NOT COMPLETED|Post-switch Period||43
10728916|NCT02776774|11892837|FG000|STARTED|Overall Study||91
10728917|NCT02776774|11892837|FG000|COMPLETED|Overall Study|Total after data cleaning|91
10728918|NCT02776774|11892837|FG000|NOT COMPLETED|Overall Study||0
10728919|NCT02776904|11892843|FG000|STARTED|Overall Study||281
10728920|NCT02776904|11892844|FG001|STARTED|Overall Study||46
10728921|NCT02776904|11892843|FG000|Gait Assessment|Overall Study||178
10728922|NCT02776904|11892844|FG001|Gait Assessment|Overall Study||32
10728923|NCT02776904|11892843|FG000|ImPACT|Overall Study||21
10728924|NCT02776904|11892844|FG001|ImPACT|Overall Study|ImPACT testing for the concussed subjects was completed for the clinical assessment (not research).|46
10728925|NCT02776904|11892843|FG000|COMPLETED|Overall Study||281
10728926|NCT02776904|11892844|FG001|COMPLETED|Overall Study||46
10728927|NCT02776904|11892843|FG000|NOT COMPLETED|Overall Study||0
10728928|NCT02776904|11892844|FG001|NOT COMPLETED|Overall Study||0
10728929|NCT02777021|11892859|FG000|STARTED|Overall Study||60
10728930|NCT02777021|11892860|FG001|STARTED|Overall Study||94
10728931|NCT02777021|11892859|FG000|COMPLETED|Overall Study||43
10728932|NCT02777021|11892860|FG001|COMPLETED|Overall Study||77
10728933|NCT02777021|11892859|FG000|NOT COMPLETED|Overall Study||17
10728934|NCT02777021|11892860|FG001|NOT COMPLETED|Overall Study||17
10728935|NCT02777086|11892868|FG000|STARTED|Overall Study||261
10728936|NCT02777086|11892869|FG001|STARTED|Overall Study||250
10728937|NCT02777086|11892868|FG000|COMPLETED|Overall Study||165
10728938|NCT02777086|11892869|FG001|COMPLETED|Overall Study||151
10728939|NCT02777086|11892868|FG000|NOT COMPLETED|Overall Study||96
10728940|NCT02777086|11892869|FG001|NOT COMPLETED|Overall Study||99
10728941|NCT02777125|11892877|FG000|STARTED|Overall Study||488
10728942|NCT02777125|11892878|FG001|STARTED|Overall Study||492
10728943|NCT02777125|11892877|FG000|COMPLETED|Overall Study||445
10728944|NCT02777125|11892878|FG001|COMPLETED|Overall Study||445
10728945|NCT02777125|11892877|FG000|NOT COMPLETED|Overall Study||43
10728946|NCT02777125|11892878|FG001|NOT COMPLETED|Overall Study||47
10728947|NCT02777242|11892885|FG000|STARTED|Overall Study||65
10728948|NCT02777242|11892885|FG000|COMPLETED|Overall Study||59
10728949|NCT02777242|11892885|FG000|NOT COMPLETED|Overall Study||6
10728950|NCT02777268|11892889|FG000|STARTED|Overall Study||16
10728951|NCT02777268|11892889|FG000|COMPLETED|Overall Study||16
10728952|NCT02777268|11892889|FG000|NOT COMPLETED|Overall Study||0
10728953|NCT02777333|11892913|FG000|STARTED|Overall Study||15
10728954|NCT02777333|11892914|FG001|STARTED|Overall Study||15
10728955|NCT02777333|11892913|FG000|COMPLETED|Overall Study||15
10728956|NCT02777333|11892914|FG001|COMPLETED|Overall Study||13
10728957|NCT02777333|11892913|FG000|NOT COMPLETED|Overall Study||0
10728958|NCT02777333|11892914|FG001|NOT COMPLETED|Overall Study||2
10777626|NCT03341533|11939534|FG000|COMPLETED|Overall Study||69
10777627|NCT03341533|11939535|FG001|COMPLETED|Overall Study||68
10777628|NCT03341533|11939534|FG000|NOT COMPLETED|Overall Study||3
10777629|NCT03341533|11939535|FG001|NOT COMPLETED|Overall Study||2
10777630|NCT03341546|11939541|FG000|STARTED|Overall Study||20
10777631|NCT03341546|11939541|FG000|COMPLETED|Overall Study||20
10777632|NCT03341546|11939541|FG000|NOT COMPLETED|Overall Study||0
10777633|NCT03341637|11939547|FG000|STARTED|Overall Study||100
10777634|NCT03341637|11939548|FG001|STARTED|Overall Study||300
10777635|NCT03341637|11939547|FG000|COMPLETED|Overall Study||95
10777636|NCT03341637|11939548|FG001|COMPLETED|Overall Study||296
10777637|NCT03341637|11939547|FG000|NOT COMPLETED|Overall Study||5
10777638|NCT03341637|11939548|FG001|NOT COMPLETED|Overall Study||4
10777639|NCT03341728|11939554|FG000|STARTED|Session 1||7
10777640|NCT03341728|11939555|FG001|STARTED|Session 1||7
10777641|NCT03341728|11939554|FG000|COMPLETED|Session 1||7
10777642|NCT03341728|11939555|FG001|COMPLETED|Session 1||7
10777643|NCT03341728|11939554|FG000|NOT COMPLETED|Session 1||0
10777644|NCT03341728|11939555|FG001|NOT COMPLETED|Session 1||0
10777645|NCT03341728|11939554|FG000|STARTED|Washout (1 Week)||7
10777646|NCT03341728|11939555|FG001|STARTED|Washout (1 Week)||7
10777647|NCT03341728|11939554|FG000|COMPLETED|Washout (1 Week)||7
10777648|NCT03341728|11939555|FG001|COMPLETED|Washout (1 Week)||7
10777649|NCT03341728|11939554|FG000|NOT COMPLETED|Washout (1 Week)||0
10777650|NCT03341728|11939555|FG001|NOT COMPLETED|Washout (1 Week)||0
10777651|NCT03341728|11939554|FG000|STARTED|Session 2||7
10777652|NCT03341728|11939555|FG001|STARTED|Session 2||7
10777653|NCT03341728|11939554|FG000|COMPLETED|Session 2||7
10777654|NCT03341728|11939555|FG001|COMPLETED|Session 2||7
10777655|NCT03341728|11939554|FG000|NOT COMPLETED|Session 2||0
10777656|NCT03341728|11939555|FG001|NOT COMPLETED|Session 2||0
10777657|NCT03341910|11939565|FG000|STARTED|Overall Study||54
10777658|NCT03341910|11939566|FG001|STARTED|Overall Study||49
10777659|NCT03341910|11939567|FG002|STARTED|Overall Study||26
10777660|NCT03341910|11939568|FG003|STARTED|Overall Study||26
10777661|NCT03341910|11939565|FG000|COMPLETED|Overall Study||54
10777662|NCT03341910|11939566|FG001|COMPLETED|Overall Study||49
10777663|NCT03341910|11939567|FG002|COMPLETED|Overall Study||26
10777664|NCT03341910|11939568|FG003|COMPLETED|Overall Study||26
10777665|NCT03341910|11939565|FG000|NOT COMPLETED|Overall Study||0
10777666|NCT03341910|11939566|FG001|NOT COMPLETED|Overall Study||0
10777667|NCT03341910|11939567|FG002|NOT COMPLETED|Overall Study||0
10777668|NCT03341910|11939568|FG003|NOT COMPLETED|Overall Study||0
10777669|NCT03341923|11939578|FG000|STARTED|Period 1, First 14 Days of Wear||67
10777670|NCT03341923|11939579|FG001|STARTED|Period 1, First 14 Days of Wear||67
10777671|NCT03341923|11939578|FG000|COMPLETED|Period 1, First 14 Days of Wear||67
10777672|NCT03341923|11939579|FG001|COMPLETED|Period 1, First 14 Days of Wear||67
10777673|NCT03341923|11939578|FG000|NOT COMPLETED|Period 1, First 14 Days of Wear||0
10777674|NCT03341923|11939579|FG001|NOT COMPLETED|Period 1, First 14 Days of Wear||0
10777675|NCT03341923|11939578|FG000|STARTED|Period 2, Second 14 Days of Wear||67
10777676|NCT03341923|11939579|FG001|STARTED|Period 2, Second 14 Days of Wear|Subject completed Period 1 but was discontinued before starting Period 2.|66
10777677|NCT03341923|11939578|FG000|COMPLETED|Period 2, Second 14 Days of Wear||67
10777678|NCT03341923|11939579|FG001|COMPLETED|Period 2, Second 14 Days of Wear||65
10777679|NCT03341923|11939578|FG000|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
10777680|NCT03341923|11939579|FG001|NOT COMPLETED|Period 2, Second 14 Days of Wear||1
10777681|NCT03341975|11939589|FG000|STARTED|Overall Study||44
10777682|NCT03341975|11939590|FG001|STARTED|Overall Study||47
10777683|NCT03341975|11939589|FG000|COMPLETED|Overall Study||44
10777684|NCT03341975|11939590|FG001|COMPLETED|Overall Study||47
10777685|NCT03341975|11939589|FG000|NOT COMPLETED|Overall Study||0
10777686|NCT03341975|11939590|FG001|NOT COMPLETED|Overall Study||0
10777693|NCT03342469|11939607|FG000|STARTED|Overall Study||9
10777694|NCT03342469|11939608|FG001|STARTED|Overall Study||9
10728959|NCT05283499|11892922|FG000|STARTED|Overall Study||26
10728960|NCT05283499|11892923|FG001|STARTED|Overall Study||27
10728961|NCT05283499|11892922|FG000|COMPLETED|Overall Study||25
10728962|NCT05283499|11892923|FG001|COMPLETED|Overall Study||25
10728963|NCT05283499|11892922|FG000|NOT COMPLETED|Overall Study||1
10728964|NCT05283499|11892923|FG001|NOT COMPLETED|Overall Study||2
10728965|NCT04919317|11892931|FG000|STARTED|Hospitalization and Wound Follow-up||26
10728966|NCT04919317|11892932|FG001|STARTED|Hospitalization and Wound Follow-up||30
10728967|NCT04919317|11892931|FG000|COMPLETED|Hospitalization and Wound Follow-up||26
10728968|NCT04919317|11892932|FG001|COMPLETED|Hospitalization and Wound Follow-up|5 patients completed the study but should not have been enrolled as they met pre-study exclusion criteria (chronic pain due to fibromyalgia)|25
10728969|NCT04919317|11892931|FG000|NOT COMPLETED|Hospitalization and Wound Follow-up||0
10728970|NCT04919317|11892932|FG001|NOT COMPLETED|Hospitalization and Wound Follow-up||5
10728971|NCT04919317|11892931|FG000|STARTED|SF-36 Quality of Life Survey Completion||26
10728972|NCT04919317|11892932|FG001|STARTED|SF-36 Quality of Life Survey Completion||25
10728973|NCT04919317|11892931|FG000|COMPLETED|SF-36 Quality of Life Survey Completion||14
10728974|NCT04919317|11892932|FG001|COMPLETED|SF-36 Quality of Life Survey Completion||19
10728975|NCT04919317|11892931|FG000|NOT COMPLETED|SF-36 Quality of Life Survey Completion||12
10728976|NCT04919317|11892932|FG001|NOT COMPLETED|SF-36 Quality of Life Survey Completion||6
10728977|NCT04647110|11892940|FG000|STARTED|Overall Study||345
10728978|NCT04647110|11892941|FG001|STARTED|Overall Study||204
10728979|NCT04647110|11892940|FG000|COMPLETED|Overall Study||345
10728980|NCT04647110|11892941|FG001|COMPLETED|Overall Study||204
10728981|NCT04647110|11892940|FG000|NOT COMPLETED|Overall Study||0
10728982|NCT04647110|11892941|FG001|NOT COMPLETED|Overall Study||0
10728983|NCT04537949|11893020|FG000|STARTED|Overall Study||12
10728984|NCT04537949|11893021|FG001|STARTED|Overall Study||12
10728985|NCT04537949|11893022|FG002|STARTED|Overall Study||12
10728986|NCT04537949|11893023|FG003|STARTED|Overall Study||12
10728987|NCT04537949|11893024|FG004|STARTED|Overall Study||12
10728988|NCT04537949|11893025|FG005|STARTED|Overall Study||12
10728989|NCT04537949|11893026|FG006|STARTED|Overall Study||12
10728990|NCT04537949|11893027|FG007|STARTED|Overall Study||12
10728991|NCT04537949|11893020|FG000|COMPLETED|Overall Study||11
10728992|NCT04537949|11893021|FG001|COMPLETED|Overall Study||12
10728993|NCT04537949|11893022|FG002|COMPLETED|Overall Study||12
10728994|NCT04537949|11893023|FG003|COMPLETED|Overall Study||12
10728995|NCT04537949|11893024|FG004|COMPLETED|Overall Study||12
10728996|NCT04537949|11893025|FG005|COMPLETED|Overall Study||12
10728997|NCT04537949|11893026|FG006|COMPLETED|Overall Study||12
10728998|NCT04537949|11893027|FG007|COMPLETED|Overall Study||12
10728999|NCT04537949|11893020|FG000|NOT COMPLETED|Overall Study||1
10729000|NCT04537949|11893021|FG001|NOT COMPLETED|Overall Study||0
10729001|NCT04537949|11893022|FG002|NOT COMPLETED|Overall Study||0
10729002|NCT04537949|11893023|FG003|NOT COMPLETED|Overall Study||0
10729003|NCT04537949|11893024|FG004|NOT COMPLETED|Overall Study||0
10729004|NCT04537949|11893025|FG005|NOT COMPLETED|Overall Study||0
10729005|NCT04537949|11893026|FG006|NOT COMPLETED|Overall Study||0
10729006|NCT04537949|11893027|FG007|NOT COMPLETED|Overall Study||0
10729007|NCT04346628|11893047|FG000|STARTED|Overall Study||74
10729008|NCT04346628|11893048|FG001|STARTED|Overall Study||75
10729009|NCT04346628|11893047|FG000|Intention-to-treat (ITT) Analysis Set|Overall Study||74
10729010|NCT04346628|11893048|FG001|Intention-to-treat (ITT) Analysis Set|Overall Study||75
10729011|NCT04346628|11893047|FG000|Symptomatic Modified ITT (smITT) Analysis Set|Overall Study||70
10729012|NCT04346628|11893048|FG001|Symptomatic Modified ITT (smITT) Analysis Set|Overall Study||65
10729013|NCT04346628|11893047|FG000|Modified ITT (mITT) Analysis|Overall Study||57
10729014|NCT04346628|11893048|FG001|Modified ITT (mITT) Analysis|Overall Study||59
10729015|NCT04346628|11893047|FG000|COMPLETED|Overall Study||68
10729016|NCT04346628|11893048|FG001|COMPLETED|Overall Study||62
10729017|NCT04346628|11893047|FG000|NOT COMPLETED|Overall Study||6
10729018|NCT04346628|11893048|FG001|NOT COMPLETED|Overall Study||13
10729031|NCT04114604|11893065|FG000|STARTED|Overall Study||10
10729032|NCT04114604|11893065|FG000|COMPLETED|Overall Study||10
10729033|NCT04114604|11893065|FG000|NOT COMPLETED|Overall Study||0
10729034|NCT04112940|11893073|FG000|STARTED|Overall Study||12
10729035|NCT04112940|11893073|FG000|COMPLETED|Overall Study||12
10729036|NCT04112940|11893073|FG000|NOT COMPLETED|Overall Study||0
10729037|NCT04064684|11893086|FG000|STARTED|Overall Study||1
10729038|NCT04064684|11893087|FG001|STARTED|Overall Study||1
10729039|NCT04064684|11893086|FG000|COMPLETED|Overall Study||1
10729040|NCT04064684|11893087|FG001|COMPLETED|Overall Study||1
10729041|NCT04064684|11893086|FG000|NOT COMPLETED|Overall Study||0
10729042|NCT04064684|11893087|FG001|NOT COMPLETED|Overall Study||0
10729043|NCT04040933|11893093|FG000|STARTED|Overall Study||36
10729044|NCT04040933|11893093|FG000|Treated|Overall Study||36
10729045|NCT04040933|11893093|FG000|COMPLETED|Overall Study||33
10729046|NCT04040933|11893093|FG000|NOT COMPLETED|Overall Study||3
10729047|NCT03763175|11893107|FG000|STARTED|Overall Study||20
10729048|NCT03763175|11893108|FG001|STARTED|Overall Study||19
10729049|NCT03763175|11893109|FG002|STARTED|Overall Study||20
10729050|NCT03763175|11893107|FG000|COMPLETED|Overall Study||19
10729051|NCT03763175|11893108|FG001|COMPLETED|Overall Study||17
10729052|NCT03763175|11893109|FG002|COMPLETED|Overall Study||19
10729053|NCT03763175|11893107|FG000|NOT COMPLETED|Overall Study||1
10729054|NCT03763175|11893108|FG001|NOT COMPLETED|Overall Study||2
10729055|NCT03763175|11893109|FG002|NOT COMPLETED|Overall Study||1
10729056|NCT03686514|11893119|FG000|STARTED|Overall Study||20
10729057|NCT03686514|11893120|FG001|STARTED|Overall Study||19
10729058|NCT03686514|11893119|FG000|Started 2018-2019 Vaccine Year|Overall Study||10
10729059|NCT03686514|11893120|FG001|Started 2018-2019 Vaccine Year|Overall Study||10
10729060|NCT03686514|11893119|FG000|Completed 2018-2019 Vaccine Follow up|Overall Study||10
10729061|NCT03686514|11893120|FG001|Completed 2018-2019 Vaccine Follow up|Overall Study||10
10729062|NCT03686514|11893119|FG000|Started 2019-2020 Vaccine Year|Overall Study||10
10729063|NCT03686514|11893120|FG001|Started 2019-2020 Vaccine Year|Overall Study||10
10729064|NCT03686514|11893119|FG000|Completed 2019-2020 Vaccine Follow up|Overall Study||10
10729065|NCT03686514|11893120|FG001|Completed 2019-2020 Vaccine Follow up|Overall Study||10
10729066|NCT03686514|11893119|FG000|COMPLETED|Overall Study||20
10729067|NCT03686514|11893120|FG001|COMPLETED|Overall Study||19
10729068|NCT03686514|11893119|FG000|NOT COMPLETED|Overall Study||0
10729069|NCT03686514|11893120|FG001|NOT COMPLETED|Overall Study||0
10729073|NCT03576976|11893132|FG000|STARTED|Overall Study||27
10729074|NCT03576976|11893133|FG001|STARTED|Overall Study||28
10729075|NCT03576976|11893132|FG000|COMPLETED|Overall Study||18
10729076|NCT03576976|11893133|FG001|COMPLETED|Overall Study||17
10729077|NCT03576976|11893132|FG000|NOT COMPLETED|Overall Study||9
10729078|NCT03576976|11893133|FG001|NOT COMPLETED|Overall Study||11
10729079|NCT03439670|11893145|FG000|STARTED|Overall Study||30
10729080|NCT03439670|11893146|FG001|STARTED|Overall Study||30
10729081|NCT03439670|11893147|FG002|STARTED|Overall Study||15
10729082|NCT03439670|11893148|FG003|STARTED|Overall Study||16
10729083|NCT03439670|11893149|FG004|STARTED|Overall Study||15
10729084|NCT03439670|11893150|FG005|STARTED|Overall Study||15
10729085|NCT03439670|11893145|FG000|COMPLETED|Overall Study||28
10729086|NCT03439670|11893146|FG001|COMPLETED|Overall Study||26
10729087|NCT03439670|11893147|FG002|COMPLETED|Overall Study||15
10729088|NCT03439670|11893148|FG003|COMPLETED|Overall Study||15
10729089|NCT03439670|11893149|FG004|COMPLETED|Overall Study||14
10729090|NCT03439670|11893150|FG005|COMPLETED|Overall Study||14
10729091|NCT03439670|11893145|FG000|NOT COMPLETED|Overall Study||2
10729092|NCT03439670|11893146|FG001|NOT COMPLETED|Overall Study||4
10729093|NCT03439670|11893147|FG002|NOT COMPLETED|Overall Study||0
10729094|NCT03439670|11893148|FG003|NOT COMPLETED|Overall Study||1
10729095|NCT03439670|11893149|FG004|NOT COMPLETED|Overall Study||1
10729096|NCT03439670|11893150|FG005|NOT COMPLETED|Overall Study||1
10729097|NCT03428997|11893160|FG000|STARTED|Overall Study||24
10729098|NCT03428997|11893160|FG000|COMPLETED|Overall Study||16
10729099|NCT03428997|11893160|FG000|NOT COMPLETED|Overall Study||8
10729100|NCT03385564|11893170|FG000|STARTED|Overall Study||7
10729101|NCT03385564|11893171|FG001|STARTED|Overall Study||15
10729102|NCT03385564|11893172|FG002|STARTED|Overall Study||21
10729103|NCT03385564|11893173|FG003|STARTED|Overall Study||26
10729104|NCT03385564|11893170|FG000|Intent to Treat Set|Overall Study||7
10729105|NCT03385564|11893171|FG001|Intent to Treat Set|Overall Study||15
10729106|NCT03385564|11893172|FG002|Intent to Treat Set|Overall Study||21
10729107|NCT03385564|11893173|FG003|Intent to Treat Set|Overall Study||26
10729108|NCT03385564|11893170|FG000|COMPLETED|Overall Study||7
10729109|NCT03385564|11893171|FG001|COMPLETED|Overall Study||14
10729110|NCT03385564|11893172|FG002|COMPLETED|Overall Study||16
10729111|NCT03385564|11893173|FG003|COMPLETED|Overall Study||17
10729112|NCT03385564|11893170|FG000|NOT COMPLETED|Overall Study||0
10729113|NCT03385564|11893171|FG001|NOT COMPLETED|Overall Study||1
10729114|NCT03385564|11893172|FG002|NOT COMPLETED|Overall Study||5
10729115|NCT03385564|11893173|FG003|NOT COMPLETED|Overall Study||9
10729116|NCT03335163|11893183|FG000|STARTED|Overall Study||48
10729117|NCT03335163|11893183|FG000|Completed Visit 2|Overall Study||32
10729118|NCT03335163|11893183|FG000|Completed Visit 3|Overall Study||31
10729119|NCT03335163|11893183|FG000|COMPLETED|Overall Study||27
10729120|NCT03335163|11893183|FG000|NOT COMPLETED|Overall Study||21
10729121|NCT03235544|11893191|FG000|STARTED|Overall Study||12
10729122|NCT03235544|11893192|FG001|STARTED|Overall Study||41
10729123|NCT03235544|11893193|FG002|STARTED|Overall Study||31
10729124|NCT03235544|11893194|FG003|STARTED|Overall Study||77
10729125|NCT03235544|11893191|FG000|COMPLETED|Overall Study||0
10729126|NCT03235544|11893192|FG001|COMPLETED|Overall Study||0
10729127|NCT03235544|11893193|FG002|COMPLETED|Overall Study||0
10729128|NCT03235544|11893194|FG003|COMPLETED|Overall Study||0
10729129|NCT03235544|11893191|FG000|NOT COMPLETED|Overall Study||12
10729130|NCT03235544|11893192|FG001|NOT COMPLETED|Overall Study||41
10729131|NCT03235544|11893193|FG002|NOT COMPLETED|Overall Study||31
10729132|NCT03235544|11893194|FG003|NOT COMPLETED|Overall Study||77
10729136|NCT03023046|11893209|FG000|STARTED|Overall Study||54
10729137|NCT03023046|11893209|FG000|COMPLETED|Overall Study||53
10729138|NCT03023046|11893209|FG000|NOT COMPLETED|Overall Study||1
10729139|NCT03004248|11893215|FG000|STARTED|Overall Study||2691
10729140|NCT03004248|11893215|FG000|Received a Single Treatment|Overall Study||1809
10729141|NCT03004248|11893215|FG000|Received Two Treatments|Overall Study||314
10729142|NCT03004248|11893215|FG000|Received Three Treatments|Overall Study||568
10729143|NCT03004248|11893215|FG000|COMPLETED|Overall Study||2314
10729144|NCT03004248|11893215|FG000|NOT COMPLETED|Overall Study||377
10729145|NCT02947646|11893223|FG000|STARTED|Overall Study||10
10729146|NCT02947646|11893224|FG001|STARTED|Overall Study||10
10729147|NCT02947646|11893223|FG000|COMPLETED|Overall Study||10
10729148|NCT02947646|11893224|FG001|COMPLETED|Overall Study||9
10729149|NCT02947646|11893223|FG000|NOT COMPLETED|Overall Study||0
10729150|NCT02947646|11893224|FG001|NOT COMPLETED|Overall Study||1
10729154|NCT02590640|11893242|FG000|STARTED|Overall Study||40
10729155|NCT02590640|11893242|FG000|COMPLETED|Overall Study||37
10729156|NCT02590640|11893242|FG000|NOT COMPLETED|Overall Study||3
10729157|NCT02522715|11893249|FG000|STARTED|Overall Study||3
10729158|NCT02522715|11893250|FG001|STARTED|Overall Study|+1 early withdrawal|33
10729159|NCT02522715|11893249|FG000|COMPLETED|Overall Study||3
10729160|NCT02522715|11893250|FG001|COMPLETED|Overall Study||33
10729161|NCT02522715|11893249|FG000|NOT COMPLETED|Overall Study||0
10729162|NCT02522715|11893250|FG001|NOT COMPLETED|Overall Study||0
10729175|NCT02421172|11893271|FG000|STARTED|Period 1||33
10729176|NCT02421172|11893272|FG001|STARTED|Period 1||33
10729177|NCT02421172|11893273|FG002|STARTED|Period 1||0
10729178|NCT02421172|11893274|FG003|STARTED|Period 1||0
10729179|NCT02421172|11893275|FG004|STARTED|Period 1||0
10729180|NCT02421172|11893271|FG000|PD Analysis Set Period 1|Period 1||31
10729181|NCT02421172|11893272|FG001|PD Analysis Set Period 1|Period 1||33
10729182|NCT02421172|11893273|FG002|PD Analysis Set Period 1|Period 1||0
10729183|NCT02421172|11893274|FG003|PD Analysis Set Period 1|Period 1||0
10729184|NCT02421172|11893275|FG004|PD Analysis Set Period 1|Period 1||0
10729185|NCT02421172|11893271|FG000|PK Analysis Set Period 1|Period 1||33
10729186|NCT02421172|11893272|FG001|PK Analysis Set Period 1|Period 1||0
10729187|NCT02421172|11893273|FG002|PK Analysis Set Period 1|Period 1||0
10729188|NCT02421172|11893274|FG003|PK Analysis Set Period 1|Period 1||0
10729189|NCT02421172|11893275|FG004|PK Analysis Set Period 1|Period 1||0
10729190|NCT02421172|11893271|FG000|COMPLETED|Period 1||29
10729191|NCT02421172|11893272|FG001|COMPLETED|Period 1||31
10729192|NCT02421172|11893273|FG002|COMPLETED|Period 1||0
10729193|NCT02421172|11893274|FG003|COMPLETED|Period 1||0
10729194|NCT02421172|11893275|FG004|COMPLETED|Period 1||0
10729195|NCT02421172|11893271|FG000|NOT COMPLETED|Period 1||4
10729196|NCT02421172|11893272|FG001|NOT COMPLETED|Period 1||2
10729197|NCT02421172|11893273|FG002|NOT COMPLETED|Period 1||0
10729198|NCT02421172|11893274|FG003|NOT COMPLETED|Period 1||0
10729199|NCT02421172|11893275|FG004|NOT COMPLETED|Period 1||0
10729200|NCT02421172|11893271|FG000|STARTED|Period 2||0
10729201|NCT02421172|11893272|FG001|STARTED|Period 2||0
10729202|NCT02421172|11893273|FG002|STARTED|Period 2||29
10729203|NCT02421172|11893274|FG003|STARTED|Period 2||16
10729204|NCT02421172|11893275|FG004|STARTED|Period 2||15
10729205|NCT02421172|11893271|FG000|COMPLETED|Period 2||0
10729206|NCT02421172|11893272|FG001|COMPLETED|Period 2||0
10729207|NCT02421172|11893273|FG002|COMPLETED|Period 2||22
10729208|NCT02421172|11893274|FG003|COMPLETED|Period 2||13
10729209|NCT02421172|11893275|FG004|COMPLETED|Period 2||14
10729210|NCT02421172|11893271|FG000|NOT COMPLETED|Period 2||0
10729211|NCT02421172|11893272|FG001|NOT COMPLETED|Period 2||0
10729212|NCT02421172|11893273|FG002|NOT COMPLETED|Period 2||7
10729213|NCT02421172|11893274|FG003|NOT COMPLETED|Period 2||3
10729214|NCT02421172|11893275|FG004|NOT COMPLETED|Period 2||1
10729215|NCT02241967|11893290|FG000|STARTED|Overall Study||30
10729216|NCT02241967|11893291|FG001|STARTED|Overall Study||30
10729217|NCT02241967|11893292|FG002|STARTED|Overall Study||30
10729218|NCT02241967|11893293|FG003|STARTED|Overall Study||29
10729219|NCT02241967|11893290|FG000|COMPLETED|Overall Study||30
10729220|NCT02241967|11893291|FG001|COMPLETED|Overall Study||30
10729221|NCT02241967|11893292|FG002|COMPLETED|Overall Study||30
10729222|NCT02241967|11893293|FG003|COMPLETED|Overall Study||29
10729223|NCT02241967|11893290|FG000|NOT COMPLETED|Overall Study||0
10729224|NCT02241967|11893291|FG001|NOT COMPLETED|Overall Study||0
10729225|NCT02241967|11893292|FG002|NOT COMPLETED|Overall Study||0
10729226|NCT02241967|11893293|FG003|NOT COMPLETED|Overall Study||0
10729227|NCT02012296|11893310|FG000|STARTED|Overall Study||33
10729228|NCT02012296|11893311|FG001|STARTED|Overall Study||33
10729229|NCT02012296|11893312|FG002|STARTED|Overall Study||22
10729230|NCT02012296|11893310|FG000|COMPLETED|Overall Study||33
10729231|NCT02012296|11893311|FG001|COMPLETED|Overall Study||32
10729232|NCT02012296|11893312|FG002|COMPLETED|Overall Study||0
10729233|NCT02012296|11893310|FG000|NOT COMPLETED|Overall Study||0
10729234|NCT02012296|11893311|FG001|NOT COMPLETED|Overall Study||1
10729235|NCT02012296|11893312|FG002|NOT COMPLETED|Overall Study||22
10729236|NCT01915498|11893342|FG000|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
10729237|NCT01915498|11893343|FG001|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
10729238|NCT01915498|11893344|FG002|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
10729239|NCT01915498|11893345|FG003|STARTED|Main Analysis (Sept 2013 - Sept 2017)||8
10729240|NCT01915498|11893346|FG004|STARTED|Main Analysis (Sept 2013 - Sept 2017)||5
10729241|NCT01915498|11893347|FG005|STARTED|Main Analysis (Sept 2013 - Sept 2017)||9
10729242|NCT01915498|11893348|FG006|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
10729243|NCT01915498|11893349|FG007|STARTED|Main Analysis (Sept 2013 - Sept 2017)||22
10729244|NCT01915498|11893350|FG008|STARTED|Main Analysis (Sept 2013 - Sept 2017)||6
10729245|NCT01915498|11893351|FG009|STARTED|Main Analysis (Sept 2013 - Sept 2017)||14
10729246|NCT01915498|11893352|FG010|STARTED|Main Analysis (Sept 2013 - Sept 2017)||9
10729247|NCT01915498|11893353|FG011|STARTED|Main Analysis (Sept 2013 - Sept 2017)||5
10729248|NCT01915498|11893354|FG012|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
10729249|NCT01915498|11893355|FG013|STARTED|Main Analysis (Sept 2013 - Sept 2017)||49
10729250|NCT01915498|11893356|FG014|STARTED|Main Analysis (Sept 2013 - Sept 2017)||25
10729251|NCT01915498|11893357|FG015|STARTED|Main Analysis (Sept 2013 - Sept 2017)||25
10729252|NCT01915498|11893358|FG016|STARTED|Main Analysis (Sept 2013 - Sept 2017)||27
10729253|NCT01915498|11893359|FG017|STARTED|Main Analysis (Sept 2013 - Sept 2017)||106
10729254|NCT01915498|11893360|FG018|STARTED|Main Analysis (Sept 2013 - Sept 2017)||0
10729255|NCT01915498|11893342|FG000|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
10729256|NCT01915498|11893343|FG001|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
10729257|NCT01915498|11893344|FG002|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
10729258|NCT01915498|11893345|FG003|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
10729259|NCT01915498|11893346|FG004|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
10729260|NCT01915498|11893347|FG005|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
10729261|NCT01915498|11893348|FG006|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
10729262|NCT01915498|11893349|FG007|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||1
10729263|NCT01915498|11893350|FG008|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
10729264|NCT01915498|11893351|FG009|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
10729265|NCT01915498|11893352|FG010|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
10729266|NCT01915498|11893353|FG011|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||1
10729267|NCT01915498|11893354|FG012|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
10729268|NCT01915498|11893355|FG013|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||3
10729269|NCT01915498|11893356|FG014|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
10729270|NCT01915498|11893357|FG015|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||2
10729271|NCT01915498|11893358|FG016|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||3
10729272|NCT01915498|11893359|FG017|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||6
10729273|NCT01915498|11893360|FG018|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
10729274|NCT01915498|11893342|FG000|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
10729275|NCT01915498|11893343|FG001|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
10729276|NCT01915498|11893344|FG002|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
10729277|NCT01915498|11893345|FG003|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||8
10729278|NCT01915498|11893346|FG004|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||5
10814756|NCT02234687|11977635|FG002|STARTED|Overall Study||4
10729279|NCT01915498|11893347|FG005|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||9
10729280|NCT01915498|11893348|FG006|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
10729281|NCT01915498|11893349|FG007|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||21
10729282|NCT01915498|11893350|FG008|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||6
10729283|NCT01915498|11893351|FG009|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||14
10729284|NCT01915498|11893352|FG010|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||9
10729285|NCT01915498|11893353|FG011|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||4
10729286|NCT01915498|11893354|FG012|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
10729287|NCT01915498|11893355|FG013|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||46
10729288|NCT01915498|11893356|FG014|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||25
10729289|NCT01915498|11893357|FG015|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||23
10729290|NCT01915498|11893358|FG016|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||24
10729291|NCT01915498|11893359|FG017|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||100
10814698|NCT02248740|11977557|FG001|STARTED|Overall Study||18
10814699|NCT02248740|11977556|FG000|COMPLETED|Overall Study||0
10814700|NCT02248740|11977557|FG001|COMPLETED|Overall Study||0
10729292|NCT01915498|11893360|FG018|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
10729293|NCT01915498|11893342|FG000|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
10729294|NCT01915498|11893343|FG001|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
10729295|NCT01915498|11893344|FG002|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
10729296|NCT01915498|11893345|FG003|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
10729297|NCT01915498|11893346|FG004|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
10729298|NCT01915498|11893347|FG005|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
10729299|NCT01915498|11893348|FG006|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
10729300|NCT01915498|11893349|FG007|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
10729301|NCT01915498|11893350|FG008|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
10729302|NCT01915498|11893351|FG009|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
10729303|NCT01915498|11893352|FG010|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
10729304|NCT01915498|11893353|FG011|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
10729305|NCT01915498|11893354|FG012|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
10729306|NCT01915498|11893355|FG013|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
10729307|NCT01915498|11893356|FG014|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
10729308|NCT01915498|11893357|FG015|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
10729309|NCT01915498|11893358|FG016|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
10729310|NCT01915498|11893359|FG017|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
10729311|NCT01915498|11893360|FG018|STARTED|Safety Follow-up (Sept 2017 to July 2019||16
10729312|NCT01915498|11893342|FG000|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10729313|NCT01915498|11893343|FG001|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10729314|NCT01915498|11893344|FG002|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10729315|NCT01915498|11893345|FG003|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10729316|NCT01915498|11893346|FG004|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10729317|NCT01915498|11893347|FG005|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10729318|NCT01915498|11893348|FG006|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10729319|NCT01915498|11893349|FG007|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10729320|NCT01915498|11893350|FG008|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10729321|NCT01915498|11893351|FG009|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10729322|NCT01915498|11893352|FG010|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10729323|NCT01915498|11893353|FG011|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10729324|NCT01915498|11893354|FG012|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10729325|NCT01915498|11893355|FG013|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10729326|NCT01915498|11893356|FG014|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10729327|NCT01915498|11893357|FG015|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10729328|NCT01915498|11893358|FG016|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10729329|NCT01915498|11893359|FG017|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10729330|NCT01915498|11893360|FG018|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||14
10729331|NCT01915498|11893342|FG000|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10729332|NCT01915498|11893343|FG001|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10729333|NCT01915498|11893344|FG002|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10729334|NCT01915498|11893345|FG003|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10729335|NCT01915498|11893346|FG004|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10729336|NCT01915498|11893347|FG005|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10729337|NCT01915498|11893348|FG006|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10729338|NCT01915498|11893349|FG007|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10729339|NCT01915498|11893350|FG008|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10729340|NCT01915498|11893351|FG009|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10729341|NCT01915498|11893352|FG010|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10729342|NCT01915498|11893353|FG011|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10729343|NCT01915498|11893354|FG012|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10729344|NCT01915498|11893355|FG013|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10729345|NCT01915498|11893356|FG014|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10729346|NCT01915498|11893357|FG015|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10729347|NCT01915498|11893358|FG016|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10729348|NCT01915498|11893359|FG017|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
10729349|NCT01915498|11893360|FG018|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||2
10729353|NCT00033631|11893454|FG000|STARTED|Overall Study||769
10729354|NCT00033631|11893455|FG001|STARTED|Overall Study||763
10729355|NCT00033631|11893454|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|751
10729356|NCT00033631|11893455|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|748
10729357|NCT00033631|11893454|FG000|NOT COMPLETED|Overall Study||18
10729358|NCT00033631|11893455|FG001|NOT COMPLETED|Overall Study||15
10777695|NCT03342469|11939609|FG002|STARTED|Overall Study||3
10777696|NCT03342469|11939610|FG003|STARTED|Overall Study||8
10777697|NCT03342469|11939607|FG000|COMPLETED|Overall Study||9
10777698|NCT03342469|11939608|FG001|COMPLETED|Overall Study||8
10777699|NCT03342469|11939609|FG002|COMPLETED|Overall Study||3
10777700|NCT03342469|11939610|FG003|COMPLETED|Overall Study||8
10777701|NCT03342469|11939607|FG000|NOT COMPLETED|Overall Study||0
10777702|NCT03342469|11939608|FG001|NOT COMPLETED|Overall Study||1
10777703|NCT03342469|11939609|FG002|NOT COMPLETED|Overall Study||0
10777704|NCT03342469|11939610|FG003|NOT COMPLETED|Overall Study||0
10777705|NCT03342560|11939621|FG000|STARTED|Overall Study||30
10777706|NCT03342560|11939621|FG000|COMPLETED|Overall Study||28
10777707|NCT03342560|11939621|FG000|NOT COMPLETED|Overall Study||2
10777708|NCT03342690|11939629|FG000|STARTED|Overall Study||1164
10777709|NCT03342690|11939629|FG000|COMPLETED|Overall Study||1139
10777710|NCT03342690|11939629|FG000|NOT COMPLETED|Overall Study||25
10729359|NCT04952701|11893462|FG000|STARTED|Control Lens||63
10729360|NCT04952701|11893462|FG000|COMPLETED|Control Lens||59
10729361|NCT04952701|11893462|FG000|NOT COMPLETED|Control Lens||4
10814701|NCT02248740|11977556|FG000|NOT COMPLETED|Overall Study||18
10814702|NCT02248740|11977557|FG001|NOT COMPLETED|Overall Study||18
10814703|NCT02239627|11977565|FG000|STARTED|Overall Study||0
10729362|NCT04952701|11893462|FG000|STARTED|Test Lens||59
10729363|NCT04952701|11893462|FG000|COMPLETED|Test Lens||58
10729364|NCT04952701|11893462|FG000|NOT COMPLETED|Test Lens||1
10729365|NCT04350606|11893468|FG000|STARTED|Overall Study||3
10729366|NCT04350606|11893468|FG000|Treated|Overall Study||3
10729367|NCT04350606|11893468|FG000|Follow-up|Overall Study||3
10729368|NCT04350606|11893468|FG000|COMPLETED|Overall Study||3
10729369|NCT04350606|11893468|FG000|NOT COMPLETED|Overall Study||0
10729370|NCT04074161|11893475|FG000|STARTED|Overall Study||126
10729371|NCT04074161|11893476|FG001|STARTED|Overall Study||127
10729372|NCT04074161|11893477|FG002|STARTED|Overall Study||85
10729373|NCT04074161|11893475|FG000|Full Analysis Set|Overall Study||126
10729374|NCT04074161|11893476|FG001|Full Analysis Set|Overall Study||127
10729375|NCT04074161|11893477|FG002|Full Analysis Set|Overall Study||85
10729376|NCT04074161|11893475|FG000|Safety Analysis Set|Overall Study||126
10729377|NCT04074161|11893476|FG001|Safety Analysis Set|Overall Study||127
10729378|NCT04074161|11893477|FG002|Safety Analysis Set|Overall Study||85
10729379|NCT04074161|11893475|FG000|COMPLETED|Overall Study||120
10729380|NCT04074161|11893476|FG001|COMPLETED|Overall Study||118
10729381|NCT04074161|11893477|FG002|COMPLETED|Overall Study||81
10729382|NCT04074161|11893475|FG000|NOT COMPLETED|Overall Study||6
10729383|NCT04074161|11893476|FG001|NOT COMPLETED|Overall Study||9
10729384|NCT04074161|11893477|FG002|NOT COMPLETED|Overall Study||4
10729385|NCT04033432|11893485|FG000|STARTED|Overall Study||14
10729386|NCT04033432|11893485|FG000|Registered for Study|Overall Study||14
10729387|NCT04033432|11893485|FG000|Started Cycle 1|Overall Study||14
10729388|NCT04033432|11893485|FG000|Started Cycle 2|Overall Study||13
10729389|NCT04033432|11893485|FG000|Started Cycle 3|Overall Study||10
10729390|NCT04033432|11893485|FG000|Started Cycle 4|Overall Study||7
10729391|NCT04033432|11893485|FG000|Started Cycle 5|Overall Study||1
10729392|NCT04033432|11893485|FG000|Started Cycle 6|Overall Study||1
10729393|NCT04033432|11893485|FG000|Started Cycle 7+|Overall Study||1
10729394|NCT04033432|11893485|FG000|COMPLETED|Overall Study||1
10729395|NCT04033432|11893485|FG000|NOT COMPLETED|Overall Study||13
10729396|NCT04030247|11893490|FG000|STARTED|Overall Study||50
10729397|NCT04030247|11893490|FG000|COMPLETED|Overall Study||33
10729398|NCT04030247|11893490|FG000|NOT COMPLETED|Overall Study||17
10729399|NCT03893565|11893499|FG000|STARTED|Double-blind Induction Phase (10 Weeks)||27
10729400|NCT03893565|11893500|FG001|STARTED|Double-blind Induction Phase (10 Weeks)||48
10729401|NCT03893565|11893501|FG002|STARTED|Double-blind Induction Phase (10 Weeks)||11
10729402|NCT03893565|11893502|FG003|STARTED|Double-blind Induction Phase (10 Weeks)||10
10729403|NCT03893565|11893503|FG004|STARTED|Double-blind Induction Phase (10 Weeks)||8
10729404|NCT03893565|11893504|FG005|STARTED|Double-blind Induction Phase (10 Weeks)||0
10729405|NCT03893565|11893505|FG006|STARTED|Double-blind Induction Phase (10 Weeks)||0
10729406|NCT03893565|11893506|FG007|STARTED|Double-blind Induction Phase (10 Weeks)||0
10729407|NCT03893565|11893507|FG008|STARTED|Double-blind Induction Phase (10 Weeks)||0
10729408|NCT03893565|11893499|FG000|COMPLETED|Double-blind Induction Phase (10 Weeks)||21
10729409|NCT03893565|11893500|FG001|COMPLETED|Double-blind Induction Phase (10 Weeks)||32
10729410|NCT03893565|11893501|FG002|COMPLETED|Double-blind Induction Phase (10 Weeks)||1
10729411|NCT03893565|11893502|FG003|COMPLETED|Double-blind Induction Phase (10 Weeks)||1
10729412|NCT03893565|11893503|FG004|COMPLETED|Double-blind Induction Phase (10 Weeks)||1
10729413|NCT03893565|11893504|FG005|COMPLETED|Double-blind Induction Phase (10 Weeks)||0
10729414|NCT03893565|11893505|FG006|COMPLETED|Double-blind Induction Phase (10 Weeks)||0
10729415|NCT03893565|11893506|FG007|COMPLETED|Double-blind Induction Phase (10 Weeks)||0
10729416|NCT03893565|11893507|FG008|COMPLETED|Double-blind Induction Phase (10 Weeks)||0
10729417|NCT03893565|11893499|FG000|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||6
10729418|NCT03893565|11893500|FG001|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||16
10729419|NCT03893565|11893501|FG002|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||10
10729420|NCT03893565|11893502|FG003|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||9
10729421|NCT03893565|11893503|FG004|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||7
10729422|NCT03893565|11893504|FG005|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||0
10729423|NCT03893565|11893505|FG006|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||0
10729424|NCT03893565|11893506|FG007|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||0
10729425|NCT03893565|11893507|FG008|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||0
10729426|NCT03893565|11893499|FG000|STARTED|Double-blind Extended Treatment(20weeks)||0
10729427|NCT03893565|11893500|FG001|STARTED|Double-blind Extended Treatment(20weeks)||0
10729428|NCT03893565|11893501|FG002|STARTED|Double-blind Extended Treatment(20weeks)||0
10729429|NCT03893565|11893502|FG003|STARTED|Double-blind Extended Treatment(20weeks)||0
10729430|NCT03893565|11893503|FG004|STARTED|Double-blind Extended Treatment(20weeks)||0
10729431|NCT03893565|11893504|FG005|STARTED|Double-blind Extended Treatment(20weeks)||5
10729432|NCT03893565|11893505|FG006|STARTED|Double-blind Extended Treatment(20weeks)||8
10729433|NCT03893565|11893506|FG007|STARTED|Double-blind Extended Treatment(20weeks)||0
10729434|NCT03893565|11893507|FG008|STARTED|Double-blind Extended Treatment(20weeks)||0
10729435|NCT03893565|11893499|FG000|COMPLETED|Double-blind Extended Treatment(20weeks)||0
10729436|NCT03893565|11893500|FG001|COMPLETED|Double-blind Extended Treatment(20weeks)||0
10814704|NCT02239627|11977566|FG001|STARTED|Overall Study||0
10729437|NCT03893565|11893501|FG002|COMPLETED|Double-blind Extended Treatment(20weeks)||0
10729438|NCT03893565|11893502|FG003|COMPLETED|Double-blind Extended Treatment(20weeks)||0
10729439|NCT03893565|11893503|FG004|COMPLETED|Double-blind Extended Treatment(20weeks)||0
10729440|NCT03893565|11893504|FG005|COMPLETED|Double-blind Extended Treatment(20weeks)||2
10729441|NCT03893565|11893505|FG006|COMPLETED|Double-blind Extended Treatment(20weeks)||4
10729442|NCT03893565|11893506|FG007|COMPLETED|Double-blind Extended Treatment(20weeks)||0
10729443|NCT03893565|11893507|FG008|COMPLETED|Double-blind Extended Treatment(20weeks)||0
10729444|NCT03893565|11893499|FG000|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0
10729445|NCT03893565|11893500|FG001|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0
10729446|NCT03893565|11893501|FG002|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0
10814705|NCT02239627|11977565|FG000|COMPLETED|Overall Study||0
10814706|NCT02239627|11977566|FG001|COMPLETED|Overall Study||0
10814707|NCT02239627|11977565|FG000|NOT COMPLETED|Overall Study||0
10814708|NCT02239627|11977566|FG001|NOT COMPLETED|Overall Study||0
10814709|NCT02244944|11977572|FG000|STARTED|Overall Study||2
10814710|NCT02244944|11977572|FG000|COMPLETED|Overall Study||0
10814711|NCT02244944|11977572|FG000|NOT COMPLETED|Overall Study||2
10814712|NCT02241187|11977576|FG000|STARTED|Overall Study||2
10814713|NCT02241187|11977576|FG000|COMPLETED|Overall Study||0
10814714|NCT02241187|11977576|FG000|NOT COMPLETED|Overall Study||2
10814715|NCT02239926|11977582|FG000|STARTED|Overall Study||0
10814716|NCT02239926|11977583|FG001|STARTED|Overall Study||2
10814717|NCT02239926|11977582|FG000|COMPLETED|Overall Study||0
10814718|NCT02239926|11977583|FG001|COMPLETED|Overall Study||1
10814719|NCT02239926|11977582|FG000|NOT COMPLETED|Overall Study||0
10814720|NCT02239926|11977583|FG001|NOT COMPLETED|Overall Study||1
10814721|NCT02231892|11977592|FG000|STARTED|Overall Study||17
10814722|NCT02231892|11977593|FG001|STARTED|Overall Study||17
10814723|NCT02231892|11977594|FG002|STARTED|Overall Study||70
10814724|NCT02231892|11977592|FG000|Sham|Overall Study||8
10814725|NCT02231892|11977593|FG001|Sham|Overall Study||5
10814726|NCT02231892|11977594|FG002|Sham|Overall Study||26
10814727|NCT02231892|11977592|FG000|100% MT|Overall Study||7
10814728|NCT02231892|11977593|FG001|100% MT|Overall Study||6
10814729|NCT02231892|11977594|FG002|100% MT|Overall Study||25
10814730|NCT02231892|11977592|FG000|110% MT|Overall Study||7
10814731|NCT02231892|11977593|FG001|110% MT|Overall Study||5
10814732|NCT02231892|11977594|FG002|110% MT|Overall Study||27
10814733|NCT02231892|11977592|FG000|COMPLETED|Overall Study||6
10814734|NCT02231892|11977593|FG001|COMPLETED|Overall Study|3 participants completed this phase and Hi Frequency MRI phase, but are only counted in Hi Freq MRI.|5
10814735|NCT02231892|11977594|FG002|COMPLETED|Overall Study|3 participants completed this phase and Hi Frequency Beh phase, but are only counted in Hi Freq MRI.|25
10814736|NCT02231892|11977592|FG000|NOT COMPLETED|Overall Study||11
10814737|NCT02231892|11977593|FG001|NOT COMPLETED|Overall Study||12
10814738|NCT02231892|11977594|FG002|NOT COMPLETED|Overall Study||45
10814739|NCT02241343|11977608|FG000|STARTED|Overall Study||1
10814740|NCT02241343|11977608|FG000|COMPLETED|Overall Study||0
10814741|NCT02241343|11977608|FG000|NOT COMPLETED|Overall Study||1
10814742|NCT02242578|11977615|FG000|STARTED|Overall Study||0
10814743|NCT02242578|11977616|FG001|STARTED|Overall Study||0
10814744|NCT02242578|11977615|FG000|COMPLETED|Overall Study||0
10814745|NCT02242578|11977616|FG001|COMPLETED|Overall Study||0
10814746|NCT02242578|11977615|FG000|NOT COMPLETED|Overall Study||0
10814747|NCT02242578|11977616|FG001|NOT COMPLETED|Overall Study||0
10814748|NCT02234011|11977622|FG000|STARTED|Overall Study||0
10814749|NCT02234011|11977622|FG000|COMPLETED|Overall Study||0
10814750|NCT02234011|11977622|FG000|NOT COMPLETED|Overall Study||0
10814751|NCT02236546|11977626|FG000|STARTED|Overall Study||3
10814752|NCT02236546|11977626|FG000|COMPLETED|Overall Study||3
10814753|NCT02236546|11977626|FG000|NOT COMPLETED|Overall Study||0
10814754|NCT02234687|11977633|FG000|STARTED|Overall Study|Study Terminated. No outcome measures were analyzed|6
10814755|NCT02234687|11977634|FG001|STARTED|Overall Study||4
10814757|NCT02234687|11977633|FG000|COMPLETED|Overall Study|Study Terminated. No outcome measures were analyzed|0
10814758|NCT02234687|11977634|FG001|COMPLETED|Overall Study||0
10814759|NCT02234687|11977635|FG002|COMPLETED|Overall Study||0
10814760|NCT02234687|11977633|FG000|NOT COMPLETED|Overall Study||6
10814761|NCT02234687|11977634|FG001|NOT COMPLETED|Overall Study||4
10814762|NCT02234687|11977635|FG002|NOT COMPLETED|Overall Study||4
10814763|NCT02224599|11977643|FG000|STARTED|Overall Study||3
10814764|NCT02224599|11977643|FG000|COMPLETED|Overall Study||1
10814765|NCT02224599|11977643|FG000|NOT COMPLETED|Overall Study||2
10814766|NCT02201472|11977647|FG000|STARTED|Overall Study||2
10814767|NCT02201472|11977647|FG000|COMPLETED|Overall Study||0
10814768|NCT02201472|11977647|FG000|NOT COMPLETED|Overall Study||2
10814769|NCT02202044|11977651|FG000|STARTED|Overall Study||0
10814770|NCT02202044|11977651|FG000|COMPLETED|Overall Study||0
10814771|NCT02202044|11977651|FG000|NOT COMPLETED|Overall Study||0
10814772|NCT02192775|11977655|FG000|STARTED|Overall Study||2
10814773|NCT02192775|11977655|FG000|COMPLETED|Overall Study||0
10814774|NCT02192775|11977655|FG000|NOT COMPLETED|Overall Study||2
10814775|NCT02200328|11977661|FG000|STARTED|Overall Study||43
10814776|NCT02200328|11977662|FG001|STARTED|Overall Study||33
10814777|NCT02200328|11977661|FG000|COMPLETED|Overall Study||0
10814778|NCT02200328|11977662|FG001|COMPLETED|Overall Study||0
10814779|NCT02200328|11977661|FG000|NOT COMPLETED|Overall Study||43
10814780|NCT02200328|11977662|FG001|NOT COMPLETED|Overall Study||33
10729447|NCT03893565|11893502|FG003|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0
10729448|NCT03893565|11893503|FG004|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0
10729449|NCT03893565|11893504|FG005|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||3
10729450|NCT03893565|11893505|FG006|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||4
10729451|NCT03893565|11893506|FG007|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0
10729452|NCT03893565|11893507|FG008|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0
10729453|NCT03893565|11893499|FG000|STARTED|Open-label Induction Phase (10 Weeks)||0
10729454|NCT03893565|11893500|FG001|STARTED|Open-label Induction Phase (10 Weeks)||0
10729455|NCT03893565|11893501|FG002|STARTED|Open-label Induction Phase (10 Weeks)||0
10729456|NCT03893565|11893502|FG003|STARTED|Open-label Induction Phase (10 Weeks)||0
10729457|NCT03893565|11893503|FG004|STARTED|Open-label Induction Phase (10 Weeks)||0
10729458|NCT03893565|11893504|FG005|STARTED|Open-label Induction Phase (10 Weeks)||0
10729459|NCT03893565|11893505|FG006|STARTED|Open-label Induction Phase (10 Weeks)||0
10729460|NCT03893565|11893506|FG007|STARTED|Open-label Induction Phase (10 Weeks)||42
10729461|NCT03893565|11893507|FG008|STARTED|Open-label Induction Phase (10 Weeks)||0
10729462|NCT03893565|11893499|FG000|COMPLETED|Open-label Induction Phase (10 Weeks)||0
10729463|NCT03893565|11893500|FG001|COMPLETED|Open-label Induction Phase (10 Weeks)||0
10729464|NCT03893565|11893501|FG002|COMPLETED|Open-label Induction Phase (10 Weeks)||0
10729465|NCT03893565|11893502|FG003|COMPLETED|Open-label Induction Phase (10 Weeks)||0
10729466|NCT03893565|11893503|FG004|COMPLETED|Open-label Induction Phase (10 Weeks)||0
10729467|NCT03893565|11893504|FG005|COMPLETED|Open-label Induction Phase (10 Weeks)||0
10729468|NCT03893565|11893505|FG006|COMPLETED|Open-label Induction Phase (10 Weeks)||0
10729469|NCT03893565|11893506|FG007|COMPLETED|Open-label Induction Phase (10 Weeks)||12
10729470|NCT03893565|11893507|FG008|COMPLETED|Open-label Induction Phase (10 Weeks)||0
10729471|NCT03893565|11893499|FG000|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0
10729472|NCT03893565|11893500|FG001|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0
10729473|NCT03893565|11893501|FG002|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0
10729474|NCT03893565|11893502|FG003|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0
10729475|NCT03893565|11893503|FG004|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0
10729476|NCT03893565|11893504|FG005|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0
10729477|NCT03893565|11893505|FG006|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0
10729478|NCT03893565|11893506|FG007|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||30
10729479|NCT03893565|11893507|FG008|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0
10729480|NCT03893565|11893499|FG000|STARTED|Open-label Extended Treatment (20 Weeks)||0
10729481|NCT03893565|11893500|FG001|STARTED|Open-label Extended Treatment (20 Weeks)||0
10729482|NCT03893565|11893501|FG002|STARTED|Open-label Extended Treatment (20 Weeks)||0
10729483|NCT03893565|11893502|FG003|STARTED|Open-label Extended Treatment (20 Weeks)||0
10729484|NCT03893565|11893503|FG004|STARTED|Open-label Extended Treatment (20 Weeks)||0
10729485|NCT03893565|11893504|FG005|STARTED|Open-label Extended Treatment (20 Weeks)||0
10729486|NCT03893565|11893505|FG006|STARTED|Open-label Extended Treatment (20 Weeks)||0
10729487|NCT03893565|11893506|FG007|STARTED|Open-label Extended Treatment (20 Weeks)||0
10729488|NCT03893565|11893507|FG008|STARTED|Open-label Extended Treatment (20 Weeks)||7
10729489|NCT03893565|11893499|FG000|COMPLETED|Open-label Extended Treatment (20 Weeks)||0
10729490|NCT03893565|11893500|FG001|COMPLETED|Open-label Extended Treatment (20 Weeks)||0
10729491|NCT03893565|11893501|FG002|COMPLETED|Open-label Extended Treatment (20 Weeks)||0
10729492|NCT03893565|11893502|FG003|COMPLETED|Open-label Extended Treatment (20 Weeks)||0
10729493|NCT03893565|11893503|FG004|COMPLETED|Open-label Extended Treatment (20 Weeks)||0
10729494|NCT03893565|11893504|FG005|COMPLETED|Open-label Extended Treatment (20 Weeks)||0
10729495|NCT03893565|11893505|FG006|COMPLETED|Open-label Extended Treatment (20 Weeks)||0
10729496|NCT03893565|11893506|FG007|COMPLETED|Open-label Extended Treatment (20 Weeks)||0
10729497|NCT03893565|11893507|FG008|COMPLETED|Open-label Extended Treatment (20 Weeks)||3
10729498|NCT03893565|11893499|FG000|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0
10729499|NCT03893565|11893500|FG001|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0
10729500|NCT03893565|11893501|FG002|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0
10729501|NCT03893565|11893502|FG003|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0
10729502|NCT03893565|11893503|FG004|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0
10729503|NCT03893565|11893504|FG005|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0
10729504|NCT03893565|11893505|FG006|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0
10729505|NCT03893565|11893506|FG007|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0
10729506|NCT03893565|11893507|FG008|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||4
10729507|NCT03701516|11893526|FG000|STARTED|Period 1||131
10729508|NCT03701516|11893527|FG001|STARTED|Period 1||132
10729509|NCT03701516|11893526|FG000|COMPLETED|Period 1||127
10729510|NCT03701516|11893527|FG001|COMPLETED|Period 1||127
10729511|NCT03701516|11893526|FG000|NOT COMPLETED|Period 1||4
10729512|NCT03701516|11893527|FG001|NOT COMPLETED|Period 1||5
10729513|NCT03701516|11893526|FG000|STARTED|Period 2||127
10729514|NCT03701516|11893527|FG001|STARTED|Period 2||127
10729515|NCT03701516|11893526|FG000|COMPLETED|Period 2||126
10729516|NCT03701516|11893527|FG001|COMPLETED|Period 2||126
10729517|NCT03701516|11893526|FG000|NOT COMPLETED|Period 2||1
10729518|NCT03701516|11893527|FG001|NOT COMPLETED|Period 2||1
10729519|NCT03650556|11893533|FG000|STARTED|Overall Study||224
10729520|NCT03650556|11893533|FG000|Ablation Procedure|Overall Study||223
10729521|NCT03650556|11893533|FG000|Pre-Discharge|Overall Study||223
10729522|NCT03650556|11893533|FG000|7-day Follow-Up|Overall Study||223
10729523|NCT03650556|11893533|FG000|3-month Follow-Up|Overall Study||210
10729524|NCT03650556|11893533|FG000|6-month Follow-up|Overall Study||197
10729525|NCT03650556|11893533|FG000|12-month Follow-Up|Overall Study||189
10729526|NCT03650556|11893533|FG000|15-month Follow-Up|Overall Study||187
10729527|NCT03650556|11893533|FG000|COMPLETED|Overall Study||187
10729528|NCT03650556|11893533|FG000|NOT COMPLETED|Overall Study||37
10729529|NCT03628716|11893540|FG000|STARTED|Overall Study||19
10729530|NCT03628716|11893541|FG001|STARTED|Overall Study||24
10729531|NCT03628716|11893540|FG000|COMPLETED|Overall Study||0
10729532|NCT03628716|11893541|FG001|COMPLETED|Overall Study||1
10729533|NCT03628716|11893540|FG000|NOT COMPLETED|Overall Study||19
10729534|NCT03628716|11893541|FG001|NOT COMPLETED|Overall Study||23
10777711|NCT03342898|11939636|FG000|STARTED|Overall Study||300
10777712|NCT03342898|11939637|FG001|STARTED|Overall Study||300
10777713|NCT03342898|11939638|FG002|STARTED|Overall Study||300
10777714|NCT03342898|11939636|FG000|COMPLETED|Overall Study||246
10777715|NCT03342898|11939637|FG001|COMPLETED|Overall Study||247
10777716|NCT03342898|11939638|FG002|COMPLETED|Overall Study||246
10777717|NCT03342898|11939636|FG000|NOT COMPLETED|Overall Study||54
10777718|NCT03342898|11939637|FG001|NOT COMPLETED|Overall Study||53
10777719|NCT03342898|11939638|FG002|NOT COMPLETED|Overall Study||54
10777720|NCT03342963|11939650|FG000|STARTED|Overall Study||27
10777721|NCT03342963|11939651|FG001|STARTED|Overall Study||27
10777722|NCT03342963|11939652|FG002|STARTED|Overall Study||10
10777723|NCT03342963|11939653|FG003|STARTED|Overall Study||10
10777724|NCT03342963|11939650|FG000|COMPLETED|Overall Study||25
10777725|NCT03342963|11939651|FG001|COMPLETED|Overall Study||25
10777726|NCT03342963|11939652|FG002|COMPLETED|Overall Study||10
10777727|NCT03342963|11939653|FG003|COMPLETED|Overall Study||10
10777728|NCT03342963|11939650|FG000|NOT COMPLETED|Overall Study||2
10777729|NCT03342963|11939651|FG001|NOT COMPLETED|Overall Study||2
10777730|NCT03342963|11939652|FG002|NOT COMPLETED|Overall Study||0
10777731|NCT03342963|11939653|FG003|NOT COMPLETED|Overall Study||0
10777732|NCT03343067|11939666|FG000|STARTED|Open Label Period: Day 1 to Month 3||7
10777733|NCT03343067|11939667|FG001|STARTED|Open Label Period: Day 1 to Month 3||3
10777734|NCT03343067|11939668|FG002|STARTED|Open Label Period: Day 1 to Month 3||1
10777735|NCT03343067|11939666|FG000|COMPLETED|Open Label Period: Day 1 to Month 3||0
10777736|NCT03343067|11939667|FG001|COMPLETED|Open Label Period: Day 1 to Month 3||3
10777737|NCT03343067|11939668|FG002|COMPLETED|Open Label Period: Day 1 to Month 3||1
10777738|NCT03343067|11939666|FG000|NOT COMPLETED|Open Label Period: Day 1 to Month 3||7
10777739|NCT03343067|11939667|FG001|NOT COMPLETED|Open Label Period: Day 1 to Month 3||0
10777740|NCT03343067|11939668|FG002|NOT COMPLETED|Open Label Period: Day 1 to Month 3||0
10777741|NCT03343067|11939666|FG000|STARTED|Double Blind Period: Month 3 to Month 6||0
10777742|NCT03343067|11939667|FG001|STARTED|Double Blind Period: Month 3 to Month 6||3
10777743|NCT03343067|11939668|FG002|STARTED|Double Blind Period: Month 3 to Month 6||1
10777744|NCT03343067|11939666|FG000|COMPLETED|Double Blind Period: Month 3 to Month 6||0
10777745|NCT03343067|11939667|FG001|COMPLETED|Double Blind Period: Month 3 to Month 6||0
10777746|NCT03343067|11939668|FG002|COMPLETED|Double Blind Period: Month 3 to Month 6||0
10777747|NCT03343067|11939666|FG000|NOT COMPLETED|Double Blind Period: Month 3 to Month 6||0
10777748|NCT03343067|11939667|FG001|NOT COMPLETED|Double Blind Period: Month 3 to Month 6||3
10777749|NCT03343067|11939668|FG002|NOT COMPLETED|Double Blind Period: Month 3 to Month 6||1
10777750|NCT03343080|11939678|FG000|STARTED|Overall Study||14
10777751|NCT03343080|11939679|FG001|STARTED|Overall Study||18
10777752|NCT03343080|11939678|FG000|COMPLETED|Overall Study||14
10777753|NCT03343080|11939679|FG001|COMPLETED|Overall Study||18
10777754|NCT03343080|11939678|FG000|NOT COMPLETED|Overall Study||0
10777755|NCT03343080|11939679|FG001|NOT COMPLETED|Overall Study||0
10777756|NCT03343639|11939687|FG000|STARTED|Overall Study||102
10777757|NCT03343639|11939688|FG001|STARTED|Overall Study||102
10777758|NCT03343639|11939687|FG000|COMPLETED|Overall Study||88
10777759|NCT03343639|11939688|FG001|COMPLETED|Overall Study||90
10777760|NCT03343639|11939687|FG000|NOT COMPLETED|Overall Study||14
10777761|NCT03343639|11939688|FG001|NOT COMPLETED|Overall Study||12
10777762|NCT03344172|11939696|FG000|STARTED|Overall Study||16
10777763|NCT03344172|11939697|FG001|STARTED|Overall Study||16
10777764|NCT03344172|11939696|FG000|COMPLETED|Overall Study||15
10777765|NCT03344172|11939697|FG001|COMPLETED|Overall Study||16
10777766|NCT03344172|11939696|FG000|NOT COMPLETED|Overall Study||1
10777767|NCT03344172|11939697|FG001|NOT COMPLETED|Overall Study||0
10777768|NCT03344510|11939703|FG000|STARTED|First Injection (5 Minutes)||21
10777769|NCT03344510|11939704|FG001|STARTED|First Injection (5 Minutes)||26
10777770|NCT03344510|11939703|FG000|Received Injection|First Injection (5 Minutes)||21
10777771|NCT03344510|11939704|FG001|Received Injection|First Injection (5 Minutes)||26
10777772|NCT03344510|11939703|FG000|COMPLETED|First Injection (5 Minutes)||21
10777773|NCT03344510|11939704|FG001|COMPLETED|First Injection (5 Minutes)||26
10777774|NCT03344510|11939703|FG000|NOT COMPLETED|First Injection (5 Minutes)||0
10777775|NCT03344510|11939704|FG001|NOT COMPLETED|First Injection (5 Minutes)||0
10777776|NCT03344510|11939703|FG000|STARTED|Wash Out (10 Minutes||21
10777777|NCT03344510|11939704|FG001|STARTED|Wash Out (10 Minutes||26
10777778|NCT03344510|11939703|FG000|COMPLETED|Wash Out (10 Minutes||21
10777779|NCT03344510|11939704|FG001|COMPLETED|Wash Out (10 Minutes||26
10777780|NCT03344510|11939703|FG000|NOT COMPLETED|Wash Out (10 Minutes||0
10777781|NCT03344510|11939704|FG001|NOT COMPLETED|Wash Out (10 Minutes||0
10777782|NCT03344510|11939703|FG000|STARTED|Second Injection (5 Minutes)||21
10729535|NCT03377699|11893551|FG000|STARTED|Overall Study||111
10729536|NCT03377699|11893552|FG001|STARTED|Overall Study||114
10729537|NCT03377699|11893551|FG000|Treated|Overall Study||110
10729538|NCT03377699|11893552|FG001|Treated|Overall Study||112
10729539|NCT03377699|11893551|FG000|SASpregnant|Overall Study||91
10729540|NCT03377699|11893552|FG001|SASpregnant|Overall Study||94
10729541|NCT03377699|11893551|FG000|FASpregnant|Overall Study||92
10729542|NCT03377699|11893552|FG001|FASpregnant|Overall Study||96
10729543|NCT03377699|11893551|FG000|COMPLETED|Overall Study||89
10729544|NCT03377699|11893552|FG001|COMPLETED|Overall Study||89
10729545|NCT03377699|11893551|FG000|NOT COMPLETED|Overall Study||22
10729546|NCT03377699|11893552|FG001|NOT COMPLETED|Overall Study||25
10729547|NCT03275350|11893562|FG000|STARTED|Overall Study||55
10729548|NCT03275350|11893563|FG001|STARTED|Overall Study||59
10729549|NCT03275350|11893562|FG000|COMPLETED|Overall Study||47
10729550|NCT03275350|11893563|FG001|COMPLETED|Overall Study||51
10729551|NCT03275350|11893562|FG000|NOT COMPLETED|Overall Study||8
10729552|NCT03275350|11893563|FG001|NOT COMPLETED|Overall Study||8
10729553|NCT03272347|11893574|FG000|STARTED|Overall Study||31
10729554|NCT03272347|11893575|FG001|STARTED|Overall Study||30
10729555|NCT03272347|11893576|FG002|STARTED|Overall Study||31
10729556|NCT03272347|11893577|FG003|STARTED|Overall Study||31
10729557|NCT03272347|11893574|FG000|Treated|Overall Study||29
10729558|NCT03272347|11893575|FG001|Treated|Overall Study||30
10729559|NCT03272347|11893576|FG002|Treated|Overall Study||31
10729560|NCT03272347|11893577|FG003|Treated|Overall Study||31
10729561|NCT03272347|11893574|FG000|COMPLETED|Overall Study||0
10729562|NCT03272347|11893575|FG001|COMPLETED|Overall Study||1
10729563|NCT03272347|11893576|FG002|COMPLETED|Overall Study||0
10729564|NCT03272347|11893577|FG003|COMPLETED|Overall Study||2
10729565|NCT03272347|11893574|FG000|NOT COMPLETED|Overall Study||31
10729566|NCT03272347|11893575|FG001|NOT COMPLETED|Overall Study||29
10729567|NCT03272347|11893576|FG002|NOT COMPLETED|Overall Study||31
10729568|NCT03272347|11893577|FG003|NOT COMPLETED|Overall Study||29
10729569|NCT03138369|11893589|FG000|STARTED|Overall Study||11
10729570|NCT03138369|11893590|FG001|STARTED|Overall Study||11
10729571|NCT03138369|11893589|FG000|COMPLETED|Overall Study||8
10729572|NCT03138369|11893590|FG001|COMPLETED|Overall Study||3
10729573|NCT03138369|11893589|FG000|NOT COMPLETED|Overall Study||3
10729574|NCT03138369|11893590|FG001|NOT COMPLETED|Overall Study||8
10729575|NCT02758184|11893599|FG000|STARTED|Overall Study||11
10729576|NCT02758184|11893600|FG001|STARTED|Overall Study||10
10729577|NCT02758184|11893599|FG000|COMPLETED|Overall Study||11
10729578|NCT02758184|11893600|FG001|COMPLETED|Overall Study||10
10729579|NCT02758184|11893599|FG000|NOT COMPLETED|Overall Study||0
10729580|NCT02758184|11893600|FG001|NOT COMPLETED|Overall Study||0
10729581|NCT02677870|11893606|FG000|STARTED|Diet Treatment (4 Weeks)||4
10729582|NCT02677870|11893607|FG001|STARTED|Diet Treatment (4 Weeks)||3
10729583|NCT02677870|11893606|FG000|COMPLETED|Diet Treatment (4 Weeks)||4
10729584|NCT02677870|11893607|FG001|COMPLETED|Diet Treatment (4 Weeks)||3
10729585|NCT02677870|11893606|FG000|NOT COMPLETED|Diet Treatment (4 Weeks)||0
10729586|NCT02677870|11893607|FG001|NOT COMPLETED|Diet Treatment (4 Weeks)||0
10729587|NCT02677870|11893606|FG000|STARTED|First Saproterin Dihydrochloride tx||4
10729588|NCT02677870|11893607|FG001|STARTED|First Saproterin Dihydrochloride tx||3
10729589|NCT02677870|11893606|FG000|COMPLETED|First Saproterin Dihydrochloride tx||4
10729590|NCT02677870|11893607|FG001|COMPLETED|First Saproterin Dihydrochloride tx||3
10729591|NCT02677870|11893606|FG000|NOT COMPLETED|First Saproterin Dihydrochloride tx||0
10729592|NCT02677870|11893607|FG001|NOT COMPLETED|First Saproterin Dihydrochloride tx||0
10729593|NCT02677870|11893606|FG000|STARTED|Washout (2 Weeks)||4
10729594|NCT02677870|11893607|FG001|STARTED|Washout (2 Weeks)||3
10729595|NCT02677870|11893606|FG000|COMPLETED|Washout (2 Weeks)||4
10729596|NCT02677870|11893607|FG001|COMPLETED|Washout (2 Weeks)||3
10729597|NCT02677870|11893606|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10729598|NCT02677870|11893607|FG001|NOT COMPLETED|Washout (2 Weeks)||0
10729599|NCT02677870|11893606|FG000|STARTED|Second Saproterin Dihydrochloride tx||4
10729600|NCT02677870|11893607|FG001|STARTED|Second Saproterin Dihydrochloride tx||3
10729601|NCT02677870|11893606|FG000|COMPLETED|Second Saproterin Dihydrochloride tx||4
10729602|NCT02677870|11893607|FG001|COMPLETED|Second Saproterin Dihydrochloride tx||3
10729603|NCT02677870|11893606|FG000|NOT COMPLETED|Second Saproterin Dihydrochloride tx||0
10814781|NCT02200042|11977670|FG000|STARTED|Overall Study||0
10814782|NCT02200042|11977671|FG001|STARTED|Overall Study||1
10814783|NCT02200042|11977670|FG000|COMPLETED|Overall Study||0
10814784|NCT02200042|11977671|FG001|COMPLETED|Overall Study||0
10814785|NCT02200042|11977670|FG000|NOT COMPLETED|Overall Study||0
10814786|NCT02200042|11977671|FG001|NOT COMPLETED|Overall Study||1
10814787|NCT02181790|11977679|FG000|STARTED|Overall Study||2
10814788|NCT02181790|11977680|FG001|STARTED|Overall Study||0
10814789|NCT02181790|11977679|FG000|COMPLETED|Overall Study||0
10814790|NCT02181790|11977680|FG001|COMPLETED|Overall Study||0
10814791|NCT02181790|11977679|FG000|NOT COMPLETED|Overall Study||2
10814792|NCT02181790|11977680|FG001|NOT COMPLETED|Overall Study||0
10814793|NCT02198833|11977690|FG000|STARTED|Overall Study|Unable to clear urine of bacteria for all but one patient therefore catheter not placed|1
10729604|NCT02677870|11893607|FG001|NOT COMPLETED|Second Saproterin Dihydrochloride tx||0
10729605|NCT02674750|11893618|FG000|STARTED|Overall Study||5
10729606|NCT02674750|11893619|FG001|STARTED|Overall Study||49
10729607|NCT02674750|11893620|FG002|STARTED|Overall Study||16
10729608|NCT02674750|11893618|FG000|COMPLETED|Overall Study||0
10729609|NCT02674750|11893619|FG001|COMPLETED|Overall Study||4
10729610|NCT02674750|11893620|FG002|COMPLETED|Overall Study||4
10729611|NCT02674750|11893618|FG000|NOT COMPLETED|Overall Study||5
10729612|NCT02674750|11893619|FG001|NOT COMPLETED|Overall Study||45
10729613|NCT02674750|11893620|FG002|NOT COMPLETED|Overall Study||12
10729614|NCT02440854|11893627|FG000|STARTED|Overall Study||80
10729615|NCT02440854|11893627|FG000|Analyzed|Overall Study||77
10729616|NCT02440854|11893627|FG000|COMPLETED|Overall Study||0
10729617|NCT02440854|11893627|FG000|NOT COMPLETED|Overall Study||80
10729618|NCT02278185|11893633|FG000|STARTED|Overall Study||10
10729619|NCT02278185|11893634|FG001|STARTED|Overall Study||9
10729620|NCT02278185|11893633|FG000|COMPLETED|Overall Study||7
10729621|NCT02278185|11893634|FG001|COMPLETED|Overall Study||7
10729622|NCT02278185|11893633|FG000|NOT COMPLETED|Overall Study||3
10729623|NCT02278185|11893634|FG001|NOT COMPLETED|Overall Study||2
10729624|NCT02154529|11893646|FG000|STARTED|Overall Study||4
10729625|NCT02154529|11893647|FG001|STARTED|Overall Study||3
10729626|NCT02154529|11893648|FG002|STARTED|Overall Study||8
10729627|NCT02154529|11893649|FG003|STARTED|Overall Study||2
10729628|NCT02154529|11893646|FG000|COMPLETED|Overall Study|Study terminated by sponsor|0
10729629|NCT02154529|11893647|FG001|COMPLETED|Overall Study|Study terminated by sponsor|0
10729630|NCT02154529|11893648|FG002|COMPLETED|Overall Study|Study terminated by sponsor|0
10729631|NCT02154529|11893649|FG003|COMPLETED|Overall Study|Study terminated by sponsor|0
10729632|NCT02154529|11893646|FG000|NOT COMPLETED|Overall Study||4
10729633|NCT02154529|11893647|FG001|NOT COMPLETED|Overall Study||3
10729634|NCT02154529|11893648|FG002|NOT COMPLETED|Overall Study||8
10729635|NCT02154529|11893649|FG003|NOT COMPLETED|Overall Study||2
10729636|NCT00788125|11893661|FG000|STARTED|Overall Study||7
10729637|NCT00788125|11893661|FG000|COMPLETED|Overall Study||1
10729638|NCT00788125|11893661|FG000|NOT COMPLETED|Overall Study||6
10729639|NCT02777554|11893667|FG000|STARTED|Overall Study||62
10729640|NCT02777554|11893668|FG001|STARTED|Overall Study||62
10729641|NCT02777554|11893669|FG002|STARTED|Overall Study||5
10729642|NCT02777554|11893670|FG003|STARTED|Overall Study||5
10729643|NCT02777554|11893671|FG004|STARTED|Overall Study||5
10729644|NCT02777554|11893672|FG005|STARTED|Overall Study||5
10729645|NCT02777554|11893667|FG000|COMPLETED|Overall Study||32
10729646|NCT02777554|11893668|FG001|COMPLETED|Overall Study||37
10729647|NCT02777554|11893669|FG002|COMPLETED|Overall Study||4
10729648|NCT02777554|11893670|FG003|COMPLETED|Overall Study||4
10729649|NCT02777554|11893671|FG004|COMPLETED|Overall Study||5
10729650|NCT02777554|11893672|FG005|COMPLETED|Overall Study||5
10729651|NCT02777554|11893667|FG000|NOT COMPLETED|Overall Study||30
10729652|NCT02777554|11893668|FG001|NOT COMPLETED|Overall Study||25
10729653|NCT02777554|11893669|FG002|NOT COMPLETED|Overall Study||1
10729654|NCT02777554|11893670|FG003|NOT COMPLETED|Overall Study||1
10729655|NCT02777554|11893671|FG004|NOT COMPLETED|Overall Study||0
10729656|NCT02777554|11893672|FG005|NOT COMPLETED|Overall Study||0
10729657|NCT02777749|11893695|FG000|STARTED|Overall Study||53
10729658|NCT02777749|11893696|FG001|STARTED|Overall Study||51
10729659|NCT02777749|11893697|FG002|STARTED|Overall Study||51
10729660|NCT02777749|11893695|FG000|COMPLETED|Overall Study||53
10729661|NCT02777749|11893696|FG001|COMPLETED|Overall Study||51
10729662|NCT02777749|11893697|FG002|COMPLETED|Overall Study||51
10729663|NCT02777749|11893695|FG000|NOT COMPLETED|Overall Study||0
10729664|NCT02777749|11893696|FG001|NOT COMPLETED|Overall Study||0
10729665|NCT02777749|11893697|FG002|NOT COMPLETED|Overall Study||0
10777783|NCT03344510|11939704|FG001|STARTED|Second Injection (5 Minutes)||26
10777784|NCT03344510|11939703|FG000|Received Injection|Second Injection (5 Minutes)||21
10777785|NCT03344510|11939704|FG001|Received Injection|Second Injection (5 Minutes)||26
10777786|NCT03344510|11939703|FG000|COMPLETED|Second Injection (5 Minutes)||21
10777787|NCT03344510|11939704|FG001|COMPLETED|Second Injection (5 Minutes)||26
10777788|NCT03344510|11939703|FG000|NOT COMPLETED|Second Injection (5 Minutes)||0
10777789|NCT03344510|11939704|FG001|NOT COMPLETED|Second Injection (5 Minutes)||0
10814794|NCT02198833|11977691|FG001|STARTED|Overall Study|Unable to clear urine of bacteria for all but one patient therefore catheter not placed.|1
10814795|NCT02198833|11977690|FG000|COMPLETED|Overall Study||1
10814796|NCT02198833|11977691|FG001|COMPLETED|Overall Study||1
10814797|NCT02198833|11977690|FG000|NOT COMPLETED|Overall Study||0
10814798|NCT02198833|11977691|FG001|NOT COMPLETED|Overall Study||0
10814799|NCT02175628|11977699|FG000|STARTED|Overall Study||6
10814800|NCT02175628|11977700|FG001|STARTED|Overall Study||17
10814801|NCT02175628|11977699|FG000|COMPLETED|Overall Study||6
10814802|NCT02175628|11977700|FG001|COMPLETED|Overall Study||17
10814803|NCT02175628|11977699|FG000|NOT COMPLETED|Overall Study||0
10814804|NCT02175628|11977700|FG001|NOT COMPLETED|Overall Study||0
10814805|NCT02177266|11977708|FG000|STARTED|Overall Study||1
10814806|NCT02177266|11977709|FG001|STARTED|Overall Study||1
10814807|NCT02177266|11977708|FG000|COMPLETED|Overall Study||0
10814808|NCT02177266|11977709|FG001|COMPLETED|Overall Study||0
10814809|NCT02177266|11977708|FG000|NOT COMPLETED|Overall Study||1
10814810|NCT02177266|11977709|FG001|NOT COMPLETED|Overall Study||1
10777790|NCT03344640|11939713|FG000|STARTED|Overall Study||49
10777791|NCT03344640|11939714|FG001|STARTED|Overall Study||47
10777792|NCT03344640|11939713|FG000|COMPLETED|Overall Study||46
10777793|NCT03344640|11939714|FG001|COMPLETED|Overall Study||44
10777794|NCT03344640|11939713|FG000|NOT COMPLETED|Overall Study||3
10777795|NCT03344640|11939714|FG001|NOT COMPLETED|Overall Study||3
10777796|NCT03344640|11939713|FG000|STARTED|Follow-up Epoch||46
10814811|NCT02184520|11977717|FG000|STARTED|Overall Study||0
10814812|NCT02184520|11977718|FG001|STARTED|Overall Study||0
10729666|NCT02777827|11893709|FG000|STARTED|Treatment Period 1||5
10729667|NCT02777827|11893710|FG001|STARTED|Treatment Period 1||5
10729668|NCT02777827|11893711|FG002|STARTED|Treatment Period 1||5
10729669|NCT02777827|11893712|FG003|STARTED|Treatment Period 1||5
10729670|NCT02777827|11893713|FG004|STARTED|Treatment Period 1||4
10729671|NCT02777827|11893714|FG005|STARTED|Treatment Period 1||6
10729672|NCT02777827|11893709|FG000|COMPLETED|Treatment Period 1||5
10729673|NCT02777827|11893710|FG001|COMPLETED|Treatment Period 1||5
10729674|NCT02777827|11893711|FG002|COMPLETED|Treatment Period 1||5
10729675|NCT02777827|11893712|FG003|COMPLETED|Treatment Period 1||5
10729676|NCT02777827|11893713|FG004|COMPLETED|Treatment Period 1||4
10729677|NCT02777827|11893714|FG005|COMPLETED|Treatment Period 1||6
10729678|NCT02777827|11893709|FG000|NOT COMPLETED|Treatment Period 1||0
10729679|NCT02777827|11893710|FG001|NOT COMPLETED|Treatment Period 1||0
10729680|NCT02777827|11893711|FG002|NOT COMPLETED|Treatment Period 1||0
10729681|NCT02777827|11893712|FG003|NOT COMPLETED|Treatment Period 1||0
10729682|NCT02777827|11893713|FG004|NOT COMPLETED|Treatment Period 1||0
10729683|NCT02777827|11893714|FG005|NOT COMPLETED|Treatment Period 1||0
10729684|NCT02777827|11893709|FG000|STARTED|Washout Between Periods 1 and 2||5
10729685|NCT02777827|11893710|FG001|STARTED|Washout Between Periods 1 and 2||5
10729686|NCT02777827|11893711|FG002|STARTED|Washout Between Periods 1 and 2||5
10729687|NCT02777827|11893712|FG003|STARTED|Washout Between Periods 1 and 2||5
10729688|NCT02777827|11893713|FG004|STARTED|Washout Between Periods 1 and 2||4
10729689|NCT02777827|11893714|FG005|STARTED|Washout Between Periods 1 and 2||6
10729690|NCT02777827|11893709|FG000|COMPLETED|Washout Between Periods 1 and 2||5
10729691|NCT02777827|11893710|FG001|COMPLETED|Washout Between Periods 1 and 2||5
10729692|NCT02777827|11893711|FG002|COMPLETED|Washout Between Periods 1 and 2||5
10729693|NCT02777827|11893712|FG003|COMPLETED|Washout Between Periods 1 and 2||5
10729694|NCT02777827|11893713|FG004|COMPLETED|Washout Between Periods 1 and 2||4
10729695|NCT02777827|11893714|FG005|COMPLETED|Washout Between Periods 1 and 2||6
10729696|NCT02777827|11893709|FG000|NOT COMPLETED|Washout Between Periods 1 and 2||0
10729697|NCT02777827|11893710|FG001|NOT COMPLETED|Washout Between Periods 1 and 2||0
10729698|NCT02777827|11893711|FG002|NOT COMPLETED|Washout Between Periods 1 and 2||0
10729699|NCT02777827|11893712|FG003|NOT COMPLETED|Washout Between Periods 1 and 2||0
10729700|NCT02777827|11893713|FG004|NOT COMPLETED|Washout Between Periods 1 and 2||0
10729701|NCT02777827|11893714|FG005|NOT COMPLETED|Washout Between Periods 1 and 2||0
10729702|NCT02777827|11893709|FG000|STARTED|Treatment Period 2||5
10729703|NCT02777827|11893710|FG001|STARTED|Treatment Period 2||5
10729704|NCT02777827|11893711|FG002|STARTED|Treatment Period 2||5
10729705|NCT02777827|11893712|FG003|STARTED|Treatment Period 2||5
10729706|NCT02777827|11893713|FG004|STARTED|Treatment Period 2||4
10729707|NCT02777827|11893714|FG005|STARTED|Treatment Period 2||6
10729708|NCT02777827|11893709|FG000|COMPLETED|Treatment Period 2||5
10729709|NCT02777827|11893710|FG001|COMPLETED|Treatment Period 2||5
10729710|NCT02777827|11893711|FG002|COMPLETED|Treatment Period 2||5
10729711|NCT02777827|11893712|FG003|COMPLETED|Treatment Period 2||5
10729712|NCT02777827|11893713|FG004|COMPLETED|Treatment Period 2||4
10729713|NCT02777827|11893714|FG005|COMPLETED|Treatment Period 2||6
10729714|NCT02777827|11893709|FG000|NOT COMPLETED|Treatment Period 2||0
10729715|NCT02777827|11893710|FG001|NOT COMPLETED|Treatment Period 2||0
10729716|NCT02777827|11893711|FG002|NOT COMPLETED|Treatment Period 2||0
10729717|NCT02777827|11893712|FG003|NOT COMPLETED|Treatment Period 2||0
10729718|NCT02777827|11893713|FG004|NOT COMPLETED|Treatment Period 2||0
10729719|NCT02777827|11893714|FG005|NOT COMPLETED|Treatment Period 2||0
10729720|NCT02777827|11893709|FG000|STARTED|Washout Between Periods 2 and 3||5
10729721|NCT02777827|11893710|FG001|STARTED|Washout Between Periods 2 and 3||5
10729722|NCT02777827|11893711|FG002|STARTED|Washout Between Periods 2 and 3||5
10729723|NCT02777827|11893712|FG003|STARTED|Washout Between Periods 2 and 3||5
10729724|NCT02777827|11893713|FG004|STARTED|Washout Between Periods 2 and 3||4
10729725|NCT02777827|11893714|FG005|STARTED|Washout Between Periods 2 and 3||6
10729726|NCT02777827|11893709|FG000|COMPLETED|Washout Between Periods 2 and 3||5
10729727|NCT02777827|11893710|FG001|COMPLETED|Washout Between Periods 2 and 3||5
10729728|NCT02777827|11893711|FG002|COMPLETED|Washout Between Periods 2 and 3||5
10729729|NCT02777827|11893712|FG003|COMPLETED|Washout Between Periods 2 and 3||5
10729730|NCT02777827|11893713|FG004|COMPLETED|Washout Between Periods 2 and 3||4
10729731|NCT02777827|11893714|FG005|COMPLETED|Washout Between Periods 2 and 3||6
10729732|NCT02777827|11893709|FG000|NOT COMPLETED|Washout Between Periods 2 and 3||0
10729733|NCT02777827|11893710|FG001|NOT COMPLETED|Washout Between Periods 2 and 3||0
10729734|NCT02777827|11893711|FG002|NOT COMPLETED|Washout Between Periods 2 and 3||0
10729735|NCT02777827|11893712|FG003|NOT COMPLETED|Washout Between Periods 2 and 3||0
10729736|NCT02777827|11893713|FG004|NOT COMPLETED|Washout Between Periods 2 and 3||0
10729737|NCT02777827|11893714|FG005|NOT COMPLETED|Washout Between Periods 2 and 3||0
10729738|NCT02777827|11893709|FG000|STARTED|Treatment Period 3||5
10729739|NCT02777827|11893710|FG001|STARTED|Treatment Period 3||5
10729740|NCT02777827|11893711|FG002|STARTED|Treatment Period 3||5
10729741|NCT02777827|11893712|FG003|STARTED|Treatment Period 3||5
10729742|NCT02777827|11893713|FG004|STARTED|Treatment Period 3||4
10729743|NCT02777827|11893714|FG005|STARTED|Treatment Period 3||6
10729744|NCT02777827|11893709|FG000|COMPLETED|Treatment Period 3||5
10729745|NCT02777827|11893710|FG001|COMPLETED|Treatment Period 3||5
10729746|NCT02777827|11893711|FG002|COMPLETED|Treatment Period 3||5
10729747|NCT02777827|11893712|FG003|COMPLETED|Treatment Period 3||5
10729748|NCT02777827|11893713|FG004|COMPLETED|Treatment Period 3||4
10729749|NCT02777827|11893714|FG005|COMPLETED|Treatment Period 3||6
10729750|NCT02777827|11893709|FG000|NOT COMPLETED|Treatment Period 3||0
10729751|NCT02777827|11893710|FG001|NOT COMPLETED|Treatment Period 3||0
10729752|NCT02777827|11893711|FG002|NOT COMPLETED|Treatment Period 3||0
10729753|NCT02777827|11893712|FG003|NOT COMPLETED|Treatment Period 3||0
10729754|NCT02777827|11893713|FG004|NOT COMPLETED|Treatment Period 3||0
10729755|NCT02777827|11893714|FG005|NOT COMPLETED|Treatment Period 3||0
10729756|NCT02777827|11893709|FG000|STARTED|Washout Between Periods 3 and 4||5
10729757|NCT02777827|11893710|FG001|STARTED|Washout Between Periods 3 and 4||5
10729758|NCT02777827|11893711|FG002|STARTED|Washout Between Periods 3 and 4||5
10729759|NCT02777827|11893712|FG003|STARTED|Washout Between Periods 3 and 4||5
10729760|NCT02777827|11893713|FG004|STARTED|Washout Between Periods 3 and 4||4
10729761|NCT02777827|11893714|FG005|STARTED|Washout Between Periods 3 and 4||6
10729762|NCT02777827|11893709|FG000|COMPLETED|Washout Between Periods 3 and 4||5
10729763|NCT02777827|11893710|FG001|COMPLETED|Washout Between Periods 3 and 4||5
10729764|NCT02777827|11893711|FG002|COMPLETED|Washout Between Periods 3 and 4||4
10729765|NCT02777827|11893712|FG003|COMPLETED|Washout Between Periods 3 and 4||5
10729766|NCT02777827|11893713|FG004|COMPLETED|Washout Between Periods 3 and 4||4
10729767|NCT02777827|11893714|FG005|COMPLETED|Washout Between Periods 3 and 4||6
10729768|NCT02777827|11893709|FG000|NOT COMPLETED|Washout Between Periods 3 and 4||0
10729769|NCT02777827|11893710|FG001|NOT COMPLETED|Washout Between Periods 3 and 4||0
10729770|NCT02777827|11893711|FG002|NOT COMPLETED|Washout Between Periods 3 and 4||1
10729771|NCT02777827|11893712|FG003|NOT COMPLETED|Washout Between Periods 3 and 4||0
10729772|NCT02777827|11893713|FG004|NOT COMPLETED|Washout Between Periods 3 and 4||0
10729773|NCT02777827|11893714|FG005|NOT COMPLETED|Washout Between Periods 3 and 4||0
10729774|NCT02777827|11893709|FG000|STARTED|Treatment Period 4||5
10729775|NCT02777827|11893710|FG001|STARTED|Treatment Period 4||5
10729776|NCT02777827|11893711|FG002|STARTED|Treatment Period 4||4
10729777|NCT02777827|11893712|FG003|STARTED|Treatment Period 4||5
10729778|NCT02777827|11893713|FG004|STARTED|Treatment Period 4||4
10729779|NCT02777827|11893714|FG005|STARTED|Treatment Period 4||6
10729780|NCT02777827|11893709|FG000|COMPLETED|Treatment Period 4||5
10729781|NCT02777827|11893710|FG001|COMPLETED|Treatment Period 4||5
10729782|NCT02777827|11893711|FG002|COMPLETED|Treatment Period 4||4
10729783|NCT02777827|11893712|FG003|COMPLETED|Treatment Period 4||5
10729784|NCT02777827|11893713|FG004|COMPLETED|Treatment Period 4||4
10729785|NCT02777827|11893714|FG005|COMPLETED|Treatment Period 4||6
10729786|NCT02777827|11893709|FG000|NOT COMPLETED|Treatment Period 4||0
10729787|NCT02777827|11893710|FG001|NOT COMPLETED|Treatment Period 4||0
10729788|NCT02777827|11893711|FG002|NOT COMPLETED|Treatment Period 4||0
10729789|NCT02777827|11893712|FG003|NOT COMPLETED|Treatment Period 4||0
10729790|NCT02777827|11893713|FG004|NOT COMPLETED|Treatment Period 4||0
10729791|NCT02777827|11893714|FG005|NOT COMPLETED|Treatment Period 4||0
10729792|NCT02777827|11893709|FG000|STARTED|Washout Between Periods 4 and 5||5
10729793|NCT02777827|11893710|FG001|STARTED|Washout Between Periods 4 and 5||5
10729794|NCT02777827|11893711|FG002|STARTED|Washout Between Periods 4 and 5||4
10729795|NCT02777827|11893712|FG003|STARTED|Washout Between Periods 4 and 5||5
10729796|NCT02777827|11893713|FG004|STARTED|Washout Between Periods 4 and 5||4
10729797|NCT02777827|11893714|FG005|STARTED|Washout Between Periods 4 and 5||6
10729798|NCT02777827|11893709|FG000|COMPLETED|Washout Between Periods 4 and 5||5
10729799|NCT02777827|11893710|FG001|COMPLETED|Washout Between Periods 4 and 5||5
10729800|NCT02777827|11893711|FG002|COMPLETED|Washout Between Periods 4 and 5||4
10729801|NCT02777827|11893712|FG003|COMPLETED|Washout Between Periods 4 and 5||5
10729802|NCT02777827|11893713|FG004|COMPLETED|Washout Between Periods 4 and 5||4
10729803|NCT02777827|11893714|FG005|COMPLETED|Washout Between Periods 4 and 5||6
10729804|NCT02777827|11893709|FG000|NOT COMPLETED|Washout Between Periods 4 and 5||0
10729805|NCT02777827|11893710|FG001|NOT COMPLETED|Washout Between Periods 4 and 5||0
10729806|NCT02777827|11893711|FG002|NOT COMPLETED|Washout Between Periods 4 and 5||0
10729807|NCT02777827|11893712|FG003|NOT COMPLETED|Washout Between Periods 4 and 5||0
10729808|NCT02777827|11893713|FG004|NOT COMPLETED|Washout Between Periods 4 and 5||0
10729809|NCT02777827|11893714|FG005|NOT COMPLETED|Washout Between Periods 4 and 5||0
10729810|NCT02777827|11893709|FG000|STARTED|Treatment Period 5||5
10729811|NCT02777827|11893710|FG001|STARTED|Treatment Period 5||5
10729812|NCT02777827|11893711|FG002|STARTED|Treatment Period 5||4
10729813|NCT02777827|11893712|FG003|STARTED|Treatment Period 5||5
10729814|NCT02777827|11893713|FG004|STARTED|Treatment Period 5||4
10729815|NCT02777827|11893714|FG005|STARTED|Treatment Period 5||6
10729816|NCT02777827|11893709|FG000|COMPLETED|Treatment Period 5||5
10729817|NCT02777827|11893710|FG001|COMPLETED|Treatment Period 5||5
10729818|NCT02777827|11893711|FG002|COMPLETED|Treatment Period 5||4
10729819|NCT02777827|11893712|FG003|COMPLETED|Treatment Period 5||5
10729820|NCT02777827|11893713|FG004|COMPLETED|Treatment Period 5||4
10729821|NCT02777827|11893714|FG005|COMPLETED|Treatment Period 5||6
10729822|NCT02777827|11893709|FG000|NOT COMPLETED|Treatment Period 5||0
10729823|NCT02777827|11893710|FG001|NOT COMPLETED|Treatment Period 5||0
10729824|NCT02777827|11893711|FG002|NOT COMPLETED|Treatment Period 5||0
10729825|NCT02777827|11893712|FG003|NOT COMPLETED|Treatment Period 5||0
10729826|NCT02777827|11893713|FG004|NOT COMPLETED|Treatment Period 5||0
10729827|NCT02777827|11893714|FG005|NOT COMPLETED|Treatment Period 5||0
10729828|NCT02777827|11893709|FG000|STARTED|Washout Between Periods 5 and 6||5
10729829|NCT02777827|11893710|FG001|STARTED|Washout Between Periods 5 and 6||5
10729830|NCT02777827|11893711|FG002|STARTED|Washout Between Periods 5 and 6||4
10729831|NCT02777827|11893712|FG003|STARTED|Washout Between Periods 5 and 6||5
10729832|NCT02777827|11893713|FG004|STARTED|Washout Between Periods 5 and 6||4
10729833|NCT02777827|11893714|FG005|STARTED|Washout Between Periods 5 and 6||6
10729834|NCT02777827|11893709|FG000|COMPLETED|Washout Between Periods 5 and 6||5
10729835|NCT02777827|11893710|FG001|COMPLETED|Washout Between Periods 5 and 6||5
10729836|NCT02777827|11893711|FG002|COMPLETED|Washout Between Periods 5 and 6||4
10729837|NCT02777827|11893712|FG003|COMPLETED|Washout Between Periods 5 and 6||5
10729838|NCT02777827|11893713|FG004|COMPLETED|Washout Between Periods 5 and 6||4
10729839|NCT02777827|11893714|FG005|COMPLETED|Washout Between Periods 5 and 6||6
10729840|NCT02777827|11893709|FG000|NOT COMPLETED|Washout Between Periods 5 and 6||0
10729841|NCT02777827|11893710|FG001|NOT COMPLETED|Washout Between Periods 5 and 6||0
10729842|NCT02777827|11893711|FG002|NOT COMPLETED|Washout Between Periods 5 and 6||0
10729843|NCT02777827|11893712|FG003|NOT COMPLETED|Washout Between Periods 5 and 6||0
10729844|NCT02777827|11893713|FG004|NOT COMPLETED|Washout Between Periods 5 and 6||0
10729845|NCT02777827|11893714|FG005|NOT COMPLETED|Washout Between Periods 5 and 6||0
10729846|NCT02777827|11893709|FG000|STARTED|Treatment Period 6||5
10729847|NCT02777827|11893710|FG001|STARTED|Treatment Period 6||5
10729848|NCT02777827|11893711|FG002|STARTED|Treatment Period 6||4
10729849|NCT02777827|11893712|FG003|STARTED|Treatment Period 6||5
10729850|NCT02777827|11893713|FG004|STARTED|Treatment Period 6||4
10729851|NCT02777827|11893714|FG005|STARTED|Treatment Period 6||6
10729852|NCT02777827|11893709|FG000|COMPLETED|Treatment Period 6||5
10729853|NCT02777827|11893710|FG001|COMPLETED|Treatment Period 6||5
10729854|NCT02777827|11893711|FG002|COMPLETED|Treatment Period 6||4
10729855|NCT02777827|11893712|FG003|COMPLETED|Treatment Period 6||5
10729856|NCT02777827|11893713|FG004|COMPLETED|Treatment Period 6||4
10729857|NCT02777827|11893714|FG005|COMPLETED|Treatment Period 6||6
10729858|NCT02777827|11893709|FG000|NOT COMPLETED|Treatment Period 6||0
10729859|NCT02777827|11893710|FG001|NOT COMPLETED|Treatment Period 6||0
10729860|NCT02777827|11893711|FG002|NOT COMPLETED|Treatment Period 6||0
10729861|NCT02777827|11893712|FG003|NOT COMPLETED|Treatment Period 6||0
10729862|NCT02777827|11893713|FG004|NOT COMPLETED|Treatment Period 6||0
10814813|NCT02184520|11977717|FG000|COMPLETED|Overall Study||0
10814814|NCT02184520|11977718|FG001|COMPLETED|Overall Study||0
10814815|NCT02184520|11977717|FG000|NOT COMPLETED|Overall Study||0
10814816|NCT02184520|11977718|FG001|NOT COMPLETED|Overall Study||0
10814817|NCT02170298|11977726|FG000|STARTED|Overall Study||1
10814818|NCT02170298|11977727|FG001|STARTED|Overall Study||5
10814819|NCT02170298|11977726|FG000|COMPLETED|Overall Study||0
10814820|NCT02170298|11977727|FG001|COMPLETED|Overall Study||4
10814821|NCT02170298|11977726|FG000|NOT COMPLETED|Overall Study||1
10814822|NCT02170298|11977727|FG001|NOT COMPLETED|Overall Study||1
10814823|NCT02177773|11977733|FG000|STARTED|Overall Study||300
10814824|NCT02177773|11977733|FG000|COMPLETED|Overall Study||300
10814825|NCT02177773|11977733|FG000|NOT COMPLETED|Overall Study||0
10814826|NCT02162979|11977739|FG000|STARTED|Overall Study||0
10814827|NCT02162979|11977740|FG001|STARTED|Overall Study||0
10814828|NCT02162979|11977739|FG000|COMPLETED|Overall Study||0
10814829|NCT02162979|11977740|FG001|COMPLETED|Overall Study||0
10814830|NCT02162979|11977739|FG000|NOT COMPLETED|Overall Study||0
10814831|NCT02162979|11977740|FG001|NOT COMPLETED|Overall Study||0
10814832|NCT02169830|11977749|FG000|STARTED|Diet Intervention (4 Weeks)||0
10814833|NCT02169830|11977750|FG001|STARTED|Diet Intervention (4 Weeks)||0
10814834|NCT02169830|11977751|FG002|STARTED|Diet Intervention (4 Weeks)||33
10814835|NCT02169830|11977749|FG000|COMPLETED|Diet Intervention (4 Weeks)||0
10814836|NCT02169830|11977750|FG001|COMPLETED|Diet Intervention (4 Weeks)||0
10814837|NCT02169830|11977751|FG002|COMPLETED|Diet Intervention (4 Weeks)||32
10814838|NCT02169830|11977749|FG000|NOT COMPLETED|Diet Intervention (4 Weeks)||0
10814839|NCT02169830|11977750|FG001|NOT COMPLETED|Diet Intervention (4 Weeks)||0
10814840|NCT02169830|11977751|FG002|NOT COMPLETED|Diet Intervention (4 Weeks)||1
10814841|NCT02169830|11977749|FG000|STARTED|Second Intervention (8 Weeks)||12
10814842|NCT02169830|11977750|FG001|STARTED|Second Intervention (8 Weeks)||5
10814843|NCT02169830|11977751|FG002|STARTED|Second Intervention (8 Weeks)||0
10814844|NCT02169830|11977749|FG000|COMPLETED|Second Intervention (8 Weeks)||9
10814845|NCT02169830|11977750|FG001|COMPLETED|Second Intervention (8 Weeks)||0
10814846|NCT02169830|11977751|FG002|COMPLETED|Second Intervention (8 Weeks)||0
10814847|NCT02169830|11977749|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||3
10814848|NCT02169830|11977750|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||5
10729935|NCT02778113|11893792|FG002|Received Study Drug|Study Period Two||4
10814849|NCT02169830|11977751|FG002|NOT COMPLETED|Second Intervention (8 Weeks)||0
10814850|NCT02169830|11977749|FG000|STARTED|Third Intervention (8 Weeks)||0
10814851|NCT02169830|11977750|FG001|STARTED|Third Intervention (8 Weeks)|These four subjects were randomized to Diet first Topiramate second, and Nortriptyline third. No subjects from this group were weaned and moved to Nortriptyline.|4
10814852|NCT02169830|11977751|FG002|STARTED|Third Intervention (8 Weeks)||0
10814853|NCT02169830|11977749|FG000|COMPLETED|Third Intervention (8 Weeks)||0
10814854|NCT02169830|11977750|FG001|COMPLETED|Third Intervention (8 Weeks)||2
10729863|NCT02777827|11893714|FG005|NOT COMPLETED|Treatment Period 6||0
10814855|NCT02169830|11977751|FG002|COMPLETED|Third Intervention (8 Weeks)||0
10814856|NCT02169830|11977749|FG000|NOT COMPLETED|Third Intervention (8 Weeks)||0
10814857|NCT02169830|11977750|FG001|NOT COMPLETED|Third Intervention (8 Weeks)||2
10814858|NCT02169830|11977751|FG002|NOT COMPLETED|Third Intervention (8 Weeks)||0
10814859|NCT02163187|11977761|FG000|STARTED|Overall Study||4
10814860|NCT02163187|11977762|FG001|STARTED|Overall Study||0
10814861|NCT02163187|11977761|FG000|Treatment|Overall Study||2
10729864|NCT02777918|11893730|FG000|STARTED|Overall Study||53
10729865|NCT02777918|11893731|FG001|STARTED|Overall Study||47
10729866|NCT02777918|11893730|FG000|COMPLETED|Overall Study||50
10729867|NCT02777918|11893731|FG001|COMPLETED|Overall Study||43
10729868|NCT02777918|11893730|FG000|NOT COMPLETED|Overall Study||3
10729869|NCT02777918|11893731|FG001|NOT COMPLETED|Overall Study||4
10729870|NCT02777931|11893739|FG000|STARTED|Overall Study||49
10729871|NCT02777931|11893740|FG001|STARTED|Overall Study||52
10729872|NCT02777931|11893739|FG000|Safety Population|Overall Study||47
10729873|NCT02777931|11893740|FG001|Safety Population|Overall Study||50
10729874|NCT02777931|11893739|FG000|Modified Intent to Treat Population|Overall Study||46
10729875|NCT02777931|11893740|FG001|Modified Intent to Treat Population|Overall Study||50
10729876|NCT02777931|11893739|FG000|COMPLETED|Overall Study||37
10729877|NCT02777931|11893740|FG001|COMPLETED|Overall Study||39
10729878|NCT02777931|11893739|FG000|NOT COMPLETED|Overall Study||12
10729879|NCT02777931|11893740|FG001|NOT COMPLETED|Overall Study||13
10729880|NCT02777944|11893748|FG000|STARTED|Overall Study||157
10729881|NCT02777944|11893749|FG001|STARTED|Overall Study||156
10729882|NCT02777944|11893748|FG000|COMPLETED|Overall Study||157
10729883|NCT02777944|11893749|FG001|COMPLETED|Overall Study||156
10729884|NCT02777944|11893748|FG000|NOT COMPLETED|Overall Study||0
10729885|NCT02777944|11893749|FG001|NOT COMPLETED|Overall Study||0
10729886|NCT02777970|11893758|FG000|STARTED|Overall Study||261
10729887|NCT02777970|11893759|FG001|STARTED|Overall Study||262
10729888|NCT02777970|11893760|FG002|STARTED|Overall Study||131
10729889|NCT02777970|11893758|FG000|COMPLETED|Overall Study||260
10729890|NCT02777970|11893759|FG001|COMPLETED|Overall Study||261
10729891|NCT02777970|11893760|FG002|COMPLETED|Overall Study||131
10729892|NCT02777970|11893758|FG000|NOT COMPLETED|Overall Study||1
10729893|NCT02777970|11893759|FG001|NOT COMPLETED|Overall Study||1
10729894|NCT02777970|11893760|FG002|NOT COMPLETED|Overall Study||0
10729895|NCT02778074|11893772|FG000|STARTED|Overall Study||72
10729896|NCT02778074|11893773|FG001|STARTED|Overall Study||72
10729897|NCT02778074|11893772|FG000|COMPLETED|Overall Study||65
10729898|NCT02778074|11893773|FG001|COMPLETED|Overall Study||62
10729899|NCT02778074|11893772|FG000|NOT COMPLETED|Overall Study||7
10729900|NCT02778074|11893773|FG001|NOT COMPLETED|Overall Study||10
10729901|NCT02778100|11893781|FG000|STARTED|Period 1 (Common Cold)||18
10729902|NCT02778100|11893782|FG001|STARTED|Period 1 (Common Cold)||18
10729903|NCT02778100|11893781|FG000|COMPLETED|Period 1 (Common Cold)||17
10729904|NCT02778100|11893782|FG001|COMPLETED|Period 1 (Common Cold)||18
10729905|NCT02778100|11893781|FG000|NOT COMPLETED|Period 1 (Common Cold)||1
10729906|NCT02778100|11893782|FG001|NOT COMPLETED|Period 1 (Common Cold)||0
10729907|NCT02778100|11893781|FG000|STARTED|Period 2 (No Cold Symptoms)||17
10729908|NCT02778100|11893782|FG001|STARTED|Period 2 (No Cold Symptoms)|Cohort 2 only administered NG to participants with a common cold who are taking oxymetazoline.|0
10729909|NCT02778100|11893781|FG000|COMPLETED|Period 2 (No Cold Symptoms)||17
10729910|NCT02778100|11893782|FG001|COMPLETED|Period 2 (No Cold Symptoms)||0
10729911|NCT02778100|11893781|FG000|NOT COMPLETED|Period 2 (No Cold Symptoms)||0
10729912|NCT02778100|11893782|FG001|NOT COMPLETED|Period 2 (No Cold Symptoms)||0
10729913|NCT02778113|11893790|FG000|STARTED|Study Period One||4
10729914|NCT02778113|11893791|FG001|STARTED|Study Period One||4
10729915|NCT02778113|11893792|FG002|STARTED|Study Period One||4
10729916|NCT02778113|11893793|FG003|STARTED|Study Period One||4
10729917|NCT02778113|11893790|FG000|Received Study Drug|Study Period One||4
10729918|NCT02778113|11893791|FG001|Received Study Drug|Study Period One||4
10729919|NCT02778113|11893792|FG002|Received Study Drug|Study Period One||4
10729920|NCT02778113|11893793|FG003|Received Study Drug|Study Period One||4
10729921|NCT02778113|11893790|FG000|COMPLETED|Study Period One||4
10729922|NCT02778113|11893791|FG001|COMPLETED|Study Period One||4
10729923|NCT02778113|11893792|FG002|COMPLETED|Study Period One||4
10729924|NCT02778113|11893793|FG003|COMPLETED|Study Period One||4
10729925|NCT02778113|11893790|FG000|NOT COMPLETED|Study Period One||0
10729926|NCT02778113|11893791|FG001|NOT COMPLETED|Study Period One||0
10729927|NCT02778113|11893792|FG002|NOT COMPLETED|Study Period One||0
10729928|NCT02778113|11893793|FG003|NOT COMPLETED|Study Period One||0
10729929|NCT02778113|11893790|FG000|STARTED|Study Period Two||4
10729930|NCT02778113|11893791|FG001|STARTED|Study Period Two||4
10729931|NCT02778113|11893792|FG002|STARTED|Study Period Two||4
10729932|NCT02778113|11893793|FG003|STARTED|Study Period Two||4
10729933|NCT02778113|11893790|FG000|Received Study Drug|Study Period Two||4
10729934|NCT02778113|11893791|FG001|Received Study Drug|Study Period Two||4
10729936|NCT02778113|11893793|FG003|Received Study Drug|Study Period Two||4
10729937|NCT02778113|11893790|FG000|COMPLETED|Study Period Two||4
10729938|NCT02778113|11893791|FG001|COMPLETED|Study Period Two||4
10729939|NCT02778113|11893792|FG002|COMPLETED|Study Period Two||4
10729940|NCT02778113|11893793|FG003|COMPLETED|Study Period Two||4
10729941|NCT02778113|11893790|FG000|NOT COMPLETED|Study Period Two||0
10729942|NCT02778113|11893791|FG001|NOT COMPLETED|Study Period Two||0
10729943|NCT02778113|11893792|FG002|NOT COMPLETED|Study Period Two||0
10729944|NCT02778113|11893793|FG003|NOT COMPLETED|Study Period Two||0
10729945|NCT02778113|11893790|FG000|STARTED|Study Period Three||4
10729946|NCT02778113|11893791|FG001|STARTED|Study Period Three||4
10729947|NCT02778113|11893792|FG002|STARTED|Study Period Three|One participant completed study period two, but did not enter study period three.|3
10729948|NCT02778113|11893793|FG003|STARTED|Study Period Three||4
10729949|NCT02778113|11893790|FG000|Received Study Drug|Study Period Three||4
10729950|NCT02778113|11893791|FG001|Received Study Drug|Study Period Three||4
10729951|NCT02778113|11893792|FG002|Received Study Drug|Study Period Three||3
10729952|NCT02778113|11893793|FG003|Received Study Drug|Study Period Three||4
10729953|NCT02778113|11893790|FG000|COMPLETED|Study Period Three||4
10729954|NCT02778113|11893791|FG001|COMPLETED|Study Period Three||4
10729955|NCT02778113|11893792|FG002|COMPLETED|Study Period Three||3
10729956|NCT02778113|11893793|FG003|COMPLETED|Study Period Three||4
10729957|NCT02778113|11893790|FG000|NOT COMPLETED|Study Period Three||0
10729958|NCT02778113|11893791|FG001|NOT COMPLETED|Study Period Three||0
10729959|NCT02778113|11893792|FG002|NOT COMPLETED|Study Period Three||0
10729960|NCT02778113|11893793|FG003|NOT COMPLETED|Study Period Three||0
10729961|NCT02778113|11893790|FG000|STARTED|Study Period Four|One participant completed study period three, but did not enter study period four.|3
10729962|NCT02778113|11893791|FG001|STARTED|Study Period Four||4
10729963|NCT02778113|11893792|FG002|STARTED|Study Period Four|One participant completed study period three, but did not enter study period four.|2
10729964|NCT02778113|11893793|FG003|STARTED|Study Period Four||4
10814862|NCT02163187|11977762|FG001|Treatment|Overall Study||0
10814863|NCT02163187|11977761|FG000|COMPLETED|Overall Study||2
10814864|NCT02163187|11977762|FG001|COMPLETED|Overall Study||0
10814865|NCT02163187|11977761|FG000|NOT COMPLETED|Overall Study||2
10814866|NCT02163187|11977762|FG001|NOT COMPLETED|Overall Study||0
10814867|NCT02161016|11977768|FG000|STARTED|Overall Study||1
10814868|NCT02161016|11977768|FG000|COMPLETED|Overall Study||0
10814869|NCT02161016|11977768|FG000|NOT COMPLETED|Overall Study||1
10814870|NCT02159040|11977772|FG000|STARTED|Overall Study||1
10814871|NCT02159040|11977772|FG000|COMPLETED|Overall Study||0
10814872|NCT02159040|11977772|FG000|NOT COMPLETED|Overall Study||1
10814873|NCT02168270|11977776|FG000|STARTED|Overall Study||4
10814874|NCT02168270|11977776|FG000|COMPLETED|Overall Study||0
10729965|NCT02778113|11893790|FG000|Received Study Drug|Study Period Four||3
10729966|NCT02778113|11893791|FG001|Received Study Drug|Study Period Four||4
10729967|NCT02778113|11893792|FG002|Received Study Drug|Study Period Four||2
10729968|NCT02778113|11893793|FG003|Received Study Drug|Study Period Four||4
10729969|NCT02778113|11893790|FG000|COMPLETED|Study Period Four||3
10729970|NCT02778113|11893791|FG001|COMPLETED|Study Period Four||4
10729971|NCT02778113|11893792|FG002|COMPLETED|Study Period Four||2
10729972|NCT02778113|11893793|FG003|COMPLETED|Study Period Four||4
10729973|NCT02778113|11893790|FG000|NOT COMPLETED|Study Period Four||0
10729974|NCT02778113|11893791|FG001|NOT COMPLETED|Study Period Four||0
10729975|NCT02778113|11893792|FG002|NOT COMPLETED|Study Period Four||0
10729976|NCT02778113|11893793|FG003|NOT COMPLETED|Study Period Four||0
10729977|NCT02778152|11893805|FG000|STARTED|Overall Study||13
10729978|NCT02778152|11893805|FG000|COMPLETED|Overall Study||13
10729979|NCT02778152|11893805|FG000|NOT COMPLETED|Overall Study||0
10729980|NCT02778555|11893812|FG000|STARTED|Overall Study||186
10729981|NCT02778555|11893813|FG001|STARTED|Overall Study||209
10729982|NCT02778555|11893814|FG002|STARTED|Overall Study||318
10729983|NCT02778555|11893812|FG000|COMPLETED|Overall Study||131
10729984|NCT02778555|11893813|FG001|COMPLETED|Overall Study||177
10729985|NCT02778555|11893814|FG002|COMPLETED|Overall Study||211
10729986|NCT02778555|11893812|FG000|NOT COMPLETED|Overall Study||55
10729987|NCT02778555|11893813|FG001|NOT COMPLETED|Overall Study||32
10729988|NCT02778555|11893814|FG002|NOT COMPLETED|Overall Study||107
10729989|NCT02778867|11893824|FG000|STARTED|Phase 1||67
10729990|NCT02778867|11893825|FG001|STARTED|Phase 1||62
10729991|NCT02778867|11893826|FG002|STARTED|Phase 1||0
10729992|NCT02778867|11893827|FG003|STARTED|Phase 1||0
10729993|NCT02778867|11893824|FG000|COMPLETED|Phase 1||65
10729994|NCT02778867|11893825|FG001|COMPLETED|Phase 1||59
10729995|NCT02778867|11893826|FG002|COMPLETED|Phase 1||0
10729996|NCT02778867|11893827|FG003|COMPLETED|Phase 1||0
10729997|NCT02778867|11893824|FG000|NOT COMPLETED|Phase 1||2
10729998|NCT02778867|11893825|FG001|NOT COMPLETED|Phase 1||3
10729999|NCT02778867|11893826|FG002|NOT COMPLETED|Phase 1||0
10730000|NCT02778867|11893827|FG003|NOT COMPLETED|Phase 1||0
10730001|NCT02778867|11893824|FG000|STARTED|Phase 2|1FED non-responders from Phase 1 have the option to undergo 6FED in Phase 2|0
10730002|NCT02778867|11893825|FG001|STARTED|Phase 2|6FED non-responders from Phase 1 have the option to undergo SGC in Phase 2|0
10730003|NCT02778867|11893826|FG002|STARTED|Phase 2|Optional phase for 1FED non-responders|21
10730004|NCT02778867|11893827|FG003|STARTED|Phase 2|Optional phase for 6FED non-responders|11
10730005|NCT02778867|11893824|FG000|COMPLETED|Phase 2||0
10730006|NCT02778867|11893825|FG001|COMPLETED|Phase 2||0
10730007|NCT02778867|11893826|FG002|COMPLETED|Phase 2||20
10730008|NCT02778867|11893827|FG003|COMPLETED|Phase 2||9
10730009|NCT02778867|11893824|FG000|NOT COMPLETED|Phase 2||0
10730010|NCT02778867|11893825|FG001|NOT COMPLETED|Phase 2||0
10730011|NCT02778867|11893826|FG002|NOT COMPLETED|Phase 2||1
10730012|NCT02778867|11893827|FG003|NOT COMPLETED|Phase 2||2
10730013|NCT02778880|11893839|FG000|STARTED|Overall Study||45
10730014|NCT02778880|11893840|FG001|STARTED|Overall Study||45
10730015|NCT02778880|11893839|FG000|COMPLETED|Overall Study||44
10730016|NCT02778880|11893840|FG001|COMPLETED|Overall Study||42
10730017|NCT02778880|11893839|FG000|NOT COMPLETED|Overall Study||1
10730018|NCT02778880|11893840|FG001|NOT COMPLETED|Overall Study||3
10730019|NCT02778932|11893848|FG000|STARTED|Overall Study||74
10730020|NCT02778932|11893849|FG001|STARTED|Overall Study||74
10814875|NCT02168270|11977776|FG000|NOT COMPLETED|Overall Study||4
10814876|NCT02157116|11977780|FG000|STARTED|Overall Study|signed consent form|13
10814877|NCT02157116|11977780|FG000|COMPLETED|Overall Study||4
10814878|NCT02157116|11977780|FG000|NOT COMPLETED|Overall Study||9
10730021|NCT02778932|11893848|FG000|COMPLETED|Overall Study||74
10730022|NCT02778932|11893849|FG001|COMPLETED|Overall Study||74
10730023|NCT02778932|11893848|FG000|NOT COMPLETED|Overall Study||0
10730024|NCT02778932|11893849|FG001|NOT COMPLETED|Overall Study||0
10730025|NCT02779075|11893857|FG000|STARTED|Overall Study||16
10730026|NCT02779075|11893858|FG001|STARTED|Overall Study||13
10730027|NCT02779075|11893857|FG000|COMPLETED|Overall Study||14
10730028|NCT02779075|11893858|FG001|COMPLETED|Overall Study||10
10730029|NCT02779075|11893857|FG000|NOT COMPLETED|Overall Study||2
10730030|NCT02779075|11893858|FG001|NOT COMPLETED|Overall Study||3
10730031|NCT02779166|11893866|FG000|STARTED|Overall Study||50
10730032|NCT02779166|11893867|FG001|STARTED|Overall Study||48
10730033|NCT02779166|11893866|FG000|COMPLETED|Overall Study||50
10730034|NCT02779166|11893867|FG001|COMPLETED|Overall Study||48
10730035|NCT02779166|11893866|FG000|NOT COMPLETED|Overall Study||0
10730036|NCT02779166|11893867|FG001|NOT COMPLETED|Overall Study||0
10730037|NCT02779491|11893877|FG000|STARTED|Overall Study||32
10730038|NCT02779491|11893878|FG001|STARTED|Overall Study||27
10730039|NCT02779491|11893879|FG002|STARTED|Overall Study||18
10730040|NCT02779491|11893880|FG003|STARTED|Overall Study||17
10730041|NCT02779491|11893877|FG000|COMPLETED|Overall Study||32
10730042|NCT02779491|11893878|FG001|COMPLETED|Overall Study||26
10730043|NCT02779491|11893879|FG002|COMPLETED|Overall Study||17
10730044|NCT02779491|11893880|FG003|COMPLETED|Overall Study||15
10730045|NCT02779491|11893877|FG000|NOT COMPLETED|Overall Study||0
10730046|NCT02779491|11893878|FG001|NOT COMPLETED|Overall Study||1
10730047|NCT02779491|11893879|FG002|NOT COMPLETED|Overall Study||1
10730048|NCT02779491|11893880|FG003|NOT COMPLETED|Overall Study||2
10730049|NCT02779543|11893892|FG000|STARTED|Overall Study||100
10730050|NCT02779543|11893893|FG001|STARTED|Overall Study||100
10730051|NCT02779543|11893892|FG000|COMPLETED|Overall Study||100
10730052|NCT02779543|11893893|FG001|COMPLETED|Overall Study||100
10730053|NCT02779543|11893892|FG000|NOT COMPLETED|Overall Study||0
10730054|NCT02779543|11893893|FG001|NOT COMPLETED|Overall Study||0
10730055|NCT02780115|11893905|FG000|STARTED|Overall Study||28
10730056|NCT02780115|11893906|FG001|STARTED|Overall Study||30
10730057|NCT02780115|11893907|FG002|STARTED|Overall Study||30
10730058|NCT02780115|11893908|FG003|STARTED|Overall Study||32
10730059|NCT02780115|11893909|FG004|STARTED|Overall Study||31
10730060|NCT02780115|11893905|FG000|COMPLETED|Overall Study||28
10730061|NCT02780115|11893906|FG001|COMPLETED|Overall Study||29
10730062|NCT02780115|11893907|FG002|COMPLETED|Overall Study||29
10730063|NCT02780115|11893908|FG003|COMPLETED|Overall Study||31
10730064|NCT02780115|11893909|FG004|COMPLETED|Overall Study||30
10730065|NCT02780115|11893905|FG000|NOT COMPLETED|Overall Study||0
10730066|NCT02780115|11893906|FG001|NOT COMPLETED|Overall Study||1
10730067|NCT02780115|11893907|FG002|NOT COMPLETED|Overall Study||1
10730068|NCT02780115|11893908|FG003|NOT COMPLETED|Overall Study||1
10730069|NCT02780115|11893909|FG004|NOT COMPLETED|Overall Study||1
10730070|NCT02780167|11893926|FG000|STARTED|Overall Study||56
10730071|NCT02780167|11893927|FG001|STARTED|Overall Study||49
10730072|NCT02780167|11893928|FG002|STARTED|Overall Study||51
10730073|NCT02780167|11893929|FG003|STARTED|Overall Study||56
10730074|NCT02780167|11893930|FG004|STARTED|Overall Study||55
10730075|NCT02780167|11893926|FG000|COMPLETED|Overall Study||28
10730076|NCT02780167|11893927|FG001|COMPLETED|Overall Study||27
10730077|NCT02780167|11893928|FG002|COMPLETED|Overall Study||27
10730078|NCT02780167|11893929|FG003|COMPLETED|Overall Study||37
10730079|NCT02780167|11893930|FG004|COMPLETED|Overall Study||38
10730080|NCT02780167|11893926|FG000|NOT COMPLETED|Overall Study||28
10730081|NCT02780167|11893927|FG001|NOT COMPLETED|Overall Study||22
10730082|NCT02780167|11893928|FG002|NOT COMPLETED|Overall Study||24
10730083|NCT02780167|11893929|FG003|NOT COMPLETED|Overall Study||19
10730084|NCT02780167|11893930|FG004|NOT COMPLETED|Overall Study||17
10730085|NCT02780349|11893942|FG000|STARTED|Overall Study||103
10730086|NCT02780349|11893942|FG000|COMPLETED|Overall Study||101
10730087|NCT02780349|11893942|FG000|NOT COMPLETED|Overall Study||2
10730088|NCT02780388|11893951|FG000|STARTED|Overall Study||15
10730089|NCT02780388|11893952|FG001|STARTED|Overall Study||8
10730090|NCT02780388|11893953|FG002|STARTED|Overall Study||10
10730091|NCT02780388|11893954|FG003|STARTED|Overall Study||12
10730092|NCT02780388|11893955|FG004|STARTED|Overall Study||12
10730093|NCT02780388|11893951|FG000|COMPLETED|Overall Study||14
10730094|NCT02780388|11893952|FG001|COMPLETED|Overall Study||6
10730095|NCT02780388|11893953|FG002|COMPLETED|Overall Study||10
10730096|NCT02780388|11893954|FG003|COMPLETED|Overall Study||12
10730097|NCT02780388|11893955|FG004|COMPLETED|Overall Study||12
10730098|NCT02780388|11893951|FG000|NOT COMPLETED|Overall Study||1
10730099|NCT02780388|11893952|FG001|NOT COMPLETED|Overall Study||2
10730100|NCT02780388|11893953|FG002|NOT COMPLETED|Overall Study||0
10730101|NCT02780388|11893954|FG003|NOT COMPLETED|Overall Study||0
10730102|NCT02780388|11893955|FG004|NOT COMPLETED|Overall Study||0
10730103|NCT02780622|11893971|FG000|STARTED|Treatment Period 1||10
10730104|NCT02780622|11893972|FG001|STARTED|Treatment Period 1||10
10730105|NCT02780622|11893971|FG000|COMPLETED|Treatment Period 1||10
10730106|NCT02780622|11893972|FG001|COMPLETED|Treatment Period 1||10
10730107|NCT02780622|11893971|FG000|NOT COMPLETED|Treatment Period 1||0
10730108|NCT02780622|11893972|FG001|NOT COMPLETED|Treatment Period 1||0
10730109|NCT02780622|11893971|FG000|STARTED|Treatment Period 2||10
10730110|NCT02780622|11893972|FG001|STARTED|Treatment Period 2||10
10730111|NCT02780622|11893971|FG000|COMPLETED|Treatment Period 2||10
10730112|NCT02780622|11893972|FG001|COMPLETED|Treatment Period 2||10
10730113|NCT02780622|11893971|FG000|NOT COMPLETED|Treatment Period 2||0
10730114|NCT02780622|11893972|FG001|NOT COMPLETED|Treatment Period 2||0
10730115|NCT02780661|11893979|FG000|STARTED|Period 1||10
10730116|NCT02780661|11893980|FG001|STARTED|Period 1||9
10730117|NCT02780661|11893979|FG000|COMPLETED|Period 1||10
10730118|NCT02780661|11893980|FG001|COMPLETED|Period 1||9
10730119|NCT02780661|11893979|FG000|NOT COMPLETED|Period 1||0
10730120|NCT02780661|11893980|FG001|NOT COMPLETED|Period 1||0
10730121|NCT02780661|11893979|FG000|STARTED|Wash Out Period||10
10730122|NCT02780661|11893980|FG001|STARTED|Wash Out Period||9
10730123|NCT02780661|11893979|FG000|COMPLETED|Wash Out Period||10
10730124|NCT02780661|11893980|FG001|COMPLETED|Wash Out Period||9
10730125|NCT02780661|11893979|FG000|NOT COMPLETED|Wash Out Period||0
10730126|NCT02780661|11893980|FG001|NOT COMPLETED|Wash Out Period||0
10730127|NCT02780661|11893979|FG000|STARTED|Period 2||10
10730128|NCT02780661|11893980|FG001|STARTED|Period 2||9
10730129|NCT02780661|11893979|FG000|COMPLETED|Period 2||10
10730130|NCT02780661|11893980|FG001|COMPLETED|Period 2||9
10730131|NCT02780661|11893979|FG000|NOT COMPLETED|Period 2||0
10730132|NCT02780661|11893980|FG001|NOT COMPLETED|Period 2||0
10730133|NCT02780687|11893989|FG000|STARTED|Overall Study||34
10730134|NCT02780687|11893990|FG001|STARTED|Overall Study||8
10730135|NCT02780687|11893989|FG000|COMPLETED|Overall Study||0
10730136|NCT02780687|11893990|FG001|COMPLETED|Overall Study||0
10730137|NCT02780687|11893989|FG000|NOT COMPLETED|Overall Study||34
10730138|NCT02780687|11893990|FG001|NOT COMPLETED|Overall Study||8
10730139|NCT02780700|11893995|FG000|STARTED|Overall Study||1
10730140|NCT02780700|11893995|FG000|COMPLETED|Overall Study||0
10730141|NCT02780700|11893995|FG000|NOT COMPLETED|Overall Study||1
10730142|NCT02780713|11893999|FG000|STARTED|Period 1: Variant A (100mg)|After washout period participants entered Treatment Period 2.|14
10730143|NCT02780713|11894000|FG001|STARTED|Period 1: Variant A (100mg)|After washout period participants entered Treatment Period 3.|0
10730144|NCT02780713|11894001|FG002|STARTED|Period 1: Variant A (100mg)|After washout period participants entered Treatment Period 4.|0
10730145|NCT02780713|11894002|FG003|STARTED|Period 1: Variant A (100mg)|After washout period participants entered Treatment Period 5.|0
10730146|NCT02780713|11894003|FG004|STARTED|Period 1: Variant A (100mg)||0
10730147|NCT02780713|11893999|FG000|COMPLETED|Period 1: Variant A (100mg)||14
10730148|NCT02780713|11894000|FG001|COMPLETED|Period 1: Variant A (100mg)||0
10730149|NCT02780713|11894001|FG002|COMPLETED|Period 1: Variant A (100mg)||0
10730150|NCT02780713|11894002|FG003|COMPLETED|Period 1: Variant A (100mg)||0
10730151|NCT02780713|11894003|FG004|COMPLETED|Period 1: Variant A (100mg)||0
10730152|NCT02780713|11893999|FG000|NOT COMPLETED|Period 1: Variant A (100mg)||0
10730153|NCT02780713|11894000|FG001|NOT COMPLETED|Period 1: Variant A (100mg)||0
10730154|NCT02780713|11894001|FG002|NOT COMPLETED|Period 1: Variant A (100mg)||0
10730155|NCT02780713|11894002|FG003|NOT COMPLETED|Period 1: Variant A (100mg)||0
10730156|NCT02780713|11894003|FG004|NOT COMPLETED|Period 1: Variant A (100mg)||0
10730157|NCT02780713|11893999|FG000|STARTED|Period 2: Reference (100mg)||0
10730158|NCT02780713|11894000|FG001|STARTED|Period 2: Reference (100mg)||14
10730159|NCT02780713|11894001|FG002|STARTED|Period 2: Reference (100mg)||0
10730160|NCT02780713|11894002|FG003|STARTED|Period 2: Reference (100mg)||0
10730161|NCT02780713|11894003|FG004|STARTED|Period 2: Reference (100mg)||0
10730162|NCT02780713|11893999|FG000|COMPLETED|Period 2: Reference (100mg)||0
10730163|NCT02780713|11894000|FG001|COMPLETED|Period 2: Reference (100mg)||14
10730164|NCT02780713|11894001|FG002|COMPLETED|Period 2: Reference (100mg)||0
10730165|NCT02780713|11894002|FG003|COMPLETED|Period 2: Reference (100mg)||0
10730166|NCT02780713|11894003|FG004|COMPLETED|Period 2: Reference (100mg)||0
10730167|NCT02780713|11893999|FG000|NOT COMPLETED|Period 2: Reference (100mg)||0
10730168|NCT02780713|11894000|FG001|NOT COMPLETED|Period 2: Reference (100mg)||0
10730169|NCT02780713|11894001|FG002|NOT COMPLETED|Period 2: Reference (100mg)||0
10730170|NCT02780713|11894002|FG003|NOT COMPLETED|Period 2: Reference (100mg)||0
10730171|NCT02780713|11894003|FG004|NOT COMPLETED|Period 2: Reference (100mg)||0
10730172|NCT02780713|11893999|FG000|STARTED|Period 3: Variant B (100mg)||0
10730173|NCT02780713|11894000|FG001|STARTED|Period 3: Variant B (100mg)||0
10730174|NCT02780713|11894001|FG002|STARTED|Period 3: Variant B (100mg)||14
10730175|NCT02780713|11894002|FG003|STARTED|Period 3: Variant B (100mg)||0
10730176|NCT02780713|11894003|FG004|STARTED|Period 3: Variant B (100mg)||0
10730177|NCT02780713|11893999|FG000|COMPLETED|Period 3: Variant B (100mg)||0
10730178|NCT02780713|11894000|FG001|COMPLETED|Period 3: Variant B (100mg)||0
10730179|NCT02780713|11894001|FG002|COMPLETED|Period 3: Variant B (100mg)||12
10730180|NCT02780713|11894002|FG003|COMPLETED|Period 3: Variant B (100mg)||0
10730181|NCT02780713|11894003|FG004|COMPLETED|Period 3: Variant B (100mg)||0
10730182|NCT02780713|11893999|FG000|NOT COMPLETED|Period 3: Variant B (100mg)||0
10730183|NCT02780713|11894000|FG001|NOT COMPLETED|Period 3: Variant B (100mg)||0
10730184|NCT02780713|11894001|FG002|NOT COMPLETED|Period 3: Variant B (100mg)||2
10730185|NCT02780713|11894002|FG003|NOT COMPLETED|Period 3: Variant B (100mg)||0
10730186|NCT02780713|11894003|FG004|NOT COMPLETED|Period 3: Variant B (100mg)||0
10730187|NCT02780713|11893999|FG000|STARTED|Period 4: Variant C (100mg)||0
10730188|NCT02780713|11894000|FG001|STARTED|Period 4: Variant C (100mg)||0
10730189|NCT02780713|11894001|FG002|STARTED|Period 4: Variant C (100mg)||0
10730190|NCT02780713|11894002|FG003|STARTED|Period 4: Variant C (100mg)||12
10730191|NCT02780713|11894003|FG004|STARTED|Period 4: Variant C (100mg)||0
10730192|NCT02780713|11893999|FG000|COMPLETED|Period 4: Variant C (100mg)||0
10730193|NCT02780713|11894000|FG001|COMPLETED|Period 4: Variant C (100mg)||0
10730194|NCT02780713|11894001|FG002|COMPLETED|Period 4: Variant C (100mg)||0
10730195|NCT02780713|11894002|FG003|COMPLETED|Period 4: Variant C (100mg)||12
10730196|NCT02780713|11894003|FG004|COMPLETED|Period 4: Variant C (100mg)||0
10730197|NCT02780713|11893999|FG000|NOT COMPLETED|Period 4: Variant C (100mg)||0
10730198|NCT02780713|11894000|FG001|NOT COMPLETED|Period 4: Variant C (100mg)||0
10730199|NCT02780713|11894001|FG002|NOT COMPLETED|Period 4: Variant C (100mg)||0
10730200|NCT02780713|11894002|FG003|NOT COMPLETED|Period 4: Variant C (100mg)||0
10730201|NCT02780713|11894003|FG004|NOT COMPLETED|Period 4: Variant C (100mg)||0
10730202|NCT02780713|11893999|FG000|STARTED|Period 5: Variant B (300mg)||0
10730203|NCT02780713|11894000|FG001|STARTED|Period 5: Variant B (300mg)||0
10730204|NCT02780713|11894001|FG002|STARTED|Period 5: Variant B (300mg)||0
10730205|NCT02780713|11894002|FG003|STARTED|Period 5: Variant B (300mg)||0
10730206|NCT02780713|11894003|FG004|STARTED|Period 5: Variant B (300mg)||12
10730207|NCT02780713|11893999|FG000|COMPLETED|Period 5: Variant B (300mg)||0
10730208|NCT02780713|11894000|FG001|COMPLETED|Period 5: Variant B (300mg)||0
10730209|NCT02780713|11894001|FG002|COMPLETED|Period 5: Variant B (300mg)||0
10730210|NCT02780713|11894002|FG003|COMPLETED|Period 5: Variant B (300mg)||0
10730211|NCT02780713|11894003|FG004|COMPLETED|Period 5: Variant B (300mg)||12
10730212|NCT02780713|11893999|FG000|NOT COMPLETED|Period 5: Variant B (300mg)||0
10730213|NCT02780713|11894000|FG001|NOT COMPLETED|Period 5: Variant B (300mg)||0
10730214|NCT02780713|11894001|FG002|NOT COMPLETED|Period 5: Variant B (300mg)||0
10730215|NCT02780713|11894002|FG003|NOT COMPLETED|Period 5: Variant B (300mg)||0
10730216|NCT02780713|11894003|FG004|NOT COMPLETED|Period 5: Variant B (300mg)||0
10730217|NCT02780765|11894024|FG000|STARTED|Overall Study||30
10730218|NCT02780765|11894025|FG001|STARTED|Overall Study||30
10730219|NCT02780765|11894024|FG000|COMPLETED|Overall Study||30
10730220|NCT02780765|11894025|FG001|COMPLETED|Overall Study||30
10730221|NCT02780765|11894024|FG000|NOT COMPLETED|Overall Study||0
10730222|NCT02780765|11894025|FG001|NOT COMPLETED|Overall Study||0
10730223|NCT02780856|11894031|FG000|STARTED|Overall Study||110
10730224|NCT02780856|11894031|FG000|COMPLETED|Overall Study||109
10730225|NCT02780856|11894031|FG000|NOT COMPLETED|Overall Study||1
10730226|NCT02780869|11894040|FG000|STARTED|Overall Study||175
10730227|NCT02780869|11894041|FG001|STARTED|Overall Study||83
10730228|NCT02780869|11894040|FG000|COMPLETED|Overall Study||162
10730229|NCT02780869|11894041|FG001|COMPLETED|Overall Study||74
10730230|NCT02780869|11894040|FG000|NOT COMPLETED|Overall Study||13
10730231|NCT02780869|11894041|FG001|NOT COMPLETED|Overall Study||9
10730232|NCT02781051|11894047|FG000|STARTED|Overall Study||16
10730233|NCT02781051|11894047|FG000|COMPLETED|Overall Study||14
10730234|NCT02781051|11894047|FG000|NOT COMPLETED|Overall Study||2
10730235|NCT02781311|11894055|FG000|STARTED|Overall Study||74
10730236|NCT02781311|11894056|FG001|STARTED|Overall Study||83
10730237|NCT02781311|11894057|FG002|STARTED|Overall Study||12
10730238|NCT02781311|11894055|FG000|Safety Population (Treated)|Overall Study||73
10730239|NCT02781311|11894056|FG001|Safety Population (Treated)|Overall Study||81
10730240|NCT02781311|11894057|FG002|Safety Population (Treated)|Overall Study||12
10730241|NCT02781311|11894055|FG000|mITT Population|Overall Study||70
10730242|NCT02781311|11894056|FG001|mITT Population|Overall Study||78
10730243|NCT02781311|11894057|FG002|mITT Population|Overall Study||11
10730244|NCT02781311|11894055|FG000|COMPLETED|Overall Study||48
10730245|NCT02781311|11894056|FG001|COMPLETED|Overall Study||57
10730246|NCT02781311|11894057|FG002|COMPLETED|Overall Study||8
10730247|NCT02781311|11894055|FG000|NOT COMPLETED|Overall Study||26
10730248|NCT02781311|11894056|FG001|NOT COMPLETED|Overall Study||26
10730249|NCT02781311|11894057|FG002|NOT COMPLETED|Overall Study||4
10730250|NCT02781324|11894066|FG000|STARTED|Overall Study||33
10730251|NCT02781324|11894067|FG001|STARTED|Overall Study||33
10730252|NCT02781324|11894066|FG000|COMPLETED|Overall Study||31
10730253|NCT02781324|11894067|FG001|COMPLETED|Overall Study||31
10730254|NCT02781324|11894066|FG000|NOT COMPLETED|Overall Study||2
10730255|NCT02781324|11894067|FG001|NOT COMPLETED|Overall Study||2
10730256|NCT02781454|11894078|FG000|STARTED|Overall Study||8
10730257|NCT02781454|11894079|FG001|STARTED|Overall Study||6
10730258|NCT02781454|11894080|FG002|STARTED|Overall Study||6
10730259|NCT02781454|11894078|FG000|COMPLETED|Overall Study||8
10730260|NCT02781454|11894079|FG001|COMPLETED|Overall Study||6
10730261|NCT02781454|11894080|FG002|COMPLETED|Overall Study||5
10730262|NCT02781454|11894078|FG000|NOT COMPLETED|Overall Study||0
10730263|NCT02781454|11894079|FG001|NOT COMPLETED|Overall Study||0
10730264|NCT02781454|11894080|FG002|NOT COMPLETED|Overall Study||1
10730265|NCT02781480|11894091|FG000|STARTED|Overall Study||9
10730266|NCT02781480|11894092|FG001|STARTED|Overall Study||3
10730267|NCT02781480|11894093|FG002|STARTED|Overall Study||3
10730268|NCT02781480|11894091|FG000|COMPLETED|Overall Study||9
10730269|NCT02781480|11894092|FG001|COMPLETED|Overall Study||3
10730270|NCT02781480|11894093|FG002|COMPLETED|Overall Study||3
10730271|NCT02781480|11894091|FG000|NOT COMPLETED|Overall Study||0
10730272|NCT02781480|11894092|FG001|NOT COMPLETED|Overall Study||0
10730273|NCT02781480|11894093|FG002|NOT COMPLETED|Overall Study||0
10730274|NCT02781558|11894103|FG000|STARTED|Overall Study||101
10730275|NCT02781558|11894104|FG001|STARTED|Overall Study||103
10730276|NCT02781558|11894103|FG000|COMPLETED|Overall Study||98
10730277|NCT02781558|11894104|FG001|COMPLETED|Overall Study||101
10730278|NCT02781558|11894103|FG000|NOT COMPLETED|Overall Study||3
10730279|NCT02781558|11894104|FG001|NOT COMPLETED|Overall Study||2
10730280|NCT02781571|11894111|FG000|STARTED|Overall Study||79
10730281|NCT02781571|11894111|FG000|COMPLETED|Overall Study||79
10730282|NCT02781571|11894111|FG000|NOT COMPLETED|Overall Study||0
10730283|NCT02781610|11894119|FG000|STARTED|Overall Study||140
10730284|NCT02781610|11894120|FG001|STARTED|Overall Study||137
10730285|NCT02781610|11894121|FG002|STARTED|Overall Study||353
10730286|NCT02781610|11894122|FG003|STARTED|Overall Study||352
10730287|NCT02781610|11894119|FG000|COMPLETED|Overall Study||134
10730288|NCT02781610|11894120|FG001|COMPLETED|Overall Study||130
10730289|NCT02781610|11894121|FG002|COMPLETED|Overall Study||336
10730290|NCT02781610|11894122|FG003|COMPLETED|Overall Study||323
10730291|NCT02781610|11894119|FG000|NOT COMPLETED|Overall Study||6
10730292|NCT02781610|11894120|FG001|NOT COMPLETED|Overall Study||7
10730293|NCT02781610|11894121|FG002|NOT COMPLETED|Overall Study||17
10730294|NCT02781610|11894122|FG003|NOT COMPLETED|Overall Study||29
10730295|NCT02781649|11894135|FG000|STARTED|Overall Study|4 in this group had insufficient viral RNA for genotyping. They were treated as 1a|7
10730296|NCT02781649|11894136|FG001|STARTED|Overall Study||0
10730297|NCT02781649|11894137|FG002|STARTED|Overall Study||3
10730298|NCT02781649|11894135|FG000|COMPLETED|Overall Study||7
10730299|NCT02781649|11894136|FG001|COMPLETED|Overall Study||0
10730300|NCT02781649|11894137|FG002|COMPLETED|Overall Study||3
10730301|NCT02781649|11894135|FG000|NOT COMPLETED|Overall Study||0
10730302|NCT02781649|11894136|FG001|NOT COMPLETED|Overall Study||0
10730303|NCT02781649|11894137|FG002|NOT COMPLETED|Overall Study||0
10730304|NCT02781818|11894148|FG000|STARTED|Overall Study||20
10730305|NCT02781818|11894149|FG001|STARTED|Overall Study||18
10730306|NCT02781818|11894150|FG002|STARTED|Overall Study||17
10730307|NCT02781818|11894148|FG000|COMPLETED|Overall Study||16
10730308|NCT02781818|11894149|FG001|COMPLETED|Overall Study||16
10730309|NCT02781818|11894150|FG002|COMPLETED|Overall Study||16
10730310|NCT02781818|11894148|FG000|NOT COMPLETED|Overall Study||4
10730311|NCT02781818|11894149|FG001|NOT COMPLETED|Overall Study||2
10730312|NCT02781818|11894150|FG002|NOT COMPLETED|Overall Study||1
10730313|NCT02781844|11894162|FG000|STARTED|Treatment Period 1||5
10730314|NCT02781844|11894163|FG001|STARTED|Treatment Period 1||4
10730315|NCT02781844|11894164|FG002|STARTED|Treatment Period 1||4
10730316|NCT02781844|11894165|FG003|STARTED|Treatment Period 1||4
10730317|NCT02781844|11894166|FG004|STARTED|Treatment Period 1||4
10730318|NCT02781844|11894167|FG005|STARTED|Treatment Period 1||5
10730319|NCT02781844|11894168|FG006|STARTED|Treatment Period 1||4
10730320|NCT02781844|11894169|FG007|STARTED|Treatment Period 1||4
10730321|NCT02781844|11894162|FG000|COMPLETED|Treatment Period 1||5
10730322|NCT02781844|11894163|FG001|COMPLETED|Treatment Period 1||4
10730323|NCT02781844|11894164|FG002|COMPLETED|Treatment Period 1||4
10730324|NCT02781844|11894165|FG003|COMPLETED|Treatment Period 1||4
10730325|NCT02781844|11894166|FG004|COMPLETED|Treatment Period 1||4
10730326|NCT02781844|11894167|FG005|COMPLETED|Treatment Period 1||4
10730327|NCT02781844|11894168|FG006|COMPLETED|Treatment Period 1||4
10730328|NCT02781844|11894169|FG007|COMPLETED|Treatment Period 1||4
10730329|NCT02781844|11894162|FG000|NOT COMPLETED|Treatment Period 1||0
10730330|NCT02781844|11894163|FG001|NOT COMPLETED|Treatment Period 1||0
10730331|NCT02781844|11894164|FG002|NOT COMPLETED|Treatment Period 1||0
10730332|NCT02781844|11894165|FG003|NOT COMPLETED|Treatment Period 1||0
10730333|NCT02781844|11894166|FG004|NOT COMPLETED|Treatment Period 1||0
10730334|NCT02781844|11894167|FG005|NOT COMPLETED|Treatment Period 1||1
10730335|NCT02781844|11894168|FG006|NOT COMPLETED|Treatment Period 1||0
10730336|NCT02781844|11894169|FG007|NOT COMPLETED|Treatment Period 1||0
10730337|NCT02781844|11894162|FG000|STARTED|Treatment Period 2||5
10730338|NCT02781844|11894163|FG001|STARTED|Treatment Period 2||4
10730339|NCT02781844|11894164|FG002|STARTED|Treatment Period 2||4
10730340|NCT02781844|11894165|FG003|STARTED|Treatment Period 2||4
10730341|NCT02781844|11894166|FG004|STARTED|Treatment Period 2||4
10730342|NCT02781844|11894167|FG005|STARTED|Treatment Period 2||4
10730343|NCT02781844|11894168|FG006|STARTED|Treatment Period 2||4
10730344|NCT02781844|11894169|FG007|STARTED|Treatment Period 2||4
10730345|NCT02781844|11894162|FG000|COMPLETED|Treatment Period 2||5
10730346|NCT02781844|11894163|FG001|COMPLETED|Treatment Period 2||4
10730347|NCT02781844|11894164|FG002|COMPLETED|Treatment Period 2||4
10730348|NCT02781844|11894165|FG003|COMPLETED|Treatment Period 2||4
10730349|NCT02781844|11894166|FG004|COMPLETED|Treatment Period 2||4
10730350|NCT02781844|11894167|FG005|COMPLETED|Treatment Period 2||4
10730351|NCT02781844|11894168|FG006|COMPLETED|Treatment Period 2||4
10730352|NCT02781844|11894169|FG007|COMPLETED|Treatment Period 2||4
10730353|NCT02781844|11894162|FG000|NOT COMPLETED|Treatment Period 2||0
10730354|NCT02781844|11894163|FG001|NOT COMPLETED|Treatment Period 2||0
10730355|NCT02781844|11894164|FG002|NOT COMPLETED|Treatment Period 2||0
10730356|NCT02781844|11894165|FG003|NOT COMPLETED|Treatment Period 2||0
10730357|NCT02781844|11894166|FG004|NOT COMPLETED|Treatment Period 2||0
10730358|NCT02781844|11894167|FG005|NOT COMPLETED|Treatment Period 2||0
10730359|NCT02781844|11894168|FG006|NOT COMPLETED|Treatment Period 2||0
10730360|NCT02781844|11894169|FG007|NOT COMPLETED|Treatment Period 2||0
10730361|NCT02782065|11894185|FG000|STARTED|Overall Study||58
10730362|NCT02782065|11894185|FG000|COMPLETED|Overall Study||58
10730363|NCT02782065|11894185|FG000|NOT COMPLETED|Overall Study||0
10730364|NCT02782169|11894192|FG000|STARTED|Overall Study||56
10730365|NCT02782169|11894193|FG001|STARTED|Overall Study||54
10730366|NCT02782169|11894192|FG000|COMPLETED|Overall Study||55
10730367|NCT02782169|11894193|FG001|COMPLETED|Overall Study||52
10730368|NCT02782169|11894192|FG000|NOT COMPLETED|Overall Study||1
10730369|NCT02782169|11894193|FG001|NOT COMPLETED|Overall Study||2
10730370|NCT02782325|11894201|FG000|STARTED|Blinded FMT Treatment (up to 24 Weeks)||4
10730371|NCT02782325|11894202|FG001|STARTED|Blinded FMT Treatment (up to 24 Weeks)||2
10730372|NCT02782325|11894203|FG002|STARTED|Blinded FMT Treatment (up to 24 Weeks)||0
10730373|NCT02782325|11894201|FG000|COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
10730374|NCT02782325|11894202|FG001|COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
10730375|NCT02782325|11894203|FG002|COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
10730376|NCT02782325|11894201|FG000|NOT COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||4
10730377|NCT02782325|11894202|FG001|NOT COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||2
10730378|NCT02782325|11894203|FG002|NOT COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
10730379|NCT02782325|11894201|FG000|STARTED|Open Label FMT Period (up to 24 Weeks)||0
10730380|NCT02782325|11894202|FG001|STARTED|Open Label FMT Period (up to 24 Weeks)||0
10730381|NCT02782325|11894203|FG002|STARTED|Open Label FMT Period (up to 24 Weeks)|1 participant decided to not participate in the open label period|5
10730382|NCT02782325|11894201|FG000|COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
10730383|NCT02782325|11894202|FG001|COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
10730384|NCT02782325|11894203|FG002|COMPLETED|Open Label FMT Period (up to 24 Weeks)||1
10730385|NCT02782325|11894201|FG000|NOT COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
10730386|NCT02782325|11894202|FG001|NOT COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
10730387|NCT02782325|11894203|FG002|NOT COMPLETED|Open Label FMT Period (up to 24 Weeks)||4
10730388|NCT02782364|11894211|FG000|STARTED|Overall Study||18
10730389|NCT02782364|11894212|FG001|STARTED|Overall Study||18
10730390|NCT02782364|11894211|FG000|COMPLETED|Overall Study||18
10730391|NCT02782364|11894212|FG001|COMPLETED|Overall Study||18
10730392|NCT02782364|11894211|FG000|NOT COMPLETED|Overall Study||0
10730393|NCT02782364|11894212|FG001|NOT COMPLETED|Overall Study||0
10730394|NCT02782377|11894219|FG000|STARTED|Overall Study||40
10730395|NCT02782377|11894219|FG000|COMPLETED|Overall Study|data from five of the patients were excluded due to interpretation difficulties|35
10730396|NCT02782377|11894219|FG000|NOT COMPLETED|Overall Study||5
10730397|NCT02782676|11894224|FG000|STARTED|Overall Study||211
10730398|NCT02782676|11894225|FG001|STARTED|Overall Study||210
10730399|NCT02782676|11894224|FG000|COMPLETED|Overall Study||211
10730400|NCT02782676|11894225|FG001|COMPLETED|Overall Study||209
10730401|NCT02782676|11894224|FG000|NOT COMPLETED|Overall Study||0
10730402|NCT02782676|11894225|FG001|NOT COMPLETED|Overall Study||1
10730403|NCT02782780|11894233|FG000|STARTED|Overall Study||46
10730404|NCT02782780|11894234|FG001|STARTED|Overall Study||39
10730405|NCT02782780|11894233|FG000|COMPLETED|Overall Study||39
10730406|NCT02782780|11894234|FG001|COMPLETED|Overall Study||32
10730407|NCT02782780|11894233|FG000|NOT COMPLETED|Overall Study||7
10814879|NCT02154087|11977784|FG000|STARTED|Overall Study||1
10814880|NCT02154087|11977784|FG000|COMPLETED|Overall Study||0
10814881|NCT02154087|11977784|FG000|NOT COMPLETED|Overall Study||1
10814882|NCT02152670|11977788|FG000|STARTED|Overall Study||1
10814883|NCT02152670|11977788|FG000|COMPLETED|Overall Study||1
10814884|NCT02152670|11977788|FG000|NOT COMPLETED|Overall Study||0
10814885|NCT02152566|11977792|FG000|STARTED|Overall Study||6
10814886|NCT02152566|11977792|FG000|COMPLETED|Overall Study||3
10814887|NCT02152566|11977792|FG000|NOT COMPLETED|Overall Study||3
10814888|NCT02137096|11977796|FG000|STARTED|Overall Study||1
10814889|NCT02137096|11977796|FG000|COMPLETED|Overall Study||1
10814890|NCT02137096|11977796|FG000|NOT COMPLETED|Overall Study||0
10814891|NCT02147834|11977802|FG000|STARTED|Overall Study||3
10814892|NCT02147834|11977803|FG001|STARTED|Overall Study||2
10814893|NCT02147834|11977802|FG000|COMPLETED|Overall Study||3
10814894|NCT02147834|11977803|FG001|COMPLETED|Overall Study||2
10814895|NCT02147834|11977802|FG000|NOT COMPLETED|Overall Study||0
10814896|NCT02147834|11977803|FG001|NOT COMPLETED|Overall Study||0
10814897|NCT02145390|11977809|FG000|STARTED|Overall Study||1
10814898|NCT02145390|11977809|FG000|COMPLETED|Overall Study||0
10814899|NCT02145390|11977809|FG000|NOT COMPLETED|Overall Study||1
10814900|NCT02132884|11977815|FG000|STARTED|Overall Study||0
10814901|NCT02132884|11977816|FG001|STARTED|Overall Study||0
10814902|NCT02132884|11977815|FG000|COMPLETED|Overall Study||0
10814903|NCT02132884|11977816|FG001|COMPLETED|Overall Study||0
10814904|NCT02132884|11977815|FG000|NOT COMPLETED|Overall Study||0
10814905|NCT02132884|11977816|FG001|NOT COMPLETED|Overall Study||0
10814906|NCT02144155|11977822|FG000|STARTED|Overall Study||14
10814907|NCT02144155|11977822|FG000|COMPLETED|Overall Study||14
10814908|NCT02144155|11977822|FG000|NOT COMPLETED|Overall Study||0
10814909|NCT02140788|11977826|FG000|STARTED|Overall Study||0
10814910|NCT02140788|11977827|FG001|STARTED|Overall Study||0
10814911|NCT02140788|11977828|FG002|STARTED|Overall Study||0
10814912|NCT02140788|11977829|FG003|STARTED|Overall Study||0
10814913|NCT02140788|11977826|FG000|COMPLETED|Overall Study||0
10814914|NCT02140788|11977827|FG001|COMPLETED|Overall Study||0
10814915|NCT02140788|11977828|FG002|COMPLETED|Overall Study||0
10814916|NCT02140788|11977829|FG003|COMPLETED|Overall Study||0
10814917|NCT02140788|11977826|FG000|NOT COMPLETED|Overall Study||0
10814918|NCT02140788|11977827|FG001|NOT COMPLETED|Overall Study||0
10814919|NCT02140788|11977828|FG002|NOT COMPLETED|Overall Study||0
10730408|NCT02782780|11894234|FG001|NOT COMPLETED|Overall Study||7
10814920|NCT02140788|11977829|FG003|NOT COMPLETED|Overall Study||0
10814921|NCT02150863|11977842|FG000|STARTED|Overall Study||0
10814922|NCT02150863|11977843|FG001|STARTED|Overall Study||1
10814923|NCT02150863|11977844|FG002|STARTED|Overall Study||0
10814924|NCT02150863|11977842|FG000|COMPLETED|Overall Study||0
10814925|NCT02150863|11977843|FG001|COMPLETED|Overall Study||0
10814926|NCT02150863|11977844|FG002|COMPLETED|Overall Study||0
10814927|NCT02150863|11977842|FG000|NOT COMPLETED|Overall Study||0
10814928|NCT02150863|11977843|FG001|NOT COMPLETED|Overall Study||1
10814929|NCT02150863|11977844|FG002|NOT COMPLETED|Overall Study||0
10814930|NCT02145169|11977852|FG000|STARTED|Overall Study||0
10730409|NCT02782923|11894240|FG000|STARTED|Overall Study||19
10730410|NCT02782923|11894240|FG000|COMPLETED|Overall Study||4
10730411|NCT02782923|11894240|FG000|NOT COMPLETED|Overall Study||15
10730412|NCT02783027|11894246|FG000|STARTED|Overall Study||39
10730413|NCT02783027|11894247|FG001|STARTED|Overall Study||44
10730414|NCT02783027|11894246|FG000|COMPLETED|Overall Study||16
10730415|NCT02783027|11894247|FG001|COMPLETED|Overall Study||27
10730416|NCT02783027|11894246|FG000|NOT COMPLETED|Overall Study||23
10730417|NCT02783027|11894247|FG001|NOT COMPLETED|Overall Study||17
10730418|NCT02783066|11894253|FG000|STARTED|Overall Study||16
10730419|NCT02783066|11894253|FG000|COMPLETED|Overall Study|complete 4-week pulseflow offloading wearing test|3
10730420|NCT02783066|11894253|FG000|NOT COMPLETED|Overall Study||13
10730421|NCT02783170|11894260|FG000|STARTED|Overall Study||43
10730422|NCT02783170|11894261|FG001|STARTED|Overall Study||38
10730423|NCT02783170|11894260|FG000|Safety Population|Overall Study|Added subject randomized to sequential but got simultaneous.|42
10730424|NCT02783170|11894261|FG001|Safety Population|Overall Study|Excluded sub. randomized but not vaccinated. Excluded sub. randomized to seq. but got simultaneous.|38
10730425|NCT02783170|11894260|FG000|COMPLETED|Overall Study||42
10730426|NCT02783170|11894261|FG001|COMPLETED|Overall Study||38
10730427|NCT02783170|11894260|FG000|NOT COMPLETED|Overall Study||1
10730428|NCT02783170|11894261|FG001|NOT COMPLETED|Overall Study||0
10730429|NCT02783443|11894270|FG000|STARTED|Overall Study||30
10730430|NCT02783443|11894271|FG001|STARTED|Overall Study||30
10730431|NCT02783443|11894270|FG000|COMPLETED|Overall Study||30
10730432|NCT02783443|11894271|FG001|COMPLETED|Overall Study||30
10730433|NCT02783443|11894270|FG000|NOT COMPLETED|Overall Study||0
10730434|NCT02783443|11894271|FG001|NOT COMPLETED|Overall Study||0
10730435|NCT02783469|11894277|FG000|STARTED|Overall Study||1915
10730436|NCT02783469|11894277|FG000|COMPLETED|Overall Study||1915
10730437|NCT02783469|11894277|FG000|NOT COMPLETED|Overall Study||0
10730438|NCT02783573|11894284|FG000|STARTED|Placebo-Controlled Treatment Period||562
10730439|NCT02783573|11894285|FG001|STARTED|Placebo-Controlled Treatment Period||590
10730440|NCT02783573|11894286|FG002|STARTED|Placebo-Controlled Treatment Period||570
10730441|NCT02783573|11894284|FG000|Received at Least 1 Dose of Study Drug|Placebo-Controlled Treatment Period||558
10730442|NCT02783573|11894285|FG001|Received at Least 1 Dose of Study Drug|Placebo-Controlled Treatment Period||588
10730443|NCT02783573|11894286|FG002|Received at Least 1 Dose of Study Drug|Placebo-Controlled Treatment Period||568
10730444|NCT02783573|11894284|FG000|COMPLETED|Placebo-Controlled Treatment Period||26
10730445|NCT02783573|11894285|FG001|COMPLETED|Placebo-Controlled Treatment Period||28
10730446|NCT02783573|11894286|FG002|COMPLETED|Placebo-Controlled Treatment Period||22
10730447|NCT02783573|11894284|FG000|NOT COMPLETED|Placebo-Controlled Treatment Period||536
10730448|NCT02783573|11894285|FG001|NOT COMPLETED|Placebo-Controlled Treatment Period||562
10730449|NCT02783573|11894286|FG002|NOT COMPLETED|Placebo-Controlled Treatment Period||548
10730450|NCT02783573|11894284|FG000|STARTED|Delayed-Start Period|Participants from placebo group were randomized to Lanabecestat 20 mg and 50 mg.|0
10730451|NCT02783573|11894285|FG001|STARTED|Delayed-Start Period|Participants completed period 1 may not have entered period 2 due to early termination of the study.|17
10730452|NCT02783573|11894286|FG002|STARTED|Delayed-Start Period|Participants completed period 1 may not have entered period 2 due to early termination of the study.|12
10730453|NCT02783573|11894284|FG000|Received at Least 1 Dose of Study Drug|Delayed-Start Period||0
10730454|NCT02783573|11894285|FG001|Received at Least 1 Dose of Study Drug|Delayed-Start Period||14
10730455|NCT02783573|11894286|FG002|Received at Least 1 Dose of Study Drug|Delayed-Start Period||12
10730456|NCT02783573|11894284|FG000|COMPLETED|Delayed-Start Period||0
10730457|NCT02783573|11894285|FG001|COMPLETED|Delayed-Start Period||0
10730458|NCT02783573|11894286|FG002|COMPLETED|Delayed-Start Period||0
10730459|NCT02783573|11894284|FG000|NOT COMPLETED|Delayed-Start Period||0
10730460|NCT02783573|11894285|FG001|NOT COMPLETED|Delayed-Start Period||17
10730461|NCT02783573|11894286|FG002|NOT COMPLETED|Delayed-Start Period||12
10730462|NCT02783599|11894297|FG000|STARTED|Overall Study||51
10730463|NCT02783599|11894297|FG000|Received At Least One Dose of Study Drug|Overall Study||51
10730464|NCT02783599|11894297|FG000|COMPLETED|Overall Study||11
10730465|NCT02783599|11894297|FG000|NOT COMPLETED|Overall Study||40
10730466|NCT02783729|11894312|FG000|STARTED|Overall Study||208
10730467|NCT02783729|11894313|FG001|STARTED|Overall Study||263
10730468|NCT02783729|11894314|FG002|STARTED|Overall Study||266
10730469|NCT02783729|11894315|FG003|STARTED|Overall Study||269
10730470|NCT02783729|11894312|FG000|COMPLETED|Overall Study||198
10730471|NCT02783729|11894313|FG001|COMPLETED|Overall Study||246
10730472|NCT02783729|11894314|FG002|COMPLETED|Overall Study||258
10730473|NCT02783729|11894315|FG003|COMPLETED|Overall Study||260
10730474|NCT02783729|11894312|FG000|NOT COMPLETED|Overall Study||10
10730475|NCT02783729|11894313|FG001|NOT COMPLETED|Overall Study||17
10730476|NCT02783729|11894314|FG002|NOT COMPLETED|Overall Study||8
10730477|NCT02783729|11894315|FG003|NOT COMPLETED|Overall Study||9
10730478|NCT02783768|11894330|FG000|STARTED|Overall Study||6
10730479|NCT02783768|11894331|FG001|STARTED|Overall Study||5
10730480|NCT02783768|11894330|FG000|COMPLETED|Overall Study||5
10730481|NCT02783768|11894331|FG001|COMPLETED|Overall Study||5
10730482|NCT02783768|11894330|FG000|NOT COMPLETED|Overall Study||1
10730483|NCT02783768|11894331|FG001|NOT COMPLETED|Overall Study||0
10730484|NCT02783820|11894341|FG000|STARTED|Overall Study||6
10730485|NCT02783820|11894342|FG001|STARTED|Overall Study||6
10730486|NCT02783820|11894343|FG002|STARTED|Overall Study||6
10730487|NCT02783820|11894344|FG003|STARTED|Overall Study||6
10730488|NCT02783820|11894341|FG000|COMPLETED|Overall Study||6
10730489|NCT02783820|11894342|FG001|COMPLETED|Overall Study||6
10730490|NCT02783820|11894343|FG002|COMPLETED|Overall Study||6
10730491|NCT02783820|11894344|FG003|COMPLETED|Overall Study||6
10730492|NCT02783820|11894341|FG000|NOT COMPLETED|Overall Study||0
10730493|NCT02783820|11894342|FG001|NOT COMPLETED|Overall Study||0
10730494|NCT02783820|11894343|FG002|NOT COMPLETED|Overall Study||0
10730495|NCT02783820|11894344|FG003|NOT COMPLETED|Overall Study||0
10730496|NCT02783898|11894356|FG000|STARTED|Overall Study||125
10730497|NCT02783898|11894357|FG001|STARTED|Overall Study||117
10730498|NCT02783898|11894356|FG000|COMPLETED|Overall Study||124
10730499|NCT02783898|11894357|FG001|COMPLETED|Overall Study||116
10730500|NCT02783898|11894356|FG000|NOT COMPLETED|Overall Study||1
10730501|NCT02783898|11894357|FG001|NOT COMPLETED|Overall Study||1
10730502|NCT02783911|11894367|FG000|STARTED|Overall Study||11
10730503|NCT02783911|11894368|FG001|STARTED|Overall Study||46
10730504|NCT02783911|11894367|FG000|COMPLETED|Overall Study||8
10730505|NCT02783911|11894368|FG001|COMPLETED|Overall Study||14
10730506|NCT02783911|11894367|FG000|NOT COMPLETED|Overall Study||3
10730507|NCT02783911|11894368|FG001|NOT COMPLETED|Overall Study||32
10730514|NCT02784106|11894385|FG000|STARTED|Double-Blind Treatment Period (12 Weeks)||32
10730515|NCT02784106|11894386|FG001|STARTED|Double-Blind Treatment Period (12 Weeks)||33
10730516|NCT02784106|11894387|FG002|STARTED|Double-Blind Treatment Period (12 Weeks)||0
10730517|NCT02784106|11894388|FG003|STARTED|Double-Blind Treatment Period (12 Weeks)||0
10730518|NCT02784106|11894385|FG000|COMPLETED|Double-Blind Treatment Period (12 Weeks)||24
10730519|NCT02784106|11894386|FG001|COMPLETED|Double-Blind Treatment Period (12 Weeks)||27
10730520|NCT02784106|11894387|FG002|COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
10730521|NCT02784106|11894388|FG003|COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
10730522|NCT02784106|11894385|FG000|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||8
10730523|NCT02784106|11894386|FG001|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||6
10730524|NCT02784106|11894387|FG002|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
10730525|NCT02784106|11894388|FG003|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
10730526|NCT02784106|11894385|FG000|STARTED|Open-Label Extension Period (26 Weeks)||0
10730527|NCT02784106|11894386|FG001|STARTED|Open-Label Extension Period (26 Weeks)||0
10730528|NCT02784106|11894387|FG002|STARTED|Open-Label Extension Period (26 Weeks)||18
10730529|NCT02784106|11894388|FG003|STARTED|Open-Label Extension Period (26 Weeks)||21
10730530|NCT02784106|11894385|FG000|COMPLETED|Open-Label Extension Period (26 Weeks)||0
10730531|NCT02784106|11894386|FG001|COMPLETED|Open-Label Extension Period (26 Weeks)||0
10730532|NCT02784106|11894387|FG002|COMPLETED|Open-Label Extension Period (26 Weeks)||15
10730533|NCT02784106|11894388|FG003|COMPLETED|Open-Label Extension Period (26 Weeks)||19
10730534|NCT02784106|11894385|FG000|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||0
10730535|NCT02784106|11894386|FG001|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||0
10730536|NCT02784106|11894387|FG002|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||3
10730537|NCT02784106|11894388|FG003|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||2
10730538|NCT02784275|11894401|FG000|STARTED|Overall Study||16
10730539|NCT02784275|11894402|FG001|STARTED|Overall Study||16
10730540|NCT02784275|11894403|FG002|STARTED|Overall Study||17
10730541|NCT02784275|11894404|FG003|STARTED|Overall Study||15
10730542|NCT02784275|11894401|FG000|COMPLETED|Overall Study||15
10730543|NCT02784275|11894402|FG001|COMPLETED|Overall Study||16
10730544|NCT02784275|11894403|FG002|COMPLETED|Overall Study||16
10730545|NCT02784275|11894404|FG003|COMPLETED|Overall Study||14
10730546|NCT02784275|11894401|FG000|NOT COMPLETED|Overall Study||1
10730547|NCT02784275|11894402|FG001|NOT COMPLETED|Overall Study||0
10730548|NCT02784275|11894403|FG002|NOT COMPLETED|Overall Study||1
10730549|NCT02784275|11894404|FG003|NOT COMPLETED|Overall Study||1
10730553|NCT02784444|11894422|FG000|STARTED|Overall Study||94
10730554|NCT02784444|11894423|FG001|STARTED|Overall Study||99
10730555|NCT02784444|11894424|FG002|STARTED|Overall Study||98
10730556|NCT02784444|11894425|FG003|STARTED|Overall Study||101
10730557|NCT02784444|11894422|FG000|COMPLETED|Overall Study||78
10730558|NCT02784444|11894423|FG001|COMPLETED|Overall Study||90
10730559|NCT02784444|11894424|FG002|COMPLETED|Overall Study||86
10730560|NCT02784444|11894425|FG003|COMPLETED|Overall Study||88
10730561|NCT02784444|11894422|FG000|NOT COMPLETED|Overall Study||16
10730562|NCT02784444|11894423|FG001|NOT COMPLETED|Overall Study||9
10730563|NCT02784444|11894424|FG002|NOT COMPLETED|Overall Study||12
10730564|NCT02784444|11894425|FG003|NOT COMPLETED|Overall Study||13
10730565|NCT02784548|11894435|FG000|STARTED|Overall Study||15
10730566|NCT02784548|11894435|FG000|COMPLETED|Overall Study||15
10730567|NCT02784548|11894435|FG000|NOT COMPLETED|Overall Study||0
10730568|NCT02784587|11894440|FG000|STARTED|Overall Study||25
10730569|NCT02784587|11894440|FG000|COMPLETED|Overall Study||25
10730570|NCT02784587|11894440|FG000|NOT COMPLETED|Overall Study||0
10730571|NCT02784613|11894444|FG000|STARTED|Overall Study||10
10730572|NCT02784613|11894444|FG000|COMPLETED|Overall Study||8
10730573|NCT02784613|11894444|FG000|NOT COMPLETED|Overall Study||2
10730574|NCT02784834|11894448|FG000|STARTED|Overall Study||2
10730575|NCT02784834|11894448|FG000|COMPLETED|Overall Study||1
10730576|NCT02784834|11894448|FG000|NOT COMPLETED|Overall Study||1
10730577|NCT02784925|11894452|FG000|STARTED|Overall Study||30
10730578|NCT02784925|11894452|FG000|COMPLETED|Overall Study||30
10730579|NCT02784925|11894452|FG000|NOT COMPLETED|Overall Study||0
10730580|NCT02785159|11894460|FG000|STARTED|Overall Study||62
10730581|NCT02785159|11894461|FG001|STARTED|Overall Study||58
10730582|NCT02785159|11894462|FG002|STARTED|Overall Study||15
10730583|NCT02785159|11894463|FG003|STARTED|Overall Study||17
10730584|NCT02785159|11894460|FG000|COMPLETED|Overall Study||51
10730585|NCT02785159|11894461|FG001|COMPLETED|Overall Study||45
10730586|NCT02785159|11894462|FG002|COMPLETED|Overall Study||12
10730587|NCT02785159|11894463|FG003|COMPLETED|Overall Study||14
10730588|NCT02785159|11894460|FG000|NOT COMPLETED|Overall Study||11
10730589|NCT02785159|11894461|FG001|NOT COMPLETED|Overall Study||13
10730590|NCT02785159|11894462|FG002|NOT COMPLETED|Overall Study||3
10730591|NCT02785159|11894463|FG003|NOT COMPLETED|Overall Study||3
10730592|NCT02785172|11894477|FG000|STARTED|Overall Study||61
10730593|NCT02785172|11894478|FG001|STARTED|Overall Study||63
10730594|NCT02785172|11894479|FG002|STARTED|Overall Study||16
10730595|NCT02785172|11894480|FG003|STARTED|Overall Study||14
10730596|NCT02785172|11894477|FG000|COMPLETED|Overall Study||61
10730597|NCT02785172|11894478|FG001|COMPLETED|Overall Study||62
10730598|NCT02785172|11894479|FG002|COMPLETED|Overall Study||15
10730599|NCT02785172|11894480|FG003|COMPLETED|Overall Study||14
10730600|NCT02785172|11894477|FG000|NOT COMPLETED|Overall Study||0
10730601|NCT02785172|11894478|FG001|NOT COMPLETED|Overall Study||1
10730602|NCT02785172|11894479|FG002|NOT COMPLETED|Overall Study||1
10730603|NCT02785172|11894480|FG003|NOT COMPLETED|Overall Study||0
10730604|NCT02785185|11894494|FG000|STARTED|Overall Study||60
10730605|NCT02785185|11894495|FG001|STARTED|Overall Study||57
10730606|NCT02785185|11894496|FG002|STARTED|Overall Study||17
10730607|NCT02785185|11894497|FG003|STARTED|Overall Study||16
10730608|NCT02785185|11894494|FG000|COMPLETED|Overall Study||59
10730609|NCT02785185|11894495|FG001|COMPLETED|Overall Study||56
10730610|NCT02785185|11894496|FG002|COMPLETED|Overall Study||15
10730611|NCT02785185|11894497|FG003|COMPLETED|Overall Study||16
10730612|NCT02785185|11894494|FG000|NOT COMPLETED|Overall Study||1
10730613|NCT02785185|11894495|FG001|NOT COMPLETED|Overall Study||1
10730614|NCT02785185|11894496|FG002|NOT COMPLETED|Overall Study||2
10730615|NCT02785185|11894497|FG003|NOT COMPLETED|Overall Study||0
10730616|NCT02785354|11894510|FG000|STARTED|Overall Study||27060
10730617|NCT02785354|11894511|FG001|STARTED|Overall Study||31388
10730618|NCT02785354|11894512|FG002|STARTED|Overall Study||44653
10730619|NCT02785354|11894510|FG000|COMPLETED|Overall Study||27060
10730620|NCT02785354|11894511|FG001|COMPLETED|Overall Study||31388
10730621|NCT02785354|11894512|FG002|COMPLETED|Overall Study||44653
10730622|NCT02785354|11894510|FG000|NOT COMPLETED|Overall Study||0
10730623|NCT02785354|11894511|FG001|NOT COMPLETED|Overall Study||0
10730624|NCT02785354|11894512|FG002|NOT COMPLETED|Overall Study||0
10730625|NCT02785406|11894523|FG000|STARTED|Overall Study||10
10730626|NCT02785406|11894524|FG001|STARTED|Overall Study||10
10730627|NCT02785406|11894523|FG000|Completed First Week|Overall Study||10
10730628|NCT02785406|11894524|FG001|Completed First Week|Overall Study||10
10730629|NCT02785406|11894523|FG000|Completed Second Week|Overall Study||10
10730630|NCT02785406|11894524|FG001|Completed Second Week|Overall Study||10
10730631|NCT02785406|11894523|FG000|COMPLETED|Overall Study||10
10730632|NCT02785406|11894524|FG001|COMPLETED|Overall Study||10
10730633|NCT02785406|11894523|FG000|NOT COMPLETED|Overall Study||0
10730634|NCT02785406|11894524|FG001|NOT COMPLETED|Overall Study||0
10730635|NCT02785432|11894532|FG000|STARTED|Overall Study||4
10730636|NCT02785432|11894533|FG001|STARTED|Overall Study||7
10730637|NCT02785432|11894532|FG000|COMPLETED|Overall Study||4
10730638|NCT02785432|11894533|FG001|COMPLETED|Overall Study||7
10730639|NCT02785432|11894532|FG000|NOT COMPLETED|Overall Study||0
10730640|NCT02785432|11894533|FG001|NOT COMPLETED|Overall Study||0
10730641|NCT02785458|11894541|FG000|STARTED|Baseline||526
10730642|NCT02785458|11894542|FG001|STARTED|Baseline||479
10730643|NCT02785458|11894541|FG000|COMPLETED|Baseline||526
10730644|NCT02785458|11894542|FG001|COMPLETED|Baseline||479
10730645|NCT02785458|11894541|FG000|NOT COMPLETED|Baseline||0
10730646|NCT02785458|11894542|FG001|NOT COMPLETED|Baseline||0
10730647|NCT02785458|11894541|FG000|STARTED|1 Month||526
10730648|NCT02785458|11894542|FG001|STARTED|1 Month||479
10730649|NCT02785458|11894541|FG000|COMPLETED|1 Month||443
10730650|NCT02785458|11894542|FG001|COMPLETED|1 Month||404
10730651|NCT02785458|11894541|FG000|NOT COMPLETED|1 Month||83
10730652|NCT02785458|11894542|FG001|NOT COMPLETED|1 Month||75
10730653|NCT02785458|11894541|FG000|STARTED|3 Months||443
10730654|NCT02785458|11894542|FG001|STARTED|3 Months||404
10730655|NCT02785458|11894541|FG000|COMPLETED|3 Months||315
10730656|NCT02785458|11894542|FG001|COMPLETED|3 Months||293
10730657|NCT02785458|11894541|FG000|NOT COMPLETED|3 Months||128
10730658|NCT02785458|11894542|FG001|NOT COMPLETED|3 Months||111
10730659|NCT02785588|11894548|FG000|STARTED|Phase 1: Initial Feasibility Assessment||49
10730660|NCT02785588|11894548|FG000|COMPLETED|Phase 1: Initial Feasibility Assessment||47
10730661|NCT02785588|11894548|FG000|NOT COMPLETED|Phase 1: Initial Feasibility Assessment||2
10730662|NCT02785588|11894548|FG000|STARTED|Phase2 Controlled Image &Data Collection|Phase 2 participants represent newly enrolled participants.|5
10730663|NCT02785588|11894548|FG000|COMPLETED|Phase2 Controlled Image &Data Collection||5
10730664|NCT02785588|11894548|FG000|NOT COMPLETED|Phase2 Controlled Image &Data Collection||0
10730665|NCT02785770|11894552|FG000|STARTED|Intervention Period 1 (1 Day)||11
10730666|NCT02785770|11894553|FG001|STARTED|Intervention Period 1 (1 Day)||11
10730667|NCT02785770|11894554|FG002|STARTED|Intervention Period 1 (1 Day)||11
10730668|NCT02785770|11894555|FG003|STARTED|Intervention Period 1 (1 Day)||11
10730669|NCT02785770|11894552|FG000|COMPLETED|Intervention Period 1 (1 Day)||11
10730670|NCT02785770|11894553|FG001|COMPLETED|Intervention Period 1 (1 Day)||11
10730671|NCT02785770|11894554|FG002|COMPLETED|Intervention Period 1 (1 Day)||11
10730672|NCT02785770|11894555|FG003|COMPLETED|Intervention Period 1 (1 Day)||11
10730673|NCT02785770|11894552|FG000|NOT COMPLETED|Intervention Period 1 (1 Day)||0
10730674|NCT02785770|11894553|FG001|NOT COMPLETED|Intervention Period 1 (1 Day)||0
10730675|NCT02785770|11894554|FG002|NOT COMPLETED|Intervention Period 1 (1 Day)||0
10730676|NCT02785770|11894555|FG003|NOT COMPLETED|Intervention Period 1 (1 Day)||0
10730677|NCT02785770|11894552|FG000|STARTED|Washout Period 1 (7 Days)||11
10730678|NCT02785770|11894553|FG001|STARTED|Washout Period 1 (7 Days)||11
10730679|NCT02785770|11894554|FG002|STARTED|Washout Period 1 (7 Days)||11
10730680|NCT02785770|11894555|FG003|STARTED|Washout Period 1 (7 Days)||11
10730681|NCT02785770|11894552|FG000|COMPLETED|Washout Period 1 (7 Days)||11
10730682|NCT02785770|11894553|FG001|COMPLETED|Washout Period 1 (7 Days)||11
10730683|NCT02785770|11894554|FG002|COMPLETED|Washout Period 1 (7 Days)||11
10730684|NCT02785770|11894555|FG003|COMPLETED|Washout Period 1 (7 Days)||11
10730685|NCT02785770|11894552|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
10730686|NCT02785770|11894553|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
10730687|NCT02785770|11894554|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
10730688|NCT02785770|11894555|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
10730689|NCT02785770|11894552|FG000|STARTED|Intervention Period 2 (1 Day)||11
10730690|NCT02785770|11894553|FG001|STARTED|Intervention Period 2 (1 Day)||11
10730691|NCT02785770|11894554|FG002|STARTED|Intervention Period 2 (1 Day)||11
10730692|NCT02785770|11894555|FG003|STARTED|Intervention Period 2 (1 Day)||11
10730693|NCT02785770|11894552|FG000|COMPLETED|Intervention Period 2 (1 Day)||11
10730694|NCT02785770|11894553|FG001|COMPLETED|Intervention Period 2 (1 Day)||10
10730695|NCT02785770|11894554|FG002|COMPLETED|Intervention Period 2 (1 Day)||10
10730696|NCT02785770|11894555|FG003|COMPLETED|Intervention Period 2 (1 Day)||11
10730697|NCT02785770|11894552|FG000|NOT COMPLETED|Intervention Period 2 (1 Day)||0
10730698|NCT02785770|11894553|FG001|NOT COMPLETED|Intervention Period 2 (1 Day)||1
10730699|NCT02785770|11894554|FG002|NOT COMPLETED|Intervention Period 2 (1 Day)||1
10730700|NCT02785770|11894555|FG003|NOT COMPLETED|Intervention Period 2 (1 Day)||0
10730701|NCT02785770|11894552|FG000|STARTED|Washout Period 2 (7 Days)||11
10730702|NCT02785770|11894553|FG001|STARTED|Washout Period 2 (7 Days)||10
10730703|NCT02785770|11894554|FG002|STARTED|Washout Period 2 (7 Days)||10
10730704|NCT02785770|11894555|FG003|STARTED|Washout Period 2 (7 Days)||11
10730705|NCT02785770|11894552|FG000|COMPLETED|Washout Period 2 (7 Days)||11
10730706|NCT02785770|11894553|FG001|COMPLETED|Washout Period 2 (7 Days)||10
10730707|NCT02785770|11894554|FG002|COMPLETED|Washout Period 2 (7 Days)||10
10730708|NCT02785770|11894555|FG003|COMPLETED|Washout Period 2 (7 Days)||11
10730709|NCT02785770|11894552|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
10730710|NCT02785770|11894553|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
10730711|NCT02785770|11894554|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
10730712|NCT02785770|11894555|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
10730713|NCT02785770|11894552|FG000|STARTED|Intervention Period 3 (1 Day)||11
10730714|NCT02785770|11894553|FG001|STARTED|Intervention Period 3 (1 Day)||10
10730715|NCT02785770|11894554|FG002|STARTED|Intervention Period 3 (1 Day)||10
10730716|NCT02785770|11894555|FG003|STARTED|Intervention Period 3 (1 Day)||11
10730717|NCT02785770|11894552|FG000|COMPLETED|Intervention Period 3 (1 Day)||11
10730718|NCT02785770|11894553|FG001|COMPLETED|Intervention Period 3 (1 Day)||10
10730719|NCT02785770|11894554|FG002|COMPLETED|Intervention Period 3 (1 Day)||10
10730720|NCT02785770|11894555|FG003|COMPLETED|Intervention Period 3 (1 Day)||10
10730721|NCT02785770|11894552|FG000|NOT COMPLETED|Intervention Period 3 (1 Day)||0
10730722|NCT02785770|11894553|FG001|NOT COMPLETED|Intervention Period 3 (1 Day)||0
10730723|NCT02785770|11894554|FG002|NOT COMPLETED|Intervention Period 3 (1 Day)||0
10730724|NCT02785770|11894555|FG003|NOT COMPLETED|Intervention Period 3 (1 Day)||1
10730725|NCT02785770|11894552|FG000|STARTED|Washout Period 3 (7 Days)||11
10730726|NCT02785770|11894553|FG001|STARTED|Washout Period 3 (7 Days)||10
10730727|NCT02785770|11894554|FG002|STARTED|Washout Period 3 (7 Days)||10
10730728|NCT02785770|11894555|FG003|STARTED|Washout Period 3 (7 Days)||10
10730729|NCT02785770|11894552|FG000|COMPLETED|Washout Period 3 (7 Days)||11
10730730|NCT02785770|11894553|FG001|COMPLETED|Washout Period 3 (7 Days)||10
10730731|NCT02785770|11894554|FG002|COMPLETED|Washout Period 3 (7 Days)||10
10730732|NCT02785770|11894555|FG003|COMPLETED|Washout Period 3 (7 Days)||10
10730733|NCT02785770|11894552|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
10730734|NCT02785770|11894553|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
10730735|NCT02785770|11894554|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
10730736|NCT02785770|11894555|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
10730737|NCT02785770|11894552|FG000|STARTED|Intervention Period 4 (1 Day)||11
10730738|NCT02785770|11894553|FG001|STARTED|Intervention Period 4 (1 Day)||10
10730739|NCT02785770|11894554|FG002|STARTED|Intervention Period 4 (1 Day)||10
10730740|NCT02785770|11894555|FG003|STARTED|Intervention Period 4 (1 Day)||10
10730741|NCT02785770|11894552|FG000|COMPLETED|Intervention Period 4 (1 Day)||11
10730742|NCT02785770|11894553|FG001|COMPLETED|Intervention Period 4 (1 Day)||10
10730743|NCT02785770|11894554|FG002|COMPLETED|Intervention Period 4 (1 Day)||10
10730744|NCT02785770|11894555|FG003|COMPLETED|Intervention Period 4 (1 Day)||10
10730745|NCT02785770|11894552|FG000|NOT COMPLETED|Intervention Period 4 (1 Day)||0
10814931|NCT02145169|11977852|FG000|COMPLETED|Overall Study||0
10814932|NCT02145169|11977852|FG000|NOT COMPLETED|Overall Study||0
10814933|NCT02130622|11977858|FG000|STARTED|Overall Study||2
10814934|NCT02130622|11977859|FG001|STARTED|Overall Study||1
10814935|NCT02130622|11977858|FG000|COMPLETED|Overall Study||2
10814936|NCT02130622|11977859|FG001|COMPLETED|Overall Study||1
10814937|NCT02130622|11977858|FG000|NOT COMPLETED|Overall Study||0
10814938|NCT02130622|11977859|FG001|NOT COMPLETED|Overall Study||0
10814939|NCT02133534|11977865|FG000|STARTED|Overall Study||1
10814940|NCT02133534|11977865|FG000|COMPLETED|Overall Study||1
10814941|NCT02133534|11977865|FG000|NOT COMPLETED|Overall Study||0
10814942|NCT02134912|11977871|FG000|STARTED|Overall Study||0
10814943|NCT02134912|11977872|FG001|STARTED|Overall Study||0
10814944|NCT02134912|11977871|FG000|COMPLETED|Overall Study||0
10814945|NCT02134912|11977872|FG001|COMPLETED|Overall Study||0
10814946|NCT02134912|11977871|FG000|NOT COMPLETED|Overall Study||0
10814947|NCT02134912|11977872|FG001|NOT COMPLETED|Overall Study||0
10814948|NCT02131155|11977880|FG000|STARTED|Overall Study|Started are treated patients.|25
10814949|NCT02131155|11977881|FG001|STARTED|Overall Study|Started are treated patients.|11
10814950|NCT02131155|11977880|FG000|COMPLETED|Overall Study|Completed are patients who completed study procedures as protocol requires.|0
10814951|NCT02131155|11977881|FG001|COMPLETED|Overall Study|Completed are patients who completed study procedures as protocol requires.|0
10814952|NCT02131155|11977880|FG000|NOT COMPLETED|Overall Study||25
10814953|NCT02131155|11977881|FG001|NOT COMPLETED|Overall Study||11
10814954|NCT02117050|11977887|FG000|STARTED|Overall Study||1
10814955|NCT02117050|11977887|FG000|COMPLETED|Overall Study||0
10814956|NCT02117050|11977887|FG000|NOT COMPLETED|Overall Study||1
10730746|NCT02785770|11894553|FG001|NOT COMPLETED|Intervention Period 4 (1 Day)||0
10730747|NCT02785770|11894554|FG002|NOT COMPLETED|Intervention Period 4 (1 Day)||0
10730748|NCT02785770|11894555|FG003|NOT COMPLETED|Intervention Period 4 (1 Day)||0
10730749|NCT02785900|11894570|FG000|STARTED|Overall Study||117
10730750|NCT02785900|11894571|FG001|STARTED|Overall Study||123
10730751|NCT02785900|11894570|FG000|COMPLETED|Overall Study||0
10730752|NCT02785900|11894571|FG001|COMPLETED|Overall Study||0
10730753|NCT02785900|11894570|FG000|NOT COMPLETED|Overall Study||117
10730754|NCT02785900|11894571|FG001|NOT COMPLETED|Overall Study||123
10730755|NCT02785913|11894577|FG000|STARTED|Overall Study||26
10730756|NCT02785913|11894577|FG000|COMPLETED|Overall Study||0
10730757|NCT02785913|11894577|FG000|NOT COMPLETED|Overall Study||26
10730758|NCT02785939|11894584|FG000|STARTED|Overall Study||31
10730759|NCT02785939|11894585|FG001|STARTED|Overall Study||10
10730760|NCT02785939|11894584|FG000|Participants Re-registered to Palbociclib After Progression on Docetaxel|Overall Study||0
10730761|NCT02785939|11894585|FG001|Participants Re-registered to Palbociclib After Progression on Docetaxel|Overall Study||1
10730762|NCT02785939|11894584|FG000|COMPLETED|Overall Study||0
10730763|NCT02785939|11894585|FG001|COMPLETED|Overall Study||0
10730764|NCT02785939|11894584|FG000|NOT COMPLETED|Overall Study||31
10730765|NCT02785939|11894585|FG001|NOT COMPLETED|Overall Study||10
10730766|NCT02786004|11894593|FG000|STARTED|Overall Study||14
10730767|NCT02786004|11894594|FG001|STARTED|Overall Study||10
10730768|NCT02786004|11894593|FG000|COMPLETED|Overall Study||14
10730769|NCT02786004|11894594|FG001|COMPLETED|Overall Study||9
10730770|NCT02786004|11894593|FG000|NOT COMPLETED|Overall Study||0
10730771|NCT02786004|11894594|FG001|NOT COMPLETED|Overall Study||1
10730772|NCT02786134|11894604|FG000|STARTED|Overall Study||25
10730773|NCT02786134|11894605|FG001|STARTED|Overall Study||25
10730774|NCT02786134|11894604|FG000|COMPLETED|Overall Study||25
10730775|NCT02786134|11894605|FG001|COMPLETED|Overall Study||25
10730776|NCT02786134|11894604|FG000|NOT COMPLETED|Overall Study||0
10730777|NCT02786134|11894605|FG001|NOT COMPLETED|Overall Study||0
10730778|NCT02786355|11894611|FG000|STARTED|Overall Study||35
10730779|NCT02786355|11894611|FG000|COMPLETED|Overall Study||35
10730780|NCT02786355|11894611|FG000|NOT COMPLETED|Overall Study||0
10730781|NCT02786719|11894618|FG000|STARTED|Overall Study||13
10730782|NCT02786719|11894618|FG000|COMPLETED|Overall Study||12
10730783|NCT02786719|11894618|FG000|NOT COMPLETED|Overall Study||1
10730784|NCT02786771|11894624|FG000|STARTED|Overall Study||63
10730785|NCT02786771|11894625|FG001|STARTED|Overall Study||62
10730786|NCT02786771|11894624|FG000|COMPLETED|Overall Study||53
10730787|NCT02786771|11894625|FG001|COMPLETED|Overall Study||56
10730788|NCT02786771|11894624|FG000|NOT COMPLETED|Overall Study||10
10730789|NCT02786771|11894625|FG001|NOT COMPLETED|Overall Study||6
10730790|NCT02786810|11894631|FG000|STARTED|Overall Study||10
10730791|NCT02786810|11894631|FG000|COMPLETED|Overall Study||10
10730792|NCT02786810|11894631|FG000|NOT COMPLETED|Overall Study||0
10730793|NCT02786836|11894635|FG000|STARTED|Overall Study||76
10730794|NCT02786836|11894635|FG000|Eligible Patients Enrolled Into the Stud|Overall Study||76
10730795|NCT02786836|11894635|FG000|COMPLETED|Overall Study||62
10730796|NCT02786836|11894635|FG000|NOT COMPLETED|Overall Study||14
10814957|NCT02110069|11977894|FG000|STARTED|Overall Study||2
10814958|NCT02110069|11977895|FG001|STARTED|Overall Study||2
10814959|NCT02110069|11977894|FG000|COMPLETED|Overall Study|subject was switched to sirolimus at maintenance course 7 for failure on Vincristine|0
10730797|NCT02786901|11894643|FG000|STARTED|Overall Study||199
10730798|NCT02786901|11894644|FG001|STARTED|Overall Study||201
10730799|NCT02786901|11894645|FG002|STARTED|Overall Study||200
10730800|NCT02786901|11894643|FG000|COMPLETED|Overall Study||122
10730801|NCT02786901|11894644|FG001|COMPLETED|Overall Study||145
10730802|NCT02786901|11894645|FG002|COMPLETED|Overall Study||159
10730803|NCT02786901|11894643|FG000|NOT COMPLETED|Overall Study||77
10730804|NCT02786901|11894644|FG001|NOT COMPLETED|Overall Study||56
10730805|NCT02786901|11894645|FG002|NOT COMPLETED|Overall Study||41
10730806|NCT02786927|11894653|FG000|STARTED|Overall Study||212
10730807|NCT02786927|11894653|FG000|COMPLETED|Overall Study||207
10730808|NCT02786927|11894653|FG000|NOT COMPLETED|Overall Study||5
10730809|NCT02786953|11894660|FG000|STARTED|Overall Study||20
10730810|NCT02786953|11894661|FG001|STARTED|Overall Study||19
10408454|NCT00754832|11552531|FG001|STARTED|Second 6 Weeks Intervention||26
10408455|NCT00754832|11552530|FG000|COMPLETED|Second 6 Weeks Intervention||17
10408456|NCT00754832|11552531|FG001|COMPLETED|Second 6 Weeks Intervention||24
10408457|NCT00754832|11552530|FG000|NOT COMPLETED|Second 6 Weeks Intervention||0
10408458|NCT00754832|11552531|FG001|NOT COMPLETED|Second 6 Weeks Intervention||2
10730811|NCT02786953|11894660|FG000|Baseline Teen Survey Data Completed|Overall Study||20
10730812|NCT02786953|11894661|FG001|Baseline Teen Survey Data Completed|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|18
10730813|NCT02786953|11894660|FG000|Baseline Parent Survey Completed|Overall Study||20
10730814|NCT02786953|11894661|FG001|Baseline Parent Survey Completed|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|18
10730815|NCT02786953|11894660|FG000|Actigraph Data Complete|Overall Study||14
10730816|NCT02786953|11894661|FG001|Actigraph Data Complete|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|17
10730817|NCT02786953|11894660|FG000|A1C Data Baseline|Overall Study||20
10730818|NCT02786953|11894661|FG001|A1C Data Baseline|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|18
10730819|NCT02786953|11894660|FG000|Session 1 Completed|Overall Study||17
10730820|NCT02786953|11894661|FG001|Session 1 Completed|Overall Study||0
10730821|NCT02786953|11894660|FG000|Session 2 Completed|Overall Study||16
10730822|NCT02786953|11894661|FG001|Session 2 Completed|Overall Study||0
10730823|NCT02786953|11894660|FG000|Session 3 Completed|Overall Study||16
10730824|NCT02786953|11894661|FG001|Session 3 Completed|Overall Study||0
10730825|NCT02786953|11894660|FG000|3 Month Teen Survey Completed|Overall Study||17
10730826|NCT02786953|11894661|FG001|3 Month Teen Survey Completed|Overall Study||18
10730827|NCT02786953|11894660|FG000|3 Month Parent Survey Completed|Overall Study||17
10730828|NCT02786953|11894661|FG001|3 Month Parent Survey Completed|Overall Study||18
10730829|NCT02786953|11894660|FG000|A1C 3 Month|Overall Study||15
10730830|NCT02786953|11894661|FG001|A1C 3 Month|Overall Study||17
10730831|NCT02786953|11894660|FG000|COMPLETED|Overall Study||17
10730832|NCT02786953|11894661|FG001|COMPLETED|Overall Study||18
10730833|NCT02786953|11894660|FG000|NOT COMPLETED|Overall Study||3
10730834|NCT02786953|11894661|FG001|NOT COMPLETED|Overall Study||1
10730835|NCT02787057|11894669|FG000|STARTED|Overall Study||40
10730836|NCT02787057|11894670|FG001|STARTED|Overall Study||40
10730837|NCT02787057|11894669|FG000|COMPLETED|Overall Study||40
10730838|NCT02787057|11894670|FG001|COMPLETED|Overall Study||40
10730839|NCT02787057|11894669|FG000|NOT COMPLETED|Overall Study||0
10730840|NCT02787057|11894670|FG001|NOT COMPLETED|Overall Study||0
10730841|NCT02787083|11894678|FG000|STARTED|Overall Study||4
10730842|NCT02787083|11894679|FG001|STARTED|Overall Study||5
10730843|NCT02787083|11894678|FG000|COMPLETED|Overall Study||1
10730844|NCT02787083|11894679|FG001|COMPLETED|Overall Study||3
10730845|NCT02787083|11894678|FG000|NOT COMPLETED|Overall Study||3
10730846|NCT02787083|11894679|FG001|NOT COMPLETED|Overall Study||2
10730847|NCT02787291|11894685|FG000|STARTED|Overall Study||227
10730848|NCT02787291|11894685|FG000|COMPLETED|Overall Study||227
10730849|NCT02787291|11894685|FG000|NOT COMPLETED|Overall Study||0
10730850|NCT02787304|11894693|FG000|STARTED|Overall Study||49
10730851|NCT02787304|11894694|FG001|STARTED|Overall Study|One subject was randomized and received 1 dose of study drug but withdrew from the study.|50
10730852|NCT02787304|11894695|FG002|STARTED|Overall Study||49
10730853|NCT02787304|11894696|FG003|STARTED|Overall Study||49
10730854|NCT02787304|11894693|FG000|COMPLETED|Overall Study||13
10730855|NCT02787304|11894694|FG001|COMPLETED|Overall Study||12
10730856|NCT02787304|11894695|FG002|COMPLETED|Overall Study||8
10730857|NCT02787304|11894696|FG003|COMPLETED|Overall Study||15
10730858|NCT02787304|11894693|FG000|NOT COMPLETED|Overall Study||36
10730859|NCT02787304|11894694|FG001|NOT COMPLETED|Overall Study||38
10730860|NCT02787304|11894695|FG002|NOT COMPLETED|Overall Study||41
10730861|NCT02787304|11894696|FG003|NOT COMPLETED|Overall Study||34
10730862|NCT02787564|11894708|FG000|STARTED|Overall Study||32
10730863|NCT02787564|11894709|FG001|STARTED|Overall Study||29
10730864|NCT02787564|11894708|FG000|COMPLETED|Overall Study|n=12 food bank users; n=13 non-food bank users|25
10730865|NCT02787564|11894709|FG001|COMPLETED|Overall Study|n=12 food bank users; n=15 non-food bank users|27
10730866|NCT02787564|11894708|FG000|NOT COMPLETED|Overall Study||7
10730867|NCT02787564|11894709|FG001|NOT COMPLETED|Overall Study||2
10730868|NCT02787655|11894717|FG000|STARTED|Overall Study||40
10730869|NCT02787655|11894718|FG001|STARTED|Overall Study||38
10730870|NCT02787655|11894717|FG000|COMPLETED|Overall Study||29
10730871|NCT02787655|11894718|FG001|COMPLETED|Overall Study||26
10730872|NCT02787655|11894717|FG000|NOT COMPLETED|Overall Study||11
10730873|NCT02787655|11894718|FG001|NOT COMPLETED|Overall Study||12
10730874|NCT02787681|11894724|FG000|STARTED|Overall Study||71
10730875|NCT02787681|11894724|FG000|COMPLETED|Overall Study||69
10730876|NCT02787681|11894724|FG000|NOT COMPLETED|Overall Study||2
10730877|NCT02787694|11894728|FG000|STARTED|Overall Study||22
10730878|NCT02787694|11894728|FG000|COMPLETED|Overall Study||17
10730879|NCT02787694|11894728|FG000|NOT COMPLETED|Overall Study||5
10777797|NCT03344640|11939714|FG001|STARTED|Follow-up Epoch||44
10312860|NCT00146172|11446336|FG001|NOT COMPLETED|Overall Study||4
10312861|NCT00146172|11446337|FG002|NOT COMPLETED|Overall Study||4
10312862|NCT00146172|11446338|FG003|NOT COMPLETED|Overall Study||6
10312863|NCT00146172|11446339|FG004|NOT COMPLETED|Overall Study||3
10312864|NCT00146172|11446340|FG005|NOT COMPLETED|Overall Study||7
10312865|NCT00146172|11446341|FG006|NOT COMPLETED|Overall Study||6
10312866|NCT00146172|11446342|FG007|NOT COMPLETED|Overall Study||40
10544550|NCT01490632|11697646|FG009|COMPLETED|Part C: Washout or Step-Down Period||0
10544551|NCT01490632|11697647|FG010|COMPLETED|Part C: Washout or Step-Down Period||0
10544552|NCT01490632|11697648|FG011|COMPLETED|Part C: Washout or Step-Down Period||0
10544553|NCT01490632|11697649|FG012|COMPLETED|Part C: Washout or Step-Down Period||10
10544554|NCT01490632|11697650|FG013|COMPLETED|Part C: Washout or Step-Down Period||6
10777798|NCT03344640|11939713|FG000|COMPLETED|Follow-up Epoch||46
10777799|NCT03344640|11939714|FG001|COMPLETED|Follow-up Epoch||42
10777800|NCT03344640|11939713|FG000|NOT COMPLETED|Follow-up Epoch||0
10777801|NCT03344640|11939714|FG001|NOT COMPLETED|Follow-up Epoch||2
10777802|NCT03344861|11939720|FG000|STARTED|Overall Study||10
10777803|NCT03344861|11939720|FG000|COMPLETED|Overall Study||10
10777804|NCT03344861|11939720|FG000|NOT COMPLETED|Overall Study||0
10777805|NCT03345108|11939724|FG000|STARTED|Period-1||8
10777806|NCT03345108|11939725|FG001|STARTED|Period-1||8
10777807|NCT03345108|11939726|FG002|STARTED|Period-1||8
10777808|NCT03345108|11939727|FG003|STARTED|Period-1||8
10777809|NCT03345108|11939728|FG004|STARTED|Period-1||8
10777810|NCT03345108|11939729|FG005|STARTED|Period-1||8
10777811|NCT03345108|11939724|FG000|COMPLETED|Period-1||8
10777812|NCT03345108|11939725|FG001|COMPLETED|Period-1||8
10777813|NCT03345108|11939726|FG002|COMPLETED|Period-1||8
10777814|NCT03345108|11939727|FG003|COMPLETED|Period-1||8
10777815|NCT03345108|11939728|FG004|COMPLETED|Period-1||8
10777816|NCT03345108|11939729|FG005|COMPLETED|Period-1||8
10777817|NCT03345108|11939724|FG000|NOT COMPLETED|Period-1||0
10777818|NCT03345108|11939725|FG001|NOT COMPLETED|Period-1||0
10777819|NCT03345108|11939726|FG002|NOT COMPLETED|Period-1||0
10777820|NCT03345108|11939727|FG003|NOT COMPLETED|Period-1||0
10777821|NCT03345108|11939728|FG004|NOT COMPLETED|Period-1||0
10777822|NCT03345108|11939729|FG005|NOT COMPLETED|Period-1||0
10777823|NCT03345108|11939724|FG000|STARTED|Period-2||8
10777824|NCT03345108|11939725|FG001|STARTED|Period-2||8
10312867|NCT00146328|11446371|FG000|STARTED|Overall Study||291
10544555|NCT01490632|11697651|FG014|COMPLETED|Part C: Washout or Step-Down Period||37
10544556|NCT01490632|11697652|FG015|COMPLETED|Part C: Washout or Step-Down Period||18
10544557|NCT01490632|11697653|FG016|COMPLETED|Part C: Washout or Step-Down Period||0
10777825|NCT03345108|11939726|FG002|STARTED|Period-2||8
10777826|NCT03345108|11939727|FG003|STARTED|Period-2||8
10777827|NCT03345108|11939728|FG004|STARTED|Period-2||8
10777828|NCT03345108|11939729|FG005|STARTED|Period-2||8
10777829|NCT03345108|11939724|FG000|COMPLETED|Period-2||8
10777830|NCT03345108|11939725|FG001|COMPLETED|Period-2||8
10777831|NCT03345108|11939726|FG002|COMPLETED|Period-2||8
10777832|NCT03345108|11939727|FG003|COMPLETED|Period-2||8
10777833|NCT03345108|11939728|FG004|COMPLETED|Period-2||8
10777834|NCT03345108|11939729|FG005|COMPLETED|Period-2||8
10777835|NCT03345108|11939724|FG000|NOT COMPLETED|Period-2||0
10777836|NCT03345108|11939725|FG001|NOT COMPLETED|Period-2||0
10777837|NCT03345108|11939726|FG002|NOT COMPLETED|Period-2||0
10777838|NCT03345108|11939727|FG003|NOT COMPLETED|Period-2||0
10777839|NCT03345108|11939728|FG004|NOT COMPLETED|Period-2||0
10777840|NCT03345108|11939729|FG005|NOT COMPLETED|Period-2||0
10777841|NCT03345108|11939724|FG000|STARTED|Period-3||7
10777842|NCT03345108|11939725|FG001|STARTED|Period-3||8
10777843|NCT03345108|11939726|FG002|STARTED|Period-3||8
10777844|NCT03345108|11939727|FG003|STARTED|Period-3||8
10777845|NCT03345108|11939728|FG004|STARTED|Period-3||8
10777846|NCT03345108|11939729|FG005|STARTED|Period-3||8
10777847|NCT03345108|11939724|FG000|COMPLETED|Period-3||7
10777848|NCT03345108|11939725|FG001|COMPLETED|Period-3||8
10777849|NCT03345108|11939726|FG002|COMPLETED|Period-3||8
10777850|NCT03345108|11939727|FG003|COMPLETED|Period-3||8
10777851|NCT03345108|11939728|FG004|COMPLETED|Period-3||8
10777852|NCT03345108|11939729|FG005|COMPLETED|Period-3||8
10777853|NCT03345108|11939724|FG000|NOT COMPLETED|Period-3||0
10777854|NCT03345108|11939725|FG001|NOT COMPLETED|Period-3||0
10777855|NCT03345108|11939726|FG002|NOT COMPLETED|Period-3||0
10777856|NCT03345108|11939727|FG003|NOT COMPLETED|Period-3||0
10777857|NCT03345108|11939728|FG004|NOT COMPLETED|Period-3||0
10777858|NCT03345108|11939729|FG005|NOT COMPLETED|Period-3||0
10777859|NCT03345160|11939737|FG000|STARTED|Overall Study||7
10777860|NCT03345160|11939737|FG000|COMPLETED|Overall Study||7
10777861|NCT03345160|11939737|FG000|NOT COMPLETED|Overall Study||0
10777862|NCT03345394|11939743|FG000|STARTED|Overall Study||48
10777863|NCT03345394|11939744|FG001|STARTED|Overall Study||50
10777864|NCT03345394|11939743|FG000|COMPLETED|Overall Study||48
10777865|NCT03345394|11939744|FG001|COMPLETED|Overall Study||50
10814960|NCT02110069|11977895|FG001|COMPLETED|Overall Study|1 subject was takend off protocol treatment at 10 months of maintenance for disease response.|2
10814961|NCT02110069|11977894|FG000|NOT COMPLETED|Overall Study||2
10730880|NCT02787863|11894740|FG000|STARTED|Overall Study||33
10730881|NCT02787863|11894741|FG001|STARTED|Overall Study||34
10730882|NCT02787863|11894742|FG002|STARTED|Overall Study||25
10730883|NCT02787863|11894743|FG003|STARTED|Overall Study||25
10730884|NCT02787863|11894744|FG004|STARTED|Overall Study||32
10730885|NCT02787863|11894745|FG005|STARTED|Overall Study||18
10730886|NCT02787863|11894746|FG006|STARTED|Overall Study||25
10730887|NCT02787863|11894747|FG007|STARTED|Overall Study||27
10730888|NCT02787863|11894740|FG000|1 Year After Vaccination|Overall Study||32
10730889|NCT02787863|11894741|FG001|1 Year After Vaccination|Overall Study||33
10730890|NCT02787863|11894742|FG002|1 Year After Vaccination|Overall Study||23
10730891|NCT02787863|11894743|FG003|1 Year After Vaccination|Overall Study||25
10730892|NCT02787863|11894744|FG004|1 Year After Vaccination|Overall Study||32
10730893|NCT02787863|11894745|FG005|1 Year After Vaccination|Overall Study||18
10730894|NCT02787863|11894746|FG006|1 Year After Vaccination|Overall Study||25
10730895|NCT02787863|11894747|FG007|1 Year After Vaccination|Overall Study||27
10730896|NCT02787863|11894740|FG000|4 Years After Vaccination|Overall Study||32
10730897|NCT02787863|11894741|FG001|4 Years After Vaccination|Overall Study||33
10730898|NCT02787863|11894742|FG002|4 Years After Vaccination|Overall Study||23
10730899|NCT02787863|11894743|FG003|4 Years After Vaccination|Overall Study||25
10730900|NCT02787863|11894744|FG004|4 Years After Vaccination|Overall Study||32
10730901|NCT02787863|11894745|FG005|4 Years After Vaccination|Overall Study||18
10730902|NCT02787863|11894746|FG006|4 Years After Vaccination|Overall Study||25
10730903|NCT02787863|11894747|FG007|4 Years After Vaccination|Overall Study||27
10730904|NCT02787863|11894740|FG000|COMPLETED|Overall Study||32
10730905|NCT02787863|11894741|FG001|COMPLETED|Overall Study||33
10730906|NCT02787863|11894742|FG002|COMPLETED|Overall Study||23
10730907|NCT02787863|11894743|FG003|COMPLETED|Overall Study||25
10730908|NCT02787863|11894744|FG004|COMPLETED|Overall Study||32
10730909|NCT02787863|11894745|FG005|COMPLETED|Overall Study||18
10730910|NCT02787863|11894746|FG006|COMPLETED|Overall Study||25
10730911|NCT02787863|11894747|FG007|COMPLETED|Overall Study||27
10730912|NCT02787863|11894740|FG000|NOT COMPLETED|Overall Study||1
10730913|NCT02787863|11894741|FG001|NOT COMPLETED|Overall Study||1
10730914|NCT02787863|11894742|FG002|NOT COMPLETED|Overall Study||2
10730915|NCT02787863|11894743|FG003|NOT COMPLETED|Overall Study||0
10730916|NCT02787863|11894744|FG004|NOT COMPLETED|Overall Study||0
10730917|NCT02787863|11894745|FG005|NOT COMPLETED|Overall Study||0
10730918|NCT02787863|11894746|FG006|NOT COMPLETED|Overall Study||0
10730919|NCT02787863|11894747|FG007|NOT COMPLETED|Overall Study||0
10730920|NCT02788019|11894790|FG000|STARTED|Overall Study||27
10730921|NCT02788019|11894791|FG001|STARTED|Overall Study||25
10730922|NCT02788019|11894790|FG000|COMPLETED|Overall Study||23
10730923|NCT02788019|11894791|FG001|COMPLETED|Overall Study||20
10730924|NCT02788019|11894790|FG000|NOT COMPLETED|Overall Study||4
10730925|NCT02788019|11894791|FG001|NOT COMPLETED|Overall Study||5
10730926|NCT02788097|11894799|FG000|STARTED|Overall Study||61
10730927|NCT02788097|11894800|FG001|STARTED|Overall Study||69
10730928|NCT02788097|11894799|FG000|COMPLETED|Overall Study||61
10730929|NCT02788097|11894800|FG001|COMPLETED|Overall Study||69
10730930|NCT02788097|11894799|FG000|NOT COMPLETED|Overall Study||0
10730931|NCT02788097|11894800|FG001|NOT COMPLETED|Overall Study||0
10730932|NCT02788175|11894806|FG000|STARTED|Overall Study||26
10730933|NCT02788175|11894806|FG000|Received Study Agent|Overall Study||20
10730934|NCT02788175|11894806|FG000|COMPLETED|Overall Study||13
10730935|NCT02788175|11894806|FG000|NOT COMPLETED|Overall Study||13
10730936|NCT02788188|11894817|FG000|STARTED|Overall Study||2
10730937|NCT02788188|11894818|FG001|STARTED|Overall Study||2
10730938|NCT02788188|11894819|FG002|STARTED|Overall Study||4
10730939|NCT02788188|11894820|FG003|STARTED|Overall Study||4
10730940|NCT02788188|11894821|FG004|STARTED|Overall Study||8
10730941|NCT02788188|11894822|FG005|STARTED|Overall Study||8
10730942|NCT02788188|11894823|FG006|STARTED|Overall Study||10
10730943|NCT02788188|11894817|FG000|COMPLETED|Overall Study||2
10730944|NCT02788188|11894818|FG001|COMPLETED|Overall Study||2
10730945|NCT02788188|11894819|FG002|COMPLETED|Overall Study||4
10730946|NCT02788188|11894820|FG003|COMPLETED|Overall Study||4
10730947|NCT02788188|11894821|FG004|COMPLETED|Overall Study||8
10730948|NCT02788188|11894822|FG005|COMPLETED|Overall Study||8
10730949|NCT02788188|11894823|FG006|COMPLETED|Overall Study||10
10730950|NCT02788188|11894817|FG000|NOT COMPLETED|Overall Study||0
10730951|NCT02788188|11894818|FG001|NOT COMPLETED|Overall Study||0
10730952|NCT02788188|11894819|FG002|NOT COMPLETED|Overall Study||0
10730953|NCT02788188|11894820|FG003|NOT COMPLETED|Overall Study||0
10730954|NCT02788188|11894821|FG004|NOT COMPLETED|Overall Study||0
10730955|NCT02788188|11894822|FG005|NOT COMPLETED|Overall Study||0
10730956|NCT02788188|11894823|FG006|NOT COMPLETED|Overall Study||0
10730957|NCT02788201|11894845|FG000|STARTED|Overall Study||1
10730958|NCT02788201|11894846|FG001|STARTED|Overall Study||1
10730959|NCT02788201|11894847|FG002|STARTED|Overall Study||1
10730960|NCT02788201|11894848|FG003|STARTED|Overall Study||1
10730961|NCT02788201|11894849|FG004|STARTED|Overall Study||1
10730962|NCT02788201|11894850|FG005|STARTED|Overall Study||3
10730963|NCT02788201|11894845|FG000|Did Not Start Treatment|Overall Study||0
10730964|NCT02788201|11894846|FG001|Did Not Start Treatment|Overall Study||0
10730965|NCT02788201|11894847|FG002|Did Not Start Treatment|Overall Study||0
10730966|NCT02788201|11894848|FG003|Did Not Start Treatment|Overall Study||0
10730967|NCT02788201|11894849|FG004|Did Not Start Treatment|Overall Study||0
10730968|NCT02788201|11894850|FG005|Did Not Start Treatment|Overall Study||3
10730969|NCT02788201|11894845|FG000|COMPLETED|Overall Study||0
10730970|NCT02788201|11894846|FG001|COMPLETED|Overall Study||0
10730971|NCT02788201|11894847|FG002|COMPLETED|Overall Study||0
10730972|NCT02788201|11894848|FG003|COMPLETED|Overall Study||0
10730973|NCT02788201|11894849|FG004|COMPLETED|Overall Study||1
10730974|NCT02788201|11894850|FG005|COMPLETED|Overall Study||0
10730975|NCT02788201|11894845|FG000|NOT COMPLETED|Overall Study||1
10730976|NCT02788201|11894846|FG001|NOT COMPLETED|Overall Study||1
10730977|NCT02788201|11894847|FG002|NOT COMPLETED|Overall Study||1
10730978|NCT02788201|11894848|FG003|NOT COMPLETED|Overall Study||1
10730979|NCT02788201|11894849|FG004|NOT COMPLETED|Overall Study||0
10730980|NCT02788201|11894850|FG005|NOT COMPLETED|Overall Study||3
10730981|NCT02788279|11894869|FG000|STARTED|Overall Study||90
10730982|NCT02788279|11894870|FG001|STARTED|Overall Study||183
10730983|NCT02788279|11894871|FG002|STARTED|Overall Study||90
10730984|NCT02788279|11894869|FG000|Received Treatment (Safety Population)|Overall Study||80
10730985|NCT02788279|11894870|FG001|Received Treatment (Safety Population)|Overall Study||179
10730986|NCT02788279|11894871|FG002|Received Treatment (Safety Population)|Overall Study||90
10730987|NCT02788279|11894869|FG000|Modified ITT Population|Overall Study||57
10730988|NCT02788279|11894870|FG001|Modified ITT Population|Overall Study||125
10730989|NCT02788279|11894871|FG002|Modified ITT Population|Overall Study||61
10730990|NCT02788279|11894869|FG000|COMPLETED|Overall Study||0
10730991|NCT02788279|11894870|FG001|COMPLETED|Overall Study||0
10730992|NCT02788279|11894871|FG002|COMPLETED|Overall Study||0
10730993|NCT02788279|11894869|FG000|NOT COMPLETED|Overall Study||90
10730994|NCT02788279|11894870|FG001|NOT COMPLETED|Overall Study||183
10730995|NCT02788279|11894871|FG002|NOT COMPLETED|Overall Study||90
10730996|NCT02788357|11894884|FG000|STARTED|Overall Study||6
10730997|NCT02788357|11894885|FG001|STARTED|Overall Study||6
10730998|NCT02788357|11894884|FG000|COMPLETED|Overall Study||3
10730999|NCT02788357|11894885|FG001|COMPLETED|Overall Study||6
10731000|NCT02788357|11894884|FG000|NOT COMPLETED|Overall Study||3
10731001|NCT02788357|11894885|FG001|NOT COMPLETED|Overall Study||0
10731002|NCT02788474|11894893|FG000|STARTED|Double Blind Treatment Period||231
10731003|NCT02788474|11894894|FG001|STARTED|Double Blind Treatment Period||116
10731004|NCT02788474|11894893|FG000|Treated|Double Blind Treatment Period||230
10731005|NCT02788474|11894894|FG001|Treated|Double Blind Treatment Period||116
10731006|NCT02788474|11894893|FG000|COMPLETED|Double Blind Treatment Period||221
10731007|NCT02788474|11894894|FG001|COMPLETED|Double Blind Treatment Period||112
10731008|NCT02788474|11894893|FG000|NOT COMPLETED|Double Blind Treatment Period||10
10731009|NCT02788474|11894894|FG001|NOT COMPLETED|Double Blind Treatment Period||4
10731010|NCT02788474|11894893|FG000|STARTED|Open Label Treatment Period||221
10731011|NCT02788474|11894894|FG001|STARTED|Open Label Treatment Period||112
10731012|NCT02788474|11894893|FG000|COMPLETED|Open Label Treatment Period||189
10731013|NCT02788474|11894894|FG001|COMPLETED|Open Label Treatment Period||100
10731014|NCT02788474|11894893|FG000|NOT COMPLETED|Open Label Treatment Period||32
10731015|NCT02788474|11894894|FG001|NOT COMPLETED|Open Label Treatment Period||12
10731016|NCT02788513|11894906|FG000|STARTED|Overall Study||123
10731017|NCT02788513|11894907|FG001|STARTED|Overall Study||122
10731018|NCT02788513|11894908|FG002|STARTED|Overall Study||122
10731019|NCT02788513|11894909|FG003|STARTED|Overall Study||123
10731020|NCT02788513|11894910|FG004|STARTED|Overall Study||120
10731021|NCT02788513|11894906|FG000|COMPLETED|Overall Study||114
10731022|NCT02788513|11894907|FG001|COMPLETED|Overall Study||114
10731023|NCT02788513|11894908|FG002|COMPLETED|Overall Study||114
10731024|NCT02788513|11894909|FG003|COMPLETED|Overall Study||117
10731025|NCT02788513|11894910|FG004|COMPLETED|Overall Study||115
10731026|NCT02788513|11894906|FG000|NOT COMPLETED|Overall Study||9
10731027|NCT02788513|11894907|FG001|NOT COMPLETED|Overall Study||8
10731028|NCT02788513|11894908|FG002|NOT COMPLETED|Overall Study||8
10731029|NCT02788513|11894909|FG003|NOT COMPLETED|Overall Study||6
10731030|NCT02788513|11894910|FG004|NOT COMPLETED|Overall Study||5
10731031|NCT02788656|11894924|FG000|STARTED|Overall Study||2
10731032|NCT02788656|11894925|FG001|STARTED|Overall Study||2
10731033|NCT02788656|11894924|FG000|COMPLETED|Overall Study||1
10731034|NCT02788656|11894925|FG001|COMPLETED|Overall Study||2
10731035|NCT02788656|11894924|FG000|NOT COMPLETED|Overall Study||1
10731036|NCT02788656|11894925|FG001|NOT COMPLETED|Overall Study||0
10731037|NCT02788747|11894934|FG000|STARTED|Overall Study||23
10731038|NCT02788747|11894935|FG001|STARTED|Overall Study||24
10731039|NCT02788747|11894936|FG002|STARTED|Overall Study||24
10731040|NCT02788747|11894934|FG000|COMPLETED|Overall Study||22
10814962|NCT02110069|11977895|FG001|NOT COMPLETED|Overall Study||0
10731041|NCT02788747|11894935|FG001|COMPLETED|Overall Study||24
10731042|NCT02788747|11894936|FG002|COMPLETED|Overall Study||24
10731043|NCT02788747|11894934|FG000|NOT COMPLETED|Overall Study||1
10731044|NCT02788747|11894935|FG001|NOT COMPLETED|Overall Study||0
10731045|NCT02788747|11894936|FG002|NOT COMPLETED|Overall Study||0
10731046|NCT02788903|11894949|FG000|STARTED|Overall Study||567908
10731047|NCT02788903|11894950|FG001|STARTED|Overall Study||2054256
10731048|NCT02788903|11894949|FG000|COMPLETED|Overall Study||567908
10731049|NCT02788903|11894950|FG001|COMPLETED|Overall Study||2054256
10731050|NCT02788903|11894949|FG000|NOT COMPLETED|Overall Study||0
10731051|NCT02788903|11894950|FG001|NOT COMPLETED|Overall Study||0
10731052|NCT02789033|11894962|FG000|STARTED|Overall Study||17
10731053|NCT02789033|11894963|FG001|STARTED|Overall Study||17
10731054|NCT02789033|11894964|FG002|STARTED|Overall Study||17
10731055|NCT02789033|11894965|FG003|STARTED|Overall Study||17
10731056|NCT02789033|11894962|FG000|COMPLETED|Overall Study||15
10731057|NCT02789033|11894963|FG001|COMPLETED|Overall Study||15
10731058|NCT02789033|11894964|FG002|COMPLETED|Overall Study||16
10731059|NCT02789033|11894965|FG003|COMPLETED|Overall Study||15
10731060|NCT02789033|11894962|FG000|NOT COMPLETED|Overall Study||2
10731061|NCT02789033|11894963|FG001|NOT COMPLETED|Overall Study||2
10731062|NCT02789033|11894964|FG002|NOT COMPLETED|Overall Study||1
10731063|NCT02789033|11894965|FG003|NOT COMPLETED|Overall Study||2
10731064|NCT02789111|11894977|FG000|STARTED|Overall Study||24
10731065|NCT02789111|11894978|FG001|STARTED|Overall Study||25
10731066|NCT02789111|11894977|FG000|COMPLETED|Overall Study||23
10731067|NCT02789111|11894978|FG001|COMPLETED|Overall Study||21
10731068|NCT02789111|11894977|FG000|NOT COMPLETED|Overall Study||1
10731069|NCT02789111|11894978|FG001|NOT COMPLETED|Overall Study||4
10731070|NCT02789137|11894986|FG000|STARTED|Overall Study||111
10731071|NCT02789137|11894986|FG000|COMPLETED|Overall Study||53
10731072|NCT02789137|11894986|FG000|NOT COMPLETED|Overall Study||58
10731073|NCT02789176|11894995|FG000|STARTED|Overall Study||99
10731074|NCT02789176|11894996|FG001|STARTED|Overall Study||55
10731075|NCT02789176|11894997|FG002|STARTED|Overall Study||95
10731076|NCT02789176|11894998|FG003|STARTED|Overall Study||54
10731077|NCT02789176|11894995|FG000|COMPLETED|Overall Study||91
10544558|NCT01490632|11697654|FG017|COMPLETED|Part C: Washout or Step-Down Period||0
10544559|NCT01490632|11697655|FG018|COMPLETED|Part C: Washout or Step-Down Period||0
10544560|NCT01490632|11697656|FG019|COMPLETED|Part C: Washout or Step-Down Period||0
10544561|NCT01490632|11697637|FG000|NOT COMPLETED|Part C: Washout or Step-Down Period||0
10731078|NCT02789176|11894996|FG001|COMPLETED|Overall Study||53
10731079|NCT02789176|11894997|FG002|COMPLETED|Overall Study||85
10731080|NCT02789176|11894998|FG003|COMPLETED|Overall Study||53
10731081|NCT02789176|11894995|FG000|NOT COMPLETED|Overall Study||8
10731082|NCT02789176|11894996|FG001|NOT COMPLETED|Overall Study||2
10731083|NCT02789176|11894997|FG002|NOT COMPLETED|Overall Study||10
10731084|NCT02789176|11894998|FG003|NOT COMPLETED|Overall Study||1
10731085|NCT02789410|11895010|FG000|STARTED|Overall Study||66
10731086|NCT02789410|11895011|FG001|STARTED|Overall Study||68
10731087|NCT02789410|11895010|FG000|COMPLETED|Overall Study||66
10731088|NCT02789410|11895011|FG001|COMPLETED|Overall Study||68
10731089|NCT02789410|11895010|FG000|NOT COMPLETED|Overall Study||0
10731090|NCT02789410|11895011|FG001|NOT COMPLETED|Overall Study||0
10731091|NCT02790073|11895017|FG000|STARTED|Overall Study||14
10731092|NCT02790073|11895017|FG000|COMPLETED|Overall Study||11
10731093|NCT02790073|11895017|FG000|NOT COMPLETED|Overall Study||3
10731094|NCT02790281|11895021|FG000|STARTED|Overall Study||33
10731095|NCT02790281|11895021|FG000|COMPLETED|Overall Study||33
10731096|NCT02790281|11895021|FG000|NOT COMPLETED|Overall Study||0
10731097|NCT02790437|11895027|FG000|STARTED|Overall Study||16
10731098|NCT02790437|11895028|FG001|STARTED|Overall Study||3
10731099|NCT02790437|11895027|FG000|COMPLETED|Overall Study||13
10731100|NCT02790437|11895028|FG001|COMPLETED|Overall Study||3
10731101|NCT02790437|11895027|FG000|NOT COMPLETED|Overall Study||3
10731102|NCT02790437|11895028|FG001|NOT COMPLETED|Overall Study||0
10731103|NCT02790463|11895043|FG000|STARTED|Overall Study||782
10731104|NCT02790463|11895044|FG001|STARTED|Overall Study||681
10731105|NCT02790463|11895043|FG000|COMPLETED|Overall Study||782
10814963|NCT02110277|11977901|FG000|STARTED|Overall Study||2
10731106|NCT02790463|11895044|FG001|COMPLETED|Overall Study||372
10731107|NCT02790463|11895043|FG000|NOT COMPLETED|Overall Study||0
10731108|NCT02790463|11895044|FG001|NOT COMPLETED|Overall Study||309
10731109|NCT02790606|11895050|FG000|STARTED|Overall Study||110
10731110|NCT02790606|11895050|FG000|COMPLETED|Overall Study||75
10731111|NCT02790606|11895050|FG000|NOT COMPLETED|Overall Study||35
10731112|NCT02790736|11895056|FG000|STARTED|Overall Study||5
10731113|NCT02790736|11895057|FG001|STARTED|Overall Study||1
10731114|NCT02790736|11895056|FG000|COMPLETED|Overall Study||5
10731115|NCT02790736|11895057|FG001|COMPLETED|Overall Study||1
10731116|NCT02790736|11895056|FG000|NOT COMPLETED|Overall Study||0
10731117|NCT02790736|11895057|FG001|NOT COMPLETED|Overall Study||0
10731118|NCT02790788|11895065|FG000|STARTED|Overall Study||46
10731119|NCT02790788|11895066|FG001|STARTED|Overall Study||54
10731120|NCT02790788|11895065|FG000|COMPLETED|Overall Study||46
10731121|NCT02790788|11895066|FG001|COMPLETED|Overall Study||54
10731122|NCT02790788|11895065|FG000|NOT COMPLETED|Overall Study||0
10731123|NCT02790788|11895066|FG001|NOT COMPLETED|Overall Study||0
10731124|NCT02791191|11895077|FG000|STARTED|Overall Study||55
10731125|NCT02791191|11895078|FG001|STARTED|Overall Study||128
10731126|NCT02791191|11895079|FG002|STARTED|Overall Study||133
10814964|NCT02110277|11977901|FG000|COMPLETED|Overall Study||0
10731127|NCT02791191|11895077|FG000|Received One Dose of Study Drug|Overall Study||55
10731128|NCT02791191|11895078|FG001|Received One Dose of Study Drug|Overall Study||127
10731129|NCT02791191|11895079|FG002|Received One Dose of Study Drug|Overall Study||133
10731130|NCT02791191|11895077|FG000|COMPLETED|Overall Study||17
10731131|NCT02791191|11895078|FG001|COMPLETED|Overall Study||17
10731132|NCT02791191|11895079|FG002|COMPLETED|Overall Study||13
10731133|NCT02791191|11895077|FG000|NOT COMPLETED|Overall Study||38
10731134|NCT02791191|11895078|FG001|NOT COMPLETED|Overall Study||111
10731135|NCT02791191|11895079|FG002|NOT COMPLETED|Overall Study||120
10731136|NCT02791269|11895089|FG000|STARTED|Overall Study||4
10731137|NCT02791269|11895090|FG001|STARTED|Overall Study||20
10731138|NCT02791269|11895089|FG000|COMPLETED|Overall Study||4
10731139|NCT02791269|11895090|FG001|COMPLETED|Overall Study||19
10814965|NCT02110277|11977901|FG000|NOT COMPLETED|Overall Study||2
10731140|NCT02791269|11895089|FG000|NOT COMPLETED|Overall Study||0
10731141|NCT02791269|11895090|FG001|NOT COMPLETED|Overall Study||1
10731142|NCT02791308|11895101|FG000|STARTED|Overall Study||195
10731143|NCT02791308|11895102|FG001|STARTED|Overall Study||196
10731144|NCT02791308|11895103|FG002|STARTED|Overall Study||196
10731145|NCT02791308|11895101|FG000|COMPLETED|Overall Study||185
10731146|NCT02791308|11895102|FG001|COMPLETED|Overall Study||187
10731147|NCT02791308|11895103|FG002|COMPLETED|Overall Study||179
10731148|NCT02791308|11895101|FG000|NOT COMPLETED|Overall Study||10
10731149|NCT02791308|11895102|FG001|NOT COMPLETED|Overall Study||9
10731150|NCT02791308|11895103|FG002|NOT COMPLETED|Overall Study||17
10731151|NCT02791399|11895113|FG000|STARTED|Overall Study||136
10731152|NCT02791399|11895114|FG001|STARTED|Overall Study||150
10731153|NCT02791399|11895113|FG000|COMPLETED|Overall Study||123
10731154|NCT02791399|11895114|FG001|COMPLETED|Overall Study||135
10731155|NCT02791399|11895113|FG000|NOT COMPLETED|Overall Study||13
10731156|NCT02791399|11895114|FG001|NOT COMPLETED|Overall Study||15
10731157|NCT02791438|11895122|FG000|STARTED|Run-In Period||22
10731158|NCT02791438|11895123|FG001|STARTED|Run-In Period||5
10731159|NCT02791438|11895122|FG000|COMPLETED|Run-In Period||22
10731160|NCT02791438|11895123|FG001|COMPLETED|Run-In Period||5
10731161|NCT02791438|11895122|FG000|NOT COMPLETED|Run-In Period||0
10731162|NCT02791438|11895123|FG001|NOT COMPLETED|Run-In Period||0
10731163|NCT02791438|11895122|FG000|STARTED|Treatment Period||22
10731164|NCT02791438|11895123|FG001|STARTED|Treatment Period||5
10731165|NCT02791438|11895122|FG000|COMPLETED|Treatment Period||19
10731166|NCT02791438|11895123|FG001|COMPLETED|Treatment Period||4
10731167|NCT02791438|11895122|FG000|NOT COMPLETED|Treatment Period||3
10731168|NCT02791438|11895123|FG001|NOT COMPLETED|Treatment Period||1
10731169|NCT02791490|11895131|FG000|STARTED|Overall Study||229
10731170|NCT02791490|11895132|FG001|STARTED|Overall Study||229
10731171|NCT02791490|11895131|FG000|COMPLETED|Overall Study||226
10731172|NCT02791490|11895132|FG001|COMPLETED|Overall Study||221
10731173|NCT02791490|11895131|FG000|NOT COMPLETED|Overall Study||3
10731174|NCT02791490|11895132|FG001|NOT COMPLETED|Overall Study||8
10731175|NCT02791516|11895140|FG000|STARTED|Overall Study||33
10731176|NCT02791516|11895141|FG001|STARTED|Overall Study||34
10408459|NCT00754845|11552539|FG000|STARTED|Overall Study||959
10408460|NCT00754845|11552540|FG001|STARTED|Overall Study||959
10408461|NCT00754845|11552539|FG000|COMPLETED|Overall Study||959
10408462|NCT00754845|11552540|FG001|COMPLETED|Overall Study||959
10731177|NCT02791516|11895140|FG000|Completed 6-month Treatment Period|Overall Study||33
10731178|NCT02791516|11895141|FG001|Completed 6-month Treatment Period|Overall Study||33
10731179|NCT02791516|11895140|FG000|COMPLETED|Overall Study||32
10731180|NCT02791516|11895141|FG001|COMPLETED|Overall Study||33
10731181|NCT02791516|11895140|FG000|NOT COMPLETED|Overall Study||1
10731182|NCT02791516|11895141|FG001|NOT COMPLETED|Overall Study||1
10731183|NCT02791659|11895149|FG000|STARTED|Overall Study||27
10731184|NCT02791659|11895150|FG001|STARTED|Overall Study||28
10731185|NCT02791659|11895149|FG000|COMPLETED|Overall Study||27
10731186|NCT02791659|11895150|FG001|COMPLETED|Overall Study||27
10731187|NCT02791659|11895149|FG000|NOT COMPLETED|Overall Study||0
10731188|NCT02791659|11895150|FG001|NOT COMPLETED|Overall Study||1
10731189|NCT02791763|11895159|FG000|STARTED|Overall Study||149
10731190|NCT02791763|11895160|FG001|STARTED|Overall Study||150
10731191|NCT02791763|11895161|FG002|STARTED|Overall Study||56
10731192|NCT02791763|11895159|FG000|COMPLETED|Overall Study||111
10731193|NCT02791763|11895160|FG001|COMPLETED|Overall Study||113
10731194|NCT02791763|11895161|FG002|COMPLETED|Overall Study||43
10731195|NCT02791763|11895159|FG000|NOT COMPLETED|Overall Study||38
10731196|NCT02791763|11895160|FG001|NOT COMPLETED|Overall Study||37
10731197|NCT02791763|11895161|FG002|NOT COMPLETED|Overall Study||13
10731198|NCT02791893|11895180|FG000|STARTED|Blinded Phase||13
10731199|NCT02791893|11895181|FG001|STARTED|Blinded Phase||14
10731200|NCT02791893|11895180|FG000|COMPLETED|Blinded Phase||10
10731201|NCT02791893|11895181|FG001|COMPLETED|Blinded Phase||10
10731202|NCT02791893|11895180|FG000|NOT COMPLETED|Blinded Phase||3
10408463|NCT00754845|11552539|FG000|NOT COMPLETED|Overall Study||0
10731203|NCT02791893|11895181|FG001|NOT COMPLETED|Blinded Phase||4
10731204|NCT02791893|11895180|FG000|STARTED|Open Label Phase||10
10731205|NCT02791893|11895181|FG001|STARTED|Open Label Phase||10
10731206|NCT02791893|11895180|FG000|COMPLETED|Open Label Phase||7
10731207|NCT02791893|11895181|FG001|COMPLETED|Open Label Phase||8
10731208|NCT02791893|11895180|FG000|NOT COMPLETED|Open Label Phase||3
10731209|NCT02791893|11895181|FG001|NOT COMPLETED|Open Label Phase||2
10731210|NCT02791906|11895189|FG000|STARTED|Overall Study||4
10731211|NCT02791906|11895190|FG001|STARTED|Overall Study||3
10731212|NCT02791906|11895189|FG000|COMPLETED|Overall Study||2
10731213|NCT02791906|11895190|FG001|COMPLETED|Overall Study||2
10731214|NCT02791906|11895189|FG000|NOT COMPLETED|Overall Study||2
10731215|NCT02791906|11895190|FG001|NOT COMPLETED|Overall Study||1
10731216|NCT02791945|11895200|FG000|STARTED|Overall Study||14
10731217|NCT02791945|11895201|FG001|STARTED|Overall Study||16
10731218|NCT02791945|11895200|FG000|COMPLETED|Overall Study||12
10731219|NCT02791945|11895201|FG001|COMPLETED|Overall Study||14
10731220|NCT02791945|11895200|FG000|NOT COMPLETED|Overall Study||2
10731221|NCT02791945|11895201|FG001|NOT COMPLETED|Overall Study||2
10731222|NCT02792049|11895209|FG000|STARTED|Overall Study||35
10408464|NCT00754845|11552540|FG001|NOT COMPLETED|Overall Study||0
10731223|NCT02792049|11895210|FG001|STARTED|Overall Study||35
10731224|NCT02792049|11895209|FG000|COMPLETED|Overall Study||35
10731225|NCT02792049|11895210|FG001|COMPLETED|Overall Study||35
10731226|NCT02792049|11895209|FG000|NOT COMPLETED|Overall Study||0
10731227|NCT02792049|11895210|FG001|NOT COMPLETED|Overall Study||0
10731228|NCT02792062|11895224|FG000|STARTED|Intervention Period 1 (6 Days)||2
10731229|NCT02792062|11895225|FG001|STARTED|Intervention Period 1 (6 Days)||2
10731230|NCT02792062|11895226|FG002|STARTED|Intervention Period 1 (6 Days)||2
10731231|NCT02792062|11895227|FG003|STARTED|Intervention Period 1 (6 Days)||2
10731232|NCT02792062|11895228|FG004|STARTED|Intervention Period 1 (6 Days)||2
10731233|NCT02792062|11895229|FG005|STARTED|Intervention Period 1 (6 Days)||2
10731234|NCT02792062|11895224|FG000|COMPLETED|Intervention Period 1 (6 Days)||2
10731235|NCT02792062|11895225|FG001|COMPLETED|Intervention Period 1 (6 Days)||2
10731236|NCT02792062|11895226|FG002|COMPLETED|Intervention Period 1 (6 Days)||2
10731237|NCT02792062|11895227|FG003|COMPLETED|Intervention Period 1 (6 Days)||2
10731238|NCT02792062|11895228|FG004|COMPLETED|Intervention Period 1 (6 Days)||2
10731239|NCT02792062|11895229|FG005|COMPLETED|Intervention Period 1 (6 Days)||2
10731240|NCT02792062|11895224|FG000|NOT COMPLETED|Intervention Period 1 (6 Days)||0
10731241|NCT02792062|11895225|FG001|NOT COMPLETED|Intervention Period 1 (6 Days)||0
10731242|NCT02792062|11895226|FG002|NOT COMPLETED|Intervention Period 1 (6 Days)||0
10731243|NCT02792062|11895227|FG003|NOT COMPLETED|Intervention Period 1 (6 Days)||0
10731244|NCT02792062|11895228|FG004|NOT COMPLETED|Intervention Period 1 (6 Days)||0
10731245|NCT02792062|11895229|FG005|NOT COMPLETED|Intervention Period 1 (6 Days)||0
10731246|NCT02792062|11895224|FG000|STARTED|Washout Period (at Least 14 Days)||2
10731247|NCT02792062|11895225|FG001|STARTED|Washout Period (at Least 14 Days)||2
10731248|NCT02792062|11895226|FG002|STARTED|Washout Period (at Least 14 Days)||2
10731249|NCT02792062|11895227|FG003|STARTED|Washout Period (at Least 14 Days)||2
10731250|NCT02792062|11895228|FG004|STARTED|Washout Period (at Least 14 Days)||2
10731251|NCT02792062|11895229|FG005|STARTED|Washout Period (at Least 14 Days)||2
10731252|NCT02792062|11895224|FG000|COMPLETED|Washout Period (at Least 14 Days)||2
10731253|NCT02792062|11895225|FG001|COMPLETED|Washout Period (at Least 14 Days)||2
10731254|NCT02792062|11895226|FG002|COMPLETED|Washout Period (at Least 14 Days)||2
10731255|NCT02792062|11895227|FG003|COMPLETED|Washout Period (at Least 14 Days)||2
10731256|NCT02792062|11895228|FG004|COMPLETED|Washout Period (at Least 14 Days)||2
10731257|NCT02792062|11895229|FG005|COMPLETED|Washout Period (at Least 14 Days)||2
10731258|NCT02792062|11895224|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10731259|NCT02792062|11895225|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10731260|NCT02792062|11895226|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10731261|NCT02792062|11895227|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10731262|NCT02792062|11895228|FG004|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10731263|NCT02792062|11895229|FG005|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10731264|NCT02792062|11895224|FG000|STARTED|Intervention Period 2 (6 Days)||2
10731265|NCT02792062|11895225|FG001|STARTED|Intervention Period 2 (6 Days)||2
10731266|NCT02792062|11895226|FG002|STARTED|Intervention Period 2 (6 Days)||2
10731267|NCT02792062|11895227|FG003|STARTED|Intervention Period 2 (6 Days)||2
10731268|NCT02792062|11895228|FG004|STARTED|Intervention Period 2 (6 Days)||2
10731269|NCT02792062|11895229|FG005|STARTED|Intervention Period 2 (6 Days)||2
10731270|NCT02792062|11895224|FG000|COMPLETED|Intervention Period 2 (6 Days)||2
10731271|NCT02792062|11895225|FG001|COMPLETED|Intervention Period 2 (6 Days)||2
10731272|NCT02792062|11895226|FG002|COMPLETED|Intervention Period 2 (6 Days)||2
10731273|NCT02792062|11895227|FG003|COMPLETED|Intervention Period 2 (6 Days)||2
10731274|NCT02792062|11895228|FG004|COMPLETED|Intervention Period 2 (6 Days)||2
10731275|NCT02792062|11895229|FG005|COMPLETED|Intervention Period 2 (6 Days)||2
10731276|NCT02792062|11895224|FG000|NOT COMPLETED|Intervention Period 2 (6 Days)||0
10731277|NCT02792062|11895225|FG001|NOT COMPLETED|Intervention Period 2 (6 Days)||0
10731278|NCT02792062|11895226|FG002|NOT COMPLETED|Intervention Period 2 (6 Days)||0
10731279|NCT02792062|11895227|FG003|NOT COMPLETED|Intervention Period 2 (6 Days)||0
10731280|NCT02792062|11895228|FG004|NOT COMPLETED|Intervention Period 2 (6 Days)||0
10731281|NCT02792062|11895229|FG005|NOT COMPLETED|Intervention Period 2 (6 Days)||0
10731282|NCT02792062|11895224|FG000|STARTED|Washout Period (at Least 14 Days)||2
10731283|NCT02792062|11895225|FG001|STARTED|Washout Period (at Least 14 Days)||2
10731284|NCT02792062|11895226|FG002|STARTED|Washout Period (at Least 14 Days)||2
10731285|NCT02792062|11895227|FG003|STARTED|Washout Period (at Least 14 Days)||2
10731286|NCT02792062|11895228|FG004|STARTED|Washout Period (at Least 14 Days)||2
10731287|NCT02792062|11895229|FG005|STARTED|Washout Period (at Least 14 Days)||2
10731288|NCT02792062|11895224|FG000|COMPLETED|Washout Period (at Least 14 Days)||1
10731289|NCT02792062|11895225|FG001|COMPLETED|Washout Period (at Least 14 Days)||2
10731290|NCT02792062|11895226|FG002|COMPLETED|Washout Period (at Least 14 Days)||2
10731291|NCT02792062|11895227|FG003|COMPLETED|Washout Period (at Least 14 Days)||2
10731292|NCT02792062|11895228|FG004|COMPLETED|Washout Period (at Least 14 Days)||2
10731293|NCT02792062|11895229|FG005|COMPLETED|Washout Period (at Least 14 Days)||2
10731294|NCT02792062|11895224|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||1
10731295|NCT02792062|11895225|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10731296|NCT02792062|11895226|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10731297|NCT02792062|11895227|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10731298|NCT02792062|11895228|FG004|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10731299|NCT02792062|11895229|FG005|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10731300|NCT02792062|11895224|FG000|STARTED|Intervention Period 3 (6 Days)||1
10731301|NCT02792062|11895225|FG001|STARTED|Intervention Period 3 (6 Days)||2
10731302|NCT02792062|11895226|FG002|STARTED|Intervention Period 3 (6 Days)||2
10731303|NCT02792062|11895227|FG003|STARTED|Intervention Period 3 (6 Days)||2
10731304|NCT02792062|11895228|FG004|STARTED|Intervention Period 3 (6 Days)||2
10731305|NCT02792062|11895229|FG005|STARTED|Intervention Period 3 (6 Days)||2
10731306|NCT02792062|11895224|FG000|COMPLETED|Intervention Period 3 (6 Days)||1
10731307|NCT02792062|11895225|FG001|COMPLETED|Intervention Period 3 (6 Days)||2
10731308|NCT02792062|11895226|FG002|COMPLETED|Intervention Period 3 (6 Days)||2
10731309|NCT02792062|11895227|FG003|COMPLETED|Intervention Period 3 (6 Days)||2
10731310|NCT02792062|11895228|FG004|COMPLETED|Intervention Period 3 (6 Days)||2
10731311|NCT02792062|11895229|FG005|COMPLETED|Intervention Period 3 (6 Days)||2
10731312|NCT02792062|11895224|FG000|NOT COMPLETED|Intervention Period 3 (6 Days)||0
10731313|NCT02792062|11895225|FG001|NOT COMPLETED|Intervention Period 3 (6 Days)||0
10731314|NCT02792062|11895226|FG002|NOT COMPLETED|Intervention Period 3 (6 Days)||0
10731315|NCT02792062|11895227|FG003|NOT COMPLETED|Intervention Period 3 (6 Days)||0
10731316|NCT02792062|11895228|FG004|NOT COMPLETED|Intervention Period 3 (6 Days)||0
10731317|NCT02792062|11895229|FG005|NOT COMPLETED|Intervention Period 3 (6 Days)||0
10731318|NCT02792192|11895241|FG000|STARTED|Overall Study||12
10731319|NCT02792192|11895242|FG001|STARTED|Overall Study||12
10731320|NCT02792192|11895243|FG002|STARTED|Overall Study||0
10731321|NCT02792192|11895244|FG003|STARTED|Overall Study||0
10731322|NCT02792192|11895241|FG000|COMPLETED|Overall Study||0
10731323|NCT02792192|11895242|FG001|COMPLETED|Overall Study||1
10731324|NCT02792192|11895243|FG002|COMPLETED|Overall Study||0
10731325|NCT02792192|11895244|FG003|COMPLETED|Overall Study||0
10731326|NCT02792192|11895241|FG000|NOT COMPLETED|Overall Study||12
10731327|NCT02792192|11895242|FG001|NOT COMPLETED|Overall Study||11
10731328|NCT02792192|11895243|FG002|NOT COMPLETED|Overall Study||0
10731329|NCT02792192|11895244|FG003|NOT COMPLETED|Overall Study||0
10731330|NCT02792218|11895257|FG000|STARTED|Overall Study||465
10731331|NCT02792218|11895258|FG001|STARTED|Overall Study||462
10731332|NCT02792218|11895257|FG000|COMPLETED|Overall Study||416
10731333|NCT02792218|11895258|FG001|COMPLETED|Overall Study||381
10731334|NCT02792218|11895257|FG000|NOT COMPLETED|Overall Study||49
10731335|NCT02792218|11895258|FG001|NOT COMPLETED|Overall Study||81
10731336|NCT02792231|11895266|FG000|STARTED|Overall Study||481
10731337|NCT02792231|11895267|FG001|STARTED|Overall Study||474
10731338|NCT02792231|11895266|FG000|COMPLETED|Overall Study||399
10731339|NCT02792231|11895267|FG001|COMPLETED|Overall Study||390
10731340|NCT02792231|11895266|FG000|NOT COMPLETED|Overall Study||82
10731341|NCT02792231|11895267|FG001|NOT COMPLETED|Overall Study||84
10731342|NCT02792504|11895273|FG000|STARTED|Overall Study||669
10731343|NCT02792504|11895273|FG000|Safety Analysis Set|Overall Study||639
10731344|NCT02792504|11895273|FG000|Efficacy Analysis Set|Overall Study||390
10731345|NCT02792504|11895273|FG000|COMPLETED|Overall Study||639
10731346|NCT02792504|11895273|FG000|NOT COMPLETED|Overall Study||30
10731347|NCT02792517|11895277|FG000|STARTED|Overall Study||41
10731348|NCT02792517|11895277|FG000|Received Erenumab|Overall Study||24
10731349|NCT02792517|11895277|FG000|COMPLETED|Overall Study||21
10731350|NCT02792517|11895277|FG000|NOT COMPLETED|Overall Study||20
10731351|NCT02792699|11895284|FG000|STARTED|Overall Study||104
10731352|NCT02792699|11895285|FG001|STARTED|Overall Study||104
10731353|NCT02792699|11895286|FG002|STARTED|Overall Study||103
10731354|NCT02792699|11895284|FG000|Received First Infusion of First Dose|Overall Study||104
10731355|NCT02792699|11895285|FG001|Received First Infusion of First Dose|Overall Study||104
10731356|NCT02792699|11895286|FG002|Received First Infusion of First Dose|Overall Study||103
10731357|NCT02792699|11895284|FG000|Received Second Infusion of First Dose|Overall Study||102
10731358|NCT02792699|11895285|FG001|Received Second Infusion of First Dose|Overall Study||103
10731359|NCT02792699|11895286|FG002|Received Second Infusion of First Dose|Overall Study||99
10731360|NCT02792699|11895284|FG000|Received First Infusion of Second Dose|Overall Study||97
10731361|NCT02792699|11895285|FG001|Received First Infusion of Second Dose|Overall Study||99
10731362|NCT02792699|11895286|FG002|Received First Infusion of Second Dose|Overall Study||95
10731363|NCT02792699|11895284|FG000|Received Second Infusion of Second Dose|Overall Study||97
10731364|NCT02792699|11895285|FG001|Received Second Infusion of Second Dose|Overall Study||99
10731365|NCT02792699|11895286|FG002|Received Second Infusion of Second Dose|Overall Study||93
10731366|NCT02792699|11895284|FG000|COMPLETED|Overall Study||95
10731367|NCT02792699|11895285|FG001|COMPLETED|Overall Study||94
10731368|NCT02792699|11895286|FG002|COMPLETED|Overall Study||93
10731369|NCT02792699|11895284|FG000|NOT COMPLETED|Overall Study||9
10731370|NCT02792699|11895285|FG001|NOT COMPLETED|Overall Study||10
10731371|NCT02792699|11895286|FG002|NOT COMPLETED|Overall Study||10
10731372|NCT02792777|11895303|FG000|STARTED|Overall Study||96
10731373|NCT02792777|11895304|FG001|STARTED|Overall Study||52
10731374|NCT02792777|11895303|FG000|COMPLETED|Overall Study||89
10731375|NCT02792777|11895304|FG001|COMPLETED|Overall Study||52
10731376|NCT02792777|11895303|FG000|NOT COMPLETED|Overall Study||7
10731377|NCT02792777|11895304|FG001|NOT COMPLETED|Overall Study||0
10731378|NCT02792829|11895319|FG000|STARTED|Treatment Period 1||10
10731379|NCT02792829|11895320|FG001|STARTED|Treatment Period 1||10
10731380|NCT02792829|11895321|FG002|STARTED|Treatment Period 1||5
10731381|NCT02792829|11895322|FG003|STARTED|Treatment Period 1||5
10731382|NCT02792829|11895323|FG004|STARTED|Treatment Period 1||5
10731383|NCT02792829|11895324|FG005|STARTED|Treatment Period 1||5
10731384|NCT02792829|11895325|FG006|STARTED|Treatment Period 1||10
10731385|NCT02792829|11895326|FG007|STARTED|Treatment Period 1||10
10731386|NCT02792829|11895319|FG000|COMPLETED|Treatment Period 1||10
10731387|NCT02792829|11895320|FG001|COMPLETED|Treatment Period 1||10
10731388|NCT02792829|11895321|FG002|COMPLETED|Treatment Period 1||5
10731389|NCT02792829|11895322|FG003|COMPLETED|Treatment Period 1||5
10731390|NCT02792829|11895323|FG004|COMPLETED|Treatment Period 1||5
10731391|NCT02792829|11895324|FG005|COMPLETED|Treatment Period 1||5
10731392|NCT02792829|11895325|FG006|COMPLETED|Treatment Period 1||10
10731393|NCT02792829|11895326|FG007|COMPLETED|Treatment Period 1||10
10731394|NCT02792829|11895319|FG000|NOT COMPLETED|Treatment Period 1||0
10731395|NCT02792829|11895320|FG001|NOT COMPLETED|Treatment Period 1||0
10731396|NCT02792829|11895321|FG002|NOT COMPLETED|Treatment Period 1||0
10731397|NCT02792829|11895322|FG003|NOT COMPLETED|Treatment Period 1||0
10731398|NCT02792829|11895323|FG004|NOT COMPLETED|Treatment Period 1||0
10731399|NCT02792829|11895324|FG005|NOT COMPLETED|Treatment Period 1||0
10731400|NCT02792829|11895325|FG006|NOT COMPLETED|Treatment Period 1||0
10731401|NCT02792829|11895326|FG007|NOT COMPLETED|Treatment Period 1||0
10731402|NCT02792829|11895319|FG000|STARTED|Wash Out Period||10
10731403|NCT02792829|11895320|FG001|STARTED|Wash Out Period||10
10731404|NCT02792829|11895321|FG002|STARTED|Wash Out Period||5
10731405|NCT02792829|11895322|FG003|STARTED|Wash Out Period||5
10731406|NCT02792829|11895323|FG004|STARTED|Wash Out Period||5
10731407|NCT02792829|11895324|FG005|STARTED|Wash Out Period||5
10731408|NCT02792829|11895325|FG006|STARTED|Wash Out Period||10
10731409|NCT02792829|11895326|FG007|STARTED|Wash Out Period||10
10731410|NCT02792829|11895319|FG000|COMPLETED|Wash Out Period||10
10731411|NCT02792829|11895320|FG001|COMPLETED|Wash Out Period||10
10731412|NCT02792829|11895321|FG002|COMPLETED|Wash Out Period||5
10731413|NCT02792829|11895322|FG003|COMPLETED|Wash Out Period||5
10731414|NCT02792829|11895323|FG004|COMPLETED|Wash Out Period||5
10731415|NCT02792829|11895324|FG005|COMPLETED|Wash Out Period||5
10731416|NCT02792829|11895325|FG006|COMPLETED|Wash Out Period||10
10731417|NCT02792829|11895326|FG007|COMPLETED|Wash Out Period||10
10731418|NCT02792829|11895319|FG000|NOT COMPLETED|Wash Out Period||0
10731419|NCT02792829|11895320|FG001|NOT COMPLETED|Wash Out Period||0
10731420|NCT02792829|11895321|FG002|NOT COMPLETED|Wash Out Period||0
10731421|NCT02792829|11895322|FG003|NOT COMPLETED|Wash Out Period||0
10731422|NCT02792829|11895323|FG004|NOT COMPLETED|Wash Out Period||0
10731423|NCT02792829|11895324|FG005|NOT COMPLETED|Wash Out Period||0
10731424|NCT02792829|11895325|FG006|NOT COMPLETED|Wash Out Period||0
10731425|NCT02792829|11895326|FG007|NOT COMPLETED|Wash Out Period||0
10731426|NCT02792829|11895319|FG000|STARTED|Treatment Period 2||10
10731427|NCT02792829|11895320|FG001|STARTED|Treatment Period 2||10
10731428|NCT02792829|11895321|FG002|STARTED|Treatment Period 2||5
10731429|NCT02792829|11895322|FG003|STARTED|Treatment Period 2||5
10731430|NCT02792829|11895323|FG004|STARTED|Treatment Period 2||5
10731431|NCT02792829|11895324|FG005|STARTED|Treatment Period 2||5
10731432|NCT02792829|11895325|FG006|STARTED|Treatment Period 2||10
10731433|NCT02792829|11895326|FG007|STARTED|Treatment Period 2||10
10731434|NCT02792829|11895319|FG000|COMPLETED|Treatment Period 2||10
10731435|NCT02792829|11895320|FG001|COMPLETED|Treatment Period 2||9
10731436|NCT02792829|11895321|FG002|COMPLETED|Treatment Period 2||5
10731437|NCT02792829|11895322|FG003|COMPLETED|Treatment Period 2||5
10731438|NCT02792829|11895323|FG004|COMPLETED|Treatment Period 2||4
10731439|NCT02792829|11895324|FG005|COMPLETED|Treatment Period 2||5
10731440|NCT02792829|11895325|FG006|COMPLETED|Treatment Period 2||9
10731441|NCT02792829|11895326|FG007|COMPLETED|Treatment Period 2||8
10731442|NCT02792829|11895319|FG000|NOT COMPLETED|Treatment Period 2||0
10731443|NCT02792829|11895320|FG001|NOT COMPLETED|Treatment Period 2||1
10731444|NCT02792829|11895321|FG002|NOT COMPLETED|Treatment Period 2||0
10731445|NCT02792829|11895322|FG003|NOT COMPLETED|Treatment Period 2||0
10731446|NCT02792829|11895323|FG004|NOT COMPLETED|Treatment Period 2||1
10731447|NCT02792829|11895324|FG005|NOT COMPLETED|Treatment Period 2||0
10731448|NCT02792829|11895325|FG006|NOT COMPLETED|Treatment Period 2||1
10731449|NCT02792829|11895326|FG007|NOT COMPLETED|Treatment Period 2||2
10731450|NCT02792959|11895352|FG000|STARTED|Overall Study||11
10731451|NCT02792959|11895352|FG000|COMPLETED|Overall Study||10
10731452|NCT02792959|11895352|FG000|NOT COMPLETED|Overall Study||1
10731453|NCT02793128|11895356|FG000|STARTED|Overall Study||71
10731454|NCT02793128|11895356|FG000|COMPLETED|Overall Study||62
10731455|NCT02793128|11895356|FG000|NOT COMPLETED|Overall Study||9
10731456|NCT02793154|11895371|FG000|STARTED|Part A (Single Group-up to 12 Days)||4
10731457|NCT02793154|11895372|FG001|STARTED|Part A (Single Group-up to 12 Days)||0
10731458|NCT02793154|11895373|FG002|STARTED|Part A (Single Group-up to 12 Days)||0
10731459|NCT02793154|11895371|FG000|COMPLETED|Part A (Single Group-up to 12 Days)||4
10731460|NCT02793154|11895372|FG001|COMPLETED|Part A (Single Group-up to 12 Days)||0
10731461|NCT02793154|11895373|FG002|COMPLETED|Part A (Single Group-up to 12 Days)||0
10731462|NCT02793154|11895371|FG000|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
10731463|NCT02793154|11895372|FG001|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
10731464|NCT02793154|11895373|FG002|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
10731465|NCT02793154|11895371|FG000|STARTED|Part B (Parallel Group-up to 84 Days)||0
10731466|NCT02793154|11895372|FG001|STARTED|Part B (Parallel Group-up to 84 Days)||0
10731467|NCT02793154|11895373|FG002|STARTED|Part B (Parallel Group-up to 84 Days)||0
10731468|NCT02793154|11895371|FG000|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
10731469|NCT02793154|11895372|FG001|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
10731470|NCT02793154|11895373|FG002|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
10731471|NCT02793154|11895371|FG000|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
10731472|NCT02793154|11895372|FG001|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
10731473|NCT02793154|11895373|FG002|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
10731474|NCT02793232|11895390|FG000|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
10731475|NCT02793232|11895391|FG001|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
10731476|NCT02793232|11895392|FG002|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
10731477|NCT02793232|11895393|FG003|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
10731478|NCT02793232|11895394|FG004|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||7
10731479|NCT02793232|11895395|FG005|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||12
10731480|NCT02793232|11895396|FG006|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||9
10731481|NCT02793232|11895397|FG007|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
10731482|NCT02793232|11895398|FG008|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||8
10731483|NCT02793232|11895390|FG000|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
10731484|NCT02793232|11895391|FG001|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
10731485|NCT02793232|11895392|FG002|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
10731486|NCT02793232|11895393|FG003|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
10731487|NCT02793232|11895394|FG004|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||6
10731488|NCT02793232|11895395|FG005|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||12
10731489|NCT02793232|11895396|FG006|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||8
10731490|NCT02793232|11895397|FG007|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
10731491|NCT02793232|11895398|FG008|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||8
10731492|NCT02793232|11895390|FG000|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
10731493|NCT02793232|11895391|FG001|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
10731494|NCT02793232|11895392|FG002|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
10731495|NCT02793232|11895393|FG003|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
10731496|NCT02793232|11895394|FG004|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||1
10731497|NCT02793232|11895395|FG005|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
10731498|NCT02793232|11895396|FG006|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||1
10731499|NCT02793232|11895397|FG007|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
10731500|NCT02793232|11895398|FG008|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
10731501|NCT02793232|11895390|FG000|STARTED|Washout Period 1(Part A:at Least 10days)||2
10731502|NCT02793232|11895391|FG001|STARTED|Washout Period 1(Part A:at Least 10days)||2
10731503|NCT02793232|11895392|FG002|STARTED|Washout Period 1(Part A:at Least 10days)||2
10731504|NCT02793232|11895393|FG003|STARTED|Washout Period 1(Part A:at Least 10days)||2
10731505|NCT02793232|11895394|FG004|STARTED|Washout Period 1(Part A:at Least 10days)||0
10731506|NCT02793232|11895395|FG005|STARTED|Washout Period 1(Part A:at Least 10days)||0
10731507|NCT02793232|11895396|FG006|STARTED|Washout Period 1(Part A:at Least 10days)||0
10731508|NCT02793232|11895397|FG007|STARTED|Washout Period 1(Part A:at Least 10days)||0
10731509|NCT02793232|11895398|FG008|STARTED|Washout Period 1(Part A:at Least 10days)||0
10731510|NCT02793232|11895390|FG000|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
10731511|NCT02793232|11895391|FG001|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
10731512|NCT02793232|11895392|FG002|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
10731513|NCT02793232|11895393|FG003|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
10731514|NCT02793232|11895394|FG004|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
10731515|NCT02793232|11895395|FG005|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
10731516|NCT02793232|11895396|FG006|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
10731517|NCT02793232|11895397|FG007|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
10731518|NCT02793232|11895398|FG008|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
10731519|NCT02793232|11895390|FG000|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
10731520|NCT02793232|11895391|FG001|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
10731521|NCT02793232|11895392|FG002|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
10731522|NCT02793232|11895393|FG003|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
10731523|NCT02793232|11895394|FG004|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
10731524|NCT02793232|11895395|FG005|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
10731525|NCT02793232|11895396|FG006|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
10731526|NCT02793232|11895397|FG007|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
10731527|NCT02793232|11895398|FG008|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
10731528|NCT02793232|11895390|FG000|STARTED|Period 2 (Part A: 5 Days)||2
10731529|NCT02793232|11895391|FG001|STARTED|Period 2 (Part A: 5 Days)||2
10731530|NCT02793232|11895392|FG002|STARTED|Period 2 (Part A: 5 Days)||2
10731531|NCT02793232|11895393|FG003|STARTED|Period 2 (Part A: 5 Days)||2
10731532|NCT02793232|11895394|FG004|STARTED|Period 2 (Part A: 5 Days)||0
10731533|NCT02793232|11895395|FG005|STARTED|Period 2 (Part A: 5 Days)||0
10731534|NCT02793232|11895396|FG006|STARTED|Period 2 (Part A: 5 Days)||0
10731535|NCT02793232|11895397|FG007|STARTED|Period 2 (Part A: 5 Days)||0
10731536|NCT02793232|11895398|FG008|STARTED|Period 2 (Part A: 5 Days)||0
10731537|NCT02793232|11895390|FG000|COMPLETED|Period 2 (Part A: 5 Days)||2
10731538|NCT02793232|11895391|FG001|COMPLETED|Period 2 (Part A: 5 Days)||2
10731539|NCT02793232|11895392|FG002|COMPLETED|Period 2 (Part A: 5 Days)||2
10731540|NCT02793232|11895393|FG003|COMPLETED|Period 2 (Part A: 5 Days)||2
10731541|NCT02793232|11895394|FG004|COMPLETED|Period 2 (Part A: 5 Days)||0
10731542|NCT02793232|11895395|FG005|COMPLETED|Period 2 (Part A: 5 Days)||0
10731543|NCT02793232|11895396|FG006|COMPLETED|Period 2 (Part A: 5 Days)||0
10731544|NCT02793232|11895397|FG007|COMPLETED|Period 2 (Part A: 5 Days)||0
10731545|NCT02793232|11895398|FG008|COMPLETED|Period 2 (Part A: 5 Days)||0
10731546|NCT02793232|11895390|FG000|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
10731547|NCT02793232|11895391|FG001|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
10731548|NCT02793232|11895392|FG002|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
10731549|NCT02793232|11895393|FG003|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
10731550|NCT02793232|11895394|FG004|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
10731551|NCT02793232|11895395|FG005|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
10731552|NCT02793232|11895396|FG006|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
10731553|NCT02793232|11895397|FG007|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
10731554|NCT02793232|11895398|FG008|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
10731555|NCT02793232|11895390|FG000|STARTED|Washout Period 2(Part A:at Least 10days)||2
10731556|NCT02793232|11895391|FG001|STARTED|Washout Period 2(Part A:at Least 10days)||2
10731557|NCT02793232|11895392|FG002|STARTED|Washout Period 2(Part A:at Least 10days)||2
10731558|NCT02793232|11895393|FG003|STARTED|Washout Period 2(Part A:at Least 10days)||2
10731559|NCT02793232|11895394|FG004|STARTED|Washout Period 2(Part A:at Least 10days)||0
10731560|NCT02793232|11895395|FG005|STARTED|Washout Period 2(Part A:at Least 10days)||0
10731561|NCT02793232|11895396|FG006|STARTED|Washout Period 2(Part A:at Least 10days)||0
10731562|NCT02793232|11895397|FG007|STARTED|Washout Period 2(Part A:at Least 10days)||0
10731563|NCT02793232|11895398|FG008|STARTED|Washout Period 2(Part A:at Least 10days)||0
10731564|NCT02793232|11895390|FG000|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
10731565|NCT02793232|11895391|FG001|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
10731566|NCT02793232|11895392|FG002|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
10731567|NCT02793232|11895393|FG003|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
10731568|NCT02793232|11895394|FG004|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
10731569|NCT02793232|11895395|FG005|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
10731570|NCT02793232|11895396|FG006|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
10731571|NCT02793232|11895397|FG007|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
10731572|NCT02793232|11895398|FG008|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
10731573|NCT02793232|11895390|FG000|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
10731574|NCT02793232|11895391|FG001|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
10731575|NCT02793232|11895392|FG002|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
10731576|NCT02793232|11895393|FG003|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
10731577|NCT02793232|11895394|FG004|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
10731578|NCT02793232|11895395|FG005|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
10731579|NCT02793232|11895396|FG006|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
10731580|NCT02793232|11895397|FG007|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
10731581|NCT02793232|11895398|FG008|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
10731582|NCT02793232|11895390|FG000|STARTED|Period 3 (Part A: 5 Days)||2
10731583|NCT02793232|11895391|FG001|STARTED|Period 3 (Part A: 5 Days)||2
10731584|NCT02793232|11895392|FG002|STARTED|Period 3 (Part A: 5 Days)||2
10731585|NCT02793232|11895393|FG003|STARTED|Period 3 (Part A: 5 Days)||2
10731586|NCT02793232|11895394|FG004|STARTED|Period 3 (Part A: 5 Days)||0
10731587|NCT02793232|11895395|FG005|STARTED|Period 3 (Part A: 5 Days)||0
10731588|NCT02793232|11895396|FG006|STARTED|Period 3 (Part A: 5 Days)||0
10731589|NCT02793232|11895397|FG007|STARTED|Period 3 (Part A: 5 Days)||0
10731590|NCT02793232|11895398|FG008|STARTED|Period 3 (Part A: 5 Days)||0
10731591|NCT02793232|11895390|FG000|COMPLETED|Period 3 (Part A: 5 Days)||2
10731592|NCT02793232|11895391|FG001|COMPLETED|Period 3 (Part A: 5 Days)||2
10731593|NCT02793232|11895392|FG002|COMPLETED|Period 3 (Part A: 5 Days)||2
10731594|NCT02793232|11895393|FG003|COMPLETED|Period 3 (Part A: 5 Days)||2
10731595|NCT02793232|11895394|FG004|COMPLETED|Period 3 (Part A: 5 Days)||0
10731596|NCT02793232|11895395|FG005|COMPLETED|Period 3 (Part A: 5 Days)||0
10731597|NCT02793232|11895396|FG006|COMPLETED|Period 3 (Part A: 5 Days)||0
10731598|NCT02793232|11895397|FG007|COMPLETED|Period 3 (Part A: 5 Days)||0
10731599|NCT02793232|11895398|FG008|COMPLETED|Period 3 (Part A: 5 Days)||0
10731600|NCT02793232|11895390|FG000|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
10731601|NCT02793232|11895391|FG001|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
10731602|NCT02793232|11895392|FG002|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
10731603|NCT02793232|11895393|FG003|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
10731604|NCT02793232|11895394|FG004|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
10731605|NCT02793232|11895395|FG005|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
10731606|NCT02793232|11895396|FG006|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
10731607|NCT02793232|11895397|FG007|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
10731608|NCT02793232|11895398|FG008|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
10731609|NCT02793232|11895390|FG000|STARTED|Washout Period 3(Part A:at Least 10days)||2
10731610|NCT02793232|11895391|FG001|STARTED|Washout Period 3(Part A:at Least 10days)||2
10731611|NCT02793232|11895392|FG002|STARTED|Washout Period 3(Part A:at Least 10days)||2
10731612|NCT02793232|11895393|FG003|STARTED|Washout Period 3(Part A:at Least 10days)||2
10731613|NCT02793232|11895394|FG004|STARTED|Washout Period 3(Part A:at Least 10days)||0
10731614|NCT02793232|11895395|FG005|STARTED|Washout Period 3(Part A:at Least 10days)||0
10731615|NCT02793232|11895396|FG006|STARTED|Washout Period 3(Part A:at Least 10days)||0
10731616|NCT02793232|11895397|FG007|STARTED|Washout Period 3(Part A:at Least 10days)||0
10731617|NCT02793232|11895398|FG008|STARTED|Washout Period 3(Part A:at Least 10days)||0
10731618|NCT02793232|11895390|FG000|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
10731619|NCT02793232|11895391|FG001|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
10731620|NCT02793232|11895392|FG002|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
10731621|NCT02793232|11895393|FG003|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
10731622|NCT02793232|11895394|FG004|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
10731623|NCT02793232|11895395|FG005|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
10731624|NCT02793232|11895396|FG006|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
10731625|NCT02793232|11895397|FG007|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
10731626|NCT02793232|11895398|FG008|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
10731627|NCT02793232|11895390|FG000|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
10731628|NCT02793232|11895391|FG001|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
10731629|NCT02793232|11895392|FG002|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
10731630|NCT02793232|11895393|FG003|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
10731631|NCT02793232|11895394|FG004|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
10731632|NCT02793232|11895395|FG005|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
10731633|NCT02793232|11895396|FG006|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
10731634|NCT02793232|11895397|FG007|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
10731635|NCT02793232|11895398|FG008|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
10731636|NCT02793232|11895390|FG000|STARTED|Period 4 (Part A: 5 Days)||2
10731637|NCT02793232|11895391|FG001|STARTED|Period 4 (Part A: 5 Days)||2
10731638|NCT02793232|11895392|FG002|STARTED|Period 4 (Part A: 5 Days)||2
10731639|NCT02793232|11895393|FG003|STARTED|Period 4 (Part A: 5 Days)||2
10731640|NCT02793232|11895394|FG004|STARTED|Period 4 (Part A: 5 Days)||0
10731641|NCT02793232|11895395|FG005|STARTED|Period 4 (Part A: 5 Days)||0
10731642|NCT02793232|11895396|FG006|STARTED|Period 4 (Part A: 5 Days)||0
10731643|NCT02793232|11895397|FG007|STARTED|Period 4 (Part A: 5 Days)||0
10731644|NCT02793232|11895398|FG008|STARTED|Period 4 (Part A: 5 Days)||0
10731645|NCT02793232|11895390|FG000|COMPLETED|Period 4 (Part A: 5 Days)||2
10731646|NCT02793232|11895391|FG001|COMPLETED|Period 4 (Part A: 5 Days)||2
10731647|NCT02793232|11895392|FG002|COMPLETED|Period 4 (Part A: 5 Days)||2
10731648|NCT02793232|11895393|FG003|COMPLETED|Period 4 (Part A: 5 Days)||2
10731649|NCT02793232|11895394|FG004|COMPLETED|Period 4 (Part A: 5 Days)||0
10731650|NCT02793232|11895395|FG005|COMPLETED|Period 4 (Part A: 5 Days)||0
10731651|NCT02793232|11895396|FG006|COMPLETED|Period 4 (Part A: 5 Days)||0
10731652|NCT02793232|11895397|FG007|COMPLETED|Period 4 (Part A: 5 Days)||0
10731653|NCT02793232|11895398|FG008|COMPLETED|Period 4 (Part A: 5 Days)||0
10731654|NCT02793232|11895390|FG000|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
10731655|NCT02793232|11895391|FG001|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
10731656|NCT02793232|11895392|FG002|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
10731657|NCT02793232|11895393|FG003|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
10731658|NCT02793232|11895394|FG004|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
10731659|NCT02793232|11895395|FG005|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
10731660|NCT02793232|11895396|FG006|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
10731661|NCT02793232|11895397|FG007|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
10731662|NCT02793232|11895398|FG008|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
10731663|NCT02793622|11895434|FG000|STARTED|Overall Study||391
10731664|NCT02793622|11895435|FG001|STARTED|Overall Study||391
10731665|NCT02793622|11895434|FG000|COMPLETED|Overall Study||338
10731666|NCT02793622|11895435|FG001|COMPLETED|Overall Study||349
10731667|NCT02793622|11895434|FG000|NOT COMPLETED|Overall Study||53
10731668|NCT02793622|11895435|FG001|NOT COMPLETED|Overall Study||42
10731669|NCT02793674|11895443|FG000|STARTED|Overall Study||9
10731670|NCT02793674|11895444|FG001|STARTED|Overall Study||12
10731671|NCT02793674|11895443|FG000|COMPLETED|Overall Study||9
10731672|NCT02793674|11895444|FG001|COMPLETED|Overall Study||12
10731673|NCT02793674|11895443|FG000|NOT COMPLETED|Overall Study||0
10731674|NCT02793674|11895444|FG001|NOT COMPLETED|Overall Study||0
10731675|NCT02793817|11895458|FG000|STARTED|Overall Study||261
10731676|NCT02793817|11895459|FG001|STARTED|Overall Study||259
10731677|NCT02793817|11895458|FG000|COMPLETED|Overall Study||258
10731678|NCT02793817|11895459|FG001|COMPLETED|Overall Study||254
10731679|NCT02793817|11895458|FG000|NOT COMPLETED|Overall Study||3
10731680|NCT02793817|11895459|FG001|NOT COMPLETED|Overall Study||5
10731681|NCT02793856|11895469|FG000|STARTED|Overall Study||2
10731682|NCT02793856|11895470|FG001|STARTED|Overall Study||4
10731683|NCT02793856|11895471|FG002|STARTED|Overall Study||3
10731684|NCT02793856|11895472|FG003|STARTED|Overall Study||3
10814966|NCT02109809|11977905|FG000|STARTED|Overall Study||4
10814967|NCT02109809|11977905|FG000|COMPLETED|Overall Study||1
10814968|NCT02109809|11977905|FG000|NOT COMPLETED|Overall Study||3
10814969|NCT02105116|11977909|FG000|STARTED|Overall Study||6
10814970|NCT02105116|11977909|FG000|COMPLETED|Overall Study||0
10814971|NCT02105116|11977909|FG000|NOT COMPLETED|Overall Study||6
10814972|NCT02099318|11977915|FG000|STARTED|Overall Study||20
10814973|NCT02099318|11977916|FG001|STARTED|Overall Study||20
10814974|NCT02099318|11977915|FG000|COMPLETED|Overall Study||20
10814975|NCT02099318|11977916|FG001|COMPLETED|Overall Study||20
10814976|NCT02099318|11977915|FG000|NOT COMPLETED|Overall Study||0
10814977|NCT02099318|11977916|FG001|NOT COMPLETED|Overall Study||0
10814978|NCT02099344|11977926|FG000|STARTED|Overall Study||1
10814979|NCT02099344|11977927|FG001|STARTED|Overall Study||0
10814980|NCT02099344|11977926|FG000|COMPLETED|Overall Study||0
10814981|NCT02099344|11977927|FG001|COMPLETED|Overall Study||0
10814982|NCT02099344|11977926|FG000|NOT COMPLETED|Overall Study||1
10814983|NCT02099344|11977927|FG001|NOT COMPLETED|Overall Study||0
10731685|NCT02793856|11895469|FG000|COMPLETED|Overall Study||2
10814984|NCT02094352|11977937|FG000|STARTED|Overall Study||2
10814985|NCT02094352|11977938|FG001|STARTED|Overall Study||1
10814986|NCT02094352|11977937|FG000|COMPLETED|Overall Study||2
10814987|NCT02094352|11977938|FG001|COMPLETED|Overall Study||1
10814988|NCT02094352|11977937|FG000|NOT COMPLETED|Overall Study||0
10814989|NCT02094352|11977938|FG001|NOT COMPLETED|Overall Study||0
10814990|NCT02096042|11977944|FG000|STARTED|Overall Study||1
10731686|NCT02793856|11895470|FG001|COMPLETED|Overall Study||4
10731687|NCT02793856|11895471|FG002|COMPLETED|Overall Study||3
10731688|NCT02793856|11895472|FG003|COMPLETED|Overall Study||3
10731689|NCT02793856|11895469|FG000|NOT COMPLETED|Overall Study||0
10731690|NCT02793856|11895470|FG001|NOT COMPLETED|Overall Study||0
10731691|NCT02793856|11895471|FG002|NOT COMPLETED|Overall Study||0
10731692|NCT02793856|11895472|FG003|NOT COMPLETED|Overall Study||0
10731693|NCT02793947|11895512|FG000|STARTED|Overall Study||47
10731694|NCT02793947|11895513|FG001|STARTED|Overall Study||55
10731695|NCT02793947|11895512|FG000|COMPLETED|Overall Study||45
10731696|NCT02793947|11895513|FG001|COMPLETED|Overall Study||50
10731697|NCT02793947|11895512|FG000|NOT COMPLETED|Overall Study||2
10731698|NCT02793947|11895513|FG001|NOT COMPLETED|Overall Study||5
10731699|NCT02794103|11895519|FG000|STARTED|Overall Study||18
10731700|NCT02794103|11895519|FG000|COMPLETED|Overall Study||15
10731701|NCT02794103|11895519|FG000|NOT COMPLETED|Overall Study||3
10731702|NCT02794207|11895525|FG000|STARTED|Overall Study||32
10731703|NCT02794207|11895526|FG001|STARTED|Overall Study||54
10731704|NCT02794207|11895525|FG000|COMPLETED|Overall Study||32
10731705|NCT02794207|11895526|FG001|COMPLETED|Overall Study||54
10731706|NCT02794207|11895525|FG000|NOT COMPLETED|Overall Study||0
10731707|NCT02794207|11895526|FG001|NOT COMPLETED|Overall Study||0
10731708|NCT02794246|11895531|FG000|STARTED|Overall Study||6
10731709|NCT02794246|11895531|FG000|Treated|Overall Study||3
10731710|NCT02794246|11895531|FG000|COMPLETED|Overall Study||0
10731711|NCT02794246|11895531|FG000|NOT COMPLETED|Overall Study||6
10731712|NCT02794441|11895537|FG000|STARTED|Overall Study||7
10731713|NCT02794441|11895538|FG001|STARTED|Overall Study||5
10731714|NCT02794441|11895537|FG000|COMPLETED|Overall Study||6
10731715|NCT02794441|11895538|FG001|COMPLETED|Overall Study||5
10731716|NCT02794441|11895537|FG000|NOT COMPLETED|Overall Study||1
10731717|NCT02794441|11895538|FG001|NOT COMPLETED|Overall Study||0
10731718|NCT02794480|11895546|FG000|STARTED|Period 1: Treatment Period 1 (28 Days)||80
10731719|NCT02794480|11895547|FG001|STARTED|Period 1: Treatment Period 1 (28 Days)||82
10731720|NCT02794480|11895548|FG002|STARTED|Period 1: Treatment Period 1 (28 Days)||81
10731721|NCT02794480|11895549|FG003|STARTED|Period 1: Treatment Period 1 (28 Days)||81
10731722|NCT02794480|11895546|FG000|COMPLETED|Period 1: Treatment Period 1 (28 Days)||80
10731723|NCT02794480|11895547|FG001|COMPLETED|Period 1: Treatment Period 1 (28 Days)||80
10731724|NCT02794480|11895548|FG002|COMPLETED|Period 1: Treatment Period 1 (28 Days)||79
10731725|NCT02794480|11895549|FG003|COMPLETED|Period 1: Treatment Period 1 (28 Days)||78
10731726|NCT02794480|11895546|FG000|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||0
10731727|NCT02794480|11895547|FG001|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||2
10731728|NCT02794480|11895548|FG002|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||2
10731729|NCT02794480|11895549|FG003|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||3
10731730|NCT02794480|11895546|FG000|STARTED|Period 2: Treatment Period 2 (28 Days)||80
10731731|NCT02794480|11895547|FG001|STARTED|Period 2: Treatment Period 2 (28 Days)||80
10731732|NCT02794480|11895548|FG002|STARTED|Period 2: Treatment Period 2 (28 Days)||79
10731733|NCT02794480|11895549|FG003|STARTED|Period 2: Treatment Period 2 (28 Days)||78
10731734|NCT02794480|11895546|FG000|COMPLETED|Period 2: Treatment Period 2 (28 Days)||79
10731735|NCT02794480|11895547|FG001|COMPLETED|Period 2: Treatment Period 2 (28 Days)||80
10731736|NCT02794480|11895548|FG002|COMPLETED|Period 2: Treatment Period 2 (28 Days)||79
10731737|NCT02794480|11895549|FG003|COMPLETED|Period 2: Treatment Period 2 (28 Days)||77
10731738|NCT02794480|11895546|FG000|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||1
10731739|NCT02794480|11895547|FG001|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||0
10731740|NCT02794480|11895548|FG002|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||0
10731741|NCT02794480|11895549|FG003|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||1
10731742|NCT02794597|11895559|FG000|STARTED|Overall Study||63
10731743|NCT02794597|11895560|FG001|STARTED|Overall Study||56
10731744|NCT02794597|11895559|FG000|COMPLETED|Overall Study||63
10731745|NCT02794597|11895560|FG001|COMPLETED|Overall Study||56
10731746|NCT02794597|11895559|FG000|NOT COMPLETED|Overall Study||0
10731747|NCT02794597|11895560|FG001|NOT COMPLETED|Overall Study||0
10731748|NCT02794727|11895569|FG000|STARTED|Overall Study||44
10731749|NCT02794727|11895570|FG001|STARTED|Overall Study||46
10731750|NCT02794727|11895571|FG002|STARTED|Overall Study||45
10731751|NCT02794727|11895569|FG000|COMPLETED|Overall Study||44
10731752|NCT02794727|11895570|FG001|COMPLETED|Overall Study||46
10731753|NCT02794727|11895571|FG002|COMPLETED|Overall Study||44
10731754|NCT02794727|11895569|FG000|NOT COMPLETED|Overall Study||0
10731755|NCT02794727|11895570|FG001|NOT COMPLETED|Overall Study||0
10731756|NCT02794727|11895571|FG002|NOT COMPLETED|Overall Study||1
10731757|NCT02794766|11895581|FG000|STARTED|Overall Study||15
10731758|NCT02794766|11895582|FG001|STARTED|Overall Study||15
10731759|NCT02794766|11895583|FG002|STARTED|Overall Study||15
10731760|NCT02794766|11895581|FG000|COMPLETED|Overall Study||15
10731761|NCT02794766|11895582|FG001|COMPLETED|Overall Study||15
10731762|NCT02794766|11895583|FG002|COMPLETED|Overall Study||14
10731763|NCT02794766|11895581|FG000|NOT COMPLETED|Overall Study||0
10731764|NCT02794766|11895582|FG001|NOT COMPLETED|Overall Study||0
10731765|NCT02794766|11895583|FG002|NOT COMPLETED|Overall Study||1
10731766|NCT02794844|11895591|FG000|STARTED|Overall Study||28
10731767|NCT02794844|11895591|FG000|COMPLETED|Overall Study||23
10731768|NCT02794844|11895591|FG000|NOT COMPLETED|Overall Study||5
10731769|NCT02794870|11895597|FG000|STARTED|Overall Study||22
10731770|NCT02794870|11895598|FG001|STARTED|Overall Study||11
10731771|NCT02794870|11895597|FG000|Received Inoculation|Overall Study||21
10731772|NCT02794870|11895598|FG001|Received Inoculation|Overall Study||11
10731773|NCT02794870|11895597|FG000|COMPLETED|Overall Study||20
10731774|NCT02794870|11895598|FG001|COMPLETED|Overall Study||11
10731775|NCT02794870|11895597|FG000|NOT COMPLETED|Overall Study||2
10731776|NCT02794870|11895598|FG001|NOT COMPLETED|Overall Study||0
10731777|NCT02794974|11895606|FG000|STARTED|Overall Study||14
10731778|NCT02794974|11895607|FG001|STARTED|Overall Study||15
10731779|NCT02794974|11895606|FG000|COMPLETED|Overall Study||14
10731780|NCT02794974|11895607|FG001|COMPLETED|Overall Study||14
10731781|NCT02794974|11895606|FG000|NOT COMPLETED|Overall Study||0
10731782|NCT02794974|11895607|FG001|NOT COMPLETED|Overall Study||1
10731783|NCT02795117|11895616|FG000|STARTED|Overall Study||193
10731784|NCT02795117|11895617|FG001|STARTED|Overall Study||193
10731785|NCT02795117|11895618|FG002|STARTED|Overall Study||100
10731786|NCT02795117|11895616|FG000|COMPLETED|Overall Study||175
10731787|NCT02795117|11895617|FG001|COMPLETED|Overall Study||166
10731788|NCT02795117|11895618|FG002|COMPLETED|Overall Study||88
10731789|NCT02795117|11895616|FG000|NOT COMPLETED|Overall Study||18
10731790|NCT02795117|11895617|FG001|NOT COMPLETED|Overall Study||27
10731791|NCT02795117|11895618|FG002|NOT COMPLETED|Overall Study||12
10731792|NCT02795767|11895629|FG000|STARTED|Overall Study||68
10731793|NCT02795767|11895630|FG001|STARTED|Overall Study||10
10731794|NCT02795767|11895631|FG002|STARTED|Overall Study||10
10731795|NCT02795767|11895629|FG000|Received at Least One Dose of Emicizumab|Overall Study||68
10731796|NCT02795767|11895630|FG001|Received at Least One Dose of Emicizumab|Overall Study||10
10731797|NCT02795767|11895631|FG002|Received at Least One Dose of Emicizumab|Overall Study||10
10731798|NCT02795767|11895629|FG000|Dose Up-Titrated to 3 mg/kg QW|Overall Study||0
10731799|NCT02795767|11895630|FG001|Dose Up-Titrated to 3 mg/kg QW|Overall Study||0
10731800|NCT02795767|11895631|FG002|Dose Up-Titrated to 3 mg/kg QW|Overall Study||3
10731801|NCT02795767|11895629|FG000|Completed 52 Weeks in Study|Overall Study||67
10731802|NCT02795767|11895630|FG001|Completed 52 Weeks in Study|Overall Study||10
10731803|NCT02795767|11895631|FG002|Completed 52 Weeks in Study|Overall Study||9
10731804|NCT02795767|11895629|FG000|COMPLETED|Overall Study||67
10731805|NCT02795767|11895630|FG001|COMPLETED|Overall Study||10
10731806|NCT02795767|11895631|FG002|COMPLETED|Overall Study||10
10731807|NCT02795767|11895629|FG000|NOT COMPLETED|Overall Study||1
10731808|NCT02795767|11895630|FG001|NOT COMPLETED|Overall Study||0
10731809|NCT02795767|11895631|FG002|NOT COMPLETED|Overall Study||0
10731810|NCT02795780|11895645|FG000|STARTED|Overall Study||25
10731811|NCT02795780|11895646|FG001|STARTED|Overall Study||54
10731812|NCT02795780|11895645|FG000|COMPLETED|Overall Study||25
10731813|NCT02795780|11895646|FG001|COMPLETED|Overall Study||54
10731814|NCT02795780|11895645|FG000|NOT COMPLETED|Overall Study||0
10731815|NCT02795780|11895646|FG001|NOT COMPLETED|Overall Study||0
10731816|NCT02795819|11895654|FG000|STARTED|Overall Study||0
10731817|NCT02795819|11895655|FG001|STARTED|Overall Study||6
10731818|NCT02795819|11895656|FG002|STARTED|Overall Study||0
10731819|NCT02795819|11895657|FG003|STARTED|Overall Study||0
10731820|NCT02795819|11895658|FG004|STARTED|Overall Study||0
10731821|NCT02795819|11895659|FG005|STARTED|Overall Study||0
10731822|NCT02795819|11895660|FG006|STARTED|Overall Study||0
10731823|NCT02795819|11895654|FG000|COMPLETED|Overall Study||0
10731824|NCT02795819|11895655|FG001|COMPLETED|Overall Study||6
10731825|NCT02795819|11895656|FG002|COMPLETED|Overall Study||0
10731826|NCT02795819|11895657|FG003|COMPLETED|Overall Study||0
10731827|NCT02795819|11895658|FG004|COMPLETED|Overall Study||0
10731828|NCT02795819|11895659|FG005|COMPLETED|Overall Study||0
10731829|NCT02795819|11895660|FG006|COMPLETED|Overall Study||0
10731830|NCT02795819|11895654|FG000|NOT COMPLETED|Overall Study||0
10731831|NCT02795819|11895655|FG001|NOT COMPLETED|Overall Study||0
10731832|NCT02795819|11895656|FG002|NOT COMPLETED|Overall Study||0
10731833|NCT02795819|11895657|FG003|NOT COMPLETED|Overall Study||0
10731834|NCT02795819|11895658|FG004|NOT COMPLETED|Overall Study||0
10731835|NCT02795819|11895659|FG005|NOT COMPLETED|Overall Study||0
10731836|NCT02795819|11895660|FG006|NOT COMPLETED|Overall Study||0
10731837|NCT02795832|11895676|FG000|STARTED|Overall Study||8
10731838|NCT02795832|11895677|FG001|STARTED|Overall Study||4
10731839|NCT02795832|11895678|FG002|STARTED|Overall Study||8
10731840|NCT02795832|11895679|FG003|STARTED|Overall Study||3
10731841|NCT02795832|11895680|FG004|STARTED|Overall Study||20
10731842|NCT02795832|11895681|FG005|STARTED|Overall Study||10
10731843|NCT02795832|11895676|FG000|COMPLETED|Overall Study||8
10731844|NCT02795832|11895677|FG001|COMPLETED|Overall Study||4
10731845|NCT02795832|11895678|FG002|COMPLETED|Overall Study||8
10814991|NCT02096042|11977945|FG001|STARTED|Overall Study||0
10731846|NCT02795832|11895679|FG003|COMPLETED|Overall Study||3
10731847|NCT02795832|11895680|FG004|COMPLETED|Overall Study||20
10731848|NCT02795832|11895681|FG005|COMPLETED|Overall Study||7
10731849|NCT02795832|11895676|FG000|NOT COMPLETED|Overall Study||0
10731850|NCT02795832|11895677|FG001|NOT COMPLETED|Overall Study||0
10731851|NCT02795832|11895678|FG002|NOT COMPLETED|Overall Study||0
10731852|NCT02795832|11895679|FG003|NOT COMPLETED|Overall Study||0
10731853|NCT02795832|11895680|FG004|NOT COMPLETED|Overall Study||0
10731854|NCT02795832|11895681|FG005|NOT COMPLETED|Overall Study||3
10731855|NCT02796092|11895705|FG000|STARTED|Overall Study||50
10731856|NCT02796092|11895706|FG001|STARTED|Overall Study||50
10731857|NCT02796092|11895705|FG000|COMPLETED|Overall Study||50
10731858|NCT02796092|11895706|FG001|COMPLETED|Overall Study||50
10731859|NCT02796092|11895705|FG000|NOT COMPLETED|Overall Study||0
10731860|NCT02796092|11895706|FG001|NOT COMPLETED|Overall Study||0
10731861|NCT02796144|11895715|FG000|STARTED|Overall Study||23
10731862|NCT02796144|11895716|FG001|STARTED|Overall Study||24
10731863|NCT02796144|11895717|FG002|STARTED|Overall Study||24
10731864|NCT02796144|11895715|FG000|COMPLETED|Overall Study||18
10731865|NCT02796144|11895716|FG001|COMPLETED|Overall Study||21
10731866|NCT02796144|11895717|FG002|COMPLETED|Overall Study||18
10731867|NCT02796144|11895715|FG000|NOT COMPLETED|Overall Study||5
10731868|NCT02796144|11895716|FG001|NOT COMPLETED|Overall Study||3
10731869|NCT02796144|11895717|FG002|NOT COMPLETED|Overall Study||6
10731870|NCT02796274|11895727|FG000|STARTED|Overall Study||219
10731871|NCT02796274|11895727|FG000|COMPLETED|Overall Study||219
10814992|NCT02096042|11977946|FG002|STARTED|Overall Study||0
10814993|NCT02096042|11977944|FG000|COMPLETED|Overall Study||0
10814994|NCT02096042|11977945|FG001|COMPLETED|Overall Study||0
10814995|NCT02096042|11977946|FG002|COMPLETED|Overall Study||0
10814996|NCT02096042|11977944|FG000|NOT COMPLETED|Overall Study||1
10814997|NCT02096042|11977945|FG001|NOT COMPLETED|Overall Study||0
10814998|NCT02096042|11977946|FG002|NOT COMPLETED|Overall Study||0
10814999|NCT02088957|11977953|FG000|STARTED|Overall Study||1
10815000|NCT02088957|11977954|FG001|STARTED|Overall Study||0
10815001|NCT02088957|11977953|FG000|COMPLETED|Overall Study||0
10815002|NCT02088957|11977954|FG001|COMPLETED|Overall Study||0
10815003|NCT02088957|11977953|FG000|NOT COMPLETED|Overall Study||1
10815004|NCT02088957|11977954|FG001|NOT COMPLETED|Overall Study||0
10815005|NCT02093689|11977963|FG000|STARTED|Overall Study||18
10815006|NCT02093689|11977964|FG001|STARTED|Overall Study||0
10815007|NCT02093689|11977965|FG002|STARTED|Overall Study||0
10815008|NCT02093689|11977963|FG000|COMPLETED|Overall Study||14
10815009|NCT02093689|11977964|FG001|COMPLETED|Overall Study||0
10815010|NCT02093689|11977965|FG002|COMPLETED|Overall Study||0
10815011|NCT02093689|11977963|FG000|NOT COMPLETED|Overall Study||4
10815012|NCT02093689|11977964|FG001|NOT COMPLETED|Overall Study||0
10815013|NCT02093689|11977965|FG002|NOT COMPLETED|Overall Study||0
10815014|NCT02091752|11977971|FG000|STARTED|Overall Study||3
10815015|NCT02091752|11977971|FG000|COMPLETED|Overall Study||0
10731872|NCT02796274|11895727|FG000|NOT COMPLETED|Overall Study||0
10731873|NCT02796300|11895733|FG000|STARTED|Overall Study||10
10731874|NCT02796300|11895734|FG001|STARTED|Overall Study||22
10731875|NCT02796300|11895733|FG000|COMPLETED|Overall Study||10
10731876|NCT02796300|11895734|FG001|COMPLETED|Overall Study||22
10731877|NCT02796300|11895733|FG000|NOT COMPLETED|Overall Study||0
10731878|NCT02796300|11895734|FG001|NOT COMPLETED|Overall Study||0
10731879|NCT02796352|11895740|FG000|STARTED|Overall Study||1
10731880|NCT02796352|11895740|FG000|COMPLETED|Overall Study||1
10731881|NCT02796352|11895740|FG000|NOT COMPLETED|Overall Study||0
10731882|NCT02796560|11895746|FG000|STARTED|Overall Study||38
10731883|NCT02796560|11895747|FG001|STARTED|Overall Study||38
10731884|NCT02796560|11895746|FG000|COMPLETED|Overall Study||34
10731885|NCT02796560|11895747|FG001|COMPLETED|Overall Study||36
10731886|NCT02796560|11895746|FG000|NOT COMPLETED|Overall Study||4
10731887|NCT02796560|11895747|FG001|NOT COMPLETED|Overall Study||2
10731888|NCT02796625|11895753|FG000|STARTED|Overall Study||80
10731889|NCT02796625|11895753|FG000|COMPLETED|Overall Study||61
10731890|NCT02796625|11895753|FG000|NOT COMPLETED|Overall Study||19
10731891|NCT02796651|11895757|FG000|STARTED|Overall Study||132
10731892|NCT02796651|11895757|FG000|Formoterol Fumarate (FF) 6 μg|Overall Study||107
10731893|NCT02796651|11895757|FG000|Formoterol Fumarate (FF) 12 μg|Overall Study||121
10731894|NCT02796651|11895757|FG000|Formoterol Fumarate (FF) 24 μg|Overall Study||105
10731895|NCT02796651|11895757|FG000|Perforomist 20 μg|Overall Study||118
10731896|NCT02796651|11895757|FG000|Perforomist 40 μg|Overall Study||108
10731897|NCT02796651|11895757|FG000|Placebo (Lactose Monohydrate)|Overall Study||38
10731898|NCT02796651|11895757|FG000|COMPLETED|Overall Study||106
10731899|NCT02796651|11895757|FG000|NOT COMPLETED|Overall Study||26
10731900|NCT02796664|11895774|FG000|STARTED|Overall Study||29
10731901|NCT02796664|11895775|FG001|STARTED|Overall Study||29
10731902|NCT02796664|11895774|FG000|COMPLETED|Overall Study||28
10731903|NCT02796664|11895775|FG001|COMPLETED|Overall Study||24
10731904|NCT02796664|11895774|FG000|NOT COMPLETED|Overall Study||1
10731905|NCT02796664|11895775|FG001|NOT COMPLETED|Overall Study||5
10731906|NCT02796677|11895787|FG000|STARTED|Overall Study||317
10731907|NCT02796677|11895788|FG001|STARTED|Overall Study||478
10731908|NCT02796677|11895789|FG002|STARTED|Overall Study||320
10731909|NCT02796677|11895790|FG003|STARTED|Overall Study||479
10731910|NCT02796677|11895787|FG000|Completed Treatment and Follow-up|Overall Study||279
10731911|NCT02796677|11895788|FG001|Completed Treatment and Follow-up|Overall Study||405
10731912|NCT02796677|11895789|FG002|Completed Treatment and Follow-up|Overall Study||267
10731913|NCT02796677|11895790|FG003|Completed Treatment and Follow-up|Overall Study||403
10731914|NCT02796677|11895787|FG000|COMPLETED|Overall Study||279
10731915|NCT02796677|11895788|FG001|COMPLETED|Overall Study||405
10815016|NCT02091752|11977971|FG000|NOT COMPLETED|Overall Study||3
10815017|NCT02068547|11977977|FG000|STARTED|Overall Study||4
10815018|NCT02068547|11977978|FG001|STARTED|Overall Study||4
10815019|NCT02068547|11977977|FG000|COMPLETED|Overall Study||0
10815020|NCT02068547|11977978|FG001|COMPLETED|Overall Study||1
10815021|NCT02068547|11977977|FG000|NOT COMPLETED|Overall Study||4
10731916|NCT02796677|11895789|FG002|COMPLETED|Overall Study||267
10731917|NCT02796677|11895790|FG003|COMPLETED|Overall Study||405
10815022|NCT02068547|11977978|FG001|NOT COMPLETED|Overall Study||3
10815023|NCT02075411|11977988|FG000|STARTED|Overall Study||0
10815024|NCT02075411|11977989|FG001|STARTED|Overall Study||0
10815025|NCT02075411|11977990|FG002|STARTED|Overall Study||0
10815026|NCT02075411|11977991|FG003|STARTED|Overall Study||1
10815027|NCT02075411|11977988|FG000|COMPLETED|Overall Study||0
10731918|NCT02796677|11895787|FG000|NOT COMPLETED|Overall Study||38
10731919|NCT02796677|11895788|FG001|NOT COMPLETED|Overall Study||73
10731920|NCT02796677|11895789|FG002|NOT COMPLETED|Overall Study||53
10731921|NCT02796677|11895790|FG003|NOT COMPLETED|Overall Study||74
10731922|NCT02796755|11895804|FG000|STARTED|Overall Study||15
10731923|NCT02796755|11895805|FG001|STARTED|Overall Study||15
10731924|NCT02796755|11895804|FG000|COMPLETED|Overall Study||13
10731925|NCT02796755|11895805|FG001|COMPLETED|Overall Study||15
10731926|NCT02796755|11895804|FG000|NOT COMPLETED|Overall Study||2
10731927|NCT02796755|11895805|FG001|NOT COMPLETED|Overall Study||0
10731928|NCT02796924|11895811|FG000|STARTED|Overall Study||10
10731929|NCT02796924|11895811|FG000|COMPLETED|Overall Study||10
10731930|NCT02796924|11895811|FG000|NOT COMPLETED|Overall Study||0
10731931|NCT02796963|11895819|FG000|STARTED|Overall Study||383
10815028|NCT02075411|11977989|FG001|COMPLETED|Overall Study||0
10815029|NCT02075411|11977990|FG002|COMPLETED|Overall Study||0
10815030|NCT02075411|11977991|FG003|COMPLETED|Overall Study||1
10815031|NCT02075411|11977988|FG000|NOT COMPLETED|Overall Study||0
10815032|NCT02075411|11977989|FG001|NOT COMPLETED|Overall Study||0
10815033|NCT02075411|11977990|FG002|NOT COMPLETED|Overall Study||0
10815034|NCT02075411|11977991|FG003|NOT COMPLETED|Overall Study||0
10815035|NCT02074904|11978003|FG000|STARTED|Overall Study||1
10815036|NCT02074904|11978004|FG001|STARTED|Overall Study||0
10815037|NCT02074904|11978003|FG000|COMPLETED|Overall Study||1
10815038|NCT02074904|11978004|FG001|COMPLETED|Overall Study||0
10815039|NCT02074904|11978003|FG000|NOT COMPLETED|Overall Study||0
10815040|NCT02074904|11978004|FG001|NOT COMPLETED|Overall Study||0
10815041|NCT02084147|11978010|FG000|STARTED|Overall Study||72
10815042|NCT02084147|11978010|FG000|COMPLETED|Overall Study||72
10815043|NCT02084147|11978010|FG000|NOT COMPLETED|Overall Study||0
10815044|NCT02081183|11978016|FG000|STARTED|Overall Study||5
10815045|NCT02081183|11978017|FG001|STARTED|Overall Study||6
10815046|NCT02081183|11978016|FG000|COMPLETED|Overall Study||1
10815047|NCT02081183|11978017|FG001|COMPLETED|Overall Study||2
10815048|NCT02081183|11978016|FG000|NOT COMPLETED|Overall Study||4
10815049|NCT02081183|11978017|FG001|NOT COMPLETED|Overall Study||4
10815050|NCT02067611|11978023|FG000|STARTED|Overall Study||72
10815051|NCT02067611|11978024|FG001|STARTED|Overall Study||72
10815052|NCT02067611|11978025|FG002|STARTED|Overall Study||72
10815053|NCT02067611|11978023|FG000|COMPLETED|Overall Study||66
10815054|NCT02067611|11978024|FG001|COMPLETED|Overall Study||66
10815055|NCT02067611|11978025|FG002|COMPLETED|Overall Study||68
10815056|NCT02067611|11978023|FG000|NOT COMPLETED|Overall Study||6
10815057|NCT02067611|11978024|FG001|NOT COMPLETED|Overall Study||6
10815058|NCT02067611|11978025|FG002|NOT COMPLETED|Overall Study||4
10815059|NCT02067104|11978037|FG000|STARTED|Overall Study||4
10815060|NCT02067104|11978038|FG001|STARTED|Overall Study||5
10815061|NCT02067104|11978037|FG000|COMPLETED|Overall Study||0
10815062|NCT02067104|11978038|FG001|COMPLETED|Overall Study||0
10815063|NCT02067104|11978037|FG000|NOT COMPLETED|Overall Study||4
10815064|NCT02067104|11978038|FG001|NOT COMPLETED|Overall Study||5
10815065|NCT02075021|11978044|FG000|STARTED|Overall Study||3
10815066|NCT02075021|11978044|FG000|COMPLETED|Overall Study||3
10815067|NCT02075021|11978044|FG000|NOT COMPLETED|Overall Study||0
10815068|NCT02057874|11978048|FG000|STARTED|Overall Study||2
10815069|NCT02057874|11978048|FG000|COMPLETED|Overall Study||1
10815070|NCT02057874|11978048|FG000|NOT COMPLETED|Overall Study||1
10815071|NCT02057237|11978053|FG000|STARTED|Overall Study||1
10815072|NCT02057237|11978053|FG000|COMPLETED|Overall Study||1
10815073|NCT02057237|11978053|FG000|NOT COMPLETED|Overall Study||0
10815074|NCT02047747|11978058|FG000|STARTED|Overall Study||4
10815075|NCT02047747|11978058|FG000|COMPLETED|Overall Study||1
10815076|NCT02047747|11978058|FG000|NOT COMPLETED|Overall Study||3
10815077|NCT02058537|11978062|FG000|STARTED|Overall Study||3
10815078|NCT02058537|11978062|FG000|COMPLETED|Overall Study||2
10815079|NCT02058537|11978062|FG000|NOT COMPLETED|Overall Study||1
10815080|NCT02057276|11978068|FG000|STARTED|Overall Study||0
10815081|NCT02057276|11978069|FG001|STARTED|Overall Study||0
10815082|NCT02057276|11978068|FG000|COMPLETED|Overall Study||0
10815083|NCT02057276|11978069|FG001|COMPLETED|Overall Study||0
10815084|NCT02057276|11978068|FG000|NOT COMPLETED|Overall Study||0
10815085|NCT02057276|11978069|FG001|NOT COMPLETED|Overall Study||0
10815086|NCT02038153|11978075|FG000|STARTED|Overall Study||3
10815087|NCT02038153|11978075|FG000|COMPLETED|Overall Study||2
10815088|NCT02038153|11978075|FG000|NOT COMPLETED|Overall Study||1
10815089|NCT02054910|11978081|FG000|STARTED|Overall Study||4
10815090|NCT02054910|11978082|FG001|STARTED|Overall Study||1
10815091|NCT02054910|11978081|FG000|COMPLETED|Overall Study||0
10815092|NCT02054910|11978082|FG001|COMPLETED|Overall Study||0
10815093|NCT02054910|11978081|FG000|NOT COMPLETED|Overall Study||4
10815094|NCT02054910|11978082|FG001|NOT COMPLETED|Overall Study||1
10815095|NCT02044302|11978092|FG000|STARTED|Overall Study||2
10815096|NCT02044302|11978093|FG001|STARTED|Overall Study||0
10815097|NCT02044302|11978092|FG000|COMPLETED|Overall Study||0
10815098|NCT02044302|11978093|FG001|COMPLETED|Overall Study||0
10815099|NCT02044302|11978092|FG000|NOT COMPLETED|Overall Study||2
10731932|NCT02796963|11895820|FG001|STARTED|Overall Study||328
10731933|NCT02796963|11895821|FG002|STARTED|Overall Study||316
10815100|NCT02044302|11978093|FG001|NOT COMPLETED|Overall Study||0
10815101|NCT02046226|11978097|FG000|STARTED|Overall Study||7
10815102|NCT02046226|11978097|FG000|COMPLETED|Overall Study||0
10815103|NCT02046226|11978097|FG000|NOT COMPLETED|Overall Study||7
10815104|NCT02044848|11978104|FG000|STARTED|Overall Study||2
10731934|NCT02796963|11895822|FG003|STARTED|Overall Study||354
10731935|NCT02796963|11895819|FG000|First Follow up|Overall Study||293
10731936|NCT02796963|11895820|FG001|First Follow up|Overall Study||279
10731937|NCT02796963|11895821|FG002|First Follow up|Overall Study||257
10731938|NCT02796963|11895822|FG003|First Follow up|Overall Study||291
10731939|NCT02796963|11895819|FG000|Second Follow up|Overall Study||280
10731940|NCT02796963|11895820|FG001|Second Follow up|Overall Study||260
10731941|NCT02796963|11895821|FG002|Second Follow up|Overall Study||255
10815105|NCT02044848|11978105|FG001|STARTED|Overall Study||3
10815106|NCT02044848|11978104|FG000|COMPLETED|Overall Study||0
10815107|NCT02044848|11978105|FG001|COMPLETED|Overall Study||0
10815108|NCT02044848|11978104|FG000|NOT COMPLETED|Overall Study||2
10815109|NCT02044848|11978105|FG001|NOT COMPLETED|Overall Study||3
10731942|NCT02796963|11895822|FG003|Second Follow up|Overall Study||293
10731943|NCT02796963|11895819|FG000|Third Follow up|Overall Study||276
10731944|NCT02796963|11895820|FG001|Third Follow up|Overall Study||237
10731945|NCT02796963|11895821|FG002|Third Follow up|Overall Study||245
10731946|NCT02796963|11895822|FG003|Third Follow up|Overall Study||286
10731947|NCT02796963|11895819|FG000|Fourth Follow up|Overall Study||275
10731948|NCT02796963|11895820|FG001|Fourth Follow up|Overall Study||233
10731949|NCT02796963|11895821|FG002|Fourth Follow up|Overall Study||236
10731950|NCT02796963|11895822|FG003|Fourth Follow up|Overall Study||263
10731951|NCT02796963|11895819|FG000|HIV Sero Converted|Overall Study||19
10731952|NCT02796963|11895820|FG001|HIV Sero Converted|Overall Study||19
10731953|NCT02796963|11895821|FG002|HIV Sero Converted|Overall Study||11
10731954|NCT02796963|11895822|FG003|HIV Sero Converted|Overall Study||19
10731955|NCT02796963|11895819|FG000|COMPLETED|Overall Study||294
10731956|NCT02796963|11895820|FG001|COMPLETED|Overall Study||252
10731957|NCT02796963|11895821|FG002|COMPLETED|Overall Study||247
10731958|NCT02796963|11895822|FG003|COMPLETED|Overall Study||282
10731959|NCT02796963|11895819|FG000|NOT COMPLETED|Overall Study||89
10731960|NCT02796963|11895820|FG001|NOT COMPLETED|Overall Study||76
10731961|NCT02796963|11895821|FG002|NOT COMPLETED|Overall Study||69
10731962|NCT02796963|11895822|FG003|NOT COMPLETED|Overall Study||72
10731963|NCT02797054|11895835|FG000|STARTED|Post-test||387
10731964|NCT02797054|11895836|FG001|STARTED|Post-test||383
10731965|NCT02797054|11895837|FG002|STARTED|Post-test||435
10731966|NCT02797054|11895835|FG000|COMPLETED|Post-test||380
10731967|NCT02797054|11895836|FG001|COMPLETED|Post-test||372
10731968|NCT02797054|11895837|FG002|COMPLETED|Post-test||87
10731969|NCT02797054|11895835|FG000|NOT COMPLETED|Post-test||7
10731970|NCT02797054|11895836|FG001|NOT COMPLETED|Post-test||11
10731971|NCT02797054|11895837|FG002|NOT COMPLETED|Post-test||348
10731972|NCT02797054|11895835|FG000|STARTED|Follow-up||387
10731973|NCT02797054|11895836|FG001|STARTED|Follow-up||383
10731974|NCT02797054|11895837|FG002|STARTED|Follow-up||435
10731975|NCT02797054|11895835|FG000|COMPLETED|Follow-up||178
10731976|NCT02797054|11895836|FG001|COMPLETED|Follow-up||155
10731977|NCT02797054|11895837|FG002|COMPLETED|Follow-up||150
10731978|NCT02797054|11895835|FG000|NOT COMPLETED|Follow-up||209
10731979|NCT02797054|11895836|FG001|NOT COMPLETED|Follow-up||228
10731980|NCT02797054|11895837|FG002|NOT COMPLETED|Follow-up||285
10731981|NCT02797080|11895845|FG000|STARTED|Overall Study||38
10731982|NCT02797080|11895845|FG000|COMPLETED|Overall Study||36
10731983|NCT02797080|11895845|FG000|NOT COMPLETED|Overall Study||2
10731984|NCT02797132|11895849|FG000|STARTED|Part A (15 Days)||12
10731985|NCT02797132|11895849|FG000|Part A (<14 kg Weight)|Part A (15 Days)||4
10731986|NCT02797132|11895849|FG000|Part A (>=14 kg Weight)|Part A (15 Days)||8
10731987|NCT02797132|11895849|FG000|COMPLETED|Part A (15 Days)||11
10731988|NCT02797132|11895849|FG000|NOT COMPLETED|Part A (15 Days)||1
10731989|NCT02797132|11895849|FG000|STARTED|Part B (24 Weeks)|Participants from Part A may have participated in Part B.|60
10731990|NCT02797132|11895849|FG000|Part B (<14 kg Weight)|Part B (24 Weeks)||19
10731991|NCT02797132|11895849|FG000|Part B (>=14 kg Weight)|Part B (24 Weeks)||41
10731992|NCT02797132|11895849|FG000|COMPLETED|Part B (24 Weeks)||57
10731993|NCT02797132|11895849|FG000|NOT COMPLETED|Part B (24 Weeks)||3
10731994|NCT02797171|11895868|FG000|STARTED|Overall Study||23
10731995|NCT02797171|11895869|FG001|STARTED|Overall Study||23
10731996|NCT02797171|11895870|FG002|STARTED|Overall Study||7
10731997|NCT02797171|11895871|FG003|STARTED|Overall Study||16
10731998|NCT02797171|11895872|FG004|STARTED|Overall Study||10
10731999|NCT02797171|11895873|FG005|STARTED|Overall Study||1
10732000|NCT02797171|11895868|FG000|Safety Population|Overall Study||23
10732001|NCT02797171|11895869|FG001|Safety Population|Overall Study||23
10732002|NCT02797171|11895870|FG002|Safety Population|Overall Study||7
10732003|NCT02797171|11895871|FG003|Safety Population|Overall Study||16
10732004|NCT02797171|11895872|FG004|Safety Population|Overall Study||10
10732005|NCT02797171|11895873|FG005|Safety Population|Overall Study||1
10732006|NCT02797171|11895868|FG000|COMPLETED|Overall Study||19
10732007|NCT02797171|11895869|FG001|COMPLETED|Overall Study||21
10732008|NCT02797171|11895870|FG002|COMPLETED|Overall Study||5
10732009|NCT02797171|11895871|FG003|COMPLETED|Overall Study||15
10732010|NCT02797171|11895872|FG004|COMPLETED|Overall Study||8
10732011|NCT02797171|11895873|FG005|COMPLETED|Overall Study||0
10732012|NCT02797171|11895868|FG000|NOT COMPLETED|Overall Study||4
10732013|NCT02797171|11895869|FG001|NOT COMPLETED|Overall Study||2
10732014|NCT02797171|11895870|FG002|NOT COMPLETED|Overall Study||2
10732015|NCT02797171|11895871|FG003|NOT COMPLETED|Overall Study||1
10732016|NCT02797171|11895872|FG004|NOT COMPLETED|Overall Study||2
10732017|NCT02797171|11895873|FG005|NOT COMPLETED|Overall Study||1
10732018|NCT02797522|11895898|FG000|STARTED|Overall Study||4
10732019|NCT02797522|11895899|FG001|STARTED|Overall Study||4
10732020|NCT02797522|11895900|FG002|STARTED|Overall Study||4
10732021|NCT02797522|11895901|FG003|STARTED|Overall Study||4
10732022|NCT02797522|11895902|FG004|STARTED|Overall Study||4
10732023|NCT02797522|11895903|FG005|STARTED|Overall Study||4
10732024|NCT02797522|11895904|FG006|STARTED|Overall Study||12
10732025|NCT02797522|11895905|FG007|STARTED|Overall Study||4
10732026|NCT02797522|11895906|FG008|STARTED|Overall Study||2
10732027|NCT02797522|11895907|FG009|STARTED|Overall Study||4
10732028|NCT02797522|11895908|FG010|STARTED|Overall Study||1
10732029|NCT02797522|11895898|FG000|COMPLETED|Overall Study||4
10732030|NCT02797522|11895899|FG001|COMPLETED|Overall Study||4
10732031|NCT02797522|11895900|FG002|COMPLETED|Overall Study||4
10732032|NCT02797522|11895901|FG003|COMPLETED|Overall Study||4
10732033|NCT02797522|11895902|FG004|COMPLETED|Overall Study||4
10732034|NCT02797522|11895903|FG005|COMPLETED|Overall Study||4
10732035|NCT02797522|11895904|FG006|COMPLETED|Overall Study||12
10732036|NCT02797522|11895905|FG007|COMPLETED|Overall Study||0
10732037|NCT02797522|11895906|FG008|COMPLETED|Overall Study||0
10732038|NCT02797522|11895907|FG009|COMPLETED|Overall Study||0
10732039|NCT02797522|11895908|FG010|COMPLETED|Overall Study||0
10732040|NCT02797522|11895898|FG000|NOT COMPLETED|Overall Study||0
10732041|NCT02797522|11895899|FG001|NOT COMPLETED|Overall Study||0
10732042|NCT02797522|11895900|FG002|NOT COMPLETED|Overall Study||0
10732043|NCT02797522|11895901|FG003|NOT COMPLETED|Overall Study||0
10732044|NCT02797522|11895902|FG004|NOT COMPLETED|Overall Study||0
10732045|NCT02797522|11895903|FG005|NOT COMPLETED|Overall Study||0
10732046|NCT02797522|11895904|FG006|NOT COMPLETED|Overall Study||0
10732047|NCT02797522|11895905|FG007|NOT COMPLETED|Overall Study||4
10732048|NCT02797522|11895906|FG008|NOT COMPLETED|Overall Study||2
10732049|NCT02797522|11895907|FG009|NOT COMPLETED|Overall Study||4
10732050|NCT02797522|11895908|FG010|NOT COMPLETED|Overall Study||1
10732051|NCT02797613|11895938|FG000|STARTED|Overall Study||55
10732052|NCT02797613|11895939|FG001|STARTED|Overall Study||55
10732053|NCT02797613|11895938|FG000|COMPLETED|Overall Study||55
10732054|NCT02797613|11895939|FG001|COMPLETED|Overall Study||55
10732055|NCT02797613|11895938|FG000|NOT COMPLETED|Overall Study||0
10732056|NCT02797613|11895939|FG001|NOT COMPLETED|Overall Study||0
10732057|NCT02797678|11895945|FG000|STARTED|Screening Phase||62
10732058|NCT02797678|11895946|FG001|STARTED|Screening Phase||0
10732059|NCT02797678|11895947|FG002|STARTED|Screening Phase||0
10732060|NCT02797678|11895948|FG003|STARTED|Screening Phase||0
10732061|NCT02797678|11895945|FG000|COMPLETED|Screening Phase||37
10732062|NCT02797678|11895946|FG001|COMPLETED|Screening Phase||0
10732063|NCT02797678|11895947|FG002|COMPLETED|Screening Phase||0
10732064|NCT02797678|11895948|FG003|COMPLETED|Screening Phase||0
10732065|NCT02797678|11895945|FG000|NOT COMPLETED|Screening Phase||25
10732066|NCT02797678|11895946|FG001|NOT COMPLETED|Screening Phase||0
10732067|NCT02797678|11895947|FG002|NOT COMPLETED|Screening Phase||0
10732068|NCT02797678|11895948|FG003|NOT COMPLETED|Screening Phase||0
10732069|NCT02797678|11895945|FG000|STARTED|First Intervention (5 Nights)||0
10732070|NCT02797678|11895946|FG001|STARTED|First Intervention (5 Nights)||20
10732071|NCT02797678|11895947|FG002|STARTED|First Intervention (5 Nights)||17
10732072|NCT02797678|11895948|FG003|STARTED|First Intervention (5 Nights)||0
10732073|NCT02797678|11895945|FG000|COMPLETED|First Intervention (5 Nights)||0
10732074|NCT02797678|11895946|FG001|COMPLETED|First Intervention (5 Nights)||19
10732075|NCT02797678|11895947|FG002|COMPLETED|First Intervention (5 Nights)||17
10732076|NCT02797678|11895948|FG003|COMPLETED|First Intervention (5 Nights)||0
10732077|NCT02797678|11895945|FG000|NOT COMPLETED|First Intervention (5 Nights)||0
10732078|NCT02797678|11895946|FG001|NOT COMPLETED|First Intervention (5 Nights)||1
10732079|NCT02797678|11895947|FG002|NOT COMPLETED|First Intervention (5 Nights)||0
10732080|NCT02797678|11895948|FG003|NOT COMPLETED|First Intervention (5 Nights)||0
10732081|NCT02797678|11895945|FG000|STARTED|Washout||0
10732082|NCT02797678|11895946|FG001|STARTED|Washout||19
10732083|NCT02797678|11895947|FG002|STARTED|Washout||17
10732084|NCT02797678|11895948|FG003|STARTED|Washout||0
10732085|NCT02797678|11895945|FG000|COMPLETED|Washout||0
10732086|NCT02797678|11895946|FG001|COMPLETED|Washout||19
10732087|NCT02797678|11895947|FG002|COMPLETED|Washout||17
10732088|NCT02797678|11895948|FG003|COMPLETED|Washout||0
10732089|NCT02797678|11895945|FG000|NOT COMPLETED|Washout||0
10732090|NCT02797678|11895946|FG001|NOT COMPLETED|Washout||0
10732091|NCT02797678|11895947|FG002|NOT COMPLETED|Washout||0
10732092|NCT02797678|11895948|FG003|NOT COMPLETED|Washout||0
10732093|NCT02797678|11895945|FG000|STARTED|Second Intervention (5 Nights)||0
10732094|NCT02797678|11895946|FG001|STARTED|Second Intervention (5 Nights)||19
10732095|NCT02797678|11895947|FG002|STARTED|Second Intervention (5 Nights)||17
10732096|NCT02797678|11895948|FG003|STARTED|Second Intervention (5 Nights)||0
10732097|NCT02797678|11895945|FG000|COMPLETED|Second Intervention (5 Nights)||0
10732098|NCT02797678|11895946|FG001|COMPLETED|Second Intervention (5 Nights)||19
10732099|NCT02797678|11895947|FG002|COMPLETED|Second Intervention (5 Nights)||16
10732100|NCT02797678|11895948|FG003|COMPLETED|Second Intervention (5 Nights)||0
10732101|NCT02797678|11895945|FG000|NOT COMPLETED|Second Intervention (5 Nights)||0
10732102|NCT02797678|11895946|FG001|NOT COMPLETED|Second Intervention (5 Nights)||0
10732103|NCT02797678|11895947|FG002|NOT COMPLETED|Second Intervention (5 Nights)||1
10732104|NCT02797678|11895948|FG003|NOT COMPLETED|Second Intervention (5 Nights)||0
10732105|NCT02797678|11895945|FG000|STARTED|Sub-Study||0
10732106|NCT02797678|11895946|FG001|STARTED|Sub-Study||0
10732107|NCT02797678|11895947|FG002|STARTED|Sub-Study||0
10732108|NCT02797678|11895948|FG003|STARTED|Sub-Study||9
10732109|NCT02797678|11895945|FG000|COMPLETED|Sub-Study||0
10732110|NCT02797678|11895946|FG001|COMPLETED|Sub-Study||0
10732111|NCT02797678|11895947|FG002|COMPLETED|Sub-Study||0
10732112|NCT02797678|11895948|FG003|COMPLETED|Sub-Study||9
10732113|NCT02797678|11895945|FG000|NOT COMPLETED|Sub-Study||0
10732114|NCT02797678|11895946|FG001|NOT COMPLETED|Sub-Study||0
10732115|NCT02797678|11895947|FG002|NOT COMPLETED|Sub-Study||0
10732116|NCT02797678|11895948|FG003|NOT COMPLETED|Sub-Study||0
10732117|NCT02797808|11895963|FG000|STARTED|Overall Study||23
10732118|NCT02797808|11895964|FG001|STARTED|Overall Study||18
10732119|NCT02797808|11895963|FG000|COMPLETED|Overall Study||16
10732120|NCT02797808|11895964|FG001|COMPLETED|Overall Study||15
10732121|NCT02797808|11895963|FG000|NOT COMPLETED|Overall Study||7
10732122|NCT02797808|11895964|FG001|NOT COMPLETED|Overall Study||3
10732123|NCT02797821|11895973|FG000|STARTED|Overall Study||8
10732124|NCT02797821|11895974|FG001|STARTED|Overall Study||10
10732125|NCT02797821|11895975|FG002|STARTED|Overall Study||9
10732274|NCT02798978|11896071|FG000|COMPLETED|Part 2 (45 Days)||0
10732126|NCT02797821|11895973|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
10732127|NCT02797821|11895974|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
10732128|NCT02797821|11895975|FG002|Received at Least 1 Dose of Study Drug|Overall Study||9
10732129|NCT02797821|11895973|FG000|COMPLETED|Overall Study||8
10732130|NCT02797821|11895974|FG001|COMPLETED|Overall Study||10
10732131|NCT02797821|11895975|FG002|COMPLETED|Overall Study||9
10732132|NCT02797821|11895973|FG000|NOT COMPLETED|Overall Study||0
10732133|NCT02797821|11895974|FG001|NOT COMPLETED|Overall Study||0
10732134|NCT02797821|11895975|FG002|NOT COMPLETED|Overall Study||0
10732135|NCT02798211|11895986|FG000|STARTED|Period 1||103
10732136|NCT02798211|11895987|FG001|STARTED|Period 1||103
10732137|NCT02798211|11895988|FG002|STARTED|Period 1||52
10732138|NCT02798211|11895989|FG003|STARTED|Period 1||0
10732139|NCT02798211|11895990|FG004|STARTED|Period 1||0
10732140|NCT02798211|11895991|FG005|STARTED|Period 1||0
10732141|NCT02798211|11895986|FG000|COMPLETED|Period 1||97
10732142|NCT02798211|11895987|FG001|COMPLETED|Period 1||93
10732143|NCT02798211|11895988|FG002|COMPLETED|Period 1||46
10732144|NCT02798211|11895989|FG003|COMPLETED|Period 1||0
10732145|NCT02798211|11895990|FG004|COMPLETED|Period 1||0
10732146|NCT02798211|11895991|FG005|COMPLETED|Period 1||0
10732147|NCT02798211|11895986|FG000|NOT COMPLETED|Period 1||6
10732148|NCT02798211|11895987|FG001|NOT COMPLETED|Period 1||10
10732149|NCT02798211|11895988|FG002|NOT COMPLETED|Period 1||6
10732150|NCT02798211|11895989|FG003|NOT COMPLETED|Period 1||0
10732151|NCT02798211|11895990|FG004|NOT COMPLETED|Period 1||0
10732152|NCT02798211|11895991|FG005|NOT COMPLETED|Period 1||0
10732153|NCT02798211|11895986|FG000|STARTED|Period 2||97
10732154|NCT02798211|11895987|FG001|STARTED|Period 2||0
10732155|NCT02798211|11895988|FG002|STARTED|Period 2||0
10732156|NCT02798211|11895989|FG003|STARTED|Period 2||50
10732157|NCT02798211|11895990|FG004|STARTED|Period 2||42
10732158|NCT02798211|11895991|FG005|STARTED|Period 2||46
10732159|NCT02798211|11895986|FG000|COMPLETED|Period 2||83
10732160|NCT02798211|11895987|FG001|COMPLETED|Period 2||0
10732161|NCT02798211|11895988|FG002|COMPLETED|Period 2||0
10732162|NCT02798211|11895989|FG003|COMPLETED|Period 2||43
10732163|NCT02798211|11895990|FG004|COMPLETED|Period 2||34
10732164|NCT02798211|11895991|FG005|COMPLETED|Period 2||40
10732165|NCT02798211|11895986|FG000|NOT COMPLETED|Period 2||14
10732166|NCT02798211|11895987|FG001|NOT COMPLETED|Period 2||0
10732167|NCT02798211|11895988|FG002|NOT COMPLETED|Period 2||0
10732168|NCT02798211|11895989|FG003|NOT COMPLETED|Period 2||7
10732169|NCT02798211|11895990|FG004|NOT COMPLETED|Period 2||8
10732170|NCT02798211|11895991|FG005|NOT COMPLETED|Period 2||6
10732171|NCT02798289|11896003|FG000|STARTED|Overall Study||55
10732172|NCT02798289|11896003|FG000|COMPLETED|Overall Study||55
10732173|NCT02798289|11896003|FG000|NOT COMPLETED|Overall Study||0
10732174|NCT02798315|11896007|FG000|STARTED|Overall Study||40
10732175|NCT02798315|11896007|FG000|COMPLETED|Overall Study||39
10732176|NCT02798315|11896007|FG000|NOT COMPLETED|Overall Study||1
10732177|NCT02798354|11896014|FG000|STARTED|First Intervention Period||1184
10732178|NCT02798354|11896015|FG001|STARTED|First Intervention Period||2176
10732179|NCT02798354|11896016|FG002|STARTED|First Intervention Period||990
10732180|NCT02798354|11896014|FG000|Control Data Error 1|First Intervention Period||440
10732181|NCT02798354|11896015|FG001|Control Data Error 1|First Intervention Period||549
10732182|NCT02798354|11896016|FG002|Control Data Error 1|First Intervention Period||345
10732183|NCT02798354|11896014|FG000|Intervention Data Error 1|First Intervention Period||744
10732184|NCT02798354|11896015|FG001|Intervention Data Error 1|First Intervention Period||1627
10732185|NCT02798354|11896016|FG002|Intervention Data Error 1|First Intervention Period||645
10732186|NCT02798354|11896014|FG000|COMPLETED|First Intervention Period||1184
10732187|NCT02798354|11896015|FG001|COMPLETED|First Intervention Period||2176
10732188|NCT02798354|11896016|FG002|COMPLETED|First Intervention Period||990
10732189|NCT02798354|11896014|FG000|NOT COMPLETED|First Intervention Period||0
10732190|NCT02798354|11896015|FG001|NOT COMPLETED|First Intervention Period||0
10732191|NCT02798354|11896016|FG002|NOT COMPLETED|First Intervention Period||0
10732192|NCT02798354|11896014|FG000|STARTED|Second Intervention Period||2617
10732193|NCT02798354|11896015|FG001|STARTED|Second Intervention Period||1047
10732194|NCT02798354|11896016|FG002|STARTED|Second Intervention Period||1368
10732195|NCT02798354|11896014|FG000|Control Data Error 2|Second Intervention Period||1378
10732196|NCT02798354|11896015|FG001|Control Data Error 2|Second Intervention Period||593
10732197|NCT02798354|11896016|FG002|Control Data Error 2|Second Intervention Period||668
10732198|NCT02798354|11896014|FG000|Intervention Data Error 2|Second Intervention Period||1239
10732199|NCT02798354|11896015|FG001|Intervention Data Error 2|Second Intervention Period||454
10732200|NCT02798354|11896016|FG002|Intervention Data Error 2|Second Intervention Period||700
10732201|NCT02798354|11896014|FG000|COMPLETED|Second Intervention Period||2617
10732202|NCT02798354|11896015|FG001|COMPLETED|Second Intervention Period||1047
10732203|NCT02798354|11896016|FG002|COMPLETED|Second Intervention Period||1368
10732204|NCT02798354|11896014|FG000|NOT COMPLETED|Second Intervention Period||0
10732205|NCT02798354|11896015|FG001|NOT COMPLETED|Second Intervention Period||0
10732206|NCT02798354|11896016|FG002|NOT COMPLETED|Second Intervention Period||0
10732207|NCT02798354|11896014|FG000|STARTED|Third Intervention Period||746
10732208|NCT02798354|11896015|FG001|STARTED|Third Intervention Period||1010
10732209|NCT02798354|11896016|FG002|STARTED|Third Intervention Period||2715
10732210|NCT02798354|11896014|FG000|Control Data Error 3|Third Intervention Period||419
10732211|NCT02798354|11896015|FG001|Control Data Error 3|Third Intervention Period||620
10732212|NCT02798354|11896016|FG002|Control Data Error 3|Third Intervention Period||1467
10732213|NCT02798354|11896014|FG000|Intervention Data Error 3|Third Intervention Period||327
10732214|NCT02798354|11896015|FG001|Intervention Data Error 3|Third Intervention Period||390
10732215|NCT02798354|11896016|FG002|Intervention Data Error 3|Third Intervention Period||1248
10732216|NCT02798354|11896014|FG000|COMPLETED|Third Intervention Period||746
10732217|NCT02798354|11896015|FG001|COMPLETED|Third Intervention Period||1010
10732218|NCT02798354|11896016|FG002|COMPLETED|Third Intervention Period||2715
10732219|NCT02798354|11896014|FG000|NOT COMPLETED|Third Intervention Period||0
10732220|NCT02798354|11896015|FG001|NOT COMPLETED|Third Intervention Period||0
10732221|NCT02798354|11896016|FG002|NOT COMPLETED|Third Intervention Period||0
10732222|NCT02798380|11896030|FG000|STARTED|Overall Study||30
10732223|NCT02798380|11896030|FG000|COMPLETED|Overall Study||30
10732224|NCT02798380|11896030|FG000|NOT COMPLETED|Overall Study||0
10732225|NCT02798627|11896036|FG000|STARTED|Overall Study||27
10732226|NCT02798627|11896037|FG001|STARTED|Overall Study||28
10732227|NCT02798627|11896036|FG000|COMPLETED|Overall Study||27
10732228|NCT02798627|11896037|FG001|COMPLETED|Overall Study||28
10732229|NCT02798627|11896036|FG000|NOT COMPLETED|Overall Study||0
10732230|NCT02798627|11896037|FG001|NOT COMPLETED|Overall Study||0
10777866|NCT03345394|11939743|FG000|NOT COMPLETED|Overall Study||0
10777867|NCT03345394|11939744|FG001|NOT COMPLETED|Overall Study||0
10777868|NCT03345407|11939757|FG000|STARTED|Overall Study||276
10777869|NCT03345407|11939758|FG001|STARTED|Overall Study||22
10777870|NCT03345407|11939759|FG002|STARTED|Overall Study||91
10777871|NCT03345407|11939760|FG003|STARTED|Overall Study||92
10777872|NCT03345407|11939761|FG004|STARTED|Overall Study||90
10777873|NCT03345407|11939762|FG005|STARTED|Overall Study||89
10777874|NCT03345407|11939763|FG006|STARTED|Overall Study||278
10777875|NCT03345407|11939757|FG000|COMPLETED|Overall Study||244
10777876|NCT03345407|11939758|FG001|COMPLETED|Overall Study||19
10777877|NCT03345407|11939759|FG002|COMPLETED|Overall Study||79
10777878|NCT03345407|11939760|FG003|COMPLETED|Overall Study||81
10777879|NCT03345407|11939761|FG004|COMPLETED|Overall Study||75
10777880|NCT03345407|11939762|FG005|COMPLETED|Overall Study||73
10777881|NCT03345407|11939763|FG006|COMPLETED|Overall Study||233
10777882|NCT03345407|11939757|FG000|NOT COMPLETED|Overall Study||32
10777883|NCT03345407|11939758|FG001|NOT COMPLETED|Overall Study||3
10777884|NCT03345407|11939759|FG002|NOT COMPLETED|Overall Study||12
10777885|NCT03345407|11939760|FG003|NOT COMPLETED|Overall Study||11
10777886|NCT03345407|11939761|FG004|NOT COMPLETED|Overall Study||15
10777887|NCT03345407|11939762|FG005|NOT COMPLETED|Overall Study||16
10777888|NCT03345407|11939763|FG006|NOT COMPLETED|Overall Study||45
10777889|NCT03345472|11939785|FG000|STARTED|Implant to 3 Months||103
10777890|NCT03345472|11939785|FG000|COMPLETED|Implant to 3 Months||99
10777891|NCT03345472|11939785|FG000|NOT COMPLETED|Implant to 3 Months||4
10777892|NCT03345472|11939785|FG000|STARTED|3 Months to 12 Months||99
10815110|NCT02042950|11978111|FG000|STARTED|Overall Study||4
10815111|NCT02042950|11978111|FG000|COMPLETED|Overall Study||0
10815112|NCT02042950|11978111|FG000|NOT COMPLETED|Overall Study||4
10777893|NCT03345472|11939785|FG000|COMPLETED|3 Months to 12 Months||91
10732231|NCT02798835|11896046|FG000|STARTED|Overall Study||60
10732232|NCT02798835|11896047|FG001|STARTED|Overall Study||60
10732233|NCT02798835|11896048|FG002|STARTED|Overall Study||60
10732234|NCT02798835|11896046|FG000|COMPLETED|Overall Study||60
10732235|NCT02798835|11896047|FG001|COMPLETED|Overall Study||60
10732236|NCT02798835|11896048|FG002|COMPLETED|Overall Study||57
10732237|NCT02798835|11896046|FG000|NOT COMPLETED|Overall Study||0
10732238|NCT02798835|11896047|FG001|NOT COMPLETED|Overall Study||0
10732239|NCT02798835|11896048|FG002|NOT COMPLETED|Overall Study||3
10732240|NCT02798861|11896056|FG000|STARTED|Overall Study||160
10732241|NCT02798861|11896056|FG000|COMPLETED|Overall Study||137
10732242|NCT02798861|11896056|FG000|NOT COMPLETED|Overall Study||23
10732243|NCT02798952|11896060|FG000|STARTED|Overall Study||302
10732244|NCT02798952|11896060|FG000|COMPLETED|Overall Study||302
10732245|NCT02798952|11896060|FG000|NOT COMPLETED|Overall Study||0
10732246|NCT02798978|11896071|FG000|STARTED|Part 1 (30 Days)||10
10732247|NCT02798978|11896072|FG001|STARTED|Part 1 (30 Days)||6
10732248|NCT02798978|11896073|FG002|STARTED|Part 1 (30 Days)||6
10732249|NCT02798978|11896074|FG003|STARTED|Part 1 (30 Days)||6
10732250|NCT02798978|11896075|FG004|STARTED|Part 1 (30 Days)||6
10732251|NCT02798978|11896076|FG005|STARTED|Part 1 (30 Days)||6
10732252|NCT02798978|11896077|FG006|STARTED|Part 1 (30 Days)||0
10732253|NCT02798978|11896071|FG000|COMPLETED|Part 1 (30 Days)||10
10732254|NCT02798978|11896072|FG001|COMPLETED|Part 1 (30 Days)||6
10732255|NCT02798978|11896073|FG002|COMPLETED|Part 1 (30 Days)||6
10732256|NCT02798978|11896074|FG003|COMPLETED|Part 1 (30 Days)||6
10732257|NCT02798978|11896075|FG004|COMPLETED|Part 1 (30 Days)||6
10732258|NCT02798978|11896076|FG005|COMPLETED|Part 1 (30 Days)||6
10732259|NCT02798978|11896077|FG006|COMPLETED|Part 1 (30 Days)||0
10732260|NCT02798978|11896071|FG000|NOT COMPLETED|Part 1 (30 Days)||0
10732261|NCT02798978|11896072|FG001|NOT COMPLETED|Part 1 (30 Days)||0
10732262|NCT02798978|11896073|FG002|NOT COMPLETED|Part 1 (30 Days)||0
10732263|NCT02798978|11896074|FG003|NOT COMPLETED|Part 1 (30 Days)||0
10732264|NCT02798978|11896075|FG004|NOT COMPLETED|Part 1 (30 Days)||0
10732265|NCT02798978|11896076|FG005|NOT COMPLETED|Part 1 (30 Days)||0
10732266|NCT02798978|11896077|FG006|NOT COMPLETED|Part 1 (30 Days)||0
10732267|NCT02798978|11896071|FG000|STARTED|Part 2 (45 Days)||0
10732268|NCT02798978|11896072|FG001|STARTED|Part 2 (45 Days)||0
10732269|NCT02798978|11896073|FG002|STARTED|Part 2 (45 Days)||0
10732270|NCT02798978|11896074|FG003|STARTED|Part 2 (45 Days)||0
10732271|NCT02798978|11896075|FG004|STARTED|Part 2 (45 Days)||0
10732272|NCT02798978|11896076|FG005|STARTED|Part 2 (45 Days)||0
10732273|NCT02798978|11896077|FG006|STARTED|Part 2 (45 Days)||0
10732275|NCT02798978|11896072|FG001|COMPLETED|Part 2 (45 Days)||0
10732276|NCT02798978|11896073|FG002|COMPLETED|Part 2 (45 Days)||0
10732277|NCT02798978|11896074|FG003|COMPLETED|Part 2 (45 Days)||0
10732278|NCT02798978|11896075|FG004|COMPLETED|Part 2 (45 Days)||0
10732279|NCT02798978|11896076|FG005|COMPLETED|Part 2 (45 Days)||0
10732280|NCT02798978|11896077|FG006|COMPLETED|Part 2 (45 Days)||0
10732281|NCT02798978|11896071|FG000|NOT COMPLETED|Part 2 (45 Days)||0
10732282|NCT02798978|11896072|FG001|NOT COMPLETED|Part 2 (45 Days)||0
10732283|NCT02798978|11896073|FG002|NOT COMPLETED|Part 2 (45 Days)||0
10732284|NCT02798978|11896074|FG003|NOT COMPLETED|Part 2 (45 Days)||0
10732285|NCT02798978|11896075|FG004|NOT COMPLETED|Part 2 (45 Days)||0
10732286|NCT02798978|11896076|FG005|NOT COMPLETED|Part 2 (45 Days)||0
10732287|NCT02798978|11896077|FG006|NOT COMPLETED|Part 2 (45 Days)||0
10732288|NCT02799069|11896102|FG000|STARTED|Overall Study||76
10732289|NCT02799069|11896103|FG001|STARTED|Overall Study||248
10732290|NCT02799069|11896104|FG002|STARTED|Overall Study||247
10732291|NCT02799069|11896102|FG000|ITT/Safety|Overall Study||76
10815113|NCT02048904|11978115|FG000|STARTED|Overall Study||142
10815114|NCT02048904|11978115|FG000|COMPLETED|Overall Study||65
10815115|NCT02048904|11978115|FG000|NOT COMPLETED|Overall Study||77
10815116|NCT02044822|11978119|FG000|STARTED|Overall Study||102
10815117|NCT02044822|11978119|FG000|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|9
10815118|NCT02044822|11978119|FG000|NOT COMPLETED|Overall Study||93
10815119|NCT02042924|11978123|FG000|STARTED|Overall Study||2
10815120|NCT02042924|11978123|FG000|COMPLETED|Overall Study||1
10815121|NCT02042924|11978123|FG000|NOT COMPLETED|Overall Study||1
10815122|NCT02043860|11978127|FG000|STARTED|Overall Study||2
10815123|NCT02043860|11978127|FG000|COMPLETED|Overall Study||2
10815124|NCT02043860|11978127|FG000|NOT COMPLETED|Overall Study||0
10815125|NCT02017522|11978131|FG000|STARTED|Overall Study||3
10815126|NCT02017522|11978131|FG000|Scan|Overall Study||2
10815127|NCT02017522|11978131|FG000|COMPLETED|Overall Study||2
10815128|NCT02017522|11978131|FG000|NOT COMPLETED|Overall Study||1
10815129|NCT02030015|11978136|FG000|STARTED|Overall Study||16
10815130|NCT02030015|11978136|FG000|COMPLETED|Overall Study||0
10815131|NCT02030015|11978136|FG000|NOT COMPLETED|Overall Study||16
10815132|NCT02015663|11978142|FG000|STARTED|Overall Study||16
10815133|NCT02015663|11978143|FG001|STARTED|Overall Study||16
10815134|NCT02015663|11978142|FG000|COMPLETED|Overall Study||1
10815135|NCT02015663|11978143|FG001|COMPLETED|Overall Study||4
10732292|NCT02799069|11896103|FG001|ITT/Safety|Overall Study||248
10732293|NCT02799069|11896104|FG002|ITT/Safety|Overall Study|1 subject received medication without Illumination and thus was excluded from ITT/safety population|246
10732294|NCT02799069|11896102|FG000|COMPLETED|Overall Study||68
10732295|NCT02799069|11896103|FG001|COMPLETED|Overall Study||241
10732296|NCT02799069|11896104|FG002|COMPLETED|Overall Study||240
10732297|NCT02799069|11896102|FG000|NOT COMPLETED|Overall Study||8
10732298|NCT02799069|11896103|FG001|NOT COMPLETED|Overall Study||7
10732299|NCT02799069|11896104|FG002|NOT COMPLETED|Overall Study||7
10732300|NCT02799082|11896114|FG000|STARTED|Overall Study||41
10732301|NCT02799082|11896115|FG001|STARTED|Overall Study||81
10732302|NCT02799082|11896114|FG000|COMPLETED|Overall Study||37
10732303|NCT02799082|11896115|FG001|COMPLETED|Overall Study||77
10732304|NCT02799082|11896114|FG000|NOT COMPLETED|Overall Study||4
10732305|NCT02799082|11896115|FG001|NOT COMPLETED|Overall Study||4
10732306|NCT02799290|11896124|FG000|STARTED|Overall Study||24
10732307|NCT02799290|11896125|FG001|STARTED|Overall Study||13
10732308|NCT02799290|11896126|FG002|STARTED|Overall Study||11
10732309|NCT02799290|11896124|FG000|COMPLETED|Overall Study||24
10732310|NCT02799290|11896125|FG001|COMPLETED|Overall Study||13
10732311|NCT02799290|11896126|FG002|COMPLETED|Overall Study||11
10732312|NCT02799290|11896124|FG000|NOT COMPLETED|Overall Study||0
10732313|NCT02799290|11896125|FG001|NOT COMPLETED|Overall Study||0
10732314|NCT02799290|11896126|FG002|NOT COMPLETED|Overall Study||0
10732315|NCT02799381|11896140|FG000|STARTED|Overall Study||33
10732316|NCT02799381|11896141|FG001|STARTED|Overall Study||28
10732317|NCT02799381|11896140|FG000|COMPLETED|Overall Study||29
10732318|NCT02799381|11896141|FG001|COMPLETED|Overall Study||25
10732319|NCT02799381|11896140|FG000|NOT COMPLETED|Overall Study||4
10732320|NCT02799381|11896141|FG001|NOT COMPLETED|Overall Study||3
10732321|NCT02799472|11896149|FG000|STARTED|Overall Study||11
10732322|NCT02799472|11896150|FG001|STARTED|Overall Study||28
10732323|NCT02799472|11896149|FG000|COMPLETED|Overall Study||7
10732324|NCT02799472|11896150|FG001|COMPLETED|Overall Study||23
10732325|NCT02799472|11896149|FG000|NOT COMPLETED|Overall Study||4
10732326|NCT02799472|11896150|FG001|NOT COMPLETED|Overall Study||5
10732327|NCT02799667|11896158|FG000|STARTED|Overall Study||55
10732328|NCT02799667|11896159|FG001|STARTED|Overall Study||55
10732329|NCT02799667|11896158|FG000|COMPLETED|Overall Study||54
10732330|NCT02799667|11896159|FG001|COMPLETED|Overall Study||54
10732331|NCT02799667|11896158|FG000|NOT COMPLETED|Overall Study||1
10732332|NCT02799667|11896159|FG001|NOT COMPLETED|Overall Study||1
10732333|NCT02799745|11896167|FG000|STARTED|Overall Study||114
10732334|NCT02799745|11896168|FG001|STARTED|Overall Study||113
10732335|NCT02799745|11896167|FG000|Treated|Overall Study||112
10732336|NCT02799745|11896168|FG001|Treated|Overall Study||113
10732337|NCT02799745|11896167|FG000|COMPLETED|Overall Study||58
10732338|NCT02799745|11896168|FG001|COMPLETED|Overall Study||42
10732339|NCT02799745|11896167|FG000|NOT COMPLETED|Overall Study||56
10732340|NCT02799745|11896168|FG001|NOT COMPLETED|Overall Study||71
10732341|NCT02799784|11896174|FG000|STARTED|Treatment Period 1 (TP1- 8 Weeks)||117
10732342|NCT02799784|11896175|FG001|STARTED|Treatment Period 1 (TP1- 8 Weeks)||119
10732343|NCT02799784|11896174|FG000|COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||111
10732344|NCT02799784|11896175|FG001|COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||118
10732345|NCT02799784|11896174|FG000|NOT COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||6
10732346|NCT02799784|11896175|FG001|NOT COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||1
10732347|NCT02799784|11896174|FG000|STARTED|Washout Period (3 Weeks)||111
10732348|NCT02799784|11896175|FG001|STARTED|Washout Period (3 Weeks)||118
10732349|NCT02799784|11896174|FG000|COMPLETED|Washout Period (3 Weeks)||111
10732350|NCT02799784|11896175|FG001|COMPLETED|Washout Period (3 Weeks)||118
10732351|NCT02799784|11896174|FG000|NOT COMPLETED|Washout Period (3 Weeks)||0
10732352|NCT02799784|11896175|FG001|NOT COMPLETED|Washout Period (3 Weeks)||0
10732353|NCT02799784|11896174|FG000|STARTED|Treatment Period 2 (TP2 - 8 Weeks)||111
10732354|NCT02799784|11896175|FG001|STARTED|Treatment Period 2 (TP2 - 8 Weeks)||118
10732355|NCT02799784|11896174|FG000|COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||110
10732356|NCT02799784|11896175|FG001|COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||115
10732357|NCT02799784|11896174|FG000|NOT COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||1
10732358|NCT02799784|11896175|FG001|NOT COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||3
10732359|NCT02800148|11896184|FG000|STARTED|Overall Study||224
10732360|NCT02800148|11896185|FG001|STARTED|Overall Study||224
10732361|NCT02800148|11896186|FG002|STARTED|Overall Study||219
10732362|NCT02800148|11896184|FG000|COMPLETED|Overall Study||199
10732363|NCT02800148|11896185|FG001|COMPLETED|Overall Study||204
10732364|NCT02800148|11896186|FG002|COMPLETED|Overall Study||194
10815136|NCT02015663|11978142|FG000|NOT COMPLETED|Overall Study||15
10815137|NCT02015663|11978143|FG001|NOT COMPLETED|Overall Study||12
10815138|NCT02029846|11978152|FG000|STARTED|Overall Study||1
10815139|NCT02029846|11978153|FG001|STARTED|Overall Study||1
10815140|NCT02029846|11978152|FG000|COMPLETED|Overall Study||0
10815141|NCT02029846|11978153|FG001|COMPLETED|Overall Study||0
10732365|NCT02800148|11896184|FG000|NOT COMPLETED|Overall Study||25
10732366|NCT02800148|11896185|FG001|NOT COMPLETED|Overall Study||20
10732367|NCT02800148|11896186|FG002|NOT COMPLETED|Overall Study||25
10732368|NCT02800213|11896196|FG000|STARTED|First Intervention||35
10732369|NCT02800213|11896197|FG001|STARTED|First Intervention||35
10732370|NCT02800213|11896196|FG000|COMPLETED|First Intervention||35
10732371|NCT02800213|11896197|FG001|COMPLETED|First Intervention||35
10732372|NCT02800213|11896196|FG000|NOT COMPLETED|First Intervention||0
10732373|NCT02800213|11896197|FG001|NOT COMPLETED|First Intervention||0
10732374|NCT02800213|11896196|FG000|STARTED|Second Intervention||35
10732375|NCT02800213|11896197|FG001|STARTED|Second Intervention||35
10732376|NCT02800213|11896196|FG000|COMPLETED|Second Intervention||35
10732377|NCT02800213|11896197|FG001|COMPLETED|Second Intervention||35
10732378|NCT02800213|11896196|FG000|NOT COMPLETED|Second Intervention||0
10732379|NCT02800213|11896197|FG001|NOT COMPLETED|Second Intervention||0
10815142|NCT02029846|11978152|FG000|NOT COMPLETED|Overall Study||1
10732380|NCT02800356|11896203|FG000|STARTED|Overall Study||20
10732381|NCT02800356|11896203|FG000|COMPLETED|Overall Study||20
10732382|NCT02800356|11896203|FG000|NOT COMPLETED|Overall Study||0
10732383|NCT02800642|11896207|FG000|STARTED|Overall Study||162
10732384|NCT02800642|11896207|FG000|COMPLETED|Overall Study||137
10732385|NCT02800642|11896207|FG000|NOT COMPLETED|Overall Study||25
10732386|NCT02800928|11896211|FG000|STARTED|Overall Study||9
10732387|NCT02800928|11896212|FG001|STARTED|Overall Study||8
10732388|NCT02800928|11896211|FG000|COMPLETED|Overall Study||7
10732389|NCT02800928|11896212|FG001|COMPLETED|Overall Study||6
10732390|NCT02800928|11896211|FG000|NOT COMPLETED|Overall Study||2
10732391|NCT02800928|11896212|FG001|NOT COMPLETED|Overall Study||2
10732392|NCT02801006|11896218|FG000|STARTED|Lens 1||22
10732393|NCT02801006|11896219|FG001|STARTED|Lens 1||19
10732394|NCT02801006|11896218|FG000|COMPLETED|Lens 1||22
10732395|NCT02801006|11896219|FG001|COMPLETED|Lens 1||19
10732396|NCT02801006|11896218|FG000|NOT COMPLETED|Lens 1||0
10732397|NCT02801006|11896219|FG001|NOT COMPLETED|Lens 1||0
10732398|NCT02801006|11896218|FG000|STARTED|Lens 2||22
10732399|NCT02801006|11896219|FG001|STARTED|Lens 2||19
10732400|NCT02801006|11896218|FG000|COMPLETED|Lens 2||22
10732401|NCT02801006|11896219|FG001|COMPLETED|Lens 2||19
10732402|NCT02801006|11896218|FG000|NOT COMPLETED|Lens 2||0
10732403|NCT02801006|11896219|FG001|NOT COMPLETED|Lens 2||0
10732404|NCT02801370|11896229|FG000|STARTED|Overall Study||130
10732405|NCT02801370|11896230|FG001|STARTED|Overall Study||132
10732406|NCT02801370|11896229|FG000|COMPLETED|Overall Study||123
10732407|NCT02801370|11896230|FG001|COMPLETED|Overall Study||132
10732408|NCT02801370|11896229|FG000|NOT COMPLETED|Overall Study||7
10732409|NCT02801370|11896230|FG001|NOT COMPLETED|Overall Study||0
10732410|NCT02801396|11896237|FG000|STARTED|Period 1||17
10732411|NCT02801396|11896238|FG001|STARTED|Period 1||17
10732412|NCT02801396|11896239|FG002|STARTED|Period 1||17
10732413|NCT02801396|11896240|FG003|STARTED|Period 1||16
10732414|NCT02801396|11896241|FG004|STARTED|Period 1||17
10732415|NCT02801396|11896242|FG005|STARTED|Period 1||17
10732416|NCT02801396|11896237|FG000|COMPLETED|Period 1||17
10732417|NCT02801396|11896238|FG001|COMPLETED|Period 1||17
10732418|NCT02801396|11896239|FG002|COMPLETED|Period 1||17
10732419|NCT02801396|11896240|FG003|COMPLETED|Period 1||16
10732420|NCT02801396|11896241|FG004|COMPLETED|Period 1||16
10732421|NCT02801396|11896242|FG005|COMPLETED|Period 1||17
10732422|NCT02801396|11896237|FG000|NOT COMPLETED|Period 1||0
10732423|NCT02801396|11896238|FG001|NOT COMPLETED|Period 1||0
10732424|NCT02801396|11896239|FG002|NOT COMPLETED|Period 1||0
10732425|NCT02801396|11896240|FG003|NOT COMPLETED|Period 1||0
10732426|NCT02801396|11896241|FG004|NOT COMPLETED|Period 1||1
10732427|NCT02801396|11896242|FG005|NOT COMPLETED|Period 1||0
10732428|NCT02801396|11896237|FG000|STARTED|Period 2||17
10732429|NCT02801396|11896238|FG001|STARTED|Period 2||17
10732430|NCT02801396|11896239|FG002|STARTED|Period 2||17
10732431|NCT02801396|11896240|FG003|STARTED|Period 2||16
10732432|NCT02801396|11896241|FG004|STARTED|Period 2||16
10732433|NCT02801396|11896242|FG005|STARTED|Period 2||17
10732434|NCT02801396|11896237|FG000|COMPLETED|Period 2||17
10732435|NCT02801396|11896238|FG001|COMPLETED|Period 2||17
10732436|NCT02801396|11896239|FG002|COMPLETED|Period 2||17
10732437|NCT02801396|11896240|FG003|COMPLETED|Period 2||16
10732438|NCT02801396|11896241|FG004|COMPLETED|Period 2||16
10732439|NCT02801396|11896242|FG005|COMPLETED|Period 2||17
10732440|NCT02801396|11896237|FG000|NOT COMPLETED|Period 2||0
10732441|NCT02801396|11896238|FG001|NOT COMPLETED|Period 2||0
10732442|NCT02801396|11896239|FG002|NOT COMPLETED|Period 2||0
10732443|NCT02801396|11896240|FG003|NOT COMPLETED|Period 2||0
10732444|NCT02801396|11896241|FG004|NOT COMPLETED|Period 2||0
10732445|NCT02801396|11896242|FG005|NOT COMPLETED|Period 2||0
10732446|NCT02801396|11896237|FG000|STARTED|Period 3||17
10732447|NCT02801396|11896238|FG001|STARTED|Period 3||17
10732448|NCT02801396|11896239|FG002|STARTED|Period 3||17
10732449|NCT02801396|11896240|FG003|STARTED|Period 3||16
10732450|NCT02801396|11896241|FG004|STARTED|Period 3||16
10732451|NCT02801396|11896242|FG005|STARTED|Period 3||17
10732452|NCT02801396|11896237|FG000|COMPLETED|Period 3||17
10732453|NCT02801396|11896238|FG001|COMPLETED|Period 3||17
10732454|NCT02801396|11896239|FG002|COMPLETED|Period 3||17
10732455|NCT02801396|11896240|FG003|COMPLETED|Period 3||16
10732456|NCT02801396|11896241|FG004|COMPLETED|Period 3||16
10732457|NCT02801396|11896242|FG005|COMPLETED|Period 3||17
10732458|NCT02801396|11896237|FG000|NOT COMPLETED|Period 3||0
10732459|NCT02801396|11896238|FG001|NOT COMPLETED|Period 3||0
10732460|NCT02801396|11896239|FG002|NOT COMPLETED|Period 3||0
10732461|NCT02801396|11896240|FG003|NOT COMPLETED|Period 3||0
10732462|NCT02801396|11896241|FG004|NOT COMPLETED|Period 3||0
10732463|NCT02801396|11896242|FG005|NOT COMPLETED|Period 3||0
10732464|NCT02801578|11896250|FG000|STARTED|Overall Study||11
10732465|NCT02801578|11896250|FG000|COMPLETED|Overall Study||9
10732466|NCT02801578|11896250|FG000|NOT COMPLETED|Overall Study||2
10732467|NCT02801617|11896256|FG000|STARTED|Overall Study||51
10732468|NCT02801617|11896257|FG001|STARTED|Overall Study||56
10732469|NCT02801617|11896256|FG000|COMPLETED|Overall Study||49
10732470|NCT02801617|11896257|FG001|COMPLETED|Overall Study||50
10732471|NCT02801617|11896256|FG000|NOT COMPLETED|Overall Study||2
10732472|NCT02801617|11896257|FG001|NOT COMPLETED|Overall Study||6
10732473|NCT02801669|11896269|FG000|STARTED|Overall Study||492
10732474|NCT02801669|11896270|FG001|STARTED|Overall Study||492
10732475|NCT02801669|11896269|FG000|Received at Least 1 Dose of Study Drug|Overall Study||492
10732476|NCT02801669|11896270|FG001|Received at Least 1 Dose of Study Drug|Overall Study||490
10732477|NCT02801669|11896269|FG000|COMPLETED|Overall Study||341
10732478|NCT02801669|11896270|FG001|COMPLETED|Overall Study||340
10732479|NCT02801669|11896269|FG000|NOT COMPLETED|Overall Study||151
10732480|NCT02801669|11896270|FG001|NOT COMPLETED|Overall Study||152
10732481|NCT02801877|11896280|FG000|STARTED|Overall Study||74
10732482|NCT02801877|11896281|FG001|STARTED|Overall Study||75
10732483|NCT02801877|11896282|FG002|STARTED|Overall Study||76
10732484|NCT02801877|11896283|FG003|STARTED|Overall Study||76
10732485|NCT02801877|11896280|FG000|COMPLETED|Overall Study||71
10732486|NCT02801877|11896281|FG001|COMPLETED|Overall Study||74
10732487|NCT02801877|11896282|FG002|COMPLETED|Overall Study||70
10732488|NCT02801877|11896283|FG003|COMPLETED|Overall Study||76
10732489|NCT02801877|11896280|FG000|NOT COMPLETED|Overall Study||3
10732490|NCT02801877|11896281|FG001|NOT COMPLETED|Overall Study||1
10732491|NCT02801877|11896282|FG002|NOT COMPLETED|Overall Study||6
10732492|NCT02801877|11896283|FG003|NOT COMPLETED|Overall Study||0
10732493|NCT02801942|11896295|FG000|STARTED|Overall Study||12
10732494|NCT02801942|11896296|FG001|STARTED|Overall Study||10
10732495|NCT02801942|11896295|FG000|COMPLETED|Overall Study||12
10732496|NCT02801942|11896296|FG001|COMPLETED|Overall Study||10
10732497|NCT02801942|11896295|FG000|NOT COMPLETED|Overall Study||0
10732498|NCT02801942|11896296|FG001|NOT COMPLETED|Overall Study||0
10732499|NCT02802111|11896304|FG000|STARTED|First Intervention (5 Min of Drug)||12
10732500|NCT02802111|11896305|FG001|STARTED|First Intervention (5 Min of Drug)||12
10732501|NCT02802111|11896304|FG000|COMPLETED|First Intervention (5 Min of Drug)||12
10732502|NCT02802111|11896305|FG001|COMPLETED|First Intervention (5 Min of Drug)||12
10732503|NCT02802111|11896304|FG000|NOT COMPLETED|First Intervention (5 Min of Drug)||0
10732504|NCT02802111|11896305|FG001|NOT COMPLETED|First Intervention (5 Min of Drug)||0
10732505|NCT02802111|11896304|FG000|STARTED|Washout (4 Hours)||12
10732506|NCT02802111|11896305|FG001|STARTED|Washout (4 Hours)||12
10732507|NCT02802111|11896304|FG000|COMPLETED|Washout (4 Hours)||12
10732508|NCT02802111|11896305|FG001|COMPLETED|Washout (4 Hours)||12
10732509|NCT02802111|11896304|FG000|NOT COMPLETED|Washout (4 Hours)||0
10732510|NCT02802111|11896305|FG001|NOT COMPLETED|Washout (4 Hours)||0
10732511|NCT02802111|11896304|FG000|STARTED|Second Intervention (5 Min of Drug)||12
10732512|NCT02802111|11896305|FG001|STARTED|Second Intervention (5 Min of Drug)||12
10732513|NCT02802111|11896304|FG000|COMPLETED|Second Intervention (5 Min of Drug)||12
10732514|NCT02802111|11896305|FG001|COMPLETED|Second Intervention (5 Min of Drug)||12
10732515|NCT02802111|11896304|FG000|NOT COMPLETED|Second Intervention (5 Min of Drug)||0
10732516|NCT02802111|11896305|FG001|NOT COMPLETED|Second Intervention (5 Min of Drug)||0
10732517|NCT02802241|11896315|FG000|STARTED|Overall Study||97
10732518|NCT02802241|11896316|FG001|STARTED|Overall Study||97
10732519|NCT02802241|11896317|FG002|STARTED|Overall Study||48
10732520|NCT02802241|11896318|FG003|STARTED|Overall Study||98
10732521|NCT02802241|11896315|FG000|Planned Analysis|Overall Study||89
10815143|NCT02029846|11978153|FG001|NOT COMPLETED|Overall Study||1
10815144|NCT02027272|11978161|FG000|STARTED|Overall Study||0
10815145|NCT02027272|11978162|FG001|STARTED|Overall Study||1
10815146|NCT02027272|11978161|FG000|COMPLETED|Overall Study||0
10815147|NCT02027272|11978162|FG001|COMPLETED|Overall Study||0
10815148|NCT02027272|11978161|FG000|NOT COMPLETED|Overall Study||0
10815149|NCT02027272|11978162|FG001|NOT COMPLETED|Overall Study||1
10815150|NCT02012608|11978170|FG000|STARTED|Overall Study||7
10815151|NCT02012608|11978171|FG001|STARTED|Overall Study||7
10815152|NCT02012608|11978170|FG000|COMPLETED|Overall Study||4
10815153|NCT02012608|11978171|FG001|COMPLETED|Overall Study||7
10815154|NCT02012608|11978170|FG000|NOT COMPLETED|Overall Study||3
10815155|NCT02012608|11978171|FG001|NOT COMPLETED|Overall Study||0
10815156|NCT02017379|11978180|FG000|STARTED|Overall Study||0
10815157|NCT02017379|11978181|FG001|STARTED|Overall Study||0
10815158|NCT02017379|11978182|FG002|STARTED|Overall Study||0
10815159|NCT02017379|11978180|FG000|COMPLETED|Overall Study||0
10815160|NCT02017379|11978181|FG001|COMPLETED|Overall Study||0
10815161|NCT02017379|11978182|FG002|COMPLETED|Overall Study||0
10815162|NCT02017379|11978180|FG000|NOT COMPLETED|Overall Study||0
10815163|NCT02017379|11978181|FG001|NOT COMPLETED|Overall Study||0
10815164|NCT02017379|11978182|FG002|NOT COMPLETED|Overall Study||0
10815165|NCT02011542|11978190|FG000|STARTED|Overall Study||30
10815166|NCT02011542|11978190|FG000|COMPLETED|Overall Study||29
10815167|NCT02011542|11978190|FG000|NOT COMPLETED|Overall Study||1
10815168|NCT02008370|11978194|FG000|STARTED|Overall Study||7
10815169|NCT02008370|11978194|FG000|COMPLETED|Overall Study||0
10815170|NCT02008370|11978194|FG000|NOT COMPLETED|Overall Study||7
10815171|NCT02009982|11978200|FG000|STARTED|Overall Study||1
10815172|NCT02009982|11978201|FG001|STARTED|Overall Study||2
10815173|NCT02009982|11978200|FG000|COMPLETED|Overall Study||1
10815174|NCT02009982|11978201|FG001|COMPLETED|Overall Study||2
10815175|NCT02009982|11978200|FG000|NOT COMPLETED|Overall Study||0
10815176|NCT02009982|11978201|FG001|NOT COMPLETED|Overall Study||0
10815177|NCT02013414|11978207|FG000|STARTED|Overall Study||9
10815178|NCT02013414|11978207|FG000|COMPLETED|Overall Study||9
10815179|NCT02013414|11978207|FG000|NOT COMPLETED|Overall Study||0
10732522|NCT02802241|11896316|FG001|Planned Analysis|Overall Study||86
10732523|NCT02802241|11896317|FG002|Planned Analysis|Overall Study|Not included in primary analysis|0
10732524|NCT02802241|11896318|FG003|Planned Analysis|Overall Study||87
10732525|NCT02802241|11896315|FG000|COMPLETED|Overall Study||68
10815180|NCT02005445|11978215|FG000|STARTED|Overall Study||2
10815181|NCT02005445|11978216|FG001|STARTED|Overall Study||2
10815182|NCT02005445|11978215|FG000|COMPLETED|Overall Study||2
10815183|NCT02005445|11978216|FG001|COMPLETED|Overall Study||1
10815184|NCT02005445|11978215|FG000|NOT COMPLETED|Overall Study||0
10732526|NCT02802241|11896316|FG001|COMPLETED|Overall Study||71
10732527|NCT02802241|11896317|FG002|COMPLETED|Overall Study|Not included in primary analysis|0
10732528|NCT02802241|11896318|FG003|COMPLETED|Overall Study||72
10732529|NCT02802241|11896315|FG000|NOT COMPLETED|Overall Study||29
10732530|NCT02802241|11896316|FG001|NOT COMPLETED|Overall Study||26
10732531|NCT02802241|11896317|FG002|NOT COMPLETED|Overall Study||48
10732532|NCT02802241|11896318|FG003|NOT COMPLETED|Overall Study||26
10732533|NCT02802319|11896330|FG000|STARTED|Overall Study||22
10732534|NCT02802319|11896331|FG001|STARTED|Overall Study||22
10732535|NCT02802319|11896330|FG000|COMPLETED|Overall Study||20
10732536|NCT02802319|11896331|FG001|COMPLETED|Overall Study||17
10732537|NCT02802319|11896330|FG000|NOT COMPLETED|Overall Study||2
10732538|NCT02802319|11896331|FG001|NOT COMPLETED|Overall Study||5
10732539|NCT02802345|11896339|FG000|STARTED|Overall Study||136
10732540|NCT02802345|11896340|FG001|STARTED|Overall Study||138
10732541|NCT02802345|11896339|FG000|Treated|Overall Study||136
10732542|NCT02802345|11896340|FG001|Treated|Overall Study||137
10732543|NCT02802345|11896339|FG000|COMPLETED|Overall Study||104
10732544|NCT02802345|11896340|FG001|COMPLETED|Overall Study||108
10732545|NCT02802345|11896339|FG000|NOT COMPLETED|Overall Study||32
10732546|NCT02802345|11896340|FG001|NOT COMPLETED|Overall Study||30
10732547|NCT02802449|11896348|FG000|STARTED|Overall Study||111
10732548|NCT02802449|11896349|FG001|STARTED|Overall Study||219
10732549|NCT02802449|11896348|FG000|COMPLETED|Overall Study||102
10732550|NCT02802449|11896349|FG001|COMPLETED|Overall Study||202
10732551|NCT02802449|11896348|FG000|NOT COMPLETED|Overall Study||9
10732552|NCT02802449|11896349|FG001|NOT COMPLETED|Overall Study||17
10732553|NCT02802501|11896358|FG000|STARTED|Double-blind (Up to Day 180)||50
10732554|NCT02802501|11896359|FG001|STARTED|Double-blind (Up to Day 180)||50
10732555|NCT02802501|11896360|FG002|STARTED|Double-blind (Up to Day 180)||50
10732556|NCT02802501|11896358|FG000|COMPLETED|Double-blind (Up to Day 180)||50
10732557|NCT02802501|11896359|FG001|COMPLETED|Double-blind (Up to Day 180)||50
10732558|NCT02802501|11896360|FG002|COMPLETED|Double-blind (Up to Day 180)||50
10732559|NCT02802501|11896358|FG000|NOT COMPLETED|Double-blind (Up to Day 180)||0
10732560|NCT02802501|11896359|FG001|NOT COMPLETED|Double-blind (Up to Day 180)||0
10732561|NCT02802501|11896360|FG002|NOT COMPLETED|Double-blind (Up to Day 180)||0
10732562|NCT02802501|11896358|FG000|STARTED|Open-Label (Day 180 to Day 195)|Participants who had no relapse prior to Day 180 received open-label Primaquine|6
10732563|NCT02802501|11896359|FG001|STARTED|Open-Label (Day 180 to Day 195)|Participants who had no relapse prior to Day 180 received open-label Primaquine|12
10732564|NCT02802501|11896360|FG002|STARTED|Open-Label (Day 180 to Day 195)|Participants who had no relapse prior to Day 180 received open-label Primaquine|26
10732565|NCT02802501|11896358|FG000|COMPLETED|Open-Label (Day 180 to Day 195)||6
10732566|NCT02802501|11896359|FG001|COMPLETED|Open-Label (Day 180 to Day 195)||12
10732567|NCT02802501|11896360|FG002|COMPLETED|Open-Label (Day 180 to Day 195)||26
10732568|NCT02802501|11896358|FG000|NOT COMPLETED|Open-Label (Day 180 to Day 195)||0
10732569|NCT02802501|11896359|FG001|NOT COMPLETED|Open-Label (Day 180 to Day 195)||0
10732570|NCT02802501|11896360|FG002|NOT COMPLETED|Open-Label (Day 180 to Day 195)||0
10732571|NCT02802514|11896373|FG000|STARTED|Session 1 (up to Day 8)||1
10732572|NCT02802514|11896374|FG001|STARTED|Session 1 (up to Day 8)||1
10732573|NCT02802514|11896375|FG002|STARTED|Session 1 (up to Day 8)||1
10732574|NCT02802514|11896376|FG003|STARTED|Session 1 (up to Day 8)||1
10732575|NCT02802514|11896373|FG000|COMPLETED|Session 1 (up to Day 8)||1
10732576|NCT02802514|11896374|FG001|COMPLETED|Session 1 (up to Day 8)||1
10732577|NCT02802514|11896375|FG002|COMPLETED|Session 1 (up to Day 8)||1
10732578|NCT02802514|11896376|FG003|COMPLETED|Session 1 (up to Day 8)||1
10732579|NCT02802514|11896373|FG000|NOT COMPLETED|Session 1 (up to Day 8)||0
10732580|NCT02802514|11896374|FG001|NOT COMPLETED|Session 1 (up to Day 8)||0
10732581|NCT02802514|11896375|FG002|NOT COMPLETED|Session 1 (up to Day 8)||0
10732582|NCT02802514|11896376|FG003|NOT COMPLETED|Session 1 (up to Day 8)||0
10732583|NCT02802514|11896373|FG000|STARTED|Wash Out Period (up to Week 9)||1
10732584|NCT02802514|11896374|FG001|STARTED|Wash Out Period (up to Week 9)||1
10732585|NCT02802514|11896375|FG002|STARTED|Wash Out Period (up to Week 9)||1
10732586|NCT02802514|11896376|FG003|STARTED|Wash Out Period (up to Week 9)||1
10732587|NCT02802514|11896373|FG000|COMPLETED|Wash Out Period (up to Week 9)||1
10732588|NCT02802514|11896374|FG001|COMPLETED|Wash Out Period (up to Week 9)||1
10732589|NCT02802514|11896375|FG002|COMPLETED|Wash Out Period (up to Week 9)||1
10732590|NCT02802514|11896376|FG003|COMPLETED|Wash Out Period (up to Week 9)||1
10732591|NCT02802514|11896373|FG000|NOT COMPLETED|Wash Out Period (up to Week 9)||0
10732592|NCT02802514|11896374|FG001|NOT COMPLETED|Wash Out Period (up to Week 9)||0
10732593|NCT02802514|11896375|FG002|NOT COMPLETED|Wash Out Period (up to Week 9)||0
10732594|NCT02802514|11896376|FG003|NOT COMPLETED|Wash Out Period (up to Week 9)||0
10732595|NCT02802514|11896373|FG000|STARTED|Session 2 (Up to Day 8)||1
10732596|NCT02802514|11896374|FG001|STARTED|Session 2 (Up to Day 8)||1
10732597|NCT02802514|11896375|FG002|STARTED|Session 2 (Up to Day 8)||1
10732598|NCT02802514|11896376|FG003|STARTED|Session 2 (Up to Day 8)||1
10732599|NCT02802514|11896373|FG000|COMPLETED|Session 2 (Up to Day 8)||1
10732600|NCT02802514|11896374|FG001|COMPLETED|Session 2 (Up to Day 8)||1
10732601|NCT02802514|11896375|FG002|COMPLETED|Session 2 (Up to Day 8)||1
10732602|NCT02802514|11896376|FG003|COMPLETED|Session 2 (Up to Day 8)||1
10732603|NCT02802514|11896373|FG000|NOT COMPLETED|Session 2 (Up to Day 8)||0
10732604|NCT02802514|11896374|FG001|NOT COMPLETED|Session 2 (Up to Day 8)||0
10732605|NCT02802514|11896375|FG002|NOT COMPLETED|Session 2 (Up to Day 8)||0
10732606|NCT02802514|11896376|FG003|NOT COMPLETED|Session 2 (Up to Day 8)||0
10732607|NCT02802735|11896392|FG000|STARTED|Overall Study||4
10732608|NCT02802735|11896393|FG001|STARTED|Overall Study||4
10732609|NCT02802735|11896394|FG002|STARTED|Overall Study||4
10732610|NCT02802735|11896395|FG003|STARTED|Overall Study||12
10732611|NCT02802735|11896396|FG004|STARTED|Overall Study||4
10732612|NCT02802735|11896392|FG000|COMPLETED|Overall Study||4
10732613|NCT02802735|11896393|FG001|COMPLETED|Overall Study||3
10732614|NCT02802735|11896394|FG002|COMPLETED|Overall Study||4
10732615|NCT02802735|11896395|FG003|COMPLETED|Overall Study||12
10732616|NCT02802735|11896396|FG004|COMPLETED|Overall Study||4
10732617|NCT02802735|11896392|FG000|NOT COMPLETED|Overall Study||0
10732618|NCT02802735|11896393|FG001|NOT COMPLETED|Overall Study||1
10732619|NCT02802735|11896394|FG002|NOT COMPLETED|Overall Study||0
10732620|NCT02802735|11896395|FG003|NOT COMPLETED|Overall Study||0
10732621|NCT02802735|11896396|FG004|NOT COMPLETED|Overall Study||0
10732622|NCT02802865|11896413|FG000|STARTED|Overall Study||35
10732623|NCT02802865|11896414|FG001|STARTED|Overall Study||35
10732624|NCT02802865|11896413|FG000|COMPLETED|Overall Study||34
10732625|NCT02802865|11896414|FG001|COMPLETED|Overall Study||33
10732626|NCT02802865|11896413|FG000|NOT COMPLETED|Overall Study||1
10732627|NCT02802865|11896414|FG001|NOT COMPLETED|Overall Study||2
10732628|NCT02802878|11896422|FG000|STARTED|Overall Study||21
10732629|NCT02802878|11896423|FG001|STARTED|Overall Study||21
10732630|NCT02802878|11896422|FG000|COMPLETED|Overall Study||17
10732631|NCT02802878|11896423|FG001|COMPLETED|Overall Study||18
10732632|NCT02802878|11896422|FG000|NOT COMPLETED|Overall Study||4
10732633|NCT02802878|11896423|FG001|NOT COMPLETED|Overall Study||3
10732634|NCT02803138|11896429|FG000|STARTED|Overall Study||236
10732635|NCT02803138|11896429|FG000|COMPLETED|Overall Study||166
10732636|NCT02803138|11896429|FG000|NOT COMPLETED|Overall Study||70
10732637|NCT02803164|11896437|FG000|STARTED|Overall Study||10
10732638|NCT02803164|11896438|FG001|STARTED|Overall Study||11
10732639|NCT02803164|11896437|FG000|COMPLETED|Overall Study||10
10732640|NCT02803164|11896438|FG001|COMPLETED|Overall Study||11
10732641|NCT02803164|11896437|FG000|NOT COMPLETED|Overall Study||0
10732642|NCT02803164|11896438|FG001|NOT COMPLETED|Overall Study||0
10732643|NCT02803229|11896448|FG000|STARTED|Overall Study||15
10732644|NCT02803229|11896449|FG001|STARTED|Overall Study||13
10732645|NCT02803229|11896448|FG000|COMPLETED|Overall Study||11
10732646|NCT02803229|11896449|FG001|COMPLETED|Overall Study||7
10732647|NCT02803229|11896448|FG000|NOT COMPLETED|Overall Study||4
10732648|NCT02803229|11896449|FG001|NOT COMPLETED|Overall Study||6
10732649|NCT02803580|11896455|FG000|STARTED|Overall Study||209
10732650|NCT02803580|11896455|FG000|COMPLETED|Overall Study||173
10732651|NCT02803580|11896455|FG000|NOT COMPLETED|Overall Study||36
10732652|NCT02803749|11896461|FG000|STARTED|Overall Study||17
10732653|NCT02803749|11896462|FG001|STARTED|Overall Study||4
10732654|NCT02803749|11896461|FG000|COMPLETED|Overall Study||12
10732655|NCT02803749|11896462|FG001|COMPLETED|Overall Study||4
10732656|NCT02803749|11896461|FG000|NOT COMPLETED|Overall Study||5
10732657|NCT02803749|11896462|FG001|NOT COMPLETED|Overall Study||0
10732658|NCT02804178|11896468|FG000|STARTED|Overall Study||10
10732659|NCT02804178|11896468|FG000|COMPLETED|Overall Study||9
10732660|NCT02804178|11896468|FG000|NOT COMPLETED|Overall Study||1
10732661|NCT02804399|11896472|FG000|STARTED|Period 1||12
10732662|NCT02804399|11896473|FG001|STARTED|Period 1||0
10732663|NCT02804399|11896472|FG000|COMPLETED|Period 1||12
10732664|NCT02804399|11896473|FG001|COMPLETED|Period 1||0
10732665|NCT02804399|11896472|FG000|NOT COMPLETED|Period 1||0
10732666|NCT02804399|11896473|FG001|NOT COMPLETED|Period 1||0
10732667|NCT02804399|11896472|FG000|STARTED|Washout Period at Least 10 Days||12
10732668|NCT02804399|11896473|FG001|STARTED|Washout Period at Least 10 Days||0
10732669|NCT02804399|11896472|FG000|COMPLETED|Washout Period at Least 10 Days||12
10732670|NCT02804399|11896473|FG001|COMPLETED|Washout Period at Least 10 Days||0
10732671|NCT02804399|11896472|FG000|NOT COMPLETED|Washout Period at Least 10 Days||0
10732672|NCT02804399|11896473|FG001|NOT COMPLETED|Washout Period at Least 10 Days||0
10732673|NCT02804399|11896472|FG000|STARTED|Period 2||0
10732674|NCT02804399|11896473|FG001|STARTED|Period 2||12
10732675|NCT02804399|11896472|FG000|COMPLETED|Period 2||0
10732676|NCT02804399|11896473|FG001|COMPLETED|Period 2||11
10732677|NCT02804399|11896472|FG000|NOT COMPLETED|Period 2||0
10732678|NCT02804399|11896473|FG001|NOT COMPLETED|Period 2||1
10732679|NCT02804594|11896484|FG000|STARTED|Overall Study||10
10732680|NCT02804594|11896485|FG001|STARTED|Overall Study||5
10732681|NCT02804594|11896484|FG000|COMPLETED|Overall Study||10
10732682|NCT02804594|11896485|FG001|COMPLETED|Overall Study||5
10732683|NCT02804594|11896484|FG000|NOT COMPLETED|Overall Study||0
10732684|NCT02804594|11896485|FG001|NOT COMPLETED|Overall Study||0
10732685|NCT02804750|11896493|FG000|STARTED|Period 1||17
10732686|NCT02804750|11896494|FG001|STARTED|Period 1||18
10732687|NCT02804750|11896493|FG000|COMPLETED|Period 1||17
10732688|NCT02804750|11896494|FG001|COMPLETED|Period 1||15
10732689|NCT02804750|11896493|FG000|NOT COMPLETED|Period 1||0
10732690|NCT02804750|11896494|FG001|NOT COMPLETED|Period 1||3
10732691|NCT02804750|11896493|FG000|STARTED|Period 2||17
10732692|NCT02804750|11896494|FG001|STARTED|Period 2||15
10732693|NCT02804750|11896493|FG000|COMPLETED|Period 2||16
10732694|NCT02804750|11896494|FG001|COMPLETED|Period 2||15
10732695|NCT02804750|11896493|FG000|NOT COMPLETED|Period 2||1
10732696|NCT02804750|11896494|FG001|NOT COMPLETED|Period 2||0
10732697|NCT02804750|11896493|FG000|STARTED|Period 3||16
10732698|NCT02804750|11896494|FG001|STARTED|Period 3||15
10732699|NCT02804750|11896493|FG000|COMPLETED|Period 3||16
10732700|NCT02804750|11896494|FG001|COMPLETED|Period 3||13
10732701|NCT02804750|11896493|FG000|NOT COMPLETED|Period 3||0
10732702|NCT02804750|11896494|FG001|NOT COMPLETED|Period 3||2
10732703|NCT02804750|11896493|FG000|STARTED|Period 4|Per-protocol, Group 1 did not participate in Period 4.|0
10732704|NCT02804750|11896494|FG001|STARTED|Period 4|One participant completed Period 3 but did not start Period 4 due to a pre-scheduled surgery.|12
10732705|NCT02804750|11896493|FG000|COMPLETED|Period 4||0
10732706|NCT02804750|11896494|FG001|COMPLETED|Period 4||7
10732707|NCT02804750|11896493|FG000|NOT COMPLETED|Period 4||0
10732708|NCT02804750|11896494|FG001|NOT COMPLETED|Period 4||5
10732709|NCT02804763|11896506|FG000|STARTED|Double-Blind Period (Week 1 to Week 24)||45
10732710|NCT02804763|11896507|FG001|STARTED|Double-Blind Period (Week 1 to Week 24)||45
10732711|NCT02804763|11896508|FG002|STARTED|Double-Blind Period (Week 1 to Week 24)||45
10732712|NCT02804763|11896509|FG003|STARTED|Double-Blind Period (Week 1 to Week 24)||47
10732713|NCT02804763|11896506|FG000|Completed Week 24|Double-Blind Period (Week 1 to Week 24)||44
10732714|NCT02804763|11896507|FG001|Completed Week 24|Double-Blind Period (Week 1 to Week 24)||45
10732715|NCT02804763|11896508|FG002|Completed Week 24|Double-Blind Period (Week 1 to Week 24)||44
10732716|NCT02804763|11896509|FG003|Completed Week 24|Double-Blind Period (Week 1 to Week 24)||45
10732717|NCT02804763|11896506|FG000|Finished Wk24 Began Observational Period|Double-Blind Period (Week 1 to Week 24)||44
10732718|NCT02804763|11896507|FG001|Finished Wk24 Began Observational Period|Double-Blind Period (Week 1 to Week 24)||44
10732719|NCT02804763|11896508|FG002|Finished Wk24 Began Observational Period|Double-Blind Period (Week 1 to Week 24)||44
10732720|NCT02804763|11896509|FG003|Finished Wk24 Began Observational Period|Double-Blind Period (Week 1 to Week 24)||45
10732721|NCT02804763|11896506|FG000|COMPLETED|Double-Blind Period (Week 1 to Week 24)||44
10732722|NCT02804763|11896507|FG001|COMPLETED|Double-Blind Period (Week 1 to Week 24)||44
10732723|NCT02804763|11896508|FG002|COMPLETED|Double-Blind Period (Week 1 to Week 24)||44
10732724|NCT02804763|11896509|FG003|COMPLETED|Double-Blind Period (Week 1 to Week 24)||45
10732725|NCT02804763|11896506|FG000|NOT COMPLETED|Double-Blind Period (Week 1 to Week 24)||1
10732726|NCT02804763|11896507|FG001|NOT COMPLETED|Double-Blind Period (Week 1 to Week 24)||1
10732727|NCT02804763|11896508|FG002|NOT COMPLETED|Double-Blind Period (Week 1 to Week 24)||1
10732728|NCT02804763|11896509|FG003|NOT COMPLETED|Double-Blind Period (Week 1 to Week 24)||2
10732729|NCT02804763|11896506|FG000|STARTED|Observational Period (Wk 24 to Wk 48)||44
10732730|NCT02804763|11896507|FG001|STARTED|Observational Period (Wk 24 to Wk 48)||44
10732731|NCT02804763|11896508|FG002|STARTED|Observational Period (Wk 24 to Wk 48)||44
10732732|NCT02804763|11896509|FG003|STARTED|Observational Period (Wk 24 to Wk 48)||45
10732733|NCT02804763|11896506|FG000|COMPLETED|Observational Period (Wk 24 to Wk 48)||38
10732734|NCT02804763|11896507|FG001|COMPLETED|Observational Period (Wk 24 to Wk 48)||43
10732735|NCT02804763|11896508|FG002|COMPLETED|Observational Period (Wk 24 to Wk 48)||41
10732736|NCT02804763|11896509|FG003|COMPLETED|Observational Period (Wk 24 to Wk 48)||42
10732737|NCT02804763|11896506|FG000|NOT COMPLETED|Observational Period (Wk 24 to Wk 48)||6
10732738|NCT02804763|11896507|FG001|NOT COMPLETED|Observational Period (Wk 24 to Wk 48)||1
10732739|NCT02804763|11896508|FG002|NOT COMPLETED|Observational Period (Wk 24 to Wk 48)||3
10732740|NCT02804763|11896509|FG003|NOT COMPLETED|Observational Period (Wk 24 to Wk 48)||3
10732741|NCT02805179|11896523|FG000|STARTED|Overall Study||26
10732742|NCT02805179|11896523|FG000|Eligible Patients That Started Dose-intensified Chemo-radiation|Overall Study||23
10732743|NCT02805179|11896523|FG000|Subset of Participants, Boosted to Both High B-value Diffusion and Perfusion|Overall Study||13
10732744|NCT02805179|11896523|FG000|COMPLETED|Overall Study||23
10732745|NCT02805179|11896523|FG000|NOT COMPLETED|Overall Study||3
10732746|NCT02805309|11896530|FG000|STARTED|Overall Study||18
10732747|NCT02805309|11896531|FG001|STARTED|Overall Study||17
10732748|NCT02805309|11896532|FG002|STARTED|Overall Study||19
10732749|NCT02805309|11896530|FG000|COMPLETED|Overall Study||16
10732750|NCT02805309|11896531|FG001|COMPLETED|Overall Study||13
10732751|NCT02805309|11896532|FG002|COMPLETED|Overall Study||16
10732752|NCT02805309|11896530|FG000|NOT COMPLETED|Overall Study||2
10732753|NCT02805309|11896531|FG001|NOT COMPLETED|Overall Study||4
10732754|NCT02805309|11896532|FG002|NOT COMPLETED|Overall Study||3
10732755|NCT02805647|11896542|FG000|STARTED|Overall Study|at the moment of submision|100
10732756|NCT02805647|11896543|FG001|STARTED|Overall Study|at the moment of submision|122
10732757|NCT02805647|11896542|FG000|COMPLETED|Overall Study|after laboratory tests|100
10732758|NCT02805647|11896543|FG001|COMPLETED|Overall Study|after laboratory tests|122
10732759|NCT02805647|11896542|FG000|NOT COMPLETED|Overall Study||0
10732760|NCT02805647|11896543|FG001|NOT COMPLETED|Overall Study||0
10732761|NCT02805660|11896556|FG000|STARTED|Overall Study||5
10732762|NCT02805660|11896557|FG001|STARTED|Overall Study||4
10732763|NCT02805660|11896558|FG002|STARTED|Overall Study||11
10732764|NCT02805660|11896559|FG003|STARTED|Overall Study||18
10732765|NCT02805660|11896560|FG004|STARTED|Overall Study||3
10732766|NCT02805660|11896561|FG005|STARTED|Overall Study||23
10732767|NCT02805660|11896562|FG006|STARTED|Overall Study||19
10732768|NCT02805660|11896556|FG000|COMPLETED|Overall Study||0
10732769|NCT02805660|11896557|FG001|COMPLETED|Overall Study||0
10732770|NCT02805660|11896558|FG002|COMPLETED|Overall Study||0
10732771|NCT02805660|11896559|FG003|COMPLETED|Overall Study||0
10732772|NCT02805660|11896560|FG004|COMPLETED|Overall Study||0
10732773|NCT02805660|11896561|FG005|COMPLETED|Overall Study||0
10732774|NCT02805660|11896562|FG006|COMPLETED|Overall Study||0
10732775|NCT02805660|11896556|FG000|NOT COMPLETED|Overall Study||5
10732776|NCT02805660|11896557|FG001|NOT COMPLETED|Overall Study||4
10815185|NCT02005445|11978216|FG001|NOT COMPLETED|Overall Study||1
10732777|NCT02805660|11896558|FG002|NOT COMPLETED|Overall Study||11
10732778|NCT02805660|11896559|FG003|NOT COMPLETED|Overall Study||18
10732779|NCT02805660|11896560|FG004|NOT COMPLETED|Overall Study||3
10732780|NCT02805660|11896561|FG005|NOT COMPLETED|Overall Study||23
10732781|NCT02805660|11896562|FG006|NOT COMPLETED|Overall Study||19
10732782|NCT02805790|11896593|FG000|STARTED|First Intervention (4 Weeks)||14
10732783|NCT02805790|11896594|FG001|STARTED|First Intervention (4 Weeks)||16
10732784|NCT02805790|11896593|FG000|COMPLETED|First Intervention (4 Weeks)||14
10732785|NCT02805790|11896594|FG001|COMPLETED|First Intervention (4 Weeks)||16
10732786|NCT02805790|11896593|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
10732787|NCT02805790|11896594|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
10732788|NCT02805790|11896593|FG000|STARTED|Washout (4 Weeks)||14
10732789|NCT02805790|11896594|FG001|STARTED|Washout (4 Weeks)||16
10732790|NCT02805790|11896593|FG000|COMPLETED|Washout (4 Weeks)||14
10732791|NCT02805790|11896594|FG001|COMPLETED|Washout (4 Weeks)||16
10732792|NCT02805790|11896593|FG000|NOT COMPLETED|Washout (4 Weeks)||0
10732793|NCT02805790|11896594|FG001|NOT COMPLETED|Washout (4 Weeks)||0
10732794|NCT02805790|11896593|FG000|STARTED|Second Intervention (4 Weeks)||14
10732795|NCT02805790|11896594|FG001|STARTED|Second Intervention (4 Weeks)||16
10732796|NCT02805790|11896593|FG000|COMPLETED|Second Intervention (4 Weeks)||14
10732797|NCT02805790|11896594|FG001|COMPLETED|Second Intervention (4 Weeks)||15
10732798|NCT02805790|11896593|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
10732799|NCT02805790|11896594|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1
10732800|NCT02805907|11896602|FG000|STARTED|Overall Study||56
10732801|NCT02805907|11896603|FG001|STARTED|Overall Study||56
10732802|NCT02805907|11896602|FG000|COMPLETED|Overall Study||53
10732803|NCT02805907|11896603|FG001|COMPLETED|Overall Study||53
10732804|NCT02805907|11896602|FG000|NOT COMPLETED|Overall Study||3
10732805|NCT02805907|11896603|FG001|NOT COMPLETED|Overall Study||3
10732806|NCT02805972|11896611|FG000|STARTED|Intervention Visit 1||23
10732807|NCT02805972|11896612|FG001|STARTED|Intervention Visit 1||18
10732808|NCT02805972|11896611|FG000|COMPLETED|Intervention Visit 1||23
10732809|NCT02805972|11896612|FG001|COMPLETED|Intervention Visit 1||18
10732810|NCT02805972|11896611|FG000|NOT COMPLETED|Intervention Visit 1||0
10732811|NCT02805972|11896612|FG001|NOT COMPLETED|Intervention Visit 1||0
10732812|NCT02805972|11896611|FG000|STARTED|Washout Period||23
10732813|NCT02805972|11896612|FG001|STARTED|Washout Period||18
10732814|NCT02805972|11896611|FG000|COMPLETED|Washout Period||20
10732815|NCT02805972|11896612|FG001|COMPLETED|Washout Period||18
10732816|NCT02805972|11896611|FG000|NOT COMPLETED|Washout Period||3
10732817|NCT02805972|11896612|FG001|NOT COMPLETED|Washout Period||0
10732818|NCT02805972|11896611|FG000|STARTED|Intervention Visit 2||20
10732819|NCT02805972|11896612|FG001|STARTED|Intervention Visit 2||18
10732820|NCT02805972|11896611|FG000|COMPLETED|Intervention Visit 2||20
10732821|NCT02805972|11896612|FG001|COMPLETED|Intervention Visit 2||18
10732822|NCT02805972|11896611|FG000|NOT COMPLETED|Intervention Visit 2||0
10732823|NCT02805972|11896612|FG001|NOT COMPLETED|Intervention Visit 2||0
10732824|NCT02806024|11896630|FG000|STARTED|Overall Study||7
10732825|NCT02806024|11896631|FG001|STARTED|Overall Study||7
10732826|NCT02806024|11896630|FG000|COMPLETED|Overall Study||6
10732827|NCT02806024|11896631|FG001|COMPLETED|Overall Study||5
10732828|NCT02806024|11896630|FG000|NOT COMPLETED|Overall Study||1
10732829|NCT02806024|11896631|FG001|NOT COMPLETED|Overall Study||2
10732830|NCT02806232|11896646|FG000|STARTED|Overall Study||60
10732831|NCT02806232|11896647|FG001|STARTED|Overall Study||60
10732832|NCT02806232|11896648|FG002|STARTED|Overall Study||60
10732833|NCT02806232|11896649|FG003|STARTED|Overall Study||60
10732834|NCT02806232|11896650|FG004|STARTED|Overall Study||60
10732835|NCT02806232|11896651|FG005|STARTED|Overall Study||60
10732836|NCT02806232|11896652|FG006|STARTED|Overall Study||60
10732837|NCT02806232|11896653|FG007|STARTED|Overall Study||20
10732838|NCT02806232|11896654|FG008|STARTED|Overall Study||4
10732839|NCT02806232|11896646|FG000|COMPLETED|Overall Study||59
10732840|NCT02806232|11896647|FG001|COMPLETED|Overall Study||56
10732841|NCT02806232|11896648|FG002|COMPLETED|Overall Study||59
10732842|NCT02806232|11896649|FG003|COMPLETED|Overall Study||60
10732843|NCT02806232|11896650|FG004|COMPLETED|Overall Study||58
10732844|NCT02806232|11896651|FG005|COMPLETED|Overall Study||58
10732845|NCT02806232|11896652|FG006|COMPLETED|Overall Study||60
10732846|NCT02806232|11896653|FG007|COMPLETED|Overall Study||20
10732847|NCT02806232|11896654|FG008|COMPLETED|Overall Study||4
10732848|NCT02806232|11896646|FG000|NOT COMPLETED|Overall Study||1
10732849|NCT02806232|11896647|FG001|NOT COMPLETED|Overall Study||4
10732850|NCT02806232|11896648|FG002|NOT COMPLETED|Overall Study||1
10732851|NCT02806232|11896649|FG003|NOT COMPLETED|Overall Study||0
10732852|NCT02806232|11896650|FG004|NOT COMPLETED|Overall Study||2
10732853|NCT02806232|11896651|FG005|NOT COMPLETED|Overall Study||2
10732854|NCT02806232|11896652|FG006|NOT COMPLETED|Overall Study||0
10732855|NCT02806232|11896653|FG007|NOT COMPLETED|Overall Study||0
10732856|NCT02806232|11896654|FG008|NOT COMPLETED|Overall Study||0
10732857|NCT02806414|11896674|FG000|STARTED|Overall Study||25
10732858|NCT02806414|11896674|FG000|COMPLETED|Overall Study||23
10732859|NCT02806414|11896674|FG000|NOT COMPLETED|Overall Study||2
10732860|NCT02806505|11896680|FG000|STARTED|Overall Study||38
10732861|NCT02806505|11896681|FG001|STARTED|Overall Study||43
10732862|NCT02806505|11896680|FG000|COMPLETED|Overall Study||28
10732863|NCT02806505|11896681|FG001|COMPLETED|Overall Study||32
10732864|NCT02806505|11896680|FG000|NOT COMPLETED|Overall Study||10
10732865|NCT02806505|11896681|FG001|NOT COMPLETED|Overall Study||11
10732866|NCT02806544|11896687|FG000|STARTED|Overall Study||35
10732867|NCT02806544|11896687|FG000|COMPLETED|Overall Study||31
10732868|NCT02806544|11896687|FG000|NOT COMPLETED|Overall Study||4
10732869|NCT02806713|11896693|FG000|STARTED|Overall Study||46
10732870|NCT02806713|11896694|FG001|STARTED|Overall Study||46
10732871|NCT02806713|11896693|FG000|COMPLETED|Overall Study||44
10732872|NCT02806713|11896694|FG001|COMPLETED|Overall Study||44
10732873|NCT02806713|11896693|FG000|NOT COMPLETED|Overall Study||2
10732874|NCT02806713|11896694|FG001|NOT COMPLETED|Overall Study||2
10732875|NCT02806726|11896700|FG000|STARTED|Overall Study|Subjects were treated contralaterally|7
10732876|NCT02806726|11896700|FG000|COMPLETED|Overall Study|Subjects were treated contralaterally|6
10732877|NCT02806726|11896700|FG000|NOT COMPLETED|Overall Study||1
10732878|NCT02806869|11896707|FG000|STARTED|First Intervention (1 Day)||24
10732879|NCT02806869|11896708|FG001|STARTED|First Intervention (1 Day)||24
10732880|NCT02806869|11896707|FG000|COMPLETED|First Intervention (1 Day)||13
10732881|NCT02806869|11896708|FG001|COMPLETED|First Intervention (1 Day)||12
10732882|NCT02806869|11896707|FG000|NOT COMPLETED|First Intervention (1 Day)||11
10732883|NCT02806869|11896708|FG001|NOT COMPLETED|First Intervention (1 Day)||12
10732884|NCT02806869|11896707|FG000|STARTED|Washout (7 Days)||7
10732885|NCT02806869|11896708|FG001|STARTED|Washout (7 Days)||7
10732886|NCT02806869|11896707|FG000|COMPLETED|Washout (7 Days)||7
10732887|NCT02806869|11896708|FG001|COMPLETED|Washout (7 Days)||7
10732888|NCT02806869|11896707|FG000|NOT COMPLETED|Washout (7 Days)||0
10732889|NCT02806869|11896708|FG001|NOT COMPLETED|Washout (7 Days)||0
10732890|NCT02806869|11896707|FG000|STARTED|Second Intervention (1 Day)||7
10732891|NCT02806869|11896708|FG001|STARTED|Second Intervention (1 Day)||7
10732892|NCT02806869|11896707|FG000|COMPLETED|Second Intervention (1 Day)||7
10732893|NCT02806869|11896708|FG001|COMPLETED|Second Intervention (1 Day)||5
10732894|NCT02806869|11896707|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10732895|NCT02806869|11896708|FG001|NOT COMPLETED|Second Intervention (1 Day)||2
10732896|NCT02806895|11896716|FG000|STARTED|Overall Study||17
10732897|NCT02806895|11896717|FG001|STARTED|Overall Study||17
10732898|NCT02806895|11896716|FG000|COMPLETED|Overall Study||16
10732899|NCT02806895|11896717|FG001|COMPLETED|Overall Study||17
10732900|NCT02806895|11896716|FG000|NOT COMPLETED|Overall Study||1
10732901|NCT02806895|11896717|FG001|NOT COMPLETED|Overall Study||0
10732902|NCT02806908|11896726|FG000|STARTED|Overall Study||11
10732903|NCT02806908|11896727|FG001|STARTED|Overall Study||13
10732904|NCT02806908|11896726|FG000|COMPLETED|Overall Study||10
10732905|NCT02806908|11896727|FG001|COMPLETED|Overall Study||12
10732906|NCT02806908|11896726|FG000|NOT COMPLETED|Overall Study||1
10732907|NCT02806908|11896727|FG001|NOT COMPLETED|Overall Study||1
10732908|NCT02806947|11896736|FG000|STARTED|Overall Study||58
10732909|NCT02806947|11896737|FG001|STARTED|Overall Study||64
10732910|NCT02806947|11896736|FG000|COMPLETED|Overall Study||53
10732911|NCT02806947|11896737|FG001|COMPLETED|Overall Study||63
10732912|NCT02806947|11896736|FG000|NOT COMPLETED|Overall Study||5
10732913|NCT02806947|11896737|FG001|NOT COMPLETED|Overall Study||1
10732914|NCT02806973|11896743|FG000|STARTED|Period 1||8
10732915|NCT02806973|11896744|FG001|STARTED|Period 1||8
10732916|NCT02806973|11896745|FG002|STARTED|Period 1||8
10732917|NCT02806973|11896746|FG003|STARTED|Period 1||8
10732918|NCT02806973|11896743|FG000|COMPLETED|Period 1||8
10732919|NCT02806973|11896744|FG001|COMPLETED|Period 1||6
10732920|NCT02806973|11896745|FG002|COMPLETED|Period 1||7
10732921|NCT02806973|11896746|FG003|COMPLETED|Period 1||6
10815186|NCT02020837|11978222|FG000|STARTED|Overall Study||2
10815187|NCT02020837|11978222|FG000|COMPLETED|Overall Study||2
10815188|NCT02020837|11978222|FG000|NOT COMPLETED|Overall Study||0
10815189|NCT02015910|11978228|FG000|STARTED|Overall Study||0
10815190|NCT02015910|11978229|FG001|STARTED|Overall Study||1
10815191|NCT02015910|11978228|FG000|COMPLETED|Overall Study||0
10815192|NCT02015910|11978229|FG001|COMPLETED|Overall Study||1
10815193|NCT02015910|11978228|FG000|NOT COMPLETED|Overall Study||0
10815194|NCT02015910|11978229|FG001|NOT COMPLETED|Overall Study||0
10815195|NCT02006927|11978235|FG000|STARTED|Overall Study||3
10815196|NCT02006927|11978235|FG000|COMPLETED|Overall Study||0
10815197|NCT02006927|11978235|FG000|NOT COMPLETED|Overall Study||3
10815198|NCT01996982|11978239|FG000|STARTED|Overall Study||7
10815199|NCT01996982|11978239|FG000|COMPLETED|Overall Study||0
10815200|NCT01996982|11978239|FG000|NOT COMPLETED|Overall Study||7
10815201|NCT02006407|11978243|FG000|STARTED|Overall Study||5
10815202|NCT02006407|11978243|FG000|COMPLETED|Overall Study||5
10732922|NCT02806973|11896743|FG000|NOT COMPLETED|Period 1||0
10732923|NCT02806973|11896744|FG001|NOT COMPLETED|Period 1||2
10732924|NCT02806973|11896745|FG002|NOT COMPLETED|Period 1||1
10732925|NCT02806973|11896746|FG003|NOT COMPLETED|Period 1||2
10732926|NCT02806973|11896743|FG000|STARTED|Period 2||8
10732927|NCT02806973|11896744|FG001|STARTED|Period 2||6
10732928|NCT02806973|11896745|FG002|STARTED|Period 2||7
10732929|NCT02806973|11896746|FG003|STARTED|Period 2||6
10732930|NCT02806973|11896743|FG000|COMPLETED|Period 2||8
10732931|NCT02806973|11896744|FG001|COMPLETED|Period 2||6
10815203|NCT02006407|11978243|FG000|NOT COMPLETED|Overall Study||0
10815204|NCT01986751|11978249|FG000|STARTED|Overall Study||10
10815205|NCT01986751|11978250|FG001|STARTED|Overall Study||4
10815206|NCT01986751|11978249|FG000|COMPLETED|Overall Study||0
10815207|NCT01986751|11978250|FG001|COMPLETED|Overall Study||2
10732932|NCT02806973|11896745|FG002|COMPLETED|Period 2||7
10815208|NCT01986751|11978249|FG000|NOT COMPLETED|Overall Study||10
10815209|NCT01986751|11978250|FG001|NOT COMPLETED|Overall Study||2
10815210|NCT01996410|11978268|FG000|STARTED|Overall Study||3
10815211|NCT01996410|11978269|FG001|STARTED|Overall Study||3
10732933|NCT02806973|11896746|FG003|COMPLETED|Period 2||6
10732934|NCT02806973|11896743|FG000|NOT COMPLETED|Period 2||0
10732935|NCT02806973|11896744|FG001|NOT COMPLETED|Period 2||0
10732936|NCT02806973|11896745|FG002|NOT COMPLETED|Period 2||0
10732937|NCT02806973|11896746|FG003|NOT COMPLETED|Period 2||0
10732938|NCT02806973|11896743|FG000|STARTED|Period 3||8
10732939|NCT02806973|11896744|FG001|STARTED|Period 3||6
10732940|NCT02806973|11896745|FG002|STARTED|Period 3||7
10732941|NCT02806973|11896746|FG003|STARTED|Period 3||6
10732942|NCT02806973|11896743|FG000|COMPLETED|Period 3||8
10732943|NCT02806973|11896744|FG001|COMPLETED|Period 3||6
10732944|NCT02806973|11896745|FG002|COMPLETED|Period 3||6
10732945|NCT02806973|11896746|FG003|COMPLETED|Period 3||3
10732946|NCT02806973|11896743|FG000|NOT COMPLETED|Period 3||0
10732947|NCT02806973|11896744|FG001|NOT COMPLETED|Period 3||0
10732948|NCT02806973|11896745|FG002|NOT COMPLETED|Period 3||1
10732949|NCT02806973|11896746|FG003|NOT COMPLETED|Period 3||3
10732950|NCT02806973|11896743|FG000|STARTED|Period 4||8
10732951|NCT02806973|11896744|FG001|STARTED|Period 4||6
10732952|NCT02806973|11896745|FG002|STARTED|Period 4||6
10732953|NCT02806973|11896746|FG003|STARTED|Period 4||3
10732954|NCT02806973|11896743|FG000|COMPLETED|Period 4||8
10732955|NCT02806973|11896744|FG001|COMPLETED|Period 4||6
10732956|NCT02806973|11896745|FG002|COMPLETED|Period 4||6
10732957|NCT02806973|11896746|FG003|COMPLETED|Period 4||3
10732958|NCT02806973|11896743|FG000|NOT COMPLETED|Period 4||0
10732959|NCT02806973|11896744|FG001|NOT COMPLETED|Period 4||0
10732960|NCT02806973|11896745|FG002|NOT COMPLETED|Period 4||0
10732961|NCT02806973|11896746|FG003|NOT COMPLETED|Period 4||0
10732962|NCT02806986|11896756|FG000|STARTED|Treatment Stage 1||61
10732963|NCT02806986|11896756|FG000|COMPLETED|Treatment Stage 1||60
10732964|NCT02806986|11896756|FG000|NOT COMPLETED|Treatment Stage 1||1
10732965|NCT02806986|11896756|FG000|STARTED|Treatment Stage 2||60
10732966|NCT02806986|11896756|FG000|COMPLETED|Treatment Stage 2||55
10732967|NCT02806986|11896756|FG000|NOT COMPLETED|Treatment Stage 2||5
10732968|NCT02807259|11896766|FG000|STARTED|Baseline (3 Months)||405
10732969|NCT02807259|11896767|FG001|STARTED|Baseline (3 Months)||404
10732970|NCT02807259|11896766|FG000|COMPLETED|Baseline (3 Months)||328
10732971|NCT02807259|11896767|FG001|COMPLETED|Baseline (3 Months)||292
10732972|NCT02807259|11896766|FG000|NOT COMPLETED|Baseline (3 Months)||77
10732973|NCT02807259|11896767|FG001|NOT COMPLETED|Baseline (3 Months)||112
10732974|NCT02807259|11896766|FG000|STARTED|Midline (3 Months)||352
10732975|NCT02807259|11896767|FG001|STARTED|Midline (3 Months)||223
10732976|NCT02807259|11896766|FG000|COMPLETED|Midline (3 Months)||322
10732977|NCT02807259|11896767|FG001|COMPLETED|Midline (3 Months)||189
10732978|NCT02807259|11896766|FG000|NOT COMPLETED|Midline (3 Months)||30
10732979|NCT02807259|11896767|FG001|NOT COMPLETED|Midline (3 Months)||34
10732980|NCT02807259|11896766|FG000|STARTED|Endline (3 Months)||323
10732981|NCT02807259|11896767|FG001|STARTED|Endline (3 Months)||346
10732982|NCT02807259|11896766|FG000|COMPLETED|Endline (3 Months)||288
10732983|NCT02807259|11896767|FG001|COMPLETED|Endline (3 Months)||259
10732984|NCT02807259|11896766|FG000|NOT COMPLETED|Endline (3 Months)||35
10732985|NCT02807259|11896767|FG001|NOT COMPLETED|Endline (3 Months)||87
10732986|NCT02807376|11896777|FG000|STARTED|Overall Study||139
10732987|NCT02807376|11896778|FG001|STARTED|Overall Study||131
10732988|NCT02807376|11896777|FG000|COMPLETED|Overall Study||136
10732989|NCT02807376|11896778|FG001|COMPLETED|Overall Study||130
10732990|NCT02807376|11896777|FG000|NOT COMPLETED|Overall Study||3
10732991|NCT02807376|11896778|FG001|NOT COMPLETED|Overall Study||1
10732992|NCT02807402|11896784|FG000|STARTED|Overall Study||522
10732993|NCT02807402|11896784|FG000|COMPLETED|Overall Study||516
10732994|NCT02807402|11896784|FG000|NOT COMPLETED|Overall Study||6
10732995|NCT02807623|11896799|FG000|STARTED|Overall Study||98
10732996|NCT02807623|11896800|FG001|STARTED|Overall Study||100
10732997|NCT02807623|11896801|FG002|STARTED|Overall Study||102
10732998|NCT02807623|11896799|FG000|COMPLETED|Overall Study||75
10732999|NCT02807623|11896800|FG001|COMPLETED|Overall Study||79
10733000|NCT02807623|11896801|FG002|COMPLETED|Overall Study||79
10733001|NCT02807623|11896799|FG000|NOT COMPLETED|Overall Study||23
10733002|NCT02807623|11896800|FG001|NOT COMPLETED|Overall Study||21
10733003|NCT02807623|11896801|FG002|NOT COMPLETED|Overall Study||23
10733004|NCT02807844|11896828|FG000|STARTED|Overall Study||6
10733005|NCT02807844|11896829|FG001|STARTED|Overall Study||12
10733006|NCT02807844|11896830|FG002|STARTED|Overall Study||12
10733007|NCT02807844|11896831|FG003|STARTED|Overall Study||13
10733008|NCT02807844|11896832|FG004|STARTED|Overall Study||6
10733009|NCT02807844|11896833|FG005|STARTED|Overall Study||11
10733010|NCT02807844|11896834|FG006|STARTED|Overall Study||20
10733011|NCT02807844|11896835|FG007|STARTED|Overall Study||20
10733012|NCT02807844|11896836|FG008|STARTED|Overall Study||21
10733013|NCT02807844|11896837|FG009|STARTED|Overall Study||20
10733014|NCT02807844|11896828|FG000|COMPLETED|Overall Study||0
10733015|NCT02807844|11896829|FG001|COMPLETED|Overall Study||0
10733016|NCT02807844|11896830|FG002|COMPLETED|Overall Study||0
10733017|NCT02807844|11896831|FG003|COMPLETED|Overall Study||0
10733018|NCT02807844|11896832|FG004|COMPLETED|Overall Study||0
10733019|NCT02807844|11896833|FG005|COMPLETED|Overall Study||0
10733020|NCT02807844|11896834|FG006|COMPLETED|Overall Study||0
10733021|NCT02807844|11896835|FG007|COMPLETED|Overall Study||0
10733022|NCT02807844|11896836|FG008|COMPLETED|Overall Study||0
10733023|NCT02807844|11896837|FG009|COMPLETED|Overall Study||0
10733024|NCT02807844|11896828|FG000|NOT COMPLETED|Overall Study||6
10733025|NCT02807844|11896829|FG001|NOT COMPLETED|Overall Study||12
10733026|NCT02807844|11896830|FG002|NOT COMPLETED|Overall Study||12
10733027|NCT02807844|11896831|FG003|NOT COMPLETED|Overall Study||13
10733028|NCT02807844|11896832|FG004|NOT COMPLETED|Overall Study||6
10733029|NCT02807844|11896833|FG005|NOT COMPLETED|Overall Study||11
10733030|NCT02807844|11896834|FG006|NOT COMPLETED|Overall Study||20
10733031|NCT02807844|11896835|FG007|NOT COMPLETED|Overall Study||20
10733032|NCT02807844|11896836|FG008|NOT COMPLETED|Overall Study||21
10733033|NCT02807844|11896837|FG009|NOT COMPLETED|Overall Study||20
10733034|NCT02807857|11896863|FG000|STARTED|Enrolled Set||1415
10733035|NCT02807857|11896863|FG000|COMPLETED|Enrolled Set||864
10733036|NCT02807857|11896863|FG000|NOT COMPLETED|Enrolled Set||551
10733037|NCT02807857|11896863|FG000|STARTED|Follow-Up Set||864
10733038|NCT02807857|11896863|FG000|COMPLETED|Follow-Up Set||680
10733039|NCT02807857|11896863|FG000|NOT COMPLETED|Follow-Up Set||184
10733040|NCT02807948|11896873|FG000|STARTED|Overall Study||132
10733041|NCT02807948|11896874|FG001|STARTED|Overall Study||57
10733042|NCT02807948|11896873|FG000|COMPLETED|Overall Study||131
10733043|NCT02807948|11896874|FG001|COMPLETED|Overall Study||57
10733044|NCT02807948|11896873|FG000|NOT COMPLETED|Overall Study||1
10733045|NCT02807948|11896874|FG001|NOT COMPLETED|Overall Study||0
10733046|NCT02808052|11896882|FG000|STARTED|Overall Study||4
10733047|NCT02808052|11896883|FG001|STARTED|Overall Study||3
10733048|NCT02808052|11896884|FG002|STARTED|Overall Study||2
10733049|NCT02808052|11896882|FG000|COMPLETED|Overall Study||4
10733050|NCT02808052|11896883|FG001|COMPLETED|Overall Study||3
10733051|NCT02808052|11896884|FG002|COMPLETED|Overall Study||2
10733052|NCT02808052|11896882|FG000|NOT COMPLETED|Overall Study||0
10733053|NCT02808052|11896883|FG001|NOT COMPLETED|Overall Study||0
10733054|NCT02808052|11896884|FG002|NOT COMPLETED|Overall Study||0
10733055|NCT02808130|11896898|FG000|STARTED|Overall Study||15
10733056|NCT02808130|11896899|FG001|STARTED|Overall Study||15
10733057|NCT02808130|11896900|FG002|STARTED|Overall Study||15
10733058|NCT02808130|11896901|FG003|STARTED|Overall Study||15
10733059|NCT02808130|11896902|FG004|STARTED|Overall Study||15
10733060|NCT02808130|11896903|FG005|STARTED|Overall Study||15
10733061|NCT02808130|11896898|FG000|COMPLETED|Overall Study||15
10733062|NCT02808130|11896899|FG001|COMPLETED|Overall Study||15
10733063|NCT02808130|11896900|FG002|COMPLETED|Overall Study||15
10733064|NCT02808130|11896901|FG003|COMPLETED|Overall Study||15
10733065|NCT02808130|11896902|FG004|COMPLETED|Overall Study||15
10733066|NCT02808130|11896903|FG005|COMPLETED|Overall Study||15
10733067|NCT02808130|11896898|FG000|NOT COMPLETED|Overall Study||0
10733068|NCT02808130|11896899|FG001|NOT COMPLETED|Overall Study||0
10733069|NCT02808130|11896900|FG002|NOT COMPLETED|Overall Study||0
10733070|NCT02808130|11896901|FG003|NOT COMPLETED|Overall Study||0
10733071|NCT02808130|11896902|FG004|NOT COMPLETED|Overall Study||0
10733072|NCT02808130|11896903|FG005|NOT COMPLETED|Overall Study||0
10733073|NCT02808312|11896925|FG000|STARTED|Overall Study||10
10733074|NCT02808312|11896926|FG001|STARTED|Overall Study||10
10733075|NCT02808312|11896927|FG002|STARTED|Overall Study||17
10733076|NCT02808312|11896928|FG003|STARTED|Overall Study||10
10733077|NCT02808312|11896929|FG004|STARTED|Overall Study||10
10733078|NCT02808312|11896925|FG000|COMPLETED|Overall Study||10
10733079|NCT02808312|11896926|FG001|COMPLETED|Overall Study||10
10733080|NCT02808312|11896927|FG002|COMPLETED|Overall Study||16
10733081|NCT02808312|11896928|FG003|COMPLETED|Overall Study||10
10733082|NCT02808312|11896929|FG004|COMPLETED|Overall Study||10
10733083|NCT02808312|11896925|FG000|NOT COMPLETED|Overall Study||0
10733084|NCT02808312|11896926|FG001|NOT COMPLETED|Overall Study||0
10733085|NCT02808312|11896927|FG002|NOT COMPLETED|Overall Study||1
10733086|NCT02808312|11896928|FG003|NOT COMPLETED|Overall Study||0
10733087|NCT02808312|11896929|FG004|NOT COMPLETED|Overall Study||0
10733088|NCT02808338|11896946|FG000|STARTED|Screening||25
10733089|NCT02808338|11896946|FG000|COMPLETED|Screening||15
10733090|NCT02808338|11896946|FG000|NOT COMPLETED|Screening||10
10733091|NCT02808338|11896946|FG000|STARTED|Overnight In-lab Polysomonography||15
10733092|NCT02808338|11896946|FG000|Modified Philips BiPAP ASV|Overnight In-lab Polysomonography||13
10733093|NCT02808338|11896946|FG000|ResMed S7 VPAP Adapt|Overnight In-lab Polysomonography||13
10733094|NCT02808338|11896946|FG000|Philips BiPAP AutoSV Advanced System One|Overnight In-lab Polysomonography||12
10733095|NCT02808338|11896946|FG000|ResMed S9 VPAP Adapt|Overnight In-lab Polysomonography||12
10733096|NCT02808338|11896946|FG000|COMPLETED|Overnight In-lab Polysomonography||13
10733097|NCT02808338|11896946|FG000|NOT COMPLETED|Overnight In-lab Polysomonography||2
10733098|NCT02808338|11896946|FG000|STARTED|Take Home Period||13
10733099|NCT02808338|11896946|FG000|COMPLETED|Take Home Period||13
10733100|NCT02808338|11896946|FG000|NOT COMPLETED|Take Home Period||0
10733101|NCT02808429|11896960|FG000|STARTED|Overall Study||5
10733102|NCT02808429|11896961|FG001|STARTED|Overall Study||6
10733103|NCT02808429|11896962|FG002|STARTED|Overall Study||5
10733104|NCT02808429|11896960|FG000|COMPLETED|Overall Study||2
10733105|NCT02808429|11896961|FG001|COMPLETED|Overall Study||5
10733106|NCT02808429|11896962|FG002|COMPLETED|Overall Study||3
10733107|NCT02808429|11896960|FG000|NOT COMPLETED|Overall Study||3
10733108|NCT02808429|11896961|FG001|NOT COMPLETED|Overall Study||1
10733109|NCT02808429|11896962|FG002|NOT COMPLETED|Overall Study||2
10733110|NCT02808819|11896972|FG000|STARTED|Overall Study||220
10733111|NCT02808819|11896973|FG001|STARTED|Overall Study||226
10733112|NCT02808819|11896972|FG000|Treated|Overall Study||220
10733113|NCT02808819|11896973|FG001|Treated|Overall Study||226
10733114|NCT02808819|11896972|FG000|COMPLETED|Overall Study||189
10733115|NCT02808819|11896973|FG001|COMPLETED|Overall Study||195
10733116|NCT02808819|11896972|FG000|NOT COMPLETED|Overall Study||31
10733117|NCT02808819|11896973|FG001|NOT COMPLETED|Overall Study||31
10733118|NCT02808975|11896982|FG000|STARTED|Overall Study||103
10733119|NCT02808975|11896983|FG001|STARTED|Overall Study||103
10733120|NCT02808975|11896982|FG000|COMPLETED|Overall Study||81
10733121|NCT02808975|11896983|FG001|COMPLETED|Overall Study||84
10733122|NCT02808975|11896982|FG000|NOT COMPLETED|Overall Study||22
10733123|NCT02808975|11896983|FG001|NOT COMPLETED|Overall Study||19
10733124|NCT02809053|11896991|FG000|STARTED|Overall Study||157
10733125|NCT02809053|11896992|FG001|STARTED|Overall Study||158
10733126|NCT02809053|11896991|FG000|Completed Treatment|Overall Study||156
10733127|NCT02809053|11896992|FG001|Completed Treatment|Overall Study||156
10733128|NCT02809053|11896991|FG000|COMPLETED|Overall Study||150
10733129|NCT02809053|11896992|FG001|COMPLETED|Overall Study||152
10733130|NCT02809053|11896991|FG000|NOT COMPLETED|Overall Study||7
10733131|NCT02809053|11896992|FG001|NOT COMPLETED|Overall Study||6
10733132|NCT02809183|11897003|FG000|STARTED|Overall Study||25
10733133|NCT02809183|11897004|FG001|STARTED|Overall Study||25
10733134|NCT02809183|11897005|FG002|STARTED|Overall Study||25
10733135|NCT02809183|11897006|FG003|STARTED|Overall Study||26
10733136|NCT02809183|11897007|FG004|STARTED|Overall Study||6
10733137|NCT02809183|11897008|FG005|STARTED|Overall Study||28
10815212|NCT01996410|11978270|FG002|STARTED|Overall Study||0
10815213|NCT01996410|11978271|FG003|STARTED|Overall Study||0
10815214|NCT01996410|11978272|FG004|STARTED|Overall Study||2
10815215|NCT01996410|11978273|FG005|STARTED|Overall Study||2
10815216|NCT01996410|11978274|FG006|STARTED|Overall Study||0
10815217|NCT01996410|11978275|FG007|STARTED|Overall Study||0
10815218|NCT01996410|11978268|FG000|COMPLETED|Overall Study||3
10815219|NCT01996410|11978269|FG001|COMPLETED|Overall Study||3
10815220|NCT01996410|11978270|FG002|COMPLETED|Overall Study||0
10815221|NCT01996410|11978271|FG003|COMPLETED|Overall Study||0
10815222|NCT01996410|11978272|FG004|COMPLETED|Overall Study||2
10815223|NCT01996410|11978273|FG005|COMPLETED|Overall Study||2
10815224|NCT01996410|11978274|FG006|COMPLETED|Overall Study||0
10815225|NCT01996410|11978275|FG007|COMPLETED|Overall Study||0
10815226|NCT01996410|11978268|FG000|NOT COMPLETED|Overall Study||0
10815227|NCT01996410|11978269|FG001|NOT COMPLETED|Overall Study||0
10815228|NCT01996410|11978270|FG002|NOT COMPLETED|Overall Study||0
10815229|NCT01996410|11978271|FG003|NOT COMPLETED|Overall Study||0
10815230|NCT01996410|11978272|FG004|NOT COMPLETED|Overall Study||0
10815231|NCT01996410|11978273|FG005|NOT COMPLETED|Overall Study||0
10815232|NCT01996410|11978274|FG006|NOT COMPLETED|Overall Study||0
10815233|NCT01996410|11978275|FG007|NOT COMPLETED|Overall Study||0
10815234|NCT01996852|11978290|FG000|STARTED|Overall Study||0
10815235|NCT01996852|11978291|FG001|STARTED|Overall Study||0
10815236|NCT01996852|11978292|FG002|STARTED|Overall Study||0
10815237|NCT01996852|11978290|FG000|COMPLETED|Overall Study||0
10815238|NCT01996852|11978291|FG001|COMPLETED|Overall Study||0
10815239|NCT01996852|11978292|FG002|COMPLETED|Overall Study||0
10815240|NCT01996852|11978290|FG000|NOT COMPLETED|Overall Study||0
10815241|NCT01996852|11978291|FG001|NOT COMPLETED|Overall Study||0
10815242|NCT01996852|11978292|FG002|NOT COMPLETED|Overall Study||0
10815243|NCT01997567|11978302|FG000|STARTED|Overall Study||0
10815244|NCT01997567|11978303|FG001|STARTED|Overall Study||0
10815245|NCT01997567|11978302|FG000|COMPLETED|Overall Study||0
10815246|NCT01997567|11978303|FG001|COMPLETED|Overall Study||0
10815247|NCT01997567|11978302|FG000|NOT COMPLETED|Overall Study||0
10815248|NCT01997567|11978303|FG001|NOT COMPLETED|Overall Study||0
10815249|NCT01977729|11978309|FG000|STARTED|Overall Study||1
10815250|NCT01977729|11978309|FG000|COMPLETED|Overall Study||0
10815251|NCT01977729|11978309|FG000|NOT COMPLETED|Overall Study||1
10815252|NCT01973062|11978315|FG000|STARTED|Overall Study||1
10815253|NCT01973062|11978315|FG000|COMPLETED|Overall Study||1
10815254|NCT01973062|11978315|FG000|NOT COMPLETED|Overall Study||0
10815255|NCT01982253|11978322|FG000|STARTED|Overall Study||2
10815256|NCT01982253|11978323|FG001|STARTED|Overall Study||4
10815257|NCT01982253|11978324|FG002|STARTED|Overall Study||4
10815258|NCT01982253|11978322|FG000|COMPLETED|Overall Study||0
10815259|NCT01982253|11978323|FG001|COMPLETED|Overall Study||0
10815260|NCT01982253|11978324|FG002|COMPLETED|Overall Study||0
10815261|NCT01982253|11978322|FG000|NOT COMPLETED|Overall Study||2
10815262|NCT01982253|11978323|FG001|NOT COMPLETED|Overall Study||4
10815263|NCT01982253|11978324|FG002|NOT COMPLETED|Overall Study||4
10815264|NCT01984268|11978332|FG000|STARTED|Overall Study||15
10815265|NCT01984268|11978332|FG000|COMPLETED|Overall Study||0
10815266|NCT01984268|11978332|FG000|NOT COMPLETED|Overall Study||15
10815267|NCT01974284|11978336|FG000|STARTED|Overall Study||7
10815268|NCT01974284|11978336|FG000|COMPLETED|Overall Study||0
10815269|NCT01974284|11978336|FG000|NOT COMPLETED|Overall Study||7
10815270|NCT01971853|11978342|FG000|STARTED|Overall Study||0
10815271|NCT01971853|11978343|FG001|STARTED|Overall Study||0
10815272|NCT01971853|11978342|FG000|COMPLETED|Overall Study||0
10733138|NCT02809183|11897003|FG000|COMPLETED|Overall Study||25
10733139|NCT02809183|11897004|FG001|COMPLETED|Overall Study||25
10733140|NCT02809183|11897005|FG002|COMPLETED|Overall Study||25
10815273|NCT01971853|11978343|FG001|COMPLETED|Overall Study||0
10815274|NCT01971853|11978342|FG000|NOT COMPLETED|Overall Study||0
10815275|NCT01971853|11978343|FG001|NOT COMPLETED|Overall Study||0
10815276|NCT01980875|11978352|FG000|STARTED|Overall Study||8
10815277|NCT01980875|11978353|FG001|STARTED|Overall Study||25
10815278|NCT01980875|11978354|FG002|STARTED|Overall Study||24
10815279|NCT01980875|11978352|FG000|COMPLETED|Overall Study||0
10815280|NCT01980875|11978353|FG001|COMPLETED|Overall Study||0
10815281|NCT01980875|11978354|FG002|COMPLETED|Overall Study||0
10733141|NCT02809183|11897006|FG003|COMPLETED|Overall Study||26
10733142|NCT02809183|11897007|FG004|COMPLETED|Overall Study||6
10733143|NCT02809183|11897008|FG005|COMPLETED|Overall Study||28
10733144|NCT02809183|11897003|FG000|NOT COMPLETED|Overall Study||0
10733145|NCT02809183|11897004|FG001|NOT COMPLETED|Overall Study||0
10733146|NCT02809183|11897005|FG002|NOT COMPLETED|Overall Study||0
10733147|NCT02809183|11897006|FG003|NOT COMPLETED|Overall Study||0
10733148|NCT02809183|11897007|FG004|NOT COMPLETED|Overall Study||0
10733149|NCT02809183|11897008|FG005|NOT COMPLETED|Overall Study||0
10733150|NCT02809430|11897025|FG000|STARTED|Overall Study||90
10733151|NCT02809430|11897025|FG000|Failed 3-night run-in Because no Evidence of Obstructive Sleep Apnea|Overall Study|14 with CPAP < 3 hours, 5 without evidence of OSA, 9 with evidence of central or complex sleep apnea|28
10733152|NCT02809430|11897025|FG000|Stopped CPAP During Inpatient Rehabilitation|Overall Study|10 of 62 participants stopped CPAP after the run-in and prior to discharge from IPR|10
10733153|NCT02809430|11897025|FG000|COMPLETED|Overall Study||52
10733154|NCT02809430|11897025|FG000|NOT COMPLETED|Overall Study||38
10733155|NCT02809833|11897032|FG000|STARTED|Overall Study||850
10733156|NCT02809833|11897032|FG000|COMPLETED|Overall Study||550
10733157|NCT02809833|11897032|FG000|NOT COMPLETED|Overall Study||300
10733158|NCT02809846|11897038|FG000|STARTED|Overall Study||17
10733159|NCT02809846|11897039|FG001|STARTED|Overall Study||16
10733160|NCT02809846|11897038|FG000|COMPLETED|Overall Study||8
10733161|NCT02809846|11897039|FG001|COMPLETED|Overall Study||9
10733162|NCT02809846|11897038|FG000|NOT COMPLETED|Overall Study||9
10733163|NCT02809846|11897039|FG001|NOT COMPLETED|Overall Study||7
10733164|NCT02809859|11897045|FG000|STARTED|Overall Study||139
10733165|NCT02809859|11897045|FG000|COMPLETED|Overall Study||125
10733166|NCT02809859|11897045|FG000|NOT COMPLETED|Overall Study||14
10733167|NCT02809911|11897051|FG000|STARTED|Overall Study|This is the Initial Treatment Population (subjects that started the Enrollment Visit / Visit 2)|22
10733168|NCT02809911|11897052|FG001|STARTED|Overall Study|This is the Initial Treatment Population (subjects that started the Enrollment Visit / Visit 2)|19
10733169|NCT02809911|11897051|FG000|COMPLETED|Overall Study|This is the Initial Treatment Population (subjects that completed the Enrollment Visit / Visit 2)|22
10733170|NCT02809911|11897052|FG001|COMPLETED|Overall Study|This is the Initial Treatment Population (subjects that completed the Enrollment Visit / Visit 2)|19
10733171|NCT02809911|11897051|FG000|NOT COMPLETED|Overall Study||0
10733172|NCT02809911|11897052|FG001|NOT COMPLETED|Overall Study||0
10733173|NCT02809976|11897058|FG000|STARTED|Overall Study||11
10733174|NCT02809976|11897058|FG000|COMPLETED|Overall Study||9
10733175|NCT02809976|11897058|FG000|NOT COMPLETED|Overall Study||2
10733176|NCT02810327|11897064|FG000|STARTED|Overall Study||76
10733177|NCT02810327|11897065|FG001|STARTED|Overall Study||41
10733178|NCT02810327|11897064|FG000|COMPLETED|Overall Study||69
10733179|NCT02810327|11897065|FG001|COMPLETED|Overall Study||34
10733180|NCT02810327|11897064|FG000|NOT COMPLETED|Overall Study||7
10733181|NCT02810327|11897065|FG001|NOT COMPLETED|Overall Study||7
10733182|NCT02810340|11897074|FG000|STARTED|Overall Study||20
10733183|NCT02810340|11897075|FG001|STARTED|Overall Study||20
10733184|NCT02810340|11897076|FG002|STARTED|Overall Study||20
10733185|NCT02810340|11897074|FG000|COMPLETED|Overall Study||19
10733186|NCT02810340|11897075|FG001|COMPLETED|Overall Study||19
10733187|NCT02810340|11897076|FG002|COMPLETED|Overall Study||19
10733188|NCT02810340|11897074|FG000|NOT COMPLETED|Overall Study||1
10733189|NCT02810340|11897075|FG001|NOT COMPLETED|Overall Study||1
10733190|NCT02810340|11897076|FG002|NOT COMPLETED|Overall Study||1
10733191|NCT02810392|11897086|FG000|STARTED|Overall Study||9
10733192|NCT02810392|11897087|FG001|STARTED|Overall Study||10
10733193|NCT02810392|11897086|FG000|COMPLETED|Overall Study||8
10733194|NCT02810392|11897087|FG001|COMPLETED|Overall Study||9
10733195|NCT02810392|11897086|FG000|NOT COMPLETED|Overall Study||1
10733196|NCT02810392|11897087|FG001|NOT COMPLETED|Overall Study||1
10733197|NCT02810509|11897095|FG000|STARTED|Overall Study||584
10733198|NCT02810509|11897096|FG001|STARTED|Overall Study||1230
10733199|NCT02810509|11897095|FG000|COMPLETED|Overall Study||584
10733200|NCT02810509|11897096|FG001|COMPLETED|Overall Study||1230
10733201|NCT02810509|11897095|FG000|NOT COMPLETED|Overall Study||0
10733202|NCT02810509|11897096|FG001|NOT COMPLETED|Overall Study||0
10733203|NCT02810873|11897106|FG000|STARTED|Overall Study||6
10733204|NCT02810873|11897107|FG001|STARTED|Overall Study||13
10733205|NCT02810873|11897106|FG000|COMPLETED|Overall Study||6
10733206|NCT02810873|11897107|FG001|COMPLETED|Overall Study||13
10733207|NCT02810873|11897106|FG000|NOT COMPLETED|Overall Study||0
10733208|NCT02810873|11897107|FG001|NOT COMPLETED|Overall Study||0
10733209|NCT02810951|11897114|FG000|STARTED|Overall Study||6
10733210|NCT02810951|11897114|FG000|FCX-007 Injection|Overall Study||6
10733211|NCT02810951|11897114|FG000|No FCX-007 Injection|Overall Study||6
10733212|NCT02810951|11897114|FG000|COMPLETED|Overall Study||5
10815282|NCT01980875|11978352|FG000|NOT COMPLETED|Overall Study||8
10815283|NCT01980875|11978353|FG001|NOT COMPLETED|Overall Study||25
10815284|NCT01980875|11978354|FG002|NOT COMPLETED|Overall Study||24
10733213|NCT02810951|11897114|FG000|NOT COMPLETED|Overall Study||1
10733214|NCT02810964|11897122|FG000|STARTED|Placebo Run-In Phase (2 Weeks)||32
10733215|NCT02810964|11897123|FG001|STARTED|Placebo Run-In Phase (2 Weeks)||32
10733216|NCT02810964|11897122|FG000|COMPLETED|Placebo Run-In Phase (2 Weeks)||32
10733217|NCT02810964|11897123|FG001|COMPLETED|Placebo Run-In Phase (2 Weeks)||32
10733218|NCT02810964|11897122|FG000|NOT COMPLETED|Placebo Run-In Phase (2 Weeks)||0
10733219|NCT02810964|11897123|FG001|NOT COMPLETED|Placebo Run-In Phase (2 Weeks)||0
10815285|NCT01982383|11978364|FG000|STARTED|Overall Study||2
10815286|NCT01982383|11978365|FG001|STARTED|Overall Study||0
10733220|NCT02810964|11897122|FG000|STARTED|Double-Blind Treatment Phase (16 Weeks)||32
10733221|NCT02810964|11897123|FG001|STARTED|Double-Blind Treatment Phase (16 Weeks)||32
10733222|NCT02810964|11897122|FG000|COMPLETED|Double-Blind Treatment Phase (16 Weeks)||29
10733223|NCT02810964|11897123|FG001|COMPLETED|Double-Blind Treatment Phase (16 Weeks)||29
10733224|NCT02810964|11897122|FG000|NOT COMPLETED|Double-Blind Treatment Phase (16 Weeks)||3
10733225|NCT02810964|11897123|FG001|NOT COMPLETED|Double-Blind Treatment Phase (16 Weeks)||3
10733226|NCT02811159|11897129|FG000|STARTED|Treatment Course 1||20
10733227|NCT02811159|11897129|FG000|COMPLETED|Treatment Course 1||19
10733228|NCT02811159|11897129|FG000|NOT COMPLETED|Treatment Course 1||1
10733229|NCT02811159|11897129|FG000|STARTED|Treatment Course 2|Not all participants who completed the Treatment Course 1 entered the Treatment Course 2.|4
10733230|NCT02811159|11897129|FG000|COMPLETED|Treatment Course 2||4
10733231|NCT02811159|11897129|FG000|NOT COMPLETED|Treatment Course 2||0
10733232|NCT02811302|11897133|FG000|STARTED|Overall Study||1495
10733233|NCT02811302|11897133|FG000|COMPLETED|Overall Study||1282
10733234|NCT02811302|11897133|FG000|NOT COMPLETED|Overall Study||213
10733235|NCT02811419|11897140|FG000|STARTED|Overall Study||369
10733236|NCT02811419|11897141|FG001|STARTED|Overall Study||371
10733237|NCT02811419|11897140|FG000|COMPLETED|Overall Study||357
10733238|NCT02811419|11897141|FG001|COMPLETED|Overall Study||358
10733239|NCT02811419|11897140|FG000|NOT COMPLETED|Overall Study||12
10733240|NCT02811419|11897141|FG001|NOT COMPLETED|Overall Study||13
10733241|NCT02811445|11897149|FG000|STARTED|Overall Study||18
10733242|NCT02811445|11897150|FG001|STARTED|Overall Study||11
10733243|NCT02811445|11897149|FG000|COMPLETED|Overall Study||18
10733244|NCT02811445|11897150|FG001|COMPLETED|Overall Study||11
10733245|NCT02811445|11897149|FG000|NOT COMPLETED|Overall Study||0
10733246|NCT02811445|11897150|FG001|NOT COMPLETED|Overall Study||0
10733247|NCT02811640|11897156|FG000|STARTED|Overall Study||12
10733248|NCT02811640|11897156|FG000|COMPLETED|Overall Study||10
10733249|NCT02811640|11897156|FG000|NOT COMPLETED|Overall Study||2
10733250|NCT02811965|11897160|FG000|STARTED|Overall Study||21
10733251|NCT02811965|11897160|FG000|COMPLETED|Overall Study||21
10733252|NCT02811965|11897160|FG000|NOT COMPLETED|Overall Study||0
10777894|NCT03345472|11939785|FG000|NOT COMPLETED|3 Months to 12 Months||8
10777895|NCT03345914|11939792|FG000|STARTED|Overall Study||123
10777896|NCT03345914|11939793|FG001|STARTED|Overall Study||122
10777897|NCT03345914|11939794|FG002|STARTED|Overall Study||122
10777898|NCT03345914|11939792|FG000|Completed Week 16 Study Treatment|Overall Study||114
10777899|NCT03345914|11939793|FG001|Completed Week 16 Study Treatment|Overall Study||118
10777900|NCT03345914|11939794|FG002|Completed Week 16 Study Treatment|Overall Study||119
10777901|NCT03345914|11939792|FG000|Completed Week 28 End of Study|Overall Study||0
10777902|NCT03345914|11939793|FG001|Completed Week 28 End of Study|Overall Study||0
10777903|NCT03345914|11939794|FG002|Completed Week 28 End of Study|Overall Study||0
10777904|NCT03345914|11939792|FG000|COMPLETED|Overall Study||0
10777905|NCT03345914|11939793|FG001|COMPLETED|Overall Study||0
10777906|NCT03345914|11939794|FG002|COMPLETED|Overall Study||0
10777907|NCT03345914|11939792|FG000|NOT COMPLETED|Overall Study||123
10777908|NCT03345914|11939793|FG001|NOT COMPLETED|Overall Study||122
10777909|NCT03345914|11939794|FG002|NOT COMPLETED|Overall Study||122
10777910|NCT03345979|11939804|FG000|STARTED|Overall Study||99
10777911|NCT03345979|11939805|FG001|STARTED|Overall Study||101
10777912|NCT03345979|11939804|FG000|COMPLETED|Overall Study||56
10777913|NCT03345979|11939805|FG001|COMPLETED|Overall Study||43
10777914|NCT03345979|11939804|FG000|NOT COMPLETED|Overall Study||43
10777915|NCT03345979|11939805|FG001|NOT COMPLETED|Overall Study||58
10777916|NCT03346057|11939815|FG000|STARTED|Overall Study||111
10777917|NCT03346057|11939816|FG001|STARTED|Overall Study||112
10777918|NCT03346057|11939817|FG002|STARTED|Overall Study||68
10777919|NCT03346057|11939818|FG003|STARTED|Overall Study||53
10777920|NCT03346057|11939815|FG000|Treated|Overall Study||105
10777921|NCT03346057|11939816|FG001|Treated|Overall Study||107
10777922|NCT03346057|11939817|FG002|Treated|Overall Study||68
10777923|NCT03346057|11939818|FG003|Treated|Overall Study||51
10777924|NCT03346057|11939815|FG000|COMPLETED|Overall Study||104
10777925|NCT03346057|11939816|FG001|COMPLETED|Overall Study||104
10777926|NCT03346057|11939817|FG002|COMPLETED|Overall Study||67
10777927|NCT03346057|11939818|FG003|COMPLETED|Overall Study||51
10777928|NCT03346057|11939815|FG000|NOT COMPLETED|Overall Study||7
10777929|NCT03346057|11939816|FG001|NOT COMPLETED|Overall Study||8
10777930|NCT03346057|11939817|FG002|NOT COMPLETED|Overall Study||1
10777931|NCT03346057|11939818|FG003|NOT COMPLETED|Overall Study||2
10779314|NCT03364309|11940870|FG011|COMPLETED|Post-Treatment Followup Period||0
10779315|NCT03364309|11940871|FG012|COMPLETED|Post-Treatment Followup Period||0
10779316|NCT03364309|11940872|FG013|COMPLETED|Post-Treatment Followup Period||0
10779317|NCT03364309|11940873|FG014|COMPLETED|Post-Treatment Followup Period||0
10779318|NCT03364309|11940874|FG015|COMPLETED|Post-Treatment Followup Period||0
10779319|NCT03364309|11940875|FG016|COMPLETED|Post-Treatment Followup Period||6
10779320|NCT03364309|11940876|FG017|COMPLETED|Post-Treatment Followup Period||344
10779321|NCT03364309|11940877|FG018|COMPLETED|Post-Treatment Followup Period||0
10779322|NCT03364309|11940859|FG000|NOT COMPLETED|Post-Treatment Followup Period||0
10779323|NCT03364309|11940860|FG001|NOT COMPLETED|Post-Treatment Followup Period||0
10779324|NCT03364309|11940861|FG002|NOT COMPLETED|Post-Treatment Followup Period||0
10779325|NCT03364309|11940862|FG003|NOT COMPLETED|Post-Treatment Followup Period||0
10779326|NCT03364309|11940863|FG004|NOT COMPLETED|Post-Treatment Followup Period||0
10779327|NCT03364309|11940864|FG005|NOT COMPLETED|Post-Treatment Followup Period||0
10779328|NCT03364309|11940865|FG006|NOT COMPLETED|Post-Treatment Followup Period||0
10733253|NCT02812160|11897178|FG000|STARTED|Overall Study||187
10733254|NCT02812160|11897179|FG001|STARTED|Overall Study||101
10733255|NCT02812160|11897178|FG000|COMPLETED|Overall Study||187
10733256|NCT02812160|11897179|FG001|COMPLETED|Overall Study||101
10733257|NCT02812160|11897178|FG000|NOT COMPLETED|Overall Study||0
10733258|NCT02812160|11897179|FG001|NOT COMPLETED|Overall Study||0
10733259|NCT02812186|11897187|FG000|STARTED|Period 1||40
10733260|NCT02812186|11897188|FG001|STARTED|Period 1||39
10733261|NCT02812186|11897187|FG000|COMPLETED|Period 1||29
10733262|NCT02812186|11897188|FG001|COMPLETED|Period 1||24
10733263|NCT02812186|11897187|FG000|NOT COMPLETED|Period 1||11
10733264|NCT02812186|11897188|FG001|NOT COMPLETED|Period 1||15
10733265|NCT02812186|11897187|FG000|STARTED|Period 2||29
10733266|NCT02812186|11897188|FG001|STARTED|Period 2||24
10733267|NCT02812186|11897187|FG000|COMPLETED|Period 2||29
10733268|NCT02812186|11897188|FG001|COMPLETED|Period 2||24
10733269|NCT02812186|11897187|FG000|NOT COMPLETED|Period 2||0
10733270|NCT02812186|11897188|FG001|NOT COMPLETED|Period 2||0
10733271|NCT02812238|11897197|FG000|STARTED|First Intervention||19
10733272|NCT02812238|11897198|FG001|STARTED|First Intervention||19
10733273|NCT02812238|11897197|FG000|COMPLETED|First Intervention||18
10733274|NCT02812238|11897198|FG001|COMPLETED|First Intervention||19
10733275|NCT02812238|11897197|FG000|NOT COMPLETED|First Intervention||1
10733276|NCT02812238|11897198|FG001|NOT COMPLETED|First Intervention||0
10733277|NCT02812238|11897197|FG000|STARTED|Second Intervention||18
10733278|NCT02812238|11897198|FG001|STARTED|Second Intervention||19
10733279|NCT02812238|11897197|FG000|COMPLETED|Second Intervention||18
10733280|NCT02812238|11897198|FG001|COMPLETED|Second Intervention||18
10733281|NCT02812238|11897197|FG000|NOT COMPLETED|Second Intervention||0
10733282|NCT02812238|11897198|FG001|NOT COMPLETED|Second Intervention||1
10733283|NCT02812342|11897204|FG000|STARTED|Overall Study||10
10733284|NCT02812342|11897204|FG000|COMPLETED|Overall Study||10
10733285|NCT02812342|11897204|FG000|NOT COMPLETED|Overall Study||0
10733286|NCT02812771|11897208|FG000|STARTED|Overall Study||62
10733287|NCT02812771|11897208|FG000|COMPLETED|Overall Study||50
10733288|NCT02812771|11897208|FG000|NOT COMPLETED|Overall Study||12
10733289|NCT02813070|11897215|FG000|STARTED|Overall Study||28
10733290|NCT02813070|11897216|FG001|STARTED|Overall Study||23
10733291|NCT02813070|11897217|FG002|STARTED|Overall Study||36
10733292|NCT02813070|11897215|FG000|Treated (Safety Population)|Overall Study||25
10733293|NCT02813070|11897216|FG001|Treated (Safety Population)|Overall Study||20
10815287|NCT01982383|11978364|FG000|COMPLETED|Overall Study||2
10815288|NCT01982383|11978365|FG001|COMPLETED|Overall Study||0
10815289|NCT01982383|11978364|FG000|NOT COMPLETED|Overall Study||0
10815290|NCT01982383|11978365|FG001|NOT COMPLETED|Overall Study||0
10815291|NCT01980342|11978371|FG000|STARTED|Overall Study||1
10815292|NCT01980342|11978371|FG000|COMPLETED|Overall Study||0
10815293|NCT01980342|11978371|FG000|NOT COMPLETED|Overall Study||1
10815294|NCT01978535|11978377|FG000|STARTED|Overall Study||1
10815295|NCT01978535|11978378|FG001|STARTED|Overall Study||2
10815296|NCT01978535|11978377|FG000|COMPLETED|Overall Study||1
10815297|NCT01978535|11978378|FG001|COMPLETED|Overall Study||2
10815298|NCT01978535|11978377|FG000|NOT COMPLETED|Overall Study||0
10815299|NCT01978535|11978378|FG001|NOT COMPLETED|Overall Study||0
10815300|NCT01974635|11978384|FG000|STARTED|Overall Study||2
10815301|NCT01974635|11978384|FG000|COMPLETED|Overall Study||2
10815302|NCT01974635|11978384|FG000|NOT COMPLETED|Overall Study||0
10815303|NCT01975467|11978391|FG000|STARTED|Overall Study|Study terminated before enrollment|0
10815304|NCT01975467|11978392|FG001|STARTED|Overall Study|Study terminated before enrollment|0
10815305|NCT01975467|11978391|FG000|COMPLETED|Overall Study||0
10815306|NCT01975467|11978392|FG001|COMPLETED|Overall Study||0
10815307|NCT01975467|11978391|FG000|NOT COMPLETED|Overall Study||0
10815308|NCT01975467|11978392|FG001|NOT COMPLETED|Overall Study||0
10815309|NCT01970462|11978400|FG000|STARTED|Overall Study||1
10815310|NCT01970462|11978401|FG001|STARTED|Overall Study||4
10815311|NCT01970462|11978400|FG000|COMPLETED|Overall Study||1
10815312|NCT01970462|11978401|FG001|COMPLETED|Overall Study||2
10815313|NCT01970462|11978400|FG000|NOT COMPLETED|Overall Study||0
10815314|NCT01970462|11978401|FG001|NOT COMPLETED|Overall Study||2
10815315|NCT01969565|11978407|FG000|STARTED|Overall Study||1
10815316|NCT01969565|11978407|FG000|COMPLETED|Overall Study||0
10815317|NCT01969565|11978407|FG000|NOT COMPLETED|Overall Study||1
10815318|NCT01968226|11978412|FG000|STARTED|Overall Study||3
10815319|NCT01968226|11978412|FG000|COMPLETED|Overall Study||1
10815320|NCT01968226|11978412|FG000|NOT COMPLETED|Overall Study||2
10815321|NCT01965782|11978416|FG000|STARTED|Overall Study||0
10815322|NCT01965782|11978416|FG000|COMPLETED|Overall Study||0
10815323|NCT01965782|11978416|FG000|NOT COMPLETED|Overall Study||0
10815324|NCT01962675|11978422|FG000|STARTED|Overall Study||7
10815325|NCT01962675|11978423|FG001|STARTED|Overall Study||7
10815326|NCT01962675|11978422|FG000|COMPLETED|Overall Study||7
10815327|NCT01962675|11978423|FG001|COMPLETED|Overall Study||7
10815328|NCT01962675|11978422|FG000|NOT COMPLETED|Overall Study||0
10815329|NCT01962675|11978423|FG001|NOT COMPLETED|Overall Study||0
10733294|NCT02813070|11897217|FG002|Treated (Safety Population)|Overall Study||25
10733295|NCT02813070|11897215|FG000|COMPLETED|Overall Study||25
10733296|NCT02813070|11897216|FG001|COMPLETED|Overall Study||20
10733297|NCT02813070|11897217|FG002|COMPLETED|Overall Study||25
10733298|NCT02813070|11897215|FG000|NOT COMPLETED|Overall Study||3
10733299|NCT02813070|11897216|FG001|NOT COMPLETED|Overall Study||3
10733300|NCT02813070|11897217|FG002|NOT COMPLETED|Overall Study||11
10815330|NCT01962974|11978431|FG000|STARTED|Overall Study||7
10733301|NCT02813265|11897226|FG000|STARTED|Overall Study||459
10733302|NCT02813265|11897227|FG001|STARTED|Overall Study||456
10733303|NCT02813265|11897226|FG000|COMPLETED|Overall Study||455
10733304|NCT02813265|11897227|FG001|COMPLETED|Overall Study||453
10733305|NCT02813265|11897226|FG000|NOT COMPLETED|Overall Study||4
10733306|NCT02813265|11897227|FG001|NOT COMPLETED|Overall Study||3
10815331|NCT01962974|11978431|FG000|COMPLETED|Overall Study||0
10815332|NCT01962974|11978431|FG000|NOT COMPLETED|Overall Study||7
10815333|NCT01954160|11978437|FG000|STARTED|Overall Study||5
10815334|NCT01954160|11978438|FG001|STARTED|Overall Study|Not started|0
10815335|NCT01954160|11978437|FG000|COMPLETED|Overall Study|Only 4 subjects completed the first early denervation. No subjects completed the late denervation.|0
10815336|NCT01954160|11978438|FG001|COMPLETED|Overall Study||0
10815337|NCT01954160|11978437|FG000|NOT COMPLETED|Overall Study||5
10815338|NCT01954160|11978438|FG001|NOT COMPLETED|Overall Study||0
10815339|NCT01951378|11978448|FG000|STARTED|Overall Study||23
10815340|NCT01951378|11978449|FG001|STARTED|Overall Study||17
10815341|NCT01951378|11978448|FG000|COMPLETED|Overall Study||0
10815342|NCT01951378|11978449|FG001|COMPLETED|Overall Study||0
10815343|NCT01951378|11978448|FG000|NOT COMPLETED|Overall Study||23
10815344|NCT01951378|11978449|FG001|NOT COMPLETED|Overall Study||17
10815345|NCT01941615|11978455|FG000|STARTED|Run in Treatment: Microgynon®||16
10815346|NCT01941615|11978455|FG000|COMPLETED|Run in Treatment: Microgynon®||16
10815347|NCT01941615|11978455|FG000|NOT COMPLETED|Run in Treatment: Microgynon®||0
10815348|NCT01941615|11978455|FG000|STARTED|Reference Treatment: Microgynon®||0
10815349|NCT01941615|11978455|FG000|COMPLETED|Reference Treatment: Microgynon®||0
10815350|NCT01941615|11978455|FG000|NOT COMPLETED|Reference Treatment: Microgynon®||0
10815351|NCT01941615|11978455|FG000|STARTED|Microgynon® Plus Deleobuvir+Faldaprevir||0
10815352|NCT01941615|11978455|FG000|COMPLETED|Microgynon® Plus Deleobuvir+Faldaprevir||0
10815353|NCT01941615|11978455|FG000|NOT COMPLETED|Microgynon® Plus Deleobuvir+Faldaprevir||0
10815354|NCT01946542|11978461|FG000|STARTED|Testing Visit 1||1
10815355|NCT01946542|11978462|FG001|STARTED|Testing Visit 1||1
10815356|NCT01946542|11978461|FG000|COMPLETED|Testing Visit 1||1
10815357|NCT01946542|11978462|FG001|COMPLETED|Testing Visit 1||1
10815358|NCT01946542|11978461|FG000|NOT COMPLETED|Testing Visit 1||0
10815359|NCT01946542|11978462|FG001|NOT COMPLETED|Testing Visit 1||0
10815360|NCT01946542|11978461|FG000|STARTED|Testing Visit 2||1
10815361|NCT01946542|11978462|FG001|STARTED|Testing Visit 2||1
10815362|NCT01946542|11978461|FG000|COMPLETED|Testing Visit 2||1
10815363|NCT01946542|11978462|FG001|COMPLETED|Testing Visit 2||1
10815364|NCT01946542|11978461|FG000|NOT COMPLETED|Testing Visit 2||0
10815365|NCT01946542|11978462|FG001|NOT COMPLETED|Testing Visit 2||0
10815366|NCT01937507|11978468|FG000|STARTED|Overall Study||2
10815367|NCT01937507|11978468|FG000|COMPLETED|Overall Study||0
10733307|NCT02813421|11897235|FG000|STARTED|Overall Study||5
10733308|NCT02813421|11897236|FG001|STARTED|Overall Study||6
10733309|NCT02813421|11897235|FG000|COMPLETED|Overall Study||3
10733310|NCT02813421|11897236|FG001|COMPLETED|Overall Study||3
10733311|NCT02813421|11897235|FG000|NOT COMPLETED|Overall Study||2
10733312|NCT02813421|11897236|FG001|NOT COMPLETED|Overall Study||3
10733313|NCT02813473|11897242|FG000|STARTED|Overall Study||223
10733314|NCT02813473|11897242|FG000|COMPLETED|Overall Study||223
10733315|NCT02813473|11897242|FG000|NOT COMPLETED|Overall Study||0
10733316|NCT02813551|11897248|FG000|STARTED|Overall Study||59
10733317|NCT02813551|11897249|FG001|STARTED|Overall Study||59
10733318|NCT02813551|11897248|FG000|COMPLETED|Overall Study||58
10733319|NCT02813551|11897249|FG001|COMPLETED|Overall Study||57
10733320|NCT02813551|11897248|FG000|NOT COMPLETED|Overall Study||1
10733321|NCT02813551|11897249|FG001|NOT COMPLETED|Overall Study||2
10733322|NCT02813577|11897255|FG000|STARTED|Overall Study||4
10733323|NCT02813577|11897255|FG000|COMPLETED|Overall Study|Study was terminated and only some results at 1 month follow up are available.|0
10733324|NCT02813577|11897255|FG000|NOT COMPLETED|Overall Study||4
10733325|NCT02813681|11897262|FG000|STARTED|Overall Study||27
10733326|NCT02813681|11897263|FG001|STARTED|Overall Study||34
10733327|NCT02813681|11897264|FG002|STARTED|Overall Study||19
10733328|NCT02813681|11897262|FG000|COMPLETED|Overall Study||22
10733329|NCT02813681|11897263|FG001|COMPLETED|Overall Study||28
10733330|NCT02813681|11897264|FG002|COMPLETED|Overall Study||19
10733331|NCT02813681|11897262|FG000|NOT COMPLETED|Overall Study||5
10733332|NCT02813681|11897263|FG001|NOT COMPLETED|Overall Study||6
10733333|NCT02813681|11897264|FG002|NOT COMPLETED|Overall Study||0
10733334|NCT02813694|11897276|FG000|STARTED|Overall Study|Intent to Treat Analysis Set|370
10733335|NCT02813694|11897277|FG001|STARTED|Overall Study|Intent to Treat Analysis Set|368
10733336|NCT02813694|11897276|FG000|COMPLETED|Overall Study||353
10733337|NCT02813694|11897277|FG001|COMPLETED|Overall Study|Completed Study (Late Follow Up Assessment)|354
10733338|NCT02813694|11897276|FG000|NOT COMPLETED|Overall Study||17
10733339|NCT02813694|11897277|FG001|NOT COMPLETED|Overall Study||14
10815368|NCT01937507|11978468|FG000|NOT COMPLETED|Overall Study||2
10815369|NCT01944059|11978472|FG000|STARTED|Overall Study||31
10815370|NCT01944059|11978472|FG000|COMPLETED|Overall Study||24
10815371|NCT01944059|11978472|FG000|NOT COMPLETED|Overall Study||7
10815372|NCT01935947|11978480|FG000|STARTED|Overall Study||4
10815373|NCT01935947|11978481|FG001|STARTED|Overall Study||4
10733340|NCT02814175|11897285|FG000|STARTED|Part 1||122
10733341|NCT02814175|11897286|FG001|STARTED|Part 1||123
10733342|NCT02814175|11897287|FG002|STARTED|Part 1||0
10733343|NCT02814175|11897288|FG003|STARTED|Part 1||0
10733344|NCT02814175|11897289|FG004|STARTED|Part 1||0
10733345|NCT02814175|11897290|FG005|STARTED|Part 1||0
10733346|NCT02814175|11897285|FG000|COMPLETED|Part 1||110
10733347|NCT02814175|11897286|FG001|COMPLETED|Part 1||117
10733348|NCT02814175|11897287|FG002|COMPLETED|Part 1||0
10733349|NCT02814175|11897288|FG003|COMPLETED|Part 1||0
10733350|NCT02814175|11897289|FG004|COMPLETED|Part 1||0
10733351|NCT02814175|11897290|FG005|COMPLETED|Part 1||0
10733352|NCT02814175|11897285|FG000|NOT COMPLETED|Part 1||12
10733353|NCT02814175|11897286|FG001|NOT COMPLETED|Part 1||6
10733354|NCT02814175|11897287|FG002|NOT COMPLETED|Part 1||0
10733355|NCT02814175|11897288|FG003|NOT COMPLETED|Part 1||0
10733356|NCT02814175|11897289|FG004|NOT COMPLETED|Part 1||0
10733357|NCT02814175|11897290|FG005|NOT COMPLETED|Part 1||0
10733358|NCT02814175|11897285|FG000|STARTED|Part 2||0
10733359|NCT02814175|11897286|FG001|STARTED|Part 2||0
10733360|NCT02814175|11897287|FG002|STARTED|Part 2||15
10733361|NCT02814175|11897288|FG003|STARTED|Part 2||95
10733362|NCT02814175|11897289|FG004|STARTED|Part 2||54
10733363|NCT02814175|11897290|FG005|STARTED|Part 2||63
10733364|NCT02814175|11897285|FG000|COMPLETED|Part 2||0
10733365|NCT02814175|11897286|FG001|COMPLETED|Part 2||0
10733366|NCT02814175|11897287|FG002|COMPLETED|Part 2||15
10733367|NCT02814175|11897288|FG003|COMPLETED|Part 2||91
10733368|NCT02814175|11897289|FG004|COMPLETED|Part 2||52
10733369|NCT02814175|11897290|FG005|COMPLETED|Part 2||57
10733370|NCT02814175|11897285|FG000|NOT COMPLETED|Part 2||0
10733371|NCT02814175|11897286|FG001|NOT COMPLETED|Part 2||0
10733372|NCT02814175|11897287|FG002|NOT COMPLETED|Part 2||0
10733373|NCT02814175|11897288|FG003|NOT COMPLETED|Part 2||4
10733374|NCT02814175|11897289|FG004|NOT COMPLETED|Part 2||2
10733375|NCT02814175|11897290|FG005|NOT COMPLETED|Part 2||6
10733376|NCT02814227|11897304|FG000|STARTED|Overall Study||52
10733377|NCT02814227|11897304|FG000|COMPLETED|Overall Study||52
10733378|NCT02814227|11897304|FG000|NOT COMPLETED|Overall Study||0
10733379|NCT02814279|11897310|FG000|STARTED|Overall Study||21
10733380|NCT02814279|11897311|FG001|STARTED|Overall Study||21
10733381|NCT02814279|11897310|FG000|COMPLETED|Overall Study||21
10733382|NCT02814279|11897311|FG001|COMPLETED|Overall Study||21
10733383|NCT02814279|11897310|FG000|NOT COMPLETED|Overall Study||0
10733384|NCT02814279|11897311|FG001|NOT COMPLETED|Overall Study||0
10733385|NCT02814448|11897322|FG000|STARTED|Overall Study||27
10733386|NCT02814448|11897323|FG001|STARTED|Overall Study||24
10733387|NCT02814448|11897324|FG002|STARTED|Overall Study||26
10733388|NCT02814448|11897325|FG003|STARTED|Overall Study||25
10733389|NCT02814448|11897326|FG004|STARTED|Overall Study||28
10733390|NCT02814448|11897322|FG000|COMPLETED|Overall Study||27
10733391|NCT02814448|11897323|FG001|COMPLETED|Overall Study||24
10733392|NCT02814448|11897324|FG002|COMPLETED|Overall Study||25
10733393|NCT02814448|11897325|FG003|COMPLETED|Overall Study||25
10733394|NCT02814448|11897326|FG004|COMPLETED|Overall Study||26
10733395|NCT02814448|11897322|FG000|NOT COMPLETED|Overall Study||0
10733396|NCT02814448|11897323|FG001|NOT COMPLETED|Overall Study||0
10733397|NCT02814448|11897324|FG002|NOT COMPLETED|Overall Study||1
10733398|NCT02814448|11897325|FG003|NOT COMPLETED|Overall Study||0
10733399|NCT02814448|11897326|FG004|NOT COMPLETED|Overall Study||2
10733400|NCT02814565|11897340|FG000|STARTED|Overall Study||90
10733401|NCT02814565|11897341|FG001|STARTED|Overall Study||90
10733402|NCT02814565|11897340|FG000|COMPLETED|Overall Study||89
10733403|NCT02814565|11897341|FG001|COMPLETED|Overall Study||88
10733404|NCT02814565|11897340|FG000|NOT COMPLETED|Overall Study||1
10733405|NCT02814565|11897341|FG001|NOT COMPLETED|Overall Study||2
10733406|NCT02814643|11897349|FG000|STARTED|Overall Study||51
10733407|NCT02814643|11897350|FG001|STARTED|Overall Study||52
10733408|NCT02814643|11897349|FG000|COMPLETED|Overall Study||50
10733409|NCT02814643|11897350|FG001|COMPLETED|Overall Study||49
10733410|NCT02814643|11897349|FG000|NOT COMPLETED|Overall Study||1
10733411|NCT02814643|11897350|FG001|NOT COMPLETED|Overall Study||3
10733412|NCT02814656|11897360|FG000|STARTED|Overall Study||6
10733413|NCT02814656|11897361|FG001|STARTED|Overall Study||6
10733414|NCT02814656|11897362|FG002|STARTED|Overall Study||6
10733415|NCT02814656|11897363|FG003|STARTED|Overall Study||6
10733416|NCT02814656|11897360|FG000|COMPLETED|Overall Study||6
10733417|NCT02814656|11897361|FG001|COMPLETED|Overall Study||6
10733418|NCT02814656|11897362|FG002|COMPLETED|Overall Study||6
10733419|NCT02814656|11897363|FG003|COMPLETED|Overall Study||6
10733420|NCT02814656|11897360|FG000|NOT COMPLETED|Overall Study||0
10733421|NCT02814656|11897361|FG001|NOT COMPLETED|Overall Study||0
10733422|NCT02814656|11897362|FG002|NOT COMPLETED|Overall Study||0
10733423|NCT02814656|11897363|FG003|NOT COMPLETED|Overall Study||0
10733424|NCT02814838|11897375|FG000|STARTED|Overall Study||50
10733425|NCT02814838|11897376|FG001|STARTED|Overall Study||26
10733426|NCT02814838|11897375|FG000|COMPLETED|Overall Study||48
10733427|NCT02814838|11897376|FG001|COMPLETED|Overall Study||25
10733428|NCT02814838|11897375|FG000|NOT COMPLETED|Overall Study||2
10733429|NCT02814838|11897376|FG001|NOT COMPLETED|Overall Study||1
10733430|NCT02814890|11897384|FG000|STARTED|Overall Study||33
10733431|NCT02814890|11897385|FG001|STARTED|Overall Study||32
10733432|NCT02814890|11897384|FG000|COMPLETED|Overall Study||30
10733433|NCT02814890|11897385|FG001|COMPLETED|Overall Study||30
10733434|NCT02814890|11897384|FG000|NOT COMPLETED|Overall Study||3
10733435|NCT02814890|11897385|FG001|NOT COMPLETED|Overall Study||2
10733436|NCT02815293|11897400|FG000|STARTED|Overall Study||10
10733437|NCT02815293|11897401|FG001|STARTED|Overall Study||8
10733438|NCT02815293|11897402|FG002|STARTED|Overall Study||18
10733439|NCT02815293|11897400|FG000|COMPLETED|Overall Study||0
10733440|NCT02815293|11897401|FG001|COMPLETED|Overall Study||0
10733441|NCT02815293|11897402|FG002|COMPLETED|Overall Study||0
10733442|NCT02815293|11897400|FG000|NOT COMPLETED|Overall Study||10
10733443|NCT02815293|11897401|FG001|NOT COMPLETED|Overall Study||8
10733444|NCT02815293|11897402|FG002|NOT COMPLETED|Overall Study||18
10733445|NCT02815644|11897410|FG000|STARTED|Treatment Period 1 + Washout||11
10733446|NCT02815644|11897411|FG001|STARTED|Treatment Period 1 + Washout||11
10733447|NCT02815644|11897410|FG000|COMPLETED|Treatment Period 1 + Washout||11
10733448|NCT02815644|11897411|FG001|COMPLETED|Treatment Period 1 + Washout||11
10733449|NCT02815644|11897410|FG000|NOT COMPLETED|Treatment Period 1 + Washout||0
10733450|NCT02815644|11897411|FG001|NOT COMPLETED|Treatment Period 1 + Washout||0
10733451|NCT02815644|11897410|FG000|STARTED|Treatment Period 2||11
10733452|NCT02815644|11897411|FG001|STARTED|Treatment Period 2||11
10733453|NCT02815644|11897410|FG000|COMPLETED|Treatment Period 2||11
10733454|NCT02815644|11897411|FG001|COMPLETED|Treatment Period 2||11
10733455|NCT02815644|11897410|FG000|NOT COMPLETED|Treatment Period 2||0
10733456|NCT02815644|11897411|FG001|NOT COMPLETED|Treatment Period 2||0
10733457|NCT02815670|11897417|FG000|STARTED|Overall Study||1
10733458|NCT02815670|11897417|FG000|COMPLETED|Overall Study||0
10733459|NCT02815670|11897417|FG000|NOT COMPLETED|Overall Study||1
10733460|NCT02815709|11897426|FG000|STARTED|Overall Study||82
10733461|NCT02815709|11897427|FG001|STARTED|Overall Study||86
10733462|NCT02815709|11897428|FG002|STARTED|Overall Study||82
10733463|NCT02815709|11897429|FG003|STARTED|Overall Study||84
10733464|NCT02815709|11897430|FG004|STARTED|Overall Study||84
10733465|NCT02815709|11897426|FG000|Treated With Study Medication|Overall Study||76
10733466|NCT02815709|11897427|FG001|Treated With Study Medication|Overall Study||79
10733467|NCT02815709|11897428|FG002|Treated With Study Medication|Overall Study||79
10733468|NCT02815709|11897429|FG003|Treated With Study Medication|Overall Study||79
10733469|NCT02815709|11897430|FG004|Treated With Study Medication|Overall Study||76
10733470|NCT02815709|11897426|FG000|COMPLETED|Overall Study|Completed Study|75
10733471|NCT02815709|11897427|FG001|COMPLETED|Overall Study|Completed Study|78
10733472|NCT02815709|11897428|FG002|COMPLETED|Overall Study|Completed Study|75
10733473|NCT02815709|11897429|FG003|COMPLETED|Overall Study|Completed Study|76
10733474|NCT02815709|11897430|FG004|COMPLETED|Overall Study|Completed Study|74
10733475|NCT02815709|11897426|FG000|NOT COMPLETED|Overall Study||7
10733476|NCT02815709|11897427|FG001|NOT COMPLETED|Overall Study||8
10733477|NCT02815709|11897428|FG002|NOT COMPLETED|Overall Study||7
10733478|NCT02815709|11897429|FG003|NOT COMPLETED|Overall Study||8
10733479|NCT02815709|11897430|FG004|NOT COMPLETED|Overall Study||10
10733480|NCT02815735|11897443|FG000|STARTED|First Intervention (4 Weeks)||36
10733481|NCT02815735|11897444|FG001|STARTED|First Intervention (4 Weeks)||38
10733482|NCT02815735|11897443|FG000|COMPLETED|First Intervention (4 Weeks)||34
10733483|NCT02815735|11897444|FG001|COMPLETED|First Intervention (4 Weeks)||37
10733484|NCT02815735|11897443|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2
10733485|NCT02815735|11897444|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1
10733486|NCT02815735|11897443|FG000|STARTED|Second Intervention (4 Weeks)||34
10733487|NCT02815735|11897444|FG001|STARTED|Second Intervention (4 Weeks)||37
10733488|NCT02815735|11897443|FG000|COMPLETED|Second Intervention (4 Weeks)||33
10733489|NCT02815735|11897444|FG001|COMPLETED|Second Intervention (4 Weeks)||37
10733490|NCT02815735|11897443|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1
10733491|NCT02815735|11897444|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
10733492|NCT02815982|11897463|FG000|STARTED|Overall Study||27
10815374|NCT01935947|11978482|FG002|STARTED|Overall Study||2
10815375|NCT01935947|11978480|FG000|Epigenetic Therapy|Overall Study||4
10815376|NCT01935947|11978481|FG001|Epigenetic Therapy|Overall Study||4
10815377|NCT01935947|11978482|FG002|Epigenetic Therapy|Overall Study||0
10815378|NCT01935947|11978480|FG000|Cytotoxic Therapy|Overall Study||3
10815379|NCT01935947|11978481|FG001|Cytotoxic Therapy|Overall Study||3
10815380|NCT01935947|11978482|FG002|Cytotoxic Therapy|Overall Study||2
10815381|NCT01935947|11978480|FG000|COMPLETED|Overall Study||1
10815382|NCT01935947|11978481|FG001|COMPLETED|Overall Study||0
10815383|NCT01935947|11978482|FG002|COMPLETED|Overall Study||0
10815384|NCT01935947|11978480|FG000|NOT COMPLETED|Overall Study||3
10815385|NCT01935947|11978481|FG001|NOT COMPLETED|Overall Study||4
10815386|NCT01935947|11978482|FG002|NOT COMPLETED|Overall Study||2
10815387|NCT01939223|11978495|FG000|STARTED|Overall Study||14
10815388|NCT01939223|11978496|FG001|STARTED|Overall Study||11
10815389|NCT01939223|11978495|FG000|Participants Received Treatment|Overall Study||14
10815390|NCT01939223|11978496|FG001|Participants Received Treatment|Overall Study||11
10815391|NCT01939223|11978495|FG000|COMPLETED|Overall Study||1
10815392|NCT01939223|11978496|FG001|COMPLETED|Overall Study||0
10815393|NCT01939223|11978495|FG000|NOT COMPLETED|Overall Study||13
10815394|NCT01939223|11978496|FG001|NOT COMPLETED|Overall Study||11
10815395|NCT01938716|11978502|FG000|STARTED|Overall Study||12
10815396|NCT01938716|11978502|FG000|COMPLETED|Overall Study||8
10815397|NCT01938716|11978502|FG000|NOT COMPLETED|Overall Study||4
10815398|NCT01936974|11978508|FG000|STARTED|Overall Study||2
10815399|NCT01936974|11978509|FG001|STARTED|Overall Study||5
10815400|NCT01936974|11978508|FG000|COMPLETED|Overall Study||0
10815401|NCT01936974|11978509|FG001|COMPLETED|Overall Study||0
10815402|NCT01936974|11978508|FG000|NOT COMPLETED|Overall Study||2
10815403|NCT01936974|11978509|FG001|NOT COMPLETED|Overall Study||5
10815404|NCT01938833|11978515|FG000|STARTED|Overall Study||9
10815405|NCT01938833|11978515|FG000|COMPLETED|Overall Study||9
10815406|NCT01938833|11978515|FG000|NOT COMPLETED|Overall Study||0
10815407|NCT01934647|11978522|FG000|STARTED|Overall Study||2
10815408|NCT01934647|11978523|FG001|STARTED|Overall Study||2
10815409|NCT01934647|11978524|FG002|STARTED|Overall Study||3
10733493|NCT02815982|11897464|FG001|STARTED|Overall Study||26
10733494|NCT02815982|11897465|FG002|STARTED|Overall Study||27
10733495|NCT02815982|11897466|FG003|STARTED|Overall Study||26
10733496|NCT02815982|11897463|FG000|COMPLETED|Overall Study||27
10733497|NCT02815982|11897464|FG001|COMPLETED|Overall Study||26
10733498|NCT02815982|11897465|FG002|COMPLETED|Overall Study||27
10733499|NCT02815982|11897466|FG003|COMPLETED|Overall Study||26
10733500|NCT02815982|11897463|FG000|NOT COMPLETED|Overall Study||0
10733501|NCT02815982|11897464|FG001|NOT COMPLETED|Overall Study||0
10733502|NCT02815982|11897465|FG002|NOT COMPLETED|Overall Study||0
10733503|NCT02815982|11897466|FG003|NOT COMPLETED|Overall Study||0
10733504|NCT02816138|11897478|FG000|STARTED|Overall Study||15
10733505|NCT02816138|11897478|FG000|COMPLETED|Overall Study||14
10733506|NCT02816138|11897478|FG000|NOT COMPLETED|Overall Study||1
10733507|NCT02816346|11897487|FG000|STARTED|Overall Study||10
10733508|NCT02816346|11897488|FG001|STARTED|Overall Study||10
10733509|NCT02816346|11897489|FG002|STARTED|Overall Study||10
10733510|NCT02816346|11897490|FG003|STARTED|Overall Study||10
10733511|NCT02816346|11897491|FG004|STARTED|Overall Study||16
10733512|NCT02816346|11897487|FG000|COMPLETED|Overall Study||10
10733513|NCT02816346|11897488|FG001|COMPLETED|Overall Study||10
10733514|NCT02816346|11897489|FG002|COMPLETED|Overall Study||10
10733515|NCT02816346|11897490|FG003|COMPLETED|Overall Study||10
10733516|NCT02816346|11897491|FG004|COMPLETED|Overall Study||16
10733517|NCT02816346|11897487|FG000|NOT COMPLETED|Overall Study||0
10733518|NCT02816346|11897488|FG001|NOT COMPLETED|Overall Study||0
10733519|NCT02816346|11897489|FG002|NOT COMPLETED|Overall Study||0
10733520|NCT02816346|11897490|FG003|NOT COMPLETED|Overall Study||0
10733521|NCT02816346|11897491|FG004|NOT COMPLETED|Overall Study||0
10733522|NCT02816398|11897503|FG000|STARTED|Overall Study||26
10733523|NCT02816398|11897503|FG000|COMPLETED|Overall Study||12
10733524|NCT02816398|11897503|FG000|NOT COMPLETED|Overall Study||14
10733525|NCT02816710|11897510|FG000|STARTED|Overall Study||38
10733526|NCT02816710|11897511|FG001|STARTED|Overall Study||38
10733527|NCT02816710|11897512|FG002|STARTED|Overall Study||36
10733528|NCT02816710|11897510|FG000|COMPLETED|Overall Study||34
10733529|NCT02816710|11897511|FG001|COMPLETED|Overall Study||35
10733530|NCT02816710|11897512|FG002|COMPLETED|Overall Study||29
10733531|NCT02816710|11897510|FG000|NOT COMPLETED|Overall Study||4
10733532|NCT02816710|11897511|FG001|NOT COMPLETED|Overall Study||3
10733533|NCT02816710|11897512|FG002|NOT COMPLETED|Overall Study||7
10733534|NCT02816723|11897525|FG000|STARTED|Overall Study||30
10733535|NCT02816723|11897526|FG001|STARTED|Overall Study||30
10733536|NCT02816723|11897525|FG000|COMPLETED|Overall Study||24
10733537|NCT02816723|11897526|FG001|COMPLETED|Overall Study||28
10733538|NCT02816723|11897525|FG000|NOT COMPLETED|Overall Study||6
10733539|NCT02816723|11897526|FG001|NOT COMPLETED|Overall Study||2
10733540|NCT02817087|11897534|FG000|STARTED|Overall Study||16
10733541|NCT02817087|11897535|FG001|STARTED|Overall Study||15
10733542|NCT02817087|11897534|FG000|COMPLETED|Overall Study|1 pt was withdrawn early d/t concurrent disease. One pt. withdrew ICF d/t transportation concerns|14
10733543|NCT02817087|11897535|FG001|COMPLETED|Overall Study||15
10733544|NCT02817087|11897534|FG000|NOT COMPLETED|Overall Study||2
10733545|NCT02817087|11897535|FG001|NOT COMPLETED|Overall Study||0
10733546|NCT02817516|11897545|FG000|STARTED|Overall Study||6
10733547|NCT02817516|11897546|FG001|STARTED|Overall Study||6
10733548|NCT02817516|11897547|FG002|STARTED|Overall Study||6
10733549|NCT02817516|11897548|FG003|STARTED|Overall Study||6
10733550|NCT02817516|11897545|FG000|COMPLETED|Overall Study||6
10733551|NCT02817516|11897546|FG001|COMPLETED|Overall Study||6
10733552|NCT02817516|11897547|FG002|COMPLETED|Overall Study||5
10733553|NCT02817516|11897548|FG003|COMPLETED|Overall Study||6
10733554|NCT02817516|11897545|FG000|NOT COMPLETED|Overall Study||0
10733555|NCT02817516|11897546|FG001|NOT COMPLETED|Overall Study||0
10733556|NCT02817516|11897547|FG002|NOT COMPLETED|Overall Study||1
10733557|NCT02817516|11897548|FG003|NOT COMPLETED|Overall Study||0
10733558|NCT02817555|11897563|FG000|STARTED|Overall Study||24
10733559|NCT02817555|11897564|FG001|STARTED|Overall Study||26
10733560|NCT02817555|11897563|FG000|COMPLETED|Overall Study||21
10733561|NCT02817555|11897564|FG001|COMPLETED|Overall Study||21
10733562|NCT02817555|11897563|FG000|NOT COMPLETED|Overall Study||3
10733563|NCT02817555|11897564|FG001|NOT COMPLETED|Overall Study||5
10733564|NCT02817594|11897570|FG000|STARTED|Overall Study||51
10733565|NCT02817594|11897570|FG000|Received Treatment|Overall Study||50
10733566|NCT02817594|11897570|FG000|COMPLETED|Overall Study||48
10733567|NCT02817594|11897570|FG000|NOT COMPLETED|Overall Study||3
10733568|NCT02817763|11897580|FG000|STARTED|Overall Study||20
10733569|NCT02817763|11897581|FG001|STARTED|Overall Study||20
10733570|NCT02817763|11897580|FG000|COMPLETED|Overall Study||20
10733571|NCT02817763|11897581|FG001|COMPLETED|Overall Study||20
10733572|NCT02817763|11897580|FG000|NOT COMPLETED|Overall Study||0
10733573|NCT02817763|11897581|FG001|NOT COMPLETED|Overall Study||0
10733574|NCT02817776|11897587|FG000|STARTED|Overall Study|33 excluded prior to procedure. 348 had study catheter inserted (Safety Population)|381
10733575|NCT02817776|11897587|FG000|COMPLETED|Overall Study||293
10733576|NCT02817776|11897587|FG000|NOT COMPLETED|Overall Study||88
10733577|NCT02817828|11897591|FG000|STARTED|Overall Study||1553
10733578|NCT02817828|11897591|FG000|COMPLETED|Overall Study||1218
10733579|NCT02817828|11897591|FG000|NOT COMPLETED|Overall Study||335
10733580|NCT02817841|11897600|FG000|STARTED|Overall Study||1864
10733581|NCT02817841|11897600|FG000|COMPLETED|Overall Study||1016
10733582|NCT02817841|11897600|FG000|NOT COMPLETED|Overall Study||848
10777932|NCT03346070|11939833|FG000|STARTED|Overall Study||41
10777933|NCT03346070|11939834|FG001|STARTED|Overall Study||41
10733583|NCT02817906|11897610|FG000|STARTED|Overall Study|87 patients were randomized but only 86 received study drug. The number completed and discontinued is based on the 86 patients that received study drug.|86
10733584|NCT02817906|11897611|FG001|STARTED|Overall Study|90 patients were randomized but only 89 received study drug. The number completed and discontinued is based on 89 patients that received study drug.|89
10733585|NCT02817906|11897610|FG000|COMPLETED|Overall Study||70
10733586|NCT02817906|11897611|FG001|COMPLETED|Overall Study||84
10733587|NCT02817906|11897610|FG000|NOT COMPLETED|Overall Study||16
10733588|NCT02817906|11897611|FG001|NOT COMPLETED|Overall Study||5
10733589|NCT02818036|11897619|FG000|STARTED|Overall Study||42
10733590|NCT02818036|11897620|FG001|STARTED|Overall Study||40
10733591|NCT02818036|11897619|FG000|COMPLETED|Overall Study||40
10733592|NCT02818036|11897620|FG001|COMPLETED|Overall Study||40
10733593|NCT02818036|11897619|FG000|NOT COMPLETED|Overall Study||2
10733594|NCT02818036|11897620|FG001|NOT COMPLETED|Overall Study||0
10733595|NCT02818114|11897626|FG000|STARTED|Overall Study||8
10733596|NCT02818114|11897626|FG000|COMPLETED|Overall Study||7
10733597|NCT02818114|11897626|FG000|NOT COMPLETED|Overall Study||1
10733598|NCT02818244|11897635|FG000|STARTED|Overall Study||25
10733599|NCT02818244|11897636|FG001|STARTED|Overall Study||25
10733600|NCT02818244|11897637|FG002|STARTED|Overall Study||25
10733601|NCT02818244|11897638|FG003|STARTED|Overall Study||25
10733602|NCT02818244|11897635|FG000|COMPLETED|Overall Study||25
10733603|NCT02818244|11897636|FG001|COMPLETED|Overall Study||25
10733604|NCT02818244|11897637|FG002|COMPLETED|Overall Study||25
10733605|NCT02818244|11897638|FG003|COMPLETED|Overall Study||25
10733606|NCT02818244|11897635|FG000|NOT COMPLETED|Overall Study||0
10733607|NCT02818244|11897636|FG001|NOT COMPLETED|Overall Study||0
10733608|NCT02818244|11897637|FG002|NOT COMPLETED|Overall Study||0
10733609|NCT02818244|11897638|FG003|NOT COMPLETED|Overall Study||0
10733610|NCT02818569|11897648|FG000|STARTED|Overall Study||8
10733611|NCT02818569|11897649|FG001|STARTED|Overall Study||7
10733612|NCT02818569|11897648|FG000|COMPLETED|Overall Study||8
10733613|NCT02818569|11897649|FG001|COMPLETED|Overall Study||7
10733614|NCT02818569|11897648|FG000|NOT COMPLETED|Overall Study||0
10733615|NCT02818569|11897649|FG001|NOT COMPLETED|Overall Study||0
10733616|NCT02818777|11897658|FG000|STARTED|Overall Study|The number of baseline participants was 13.|13
10733617|NCT02818777|11897658|FG000|COMPLETED|Overall Study||10
10733618|NCT02818777|11897658|FG000|NOT COMPLETED|Overall Study||3
10733619|NCT02818998|11897671|FG000|STARTED|Overall Study||155
10733620|NCT02818998|11897672|FG001|STARTED|Overall Study||154
10733621|NCT02818998|11897673|FG002|STARTED|Overall Study||154
10733622|NCT02818998|11897671|FG000|Completed Week 52 Visit|Overall Study||144
10733623|NCT02818998|11897672|FG001|Completed Week 52 Visit|Overall Study||146
10733624|NCT02818998|11897673|FG002|Completed Week 52 Visit|Overall Study||140
10733625|NCT02818998|11897671|FG000|COMPLETED|Overall Study||137
10733626|NCT02818998|11897672|FG001|COMPLETED|Overall Study||138
10733627|NCT02818998|11897673|FG002|COMPLETED|Overall Study||136
10733628|NCT02818998|11897671|FG000|NOT COMPLETED|Overall Study||18
10733629|NCT02818998|11897672|FG001|NOT COMPLETED|Overall Study||16
10733630|NCT02818998|11897673|FG002|NOT COMPLETED|Overall Study||18
10733631|NCT02819011|11897683|FG000|STARTED|Overall Study||22
10733632|NCT02819011|11897684|FG001|STARTED|Overall Study||22
10733633|NCT02819011|11897683|FG000|COMPLETED|Overall Study||15
10733634|NCT02819011|11897684|FG001|COMPLETED|Overall Study||17
10733635|NCT02819011|11897683|FG000|NOT COMPLETED|Overall Study||7
10733636|NCT02819011|11897684|FG001|NOT COMPLETED|Overall Study||5
10733637|NCT02819284|11897693|FG000|STARTED|Overall Study||452
10733638|NCT02819284|11897694|FG001|STARTED|Overall Study||453
10733639|NCT02819284|11897693|FG000|COMPLETED|Overall Study||447
10733640|NCT02819284|11897694|FG001|COMPLETED|Overall Study||448
10733641|NCT02819284|11897693|FG000|NOT COMPLETED|Overall Study||5
10733642|NCT02819284|11897694|FG001|NOT COMPLETED|Overall Study||5
10733643|NCT02819297|11897702|FG000|STARTED|Overall Study||299
10733644|NCT02819297|11897703|FG001|STARTED|Overall Study||304
10733645|NCT02819297|11897702|FG000|COMPLETED|Overall Study||239
10733646|NCT02819297|11897703|FG001|COMPLETED|Overall Study||252
10733647|NCT02819297|11897702|FG000|NOT COMPLETED|Overall Study||60
10733648|NCT02819297|11897703|FG001|NOT COMPLETED|Overall Study||52
10733649|NCT02819310|11897709|FG000|STARTED|Overall Study||330
10733650|NCT02819310|11897709|FG000|COMPLETED|Overall Study||221
10733651|NCT02819310|11897709|FG000|NOT COMPLETED|Overall Study||109
10733652|NCT02819323|11897716|FG000|STARTED|Overall Study||31
10733653|NCT02819323|11897717|FG001|STARTED|Overall Study||28
10733654|NCT02819323|11897718|FG002|STARTED|Overall Study||32
10733655|NCT02819323|11897716|FG000|COMPLETED|Overall Study||26
10733656|NCT02819323|11897717|FG001|COMPLETED|Overall Study||26
10733657|NCT02819323|11897718|FG002|COMPLETED|Overall Study||31
10733658|NCT02819323|11897716|FG000|NOT COMPLETED|Overall Study||5
10733659|NCT02819323|11897717|FG001|NOT COMPLETED|Overall Study||2
10733660|NCT02819323|11897718|FG002|NOT COMPLETED|Overall Study||1
10733661|NCT02819557|11897726|FG000|STARTED|Overall Study||14
10733662|NCT02819557|11897726|FG000|Safety Population|Overall Study||14
10733663|NCT02819557|11897726|FG000|Pharmacokinetics (PK) Population|Overall Study||14
10733664|NCT02819557|11897726|FG000|Evaluable Population|Overall Study||14
10733665|NCT02819557|11897726|FG000|COMPLETED|Overall Study||14
10733666|NCT02819557|11897726|FG000|NOT COMPLETED|Overall Study||0
10733667|NCT02819726|11897733|FG000|STARTED|Part A (All Participants)||98
10733668|NCT02819726|11897734|FG001|STARTED|Part A (All Participants)||98
10733669|NCT02819726|11897735|FG002|STARTED|Part A (All Participants)||98
10733670|NCT02819726|11897736|FG003|STARTED|Part A (All Participants)||0
10733671|NCT02819726|11897733|FG000|COMPLETED|Part A (All Participants)||92
10733672|NCT02819726|11897734|FG001|COMPLETED|Part A (All Participants)||88
10733673|NCT02819726|11897735|FG002|COMPLETED|Part A (All Participants)||87
10733674|NCT02819726|11897736|FG003|COMPLETED|Part A (All Participants)||0
10733675|NCT02819726|11897733|FG000|NOT COMPLETED|Part A (All Participants)||6
10733676|NCT02819726|11897734|FG001|NOT COMPLETED|Part A (All Participants)||10
10733677|NCT02819726|11897735|FG002|NOT COMPLETED|Part A (All Participants)||11
10733678|NCT02819726|11897736|FG003|NOT COMPLETED|Part A (All Participants)||0
10733679|NCT02819726|11897733|FG000|STARTED|Part B (All Participants)|19 participants who completed Part A were not eligible for Part B|73
10733680|NCT02819726|11897734|FG001|STARTED|Part B (All Participants)|18 participants completing Part A were not eligible for Part B|70
10733681|NCT02819726|11897735|FG002|STARTED|Part B (All Participants)|5 participants completing Part A were ineligible for Part B.|39
10733682|NCT02819726|11897736|FG003|STARTED|Part B (All Participants)|5 participants completing Part A were ineligible for Part B.|38
10733683|NCT02819726|11897733|FG000|COMPLETED|Part B (All Participants)||70
10733684|NCT02819726|11897734|FG001|COMPLETED|Part B (All Participants)||68
10733685|NCT02819726|11897735|FG002|COMPLETED|Part B (All Participants)||35
10733686|NCT02819726|11897736|FG003|COMPLETED|Part B (All Participants)||36
10733687|NCT02819726|11897733|FG000|NOT COMPLETED|Part B (All Participants)||3
10733688|NCT02819726|11897734|FG001|NOT COMPLETED|Part B (All Participants)||2
10733689|NCT02819726|11897735|FG002|NOT COMPLETED|Part B (All Participants)||4
10733690|NCT02819726|11897736|FG003|NOT COMPLETED|Part B (All Participants)||2
10733691|NCT02819973|11897747|FG000|STARTED|Overall Study||114
10733692|NCT02819973|11897748|FG001|STARTED|Overall Study||114
10733693|NCT02819973|11897749|FG002|STARTED|Overall Study||115
10733694|NCT02819973|11897747|FG000|COMPLETED|Overall Study|2 withdrawn by request, 4 determined after randomization to be not eligible|108
10733695|NCT02819973|11897748|FG001|COMPLETED|Overall Study|3 determined after randomization to be not eligible|111
10733696|NCT02819973|11897749|FG002|COMPLETED|Overall Study|2 withdrawn by request, 2 determined after randomization to be not eligible|111
10733697|NCT02819973|11897747|FG000|NOT COMPLETED|Overall Study||6
10733698|NCT02819973|11897748|FG001|NOT COMPLETED|Overall Study||3
10733699|NCT02819973|11897749|FG002|NOT COMPLETED|Overall Study||4
10733700|NCT02820038|11897767|FG000|STARTED|Overall Study||78
10733701|NCT02820038|11897768|FG001|STARTED|Overall Study||77
10733702|NCT02820038|11897769|FG002|STARTED|Overall Study||65
10733703|NCT02820038|11897770|FG003|STARTED|Overall Study||66
10733704|NCT02820038|11897767|FG000|COMPLETED|Overall Study||68
10733705|NCT02820038|11897768|FG001|COMPLETED|Overall Study||52
10733706|NCT02820038|11897769|FG002|COMPLETED|Overall Study||60
10733707|NCT02820038|11897770|FG003|COMPLETED|Overall Study||44
10733708|NCT02820038|11897767|FG000|NOT COMPLETED|Overall Study||10
10733709|NCT02820038|11897768|FG001|NOT COMPLETED|Overall Study||25
10733710|NCT02820038|11897769|FG002|NOT COMPLETED|Overall Study||5
10733711|NCT02820038|11897770|FG003|NOT COMPLETED|Overall Study||22
10733712|NCT02820181|11897783|FG000|STARTED|Overall Study||30
10733713|NCT02820181|11897784|FG001|STARTED|Overall Study||30
10733714|NCT02820181|11897783|FG000|COMPLETED|Overall Study||30
10733715|NCT02820181|11897784|FG001|COMPLETED|Overall Study||30
10733716|NCT02820181|11897783|FG000|NOT COMPLETED|Overall Study||0
10733717|NCT02820181|11897784|FG001|NOT COMPLETED|Overall Study||0
10733718|NCT02820298|11897792|FG000|STARTED|Overall Study||13
10733719|NCT02820298|11897793|FG001|STARTED|Overall Study||12
10733720|NCT02820298|11897792|FG000|COMPLETED|Overall Study||12
10733721|NCT02820298|11897793|FG001|COMPLETED|Overall Study||10
10733722|NCT02820298|11897792|FG000|NOT COMPLETED|Overall Study||1
10733723|NCT02820298|11897793|FG001|NOT COMPLETED|Overall Study||2
10733724|NCT02820324|11897810|FG000|STARTED|Overall Study||78
10733725|NCT02820324|11897811|FG001|STARTED|Overall Study||82
10733726|NCT02820324|11897812|FG002|STARTED|Overall Study||82
10733727|NCT02820324|11897813|FG003|STARTED|Overall Study||82
10733728|NCT02820324|11897814|FG004|STARTED|Overall Study||83
10733729|NCT02820324|11897810|FG000|Treated With Study Medication|Overall Study||77
10733730|NCT02820324|11897811|FG001|Treated With Study Medication|Overall Study||80
10733731|NCT02820324|11897812|FG002|Treated With Study Medication|Overall Study||80
10733732|NCT02820324|11897813|FG003|Treated With Study Medication|Overall Study||81
10733733|NCT02820324|11897814|FG004|Treated With Study Medication|Overall Study||83
10733734|NCT02820324|11897810|FG000|COMPLETED|Overall Study||76
10733735|NCT02820324|11897811|FG001|COMPLETED|Overall Study||79
10733736|NCT02820324|11897812|FG002|COMPLETED|Overall Study||79
10733737|NCT02820324|11897813|FG003|COMPLETED|Overall Study||79
10733738|NCT02820324|11897814|FG004|COMPLETED|Overall Study||80
10733739|NCT02820324|11897810|FG000|NOT COMPLETED|Overall Study||2
10733740|NCT02820324|11897811|FG001|NOT COMPLETED|Overall Study||3
10733741|NCT02820324|11897812|FG002|NOT COMPLETED|Overall Study||3
10733742|NCT02820324|11897813|FG003|NOT COMPLETED|Overall Study||3
10733743|NCT02820324|11897814|FG004|NOT COMPLETED|Overall Study||3
10733744|NCT02820597|11897826|FG000|STARTED|Overall Study||27
10733745|NCT02820597|11897826|FG000|1-day Post Treatment|Overall Study||27
10733746|NCT02820597|11897826|FG000|7-day Post Treatment|Overall Study||27
10733747|NCT02820597|11897826|FG000|30-day Post Treatment|Overall Study||27
10733748|NCT02820597|11897826|FG000|90-day Post Treatment|Overall Study|2 participants missed the 90-day visit, 1 participant was lost to follow-up.|24
10733749|NCT02820597|11897826|FG000|180-day Post Treatment|Overall Study|3 participants missed the 180-day visit, 3 participants were lost to follow-up.|21
10733750|NCT02820597|11897826|FG000|COMPLETED|Overall Study|12 participants were lost to follow-up.|15
10733751|NCT02820597|11897826|FG000|NOT COMPLETED|Overall Study||12
10733752|NCT02820844|11897832|FG000|STARTED|Double-blinded (Up to 48 Weeks)||124
10733753|NCT02820844|11897833|FG001|STARTED|Double-blinded (Up to 48 Weeks)||124
10733754|NCT02820844|11897834|FG002|STARTED|Double-blinded (Up to 48 Weeks)||0
10733755|NCT02820844|11897835|FG003|STARTED|Double-blinded (Up to 48 Weeks)||0
10733756|NCT02820844|11897836|FG004|STARTED|Double-blinded (Up to 48 Weeks)||0
10733757|NCT02820844|11897837|FG005|STARTED|Double-blinded (Up to 48 Weeks)||0
10733758|NCT02820844|11897832|FG000|COMPLETED|Double-blinded (Up to 48 Weeks)||119
10733759|NCT02820844|11897833|FG001|COMPLETED|Double-blinded (Up to 48 Weeks)||115
10733760|NCT02820844|11897834|FG002|COMPLETED|Double-blinded (Up to 48 Weeks)||0
10733761|NCT02820844|11897835|FG003|COMPLETED|Double-blinded (Up to 48 Weeks)||0
10733762|NCT02820844|11897836|FG004|COMPLETED|Double-blinded (Up to 48 Weeks)||0
10733763|NCT02820844|11897837|FG005|COMPLETED|Double-blinded (Up to 48 Weeks)||0
10733764|NCT02820844|11897832|FG000|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||5
10733765|NCT02820844|11897833|FG001|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||9
10733766|NCT02820844|11897834|FG002|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
10733767|NCT02820844|11897835|FG003|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
10733768|NCT02820844|11897836|FG004|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
10733769|NCT02820844|11897837|FG005|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
10733770|NCT02820844|11897832|FG000|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
10733771|NCT02820844|11897833|FG001|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
10733772|NCT02820844|11897834|FG002|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||108
10733773|NCT02820844|11897835|FG003|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||88
10733774|NCT02820844|11897836|FG004|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
10733775|NCT02820844|11897837|FG005|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
10733776|NCT02820844|11897832|FG000|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
10733777|NCT02820844|11897833|FG001|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
10733778|NCT02820844|11897834|FG002|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||99
10733779|NCT02820844|11897835|FG003|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||84
10733780|NCT02820844|11897836|FG004|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
10733781|NCT02820844|11897837|FG005|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
10733782|NCT02820844|11897832|FG000|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
10733783|NCT02820844|11897833|FG001|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
10733784|NCT02820844|11897834|FG002|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||9
10733785|NCT02820844|11897835|FG003|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||4
10733786|NCT02820844|11897836|FG004|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
10733787|NCT02820844|11897837|FG005|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
10733788|NCT02820844|11897832|FG000|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
10733789|NCT02820844|11897833|FG001|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
10733790|NCT02820844|11897834|FG002|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
10733791|NCT02820844|11897835|FG003|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
10733792|NCT02820844|11897836|FG004|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||56
10733793|NCT02820844|11897837|FG005|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||43
10733794|NCT02820844|11897832|FG000|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
10733795|NCT02820844|11897833|FG001|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
10733796|NCT02820844|11897834|FG002|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
10733797|NCT02820844|11897835|FG003|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
10733798|NCT02820844|11897836|FG004|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||54
10733799|NCT02820844|11897837|FG005|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||42
10733800|NCT02820844|11897832|FG000|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
10733801|NCT02820844|11897833|FG001|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
10733802|NCT02820844|11897834|FG002|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
10733803|NCT02820844|11897835|FG003|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
10733804|NCT02820844|11897836|FG004|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||2
10733805|NCT02820844|11897837|FG005|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||1
10733806|NCT02820870|11897856|FG000|STARTED|Before Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|15
10733807|NCT02820870|11897857|FG001|STARTED|Before Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|28
10733808|NCT02820870|11897856|FG000|COMPLETED|Before Intervention||15
10733809|NCT02820870|11897857|FG001|COMPLETED|Before Intervention||28
10733810|NCT02820870|11897856|FG000|NOT COMPLETED|Before Intervention||0
10733811|NCT02820870|11897857|FG001|NOT COMPLETED|Before Intervention||0
10733812|NCT02820870|11897856|FG000|STARTED|Intervention||15
10733813|NCT02820870|11897857|FG001|STARTED|Intervention||28
10733814|NCT02820870|11897856|FG000|COMPLETED|Intervention||15
10733815|NCT02820870|11897857|FG001|COMPLETED|Intervention||28
10733816|NCT02820870|11897856|FG000|NOT COMPLETED|Intervention||0
10733817|NCT02820870|11897857|FG001|NOT COMPLETED|Intervention||0
10733818|NCT02820870|11897856|FG000|STARTED|Post Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|15
10733819|NCT02820870|11897857|FG001|STARTED|Post Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|28
10733820|NCT02820870|11897856|FG000|COMPLETED|Post Intervention||15
10733821|NCT02820870|11897857|FG001|COMPLETED|Post Intervention||28
10733822|NCT02820870|11897856|FG000|NOT COMPLETED|Post Intervention||0
10733823|NCT02820870|11897857|FG001|NOT COMPLETED|Post Intervention||0
10733824|NCT02821104|11897865|FG000|STARTED|Overall Study||77
10733825|NCT02821104|11897865|FG000|COMPLETED|Overall Study||77
10733826|NCT02821104|11897865|FG000|NOT COMPLETED|Overall Study||0
10733827|NCT02821338|11897872|FG000|STARTED|Overall Study||15
10733828|NCT02821338|11897873|FG001|STARTED|Overall Study||15
10733829|NCT02821338|11897872|FG000|COMPLETED|Overall Study|12 out of 15 subjects assigned to Sequence 1 completed the study, and provided two data points.|12
10733830|NCT02821338|11897873|FG001|COMPLETED|Overall Study|13 out of 15 subjects assigned to Sequence 2 completed the study, and provided two data points.|13
10733831|NCT02821338|11897872|FG000|NOT COMPLETED|Overall Study||3
10733832|NCT02821338|11897873|FG001|NOT COMPLETED|Overall Study||2
10733833|NCT02821403|11897881|FG000|STARTED|"First Intervention (1 Month)"||40
10733834|NCT02821403|11897882|FG001|STARTED|"First Intervention (1 Month)"||40
10733835|NCT02821403|11897881|FG000|Used Clear Lens|"First Intervention (1 Month)"||13
10733836|NCT02821403|11897882|FG001|Used Clear Lens|"First Intervention (1 Month)"||13
10733837|NCT02821403|11897881|FG000|Used Yellow Tinted Lens|"First Intervention (1 Month)"||13
10733838|NCT02821403|11897882|FG001|Used Yellow Tinted Lens|"First Intervention (1 Month)"||14
10733839|NCT02821403|11897881|FG000|Used Blue-filtering Coated Lens|"First Intervention (1 Month)"||14
10733840|NCT02821403|11897882|FG001|Used Blue-filtering Coated Lens|"First Intervention (1 Month)"||13
10733841|NCT02821403|11897881|FG000|COMPLETED|"First Intervention (1 Month)"||40
10733842|NCT02821403|11897882|FG001|COMPLETED|"First Intervention (1 Month)"||40
10733843|NCT02821403|11897881|FG000|NOT COMPLETED|"First Intervention (1 Month)"||0
10733844|NCT02821403|11897882|FG001|NOT COMPLETED|"First Intervention (1 Month)"||0
10733845|NCT02821403|11897881|FG000|STARTED|"Second Intervention (1 Month)"||40
10733846|NCT02821403|11897882|FG001|STARTED|"Second Intervention (1 Month)"||40
10733847|NCT02821403|11897881|FG000|Used Clear Lens|"Second Intervention (1 Month)"||13
10733848|NCT02821403|11897882|FG001|Used Clear Lens|"Second Intervention (1 Month)"||14
10733849|NCT02821403|11897881|FG000|Used Yellow Tinted Lens|"Second Intervention (1 Month)"||14
10733850|NCT02821403|11897882|FG001|Used Yellow Tinted Lens|"Second Intervention (1 Month)"||13
10733851|NCT02821403|11897881|FG000|Used Blue-filtering Coated Lens|"Second Intervention (1 Month)"||13
10733852|NCT02821403|11897882|FG001|Used Blue-filtering Coated Lens|"Second Intervention (1 Month)"||13
10733853|NCT02821403|11897881|FG000|COMPLETED|"Second Intervention (1 Month)"||40
10733854|NCT02821403|11897882|FG001|COMPLETED|"Second Intervention (1 Month)"||40
10733855|NCT02821403|11897881|FG000|NOT COMPLETED|"Second Intervention (1 Month)"||0
10733856|NCT02821403|11897882|FG001|NOT COMPLETED|"Second Intervention (1 Month)"||0
10733857|NCT02821403|11897881|FG000|STARTED|"Third Intervention (1 Month)"||40
10733858|NCT02821403|11897882|FG001|STARTED|"Third Intervention (1 Month)"||40
10733859|NCT02821403|11897881|FG000|Used Clear Lens|"Third Intervention (1 Month)"||14
10733860|NCT02821403|11897882|FG001|Used Clear Lens|"Third Intervention (1 Month)"||13
10733861|NCT02821403|11897881|FG000|Used Yellow Tinted Lens|"Third Intervention (1 Month)"||13
10733862|NCT02821403|11897882|FG001|Used Yellow Tinted Lens|"Third Intervention (1 Month)"||13
10733863|NCT02821403|11897881|FG000|Used Blue-filtering Coated Lens|"Third Intervention (1 Month)"||13
10733864|NCT02821403|11897882|FG001|Used Blue-filtering Coated Lens|"Third Intervention (1 Month)"||14
10733865|NCT02821403|11897881|FG000|COMPLETED|"Third Intervention (1 Month)"||40
10733866|NCT02821403|11897882|FG001|COMPLETED|"Third Intervention (1 Month)"||40
10733867|NCT02821403|11897881|FG000|NOT COMPLETED|"Third Intervention (1 Month)"||0
10733868|NCT02821403|11897882|FG001|NOT COMPLETED|"Third Intervention (1 Month)"||0
10733869|NCT02821416|11897896|FG000|STARTED|Overall Study||23
10733870|NCT02821416|11897897|FG001|STARTED|Overall Study||23
10733871|NCT02821416|11897896|FG000|COMPLETED|Overall Study||20
10733872|NCT02821416|11897897|FG001|COMPLETED|Overall Study||22
10733873|NCT02821416|11897896|FG000|NOT COMPLETED|Overall Study||3
10733874|NCT02821416|11897897|FG001|NOT COMPLETED|Overall Study||1
10733875|NCT02821455|11897904|FG000|STARTED|Overall Study||19
10733876|NCT02821455|11897904|FG000|COMPLETED|Overall Study||19
10733877|NCT02821455|11897904|FG000|NOT COMPLETED|Overall Study||0
10733878|NCT02821715|11897908|FG000|STARTED|Overall Study||8
10733879|NCT02821715|11897909|FG001|STARTED|Overall Study||8
10733880|NCT02821715|11897910|FG002|STARTED|Overall Study||8
10733881|NCT02821715|11897911|FG003|STARTED|Overall Study||9
10733882|NCT02821715|11897912|FG004|STARTED|Overall Study||6
10733883|NCT02821715|11897913|FG005|STARTED|Overall Study||9
10733884|NCT02821715|11897908|FG000|COMPLETED|Overall Study||7
10733885|NCT02821715|11897909|FG001|COMPLETED|Overall Study||8
10733886|NCT02821715|11897910|FG002|COMPLETED|Overall Study||8
10733887|NCT02821715|11897911|FG003|COMPLETED|Overall Study||9
10733888|NCT02821715|11897912|FG004|COMPLETED|Overall Study||6
10733889|NCT02821715|11897913|FG005|COMPLETED|Overall Study||9
10733890|NCT02821715|11897908|FG000|NOT COMPLETED|Overall Study||1
10733891|NCT02821715|11897909|FG001|NOT COMPLETED|Overall Study||0
10733892|NCT02821715|11897910|FG002|NOT COMPLETED|Overall Study||0
10733893|NCT02821715|11897911|FG003|NOT COMPLETED|Overall Study||0
10733894|NCT02821715|11897912|FG004|NOT COMPLETED|Overall Study||0
10733895|NCT02821715|11897913|FG005|NOT COMPLETED|Overall Study||0
10733896|NCT02821819|11897921|FG000|STARTED|Overall Study||15
10733897|NCT02821819|11897921|FG000|COMPLETED|Overall Study||14
10733898|NCT02821819|11897921|FG000|NOT COMPLETED|Overall Study||1
10733899|NCT02821910|11897931|FG000|STARTED|Overall Study||7
10733900|NCT02821910|11897932|FG001|STARTED|Overall Study||8
10733901|NCT02821910|11897933|FG002|STARTED|Overall Study||10
10733902|NCT02821910|11897934|FG003|STARTED|Overall Study||10
10733903|NCT02821910|11897935|FG004|STARTED|Overall Study||7
10733904|NCT02821910|11897936|FG005|STARTED|Overall Study||8
10733905|NCT02821910|11897931|FG000|COMPLETED|Overall Study||6
10733906|NCT02821910|11897932|FG001|COMPLETED|Overall Study||8
10733907|NCT02821910|11897933|FG002|COMPLETED|Overall Study||8
10733908|NCT02821910|11897934|FG003|COMPLETED|Overall Study||10
10733909|NCT02821910|11897935|FG004|COMPLETED|Overall Study||7
10733910|NCT02821910|11897936|FG005|COMPLETED|Overall Study||7
10733911|NCT02821910|11897931|FG000|NOT COMPLETED|Overall Study||1
10733912|NCT02821910|11897932|FG001|NOT COMPLETED|Overall Study||0
10733913|NCT02821910|11897933|FG002|NOT COMPLETED|Overall Study||2
10733914|NCT02821910|11897934|FG003|NOT COMPLETED|Overall Study||0
10733915|NCT02821910|11897935|FG004|NOT COMPLETED|Overall Study||0
10733916|NCT02821910|11897936|FG005|NOT COMPLETED|Overall Study||1
10733917|NCT02821962|11897952|FG000|STARTED|Overall Study||19
10815410|NCT01934647|11978522|FG000|COMPLETED|Overall Study||2
10815411|NCT01934647|11978523|FG001|COMPLETED|Overall Study||2
10815412|NCT01934647|11978524|FG002|COMPLETED|Overall Study||3
10815413|NCT01934647|11978522|FG000|NOT COMPLETED|Overall Study||0
10815414|NCT01934647|11978523|FG001|NOT COMPLETED|Overall Study||0
10815415|NCT01934647|11978524|FG002|NOT COMPLETED|Overall Study||0
10815416|NCT01934504|11978536|FG000|STARTED|Overall Study||6
10815417|NCT01934504|11978537|FG001|STARTED|Overall Study||3
10815418|NCT01934504|11978538|FG002|STARTED|Overall Study||16
10408465|NCT00754923|11552548|FG000|STARTED|Overall Study||11
10408466|NCT00754923|11552548|FG000|COMPLETED|Overall Study||11
10408467|NCT00754923|11552548|FG000|NOT COMPLETED|Overall Study||0
10733918|NCT02821962|11897953|FG001|STARTED|Overall Study||21
10733919|NCT02821962|11897952|FG000|COMPLETED|Overall Study||17
10733920|NCT02821962|11897953|FG001|COMPLETED|Overall Study||21
10733921|NCT02821962|11897952|FG000|NOT COMPLETED|Overall Study||2
10733922|NCT02821962|11897953|FG001|NOT COMPLETED|Overall Study||0
10733923|NCT02822222|11897961|FG000|STARTED|Overall Study||16
10733924|NCT02822222|11897962|FG001|STARTED|Overall Study||6
10733925|NCT02822222|11897961|FG000|COMPLETED|Overall Study||15
10733926|NCT02822222|11897962|FG001|COMPLETED|Overall Study||6
10733927|NCT02822222|11897961|FG000|NOT COMPLETED|Overall Study||1
10815419|NCT01934504|11978539|FG003|STARTED|Overall Study||8
10815420|NCT01934504|11978536|FG000|COMPLETED|Overall Study||5
10815421|NCT01934504|11978537|FG001|COMPLETED|Overall Study||3
10815422|NCT01934504|11978538|FG002|COMPLETED|Overall Study||11
10815423|NCT01934504|11978539|FG003|COMPLETED|Overall Study||1
10815424|NCT01934504|11978536|FG000|NOT COMPLETED|Overall Study||1
10815425|NCT01934504|11978537|FG001|NOT COMPLETED|Overall Study||0
10815426|NCT01934504|11978538|FG002|NOT COMPLETED|Overall Study||5
10815427|NCT01934504|11978539|FG003|NOT COMPLETED|Overall Study||7
10815428|NCT01928082|11978549|FG000|STARTED|Overall Study||1
10815429|NCT01928082|11978549|FG000|COMPLETED|Overall Study||0
10815430|NCT01928082|11978549|FG000|NOT COMPLETED|Overall Study||1
10815431|NCT01928615|11978553|FG000|STARTED|Overall Study||2
10815432|NCT01928615|11978553|FG000|COMPLETED|Overall Study||0
10815433|NCT01928615|11978553|FG000|NOT COMPLETED|Overall Study||2
10815434|NCT01911793|11978560|FG000|STARTED|Overall Study||1
10815435|NCT01911793|11978561|FG001|STARTED|Overall Study||5
10815436|NCT01911793|11978560|FG000|COMPLETED|Overall Study||0
10815437|NCT01911793|11978561|FG001|COMPLETED|Overall Study||0
10815438|NCT01911793|11978560|FG000|NOT COMPLETED|Overall Study||1
10815439|NCT01911793|11978561|FG001|NOT COMPLETED|Overall Study||5
10815440|NCT01912404|11978569|FG000|STARTED|Overall Study||3
10815441|NCT01912404|11978570|FG001|STARTED|Overall Study||2
10815442|NCT01912404|11978569|FG000|COMPLETED|Overall Study||2
10815443|NCT01912404|11978570|FG001|COMPLETED|Overall Study||2
10815444|NCT01912404|11978569|FG000|NOT COMPLETED|Overall Study||1
10815445|NCT01912404|11978570|FG001|NOT COMPLETED|Overall Study||0
10815446|NCT01910389|11978578|FG000|STARTED|Overall Study||15
10815447|NCT01910389|11978579|FG001|STARTED|Overall Study||8
10815448|NCT01910389|11978578|FG000|COMPLETED|Overall Study||0
10815449|NCT01910389|11978579|FG001|COMPLETED|Overall Study||0
10815450|NCT01910389|11978578|FG000|NOT COMPLETED|Overall Study||15
10815451|NCT01910389|11978579|FG001|NOT COMPLETED|Overall Study||8
10815452|NCT01921114|11978587|FG000|STARTED|Overall Study||0
10815453|NCT01921114|11978588|FG001|STARTED|Overall Study||0
10815454|NCT01921114|11978587|FG000|COMPLETED|Overall Study||0
10815455|NCT01921114|11978588|FG001|COMPLETED|Overall Study||0
10815456|NCT01921114|11978587|FG000|NOT COMPLETED|Overall Study||0
10815457|NCT01921114|11978588|FG001|NOT COMPLETED|Overall Study||0
10815458|NCT01916590|11978596|FG000|STARTED|Overall Study||4
10815459|NCT01916590|11978597|FG001|STARTED|Overall Study||3
10815460|NCT01916590|11978596|FG000|COMPLETED|Overall Study||4
10733928|NCT02822222|11897962|FG001|NOT COMPLETED|Overall Study||0
10733929|NCT02822235|11897970|FG000|STARTED|Cross-sectional Phase (Day 1)||264
10733930|NCT02822235|11897971|FG001|STARTED|Cross-sectional Phase (Day 1)||143
10733931|NCT02822235|11897970|FG000|COMPLETED|Cross-sectional Phase (Day 1)||118
10815461|NCT01916590|11978597|FG001|COMPLETED|Overall Study||3
10815462|NCT01916590|11978596|FG000|NOT COMPLETED|Overall Study||0
10815463|NCT01916590|11978597|FG001|NOT COMPLETED|Overall Study||0
10815464|NCT01913327|11978605|FG000|STARTED|Overall Study||1
10815465|NCT01913327|11978606|FG001|STARTED|Overall Study||2
10815466|NCT01913327|11978605|FG000|COMPLETED|Overall Study||1
10815467|NCT01913327|11978606|FG001|COMPLETED|Overall Study||1
10733932|NCT02822235|11897971|FG001|COMPLETED|Cross-sectional Phase (Day 1)||36
10733933|NCT02822235|11897970|FG000|NOT COMPLETED|Cross-sectional Phase (Day 1)||146
10733934|NCT02822235|11897971|FG001|NOT COMPLETED|Cross-sectional Phase (Day 1)||107
10815468|NCT01913327|11978605|FG000|NOT COMPLETED|Overall Study||0
10815469|NCT01913327|11978606|FG001|NOT COMPLETED|Overall Study||1
10733935|NCT02822235|11897970|FG000|STARTED|Prospective Phase (Day 1 up to Month 12)||118
10733936|NCT02822235|11897971|FG001|STARTED|Prospective Phase (Day 1 up to Month 12)||36
10733937|NCT02822235|11897970|FG000|COMPLETED|Prospective Phase (Day 1 up to Month 12)||107
10733938|NCT02822235|11897971|FG001|COMPLETED|Prospective Phase (Day 1 up to Month 12)||34
10733939|NCT02822235|11897970|FG000|NOT COMPLETED|Prospective Phase (Day 1 up to Month 12)||11
10733940|NCT02822235|11897971|FG001|NOT COMPLETED|Prospective Phase (Day 1 up to Month 12)||2
10733941|NCT02822287|11897984|FG000|STARTED|Overall Study||57
10733942|NCT02822287|11897984|FG000|COMPLETED|Overall Study||57
10733943|NCT02822287|11897984|FG000|NOT COMPLETED|Overall Study||0
10733944|NCT02822599|11897990|FG000|STARTED|Overall Study|First subject enrolled on 6-1-17.|15
10733945|NCT02822599|11897991|FG001|STARTED|Overall Study|First subject enrolled on 6-1-17.|15
10733946|NCT02822599|11897990|FG000|COMPLETED|Overall Study||15
10733947|NCT02822599|11897991|FG001|COMPLETED|Overall Study||15
10733948|NCT02822599|11897990|FG000|NOT COMPLETED|Overall Study||0
10733949|NCT02822599|11897991|FG001|NOT COMPLETED|Overall Study||0
10733950|NCT02822612|11898002|FG000|STARTED|Overall Study||14
10733951|NCT02822612|11898003|FG001|STARTED|Overall Study||13
10733952|NCT02822612|11898004|FG002|STARTED|Overall Study||14
10733953|NCT02822612|11898005|FG003|STARTED|Overall Study||4
10733954|NCT02822612|11898006|FG004|STARTED|Overall Study||15
10733955|NCT02822612|11898002|FG000|COMPLETED|Overall Study||14
10733956|NCT02822612|11898003|FG001|COMPLETED|Overall Study||13
10733957|NCT02822612|11898004|FG002|COMPLETED|Overall Study||14
10733958|NCT02822612|11898005|FG003|COMPLETED|Overall Study||4
10733959|NCT02822612|11898006|FG004|COMPLETED|Overall Study||15
10733960|NCT02822612|11898002|FG000|NOT COMPLETED|Overall Study||0
10733961|NCT02822612|11898003|FG001|NOT COMPLETED|Overall Study||0
10733962|NCT02822612|11898004|FG002|NOT COMPLETED|Overall Study||0
10733963|NCT02822612|11898005|FG003|NOT COMPLETED|Overall Study||0
10733964|NCT02822612|11898006|FG004|NOT COMPLETED|Overall Study||0
10733965|NCT02822794|11898022|FG000|STARTED|Overall Study||57
10733966|NCT02822794|11898023|FG001|STARTED|Overall Study||60
10733967|NCT02822794|11898022|FG000|COMPLETED|Overall Study||56
10733968|NCT02822794|11898023|FG001|COMPLETED|Overall Study||60
10733969|NCT02822794|11898022|FG000|NOT COMPLETED|Overall Study||1
10733970|NCT02822794|11898023|FG001|NOT COMPLETED|Overall Study||0
10733971|NCT02822885|11898036|FG000|STARTED|Overall Study||70
10733972|NCT02822885|11898036|FG000|COMPLETED|Overall Study||70
10733973|NCT02822885|11898036|FG000|NOT COMPLETED|Overall Study||0
10733974|NCT02822950|11898040|FG000|STARTED|Overall Study||10
10733975|NCT02822950|11898040|FG000|COMPLETED|Overall Study||10
10733976|NCT02822950|11898040|FG000|NOT COMPLETED|Overall Study||0
10733977|NCT02823080|11898046|FG000|STARTED|Overall Study||24
10733978|NCT02823080|11898047|FG001|STARTED|Overall Study||24
10733979|NCT02823080|11898046|FG000|COMPLETED|Overall Study||24
10733980|NCT02823080|11898047|FG001|COMPLETED|Overall Study||24
10733981|NCT02823080|11898046|FG000|NOT COMPLETED|Overall Study||0
10733982|NCT02823080|11898047|FG001|NOT COMPLETED|Overall Study||0
10733983|NCT02823431|11898056|FG000|STARTED|Overall Study||11
10733984|NCT02823431|11898057|FG001|STARTED|Overall Study||12
10733985|NCT02823431|11898056|FG000|COMPLETED|Overall Study||11
10733986|NCT02823431|11898057|FG001|COMPLETED|Overall Study||12
10733987|NCT02823431|11898056|FG000|NOT COMPLETED|Overall Study||0
10733988|NCT02823431|11898057|FG001|NOT COMPLETED|Overall Study||0
10733989|NCT02823470|11898065|FG000|STARTED|Overall Study||9
10733990|NCT02823470|11898066|FG001|STARTED|Overall Study||15
10733991|NCT02823470|11898065|FG000|COMPLETED|Overall Study||0
10733992|NCT02823470|11898066|FG001|COMPLETED|Overall Study||0
10733993|NCT02823470|11898065|FG000|NOT COMPLETED|Overall Study||9
10733994|NCT02823470|11898066|FG001|NOT COMPLETED|Overall Study||15
10733995|NCT02823600|11898075|FG000|STARTED|Overall Study||68
10733996|NCT02823600|11898075|FG000|COMPLETED|Overall Study||68
10733997|NCT02823600|11898075|FG000|NOT COMPLETED|Overall Study||0
10733998|NCT02823964|11898081|FG000|STARTED|Overall Study||25
10733999|NCT02823964|11898081|FG000|COMPLETED|Overall Study||20
10734000|NCT02823964|11898081|FG000|NOT COMPLETED|Overall Study||5
10734001|NCT02824224|11898087|FG000|STARTED|Overall Study||19
10734002|NCT02824224|11898088|FG001|STARTED|Overall Study||18
10734003|NCT02824224|11898087|FG000|COMPLETED|Overall Study||17
10734004|NCT02824224|11898088|FG001|COMPLETED|Overall Study||17
10734005|NCT02824224|11898087|FG000|NOT COMPLETED|Overall Study||2
10734006|NCT02824224|11898088|FG001|NOT COMPLETED|Overall Study||1
10734007|NCT02824432|11898096|FG000|STARTED|Overall Study||18
10734008|NCT02824432|11898097|FG001|STARTED|Overall Study||19
10734009|NCT02824432|11898096|FG000|COMPLETED|Overall Study||17
10734010|NCT02824432|11898097|FG001|COMPLETED|Overall Study||19
10734011|NCT02824432|11898096|FG000|NOT COMPLETED|Overall Study||1
10734012|NCT02824432|11898097|FG001|NOT COMPLETED|Overall Study||0
10734013|NCT02824562|11898105|FG000|STARTED|Overall Study||22
10734014|NCT02824562|11898106|FG001|STARTED|Overall Study||22
10734015|NCT02824562|11898105|FG000|COMPLETED|Overall Study||19
10734016|NCT02824562|11898106|FG001|COMPLETED|Overall Study||17
10734017|NCT02824562|11898105|FG000|NOT COMPLETED|Overall Study||3
10734018|NCT02824562|11898106|FG001|NOT COMPLETED|Overall Study||5
10734019|NCT02824913|11898114|FG000|STARTED|First Intervention (1 Day)||1
10815470|NCT01902888|11978612|FG000|STARTED|Overall Study||3
10734020|NCT02824913|11898115|FG001|STARTED|First Intervention (1 Day)||0
10734021|NCT02824913|11898114|FG000|COMPLETED|First Intervention (1 Day)|Only one subject was enrolled in the study and received both study treatments.|1
10734022|NCT02824913|11898115|FG001|COMPLETED|First Intervention (1 Day)||0
10815471|NCT01902888|11978612|FG000|COMPLETED|Overall Study||0
10734023|NCT02824913|11898114|FG000|NOT COMPLETED|First Intervention (1 Day)||0
10734024|NCT02824913|11898115|FG001|NOT COMPLETED|First Intervention (1 Day)||0
10544562|NCT01490632|11697638|FG001|NOT COMPLETED|Part C: Washout or Step-Down Period||0
10544563|NCT01490632|11697639|FG002|NOT COMPLETED|Part C: Washout or Step-Down Period||0
10544564|NCT01490632|11697640|FG003|NOT COMPLETED|Part C: Washout or Step-Down Period||0
10544565|NCT01490632|11697641|FG004|NOT COMPLETED|Part C: Washout or Step-Down Period||0
10544566|NCT01490632|11697642|FG005|NOT COMPLETED|Part C: Washout or Step-Down Period||0
10734025|NCT02824913|11898114|FG000|STARTED|Washout (7-14 Days)||1
10734026|NCT02824913|11898115|FG001|STARTED|Washout (7-14 Days)||0
10734027|NCT02824913|11898114|FG000|COMPLETED|Washout (7-14 Days)||1
10734028|NCT02824913|11898115|FG001|COMPLETED|Washout (7-14 Days)||0
10734029|NCT02824913|11898114|FG000|NOT COMPLETED|Washout (7-14 Days)||0
10734030|NCT02824913|11898115|FG001|NOT COMPLETED|Washout (7-14 Days)||0
10734031|NCT02824913|11898114|FG000|STARTED|Second Intervention (1 Day)||1
10734032|NCT02824913|11898115|FG001|STARTED|Second Intervention (1 Day)||0
10734033|NCT02824913|11898114|FG000|COMPLETED|Second Intervention (1 Day)||1
10734034|NCT02824913|11898115|FG001|COMPLETED|Second Intervention (1 Day)||0
10734035|NCT02824913|11898114|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10734036|NCT02824913|11898115|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10734037|NCT02825212|11898123|FG000|STARTED|Overall Study||10
10734038|NCT02825212|11898123|FG000|COMPLETED|Overall Study||10
10734039|NCT02825212|11898123|FG000|NOT COMPLETED|Overall Study||0
10815472|NCT01902888|11978612|FG000|NOT COMPLETED|Overall Study||3
10815473|NCT01901224|11978616|FG000|STARTED|Overall Study||2
10815474|NCT01901224|11978616|FG000|COMPLETED|Overall Study||0
10815475|NCT01901224|11978616|FG000|NOT COMPLETED|Overall Study||2
10815476|NCT01910441|11978622|FG000|STARTED|Overall Study||48
10815477|NCT01910441|11978623|FG001|STARTED|Overall Study||47
10815478|NCT01910441|11978622|FG000|COMPLETED|Overall Study||41
10815479|NCT01910441|11978623|FG001|COMPLETED|Overall Study||37
10815480|NCT01910441|11978622|FG000|NOT COMPLETED|Overall Study||7
10815481|NCT01910441|11978623|FG001|NOT COMPLETED|Overall Study||10
10815482|NCT01902966|11978629|FG000|STARTED|Overall Study||5
10815483|NCT01902966|11978629|FG000|COMPLETED|Overall Study||2
10815484|NCT01902966|11978629|FG000|NOT COMPLETED|Overall Study||3
10815485|NCT01901679|11978635|FG000|STARTED|Overall Study||5
10815486|NCT01901679|11978636|FG001|STARTED|Overall Study||5
10815487|NCT01901679|11978635|FG000|COMPLETED|Overall Study||5
10815488|NCT01901679|11978636|FG001|COMPLETED|Overall Study||5
10815489|NCT01901679|11978635|FG000|NOT COMPLETED|Overall Study||0
10815490|NCT01901679|11978636|FG001|NOT COMPLETED|Overall Study||0
10815491|NCT01900730|11978644|FG000|STARTED|Overall Study||3
10815492|NCT01900730|11978645|FG001|STARTED|Overall Study||0
10815493|NCT01900730|11978644|FG000|COMPLETED|Overall Study||1
10815494|NCT01900730|11978645|FG001|COMPLETED|Overall Study||0
10815495|NCT01900730|11978644|FG000|NOT COMPLETED|Overall Study||2
10815496|NCT01900730|11978645|FG001|NOT COMPLETED|Overall Study||0
10815497|NCT01877564|11978653|FG000|STARTED|Overall Study||6
10815498|NCT01877564|11978654|FG001|STARTED|Overall Study||4
10815499|NCT01877564|11978653|FG000|COMPLETED|Overall Study||6
10815500|NCT01877564|11978654|FG001|COMPLETED|Overall Study||4
10815501|NCT01877564|11978653|FG000|NOT COMPLETED|Overall Study||0
10815502|NCT01877564|11978654|FG001|NOT COMPLETED|Overall Study||0
10815503|NCT01890694|11978662|FG000|STARTED|Overall Study||1
10815504|NCT01890694|11978663|FG001|STARTED|Overall Study||1
10815505|NCT01890694|11978662|FG000|COMPLETED|Overall Study||0
10815506|NCT01890694|11978663|FG001|COMPLETED|Overall Study||0
10815507|NCT01890694|11978662|FG000|NOT COMPLETED|Overall Study||1
10815508|NCT01890694|11978663|FG001|NOT COMPLETED|Overall Study||1
10815509|NCT01900626|11978673|FG000|STARTED|Overall Study||1
10815510|NCT01900626|11978674|FG001|STARTED|Overall Study||1
10815511|NCT01900626|11978673|FG000|COMPLETED|Overall Study||0
10815512|NCT01900626|11978674|FG001|COMPLETED|Overall Study||0
10815513|NCT01900626|11978673|FG000|NOT COMPLETED|Overall Study||1
10815514|NCT01900626|11978674|FG001|NOT COMPLETED|Overall Study||1
10815515|NCT01890577|11978682|FG000|STARTED|Overall Study||28
10815516|NCT01890577|11978682|FG000|COMPLETED|Overall Study||0
10815517|NCT01890577|11978682|FG000|NOT COMPLETED|Overall Study||28
10815518|NCT01895959|11978686|FG000|STARTED|Overall Study||12
10815519|NCT01895959|11978686|FG000|COMPLETED|Overall Study||10
10815520|NCT01895959|11978686|FG000|NOT COMPLETED|Overall Study||2
10815521|NCT01889420|11978690|FG000|STARTED|Overall Study||1
10815522|NCT01889420|11978690|FG000|COMPLETED|Overall Study||1
10815523|NCT01889420|11978690|FG000|NOT COMPLETED|Overall Study||0
10815524|NCT01884077|11978696|FG000|STARTED|Overall Study||8
10815525|NCT01884077|11978697|FG001|STARTED|Overall Study||11
10815526|NCT01884077|11978696|FG000|COMPLETED|Overall Study||0
10815527|NCT01884077|11978697|FG001|COMPLETED|Overall Study||1
10815528|NCT01884077|11978696|FG000|NOT COMPLETED|Overall Study||8
10815529|NCT01884077|11978697|FG001|NOT COMPLETED|Overall Study||10
10815530|NCT01881984|11978703|FG000|STARTED|Overall Study||4
10815531|NCT01881984|11978703|FG000|COMPLETED|Overall Study||4
10734040|NCT02825251|11898129|FG000|STARTED|Overall Study||236
10734041|NCT02825251|11898130|FG001|STARTED|Overall Study||236
10734042|NCT02825251|11898129|FG000|COMPLETED|Overall Study||233
10815532|NCT01881984|11978703|FG000|NOT COMPLETED|Overall Study||0
10815533|NCT01893359|11978710|FG000|STARTED|Overall Study||0
10815534|NCT01893359|11978711|FG001|STARTED|Overall Study||2
10815535|NCT01893359|11978712|FG002|STARTED|Overall Study||0
10815536|NCT01893359|11978710|FG000|COMPLETED|Overall Study||0
10815537|NCT01893359|11978711|FG001|COMPLETED|Overall Study||2
10734043|NCT02825251|11898130|FG001|COMPLETED|Overall Study||230
10734044|NCT02825251|11898129|FG000|NOT COMPLETED|Overall Study||3
10734045|NCT02825251|11898130|FG001|NOT COMPLETED|Overall Study||6
10734046|NCT02825420|11898138|FG000|STARTED|Overall Study||131
10734047|NCT02825420|11898139|FG001|STARTED|Overall Study||89
10734048|NCT02825420|11898138|FG000|COMPLETED|Overall Study||88
10734049|NCT02825420|11898139|FG001|COMPLETED|Overall Study||72
10734050|NCT02825420|11898138|FG000|NOT COMPLETED|Overall Study||43
10734051|NCT02825420|11898139|FG001|NOT COMPLETED|Overall Study||17
10734052|NCT02825550|11898150|FG000|STARTED|Overall Study||13
10734053|NCT02825550|11898150|FG000|COMPLETED|Overall Study||12
10734054|NCT02825550|11898150|FG000|NOT COMPLETED|Overall Study||1
10734055|NCT02825680|11898158|FG000|STARTED|Overall Study||82
10734056|NCT02825680|11898159|FG001|STARTED|Overall Study||55
10734057|NCT02825680|11898158|FG000|COMPLETED|Overall Study||82
10734058|NCT02825680|11898159|FG001|COMPLETED|Overall Study||39
10734059|NCT02825680|11898158|FG000|NOT COMPLETED|Overall Study||0
10734060|NCT02825680|11898159|FG001|NOT COMPLETED|Overall Study||16
10734061|NCT02825849|11898167|FG000|STARTED|Overall Study||22
10734062|NCT02825849|11898168|FG001|STARTED|Overall Study||5
10734063|NCT02825849|11898167|FG000|COMPLETED|Overall Study||22
10734064|NCT02825849|11898168|FG001|COMPLETED|Overall Study||5
10734065|NCT02825849|11898167|FG000|NOT COMPLETED|Overall Study||0
10734066|NCT02825849|11898168|FG001|NOT COMPLETED|Overall Study||0
10734067|NCT02825966|11898174|FG000|STARTED|Overall Study||35
10734068|NCT02825966|11898174|FG000|COMPLETED|Overall Study||35
10734069|NCT02825966|11898174|FG000|NOT COMPLETED|Overall Study||0
10734070|NCT02825992|11898181|FG000|STARTED|Overall Study|The procedure was terminated for clinical reasons in 2 patients, therefore only 127 were treated.|129
10734071|NCT02825992|11898181|FG000|COMPLETED|Overall Study||121
10734072|NCT02825992|11898181|FG000|NOT COMPLETED|Overall Study||8
10734073|NCT02826421|11898195|FG000|STARTED|Overall Study||22
10734074|NCT02826421|11898196|FG001|STARTED|Overall Study||29
10734075|NCT02826421|11898197|FG002|STARTED|Overall Study||28
10734076|NCT02826421|11898198|FG003|STARTED|Overall Study||30
10734077|NCT02826421|11898195|FG000|Treated|Overall Study||19
10734078|NCT02826421|11898196|FG001|Treated|Overall Study||26
10734079|NCT02826421|11898197|FG002|Treated|Overall Study||26
10734080|NCT02826421|11898198|FG003|Treated|Overall Study||28
10734081|NCT02826421|11898195|FG000|COMPLETED|Overall Study||19
10734082|NCT02826421|11898196|FG001|COMPLETED|Overall Study||26
10734083|NCT02826421|11898197|FG002|COMPLETED|Overall Study||26
10734084|NCT02826421|11898198|FG003|COMPLETED|Overall Study||28
10734085|NCT02826421|11898195|FG000|NOT COMPLETED|Overall Study||3
10734086|NCT02826421|11898196|FG001|NOT COMPLETED|Overall Study||3
10734087|NCT02826421|11898197|FG002|NOT COMPLETED|Overall Study||2
10734088|NCT02826421|11898198|FG003|NOT COMPLETED|Overall Study||2
10734089|NCT02826603|11898211|FG000|STARTED|Overall Study||550
10734090|NCT02826603|11898212|FG001|STARTED|Overall Study||552
10734091|NCT02826603|11898211|FG000|COMPLETED|Overall Study||489
10734092|NCT02826603|11898212|FG001|COMPLETED|Overall Study||488
10734093|NCT02826603|11898211|FG000|NOT COMPLETED|Overall Study||61
10734094|NCT02826603|11898212|FG001|NOT COMPLETED|Overall Study||64
10734095|NCT02826694|11898221|FG000|STARTED|Overall Study||61
10734096|NCT02826694|11898222|FG001|STARTED|Overall Study||45
10734097|NCT02826694|11898221|FG000|Decision Group|Overall Study||41
10734098|NCT02826694|11898222|FG001|Decision Group|Overall Study||30
10734099|NCT02826694|11898221|FG000|Control Group|Overall Study||20
10734100|NCT02826694|11898222|FG001|Control Group|Overall Study||15
10734101|NCT02826694|11898221|FG000|COMPLETED|Overall Study||61
10734102|NCT02826694|11898222|FG001|COMPLETED|Overall Study||45
10734103|NCT02826694|11898221|FG000|NOT COMPLETED|Overall Study||0
10734104|NCT02826694|11898222|FG001|NOT COMPLETED|Overall Study||0
10777934|NCT03346070|11939835|FG002|STARTED|Overall Study||41
10777935|NCT03346070|11939836|FG003|STARTED|Overall Study||42
10777936|NCT03346070|11939837|FG004|STARTED|Overall Study||42
10777937|NCT03346070|11939833|FG000|Treated|Overall Study||38
10777938|NCT03346070|11939834|FG001|Treated|Overall Study||38
10777939|NCT03346070|11939835|FG002|Treated|Overall Study||38
10777940|NCT03346070|11939836|FG003|Treated|Overall Study||36
10777941|NCT03346070|11939837|FG004|Treated|Overall Study||38
10777942|NCT03346070|11939833|FG000|COMPLETED|Overall Study||38
10777943|NCT03346070|11939834|FG001|COMPLETED|Overall Study||37
10777944|NCT03346070|11939835|FG002|COMPLETED|Overall Study||37
10777945|NCT03346070|11939836|FG003|COMPLETED|Overall Study||36
10777946|NCT03346070|11939837|FG004|COMPLETED|Overall Study||37
10777947|NCT03346070|11939833|FG000|NOT COMPLETED|Overall Study||3
10777948|NCT03346070|11939834|FG001|NOT COMPLETED|Overall Study||4
10777949|NCT03346070|11939835|FG002|NOT COMPLETED|Overall Study||4
10777950|NCT03346070|11939836|FG003|NOT COMPLETED|Overall Study||6
10777951|NCT03346070|11939837|FG004|NOT COMPLETED|Overall Study||5
10777952|NCT03346161|11939853|FG000|STARTED|Overall Study||60
10777953|NCT03346161|11939854|FG001|STARTED|Overall Study||60
10777954|NCT03346161|11939853|FG000|COMPLETED|Overall Study||60
10777955|NCT03346161|11939854|FG001|COMPLETED|Overall Study||60
10777956|NCT03346161|11939853|FG000|NOT COMPLETED|Overall Study||0
10777957|NCT03346161|11939854|FG001|NOT COMPLETED|Overall Study||0
10777958|NCT03346759|11939862|FG000|STARTED|Enrollment to Baseline Data Collected||15
10777959|NCT03346759|11939863|FG001|STARTED|Enrollment to Baseline Data Collected||13
10777960|NCT03346759|11939862|FG000|COMPLETED|Enrollment to Baseline Data Collected|Participants assigned to the Tampon A First arm who provided at least one vaginal microbiota sample.|13
10779329|NCT03364309|11940866|FG007|NOT COMPLETED|Post-Treatment Followup Period||0
10815538|NCT01893359|11978712|FG002|COMPLETED|Overall Study||0
10815539|NCT01893359|11978710|FG000|NOT COMPLETED|Overall Study||0
10815540|NCT01893359|11978711|FG001|NOT COMPLETED|Overall Study||0
10815541|NCT01893359|11978712|FG002|NOT COMPLETED|Overall Study||0
10815542|NCT01883908|11978722|FG000|STARTED|Overall Study||3
10815543|NCT01883908|11978723|FG001|STARTED|Overall Study||1
10815544|NCT01883908|11978722|FG000|COMPLETED|Overall Study||3
10815545|NCT01883908|11978723|FG001|COMPLETED|Overall Study||1
10815546|NCT01883908|11978722|FG000|NOT COMPLETED|Overall Study||0
10734105|NCT02826798|11898235|FG000|STARTED|Overall Study||25
10734106|NCT02826798|11898236|FG001|STARTED|Overall Study||26
10734107|NCT02826798|11898237|FG002|STARTED|Overall Study||26
10734108|NCT02826798|11898238|FG003|STARTED|Overall Study||25
10734109|NCT02826798|11898239|FG004|STARTED|Overall Study||26
10734110|NCT02826798|11898235|FG000|COMPLETED|Overall Study||25
10734111|NCT02826798|11898236|FG001|COMPLETED|Overall Study||25
10734112|NCT02826798|11898237|FG002|COMPLETED|Overall Study||26
10734113|NCT02826798|11898238|FG003|COMPLETED|Overall Study||24
10734114|NCT02826798|11898239|FG004|COMPLETED|Overall Study||26
10734115|NCT02826798|11898235|FG000|NOT COMPLETED|Overall Study||0
10734116|NCT02826798|11898236|FG001|NOT COMPLETED|Overall Study||1
10734117|NCT02826798|11898237|FG002|NOT COMPLETED|Overall Study||0
10734118|NCT02826798|11898238|FG003|NOT COMPLETED|Overall Study||1
10734119|NCT02826798|11898239|FG004|NOT COMPLETED|Overall Study||0
10734120|NCT02827500|11898253|FG000|STARTED|Overall Study||52
10734121|NCT02827500|11898254|FG001|STARTED|Overall Study||52
10734122|NCT02827500|11898253|FG000|COMPLETED|Overall Study||33
10734123|NCT02827500|11898254|FG001|COMPLETED|Overall Study||45
10734124|NCT02827500|11898253|FG000|NOT COMPLETED|Overall Study||19
10734125|NCT02827500|11898254|FG001|NOT COMPLETED|Overall Study||7
10734126|NCT02827708|11898262|FG000|STARTED|Overall Study||163
10734127|NCT02827708|11898263|FG001|STARTED|Overall Study||161
10734128|NCT02827708|11898262|FG000|Full Analysis Set (FAS)|Overall Study||163
10734129|NCT02827708|11898263|FG001|Full Analysis Set (FAS)|Overall Study||161
10734130|NCT02827708|11898262|FG000|Safety Analysis Set (SAS)|Overall Study||163
10734131|NCT02827708|11898263|FG001|Safety Analysis Set (SAS)|Overall Study||161
10734132|NCT02827708|11898262|FG000|COMPLETED|Overall Study||158
10734133|NCT02827708|11898263|FG001|COMPLETED|Overall Study||156
10734134|NCT02827708|11898262|FG000|NOT COMPLETED|Overall Study||5
10734135|NCT02827708|11898263|FG001|NOT COMPLETED|Overall Study||5
10734136|NCT02828020|11898272|FG000|STARTED|Treatment Period||559
10734137|NCT02828020|11898273|FG001|STARTED|Treatment Period||556
10734138|NCT02828020|11898274|FG002|STARTED|Treatment Period||557
10734139|NCT02828020|11898272|FG000|Safety Population: Received Study Drug|Treatment Period||485
10734140|NCT02828020|11898273|FG001|Safety Population: Received Study Drug|Treatment Period||466
10734141|NCT02828020|11898274|FG002|Safety Population: Received Study Drug|Treatment Period||485
10734142|NCT02828020|11898272|FG000|COMPLETED|Treatment Period||479
10734143|NCT02828020|11898273|FG001|COMPLETED|Treatment Period||457
10734144|NCT02828020|11898274|FG002|COMPLETED|Treatment Period||479
10734145|NCT02828020|11898272|FG000|NOT COMPLETED|Treatment Period||80
10734146|NCT02828020|11898273|FG001|NOT COMPLETED|Treatment Period||99
10734147|NCT02828020|11898274|FG002|NOT COMPLETED|Treatment Period||78
10734148|NCT02828020|11898272|FG000|STARTED|Safety Follow-up Period|1 participant who did not complete the Treatment Period, was counted in the Safety Follow-up Period.|480
10734149|NCT02828020|11898273|FG001|STARTED|Safety Follow-up Period|1 participant who did not complete the Treatment Period, was counted in the Safety Follow-up Period.|458
10734150|NCT02828020|11898274|FG002|STARTED|Safety Follow-up Period|1 participant who did not complete the Treatment Period, was counted in the Safety Follow-up Period.|480
10734151|NCT02828020|11898272|FG000|COMPLETED|Safety Follow-up Period||460
10734152|NCT02828020|11898273|FG001|COMPLETED|Safety Follow-up Period||440
10734153|NCT02828020|11898274|FG002|COMPLETED|Safety Follow-up Period||461
10734154|NCT02828020|11898272|FG000|NOT COMPLETED|Safety Follow-up Period||20
10734155|NCT02828020|11898273|FG001|NOT COMPLETED|Safety Follow-up Period||18
10734156|NCT02828020|11898274|FG002|NOT COMPLETED|Safety Follow-up Period||19
10734157|NCT02828111|11898287|FG000|STARTED|Overall Study||6
10734158|NCT02828111|11898288|FG001|STARTED|Overall Study||6
10734159|NCT02828111|11898289|FG002|STARTED|Overall Study||6
10734160|NCT02828111|11898290|FG003|STARTED|Overall Study||6
10734161|NCT02828111|11898291|FG004|STARTED|Overall Study||12
10734162|NCT02828111|11898287|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
10734163|NCT02828111|11898288|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
10734164|NCT02828111|11898289|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
10734165|NCT02828111|11898290|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
10734166|NCT02828111|11898291|FG004|Received at Least 1 Dose of Study Drug|Overall Study||12
10734167|NCT02828111|11898287|FG000|COMPLETED|Overall Study||6
10734168|NCT02828111|11898288|FG001|COMPLETED|Overall Study||6
10734169|NCT02828111|11898289|FG002|COMPLETED|Overall Study||4
10734170|NCT02828111|11898290|FG003|COMPLETED|Overall Study||5
10734171|NCT02828111|11898291|FG004|COMPLETED|Overall Study||11
10734172|NCT02828111|11898287|FG000|NOT COMPLETED|Overall Study||0
10734173|NCT02828111|11898288|FG001|NOT COMPLETED|Overall Study||0
10734174|NCT02828111|11898289|FG002|NOT COMPLETED|Overall Study||2
10734175|NCT02828111|11898290|FG003|NOT COMPLETED|Overall Study||1
10815547|NCT01883908|11978723|FG001|NOT COMPLETED|Overall Study||0
10734176|NCT02828111|11898291|FG004|NOT COMPLETED|Overall Study||1
10815548|NCT01887288|11978729|FG000|STARTED|Overall Study||16
10815549|NCT01887288|11978729|FG000|COMPLETED|Overall Study||0
10815550|NCT01887288|11978729|FG000|NOT COMPLETED|Overall Study||16
10734177|NCT02828137|11898315|FG000|STARTED|Overall Study||41
10734178|NCT02828137|11898316|FG001|STARTED|Overall Study||41
10734179|NCT02828137|11898317|FG002|STARTED|Overall Study||41
10734180|NCT02828137|11898315|FG000|COMPLETED|Overall Study||41
10734181|NCT02828137|11898316|FG001|COMPLETED|Overall Study||41
10734182|NCT02828137|11898317|FG002|COMPLETED|Overall Study||41
10734183|NCT02828137|11898315|FG000|NOT COMPLETED|Overall Study||0
10734184|NCT02828137|11898316|FG001|NOT COMPLETED|Overall Study||0
10734185|NCT02828137|11898317|FG002|NOT COMPLETED|Overall Study||0
10734186|NCT02828241|11898327|FG000|STARTED|Overall Study||38
10734187|NCT02828241|11898328|FG001|STARTED|Overall Study||23
10734188|NCT02828241|11898327|FG000|COMPLETED|Overall Study||30
10734189|NCT02828241|11898328|FG001|COMPLETED|Overall Study||21
10734190|NCT02828241|11898327|FG000|NOT COMPLETED|Overall Study||8
10734191|NCT02828241|11898328|FG001|NOT COMPLETED|Overall Study||2
10734192|NCT02828267|11898339|FG000|STARTED|Overall Study||10
10734193|NCT02828267|11898340|FG001|STARTED|Overall Study||21
10734194|NCT02828267|11898341|FG002|STARTED|Overall Study||24
10734195|NCT02828267|11898342|FG003|STARTED|Overall Study||20
10734196|NCT02828267|11898339|FG000|COMPLETED|Overall Study||10
10734197|NCT02828267|11898340|FG001|COMPLETED|Overall Study||21
10734198|NCT02828267|11898341|FG002|COMPLETED|Overall Study||24
10734199|NCT02828267|11898342|FG003|COMPLETED|Overall Study||20
10734200|NCT02828267|11898339|FG000|NOT COMPLETED|Overall Study||0
10734201|NCT02828267|11898340|FG001|NOT COMPLETED|Overall Study||0
10734202|NCT02828267|11898341|FG002|NOT COMPLETED|Overall Study||0
10734203|NCT02828267|11898342|FG003|NOT COMPLETED|Overall Study||0
10734204|NCT02828358|11898356|FG000|STARTED|Overall Study||56
10734205|NCT02828358|11898357|FG001|STARTED|Overall Study||22
10734206|NCT02828358|11898356|FG000|COMPLETED|Overall Study||11
10734207|NCT02828358|11898357|FG001|COMPLETED|Overall Study||0
10734208|NCT02828358|11898356|FG000|NOT COMPLETED|Overall Study||45
10734209|NCT02828358|11898357|FG001|NOT COMPLETED|Overall Study||22
10734210|NCT02828436|11898362|FG000|STARTED|Period 1||0
10734211|NCT02828436|11898363|FG001|STARTED|Period 1||9
10734212|NCT02828436|11898362|FG000|COMPLETED|Period 1||0
10734213|NCT02828436|11898363|FG001|COMPLETED|Period 1||5
10734214|NCT02828436|11898362|FG000|NOT COMPLETED|Period 1||0
10734215|NCT02828436|11898363|FG001|NOT COMPLETED|Period 1||4
10734216|NCT02828436|11898362|FG000|STARTED|Period 2||9
10734217|NCT02828436|11898363|FG001|STARTED|Period 2||0
10734218|NCT02828436|11898362|FG000|COMPLETED|Period 2||1
10734219|NCT02828436|11898363|FG001|COMPLETED|Period 2||0
10734220|NCT02828436|11898362|FG000|NOT COMPLETED|Period 2||8
10734221|NCT02828436|11898363|FG001|NOT COMPLETED|Period 2||0
10734222|NCT02828644|11898371|FG000|STARTED|Overall Study||88
10734223|NCT02828644|11898372|FG001|STARTED|Overall Study||87
10734224|NCT02828644|11898371|FG000|COMPLETED|Overall Study||65
10734225|NCT02828644|11898372|FG001|COMPLETED|Overall Study||65
10734226|NCT02828644|11898371|FG000|NOT COMPLETED|Overall Study||23
10734227|NCT02828644|11898372|FG001|NOT COMPLETED|Overall Study||22
10734228|NCT02829034|11898381|FG000|STARTED|Overall Study||14
10734229|NCT02829034|11898382|FG001|STARTED|Overall Study||8
10734230|NCT02829034|11898381|FG000|COMPLETED|Overall Study||9
10734231|NCT02829034|11898382|FG001|COMPLETED|Overall Study||6
10734232|NCT02829034|11898381|FG000|NOT COMPLETED|Overall Study||5
10734233|NCT02829034|11898382|FG001|NOT COMPLETED|Overall Study||2
10734234|NCT02829138|11898390|FG000|STARTED|Overall Study||29
10734235|NCT02829138|11898391|FG001|STARTED|Overall Study||28
10734236|NCT02829138|11898390|FG000|COMPLETED|Overall Study||28
10734237|NCT02829138|11898391|FG001|COMPLETED|Overall Study||28
10734238|NCT02829138|11898390|FG000|NOT COMPLETED|Overall Study||1
10734239|NCT02829138|11898391|FG001|NOT COMPLETED|Overall Study||0
10734240|NCT02829294|11898397|FG000|STARTED|Overall Study||19
10734241|NCT02829294|11898397|FG000|COMPLETED|Overall Study||19
10734242|NCT02829294|11898397|FG000|NOT COMPLETED|Overall Study||0
10734243|NCT02829307|11898403|FG000|STARTED|Overall Study||8
10734244|NCT02829307|11898403|FG000|COMPLETED|Overall Study||8
10734245|NCT02829307|11898403|FG000|NOT COMPLETED|Overall Study||0
10734246|NCT02829320|11898407|FG000|STARTED|Overall Study||28
10734247|NCT02829320|11898407|FG000|COMPLETED|Overall Study||28
10734248|NCT02829320|11898407|FG000|NOT COMPLETED|Overall Study||0
10734249|NCT02829463|11898420|FG000|STARTED|Overall Study||59
10734250|NCT02829463|11898421|FG001|STARTED|Overall Study||62
10734251|NCT02829463|11898420|FG000|COMPLETED|Overall Study||59
10734252|NCT02829463|11898421|FG001|COMPLETED|Overall Study||62
10734253|NCT02829463|11898420|FG000|NOT COMPLETED|Overall Study||0
10734254|NCT02829463|11898421|FG001|NOT COMPLETED|Overall Study||0
10734255|NCT02829775|11898427|FG000|STARTED|Overall Study||9
10734256|NCT02829775|11898427|FG000|COMPLETED|Overall Study||4
10734257|NCT02829775|11898427|FG000|NOT COMPLETED|Overall Study||5
10734258|NCT02829944|11898434|FG000|STARTED|Overall Study||44
10734259|NCT02829944|11898435|FG001|STARTED|Overall Study||40
10734260|NCT02829944|11898434|FG000|COMPLETED|Overall Study||38
10734261|NCT02829944|11898435|FG001|COMPLETED|Overall Study||33
10734262|NCT02829944|11898434|FG000|NOT COMPLETED|Overall Study||6
10734263|NCT02829944|11898435|FG001|NOT COMPLETED|Overall Study||7
10734264|NCT02829983|11898443|FG000|STARTED|Overall Study||20
10734265|NCT02829983|11898444|FG001|STARTED|Overall Study||20
10734266|NCT02829983|11898443|FG000|COMPLETED|Overall Study||20
10734267|NCT02829983|11898444|FG001|COMPLETED|Overall Study||20
10734268|NCT02829983|11898443|FG000|NOT COMPLETED|Overall Study||0
10734269|NCT02829983|11898444|FG001|NOT COMPLETED|Overall Study||0
10734270|NCT02829996|11898455|FG000|STARTED|Overall Study||39
10734271|NCT02829996|11898456|FG001|STARTED|Overall Study||39
10734272|NCT02829996|11898457|FG002|STARTED|Overall Study||40
10734273|NCT02829996|11898458|FG003|STARTED|Overall Study||41
10734274|NCT02829996|11898459|FG004|STARTED|Overall Study||42
10734275|NCT02829996|11898455|FG000|COMPLETED|Overall Study||38
10734276|NCT02829996|11898456|FG001|COMPLETED|Overall Study||39
10734277|NCT02829996|11898457|FG002|COMPLETED|Overall Study||40
10734278|NCT02829996|11898458|FG003|COMPLETED|Overall Study||41
10734279|NCT02829996|11898459|FG004|COMPLETED|Overall Study||42
10734280|NCT02829996|11898455|FG000|NOT COMPLETED|Overall Study||1
10734281|NCT02829996|11898456|FG001|NOT COMPLETED|Overall Study||0
10734282|NCT02829996|11898457|FG002|NOT COMPLETED|Overall Study||0
10734283|NCT02829996|11898458|FG003|NOT COMPLETED|Overall Study||0
10734284|NCT02829996|11898459|FG004|NOT COMPLETED|Overall Study||0
10734285|NCT02830074|11898473|FG000|STARTED|Overall Study||32
10734286|NCT02830074|11898474|FG001|STARTED|Overall Study||31
10734287|NCT02830074|11898473|FG000|COMPLETED|Overall Study||32
10734288|NCT02830074|11898474|FG001|COMPLETED|Overall Study||31
10734289|NCT02830074|11898473|FG000|NOT COMPLETED|Overall Study||0
10734290|NCT02830074|11898474|FG001|NOT COMPLETED|Overall Study||0
10734291|NCT02830087|11898487|FG000|STARTED|Overall Study||4
10734292|NCT02830087|11898488|FG001|STARTED|Overall Study||4
10734293|NCT02830087|11898489|FG002|STARTED|Overall Study||4
10734294|NCT02830087|11898490|FG003|STARTED|Overall Study||3
10734295|NCT02830087|11898491|FG004|STARTED|Overall Study||3
10734296|NCT02830087|11898492|FG005|STARTED|Overall Study||3
10734297|NCT02830087|11898487|FG000|COMPLETED|Overall Study||0
10734298|NCT02830087|11898488|FG001|COMPLETED|Overall Study||0
10734299|NCT02830087|11898489|FG002|COMPLETED|Overall Study||0
10734300|NCT02830087|11898490|FG003|COMPLETED|Overall Study||0
10734301|NCT02830087|11898491|FG004|COMPLETED|Overall Study||0
10734302|NCT02830087|11898492|FG005|COMPLETED|Overall Study||0
10734303|NCT02830087|11898487|FG000|NOT COMPLETED|Overall Study||4
10734304|NCT02830087|11898488|FG001|NOT COMPLETED|Overall Study||4
10734305|NCT02830087|11898489|FG002|NOT COMPLETED|Overall Study||4
10734306|NCT02830087|11898490|FG003|NOT COMPLETED|Overall Study||3
10734307|NCT02830087|11898491|FG004|NOT COMPLETED|Overall Study||3
10734308|NCT02830087|11898492|FG005|NOT COMPLETED|Overall Study||3
10734309|NCT02830438|11898506|FG000|STARTED|Overall Study||8
10734310|NCT02830438|11898506|FG000|COMPLETED|Overall Study||8
10734311|NCT02830438|11898506|FG000|NOT COMPLETED|Overall Study||0
10734312|NCT02830776|11898510|FG000|STARTED|Overall Study||15
10734313|NCT02830776|11898510|FG000|COMPLETED|Overall Study||14
10734314|NCT02830776|11898510|FG000|NOT COMPLETED|Overall Study||1
10734315|NCT02830880|11898515|FG000|STARTED|Overall Study||7
10734316|NCT02830880|11898515|FG000|Completed Visit After Cyle 1|Overall Study||7
10734317|NCT02830880|11898515|FG000|COMPLETED|Overall Study||4
10734318|NCT02830880|11898515|FG000|NOT COMPLETED|Overall Study||3
10815551|NCT01881932|11978736|FG000|STARTED|Overall Study||2
10815552|NCT01881932|11978737|FG001|STARTED|Overall Study||4
10815553|NCT01881932|11978738|FG002|STARTED|Overall Study||13
10815554|NCT01881932|11978736|FG000|COMPLETED|Overall Study||2
10815555|NCT01881932|11978737|FG001|COMPLETED|Overall Study||4
10815556|NCT01881932|11978738|FG002|COMPLETED|Overall Study||13
10815557|NCT01881932|11978736|FG000|NOT COMPLETED|Overall Study||0
10815558|NCT01881932|11978737|FG001|NOT COMPLETED|Overall Study||0
10815559|NCT01881932|11978738|FG002|NOT COMPLETED|Overall Study||0
10815560|NCT01878786|11978749|FG000|STARTED|Overall Study||9
10815561|NCT01878786|11978750|FG001|STARTED|Overall Study||9
10815562|NCT01878786|11978751|FG002|STARTED|Overall Study||7
10815563|NCT01878786|11978749|FG000|COMPLETED|Overall Study|Study closed prematurely|0
10815564|NCT01878786|11978750|FG001|COMPLETED|Overall Study|Study closed prematurely|0
10815565|NCT01878786|11978751|FG002|COMPLETED|Overall Study|Study closed prematurely; 1 patient was a screen fail|0
10815566|NCT01878786|11978749|FG000|NOT COMPLETED|Overall Study||9
10815567|NCT01878786|11978750|FG001|NOT COMPLETED|Overall Study||9
10815568|NCT01878786|11978751|FG002|NOT COMPLETED|Overall Study||7
10815569|NCT01877343|11978762|FG000|STARTED|Overall Study||2
10815570|NCT01877343|11978763|FG001|STARTED|Overall Study||3
10815571|NCT01877343|11978764|FG002|STARTED|Overall Study||0
10815572|NCT01877343|11978765|FG003|STARTED|Overall Study||0
10815573|NCT01877343|11978766|FG004|STARTED|Overall Study||0
10815574|NCT01877343|11978767|FG005|STARTED|Overall Study||5
10815575|NCT01877343|11978768|FG006|STARTED|Overall Study||0
10815576|NCT01877343|11978762|FG000|COMPLETED|Overall Study||2
10815577|NCT01877343|11978763|FG001|COMPLETED|Overall Study||3
10815578|NCT01877343|11978764|FG002|COMPLETED|Overall Study||0
10734319|NCT02830893|11898521|FG000|STARTED|Overall Study||12
10734320|NCT02830893|11898522|FG001|STARTED|Overall Study||11
10734321|NCT02830893|11898521|FG000|COMPLETED|Overall Study||11
10734322|NCT02830893|11898522|FG001|COMPLETED|Overall Study||8
10734323|NCT02830893|11898521|FG000|NOT COMPLETED|Overall Study||1
10734324|NCT02830893|11898522|FG001|NOT COMPLETED|Overall Study||3
10734325|NCT02831387|11898530|FG000|STARTED|Overall Study||23
10734326|NCT02831387|11898531|FG001|STARTED|Overall Study||24
10734327|NCT02831387|11898530|FG000|COMPLETED|Overall Study||22
10734328|NCT02831387|11898531|FG001|COMPLETED|Overall Study||22
10734329|NCT02831387|11898530|FG000|NOT COMPLETED|Overall Study||1
10734330|NCT02831387|11898531|FG001|NOT COMPLETED|Overall Study||2
10734331|NCT02831569|11898537|FG000|STARTED|Overall Study||80
10734332|NCT02831569|11898537|FG000|COMPLETED|Overall Study||80
10734333|NCT02831569|11898537|FG000|NOT COMPLETED|Overall Study||0
10815579|NCT01877343|11978765|FG003|COMPLETED|Overall Study||0
10815580|NCT01877343|11978766|FG004|COMPLETED|Overall Study||0
10734334|NCT02831660|11898541|FG000|STARTED|Overall Study||1
10734335|NCT02831660|11898541|FG000|COMPLETED|Overall Study||1
10734336|NCT02831660|11898541|FG000|NOT COMPLETED|Overall Study||0
10734337|NCT02831816|11898545|FG000|STARTED|Overall Study||640
10734338|NCT02831816|11898545|FG000|ZP|Overall Study||589
10734339|NCT02831816|11898545|FG000|CP|Overall Study||590
10734340|NCT02831816|11898545|FG000|Vehicle|Overall Study||131
10734341|NCT02831816|11898545|FG000|COMPLETED|Overall Study||640
10734342|NCT02831816|11898545|FG000|NOT COMPLETED|Overall Study||0
10734343|NCT02831855|11898556|FG000|STARTED|Open Label Phase (24 Weeks)||694
10734344|NCT02831855|11898557|FG001|STARTED|Open Label Phase (24 Weeks)||0
10734345|NCT02831855|11898558|FG002|STARTED|Open Label Phase (24 Weeks)||0
10734346|NCT02831855|11898556|FG000|COMPLETED|Open Label Phase (24 Weeks)||623
10734347|NCT02831855|11898557|FG001|COMPLETED|Open Label Phase (24 Weeks)||0
10734348|NCT02831855|11898558|FG002|COMPLETED|Open Label Phase (24 Weeks)||0
10734349|NCT02831855|11898556|FG000|NOT COMPLETED|Open Label Phase (24 Weeks)||71
10734350|NCT02831855|11898557|FG001|NOT COMPLETED|Open Label Phase (24 Weeks)||0
10734351|NCT02831855|11898558|FG002|NOT COMPLETED|Open Label Phase (24 Weeks)||0
10734352|NCT02831855|11898556|FG000|STARTED|Double Blind Phase (24 Weeks)||0
10734353|NCT02831855|11898557|FG001|STARTED|Double Blind Phase (24 Weeks)|Only eligible participants from open label phase, were randomized into double blind phase.|267
10734354|NCT02831855|11898558|FG002|STARTED|Double Blind Phase (24 Weeks)|Only eligible participants from open label phase, were randomized into double blind phase. .|266
10734355|NCT02831855|11898556|FG000|Treated|Double Blind Phase (24 Weeks)||0
10734356|NCT02831855|11898557|FG001|Treated|Double Blind Phase (24 Weeks)||264
10734357|NCT02831855|11898558|FG002|Treated|Double Blind Phase (24 Weeks)||266
10734358|NCT02831855|11898556|FG000|COMPLETED|Double Blind Phase (24 Weeks)||0
10734359|NCT02831855|11898557|FG001|COMPLETED|Double Blind Phase (24 Weeks)||238
10734360|NCT02831855|11898558|FG002|COMPLETED|Double Blind Phase (24 Weeks)||247
10734361|NCT02831855|11898556|FG000|NOT COMPLETED|Double Blind Phase (24 Weeks)||0
10734362|NCT02831855|11898557|FG001|NOT COMPLETED|Double Blind Phase (24 Weeks)||29
10734363|NCT02831855|11898558|FG002|NOT COMPLETED|Double Blind Phase (24 Weeks)||19
10734364|NCT02831998|11898568|FG000|STARTED|Overall Study||440
10734365|NCT02831998|11898568|FG000|ZP|Overall Study||400
10734366|NCT02831998|11898568|FG000|CP|Overall Study||400
10734367|NCT02831998|11898568|FG000|Vehicle|Overall Study||80
10734368|NCT02831998|11898568|FG000|COMPLETED|Overall Study||440
10734369|NCT02831998|11898568|FG000|NOT COMPLETED|Overall Study||0
10734370|NCT02832037|11898584|FG000|STARTED|Overall Study||85
10734371|NCT02832037|11898585|FG001|STARTED|Overall Study||84
10734372|NCT02832037|11898586|FG002|STARTED|Overall Study||85
10734373|NCT02832037|11898587|FG003|STARTED|Overall Study||85
10734374|NCT02832037|11898588|FG004|STARTED|Overall Study||170
10734375|NCT02832037|11898584|FG000|COMPLETED|Overall Study||66
10734376|NCT02832037|11898585|FG001|COMPLETED|Overall Study||72
10734377|NCT02832037|11898586|FG002|COMPLETED|Overall Study||77
10734378|NCT02832037|11898587|FG003|COMPLETED|Overall Study||78
10734379|NCT02832037|11898588|FG004|COMPLETED|Overall Study||151
10734380|NCT02832037|11898584|FG000|NOT COMPLETED|Overall Study||19
10734381|NCT02832037|11898585|FG001|NOT COMPLETED|Overall Study||12
10734382|NCT02832037|11898586|FG002|NOT COMPLETED|Overall Study||8
10734383|NCT02832037|11898587|FG003|NOT COMPLETED|Overall Study||7
10734384|NCT02832037|11898588|FG004|NOT COMPLETED|Overall Study||19
10734385|NCT02832115|11898602|FG000|STARTED|Overall Study||48
10734386|NCT02832115|11898603|FG001|STARTED|Overall Study||52
10734387|NCT02832115|11898602|FG000|COMPLETED|Overall Study||48
10734388|NCT02832115|11898603|FG001|COMPLETED|Overall Study||52
10734389|NCT02832115|11898602|FG000|NOT COMPLETED|Overall Study||0
10734390|NCT02832115|11898603|FG001|NOT COMPLETED|Overall Study||0
10734391|NCT02832154|11898609|FG000|STARTED|Overall Study||43
10734392|NCT02832154|11898609|FG000|COMPLETED|Overall Study||43
10734393|NCT02832154|11898609|FG000|NOT COMPLETED|Overall Study||0
10734394|NCT02832284|11898613|FG000|STARTED|Overall Study||23
10734395|NCT02832284|11898613|FG000|COMPLETED|Overall Study||23
10734396|NCT02832284|11898613|FG000|NOT COMPLETED|Overall Study||0
10734397|NCT02832375|11898619|FG000|STARTED|Overall Study||121
10734398|NCT02832375|11898620|FG001|STARTED|Overall Study||121
10734399|NCT02832375|11898619|FG000|COMPLETED|Overall Study||119
10734400|NCT02832375|11898620|FG001|COMPLETED|Overall Study||121
10734401|NCT02832375|11898619|FG000|NOT COMPLETED|Overall Study||2
10734402|NCT02832375|11898620|FG001|NOT COMPLETED|Overall Study||0
10734403|NCT02832622|11898627|FG000|STARTED|Overall Study||2169
10734404|NCT02832622|11898627|FG000|COMPLETED|Overall Study||433
10734405|NCT02832622|11898627|FG000|NOT COMPLETED|Overall Study||1736
10734406|NCT02832674|11898632|FG000|STARTED|Overall Study||72
10734407|NCT02832674|11898632|FG000|COMPLETED|Overall Study||67
10734408|NCT02832674|11898632|FG000|NOT COMPLETED|Overall Study||5
10734409|NCT02833077|11898638|FG000|STARTED|Overall Study||144
10734410|NCT02833077|11898639|FG001|STARTED|Overall Study||48
10734411|NCT02833077|11898638|FG000|Participants Treated|Overall Study||144
10734412|NCT02833077|11898639|FG001|Participants Treated|Overall Study||38
10734413|NCT02833077|11898638|FG000|COMPLETED|Overall Study||127
10734414|NCT02833077|11898639|FG001|COMPLETED|Overall Study|Includes participants who completed the study but did not receive the optional treatment.|40
10734415|NCT02833077|11898638|FG000|NOT COMPLETED|Overall Study||17
10734416|NCT02833077|11898639|FG001|NOT COMPLETED|Overall Study||8
10734417|NCT02833337|11898646|FG000|STARTED|Overall Study||180
10734418|NCT02833337|11898646|FG000|COMPLETED|Overall Study||180
10734419|NCT02833337|11898646|FG000|NOT COMPLETED|Overall Study||0
10734420|NCT02833350|11898657|FG000|STARTED|Overall Study||40
10734421|NCT02833350|11898658|FG001|STARTED|Overall Study||109
10734422|NCT02833350|11898659|FG002|STARTED|Overall Study||110
10734423|NCT02833350|11898660|FG003|STARTED|Overall Study||110
10734424|NCT02833350|11898661|FG004|STARTED|Overall Study||111
10734425|NCT02833350|11898662|FG005|STARTED|Overall Study||49
10734426|NCT02833350|11898663|FG006|STARTED|Overall Study||49
10734427|NCT02833350|11898657|FG000|Randomized|Overall Study||40
10734428|NCT02833350|11898658|FG001|Randomized|Overall Study||109
10734429|NCT02833350|11898659|FG002|Randomized|Overall Study||110
10734430|NCT02833350|11898660|FG003|Randomized|Overall Study||110
10734431|NCT02833350|11898661|FG004|Randomized|Overall Study||111
10734432|NCT02833350|11898662|FG005|Randomized|Overall Study||48
10734433|NCT02833350|11898663|FG006|Randomized|Overall Study||50
10734434|NCT02833350|11898657|FG000|COMPLETED|Overall Study||37
10734435|NCT02833350|11898658|FG001|COMPLETED|Overall Study||100
10734436|NCT02833350|11898659|FG002|COMPLETED|Overall Study||102
10734437|NCT02833350|11898660|FG003|COMPLETED|Overall Study||102
10734438|NCT02833350|11898661|FG004|COMPLETED|Overall Study||108
10734439|NCT02833350|11898662|FG005|COMPLETED|Overall Study||48
10734440|NCT02833350|11898663|FG006|COMPLETED|Overall Study||44
10734441|NCT02833350|11898657|FG000|NOT COMPLETED|Overall Study||3
10734442|NCT02833350|11898658|FG001|NOT COMPLETED|Overall Study||9
10734443|NCT02833350|11898659|FG002|NOT COMPLETED|Overall Study||8
10734444|NCT02833350|11898660|FG003|NOT COMPLETED|Overall Study||8
10734445|NCT02833350|11898661|FG004|NOT COMPLETED|Overall Study||3
10734446|NCT02833350|11898662|FG005|NOT COMPLETED|Overall Study||1
10734447|NCT02833350|11898663|FG006|NOT COMPLETED|Overall Study||5
10734448|NCT02833415|11898684|FG000|STARTED|Overall Study||20
10734449|NCT02833415|11898685|FG001|STARTED|Overall Study||20
10734450|NCT02833415|11898684|FG000|COMPLETED|Overall Study||18
10734451|NCT02833415|11898685|FG001|COMPLETED|Overall Study||17
10734452|NCT02833415|11898684|FG000|NOT COMPLETED|Overall Study||2
10734453|NCT02833415|11898685|FG001|NOT COMPLETED|Overall Study||3
10734454|NCT02833857|11898691|FG000|STARTED|Overall Study||11
10734455|NCT02833857|11898691|FG000|COMPLETED|Overall Study||11
10734456|NCT02833857|11898691|FG000|NOT COMPLETED|Overall Study||0
10734457|NCT02833922|11898695|FG000|STARTED|Overall Study||718
10734458|NCT02833922|11898695|FG000|COMPLETED|Overall Study||336
10734459|NCT02833922|11898695|FG000|NOT COMPLETED|Overall Study||382
10734460|NCT02833948|11898701|FG000|STARTED|Overall Study||116
10734461|NCT02833948|11898702|FG001|STARTED|Overall Study||115
10734462|NCT02833948|11898701|FG000|COMPLETED|Overall Study||101
10734463|NCT02833948|11898702|FG001|COMPLETED|Overall Study||97
10734464|NCT02833948|11898701|FG000|NOT COMPLETED|Overall Study||15
10734465|NCT02833948|11898702|FG001|NOT COMPLETED|Overall Study||18
10815581|NCT01877343|11978767|FG005|COMPLETED|Overall Study||5
10815582|NCT01877343|11978768|FG006|COMPLETED|Overall Study||0
10815583|NCT01877343|11978762|FG000|NOT COMPLETED|Overall Study||0
10815584|NCT01877343|11978763|FG001|NOT COMPLETED|Overall Study||0
10815585|NCT01877343|11978764|FG002|NOT COMPLETED|Overall Study||0
10815586|NCT01877343|11978765|FG003|NOT COMPLETED|Overall Study||0
10815587|NCT01877343|11978766|FG004|NOT COMPLETED|Overall Study||0
10815588|NCT01877343|11978767|FG005|NOT COMPLETED|Overall Study||0
10815589|NCT01877343|11978768|FG006|NOT COMPLETED|Overall Study||0
10815590|NCT01861717|11978772|FG000|STARTED|Overall Study||4
10815591|NCT01861717|11978772|FG000|COMPLETED|Overall Study||2
10815592|NCT01861717|11978772|FG000|NOT COMPLETED|Overall Study||2
10815593|NCT01866709|11978779|FG000|STARTED|Overall Study||15
10815594|NCT01866709|11978780|FG001|STARTED|Overall Study||17
10815595|NCT01866709|11978779|FG000|COMPLETED|Overall Study||14
10815596|NCT01866709|11978780|FG001|COMPLETED|Overall Study||17
10815597|NCT01866709|11978779|FG000|NOT COMPLETED|Overall Study||1
10815598|NCT01866709|11978780|FG001|NOT COMPLETED|Overall Study||0
10815599|NCT01860040|11978788|FG000|STARTED|Overall Study|did not meet recruitment goal|1
10815600|NCT01860040|11978789|FG001|STARTED|Overall Study|did not meet recruitment goal|0
10815601|NCT01860040|11978788|FG000|COMPLETED|Overall Study|did not meet recruitment goal|0
10815602|NCT01860040|11978789|FG001|COMPLETED|Overall Study|did not meet recruitment goal|0
10815603|NCT01860040|11978788|FG000|NOT COMPLETED|Overall Study||1
10815604|NCT01860040|11978789|FG001|NOT COMPLETED|Overall Study||0
10815605|NCT01869478|11978796|FG000|STARTED|Overall Study||0
10815606|NCT01869478|11978797|FG001|STARTED|Overall Study||1
10815607|NCT01869478|11978796|FG000|COMPLETED|Overall Study||0
10815608|NCT01869478|11978797|FG001|COMPLETED|Overall Study||1
10815609|NCT01869478|11978796|FG000|NOT COMPLETED|Overall Study||0
10815610|NCT01869478|11978797|FG001|NOT COMPLETED|Overall Study||0
10815611|NCT01851174|11978803|FG000|STARTED|Overall Study||15
10815612|NCT01851174|11978803|FG000|COMPLETED|Overall Study||15
10815613|NCT01851174|11978803|FG000|NOT COMPLETED|Overall Study||0
10815614|NCT01846182|11978810|FG000|STARTED|Overall Study|Unclear due to assignment records.|0
10815615|NCT01846182|11978811|FG001|STARTED|Overall Study|Unclear due to assignment records.|0
10815616|NCT01846182|11978812|FG002|STARTED|Overall Study|Unclear due to assignment records.|0
10815617|NCT01846182|11978810|FG000|COMPLETED|Overall Study|The data on completion subjects is corrupted and not reliable for interpretation.|0
10815618|NCT01846182|11978811|FG001|COMPLETED|Overall Study|The data on completion subjects is corrupted and not reliable for interpretation.|0
10815619|NCT01846182|11978812|FG002|COMPLETED|Overall Study|The data on completion subjects is corrupted and not reliable for interpretation.|0
10815620|NCT01846182|11978810|FG000|NOT COMPLETED|Overall Study||0
10734466|NCT02833974|11898714|FG000|STARTED|Overall Study||14
10734467|NCT02833974|11898715|FG001|STARTED|Overall Study||22
10734468|NCT02833974|11898714|FG000|COMPLETED|Overall Study||13
10734469|NCT02833974|11898715|FG001|COMPLETED|Overall Study||19
10734470|NCT02833974|11898714|FG000|NOT COMPLETED|Overall Study||1
10734471|NCT02833974|11898715|FG001|NOT COMPLETED|Overall Study||3
10734472|NCT02834247|11898725|FG000|STARTED|Dose Escalation Phase||8
10734473|NCT02834247|11898726|FG001|STARTED|Dose Escalation Phase||11
10734474|NCT02834247|11898727|FG002|STARTED|Dose Escalation Phase||5
10734475|NCT02834247|11898728|FG003|STARTED|Dose Escalation Phase||0
10734476|NCT02834247|11898725|FG000|COMPLETED|Dose Escalation Phase||0
10734477|NCT02834247|11898726|FG001|COMPLETED|Dose Escalation Phase||0
10734478|NCT02834247|11898727|FG002|COMPLETED|Dose Escalation Phase||0
10734479|NCT02834247|11898728|FG003|COMPLETED|Dose Escalation Phase||0
10734480|NCT02834247|11898725|FG000|NOT COMPLETED|Dose Escalation Phase||8
10734481|NCT02834247|11898726|FG001|NOT COMPLETED|Dose Escalation Phase||11
10734482|NCT02834247|11898727|FG002|NOT COMPLETED|Dose Escalation Phase||5
10734483|NCT02834247|11898728|FG003|NOT COMPLETED|Dose Escalation Phase||0
10734484|NCT02834247|11898725|FG000|STARTED|Dose Expansion Phase||0
10734485|NCT02834247|11898726|FG001|STARTED|Dose Expansion Phase||0
10734486|NCT02834247|11898727|FG002|STARTED|Dose Expansion Phase||0
10734487|NCT02834247|11898728|FG003|STARTED|Dose Expansion Phase||17
10734488|NCT02834247|11898725|FG000|COMPLETED|Dose Expansion Phase||0
10734489|NCT02834247|11898726|FG001|COMPLETED|Dose Expansion Phase||0
10734490|NCT02834247|11898727|FG002|COMPLETED|Dose Expansion Phase||0
10734491|NCT02834247|11898728|FG003|COMPLETED|Dose Expansion Phase||0
10734492|NCT02834247|11898725|FG000|NOT COMPLETED|Dose Expansion Phase||0
10734493|NCT02834247|11898726|FG001|NOT COMPLETED|Dose Expansion Phase||0
10734494|NCT02834247|11898727|FG002|NOT COMPLETED|Dose Expansion Phase||0
10734495|NCT02834247|11898728|FG003|NOT COMPLETED|Dose Expansion Phase||17
10734496|NCT02834390|11898742|FG000|STARTED|Induction Phase||4
10734497|NCT02834390|11898743|FG001|STARTED|Induction Phase||3
10734498|NCT02834390|11898742|FG000|COMPLETED|Induction Phase||2
10734499|NCT02834390|11898743|FG001|COMPLETED|Induction Phase||1
10734500|NCT02834390|11898742|FG000|NOT COMPLETED|Induction Phase||2
10734501|NCT02834390|11898743|FG001|NOT COMPLETED|Induction Phase||2
10734502|NCT02834390|11898742|FG000|STARTED|Consolidation Phase||2
10734503|NCT02834390|11898743|FG001|STARTED|Consolidation Phase||1
10734504|NCT02834390|11898742|FG000|COMPLETED|Consolidation Phase||1
10734505|NCT02834390|11898743|FG001|COMPLETED|Consolidation Phase||0
10734506|NCT02834390|11898742|FG000|NOT COMPLETED|Consolidation Phase||1
10734507|NCT02834390|11898743|FG001|NOT COMPLETED|Consolidation Phase||1
10734508|NCT02834624|11898751|FG000|STARTED|Overall Study||15
10734509|NCT02834624|11898752|FG001|STARTED|Overall Study||15
10734510|NCT02834624|11898751|FG000|COMPLETED|Overall Study||15
10734511|NCT02834624|11898752|FG001|COMPLETED|Overall Study||15
10734512|NCT02834624|11898751|FG000|NOT COMPLETED|Overall Study||0
10734513|NCT02834624|11898752|FG001|NOT COMPLETED|Overall Study||0
10734514|NCT02834663|11898759|FG000|STARTED|Overall Study|Unit means the eye. One eye was included per patient|25
10734515|NCT02834663|11898759|FG000|COMPLETED|Overall Study|Unit means the eye. One eye was included per patient|25
10734516|NCT02834663|11898759|FG000|NOT COMPLETED|Overall Study||0
10734517|NCT02834806|11898777|FG000|STARTED|Overall Study||58
10734518|NCT02834806|11898777|FG000|COMPLETED|Overall Study||58
10734519|NCT02834806|11898777|FG000|NOT COMPLETED|Overall Study||0
10734520|NCT02834819|11898783|FG000|STARTED|Overall Study||9
10734521|NCT02834819|11898784|FG001|STARTED|Overall Study||9
10734522|NCT02834819|11898783|FG000|COMPLETED|Overall Study||4
10734523|NCT02834819|11898784|FG001|COMPLETED|Overall Study||9
10734524|NCT02834819|11898783|FG000|NOT COMPLETED|Overall Study||5
10734525|NCT02834819|11898784|FG001|NOT COMPLETED|Overall Study||0
10734526|NCT02835092|11898793|FG000|STARTED|Overall Study||66
10734527|NCT02835092|11898794|FG001|STARTED|Overall Study||65
10734528|NCT02835092|11898795|FG002|STARTED|Overall Study||67
10734529|NCT02835092|11898793|FG000|COMPLETED|Overall Study||63
10734530|NCT02835092|11898794|FG001|COMPLETED|Overall Study||57
10734531|NCT02835092|11898795|FG002|COMPLETED|Overall Study||64
10734532|NCT02835092|11898793|FG000|NOT COMPLETED|Overall Study||3
10734533|NCT02835092|11898794|FG001|NOT COMPLETED|Overall Study||8
10734534|NCT02835092|11898795|FG002|NOT COMPLETED|Overall Study||3
10734535|NCT02835274|11898805|FG000|STARTED|Overall Study||6
10734536|NCT02835274|11898806|FG001|STARTED|Overall Study||6
10734537|NCT02835274|11898805|FG000|COMPLETED|Overall Study||6
10734538|NCT02835274|11898806|FG001|COMPLETED|Overall Study||6
10734539|NCT02835274|11898805|FG000|NOT COMPLETED|Overall Study||0
10734540|NCT02835274|11898806|FG001|NOT COMPLETED|Overall Study||0
10734541|NCT02835339|11898814|FG000|STARTED|Overall Study||31
10734542|NCT02835339|11898815|FG001|STARTED|Overall Study||35
10734543|NCT02835339|11898814|FG000|COMPLETED|Overall Study||18
10734544|NCT02835339|11898815|FG001|COMPLETED|Overall Study||19
10734545|NCT02835339|11898814|FG000|NOT COMPLETED|Overall Study||13
10734546|NCT02835339|11898815|FG001|NOT COMPLETED|Overall Study||16
10734547|NCT02835495|11898823|FG000|STARTED|Overall Study|26 randomized, however, one had to withdraw pre-intervention initiation due to cancer diagnosis.|26
10734548|NCT02835495|11898824|FG001|STARTED|Overall Study||25
10734549|NCT02835495|11898823|FG000|Intervention Start|Overall Study||25
10734550|NCT02835495|11898824|FG001|Intervention Start|Overall Study||25
10734551|NCT02835495|11898823|FG000|COMPLETED|Overall Study||21
10734552|NCT02835495|11898824|FG001|COMPLETED|Overall Study||23
10734553|NCT02835495|11898823|FG000|NOT COMPLETED|Overall Study||5
10734554|NCT02835495|11898824|FG001|NOT COMPLETED|Overall Study||2
10734555|NCT02835625|11898834|FG000|STARTED|Overall Study||14734
10734556|NCT02835625|11898835|FG001|STARTED|Overall Study||14719
10734557|NCT02835625|11898834|FG000|COMPLETED|Overall Study||14734
10734558|NCT02835625|11898835|FG001|COMPLETED|Overall Study||14719
10734559|NCT02835625|11898834|FG000|NOT COMPLETED|Overall Study||0
10734560|NCT02835625|11898835|FG001|NOT COMPLETED|Overall Study||0
10734561|NCT02835677|11898842|FG000|STARTED|Overall Study||25
10734562|NCT02835677|11898842|FG000|COMPLETED|Overall Study||25
10734563|NCT02835677|11898842|FG000|NOT COMPLETED|Overall Study||0
10734564|NCT02835820|11898848|FG000|STARTED|Overall Study||7
10734565|NCT02835820|11898849|FG001|STARTED|Overall Study||10
10734566|NCT02835820|11898848|FG000|Baseline Screen (OGTT)|Overall Study||7
10734567|NCT02835820|11898849|FG001|Baseline Screen (OGTT)|Overall Study||7
10734568|NCT02835820|11898848|FG000|COMPLETED|Overall Study||7
10734569|NCT02835820|11898849|FG001|COMPLETED|Overall Study||7
10734570|NCT02835820|11898848|FG000|NOT COMPLETED|Overall Study||0
10734571|NCT02835820|11898849|FG001|NOT COMPLETED|Overall Study||3
10734572|NCT02835846|11898855|FG000|STARTED|Overall Study||35
10734573|NCT02835846|11898855|FG000|COMPLETED|Overall Study||24
10734574|NCT02835846|11898855|FG000|NOT COMPLETED|Overall Study||11
10734575|NCT02836496|11898861|FG000|STARTED|Overall Study||54
10734576|NCT02836496|11898862|FG001|STARTED|Overall Study||54
10734577|NCT02836496|11898861|FG000|COMPLETED|Overall Study||52
10734578|NCT02836496|11898862|FG001|COMPLETED|Overall Study||52
10734579|NCT02836496|11898861|FG000|NOT COMPLETED|Overall Study||2
10734580|NCT02836496|11898862|FG001|NOT COMPLETED|Overall Study||2
10734581|NCT02836613|11898870|FG000|STARTED|Overall Study||80
10734582|NCT02836613|11898871|FG001|STARTED|Overall Study||80
10734583|NCT02836613|11898870|FG000|COMPLETED|Overall Study||79
10734584|NCT02836613|11898871|FG001|COMPLETED|Overall Study||77
10734585|NCT02836613|11898870|FG000|NOT COMPLETED|Overall Study||1
10734586|NCT02836613|11898871|FG001|NOT COMPLETED|Overall Study||3
10734587|NCT02836652|11898879|FG000|STARTED|Overall Study||35
10734588|NCT02836652|11898880|FG001|STARTED|Overall Study||37
10734589|NCT02836652|11898879|FG000|As-treated Population|Overall Study||31
10734590|NCT02836652|11898880|FG001|As-treated Population|Overall Study||34
10734591|NCT02836652|11898879|FG000|COMPLETED|Overall Study||17
10734592|NCT02836652|11898880|FG001|COMPLETED|Overall Study||18
10734593|NCT02836652|11898879|FG000|NOT COMPLETED|Overall Study||18
10734594|NCT02836652|11898880|FG001|NOT COMPLETED|Overall Study||19
10734595|NCT02836769|11898886|FG000|STARTED|Overall Study||35
10734596|NCT02836769|11898886|FG000|Received Intervention|Overall Study||30
10734597|NCT02836769|11898886|FG000|Completed Post-test Assessment|Overall Study||21
10734598|NCT02836769|11898886|FG000|COMPLETED|Overall Study||20
10734599|NCT02836769|11898886|FG000|NOT COMPLETED|Overall Study||15
10734600|NCT02836873|11898892|FG000|STARTED|Overall Study||157
10734601|NCT02836873|11898893|FG001|STARTED|Overall Study||155
10734602|NCT02836873|11898892|FG000|COMPLETED|Overall Study||152
10734603|NCT02836873|11898893|FG001|COMPLETED|Overall Study||144
10734604|NCT02836873|11898892|FG000|NOT COMPLETED|Overall Study||5
10734605|NCT02836873|11898893|FG001|NOT COMPLETED|Overall Study||11
10734606|NCT02836990|11898901|FG000|STARTED|Overall Study||50
10734607|NCT02836990|11898902|FG001|STARTED|Overall Study||55
10734608|NCT02836990|11898901|FG000|COMPLETED|Overall Study||50
10734609|NCT02836990|11898902|FG001|COMPLETED|Overall Study||55
10734610|NCT02836990|11898901|FG000|NOT COMPLETED|Overall Study||0
10734611|NCT02836990|11898902|FG001|NOT COMPLETED|Overall Study||0
10734612|NCT02837237|11898910|FG000|STARTED|Overall Study||11
10734613|NCT02837237|11898910|FG000|COMPLETED|Overall Study||11
10734614|NCT02837237|11898910|FG000|NOT COMPLETED|Overall Study||0
10734615|NCT02837328|11898916|FG000|STARTED|Overall Study||29
10734616|NCT02837328|11898917|FG001|STARTED|Overall Study||30
10734617|NCT02837328|11898916|FG000|COMPLETED|Overall Study||29
10734618|NCT02837328|11898917|FG001|COMPLETED|Overall Study||30
10734619|NCT02837328|11898916|FG000|NOT COMPLETED|Overall Study||0
10734620|NCT02837328|11898917|FG001|NOT COMPLETED|Overall Study||0
10734621|NCT02837731|11898925|FG000|STARTED|Allocation||102
10734622|NCT02837731|11898926|FG001|STARTED|Allocation||48
10734623|NCT02837731|11898925|FG000|COMPLETED|Allocation||83
10734624|NCT02837731|11898926|FG001|COMPLETED|Allocation||41
10734625|NCT02837731|11898925|FG000|NOT COMPLETED|Allocation||19
10734626|NCT02837731|11898926|FG001|NOT COMPLETED|Allocation||7
10734627|NCT02837731|11898925|FG000|STARTED|Follow-up||83
10734628|NCT02837731|11898926|FG001|STARTED|Follow-up||41
10734629|NCT02837731|11898925|FG000|COMPLETED|Follow-up||83
10734630|NCT02837731|11898926|FG001|COMPLETED|Follow-up||41
10734631|NCT02837731|11898925|FG000|NOT COMPLETED|Follow-up||0
10734632|NCT02837731|11898926|FG001|NOT COMPLETED|Follow-up||0
10734633|NCT02837731|11898925|FG000|STARTED|Analysis||83
10734634|NCT02837731|11898926|FG001|STARTED|Analysis||41
10734635|NCT02837731|11898925|FG000|COMPLETED|Analysis||83
10734636|NCT02837731|11898926|FG001|COMPLETED|Analysis||41
10734637|NCT02837731|11898925|FG000|NOT COMPLETED|Analysis||0
10734638|NCT02837731|11898926|FG001|NOT COMPLETED|Analysis||0
10734639|NCT02837744|11898932|FG000|STARTED|Overall Study||70
10734640|NCT02837744|11898932|FG000|COMPLETED|Overall Study||70
10734641|NCT02837744|11898932|FG000|NOT COMPLETED|Overall Study||0
10734642|NCT02837913|11898938|FG000|STARTED|Overall Study||10
10734643|NCT02837913|11898939|FG001|STARTED|Overall Study||9
10734644|NCT02837913|11898938|FG000|COMPLETED|Overall Study||10
10734645|NCT02837913|11898939|FG001|COMPLETED|Overall Study||9
10734646|NCT02837913|11898938|FG000|NOT COMPLETED|Overall Study||0
10734647|NCT02837913|11898939|FG001|NOT COMPLETED|Overall Study||0
10734648|NCT02837952|11898947|FG000|STARTED|Overall Study||41
10734649|NCT02837952|11898948|FG001|STARTED|Overall Study||82
10734650|NCT02837952|11898947|FG000|COMPLETED|Overall Study||36
10734651|NCT02837952|11898948|FG001|COMPLETED|Overall Study||76
10734652|NCT02837952|11898947|FG000|NOT COMPLETED|Overall Study||5
10734653|NCT02837952|11898948|FG001|NOT COMPLETED|Overall Study||6
10734654|NCT02838017|11898956|FG000|STARTED|Overall Study||252
10734655|NCT02838017|11898957|FG001|STARTED|Overall Study||252
10734656|NCT02838017|11898956|FG000|COMPLETED|Overall Study||238
10734657|NCT02838017|11898957|FG001|COMPLETED|Overall Study||241
10734658|NCT02838017|11898956|FG000|NOT COMPLETED|Overall Study||14
10734659|NCT02838017|11898957|FG001|NOT COMPLETED|Overall Study||11
10734660|NCT02838134|11898965|FG000|STARTED|Overall Study||50
10734661|NCT02838134|11898966|FG001|STARTED|Overall Study||51
10734662|NCT02838134|11898965|FG000|COMPLETED|Overall Study||48
10734663|NCT02838134|11898966|FG001|COMPLETED|Overall Study||48
10734664|NCT02838134|11898965|FG000|NOT COMPLETED|Overall Study||2
10734665|NCT02838134|11898966|FG001|NOT COMPLETED|Overall Study||3
10734666|NCT02838407|11898972|FG000|STARTED|Overall Study||197
10734667|NCT02838407|11898972|FG000|COMPLETED|Overall Study||197
10734668|NCT02838407|11898972|FG000|NOT COMPLETED|Overall Study||0
10734669|NCT02838420|11898978|FG000|STARTED|Overall Study||125
10734670|NCT02838420|11898979|FG001|STARTED|Overall Study||62
10734671|NCT02838420|11898978|FG000|COMPLETED|Overall Study||0
10734672|NCT02838420|11898979|FG001|COMPLETED|Overall Study||0
10734673|NCT02838420|11898978|FG000|NOT COMPLETED|Overall Study||125
10734674|NCT02838420|11898979|FG001|NOT COMPLETED|Overall Study||62
10734675|NCT02838628|11898987|FG000|STARTED|Treatment and Follow-up Period||84
10734676|NCT02838628|11898988|FG001|STARTED|Treatment and Follow-up Period||84
10734677|NCT02838628|11898987|FG000|COMPLETED|Treatment and Follow-up Period||84
10734678|NCT02838628|11898988|FG001|COMPLETED|Treatment and Follow-up Period||84
10734679|NCT02838628|11898987|FG000|NOT COMPLETED|Treatment and Follow-up Period||0
10734680|NCT02838628|11898988|FG001|NOT COMPLETED|Treatment and Follow-up Period||0
10734681|NCT02838628|11898987|FG000|STARTED|Recurrence Follow-up Period||36
10734682|NCT02838628|11898988|FG001|STARTED|Recurrence Follow-up Period||27
10734683|NCT02838628|11898987|FG000|COMPLETED|Recurrence Follow-up Period||16
10734684|NCT02838628|11898988|FG001|COMPLETED|Recurrence Follow-up Period||10
10734685|NCT02838628|11898987|FG000|NOT COMPLETED|Recurrence Follow-up Period||20
10734686|NCT02838628|11898988|FG001|NOT COMPLETED|Recurrence Follow-up Period||17
10734687|NCT02838901|11898997|FG000|STARTED|Overall Study||9
10734688|NCT02838901|11898998|FG001|STARTED|Overall Study||9
10734689|NCT02838901|11898997|FG000|COMPLETED|Overall Study||7
10734690|NCT02838901|11898998|FG001|COMPLETED|Overall Study||7
10734691|NCT02838901|11898997|FG000|NOT COMPLETED|Overall Study||2
10734692|NCT02838901|11898998|FG001|NOT COMPLETED|Overall Study||2
10734693|NCT02839200|11899012|FG000|STARTED|Overall Study||60
10815621|NCT01846182|11978811|FG001|NOT COMPLETED|Overall Study||0
10815622|NCT01846182|11978812|FG002|NOT COMPLETED|Overall Study||0
10815623|NCT01844206|11978824|FG000|STARTED|Overall Study||2
10815624|NCT01844206|11978825|FG001|STARTED|Overall Study||3
10815625|NCT01844206|11978824|FG000|COMPLETED|Overall Study||2
10815626|NCT01844206|11978825|FG001|COMPLETED|Overall Study|One patient requested that epidural catheter be removed during the first post-operative day.|2
10815627|NCT01844206|11978824|FG000|NOT COMPLETED|Overall Study||0
10815628|NCT01844206|11978825|FG001|NOT COMPLETED|Overall Study||1
10815629|NCT01856322|11978834|FG000|STARTED|Overall Study||0
10815630|NCT01856322|11978835|FG001|STARTED|Overall Study||0
10815631|NCT01856322|11978836|FG002|STARTED|Overall Study||3
10815632|NCT01856322|11978834|FG000|COMPLETED|Overall Study||0
10815633|NCT01856322|11978835|FG001|COMPLETED|Overall Study||0
10815634|NCT01856322|11978836|FG002|COMPLETED|Overall Study||0
10815635|NCT01856322|11978834|FG000|NOT COMPLETED|Overall Study||0
10815636|NCT01856322|11978835|FG001|NOT COMPLETED|Overall Study||0
10815637|NCT01856322|11978836|FG002|NOT COMPLETED|Overall Study||3
10815638|NCT01853176|11978845|FG000|STARTED|Overall Study||4
10815639|NCT01853176|11978846|FG001|STARTED|Overall Study||0
10815640|NCT01853176|11978845|FG000|COMPLETED|Overall Study||0
10815641|NCT01853176|11978846|FG001|COMPLETED|Overall Study||0
10815642|NCT01853176|11978845|FG000|NOT COMPLETED|Overall Study||4
10815643|NCT01853176|11978846|FG001|NOT COMPLETED|Overall Study||0
10815644|NCT01857271|11978852|FG000|STARTED|Overall Study||3
10815645|NCT01857271|11978852|FG000|COMPLETED|Overall Study||2
10815646|NCT01857271|11978852|FG000|NOT COMPLETED|Overall Study||1
10815647|NCT01856361|11978858|FG000|STARTED|Overall Study||1
10815648|NCT01856361|11978859|FG001|STARTED|Overall Study||1
10815649|NCT01856361|11978858|FG000|COMPLETED|Overall Study||1
10815650|NCT01856361|11978859|FG001|COMPLETED|Overall Study||1
10815651|NCT01856361|11978858|FG000|NOT COMPLETED|Overall Study||0
10815652|NCT01856361|11978859|FG001|NOT COMPLETED|Overall Study||0
10815653|NCT01853982|11978867|FG000|STARTED|Overall Study||2
10734694|NCT02839200|11899013|FG001|STARTED|Overall Study||59
10734695|NCT02839200|11899014|FG002|STARTED|Overall Study||60
10815654|NCT01853982|11978868|FG001|STARTED|Overall Study||2
10734696|NCT02839200|11899015|FG003|STARTED|Overall Study||61
10734697|NCT02839200|11899016|FG004|STARTED|Overall Study||60
10734698|NCT02839200|11899017|FG005|STARTED|Overall Study||60
10734699|NCT02839200|11899012|FG000|COMPLETED|Overall Study||56
10734700|NCT02839200|11899013|FG001|COMPLETED|Overall Study||58
10734701|NCT02839200|11899014|FG002|COMPLETED|Overall Study||59
10815655|NCT01853982|11978867|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2
10734702|NCT02839200|11899015|FG003|COMPLETED|Overall Study||61
10734703|NCT02839200|11899016|FG004|COMPLETED|Overall Study||58
10734704|NCT02839200|11899017|FG005|COMPLETED|Overall Study||59
10734705|NCT02839200|11899012|FG000|NOT COMPLETED|Overall Study||4
10734706|NCT02839200|11899013|FG001|NOT COMPLETED|Overall Study||1
10734707|NCT02839200|11899014|FG002|NOT COMPLETED|Overall Study||1
10734708|NCT02839200|11899015|FG003|NOT COMPLETED|Overall Study||0
10734709|NCT02839200|11899016|FG004|NOT COMPLETED|Overall Study||2
10734710|NCT02839200|11899017|FG005|NOT COMPLETED|Overall Study||1
10734711|NCT02839330|11899035|FG000|STARTED|Overall Study||804
10734712|NCT02839330|11899036|FG001|STARTED|Overall Study||799
10734713|NCT02839330|11899037|FG002|STARTED|Overall Study||795
10734714|NCT02839330|11899038|FG003|STARTED|Overall Study||798
10734715|NCT02839330|11899035|FG000|Exposed|Overall Study||804
10734716|NCT02839330|11899036|FG001|Exposed|Overall Study||797
10734717|NCT02839330|11899037|FG002|Exposed|Overall Study||793
10734718|NCT02839330|11899038|FG003|Exposed|Overall Study||797
10734719|NCT02839330|11899035|FG000|COMPLETED|Overall Study||746
10734720|NCT02839330|11899036|FG001|COMPLETED|Overall Study||741
10734721|NCT02839330|11899037|FG002|COMPLETED|Overall Study||747
10734722|NCT02839330|11899038|FG003|COMPLETED|Overall Study||747
10734723|NCT02839330|11899035|FG000|NOT COMPLETED|Overall Study||58
10734724|NCT02839330|11899036|FG001|NOT COMPLETED|Overall Study||58
10734725|NCT02839330|11899037|FG002|NOT COMPLETED|Overall Study||48
10734726|NCT02839330|11899038|FG003|NOT COMPLETED|Overall Study||51
10734727|NCT02839681|11899049|FG000|STARTED|Overall Study||2
10734728|NCT02839681|11899049|FG000|COMPLETED|Overall Study||0
10734729|NCT02839681|11899049|FG000|NOT COMPLETED|Overall Study||2
10734730|NCT02839746|11899053|FG000|STARTED|Overall Study||671
10734731|NCT02839746|11899053|FG000|COMPLETED|Overall Study||659
10734732|NCT02839746|11899053|FG000|NOT COMPLETED|Overall Study||12
10734733|NCT02839772|11899059|FG000|STARTED|Overall Study|Stratification was used. Clinic A enrolled 94 participants and Clinic B 99 participants|97
10734734|NCT02839772|11899060|FG001|STARTED|Overall Study||96
10734735|NCT02839772|11899059|FG000|COMPLETED|Overall Study|1 participant in Clinic B did not return for the 3 months post- intervention data collection.|96
10734736|NCT02839772|11899060|FG001|COMPLETED|Overall Study||96
10734737|NCT02839772|11899059|FG000|NOT COMPLETED|Overall Study||1
10734738|NCT02839772|11899060|FG001|NOT COMPLETED|Overall Study||0
10734739|NCT02839798|11899080|FG000|STARTED|Overall Study||6
10734740|NCT02839798|11899080|FG000|COMPLETED|Overall Study||4
10734741|NCT02839798|11899080|FG000|NOT COMPLETED|Overall Study||2
10734742|NCT02839876|11899086|FG000|STARTED|Overall Study||41
10734743|NCT02839876|11899087|FG001|STARTED|Overall Study||40
10734744|NCT02839876|11899086|FG000|COMPLETED|Overall Study||31
10734745|NCT02839876|11899087|FG001|COMPLETED|Overall Study||29
10734746|NCT02839876|11899086|FG000|NOT COMPLETED|Overall Study||10
10734747|NCT02839876|11899087|FG001|NOT COMPLETED|Overall Study||11
10734748|NCT02839889|11899095|FG000|STARTED|Randomization Period||2
10734749|NCT02839889|11899096|FG001|STARTED|Randomization Period||3
10734750|NCT02839889|11899095|FG000|COMPLETED|Randomization Period||2
10734751|NCT02839889|11899096|FG001|COMPLETED|Randomization Period||3
10734752|NCT02839889|11899095|FG000|NOT COMPLETED|Randomization Period||0
10734753|NCT02839889|11899096|FG001|NOT COMPLETED|Randomization Period||0
10734754|NCT02839889|11899095|FG000|STARTED|Open-Label Period||0
10734755|NCT02839889|11899096|FG001|STARTED|Open-Label Period||5
10734756|NCT02839889|11899095|FG000|COMPLETED|Open-Label Period||0
10734757|NCT02839889|11899096|FG001|COMPLETED|Open-Label Period||4
10734758|NCT02839889|11899095|FG000|NOT COMPLETED|Open-Label Period||0
10734759|NCT02839889|11899096|FG001|NOT COMPLETED|Open-Label Period||1
10734760|NCT02839902|11899104|FG000|STARTED|Overall Study||24
10734761|NCT02839902|11899105|FG001|STARTED|Overall Study||29
10734762|NCT02839902|11899104|FG000|COMPLETED|Overall Study||24
10734763|NCT02839902|11899105|FG001|COMPLETED|Overall Study||29
10734764|NCT02839902|11899104|FG000|NOT COMPLETED|Overall Study||0
10734765|NCT02839902|11899105|FG001|NOT COMPLETED|Overall Study||0
10734766|NCT02840097|11899114|FG000|STARTED|Overall Study||9
10734767|NCT02840097|11899115|FG001|STARTED|Overall Study||10
10734768|NCT02840097|11899116|FG002|STARTED|Overall Study||12
10734769|NCT02840097|11899114|FG000|COMPLETED|Overall Study||9
10734770|NCT02840097|11899115|FG001|COMPLETED|Overall Study||10
10734771|NCT02840097|11899116|FG002|COMPLETED|Overall Study||12
10734772|NCT02840097|11899114|FG000|NOT COMPLETED|Overall Study||0
10734773|NCT02840097|11899115|FG001|NOT COMPLETED|Overall Study||0
10734774|NCT02840097|11899116|FG002|NOT COMPLETED|Overall Study||0
10734775|NCT02840253|11899127|FG000|STARTED|Overall Study||23
10734776|NCT02840253|11899127|FG000|COMPLETED|Overall Study||19
10734777|NCT02840253|11899127|FG000|NOT COMPLETED|Overall Study||4
10734778|NCT02840461|11899134|FG000|STARTED|Overall Study||259
10734779|NCT02840461|11899135|FG001|STARTED|Overall Study||257
10734780|NCT02840461|11899136|FG002|STARTED|Overall Study||114
10734781|NCT02840461|11899134|FG000|COMPLETED|Overall Study||236
10734782|NCT02840461|11899135|FG001|COMPLETED|Overall Study||235
10734783|NCT02840461|11899136|FG002|COMPLETED|Overall Study||100
10734784|NCT02840461|11899134|FG000|NOT COMPLETED|Overall Study||23
10734785|NCT02840461|11899135|FG001|NOT COMPLETED|Overall Study||22
10734786|NCT02840461|11899136|FG002|NOT COMPLETED|Overall Study||14
10734787|NCT02840474|11899147|FG000|STARTED|Overall Study||7
10734788|NCT02840474|11899148|FG001|STARTED|Overall Study||9
10734789|NCT02840474|11899147|FG000|Received Study Product|Overall Study||7
10734790|NCT02840474|11899148|FG001|Received Study Product|Overall Study||9
10734791|NCT02840474|11899147|FG000|COMPLETED|Overall Study||6
10734792|NCT02840474|11899148|FG001|COMPLETED|Overall Study||9
10734793|NCT02840474|11899147|FG000|NOT COMPLETED|Overall Study||1
10734794|NCT02840474|11899148|FG001|NOT COMPLETED|Overall Study||0
10734795|NCT02840721|11899154|FG000|STARTED|Treatment Period||50
10734796|NCT02840721|11899154|FG000|COMPLETED|Treatment Period||49
10734797|NCT02840721|11899154|FG000|NOT COMPLETED|Treatment Period||1
10734798|NCT02840721|11899154|FG000|STARTED|Follow-Up||49
10734799|NCT02840721|11899154|FG000|COMPLETED|Follow-Up||42
10734800|NCT02840721|11899154|FG000|NOT COMPLETED|Follow-Up||7
10734801|NCT02840916|11899160|FG000|STARTED|Overall Study||33
10734802|NCT02840916|11899161|FG001|STARTED|Overall Study||33
10734803|NCT02840916|11899160|FG000|COMPLETED|Overall Study||32
10734804|NCT02840916|11899161|FG001|COMPLETED|Overall Study||30
10734805|NCT02840916|11899160|FG000|NOT COMPLETED|Overall Study||1
10734806|NCT02840916|11899161|FG001|NOT COMPLETED|Overall Study||3
10734807|NCT02841033|11899167|FG000|STARTED|Overall Study||22
10734808|NCT02841033|11899167|FG000|COMPLETED|Overall Study||22
10734809|NCT02841033|11899167|FG000|NOT COMPLETED|Overall Study||0
10734810|NCT02841046|11899173|FG000|STARTED|Overall Study||25
10734811|NCT02841046|11899174|FG001|STARTED|Overall Study||25
10734812|NCT02841046|11899173|FG000|COMPLETED|Overall Study||25
10734813|NCT02841046|11899174|FG001|COMPLETED|Overall Study||25
10734814|NCT02841046|11899173|FG000|NOT COMPLETED|Overall Study||0
10734815|NCT02841046|11899174|FG001|NOT COMPLETED|Overall Study||0
10734816|NCT02841189|11899180|FG000|STARTED|Overall Study||100
10734817|NCT02841189|11899180|FG000|COMPLETED|Overall Study||65
10734818|NCT02841189|11899180|FG000|NOT COMPLETED|Overall Study||35
10734819|NCT02841241|11899184|FG000|STARTED|Overall Study||7
10734820|NCT02841241|11899184|FG000|COMPLETED|Overall Study||7
10734821|NCT02841241|11899184|FG000|NOT COMPLETED|Overall Study||0
10734822|NCT02841267|11899191|FG000|STARTED|Lead-in (Untreated)||4
10734823|NCT02841267|11899192|FG001|STARTED|Lead-in (Untreated)||7
10734824|NCT02841267|11899193|FG002|STARTED|Lead-in (Untreated)||8
10734825|NCT02841267|11899191|FG000|COMPLETED|Lead-in (Untreated)||4
10734826|NCT02841267|11899192|FG001|COMPLETED|Lead-in (Untreated)||7
10734827|NCT02841267|11899193|FG002|COMPLETED|Lead-in (Untreated)||8
10734828|NCT02841267|11899191|FG000|NOT COMPLETED|Lead-in (Untreated)||0
10734829|NCT02841267|11899192|FG001|NOT COMPLETED|Lead-in (Untreated)||0
10734830|NCT02841267|11899193|FG002|NOT COMPLETED|Lead-in (Untreated)||0
10734831|NCT02841267|11899191|FG000|STARTED|Treatment Period|Cohort 1 was invited to continue receiving 40mg/kg of study drug every 4 weeks for 28 weeks.|4
10734832|NCT02841267|11899192|FG001|STARTED|Treatment Period||7
10734833|NCT02841267|11899193|FG002|STARTED|Treatment Period||8
10734834|NCT02841267|11899191|FG000|COMPLETED|Treatment Period||4
10734835|NCT02841267|11899192|FG001|COMPLETED|Treatment Period||7
10734836|NCT02841267|11899193|FG002|COMPLETED|Treatment Period||8
10734837|NCT02841267|11899191|FG000|NOT COMPLETED|Treatment Period||0
10734838|NCT02841267|11899192|FG001|NOT COMPLETED|Treatment Period||0
10734839|NCT02841267|11899193|FG002|NOT COMPLETED|Treatment Period||0
10734840|NCT02841267|11899191|FG000|STARTED|Extension Study|Cohort 1 was invited to continue receiving 40mg/kg of study drug every 4 weeks for 28 weeks.|4
10734841|NCT02841267|11899192|FG001|STARTED|Extension Study|Cohort 2 was invited to continue receiving 40mg/kg of study drug every 4 weeks for 40 weeks.|6
10734842|NCT02841267|11899193|FG002|STARTED|Extension Study|Cohort 3 was invited to continue receiving 40mg/kg of study drug every 4 weeks for 24 weeks.|6
10734843|NCT02841267|11899191|FG000|COMPLETED|Extension Study||4
10734844|NCT02841267|11899192|FG001|COMPLETED|Extension Study||6
10734845|NCT02841267|11899193|FG002|COMPLETED|Extension Study||6
10734846|NCT02841267|11899191|FG000|NOT COMPLETED|Extension Study||0
10734847|NCT02841267|11899192|FG001|NOT COMPLETED|Extension Study||0
10734848|NCT02841267|11899193|FG002|NOT COMPLETED|Extension Study||0
10777961|NCT03346759|11939863|FG001|COMPLETED|Enrollment to Baseline Data Collected|Participants assigned to the Tampon B First arm who provided at least one vaginal microbiota sample.|10
10777962|NCT03346759|11939862|FG000|NOT COMPLETED|Enrollment to Baseline Data Collected||2
10777963|NCT03346759|11939863|FG001|NOT COMPLETED|Enrollment to Baseline Data Collected||3
10777964|NCT03346759|11939862|FG000|STARTED|First Menstrual Cycle||13
10777965|NCT03346759|11939863|FG001|STARTED|First Menstrual Cycle||10
10777966|NCT03346759|11939862|FG000|COMPLETED|First Menstrual Cycle||12
10777967|NCT03346759|11939863|FG001|COMPLETED|First Menstrual Cycle||10
10777968|NCT03346759|11939862|FG000|NOT COMPLETED|First Menstrual Cycle||1
10777969|NCT03346759|11939863|FG001|NOT COMPLETED|First Menstrual Cycle||0
10777970|NCT03346759|11939862|FG000|STARTED|Second Menstrual Cycle||12
10777971|NCT03346759|11939863|FG001|STARTED|Second Menstrual Cycle||10
10777972|NCT03346759|11939862|FG000|COMPLETED|Second Menstrual Cycle||11
10777973|NCT03346759|11939863|FG001|COMPLETED|Second Menstrual Cycle||10
10777974|NCT03346759|11939862|FG000|NOT COMPLETED|Second Menstrual Cycle||1
10777975|NCT03346759|11939863|FG001|NOT COMPLETED|Second Menstrual Cycle||0
10777976|NCT03346759|11939862|FG000|STARTED|Third Menstrual Cycle||11
10777977|NCT03346759|11939863|FG001|STARTED|Third Menstrual Cycle||10
10777978|NCT03346759|11939862|FG000|COMPLETED|Third Menstrual Cycle||11
10777979|NCT03346759|11939863|FG001|COMPLETED|Third Menstrual Cycle||10
10777980|NCT03346759|11939862|FG000|NOT COMPLETED|Third Menstrual Cycle||0
10777981|NCT03346759|11939863|FG001|NOT COMPLETED|Third Menstrual Cycle||0
10777982|NCT03346850|11939872|FG000|STARTED|Overall Study||20
10777983|NCT03346850|11939873|FG001|STARTED|Overall Study||20
10777984|NCT03346850|11939872|FG000|COMPLETED|Overall Study||18
10777985|NCT03346850|11939873|FG001|COMPLETED|Overall Study||17
10777986|NCT03346850|11939872|FG000|NOT COMPLETED|Overall Study||2
10777987|NCT03346850|11939873|FG001|NOT COMPLETED|Overall Study||3
10734849|NCT02841397|11899209|FG000|STARTED|Overall Study||50
10734850|NCT02841397|11899209|FG000|COMPLETED|Overall Study||48
10734851|NCT02841397|11899209|FG000|NOT COMPLETED|Overall Study||2
10734852|NCT02841449|11899215|FG000|STARTED|Overall Study||7
10734853|NCT02841449|11899216|FG001|STARTED|Overall Study||9
10734854|NCT02841449|11899215|FG000|COMPLETED|Overall Study||7
10734855|NCT02841449|11899216|FG001|COMPLETED|Overall Study||9
10734856|NCT02841449|11899215|FG000|NOT COMPLETED|Overall Study||0
10734857|NCT02841449|11899216|FG001|NOT COMPLETED|Overall Study||0
10734858|NCT02841709|11899222|FG000|STARTED|1st Intervention||12
10734859|NCT02841709|11899223|FG001|STARTED|1st Intervention||11
10734860|NCT02841709|11899224|FG002|STARTED|1st Intervention||12
10734861|NCT02841709|11899225|FG003|STARTED|1st Intervention||12
10734862|NCT02841709|11899226|FG004|STARTED|1st Intervention||11
10734863|NCT02841709|11899222|FG000|COMPLETED|1st Intervention||12
10734864|NCT02841709|11899223|FG001|COMPLETED|1st Intervention||11
10734865|NCT02841709|11899224|FG002|COMPLETED|1st Intervention||12
10734866|NCT02841709|11899225|FG003|COMPLETED|1st Intervention||12
10734867|NCT02841709|11899226|FG004|COMPLETED|1st Intervention||11
10734868|NCT02841709|11899222|FG000|NOT COMPLETED|1st Intervention||0
10734869|NCT02841709|11899223|FG001|NOT COMPLETED|1st Intervention||0
10734870|NCT02841709|11899224|FG002|NOT COMPLETED|1st Intervention||0
10734871|NCT02841709|11899225|FG003|NOT COMPLETED|1st Intervention||0
10734872|NCT02841709|11899226|FG004|NOT COMPLETED|1st Intervention||0
10734873|NCT02841709|11899222|FG000|STARTED|Washout Period 1||12
10734874|NCT02841709|11899223|FG001|STARTED|Washout Period 1||11
10734875|NCT02841709|11899224|FG002|STARTED|Washout Period 1||12
10734876|NCT02841709|11899225|FG003|STARTED|Washout Period 1||12
10734877|NCT02841709|11899226|FG004|STARTED|Washout Period 1||11
10734878|NCT02841709|11899222|FG000|COMPLETED|Washout Period 1||12
10734879|NCT02841709|11899223|FG001|COMPLETED|Washout Period 1||11
10734880|NCT02841709|11899224|FG002|COMPLETED|Washout Period 1||12
10734881|NCT02841709|11899225|FG003|COMPLETED|Washout Period 1||12
10734882|NCT02841709|11899226|FG004|COMPLETED|Washout Period 1||11
10734883|NCT02841709|11899222|FG000|NOT COMPLETED|Washout Period 1||0
10734884|NCT02841709|11899223|FG001|NOT COMPLETED|Washout Period 1||0
10734885|NCT02841709|11899224|FG002|NOT COMPLETED|Washout Period 1||0
10734886|NCT02841709|11899225|FG003|NOT COMPLETED|Washout Period 1||0
10734887|NCT02841709|11899226|FG004|NOT COMPLETED|Washout Period 1||0
10734888|NCT02841709|11899222|FG000|STARTED|2nd Intervention||12
10734889|NCT02841709|11899223|FG001|STARTED|2nd Intervention||11
10734890|NCT02841709|11899224|FG002|STARTED|2nd Intervention||12
10734891|NCT02841709|11899225|FG003|STARTED|2nd Intervention||12
10734892|NCT02841709|11899226|FG004|STARTED|2nd Intervention||11
10734893|NCT02841709|11899222|FG000|COMPLETED|2nd Intervention||12
10734894|NCT02841709|11899223|FG001|COMPLETED|2nd Intervention||11
10734895|NCT02841709|11899224|FG002|COMPLETED|2nd Intervention||12
10734896|NCT02841709|11899225|FG003|COMPLETED|2nd Intervention||12
10734897|NCT02841709|11899226|FG004|COMPLETED|2nd Intervention||11
10734898|NCT02841709|11899222|FG000|NOT COMPLETED|2nd Intervention||0
10734899|NCT02841709|11899223|FG001|NOT COMPLETED|2nd Intervention||0
10734900|NCT02841709|11899224|FG002|NOT COMPLETED|2nd Intervention||0
10734901|NCT02841709|11899225|FG003|NOT COMPLETED|2nd Intervention||0
10734902|NCT02841709|11899226|FG004|NOT COMPLETED|2nd Intervention||0
10734903|NCT02841709|11899222|FG000|STARTED|Washout Period 2||12
10734904|NCT02841709|11899223|FG001|STARTED|Washout Period 2||11
10734905|NCT02841709|11899224|FG002|STARTED|Washout Period 2||12
10734906|NCT02841709|11899225|FG003|STARTED|Washout Period 2||12
10734907|NCT02841709|11899226|FG004|STARTED|Washout Period 2||11
10734908|NCT02841709|11899222|FG000|COMPLETED|Washout Period 2||12
10734909|NCT02841709|11899223|FG001|COMPLETED|Washout Period 2||11
10734910|NCT02841709|11899224|FG002|COMPLETED|Washout Period 2||12
10734911|NCT02841709|11899225|FG003|COMPLETED|Washout Period 2||12
10734912|NCT02841709|11899226|FG004|COMPLETED|Washout Period 2||11
10734913|NCT02841709|11899222|FG000|NOT COMPLETED|Washout Period 2||0
10734914|NCT02841709|11899223|FG001|NOT COMPLETED|Washout Period 2||0
10734915|NCT02841709|11899224|FG002|NOT COMPLETED|Washout Period 2||0
10734916|NCT02841709|11899225|FG003|NOT COMPLETED|Washout Period 2||0
10734917|NCT02841709|11899226|FG004|NOT COMPLETED|Washout Period 2||0
10734918|NCT02841709|11899222|FG000|STARTED|3rd Intervention||12
10734919|NCT02841709|11899223|FG001|STARTED|3rd Intervention||11
10734920|NCT02841709|11899224|FG002|STARTED|3rd Intervention||12
10734921|NCT02841709|11899225|FG003|STARTED|3rd Intervention||12
10734922|NCT02841709|11899226|FG004|STARTED|3rd Intervention||11
10734923|NCT02841709|11899222|FG000|COMPLETED|3rd Intervention||12
10734924|NCT02841709|11899223|FG001|COMPLETED|3rd Intervention||11
10734925|NCT02841709|11899224|FG002|COMPLETED|3rd Intervention||12
10734926|NCT02841709|11899225|FG003|COMPLETED|3rd Intervention||12
10734927|NCT02841709|11899226|FG004|COMPLETED|3rd Intervention||11
10734928|NCT02841709|11899222|FG000|NOT COMPLETED|3rd Intervention||0
10734929|NCT02841709|11899223|FG001|NOT COMPLETED|3rd Intervention||0
10734930|NCT02841709|11899224|FG002|NOT COMPLETED|3rd Intervention||0
10734931|NCT02841709|11899225|FG003|NOT COMPLETED|3rd Intervention||0
10734932|NCT02841709|11899226|FG004|NOT COMPLETED|3rd Intervention||0
10734933|NCT02841709|11899222|FG000|STARTED|Washout Period 3||12
10734934|NCT02841709|11899223|FG001|STARTED|Washout Period 3||11
10734935|NCT02841709|11899224|FG002|STARTED|Washout Period 3||12
10734936|NCT02841709|11899225|FG003|STARTED|Washout Period 3||12
10734937|NCT02841709|11899226|FG004|STARTED|Washout Period 3||11
10734938|NCT02841709|11899222|FG000|COMPLETED|Washout Period 3||12
10734939|NCT02841709|11899223|FG001|COMPLETED|Washout Period 3||11
10734940|NCT02841709|11899224|FG002|COMPLETED|Washout Period 3||12
10734941|NCT02841709|11899225|FG003|COMPLETED|Washout Period 3||12
10734942|NCT02841709|11899226|FG004|COMPLETED|Washout Period 3||11
10734943|NCT02841709|11899222|FG000|NOT COMPLETED|Washout Period 3||0
10734944|NCT02841709|11899223|FG001|NOT COMPLETED|Washout Period 3||0
10734945|NCT02841709|11899224|FG002|NOT COMPLETED|Washout Period 3||0
10734946|NCT02841709|11899225|FG003|NOT COMPLETED|Washout Period 3||0
10734947|NCT02841709|11899226|FG004|NOT COMPLETED|Washout Period 3||0
10734948|NCT02841709|11899222|FG000|STARTED|4th Intervention||12
10734949|NCT02841709|11899223|FG001|STARTED|4th Intervention||11
10734950|NCT02841709|11899224|FG002|STARTED|4th Intervention||12
10734951|NCT02841709|11899225|FG003|STARTED|4th Intervention||12
10734952|NCT02841709|11899226|FG004|STARTED|4th Intervention||11
10734953|NCT02841709|11899222|FG000|COMPLETED|4th Intervention||12
10734954|NCT02841709|11899223|FG001|COMPLETED|4th Intervention||11
10734955|NCT02841709|11899224|FG002|COMPLETED|4th Intervention||12
10734956|NCT02841709|11899225|FG003|COMPLETED|4th Intervention||12
10734957|NCT02841709|11899226|FG004|COMPLETED|4th Intervention||11
10734958|NCT02841709|11899222|FG000|NOT COMPLETED|4th Intervention||0
10734959|NCT02841709|11899223|FG001|NOT COMPLETED|4th Intervention||0
10734960|NCT02841709|11899224|FG002|NOT COMPLETED|4th Intervention||0
10734961|NCT02841709|11899225|FG003|NOT COMPLETED|4th Intervention||0
10734962|NCT02841709|11899226|FG004|NOT COMPLETED|4th Intervention||0
10734963|NCT02841709|11899222|FG000|STARTED|Washout Period 4||12
10734964|NCT02841709|11899223|FG001|STARTED|Washout Period 4||11
10734965|NCT02841709|11899224|FG002|STARTED|Washout Period 4||12
10734966|NCT02841709|11899225|FG003|STARTED|Washout Period 4||12
10734967|NCT02841709|11899226|FG004|STARTED|Washout Period 4||11
10734968|NCT02841709|11899222|FG000|COMPLETED|Washout Period 4||12
10734969|NCT02841709|11899223|FG001|COMPLETED|Washout Period 4||11
10734970|NCT02841709|11899224|FG002|COMPLETED|Washout Period 4||12
10734971|NCT02841709|11899225|FG003|COMPLETED|Washout Period 4||12
10734972|NCT02841709|11899226|FG004|COMPLETED|Washout Period 4||11
10734973|NCT02841709|11899222|FG000|NOT COMPLETED|Washout Period 4||0
10734974|NCT02841709|11899223|FG001|NOT COMPLETED|Washout Period 4||0
10734975|NCT02841709|11899224|FG002|NOT COMPLETED|Washout Period 4||0
10734976|NCT02841709|11899225|FG003|NOT COMPLETED|Washout Period 4||0
10734977|NCT02841709|11899226|FG004|NOT COMPLETED|Washout Period 4||0
10734978|NCT02841709|11899222|FG000|STARTED|5th Intervention||12
10734979|NCT02841709|11899223|FG001|STARTED|5th Intervention||11
10734980|NCT02841709|11899224|FG002|STARTED|5th Intervention||12
10734981|NCT02841709|11899225|FG003|STARTED|5th Intervention||12
10734982|NCT02841709|11899226|FG004|STARTED|5th Intervention||11
10734983|NCT02841709|11899222|FG000|COMPLETED|5th Intervention|Note: In total, 2 subjects did not complete Sequence 1.|10
10734984|NCT02841709|11899223|FG001|COMPLETED|5th Intervention||11
10734985|NCT02841709|11899224|FG002|COMPLETED|5th Intervention||12
10734986|NCT02841709|11899225|FG003|COMPLETED|5th Intervention||12
10734987|NCT02841709|11899226|FG004|COMPLETED|5th Intervention|Note: In total, 2 subjects did not complete Sequence 5.|9
10734988|NCT02841709|11899222|FG000|NOT COMPLETED|5th Intervention||2
10734989|NCT02841709|11899223|FG001|NOT COMPLETED|5th Intervention||0
10734990|NCT02841709|11899224|FG002|NOT COMPLETED|5th Intervention||0
10734991|NCT02841709|11899225|FG003|NOT COMPLETED|5th Intervention||0
10734992|NCT02841709|11899226|FG004|NOT COMPLETED|5th Intervention||2
10734993|NCT02841787|11899242|FG000|STARTED|Overall Study||12
10734994|NCT02841787|11899243|FG001|STARTED|Overall Study||23
10734995|NCT02841787|11899244|FG002|STARTED|Overall Study||12
10734996|NCT02841787|11899242|FG000|COMPLETED|Overall Study||9
10734997|NCT02841787|11899243|FG001|COMPLETED|Overall Study||19
10734998|NCT02841787|11899244|FG002|COMPLETED|Overall Study||12
10734999|NCT02841787|11899242|FG000|NOT COMPLETED|Overall Study||3
10735000|NCT02841787|11899243|FG001|NOT COMPLETED|Overall Study||4
10735001|NCT02841787|11899244|FG002|NOT COMPLETED|Overall Study||0
10735002|NCT02842060|11899254|FG000|STARTED|Overall Study||120
10735003|NCT02842060|11899255|FG001|STARTED|Overall Study||60
10735004|NCT02842060|11899254|FG000|COMPLETED|Overall Study||120
10735005|NCT02842060|11899255|FG001|COMPLETED|Overall Study||60
10735006|NCT02842060|11899254|FG000|NOT COMPLETED|Overall Study||0
10735007|NCT02842060|11899255|FG001|NOT COMPLETED|Overall Study||0
10735008|NCT02842073|11899261|FG000|STARTED|Overall Study||12
10735009|NCT02842073|11899261|FG000|COMPLETED|Overall Study||11
10735010|NCT02842073|11899261|FG000|NOT COMPLETED|Overall Study||1
10735017|NCT02842151|11899274|FG000|STARTED|Overall Study||150
10735018|NCT02842151|11899274|FG000|COMPLETED|Overall Study||148
10735019|NCT02842151|11899274|FG000|NOT COMPLETED|Overall Study||2
10735020|NCT02842242|11899282|FG000|STARTED|Overall Study||11
10735021|NCT02842242|11899283|FG001|STARTED|Overall Study||10
10735022|NCT02842242|11899282|FG000|COMPLETED|Overall Study||10
10735023|NCT02842242|11899283|FG001|COMPLETED|Overall Study||10
10735024|NCT02842242|11899282|FG000|NOT COMPLETED|Overall Study||1
10735025|NCT02842242|11899283|FG001|NOT COMPLETED|Overall Study||0
10735026|NCT02842736|11899289|FG000|STARTED|Overall Study|Treated|242
10735027|NCT02842736|11899289|FG000|Known Month 12 Outcome|Overall Study||230
10735028|NCT02842736|11899289|FG000|24 Month Visit Performed|Overall Study||210
10735029|NCT02842736|11899289|FG000|COMPLETED|Overall Study|36 Month Visit Completed|201
10735030|NCT02842736|11899289|FG000|NOT COMPLETED|Overall Study||41
10735031|NCT02843178|11899297|FG000|STARTED|Overall Study||86
10735032|NCT02843178|11899298|FG001|STARTED|Overall Study||90
10735033|NCT02843178|11899299|FG002|STARTED|Overall Study||92
10735034|NCT02843178|11899300|FG003|STARTED|Overall Study||91
10735035|NCT02843178|11899297|FG000|COMPLETED|Overall Study||78
10735036|NCT02843178|11899298|FG001|COMPLETED|Overall Study||82
10735037|NCT02843178|11899299|FG002|COMPLETED|Overall Study||85
10735038|NCT02843178|11899300|FG003|COMPLETED|Overall Study||87
10735039|NCT02843178|11899297|FG000|NOT COMPLETED|Overall Study||8
10735040|NCT02843178|11899298|FG001|NOT COMPLETED|Overall Study||8
10735041|NCT02843178|11899299|FG002|NOT COMPLETED|Overall Study||7
10735042|NCT02843178|11899300|FG003|NOT COMPLETED|Overall Study||4
10735043|NCT02843529|11899312|FG000|STARTED|Overall Study||244
10735044|NCT02843529|11899313|FG001|STARTED|Overall Study||304
10735045|NCT02843529|11899312|FG000|COMPLETED|Overall Study||213
10735046|NCT02843529|11899313|FG001|COMPLETED|Overall Study||283
10735047|NCT02843529|11899312|FG000|NOT COMPLETED|Overall Study||31
10735048|NCT02843529|11899313|FG001|NOT COMPLETED|Overall Study||21
10735049|NCT02843659|11899322|FG000|STARTED|Overall Study||5
10735050|NCT02843659|11899323|FG001|STARTED|Overall Study||6
10735051|NCT02843659|11899324|FG002|STARTED|Overall Study||7
10735052|NCT02843659|11899322|FG000|COMPLETED|Overall Study||1
10735053|NCT02843659|11899323|FG001|COMPLETED|Overall Study||0
10815656|NCT01853982|11978868|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2
10815657|NCT01853982|11978867|FG000|COMPLETED|Overall Study||0
10815658|NCT01853982|11978868|FG001|COMPLETED|Overall Study||1
10815659|NCT01853982|11978867|FG000|NOT COMPLETED|Overall Study||2
10815660|NCT01853982|11978868|FG001|NOT COMPLETED|Overall Study||1
10815661|NCT01841931|11978874|FG000|STARTED|Overall Study||4
10815662|NCT01841931|11978874|FG000|COMPLETED|Overall Study|As the PI left the institution the study was terminated|0
10815663|NCT01841931|11978874|FG000|NOT COMPLETED|Overall Study||4
10815664|NCT01836809|11978882|FG000|STARTED|Overall Study||0
10815665|NCT01836809|11978883|FG001|STARTED|Overall Study||0
10815666|NCT01836809|11978884|FG002|STARTED|Overall Study||0
10815667|NCT01836809|11978885|FG003|STARTED|Overall Study||2
10815668|NCT01836809|11978882|FG000|COMPLETED|Overall Study||0
10815669|NCT01836809|11978883|FG001|COMPLETED|Overall Study||0
10815670|NCT01836809|11978884|FG002|COMPLETED|Overall Study||0
10815671|NCT01836809|11978885|FG003|COMPLETED|Overall Study||0
10815672|NCT01836809|11978882|FG000|NOT COMPLETED|Overall Study||0
10815673|NCT01836809|11978883|FG001|NOT COMPLETED|Overall Study||0
10815674|NCT01836809|11978884|FG002|NOT COMPLETED|Overall Study||0
10815675|NCT01836809|11978885|FG003|NOT COMPLETED|Overall Study||2
10735054|NCT02843659|11899324|FG002|COMPLETED|Overall Study||2
10735055|NCT02843659|11899322|FG000|NOT COMPLETED|Overall Study||4
10735056|NCT02843659|11899323|FG001|NOT COMPLETED|Overall Study||6
10735057|NCT02843659|11899324|FG002|NOT COMPLETED|Overall Study||5
10312868|NCT00146328|11446372|FG001|STARTED|Overall Study||255
10312869|NCT00146328|11446373|FG002|STARTED|Overall Study||449
10312870|NCT00146328|11446371|FG000|COMPLETED|Overall Study||150
10312871|NCT00146328|11446372|FG001|COMPLETED|Overall Study||101
10312872|NCT00146328|11446373|FG002|COMPLETED|Overall Study||158
10312873|NCT00146328|11446371|FG000|NOT COMPLETED|Overall Study||141
10312874|NCT00146328|11446372|FG001|NOT COMPLETED|Overall Study||154
10312875|NCT00146328|11446373|FG002|NOT COMPLETED|Overall Study||291
10312876|NCT00146640|11446383|FG000|STARTED|Overall Study||144
10312877|NCT00146640|11446384|FG001|STARTED|Overall Study||144
10735058|NCT02844439|11899332|FG000|STARTED|Overall Study|"All Subjects with Glioblastoma:~24 subjects with EGFR-gene amplified + 16 subjects without EGFR gene-amplified nor EGFRvIII^pos"|40
10735059|NCT02844439|11899332|FG000|Subpopulation A (EGFR Gene Amplified Glioblastoma)|Overall Study||24
10735060|NCT02844439|11899332|FG000|Subpopulation B (EGFRvIII^Pos Glioblastoma)|Overall Study||11
10735061|NCT02844439|11899332|FG000|COMPLETED|Overall Study||0
10735062|NCT02844439|11899332|FG000|NOT COMPLETED|Overall Study||40
10735063|NCT02844543|11899343|FG000|STARTED|Overall Study||155
10735064|NCT02844543|11899343|FG000|COMPLETED|Overall Study||150
10735065|NCT02844543|11899343|FG000|NOT COMPLETED|Overall Study||5
10735066|NCT02844569|11899349|FG000|STARTED|Overall Study||12
10735067|NCT02844569|11899350|FG001|STARTED|Overall Study||12
10735068|NCT02844569|11899349|FG000|COMPLETED|Overall Study||12
10735069|NCT02844569|11899350|FG001|COMPLETED|Overall Study||12
10735070|NCT02844569|11899349|FG000|NOT COMPLETED|Overall Study||0
10735071|NCT02844569|11899350|FG001|NOT COMPLETED|Overall Study||0
10735072|NCT02844582|11899356|FG000|STARTED|Overall Study||2
10735073|NCT02844582|11899356|FG000|COMPLETED|Overall Study||2
10735074|NCT02844582|11899356|FG000|NOT COMPLETED|Overall Study||0
10735075|NCT02844920|11899360|FG000|STARTED|Overall Study||37
10735076|NCT02844920|11899360|FG000|Completed Without Evaluable Videos|Overall Study|Participants with completed the follow-up but without evaluable hysteroscopy videos|1
10735077|NCT02844920|11899360|FG000|Completed With Evaluable Videos|Overall Study|Participants with completed the follow-up and evaluable hysteroscopy videos|34
10735078|NCT02844920|11899360|FG000|Completed, Eval. Data, Opposing Fibroids|Overall Study|Participants with completed the follow-up, evaluable hysteroscopy videos, and opposing fibroids|6
10735079|NCT02844920|11899360|FG000|COMPLETED|Overall Study|Participants with completed the follow-up|35
10735080|NCT02844920|11899360|FG000|NOT COMPLETED|Overall Study||2
10735081|NCT02844998|11899367|FG000|STARTED|Overall Study||42
10735082|NCT02844998|11899368|FG001|STARTED|Overall Study||39
10735083|NCT02844998|11899369|FG002|STARTED|Overall Study||39
10735084|NCT02844998|11899367|FG000|COMPLETED|Overall Study||35
10735085|NCT02844998|11899368|FG001|COMPLETED|Overall Study||35
10735086|NCT02844998|11899369|FG002|COMPLETED|Overall Study||35
10735087|NCT02844998|11899367|FG000|NOT COMPLETED|Overall Study||7
10735088|NCT02844998|11899368|FG001|NOT COMPLETED|Overall Study||4
10735089|NCT02844998|11899369|FG002|NOT COMPLETED|Overall Study||4
10735090|NCT02845336|11899379|FG000|STARTED|Overall Study||6
10735091|NCT02845336|11899380|FG001|STARTED|Overall Study||1
10735092|NCT02845336|11899379|FG000|COMPLETED|Overall Study||1
10735093|NCT02845336|11899380|FG001|COMPLETED|Overall Study||0
10735094|NCT02845336|11899379|FG000|NOT COMPLETED|Overall Study||5
10735095|NCT02845336|11899380|FG001|NOT COMPLETED|Overall Study||1
10735096|NCT02845375|11899389|FG000|STARTED|Overall Study||13
10735097|NCT02845375|11899390|FG001|STARTED|Overall Study||14
10735098|NCT02845375|11899391|FG002|STARTED|Overall Study||13
10735099|NCT02845375|11899389|FG000|COMPLETED|Overall Study||12
10735100|NCT02845375|11899390|FG001|COMPLETED|Overall Study||12
10735101|NCT02845375|11899391|FG002|COMPLETED|Overall Study||12
10735102|NCT02845375|11899389|FG000|NOT COMPLETED|Overall Study||1
10735103|NCT02845375|11899390|FG001|NOT COMPLETED|Overall Study||2
10735104|NCT02845375|11899391|FG002|NOT COMPLETED|Overall Study||1
10735105|NCT02845674|11899401|FG000|STARTED|Overall Study||129
10735106|NCT02845674|11899402|FG001|STARTED|Overall Study||129
10735107|NCT02845674|11899401|FG000|COMPLETED|Overall Study||111
10735108|NCT02845674|11899402|FG001|COMPLETED|Overall Study||79
10735109|NCT02845674|11899401|FG000|NOT COMPLETED|Overall Study||18
10735110|NCT02845674|11899402|FG001|NOT COMPLETED|Overall Study||50
10735111|NCT02845700|11899410|FG000|STARTED|Baseline Appointment||6
10735112|NCT02845700|11899411|FG001|STARTED|Baseline Appointment||7
10735113|NCT02845700|11899410|FG000|COMPLETED|Baseline Appointment||6
10735114|NCT02845700|11899411|FG001|COMPLETED|Baseline Appointment||7
10735115|NCT02845700|11899410|FG000|NOT COMPLETED|Baseline Appointment||0
10735116|NCT02845700|11899411|FG001|NOT COMPLETED|Baseline Appointment||0
10735117|NCT02845700|11899410|FG000|STARTED|Intervention Session 1|1 participant withdrew after completing the Baseline Appointment|5
10735118|NCT02845700|11899411|FG001|STARTED|Intervention Session 1|1 participant withdrew after completing the Baseline Appointment|6
10735119|NCT02845700|11899410|FG000|COMPLETED|Intervention Session 1||5
10735120|NCT02845700|11899411|FG001|COMPLETED|Intervention Session 1||6
10735121|NCT02845700|11899410|FG000|NOT COMPLETED|Intervention Session 1||0
10735122|NCT02845700|11899411|FG001|NOT COMPLETED|Intervention Session 1||0
10735123|NCT02845700|11899410|FG000|STARTED|Intervention Session 2||5
10735124|NCT02845700|11899411|FG001|STARTED|Intervention Session 2||6
10735125|NCT02845700|11899410|FG000|COMPLETED|Intervention Session 2||5
10735126|NCT02845700|11899411|FG001|COMPLETED|Intervention Session 2||6
10735127|NCT02845700|11899410|FG000|NOT COMPLETED|Intervention Session 2||0
10735128|NCT02845700|11899411|FG001|NOT COMPLETED|Intervention Session 2||0
10735129|NCT02845700|11899410|FG000|STARTED|Month 1 Follow-Up|3 participants withdrew after completing the Intervention 2 Appointment|2
10735130|NCT02845700|11899411|FG001|STARTED|Month 1 Follow-Up|2 participants withdrew after completing the Intervention 2 Appointment|4
10735131|NCT02845700|11899410|FG000|COMPLETED|Month 1 Follow-Up||2
10735132|NCT02845700|11899411|FG001|COMPLETED|Month 1 Follow-Up||4
10735133|NCT02845700|11899410|FG000|NOT COMPLETED|Month 1 Follow-Up||0
10735134|NCT02845700|11899411|FG001|NOT COMPLETED|Month 1 Follow-Up||0
10735135|NCT02845752|11899419|FG000|STARTED|First Intervention (7 Days)||7
10735136|NCT02845752|11899420|FG001|STARTED|First Intervention (7 Days)||7
10735137|NCT02845752|11899419|FG000|COMPLETED|First Intervention (7 Days)||7
10735138|NCT02845752|11899420|FG001|COMPLETED|First Intervention (7 Days)||7
10735139|NCT02845752|11899419|FG000|NOT COMPLETED|First Intervention (7 Days)||0
10735140|NCT02845752|11899420|FG001|NOT COMPLETED|First Intervention (7 Days)||0
10735141|NCT02845752|11899419|FG000|STARTED|Washout (14 Days)||7
10735142|NCT02845752|11899420|FG001|STARTED|Washout (14 Days)||7
10735143|NCT02845752|11899419|FG000|COMPLETED|Washout (14 Days)||7
10735144|NCT02845752|11899420|FG001|COMPLETED|Washout (14 Days)||7
10735145|NCT02845752|11899419|FG000|NOT COMPLETED|Washout (14 Days)||0
10735146|NCT02845752|11899420|FG001|NOT COMPLETED|Washout (14 Days)||0
10735147|NCT02845752|11899419|FG000|STARTED|Second Intervention (7 Days)||7
10735148|NCT02845752|11899420|FG001|STARTED|Second Intervention (7 Days)||7
10735149|NCT02845752|11899419|FG000|COMPLETED|Second Intervention (7 Days)||7
10735150|NCT02845752|11899420|FG001|COMPLETED|Second Intervention (7 Days)||7
10735151|NCT02845752|11899419|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
10735152|NCT02845752|11899420|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
10735153|NCT02846233|11899428|FG000|STARTED|Overall Study||12
10735154|NCT02846233|11899429|FG001|STARTED|Overall Study||10
10735155|NCT02846233|11899428|FG000|COMPLETED|Overall Study||10
10735156|NCT02846233|11899429|FG001|COMPLETED|Overall Study||8
10735157|NCT02846233|11899428|FG000|NOT COMPLETED|Overall Study||2
10735158|NCT02846233|11899429|FG001|NOT COMPLETED|Overall Study||2
10735159|NCT02846324|11899439|FG000|STARTED|Overall Study||9
10735160|NCT02846324|11899440|FG001|STARTED|Overall Study||6
10735161|NCT02846324|11899441|FG002|STARTED|Overall Study||14
10735162|NCT02846324|11899442|FG003|STARTED|Overall Study||10
10735163|NCT02846324|11899439|FG000|Completed Study Treatment|Overall Study||7
10735164|NCT02846324|11899440|FG001|Completed Study Treatment|Overall Study||5
10735165|NCT02846324|11899441|FG002|Completed Study Treatment|Overall Study||11
10735166|NCT02846324|11899442|FG003|Completed Study Treatment|Overall Study||10
10735167|NCT02846324|11899439|FG000|COMPLETED|Overall Study||7
10735168|NCT02846324|11899440|FG001|COMPLETED|Overall Study||6
10735169|NCT02846324|11899441|FG002|COMPLETED|Overall Study||10
10735170|NCT02846324|11899442|FG003|COMPLETED|Overall Study||10
10735171|NCT02846324|11899439|FG000|NOT COMPLETED|Overall Study||2
10735172|NCT02846324|11899440|FG001|NOT COMPLETED|Overall Study||0
10735173|NCT02846324|11899441|FG002|NOT COMPLETED|Overall Study||4
10735174|NCT02846324|11899442|FG003|NOT COMPLETED|Overall Study||0
10735175|NCT02846415|11899463|FG000|STARTED|Overall Study||18
10735176|NCT02846415|11899464|FG001|STARTED|Overall Study||12
10735177|NCT02846415|11899463|FG000|COMPLETED|Overall Study||15
10735178|NCT02846415|11899464|FG001|COMPLETED|Overall Study||11
10735179|NCT02846415|11899463|FG000|NOT COMPLETED|Overall Study||3
10735180|NCT02846415|11899464|FG001|NOT COMPLETED|Overall Study||1
10735181|NCT02846558|11899474|FG000|STARTED|Overall Study||15
10735182|NCT02846558|11899475|FG001|STARTED|Overall Study||12
10735183|NCT02846558|11899476|FG002|STARTED|Overall Study||14
10735184|NCT02846558|11899477|FG003|STARTED|Overall Study||13
10735185|NCT02846558|11899474|FG000|Baseline Study Visit|Overall Study||10
10735186|NCT02846558|11899475|FG001|Baseline Study Visit|Overall Study||9
10735187|NCT02846558|11899476|FG002|Baseline Study Visit|Overall Study||14
10735188|NCT02846558|11899477|FG003|Baseline Study Visit|Overall Study||12
10735189|NCT02846558|11899474|FG000|3 Month Study Visit|Overall Study||7
10735190|NCT02846558|11899475|FG001|3 Month Study Visit|Overall Study||8
10735191|NCT02846558|11899476|FG002|3 Month Study Visit|Overall Study||12
10735192|NCT02846558|11899477|FG003|3 Month Study Visit|Overall Study||11
10544567|NCT01490632|11697643|FG006|NOT COMPLETED|Part C: Washout or Step-Down Period||0
10544568|NCT01490632|11697644|FG007|NOT COMPLETED|Part C: Washout or Step-Down Period||0
10544569|NCT01490632|11697645|FG008|NOT COMPLETED|Part C: Washout or Step-Down Period||0
10735193|NCT02846558|11899474|FG000|COMPLETED|Overall Study||7
10735194|NCT02846558|11899475|FG001|COMPLETED|Overall Study||8
10735195|NCT02846558|11899476|FG002|COMPLETED|Overall Study||12
10735196|NCT02846558|11899477|FG003|COMPLETED|Overall Study||11
10735197|NCT02846558|11899474|FG000|NOT COMPLETED|Overall Study||8
10735198|NCT02846558|11899475|FG001|NOT COMPLETED|Overall Study||4
10735199|NCT02846558|11899476|FG002|NOT COMPLETED|Overall Study||2
10735200|NCT02846558|11899477|FG003|NOT COMPLETED|Overall Study||2
10735201|NCT02846714|11899494|FG000|STARTED|Overall Study||42
10735202|NCT02846714|11899494|FG000|COMPLETED|Overall Study||36
10735203|NCT02846714|11899494|FG000|NOT COMPLETED|Overall Study||6
10735204|NCT02846740|11899500|FG000|STARTED|Overall Study||15
10735205|NCT02846740|11899501|FG001|STARTED|Overall Study||15
10735206|NCT02846740|11899500|FG000|COMPLETED|Overall Study||15
10735207|NCT02846740|11899501|FG001|COMPLETED|Overall Study||14
10735208|NCT02846740|11899500|FG000|NOT COMPLETED|Overall Study||0
10735209|NCT02846740|11899501|FG001|NOT COMPLETED|Overall Study||1
10735210|NCT02846779|11899510|FG000|STARTED|Overall Study||2000
10735211|NCT02846779|11899511|FG001|STARTED|Overall Study||2000
10735212|NCT02846779|11899512|FG002|STARTED|Overall Study||2000
10735213|NCT02846779|11899510|FG000|COMPLETED|Overall Study||1861
10735214|NCT02846779|11899511|FG001|COMPLETED|Overall Study||1873
10735215|NCT02846779|11899512|FG002|COMPLETED|Overall Study||1862
10735216|NCT02846779|11899510|FG000|NOT COMPLETED|Overall Study||139
10735217|NCT02846779|11899511|FG001|NOT COMPLETED|Overall Study||127
10544570|NCT01490632|11697646|FG009|NOT COMPLETED|Part C: Washout or Step-Down Period||0
10735218|NCT02846779|11899512|FG002|NOT COMPLETED|Overall Study||138
10735219|NCT02846792|11899520|FG000|STARTED|Overall Study||5
10735220|NCT02846792|11899520|FG000|COMPLETED|Overall Study||5
10735221|NCT02846792|11899520|FG000|NOT COMPLETED|Overall Study||0
10735222|NCT02847169|11899524|FG000|STARTED|First Intervention (1 Week)||15
10735223|NCT02847169|11899525|FG001|STARTED|First Intervention (1 Week)||15
10735224|NCT02847169|11899524|FG000|COMPLETED|First Intervention (1 Week)||15
10735225|NCT02847169|11899525|FG001|COMPLETED|First Intervention (1 Week)||15
10735226|NCT02847169|11899524|FG000|NOT COMPLETED|First Intervention (1 Week)||0
10735227|NCT02847169|11899525|FG001|NOT COMPLETED|First Intervention (1 Week)||0
10735228|NCT02847169|11899524|FG000|STARTED|Second Intervention (1 Week)||15
10735229|NCT02847169|11899525|FG001|STARTED|Second Intervention (1 Week)||15
10735230|NCT02847169|11899524|FG000|COMPLETED|Second Intervention (1 Week)||15
10735231|NCT02847169|11899525|FG001|COMPLETED|Second Intervention (1 Week)||15
10735232|NCT02847169|11899524|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
10735233|NCT02847169|11899525|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
10735234|NCT02847182|11899548|FG000|STARTED|Overall Study||119
10735235|NCT02847182|11899549|FG001|STARTED|Overall Study||61
10735236|NCT02847182|11899548|FG000|First Intervention (6 Months)|Overall Study||119
10735237|NCT02847182|11899549|FG001|First Intervention (6 Months)|Overall Study||61
10735238|NCT02847182|11899548|FG000|Second Intervention (6 Months)|Overall Study||61
10735239|NCT02847182|11899549|FG001|Second Intervention (6 Months)|Overall Study||119
10735240|NCT02847182|11899548|FG000|COMPLETED|Overall Study||119
10735241|NCT02847182|11899549|FG001|COMPLETED|Overall Study||60
10735242|NCT02847182|11899548|FG000|NOT COMPLETED|Overall Study||0
10735243|NCT02847182|11899549|FG001|NOT COMPLETED|Overall Study||1
10735244|NCT02847260|11899561|FG000|STARTED|Overall Study||39
10735245|NCT02847260|11899561|FG000|COMPLETED|Overall Study||32
10735246|NCT02847260|11899561|FG000|NOT COMPLETED|Overall Study||7
10735247|NCT02847494|11899567|FG000|STARTED|Overall Study||109
10735248|NCT02847494|11899568|FG001|STARTED|Overall Study||111
10735249|NCT02847494|11899567|FG000|COMPLETED|Overall Study||101
10735250|NCT02847494|11899568|FG001|COMPLETED|Overall Study||106
10735251|NCT02847494|11899567|FG000|NOT COMPLETED|Overall Study||8
10735252|NCT02847494|11899568|FG001|NOT COMPLETED|Overall Study||5
10735253|NCT02847650|11899576|FG000|STARTED|Overall Study||29
10735254|NCT02847650|11899577|FG001|STARTED|Overall Study||28
10735255|NCT02847650|11899576|FG000|COMPLETED|Overall Study||25
10735256|NCT02847650|11899577|FG001|COMPLETED|Overall Study||22
10735257|NCT02847650|11899576|FG000|NOT COMPLETED|Overall Study||4
10735258|NCT02847650|11899577|FG001|NOT COMPLETED|Overall Study||6
10735259|NCT02847858|11899585|FG000|STARTED|Overall Study||693
10735260|NCT02847858|11899586|FG001|STARTED|Overall Study||667
10735261|NCT02847858|11899585|FG000|COMPLETED|Overall Study||292
10735262|NCT02847858|11899586|FG001|COMPLETED|Overall Study||398
10735263|NCT02847858|11899585|FG000|NOT COMPLETED|Overall Study||401
10735264|NCT02847858|11899586|FG001|NOT COMPLETED|Overall Study||269
10735265|NCT02848079|11899597|FG000|STARTED|Overall Study||41
10735266|NCT02848079|11899597|FG000|Receieved Study Treatment|Overall Study||41
10735267|NCT02848079|11899597|FG000|Discontinued|Overall Study||41
10735268|NCT02848079|11899597|FG000|COMPLETED|Overall Study||41
10735269|NCT02848079|11899597|FG000|NOT COMPLETED|Overall Study||0
10735270|NCT02848222|11899604|FG000|STARTED|Overall Study||25
10735271|NCT02848222|11899605|FG001|STARTED|Overall Study||18
10735272|NCT02848222|11899606|FG002|STARTED|Overall Study||17
10735273|NCT02848222|11899604|FG000|COMPLETED|Overall Study||18
10735274|NCT02848222|11899605|FG001|COMPLETED|Overall Study||17
10735275|NCT02848222|11899606|FG002|COMPLETED|Overall Study||17
10735276|NCT02848222|11899604|FG000|NOT COMPLETED|Overall Study||7
10735277|NCT02848222|11899605|FG001|NOT COMPLETED|Overall Study||1
10735278|NCT02848222|11899606|FG002|NOT COMPLETED|Overall Study||0
10735279|NCT02848313|11899616|FG000|STARTED|Overall Study||21
10735280|NCT02848313|11899617|FG001|STARTED|Overall Study||19
10735281|NCT02848313|11899616|FG000|COMPLETED|Overall Study||18
10735282|NCT02848313|11899617|FG001|COMPLETED|Overall Study||15
10735283|NCT02848313|11899616|FG000|NOT COMPLETED|Overall Study||3
10735284|NCT02848313|11899617|FG001|NOT COMPLETED|Overall Study||4
10735285|NCT02848326|11899629|FG000|STARTED|Treatment Period||186
10735286|NCT02848326|11899630|FG001|STARTED|Treatment Period||94
10735287|NCT02848326|11899631|FG002|STARTED|Treatment Period||185
10735288|NCT02848326|11899632|FG003|STARTED|Treatment Period||187
10735289|NCT02848326|11899633|FG004|STARTED|Treatment Period||89
10735290|NCT02848326|11899634|FG005|STARTED|Treatment Period||93
10735291|NCT02848326|11899629|FG000|Safety Population: Received Study Drug|Treatment Period||186
10735292|NCT02848326|11899630|FG001|Safety Population: Received Study Drug|Treatment Period||93
10735293|NCT02848326|11899631|FG002|Safety Population: Received Study Drug|Treatment Period||183
10735294|NCT02848326|11899632|FG003|Safety Population: Received Study Drug|Treatment Period||186
10735295|NCT02848326|11899633|FG004|Safety Population: Received Study Drug|Treatment Period||86
10735296|NCT02848326|11899634|FG005|Safety Population: Received Study Drug|Treatment Period||91
10735297|NCT02848326|11899629|FG000|COMPLETED|Treatment Period||148
10735298|NCT02848326|11899630|FG001|COMPLETED|Treatment Period||80
10735299|NCT02848326|11899631|FG002|COMPLETED|Treatment Period||149
10735300|NCT02848326|11899632|FG003|COMPLETED|Treatment Period||164
10735301|NCT02848326|11899633|FG004|COMPLETED|Treatment Period||70
10735302|NCT02848326|11899634|FG005|COMPLETED|Treatment Period||73
10735303|NCT02848326|11899629|FG000|NOT COMPLETED|Treatment Period||38
10735304|NCT02848326|11899630|FG001|NOT COMPLETED|Treatment Period||14
10735305|NCT02848326|11899631|FG002|NOT COMPLETED|Treatment Period||36
10735306|NCT02848326|11899632|FG003|NOT COMPLETED|Treatment Period||23
10735307|NCT02848326|11899633|FG004|NOT COMPLETED|Treatment Period||19
10735308|NCT02848326|11899634|FG005|NOT COMPLETED|Treatment Period||20
10735309|NCT02848326|11899629|FG000|STARTED|Safety Follow-up Period||161
10735310|NCT02848326|11899630|FG001|STARTED|Safety Follow-up Period||84
10735311|NCT02848326|11899631|FG002|STARTED|Safety Follow-up Period||156
10735312|NCT02848326|11899632|FG003|STARTED|Safety Follow-up Period||169
10735313|NCT02848326|11899633|FG004|STARTED|Safety Follow-up Period||77
10735314|NCT02848326|11899634|FG005|STARTED|Safety Follow-up Period||82
10735315|NCT02848326|11899629|FG000|COMPLETED|Safety Follow-up Period||157
10735316|NCT02848326|11899630|FG001|COMPLETED|Safety Follow-up Period||83
10735317|NCT02848326|11899631|FG002|COMPLETED|Safety Follow-up Period||153
10735318|NCT02848326|11899632|FG003|COMPLETED|Safety Follow-up Period||169
10735319|NCT02848326|11899633|FG004|COMPLETED|Safety Follow-up Period||76
10735320|NCT02848326|11899634|FG005|COMPLETED|Safety Follow-up Period||77
10735321|NCT02848326|11899629|FG000|NOT COMPLETED|Safety Follow-up Period||4
10735322|NCT02848326|11899630|FG001|NOT COMPLETED|Safety Follow-up Period||1
10815679|NCT01834144|11978905|FG000|STARTED|Overall Study||1
10815680|NCT01834144|11978906|FG001|STARTED|Overall Study||3
10815681|NCT01834144|11978905|FG000|COMPLETED|Overall Study||1
10815682|NCT01834144|11978906|FG001|COMPLETED|Overall Study||2
10815683|NCT01834144|11978905|FG000|NOT COMPLETED|Overall Study||0
10815684|NCT01834144|11978906|FG001|NOT COMPLETED|Overall Study||1
10815685|NCT01821963|11978912|FG000|STARTED|Overall Study||1
10815686|NCT01821963|11978912|FG000|COMPLETED|Overall Study||0
10815687|NCT01821963|11978912|FG000|NOT COMPLETED|Overall Study||1
10815688|NCT01821898|11978918|FG000|STARTED|Overall Study||2
10815689|NCT01821898|11978919|FG001|STARTED|Overall Study||1
10815690|NCT01821898|11978918|FG000|COMPLETED|Overall Study||0
10815691|NCT01821898|11978919|FG001|COMPLETED|Overall Study||0
10815692|NCT01821898|11978918|FG000|NOT COMPLETED|Overall Study||2
10815693|NCT01821898|11978919|FG001|NOT COMPLETED|Overall Study||1
10815694|NCT01814722|11978929|FG000|STARTED|Overall Study||36
10815695|NCT01814722|11978930|FG001|STARTED|Overall Study||21
10815696|NCT01814722|11978931|FG002|STARTED|Overall Study||6
10815697|NCT01814722|11978929|FG000|COMPLETED|Overall Study||36
10815698|NCT01814722|11978930|FG001|COMPLETED|Overall Study||21
10815699|NCT01814722|11978931|FG002|COMPLETED|Overall Study||6
10815700|NCT01814722|11978929|FG000|NOT COMPLETED|Overall Study||0
10815701|NCT01814722|11978930|FG001|NOT COMPLETED|Overall Study||0
10815702|NCT01814722|11978931|FG002|NOT COMPLETED|Overall Study||0
10815703|NCT01830790|11978941|FG000|STARTED|Overall Study||0
10815704|NCT01830790|11978942|FG001|STARTED|Overall Study||10
10815705|NCT01830790|11978941|FG000|COMPLETED|Overall Study||0
10815706|NCT01830790|11978942|FG001|COMPLETED|Overall Study||10
10815707|NCT01830790|11978941|FG000|NOT COMPLETED|Overall Study||0
10815708|NCT01830790|11978942|FG001|NOT COMPLETED|Overall Study||0
10815709|NCT01829477|11978950|FG000|STARTED|Overall Study||17
10815710|NCT01829477|11978951|FG001|STARTED|Overall Study||16
10815711|NCT01829477|11978950|FG000|COMPLETED|Overall Study||1
10815712|NCT01829477|11978951|FG001|COMPLETED|Overall Study||1
10815713|NCT01829477|11978950|FG000|NOT COMPLETED|Overall Study||16
10815714|NCT01829477|11978951|FG001|NOT COMPLETED|Overall Study||15
10815715|NCT01803711|11978959|FG000|STARTED|Overall Study||2
10815716|NCT01803711|11978960|FG001|STARTED|Overall Study||3
10815717|NCT01803711|11978959|FG000|COMPLETED|Overall Study||1
10815718|NCT01803711|11978960|FG001|COMPLETED|Overall Study||2
10815719|NCT01803711|11978959|FG000|NOT COMPLETED|Overall Study||1
10815720|NCT01803711|11978960|FG001|NOT COMPLETED|Overall Study||1
10815721|NCT01821859|11978968|FG000|STARTED|Overall Study||5
10815722|NCT01821859|11978968|FG000|COMPLETED|Overall Study||0
10815723|NCT01821859|11978968|FG000|NOT COMPLETED|Overall Study||5
10815724|NCT01808950|11978975|FG000|STARTED|Overall Study||1
10815725|NCT01808950|11978976|FG001|STARTED|Overall Study||3
10815726|NCT01808950|11978977|FG002|STARTED|Overall Study||0
10815727|NCT01808950|11978975|FG000|COMPLETED|Overall Study||1
10815728|NCT01808950|11978976|FG001|COMPLETED|Overall Study||3
10815729|NCT01808950|11978977|FG002|COMPLETED|Overall Study||0
10815730|NCT01808950|11978975|FG000|NOT COMPLETED|Overall Study||0
10815731|NCT01808950|11978976|FG001|NOT COMPLETED|Overall Study||0
10815732|NCT01808950|11978977|FG002|NOT COMPLETED|Overall Study||0
10815733|NCT01806051|11978988|FG000|STARTED|Overall Study||6
10815734|NCT01806051|11978988|FG000|COMPLETED|Overall Study||0
10815735|NCT01806051|11978988|FG000|NOT COMPLETED|Overall Study||6
10815736|NCT01808794|11978996|FG000|STARTED|Overall Study||0
10815737|NCT01808794|11978997|FG001|STARTED|Overall Study||0
10735323|NCT02848326|11899631|FG002|NOT COMPLETED|Safety Follow-up Period||3
10735324|NCT02848326|11899632|FG003|NOT COMPLETED|Safety Follow-up Period||0
10735325|NCT02848326|11899633|FG004|NOT COMPLETED|Safety Follow-up Period||1
10735326|NCT02848326|11899634|FG005|NOT COMPLETED|Safety Follow-up Period||5
10735327|NCT02848599|11899650|FG000|STARTED|Overall Study||42
10735328|NCT02848599|11899651|FG001|STARTED|Overall Study||44
10735329|NCT02848599|11899650|FG000|COMPLETED|Overall Study||35
10735330|NCT02848599|11899651|FG001|COMPLETED|Overall Study||35
10735331|NCT02848599|11899650|FG000|NOT COMPLETED|Overall Study||7
10735332|NCT02848599|11899651|FG001|NOT COMPLETED|Overall Study||9
10735333|NCT02848651|11899659|FG000|STARTED|Overall Study||153
10735334|NCT02848651|11899659|FG000|Received Treatment|Overall Study||152
10815738|NCT01808794|11978996|FG000|COMPLETED|Overall Study||0
10815739|NCT01808794|11978997|FG001|COMPLETED|Overall Study||0
10815740|NCT01808794|11978996|FG000|NOT COMPLETED|Overall Study||0
10815741|NCT01808794|11978997|FG001|NOT COMPLETED|Overall Study||0
10815742|NCT01809899|11979005|FG000|STARTED|Overall Study||8
10815743|NCT01809899|11979006|FG001|STARTED|Overall Study||4
10815744|NCT01809899|11979005|FG000|COMPLETED|Overall Study||8
10815745|NCT01809899|11979006|FG001|COMPLETED|Overall Study||4
10815746|NCT01809899|11979005|FG000|NOT COMPLETED|Overall Study||0
10815747|NCT01809899|11979006|FG001|NOT COMPLETED|Overall Study||0
10735335|NCT02848651|11899659|FG000|COMPLETED|Overall Study||47
10735336|NCT02848651|11899659|FG000|NOT COMPLETED|Overall Study||106
10735337|NCT02848664|11899679|FG000|STARTED|Overall Study||11
10735338|NCT02848664|11899679|FG000|COMPLETED|Overall Study||7
10735339|NCT02848664|11899679|FG000|NOT COMPLETED|Overall Study||4
10735340|NCT02848729|11899689|FG000|STARTED|Overall Study||27
10735341|NCT02848729|11899690|FG001|STARTED|Overall Study||23
10735342|NCT02848729|11899689|FG000|Per Protocol Population|Overall Study||11
10735343|NCT02848729|11899690|FG001|Per Protocol Population|Overall Study||11
10735344|NCT02848729|11899689|FG000|Safety Population|Overall Study||27
10735345|NCT02848729|11899690|FG001|Safety Population|Overall Study||23
10735346|NCT02848729|11899689|FG000|COMPLETED|Overall Study||11
10815748|NCT01810302|11979015|FG000|STARTED|Overall Study||1
10815749|NCT01810302|11979016|FG001|STARTED|Overall Study||1
10815750|NCT01810302|11979015|FG000|COMPLETED|Overall Study||0
10815751|NCT01810302|11979016|FG001|COMPLETED|Overall Study||0
10815752|NCT01810302|11979015|FG000|NOT COMPLETED|Overall Study||1
10815753|NCT01810302|11979016|FG001|NOT COMPLETED|Overall Study||1
10815754|NCT01806961|11979022|FG000|STARTED|Overall Study||16
10815755|NCT01806961|11979022|FG000|COMPLETED|Overall Study||0
10815756|NCT01806961|11979022|FG000|NOT COMPLETED|Overall Study||16
10815757|NCT01804166|11979026|FG000|STARTED|Overall Study||1
10815758|NCT01804166|11979026|FG000|COMPLETED|Overall Study||1
10815759|NCT01804166|11979026|FG000|NOT COMPLETED|Overall Study||0
10815760|NCT01783015|11979032|FG000|STARTED|Blinded Treatment||11
10815761|NCT01783015|11979033|FG001|STARTED|Blinded Treatment||5
10815762|NCT01783015|11979034|FG002|STARTED|Blinded Treatment||0
10815763|NCT01783015|11979032|FG000|Treated|Blinded Treatment||11
10815764|NCT01783015|11979033|FG001|Treated|Blinded Treatment||5
10815765|NCT01783015|11979034|FG002|Treated|Blinded Treatment||0
10815766|NCT01783015|11979032|FG000|COMPLETED|Blinded Treatment||9
10815767|NCT01783015|11979033|FG001|COMPLETED|Blinded Treatment||2
10815768|NCT01783015|11979034|FG002|COMPLETED|Blinded Treatment||0
10815769|NCT01783015|11979032|FG000|NOT COMPLETED|Blinded Treatment||2
10815770|NCT01783015|11979033|FG001|NOT COMPLETED|Blinded Treatment||3
10815771|NCT01783015|11979034|FG002|NOT COMPLETED|Blinded Treatment||0
10815772|NCT01783015|11979032|FG000|STARTED|Open Label Treatment||0
10815773|NCT01783015|11979033|FG001|STARTED|Open Label Treatment||0
10815774|NCT01783015|11979034|FG002|STARTED|Open Label Treatment||11
10815775|NCT01783015|11979032|FG000|COMPLETED|Open Label Treatment||0
10815776|NCT01783015|11979033|FG001|COMPLETED|Open Label Treatment||0
10815777|NCT01783015|11979034|FG002|COMPLETED|Open Label Treatment||5
10815778|NCT01783015|11979032|FG000|NOT COMPLETED|Open Label Treatment||0
10815779|NCT01783015|11979033|FG001|NOT COMPLETED|Open Label Treatment||0
10815780|NCT01783015|11979034|FG002|NOT COMPLETED|Open Label Treatment||6
10815781|NCT01800162|11979045|FG000|STARTED|Overall Study|1 subject was randomized to uterine evacuation on 6/26/2013.|1
10815782|NCT01800162|11979046|FG001|STARTED|Overall Study||0
10815783|NCT01800162|11979047|FG002|STARTED|Overall Study|1 subject randomized to expectant management on 11/1/2013.|1
10815784|NCT01800162|11979045|FG000|COMPLETED|Overall Study||1
10815785|NCT01800162|11979046|FG001|COMPLETED|Overall Study||0
10815786|NCT01800162|11979047|FG002|COMPLETED|Overall Study||1
10815787|NCT01800162|11979045|FG000|NOT COMPLETED|Overall Study||0
10815788|NCT01800162|11979046|FG001|NOT COMPLETED|Overall Study||0
10815789|NCT01800162|11979047|FG002|NOT COMPLETED|Overall Study||0
10815790|NCT01794936|11979055|FG000|STARTED|Overall Study||9
10815791|NCT01794936|11979055|FG000|COMPLETED|Overall Study||9
10815792|NCT01794936|11979055|FG000|NOT COMPLETED|Overall Study||0
10815793|NCT01797380|11979061|FG000|STARTED|Overall Study|Terminated due to lack of enrollment|3
10815794|NCT01797380|11979062|FG001|STARTED|Overall Study||2
10815795|NCT01797380|11979061|FG000|COMPLETED|Overall Study|Terminated due to lack of enrollment|0
10815796|NCT01797380|11979062|FG001|COMPLETED|Overall Study||0
10815797|NCT01797380|11979061|FG000|NOT COMPLETED|Overall Study||3
10815798|NCT01797380|11979062|FG001|NOT COMPLETED|Overall Study||2
10815799|NCT01781026|11979068|FG000|STARTED|Overall Study||2
10815800|NCT01781026|11979068|FG000|COMPLETED|Overall Study||0
10815801|NCT01781026|11979068|FG000|NOT COMPLETED|Overall Study||2
10815802|NCT01788475|11979075|FG000|STARTED|Overall Study||3
10815803|NCT01788475|11979076|FG001|STARTED|Overall Study||0
10815804|NCT01788475|11979077|FG002|STARTED|Overall Study||0
10815805|NCT01788475|11979075|FG000|COMPLETED|Overall Study||0
10815806|NCT01788475|11979076|FG001|COMPLETED|Overall Study||0
10815807|NCT01788475|11979077|FG002|COMPLETED|Overall Study||0
10815808|NCT01788475|11979075|FG000|NOT COMPLETED|Overall Study||3
10815809|NCT01788475|11979076|FG001|NOT COMPLETED|Overall Study||0
10815810|NCT01788475|11979077|FG002|NOT COMPLETED|Overall Study||0
10815811|NCT01784991|11979087|FG000|STARTED|Overall Study||0
10815812|NCT01784991|11979088|FG001|STARTED|Overall Study||0
10815813|NCT01784991|11979087|FG000|COMPLETED|Overall Study||0
10815814|NCT01784991|11979088|FG001|COMPLETED|Overall Study||0
10815815|NCT01784991|11979087|FG000|NOT COMPLETED|Overall Study||0
10815816|NCT01784991|11979088|FG001|NOT COMPLETED|Overall Study||0
10815817|NCT01777854|11979094|FG000|STARTED|Overall Study||3
10815818|NCT01777854|11979095|FG001|STARTED|Overall Study||3
10815819|NCT01777854|11979094|FG000|COMPLETED|Overall Study||0
10815820|NCT01777854|11979095|FG001|COMPLETED|Overall Study||0
10735347|NCT02848729|11899690|FG001|COMPLETED|Overall Study||12
10735348|NCT02848729|11899689|FG000|NOT COMPLETED|Overall Study||16
10815821|NCT01777854|11979094|FG000|NOT COMPLETED|Overall Study||3
10815822|NCT01777854|11979095|FG001|NOT COMPLETED|Overall Study||3
10735349|NCT02848729|11899690|FG001|NOT COMPLETED|Overall Study||11
10735350|NCT02848833|11899703|FG000|STARTED|Overall Study||3368
10735351|NCT02848833|11899703|FG000|COMPLETED|Overall Study||3231
10735352|NCT02848833|11899703|FG000|NOT COMPLETED|Overall Study||137
10735393|NCT02849184|11899726|FG000|STARTED|Overall Study||40
10735394|NCT02849184|11899727|FG001|STARTED|Overall Study||42
10735395|NCT02849184|11899726|FG000|COMPLETED|Overall Study||40
10735396|NCT02849184|11899727|FG001|COMPLETED|Overall Study||42
10735397|NCT02849184|11899726|FG000|NOT COMPLETED|Overall Study||0
10735398|NCT02849184|11899727|FG001|NOT COMPLETED|Overall Study||0
10735399|NCT02849418|11899735|FG000|STARTED|Double-blinded (Up to 48 Weeks)||10
10735400|NCT02849418|11899736|FG001|STARTED|Double-blinded (Up to 48 Weeks)||11
10735401|NCT02849418|11899737|FG002|STARTED|Double-blinded (Up to 48 Weeks)||0
10735402|NCT02849418|11899738|FG003|STARTED|Double-blinded (Up to 48 Weeks)||0
10735403|NCT02849418|11899739|FG004|STARTED|Double-blinded (Up to 48 Weeks)||0
10735404|NCT02849418|11899740|FG005|STARTED|Double-blinded (Up to 48 Weeks)||0
10735405|NCT02849418|11899735|FG000|COMPLETED|Double-blinded (Up to 48 Weeks)||10
10735406|NCT02849418|11899736|FG001|COMPLETED|Double-blinded (Up to 48 Weeks)||11
10735407|NCT02849418|11899737|FG002|COMPLETED|Double-blinded (Up to 48 Weeks)||0
10735408|NCT02849418|11899738|FG003|COMPLETED|Double-blinded (Up to 48 Weeks)||0
10735409|NCT02849418|11899739|FG004|COMPLETED|Double-blinded (Up to 48 Weeks)||0
10735410|NCT02849418|11899740|FG005|COMPLETED|Double-blinded (Up to 48 Weeks)||0
10735411|NCT02849418|11899735|FG000|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
10735412|NCT02849418|11899736|FG001|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
10735413|NCT02849418|11899737|FG002|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
10735414|NCT02849418|11899738|FG003|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
10735415|NCT02849418|11899739|FG004|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
10735416|NCT02849418|11899740|FG005|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
10735417|NCT02849418|11899735|FG000|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
10735418|NCT02849418|11899736|FG001|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
10735419|NCT02849418|11899737|FG002|STARTED|Open-label(2nd Treatment-Week 12 to 48)||10
10735420|NCT02849418|11899738|FG003|STARTED|Open-label(2nd Treatment-Week 12 to 48)||6
10735421|NCT02849418|11899739|FG004|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
10735422|NCT02849418|11899740|FG005|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
10735423|NCT02849418|11899735|FG000|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
10735424|NCT02849418|11899736|FG001|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
10735425|NCT02849418|11899737|FG002|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||10
10735426|NCT02849418|11899738|FG003|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||6
10735427|NCT02849418|11899739|FG004|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
10735428|NCT02849418|11899740|FG005|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
10735429|NCT02849418|11899735|FG000|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
10735430|NCT02849418|11899736|FG001|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
10735431|NCT02849418|11899737|FG002|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
10735432|NCT02849418|11899738|FG003|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
10735433|NCT02849418|11899739|FG004|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
10735434|NCT02849418|11899740|FG005|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
10735435|NCT02849418|11899735|FG000|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
10735436|NCT02849418|11899736|FG001|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
10735437|NCT02849418|11899737|FG002|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
10735438|NCT02849418|11899738|FG003|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
10735439|NCT02849418|11899739|FG004|STARTED|Open-label(3rd Treatment-Week 12 to 48)||5
10735440|NCT02849418|11899740|FG005|STARTED|Open-label(3rd Treatment-Week 12 to 48)||3
10735441|NCT02849418|11899735|FG000|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
10735442|NCT02849418|11899736|FG001|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
10735443|NCT02849418|11899737|FG002|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
10735444|NCT02849418|11899738|FG003|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
10735445|NCT02849418|11899739|FG004|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||5
10735446|NCT02849418|11899740|FG005|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||3
10735447|NCT02849418|11899735|FG000|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
10735448|NCT02849418|11899736|FG001|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
10735449|NCT02849418|11899737|FG002|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
10735450|NCT02849418|11899738|FG003|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
10735451|NCT02849418|11899739|FG004|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
10735452|NCT02849418|11899740|FG005|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
10735453|NCT02849509|11899759|FG000|STARTED|Overall Study||379
10735454|NCT02849509|11899760|FG001|STARTED|Overall Study||591
10735455|NCT02849509|11899761|FG002|STARTED|Overall Study||343
10735456|NCT02849509|11899759|FG000|COMPLETED|Overall Study|Not prematurely discontinued from Pradaxa or VKA|289
10735457|NCT02849509|11899760|FG001|COMPLETED|Overall Study|Not prematurely discontinued from Pradaxa or VKA|425
10735458|NCT02849509|11899761|FG002|COMPLETED|Overall Study|Not prematurely discontinued from Pradaxa or VKA|258
10735459|NCT02849509|11899759|FG000|NOT COMPLETED|Overall Study||90
10735460|NCT02849509|11899760|FG001|NOT COMPLETED|Overall Study||166
10735461|NCT02849509|11899761|FG002|NOT COMPLETED|Overall Study||85
10544571|NCT01490632|11697647|FG010|NOT COMPLETED|Part C: Washout or Step-Down Period||0
10544572|NCT01490632|11697648|FG011|NOT COMPLETED|Part C: Washout or Step-Down Period||0
10544573|NCT01490632|11697649|FG012|NOT COMPLETED|Part C: Washout or Step-Down Period||5
10544574|NCT01490632|11697650|FG013|NOT COMPLETED|Part C: Washout or Step-Down Period||10
10544575|NCT01490632|11697651|FG014|NOT COMPLETED|Part C: Washout or Step-Down Period||18
10544576|NCT01490632|11697652|FG015|NOT COMPLETED|Part C: Washout or Step-Down Period||37
10544577|NCT01490632|11697653|FG016|NOT COMPLETED|Part C: Washout or Step-Down Period||0
10544578|NCT01490632|11697654|FG017|NOT COMPLETED|Part C: Washout or Step-Down Period||0
10544579|NCT01490632|11697655|FG018|NOT COMPLETED|Part C: Washout or Step-Down Period||0
10544580|NCT01490632|11697656|FG019|NOT COMPLETED|Part C: Washout or Step-Down Period||0
10544581|NCT01490632|11697637|FG000|STARTED|Part D: Re-Treatment Period||0
10544582|NCT01490632|11697638|FG001|STARTED|Part D: Re-Treatment Period||0
10544583|NCT01490632|11697639|FG002|STARTED|Part D: Re-Treatment Period||0
10544584|NCT01490632|11697640|FG003|STARTED|Part D: Re-Treatment Period||0
10544585|NCT01490632|11697641|FG004|STARTED|Part D: Re-Treatment Period||0
10544586|NCT01490632|11697642|FG005|STARTED|Part D: Re-Treatment Period||0
10544587|NCT01490632|11697643|FG006|STARTED|Part D: Re-Treatment Period||0
10544588|NCT01490632|11697644|FG007|STARTED|Part D: Re-Treatment Period||0
10544589|NCT01490632|11697645|FG008|STARTED|Part D: Re-Treatment Period||0
10544590|NCT01490632|11697646|FG009|STARTED|Part D: Re-Treatment Period||0
10544591|NCT01490632|11697647|FG010|STARTED|Part D: Re-Treatment Period||0
10544592|NCT01490632|11697648|FG011|STARTED|Part D: Re-Treatment Period||0
10544593|NCT01490632|11697649|FG012|STARTED|Part D: Re-Treatment Period|Responders receiving 2 or 4 mg were re-randomized to receive placebo.|0
10735462|NCT02849678|11899773|FG000|STARTED|Overall Study||20
10735463|NCT02849678|11899774|FG001|STARTED|Overall Study||24
10735464|NCT02849678|11899773|FG000|COMPLETED|Overall Study||17
10735465|NCT02849678|11899774|FG001|COMPLETED|Overall Study||18
10735466|NCT02849678|11899773|FG000|NOT COMPLETED|Overall Study||3
10735467|NCT02849678|11899774|FG001|NOT COMPLETED|Overall Study||6
10735468|NCT02849704|11899782|FG000|STARTED|Washout Period - CP Subj on PERT - 3days||11
10735469|NCT02849704|11899783|FG001|STARTED|Washout Period - CP Subj on PERT - 3days||0
10735470|NCT02849704|11899782|FG000|COMPLETED|Washout Period - CP Subj on PERT - 3days||11
10735471|NCT02849704|11899783|FG001|COMPLETED|Washout Period - CP Subj on PERT - 3days||0
10735472|NCT02849704|11899782|FG000|NOT COMPLETED|Washout Period - CP Subj on PERT - 3days||0
10735473|NCT02849704|11899783|FG001|NOT COMPLETED|Washout Period - CP Subj on PERT - 3days||0
10735474|NCT02849704|11899782|FG000|STARTED|Baseline Assessments - All Subj - 7 Days||24
10735475|NCT02849704|11899783|FG001|STARTED|Baseline Assessments - All Subj - 7 Days||24
10735476|NCT02849704|11899782|FG000|COMPLETED|Baseline Assessments - All Subj - 7 Days||24
10544594|NCT01490632|11697650|FG013|STARTED|Part D: Re-Treatment Period|Responders receiving 2 or 4 mg were re-randomized to receive half of the dose from Part B.|0
10735477|NCT02849704|11899783|FG001|COMPLETED|Baseline Assessments - All Subj - 7 Days||24
10735478|NCT02849704|11899782|FG000|NOT COMPLETED|Baseline Assessments - All Subj - 7 Days||0
10735479|NCT02849704|11899783|FG001|NOT COMPLETED|Baseline Assessments - All Subj - 7 Days||0
10735480|NCT02849704|11899782|FG000|STARTED|Assessment on PERT - CP Subj - 16 Days||24
10735481|NCT02849704|11899783|FG001|STARTED|Assessment on PERT - CP Subj - 16 Days||0
10735482|NCT02849704|11899782|FG000|COMPLETED|Assessment on PERT - CP Subj - 16 Days||21
10735483|NCT02849704|11899783|FG001|COMPLETED|Assessment on PERT - CP Subj - 16 Days||0
10735484|NCT02849704|11899782|FG000|NOT COMPLETED|Assessment on PERT - CP Subj - 16 Days||3
10735485|NCT02849704|11899783|FG001|NOT COMPLETED|Assessment on PERT - CP Subj - 16 Days||0
10735486|NCT02849938|11899795|FG000|STARTED|Overall Study||9
10735487|NCT02849938|11899796|FG001|STARTED|Overall Study||15
10735488|NCT02849938|11899795|FG000|COMPLETED|Overall Study||9
10735489|NCT02849938|11899796|FG001|COMPLETED|Overall Study||15
10735490|NCT02849938|11899795|FG000|NOT COMPLETED|Overall Study||0
10735491|NCT02849938|11899796|FG001|NOT COMPLETED|Overall Study||0
10735492|NCT02850068|11899802|FG000|STARTED|Overall Study||20
10735493|NCT02850068|11899802|FG000|COMPLETED|Overall Study||0
10735494|NCT02850068|11899802|FG000|NOT COMPLETED|Overall Study||20
10735495|NCT02850159|11899808|FG000|STARTED|Overall Study||16
10735496|NCT02850159|11899809|FG001|STARTED|Overall Study||16
10735497|NCT02850159|11899808|FG000|COMPLETED|Overall Study||16
10735498|NCT02850159|11899809|FG001|COMPLETED|Overall Study||16
10735499|NCT02850159|11899808|FG000|NOT COMPLETED|Overall Study||0
10735500|NCT02850159|11899809|FG001|NOT COMPLETED|Overall Study||0
10735501|NCT02850276|11899815|FG000|STARTED|Overall Study||76
10735502|NCT02850276|11899815|FG000|COMPLETED|Overall Study||15
10735503|NCT02850276|11899815|FG000|NOT COMPLETED|Overall Study||61
10735504|NCT02850601|11899822|FG000|STARTED|Overall Study||12
10735505|NCT02850601|11899823|FG001|STARTED|Overall Study||12
10735506|NCT02850601|11899822|FG000|COMPLETED|Overall Study||12
10735507|NCT02850601|11899823|FG001|COMPLETED|Overall Study||12
10735508|NCT02850601|11899822|FG000|NOT COMPLETED|Overall Study||0
10735509|NCT02850601|11899823|FG001|NOT COMPLETED|Overall Study||0
10735510|NCT02850965|11899831|FG000|STARTED|Overall Study||159
10735511|NCT02850965|11899832|FG001|STARTED|Overall Study||159
10735512|NCT02850965|11899831|FG000|Treated|Overall Study||159
10735513|NCT02850965|11899832|FG001|Treated|Overall Study||158
10735514|NCT02850965|11899831|FG000|COMPLETED|Overall Study||141
10735515|NCT02850965|11899832|FG001|COMPLETED|Overall Study||134
10735516|NCT02850965|11899831|FG000|NOT COMPLETED|Overall Study||18
10735517|NCT02850965|11899832|FG001|NOT COMPLETED|Overall Study||25
10735518|NCT02850978|11899838|FG000|STARTED|Overall Study||1335
10735519|NCT02850978|11899838|FG000|Case Report Form (CRF) Collected|Overall Study||1308
10735520|NCT02850978|11899838|FG000|Treated|Overall Study||1308
10735521|NCT02850978|11899838|FG000|COMPLETED|Overall Study||909
10735522|NCT02850978|11899838|FG000|NOT COMPLETED|Overall Study||426
10735523|NCT02851069|11899842|FG000|STARTED|Overall Study||65
10735524|NCT02851069|11899842|FG000|COMPLETED|Overall Study||59
10735525|NCT02851069|11899842|FG000|NOT COMPLETED|Overall Study||6
10735526|NCT02851108|11899849|FG000|STARTED|Overall Study||50
10735527|NCT02851108|11899850|FG001|STARTED|Overall Study||50
10735528|NCT02851108|11899849|FG000|COMPLETED|Overall Study||42
10735529|NCT02851108|11899850|FG001|COMPLETED|Overall Study||49
10735530|NCT02851108|11899849|FG000|NOT COMPLETED|Overall Study||8
10735531|NCT02851108|11899850|FG001|NOT COMPLETED|Overall Study||1
10735532|NCT02851615|11899858|FG000|STARTED|Overall Study||27
10735533|NCT02851615|11899859|FG001|STARTED|Overall Study||31
10735534|NCT02851615|11899858|FG000|COMPLETED|Overall Study||26
10735535|NCT02851615|11899859|FG001|COMPLETED|Overall Study||27
10735536|NCT02851615|11899858|FG000|NOT COMPLETED|Overall Study||1
10735537|NCT02851615|11899859|FG001|NOT COMPLETED|Overall Study||4
10735538|NCT02851823|11899866|FG000|STARTED|Overall Study||25
10735539|NCT02851823|11899866|FG000|1 Month|Overall Study||25
10735540|NCT02851823|11899866|FG000|3 Months|Overall Study||25
10735541|NCT02851823|11899866|FG000|COMPLETED|Overall Study||25
10735542|NCT02851823|11899866|FG000|NOT COMPLETED|Overall Study||0
10735573|NCT02852265|11899897|FG000|STARTED|1-month Follow-up||10
10735574|NCT02852265|11899898|FG001|STARTED|1-month Follow-up||10
10735575|NCT02852265|11899897|FG000|COMPLETED|1-month Follow-up||10
10735576|NCT02852265|11899898|FG001|COMPLETED|1-month Follow-up||10
10735577|NCT02852265|11899897|FG000|NOT COMPLETED|1-month Follow-up||0
10735578|NCT02852265|11899898|FG001|NOT COMPLETED|1-month Follow-up||0
10735579|NCT02852265|11899897|FG000|STARTED|3-month Follow-up||10
10735580|NCT02852265|11899898|FG001|STARTED|3-month Follow-up||10
10735581|NCT02852265|11899897|FG000|COMPLETED|3-month Follow-up||9
10735582|NCT02852265|11899898|FG001|COMPLETED|3-month Follow-up||9
10735583|NCT02852265|11899897|FG000|NOT COMPLETED|3-month Follow-up||1
10735584|NCT02852265|11899898|FG001|NOT COMPLETED|3-month Follow-up||1
10815823|NCT01760993|11979099|FG000|STARTED|Overall Study||0
10312878|NCT00146640|11446383|FG000|COMPLETED|Overall Study||121
10312879|NCT00146640|11446384|FG001|COMPLETED|Overall Study||130
10312880|NCT00146640|11446383|FG000|NOT COMPLETED|Overall Study||23
10312881|NCT00146640|11446384|FG001|NOT COMPLETED|Overall Study||14
10312882|NCT00146757|11446390|FG000|STARTED|Overall Study||16
10312883|NCT00146757|11446391|FG001|STARTED|Overall Study||4
10312884|NCT00146757|11446390|FG000|COMPLETED|Overall Study||14
10312885|NCT00146757|11446391|FG001|COMPLETED|Overall Study||4
10312886|NCT00146757|11446390|FG000|NOT COMPLETED|Overall Study||2
10408468|NCT00754936|11552552|FG000|STARTED|Overall Study||71
10408469|NCT00754936|11552552|FG000|COMPLETED|Overall Study||59
10408470|NCT00754936|11552552|FG000|NOT COMPLETED|Overall Study||12
10408471|NCT00755040|11552558|FG000|STARTED|Overall Study||83
10408472|NCT00755040|11552559|FG001|STARTED|Overall Study||81
10815824|NCT01760993|11979099|FG000|COMPLETED|Overall Study||0
10815825|NCT01760993|11979099|FG000|NOT COMPLETED|Overall Study||0
10815826|NCT01772719|11979103|FG000|STARTED|Overall Study||7
10815827|NCT01772719|11979103|FG000|COMPLETED|Overall Study||0
10815828|NCT01772719|11979103|FG000|NOT COMPLETED|Overall Study||7
10815829|NCT01764997|11979115|FG000|STARTED|Run-in Period||776
10815830|NCT01764997|11979116|FG001|STARTED|Run-in Period||0
10815831|NCT01764997|11979117|FG002|STARTED|Run-in Period||0
10815832|NCT01764997|11979118|FG003|STARTED|Run-in Period||0
10815833|NCT01764997|11979119|FG004|STARTED|Run-in Period||0
10815834|NCT01764997|11979115|FG000|COMPLETED|Run-in Period|43 participants proceeded to randomized treatment and 322 proceeded to open-label sub-study.|738
10815835|NCT01764997|11979116|FG001|COMPLETED|Run-in Period||0
10815836|NCT01764997|11979117|FG002|COMPLETED|Run-in Period||0
10815837|NCT01764997|11979118|FG003|COMPLETED|Run-in Period||0
10815838|NCT01764997|11979119|FG004|COMPLETED|Run-in Period||0
10815839|NCT01764997|11979115|FG000|NOT COMPLETED|Run-in Period||38
10815840|NCT01764997|11979116|FG001|NOT COMPLETED|Run-in Period||0
10815841|NCT01764997|11979117|FG002|NOT COMPLETED|Run-in Period||0
10815842|NCT01764997|11979118|FG003|NOT COMPLETED|Run-in Period||0
10815843|NCT01764997|11979119|FG004|NOT COMPLETED|Run-in Period||0
10815844|NCT01764997|11979115|FG000|STARTED|Study Drug Treatment Period||0
10815845|NCT01764997|11979116|FG001|STARTED|Study Drug Treatment Period||17
10815846|NCT01764997|11979117|FG002|STARTED|Study Drug Treatment Period||13
10815847|NCT01764997|11979118|FG003|STARTED|Study Drug Treatment Period||13
10815848|NCT01764997|11979119|FG004|STARTED|Study Drug Treatment Period||322
10815849|NCT01764997|11979115|FG000|COMPLETED|Study Drug Treatment Period||0
10815850|NCT01764997|11979116|FG001|COMPLETED|Study Drug Treatment Period||16
10815851|NCT01764997|11979117|FG002|COMPLETED|Study Drug Treatment Period||13
10815852|NCT01764997|11979118|FG003|COMPLETED|Study Drug Treatment Period||13
10815853|NCT01764997|11979119|FG004|COMPLETED|Study Drug Treatment Period||286
10312887|NCT00146757|11446391|FG001|NOT COMPLETED|Overall Study||0
10312888|NCT00146770|11446399|FG000|STARTED|Overall Study||23
10312889|NCT00146770|11446400|FG001|STARTED|Overall Study||22
10312890|NCT00146770|11446399|FG000|COMPLETED|Overall Study||18
10312891|NCT00146770|11446400|FG001|COMPLETED|Overall Study||22
10312892|NCT00146770|11446399|FG000|NOT COMPLETED|Overall Study||5
10312893|NCT00146770|11446400|FG001|NOT COMPLETED|Overall Study||0
10312894|NCT00146848|11446409|FG000|STARTED|Pre-randomization|Registered|1742
10312895|NCT00146848|11446410|FG001|STARTED|Pre-randomization||0
10408473|NCT00755040|11552558|FG000|COMPLETED|Overall Study||40
10408474|NCT00755040|11552559|FG001|COMPLETED|Overall Study||47
10815854|NCT01764997|11979115|FG000|NOT COMPLETED|Study Drug Treatment Period||0
10815855|NCT01764997|11979116|FG001|NOT COMPLETED|Study Drug Treatment Period||1
10815856|NCT01764997|11979117|FG002|NOT COMPLETED|Study Drug Treatment Period||0
10815857|NCT01764997|11979118|FG003|NOT COMPLETED|Study Drug Treatment Period||0
10815858|NCT01764997|11979119|FG004|NOT COMPLETED|Study Drug Treatment Period||36
10815859|NCT01760941|11979129|FG000|STARTED|Overall Study||1
10815860|NCT01760941|11979129|FG000|COMPLETED|Overall Study||1
10815861|NCT01760941|11979129|FG000|NOT COMPLETED|Overall Study||0
10815862|NCT01769443|11979135|FG000|STARTED|Overall Study||1
10815863|NCT01769443|11979136|FG001|STARTED|Overall Study||1
10735585|NCT02852265|11899897|FG000|STARTED|6-month Follow-up||9
10735586|NCT02852265|11899898|FG001|STARTED|6-month Follow-up||9
10735587|NCT02852265|11899897|FG000|COMPLETED|6-month Follow-up||9
10735588|NCT02852265|11899898|FG001|COMPLETED|6-month Follow-up||9
10735589|NCT02852265|11899897|FG000|NOT COMPLETED|6-month Follow-up||0
10735590|NCT02852265|11899898|FG001|NOT COMPLETED|6-month Follow-up||0
10735591|NCT02852330|11899908|FG000|STARTED|Overall Study||20
10735592|NCT02852330|11899908|FG000|COMPLETED|Overall Study||20
10735593|NCT02852330|11899908|FG000|NOT COMPLETED|Overall Study||0
10735594|NCT02852434|11899914|FG000|STARTED|Overall Study||36
10735595|NCT02852434|11899915|FG001|STARTED|Overall Study||36
10735596|NCT02852434|11899914|FG000|COMPLETED|Overall Study||34
10735597|NCT02852434|11899915|FG001|COMPLETED|Overall Study||35
10735598|NCT02852434|11899914|FG000|NOT COMPLETED|Overall Study||2
10735599|NCT02852434|11899915|FG001|NOT COMPLETED|Overall Study||1
10735600|NCT02853032|11899923|FG000|STARTED|Overall Study||60
10735601|NCT02853032|11899924|FG001|STARTED|Overall Study||59
10735602|NCT02853032|11899923|FG000|COMPLETED|Overall Study|"Evaluable = 10 or more irTMS sessions Completers = 15 or more irTMS sessions"|51
10735603|NCT02853032|11899924|FG001|COMPLETED|Overall Study|"Evaluable = 10 or more irTMS sessions Completers = 15 or more irTMS sessions"|56
10735604|NCT02853032|11899923|FG000|NOT COMPLETED|Overall Study||9
10735605|NCT02853032|11899924|FG001|NOT COMPLETED|Overall Study||3
10735606|NCT02853123|11899932|FG000|STARTED|Treatment Period 1||52
10735607|NCT02853123|11899933|FG001|STARTED|Treatment Period 1||54
10735608|NCT02853123|11899932|FG000|COMPLETED|Treatment Period 1||52
10735609|NCT02853123|11899933|FG001|COMPLETED|Treatment Period 1||51
10735610|NCT02853123|11899932|FG000|NOT COMPLETED|Treatment Period 1||0
10735611|NCT02853123|11899933|FG001|NOT COMPLETED|Treatment Period 1||3
10735612|NCT02853123|11899932|FG000|STARTED|Washout Period||52
10735613|NCT02853123|11899933|FG001|STARTED|Washout Period||51
10735614|NCT02853123|11899932|FG000|COMPLETED|Washout Period||51
10735615|NCT02853123|11899933|FG001|COMPLETED|Washout Period||48
10735616|NCT02853123|11899932|FG000|NOT COMPLETED|Washout Period||1
10735617|NCT02853123|11899933|FG001|NOT COMPLETED|Washout Period||3
10735618|NCT02853123|11899932|FG000|STARTED|Treatment Period 2||51
10735619|NCT02853123|11899933|FG001|STARTED|Treatment Period 2||48
10735620|NCT02853123|11899932|FG000|COMPLETED|Treatment Period 2||51
10735621|NCT02853123|11899933|FG001|COMPLETED|Treatment Period 2||48
10735622|NCT02853123|11899932|FG000|NOT COMPLETED|Treatment Period 2||0
10735623|NCT02853123|11899933|FG001|NOT COMPLETED|Treatment Period 2||0
10735624|NCT02853318|11899940|FG000|STARTED|Overall Study||40
10735625|NCT02853318|11899940|FG000|COMPLETED|Overall Study||39
10735626|NCT02853318|11899940|FG000|NOT COMPLETED|Overall Study||1
10735627|NCT02853435|11899947|FG000|STARTED|Part 1a, Period 1 (3 Days)||9
10735628|NCT02853435|11899948|FG001|STARTED|Part 1a, Period 1 (3 Days)||9
10735629|NCT02853435|11899949|FG002|STARTED|Part 1a, Period 1 (3 Days)||8
10735630|NCT02853435|11899950|FG003|STARTED|Part 1a, Period 1 (3 Days)||0
10735631|NCT02853435|11899951|FG004|STARTED|Part 1a, Period 1 (3 Days)||0
10735632|NCT02853435|11899952|FG005|STARTED|Part 1a, Period 1 (3 Days)||0
10735633|NCT02853435|11899947|FG000|COMPLETED|Part 1a, Period 1 (3 Days)||9
10735634|NCT02853435|11899948|FG001|COMPLETED|Part 1a, Period 1 (3 Days)||9
10735635|NCT02853435|11899949|FG002|COMPLETED|Part 1a, Period 1 (3 Days)||8
10735636|NCT02853435|11899950|FG003|COMPLETED|Part 1a, Period 1 (3 Days)||0
10735637|NCT02853435|11899951|FG004|COMPLETED|Part 1a, Period 1 (3 Days)||0
10735638|NCT02853435|11899952|FG005|COMPLETED|Part 1a, Period 1 (3 Days)||0
10735639|NCT02853435|11899947|FG000|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
10735640|NCT02853435|11899948|FG001|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
10735641|NCT02853435|11899949|FG002|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
10735642|NCT02853435|11899950|FG003|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
10735643|NCT02853435|11899951|FG004|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
10735644|NCT02853435|11899952|FG005|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
10735645|NCT02853435|11899947|FG000|STARTED|Part 1a, Washout Period 1 (3 Days)||9
10735646|NCT02853435|11899948|FG001|STARTED|Part 1a, Washout Period 1 (3 Days)||9
10735647|NCT02853435|11899949|FG002|STARTED|Part 1a, Washout Period 1 (3 Days)||8
10735648|NCT02853435|11899950|FG003|STARTED|Part 1a, Washout Period 1 (3 Days)||0
10735649|NCT02853435|11899951|FG004|STARTED|Part 1a, Washout Period 1 (3 Days)||0
10735650|NCT02853435|11899952|FG005|STARTED|Part 1a, Washout Period 1 (3 Days)||0
10735651|NCT02853435|11899947|FG000|COMPLETED|Part 1a, Washout Period 1 (3 Days)||9
10735652|NCT02853435|11899948|FG001|COMPLETED|Part 1a, Washout Period 1 (3 Days)||9
10735653|NCT02853435|11899949|FG002|COMPLETED|Part 1a, Washout Period 1 (3 Days)||8
10735654|NCT02853435|11899950|FG003|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
10735655|NCT02853435|11899951|FG004|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
10735656|NCT02853435|11899952|FG005|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
10735657|NCT02853435|11899947|FG000|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
10735658|NCT02853435|11899948|FG001|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
10735659|NCT02853435|11899949|FG002|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
10735660|NCT02853435|11899950|FG003|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
10735661|NCT02853435|11899951|FG004|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
10735662|NCT02853435|11899952|FG005|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
10735663|NCT02853435|11899947|FG000|STARTED|Part 1a, Period 2 (3 Days)||9
10735664|NCT02853435|11899948|FG001|STARTED|Part 1a, Period 2 (3 Days)||9
10735665|NCT02853435|11899949|FG002|STARTED|Part 1a, Period 2 (3 Days)||8
10735666|NCT02853435|11899950|FG003|STARTED|Part 1a, Period 2 (3 Days)||0
10735667|NCT02853435|11899951|FG004|STARTED|Part 1a, Period 2 (3 Days)||0
10735668|NCT02853435|11899952|FG005|STARTED|Part 1a, Period 2 (3 Days)||0
10735669|NCT02853435|11899947|FG000|COMPLETED|Part 1a, Period 2 (3 Days)||9
10735670|NCT02853435|11899948|FG001|COMPLETED|Part 1a, Period 2 (3 Days)||9
10735671|NCT02853435|11899949|FG002|COMPLETED|Part 1a, Period 2 (3 Days)||8
10735672|NCT02853435|11899950|FG003|COMPLETED|Part 1a, Period 2 (3 Days)||0
10735673|NCT02853435|11899951|FG004|COMPLETED|Part 1a, Period 2 (3 Days)||0
10735674|NCT02853435|11899952|FG005|COMPLETED|Part 1a, Period 2 (3 Days)||0
10735675|NCT02853435|11899947|FG000|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
10735676|NCT02853435|11899948|FG001|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
10735677|NCT02853435|11899949|FG002|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
10735678|NCT02853435|11899950|FG003|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
10735679|NCT02853435|11899951|FG004|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
10735680|NCT02853435|11899952|FG005|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
10735681|NCT02853435|11899947|FG000|STARTED|Part 1a, Washout Period 2 (3 Days)||9
10735682|NCT02853435|11899948|FG001|STARTED|Part 1a, Washout Period 2 (3 Days)||9
10735683|NCT02853435|11899949|FG002|STARTED|Part 1a, Washout Period 2 (3 Days)||8
10735684|NCT02853435|11899950|FG003|STARTED|Part 1a, Washout Period 2 (3 Days)||0
10735685|NCT02853435|11899951|FG004|STARTED|Part 1a, Washout Period 2 (3 Days)||0
10735686|NCT02853435|11899952|FG005|STARTED|Part 1a, Washout Period 2 (3 Days)||0
10735687|NCT02853435|11899947|FG000|COMPLETED|Part 1a, Washout Period 2 (3 Days)||9
10735688|NCT02853435|11899948|FG001|COMPLETED|Part 1a, Washout Period 2 (3 Days)||9
10735689|NCT02853435|11899949|FG002|COMPLETED|Part 1a, Washout Period 2 (3 Days)||8
10735690|NCT02853435|11899950|FG003|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
10735691|NCT02853435|11899951|FG004|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
10735692|NCT02853435|11899952|FG005|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
10735693|NCT02853435|11899947|FG000|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
10735694|NCT02853435|11899948|FG001|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
10735695|NCT02853435|11899949|FG002|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
10735696|NCT02853435|11899950|FG003|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
10735697|NCT02853435|11899951|FG004|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
10735698|NCT02853435|11899952|FG005|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
10735699|NCT02853435|11899947|FG000|STARTED|Part 1a, Period 3 (3 Days)||9
10735700|NCT02853435|11899948|FG001|STARTED|Part 1a, Period 3 (3 Days)||9
10735701|NCT02853435|11899949|FG002|STARTED|Part 1a, Period 3 (3 Days)||8
10735702|NCT02853435|11899950|FG003|STARTED|Part 1a, Period 3 (3 Days)||0
10735703|NCT02853435|11899951|FG004|STARTED|Part 1a, Period 3 (3 Days)||0
10735704|NCT02853435|11899952|FG005|STARTED|Part 1a, Period 3 (3 Days)||0
10735705|NCT02853435|11899947|FG000|COMPLETED|Part 1a, Period 3 (3 Days)||9
10735706|NCT02853435|11899948|FG001|COMPLETED|Part 1a, Period 3 (3 Days)||9
10735707|NCT02853435|11899949|FG002|COMPLETED|Part 1a, Period 3 (3 Days)||8
10735708|NCT02853435|11899950|FG003|COMPLETED|Part 1a, Period 3 (3 Days)||0
10735709|NCT02853435|11899951|FG004|COMPLETED|Part 1a, Period 3 (3 Days)||0
10735710|NCT02853435|11899952|FG005|COMPLETED|Part 1a, Period 3 (3 Days)||0
10661139|NCT02257177|11822991|FG008|COMPLETED|Overall Study||5
10661140|NCT02257177|11822992|FG009|COMPLETED|Overall Study||4
10661141|NCT02257177|11822993|FG010|COMPLETED|Overall Study||9
10661142|NCT02257177|11822983|FG000|NOT COMPLETED|Overall Study||0
10661143|NCT02257177|11822984|FG001|NOT COMPLETED|Overall Study||0
10661144|NCT02257177|11822985|FG002|NOT COMPLETED|Overall Study||0
10661145|NCT02257177|11822986|FG003|NOT COMPLETED|Overall Study||0
10661146|NCT02257177|11822987|FG004|NOT COMPLETED|Overall Study||0
10661147|NCT02257177|11822988|FG005|NOT COMPLETED|Overall Study||0
10661148|NCT02257177|11822989|FG006|NOT COMPLETED|Overall Study||0
10661149|NCT02257177|11822990|FG007|NOT COMPLETED|Overall Study||0
10661150|NCT02257177|11822991|FG008|NOT COMPLETED|Overall Study||0
10735711|NCT02853435|11899947|FG000|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
10735712|NCT02853435|11899948|FG001|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
10735713|NCT02853435|11899949|FG002|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
10735714|NCT02853435|11899950|FG003|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
10735715|NCT02853435|11899951|FG004|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
10735716|NCT02853435|11899952|FG005|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
10735717|NCT02853435|11899947|FG000|STARTED|Part 2, Period 1 (3 Days)||0
10735718|NCT02853435|11899948|FG001|STARTED|Part 2, Period 1 (3 Days)||0
10735719|NCT02853435|11899949|FG002|STARTED|Part 2, Period 1 (3 Days)||0
10735720|NCT02853435|11899950|FG003|STARTED|Part 2, Period 1 (3 Days)||10
10735721|NCT02853435|11899951|FG004|STARTED|Part 2, Period 1 (3 Days)||0
10735722|NCT02853435|11899952|FG005|STARTED|Part 2, Period 1 (3 Days)||0
10735723|NCT02853435|11899947|FG000|COMPLETED|Part 2, Period 1 (3 Days)||0
10735724|NCT02853435|11899948|FG001|COMPLETED|Part 2, Period 1 (3 Days)||0
10735725|NCT02853435|11899949|FG002|COMPLETED|Part 2, Period 1 (3 Days)||0
10735726|NCT02853435|11899950|FG003|COMPLETED|Part 2, Period 1 (3 Days)||10
10735727|NCT02853435|11899951|FG004|COMPLETED|Part 2, Period 1 (3 Days)||0
10735728|NCT02853435|11899952|FG005|COMPLETED|Part 2, Period 1 (3 Days)||0
10735729|NCT02853435|11899947|FG000|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
10735730|NCT02853435|11899948|FG001|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
10735731|NCT02853435|11899949|FG002|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
10735732|NCT02853435|11899950|FG003|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
10735733|NCT02853435|11899951|FG004|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
10735734|NCT02853435|11899952|FG005|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
10661151|NCT02257177|11822992|FG009|NOT COMPLETED|Overall Study||1
10661152|NCT02257177|11822993|FG010|NOT COMPLETED|Overall Study||0
10735735|NCT02853435|11899947|FG000|STARTED|Part 2, Washout Period 1 (3 Days)||0
10735736|NCT02853435|11899948|FG001|STARTED|Part 2, Washout Period 1 (3 Days)||0
10735737|NCT02853435|11899949|FG002|STARTED|Part 2, Washout Period 1 (3 Days)||0
10735738|NCT02853435|11899950|FG003|STARTED|Part 2, Washout Period 1 (3 Days)||10
10735739|NCT02853435|11899951|FG004|STARTED|Part 2, Washout Period 1 (3 Days)||0
10735740|NCT02853435|11899952|FG005|STARTED|Part 2, Washout Period 1 (3 Days)||0
10735741|NCT02853435|11899947|FG000|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
10735742|NCT02853435|11899948|FG001|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
10735743|NCT02853435|11899949|FG002|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
10735744|NCT02853435|11899950|FG003|COMPLETED|Part 2, Washout Period 1 (3 Days)||10
10735745|NCT02853435|11899951|FG004|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
10735746|NCT02853435|11899952|FG005|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
10735747|NCT02853435|11899947|FG000|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
10735748|NCT02853435|11899948|FG001|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
10735749|NCT02853435|11899949|FG002|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
10735750|NCT02853435|11899950|FG003|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
10735751|NCT02853435|11899951|FG004|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
10735752|NCT02853435|11899952|FG005|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
10735753|NCT02853435|11899947|FG000|STARTED|Part 2, Period 2 (3 Days)||0
10735754|NCT02853435|11899948|FG001|STARTED|Part 2, Period 2 (3 Days)||0
10735755|NCT02853435|11899949|FG002|STARTED|Part 2, Period 2 (3 Days)||0
10735756|NCT02853435|11899950|FG003|STARTED|Part 2, Period 2 (3 Days)||10
10735757|NCT02853435|11899951|FG004|STARTED|Part 2, Period 2 (3 Days)||0
10735758|NCT02853435|11899952|FG005|STARTED|Part 2, Period 2 (3 Days)||0
10735759|NCT02853435|11899947|FG000|COMPLETED|Part 2, Period 2 (3 Days)||0
10735760|NCT02853435|11899948|FG001|COMPLETED|Part 2, Period 2 (3 Days)||0
10735761|NCT02853435|11899949|FG002|COMPLETED|Part 2, Period 2 (3 Days)||0
10735762|NCT02853435|11899950|FG003|COMPLETED|Part 2, Period 2 (3 Days)||10
10735763|NCT02853435|11899951|FG004|COMPLETED|Part 2, Period 2 (3 Days)||0
10735764|NCT02853435|11899952|FG005|COMPLETED|Part 2, Period 2 (3 Days)||0
10735765|NCT02853435|11899947|FG000|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
10735766|NCT02853435|11899948|FG001|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
10735767|NCT02853435|11899949|FG002|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
10735768|NCT02853435|11899950|FG003|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
10815864|NCT01769443|11979135|FG000|COMPLETED|Overall Study||0
10815865|NCT01769443|11979136|FG001|COMPLETED|Overall Study||1
10735769|NCT02853435|11899951|FG004|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
10735770|NCT02853435|11899952|FG005|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
10735771|NCT02853435|11899947|FG000|STARTED|Part 3, Period 1 (3 Days)||0
10735772|NCT02853435|11899948|FG001|STARTED|Part 3, Period 1 (3 Days)||0
10735773|NCT02853435|11899949|FG002|STARTED|Part 3, Period 1 (3 Days)||0
10735774|NCT02853435|11899950|FG003|STARTED|Part 3, Period 1 (3 Days)||0
10408475|NCT00755040|11552558|FG000|NOT COMPLETED|Overall Study||43
10408476|NCT00755040|11552559|FG001|NOT COMPLETED|Overall Study||34
10408477|NCT00755079|11552567|FG000|STARTED|Overall Study||18
10408478|NCT00755079|11552568|FG001|STARTED|Overall Study||22
10735775|NCT02853435|11899951|FG004|STARTED|Part 3, Period 1 (3 Days)||10
10735776|NCT02853435|11899952|FG005|STARTED|Part 3, Period 1 (3 Days)||2
10735777|NCT02853435|11899947|FG000|COMPLETED|Part 3, Period 1 (3 Days)||0
10735778|NCT02853435|11899948|FG001|COMPLETED|Part 3, Period 1 (3 Days)||0
10735779|NCT02853435|11899949|FG002|COMPLETED|Part 3, Period 1 (3 Days)||0
10735780|NCT02853435|11899950|FG003|COMPLETED|Part 3, Period 1 (3 Days)||0
10735781|NCT02853435|11899951|FG004|COMPLETED|Part 3, Period 1 (3 Days)||10
10735782|NCT02853435|11899952|FG005|COMPLETED|Part 3, Period 1 (3 Days)||2
10735783|NCT02853435|11899947|FG000|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
10735784|NCT02853435|11899948|FG001|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
10735785|NCT02853435|11899949|FG002|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
10735786|NCT02853435|11899950|FG003|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
10735787|NCT02853435|11899951|FG004|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
10735788|NCT02853435|11899952|FG005|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
10735789|NCT02853435|11899947|FG000|STARTED|Part 3, Washout Period 1 (3 Days)||0
10735790|NCT02853435|11899948|FG001|STARTED|Part 3, Washout Period 1 (3 Days)||0
10735791|NCT02853435|11899949|FG002|STARTED|Part 3, Washout Period 1 (3 Days)||0
10735792|NCT02853435|11899950|FG003|STARTED|Part 3, Washout Period 1 (3 Days)||0
10735793|NCT02853435|11899951|FG004|STARTED|Part 3, Washout Period 1 (3 Days)||10
10735794|NCT02853435|11899952|FG005|STARTED|Part 3, Washout Period 1 (3 Days)||2
10735795|NCT02853435|11899947|FG000|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
10735796|NCT02853435|11899948|FG001|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
10735797|NCT02853435|11899949|FG002|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
10735798|NCT02853435|11899950|FG003|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
10735799|NCT02853435|11899951|FG004|COMPLETED|Part 3, Washout Period 1 (3 Days)||10
10735800|NCT02853435|11899952|FG005|COMPLETED|Part 3, Washout Period 1 (3 Days)||2
10815866|NCT01769443|11979135|FG000|NOT COMPLETED|Overall Study||1
10815867|NCT01769443|11979136|FG001|NOT COMPLETED|Overall Study||0
10735801|NCT02853435|11899947|FG000|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
10735802|NCT02853435|11899948|FG001|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
10815868|NCT01760889|11979146|FG000|STARTED|Overall Study||0
10815869|NCT01760889|11979147|FG001|STARTED|Overall Study||0
10408479|NCT00755079|11552567|FG000|COMPLETED|Overall Study||17
10408480|NCT00755079|11552568|FG001|COMPLETED|Overall Study||16
10408481|NCT00755079|11552567|FG000|NOT COMPLETED|Overall Study||1
10408482|NCT00755079|11552568|FG001|NOT COMPLETED|Overall Study||6
10735803|NCT02853435|11899949|FG002|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
10735804|NCT02853435|11899950|FG003|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
10735805|NCT02853435|11899951|FG004|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
10735806|NCT02853435|11899952|FG005|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
10735807|NCT02853435|11899947|FG000|STARTED|Part 3, Period 2 (3 Days)||0
10735808|NCT02853435|11899948|FG001|STARTED|Part 3, Period 2 (3 Days)||0
10735809|NCT02853435|11899949|FG002|STARTED|Part 3, Period 2 (3 Days)||0
10735810|NCT02853435|11899950|FG003|STARTED|Part 3, Period 2 (3 Days)||0
10735811|NCT02853435|11899951|FG004|STARTED|Part 3, Period 2 (3 Days)||10
10735812|NCT02853435|11899952|FG005|STARTED|Part 3, Period 2 (3 Days)||2
10735813|NCT02853435|11899947|FG000|COMPLETED|Part 3, Period 2 (3 Days)||0
10735814|NCT02853435|11899948|FG001|COMPLETED|Part 3, Period 2 (3 Days)||0
10735815|NCT02853435|11899949|FG002|COMPLETED|Part 3, Period 2 (3 Days)||0
10735816|NCT02853435|11899950|FG003|COMPLETED|Part 3, Period 2 (3 Days)||0
10735817|NCT02853435|11899951|FG004|COMPLETED|Part 3, Period 2 (3 Days)||10
10735818|NCT02853435|11899952|FG005|COMPLETED|Part 3, Period 2 (3 Days)||2
10735819|NCT02853435|11899947|FG000|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
10735820|NCT02853435|11899948|FG001|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
10735821|NCT02853435|11899949|FG002|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
10735822|NCT02853435|11899950|FG003|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
10735823|NCT02853435|11899951|FG004|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
10735824|NCT02853435|11899952|FG005|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
10735825|NCT02853435|11899947|FG000|STARTED|Part 3, Washout Period 2 (3 Days)||0
10735826|NCT02853435|11899948|FG001|STARTED|Part 3, Washout Period 2 (3 Days)||0
10735827|NCT02853435|11899949|FG002|STARTED|Part 3, Washout Period 2 (3 Days)||0
10735828|NCT02853435|11899950|FG003|STARTED|Part 3, Washout Period 2 (3 Days)||0
10735829|NCT02853435|11899951|FG004|STARTED|Part 3, Washout Period 2 (3 Days)||10
10735830|NCT02853435|11899952|FG005|STARTED|Part 3, Washout Period 2 (3 Days)||2
10735831|NCT02853435|11899947|FG000|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
10735832|NCT02853435|11899948|FG001|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
10735833|NCT02853435|11899949|FG002|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
10735834|NCT02853435|11899950|FG003|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
10735835|NCT02853435|11899951|FG004|COMPLETED|Part 3, Washout Period 2 (3 Days)||9
10735836|NCT02853435|11899952|FG005|COMPLETED|Part 3, Washout Period 2 (3 Days)||2
10735837|NCT02853435|11899947|FG000|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
10735838|NCT02853435|11899948|FG001|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
10735839|NCT02853435|11899949|FG002|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
10735840|NCT02853435|11899950|FG003|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
10735841|NCT02853435|11899951|FG004|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||1
10735842|NCT02853435|11899952|FG005|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
10735843|NCT02853435|11899947|FG000|STARTED|Part 3, Period 3 (3 Days)||0
10735844|NCT02853435|11899948|FG001|STARTED|Part 3, Period 3 (3 Days)||0
10735845|NCT02853435|11899949|FG002|STARTED|Part 3, Period 3 (3 Days)||0
10735846|NCT02853435|11899950|FG003|STARTED|Part 3, Period 3 (3 Days)||0
10735847|NCT02853435|11899951|FG004|STARTED|Part 3, Period 3 (3 Days)||9
10735848|NCT02853435|11899952|FG005|STARTED|Part 3, Period 3 (3 Days)||2
10735849|NCT02853435|11899947|FG000|COMPLETED|Part 3, Period 3 (3 Days)||0
10735850|NCT02853435|11899948|FG001|COMPLETED|Part 3, Period 3 (3 Days)||0
10735851|NCT02853435|11899949|FG002|COMPLETED|Part 3, Period 3 (3 Days)||0
10735852|NCT02853435|11899950|FG003|COMPLETED|Part 3, Period 3 (3 Days)||0
10735853|NCT02853435|11899951|FG004|COMPLETED|Part 3, Period 3 (3 Days)||9
10735854|NCT02853435|11899952|FG005|COMPLETED|Part 3, Period 3 (3 Days)||2
10735855|NCT02853435|11899947|FG000|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
10735856|NCT02853435|11899948|FG001|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
10735857|NCT02853435|11899949|FG002|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
10735858|NCT02853435|11899950|FG003|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
10735859|NCT02853435|11899951|FG004|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
10735860|NCT02853435|11899952|FG005|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
10735861|NCT02853929|11899984|FG000|STARTED|Overall Study||270
10735862|NCT02853929|11899985|FG001|STARTED|Overall Study||281
10735863|NCT02853929|11899984|FG000|Vaccinated|Overall Study||263
10735864|NCT02853929|11899985|FG001|Vaccinated|Overall Study||277
10735865|NCT02853929|11899984|FG000|COMPLETED|Overall Study||259
10735866|NCT02853929|11899985|FG001|COMPLETED|Overall Study||277
10735867|NCT02853929|11899984|FG000|NOT COMPLETED|Overall Study||11
10735868|NCT02853929|11899985|FG001|NOT COMPLETED|Overall Study||4
10735869|NCT02854059|11899993|FG000|STARTED|Overall Study||2
10735870|NCT02854059|11899994|FG001|STARTED|Overall Study||0
10735871|NCT02854059|11899993|FG000|COMPLETED|Overall Study||2
10735872|NCT02854059|11899994|FG001|COMPLETED|Overall Study||0
10735873|NCT02854059|11899993|FG000|NOT COMPLETED|Overall Study||0
10815870|NCT01760889|11979148|FG002|STARTED|Overall Study||0
10815871|NCT01760889|11979146|FG000|COMPLETED|Overall Study||0
10815872|NCT01760889|11979147|FG001|COMPLETED|Overall Study||0
10815873|NCT01760889|11979148|FG002|COMPLETED|Overall Study||0
10815874|NCT01760889|11979146|FG000|NOT COMPLETED|Overall Study||0
10815875|NCT01760889|11979147|FG001|NOT COMPLETED|Overall Study||0
10735874|NCT02854059|11899994|FG001|NOT COMPLETED|Overall Study||0
10735875|NCT02854527|11900010|FG000|STARTED|Overall Study||3
10735876|NCT02854527|11900011|FG001|STARTED|Overall Study||3
10735877|NCT02854527|11900012|FG002|STARTED|Overall Study||3
10735878|NCT02854527|11900013|FG003|STARTED|Overall Study||3
10815876|NCT01760889|11979148|FG002|NOT COMPLETED|Overall Study||0
10815877|NCT01749826|11979158|FG000|STARTED|Overall Study||20
10735879|NCT02854527|11900014|FG004|STARTED|Overall Study||3
10735880|NCT02854527|11900015|FG005|STARTED|Overall Study||3
10735881|NCT02854527|11900016|FG006|STARTED|Overall Study||3
10735882|NCT02854527|11900017|FG007|STARTED|Overall Study||3
10735883|NCT02854527|11900018|FG008|STARTED|Overall Study||3
10735884|NCT02854527|11900019|FG009|STARTED|Overall Study||3
10735885|NCT02854527|11900010|FG000|Received R1|Overall Study||3
10735886|NCT02854527|11900011|FG001|Received R1|Overall Study||3
10735887|NCT02854527|11900012|FG002|Received R1|Overall Study||3
10735888|NCT02854527|11900013|FG003|Received R1|Overall Study||2
10735889|NCT02854527|11900014|FG004|Received R1|Overall Study||2
10735890|NCT02854527|11900015|FG005|Received R1|Overall Study||3
10735891|NCT02854527|11900016|FG006|Received R1|Overall Study||3
10735892|NCT02854527|11900017|FG007|Received R1|Overall Study||3
10735893|NCT02854527|11900018|FG008|Received R1|Overall Study||3
10735894|NCT02854527|11900019|FG009|Received R1|Overall Study||3
10735895|NCT02854527|11900010|FG000|Received R2|Overall Study||3
10735896|NCT02854527|11900011|FG001|Received R2|Overall Study||3
10735897|NCT02854527|11900012|FG002|Received R2|Overall Study||3
10735898|NCT02854527|11900013|FG003|Received R2|Overall Study||3
10735899|NCT02854527|11900014|FG004|Received R2|Overall Study||3
10735900|NCT02854527|11900015|FG005|Received R2|Overall Study||3
10735901|NCT02854527|11900016|FG006|Received R2|Overall Study||3
10735902|NCT02854527|11900017|FG007|Received R2|Overall Study||3
10735903|NCT02854527|11900018|FG008|Received R2|Overall Study||3
10735904|NCT02854527|11900019|FG009|Received R2|Overall Study||3
10735905|NCT02854527|11900010|FG000|Received R3|Overall Study||3
10735906|NCT02854527|11900011|FG001|Received R3|Overall Study||3
10735907|NCT02854527|11900012|FG002|Received R3|Overall Study||3
10735908|NCT02854527|11900013|FG003|Received R3|Overall Study||2
10735909|NCT02854527|11900014|FG004|Received R3|Overall Study||3
10735910|NCT02854527|11900015|FG005|Received R3|Overall Study||3
10735911|NCT02854527|11900016|FG006|Received R3|Overall Study||3
10735912|NCT02854527|11900017|FG007|Received R3|Overall Study||3
10735913|NCT02854527|11900018|FG008|Received R3|Overall Study||3
10735914|NCT02854527|11900019|FG009|Received R3|Overall Study||3
10735915|NCT02854527|11900010|FG000|Received R4|Overall Study||3
10735916|NCT02854527|11900011|FG001|Received R4|Overall Study||3
10735917|NCT02854527|11900012|FG002|Received R4|Overall Study||3
10735918|NCT02854527|11900013|FG003|Received R4|Overall Study||2
10735919|NCT02854527|11900014|FG004|Received R4|Overall Study||3
10735920|NCT02854527|11900015|FG005|Received R4|Overall Study||3
10735921|NCT02854527|11900016|FG006|Received R4|Overall Study||3
10735922|NCT02854527|11900017|FG007|Received R4|Overall Study||3
10735923|NCT02854527|11900018|FG008|Received R4|Overall Study||3
10735924|NCT02854527|11900019|FG009|Received R4|Overall Study||3
10735925|NCT02854527|11900010|FG000|Received T|Overall Study||3
10735926|NCT02854527|11900011|FG001|Received T|Overall Study||3
10735927|NCT02854527|11900012|FG002|Received T|Overall Study||3
10735928|NCT02854527|11900013|FG003|Received T|Overall Study||2
10735929|NCT02854527|11900014|FG004|Received T|Overall Study||2
10735930|NCT02854527|11900015|FG005|Received T|Overall Study||3
10735931|NCT02854527|11900016|FG006|Received T|Overall Study||3
10735932|NCT02854527|11900017|FG007|Received T|Overall Study||3
10735933|NCT02854527|11900018|FG008|Received T|Overall Study||3
10735934|NCT02854527|11900019|FG009|Received T|Overall Study||3
10735935|NCT02854527|11900010|FG000|COMPLETED|Overall Study||3
10735936|NCT02854527|11900011|FG001|COMPLETED|Overall Study||3
10735937|NCT02854527|11900012|FG002|COMPLETED|Overall Study||3
10735938|NCT02854527|11900013|FG003|COMPLETED|Overall Study||2
10735939|NCT02854527|11900014|FG004|COMPLETED|Overall Study||2
10735940|NCT02854527|11900015|FG005|COMPLETED|Overall Study||3
10735941|NCT02854527|11900016|FG006|COMPLETED|Overall Study||3
10735942|NCT02854527|11900017|FG007|COMPLETED|Overall Study||3
10735943|NCT02854527|11900018|FG008|COMPLETED|Overall Study||3
10735944|NCT02854527|11900019|FG009|COMPLETED|Overall Study||3
10735945|NCT02854527|11900010|FG000|NOT COMPLETED|Overall Study||0
10735946|NCT02854527|11900011|FG001|NOT COMPLETED|Overall Study||0
10735947|NCT02854527|11900012|FG002|NOT COMPLETED|Overall Study||0
10735948|NCT02854527|11900013|FG003|NOT COMPLETED|Overall Study||1
10735949|NCT02854527|11900014|FG004|NOT COMPLETED|Overall Study||1
10735950|NCT02854527|11900015|FG005|NOT COMPLETED|Overall Study||0
10735951|NCT02854527|11900016|FG006|NOT COMPLETED|Overall Study||0
10735952|NCT02854527|11900017|FG007|NOT COMPLETED|Overall Study||0
10735953|NCT02854527|11900018|FG008|NOT COMPLETED|Overall Study||0
10735954|NCT02854527|11900019|FG009|NOT COMPLETED|Overall Study||0
10735955|NCT02854540|11900031|FG000|STARTED|Overall Study||13
10735956|NCT02854540|11900031|FG000|COMPLETED|Overall Study||11
10735957|NCT02854540|11900031|FG000|NOT COMPLETED|Overall Study||2
10735958|NCT02854605|11900040|FG000|STARTED|Overall Study||56
10735959|NCT02854605|11900041|FG001|STARTED|Overall Study||56
10735960|NCT02854605|11900042|FG002|STARTED|Overall Study||28
10735961|NCT02854605|11900040|FG000|COMPLETED|Overall Study||53
10735962|NCT02854605|11900041|FG001|COMPLETED|Overall Study||49
10735963|NCT02854605|11900042|FG002|COMPLETED|Overall Study||24
10735964|NCT02854605|11900040|FG000|NOT COMPLETED|Overall Study||3
10735965|NCT02854605|11900041|FG001|NOT COMPLETED|Overall Study||7
10735966|NCT02854605|11900042|FG002|NOT COMPLETED|Overall Study||4
10735967|NCT02854631|11900052|FG000|STARTED|Overall Study||52
10735968|NCT02854631|11900053|FG001|STARTED|Overall Study||52
10735969|NCT02854631|11900052|FG000|COMPLETED|Overall Study||26
10735970|NCT02854631|11900053|FG001|COMPLETED|Overall Study||37
10735971|NCT02854631|11900052|FG000|NOT COMPLETED|Overall Study||26
10735972|NCT02854631|11900053|FG001|NOT COMPLETED|Overall Study||15
10735973|NCT02854800|11900062|FG000|STARTED|Overall Study||32
10735974|NCT02854800|11900063|FG001|STARTED|Overall Study||28
10735975|NCT02854800|11900064|FG002|STARTED|Overall Study||14
10735976|NCT02854800|11900062|FG000|COMPLETED|Overall Study||12
10735977|NCT02854800|11900063|FG001|COMPLETED|Overall Study||15
10735978|NCT02854800|11900064|FG002|COMPLETED|Overall Study||8
10735979|NCT02854800|11900062|FG000|NOT COMPLETED|Overall Study||20
10735980|NCT02854800|11900063|FG001|NOT COMPLETED|Overall Study||13
10735981|NCT02854800|11900064|FG002|NOT COMPLETED|Overall Study||6
10735982|NCT02855086|11900077|FG000|STARTED|Overall Study||2
10735983|NCT02855086|11900078|FG001|STARTED|Overall Study||1
10735984|NCT02855086|11900077|FG000|COMPLETED|Overall Study||2
10735985|NCT02855086|11900078|FG001|COMPLETED|Overall Study||1
10735986|NCT02855086|11900077|FG000|NOT COMPLETED|Overall Study||0
10735987|NCT02855086|11900078|FG001|NOT COMPLETED|Overall Study||0
10735988|NCT02855164|11900092|FG000|STARTED|Parts A + B (Randomized Set)||14
10735989|NCT02855164|11900093|FG001|STARTED|Parts A + B (Randomized Set)||16
10735990|NCT02855164|11900094|FG002|STARTED|Parts A + B (Randomized Set)||37
10735991|NCT02855164|11900095|FG003|STARTED|Parts A + B (Randomized Set)||85
10735992|NCT02855164|11900096|FG004|STARTED|Parts A + B (Randomized Set)||46
10815878|NCT01749826|11979159|FG001|STARTED|Overall Study||0
10815879|NCT01749826|11979158|FG000|COMPLETED|Overall Study||0
10815880|NCT01749826|11979159|FG001|COMPLETED|Overall Study||0
10815881|NCT01749826|11979158|FG000|NOT COMPLETED|Overall Study||20
10815882|NCT01749826|11979159|FG001|NOT COMPLETED|Overall Study||0
10815883|NCT01756586|11979167|FG000|STARTED|Overall Study||2
10815884|NCT01756586|11979168|FG001|STARTED|Overall Study||2
10815885|NCT01756586|11979167|FG000|COMPLETED|Overall Study||0
10815886|NCT01756586|11979168|FG001|COMPLETED|Overall Study||0
10815887|NCT01756586|11979167|FG000|NOT COMPLETED|Overall Study||2
10815888|NCT01756586|11979168|FG001|NOT COMPLETED|Overall Study||2
10815889|NCT01754987|11979176|FG000|STARTED|Overall Study||5
10815890|NCT01754987|11979177|FG001|STARTED|Overall Study||0
10815891|NCT01754987|11979176|FG000|COMPLETED|Overall Study||5
10815892|NCT01754987|11979177|FG001|COMPLETED|Overall Study||0
10815893|NCT01754987|11979176|FG000|NOT COMPLETED|Overall Study||0
10815894|NCT01754987|11979177|FG001|NOT COMPLETED|Overall Study||0
10815895|NCT01756560|11979185|FG000|STARTED|Overall Study||2
10815896|NCT01756560|11979186|FG001|STARTED|Overall Study||0
10815897|NCT01756560|11979185|FG000|COMPLETED|Overall Study||0
10815898|NCT01756560|11979186|FG001|COMPLETED|Overall Study||0
10815899|NCT01756560|11979185|FG000|NOT COMPLETED|Overall Study||2
10815900|NCT01756560|11979186|FG001|NOT COMPLETED|Overall Study||0
10815901|NCT01756573|11979195|FG000|STARTED|Overall Study||3
10815902|NCT01756573|11979196|FG001|STARTED|Overall Study||1
10815903|NCT01756573|11979197|FG002|STARTED|Overall Study||1
10815904|NCT01756573|11979195|FG000|COMPLETED|Overall Study||3
10815905|NCT01756573|11979196|FG001|COMPLETED|Overall Study||1
10815906|NCT01756573|11979197|FG002|COMPLETED|Overall Study||1
10815907|NCT01756573|11979195|FG000|NOT COMPLETED|Overall Study||0
10815908|NCT01756573|11979196|FG001|NOT COMPLETED|Overall Study||0
10815909|NCT01756573|11979197|FG002|NOT COMPLETED|Overall Study||0
10815910|NCT01745913|11979207|FG000|STARTED|Overall Study||1
10815911|NCT01745913|11979208|FG001|STARTED|Overall Study||1
10815912|NCT01745913|11979207|FG000|COMPLETED|Overall Study||0
10815913|NCT01745913|11979208|FG001|COMPLETED|Overall Study||0
10815914|NCT01745913|11979207|FG000|NOT COMPLETED|Overall Study||1
10815915|NCT01745913|11979208|FG001|NOT COMPLETED|Overall Study||1
10815916|NCT01752023|11979220|FG000|STARTED|Overall Study||2
10815917|NCT01752023|11979221|FG001|STARTED|Overall Study||1
10815918|NCT01752023|11979220|FG000|COMPLETED|Overall Study||0
10815919|NCT01752023|11979221|FG001|COMPLETED|Overall Study||0
10815920|NCT01752023|11979220|FG000|NOT COMPLETED|Overall Study||2
10815921|NCT01752023|11979221|FG001|NOT COMPLETED|Overall Study||1
10815922|NCT01740154|11979231|FG000|STARTED|Overall Study||13
10815923|NCT01740154|11979231|FG000|COMPLETED|Overall Study||12
10815924|NCT01740154|11979231|FG000|NOT COMPLETED|Overall Study||1
10815925|NCT01748890|11979235|FG000|STARTED|Overall Study||4
10815926|NCT01748890|11979235|FG000|COMPLETED|Overall Study|Insufficient recruitment for analysis|0
10815927|NCT01748890|11979235|FG000|NOT COMPLETED|Overall Study||4
10815928|NCT01748162|11979241|FG000|STARTED|Overall Study||5
10815929|NCT01748162|11979242|FG001|STARTED|Overall Study||5
10815930|NCT01748162|11979241|FG000|Started 6 Month Initial Treatment Plan|Overall Study||2
10815931|NCT01748162|11979242|FG001|Started 6 Month Initial Treatment Plan|Overall Study||2
10815932|NCT01748162|11979241|FG000|Completed 6 Month Initial Treatment|Overall Study||0
10815933|NCT01748162|11979242|FG001|Completed 6 Month Initial Treatment|Overall Study||0
10815934|NCT01748162|11979241|FG000|Started 6 Month Followup|Overall Study|No participants in either arm had additional croup episodes in the first 6 months; study terminated.|0
10815935|NCT01748162|11979242|FG001|Started 6 Month Followup|Overall Study|No participants in either arm had additional croup episodes in the first 6 months; study terminated.|0
10815936|NCT01748162|11979241|FG000|COMPLETED|Overall Study||0
10815937|NCT01748162|11979242|FG001|COMPLETED|Overall Study||0
10815938|NCT01748162|11979241|FG000|NOT COMPLETED|Overall Study||5
10815939|NCT01748162|11979242|FG001|NOT COMPLETED|Overall Study||5
10815940|NCT01738698|11979252|FG000|STARTED|Overall Study||0
10815941|NCT01738698|11979253|FG001|STARTED|Overall Study||0
10735993|NCT02855164|11900097|FG005|STARTED|Parts A + B (Randomized Set)||0
10735994|NCT02855164|11900098|FG006|STARTED|Parts A + B (Randomized Set)||0
10815942|NCT01738698|11979254|FG002|STARTED|Overall Study||0
10815943|NCT01738698|11979255|FG003|STARTED|Overall Study||0
10815944|NCT01738698|11979252|FG000|COMPLETED|Overall Study||0
10735995|NCT02855164|11900099|FG007|STARTED|Parts A + B (Randomized Set)||0
10735996|NCT02855164|11900092|FG000|COMPLETED|Parts A + B (Randomized Set)||14
10735997|NCT02855164|11900093|FG001|COMPLETED|Parts A + B (Randomized Set)||16
10735998|NCT02855164|11900094|FG002|COMPLETED|Parts A + B (Randomized Set)||36
10735999|NCT02855164|11900095|FG003|COMPLETED|Parts A + B (Randomized Set)||77
10736000|NCT02855164|11900096|FG004|COMPLETED|Parts A + B (Randomized Set)||45
10736001|NCT02855164|11900097|FG005|COMPLETED|Parts A + B (Randomized Set)||0
10736002|NCT02855164|11900098|FG006|COMPLETED|Parts A + B (Randomized Set)||0
10736003|NCT02855164|11900099|FG007|COMPLETED|Parts A + B (Randomized Set)||0
10736004|NCT02855164|11900092|FG000|NOT COMPLETED|Parts A + B (Randomized Set)||0
10736005|NCT02855164|11900093|FG001|NOT COMPLETED|Parts A + B (Randomized Set)||0
10736006|NCT02855164|11900094|FG002|NOT COMPLETED|Parts A + B (Randomized Set)||1
10736007|NCT02855164|11900095|FG003|NOT COMPLETED|Parts A + B (Randomized Set)||8
10736008|NCT02855164|11900096|FG004|NOT COMPLETED|Parts A + B (Randomized Set)||1
10736009|NCT02855164|11900097|FG005|NOT COMPLETED|Parts A + B (Randomized Set)||0
10736010|NCT02855164|11900098|FG006|NOT COMPLETED|Parts A + B (Randomized Set)||0
10736011|NCT02855164|11900099|FG007|NOT COMPLETED|Parts A + B (Randomized Set)||0
10736012|NCT02855164|11900092|FG000|STARTED|Part C (Randomized Set)||0
10736013|NCT02855164|11900093|FG001|STARTED|Part C (Randomized Set)||0
10736014|NCT02855164|11900094|FG002|STARTED|Part C (Randomized Set)||0
10736015|NCT02855164|11900095|FG003|STARTED|Part C (Randomized Set)||0
10736016|NCT02855164|11900096|FG004|STARTED|Part C (Randomized Set)||0
10736017|NCT02855164|11900097|FG005|STARTED|Part C (Randomized Set)||50
10736018|NCT02855164|11900098|FG006|STARTED|Part C (Randomized Set)||51
10736019|NCT02855164|11900099|FG007|STARTED|Part C (Randomized Set)||51
10736020|NCT02855164|11900092|FG000|COMPLETED|Part C (Randomized Set)||0
10736021|NCT02855164|11900093|FG001|COMPLETED|Part C (Randomized Set)||0
10736022|NCT02855164|11900094|FG002|COMPLETED|Part C (Randomized Set)||0
10736023|NCT02855164|11900095|FG003|COMPLETED|Part C (Randomized Set)||0
10736024|NCT02855164|11900096|FG004|COMPLETED|Part C (Randomized Set)||0
10736025|NCT02855164|11900097|FG005|COMPLETED|Part C (Randomized Set)||38
10736026|NCT02855164|11900098|FG006|COMPLETED|Part C (Randomized Set)||37
10736027|NCT02855164|11900099|FG007|COMPLETED|Part C (Randomized Set)||44
10736028|NCT02855164|11900092|FG000|NOT COMPLETED|Part C (Randomized Set)||0
10736029|NCT02855164|11900093|FG001|NOT COMPLETED|Part C (Randomized Set)||0
10736030|NCT02855164|11900094|FG002|NOT COMPLETED|Part C (Randomized Set)||0
10736031|NCT02855164|11900095|FG003|NOT COMPLETED|Part C (Randomized Set)||0
10736032|NCT02855164|11900096|FG004|NOT COMPLETED|Part C (Randomized Set)||0
10736033|NCT02855164|11900097|FG005|NOT COMPLETED|Part C (Randomized Set)||12
10736034|NCT02855164|11900098|FG006|NOT COMPLETED|Part C (Randomized Set)||14
10736035|NCT02855164|11900099|FG007|NOT COMPLETED|Part C (Randomized Set)||7
10736036|NCT02855281|11900137|FG000|STARTED|Overall Study||50
10736037|NCT02855281|11900137|FG000|COMPLETED|Overall Study||50
10736038|NCT02855281|11900137|FG000|NOT COMPLETED|Overall Study||0
10736039|NCT02855359|11900147|FG000|STARTED|Overall Study||11
10736040|NCT02855359|11900148|FG001|STARTED|Overall Study||13
10736041|NCT02855359|11900149|FG002|STARTED|Overall Study||0
10736042|NCT02855359|11900150|FG003|STARTED|Overall Study||0
10736043|NCT02855359|11900147|FG000|COMPLETED|Overall Study||0
10736044|NCT02855359|11900148|FG001|COMPLETED|Overall Study||0
10736045|NCT02855359|11900149|FG002|COMPLETED|Overall Study||0
10736046|NCT02855359|11900150|FG003|COMPLETED|Overall Study||0
10736047|NCT02855359|11900147|FG000|NOT COMPLETED|Overall Study||11
10736048|NCT02855359|11900148|FG001|NOT COMPLETED|Overall Study||13
10736049|NCT02855359|11900149|FG002|NOT COMPLETED|Overall Study||0
10736050|NCT02855359|11900150|FG003|NOT COMPLETED|Overall Study||0
10736051|NCT02855437|11900158|FG000|STARTED|Phase 1||23
10736052|NCT02855437|11900159|FG001|STARTED|Phase 1||21
10736053|NCT02855437|11900158|FG000|COMPLETED|Phase 1||21
10736054|NCT02855437|11900159|FG001|COMPLETED|Phase 1||19
10736055|NCT02855437|11900158|FG000|NOT COMPLETED|Phase 1||2
10736056|NCT02855437|11900159|FG001|NOT COMPLETED|Phase 1||2
10736057|NCT02855437|11900158|FG000|STARTED|Crossover Period (Same Day)||21
10736058|NCT02855437|11900159|FG001|STARTED|Crossover Period (Same Day)||19
10736059|NCT02855437|11900158|FG000|COMPLETED|Crossover Period (Same Day)||21
10736060|NCT02855437|11900159|FG001|COMPLETED|Crossover Period (Same Day)||19
10736061|NCT02855437|11900158|FG000|NOT COMPLETED|Crossover Period (Same Day)||0
10736062|NCT02855437|11900159|FG001|NOT COMPLETED|Crossover Period (Same Day)||0
10736063|NCT02855437|11900158|FG000|STARTED|Phase 2||21
10736064|NCT02855437|11900159|FG001|STARTED|Phase 2||19
10736065|NCT02855437|11900158|FG000|COMPLETED|Phase 2||20
10736066|NCT02855437|11900159|FG001|COMPLETED|Phase 2||18
10736067|NCT02855437|11900158|FG000|NOT COMPLETED|Phase 2||1
10736068|NCT02855437|11900159|FG001|NOT COMPLETED|Phase 2||1
10736069|NCT02855450|11900168|FG000|STARTED|Overall Study||40
10736070|NCT02855450|11900169|FG001|STARTED|Overall Study||20
10736071|NCT02855450|11900168|FG000|COMPLETED|Overall Study||35
10736072|NCT02855450|11900169|FG001|COMPLETED|Overall Study||20
10736073|NCT02855450|11900168|FG000|NOT COMPLETED|Overall Study||5
10736074|NCT02855450|11900169|FG001|NOT COMPLETED|Overall Study||0
10736075|NCT02855541|11900175|FG000|STARTED|Overall Study||25
10736076|NCT02855541|11900175|FG000|COMPLETED|Overall Study||21
10736077|NCT02855541|11900175|FG000|NOT COMPLETED|Overall Study||4
10736078|NCT02855567|11900181|FG000|STARTED|Overall Study||54
10736079|NCT02855567|11900182|FG001|STARTED|Overall Study||56
10736080|NCT02855567|11900181|FG000|COMPLETED|Overall Study||54
10736081|NCT02855567|11900182|FG001|COMPLETED|Overall Study||56
10736082|NCT02855567|11900181|FG000|NOT COMPLETED|Overall Study||0
10736083|NCT02855567|11900182|FG001|NOT COMPLETED|Overall Study||0
10736084|NCT02856035|11900188|FG000|STARTED|Overall Study||4
10736085|NCT02856035|11900188|FG000|COMPLETED|Overall Study||4
10736086|NCT02856035|11900188|FG000|NOT COMPLETED|Overall Study||0
10736087|NCT02856282|11900192|FG000|STARTED|Overall Study||46
10736088|NCT02856282|11900192|FG000|COMPLETED|Overall Study||45
10736089|NCT02856282|11900192|FG000|NOT COMPLETED|Overall Study||1
10736090|NCT02856490|11900199|FG000|STARTED|Overall Study||2
10736091|NCT02856490|11900200|FG001|STARTED|Overall Study||2
10736092|NCT02856490|11900201|FG002|STARTED|Overall Study||2
10736093|NCT02856490|11900199|FG000|COMPLETED|Overall Study||2
10736094|NCT02856490|11900200|FG001|COMPLETED|Overall Study||2
10736095|NCT02856490|11900201|FG002|COMPLETED|Overall Study||2
10736096|NCT02856490|11900199|FG000|NOT COMPLETED|Overall Study||0
10736097|NCT02856490|11900200|FG001|NOT COMPLETED|Overall Study||0
10736098|NCT02856490|11900201|FG002|NOT COMPLETED|Overall Study||0
10736099|NCT02856555|11900212|FG000|STARTED|Overall Study||51
10736100|NCT02856555|11900213|FG001|STARTED|Overall Study||50
10736101|NCT02856555|11900214|FG002|STARTED|Overall Study||26
10736102|NCT02856555|11900212|FG000|COMPLETED|Overall Study||46
10736103|NCT02856555|11900213|FG001|COMPLETED|Overall Study||46
10736104|NCT02856555|11900214|FG002|COMPLETED|Overall Study||26
10736105|NCT02856555|11900212|FG000|NOT COMPLETED|Overall Study||5
10736106|NCT02856555|11900213|FG001|NOT COMPLETED|Overall Study||4
10736107|NCT02856555|11900214|FG002|NOT COMPLETED|Overall Study||0
10736108|NCT02856802|11900224|FG000|STARTED|Double-Blind Treatment Period 1|4 of 54 randomized subjects did not start; 2 had no migraines, 1 withdrew, 1 lost to follow-up.|50
10736109|NCT02856802|11900225|FG001|STARTED|Double-Blind Treatment Period 1|10 of 53 randomized subjects did not start; 6 had no migraines, 3 withdrew, 1 sponsor terminated.|43
10736110|NCT02856802|11900224|FG000|COMPLETED|Double-Blind Treatment Period 1||48
10736111|NCT02856802|11900225|FG001|COMPLETED|Double-Blind Treatment Period 1||38
10736112|NCT02856802|11900224|FG000|NOT COMPLETED|Double-Blind Treatment Period 1||2
10736113|NCT02856802|11900225|FG001|NOT COMPLETED|Double-Blind Treatment Period 1||5
10736114|NCT02856802|11900224|FG000|STARTED|Double-Blind Treatment Period 2|6 of 43 re-randomized subjects did not start; 5 had no migraines, for 1 protocol deviation.|37
10736115|NCT02856802|11900225|FG001|STARTED|Double-Blind Treatment Period 2|5 of 43 re-randomized subjects did not start; 4 had no migraines, for 1 prohibited drug use.|38
10736116|NCT02856802|11900224|FG000|COMPLETED|Double-Blind Treatment Period 2||36
10736117|NCT02856802|11900225|FG001|COMPLETED|Double-Blind Treatment Period 2||38
10736118|NCT02856802|11900224|FG000|NOT COMPLETED|Double-Blind Treatment Period 2||1
10736119|NCT02856802|11900225|FG001|NOT COMPLETED|Double-Blind Treatment Period 2||0
10736120|NCT02856828|11900237|FG000|STARTED|Overall Study||2
10736121|NCT02856828|11900238|FG001|STARTED|Overall Study||3
10736122|NCT02856828|11900237|FG000|COMPLETED|Overall Study||2
10736123|NCT02856828|11900238|FG001|COMPLETED|Overall Study||3
10736124|NCT02856828|11900237|FG000|NOT COMPLETED|Overall Study||0
10736125|NCT02856828|11900238|FG001|NOT COMPLETED|Overall Study||0
10736126|NCT02856880|11900252|FG000|STARTED|Overall Study||45
10736127|NCT02856880|11900252|FG000|Received Test Zinc-IPMP|Overall Study||44
10736128|NCT02856880|11900252|FG000|Received Test Zinc Non-IPMP|Overall Study||44
10736129|NCT02856880|11900252|FG000|Received Positive Control|Overall Study||45
10736130|NCT02856880|11900252|FG000|Received Non-SLS Negative Control|Overall Study||44
10736131|NCT02856880|11900252|FG000|Received SLS Negative Control|Overall Study||44
10736132|NCT02856880|11900252|FG000|COMPLETED|Overall Study||44
10736133|NCT02856880|11900252|FG000|NOT COMPLETED|Overall Study||1
10736134|NCT02857283|11900273|FG000|STARTED|First Exposure||8
10736135|NCT02857283|11900274|FG001|STARTED|First Exposure||7
10736136|NCT02857283|11900273|FG000|COMPLETED|First Exposure||7
10736137|NCT02857283|11900274|FG001|COMPLETED|First Exposure||7
10736138|NCT02857283|11900273|FG000|NOT COMPLETED|First Exposure||1
10736139|NCT02857283|11900274|FG001|NOT COMPLETED|First Exposure||0
10736140|NCT02857283|11900273|FG000|STARTED|Washout (2 Weeks)||7
10736141|NCT02857283|11900274|FG001|STARTED|Washout (2 Weeks)||7
10736142|NCT02857283|11900273|FG000|COMPLETED|Washout (2 Weeks)||7
10736143|NCT02857283|11900274|FG001|COMPLETED|Washout (2 Weeks)||7
10736144|NCT02857283|11900273|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10736145|NCT02857283|11900274|FG001|NOT COMPLETED|Washout (2 Weeks)||0
10736146|NCT02857283|11900273|FG000|STARTED|Second Exposure||7
10736147|NCT02857283|11900274|FG001|STARTED|Second Exposure||7
10736148|NCT02857283|11900273|FG000|COMPLETED|Second Exposure||7
10736149|NCT02857283|11900274|FG001|COMPLETED|Second Exposure||7
10736150|NCT02857283|11900273|FG000|NOT COMPLETED|Second Exposure||0
10736151|NCT02857283|11900274|FG001|NOT COMPLETED|Second Exposure||0
10736152|NCT02857816|11900281|FG000|STARTED|Overall Study||154
10736153|NCT02857816|11900281|FG000|Subjects Qualified and Treated With PTNM|Overall Study||120
10736154|NCT02857816|11900281|FG000|COMPLETED|Overall Study||116
10736155|NCT02857816|11900281|FG000|NOT COMPLETED|Overall Study||38
10736156|NCT02858050|11900288|FG000|STARTED|Overall Study||20
10736157|NCT02858050|11900289|FG001|STARTED|Overall Study||20
10736158|NCT02858050|11900288|FG000|COMPLETED|Overall Study||20
10736159|NCT02858050|11900289|FG001|COMPLETED|Overall Study||20
10736160|NCT02858050|11900288|FG000|NOT COMPLETED|Overall Study||0
10736161|NCT02858050|11900289|FG001|NOT COMPLETED|Overall Study||0
10736162|NCT02858076|11900297|FG000|STARTED|Overall Study||100
10736163|NCT02858076|11900298|FG001|STARTED|Overall Study||105
10736164|NCT02858076|11900297|FG000|COMPLETED|Overall Study||90
10736165|NCT02858076|11900298|FG001|COMPLETED|Overall Study||87
10736166|NCT02858076|11900297|FG000|NOT COMPLETED|Overall Study||10
10736167|NCT02858076|11900298|FG001|NOT COMPLETED|Overall Study||18
10736168|NCT02858180|11900308|FG000|STARTED|Overall Study||10
10736169|NCT02858180|11900309|FG001|STARTED|Overall Study||5
10736170|NCT02858180|11900308|FG000|COMPLETED|Overall Study|Completed a 12-week course of therapy.|10
10736171|NCT02858180|11900309|FG001|COMPLETED|Overall Study|Completed a 12-week course of therapy.|3
10736172|NCT02858180|11900308|FG000|NOT COMPLETED|Overall Study||0
10736173|NCT02858180|11900309|FG001|NOT COMPLETED|Overall Study||2
10736174|NCT02858349|11900315|FG000|STARTED|Overall Study||10
10736175|NCT02858349|11900315|FG000|COMPLETED|Overall Study||10
10736176|NCT02858349|11900315|FG000|NOT COMPLETED|Overall Study||0
10777988|NCT03346902|11939881|FG000|STARTED|Overall Study||4
10777989|NCT03346902|11939882|FG001|STARTED|Overall Study||8
10777990|NCT03346902|11939881|FG000|COMPLETED|Overall Study||4
10777991|NCT03346902|11939882|FG001|COMPLETED|Overall Study||8
10777992|NCT03346902|11939881|FG000|NOT COMPLETED|Overall Study||0
10777993|NCT03346902|11939882|FG001|NOT COMPLETED|Overall Study||0
10777994|NCT03347188|11939890|FG000|STARTED|Double-blind (DB) Period (12 Weeks)||44
10777995|NCT03347188|11939891|FG001|STARTED|Double-blind (DB) Period (12 Weeks)||43
10777996|NCT03347188|11939890|FG000|Received at Least 1 Dose of Study Drug|Double-blind (DB) Period (12 Weeks)||43
10777997|NCT03347188|11939891|FG001|Received at Least 1 Dose of Study Drug|Double-blind (DB) Period (12 Weeks)||43
10777998|NCT03347188|11939890|FG000|Full Analysis Set (FAS)|Double-blind (DB) Period (12 Weeks)||42
10777999|NCT03347188|11939891|FG001|Full Analysis Set (FAS)|Double-blind (DB) Period (12 Weeks)||43
10778000|NCT03347188|11939890|FG000|COMPLETED|Double-blind (DB) Period (12 Weeks)||29
10778001|NCT03347188|11939891|FG001|COMPLETED|Double-blind (DB) Period (12 Weeks)||26
10778002|NCT03347188|11939890|FG000|NOT COMPLETED|Double-blind (DB) Period (12 Weeks)||15
10778003|NCT03347188|11939891|FG001|NOT COMPLETED|Double-blind (DB) Period (12 Weeks)||17
10778004|NCT03347188|11939890|FG000|STARTED|Open-label (OL) Period (12 Weeks)||35
10778005|NCT03347188|11939891|FG001|STARTED|Open-label (OL) Period (12 Weeks)||35
10778006|NCT03347188|11939890|FG000|Entered in OL Period for Anti-drug Antibody (ADA) Only|Open-label (OL) Period (12 Weeks)||26
10778007|NCT03347188|11939891|FG001|Entered in OL Period for Anti-drug Antibody (ADA) Only|Open-label (OL) Period (12 Weeks)||28
10778008|NCT03347188|11939890|FG000|Received at Least 1 Dose of Study Drug|Open-label (OL) Period (12 Weeks)||9
10778009|NCT03347188|11939891|FG001|Received at Least 1 Dose of Study Drug|Open-label (OL) Period (12 Weeks)||7
10815945|NCT01738698|11979253|FG001|COMPLETED|Overall Study||0
10815946|NCT01738698|11979254|FG002|COMPLETED|Overall Study||0
10815947|NCT01738698|11979255|FG003|COMPLETED|Overall Study||0
10815948|NCT01738698|11979252|FG000|NOT COMPLETED|Overall Study||0
10815949|NCT01738698|11979253|FG001|NOT COMPLETED|Overall Study||0
10815950|NCT01738698|11979254|FG002|NOT COMPLETED|Overall Study||0
10815951|NCT01738698|11979255|FG003|NOT COMPLETED|Overall Study||0
10815952|NCT01732926|11979267|FG000|STARTED|Overall Study||320
10815953|NCT01732926|11979268|FG001|STARTED|Overall Study||155
10815954|NCT01732926|11979267|FG000|COMPLETED|Overall Study||53
10815955|NCT01732926|11979268|FG001|COMPLETED|Overall Study||45
10815956|NCT01732926|11979267|FG000|NOT COMPLETED|Overall Study||267
10815957|NCT01732926|11979268|FG001|NOT COMPLETED|Overall Study||110
10815958|NCT01727167|11979276|FG000|STARTED|Overall Study||1
10815959|NCT01727167|11979277|FG001|STARTED|Overall Study||0
10815960|NCT01727167|11979276|FG000|COMPLETED|Overall Study||1
10815961|NCT01727167|11979277|FG001|COMPLETED|Overall Study||0
10815962|NCT01727167|11979276|FG000|NOT COMPLETED|Overall Study||0
10815963|NCT01727167|11979277|FG001|NOT COMPLETED|Overall Study||0
10815964|NCT01732913|11979285|FG000|STARTED|Overall Study||198
10815965|NCT01732913|11979286|FG001|STARTED|Overall Study||97
10815966|NCT01732913|11979285|FG000|COMPLETED|Overall Study||42
10815967|NCT01732913|11979286|FG001|COMPLETED|Overall Study||28
10815968|NCT01732913|11979285|FG000|NOT COMPLETED|Overall Study||156
10815969|NCT01732913|11979286|FG001|NOT COMPLETED|Overall Study||69
10815970|NCT01732211|11979292|FG000|STARTED|Overall Study||1
10815971|NCT01732211|11979292|FG000|COMPLETED|Overall Study||1
10815972|NCT01732211|11979292|FG000|NOT COMPLETED|Overall Study||0
10815973|NCT01716052|11979298|FG000|STARTED|Overall Study||1
10815974|NCT01716052|11979299|FG001|STARTED|Overall Study||1
10815975|NCT01716052|11979298|FG000|COMPLETED|Overall Study||0
10815976|NCT01716052|11979299|FG001|COMPLETED|Overall Study||0
10815977|NCT01716052|11979298|FG000|NOT COMPLETED|Overall Study||1
10815978|NCT01716052|11979299|FG001|NOT COMPLETED|Overall Study||1
10815979|NCT01718444|11979307|FG000|STARTED|Overall Study||0
10815980|NCT01718444|11979308|FG001|STARTED|Overall Study||0
10815981|NCT01718444|11979307|FG000|COMPLETED|Overall Study||0
10815982|NCT01718444|11979308|FG001|COMPLETED|Overall Study||0
10815983|NCT01718444|11979307|FG000|NOT COMPLETED|Overall Study||0
10815984|NCT01718444|11979308|FG001|NOT COMPLETED|Overall Study||0
10815985|NCT01712854|11979314|FG000|STARTED|Overall Study||9
10815986|NCT01712854|11979314|FG000|COMPLETED|Overall Study||8
10815987|NCT01712854|11979314|FG000|NOT COMPLETED|Overall Study||1
10815988|NCT01717482|11979320|FG000|STARTED|Overall Study||4
10815989|NCT01717482|11979321|FG001|STARTED|Overall Study||2
10815990|NCT01717482|11979320|FG000|COMPLETED|Overall Study||0
10815991|NCT01717482|11979321|FG001|COMPLETED|Overall Study||2
10778010|NCT03347188|11939890|FG000|COMPLETED|Open-label (OL) Period (12 Weeks)||8
10778011|NCT03347188|11939891|FG001|COMPLETED|Open-label (OL) Period (12 Weeks)||6
10778012|NCT03347188|11939890|FG000|NOT COMPLETED|Open-label (OL) Period (12 Weeks)||27
10778013|NCT03347188|11939891|FG001|NOT COMPLETED|Open-label (OL) Period (12 Weeks)||29
10815992|NCT01717482|11979320|FG000|NOT COMPLETED|Overall Study||4
10815993|NCT01717482|11979321|FG001|NOT COMPLETED|Overall Study||0
10815994|NCT01702896|11979328|FG000|STARTED|Overall Study||8
10815995|NCT01702896|11979328|FG000|COMPLETED|Overall Study||0
10815996|NCT01702896|11979328|FG000|NOT COMPLETED|Overall Study||8
10815997|NCT01709136|11979334|FG000|STARTED|Overall Study||3
10815998|NCT01709136|11979334|FG000|COMPLETED|Overall Study||3
10815999|NCT01709136|11979334|FG000|NOT COMPLETED|Overall Study||0
10736177|NCT02858362|11900322|FG000|STARTED|Overall Study||30
10736178|NCT02858362|11900323|FG001|STARTED|Overall Study||10
10736179|NCT02858362|11900324|FG002|STARTED|Overall Study||3
10736180|NCT02858362|11900322|FG000|Did Not Enter Extension Phase|Overall Study||1
10736181|NCT02858362|11900323|FG001|Did Not Enter Extension Phase|Overall Study||2
10736182|NCT02858362|11900324|FG002|Did Not Enter Extension Phase|Overall Study||0
10736183|NCT02858362|11900322|FG000|COMPLETED|Overall Study||28
10736184|NCT02858362|11900323|FG001|COMPLETED|Overall Study||9
10736185|NCT02858362|11900324|FG002|COMPLETED|Overall Study||0
10736186|NCT02858362|11900322|FG000|NOT COMPLETED|Overall Study||2
10736187|NCT02858362|11900323|FG001|NOT COMPLETED|Overall Study||1
10736188|NCT02858362|11900324|FG002|NOT COMPLETED|Overall Study||3
10736189|NCT02858401|11900344|FG000|STARTED|Overall Study||6
10736190|NCT02858401|11900345|FG001|STARTED|Overall Study||6
10736191|NCT02858401|11900346|FG002|STARTED|Overall Study||6
10736192|NCT02858401|11900347|FG003|STARTED|Overall Study||6
10736193|NCT02858401|11900348|FG004|STARTED|Overall Study||6
10736194|NCT02858401|11900349|FG005|STARTED|Overall Study||6
10736195|NCT02858401|11900350|FG006|STARTED|Overall Study||12
10736196|NCT02858401|11900344|FG000|COMPLETED|Overall Study||6
10736197|NCT02858401|11900345|FG001|COMPLETED|Overall Study||5
10736198|NCT02858401|11900346|FG002|COMPLETED|Overall Study||6
10736199|NCT02858401|11900347|FG003|COMPLETED|Overall Study||6
10736200|NCT02858401|11900348|FG004|COMPLETED|Overall Study||6
10736201|NCT02858401|11900349|FG005|COMPLETED|Overall Study||5
10736202|NCT02858401|11900350|FG006|COMPLETED|Overall Study||12
10736203|NCT02858401|11900344|FG000|NOT COMPLETED|Overall Study||0
10736204|NCT02858401|11900345|FG001|NOT COMPLETED|Overall Study||1
10736205|NCT02858401|11900346|FG002|NOT COMPLETED|Overall Study||0
10736206|NCT02858401|11900347|FG003|NOT COMPLETED|Overall Study||0
10736207|NCT02858401|11900348|FG004|NOT COMPLETED|Overall Study||0
10736208|NCT02858401|11900349|FG005|NOT COMPLETED|Overall Study||1
10736209|NCT02858401|11900350|FG006|NOT COMPLETED|Overall Study||0
10736210|NCT02858440|11900375|FG000|STARTED|Overall Study||235
10736211|NCT02858440|11900375|FG000|COMPLETED|Overall Study||223
10736212|NCT02858440|11900375|FG000|NOT COMPLETED|Overall Study||12
10736213|NCT02858492|11900383|FG000|STARTED|Overall Study||3
10736214|NCT02858492|11900384|FG001|STARTED|Overall Study||15
10736215|NCT02858492|11900385|FG002|STARTED|Overall Study||5
10736216|NCT02858492|11900386|FG003|STARTED|Overall Study||28
10736217|NCT02858492|11900383|FG000|COMPLETED|Overall Study||3
10736218|NCT02858492|11900384|FG001|COMPLETED|Overall Study||14
10736219|NCT02858492|11900385|FG002|COMPLETED|Overall Study||5
10736220|NCT02858492|11900386|FG003|COMPLETED|Overall Study||22
10736221|NCT02858492|11900383|FG000|NOT COMPLETED|Overall Study||0
10736222|NCT02858492|11900384|FG001|NOT COMPLETED|Overall Study||1
10736223|NCT02858492|11900385|FG002|NOT COMPLETED|Overall Study||0
10736224|NCT02858492|11900386|FG003|NOT COMPLETED|Overall Study||6
10736225|NCT02858713|11900400|FG000|STARTED|Overall Study||68
10736226|NCT02858713|11900401|FG001|STARTED|Overall Study||66
10736227|NCT02858713|11900400|FG000|COMPLETED|Overall Study||61
10736228|NCT02858713|11900401|FG001|COMPLETED|Overall Study||61
10736229|NCT02858713|11900400|FG000|NOT COMPLETED|Overall Study||7
10736230|NCT02858713|11900401|FG001|NOT COMPLETED|Overall Study||5
10736231|NCT02858726|11900415|FG000|STARTED|Overall Study||44
10736232|NCT02858726|11900416|FG001|STARTED|Overall Study||42
10736233|NCT02858726|11900417|FG002|STARTED|Overall Study||44
10736234|NCT02858726|11900418|FG003|STARTED|Overall Study||45
10736235|NCT02858726|11900415|FG000|COMPLETED|Overall Study||39
10736236|NCT02858726|11900416|FG001|COMPLETED|Overall Study||35
10736237|NCT02858726|11900417|FG002|COMPLETED|Overall Study||33
10736238|NCT02858726|11900418|FG003|COMPLETED|Overall Study||42
10736239|NCT02858726|11900415|FG000|NOT COMPLETED|Overall Study||5
10736240|NCT02858726|11900416|FG001|NOT COMPLETED|Overall Study||7
10736241|NCT02858726|11900417|FG002|NOT COMPLETED|Overall Study||11
10736242|NCT02858726|11900418|FG003|NOT COMPLETED|Overall Study||3
10736243|NCT02859142|11900434|FG000|STARTED|Overall Study||61
10736244|NCT02859142|11900435|FG001|STARTED|Overall Study||61
10736245|NCT02859142|11900434|FG000|COMPLETED|Overall Study||57
10736246|NCT02859142|11900435|FG001|COMPLETED|Overall Study||52
10736247|NCT02859142|11900434|FG000|NOT COMPLETED|Overall Study||4
10736248|NCT02859142|11900435|FG001|NOT COMPLETED|Overall Study||9
10736249|NCT02859246|11900441|FG000|STARTED|Overall Study|15 subjects were enrolled into study|15
10736250|NCT02859246|11900441|FG000|COMPLETED|Overall Study|10 subjects completed the study|10
10736251|NCT02859246|11900441|FG000|NOT COMPLETED|Overall Study||5
10736252|NCT02859324|11900449|FG000|STARTED|Overall Study||7
10736253|NCT02859324|11900450|FG001|STARTED|Overall Study||9
10736254|NCT02859324|11900451|FG002|STARTED|Overall Study||5
10736255|NCT02859324|11900449|FG000|COMPLETED|Overall Study||0
10736256|NCT02859324|11900450|FG001|COMPLETED|Overall Study||0
10736257|NCT02859324|11900451|FG002|COMPLETED|Overall Study||0
10736258|NCT02859324|11900449|FG000|NOT COMPLETED|Overall Study||7
10736259|NCT02859324|11900450|FG001|NOT COMPLETED|Overall Study||9
10736260|NCT02859324|11900451|FG002|NOT COMPLETED|Overall Study||5
10736261|NCT02859441|11900459|FG000|STARTED|Overall Study||3
10816000|NCT01708057|11979341|FG000|STARTED|Overall Study||1
10816001|NCT01708057|11979342|FG001|STARTED|Overall Study||1
10736262|NCT02859441|11900459|FG000|COMPLETED|Overall Study||3
10736263|NCT02859441|11900459|FG000|NOT COMPLETED|Overall Study||0
10736264|NCT02859454|11900480|FG000|STARTED|Overall Study||13
10736265|NCT02859454|11900480|FG000|COMPLETED|Overall Study||12
10736266|NCT02859454|11900480|FG000|NOT COMPLETED|Overall Study||1
10736267|NCT02859597|11900489|FG000|STARTED|Overall Study|started Dec 2016|22
10736268|NCT02859597|11900490|FG001|STARTED|Overall Study|Started Dec 2016|19
10736269|NCT02859597|11900489|FG000|COMPLETED|Overall Study|September 2018|22
10736270|NCT02859597|11900490|FG001|COMPLETED|Overall Study|September 2018|19
10736271|NCT02859597|11900489|FG000|NOT COMPLETED|Overall Study||0
10736272|NCT02859597|11900490|FG001|NOT COMPLETED|Overall Study||0
10736273|NCT02860130|11900500|FG000|STARTED|Overall Study||17
10736274|NCT02860130|11900501|FG001|STARTED|Overall Study||17
10736275|NCT02860130|11900500|FG000|COMPLETED|Overall Study||10
10736276|NCT02860130|11900501|FG001|COMPLETED|Overall Study||8
10736277|NCT02860130|11900500|FG000|NOT COMPLETED|Overall Study||7
10736278|NCT02860130|11900501|FG001|NOT COMPLETED|Overall Study||9
10736279|NCT02860286|11900509|FG000|STARTED|Overall Study||13
10736280|NCT02860286|11900510|FG001|STARTED|Overall Study||61
10736281|NCT02860286|11900509|FG000|COMPLETED|Overall Study||13
10736282|NCT02860286|11900510|FG001|COMPLETED|Overall Study||61
10736283|NCT02860286|11900509|FG000|NOT COMPLETED|Overall Study||0
10736284|NCT02860286|11900510|FG001|NOT COMPLETED|Overall Study||0
10736285|NCT02860507|11900527|FG000|STARTED|Overall Study||25
10736286|NCT02860507|11900528|FG001|STARTED|Overall Study||25
10736287|NCT02860507|11900527|FG000|COMPLETED|Overall Study||25
10736288|NCT02860507|11900528|FG001|COMPLETED|Overall Study||25
10736289|NCT02860507|11900527|FG000|NOT COMPLETED|Overall Study||0
10736290|NCT02860507|11900528|FG001|NOT COMPLETED|Overall Study||0
10736291|NCT02860546|11900534|FG000|STARTED|Overall Study||18
10736292|NCT02860546|11900534|FG000|COMPLETED|Overall Study||0
10736293|NCT02860546|11900534|FG000|NOT COMPLETED|Overall Study||18
10736294|NCT02860845|11900540|FG000|STARTED|Overall Study||24
10736295|NCT02860845|11900541|FG001|STARTED|Overall Study||24
10736296|NCT02860845|11900540|FG000|Analyzed Patients|Overall Study||22
10736297|NCT02860845|11900541|FG001|Analyzed Patients|Overall Study||23
10736298|NCT02860845|11900540|FG000|COMPLETED|Overall Study||22
10736299|NCT02860845|11900541|FG001|COMPLETED|Overall Study||23
10736300|NCT02860845|11900540|FG000|NOT COMPLETED|Overall Study||2
10736301|NCT02860845|11900541|FG001|NOT COMPLETED|Overall Study||1
10736302|NCT02860988|11900553|FG000|STARTED|Overall Study||201
10736303|NCT02860988|11900554|FG001|STARTED|Overall Study||200
10736304|NCT02860988|11900553|FG000|COMPLETED|Overall Study||117
10736305|NCT02860988|11900554|FG001|COMPLETED|Overall Study||94
10736306|NCT02860988|11900553|FG000|NOT COMPLETED|Overall Study||84
10736307|NCT02860988|11900554|FG001|NOT COMPLETED|Overall Study||106
10736308|NCT02861118|11900562|FG000|STARTED|Overall Study||194
10736309|NCT02861118|11900563|FG001|STARTED|Overall Study||116
10736310|NCT02861118|11900562|FG000|COMPLETED|Overall Study||194
10736311|NCT02861118|11900563|FG001|COMPLETED|Overall Study||116
10736312|NCT02861118|11900562|FG000|NOT COMPLETED|Overall Study||0
10736313|NCT02861118|11900563|FG001|NOT COMPLETED|Overall Study||0
10736314|NCT02861131|11900573|FG000|STARTED|Overall Study||100
10736315|NCT02861131|11900574|FG001|STARTED|Overall Study||100
10736316|NCT02861131|11900573|FG000|COMPLETED|Overall Study||100
10736317|NCT02861131|11900574|FG001|COMPLETED|Overall Study||100
10736318|NCT02861131|11900573|FG000|NOT COMPLETED|Overall Study||0
10736319|NCT02861131|11900574|FG001|NOT COMPLETED|Overall Study||0
10736320|NCT02861534|11900582|FG000|STARTED|Overall Study||2526
10736321|NCT02861534|11900583|FG001|STARTED|Overall Study||2524
10736322|NCT02861534|11900582|FG000|Treated|Overall Study||2519
10736323|NCT02861534|11900583|FG001|Treated|Overall Study||2515
10736324|NCT02861534|11900582|FG000|COMPLETED|Overall Study||1952
10736325|NCT02861534|11900583|FG001|COMPLETED|Overall Study||1937
10736326|NCT02861534|11900582|FG000|NOT COMPLETED|Overall Study||574
10736327|NCT02861534|11900583|FG001|NOT COMPLETED|Overall Study||587
10736328|NCT02861586|11900597|FG000|STARTED|Overall Study||51
10736329|NCT02861586|11900598|FG001|STARTED|Overall Study||18
10736330|NCT02861586|11900599|FG002|STARTED|Overall Study||47
10736331|NCT02861586|11900600|FG003|STARTED|Overall Study||16
10736332|NCT02861586|11900601|FG004|STARTED|Overall Study||47
10736333|NCT02861586|11900602|FG005|STARTED|Overall Study||50
10736334|NCT02861586|11900603|FG006|STARTED|Overall Study||18
10736335|NCT02861586|11900604|FG007|STARTED|Overall Study||16
10736336|NCT02861586|11900597|FG000|COMPLETED|Overall Study||47
10736337|NCT02861586|11900598|FG001|COMPLETED|Overall Study||15
10736338|NCT02861586|11900599|FG002|COMPLETED|Overall Study||46
10736339|NCT02861586|11900600|FG003|COMPLETED|Overall Study||16
10736340|NCT02861586|11900601|FG004|COMPLETED|Overall Study||47
10736341|NCT02861586|11900602|FG005|COMPLETED|Overall Study||45
10736342|NCT02861586|11900603|FG006|COMPLETED|Overall Study||17
10736343|NCT02861586|11900604|FG007|COMPLETED|Overall Study||16
10736344|NCT02861586|11900597|FG000|NOT COMPLETED|Overall Study||4
10736345|NCT02861586|11900598|FG001|NOT COMPLETED|Overall Study||3
10736346|NCT02861586|11900599|FG002|NOT COMPLETED|Overall Study||1
10736347|NCT02861586|11900600|FG003|NOT COMPLETED|Overall Study||0
10736348|NCT02861586|11900601|FG004|NOT COMPLETED|Overall Study||0
10736349|NCT02861586|11900602|FG005|NOT COMPLETED|Overall Study||5
10736350|NCT02861586|11900603|FG006|NOT COMPLETED|Overall Study||1
10736351|NCT02861586|11900604|FG007|NOT COMPLETED|Overall Study||0
10736352|NCT02861664|11900629|FG000|STARTED|Overall Study||67
10736353|NCT02861664|11900630|FG001|STARTED|Overall Study||68
10736354|NCT02861664|11900629|FG000|COMPLETED|Overall Study||67
10736355|NCT02861664|11900630|FG001|COMPLETED|Overall Study||67
10736356|NCT02861664|11900629|FG000|NOT COMPLETED|Overall Study||0
10736357|NCT02861664|11900630|FG001|NOT COMPLETED|Overall Study||1
10736358|NCT02861807|11900638|FG000|STARTED|Overall Study||47
10736359|NCT02861807|11900639|FG001|STARTED|Overall Study||37
10736360|NCT02861807|11900638|FG000|Attended Post-treatment Assessment|Overall Study||34
10736361|NCT02861807|11900639|FG001|Attended Post-treatment Assessment|Overall Study||18
10736362|NCT02861807|11900638|FG000|Attended 2-month Follow-up|Overall Study||32
10736363|NCT02861807|11900639|FG001|Attended 2-month Follow-up|Overall Study||20
10736364|NCT02861807|11900638|FG000|COMPLETED|Overall Study||35
10736365|NCT02861807|11900639|FG001|COMPLETED|Overall Study||23
10736366|NCT02861807|11900638|FG000|NOT COMPLETED|Overall Study||12
10736367|NCT02861807|11900639|FG001|NOT COMPLETED|Overall Study||14
10736368|NCT02861937|11900648|FG000|STARTED|Overall Study||10
10736369|NCT02861937|11900649|FG001|STARTED|Overall Study||12
10736370|NCT02861937|11900650|FG002|STARTED|Overall Study||12
10736371|NCT02861937|11900648|FG000|COMPLETED|Overall Study||10
10736372|NCT02861937|11900649|FG001|COMPLETED|Overall Study||12
10736373|NCT02861937|11900650|FG002|COMPLETED|Overall Study||12
10736374|NCT02861937|11900648|FG000|NOT COMPLETED|Overall Study||0
10736375|NCT02861937|11900649|FG001|NOT COMPLETED|Overall Study||0
10736376|NCT02861937|11900650|FG002|NOT COMPLETED|Overall Study||0
10736377|NCT02862080|11900661|FG000|STARTED|7 Days Before Any Intervention||1
10736378|NCT02862080|11900662|FG001|STARTED|7 Days Before Any Intervention||1
10736379|NCT02862080|11900663|FG002|STARTED|7 Days Before Any Intervention||1
10736380|NCT02862080|11900664|FG003|STARTED|7 Days Before Any Intervention||1
10736381|NCT02862080|11900661|FG000|COMPLETED|7 Days Before Any Intervention||1
10736382|NCT02862080|11900662|FG001|COMPLETED|7 Days Before Any Intervention||1
10736383|NCT02862080|11900663|FG002|COMPLETED|7 Days Before Any Intervention||1
10736384|NCT02862080|11900664|FG003|COMPLETED|7 Days Before Any Intervention||1
10736385|NCT02862080|11900661|FG000|NOT COMPLETED|7 Days Before Any Intervention||0
10736386|NCT02862080|11900662|FG001|NOT COMPLETED|7 Days Before Any Intervention||0
10736387|NCT02862080|11900663|FG002|NOT COMPLETED|7 Days Before Any Intervention||0
10736388|NCT02862080|11900664|FG003|NOT COMPLETED|7 Days Before Any Intervention||0
10736389|NCT02862080|11900661|FG000|STARTED|3 Days Before Any Intervention||1
10736390|NCT02862080|11900662|FG001|STARTED|3 Days Before Any Intervention||1
10736391|NCT02862080|11900663|FG002|STARTED|3 Days Before Any Intervention||1
10736392|NCT02862080|11900664|FG003|STARTED|3 Days Before Any Intervention||1
10736393|NCT02862080|11900661|FG000|COMPLETED|3 Days Before Any Intervention||1
10736394|NCT02862080|11900662|FG001|COMPLETED|3 Days Before Any Intervention||1
10736395|NCT02862080|11900663|FG002|COMPLETED|3 Days Before Any Intervention||1
10736396|NCT02862080|11900664|FG003|COMPLETED|3 Days Before Any Intervention||1
10736397|NCT02862080|11900661|FG000|NOT COMPLETED|3 Days Before Any Intervention||0
10736398|NCT02862080|11900662|FG001|NOT COMPLETED|3 Days Before Any Intervention||0
10736399|NCT02862080|11900663|FG002|NOT COMPLETED|3 Days Before Any Intervention||0
10736400|NCT02862080|11900664|FG003|NOT COMPLETED|3 Days Before Any Intervention||0
10736401|NCT02862080|11900661|FG000|STARTED|Intervention 1 (1 Week)||1
10736402|NCT02862080|11900662|FG001|STARTED|Intervention 1 (1 Week)||1
10736403|NCT02862080|11900663|FG002|STARTED|Intervention 1 (1 Week)||1
10736404|NCT02862080|11900664|FG003|STARTED|Intervention 1 (1 Week)||1
10736405|NCT02862080|11900661|FG000|COMPLETED|Intervention 1 (1 Week)||1
10736406|NCT02862080|11900662|FG001|COMPLETED|Intervention 1 (1 Week)||1
10736407|NCT02862080|11900663|FG002|COMPLETED|Intervention 1 (1 Week)||1
10736408|NCT02862080|11900664|FG003|COMPLETED|Intervention 1 (1 Week)||1
10736409|NCT02862080|11900661|FG000|NOT COMPLETED|Intervention 1 (1 Week)||0
10736410|NCT02862080|11900662|FG001|NOT COMPLETED|Intervention 1 (1 Week)||0
10736411|NCT02862080|11900663|FG002|NOT COMPLETED|Intervention 1 (1 Week)||0
10736412|NCT02862080|11900664|FG003|NOT COMPLETED|Intervention 1 (1 Week)||0
10736413|NCT02862080|11900661|FG000|STARTED|Washout (1 Week)||1
10736414|NCT02862080|11900662|FG001|STARTED|Washout (1 Week)||1
10736415|NCT02862080|11900663|FG002|STARTED|Washout (1 Week)||1
10736416|NCT02862080|11900664|FG003|STARTED|Washout (1 Week)||1
10736417|NCT02862080|11900661|FG000|COMPLETED|Washout (1 Week)||1
10736418|NCT02862080|11900662|FG001|COMPLETED|Washout (1 Week)||1
10736419|NCT02862080|11900663|FG002|COMPLETED|Washout (1 Week)||1
10736420|NCT02862080|11900664|FG003|COMPLETED|Washout (1 Week)||1
10736421|NCT02862080|11900661|FG000|NOT COMPLETED|Washout (1 Week)||0
10736422|NCT02862080|11900662|FG001|NOT COMPLETED|Washout (1 Week)||0
10736423|NCT02862080|11900663|FG002|NOT COMPLETED|Washout (1 Week)||0
10736424|NCT02862080|11900664|FG003|NOT COMPLETED|Washout (1 Week)||0
10736425|NCT02862080|11900661|FG000|STARTED|Intervention 2 (1 Week)||1
10736426|NCT02862080|11900662|FG001|STARTED|Intervention 2 (1 Week)||1
10736427|NCT02862080|11900663|FG002|STARTED|Intervention 2 (1 Week)||1
10736428|NCT02862080|11900664|FG003|STARTED|Intervention 2 (1 Week)||1
10736429|NCT02862080|11900661|FG000|COMPLETED|Intervention 2 (1 Week)||1
10736430|NCT02862080|11900662|FG001|COMPLETED|Intervention 2 (1 Week)||1
10736431|NCT02862080|11900663|FG002|COMPLETED|Intervention 2 (1 Week)||1
10736432|NCT02862080|11900664|FG003|COMPLETED|Intervention 2 (1 Week)||1
10736433|NCT02862080|11900661|FG000|NOT COMPLETED|Intervention 2 (1 Week)||0
10736434|NCT02862080|11900662|FG001|NOT COMPLETED|Intervention 2 (1 Week)||0
10736435|NCT02862080|11900663|FG002|NOT COMPLETED|Intervention 2 (1 Week)||0
10736436|NCT02862080|11900664|FG003|NOT COMPLETED|Intervention 2 (1 Week)||0
10736437|NCT02862080|11900661|FG000|STARTED|Washout (1 Week)||1
10736438|NCT02862080|11900662|FG001|STARTED|Washout (1 Week)||1
10736439|NCT02862080|11900663|FG002|STARTED|Washout (1 Week)||1
10736440|NCT02862080|11900664|FG003|STARTED|Washout (1 Week)||1
10736441|NCT02862080|11900661|FG000|COMPLETED|Washout (1 Week)||1
10736442|NCT02862080|11900662|FG001|COMPLETED|Washout (1 Week)||1
10736443|NCT02862080|11900663|FG002|COMPLETED|Washout (1 Week)||1
10736444|NCT02862080|11900664|FG003|COMPLETED|Washout (1 Week)||1
10736445|NCT02862080|11900661|FG000|NOT COMPLETED|Washout (1 Week)||0
10736446|NCT02862080|11900662|FG001|NOT COMPLETED|Washout (1 Week)||0
10736447|NCT02862080|11900663|FG002|NOT COMPLETED|Washout (1 Week)||0
10736448|NCT02862080|11900664|FG003|NOT COMPLETED|Washout (1 Week)||0
10736449|NCT02862080|11900661|FG000|STARTED|Intervention 1 Again (1 Week)||1
10736450|NCT02862080|11900662|FG001|STARTED|Intervention 1 Again (1 Week)||1
10736451|NCT02862080|11900663|FG002|STARTED|Intervention 1 Again (1 Week)||1
10736452|NCT02862080|11900664|FG003|STARTED|Intervention 1 Again (1 Week)||1
10736453|NCT02862080|11900661|FG000|COMPLETED|Intervention 1 Again (1 Week)||1
10736454|NCT02862080|11900662|FG001|COMPLETED|Intervention 1 Again (1 Week)||1
10736455|NCT02862080|11900663|FG002|COMPLETED|Intervention 1 Again (1 Week)||1
10736456|NCT02862080|11900664|FG003|COMPLETED|Intervention 1 Again (1 Week)||1
10736457|NCT02862080|11900661|FG000|NOT COMPLETED|Intervention 1 Again (1 Week)||0
10736458|NCT02862080|11900662|FG001|NOT COMPLETED|Intervention 1 Again (1 Week)||0
10736459|NCT02862080|11900663|FG002|NOT COMPLETED|Intervention 1 Again (1 Week)||0
10736460|NCT02862080|11900664|FG003|NOT COMPLETED|Intervention 1 Again (1 Week)||0
10736461|NCT02862106|11900680|FG000|STARTED|Overall Study||183
10736462|NCT02862106|11900681|FG001|STARTED|Overall Study||26
10736463|NCT02862106|11900680|FG000|COMPLETED|Overall Study||145
10736464|NCT02862106|11900681|FG001|COMPLETED|Overall Study||20
10736465|NCT02862106|11900680|FG000|NOT COMPLETED|Overall Study||38
10736466|NCT02862106|11900681|FG001|NOT COMPLETED|Overall Study||6
10736467|NCT02862535|11900697|FG000|STARTED|Overall Study||9
10736468|NCT02862535|11900698|FG001|STARTED|Overall Study||6
10736469|NCT02862535|11900699|FG002|STARTED|Overall Study||10
10736470|NCT02862535|11900700|FG003|STARTED|Overall Study||11
10736471|NCT02862535|11900697|FG000|COMPLETED|Overall Study||0
10736472|NCT02862535|11900698|FG001|COMPLETED|Overall Study||0
10736473|NCT02862535|11900699|FG002|COMPLETED|Overall Study||0
10736474|NCT02862535|11900700|FG003|COMPLETED|Overall Study||0
10736475|NCT02862535|11900697|FG000|NOT COMPLETED|Overall Study||9
10736476|NCT02862535|11900698|FG001|NOT COMPLETED|Overall Study||6
10736477|NCT02862535|11900699|FG002|NOT COMPLETED|Overall Study||10
10736478|NCT02862535|11900700|FG003|NOT COMPLETED|Overall Study||11
10736479|NCT02862574|11900713|FG000|STARTED|Double-Blind Treatment Period||5
10736480|NCT02862574|11900714|FG001|STARTED|Double-Blind Treatment Period||5
10736481|NCT02862574|11900715|FG002|STARTED|Double-Blind Treatment Period||5
10736482|NCT02862574|11900713|FG000|COMPLETED|Double-Blind Treatment Period||2
10736483|NCT02862574|11900714|FG001|COMPLETED|Double-Blind Treatment Period||3
10736484|NCT02862574|11900715|FG002|COMPLETED|Double-Blind Treatment Period||1
10736485|NCT02862574|11900713|FG000|NOT COMPLETED|Double-Blind Treatment Period||3
10736486|NCT02862574|11900714|FG001|NOT COMPLETED|Double-Blind Treatment Period||2
10736487|NCT02862574|11900715|FG002|NOT COMPLETED|Double-Blind Treatment Period||4
10736488|NCT02862574|11900713|FG000|STARTED|Open-Label Treatment Period||2
10736489|NCT02862574|11900714|FG001|STARTED|Open-Label Treatment Period||3
10736490|NCT02862574|11900715|FG002|STARTED|Open-Label Treatment Period||1
10736491|NCT02862574|11900713|FG000|COMPLETED|Open-Label Treatment Period||0
10736492|NCT02862574|11900714|FG001|COMPLETED|Open-Label Treatment Period||0
10736493|NCT02862574|11900715|FG002|COMPLETED|Open-Label Treatment Period||0
10736494|NCT02862574|11900713|FG000|NOT COMPLETED|Open-Label Treatment Period||2
10736495|NCT02862574|11900714|FG001|NOT COMPLETED|Open-Label Treatment Period||3
10736496|NCT02862574|11900715|FG002|NOT COMPLETED|Open-Label Treatment Period||1
10736497|NCT02862600|11900724|FG000|STARTED|Period 1--Perhexiline-low Target Range|First subject underwent baseline functional assessment and perhexiline dosing on August 22, 2016|35
10736498|NCT02862600|11900724|FG000|COMPLETED|Period 1--Perhexiline-low Target Range|Study terminated on April 26, 2017 due to lack of efficacy.|22
10736499|NCT02862600|11900724|FG000|NOT COMPLETED|Period 1--Perhexiline-low Target Range||13
10736500|NCT02862600|11900724|FG000|STARTED|Period 2--Perhexiline-high Target Range|First subject completed Period 1 and moved into Period 2 perhexiline dosing on October 17, 2016|22
10736501|NCT02862600|11900724|FG000|COMPLETED|Period 2--Perhexiline-high Target Range|Study terminated on April 26, 2017 due to lack of efficacy in first 15 subjects completing Period 2.|15
10736502|NCT02862600|11900724|FG000|NOT COMPLETED|Period 2--Perhexiline-high Target Range||7
10736503|NCT02862730|11900730|FG000|STARTED|Tslim Training Visit (2 Weeks)||4
10736504|NCT02862730|11900731|FG001|STARTED|Tslim Training Visit (2 Weeks)||1
10736505|NCT02862730|11900732|FG002|STARTED|Tslim Training Visit (2 Weeks)||8
10736506|NCT02862730|11900733|FG003|STARTED|Tslim Training Visit (2 Weeks)||5
10736507|NCT02862730|11900734|FG004|STARTED|Tslim Training Visit (2 Weeks)||5
10736508|NCT02862730|11900735|FG005|STARTED|Tslim Training Visit (2 Weeks)||1
10736509|NCT02862730|11900736|FG006|STARTED|Tslim Training Visit (2 Weeks)||1
10736510|NCT02862730|11900730|FG000|COMPLETED|Tslim Training Visit (2 Weeks)||4
10736511|NCT02862730|11900731|FG001|COMPLETED|Tslim Training Visit (2 Weeks)||1
10736512|NCT02862730|11900732|FG002|COMPLETED|Tslim Training Visit (2 Weeks)||7
10736513|NCT02862730|11900733|FG003|COMPLETED|Tslim Training Visit (2 Weeks)||5
10736514|NCT02862730|11900734|FG004|COMPLETED|Tslim Training Visit (2 Weeks)||5
10736515|NCT02862730|11900735|FG005|COMPLETED|Tslim Training Visit (2 Weeks)||1
10736516|NCT02862730|11900736|FG006|COMPLETED|Tslim Training Visit (2 Weeks)||1
10736517|NCT02862730|11900730|FG000|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
10736518|NCT02862730|11900731|FG001|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
10736519|NCT02862730|11900732|FG002|NOT COMPLETED|Tslim Training Visit (2 Weeks)||1
10736520|NCT02862730|11900733|FG003|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
10736521|NCT02862730|11900734|FG004|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
10736522|NCT02862730|11900735|FG005|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
10736523|NCT02862730|11900736|FG006|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
10736524|NCT02862730|11900730|FG000|STARTED|First Rest Period (1-12 Weeks)||4
10736525|NCT02862730|11900731|FG001|STARTED|First Rest Period (1-12 Weeks)||1
10736526|NCT02862730|11900732|FG002|STARTED|First Rest Period (1-12 Weeks)||7
10736527|NCT02862730|11900733|FG003|STARTED|First Rest Period (1-12 Weeks)||5
10736528|NCT02862730|11900734|FG004|STARTED|First Rest Period (1-12 Weeks)||5
10736529|NCT02862730|11900735|FG005|STARTED|First Rest Period (1-12 Weeks)||1
10736530|NCT02862730|11900736|FG006|STARTED|First Rest Period (1-12 Weeks)||1
10736531|NCT02862730|11900730|FG000|COMPLETED|First Rest Period (1-12 Weeks)||4
10736532|NCT02862730|11900731|FG001|COMPLETED|First Rest Period (1-12 Weeks)||1
10736533|NCT02862730|11900732|FG002|COMPLETED|First Rest Period (1-12 Weeks)||7
10736534|NCT02862730|11900733|FG003|COMPLETED|First Rest Period (1-12 Weeks)||5
10736535|NCT02862730|11900734|FG004|COMPLETED|First Rest Period (1-12 Weeks)||5
10736536|NCT02862730|11900735|FG005|COMPLETED|First Rest Period (1-12 Weeks)||1
10736537|NCT02862730|11900736|FG006|COMPLETED|First Rest Period (1-12 Weeks)||1
10736538|NCT02862730|11900730|FG000|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
10736539|NCT02862730|11900731|FG001|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
10736540|NCT02862730|11900732|FG002|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
10736541|NCT02862730|11900733|FG003|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
10736542|NCT02862730|11900734|FG004|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
10736543|NCT02862730|11900735|FG005|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
10736544|NCT02862730|11900736|FG006|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
10736545|NCT02862730|11900730|FG000|STARTED|First Intervention (84 Hours)||4
10736546|NCT02862730|11900731|FG001|STARTED|First Intervention (84 Hours)||1
10736547|NCT02862730|11900732|FG002|STARTED|First Intervention (84 Hours)||7
10736548|NCT02862730|11900733|FG003|STARTED|First Intervention (84 Hours)||5
10736549|NCT02862730|11900734|FG004|STARTED|First Intervention (84 Hours)||5
10736550|NCT02862730|11900735|FG005|STARTED|First Intervention (84 Hours)||1
10736551|NCT02862730|11900736|FG006|STARTED|First Intervention (84 Hours)||1
10736552|NCT02862730|11900730|FG000|COMPLETED|First Intervention (84 Hours)||4
10736553|NCT02862730|11900731|FG001|COMPLETED|First Intervention (84 Hours)||1
10736554|NCT02862730|11900732|FG002|COMPLETED|First Intervention (84 Hours)||7
10736555|NCT02862730|11900733|FG003|COMPLETED|First Intervention (84 Hours)||5
10736556|NCT02862730|11900734|FG004|COMPLETED|First Intervention (84 Hours)||5
10736557|NCT02862730|11900735|FG005|COMPLETED|First Intervention (84 Hours)||1
10736558|NCT02862730|11900736|FG006|COMPLETED|First Intervention (84 Hours)||1
10408483|NCT00755105|11552577|FG000|STARTED|Overall Study||38
10408484|NCT00755105|11552578|FG001|STARTED|Overall Study||30
10408485|NCT00755105|11552579|FG002|STARTED|Overall Study||9
10408486|NCT00755105|11552577|FG000|COMPLETED|Overall Study||29
10408487|NCT00755105|11552578|FG001|COMPLETED|Overall Study||19
10408488|NCT00755105|11552579|FG002|COMPLETED|Overall Study||5
10736559|NCT02862730|11900730|FG000|NOT COMPLETED|First Intervention (84 Hours)||0
10736560|NCT02862730|11900731|FG001|NOT COMPLETED|First Intervention (84 Hours)||0
10736561|NCT02862730|11900732|FG002|NOT COMPLETED|First Intervention (84 Hours)||0
10736562|NCT02862730|11900733|FG003|NOT COMPLETED|First Intervention (84 Hours)||0
10736563|NCT02862730|11900734|FG004|NOT COMPLETED|First Intervention (84 Hours)||0
10736564|NCT02862730|11900735|FG005|NOT COMPLETED|First Intervention (84 Hours)||0
10736565|NCT02862730|11900736|FG006|NOT COMPLETED|First Intervention (84 Hours)||0
10736566|NCT02862730|11900730|FG000|STARTED|Second Rest Period (7-45 Days)||4
10736567|NCT02862730|11900731|FG001|STARTED|Second Rest Period (7-45 Days)||1
10736568|NCT02862730|11900732|FG002|STARTED|Second Rest Period (7-45 Days)||7
10736569|NCT02862730|11900733|FG003|STARTED|Second Rest Period (7-45 Days)||5
10736570|NCT02862730|11900734|FG004|STARTED|Second Rest Period (7-45 Days)||5
10736571|NCT02862730|11900735|FG005|STARTED|Second Rest Period (7-45 Days)||1
10816002|NCT01708057|11979343|FG002|STARTED|Overall Study||1
10816003|NCT01708057|11979341|FG000|COMPLETED|Overall Study||0
10816004|NCT01708057|11979342|FG001|COMPLETED|Overall Study||0
10816005|NCT01708057|11979343|FG002|COMPLETED|Overall Study||0
10816006|NCT01708057|11979341|FG000|NOT COMPLETED|Overall Study||1
10816007|NCT01708057|11979342|FG001|NOT COMPLETED|Overall Study||1
10816008|NCT01708057|11979343|FG002|NOT COMPLETED|Overall Study||1
10816009|NCT01697332|11979357|FG000|STARTED|Overall Study||1
10816010|NCT01697332|11979357|FG000|COMPLETED|Overall Study||1
10816011|NCT01697332|11979357|FG000|NOT COMPLETED|Overall Study||0
10816012|NCT01693367|11979363|FG000|STARTED|Overall Study||2
10816013|NCT01693367|11979364|FG001|STARTED|Overall Study||3
10816014|NCT01693367|11979363|FG000|COMPLETED|Overall Study||1
10816015|NCT01693367|11979364|FG001|COMPLETED|Overall Study||1
10816016|NCT01693367|11979363|FG000|NOT COMPLETED|Overall Study||1
10816017|NCT01693367|11979364|FG001|NOT COMPLETED|Overall Study||2
10816018|NCT01705106|11979370|FG000|STARTED|Overall Study||21
10816019|NCT01705106|11979370|FG000|COMPLETED|Overall Study||21
10816020|NCT01705106|11979370|FG000|NOT COMPLETED|Overall Study||0
10816021|NCT01702909|11979374|FG000|STARTED|Overall Study||7
10816022|NCT01702909|11979374|FG000|COMPLETED|Overall Study||7
10816023|NCT01702909|11979374|FG000|NOT COMPLETED|Overall Study||0
10816024|NCT01701622|11979378|FG000|STARTED|Overall Study||1
10408489|NCT00755105|11552577|FG000|NOT COMPLETED|Overall Study||9
10408490|NCT00755105|11552578|FG001|NOT COMPLETED|Overall Study||11
10736572|NCT02862730|11900736|FG006|STARTED|Second Rest Period (7-45 Days)||1
10736573|NCT02862730|11900730|FG000|COMPLETED|Second Rest Period (7-45 Days)||4
10736574|NCT02862730|11900731|FG001|COMPLETED|Second Rest Period (7-45 Days)||1
10736575|NCT02862730|11900732|FG002|COMPLETED|Second Rest Period (7-45 Days)||7
10736576|NCT02862730|11900733|FG003|COMPLETED|Second Rest Period (7-45 Days)||5
10736577|NCT02862730|11900734|FG004|COMPLETED|Second Rest Period (7-45 Days)||5
10736578|NCT02862730|11900735|FG005|COMPLETED|Second Rest Period (7-45 Days)||1
10736579|NCT02862730|11900736|FG006|COMPLETED|Second Rest Period (7-45 Days)||1
10736580|NCT02862730|11900730|FG000|NOT COMPLETED|Second Rest Period (7-45 Days)||0
10736581|NCT02862730|11900731|FG001|NOT COMPLETED|Second Rest Period (7-45 Days)||0
10736582|NCT02862730|11900732|FG002|NOT COMPLETED|Second Rest Period (7-45 Days)||0
10736583|NCT02862730|11900733|FG003|NOT COMPLETED|Second Rest Period (7-45 Days)||0
10736584|NCT02862730|11900734|FG004|NOT COMPLETED|Second Rest Period (7-45 Days)||0
10736585|NCT02862730|11900735|FG005|NOT COMPLETED|Second Rest Period (7-45 Days)||0
10736586|NCT02862730|11900736|FG006|NOT COMPLETED|Second Rest Period (7-45 Days)||0
10736587|NCT02862730|11900730|FG000|STARTED|Second Intervention (84 Hours)||4
10736588|NCT02862730|11900731|FG001|STARTED|Second Intervention (84 Hours)||1
10736589|NCT02862730|11900732|FG002|STARTED|Second Intervention (84 Hours)||7
10736590|NCT02862730|11900733|FG003|STARTED|Second Intervention (84 Hours)||5
10736591|NCT02862730|11900734|FG004|STARTED|Second Intervention (84 Hours)||5
10736592|NCT02862730|11900735|FG005|STARTED|Second Intervention (84 Hours)||1
10736593|NCT02862730|11900736|FG006|STARTED|Second Intervention (84 Hours)||1
10736594|NCT02862730|11900730|FG000|COMPLETED|Second Intervention (84 Hours)||3
10736595|NCT02862730|11900731|FG001|COMPLETED|Second Intervention (84 Hours)||1
10736596|NCT02862730|11900732|FG002|COMPLETED|Second Intervention (84 Hours)||7
10736597|NCT02862730|11900733|FG003|COMPLETED|Second Intervention (84 Hours)||5
10736598|NCT02862730|11900734|FG004|COMPLETED|Second Intervention (84 Hours)||5
10736599|NCT02862730|11900735|FG005|COMPLETED|Second Intervention (84 Hours)||1
10736600|NCT02862730|11900736|FG006|COMPLETED|Second Intervention (84 Hours)||1
10736601|NCT02862730|11900730|FG000|NOT COMPLETED|Second Intervention (84 Hours)||1
10736602|NCT02862730|11900731|FG001|NOT COMPLETED|Second Intervention (84 Hours)||0
10736603|NCT02862730|11900732|FG002|NOT COMPLETED|Second Intervention (84 Hours)||0
10736604|NCT02862730|11900733|FG003|NOT COMPLETED|Second Intervention (84 Hours)||0
10736605|NCT02862730|11900734|FG004|NOT COMPLETED|Second Intervention (84 Hours)||0
10736606|NCT02862730|11900735|FG005|NOT COMPLETED|Second Intervention (84 Hours)||0
10736607|NCT02862730|11900736|FG006|NOT COMPLETED|Second Intervention (84 Hours)||0
10736608|NCT02862730|11900730|FG000|STARTED|Third Rest Period (7-45 Days)||3
10736609|NCT02862730|11900731|FG001|STARTED|Third Rest Period (7-45 Days)||1
10736610|NCT02862730|11900732|FG002|STARTED|Third Rest Period (7-45 Days)||7
10736611|NCT02862730|11900733|FG003|STARTED|Third Rest Period (7-45 Days)||5
10736612|NCT02862730|11900734|FG004|STARTED|Third Rest Period (7-45 Days)||5
10736613|NCT02862730|11900735|FG005|STARTED|Third Rest Period (7-45 Days)||1
10736614|NCT02862730|11900736|FG006|STARTED|Third Rest Period (7-45 Days)||1
10736615|NCT02862730|11900730|FG000|COMPLETED|Third Rest Period (7-45 Days)||3
10736616|NCT02862730|11900731|FG001|COMPLETED|Third Rest Period (7-45 Days)||1
10736617|NCT02862730|11900732|FG002|COMPLETED|Third Rest Period (7-45 Days)||6
10736618|NCT02862730|11900733|FG003|COMPLETED|Third Rest Period (7-45 Days)||5
10736619|NCT02862730|11900734|FG004|COMPLETED|Third Rest Period (7-45 Days)||4
10736620|NCT02862730|11900735|FG005|COMPLETED|Third Rest Period (7-45 Days)||1
10736621|NCT02862730|11900736|FG006|COMPLETED|Third Rest Period (7-45 Days)||1
10736622|NCT02862730|11900730|FG000|NOT COMPLETED|Third Rest Period (7-45 Days)||0
10736623|NCT02862730|11900731|FG001|NOT COMPLETED|Third Rest Period (7-45 Days)||0
10736624|NCT02862730|11900732|FG002|NOT COMPLETED|Third Rest Period (7-45 Days)||1
10736625|NCT02862730|11900733|FG003|NOT COMPLETED|Third Rest Period (7-45 Days)||0
10736626|NCT02862730|11900734|FG004|NOT COMPLETED|Third Rest Period (7-45 Days)||1
10736627|NCT02862730|11900735|FG005|NOT COMPLETED|Third Rest Period (7-45 Days)||0
10736628|NCT02862730|11900736|FG006|NOT COMPLETED|Third Rest Period (7-45 Days)||0
10736629|NCT02862730|11900730|FG000|STARTED|Third Intervention (84 Hours)||3
10736630|NCT02862730|11900731|FG001|STARTED|Third Intervention (84 Hours)||1
10736631|NCT02862730|11900732|FG002|STARTED|Third Intervention (84 Hours)||6
10736632|NCT02862730|11900733|FG003|STARTED|Third Intervention (84 Hours)||5
10736633|NCT02862730|11900734|FG004|STARTED|Third Intervention (84 Hours)||4
10736634|NCT02862730|11900735|FG005|STARTED|Third Intervention (84 Hours)||1
10736635|NCT02862730|11900736|FG006|STARTED|Third Intervention (84 Hours)||1
10736636|NCT02862730|11900730|FG000|COMPLETED|Third Intervention (84 Hours)||3
10736637|NCT02862730|11900731|FG001|COMPLETED|Third Intervention (84 Hours)||1
10736638|NCT02862730|11900732|FG002|COMPLETED|Third Intervention (84 Hours)||6
10736639|NCT02862730|11900733|FG003|COMPLETED|Third Intervention (84 Hours)||4
10736640|NCT02862730|11900734|FG004|COMPLETED|Third Intervention (84 Hours)||4
10736641|NCT02862730|11900735|FG005|COMPLETED|Third Intervention (84 Hours)||1
10736642|NCT02862730|11900736|FG006|COMPLETED|Third Intervention (84 Hours)||1
10736643|NCT02862730|11900730|FG000|NOT COMPLETED|Third Intervention (84 Hours)||0
10736644|NCT02862730|11900731|FG001|NOT COMPLETED|Third Intervention (84 Hours)||0
10736645|NCT02862730|11900732|FG002|NOT COMPLETED|Third Intervention (84 Hours)||0
10736646|NCT02862730|11900733|FG003|NOT COMPLETED|Third Intervention (84 Hours)||1
10736647|NCT02862730|11900734|FG004|NOT COMPLETED|Third Intervention (84 Hours)||0
10736648|NCT02862730|11900735|FG005|NOT COMPLETED|Third Intervention (84 Hours)||0
10736649|NCT02862730|11900736|FG006|NOT COMPLETED|Third Intervention (84 Hours)||0
10736650|NCT02862730|11900730|FG000|STARTED|Fourth Rest Period (7-45 Days)||3
10736651|NCT02862730|11900731|FG001|STARTED|Fourth Rest Period (7-45 Days)||1
10736652|NCT02862730|11900732|FG002|STARTED|Fourth Rest Period (7-45 Days)||6
10736653|NCT02862730|11900733|FG003|STARTED|Fourth Rest Period (7-45 Days)||4
10736654|NCT02862730|11900734|FG004|STARTED|Fourth Rest Period (7-45 Days)||4
10736655|NCT02862730|11900735|FG005|STARTED|Fourth Rest Period (7-45 Days)||1
10736656|NCT02862730|11900736|FG006|STARTED|Fourth Rest Period (7-45 Days)||1
10736657|NCT02862730|11900730|FG000|COMPLETED|Fourth Rest Period (7-45 Days)||3
10736658|NCT02862730|11900731|FG001|COMPLETED|Fourth Rest Period (7-45 Days)||1
10736659|NCT02862730|11900732|FG002|COMPLETED|Fourth Rest Period (7-45 Days)||6
10736660|NCT02862730|11900733|FG003|COMPLETED|Fourth Rest Period (7-45 Days)||4
10736661|NCT02862730|11900734|FG004|COMPLETED|Fourth Rest Period (7-45 Days)||4
10736662|NCT02862730|11900735|FG005|COMPLETED|Fourth Rest Period (7-45 Days)||1
10736663|NCT02862730|11900736|FG006|COMPLETED|Fourth Rest Period (7-45 Days)||1
10736664|NCT02862730|11900730|FG000|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
10736665|NCT02862730|11900731|FG001|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
10736666|NCT02862730|11900732|FG002|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
10736667|NCT02862730|11900733|FG003|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
10736668|NCT02862730|11900734|FG004|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
10736669|NCT02862730|11900735|FG005|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
10736670|NCT02862730|11900736|FG006|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
10736671|NCT02862730|11900730|FG000|STARTED|Fourth Intervention (84 Hours)||3
10736672|NCT02862730|11900731|FG001|STARTED|Fourth Intervention (84 Hours)||1
10736673|NCT02862730|11900732|FG002|STARTED|Fourth Intervention (84 Hours)||6
10736674|NCT02862730|11900733|FG003|STARTED|Fourth Intervention (84 Hours)||4
10736675|NCT02862730|11900734|FG004|STARTED|Fourth Intervention (84 Hours)||4
10736676|NCT02862730|11900735|FG005|STARTED|Fourth Intervention (84 Hours)||1
10736677|NCT02862730|11900736|FG006|STARTED|Fourth Intervention (84 Hours)||1
10736678|NCT02862730|11900730|FG000|COMPLETED|Fourth Intervention (84 Hours)||3
10736679|NCT02862730|11900731|FG001|COMPLETED|Fourth Intervention (84 Hours)||1
10736680|NCT02862730|11900732|FG002|COMPLETED|Fourth Intervention (84 Hours)||6
10736681|NCT02862730|11900733|FG003|COMPLETED|Fourth Intervention (84 Hours)||4
10736682|NCT02862730|11900734|FG004|COMPLETED|Fourth Intervention (84 Hours)||4
10736683|NCT02862730|11900735|FG005|COMPLETED|Fourth Intervention (84 Hours)||1
10736684|NCT02862730|11900736|FG006|COMPLETED|Fourth Intervention (84 Hours)||1
10736685|NCT02862730|11900730|FG000|NOT COMPLETED|Fourth Intervention (84 Hours)||0
10736686|NCT02862730|11900731|FG001|NOT COMPLETED|Fourth Intervention (84 Hours)||0
10736687|NCT02862730|11900732|FG002|NOT COMPLETED|Fourth Intervention (84 Hours)||0
10736688|NCT02862730|11900733|FG003|NOT COMPLETED|Fourth Intervention (84 Hours)||0
10736689|NCT02862730|11900734|FG004|NOT COMPLETED|Fourth Intervention (84 Hours)||0
10736690|NCT02862730|11900735|FG005|NOT COMPLETED|Fourth Intervention (84 Hours)||0
10736691|NCT02862730|11900736|FG006|NOT COMPLETED|Fourth Intervention (84 Hours)||0
10736692|NCT02862912|11900753|FG000|STARTED|Overall Study||23
10736693|NCT02862912|11900754|FG001|STARTED|Overall Study||20
10736694|NCT02862912|11900753|FG000|COMPLETED|Overall Study||22
10736695|NCT02862912|11900754|FG001|COMPLETED|Overall Study||20
10736696|NCT02862912|11900753|FG000|NOT COMPLETED|Overall Study||1
10736697|NCT02862912|11900754|FG001|NOT COMPLETED|Overall Study||0
10736698|NCT02863198|11900764|FG000|STARTED|Overall Study||60
10736699|NCT02863198|11900765|FG001|STARTED|Overall Study||60
10736700|NCT02863198|11900764|FG000|COMPLETED|Overall Study||60
10736701|NCT02863198|11900765|FG001|COMPLETED|Overall Study||60
10736702|NCT02863198|11900764|FG000|NOT COMPLETED|Overall Study||0
10736703|NCT02863198|11900765|FG001|NOT COMPLETED|Overall Study||0
10736704|NCT02863263|11900773|FG000|STARTED|Overall Study||3
10736705|NCT02863263|11900774|FG001|STARTED|Overall Study||2
10736706|NCT02863263|11900773|FG000|COMPLETED|Overall Study||2
10736707|NCT02863263|11900774|FG001|COMPLETED|Overall Study||1
10736708|NCT02863263|11900773|FG000|NOT COMPLETED|Overall Study||1
10736709|NCT02863263|11900774|FG001|NOT COMPLETED|Overall Study||1
10736710|NCT02863289|11900780|FG000|STARTED|Overall Study|Study started on 01/11/2016, with 118 study participants.|118
10816025|NCT01701622|11979378|FG000|COMPLETED|Overall Study||1
10816026|NCT01701622|11979378|FG000|NOT COMPLETED|Overall Study||0
10816027|NCT01697800|11979385|FG000|STARTED|Overall Study||15
10816028|NCT01697800|11979386|FG001|STARTED|Overall Study||25
10816029|NCT01697800|11979385|FG000|COMPLETED|Overall Study||15
10816030|NCT01697800|11979386|FG001|COMPLETED|Overall Study||24
10816031|NCT01697800|11979385|FG000|NOT COMPLETED|Overall Study||0
10816032|NCT01697800|11979386|FG001|NOT COMPLETED|Overall Study||1
10816033|NCT01700348|11979392|FG000|STARTED|Overall Study||116
10816034|NCT01700348|11979392|FG000|COMPLETED|Overall Study||93
10816035|NCT01700348|11979392|FG000|NOT COMPLETED|Overall Study||23
10816036|NCT01693484|11979398|FG000|STARTED|Overall Study||13
10816037|NCT01693484|11979398|FG000|COMPLETED|Overall Study|Study closed by PI|0
10816038|NCT01693484|11979398|FG000|NOT COMPLETED|Overall Study||13
10816039|NCT01693653|11979404|FG000|STARTED|Overall Study||1
10736711|NCT02863289|11900780|FG000|COMPLETED|Overall Study|Study completed on 01/03/2017, 35 study participants have returned the questionnaire.|35
10736712|NCT02863289|11900780|FG000|NOT COMPLETED|Overall Study||83
10816040|NCT01693653|11979405|FG001|STARTED|Overall Study||0
10736723|NCT02863354|11900796|FG000|STARTED|Year 1||23
10736724|NCT02863354|11900797|FG001|STARTED|Year 1||20
10736725|NCT02863354|11900796|FG000|COMPLETED|Year 1||19
10736726|NCT02863354|11900797|FG001|COMPLETED|Year 1||18
10736727|NCT02863354|11900796|FG000|NOT COMPLETED|Year 1||4
10736728|NCT02863354|11900797|FG001|NOT COMPLETED|Year 1||2
10736729|NCT02863354|11900796|FG000|STARTED|Year 2||19
10736730|NCT02863354|11900797|FG001|STARTED|Year 2||18
10736731|NCT02863354|11900796|FG000|COMPLETED|Year 2||17
10736732|NCT02863354|11900797|FG001|COMPLETED|Year 2||16
10736733|NCT02863354|11900796|FG000|NOT COMPLETED|Year 2||2
10736734|NCT02863354|11900797|FG001|NOT COMPLETED|Year 2||2
10736750|NCT02863575|11900819|FG000|STARTED|Overall Study||161
10736751|NCT02863575|11900820|FG001|STARTED|Overall Study||161
10736752|NCT02863575|11900821|FG002|STARTED|Overall Study||52
10736753|NCT02863575|11900819|FG000|COMPLETED|Overall Study||160
10736754|NCT02863575|11900820|FG001|COMPLETED|Overall Study||159
10736755|NCT02863575|11900821|FG002|COMPLETED|Overall Study||51
10736756|NCT02863575|11900819|FG000|NOT COMPLETED|Overall Study||1
10736757|NCT02863575|11900820|FG001|NOT COMPLETED|Overall Study||2
10736758|NCT02863575|11900821|FG002|NOT COMPLETED|Overall Study||1
10736759|NCT02864069|11900832|FG000|STARTED|Overall Study||18
10736760|NCT02864069|11900833|FG001|STARTED|Overall Study||13
10736761|NCT02864069|11900834|FG002|STARTED|Overall Study||21
10736762|NCT02864069|11900832|FG000|COMPLETED|Overall Study||12
10736763|NCT02864069|11900833|FG001|COMPLETED|Overall Study||5
10736764|NCT02864069|11900834|FG002|COMPLETED|Overall Study||13
10736765|NCT02864069|11900832|FG000|NOT COMPLETED|Overall Study||6
10736766|NCT02864069|11900833|FG001|NOT COMPLETED|Overall Study||8
10736767|NCT02864069|11900834|FG002|NOT COMPLETED|Overall Study||8
10736768|NCT02864082|11900844|FG000|STARTED|Overall Study||10
10736769|NCT02864082|11900845|FG001|STARTED|Overall Study||9
10736770|NCT02864082|11900844|FG000|COMPLETED|Overall Study||7
10736771|NCT02864082|11900845|FG001|COMPLETED|Overall Study||5
10736772|NCT02864082|11900844|FG000|NOT COMPLETED|Overall Study||3
10736773|NCT02864082|11900845|FG001|NOT COMPLETED|Overall Study||4
10736774|NCT02864316|11900867|FG000|STARTED|Overall Study||2
10736775|NCT02864316|11900868|FG001|STARTED|Overall Study||2
10736776|NCT02864316|11900867|FG000|COMPLETED|Overall Study||0
10736777|NCT02864316|11900868|FG001|COMPLETED|Overall Study||0
10736778|NCT02864316|11900867|FG000|NOT COMPLETED|Overall Study||2
10736779|NCT02864316|11900868|FG001|NOT COMPLETED|Overall Study||2
10736780|NCT02864342|11900876|FG000|STARTED|Overall Study||70
10736781|NCT02864342|11900877|FG001|STARTED|Overall Study||68
10736782|NCT02864342|11900876|FG000|Full Analysis Set (FAS)|Overall Study||70
10736783|NCT02864342|11900877|FG001|Full Analysis Set (FAS)|Overall Study||67
10736784|NCT02864342|11900876|FG000|COMPLETED|Overall Study||55
10736785|NCT02864342|11900877|FG001|COMPLETED|Overall Study||49
10736786|NCT02864342|11900876|FG000|NOT COMPLETED|Overall Study||15
10736787|NCT02864342|11900877|FG001|NOT COMPLETED|Overall Study||19
10736788|NCT02864355|11900886|FG000|STARTED|Overall Study||25
10736789|NCT02864355|11900887|FG001|STARTED|Overall Study||28
10736790|NCT02864355|11900886|FG000|COMPLETED|Overall Study||23
10736791|NCT02864355|11900887|FG001|COMPLETED|Overall Study||25
10736792|NCT02864355|11900886|FG000|NOT COMPLETED|Overall Study||2
10736793|NCT02864355|11900887|FG001|NOT COMPLETED|Overall Study||3
10736794|NCT02864381|11900895|FG000|STARTED|Overall Study||72
10736795|NCT02864381|11900896|FG001|STARTED|Overall Study||72
10736796|NCT02864381|11900895|FG000|COMPLETED|Overall Study||0
10736797|NCT02864381|11900896|FG001|COMPLETED|Overall Study||0
10736798|NCT02864381|11900895|FG000|NOT COMPLETED|Overall Study||72
10736799|NCT02864381|11900896|FG001|NOT COMPLETED|Overall Study||72
10736808|NCT02864706|11900913|FG000|STARTED|Overall Study||48
10736809|NCT02864706|11900914|FG001|STARTED|Overall Study||47
10736810|NCT02864706|11900913|FG000|Safety Set|Overall Study||48
10736811|NCT02864706|11900914|FG001|Safety Set|Overall Study||47
10736812|NCT02864706|11900913|FG000|Intent to Treat|Overall Study||46
10736813|NCT02864706|11900914|FG001|Intent to Treat|Overall Study||47
10736814|NCT02864706|11900913|FG000|COMPLETED|Overall Study||48
10736815|NCT02864706|11900914|FG001|COMPLETED|Overall Study||47
10736816|NCT02864706|11900913|FG000|NOT COMPLETED|Overall Study||0
10736817|NCT02864706|11900914|FG001|NOT COMPLETED|Overall Study||0
10736818|NCT02864732|11900922|FG000|STARTED|Overall Study||15
10736819|NCT02864732|11900923|FG001|STARTED|Overall Study||15
10736820|NCT02864732|11900922|FG000|COMPLETED|Overall Study||13
10736821|NCT02864732|11900923|FG001|COMPLETED|Overall Study||13
10736822|NCT02864732|11900922|FG000|NOT COMPLETED|Overall Study||2
10736823|NCT02864732|11900923|FG001|NOT COMPLETED|Overall Study||2
10736824|NCT02865343|11900932|FG000|STARTED|Overall Study||6
10736825|NCT02865343|11900933|FG001|STARTED|Overall Study||5
10736826|NCT02865343|11900932|FG000|COMPLETED|Overall Study||6
10736827|NCT02865343|11900933|FG001|COMPLETED|Overall Study||3
10736828|NCT02865343|11900932|FG000|NOT COMPLETED|Overall Study||0
10736829|NCT02865343|11900933|FG001|NOT COMPLETED|Overall Study||2
10736830|NCT02865434|11900952|FG000|STARTED|Overall Study||3
10816041|NCT01693653|11979404|FG000|COMPLETED|Overall Study||1
10816042|NCT01693653|11979405|FG001|COMPLETED|Overall Study||0
10816043|NCT01693653|11979404|FG000|NOT COMPLETED|Overall Study||0
10816044|NCT01693653|11979405|FG001|NOT COMPLETED|Overall Study||0
10816045|NCT01692691|11979411|FG000|STARTED|Overall Study||1
10816046|NCT01692691|11979411|FG000|COMPLETED|Overall Study||1
10816047|NCT01692691|11979411|FG000|NOT COMPLETED|Overall Study||0
10816048|NCT01691079|11979419|FG000|STARTED|Overall Study||0
10816049|NCT01691079|11979420|FG001|STARTED|Overall Study||0
10816050|NCT01691079|11979419|FG000|COMPLETED|Overall Study||0
10816051|NCT01691079|11979420|FG001|COMPLETED|Overall Study||0
10816052|NCT01691079|11979419|FG000|NOT COMPLETED|Overall Study||0
10816053|NCT01691079|11979420|FG001|NOT COMPLETED|Overall Study||0
10816054|NCT01690910|11979428|FG000|STARTED|Overall Study|The study was never completed due to feasibility issues.|0
10816055|NCT01690910|11979429|FG001|STARTED|Overall Study||0
10816056|NCT01690910|11979428|FG000|COMPLETED|Overall Study||0
10816057|NCT01690910|11979429|FG001|COMPLETED|Overall Study||0
10816058|NCT01690910|11979428|FG000|NOT COMPLETED|Overall Study||0
10816059|NCT01690910|11979429|FG001|NOT COMPLETED|Overall Study||0
10816060|NCT01689974|11979437|FG000|STARTED|Overall Study||5
10816061|NCT01689974|11979438|FG001|STARTED|Overall Study||5
10816062|NCT01689974|11979437|FG000|COMPLETED|Overall Study||0
10816063|NCT01689974|11979438|FG001|COMPLETED|Overall Study||0
10816064|NCT01689974|11979437|FG000|NOT COMPLETED|Overall Study||5
10816065|NCT01689974|11979438|FG001|NOT COMPLETED|Overall Study||5
10816066|NCT01676961|11979444|FG000|STARTED|Overall Study||5
10816067|NCT01676961|11979444|FG000|COMPLETED|Overall Study||0
10816068|NCT01676961|11979444|FG000|NOT COMPLETED|Overall Study||5
10816069|NCT01681589|11979451|FG000|STARTED|Overall Study||0
10816070|NCT01681589|11979452|FG001|STARTED|Overall Study||0
10816071|NCT01681589|11979453|FG002|STARTED|Overall Study||0
10816072|NCT01681589|11979451|FG000|COMPLETED|Overall Study||0
10816073|NCT01681589|11979452|FG001|COMPLETED|Overall Study||0
10816074|NCT01681589|11979453|FG002|COMPLETED|Overall Study||0
10816075|NCT01681589|11979451|FG000|NOT COMPLETED|Overall Study||0
10816076|NCT01681589|11979452|FG001|NOT COMPLETED|Overall Study||0
10816077|NCT01681589|11979453|FG002|NOT COMPLETED|Overall Study||0
10816078|NCT01681745|11979461|FG000|STARTED|Overall Study||0
10816079|NCT01681745|11979461|FG000|COMPLETED|Overall Study||0
10816080|NCT01681745|11979461|FG000|NOT COMPLETED|Overall Study||0
10816081|NCT01682928|11979467|FG000|STARTED|Overall Study|2 subjects in this Arm|2
10816082|NCT01682928|11979468|FG001|STARTED|Overall Study|2 subjects in this Arm|2
10816083|NCT01682928|11979467|FG000|COMPLETED|Overall Study||2
10816084|NCT01682928|11979468|FG001|COMPLETED|Overall Study||2
10816085|NCT01682928|11979467|FG000|NOT COMPLETED|Overall Study||0
10816086|NCT01682928|11979468|FG001|NOT COMPLETED|Overall Study||0
10816087|NCT01668940|11979480|FG000|STARTED|Overall Study||17
10816088|NCT01668940|11979481|FG001|STARTED|Overall Study||14
10816089|NCT01668940|11979482|FG002|STARTED|Overall Study||9
10816090|NCT01668940|11979483|FG003|STARTED|Overall Study||14
10736831|NCT02865434|11900953|FG001|STARTED|Overall Study||3
10736832|NCT02865434|11900954|FG002|STARTED|Overall Study||3
10736833|NCT02865434|11900955|FG003|STARTED|Overall Study||3
10736834|NCT02865434|11900956|FG004|STARTED|Overall Study||3
10736835|NCT02865434|11900957|FG005|STARTED|Overall Study||3
10736836|NCT02865434|11900958|FG006|STARTED|Overall Study||3
10736837|NCT02865434|11900959|FG007|STARTED|Overall Study||3
10736838|NCT02865434|11900960|FG008|STARTED|Overall Study||3
10736839|NCT02865434|11900961|FG009|STARTED|Overall Study||6
10736840|NCT02865434|11900962|FG010|STARTED|Overall Study||6
10736841|NCT02865434|11900952|FG000|COMPLETED|Overall Study||3
10736842|NCT02865434|11900953|FG001|COMPLETED|Overall Study||3
10736843|NCT02865434|11900954|FG002|COMPLETED|Overall Study||3
10736844|NCT02865434|11900955|FG003|COMPLETED|Overall Study||3
10736845|NCT02865434|11900956|FG004|COMPLETED|Overall Study||3
10816091|NCT01668940|11979480|FG000|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|17
10816092|NCT01668940|11979481|FG001|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|14
10816093|NCT01668940|11979482|FG002|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|9
10736846|NCT02865434|11900957|FG005|COMPLETED|Overall Study||3
10736847|NCT02865434|11900958|FG006|COMPLETED|Overall Study||3
10736848|NCT02865434|11900959|FG007|COMPLETED|Overall Study||3
10736849|NCT02865434|11900960|FG008|COMPLETED|Overall Study||3
10736850|NCT02865434|11900961|FG009|COMPLETED|Overall Study||6
10736851|NCT02865434|11900962|FG010|COMPLETED|Overall Study||6
10736852|NCT02865434|11900952|FG000|NOT COMPLETED|Overall Study||0
10736853|NCT02865434|11900953|FG001|NOT COMPLETED|Overall Study||0
10736854|NCT02865434|11900954|FG002|NOT COMPLETED|Overall Study||0
10736855|NCT02865434|11900955|FG003|NOT COMPLETED|Overall Study||0
10736856|NCT02865434|11900956|FG004|NOT COMPLETED|Overall Study||0
10736857|NCT02865434|11900957|FG005|NOT COMPLETED|Overall Study||0
10736858|NCT02865434|11900958|FG006|NOT COMPLETED|Overall Study||0
10736859|NCT02865434|11900959|FG007|NOT COMPLETED|Overall Study||0
10736860|NCT02865434|11900960|FG008|NOT COMPLETED|Overall Study||0
10736861|NCT02865434|11900961|FG009|NOT COMPLETED|Overall Study||0
10736862|NCT02865434|11900962|FG010|NOT COMPLETED|Overall Study||0
10736863|NCT02865499|11900992|FG000|STARTED|Baseline||8
10736864|NCT02865499|11900992|FG000|COMPLETED|Baseline||6
10736865|NCT02865499|11900992|FG000|NOT COMPLETED|Baseline||2
10736866|NCT02865499|11900992|FG000|STARTED|8 Weeks||6
10736867|NCT02865499|11900992|FG000|COMPLETED|8 Weeks||6
10736868|NCT02865499|11900992|FG000|NOT COMPLETED|8 Weeks||0
10736869|NCT02865499|11900992|FG000|STARTED|12 Weeks||6
10736870|NCT02865499|11900992|FG000|COMPLETED|12 Weeks||6
10736871|NCT02865499|11900992|FG000|NOT COMPLETED|12 Weeks||0
10736872|NCT02865538|11901001|FG000|STARTED|Overall Study||18
10736873|NCT02865538|11901002|FG001|STARTED|Overall Study||15
10736874|NCT02865538|11901003|FG002|STARTED|Overall Study||15
10736875|NCT02865538|11901004|FG003|STARTED|Overall Study||15
10736876|NCT02865538|11901005|FG004|STARTED|Overall Study||13
10736877|NCT02865538|11901001|FG000|COMPLETED|Overall Study||17
10736878|NCT02865538|11901002|FG001|COMPLETED|Overall Study||15
10736879|NCT02865538|11901003|FG002|COMPLETED|Overall Study||14
10736880|NCT02865538|11901004|FG003|COMPLETED|Overall Study||15
10736881|NCT02865538|11901005|FG004|COMPLETED|Overall Study||13
10736882|NCT02865538|11901001|FG000|NOT COMPLETED|Overall Study||1
10736883|NCT02865538|11901002|FG001|NOT COMPLETED|Overall Study||0
10736884|NCT02865538|11901003|FG002|NOT COMPLETED|Overall Study||1
10736885|NCT02865538|11901004|FG003|NOT COMPLETED|Overall Study||0
10736886|NCT02865538|11901005|FG004|NOT COMPLETED|Overall Study||0
10736887|NCT02865590|11901019|FG000|STARTED|Overall Study||8
10736888|NCT02865590|11901020|FG001|STARTED|Overall Study||8
10736889|NCT02865590|11901019|FG000|COMPLETED|Overall Study||8
10736890|NCT02865590|11901020|FG001|COMPLETED|Overall Study||8
10736891|NCT02865590|11901019|FG000|NOT COMPLETED|Overall Study||0
10736892|NCT02865590|11901020|FG001|NOT COMPLETED|Overall Study||0
10736893|NCT02865720|11901028|FG000|STARTED|Overall Study||0
10736894|NCT02865720|11901029|FG001|STARTED|Overall Study||8
10736895|NCT02865720|11901028|FG000|COMPLETED|Overall Study||0
10736896|NCT02865720|11901029|FG001|COMPLETED|Overall Study||8
10736897|NCT02865720|11901028|FG000|NOT COMPLETED|Overall Study||0
10736898|NCT02865720|11901029|FG001|NOT COMPLETED|Overall Study||0
10736902|NCT02866175|11901041|FG000|STARTED|Overall Study||751
10736903|NCT02866175|11901042|FG001|STARTED|Overall Study||755
10736904|NCT02866175|11901041|FG000|COMPLETED|Overall Study||616
10736905|NCT02866175|11901042|FG001|COMPLETED|Overall Study||580
10736906|NCT02866175|11901041|FG000|NOT COMPLETED|Overall Study||135
10736907|NCT02866175|11901042|FG001|NOT COMPLETED|Overall Study||175
10736918|NCT02866942|11901058|FG000|STARTED|Overall Study||479
10736919|NCT02866942|11901058|FG000|COMPLETED|Overall Study||478
10736920|NCT02866942|11901058|FG000|NOT COMPLETED|Overall Study||1
10736921|NCT02867059|11901064|FG000|STARTED|Overall Study||7
10736922|NCT02867059|11901065|FG001|STARTED|Overall Study||10
10736923|NCT02867059|11901064|FG000|COMPLETED|Overall Study||7
10736924|NCT02867059|11901065|FG001|COMPLETED|Overall Study||8
10736925|NCT02867059|11901064|FG000|NOT COMPLETED|Overall Study||0
10736926|NCT02867059|11901065|FG001|NOT COMPLETED|Overall Study||2
10736927|NCT02867150|11901071|FG000|STARTED|Overall Study||58
10736928|NCT02867150|11901071|FG000|COMPLETED|Overall Study||58
10736929|NCT02867150|11901071|FG000|NOT COMPLETED|Overall Study||0
10736930|NCT02867163|11901075|FG000|STARTED|Overall Study||25
10736931|NCT02867163|11901075|FG000|COMPLETED|Overall Study||25
10736932|NCT02867163|11901075|FG000|NOT COMPLETED|Overall Study||0
10736933|NCT02867202|11901081|FG000|STARTED|Overall Study||83
10736934|NCT02867202|11901082|FG001|STARTED|Overall Study||88
10736935|NCT02867202|11901081|FG000|COMPLETED|Overall Study||62
10736936|NCT02867202|11901082|FG001|COMPLETED|Overall Study||56
10736937|NCT02867202|11901081|FG000|NOT COMPLETED|Overall Study||21
10736938|NCT02867202|11901082|FG001|NOT COMPLETED|Overall Study||32
10736939|NCT02867605|11901088|FG000|STARTED|Overall Study||20
10736940|NCT02867605|11901088|FG000|COMPLETED|Overall Study||20
10736941|NCT02867605|11901088|FG000|NOT COMPLETED|Overall Study||0
10736942|NCT02867618|11901105|FG000|STARTED|Overall Study||11
10736943|NCT02867618|11901105|FG000|COMPLETED|Overall Study||11
10736944|NCT02867618|11901105|FG000|NOT COMPLETED|Overall Study||0
10736945|NCT02867709|11901112|FG000|STARTED|Treatment Period||563
10736946|NCT02867709|11901113|FG001|STARTED|Treatment Period||561
10736947|NCT02867709|11901114|FG002|STARTED|Treatment Period||562
10736948|NCT02867709|11901112|FG000|Safety Population: Received Study Drug|Treatment Period||499
10736949|NCT02867709|11901113|FG001|Safety Population: Received Study Drug|Treatment Period||478
10736950|NCT02867709|11901114|FG002|Safety Population: Received Study Drug|Treatment Period||488
10736951|NCT02867709|11901112|FG000|COMPLETED|Treatment Period||493
10736952|NCT02867709|11901113|FG001|COMPLETED|Treatment Period||474
10736953|NCT02867709|11901114|FG002|COMPLETED|Treatment Period||487
10736954|NCT02867709|11901112|FG000|NOT COMPLETED|Treatment Period||70
10736955|NCT02867709|11901113|FG001|NOT COMPLETED|Treatment Period||87
10736956|NCT02867709|11901114|FG002|NOT COMPLETED|Treatment Period||75
10736957|NCT02867709|11901112|FG000|STARTED|Safety Follow-up Period||493
10736958|NCT02867709|11901113|FG001|STARTED|Safety Follow-up Period||474
10736959|NCT02867709|11901114|FG002|STARTED|Safety Follow-up Period||487
10736960|NCT02867709|11901112|FG000|COMPLETED|Safety Follow-up Period||482
10736961|NCT02867709|11901113|FG001|COMPLETED|Safety Follow-up Period||459
10736962|NCT02867709|11901114|FG002|COMPLETED|Safety Follow-up Period||473
10736963|NCT02867709|11901112|FG000|NOT COMPLETED|Safety Follow-up Period||11
10736964|NCT02867709|11901113|FG001|NOT COMPLETED|Safety Follow-up Period||15
10736965|NCT02867709|11901114|FG002|NOT COMPLETED|Safety Follow-up Period||14
10736966|NCT02867995|11901124|FG000|STARTED|Overall Study|Total patients consented|9
10736967|NCT02867995|11901125|FG001|STARTED|Overall Study|Total patients consented|30
10736968|NCT02867995|11901124|FG000|COMPLETED|Overall Study|Total patients completed|9
10736969|NCT02867995|11901125|FG001|COMPLETED|Overall Study|Total patients completed|27
10736970|NCT02867995|11901124|FG000|NOT COMPLETED|Overall Study||0
10736971|NCT02867995|11901125|FG001|NOT COMPLETED|Overall Study||3
10736972|NCT02868216|11901137|FG000|STARTED|Overall Study||43
10736973|NCT02868216|11901138|FG001|STARTED|Overall Study||47
10736974|NCT02868216|11901137|FG000|COMPLETED|Overall Study||35
10736975|NCT02868216|11901138|FG001|COMPLETED|Overall Study||41
10736976|NCT02868216|11901137|FG000|NOT COMPLETED|Overall Study||8
10736977|NCT02868216|11901138|FG001|NOT COMPLETED|Overall Study||6
10736978|NCT02868229|11901148|FG000|STARTED|Overall Study||12
10736979|NCT02868229|11901149|FG001|STARTED|Overall Study||16
10736980|NCT02868229|11901150|FG002|STARTED|Overall Study||16
10736981|NCT02868229|11901151|FG003|STARTED|Overall Study||17
10736982|NCT02868229|11901148|FG000|Intent to Treat (ITT) Population|Overall Study||12
10736983|NCT02868229|11901149|FG001|Intent to Treat (ITT) Population|Overall Study||16
10816094|NCT01668940|11979483|FG003|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|14
10816095|NCT01668940|11979480|FG000|NOT COMPLETED|Overall Study||0
10816096|NCT01668940|11979481|FG001|NOT COMPLETED|Overall Study||0
10816097|NCT01668940|11979482|FG002|NOT COMPLETED|Overall Study||0
10816098|NCT01668940|11979483|FG003|NOT COMPLETED|Overall Study||0
10816099|NCT01663285|11979493|FG000|STARTED|Overall Study||1
10816100|NCT01663285|11979493|FG000|COMPLETED|Overall Study||1
10816101|NCT01663285|11979493|FG000|NOT COMPLETED|Overall Study||0
10816102|NCT01683864|11979500|FG000|STARTED|Overall Study||0
10816103|NCT01683864|11979501|FG001|STARTED|Overall Study||0
10816104|NCT01683864|11979502|FG002|STARTED|Overall Study||0
10816105|NCT01683864|11979500|FG000|COMPLETED|Overall Study||0
10816106|NCT01683864|11979501|FG001|COMPLETED|Overall Study||0
10816107|NCT01683864|11979502|FG002|COMPLETED|Overall Study||0
10816108|NCT01683864|11979500|FG000|NOT COMPLETED|Overall Study||0
10816109|NCT01683864|11979501|FG001|NOT COMPLETED|Overall Study||0
10816110|NCT01683864|11979502|FG002|NOT COMPLETED|Overall Study||0
10816111|NCT01675011|11979512|FG000|STARTED|Overall Study||3
10816112|NCT01675011|11979513|FG001|STARTED|Overall Study||1
10816113|NCT01675011|11979512|FG000|COMPLETED|Overall Study||0
10816114|NCT01675011|11979513|FG001|COMPLETED|Overall Study||0
10816115|NCT01675011|11979512|FG000|NOT COMPLETED|Overall Study||3
10816116|NCT01675011|11979513|FG001|NOT COMPLETED|Overall Study||1
10816117|NCT01673425|11979519|FG000|STARTED|Overall Study||5
10816118|NCT01673425|11979519|FG000|COMPLETED|Overall Study||4
10816119|NCT01673425|11979519|FG000|NOT COMPLETED|Overall Study||1
10816120|NCT01673061|11979525|FG000|STARTED|Overall Study||0
10816121|NCT01673061|11979526|FG001|STARTED|Overall Study||0
10816122|NCT01673061|11979525|FG000|COMPLETED|Overall Study||0
10816123|NCT01673061|11979526|FG001|COMPLETED|Overall Study||0
10816124|NCT01673061|11979525|FG000|NOT COMPLETED|Overall Study||0
10816125|NCT01673061|11979526|FG001|NOT COMPLETED|Overall Study||0
10816126|NCT01675960|11979534|FG000|STARTED|Overall Study||2
10816127|NCT01675960|11979535|FG001|STARTED|Overall Study||0
10816128|NCT01675960|11979534|FG000|COMPLETED|Overall Study||2
10816129|NCT01675960|11979535|FG001|COMPLETED|Overall Study||0
10816130|NCT01675960|11979534|FG000|NOT COMPLETED|Overall Study||0
10816131|NCT01675960|11979535|FG001|NOT COMPLETED|Overall Study||0
10816132|NCT01668147|11979541|FG000|STARTED|Overall Study||13
10816133|NCT01668147|11979541|FG000|COMPLETED|Overall Study||7
10816134|NCT01668147|11979541|FG000|NOT COMPLETED|Overall Study||6
10816135|NCT01676701|11979551|FG000|STARTED|Overall Study||4
10816136|NCT01676701|11979552|FG001|STARTED|Overall Study||4
10736984|NCT02868229|11901150|FG002|Intent to Treat (ITT) Population|Overall Study||16
10736985|NCT02868229|11901151|FG003|Intent to Treat (ITT) Population|Overall Study||17
10736986|NCT02868229|11901148|FG000|Pharmacodynamic (PD) Population|Overall Study||12
10736987|NCT02868229|11901149|FG001|Pharmacodynamic (PD) Population|Overall Study||16
10736988|NCT02868229|11901150|FG002|Pharmacodynamic (PD) Population|Overall Study||13
10736989|NCT02868229|11901151|FG003|Pharmacodynamic (PD) Population|Overall Study||12
10736990|NCT02868229|11901148|FG000|Pharmacokinetic (PK) Population|Overall Study||12
10736991|NCT02868229|11901149|FG001|Pharmacokinetic (PK) Population|Overall Study||16
10736992|NCT02868229|11901150|FG002|Pharmacokinetic (PK) Population|Overall Study||16
10736993|NCT02868229|11901151|FG003|Pharmacokinetic (PK) Population|Overall Study||17
10736994|NCT02868229|11901148|FG000|Safety Analysis Population|Overall Study||12
10736995|NCT02868229|11901149|FG001|Safety Analysis Population|Overall Study||16
10736996|NCT02868229|11901150|FG002|Safety Analysis Population|Overall Study||16
10736997|NCT02868229|11901151|FG003|Safety Analysis Population|Overall Study||17
10736998|NCT02868229|11901148|FG000|Maximum Tolerated Dose (MTD) Population|Overall Study||12
10736999|NCT02868229|11901149|FG001|Maximum Tolerated Dose (MTD) Population|Overall Study||16
10737000|NCT02868229|11901150|FG002|Maximum Tolerated Dose (MTD) Population|Overall Study||16
10737001|NCT02868229|11901151|FG003|Maximum Tolerated Dose (MTD) Population|Overall Study||16
10737002|NCT02868229|11901148|FG000|COMPLETED|Overall Study||11
10737003|NCT02868229|11901149|FG001|COMPLETED|Overall Study||16
10737004|NCT02868229|11901150|FG002|COMPLETED|Overall Study||15
10737005|NCT02868229|11901151|FG003|COMPLETED|Overall Study||12
10737006|NCT02868229|11901148|FG000|NOT COMPLETED|Overall Study||1
10737007|NCT02868229|11901149|FG001|NOT COMPLETED|Overall Study||0
10737008|NCT02868229|11901150|FG002|NOT COMPLETED|Overall Study||1
10737009|NCT02868229|11901151|FG003|NOT COMPLETED|Overall Study||5
10737010|NCT02868242|11901166|FG000|STARTED|Overall Study||19
10737011|NCT02868242|11901166|FG000|COMPLETED|Overall Study||19
10737012|NCT02868242|11901166|FG000|NOT COMPLETED|Overall Study||0
10737013|NCT02868281|11901174|FG000|STARTED|Overall Study||252
10737014|NCT02868281|11901175|FG001|STARTED|Overall Study||278
10737015|NCT02868281|11901174|FG000|COMPLETED|Overall Study||209
10737016|NCT02868281|11901175|FG001|COMPLETED|Overall Study||234
10737017|NCT02868281|11901174|FG000|NOT COMPLETED|Overall Study||43
10737018|NCT02868281|11901175|FG001|NOT COMPLETED|Overall Study||44
10737019|NCT02868554|11901184|FG000|STARTED|Overall Study||10
10737020|NCT02868554|11901185|FG001|STARTED|Overall Study||12
10737021|NCT02868554|11901186|FG002|STARTED|Overall Study||12
10737022|NCT02868554|11901184|FG000|COMPLETED|Overall Study||7
10737023|NCT02868554|11901185|FG001|COMPLETED|Overall Study||12
10737024|NCT02868554|11901186|FG002|COMPLETED|Overall Study||11
10737025|NCT02868554|11901184|FG000|NOT COMPLETED|Overall Study||3
10737026|NCT02868554|11901185|FG001|NOT COMPLETED|Overall Study||0
10737027|NCT02868554|11901186|FG002|NOT COMPLETED|Overall Study||1
10737028|NCT02869295|11901199|FG000|STARTED|Overall Study||4
10737029|NCT02869295|11901200|FG001|STARTED|Overall Study||11
10737030|NCT02869295|11901201|FG002|STARTED|Overall Study||6
10737031|NCT02869295|11901202|FG003|STARTED|Overall Study||6
10737032|NCT02869295|11901203|FG004|STARTED|Overall Study||1
10737033|NCT02869295|11901199|FG000|COMPLETED|Overall Study||0
10737034|NCT02869295|11901200|FG001|COMPLETED|Overall Study||0
10737035|NCT02869295|11901201|FG002|COMPLETED|Overall Study||0
10737036|NCT02869295|11901202|FG003|COMPLETED|Overall Study||0
10737037|NCT02869295|11901203|FG004|COMPLETED|Overall Study||0
10737038|NCT02869295|11901199|FG000|NOT COMPLETED|Overall Study||4
10737039|NCT02869295|11901200|FG001|NOT COMPLETED|Overall Study||11
10737040|NCT02869295|11901201|FG002|NOT COMPLETED|Overall Study||6
10737041|NCT02869295|11901202|FG003|NOT COMPLETED|Overall Study||6
10737042|NCT02869295|11901203|FG004|NOT COMPLETED|Overall Study||1
10737043|NCT02869334|11901217|FG000|STARTED|Overall Study||10
10737044|NCT02869334|11901218|FG001|STARTED|Overall Study||10
10737045|NCT02869334|11901217|FG000|COMPLETED|Overall Study||2
10737046|NCT02869334|11901218|FG001|COMPLETED|Overall Study||3
10737047|NCT02869334|11901217|FG000|NOT COMPLETED|Overall Study||8
10737048|NCT02869334|11901218|FG001|NOT COMPLETED|Overall Study||7
10737049|NCT02869438|11901226|FG000|STARTED|Overall Study||118
10737050|NCT02869438|11901227|FG001|STARTED|Overall Study||115
10737051|NCT02869438|11901226|FG000|COMPLETED|Overall Study||115
10737052|NCT02869438|11901227|FG001|COMPLETED|Overall Study||113
10737053|NCT02869438|11901226|FG000|NOT COMPLETED|Overall Study||3
10737054|NCT02869438|11901227|FG001|NOT COMPLETED|Overall Study||2
10737055|NCT02869451|11901233|FG000|STARTED|Overall Study||5
10737056|NCT02869451|11901233|FG000|COMPLETED|Overall Study||5
10737057|NCT02869451|11901233|FG000|NOT COMPLETED|Overall Study||0
10737058|NCT02869893|11901237|FG000|STARTED|Overall Study||57
10737059|NCT02869893|11901237|FG000|COMPLETED|Overall Study||50
10737060|NCT02869893|11901237|FG000|NOT COMPLETED|Overall Study||7
10737061|NCT02870101|11901242|FG000|STARTED|Overall Study||2767
10737062|NCT02870101|11901242|FG000|COMPLETED|Overall Study||2598
10737063|NCT02870101|11901242|FG000|NOT COMPLETED|Overall Study||169
10737064|NCT02870205|11901261|FG000|STARTED|Overall Study||294
10737065|NCT02870205|11901262|FG001|STARTED|Overall Study||294
10737066|NCT02870205|11901263|FG002|STARTED|Overall Study||294
10737067|NCT02870205|11901264|FG003|STARTED|Overall Study||294
10737068|NCT02870205|11901261|FG000|COMPLETED|Overall Study||284
10737069|NCT02870205|11901262|FG001|COMPLETED|Overall Study||289
10737070|NCT02870205|11901263|FG002|COMPLETED|Overall Study||287
10737071|NCT02870205|11901264|FG003|COMPLETED|Overall Study||287
10737072|NCT02870205|11901261|FG000|NOT COMPLETED|Overall Study||10
10737073|NCT02870205|11901262|FG001|NOT COMPLETED|Overall Study||5
10737074|NCT02870205|11901263|FG002|NOT COMPLETED|Overall Study||7
10737075|NCT02870205|11901264|FG003|NOT COMPLETED|Overall Study||7
10737076|NCT02870283|11901277|FG000|STARTED|Overall Study||38
10737077|NCT02870283|11901278|FG001|STARTED|Overall Study||35
10737078|NCT02870283|11901279|FG002|STARTED|Overall Study||34
10737079|NCT02870283|11901277|FG000|COMPLETED|Overall Study||35
10737080|NCT02870283|11901278|FG001|COMPLETED|Overall Study||26
10737081|NCT02870283|11901279|FG002|COMPLETED|Overall Study||15
10737082|NCT02870283|11901277|FG000|NOT COMPLETED|Overall Study||3
10737083|NCT02870283|11901278|FG001|NOT COMPLETED|Overall Study||9
10737084|NCT02870283|11901279|FG002|NOT COMPLETED|Overall Study||19
10737085|NCT02870309|11901287|FG000|STARTED|Overall Study||4
10737086|NCT02870309|11901287|FG000|COMPLETED|Overall Study||4
10737087|NCT02870309|11901287|FG000|NOT COMPLETED|Overall Study||0
10737088|NCT02870933|11901293|FG000|STARTED|Overall Study||15
10737089|NCT02870933|11901294|FG001|STARTED|Overall Study||15
10737090|NCT02870933|11901293|FG000|COMPLETED|Overall Study||13
10737091|NCT02870933|11901294|FG001|COMPLETED|Overall Study||13
10737092|NCT02870933|11901293|FG000|NOT COMPLETED|Overall Study||2
10737093|NCT02870933|11901294|FG001|NOT COMPLETED|Overall Study||2
10737094|NCT02870972|11901306|FG000|STARTED|Overall Study||18
10737095|NCT02870972|11901307|FG001|STARTED|Overall Study||14
10737096|NCT02870972|11901308|FG002|STARTED|Overall Study||14
10737097|NCT02870972|11901309|FG003|STARTED|Overall Study||7
10737098|NCT02870972|11901310|FG004|STARTED|Overall Study||22
10737099|NCT02870972|11901306|FG000|COMPLETED|Overall Study||17
10737100|NCT02870972|11901307|FG001|COMPLETED|Overall Study||14
10737101|NCT02870972|11901308|FG002|COMPLETED|Overall Study||14
10737102|NCT02870972|11901309|FG003|COMPLETED|Overall Study||7
10737103|NCT02870972|11901310|FG004|COMPLETED|Overall Study||22
10737104|NCT02870972|11901306|FG000|NOT COMPLETED|Overall Study||1
10737105|NCT02870972|11901307|FG001|NOT COMPLETED|Overall Study||0
10737106|NCT02870972|11901308|FG002|NOT COMPLETED|Overall Study||0
10737107|NCT02870972|11901309|FG003|NOT COMPLETED|Overall Study||0
10737108|NCT02870972|11901310|FG004|NOT COMPLETED|Overall Study||0
10737109|NCT02871011|11901326|FG000|STARTED|Overall Study||7
10737110|NCT02871011|11901327|FG001|STARTED|Overall Study||13
10737111|NCT02871011|11901326|FG000|COMPLETED|Overall Study||7
10737112|NCT02871011|11901327|FG001|COMPLETED|Overall Study||13
10737113|NCT02871011|11901326|FG000|NOT COMPLETED|Overall Study||0
10737114|NCT02871011|11901327|FG001|NOT COMPLETED|Overall Study||0
10737115|NCT02871128|11901336|FG000|STARTED|Overall Study||20
10737116|NCT02871128|11901337|FG001|STARTED|Overall Study||20
10737117|NCT02871128|11901338|FG002|STARTED|Overall Study||16
10737118|NCT02871128|11901336|FG000|COMPLETED|Overall Study||20
10737119|NCT02871128|11901337|FG001|COMPLETED|Overall Study||19
10737120|NCT02871128|11901338|FG002|COMPLETED|Overall Study||15
10737121|NCT02871128|11901336|FG000|NOT COMPLETED|Overall Study||0
10737122|NCT02871128|11901337|FG001|NOT COMPLETED|Overall Study||1
10737123|NCT02871128|11901338|FG002|NOT COMPLETED|Overall Study||1
10737124|NCT02871375|11901346|FG000|STARTED|Period 1, First 14 Days of Wear||89
10737125|NCT02871375|11901347|FG001|STARTED|Period 1, First 14 Days of Wear||77
10737126|NCT02871375|11901346|FG000|COMPLETED|Period 1, First 14 Days of Wear||89
10737127|NCT02871375|11901347|FG001|COMPLETED|Period 1, First 14 Days of Wear||76
10737128|NCT02871375|11901346|FG000|NOT COMPLETED|Period 1, First 14 Days of Wear||0
10737129|NCT02871375|11901347|FG001|NOT COMPLETED|Period 1, First 14 Days of Wear||1
10737130|NCT02871375|11901346|FG000|STARTED|Period 2, Second 14 Days of Wear||89
10737131|NCT02871375|11901347|FG001|STARTED|Period 2, Second 14 Days of Wear||76
10737132|NCT02871375|11901346|FG000|COMPLETED|Period 2, Second 14 Days of Wear||89
10737133|NCT02871375|11901347|FG001|COMPLETED|Period 2, Second 14 Days of Wear||76
10737134|NCT02871375|11901346|FG000|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
10737135|NCT02871375|11901347|FG001|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
10737136|NCT02871440|11901358|FG000|STARTED|Overall Study||12
10737137|NCT02871440|11901359|FG001|STARTED|Overall Study||13
10737138|NCT02871440|11901360|FG002|STARTED|Overall Study||15
10737139|NCT02871440|11901358|FG000|COMPLETED|Overall Study||12
10737140|NCT02871440|11901359|FG001|COMPLETED|Overall Study||13
10737141|NCT02871440|11901360|FG002|COMPLETED|Overall Study||15
10737142|NCT02871440|11901358|FG000|NOT COMPLETED|Overall Study||0
10737143|NCT02871440|11901359|FG001|NOT COMPLETED|Overall Study||0
10737144|NCT02871440|11901360|FG002|NOT COMPLETED|Overall Study||0
10737145|NCT02871479|11901374|FG000|STARTED|Overall Study||36
10737146|NCT02871479|11901375|FG001|STARTED|Overall Study||24
10737147|NCT02871479|11901376|FG002|STARTED|Overall Study||11
10737148|NCT02871479|11901374|FG000|COMPLETED|Overall Study||33
10737149|NCT02871479|11901375|FG001|COMPLETED|Overall Study||21
10737150|NCT02871479|11901376|FG002|COMPLETED|Overall Study||11
10737151|NCT02871479|11901374|FG000|NOT COMPLETED|Overall Study||3
10737152|NCT02871479|11901375|FG001|NOT COMPLETED|Overall Study||3
10737153|NCT02871479|11901376|FG002|NOT COMPLETED|Overall Study||0
10737154|NCT02871492|11901387|FG000|STARTED|Overall Study||73
10737155|NCT02871492|11901388|FG001|STARTED|Overall Study||73
10737156|NCT02871492|11901389|FG002|STARTED|Overall Study||77
10737157|NCT02871492|11901387|FG000|COMPLETED|Overall Study||67
10737158|NCT02871492|11901388|FG001|COMPLETED|Overall Study||70
10737159|NCT02871492|11901389|FG002|COMPLETED|Overall Study||71
10737160|NCT02871492|11901387|FG000|NOT COMPLETED|Overall Study||6
10737161|NCT02871492|11901388|FG001|NOT COMPLETED|Overall Study||3
10737162|NCT02871492|11901389|FG002|NOT COMPLETED|Overall Study||6
10737163|NCT02871570|11901399|FG000|STARTED|Overall Study||8
10737164|NCT02871570|11901400|FG001|STARTED|Overall Study||8
10737165|NCT02871570|11901399|FG000|COMPLETED|Overall Study||8
10737166|NCT02871570|11901400|FG001|COMPLETED|Overall Study||8
10737167|NCT02871570|11901399|FG000|NOT COMPLETED|Overall Study||0
10737168|NCT02871570|11901400|FG001|NOT COMPLETED|Overall Study||0
10737169|NCT02871635|11901408|FG000|STARTED|Overall Study||72
10737170|NCT02871635|11901409|FG001|STARTED|Overall Study||75
10737171|NCT02871635|11901408|FG000|COMPLETED|Overall Study||54
10737172|NCT02871635|11901409|FG001|COMPLETED|Overall Study||56
10737173|NCT02871635|11901408|FG000|NOT COMPLETED|Overall Study||18
10737174|NCT02871635|11901409|FG001|NOT COMPLETED|Overall Study||19
10737175|NCT02871739|11901421|FG000|STARTED|Overall Study||6
10737176|NCT02871739|11901422|FG001|STARTED|Overall Study||6
10737177|NCT02871739|11901423|FG002|STARTED|Overall Study||4
10737178|NCT02871739|11901424|FG003|STARTED|Overall Study||7
10737179|NCT02871739|11901421|FG000|Completed First SPI|Overall Study||3
10737180|NCT02871739|11901422|FG001|Completed First SPI|Overall Study||5
10737181|NCT02871739|11901423|FG002|Completed First SPI|Overall Study||4
10737182|NCT02871739|11901424|FG003|Completed First SPI|Overall Study||6
10737183|NCT02871739|11901421|FG000|Completed Second SPI|Overall Study||3
10737184|NCT02871739|11901422|FG001|Completed Second SPI|Overall Study||4
10737185|NCT02871739|11901423|FG002|Completed Second SPI|Overall Study||4
10737186|NCT02871739|11901424|FG003|Completed Second SPI|Overall Study||5
10737187|NCT02871739|11901421|FG000|Complete Final Survey|Overall Study||3
10737188|NCT02871739|11901422|FG001|Complete Final Survey|Overall Study||4
10737189|NCT02871739|11901423|FG002|Complete Final Survey|Overall Study||4
10737190|NCT02871739|11901424|FG003|Complete Final Survey|Overall Study||5
10737191|NCT02871739|11901421|FG000|COMPLETED|Overall Study||3
10737192|NCT02871739|11901422|FG001|COMPLETED|Overall Study||4
10737193|NCT02871739|11901423|FG002|COMPLETED|Overall Study||4
10737194|NCT02871739|11901424|FG003|COMPLETED|Overall Study||5
10737195|NCT02871739|11901421|FG000|NOT COMPLETED|Overall Study||3
10737196|NCT02871739|11901422|FG001|NOT COMPLETED|Overall Study||2
10737197|NCT02871739|11901423|FG002|NOT COMPLETED|Overall Study||0
10737198|NCT02871739|11901424|FG003|NOT COMPLETED|Overall Study||2
10737199|NCT02872012|11901439|FG000|STARTED|Overall Study||4
10737200|NCT02872012|11901440|FG001|STARTED|Overall Study||7
10737201|NCT02872012|11901441|FG002|STARTED|Overall Study||4
10737202|NCT02872012|11901442|FG003|STARTED|Overall Study||3
10737203|NCT02872012|11901443|FG004|STARTED|Overall Study||5
10737204|NCT02872012|11901439|FG000|COMPLETED|Overall Study||3
10737205|NCT02872012|11901440|FG001|COMPLETED|Overall Study||7
10737206|NCT02872012|11901441|FG002|COMPLETED|Overall Study||4
10737207|NCT02872012|11901442|FG003|COMPLETED|Overall Study||3
10737208|NCT02872012|11901443|FG004|COMPLETED|Overall Study||5
10737209|NCT02872012|11901439|FG000|NOT COMPLETED|Overall Study||1
10737210|NCT02872012|11901440|FG001|NOT COMPLETED|Overall Study||0
10737211|NCT02872012|11901441|FG002|NOT COMPLETED|Overall Study||0
10737212|NCT02872012|11901442|FG003|NOT COMPLETED|Overall Study||0
10737213|NCT02872012|11901443|FG004|NOT COMPLETED|Overall Study||0
10737214|NCT02872103|11901459|FG000|STARTED|Cycle 1||83
10737215|NCT02872103|11901460|FG001|STARTED|Cycle 1||39
10737216|NCT02872103|11901459|FG000|COMPLETED|Cycle 1||83
10737217|NCT02872103|11901460|FG001|COMPLETED|Cycle 1||38
10737218|NCT02872103|11901459|FG000|NOT COMPLETED|Cycle 1||0
10737219|NCT02872103|11901460|FG001|NOT COMPLETED|Cycle 1||1
10737220|NCT02872103|11901459|FG000|STARTED|Cycle 2-4||83
10737221|NCT02872103|11901460|FG001|STARTED|Cycle 2-4|1 subject withdrawn in Cycle 1|38
10737222|NCT02872103|11901459|FG000|COMPLETED|Cycle 2-4||81
10737223|NCT02872103|11901460|FG001|COMPLETED|Cycle 2-4||37
10737224|NCT02872103|11901459|FG000|NOT COMPLETED|Cycle 2-4||2
10737225|NCT02872103|11901460|FG001|NOT COMPLETED|Cycle 2-4||1
10737226|NCT02872142|11901468|FG000|STARTED|Overall Study||12
10737227|NCT02872142|11901468|FG000|COMPLETED|Overall Study||6
10737228|NCT02872142|11901468|FG000|NOT COMPLETED|Overall Study||6
10737229|NCT02872285|11901474|FG000|STARTED|Overall Study||22
10737230|NCT02872285|11901475|FG001|STARTED|Overall Study||11
10737231|NCT02872285|11901474|FG000|COMPLETED|Overall Study||17
10737232|NCT02872285|11901475|FG001|COMPLETED|Overall Study||9
10737233|NCT02872285|11901474|FG000|NOT COMPLETED|Overall Study||5
10737234|NCT02872285|11901475|FG001|NOT COMPLETED|Overall Study||2
10737235|NCT02872311|11901486|FG000|STARTED|Overall Study||59
10737236|NCT02872311|11901487|FG001|STARTED|Overall Study||60
10737237|NCT02872311|11901488|FG002|STARTED|Overall Study||20
10737238|NCT02872311|11901489|FG003|STARTED|Overall Study||20
10737239|NCT02872311|11901490|FG004|STARTED|Overall Study||20
10737240|NCT02872311|11901486|FG000|COMPLETED|Overall Study||55
10737241|NCT02872311|11901487|FG001|COMPLETED|Overall Study||58
10737242|NCT02872311|11901488|FG002|COMPLETED|Overall Study||19
10737243|NCT02872311|11901489|FG003|COMPLETED|Overall Study||20
10737244|NCT02872311|11901490|FG004|COMPLETED|Overall Study||20
10737245|NCT02872311|11901486|FG000|NOT COMPLETED|Overall Study||4
10737246|NCT02872311|11901487|FG001|NOT COMPLETED|Overall Study||2
10737247|NCT02872311|11901488|FG002|NOT COMPLETED|Overall Study||1
10737248|NCT02872311|11901489|FG003|NOT COMPLETED|Overall Study||0
10737249|NCT02872311|11901490|FG004|NOT COMPLETED|Overall Study||0
10737250|NCT02872857|11901520|FG000|STARTED|Phase 1||15
10737251|NCT02872857|11901521|FG001|STARTED|Phase 1||15
10737252|NCT02872857|11901522|FG002|STARTED|Phase 1||0
10737253|NCT02872857|11901523|FG003|STARTED|Phase 1||0
10737254|NCT02872857|11901520|FG000|COMPLETED|Phase 1||15
10737255|NCT02872857|11901521|FG001|COMPLETED|Phase 1||15
10737256|NCT02872857|11901522|FG002|COMPLETED|Phase 1||0
10737257|NCT02872857|11901523|FG003|COMPLETED|Phase 1||0
10737258|NCT02872857|11901520|FG000|NOT COMPLETED|Phase 1||0
10737259|NCT02872857|11901521|FG001|NOT COMPLETED|Phase 1||0
10737260|NCT02872857|11901522|FG002|NOT COMPLETED|Phase 1||0
10737261|NCT02872857|11901523|FG003|NOT COMPLETED|Phase 1||0
10737262|NCT02872857|11901520|FG000|STARTED|Phase 2||0
10737263|NCT02872857|11901521|FG001|STARTED|Phase 2||0
10737264|NCT02872857|11901522|FG002|STARTED|Phase 2||15
10737265|NCT02872857|11901523|FG003|STARTED|Phase 2||15
10737266|NCT02872857|11901520|FG000|COMPLETED|Phase 2||0
10737267|NCT02872857|11901521|FG001|COMPLETED|Phase 2||0
10737268|NCT02872857|11901522|FG002|COMPLETED|Phase 2||15
10737269|NCT02872857|11901523|FG003|COMPLETED|Phase 2||15
10737270|NCT02872857|11901520|FG000|NOT COMPLETED|Phase 2||0
10737271|NCT02872857|11901521|FG001|NOT COMPLETED|Phase 2||0
10737272|NCT02872857|11901522|FG002|NOT COMPLETED|Phase 2||0
10737273|NCT02872857|11901523|FG003|NOT COMPLETED|Phase 2||0
10737274|NCT02872909|11901531|FG000|STARTED|Overall Study||32
10737275|NCT02872909|11901532|FG001|STARTED|Overall Study||18
10737276|NCT02872909|11901531|FG000|COMPLETED|Overall Study||32
10737277|NCT02872909|11901532|FG001|COMPLETED|Overall Study||18
10737278|NCT02872909|11901531|FG000|NOT COMPLETED|Overall Study||0
10737279|NCT02872909|11901532|FG001|NOT COMPLETED|Overall Study||0
10737280|NCT02872935|11901540|FG000|STARTED|Overall Study||11
10737281|NCT02872935|11901541|FG001|STARTED|Overall Study||11
10737282|NCT02872935|11901540|FG000|COMPLETED|Overall Study||11
10737283|NCT02872935|11901541|FG001|COMPLETED|Overall Study|One subject consented but did no proceed with the study.|10
10737284|NCT02872935|11901540|FG000|NOT COMPLETED|Overall Study||0
10737285|NCT02872935|11901541|FG001|NOT COMPLETED|Overall Study||1
10737286|NCT02873104|11901549|FG000|STARTED|Overall Study||47
10737287|NCT02873104|11901550|FG001|STARTED|Overall Study||23
10737288|NCT02873104|11901549|FG000|COMPLETED|Overall Study||46
10737289|NCT02873104|11901550|FG001|COMPLETED|Overall Study||23
10737290|NCT02873104|11901549|FG000|NOT COMPLETED|Overall Study||1
10737291|NCT02873104|11901550|FG001|NOT COMPLETED|Overall Study||0
10778014|NCT03347279|11939899|FG000|STARTED|Overall Study||529
10778015|NCT03347279|11939900|FG001|STARTED|Overall Study||532
10778016|NCT03347279|11939899|FG000|Received Treatment|Overall Study||528
10778017|NCT03347279|11939900|FG001|Received Treatment|Overall Study||531
10778018|NCT03347279|11939899|FG000|COMPLETED|Overall Study||513
10778019|NCT03347279|11939900|FG001|COMPLETED|Overall Study||509
10778020|NCT03347279|11939899|FG000|NOT COMPLETED|Overall Study||16
10778021|NCT03347279|11939900|FG001|NOT COMPLETED|Overall Study||23
10778022|NCT03347695|11939908|FG000|STARTED|Overall Study||20
10778023|NCT03347695|11939909|FG001|STARTED|Overall Study||120
10778024|NCT03347695|11939908|FG000|COMPLETED|Overall Study||20
10778025|NCT03347695|11939909|FG001|COMPLETED|Overall Study||115
10778026|NCT03347695|11939908|FG000|NOT COMPLETED|Overall Study||0
10778027|NCT03347695|11939909|FG001|NOT COMPLETED|Overall Study||5
10778028|NCT03348683|11939919|FG000|STARTED|Overall Study||121
10778029|NCT03348683|11939920|FG001|STARTED|Overall Study||119
10778030|NCT03348683|11939919|FG000|COMPLETED|Overall Study||121
10778031|NCT03348683|11939920|FG001|COMPLETED|Overall Study||119
10778032|NCT03348683|11939919|FG000|NOT COMPLETED|Overall Study||0
10778033|NCT03348683|11939920|FG001|NOT COMPLETED|Overall Study||0
10778034|NCT03349034|11939928|FG000|STARTED|Overall Study||12
10778035|NCT03349034|11939929|FG001|STARTED|Overall Study||12
10778036|NCT03349034|11939928|FG000|COMPLETED|Overall Study||8
10778037|NCT03349034|11939929|FG001|COMPLETED|Overall Study||10
10778038|NCT03349034|11939928|FG000|NOT COMPLETED|Overall Study||4
10778039|NCT03349034|11939929|FG001|NOT COMPLETED|Overall Study||2
10778040|NCT03349060|11939940|FG000|STARTED|Overall Study||156
10778041|NCT03349060|11939941|FG001|STARTED|Overall Study||154
10778042|NCT03349060|11939942|FG002|STARTED|Overall Study||77
10778043|NCT03349060|11939940|FG000|COMPLETED|Overall Study||135
10778044|NCT03349060|11939941|FG001|COMPLETED|Overall Study||137
10778045|NCT03349060|11939942|FG002|COMPLETED|Overall Study||61
10778046|NCT03349060|11939940|FG000|NOT COMPLETED|Overall Study||21
10778047|NCT03349060|11939941|FG001|NOT COMPLETED|Overall Study||17
10778048|NCT03349060|11939942|FG002|NOT COMPLETED|Overall Study||16
10778049|NCT03349099|11939952|FG000|STARTED|Overall Study||48
10778050|NCT03349099|11939953|FG001|STARTED|Overall Study||47
10778051|NCT03349099|11939952|FG000|COMPLETED|Overall Study||44
10778052|NCT03349099|11939953|FG001|COMPLETED|Overall Study||43
10778053|NCT03349099|11939952|FG000|NOT COMPLETED|Overall Study||4
10778054|NCT03349099|11939953|FG001|NOT COMPLETED|Overall Study||4
10778055|NCT03349333|11939959|FG000|STARTED|Overall Study||71
10778056|NCT03349333|11939959|FG000|COMPLETED|Overall Study||0
10778057|NCT03349333|11939959|FG000|NOT COMPLETED|Overall Study||71
10778058|NCT03349437|11939963|FG000|STARTED|Screening||25
10778059|NCT03349437|11939964|FG001|STARTED|Screening||0
10778060|NCT03349437|11939965|FG002|STARTED|Screening||0
10778061|NCT03349437|11939963|FG000|COMPLETED|Screening||20
10778062|NCT03349437|11939964|FG001|COMPLETED|Screening||0
10778063|NCT03349437|11939965|FG002|COMPLETED|Screening||0
10778064|NCT03349437|11939963|FG000|NOT COMPLETED|Screening||5
10778065|NCT03349437|11939964|FG001|NOT COMPLETED|Screening||0
10778066|NCT03349437|11939965|FG002|NOT COMPLETED|Screening||0
10778067|NCT03349437|11939963|FG000|STARTED|Intervention||0
10778068|NCT03349437|11939964|FG001|STARTED|Intervention||10
10778069|NCT03349437|11939965|FG002|STARTED|Intervention||10
10778070|NCT03349437|11939963|FG000|COMPLETED|Intervention||0
10778071|NCT03349437|11939964|FG001|COMPLETED|Intervention||10
10778072|NCT03349437|11939965|FG002|COMPLETED|Intervention||10
10778073|NCT03349437|11939963|FG000|NOT COMPLETED|Intervention||0
10778074|NCT03349437|11939964|FG001|NOT COMPLETED|Intervention||0
10737292|NCT02873208|11901556|FG000|STARTED|Overall Study||265
10737293|NCT02873208|11901556|FG000|COMPLETED|Overall Study||167
10737294|NCT02873208|11901556|FG000|NOT COMPLETED|Overall Study||98
10737295|NCT02873221|11901563|FG000|STARTED|Treatment Period||417
10737296|NCT02873221|11901564|FG001|STARTED|Treatment Period||417
10737297|NCT02873221|11901565|FG002|STARTED|Treatment Period||420
10737298|NCT02873221|11901563|FG000|Safety Population: Received Study Drug|Treatment Period||417
10737299|NCT02873221|11901564|FG001|Safety Population: Received Study Drug|Treatment Period||404
10737300|NCT02873221|11901565|FG002|Safety Population: Received Study Drug|Treatment Period||409
10737301|NCT02873221|11901563|FG000|COMPLETED|Treatment Period||329
10737302|NCT02873221|11901564|FG001|COMPLETED|Treatment Period||291
10737303|NCT02873221|11901565|FG002|COMPLETED|Treatment Period||315
10737304|NCT02873221|11901563|FG000|NOT COMPLETED|Treatment Period||88
10816137|NCT01676701|11979551|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
10816138|NCT01676701|11979552|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4
10816139|NCT01676701|11979551|FG000|Completed Post-Treatment Follow-Up|Overall Study||4
10816140|NCT01676701|11979552|FG001|Completed Post-Treatment Follow-Up|Overall Study||4
10816141|NCT01676701|11979551|FG000|COMPLETED|Overall Study||0
10816142|NCT01676701|11979552|FG001|COMPLETED|Overall Study||0
10816143|NCT01676701|11979551|FG000|NOT COMPLETED|Overall Study||4
10816144|NCT01676701|11979552|FG001|NOT COMPLETED|Overall Study||4
10816145|NCT01669148|11979560|FG000|STARTED|Overall Study||496
10816146|NCT01669148|11979560|FG000|COMPLETED|Overall Study||426
10816147|NCT01669148|11979560|FG000|NOT COMPLETED|Overall Study||70
10816148|NCT01662102|11979567|FG000|STARTED|Overall Study||1
10816149|NCT01662102|11979568|FG001|STARTED|Overall Study||0
10816150|NCT01662102|11979567|FG000|COMPLETED|Overall Study||0
10816151|NCT01662102|11979568|FG001|COMPLETED|Overall Study||0
10816152|NCT01662102|11979567|FG000|NOT COMPLETED|Overall Study||1
10816153|NCT01662102|11979568|FG001|NOT COMPLETED|Overall Study||0
10816154|NCT01659554|11979575|FG000|STARTED|Overall Study|4 subjects enrolled; 4 subjects treated and 4 did not complete protocol schema|4
10816155|NCT01659554|11979575|FG000|COMPLETED|Overall Study||0
10816156|NCT01659554|11979575|FG000|NOT COMPLETED|Overall Study||4
10816157|NCT01658813|11979579|FG000|STARTED|Overall Study||18
10816158|NCT01658813|11979579|FG000|Eligible|Overall Study||18
10816159|NCT01658813|11979579|FG000|Treated|Overall Study||18
10816160|NCT01658813|11979579|FG000|COMPLETED|Overall Study||15
10816161|NCT01658813|11979579|FG000|NOT COMPLETED|Overall Study||3
10816162|NCT01648296|11979589|FG000|STARTED|Overall Study||11
10816163|NCT01648296|11979590|FG001|STARTED|Overall Study||17
10816164|NCT01648296|11979589|FG000|COMPLETED|Overall Study||11
10816165|NCT01648296|11979590|FG001|COMPLETED|Overall Study||17
10816166|NCT01648296|11979589|FG000|NOT COMPLETED|Overall Study||0
10816167|NCT01648296|11979590|FG001|NOT COMPLETED|Overall Study||0
10816168|NCT01649505|11979600|FG000|STARTED|Overall Study||1
10816169|NCT01649505|11979601|FG001|STARTED|Overall Study||1
10816170|NCT01649505|11979600|FG000|COMPLETED|Overall Study||0
10816171|NCT01649505|11979601|FG001|COMPLETED|Overall Study||0
10816172|NCT01649505|11979600|FG000|NOT COMPLETED|Overall Study||1
10816173|NCT01649505|11979601|FG001|NOT COMPLETED|Overall Study||1
10816174|NCT01642732|11979607|FG000|STARTED|Overall Study||1
10816175|NCT01642732|11979607|FG000|COMPLETED|Overall Study||0
10816176|NCT01642732|11979607|FG000|NOT COMPLETED|Overall Study||1
10816177|NCT01645709|11979613|FG000|STARTED|Overall Study|Study was terminated; not made unblind|0
10816178|NCT01645709|11979614|FG001|STARTED|Overall Study|Study was terminated; not made unblind|0
10816179|NCT01645709|11979613|FG000|COMPLETED|Overall Study|Study was terminated; not made unblind|0
10816180|NCT01645709|11979614|FG001|COMPLETED|Overall Study|Study was terminated; not made unblind|0
10816181|NCT01645709|11979613|FG000|NOT COMPLETED|Overall Study||0
10816182|NCT01645709|11979614|FG001|NOT COMPLETED|Overall Study||0
10816183|NCT01648270|11979620|FG000|STARTED|Intravenous Buprenorphine||25
10816184|NCT01648270|11979620|FG000|COMPLETED|Intravenous Buprenorphine||13
10816185|NCT01648270|11979620|FG000|NOT COMPLETED|Intravenous Buprenorphine||12
10816186|NCT01648270|11979620|FG000|STARTED|Sublingual Buprenorphine||13
10816187|NCT01648270|11979620|FG000|COMPLETED|Sublingual Buprenorphine||13
10816188|NCT01648270|11979620|FG000|NOT COMPLETED|Sublingual Buprenorphine||0
10816189|NCT01648270|11979620|FG000|STARTED|Cyclosporine Plus IV Buprenorphine||13
10816190|NCT01648270|11979620|FG000|COMPLETED|Cyclosporine Plus IV Buprenorphine||13
10816191|NCT01648270|11979620|FG000|NOT COMPLETED|Cyclosporine Plus IV Buprenorphine||0
10816192|NCT01648270|11979620|FG000|STARTED|Cyclosporine + Sublingual Buprenorphine||13
10816193|NCT01648270|11979620|FG000|COMPLETED|Cyclosporine + Sublingual Buprenorphine||13
10816194|NCT01648270|11979620|FG000|NOT COMPLETED|Cyclosporine + Sublingual Buprenorphine||0
10816195|NCT01643525|11979630|FG000|STARTED|Overall Study||29
10816196|NCT01643525|11979630|FG000|COMPLETED|Overall Study||29
10816197|NCT01643525|11979630|FG000|NOT COMPLETED|Overall Study||0
10816198|NCT01641601|11979636|FG000|STARTED|Overall Study||3
10816199|NCT01641601|11979637|FG001|STARTED|Overall Study||5
10816200|NCT01641601|11979636|FG000|COMPLETED|Overall Study|Study discontinued prior to data collection.|0
10816201|NCT01641601|11979637|FG001|COMPLETED|Overall Study|Study discontinued prior to data collection.|0
10816202|NCT01641601|11979636|FG000|NOT COMPLETED|Overall Study||3
10816203|NCT01641601|11979637|FG001|NOT COMPLETED|Overall Study||5
10816204|NCT01633814|11979643|FG000|STARTED|Overall Study||4
10816205|NCT01633814|11979643|FG000|COMPLETED|Overall Study||4
10816206|NCT01633814|11979643|FG000|NOT COMPLETED|Overall Study||0
10816207|NCT01636466|11979649|FG000|STARTED|Overall Study||1
10816208|NCT01636466|11979650|FG001|STARTED|Overall Study||0
10737305|NCT02873221|11901564|FG001|NOT COMPLETED|Treatment Period||126
10737306|NCT02873221|11901565|FG002|NOT COMPLETED|Treatment Period||105
10737307|NCT02873221|11901563|FG000|STARTED|Safety Follow-up Period||350
10737308|NCT02873221|11901564|FG001|STARTED|Safety Follow-up Period||356
10737309|NCT02873221|11901565|FG002|STARTED|Safety Follow-up Period||364
10737310|NCT02873221|11901563|FG000|COMPLETED|Safety Follow-up Period||343
10816209|NCT01636466|11979649|FG000|COMPLETED|Overall Study||0
10816210|NCT01636466|11979650|FG001|COMPLETED|Overall Study||0
10816211|NCT01636466|11979649|FG000|NOT COMPLETED|Overall Study||1
10816212|NCT01636466|11979650|FG001|NOT COMPLETED|Overall Study||0
10816213|NCT01629329|11979658|FG000|STARTED|Overall Study||0
10816214|NCT01629329|11979659|FG001|STARTED|Overall Study||0
10816215|NCT01629329|11979658|FG000|COMPLETED|Overall Study||0
10816216|NCT01629329|11979659|FG001|COMPLETED|Overall Study||0
10816217|NCT01629329|11979658|FG000|NOT COMPLETED|Overall Study||0
10816218|NCT01629329|11979659|FG001|NOT COMPLETED|Overall Study||0
10816219|NCT01627899|11979665|FG000|STARTED|Overall Study||5
10816220|NCT01627899|11979665|FG000|COMPLETED|Overall Study||0
10816221|NCT01627899|11979665|FG000|NOT COMPLETED|Overall Study||5
10816222|NCT01632020|11979671|FG000|STARTED|Overall Study||4
10816223|NCT01632020|11979672|FG001|STARTED|Overall Study||3
10816224|NCT01632020|11979671|FG000|COMPLETED|Overall Study||2
10816225|NCT01632020|11979672|FG001|COMPLETED|Overall Study||3
10816226|NCT01632020|11979671|FG000|NOT COMPLETED|Overall Study||2
10816227|NCT01632020|11979672|FG001|NOT COMPLETED|Overall Study||0
10816228|NCT01602471|11979678|FG000|STARTED|Overall Study||4
10816229|NCT01602471|11979678|FG000|COMPLETED|Overall Study||4
10816230|NCT01602471|11979678|FG000|NOT COMPLETED|Overall Study||0
10816231|NCT01619800|11979684|FG000|STARTED|Overall Study||2
10816232|NCT01619800|11979685|FG001|STARTED|Overall Study||0
10816233|NCT01619800|11979684|FG000|COMPLETED|Overall Study||0
10816234|NCT01619800|11979685|FG001|COMPLETED|Overall Study||0
10816235|NCT01619800|11979684|FG000|NOT COMPLETED|Overall Study||2
10816236|NCT01619800|11979685|FG001|NOT COMPLETED|Overall Study||0
10816237|NCT01608906|11979691|FG000|STARTED|Overall Study||152
10816238|NCT01608906|11979691|FG000|COMPLETED|Overall Study||113
10816239|NCT01608906|11979691|FG000|NOT COMPLETED|Overall Study||39
10816240|NCT01621737|11979696|FG000|STARTED|Overall Study||0
10816241|NCT01621737|11979696|FG000|COMPLETED|Overall Study||0
10816242|NCT01621737|11979696|FG000|NOT COMPLETED|Overall Study||0
10816243|NCT01614067|11979702|FG000|STARTED|Overall Study||15
10816244|NCT01614067|11979703|FG001|STARTED|Overall Study||15
10816245|NCT01614067|11979702|FG000|COMPLETED|Overall Study||0
10816246|NCT01614067|11979703|FG001|COMPLETED|Overall Study||0
10816247|NCT01614067|11979702|FG000|NOT COMPLETED|Overall Study||15
10816248|NCT01614067|11979703|FG001|NOT COMPLETED|Overall Study||15
10816249|NCT01607320|11979709|FG000|STARTED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
10816250|NCT01607320|11979710|FG001|STARTED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
10816251|NCT01607320|11979709|FG000|COMPLETED|Overall Study|The study was randomized between the 2 treatments and was never unblinded,so unknown.|0
10816252|NCT01607320|11979710|FG001|COMPLETED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
10816253|NCT01607320|11979709|FG000|NOT COMPLETED|Overall Study||0
10816254|NCT01607320|11979710|FG001|NOT COMPLETED|Overall Study||0
10816255|NCT01605019|11979716|FG000|STARTED|Overall Study||4
10816256|NCT01605019|11979717|FG001|STARTED|Overall Study||0
10816257|NCT01605019|11979716|FG000|COMPLETED|Overall Study||1
10816258|NCT01605019|11979717|FG001|COMPLETED|Overall Study||0
10816259|NCT01605019|11979716|FG000|NOT COMPLETED|Overall Study||3
10816260|NCT01605019|11979717|FG001|NOT COMPLETED|Overall Study||0
10737311|NCT02873221|11901564|FG001|COMPLETED|Safety Follow-up Period||339
10737312|NCT02873221|11901565|FG002|COMPLETED|Safety Follow-up Period||350
10737313|NCT02873221|11901563|FG000|NOT COMPLETED|Safety Follow-up Period||7
10737314|NCT02873221|11901564|FG001|NOT COMPLETED|Safety Follow-up Period||17
10737315|NCT02873221|11901565|FG002|NOT COMPLETED|Safety Follow-up Period||14
10737316|NCT02873286|11901578|FG000|STARTED|Main Study||78
10737317|NCT02873286|11901579|FG001|STARTED|Main Study||89
10737318|NCT02873286|11901580|FG002|STARTED|Main Study||80
10737319|NCT02873286|11901581|FG003|STARTED|Main Study||90
10737320|NCT02873286|11901582|FG004|STARTED|Main Study||83
10737321|NCT02873286|11901578|FG000|COMPLETED|Main Study||76
10737322|NCT02873286|11901579|FG001|COMPLETED|Main Study||84
10737323|NCT02873286|11901580|FG002|COMPLETED|Main Study||78
10737324|NCT02873286|11901581|FG003|COMPLETED|Main Study||89
10737325|NCT02873286|11901582|FG004|COMPLETED|Main Study||81
10737326|NCT02873286|11901578|FG000|NOT COMPLETED|Main Study||2
10737327|NCT02873286|11901579|FG001|NOT COMPLETED|Main Study||5
10737328|NCT02873286|11901580|FG002|NOT COMPLETED|Main Study||2
10737329|NCT02873286|11901581|FG003|NOT COMPLETED|Main Study||1
10737330|NCT02873286|11901582|FG004|NOT COMPLETED|Main Study||2
10737331|NCT02873286|11901578|FG000|STARTED|Booster Substudy||43
10737332|NCT02873286|11901579|FG001|STARTED|Booster Substudy||0
10737333|NCT02873286|11901580|FG002|STARTED|Booster Substudy||45
10737334|NCT02873286|11901581|FG003|STARTED|Booster Substudy||0
10737335|NCT02873286|11901582|FG004|STARTED|Booster Substudy||0
10737336|NCT02873286|11901578|FG000|COMPLETED|Booster Substudy||43
10737337|NCT02873286|11901579|FG001|COMPLETED|Booster Substudy||0
10737338|NCT02873286|11901580|FG002|COMPLETED|Booster Substudy||45
10737339|NCT02873286|11901581|FG003|COMPLETED|Booster Substudy||0
10737340|NCT02873286|11901582|FG004|COMPLETED|Booster Substudy||0
10737341|NCT02873286|11901578|FG000|NOT COMPLETED|Booster Substudy||0
10737342|NCT02873286|11901579|FG001|NOT COMPLETED|Booster Substudy||0
10737343|NCT02873286|11901580|FG002|NOT COMPLETED|Booster Substudy||0
10737344|NCT02873286|11901581|FG003|NOT COMPLETED|Booster Substudy||0
10737345|NCT02873286|11901582|FG004|NOT COMPLETED|Booster Substudy||0
10737346|NCT02873338|11901597|FG000|STARTED|Overall Study||26
10737347|NCT02873338|11901598|FG001|STARTED|Overall Study||25
10737348|NCT02873338|11901599|FG002|STARTED|Overall Study||24
10737349|NCT02873338|11901597|FG000|COMPLETED|Overall Study||8
10737350|NCT02873338|11901598|FG001|COMPLETED|Overall Study||4
10737351|NCT02873338|11901599|FG002|COMPLETED|Overall Study||6
10737352|NCT02873338|11901597|FG000|NOT COMPLETED|Overall Study||18
10737353|NCT02873338|11901598|FG001|NOT COMPLETED|Overall Study||21
10737354|NCT02873338|11901599|FG002|NOT COMPLETED|Overall Study||18
10737355|NCT02873377|11901609|FG000|STARTED|Period 1: Enrollment||65
10737356|NCT02873377|11901610|FG001|STARTED|Period 1: Enrollment||69
10737357|NCT02873377|11901609|FG000|COMPLETED|Period 1: Enrollment||65
10737358|NCT02873377|11901610|FG001|COMPLETED|Period 1: Enrollment||69
10737359|NCT02873377|11901609|FG000|NOT COMPLETED|Period 1: Enrollment||0
10737360|NCT02873377|11901610|FG001|NOT COMPLETED|Period 1: Enrollment||0
10737361|NCT02873377|11901609|FG000|STARTED|Period Title 2: 3 Months Follow up||65
10737362|NCT02873377|11901610|FG001|STARTED|Period Title 2: 3 Months Follow up||69
10737363|NCT02873377|11901609|FG000|COMPLETED|Period Title 2: 3 Months Follow up||43
10737364|NCT02873377|11901610|FG001|COMPLETED|Period Title 2: 3 Months Follow up||47
10737365|NCT02873377|11901609|FG000|NOT COMPLETED|Period Title 2: 3 Months Follow up||22
10737366|NCT02873377|11901610|FG001|NOT COMPLETED|Period Title 2: 3 Months Follow up||22
10737367|NCT02873377|11901609|FG000|STARTED|Period Title 3: 6 Months Follow up||65
10737368|NCT02873377|11901610|FG001|STARTED|Period Title 3: 6 Months Follow up||69
10737369|NCT02873377|11901609|FG000|COMPLETED|Period Title 3: 6 Months Follow up||50
10737370|NCT02873377|11901610|FG001|COMPLETED|Period Title 3: 6 Months Follow up||46
10737371|NCT02873377|11901609|FG000|NOT COMPLETED|Period Title 3: 6 Months Follow up||15
10737372|NCT02873377|11901610|FG001|NOT COMPLETED|Period Title 3: 6 Months Follow up||23
10737373|NCT02873429|11901619|FG000|STARTED|Baseline||109
10737374|NCT02873429|11901620|FG001|STARTED|Baseline||100
10737375|NCT02873429|11901619|FG000|COMPLETED|Baseline||109
10737376|NCT02873429|11901620|FG001|COMPLETED|Baseline||100
10737377|NCT02873429|11901619|FG000|NOT COMPLETED|Baseline||0
10737378|NCT02873429|11901620|FG001|NOT COMPLETED|Baseline||0
10737379|NCT02873429|11901619|FG000|STARTED|6-8 Weeks|4 CAM participants not eligible to complete follow ups because they did not continue treatment.|105
10737380|NCT02873429|11901620|FG001|STARTED|6-8 Weeks|2 Con. participants not eligible to complete follow ups because they did not continue treatment.|98
10737381|NCT02873429|11901619|FG000|COMPLETED|6-8 Weeks||95
10737382|NCT02873429|11901620|FG001|COMPLETED|6-8 Weeks||97
10737383|NCT02873429|11901619|FG000|NOT COMPLETED|6-8 Weeks||10
10737384|NCT02873429|11901620|FG001|NOT COMPLETED|6-8 Weeks||1
10737385|NCT02873429|11901619|FG000|STARTED|16 Weeks|10 CAM participants Missed 6-8 week but are eligible for 16 week|105
10737386|NCT02873429|11901620|FG001|STARTED|16 Weeks|1 Conv. participant Missed 6-8 week but was eligible for 16 week|98
10737387|NCT02873429|11901619|FG000|COMPLETED|16 Weeks||100
10737388|NCT02873429|11901620|FG001|COMPLETED|16 Weeks||96
10737389|NCT02873429|11901619|FG000|NOT COMPLETED|16 Weeks||5
10737390|NCT02873429|11901620|FG001|NOT COMPLETED|16 Weeks||2
10737391|NCT02873481|11901628|FG000|STARTED|Overall Study||15
10737392|NCT02873481|11901629|FG001|STARTED|Overall Study||17
10737393|NCT02873481|11901628|FG000|COMPLETED|Overall Study||15
10737394|NCT02873481|11901629|FG001|COMPLETED|Overall Study||17
10737395|NCT02873481|11901628|FG000|NOT COMPLETED|Overall Study||0
10737396|NCT02873481|11901629|FG001|NOT COMPLETED|Overall Study||0
10737397|NCT02873585|11901635|FG000|STARTED|Overall Study||32
10737398|NCT02873585|11901635|FG000|COMPLETED|Overall Study||32
10737399|NCT02873585|11901635|FG000|NOT COMPLETED|Overall Study||0
10737400|NCT02873689|11901645|FG000|STARTED|Overall Study||109
10737401|NCT02873689|11901646|FG001|STARTED|Overall Study||108
10737402|NCT02873689|11901645|FG000|Treated|Overall Study||108
10737403|NCT02873689|11901646|FG001|Treated|Overall Study||107
10737404|NCT02873689|11901645|FG000|COMPLETED|Overall Study||102
10737405|NCT02873689|11901646|FG001|COMPLETED|Overall Study||103
10737406|NCT02873689|11901645|FG000|NOT COMPLETED|Overall Study||7
10737407|NCT02873689|11901646|FG001|NOT COMPLETED|Overall Study||5
10737408|NCT02873702|11901654|FG000|STARTED|Healing Period (up to Week 8)||20
10737409|NCT02873702|11901655|FG001|STARTED|Healing Period (up to Week 8)||17
10737410|NCT02873702|11901656|FG002|STARTED|Healing Period (up to Week 8)||0
10737411|NCT02873702|11901657|FG003|STARTED|Healing Period (up to Week 8)||0
10737412|NCT02873702|11901654|FG000|COMPLETED|Healing Period (up to Week 8)||19
10737413|NCT02873702|11901655|FG001|COMPLETED|Healing Period (up to Week 8)||16
10737414|NCT02873702|11901656|FG002|COMPLETED|Healing Period (up to Week 8)||0
10737415|NCT02873702|11901657|FG003|COMPLETED|Healing Period (up to Week 8)||0
10737416|NCT02873702|11901654|FG000|NOT COMPLETED|Healing Period (up to Week 8)||1
10737417|NCT02873702|11901655|FG001|NOT COMPLETED|Healing Period (up to Week 8)||1
10737418|NCT02873702|11901656|FG002|NOT COMPLETED|Healing Period (up to Week 8)||0
10737419|NCT02873702|11901657|FG003|NOT COMPLETED|Healing Period (up to Week 8)||0
10737420|NCT02873702|11901654|FG000|STARTED|Maintenance Period (up to Month 6)||0
10737421|NCT02873702|11901655|FG001|STARTED|Maintenance Period (up to Month 6)||0
10737422|NCT02873702|11901656|FG002|STARTED|Maintenance Period (up to Month 6)||8
10737423|NCT02873702|11901657|FG003|STARTED|Maintenance Period (up to Month 6)||8
10737424|NCT02873702|11901654|FG000|COMPLETED|Maintenance Period (up to Month 6)||0
10737425|NCT02873702|11901655|FG001|COMPLETED|Maintenance Period (up to Month 6)||0
10737426|NCT02873702|11901656|FG002|COMPLETED|Maintenance Period (up to Month 6)||1
10737427|NCT02873702|11901657|FG003|COMPLETED|Maintenance Period (up to Month 6)||6
10737428|NCT02873702|11901654|FG000|NOT COMPLETED|Maintenance Period (up to Month 6)||0
10737429|NCT02873702|11901655|FG001|NOT COMPLETED|Maintenance Period (up to Month 6)||0
10737430|NCT02873702|11901656|FG002|NOT COMPLETED|Maintenance Period (up to Month 6)||7
10737431|NCT02873702|11901657|FG003|NOT COMPLETED|Maintenance Period (up to Month 6)||2
10737432|NCT02873754|11901667|FG000|STARTED|Overall Study||11
10737433|NCT02873754|11901667|FG000|COMPLETED|Overall Study||5
10737434|NCT02873754|11901667|FG000|NOT COMPLETED|Overall Study||6
10737435|NCT02873923|11901671|FG000|STARTED|Overall Study||2846
10737436|NCT02873923|11901671|FG000|COMPLETED|Overall Study||2846
10737437|NCT02873923|11901671|FG000|NOT COMPLETED|Overall Study||0
10737438|NCT02873936|11901678|FG000|STARTED|Overall Study||148
10737439|NCT02873936|11901679|FG001|STARTED|Overall Study||153
10737440|NCT02873936|11901680|FG002|STARTED|Overall Study||148
10737441|NCT02873936|11901678|FG000|COMPLETED|Overall Study||135
10737442|NCT02873936|11901679|FG001|COMPLETED|Overall Study||130
10816261|NCT01609231|11979725|FG000|STARTED|Overall Study||6
10816262|NCT01609231|11979726|FG001|STARTED|Overall Study||5
10816263|NCT01609231|11979725|FG000|COMPLETED|Overall Study||3
10816264|NCT01609231|11979726|FG001|COMPLETED|Overall Study||2
10816265|NCT01609231|11979725|FG000|NOT COMPLETED|Overall Study||3
10816266|NCT01609231|11979726|FG001|NOT COMPLETED|Overall Study||3
10816267|NCT01602198|11979734|FG000|STARTED|Overall Study||0
10816268|NCT01602198|11979735|FG001|STARTED|Overall Study||1
10816269|NCT01602198|11979734|FG000|COMPLETED|Overall Study||0
10816270|NCT01602198|11979735|FG001|COMPLETED|Overall Study||1
10816271|NCT01602198|11979734|FG000|NOT COMPLETED|Overall Study||0
10816272|NCT01602198|11979735|FG001|NOT COMPLETED|Overall Study||0
10816273|NCT01606150|11979743|FG000|STARTED|Overall Study||0
10816274|NCT01606150|11979744|FG001|STARTED|Overall Study||0
10816275|NCT01606150|11979743|FG000|COMPLETED|Overall Study|Enrollment was only for two months in 2012 due to technical and enrollment problems|0
10816276|NCT01606150|11979744|FG001|COMPLETED|Overall Study|Enrollment was only for two months in 2012 due to technical and enrollment problems|0
10816277|NCT01606150|11979743|FG000|NOT COMPLETED|Overall Study||0
10816278|NCT01606150|11979744|FG001|NOT COMPLETED|Overall Study||0
10816279|NCT01603043|11979752|FG000|STARTED|Overall Study||7
10816280|NCT01603043|11979753|FG001|STARTED|Overall Study||3
10816281|NCT01603043|11979752|FG000|COMPLETED|Overall Study||0
10816282|NCT01603043|11979753|FG001|COMPLETED|Overall Study||0
10816283|NCT01603043|11979752|FG000|NOT COMPLETED|Overall Study||7
10816284|NCT01603043|11979753|FG001|NOT COMPLETED|Overall Study||3
10816285|NCT01605370|11979761|FG000|STARTED|Overall Study||1
10816286|NCT01605370|11979762|FG001|STARTED|Overall Study||0
10816287|NCT01605370|11979761|FG000|COMPLETED|Overall Study||0
10816288|NCT01605370|11979762|FG001|COMPLETED|Overall Study||0
10816289|NCT01605370|11979761|FG000|NOT COMPLETED|Overall Study||1
10737443|NCT02873936|11901680|FG002|COMPLETED|Overall Study||116
10737444|NCT02873936|11901678|FG000|NOT COMPLETED|Overall Study||13
10737445|NCT02873936|11901679|FG001|NOT COMPLETED|Overall Study||23
10737446|NCT02873936|11901680|FG002|NOT COMPLETED|Overall Study||32
10737447|NCT02874066|11901688|FG000|STARTED|Overall Study||46
10737448|NCT02874066|11901688|FG000|COMPLETED|Overall Study||46
10737449|NCT02874066|11901688|FG000|NOT COMPLETED|Overall Study||0
10737450|NCT02874092|11901694|FG000|STARTED|Overall Study||7
10737451|NCT02874092|11901695|FG001|STARTED|Overall Study||2
10737452|NCT02874092|11901694|FG000|COMPLETED|Overall Study||7
10737453|NCT02874092|11901695|FG001|COMPLETED|Overall Study||2
10737454|NCT02874092|11901694|FG000|NOT COMPLETED|Overall Study||0
10737455|NCT02874092|11901695|FG001|NOT COMPLETED|Overall Study||0
10816290|NCT01605370|11979762|FG001|NOT COMPLETED|Overall Study||0
10816291|NCT01605617|11979770|FG000|STARTED|First Intervention||2
10816292|NCT01605617|11979771|FG001|STARTED|First Intervention||2
10816293|NCT01605617|11979770|FG000|COMPLETED|First Intervention||2
10816294|NCT01605617|11979771|FG001|COMPLETED|First Intervention||1
10816295|NCT01605617|11979770|FG000|NOT COMPLETED|First Intervention||0
10737456|NCT02874404|11901700|FG000|STARTED|Overall Study||13
10737457|NCT02874404|11901700|FG000|COMPLETED|Overall Study||13
10737458|NCT02874404|11901700|FG000|NOT COMPLETED|Overall Study||0
10737459|NCT02874534|11901707|FG000|STARTED|Overall Study||31
10737460|NCT02874534|11901708|FG001|STARTED|Overall Study||26
10737461|NCT02874534|11901707|FG000|COMPLETED|Overall Study||23
10737462|NCT02874534|11901708|FG001|COMPLETED|Overall Study||15
10737463|NCT02874534|11901707|FG000|NOT COMPLETED|Overall Study||8
10737464|NCT02874534|11901708|FG001|NOT COMPLETED|Overall Study||11
10737465|NCT02874794|11901716|FG000|STARTED|Overall Study||233
10737466|NCT02874794|11901717|FG001|STARTED|Overall Study||232
10816296|NCT01605617|11979771|FG001|NOT COMPLETED|First Intervention||1
10816297|NCT01605617|11979770|FG000|STARTED|Washout Period of 4 Weeks||2
10816298|NCT01605617|11979771|FG001|STARTED|Washout Period of 4 Weeks||1
10816299|NCT01605617|11979770|FG000|COMPLETED|Washout Period of 4 Weeks||0
10816300|NCT01605617|11979771|FG001|COMPLETED|Washout Period of 4 Weeks||0
10816301|NCT01605617|11979770|FG000|NOT COMPLETED|Washout Period of 4 Weeks||2
10816302|NCT01605617|11979771|FG001|NOT COMPLETED|Washout Period of 4 Weeks||1
10816303|NCT01605617|11979770|FG000|STARTED|Second Intervention||0
10816304|NCT01605617|11979771|FG001|STARTED|Second Intervention||0
10816305|NCT01605617|11979770|FG000|COMPLETED|Second Intervention||0
10816306|NCT01605617|11979771|FG001|COMPLETED|Second Intervention||0
10816307|NCT01605617|11979770|FG000|NOT COMPLETED|Second Intervention||0
10816308|NCT01605617|11979771|FG001|NOT COMPLETED|Second Intervention||0
10816309|NCT01606709|11979781|FG000|STARTED|Overall Study||4
10816310|NCT01606709|11979782|FG001|STARTED|Overall Study||3
10816311|NCT01606709|11979781|FG000|COMPLETED|Overall Study||4
10816312|NCT01606709|11979782|FG001|COMPLETED|Overall Study||3
10816313|NCT01606709|11979781|FG000|NOT COMPLETED|Overall Study||0
10816314|NCT01606709|11979782|FG001|NOT COMPLETED|Overall Study||0
10816315|NCT01603121|11979788|FG000|STARTED|First Intervention, 10 Hours||1
10816316|NCT01603121|11979789|FG001|STARTED|First Intervention, 10 Hours||0
10816317|NCT01603121|11979788|FG000|COMPLETED|First Intervention, 10 Hours||1
10816318|NCT01603121|11979789|FG001|COMPLETED|First Intervention, 10 Hours||0
10816319|NCT01603121|11979788|FG000|NOT COMPLETED|First Intervention, 10 Hours||0
10816320|NCT01603121|11979789|FG001|NOT COMPLETED|First Intervention, 10 Hours||0
10816321|NCT01603121|11979788|FG000|STARTED|Second Intervention, 10 Hours||1
10816322|NCT01603121|11979789|FG001|STARTED|Second Intervention, 10 Hours||0
10816323|NCT01603121|11979788|FG000|COMPLETED|Second Intervention, 10 Hours||0
10816324|NCT01603121|11979789|FG001|COMPLETED|Second Intervention, 10 Hours||0
10816325|NCT01603121|11979788|FG000|NOT COMPLETED|Second Intervention, 10 Hours||1
10816326|NCT01603121|11979789|FG001|NOT COMPLETED|Second Intervention, 10 Hours||0
10816327|NCT01602016|11979795|FG000|STARTED|Overall Study||0
10816328|NCT01602016|11979795|FG000|COMPLETED|Overall Study||0
10816329|NCT01602016|11979795|FG000|NOT COMPLETED|Overall Study||0
10816330|NCT01603394|11979802|FG000|STARTED|Overall Study||9
10816331|NCT01603394|11979802|FG000|COMPLETED|Overall Study||8
10816332|NCT01603394|11979802|FG000|NOT COMPLETED|Overall Study||1
10816333|NCT01592383|11979806|FG000|STARTED|Overall Study||2
10816334|NCT01592383|11979806|FG000|COMPLETED|Overall Study||1
10816335|NCT01592383|11979806|FG000|NOT COMPLETED|Overall Study||1
10816336|NCT01598025|11979813|FG000|STARTED|Overall Study||0
10816337|NCT01598025|11979814|FG001|STARTED|Overall Study||3
10816338|NCT01598025|11979813|FG000|COMPLETED|Overall Study||0
10816339|NCT01598025|11979814|FG001|COMPLETED|Overall Study||0
10816340|NCT01598025|11979813|FG000|NOT COMPLETED|Overall Study||0
10816341|NCT01598025|11979814|FG001|NOT COMPLETED|Overall Study||3
10816342|NCT01587963|11979821|FG000|STARTED|Overall Study||7
10816343|NCT01587963|11979822|FG001|STARTED|Overall Study||4
10816344|NCT01587963|11979821|FG000|COMPLETED|Overall Study||6
10816345|NCT01587963|11979822|FG001|COMPLETED|Overall Study||4
10816346|NCT01587963|11979821|FG000|NOT COMPLETED|Overall Study||1
10816347|NCT01587963|11979822|FG001|NOT COMPLETED|Overall Study||0
10816348|NCT01591096|11979828|FG000|STARTED|Overall Study||1
10816349|NCT01591096|11979828|FG000|COMPLETED|Overall Study||0
10816350|NCT01591096|11979828|FG000|NOT COMPLETED|Overall Study||1
10816351|NCT01591954|11979832|FG000|STARTED|Overall Study||1
10816352|NCT01591954|11979832|FG000|COMPLETED|Overall Study||1
10816353|NCT01591954|11979832|FG000|NOT COMPLETED|Overall Study||0
10816354|NCT01589926|11979838|FG000|STARTED|Overall Study||0
10816355|NCT01589926|11979839|FG001|STARTED|Overall Study||0
10737467|NCT02874794|11901716|FG000|COMPLETED|Overall Study||226
10737468|NCT02874794|11901717|FG001|COMPLETED|Overall Study||221
10737469|NCT02874794|11901716|FG000|NOT COMPLETED|Overall Study||7
10737470|NCT02874794|11901717|FG001|NOT COMPLETED|Overall Study||11
10737471|NCT02874846|11901728|FG000|STARTED|Overall Study||8
10737472|NCT02874846|11901729|FG001|STARTED|Overall Study||4
10737473|NCT02874846|11901728|FG000|COMPLETED|Overall Study||8
10737474|NCT02874846|11901729|FG001|COMPLETED|Overall Study||4
10737475|NCT02874846|11901728|FG000|NOT COMPLETED|Overall Study||0
10737476|NCT02874846|11901729|FG001|NOT COMPLETED|Overall Study||0
10737477|NCT02874924|11901739|FG000|STARTED|Overall Study||14
10816356|NCT01589926|11979838|FG000|COMPLETED|Overall Study||0
10816357|NCT01589926|11979839|FG001|COMPLETED|Overall Study||0
10816358|NCT01589926|11979838|FG000|NOT COMPLETED|Overall Study||0
10816359|NCT01589926|11979839|FG001|NOT COMPLETED|Overall Study||0
10816360|NCT01576575|11979845|FG000|STARTED|Buprenorphine Control||21
10816361|NCT01576575|11979845|FG000|COMPLETED|Buprenorphine Control||18
10816362|NCT01576575|11979845|FG000|NOT COMPLETED|Buprenorphine Control||3
10737478|NCT02874924|11901740|FG001|STARTED|Overall Study||14
10737479|NCT02874924|11901741|FG002|STARTED|Overall Study||6
10737480|NCT02874924|11901739|FG000|COMPLETED|Overall Study||11
10737481|NCT02874924|11901740|FG001|COMPLETED|Overall Study||14
10737482|NCT02874924|11901741|FG002|COMPLETED|Overall Study||6
10737483|NCT02874924|11901739|FG000|NOT COMPLETED|Overall Study||3
10737484|NCT02874924|11901740|FG001|NOT COMPLETED|Overall Study||0
10737485|NCT02874924|11901741|FG002|NOT COMPLETED|Overall Study||0
10737486|NCT02875028|11901751|FG000|STARTED|First Intervention (24 Hours)||8
10737487|NCT02875028|11901752|FG001|STARTED|First Intervention (24 Hours)||8
10737488|NCT02875028|11901751|FG000|COMPLETED|First Intervention (24 Hours)||8
10737489|NCT02875028|11901752|FG001|COMPLETED|First Intervention (24 Hours)||8
10737490|NCT02875028|11901751|FG000|NOT COMPLETED|First Intervention (24 Hours)||0
10737491|NCT02875028|11901752|FG001|NOT COMPLETED|First Intervention (24 Hours)||0
10737492|NCT02875028|11901751|FG000|STARTED|Washout Period||8
10816363|NCT01576575|11979845|FG000|STARTED|Buprenorphine + Rifampin||18
10816364|NCT01576575|11979845|FG000|COMPLETED|Buprenorphine + Rifampin||15
10816365|NCT01576575|11979845|FG000|NOT COMPLETED|Buprenorphine + Rifampin||3
10816366|NCT01576575|11979845|FG000|STARTED|Buprenorphine + Grapefruit||15
10816367|NCT01576575|11979845|FG000|COMPLETED|Buprenorphine + Grapefruit||14
10816368|NCT01576575|11979845|FG000|NOT COMPLETED|Buprenorphine + Grapefruit||1
10816369|NCT01576575|11979845|FG000|STARTED|Buprenorphine + Ketoconazole||14
10816370|NCT01576575|11979845|FG000|COMPLETED|Buprenorphine + Ketoconazole||14
10816371|NCT01576575|11979845|FG000|NOT COMPLETED|Buprenorphine + Ketoconazole||0
10737493|NCT02875028|11901752|FG001|STARTED|Washout Period||8
10737494|NCT02875028|11901751|FG000|COMPLETED|Washout Period||8
10737495|NCT02875028|11901752|FG001|COMPLETED|Washout Period||7
10737496|NCT02875028|11901751|FG000|NOT COMPLETED|Washout Period||0
10737497|NCT02875028|11901752|FG001|NOT COMPLETED|Washout Period||1
10737498|NCT02875028|11901751|FG000|STARTED|Second Intervention (24 Hours)||8
10737499|NCT02875028|11901752|FG001|STARTED|Second Intervention (24 Hours)||7
10737500|NCT02875028|11901751|FG000|COMPLETED|Second Intervention (24 Hours)||8
10737501|NCT02875028|11901752|FG001|COMPLETED|Second Intervention (24 Hours)||7
10737502|NCT02875028|11901751|FG000|NOT COMPLETED|Second Intervention (24 Hours)||0
10737503|NCT02875028|11901752|FG001|NOT COMPLETED|Second Intervention (24 Hours)||0
10737504|NCT02875080|11901763|FG000|STARTED|Overall Study||6
10816372|NCT01590394|11979855|FG000|STARTED|Overall Study||3
10816373|NCT01590394|11979855|FG000|COMPLETED|Overall Study||3
10816374|NCT01590394|11979855|FG000|NOT COMPLETED|Overall Study||0
10816375|NCT01577628|11979861|FG000|STARTED|Overall Study||0
10816376|NCT01577628|11979862|FG001|STARTED|Overall Study||0
10816377|NCT01577628|11979863|FG002|STARTED|Overall Study||2
10816378|NCT01577628|11979861|FG000|COMPLETED|Overall Study||0
10816379|NCT01577628|11979862|FG001|COMPLETED|Overall Study||0
10737505|NCT02875080|11901764|FG001|STARTED|Overall Study||6
10737506|NCT02875080|11901765|FG002|STARTED|Overall Study||6
10737507|NCT02875080|11901763|FG000|COMPLETED|Overall Study||4
10737508|NCT02875080|11901764|FG001|COMPLETED|Overall Study||6
10737509|NCT02875080|11901765|FG002|COMPLETED|Overall Study||6
10737510|NCT02875080|11901763|FG000|NOT COMPLETED|Overall Study||2
10737511|NCT02875080|11901764|FG001|NOT COMPLETED|Overall Study||0
10737512|NCT02875080|11901765|FG002|NOT COMPLETED|Overall Study||0
10737513|NCT02875340|11901773|FG000|STARTED|Overall Study||8
10737514|NCT02875340|11901773|FG000|COMPLETED|Overall Study|No patients completed 6 months of continuous treatment|0
10737515|NCT02875340|11901773|FG000|NOT COMPLETED|Overall Study||8
10737516|NCT02875366|11901785|FG000|STARTED|Overall Study||36
10737517|NCT02875366|11901786|FG001|STARTED|Overall Study||34
10737518|NCT02875366|11901785|FG000|COMPLETED|Overall Study||36
10737519|NCT02875366|11901786|FG001|COMPLETED|Overall Study||31
10737520|NCT02875366|11901785|FG000|NOT COMPLETED|Overall Study||0
10737521|NCT02875366|11901786|FG001|NOT COMPLETED|Overall Study||3
10737522|NCT02875392|11901794|FG000|STARTED|Overall Study||28
10737523|NCT02875392|11901795|FG001|STARTED|Overall Study||29
10737524|NCT02875392|11901794|FG000|COMPLETED|Overall Study||21
10737525|NCT02875392|11901795|FG001|COMPLETED|Overall Study||21
10737526|NCT02875392|11901794|FG000|NOT COMPLETED|Overall Study||7
10737527|NCT02875392|11901795|FG001|NOT COMPLETED|Overall Study||8
10737528|NCT02875613|11901801|FG000|STARTED|Overall Study||5
10737529|NCT02875613|11901801|FG000|COMPLETED|Overall Study||4
10737530|NCT02875613|11901801|FG000|NOT COMPLETED|Overall Study||1
10737531|NCT02875834|11901809|FG000|STARTED|Open-label Phase||267
10737532|NCT02875834|11901810|FG001|STARTED|Open-label Phase||0
10737533|NCT02875834|11901811|FG002|STARTED|Open-label Phase||0
10737534|NCT02875834|11901812|FG003|STARTED|Open-label Phase||0
10737535|NCT02875834|11901809|FG000|COMPLETED|Open-label Phase||260
10737536|NCT02875834|11901810|FG001|COMPLETED|Open-label Phase||0
10737537|NCT02875834|11901811|FG002|COMPLETED|Open-label Phase||0
10737538|NCT02875834|11901812|FG003|COMPLETED|Open-label Phase||0
10737539|NCT02875834|11901809|FG000|NOT COMPLETED|Open-label Phase||7
10737540|NCT02875834|11901810|FG001|NOT COMPLETED|Open-label Phase||0
10737541|NCT02875834|11901811|FG002|NOT COMPLETED|Open-label Phase||0
10737542|NCT02875834|11901812|FG003|NOT COMPLETED|Open-label Phase||0
10816380|NCT01577628|11979863|FG002|COMPLETED|Overall Study||0
10816381|NCT01577628|11979861|FG000|NOT COMPLETED|Overall Study||0
10737543|NCT02875834|11901809|FG000|STARTED|Randomized Treatment Phase|No subjects were randomized in 10g TID group in RTP.|0
10778075|NCT03349437|11939965|FG002|NOT COMPLETED|Intervention||0
10816382|NCT01577628|11979862|FG001|NOT COMPLETED|Overall Study||0
10816383|NCT01577628|11979863|FG002|NOT COMPLETED|Overall Study||2
10737544|NCT02875834|11901810|FG001|STARTED|Randomized Treatment Phase|99 subjects were randomized in 5g QD group in RTP.|99
10737545|NCT02875834|11901811|FG002|STARTED|Randomized Treatment Phase|99 subjects were randomized in 10g QD group in RTP.|99
10737546|NCT02875834|11901812|FG003|STARTED|Randomized Treatment Phase|50 subjects were randomized in placebo group in RTP.|50
10737547|NCT02875834|11901809|FG000|COMPLETED|Randomized Treatment Phase||0
10737548|NCT02875834|11901810|FG001|COMPLETED|Randomized Treatment Phase||85
10737549|NCT02875834|11901811|FG002|COMPLETED|Randomized Treatment Phase||88
10737550|NCT02875834|11901812|FG003|COMPLETED|Randomized Treatment Phase||41
10737551|NCT02875834|11901809|FG000|NOT COMPLETED|Randomized Treatment Phase||0
10737552|NCT02875834|11901810|FG001|NOT COMPLETED|Randomized Treatment Phase||14
10737553|NCT02875834|11901811|FG002|NOT COMPLETED|Randomized Treatment Phase||11
10737554|NCT02875834|11901812|FG003|NOT COMPLETED|Randomized Treatment Phase||9
10737555|NCT02875977|11901824|FG000|STARTED|Overall Study||100
10737556|NCT02875977|11901825|FG001|STARTED|Overall Study||100
10737557|NCT02875977|11901824|FG000|COMPLETED|Overall Study||58
10737558|NCT02875977|11901825|FG001|COMPLETED|Overall Study||71
10737559|NCT02875977|11901824|FG000|NOT COMPLETED|Overall Study||42
10737560|NCT02875977|11901825|FG001|NOT COMPLETED|Overall Study||29
10737561|NCT02876055|11901834|FG000|STARTED|Overall Study||42
10737562|NCT02876055|11901835|FG001|STARTED|Overall Study||41
10737563|NCT02876055|11901836|FG002|STARTED|Overall Study||42
10737564|NCT02876055|11901834|FG000|COMPLETED|Overall Study||42
10737565|NCT02876055|11901835|FG001|COMPLETED|Overall Study||41
10737566|NCT02876055|11901836|FG002|COMPLETED|Overall Study||42
10737567|NCT02876055|11901834|FG000|NOT COMPLETED|Overall Study||0
10737568|NCT02876055|11901835|FG001|NOT COMPLETED|Overall Study||0
10737569|NCT02876055|11901836|FG002|NOT COMPLETED|Overall Study||0
10737570|NCT02876159|11901846|FG000|STARTED|Overall Study||10
10737571|NCT02876159|11901847|FG001|STARTED|Overall Study||10
10737572|NCT02876159|11901846|FG000|COMPLETED|Overall Study||10
10737573|NCT02876159|11901847|FG001|COMPLETED|Overall Study||10
10737574|NCT02876159|11901846|FG000|NOT COMPLETED|Overall Study||0
10737575|NCT02876159|11901847|FG001|NOT COMPLETED|Overall Study||0
10737576|NCT02876575|11901856|FG000|STARTED|Overall Study||48
10737577|NCT02876575|11901856|FG000|COMPLETED|Overall Study||48
10737578|NCT02876575|11901856|FG000|NOT COMPLETED|Overall Study||0
10737579|NCT02876601|11901865|FG000|STARTED|First Intervention (24 Hours)||8
10737580|NCT02876601|11901866|FG001|STARTED|First Intervention (24 Hours)||8
10737581|NCT02876601|11901867|FG002|STARTED|First Intervention (24 Hours)||2
10737582|NCT02876601|11901868|FG003|STARTED|First Intervention (24 Hours)||2
10816384|NCT01582100|11979869|FG000|STARTED|Overall Study||2
10816385|NCT01582100|11979869|FG000|COMPLETED|Overall Study||0
10816386|NCT01582100|11979869|FG000|NOT COMPLETED|Overall Study||2
10816387|NCT01583647|11979873|FG000|STARTED|Overall Study||10
10816388|NCT01583647|11979874|FG001|STARTED|Overall Study|Study terminated prior to Panel B being conducted.|0
10816389|NCT01583647|11979873|FG000|COMPLETED|Overall Study||10
10816390|NCT01583647|11979874|FG001|COMPLETED|Overall Study||0
10816391|NCT01583647|11979873|FG000|NOT COMPLETED|Overall Study||0
10816392|NCT01583647|11979874|FG001|NOT COMPLETED|Overall Study||0
10816393|NCT01575028|11979882|FG000|STARTED|Overall Study||2
10816394|NCT01575028|11979883|FG001|STARTED|Overall Study||1
10816395|NCT01575028|11979882|FG000|COMPLETED|Overall Study||2
10816396|NCT01575028|11979883|FG001|COMPLETED|Overall Study||0
10816397|NCT01575028|11979882|FG000|NOT COMPLETED|Overall Study||0
10816398|NCT01575028|11979883|FG001|NOT COMPLETED|Overall Study||1
10816399|NCT01578785|11979891|FG000|STARTED|Overall Study||59
10816400|NCT01578785|11979892|FG001|STARTED|Overall Study||119
10816401|NCT01578785|11979891|FG000|COMPLETED|Overall Study||0
10816402|NCT01578785|11979892|FG001|COMPLETED|Overall Study||0
10816403|NCT01578785|11979891|FG000|NOT COMPLETED|Overall Study||59
10816404|NCT01578785|11979892|FG001|NOT COMPLETED|Overall Study||119
10816405|NCT01576549|11979898|FG000|STARTED|Overall Study||2
10816406|NCT01576549|11979898|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2
10816407|NCT01576549|11979898|FG000|Completed Post-Treatment Follow-Up|Overall Study|Each participant discontinued dosing and completed the Post-Treatment Follow-Up Period.|2
10816408|NCT01576549|11979898|FG000|COMPLETED|Overall Study||0
10816409|NCT01576549|11979898|FG000|NOT COMPLETED|Overall Study||2
10816410|NCT01570634|11979903|FG000|STARTED|Overall Study||2
10816411|NCT01570634|11979903|FG000|COMPLETED|Overall Study||2
10816412|NCT01570634|11979903|FG000|NOT COMPLETED|Overall Study||0
10816413|NCT01566370|11979909|FG000|STARTED|Overall Study||2
10816414|NCT01566370|11979910|FG001|STARTED|Overall Study||1
10816415|NCT01566370|11979909|FG000|COMPLETED|Overall Study||0
10816416|NCT01566370|11979910|FG001|COMPLETED|Overall Study||0
10816417|NCT01566370|11979909|FG000|NOT COMPLETED|Overall Study||2
10816418|NCT01566370|11979910|FG001|NOT COMPLETED|Overall Study||1
10816419|NCT01561989|11979918|FG000|STARTED|Overall Study||5
10816420|NCT01561989|11979919|FG001|STARTED|Overall Study||6
10816421|NCT01561989|11979918|FG000|COMPLETED|Overall Study||0
10816422|NCT01561989|11979919|FG001|COMPLETED|Overall Study||0
10816423|NCT01561989|11979918|FG000|NOT COMPLETED|Overall Study||5
10816424|NCT01561989|11979919|FG001|NOT COMPLETED|Overall Study||6
10816425|NCT01564732|11979927|FG000|STARTED|Overall Study||6
10816426|NCT01564732|11979928|FG001|STARTED|Overall Study||5
10737583|NCT02876601|11901865|FG000|COMPLETED|First Intervention (24 Hours)||8
10737584|NCT02876601|11901866|FG001|COMPLETED|First Intervention (24 Hours)||8
10816427|NCT01564732|11979927|FG000|COMPLETED|Overall Study||0
10816428|NCT01564732|11979928|FG001|COMPLETED|Overall Study||0
10816429|NCT01564732|11979927|FG000|NOT COMPLETED|Overall Study||6
10737585|NCT02876601|11901867|FG002|COMPLETED|First Intervention (24 Hours)||2
10737586|NCT02876601|11901868|FG003|COMPLETED|First Intervention (24 Hours)||2
10737587|NCT02876601|11901865|FG000|NOT COMPLETED|First Intervention (24 Hours)||0
10737588|NCT02876601|11901866|FG001|NOT COMPLETED|First Intervention (24 Hours)||0
10737589|NCT02876601|11901867|FG002|NOT COMPLETED|First Intervention (24 Hours)||0
10737590|NCT02876601|11901868|FG003|NOT COMPLETED|First Intervention (24 Hours)||0
10737591|NCT02876601|11901865|FG000|STARTED|Washout (Minimum of 6 Weeks)||8
10737592|NCT02876601|11901866|FG001|STARTED|Washout (Minimum of 6 Weeks)||8
10737593|NCT02876601|11901867|FG002|STARTED|Washout (Minimum of 6 Weeks)||2
10737594|NCT02876601|11901868|FG003|STARTED|Washout (Minimum of 6 Weeks)||2
10737595|NCT02876601|11901865|FG000|COMPLETED|Washout (Minimum of 6 Weeks)||8
10737596|NCT02876601|11901866|FG001|COMPLETED|Washout (Minimum of 6 Weeks)||8
10737597|NCT02876601|11901867|FG002|COMPLETED|Washout (Minimum of 6 Weeks)||1
10737598|NCT02876601|11901868|FG003|COMPLETED|Washout (Minimum of 6 Weeks)||2
10737599|NCT02876601|11901865|FG000|NOT COMPLETED|Washout (Minimum of 6 Weeks)||0
10737600|NCT02876601|11901866|FG001|NOT COMPLETED|Washout (Minimum of 6 Weeks)||0
10737601|NCT02876601|11901867|FG002|NOT COMPLETED|Washout (Minimum of 6 Weeks)||1
10737602|NCT02876601|11901868|FG003|NOT COMPLETED|Washout (Minimum of 6 Weeks)||0
10737603|NCT02876601|11901865|FG000|STARTED|Second Intervention (24 Hours)||8
10737604|NCT02876601|11901866|FG001|STARTED|Second Intervention (24 Hours)||8
10737605|NCT02876601|11901867|FG002|STARTED|Second Intervention (24 Hours)||1
10737606|NCT02876601|11901868|FG003|STARTED|Second Intervention (24 Hours)||2
10737607|NCT02876601|11901865|FG000|COMPLETED|Second Intervention (24 Hours)||8
10737608|NCT02876601|11901866|FG001|COMPLETED|Second Intervention (24 Hours)||8
10737609|NCT02876601|11901867|FG002|COMPLETED|Second Intervention (24 Hours)||1
10737610|NCT02876601|11901868|FG003|COMPLETED|Second Intervention (24 Hours)||2
10737611|NCT02876601|11901865|FG000|NOT COMPLETED|Second Intervention (24 Hours)||0
10737612|NCT02876601|11901866|FG001|NOT COMPLETED|Second Intervention (24 Hours)||0
10737613|NCT02876601|11901867|FG002|NOT COMPLETED|Second Intervention (24 Hours)||0
10737614|NCT02876601|11901868|FG003|NOT COMPLETED|Second Intervention (24 Hours)||0
10737615|NCT02876757|11901915|FG000|STARTED|Overall Study||93197
10737616|NCT02876757|11901916|FG001|STARTED|Overall Study||93197
10737617|NCT02876757|11901915|FG000|COMPLETED|Overall Study||93197
10737618|NCT02876757|11901916|FG001|COMPLETED|Overall Study||93197
10737619|NCT02876757|11901915|FG000|NOT COMPLETED|Overall Study||0
10737620|NCT02876757|11901916|FG001|NOT COMPLETED|Overall Study||0
10737621|NCT02876887|11901924|FG000|STARTED|Overall Study||23
10737622|NCT02876887|11901925|FG001|STARTED|Overall Study||21
10737623|NCT02876887|11901924|FG000|COMPLETED|Overall Study||19
10737624|NCT02876887|11901925|FG001|COMPLETED|Overall Study||21
10737625|NCT02876887|11901924|FG000|NOT COMPLETED|Overall Study||4
10737626|NCT02876887|11901925|FG001|NOT COMPLETED|Overall Study||0
10737627|NCT02876900|11901934|FG000|STARTED|Overall Study||205
10737628|NCT02876900|11901935|FG001|STARTED|Overall Study||206
10737629|NCT02876900|11901936|FG002|STARTED|Overall Study||206
10737630|NCT02876900|11901934|FG000|COMPLETED|Overall Study||166
10737631|NCT02876900|11901935|FG001|COMPLETED|Overall Study||158
10737632|NCT02876900|11901936|FG002|COMPLETED|Overall Study||162
10737633|NCT02876900|11901934|FG000|NOT COMPLETED|Overall Study||39
10737634|NCT02876900|11901935|FG001|NOT COMPLETED|Overall Study||48
10737635|NCT02876900|11901936|FG002|NOT COMPLETED|Overall Study||44
10737636|NCT02876926|11901947|FG000|STARTED|Overall Study||21
10737637|NCT02876926|11901948|FG001|STARTED|Overall Study||22
10737638|NCT02876926|11901949|FG002|STARTED|Overall Study||22
10737639|NCT02876926|11901947|FG000|COMPLETED|Overall Study||3
10737640|NCT02876926|11901948|FG001|COMPLETED|Overall Study||3
10737641|NCT02876926|11901949|FG002|COMPLETED|Overall Study||2
10737642|NCT02876926|11901947|FG000|NOT COMPLETED|Overall Study||18
10737643|NCT02876926|11901948|FG001|NOT COMPLETED|Overall Study||19
10737644|NCT02876926|11901949|FG002|NOT COMPLETED|Overall Study||20
10737645|NCT02877004|11901960|FG000|STARTED|Overall Study||20
10737646|NCT02877004|11901961|FG001|STARTED|Overall Study||20
10737647|NCT02877004|11901962|FG002|STARTED|Overall Study||20
10737648|NCT02877004|11901960|FG000|COMPLETED|Overall Study||20
10737649|NCT02877004|11901961|FG001|COMPLETED|Overall Study||20
10737650|NCT02877004|11901962|FG002|COMPLETED|Overall Study||19
10737651|NCT02877004|11901960|FG000|NOT COMPLETED|Overall Study||0
10737652|NCT02877004|11901961|FG001|NOT COMPLETED|Overall Study||0
10737653|NCT02877004|11901962|FG002|NOT COMPLETED|Overall Study||1
10737654|NCT02877082|11901970|FG000|STARTED|Overall Study||5
10737655|NCT02877082|11901970|FG000|COMPLETED|Overall Study||0
10737656|NCT02877082|11901970|FG000|NOT COMPLETED|Overall Study||5
10737657|NCT02877095|11901976|FG000|STARTED|Overall Study|First patient enrolled 1/9/17.|20
10737658|NCT02877095|11901977|FG001|STARTED|Overall Study||20
10737659|NCT02877095|11901976|FG000|COMPLETED|Overall Study||20
10737660|NCT02877095|11901977|FG001|COMPLETED|Overall Study||20
10737661|NCT02877095|11901976|FG000|NOT COMPLETED|Overall Study||0
10737662|NCT02877095|11901977|FG001|NOT COMPLETED|Overall Study||0
10737663|NCT02877485|11901985|FG000|STARTED|Overall Study||22
10737664|NCT02877485|11901986|FG001|STARTED|Overall Study||20
10737665|NCT02877485|11901985|FG000|COMPLETED|Overall Study||22
10737666|NCT02877485|11901986|FG001|COMPLETED|Overall Study||20
10737667|NCT02877485|11901985|FG000|NOT COMPLETED|Overall Study||0
10737668|NCT02877485|11901986|FG001|NOT COMPLETED|Overall Study||0
10737669|NCT02877680|11901995|FG000|STARTED|Overall Study||55
10737670|NCT02877680|11901996|FG001|STARTED|Overall Study||25
10737671|NCT02877680|11901995|FG000|COMPLETED|Overall Study||54
10737672|NCT02877680|11901996|FG001|COMPLETED|Overall Study||24
10737673|NCT02877680|11901995|FG000|NOT COMPLETED|Overall Study||1
10737674|NCT02877680|11901996|FG001|NOT COMPLETED|Overall Study||1
10737675|NCT02877927|11902008|FG000|STARTED|Overall Study||368
10737676|NCT02877927|11902009|FG001|STARTED|Overall Study||367
10737677|NCT02877927|11902008|FG000|COMPLETED|Overall Study||314
10737678|NCT02877927|11902009|FG001|COMPLETED|Overall Study||310
10737679|NCT02877927|11902008|FG000|NOT COMPLETED|Overall Study||54
10737680|NCT02877927|11902009|FG001|NOT COMPLETED|Overall Study||57
10737681|NCT02878057|11902015|FG000|STARTED|Overall Study||30
10737682|NCT02878057|11902015|FG000|COMPLETED|Overall Study||26
10737683|NCT02878057|11902015|FG000|NOT COMPLETED|Overall Study||4
10737684|NCT02878213|11902019|FG000|STARTED|Overall Study||39
10737685|NCT02878213|11902019|FG000|COMPLETED|Overall Study||36
10737686|NCT02878213|11902019|FG000|NOT COMPLETED|Overall Study||3
10737687|NCT02878330|11902026|FG000|STARTED|Overall Study||484
10737688|NCT02878330|11902027|FG001|STARTED|Overall Study||969
10737689|NCT02878330|11902026|FG000|COMPLETED|Overall Study||455
10737690|NCT02878330|11902027|FG001|COMPLETED|Overall Study||913
10737691|NCT02878330|11902026|FG000|NOT COMPLETED|Overall Study||29
10737692|NCT02878330|11902027|FG001|NOT COMPLETED|Overall Study||56
10737693|NCT02878382|11902034|FG000|STARTED|Overall Study|total 20 patients.split-scalp: 20 split -scalp received CAL-PDT and the other 20 received C-PDT|20
10737694|NCT02878382|11902035|FG001|STARTED|Overall Study|otal 20 patients.split-scalp: 20 split -scalp received CAL-PDT and the other 20 received C-PDT|20
10737695|NCT02878382|11902034|FG000|COMPLETED|Overall Study||20
10737696|NCT02878382|11902035|FG001|COMPLETED|Overall Study||20
10737697|NCT02878382|11902034|FG000|NOT COMPLETED|Overall Study||0
10737698|NCT02878382|11902035|FG001|NOT COMPLETED|Overall Study||0
10737699|NCT02878486|11902045|FG000|STARTED|Overall Study||3
10737700|NCT02878486|11902046|FG001|STARTED|Overall Study||3
10737701|NCT02878486|11902045|FG000|COMPLETED|Overall Study||3
10737702|NCT02878486|11902046|FG001|COMPLETED|Overall Study||3
10737703|NCT02878486|11902045|FG000|NOT COMPLETED|Overall Study||0
10737704|NCT02878486|11902046|FG001|NOT COMPLETED|Overall Study||0
10737705|NCT02878590|11902052|FG000|STARTED|Overall Study||12
10737706|NCT02878590|11902052|FG000|COMPLETED|Overall Study||10
10737707|NCT02878590|11902052|FG000|NOT COMPLETED|Overall Study||2
10737708|NCT02879032|11902056|FG000|STARTED|Overall Study||130
10737709|NCT02879032|11902056|FG000|COMPLETED|Overall Study||130
10737710|NCT02879032|11902056|FG000|NOT COMPLETED|Overall Study||0
10737711|NCT02879383|11902066|FG000|STARTED|First 24 Weeks||39
10737712|NCT02879383|11902067|FG001|STARTED|First 24 Weeks||37
10737713|NCT02879383|11902068|FG002|STARTED|First 24 Weeks||17
10737714|NCT02879383|11902069|FG003|STARTED|First 24 Weeks||16
10737715|NCT02879383|11902066|FG000|COMPLETED|First 24 Weeks||39
10737716|NCT02879383|11902067|FG001|COMPLETED|First 24 Weeks||36
10737717|NCT02879383|11902068|FG002|COMPLETED|First 24 Weeks||17
10737718|NCT02879383|11902069|FG003|COMPLETED|First 24 Weeks||16
10737719|NCT02879383|11902066|FG000|NOT COMPLETED|First 24 Weeks||0
10737720|NCT02879383|11902067|FG001|NOT COMPLETED|First 24 Weeks||1
10737721|NCT02879383|11902068|FG002|NOT COMPLETED|First 24 Weeks||0
10737722|NCT02879383|11902069|FG003|NOT COMPLETED|First 24 Weeks||0
10737723|NCT02879383|11902066|FG000|STARTED|Second 24 Weeks (Crossover for Sham)||33
10737724|NCT02879383|11902067|FG001|STARTED|Second 24 Weeks (Crossover for Sham)||0
10737725|NCT02879383|11902068|FG002|STARTED|Second 24 Weeks (Crossover for Sham)||4
10737726|NCT02879383|11902069|FG003|STARTED|Second 24 Weeks (Crossover for Sham)||0
10737727|NCT02879383|11902066|FG000|COMPLETED|Second 24 Weeks (Crossover for Sham)||33
10737728|NCT02879383|11902067|FG001|COMPLETED|Second 24 Weeks (Crossover for Sham)||0
10737729|NCT02879383|11902068|FG002|COMPLETED|Second 24 Weeks (Crossover for Sham)||4
10737730|NCT02879383|11902069|FG003|COMPLETED|Second 24 Weeks (Crossover for Sham)||0
10737731|NCT02879383|11902066|FG000|NOT COMPLETED|Second 24 Weeks (Crossover for Sham)||0
10737732|NCT02879383|11902067|FG001|NOT COMPLETED|Second 24 Weeks (Crossover for Sham)||0
10737733|NCT02879383|11902068|FG002|NOT COMPLETED|Second 24 Weeks (Crossover for Sham)||0
10737734|NCT02879383|11902069|FG003|NOT COMPLETED|Second 24 Weeks (Crossover for Sham)||0
10737735|NCT02879578|11902084|FG000|STARTED|Overall Study||33
10737736|NCT02879578|11902085|FG001|STARTED|Overall Study||41
10737737|NCT02879578|11902086|FG002|STARTED|Overall Study||81
10737738|NCT02879578|11902084|FG000|Safety Analysis Set|Overall Study||33
10737739|NCT02879578|11902085|FG001|Safety Analysis Set|Overall Study||40
10737740|NCT02879578|11902086|FG002|Safety Analysis Set|Overall Study||79
10737741|NCT02879578|11902084|FG000|COMPLETED|Overall Study||23
10737742|NCT02879578|11902085|FG001|COMPLETED|Overall Study||32
10737743|NCT02879578|11902086|FG002|COMPLETED|Overall Study||49
10737744|NCT02879578|11902084|FG000|NOT COMPLETED|Overall Study||10
10737745|NCT02879578|11902085|FG001|NOT COMPLETED|Overall Study||9
10737746|NCT02879578|11902086|FG002|NOT COMPLETED|Overall Study||32
10737747|NCT02879747|11902097|FG000|STARTED|Overall Study||27
10737748|NCT02879747|11902098|FG001|STARTED|Overall Study||38
10737749|NCT02879747|11902099|FG002|STARTED|Overall Study||33
10737750|NCT02879747|11902097|FG000|COMPLETED|Overall Study||23
10737751|NCT02879747|11902098|FG001|COMPLETED|Overall Study||32
10737752|NCT02879747|11902099|FG002|COMPLETED|Overall Study||31
10737753|NCT02879747|11902097|FG000|NOT COMPLETED|Overall Study||4
10737754|NCT02879747|11902098|FG001|NOT COMPLETED|Overall Study||6
10737755|NCT02879747|11902099|FG002|NOT COMPLETED|Overall Study||2
10737756|NCT02879812|11902118|FG000|STARTED|Overall Study||23370
10737757|NCT02879812|11902119|FG001|STARTED|Overall Study||22480
10737758|NCT02879812|11902118|FG000|COMPLETED|Overall Study||22153
10737759|NCT02879812|11902119|FG001|COMPLETED|Overall Study||21029
10737760|NCT02879812|11902118|FG000|NOT COMPLETED|Overall Study||1217
10737761|NCT02879812|11902119|FG001|NOT COMPLETED|Overall Study||1451
10737762|NCT02879994|11902125|FG000|STARTED|Overall Study||11
10737763|NCT02879994|11902125|FG000|COMPLETED|Overall Study||0
10737764|NCT02879994|11902125|FG000|NOT COMPLETED|Overall Study||11
10737765|NCT02880137|11902129|FG000|STARTED|Overall Study||36
10737766|NCT02880137|11902129|FG000|COMPLETED|Overall Study||36
10737767|NCT02880137|11902129|FG000|NOT COMPLETED|Overall Study||0
10737768|NCT02880176|11902135|FG000|STARTED|Overall Study||23
10737769|NCT02880176|11902136|FG001|STARTED|Overall Study||11
10737770|NCT02880176|11902135|FG000|Underwent Cystectomy|Overall Study||22
10737771|NCT02880176|11902136|FG001|Underwent Cystectomy|Overall Study||11
10737772|NCT02880176|11902135|FG000|Collected Postop Step Data|Overall Study||22
10737773|NCT02880176|11902136|FG001|Collected Postop Step Data|Overall Study||11
10737774|NCT02880176|11902135|FG000|Responded to 30 Day Survey|Overall Study||20
10737775|NCT02880176|11902136|FG001|Responded to 30 Day Survey|Overall Study||9
10737776|NCT02880176|11902135|FG000|COMPLETED|Overall Study||20
10737777|NCT02880176|11902136|FG001|COMPLETED|Overall Study||9
10737778|NCT02880176|11902135|FG000|NOT COMPLETED|Overall Study||3
10737779|NCT02880176|11902136|FG001|NOT COMPLETED|Overall Study||2
10737780|NCT02880228|11902142|FG000|STARTED|Overall Study||11
10737781|NCT02880228|11902142|FG000|COMPLETED|Overall Study||11
10737782|NCT02880228|11902142|FG000|NOT COMPLETED|Overall Study||0
10737783|NCT02880254|11902148|FG000|STARTED|Overall Study||13
10737784|NCT02880254|11902149|FG001|STARTED|Overall Study||14
10737785|NCT02880254|11902148|FG000|COMPLETED|Overall Study||4
10737786|NCT02880254|11902149|FG001|COMPLETED|Overall Study||4
10737787|NCT02880254|11902148|FG000|NOT COMPLETED|Overall Study||9
10737788|NCT02880254|11902149|FG001|NOT COMPLETED|Overall Study||10
10737789|NCT02880475|11902157|FG000|STARTED|Overall Study||13
10737790|NCT02880475|11902158|FG001|STARTED|Overall Study||17
10737791|NCT02880475|11902157|FG000|COMPLETED|Overall Study||13
10737792|NCT02880475|11902158|FG001|COMPLETED|Overall Study||17
10737793|NCT02880475|11902157|FG000|NOT COMPLETED|Overall Study||0
10737794|NCT02880475|11902158|FG001|NOT COMPLETED|Overall Study||0
10737795|NCT02880514|11902166|FG000|STARTED|Overall Study|A total of 50 subjects with one sinus side assigned to the treatment group|50
10737796|NCT02880514|11902167|FG001|STARTED|Overall Study|A total of 50 subjects with one sinus side assigned to the control group|50
10737797|NCT02880514|11902166|FG000|COMPLETED|Overall Study||50
10737798|NCT02880514|11902167|FG001|COMPLETED|Overall Study||50
10737799|NCT02880514|11902166|FG000|NOT COMPLETED|Overall Study||0
10737800|NCT02880514|11902167|FG001|NOT COMPLETED|Overall Study||0
10737801|NCT02880761|11902176|FG000|STARTED|Overall Study||103
10737802|NCT02880761|11902177|FG001|STARTED|Overall Study||106
10737803|NCT02880761|11902176|FG000|COMPLETED|Overall Study||87
10737804|NCT02880761|11902177|FG001|COMPLETED|Overall Study||85
10737805|NCT02880761|11902176|FG000|NOT COMPLETED|Overall Study||16
10737806|NCT02880761|11902177|FG001|NOT COMPLETED|Overall Study||21
10737807|NCT02880852|11902183|FG000|STARTED|Overall Study||20
10737808|NCT02880852|11902183|FG000|COMPLETED|Overall Study||20
10737809|NCT02880852|11902183|FG000|NOT COMPLETED|Overall Study||0
10737810|NCT02880865|11902189|FG000|STARTED|Overall Study||314
10737811|NCT02880865|11902190|FG001|STARTED|Overall Study||314
10737812|NCT02880865|11902189|FG000|Received MMR Dose 1|Overall Study||314
10737813|NCT02880865|11902190|FG001|Received MMR Dose 1|Overall Study||314
10737814|NCT02880865|11902189|FG000|Received CD-JEV|Overall Study||314
10737815|NCT02880865|11902190|FG001|Received CD-JEV|Overall Study||309
10737816|NCT02880865|11902189|FG000|Received MMR Dose 2|Overall Study||313
10737817|NCT02880865|11902190|FG001|Received MMR Dose 2|Overall Study||311
10737818|NCT02880865|11902189|FG000|COMPLETED|Overall Study||313
10737819|NCT02880865|11902190|FG001|COMPLETED|Overall Study||311
10737820|NCT02880865|11902189|FG000|NOT COMPLETED|Overall Study||1
10737821|NCT02880865|11902190|FG001|NOT COMPLETED|Overall Study||3
10737822|NCT02881008|11902223|FG000|STARTED|Overall Study||8
10737823|NCT02881008|11902224|FG001|STARTED|Overall Study||8
10737824|NCT02881008|11902225|FG002|STARTED|Overall Study||8
10737825|NCT02881008|11902226|FG003|STARTED|Overall Study||8
10737826|NCT02881008|11902227|FG004|STARTED|Overall Study||8
10737827|NCT02881008|11902228|FG005|STARTED|Overall Study||8
10737828|NCT02881008|11902223|FG000|COMPLETED|Overall Study||8
10737829|NCT02881008|11902224|FG001|COMPLETED|Overall Study||8
10737830|NCT02881008|11902225|FG002|COMPLETED|Overall Study||8
10737831|NCT02881008|11902226|FG003|COMPLETED|Overall Study||8
10737832|NCT02881008|11902227|FG004|COMPLETED|Overall Study||8
10737833|NCT02881008|11902228|FG005|COMPLETED|Overall Study||8
10737834|NCT02881008|11902223|FG000|NOT COMPLETED|Overall Study||0
10737835|NCT02881008|11902224|FG001|NOT COMPLETED|Overall Study||0
10737836|NCT02881008|11902225|FG002|NOT COMPLETED|Overall Study||0
10737837|NCT02881008|11902226|FG003|NOT COMPLETED|Overall Study||0
10737838|NCT02881008|11902227|FG004|NOT COMPLETED|Overall Study||0
10737839|NCT02881008|11902228|FG005|NOT COMPLETED|Overall Study||0
10737840|NCT02881047|11902245|FG000|STARTED|Overall Study||8
10737841|NCT02881047|11902245|FG000|COMPLETED|Overall Study||6
10737842|NCT02881047|11902245|FG000|NOT COMPLETED|Overall Study||2
10737843|NCT02881112|11902249|FG000|STARTED|Overall Study||180
10737844|NCT02881112|11902249|FG000|COMPLETED|Overall Study||152
10737845|NCT02881112|11902249|FG000|NOT COMPLETED|Overall Study||28
10737846|NCT02881567|11902253|FG000|STARTED|Overall Study||41
10737847|NCT02881567|11902253|FG000|COMPLETED|Overall Study||23
10737848|NCT02881567|11902253|FG000|NOT COMPLETED|Overall Study||18
10737849|NCT02881658|11902259|FG000|STARTED|Overall Study||100
10737850|NCT02881658|11902260|FG001|STARTED|Overall Study||101
10737851|NCT02881658|11902259|FG000|COMPLETED|Overall Study||98
10737852|NCT02881658|11902260|FG001|COMPLETED|Overall Study||96
10737853|NCT02881658|11902259|FG000|NOT COMPLETED|Overall Study||2
10737854|NCT02881658|11902260|FG001|NOT COMPLETED|Overall Study||5
10737855|NCT02881775|11902268|FG000|STARTED|Baseline||11
10737856|NCT02881775|11902269|FG001|STARTED|Baseline||9
10737857|NCT02881775|11902268|FG000|COMPLETED|Baseline||11
10737858|NCT02881775|11902269|FG001|COMPLETED|Baseline||9
10737859|NCT02881775|11902268|FG000|NOT COMPLETED|Baseline||0
10737860|NCT02881775|11902269|FG001|NOT COMPLETED|Baseline||0
10737861|NCT02881775|11902268|FG000|STARTED|First Intervention (1-hr Session)|Two participants dropped out prior to First Intervention (1-hr Session).|9
10737862|NCT02881775|11902269|FG001|STARTED|First Intervention (1-hr Session)|Two participants dropped out prior to First Intervention (1-hr Session).|7
10737863|NCT02881775|11902268|FG000|COMPLETED|First Intervention (1-hr Session)||9
10737864|NCT02881775|11902269|FG001|COMPLETED|First Intervention (1-hr Session)||7
10737865|NCT02881775|11902268|FG000|NOT COMPLETED|First Intervention (1-hr Session)||0
10737866|NCT02881775|11902269|FG001|NOT COMPLETED|First Intervention (1-hr Session)||0
10737867|NCT02881775|11902268|FG000|STARTED|Washout (1 Week)||9
10737868|NCT02881775|11902269|FG001|STARTED|Washout (1 Week)||7
10737869|NCT02881775|11902268|FG000|COMPLETED|Washout (1 Week)||9
10737870|NCT02881775|11902269|FG001|COMPLETED|Washout (1 Week)||7
10737871|NCT02881775|11902268|FG000|NOT COMPLETED|Washout (1 Week)||0
10737872|NCT02881775|11902269|FG001|NOT COMPLETED|Washout (1 Week)||0
10737873|NCT02881775|11902268|FG000|STARTED|Second Intervention (1-Hour Session)||9
10737874|NCT02881775|11902269|FG001|STARTED|Second Intervention (1-Hour Session)||7
10737875|NCT02881775|11902268|FG000|COMPLETED|Second Intervention (1-Hour Session)||9
10737876|NCT02881775|11902269|FG001|COMPLETED|Second Intervention (1-Hour Session)||7
10737877|NCT02881775|11902268|FG000|NOT COMPLETED|Second Intervention (1-Hour Session)||0
10737878|NCT02881775|11902269|FG001|NOT COMPLETED|Second Intervention (1-Hour Session)||0
10737879|NCT02881840|11902275|FG000|STARTED|Overall Study||6
10737880|NCT02881840|11902275|FG000|COMPLETED|Overall Study||6
10737881|NCT02881840|11902275|FG000|NOT COMPLETED|Overall Study||0
10737882|NCT02881996|11902281|FG000|STARTED|Overall Study||45
10737883|NCT02881996|11902282|FG001|STARTED|Overall Study||45
10737884|NCT02881996|11902281|FG000|COMPLETED|Overall Study||39
10737885|NCT02881996|11902282|FG001|COMPLETED|Overall Study||43
10737886|NCT02881996|11902281|FG000|NOT COMPLETED|Overall Study||6
10737887|NCT02881996|11902282|FG001|NOT COMPLETED|Overall Study||2
10737888|NCT02882152|11902290|FG000|STARTED|Overall Study||20
10737889|NCT02882152|11902291|FG001|STARTED|Overall Study||20
10737890|NCT02882152|11902290|FG000|COMPLETED|Overall Study||19
10737891|NCT02882152|11902291|FG001|COMPLETED|Overall Study||20
10737892|NCT02882152|11902290|FG000|NOT COMPLETED|Overall Study||1
10737893|NCT02882152|11902291|FG001|NOT COMPLETED|Overall Study||0
10737894|NCT02882178|11902297|FG000|STARTED|Overall Study||18
10737895|NCT02882178|11902297|FG000|COMPLETED|Overall Study||18
10737896|NCT02882178|11902297|FG000|NOT COMPLETED|Overall Study||0
10737897|NCT02882633|11902303|FG000|STARTED|Overall Study||25
10737898|NCT02882633|11902304|FG001|STARTED|Overall Study||25
10737899|NCT02882633|11902303|FG000|COMPLETED|Overall Study||23
10737900|NCT02882633|11902304|FG001|COMPLETED|Overall Study||25
10737901|NCT02882633|11902303|FG000|NOT COMPLETED|Overall Study||2
10737902|NCT02882633|11902304|FG001|NOT COMPLETED|Overall Study||0
10737903|NCT02882711|11902310|FG000|STARTED|Overall Study||6
10737904|NCT02882711|11902310|FG000|COMPLETED|Overall Study||2
10737905|NCT02882711|11902310|FG000|NOT COMPLETED|Overall Study||4
10737906|NCT02882854|11902316|FG000|STARTED|Overall Study||40
10737907|NCT02882854|11902317|FG001|STARTED|Overall Study||44
10737908|NCT02882854|11902316|FG000|COMPLETED|Overall Study||39
10737909|NCT02882854|11902317|FG001|COMPLETED|Overall Study||41
10737910|NCT02882854|11902316|FG000|NOT COMPLETED|Overall Study||1
10737911|NCT02882854|11902317|FG001|NOT COMPLETED|Overall Study||3
10737912|NCT02883244|11902325|FG000|STARTED|Overall Study||24
10737913|NCT02883244|11902326|FG001|STARTED|Overall Study||26
10737914|NCT02883244|11902325|FG000|COMPLETED|Overall Study||24
10737915|NCT02883244|11902326|FG001|COMPLETED|Overall Study||25
10737916|NCT02883244|11902325|FG000|NOT COMPLETED|Overall Study||0
10737917|NCT02883244|11902326|FG001|NOT COMPLETED|Overall Study||1
10737918|NCT02883452|11902338|FG000|STARTED|Overall Study|This cohort is only for Part 1.|13
10737919|NCT02883452|11902339|FG001|STARTED|Overall Study|This cohort is only for Part 1.|11
10737920|NCT02883452|11902340|FG002|STARTED|Overall Study|This cohort is only for Part 1.|12
10737921|NCT02883452|11902341|FG003|STARTED|Overall Study|This cohort is only for Part 1.|8
10737922|NCT02883452|11902342|FG004|STARTED|Overall Study|This arm is for Part 2. All of the patients in Part 2 were screened only for Part 2.|66
10737923|NCT02883452|11902343|FG005|STARTED|Overall Study|This arm is for Part 2. All of the patients in Part 2 were screened only for Part 2.|65
10737924|NCT02883452|11902338|FG000|COMPLETED|Overall Study||8
10737925|NCT02883452|11902339|FG001|COMPLETED|Overall Study||9
10737926|NCT02883452|11902340|FG002|COMPLETED|Overall Study||7
10737927|NCT02883452|11902341|FG003|COMPLETED|Overall Study||6
10737928|NCT02883452|11902342|FG004|COMPLETED|Overall Study||55
10737929|NCT02883452|11902343|FG005|COMPLETED|Overall Study||50
10737930|NCT02883452|11902338|FG000|NOT COMPLETED|Overall Study||5
10737931|NCT02883452|11902339|FG001|NOT COMPLETED|Overall Study||2
10737932|NCT02883452|11902340|FG002|NOT COMPLETED|Overall Study||5
10737933|NCT02883452|11902341|FG003|NOT COMPLETED|Overall Study||2
10737934|NCT02883452|11902342|FG004|NOT COMPLETED|Overall Study||11
10737935|NCT02883452|11902343|FG005|NOT COMPLETED|Overall Study||15
10737936|NCT02884089|11902358|FG000|STARTED|Period 1||11
10737937|NCT02884089|11902359|FG001|STARTED|Period 1||11
10737938|NCT02884089|11902360|FG002|STARTED|Period 1||9
10737939|NCT02884089|11902361|FG003|STARTED|Period 1||9
10737940|NCT02884089|11902358|FG000|Received at Least One Dose of Study Drug|Period 1||11
10737941|NCT02884089|11902359|FG001|Received at Least One Dose of Study Drug|Period 1||11
10737942|NCT02884089|11902360|FG002|Received at Least One Dose of Study Drug|Period 1||9
10737943|NCT02884089|11902361|FG003|Received at Least One Dose of Study Drug|Period 1||9
10737944|NCT02884089|11902358|FG000|COMPLETED|Period 1||9
10737945|NCT02884089|11902359|FG001|COMPLETED|Period 1||9
10737946|NCT02884089|11902360|FG002|COMPLETED|Period 1||9
10737947|NCT02884089|11902361|FG003|COMPLETED|Period 1||9
10737948|NCT02884089|11902358|FG000|NOT COMPLETED|Period 1||2
10737949|NCT02884089|11902359|FG001|NOT COMPLETED|Period 1||2
10737950|NCT02884089|11902360|FG002|NOT COMPLETED|Period 1||0
10737951|NCT02884089|11902361|FG003|NOT COMPLETED|Period 1||0
10737952|NCT02884089|11902358|FG000|STARTED|Washout Period 1||9
10737953|NCT02884089|11902359|FG001|STARTED|Washout Period 1||9
10737954|NCT02884089|11902360|FG002|STARTED|Washout Period 1||9
10737955|NCT02884089|11902361|FG003|STARTED|Washout Period 1||9
10737956|NCT02884089|11902358|FG000|COMPLETED|Washout Period 1||9
10737957|NCT02884089|11902359|FG001|COMPLETED|Washout Period 1||7
10737958|NCT02884089|11902360|FG002|COMPLETED|Washout Period 1||9
10737959|NCT02884089|11902361|FG003|COMPLETED|Washout Period 1||8
10737960|NCT02884089|11902358|FG000|NOT COMPLETED|Washout Period 1||0
10737961|NCT02884089|11902359|FG001|NOT COMPLETED|Washout Period 1||2
10737962|NCT02884089|11902360|FG002|NOT COMPLETED|Washout Period 1||0
10737963|NCT02884089|11902361|FG003|NOT COMPLETED|Washout Period 1||1
10737964|NCT02884089|11902358|FG000|STARTED|Period 2||9
10737965|NCT02884089|11902359|FG001|STARTED|Period 2||7
10737966|NCT02884089|11902360|FG002|STARTED|Period 2||9
10737967|NCT02884089|11902361|FG003|STARTED|Period 2||8
10737968|NCT02884089|11902358|FG000|COMPLETED|Period 2||8
10737969|NCT02884089|11902359|FG001|COMPLETED|Period 2||7
10737970|NCT02884089|11902360|FG002|COMPLETED|Period 2||9
10737971|NCT02884089|11902361|FG003|COMPLETED|Period 2||8
10737972|NCT02884089|11902358|FG000|NOT COMPLETED|Period 2||1
10737973|NCT02884089|11902359|FG001|NOT COMPLETED|Period 2||0
10737974|NCT02884089|11902360|FG002|NOT COMPLETED|Period 2||0
10737975|NCT02884089|11902361|FG003|NOT COMPLETED|Period 2||0
10737976|NCT02884089|11902358|FG000|STARTED|Washout Period 2||8
10737977|NCT02884089|11902359|FG001|STARTED|Washout Period 2||7
10737978|NCT02884089|11902360|FG002|STARTED|Washout Period 2||9
10737979|NCT02884089|11902361|FG003|STARTED|Washout Period 2||8
10737980|NCT02884089|11902358|FG000|COMPLETED|Washout Period 2||8
10737981|NCT02884089|11902359|FG001|COMPLETED|Washout Period 2||7
10737982|NCT02884089|11902360|FG002|COMPLETED|Washout Period 2||9
10737983|NCT02884089|11902361|FG003|COMPLETED|Washout Period 2||8
10737984|NCT02884089|11902358|FG000|NOT COMPLETED|Washout Period 2||0
10737985|NCT02884089|11902359|FG001|NOT COMPLETED|Washout Period 2||0
10737986|NCT02884089|11902360|FG002|NOT COMPLETED|Washout Period 2||0
10737987|NCT02884089|11902361|FG003|NOT COMPLETED|Washout Period 2||0
10737988|NCT02884089|11902358|FG000|STARTED|Period 3||8
10737989|NCT02884089|11902359|FG001|STARTED|Period 3||7
10737990|NCT02884089|11902360|FG002|STARTED|Period 3||9
10737991|NCT02884089|11902361|FG003|STARTED|Period 3||8
10737992|NCT02884089|11902358|FG000|COMPLETED|Period 3||8
10737993|NCT02884089|11902359|FG001|COMPLETED|Period 3||7
10737994|NCT02884089|11902360|FG002|COMPLETED|Period 3||8
10737995|NCT02884089|11902361|FG003|COMPLETED|Period 3||8
10737996|NCT02884089|11902358|FG000|NOT COMPLETED|Period 3||0
10737997|NCT02884089|11902359|FG001|NOT COMPLETED|Period 3||0
10737998|NCT02884089|11902360|FG002|NOT COMPLETED|Period 3||1
10737999|NCT02884089|11902361|FG003|NOT COMPLETED|Period 3||0
10738000|NCT02884089|11902358|FG000|STARTED|Washout Period 3||8
10738001|NCT02884089|11902359|FG001|STARTED|Washout Period 3||7
10738002|NCT02884089|11902360|FG002|STARTED|Washout Period 3||8
10738003|NCT02884089|11902361|FG003|STARTED|Washout Period 3||8
10738004|NCT02884089|11902358|FG000|COMPLETED|Washout Period 3||8
10738005|NCT02884089|11902359|FG001|COMPLETED|Washout Period 3||7
10738006|NCT02884089|11902360|FG002|COMPLETED|Washout Period 3||7
10738007|NCT02884089|11902361|FG003|COMPLETED|Washout Period 3||7
10738008|NCT02884089|11902358|FG000|NOT COMPLETED|Washout Period 3||0
10738009|NCT02884089|11902359|FG001|NOT COMPLETED|Washout Period 3||0
10738010|NCT02884089|11902360|FG002|NOT COMPLETED|Washout Period 3||1
10738011|NCT02884089|11902361|FG003|NOT COMPLETED|Washout Period 3||1
10738012|NCT02884089|11902358|FG000|STARTED|Period 4||8
10816430|NCT01564732|11979928|FG001|NOT COMPLETED|Overall Study||5
10816431|NCT01560507|11979937|FG000|STARTED|Overall Study||5
10738013|NCT02884089|11902359|FG001|STARTED|Period 4||7
10738014|NCT02884089|11902360|FG002|STARTED|Period 4||7
10738015|NCT02884089|11902361|FG003|STARTED|Period 4||7
10738016|NCT02884089|11902358|FG000|COMPLETED|Period 4||7
10738017|NCT02884089|11902359|FG001|COMPLETED|Period 4||6
10738018|NCT02884089|11902360|FG002|COMPLETED|Period 4||7
10816432|NCT01560507|11979938|FG001|STARTED|Overall Study||2
10738019|NCT02884089|11902361|FG003|COMPLETED|Period 4||7
10738020|NCT02884089|11902358|FG000|NOT COMPLETED|Period 4||1
10738021|NCT02884089|11902359|FG001|NOT COMPLETED|Period 4||1
10738022|NCT02884089|11902360|FG002|NOT COMPLETED|Period 4||0
10738023|NCT02884089|11902361|FG003|NOT COMPLETED|Period 4||0
10738024|NCT02884089|11902358|FG000|STARTED|Follow-up Visit||7
10738025|NCT02884089|11902359|FG001|STARTED|Follow-up Visit||6
10738026|NCT02884089|11902360|FG002|STARTED|Follow-up Visit||7
10738027|NCT02884089|11902361|FG003|STARTED|Follow-up Visit||7
10738028|NCT02884089|11902358|FG000|COMPLETED|Follow-up Visit||6
10738029|NCT02884089|11902359|FG001|COMPLETED|Follow-up Visit||6
10738030|NCT02884089|11902360|FG002|COMPLETED|Follow-up Visit||7
10738031|NCT02884089|11902361|FG003|COMPLETED|Follow-up Visit||6
10738032|NCT02884089|11902358|FG000|NOT COMPLETED|Follow-up Visit||1
10738033|NCT02884089|11902359|FG001|NOT COMPLETED|Follow-up Visit||0
10738034|NCT02884089|11902360|FG002|NOT COMPLETED|Follow-up Visit||0
10738035|NCT02884089|11902361|FG003|NOT COMPLETED|Follow-up Visit||1
10738036|NCT02884414|11902371|FG000|STARTED|Overall Study||56
10738037|NCT02884414|11902371|FG000|COMPLETED|Overall Study||56
10738038|NCT02884414|11902371|FG000|NOT COMPLETED|Overall Study||0
10738039|NCT02884427|11902378|FG000|STARTED|Overall Study||48
10738040|NCT02884427|11902379|FG001|STARTED|Overall Study||52
10738041|NCT02884427|11902380|FG002|STARTED|Overall Study||50
10738042|NCT02884427|11902378|FG000|COMPLETED|Overall Study||48
10738043|NCT02884427|11902379|FG001|COMPLETED|Overall Study||52
10738044|NCT02884427|11902380|FG002|COMPLETED|Overall Study||50
10738045|NCT02884427|11902378|FG000|NOT COMPLETED|Overall Study||0
10738046|NCT02884427|11902379|FG001|NOT COMPLETED|Overall Study||0
10738047|NCT02884427|11902380|FG002|NOT COMPLETED|Overall Study||0
10738048|NCT02884492|11902390|FG000|STARTED|Overall Study||7
10738049|NCT02884492|11902391|FG001|STARTED|Overall Study||10
10738050|NCT02884492|11902390|FG000|COMPLETED|Overall Study||7
10738051|NCT02884492|11902391|FG001|COMPLETED|Overall Study||10
10738052|NCT02884492|11902390|FG000|NOT COMPLETED|Overall Study||0
10738053|NCT02884492|11902391|FG001|NOT COMPLETED|Overall Study||0
10738054|NCT02885012|11902399|FG000|STARTED|Overall Study||1
10738055|NCT02885012|11902400|FG001|STARTED|Overall Study||2
10738056|NCT02885012|11902399|FG000|COMPLETED|Overall Study||1
10738057|NCT02885012|11902400|FG001|COMPLETED|Overall Study||2
10738058|NCT02885012|11902399|FG000|NOT COMPLETED|Overall Study||0
10738059|NCT02885012|11902400|FG001|NOT COMPLETED|Overall Study||0
10738060|NCT02885025|11902410|FG000|STARTED|Overall Study||16
10738061|NCT02885025|11902411|FG001|STARTED|Overall Study||14
10738062|NCT02885025|11902412|FG002|STARTED|Overall Study||9
10738063|NCT02885025|11902413|FG003|STARTED|Overall Study||8
10738064|NCT02885025|11902410|FG000|COMPLETED|Overall Study||16
10738065|NCT02885025|11902411|FG001|COMPLETED|Overall Study||12
10738066|NCT02885025|11902412|FG002|COMPLETED|Overall Study||9
10738067|NCT02885025|11902413|FG003|COMPLETED|Overall Study||8
10738068|NCT02885025|11902410|FG000|NOT COMPLETED|Overall Study||0
10738069|NCT02885025|11902411|FG001|NOT COMPLETED|Overall Study||2
10738070|NCT02885025|11902412|FG002|NOT COMPLETED|Overall Study||0
10738071|NCT02885025|11902413|FG003|NOT COMPLETED|Overall Study||0
10738072|NCT02885181|11902431|FG000|STARTED|Overall Study||20
10738073|NCT02885181|11902432|FG001|STARTED|Overall Study||20
10738074|NCT02885181|11902433|FG002|STARTED|Overall Study||21
10738075|NCT02885181|11902434|FG003|STARTED|Overall Study||22
10738076|NCT02885181|11902431|FG000|COMPLETED|Overall Study||20
10816433|NCT01560507|11979939|FG002|STARTED|Overall Study||2
10816434|NCT01560507|11979937|FG000|COMPLETED|Overall Study||1
10816435|NCT01560507|11979938|FG001|COMPLETED|Overall Study||0
10738077|NCT02885181|11902432|FG001|COMPLETED|Overall Study||19
10738078|NCT02885181|11902433|FG002|COMPLETED|Overall Study||21
10738079|NCT02885181|11902434|FG003|COMPLETED|Overall Study||19
10738080|NCT02885181|11902431|FG000|NOT COMPLETED|Overall Study||0
10738081|NCT02885181|11902432|FG001|NOT COMPLETED|Overall Study||1
10738082|NCT02885181|11902433|FG002|NOT COMPLETED|Overall Study||0
10738083|NCT02885181|11902434|FG003|NOT COMPLETED|Overall Study||3
10738084|NCT02885246|11902448|FG000|STARTED|Overall Study||1839
10738085|NCT02885246|11902448|FG000|COMPLETED|Overall Study||1839
10738086|NCT02885246|11902448|FG000|NOT COMPLETED|Overall Study||0
10738087|NCT02885350|11902456|FG000|STARTED|Overall Study||20
10738088|NCT02885350|11902457|FG001|STARTED|Overall Study||20
10738089|NCT02885350|11902458|FG002|STARTED|Overall Study||20
10738090|NCT02885350|11902459|FG003|STARTED|Overall Study||20
10738091|NCT02885350|11902456|FG000|COMPLETED|Overall Study||20
10738092|NCT02885350|11902457|FG001|COMPLETED|Overall Study||20
10738093|NCT02885350|11902458|FG002|COMPLETED|Overall Study||20
10738094|NCT02885350|11902459|FG003|COMPLETED|Overall Study||20
10738095|NCT02885350|11902456|FG000|NOT COMPLETED|Overall Study||0
10738096|NCT02885350|11902457|FG001|NOT COMPLETED|Overall Study||0
10738097|NCT02885350|11902458|FG002|NOT COMPLETED|Overall Study||0
10738098|NCT02885350|11902459|FG003|NOT COMPLETED|Overall Study||0
10738099|NCT02885506|11902479|FG000|STARTED|Part A||6
10738100|NCT02885506|11902480|FG001|STARTED|Part A||6
10738101|NCT02885506|11902481|FG002|STARTED|Part A||6
10738102|NCT02885506|11902482|FG003|STARTED|Part A||6
10738103|NCT02885506|11902483|FG004|STARTED|Part A||6
10738104|NCT02885506|11902484|FG005|STARTED|Part A||6
10738105|NCT02885506|11902485|FG006|STARTED|Part A||6
10738106|NCT02885506|11902486|FG007|STARTED|Part A||14
10738107|NCT02885506|11902487|FG008|STARTED|Part A||0
10738108|NCT02885506|11902488|FG009|STARTED|Part A||0
10738109|NCT02885506|11902479|FG000|COMPLETED|Part A||6
10738110|NCT02885506|11902480|FG001|COMPLETED|Part A||6
10738111|NCT02885506|11902481|FG002|COMPLETED|Part A||6
10738112|NCT02885506|11902482|FG003|COMPLETED|Part A||6
10738113|NCT02885506|11902483|FG004|COMPLETED|Part A||6
10738114|NCT02885506|11902484|FG005|COMPLETED|Part A||6
10738115|NCT02885506|11902485|FG006|COMPLETED|Part A||6
10738116|NCT02885506|11902486|FG007|COMPLETED|Part A||14
10738117|NCT02885506|11902487|FG008|COMPLETED|Part A||0
10816436|NCT01560507|11979939|FG002|COMPLETED|Overall Study||0
10738118|NCT02885506|11902488|FG009|COMPLETED|Part A||0
10738119|NCT02885506|11902479|FG000|NOT COMPLETED|Part A||0
10738120|NCT02885506|11902480|FG001|NOT COMPLETED|Part A||0
10738121|NCT02885506|11902481|FG002|NOT COMPLETED|Part A||0
10738122|NCT02885506|11902482|FG003|NOT COMPLETED|Part A||0
10738123|NCT02885506|11902483|FG004|NOT COMPLETED|Part A||0
10738124|NCT02885506|11902484|FG005|NOT COMPLETED|Part A||0
10738125|NCT02885506|11902485|FG006|NOT COMPLETED|Part A||0
10738126|NCT02885506|11902486|FG007|NOT COMPLETED|Part A||0
10738127|NCT02885506|11902487|FG008|NOT COMPLETED|Part A||0
10738128|NCT02885506|11902488|FG009|NOT COMPLETED|Part A||0
10738129|NCT02885506|11902479|FG000|STARTED|Part B||0
10738130|NCT02885506|11902480|FG001|STARTED|Part B||0
10738131|NCT02885506|11902481|FG002|STARTED|Part B||0
10738132|NCT02885506|11902482|FG003|STARTED|Part B||0
10738133|NCT02885506|11902483|FG004|STARTED|Part B||0
10738134|NCT02885506|11902484|FG005|STARTED|Part B||0
10738135|NCT02885506|11902485|FG006|STARTED|Part B||0
10738136|NCT02885506|11902486|FG007|STARTED|Part B||0
10738137|NCT02885506|11902487|FG008|STARTED|Part B||4
10738138|NCT02885506|11902488|FG009|STARTED|Part B||4
10738139|NCT02885506|11902479|FG000|COMPLETED|Part B||0
10738140|NCT02885506|11902480|FG001|COMPLETED|Part B||0
10738141|NCT02885506|11902481|FG002|COMPLETED|Part B||0
10738142|NCT02885506|11902482|FG003|COMPLETED|Part B||0
10738143|NCT02885506|11902483|FG004|COMPLETED|Part B||0
10738144|NCT02885506|11902484|FG005|COMPLETED|Part B||0
10738145|NCT02885506|11902485|FG006|COMPLETED|Part B||0
10738146|NCT02885506|11902486|FG007|COMPLETED|Part B||0
10738147|NCT02885506|11902487|FG008|COMPLETED|Part B||4
10738148|NCT02885506|11902488|FG009|COMPLETED|Part B||4
10738149|NCT02885506|11902479|FG000|NOT COMPLETED|Part B||0
10738150|NCT02885506|11902480|FG001|NOT COMPLETED|Part B||0
10738151|NCT02885506|11902481|FG002|NOT COMPLETED|Part B||0
10738152|NCT02885506|11902482|FG003|NOT COMPLETED|Part B||0
10738153|NCT02885506|11902483|FG004|NOT COMPLETED|Part B||0
10738154|NCT02885506|11902484|FG005|NOT COMPLETED|Part B||0
10738155|NCT02885506|11902485|FG006|NOT COMPLETED|Part B||0
10738156|NCT02885506|11902486|FG007|NOT COMPLETED|Part B||0
10738157|NCT02885506|11902487|FG008|NOT COMPLETED|Part B||0
10738158|NCT02885506|11902488|FG009|NOT COMPLETED|Part B||0
10738159|NCT02885636|11902514|FG000|STARTED|Overall Study||15
10738160|NCT02885636|11902515|FG001|STARTED|Overall Study||15
10738161|NCT02885636|11902514|FG000|COMPLETED|Overall Study||15
10738162|NCT02885636|11902515|FG001|COMPLETED|Overall Study||15
10738163|NCT02885636|11902514|FG000|NOT COMPLETED|Overall Study||0
10738164|NCT02885636|11902515|FG001|NOT COMPLETED|Overall Study||0
10738165|NCT02886234|11902523|FG000|STARTED|Overall Study||20
10738166|NCT02886234|11902524|FG001|STARTED|Overall Study||24
10738167|NCT02886234|11902523|FG000|COMPLETED|Overall Study||20
10738168|NCT02886234|11902524|FG001|COMPLETED|Overall Study||22
10738169|NCT02886234|11902523|FG000|NOT COMPLETED|Overall Study||0
10738170|NCT02886234|11902524|FG001|NOT COMPLETED|Overall Study||2
10738171|NCT02886338|11902530|FG000|STARTED|Overall Study||10
10738172|NCT02886338|11902530|FG000|COMPLETED|Overall Study||9
10738173|NCT02886338|11902530|FG000|NOT COMPLETED|Overall Study||1
10738174|NCT02886494|11902536|FG000|STARTED|Overall Study||60
10738175|NCT02886494|11902537|FG001|STARTED|Overall Study||20
10738176|NCT02886494|11902536|FG000|COMPLETED|Overall Study||43
10738177|NCT02886494|11902537|FG001|COMPLETED|Overall Study||16
10738178|NCT02886494|11902536|FG000|NOT COMPLETED|Overall Study||17
10738179|NCT02886494|11902537|FG001|NOT COMPLETED|Overall Study||4
10738180|NCT02886624|11902546|FG000|STARTED|8-week Treatment||30
10738181|NCT02886624|11902546|FG000|COMPLETED|8-week Treatment||30
10738182|NCT02886624|11902546|FG000|NOT COMPLETED|8-week Treatment||0
10738183|NCT02886624|11902546|FG000|STARTED|12-week Post Treatment Follow-up||30
10738184|NCT02886624|11902546|FG000|COMPLETED|12-week Post Treatment Follow-up||29
10738185|NCT02886624|11902546|FG000|NOT COMPLETED|12-week Post Treatment Follow-up||1
10738186|NCT02886624|11902546|FG000|STARTED|48-week Post Treatment Follow-up||29
10738187|NCT02886624|11902546|FG000|COMPLETED|48-week Post Treatment Follow-up||28
10738188|NCT02886624|11902546|FG000|NOT COMPLETED|48-week Post Treatment Follow-up||1
10738189|NCT02886702|11902553|FG000|STARTED|Overall Study||284
10738190|NCT02886702|11902554|FG001|STARTED|Overall Study||286
10738191|NCT02886702|11902555|FG002|STARTED|Overall Study||285
10738192|NCT02886702|11902553|FG000|Modified Intent-to Treat (mITT)|Overall Study||263
10738193|NCT02886702|11902554|FG001|Modified Intent-to Treat (mITT)|Overall Study||266
10738194|NCT02886702|11902555|FG002|Modified Intent-to Treat (mITT)|Overall Study||275
10738195|NCT02886702|11902553|FG000|Per-Protocol Population (PP)|Overall Study||208
10738196|NCT02886702|11902554|FG001|Per-Protocol Population (PP)|Overall Study||209
10738197|NCT02886702|11902555|FG002|Per-Protocol Population (PP)|Overall Study||201
10738198|NCT02886702|11902553|FG000|COMPLETED|Overall Study||236
10738199|NCT02886702|11902554|FG001|COMPLETED|Overall Study||235
10738200|NCT02886702|11902555|FG002|COMPLETED|Overall Study||232
10738201|NCT02886702|11902553|FG000|NOT COMPLETED|Overall Study||48
10738202|NCT02886702|11902554|FG001|NOT COMPLETED|Overall Study||51
10738203|NCT02886702|11902555|FG002|NOT COMPLETED|Overall Study||53
10738204|NCT02886715|11902566|FG000|STARTED|Overall Study||442
10738205|NCT02886715|11902567|FG001|STARTED|Overall Study||445
10738206|NCT02886715|11902568|FG002|STARTED|Overall Study||223
10738207|NCT02886715|11902566|FG000|Modified ITT (mITT)|Overall Study||421
10738208|NCT02886715|11902567|FG001|Modified ITT (mITT)|Overall Study||418
10738209|NCT02886715|11902568|FG002|Modified ITT (mITT)|Overall Study||217
10738210|NCT02886715|11902566|FG000|Per Protocol (PP) Population|Overall Study||346
10778076|NCT03349515|11939974|FG000|STARTED|Overall Study||55
10738211|NCT02886715|11902567|FG001|Per Protocol (PP) Population|Overall Study||351
10738212|NCT02886715|11902568|FG002|Per Protocol (PP) Population|Overall Study||176
10738213|NCT02886715|11902566|FG000|COMPLETED|Overall Study||378
10738214|NCT02886715|11902567|FG001|COMPLETED|Overall Study||390
10738215|NCT02886715|11902568|FG002|COMPLETED|Overall Study||203
10738216|NCT02886715|11902566|FG000|NOT COMPLETED|Overall Study||64
10738217|NCT02886715|11902567|FG001|NOT COMPLETED|Overall Study||55
10738218|NCT02886715|11902568|FG002|NOT COMPLETED|Overall Study||20
10738219|NCT02886728|11902580|FG000|STARTED|Overall Study||417
10738220|NCT02886728|11902581|FG001|STARTED|Overall Study||207
10738221|NCT02886728|11902582|FG002|STARTED|Overall Study||210
10738222|NCT02886728|11902583|FG003|STARTED|Overall Study||418
10738223|NCT02886728|11902580|FG000|COMPLETED|Overall Study||345
10738224|NCT02886728|11902581|FG001|COMPLETED|Overall Study||175
10738225|NCT02886728|11902582|FG002|COMPLETED|Overall Study||174
10408491|NCT00755105|11552579|FG002|NOT COMPLETED|Overall Study||4
10408492|NCT00755131|11552589|FG000|STARTED|Overall Study||37
10408493|NCT00755131|11552590|FG001|STARTED|Overall Study||38
10408494|NCT00755131|11552589|FG000|COMPLETED|Overall Study||37
10408495|NCT00755131|11552590|FG001|COMPLETED|Overall Study||38
10408496|NCT00755131|11552589|FG000|NOT COMPLETED|Overall Study||0
10408497|NCT00755131|11552590|FG001|NOT COMPLETED|Overall Study||0
10738226|NCT02886728|11902583|FG003|COMPLETED|Overall Study||331
10738227|NCT02886728|11902580|FG000|NOT COMPLETED|Overall Study||72
10738228|NCT02886728|11902581|FG001|NOT COMPLETED|Overall Study||32
10738229|NCT02886728|11902582|FG002|NOT COMPLETED|Overall Study||36
10738230|NCT02886728|11902583|FG003|NOT COMPLETED|Overall Study||87
10738231|NCT02886923|11902593|FG000|STARTED|Period 1||12
10738232|NCT02886923|11902594|FG001|STARTED|Period 1||11
10738233|NCT02886923|11902593|FG000|COMPLETED|Period 1||12
10738234|NCT02886923|11902594|FG001|COMPLETED|Period 1||11
10738235|NCT02886923|11902593|FG000|NOT COMPLETED|Period 1||0
10738236|NCT02886923|11902594|FG001|NOT COMPLETED|Period 1||0
10738237|NCT02886923|11902593|FG000|STARTED|Period 2||12
10738238|NCT02886923|11902594|FG001|STARTED|Period 2||11
10738239|NCT02886923|11902593|FG000|COMPLETED|Period 2||12
10738240|NCT02886923|11902594|FG001|COMPLETED|Period 2||11
10738241|NCT02886923|11902593|FG000|NOT COMPLETED|Period 2||0
10738242|NCT02886923|11902594|FG001|NOT COMPLETED|Period 2||0
10738243|NCT02887183|11902600|FG000|STARTED|Overall Study||795
10738244|NCT02887183|11902600|FG000|Full Analysis Set|Overall Study||794
10738245|NCT02887183|11902600|FG000|COMPLETED|Overall Study||654
10738246|NCT02887183|11902600|FG000|NOT COMPLETED|Overall Study||141
10738247|NCT02887404|11902606|FG000|STARTED|Overall Study||150
10738248|NCT02887404|11902607|FG001|STARTED|Overall Study||149
10738249|NCT02887404|11902606|FG000|COMPLETED|Overall Study||150
10738250|NCT02887404|11902607|FG001|COMPLETED|Overall Study||149
10738251|NCT02887404|11902606|FG000|NOT COMPLETED|Overall Study||0
10738252|NCT02887404|11902607|FG001|NOT COMPLETED|Overall Study||0
10738253|NCT02887521|11902616|FG000|STARTED|Overall Study||4
10738254|NCT02887521|11902617|FG001|STARTED|Overall Study||5
10738255|NCT02887521|11902616|FG000|COMPLETED|Overall Study||4
10738256|NCT02887521|11902617|FG001|COMPLETED|Overall Study||2
10738257|NCT02887521|11902616|FG000|NOT COMPLETED|Overall Study||0
10738258|NCT02887521|11902617|FG001|NOT COMPLETED|Overall Study||3
10778077|NCT03349515|11939975|FG001|STARTED|Overall Study||51
10778078|NCT03349515|11939974|FG000|COMPLETED|Overall Study||50
10778079|NCT03349515|11939975|FG001|COMPLETED|Overall Study||50
10778080|NCT03349515|11939974|FG000|NOT COMPLETED|Overall Study||5
10778081|NCT03349515|11939975|FG001|NOT COMPLETED|Overall Study||1
10778082|NCT03349567|11939985|FG000|STARTED|Overall Study||2
10778083|NCT03349567|11939986|FG001|STARTED|Overall Study||2
10778084|NCT03349567|11939985|FG000|COMPLETED|Overall Study||2
10778085|NCT03349567|11939986|FG001|COMPLETED|Overall Study||2
10778086|NCT03349567|11939985|FG000|NOT COMPLETED|Overall Study||0
10778087|NCT03349567|11939986|FG001|NOT COMPLETED|Overall Study||0
10778088|NCT03349632|11939994|FG000|STARTED|Period 1, First Week of Wear||11
10778089|NCT03349632|11939995|FG001|STARTED|Period 1, First Week of Wear||11
10778090|NCT03349632|11939996|FG002|STARTED|Period 1, First Week of Wear||11
10778091|NCT03349632|11939997|FG003|STARTED|Period 1, First Week of Wear||11
10778092|NCT03349632|11939998|FG004|STARTED|Period 1, First Week of Wear||11
10778093|NCT03349632|11939999|FG005|STARTED|Period 1, First Week of Wear||11
10778094|NCT03349632|11939994|FG000|COMPLETED|Period 1, First Week of Wear||11
10778095|NCT03349632|11939995|FG001|COMPLETED|Period 1, First Week of Wear||11
10778096|NCT03349632|11939996|FG002|COMPLETED|Period 1, First Week of Wear||11
10778097|NCT03349632|11939997|FG003|COMPLETED|Period 1, First Week of Wear||11
10778098|NCT03349632|11939998|FG004|COMPLETED|Period 1, First Week of Wear||11
10408498|NCT00755183|11552598|FG000|STARTED|Overall Study||30
10408499|NCT00755183|11552599|FG001|STARTED|Overall Study||30
10408500|NCT00755183|11552598|FG000|COMPLETED|Overall Study||23
10408501|NCT00755183|11552599|FG001|COMPLETED|Overall Study||24
10408502|NCT00755183|11552598|FG000|NOT COMPLETED|Overall Study||7
10408503|NCT00755183|11552599|FG001|NOT COMPLETED|Overall Study||6
10408504|NCT00755196|11552607|FG000|STARTED|Overall Study||30
10408505|NCT00755196|11552607|FG000|COMPLETED|Overall Study||28
10408506|NCT00755196|11552607|FG000|NOT COMPLETED|Overall Study||2
10408507|NCT00755222|11552614|FG000|STARTED|Overall Study||111
10408508|NCT00755222|11552615|FG001|STARTED|Overall Study||36
10408509|NCT00755222|11552614|FG000|COMPLETED|Overall Study||103
10408510|NCT00755222|11552615|FG001|COMPLETED|Overall Study||34
10778099|NCT03349632|11939999|FG005|COMPLETED|Period 1, First Week of Wear||11
10779387|NCT03365154|11940969|FG000|NOT COMPLETED|Overall Study||0
10738259|NCT02887989|11902625|FG000|STARTED|Overall Study||70
10738260|NCT02887989|11902626|FG001|STARTED|Overall Study||70
10738261|NCT02887989|11902625|FG000|COMPLETED|Overall Study||61
10738262|NCT02887989|11902626|FG001|COMPLETED|Overall Study||59
10738263|NCT02887989|11902625|FG000|NOT COMPLETED|Overall Study||9
10738264|NCT02887989|11902626|FG001|NOT COMPLETED|Overall Study||11
10738265|NCT02888080|11902634|FG000|STARTED|Overall Study||20
10738266|NCT02888080|11902635|FG001|STARTED|Overall Study||20
10738267|NCT02888080|11902634|FG000|COMPLETED|Overall Study||18
10738268|NCT02888080|11902635|FG001|COMPLETED|Overall Study||15
10738269|NCT02888080|11902634|FG000|NOT COMPLETED|Overall Study||2
10738270|NCT02888080|11902635|FG001|NOT COMPLETED|Overall Study||5
10738271|NCT02888093|11902643|FG000|STARTED|Overall Study||22
10738272|NCT02888093|11902644|FG001|STARTED|Overall Study||22
10738273|NCT02888093|11902643|FG000|COMPLETED|Overall Study||20
10738274|NCT02888093|11902644|FG001|COMPLETED|Overall Study||20
10738275|NCT02888093|11902643|FG000|NOT COMPLETED|Overall Study||2
10738276|NCT02888093|11902644|FG001|NOT COMPLETED|Overall Study||2
10738277|NCT02888106|11902658|FG000|STARTED|Overall Study||15
10738278|NCT02888106|11902659|FG001|STARTED|Overall Study||15
10738279|NCT02888106|11902660|FG002|STARTED|Overall Study||15
10738280|NCT02888106|11902661|FG003|STARTED|Overall Study||15
10738281|NCT02888106|11902662|FG004|STARTED|Overall Study||15
10738282|NCT02888106|11902663|FG005|STARTED|Overall Study||15
10738283|NCT02888106|11902658|FG000|COMPLETED|Overall Study||10
10738284|NCT02888106|11902659|FG001|COMPLETED|Overall Study||13
10738285|NCT02888106|11902660|FG002|COMPLETED|Overall Study||15
10738286|NCT02888106|11902661|FG003|COMPLETED|Overall Study||13
10738287|NCT02888106|11902662|FG004|COMPLETED|Overall Study||14
10738288|NCT02888106|11902663|FG005|COMPLETED|Overall Study||14
10738289|NCT02888106|11902658|FG000|NOT COMPLETED|Overall Study||5
10738290|NCT02888106|11902659|FG001|NOT COMPLETED|Overall Study||2
10738291|NCT02888106|11902660|FG002|NOT COMPLETED|Overall Study||0
10738292|NCT02888106|11902661|FG003|NOT COMPLETED|Overall Study||2
10738293|NCT02888106|11902662|FG004|NOT COMPLETED|Overall Study||1
10738294|NCT02888106|11902663|FG005|NOT COMPLETED|Overall Study||1
10738295|NCT02888171|11902685|FG000|STARTED|Overall Study||30
10738296|NCT02888171|11902686|FG001|STARTED|Overall Study||30
10738297|NCT02888171|11902685|FG000|COMPLETED|Overall Study||25
10738298|NCT02888171|11902686|FG001|COMPLETED|Overall Study||26
10738299|NCT02888171|11902685|FG000|NOT COMPLETED|Overall Study||5
10738300|NCT02888171|11902686|FG001|NOT COMPLETED|Overall Study||4
10738301|NCT02888665|11902695|FG000|STARTED|Overall Study||3
10738302|NCT02888665|11902696|FG001|STARTED|Overall Study||3
10738303|NCT02888665|11902697|FG002|STARTED|Overall Study||31
10738304|NCT02888665|11902695|FG000|COMPLETED|Overall Study||3
10738305|NCT02888665|11902696|FG001|COMPLETED|Overall Study||3
10738306|NCT02888665|11902697|FG002|COMPLETED|Overall Study||31
10738307|NCT02888665|11902695|FG000|NOT COMPLETED|Overall Study||0
10738308|NCT02888665|11902696|FG001|NOT COMPLETED|Overall Study||0
10738309|NCT02888665|11902697|FG002|NOT COMPLETED|Overall Study||0
10738310|NCT02888691|11902706|FG000|STARTED|First Intervention Period||7
10738311|NCT02888691|11902707|FG001|STARTED|First Intervention Period||7
10738312|NCT02888691|11902706|FG000|COMPLETED|First Intervention Period||6
10738313|NCT02888691|11902707|FG001|COMPLETED|First Intervention Period||7
10738314|NCT02888691|11902706|FG000|NOT COMPLETED|First Intervention Period||1
10738315|NCT02888691|11902707|FG001|NOT COMPLETED|First Intervention Period||0
10738316|NCT02888691|11902706|FG000|STARTED|Second Intervention Period|This is a cross-over study. Therefore starters does not necessarily equal completers of period 1.|7
10738317|NCT02888691|11902707|FG001|STARTED|Second Intervention Period||5
10738318|NCT02888691|11902706|FG000|COMPLETED|Second Intervention Period||7
10738319|NCT02888691|11902707|FG001|COMPLETED|Second Intervention Period||3
10738320|NCT02888691|11902706|FG000|NOT COMPLETED|Second Intervention Period||0
10738321|NCT02888691|11902707|FG001|NOT COMPLETED|Second Intervention Period||2
10738322|NCT02888756|11902716|FG000|STARTED|Vaccination Period||16
10738323|NCT02888756|11902717|FG001|STARTED|Vaccination Period||9
10738324|NCT02888756|11902718|FG002|STARTED|Vaccination Period||8
10738325|NCT02888756|11902716|FG000|COMPLETED|Vaccination Period||16
10738326|NCT02888756|11902717|FG001|COMPLETED|Vaccination Period||9
10738327|NCT02888756|11902718|FG002|COMPLETED|Vaccination Period||8
10738328|NCT02888756|11902716|FG000|NOT COMPLETED|Vaccination Period||0
10738329|NCT02888756|11902717|FG001|NOT COMPLETED|Vaccination Period||0
10738330|NCT02888756|11902718|FG002|NOT COMPLETED|Vaccination Period||0
10738331|NCT02888756|11902716|FG000|STARTED|Analytical Treatment Interruption||15
10738332|NCT02888756|11902717|FG001|STARTED|Analytical Treatment Interruption||9
10738333|NCT02888756|11902718|FG002|STARTED|Analytical Treatment Interruption||8
10738334|NCT02888756|11902716|FG000|COMPLETED|Analytical Treatment Interruption||5
10738335|NCT02888756|11902717|FG001|COMPLETED|Analytical Treatment Interruption||3
10738336|NCT02888756|11902718|FG002|COMPLETED|Analytical Treatment Interruption||3
10738337|NCT02888756|11902716|FG000|NOT COMPLETED|Analytical Treatment Interruption||10
10738338|NCT02888756|11902717|FG001|NOT COMPLETED|Analytical Treatment Interruption||6
10738339|NCT02888756|11902718|FG002|NOT COMPLETED|Analytical Treatment Interruption||5
10738340|NCT02889289|11902726|FG000|STARTED|Overall Study||1
10738341|NCT02889289|11902726|FG000|COMPLETED|Overall Study||1
10738342|NCT02889289|11902726|FG000|NOT COMPLETED|Overall Study||0
10738343|NCT02889393|11902732|FG000|STARTED|Overall Study||3
10738344|NCT02889393|11902733|FG001|STARTED|Overall Study||3
10738345|NCT02889393|11902732|FG000|COMPLETED|Overall Study||3
10738346|NCT02889393|11902733|FG001|COMPLETED|Overall Study||3
10738347|NCT02889393|11902732|FG000|NOT COMPLETED|Overall Study||0
10738348|NCT02889393|11902733|FG001|NOT COMPLETED|Overall Study||0
10738349|NCT02889510|11902740|FG000|STARTED|Overall Study||35
10738350|NCT02889510|11902741|FG001|STARTED|Overall Study||37
10738351|NCT02889510|11902740|FG000|COMPLETED|Overall Study||27
10738352|NCT02889510|11902741|FG001|COMPLETED|Overall Study||32
10738353|NCT02889510|11902740|FG000|NOT COMPLETED|Overall Study||8
10738354|NCT02889510|11902741|FG001|NOT COMPLETED|Overall Study||5
10738355|NCT02889562|11902749|FG000|STARTED|Overall Study||28
10738356|NCT02889562|11902750|FG001|STARTED|Overall Study||28
10738357|NCT02889562|11902749|FG000|COMPLETED|Overall Study||28
10738358|NCT02889562|11902750|FG001|COMPLETED|Overall Study||26
10738359|NCT02889562|11902749|FG000|NOT COMPLETED|Overall Study||0
10738360|NCT02889562|11902750|FG001|NOT COMPLETED|Overall Study||2
10738361|NCT02889796|11902760|FG000|STARTED|Overall Study||477
10738362|NCT02889796|11902761|FG001|STARTED|Overall Study||480
10738363|NCT02889796|11902762|FG002|STARTED|Overall Study||325
10738364|NCT02889796|11902763|FG003|STARTED|Overall Study||190
10738365|NCT02889796|11902764|FG004|STARTED|Overall Study||191
10738366|NCT02889796|11902765|FG005|STARTED|Overall Study||96
10738367|NCT02889796|11902760|FG000|COMPLETED|Overall Study||424
10738368|NCT02889796|11902761|FG001|COMPLETED|Overall Study||422
10738369|NCT02889796|11902762|FG002|COMPLETED|Overall Study||281
10738370|NCT02889796|11902763|FG003|COMPLETED|Overall Study||181
10738371|NCT02889796|11902764|FG004|COMPLETED|Overall Study||185
10738372|NCT02889796|11902765|FG005|COMPLETED|Overall Study|Completed 24 weeks of placebo treatment and not rerandomized to Filgotinib 200 mg or 100 mg groups|24
10738373|NCT02889796|11902760|FG000|NOT COMPLETED|Overall Study||53
10738374|NCT02889796|11902761|FG001|NOT COMPLETED|Overall Study||58
10738375|NCT02889796|11902762|FG002|NOT COMPLETED|Overall Study||44
10738376|NCT02889796|11902763|FG003|NOT COMPLETED|Overall Study||9
10738377|NCT02889796|11902764|FG004|NOT COMPLETED|Overall Study||6
10738378|NCT02889796|11902765|FG005|NOT COMPLETED|Overall Study||72
10738379|NCT02889861|11902788|FG000|STARTED|Overall Study||3
10738380|NCT02889861|11902788|FG000|COMPLETED|Overall Study||1
10738381|NCT02889861|11902788|FG000|NOT COMPLETED|Overall Study||2
10738382|NCT02890303|11902797|FG000|STARTED|Overall Study||100
10738383|NCT02890303|11902797|FG000|COMPLETED|Overall Study||100
10738384|NCT02890303|11902797|FG000|NOT COMPLETED|Overall Study||0
10738385|NCT02890381|11902803|FG000|STARTED|Overall Study||11
10738386|NCT02890381|11902804|FG001|STARTED|Overall Study||6
10738387|NCT02890381|11902803|FG000|COMPLETED|Overall Study||11
10738388|NCT02890381|11902804|FG001|COMPLETED|Overall Study||6
10738389|NCT02890381|11902803|FG000|NOT COMPLETED|Overall Study||0
10738390|NCT02890381|11902804|FG001|NOT COMPLETED|Overall Study||0
10738391|NCT02890992|11902818|FG000|STARTED|12 Weeks Open-Label Dose Finding Period||4
10738392|NCT02890992|11902819|FG001|STARTED|12 Weeks Open-Label Dose Finding Period||6
10738393|NCT02890992|11902820|FG002|STARTED|12 Weeks Open-Label Dose Finding Period||4
10738394|NCT02890992|11902821|FG003|STARTED|12 Weeks Open-Label Dose Finding Period||6
10738395|NCT02890992|11902822|FG004|STARTED|12 Weeks Open-Label Dose Finding Period||6
10738396|NCT02890992|11902823|FG005|STARTED|12 Weeks Open-Label Dose Finding Period||5
10738397|NCT02890992|11902824|FG006|STARTED|12 Weeks Open-Label Dose Finding Period||6
10738398|NCT02890992|11902825|FG007|STARTED|12 Weeks Open-Label Dose Finding Period||5
10816437|NCT01560507|11979937|FG000|NOT COMPLETED|Overall Study||4
10816438|NCT01560507|11979938|FG001|NOT COMPLETED|Overall Study||2
10816439|NCT01560507|11979939|FG002|NOT COMPLETED|Overall Study||2
10816440|NCT01557881|11979950|FG000|STARTED|Overall Study||98
10816441|NCT01557881|11979950|FG000|COMPLETED|Overall Study||98
10816442|NCT01557881|11979950|FG000|NOT COMPLETED|Overall Study||0
10816443|NCT01555489|11979954|FG000|STARTED|Overall Study||11
10816444|NCT01555489|11979954|FG000|COMPLETED|Overall Study||11
10816445|NCT01555489|11979954|FG000|NOT COMPLETED|Overall Study||0
10816446|NCT01549977|11979960|FG000|STARTED|Overall Study||1
10816447|NCT01549977|11979961|FG001|STARTED|Overall Study||0
10816448|NCT01549977|11979960|FG000|COMPLETED|Overall Study||1
10816449|NCT01549977|11979961|FG001|COMPLETED|Overall Study||0
10816450|NCT01549977|11979960|FG000|NOT COMPLETED|Overall Study||0
10816451|NCT01549977|11979961|FG001|NOT COMPLETED|Overall Study||0
10816452|NCT01558492|11979967|FG000|STARTED|Overall Study||3
10816453|NCT01558492|11979967|FG000|COMPLETED|Overall Study||3
10816454|NCT01558492|11979967|FG000|NOT COMPLETED|Overall Study||0
10816455|NCT01550562|11979971|FG000|STARTED|First Intervention, 4 - 5 Days||1
10816456|NCT01550562|11979971|FG000|COMPLETED|First Intervention, 4 - 5 Days||1
10816457|NCT01550562|11979971|FG000|NOT COMPLETED|First Intervention, 4 - 5 Days||0
10816458|NCT01550562|11979971|FG000|STARTED|Second Intervention, 4 - 5 Days||1
10816459|NCT01550562|11979971|FG000|COMPLETED|Second Intervention, 4 - 5 Days||1
10816460|NCT01550562|11979971|FG000|NOT COMPLETED|Second Intervention, 4 - 5 Days||0
10816461|NCT01550562|11979971|FG000|STARTED|Third Intervention, 4 - 5 Days||1
10816462|NCT01550562|11979971|FG000|COMPLETED|Third Intervention, 4 - 5 Days||1
10816463|NCT01550562|11979971|FG000|NOT COMPLETED|Third Intervention, 4 - 5 Days||0
10816464|NCT01561495|11979975|FG000|STARTED|Overall Study||1
10816465|NCT01561495|11979975|FG000|COMPLETED|Overall Study||1
10738399|NCT02890992|11902818|FG000|Treated|12 Weeks Open-Label Dose Finding Period||4
10738400|NCT02890992|11902819|FG001|Treated|12 Weeks Open-Label Dose Finding Period||6
10738401|NCT02890992|11902820|FG002|Treated|12 Weeks Open-Label Dose Finding Period||4
10738402|NCT02890992|11902821|FG003|Treated|12 Weeks Open-Label Dose Finding Period||6
10816466|NCT01561495|11979975|FG000|NOT COMPLETED|Overall Study||0
10816467|NCT01555073|11979983|FG000|STARTED|Overall Study||7
10738403|NCT02890992|11902822|FG004|Treated|12 Weeks Open-Label Dose Finding Period||6
10738404|NCT02890992|11902823|FG005|Treated|12 Weeks Open-Label Dose Finding Period||5
10738405|NCT02890992|11902824|FG006|Treated|12 Weeks Open-Label Dose Finding Period||6
10738406|NCT02890992|11902825|FG007|Treated|12 Weeks Open-Label Dose Finding Period||5
10738407|NCT02890992|11902818|FG000|COMPLETED|12 Weeks Open-Label Dose Finding Period|Out of 4 participants, 3 participants entered into the open-label extension (OLE) period.|4
10738408|NCT02890992|11902819|FG001|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
10738409|NCT02890992|11902820|FG002|COMPLETED|12 Weeks Open-Label Dose Finding Period||4
10738410|NCT02890992|11902821|FG003|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
10738411|NCT02890992|11902822|FG004|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
10738412|NCT02890992|11902823|FG005|COMPLETED|12 Weeks Open-Label Dose Finding Period||5
10738413|NCT02890992|11902824|FG006|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
10738414|NCT02890992|11902825|FG007|COMPLETED|12 Weeks Open-Label Dose Finding Period||5
10738415|NCT02890992|11902818|FG000|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
10738416|NCT02890992|11902819|FG001|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
10738417|NCT02890992|11902820|FG002|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
10738418|NCT02890992|11902821|FG003|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
10738419|NCT02890992|11902822|FG004|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
10738420|NCT02890992|11902823|FG005|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
10738421|NCT02890992|11902824|FG006|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
10738422|NCT02890992|11902825|FG007|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
10738423|NCT02890992|11902818|FG000|STARTED|130 Weeks Open-Label Extension Period|3 participants from Open-Label Dose Finding Period (OLDFI) entered in OLE period.|3
10738424|NCT02890992|11902819|FG001|STARTED|130 Weeks Open-Label Extension Period||6
10738425|NCT02890992|11902820|FG002|STARTED|130 Weeks Open-Label Extension Period||4
10738426|NCT02890992|11902821|FG003|STARTED|130 Weeks Open-Label Extension Period||6
10738427|NCT02890992|11902822|FG004|STARTED|130 Weeks Open-Label Extension Period||6
10738428|NCT02890992|11902823|FG005|STARTED|130 Weeks Open-Label Extension Period||5
10738429|NCT02890992|11902824|FG006|STARTED|130 Weeks Open-Label Extension Period||6
10738430|NCT02890992|11902825|FG007|STARTED|130 Weeks Open-Label Extension Period||5
10738431|NCT02890992|11902818|FG000|Treated|130 Weeks Open-Label Extension Period||3
10738432|NCT02890992|11902819|FG001|Treated|130 Weeks Open-Label Extension Period||6
10738433|NCT02890992|11902820|FG002|Treated|130 Weeks Open-Label Extension Period||4
10738434|NCT02890992|11902821|FG003|Treated|130 Weeks Open-Label Extension Period||6
10738435|NCT02890992|11902822|FG004|Treated|130 Weeks Open-Label Extension Period||6
10738436|NCT02890992|11902823|FG005|Treated|130 Weeks Open-Label Extension Period||5
10738437|NCT02890992|11902824|FG006|Treated|130 Weeks Open-Label Extension Period||5
10738438|NCT02890992|11902825|FG007|Treated|130 Weeks Open-Label Extension Period||4
10738439|NCT02890992|11902818|FG000|COMPLETED|130 Weeks Open-Label Extension Period||3
10738440|NCT02890992|11902819|FG001|COMPLETED|130 Weeks Open-Label Extension Period||3
10738441|NCT02890992|11902820|FG002|COMPLETED|130 Weeks Open-Label Extension Period||4
10738442|NCT02890992|11902821|FG003|COMPLETED|130 Weeks Open-Label Extension Period||6
10738443|NCT02890992|11902822|FG004|COMPLETED|130 Weeks Open-Label Extension Period||6
10738444|NCT02890992|11902823|FG005|COMPLETED|130 Weeks Open-Label Extension Period||5
10738445|NCT02890992|11902824|FG006|COMPLETED|130 Weeks Open-Label Extension Period||5
10738446|NCT02890992|11902825|FG007|COMPLETED|130 Weeks Open-Label Extension Period||4
10738447|NCT02890992|11902818|FG000|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
10738448|NCT02890992|11902819|FG001|NOT COMPLETED|130 Weeks Open-Label Extension Period||3
10738449|NCT02890992|11902820|FG002|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
10738450|NCT02890992|11902821|FG003|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
10738451|NCT02890992|11902822|FG004|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
10738452|NCT02890992|11902823|FG005|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
10738453|NCT02890992|11902824|FG006|NOT COMPLETED|130 Weeks Open-Label Extension Period||1
10738454|NCT02890992|11902825|FG007|NOT COMPLETED|130 Weeks Open-Label Extension Period||1
10738455|NCT02891070|11902852|FG000|STARTED|Overall Study||110
10816468|NCT01555073|11979984|FG001|STARTED|Overall Study||3
10816469|NCT01555073|11979985|FG002|STARTED|Overall Study||7
10816470|NCT01555073|11979986|FG003|STARTED|Overall Study||6
10816471|NCT01555073|11979983|FG000|COMPLETED|Overall Study||6
10816472|NCT01555073|11979984|FG001|COMPLETED|Overall Study||1
10816473|NCT01555073|11979985|FG002|COMPLETED|Overall Study||7
10816474|NCT01555073|11979986|FG003|COMPLETED|Overall Study||1
10816475|NCT01555073|11979983|FG000|NOT COMPLETED|Overall Study||1
10816476|NCT01555073|11979984|FG001|NOT COMPLETED|Overall Study||2
10816477|NCT01555073|11979985|FG002|NOT COMPLETED|Overall Study||0
10816478|NCT01555073|11979986|FG003|NOT COMPLETED|Overall Study||5
10816479|NCT01551082|11979996|FG000|STARTED|Overall Study||12
10816480|NCT01551082|11979996|FG000|COMPLETED|Overall Study||12
10816481|NCT01551082|11979996|FG000|NOT COMPLETED|Overall Study||0
10816482|NCT01556009|11980002|FG000|STARTED|Overall Study||0
10816483|NCT01556009|11980003|FG001|STARTED|Overall Study||0
10816484|NCT01556009|11980002|FG000|COMPLETED|Overall Study||0
10816485|NCT01556009|11980003|FG001|COMPLETED|Overall Study||0
10816486|NCT01556009|11980002|FG000|NOT COMPLETED|Overall Study||0
10816487|NCT01556009|11980003|FG001|NOT COMPLETED|Overall Study||0
10816488|NCT01550510|11980011|FG000|STARTED|Overall Study||4
10816489|NCT01550510|11980012|FG001|STARTED|Overall Study||0
10816490|NCT01550510|11980011|FG000|COMPLETED|Overall Study||4
10816491|NCT01550510|11980012|FG001|COMPLETED|Overall Study||0
10738456|NCT02891070|11902853|FG001|STARTED|Overall Study||114
10738457|NCT02891070|11902852|FG000|COMPLETED|Overall Study||100
10738458|NCT02891070|11902853|FG001|COMPLETED|Overall Study||106
10738459|NCT02891070|11902852|FG000|NOT COMPLETED|Overall Study||10
10738460|NCT02891070|11902853|FG001|NOT COMPLETED|Overall Study||8
10738461|NCT02891174|11902861|FG000|STARTED|First Intervention (24 Hours)||20
10738462|NCT02891174|11902862|FG001|STARTED|First Intervention (24 Hours)||23
10738463|NCT02891174|11902861|FG000|Received First Intervention|First Intervention (24 Hours)||19
10738464|NCT02891174|11902862|FG001|Received First Intervention|First Intervention (24 Hours)||18
10738465|NCT02891174|11902861|FG000|COMPLETED|First Intervention (24 Hours)||17
10738466|NCT02891174|11902862|FG001|COMPLETED|First Intervention (24 Hours)||10
10738467|NCT02891174|11902861|FG000|NOT COMPLETED|First Intervention (24 Hours)||3
10738468|NCT02891174|11902862|FG001|NOT COMPLETED|First Intervention (24 Hours)||13
10738469|NCT02891174|11902861|FG000|STARTED|Second Intervention (24 Hours)||17
10738470|NCT02891174|11902862|FG001|STARTED|Second Intervention (24 Hours)||10
10738471|NCT02891174|11902861|FG000|COMPLETED|Second Intervention (24 Hours)||11
10738472|NCT02891174|11902862|FG001|COMPLETED|Second Intervention (24 Hours)||3
10738473|NCT02891174|11902861|FG000|NOT COMPLETED|Second Intervention (24 Hours)||6
10738474|NCT02891174|11902862|FG001|NOT COMPLETED|Second Intervention (24 Hours)||7
10738475|NCT02891200|11902874|FG000|STARTED|Overall Study||145
10738476|NCT02891200|11902875|FG001|STARTED|Overall Study||147
10738477|NCT02891200|11902874|FG000|COMPLETED|Overall Study||103
10738478|NCT02891200|11902875|FG001|COMPLETED|Overall Study||98
10738479|NCT02891200|11902874|FG000|NOT COMPLETED|Overall Study||42
10738480|NCT02891200|11902875|FG001|NOT COMPLETED|Overall Study||49
10738481|NCT02891408|11902888|FG000|STARTED|Overall Study||10
10738482|NCT02891408|11902889|FG001|STARTED|Overall Study||10
10738483|NCT02891408|11902890|FG002|STARTED|Overall Study||14
10738484|NCT02891408|11902891|FG003|STARTED|Overall Study||10
10738485|NCT02891408|11902892|FG004|STARTED|Overall Study||10
10738486|NCT02891408|11902893|FG005|STARTED|Overall Study||10
10738487|NCT02891408|11902894|FG006|STARTED|Overall Study||10
10738488|NCT02891408|11902888|FG000|COMPLETED|Overall Study||10
10738489|NCT02891408|11902889|FG001|COMPLETED|Overall Study||10
10738490|NCT02891408|11902890|FG002|COMPLETED|Overall Study||13
10738491|NCT02891408|11902891|FG003|COMPLETED|Overall Study||10
10738492|NCT02891408|11902892|FG004|COMPLETED|Overall Study||10
10738493|NCT02891408|11902893|FG005|COMPLETED|Overall Study||10
10738494|NCT02891408|11902894|FG006|COMPLETED|Overall Study||10
10738495|NCT02891408|11902888|FG000|NOT COMPLETED|Overall Study||0
10738496|NCT02891408|11902889|FG001|NOT COMPLETED|Overall Study||0
10738497|NCT02891408|11902890|FG002|NOT COMPLETED|Overall Study||1
10738498|NCT02891408|11902891|FG003|NOT COMPLETED|Overall Study||0
10738499|NCT02891408|11902892|FG004|NOT COMPLETED|Overall Study||0
10738500|NCT02891408|11902893|FG005|NOT COMPLETED|Overall Study||0
10738501|NCT02891408|11902894|FG006|NOT COMPLETED|Overall Study||0
10738502|NCT02891629|11902922|FG000|STARTED|Overall Study||10
10738503|NCT02891629|11902923|FG001|STARTED|Overall Study||5
10738504|NCT02891629|11902922|FG000|COMPLETED|Overall Study||10
10738505|NCT02891629|11902923|FG001|COMPLETED|Overall Study||4
10738506|NCT02891629|11902922|FG000|NOT COMPLETED|Overall Study||0
10738507|NCT02891629|11902923|FG001|NOT COMPLETED|Overall Study||1
10738508|NCT02891681|11902932|FG000|STARTED|Overall Study||39
10738509|NCT02891681|11902933|FG001|STARTED|Overall Study||1
10738510|NCT02891681|11902934|FG002|STARTED|Overall Study||1
10738511|NCT02891681|11902932|FG000|COMPLETED|Overall Study||36
10738512|NCT02891681|11902933|FG001|COMPLETED|Overall Study||1
10738513|NCT02891681|11902934|FG002|COMPLETED|Overall Study||0
10738514|NCT02891681|11902932|FG000|NOT COMPLETED|Overall Study||3
10738515|NCT02891681|11902933|FG001|NOT COMPLETED|Overall Study||0
10738516|NCT02891681|11902934|FG002|NOT COMPLETED|Overall Study||1
10738517|NCT02891850|11902944|FG000|STARTED|Overall Study||111
10738518|NCT02891850|11902945|FG001|STARTED|Overall Study||114
10738519|NCT02891850|11902944|FG000|COMPLETED|Overall Study||104
10738520|NCT02891850|11902945|FG001|COMPLETED|Overall Study||107
10738521|NCT02891850|11902944|FG000|NOT COMPLETED|Overall Study||7
10738522|NCT02891850|11902945|FG001|NOT COMPLETED|Overall Study||7
10738523|NCT02891863|11902951|FG000|STARTED|Overall Study||9
10738524|NCT02891863|11902951|FG000|COMPLETED|Overall Study||9
10738525|NCT02891863|11902951|FG000|NOT COMPLETED|Overall Study||0
10738526|NCT02891915|11902957|FG000|STARTED|Overall Study||192
10738527|NCT02891915|11902958|FG001|STARTED|Overall Study||193
10738528|NCT02891915|11902957|FG000|COMPLETED|Overall Study||179
10738529|NCT02891915|11902958|FG001|COMPLETED|Overall Study||181
10738530|NCT02891915|11902957|FG000|NOT COMPLETED|Overall Study||13
10738531|NCT02891915|11902958|FG001|NOT COMPLETED|Overall Study||12
10738532|NCT02892019|11902966|FG000|STARTED|Overall Study||41
10738533|NCT02892019|11902967|FG001|STARTED|Overall Study||39
10738534|NCT02892019|11902966|FG000|COMPLETED|Overall Study||40
10738535|NCT02892019|11902967|FG001|COMPLETED|Overall Study||36
10738536|NCT02892019|11902966|FG000|NOT COMPLETED|Overall Study||1
10738537|NCT02892019|11902967|FG001|NOT COMPLETED|Overall Study||3
10738538|NCT02892110|11902975|FG000|STARTED|Overall Study||35
10738539|NCT02892110|11902976|FG001|STARTED|Overall Study||37
10738540|NCT02892110|11902975|FG000|COMPLETED|Overall Study||22
10738541|NCT02892110|11902976|FG001|COMPLETED|Overall Study||25
10738542|NCT02892110|11902975|FG000|NOT COMPLETED|Overall Study||13
10738543|NCT02892110|11902976|FG001|NOT COMPLETED|Overall Study||12
10738544|NCT02892344|11902984|FG000|STARTED|Overall Study||398
10738545|NCT02892344|11902985|FG001|STARTED|Overall Study||404
10738546|NCT02892344|11902984|FG000|Full Analysis Set|Overall Study||395
10738547|NCT02892344|11902985|FG001|Full Analysis Set|Overall Study||399
10738548|NCT02892344|11902984|FG000|COMPLETED|Overall Study||394
10738549|NCT02892344|11902985|FG001|COMPLETED|Overall Study||383
10738550|NCT02892344|11902984|FG000|NOT COMPLETED|Overall Study||4
10738551|NCT02892344|11902985|FG001|NOT COMPLETED|Overall Study||21
10738552|NCT02892409|11902993|FG000|STARTED|Overall Study||15
10738553|NCT02892409|11902994|FG001|STARTED|Overall Study||15
10738554|NCT02892409|11902993|FG000|COMPLETED|Overall Study||12
10738555|NCT02892409|11902994|FG001|COMPLETED|Overall Study||14
10738556|NCT02892409|11902993|FG000|NOT COMPLETED|Overall Study||3
10738557|NCT02892409|11902994|FG001|NOT COMPLETED|Overall Study||1
10738558|NCT02892422|11903000|FG000|STARTED|Overall Study|528 participants were enrolled, 524 from study 16159A and 4 from study 16323A|528
10738559|NCT02892422|11903000|FG000|COMPLETED|Overall Study||318
10738560|NCT02892422|11903000|FG000|NOT COMPLETED|Overall Study||210
10738561|NCT02892448|11903007|FG000|STARTED|Overall Study||12
10738562|NCT02892448|11903008|FG001|STARTED|Overall Study||12
10738563|NCT02892448|11903009|FG002|STARTED|Overall Study||11
10738564|NCT02892448|11903007|FG000|COMPLETED|Overall Study||10
10738565|NCT02892448|11903008|FG001|COMPLETED|Overall Study||10
10738566|NCT02892448|11903009|FG002|COMPLETED|Overall Study||10
10738567|NCT02892448|11903007|FG000|NOT COMPLETED|Overall Study||2
10738568|NCT02892448|11903008|FG001|NOT COMPLETED|Overall Study||2
10738569|NCT02892448|11903009|FG002|NOT COMPLETED|Overall Study||1
10738570|NCT02892513|11903019|FG000|STARTED|Overall Study||28
10738571|NCT02892513|11903020|FG001|STARTED|Overall Study|did not receive allocated intervention = 1 (withdrew per participant request)|25
10738572|NCT02892513|11903019|FG000|COMPLETED|Overall Study|Discontinued intervention early = 5; excluded from analysis = 0|28
10738573|NCT02892513|11903020|FG001|COMPLETED|Overall Study|Discontinued intervention early = 6; excluded from analysis = 1|24
10738574|NCT02892513|11903019|FG000|NOT COMPLETED|Overall Study||0
10738575|NCT02892513|11903020|FG001|NOT COMPLETED|Overall Study||1
10738576|NCT02892734|11903026|FG000|STARTED|Treatment on Study||3
10738577|NCT02892734|11903026|FG000|Completed 1st Cycle/Response at 12 Weeks|Treatment on Study||1
10738578|NCT02892734|11903026|FG000|Went on to Start Cycle 2|Treatment on Study||1
10738579|NCT02892734|11903026|FG000|COMPLETED|Treatment on Study||1
10738580|NCT02892734|11903026|FG000|NOT COMPLETED|Treatment on Study||2
10738581|NCT02892734|11903026|FG000|STARTED|Follow up for 2 Years||3
10738582|NCT02892734|11903026|FG000|COMPLETED|Follow up for 2 Years||0
10738583|NCT02892734|11903026|FG000|NOT COMPLETED|Follow up for 2 Years||3
10738584|NCT02892760|11903030|FG000|STARTED|Overall Study||17
10738585|NCT02892760|11903030|FG000|Received Intervention|Overall Study||15
10738586|NCT02892760|11903030|FG000|COMPLETED|Overall Study||14
10738587|NCT02892760|11903030|FG000|NOT COMPLETED|Overall Study||3
10738588|NCT02893878|11903037|FG000|STARTED|Overall Study||13861
10738589|NCT02893878|11903038|FG001|STARTED|Overall Study||2295
10738590|NCT02893878|11903039|FG002|STARTED|Overall Study||3178
10738591|NCT02893878|11903037|FG000|COMPLETED|Overall Study||13861
10738592|NCT02893878|11903038|FG001|COMPLETED|Overall Study||2295
10738593|NCT02893878|11903039|FG002|COMPLETED|Overall Study||3178
10738594|NCT02893878|11903037|FG000|NOT COMPLETED|Overall Study||0
10738595|NCT02893878|11903038|FG001|NOT COMPLETED|Overall Study||0
10738596|NCT02893878|11903039|FG002|NOT COMPLETED|Overall Study||0
10738597|NCT02894502|11903053|FG000|STARTED|Baseline||155
10738598|NCT02894502|11903054|FG001|STARTED|Baseline||177
10738599|NCT02894502|11903055|FG002|STARTED|Baseline||178
10738600|NCT02894502|11903053|FG000|COMPLETED|Baseline||128
10738601|NCT02894502|11903054|FG001|COMPLETED|Baseline||145
10738602|NCT02894502|11903055|FG002|COMPLETED|Baseline||133
10738603|NCT02894502|11903053|FG000|NOT COMPLETED|Baseline||27
10738604|NCT02894502|11903054|FG001|NOT COMPLETED|Baseline||32
10738605|NCT02894502|11903055|FG002|NOT COMPLETED|Baseline||45
10738606|NCT02894502|11903053|FG000|STARTED|First Follow up||128
10738607|NCT02894502|11903054|FG001|STARTED|First Follow up||145
10738608|NCT02894502|11903055|FG002|STARTED|First Follow up||133
10738609|NCT02894502|11903053|FG000|COMPLETED|First Follow up||94
10738610|NCT02894502|11903054|FG001|COMPLETED|First Follow up||114
10738611|NCT02894502|11903055|FG002|COMPLETED|First Follow up||93
10738612|NCT02894502|11903053|FG000|NOT COMPLETED|First Follow up||34
10816492|NCT01550510|11980011|FG000|NOT COMPLETED|Overall Study||0
10816493|NCT01550510|11980012|FG001|NOT COMPLETED|Overall Study||0
10816494|NCT01541397|11980021|FG000|STARTED|Overall Study||4
10816495|NCT01541397|11980022|FG001|STARTED|Overall Study||2
10816496|NCT01541397|11980021|FG000|COMPLETED|Overall Study||0
10816497|NCT01541397|11980022|FG001|COMPLETED|Overall Study||0
10816498|NCT01541397|11980021|FG000|NOT COMPLETED|Overall Study||4
10816499|NCT01541397|11980022|FG001|NOT COMPLETED|Overall Study||2
10816500|NCT01546207|11980028|FG000|STARTED|Overall Study||4
10816501|NCT01546207|11980028|FG000|COMPLETED|Overall Study||3
10816502|NCT01546207|11980028|FG000|NOT COMPLETED|Overall Study||1
10816503|NCT01553240|11980032|FG000|STARTED|Overall Study||0
10816504|NCT01553240|11980032|FG000|COMPLETED|Overall Study||0
10816505|NCT01553240|11980032|FG000|NOT COMPLETED|Overall Study||0
10816506|NCT01547728|11980036|FG000|STARTED|Overall Study||42
10816507|NCT01547728|11980036|FG000|COMPLETED|Overall Study||1
10816508|NCT01547728|11980036|FG000|NOT COMPLETED|Overall Study||41
10816509|NCT01548651|11980042|FG000|STARTED|Overall Study||4
10816510|NCT01548651|11980043|FG001|STARTED|Overall Study||4
10816511|NCT01548651|11980042|FG000|COMPLETED|Overall Study||3
10816512|NCT01548651|11980043|FG001|COMPLETED|Overall Study||4
10816513|NCT01548651|11980042|FG000|NOT COMPLETED|Overall Study||1
10738613|NCT02894502|11903054|FG001|NOT COMPLETED|First Follow up||31
10738614|NCT02894502|11903055|FG002|NOT COMPLETED|First Follow up||40
10738615|NCT02894502|11903053|FG000|STARTED|Second Follow up||94
10738616|NCT02894502|11903054|FG001|STARTED|Second Follow up||114
10738617|NCT02894502|11903055|FG002|STARTED|Second Follow up||93
10738618|NCT02894502|11903053|FG000|COMPLETED|Second Follow up||79
10738619|NCT02894502|11903054|FG001|COMPLETED|Second Follow up||96
10738620|NCT02894502|11903055|FG002|COMPLETED|Second Follow up||79
10738621|NCT02894502|11903053|FG000|NOT COMPLETED|Second Follow up||15
10738622|NCT02894502|11903054|FG001|NOT COMPLETED|Second Follow up||18
10738623|NCT02894502|11903055|FG002|NOT COMPLETED|Second Follow up||14
10738624|NCT02894502|11903053|FG000|STARTED|Third Follow up||79
10738625|NCT02894502|11903054|FG001|STARTED|Third Follow up||96
10738626|NCT02894502|11903055|FG002|STARTED|Third Follow up||79
10738627|NCT02894502|11903053|FG000|COMPLETED|Third Follow up||73
10738628|NCT02894502|11903054|FG001|COMPLETED|Third Follow up||89
10738629|NCT02894502|11903055|FG002|COMPLETED|Third Follow up||76
10738630|NCT02894502|11903053|FG000|NOT COMPLETED|Third Follow up||6
10738631|NCT02894502|11903054|FG001|NOT COMPLETED|Third Follow up||7
10738632|NCT02894502|11903055|FG002|NOT COMPLETED|Third Follow up||3
10738633|NCT02894840|11903070|FG000|STARTED|Overall Study||20
10738634|NCT02894840|11903071|FG001|STARTED|Overall Study||20
10738635|NCT02894840|11903072|FG002|STARTED|Overall Study||200
10738636|NCT02894840|11903073|FG003|STARTED|Overall Study||100
10738637|NCT02894840|11903070|FG000|COMPLETED|Overall Study||19
10738638|NCT02894840|11903071|FG001|COMPLETED|Overall Study||20
10738639|NCT02894840|11903072|FG002|COMPLETED|Overall Study||197
10738640|NCT02894840|11903073|FG003|COMPLETED|Overall Study||100
10738641|NCT02894840|11903070|FG000|NOT COMPLETED|Overall Study||1
10738642|NCT02894840|11903071|FG001|NOT COMPLETED|Overall Study||0
10738643|NCT02894840|11903072|FG002|NOT COMPLETED|Overall Study||3
10738644|NCT02894840|11903073|FG003|NOT COMPLETED|Overall Study||0
10738645|NCT02895035|11903088|FG000|STARTED|Overall Study||23
10738646|NCT02895035|11903089|FG001|STARTED|Overall Study||36
10738647|NCT02895035|11903088|FG000|COMPLETED|Overall Study||18
10738648|NCT02895035|11903089|FG001|COMPLETED|Overall Study||24
10738649|NCT02895035|11903088|FG000|NOT COMPLETED|Overall Study||5
10738650|NCT02895035|11903089|FG001|NOT COMPLETED|Overall Study||12
10738651|NCT02895100|11903099|FG000|STARTED|Overall Study||25
10738652|NCT02895100|11903100|FG001|STARTED|Overall Study||25
10738653|NCT02895100|11903101|FG002|STARTED|Overall Study||23
10738654|NCT02895100|11903102|FG003|STARTED|Overall Study||25
10738655|NCT02895100|11903099|FG000|COMPLETED|Overall Study||14
10738656|NCT02895100|11903100|FG001|COMPLETED|Overall Study||14
10738657|NCT02895100|11903101|FG002|COMPLETED|Overall Study||15
10738658|NCT02895100|11903102|FG003|COMPLETED|Overall Study||15
10738659|NCT02895100|11903099|FG000|NOT COMPLETED|Overall Study||11
10738660|NCT02895100|11903100|FG001|NOT COMPLETED|Overall Study||11
10738661|NCT02895100|11903101|FG002|NOT COMPLETED|Overall Study||8
10738662|NCT02895100|11903102|FG003|NOT COMPLETED|Overall Study||10
10738663|NCT02895295|11903115|FG000|STARTED|Overall Study||384
10738664|NCT02895295|11903116|FG001|STARTED|Overall Study||410
10738665|NCT02895295|11903117|FG002|STARTED|Overall Study||391
10738666|NCT02895295|11903115|FG000|COMPLETED|Overall Study||313
10738667|NCT02895295|11903116|FG001|COMPLETED|Overall Study||316
10738668|NCT02895295|11903117|FG002|COMPLETED|Overall Study||299
10738669|NCT02895295|11903115|FG000|NOT COMPLETED|Overall Study||71
10738670|NCT02895295|11903116|FG001|NOT COMPLETED|Overall Study||94
10738671|NCT02895295|11903117|FG002|NOT COMPLETED|Overall Study||92
10738672|NCT02895347|11903127|FG000|STARTED|Overall Study||20
10738673|NCT02895347|11903128|FG001|STARTED|Overall Study||20
10738674|NCT02895347|11903127|FG000|COMPLETED|Overall Study||17
10738675|NCT02895347|11903128|FG001|COMPLETED|Overall Study||19
10738676|NCT02895347|11903127|FG000|NOT COMPLETED|Overall Study||3
10738677|NCT02895347|11903128|FG001|NOT COMPLETED|Overall Study||1
10738678|NCT02895360|11903141|FG000|STARTED|Phase 1 - 30 mg/m² Cohort||4
10738679|NCT02895360|11903142|FG001|STARTED|Phase 1 - 30 mg/m² Cohort||0
10738680|NCT02895360|11903143|FG002|STARTED|Phase 1 - 30 mg/m² Cohort||0
10738681|NCT02895360|11903144|FG003|STARTED|Phase 1 - 30 mg/m² Cohort||0
10738682|NCT02895360|11903145|FG004|STARTED|Phase 1 - 30 mg/m² Cohort||0
10738683|NCT02895360|11903146|FG005|STARTED|Phase 1 - 30 mg/m² Cohort||0
10738684|NCT02895360|11903141|FG000|COMPLETED|Phase 1 - 30 mg/m² Cohort||0
10738685|NCT02895360|11903142|FG001|COMPLETED|Phase 1 - 30 mg/m² Cohort||0
10738686|NCT02895360|11903143|FG002|COMPLETED|Phase 1 - 30 mg/m² Cohort||0
10738687|NCT02895360|11903144|FG003|COMPLETED|Phase 1 - 30 mg/m² Cohort||0
10738688|NCT02895360|11903145|FG004|COMPLETED|Phase 1 - 30 mg/m² Cohort||0
10816514|NCT01548651|11980043|FG001|NOT COMPLETED|Overall Study||0
10738689|NCT02895360|11903146|FG005|COMPLETED|Phase 1 - 30 mg/m² Cohort||0
10738690|NCT02895360|11903141|FG000|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||4
10738691|NCT02895360|11903142|FG001|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||0
10816515|NCT01545648|11980049|FG000|STARTED|Overall Study||4
10738692|NCT02895360|11903143|FG002|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||0
10738693|NCT02895360|11903144|FG003|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||0
10738694|NCT02895360|11903145|FG004|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||0
10738695|NCT02895360|11903146|FG005|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||0
10738696|NCT02895360|11903141|FG000|STARTED|Phase 1 - 45 mg/m² Cohort||0
10738697|NCT02895360|11903142|FG001|STARTED|Phase 1 - 45 mg/m² Cohort||3
10738698|NCT02895360|11903143|FG002|STARTED|Phase 1 - 45 mg/m² Cohort||0
10738699|NCT02895360|11903144|FG003|STARTED|Phase 1 - 45 mg/m² Cohort||0
10738700|NCT02895360|11903145|FG004|STARTED|Phase 1 - 45 mg/m² Cohort||0
10738701|NCT02895360|11903146|FG005|STARTED|Phase 1 - 45 mg/m² Cohort||0
10738702|NCT02895360|11903141|FG000|COMPLETED|Phase 1 - 45 mg/m² Cohort||0
10738703|NCT02895360|11903142|FG001|COMPLETED|Phase 1 - 45 mg/m² Cohort||0
10738704|NCT02895360|11903143|FG002|COMPLETED|Phase 1 - 45 mg/m² Cohort||0
10738705|NCT02895360|11903144|FG003|COMPLETED|Phase 1 - 45 mg/m² Cohort||0
10738706|NCT02895360|11903145|FG004|COMPLETED|Phase 1 - 45 mg/m² Cohort||0
10738707|NCT02895360|11903146|FG005|COMPLETED|Phase 1 - 45 mg/m² Cohort||0
10738708|NCT02895360|11903141|FG000|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||0
10738709|NCT02895360|11903142|FG001|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||3
10738710|NCT02895360|11903143|FG002|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||0
10738711|NCT02895360|11903144|FG003|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||0
10738712|NCT02895360|11903145|FG004|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||0
10738713|NCT02895360|11903146|FG005|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||0
10738714|NCT02895360|11903141|FG000|STARTED|Phase 1 - 70 mg/m² Cohort||0
10738715|NCT02895360|11903142|FG001|STARTED|Phase 1 - 70 mg/m² Cohort||0
10738716|NCT02895360|11903143|FG002|STARTED|Phase 1 - 70 mg/m² Cohort||9
10738717|NCT02895360|11903144|FG003|STARTED|Phase 1 - 70 mg/m² Cohort||0
10738718|NCT02895360|11903145|FG004|STARTED|Phase 1 - 70 mg/m² Cohort||0
10738719|NCT02895360|11903146|FG005|STARTED|Phase 1 - 70 mg/m² Cohort||0
10738720|NCT02895360|11903141|FG000|COMPLETED|Phase 1 - 70 mg/m² Cohort||0
10738721|NCT02895360|11903142|FG001|COMPLETED|Phase 1 - 70 mg/m² Cohort||0
10738722|NCT02895360|11903143|FG002|COMPLETED|Phase 1 - 70 mg/m² Cohort||0
10738723|NCT02895360|11903144|FG003|COMPLETED|Phase 1 - 70 mg/m² Cohort||0
10738724|NCT02895360|11903145|FG004|COMPLETED|Phase 1 - 70 mg/m² Cohort||0
10738725|NCT02895360|11903146|FG005|COMPLETED|Phase 1 - 70 mg/m² Cohort||0
10738726|NCT02895360|11903141|FG000|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||0
10738727|NCT02895360|11903142|FG001|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||0
10738728|NCT02895360|11903143|FG002|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||9
10738729|NCT02895360|11903144|FG003|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||0
10738730|NCT02895360|11903145|FG004|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||0
10738731|NCT02895360|11903146|FG005|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||0
10738732|NCT02895360|11903141|FG000|STARTED|Phase 1 - 90 mg/m² Cohort||0
10738733|NCT02895360|11903142|FG001|STARTED|Phase 1 - 90 mg/m² Cohort||0
10738734|NCT02895360|11903143|FG002|STARTED|Phase 1 - 90 mg/m² Cohort||0
10738735|NCT02895360|11903144|FG003|STARTED|Phase 1 - 90 mg/m² Cohort||4
10738736|NCT02895360|11903145|FG004|STARTED|Phase 1 - 90 mg/m² Cohort||0
10738737|NCT02895360|11903146|FG005|STARTED|Phase 1 - 90 mg/m² Cohort||0
10738738|NCT02895360|11903141|FG000|COMPLETED|Phase 1 - 90 mg/m² Cohort||0
10738739|NCT02895360|11903142|FG001|COMPLETED|Phase 1 - 90 mg/m² Cohort||0
10738740|NCT02895360|11903143|FG002|COMPLETED|Phase 1 - 90 mg/m² Cohort||0
10738741|NCT02895360|11903144|FG003|COMPLETED|Phase 1 - 90 mg/m² Cohort||0
10738742|NCT02895360|11903145|FG004|COMPLETED|Phase 1 - 90 mg/m² Cohort||0
10738743|NCT02895360|11903146|FG005|COMPLETED|Phase 1 - 90 mg/m² Cohort||0
10738744|NCT02895360|11903141|FG000|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||0
10738745|NCT02895360|11903142|FG001|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||0
10738746|NCT02895360|11903143|FG002|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||0
10738747|NCT02895360|11903144|FG003|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||4
10738748|NCT02895360|11903145|FG004|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||0
10738749|NCT02895360|11903146|FG005|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||0
10738750|NCT02895360|11903141|FG000|STARTED|Phase 2a||0
10738751|NCT02895360|11903142|FG001|STARTED|Phase 2a||0
10738752|NCT02895360|11903143|FG002|STARTED|Phase 2a||0
10738753|NCT02895360|11903144|FG003|STARTED|Phase 2a||0
10738754|NCT02895360|11903145|FG004|STARTED|Phase 2a||11
10738755|NCT02895360|11903146|FG005|STARTED|Phase 2a||12
10738756|NCT02895360|11903141|FG000|COMPLETED|Phase 2a||0
10738757|NCT02895360|11903142|FG001|COMPLETED|Phase 2a||0
10738758|NCT02895360|11903143|FG002|COMPLETED|Phase 2a||0
10738759|NCT02895360|11903144|FG003|COMPLETED|Phase 2a||0
10738760|NCT02895360|11903145|FG004|COMPLETED|Phase 2a||0
10738761|NCT02895360|11903146|FG005|COMPLETED|Phase 2a||0
10738762|NCT02895360|11903141|FG000|NOT COMPLETED|Phase 2a||0
10738763|NCT02895360|11903142|FG001|NOT COMPLETED|Phase 2a||0
10738764|NCT02895360|11903143|FG002|NOT COMPLETED|Phase 2a||0
10738765|NCT02895360|11903144|FG003|NOT COMPLETED|Phase 2a||0
10738766|NCT02895360|11903145|FG004|NOT COMPLETED|Phase 2a||11
10738767|NCT02895360|11903146|FG005|NOT COMPLETED|Phase 2a||12
10738768|NCT02895945|11903180|FG000|STARTED|Overall Study||7
10738769|NCT02895945|11903181|FG001|STARTED|Overall Study||1
10738770|NCT02895945|11903180|FG000|SAS|Overall Study||7
10738771|NCT02895945|11903181|FG001|SAS|Overall Study||1
10738772|NCT02895945|11903180|FG000|FAS|Overall Study||7
10738773|NCT02895945|11903181|FG001|FAS|Overall Study||0
10738774|NCT02895945|11903180|FG000|COMPLETED|Overall Study||5
10738775|NCT02895945|11903181|FG001|COMPLETED|Overall Study||0
10738776|NCT02895945|11903180|FG000|NOT COMPLETED|Overall Study||2
10738777|NCT02895945|11903181|FG001|NOT COMPLETED|Overall Study||1
10738778|NCT02896075|11903187|FG000|STARTED|Overall Study||40
10738779|NCT02896075|11903187|FG000|Leg Soreness|Overall Study||40
10738780|NCT02896075|11903187|FG000|COMPLETED|Overall Study||40
10738781|NCT02896075|11903187|FG000|NOT COMPLETED|Overall Study||0
10738782|NCT02896127|11903196|FG000|STARTED|COMPLETED WEEK 52||305
10738783|NCT02896127|11903197|FG001|STARTED|COMPLETED WEEK 52|Includes participants originally assigned to placebo and switched to AIN457150 mg after Wk 16.|153
10738784|NCT02896127|11903196|FG000|COMPLETED|COMPLETED WEEK 52||278
10738785|NCT02896127|11903197|FG001|COMPLETED|COMPLETED WEEK 52||142
10738786|NCT02896127|11903196|FG000|NOT COMPLETED|COMPLETED WEEK 52||27
10738787|NCT02896127|11903197|FG001|NOT COMPLETED|COMPLETED WEEK 52||11
10738788|NCT02896127|11903196|FG000|STARTED|COMPLETED POST-TREATMENT FOLLOW UP|Participants enter follow-up if they exited before Wk 52 Thus numbers different from previous period|280
10738789|NCT02896127|11903197|FG001|STARTED|COMPLETED POST-TREATMENT FOLLOW UP|Participants enter follow-up if they exited before Wk 52 Thus numbers different from previous period|139
10738790|NCT02896127|11903196|FG000|COMPLETED|COMPLETED POST-TREATMENT FOLLOW UP|Participants enter follow-up if they exited before Wk 52 Thus numbers different from previous period|276
10738791|NCT02896127|11903197|FG001|COMPLETED|COMPLETED POST-TREATMENT FOLLOW UP|Participants enter follow-up if they exited before Wk 52 Thus numbers different from previous period|134
10738792|NCT02896127|11903196|FG000|NOT COMPLETED|COMPLETED POST-TREATMENT FOLLOW UP||4
10738793|NCT02896127|11903197|FG001|NOT COMPLETED|COMPLETED POST-TREATMENT FOLLOW UP||5
10738794|NCT02896296|11903203|FG000|STARTED|Overall Study||208
10738795|NCT02896296|11903203|FG000|COMPLETED|Overall Study||166
10738796|NCT02896296|11903203|FG000|NOT COMPLETED|Overall Study||42
10738797|NCT02896361|11903207|FG000|STARTED|First Intervention (2 Weeks)||9
10738798|NCT02896361|11903208|FG001|STARTED|First Intervention (2 Weeks)||10
10738799|NCT02896361|11903209|FG002|STARTED|First Intervention (2 Weeks)||8
10738800|NCT02896361|11903207|FG000|COMPLETED|First Intervention (2 Weeks)||9
10738801|NCT02896361|11903208|FG001|COMPLETED|First Intervention (2 Weeks)||10
10738802|NCT02896361|11903209|FG002|COMPLETED|First Intervention (2 Weeks)||8
10738803|NCT02896361|11903207|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
10738804|NCT02896361|11903208|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
10738805|NCT02896361|11903209|FG002|NOT COMPLETED|First Intervention (2 Weeks)||0
10738806|NCT02896361|11903207|FG000|STARTED|Second Intervention (2 Weeks)||9
10738807|NCT02896361|11903208|FG001|STARTED|Second Intervention (2 Weeks)||10
10738808|NCT02896361|11903209|FG002|STARTED|Second Intervention (2 Weeks)||8
10738809|NCT02896361|11903207|FG000|COMPLETED|Second Intervention (2 Weeks)||9
10738810|NCT02896361|11903208|FG001|COMPLETED|Second Intervention (2 Weeks)||10
10738811|NCT02896361|11903209|FG002|COMPLETED|Second Intervention (2 Weeks)||8
10738812|NCT02896361|11903207|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
10738813|NCT02896361|11903208|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
10738814|NCT02896361|11903209|FG002|NOT COMPLETED|Second Intervention (2 Weeks)||0
10738815|NCT02896361|11903207|FG000|STARTED|Third Intervention (2 Weeks)||9
10738816|NCT02896361|11903208|FG001|STARTED|Third Intervention (2 Weeks)||10
10738817|NCT02896361|11903209|FG002|STARTED|Third Intervention (2 Weeks)||8
10738818|NCT02896361|11903207|FG000|COMPLETED|Third Intervention (2 Weeks)||8
10738819|NCT02896361|11903208|FG001|COMPLETED|Third Intervention (2 Weeks)||9
10738820|NCT02896361|11903209|FG002|COMPLETED|Third Intervention (2 Weeks)||8
10738821|NCT02896361|11903207|FG000|NOT COMPLETED|Third Intervention (2 Weeks)||1
10738822|NCT02896361|11903208|FG001|NOT COMPLETED|Third Intervention (2 Weeks)||1
10738823|NCT02896361|11903209|FG002|NOT COMPLETED|Third Intervention (2 Weeks)||0
10738824|NCT02896400|11903237|FG000|STARTED|Baseline||66
10738825|NCT02896400|11903238|FG001|STARTED|Baseline||66
10738826|NCT02896400|11903239|FG002|STARTED|Baseline||66
10738827|NCT02896400|11903240|FG003|STARTED|Baseline||66
10738828|NCT02896400|11903241|FG004|STARTED|Baseline||66
10738829|NCT02896400|11903242|FG005|STARTED|Baseline||66
10738830|NCT02896400|11903243|FG006|STARTED|Baseline||66
10738831|NCT02896400|11903244|FG007|STARTED|Baseline||66
10738832|NCT02896400|11903245|FG008|STARTED|Baseline||66
10738833|NCT02896400|11903246|FG009|STARTED|Baseline||66
10738834|NCT02896400|11903247|FG010|STARTED|Baseline||66
10738835|NCT02896400|11903248|FG011|STARTED|Baseline||66
10738836|NCT02896400|11903249|FG012|STARTED|Baseline||66
10738837|NCT02896400|11903250|FG013|STARTED|Baseline||66
10738838|NCT02896400|11903251|FG014|STARTED|Baseline||66
10738839|NCT02896400|11903252|FG015|STARTED|Baseline||66
10738840|NCT02896400|11903237|FG000|COMPLETED|Baseline||66
10738841|NCT02896400|11903238|FG001|COMPLETED|Baseline||66
10738842|NCT02896400|11903239|FG002|COMPLETED|Baseline||66
10738843|NCT02896400|11903240|FG003|COMPLETED|Baseline||66
10738844|NCT02896400|11903241|FG004|COMPLETED|Baseline||66
10738845|NCT02896400|11903242|FG005|COMPLETED|Baseline||66
10738846|NCT02896400|11903243|FG006|COMPLETED|Baseline||66
10738847|NCT02896400|11903244|FG007|COMPLETED|Baseline||66
10738848|NCT02896400|11903245|FG008|COMPLETED|Baseline||66
10738849|NCT02896400|11903246|FG009|COMPLETED|Baseline||66
10738850|NCT02896400|11903247|FG010|COMPLETED|Baseline||66
10738851|NCT02896400|11903248|FG011|COMPLETED|Baseline||66
10738852|NCT02896400|11903249|FG012|COMPLETED|Baseline||66
10738853|NCT02896400|11903250|FG013|COMPLETED|Baseline||66
10738854|NCT02896400|11903251|FG014|COMPLETED|Baseline||66
10738855|NCT02896400|11903252|FG015|COMPLETED|Baseline||66
10738856|NCT02896400|11903237|FG000|NOT COMPLETED|Baseline||0
10738857|NCT02896400|11903238|FG001|NOT COMPLETED|Baseline||0
10738858|NCT02896400|11903239|FG002|NOT COMPLETED|Baseline||0
10738859|NCT02896400|11903240|FG003|NOT COMPLETED|Baseline||0
10738860|NCT02896400|11903241|FG004|NOT COMPLETED|Baseline||0
10738861|NCT02896400|11903242|FG005|NOT COMPLETED|Baseline||0
10738862|NCT02896400|11903243|FG006|NOT COMPLETED|Baseline||0
10738863|NCT02896400|11903244|FG007|NOT COMPLETED|Baseline||0
10738864|NCT02896400|11903245|FG008|NOT COMPLETED|Baseline||0
10738865|NCT02896400|11903246|FG009|NOT COMPLETED|Baseline||0
10738866|NCT02896400|11903247|FG010|NOT COMPLETED|Baseline||0
10738867|NCT02896400|11903248|FG011|NOT COMPLETED|Baseline||0
10738868|NCT02896400|11903249|FG012|NOT COMPLETED|Baseline||0
10738869|NCT02896400|11903250|FG013|NOT COMPLETED|Baseline||0
10738870|NCT02896400|11903251|FG014|NOT COMPLETED|Baseline||0
10738871|NCT02896400|11903252|FG015|NOT COMPLETED|Baseline||0
10738872|NCT02896400|11903237|FG000|STARTED|1 Month Follow-up||66
10738873|NCT02896400|11903238|FG001|STARTED|1 Month Follow-up||66
10738874|NCT02896400|11903239|FG002|STARTED|1 Month Follow-up||66
10738875|NCT02896400|11903240|FG003|STARTED|1 Month Follow-up||66
10738876|NCT02896400|11903241|FG004|STARTED|1 Month Follow-up||66
10738877|NCT02896400|11903242|FG005|STARTED|1 Month Follow-up||66
10738878|NCT02896400|11903243|FG006|STARTED|1 Month Follow-up||66
10738879|NCT02896400|11903244|FG007|STARTED|1 Month Follow-up||66
10738880|NCT02896400|11903245|FG008|STARTED|1 Month Follow-up||66
10738881|NCT02896400|11903246|FG009|STARTED|1 Month Follow-up||66
10738882|NCT02896400|11903247|FG010|STARTED|1 Month Follow-up||66
10738883|NCT02896400|11903248|FG011|STARTED|1 Month Follow-up||66
10738884|NCT02896400|11903249|FG012|STARTED|1 Month Follow-up||66
10738885|NCT02896400|11903250|FG013|STARTED|1 Month Follow-up||66
10738886|NCT02896400|11903251|FG014|STARTED|1 Month Follow-up||66
10816516|NCT01545648|11980049|FG000|6 Months of Treatment|Overall Study||4
10816517|NCT01545648|11980049|FG000|COMPLETED|Overall Study||4
10816518|NCT01545648|11980049|FG000|NOT COMPLETED|Overall Study||0
10816519|NCT01546883|11980053|FG000|STARTED|Overall Study||14
10816520|NCT01546883|11980053|FG000|COMPLETED|Overall Study||2
10816521|NCT01546883|11980053|FG000|NOT COMPLETED|Overall Study||12
10816522|NCT01545518|11980057|FG000|STARTED|Overall Study||20
10816523|NCT01545518|11980057|FG000|COMPLETED|Overall Study||20
10816524|NCT01545518|11980057|FG000|NOT COMPLETED|Overall Study||0
10816525|NCT01536015|11980063|FG000|STARTED|Overall Study||12
10816526|NCT01536015|11980064|FG001|STARTED|Overall Study||13
10408511|NCT00755222|11552614|FG000|NOT COMPLETED|Overall Study||8
10408512|NCT00755222|11552615|FG001|NOT COMPLETED|Overall Study||2
10408513|NCT00755235|11552623|FG000|STARTED|Overall Study||106
10408514|NCT00755235|11552624|FG001|STARTED|Overall Study||102
10408515|NCT00755235|11552623|FG000|COMPLETED|Overall Study||104
10408516|NCT00755235|11552624|FG001|COMPLETED|Overall Study||93
10408517|NCT00755235|11552623|FG000|NOT COMPLETED|Overall Study||2
10408518|NCT00755235|11552624|FG001|NOT COMPLETED|Overall Study||9
10408519|NCT00755274|11552632|FG000|STARTED|Overall Study||24
10408520|NCT00755274|11552633|FG001|STARTED|Overall Study||8
10408521|NCT00755274|11552632|FG000|COMPLETED|Overall Study||24
10408522|NCT00755274|11552633|FG001|COMPLETED|Overall Study||8
10408523|NCT00755274|11552632|FG000|NOT COMPLETED|Overall Study||0
10408524|NCT00755274|11552633|FG001|NOT COMPLETED|Overall Study||0
10408525|NCT00755326|11552641|FG000|STARTED|Overall Study||47
10408526|NCT00755326|11552642|FG001|STARTED|Overall Study||45
10408527|NCT00755326|11552641|FG000|COMPLETED|Overall Study||45
10408528|NCT00755326|11552642|FG001|COMPLETED|Overall Study||42
10408529|NCT00755326|11552641|FG000|NOT COMPLETED|Overall Study||2
10408530|NCT00755326|11552642|FG001|NOT COMPLETED|Overall Study||3
10408531|NCT00755417|11552652|FG000|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|174
10738906|NCT02896400|11903239|FG002|NOT COMPLETED|1 Month Follow-up||5
10408532|NCT00755417|11552653|FG001|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|181
10408533|NCT00755417|11552654|FG002|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|177
10408534|NCT00755417|11552652|FG000|COMPLETED|Overall Study||112
10408535|NCT00755417|11552653|FG001|COMPLETED|Overall Study||126
10408536|NCT00755417|11552654|FG002|COMPLETED|Overall Study||135
10408537|NCT00755417|11552652|FG000|NOT COMPLETED|Overall Study||62
10408538|NCT00755417|11552653|FG001|NOT COMPLETED|Overall Study||55
10408539|NCT00755417|11552654|FG002|NOT COMPLETED|Overall Study||42
10408540|NCT00755716|11552665|FG000|STARTED|Overall Study||19
10408541|NCT00755716|11552666|FG001|STARTED|Overall Study||19
10408542|NCT00755716|11552667|FG002|STARTED|Overall Study||19
10408543|NCT00755716|11552665|FG000|COMPLETED|Overall Study||11
10408544|NCT00755716|11552666|FG001|COMPLETED|Overall Study||11
10408545|NCT00755716|11552667|FG002|COMPLETED|Overall Study||16
10408546|NCT00755716|11552665|FG000|NOT COMPLETED|Overall Study||8
10408547|NCT00755716|11552666|FG001|NOT COMPLETED|Overall Study||8
10408548|NCT00755716|11552667|FG002|NOT COMPLETED|Overall Study||3
10408549|NCT00755755|11552678|FG000|STARTED|Overall Study|Safety population|95
10408550|NCT00755755|11552679|FG001|STARTED|Overall Study|Safety population|98
10408551|NCT00755755|11552680|FG002|STARTED|Overall Study|Safety population|48
10408552|NCT00755755|11552678|FG000|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|89
10408553|NCT00755755|11552679|FG001|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|90
10408554|NCT00755755|11552680|FG002|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|45
10408555|NCT00755755|11552678|FG000|NOT COMPLETED|Overall Study||6
10408556|NCT00755755|11552679|FG001|NOT COMPLETED|Overall Study||8
10408557|NCT00755755|11552680|FG002|NOT COMPLETED|Overall Study||3
10408558|NCT00755807|11552690|FG000|STARTED|Acute Phase||118
10408559|NCT00755807|11552691|FG001|STARTED|Acute Phase||121
10408560|NCT00755807|11552690|FG000|COMPLETED|Acute Phase||100
10408561|NCT00755807|11552691|FG001|COMPLETED|Acute Phase||109
10816527|NCT01536015|11980063|FG000|COMPLETED|Overall Study||4
10408562|NCT00755807|11552690|FG000|NOT COMPLETED|Acute Phase||18
10408563|NCT00755807|11552691|FG001|NOT COMPLETED|Acute Phase||12
10408564|NCT00755807|11552690|FG000|STARTED|Open-label Extension Phase||100
10408565|NCT00755807|11552691|FG001|STARTED|Open-label Extension Phase||109
10408566|NCT00755807|11552690|FG000|COMPLETED|Open-label Extension Phase||82
10408567|NCT00755807|11552691|FG001|COMPLETED|Open-label Extension Phase||93
10408568|NCT00755807|11552690|FG000|NOT COMPLETED|Open-label Extension Phase||18
10408569|NCT00755807|11552691|FG001|NOT COMPLETED|Open-label Extension Phase||16
10738887|NCT02896400|11903252|FG015|STARTED|1 Month Follow-up||66
10408570|NCT00755846|11552707|FG000|STARTED|Overall Study||43
10408571|NCT00755846|11552708|FG001|STARTED|Overall Study||44
10408572|NCT00755846|11552709|FG002|STARTED|Overall Study||44
10408573|NCT00755846|11552710|FG003|STARTED|Overall Study||45
10408574|NCT00755846|11552711|FG004|STARTED|Overall Study||44
10408575|NCT00755846|11552712|FG005|STARTED|Overall Study||45
10408576|NCT00755846|11552707|FG000|COMPLETED|Overall Study||18
10408577|NCT00755846|11552708|FG001|COMPLETED|Overall Study||27
10408578|NCT00755846|11552709|FG002|COMPLETED|Overall Study||32
10408579|NCT00755846|11552710|FG003|COMPLETED|Overall Study||32
10408580|NCT00755846|11552711|FG004|COMPLETED|Overall Study||27
10408581|NCT00755846|11552712|FG005|COMPLETED|Overall Study||31
10408582|NCT00755846|11552707|FG000|NOT COMPLETED|Overall Study||25
10408583|NCT00755846|11552708|FG001|NOT COMPLETED|Overall Study||17
10408584|NCT00755846|11552709|FG002|NOT COMPLETED|Overall Study||12
10408585|NCT00755846|11552710|FG003|NOT COMPLETED|Overall Study||13
10408586|NCT00755846|11552711|FG004|NOT COMPLETED|Overall Study||17
10408587|NCT00755846|11552712|FG005|NOT COMPLETED|Overall Study||14
10408588|NCT00755911|11552728|FG000|STARTED|Overall Study||12
10408589|NCT00755911|11552729|FG001|STARTED|Overall Study||12
10408590|NCT00755911|11552728|FG000|COMPLETED|Overall Study||12
10408591|NCT00755911|11552729|FG001|COMPLETED|Overall Study||12
10408592|NCT00755911|11552728|FG000|NOT COMPLETED|Overall Study||0
10408593|NCT00755911|11552729|FG001|NOT COMPLETED|Overall Study||0
10408594|NCT00755937|11552735|FG000|STARTED|Recruitment|Subjects registered in the program|556
10408595|NCT00755937|11552735|FG000|COMPLETED|Recruitment|Subjects who had a baseline visit and at least 1 additional follow-up visit (analyzed population)|392
10408596|NCT00755937|11552735|FG000|NOT COMPLETED|Recruitment||164
10738888|NCT02896400|11903237|FG000|COMPLETED|1 Month Follow-up||59
10738889|NCT02896400|11903238|FG001|COMPLETED|1 Month Follow-up||59
10738890|NCT02896400|11903239|FG002|COMPLETED|1 Month Follow-up||61
10738891|NCT02896400|11903240|FG003|COMPLETED|1 Month Follow-up||58
10738892|NCT02896400|11903241|FG004|COMPLETED|1 Month Follow-up||57
10738893|NCT02896400|11903242|FG005|COMPLETED|1 Month Follow-up||60
10738894|NCT02896400|11903243|FG006|COMPLETED|1 Month Follow-up||61
10738895|NCT02896400|11903244|FG007|COMPLETED|1 Month Follow-up||60
10738896|NCT02896400|11903245|FG008|COMPLETED|1 Month Follow-up||62
10738897|NCT02896400|11903246|FG009|COMPLETED|1 Month Follow-up||59
10738898|NCT02896400|11903247|FG010|COMPLETED|1 Month Follow-up||61
10738899|NCT02896400|11903248|FG011|COMPLETED|1 Month Follow-up||61
10738900|NCT02896400|11903249|FG012|COMPLETED|1 Month Follow-up||63
10738901|NCT02896400|11903250|FG013|COMPLETED|1 Month Follow-up||62
10738902|NCT02896400|11903251|FG014|COMPLETED|1 Month Follow-up||65
10738903|NCT02896400|11903252|FG015|COMPLETED|1 Month Follow-up||63
10738904|NCT02896400|11903237|FG000|NOT COMPLETED|1 Month Follow-up||7
10738905|NCT02896400|11903238|FG001|NOT COMPLETED|1 Month Follow-up||7
10738907|NCT02896400|11903240|FG003|NOT COMPLETED|1 Month Follow-up||8
10738908|NCT02896400|11903241|FG004|NOT COMPLETED|1 Month Follow-up||9
10738909|NCT02896400|11903242|FG005|NOT COMPLETED|1 Month Follow-up||6
10738910|NCT02896400|11903243|FG006|NOT COMPLETED|1 Month Follow-up||5
10738911|NCT02896400|11903244|FG007|NOT COMPLETED|1 Month Follow-up||6
10738912|NCT02896400|11903245|FG008|NOT COMPLETED|1 Month Follow-up||4
10738913|NCT02896400|11903246|FG009|NOT COMPLETED|1 Month Follow-up||7
10738914|NCT02896400|11903247|FG010|NOT COMPLETED|1 Month Follow-up||5
10738915|NCT02896400|11903248|FG011|NOT COMPLETED|1 Month Follow-up||5
10738916|NCT02896400|11903249|FG012|NOT COMPLETED|1 Month Follow-up||3
10738917|NCT02896400|11903250|FG013|NOT COMPLETED|1 Month Follow-up||4
10738918|NCT02896400|11903251|FG014|NOT COMPLETED|1 Month Follow-up||1
10738919|NCT02896400|11903252|FG015|NOT COMPLETED|1 Month Follow-up||3
10738920|NCT02896400|11903237|FG000|STARTED|3 Month Follow-up||66
10738921|NCT02896400|11903238|FG001|STARTED|3 Month Follow-up||66
10738922|NCT02896400|11903239|FG002|STARTED|3 Month Follow-up||66
10738923|NCT02896400|11903240|FG003|STARTED|3 Month Follow-up||66
10738924|NCT02896400|11903241|FG004|STARTED|3 Month Follow-up||66
10738925|NCT02896400|11903242|FG005|STARTED|3 Month Follow-up||66
10738926|NCT02896400|11903243|FG006|STARTED|3 Month Follow-up||66
10738927|NCT02896400|11903244|FG007|STARTED|3 Month Follow-up||66
10738928|NCT02896400|11903245|FG008|STARTED|3 Month Follow-up||66
10738929|NCT02896400|11903246|FG009|STARTED|3 Month Follow-up||66
10738930|NCT02896400|11903247|FG010|STARTED|3 Month Follow-up||66
10738931|NCT02896400|11903248|FG011|STARTED|3 Month Follow-up||66
10738932|NCT02896400|11903249|FG012|STARTED|3 Month Follow-up||66
10738933|NCT02896400|11903250|FG013|STARTED|3 Month Follow-up||66
10738934|NCT02896400|11903251|FG014|STARTED|3 Month Follow-up||66
10738935|NCT02896400|11903252|FG015|STARTED|3 Month Follow-up||65
10738936|NCT02896400|11903237|FG000|COMPLETED|3 Month Follow-up||60
10738937|NCT02896400|11903238|FG001|COMPLETED|3 Month Follow-up||63
10408597|NCT00755937|11552735|FG000|STARTED|Observational Follow-up||392
10408598|NCT00755937|11552735|FG000|COMPLETED|Observational Follow-up|Subjects followed until end of study/subjects for whom end of participation data were collected|244
10408599|NCT00755937|11552735|FG000|NOT COMPLETED|Observational Follow-up||148
10408600|NCT00756002|11552741|FG000|STARTED|Placebo Run-in||488
10408601|NCT00756002|11552742|FG001|STARTED|Placebo Run-in||0
10408602|NCT00756002|11552741|FG000|COMPLETED|Placebo Run-in||259
10408603|NCT00756002|11552742|FG001|COMPLETED|Placebo Run-in||0
10738938|NCT02896400|11903239|FG002|COMPLETED|3 Month Follow-up||60
10738939|NCT02896400|11903240|FG003|COMPLETED|3 Month Follow-up||55
10738940|NCT02896400|11903241|FG004|COMPLETED|3 Month Follow-up||54
10738941|NCT02896400|11903242|FG005|COMPLETED|3 Month Follow-up||60
10738942|NCT02896400|11903243|FG006|COMPLETED|3 Month Follow-up||62
10738943|NCT02896400|11903244|FG007|COMPLETED|3 Month Follow-up||63
10738944|NCT02896400|11903245|FG008|COMPLETED|3 Month Follow-up||60
10738945|NCT02896400|11903246|FG009|COMPLETED|3 Month Follow-up||61
10738946|NCT02896400|11903247|FG010|COMPLETED|3 Month Follow-up||60
10738947|NCT02896400|11903248|FG011|COMPLETED|3 Month Follow-up||60
10738948|NCT02896400|11903249|FG012|COMPLETED|3 Month Follow-up||63
10738949|NCT02896400|11903250|FG013|COMPLETED|3 Month Follow-up||60
10738950|NCT02896400|11903251|FG014|COMPLETED|3 Month Follow-up||62
10738951|NCT02896400|11903252|FG015|COMPLETED|3 Month Follow-up||63
10738952|NCT02896400|11903237|FG000|NOT COMPLETED|3 Month Follow-up||6
10738953|NCT02896400|11903238|FG001|NOT COMPLETED|3 Month Follow-up||3
10738954|NCT02896400|11903239|FG002|NOT COMPLETED|3 Month Follow-up||6
10738955|NCT02896400|11903240|FG003|NOT COMPLETED|3 Month Follow-up||11
10738956|NCT02896400|11903241|FG004|NOT COMPLETED|3 Month Follow-up||12
10738957|NCT02896400|11903242|FG005|NOT COMPLETED|3 Month Follow-up||6
10738958|NCT02896400|11903243|FG006|NOT COMPLETED|3 Month Follow-up||4
10738959|NCT02896400|11903244|FG007|NOT COMPLETED|3 Month Follow-up||3
10738960|NCT02896400|11903245|FG008|NOT COMPLETED|3 Month Follow-up||6
10738961|NCT02896400|11903246|FG009|NOT COMPLETED|3 Month Follow-up||5
10738962|NCT02896400|11903247|FG010|NOT COMPLETED|3 Month Follow-up||6
10738963|NCT02896400|11903248|FG011|NOT COMPLETED|3 Month Follow-up||6
10738964|NCT02896400|11903249|FG012|NOT COMPLETED|3 Month Follow-up||3
10738965|NCT02896400|11903250|FG013|NOT COMPLETED|3 Month Follow-up||6
10738966|NCT02896400|11903251|FG014|NOT COMPLETED|3 Month Follow-up||4
10738967|NCT02896400|11903252|FG015|NOT COMPLETED|3 Month Follow-up||2
10738968|NCT02896400|11903237|FG000|STARTED|Biochemical Verification at 3 Months||60
10738969|NCT02896400|11903238|FG001|STARTED|Biochemical Verification at 3 Months||63
10738970|NCT02896400|11903239|FG002|STARTED|Biochemical Verification at 3 Months||60
10738971|NCT02896400|11903240|FG003|STARTED|Biochemical Verification at 3 Months||55
10738972|NCT02896400|11903241|FG004|STARTED|Biochemical Verification at 3 Months||54
10738973|NCT02896400|11903242|FG005|STARTED|Biochemical Verification at 3 Months||60
10738974|NCT02896400|11903243|FG006|STARTED|Biochemical Verification at 3 Months||62
10738975|NCT02896400|11903244|FG007|STARTED|Biochemical Verification at 3 Months||63
10738976|NCT02896400|11903245|FG008|STARTED|Biochemical Verification at 3 Months||60
10738977|NCT02896400|11903246|FG009|STARTED|Biochemical Verification at 3 Months||61
10738978|NCT02896400|11903247|FG010|STARTED|Biochemical Verification at 3 Months||60
10738979|NCT02896400|11903248|FG011|STARTED|Biochemical Verification at 3 Months||60
10738980|NCT02896400|11903249|FG012|STARTED|Biochemical Verification at 3 Months||63
10738981|NCT02896400|11903250|FG013|STARTED|Biochemical Verification at 3 Months||60
10738982|NCT02896400|11903251|FG014|STARTED|Biochemical Verification at 3 Months||62
10738983|NCT02896400|11903252|FG015|STARTED|Biochemical Verification at 3 Months||63
10738984|NCT02896400|11903237|FG000|COMPLETED|Biochemical Verification at 3 Months||14
10738985|NCT02896400|11903238|FG001|COMPLETED|Biochemical Verification at 3 Months||15
10738986|NCT02896400|11903239|FG002|COMPLETED|Biochemical Verification at 3 Months||13
10738987|NCT02896400|11903240|FG003|COMPLETED|Biochemical Verification at 3 Months||14
10738988|NCT02896400|11903241|FG004|COMPLETED|Biochemical Verification at 3 Months||9
10738989|NCT02896400|11903242|FG005|COMPLETED|Biochemical Verification at 3 Months||11
10738990|NCT02896400|11903243|FG006|COMPLETED|Biochemical Verification at 3 Months||11
10738991|NCT02896400|11903244|FG007|COMPLETED|Biochemical Verification at 3 Months||14
10738992|NCT02896400|11903245|FG008|COMPLETED|Biochemical Verification at 3 Months||15
10738993|NCT02896400|11903246|FG009|COMPLETED|Biochemical Verification at 3 Months||8
10738994|NCT02896400|11903247|FG010|COMPLETED|Biochemical Verification at 3 Months||5
10738995|NCT02896400|11903248|FG011|COMPLETED|Biochemical Verification at 3 Months||19
10738996|NCT02896400|11903249|FG012|COMPLETED|Biochemical Verification at 3 Months||10
10738997|NCT02896400|11903250|FG013|COMPLETED|Biochemical Verification at 3 Months||12
10738998|NCT02896400|11903251|FG014|COMPLETED|Biochemical Verification at 3 Months||7
10738999|NCT02896400|11903252|FG015|COMPLETED|Biochemical Verification at 3 Months||6
10739000|NCT02896400|11903237|FG000|NOT COMPLETED|Biochemical Verification at 3 Months||46
10739001|NCT02896400|11903238|FG001|NOT COMPLETED|Biochemical Verification at 3 Months||48
10739002|NCT02896400|11903239|FG002|NOT COMPLETED|Biochemical Verification at 3 Months||47
10739003|NCT02896400|11903240|FG003|NOT COMPLETED|Biochemical Verification at 3 Months||41
10739004|NCT02896400|11903241|FG004|NOT COMPLETED|Biochemical Verification at 3 Months||45
10739005|NCT02896400|11903242|FG005|NOT COMPLETED|Biochemical Verification at 3 Months||49
10739006|NCT02896400|11903243|FG006|NOT COMPLETED|Biochemical Verification at 3 Months||51
10739007|NCT02896400|11903244|FG007|NOT COMPLETED|Biochemical Verification at 3 Months||49
10739008|NCT02896400|11903245|FG008|NOT COMPLETED|Biochemical Verification at 3 Months||45
10739009|NCT02896400|11903246|FG009|NOT COMPLETED|Biochemical Verification at 3 Months||53
10739010|NCT02896400|11903247|FG010|NOT COMPLETED|Biochemical Verification at 3 Months||55
10739011|NCT02896400|11903248|FG011|NOT COMPLETED|Biochemical Verification at 3 Months||41
10739012|NCT02896400|11903249|FG012|NOT COMPLETED|Biochemical Verification at 3 Months||53
10739013|NCT02896400|11903250|FG013|NOT COMPLETED|Biochemical Verification at 3 Months||48
10739014|NCT02896400|11903251|FG014|NOT COMPLETED|Biochemical Verification at 3 Months||55
10739015|NCT02896400|11903252|FG015|NOT COMPLETED|Biochemical Verification at 3 Months||57
10739016|NCT02896569|11903280|FG000|STARTED|Overall Study||25
10739017|NCT02896569|11903281|FG001|STARTED|Overall Study||24
10739018|NCT02896569|11903280|FG000|COMPLETED|Overall Study||21
10739019|NCT02896569|11903281|FG001|COMPLETED|Overall Study||19
10739020|NCT02896569|11903280|FG000|NOT COMPLETED|Overall Study||4
10739021|NCT02896569|11903281|FG001|NOT COMPLETED|Overall Study||5
10739022|NCT02896595|11903289|FG000|STARTED|Overall Study||50
10739023|NCT02896595|11903290|FG001|STARTED|Overall Study||50
10739024|NCT02896595|11903289|FG000|COMPLETED|Overall Study||50
10739025|NCT02896595|11903290|FG001|COMPLETED|Overall Study||50
10739026|NCT02896595|11903289|FG000|NOT COMPLETED|Overall Study||0
10739027|NCT02896595|11903290|FG001|NOT COMPLETED|Overall Study||0
10739028|NCT02896907|11903296|FG000|STARTED|Overall Study||8
10739029|NCT02896907|11903296|FG000|COMPLETED|Overall Study||8
10739030|NCT02896907|11903296|FG000|NOT COMPLETED|Overall Study||0
10739031|NCT02897115|11903302|FG000|STARTED|Overall Study||14
10739032|NCT02897115|11903303|FG001|STARTED|Overall Study||8
10739033|NCT02897115|11903302|FG000|COMPLETED|Overall Study||3
10739034|NCT02897115|11903303|FG001|COMPLETED|Overall Study||0
10739035|NCT02897115|11903302|FG000|NOT COMPLETED|Overall Study||11
10739036|NCT02897115|11903303|FG001|NOT COMPLETED|Overall Study||8
10739037|NCT02897141|11903311|FG000|STARTED|Overall Study||40
10739038|NCT02897141|11903312|FG001|STARTED|Overall Study||40
10739039|NCT02897141|11903311|FG000|COMPLETED|Overall Study||38
10739040|NCT02897141|11903312|FG001|COMPLETED|Overall Study||39
10739041|NCT02897141|11903311|FG000|NOT COMPLETED|Overall Study||2
10739042|NCT02897141|11903312|FG001|NOT COMPLETED|Overall Study||1
10739043|NCT02897349|11903331|FG000|STARTED|Overall Study||102
10739044|NCT02897349|11903332|FG001|STARTED|Overall Study||104
10739045|NCT02897349|11903331|FG000|COMPLETED|Overall Study||97
10739046|NCT02897349|11903332|FG001|COMPLETED|Overall Study||98
10739047|NCT02897349|11903331|FG000|NOT COMPLETED|Overall Study||5
10739048|NCT02897349|11903332|FG001|NOT COMPLETED|Overall Study||6
10739049|NCT02898103|11903340|FG000|STARTED|Overall Study||4
10739050|NCT02898103|11903341|FG001|STARTED|Overall Study||3
10739051|NCT02898103|11903340|FG000|COMPLETED|Overall Study||4
10739052|NCT02898103|11903341|FG001|COMPLETED|Overall Study||3
10739053|NCT02898103|11903340|FG000|NOT COMPLETED|Overall Study||0
10739054|NCT02898103|11903341|FG001|NOT COMPLETED|Overall Study||0
10739055|NCT02898116|11903351|FG000|STARTED|Overall Study||2
10739056|NCT02898116|11903351|FG000|COMPLETED|Overall Study||0
10739057|NCT02898116|11903351|FG000|NOT COMPLETED|Overall Study||2
10739058|NCT02898454|11903358|FG000|STARTED|Overall Study||153
10739059|NCT02898454|11903359|FG001|STARTED|Overall Study||145
10739060|NCT02898454|11903360|FG002|STARTED|Overall Study||150
10739061|NCT02898454|11903358|FG000|Intent-to-Treat (ITT) Population|Overall Study||153
10739062|NCT02898454|11903359|FG001|Intent-to-Treat (ITT) Population|Overall Study||145
10739063|NCT02898454|11903360|FG002|Intent-to-Treat (ITT) Population|Overall Study||150
10739064|NCT02898454|11903358|FG000|Treated|Overall Study||152
10739065|NCT02898454|11903359|FG001|Treated|Overall Study||145
10739066|NCT02898454|11903360|FG002|Treated|Overall Study||150
10739067|NCT02898454|11903358|FG000|Safety Population|Overall Study|2 participants randomized to placebo received 1 dose of dupilumab:counted in 300 mg q2w then q4w arm|150
10739142|NCT02899689|11903459|FG000|NOT COMPLETED|Overall Study||0
10739068|NCT02898454|11903359|FG001|Safety Population|Overall Study|1 randomized to dupilumab q2w arm received 1dose of placebo: counted in 300 mg q2w then q4w arm.|148
10739069|NCT02898454|11903360|FG002|Safety Population|Overall Study||149
10739070|NCT02898454|11903358|FG000|COMPLETED|Overall Study||136
10739071|NCT02898454|11903359|FG001|COMPLETED|Overall Study||140
10739072|NCT02898454|11903360|FG002|COMPLETED|Overall Study||144
10739073|NCT02898454|11903358|FG000|NOT COMPLETED|Overall Study||17
10739074|NCT02898454|11903359|FG001|NOT COMPLETED|Overall Study||5
10816528|NCT01536015|11980064|FG001|COMPLETED|Overall Study||3
10816529|NCT01536015|11980063|FG000|NOT COMPLETED|Overall Study||8
10816530|NCT01536015|11980064|FG001|NOT COMPLETED|Overall Study||10
10816531|NCT01539590|11980072|FG000|STARTED|Overall Study||3
10816532|NCT01539590|11980073|FG001|STARTED|Overall Study||2
10816533|NCT01539590|11980072|FG000|Complete Study Treatment|Overall Study||1
10816534|NCT01539590|11980073|FG001|Complete Study Treatment|Overall Study||2
10816535|NCT01539590|11980072|FG000|COMPLETED|Overall Study||0
10816536|NCT01539590|11980073|FG001|COMPLETED|Overall Study||2
10816537|NCT01539590|11980072|FG000|NOT COMPLETED|Overall Study||3
10816538|NCT01539590|11980073|FG001|NOT COMPLETED|Overall Study||0
10816545|NCT01534676|11980090|FG000|STARTED|Overall Study||2
10816546|NCT01534676|11980091|FG001|STARTED|Overall Study||1
10816547|NCT01534676|11980090|FG000|COMPLETED|Overall Study||0
10739075|NCT02898454|11903360|FG002|NOT COMPLETED|Overall Study||6
10739076|NCT02898597|11903375|FG000|STARTED|Overall Study||25
10739077|NCT02898597|11903376|FG001|STARTED|Overall Study||24
10739078|NCT02898597|11903375|FG000|COMPLETED|Overall Study||21
10739079|NCT02898597|11903376|FG001|COMPLETED|Overall Study||12
10739080|NCT02898597|11903375|FG000|NOT COMPLETED|Overall Study||4
10739081|NCT02898597|11903376|FG001|NOT COMPLETED|Overall Study||12
10739082|NCT02898662|11903384|FG000|STARTED|Overall Study||40
10816548|NCT01534676|11980091|FG001|COMPLETED|Overall Study||0
10816549|NCT01534676|11980090|FG000|NOT COMPLETED|Overall Study||2
10739083|NCT02898662|11903385|FG001|STARTED|Overall Study||41
10739084|NCT02898662|11903384|FG000|Completed Treatment|Overall Study||25
10739085|NCT02898662|11903385|FG001|Completed Treatment|Overall Study||29
10739086|NCT02898662|11903384|FG000|COMPLETED|Overall Study||11
10739087|NCT02898662|11903385|FG001|COMPLETED|Overall Study||13
10739088|NCT02898662|11903384|FG000|NOT COMPLETED|Overall Study||29
10739089|NCT02898662|11903385|FG001|NOT COMPLETED|Overall Study||28
10739090|NCT02898740|11903393|FG000|STARTED|Overall Study||21
10739091|NCT02898740|11903394|FG001|STARTED|Overall Study||19
10739092|NCT02898740|11903393|FG000|COMPLETED|Overall Study||21
10739093|NCT02898740|11903394|FG001|COMPLETED|Overall Study||19
10739094|NCT02898740|11903393|FG000|NOT COMPLETED|Overall Study||0
10739095|NCT02898740|11903394|FG001|NOT COMPLETED|Overall Study||0
10739096|NCT02898974|11903402|FG000|STARTED|Overall Study||13
10739097|NCT02898974|11903403|FG001|STARTED|Overall Study||9
10739098|NCT02898974|11903402|FG000|COMPLETED|Overall Study||13
10739099|NCT02898974|11903403|FG001|COMPLETED|Overall Study||9
10739100|NCT02898974|11903402|FG000|NOT COMPLETED|Overall Study||0
10739101|NCT02898974|11903403|FG001|NOT COMPLETED|Overall Study||0
10739102|NCT02899156|11903411|FG000|STARTED|Overall Study||11
10739103|NCT02899156|11903412|FG001|STARTED|Overall Study||11
10739104|NCT02899156|11903411|FG000|COMPLETED|Overall Study||10
10739105|NCT02899156|11903412|FG001|COMPLETED|Overall Study||10
10739106|NCT02899156|11903411|FG000|NOT COMPLETED|Overall Study||1
10739107|NCT02899156|11903412|FG001|NOT COMPLETED|Overall Study||1
10739108|NCT02899195|11903418|FG000|STARTED|Concurrent Durvalumab||55
10739109|NCT02899195|11903418|FG000|COMPLETED|Concurrent Durvalumab||44
10739110|NCT02899195|11903418|FG000|NOT COMPLETED|Concurrent Durvalumab||11
10739111|NCT02899195|11903418|FG000|STARTED|Maintenance Durvalumab||44
10739112|NCT02899195|11903418|FG000|COMPLETED|Maintenance Durvalumab||10
10739113|NCT02899195|11903418|FG000|NOT COMPLETED|Maintenance Durvalumab||34
10739114|NCT02899338|11903424|FG000|STARTED|Overall Study||81
10739115|NCT02899338|11903425|FG001|STARTED|Overall Study||81
10739116|NCT02899338|11903424|FG000|COMPLETED|Overall Study||78
10739117|NCT02899338|11903425|FG001|COMPLETED|Overall Study||79
10739118|NCT02899338|11903424|FG000|NOT COMPLETED|Overall Study||3
10739119|NCT02899338|11903425|FG001|NOT COMPLETED|Overall Study||2
10739120|NCT02899377|11903433|FG000|STARTED|Overall Study||13
10739121|NCT02899377|11903434|FG001|STARTED|Overall Study||12
10739122|NCT02899377|11903433|FG000|COMPLETED|Overall Study||12
10739123|NCT02899377|11903434|FG001|COMPLETED|Overall Study||12
10739124|NCT02899377|11903433|FG000|NOT COMPLETED|Overall Study||1
10739125|NCT02899377|11903434|FG001|NOT COMPLETED|Overall Study||0
10739126|NCT02899650|11903445|FG000|STARTED|Overall Study||15
10739127|NCT02899650|11903446|FG001|STARTED|Overall Study||10
10739128|NCT02899650|11903447|FG002|STARTED|Overall Study||14
10739129|NCT02899650|11903448|FG003|STARTED|Overall Study|We were not able to recruit older unfit adults so this group was dropped from the study.|0
10739130|NCT02899650|11903445|FG000|COMPLETED|Overall Study||15
10739131|NCT02899650|11903446|FG001|COMPLETED|Overall Study||10
10739132|NCT02899650|11903447|FG002|COMPLETED|Overall Study||14
10739133|NCT02899650|11903448|FG003|COMPLETED|Overall Study||0
10739134|NCT02899650|11903445|FG000|NOT COMPLETED|Overall Study||0
10739135|NCT02899650|11903446|FG001|NOT COMPLETED|Overall Study||0
10739136|NCT02899650|11903447|FG002|NOT COMPLETED|Overall Study||0
10739137|NCT02899650|11903448|FG003|NOT COMPLETED|Overall Study||0
10739138|NCT02899689|11903459|FG000|STARTED|Overall Study||209
10739139|NCT02899689|11903460|FG001|STARTED|Overall Study||210
10739140|NCT02899689|11903459|FG000|COMPLETED|Overall Study||209
10739141|NCT02899689|11903460|FG001|COMPLETED|Overall Study||208
10739143|NCT02899689|11903460|FG001|NOT COMPLETED|Overall Study||2
10739144|NCT02899884|11903466|FG000|STARTED|Overall Study||3765
10739145|NCT02899884|11903466|FG000|COMPLETED|Overall Study||3765
10739146|NCT02899884|11903466|FG000|NOT COMPLETED|Overall Study||0
10739147|NCT02899962|11903470|FG000|STARTED|Open-label Phase||650
10739148|NCT02899962|11903471|FG001|STARTED|Open-label Phase||0
10739149|NCT02899962|11903472|FG002|STARTED|Open-label Phase||0
10739150|NCT02899962|11903470|FG000|COMPLETED|Open-label Phase||623
10739151|NCT02899962|11903471|FG001|COMPLETED|Open-label Phase||0
10739152|NCT02899962|11903472|FG002|COMPLETED|Open-label Phase||0
10739153|NCT02899962|11903470|FG000|NOT COMPLETED|Open-label Phase||27
10739154|NCT02899962|11903471|FG001|NOT COMPLETED|Open-label Phase||0
10739155|NCT02899962|11903472|FG002|NOT COMPLETED|Open-label Phase||0
10739156|NCT02899962|11903470|FG000|STARTED|Maintenance Phase||0
10739157|NCT02899962|11903471|FG001|STARTED|Maintenance Phase||272
10739158|NCT02899962|11903472|FG002|STARTED|Maintenance Phase||273
10739159|NCT02899962|11903470|FG000|COMPLETED|Maintenance Phase||0
10816550|NCT01534676|11980091|FG001|NOT COMPLETED|Overall Study||1
10739160|NCT02899962|11903471|FG001|COMPLETED|Maintenance Phase||131
10739161|NCT02899962|11903472|FG002|COMPLETED|Maintenance Phase||120
10739162|NCT02899962|11903470|FG000|NOT COMPLETED|Maintenance Phase||0
10739163|NCT02899962|11903471|FG001|NOT COMPLETED|Maintenance Phase||141
10739164|NCT02899962|11903472|FG002|NOT COMPLETED|Maintenance Phase||153
10739165|NCT02899988|11903483|FG000|STARTED|Induction Period (16 Weeks)||52
10739166|NCT02899988|11903484|FG001|STARTED|Induction Period (16 Weeks)||51
10739167|NCT02899988|11903485|FG002|STARTED|Induction Period (16 Weeks)||51
10739168|NCT02899988|11903486|FG003|STARTED|Induction Period (16 Weeks)||51
10739169|NCT02899988|11903487|FG004|STARTED|Induction Period (16 Weeks)||0
10739170|NCT02899988|11903488|FG005|STARTED|Induction Period (16 Weeks)||0
10739171|NCT02899988|11903489|FG006|STARTED|Induction Period (16 Weeks)||0
10739172|NCT02899988|11903490|FG007|STARTED|Induction Period (16 Weeks)||0
10739173|NCT02899988|11903491|FG008|STARTED|Induction Period (16 Weeks)||0
10739174|NCT02899988|11903492|FG009|STARTED|Induction Period (16 Weeks)||0
10739175|NCT02899988|11903493|FG010|STARTED|Induction Period (16 Weeks)||0
10739176|NCT02899988|11903483|FG000|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||52
10739177|NCT02899988|11903484|FG001|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||51
10739178|NCT02899988|11903485|FG002|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||51
10739179|NCT02899988|11903486|FG003|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||51
10739180|NCT02899988|11903487|FG004|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
10739181|NCT02899988|11903488|FG005|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
10739182|NCT02899988|11903489|FG006|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
10739183|NCT02899988|11903490|FG007|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
10739184|NCT02899988|11903491|FG008|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
10739185|NCT02899988|11903492|FG009|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
10739186|NCT02899988|11903493|FG010|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
10739187|NCT02899988|11903483|FG000|COMPLETED|Induction Period (16 Weeks)||50
10739188|NCT02899988|11903484|FG001|COMPLETED|Induction Period (16 Weeks)||49
10739189|NCT02899988|11903485|FG002|COMPLETED|Induction Period (16 Weeks)||51
10739190|NCT02899988|11903486|FG003|COMPLETED|Induction Period (16 Weeks)||49
10739191|NCT02899988|11903487|FG004|COMPLETED|Induction Period (16 Weeks)||0
10739192|NCT02899988|11903488|FG005|COMPLETED|Induction Period (16 Weeks)||0
10739193|NCT02899988|11903489|FG006|COMPLETED|Induction Period (16 Weeks)||0
10739194|NCT02899988|11903490|FG007|COMPLETED|Induction Period (16 Weeks)||0
10739195|NCT02899988|11903491|FG008|COMPLETED|Induction Period (16 Weeks)||0
10739196|NCT02899988|11903492|FG009|COMPLETED|Induction Period (16 Weeks)||0
10739197|NCT02899988|11903493|FG010|COMPLETED|Induction Period (16 Weeks)||0
10739198|NCT02899988|11903483|FG000|NOT COMPLETED|Induction Period (16 Weeks)||2
10739199|NCT02899988|11903484|FG001|NOT COMPLETED|Induction Period (16 Weeks)||2
10739200|NCT02899988|11903485|FG002|NOT COMPLETED|Induction Period (16 Weeks)||0
10739201|NCT02899988|11903486|FG003|NOT COMPLETED|Induction Period (16 Weeks)||2
10739202|NCT02899988|11903487|FG004|NOT COMPLETED|Induction Period (16 Weeks)||0
10739203|NCT02899988|11903488|FG005|NOT COMPLETED|Induction Period (16 Weeks)||0
10739204|NCT02899988|11903489|FG006|NOT COMPLETED|Induction Period (16 Weeks)||0
10739205|NCT02899988|11903490|FG007|NOT COMPLETED|Induction Period (16 Weeks)||0
10739206|NCT02899988|11903491|FG008|NOT COMPLETED|Induction Period (16 Weeks)||0
10739207|NCT02899988|11903492|FG009|NOT COMPLETED|Induction Period (16 Weeks)||0
10739208|NCT02899988|11903493|FG010|NOT COMPLETED|Induction Period (16 Weeks)||0
10739209|NCT02899988|11903483|FG000|STARTED|Maintenance Period (88 Weeks)|No participants received placebo during maintenance period.|0
10739210|NCT02899988|11903484|FG001|STARTED|Maintenance Period (88 Weeks)|No participants received 30 mg mirikizumab Q8W in both induction and maintenance.|0
10739211|NCT02899988|11903485|FG002|STARTED|Maintenance Period (88 Weeks)|No participants received 100 mg mirikizumab Q8W in both induction and maintenance.|0
10739212|NCT02899988|11903486|FG003|STARTED|Maintenance Period (88 Weeks)||0
10739213|NCT02899988|11903487|FG004|STARTED|Maintenance Period (88 Weeks)|Participants received 30 mg mirikizumab Q8W during induction period.|15
10739214|NCT02899988|11903488|FG005|STARTED|Maintenance Period (88 Weeks)|Participants received 100 mg mirikizumab Q8W during induction period.|30
10739215|NCT02899988|11903489|FG006|STARTED|Maintenance Period (88 Weeks)|Participants received 300 mg mirikizumab Q8W during induction period.|34
10739216|NCT02899988|11903490|FG007|STARTED|Maintenance Period (88 Weeks)|Participants received placebo during induction period.|50
10739217|NCT02899988|11903491|FG008|STARTED|Maintenance Period (88 Weeks)|Participants received 30 mg mirikizumab Q8W during induction arm.|34
10739218|NCT02899988|11903492|FG009|STARTED|Maintenance Period (88 Weeks)|Participants received 100 mg mirikizumab Q8W during induction arm.|21
10739219|NCT02899988|11903493|FG010|STARTED|Maintenance Period (88 Weeks)|Participants received 300 mg mirikizumab Q8W during induction arm.|15
10739220|NCT02899988|11903483|FG000|Rescue Participants|Maintenance Period (88 Weeks)||0
10739221|NCT02899988|11903484|FG001|Rescue Participants|Maintenance Period (88 Weeks)||0
10739222|NCT02899988|11903485|FG002|Rescue Participants|Maintenance Period (88 Weeks)||0
10739223|NCT02899988|11903486|FG003|Rescue Participants|Maintenance Period (88 Weeks)|In PRN not regaining ≥ PASI 90 after 3 consecutive doses of drug or have < PASI 50 after 1 dose.|10
10739224|NCT02899988|11903487|FG004|Rescue Participants|Maintenance Period (88 Weeks)||0
10739225|NCT02899988|11903488|FG005|Rescue Participants|Maintenance Period (88 Weeks)||0
10739226|NCT02899988|11903489|FG006|Rescue Participants|Maintenance Period (88 Weeks)||0
10739227|NCT02899988|11903490|FG007|Rescue Participants|Maintenance Period (88 Weeks)||0
10739228|NCT02899988|11903491|FG008|Rescue Participants|Maintenance Period (88 Weeks)||0
10739229|NCT02899988|11903492|FG009|Rescue Participants|Maintenance Period (88 Weeks)||0
10739230|NCT02899988|11903493|FG010|Rescue Participants|Maintenance Period (88 Weeks)||0
10739231|NCT02899988|11903483|FG000|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0
10739232|NCT02899988|11903484|FG001|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0
10739233|NCT02899988|11903485|FG002|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0
10739234|NCT02899988|11903486|FG003|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||13
10739235|NCT02899988|11903487|FG004|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||9
10739236|NCT02899988|11903488|FG005|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||18
10739237|NCT02899988|11903489|FG006|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||26
10739238|NCT02899988|11903490|FG007|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||42
10739239|NCT02899988|11903491|FG008|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||24
10739240|NCT02899988|11903492|FG009|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||17
10739241|NCT02899988|11903493|FG010|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0
10739242|NCT02899988|11903483|FG000|COMPLETED|Maintenance Period (88 Weeks)||0
10739243|NCT02899988|11903484|FG001|COMPLETED|Maintenance Period (88 Weeks)||0
10739244|NCT02899988|11903485|FG002|COMPLETED|Maintenance Period (88 Weeks)||0
10739245|NCT02899988|11903486|FG003|COMPLETED|Maintenance Period (88 Weeks)||0
10739246|NCT02899988|11903487|FG004|COMPLETED|Maintenance Period (88 Weeks)||13
10816551|NCT01533753|11980099|FG000|STARTED|Overall Study||2
10816552|NCT01533753|11980100|FG001|STARTED|Overall Study||3
10816553|NCT01533753|11980099|FG000|COMPLETED|Overall Study||2
10816554|NCT01533753|11980100|FG001|COMPLETED|Overall Study||3
10816555|NCT01533753|11980099|FG000|NOT COMPLETED|Overall Study||0
10816556|NCT01533753|11980100|FG001|NOT COMPLETED|Overall Study||0
10816557|NCT01534143|11980106|FG000|STARTED|Overall Study||1
10816558|NCT01534143|11980106|FG000|COMPLETED|Overall Study||1
10408604|NCT00756002|11552741|FG000|NOT COMPLETED|Placebo Run-in||229
10408605|NCT00756002|11552742|FG001|NOT COMPLETED|Placebo Run-in||0
10739247|NCT02899988|11903488|FG005|COMPLETED|Maintenance Period (88 Weeks)||27
10739248|NCT02899988|11903489|FG006|COMPLETED|Maintenance Period (88 Weeks)||30
10739249|NCT02899988|11903490|FG007|COMPLETED|Maintenance Period (88 Weeks)||45
10739250|NCT02899988|11903491|FG008|COMPLETED|Maintenance Period (88 Weeks)||30
10739251|NCT02899988|11903492|FG009|COMPLETED|Maintenance Period (88 Weeks)||19
10739252|NCT02899988|11903493|FG010|COMPLETED|Maintenance Period (88 Weeks)||13
10739253|NCT02899988|11903483|FG000|NOT COMPLETED|Maintenance Period (88 Weeks)||0
10739254|NCT02899988|11903484|FG001|NOT COMPLETED|Maintenance Period (88 Weeks)||0
10739255|NCT02899988|11903485|FG002|NOT COMPLETED|Maintenance Period (88 Weeks)||0
10739256|NCT02899988|11903486|FG003|NOT COMPLETED|Maintenance Period (88 Weeks)||0
10739257|NCT02899988|11903487|FG004|NOT COMPLETED|Maintenance Period (88 Weeks)||2
10739258|NCT02899988|11903488|FG005|NOT COMPLETED|Maintenance Period (88 Weeks)||3
10739259|NCT02899988|11903489|FG006|NOT COMPLETED|Maintenance Period (88 Weeks)||4
10739260|NCT02899988|11903490|FG007|NOT COMPLETED|Maintenance Period (88 Weeks)||5
10739261|NCT02899988|11903491|FG008|NOT COMPLETED|Maintenance Period (88 Weeks)||4
10739262|NCT02899988|11903492|FG009|NOT COMPLETED|Maintenance Period (88 Weeks)||2
10739263|NCT02899988|11903493|FG010|NOT COMPLETED|Maintenance Period (88 Weeks)||2
10739264|NCT02899988|11903483|FG000|STARTED|Follow-Up (16 Weeks)||0
10739265|NCT02899988|11903484|FG001|STARTED|Follow-Up (16 Weeks)||0
10739266|NCT02899988|11903485|FG002|STARTED|Follow-Up (16 Weeks)||0
10739267|NCT02899988|11903486|FG003|STARTED|Follow-Up (16 Weeks)||0
10739268|NCT02899988|11903487|FG004|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|2
10739269|NCT02899988|11903488|FG005|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|4
10739270|NCT02899988|11903489|FG006|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|3
10739271|NCT02899988|11903490|FG007|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|3
10739272|NCT02899988|11903491|FG008|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|6
10739273|NCT02899988|11903492|FG009|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|2
10739274|NCT02899988|11903493|FG010|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|0
10739275|NCT02899988|11903483|FG000|COMPLETED|Follow-Up (16 Weeks)||0
10739276|NCT02899988|11903484|FG001|COMPLETED|Follow-Up (16 Weeks)||0
10739277|NCT02899988|11903485|FG002|COMPLETED|Follow-Up (16 Weeks)||0
10739278|NCT02899988|11903486|FG003|COMPLETED|Follow-Up (16 Weeks)||0
10739279|NCT02899988|11903487|FG004|COMPLETED|Follow-Up (16 Weeks)||2
10739280|NCT02899988|11903488|FG005|COMPLETED|Follow-Up (16 Weeks)||4
10739281|NCT02899988|11903489|FG006|COMPLETED|Follow-Up (16 Weeks)||3
10739282|NCT02899988|11903490|FG007|COMPLETED|Follow-Up (16 Weeks)||3
10739283|NCT02899988|11903491|FG008|COMPLETED|Follow-Up (16 Weeks)||6
10739284|NCT02899988|11903492|FG009|COMPLETED|Follow-Up (16 Weeks)||2
10739285|NCT02899988|11903493|FG010|COMPLETED|Follow-Up (16 Weeks)||0
10739286|NCT02899988|11903483|FG000|NOT COMPLETED|Follow-Up (16 Weeks)||0
10739287|NCT02899988|11903484|FG001|NOT COMPLETED|Follow-Up (16 Weeks)||0
10739288|NCT02899988|11903485|FG002|NOT COMPLETED|Follow-Up (16 Weeks)||0
10739289|NCT02899988|11903486|FG003|NOT COMPLETED|Follow-Up (16 Weeks)||0
10739290|NCT02899988|11903487|FG004|NOT COMPLETED|Follow-Up (16 Weeks)||0
10739291|NCT02899988|11903488|FG005|NOT COMPLETED|Follow-Up (16 Weeks)||0
10739292|NCT02899988|11903489|FG006|NOT COMPLETED|Follow-Up (16 Weeks)||0
10739293|NCT02899988|11903490|FG007|NOT COMPLETED|Follow-Up (16 Weeks)||0
10739294|NCT02899988|11903491|FG008|NOT COMPLETED|Follow-Up (16 Weeks)||0
10739295|NCT02899988|11903492|FG009|NOT COMPLETED|Follow-Up (16 Weeks)||0
10739296|NCT02899988|11903493|FG010|NOT COMPLETED|Follow-Up (16 Weeks)||0
10816559|NCT01534143|11980106|FG000|NOT COMPLETED|Overall Study||0
10816560|NCT01530880|11980110|FG000|STARTED|Overall Study||35
10816561|NCT01530880|11980110|FG000|COMPLETED|Overall Study||35
10408606|NCT00756002|11552741|FG000|STARTED|Double-Blind Treatment Period||129
10408607|NCT00756002|11552742|FG001|STARTED|Double-Blind Treatment Period||130
10408608|NCT00756002|11552741|FG000|COMPLETED|Double-Blind Treatment Period||114
10408609|NCT00756002|11552742|FG001|COMPLETED|Double-Blind Treatment Period||115
10408610|NCT00756002|11552741|FG000|NOT COMPLETED|Double-Blind Treatment Period||15
10408611|NCT00756002|11552742|FG001|NOT COMPLETED|Double-Blind Treatment Period||15
10408612|NCT00756002|11552741|FG000|STARTED|Placebo Run-out||114
10408613|NCT00756002|11552742|FG001|STARTED|Placebo Run-out||0
10408614|NCT00756002|11552741|FG000|COMPLETED|Placebo Run-out||114
10408615|NCT00756002|11552742|FG001|COMPLETED|Placebo Run-out||0
10408616|NCT00756002|11552741|FG000|NOT COMPLETED|Placebo Run-out||0
10408617|NCT00756002|11552742|FG001|NOT COMPLETED|Placebo Run-out||0
10408618|NCT00756093|11552748|FG000|STARTED|First Intervention||5
10408619|NCT00756093|11552749|FG001|STARTED|First Intervention||5
10408620|NCT00756093|11552750|FG002|STARTED|First Intervention||5
10408621|NCT00756093|11552751|FG003|STARTED|First Intervention||5
10408622|NCT00756093|11552748|FG000|COMPLETED|First Intervention||5
10408623|NCT00756093|11552749|FG001|COMPLETED|First Intervention||5
10408624|NCT00756093|11552750|FG002|COMPLETED|First Intervention||5
10408625|NCT00756093|11552751|FG003|COMPLETED|First Intervention||5
10408626|NCT00756093|11552748|FG000|NOT COMPLETED|First Intervention||0
10408627|NCT00756093|11552749|FG001|NOT COMPLETED|First Intervention||0
10408628|NCT00756093|11552750|FG002|NOT COMPLETED|First Intervention||0
10408629|NCT00756093|11552751|FG003|NOT COMPLETED|First Intervention||0
10408630|NCT00756093|11552748|FG000|STARTED|Second Intervention||5
10408631|NCT00756093|11552749|FG001|STARTED|Second Intervention||5
10408632|NCT00756093|11552750|FG002|STARTED|Second Intervention||5
10408633|NCT00756093|11552751|FG003|STARTED|Second Intervention||5
10408634|NCT00756093|11552748|FG000|COMPLETED|Second Intervention||5
10408635|NCT00756093|11552749|FG001|COMPLETED|Second Intervention||5
10408636|NCT00756093|11552750|FG002|COMPLETED|Second Intervention||5
10408637|NCT00756093|11552751|FG003|COMPLETED|Second Intervention||5
10408638|NCT00756093|11552748|FG000|NOT COMPLETED|Second Intervention||0
10408639|NCT00756093|11552749|FG001|NOT COMPLETED|Second Intervention||0
10408640|NCT00756093|11552750|FG002|NOT COMPLETED|Second Intervention||0
10408641|NCT00756093|11552751|FG003|NOT COMPLETED|Second Intervention||0
10408642|NCT00756093|11552748|FG000|STARTED|Third Intervention||5
10408643|NCT00756093|11552749|FG001|STARTED|Third Intervention||5
10408644|NCT00756093|11552750|FG002|STARTED|Third Intervention||5
10408645|NCT00756093|11552751|FG003|STARTED|Third Intervention||5
10408646|NCT00756093|11552748|FG000|COMPLETED|Third Intervention||5
10408647|NCT00756093|11552749|FG001|COMPLETED|Third Intervention||5
10408648|NCT00756093|11552750|FG002|COMPLETED|Third Intervention||5
10408649|NCT00756093|11552751|FG003|COMPLETED|Third Intervention||5
10408650|NCT00756093|11552748|FG000|NOT COMPLETED|Third Intervention||0
10408651|NCT00756093|11552749|FG001|NOT COMPLETED|Third Intervention||0
10408652|NCT00756093|11552750|FG002|NOT COMPLETED|Third Intervention||0
10408653|NCT00756093|11552751|FG003|NOT COMPLETED|Third Intervention||0
10408654|NCT00756093|11552748|FG000|STARTED|Fourth Intervention||5
10408655|NCT00756093|11552749|FG001|STARTED|Fourth Intervention||5
10408656|NCT00756093|11552750|FG002|STARTED|Fourth Intervention||5
10408657|NCT00756093|11552751|FG003|STARTED|Fourth Intervention||5
10408658|NCT00756093|11552748|FG000|COMPLETED|Fourth Intervention||5
10408659|NCT00756093|11552749|FG001|COMPLETED|Fourth Intervention||5
10739297|NCT02900092|11903525|FG000|STARTED|Overall Study||10
10739298|NCT02900092|11903525|FG000|COMPLETED|Overall Study||9
10739299|NCT02900092|11903525|FG000|NOT COMPLETED|Overall Study||1
10739300|NCT02900170|11903529|FG000|STARTED|Overall Study||8
10739301|NCT02900170|11903529|FG000|COMPLETED|Overall Study||0
10739302|NCT02900170|11903529|FG000|NOT COMPLETED|Overall Study||8
10739303|NCT02900378|11903535|FG000|STARTED|Randomization (Visit 2)||310
10739304|NCT02900378|11903536|FG001|STARTED|Randomization (Visit 2)||311
10739305|NCT02900378|11903535|FG000|COMPLETED|Randomization (Visit 2)||287
10739306|NCT02900378|11903536|FG001|COMPLETED|Randomization (Visit 2)||283
10739307|NCT02900378|11903535|FG000|NOT COMPLETED|Randomization (Visit 2)||23
10739308|NCT02900378|11903536|FG001|NOT COMPLETED|Randomization (Visit 2)||28
10739309|NCT02900378|11903535|FG000|STARTED|Treatment Phase||309
10739310|NCT02900378|11903536|FG001|STARTED|Treatment Phase||310
10739311|NCT02900378|11903535|FG000|Full Analysis Set|Treatment Phase||302
10739312|NCT02900378|11903536|FG001|Full Analysis Set|Treatment Phase||302
10739313|NCT02900378|11903535|FG000|COMPLETED|Treatment Phase||309
10739314|NCT02900378|11903536|FG001|COMPLETED|Treatment Phase||310
10739315|NCT02900378|11903535|FG000|NOT COMPLETED|Treatment Phase||0
10739316|NCT02900378|11903536|FG001|NOT COMPLETED|Treatment Phase||0
10816562|NCT01530880|11980110|FG000|NOT COMPLETED|Overall Study||0
10408660|NCT00756093|11552750|FG002|COMPLETED|Fourth Intervention||5
10408661|NCT00756093|11552751|FG003|COMPLETED|Fourth Intervention||5
10408662|NCT00756093|11552748|FG000|NOT COMPLETED|Fourth Intervention||0
10408663|NCT00756093|11552749|FG001|NOT COMPLETED|Fourth Intervention||0
10408664|NCT00756093|11552750|FG002|NOT COMPLETED|Fourth Intervention||0
10408665|NCT00756093|11552751|FG003|NOT COMPLETED|Fourth Intervention||0
10408666|NCT00756106|11552761|FG000|STARTED|Overall Study||15
10408667|NCT00756106|11552761|FG000|COMPLETED|Overall Study||3
10408668|NCT00756106|11552761|FG000|NOT COMPLETED|Overall Study||12
10408669|NCT00756236|11552768|FG000|STARTED|Overall Study||20
10408670|NCT00756236|11552769|FG001|STARTED|Overall Study||20
10408671|NCT00756236|11552770|FG002|STARTED|Overall Study||20
10408672|NCT00756236|11552768|FG000|COMPLETED|Overall Study||20
10816563|NCT01530087|11980115|FG000|STARTED|Overall Study||3
10816564|NCT01530087|11980115|FG000|COMPLETED|Overall Study||1
10408673|NCT00756236|11552769|FG001|COMPLETED|Overall Study||20
10816565|NCT01530087|11980115|FG000|NOT COMPLETED|Overall Study||2
10816566|NCT01527942|11980122|FG000|STARTED|Overall Study||16
10739317|NCT02901054|11903542|FG000|STARTED|Overall Study|19 consented, 3 withdrew prior to intervention, 1 received study drug but surgery was cancelled.|19
10739318|NCT02901054|11903542|FG000|COMPLETED|Overall Study||15
10739319|NCT02901054|11903542|FG000|NOT COMPLETED|Overall Study||4
10739320|NCT02901080|11903546|FG000|STARTED|Overall Study||161
10739321|NCT02901080|11903546|FG000|COMPLETED|Overall Study||112
10739322|NCT02901080|11903546|FG000|NOT COMPLETED|Overall Study||49
10739323|NCT02901249|11903552|FG000|STARTED|Overall Study||68
10739324|NCT02901249|11903552|FG000|COMPLETED|Overall Study|Primary and secondary outcomes are assessed just at the end of the protocol, not at each step|43
10739325|NCT02901249|11903552|FG000|NOT COMPLETED|Overall Study||25
10739326|NCT02901275|11903556|FG000|STARTED|Overall Study||29
10739327|NCT02901275|11903556|FG000|Placebo + Placebo|Overall Study||29
10739328|NCT02901275|11903556|FG000|Hydromorphone (Oral) 4mg + Placebo|Overall Study||29
10739329|NCT02901275|11903556|FG000|Hydromorphone (Oral) 4mg + Dronabinol (Oral) 2.5mg|Overall Study||29
10739330|NCT02901275|11903556|FG000|Hydromorphone (Oral) 4mg + Dronabinol (Oral) 5mg|Overall Study||29
10739331|NCT02901275|11903556|FG000|Hydromorphone (Oral) 4mg + Dronabinol (Oral) 10mg|Overall Study||29
10739332|NCT02901275|11903556|FG000|COMPLETED|Overall Study||29
10739333|NCT02901275|11903556|FG000|NOT COMPLETED|Overall Study||0
10739334|NCT02901431|11903576|FG000|STARTED|PK Part||12
10739335|NCT02901431|11903577|FG001|STARTED|PK Part||11
10739336|NCT02901431|11903578|FG002|STARTED|PK Part||15
10739337|NCT02901431|11903579|FG003|STARTED|PK Part||0
10739338|NCT02901431|11903580|FG004|STARTED|PK Part||0
10739339|NCT02901431|11903581|FG005|STARTED|PK Part||0
10739340|NCT02901431|11903582|FG006|STARTED|PK Part||0
10739341|NCT02901431|11903583|FG007|STARTED|PK Part||0
10739342|NCT02901431|11903584|FG008|STARTED|PK Part||0
10739343|NCT02901431|11903585|FG009|STARTED|PK Part||0
10739344|NCT02901431|11903586|FG010|STARTED|PK Part||0
10739345|NCT02901431|11903587|FG011|STARTED|PK Part||0
10739346|NCT02901431|11903588|FG012|STARTED|PK Part||0
10739347|NCT02901431|11903576|FG000|COMPLETED|PK Part||5
10739348|NCT02901431|11903577|FG001|COMPLETED|PK Part||5
10739349|NCT02901431|11903578|FG002|COMPLETED|PK Part||6
10739350|NCT02901431|11903579|FG003|COMPLETED|PK Part||0
10739351|NCT02901431|11903580|FG004|COMPLETED|PK Part||0
10739352|NCT02901431|11903581|FG005|COMPLETED|PK Part||0
10739353|NCT02901431|11903582|FG006|COMPLETED|PK Part||0
10739354|NCT02901431|11903583|FG007|COMPLETED|PK Part||0
10739355|NCT02901431|11903584|FG008|COMPLETED|PK Part||0
10739356|NCT02901431|11903585|FG009|COMPLETED|PK Part||0
10739357|NCT02901431|11903586|FG010|COMPLETED|PK Part||0
10739358|NCT02901431|11903587|FG011|COMPLETED|PK Part||0
10739359|NCT02901431|11903588|FG012|COMPLETED|PK Part||0
10739360|NCT02901431|11903576|FG000|NOT COMPLETED|PK Part||7
10739361|NCT02901431|11903577|FG001|NOT COMPLETED|PK Part||6
10739362|NCT02901431|11903578|FG002|NOT COMPLETED|PK Part||9
10739363|NCT02901431|11903579|FG003|NOT COMPLETED|PK Part||0
10739364|NCT02901431|11903580|FG004|NOT COMPLETED|PK Part||0
10739365|NCT02901431|11903581|FG005|NOT COMPLETED|PK Part||0
10739366|NCT02901431|11903582|FG006|NOT COMPLETED|PK Part||0
10739367|NCT02901431|11903583|FG007|NOT COMPLETED|PK Part||0
10739368|NCT02901431|11903584|FG008|NOT COMPLETED|PK Part||0
10739369|NCT02901431|11903585|FG009|NOT COMPLETED|PK Part||0
10739370|NCT02901431|11903586|FG010|NOT COMPLETED|PK Part||0
10739371|NCT02901431|11903587|FG011|NOT COMPLETED|PK Part||0
10739372|NCT02901431|11903588|FG012|NOT COMPLETED|PK Part||0
10739373|NCT02901431|11903576|FG000|STARTED|Main Treatment Part||0
10739374|NCT02901431|11903577|FG001|STARTED|Main Treatment Part||0
10739375|NCT02901431|11903578|FG002|STARTED|Main Treatment Part||0
10739376|NCT02901431|11903579|FG003|STARTED|Main Treatment Part||112
10739377|NCT02901431|11903580|FG004|STARTED|Main Treatment Part||57
10739378|NCT02901431|11903581|FG005|STARTED|Main Treatment Part||66
10739379|NCT02901431|11903582|FG006|STARTED|Main Treatment Part||66
10739380|NCT02901431|11903583|FG007|STARTED|Main Treatment Part||7
10739381|NCT02901431|11903584|FG008|STARTED|Main Treatment Part||0
10739382|NCT02901431|11903585|FG009|STARTED|Main Treatment Part||0
10739383|NCT02901431|11903586|FG010|STARTED|Main Treatment Part||0
10739384|NCT02901431|11903587|FG011|STARTED|Main Treatment Part||0
10739385|NCT02901431|11903588|FG012|STARTED|Main Treatment Part||0
10739386|NCT02901431|11903576|FG000|COMPLETED|Main Treatment Part||0
10739387|NCT02901431|11903577|FG001|COMPLETED|Main Treatment Part||0
10739388|NCT02901431|11903578|FG002|COMPLETED|Main Treatment Part||0
10739389|NCT02901431|11903579|FG003|COMPLETED|Main Treatment Part||86
10739390|NCT02901431|11903580|FG004|COMPLETED|Main Treatment Part||50
10739391|NCT02901431|11903581|FG005|COMPLETED|Main Treatment Part||54
10739392|NCT02901431|11903582|FG006|COMPLETED|Main Treatment Part||55
10739393|NCT02901431|11903583|FG007|COMPLETED|Main Treatment Part||7
10739394|NCT02901431|11903584|FG008|COMPLETED|Main Treatment Part||0
10739395|NCT02901431|11903585|FG009|COMPLETED|Main Treatment Part||0
10739396|NCT02901431|11903586|FG010|COMPLETED|Main Treatment Part||0
10739397|NCT02901431|11903587|FG011|COMPLETED|Main Treatment Part||0
10739398|NCT02901431|11903588|FG012|COMPLETED|Main Treatment Part||0
10739399|NCT02901431|11903576|FG000|NOT COMPLETED|Main Treatment Part||0
10739400|NCT02901431|11903577|FG001|NOT COMPLETED|Main Treatment Part||0
10739401|NCT02901431|11903578|FG002|NOT COMPLETED|Main Treatment Part||0
10739402|NCT02901431|11903579|FG003|NOT COMPLETED|Main Treatment Part||26
10739403|NCT02901431|11903580|FG004|NOT COMPLETED|Main Treatment Part||7
10739404|NCT02901431|11903581|FG005|NOT COMPLETED|Main Treatment Part||12
10739405|NCT02901431|11903582|FG006|NOT COMPLETED|Main Treatment Part||11
10739406|NCT02901431|11903583|FG007|NOT COMPLETED|Main Treatment Part||0
10739407|NCT02901431|11903584|FG008|NOT COMPLETED|Main Treatment Part||0
10739408|NCT02901431|11903585|FG009|NOT COMPLETED|Main Treatment Part||0
10739409|NCT02901431|11903586|FG010|NOT COMPLETED|Main Treatment Part||0
10739410|NCT02901431|11903587|FG011|NOT COMPLETED|Main Treatment Part||0
10739411|NCT02901431|11903588|FG012|NOT COMPLETED|Main Treatment Part||0
10739412|NCT02901431|11903576|FG000|STARTED|Open Label Part||0
10739413|NCT02901431|11903577|FG001|STARTED|Open Label Part||0
10739414|NCT02901431|11903578|FG002|STARTED|Open Label Part||0
10739415|NCT02901431|11903579|FG003|STARTED|Open Label Part||0
10739416|NCT02901431|11903580|FG004|STARTED|Open Label Part||0
10739417|NCT02901431|11903581|FG005|STARTED|Open Label Part||0
10739418|NCT02901431|11903582|FG006|STARTED|Open Label Part||0
10739419|NCT02901431|11903583|FG007|STARTED|Open Label Part||0
10739420|NCT02901431|11903584|FG008|STARTED|Open Label Part||68
10739421|NCT02901431|11903585|FG009|STARTED|Open Label Part||35
10739422|NCT02901431|11903586|FG010|STARTED|Open Label Part||40
10739423|NCT02901431|11903587|FG011|STARTED|Open Label Part||46
10739424|NCT02901431|11903588|FG012|STARTED|Open Label Part||5
10739425|NCT02901431|11903576|FG000|COMPLETED|Open Label Part||0
10739426|NCT02901431|11903577|FG001|COMPLETED|Open Label Part||0
10739427|NCT02901431|11903578|FG002|COMPLETED|Open Label Part||0
10739428|NCT02901431|11903579|FG003|COMPLETED|Open Label Part||0
10739429|NCT02901431|11903580|FG004|COMPLETED|Open Label Part||0
10739430|NCT02901431|11903581|FG005|COMPLETED|Open Label Part||0
10739431|NCT02901431|11903582|FG006|COMPLETED|Open Label Part||0
10739432|NCT02901431|11903583|FG007|COMPLETED|Open Label Part||0
10739433|NCT02901431|11903584|FG008|COMPLETED|Open Label Part||20
10739434|NCT02901431|11903585|FG009|COMPLETED|Open Label Part||11
10739435|NCT02901431|11903586|FG010|COMPLETED|Open Label Part||11
10739436|NCT02901431|11903587|FG011|COMPLETED|Open Label Part||7
10739437|NCT02901431|11903588|FG012|COMPLETED|Open Label Part||2
10739438|NCT02901431|11903576|FG000|NOT COMPLETED|Open Label Part||0
10739439|NCT02901431|11903577|FG001|NOT COMPLETED|Open Label Part||0
10739440|NCT02901431|11903578|FG002|NOT COMPLETED|Open Label Part||0
10739441|NCT02901431|11903579|FG003|NOT COMPLETED|Open Label Part||0
10739442|NCT02901431|11903580|FG004|NOT COMPLETED|Open Label Part||0
10739443|NCT02901431|11903581|FG005|NOT COMPLETED|Open Label Part||0
10739444|NCT02901431|11903582|FG006|NOT COMPLETED|Open Label Part||0
10739445|NCT02901431|11903583|FG007|NOT COMPLETED|Open Label Part||0
10739446|NCT02901431|11903584|FG008|NOT COMPLETED|Open Label Part||48
10739447|NCT02901431|11903585|FG009|NOT COMPLETED|Open Label Part||24
10739448|NCT02901431|11903586|FG010|NOT COMPLETED|Open Label Part||29
10739449|NCT02901431|11903587|FG011|NOT COMPLETED|Open Label Part||39
10739450|NCT02901431|11903588|FG012|NOT COMPLETED|Open Label Part||3
10739451|NCT02901899|11903613|FG000|STARTED|Reached 1st Response Assessment||45
10739452|NCT02901899|11903613|FG000|Registered|Reached 1st Response Assessment||45
10739453|NCT02901899|11903613|FG000|Started Treatment|Reached 1st Response Assessment||43
10739454|NCT02901899|11903613|FG000|Attempted 2 Cycles of Treatment/Reached First Response|Reached 1st Response Assessment||37
10739455|NCT02901899|11903613|FG000|COMPLETED|Reached 1st Response Assessment||37
10739456|NCT02901899|11903613|FG000|NOT COMPLETED|Reached 1st Response Assessment||8
10739457|NCT02901899|11903613|FG000|STARTED|Continued Treatment After 1st Response||37
10739458|NCT02901899|11903613|FG000|Went on to Start Cycle 3|Continued Treatment After 1st Response||21
10739459|NCT02901899|11903613|FG000|COMPLETED|Continued Treatment After 1st Response||21
10739460|NCT02901899|11903613|FG000|NOT COMPLETED|Continued Treatment After 1st Response||16
10739461|NCT02901899|11903613|FG000|STARTED|Follow up|All patients who receive at least one dose of study drug go into the follow up period.|43
10739462|NCT02901899|11903613|FG000|COMPLETED|Follow up||27
10739463|NCT02901899|11903613|FG000|NOT COMPLETED|Follow up||16
10739464|NCT02901951|11903617|FG000|STARTED|Overall Study||103
10739465|NCT02901951|11903617|FG000|COMPLETED|Overall Study||103
10739466|NCT02901951|11903617|FG000|NOT COMPLETED|Overall Study||0
10816567|NCT01527942|11980123|FG001|STARTED|Overall Study||18
10816568|NCT01527942|11980122|FG000|COMPLETED|Overall Study||16
10816569|NCT01527942|11980123|FG001|COMPLETED|Overall Study||18
10816570|NCT01527942|11980122|FG000|NOT COMPLETED|Overall Study||0
10816571|NCT01527942|11980123|FG001|NOT COMPLETED|Overall Study||0
10816572|NCT01521143|11980133|FG000|STARTED|Overall Study||40
10816573|NCT01521143|11980134|FG001|STARTED|Overall Study||36
10816574|NCT01521143|11980135|FG002|STARTED|Overall Study||8
10816575|NCT01521143|11980136|FG003|STARTED|Overall Study||7
10816576|NCT01521143|11980133|FG000|Received Treatment|Overall Study||20
10816577|NCT01521143|11980134|FG001|Received Treatment|Overall Study||20
10816578|NCT01521143|11980135|FG002|Received Treatment|Overall Study||3
10816579|NCT01521143|11980136|FG003|Received Treatment|Overall Study||4
10816580|NCT01521143|11980133|FG000|COMPLETED|Overall Study||11
10816581|NCT01521143|11980134|FG001|COMPLETED|Overall Study||10
10816582|NCT01521143|11980135|FG002|COMPLETED|Overall Study||0
10816583|NCT01521143|11980136|FG003|COMPLETED|Overall Study||0
10816584|NCT01521143|11980133|FG000|NOT COMPLETED|Overall Study||29
10816585|NCT01521143|11980134|FG001|NOT COMPLETED|Overall Study||26
10739467|NCT02902081|11903621|FG000|STARTED|Overall Study||38
10739468|NCT02902081|11903621|FG000|COMPLETED|Overall Study||38
10739469|NCT02902081|11903621|FG000|NOT COMPLETED|Overall Study||0
10739470|NCT02902146|11903631|FG000|STARTED|Overall Study||381
10739471|NCT02902146|11903632|FG001|STARTED|Overall Study||376
10739472|NCT02902146|11903631|FG000|COMPLETED|Overall Study||381
10739473|NCT02902146|11903632|FG001|COMPLETED|Overall Study||376
10816586|NCT01521143|11980135|FG002|NOT COMPLETED|Overall Study||8
10816587|NCT01521143|11980136|FG003|NOT COMPLETED|Overall Study||7
10816588|NCT01532635|11980146|FG000|STARTED|Overall Study||4
10816589|NCT01532635|11980146|FG000|COMPLETED|Overall Study||4
10739474|NCT02902146|11903631|FG000|NOT COMPLETED|Overall Study||0
10739475|NCT02902146|11903632|FG001|NOT COMPLETED|Overall Study||0
10739476|NCT02902172|11903640|FG000|STARTED|Overall Study||16
10739477|NCT02902172|11903641|FG001|STARTED|Overall Study||20
10739478|NCT02902172|11903640|FG000|COMPLETED|Overall Study||16
10739479|NCT02902172|11903641|FG001|COMPLETED|Overall Study||20
10739480|NCT02902172|11903640|FG000|NOT COMPLETED|Overall Study||0
10739481|NCT02902172|11903641|FG001|NOT COMPLETED|Overall Study||0
10739482|NCT02902237|11903648|FG000|STARTED|Overall Study||17
10739483|NCT02902237|11903648|FG000|COMPLETED|Overall Study|STUDY INITIATION: 2017 03 29, 1st Patient In, STUDY COMPLETION: 2019 11 05, Date of Study End|17
10739484|NCT02902237|11903648|FG000|NOT COMPLETED|Overall Study||0
10739485|NCT02902770|11903662|FG000|STARTED|Overall Study||50
10739486|NCT02902770|11903663|FG001|STARTED|Overall Study||50
10739487|NCT02902770|11903664|FG002|STARTED|Overall Study||50
10739488|NCT02902770|11903662|FG000|COMPLETED|Overall Study||50
10739489|NCT02902770|11903663|FG001|COMPLETED|Overall Study||50
10739490|NCT02902770|11903664|FG002|COMPLETED|Overall Study||50
10739491|NCT02902770|11903662|FG000|NOT COMPLETED|Overall Study||0
10739492|NCT02902770|11903663|FG001|NOT COMPLETED|Overall Study||0
10739493|NCT02902770|11903664|FG002|NOT COMPLETED|Overall Study||0
10739494|NCT02902809|11903672|FG000|STARTED|Overall Study||28
10739495|NCT02902809|11903672|FG000|Treatment Received|Overall Study||28
10739496|NCT02902809|11903672|FG000|Treatment Completed|Overall Study||2
10739497|NCT02902809|11903672|FG000|COMPLETED|Overall Study||0
10739498|NCT02902809|11903672|FG000|NOT COMPLETED|Overall Study||28
10739499|NCT02902913|11903676|FG000|STARTED|Overall Study||9
10739500|NCT02902913|11903676|FG000|First Intervention (1 Day)|Overall Study||9
10739501|NCT02902913|11903676|FG000|Washout (7 Days)|Overall Study||9
10739502|NCT02902913|11903676|FG000|Second Intervention (1 Day)|Overall Study||9
10739503|NCT02902913|11903676|FG000|Washout (7 Days)|Overall Study||9
10739504|NCT02902913|11903676|FG000|Third Intervention (1 Day)|Overall Study||9
10739505|NCT02902913|11903676|FG000|Washout (7 Days)|Overall Study||9
10739506|NCT02902913|11903676|FG000|Ibuprofen (400mg)|Overall Study||9
10739507|NCT02902913|11903676|FG000|COMPLETED|Overall Study||9
10739508|NCT02902913|11903676|FG000|NOT COMPLETED|Overall Study||0
10739509|NCT02902965|11903684|FG000|STARTED|Overall Study||74
10739510|NCT02902965|11903684|FG000|COMPLETED|Overall Study||64
10739511|NCT02902965|11903684|FG000|NOT COMPLETED|Overall Study||10
10739512|NCT02903030|11903691|FG000|STARTED|First Intervention (8 Weeks)||8
10739513|NCT02903030|11903692|FG001|STARTED|First Intervention (8 Weeks)||5
10739514|NCT02903030|11903691|FG000|Received Intervention|First Intervention (8 Weeks)||6
10739515|NCT02903030|11903692|FG001|Received Intervention|First Intervention (8 Weeks)||4
10739516|NCT02903030|11903691|FG000|COMPLETED|First Intervention (8 Weeks)||6
10739517|NCT02903030|11903692|FG001|COMPLETED|First Intervention (8 Weeks)||4
10739518|NCT02903030|11903691|FG000|NOT COMPLETED|First Intervention (8 Weeks)||2
10739519|NCT02903030|11903692|FG001|NOT COMPLETED|First Intervention (8 Weeks)||1
10739520|NCT02903030|11903691|FG000|STARTED|Washout (3 Weeks)||6
10739521|NCT02903030|11903692|FG001|STARTED|Washout (3 Weeks)||4
10739522|NCT02903030|11903691|FG000|COMPLETED|Washout (3 Weeks)||6
10739523|NCT02903030|11903692|FG001|COMPLETED|Washout (3 Weeks)||4
10739524|NCT02903030|11903691|FG000|NOT COMPLETED|Washout (3 Weeks)||0
10739525|NCT02903030|11903692|FG001|NOT COMPLETED|Washout (3 Weeks)||0
10739526|NCT02903030|11903691|FG000|STARTED|Second Intervention (8 Weeks)||6
10739527|NCT02903030|11903692|FG001|STARTED|Second Intervention (8 Weeks)||4
10739528|NCT02903030|11903691|FG000|COMPLETED|Second Intervention (8 Weeks)||6
10739529|NCT02903030|11903692|FG001|COMPLETED|Second Intervention (8 Weeks)||4
10739530|NCT02903030|11903691|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||0
10739531|NCT02903030|11903692|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0
10739532|NCT02903121|11903703|FG000|STARTED|Overall Study||57
10739533|NCT02903121|11903704|FG001|STARTED|Overall Study||52
10739534|NCT02903121|11903703|FG000|COMPLETED|Overall Study||34
10739535|NCT02903121|11903704|FG001|COMPLETED|Overall Study||38
10739536|NCT02903121|11903703|FG000|NOT COMPLETED|Overall Study||23
10739537|NCT02903121|11903704|FG001|NOT COMPLETED|Overall Study||14
10739538|NCT02903238|11903710|FG000|STARTED|Overall Study||21
10739539|NCT02903238|11903710|FG000|COMPLETED|Overall Study||17
10739540|NCT02903238|11903710|FG000|NOT COMPLETED|Overall Study||4
10739541|NCT02903368|11903717|FG000|STARTED|Overall Study||59
10739542|NCT02903368|11903718|FG001|STARTED|Overall Study||59
10739543|NCT02903368|11903717|FG000|COMPLETED|Overall Study||55
10739544|NCT02903368|11903718|FG001|COMPLETED|Overall Study||59
10739545|NCT02903368|11903717|FG000|NOT COMPLETED|Overall Study||4
10739546|NCT02903368|11903718|FG001|NOT COMPLETED|Overall Study||0
10739547|NCT02903394|11903729|FG000|STARTED|Overall Study||5
10739548|NCT02903394|11903730|FG001|STARTED|Overall Study||50
10739549|NCT02903394|11903729|FG000|COMPLETED|Overall Study||5
10739550|NCT02903394|11903730|FG001|COMPLETED|Overall Study||50
10739551|NCT02903394|11903729|FG000|NOT COMPLETED|Overall Study||0
10739552|NCT02903394|11903730|FG001|NOT COMPLETED|Overall Study||0
10739553|NCT02903407|11903739|FG000|STARTED|Overall Study||4
10739554|NCT02903407|11903740|FG001|STARTED|Overall Study||3
10739555|NCT02903407|11903739|FG000|COMPLETED|Overall Study||4
10739556|NCT02903407|11903740|FG001|COMPLETED|Overall Study||3
10739557|NCT02903407|11903739|FG000|NOT COMPLETED|Overall Study||0
10739558|NCT02903407|11903740|FG001|NOT COMPLETED|Overall Study||0
10739559|NCT02903420|11903746|FG000|STARTED|Overall Study||28
10739560|NCT02903420|11903746|FG000|COMPLETED|Overall Study||25
10739561|NCT02903420|11903746|FG000|NOT COMPLETED|Overall Study||3
10739562|NCT02903446|11903752|FG000|STARTED|Overall Study||10
10739563|NCT02903446|11903753|FG001|STARTED|Overall Study||10
10739564|NCT02903446|11903752|FG000|COMPLETED|Overall Study||10
10739565|NCT02903446|11903753|FG001|COMPLETED|Overall Study||10
10739566|NCT02903446|11903752|FG000|NOT COMPLETED|Overall Study||0
10739567|NCT02903446|11903753|FG001|NOT COMPLETED|Overall Study||0
10739568|NCT02903511|11903761|FG000|STARTED|Overall Study||26
10739569|NCT02903511|11903762|FG001|STARTED|Overall Study||25
10739570|NCT02903511|11903761|FG000|Received Intervention|Overall Study||25
10739571|NCT02903511|11903762|FG001|Received Intervention|Overall Study||25
10739572|NCT02903511|11903761|FG000|COMPLETED|Overall Study||22
10739573|NCT02903511|11903762|FG001|COMPLETED|Overall Study||23
10739574|NCT02903511|11903761|FG000|NOT COMPLETED|Overall Study||4
10739575|NCT02903511|11903762|FG001|NOT COMPLETED|Overall Study||2
10739576|NCT02903836|11903771|FG000|STARTED|Overall Study||74
10739577|NCT02903836|11903772|FG001|STARTED|Overall Study||73
10739578|NCT02903836|11903773|FG002|STARTED|Overall Study||77
10739579|NCT02903836|11903771|FG000|COMPLETED|Overall Study||71
10739580|NCT02903836|11903772|FG001|COMPLETED|Overall Study||69
10739581|NCT02903836|11903773|FG002|COMPLETED|Overall Study||73
10739582|NCT02903836|11903771|FG000|NOT COMPLETED|Overall Study||3
10739583|NCT02903836|11903772|FG001|NOT COMPLETED|Overall Study||4
10739584|NCT02903836|11903773|FG002|NOT COMPLETED|Overall Study||4
10739585|NCT02903966|11903783|FG000|STARTED|Part A (Day 1 to 43)||12
10739586|NCT02903966|11903784|FG001|STARTED|Part A (Day 1 to 43)||24
10739587|NCT02903966|11903783|FG000|COMPLETED|Part A (Day 1 to 43)||11
10739588|NCT02903966|11903784|FG001|COMPLETED|Part A (Day 1 to 43)||24
10739589|NCT02903966|11903783|FG000|NOT COMPLETED|Part A (Day 1 to 43)||1
10739590|NCT02903966|11903784|FG001|NOT COMPLETED|Part A (Day 1 to 43)||0
10739591|NCT02903966|11903783|FG000|STARTED|Part B (Day 44 to 112)||11
10739592|NCT02903966|11903784|FG001|STARTED|Part B (Day 44 to 112)||24
10739593|NCT02903966|11903783|FG000|COMPLETED|Part B (Day 44 to 112)||11
10739594|NCT02903966|11903784|FG001|COMPLETED|Part B (Day 44 to 112)||22
10739595|NCT02903966|11903783|FG000|NOT COMPLETED|Part B (Day 44 to 112)||0
10739596|NCT02903966|11903784|FG001|NOT COMPLETED|Part B (Day 44 to 112)||2
10778100|NCT03349632|11939994|FG000|NOT COMPLETED|Period 1, First Week of Wear||0
10778101|NCT03349632|11939995|FG001|NOT COMPLETED|Period 1, First Week of Wear||0
10778102|NCT03349632|11939996|FG002|NOT COMPLETED|Period 1, First Week of Wear||0
10778103|NCT03349632|11939997|FG003|NOT COMPLETED|Period 1, First Week of Wear||0
10778104|NCT03349632|11939998|FG004|NOT COMPLETED|Period 1, First Week of Wear||0
10778105|NCT03349632|11939999|FG005|NOT COMPLETED|Period 1, First Week of Wear||0
10778106|NCT03349632|11939994|FG000|STARTED|Period 2, Second Week of Wear||11
10778107|NCT03349632|11939995|FG001|STARTED|Period 2, Second Week of Wear||11
10778108|NCT03349632|11939996|FG002|STARTED|Period 2, Second Week of Wear||11
10778109|NCT03349632|11939997|FG003|STARTED|Period 2, Second Week of Wear||11
10778110|NCT03349632|11939998|FG004|STARTED|Period 2, Second Week of Wear||11
10778111|NCT03349632|11939999|FG005|STARTED|Period 2, Second Week of Wear||11
10778112|NCT03349632|11939994|FG000|COMPLETED|Period 2, Second Week of Wear||11
10778113|NCT03349632|11939995|FG001|COMPLETED|Period 2, Second Week of Wear||11
10778114|NCT03349632|11939996|FG002|COMPLETED|Period 2, Second Week of Wear||11
10778115|NCT03349632|11939997|FG003|COMPLETED|Period 2, Second Week of Wear||11
10778116|NCT03349632|11939998|FG004|COMPLETED|Period 2, Second Week of Wear||11
10778117|NCT03349632|11939999|FG005|COMPLETED|Period 2, Second Week of Wear||11
10778118|NCT03349632|11939994|FG000|NOT COMPLETED|Period 2, Second Week of Wear||0
10778119|NCT03349632|11939995|FG001|NOT COMPLETED|Period 2, Second Week of Wear||0
10778120|NCT03349632|11939996|FG002|NOT COMPLETED|Period 2, Second Week of Wear||0
10778121|NCT03349632|11939997|FG003|NOT COMPLETED|Period 2, Second Week of Wear||0
10778122|NCT03349632|11939998|FG004|NOT COMPLETED|Period 2, Second Week of Wear||0
10778123|NCT03349632|11939999|FG005|NOT COMPLETED|Period 2, Second Week of Wear||0
10778124|NCT03349710|11940017|FG000|STARTED|Randomized||12
10778125|NCT03349710|11940018|FG001|STARTED|Randomized||10
10778126|NCT03349710|11940019|FG002|STARTED|Randomized||27
10778127|NCT03349710|11940020|FG003|STARTED|Randomized||25
10778128|NCT03349710|11940017|FG000|COMPLETED|Randomized||12
10778129|NCT03349710|11940018|FG001|COMPLETED|Randomized||10
10778130|NCT03349710|11940019|FG002|COMPLETED|Randomized||27
10778131|NCT03349710|11940020|FG003|COMPLETED|Randomized||24
10778132|NCT03349710|11940017|FG000|NOT COMPLETED|Randomized||0
10778133|NCT03349710|11940018|FG001|NOT COMPLETED|Randomized||0
10778134|NCT03349710|11940019|FG002|NOT COMPLETED|Randomized||0
10778135|NCT03349710|11940020|FG003|NOT COMPLETED|Randomized||1
10778136|NCT03349710|11940017|FG000|STARTED|Treatment Period||12
10778137|NCT03349710|11940018|FG001|STARTED|Treatment Period||10
10778138|NCT03349710|11940019|FG002|STARTED|Treatment Period||27
10778139|NCT03349710|11940020|FG003|STARTED|Treatment Period||24
10778140|NCT03349710|11940017|FG000|COMPLETED|Treatment Period||0
10778141|NCT03349710|11940018|FG001|COMPLETED|Treatment Period||0
10778142|NCT03349710|11940019|FG002|COMPLETED|Treatment Period||0
10778143|NCT03349710|11940020|FG003|COMPLETED|Treatment Period||0
10778144|NCT03349710|11940017|FG000|NOT COMPLETED|Treatment Period||12
10778145|NCT03349710|11940018|FG001|NOT COMPLETED|Treatment Period||10
10778146|NCT03349710|11940019|FG002|NOT COMPLETED|Treatment Period||27
10778147|NCT03349710|11940020|FG003|NOT COMPLETED|Treatment Period||24
10778148|NCT03349892|11940030|FG000|STARTED|Overall Study||1
10778149|NCT03349892|11940030|FG000|COMPLETED|Overall Study||1
10778150|NCT03349892|11940030|FG000|NOT COMPLETED|Overall Study||0
10778151|NCT03350217|11940036|FG000|STARTED|Overall Study||79
10739597|NCT02904057|11903798|FG000|STARTED|Overall Study||19
10739598|NCT02904057|11903799|FG001|STARTED|Overall Study||10
10739599|NCT02904057|11903798|FG000|COMPLETED|Overall Study||19
10739600|NCT02904057|11903799|FG001|COMPLETED|Overall Study||10
10739601|NCT02904057|11903798|FG000|NOT COMPLETED|Overall Study||0
10739602|NCT02904057|11903799|FG001|NOT COMPLETED|Overall Study||0
10739603|NCT02904096|11903807|FG000|STARTED|Overall Study||130
10739604|NCT02904096|11903808|FG001|STARTED|Overall Study||126
10739605|NCT02904096|11903807|FG000|COMPLETED|Overall Study||111
10739606|NCT02904096|11903808|FG001|COMPLETED|Overall Study||105
10739607|NCT02904096|11903807|FG000|NOT COMPLETED|Overall Study||19
10739608|NCT02904096|11903808|FG001|NOT COMPLETED|Overall Study||21
10739609|NCT02904200|11903814|FG000|STARTED|Overall Study|One pat. early terminated on own decision, due to travelling distance between home and hospital.|2
10739610|NCT02904200|11903815|FG001|STARTED|Overall Study|No statistical evaluation was performed because only 2 subjects were included in one arm.|0
10739611|NCT02904200|11903814|FG000|COMPLETED|Overall Study||1
10739612|NCT02904200|11903815|FG001|COMPLETED|Overall Study||0
10739613|NCT02904200|11903814|FG000|NOT COMPLETED|Overall Study||1
10739614|NCT02904200|11903815|FG001|NOT COMPLETED|Overall Study||0
10739615|NCT02904226|11903827|FG000|STARTED|Overall Study||40
10739616|NCT02904226|11903828|FG001|STARTED|Overall Study||31
10739617|NCT02904226|11903829|FG002|STARTED|Overall Study||30
10739618|NCT02904226|11903830|FG003|STARTED|Overall Study||100
10739619|NCT02904226|11903831|FG004|STARTED|Overall Study||11
10739620|NCT02904226|11903832|FG005|STARTED|Overall Study||0
10739621|NCT02904226|11903833|FG006|STARTED|Overall Study||6
10739622|NCT02904226|11903834|FG007|STARTED|Overall Study||0
10739623|NCT02904226|11903827|FG000|COMPLETED|Overall Study||0
10739624|NCT02904226|11903828|FG001|COMPLETED|Overall Study||2
10739625|NCT02904226|11903829|FG002|COMPLETED|Overall Study||0
10739626|NCT02904226|11903830|FG003|COMPLETED|Overall Study||4
10739627|NCT02904226|11903831|FG004|COMPLETED|Overall Study||0
10739628|NCT02904226|11903832|FG005|COMPLETED|Overall Study||0
10739629|NCT02904226|11903833|FG006|COMPLETED|Overall Study||0
10739630|NCT02904226|11903834|FG007|COMPLETED|Overall Study||0
10739631|NCT02904226|11903827|FG000|NOT COMPLETED|Overall Study||40
10739632|NCT02904226|11903828|FG001|NOT COMPLETED|Overall Study||29
10739633|NCT02904226|11903829|FG002|NOT COMPLETED|Overall Study||30
10739634|NCT02904226|11903830|FG003|NOT COMPLETED|Overall Study||96
10739635|NCT02904226|11903831|FG004|NOT COMPLETED|Overall Study||11
10739636|NCT02904226|11903832|FG005|NOT COMPLETED|Overall Study||0
10739637|NCT02904226|11903833|FG006|NOT COMPLETED|Overall Study||6
10739638|NCT02904226|11903834|FG007|NOT COMPLETED|Overall Study||0
10739639|NCT02904265|11903852|FG000|STARTED|Overall Study|Study closed due to only 3 participants recruited|1
10739640|NCT02904265|11903853|FG001|STARTED|Overall Study|Study closed due to only 3 participants recruited|2
10739641|NCT02904265|11903852|FG000|COMPLETED|Overall Study||0
10739642|NCT02904265|11903853|FG001|COMPLETED|Overall Study||0
10739643|NCT02904265|11903852|FG000|NOT COMPLETED|Overall Study||1
10739644|NCT02904265|11903853|FG001|NOT COMPLETED|Overall Study||2
10739645|NCT02904512|11903861|FG000|STARTED|Overall Study||9
10739646|NCT02904512|11903862|FG001|STARTED|Overall Study||7
10739647|NCT02904512|11903861|FG000|COMPLETED|Overall Study||6
10739648|NCT02904512|11903862|FG001|COMPLETED|Overall Study||7
10739649|NCT02904512|11903861|FG000|NOT COMPLETED|Overall Study||3
10739650|NCT02904512|11903862|FG001|NOT COMPLETED|Overall Study||0
10739651|NCT02904902|11903868|FG000|STARTED|Overall Study||15
10739652|NCT02904902|11903868|FG000|COMPLETED|Overall Study||14
10739653|NCT02904902|11903868|FG000|NOT COMPLETED|Overall Study||1
10739654|NCT02904915|11903874|FG000|STARTED|Overall Study||25
10739655|NCT02904915|11903875|FG001|STARTED|Overall Study||25
10739656|NCT02904915|11903874|FG000|COMPLETED|Overall Study||25
10739657|NCT02904915|11903875|FG001|COMPLETED|Overall Study||25
10739658|NCT02904915|11903874|FG000|NOT COMPLETED|Overall Study||0
10739659|NCT02904915|11903875|FG001|NOT COMPLETED|Overall Study||0
10816590|NCT01532635|11980146|FG000|NOT COMPLETED|Overall Study||0
10816591|NCT01531387|11980152|FG000|STARTED|Overall Study||11
10816592|NCT01531387|11980153|FG001|STARTED|Overall Study||11
10816593|NCT01531387|11980152|FG000|COMPLETED|Overall Study||0
10816594|NCT01531387|11980153|FG001|COMPLETED|Overall Study||0
10816595|NCT01531387|11980152|FG000|NOT COMPLETED|Overall Study||11
10816596|NCT01531387|11980153|FG001|NOT COMPLETED|Overall Study||11
10816597|NCT01532362|11980161|FG000|STARTED|Overall Study||1
10816598|NCT01532362|11980162|FG001|STARTED|Overall Study||0
10816599|NCT01532362|11980161|FG000|COMPLETED|Overall Study||1
10816600|NCT01532362|11980162|FG001|COMPLETED|Overall Study||0
10816601|NCT01532362|11980161|FG000|NOT COMPLETED|Overall Study||0
10816602|NCT01532362|11980162|FG001|NOT COMPLETED|Overall Study||0
10816603|NCT01527292|11980172|FG000|STARTED|Overall Study||0
10816604|NCT01527292|11980173|FG001|STARTED|Overall Study||3
10816605|NCT01527292|11980172|FG000|COMPLETED|Overall Study||0
10816606|NCT01527292|11980173|FG001|COMPLETED|Overall Study||0
10816607|NCT01527292|11980172|FG000|NOT COMPLETED|Overall Study||0
10816608|NCT01527292|11980173|FG001|NOT COMPLETED|Overall Study||3
10816609|NCT01525745|11980181|FG000|STARTED|Overall Study||4
10816610|NCT01525745|11980182|FG001|STARTED|Overall Study||2
10816611|NCT01525745|11980181|FG000|COMPLETED|Overall Study||3
10816612|NCT01525745|11980182|FG001|COMPLETED|Overall Study||1
10816613|NCT01525745|11980181|FG000|NOT COMPLETED|Overall Study||1
10816614|NCT01525745|11980182|FG001|NOT COMPLETED|Overall Study||1
10816615|NCT01528696|11980192|FG000|STARTED|Overall Study||18
10816616|NCT01528696|11980193|FG001|STARTED|Overall Study||19
10816617|NCT01528696|11980192|FG000|Hospital Stay (2-5 Days)|Overall Study||18
10816618|NCT01528696|11980193|FG001|Hospital Stay (2-5 Days)|Overall Study||19
10816619|NCT01528696|11980192|FG000|COMPLETED|Overall Study||0
10816620|NCT01528696|11980193|FG001|COMPLETED|Overall Study||0
10816621|NCT01528696|11980192|FG000|NOT COMPLETED|Overall Study||18
10816622|NCT01528696|11980193|FG001|NOT COMPLETED|Overall Study||19
10816623|NCT01526408|11980201|FG000|STARTED|Overall Study|early termination of study and sponsor organization closed|0
10816624|NCT01526408|11980202|FG001|STARTED|Overall Study|early termination of study and sponsor organization closed|0
10816625|NCT01526408|11980201|FG000|COMPLETED|Overall Study|early termination of study and sponsor organization closed|0
10816626|NCT01526408|11980202|FG001|COMPLETED|Overall Study|early termination of study and sponsor organization closed|0
10816627|NCT01526408|11980201|FG000|NOT COMPLETED|Overall Study||0
10816628|NCT01526408|11980202|FG001|NOT COMPLETED|Overall Study||0
10816629|NCT01528293|11980210|FG000|STARTED|Overall Study||1
10816630|NCT01528293|11980211|FG001|STARTED|Overall Study||1
10816631|NCT01528293|11980210|FG000|COMPLETED|Overall Study||0
10816632|NCT01528293|11980211|FG001|COMPLETED|Overall Study||1
10816633|NCT01528293|11980210|FG000|NOT COMPLETED|Overall Study||1
10816634|NCT01528293|11980211|FG001|NOT COMPLETED|Overall Study||0
10816635|NCT01525927|11980219|FG000|STARTED|Overall Study||0
10816636|NCT01525927|11980219|FG000|COMPLETED|Overall Study||0
10816637|NCT01525927|11980219|FG000|NOT COMPLETED|Overall Study||0
10816638|NCT01520714|11980227|FG000|STARTED|Overall Study||0
10816639|NCT01520714|11980228|FG001|STARTED|Overall Study||11
10816640|NCT01520714|11980227|FG000|COMPLETED|Overall Study||0
10816641|NCT01520714|11980228|FG001|COMPLETED|Overall Study||5
10816642|NCT01520714|11980227|FG000|NOT COMPLETED|Overall Study||0
10816643|NCT01520714|11980228|FG001|NOT COMPLETED|Overall Study||6
10816644|NCT01507233|11980236|FG000|STARTED|Overall Study||5
10816645|NCT01507233|11980237|FG001|STARTED|Overall Study||0
10816646|NCT01507233|11980236|FG000|COMPLETED|Overall Study||5
10816647|NCT01507233|11980237|FG001|COMPLETED|Overall Study||0
10816648|NCT01507233|11980236|FG000|NOT COMPLETED|Overall Study||0
10816649|NCT01507233|11980237|FG001|NOT COMPLETED|Overall Study||0
10816650|NCT01516034|11980243|FG000|STARTED|Overall Study||8
10816651|NCT01516034|11980243|FG000|COMPLETED|Overall Study||0
10816652|NCT01516034|11980243|FG000|NOT COMPLETED|Overall Study||8
10816653|NCT01500772|11980247|FG000|STARTED|Overall Study||6
10816654|NCT01500772|11980247|FG000|COMPLETED|Overall Study||0
10816655|NCT01500772|11980247|FG000|NOT COMPLETED|Overall Study||6
10816656|NCT01517763|11980254|FG000|STARTED|Overall Study||0
10816657|NCT01517763|11980255|FG001|STARTED|Overall Study||0
10816658|NCT01517763|11980256|FG002|STARTED|Overall Study||0
10816659|NCT01517763|11980254|FG000|COMPLETED|Overall Study||0
10816660|NCT01517763|11980255|FG001|COMPLETED|Overall Study||0
10816661|NCT01517763|11980256|FG002|COMPLETED|Overall Study||0
10816662|NCT01517763|11980254|FG000|NOT COMPLETED|Overall Study||0
10816663|NCT01517763|11980255|FG001|NOT COMPLETED|Overall Study||0
10816664|NCT01517763|11980256|FG002|NOT COMPLETED|Overall Study||0
10739708|NCT02905149|11903943|FG000|STARTED|Overall Study||30
10739709|NCT02905149|11903944|FG001|STARTED|Overall Study||30
10739710|NCT02905149|11903943|FG000|COMPLETED|Overall Study||28
10739711|NCT02905149|11903944|FG001|COMPLETED|Overall Study||30
10739712|NCT02905149|11903943|FG000|NOT COMPLETED|Overall Study||2
10739713|NCT02905149|11903944|FG001|NOT COMPLETED|Overall Study||0
10739714|NCT02905266|11903952|FG000|STARTED|Treatment Phase Part 1||53
10739715|NCT02905266|11903953|FG001|STARTED|Treatment Phase Part 1||53
10739716|NCT02905266|11903952|FG000|COMPLETED|Treatment Phase Part 1||24
10739717|NCT02905266|11903953|FG001|COMPLETED|Treatment Phase Part 1||30
10739718|NCT02905266|11903952|FG000|NOT COMPLETED|Treatment Phase Part 1||29
10739719|NCT02905266|11903953|FG001|NOT COMPLETED|Treatment Phase Part 1||23
10739720|NCT02905266|11903952|FG000|STARTED|Transition From Part 1 to Part 2||24
10739721|NCT02905266|11903953|FG001|STARTED|Transition From Part 1 to Part 2||30
10739722|NCT02905266|11903952|FG000|COMPLETED|Transition From Part 1 to Part 2||20
10739723|NCT02905266|11903953|FG001|COMPLETED|Transition From Part 1 to Part 2||22
10739724|NCT02905266|11903952|FG000|NOT COMPLETED|Transition From Part 1 to Part 2||4
10739725|NCT02905266|11903953|FG001|NOT COMPLETED|Transition From Part 1 to Part 2||8
10739726|NCT02905266|11903952|FG000|STARTED|Maintenance Phase Part 2||20
10739727|NCT02905266|11903953|FG001|STARTED|Maintenance Phase Part 2||22
10739728|NCT02905266|11903952|FG000|COMPLETED|Maintenance Phase Part 2||8
10739729|NCT02905266|11903953|FG001|COMPLETED|Maintenance Phase Part 2||14
10739730|NCT02905266|11903952|FG000|NOT COMPLETED|Maintenance Phase Part 2||12
10739731|NCT02905266|11903953|FG001|NOT COMPLETED|Maintenance Phase Part 2||8
10739732|NCT02905331|11903961|FG000|STARTED|Placebo Controlled Period(Week[wk] 0-16)||16
10739733|NCT02905331|11903962|FG001|STARTED|Placebo Controlled Period(Week[wk] 0-16)||62
10739734|NCT02905331|11903963|FG002|STARTED|Placebo Controlled Period(Week[wk] 0-16)||0
10739735|NCT02905331|11903961|FG000|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||13
10739736|NCT02905331|11903962|FG001|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||61
10739737|NCT02905331|11903963|FG002|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||0
10739738|NCT02905331|11903961|FG000|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||3
10739739|NCT02905331|11903962|FG001|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||1
10739740|NCT02905331|11903963|FG002|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||0
10739741|NCT02905331|11903961|FG000|STARTED|Active Treatment and Follow up (wk16-40)||0
10739742|NCT02905331|11903962|FG001|STARTED|Active Treatment and Follow up (wk16-40)||61
10739743|NCT02905331|11903963|FG002|STARTED|Active Treatment and Follow up (wk16-40)||13
10739744|NCT02905331|11903961|FG000|COMPLETED|Active Treatment and Follow up (wk16-40)||0
10739745|NCT02905331|11903962|FG001|COMPLETED|Active Treatment and Follow up (wk16-40)||53
10739746|NCT02905331|11903963|FG002|COMPLETED|Active Treatment and Follow up (wk16-40)||13
10739747|NCT02905331|11903961|FG000|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||0
10739748|NCT02905331|11903962|FG001|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||8
10739749|NCT02905331|11903963|FG002|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||0
10739750|NCT02905435|11903971|FG000|STARTED|Overall Study||14
10739751|NCT02905435|11903971|FG000|COMPLETED|Overall Study||7
10739752|NCT02905435|11903971|FG000|NOT COMPLETED|Overall Study||7
10739753|NCT02905825|11903976|FG000|STARTED|Overall Study||53
10739754|NCT02905825|11903976|FG000|COMPLETED|Overall Study||41
10739755|NCT02905825|11903976|FG000|NOT COMPLETED|Overall Study||12
10739756|NCT02905981|11903980|FG000|STARTED|Overall Study||1
10739757|NCT02905981|11903980|FG000|COMPLETED|Overall Study||0
10739758|NCT02905981|11903980|FG000|NOT COMPLETED|Overall Study||1
10739759|NCT02906358|11903986|FG000|STARTED|Overall Study||58
10739760|NCT02906358|11903987|FG001|STARTED|Overall Study||53
10739761|NCT02906358|11903986|FG000|Completed 3 Month Measures|Overall Study||36
10739762|NCT02906358|11903987|FG001|Completed 3 Month Measures|Overall Study||33
10739763|NCT02906358|11903986|FG000|COMPLETED|Overall Study||36
10739764|NCT02906358|11903987|FG001|COMPLETED|Overall Study||31
10739765|NCT02906358|11903986|FG000|NOT COMPLETED|Overall Study||22
10739766|NCT02906358|11903987|FG001|NOT COMPLETED|Overall Study||22
10739767|NCT02906566|11903995|FG000|STARTED|Overall Study||24
10739768|NCT02906566|11903996|FG001|STARTED|Overall Study||10
10739769|NCT02906566|11903995|FG000|COMPLETED|Overall Study||21
10739770|NCT02906566|11903996|FG001|COMPLETED|Overall Study||10
10739771|NCT02906566|11903995|FG000|NOT COMPLETED|Overall Study||3
10739772|NCT02906566|11903996|FG001|NOT COMPLETED|Overall Study||0
10739773|NCT02906579|11904004|FG000|STARTED|Overall Study||11
10739774|NCT02906579|11904004|FG000|Completed Cycle 1 (Placebo)|Overall Study||11
10816665|NCT01507584|11980264|FG000|STARTED|Overall Study||0
10816666|NCT01507584|11980264|FG000|COMPLETED|Overall Study||0
10739775|NCT02906579|11904004|FG000|Completed Cycle 2 (10 mg IW-1973)|Overall Study||11
10739776|NCT02906579|11904004|FG000|Completed Cycle 3 (20 mg IW-1973)|Overall Study||11
10739777|NCT02906579|11904004|FG000|Completed Cycle 4 (30 mg IW-1973)|Overall Study||10
10739778|NCT02906579|11904004|FG000|Completed Cycle 5 (40 mg IW-1973)|Overall Study||9
10739779|NCT02906579|11904004|FG000|Completed Cycle 6 (50 mg IW-1973)|Overall Study||9
10739780|NCT02906579|11904004|FG000|COMPLETED|Overall Study||9
10739781|NCT02906579|11904004|FG000|NOT COMPLETED|Overall Study||2
10739782|NCT02906644|11904026|FG000|STARTED|First 2 Weeks||31
10739783|NCT02906644|11904027|FG001|STARTED|First 2 Weeks||30
10739784|NCT02906644|11904026|FG000|COMPLETED|First 2 Weeks||30
10739785|NCT02906644|11904027|FG001|COMPLETED|First 2 Weeks||27
10739786|NCT02906644|11904026|FG000|NOT COMPLETED|First 2 Weeks||1
10739787|NCT02906644|11904027|FG001|NOT COMPLETED|First 2 Weeks||3
10739788|NCT02906644|11904026|FG000|STARTED|Weeks 3 to 14|All participants receiving active Lorcaserin plus nicotine patches starting at the 2nd study visit.|30
10739789|NCT02906644|11904027|FG001|STARTED|Weeks 3 to 14|All participants receiving active Lorcaserin plus nicotine patches starting at the 2nd study visit.|27
10739790|NCT02906644|11904026|FG000|Final Study Visit|Weeks 3 to 14|All participants receiving only 1 week of 14mg & 1 week of 7mg nicotine patches at this visit.|17
10739791|NCT02906644|11904027|FG001|Final Study Visit|Weeks 3 to 14|All participants receiving only 1 week of 14mg & 1 week of 7mg nicotine patches at this visit.|20
10739792|NCT02906644|11904026|FG000|Follow-up (6 Months Post Quit Day)|Weeks 3 to 14||14
10739793|NCT02906644|11904027|FG001|Follow-up (6 Months Post Quit Day)|Weeks 3 to 14||16
10739794|NCT02906644|11904026|FG000|COMPLETED|Weeks 3 to 14||14
10739795|NCT02906644|11904027|FG001|COMPLETED|Weeks 3 to 14||16
10739796|NCT02906644|11904026|FG000|NOT COMPLETED|Weeks 3 to 14||16
10739797|NCT02906644|11904027|FG001|NOT COMPLETED|Weeks 3 to 14||11
10739798|NCT02906670|11904044|FG000|STARTED|Cohort 1, QW||1
10739799|NCT02906670|11904045|FG001|STARTED|Cohort 1, QW||0
10739800|NCT02906670|11904046|FG002|STARTED|Cohort 1, QW||0
10739801|NCT02906670|11904047|FG003|STARTED|Cohort 1, QW||0
10739802|NCT02906670|11904048|FG004|STARTED|Cohort 1, QW||0
10739803|NCT02906670|11904049|FG005|STARTED|Cohort 1, QW||0
10739804|NCT02906670|11904050|FG006|STARTED|Cohort 1, QW||0
10739805|NCT02906670|11904051|FG007|STARTED|Cohort 1, QW||0
10739806|NCT02906670|11904052|FG008|STARTED|Cohort 1, QW||0
10739807|NCT02906670|11904053|FG009|STARTED|Cohort 1, QW||0
10739808|NCT02906670|11904044|FG000|COMPLETED|Cohort 1, QW||0
10739809|NCT02906670|11904045|FG001|COMPLETED|Cohort 1, QW||0
10739810|NCT02906670|11904046|FG002|COMPLETED|Cohort 1, QW||0
10739811|NCT02906670|11904047|FG003|COMPLETED|Cohort 1, QW||0
10739812|NCT02906670|11904048|FG004|COMPLETED|Cohort 1, QW||0
10739813|NCT02906670|11904049|FG005|COMPLETED|Cohort 1, QW||0
10739814|NCT02906670|11904050|FG006|COMPLETED|Cohort 1, QW||0
10739815|NCT02906670|11904051|FG007|COMPLETED|Cohort 1, QW||0
10739816|NCT02906670|11904052|FG008|COMPLETED|Cohort 1, QW||0
10739817|NCT02906670|11904053|FG009|COMPLETED|Cohort 1, QW||0
10739818|NCT02906670|11904044|FG000|NOT COMPLETED|Cohort 1, QW||1
10739819|NCT02906670|11904045|FG001|NOT COMPLETED|Cohort 1, QW||0
10739820|NCT02906670|11904046|FG002|NOT COMPLETED|Cohort 1, QW||0
10739821|NCT02906670|11904047|FG003|NOT COMPLETED|Cohort 1, QW||0
10739822|NCT02906670|11904048|FG004|NOT COMPLETED|Cohort 1, QW||0
10739823|NCT02906670|11904049|FG005|NOT COMPLETED|Cohort 1, QW||0
10739824|NCT02906670|11904050|FG006|NOT COMPLETED|Cohort 1, QW||0
10739825|NCT02906670|11904051|FG007|NOT COMPLETED|Cohort 1, QW||0
10739826|NCT02906670|11904052|FG008|NOT COMPLETED|Cohort 1, QW||0
10739827|NCT02906670|11904053|FG009|NOT COMPLETED|Cohort 1, QW||0
10739828|NCT02906670|11904044|FG000|STARTED|Cohort 2, QW||0
10739829|NCT02906670|11904045|FG001|STARTED|Cohort 2, QW||1
10739830|NCT02906670|11904046|FG002|STARTED|Cohort 2, QW||0
10739831|NCT02906670|11904047|FG003|STARTED|Cohort 2, QW||0
10739832|NCT02906670|11904048|FG004|STARTED|Cohort 2, QW||0
10739833|NCT02906670|11904049|FG005|STARTED|Cohort 2, QW||0
10739834|NCT02906670|11904050|FG006|STARTED|Cohort 2, QW||0
10739835|NCT02906670|11904051|FG007|STARTED|Cohort 2, QW||0
10739836|NCT02906670|11904052|FG008|STARTED|Cohort 2, QW||0
10739837|NCT02906670|11904053|FG009|STARTED|Cohort 2, QW||0
10739838|NCT02906670|11904044|FG000|COMPLETED|Cohort 2, QW||0
10739839|NCT02906670|11904045|FG001|COMPLETED|Cohort 2, QW||0
10739840|NCT02906670|11904046|FG002|COMPLETED|Cohort 2, QW||0
10739841|NCT02906670|11904047|FG003|COMPLETED|Cohort 2, QW||0
10739842|NCT02906670|11904048|FG004|COMPLETED|Cohort 2, QW||0
10739843|NCT02906670|11904049|FG005|COMPLETED|Cohort 2, QW||0
10739844|NCT02906670|11904050|FG006|COMPLETED|Cohort 2, QW||0
10739845|NCT02906670|11904051|FG007|COMPLETED|Cohort 2, QW||0
10739846|NCT02906670|11904052|FG008|COMPLETED|Cohort 2, QW||0
10739847|NCT02906670|11904053|FG009|COMPLETED|Cohort 2, QW||0
10739848|NCT02906670|11904044|FG000|NOT COMPLETED|Cohort 2, QW||0
10739849|NCT02906670|11904045|FG001|NOT COMPLETED|Cohort 2, QW||1
10739850|NCT02906670|11904046|FG002|NOT COMPLETED|Cohort 2, QW||0
10739851|NCT02906670|11904047|FG003|NOT COMPLETED|Cohort 2, QW||0
10739852|NCT02906670|11904048|FG004|NOT COMPLETED|Cohort 2, QW||0
10739853|NCT02906670|11904049|FG005|NOT COMPLETED|Cohort 2, QW||0
10739854|NCT02906670|11904050|FG006|NOT COMPLETED|Cohort 2, QW||0
10739855|NCT02906670|11904051|FG007|NOT COMPLETED|Cohort 2, QW||0
10739856|NCT02906670|11904052|FG008|NOT COMPLETED|Cohort 2, QW||0
10739857|NCT02906670|11904053|FG009|NOT COMPLETED|Cohort 2, QW||0
10739858|NCT02906670|11904044|FG000|STARTED|Cohort 3, QW||0
10739859|NCT02906670|11904045|FG001|STARTED|Cohort 3, QW||0
10739860|NCT02906670|11904046|FG002|STARTED|Cohort 3, QW||4
10739861|NCT02906670|11904047|FG003|STARTED|Cohort 3, QW||0
10739862|NCT02906670|11904048|FG004|STARTED|Cohort 3, QW||0
10739863|NCT02906670|11904049|FG005|STARTED|Cohort 3, QW||0
10739864|NCT02906670|11904050|FG006|STARTED|Cohort 3, QW||0
10739865|NCT02906670|11904051|FG007|STARTED|Cohort 3, QW||0
10739866|NCT02906670|11904052|FG008|STARTED|Cohort 3, QW||0
10739867|NCT02906670|11904053|FG009|STARTED|Cohort 3, QW||0
10739868|NCT02906670|11904044|FG000|COMPLETED|Cohort 3, QW||0
10739869|NCT02906670|11904045|FG001|COMPLETED|Cohort 3, QW||0
10739870|NCT02906670|11904046|FG002|COMPLETED|Cohort 3, QW||0
10739871|NCT02906670|11904047|FG003|COMPLETED|Cohort 3, QW||0
10739872|NCT02906670|11904048|FG004|COMPLETED|Cohort 3, QW||0
10739873|NCT02906670|11904049|FG005|COMPLETED|Cohort 3, QW||0
10739874|NCT02906670|11904050|FG006|COMPLETED|Cohort 3, QW||0
10739875|NCT02906670|11904051|FG007|COMPLETED|Cohort 3, QW||0
10739876|NCT02906670|11904052|FG008|COMPLETED|Cohort 3, QW||0
10739877|NCT02906670|11904053|FG009|COMPLETED|Cohort 3, QW||0
10739878|NCT02906670|11904044|FG000|NOT COMPLETED|Cohort 3, QW||0
10739879|NCT02906670|11904045|FG001|NOT COMPLETED|Cohort 3, QW||0
10739880|NCT02906670|11904046|FG002|NOT COMPLETED|Cohort 3, QW||4
10739881|NCT02906670|11904047|FG003|NOT COMPLETED|Cohort 3, QW||0
10739882|NCT02906670|11904048|FG004|NOT COMPLETED|Cohort 3, QW||0
10739883|NCT02906670|11904049|FG005|NOT COMPLETED|Cohort 3, QW||0
10739884|NCT02906670|11904050|FG006|NOT COMPLETED|Cohort 3, QW||0
10739885|NCT02906670|11904051|FG007|NOT COMPLETED|Cohort 3, QW||0
10739886|NCT02906670|11904052|FG008|NOT COMPLETED|Cohort 3, QW||0
10739887|NCT02906670|11904053|FG009|NOT COMPLETED|Cohort 3, QW||0
10739888|NCT02906670|11904044|FG000|STARTED|Cohort 4, Q2W||0
10739889|NCT02906670|11904045|FG001|STARTED|Cohort 4, Q2W||0
10739890|NCT02906670|11904046|FG002|STARTED|Cohort 4, Q2W||0
10739891|NCT02906670|11904047|FG003|STARTED|Cohort 4, Q2W||0
10739892|NCT02906670|11904048|FG004|STARTED|Cohort 4, Q2W||0
10739893|NCT02906670|11904049|FG005|STARTED|Cohort 4, Q2W||3
10739894|NCT02906670|11904050|FG006|STARTED|Cohort 4, Q2W||0
10739895|NCT02906670|11904051|FG007|STARTED|Cohort 4, Q2W||0
10739896|NCT02906670|11904052|FG008|STARTED|Cohort 4, Q2W||0
10739897|NCT02906670|11904053|FG009|STARTED|Cohort 4, Q2W||0
10739898|NCT02906670|11904044|FG000|COMPLETED|Cohort 4, Q2W||0
10739899|NCT02906670|11904045|FG001|COMPLETED|Cohort 4, Q2W||0
10739900|NCT02906670|11904046|FG002|COMPLETED|Cohort 4, Q2W||0
10739901|NCT02906670|11904047|FG003|COMPLETED|Cohort 4, Q2W||0
10739902|NCT02906670|11904048|FG004|COMPLETED|Cohort 4, Q2W||0
10739903|NCT02906670|11904049|FG005|COMPLETED|Cohort 4, Q2W||0
10739904|NCT02906670|11904050|FG006|COMPLETED|Cohort 4, Q2W||0
10739905|NCT02906670|11904051|FG007|COMPLETED|Cohort 4, Q2W||0
10739906|NCT02906670|11904052|FG008|COMPLETED|Cohort 4, Q2W||0
10739907|NCT02906670|11904053|FG009|COMPLETED|Cohort 4, Q2W||0
10739908|NCT02906670|11904044|FG000|NOT COMPLETED|Cohort 4, Q2W||0
10739909|NCT02906670|11904045|FG001|NOT COMPLETED|Cohort 4, Q2W||0
10739910|NCT02906670|11904046|FG002|NOT COMPLETED|Cohort 4, Q2W||0
10739911|NCT02906670|11904047|FG003|NOT COMPLETED|Cohort 4, Q2W||0
10739912|NCT02906670|11904048|FG004|NOT COMPLETED|Cohort 4, Q2W||0
10739913|NCT02906670|11904049|FG005|NOT COMPLETED|Cohort 4, Q2W||3
10739914|NCT02906670|11904050|FG006|NOT COMPLETED|Cohort 4, Q2W||0
10739915|NCT02906670|11904051|FG007|NOT COMPLETED|Cohort 4, Q2W||0
10739916|NCT02906670|11904052|FG008|NOT COMPLETED|Cohort 4, Q2W||0
10739917|NCT02906670|11904053|FG009|NOT COMPLETED|Cohort 4, Q2W||0
10739918|NCT02906670|11904044|FG000|STARTED|Cohort 5, Q2W||0
10739919|NCT02906670|11904045|FG001|STARTED|Cohort 5, Q2W||0
10739920|NCT02906670|11904046|FG002|STARTED|Cohort 5, Q2W||0
10739921|NCT02906670|11904047|FG003|STARTED|Cohort 5, Q2W||0
10739922|NCT02906670|11904048|FG004|STARTED|Cohort 5, Q2W||0
10739923|NCT02906670|11904049|FG005|STARTED|Cohort 5, Q2W||0
10739924|NCT02906670|11904050|FG006|STARTED|Cohort 5, Q2W||7
10739925|NCT02906670|11904051|FG007|STARTED|Cohort 5, Q2W||0
10739926|NCT02906670|11904052|FG008|STARTED|Cohort 5, Q2W||0
10739927|NCT02906670|11904053|FG009|STARTED|Cohort 5, Q2W||0
10739928|NCT02906670|11904044|FG000|COMPLETED|Cohort 5, Q2W||0
10739929|NCT02906670|11904045|FG001|COMPLETED|Cohort 5, Q2W||0
10739930|NCT02906670|11904046|FG002|COMPLETED|Cohort 5, Q2W||0
10739931|NCT02906670|11904047|FG003|COMPLETED|Cohort 5, Q2W||0
10739932|NCT02906670|11904048|FG004|COMPLETED|Cohort 5, Q2W||0
10739933|NCT02906670|11904049|FG005|COMPLETED|Cohort 5, Q2W||0
10739934|NCT02906670|11904050|FG006|COMPLETED|Cohort 5, Q2W||0
10739935|NCT02906670|11904051|FG007|COMPLETED|Cohort 5, Q2W||0
10739936|NCT02906670|11904052|FG008|COMPLETED|Cohort 5, Q2W||0
10739937|NCT02906670|11904053|FG009|COMPLETED|Cohort 5, Q2W||0
10739938|NCT02906670|11904044|FG000|NOT COMPLETED|Cohort 5, Q2W||0
10739939|NCT02906670|11904045|FG001|NOT COMPLETED|Cohort 5, Q2W||0
10739940|NCT02906670|11904046|FG002|NOT COMPLETED|Cohort 5, Q2W||0
10739941|NCT02906670|11904047|FG003|NOT COMPLETED|Cohort 5, Q2W||0
10739942|NCT02906670|11904048|FG004|NOT COMPLETED|Cohort 5, Q2W||0
10739943|NCT02906670|11904049|FG005|NOT COMPLETED|Cohort 5, Q2W||0
10739944|NCT02906670|11904050|FG006|NOT COMPLETED|Cohort 5, Q2W||7
10739945|NCT02906670|11904051|FG007|NOT COMPLETED|Cohort 5, Q2W||0
10739946|NCT02906670|11904052|FG008|NOT COMPLETED|Cohort 5, Q2W||0
10739947|NCT02906670|11904053|FG009|NOT COMPLETED|Cohort 5, Q2W||0
10739948|NCT02906670|11904044|FG000|STARTED|Cohort 5P, Q2W||0
10739949|NCT02906670|11904045|FG001|STARTED|Cohort 5P, Q2W||0
10739950|NCT02906670|11904046|FG002|STARTED|Cohort 5P, Q2W||0
10739951|NCT02906670|11904047|FG003|STARTED|Cohort 5P, Q2W||0
10739952|NCT02906670|11904048|FG004|STARTED|Cohort 5P, Q2W||0
10739953|NCT02906670|11904049|FG005|STARTED|Cohort 5P, Q2W||0
10739954|NCT02906670|11904050|FG006|STARTED|Cohort 5P, Q2W||0
10739955|NCT02906670|11904051|FG007|STARTED|Cohort 5P, Q2W||3
10739956|NCT02906670|11904052|FG008|STARTED|Cohort 5P, Q2W||0
10739957|NCT02906670|11904053|FG009|STARTED|Cohort 5P, Q2W||0
10739958|NCT02906670|11904044|FG000|COMPLETED|Cohort 5P, Q2W||0
10739959|NCT02906670|11904045|FG001|COMPLETED|Cohort 5P, Q2W||0
10739960|NCT02906670|11904046|FG002|COMPLETED|Cohort 5P, Q2W||0
10739961|NCT02906670|11904047|FG003|COMPLETED|Cohort 5P, Q2W||0
10739962|NCT02906670|11904048|FG004|COMPLETED|Cohort 5P, Q2W||0
10739963|NCT02906670|11904049|FG005|COMPLETED|Cohort 5P, Q2W||0
10816667|NCT01507584|11980264|FG000|NOT COMPLETED|Overall Study||0
10816668|NCT01510756|11980268|FG000|STARTED|Overall Study||4
10816669|NCT01510756|11980268|FG000|COMPLETED|Overall Study||0
10816670|NCT01510756|11980268|FG000|NOT COMPLETED|Overall Study||4
10816671|NCT01511081|11980274|FG000|STARTED|Overall Study||8
10816672|NCT01511081|11980275|FG001|STARTED|Overall Study||9
10816673|NCT01511081|11980274|FG000|COMPLETED|Overall Study||8
10816674|NCT01511081|11980275|FG001|COMPLETED|Overall Study||9
10816675|NCT01511081|11980274|FG000|NOT COMPLETED|Overall Study||0
10816676|NCT01511081|11980275|FG001|NOT COMPLETED|Overall Study||0
10816677|NCT01500109|11980284|FG000|STARTED|Overall Study||0
10816678|NCT01500109|11980285|FG001|STARTED|Overall Study||0
10816679|NCT01500109|11980286|FG002|STARTED|Overall Study||0
10816680|NCT01500109|11980284|FG000|COMPLETED|Overall Study||0
10816681|NCT01500109|11980285|FG001|COMPLETED|Overall Study||0
10816682|NCT01500109|11980286|FG002|COMPLETED|Overall Study||0
10816683|NCT01500109|11980284|FG000|NOT COMPLETED|Overall Study||0
10816684|NCT01500109|11980285|FG001|NOT COMPLETED|Overall Study||0
10816685|NCT01500109|11980286|FG002|NOT COMPLETED|Overall Study||0
10816686|NCT01509053|11980294|FG000|STARTED|Oral Aripirazole (Phase A)||19
10816687|NCT01509053|11980294|FG000|COMPLETED|Oral Aripirazole (Phase A)||8
10816688|NCT01509053|11980294|FG000|NOT COMPLETED|Oral Aripirazole (Phase A)||11
10816689|NCT01509053|11980294|FG000|STARTED|Aripiprazole IM Depot Treatment Phase(B)|Includes 8 patients from Phase A + 11 patients who entered directly into Phase B.|19
10816690|NCT01509053|11980294|FG000|COMPLETED|Aripiprazole IM Depot Treatment Phase(B)||3
10816691|NCT01509053|11980294|FG000|NOT COMPLETED|Aripiprazole IM Depot Treatment Phase(B)||16
10816692|NCT01509053|11980294|FG000|STARTED|Aripiprazole IM Depot Extension Phase(C)||3
10816693|NCT01509053|11980294|FG000|COMPLETED|Aripiprazole IM Depot Extension Phase(C)||0
10816694|NCT01509053|11980294|FG000|NOT COMPLETED|Aripiprazole IM Depot Extension Phase(C)||3
10816695|NCT01495988|11980306|FG000|STARTED|Vem +/- Bev (Protocol v2.0)||0
10816696|NCT01495988|11980307|FG001|STARTED|Vem +/- Bev (Protocol v2.0)||0
10816697|NCT01495988|11980308|FG002|STARTED|Vem +/- Bev (Protocol v2.0)||5
10816698|NCT01495988|11980309|FG003|STARTED|Vem +/- Bev (Protocol v2.0)||3
10816699|NCT01495988|11980306|FG000|COMPLETED|Vem +/- Bev (Protocol v2.0)||0
10816700|NCT01495988|11980307|FG001|COMPLETED|Vem +/- Bev (Protocol v2.0)||0
10816701|NCT01495988|11980308|FG002|COMPLETED|Vem +/- Bev (Protocol v2.0)||5
10816702|NCT01495988|11980309|FG003|COMPLETED|Vem +/- Bev (Protocol v2.0)||3
10816703|NCT01495988|11980306|FG000|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
10816704|NCT01495988|11980307|FG001|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
10816705|NCT01495988|11980308|FG002|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
10816706|NCT01495988|11980309|FG003|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
10408674|NCT00756236|11552770|FG002|COMPLETED|Overall Study||20
10408675|NCT00756236|11552768|FG000|NOT COMPLETED|Overall Study||0
10408676|NCT00756236|11552769|FG001|NOT COMPLETED|Overall Study||0
10408677|NCT00756236|11552770|FG002|NOT COMPLETED|Overall Study||0
10408678|NCT00756275|11552780|FG000|STARTED|Overall Study||60
10408679|NCT00756275|11552781|FG001|STARTED|Overall Study||77
10408680|NCT00756275|11552780|FG000|COMPLETED|Overall Study||31
10408681|NCT00756275|11552781|FG001|COMPLETED|Overall Study||49
10408682|NCT00756275|11552780|FG000|NOT COMPLETED|Overall Study||29
10408683|NCT00756275|11552781|FG001|NOT COMPLETED|Overall Study||28
10408684|NCT00756314|11552789|FG000|STARTED|Overall Study||123
10408685|NCT00756314|11552790|FG001|STARTED|Overall Study||123
10408686|NCT00756314|11552789|FG000|COMPLETED|Overall Study|"2 participants discontinued the intervention and were analyzed by intention to treat analysis."|121
10408687|NCT00756314|11552790|FG001|COMPLETED|Overall Study|"4 participants did not do the follow up, 55 discontinued and were analyzed by intention to treat"|64
10408688|NCT00756314|11552789|FG000|NOT COMPLETED|Overall Study||2
10816707|NCT01495988|11980306|FG000|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
10816708|NCT01495988|11980307|FG001|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||2
10816709|NCT01495988|11980308|FG002|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
10816710|NCT01495988|11980309|FG003|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
10408689|NCT00756314|11552790|FG001|NOT COMPLETED|Overall Study||59
10816711|NCT01495988|11980306|FG000|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
10816712|NCT01495988|11980307|FG001|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||2
10816713|NCT01495988|11980308|FG002|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
10816714|NCT01495988|11980309|FG003|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
10816715|NCT01495988|11980306|FG000|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
10408690|NCT00756444|11552798|FG000|STARTED|Overall Study||33
10739964|NCT02906670|11904050|FG006|COMPLETED|Cohort 5P, Q2W||0
10739965|NCT02906670|11904051|FG007|COMPLETED|Cohort 5P, Q2W||0
10816716|NCT01495988|11980307|FG001|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
10739966|NCT02906670|11904052|FG008|COMPLETED|Cohort 5P, Q2W||0
10739967|NCT02906670|11904053|FG009|COMPLETED|Cohort 5P, Q2W||0
10739968|NCT02906670|11904044|FG000|NOT COMPLETED|Cohort 5P, Q2W||0
10739969|NCT02906670|11904045|FG001|NOT COMPLETED|Cohort 5P, Q2W||0
10739970|NCT02906670|11904046|FG002|NOT COMPLETED|Cohort 5P, Q2W||0
10739971|NCT02906670|11904047|FG003|NOT COMPLETED|Cohort 5P, Q2W||0
10739972|NCT02906670|11904048|FG004|NOT COMPLETED|Cohort 5P, Q2W||0
10739973|NCT02906670|11904049|FG005|NOT COMPLETED|Cohort 5P, Q2W||0
10739974|NCT02906670|11904050|FG006|NOT COMPLETED|Cohort 5P, Q2W||0
10739975|NCT02906670|11904051|FG007|NOT COMPLETED|Cohort 5P, Q2W||3
10739976|NCT02906670|11904052|FG008|NOT COMPLETED|Cohort 5P, Q2W||0
10739977|NCT02906670|11904053|FG009|NOT COMPLETED|Cohort 5P, Q2W||0
10739978|NCT02906670|11904044|FG000|STARTED|Cohort 6P, Q2W||0
10739979|NCT02906670|11904045|FG001|STARTED|Cohort 6P, Q2W||0
10739980|NCT02906670|11904046|FG002|STARTED|Cohort 6P, Q2W||0
10739981|NCT02906670|11904047|FG003|STARTED|Cohort 6P, Q2W||0
10739982|NCT02906670|11904048|FG004|STARTED|Cohort 6P, Q2W||0
10739983|NCT02906670|11904049|FG005|STARTED|Cohort 6P, Q2W||0
10739984|NCT02906670|11904050|FG006|STARTED|Cohort 6P, Q2W||0
10739985|NCT02906670|11904051|FG007|STARTED|Cohort 6P, Q2W||0
10739986|NCT02906670|11904052|FG008|STARTED|Cohort 6P, Q2W||4
10739987|NCT02906670|11904053|FG009|STARTED|Cohort 6P, Q2W||0
10739988|NCT02906670|11904044|FG000|COMPLETED|Cohort 6P, Q2W||0
10739989|NCT02906670|11904045|FG001|COMPLETED|Cohort 6P, Q2W||0
10739990|NCT02906670|11904046|FG002|COMPLETED|Cohort 6P, Q2W||0
10739991|NCT02906670|11904047|FG003|COMPLETED|Cohort 6P, Q2W||0
10739992|NCT02906670|11904048|FG004|COMPLETED|Cohort 6P, Q2W||0
10739993|NCT02906670|11904049|FG005|COMPLETED|Cohort 6P, Q2W||0
10739994|NCT02906670|11904050|FG006|COMPLETED|Cohort 6P, Q2W||0
10739995|NCT02906670|11904051|FG007|COMPLETED|Cohort 6P, Q2W||0
10739996|NCT02906670|11904052|FG008|COMPLETED|Cohort 6P, Q2W||0
10739997|NCT02906670|11904053|FG009|COMPLETED|Cohort 6P, Q2W||0
10739998|NCT02906670|11904044|FG000|NOT COMPLETED|Cohort 6P, Q2W||0
10739999|NCT02906670|11904045|FG001|NOT COMPLETED|Cohort 6P, Q2W||0
10740000|NCT02906670|11904046|FG002|NOT COMPLETED|Cohort 6P, Q2W||0
10740001|NCT02906670|11904047|FG003|NOT COMPLETED|Cohort 6P, Q2W||0
10740002|NCT02906670|11904048|FG004|NOT COMPLETED|Cohort 6P, Q2W||0
10740003|NCT02906670|11904049|FG005|NOT COMPLETED|Cohort 6P, Q2W||0
10740004|NCT02906670|11904050|FG006|NOT COMPLETED|Cohort 6P, Q2W||0
10740005|NCT02906670|11904051|FG007|NOT COMPLETED|Cohort 6P, Q2W||0
10740006|NCT02906670|11904052|FG008|NOT COMPLETED|Cohort 6P, Q2W||4
10740007|NCT02906670|11904053|FG009|NOT COMPLETED|Cohort 6P, Q2W||0
10740008|NCT02906670|11904044|FG000|STARTED|Cohort 4P, QW||0
10740009|NCT02906670|11904045|FG001|STARTED|Cohort 4P, QW||0
10740010|NCT02906670|11904046|FG002|STARTED|Cohort 4P, QW||0
10740011|NCT02906670|11904047|FG003|STARTED|Cohort 4P, QW||3
10740012|NCT02906670|11904048|FG004|STARTED|Cohort 4P, QW||0
10740013|NCT02906670|11904049|FG005|STARTED|Cohort 4P, QW||0
10740014|NCT02906670|11904050|FG006|STARTED|Cohort 4P, QW||0
10740015|NCT02906670|11904051|FG007|STARTED|Cohort 4P, QW||0
10740016|NCT02906670|11904052|FG008|STARTED|Cohort 4P, QW||0
10740017|NCT02906670|11904053|FG009|STARTED|Cohort 4P, QW||0
10740018|NCT02906670|11904044|FG000|COMPLETED|Cohort 4P, QW||0
10740019|NCT02906670|11904045|FG001|COMPLETED|Cohort 4P, QW||0
10740020|NCT02906670|11904046|FG002|COMPLETED|Cohort 4P, QW||0
10740021|NCT02906670|11904047|FG003|COMPLETED|Cohort 4P, QW||0
10740022|NCT02906670|11904048|FG004|COMPLETED|Cohort 4P, QW||0
10740023|NCT02906670|11904049|FG005|COMPLETED|Cohort 4P, QW||0
10740024|NCT02906670|11904050|FG006|COMPLETED|Cohort 4P, QW||0
10740025|NCT02906670|11904051|FG007|COMPLETED|Cohort 4P, QW||0
10740026|NCT02906670|11904052|FG008|COMPLETED|Cohort 4P, QW||0
10740027|NCT02906670|11904053|FG009|COMPLETED|Cohort 4P, QW||0
10740028|NCT02906670|11904044|FG000|NOT COMPLETED|Cohort 4P, QW||0
10740029|NCT02906670|11904045|FG001|NOT COMPLETED|Cohort 4P, QW||0
10740030|NCT02906670|11904046|FG002|NOT COMPLETED|Cohort 4P, QW||0
10740031|NCT02906670|11904047|FG003|NOT COMPLETED|Cohort 4P, QW||3
10740032|NCT02906670|11904048|FG004|NOT COMPLETED|Cohort 4P, QW||0
10740033|NCT02906670|11904049|FG005|NOT COMPLETED|Cohort 4P, QW||0
10740034|NCT02906670|11904050|FG006|NOT COMPLETED|Cohort 4P, QW||0
10740035|NCT02906670|11904051|FG007|NOT COMPLETED|Cohort 4P, QW||0
10740036|NCT02906670|11904052|FG008|NOT COMPLETED|Cohort 4P, QW||0
10740037|NCT02906670|11904053|FG009|NOT COMPLETED|Cohort 4P, QW||0
10740038|NCT02906670|11904044|FG000|STARTED|Cohort 7P, Q2W||0
10740039|NCT02906670|11904045|FG001|STARTED|Cohort 7P, Q2W||0
10740040|NCT02906670|11904046|FG002|STARTED|Cohort 7P, Q2W||0
10740041|NCT02906670|11904047|FG003|STARTED|Cohort 7P, Q2W||0
10740042|NCT02906670|11904048|FG004|STARTED|Cohort 7P, Q2W||0
10740043|NCT02906670|11904049|FG005|STARTED|Cohort 7P, Q2W||0
10740044|NCT02906670|11904050|FG006|STARTED|Cohort 7P, Q2W||0
10740045|NCT02906670|11904051|FG007|STARTED|Cohort 7P, Q2W||0
10740046|NCT02906670|11904052|FG008|STARTED|Cohort 7P, Q2W||0
10740047|NCT02906670|11904053|FG009|STARTED|Cohort 7P, Q2W||3
10740048|NCT02906670|11904044|FG000|COMPLETED|Cohort 7P, Q2W||0
10740049|NCT02906670|11904045|FG001|COMPLETED|Cohort 7P, Q2W||0
10740050|NCT02906670|11904046|FG002|COMPLETED|Cohort 7P, Q2W||0
10740051|NCT02906670|11904047|FG003|COMPLETED|Cohort 7P, Q2W||0
10740052|NCT02906670|11904048|FG004|COMPLETED|Cohort 7P, Q2W||0
10740053|NCT02906670|11904049|FG005|COMPLETED|Cohort 7P, Q2W||0
10740054|NCT02906670|11904050|FG006|COMPLETED|Cohort 7P, Q2W||0
10740055|NCT02906670|11904051|FG007|COMPLETED|Cohort 7P, Q2W||0
10740056|NCT02906670|11904052|FG008|COMPLETED|Cohort 7P, Q2W||0
10740057|NCT02906670|11904053|FG009|COMPLETED|Cohort 7P, Q2W||0
10740058|NCT02906670|11904044|FG000|NOT COMPLETED|Cohort 7P, Q2W||0
10740059|NCT02906670|11904045|FG001|NOT COMPLETED|Cohort 7P, Q2W||0
10740060|NCT02906670|11904046|FG002|NOT COMPLETED|Cohort 7P, Q2W||0
10740061|NCT02906670|11904047|FG003|NOT COMPLETED|Cohort 7P, Q2W||0
10740062|NCT02906670|11904048|FG004|NOT COMPLETED|Cohort 7P, Q2W||0
10740063|NCT02906670|11904049|FG005|NOT COMPLETED|Cohort 7P, Q2W||0
10740064|NCT02906670|11904050|FG006|NOT COMPLETED|Cohort 7P, Q2W||0
10740065|NCT02906670|11904051|FG007|NOT COMPLETED|Cohort 7P, Q2W||0
10740066|NCT02906670|11904052|FG008|NOT COMPLETED|Cohort 7P, Q2W||0
10740067|NCT02906670|11904053|FG009|NOT COMPLETED|Cohort 7P, Q2W||3
10740068|NCT02906670|11904044|FG000|STARTED|Cohort 5P, QW||0
10740069|NCT02906670|11904045|FG001|STARTED|Cohort 5P, QW||0
10740070|NCT02906670|11904046|FG002|STARTED|Cohort 5P, QW||0
10740071|NCT02906670|11904047|FG003|STARTED|Cohort 5P, QW||0
10740072|NCT02906670|11904048|FG004|STARTED|Cohort 5P, QW||3
10740073|NCT02906670|11904049|FG005|STARTED|Cohort 5P, QW||0
10740074|NCT02906670|11904050|FG006|STARTED|Cohort 5P, QW||0
10740075|NCT02906670|11904051|FG007|STARTED|Cohort 5P, QW||0
10740076|NCT02906670|11904052|FG008|STARTED|Cohort 5P, QW||0
10740077|NCT02906670|11904053|FG009|STARTED|Cohort 5P, QW||0
10740078|NCT02906670|11904044|FG000|COMPLETED|Cohort 5P, QW||0
10740079|NCT02906670|11904045|FG001|COMPLETED|Cohort 5P, QW||0
10740080|NCT02906670|11904046|FG002|COMPLETED|Cohort 5P, QW||0
10740081|NCT02906670|11904047|FG003|COMPLETED|Cohort 5P, QW||0
10740082|NCT02906670|11904048|FG004|COMPLETED|Cohort 5P, QW||0
10740083|NCT02906670|11904049|FG005|COMPLETED|Cohort 5P, QW||0
10740084|NCT02906670|11904050|FG006|COMPLETED|Cohort 5P, QW||0
10740085|NCT02906670|11904051|FG007|COMPLETED|Cohort 5P, QW||0
10740086|NCT02906670|11904052|FG008|COMPLETED|Cohort 5P, QW||0
10740087|NCT02906670|11904053|FG009|COMPLETED|Cohort 5P, QW||0
10740088|NCT02906670|11904044|FG000|NOT COMPLETED|Cohort 5P, QW||0
10740089|NCT02906670|11904045|FG001|NOT COMPLETED|Cohort 5P, QW||0
10740090|NCT02906670|11904046|FG002|NOT COMPLETED|Cohort 5P, QW||0
10740091|NCT02906670|11904047|FG003|NOT COMPLETED|Cohort 5P, QW||0
10740092|NCT02906670|11904048|FG004|NOT COMPLETED|Cohort 5P, QW||3
10740093|NCT02906670|11904049|FG005|NOT COMPLETED|Cohort 5P, QW||0
10740094|NCT02906670|11904050|FG006|NOT COMPLETED|Cohort 5P, QW||0
10740095|NCT02906670|11904051|FG007|NOT COMPLETED|Cohort 5P, QW||0
10740096|NCT02906670|11904052|FG008|NOT COMPLETED|Cohort 5P, QW||0
10740097|NCT02906670|11904053|FG009|NOT COMPLETED|Cohort 5P, QW||0
10740098|NCT02906696|11904103|FG000|STARTED|Overall Study||8
10740099|NCT02906696|11904103|FG000|COMPLETED|Overall Study||8
10740100|NCT02906696|11904103|FG000|NOT COMPLETED|Overall Study||0
10740101|NCT02906709|11904109|FG000|STARTED|Phase A (Week 0 to Week 16)||123
10740102|NCT02906709|11904110|FG001|STARTED|Phase A (Week 0 to Week 16)||61
10740103|NCT02906709|11904109|FG000|COMPLETED|Phase A (Week 0 to Week 16)||122
10740104|NCT02906709|11904110|FG001|COMPLETED|Phase A (Week 0 to Week 16)||58
10740105|NCT02906709|11904109|FG000|NOT COMPLETED|Phase A (Week 0 to Week 16)||1
10740106|NCT02906709|11904110|FG001|NOT COMPLETED|Phase A (Week 0 to Week 16)||3
10740107|NCT02906709|11904109|FG000|STARTED|Phase B (Extension, Week 17 to Week 52)||122
10740108|NCT02906709|11904110|FG001|STARTED|Phase B (Extension, Week 17 to Week 52)||58
10740109|NCT02906709|11904109|FG000|COMPLETED|Phase B (Extension, Week 17 to Week 52)||117
10740110|NCT02906709|11904110|FG001|COMPLETED|Phase B (Extension, Week 17 to Week 52)||58
10740111|NCT02906709|11904109|FG000|NOT COMPLETED|Phase B (Extension, Week 17 to Week 52)||5
10740112|NCT02906709|11904110|FG001|NOT COMPLETED|Phase B (Extension, Week 17 to Week 52)||0
10740113|NCT02906813|11904125|FG000|STARTED|Intervention Period 1 (3 Days)||3
10740114|NCT02906813|11904126|FG001|STARTED|Intervention Period 1 (3 Days)||3
10740115|NCT02906813|11904127|FG002|STARTED|Intervention Period 1 (3 Days)||3
10740116|NCT02906813|11904125|FG000|COMPLETED|Intervention Period 1 (3 Days)||3
10740117|NCT02906813|11904126|FG001|COMPLETED|Intervention Period 1 (3 Days)||3
10740118|NCT02906813|11904127|FG002|COMPLETED|Intervention Period 1 (3 Days)||3
10740119|NCT02906813|11904125|FG000|NOT COMPLETED|Intervention Period 1 (3 Days)||0
10740120|NCT02906813|11904126|FG001|NOT COMPLETED|Intervention Period 1 (3 Days)||0
10740121|NCT02906813|11904127|FG002|NOT COMPLETED|Intervention Period 1 (3 Days)||0
10740122|NCT02906813|11904125|FG000|STARTED|Washout Period 1 (at Least 3 Days)||3
10740123|NCT02906813|11904126|FG001|STARTED|Washout Period 1 (at Least 3 Days)||3
10740124|NCT02906813|11904127|FG002|STARTED|Washout Period 1 (at Least 3 Days)||3
10740125|NCT02906813|11904125|FG000|COMPLETED|Washout Period 1 (at Least 3 Days)||3
10740126|NCT02906813|11904126|FG001|COMPLETED|Washout Period 1 (at Least 3 Days)||3
10740127|NCT02906813|11904127|FG002|COMPLETED|Washout Period 1 (at Least 3 Days)||3
10740128|NCT02906813|11904125|FG000|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0
10740129|NCT02906813|11904126|FG001|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0
10740130|NCT02906813|11904127|FG002|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0
10740131|NCT02906813|11904125|FG000|STARTED|Intervention Period 2 (3 Days)||3
10740132|NCT02906813|11904126|FG001|STARTED|Intervention Period 2 (3 Days)||3
10740133|NCT02906813|11904127|FG002|STARTED|Intervention Period 2 (3 Days)||3
10740134|NCT02906813|11904125|FG000|COMPLETED|Intervention Period 2 (3 Days)||3
10740135|NCT02906813|11904126|FG001|COMPLETED|Intervention Period 2 (3 Days)||3
10740136|NCT02906813|11904127|FG002|COMPLETED|Intervention Period 2 (3 Days)||3
10740137|NCT02906813|11904125|FG000|NOT COMPLETED|Intervention Period 2 (3 Days)||0
10740138|NCT02906813|11904126|FG001|NOT COMPLETED|Intervention Period 2 (3 Days)||0
10740139|NCT02906813|11904127|FG002|NOT COMPLETED|Intervention Period 2 (3 Days)||0
10740140|NCT02906813|11904125|FG000|STARTED|Washout Period 2 (at Least 3 Days)||3
10740141|NCT02906813|11904126|FG001|STARTED|Washout Period 2 (at Least 3 Days)||3
10740142|NCT02906813|11904127|FG002|STARTED|Washout Period 2 (at Least 3 Days)||3
10740143|NCT02906813|11904125|FG000|COMPLETED|Washout Period 2 (at Least 3 Days)||3
10740144|NCT02906813|11904126|FG001|COMPLETED|Washout Period 2 (at Least 3 Days)||3
10740145|NCT02906813|11904127|FG002|COMPLETED|Washout Period 2 (at Least 3 Days)||3
10740146|NCT02906813|11904125|FG000|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0
10740147|NCT02906813|11904126|FG001|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0
10740148|NCT02906813|11904127|FG002|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0
10740149|NCT02906813|11904125|FG000|STARTED|Intervention Period 3 (3 Days)||3
10740150|NCT02906813|11904126|FG001|STARTED|Intervention Period 3 (3 Days)||3
10740151|NCT02906813|11904127|FG002|STARTED|Intervention Period 3 (3 Days)||3
10740152|NCT02906813|11904125|FG000|COMPLETED|Intervention Period 3 (3 Days)||3
10740153|NCT02906813|11904126|FG001|COMPLETED|Intervention Period 3 (3 Days)||3
10740154|NCT02906813|11904127|FG002|COMPLETED|Intervention Period 3 (3 Days)||3
10740155|NCT02906813|11904125|FG000|NOT COMPLETED|Intervention Period 3 (3 Days)||0
10740156|NCT02906813|11904126|FG001|NOT COMPLETED|Intervention Period 3 (3 Days)||0
10740157|NCT02906813|11904127|FG002|NOT COMPLETED|Intervention Period 3 (3 Days)||0
10740158|NCT02906917|11904137|FG000|STARTED|Initiation Period (Week 0-26)||267
10740159|NCT02906917|11904138|FG001|STARTED|Initiation Period (Week 0-26)||265
10740160|NCT02906917|11904137|FG000|Exposed|Initiation Period (Week 0-26)||265
10740161|NCT02906917|11904138|FG001|Exposed|Initiation Period (Week 0-26)||263
10740162|NCT02906917|11904137|FG000|COMPLETED|Initiation Period (Week 0-26)||261
10740163|NCT02906917|11904138|FG001|COMPLETED|Initiation Period (Week 0-26)||254
10740164|NCT02906917|11904137|FG000|NOT COMPLETED|Initiation Period (Week 0-26)||6
10740165|NCT02906917|11904138|FG001|NOT COMPLETED|Initiation Period (Week 0-26)||11
10740166|NCT02906917|11904137|FG000|STARTED|Intensification Period (Week 26-38)||261
10740167|NCT02906917|11904138|FG001|STARTED|Intensification Period (Week 26-38)||254
10740168|NCT02906917|11904137|FG000|COMPLETED|Intensification Period (Week 26-38)||252
10740169|NCT02906917|11904138|FG001|COMPLETED|Intensification Period (Week 26-38)||247
10740170|NCT02906917|11904137|FG000|NOT COMPLETED|Intensification Period (Week 26-38)||9
10740171|NCT02906917|11904138|FG001|NOT COMPLETED|Intensification Period (Week 26-38)||7
10740192|NCT02907073|11904164|FG000|STARTED|Overall Study||8
10740193|NCT02907073|11904165|FG001|STARTED|Overall Study||0
10740194|NCT02907073|11904166|FG002|STARTED|Overall Study||0
10740195|NCT02907073|11904164|FG000|COMPLETED|Overall Study||8
10740196|NCT02907073|11904165|FG001|COMPLETED|Overall Study||0
10740197|NCT02907073|11904166|FG002|COMPLETED|Overall Study||0
10740198|NCT02907073|11904164|FG000|NOT COMPLETED|Overall Study||0
10740199|NCT02907073|11904165|FG001|NOT COMPLETED|Overall Study||0
10740200|NCT02907073|11904166|FG002|NOT COMPLETED|Overall Study||0
10740201|NCT02907177|11904176|FG000|STARTED|Overall Study||68
10740202|NCT02907177|11904177|FG001|STARTED|Overall Study||68
10740203|NCT02907177|11904176|FG000|Treated|Overall Study||67
10740204|NCT02907177|11904177|FG001|Treated|Overall Study||68
10740205|NCT02907177|11904176|FG000|Randomized Analysis Set|Overall Study||68
10740206|NCT02907177|11904177|FG001|Randomized Analysis Set|Overall Study||68
10740207|NCT02907177|11904176|FG000|COMPLETED|Overall Study||0
10740208|NCT02907177|11904177|FG001|COMPLETED|Overall Study||0
10740209|NCT02907177|11904176|FG000|NOT COMPLETED|Overall Study||68
10740210|NCT02907177|11904177|FG001|NOT COMPLETED|Overall Study||68
10740211|NCT02907216|11904185|FG000|STARTED|Overall Study||147
10740212|NCT02907216|11904186|FG001|STARTED|Overall Study||145
10740213|NCT02907216|11904185|FG000|COMPLETED|Overall Study||146
10740214|NCT02907216|11904186|FG001|COMPLETED|Overall Study||144
10740215|NCT02907216|11904185|FG000|NOT COMPLETED|Overall Study||1
10740216|NCT02907216|11904186|FG001|NOT COMPLETED|Overall Study||1
10740217|NCT02907268|11904194|FG000|STARTED|Overall Study||5
10740218|NCT02907268|11904195|FG001|STARTED|Overall Study||5
10740219|NCT02907268|11904194|FG000|COMPLETED|Overall Study||5
10740220|NCT02907268|11904195|FG001|COMPLETED|Overall Study||5
10740221|NCT02907268|11904194|FG000|NOT COMPLETED|Overall Study||0
10740222|NCT02907268|11904195|FG001|NOT COMPLETED|Overall Study||0
10740223|NCT02907463|11904200|FG000|STARTED|Overall Study||280
10740224|NCT02907463|11904200|FG000|Enrolled Cohort|Overall Study||280
10740225|NCT02907463|11904200|FG000|Per Protocol Cohort|Overall Study||276
10740226|NCT02907463|11904200|FG000|COMPLETED|Overall Study||243
10740227|NCT02907463|11904200|FG000|NOT COMPLETED|Overall Study||37
10740228|NCT02907489|11904214|FG000|STARTED|Overall Study||42
10740229|NCT02907489|11904215|FG001|STARTED|Overall Study||42
10740230|NCT02907489|11904214|FG000|COMPLETED|Overall Study||40
10740231|NCT02907489|11904215|FG001|COMPLETED|Overall Study||41
10740232|NCT02907489|11904214|FG000|NOT COMPLETED|Overall Study||2
10740233|NCT02907489|11904215|FG001|NOT COMPLETED|Overall Study||1
10740234|NCT02907619|11904224|FG000|STARTED|Overall Study||19
10740235|NCT02907619|11904225|FG001|STARTED|Overall Study||20
10740236|NCT02907619|11904226|FG002|STARTED|Overall Study||20
10740237|NCT02907619|11904224|FG000|Received Treatment|Overall Study||19
10740238|NCT02907619|11904225|FG001|Received Treatment|Overall Study||20
10740239|NCT02907619|11904226|FG002|Received Treatment|Overall Study||20
10740240|NCT02907619|11904224|FG000|COMPLETED|Overall Study||0
10740241|NCT02907619|11904225|FG001|COMPLETED|Overall Study||0
10740242|NCT02907619|11904226|FG002|COMPLETED|Overall Study||0
10740243|NCT02907619|11904224|FG000|NOT COMPLETED|Overall Study||19
10740244|NCT02907619|11904225|FG001|NOT COMPLETED|Overall Study||20
10740245|NCT02907619|11904226|FG002|NOT COMPLETED|Overall Study||20
10740246|NCT02907814|11904238|FG000|STARTED|Overall Study||6
10740247|NCT02907814|11904239|FG001|STARTED|Overall Study||0
10740248|NCT02907814|11904238|FG000|COMPLETED|Overall Study||0
10740249|NCT02907814|11904239|FG001|COMPLETED|Overall Study||0
10740250|NCT02907814|11904238|FG000|NOT COMPLETED|Overall Study||6
10740251|NCT02907814|11904239|FG001|NOT COMPLETED|Overall Study||0
10740252|NCT02907892|11904247|FG000|STARTED|Overall Study||277
10740253|NCT02907892|11904248|FG001|STARTED|Overall Study||276
10740254|NCT02907892|11904247|FG000|COMPLETED|Overall Study||250
10740255|NCT02907892|11904248|FG001|COMPLETED|Overall Study||236
10740256|NCT02907892|11904247|FG000|NOT COMPLETED|Overall Study||27
10740257|NCT02907892|11904248|FG001|NOT COMPLETED|Overall Study||40
10740258|NCT02907918|11904254|FG000|STARTED|Overall Study||26
10740259|NCT02907918|11904254|FG000|COMPLETED|Overall Study||26
10740260|NCT02907918|11904254|FG000|NOT COMPLETED|Overall Study||0
10740261|NCT02908100|11904264|FG000|STARTED|Overall Study||86
10740262|NCT02908100|11904265|FG001|STARTED|Overall Study||87
10740263|NCT02908100|11904266|FG002|STARTED|Overall Study||87
10740264|NCT02908100|11904264|FG000|COMPLETED|Overall Study||63
10740265|NCT02908100|11904265|FG001|COMPLETED|Overall Study||66
10740266|NCT02908100|11904266|FG002|COMPLETED|Overall Study||66
10740267|NCT02908100|11904264|FG000|NOT COMPLETED|Overall Study||23
10740268|NCT02908100|11904265|FG001|NOT COMPLETED|Overall Study||21
10740269|NCT02908100|11904266|FG002|NOT COMPLETED|Overall Study||21
10740270|NCT02908178|11904280|FG000|STARTED|Overall Study|The sample prior to Mahalanobis matching.|2409
10740271|NCT02908178|11904281|FG001|STARTED|Overall Study|The sample prior to Mahalanobis matching.|13106
10740272|NCT02908178|11904282|FG002|STARTED|Overall Study|The sample prior to Mahalanobis matching.|1992
10740273|NCT02908178|11904283|FG003|STARTED|Overall Study|The sample prior to Mahalanobis matching.|10784
10740274|NCT02908178|11904280|FG000|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|2409
10740275|NCT02908178|11904281|FG001|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|4718
10816717|NCT01495988|11980308|FG002|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
10816718|NCT01495988|11980309|FG003|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
10816719|NCT01498991|11980319|FG000|STARTED|Overall Study||2
10816720|NCT01498991|11980319|FG000|COMPLETED|Overall Study||2
10816721|NCT01498991|11980319|FG000|NOT COMPLETED|Overall Study||0
10816722|NCT01497171|11980325|FG000|STARTED|Overall Study||2
10816723|NCT01497171|11980326|FG001|STARTED|Overall Study||3
10816724|NCT01497171|11980325|FG000|COMPLETED|Overall Study||2
10816725|NCT01497171|11980326|FG001|COMPLETED|Overall Study||3
10816726|NCT01497171|11980325|FG000|NOT COMPLETED|Overall Study||0
10816727|NCT01497171|11980326|FG001|NOT COMPLETED|Overall Study||0
10816728|NCT01483872|11980332|FG000|STARTED|Overall Study||0
10740276|NCT02908178|11904282|FG002|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|1992
10740277|NCT02908178|11904283|FG003|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|3965
10740278|NCT02908178|11904280|FG000|NOT COMPLETED|Overall Study||0
10740279|NCT02908178|11904281|FG001|NOT COMPLETED|Overall Study||8388
10740280|NCT02908178|11904282|FG002|NOT COMPLETED|Overall Study||0
10740281|NCT02908178|11904283|FG003|NOT COMPLETED|Overall Study||6819
10740282|NCT02908347|11904294|FG000|STARTED|Overall Study||23
10740283|NCT02908347|11904295|FG001|STARTED|Overall Study||23
10740284|NCT02908347|11904294|FG000|COMPLETED|Overall Study||22
10740285|NCT02908347|11904295|FG001|COMPLETED|Overall Study||22
10740286|NCT02908347|11904294|FG000|NOT COMPLETED|Overall Study||1
10740287|NCT02908347|11904295|FG001|NOT COMPLETED|Overall Study||1
10740288|NCT02908464|11904317|FG000|STARTED|Overall Study||22
10740289|NCT02908464|11904318|FG001|STARTED|Overall Study||23
10740290|NCT02908464|11904317|FG000|COMPLETED|Overall Study||20
10740291|NCT02908464|11904318|FG001|COMPLETED|Overall Study||20
10740292|NCT02908464|11904317|FG000|NOT COMPLETED|Overall Study||2
10740293|NCT02908464|11904318|FG001|NOT COMPLETED|Overall Study||3
10740294|NCT02908490|11904327|FG000|STARTED|Overall Study||12
10740295|NCT02908490|11904328|FG001|STARTED|Overall Study||13
10740296|NCT02908490|11904327|FG000|COMPLETED|Overall Study||10
10816729|NCT01483872|11980333|FG001|STARTED|Overall Study||1
10816730|NCT01483872|11980332|FG000|COMPLETED|Overall Study||0
10740297|NCT02908490|11904328|FG001|COMPLETED|Overall Study||11
10740298|NCT02908490|11904327|FG000|NOT COMPLETED|Overall Study||2
10740299|NCT02908490|11904328|FG001|NOT COMPLETED|Overall Study||2
10740300|NCT02908529|11904334|FG000|STARTED|Overall Study||10
10740301|NCT02908529|11904335|FG001|STARTED|Overall Study||12
10740302|NCT02908529|11904334|FG000|COMPLETED|Overall Study||10
10740303|NCT02908529|11904335|FG001|COMPLETED|Overall Study||10
10740304|NCT02908529|11904334|FG000|NOT COMPLETED|Overall Study||0
10740305|NCT02908529|11904335|FG001|NOT COMPLETED|Overall Study||2
10740306|NCT02908620|11904347|FG000|STARTED|Overall Study||10
10740307|NCT02908620|11904348|FG001|STARTED|Overall Study||10
10740308|NCT02908620|11904349|FG002|STARTED|Overall Study||10
10740309|NCT02908620|11904350|FG003|STARTED|Overall Study||10
10740310|NCT02908620|11904347|FG000|COMPLETED|Overall Study||10
10740311|NCT02908620|11904348|FG001|COMPLETED|Overall Study||10
10740312|NCT02908620|11904349|FG002|COMPLETED|Overall Study||10
10740313|NCT02908620|11904350|FG003|COMPLETED|Overall Study||10
10740314|NCT02908620|11904347|FG000|NOT COMPLETED|Overall Study||0
10740315|NCT02908620|11904348|FG001|NOT COMPLETED|Overall Study||0
10740316|NCT02908620|11904349|FG002|NOT COMPLETED|Overall Study||0
10740317|NCT02908620|11904350|FG003|NOT COMPLETED|Overall Study||0
10740318|NCT02908841|11904366|FG000|STARTED|Overall Study||10
10740319|NCT02908841|11904367|FG001|STARTED|Overall Study||12
10740320|NCT02908841|11904366|FG000|COMPLETED|Overall Study||6
10740321|NCT02908841|11904367|FG001|COMPLETED|Overall Study||12
10740322|NCT02908841|11904366|FG000|NOT COMPLETED|Overall Study||4
10740323|NCT02908841|11904367|FG001|NOT COMPLETED|Overall Study||0
10740324|NCT02908880|11904373|FG000|STARTED|Overall Study|Subjects within the Primary Analysis Cohort that received the MANTA Device|263
10740325|NCT02908880|11904373|FG000|COMPLETED|Overall Study|Subjects within the Primary Analysis Cohort that completed all follow-up time points.|236
10740326|NCT02908880|11904373|FG000|NOT COMPLETED|Overall Study||27
10740327|NCT02909101|11904379|FG000|STARTED|Overall Study||29
10740328|NCT02909101|11904380|FG001|STARTED|Overall Study||29
10740329|NCT02909101|11904379|FG000|COMPLETED|Overall Study||28
10740330|NCT02909101|11904380|FG001|COMPLETED|Overall Study||28
10740331|NCT02909101|11904379|FG000|NOT COMPLETED|Overall Study||1
10740332|NCT02909101|11904380|FG001|NOT COMPLETED|Overall Study||1
10740333|NCT02909140|11904389|FG000|STARTED|Overall Study||0
10740334|NCT02909140|11904390|FG001|STARTED|Overall Study||2
10740335|NCT02909140|11904391|FG002|STARTED|Overall Study||0
10740336|NCT02909140|11904389|FG000|COMPLETED|Overall Study||0
10740337|NCT02909140|11904390|FG001|COMPLETED|Overall Study||2
10740338|NCT02909140|11904391|FG002|COMPLETED|Overall Study||0
10740339|NCT02909140|11904389|FG000|NOT COMPLETED|Overall Study||0
10740340|NCT02909140|11904390|FG001|NOT COMPLETED|Overall Study||0
10740341|NCT02909140|11904391|FG002|NOT COMPLETED|Overall Study||0
10740342|NCT02909153|11904404|FG000|STARTED|Overall Study||6
10740343|NCT02909153|11904405|FG001|STARTED|Overall Study||6
10740344|NCT02909153|11904406|FG002|STARTED|Overall Study||6
10740345|NCT02909153|11904407|FG003|STARTED|Overall Study||6
10740346|NCT02909153|11904408|FG004|STARTED|Overall Study||6
10740347|NCT02909153|11904404|FG000|Triferic in Dianeal PD Solution|Overall Study||6
10740348|NCT02909153|11904405|FG001|Triferic in Dianeal PD Solution|Overall Study||6
10740349|NCT02909153|11904406|FG002|Triferic in Dianeal PD Solution|Overall Study||6
10740350|NCT02909153|11904407|FG003|Triferic in Dianeal PD Solution|Overall Study||0
10740351|NCT02909153|11904408|FG004|Triferic in Dianeal PD Solution|Overall Study||0
10740352|NCT02909153|11904404|FG000|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
10740353|NCT02909153|11904405|FG001|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||5
10740354|NCT02909153|11904406|FG002|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
10740355|NCT02909153|11904407|FG003|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
10740356|NCT02909153|11904408|FG004|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
10740357|NCT02909153|11904404|FG000|Triferic in Extraneal PD Solution|Overall Study||0
10740358|NCT02909153|11904405|FG001|Triferic in Extraneal PD Solution|Overall Study||0
10740359|NCT02909153|11904406|FG002|Triferic in Extraneal PD Solution|Overall Study||0
10740360|NCT02909153|11904407|FG003|Triferic in Extraneal PD Solution|Overall Study||6
10740361|NCT02909153|11904408|FG004|Triferic in Extraneal PD Solution|Overall Study||6
10740362|NCT02909153|11904404|FG000|COMPLETED|Overall Study||6
10740363|NCT02909153|11904405|FG001|COMPLETED|Overall Study||5
10740364|NCT02909153|11904406|FG002|COMPLETED|Overall Study||6
10740365|NCT02909153|11904407|FG003|COMPLETED|Overall Study||6
10740366|NCT02909153|11904408|FG004|COMPLETED|Overall Study||6
10740367|NCT02909153|11904404|FG000|NOT COMPLETED|Overall Study||0
10740368|NCT02909153|11904405|FG001|NOT COMPLETED|Overall Study||1
10740369|NCT02909153|11904406|FG002|NOT COMPLETED|Overall Study||0
10740370|NCT02909153|11904407|FG003|NOT COMPLETED|Overall Study||0
10740371|NCT02909153|11904408|FG004|NOT COMPLETED|Overall Study||0
10740372|NCT02909439|11904422|FG000|STARTED|Overall Study||31
10740373|NCT02909439|11904423|FG001|STARTED|Overall Study||31
10740374|NCT02909439|11904422|FG000|COMPLETED|Overall Study||31
10740375|NCT02909439|11904423|FG001|COMPLETED|Overall Study||31
10740376|NCT02909439|11904422|FG000|NOT COMPLETED|Overall Study||0
10740377|NCT02909439|11904423|FG001|NOT COMPLETED|Overall Study||0
10740378|NCT02909504|11904429|FG000|STARTED|Overall Study||24
10740379|NCT02909504|11904429|FG000|COMPLETED|Overall Study||12
10740380|NCT02909504|11904429|FG000|NOT COMPLETED|Overall Study||12
10740381|NCT02909764|11904436|FG000|STARTED|Overall Study||19
10740382|NCT02909764|11904437|FG001|STARTED|Overall Study||20
10740383|NCT02909764|11904436|FG000|COMPLETED|Overall Study||19
10740384|NCT02909764|11904437|FG001|COMPLETED|Overall Study||20
10740385|NCT02909764|11904436|FG000|NOT COMPLETED|Overall Study||0
10740386|NCT02909764|11904437|FG001|NOT COMPLETED|Overall Study||0
10740387|NCT02909907|11904448|FG000|STARTED|Overall Study||10
10740388|NCT02909907|11904449|FG001|STARTED|Overall Study||10
10740389|NCT02909907|11904448|FG000|COMPLETED|Overall Study||10
10740390|NCT02909907|11904449|FG001|COMPLETED|Overall Study||9
10740391|NCT02909907|11904448|FG000|NOT COMPLETED|Overall Study||0
10740392|NCT02909907|11904449|FG001|NOT COMPLETED|Overall Study||1
10740393|NCT02909959|11904457|FG000|STARTED|Overall Study||24
10740394|NCT02909959|11904458|FG001|STARTED|Overall Study||24
10740395|NCT02909959|11904457|FG000|COMPLETED|Overall Study||24
10740396|NCT02909959|11904458|FG001|COMPLETED|Overall Study||24
10740397|NCT02909959|11904457|FG000|NOT COMPLETED|Overall Study||0
10740398|NCT02909959|11904458|FG001|NOT COMPLETED|Overall Study||0
10740399|NCT02910011|11904464|FG000|STARTED|Overall Study||15
10740400|NCT02910011|11904464|FG000|COMPLETED|Overall Study||13
10740401|NCT02910011|11904464|FG000|NOT COMPLETED|Overall Study||2
10740402|NCT02910037|11904470|FG000|STARTED|Overall Study||214
10740403|NCT02910037|11904470|FG000|COMPLETED|Overall Study||204
10740404|NCT02910037|11904470|FG000|NOT COMPLETED|Overall Study||10
10740405|NCT02910063|11904490|FG000|STARTED|Phase 2||41
10740406|NCT02910063|11904491|FG001|STARTED|Phase 2|Participants in this Phase 3 arm were not included in the Phase 2 period.|0
10740407|NCT02910063|11904492|FG002|STARTED|Phase 2|Participants in this Phase 3 arm were not included in the Phase 2 period.|0
10740408|NCT02910063|11904490|FG000|Started Cycle 1|Phase 2||41
10740409|NCT02910063|11904491|FG001|Started Cycle 1|Phase 2||0
10740410|NCT02910063|11904492|FG002|Started Cycle 1|Phase 2||0
10740411|NCT02910063|11904490|FG000|Started Optional Cycle 2|Phase 2||4
10740412|NCT02910063|11904491|FG001|Started Optional Cycle 2|Phase 2||0
10740413|NCT02910063|11904492|FG002|Started Optional Cycle 2|Phase 2||0
10740414|NCT02910063|11904490|FG000|COMPLETED|Phase 2||13
10740415|NCT02910063|11904491|FG001|COMPLETED|Phase 2||0
10740416|NCT02910063|11904492|FG002|COMPLETED|Phase 2||0
10740417|NCT02910063|11904490|FG000|NOT COMPLETED|Phase 2||28
10740418|NCT02910063|11904491|FG001|NOT COMPLETED|Phase 2||0
10740419|NCT02910063|11904492|FG002|NOT COMPLETED|Phase 2||0
10740420|NCT02910063|11904490|FG000|STARTED|Phase 3|Participants in this Phase 2 arm were not included in the Phase 3 period.|0
10740421|NCT02910063|11904491|FG001|STARTED|Phase 3||0
10740422|NCT02910063|11904492|FG002|STARTED|Phase 3||0
10740423|NCT02910063|11904490|FG000|COMPLETED|Phase 3||0
10740424|NCT02910063|11904491|FG001|COMPLETED|Phase 3||0
10740425|NCT02910063|11904492|FG002|COMPLETED|Phase 3||0
10740426|NCT02910063|11904490|FG000|NOT COMPLETED|Phase 3||0
10740427|NCT02910063|11904491|FG001|NOT COMPLETED|Phase 3||0
10740428|NCT02910063|11904492|FG002|NOT COMPLETED|Phase 3||0
10740429|NCT02910089|11904503|FG000|STARTED|Overall Study|Patients allocated to intervention|700
10740430|NCT02910089|11904504|FG001|STARTED|Overall Study|Patients allocated to control|700
10740431|NCT02910089|11904503|FG000|COMPLETED|Overall Study|22 patients ineligible (3.1%)|678
10740432|NCT02910089|11904504|FG001|COMPLETED|Overall Study|16 Patients ineligible (2.3%)|684
10740433|NCT02910089|11904503|FG000|NOT COMPLETED|Overall Study||22
10740434|NCT02910089|11904504|FG001|NOT COMPLETED|Overall Study||16
10740435|NCT02910102|11904512|FG000|STARTED|Overall Study||21
10740436|NCT02910102|11904513|FG001|STARTED|Overall Study||17
10740437|NCT02910102|11904512|FG000|Safety Population|Overall Study||21
10740438|NCT02910102|11904513|FG001|Safety Population|Overall Study||17
10740439|NCT02910102|11904512|FG000|Intent to Treat (ITT) Population|Overall Study||21
10740440|NCT02910102|11904513|FG001|Intent to Treat (ITT) Population|Overall Study||17
10740441|NCT02910102|11904512|FG000|Per-Protocol Population|Overall Study||20
10740442|NCT02910102|11904513|FG001|Per-Protocol Population|Overall Study||17
10740443|NCT02910102|11904512|FG000|COMPLETED|Overall Study||21
10740444|NCT02910102|11904513|FG001|COMPLETED|Overall Study||17
10740445|NCT02910102|11904512|FG000|NOT COMPLETED|Overall Study||0
10740446|NCT02910102|11904513|FG001|NOT COMPLETED|Overall Study||0
10740447|NCT02910167|11904524|FG000|STARTED|Overall Study||360
10740448|NCT02910167|11904524|FG000|COMPLETED|Overall Study||341
10740449|NCT02910167|11904524|FG000|NOT COMPLETED|Overall Study||19
10740450|NCT02910362|11904530|FG000|STARTED|Overall Study||8
10740451|NCT02910362|11904531|FG001|STARTED|Overall Study||7
10740452|NCT02910362|11904530|FG000|COMPLETED|Overall Study||8
10740453|NCT02910362|11904531|FG001|COMPLETED|Overall Study||7
10740454|NCT02910362|11904530|FG000|NOT COMPLETED|Overall Study||0
10740455|NCT02910362|11904531|FG001|NOT COMPLETED|Overall Study||0
10740456|NCT02910466|11904537|FG000|STARTED|Overall Study||39
10740457|NCT02910466|11904537|FG000|Safety Set|Overall Study||39
10740458|NCT02910466|11904537|FG000|Treated|Overall Study||36
10740459|NCT02910466|11904537|FG000|COMPLETED|Overall Study||0
10740460|NCT02910466|11904537|FG000|NOT COMPLETED|Overall Study||39
10740461|NCT02910674|11904541|FG000|STARTED|Overall Study||102
10740462|NCT02910674|11904541|FG000|COMPLETED|Overall Study||102
10740463|NCT02910674|11904541|FG000|NOT COMPLETED|Overall Study||0
10740464|NCT02910713|11904546|FG000|STARTED|Overall Study||185
10740465|NCT02910713|11904546|FG000|Safety Population: Entered CAE|Overall Study||171
10740466|NCT02910713|11904546|FG000|COMPLETED|Overall Study|Completed=Completed both Intranasal and Extranasal applications.|143
10740467|NCT02910713|11904546|FG000|NOT COMPLETED|Overall Study||42
10740468|NCT02910739|11904553|FG000|STARTED|Overall Study||8
10740469|NCT02910739|11904554|FG001|STARTED|Overall Study||8
10740470|NCT02910739|11904555|FG002|STARTED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
10740471|NCT02910739|11904556|FG003|STARTED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
10740472|NCT02910739|11904553|FG000|COMPLETED|Overall Study||7
10740473|NCT02910739|11904554|FG001|COMPLETED|Overall Study||8
10740474|NCT02910739|11904555|FG002|COMPLETED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
10778152|NCT03350217|11940037|FG001|STARTED|Overall Study||81
10740475|NCT02910739|11904556|FG003|COMPLETED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
10740476|NCT02910739|11904553|FG000|NOT COMPLETED|Overall Study||1
10740477|NCT02910739|11904554|FG001|NOT COMPLETED|Overall Study||0
10740478|NCT02910739|11904555|FG002|NOT COMPLETED|Overall Study||0
10740479|NCT02910739|11904556|FG003|NOT COMPLETED|Overall Study||0
10740480|NCT02911025|11904562|FG000|STARTED|Overall Study||13
10740481|NCT02911025|11904562|FG000|COMPLETED|Overall Study||10
10740482|NCT02911025|11904562|FG000|NOT COMPLETED|Overall Study||3
10740483|NCT02911116|11904568|FG000|STARTED|Overall Study||5
10740484|NCT02911116|11904569|FG001|STARTED|Overall Study||3
10740485|NCT02911116|11904568|FG000|COMPLETED|Overall Study||4
10740486|NCT02911116|11904569|FG001|COMPLETED|Overall Study||2
10740487|NCT02911116|11904568|FG000|NOT COMPLETED|Overall Study||1
10740488|NCT02911116|11904569|FG001|NOT COMPLETED|Overall Study||1
10740489|NCT02911285|11904577|FG000|STARTED|Overall Study||49
10740490|NCT02911285|11904578|FG001|STARTED|Overall Study||41
10740491|NCT02911285|11904577|FG000|COMPLETED|Overall Study||40
10740492|NCT02911285|11904578|FG001|COMPLETED|Overall Study||36
10740493|NCT02911285|11904577|FG000|NOT COMPLETED|Overall Study||9
10740494|NCT02911285|11904578|FG001|NOT COMPLETED|Overall Study||5
10740495|NCT02911324|11904590|FG000|STARTED|Overall Study||9
10740496|NCT02911324|11904591|FG001|STARTED|Overall Study||7
10740497|NCT02911324|11904590|FG000|COMPLETED|Overall Study||6
10740498|NCT02911324|11904591|FG001|COMPLETED|Overall Study||6
10740499|NCT02911324|11904590|FG000|NOT COMPLETED|Overall Study||3
10740500|NCT02911324|11904591|FG001|NOT COMPLETED|Overall Study||1
10740501|NCT02911519|11904600|FG000|STARTED|Overall Study||90
10740502|NCT02911519|11904601|FG001|STARTED|Overall Study||86
10740503|NCT02911519|11904600|FG000|COMPLETED|Overall Study||88
10740504|NCT02911519|11904601|FG001|COMPLETED|Overall Study||82
10740505|NCT02911519|11904600|FG000|NOT COMPLETED|Overall Study||2
10740506|NCT02911519|11904601|FG001|NOT COMPLETED|Overall Study||4
10740507|NCT02911688|11904609|FG000|STARTED|First Intervention||9
10740508|NCT02911688|11904610|FG001|STARTED|First Intervention||9
10740509|NCT02911688|11904609|FG000|Received Intervention|First Intervention||9
10816731|NCT01483872|11980333|FG001|COMPLETED|Overall Study||1
10816732|NCT01483872|11980332|FG000|NOT COMPLETED|Overall Study||0
10816733|NCT01483872|11980333|FG001|NOT COMPLETED|Overall Study||0
10816734|NCT01487499|11980337|FG000|STARTED|Overall Study||4
10816735|NCT01487499|11980337|FG000|COMPLETED|Overall Study||4
10816736|NCT01487499|11980337|FG000|NOT COMPLETED|Overall Study||0
10816737|NCT01478113|11980343|FG000|STARTED|Overall Study||2
10816738|NCT01478113|11980344|FG001|STARTED|Overall Study||2
10816739|NCT01478113|11980343|FG000|COMPLETED|Overall Study||1
10816740|NCT01478113|11980344|FG001|COMPLETED|Overall Study||1
10816741|NCT01478113|11980343|FG000|NOT COMPLETED|Overall Study||1
10816742|NCT01478113|11980344|FG001|NOT COMPLETED|Overall Study||1
10816743|NCT01483209|11980352|FG000|STARTED|Overall Study||2
10816744|NCT01483209|11980352|FG000|COMPLETED|Overall Study||1
10816745|NCT01483209|11980352|FG000|NOT COMPLETED|Overall Study||1
10816746|NCT01484314|11980356|FG000|STARTED|Overall Study||1
10816747|NCT01484314|11980356|FG000|COMPLETED|Overall Study||1
10816748|NCT01484314|11980356|FG000|NOT COMPLETED|Overall Study||0
10816749|NCT01482598|11980362|FG000|STARTED|Overall Study||66
10816750|NCT01482598|11980363|FG001|STARTED|Overall Study||73
10816751|NCT01482598|11980362|FG000|COMPLETED|Overall Study||50
10816752|NCT01482598|11980363|FG001|COMPLETED|Overall Study||51
10816753|NCT01482598|11980362|FG000|NOT COMPLETED|Overall Study||16
10816754|NCT01482598|11980363|FG001|NOT COMPLETED|Overall Study||22
10816755|NCT01479010|11980369|FG000|STARTED|Overall Study||2
10816756|NCT01479010|11980369|FG000|COMPLETED|Overall Study||1
10816757|NCT01479010|11980369|FG000|NOT COMPLETED|Overall Study||1
10816758|NCT01482325|11980373|FG000|STARTED|Overall Study||31
10816759|NCT01482325|11980373|FG000|COMPLETED|Overall Study||31
10816760|NCT01482325|11980373|FG000|NOT COMPLETED|Overall Study||0
10816761|NCT01477177|11980377|FG000|STARTED|Overall Study||4
10816762|NCT01477177|11980377|FG000|COMPLETED|Overall Study||4
10816763|NCT01477177|11980377|FG000|NOT COMPLETED|Overall Study||0
10816764|NCT01473732|11980383|FG000|STARTED|Overall Study||2
10816765|NCT01473732|11980384|FG001|STARTED|Overall Study||0
10816766|NCT01473732|11980383|FG000|COMPLETED|Overall Study||0
10816767|NCT01473732|11980384|FG001|COMPLETED|Overall Study||0
10816768|NCT01473732|11980383|FG000|NOT COMPLETED|Overall Study||2
10816769|NCT01473732|11980384|FG001|NOT COMPLETED|Overall Study||0
10816770|NCT01472692|11980392|FG000|STARTED|Overall Study||0
10816771|NCT01472692|11980393|FG001|STARTED|Overall Study||0
10816772|NCT01472692|11980392|FG000|COMPLETED|Overall Study||0
10816773|NCT01472692|11980393|FG001|COMPLETED|Overall Study||0
10816774|NCT01472692|11980392|FG000|NOT COMPLETED|Overall Study||0
10816775|NCT01472692|11980393|FG001|NOT COMPLETED|Overall Study||0
10816776|NCT01465230|11980399|FG000|STARTED|Overall Study||2
10816777|NCT01465230|11980399|FG000|COMPLETED|Overall Study||0
10740510|NCT02911688|11904610|FG001|Received Intervention|First Intervention||9
10740511|NCT02911688|11904609|FG000|COMPLETED|First Intervention||9
10740512|NCT02911688|11904610|FG001|COMPLETED|First Intervention||9
10740513|NCT02911688|11904609|FG000|NOT COMPLETED|First Intervention||0
10816778|NCT01465230|11980399|FG000|NOT COMPLETED|Overall Study||2
10816779|NCT01464723|11980403|FG000|STARTED|Overall Study||0
10816780|NCT01464723|11980403|FG000|COMPLETED|Overall Study||0
10740514|NCT02911688|11904610|FG001|NOT COMPLETED|First Intervention||0
10740515|NCT02911688|11904609|FG000|STARTED|Washout||9
10816781|NCT01464723|11980403|FG000|NOT COMPLETED|Overall Study||0
10740516|NCT02911688|11904610|FG001|STARTED|Washout||9
10740517|NCT02911688|11904609|FG000|COMPLETED|Washout||8
10740518|NCT02911688|11904610|FG001|COMPLETED|Washout||7
10740519|NCT02911688|11904609|FG000|NOT COMPLETED|Washout||1
10740520|NCT02911688|11904610|FG001|NOT COMPLETED|Washout||2
10740521|NCT02911688|11904609|FG000|STARTED|Second Intervention||8
10740522|NCT02911688|11904610|FG001|STARTED|Second Intervention||7
10740523|NCT02911688|11904609|FG000|COMPLETED|Second Intervention||8
10740524|NCT02911688|11904610|FG001|COMPLETED|Second Intervention||7
10740525|NCT02911688|11904609|FG000|NOT COMPLETED|Second Intervention||0
10740526|NCT02911688|11904610|FG001|NOT COMPLETED|Second Intervention||0
10740527|NCT02911753|11904621|FG000|STARTED|Overall Study||21
10740528|NCT02911753|11904622|FG001|STARTED|Overall Study||19
10740529|NCT02911753|11904623|FG002|STARTED|Overall Study||10
10740530|NCT02911753|11904621|FG000|COMPLETED|Overall Study||18
10740531|NCT02911753|11904622|FG001|COMPLETED|Overall Study||16
10740532|NCT02911753|11904623|FG002|COMPLETED|Overall Study||10
10740533|NCT02911753|11904621|FG000|NOT COMPLETED|Overall Study||3
10740534|NCT02911753|11904622|FG001|NOT COMPLETED|Overall Study||3
10740535|NCT02911753|11904623|FG002|NOT COMPLETED|Overall Study||0
10740536|NCT02911818|11904652|FG000|STARTED|52 Week Study||50
10740537|NCT02911818|11904653|FG001|STARTED|52 Week Study||50
10740538|NCT02911818|11904654|FG002|STARTED|52 Week Study||50
10740539|NCT02911818|11904655|FG003|STARTED|52 Week Study||0
10740540|NCT02911818|11904656|FG004|STARTED|52 Week Study||0
10740541|NCT02911818|11904652|FG000|COMPLETED|52 Week Study||46
10740542|NCT02911818|11904653|FG001|COMPLETED|52 Week Study||45
10740543|NCT02911818|11904654|FG002|COMPLETED|52 Week Study||46
10740544|NCT02911818|11904655|FG003|COMPLETED|52 Week Study||0
10740545|NCT02911818|11904656|FG004|COMPLETED|52 Week Study||0
10740546|NCT02911818|11904652|FG000|NOT COMPLETED|52 Week Study||4
10740547|NCT02911818|11904653|FG001|NOT COMPLETED|52 Week Study||5
10740548|NCT02911818|11904654|FG002|NOT COMPLETED|52 Week Study||4
10740549|NCT02911818|11904655|FG003|NOT COMPLETED|52 Week Study||0
10740550|NCT02911818|11904656|FG004|NOT COMPLETED|52 Week Study||0
10740551|NCT02911818|11904652|FG000|STARTED|12 Week Extension Study||0
10740552|NCT02911818|11904653|FG001|STARTED|12 Week Extension Study||0
10740553|NCT02911818|11904654|FG002|STARTED|12 Week Extension Study||0
10740554|NCT02911818|11904655|FG003|STARTED|12 Week Extension Study||22
10740555|NCT02911818|11904656|FG004|STARTED|12 Week Extension Study||23
10740556|NCT02911818|11904652|FG000|COMPLETED|12 Week Extension Study||0
10740557|NCT02911818|11904653|FG001|COMPLETED|12 Week Extension Study||0
10740558|NCT02911818|11904654|FG002|COMPLETED|12 Week Extension Study||0
10740559|NCT02911818|11904655|FG003|COMPLETED|12 Week Extension Study||22
10740560|NCT02911818|11904656|FG004|COMPLETED|12 Week Extension Study||22
10740561|NCT02911818|11904652|FG000|NOT COMPLETED|12 Week Extension Study||0
10740562|NCT02911818|11904653|FG001|NOT COMPLETED|12 Week Extension Study||0
10740563|NCT02911818|11904654|FG002|NOT COMPLETED|12 Week Extension Study||0
10740564|NCT02911818|11904655|FG003|NOT COMPLETED|12 Week Extension Study||0
10740565|NCT02911818|11904656|FG004|NOT COMPLETED|12 Week Extension Study||1
10740566|NCT02911844|11904670|FG000|STARTED|Overall Study||5
10740567|NCT02911844|11904670|FG000|COMPLETED|Overall Study||5
10740568|NCT02911844|11904670|FG000|NOT COMPLETED|Overall Study||0
10740569|NCT02911857|11904677|FG000|STARTED|Overall Study||2
10740570|NCT02911857|11904678|FG001|STARTED|Overall Study||1
10740571|NCT02911857|11904679|FG002|STARTED|Overall Study||1
10740572|NCT02911857|11904677|FG000|COMPLETED|Overall Study||2
10740573|NCT02911857|11904678|FG001|COMPLETED|Overall Study||1
10740574|NCT02911857|11904679|FG002|COMPLETED|Overall Study||1
10740575|NCT02911857|11904677|FG000|NOT COMPLETED|Overall Study||0
10740576|NCT02911857|11904678|FG001|NOT COMPLETED|Overall Study||0
10740577|NCT02911857|11904679|FG002|NOT COMPLETED|Overall Study||0
10740578|NCT02911909|11904689|FG000|STARTED|Overall Study||4
10740579|NCT02911909|11904690|FG001|STARTED|Overall Study||3
10740580|NCT02911909|11904689|FG000|COMPLETED|Overall Study||2
10740581|NCT02911909|11904690|FG001|COMPLETED|Overall Study|No Data was obtained in the study group.|0
10740582|NCT02911909|11904689|FG000|NOT COMPLETED|Overall Study||2
10740583|NCT02911909|11904690|FG001|NOT COMPLETED|Overall Study||3
10740584|NCT02911922|11904698|FG000|STARTED|Overall Study||1
10740585|NCT02911922|11904699|FG001|STARTED|Overall Study||0
10740586|NCT02911922|11904698|FG000|COMPLETED|Overall Study||1
10740587|NCT02911922|11904699|FG001|COMPLETED|Overall Study||0
10740588|NCT02911922|11904698|FG000|NOT COMPLETED|Overall Study||0
10740589|NCT02911922|11904699|FG001|NOT COMPLETED|Overall Study||0
10740590|NCT02911948|11904709|FG000|STARTED|Overall Study||105
10740591|NCT02911948|11904710|FG001|STARTED|Overall Study||105
10740592|NCT02911948|11904709|FG000|COMPLETED|Overall Study||105
10740593|NCT02911948|11904710|FG001|COMPLETED|Overall Study||98
10740594|NCT02911948|11904709|FG000|NOT COMPLETED|Overall Study||0
10740595|NCT02911948|11904710|FG001|NOT COMPLETED|Overall Study||7
10740596|NCT02912195|11904718|FG000|STARTED|Overall Study||16
10740597|NCT02912195|11904719|FG001|STARTED|Overall Study||16
10740598|NCT02912195|11904718|FG000|COMPLETED|Overall Study||16
10740599|NCT02912195|11904719|FG001|COMPLETED|Overall Study||16
10740600|NCT02912195|11904718|FG000|NOT COMPLETED|Overall Study||0
10740601|NCT02912195|11904719|FG001|NOT COMPLETED|Overall Study||0
10740602|NCT02912364|11904725|FG000|STARTED|Treatment 1||23
10740603|NCT02912364|11904726|FG001|STARTED|Treatment 1||23
10740604|NCT02912364|11904725|FG000|Received Intervention|Treatment 1||18
10740605|NCT02912364|11904726|FG001|Received Intervention|Treatment 1||18
10740606|NCT02912364|11904725|FG000|COMPLETED|Treatment 1||13
10740607|NCT02912364|11904726|FG001|COMPLETED|Treatment 1||11
10740608|NCT02912364|11904725|FG000|NOT COMPLETED|Treatment 1||10
10740609|NCT02912364|11904726|FG001|NOT COMPLETED|Treatment 1||12
10740610|NCT02912364|11904725|FG000|STARTED|Washout Period||13
10740611|NCT02912364|11904726|FG001|STARTED|Washout Period||11
10740612|NCT02912364|11904725|FG000|COMPLETED|Washout Period||13
10740613|NCT02912364|11904726|FG001|COMPLETED|Washout Period||11
10740614|NCT02912364|11904725|FG000|NOT COMPLETED|Washout Period||0
10740615|NCT02912364|11904726|FG001|NOT COMPLETED|Washout Period||0
10740616|NCT02912364|11904725|FG000|STARTED|Treatment 2||13
10740617|NCT02912364|11904726|FG001|STARTED|Treatment 2||11
10740618|NCT02912364|11904725|FG000|Received Intervention|Treatment 2||12
10740619|NCT02912364|11904726|FG001|Received Intervention|Treatment 2||11
10740620|NCT02912364|11904725|FG000|COMPLETED|Treatment 2||12
10740621|NCT02912364|11904726|FG001|COMPLETED|Treatment 2||11
10740622|NCT02912364|11904725|FG000|NOT COMPLETED|Treatment 2||1
10740623|NCT02912364|11904726|FG001|NOT COMPLETED|Treatment 2||0
10740624|NCT02912455|11904737|FG000|STARTED|Overall Study||11
10740625|NCT02912455|11904738|FG001|STARTED|Overall Study||5
10740626|NCT02912455|11904737|FG000|COMPLETED|Overall Study||9
10740627|NCT02912455|11904738|FG001|COMPLETED|Overall Study||2
10740628|NCT02912455|11904737|FG000|NOT COMPLETED|Overall Study||2
10740629|NCT02912455|11904738|FG001|NOT COMPLETED|Overall Study||3
10740630|NCT02912468|11904746|FG000|STARTED|Overall Study||133
10740631|NCT02912468|11904747|FG001|STARTED|Overall Study||143
10740632|NCT02912468|11904746|FG000|Treated|Overall Study||133
10740633|NCT02912468|11904747|FG001|Treated|Overall Study||142
10740634|NCT02912468|11904746|FG000|Safety Population|Overall Study||132
10740635|NCT02912468|11904747|FG001|Safety Population|Overall Study||143
10740636|NCT02912468|11904746|FG000|COMPLETED|Overall Study||124
10740637|NCT02912468|11904747|FG001|COMPLETED|Overall Study||138
10740638|NCT02912468|11904746|FG000|NOT COMPLETED|Overall Study||9
10740639|NCT02912468|11904747|FG001|NOT COMPLETED|Overall Study||5
10740640|NCT02912650|11904758|FG000|STARTED|Overall Study||56
10740641|NCT02912650|11904759|FG001|STARTED|Overall Study||172
10740642|NCT02912650|11904760|FG002|STARTED|Overall Study||175
10740643|NCT02912650|11904761|FG003|STARTED|Overall Study||165
10740644|NCT02912650|11904758|FG000|COMPLETED|Overall Study||55
10740645|NCT02912650|11904759|FG001|COMPLETED|Overall Study||172
10740646|NCT02912650|11904760|FG002|COMPLETED|Overall Study||173
10740647|NCT02912650|11904761|FG003|COMPLETED|Overall Study||160
10740648|NCT02912650|11904758|FG000|NOT COMPLETED|Overall Study||1
10740649|NCT02912650|11904759|FG001|NOT COMPLETED|Overall Study||0
10740650|NCT02912650|11904760|FG002|NOT COMPLETED|Overall Study||2
10740651|NCT02912650|11904761|FG003|NOT COMPLETED|Overall Study||5
10740652|NCT02913105|11904774|FG000|STARTED|Overall Study||37
10740653|NCT02913105|11904775|FG001|STARTED|Overall Study||44
10740654|NCT02913105|11904776|FG002|STARTED|Overall Study||40
10740655|NCT02913105|11904774|FG000|COMPLETED|Overall Study||22
10740656|NCT02913105|11904775|FG001|COMPLETED|Overall Study||39
10740657|NCT02913105|11904776|FG002|COMPLETED|Overall Study||33
10740658|NCT02913105|11904774|FG000|NOT COMPLETED|Overall Study||15
10740659|NCT02913105|11904775|FG001|NOT COMPLETED|Overall Study||5
10740660|NCT02913105|11904776|FG002|NOT COMPLETED|Overall Study||7
10740661|NCT02913326|11904787|FG000|STARTED|Overall Study||60
10740662|NCT02913326|11904788|FG001|STARTED|Overall Study||60
10740663|NCT02913326|11904787|FG000|COMPLETED|Overall Study||59
10740664|NCT02913326|11904788|FG001|COMPLETED|Overall Study||58
10740665|NCT02913326|11904787|FG000|NOT COMPLETED|Overall Study||1
10740666|NCT02913326|11904788|FG001|NOT COMPLETED|Overall Study||2
10740667|NCT02913521|11904797|FG000|STARTED|Overall Study||316
10740668|NCT02913521|11904798|FG001|STARTED|Overall Study||312
10740669|NCT02913521|11904799|FG002|STARTED|Overall Study||306
10740670|NCT02913521|11904797|FG000|COMPLETED|Overall Study||263
10740671|NCT02913521|11904798|FG001|COMPLETED|Overall Study||262
10740672|NCT02913521|11904799|FG002|COMPLETED|Overall Study||261
10740673|NCT02913521|11904797|FG000|NOT COMPLETED|Overall Study||53
10740674|NCT02913521|11904798|FG001|NOT COMPLETED|Overall Study||50
10740675|NCT02913521|11904799|FG002|NOT COMPLETED|Overall Study||45
10740676|NCT02913924|11904809|FG000|STARTED|Overall Study||34
10740677|NCT02913924|11904810|FG001|STARTED|Overall Study||34
10740678|NCT02913924|11904809|FG000|COMPLETED|Overall Study||21
10740679|NCT02913924|11904810|FG001|COMPLETED|Overall Study||21
10740680|NCT02913924|11904809|FG000|NOT COMPLETED|Overall Study||13
10740681|NCT02913924|11904810|FG001|NOT COMPLETED|Overall Study||13
10816782|NCT01446250|11980407|FG000|STARTED|Treatment Period 1||5
10740682|NCT02914119|11904816|FG000|STARTED|Overall Study||30430
10740683|NCT02914119|11904816|FG000|COMPLETED|Overall Study||30430
10740684|NCT02914119|11904816|FG000|NOT COMPLETED|Overall Study||0
10740685|NCT02914132|11904820|FG000|STARTED|Overall Study||15
10740686|NCT02914132|11904820|FG000|COMPLETED|Overall Study||15
10740687|NCT02914132|11904820|FG000|NOT COMPLETED|Overall Study||0
10740688|NCT02914184|11904828|FG000|STARTED|Overall Study||400
10740689|NCT02914184|11904829|FG001|STARTED|Overall Study||396
10740690|NCT02914184|11904830|FG002|STARTED|Overall Study||402
10740691|NCT02914184|11904831|FG003|STARTED|Overall Study||402
10740692|NCT02914184|11904828|FG000|COMPLETED|Overall Study||386
10740693|NCT02914184|11904829|FG001|COMPLETED|Overall Study||383
10740694|NCT02914184|11904830|FG002|COMPLETED|Overall Study||385
10740695|NCT02914184|11904831|FG003|COMPLETED|Overall Study||391
10740696|NCT02914184|11904828|FG000|NOT COMPLETED|Overall Study||14
10740697|NCT02914184|11904829|FG001|NOT COMPLETED|Overall Study||13
10740698|NCT02914184|11904830|FG002|NOT COMPLETED|Overall Study||17
10740699|NCT02914184|11904831|FG003|NOT COMPLETED|Overall Study||11
10740700|NCT02914210|11904845|FG000|STARTED|Overall Study||153
10740701|NCT02914210|11904846|FG001|STARTED|Overall Study||153
10740702|NCT02914210|11904845|FG000|COMPLETED|Overall Study||143
10740703|NCT02914210|11904846|FG001|COMPLETED|Overall Study||144
10740704|NCT02914210|11904845|FG000|NOT COMPLETED|Overall Study||10
10740705|NCT02914210|11904846|FG001|NOT COMPLETED|Overall Study||9
10740706|NCT02914236|11904852|FG000|STARTED|Overall Study||50
10740707|NCT02914236|11904852|FG000|4-week Follow-up Visit|Overall Study||50
10740708|NCT02914236|11904852|FG000|12-week Follow-up Visit|Overall Study||50
10740709|NCT02914236|11904852|FG000|26-week Follow-up Visit|Overall Study||49
10740710|NCT02914236|11904852|FG000|COMPLETED|Overall Study||49
10740711|NCT02914236|11904852|FG000|NOT COMPLETED|Overall Study||1
10740712|NCT02914275|11904858|FG000|STARTED|Overall Study||1687
10740713|NCT02914275|11904859|FG001|STARTED|Overall Study||563
10740714|NCT02914275|11904858|FG000|Included in Clinical Database / FAS|Overall Study||1684
10740715|NCT02914275|11904859|FG001|Included in Clinical Database / FAS|Overall Study||563
10740716|NCT02914275|11904858|FG000|COMPLETED|Overall Study||1566
10740717|NCT02914275|11904859|FG001|COMPLETED|Overall Study||521
10740718|NCT02914275|11904858|FG000|NOT COMPLETED|Overall Study||121
10740719|NCT02914275|11904859|FG001|NOT COMPLETED|Overall Study||42
10740720|NCT02914457|11904869|FG000|STARTED|Overall Study||31
10740721|NCT02914457|11904869|FG000|COMPLETED|Overall Study|Subjects who completed electrophysiological study with analyzable data|25
10740722|NCT02914457|11904869|FG000|NOT COMPLETED|Overall Study||6
10740723|NCT02914509|11904875|FG000|STARTED|Overall Study||348
10740724|NCT02914509|11904876|FG001|STARTED|Overall Study||217
10740725|NCT02914509|11904875|FG000|COMPLETED|Overall Study||343
10740726|NCT02914509|11904876|FG001|COMPLETED|Overall Study||211
10740727|NCT02914509|11904875|FG000|NOT COMPLETED|Overall Study||5
10740728|NCT02914509|11904876|FG001|NOT COMPLETED|Overall Study||6
10740729|NCT02914522|11904890|FG000|STARTED|Induction Study: Up to Week 11||245
10740730|NCT02914522|11904891|FG001|STARTED|Induction Study: Up to Week 11||278
10740731|NCT02914522|11904892|FG002|STARTED|Induction Study: Up to Week 11||137
10740732|NCT02914522|11904893|FG003|STARTED|Induction Study: Up to Week 11||262
10740733|NCT02914522|11904894|FG004|STARTED|Induction Study: Up to Week 11||286
10740734|NCT02914522|11904895|FG005|STARTED|Induction Study: Up to Week 11||143
10740735|NCT02914522|11904896|FG006|STARTED|Induction Study: Up to Week 11||0
10740736|NCT02914522|11904897|FG007|STARTED|Induction Study: Up to Week 11||0
10740737|NCT02914522|11904898|FG008|STARTED|Induction Study: Up to Week 11||0
10740738|NCT02914522|11904899|FG009|STARTED|Induction Study: Up to Week 11||0
10740739|NCT02914522|11904900|FG010|STARTED|Induction Study: Up to Week 11||0
10740740|NCT02914522|11904890|FG000|COMPLETED|Induction Study: Up to Week 11||235
10740741|NCT02914522|11904891|FG001|COMPLETED|Induction Study: Up to Week 11||256
10740742|NCT02914522|11904892|FG002|COMPLETED|Induction Study: Up to Week 11||127
10740743|NCT02914522|11904893|FG003|COMPLETED|Induction Study: Up to Week 11||234
10740744|NCT02914522|11904894|FG004|COMPLETED|Induction Study: Up to Week 11||262
10740745|NCT02914522|11904895|FG005|COMPLETED|Induction Study: Up to Week 11||127
10740746|NCT02914522|11904896|FG006|COMPLETED|Induction Study: Up to Week 11||0
10740747|NCT02914522|11904897|FG007|COMPLETED|Induction Study: Up to Week 11||0
10740748|NCT02914522|11904898|FG008|COMPLETED|Induction Study: Up to Week 11||0
10740749|NCT02914522|11904899|FG009|COMPLETED|Induction Study: Up to Week 11||0
10740750|NCT02914522|11904900|FG010|COMPLETED|Induction Study: Up to Week 11||0
10740751|NCT02914522|11904890|FG000|NOT COMPLETED|Induction Study: Up to Week 11||10
10740752|NCT02914522|11904891|FG001|NOT COMPLETED|Induction Study: Up to Week 11||22
10740753|NCT02914522|11904892|FG002|NOT COMPLETED|Induction Study: Up to Week 11||10
10740754|NCT02914522|11904893|FG003|NOT COMPLETED|Induction Study: Up to Week 11||28
10740755|NCT02914522|11904894|FG004|NOT COMPLETED|Induction Study: Up to Week 11||24
10740756|NCT02914522|11904895|FG005|NOT COMPLETED|Induction Study: Up to Week 11||16
10740757|NCT02914522|11904896|FG006|NOT COMPLETED|Induction Study: Up to Week 11||0
10740758|NCT02914522|11904897|FG007|NOT COMPLETED|Induction Study: Up to Week 11||0
10740759|NCT02914522|11904898|FG008|NOT COMPLETED|Induction Study: Up to Week 11||0
10740760|NCT02914522|11904899|FG009|NOT COMPLETED|Induction Study: Up to Week 11||0
10740761|NCT02914522|11904900|FG010|NOT COMPLETED|Induction Study: Up to Week 11||0
10740762|NCT02914522|11904890|FG000|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|0
10740763|NCT02914522|11904891|FG001|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|0
10740764|NCT02914522|11904892|FG002|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|0
10740765|NCT02914522|11904893|FG003|STARTED|Maintenance Study: Week 11 to Week 58||0
10740766|NCT02914522|11904894|FG004|STARTED|Maintenance Study: Week 11 to Week 58||0
10740767|NCT02914522|11904895|FG005|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|0
10740768|NCT02914522|11904896|FG006|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|202
10740769|NCT02914522|11904897|FG007|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|99
10740770|NCT02914522|11904898|FG008|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|179
10740771|NCT02914522|11904899|FG009|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|91
10740772|NCT02914522|11904900|FG010|STARTED|Maintenance Study: Week 11 to Week 58||93
10740773|NCT02914522|11904890|FG000|COMPLETED|Maintenance Study: Week 11 to Week 58||0
10740774|NCT02914522|11904891|FG001|COMPLETED|Maintenance Study: Week 11 to Week 58||0
10740775|NCT02914522|11904892|FG002|COMPLETED|Maintenance Study: Week 11 to Week 58||0
10740776|NCT02914522|11904893|FG003|COMPLETED|Maintenance Study: Week 11 to Week 58||0
10740777|NCT02914522|11904894|FG004|COMPLETED|Maintenance Study: Week 11 to Week 58||0
10740778|NCT02914522|11904895|FG005|COMPLETED|Maintenance Study: Week 11 to Week 58||0
10740779|NCT02914522|11904896|FG006|COMPLETED|Maintenance Study: Week 11 to Week 58||150
10740780|NCT02914522|11904897|FG007|COMPLETED|Maintenance Study: Week 11 to Week 58||41
10740781|NCT02914522|11904898|FG008|COMPLETED|Maintenance Study: Week 11 to Week 58||104
10740782|NCT02914522|11904899|FG009|COMPLETED|Maintenance Study: Week 11 to Week 58||42
10740783|NCT02914522|11904900|FG010|COMPLETED|Maintenance Study: Week 11 to Week 58||64
10740784|NCT02914522|11904890|FG000|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0
10740785|NCT02914522|11904891|FG001|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0
10740786|NCT02914522|11904892|FG002|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0
10740787|NCT02914522|11904893|FG003|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0
10740788|NCT02914522|11904894|FG004|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0
10740789|NCT02914522|11904895|FG005|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0
10740790|NCT02914522|11904896|FG006|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||52
10740791|NCT02914522|11904897|FG007|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||58
10740792|NCT02914522|11904898|FG008|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||75
10740793|NCT02914522|11904899|FG009|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||49
10740794|NCT02914522|11904900|FG010|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||29
10740795|NCT02914548|11904930|FG000|STARTED|Overall Study||67
10740796|NCT02914548|11904931|FG001|STARTED|Overall Study||67
10740797|NCT02914548|11904932|FG002|STARTED|Overall Study||66
10740798|NCT02914548|11904930|FG000|COMPLETED|Overall Study||46
10740799|NCT02914548|11904931|FG001|COMPLETED|Overall Study||53
10740800|NCT02914548|11904932|FG002|COMPLETED|Overall Study||46
10816783|NCT01446250|11980408|FG001|STARTED|Treatment Period 1||3
10816784|NCT01446250|11980409|FG002|STARTED|Treatment Period 1||0
10816785|NCT01446250|11980410|FG003|STARTED|Treatment Period 1||0
10816786|NCT01446250|11980407|FG000|COMPLETED|Treatment Period 1||5
10816787|NCT01446250|11980408|FG001|COMPLETED|Treatment Period 1||2
10816788|NCT01446250|11980409|FG002|COMPLETED|Treatment Period 1||0
10816789|NCT01446250|11980410|FG003|COMPLETED|Treatment Period 1||0
10816790|NCT01446250|11980407|FG000|NOT COMPLETED|Treatment Period 1||0
10816791|NCT01446250|11980408|FG001|NOT COMPLETED|Treatment Period 1||1
10816792|NCT01446250|11980409|FG002|NOT COMPLETED|Treatment Period 1||0
10816793|NCT01446250|11980410|FG003|NOT COMPLETED|Treatment Period 1||0
10816794|NCT01446250|11980407|FG000|STARTED|Clinical Hold||0
10816795|NCT01446250|11980408|FG001|STARTED|Clinical Hold||2
10816796|NCT01446250|11980409|FG002|STARTED|Clinical Hold||5
10816797|NCT01446250|11980410|FG003|STARTED|Clinical Hold||0
10816798|NCT01446250|11980407|FG000|COMPLETED|Clinical Hold||0
10816799|NCT01446250|11980408|FG001|COMPLETED|Clinical Hold||2
10816800|NCT01446250|11980409|FG002|COMPLETED|Clinical Hold||5
10816801|NCT01446250|11980410|FG003|COMPLETED|Clinical Hold||0
10816802|NCT01446250|11980407|FG000|NOT COMPLETED|Clinical Hold||0
10816803|NCT01446250|11980408|FG001|NOT COMPLETED|Clinical Hold||0
10816804|NCT01446250|11980409|FG002|NOT COMPLETED|Clinical Hold||0
10816805|NCT01446250|11980410|FG003|NOT COMPLETED|Clinical Hold||0
10816806|NCT01446250|11980407|FG000|STARTED|Treatment Period 2||0
10816807|NCT01446250|11980408|FG001|STARTED|Treatment Period 2||7
10816808|NCT01446250|11980409|FG002|STARTED|Treatment Period 2||0
10816809|NCT01446250|11980410|FG003|STARTED|Treatment Period 2||0
10816810|NCT01446250|11980407|FG000|COMPLETED|Treatment Period 2||0
10816811|NCT01446250|11980408|FG001|COMPLETED|Treatment Period 2||6
10816812|NCT01446250|11980409|FG002|COMPLETED|Treatment Period 2||0
10816813|NCT01446250|11980410|FG003|COMPLETED|Treatment Period 2||0
10816814|NCT01446250|11980407|FG000|NOT COMPLETED|Treatment Period 2||0
10816815|NCT01446250|11980408|FG001|NOT COMPLETED|Treatment Period 2||1
10816816|NCT01446250|11980409|FG002|NOT COMPLETED|Treatment Period 2||0
10816817|NCT01446250|11980410|FG003|NOT COMPLETED|Treatment Period 2||0
10816818|NCT01446250|11980407|FG000|STARTED|Follow-up||0
10816819|NCT01446250|11980408|FG001|STARTED|Follow-up||0
10816820|NCT01446250|11980409|FG002|STARTED|Follow-up||0
10816821|NCT01446250|11980410|FG003|STARTED|Follow-up||6
10816822|NCT01446250|11980407|FG000|COMPLETED|Follow-up||0
10816823|NCT01446250|11980408|FG001|COMPLETED|Follow-up||0
10816824|NCT01446250|11980409|FG002|COMPLETED|Follow-up||0
10816825|NCT01446250|11980410|FG003|COMPLETED|Follow-up||0
10816826|NCT01446250|11980407|FG000|NOT COMPLETED|Follow-up||0
10816827|NCT01446250|11980408|FG001|NOT COMPLETED|Follow-up||0
10816828|NCT01446250|11980409|FG002|NOT COMPLETED|Follow-up||0
10816829|NCT01446250|11980410|FG003|NOT COMPLETED|Follow-up||6
10816830|NCT01463293|11980421|FG000|STARTED|Overall Study||74
10816831|NCT01463293|11980422|FG001|STARTED|Overall Study||79
10816832|NCT01463293|11980423|FG002|STARTED|Overall Study||71
10816833|NCT01463293|11980421|FG000|COMPLETED|Overall Study||68
10816834|NCT01463293|11980422|FG001|COMPLETED|Overall Study||63
10816835|NCT01463293|11980423|FG002|COMPLETED|Overall Study||59
10816836|NCT01463293|11980421|FG000|NOT COMPLETED|Overall Study||6
10816837|NCT01463293|11980422|FG001|NOT COMPLETED|Overall Study||16
10816838|NCT01463293|11980423|FG002|NOT COMPLETED|Overall Study||12
10816839|NCT01457053|11980431|FG000|STARTED|Overall Study||2
10816840|NCT01457053|11980432|FG001|STARTED|Overall Study||2
10740801|NCT02914548|11904930|FG000|NOT COMPLETED|Overall Study||21
10740802|NCT02914548|11904931|FG001|NOT COMPLETED|Overall Study||14
10740803|NCT02914548|11904932|FG002|NOT COMPLETED|Overall Study||20
10740804|NCT02914795|11904942|FG000|STARTED|Overall Study||77
10740805|NCT02914795|11904943|FG001|STARTED|Overall Study||22
10740806|NCT02914795|11904942|FG000|COMPLETED|Overall Study||77
10740807|NCT02914795|11904943|FG001|COMPLETED|Overall Study||22
10740808|NCT02914795|11904942|FG000|NOT COMPLETED|Overall Study||0
10740809|NCT02914795|11904943|FG001|NOT COMPLETED|Overall Study||0
10740810|NCT02914834|11904953|FG000|STARTED|Overall Study||12
10740811|NCT02914834|11904954|FG001|STARTED|Overall Study||15
10740812|NCT02914834|11904953|FG000|COMPLETED|Overall Study||11
10740813|NCT02914834|11904954|FG001|COMPLETED|Overall Study||13
10740814|NCT02914834|11904953|FG000|NOT COMPLETED|Overall Study||1
10740815|NCT02914834|11904954|FG001|NOT COMPLETED|Overall Study||2
10740816|NCT02915029|11904962|FG000|STARTED|Overall Study||63
10740817|NCT02915029|11904963|FG001|STARTED|Overall Study||62
10740818|NCT02915029|11904962|FG000|COMPLETED|Overall Study||50
10740819|NCT02915029|11904963|FG001|COMPLETED|Overall Study||48
10740820|NCT02915029|11904962|FG000|NOT COMPLETED|Overall Study||13
10740821|NCT02915029|11904963|FG001|NOT COMPLETED|Overall Study||14
10740822|NCT02915159|11904971|FG000|STARTED|Overall Study||92
10740823|NCT02915159|11904972|FG001|STARTED|Overall Study||95
10740824|NCT02915159|11904971|FG000|COMPLETED|Overall Study||81
10740825|NCT02915159|11904972|FG001|COMPLETED|Overall Study||87
10740826|NCT02915159|11904971|FG000|NOT COMPLETED|Overall Study||11
10740827|NCT02915159|11904972|FG001|NOT COMPLETED|Overall Study||8
10778153|NCT03350217|11940036|FG000|COMPLETED|Overall Study||77
10778154|NCT03350217|11940037|FG001|COMPLETED|Overall Study||81
10778155|NCT03350217|11940036|FG000|NOT COMPLETED|Overall Study||2
10778156|NCT03350217|11940037|FG001|NOT COMPLETED|Overall Study||0
10778157|NCT03350256|11940043|FG000|STARTED|Overall Study||60
10778158|NCT03350256|11940043|FG000|Spinal Cord Stimulation Trial|Overall Study|Subject that underwent SCS trial|50
10778159|NCT03350256|11940043|FG000|Permanent Implant|Overall Study|subjects that underwent permanent SCS implant|35
10778160|NCT03350256|11940043|FG000|1 Month Follow up|Overall Study||30
10778161|NCT03350256|11940043|FG000|3 Month Follow up|Overall Study||27
10778162|NCT03350256|11940043|FG000|6 Month Follow up|Overall Study||24
10778163|NCT03350256|11940043|FG000|COMPLETED|Overall Study||24
10778164|NCT03350256|11940043|FG000|NOT COMPLETED|Overall Study||36
10778165|NCT03350542|11940047|FG000|STARTED|Overall Study||100
10778166|NCT03350542|11940047|FG000|Completed 12-Month Clinical F/U|Overall Study||96
10778167|NCT03350542|11940047|FG000|Death With no 12-month F/U|Overall Study||4
10778168|NCT03350542|11940047|FG000|COMPLETED|Overall Study||96
10778169|NCT03350542|11940047|FG000|NOT COMPLETED|Overall Study||4
10778170|NCT03350672|11940054|FG000|STARTED|Overall Study||17
10778171|NCT03350672|11940055|FG001|STARTED|Overall Study||10
10778172|NCT03350672|11940056|FG002|STARTED|Overall Study||10
10778173|NCT03350672|11940054|FG000|COMPLETED|Overall Study||10
10778174|NCT03350672|11940055|FG001|COMPLETED|Overall Study||10
10778175|NCT03350672|11940056|FG002|COMPLETED|Overall Study||10
10778176|NCT03350672|11940054|FG000|NOT COMPLETED|Overall Study||7
10778177|NCT03350672|11940055|FG001|NOT COMPLETED|Overall Study||0
10778178|NCT03350672|11940056|FG002|NOT COMPLETED|Overall Study||0
10778179|NCT03350724|11940066|FG000|STARTED|Overall Study||17
10778180|NCT03350724|11940067|FG001|STARTED|Overall Study||17
10778181|NCT03350724|11940066|FG000|COMPLETED|Overall Study||17
10778182|NCT03350724|11940067|FG001|COMPLETED|Overall Study||17
10778183|NCT03350724|11940066|FG000|NOT COMPLETED|Overall Study||0
10778184|NCT03350724|11940067|FG001|NOT COMPLETED|Overall Study||0
10778185|NCT03350919|11940075|FG000|STARTED|Overall Study||25
10778186|NCT03350919|11940076|FG001|STARTED|Overall Study||23
10778187|NCT03350919|11940075|FG000|COMPLETED|Overall Study||23
10778188|NCT03350919|11940076|FG001|COMPLETED|Overall Study||23
10778189|NCT03350919|11940075|FG000|NOT COMPLETED|Overall Study||2
10778190|NCT03350919|11940076|FG001|NOT COMPLETED|Overall Study||0
10778191|NCT03351101|11940086|FG000|STARTED|Overall Study||136
10778192|NCT03351101|11940087|FG001|STARTED|Overall Study||132
10778193|NCT03351101|11940086|FG000|COMPLETED|Overall Study||135
10778194|NCT03351101|11940087|FG001|COMPLETED|Overall Study||129
10778195|NCT03351101|11940086|FG000|NOT COMPLETED|Overall Study||1
10778196|NCT03351101|11940087|FG001|NOT COMPLETED|Overall Study||3
10778197|NCT03351114|11940093|FG000|STARTED|Overall Study||8
10778198|NCT03351114|11940093|FG000|COMPLETED|Overall Study||7
10778199|NCT03351114|11940093|FG000|NOT COMPLETED|Overall Study||1
10778200|NCT03351231|11940097|FG000|STARTED|Combination Therapy Period|Started = initiated and completed monotherapy, then initiated combination therapy|5
10778201|NCT03351231|11940097|FG000|COMPLETED|Combination Therapy Period|Completed = finished combination therapy|0
10778202|NCT03351231|11940097|FG000|NOT COMPLETED|Combination Therapy Period||5
10778203|NCT03351231|11940097|FG000|STARTED|Safety Follow-Up Period|Started = Initiated Safety Follow-up|3
10778204|NCT03351231|11940097|FG000|COMPLETED|Safety Follow-Up Period|Completed = Finishing safety follow-up and continuing in study|0
10778205|NCT03351231|11940097|FG000|NOT COMPLETED|Safety Follow-Up Period||3
10778206|NCT03351335|11940104|FG000|STARTED|Overall Study||21
10778207|NCT03351335|11940105|FG001|STARTED|Overall Study||19
10778208|NCT03351335|11940106|FG002|STARTED|Overall Study||20
10778209|NCT03351335|11940104|FG000|COMPLETED|Overall Study||21
10778210|NCT03351335|11940105|FG001|COMPLETED|Overall Study||19
10778211|NCT03351335|11940106|FG002|COMPLETED|Overall Study||16
10740828|NCT02915705|11904984|FG000|STARTED|Treatment Period||32
10740829|NCT02915705|11904985|FG001|STARTED|Treatment Period||29
10740830|NCT02915705|11904984|FG000|Completed Week 40|Treatment Period||32
10740831|NCT02915705|11904985|FG001|Completed Week 40|Treatment Period||29
10740832|NCT02915705|11904984|FG000|Completed Week 64|Treatment Period||32
10740833|NCT02915705|11904985|FG001|Completed Week 64|Treatment Period||29
10740834|NCT02915705|11904984|FG000|COMPLETED|Treatment Period||32
10740835|NCT02915705|11904985|FG001|COMPLETED|Treatment Period||29
10740836|NCT02915705|11904984|FG000|NOT COMPLETED|Treatment Period||0
10740837|NCT02915705|11904985|FG001|NOT COMPLETED|Treatment Period||0
10740838|NCT02915705|11904984|FG000|STARTED|Long Term Extension Period|6 participants did not enter the extension period|26
10740839|NCT02915705|11904985|FG001|STARTED|Long Term Extension Period|4 participants did not enter the extension period|25
10740840|NCT02915705|11904984|FG000|COMPLETED|Long Term Extension Period||26
10740841|NCT02915705|11904985|FG001|COMPLETED|Long Term Extension Period||25
10740842|NCT02915705|11904984|FG000|NOT COMPLETED|Long Term Extension Period||0
10740843|NCT02915705|11904985|FG001|NOT COMPLETED|Long Term Extension Period||0
10740844|NCT02915744|11904996|FG000|STARTED|Overall Study||92
10740845|NCT02915744|11904997|FG001|STARTED|Overall Study||86
10740846|NCT02915744|11904996|FG000|COMPLETED|Overall Study||13
10740847|NCT02915744|11904997|FG001|COMPLETED|Overall Study||9
10740848|NCT02915744|11904996|FG000|NOT COMPLETED|Overall Study||79
10740849|NCT02915744|11904997|FG001|NOT COMPLETED|Overall Study||77
10740850|NCT02915835|11905007|FG000|STARTED|Overall Study||9
10740851|NCT02915835|11905008|FG001|STARTED|Overall Study||8
10740852|NCT02915835|11905007|FG000|COMPLETED|Overall Study||8
10740853|NCT02915835|11905008|FG001|COMPLETED|Overall Study||7
10740854|NCT02915835|11905007|FG000|NOT COMPLETED|Overall Study||1
10740855|NCT02915835|11905008|FG001|NOT COMPLETED|Overall Study||1
10740856|NCT02915874|11905016|FG000|STARTED|Overall Study||44
10740857|NCT02915874|11905017|FG001|STARTED|Overall Study||28
10740858|NCT02915874|11905016|FG000|Week 6 Follow Up|Overall Study||41
10740859|NCT02915874|11905017|FG001|Week 6 Follow Up|Overall Study||26
10740860|NCT02915874|11905016|FG000|COMPLETED|Overall Study||38
10740861|NCT02915874|11905017|FG001|COMPLETED|Overall Study||22
10740862|NCT02915874|11905016|FG000|NOT COMPLETED|Overall Study||6
10740863|NCT02915874|11905017|FG001|NOT COMPLETED|Overall Study||6
10740864|NCT02915978|11905026|FG000|STARTED|Overall Study||15
10740865|NCT02915978|11905027|FG001|STARTED|Overall Study||15
10740866|NCT02915978|11905028|FG002|STARTED|Overall Study||15
10740867|NCT02915978|11905026|FG000|COMPLETED|Overall Study||13
10740868|NCT02915978|11905027|FG001|COMPLETED|Overall Study||14
10740869|NCT02915978|11905028|FG002|COMPLETED|Overall Study||15
10740870|NCT02915978|11905026|FG000|NOT COMPLETED|Overall Study||2
10740871|NCT02915978|11905027|FG001|NOT COMPLETED|Overall Study||1
10740872|NCT02915978|11905028|FG002|NOT COMPLETED|Overall Study||0
10740873|NCT02916056|11905036|FG000|STARTED|Overall Study||297
10740874|NCT02916056|11905036|FG000|COMPLETED|Overall Study||0
10740875|NCT02916056|11905036|FG000|NOT COMPLETED|Overall Study||297
10740876|NCT02916407|11905042|FG000|STARTED|Overall Study||28
10740877|NCT02916407|11905043|FG001|STARTED|Overall Study||28
10740878|NCT02916407|11905042|FG000|COMPLETED|Overall Study||28
10740879|NCT02916407|11905043|FG001|COMPLETED|Overall Study||28
10740880|NCT02916407|11905042|FG000|NOT COMPLETED|Overall Study||0
10740881|NCT02916407|11905043|FG001|NOT COMPLETED|Overall Study||0
10740882|NCT02916433|11905051|FG000|STARTED|Overall Study||3
10740883|NCT02916433|11905052|FG001|STARTED|Overall Study||2
10740884|NCT02916433|11905051|FG000|COMPLETED|Overall Study||1
10740885|NCT02916433|11905052|FG001|COMPLETED|Overall Study||2
10740886|NCT02916433|11905051|FG000|NOT COMPLETED|Overall Study||2
10740887|NCT02916433|11905052|FG001|NOT COMPLETED|Overall Study||0
10740888|NCT02916498|11905063|FG000|STARTED|First Intervention, 21 Days||2
10740889|NCT02916498|11905064|FG001|STARTED|First Intervention, 21 Days||4
10740890|NCT02916498|11905063|FG000|COMPLETED|First Intervention, 21 Days||2
10740891|NCT02916498|11905064|FG001|COMPLETED|First Intervention, 21 Days||4
10740892|NCT02916498|11905063|FG000|NOT COMPLETED|First Intervention, 21 Days||0
10740893|NCT02916498|11905064|FG001|NOT COMPLETED|First Intervention, 21 Days||0
10740894|NCT02916498|11905063|FG000|STARTED|Second Intervention, 21 Days||2
10740895|NCT02916498|11905064|FG001|STARTED|Second Intervention, 21 Days||4
10740896|NCT02916498|11905063|FG000|COMPLETED|Second Intervention, 21 Days||2
10740897|NCT02916498|11905064|FG001|COMPLETED|Second Intervention, 21 Days||4
10740898|NCT02916498|11905063|FG000|NOT COMPLETED|Second Intervention, 21 Days||0
10740899|NCT02916498|11905064|FG001|NOT COMPLETED|Second Intervention, 21 Days||0
10740900|NCT02916563|11905070|FG000|STARTED|Overall Study||50
10740901|NCT02916563|11905070|FG000|COMPLETED|Overall Study||50
10740902|NCT02916563|11905070|FG000|NOT COMPLETED|Overall Study||0
10740903|NCT02916693|11905074|FG000|STARTED|Overall Study||20
10740904|NCT02916693|11905074|FG000|COMPLETED|Overall Study||13
10740905|NCT02916693|11905074|FG000|NOT COMPLETED|Overall Study||7
10740906|NCT02916745|11905082|FG000|STARTED|Overall Study||5
10740907|NCT02916745|11905082|FG000|COMPLETED|Overall Study||5
10740908|NCT02916745|11905082|FG000|NOT COMPLETED|Overall Study||0
10740909|NCT02916927|11905088|FG000|STARTED|Overall Study||31
10740910|NCT02916927|11905089|FG001|STARTED|Overall Study||31
10740911|NCT02916927|11905088|FG000|Received Study Drug|Overall Study||31
10740912|NCT02916927|11905089|FG001|Received Study Drug|Overall Study||29
10740913|NCT02916927|11905088|FG000|COMPLETED|Overall Study||30
10740914|NCT02916927|11905089|FG001|COMPLETED|Overall Study|1 participant was in radiology for the 45 and 60 minute time points.|28
10740915|NCT02916927|11905088|FG000|NOT COMPLETED|Overall Study||1
10740916|NCT02916927|11905089|FG001|NOT COMPLETED|Overall Study||3
10740917|NCT02917031|11905098|FG000|STARTED|Overall Study||112
10740918|NCT02917031|11905099|FG001|STARTED|Overall Study||115
10740919|NCT02917031|11905100|FG002|STARTED|Overall Study||120
10740920|NCT02917031|11905098|FG000|COMPLETED|Overall Study||94
10740921|NCT02917031|11905099|FG001|COMPLETED|Overall Study||102
10740922|NCT02917031|11905100|FG002|COMPLETED|Overall Study||105
10740923|NCT02917031|11905098|FG000|NOT COMPLETED|Overall Study||18
10740924|NCT02917031|11905099|FG001|NOT COMPLETED|Overall Study||13
10740925|NCT02917031|11905100|FG002|NOT COMPLETED|Overall Study||15
10740926|NCT02917122|11905111|FG000|STARTED|Overall Study||8
10740927|NCT02917122|11905112|FG001|STARTED|Overall Study||7
10740928|NCT02917122|11905111|FG000|COMPLETED|Overall Study||8
10740929|NCT02917122|11905112|FG001|COMPLETED|Overall Study||7
10740930|NCT02917122|11905111|FG000|NOT COMPLETED|Overall Study||0
10740931|NCT02917122|11905112|FG001|NOT COMPLETED|Overall Study||0
10740932|NCT02917265|11905120|FG000|STARTED|Overall Study||5
10740933|NCT02917265|11905121|FG001|STARTED|Overall Study||2
10740934|NCT02917265|11905120|FG000|COMPLETED|Overall Study||3
10740935|NCT02917265|11905121|FG001|COMPLETED|Overall Study||2
10740936|NCT02917265|11905120|FG000|NOT COMPLETED|Overall Study||2
10740937|NCT02917265|11905121|FG001|NOT COMPLETED|Overall Study||0
10740938|NCT02917278|11905131|FG000|STARTED|Overall Study||10
10740939|NCT02917278|11905132|FG001|STARTED|Overall Study||9
10740940|NCT02917278|11905131|FG000|COMPLETED|Overall Study||9
10740941|NCT02917278|11905132|FG001|COMPLETED|Overall Study||9
10740942|NCT02917278|11905131|FG000|NOT COMPLETED|Overall Study||1
10740943|NCT02917278|11905132|FG001|NOT COMPLETED|Overall Study||0
10740944|NCT02917447|11905140|FG000|STARTED|Overall Study||51
10740945|NCT02917447|11905141|FG001|STARTED|Overall Study||51
10740946|NCT02917447|11905140|FG000|COMPLETED|Overall Study||44
10740947|NCT02917447|11905141|FG001|COMPLETED|Overall Study||48
10740948|NCT02917447|11905140|FG000|NOT COMPLETED|Overall Study||7
10740949|NCT02917447|11905141|FG001|NOT COMPLETED|Overall Study||3
10740950|NCT02917603|11905149|FG000|STARTED|Overall Study||20
10740951|NCT02917603|11905150|FG001|STARTED|Overall Study||20
10740952|NCT02917603|11905149|FG000|COMPLETED|Overall Study||19
10740953|NCT02917603|11905150|FG001|COMPLETED|Overall Study||16
10740954|NCT02917603|11905149|FG000|NOT COMPLETED|Overall Study||1
10740955|NCT02917603|11905150|FG001|NOT COMPLETED|Overall Study||4
10740956|NCT02917642|11905159|FG000|STARTED|Overall Study||25
10740957|NCT02917642|11905160|FG001|STARTED|Overall Study||25
10740958|NCT02917642|11905159|FG000|COMPLETED|Overall Study||25
10740959|NCT02917642|11905160|FG001|COMPLETED|Overall Study||25
10740960|NCT02917642|11905159|FG000|NOT COMPLETED|Overall Study||0
10740961|NCT02917642|11905160|FG001|NOT COMPLETED|Overall Study||0
10740962|NCT02917941|11905166|FG000|STARTED|Treatment Period||34
10740963|NCT02917941|11905166|FG000|COMPLETED|Treatment Period||10
10740964|NCT02917941|11905166|FG000|NOT COMPLETED|Treatment Period||24
10740965|NCT02917941|11905166|FG000|STARTED|Survival Follow-up Period||31
10740966|NCT02917941|11905166|FG000|COMPLETED|Survival Follow-up Period||26
10740967|NCT02917941|11905166|FG000|NOT COMPLETED|Survival Follow-up Period||5
10740968|NCT02918071|11905170|FG000|STARTED|Overall Study||121
10740969|NCT02918071|11905170|FG000|COMPLETED|Overall Study||118
10740970|NCT02918071|11905170|FG000|NOT COMPLETED|Overall Study||3
10740971|NCT02918097|11905174|FG000|STARTED|Overall Study||78
10740972|NCT02918097|11905174|FG000|COMPLETED|Overall Study|Primary and secondary outcomes are assessed just at the end of the protocol, not at each step|58
10740973|NCT02918097|11905174|FG000|NOT COMPLETED|Overall Study||20
10740974|NCT02918266|11905189|FG000|STARTED|Part 1||6
10740975|NCT02918266|11905190|FG001|STARTED|Part 1||0
10740976|NCT02918266|11905191|FG002|STARTED|Part 1||0
10740977|NCT02918266|11905192|FG003|STARTED|Part 1||0
10740978|NCT02918266|11905193|FG004|STARTED|Part 1||0
10740979|NCT02918266|11905194|FG005|STARTED|Part 1||0
10740980|NCT02918266|11905195|FG006|STARTED|Part 1||0
10740981|NCT02918266|11905196|FG007|STARTED|Part 1||0
10740982|NCT02918266|11905197|FG008|STARTED|Part 1||0
10740983|NCT02918266|11905198|FG009|STARTED|Part 1||0
10740984|NCT02918266|11905199|FG010|STARTED|Part 1||0
10740985|NCT02918266|11905189|FG000|COMPLETED|Part 1||6
10740986|NCT02918266|11905190|FG001|COMPLETED|Part 1||0
10740987|NCT02918266|11905191|FG002|COMPLETED|Part 1||0
10740988|NCT02918266|11905192|FG003|COMPLETED|Part 1||0
10740989|NCT02918266|11905193|FG004|COMPLETED|Part 1||0
10740990|NCT02918266|11905194|FG005|COMPLETED|Part 1||0
10740991|NCT02918266|11905195|FG006|COMPLETED|Part 1||0
10740992|NCT02918266|11905196|FG007|COMPLETED|Part 1||0
10740993|NCT02918266|11905197|FG008|COMPLETED|Part 1||0
10740994|NCT02918266|11905198|FG009|COMPLETED|Part 1||0
10740995|NCT02918266|11905199|FG010|COMPLETED|Part 1||0
10740996|NCT02918266|11905189|FG000|NOT COMPLETED|Part 1||0
10740997|NCT02918266|11905190|FG001|NOT COMPLETED|Part 1||0
10740998|NCT02918266|11905191|FG002|NOT COMPLETED|Part 1||0
10740999|NCT02918266|11905192|FG003|NOT COMPLETED|Part 1||0
10741000|NCT02918266|11905193|FG004|NOT COMPLETED|Part 1||0
10741001|NCT02918266|11905194|FG005|NOT COMPLETED|Part 1||0
10741002|NCT02918266|11905195|FG006|NOT COMPLETED|Part 1||0
10741003|NCT02918266|11905196|FG007|NOT COMPLETED|Part 1||0
10741004|NCT02918266|11905197|FG008|NOT COMPLETED|Part 1||0
10741005|NCT02918266|11905198|FG009|NOT COMPLETED|Part 1||0
10741006|NCT02918266|11905199|FG010|NOT COMPLETED|Part 1||0
10741007|NCT02918266|11905189|FG000|STARTED|Part 2: Intervention Period 1 (2 Days)||0
10741008|NCT02918266|11905190|FG001|STARTED|Part 2: Intervention Period 1 (2 Days)||1
10741009|NCT02918266|11905191|FG002|STARTED|Part 2: Intervention Period 1 (2 Days)||1
10741010|NCT02918266|11905192|FG003|STARTED|Part 2: Intervention Period 1 (2 Days)||1
10741011|NCT02918266|11905193|FG004|STARTED|Part 2: Intervention Period 1 (2 Days)||1
10741012|NCT02918266|11905194|FG005|STARTED|Part 2: Intervention Period 1 (2 Days)||1
10741013|NCT02918266|11905195|FG006|STARTED|Part 2: Intervention Period 1 (2 Days)||2
10741014|NCT02918266|11905196|FG007|STARTED|Part 2: Intervention Period 1 (2 Days)||1
10741015|NCT02918266|11905197|FG008|STARTED|Part 2: Intervention Period 1 (2 Days)||2
10741016|NCT02918266|11905198|FG009|STARTED|Part 2: Intervention Period 1 (2 Days)||1
10741017|NCT02918266|11905199|FG010|STARTED|Part 2: Intervention Period 1 (2 Days)||1
10741018|NCT02918266|11905189|FG000|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
10741019|NCT02918266|11905190|FG001|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
10741020|NCT02918266|11905191|FG002|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
10741021|NCT02918266|11905192|FG003|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
10741022|NCT02918266|11905193|FG004|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
10741023|NCT02918266|11905194|FG005|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
10741024|NCT02918266|11905195|FG006|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
10741025|NCT02918266|11905196|FG007|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
10741026|NCT02918266|11905197|FG008|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
10741027|NCT02918266|11905198|FG009|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
10741028|NCT02918266|11905199|FG010|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
10741029|NCT02918266|11905189|FG000|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
10741030|NCT02918266|11905190|FG001|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
10741031|NCT02918266|11905191|FG002|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
10741032|NCT02918266|11905192|FG003|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
10741033|NCT02918266|11905193|FG004|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
10741034|NCT02918266|11905194|FG005|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
10741035|NCT02918266|11905195|FG006|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||2
10741036|NCT02918266|11905196|FG007|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
10741037|NCT02918266|11905197|FG008|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||2
10741038|NCT02918266|11905198|FG009|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
10741039|NCT02918266|11905199|FG010|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
10741040|NCT02918266|11905189|FG000|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
10741041|NCT02918266|11905190|FG001|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
10741042|NCT02918266|11905191|FG002|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
10741043|NCT02918266|11905192|FG003|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
10741044|NCT02918266|11905193|FG004|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
10741045|NCT02918266|11905194|FG005|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
10741046|NCT02918266|11905195|FG006|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
10741047|NCT02918266|11905196|FG007|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
10741048|NCT02918266|11905197|FG008|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
10741049|NCT02918266|11905198|FG009|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
10741050|NCT02918266|11905199|FG010|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
10741051|NCT02918266|11905189|FG000|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
10741052|NCT02918266|11905190|FG001|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
10741053|NCT02918266|11905191|FG002|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
10741054|NCT02918266|11905192|FG003|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
10741055|NCT02918266|11905193|FG004|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
10741056|NCT02918266|11905194|FG005|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
10741057|NCT02918266|11905195|FG006|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
10741058|NCT02918266|11905196|FG007|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
10741059|NCT02918266|11905197|FG008|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
10741060|NCT02918266|11905198|FG009|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
10741061|NCT02918266|11905199|FG010|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
10741062|NCT02918266|11905189|FG000|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
10741063|NCT02918266|11905190|FG001|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
10741064|NCT02918266|11905191|FG002|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
10741065|NCT02918266|11905192|FG003|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
10741066|NCT02918266|11905193|FG004|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
10741067|NCT02918266|11905194|FG005|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
10741068|NCT02918266|11905195|FG006|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
10741069|NCT02918266|11905196|FG007|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
10741070|NCT02918266|11905197|FG008|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
10741071|NCT02918266|11905198|FG009|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
10741072|NCT02918266|11905199|FG010|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
10741073|NCT02918266|11905189|FG000|STARTED|Part 2: Intervention Period 2 (2 Days)||0
10741074|NCT02918266|11905190|FG001|STARTED|Part 2: Intervention Period 2 (2 Days)||0
10741075|NCT02918266|11905191|FG002|STARTED|Part 2: Intervention Period 2 (2 Days)||0
10741076|NCT02918266|11905192|FG003|STARTED|Part 2: Intervention Period 2 (2 Days)||0
10741077|NCT02918266|11905193|FG004|STARTED|Part 2: Intervention Period 2 (2 Days)||0
10741078|NCT02918266|11905194|FG005|STARTED|Part 2: Intervention Period 2 (2 Days)||0
10741079|NCT02918266|11905195|FG006|STARTED|Part 2: Intervention Period 2 (2 Days)||0
10741080|NCT02918266|11905196|FG007|STARTED|Part 2: Intervention Period 2 (2 Days)||0
10741081|NCT02918266|11905197|FG008|STARTED|Part 2: Intervention Period 2 (2 Days)||0
10741082|NCT02918266|11905198|FG009|STARTED|Part 2: Intervention Period 2 (2 Days)||0
10741083|NCT02918266|11905199|FG010|STARTED|Part 2: Intervention Period 2 (2 Days)||0
10741084|NCT02918266|11905189|FG000|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
10741085|NCT02918266|11905190|FG001|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
10741086|NCT02918266|11905191|FG002|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
10741087|NCT02918266|11905192|FG003|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
10741088|NCT02918266|11905193|FG004|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
10741089|NCT02918266|11905194|FG005|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
10741090|NCT02918266|11905195|FG006|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
10741091|NCT02918266|11905196|FG007|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
10741092|NCT02918266|11905197|FG008|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
10741093|NCT02918266|11905198|FG009|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
10741094|NCT02918266|11905199|FG010|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
10741095|NCT02918266|11905189|FG000|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
10741096|NCT02918266|11905190|FG001|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
10741097|NCT02918266|11905191|FG002|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
10741098|NCT02918266|11905192|FG003|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
10741099|NCT02918266|11905193|FG004|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
10741100|NCT02918266|11905194|FG005|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
10741101|NCT02918266|11905195|FG006|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
10741102|NCT02918266|11905196|FG007|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
10741103|NCT02918266|11905197|FG008|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
10741104|NCT02918266|11905198|FG009|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
10741105|NCT02918266|11905199|FG010|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
10741106|NCT02918266|11905189|FG000|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
10816841|NCT01457053|11980431|FG000|COMPLETED|Overall Study||1
10816842|NCT01457053|11980432|FG001|COMPLETED|Overall Study||1
10816843|NCT01457053|11980431|FG000|NOT COMPLETED|Overall Study||1
10816844|NCT01457053|11980432|FG001|NOT COMPLETED|Overall Study||1
10816845|NCT01451723|11980440|FG000|STARTED|Overall Study||6
10816846|NCT01451723|11980441|FG001|STARTED|Overall Study||5
10816847|NCT01451723|11980440|FG000|COMPLETED|Overall Study||0
10816848|NCT01451723|11980441|FG001|COMPLETED|Overall Study||0
10741107|NCT02918266|11905190|FG001|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
10741108|NCT02918266|11905191|FG002|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
10741109|NCT02918266|11905192|FG003|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
10741110|NCT02918266|11905193|FG004|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
10741111|NCT02918266|11905194|FG005|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
10741112|NCT02918266|11905195|FG006|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
10741113|NCT02918266|11905196|FG007|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
10741114|NCT02918266|11905197|FG008|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
10741115|NCT02918266|11905198|FG009|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
10741116|NCT02918266|11905199|FG010|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
10741117|NCT02918266|11905189|FG000|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
10741118|NCT02918266|11905190|FG001|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
10741119|NCT02918266|11905191|FG002|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
10741120|NCT02918266|11905192|FG003|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
10741121|NCT02918266|11905193|FG004|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
10741122|NCT02918266|11905194|FG005|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
10741123|NCT02918266|11905195|FG006|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
10741124|NCT02918266|11905196|FG007|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
10741125|NCT02918266|11905197|FG008|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
10741126|NCT02918266|11905198|FG009|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
10741127|NCT02918266|11905199|FG010|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
10741128|NCT02918266|11905189|FG000|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
10741129|NCT02918266|11905190|FG001|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
10741130|NCT02918266|11905191|FG002|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
10741131|NCT02918266|11905192|FG003|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
10741132|NCT02918266|11905193|FG004|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
10741133|NCT02918266|11905194|FG005|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
10741134|NCT02918266|11905195|FG006|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
10741135|NCT02918266|11905196|FG007|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
10741136|NCT02918266|11905197|FG008|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
10741137|NCT02918266|11905198|FG009|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
10741138|NCT02918266|11905199|FG010|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
10741139|NCT02918266|11905189|FG000|STARTED|Part 2: Intervention Period 3 (2 Days)||0
10741140|NCT02918266|11905190|FG001|STARTED|Part 2: Intervention Period 3 (2 Days)||0
10741141|NCT02918266|11905191|FG002|STARTED|Part 2: Intervention Period 3 (2 Days)||0
10741142|NCT02918266|11905192|FG003|STARTED|Part 2: Intervention Period 3 (2 Days)||0
10741143|NCT02918266|11905193|FG004|STARTED|Part 2: Intervention Period 3 (2 Days)||0
10741144|NCT02918266|11905194|FG005|STARTED|Part 2: Intervention Period 3 (2 Days)||0
10741145|NCT02918266|11905195|FG006|STARTED|Part 2: Intervention Period 3 (2 Days)||0
10741146|NCT02918266|11905196|FG007|STARTED|Part 2: Intervention Period 3 (2 Days)||0
10741147|NCT02918266|11905197|FG008|STARTED|Part 2: Intervention Period 3 (2 Days)||0
10816849|NCT01451723|11980440|FG000|NOT COMPLETED|Overall Study||6
10816850|NCT01451723|11980441|FG001|NOT COMPLETED|Overall Study||5
10816851|NCT01440517|11980447|FG000|STARTED|Overall Study||5
10741148|NCT02918266|11905198|FG009|STARTED|Part 2: Intervention Period 3 (2 Days)||0
10741149|NCT02918266|11905199|FG010|STARTED|Part 2: Intervention Period 3 (2 Days)||0
10741150|NCT02918266|11905189|FG000|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
10741151|NCT02918266|11905190|FG001|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
10741152|NCT02918266|11905191|FG002|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
10741153|NCT02918266|11905192|FG003|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
10741154|NCT02918266|11905193|FG004|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
10741155|NCT02918266|11905194|FG005|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
10741156|NCT02918266|11905195|FG006|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
10741157|NCT02918266|11905196|FG007|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
10741158|NCT02918266|11905197|FG008|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
10741159|NCT02918266|11905198|FG009|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
10741160|NCT02918266|11905199|FG010|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
10741161|NCT02918266|11905189|FG000|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
10741162|NCT02918266|11905190|FG001|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
10741163|NCT02918266|11905191|FG002|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
10741164|NCT02918266|11905192|FG003|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
10741165|NCT02918266|11905193|FG004|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
10741166|NCT02918266|11905194|FG005|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
10741167|NCT02918266|11905195|FG006|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
10741168|NCT02918266|11905196|FG007|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
10741169|NCT02918266|11905197|FG008|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
10741170|NCT02918266|11905198|FG009|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
10741171|NCT02918266|11905199|FG010|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
10741172|NCT02918266|11905189|FG000|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
10741173|NCT02918266|11905190|FG001|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
10741174|NCT02918266|11905191|FG002|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
10741175|NCT02918266|11905192|FG003|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
10741176|NCT02918266|11905193|FG004|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
10741177|NCT02918266|11905194|FG005|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
10741178|NCT02918266|11905195|FG006|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
10741179|NCT02918266|11905196|FG007|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
10741180|NCT02918266|11905197|FG008|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
10741181|NCT02918266|11905198|FG009|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
10741182|NCT02918266|11905199|FG010|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
10741183|NCT02918266|11905189|FG000|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
10741184|NCT02918266|11905190|FG001|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
10741185|NCT02918266|11905191|FG002|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
10741186|NCT02918266|11905192|FG003|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
10741187|NCT02918266|11905193|FG004|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
10741188|NCT02918266|11905194|FG005|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
10741189|NCT02918266|11905195|FG006|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
10741190|NCT02918266|11905196|FG007|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
10741191|NCT02918266|11905197|FG008|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
10741192|NCT02918266|11905198|FG009|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
10741193|NCT02918266|11905199|FG010|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
10741194|NCT02918266|11905189|FG000|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
10741195|NCT02918266|11905190|FG001|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
10741196|NCT02918266|11905191|FG002|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
10741197|NCT02918266|11905192|FG003|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
10741198|NCT02918266|11905193|FG004|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
10741199|NCT02918266|11905194|FG005|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
10741200|NCT02918266|11905195|FG006|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
10741201|NCT02918266|11905196|FG007|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
10741202|NCT02918266|11905197|FG008|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
10741203|NCT02918266|11905198|FG009|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
10741204|NCT02918266|11905199|FG010|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
10741205|NCT02918266|11905189|FG000|STARTED|Part 2: Intervention Period 4 (2 Days)||0
10741206|NCT02918266|11905190|FG001|STARTED|Part 2: Intervention Period 4 (2 Days)||0
10741207|NCT02918266|11905191|FG002|STARTED|Part 2: Intervention Period 4 (2 Days)||0
10741208|NCT02918266|11905192|FG003|STARTED|Part 2: Intervention Period 4 (2 Days)||0
10741209|NCT02918266|11905193|FG004|STARTED|Part 2: Intervention Period 4 (2 Days)||0
10741210|NCT02918266|11905194|FG005|STARTED|Part 2: Intervention Period 4 (2 Days)||0
10741211|NCT02918266|11905195|FG006|STARTED|Part 2: Intervention Period 4 (2 Days)||0
10741212|NCT02918266|11905196|FG007|STARTED|Part 2: Intervention Period 4 (2 Days)||0
10741213|NCT02918266|11905197|FG008|STARTED|Part 2: Intervention Period 4 (2 Days)||0
10741214|NCT02918266|11905198|FG009|STARTED|Part 2: Intervention Period 4 (2 Days)||0
10741215|NCT02918266|11905199|FG010|STARTED|Part 2: Intervention Period 4 (2 Days)||0
10741216|NCT02918266|11905189|FG000|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
10741217|NCT02918266|11905190|FG001|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
10741218|NCT02918266|11905191|FG002|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
10741219|NCT02918266|11905192|FG003|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
10741220|NCT02918266|11905193|FG004|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
10741221|NCT02918266|11905194|FG005|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
10741222|NCT02918266|11905195|FG006|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
10741223|NCT02918266|11905196|FG007|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
10741224|NCT02918266|11905197|FG008|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
10741225|NCT02918266|11905198|FG009|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
10741226|NCT02918266|11905199|FG010|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
10741227|NCT02918266|11905189|FG000|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
10741228|NCT02918266|11905190|FG001|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
10741229|NCT02918266|11905191|FG002|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
10741230|NCT02918266|11905192|FG003|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
10741231|NCT02918266|11905193|FG004|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
10741232|NCT02918266|11905194|FG005|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
10741233|NCT02918266|11905195|FG006|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
10741234|NCT02918266|11905196|FG007|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
10741235|NCT02918266|11905197|FG008|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
10741236|NCT02918266|11905198|FG009|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
10741237|NCT02918266|11905199|FG010|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
10741238|NCT02918266|11905189|FG000|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
10741239|NCT02918266|11905190|FG001|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
10741240|NCT02918266|11905191|FG002|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
10741241|NCT02918266|11905192|FG003|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
10741242|NCT02918266|11905193|FG004|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
10741243|NCT02918266|11905194|FG005|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
10741244|NCT02918266|11905195|FG006|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
10741245|NCT02918266|11905196|FG007|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
10741246|NCT02918266|11905197|FG008|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
10741247|NCT02918266|11905198|FG009|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
10741248|NCT02918266|11905199|FG010|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
10741249|NCT02918266|11905189|FG000|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
10741250|NCT02918266|11905190|FG001|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
10741251|NCT02918266|11905191|FG002|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
10741252|NCT02918266|11905192|FG003|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
10741253|NCT02918266|11905193|FG004|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
10741254|NCT02918266|11905194|FG005|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
10741255|NCT02918266|11905195|FG006|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
10741256|NCT02918266|11905196|FG007|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
10741257|NCT02918266|11905197|FG008|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
10741258|NCT02918266|11905198|FG009|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
10741259|NCT02918266|11905199|FG010|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
10741260|NCT02918266|11905189|FG000|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
10741261|NCT02918266|11905190|FG001|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
10741262|NCT02918266|11905191|FG002|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
10741263|NCT02918266|11905192|FG003|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
10741264|NCT02918266|11905193|FG004|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
10741265|NCT02918266|11905194|FG005|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
10741266|NCT02918266|11905195|FG006|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
10741267|NCT02918266|11905196|FG007|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
10741268|NCT02918266|11905197|FG008|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
10741269|NCT02918266|11905198|FG009|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
10741270|NCT02918266|11905199|FG010|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
10741271|NCT02918266|11905189|FG000|STARTED|Part 2: Intervention Period 5 (2 Days)||0
10741272|NCT02918266|11905190|FG001|STARTED|Part 2: Intervention Period 5 (2 Days)||0
10741273|NCT02918266|11905191|FG002|STARTED|Part 2: Intervention Period 5 (2 Days)||0
10741274|NCT02918266|11905192|FG003|STARTED|Part 2: Intervention Period 5 (2 Days)||0
10741275|NCT02918266|11905193|FG004|STARTED|Part 2: Intervention Period 5 (2 Days)||0
10741276|NCT02918266|11905194|FG005|STARTED|Part 2: Intervention Period 5 (2 Days)||0
10741277|NCT02918266|11905195|FG006|STARTED|Part 2: Intervention Period 5 (2 Days)||0
10741278|NCT02918266|11905196|FG007|STARTED|Part 2: Intervention Period 5 (2 Days)||0
10741279|NCT02918266|11905197|FG008|STARTED|Part 2: Intervention Period 5 (2 Days)||0
10741280|NCT02918266|11905198|FG009|STARTED|Part 2: Intervention Period 5 (2 Days)||0
10741281|NCT02918266|11905199|FG010|STARTED|Part 2: Intervention Period 5 (2 Days)||0
10741282|NCT02918266|11905189|FG000|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
10741283|NCT02918266|11905190|FG001|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
10741284|NCT02918266|11905191|FG002|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
10741285|NCT02918266|11905192|FG003|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
10741286|NCT02918266|11905193|FG004|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
10741287|NCT02918266|11905194|FG005|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
10741288|NCT02918266|11905195|FG006|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
10741289|NCT02918266|11905196|FG007|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
10741290|NCT02918266|11905197|FG008|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
10741291|NCT02918266|11905198|FG009|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
10741292|NCT02918266|11905199|FG010|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
10741293|NCT02918266|11905189|FG000|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
10741294|NCT02918266|11905190|FG001|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
10741295|NCT02918266|11905191|FG002|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
10741296|NCT02918266|11905192|FG003|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
10741297|NCT02918266|11905193|FG004|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
10741298|NCT02918266|11905194|FG005|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
10741299|NCT02918266|11905195|FG006|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
10741300|NCT02918266|11905196|FG007|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
10741301|NCT02918266|11905197|FG008|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
10741302|NCT02918266|11905198|FG009|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
10741303|NCT02918266|11905199|FG010|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
10816852|NCT01440517|11980447|FG000|COMPLETED|Overall Study||4
10816853|NCT01440517|11980447|FG000|NOT COMPLETED|Overall Study||1
10816854|NCT01440595|11980453|FG000|STARTED|Overall Study||1
10816855|NCT01440595|11980454|FG001|STARTED|Overall Study||3
10816856|NCT01440595|11980455|FG002|STARTED|Overall Study||1
10816857|NCT01440595|11980453|FG000|COMPLETED|Overall Study||0
10816858|NCT01440595|11980454|FG001|COMPLETED|Overall Study||0
10816859|NCT01440595|11980455|FG002|COMPLETED|Overall Study||0
10816860|NCT01440595|11980453|FG000|NOT COMPLETED|Overall Study||1
10816861|NCT01440595|11980454|FG001|NOT COMPLETED|Overall Study||3
10816862|NCT01440595|11980455|FG002|NOT COMPLETED|Overall Study||1
10816863|NCT01446796|11980461|FG000|STARTED|Overall Study||3
10816864|NCT01446796|11980462|FG001|STARTED|Overall Study||0
10816865|NCT01446796|11980461|FG000|COMPLETED|Overall Study|"Study terminated early~One subject of three withdrew prior to randomization and did not start"|2
10816866|NCT01446796|11980462|FG001|COMPLETED|Overall Study|Study terminated early|0
10816867|NCT01446796|11980461|FG000|NOT COMPLETED|Overall Study||1
10816868|NCT01446796|11980462|FG001|NOT COMPLETED|Overall Study||0
10816869|NCT01443923|11980472|FG000|STARTED|Overall Study||3
10816870|NCT01443923|11980473|FG001|STARTED|Overall Study||1
10816871|NCT01443923|11980472|FG000|COMPLETED|Overall Study||2
10816872|NCT01443923|11980473|FG001|COMPLETED|Overall Study||1
10816873|NCT01443923|11980472|FG000|NOT COMPLETED|Overall Study||1
10816874|NCT01443923|11980473|FG001|NOT COMPLETED|Overall Study||0
10741304|NCT02918279|11905221|FG000|STARTED|Overall Study||125
10741305|NCT02918279|11905222|FG001|STARTED|Overall Study||126
10741306|NCT02918279|11905221|FG000|Full Analysis Set|Overall Study||125
10741307|NCT02918279|11905222|FG001|Full Analysis Set|Overall Study||126
10741308|NCT02918279|11905221|FG000|Safety Analysis Set|Overall Study||125
10741309|NCT02918279|11905222|FG001|Safety Analysis Set|Overall Study||126
10741310|NCT02918279|11905221|FG000|COMPLETED|Overall Study||112
10741311|NCT02918279|11905222|FG001|COMPLETED|Overall Study||103
10741312|NCT02918279|11905221|FG000|NOT COMPLETED|Overall Study||13
10741313|NCT02918279|11905222|FG001|NOT COMPLETED|Overall Study||23
10741314|NCT02918318|11905232|FG000|STARTED|Double-blind Induction Phase: 4 Weeks||41
10741315|NCT02918318|11905233|FG001|STARTED|Double-blind Induction Phase: 4 Weeks||40
10741316|NCT02918318|11905234|FG002|STARTED|Double-blind Induction Phase: 4 Weeks||41
10741317|NCT02918318|11905235|FG003|STARTED|Double-blind Induction Phase: 4 Weeks||80
10741318|NCT02918318|11905236|FG004|STARTED|Double-blind Induction Phase: 4 Weeks||0
10741319|NCT02918318|11905232|FG000|Responders|Double-blind Induction Phase: 4 Weeks||13
10741320|NCT02918318|11905233|FG001|Responders|Double-blind Induction Phase: 4 Weeks||11
10741321|NCT02918318|11905234|FG002|Responders|Double-blind Induction Phase: 4 Weeks||17
10741322|NCT02918318|11905235|FG003|Responders|Double-blind Induction Phase: 4 Weeks||27
10741323|NCT02918318|11905236|FG004|Responders|Double-blind Induction Phase: 4 Weeks||0
10741324|NCT02918318|11905232|FG000|COMPLETED|Double-blind Induction Phase: 4 Weeks||39
10741325|NCT02918318|11905233|FG001|COMPLETED|Double-blind Induction Phase: 4 Weeks||33
10741326|NCT02918318|11905234|FG002|COMPLETED|Double-blind Induction Phase: 4 Weeks||39
10741327|NCT02918318|11905235|FG003|COMPLETED|Double-blind Induction Phase: 4 Weeks||72
10741328|NCT02918318|11905236|FG004|COMPLETED|Double-blind Induction Phase: 4 Weeks||0
10741329|NCT02918318|11905232|FG000|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||2
10741330|NCT02918318|11905233|FG001|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||7
10741331|NCT02918318|11905234|FG002|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||2
10741332|NCT02918318|11905235|FG003|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||8
10741333|NCT02918318|11905236|FG004|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||0
10741334|NCT02918318|11905232|FG000|STARTED|Double-blind Follow-up Phase: 4 Weeks||27
10741335|NCT02918318|11905233|FG001|STARTED|Double-blind Follow-up Phase: 4 Weeks||28
10741336|NCT02918318|11905234|FG002|STARTED|Double-blind Follow-up Phase: 4 Weeks||24
10741337|NCT02918318|11905235|FG003|STARTED|Double-blind Follow-up Phase: 4 Weeks||53
10741338|NCT02918318|11905236|FG004|STARTED|Double-blind Follow-up Phase: 4 Weeks||0
10741339|NCT02918318|11905232|FG000|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||26
10741340|NCT02918318|11905233|FG001|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||28
10741341|NCT02918318|11905234|FG002|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||23
10741342|NCT02918318|11905235|FG003|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||50
10741343|NCT02918318|11905236|FG004|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||0
10741344|NCT02918318|11905232|FG000|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||1
10741345|NCT02918318|11905233|FG001|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||0
10741346|NCT02918318|11905234|FG002|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||1
10741347|NCT02918318|11905235|FG003|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||3
10741348|NCT02918318|11905236|FG004|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||0
10741349|NCT02918318|11905232|FG000|STARTED|Posttreatment Phase: Up to 24 Weeks||13
10741350|NCT02918318|11905233|FG001|STARTED|Posttreatment Phase: Up to 24 Weeks||11
10741351|NCT02918318|11905234|FG002|STARTED|Posttreatment Phase: Up to 24 Weeks||17
10741352|NCT02918318|11905235|FG003|STARTED|Posttreatment Phase: Up to 24 Weeks||27
10741353|NCT02918318|11905236|FG004|STARTED|Posttreatment Phase: Up to 24 Weeks||0
10741354|NCT02918318|11905232|FG000|COMPLETED|Posttreatment Phase: Up to 24 Weeks||12
10741355|NCT02918318|11905233|FG001|COMPLETED|Posttreatment Phase: Up to 24 Weeks||8
10741356|NCT02918318|11905234|FG002|COMPLETED|Posttreatment Phase: Up to 24 Weeks||16
10741357|NCT02918318|11905235|FG003|COMPLETED|Posttreatment Phase: Up to 24 Weeks||25
10741358|NCT02918318|11905236|FG004|COMPLETED|Posttreatment Phase: Up to 24 Weeks||0
10741359|NCT02918318|11905232|FG000|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||1
10741360|NCT02918318|11905233|FG001|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||3
10741361|NCT02918318|11905234|FG002|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||1
10741362|NCT02918318|11905235|FG003|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||2
10741363|NCT02918318|11905236|FG004|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||0
10741364|NCT02918318|11905232|FG000|STARTED|Open Label Treatment Phase: 4 Weeks||0
10741365|NCT02918318|11905233|FG001|STARTED|Open Label Treatment Phase: 4 Weeks||0
10741366|NCT02918318|11905234|FG002|STARTED|Open Label Treatment Phase: 4 Weeks||0
10741367|NCT02918318|11905235|FG003|STARTED|Open Label Treatment Phase: 4 Weeks||0
10741368|NCT02918318|11905236|FG004|STARTED|Open Label Treatment Phase: 4 Weeks||48
10741369|NCT02918318|11905232|FG000|COMPLETED|Open Label Treatment Phase: 4 Weeks||0
10741370|NCT02918318|11905233|FG001|COMPLETED|Open Label Treatment Phase: 4 Weeks||0
10741371|NCT02918318|11905234|FG002|COMPLETED|Open Label Treatment Phase: 4 Weeks||0
10741372|NCT02918318|11905235|FG003|COMPLETED|Open Label Treatment Phase: 4 Weeks||0
10741373|NCT02918318|11905236|FG004|COMPLETED|Open Label Treatment Phase: 4 Weeks||47
10741374|NCT02918318|11905232|FG000|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0
10741375|NCT02918318|11905233|FG001|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0
10741376|NCT02918318|11905234|FG002|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0
10741377|NCT02918318|11905235|FG003|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0
10741378|NCT02918318|11905236|FG004|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||1
10741379|NCT02918318|11905232|FG000|STARTED|Open Label Follow-up Phase: 4 Weeks||0
10741380|NCT02918318|11905233|FG001|STARTED|Open Label Follow-up Phase: 4 Weeks||0
10741381|NCT02918318|11905234|FG002|STARTED|Open Label Follow-up Phase: 4 Weeks||0
10741382|NCT02918318|11905235|FG003|STARTED|Open Label Follow-up Phase: 4 Weeks||0
10741383|NCT02918318|11905236|FG004|STARTED|Open Label Follow-up Phase: 4 Weeks||48
10741384|NCT02918318|11905232|FG000|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
10741385|NCT02918318|11905233|FG001|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
10741386|NCT02918318|11905234|FG002|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
10741387|NCT02918318|11905235|FG003|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
10741388|NCT02918318|11905236|FG004|COMPLETED|Open Label Follow-up Phase: 4 Weeks||47
10741389|NCT02918318|11905232|FG000|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
10741390|NCT02918318|11905233|FG001|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
10741391|NCT02918318|11905234|FG002|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
10741392|NCT02918318|11905235|FG003|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
10741393|NCT02918318|11905236|FG004|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||1
10741394|NCT02918357|11905257|FG000|STARTED|Overall Study||385
10741395|NCT02918357|11905257|FG000|Investigational Drug Administration|Overall Study||385
10741396|NCT02918357|11905257|FG000|PET/CT Scan|Overall Study||385
10741397|NCT02918357|11905257|FG000|COMPLETED|Overall Study||385
10741398|NCT02918357|11905257|FG000|NOT COMPLETED|Overall Study||0
10741399|NCT02918396|11905282|FG000|STARTED|Overall Study||2
10741400|NCT02918396|11905283|FG001|STARTED|Overall Study||1
10741401|NCT02918396|11905284|FG002|STARTED|Overall Study||2
10741402|NCT02918396|11905282|FG000|COMPLETED|Overall Study||2
10741403|NCT02918396|11905283|FG001|COMPLETED|Overall Study||1
10741404|NCT02918396|11905284|FG002|COMPLETED|Overall Study||2
10741405|NCT02918396|11905282|FG000|NOT COMPLETED|Overall Study||0
10741406|NCT02918396|11905283|FG001|NOT COMPLETED|Overall Study||0
10741407|NCT02918396|11905284|FG002|NOT COMPLETED|Overall Study||0
10741408|NCT02918552|11905294|FG000|STARTED|Overall Study||7
10741409|NCT02918552|11905295|FG001|STARTED|Overall Study||8
10741410|NCT02918552|11905294|FG000|COMPLETED|Overall Study||6
10741411|NCT02918552|11905295|FG001|COMPLETED|Overall Study||6
10741412|NCT02918552|11905294|FG000|NOT COMPLETED|Overall Study||1
10741413|NCT02918552|11905295|FG001|NOT COMPLETED|Overall Study||2
10741414|NCT02918617|11905310|FG000|STARTED|Overall Study||21
10741415|NCT02918617|11905311|FG001|STARTED|Overall Study||20
10741416|NCT02918617|11905312|FG002|STARTED|Overall Study||22
10741417|NCT02918617|11905313|FG003|STARTED|Overall Study||22
10741418|NCT02918617|11905314|FG004|STARTED|Overall Study||24
10741419|NCT02918617|11905315|FG005|STARTED|Overall Study||20
10741420|NCT02918617|11905316|FG006|STARTED|Overall Study||22
10741421|NCT02918617|11905317|FG007|STARTED|Overall Study||26
10741422|NCT02918617|11905318|FG008|STARTED|Overall Study||26
10741423|NCT02918617|11905310|FG000|COMPLETED|Overall Study||20
10741424|NCT02918617|11905311|FG001|COMPLETED|Overall Study||20
10741425|NCT02918617|11905312|FG002|COMPLETED|Overall Study||19
10741426|NCT02918617|11905313|FG003|COMPLETED|Overall Study||22
10741427|NCT02918617|11905314|FG004|COMPLETED|Overall Study||24
10741428|NCT02918617|11905315|FG005|COMPLETED|Overall Study||20
10741429|NCT02918617|11905316|FG006|COMPLETED|Overall Study||22
10741430|NCT02918617|11905317|FG007|COMPLETED|Overall Study||25
10741431|NCT02918617|11905318|FG008|COMPLETED|Overall Study||26
10741432|NCT02918617|11905310|FG000|NOT COMPLETED|Overall Study||1
10741433|NCT02918617|11905311|FG001|NOT COMPLETED|Overall Study||0
10741434|NCT02918617|11905312|FG002|NOT COMPLETED|Overall Study||3
10741435|NCT02918617|11905313|FG003|NOT COMPLETED|Overall Study||0
10741436|NCT02918617|11905314|FG004|NOT COMPLETED|Overall Study||0
10741437|NCT02918617|11905315|FG005|NOT COMPLETED|Overall Study||0
10741438|NCT02918617|11905316|FG006|NOT COMPLETED|Overall Study||0
10741439|NCT02918617|11905317|FG007|NOT COMPLETED|Overall Study||1
10741440|NCT02918617|11905318|FG008|NOT COMPLETED|Overall Study||0
10741441|NCT02918630|11905340|FG000|STARTED|Overall Study||4
10741442|NCT02918630|11905341|FG001|STARTED|Overall Study||3
10741443|NCT02918630|11905340|FG000|COMPLETED|Overall Study||4
10741444|NCT02918630|11905341|FG001|COMPLETED|Overall Study||3
10741445|NCT02918630|11905340|FG000|NOT COMPLETED|Overall Study||0
10741446|NCT02918630|11905341|FG001|NOT COMPLETED|Overall Study||0
10741447|NCT02918656|11905350|FG000|STARTED|Overall Study||54
10741448|NCT02918656|11905351|FG001|STARTED|Overall Study||60
10741449|NCT02918656|11905352|FG002|STARTED|Overall Study||57
10741450|NCT02918656|11905350|FG000|COMPLETED|Overall Study||54
10741451|NCT02918656|11905351|FG001|COMPLETED|Overall Study||60
10741452|NCT02918656|11905352|FG002|COMPLETED|Overall Study||57
10741453|NCT02918656|11905350|FG000|NOT COMPLETED|Overall Study||0
10741454|NCT02918656|11905351|FG001|NOT COMPLETED|Overall Study||0
10741455|NCT02918656|11905352|FG002|NOT COMPLETED|Overall Study||0
10741456|NCT02918669|11905360|FG000|STARTED|Overall Study||12
10741457|NCT02918669|11905360|FG000|COMPLETED|Overall Study||8
10741458|NCT02918669|11905360|FG000|NOT COMPLETED|Overall Study||4
10741462|NCT02918773|11905371|FG000|STARTED|Overall Study||11
10741463|NCT02918773|11905372|FG001|STARTED|Overall Study||11
10741464|NCT02918773|11905371|FG000|COMPLETED|Overall Study||11
10741465|NCT02918773|11905372|FG001|COMPLETED|Overall Study||11
10741466|NCT02918773|11905371|FG000|NOT COMPLETED|Overall Study||0
10741467|NCT02918773|11905372|FG001|NOT COMPLETED|Overall Study||0
10741468|NCT02918851|11905382|FG000|STARTED|Overall Study||14
10741469|NCT02918851|11905383|FG001|STARTED|Overall Study||14
10741470|NCT02918851|11905384|FG002|STARTED|Overall Study||14
10816875|NCT01439347|11980481|FG000|STARTED|Overall Study||13
10816876|NCT01439347|11980482|FG001|STARTED|Overall Study||13
10816877|NCT01439347|11980481|FG000|COMPLETED|Overall Study||0
10816878|NCT01439347|11980482|FG001|COMPLETED|Overall Study||0
10816879|NCT01439347|11980481|FG000|NOT COMPLETED|Overall Study||13
10816880|NCT01439347|11980482|FG001|NOT COMPLETED|Overall Study||13
10816881|NCT01440452|11980492|FG000|STARTED|Overall Study||6
10816882|NCT01440452|11980493|FG001|STARTED|Overall Study||7
10816883|NCT01440452|11980494|FG002|STARTED|Overall Study||8
10816884|NCT01440452|11980495|FG003|STARTED|Overall Study||4
10816885|NCT01440452|11980492|FG000|COMPLETED|Overall Study||6
10816886|NCT01440452|11980493|FG001|COMPLETED|Overall Study||7
10816887|NCT01440452|11980494|FG002|COMPLETED|Overall Study||8
10816888|NCT01440452|11980495|FG003|COMPLETED|Overall Study||4
10816889|NCT01440452|11980492|FG000|NOT COMPLETED|Overall Study||0
10816890|NCT01440452|11980493|FG001|NOT COMPLETED|Overall Study||0
10816891|NCT01440452|11980494|FG002|NOT COMPLETED|Overall Study||0
10816892|NCT01440452|11980495|FG003|NOT COMPLETED|Overall Study||0
10816893|NCT01433471|11980507|FG000|STARTED|Overall Study||2
10816894|NCT01433471|11980508|FG001|STARTED|Overall Study||2
10816895|NCT01433471|11980507|FG000|COMPLETED|Overall Study||2
10741471|NCT02918851|11905382|FG000|COMPLETED|Overall Study||10
10741472|NCT02918851|11905383|FG001|COMPLETED|Overall Study||10
10741473|NCT02918851|11905384|FG002|COMPLETED|Overall Study||10
10741474|NCT02918851|11905382|FG000|NOT COMPLETED|Overall Study||4
10741475|NCT02918851|11905383|FG001|NOT COMPLETED|Overall Study||4
10741476|NCT02918851|11905384|FG002|NOT COMPLETED|Overall Study||4
10741477|NCT02918877|11905394|FG000|STARTED|Overall Study||24
10741478|NCT02918877|11905395|FG001|STARTED|Overall Study||25
10741479|NCT02918877|11905394|FG000|COMPLETED|Overall Study||18
10741480|NCT02918877|11905395|FG001|COMPLETED|Overall Study||22
10741481|NCT02918877|11905394|FG000|NOT COMPLETED|Overall Study||6
10741482|NCT02918877|11905395|FG001|NOT COMPLETED|Overall Study||3
10741483|NCT02918968|11905403|FG000|STARTED|1st Line AAT||102
10741484|NCT02918968|11905404|FG001|STARTED|1st Line AAT||104
10741485|NCT02918968|11905403|FG000|Maintained 1st Line AAT Without Progression|1st Line AAT||25
10741486|NCT02918968|11905404|FG001|Maintained 1st Line AAT Without Progression|1st Line AAT||8
10741487|NCT02918968|11905403|FG000|COMPLETED|1st Line AAT||73
10741488|NCT02918968|11905404|FG001|COMPLETED|1st Line AAT||93
10741489|NCT02918968|11905403|FG000|NOT COMPLETED|1st Line AAT||29
10741490|NCT02918968|11905404|FG001|NOT COMPLETED|1st Line AAT||11
10741491|NCT02918968|11905403|FG000|STARTED|2nd Line AAT|Participants who maintained 1st line AAT without progression did not enter 2nd line AAT|48
10816896|NCT01433471|11980508|FG001|COMPLETED|Overall Study||1
10816897|NCT01433471|11980507|FG000|NOT COMPLETED|Overall Study||0
10816898|NCT01433471|11980508|FG001|NOT COMPLETED|Overall Study||1
10816899|NCT01436084|11980516|FG000|STARTED|Overall Study||4
10816900|NCT01436084|11980516|FG000|COMPLETED|Overall Study||0
10816901|NCT01436084|11980516|FG000|NOT COMPLETED|Overall Study||4
10741492|NCT02918968|11905404|FG001|STARTED|2nd Line AAT|Participants who maintained 1st line AAT without progression did not enter 2nd line AAT|85
10741493|NCT02918968|11905403|FG000|COMPLETED|2nd Line AAT||23
10741494|NCT02918968|11905404|FG001|COMPLETED|2nd Line AAT||73
10741495|NCT02918968|11905403|FG000|NOT COMPLETED|2nd Line AAT||25
10741496|NCT02918968|11905404|FG001|NOT COMPLETED|2nd Line AAT||12
10741497|NCT02919007|11905412|FG000|STARTED|Overall Study||25
10741498|NCT02919007|11905412|FG000|COMPLETED|Overall Study||25
10741499|NCT02919007|11905412|FG000|NOT COMPLETED|Overall Study||0
10741500|NCT02919111|11905416|FG000|STARTED|Overall Study||299
10741501|NCT02919111|11905416|FG000|COMPLETED|Overall Study||299
10741502|NCT02919111|11905416|FG000|NOT COMPLETED|Overall Study||0
10741503|NCT02919267|11905424|FG000|STARTED|Overall Study||10
10741504|NCT02919267|11905425|FG001|STARTED|Overall Study||12
10741505|NCT02919267|11905426|FG002|STARTED|Overall Study||13
10741506|NCT02919267|11905427|FG003|STARTED|Overall Study||14
10741507|NCT02919267|11905424|FG000|COMPLETED|Overall Study||10
10741508|NCT02919267|11905425|FG001|COMPLETED|Overall Study||9
10741509|NCT02919267|11905426|FG002|COMPLETED|Overall Study||10
10741510|NCT02919267|11905427|FG003|COMPLETED|Overall Study||10
10741511|NCT02919267|11905424|FG000|NOT COMPLETED|Overall Study||0
10741512|NCT02919267|11905425|FG001|NOT COMPLETED|Overall Study||3
10741513|NCT02919267|11905426|FG002|NOT COMPLETED|Overall Study||3
10741514|NCT02919267|11905427|FG003|NOT COMPLETED|Overall Study||4
10741515|NCT02919423|11905439|FG000|STARTED|Overall Study||6
10741516|NCT02919423|11905440|FG001|STARTED|Overall Study||25
10741517|NCT02919423|11905439|FG000|COMPLETED|Overall Study||4
10741518|NCT02919423|11905440|FG001|COMPLETED|Overall Study||16
10741519|NCT02919423|11905439|FG000|NOT COMPLETED|Overall Study||2
10741520|NCT02919423|11905440|FG001|NOT COMPLETED|Overall Study||9
10741521|NCT02919475|11905451|FG000|STARTED|Overall Study||52
10741522|NCT02919475|11905452|FG001|STARTED|Overall Study||52
10741523|NCT02919475|11905453|FG002|STARTED|Overall Study||52
10741524|NCT02919475|11905454|FG003|STARTED|Overall Study||51
10741525|NCT02919475|11905455|FG004|STARTED|Overall Study||52
10741526|NCT02919475|11905451|FG000|Started Dosing|Overall Study||51
10741527|NCT02919475|11905452|FG001|Started Dosing|Overall Study||52
10741528|NCT02919475|11905453|FG002|Started Dosing|Overall Study||52
10741529|NCT02919475|11905454|FG003|Started Dosing|Overall Study||51
10741530|NCT02919475|11905455|FG004|Started Dosing|Overall Study||52
10741531|NCT02919475|11905451|FG000|COMPLETED|Overall Study||46
10741532|NCT02919475|11905452|FG001|COMPLETED|Overall Study||44
10741533|NCT02919475|11905453|FG002|COMPLETED|Overall Study||47
10741534|NCT02919475|11905454|FG003|COMPLETED|Overall Study||38
10741535|NCT02919475|11905455|FG004|COMPLETED|Overall Study||48
10741536|NCT02919475|11905451|FG000|NOT COMPLETED|Overall Study||6
10741537|NCT02919475|11905452|FG001|NOT COMPLETED|Overall Study||8
10741538|NCT02919475|11905453|FG002|NOT COMPLETED|Overall Study||5
10741539|NCT02919475|11905454|FG003|NOT COMPLETED|Overall Study||13
10741540|NCT02919475|11905455|FG004|NOT COMPLETED|Overall Study||4
10741541|NCT02919657|11905467|FG000|STARTED|Overall Study|10 Participants|10
10741542|NCT02919657|11905468|FG001|STARTED|Overall Study|10 Participants|10
10816902|NCT01434511|11980520|FG000|STARTED|Overall Study||1
10816903|NCT01434511|11980520|FG000|COMPLETED|Overall Study||1
10816904|NCT01434511|11980520|FG000|NOT COMPLETED|Overall Study||0
10816905|NCT01426555|11980526|FG000|STARTED|Overall Study||35
10816906|NCT01426555|11980527|FG001|STARTED|Overall Study||35
10816907|NCT01426555|11980526|FG000|COMPLETED|Overall Study||17
10816908|NCT01426555|11980527|FG001|COMPLETED|Overall Study||20
10408691|NCT00756444|11552799|FG001|STARTED|Overall Study||34
10408692|NCT00756444|11552798|FG000|COMPLETED|Overall Study||18
10408693|NCT00756444|11552799|FG001|COMPLETED|Overall Study||13
10408694|NCT00756444|11552798|FG000|NOT COMPLETED|Overall Study||15
10816909|NCT01426555|11980526|FG000|NOT COMPLETED|Overall Study||18
10816910|NCT01426555|11980527|FG001|NOT COMPLETED|Overall Study||15
10816911|NCT01434745|11980537|FG000|STARTED|Overall Study||0
10816912|NCT01434745|11980538|FG001|STARTED|Overall Study||0
10816913|NCT01434745|11980537|FG000|COMPLETED|Overall Study||0
10816914|NCT01434745|11980538|FG001|COMPLETED|Overall Study||0
10816915|NCT01434745|11980537|FG000|NOT COMPLETED|Overall Study||0
10816916|NCT01434745|11980538|FG001|NOT COMPLETED|Overall Study||0
10816917|NCT01415986|11980544|FG000|STARTED|Overall Study||1
10816918|NCT01415986|11980544|FG000|COMPLETED|Overall Study|Study terminated|0
10816919|NCT01415986|11980544|FG000|NOT COMPLETED|Overall Study||1
10816920|NCT01410799|11980549|FG000|STARTED|Overall Study||13
10816921|NCT01410799|11980549|FG000|COMPLETED|Overall Study||0
10816922|NCT01410799|11980549|FG000|NOT COMPLETED|Overall Study||13
10408695|NCT00756444|11552799|FG001|NOT COMPLETED|Overall Study||21
10741543|NCT02919657|11905467|FG000|COMPLETED|Overall Study|completed with the same initial 10 participants|10
10741544|NCT02919657|11905468|FG001|COMPLETED|Overall Study|completed with the same initial 10 participants|10
10741545|NCT02919657|11905467|FG000|NOT COMPLETED|Overall Study||0
10741546|NCT02919657|11905468|FG001|NOT COMPLETED|Overall Study||0
10741547|NCT02919696|11905476|FG000|STARTED|Overall Study||12
10741548|NCT02919696|11905477|FG001|STARTED|Overall Study||14
10816923|NCT01426113|11980555|FG000|STARTED|Overall Study||3
10816924|NCT01426113|11980556|FG001|STARTED|Overall Study||3
10816925|NCT01426113|11980555|FG000|COMPLETED|Overall Study||2
10816926|NCT01426113|11980556|FG001|COMPLETED|Overall Study||1
10816927|NCT01426113|11980555|FG000|NOT COMPLETED|Overall Study||1
10408696|NCT00756457|11552808|FG000|STARTED|Overall Study||20
10741549|NCT02919696|11905476|FG000|Received at Least One Dose of Study Drug|Overall Study||12
10741550|NCT02919696|11905477|FG001|Received at Least One Dose of Study Drug|Overall Study||13
10741551|NCT02919696|11905476|FG000|PK 100 mg Abemaciclib Dose|Overall Study||5
10741552|NCT02919696|11905477|FG001|PK 100 mg Abemaciclib Dose|Overall Study||0
10741553|NCT02919696|11905476|FG000|PK 150 mg Abemaciclib Dose|Overall Study||0
10741554|NCT02919696|11905477|FG001|PK 150 mg Abemaciclib Dose|Overall Study||2
10741555|NCT02919696|11905476|FG000|Death On Treatment|Overall Study||1
10741556|NCT02919696|11905477|FG001|Death On Treatment|Overall Study||0
10741557|NCT02919696|11905476|FG000|Progressive Disease|Overall Study||7
10741558|NCT02919696|11905477|FG001|Progressive Disease|Overall Study||9
10741559|NCT02919696|11905476|FG000|COMPLETED|Overall Study||8
10741560|NCT02919696|11905477|FG001|COMPLETED|Overall Study||9
10741561|NCT02919696|11905476|FG000|NOT COMPLETED|Overall Study||4
10741562|NCT02919696|11905477|FG001|NOT COMPLETED|Overall Study||5
10741563|NCT02919761|11905489|FG000|STARTED|Part 1: Open Label||259
10741564|NCT02919761|11905490|FG001|STARTED|Part 1: Open Label|Part 2 Blinded groups were not evaluated as such during Part 1|0
10741565|NCT02919761|11905491|FG002|STARTED|Part 1: Open Label||0
10741566|NCT02919761|11905489|FG000|mITT Population|Part 1: Open Label||259
10741567|NCT02919761|11905490|FG001|mITT Population|Part 1: Open Label||0
10741568|NCT02919761|11905491|FG002|mITT Population|Part 1: Open Label||0
10741569|NCT02919761|11905489|FG000|Safety Population|Part 1: Open Label||259
10741570|NCT02919761|11905490|FG001|Safety Population|Part 1: Open Label||0
10741571|NCT02919761|11905491|FG002|Safety Population|Part 1: Open Label||0
10741572|NCT02919761|11905489|FG000|Per Protocol Population|Part 1: Open Label||236
10741573|NCT02919761|11905490|FG001|Per Protocol Population|Part 1: Open Label||0
10741574|NCT02919761|11905491|FG002|Per Protocol Population|Part 1: Open Label||0
10741575|NCT02919761|11905489|FG000|COMPLETED|Part 1: Open Label||235
10741576|NCT02919761|11905490|FG001|COMPLETED|Part 1: Open Label||0
10741577|NCT02919761|11905491|FG002|COMPLETED|Part 1: Open Label||0
10741578|NCT02919761|11905489|FG000|NOT COMPLETED|Part 1: Open Label||24
10741579|NCT02919761|11905490|FG001|NOT COMPLETED|Part 1: Open Label||0
10741580|NCT02919761|11905491|FG002|NOT COMPLETED|Part 1: Open Label||0
10741581|NCT02919761|11905489|FG000|STARTED|Part 2: Double-blind|154 of the original Part 1 participants continued to Part 2, randomized to Acthar or placebo|0
10741582|NCT02919761|11905490|FG001|STARTED|Part 2: Double-blind|77 participants who completed Part 1 were to receive Acthar for an additional 12 weeks in Part 2|77
10741583|NCT02919761|11905491|FG002|STARTED|Part 2: Double-blind|77 participants who completed Part 1 were to receive placebo for an additional 12 weeks in Part 2|77
10741584|NCT02919761|11905489|FG000|Safety Population|Part 2: Double-blind||0
10741585|NCT02919761|11905490|FG001|Safety Population|Part 2: Double-blind||77
10741586|NCT02919761|11905491|FG002|Safety Population|Part 2: Double-blind||77
10741587|NCT02919761|11905489|FG000|mITT Population|Part 2: Double-blind||0
10741588|NCT02919761|11905490|FG001|mITT Population|Part 2: Double-blind||77
10741589|NCT02919761|11905491|FG002|mITT Population|Part 2: Double-blind||76
10741590|NCT02919761|11905489|FG000|Per Protocol Population|Part 2: Double-blind||0
10741591|NCT02919761|11905490|FG001|Per Protocol Population|Part 2: Double-blind||76
10741592|NCT02919761|11905491|FG002|Per Protocol Population|Part 2: Double-blind||73
10741593|NCT02919761|11905489|FG000|COMPLETED|Part 2: Double-blind||0
10741594|NCT02919761|11905490|FG001|COMPLETED|Part 2: Double-blind||71
10816928|NCT01426113|11980556|FG001|NOT COMPLETED|Overall Study||2
10816929|NCT01426516|11980564|FG000|STARTED|Overall Study||12
10816930|NCT01426516|11980565|FG001|STARTED|Overall Study||17
10816931|NCT01426516|11980564|FG000|COMPLETED|Overall Study||12
10816932|NCT01426516|11980565|FG001|COMPLETED|Overall Study||17
10816933|NCT01426516|11980564|FG000|NOT COMPLETED|Overall Study||0
10816934|NCT01426516|11980565|FG001|NOT COMPLETED|Overall Study||0
10816935|NCT01420965|11980574|FG000|STARTED|Overall Study||2
10816936|NCT01420965|11980575|FG001|STARTED|Overall Study||2
10816937|NCT01420965|11980576|FG002|STARTED|Overall Study||3
10816938|NCT01420965|11980574|FG000|COMPLETED|Overall Study||1
10816939|NCT01420965|11980575|FG001|COMPLETED|Overall Study||1
10816940|NCT01420965|11980576|FG002|COMPLETED|Overall Study||3
10816941|NCT01420965|11980574|FG000|NOT COMPLETED|Overall Study||1
10816942|NCT01420965|11980575|FG001|NOT COMPLETED|Overall Study||1
10816943|NCT01420965|11980576|FG002|NOT COMPLETED|Overall Study||0
10816944|NCT01417377|11980584|FG000|STARTED|Overall Study||22
10816945|NCT01417377|11980584|FG000|Treated|Overall Study||21
10816946|NCT01417377|11980584|FG000|COMPLETED|Overall Study||9
10816947|NCT01417377|11980584|FG000|NOT COMPLETED|Overall Study||13
10816948|NCT01416272|11980588|FG000|STARTED|Overall Study||12
10816949|NCT01416272|11980588|FG000|COMPLETED|Overall Study||8
10816950|NCT01416272|11980588|FG000|NOT COMPLETED|Overall Study||4
10816951|NCT01414166|11980594|FG000|STARTED|Overall Study||122
10816952|NCT01414166|11980595|FG001|STARTED|Overall Study||122
10816953|NCT01414166|11980594|FG000|Treated|Overall Study||120
10816954|NCT01414166|11980595|FG001|Treated|Overall Study||121
10816955|NCT01414166|11980594|FG000|COMPLETED|Overall Study||31
10816956|NCT01414166|11980595|FG001|COMPLETED|Overall Study||39
10816957|NCT01414166|11980594|FG000|NOT COMPLETED|Overall Study||91
10816958|NCT01414166|11980595|FG001|NOT COMPLETED|Overall Study||83
10816959|NCT01406860|11980603|FG000|STARTED|Overall Study||11
10816960|NCT01406860|11980604|FG001|STARTED|Overall Study||8
10816961|NCT01406860|11980603|FG000|COMPLETED|Overall Study||11
10816962|NCT01406860|11980604|FG001|COMPLETED|Overall Study||8
10816963|NCT01406860|11980603|FG000|NOT COMPLETED|Overall Study||0
10816964|NCT01406860|11980604|FG001|NOT COMPLETED|Overall Study||0
10741595|NCT02919761|11905491|FG002|COMPLETED|Part 2: Double-blind||56
10741596|NCT02919761|11905489|FG000|NOT COMPLETED|Part 2: Double-blind||0
10741597|NCT02919761|11905490|FG001|NOT COMPLETED|Part 2: Double-blind||6
10741598|NCT02919761|11905491|FG002|NOT COMPLETED|Part 2: Double-blind||21
10741599|NCT02919813|11905504|FG000|STARTED|Overall Study||14
10741600|NCT02919813|11905505|FG001|STARTED|Overall Study||17
10741601|NCT02919813|11905504|FG000|COMPLETED|Overall Study||14
10741602|NCT02919813|11905505|FG001|COMPLETED|Overall Study||17
10741603|NCT02919813|11905504|FG000|NOT COMPLETED|Overall Study||0
10741604|NCT02919813|11905505|FG001|NOT COMPLETED|Overall Study||0
10741605|NCT02919826|11905513|FG000|STARTED|Overall Study||10
10741606|NCT02919826|11905514|FG001|STARTED|Overall Study||10
10741607|NCT02919826|11905513|FG000|COMPLETED|Overall Study||10
10741608|NCT02919826|11905514|FG001|COMPLETED|Overall Study||8
10741609|NCT02919826|11905513|FG000|NOT COMPLETED|Overall Study||0
10741610|NCT02919826|11905514|FG001|NOT COMPLETED|Overall Study||2
10741611|NCT02919995|11905528|FG000|STARTED|Overall Study||1
10741612|NCT02919995|11905529|FG001|STARTED|Overall Study||2
10741613|NCT02919995|11905530|FG002|STARTED|Overall Study||2
10741614|NCT02919995|11905531|FG003|STARTED|Overall Study||2
10741615|NCT02919995|11905532|FG004|STARTED|Overall Study||1
10741616|NCT02919995|11905533|FG005|STARTED|Overall Study||2
10741617|NCT02919995|11905528|FG000|COMPLETED|Overall Study||1
10741618|NCT02919995|11905529|FG001|COMPLETED|Overall Study||2
10741619|NCT02919995|11905530|FG002|COMPLETED|Overall Study||2
10741620|NCT02919995|11905531|FG003|COMPLETED|Overall Study||2
10741621|NCT02919995|11905532|FG004|COMPLETED|Overall Study||1
10741622|NCT02919995|11905533|FG005|COMPLETED|Overall Study||1
10741623|NCT02919995|11905528|FG000|NOT COMPLETED|Overall Study||0
10741624|NCT02919995|11905529|FG001|NOT COMPLETED|Overall Study||0
10741625|NCT02919995|11905530|FG002|NOT COMPLETED|Overall Study||0
10741626|NCT02919995|11905531|FG003|NOT COMPLETED|Overall Study||0
10741627|NCT02919995|11905532|FG004|NOT COMPLETED|Overall Study||0
10741628|NCT02919995|11905533|FG005|NOT COMPLETED|Overall Study||1
10741629|NCT02920528|11905544|FG000|STARTED|Overall Study||35
10741630|NCT02920528|11905545|FG001|STARTED|Overall Study||36
10741631|NCT02920528|11905546|FG002|STARTED|Overall Study||35
10741632|NCT02920528|11905544|FG000|COMPLETED|Overall Study||32
10741633|NCT02920528|11905545|FG001|COMPLETED|Overall Study||35
10741634|NCT02920528|11905546|FG002|COMPLETED|Overall Study||30
10741635|NCT02920528|11905544|FG000|NOT COMPLETED|Overall Study||3
10741636|NCT02920528|11905545|FG001|NOT COMPLETED|Overall Study||1
10741637|NCT02920528|11905546|FG002|NOT COMPLETED|Overall Study||5
10741638|NCT02920749|11905558|FG000|STARTED|Overall Study||30
10741639|NCT02920749|11905559|FG001|STARTED|Overall Study||30
10741640|NCT02920749|11905560|FG002|STARTED|Overall Study||30
10741641|NCT02920749|11905561|FG003|STARTED|Overall Study||30
10741642|NCT02920749|11905558|FG000|COMPLETED|Overall Study||30
10741643|NCT02920749|11905559|FG001|COMPLETED|Overall Study||30
10741644|NCT02920749|11905560|FG002|COMPLETED|Overall Study||30
10741645|NCT02920749|11905561|FG003|COMPLETED|Overall Study||30
10741646|NCT02920749|11905558|FG000|NOT COMPLETED|Overall Study||0
10741647|NCT02920749|11905559|FG001|NOT COMPLETED|Overall Study||0
10741648|NCT02920749|11905560|FG002|NOT COMPLETED|Overall Study||0
10741649|NCT02920749|11905561|FG003|NOT COMPLETED|Overall Study||0
10741650|NCT02920918|11905577|FG000|STARTED|Overall Study||17
10741651|NCT02920918|11905578|FG001|STARTED|Overall Study||19
10741652|NCT02920918|11905577|FG000|COMPLETED|Overall Study||17
10741653|NCT02920918|11905578|FG001|COMPLETED|Overall Study||19
10741654|NCT02920918|11905577|FG000|NOT COMPLETED|Overall Study||0
10741655|NCT02920918|11905578|FG001|NOT COMPLETED|Overall Study||0
10741656|NCT02920957|11905584|FG000|STARTED|First Intervention : 1 Month||46
10741657|NCT02920957|11905585|FG001|STARTED|First Intervention : 1 Month||41
10741658|NCT02920957|11905584|FG000|COMPLETED|First Intervention : 1 Month||42
10741659|NCT02920957|11905585|FG001|COMPLETED|First Intervention : 1 Month||41
10741660|NCT02920957|11905584|FG000|NOT COMPLETED|First Intervention : 1 Month||4
10741661|NCT02920957|11905585|FG001|NOT COMPLETED|First Intervention : 1 Month||0
10741662|NCT02920957|11905584|FG000|STARTED|Second Intervention: 1 Month||42
10741663|NCT02920957|11905585|FG001|STARTED|Second Intervention: 1 Month||41
10741664|NCT02920957|11905584|FG000|COMPLETED|Second Intervention: 1 Month||42
10741665|NCT02920957|11905585|FG001|COMPLETED|Second Intervention: 1 Month||40
10741666|NCT02920957|11905584|FG000|NOT COMPLETED|Second Intervention: 1 Month||0
10741667|NCT02920957|11905585|FG001|NOT COMPLETED|Second Intervention: 1 Month||1
10741668|NCT02920970|11905602|FG000|STARTED|First Intervention||38
10741669|NCT02920970|11905603|FG001|STARTED|First Intervention||32
10741670|NCT02920970|11905602|FG000|COMPLETED|First Intervention||38
10741671|NCT02920970|11905603|FG001|COMPLETED|First Intervention||30
10741672|NCT02920970|11905602|FG000|NOT COMPLETED|First Intervention||0
10741673|NCT02920970|11905603|FG001|NOT COMPLETED|First Intervention||2
10741674|NCT02920970|11905602|FG000|STARTED|Second Intervention||38
10741675|NCT02920970|11905603|FG001|STARTED|Second Intervention||30
10741676|NCT02920970|11905602|FG000|COMPLETED|Second Intervention||37
10741677|NCT02920970|11905603|FG001|COMPLETED|Second Intervention||30
10741678|NCT02920970|11905602|FG000|NOT COMPLETED|Second Intervention||1
10741679|NCT02920970|11905603|FG001|NOT COMPLETED|Second Intervention||0
10741680|NCT02920983|11905611|FG000|STARTED|Dispense 1||8
10741681|NCT02920983|11905612|FG001|STARTED|Dispense 1||10
10741682|NCT02920983|11905613|FG002|STARTED|Dispense 1||7
10741683|NCT02920983|11905614|FG003|STARTED|Dispense 1||6
10741684|NCT02920983|11905615|FG004|STARTED|Dispense 1||13
10741685|NCT02920983|11905616|FG005|STARTED|Dispense 1||7
10741686|NCT02920983|11905611|FG000|COMPLETED|Dispense 1||8
10741687|NCT02920983|11905612|FG001|COMPLETED|Dispense 1||10
10741688|NCT02920983|11905613|FG002|COMPLETED|Dispense 1||7
10741689|NCT02920983|11905614|FG003|COMPLETED|Dispense 1||6
10741690|NCT02920983|11905615|FG004|COMPLETED|Dispense 1||12
10741691|NCT02920983|11905616|FG005|COMPLETED|Dispense 1||7
10741692|NCT02920983|11905611|FG000|NOT COMPLETED|Dispense 1||0
10741693|NCT02920983|11905612|FG001|NOT COMPLETED|Dispense 1||0
10741694|NCT02920983|11905613|FG002|NOT COMPLETED|Dispense 1||0
10741695|NCT02920983|11905614|FG003|NOT COMPLETED|Dispense 1||0
10741696|NCT02920983|11905615|FG004|NOT COMPLETED|Dispense 1||1
10741697|NCT02920983|11905616|FG005|NOT COMPLETED|Dispense 1||0
10741698|NCT02920983|11905611|FG000|STARTED|Dispense 2||8
10741699|NCT02920983|11905612|FG001|STARTED|Dispense 2||10
10741700|NCT02920983|11905613|FG002|STARTED|Dispense 2||7
10741701|NCT02920983|11905614|FG003|STARTED|Dispense 2||6
10741702|NCT02920983|11905615|FG004|STARTED|Dispense 2||13
10741703|NCT02920983|11905616|FG005|STARTED|Dispense 2||7
10741704|NCT02920983|11905611|FG000|COMPLETED|Dispense 2||7
10741705|NCT02920983|11905612|FG001|COMPLETED|Dispense 2||10
10741706|NCT02920983|11905613|FG002|COMPLETED|Dispense 2||7
10741707|NCT02920983|11905614|FG003|COMPLETED|Dispense 2||6
10741708|NCT02920983|11905615|FG004|COMPLETED|Dispense 2||12
10741709|NCT02920983|11905616|FG005|COMPLETED|Dispense 2||7
10741710|NCT02920983|11905611|FG000|NOT COMPLETED|Dispense 2||1
10741711|NCT02920983|11905612|FG001|NOT COMPLETED|Dispense 2||0
10741712|NCT02920983|11905613|FG002|NOT COMPLETED|Dispense 2||0
10741713|NCT02920983|11905614|FG003|NOT COMPLETED|Dispense 2||0
10741714|NCT02920983|11905615|FG004|NOT COMPLETED|Dispense 2||1
10741715|NCT02920983|11905616|FG005|NOT COMPLETED|Dispense 2||0
10741716|NCT02920983|11905611|FG000|STARTED|Dispense 3||8
10741717|NCT02920983|11905612|FG001|STARTED|Dispense 3||10
10741718|NCT02920983|11905613|FG002|STARTED|Dispense 3||7
10741719|NCT02920983|11905614|FG003|STARTED|Dispense 3||6
10741720|NCT02920983|11905615|FG004|STARTED|Dispense 3||13
10741721|NCT02920983|11905616|FG005|STARTED|Dispense 3||7
10741722|NCT02920983|11905611|FG000|COMPLETED|Dispense 3||7
10741723|NCT02920983|11905612|FG001|COMPLETED|Dispense 3||9
10741724|NCT02920983|11905613|FG002|COMPLETED|Dispense 3||7
10741725|NCT02920983|11905614|FG003|COMPLETED|Dispense 3||6
10741726|NCT02920983|11905615|FG004|COMPLETED|Dispense 3||12
10741727|NCT02920983|11905616|FG005|COMPLETED|Dispense 3||7
10741728|NCT02920983|11905611|FG000|NOT COMPLETED|Dispense 3||1
10741729|NCT02920983|11905612|FG001|NOT COMPLETED|Dispense 3||1
10741730|NCT02920983|11905613|FG002|NOT COMPLETED|Dispense 3||0
10741731|NCT02920983|11905614|FG003|NOT COMPLETED|Dispense 3||0
10741732|NCT02920983|11905615|FG004|NOT COMPLETED|Dispense 3||1
10741733|NCT02920983|11905616|FG005|NOT COMPLETED|Dispense 3||0
10741734|NCT02921061|11905624|FG000|STARTED|Overall Study||28
10741735|NCT02921061|11905624|FG000|COMPLETED|Overall Study||28
10741736|NCT02921061|11905624|FG000|NOT COMPLETED|Overall Study||0
10741737|NCT02921087|11905630|FG000|STARTED|Overall Study||12
10741738|NCT02921087|11905631|FG001|STARTED|Overall Study||11
10741739|NCT02921087|11905630|FG000|COMPLETED|Overall Study||12
10741740|NCT02921087|11905631|FG001|COMPLETED|Overall Study|One subject dropped out prior to 1 week of lens wear while wearing the control lens (lens 1).|10
10741741|NCT02921087|11905630|FG000|NOT COMPLETED|Overall Study||0
10741742|NCT02921087|11905631|FG001|NOT COMPLETED|Overall Study||1
10741743|NCT02921295|11905647|FG000|STARTED|Sidekicks||1
10741744|NCT02921295|11905647|FG000|COMPLETED|Sidekicks||1
10741745|NCT02921295|11905647|FG000|NOT COMPLETED|Sidekicks||0
10741746|NCT02921295|11905647|FG000|STARTED|Conventional Prostheses||1
10741747|NCT02921295|11905647|FG000|COMPLETED|Conventional Prostheses||1
10741748|NCT02921295|11905647|FG000|NOT COMPLETED|Conventional Prostheses||0
10741749|NCT02921386|11905656|FG000|STARTED|Sequence A: Fasting||18
10741750|NCT02921386|11905656|FG000|COMPLETED|Sequence A: Fasting||18
10741751|NCT02921386|11905656|FG000|NOT COMPLETED|Sequence A: Fasting||0
10741752|NCT02921386|11905656|FG000|STARTED|Sequence B: 15 g Fat Breakfast||18
10741753|NCT02921386|11905656|FG000|COMPLETED|Sequence B: 15 g Fat Breakfast||18
10741754|NCT02921386|11905656|FG000|NOT COMPLETED|Sequence B: 15 g Fat Breakfast||0
10741755|NCT02921386|11905656|FG000|STARTED|Sequence C: 30 g Fat Breakfast||18
10741756|NCT02921386|11905656|FG000|COMPLETED|Sequence C: 30 g Fat Breakfast||18
10741757|NCT02921386|11905656|FG000|NOT COMPLETED|Sequence C: 30 g Fat Breakfast||0
10741758|NCT02921386|11905656|FG000|STARTED|Sequence D: 45 g Fat Breakfast||18
10741759|NCT02921386|11905656|FG000|COMPLETED|Sequence D: 45 g Fat Breakfast||18
10741760|NCT02921386|11905656|FG000|NOT COMPLETED|Sequence D: 45 g Fat Breakfast||0
10741761|NCT02921386|11905656|FG000|STARTED|Sequence E: FDA High Fat Breakfast||18
10741762|NCT02921386|11905656|FG000|COMPLETED|Sequence E: FDA High Fat Breakfast||18
10741763|NCT02921386|11905656|FG000|NOT COMPLETED|Sequence E: FDA High Fat Breakfast||0
10741764|NCT02921412|11905664|FG000|STARTED|Overall Study||36
10741765|NCT02921412|11905664|FG000|COMPLETED|Overall Study||36
10741766|NCT02921412|11905664|FG000|NOT COMPLETED|Overall Study||0
10741767|NCT02921425|11905675|FG000|STARTED|Overall Study||47
10741768|NCT02921425|11905675|FG000|Second Visit|Overall Study|Participants had to wear an accelerometer and make entries into their PHR over the previous 7 days.|47
10741769|NCT02921425|11905675|FG000|COMPLETED|Overall Study||38
10741770|NCT02921425|11905675|FG000|NOT COMPLETED|Overall Study||9
10741771|NCT02921490|11905679|FG000|STARTED|Overall Study||10
10741772|NCT02921490|11905679|FG000|COMPLETED|Overall Study||10
10741773|NCT02921490|11905679|FG000|NOT COMPLETED|Overall Study||0
10741774|NCT02921737|11905683|FG000|STARTED|Overall Study||7
10741775|NCT02921737|11905683|FG000|COMPLETED|Overall Study||7
10741776|NCT02921737|11905683|FG000|NOT COMPLETED|Overall Study||0
10741777|NCT02921750|11905689|FG000|STARTED|Overall Study||124
10741778|NCT02921750|11905690|FG001|STARTED|Overall Study||124
10741779|NCT02921750|11905689|FG000|Intention to Treat (ITT)|Overall Study||122
10741780|NCT02921750|11905690|FG001|Intention to Treat (ITT)|Overall Study||123
10741781|NCT02921750|11905689|FG000|Per Protocol (PP)|Overall Study||100
10741782|NCT02921750|11905690|FG001|Per Protocol (PP)|Overall Study||107
10741783|NCT02921750|11905689|FG000|Completed 6 Weeks Follow-up (PP)|Overall Study||97
10741784|NCT02921750|11905690|FG001|Completed 6 Weeks Follow-up (PP)|Overall Study||104
10741785|NCT02921750|11905689|FG000|Subgroup Followed for 24 Weeks (ITT)|Overall Study||35
10741786|NCT02921750|11905690|FG001|Subgroup Followed for 24 Weeks (ITT)|Overall Study||40
10741787|NCT02921750|11905689|FG000|Subgroup Followed for 24 Weeks (PP)|Overall Study||19
10741788|NCT02921750|11905690|FG001|Subgroup Followed for 24 Weeks (PP)|Overall Study||36
10741789|NCT02921750|11905689|FG000|COMPLETED|Overall Study||115
10741790|NCT02921750|11905690|FG001|COMPLETED|Overall Study||113
10741791|NCT02921750|11905689|FG000|NOT COMPLETED|Overall Study||9
10741792|NCT02921750|11905690|FG001|NOT COMPLETED|Overall Study||11
10741793|NCT02921841|11905701|FG000|STARTED|Overall Study||68
10741794|NCT02921841|11905702|FG001|STARTED|Overall Study||57
10741795|NCT02921841|11905701|FG000|COMPLETED|Overall Study||52
10741796|NCT02921841|11905702|FG001|COMPLETED|Overall Study||44
10741797|NCT02921841|11905701|FG000|NOT COMPLETED|Overall Study||16
10741798|NCT02921841|11905702|FG001|NOT COMPLETED|Overall Study||13
10741799|NCT02922153|11905710|FG000|STARTED|Overall Study||65
10741800|NCT02922153|11905711|FG001|STARTED|Overall Study||19
10741801|NCT02922153|11905710|FG000|COMPLETED|Overall Study||55
10741802|NCT02922153|11905711|FG001|COMPLETED|Overall Study||17
10741803|NCT02922153|11905710|FG000|NOT COMPLETED|Overall Study||10
10741804|NCT02922153|11905711|FG001|NOT COMPLETED|Overall Study||2
10741805|NCT02922582|11905721|FG000|STARTED|Overall Study||4
10741806|NCT02922582|11905722|FG001|STARTED|Overall Study||4
10741807|NCT02922582|11905723|FG002|STARTED|Overall Study||4
10741808|NCT02922582|11905724|FG003|STARTED|Overall Study||4
10741809|NCT02922582|11905721|FG000|COMPLETED|Overall Study||4
10741810|NCT02922582|11905722|FG001|COMPLETED|Overall Study||3
10741811|NCT02922582|11905723|FG002|COMPLETED|Overall Study||4
10741812|NCT02922582|11905724|FG003|COMPLETED|Overall Study||4
10741813|NCT02922582|11905721|FG000|NOT COMPLETED|Overall Study||0
10741814|NCT02922582|11905722|FG001|NOT COMPLETED|Overall Study||1
10741815|NCT02922582|11905723|FG002|NOT COMPLETED|Overall Study||0
10741816|NCT02922582|11905724|FG003|NOT COMPLETED|Overall Study||0
10741817|NCT02922634|11905734|FG000|STARTED|Overall Study||229
10741818|NCT02922634|11905734|FG000|COMPLETED|Overall Study||219
10741819|NCT02922634|11905734|FG000|NOT COMPLETED|Overall Study||10
10741820|NCT02922738|11905747|FG000|STARTED|Overall Study|158 patients and 17 providers|175
10741821|NCT02922738|11905748|FG001|STARTED|Overall Study|275 patients and 15 providers|290
10741822|NCT02922738|11905747|FG000|COMPLETED|Overall Study||175
10741823|NCT02922738|11905748|FG001|COMPLETED|Overall Study||290
10741824|NCT02922738|11905747|FG000|NOT COMPLETED|Overall Study||0
10741825|NCT02922738|11905748|FG001|NOT COMPLETED|Overall Study||0
10741826|NCT02922868|11905758|FG000|STARTED|Overall Study||30
10741827|NCT02922868|11905759|FG001|STARTED|Overall Study||30
10741828|NCT02922868|11905758|FG000|COMPLETED|Overall Study||30
10741829|NCT02922868|11905759|FG001|COMPLETED|Overall Study||30
10741830|NCT02922868|11905758|FG000|NOT COMPLETED|Overall Study||0
10741831|NCT02922868|11905759|FG001|NOT COMPLETED|Overall Study||0
10741832|NCT02922959|11905767|FG000|STARTED|Overall Study||40
10741833|NCT02922959|11905768|FG001|STARTED|Overall Study||40
10741834|NCT02922959|11905767|FG000|3 Weeks|Overall Study|n=38 (95.0%)|38
10741835|NCT02922959|11905768|FG001|3 Weeks|Overall Study|n=36 (90.0%)|36
10741836|NCT02922959|11905767|FG000|3 Months|Overall Study|n=35 (87.5%)|35
10741837|NCT02922959|11905768|FG001|3 Months|Overall Study|n=31 (77.5%)|31
10741838|NCT02922959|11905767|FG000|6 Months|Overall Study|n=28 (70.0%)|28
10741839|NCT02922959|11905768|FG001|6 Months|Overall Study|n=30 (75.0%)|30
10741840|NCT02922959|11905767|FG000|12 Months|Overall Study|n=21 (52.5%)|21
10741841|NCT02922959|11905768|FG001|12 Months|Overall Study|n=23 (57.5%)|23
10741842|NCT02922959|11905767|FG000|COMPLETED|Overall Study||21
10741843|NCT02922959|11905768|FG001|COMPLETED|Overall Study||23
10741844|NCT02922959|11905767|FG000|NOT COMPLETED|Overall Study||19
10741845|NCT02922959|11905768|FG001|NOT COMPLETED|Overall Study||17
10741846|NCT02923115|11905780|FG000|STARTED|Overall Study||12
10741847|NCT02923115|11905781|FG001|STARTED|Overall Study||16
10741848|NCT02923115|11905782|FG002|STARTED|Overall Study||23
10741849|NCT02923115|11905783|FG003|STARTED|Overall Study||23
10741850|NCT02923115|11905784|FG004|STARTED|Overall Study||22
10741851|NCT02923115|11905785|FG005|STARTED|Overall Study||38
10741852|NCT02923115|11905780|FG000|Treated|Overall Study||12
10741853|NCT02923115|11905781|FG001|Treated|Overall Study||16
10741854|NCT02923115|11905782|FG002|Treated|Overall Study||20
10741855|NCT02923115|11905783|FG003|Treated|Overall Study||22
10741856|NCT02923115|11905784|FG004|Treated|Overall Study||17
10741857|NCT02923115|11905785|FG005|Treated|Overall Study||38
10741858|NCT02923115|11905780|FG000|COMPLETED|Overall Study||12
10741859|NCT02923115|11905781|FG001|COMPLETED|Overall Study||15
10741860|NCT02923115|11905782|FG002|COMPLETED|Overall Study||20
10741861|NCT02923115|11905783|FG003|COMPLETED|Overall Study||21
10741862|NCT02923115|11905784|FG004|COMPLETED|Overall Study||17
10741863|NCT02923115|11905785|FG005|COMPLETED|Overall Study||38
10741864|NCT02923115|11905780|FG000|NOT COMPLETED|Overall Study||0
10741865|NCT02923115|11905781|FG001|NOT COMPLETED|Overall Study||1
10741866|NCT02923115|11905782|FG002|NOT COMPLETED|Overall Study||3
10741867|NCT02923115|11905783|FG003|NOT COMPLETED|Overall Study||2
10741868|NCT02923115|11905784|FG004|NOT COMPLETED|Overall Study||5
10741869|NCT02923115|11905785|FG005|NOT COMPLETED|Overall Study||0
10741870|NCT02923167|11905799|FG000|STARTED|Overall Study||6
10741871|NCT02923167|11905799|FG000|COMPLETED|Overall Study||4
10741872|NCT02923167|11905799|FG000|NOT COMPLETED|Overall Study||2
10741876|NCT02923245|11905810|FG000|STARTED|Overall Study||60
10741877|NCT02923245|11905811|FG001|STARTED|Overall Study||60
10741878|NCT02923245|11905810|FG000|COMPLETED|Overall Study||58
10741879|NCT02923245|11905811|FG001|COMPLETED|Overall Study||59
10741880|NCT02923245|11905810|FG000|NOT COMPLETED|Overall Study||2
10741881|NCT02923245|11905811|FG001|NOT COMPLETED|Overall Study||1
10741882|NCT02923271|11905820|FG000|STARTED|Overall Study||18
10741883|NCT02923271|11905821|FG001|STARTED|Overall Study||16
10741884|NCT02923271|11905820|FG000|COMPLETED|Overall Study||10
10741885|NCT02923271|11905821|FG001|COMPLETED|Overall Study||14
10741886|NCT02923271|11905820|FG000|NOT COMPLETED|Overall Study||8
10741887|NCT02923271|11905821|FG001|NOT COMPLETED|Overall Study||2
10741888|NCT02923349|11905834|FG000|STARTED|Overall Study||4
10741889|NCT02923349|11905835|FG001|STARTED|Overall Study||4
10741890|NCT02923349|11905836|FG002|STARTED|Overall Study||22
10741891|NCT02923349|11905837|FG003|STARTED|Overall Study||18
10741892|NCT02923349|11905838|FG004|STARTED|Overall Study||23
10741893|NCT02923349|11905839|FG005|STARTED|Overall Study||12
10741894|NCT02923349|11905840|FG006|STARTED|Overall Study||4
10741895|NCT02923349|11905834|FG000|COMPLETED|Overall Study||0
10741896|NCT02923349|11905835|FG001|COMPLETED|Overall Study||0
10741897|NCT02923349|11905836|FG002|COMPLETED|Overall Study||5
10741898|NCT02923349|11905837|FG003|COMPLETED|Overall Study||2
10741899|NCT02923349|11905838|FG004|COMPLETED|Overall Study||4
10741900|NCT02923349|11905839|FG005|COMPLETED|Overall Study||5
10741901|NCT02923349|11905840|FG006|COMPLETED|Overall Study||1
10741902|NCT02923349|11905834|FG000|NOT COMPLETED|Overall Study||4
10741903|NCT02923349|11905835|FG001|NOT COMPLETED|Overall Study||4
10741904|NCT02923349|11905836|FG002|NOT COMPLETED|Overall Study||17
10741905|NCT02923349|11905837|FG003|NOT COMPLETED|Overall Study||16
10741906|NCT02923349|11905838|FG004|NOT COMPLETED|Overall Study||19
10741907|NCT02923349|11905839|FG005|NOT COMPLETED|Overall Study||7
10741908|NCT02923349|11905840|FG006|NOT COMPLETED|Overall Study||3
10741909|NCT02923427|11905858|FG000|STARTED|Overall Study||55
10741910|NCT02923427|11905859|FG001|STARTED|Overall Study||57
10741911|NCT02923427|11905858|FG000|COMPLETED|Overall Study|"The reasons:~n= 2 Convert to Laparotomy n=1 Desaturation n=1 LMA-S can not be placed"|51
10741912|NCT02923427|11905859|FG001|COMPLETED|Overall Study|"The reasons:~n = 2 Convert to Laparotomy"|55
10741913|NCT02923427|11905858|FG000|NOT COMPLETED|Overall Study||4
10741914|NCT02923427|11905859|FG001|NOT COMPLETED|Overall Study||2
10741915|NCT02923895|11905867|FG000|STARTED|Overall Study||97
10741916|NCT02923895|11905868|FG001|STARTED|Overall Study||95
10741917|NCT02923895|11905867|FG000|COMPLETED|Overall Study||97
10741918|NCT02923895|11905868|FG001|COMPLETED|Overall Study||95
10741919|NCT02923895|11905867|FG000|NOT COMPLETED|Overall Study||0
10741920|NCT02923895|11905868|FG001|NOT COMPLETED|Overall Study||0
10741921|NCT02923921|11905876|FG000|STARTED|Overall Study||283
10741922|NCT02923921|11905877|FG001|STARTED|Overall Study||284
10741923|NCT02923921|11905876|FG000|Received at Least 1 Dose of Study Drug|Overall Study||278
10741924|NCT02923921|11905877|FG001|Received at Least 1 Dose of Study Drug|Overall Study||251
10741925|NCT02923921|11905876|FG000|Safety Population|Overall Study||278
10741926|NCT02923921|11905877|FG001|Safety Population|Overall Study||251
10741927|NCT02923921|11905876|FG000|COMPLETED|Overall Study||230
10741928|NCT02923921|11905877|FG001|COMPLETED|Overall Study||227
10741929|NCT02923921|11905876|FG000|NOT COMPLETED|Overall Study||53
10741930|NCT02923921|11905877|FG001|NOT COMPLETED|Overall Study||57
10741931|NCT02924051|11905885|FG000|STARTED|Overall Study||82
10741932|NCT02924051|11905886|FG001|STARTED|Overall Study||106
10741933|NCT02924051|11905885|FG000|COMPLETED|Overall Study||81
10741934|NCT02924051|11905886|FG001|COMPLETED|Overall Study||97
10741935|NCT02924051|11905885|FG000|NOT COMPLETED|Overall Study||1
10741936|NCT02924051|11905886|FG001|NOT COMPLETED|Overall Study||9
10741937|NCT02924350|11905896|FG000|STARTED|Overall Study||102
10741938|NCT02924350|11905897|FG001|STARTED|Overall Study||102
10741939|NCT02924350|11905896|FG000|COMPLETED|Overall Study||102
10741940|NCT02924350|11905897|FG001|COMPLETED|Overall Study||100
10741941|NCT02924350|11905896|FG000|NOT COMPLETED|Overall Study||0
10741942|NCT02924350|11905897|FG001|NOT COMPLETED|Overall Study||2
10741943|NCT02924428|11905905|FG000|STARTED|Overall Study||20
10741944|NCT02924428|11905906|FG001|STARTED|Overall Study||19
10741945|NCT02924428|11905905|FG000|COMPLETED|Overall Study||16
10741946|NCT02924428|11905906|FG001|COMPLETED|Overall Study||14
10741947|NCT02924428|11905905|FG000|NOT COMPLETED|Overall Study||4
10741948|NCT02924428|11905906|FG001|NOT COMPLETED|Overall Study||5
10741949|NCT02924688|11905918|FG000|STARTED|Overall Study||407
10741950|NCT02924688|11905919|FG001|STARTED|Overall Study||405
10741951|NCT02924688|11905920|FG002|STARTED|Overall Study||406
10741952|NCT02924688|11905921|FG003|STARTED|Overall Study||406
10741953|NCT02924688|11905922|FG004|STARTED|Overall Study||404
10741954|NCT02924688|11905923|FG005|STARTED|Overall Study||408
10741955|NCT02924688|11905918|FG000|COMPLETED|Overall Study||374
10741956|NCT02924688|11905919|FG001|COMPLETED|Overall Study||374
10741957|NCT02924688|11905920|FG002|COMPLETED|Overall Study||383
10741958|NCT02924688|11905921|FG003|COMPLETED|Overall Study||378
10741959|NCT02924688|11905922|FG004|COMPLETED|Overall Study||381
10741960|NCT02924688|11905923|FG005|COMPLETED|Overall Study||384
10741961|NCT02924688|11905918|FG000|NOT COMPLETED|Overall Study||33
10741962|NCT02924688|11905919|FG001|NOT COMPLETED|Overall Study||31
10741963|NCT02924688|11905920|FG002|NOT COMPLETED|Overall Study||23
10741964|NCT02924688|11905921|FG003|NOT COMPLETED|Overall Study||28
10741965|NCT02924688|11905922|FG004|NOT COMPLETED|Overall Study||23
10741966|NCT02924688|11905923|FG005|NOT COMPLETED|Overall Study||24
10741967|NCT02924883|11905942|FG000|STARTED|Overall Study||133
10741968|NCT02924883|11905943|FG001|STARTED|Overall Study||69
10741969|NCT02924883|11905942|FG000|COMPLETED|Overall Study||0
10741970|NCT02924883|11905943|FG001|COMPLETED|Overall Study||0
10741971|NCT02924883|11905942|FG000|NOT COMPLETED|Overall Study||133
10741972|NCT02924883|11905943|FG001|NOT COMPLETED|Overall Study||69
10741973|NCT02925078|11905953|FG000|STARTED|Overall Study||14
10741974|NCT02925078|11905954|FG001|STARTED|Overall Study||16
10741975|NCT02925078|11905953|FG000|COMPLETED|Overall Study||13
10741976|NCT02925078|11905954|FG001|COMPLETED|Overall Study||13
10741977|NCT02925078|11905953|FG000|NOT COMPLETED|Overall Study||1
10741978|NCT02925078|11905954|FG001|NOT COMPLETED|Overall Study||3
10741979|NCT02925117|11905964|FG000|STARTED|Period 1 (Weeks 0 - 16)||41
10741980|NCT02925117|11905965|FG001|STARTED|Period 1 (Weeks 0 - 16)||42
10741981|NCT02925117|11905966|FG002|STARTED|Period 1 (Weeks 0 - 16)||42
10741982|NCT02925117|11905967|FG003|STARTED|Period 1 (Weeks 0 - 16)||42
10741983|NCT02925117|11905968|FG004|STARTED|Period 1 (Weeks 0 - 16)||0
10741984|NCT02925117|11905969|FG005|STARTED|Period 1 (Weeks 0 - 16)||0
10741985|NCT02925117|11905970|FG006|STARTED|Period 1 (Weeks 0 - 16)||0
10741986|NCT02925117|11905971|FG007|STARTED|Period 1 (Weeks 0 - 16)||0
10741987|NCT02925117|11905972|FG008|STARTED|Period 1 (Weeks 0 - 16)||0
10741988|NCT02925117|11905973|FG009|STARTED|Period 1 (Weeks 0 - 16)||0
10741989|NCT02925117|11905974|FG010|STARTED|Period 1 (Weeks 0 - 16)||0
10741990|NCT02925117|11905975|FG011|STARTED|Period 1 (Weeks 0 - 16)||0
10741991|NCT02925117|11905964|FG000|Received Treatment|Period 1 (Weeks 0 - 16)||40
10741992|NCT02925117|11905965|FG001|Received Treatment|Period 1 (Weeks 0 - 16)||42
10741993|NCT02925117|11905966|FG002|Received Treatment|Period 1 (Weeks 0 - 16)||42
10741994|NCT02925117|11905967|FG003|Received Treatment|Period 1 (Weeks 0 - 16)||42
10741995|NCT02925117|11905968|FG004|Received Treatment|Period 1 (Weeks 0 - 16)||0
10741996|NCT02925117|11905969|FG005|Received Treatment|Period 1 (Weeks 0 - 16)||0
10741997|NCT02925117|11905970|FG006|Received Treatment|Period 1 (Weeks 0 - 16)||0
10741998|NCT02925117|11905971|FG007|Received Treatment|Period 1 (Weeks 0 - 16)||0
10741999|NCT02925117|11905972|FG008|Received Treatment|Period 1 (Weeks 0 - 16)||0
10742000|NCT02925117|11905973|FG009|Received Treatment|Period 1 (Weeks 0 - 16)||0
10742001|NCT02925117|11905974|FG010|Received Treatment|Period 1 (Weeks 0 - 16)||0
10742002|NCT02925117|11905975|FG011|Received Treatment|Period 1 (Weeks 0 - 16)||0
10742003|NCT02925117|11905964|FG000|COMPLETED|Period 1 (Weeks 0 - 16)||23
10742004|NCT02925117|11905965|FG001|COMPLETED|Period 1 (Weeks 0 - 16)||31
10742005|NCT02925117|11905966|FG002|COMPLETED|Period 1 (Weeks 0 - 16)||37
10742006|NCT02925117|11905967|FG003|COMPLETED|Period 1 (Weeks 0 - 16)||39
10742007|NCT02925117|11905968|FG004|COMPLETED|Period 1 (Weeks 0 - 16)||0
10742008|NCT02925117|11905969|FG005|COMPLETED|Period 1 (Weeks 0 - 16)||0
10742009|NCT02925117|11905970|FG006|COMPLETED|Period 1 (Weeks 0 - 16)||0
10742010|NCT02925117|11905971|FG007|COMPLETED|Period 1 (Weeks 0 - 16)||0
10742011|NCT02925117|11905972|FG008|COMPLETED|Period 1 (Weeks 0 - 16)||0
10742012|NCT02925117|11905973|FG009|COMPLETED|Period 1 (Weeks 0 - 16)||0
10742013|NCT02925117|11905974|FG010|COMPLETED|Period 1 (Weeks 0 - 16)||0
10742014|NCT02925117|11905975|FG011|COMPLETED|Period 1 (Weeks 0 - 16)||0
10742015|NCT02925117|11905964|FG000|NOT COMPLETED|Period 1 (Weeks 0 - 16)||18
10742016|NCT02925117|11905965|FG001|NOT COMPLETED|Period 1 (Weeks 0 - 16)||11
10742017|NCT02925117|11905966|FG002|NOT COMPLETED|Period 1 (Weeks 0 - 16)||5
10742018|NCT02925117|11905967|FG003|NOT COMPLETED|Period 1 (Weeks 0 - 16)||3
10742019|NCT02925117|11905968|FG004|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
10742020|NCT02925117|11905969|FG005|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
10742021|NCT02925117|11905970|FG006|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
10742022|NCT02925117|11905971|FG007|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
10742023|NCT02925117|11905972|FG008|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
10742024|NCT02925117|11905973|FG009|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
10742025|NCT02925117|11905974|FG010|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
10742026|NCT02925117|11905975|FG011|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
10742027|NCT02925117|11905964|FG000|STARTED|Period 2 (Weeks 16 - 88)||0
10742028|NCT02925117|11905965|FG001|STARTED|Period 2 (Weeks 16 - 88)||0
10742029|NCT02925117|11905966|FG002|STARTED|Period 2 (Weeks 16 - 88)||0
10742030|NCT02925117|11905967|FG003|STARTED|Period 2 (Weeks 16 - 88)||0
10742031|NCT02925117|11905968|FG004|STARTED|Period 2 (Weeks 16 - 88)||10
10742032|NCT02925117|11905969|FG005|STARTED|Period 2 (Weeks 16 - 88)||10
10742033|NCT02925117|11905970|FG006|STARTED|Period 2 (Weeks 16 - 88)||15
10742034|NCT02925117|11905971|FG007|STARTED|Period 2 (Weeks 16 - 88)||16
10742035|NCT02925117|11905972|FG008|STARTED|Period 2 (Weeks 16 - 88)||19
10742036|NCT02925117|11905973|FG009|STARTED|Period 2 (Weeks 16 - 88)||18
10742037|NCT02925117|11905974|FG010|STARTED|Period 2 (Weeks 16 - 88)||19
10742038|NCT02925117|11905975|FG011|STARTED|Period 2 (Weeks 16 - 88)||19
10742039|NCT02925117|11905964|FG000|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0
10742040|NCT02925117|11905965|FG001|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0
10742041|NCT02925117|11905966|FG002|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0
10742042|NCT02925117|11905967|FG003|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0
10742043|NCT02925117|11905968|FG004|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||8
10742044|NCT02925117|11905969|FG005|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||1
10742045|NCT02925117|11905970|FG006|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||13
10742046|NCT02925117|11905971|FG007|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||12
10742047|NCT02925117|11905972|FG008|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||17
10742048|NCT02925117|11905973|FG009|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||12
10742049|NCT02925117|11905974|FG010|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||14
10742050|NCT02925117|11905975|FG011|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||4
10742051|NCT02925117|11905964|FG000|COMPLETED|Period 2 (Weeks 16 - 88)||0
10742052|NCT02925117|11905965|FG001|COMPLETED|Period 2 (Weeks 16 - 88)||0
10742053|NCT02925117|11905966|FG002|COMPLETED|Period 2 (Weeks 16 - 88)||0
10742054|NCT02925117|11905967|FG003|COMPLETED|Period 2 (Weeks 16 - 88)||0
10742055|NCT02925117|11905968|FG004|COMPLETED|Period 2 (Weeks 16 - 88)||8
10742056|NCT02925117|11905969|FG005|COMPLETED|Period 2 (Weeks 16 - 88)||5
10742057|NCT02925117|11905970|FG006|COMPLETED|Period 2 (Weeks 16 - 88)||9
10742058|NCT02925117|11905971|FG007|COMPLETED|Period 2 (Weeks 16 - 88)||11
10742059|NCT02925117|11905972|FG008|COMPLETED|Period 2 (Weeks 16 - 88)||13
10742060|NCT02925117|11905973|FG009|COMPLETED|Period 2 (Weeks 16 - 88)||12
10742061|NCT02925117|11905974|FG010|COMPLETED|Period 2 (Weeks 16 - 88)||11
10742062|NCT02925117|11905975|FG011|COMPLETED|Period 2 (Weeks 16 - 88)||14
10742063|NCT02925117|11905964|FG000|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0
10742064|NCT02925117|11905965|FG001|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0
10742065|NCT02925117|11905966|FG002|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0
10742066|NCT02925117|11905967|FG003|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0
10742067|NCT02925117|11905968|FG004|NOT COMPLETED|Period 2 (Weeks 16 - 88)||2
10742068|NCT02925117|11905969|FG005|NOT COMPLETED|Period 2 (Weeks 16 - 88)||5
10742069|NCT02925117|11905970|FG006|NOT COMPLETED|Period 2 (Weeks 16 - 88)||6
10742070|NCT02925117|11905971|FG007|NOT COMPLETED|Period 2 (Weeks 16 - 88)||5
10742071|NCT02925117|11905972|FG008|NOT COMPLETED|Period 2 (Weeks 16 - 88)||6
10742072|NCT02925117|11905973|FG009|NOT COMPLETED|Period 2 (Weeks 16 - 88)||6
10742073|NCT02925117|11905974|FG010|NOT COMPLETED|Period 2 (Weeks 16 - 88)||8
10742074|NCT02925117|11905975|FG011|NOT COMPLETED|Period 2 (Weeks 16 - 88)||5
10742075|NCT02925143|11905997|FG000|STARTED|Overall Study||6525
10742076|NCT02925143|11905997|FG000|Participants Receiving Depolarizing Neuromuscular Blocking Agent (NMBA) (Succinylcholine)|Overall Study||3099
10742077|NCT02925143|11905997|FG000|Participants Receiving Non-depolarizing Neuromuscular Blocking Agent (NMBA)|Overall Study||3426
10742078|NCT02925143|11905997|FG000|COMPLETED|Overall Study||6525
10742079|NCT02925143|11905997|FG000|NOT COMPLETED|Overall Study||0
10742080|NCT02925312|11906003|FG000|STARTED|Overall Study||125
10742081|NCT02925312|11906004|FG001|STARTED|Overall Study||294
10742082|NCT02925312|11906003|FG000|COMPLETED|Overall Study||98
10742083|NCT02925312|11906004|FG001|COMPLETED|Overall Study||294
10742084|NCT02925312|11906003|FG000|NOT COMPLETED|Overall Study||27
10742085|NCT02925312|11906004|FG001|NOT COMPLETED|Overall Study||0
10742086|NCT02925403|11906012|FG000|STARTED|Overall Study||8
10742087|NCT02925403|11906013|FG001|STARTED|Overall Study||5
10742088|NCT02925403|11906012|FG000|COMPLETED|Overall Study||8
10742089|NCT02925403|11906013|FG001|COMPLETED|Overall Study||4
10742090|NCT02925403|11906012|FG000|NOT COMPLETED|Overall Study||0
10742091|NCT02925403|11906013|FG001|NOT COMPLETED|Overall Study||1
10742092|NCT02925455|11906021|FG000|STARTED|Overall Study||9
10742093|NCT02925455|11906022|FG001|STARTED|Overall Study||6
10742094|NCT02925455|11906021|FG000|COMPLETED|Overall Study||7
10742095|NCT02925455|11906022|FG001|COMPLETED|Overall Study||6
10742096|NCT02925455|11906021|FG000|NOT COMPLETED|Overall Study||2
10742097|NCT02925455|11906022|FG001|NOT COMPLETED|Overall Study||0
10742098|NCT02925494|11906032|FG000|STARTED|Treatment Period||59
10742099|NCT02925494|11906033|FG001|STARTED|Treatment Period||58
10742100|NCT02925494|11906034|FG002|STARTED|Treatment Period||98
10742101|NCT02925494|11906035|FG003|STARTED|Treatment Period||218
10742102|NCT02925494|11906032|FG000|COMPLETED|Treatment Period||50
10742103|NCT02925494|11906033|FG001|COMPLETED|Treatment Period||43
10742104|NCT02925494|11906034|FG002|COMPLETED|Treatment Period||79
10742105|NCT02925494|11906035|FG003|COMPLETED|Treatment Period||182
10742106|NCT02925494|11906032|FG000|NOT COMPLETED|Treatment Period||9
10742107|NCT02925494|11906033|FG001|NOT COMPLETED|Treatment Period||15
10742108|NCT02925494|11906034|FG002|NOT COMPLETED|Treatment Period||19
10742109|NCT02925494|11906035|FG003|NOT COMPLETED|Treatment Period||36
10742110|NCT02925494|11906032|FG000|STARTED|Post-Treatment Follow-Up Period||54
10742111|NCT02925494|11906033|FG001|STARTED|Post-Treatment Follow-Up Period||47
10742112|NCT02925494|11906034|FG002|STARTED|Post-Treatment Follow-Up Period||88
10742113|NCT02925494|11906035|FG003|STARTED|Post-Treatment Follow-Up Period||184
10742114|NCT02925494|11906032|FG000|COMPLETED|Post-Treatment Follow-Up Period||40
10742115|NCT02925494|11906033|FG001|COMPLETED|Post-Treatment Follow-Up Period||37
10742116|NCT02925494|11906034|FG002|COMPLETED|Post-Treatment Follow-Up Period||64
10742117|NCT02925494|11906035|FG003|COMPLETED|Post-Treatment Follow-Up Period||134
10742118|NCT02925494|11906032|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||14
10742119|NCT02925494|11906033|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||10
10742120|NCT02925494|11906034|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||24
10742121|NCT02925494|11906035|FG003|NOT COMPLETED|Post-Treatment Follow-Up Period||50
10742122|NCT02925611|11906048|FG000|STARTED|Overall Study||30
10742123|NCT02925611|11906049|FG001|STARTED|Overall Study||30
10742124|NCT02925611|11906048|FG000|COMPLETED|Overall Study||30
10742125|NCT02925611|11906049|FG001|COMPLETED|Overall Study||30
10742126|NCT02925611|11906048|FG000|NOT COMPLETED|Overall Study||0
10742127|NCT02925611|11906049|FG001|NOT COMPLETED|Overall Study||0
10742128|NCT02925741|11906057|FG000|STARTED|Overall Study||1637
10742129|NCT02925741|11906058|FG001|STARTED|Overall Study||1706
10742130|NCT02925741|11906057|FG000|COMPLETED|Overall Study||1626
10742131|NCT02925741|11906058|FG001|COMPLETED|Overall Study||1706
10742132|NCT02925741|11906057|FG000|NOT COMPLETED|Overall Study||11
10742133|NCT02925741|11906058|FG001|NOT COMPLETED|Overall Study||0
10742134|NCT02925858|11906069|FG000|STARTED|Overall Study||42
10742135|NCT02925858|11906070|FG001|STARTED|Overall Study||38
10742136|NCT02925858|11906069|FG000|COMPLETED|Overall Study||42
10742137|NCT02925858|11906070|FG001|COMPLETED|Overall Study||38
10742138|NCT02925858|11906069|FG000|NOT COMPLETED|Overall Study||0
10742139|NCT02925858|11906070|FG001|NOT COMPLETED|Overall Study||0
10742140|NCT02925923|11906078|FG000|STARTED|Overall Study||50
10742141|NCT02925923|11906079|FG001|STARTED|Overall Study||50
10742142|NCT02925923|11906078|FG000|COMPLETED|Overall Study||50
10742143|NCT02925923|11906079|FG001|COMPLETED|Overall Study||48
10742144|NCT02925923|11906078|FG000|NOT COMPLETED|Overall Study||0
10742145|NCT02925923|11906079|FG001|NOT COMPLETED|Overall Study||2
10742146|NCT02926027|11906087|FG000|STARTED|Overall Study||40
10742147|NCT02926027|11906088|FG001|STARTED|Overall Study||40
10742148|NCT02926027|11906087|FG000|COMPLETED|Overall Study||31
10742149|NCT02926027|11906088|FG001|COMPLETED|Overall Study||37
10742150|NCT02926027|11906087|FG000|NOT COMPLETED|Overall Study||9
10742151|NCT02926027|11906088|FG001|NOT COMPLETED|Overall Study||3
10742152|NCT02926209|11906094|FG000|STARTED|Study Cohort|Training cohort patients Aer-O-Scope as first followed by a conventional colonoscopy|42
10742153|NCT02926209|11906095|FG001|STARTED|Study Cohort||37
10742154|NCT02926209|11906094|FG000|COMPLETED|Study Cohort||41
10742155|NCT02926209|11906095|FG001|COMPLETED|Study Cohort||37
10742156|NCT02926209|11906094|FG000|NOT COMPLETED|Study Cohort||1
10742157|NCT02926209|11906095|FG001|NOT COMPLETED|Study Cohort||0
10742158|NCT02926209|11906094|FG000|STARTED|Training Cohort - First Patients||20
10742159|NCT02926209|11906095|FG001|STARTED|Training Cohort - First Patients||0
10742160|NCT02926209|11906094|FG000|COMPLETED|Training Cohort - First Patients||20
10742161|NCT02926209|11906095|FG001|COMPLETED|Training Cohort - First Patients||0
10742162|NCT02926209|11906094|FG000|NOT COMPLETED|Training Cohort - First Patients||0
10742163|NCT02926209|11906095|FG001|NOT COMPLETED|Training Cohort - First Patients||0
10742164|NCT02926573|11906104|FG000|STARTED|Overall Study||55
10742165|NCT02926573|11906105|FG001|STARTED|Overall Study||55
10742166|NCT02926573|11906104|FG000|COMPLETED|Overall Study||44
10816965|NCT01401049|11980613|FG000|STARTED|Overall Study|Due to flooding from Hurricane Sandy at our site, all files and pertinent patient data were lost.|0
10816966|NCT01401049|11980614|FG001|STARTED|Overall Study|Due to flooding from Hurricane Sandy at our site, all files and pertinent patient data were lost.|0
10816967|NCT01401049|11980613|FG000|COMPLETED|Overall Study||0
10816968|NCT01401049|11980614|FG001|COMPLETED|Overall Study||0
10816969|NCT01401049|11980613|FG000|NOT COMPLETED|Overall Study||0
10816970|NCT01401049|11980614|FG001|NOT COMPLETED|Overall Study||0
10816971|NCT01409031|11980622|FG000|STARTED|Overall Study||1
10816972|NCT01409031|11980623|FG001|STARTED|Overall Study||2
10816973|NCT01409031|11980622|FG000|COMPLETED|Overall Study||0
10816974|NCT01409031|11980623|FG001|COMPLETED|Overall Study||2
10816975|NCT01409031|11980622|FG000|NOT COMPLETED|Overall Study||1
10816976|NCT01409031|11980623|FG001|NOT COMPLETED|Overall Study||0
10816977|NCT01402531|11980629|FG000|STARTED|Overall Study||0
10816978|NCT01402531|11980629|FG000|COMPLETED|Overall Study||0
10816979|NCT01402531|11980629|FG000|NOT COMPLETED|Overall Study||0
10816980|NCT01394926|11980633|FG000|STARTED|Overall Study||21
10816981|NCT01394926|11980633|FG000|COMPLETED|Overall Study||21
10816982|NCT01394926|11980633|FG000|NOT COMPLETED|Overall Study||0
10816983|NCT01383681|11980642|FG000|STARTED|Overall Study||235
10816984|NCT01383681|11980642|FG000|COMPLETED|Overall Study||189
10816985|NCT01383681|11980642|FG000|NOT COMPLETED|Overall Study||46
10816986|NCT01403194|11980646|FG000|STARTED|Overall Study||11
10816987|NCT01403194|11980646|FG000|COMPLETED|Overall Study||1
10816988|NCT01403194|11980646|FG000|NOT COMPLETED|Overall Study||10
10816989|NCT01397552|11980652|FG000|STARTED|Overall Study||4
10816990|NCT01397552|11980653|FG001|STARTED|Overall Study||4
10816991|NCT01397552|11980652|FG000|COMPLETED|Overall Study||1
10742167|NCT02926573|11906105|FG001|COMPLETED|Overall Study||46
10742168|NCT02926573|11906104|FG000|NOT COMPLETED|Overall Study||11
10742169|NCT02926573|11906105|FG001|NOT COMPLETED|Overall Study||9
10742170|NCT02926677|11906114|FG000|STARTED|Overall Study||25
10742171|NCT02926677|11906115|FG001|STARTED|Overall Study||22
10816992|NCT01397552|11980653|FG001|COMPLETED|Overall Study||3
10816993|NCT01397552|11980652|FG000|NOT COMPLETED|Overall Study||3
10816994|NCT01397552|11980653|FG001|NOT COMPLETED|Overall Study||1
10816995|NCT01392170|11980659|FG000|STARTED|Overall Study||2
10816996|NCT01392170|11980659|FG000|COMPLETED|Overall Study||0
10816997|NCT01392170|11980659|FG000|NOT COMPLETED|Overall Study||2
10742172|NCT02926677|11906116|FG002|STARTED|Overall Study||26
10742173|NCT02926677|11906114|FG000|COMPLETED|Overall Study||8
10742174|NCT02926677|11906115|FG001|COMPLETED|Overall Study||8
10742175|NCT02926677|11906116|FG002|COMPLETED|Overall Study||6
10742176|NCT02926677|11906114|FG000|NOT COMPLETED|Overall Study||17
10742177|NCT02926677|11906115|FG001|NOT COMPLETED|Overall Study||14
10742178|NCT02926677|11906116|FG002|NOT COMPLETED|Overall Study||20
10778212|NCT03351335|11940104|FG000|NOT COMPLETED|Overall Study||0
10778213|NCT03351335|11940105|FG001|NOT COMPLETED|Overall Study||0
10778214|NCT03351335|11940106|FG002|NOT COMPLETED|Overall Study||4
10778215|NCT03351478|11940117|FG000|STARTED|Overall Study||307
10778216|NCT03351478|11940118|FG001|STARTED|Overall Study||309
10778217|NCT03351478|11940119|FG002|STARTED|Overall Study||154
10778218|NCT03351478|11940117|FG000|COMPLETED|Overall Study||293
10778219|NCT03351478|11940118|FG001|COMPLETED|Overall Study||292
10778220|NCT03351478|11940119|FG002|COMPLETED|Overall Study||147
10778221|NCT03351478|11940117|FG000|NOT COMPLETED|Overall Study||14
10778222|NCT03351478|11940118|FG001|NOT COMPLETED|Overall Study||17
10778223|NCT03351478|11940119|FG002|NOT COMPLETED|Overall Study||7
10778224|NCT03351608|11940132|FG000|STARTED|Overall Study||19
10778225|NCT03351608|11940133|FG001|STARTED|Overall Study||23
10778226|NCT03351608|11940134|FG002|STARTED|Overall Study||35
10778227|NCT03351608|11940135|FG003|STARTED|Overall Study||176
10778228|NCT03351608|11940136|FG004|STARTED|Overall Study||35
10778229|NCT03351608|11940132|FG000|Treated|Overall Study||18
10778230|NCT03351608|11940133|FG001|Treated|Overall Study||22
10778231|NCT03351608|11940134|FG002|Treated|Overall Study||33
10778232|NCT03351608|11940135|FG003|Treated|Overall Study||169
10778233|NCT03351608|11940136|FG004|Treated|Overall Study||34
10778234|NCT03351608|11940132|FG000|COMPLETED|Overall Study||18
10778235|NCT03351608|11940133|FG001|COMPLETED|Overall Study||21
10778236|NCT03351608|11940134|FG002|COMPLETED|Overall Study||32
10778237|NCT03351608|11940135|FG003|COMPLETED|Overall Study||168
10778238|NCT03351608|11940136|FG004|COMPLETED|Overall Study||33
10778239|NCT03351608|11940132|FG000|NOT COMPLETED|Overall Study||1
10778240|NCT03351608|11940133|FG001|NOT COMPLETED|Overall Study||2
10778241|NCT03351608|11940134|FG002|NOT COMPLETED|Overall Study||3
10778242|NCT03351608|11940135|FG003|NOT COMPLETED|Overall Study||8
10778243|NCT03351608|11940136|FG004|NOT COMPLETED|Overall Study||2
10778244|NCT03351699|11940164|FG000|STARTED|Overall Study||6
10778245|NCT03351699|11940165|FG001|STARTED|Overall Study||6
10778246|NCT03351699|11940166|FG002|STARTED|Overall Study||6
10778247|NCT03351699|11940167|FG003|STARTED|Overall Study||6
10778248|NCT03351699|11940168|FG004|STARTED|Overall Study|Panel F did not enroll, following evaluation of earlier Panel data.|0
10778249|NCT03351699|11940164|FG000|COMPLETED|Overall Study||6
10778250|NCT03351699|11940165|FG001|COMPLETED|Overall Study||6
10778251|NCT03351699|11940166|FG002|COMPLETED|Overall Study||6
10778252|NCT03351699|11940167|FG003|COMPLETED|Overall Study||6
10778253|NCT03351699|11940168|FG004|COMPLETED|Overall Study|Panel F did not enroll, following evaluation of earlier Panel data.|0
10778254|NCT03351699|11940164|FG000|NOT COMPLETED|Overall Study||0
10778255|NCT03351699|11940165|FG001|NOT COMPLETED|Overall Study||0
10778256|NCT03351699|11940166|FG002|NOT COMPLETED|Overall Study||0
10778257|NCT03351699|11940167|FG003|NOT COMPLETED|Overall Study||0
10778258|NCT03351699|11940168|FG004|NOT COMPLETED|Overall Study||0
10778259|NCT03351738|11940192|FG000|STARTED|Overall Study||23
10778260|NCT03351738|11940193|FG001|STARTED|Overall Study||20
10778261|NCT03351738|11940194|FG002|STARTED|Overall Study||24
10778262|NCT03351738|11940195|FG003|STARTED|Overall Study||22
10778263|NCT03351738|11940196|FG004|STARTED|Overall Study||21
10778264|NCT03351738|11940197|FG005|STARTED|Overall Study||22
10778265|NCT03351738|11940192|FG000|COMPLETED|Overall Study||23
10778266|NCT03351738|11940193|FG001|COMPLETED|Overall Study||19
10778267|NCT03351738|11940194|FG002|COMPLETED|Overall Study||24
10778268|NCT03351738|11940195|FG003|COMPLETED|Overall Study||21
10778269|NCT03351738|11940196|FG004|COMPLETED|Overall Study||21
10778270|NCT03351738|11940197|FG005|COMPLETED|Overall Study||22
10778271|NCT03351738|11940192|FG000|NOT COMPLETED|Overall Study||0
10778272|NCT03351738|11940193|FG001|NOT COMPLETED|Overall Study||1
10778273|NCT03351738|11940194|FG002|NOT COMPLETED|Overall Study||0
10778274|NCT03351738|11940195|FG003|NOT COMPLETED|Overall Study||1
10778275|NCT03351738|11940196|FG004|NOT COMPLETED|Overall Study||0
10778276|NCT03351738|11940197|FG005|NOT COMPLETED|Overall Study||0
10778277|NCT03351933|11940216|FG000|STARTED|Overall Study||28
10778278|NCT03351933|11940216|FG000|COMPLETED|Overall Study||26
10778279|NCT03351933|11940216|FG000|NOT COMPLETED|Overall Study||2
10778280|NCT03352245|11940222|FG000|STARTED|Overall Study||20
10778281|NCT03352245|11940223|FG001|STARTED|Overall Study||20
10778282|NCT03352245|11940222|FG000|COMPLETED|Overall Study||20
10778283|NCT03352245|11940223|FG001|COMPLETED|Overall Study||19
10778284|NCT03352245|11940222|FG000|NOT COMPLETED|Overall Study||0
10778285|NCT03352245|11940223|FG001|NOT COMPLETED|Overall Study||1
10778286|NCT03352323|11940229|FG000|STARTED|Overall Study||50
10778287|NCT03352323|11940229|FG000|COMPLETED|Overall Study||49
10778288|NCT03352323|11940229|FG000|NOT COMPLETED|Overall Study||1
10778289|NCT03352414|11940235|FG000|STARTED|Overall Study||42
10778290|NCT03352414|11940236|FG001|STARTED|Overall Study||42
10778291|NCT03352414|11940235|FG000|Allocated|Overall Study||30
10778292|NCT03352414|11940236|FG001|Allocated|Overall Study||32
10778293|NCT03352414|11940235|FG000|COMPLETED|Overall Study||30
10778294|NCT03352414|11940236|FG001|COMPLETED|Overall Study||32
10778295|NCT03352414|11940235|FG000|NOT COMPLETED|Overall Study||12
10778296|NCT03352414|11940236|FG001|NOT COMPLETED|Overall Study||10
10778297|NCT03352453|11940246|FG000|STARTED|Overall Study||66
10778298|NCT03352453|11940247|FG001|STARTED|Overall Study||72
10778299|NCT03352453|11940246|FG000|COMPLETED|Overall Study||44
10742179|NCT02926937|11906128|FG000|STARTED|Overall Study||150
10742180|NCT02926937|11906129|FG001|STARTED|Overall Study||142
10742181|NCT02926937|11906130|FG002|STARTED|Overall Study||107
10742182|NCT02926937|11906128|FG000|COMPLETED|Overall Study||131
10742183|NCT02926937|11906129|FG001|COMPLETED|Overall Study||127
10742184|NCT02926937|11906130|FG002|COMPLETED|Overall Study||96
10742185|NCT02926937|11906128|FG000|NOT COMPLETED|Overall Study||19
10742186|NCT02926937|11906129|FG001|NOT COMPLETED|Overall Study||15
10742187|NCT02926937|11906130|FG002|NOT COMPLETED|Overall Study||11
10742188|NCT02926950|11906141|FG000|STARTED|Overall Study||259
10742189|NCT02926950|11906142|FG001|STARTED|Overall Study||259
10742190|NCT02926950|11906141|FG000|COMPLETED|Overall Study||210
10816998|NCT01389817|11980665|FG000|STARTED|Overall Study||4
10816999|NCT01389817|11980666|FG001|STARTED|Overall Study||0
10817000|NCT01389817|11980665|FG000|COMPLETED|Overall Study||0
10817001|NCT01389817|11980666|FG001|COMPLETED|Overall Study||0
10817002|NCT01389817|11980665|FG000|NOT COMPLETED|Overall Study||4
10817003|NCT01389817|11980666|FG001|NOT COMPLETED|Overall Study||0
10817004|NCT01397695|11980672|FG000|STARTED|Overall Study||0
10817005|NCT01397695|11980672|FG000|COMPLETED|Overall Study||0
10817006|NCT01397695|11980672|FG000|NOT COMPLETED|Overall Study||0
10817007|NCT01390181|11980676|FG000|STARTED|Overall Study||4
10817008|NCT01390181|11980676|FG000|COMPLETED|Overall Study||0
10817009|NCT01390181|11980676|FG000|NOT COMPLETED|Overall Study||4
10817010|NCT01385033|11980682|FG000|STARTED|Part I|These subjects did not participate in Part II or III|6
10817011|NCT01385033|11980683|FG001|STARTED|Part I|These subjects did not participate in Part II or III|14
10817012|NCT01385033|11980684|FG002|STARTED|Part I||0
10817013|NCT01385033|11980685|FG003|STARTED|Part I||0
10817014|NCT01385033|11980686|FG004|STARTED|Part I||0
10817015|NCT01385033|11980687|FG005|STARTED|Part I||0
10742191|NCT02926950|11906142|FG001|COMPLETED|Overall Study||211
10742192|NCT02926950|11906141|FG000|NOT COMPLETED|Overall Study||49
10742193|NCT02926950|11906142|FG001|NOT COMPLETED|Overall Study||48
10817016|NCT01385033|11980682|FG000|COMPLETED|Part I||6
10817017|NCT01385033|11980683|FG001|COMPLETED|Part I||14
10817018|NCT01385033|11980684|FG002|COMPLETED|Part I||0
10817019|NCT01385033|11980685|FG003|COMPLETED|Part I||0
10817020|NCT01385033|11980686|FG004|COMPLETED|Part I||0
10817021|NCT01385033|11980687|FG005|COMPLETED|Part I||0
10817022|NCT01385033|11980682|FG000|NOT COMPLETED|Part I||0
10817023|NCT01385033|11980683|FG001|NOT COMPLETED|Part I||0
10817024|NCT01385033|11980684|FG002|NOT COMPLETED|Part I||0
10817025|NCT01385033|11980685|FG003|NOT COMPLETED|Part I||0
10817026|NCT01385033|11980686|FG004|NOT COMPLETED|Part I||0
10817027|NCT01385033|11980687|FG005|NOT COMPLETED|Part I||0
10817028|NCT01385033|11980682|FG000|STARTED|Part II||0
10817029|NCT01385033|11980683|FG001|STARTED|Part II||0
10817030|NCT01385033|11980684|FG002|STARTED|Part II||0
10817031|NCT01385033|11980685|FG003|STARTED|Part II||0
10742234|NCT02927171|11906215|FG000|STARTED|Overall Study||53
10742235|NCT02927171|11906216|FG001|STARTED|Overall Study||51
10742236|NCT02927171|11906215|FG000|COMPLETED|Overall Study||53
10742237|NCT02927171|11906216|FG001|COMPLETED|Overall Study||50
10742238|NCT02927171|11906215|FG000|NOT COMPLETED|Overall Study||0
10742239|NCT02927171|11906216|FG001|NOT COMPLETED|Overall Study||1
10742240|NCT02927223|11906222|FG000|STARTED|Overall Study||6
10742241|NCT02927223|11906222|FG000|COMPLETED|Overall Study||6
10742242|NCT02927223|11906222|FG000|NOT COMPLETED|Overall Study||0
10742246|NCT02927327|11906234|FG000|STARTED|Overall Study||30
10742247|NCT02927327|11906235|FG001|STARTED|Overall Study||31
10742248|NCT02927327|11906234|FG000|COMPLETED|Overall Study||30
10742249|NCT02927327|11906235|FG001|COMPLETED|Overall Study||31
10742250|NCT02927327|11906234|FG000|NOT COMPLETED|Overall Study||0
10742251|NCT02927327|11906235|FG001|NOT COMPLETED|Overall Study||0
10742252|NCT02927366|11906243|FG000|STARTED|Overall Study||6
10742253|NCT02927366|11906244|FG001|STARTED|Overall Study||2
10742254|NCT02927366|11906243|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||6
10742255|NCT02927366|11906244|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||2
10742256|NCT02927366|11906243|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||4
10742257|NCT02927366|11906244|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||0
10742258|NCT02927366|11906243|FG000|COMPLETED|Overall Study||4
10742259|NCT02927366|11906244|FG001|COMPLETED|Overall Study||2
10742260|NCT02927366|11906243|FG000|NOT COMPLETED|Overall Study||2
10742261|NCT02927366|11906244|FG001|NOT COMPLETED|Overall Study||0
10742262|NCT02927431|11906253|FG000|STARTED|Overall Study||2
10742263|NCT02927431|11906254|FG001|STARTED|Overall Study||4
10742264|NCT02927431|11906255|FG002|STARTED|Overall Study||4
10742265|NCT02927431|11906253|FG000|COMPLETED|Overall Study||2
10742266|NCT02927431|11906254|FG001|COMPLETED|Overall Study||4
10742267|NCT02927431|11906255|FG002|COMPLETED|Overall Study||3
10742268|NCT02927431|11906253|FG000|NOT COMPLETED|Overall Study||0
10742269|NCT02927431|11906254|FG001|NOT COMPLETED|Overall Study||0
10742270|NCT02927431|11906255|FG002|NOT COMPLETED|Overall Study||1
10742271|NCT02927457|11906267|FG000|STARTED|Overall Study||0
10742272|NCT02927457|11906268|FG001|STARTED|Overall Study||11
10742273|NCT02927457|11906267|FG000|COMPLETED|Overall Study||0
10742274|NCT02927457|11906268|FG001|COMPLETED|Overall Study||11
10742275|NCT02927457|11906267|FG000|NOT COMPLETED|Overall Study||0
10742276|NCT02927457|11906268|FG001|NOT COMPLETED|Overall Study||0
10742277|NCT02927639|11906280|FG000|STARTED|Overall Study||83
10742278|NCT02927639|11906281|FG001|STARTED|Overall Study|1 subj was inadvertently enrolled in another interventional study just before enrolling so removed.|82
10742279|NCT02927639|11906280|FG000|COMPLETED|Overall Study||10
10742280|NCT02927639|11906281|FG001|COMPLETED|Overall Study||13
10742281|NCT02927639|11906280|FG000|NOT COMPLETED|Overall Study||73
10742282|NCT02927639|11906281|FG001|NOT COMPLETED|Overall Study||69
10742283|NCT02927795|11906287|FG000|STARTED|Overall Study||257
10742284|NCT02927795|11906287|FG000|Treated|Overall Study||253
10742285|NCT02927795|11906287|FG000|COMPLETED|Overall Study||234
10742286|NCT02927795|11906287|FG000|NOT COMPLETED|Overall Study||23
10742287|NCT02927834|11906294|FG000|STARTED|Overall Study||8
10742288|NCT02927834|11906295|FG001|STARTED|Overall Study||8
10742289|NCT02927834|11906296|FG002|STARTED|Overall Study||8
10742290|NCT02927834|11906294|FG000|COMPLETED|Overall Study||7
10742291|NCT02927834|11906295|FG001|COMPLETED|Overall Study||6
10742292|NCT02927834|11906296|FG002|COMPLETED|Overall Study||6
10742293|NCT02927834|11906294|FG000|NOT COMPLETED|Overall Study||1
10742294|NCT02927834|11906295|FG001|NOT COMPLETED|Overall Study||2
10742295|NCT02927834|11906296|FG002|NOT COMPLETED|Overall Study||2
10742296|NCT02927873|11906310|FG000|STARTED|Overall Study||11
10742297|NCT02927873|11906311|FG001|STARTED|Overall Study||14
10742298|NCT02927873|11906312|FG002|STARTED|Overall Study||18
10742299|NCT02927873|11906313|FG003|STARTED|Overall Study||11
10742300|NCT02927873|11906314|FG004|STARTED|Overall Study||11
10742301|NCT02927873|11906315|FG005|STARTED|Overall Study||17
10742302|NCT02927873|11906310|FG000|COMPLETED|Overall Study||9
10742303|NCT02927873|11906311|FG001|COMPLETED|Overall Study||11
10742304|NCT02927873|11906312|FG002|COMPLETED|Overall Study||18
10742305|NCT02927873|11906313|FG003|COMPLETED|Overall Study||11
10742306|NCT02927873|11906314|FG004|COMPLETED|Overall Study||11
10742307|NCT02927873|11906315|FG005|COMPLETED|Overall Study||16
10742308|NCT02927873|11906310|FG000|NOT COMPLETED|Overall Study||2
10742309|NCT02927873|11906311|FG001|NOT COMPLETED|Overall Study||3
10742310|NCT02927873|11906312|FG002|NOT COMPLETED|Overall Study||0
10742311|NCT02927873|11906313|FG003|NOT COMPLETED|Overall Study||0
10742312|NCT02927873|11906314|FG004|NOT COMPLETED|Overall Study||0
10742313|NCT02927873|11906315|FG005|NOT COMPLETED|Overall Study||1
10742314|NCT02927925|11906329|FG000|STARTED|Overall Study||32
10742315|NCT02927925|11906329|FG000|COMPLETED|Overall Study||0
10742316|NCT02927925|11906329|FG000|NOT COMPLETED|Overall Study||32
10742317|NCT02928029|11906335|FG000|STARTED|Overall Study||3
10742318|NCT02928029|11906336|FG001|STARTED|Overall Study||4
10742319|NCT02928029|11906335|FG000|COMPLETED|Overall Study||0
10742320|NCT02928029|11906336|FG001|COMPLETED|Overall Study||0
10742321|NCT02928029|11906335|FG000|NOT COMPLETED|Overall Study||3
10742322|NCT02928029|11906336|FG001|NOT COMPLETED|Overall Study||4
10742323|NCT02928055|11906345|FG000|STARTED|Overall Study||8
10742324|NCT02928055|11906346|FG001|STARTED|Overall Study||8
10742325|NCT02928055|11906347|FG002|STARTED|Overall Study||7
10742326|NCT02928055|11906345|FG000|End of Treatment|Overall Study||8
10742327|NCT02928055|11906346|FG001|End of Treatment|Overall Study||8
10742328|NCT02928055|11906347|FG002|End of Treatment|Overall Study||6
10742329|NCT02928055|11906345|FG000|1 Month Follow up|Overall Study||7
10742330|NCT02928055|11906346|FG001|1 Month Follow up|Overall Study||7
10742331|NCT02928055|11906347|FG002|1 Month Follow up|Overall Study||6
10742332|NCT02928055|11906345|FG000|2 Month Follow up|Overall Study||6
10742333|NCT02928055|11906346|FG001|2 Month Follow up|Overall Study||7
10742334|NCT02928055|11906347|FG002|2 Month Follow up|Overall Study||5
10408697|NCT00756457|11552809|FG001|STARTED|Overall Study||19
10408698|NCT00756457|11552808|FG000|COMPLETED|Overall Study|One participant in the Active treatment group decided to have surgery after the 2 week follow-up.|19
10408699|NCT00756457|11552809|FG001|COMPLETED|Overall Study|One participant moved overseas; the other participant resumed cancer treatment|17
10408700|NCT00756457|11552808|FG000|NOT COMPLETED|Overall Study||1
10742335|NCT02928055|11906345|FG000|3 Month Follow up|Overall Study||5
10742336|NCT02928055|11906346|FG001|3 Month Follow up|Overall Study||6
10742337|NCT02928055|11906347|FG002|3 Month Follow up|Overall Study||5
10742338|NCT02928055|11906345|FG000|COMPLETED|Overall Study||5
10742339|NCT02928055|11906346|FG001|COMPLETED|Overall Study||6
10817032|NCT01385033|11980686|FG004|STARTED|Part II||0
10817033|NCT01385033|11980687|FG005|STARTED|Part II||0
10817034|NCT01385033|11980682|FG000|COMPLETED|Part II||0
10817035|NCT01385033|11980683|FG001|COMPLETED|Part II||0
10817036|NCT01385033|11980684|FG002|COMPLETED|Part II||0
10742340|NCT02928055|11906347|FG002|COMPLETED|Overall Study||5
10742341|NCT02928055|11906345|FG000|NOT COMPLETED|Overall Study||3
10742342|NCT02928055|11906346|FG001|NOT COMPLETED|Overall Study||2
10742343|NCT02928055|11906347|FG002|NOT COMPLETED|Overall Study||2
10742344|NCT02928380|11906355|FG000|STARTED|Period 1||13
10742345|NCT02928380|11906356|FG001|STARTED|Period 1||14
10742346|NCT02928380|11906357|FG002|STARTED|Period 1||14
10742347|NCT02928380|11906358|FG003|STARTED|Period 1||14
10742348|NCT02928380|11906359|FG004|STARTED|Period 1||14
10742349|NCT02928380|11906360|FG005|STARTED|Period 1||14
10742350|NCT02928380|11906355|FG000|COMPLETED|Period 1||13
10742351|NCT02928380|11906356|FG001|COMPLETED|Period 1||14
10742352|NCT02928380|11906357|FG002|COMPLETED|Period 1||14
10742353|NCT02928380|11906358|FG003|COMPLETED|Period 1||14
10742354|NCT02928380|11906359|FG004|COMPLETED|Period 1||14
10742355|NCT02928380|11906360|FG005|COMPLETED|Period 1||14
10742356|NCT02928380|11906355|FG000|NOT COMPLETED|Period 1||0
10742357|NCT02928380|11906356|FG001|NOT COMPLETED|Period 1||0
10742358|NCT02928380|11906357|FG002|NOT COMPLETED|Period 1||0
10742359|NCT02928380|11906358|FG003|NOT COMPLETED|Period 1||0
10742360|NCT02928380|11906359|FG004|NOT COMPLETED|Period 1||0
10742361|NCT02928380|11906360|FG005|NOT COMPLETED|Period 1||0
10742362|NCT02928380|11906355|FG000|STARTED|Wash Out Period 1||13
10742363|NCT02928380|11906356|FG001|STARTED|Wash Out Period 1||14
10742364|NCT02928380|11906357|FG002|STARTED|Wash Out Period 1||14
10742365|NCT02928380|11906358|FG003|STARTED|Wash Out Period 1||14
10742366|NCT02928380|11906359|FG004|STARTED|Wash Out Period 1||14
10742367|NCT02928380|11906360|FG005|STARTED|Wash Out Period 1||14
10742368|NCT02928380|11906355|FG000|COMPLETED|Wash Out Period 1||13
10742369|NCT02928380|11906356|FG001|COMPLETED|Wash Out Period 1||14
10742370|NCT02928380|11906357|FG002|COMPLETED|Wash Out Period 1||14
10742371|NCT02928380|11906358|FG003|COMPLETED|Wash Out Period 1||14
10742372|NCT02928380|11906359|FG004|COMPLETED|Wash Out Period 1||14
10742373|NCT02928380|11906360|FG005|COMPLETED|Wash Out Period 1||14
10742374|NCT02928380|11906355|FG000|NOT COMPLETED|Wash Out Period 1||0
10742375|NCT02928380|11906356|FG001|NOT COMPLETED|Wash Out Period 1||0
10742376|NCT02928380|11906357|FG002|NOT COMPLETED|Wash Out Period 1||0
10742377|NCT02928380|11906358|FG003|NOT COMPLETED|Wash Out Period 1||0
10742378|NCT02928380|11906359|FG004|NOT COMPLETED|Wash Out Period 1||0
10742379|NCT02928380|11906360|FG005|NOT COMPLETED|Wash Out Period 1||0
10742380|NCT02928380|11906355|FG000|STARTED|Period 2||13
10742381|NCT02928380|11906356|FG001|STARTED|Period 2||14
10742382|NCT02928380|11906357|FG002|STARTED|Period 2||14
10742383|NCT02928380|11906358|FG003|STARTED|Period 2||14
10742384|NCT02928380|11906359|FG004|STARTED|Period 2||14
10742385|NCT02928380|11906360|FG005|STARTED|Period 2||14
10742386|NCT02928380|11906355|FG000|COMPLETED|Period 2||13
10742387|NCT02928380|11906356|FG001|COMPLETED|Period 2||14
10742388|NCT02928380|11906357|FG002|COMPLETED|Period 2||14
10742389|NCT02928380|11906358|FG003|COMPLETED|Period 2||14
10742390|NCT02928380|11906359|FG004|COMPLETED|Period 2||14
10742391|NCT02928380|11906360|FG005|COMPLETED|Period 2||14
10742392|NCT02928380|11906355|FG000|NOT COMPLETED|Period 2||0
10742393|NCT02928380|11906356|FG001|NOT COMPLETED|Period 2||0
10742394|NCT02928380|11906357|FG002|NOT COMPLETED|Period 2||0
10742395|NCT02928380|11906358|FG003|NOT COMPLETED|Period 2||0
10742396|NCT02928380|11906359|FG004|NOT COMPLETED|Period 2||0
10817037|NCT01385033|11980685|FG003|COMPLETED|Part II||0
10742397|NCT02928380|11906360|FG005|NOT COMPLETED|Period 2||0
10742398|NCT02928380|11906355|FG000|STARTED|Wash Out Period 2||13
10742399|NCT02928380|11906356|FG001|STARTED|Wash Out Period 2||14
10742400|NCT02928380|11906357|FG002|STARTED|Wash Out Period 2||14
10742401|NCT02928380|11906358|FG003|STARTED|Wash Out Period 2||14
10742402|NCT02928380|11906359|FG004|STARTED|Wash Out Period 2||14
10742403|NCT02928380|11906360|FG005|STARTED|Wash Out Period 2||14
10742404|NCT02928380|11906355|FG000|COMPLETED|Wash Out Period 2||13
10742405|NCT02928380|11906356|FG001|COMPLETED|Wash Out Period 2||14
10817038|NCT01385033|11980686|FG004|COMPLETED|Part II||0
10817039|NCT01385033|11980687|FG005|COMPLETED|Part II||0
10742406|NCT02928380|11906357|FG002|COMPLETED|Wash Out Period 2||14
10742407|NCT02928380|11906358|FG003|COMPLETED|Wash Out Period 2||14
10742408|NCT02928380|11906359|FG004|COMPLETED|Wash Out Period 2||14
10742409|NCT02928380|11906360|FG005|COMPLETED|Wash Out Period 2||14
10742410|NCT02928380|11906355|FG000|NOT COMPLETED|Wash Out Period 2||0
10742411|NCT02928380|11906356|FG001|NOT COMPLETED|Wash Out Period 2||0
10742412|NCT02928380|11906357|FG002|NOT COMPLETED|Wash Out Period 2||0
10742413|NCT02928380|11906358|FG003|NOT COMPLETED|Wash Out Period 2||0
10742414|NCT02928380|11906359|FG004|NOT COMPLETED|Wash Out Period 2||0
10742415|NCT02928380|11906360|FG005|NOT COMPLETED|Wash Out Period 2||0
10742416|NCT02928380|11906355|FG000|STARTED|Period 3||13
10742417|NCT02928380|11906356|FG001|STARTED|Period 3||14
10742418|NCT02928380|11906357|FG002|STARTED|Period 3||14
10742419|NCT02928380|11906358|FG003|STARTED|Period 3||14
10742420|NCT02928380|11906359|FG004|STARTED|Period 3||14
10742421|NCT02928380|11906360|FG005|STARTED|Period 3||14
10742422|NCT02928380|11906355|FG000|COMPLETED|Period 3||13
10742423|NCT02928380|11906356|FG001|COMPLETED|Period 3||14
10742424|NCT02928380|11906357|FG002|COMPLETED|Period 3||14
10742425|NCT02928380|11906358|FG003|COMPLETED|Period 3||14
10742426|NCT02928380|11906359|FG004|COMPLETED|Period 3||14
10742427|NCT02928380|11906360|FG005|COMPLETED|Period 3||14
10742428|NCT02928380|11906355|FG000|NOT COMPLETED|Period 3||0
10742429|NCT02928380|11906356|FG001|NOT COMPLETED|Period 3||0
10742430|NCT02928380|11906357|FG002|NOT COMPLETED|Period 3||0
10742431|NCT02928380|11906358|FG003|NOT COMPLETED|Period 3||0
10742432|NCT02928380|11906359|FG004|NOT COMPLETED|Period 3||0
10742433|NCT02928380|11906360|FG005|NOT COMPLETED|Period 3||0
10742434|NCT02928536|11906371|FG000|STARTED|Overall Study||11902
10742435|NCT02928536|11906371|FG000|COMPLETED|Overall Study||11902
10742436|NCT02928536|11906371|FG000|NOT COMPLETED|Overall Study||0
10742437|NCT02928770|11906375|FG000|STARTED|Overall Study||32
10742438|NCT02928770|11906375|FG000|COMPLETED|Overall Study||30
10742439|NCT02928770|11906375|FG000|NOT COMPLETED|Overall Study||2
10742440|NCT02928848|11906381|FG000|STARTED|Arm 1||9
10742441|NCT02928848|11906382|FG001|STARTED|Arm 1||7
10742442|NCT02928848|11906381|FG000|COMPLETED|Arm 1||9
10742443|NCT02928848|11906382|FG001|COMPLETED|Arm 1||6
10742444|NCT02928848|11906381|FG000|NOT COMPLETED|Arm 1||0
10742445|NCT02928848|11906382|FG001|NOT COMPLETED|Arm 1||1
10742446|NCT02928848|11906381|FG000|STARTED|Arm 2||9
10742447|NCT02928848|11906382|FG001|STARTED|Arm 2||6
10742448|NCT02928848|11906381|FG000|COMPLETED|Arm 2||8
10742449|NCT02928848|11906382|FG001|COMPLETED|Arm 2||6
10742450|NCT02928848|11906381|FG000|NOT COMPLETED|Arm 2||1
10742451|NCT02928848|11906382|FG001|NOT COMPLETED|Arm 2||0
10742452|NCT02928952|11906392|FG000|STARTED|Overall Study||65
10742453|NCT02928952|11906393|FG001|STARTED|Overall Study||67
10742454|NCT02928952|11906392|FG000|COMPLETED|Overall Study||55
10742455|NCT02928952|11906393|FG001|COMPLETED|Overall Study||60
10742456|NCT02928952|11906392|FG000|NOT COMPLETED|Overall Study||10
10742457|NCT02928952|11906393|FG001|NOT COMPLETED|Overall Study||7
10742458|NCT02929329|11906401|FG000|STARTED|Overall Study||4112
10742459|NCT02929329|11906402|FG001|STARTED|Overall Study||4120
10742460|NCT02929329|11906401|FG000|Received Treatment|Overall Study||4101
10742461|NCT02929329|11906402|FG001|Received Treatment|Overall Study||4110
10742462|NCT02929329|11906401|FG000|COMPLETED|Overall Study|7 participants in this group who discontinued the study had unknown vital status at the end of study|3008
10742463|NCT02929329|11906402|FG001|COMPLETED|Overall Study|9 participants in this group who discontinued the study had unknown vital status at the end of study|3028
10742464|NCT02929329|11906401|FG000|NOT COMPLETED|Overall Study||1104
10742465|NCT02929329|11906402|FG001|NOT COMPLETED|Overall Study||1092
10742466|NCT02929407|11906412|FG000|STARTED|Overall Study||4
10742467|NCT02929407|11906412|FG000|COMPLETED|Overall Study||3
10742468|NCT02929407|11906412|FG000|NOT COMPLETED|Overall Study||1
10742469|NCT02929498|11906419|FG000|STARTED|Part 1: Dose Confirmation (Upto 2 Years)||5
10742470|NCT02929498|11906420|FG001|STARTED|Part 1: Dose Confirmation (Upto 2 Years)||0
10742471|NCT02929498|11906421|FG002|STARTED|Part 1: Dose Confirmation (Upto 2 Years)||0
10742472|NCT02929498|11906419|FG000|COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
10742473|NCT02929498|11906420|FG001|COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
10742474|NCT02929498|11906421|FG002|COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
10742475|NCT02929498|11906419|FG000|NOT COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||5
10742476|NCT02929498|11906420|FG001|NOT COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
10742477|NCT02929498|11906421|FG002|NOT COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
10817078|NCT01372618|11980711|FG000|NOT COMPLETED|Overall Study||9
10742478|NCT02929498|11906419|FG000|STARTED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
10742479|NCT02929498|11906420|FG001|STARTED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
10742480|NCT02929498|11906421|FG002|STARTED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
10742481|NCT02929498|11906419|FG000|COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
10742482|NCT02929498|11906420|FG001|COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
10742483|NCT02929498|11906421|FG002|COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
10742484|NCT02929498|11906419|FG000|NOT COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
10742485|NCT02929498|11906420|FG001|NOT COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
10742486|NCT02929498|11906421|FG002|NOT COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
10742487|NCT02929667|11906429|FG000|STARTED|Overall Study||11
10742488|NCT02929667|11906430|FG001|STARTED|Overall Study||11
10742489|NCT02929667|11906429|FG000|COMPLETED|Overall Study||11
10742490|NCT02929667|11906430|FG001|COMPLETED|Overall Study||11
10742491|NCT02929667|11906429|FG000|NOT COMPLETED|Overall Study||0
10742492|NCT02929667|11906430|FG001|NOT COMPLETED|Overall Study||0
10817040|NCT01385033|11980682|FG000|NOT COMPLETED|Part II||0
10817041|NCT01385033|11980683|FG001|NOT COMPLETED|Part II||0
10817042|NCT01385033|11980684|FG002|NOT COMPLETED|Part II||0
10817043|NCT01385033|11980685|FG003|NOT COMPLETED|Part II||0
10817044|NCT01385033|11980686|FG004|NOT COMPLETED|Part II||0
10817045|NCT01385033|11980687|FG005|NOT COMPLETED|Part II||0
10742493|NCT02929823|11906441|FG000|STARTED|Overall Study||42
10742494|NCT02929823|11906442|FG001|STARTED|Overall Study||46
10742495|NCT02929823|11906443|FG002|STARTED|Overall Study||42
10742496|NCT02929823|11906441|FG000|COMPLETED|Overall Study||39
10742497|NCT02929823|11906442|FG001|COMPLETED|Overall Study||40
10742498|NCT02929823|11906443|FG002|COMPLETED|Overall Study||38
10742499|NCT02929823|11906441|FG000|NOT COMPLETED|Overall Study||3
10742500|NCT02929823|11906442|FG001|NOT COMPLETED|Overall Study||6
10742501|NCT02929823|11906443|FG002|NOT COMPLETED|Overall Study||4
10742502|NCT02929979|11906453|FG000|STARTED|Overall Study||52
10742503|NCT02929979|11906454|FG001|STARTED|Overall Study||38
10742504|NCT02929979|11906453|FG000|COMPLETED|Overall Study||25
10742505|NCT02929979|11906454|FG001|COMPLETED|Overall Study||28
10742506|NCT02929979|11906453|FG000|NOT COMPLETED|Overall Study||27
10742507|NCT02929979|11906454|FG001|NOT COMPLETED|Overall Study||10
10742508|NCT02930005|11906463|FG000|STARTED|Overall Study||2
10742509|NCT02930005|11906464|FG001|STARTED|Overall Study||6
10742510|NCT02930005|11906463|FG000|Completed 2 Weeks|Overall Study||2
10742511|NCT02930005|11906464|FG001|Completed 2 Weeks|Overall Study||2
10742512|NCT02930005|11906463|FG000|COMPLETED|Overall Study||1
10742513|NCT02930005|11906464|FG001|COMPLETED|Overall Study||1
10742514|NCT02930005|11906463|FG000|NOT COMPLETED|Overall Study||1
10742515|NCT02930005|11906464|FG001|NOT COMPLETED|Overall Study||5
10742516|NCT02930018|11906472|FG000|STARTED|Overall Study||556
10742517|NCT02930018|11906473|FG001|STARTED|Overall Study||549
10742518|NCT02930018|11906472|FG000|COMPLETED|Overall Study||550
10742519|NCT02930018|11906473|FG001|COMPLETED|Overall Study||546
10742520|NCT02930018|11906472|FG000|NOT COMPLETED|Overall Study||6
10742521|NCT02930018|11906473|FG001|NOT COMPLETED|Overall Study||3
10742522|NCT02930174|11906481|FG000|STARTED|Overall Study||12
10742523|NCT02930174|11906482|FG001|STARTED|Overall Study||8
10742524|NCT02930174|11906481|FG000|COMPLETED|Overall Study||12
10742525|NCT02930174|11906482|FG001|COMPLETED|Overall Study||8
10742526|NCT02930174|11906481|FG000|NOT COMPLETED|Overall Study||0
10817046|NCT01385033|11980682|FG000|STARTED|Part III||0
10817047|NCT01385033|11980683|FG001|STARTED|Part III||0
10817048|NCT01385033|11980684|FG002|STARTED|Part III||0
10817049|NCT01385033|11980685|FG003|STARTED|Part III||0
10817050|NCT01385033|11980686|FG004|STARTED|Part III||0
10817051|NCT01385033|11980687|FG005|STARTED|Part III||0
10817052|NCT01385033|11980682|FG000|COMPLETED|Part III||0
10817053|NCT01385033|11980683|FG001|COMPLETED|Part III||0
10817054|NCT01385033|11980684|FG002|COMPLETED|Part III||0
10817055|NCT01385033|11980685|FG003|COMPLETED|Part III||0
10817056|NCT01385033|11980686|FG004|COMPLETED|Part III||0
10817057|NCT01385033|11980687|FG005|COMPLETED|Part III||0
10817058|NCT01385033|11980682|FG000|NOT COMPLETED|Part III||0
10817059|NCT01385033|11980683|FG001|NOT COMPLETED|Part III||0
10817060|NCT01385033|11980684|FG002|NOT COMPLETED|Part III||0
10817061|NCT01385033|11980685|FG003|NOT COMPLETED|Part III||0
10817062|NCT01385033|11980686|FG004|NOT COMPLETED|Part III||0
10817063|NCT01385033|11980687|FG005|NOT COMPLETED|Part III||0
10817064|NCT01394211|11980694|FG000|STARTED|Overall Study||2
10817065|NCT01394211|11980694|FG000|COMPLETED|Overall Study||0
10817066|NCT01394211|11980694|FG000|NOT COMPLETED|Overall Study||2
10817067|NCT01377441|11980700|FG000|STARTED|Overall Study||0
10817068|NCT01377441|11980701|FG001|STARTED|Overall Study||0
10817069|NCT01377441|11980700|FG000|COMPLETED|Overall Study|All data for this study was lost after Hurricane Sandy.|0
10817070|NCT01377441|11980701|FG001|COMPLETED|Overall Study|All data for this study was lost after Hurricane Sandy.|0
10817071|NCT01377441|11980700|FG000|NOT COMPLETED|Overall Study||0
10817072|NCT01377441|11980701|FG001|NOT COMPLETED|Overall Study||0
10742527|NCT02930174|11906482|FG001|NOT COMPLETED|Overall Study||0
10742528|NCT02930226|11906496|FG000|STARTED|Overall Study||4
10742529|NCT02930226|11906497|FG001|STARTED|Overall Study||4
10742530|NCT02930226|11906498|FG002|STARTED|Overall Study||4
10817073|NCT01383447|11980707|FG000|STARTED|Overall Study||2
10817074|NCT01383447|11980707|FG000|COMPLETED|Overall Study||0
10817075|NCT01383447|11980707|FG000|NOT COMPLETED|Overall Study||2
10817076|NCT01372618|11980711|FG000|STARTED|Overall Study||9
10817077|NCT01372618|11980711|FG000|COMPLETED|Overall Study||0
10817079|NCT01385280|11980715|FG000|STARTED|Overall Study||13
10817080|NCT01385280|11980715|FG000|COMPLETED|Overall Study||13
10742531|NCT02930226|11906499|FG003|STARTED|Overall Study||4
10742532|NCT02930226|11906500|FG004|STARTED|Overall Study||4
10742533|NCT02930226|11906501|FG005|STARTED|Overall Study||4
10742534|NCT02930226|11906496|FG000|COMPLETED|Overall Study||4
10742535|NCT02930226|11906497|FG001|COMPLETED|Overall Study||4
10742536|NCT02930226|11906498|FG002|COMPLETED|Overall Study||4
10742537|NCT02930226|11906499|FG003|COMPLETED|Overall Study||4
10742538|NCT02930226|11906500|FG004|COMPLETED|Overall Study||3
10742539|NCT02930226|11906501|FG005|COMPLETED|Overall Study||4
10817081|NCT01385280|11980715|FG000|NOT COMPLETED|Overall Study||0
10817082|NCT01379274|11980719|FG000|STARTED|Overall Study||2
10817083|NCT01379274|11980719|FG000|COMPLETED|Overall Study||1
10742540|NCT02930226|11906496|FG000|NOT COMPLETED|Overall Study||0
10742541|NCT02930226|11906497|FG001|NOT COMPLETED|Overall Study||0
10742542|NCT02930226|11906498|FG002|NOT COMPLETED|Overall Study||0
10742543|NCT02930226|11906499|FG003|NOT COMPLETED|Overall Study||0
10742544|NCT02930226|11906500|FG004|NOT COMPLETED|Overall Study||1
10742545|NCT02930226|11906501|FG005|NOT COMPLETED|Overall Study||0
10742546|NCT02930343|11906519|FG000|STARTED|Overall Study||68
10742547|NCT02930343|11906520|FG001|STARTED|Overall Study||68
10742548|NCT02930343|11906519|FG000|COMPLETED|Overall Study||59
10742549|NCT02930343|11906520|FG001|COMPLETED|Overall Study||61
10742550|NCT02930343|11906519|FG000|NOT COMPLETED|Overall Study||9
10742551|NCT02930343|11906520|FG001|NOT COMPLETED|Overall Study||7
10742552|NCT02930824|11906530|FG000|STARTED|Overall Study||62
10742553|NCT02930824|11906531|FG001|STARTED|Overall Study||63
10742554|NCT02930824|11906532|FG002|STARTED|Overall Study||30
10742555|NCT02930824|11906533|FG003|STARTED|Overall Study||30
10742556|NCT02930824|11906530|FG000|COMPLETED|Overall Study||56
10742557|NCT02930824|11906531|FG001|COMPLETED|Overall Study||57
10742558|NCT02930824|11906532|FG002|COMPLETED|Overall Study||20
10742559|NCT02930824|11906533|FG003|COMPLETED|Overall Study||23
10742560|NCT02930824|11906530|FG000|NOT COMPLETED|Overall Study||6
10742561|NCT02930824|11906531|FG001|NOT COMPLETED|Overall Study||6
10742562|NCT02930824|11906532|FG002|NOT COMPLETED|Overall Study||10
10742563|NCT02930824|11906533|FG003|NOT COMPLETED|Overall Study||7
10742564|NCT02930837|11906549|FG000|STARTED|Overall Study|Started are treated patients|120
10742565|NCT02930837|11906549|FG000|COMPLETED|Overall Study|Completed the trial|108
10742566|NCT02930837|11906549|FG000|NOT COMPLETED|Overall Study||12
10742567|NCT02930941|11906555|FG000|STARTED|Overall Study||17
10742568|NCT02930941|11906556|FG001|STARTED|Overall Study||18
10742569|NCT02930941|11906555|FG000|COMPLETED|Overall Study||16
10742570|NCT02930941|11906556|FG001|COMPLETED|Overall Study||16
10742571|NCT02930941|11906555|FG000|NOT COMPLETED|Overall Study||1
10742572|NCT02930941|11906556|FG001|NOT COMPLETED|Overall Study||2
10742573|NCT02930980|11906566|FG000|STARTED|Overall Study||43
10742574|NCT02930980|11906566|FG000|COMPLETED|Overall Study||43
10742575|NCT02930980|11906566|FG000|NOT COMPLETED|Overall Study||0
10742576|NCT02931045|11906572|FG000|STARTED|Overall Study||30
10742577|NCT02931045|11906573|FG001|STARTED|Overall Study||30
10742578|NCT02931045|11906572|FG000|COMPLETED|Overall Study||27
10742579|NCT02931045|11906573|FG001|COMPLETED|Overall Study||28
10742580|NCT02931045|11906572|FG000|NOT COMPLETED|Overall Study||3
10742581|NCT02931045|11906573|FG001|NOT COMPLETED|Overall Study||2
10742582|NCT02931253|11906581|FG000|STARTED|Overall Study||2
10742583|NCT02931253|11906582|FG001|STARTED|Overall Study||4
10742584|NCT02931253|11906581|FG000|COMPLETED|Overall Study||2
10742585|NCT02931253|11906582|FG001|COMPLETED|Overall Study||4
10742586|NCT02931253|11906581|FG000|NOT COMPLETED|Overall Study||0
10742587|NCT02931253|11906582|FG001|NOT COMPLETED|Overall Study||0
10742588|NCT02931396|11906590|FG000|STARTED|Overall Study||10
10817084|NCT01379274|11980719|FG000|NOT COMPLETED|Overall Study||1
10817085|NCT01379469|11980725|FG000|STARTED|Overall Study||13
10817086|NCT01379469|11980726|FG001|STARTED|Overall Study||7
10817087|NCT01379469|11980725|FG000|COMPLETED|Overall Study||1
10817088|NCT01379469|11980726|FG001|COMPLETED|Overall Study||3
10817089|NCT01379469|11980725|FG000|NOT COMPLETED|Overall Study||12
10817090|NCT01379469|11980726|FG001|NOT COMPLETED|Overall Study||4
10817091|NCT01369641|11980732|FG000|STARTED|Overall Study||1
10312896|NCT00146848|11446411|FG002|STARTED|Pre-randomization||0
10312897|NCT00146848|11446409|FG000|COMPLETED|Pre-randomization|Reached 6-week visit and were randomized|1433
10312898|NCT00146848|11446410|FG001|COMPLETED|Pre-randomization||0
10312899|NCT00146848|11446411|FG002|COMPLETED|Pre-randomization||0
10312900|NCT00146848|11446409|FG000|NOT COMPLETED|Pre-randomization||309
10312901|NCT00146848|11446410|FG001|NOT COMPLETED|Pre-randomization||0
10312902|NCT00146848|11446411|FG002|NOT COMPLETED|Pre-randomization||0
10312903|NCT00146848|11446409|FG000|STARTED|Post-randomization||475
10312904|NCT00146848|11446410|FG001|STARTED|Post-randomization||488
10312905|NCT00146848|11446411|FG002|STARTED|Post-randomization||470
10312906|NCT00146848|11446409|FG000|COMPLETED|Post-randomization||437
10312907|NCT00146848|11446410|FG001|COMPLETED|Post-randomization||441
10312908|NCT00146848|11446411|FG002|COMPLETED|Post-randomization||431
10312909|NCT00146848|11446409|FG000|NOT COMPLETED|Post-randomization||38
10312910|NCT00146848|11446410|FG001|NOT COMPLETED|Post-randomization||47
10312911|NCT00146848|11446411|FG002|NOT COMPLETED|Post-randomization||39
10312912|NCT00147017|11446422|FG000|STARTED|Overall Study||6
10312913|NCT00147017|11446423|FG001|STARTED|Overall Study||7
10312914|NCT00147017|11446424|FG002|STARTED|Overall Study||4
10408701|NCT00756457|11552809|FG001|NOT COMPLETED|Overall Study||2
10742589|NCT02931396|11906591|FG001|STARTED|Overall Study||10
10742590|NCT02931396|11906590|FG000|COMPLETED|Overall Study||5
10742591|NCT02931396|11906591|FG001|COMPLETED|Overall Study||10
10742592|NCT02931396|11906590|FG000|NOT COMPLETED|Overall Study||5
10742593|NCT02931396|11906591|FG001|NOT COMPLETED|Overall Study||0
10742594|NCT02931539|11906599|FG000|STARTED|Period 1: Treatment Phase||117
10742595|NCT02931539|11906600|FG001|STARTED|Period 1: Treatment Phase||235
10742596|NCT02931539|11906601|FG002|STARTED|Period 1: Treatment Phase||0
10742597|NCT02931539|11906599|FG000|Treated Participants|Period 1: Treatment Phase||116
10817092|NCT01369641|11980732|FG000|COMPLETED|Overall Study||0
10817093|NCT01369641|11980732|FG000|NOT COMPLETED|Overall Study||1
10408702|NCT00756470|11552831|FG000|STARTED|Overall Study||15
10742598|NCT02931539|11906600|FG001|Treated Participants|Period 1: Treatment Phase||234
10742599|NCT02931539|11906601|FG002|Treated Participants|Period 1: Treatment Phase||0
10742600|NCT02931539|11906599|FG000|IAT (Ganciclovir/ Valganciclovir)|Period 1: Treatment Phase||56
10742601|NCT02931539|11906600|FG001|IAT (Ganciclovir/ Valganciclovir)|Period 1: Treatment Phase||0
10742602|NCT02931539|11906601|FG002|IAT (Ganciclovir/ Valganciclovir)|Period 1: Treatment Phase||0
10742603|NCT02931539|11906599|FG000|IAT (Foscarnet)|Period 1: Treatment Phase||47
10742604|NCT02931539|11906600|FG001|IAT (Foscarnet)|Period 1: Treatment Phase||0
10742605|NCT02931539|11906601|FG002|IAT (Foscarnet)|Period 1: Treatment Phase||0
10742606|NCT02931539|11906599|FG000|IAT (Cidofovir)|Period 1: Treatment Phase||6
10742607|NCT02931539|11906600|FG001|IAT (Cidofovir)|Period 1: Treatment Phase||0
10742608|NCT02931539|11906601|FG002|IAT (Cidofovir)|Period 1: Treatment Phase||0
10742609|NCT02931539|11906599|FG000|IAT (Foscarnet + Valganciclovir/Ganciclovir)|Period 1: Treatment Phase||7
10742610|NCT02931539|11906600|FG001|IAT (Foscarnet + Valganciclovir/Ganciclovir)|Period 1: Treatment Phase||0
10742611|NCT02931539|11906601|FG002|IAT (Foscarnet + Valganciclovir/Ganciclovir)|Period 1: Treatment Phase||0
10742612|NCT02931539|11906599|FG000|COMPLETED|Period 1: Treatment Phase||58
10742613|NCT02931539|11906600|FG001|COMPLETED|Period 1: Treatment Phase||199
10742614|NCT02931539|11906601|FG002|COMPLETED|Period 1: Treatment Phase||0
10742615|NCT02931539|11906599|FG000|NOT COMPLETED|Period 1: Treatment Phase||59
10742616|NCT02931539|11906600|FG001|NOT COMPLETED|Period 1: Treatment Phase||36
10742617|NCT02931539|11906601|FG002|NOT COMPLETED|Period 1: Treatment Phase||0
10742618|NCT02931539|11906599|FG000|STARTED|Period 2: Maribavir Rescue Therapy||0
10742619|NCT02931539|11906600|FG001|STARTED|Period 2: Maribavir Rescue Therapy||0
10742620|NCT02931539|11906601|FG002|STARTED|Period 2: Maribavir Rescue Therapy||22
10742621|NCT02931539|11906599|FG000|COMPLETED|Period 2: Maribavir Rescue Therapy||0
10742622|NCT02931539|11906600|FG001|COMPLETED|Period 2: Maribavir Rescue Therapy||0
10742623|NCT02931539|11906601|FG002|COMPLETED|Period 2: Maribavir Rescue Therapy||20
10742624|NCT02931539|11906599|FG000|NOT COMPLETED|Period 2: Maribavir Rescue Therapy||0
10742625|NCT02931539|11906600|FG001|NOT COMPLETED|Period 2: Maribavir Rescue Therapy||0
10742626|NCT02931539|11906601|FG002|NOT COMPLETED|Period 2: Maribavir Rescue Therapy||2
10742627|NCT02931565|11906616|FG000|STARTED|Overall Study||2
10742628|NCT02931565|11906617|FG001|STARTED|Overall Study||7
10742629|NCT02931565|11906616|FG000|COMPLETED|Overall Study||2
10742630|NCT02931565|11906617|FG001|COMPLETED|Overall Study||7
10742631|NCT02931565|11906616|FG000|NOT COMPLETED|Overall Study||0
10742632|NCT02931565|11906617|FG001|NOT COMPLETED|Overall Study||0
10742633|NCT02931838|11906630|FG000|STARTED|Overall Study||45
10742634|NCT02931838|11906631|FG001|STARTED|Overall Study||44
10742635|NCT02931838|11906632|FG002|STARTED|Overall Study||44
10742636|NCT02931838|11906633|FG003|STARTED|Overall Study||45
10742637|NCT02931838|11906634|FG004|STARTED|Overall Study||45
10742638|NCT02931838|11906635|FG005|STARTED|Overall Study||44
10742639|NCT02931838|11906630|FG000|COMPLETED|Overall Study||31
10742640|NCT02931838|11906631|FG001|COMPLETED|Overall Study||34
10742641|NCT02931838|11906632|FG002|COMPLETED|Overall Study||36
10742642|NCT02931838|11906633|FG003|COMPLETED|Overall Study||42
10742643|NCT02931838|11906634|FG004|COMPLETED|Overall Study||39
10742644|NCT02931838|11906635|FG005|COMPLETED|Overall Study||42
10742645|NCT02931838|11906630|FG000|NOT COMPLETED|Overall Study||14
10742646|NCT02931838|11906631|FG001|NOT COMPLETED|Overall Study||10
10742647|NCT02931838|11906632|FG002|NOT COMPLETED|Overall Study||8
10742648|NCT02931838|11906633|FG003|NOT COMPLETED|Overall Study||3
10742649|NCT02931838|11906634|FG004|NOT COMPLETED|Overall Study||6
10742650|NCT02931838|11906635|FG005|NOT COMPLETED|Overall Study||2
10742651|NCT02932228|11906656|FG000|STARTED|Overall Study||150
10742652|NCT02932228|11906657|FG001|STARTED|Overall Study||433
10742653|NCT02932228|11906656|FG000|COMPLETED|Overall Study||140
10742654|NCT02932228|11906657|FG001|COMPLETED|Overall Study||405
10742655|NCT02932228|11906656|FG000|NOT COMPLETED|Overall Study||10
10742656|NCT02932228|11906657|FG001|NOT COMPLETED|Overall Study||28
10742657|NCT02932267|11906665|FG000|STARTED|Overall Study||50
10742658|NCT02932267|11906665|FG000|COMPLETED|Overall Study||42
10742659|NCT02932267|11906665|FG000|NOT COMPLETED|Overall Study||8
10742660|NCT02932306|11906671|FG000|STARTED|Overall Study||406
10742661|NCT02932306|11906672|FG001|STARTED|Overall Study||414
10742662|NCT02932306|11906671|FG000|Intent-to-treat (ITT) Population|Overall Study||406
10742663|NCT02932306|11906672|FG001|Intent-to-treat (ITT) Population|Overall Study||414
10742664|NCT02932306|11906671|FG000|Safety Population|Overall Study||378
10742665|NCT02932306|11906672|FG001|Safety Population|Overall Study||385
10742666|NCT02932306|11906671|FG000|COMPLETED|Overall Study||338
10742667|NCT02932306|11906672|FG001|COMPLETED|Overall Study||337
10742668|NCT02932306|11906671|FG000|NOT COMPLETED|Overall Study||68
10742669|NCT02932306|11906672|FG001|NOT COMPLETED|Overall Study||77
10742670|NCT02932462|11906680|FG000|STARTED|Overall Study||184
10742671|NCT02932462|11906681|FG001|STARTED|Overall Study||189
10742672|NCT02932462|11906680|FG000|COMPLETED|Overall Study||177
10742673|NCT02932462|11906681|FG001|COMPLETED|Overall Study||176
10742674|NCT02932462|11906680|FG000|NOT COMPLETED|Overall Study||7
10742675|NCT02932462|11906681|FG001|NOT COMPLETED|Overall Study||13
10742676|NCT02932787|11906689|FG000|STARTED|Overall Study||22
10742677|NCT02932787|11906690|FG001|STARTED|Overall Study||9
10742678|NCT02932787|11906689|FG000|COMPLETED|Overall Study||22
10742679|NCT02932787|11906690|FG001|COMPLETED|Overall Study||9
10742680|NCT02932787|11906689|FG000|NOT COMPLETED|Overall Study||0
10742681|NCT02932787|11906690|FG001|NOT COMPLETED|Overall Study||0
10742682|NCT02932878|11906701|FG000|STARTED|Overall Study||15
10742683|NCT02932878|11906702|FG001|STARTED|Overall Study||1
10742684|NCT02932878|11906701|FG000|COMPLETED|Overall Study||13
10742685|NCT02932878|11906702|FG001|COMPLETED|Overall Study||0
10742686|NCT02932878|11906701|FG000|NOT COMPLETED|Overall Study||2
10742687|NCT02932878|11906702|FG001|NOT COMPLETED|Overall Study||1
10742688|NCT02932891|11906708|FG000|STARTED|Overall Study||28
10742689|NCT02932891|11906708|FG000|COMPLETED|Overall Study||24
10742690|NCT02932891|11906708|FG000|NOT COMPLETED|Overall Study||4
10742691|NCT02932904|11906716|FG000|STARTED|Overall Study||92
10742692|NCT02932904|11906717|FG001|STARTED|Overall Study||85
10742693|NCT02932904|11906718|FG002|STARTED|Overall Study||91
10742694|NCT02932904|11906719|FG003|STARTED|Overall Study||93
10742695|NCT02932904|11906716|FG000|Treated|Overall Study||91
10742696|NCT02932904|11906717|FG001|Treated|Overall Study||84
10742697|NCT02932904|11906718|FG002|Treated|Overall Study||91
10742698|NCT02932904|11906719|FG003|Treated|Overall Study||91
10742699|NCT02932904|11906716|FG000|COMPLETED|Overall Study||76
10742700|NCT02932904|11906717|FG001|COMPLETED|Overall Study||67
10742701|NCT02932904|11906718|FG002|COMPLETED|Overall Study||68
10742702|NCT02932904|11906719|FG003|COMPLETED|Overall Study||79
10742703|NCT02932904|11906716|FG000|NOT COMPLETED|Overall Study||16
10742704|NCT02932904|11906717|FG001|NOT COMPLETED|Overall Study||18
10742705|NCT02932904|11906718|FG002|NOT COMPLETED|Overall Study||23
10742706|NCT02932904|11906719|FG003|NOT COMPLETED|Overall Study||14
10742707|NCT02932943|11906734|FG000|STARTED|Overall Study||227
10742708|NCT02932943|11906735|FG001|STARTED|Overall Study||231
10742709|NCT02932943|11906734|FG000|COMPLETED|Overall Study||222
10742710|NCT02932943|11906735|FG001|COMPLETED|Overall Study||224
10742711|NCT02932943|11906734|FG000|NOT COMPLETED|Overall Study||5
10742712|NCT02932943|11906735|FG001|NOT COMPLETED|Overall Study||7
10742713|NCT02933034|11906741|FG000|STARTED|Overall Study||33
10742714|NCT02933034|11906741|FG000|Received Both MEMRI and DEMRI Scans|Overall Study||24
10742715|NCT02933034|11906741|FG000|COMPLETED|Overall Study||24
10742716|NCT02933034|11906741|FG000|NOT COMPLETED|Overall Study||9
10742717|NCT02933060|11906747|FG000|STARTED|Overall Study||25
10742718|NCT02933060|11906748|FG001|STARTED|Overall Study||25
10742719|NCT02933060|11906747|FG000|COMPLETED|Overall Study||25
10742720|NCT02933060|11906748|FG001|COMPLETED|Overall Study||24
10742721|NCT02933060|11906747|FG000|NOT COMPLETED|Overall Study||0
10742722|NCT02933060|11906748|FG001|NOT COMPLETED|Overall Study||1
10742723|NCT02933320|11906758|FG000|STARTED|Overall Study||13
10742724|NCT02933320|11906759|FG001|STARTED|Overall Study||1
10742725|NCT02933320|11906760|FG002|STARTED|Overall Study|Trial terminated early|0
10742726|NCT02933320|11906761|FG003|STARTED|Overall Study|Trial terminated early|0
10742727|NCT02933320|11906758|FG000|COMPLETED|Overall Study||13
10742728|NCT02933320|11906759|FG001|COMPLETED|Overall Study||1
10742729|NCT02933320|11906760|FG002|COMPLETED|Overall Study||0
10742730|NCT02933320|11906761|FG003|COMPLETED|Overall Study||0
10742731|NCT02933320|11906758|FG000|NOT COMPLETED|Overall Study||0
10742732|NCT02933320|11906759|FG001|NOT COMPLETED|Overall Study||0
10742733|NCT02933320|11906760|FG002|NOT COMPLETED|Overall Study||0
10742734|NCT02933320|11906761|FG003|NOT COMPLETED|Overall Study||0
10742735|NCT02933372|11906773|FG000|STARTED|Overall Study||15
10742736|NCT02933372|11906774|FG001|STARTED|Overall Study||10
10742737|NCT02933372|11906773|FG000|COMPLETED|Overall Study||15
10742738|NCT02933372|11906774|FG001|COMPLETED|Overall Study||10
10742739|NCT02933372|11906773|FG000|NOT COMPLETED|Overall Study||0
10742740|NCT02933372|11906774|FG001|NOT COMPLETED|Overall Study||0
10742741|NCT02933450|11906782|FG000|STARTED|Overall Study||20
10742742|NCT02933450|11906783|FG001|STARTED|Overall Study||23
10742743|NCT02933450|11906782|FG000|COMPLETED|Overall Study||15
10742744|NCT02933450|11906783|FG001|COMPLETED|Overall Study||15
10742745|NCT02933450|11906782|FG000|NOT COMPLETED|Overall Study||5
10742746|NCT02933450|11906783|FG001|NOT COMPLETED|Overall Study||8
10742747|NCT02933476|11906789|FG000|STARTED|Overall Study||5
10742748|NCT02933476|11906789|FG000|COMPLETED|Overall Study||5
10742749|NCT02933476|11906789|FG000|NOT COMPLETED|Overall Study||0
10742760|NCT02933502|11906807|FG000|STARTED|Overall Study||3
10742761|NCT02933502|11906807|FG000|COMPLETED|Overall Study||3
10742762|NCT02933502|11906807|FG000|NOT COMPLETED|Overall Study||0
10742763|NCT02933528|11906811|FG000|STARTED|Overall Study||24
10742764|NCT02933528|11906811|FG000|COMPLETED|Overall Study||22
10742765|NCT02933528|11906811|FG000|NOT COMPLETED|Overall Study||2
10742766|NCT02933866|11906817|FG000|STARTED|Overall Study||186
10742767|NCT02933866|11906818|FG001|STARTED|Overall Study||185
10742768|NCT02933866|11906817|FG000|COMPLETED|Overall Study||174
10742769|NCT02933866|11906818|FG001|COMPLETED|Overall Study||176
10742770|NCT02933866|11906817|FG000|NOT COMPLETED|Overall Study||12
10742771|NCT02933866|11906818|FG001|NOT COMPLETED|Overall Study||9
10742772|NCT02933879|11906827|FG000|STARTED|Overall Study||64
10742773|NCT02933879|11906828|FG001|STARTED|Overall Study||62
10817094|NCT01365156|11980738|FG000|STARTED|Overall Study||14
10817095|NCT01365156|11980739|FG001|STARTED|Overall Study||14
10817096|NCT01365156|11980738|FG000|COMPLETED|Overall Study||14
10817097|NCT01365156|11980739|FG001|COMPLETED|Overall Study||14
10817098|NCT01365156|11980738|FG000|NOT COMPLETED|Overall Study||0
10817099|NCT01365156|11980739|FG001|NOT COMPLETED|Overall Study||0
10817100|NCT01359254|11980747|FG000|STARTED|Overall Study||1
10817101|NCT01359254|11980748|FG001|STARTED|Overall Study||0
10817102|NCT01359254|11980747|FG000|COMPLETED|Overall Study||0
10817103|NCT01359254|11980748|FG001|COMPLETED|Overall Study||0
10817104|NCT01359254|11980747|FG000|NOT COMPLETED|Overall Study||1
10817105|NCT01359254|11980748|FG001|NOT COMPLETED|Overall Study||0
10817106|NCT01347632|11980754|FG000|STARTED|Overall Study||35
10817107|NCT01347632|11980754|FG000|COMPLETED|Overall Study||33
10742774|NCT02933879|11906829|FG002|STARTED|Overall Study||58
10742775|NCT02933879|11906827|FG000|COMPLETED|Overall Study||48
10742776|NCT02933879|11906828|FG001|COMPLETED|Overall Study||48
10742777|NCT02933879|11906829|FG002|COMPLETED|Overall Study||41
10742778|NCT02933879|11906827|FG000|NOT COMPLETED|Overall Study||16
10742779|NCT02933879|11906828|FG001|NOT COMPLETED|Overall Study||14
10742780|NCT02933879|11906829|FG002|NOT COMPLETED|Overall Study||17
10742781|NCT02934178|11906841|FG000|STARTED|Received Vaccination 1||12
10742782|NCT02934178|11906842|FG001|STARTED|Received Vaccination 1||4
10742783|NCT02934178|11906841|FG000|COMPLETED|Received Vaccination 1||12
10742784|NCT02934178|11906842|FG001|COMPLETED|Received Vaccination 1||4
10742785|NCT02934178|11906841|FG000|NOT COMPLETED|Received Vaccination 1||0
10742786|NCT02934178|11906842|FG001|NOT COMPLETED|Received Vaccination 1||0
10742787|NCT02934178|11906841|FG000|STARTED|Received Vaccination 2||12
10742788|NCT02934178|11906842|FG001|STARTED|Received Vaccination 2||4
10742789|NCT02934178|11906841|FG000|COMPLETED|Received Vaccination 2||12
10742790|NCT02934178|11906842|FG001|COMPLETED|Received Vaccination 2||3
10742791|NCT02934178|11906841|FG000|NOT COMPLETED|Received Vaccination 2||0
10742792|NCT02934178|11906842|FG001|NOT COMPLETED|Received Vaccination 2||1
10742793|NCT02934178|11906841|FG000|STARTED|Received Vaccination 3||12
10742794|NCT02934178|11906842|FG001|STARTED|Received Vaccination 3||3
10742795|NCT02934178|11906841|FG000|COMPLETED|Received Vaccination 3||11
10742796|NCT02934178|11906842|FG001|COMPLETED|Received Vaccination 3||3
10742797|NCT02934178|11906841|FG000|NOT COMPLETED|Received Vaccination 3||1
10742798|NCT02934178|11906842|FG001|NOT COMPLETED|Received Vaccination 3||0
10742799|NCT02934191|11906851|FG000|STARTED|Overall Study||87
10742800|NCT02934191|11906852|FG001|STARTED|Overall Study||85
10742801|NCT02934191|11906851|FG000|COMPLETED|Overall Study||87
10742802|NCT02934191|11906852|FG001|COMPLETED|Overall Study||85
10742803|NCT02934191|11906851|FG000|NOT COMPLETED|Overall Study||0
10742804|NCT02934191|11906852|FG001|NOT COMPLETED|Overall Study||0
10742805|NCT02934347|11906860|FG000|STARTED|Overall Study||374
10742806|NCT02934347|11906861|FG001|STARTED|Overall Study||407
10742807|NCT02934347|11906860|FG000|COMPLETED|Overall Study||374
10742808|NCT02934347|11906861|FG001|COMPLETED|Overall Study||407
10742809|NCT02934347|11906860|FG000|NOT COMPLETED|Overall Study||0
10742810|NCT02934347|11906861|FG001|NOT COMPLETED|Overall Study||0
10742811|NCT02934555|11906869|FG000|STARTED|Overall Study||23
10742812|NCT02934555|11906870|FG001|STARTED|Overall Study||25
10742813|NCT02934555|11906869|FG000|COMPLETED|Overall Study||21
10742814|NCT02934555|11906870|FG001|COMPLETED|Overall Study||22
10742815|NCT02934555|11906869|FG000|NOT COMPLETED|Overall Study||2
10742816|NCT02934555|11906870|FG001|NOT COMPLETED|Overall Study||3
10742817|NCT02934698|11906876|FG000|STARTED|Overall Study||2
10742818|NCT02934698|11906876|FG000|COMPLETED|Overall Study||2
10742819|NCT02934698|11906876|FG000|NOT COMPLETED|Overall Study||0
10742820|NCT02935036|11906882|FG000|STARTED|Overall Study||147
10742821|NCT02935036|11906883|FG001|STARTED|Overall Study||147
10742822|NCT02935036|11906882|FG000|COMPLETED|Overall Study||137
10742823|NCT02935036|11906883|FG001|COMPLETED|Overall Study||136
10742824|NCT02935036|11906882|FG000|NOT COMPLETED|Overall Study||10
10742825|NCT02935036|11906883|FG001|NOT COMPLETED|Overall Study||11
10742826|NCT02935062|11906892|FG000|STARTED|Overall Study||8
10742827|NCT02935062|11906893|FG001|STARTED|Overall Study||8
10742828|NCT02935062|11906894|FG002|STARTED|Overall Study||8
10742829|NCT02935062|11906892|FG000|COMPLETED|Overall Study||8
10742830|NCT02935062|11906893|FG001|COMPLETED|Overall Study||8
10742831|NCT02935062|11906894|FG002|COMPLETED|Overall Study||8
10742832|NCT02935062|11906892|FG000|NOT COMPLETED|Overall Study||0
10742833|NCT02935062|11906893|FG001|NOT COMPLETED|Overall Study||0
10742834|NCT02935062|11906894|FG002|NOT COMPLETED|Overall Study||0
10742835|NCT02935088|11906902|FG000|STARTED|Overall Study||2217
10742836|NCT02935088|11906902|FG000|COMPLETED|Overall Study||2115
10742837|NCT02935088|11906902|FG000|NOT COMPLETED|Overall Study||102
10742838|NCT02935179|11906915|FG000|STARTED|Overall Study||30
10742839|NCT02935179|11906916|FG001|STARTED|Overall Study||30
10742840|NCT02935179|11906915|FG000|COMPLETED|Overall Study||29
10742841|NCT02935179|11906916|FG001|COMPLETED|Overall Study||29
10742842|NCT02935179|11906915|FG000|NOT COMPLETED|Overall Study||1
10742843|NCT02935179|11906916|FG001|NOT COMPLETED|Overall Study||1
10742844|NCT02935192|11906924|FG000|STARTED|Overall Study|312 subjects were included in the Full Protocol Analysis because 8 withdrew without getting product.|320
10817108|NCT01347632|11980754|FG000|NOT COMPLETED|Overall Study||2
10817109|NCT01356667|11980760|FG000|STARTED|Overall Study||4
10817110|NCT01356667|11980761|FG001|STARTED|Overall Study||6
10817111|NCT01356667|11980760|FG000|COMPLETED|Overall Study||0
10817112|NCT01356667|11980761|FG001|COMPLETED|Overall Study||0
10817113|NCT01356667|11980760|FG000|NOT COMPLETED|Overall Study||4
10742845|NCT02935192|11906925|FG001|STARTED|Overall Study|156 subjects were included in the Full Protocol Analysis because 4 withdrew without getting product.|160
10742846|NCT02935192|11906924|FG000|Received Vaccine/Placebo|Overall Study||312
10742847|NCT02935192|11906925|FG001|Received Vaccine/Placebo|Overall Study||156
10742848|NCT02935192|11906924|FG000|COMPLETED|Overall Study||312
10742849|NCT02935192|11906925|FG001|COMPLETED|Overall Study||156
10742850|NCT02935192|11906924|FG000|NOT COMPLETED|Overall Study||8
10742851|NCT02935192|11906925|FG001|NOT COMPLETED|Overall Study||4
10742852|NCT02935452|11906933|FG000|STARTED|Overall Study||30
10742853|NCT02935452|11906934|FG001|STARTED|Overall Study||30
10742854|NCT02935452|11906933|FG000|COMPLETED|Overall Study||27
10742855|NCT02935452|11906934|FG001|COMPLETED|Overall Study||29
10742856|NCT02935452|11906933|FG000|NOT COMPLETED|Overall Study||3
10742857|NCT02935452|11906934|FG001|NOT COMPLETED|Overall Study||1
10742858|NCT02935543|11906940|FG000|STARTED|Overall Study||1
10742859|NCT02935543|11906940|FG000|COMPLETED|Overall Study||1
10742860|NCT02935543|11906940|FG000|NOT COMPLETED|Overall Study||0
10742861|NCT02935673|11906947|FG000|STARTED|Overall Study||16
10742862|NCT02935673|11906948|FG001|STARTED|Overall Study||27
10742863|NCT02935673|11906949|FG002|STARTED|Overall Study||6
10742864|NCT02935673|11906947|FG000|COMPLETED|Overall Study||15
10742865|NCT02935673|11906948|FG001|COMPLETED|Overall Study||24
10742866|NCT02935673|11906949|FG002|COMPLETED|Overall Study||6
10742867|NCT02935673|11906947|FG000|NOT COMPLETED|Overall Study||1
10742868|NCT02935673|11906948|FG001|NOT COMPLETED|Overall Study||3
10817114|NCT01356667|11980761|FG001|NOT COMPLETED|Overall Study||6
10817115|NCT01354951|11980769|FG000|STARTED|Overall Study||3
10817116|NCT01354951|11980769|FG000|COMPLETED|Overall Study||1
10817117|NCT01354951|11980769|FG000|NOT COMPLETED|Overall Study||2
10817118|NCT01350232|11980773|FG000|STARTED|Overall Study||2
10817119|NCT01350232|11980773|FG000|COMPLETED|Overall Study||2
10817120|NCT01350232|11980773|FG000|NOT COMPLETED|Overall Study||0
10817121|NCT01350583|11980777|FG000|STARTED|Overall Study||2
10817122|NCT01350583|11980777|FG000|COMPLETED|Overall Study||2
10817123|NCT01350583|11980777|FG000|NOT COMPLETED|Overall Study||0
10817124|NCT01352416|11980785|FG000|STARTED|Overall Study||4
10817125|NCT01352416|11980786|FG001|STARTED|Overall Study||7
10817126|NCT01352416|11980787|FG002|STARTED|Overall Study||2
10817127|NCT01352416|11980788|FG003|STARTED|Overall Study||2
10817128|NCT01352416|11980785|FG000|COMPLETED|Overall Study||3
10817129|NCT01352416|11980786|FG001|COMPLETED|Overall Study||5
10817130|NCT01352416|11980787|FG002|COMPLETED|Overall Study||0
10817131|NCT01352416|11980788|FG003|COMPLETED|Overall Study||1
10817132|NCT01352416|11980785|FG000|NOT COMPLETED|Overall Study||1
10817133|NCT01352416|11980786|FG001|NOT COMPLETED|Overall Study||2
10817134|NCT01352416|11980787|FG002|NOT COMPLETED|Overall Study||2
10817135|NCT01352416|11980788|FG003|NOT COMPLETED|Overall Study||1
10817136|NCT01350258|11980798|FG000|STARTED|Overall Study||8
10817137|NCT01350258|11980798|FG000|COMPLETED|Overall Study||8
10817138|NCT01350258|11980798|FG000|NOT COMPLETED|Overall Study||0
10817139|NCT01349595|11980804|FG000|STARTED|Overall Study||2
10817140|NCT01349595|11980805|FG001|STARTED|Overall Study||2
10817141|NCT01349595|11980804|FG000|COMPLETED|Overall Study||0
10817142|NCT01349595|11980805|FG001|COMPLETED|Overall Study||0
10817143|NCT01349595|11980804|FG000|NOT COMPLETED|Overall Study||2
10817144|NCT01349595|11980805|FG001|NOT COMPLETED|Overall Study||2
10817145|NCT01337609|11980814|FG000|STARTED|Overall Study||1
10817146|NCT01337609|11980815|FG001|STARTED|Overall Study||2
10817147|NCT01337609|11980816|FG002|STARTED|Overall Study||2
10817148|NCT01337609|11980814|FG000|COMPLETED|Overall Study||0
10817149|NCT01337609|11980815|FG001|COMPLETED|Overall Study||2
10817150|NCT01337609|11980816|FG002|COMPLETED|Overall Study||2
10817151|NCT01337609|11980814|FG000|NOT COMPLETED|Overall Study||1
10817152|NCT01337609|11980815|FG001|NOT COMPLETED|Overall Study||0
10817153|NCT01337609|11980816|FG002|NOT COMPLETED|Overall Study||0
10817154|NCT01347840|11980824|FG000|STARTED|Overall Study|1 subject enrolled but withdrew consent|1
10817155|NCT01347840|11980824|FG000|COMPLETED|Overall Study||0
10817156|NCT01347840|11980824|FG000|NOT COMPLETED|Overall Study||1
10817157|NCT01340573|11980828|FG000|STARTED|Overall Study||3
10817158|NCT01340573|11980828|FG000|COMPLETED|Overall Study||0
10817159|NCT01340573|11980828|FG000|NOT COMPLETED|Overall Study||3
10817160|NCT01335997|11980835|FG000|STARTED|Period I and II||577
10817161|NCT01335997|11980836|FG001|STARTED|Period I and II||562
10817162|NCT01335997|11980835|FG000|COMPLETED|Period I and II||84
10817163|NCT01335997|11980836|FG001|COMPLETED|Period I and II||83
10817164|NCT01335997|11980835|FG000|NOT COMPLETED|Period I and II||493
10817165|NCT01335997|11980836|FG001|NOT COMPLETED|Period I and II||479
10817166|NCT01335997|11980835|FG000|STARTED|Period III||84
10817167|NCT01335997|11980836|FG001|STARTED|Period III||83
10817168|NCT01335997|11980835|FG000|COMPLETED|Period III||6
10817169|NCT01335997|11980836|FG001|COMPLETED|Period III||4
10817170|NCT01335997|11980835|FG000|NOT COMPLETED|Period III||78
10817171|NCT01335997|11980836|FG001|NOT COMPLETED|Period III||79
10742869|NCT02935673|11906949|FG002|NOT COMPLETED|Overall Study||0
10742870|NCT02935699|11906961|FG000|STARTED|Overall Study||127
10742871|NCT02935699|11906962|FG001|STARTED|Overall Study||135
10817172|NCT01340885|11980847|FG000|STARTED|Overall Study||0
10817173|NCT01340885|11980848|FG001|STARTED|Overall Study||0
10817174|NCT01340885|11980849|FG002|STARTED|Overall Study||0
10817175|NCT01340885|11980847|FG000|COMPLETED|Overall Study||0
10817176|NCT01340885|11980848|FG001|COMPLETED|Overall Study||0
10817177|NCT01340885|11980849|FG002|COMPLETED|Overall Study||0
10817178|NCT01340885|11980847|FG000|NOT COMPLETED|Overall Study||0
10742872|NCT02935699|11906961|FG000|COMPLETED|Overall Study||127
10742873|NCT02935699|11906962|FG001|COMPLETED|Overall Study||135
10742874|NCT02935699|11906961|FG000|NOT COMPLETED|Overall Study||0
10742875|NCT02935699|11906962|FG001|NOT COMPLETED|Overall Study||0
10742876|NCT02935738|11906972|FG000|STARTED|Overall Study||67
10742877|NCT02935738|11906973|FG001|STARTED|Overall Study||74
10742878|NCT02935738|11906974|FG002|STARTED|Overall Study||47
10742879|NCT02935738|11906975|FG003|STARTED|Overall Study||53
10742880|NCT02935738|11906972|FG000|COMPLETED|Overall Study||50
10742881|NCT02935738|11906973|FG001|COMPLETED|Overall Study||53
10742882|NCT02935738|11906974|FG002|COMPLETED|Overall Study||46
10742883|NCT02935738|11906975|FG003|COMPLETED|Overall Study||48
10742884|NCT02935738|11906972|FG000|NOT COMPLETED|Overall Study||17
10742885|NCT02935738|11906973|FG001|NOT COMPLETED|Overall Study||21
10742886|NCT02935738|11906974|FG002|NOT COMPLETED|Overall Study||1
10742887|NCT02935738|11906975|FG003|NOT COMPLETED|Overall Study||5
10742888|NCT02935842|11906989|FG000|STARTED|Testing and Therapy Period 1||8
10742889|NCT02935842|11906990|FG001|STARTED|Testing and Therapy Period 1||6
10742890|NCT02935842|11906991|FG002|STARTED|Testing and Therapy Period 1||6
10742891|NCT02935842|11906992|FG003|STARTED|Testing and Therapy Period 1|Due to limited staff capacity, HC have only been included in the final tranche.|0
10742892|NCT02935842|11906989|FG000|COMPLETED|Testing and Therapy Period 1||8
10742893|NCT02935842|11906990|FG001|COMPLETED|Testing and Therapy Period 1||6
10817179|NCT01340885|11980848|FG001|NOT COMPLETED|Overall Study||0
10817180|NCT01340885|11980849|FG002|NOT COMPLETED|Overall Study||0
10817181|NCT01341587|11980859|FG000|STARTED|Overall Study||4
10817182|NCT01341587|11980860|FG001|STARTED|Overall Study||10
10817183|NCT01341587|11980859|FG000|COMPLETED|Overall Study||0
10817184|NCT01341587|11980860|FG001|COMPLETED|Overall Study||0
10817185|NCT01341587|11980859|FG000|NOT COMPLETED|Overall Study||4
10817186|NCT01341587|11980860|FG001|NOT COMPLETED|Overall Study||10
10817187|NCT01326923|11980866|FG000|STARTED|Overall Study||7
10817188|NCT01326923|11980866|FG000|COMPLETED|Overall Study||7
10817189|NCT01326923|11980866|FG000|NOT COMPLETED|Overall Study||0
10817190|NCT01332799|11980872|FG000|STARTED|Overall Study||10
10817191|NCT01332799|11980873|FG001|STARTED|Overall Study||10
10817192|NCT01332799|11980872|FG000|COMPLETED|Overall Study||0
10817193|NCT01332799|11980873|FG001|COMPLETED|Overall Study||0
10817194|NCT01332799|11980872|FG000|NOT COMPLETED|Overall Study||10
10817195|NCT01332799|11980873|FG001|NOT COMPLETED|Overall Study||10
10817196|NCT01329549|11980879|FG000|STARTED|Overall Study||2
10817197|NCT01329549|11980879|FG000|COMPLETED|Overall Study||0
10817198|NCT01329549|11980879|FG000|NOT COMPLETED|Overall Study||2
10817199|NCT01326845|11980885|FG000|STARTED|Overall Study||7
10817200|NCT01326845|11980886|FG001|STARTED|Overall Study||5
10817201|NCT01326845|11980885|FG000|COMPLETED|Overall Study|Study terminated early|0
10817202|NCT01326845|11980886|FG001|COMPLETED|Overall Study|Study terminated early|0
10817203|NCT01326845|11980885|FG000|NOT COMPLETED|Overall Study||7
10817204|NCT01326845|11980886|FG001|NOT COMPLETED|Overall Study||5
10817205|NCT01329341|11980892|FG000|STARTED|Overall Study||60
10817206|NCT01329341|11980892|FG000|COMPLETED|Overall Study||16
10817207|NCT01329341|11980892|FG000|NOT COMPLETED|Overall Study||44
10817208|NCT01319760|11980898|FG000|STARTED|Overall Study|The study experienced a very low enrollment rate. the sponsor decided to stop the study.|0
10817209|NCT01319760|11980899|FG001|STARTED|Overall Study||5
10817210|NCT01319760|11980898|FG000|COMPLETED|Overall Study|The study experienced a very low enrollment rate. the sponsor decided to stop the study.|0
10817211|NCT01319760|11980899|FG001|COMPLETED|Overall Study||5
10817212|NCT01319760|11980898|FG000|NOT COMPLETED|Overall Study||0
10817213|NCT01319760|11980899|FG001|NOT COMPLETED|Overall Study||0
10817214|NCT01320683|11980905|FG000|STARTED|Overall Study||1
10817215|NCT01320683|11980905|FG000|COMPLETED|Overall Study||0
10817216|NCT01320683|11980905|FG000|NOT COMPLETED|Overall Study||1
10817217|NCT01313273|11980911|FG000|STARTED|Overall Study||2
10817218|NCT01313273|11980912|FG001|STARTED|Overall Study||1
10817219|NCT01313273|11980911|FG000|COMPLETED|Overall Study||0
10817220|NCT01313273|11980912|FG001|COMPLETED|Overall Study||0
10817221|NCT01313273|11980911|FG000|NOT COMPLETED|Overall Study||2
10817222|NCT01313273|11980912|FG001|NOT COMPLETED|Overall Study||1
10817223|NCT01321008|11980918|FG000|STARTED|Overall Study||1
10817224|NCT01321008|11980918|FG000|COMPLETED|Overall Study||0
10817225|NCT01321008|11980918|FG000|NOT COMPLETED|Overall Study||1
10817226|NCT01310803|11980924|FG000|STARTED|Overall Study||1
10817227|NCT01310803|11980925|FG001|STARTED|Overall Study||0
10817228|NCT01310803|11980924|FG000|COMPLETED|Overall Study||0
10817229|NCT01310803|11980925|FG001|COMPLETED|Overall Study||0
10817230|NCT01310803|11980924|FG000|NOT COMPLETED|Overall Study||1
10817231|NCT01310803|11980925|FG001|NOT COMPLETED|Overall Study||0
10817232|NCT01309581|11980933|FG000|STARTED|Overall Study||2
10817233|NCT01309581|11980934|FG001|STARTED|Overall Study||1
10817234|NCT01309581|11980933|FG000|COMPLETED|Overall Study||2
10817235|NCT01309581|11980934|FG001|COMPLETED|Overall Study||1
10817236|NCT01309581|11980933|FG000|NOT COMPLETED|Overall Study||0
10817237|NCT01309581|11980934|FG001|NOT COMPLETED|Overall Study||0
10817238|NCT01315873|11980940|FG000|STARTED|Overall Study||24
10817239|NCT01315873|11980940|FG000|COMPLETED|Overall Study||24
10817240|NCT01315873|11980940|FG000|NOT COMPLETED|Overall Study||0
10817241|NCT01313923|11980944|FG000|STARTED|Overall Study||3
10817242|NCT01313923|11980944|FG000|COMPLETED|Overall Study||0
10817243|NCT01313923|11980944|FG000|NOT COMPLETED|Overall Study||3
10817244|NCT01321697|11980948|FG000|STARTED|Overall Study||7
10817245|NCT01321697|11980948|FG000|COMPLETED|Overall Study||0
10742894|NCT02935842|11906991|FG002|COMPLETED|Testing and Therapy Period 1||6
10742895|NCT02935842|11906992|FG003|COMPLETED|Testing and Therapy Period 1||0
10742896|NCT02935842|11906989|FG000|NOT COMPLETED|Testing and Therapy Period 1||0
10742897|NCT02935842|11906990|FG001|NOT COMPLETED|Testing and Therapy Period 1||0
10742898|NCT02935842|11906991|FG002|NOT COMPLETED|Testing and Therapy Period 1||0
10742899|NCT02935842|11906992|FG003|NOT COMPLETED|Testing and Therapy Period 1||0
10742900|NCT02935842|11906989|FG000|STARTED|Testing and Therapy Period 2||8
10742901|NCT02935842|11906990|FG001|STARTED|Testing and Therapy Period 2||6
10742902|NCT02935842|11906991|FG002|STARTED|Testing and Therapy Period 2||6
10742903|NCT02935842|11906992|FG003|STARTED|Testing and Therapy Period 2|Due to limited staff capacity, HC have only been included in the final tranche.|0
10742904|NCT02935842|11906989|FG000|COMPLETED|Testing and Therapy Period 2||6
10742905|NCT02935842|11906990|FG001|COMPLETED|Testing and Therapy Period 2||6
10742906|NCT02935842|11906991|FG002|COMPLETED|Testing and Therapy Period 2||6
10742907|NCT02935842|11906992|FG003|COMPLETED|Testing and Therapy Period 2||0
10742908|NCT02935842|11906989|FG000|NOT COMPLETED|Testing and Therapy Period 2||2
10742909|NCT02935842|11906990|FG001|NOT COMPLETED|Testing and Therapy Period 2||0
10742910|NCT02935842|11906991|FG002|NOT COMPLETED|Testing and Therapy Period 2||0
10742911|NCT02935842|11906992|FG003|NOT COMPLETED|Testing and Therapy Period 2||0
10742912|NCT02935842|11906989|FG000|STARTED|Testing and Therapy Period 3||6
10742913|NCT02935842|11906990|FG001|STARTED|Testing and Therapy Period 3||6
10742914|NCT02935842|11906991|FG002|STARTED|Testing and Therapy Period 3||6
10742915|NCT02935842|11906992|FG003|STARTED|Testing and Therapy Period 3|HC received no interventions. They have only been tested at BL, 4 Weeks and 6 Months.|18
10742916|NCT02935842|11906989|FG000|COMPLETED|Testing and Therapy Period 3||3
10742917|NCT02935842|11906990|FG001|COMPLETED|Testing and Therapy Period 3||2
10742918|NCT02935842|11906991|FG002|COMPLETED|Testing and Therapy Period 3||1
10742919|NCT02935842|11906992|FG003|COMPLETED|Testing and Therapy Period 3||17
10742920|NCT02935842|11906989|FG000|NOT COMPLETED|Testing and Therapy Period 3||3
10742921|NCT02935842|11906990|FG001|NOT COMPLETED|Testing and Therapy Period 3||4
10742922|NCT02935842|11906991|FG002|NOT COMPLETED|Testing and Therapy Period 3||5
10742923|NCT02935842|11906992|FG003|NOT COMPLETED|Testing and Therapy Period 3||1
10742924|NCT02935894|11907009|FG000|STARTED|Overall Study||14
10742925|NCT02935894|11907009|FG000|COMPLETED|Overall Study||13
10742926|NCT02935894|11907009|FG000|NOT COMPLETED|Overall Study||1
10742927|NCT02936037|11907015|FG000|STARTED|Double-Blind Treatment Period||316
10742928|NCT02936037|11907016|FG001|STARTED|Double-Blind Treatment Period||326
10742929|NCT02936037|11907015|FG000|COMPLETED|Double-Blind Treatment Period||267
10742930|NCT02936037|11907016|FG001|COMPLETED|Double-Blind Treatment Period||261
10742931|NCT02936037|11907015|FG000|NOT COMPLETED|Double-Blind Treatment Period||49
10742932|NCT02936037|11907016|FG001|NOT COMPLETED|Double-Blind Treatment Period||65
10742933|NCT02936037|11907015|FG000|STARTED|Open Label Extension||0
10742934|NCT02936037|11907016|FG001|STARTED|Open Label Extension||528
10742935|NCT02936037|11907015|FG000|COMPLETED|Open Label Extension||0
10742936|NCT02936037|11907016|FG001|COMPLETED|Open Label Extension||518
10742937|NCT02936037|11907015|FG000|NOT COMPLETED|Open Label Extension||0
10742938|NCT02936037|11907016|FG001|NOT COMPLETED|Open Label Extension||10
10742939|NCT02936076|11907024|FG000|STARTED|Overall Study||25
10742940|NCT02936076|11907025|FG001|STARTED|Overall Study||24
10742941|NCT02936076|11907024|FG000|COMPLETED|Overall Study||19
10742942|NCT02936076|11907025|FG001|COMPLETED|Overall Study||20
10742943|NCT02936076|11907024|FG000|NOT COMPLETED|Overall Study||6
10742944|NCT02936076|11907025|FG001|NOT COMPLETED|Overall Study||4
10742945|NCT02936479|11907031|FG000|STARTED|Overall Study||1
10742946|NCT02936479|11907031|FG000|COMPLETED|Overall Study||1
10742947|NCT02936479|11907031|FG000|NOT COMPLETED|Overall Study||0
10742948|NCT02936635|11907037|FG000|STARTED|Overall Study||115
10742949|NCT02936635|11907038|FG001|STARTED|Overall Study||165
10742950|NCT02936635|11907037|FG000|COMPLETED|Overall Study||0
10742951|NCT02936635|11907038|FG001|COMPLETED|Overall Study||0
10742952|NCT02936635|11907037|FG000|NOT COMPLETED|Overall Study||115
10742953|NCT02936635|11907038|FG001|NOT COMPLETED|Overall Study||165
10742954|NCT02936648|11907044|FG000|STARTED|Overall Study||2209
10742955|NCT02936648|11907044|FG000|COMPLETED|Overall Study||2209
10742956|NCT02936648|11907044|FG000|NOT COMPLETED|Overall Study||0
10742957|NCT02936869|11907050|FG000|STARTED|Overall Study||104
10742958|NCT02936869|11907051|FG001|STARTED|Overall Study||103
10742959|NCT02936869|11907050|FG000|COMPLETED|Overall Study||102
10742960|NCT02936869|11907051|FG001|COMPLETED|Overall Study||98
10742961|NCT02936869|11907050|FG000|NOT COMPLETED|Overall Study||2
10742962|NCT02936869|11907051|FG001|NOT COMPLETED|Overall Study||5
10742963|NCT02937116|11907070|FG000|STARTED|Overall Study||3
10742964|NCT02937116|11907071|FG001|STARTED|Overall Study||3
10742965|NCT02937116|11907072|FG002|STARTED|Overall Study||3
10742966|NCT02937116|11907073|FG003|STARTED|Overall Study||3
10742967|NCT02937116|11907074|FG004|STARTED|Overall Study||22
10742968|NCT02937116|11907075|FG005|STARTED|Overall Study||87
10742969|NCT02937116|11907076|FG006|STARTED|Overall Study||37
10742970|NCT02937116|11907077|FG007|STARTED|Overall Study||21
10742971|NCT02937116|11907078|FG008|STARTED|Overall Study||20
10742972|NCT02937116|11907079|FG009|STARTED|Overall Study||20
10742973|NCT02937116|11907080|FG010|STARTED|Overall Study||7
10742974|NCT02937116|11907081|FG011|STARTED|Overall Study||7
10742975|NCT02937116|11907070|FG000|COMPLETED|Overall Study||0
10742976|NCT02937116|11907071|FG001|COMPLETED|Overall Study||0
10742977|NCT02937116|11907072|FG002|COMPLETED|Overall Study||0
10742978|NCT02937116|11907073|FG003|COMPLETED|Overall Study||0
10742979|NCT02937116|11907074|FG004|COMPLETED|Overall Study||0
10742980|NCT02937116|11907075|FG005|COMPLETED|Overall Study||0
10742981|NCT02937116|11907076|FG006|COMPLETED|Overall Study||0
10742982|NCT02937116|11907077|FG007|COMPLETED|Overall Study||0
10742983|NCT02937116|11907078|FG008|COMPLETED|Overall Study||0
10742984|NCT02937116|11907079|FG009|COMPLETED|Overall Study||0
10742985|NCT02937116|11907080|FG010|COMPLETED|Overall Study||0
10742986|NCT02937116|11907081|FG011|COMPLETED|Overall Study||0
10742987|NCT02937116|11907070|FG000|NOT COMPLETED|Overall Study||3
10742988|NCT02937116|11907071|FG001|NOT COMPLETED|Overall Study||3
10742989|NCT02937116|11907072|FG002|NOT COMPLETED|Overall Study||3
10742990|NCT02937116|11907073|FG003|NOT COMPLETED|Overall Study||3
10742991|NCT02937116|11907074|FG004|NOT COMPLETED|Overall Study||22
10742992|NCT02937116|11907075|FG005|NOT COMPLETED|Overall Study||87
10742993|NCT02937116|11907076|FG006|NOT COMPLETED|Overall Study||37
10742994|NCT02937116|11907077|FG007|NOT COMPLETED|Overall Study||21
10742995|NCT02937116|11907078|FG008|NOT COMPLETED|Overall Study||20
10742996|NCT02937116|11907079|FG009|NOT COMPLETED|Overall Study||20
10742997|NCT02937116|11907080|FG010|NOT COMPLETED|Overall Study||7
10742998|NCT02937116|11907081|FG011|NOT COMPLETED|Overall Study||7
10742999|NCT02937168|11907107|FG000|STARTED|PET/CT Screening Period (21 Days)||5
10743000|NCT02937168|11907108|FG001|STARTED|PET/CT Screening Period (21 Days)||0
10743001|NCT02937168|11907109|FG002|STARTED|PET/CT Screening Period (21 Days)||0
10743002|NCT02937168|11907107|FG000|COMPLETED|PET/CT Screening Period (21 Days)||5
10743003|NCT02937168|11907108|FG001|COMPLETED|PET/CT Screening Period (21 Days)||0
10743004|NCT02937168|11907109|FG002|COMPLETED|PET/CT Screening Period (21 Days)||0
10743005|NCT02937168|11907107|FG000|NOT COMPLETED|PET/CT Screening Period (21 Days)||0
10743006|NCT02937168|11907108|FG001|NOT COMPLETED|PET/CT Screening Period (21 Days)||0
10743007|NCT02937168|11907109|FG002|NOT COMPLETED|PET/CT Screening Period (21 Days)||0
10743008|NCT02937168|11907107|FG000|STARTED|Double-Blind Treatment Period (6 Weeks)||0
10743009|NCT02937168|11907108|FG001|STARTED|Double-Blind Treatment Period (6 Weeks)||0
10743010|NCT02937168|11907109|FG002|STARTED|Double-Blind Treatment Period (6 Weeks)||0
10743011|NCT02937168|11907107|FG000|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
10743012|NCT02937168|11907108|FG001|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
10743013|NCT02937168|11907109|FG002|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
10743014|NCT02937168|11907107|FG000|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
10743015|NCT02937168|11907108|FG001|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
10743016|NCT02937168|11907109|FG002|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
10743017|NCT02937194|11907117|FG000|STARTED|1-year Followup||294
10743018|NCT02937194|11907118|FG001|STARTED|1-year Followup||286
10743019|NCT02937194|11907117|FG000|COMPLETED|1-year Followup||223
10743020|NCT02937194|11907118|FG001|COMPLETED|1-year Followup||218
10743021|NCT02937194|11907117|FG000|NOT COMPLETED|1-year Followup||71
10743022|NCT02937194|11907118|FG001|NOT COMPLETED|1-year Followup||68
10743023|NCT02937194|11907117|FG000|STARTED|2-years Followup|The researchers contacted all the participants recruited/enrolled at baseline at each follow-up regardless if they had participated in the previous follow-up or not. So the number started equals 294 for each follow-up.|294
10743024|NCT02937194|11907118|FG001|STARTED|2-years Followup|The researchers contacted all the participants recruited/enrolled at baseline at each follow-up regardless if they had participated in the previous follow-up or not. So the number started equals 286 for each follow-up.|286
10743025|NCT02937194|11907117|FG000|COMPLETED|2-years Followup||216
10743026|NCT02937194|11907118|FG001|COMPLETED|2-years Followup||208
10743027|NCT02937194|11907117|FG000|NOT COMPLETED|2-years Followup||78
10743028|NCT02937194|11907118|FG001|NOT COMPLETED|2-years Followup||78
10743029|NCT02937194|11907117|FG000|STARTED|3-years Followup|The researchers contacted all the participants recruited/enrolled at baseline at each follow-up regardless if they had participated in the previous follow-up or not. So the number started equals 294 for each follow-up.|294
10743030|NCT02937194|11907118|FG001|STARTED|3-years Followup|The researchers contacted all the participants recruited/enrolled at baseline at each follow-up regardless if they had participated in the previous follow-up or not. So the number started equals 286 for each follow-up.|286
10743031|NCT02937194|11907117|FG000|COMPLETED|3-years Followup||228
10743032|NCT02937194|11907118|FG001|COMPLETED|3-years Followup||208
10743033|NCT02937194|11907117|FG000|NOT COMPLETED|3-years Followup||66
10743034|NCT02937194|11907118|FG001|NOT COMPLETED|3-years Followup||78
10743035|NCT02937350|11907127|FG000|STARTED|Overall Study||43
10743036|NCT02937350|11907128|FG001|STARTED|Overall Study||25
10743037|NCT02937350|11907129|FG002|STARTED|Overall Study||20
10743038|NCT02937350|11907127|FG000|COMPLETED|Overall Study||43
10743039|NCT02937350|11907128|FG001|COMPLETED|Overall Study||24
10743040|NCT02937350|11907129|FG002|COMPLETED|Overall Study||20
10743041|NCT02937350|11907127|FG000|NOT COMPLETED|Overall Study||0
10743042|NCT02937350|11907128|FG001|NOT COMPLETED|Overall Study||1
10743043|NCT02937350|11907129|FG002|NOT COMPLETED|Overall Study||0
10743044|NCT02937454|11907137|FG000|STARTED|Overall Study||567
10743045|NCT02937454|11907138|FG001|STARTED|Overall Study||565
10743046|NCT02937454|11907137|FG000|Started Treatment|Overall Study||559
10743047|NCT02937454|11907138|FG001|Started Treatment|Overall Study||551
10743048|NCT02937454|11907137|FG000|COMPLETED|Overall Study||427
10743049|NCT02937454|11907138|FG001|COMPLETED|Overall Study||437
10743050|NCT02937454|11907137|FG000|NOT COMPLETED|Overall Study||140
10743051|NCT02937454|11907138|FG001|NOT COMPLETED|Overall Study||128
10743052|NCT02937506|11907147|FG000|STARTED|Overall Study||300
10743053|NCT02937506|11907148|FG001|STARTED|Overall Study||300
10743054|NCT02937506|11907147|FG000|COMPLETED|Overall Study||300
10743055|NCT02937506|11907148|FG001|COMPLETED|Overall Study||300
10743056|NCT02937506|11907147|FG000|NOT COMPLETED|Overall Study||0
10743057|NCT02937506|11907148|FG001|NOT COMPLETED|Overall Study||0
10743058|NCT02937545|11907156|FG000|STARTED|Overall Study||69
10743059|NCT02937545|11907157|FG001|STARTED|Overall Study||85
10743060|NCT02937545|11907158|FG002|STARTED|Overall Study||15
10743061|NCT02937545|11907159|FG003|STARTED|Overall Study||21
10743062|NCT02937545|11907156|FG000|COMPLETED|Overall Study||67
10743063|NCT02937545|11907157|FG001|COMPLETED|Overall Study||83
10743064|NCT02937545|11907158|FG002|COMPLETED|Overall Study||9
10743065|NCT02937545|11907159|FG003|COMPLETED|Overall Study||14
10743066|NCT02937545|11907156|FG000|NOT COMPLETED|Overall Study||2
10743067|NCT02937545|11907157|FG001|NOT COMPLETED|Overall Study||2
10743068|NCT02937545|11907158|FG002|NOT COMPLETED|Overall Study||6
10743069|NCT02937545|11907159|FG003|NOT COMPLETED|Overall Study||7
10743070|NCT02937558|11907172|FG000|STARTED|Double-blind Phase||3
10743071|NCT02937558|11907173|FG001|STARTED|Double-blind Phase||2
10743072|NCT02937558|11907172|FG000|COMPLETED|Double-blind Phase||3
10743073|NCT02937558|11907173|FG001|COMPLETED|Double-blind Phase||2
10743074|NCT02937558|11907172|FG000|NOT COMPLETED|Double-blind Phase||0
10743075|NCT02937558|11907173|FG001|NOT COMPLETED|Double-blind Phase||0
10743076|NCT02937558|11907172|FG000|STARTED|Open-label Phase||5
10743077|NCT02937558|11907173|FG001|STARTED|Open-label Phase||0
10743078|NCT02937558|11907172|FG000|COMPLETED|Open-label Phase||5
10743079|NCT02937558|11907173|FG001|COMPLETED|Open-label Phase||0
10743080|NCT02937558|11907172|FG000|NOT COMPLETED|Open-label Phase||0
10743081|NCT02937558|11907173|FG001|NOT COMPLETED|Open-label Phase||0
10743082|NCT02937584|11907180|FG000|STARTED|Period 1||11
10743083|NCT02937584|11907181|FG001|STARTED|Period 1||12
10743084|NCT02937584|11907180|FG000|COMPLETED|Period 1||10
10743085|NCT02937584|11907181|FG001|COMPLETED|Period 1||10
10743086|NCT02937584|11907180|FG000|NOT COMPLETED|Period 1||1
10743087|NCT02937584|11907181|FG001|NOT COMPLETED|Period 1||2
10743088|NCT02937584|11907180|FG000|STARTED|Washout||10
10743089|NCT02937584|11907181|FG001|STARTED|Washout||10
10743090|NCT02937584|11907180|FG000|COMPLETED|Washout||10
10743091|NCT02937584|11907181|FG001|COMPLETED|Washout||9
10743092|NCT02937584|11907180|FG000|NOT COMPLETED|Washout||0
10743093|NCT02937584|11907181|FG001|NOT COMPLETED|Washout||1
10743094|NCT02937584|11907180|FG000|STARTED|Period 2||10
10743095|NCT02937584|11907181|FG001|STARTED|Period 2||9
10817246|NCT01321697|11980948|FG000|NOT COMPLETED|Overall Study||7
10817247|NCT01312428|11980954|FG000|STARTED|Overall Study||3
10817248|NCT01312428|11980955|FG001|STARTED|Overall Study||4
10817249|NCT01312428|11980954|FG000|COMPLETED|Overall Study||0
10817250|NCT01312428|11980955|FG001|COMPLETED|Overall Study||0
10817251|NCT01312428|11980954|FG000|NOT COMPLETED|Overall Study||3
10817252|NCT01312428|11980955|FG001|NOT COMPLETED|Overall Study||4
10817253|NCT01313416|11980963|FG000|STARTED|Overall Study||2
10817254|NCT01313416|11980963|FG000|COMPLETED|Overall Study||2
10817255|NCT01313416|11980963|FG000|NOT COMPLETED|Overall Study||0
10817256|NCT01303003|11980969|FG000|STARTED|Overall Study||0
10817257|NCT01303003|11980970|FG001|STARTED|Overall Study||0
10817258|NCT01303003|11980969|FG000|COMPLETED|Overall Study||0
10817259|NCT01303003|11980970|FG001|COMPLETED|Overall Study||0
10817260|NCT01303003|11980969|FG000|NOT COMPLETED|Overall Study||0
10817261|NCT01303003|11980970|FG001|NOT COMPLETED|Overall Study||0
10817262|NCT01302444|11980978|FG000|STARTED|Overall Study||1
10817263|NCT01302444|11980979|FG001|STARTED|Overall Study||0
10817264|NCT01302444|11980978|FG000|COMPLETED|Overall Study||1
10817265|NCT01302444|11980979|FG001|COMPLETED|Overall Study||0
10817266|NCT01302444|11980978|FG000|NOT COMPLETED|Overall Study||0
10817267|NCT01302444|11980979|FG001|NOT COMPLETED|Overall Study||0
10817268|NCT01301963|11980987|FG000|STARTED|Overall Study||5
10817269|NCT01301963|11980988|FG001|STARTED|Overall Study||4
10817270|NCT01301963|11980987|FG000|COMPLETED|Overall Study||5
10817271|NCT01301963|11980988|FG001|COMPLETED|Overall Study||4
10817272|NCT01301963|11980987|FG000|NOT COMPLETED|Overall Study||0
10817273|NCT01301963|11980988|FG001|NOT COMPLETED|Overall Study||0
10817274|NCT01298921|11980996|FG000|STARTED|Overall Study||0
10408703|NCT00756470|11552831|FG000|COMPLETED|Overall Study||10
10743096|NCT02937584|11907180|FG000|COMPLETED|Period 2||10
10743097|NCT02937584|11907181|FG001|COMPLETED|Period 2||9
10743098|NCT02937584|11907180|FG000|NOT COMPLETED|Period 2||0
10743099|NCT02937584|11907181|FG001|NOT COMPLETED|Period 2||0
10743100|NCT02937623|11907189|FG000|STARTED|Overall Study||60
10743101|NCT02937623|11907190|FG001|STARTED|Overall Study||60
10743102|NCT02937623|11907189|FG000|COMPLETED|Overall Study||60
10743103|NCT02937623|11907190|FG001|COMPLETED|Overall Study||60
10743104|NCT02937623|11907189|FG000|NOT COMPLETED|Overall Study||0
10743105|NCT02937623|11907190|FG001|NOT COMPLETED|Overall Study||0
10743106|NCT02937636|11907198|FG000|STARTED|Overall Study||63
10743107|NCT02937636|11907199|FG001|STARTED|Overall Study||65
10743108|NCT02937636|11907198|FG000|COMPLETED|Overall Study||60
10743109|NCT02937636|11907199|FG001|COMPLETED|Overall Study||63
10743110|NCT02937636|11907198|FG000|NOT COMPLETED|Overall Study||3
10743111|NCT02937636|11907199|FG001|NOT COMPLETED|Overall Study||2
10743112|NCT02937701|11907208|FG000|STARTED|Day 1 to Week 22||279
10743113|NCT02937701|11907209|FG001|STARTED|Day 1 to Week 22||279
10743114|NCT02937701|11907210|FG002|STARTED|Day 1 to Week 22||0
10743115|NCT02937701|11907211|FG003|STARTED|Day 1 to Week 22||0
10743116|NCT02937701|11907212|FG004|STARTED|Day 1 to Week 22||0
10743117|NCT02937701|11907208|FG000|Received Treatment|Day 1 to Week 22||278
10817275|NCT01298921|11980997|FG001|STARTED|Overall Study||0
10817276|NCT01298921|11980996|FG000|COMPLETED|Overall Study||0
10743118|NCT02937701|11907209|FG001|Received Treatment|Day 1 to Week 22||278
10743119|NCT02937701|11907210|FG002|Received Treatment|Day 1 to Week 22||0
10743120|NCT02937701|11907211|FG003|Received Treatment|Day 1 to Week 22||0
10743121|NCT02937701|11907212|FG004|Received Treatment|Day 1 to Week 22||0
10743122|NCT02937701|11907208|FG000|COMPLETED|Day 1 to Week 22||244
10743123|NCT02937701|11907209|FG001|COMPLETED|Day 1 to Week 22||240
10743124|NCT02937701|11907210|FG002|COMPLETED|Day 1 to Week 22||0
10743125|NCT02937701|11907211|FG003|COMPLETED|Day 1 to Week 22||0
10743126|NCT02937701|11907212|FG004|COMPLETED|Day 1 to Week 22||0
10743127|NCT02937701|11907208|FG000|NOT COMPLETED|Day 1 to Week 22||35
10743128|NCT02937701|11907209|FG001|NOT COMPLETED|Day 1 to Week 22||39
10743129|NCT02937701|11907210|FG002|NOT COMPLETED|Day 1 to Week 22||0
10743130|NCT02937701|11907211|FG003|NOT COMPLETED|Day 1 to Week 22||0
10743131|NCT02937701|11907212|FG004|NOT COMPLETED|Day 1 to Week 22||0
10743132|NCT02937701|11907208|FG000|STARTED|Week 22 to Week 50||0
10743133|NCT02937701|11907209|FG001|STARTED|Week 22 to Week 50||0
10743134|NCT02937701|11907210|FG002|STARTED|Week 22 to Week 50||244
10743135|NCT02937701|11907211|FG003|STARTED|Week 22 to Week 50||121
10743136|NCT02937701|11907212|FG004|STARTED|Week 22 to Week 50||119
10743137|NCT02937701|11907208|FG000|COMPLETED|Week 22 to Week 50||0
10743138|NCT02937701|11907209|FG001|COMPLETED|Week 22 to Week 50||0
10743139|NCT02937701|11907210|FG002|COMPLETED|Week 22 to Week 50||212
10743140|NCT02937701|11907211|FG003|COMPLETED|Week 22 to Week 50||113
10743141|NCT02937701|11907212|FG004|COMPLETED|Week 22 to Week 50||110
10743142|NCT02937701|11907208|FG000|NOT COMPLETED|Week 22 to Week 50||0
10743143|NCT02937701|11907209|FG001|NOT COMPLETED|Week 22 to Week 50||0
10743144|NCT02937701|11907210|FG002|NOT COMPLETED|Week 22 to Week 50||32
10743145|NCT02937701|11907211|FG003|NOT COMPLETED|Week 22 to Week 50||8
10743146|NCT02937701|11907212|FG004|NOT COMPLETED|Week 22 to Week 50||9
10743147|NCT02937740|11907226|FG000|STARTED|BID for 90 Days, 22 mg/Day||24
10743148|NCT02937740|11907227|FG001|STARTED|BID for 90 Days, 22 mg/Day||93
10743149|NCT02937740|11907226|FG000|COMPLETED|BID for 90 Days, 22 mg/Day||19
10743150|NCT02937740|11907227|FG001|COMPLETED|BID for 90 Days, 22 mg/Day||62
10743151|NCT02937740|11907226|FG000|NOT COMPLETED|BID for 90 Days, 22 mg/Day||5
10743152|NCT02937740|11907227|FG001|NOT COMPLETED|BID for 90 Days, 22 mg/Day||31
10743153|NCT02937740|11907226|FG000|STARTED|Uptitrated to TID on Day 90 for 30 Days||13
10743154|NCT02937740|11907227|FG001|STARTED|Uptitrated to TID on Day 90 for 30 Days||17
10743155|NCT02937740|11907226|FG000|COMPLETED|Uptitrated to TID on Day 90 for 30 Days||12
10743156|NCT02937740|11907227|FG001|COMPLETED|Uptitrated to TID on Day 90 for 30 Days||15
10743157|NCT02937740|11907226|FG000|NOT COMPLETED|Uptitrated to TID on Day 90 for 30 Days||1
10743158|NCT02937740|11907227|FG001|NOT COMPLETED|Uptitrated to TID on Day 90 for 30 Days||2
10743159|NCT02937870|11907239|FG000|STARTED|Overall Study||23
10743160|NCT02937870|11907239|FG000|Received Test Adhesive 1|Overall Study||21
10743161|NCT02937870|11907239|FG000|Received Test Adhesive 2|Overall Study||22
10743162|NCT02937870|11907239|FG000|Received Positive Control Adhesive|Overall Study||21
10743163|NCT02937870|11907239|FG000|Received no Adhesive|Overall Study||20
10743164|NCT02937870|11907239|FG000|COMPLETED|Overall Study||20
10743165|NCT02937870|11907239|FG000|NOT COMPLETED|Overall Study||3
10778300|NCT03352453|11940247|FG001|COMPLETED|Overall Study||40
10778301|NCT03352453|11940246|FG000|NOT COMPLETED|Overall Study||22
10778302|NCT03352453|11940247|FG001|NOT COMPLETED|Overall Study||32
10778303|NCT03352609|11940255|FG000|STARTED|Overall Study||2
10778304|NCT03352609|11940256|FG001|STARTED|Overall Study||3
10778305|NCT03352609|11940255|FG000|COMPLETED|Overall Study||2
10778306|NCT03352609|11940256|FG001|COMPLETED|Overall Study||3
10778307|NCT03352609|11940255|FG000|NOT COMPLETED|Overall Study||0
10778308|NCT03352609|11940256|FG001|NOT COMPLETED|Overall Study||0
10778309|NCT03352713|11940262|FG000|STARTED|Overall Study||185
10778310|NCT03352713|11940262|FG000|COMPLETED|Overall Study|Participants who completed at least 1 EMA for inclusion in data analysis|159
10778311|NCT03352713|11940262|FG000|NOT COMPLETED|Overall Study||26
10778312|NCT03353220|11940266|FG000|STARTED|First Intervention (7 Days) - Phase 1||14
10778313|NCT03353220|11940267|FG001|STARTED|First Intervention (7 Days) - Phase 1||16
10778314|NCT03353220|11940266|FG000|COMPLETED|First Intervention (7 Days) - Phase 1||14
10778315|NCT03353220|11940267|FG001|COMPLETED|First Intervention (7 Days) - Phase 1||16
10778316|NCT03353220|11940266|FG000|NOT COMPLETED|First Intervention (7 Days) - Phase 1||0
10778317|NCT03353220|11940267|FG001|NOT COMPLETED|First Intervention (7 Days) - Phase 1||0
10778318|NCT03353220|11940266|FG000|STARTED|Washout (3 Weeks) - Phase 1||14
10778319|NCT03353220|11940267|FG001|STARTED|Washout (3 Weeks) - Phase 1||16
10778320|NCT03353220|11940266|FG000|COMPLETED|Washout (3 Weeks) - Phase 1||14
10778321|NCT03353220|11940267|FG001|COMPLETED|Washout (3 Weeks) - Phase 1||16
10778322|NCT03353220|11940266|FG000|NOT COMPLETED|Washout (3 Weeks) - Phase 1||0
10778323|NCT03353220|11940267|FG001|NOT COMPLETED|Washout (3 Weeks) - Phase 1||0
10778324|NCT03353220|11940266|FG000|STARTED|Second Intervention (7 Days) - Phase 1||14
10778325|NCT03353220|11940267|FG001|STARTED|Second Intervention (7 Days) - Phase 1||16
10778326|NCT03353220|11940266|FG000|COMPLETED|Second Intervention (7 Days) - Phase 1||14
10778327|NCT03353220|11940267|FG001|COMPLETED|Second Intervention (7 Days) - Phase 1||16
10778328|NCT03353220|11940266|FG000|NOT COMPLETED|Second Intervention (7 Days) - Phase 1||0
10778329|NCT03353220|11940267|FG001|NOT COMPLETED|Second Intervention (7 Days) - Phase 1||0
10778330|NCT03353220|11940266|FG000|STARTED|Third Intervention (6 Months) - Phase 2||14
10778331|NCT03353220|11940267|FG001|STARTED|Third Intervention (6 Months) - Phase 2||16
10778332|NCT03353220|11940266|FG000|COMPLETED|Third Intervention (6 Months) - Phase 2||10
10778333|NCT03353220|11940267|FG001|COMPLETED|Third Intervention (6 Months) - Phase 2||9
10743166|NCT02938052|11907253|FG000|STARTED|Overall Study||10
10743167|NCT02938052|11907253|FG000|COMPLETED|Overall Study||10
10743168|NCT02938052|11907253|FG000|NOT COMPLETED|Overall Study||0
10743169|NCT02938169|11907262|FG000|STARTED|Overall Study||15
10743170|NCT02938169|11907263|FG001|STARTED|Overall Study||15
10743171|NCT02938169|11907264|FG002|STARTED|Overall Study||15
10743172|NCT02938169|11907265|FG003|STARTED|Overall Study||15
10743173|NCT02938169|11907262|FG000|COMPLETED|Overall Study||13
10743174|NCT02938169|11907263|FG001|COMPLETED|Overall Study||13
10743175|NCT02938169|11907264|FG002|COMPLETED|Overall Study||10
10743176|NCT02938169|11907265|FG003|COMPLETED|Overall Study||12
10743177|NCT02938169|11907262|FG000|NOT COMPLETED|Overall Study||2
10743178|NCT02938169|11907263|FG001|NOT COMPLETED|Overall Study||2
10743179|NCT02938169|11907264|FG002|NOT COMPLETED|Overall Study||5
10743180|NCT02938169|11907265|FG003|NOT COMPLETED|Overall Study||3
10743181|NCT02938494|11907286|FG000|STARTED|Overall Study||69
10743182|NCT02938494|11907287|FG001|STARTED|Overall Study||72
10743183|NCT02938494|11907288|FG002|STARTED|Overall Study||34
10743184|NCT02938494|11907289|FG003|STARTED|Overall Study||35
10743185|NCT02938494|11907286|FG000|COMPLETED|Overall Study||65
10743186|NCT02938494|11907287|FG001|COMPLETED|Overall Study||63
10743187|NCT02938494|11907288|FG002|COMPLETED|Overall Study||30
10743188|NCT02938494|11907289|FG003|COMPLETED|Overall Study||31
10743189|NCT02938494|11907286|FG000|NOT COMPLETED|Overall Study||4
10743190|NCT02938494|11907287|FG001|NOT COMPLETED|Overall Study||9
10743191|NCT02938494|11907288|FG002|NOT COMPLETED|Overall Study||4
10743192|NCT02938494|11907289|FG003|NOT COMPLETED|Overall Study||4
10743193|NCT02938585|11907302|FG000|STARTED|Overall Study||9
10743194|NCT02938585|11907303|FG001|STARTED|Overall Study||33
10743195|NCT02938585|11907304|FG002|STARTED|Overall Study||11
10743196|NCT02938585|11907305|FG003|STARTED|Overall Study||15
10743197|NCT02938585|11907302|FG000|Exposed to Prophylaxis Regimen|Overall Study||9
10743198|NCT02938585|11907303|FG001|Exposed to Prophylaxis Regimen|Overall Study||31
10743199|NCT02938585|11907304|FG002|Exposed to Prophylaxis Regimen|Overall Study||11
10743200|NCT02938585|11907305|FG003|Exposed to Prophylaxis Regimen|Overall Study||12
10743201|NCT02938585|11907302|FG000|Exposed to On-demand Regimen|Overall Study||1
10743202|NCT02938585|11907303|FG001|Exposed to On-demand Regimen|Overall Study||7
10743203|NCT02938585|11907304|FG002|Exposed to On-demand Regimen|Overall Study||1
10743204|NCT02938585|11907305|FG003|Exposed to On-demand Regimen|Overall Study||8
10817277|NCT01298921|11980997|FG001|COMPLETED|Overall Study||0
10817278|NCT01298921|11980996|FG000|NOT COMPLETED|Overall Study||0
10817279|NCT01298921|11980997|FG001|NOT COMPLETED|Overall Study||0
10817280|NCT01292070|11981005|FG000|STARTED|Overall Study||4
10817281|NCT01292070|11981005|FG000|COMPLETED|Overall Study||4
10817282|NCT01292070|11981005|FG000|NOT COMPLETED|Overall Study||0
10817283|NCT01292265|11981009|FG000|STARTED|Overall Study||3
10817284|NCT01292265|11981009|FG000|COMPLETED|Overall Study||3
10817285|NCT01292265|11981009|FG000|NOT COMPLETED|Overall Study||0
10817286|NCT01290822|11981013|FG000|STARTED|Overall Study||12
10817287|NCT01290822|11981013|FG000|COMPLETED|Overall Study||1
10817288|NCT01290822|11981013|FG000|NOT COMPLETED|Overall Study||11
10817289|NCT01290718|11981017|FG000|STARTED|Overall Study||4
10817290|NCT01290718|11981017|FG000|COMPLETED|Overall Study||0
10817291|NCT01290718|11981017|FG000|NOT COMPLETED|Overall Study||4
10817292|NCT01293123|11981023|FG000|STARTED|Overall Study||1
10817293|NCT01293123|11981024|FG001|STARTED|Overall Study||1
10817294|NCT01293123|11981023|FG000|COMPLETED|Overall Study||1
10817295|NCT01293123|11981024|FG001|COMPLETED|Overall Study||0
10817296|NCT01293123|11981023|FG000|NOT COMPLETED|Overall Study||0
10817297|NCT01293123|11981024|FG001|NOT COMPLETED|Overall Study||1
10817298|NCT01294046|11981030|FG000|STARTED|Overall Study||3
10817299|NCT01294046|11981030|FG000|COMPLETED|Overall Study||0
10817300|NCT01294046|11981030|FG000|NOT COMPLETED|Overall Study||3
10817301|NCT01280643|11981046|FG000|STARTED|Overall Study||0
10817302|NCT01280643|11981047|FG001|STARTED|Overall Study||1
10817303|NCT01280643|11981048|FG002|STARTED|Overall Study||1
10817304|NCT01280643|11981049|FG003|STARTED|Overall Study||1
10817305|NCT01280643|11981050|FG004|STARTED|Overall Study||0
10817306|NCT01280643|11981051|FG005|STARTED|Overall Study||0
10817307|NCT01280643|11981052|FG006|STARTED|Overall Study||0
10817308|NCT01280643|11981053|FG007|STARTED|Overall Study||0
10817309|NCT01280643|11981054|FG008|STARTED|Overall Study||0
10817310|NCT01280643|11981046|FG000|COMPLETED|Overall Study||0
10817311|NCT01280643|11981047|FG001|COMPLETED|Overall Study||0
10817312|NCT01280643|11981048|FG002|COMPLETED|Overall Study||1
10817313|NCT01280643|11981049|FG003|COMPLETED|Overall Study||1
10743205|NCT02938585|11907302|FG000|COMPLETED|Overall Study||9
10743206|NCT02938585|11907303|FG001|COMPLETED|Overall Study||32
10743207|NCT02938585|11907304|FG002|COMPLETED|Overall Study||11
10743208|NCT02938585|11907305|FG003|COMPLETED|Overall Study||10
10743209|NCT02938585|11907302|FG000|NOT COMPLETED|Overall Study||0
10743210|NCT02938585|11907303|FG001|NOT COMPLETED|Overall Study||1
10743211|NCT02938585|11907304|FG002|NOT COMPLETED|Overall Study||0
10743212|NCT02938585|11907305|FG003|NOT COMPLETED|Overall Study||5
10743213|NCT02938949|11907331|FG000|STARTED|Overall Study||10
10743214|NCT02938949|11907332|FG001|STARTED|Overall Study||10
10743215|NCT02938949|11907331|FG000|COMPLETED|Overall Study||10
10817314|NCT01280643|11981050|FG004|COMPLETED|Overall Study||0
10817315|NCT01280643|11981051|FG005|COMPLETED|Overall Study||0
10817316|NCT01280643|11981052|FG006|COMPLETED|Overall Study||0
10817317|NCT01280643|11981053|FG007|COMPLETED|Overall Study||0
10817318|NCT01280643|11981054|FG008|COMPLETED|Overall Study||0
10743216|NCT02938949|11907332|FG001|COMPLETED|Overall Study||10
10743217|NCT02938949|11907331|FG000|NOT COMPLETED|Overall Study||0
10743218|NCT02938949|11907332|FG001|NOT COMPLETED|Overall Study||0
10743219|NCT02939014|11907340|FG000|STARTED|Overall Study||30
10743220|NCT02939014|11907341|FG001|STARTED|Overall Study||9
10743221|NCT02939014|11907340|FG000|COMPLETED|Overall Study||25
10743222|NCT02939014|11907341|FG001|COMPLETED|Overall Study||6
10743223|NCT02939014|11907340|FG000|NOT COMPLETED|Overall Study||5
10743224|NCT02939014|11907341|FG001|NOT COMPLETED|Overall Study||3
10743225|NCT02939079|11907350|FG000|STARTED|Overall Study||25
10743226|NCT02939079|11907351|FG001|STARTED|Overall Study||25
10743227|NCT02939079|11907350|FG000|COMPLETED|Overall Study||21
10743228|NCT02939079|11907351|FG001|COMPLETED|Overall Study||20
10743229|NCT02939079|11907350|FG000|NOT COMPLETED|Overall Study||4
10743230|NCT02939079|11907351|FG001|NOT COMPLETED|Overall Study||5
10743231|NCT02939105|11907357|FG000|STARTED|Overall Study||15
10743232|NCT02939105|11907357|FG000|COMPLETED|Overall Study||15
10743233|NCT02939105|11907357|FG000|NOT COMPLETED|Overall Study||0
10743234|NCT02939131|11907364|FG000|STARTED|Overall Study|One additional site in the COMB-R group withdrew prior to the start of participant enrollment.|81
10743235|NCT02939131|11907365|FG001|STARTED|Overall Study||75
10743236|NCT02939131|11907364|FG000|Week 24 Visit|Overall Study|These are the numbers still on study at week 24|74
10743237|NCT02939131|11907365|FG001|Week 24 Visit|Overall Study||72
10743238|NCT02939131|11907364|FG000|COMPLETED|Overall Study||70
10743239|NCT02939131|11907365|FG001|COMPLETED|Overall Study||66
10743240|NCT02939131|11907364|FG000|NOT COMPLETED|Overall Study||11
10743241|NCT02939131|11907365|FG001|NOT COMPLETED|Overall Study||9
10743242|NCT02939170|11907374|FG000|STARTED|Overall Study||40
10743243|NCT02939170|11907375|FG001|STARTED|Overall Study||40
10743244|NCT02939170|11907374|FG000|COMPLETED|Overall Study||40
10743245|NCT02939170|11907375|FG001|COMPLETED|Overall Study||40
10743246|NCT02939170|11907374|FG000|NOT COMPLETED|Overall Study||0
10743247|NCT02939170|11907375|FG001|NOT COMPLETED|Overall Study||0
10743248|NCT02939326|11907390|FG000|STARTED|Overall Study||7
10743249|NCT02939326|11907391|FG001|STARTED|Overall Study||5
10743250|NCT02939326|11907392|FG002|STARTED|Overall Study||5
10743251|NCT02939326|11907393|FG003|STARTED|Overall Study||5
10743252|NCT02939326|11907394|FG004|STARTED|Overall Study||5
10743253|NCT02939326|11907395|FG005|STARTED|Overall Study||5
10743254|NCT02939326|11907396|FG006|STARTED|Overall Study||5
10743255|NCT02939326|11907397|FG007|STARTED|Overall Study||5
10743256|NCT02939326|11907390|FG000|COMPLETED|Overall Study||7
10743257|NCT02939326|11907391|FG001|COMPLETED|Overall Study||5
10743258|NCT02939326|11907392|FG002|COMPLETED|Overall Study||5
10743259|NCT02939326|11907393|FG003|COMPLETED|Overall Study||5
10743260|NCT02939326|11907394|FG004|COMPLETED|Overall Study||5
10743261|NCT02939326|11907395|FG005|COMPLETED|Overall Study||5
10743262|NCT02939326|11907396|FG006|COMPLETED|Overall Study||5
10743263|NCT02939326|11907397|FG007|COMPLETED|Overall Study||5
10743264|NCT02939326|11907390|FG000|NOT COMPLETED|Overall Study||0
10743265|NCT02939326|11907391|FG001|NOT COMPLETED|Overall Study||0
10743266|NCT02939326|11907392|FG002|NOT COMPLETED|Overall Study||0
10743267|NCT02939326|11907393|FG003|NOT COMPLETED|Overall Study||0
10743268|NCT02939326|11907394|FG004|NOT COMPLETED|Overall Study||0
10743269|NCT02939326|11907395|FG005|NOT COMPLETED|Overall Study||0
10743270|NCT02939326|11907396|FG006|NOT COMPLETED|Overall Study||0
10743271|NCT02939326|11907397|FG007|NOT COMPLETED|Overall Study||0
10743272|NCT02939560|11907415|FG000|STARTED|Overall Study||13
10743273|NCT02939560|11907415|FG000|COMPLETED|Overall Study||10
10743274|NCT02939560|11907415|FG000|NOT COMPLETED|Overall Study||3
10743275|NCT02939599|11907421|FG000|STARTED|Overall Study||3
10743276|NCT02939599|11907422|FG001|STARTED|Overall Study||2
10743277|NCT02939599|11907421|FG000|COMPLETED|Overall Study||0
10743278|NCT02939599|11907422|FG001|COMPLETED|Overall Study||0
10743279|NCT02939599|11907421|FG000|NOT COMPLETED|Overall Study||3
10743280|NCT02939599|11907422|FG001|NOT COMPLETED|Overall Study||2
10743281|NCT02939651|11907429|FG000|STARTED|Overall Study||21
10743282|NCT02939651|11907429|FG000|COMPLETED|Overall Study||21
10743283|NCT02939651|11907429|FG000|NOT COMPLETED|Overall Study||0
10743284|NCT02939716|11907433|FG000|STARTED|Overall Study||3
10743285|NCT02939716|11907434|FG001|STARTED|Overall Study||3
10743286|NCT02939716|11907435|FG002|STARTED|Overall Study||3
10743287|NCT02939716|11907436|FG003|STARTED|Overall Study||3
10743288|NCT02939716|11907437|FG004|STARTED|Overall Study||3
10743289|NCT02939716|11907438|FG005|STARTED|Overall Study||3
10743290|NCT02939716|11907433|FG000|COMPLETED|Overall Study||3
10743291|NCT02939716|11907434|FG001|COMPLETED|Overall Study||3
10743292|NCT02939716|11907435|FG002|COMPLETED|Overall Study||3
10743293|NCT02939716|11907436|FG003|COMPLETED|Overall Study||2
10743294|NCT02939716|11907437|FG004|COMPLETED|Overall Study||2
10743295|NCT02939716|11907438|FG005|COMPLETED|Overall Study||2
10743296|NCT02939716|11907433|FG000|NOT COMPLETED|Overall Study||0
10743297|NCT02939716|11907434|FG001|NOT COMPLETED|Overall Study||0
10743298|NCT02939716|11907435|FG002|NOT COMPLETED|Overall Study||0
10743299|NCT02939716|11907436|FG003|NOT COMPLETED|Overall Study||1
10743300|NCT02939716|11907437|FG004|NOT COMPLETED|Overall Study||1
10743301|NCT02939716|11907438|FG005|NOT COMPLETED|Overall Study||1
10743302|NCT02939781|11907455|FG000|STARTED|Overall Study||12
10743303|NCT02939781|11907455|FG000|COMPLETED|Overall Study||3
10743304|NCT02939781|11907455|FG000|NOT COMPLETED|Overall Study||9
10743305|NCT02939937|11907462|FG000|STARTED|Overall Study|5 patients had drug reaction and 1 patient excluded from study,|21
10743306|NCT02939937|11907463|FG001|STARTED|Overall Study|3 patients excluded from study|50
10743307|NCT02939937|11907462|FG000|COMPLETED|Overall Study||15
10743308|NCT02939937|11907463|FG001|COMPLETED|Overall Study||47
10743309|NCT02939937|11907462|FG000|NOT COMPLETED|Overall Study||6
10743310|NCT02939937|11907463|FG001|NOT COMPLETED|Overall Study||3
10743311|NCT02939950|11907471|FG000|STARTED|Overall Study||406
10743312|NCT02939950|11907472|FG001|STARTED|Overall Study||410
10743313|NCT02939950|11907471|FG000|Dispensed the Assigned Lenses|Overall Study||405
10743314|NCT02939950|11907472|FG001|Dispensed the Assigned Lenses|Overall Study||410
10743315|NCT02939950|11907471|FG000|Eligible at Baseline|Overall Study||403
10743316|NCT02939950|11907472|FG001|Eligible at Baseline|Overall Study||402
10743317|NCT02939950|11907471|FG000|COMPLETED|Overall Study||340
10743318|NCT02939950|11907472|FG001|COMPLETED|Overall Study||329
10743319|NCT02939950|11907471|FG000|NOT COMPLETED|Overall Study||66
10743320|NCT02939950|11907472|FG001|NOT COMPLETED|Overall Study||81
10743321|NCT02940249|11907478|FG000|STARTED|Overall Study||34
10743322|NCT02940249|11907478|FG000|COMPLETED|Overall Study||30
10743323|NCT02940249|11907478|FG000|NOT COMPLETED|Overall Study||4
10743324|NCT02940327|11907488|FG000|STARTED|Overall Study||24
10743325|NCT02940327|11907488|FG000|COMPLETED|Overall Study||24
10743326|NCT02940327|11907488|FG000|NOT COMPLETED|Overall Study||0
10743327|NCT02940392|11907493|FG000|STARTED|Overall Study||15
10743328|NCT02940392|11907493|FG000|COMPLETED|Overall Study||7
10743329|NCT02940392|11907493|FG000|NOT COMPLETED|Overall Study||8
10743330|NCT02940574|11907499|FG000|STARTED|From Study Start to 1-month Follow-up||22
10743331|NCT02940574|11907500|FG001|STARTED|From Study Start to 1-month Follow-up||18
10743332|NCT02940574|11907499|FG000|COMPLETED|From Study Start to 1-month Follow-up|Discontinued intervention (N=1): self-termination unrelated to treatment|21
10743333|NCT02940574|11907500|FG001|COMPLETED|From Study Start to 1-month Follow-up|All participants completed, but data from 1 participant was not included in analyses.|18
10743334|NCT02940574|11907499|FG000|NOT COMPLETED|From Study Start to 1-month Follow-up||1
10743335|NCT02940574|11907500|FG001|NOT COMPLETED|From Study Start to 1-month Follow-up||0
10743336|NCT02940574|11907499|FG000|STARTED|1-year Follow-up||21
10743337|NCT02940574|11907500|FG001|STARTED|1-year Follow-up||18
10743338|NCT02940574|11907499|FG000|COMPLETED|1-year Follow-up||18
10743339|NCT02940574|11907500|FG001|COMPLETED|1-year Follow-up||14
10743340|NCT02940574|11907499|FG000|NOT COMPLETED|1-year Follow-up||3
10743341|NCT02940574|11907500|FG001|NOT COMPLETED|1-year Follow-up||4
10743342|NCT02940626|11907512|FG000|STARTED|Overall Study||77
10743343|NCT02940626|11907513|FG001|STARTED|Overall Study||78
10743344|NCT02940626|11907512|FG000|Randomized Into Primary Prevention Study|Overall Study||77
10743345|NCT02940626|11907513|FG001|Randomized Into Primary Prevention Study|Overall Study||77
10743346|NCT02940626|11907512|FG000|Randomized Into Treatment Sub-study|Overall Study||0
10743347|NCT02940626|11907513|FG001|Randomized Into Treatment Sub-study|Overall Study||1
10743348|NCT02940626|11907512|FG000|Received Study Treatment|Overall Study||77
10743349|NCT02940626|11907513|FG001|Received Study Treatment|Overall Study||77
10743350|NCT02940626|11907512|FG000|Completed Through Study Day 22|Overall Study||42
10743351|NCT02940626|11907513|FG001|Completed Through Study Day 22|Overall Study||49
10743352|NCT02940626|11907512|FG000|COMPLETED|Overall Study||30
10743353|NCT02940626|11907513|FG001|COMPLETED|Overall Study||43
10743354|NCT02940626|11907512|FG000|NOT COMPLETED|Overall Study||47
10743355|NCT02940626|11907513|FG001|NOT COMPLETED|Overall Study||35
10743356|NCT02940691|11907521|FG000|STARTED|Overall Study||32
10743357|NCT02940691|11907521|FG000|COMPLETED|Overall Study||26
10743358|NCT02940691|11907521|FG000|NOT COMPLETED|Overall Study||6
10743359|NCT02940730|11907528|FG000|STARTED|Intervention 1||10
10743360|NCT02940730|11907529|FG001|STARTED|Intervention 1||0
10743361|NCT02940730|11907528|FG000|Received Intervention|Intervention 1||10
10743362|NCT02940730|11907529|FG001|Received Intervention|Intervention 1||0
10743363|NCT02940730|11907528|FG000|COMPLETED|Intervention 1||10
10743364|NCT02940730|11907529|FG001|COMPLETED|Intervention 1||0
10743365|NCT02940730|11907528|FG000|NOT COMPLETED|Intervention 1||0
10743366|NCT02940730|11907529|FG001|NOT COMPLETED|Intervention 1||0
10743367|NCT02940730|11907528|FG000|STARTED|Intervention 2||10
10743368|NCT02940730|11907529|FG001|STARTED|Intervention 2||0
10743369|NCT02940730|11907528|FG000|Received Intervention|Intervention 2||3
10743370|NCT02940730|11907529|FG001|Received Intervention|Intervention 2||0
10743371|NCT02940730|11907528|FG000|COMPLETED|Intervention 2||3
10743372|NCT02940730|11907529|FG001|COMPLETED|Intervention 2||0
10743373|NCT02940730|11907528|FG000|NOT COMPLETED|Intervention 2||7
10743374|NCT02940730|11907529|FG001|NOT COMPLETED|Intervention 2||0
10743375|NCT02940860|11907537|FG000|STARTED|Overall Study||1027
10743376|NCT02940860|11907538|FG001|STARTED|Overall Study||511
10743377|NCT02940860|11907537|FG000|COMPLETED|Overall Study||971
10743378|NCT02940860|11907538|FG001|COMPLETED|Overall Study||476
10743379|NCT02940860|11907537|FG000|NOT COMPLETED|Overall Study||56
10743380|NCT02940860|11907538|FG001|NOT COMPLETED|Overall Study||35
10743381|NCT02940886|11907548|FG000|STARTED|Overall Study|Intention-to-treat analysis set included 1009 subjects, safety analysis set included 989 subjects.|1009
10743382|NCT02940886|11907549|FG001|STARTED|Overall Study|Intention-to-treat analysis set included 503 subjects, safety analysis set included 494 subjects.|503
10743383|NCT02940886|11907548|FG000|Safety Analysis Set|Overall Study||989
10743384|NCT02940886|11907549|FG001|Safety Analysis Set|Overall Study||494
10743385|NCT02940886|11907548|FG000|COMPLETED|Overall Study||907
10743386|NCT02940886|11907549|FG001|COMPLETED|Overall Study||449
10743387|NCT02940886|11907548|FG000|NOT COMPLETED|Overall Study||102
10743388|NCT02940886|11907549|FG001|NOT COMPLETED|Overall Study||54
10779388|NCT03365778|11940976|FG000|STARTED|Overall Study||16
10743389|NCT02941523|11907559|FG000|STARTED|Monotherapy|8 received NOX66 400 mg monotherapy and combination therapy with carboplatin.|8
10743390|NCT02941523|11907560|FG001|STARTED|Monotherapy||8
10743391|NCT02941523|11907559|FG000|COMPLETED|Monotherapy||8
10743392|NCT02941523|11907560|FG001|COMPLETED|Monotherapy||7
10743393|NCT02941523|11907559|FG000|NOT COMPLETED|Monotherapy||0
10743394|NCT02941523|11907560|FG001|NOT COMPLETED|Monotherapy||1
10743395|NCT02941523|11907559|FG000|STARTED|Carboplatin Combination Therapy|All continued to combination therapy|8
10743396|NCT02941523|11907560|FG001|STARTED|Carboplatin Combination Therapy|7 continued to combination therapy; 3 started combination therapy only|10
10743397|NCT02941523|11907559|FG000|COMPLETED|Carboplatin Combination Therapy||3
10743398|NCT02941523|11907560|FG001|COMPLETED|Carboplatin Combination Therapy||6
10743399|NCT02941523|11907559|FG000|NOT COMPLETED|Carboplatin Combination Therapy||5
10743400|NCT02941523|11907560|FG001|NOT COMPLETED|Carboplatin Combination Therapy||4
10743401|NCT02941614|11907576|FG000|STARTED|Overall Study||744
10743402|NCT02941614|11907577|FG001|STARTED|Overall Study||692
10743403|NCT02941614|11907576|FG000|COMPLETED|Overall Study||603
10743404|NCT02941614|11907577|FG001|COMPLETED|Overall Study||446
10743405|NCT02941614|11907576|FG000|NOT COMPLETED|Overall Study||141
10743406|NCT02941614|11907577|FG001|NOT COMPLETED|Overall Study||246
10743407|NCT02941627|11907585|FG000|STARTED|Overall Study|Among 53 patients enrolled: 1 passed away after the informed consent completion, 1 was not implanted for surgical failure, and 1 for cholesteatoma discovered during surgical procedure. This last patient was included in safety analysis as defined in the protocol. Therefore, among 53 patients enrolled 51 were evaluated for safety outcomes, and 50 were successfully implanted and complete the study.|53
10743408|NCT02941627|11907585|FG000|Clinical Safety on Overall Participants|Overall Study||51
10743409|NCT02941627|11907585|FG000|Clinical Efficiency on English Speaking Participants|Overall Study|Among the 50 patients successfully implanted 33 English speaking participant complete speech performance measure.|33
10743410|NCT02941627|11907585|FG000|COMPLETED|Overall Study||50
10743411|NCT02941627|11907585|FG000|NOT COMPLETED|Overall Study||3
10743412|NCT02941640|11907599|FG000|STARTED|Overall Study||30
10743413|NCT02941640|11907600|FG001|STARTED|Overall Study||30
10743414|NCT02941640|11907601|FG002|STARTED|Overall Study||30
10743415|NCT02941640|11907602|FG003|STARTED|Overall Study||30
10743416|NCT02941640|11907599|FG000|COMPLETED|Overall Study||30
10743417|NCT02941640|11907600|FG001|COMPLETED|Overall Study||30
10743418|NCT02941640|11907601|FG002|COMPLETED|Overall Study||30
10743419|NCT02941640|11907602|FG003|COMPLETED|Overall Study||30
10743420|NCT02941640|11907599|FG000|NOT COMPLETED|Overall Study||0
10743421|NCT02941640|11907600|FG001|NOT COMPLETED|Overall Study||0
10743422|NCT02941640|11907601|FG002|NOT COMPLETED|Overall Study||0
10743423|NCT02941640|11907602|FG003|NOT COMPLETED|Overall Study||0
10743424|NCT02941692|11907614|FG000|STARTED|Overall Study||32
10743425|NCT02941692|11907615|FG001|STARTED|Overall Study||34
10743426|NCT02941692|11907614|FG000|COMPLETED|Overall Study||32
10743427|NCT02941692|11907615|FG001|COMPLETED|Overall Study||34
10743428|NCT02941692|11907614|FG000|NOT COMPLETED|Overall Study||0
10743429|NCT02941692|11907615|FG001|NOT COMPLETED|Overall Study||0
10743430|NCT02942160|11907621|FG000|STARTED|Overall Study|Observation Phase prior to open-label treatment phase|259
10743431|NCT02942160|11907621|FG000|EN3835-202 Participants|Overall Study|Observation Phase Completed|222
10743432|NCT02942160|11907621|FG000|EN3835 Treated Subjects in EN3835-202|Overall Study|EN3835 Treated Participants in EN3835-202 Started|200
10743433|NCT02942160|11907621|FG000|COMPLETED|Overall Study|EN3835 Treated Participants in EN3835-202 Completed|156
10743434|NCT02942160|11907621|FG000|NOT COMPLETED|Overall Study||103
10743435|NCT02942264|11907638|FG000|STARTED|Phase 1 MTD Finding Stage||6
10743436|NCT02942264|11907639|FG001|STARTED|Phase 1 MTD Finding Stage||13
10743437|NCT02942264|11907640|FG002|STARTED|Phase 1 MTD Finding Stage||3
10743438|NCT02942264|11907641|FG003|STARTED|Phase 1 MTD Finding Stage||6
10743439|NCT02942264|11907642|FG004|STARTED|Phase 1 MTD Finding Stage||3
10743440|NCT02942264|11907643|FG005|STARTED|Phase 1 MTD Finding Stage||2
10743441|NCT02942264|11907644|FG006|STARTED|Phase 1 MTD Finding Stage||7
10743442|NCT02942264|11907645|FG007|STARTED|Phase 1 MTD Finding Stage||0
10743443|NCT02942264|11907646|FG008|STARTED|Phase 1 MTD Finding Stage||0
10743444|NCT02942264|11907638|FG000|COMPLETED|Phase 1 MTD Finding Stage||6
10743445|NCT02942264|11907639|FG001|COMPLETED|Phase 1 MTD Finding Stage||12
10743446|NCT02942264|11907640|FG002|COMPLETED|Phase 1 MTD Finding Stage||3
10743447|NCT02942264|11907641|FG003|COMPLETED|Phase 1 MTD Finding Stage||6
10743448|NCT02942264|11907642|FG004|COMPLETED|Phase 1 MTD Finding Stage||3
10743449|NCT02942264|11907643|FG005|COMPLETED|Phase 1 MTD Finding Stage||2
10743450|NCT02942264|11907644|FG006|COMPLETED|Phase 1 MTD Finding Stage||6
10743451|NCT02942264|11907645|FG007|COMPLETED|Phase 1 MTD Finding Stage||0
10743452|NCT02942264|11907646|FG008|COMPLETED|Phase 1 MTD Finding Stage||0
10743453|NCT02942264|11907638|FG000|NOT COMPLETED|Phase 1 MTD Finding Stage||0
10743454|NCT02942264|11907639|FG001|NOT COMPLETED|Phase 1 MTD Finding Stage||1
10743455|NCT02942264|11907640|FG002|NOT COMPLETED|Phase 1 MTD Finding Stage||0
10743456|NCT02942264|11907641|FG003|NOT COMPLETED|Phase 1 MTD Finding Stage||0
10743457|NCT02942264|11907642|FG004|NOT COMPLETED|Phase 1 MTD Finding Stage||0
10743458|NCT02942264|11907643|FG005|NOT COMPLETED|Phase 1 MTD Finding Stage||0
10743459|NCT02942264|11907644|FG006|NOT COMPLETED|Phase 1 MTD Finding Stage||1
10743460|NCT02942264|11907645|FG007|NOT COMPLETED|Phase 1 MTD Finding Stage||0
10743461|NCT02942264|11907646|FG008|NOT COMPLETED|Phase 1 MTD Finding Stage||0
10743462|NCT02942264|11907638|FG000|STARTED|Phase 1 Cohort Expansion Stage||0
10743463|NCT02942264|11907639|FG001|STARTED|Phase 1 Cohort Expansion Stage||0
10743464|NCT02942264|11907640|FG002|STARTED|Phase 1 Cohort Expansion Stage||0
10743465|NCT02942264|11907641|FG003|STARTED|Phase 1 Cohort Expansion Stage||0
10743466|NCT02942264|11907642|FG004|STARTED|Phase 1 Cohort Expansion Stage||0
10743467|NCT02942264|11907643|FG005|STARTED|Phase 1 Cohort Expansion Stage||0
10743468|NCT02942264|11907644|FG006|STARTED|Phase 1 Cohort Expansion Stage||0
10743469|NCT02942264|11907645|FG007|STARTED|Phase 1 Cohort Expansion Stage||6
10743470|NCT02942264|11907646|FG008|STARTED|Phase 1 Cohort Expansion Stage||7
10743471|NCT02942264|11907638|FG000|COMPLETED|Phase 1 Cohort Expansion Stage||0
10743472|NCT02942264|11907639|FG001|COMPLETED|Phase 1 Cohort Expansion Stage||0
10743473|NCT02942264|11907640|FG002|COMPLETED|Phase 1 Cohort Expansion Stage||0
10743474|NCT02942264|11907641|FG003|COMPLETED|Phase 1 Cohort Expansion Stage||0
10743475|NCT02942264|11907642|FG004|COMPLETED|Phase 1 Cohort Expansion Stage||0
10743476|NCT02942264|11907643|FG005|COMPLETED|Phase 1 Cohort Expansion Stage||0
10743477|NCT02942264|11907644|FG006|COMPLETED|Phase 1 Cohort Expansion Stage||0
10743478|NCT02942264|11907645|FG007|COMPLETED|Phase 1 Cohort Expansion Stage||6
10743479|NCT02942264|11907646|FG008|COMPLETED|Phase 1 Cohort Expansion Stage||6
10743480|NCT02942264|11907638|FG000|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
10743481|NCT02942264|11907639|FG001|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
10743482|NCT02942264|11907640|FG002|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
10743483|NCT02942264|11907641|FG003|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
10743484|NCT02942264|11907642|FG004|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
10743485|NCT02942264|11907643|FG005|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
10743486|NCT02942264|11907644|FG006|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
10743487|NCT02942264|11907645|FG007|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
10743488|NCT02942264|11907646|FG008|NOT COMPLETED|Phase 1 Cohort Expansion Stage||1
10743489|NCT02942407|11907673|FG000|STARTED|Overall Study||82
10743490|NCT02942407|11907674|FG001|STARTED|Overall Study||72
10743491|NCT02942407|11907673|FG000|COMPLETED|Overall Study||56
10743492|NCT02942407|11907674|FG001|COMPLETED|Overall Study||48
10743493|NCT02942407|11907673|FG000|NOT COMPLETED|Overall Study||26
10743494|NCT02942407|11907674|FG001|NOT COMPLETED|Overall Study||24
10743495|NCT02942485|11907690|FG000|STARTED|Overall Study||7
10743496|NCT02942485|11907691|FG001|STARTED|Overall Study||1
10743497|NCT02942485|11907690|FG000|COMPLETED|Overall Study||6
10743498|NCT02942485|11907691|FG001|COMPLETED|Overall Study||1
10743499|NCT02942485|11907690|FG000|NOT COMPLETED|Overall Study||1
10743500|NCT02942485|11907691|FG001|NOT COMPLETED|Overall Study||0
10743501|NCT02942576|11907699|FG000|STARTED|Overall Study||405
10743502|NCT02942576|11907700|FG001|STARTED|Overall Study||197
10743503|NCT02942576|11907699|FG000|COMPLETED|Overall Study||359
10743504|NCT02942576|11907700|FG001|COMPLETED|Overall Study||174
10743505|NCT02942576|11907699|FG000|NOT COMPLETED|Overall Study||46
10743506|NCT02942576|11907700|FG001|NOT COMPLETED|Overall Study||23
10743507|NCT02942654|11907706|FG000|STARTED|Period 1||16
10743508|NCT02942654|11907707|FG001|STARTED|Period 1||16
10743509|NCT02942654|11907706|FG000|Received at Least 1 Dose of Study Drug|Period 1||16
10743510|NCT02942654|11907707|FG001|Received at Least 1 Dose of Study Drug|Period 1||16
10743511|NCT02942654|11907706|FG000|COMPLETED|Period 1||16
10743512|NCT02942654|11907707|FG001|COMPLETED|Period 1||16
10743513|NCT02942654|11907706|FG000|NOT COMPLETED|Period 1||0
10743514|NCT02942654|11907707|FG001|NOT COMPLETED|Period 1||0
10743515|NCT02942654|11907706|FG000|STARTED|Washout||16
10743516|NCT02942654|11907707|FG001|STARTED|Washout||16
10743517|NCT02942654|11907706|FG000|COMPLETED|Washout||16
10743518|NCT02942654|11907707|FG001|COMPLETED|Washout||16
10743519|NCT02942654|11907706|FG000|NOT COMPLETED|Washout||0
10743520|NCT02942654|11907707|FG001|NOT COMPLETED|Washout||0
10743521|NCT02942654|11907706|FG000|STARTED|Period 2||16
10743522|NCT02942654|11907707|FG001|STARTED|Period 2||16
10743523|NCT02942654|11907706|FG000|COMPLETED|Period 2||16
10743524|NCT02942654|11907707|FG001|COMPLETED|Period 2||16
10743525|NCT02942654|11907706|FG000|NOT COMPLETED|Period 2||0
10743526|NCT02942654|11907707|FG001|NOT COMPLETED|Period 2||0
10743527|NCT02942771|11907718|FG000|STARTED|Overall Study||9
10743528|NCT02942771|11907719|FG001|STARTED|Overall Study||6
10743529|NCT02942771|11907720|FG002|STARTED|Overall Study||6
10743530|NCT02942771|11907721|FG003|STARTED|Overall Study||6
10743531|NCT02942771|11907722|FG004|STARTED|Overall Study||8
10743532|NCT02942771|11907718|FG000|COMPLETED|Overall Study||6
10743533|NCT02942771|11907719|FG001|COMPLETED|Overall Study||6
10743534|NCT02942771|11907720|FG002|COMPLETED|Overall Study||6
10743535|NCT02942771|11907721|FG003|COMPLETED|Overall Study||6
10743536|NCT02942771|11907722|FG004|COMPLETED|Overall Study||4
10743537|NCT02942771|11907718|FG000|NOT COMPLETED|Overall Study||3
10743538|NCT02942771|11907719|FG001|NOT COMPLETED|Overall Study||0
10743539|NCT02942771|11907720|FG002|NOT COMPLETED|Overall Study||0
10743540|NCT02942771|11907721|FG003|NOT COMPLETED|Overall Study||0
10743541|NCT02942771|11907722|FG004|NOT COMPLETED|Overall Study||4
10743542|NCT02942979|11907736|FG000|STARTED|Step 0||108
10743543|NCT02942979|11907737|FG001|STARTED|Step 0||0
10743544|NCT02942979|11907736|FG000|COMPLETED|Step 0||108
10743545|NCT02942979|11907737|FG001|COMPLETED|Step 0|This is a stepped wedge design - all participants received both MISSION Implementation as Usual and Facilitation|0
10743546|NCT02942979|11907736|FG000|NOT COMPLETED|Step 0||0
10743547|NCT02942979|11907737|FG001|NOT COMPLETED|Step 0||0
10743548|NCT02942979|11907736|FG000|STARTED|Step 1||15
10743549|NCT02942979|11907737|FG001|STARTED|Step 1||93
10743550|NCT02942979|11907736|FG000|COMPLETED|Step 1||15
10743551|NCT02942979|11907737|FG001|COMPLETED|Step 1||93
10743552|NCT02942979|11907736|FG000|NOT COMPLETED|Step 1||0
10743553|NCT02942979|11907737|FG001|NOT COMPLETED|Step 1||0
10743554|NCT02942979|11907736|FG000|STARTED|Step 2||0
10743555|NCT02942979|11907737|FG001|STARTED|Step 2||108
10743556|NCT02942979|11907736|FG000|COMPLETED|Step 2||0
10743557|NCT02942979|11907737|FG001|COMPLETED|Step 2||108
10743558|NCT02942979|11907736|FG000|NOT COMPLETED|Step 2||0
10743559|NCT02942979|11907737|FG001|NOT COMPLETED|Step 2||0
10743560|NCT02943070|11907743|FG000|STARTED|Overall Study||50
10743561|NCT02943070|11907743|FG000|COMPLETED|Overall Study||7
10743562|NCT02943070|11907743|FG000|NOT COMPLETED|Overall Study||43
10743563|NCT02943096|11907756|FG000|STARTED|Overall Study||3
10743564|NCT02943096|11907757|FG001|STARTED|Overall Study||3
10743565|NCT02943096|11907756|FG000|COMPLETED|Overall Study||3
10743566|NCT02943096|11907757|FG001|COMPLETED|Overall Study||2
10743567|NCT02943096|11907756|FG000|NOT COMPLETED|Overall Study||0
10743568|NCT02943096|11907757|FG001|NOT COMPLETED|Overall Study||1
10743569|NCT02943213|11907763|FG000|STARTED|Treatment Period 1||20
10743570|NCT02943213|11907763|FG000|COMPLETED|Treatment Period 1||20
10743571|NCT02943213|11907763|FG000|NOT COMPLETED|Treatment Period 1||0
10743572|NCT02943213|11907763|FG000|STARTED|Treatment Period 2||20
10743573|NCT02943213|11907763|FG000|COMPLETED|Treatment Period 2||20
10743574|NCT02943213|11907763|FG000|NOT COMPLETED|Treatment Period 2||0
10743575|NCT02943226|11907771|FG000|STARTED|Overall Study||31
10743576|NCT02943226|11907772|FG001|STARTED|Overall Study||30
10743577|NCT02943226|11907771|FG000|COMPLETED|Overall Study||31
10743578|NCT02943226|11907772|FG001|COMPLETED|Overall Study||30
10743579|NCT02943226|11907771|FG000|NOT COMPLETED|Overall Study||0
10408704|NCT00756470|11552831|FG000|NOT COMPLETED|Overall Study||5
10408705|NCT00756496|11552835|FG000|STARTED|Overall Study||442
10408706|NCT00756496|11552835|FG000|COMPLETED|Overall Study||442
10743580|NCT02943226|11907772|FG001|NOT COMPLETED|Overall Study||0
10743581|NCT02943447|11907781|FG000|STARTED|Blinded Study Phase||28
10743582|NCT02943447|11907782|FG001|STARTED|Blinded Study Phase||30
10743583|NCT02943447|11907783|FG002|STARTED|Blinded Study Phase||13
10743584|NCT02943447|11907781|FG000|COMPLETED|Blinded Study Phase||23
10743585|NCT02943447|11907782|FG001|COMPLETED|Blinded Study Phase||28
10743586|NCT02943447|11907783|FG002|COMPLETED|Blinded Study Phase||12
10743587|NCT02943447|11907781|FG000|NOT COMPLETED|Blinded Study Phase||5
10743588|NCT02943447|11907782|FG001|NOT COMPLETED|Blinded Study Phase||2
10743589|NCT02943447|11907783|FG002|NOT COMPLETED|Blinded Study Phase||1
10743590|NCT02943447|11907781|FG000|STARTED|Open-Label Extension Phase||23
10743591|NCT02943447|11907782|FG001|STARTED|Open-Label Extension Phase||28
10743592|NCT02943447|11907783|FG002|STARTED|Open-Label Extension Phase||12
10743593|NCT02943447|11907781|FG000|COMPLETED|Open-Label Extension Phase||5
10743594|NCT02943447|11907782|FG001|COMPLETED|Open-Label Extension Phase||3
10743595|NCT02943447|11907783|FG002|COMPLETED|Open-Label Extension Phase||2
10743596|NCT02943447|11907781|FG000|NOT COMPLETED|Open-Label Extension Phase||18
10743597|NCT02943447|11907782|FG001|NOT COMPLETED|Open-Label Extension Phase||25
10743598|NCT02943447|11907783|FG002|NOT COMPLETED|Open-Label Extension Phase||10
10743599|NCT02943460|11907803|FG000|STARTED|Blinded Study Phase||22
10743600|NCT02943460|11907804|FG001|STARTED|Blinded Study Phase||20
10743601|NCT02943460|11907805|FG002|STARTED|Blinded Study Phase||10
10743602|NCT02943460|11907803|FG000|COMPLETED|Blinded Study Phase||19
10743603|NCT02943460|11907804|FG001|COMPLETED|Blinded Study Phase||19
10743604|NCT02943460|11907805|FG002|COMPLETED|Blinded Study Phase||10
10743605|NCT02943460|11907803|FG000|NOT COMPLETED|Blinded Study Phase||3
10743606|NCT02943460|11907804|FG001|NOT COMPLETED|Blinded Study Phase||1
10743607|NCT02943460|11907805|FG002|NOT COMPLETED|Blinded Study Phase||0
10743608|NCT02943460|11907803|FG000|STARTED|Open Label Extension (OLE) Phase||19
10743609|NCT02943460|11907804|FG001|STARTED|Open Label Extension (OLE) Phase|1 participant completed the Blinded Study Phase, but did not continue in the OLE Phase.|18
10743610|NCT02943460|11907805|FG002|STARTED|Open Label Extension (OLE) Phase||10
10743611|NCT02943460|11907803|FG000|COMPLETED|Open Label Extension (OLE) Phase||14
10743612|NCT02943460|11907804|FG001|COMPLETED|Open Label Extension (OLE) Phase||11
10743613|NCT02943460|11907805|FG002|COMPLETED|Open Label Extension (OLE) Phase||8
10743614|NCT02943460|11907803|FG000|NOT COMPLETED|Open Label Extension (OLE) Phase||5
10743615|NCT02943460|11907804|FG001|NOT COMPLETED|Open Label Extension (OLE) Phase||7
10743616|NCT02943460|11907805|FG002|NOT COMPLETED|Open Label Extension (OLE) Phase||2
10743617|NCT02943473|11907814|FG000|STARTED|Overall Study||9
10743618|NCT02943473|11907814|FG000|COMPLETED|Overall Study||3
10743619|NCT02943473|11907814|FG000|NOT COMPLETED|Overall Study||6
10743620|NCT02943499|11907820|FG000|STARTED|Overall Study||41
10743621|NCT02943499|11907821|FG001|STARTED|Overall Study||39
10743622|NCT02943499|11907820|FG000|COMPLETED|Overall Study||34
10743623|NCT02943499|11907821|FG001|COMPLETED|Overall Study||34
10743624|NCT02943499|11907820|FG000|NOT COMPLETED|Overall Study||7
10743625|NCT02943499|11907821|FG001|NOT COMPLETED|Overall Study||5
10817319|NCT01280643|11981046|FG000|NOT COMPLETED|Overall Study||0
10743626|NCT02943564|11907830|FG000|STARTED|Overall Study||217
10743627|NCT02943564|11907831|FG001|STARTED|Overall Study||211
10743628|NCT02943564|11907832|FG002|STARTED|Overall Study||210
10743629|NCT02943564|11907830|FG000|Responder|Overall Study||83
10743630|NCT02943564|11907831|FG001|Responder|Overall Study||77
10743631|NCT02943564|11907832|FG002|Responder|Overall Study||77
10743632|NCT02943564|11907830|FG000|Non-Responder|Overall Study||134
10743633|NCT02943564|11907831|FG001|Non-Responder|Overall Study||134
10743634|NCT02943564|11907832|FG002|Non-Responder|Overall Study||133
10743635|NCT02943564|11907830|FG000|COMPLETED|Overall Study||207
10743636|NCT02943564|11907831|FG001|COMPLETED|Overall Study||198
10408707|NCT00756496|11552835|FG000|NOT COMPLETED|Overall Study||0
10743637|NCT02943564|11907832|FG002|COMPLETED|Overall Study||201
10743638|NCT02943564|11907830|FG000|NOT COMPLETED|Overall Study||10
10743639|NCT02943564|11907831|FG001|NOT COMPLETED|Overall Study||13
10743640|NCT02943564|11907832|FG002|NOT COMPLETED|Overall Study||9
10743641|NCT02943577|11907842|FG000|STARTED|Overall Study||209
10743642|NCT02943577|11907843|FG001|STARTED|Overall Study||206
10743643|NCT02943577|11907842|FG000|COMPLETED|Overall Study||204
10743644|NCT02943577|11907843|FG001|COMPLETED|Overall Study||201
10743645|NCT02943577|11907842|FG000|NOT COMPLETED|Overall Study||5
10743646|NCT02943577|11907843|FG001|NOT COMPLETED|Overall Study||5
10743647|NCT02943668|11907849|FG000|STARTED|Overall Study||2
10743648|NCT02943668|11907849|FG000|COMPLETED|Overall Study||1
10743649|NCT02943668|11907849|FG000|NOT COMPLETED|Overall Study||1
10743650|NCT02943941|11907856|FG000|STARTED|Overall Study||16
10743651|NCT02943941|11907856|FG000|COMPLETED|Overall Study||16
10743652|NCT02943941|11907856|FG000|NOT COMPLETED|Overall Study||0
10743653|NCT02944383|11907864|FG000|STARTED|Overall Study||30
10743654|NCT02944383|11907865|FG001|STARTED|Overall Study||30
10743655|NCT02944383|11907866|FG002|STARTED|Overall Study||31
10743656|NCT02944383|11907864|FG000|COMPLETED|Overall Study||29
10743657|NCT02944383|11907865|FG001|COMPLETED|Overall Study||30
10743658|NCT02944383|11907866|FG002|COMPLETED|Overall Study||30
10743659|NCT02944383|11907864|FG000|NOT COMPLETED|Overall Study||1
10743660|NCT02944383|11907865|FG001|NOT COMPLETED|Overall Study||0
10743661|NCT02944383|11907866|FG002|NOT COMPLETED|Overall Study||1
10743662|NCT02944448|11907878|FG000|STARTED|Overall Study||316
10743663|NCT02944448|11907879|FG001|STARTED|Overall Study||160
10743664|NCT02944448|11907878|FG000|COMPLETED|Overall Study||227
10743665|NCT02944448|11907879|FG001|COMPLETED|Overall Study||136
10743666|NCT02944448|11907878|FG000|NOT COMPLETED|Overall Study||89
10743667|NCT02944448|11907879|FG001|NOT COMPLETED|Overall Study||24
10743668|NCT02944461|11907886|FG000|STARTED|Overall Study||20
10743669|NCT02944461|11907886|FG000|COMPLETED|Overall Study||15
10743670|NCT02944461|11907886|FG000|NOT COMPLETED|Overall Study||5
10743671|NCT02944565|11907890|FG000|STARTED|Overall Study||28
10743672|NCT02944565|11907890|FG000|COMPLETED|Overall Study||28
10743673|NCT02944565|11907890|FG000|NOT COMPLETED|Overall Study||0
10743674|NCT02944656|11907897|FG000|STARTED|Overall Study||57
10743675|NCT02944656|11907898|FG001|STARTED|Overall Study||57
10743676|NCT02944656|11907897|FG000|Completed Procedure Day|Overall Study||54
10743677|NCT02944656|11907898|FG001|Completed Procedure Day|Overall Study||57
10743678|NCT02944656|11907897|FG000|Completed Day 1 Follow up|Overall Study||47
10817320|NCT01280643|11981047|FG001|NOT COMPLETED|Overall Study||1
10817321|NCT01280643|11981048|FG002|NOT COMPLETED|Overall Study||0
10817322|NCT01280643|11981049|FG003|NOT COMPLETED|Overall Study||0
10817323|NCT01280643|11981050|FG004|NOT COMPLETED|Overall Study||0
10817324|NCT01280643|11981051|FG005|NOT COMPLETED|Overall Study||0
10817325|NCT01280643|11981052|FG006|NOT COMPLETED|Overall Study||0
10817326|NCT01280643|11981053|FG007|NOT COMPLETED|Overall Study||0
10817327|NCT01280643|11981054|FG008|NOT COMPLETED|Overall Study||0
10817328|NCT01281124|11981074|FG000|STARTED|Overall Study||1
10817329|NCT01281124|11981074|FG000|COMPLETED|Overall Study||0
10817330|NCT01281124|11981074|FG000|NOT COMPLETED|Overall Study||1
10817331|NCT01272141|11981080|FG000|STARTED|Overall Study||5
10817332|NCT01272141|11981080|FG000|COMPLETED|Overall Study||5
10817333|NCT01272141|11981080|FG000|NOT COMPLETED|Overall Study||0
10817334|NCT01282216|11981086|FG000|STARTED|Overall Study||18
10817335|NCT01282216|11981087|FG001|STARTED|Overall Study||26
10817336|NCT01282216|11981088|FG002|STARTED|Overall Study||52
10817337|NCT01282216|11981089|FG003|STARTED|Overall Study||8
10817338|NCT01282216|11981086|FG000|COMPLETED|Overall Study||18
10817339|NCT01282216|11981087|FG001|COMPLETED|Overall Study||26
10817340|NCT01282216|11981088|FG002|COMPLETED|Overall Study||19
10817341|NCT01282216|11981089|FG003|COMPLETED|Overall Study||0
10817342|NCT01282216|11981086|FG000|NOT COMPLETED|Overall Study||0
10817343|NCT01282216|11981087|FG001|NOT COMPLETED|Overall Study||0
10817344|NCT01282216|11981088|FG002|NOT COMPLETED|Overall Study||33
10817345|NCT01282216|11981089|FG003|NOT COMPLETED|Overall Study||8
10817346|NCT01284491|11981095|FG000|STARTED|Overall Study||13
10817347|NCT01284491|11981095|FG000|COMPLETED|Overall Study||0
10817348|NCT01284491|11981095|FG000|NOT COMPLETED|Overall Study||13
10817349|NCT01284504|11981103|FG000|STARTED|Overall Study||0
10817350|NCT01284504|11981104|FG001|STARTED|Overall Study||0
10817351|NCT01284504|11981103|FG000|COMPLETED|Overall Study||0
10817352|NCT01284504|11981104|FG001|COMPLETED|Overall Study||0
10817353|NCT01284504|11981103|FG000|NOT COMPLETED|Overall Study||0
10817354|NCT01284504|11981104|FG001|NOT COMPLETED|Overall Study||0
10817355|NCT01269034|11981114|FG000|STARTED|Overall Study||1
10743679|NCT02944656|11907898|FG001|Completed Day 1 Follow up|Overall Study||47
10743680|NCT02944656|11907897|FG000|COMPLETED|Overall Study||47
10743681|NCT02944656|11907898|FG001|COMPLETED|Overall Study||47
10817356|NCT01269034|11981115|FG001|STARTED|Overall Study||2
10817357|NCT01269034|11981116|FG002|STARTED|Overall Study||1
10817358|NCT01269034|11981117|FG003|STARTED|Overall Study||9
10817359|NCT01269034|11981114|FG000|COMPLETED|Overall Study||0
10817360|NCT01269034|11981115|FG001|COMPLETED|Overall Study||2
10743682|NCT02944656|11907897|FG000|NOT COMPLETED|Overall Study||10
10743683|NCT02944656|11907898|FG001|NOT COMPLETED|Overall Study||10
10743684|NCT02944968|11907904|FG000|STARTED|Overall Study||51
10743685|NCT02944968|11907904|FG000|COMPLETED|Overall Study||48
10743686|NCT02944968|11907904|FG000|NOT COMPLETED|Overall Study||3
10743687|NCT02945046|11907911|FG000|STARTED|Overall Study||59
10743688|NCT02945046|11907912|FG001|STARTED|Overall Study||55
10817361|NCT01269034|11981116|FG002|COMPLETED|Overall Study||1
10817362|NCT01269034|11981117|FG003|COMPLETED|Overall Study||9
10743689|NCT02945046|11907913|FG002|STARTED|Overall Study||55
10743690|NCT02945046|11907911|FG000|Safety Analysis Set|Overall Study||59
10743691|NCT02945046|11907912|FG001|Safety Analysis Set|Overall Study||55
10743692|NCT02945046|11907913|FG002|Safety Analysis Set|Overall Study||55
10743693|NCT02945046|11907911|FG000|Full Analysis Set|Overall Study||57
10743694|NCT02945046|11907912|FG001|Full Analysis Set|Overall Study||53
10743695|NCT02945046|11907913|FG002|Full Analysis Set|Overall Study||55
10743696|NCT02945046|11907911|FG000|COMPLETED|Overall Study||46
10743697|NCT02945046|11907912|FG001|COMPLETED|Overall Study||42
10743698|NCT02945046|11907913|FG002|COMPLETED|Overall Study||40
10743699|NCT02945046|11907911|FG000|NOT COMPLETED|Overall Study||13
10743700|NCT02945046|11907912|FG001|NOT COMPLETED|Overall Study||13
10743701|NCT02945046|11907913|FG002|NOT COMPLETED|Overall Study||15
10743702|NCT02945150|11907921|FG000|STARTED|Overall Study||8
10743703|NCT02945150|11907921|FG000|SVR12|Overall Study||8
10743704|NCT02945150|11907921|FG000|COMPLETED|Overall Study||8
10743705|NCT02945150|11907921|FG000|NOT COMPLETED|Overall Study||0
10743706|NCT02945254|11907927|FG000|STARTED|Overall Study||10
10743707|NCT02945254|11907928|FG001|STARTED|Overall Study||10
10743708|NCT02945254|11907927|FG000|COMPLETED|Overall Study||8
10743709|NCT02945254|11907928|FG001|COMPLETED|Overall Study||10
10743710|NCT02945254|11907927|FG000|NOT COMPLETED|Overall Study||2
10743711|NCT02945254|11907928|FG001|NOT COMPLETED|Overall Study||0
10743712|NCT02945410|11907940|FG000|STARTED|Intervention 1 (5 Days)||3
10743713|NCT02945410|11907941|FG001|STARTED|Intervention 1 (5 Days)||4
10743714|NCT02945410|11907942|FG002|STARTED|Intervention 1 (5 Days)||2
10743715|NCT02945410|11907943|FG003|STARTED|Intervention 1 (5 Days)||3
10743716|NCT02945410|11907944|FG004|STARTED|Intervention 1 (5 Days)||2
10743717|NCT02945410|11907945|FG005|STARTED|Intervention 1 (5 Days)||1
10743718|NCT02945410|11907940|FG000|COMPLETED|Intervention 1 (5 Days)||2
10743719|NCT02945410|11907941|FG001|COMPLETED|Intervention 1 (5 Days)||1
10743720|NCT02945410|11907942|FG002|COMPLETED|Intervention 1 (5 Days)||2
10743721|NCT02945410|11907943|FG003|COMPLETED|Intervention 1 (5 Days)||3
10743722|NCT02945410|11907944|FG004|COMPLETED|Intervention 1 (5 Days)||2
10743723|NCT02945410|11907945|FG005|COMPLETED|Intervention 1 (5 Days)||0
10743724|NCT02945410|11907940|FG000|NOT COMPLETED|Intervention 1 (5 Days)||1
10743725|NCT02945410|11907941|FG001|NOT COMPLETED|Intervention 1 (5 Days)||3
10743726|NCT02945410|11907942|FG002|NOT COMPLETED|Intervention 1 (5 Days)||0
10743727|NCT02945410|11907943|FG003|NOT COMPLETED|Intervention 1 (5 Days)||0
10743728|NCT02945410|11907944|FG004|NOT COMPLETED|Intervention 1 (5 Days)||0
10743729|NCT02945410|11907945|FG005|NOT COMPLETED|Intervention 1 (5 Days)||1
10743730|NCT02945410|11907940|FG000|STARTED|Washout 1 (14 Days)||2
10743731|NCT02945410|11907941|FG001|STARTED|Washout 1 (14 Days)||1
10743732|NCT02945410|11907942|FG002|STARTED|Washout 1 (14 Days)||2
10743733|NCT02945410|11907943|FG003|STARTED|Washout 1 (14 Days)||3
10743734|NCT02945410|11907944|FG004|STARTED|Washout 1 (14 Days)||2
10743735|NCT02945410|11907945|FG005|STARTED|Washout 1 (14 Days)||0
10743736|NCT02945410|11907940|FG000|COMPLETED|Washout 1 (14 Days)||2
10743737|NCT02945410|11907941|FG001|COMPLETED|Washout 1 (14 Days)||1
10743738|NCT02945410|11907942|FG002|COMPLETED|Washout 1 (14 Days)||0
10743739|NCT02945410|11907943|FG003|COMPLETED|Washout 1 (14 Days)||3
10743740|NCT02945410|11907944|FG004|COMPLETED|Washout 1 (14 Days)||1
10743741|NCT02945410|11907945|FG005|COMPLETED|Washout 1 (14 Days)||0
10743742|NCT02945410|11907940|FG000|NOT COMPLETED|Washout 1 (14 Days)||0
10743743|NCT02945410|11907941|FG001|NOT COMPLETED|Washout 1 (14 Days)||0
10743744|NCT02945410|11907942|FG002|NOT COMPLETED|Washout 1 (14 Days)||2
10312915|NCT00147017|11446422|FG000|COMPLETED|Overall Study||6
10312916|NCT00147017|11446423|FG001|COMPLETED|Overall Study||7
10312917|NCT00147017|11446424|FG002|COMPLETED|Overall Study||4
10312918|NCT00147017|11446422|FG000|NOT COMPLETED|Overall Study||0
10312919|NCT00147017|11446423|FG001|NOT COMPLETED|Overall Study||0
10312920|NCT00147017|11446424|FG002|NOT COMPLETED|Overall Study||0
10312921|NCT00147030|11446434|FG000|STARTED|Overall Study||163
10312922|NCT00147030|11446435|FG001|STARTED|Overall Study||162
10312923|NCT00147030|11446434|FG000|COMPLETED|Overall Study||163
10312924|NCT00147030|11446435|FG001|COMPLETED|Overall Study||162
10312925|NCT00147030|11446434|FG000|NOT COMPLETED|Overall Study||0
10743745|NCT02945410|11907943|FG003|NOT COMPLETED|Washout 1 (14 Days)||0
10743746|NCT02945410|11907944|FG004|NOT COMPLETED|Washout 1 (14 Days)||1
10312926|NCT00147030|11446435|FG001|NOT COMPLETED|Overall Study||0
10312927|NCT00147043|11446443|FG000|STARTED|Overall Study||5
10312928|NCT00147043|11446443|FG000|COMPLETED|Overall Study||5
10312929|NCT00147043|11446443|FG000|NOT COMPLETED|Overall Study||0
10743747|NCT02945410|11907945|FG005|NOT COMPLETED|Washout 1 (14 Days)||0
10743748|NCT02945410|11907940|FG000|STARTED|Intervention 2 (5 Days)||2
10743749|NCT02945410|11907941|FG001|STARTED|Intervention 2 (5 Days)||1
10743750|NCT02945410|11907942|FG002|STARTED|Intervention 2 (5 Days)||0
10743751|NCT02945410|11907943|FG003|STARTED|Intervention 2 (5 Days)||3
10743752|NCT02945410|11907944|FG004|STARTED|Intervention 2 (5 Days)||1
10743753|NCT02945410|11907945|FG005|STARTED|Intervention 2 (5 Days)||0
10743754|NCT02945410|11907940|FG000|COMPLETED|Intervention 2 (5 Days)||2
10743755|NCT02945410|11907941|FG001|COMPLETED|Intervention 2 (5 Days)||1
10743756|NCT02945410|11907942|FG002|COMPLETED|Intervention 2 (5 Days)||0
10743757|NCT02945410|11907943|FG003|COMPLETED|Intervention 2 (5 Days)||3
10743758|NCT02945410|11907944|FG004|COMPLETED|Intervention 2 (5 Days)||1
10743759|NCT02945410|11907945|FG005|COMPLETED|Intervention 2 (5 Days)||0
10743760|NCT02945410|11907940|FG000|NOT COMPLETED|Intervention 2 (5 Days)||0
10743761|NCT02945410|11907941|FG001|NOT COMPLETED|Intervention 2 (5 Days)||0
10743762|NCT02945410|11907942|FG002|NOT COMPLETED|Intervention 2 (5 Days)||0
10743763|NCT02945410|11907943|FG003|NOT COMPLETED|Intervention 2 (5 Days)||0
10743764|NCT02945410|11907944|FG004|NOT COMPLETED|Intervention 2 (5 Days)||0
10743765|NCT02945410|11907945|FG005|NOT COMPLETED|Intervention 2 (5 Days)||0
10743766|NCT02945410|11907940|FG000|STARTED|Washout 2 (14 Days)||2
10743767|NCT02945410|11907941|FG001|STARTED|Washout 2 (14 Days)||1
10743768|NCT02945410|11907942|FG002|STARTED|Washout 2 (14 Days)||0
10743769|NCT02945410|11907943|FG003|STARTED|Washout 2 (14 Days)||3
10743770|NCT02945410|11907944|FG004|STARTED|Washout 2 (14 Days)||1
10743771|NCT02945410|11907945|FG005|STARTED|Washout 2 (14 Days)||0
10743772|NCT02945410|11907940|FG000|COMPLETED|Washout 2 (14 Days)||2
10743773|NCT02945410|11907941|FG001|COMPLETED|Washout 2 (14 Days)||1
10743774|NCT02945410|11907942|FG002|COMPLETED|Washout 2 (14 Days)||0
10743775|NCT02945410|11907943|FG003|COMPLETED|Washout 2 (14 Days)||3
10743776|NCT02945410|11907944|FG004|COMPLETED|Washout 2 (14 Days)||1
10743777|NCT02945410|11907945|FG005|COMPLETED|Washout 2 (14 Days)||0
10743778|NCT02945410|11907940|FG000|NOT COMPLETED|Washout 2 (14 Days)||0
10743779|NCT02945410|11907941|FG001|NOT COMPLETED|Washout 2 (14 Days)||0
10743780|NCT02945410|11907942|FG002|NOT COMPLETED|Washout 2 (14 Days)||0
10743781|NCT02945410|11907943|FG003|NOT COMPLETED|Washout 2 (14 Days)||0
10743782|NCT02945410|11907944|FG004|NOT COMPLETED|Washout 2 (14 Days)||0
10743783|NCT02945410|11907945|FG005|NOT COMPLETED|Washout 2 (14 Days)||0
10743784|NCT02945410|11907940|FG000|STARTED|Intervention 3 (5 Days)||2
10743785|NCT02945410|11907941|FG001|STARTED|Intervention 3 (5 Days)||1
10743786|NCT02945410|11907942|FG002|STARTED|Intervention 3 (5 Days)||0
10743787|NCT02945410|11907943|FG003|STARTED|Intervention 3 (5 Days)||3
10743788|NCT02945410|11907944|FG004|STARTED|Intervention 3 (5 Days)||1
10743789|NCT02945410|11907945|FG005|STARTED|Intervention 3 (5 Days)||0
10743790|NCT02945410|11907940|FG000|COMPLETED|Intervention 3 (5 Days)||2
10743791|NCT02945410|11907941|FG001|COMPLETED|Intervention 3 (5 Days)||1
10743792|NCT02945410|11907942|FG002|COMPLETED|Intervention 3 (5 Days)||0
10743793|NCT02945410|11907943|FG003|COMPLETED|Intervention 3 (5 Days)||3
10743794|NCT02945410|11907944|FG004|COMPLETED|Intervention 3 (5 Days)||1
10743795|NCT02945410|11907945|FG005|COMPLETED|Intervention 3 (5 Days)||0
10743796|NCT02945410|11907940|FG000|NOT COMPLETED|Intervention 3 (5 Days)||0
10743797|NCT02945410|11907941|FG001|NOT COMPLETED|Intervention 3 (5 Days)||0
10743798|NCT02945410|11907942|FG002|NOT COMPLETED|Intervention 3 (5 Days)||0
10743799|NCT02945410|11907943|FG003|NOT COMPLETED|Intervention 3 (5 Days)||0
10743800|NCT02945410|11907944|FG004|NOT COMPLETED|Intervention 3 (5 Days)||0
10743801|NCT02945410|11907945|FG005|NOT COMPLETED|Intervention 3 (5 Days)||0
10743802|NCT02945553|11907955|FG000|STARTED|Overall Study||14
10743803|NCT02945553|11907956|FG001|STARTED|Overall Study||11
10743804|NCT02945553|11907955|FG000|COMPLETED|Overall Study|Included in analysis for primary aim.|11
10743805|NCT02945553|11907956|FG001|COMPLETED|Overall Study|Included in analysis for primary aim.|9
10743806|NCT02945553|11907955|FG000|NOT COMPLETED|Overall Study||3
10743807|NCT02945553|11907956|FG001|NOT COMPLETED|Overall Study||2
10743808|NCT02945657|11907966|FG000|STARTED|Overall Study||32
10743809|NCT02945657|11907966|FG000|COMPLETED|Overall Study||28
10743810|NCT02945657|11907966|FG000|NOT COMPLETED|Overall Study||4
10743811|NCT02946021|11907973|FG000|STARTED|Overall Study||6
10743812|NCT02946021|11907974|FG001|STARTED|Overall Study||5
10743813|NCT02946021|11907973|FG000|COMPLETED|Overall Study||6
10743814|NCT02946021|11907974|FG001|COMPLETED|Overall Study||5
10743815|NCT02946021|11907973|FG000|NOT COMPLETED|Overall Study||0
10743816|NCT02946021|11907974|FG001|NOT COMPLETED|Overall Study||0
10743817|NCT02946034|11907980|FG000|STARTED|Overall Study||10
10743818|NCT02946034|11907980|FG000|COMPLETED|Overall Study||10
10743819|NCT02946034|11907980|FG000|NOT COMPLETED|Overall Study||0
10743820|NCT02946073|11907990|FG000|STARTED|Titration Phase||811
10743821|NCT02946073|11907991|FG001|STARTED|Titration Phase||0
10743822|NCT02946073|11907992|FG002|STARTED|Titration Phase||98
10743823|NCT02946073|11907993|FG003|STARTED|Titration Phase||0
10743824|NCT02946073|11907990|FG000|COMPLETED|Titration Phase||222
10743825|NCT02946073|11907991|FG001|COMPLETED|Titration Phase||0
10743826|NCT02946073|11907992|FG002|COMPLETED|Titration Phase||75
10743827|NCT02946073|11907993|FG003|COMPLETED|Titration Phase||0
10743828|NCT02946073|11907990|FG000|NOT COMPLETED|Titration Phase||589
10743829|NCT02946073|11907991|FG001|NOT COMPLETED|Titration Phase||0
10743830|NCT02946073|11907992|FG002|NOT COMPLETED|Titration Phase||23
10743831|NCT02946073|11907993|FG003|NOT COMPLETED|Titration Phase||0
10743832|NCT02946073|11907990|FG000|STARTED|Double Blind Phase||112
10743833|NCT02946073|11907991|FG001|STARTED|Double Blind Phase||110
10743834|NCT02946073|11907992|FG002|STARTED|Double Blind Phase||0
10743835|NCT02946073|11907993|FG003|STARTED|Double Blind Phase||0
10743836|NCT02946073|11907990|FG000|COMPLETED|Double Blind Phase||88
10743837|NCT02946073|11907991|FG001|COMPLETED|Double Blind Phase||70
10743838|NCT02946073|11907992|FG002|COMPLETED|Double Blind Phase||0
10743839|NCT02946073|11907993|FG003|COMPLETED|Double Blind Phase||0
10743840|NCT02946073|11907990|FG000|NOT COMPLETED|Double Blind Phase||24
10743841|NCT02946073|11907991|FG001|NOT COMPLETED|Double Blind Phase||40
10743842|NCT02946073|11907992|FG002|NOT COMPLETED|Double Blind Phase||0
10743843|NCT02946073|11907993|FG003|NOT COMPLETED|Double Blind Phase||0
10743844|NCT02946073|11907990|FG000|STARTED|Open Label Phase||0
10743845|NCT02946073|11907991|FG001|STARTED|Open Label Phase||0
10743846|NCT02946073|11907992|FG002|STARTED|Open Label Phase||75
10743847|NCT02946073|11907993|FG003|STARTED|Open Label Phase||57
10743848|NCT02946073|11907990|FG000|COMPLETED|Open Label Phase||0
10743849|NCT02946073|11907991|FG001|COMPLETED|Open Label Phase||0
10743850|NCT02946073|11907992|FG002|COMPLETED|Open Label Phase||54
10743851|NCT02946073|11907993|FG003|COMPLETED|Open Label Phase||44
10743852|NCT02946073|11907990|FG000|NOT COMPLETED|Open Label Phase||0
10743853|NCT02946073|11907991|FG001|NOT COMPLETED|Open Label Phase||0
10743854|NCT02946073|11907992|FG002|NOT COMPLETED|Open Label Phase||21
10743855|NCT02946073|11907993|FG003|NOT COMPLETED|Open Label Phase||13
10743856|NCT02946229|11908012|FG000|STARTED|Overall Study||142
10743857|NCT02946229|11908012|FG000|COMPLETED|Overall Study||142
10743858|NCT02946229|11908012|FG000|NOT COMPLETED|Overall Study||0
10743859|NCT02946385|11908022|FG000|STARTED|Overall Study||126
10743860|NCT02946385|11908023|FG001|STARTED|Overall Study||127
10743861|NCT02946385|11908024|FG002|STARTED|Overall Study||99
10743862|NCT02946385|11908025|FG003|STARTED|Overall Study||74
10743863|NCT02946385|11908026|FG004|STARTED|Overall Study||101
10743864|NCT02946385|11908027|FG005|STARTED|Overall Study||77
10743865|NCT02946385|11908022|FG000|COMPLETED|Overall Study||126
10743866|NCT02946385|11908023|FG001|COMPLETED|Overall Study||127
10743867|NCT02946385|11908024|FG002|COMPLETED|Overall Study||96
10743868|NCT02946385|11908025|FG003|COMPLETED|Overall Study||74
10743869|NCT02946385|11908026|FG004|COMPLETED|Overall Study||99
10743870|NCT02946385|11908027|FG005|COMPLETED|Overall Study||76
10743871|NCT02946385|11908022|FG000|NOT COMPLETED|Overall Study||0
10743872|NCT02946385|11908023|FG001|NOT COMPLETED|Overall Study||0
10743873|NCT02946385|11908024|FG002|NOT COMPLETED|Overall Study||3
10743874|NCT02946385|11908025|FG003|NOT COMPLETED|Overall Study||0
10743875|NCT02946385|11908026|FG004|NOT COMPLETED|Overall Study||2
10743876|NCT02946385|11908027|FG005|NOT COMPLETED|Overall Study||1
10743893|NCT02946489|11908056|FG000|STARTED|Overall Study||8
10743894|NCT02946489|11908056|FG000|COMPLETED|Overall Study||8
10743895|NCT02946489|11908056|FG000|NOT COMPLETED|Overall Study||0
10743896|NCT02946515|11908062|FG000|STARTED|Overall Study||22
10743897|NCT02946515|11908063|FG001|STARTED|Overall Study||22
10743898|NCT02946515|11908062|FG000|COMPLETED|Overall Study||20
10743899|NCT02946515|11908063|FG001|COMPLETED|Overall Study||21
10743900|NCT02946515|11908062|FG000|NOT COMPLETED|Overall Study||2
10743901|NCT02946515|11908063|FG001|NOT COMPLETED|Overall Study||1
10743902|NCT02946580|11908071|FG000|STARTED|Overall Study||28
10743903|NCT02946580|11908072|FG001|STARTED|Overall Study||25
10743904|NCT02946580|11908071|FG000|COMPLETED|Overall Study||27
10743905|NCT02946580|11908072|FG001|COMPLETED|Overall Study||20
10743906|NCT02946580|11908071|FG000|NOT COMPLETED|Overall Study||1
10743907|NCT02946580|11908072|FG001|NOT COMPLETED|Overall Study||5
10743908|NCT02946892|11908078|FG000|STARTED|First Intervention (12 Weeks)||11
10743909|NCT02946892|11908079|FG001|STARTED|First Intervention (12 Weeks)||15
10743910|NCT02946892|11908078|FG000|COMPLETED|First Intervention (12 Weeks)||11
10743911|NCT02946892|11908079|FG001|COMPLETED|First Intervention (12 Weeks)||14
10743912|NCT02946892|11908078|FG000|NOT COMPLETED|First Intervention (12 Weeks)||0
10743913|NCT02946892|11908079|FG001|NOT COMPLETED|First Intervention (12 Weeks)||1
10743914|NCT02946892|11908078|FG000|STARTED|Washout (6 Weeks)||11
10743915|NCT02946892|11908079|FG001|STARTED|Washout (6 Weeks)||14
10743916|NCT02946892|11908078|FG000|COMPLETED|Washout (6 Weeks)||9
10743917|NCT02946892|11908079|FG001|COMPLETED|Washout (6 Weeks)||14
10743918|NCT02946892|11908078|FG000|NOT COMPLETED|Washout (6 Weeks)||2
10743919|NCT02946892|11908079|FG001|NOT COMPLETED|Washout (6 Weeks)||0
10743920|NCT02946892|11908078|FG000|STARTED|Second Intervention||9
10743921|NCT02946892|11908079|FG001|STARTED|Second Intervention||14
10743922|NCT02946892|11908078|FG000|COMPLETED|Second Intervention||9
10743923|NCT02946892|11908079|FG001|COMPLETED|Second Intervention||14
10743924|NCT02946892|11908078|FG000|NOT COMPLETED|Second Intervention||0
10743925|NCT02946892|11908079|FG001|NOT COMPLETED|Second Intervention||0
10743926|NCT02946918|11908087|FG000|STARTED|Overall Study||6
10743927|NCT02946918|11908088|FG001|STARTED|Overall Study||8
10743928|NCT02946918|11908087|FG000|COMPLETED|Overall Study||5
10743929|NCT02946918|11908088|FG001|COMPLETED|Overall Study||5
10743930|NCT02946918|11908087|FG000|NOT COMPLETED|Overall Study||1
10743931|NCT02946918|11908088|FG001|NOT COMPLETED|Overall Study||3
10743932|NCT02947984|11908096|FG000|STARTED|Overall Study||22
10743933|NCT02947984|11908097|FG001|STARTED|Overall Study||22
10743934|NCT02947984|11908096|FG000|COMPLETED|Overall Study||22
10743935|NCT02947984|11908097|FG001|COMPLETED|Overall Study||22
10743936|NCT02947984|11908096|FG000|NOT COMPLETED|Overall Study||0
10743937|NCT02947984|11908097|FG001|NOT COMPLETED|Overall Study||0
10743938|NCT02947997|11908103|FG000|STARTED|Overall Study||4
10743939|NCT02947997|11908103|FG000|COMPLETED|Overall Study||4
10743940|NCT02947997|11908103|FG000|NOT COMPLETED|Overall Study||0
10743941|NCT02948257|11908107|FG000|STARTED|Overall Study||52
10743942|NCT02948257|11908107|FG000|COMPLETED|Overall Study||52
10743943|NCT02948257|11908107|FG000|NOT COMPLETED|Overall Study||0
10743944|NCT02948426|11908115|FG000|STARTED|Overall Study||3
10743945|NCT02948426|11908116|FG001|STARTED|Overall Study||6
10743946|NCT02948426|11908117|FG002|STARTED|Overall Study||3
10743947|NCT02948426|11908118|FG003|STARTED|Overall Study||6
10743948|NCT02948426|11908115|FG000|COMPLETED|Overall Study||3
10743949|NCT02948426|11908116|FG001|COMPLETED|Overall Study||6
10743950|NCT02948426|11908117|FG002|COMPLETED|Overall Study||3
10743951|NCT02948426|11908118|FG003|COMPLETED|Overall Study||6
10743952|NCT02948426|11908115|FG000|NOT COMPLETED|Overall Study||0
10743953|NCT02948426|11908116|FG001|NOT COMPLETED|Overall Study||0
10743954|NCT02948426|11908117|FG002|NOT COMPLETED|Overall Study||0
10743955|NCT02948426|11908118|FG003|NOT COMPLETED|Overall Study||0
10743956|NCT02948582|11908130|FG000|STARTED|Treatment Period 1||7
10743957|NCT02948582|11908131|FG001|STARTED|Treatment Period 1||7
10743958|NCT02948582|11908132|FG002|STARTED|Treatment Period 1||7
10743959|NCT02948582|11908133|FG003|STARTED|Treatment Period 1||7
10743960|NCT02948582|11908134|FG004|STARTED|Treatment Period 1||7
10743961|NCT02948582|11908135|FG005|STARTED|Treatment Period 1||7
10743962|NCT02948582|11908130|FG000|COMPLETED|Treatment Period 1||7
10743963|NCT02948582|11908131|FG001|COMPLETED|Treatment Period 1||7
10743964|NCT02948582|11908132|FG002|COMPLETED|Treatment Period 1||7
10817363|NCT01269034|11981114|FG000|NOT COMPLETED|Overall Study||1
10817364|NCT01269034|11981115|FG001|NOT COMPLETED|Overall Study||0
10817365|NCT01269034|11981116|FG002|NOT COMPLETED|Overall Study||0
10817366|NCT01269034|11981117|FG003|NOT COMPLETED|Overall Study||0
10817367|NCT01274533|11981127|FG000|STARTED|Overall Study||4
10817368|NCT01274533|11981127|FG000|COMPLETED|Overall Study||0
10817369|NCT01274533|11981127|FG000|NOT COMPLETED|Overall Study||4
10817370|NCT01279616|11981131|FG000|STARTED|Overall Study||8
10817371|NCT01279616|11981131|FG000|COMPLETED|Overall Study||1
10817372|NCT01279616|11981131|FG000|NOT COMPLETED|Overall Study||7
10817373|NCT01276054|11981137|FG000|STARTED|Overall Study||2
10817374|NCT01276054|11981138|FG001|STARTED|Overall Study||2
10817375|NCT01276054|11981137|FG000|COMPLETED|Overall Study||0
10817376|NCT01276054|11981138|FG001|COMPLETED|Overall Study||0
10817377|NCT01276054|11981137|FG000|NOT COMPLETED|Overall Study||2
10817378|NCT01276054|11981138|FG001|NOT COMPLETED|Overall Study||2
10817379|NCT01264965|11981144|FG000|STARTED|Overall Study||25
10817380|NCT01264965|11981144|FG000|COMPLETED|Overall Study||15
10817381|NCT01264965|11981144|FG000|NOT COMPLETED|Overall Study||10
10817382|NCT01266824|11981150|FG000|STARTED|Overall Study||2
10817383|NCT01266824|11981151|FG001|STARTED|Overall Study||3
10817384|NCT01266824|11981150|FG000|COMPLETED|Overall Study||0
10817385|NCT01266824|11981151|FG001|COMPLETED|Overall Study||0
10817386|NCT01266824|11981150|FG000|NOT COMPLETED|Overall Study||2
10817387|NCT01266824|11981151|FG001|NOT COMPLETED|Overall Study||3
10817388|NCT01264835|11981157|FG000|STARTED|Overall Study||2
10817389|NCT01264835|11981157|FG000|COMPLETED|Overall Study||1
10817390|NCT01264835|11981157|FG000|NOT COMPLETED|Overall Study||1
10817391|NCT01274429|11981161|FG000|STARTED|Overall Study||5
10817392|NCT01274429|11981161|FG000|COMPLETED|Overall Study||0
10743965|NCT02948582|11908133|FG003|COMPLETED|Treatment Period 1||7
10743966|NCT02948582|11908134|FG004|COMPLETED|Treatment Period 1||7
10743967|NCT02948582|11908135|FG005|COMPLETED|Treatment Period 1||7
10743968|NCT02948582|11908130|FG000|NOT COMPLETED|Treatment Period 1||0
10743969|NCT02948582|11908131|FG001|NOT COMPLETED|Treatment Period 1||0
10743970|NCT02948582|11908132|FG002|NOT COMPLETED|Treatment Period 1||0
10743971|NCT02948582|11908133|FG003|NOT COMPLETED|Treatment Period 1||0
10743972|NCT02948582|11908134|FG004|NOT COMPLETED|Treatment Period 1||0
10817393|NCT01274429|11981161|FG000|NOT COMPLETED|Overall Study||5
10817394|NCT01273064|11981170|FG000|STARTED|Overall Study||23
10817395|NCT01273064|11981171|FG001|STARTED|Overall Study||30
10743973|NCT02948582|11908135|FG005|NOT COMPLETED|Treatment Period 1||0
10743974|NCT02948582|11908130|FG000|STARTED|Washout Period 1||7
10743975|NCT02948582|11908131|FG001|STARTED|Washout Period 1||7
10743976|NCT02948582|11908132|FG002|STARTED|Washout Period 1||7
10743977|NCT02948582|11908133|FG003|STARTED|Washout Period 1||7
10743978|NCT02948582|11908134|FG004|STARTED|Washout Period 1||7
10743979|NCT02948582|11908135|FG005|STARTED|Washout Period 1||7
10743980|NCT02948582|11908130|FG000|COMPLETED|Washout Period 1||7
10743981|NCT02948582|11908131|FG001|COMPLETED|Washout Period 1||5
10817396|NCT01273064|11981172|FG002|STARTED|Overall Study||31
10817397|NCT01273064|11981173|FG003|STARTED|Overall Study||20
10817398|NCT01273064|11981174|FG004|STARTED|Overall Study|Began study on the placebo arm, and crossed over to CTS-1027 15 mg at Wk 12 due to lack of response|10
10817399|NCT01273064|11981170|FG000|COMPLETED|Overall Study||0
10743982|NCT02948582|11908132|FG002|COMPLETED|Washout Period 1||7
10743983|NCT02948582|11908133|FG003|COMPLETED|Washout Period 1||7
10743984|NCT02948582|11908134|FG004|COMPLETED|Washout Period 1||7
10743985|NCT02948582|11908135|FG005|COMPLETED|Washout Period 1||6
10743986|NCT02948582|11908130|FG000|NOT COMPLETED|Washout Period 1||0
10743987|NCT02948582|11908131|FG001|NOT COMPLETED|Washout Period 1||2
10743988|NCT02948582|11908132|FG002|NOT COMPLETED|Washout Period 1||0
10743989|NCT02948582|11908133|FG003|NOT COMPLETED|Washout Period 1||0
10743990|NCT02948582|11908134|FG004|NOT COMPLETED|Washout Period 1||0
10743991|NCT02948582|11908135|FG005|NOT COMPLETED|Washout Period 1||1
10743992|NCT02948582|11908130|FG000|STARTED|Treatment Period 2||7
10743993|NCT02948582|11908131|FG001|STARTED|Treatment Period 2||5
10743994|NCT02948582|11908132|FG002|STARTED|Treatment Period 2||7
10743995|NCT02948582|11908133|FG003|STARTED|Treatment Period 2||7
10743996|NCT02948582|11908134|FG004|STARTED|Treatment Period 2||7
10743997|NCT02948582|11908135|FG005|STARTED|Treatment Period 2||6
10743998|NCT02948582|11908130|FG000|COMPLETED|Treatment Period 2||7
10743999|NCT02948582|11908131|FG001|COMPLETED|Treatment Period 2||5
10744000|NCT02948582|11908132|FG002|COMPLETED|Treatment Period 2||7
10744001|NCT02948582|11908133|FG003|COMPLETED|Treatment Period 2||7
10744002|NCT02948582|11908134|FG004|COMPLETED|Treatment Period 2||7
10744003|NCT02948582|11908135|FG005|COMPLETED|Treatment Period 2||6
10744004|NCT02948582|11908130|FG000|NOT COMPLETED|Treatment Period 2||0
10744005|NCT02948582|11908131|FG001|NOT COMPLETED|Treatment Period 2||0
10744006|NCT02948582|11908132|FG002|NOT COMPLETED|Treatment Period 2||0
10744007|NCT02948582|11908133|FG003|NOT COMPLETED|Treatment Period 2||0
10744008|NCT02948582|11908134|FG004|NOT COMPLETED|Treatment Period 2||0
10744009|NCT02948582|11908135|FG005|NOT COMPLETED|Treatment Period 2||0
10744010|NCT02948582|11908130|FG000|STARTED|Washout Period 2||7
10744011|NCT02948582|11908131|FG001|STARTED|Washout Period 2||5
10744012|NCT02948582|11908132|FG002|STARTED|Washout Period 2||7
10744013|NCT02948582|11908133|FG003|STARTED|Washout Period 2||7
10744014|NCT02948582|11908134|FG004|STARTED|Washout Period 2||7
10744015|NCT02948582|11908135|FG005|STARTED|Washout Period 2||6
10744016|NCT02948582|11908130|FG000|COMPLETED|Washout Period 2||7
10744017|NCT02948582|11908131|FG001|COMPLETED|Washout Period 2||4
10744018|NCT02948582|11908132|FG002|COMPLETED|Washout Period 2||7
10744019|NCT02948582|11908133|FG003|COMPLETED|Washout Period 2||6
10744020|NCT02948582|11908134|FG004|COMPLETED|Washout Period 2||7
10744021|NCT02948582|11908135|FG005|COMPLETED|Washout Period 2||6
10744022|NCT02948582|11908130|FG000|NOT COMPLETED|Washout Period 2||0
10744023|NCT02948582|11908131|FG001|NOT COMPLETED|Washout Period 2||1
10744024|NCT02948582|11908132|FG002|NOT COMPLETED|Washout Period 2||0
10744025|NCT02948582|11908133|FG003|NOT COMPLETED|Washout Period 2||1
10744026|NCT02948582|11908134|FG004|NOT COMPLETED|Washout Period 2||0
10744027|NCT02948582|11908135|FG005|NOT COMPLETED|Washout Period 2||0
10744028|NCT02948582|11908130|FG000|STARTED|Treatment Period 3||7
10744029|NCT02948582|11908131|FG001|STARTED|Treatment Period 3||4
10744030|NCT02948582|11908132|FG002|STARTED|Treatment Period 3||7
10744031|NCT02948582|11908133|FG003|STARTED|Treatment Period 3||6
10744032|NCT02948582|11908134|FG004|STARTED|Treatment Period 3||7
10744033|NCT02948582|11908135|FG005|STARTED|Treatment Period 3||6
10744034|NCT02948582|11908130|FG000|COMPLETED|Treatment Period 3||7
10744035|NCT02948582|11908131|FG001|COMPLETED|Treatment Period 3||4
10744036|NCT02948582|11908132|FG002|COMPLETED|Treatment Period 3||7
10744037|NCT02948582|11908133|FG003|COMPLETED|Treatment Period 3||6
10744038|NCT02948582|11908134|FG004|COMPLETED|Treatment Period 3||7
10744039|NCT02948582|11908135|FG005|COMPLETED|Treatment Period 3||6
10744040|NCT02948582|11908130|FG000|NOT COMPLETED|Treatment Period 3||0
10744041|NCT02948582|11908131|FG001|NOT COMPLETED|Treatment Period 3||0
10744042|NCT02948582|11908132|FG002|NOT COMPLETED|Treatment Period 3||0
10744043|NCT02948582|11908133|FG003|NOT COMPLETED|Treatment Period 3||0
10744044|NCT02948582|11908134|FG004|NOT COMPLETED|Treatment Period 3||0
10744045|NCT02948582|11908135|FG005|NOT COMPLETED|Treatment Period 3||0
10744046|NCT02948582|11908130|FG000|STARTED|Washout Period 3||7
10744047|NCT02948582|11908131|FG001|STARTED|Washout Period 3||4
10744048|NCT02948582|11908132|FG002|STARTED|Washout Period 3||7
10744049|NCT02948582|11908133|FG003|STARTED|Washout Period 3||6
10744050|NCT02948582|11908134|FG004|STARTED|Washout Period 3||7
10744051|NCT02948582|11908135|FG005|STARTED|Washout Period 3||6
10744052|NCT02948582|11908130|FG000|COMPLETED|Washout Period 3||7
10744053|NCT02948582|11908131|FG001|COMPLETED|Washout Period 3||4
10744054|NCT02948582|11908132|FG002|COMPLETED|Washout Period 3||7
10744055|NCT02948582|11908133|FG003|COMPLETED|Washout Period 3||6
10744056|NCT02948582|11908134|FG004|COMPLETED|Washout Period 3||7
10744057|NCT02948582|11908135|FG005|COMPLETED|Washout Period 3||6
10817400|NCT01273064|11981171|FG001|COMPLETED|Overall Study||0
10817401|NCT01273064|11981172|FG002|COMPLETED|Overall Study||0
10817402|NCT01273064|11981173|FG003|COMPLETED|Overall Study||0
10817403|NCT01273064|11981174|FG004|COMPLETED|Overall Study||0
10817404|NCT01273064|11981170|FG000|NOT COMPLETED|Overall Study||23
10817405|NCT01273064|11981171|FG001|NOT COMPLETED|Overall Study||30
10817406|NCT01273064|11981172|FG002|NOT COMPLETED|Overall Study||31
10817407|NCT01273064|11981173|FG003|NOT COMPLETED|Overall Study||20
10817408|NCT01273064|11981174|FG004|NOT COMPLETED|Overall Study||10
10817409|NCT01274559|11981188|FG000|STARTED|Overall Study||587
10744058|NCT02948582|11908130|FG000|NOT COMPLETED|Washout Period 3||0
10744059|NCT02948582|11908131|FG001|NOT COMPLETED|Washout Period 3||0
10744060|NCT02948582|11908132|FG002|NOT COMPLETED|Washout Period 3||0
10744061|NCT02948582|11908133|FG003|NOT COMPLETED|Washout Period 3||0
10744062|NCT02948582|11908134|FG004|NOT COMPLETED|Washout Period 3||0
10744063|NCT02948582|11908135|FG005|NOT COMPLETED|Washout Period 3||0
10744064|NCT02948582|11908130|FG000|STARTED|Treatment Period 4||7
10744065|NCT02948582|11908131|FG001|STARTED|Treatment Period 4||4
10744066|NCT02948582|11908132|FG002|STARTED|Treatment Period 4||7
10744067|NCT02948582|11908133|FG003|STARTED|Treatment Period 4||6
10744068|NCT02948582|11908134|FG004|STARTED|Treatment Period 4||7
10744069|NCT02948582|11908135|FG005|STARTED|Treatment Period 4||6
10744070|NCT02948582|11908130|FG000|COMPLETED|Treatment Period 4||7
10744071|NCT02948582|11908131|FG001|COMPLETED|Treatment Period 4||4
10744072|NCT02948582|11908132|FG002|COMPLETED|Treatment Period 4||7
10744073|NCT02948582|11908133|FG003|COMPLETED|Treatment Period 4||6
10744074|NCT02948582|11908134|FG004|COMPLETED|Treatment Period 4||7
10744075|NCT02948582|11908135|FG005|COMPLETED|Treatment Period 4||6
10744076|NCT02948582|11908130|FG000|NOT COMPLETED|Treatment Period 4||0
10744077|NCT02948582|11908131|FG001|NOT COMPLETED|Treatment Period 4||0
10744078|NCT02948582|11908132|FG002|NOT COMPLETED|Treatment Period 4||0
10744079|NCT02948582|11908133|FG003|NOT COMPLETED|Treatment Period 4||0
10744080|NCT02948582|11908134|FG004|NOT COMPLETED|Treatment Period 4||0
10744081|NCT02948582|11908135|FG005|NOT COMPLETED|Treatment Period 4||0
10744082|NCT02948582|11908130|FG000|STARTED|Washout Period 4||7
10744083|NCT02948582|11908131|FG001|STARTED|Washout Period 4||4
10744084|NCT02948582|11908132|FG002|STARTED|Washout Period 4||7
10744085|NCT02948582|11908133|FG003|STARTED|Washout Period 4||6
10744086|NCT02948582|11908134|FG004|STARTED|Washout Period 4||7
10744087|NCT02948582|11908135|FG005|STARTED|Washout Period 4||6
10744088|NCT02948582|11908130|FG000|COMPLETED|Washout Period 4||6
10744089|NCT02948582|11908131|FG001|COMPLETED|Washout Period 4||4
10744090|NCT02948582|11908132|FG002|COMPLETED|Washout Period 4||6
10744091|NCT02948582|11908133|FG003|COMPLETED|Washout Period 4||6
10744092|NCT02948582|11908134|FG004|COMPLETED|Washout Period 4||7
10744093|NCT02948582|11908135|FG005|COMPLETED|Washout Period 4||6
10744094|NCT02948582|11908130|FG000|NOT COMPLETED|Washout Period 4||1
10744095|NCT02948582|11908131|FG001|NOT COMPLETED|Washout Period 4||0
10744096|NCT02948582|11908132|FG002|NOT COMPLETED|Washout Period 4||1
10744097|NCT02948582|11908133|FG003|NOT COMPLETED|Washout Period 4||0
10744098|NCT02948582|11908134|FG004|NOT COMPLETED|Washout Period 4||0
10744099|NCT02948582|11908135|FG005|NOT COMPLETED|Washout Period 4||0
10744100|NCT02948582|11908130|FG000|STARTED|Treatment Period 5||6
10744101|NCT02948582|11908131|FG001|STARTED|Treatment Period 5||4
10744102|NCT02948582|11908132|FG002|STARTED|Treatment Period 5||6
10744103|NCT02948582|11908133|FG003|STARTED|Treatment Period 5||6
10744104|NCT02948582|11908134|FG004|STARTED|Treatment Period 5||7
10744105|NCT02948582|11908135|FG005|STARTED|Treatment Period 5||6
10744106|NCT02948582|11908130|FG000|COMPLETED|Treatment Period 5||6
10744107|NCT02948582|11908131|FG001|COMPLETED|Treatment Period 5||4
10744108|NCT02948582|11908132|FG002|COMPLETED|Treatment Period 5||6
10744109|NCT02948582|11908133|FG003|COMPLETED|Treatment Period 5||6
10744110|NCT02948582|11908134|FG004|COMPLETED|Treatment Period 5||7
10744111|NCT02948582|11908135|FG005|COMPLETED|Treatment Period 5||6
10744112|NCT02948582|11908130|FG000|NOT COMPLETED|Treatment Period 5||0
10744113|NCT02948582|11908131|FG001|NOT COMPLETED|Treatment Period 5||0
10744114|NCT02948582|11908132|FG002|NOT COMPLETED|Treatment Period 5||0
10744115|NCT02948582|11908133|FG003|NOT COMPLETED|Treatment Period 5||0
10744116|NCT02948582|11908134|FG004|NOT COMPLETED|Treatment Period 5||0
10744117|NCT02948582|11908135|FG005|NOT COMPLETED|Treatment Period 5||0
10744118|NCT02948582|11908130|FG000|STARTED|Washout Period 5||6
10312930|NCT00147069|11446452|FG000|STARTED|Overall Study||15
10312931|NCT00147069|11446453|FG001|STARTED|Overall Study||15
10312932|NCT00147069|11446454|FG002|STARTED|Overall Study||15
10312933|NCT00147069|11446455|FG003|STARTED|Overall Study||15
10312934|NCT00147069|11446452|FG000|COMPLETED|Overall Study||15
10312935|NCT00147069|11446453|FG001|COMPLETED|Overall Study||15
10312936|NCT00147069|11446454|FG002|COMPLETED|Overall Study||15
10312937|NCT00147069|11446455|FG003|COMPLETED|Overall Study||15
10312938|NCT00147069|11446452|FG000|NOT COMPLETED|Overall Study||0
10312939|NCT00147069|11446453|FG001|NOT COMPLETED|Overall Study||0
10744119|NCT02948582|11908131|FG001|STARTED|Washout Period 5||4
10744120|NCT02948582|11908132|FG002|STARTED|Washout Period 5||6
10744121|NCT02948582|11908133|FG003|STARTED|Washout Period 5||6
10744122|NCT02948582|11908134|FG004|STARTED|Washout Period 5||7
10744123|NCT02948582|11908135|FG005|STARTED|Washout Period 5||6
10744124|NCT02948582|11908130|FG000|COMPLETED|Washout Period 5||6
10744125|NCT02948582|11908131|FG001|COMPLETED|Washout Period 5||4
10744126|NCT02948582|11908132|FG002|COMPLETED|Washout Period 5||6
10744127|NCT02948582|11908133|FG003|COMPLETED|Washout Period 5||6
10744128|NCT02948582|11908134|FG004|COMPLETED|Washout Period 5||7
10744129|NCT02948582|11908135|FG005|COMPLETED|Washout Period 5||6
10744130|NCT02948582|11908130|FG000|NOT COMPLETED|Washout Period 5||0
10744131|NCT02948582|11908131|FG001|NOT COMPLETED|Washout Period 5||0
10312940|NCT00147069|11446454|FG002|NOT COMPLETED|Overall Study||0
10312941|NCT00147069|11446455|FG003|NOT COMPLETED|Overall Study||0
10312942|NCT00147082|11446468|FG000|STARTED|Overall Study||37
10744132|NCT02948582|11908132|FG002|NOT COMPLETED|Washout Period 5||0
10744133|NCT02948582|11908133|FG003|NOT COMPLETED|Washout Period 5||0
10312943|NCT00147082|11446469|FG001|STARTED|Overall Study||33
10744134|NCT02948582|11908134|FG004|NOT COMPLETED|Washout Period 5||0
10744135|NCT02948582|11908135|FG005|NOT COMPLETED|Washout Period 5||0
10744136|NCT02948582|11908130|FG000|STARTED|Treatment Period 6||6
10744137|NCT02948582|11908131|FG001|STARTED|Treatment Period 6||4
10744138|NCT02948582|11908132|FG002|STARTED|Treatment Period 6||6
10744139|NCT02948582|11908133|FG003|STARTED|Treatment Period 6||6
10744140|NCT02948582|11908134|FG004|STARTED|Treatment Period 6||7
10744141|NCT02948582|11908135|FG005|STARTED|Treatment Period 6||6
10744142|NCT02948582|11908130|FG000|COMPLETED|Treatment Period 6||6
10744143|NCT02948582|11908131|FG001|COMPLETED|Treatment Period 6||4
10744144|NCT02948582|11908132|FG002|COMPLETED|Treatment Period 6||6
10744145|NCT02948582|11908133|FG003|COMPLETED|Treatment Period 6||6
10744146|NCT02948582|11908134|FG004|COMPLETED|Treatment Period 6||7
10744147|NCT02948582|11908135|FG005|COMPLETED|Treatment Period 6||6
10744148|NCT02948582|11908130|FG000|NOT COMPLETED|Treatment Period 6||0
10744149|NCT02948582|11908131|FG001|NOT COMPLETED|Treatment Period 6||0
10744150|NCT02948582|11908132|FG002|NOT COMPLETED|Treatment Period 6||0
10744151|NCT02948582|11908133|FG003|NOT COMPLETED|Treatment Period 6||0
10744152|NCT02948582|11908134|FG004|NOT COMPLETED|Treatment Period 6||0
10744153|NCT02948582|11908135|FG005|NOT COMPLETED|Treatment Period 6||0
10744154|NCT02948582|11908130|FG000|STARTED|Wshout Period 6||6
10744155|NCT02948582|11908131|FG001|STARTED|Wshout Period 6||4
10744156|NCT02948582|11908132|FG002|STARTED|Wshout Period 6||6
10744157|NCT02948582|11908133|FG003|STARTED|Wshout Period 6||6
10744158|NCT02948582|11908134|FG004|STARTED|Wshout Period 6||7
10744159|NCT02948582|11908135|FG005|STARTED|Wshout Period 6||6
10744160|NCT02948582|11908130|FG000|COMPLETED|Wshout Period 6||6
10744161|NCT02948582|11908131|FG001|COMPLETED|Wshout Period 6||4
10744162|NCT02948582|11908132|FG002|COMPLETED|Wshout Period 6||6
10744163|NCT02948582|11908133|FG003|COMPLETED|Wshout Period 6||6
10744164|NCT02948582|11908134|FG004|COMPLETED|Wshout Period 6||7
10744165|NCT02948582|11908135|FG005|COMPLETED|Wshout Period 6||6
10744166|NCT02948582|11908130|FG000|NOT COMPLETED|Wshout Period 6||0
10744167|NCT02948582|11908131|FG001|NOT COMPLETED|Wshout Period 6||0
10744168|NCT02948582|11908132|FG002|NOT COMPLETED|Wshout Period 6||0
10744169|NCT02948582|11908133|FG003|NOT COMPLETED|Wshout Period 6||0
10744170|NCT02948582|11908134|FG004|NOT COMPLETED|Wshout Period 6||0
10744171|NCT02948582|11908135|FG005|NOT COMPLETED|Wshout Period 6||0
10744172|NCT02948634|11908151|FG000|STARTED|Overall Study||17
10744173|NCT02948634|11908152|FG001|STARTED|Overall Study||11
10744174|NCT02948634|11908151|FG000|COMPLETED|Overall Study||7
10744175|NCT02948634|11908152|FG001|COMPLETED|Overall Study||9
10744176|NCT02948634|11908151|FG000|NOT COMPLETED|Overall Study||10
10744177|NCT02948634|11908152|FG001|NOT COMPLETED|Overall Study||2
10744178|NCT02948777|11908158|FG000|STARTED|Overall Study||14
10744179|NCT02948777|11908158|FG000|COMPLETED|Overall Study||13
10744180|NCT02948777|11908158|FG000|NOT COMPLETED|Overall Study||1
10744184|NCT02949011|11908185|FG000|STARTED|Overall Study||730
10408708|NCT00756548|11552842|FG000|STARTED|Overall Study||186
10408709|NCT00756548|11552843|FG001|STARTED|Overall Study||185
10408710|NCT00756548|11552842|FG000|COMPLETED|Overall Study||184
10408711|NCT00756548|11552843|FG001|COMPLETED|Overall Study||185
10408712|NCT00756548|11552842|FG000|NOT COMPLETED|Overall Study||2
10408713|NCT00756548|11552843|FG001|NOT COMPLETED|Overall Study||0
10408714|NCT00756561|11552851|FG000|STARTED|Overall Study||10
10744185|NCT02949011|11908186|FG001|STARTED|Overall Study||729
10744186|NCT02949011|11908187|FG002|STARTED|Overall Study||725
10744187|NCT02949011|11908185|FG000|Received Study Drug|Overall Study||728
10744188|NCT02949011|11908186|FG001|Received Study Drug|Overall Study|Includes one participant who received baloxavir marboxil in error|728
10744189|NCT02949011|11908187|FG002|Received Study Drug|Overall Study|Includes one participant who received baloxavir marboxil in error|722
10744190|NCT02949011|11908185|FG000|Intention to Treat Infected Population|Overall Study||388
10744191|NCT02949011|11908186|FG001|Intention to Treat Infected Population|Overall Study||386
10744192|NCT02949011|11908187|FG002|Intention to Treat Infected Population|Overall Study||389
10744193|NCT02949011|11908185|FG000|COMPLETED|Overall Study||697
10744194|NCT02949011|11908186|FG001|COMPLETED|Overall Study||695
10744195|NCT02949011|11908187|FG002|COMPLETED|Overall Study||683
10744196|NCT02949011|11908185|FG000|NOT COMPLETED|Overall Study||33
10744197|NCT02949011|11908186|FG001|NOT COMPLETED|Overall Study||34
10744198|NCT02949011|11908187|FG002|NOT COMPLETED|Overall Study||42
10744199|NCT02949024|11908197|FG000|STARTED|Overall Study||10
10744200|NCT02949024|11908198|FG001|STARTED|Overall Study||10
10744201|NCT02949024|11908197|FG000|COMPLETED|Overall Study||10
10744202|NCT02949024|11908198|FG001|COMPLETED|Overall Study||9
10744203|NCT02949024|11908197|FG000|NOT COMPLETED|Overall Study||0
10744204|NCT02949024|11908198|FG001|NOT COMPLETED|Overall Study||1
10744205|NCT02949141|11908206|FG000|STARTED|Overall Study||62
10408715|NCT00756561|11552851|FG000|COMPLETED|Overall Study||10
10744206|NCT02949141|11908206|FG000|COMPLETED|Overall Study||62
10744207|NCT02949141|11908206|FG000|NOT COMPLETED|Overall Study||0
10744208|NCT02949271|11908215|FG000|STARTED|Overall Study||90
10744209|NCT02949271|11908216|FG001|STARTED|Overall Study||89
10744210|NCT02949271|11908215|FG000|COMPLETED|Overall Study||61
10744211|NCT02949271|11908216|FG001|COMPLETED|Overall Study||59
10744212|NCT02949271|11908215|FG000|NOT COMPLETED|Overall Study||29
10744213|NCT02949271|11908216|FG001|NOT COMPLETED|Overall Study||30
10744214|NCT02949362|11908224|FG000|STARTED|Retrospective Period||24
10744215|NCT02949362|11908225|FG001|STARTED|Retrospective Period||5
10744216|NCT02949362|11908226|FG002|STARTED|Retrospective Period||0
10744217|NCT02949362|11908227|FG003|STARTED|Retrospective Period||0
10744218|NCT02949362|11908224|FG000|COMPLETED|Retrospective Period||20
10744219|NCT02949362|11908225|FG001|COMPLETED|Retrospective Period||4
10744220|NCT02949362|11908226|FG002|COMPLETED|Retrospective Period||0
10744221|NCT02949362|11908227|FG003|COMPLETED|Retrospective Period||0
10744222|NCT02949362|11908224|FG000|NOT COMPLETED|Retrospective Period||4
10744223|NCT02949362|11908225|FG001|NOT COMPLETED|Retrospective Period||1
10744224|NCT02949362|11908226|FG002|NOT COMPLETED|Retrospective Period||0
10744225|NCT02949362|11908227|FG003|NOT COMPLETED|Retrospective Period||0
10744226|NCT02949362|11908224|FG000|STARTED|Prospective Period||0
10744227|NCT02949362|11908225|FG001|STARTED|Prospective Period||0
10744228|NCT02949362|11908226|FG002|STARTED|Prospective Period|Participants were enrolled from retrospective period.|5
10744229|NCT02949362|11908227|FG003|STARTED|Prospective Period|Participants were enrolled from retrospective period.|19
10744230|NCT02949362|11908224|FG000|COMPLETED|Prospective Period||0
10744231|NCT02949362|11908225|FG001|COMPLETED|Prospective Period||0
10744232|NCT02949362|11908226|FG002|COMPLETED|Prospective Period||4
10744233|NCT02949362|11908227|FG003|COMPLETED|Prospective Period||15
10744234|NCT02949362|11908224|FG000|NOT COMPLETED|Prospective Period||0
10744235|NCT02949362|11908225|FG001|NOT COMPLETED|Prospective Period||0
10744236|NCT02949362|11908226|FG002|NOT COMPLETED|Prospective Period||1
10744237|NCT02949362|11908227|FG003|NOT COMPLETED|Prospective Period||4
10744238|NCT02949518|11908241|FG000|STARTED|Overall Study||28
10744239|NCT02949518|11908242|FG001|STARTED|Overall Study||28
10744240|NCT02949518|11908241|FG000|COMPLETED|Overall Study||25
10744241|NCT02949518|11908242|FG001|COMPLETED|Overall Study||26
10744242|NCT02949518|11908241|FG000|NOT COMPLETED|Overall Study||3
10744243|NCT02949518|11908242|FG001|NOT COMPLETED|Overall Study||2
10744244|NCT02949674|11908253|FG000|STARTED|Overall Study||31
10744245|NCT02949674|11908254|FG001|STARTED|Overall Study||31
10744246|NCT02949674|11908255|FG002|STARTED|Overall Study||31
10744247|NCT02949674|11908253|FG000|COMPLETED|Overall Study||31
10744248|NCT02949674|11908254|FG001|COMPLETED|Overall Study||31
10744249|NCT02949674|11908255|FG002|COMPLETED|Overall Study||31
10744250|NCT02949674|11908253|FG000|NOT COMPLETED|Overall Study||0
10744251|NCT02949674|11908254|FG001|NOT COMPLETED|Overall Study||0
10744252|NCT02949674|11908255|FG002|NOT COMPLETED|Overall Study||0
10744253|NCT02949908|11908263|FG000|STARTED|Overall Study||2
10744254|NCT02949908|11908263|FG000|COMPLETED|Overall Study||0
10744255|NCT02949908|11908263|FG000|NOT COMPLETED|Overall Study||2
10744256|NCT02949921|11908269|FG000|STARTED|Overall Study||10
10744257|NCT02949921|11908270|FG001|STARTED|Overall Study||10
10744258|NCT02949921|11908269|FG000|COMPLETED|Overall Study||10
10744259|NCT02949921|11908270|FG001|COMPLETED|Overall Study||10
10744260|NCT02949921|11908269|FG000|NOT COMPLETED|Overall Study||0
10744261|NCT02949921|11908270|FG001|NOT COMPLETED|Overall Study||0
10744262|NCT02949973|11908276|FG000|STARTED|Overall Study||10
10744263|NCT02949973|11908276|FG000|COMPLETED|Overall Study||9
10744264|NCT02949973|11908276|FG000|NOT COMPLETED|Overall Study||1
10744265|NCT02950025|11908282|FG000|STARTED|Overall Study||2
10744266|NCT02950025|11908283|FG001|STARTED|Overall Study||3
10744267|NCT02950025|11908282|FG000|COMPLETED|Overall Study||2
10744268|NCT02950025|11908283|FG001|COMPLETED|Overall Study||3
10744269|NCT02950025|11908282|FG000|NOT COMPLETED|Overall Study||0
10744270|NCT02950025|11908283|FG001|NOT COMPLETED|Overall Study||0
10744271|NCT02950467|11908289|FG000|STARTED|Open-label Treatment||18
10744272|NCT02950467|11908289|FG000|COMPLETED|Open-label Treatment|1 participant completed study period but missed some visits due to an adverse event (AE).|18
10744273|NCT02950467|11908289|FG000|NOT COMPLETED|Open-label Treatment||0
10744274|NCT02950467|11908289|FG000|STARTED|3-month Follow-up||18
10744275|NCT02950467|11908289|FG000|COMPLETED|3-month Follow-up|All participants completed the safety follow-up assessment, but not all completed outcomes measures.|18
10744276|NCT02950467|11908289|FG000|NOT COMPLETED|3-month Follow-up||0
10744277|NCT02950545|11908299|FG000|STARTED|Session 1 (70 Minutes)||9
10744278|NCT02950545|11908300|FG001|STARTED|Session 1 (70 Minutes)||9
10744279|NCT02950545|11908301|FG002|STARTED|Session 1 (70 Minutes)||7
10744280|NCT02950545|11908302|FG003|STARTED|Session 1 (70 Minutes)||8
10744281|NCT02950545|11908303|FG004|STARTED|Session 1 (70 Minutes)||8
10744282|NCT02950545|11908304|FG005|STARTED|Session 1 (70 Minutes)||10
10744283|NCT02950545|11908299|FG000|COMPLETED|Session 1 (70 Minutes)||9
10744284|NCT02950545|11908300|FG001|COMPLETED|Session 1 (70 Minutes)||9
10744285|NCT02950545|11908301|FG002|COMPLETED|Session 1 (70 Minutes)||7
10744286|NCT02950545|11908302|FG003|COMPLETED|Session 1 (70 Minutes)||8
10744287|NCT02950545|11908303|FG004|COMPLETED|Session 1 (70 Minutes)||8
10744288|NCT02950545|11908304|FG005|COMPLETED|Session 1 (70 Minutes)||9
10744289|NCT02950545|11908299|FG000|NOT COMPLETED|Session 1 (70 Minutes)||0
10744290|NCT02950545|11908300|FG001|NOT COMPLETED|Session 1 (70 Minutes)||0
10744291|NCT02950545|11908301|FG002|NOT COMPLETED|Session 1 (70 Minutes)||0
10744292|NCT02950545|11908302|FG003|NOT COMPLETED|Session 1 (70 Minutes)||0
10744293|NCT02950545|11908303|FG004|NOT COMPLETED|Session 1 (70 Minutes)||0
10744294|NCT02950545|11908304|FG005|NOT COMPLETED|Session 1 (70 Minutes)||1
10744295|NCT02950545|11908299|FG000|STARTED|Washout 1 (5 Minutes)||9
10744296|NCT02950545|11908300|FG001|STARTED|Washout 1 (5 Minutes)||9
10744297|NCT02950545|11908301|FG002|STARTED|Washout 1 (5 Minutes)||7
10744298|NCT02950545|11908302|FG003|STARTED|Washout 1 (5 Minutes)||8
10744299|NCT02950545|11908303|FG004|STARTED|Washout 1 (5 Minutes)||8
10744300|NCT02950545|11908304|FG005|STARTED|Washout 1 (5 Minutes)||9
10744301|NCT02950545|11908299|FG000|COMPLETED|Washout 1 (5 Minutes)||8
10744302|NCT02950545|11908300|FG001|COMPLETED|Washout 1 (5 Minutes)||9
10744303|NCT02950545|11908301|FG002|COMPLETED|Washout 1 (5 Minutes)||7
10744304|NCT02950545|11908302|FG003|COMPLETED|Washout 1 (5 Minutes)||7
10744305|NCT02950545|11908303|FG004|COMPLETED|Washout 1 (5 Minutes)||8
10744306|NCT02950545|11908304|FG005|COMPLETED|Washout 1 (5 Minutes)||8
10744307|NCT02950545|11908299|FG000|NOT COMPLETED|Washout 1 (5 Minutes)||1
10744308|NCT02950545|11908300|FG001|NOT COMPLETED|Washout 1 (5 Minutes)||0
10744309|NCT02950545|11908301|FG002|NOT COMPLETED|Washout 1 (5 Minutes)||0
10744310|NCT02950545|11908302|FG003|NOT COMPLETED|Washout 1 (5 Minutes)||1
10744311|NCT02950545|11908303|FG004|NOT COMPLETED|Washout 1 (5 Minutes)||0
10744312|NCT02950545|11908304|FG005|NOT COMPLETED|Washout 1 (5 Minutes)||1
10744313|NCT02950545|11908299|FG000|STARTED|Session 2 (70 Minutes)||8
10744314|NCT02950545|11908300|FG001|STARTED|Session 2 (70 Minutes)||9
10744315|NCT02950545|11908301|FG002|STARTED|Session 2 (70 Minutes)||7
10744316|NCT02950545|11908302|FG003|STARTED|Session 2 (70 Minutes)||7
10744317|NCT02950545|11908303|FG004|STARTED|Session 2 (70 Minutes)||8
10744318|NCT02950545|11908304|FG005|STARTED|Session 2 (70 Minutes)||8
10744319|NCT02950545|11908299|FG000|COMPLETED|Session 2 (70 Minutes)||8
10744320|NCT02950545|11908300|FG001|COMPLETED|Session 2 (70 Minutes)||9
10744321|NCT02950545|11908301|FG002|COMPLETED|Session 2 (70 Minutes)||7
10744322|NCT02950545|11908302|FG003|COMPLETED|Session 2 (70 Minutes)||7
10744323|NCT02950545|11908303|FG004|COMPLETED|Session 2 (70 Minutes)||7
10744324|NCT02950545|11908304|FG005|COMPLETED|Session 2 (70 Minutes)||8
10744325|NCT02950545|11908299|FG000|NOT COMPLETED|Session 2 (70 Minutes)||0
10744326|NCT02950545|11908300|FG001|NOT COMPLETED|Session 2 (70 Minutes)||0
10744327|NCT02950545|11908301|FG002|NOT COMPLETED|Session 2 (70 Minutes)||0
10744328|NCT02950545|11908302|FG003|NOT COMPLETED|Session 2 (70 Minutes)||0
10744329|NCT02950545|11908303|FG004|NOT COMPLETED|Session 2 (70 Minutes)||1
10744330|NCT02950545|11908304|FG005|NOT COMPLETED|Session 2 (70 Minutes)||0
10744331|NCT02950545|11908299|FG000|STARTED|Washout 2 (5 Minutes)||8
10744332|NCT02950545|11908300|FG001|STARTED|Washout 2 (5 Minutes)||9
10744333|NCT02950545|11908301|FG002|STARTED|Washout 2 (5 Minutes)||7
10744334|NCT02950545|11908302|FG003|STARTED|Washout 2 (5 Minutes)||7
10744335|NCT02950545|11908303|FG004|STARTED|Washout 2 (5 Minutes)||7
10744336|NCT02950545|11908304|FG005|STARTED|Washout 2 (5 Minutes)||8
10744337|NCT02950545|11908299|FG000|COMPLETED|Washout 2 (5 Minutes)||7
10744338|NCT02950545|11908300|FG001|COMPLETED|Washout 2 (5 Minutes)||9
10744339|NCT02950545|11908301|FG002|COMPLETED|Washout 2 (5 Minutes)||7
10744340|NCT02950545|11908302|FG003|COMPLETED|Washout 2 (5 Minutes)||7
10744341|NCT02950545|11908303|FG004|COMPLETED|Washout 2 (5 Minutes)||7
10744342|NCT02950545|11908304|FG005|COMPLETED|Washout 2 (5 Minutes)||8
10744343|NCT02950545|11908299|FG000|NOT COMPLETED|Washout 2 (5 Minutes)||1
10744344|NCT02950545|11908300|FG001|NOT COMPLETED|Washout 2 (5 Minutes)||0
10744345|NCT02950545|11908301|FG002|NOT COMPLETED|Washout 2 (5 Minutes)||0
10744346|NCT02950545|11908302|FG003|NOT COMPLETED|Washout 2 (5 Minutes)||0
10744347|NCT02950545|11908303|FG004|NOT COMPLETED|Washout 2 (5 Minutes)||0
10744348|NCT02950545|11908304|FG005|NOT COMPLETED|Washout 2 (5 Minutes)||0
10744349|NCT02950545|11908299|FG000|STARTED|Session 3 (70 Minutes)||7
10744350|NCT02950545|11908300|FG001|STARTED|Session 3 (70 Minutes)||9
10744351|NCT02950545|11908301|FG002|STARTED|Session 3 (70 Minutes)||7
10744352|NCT02950545|11908302|FG003|STARTED|Session 3 (70 Minutes)||7
10744353|NCT02950545|11908303|FG004|STARTED|Session 3 (70 Minutes)||7
10744354|NCT02950545|11908304|FG005|STARTED|Session 3 (70 Minutes)||8
10744355|NCT02950545|11908299|FG000|COMPLETED|Session 3 (70 Minutes)||7
10744356|NCT02950545|11908300|FG001|COMPLETED|Session 3 (70 Minutes)||9
10744357|NCT02950545|11908301|FG002|COMPLETED|Session 3 (70 Minutes)||7
10744358|NCT02950545|11908302|FG003|COMPLETED|Session 3 (70 Minutes)||7
10744359|NCT02950545|11908303|FG004|COMPLETED|Session 3 (70 Minutes)||7
10744360|NCT02950545|11908304|FG005|COMPLETED|Session 3 (70 Minutes)||7
10744361|NCT02950545|11908299|FG000|NOT COMPLETED|Session 3 (70 Minutes)||0
10744362|NCT02950545|11908300|FG001|NOT COMPLETED|Session 3 (70 Minutes)||0
10744363|NCT02950545|11908301|FG002|NOT COMPLETED|Session 3 (70 Minutes)||0
10744364|NCT02950545|11908302|FG003|NOT COMPLETED|Session 3 (70 Minutes)||0
10744365|NCT02950545|11908303|FG004|NOT COMPLETED|Session 3 (70 Minutes)||0
10744366|NCT02950545|11908304|FG005|NOT COMPLETED|Session 3 (70 Minutes)||1
10744367|NCT02950558|11908312|FG000|STARTED|Overall Study||8
10744368|NCT02950558|11908313|FG001|STARTED|Overall Study||6
10744369|NCT02950558|11908312|FG000|12 Month Pain Questionnaire|Overall Study||6
10744370|NCT02950558|11908313|FG001|12 Month Pain Questionnaire|Overall Study||6
10744371|NCT02950558|11908312|FG000|COMPLETED|Overall Study||6
10744372|NCT02950558|11908313|FG001|COMPLETED|Overall Study||6
10744373|NCT02950558|11908312|FG000|NOT COMPLETED|Overall Study||2
10744374|NCT02950558|11908313|FG001|NOT COMPLETED|Overall Study||0
10744375|NCT02950753|11908322|FG000|STARTED|Overall Study||15
10744376|NCT02950753|11908323|FG001|STARTED|Overall Study||15
10744377|NCT02950753|11908322|FG000|COMPLETED|Overall Study||15
10744378|NCT02950753|11908323|FG001|COMPLETED|Overall Study||15
10744379|NCT02950753|11908322|FG000|NOT COMPLETED|Overall Study||0
10744380|NCT02950753|11908323|FG001|NOT COMPLETED|Overall Study||0
10744381|NCT02950831|11908329|FG000|STARTED|Overall Study||27
10744382|NCT02950831|11908329|FG000|Complete Trial|Overall Study||26
10744383|NCT02950831|11908329|FG000|Permanent Implant|Overall Study||20
10744384|NCT02950831|11908329|FG000|4 Week Follow up|Overall Study||20
10744385|NCT02950831|11908329|FG000|8 Weeks Follow up|Overall Study||19
10744386|NCT02950831|11908329|FG000|COMPLETED|Overall Study||18
10744387|NCT02950831|11908329|FG000|NOT COMPLETED|Overall Study||9
10744388|NCT02951143|11908339|FG000|STARTED|Overall Study||97
10744389|NCT02951143|11908340|FG001|STARTED|Overall Study||41
10744390|NCT02951143|11908341|FG002|STARTED|Overall Study||47
10744391|NCT02951143|11908342|FG003|STARTED|Overall Study||39
10744392|NCT02951143|11908343|FG004|STARTED|Overall Study||37
10744393|NCT02951143|11908344|FG005|STARTED|Overall Study||44
10744394|NCT02951143|11908339|FG000|COMPLETED|Overall Study||36
10744395|NCT02951143|11908340|FG001|COMPLETED|Overall Study||32
10744396|NCT02951143|11908341|FG002|COMPLETED|Overall Study||29
10744397|NCT02951143|11908342|FG003|COMPLETED|Overall Study||30
10744398|NCT02951143|11908343|FG004|COMPLETED|Overall Study||31
10744399|NCT02951143|11908344|FG005|COMPLETED|Overall Study||29
10744400|NCT02951143|11908339|FG000|NOT COMPLETED|Overall Study||61
10744401|NCT02951143|11908340|FG001|NOT COMPLETED|Overall Study||9
10744402|NCT02951143|11908341|FG002|NOT COMPLETED|Overall Study||18
10744403|NCT02951143|11908342|FG003|NOT COMPLETED|Overall Study||9
10744404|NCT02951143|11908343|FG004|NOT COMPLETED|Overall Study||6
10744405|NCT02951143|11908344|FG005|NOT COMPLETED|Overall Study||15
10778334|NCT03353220|11940266|FG000|NOT COMPLETED|Third Intervention (6 Months) - Phase 2||4
10778335|NCT03353220|11940267|FG001|NOT COMPLETED|Third Intervention (6 Months) - Phase 2||7
10778336|NCT03353246|11940273|FG000|STARTED|Overall Study||500
10778337|NCT03353246|11940273|FG000|COMPLETED|Overall Study||500
10778338|NCT03353246|11940273|FG000|NOT COMPLETED|Overall Study||0
10778339|NCT03353740|11940277|FG000|STARTED|Overall Study||346
10778340|NCT03353740|11940277|FG000|COMPLETED|Overall Study||294
10778341|NCT03353740|11940277|FG000|NOT COMPLETED|Overall Study||52
10778342|NCT03353753|11940283|FG000|STARTED|Overall Study||85
10778343|NCT03353753|11940284|FG001|STARTED|Overall Study|1 patient was randomized but not dosed|44
10778344|NCT03353753|11940283|FG000|COMPLETED|Overall Study||46
10778345|NCT03353753|11940284|FG001|COMPLETED|Overall Study||35
10778346|NCT03353753|11940283|FG000|NOT COMPLETED|Overall Study||39
10778347|NCT03353753|11940284|FG001|NOT COMPLETED|Overall Study||9
10778348|NCT03354325|11940292|FG000|STARTED|Overall Study||151
10778349|NCT03354325|11940293|FG001|STARTED|Overall Study||153
10778350|NCT03354325|11940292|FG000|COMPLETED|Overall Study||131
10778351|NCT03354325|11940293|FG001|COMPLETED|Overall Study||138
10778352|NCT03354325|11940292|FG000|NOT COMPLETED|Overall Study||20
10778353|NCT03354325|11940293|FG001|NOT COMPLETED|Overall Study||15
10778354|NCT03354429|11940301|FG000|STARTED|Overall Study||5523
10778355|NCT03354429|11940302|FG001|STARTED|Overall Study||5493
10778356|NCT03354429|11940301|FG000|COMPLETED|Overall Study||5514
10778357|NCT03354429|11940302|FG001|COMPLETED|Overall Study||5486
10778358|NCT03354429|11940301|FG000|NOT COMPLETED|Overall Study||9
10778359|NCT03354429|11940302|FG001|NOT COMPLETED|Overall Study||7
10778360|NCT03354598|11940310|FG000|STARTED|Overall Study||835
10778361|NCT03354598|11940311|FG001|STARTED|Overall Study||836
10778362|NCT03354598|11940310|FG000|Microbiologic Modified Intent to Treat Resistant (Micro-MITTR) Participants|Overall Study||147
10778363|NCT03354598|11940311|FG001|Microbiologic Modified Intent to Treat Resistant (Micro-MITTR) Participants|Overall Study||139
10778364|NCT03354598|11940310|FG000|Microbiologic Modified Intent to Treat Susceptible (Micro-MITTS) Participants|Overall Study||370
10778365|NCT03354598|11940311|FG001|Microbiologic Modified Intent to Treat Susceptible (Micro-MITTS) Participants|Overall Study||415
10778366|NCT03354598|11940310|FG000|Microbiologic Modified Intent to Treat (Micro-MITT) Participants|Overall Study||517
10778367|NCT03354598|11940311|FG001|Microbiologic Modified Intent to Treat (Micro-MITT) Participants|Overall Study||554
10778368|NCT03354598|11940310|FG000|Modified Intent to Treat (MITT) Participants|Overall Study||785
10778369|NCT03354598|11940311|FG001|Modified Intent to Treat (MITT) Participants|Overall Study||794
10778370|NCT03354598|11940310|FG000|Intent to Treat (ITT) Participants|Overall Study||787
10778371|NCT03354598|11940311|FG001|Intent to Treat (ITT) Participants|Overall Study||803
10778372|NCT03354598|11940310|FG000|Safety Participants|Overall Study||833
10778373|NCT03354598|11940311|FG001|Safety Participants|Overall Study||827
10778374|NCT03354598|11940310|FG000|COMPLETED|Overall Study||755
10778375|NCT03354598|11940311|FG001|COMPLETED|Overall Study||761
10778376|NCT03354598|11940310|FG000|NOT COMPLETED|Overall Study||80
10778377|NCT03354598|11940311|FG001|NOT COMPLETED|Overall Study||75
10778378|NCT03354637|11940320|FG000|STARTED|Double-blind Period||43
10778379|NCT03354637|11940321|FG001|STARTED|Double-blind Period||44
10778380|NCT03354637|11940322|FG002|STARTED|Double-blind Period||42
10778381|NCT03354637|11940320|FG000|COMPLETED|Double-blind Period||26
10778382|NCT03354637|11940321|FG001|COMPLETED|Double-blind Period||31
10778383|NCT03354637|11940322|FG002|COMPLETED|Double-blind Period||35
10778384|NCT03354637|11940320|FG000|NOT COMPLETED|Double-blind Period||17
10778385|NCT03354637|11940321|FG001|NOT COMPLETED|Double-blind Period||13
10778386|NCT03354637|11940322|FG002|NOT COMPLETED|Double-blind Period||7
10778387|NCT03354637|11940320|FG000|STARTED|Open Label Extension||0
10778388|NCT03354637|11940321|FG001|STARTED|Open Label Extension||0
10778389|NCT03354637|11940322|FG002|STARTED|Open Label Extension||61
10778390|NCT03354637|11940320|FG000|COMPLETED|Open Label Extension||0
10778391|NCT03354637|11940321|FG001|COMPLETED|Open Label Extension||0
10744406|NCT02951156|11908361|FG000|STARTED|Overall Study||9
10744407|NCT02951156|11908362|FG001|STARTED|Overall Study||9
10744408|NCT02951156|11908363|FG002|STARTED|Overall Study||11
10744409|NCT02951156|11908361|FG000|COMPLETED|Overall Study||0
10744410|NCT02951156|11908362|FG001|COMPLETED|Overall Study||0
10744411|NCT02951156|11908363|FG002|COMPLETED|Overall Study||1
10744412|NCT02951156|11908361|FG000|NOT COMPLETED|Overall Study||9
10744413|NCT02951156|11908362|FG001|NOT COMPLETED|Overall Study||9
10744414|NCT02951156|11908363|FG002|NOT COMPLETED|Overall Study||10
10744415|NCT02951182|11908378|FG000|STARTED|Overall Study||11
10744416|NCT02951182|11908379|FG001|STARTED|Overall Study||9
10744417|NCT02951182|11908380|FG002|STARTED|Overall Study||9
10744418|NCT02951182|11908381|FG003|STARTED|Overall Study||18
10744419|NCT02951182|11908382|FG004|STARTED|Overall Study||6
10744420|NCT02951182|11908383|FG005|STARTED|Overall Study||20
10744421|NCT02951182|11908378|FG000|COMPLETED|Overall Study||11
10744422|NCT02951182|11908379|FG001|COMPLETED|Overall Study||9
10744423|NCT02951182|11908380|FG002|COMPLETED|Overall Study||9
10744424|NCT02951182|11908381|FG003|COMPLETED|Overall Study||18
10744425|NCT02951182|11908382|FG004|COMPLETED|Overall Study||6
10744426|NCT02951182|11908383|FG005|COMPLETED|Overall Study||20
10744427|NCT02951182|11908378|FG000|NOT COMPLETED|Overall Study||0
10744428|NCT02951182|11908379|FG001|NOT COMPLETED|Overall Study||0
10744429|NCT02951182|11908380|FG002|NOT COMPLETED|Overall Study||0
10744430|NCT02951182|11908381|FG003|NOT COMPLETED|Overall Study||0
10744431|NCT02951182|11908382|FG004|NOT COMPLETED|Overall Study||0
10744432|NCT02951182|11908383|FG005|NOT COMPLETED|Overall Study||0
10744433|NCT02951195|11908411|FG000|STARTED|Overall Study||8
10744434|NCT02951195|11908412|FG001|STARTED|Overall Study||6
10744435|NCT02951195|11908413|FG002|STARTED|Overall Study||10
10744436|NCT02951195|11908414|FG003|STARTED|Overall Study||10
10744437|NCT02951195|11908415|FG004|STARTED|Overall Study||4
10744438|NCT02951195|11908416|FG005|STARTED|Overall Study||10
10744439|NCT02951195|11908417|FG006|STARTED|Overall Study||7
10744440|NCT02951195|11908418|FG007|STARTED|Overall Study||21
10744441|NCT02951195|11908411|FG000|COMPLETED|Overall Study||8
10744442|NCT02951195|11908412|FG001|COMPLETED|Overall Study||6
10744443|NCT02951195|11908413|FG002|COMPLETED|Overall Study||10
10744444|NCT02951195|11908414|FG003|COMPLETED|Overall Study||10
10744445|NCT02951195|11908415|FG004|COMPLETED|Overall Study||4
10744446|NCT02951195|11908416|FG005|COMPLETED|Overall Study||10
10744447|NCT02951195|11908417|FG006|COMPLETED|Overall Study||7
10744448|NCT02951195|11908418|FG007|COMPLETED|Overall Study||21
10744449|NCT02951195|11908411|FG000|NOT COMPLETED|Overall Study||0
10744450|NCT02951195|11908412|FG001|NOT COMPLETED|Overall Study||0
10744451|NCT02951195|11908413|FG002|NOT COMPLETED|Overall Study||0
10744452|NCT02951195|11908414|FG003|NOT COMPLETED|Overall Study||0
10744453|NCT02951195|11908415|FG004|NOT COMPLETED|Overall Study||0
10744454|NCT02951195|11908416|FG005|NOT COMPLETED|Overall Study||0
10744455|NCT02951195|11908417|FG006|NOT COMPLETED|Overall Study||0
10744456|NCT02951195|11908418|FG007|NOT COMPLETED|Overall Study||0
10744457|NCT02951273|11908446|FG000|STARTED|Overall Study||30
10744458|NCT02951273|11908446|FG000|COMPLETED|Overall Study||27
10744459|NCT02951273|11908446|FG000|NOT COMPLETED|Overall Study||3
10744460|NCT02951312|11908454|FG000|STARTED|Study Part 1||6
10744461|NCT02951312|11908455|FG001|STARTED|Study Part 1||6
10744462|NCT02951312|11908456|FG002|STARTED|Study Part 1||0
10744463|NCT02951312|11908457|FG003|STARTED|Study Part 1||0
10744464|NCT02951312|11908454|FG000|COMPLETED|Study Part 1||6
10744465|NCT02951312|11908455|FG001|COMPLETED|Study Part 1||6
10744466|NCT02951312|11908456|FG002|COMPLETED|Study Part 1||0
10744467|NCT02951312|11908457|FG003|COMPLETED|Study Part 1||0
10744468|NCT02951312|11908454|FG000|NOT COMPLETED|Study Part 1||0
10744469|NCT02951312|11908455|FG001|NOT COMPLETED|Study Part 1||0
10744470|NCT02951312|11908456|FG002|NOT COMPLETED|Study Part 1||0
10744471|NCT02951312|11908457|FG003|NOT COMPLETED|Study Part 1||0
10744472|NCT02951312|11908454|FG000|STARTED|Study Part 2||0
10744473|NCT02951312|11908455|FG001|STARTED|Study Part 2||0
10744474|NCT02951312|11908456|FG002|STARTED|Study Part 2||6
10744475|NCT02951312|11908457|FG003|STARTED|Study Part 2||6
10744476|NCT02951312|11908454|FG000|COMPLETED|Study Part 2||0
10744477|NCT02951312|11908455|FG001|COMPLETED|Study Part 2||0
10744478|NCT02951312|11908456|FG002|COMPLETED|Study Part 2||6
10744479|NCT02951312|11908457|FG003|COMPLETED|Study Part 2||6
10744480|NCT02951312|11908454|FG000|NOT COMPLETED|Study Part 2||0
10744481|NCT02951312|11908455|FG001|NOT COMPLETED|Study Part 2||0
10744482|NCT02951312|11908456|FG002|NOT COMPLETED|Study Part 2||0
10744483|NCT02951312|11908457|FG003|NOT COMPLETED|Study Part 2||0
10744484|NCT02951351|11908479|FG000|STARTED|Overall Study||19
10744485|NCT02951351|11908480|FG001|STARTED|Overall Study||17
10744486|NCT02951351|11908479|FG000|COMPLETED|Overall Study||19
10744487|NCT02951351|11908480|FG001|COMPLETED|Overall Study||17
10744488|NCT02951351|11908479|FG000|NOT COMPLETED|Overall Study||0
10744489|NCT02951351|11908480|FG001|NOT COMPLETED|Overall Study||0
10744490|NCT02951429|11908488|FG000|STARTED|Overall Study||88
10744491|NCT02951429|11908489|FG001|STARTED|Overall Study||89
10744492|NCT02951429|11908488|FG000|COMPLETED|Overall Study||16
10744493|NCT02951429|11908489|FG001|COMPLETED|Overall Study||6
10744494|NCT02951429|11908488|FG000|NOT COMPLETED|Overall Study||72
10744495|NCT02951429|11908489|FG001|NOT COMPLETED|Overall Study||83
10744496|NCT02951533|11908497|FG000|STARTED|Part I (Week 0 Through Week 24)||60
10744497|NCT02951533|11908498|FG001|STARTED|Part I (Week 0 Through Week 24)||59
10744498|NCT02951533|11908499|FG002|STARTED|Part I (Week 0 Through Week 24)||0
10744499|NCT02951533|11908497|FG000|Treated|Part I (Week 0 Through Week 24)||60
10744500|NCT02951533|11908498|FG001|Treated|Part I (Week 0 Through Week 24)||58
10744501|NCT02951533|11908499|FG002|Treated|Part I (Week 0 Through Week 24)||0
10744502|NCT02951533|11908497|FG000|COMPLETED|Part I (Week 0 Through Week 24)||56
10744503|NCT02951533|11908498|FG001|COMPLETED|Part I (Week 0 Through Week 24)||36
10744504|NCT02951533|11908499|FG002|COMPLETED|Part I (Week 0 Through Week 24)||0
10744505|NCT02951533|11908497|FG000|NOT COMPLETED|Part I (Week 0 Through Week 24)||4
10744506|NCT02951533|11908498|FG001|NOT COMPLETED|Part I (Week 0 Through Week 24)||23
10744507|NCT02951533|11908499|FG002|NOT COMPLETED|Part I (Week 0 Through Week 24)||0
10744508|NCT02951533|11908497|FG000|STARTED|Part IIa (Week 24 Through Week 32)||56
10744509|NCT02951533|11908498|FG001|STARTED|Part IIa (Week 24 Through Week 32)|1 participant did not sign informed consent form (ICF) for Study Part II but completed Study Part I.|35
10744510|NCT02951533|11908499|FG002|STARTED|Part IIa (Week 24 Through Week 32)||0
10744511|NCT02951533|11908497|FG000|PASI 75 Responder at Week 32|Part IIa (Week 24 Through Week 32)||54
10744512|NCT02951533|11908498|FG001|PASI 75 Responder at Week 32|Part IIa (Week 24 Through Week 32)||14
10744513|NCT02951533|11908499|FG002|PASI 75 Responder at Week 32|Part IIa (Week 24 Through Week 32)||0
10744514|NCT02951533|11908497|FG000|PASI 75 Non-responder at Week 32|Part IIa (Week 24 Through Week 32)||1
10544630|NCT01490632|11697646|FG009|NOT COMPLETED|Part D: Re-Treatment Period||0
10744515|NCT02951533|11908498|FG001|PASI 75 Non-responder at Week 32|Part IIa (Week 24 Through Week 32)||20
10744516|NCT02951533|11908499|FG002|PASI 75 Non-responder at Week 32|Part IIa (Week 24 Through Week 32)||0
10744517|NCT02951533|11908497|FG000|COMPLETED|Part IIa (Week 24 Through Week 32)||55
10744518|NCT02951533|11908498|FG001|COMPLETED|Part IIa (Week 24 Through Week 32)||34
10744519|NCT02951533|11908499|FG002|COMPLETED|Part IIa (Week 24 Through Week 32)||0
10744520|NCT02951533|11908497|FG000|NOT COMPLETED|Part IIa (Week 24 Through Week 32)||1
10744521|NCT02951533|11908498|FG001|NOT COMPLETED|Part IIa (Week 24 Through Week 32)||1
10744522|NCT02951533|11908499|FG002|NOT COMPLETED|Part IIa (Week 24 Through Week 32)||0
10744523|NCT02951533|11908497|FG000|STARTED|Part IIb (Week 32 Through Week 56)||55
10744524|NCT02951533|11908498|FG001|STARTED|Part IIb (Week 32 Through Week 56)|Out of 34 participants in the FAE group, 14 PASI 75 responders remained on FAE treatment.|14
10744525|NCT02951533|11908499|FG002|STARTED|Part IIb (Week 32 Through Week 56)|Out of 34 participants in FAE group, 20 PASI 75 non-responders switched to GUS group.|20
10744526|NCT02951533|11908497|FG000|COMPLETED|Part IIb (Week 32 Through Week 56)||54
10744527|NCT02951533|11908498|FG001|COMPLETED|Part IIb (Week 32 Through Week 56)||10
10744528|NCT02951533|11908499|FG002|COMPLETED|Part IIb (Week 32 Through Week 56)||20
10744529|NCT02951533|11908497|FG000|NOT COMPLETED|Part IIb (Week 32 Through Week 56)||1
10744530|NCT02951533|11908498|FG001|NOT COMPLETED|Part IIb (Week 32 Through Week 56)||4
10744531|NCT02951533|11908499|FG002|NOT COMPLETED|Part IIb (Week 32 Through Week 56)||0
10744532|NCT02951533|11908497|FG000|STARTED|Part III (Week 64 Through Week 100)|18 participants were not eligible to enter Part III.|36
10778392|NCT03354637|11940322|FG002|COMPLETED|Open Label Extension||33
10817410|NCT01274559|11981189|FG001|STARTED|Overall Study||586
10817411|NCT01274559|11981188|FG000|Treated|Overall Study||572
10817412|NCT01274559|11981189|FG001|Treated|Overall Study||572
10817413|NCT01274559|11981188|FG000|COMPLETED|Overall Study||390
10817414|NCT01274559|11981189|FG001|COMPLETED|Overall Study||441
10817415|NCT01274559|11981188|FG000|NOT COMPLETED|Overall Study||197
10817416|NCT01274559|11981189|FG001|NOT COMPLETED|Overall Study||145
10817417|NCT01270581|11981197|FG000|STARTED|Overall Study||4
10817418|NCT01270581|11981198|FG001|STARTED|Overall Study||3
10817419|NCT01270581|11981197|FG000|COMPLETED|Overall Study||3
10817420|NCT01270581|11981198|FG001|COMPLETED|Overall Study||3
10817421|NCT01270581|11981197|FG000|NOT COMPLETED|Overall Study||1
10817422|NCT01270581|11981198|FG001|NOT COMPLETED|Overall Study||0
10817423|NCT01269749|11981206|FG000|STARTED|Overall Study||16
10817424|NCT01269749|11981207|FG001|STARTED|Overall Study||3
10817425|NCT01269749|11981206|FG000|COMPLETED|Overall Study||16
10817426|NCT01269749|11981207|FG001|COMPLETED|Overall Study||3
10817427|NCT01269749|11981206|FG000|NOT COMPLETED|Overall Study||0
10817428|NCT01269749|11981207|FG001|NOT COMPLETED|Overall Study||0
10817429|NCT01270919|11981213|FG000|STARTED|Overall Study|One participant was enrolled but was censored.|0
10817430|NCT01270919|11981213|FG000|COMPLETED|Overall Study||0
10817431|NCT01270919|11981213|FG000|NOT COMPLETED|Overall Study||0
10817432|NCT01262339|11981217|FG000|STARTED|Overall Study||2
10817433|NCT01262339|11981217|FG000|COMPLETED|Overall Study||2
10817434|NCT01262339|11981217|FG000|NOT COMPLETED|Overall Study||0
10817435|NCT01267825|11981223|FG000|STARTED|Overall Study||1
10817436|NCT01267825|11981224|FG001|STARTED|Overall Study||0
10817437|NCT01267825|11981223|FG000|COMPLETED|Overall Study||0
10817438|NCT01267825|11981224|FG001|COMPLETED|Overall Study||0
10817439|NCT01267825|11981223|FG000|NOT COMPLETED|Overall Study||1
10817440|NCT01267825|11981224|FG001|NOT COMPLETED|Overall Study||0
10817441|NCT01259284|11981233|FG000|STARTED|Overall Study||2
10817442|NCT01259284|11981234|FG001|STARTED|Overall Study||0
10817443|NCT01259284|11981235|FG002|STARTED|Overall Study||0
10817444|NCT01259284|11981233|FG000|COMPLETED|Overall Study||0
10817445|NCT01259284|11981234|FG001|COMPLETED|Overall Study||0
10817446|NCT01259284|11981235|FG002|COMPLETED|Overall Study||0
10817447|NCT01259284|11981233|FG000|NOT COMPLETED|Overall Study||2
10817448|NCT01259284|11981234|FG001|NOT COMPLETED|Overall Study||0
10817449|NCT01259284|11981235|FG002|NOT COMPLETED|Overall Study||0
10744533|NCT02951533|11908498|FG001|STARTED|Part III (Week 64 Through Week 100)|10 participants in the FAE group were not eligible to enter Part III.|0
10744534|NCT02951533|11908499|FG002|STARTED|Part III (Week 64 Through Week 100)|8 participants were not eligible to enter Part III.|12
10744535|NCT02951533|11908497|FG000|COMPLETED|Part III (Week 64 Through Week 100)||32
10744536|NCT02951533|11908498|FG001|COMPLETED|Part III (Week 64 Through Week 100)||0
10744537|NCT02951533|11908499|FG002|COMPLETED|Part III (Week 64 Through Week 100)||10
10744538|NCT02951533|11908497|FG000|NOT COMPLETED|Part III (Week 64 Through Week 100)||4
10744539|NCT02951533|11908498|FG001|NOT COMPLETED|Part III (Week 64 Through Week 100)||0
10744540|NCT02951533|11908499|FG002|NOT COMPLETED|Part III (Week 64 Through Week 100)||2
10744541|NCT02951702|11908518|FG000|STARTED|Overall Study||34
10744542|NCT02951702|11908519|FG001|STARTED|Overall Study||17
10744543|NCT02951702|11908518|FG000|COMPLETED|Overall Study||34
10744544|NCT02951702|11908519|FG001|COMPLETED|Overall Study||17
10744545|NCT02951702|11908518|FG000|NOT COMPLETED|Overall Study||0
10744546|NCT02951702|11908519|FG001|NOT COMPLETED|Overall Study||0
10744547|NCT02951780|11908534|FG000|STARTED|Period 1||3
10744548|NCT02951780|11908535|FG001|STARTED|Period 1||2
10744549|NCT02951780|11908536|FG002|STARTED|Period 1||3
10744550|NCT02951780|11908537|FG003|STARTED|Period 1||3
10744551|NCT02951780|11908538|FG004|STARTED|Period 1||2
10744552|NCT02951780|11908539|FG005|STARTED|Period 1||3
10744553|NCT02951780|11908540|FG006|STARTED|Period 1||2
10744554|NCT02951780|11908541|FG007|STARTED|Period 1||3
10744555|NCT02951780|11908542|FG008|STARTED|Period 1||2
10744556|NCT02951780|11908534|FG000|COMPLETED|Period 1||3
10744557|NCT02951780|11908535|FG001|COMPLETED|Period 1||2
10544595|NCT01490632|11697651|FG014|STARTED|Part D: Re-Treatment Period|Responders receiving 8 or 10 mg were re-randomized to receive placebo.|0
10544596|NCT01490632|11697652|FG015|STARTED|Part D: Re-Treatment Period|Responders receiving 8 or 10 mg were re-randomized to receive 4 mg.|0
10544597|NCT01490632|11697653|FG016|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 2 mg.|3
10544598|NCT01490632|11697654|FG017|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 4 mg.|13
10544599|NCT01490632|11697655|FG018|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 8 mg.|19
10544600|NCT01490632|11697656|FG019|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 10 mg.|37
10544601|NCT01490632|11697637|FG000|COMPLETED|Part D: Re-Treatment Period||0
10544602|NCT01490632|11697638|FG001|COMPLETED|Part D: Re-Treatment Period||0
10544603|NCT01490632|11697639|FG002|COMPLETED|Part D: Re-Treatment Period||0
10544604|NCT01490632|11697640|FG003|COMPLETED|Part D: Re-Treatment Period||0
10544605|NCT01490632|11697641|FG004|COMPLETED|Part D: Re-Treatment Period||0
10744558|NCT02951780|11908536|FG002|COMPLETED|Period 1||3
10744559|NCT02951780|11908537|FG003|COMPLETED|Period 1||2
10817450|NCT01249157|11981243|FG000|STARTED|Overall Study||1
10817451|NCT01249157|11981243|FG000|COMPLETED|Overall Study|No data displayed because Outcome Measure has zero total participants analyzed.|0
10817452|NCT01249157|11981243|FG000|NOT COMPLETED|Overall Study||1
10817453|NCT01263028|11981247|FG000|STARTED|Overall Study||6
10817454|NCT01263028|11981247|FG000|COMPLETED|Overall Study||0
10817455|NCT01263028|11981247|FG000|NOT COMPLETED|Overall Study||6
10817456|NCT01256281|11981251|FG000|STARTED|Overall Study||2
10817457|NCT01256281|11981251|FG000|COMPLETED|Overall Study||2
10817458|NCT01256281|11981251|FG000|NOT COMPLETED|Overall Study||0
10817459|NCT01253668|11981255|FG000|STARTED|Overall Study||0
10817460|NCT01253668|11981255|FG000|COMPLETED|Overall Study||0
10817461|NCT01253668|11981255|FG000|NOT COMPLETED|Overall Study||0
10817462|NCT01259024|11981259|FG000|STARTED|Overall Study||1
10817463|NCT01259024|11981259|FG000|COMPLETED|Overall Study||0
10817464|NCT01259024|11981259|FG000|NOT COMPLETED|Overall Study||1
10817465|NCT01251952|11981263|FG000|STARTED|Overall Study||2
10817466|NCT01251952|11981263|FG000|COMPLETED|Overall Study||1
10817467|NCT01251952|11981263|FG000|NOT COMPLETED|Overall Study||1
10817468|NCT01251120|11981269|FG000|STARTED|Overall Study||1
10817469|NCT01251120|11981270|FG001|STARTED|Overall Study||1
10817470|NCT01251120|11981269|FG000|COMPLETED|Overall Study||1
10817471|NCT01251120|11981270|FG001|COMPLETED|Overall Study||0
10817472|NCT01251120|11981269|FG000|NOT COMPLETED|Overall Study||0
10817473|NCT01251120|11981270|FG001|NOT COMPLETED|Overall Study||1
10817474|NCT01248130|11981278|FG000|STARTED|Overall Study||3
10817475|NCT01248130|11981279|FG001|STARTED|Overall Study||4
10817476|NCT01248130|11981278|FG000|COMPLETED|Overall Study||1
10817477|NCT01248130|11981279|FG001|COMPLETED|Overall Study||4
10817478|NCT01248130|11981278|FG000|NOT COMPLETED|Overall Study||2
10817479|NCT01248130|11981279|FG001|NOT COMPLETED|Overall Study||0
10817480|NCT01243892|11981287|FG000|STARTED|Overall Study||15
10817481|NCT01243892|11981288|FG001|STARTED|Overall Study||3
10817482|NCT01243892|11981287|FG000|COMPLETED|Overall Study||13
10817483|NCT01243892|11981288|FG001|COMPLETED|Overall Study||3
10817484|NCT01243892|11981287|FG000|NOT COMPLETED|Overall Study||2
10817485|NCT01243892|11981288|FG001|NOT COMPLETED|Overall Study||0
10817486|NCT01246011|11981297|FG000|STARTED|Overall Study||0
10817487|NCT01246011|11981298|FG001|STARTED|Overall Study||0
10817488|NCT01246011|11981299|FG002|STARTED|Overall Study||9
10817489|NCT01246011|11981297|FG000|COMPLETED|Overall Study||0
10817490|NCT01246011|11981298|FG001|COMPLETED|Overall Study||0
10817491|NCT01246011|11981299|FG002|COMPLETED|Overall Study||5
10817492|NCT01246011|11981297|FG000|NOT COMPLETED|Overall Study||0
10817493|NCT01246011|11981298|FG001|NOT COMPLETED|Overall Study||0
10817494|NCT01246011|11981299|FG002|NOT COMPLETED|Overall Study||4
10544606|NCT01490632|11697642|FG005|COMPLETED|Part D: Re-Treatment Period||0
10544607|NCT01490632|11697643|FG006|COMPLETED|Part D: Re-Treatment Period||0
10544608|NCT01490632|11697644|FG007|COMPLETED|Part D: Re-Treatment Period||0
10544609|NCT01490632|11697645|FG008|COMPLETED|Part D: Re-Treatment Period||0
10544610|NCT01490632|11697646|FG009|COMPLETED|Part D: Re-Treatment Period||0
10544611|NCT01490632|11697647|FG010|COMPLETED|Part D: Re-Treatment Period||0
10544612|NCT01490632|11697648|FG011|COMPLETED|Part D: Re-Treatment Period||0
10544613|NCT01490632|11697649|FG012|COMPLETED|Part D: Re-Treatment Period||0
10544614|NCT01490632|11697650|FG013|COMPLETED|Part D: Re-Treatment Period||0
10544615|NCT01490632|11697651|FG014|COMPLETED|Part D: Re-Treatment Period||0
10544616|NCT01490632|11697652|FG015|COMPLETED|Part D: Re-Treatment Period||0
10544617|NCT01490632|11697653|FG016|COMPLETED|Part D: Re-Treatment Period||3
10544618|NCT01490632|11697654|FG017|COMPLETED|Part D: Re-Treatment Period||8
10544619|NCT01490632|11697655|FG018|COMPLETED|Part D: Re-Treatment Period||12
10544620|NCT01490632|11697656|FG019|COMPLETED|Part D: Re-Treatment Period||30
10544621|NCT01490632|11697637|FG000|NOT COMPLETED|Part D: Re-Treatment Period||0
10544622|NCT01490632|11697638|FG001|NOT COMPLETED|Part D: Re-Treatment Period||0
10544623|NCT01490632|11697639|FG002|NOT COMPLETED|Part D: Re-Treatment Period||0
10544624|NCT01490632|11697640|FG003|NOT COMPLETED|Part D: Re-Treatment Period||0
10544625|NCT01490632|11697641|FG004|NOT COMPLETED|Part D: Re-Treatment Period||0
10544626|NCT01490632|11697642|FG005|NOT COMPLETED|Part D: Re-Treatment Period||0
10544627|NCT01490632|11697643|FG006|NOT COMPLETED|Part D: Re-Treatment Period||0
10544628|NCT01490632|11697644|FG007|NOT COMPLETED|Part D: Re-Treatment Period||0
10544629|NCT01490632|11697645|FG008|NOT COMPLETED|Part D: Re-Treatment Period||0
10544631|NCT01490632|11697647|FG010|NOT COMPLETED|Part D: Re-Treatment Period||0
10544632|NCT01490632|11697648|FG011|NOT COMPLETED|Part D: Re-Treatment Period||0
10544633|NCT01490632|11697649|FG012|NOT COMPLETED|Part D: Re-Treatment Period||0
10544634|NCT01490632|11697650|FG013|NOT COMPLETED|Part D: Re-Treatment Period||0
10544635|NCT01490632|11697651|FG014|NOT COMPLETED|Part D: Re-Treatment Period||0
10544636|NCT01490632|11697652|FG015|NOT COMPLETED|Part D: Re-Treatment Period||0
10544637|NCT01490632|11697653|FG016|NOT COMPLETED|Part D: Re-Treatment Period||0
10544638|NCT01490632|11697654|FG017|NOT COMPLETED|Part D: Re-Treatment Period||5
10544639|NCT01490632|11697655|FG018|NOT COMPLETED|Part D: Re-Treatment Period||7
10544640|NCT01490632|11697656|FG019|NOT COMPLETED|Part D: Re-Treatment Period||7
10544641|NCT01490684|11697699|FG000|STARTED|Overall Study||162
10544642|NCT01490684|11697699|FG000|COMPLETED|Overall Study||162
10544643|NCT01490684|11697699|FG000|NOT COMPLETED|Overall Study||0
10544644|NCT01490697|11697705|FG000|STARTED|Overall Study||16
10544645|NCT01490697|11697706|FG001|STARTED|Overall Study||18
10544646|NCT01490697|11697705|FG000|COMPLETED|Overall Study||15
10544647|NCT01490697|11697706|FG001|COMPLETED|Overall Study||16
10544648|NCT01490697|11697705|FG000|NOT COMPLETED|Overall Study||1
10544649|NCT01490697|11697706|FG001|NOT COMPLETED|Overall Study||2
10544650|NCT01490723|11697712|FG000|STARTED|Overall Study||20
10544651|NCT01490723|11697712|FG000|COMPLETED|Overall Study||20
10544652|NCT01490723|11697712|FG000|NOT COMPLETED|Overall Study||0
10544653|NCT01490788|11697716|FG000|STARTED|Overall Study||5
10544654|NCT01490788|11697717|FG001|STARTED|Overall Study||5
10544655|NCT01490788|11697718|FG002|STARTED|Overall Study||5
10544656|NCT01490788|11697719|FG003|STARTED|Overall Study||5
10544657|NCT01490788|11697720|FG004|STARTED|Overall Study||5
10544658|NCT01490788|11697721|FG005|STARTED|Overall Study||5
10544659|NCT01490788|11697716|FG000|COMPLETED|Overall Study||4
10544660|NCT01490788|11697717|FG001|COMPLETED|Overall Study||5
10544661|NCT01490788|11697718|FG002|COMPLETED|Overall Study||5
10544662|NCT01490788|11697719|FG003|COMPLETED|Overall Study||5
10544663|NCT01490788|11697720|FG004|COMPLETED|Overall Study||5
10544664|NCT01490788|11697721|FG005|COMPLETED|Overall Study||5
10544665|NCT01490788|11697716|FG000|NOT COMPLETED|Overall Study||1
10544666|NCT01490788|11697717|FG001|NOT COMPLETED|Overall Study||0
10544667|NCT01490788|11697718|FG002|NOT COMPLETED|Overall Study||0
10544668|NCT01490788|11697719|FG003|NOT COMPLETED|Overall Study||0
10544669|NCT01490788|11697720|FG004|NOT COMPLETED|Overall Study||0
10544670|NCT01490788|11697721|FG005|NOT COMPLETED|Overall Study||0
10544671|NCT01490814|11697731|FG000|STARTED|Overall Study|378 subjects randomized to Cryoballoon arm|378
10544672|NCT01490814|11697732|FG001|STARTED|Overall Study|384 subjects randomized to radiofrequency arm|384
10544673|NCT01490814|11697731|FG000|COMPLETED|Overall Study|374 received ablation|374
10544674|NCT01490814|11697732|FG001|COMPLETED|Overall Study|376 received ablation|376
10544675|NCT01490814|11697731|FG000|NOT COMPLETED|Overall Study||4
10544676|NCT01490814|11697732|FG001|NOT COMPLETED|Overall Study||8
10544677|NCT01490840|11697740|FG000|STARTED|Phase 1||94
10544678|NCT01490840|11697741|FG001|STARTED|Phase 1||84
10544679|NCT01490840|11697740|FG000|Modified Full Analysis Set|Phase 1||56
10661153|NCT02257372|11823019|FG000|STARTED|Overall Study||117
10661154|NCT02257372|11823020|FG001|STARTED|Overall Study||119
10661155|NCT02257372|11823019|FG000|COMPLETED|Overall Study||110
10661156|NCT02257372|11823020|FG001|COMPLETED|Overall Study||109
10661157|NCT02257372|11823019|FG000|NOT COMPLETED|Overall Study||7
10661158|NCT02257372|11823020|FG001|NOT COMPLETED|Overall Study||10
10661159|NCT02257385|11823028|FG000|STARTED|Overall Study||482
10661160|NCT02257385|11823029|FG001|STARTED|Overall Study||479
10661161|NCT02257385|11823028|FG000|COMPLETED|Overall Study||460
10661162|NCT02257385|11823029|FG001|COMPLETED|Overall Study||457
10661163|NCT02257385|11823028|FG000|NOT COMPLETED|Overall Study||22
10661164|NCT02257385|11823029|FG001|NOT COMPLETED|Overall Study||22
10544680|NCT01490840|11697741|FG001|Modified Full Analysis Set|Phase 1||83
10544681|NCT01490840|11697740|FG000|COMPLETED|Phase 1||84
10544682|NCT01490840|11697741|FG001|COMPLETED|Phase 1||78
10544683|NCT01490840|11697740|FG000|NOT COMPLETED|Phase 1||10
10544684|NCT01490840|11697741|FG001|NOT COMPLETED|Phase 1||6
10544685|NCT01490840|11697740|FG000|STARTED|Phase 2|3 participants discontinued between phase 1 and phase 2|81
10544686|NCT01490840|11697741|FG001|STARTED|Phase 2|4 participants discontinued between phase 1 and phase 2|74
10544687|NCT01490840|11697740|FG000|COMPLETED|Phase 2||75
10544688|NCT01490840|11697741|FG001|COMPLETED|Phase 2||68
10544689|NCT01490840|11697740|FG000|NOT COMPLETED|Phase 2||6
10544690|NCT01490840|11697741|FG001|NOT COMPLETED|Phase 2||6
10544691|NCT01490866|11697747|FG000|STARTED|FOLFOX/Bevacizumab Treatment||70
10544692|NCT01490866|11697747|FG000|COMPLETED|FOLFOX/Bevacizumab Treatment||49
10544693|NCT01490866|11697747|FG000|NOT COMPLETED|FOLFOX/Bevacizumab Treatment||21
10544694|NCT01490866|11697747|FG000|STARTED|Axitinib Maintenance Therapy||49
10544695|NCT01490866|11697747|FG000|COMPLETED|Axitinib Maintenance Therapy|No protocol defined endpoint to Axitinib maintenance treatment.|0
10544696|NCT01490866|11697747|FG000|NOT COMPLETED|Axitinib Maintenance Therapy||49
10544697|NCT01490892|11697754|FG000|STARTED|Overall Study||219
10544698|NCT01490892|11697754|FG000|COMPLETED|Overall Study||219
10544699|NCT01490892|11697754|FG000|NOT COMPLETED|Overall Study||0
10544700|NCT01490918|11697761|FG000|STARTED|Overall Study||65
10544701|NCT01490918|11697762|FG001|STARTED|Overall Study||66
10544702|NCT01490918|11697763|FG002|STARTED|Overall Study||34
10544703|NCT01490918|11697761|FG000|COMPLETED|Overall Study||52
10544704|NCT01490918|11697762|FG001|COMPLETED|Overall Study||52
10544705|NCT01490918|11697763|FG002|COMPLETED|Overall Study||22
10544706|NCT01490918|11697761|FG000|NOT COMPLETED|Overall Study||13
10544707|NCT01490918|11697762|FG001|NOT COMPLETED|Overall Study||14
10544708|NCT01490918|11697763|FG002|NOT COMPLETED|Overall Study||12
10544709|NCT01490931|11697775|FG000|STARTED|Overall Study||25
10544710|NCT01490931|11697775|FG000|COMPLETED|Overall Study||25
10544711|NCT01490931|11697775|FG000|NOT COMPLETED|Overall Study||0
10544712|NCT01491022|11697781|FG000|STARTED|Intervention 1||10
10544713|NCT01491022|11697782|FG001|STARTED|Intervention 1||12
10544714|NCT01491022|11697781|FG000|COMPLETED|Intervention 1||9
10544715|NCT01491022|11697782|FG001|COMPLETED|Intervention 1||11
10544716|NCT01491022|11697781|FG000|NOT COMPLETED|Intervention 1||1
10544717|NCT01491022|11697782|FG001|NOT COMPLETED|Intervention 1||1
10544718|NCT01491022|11697781|FG000|STARTED|2 Week Washout||9
10544719|NCT01491022|11697782|FG001|STARTED|2 Week Washout||11
10544720|NCT01491022|11697781|FG000|COMPLETED|2 Week Washout||9
10544721|NCT01491022|11697782|FG001|COMPLETED|2 Week Washout||11
10544722|NCT01491022|11697781|FG000|NOT COMPLETED|2 Week Washout||0
10544723|NCT01491022|11697782|FG001|NOT COMPLETED|2 Week Washout||0
10544724|NCT01491022|11697781|FG000|STARTED|Intervention 2||9
10544725|NCT01491022|11697782|FG001|STARTED|Intervention 2||11
10544726|NCT01491022|11697781|FG000|COMPLETED|Intervention 2||8
10544727|NCT01491022|11697782|FG001|COMPLETED|Intervention 2||11
10544728|NCT01491022|11697781|FG000|NOT COMPLETED|Intervention 2||1
10544729|NCT01491022|11697782|FG001|NOT COMPLETED|Intervention 2||0
10544730|NCT01491035|11697800|FG000|STARTED|Overall Study||6
10544731|NCT01491035|11697801|FG001|STARTED|Overall Study||6
10544732|NCT01491035|11697802|FG002|STARTED|Overall Study||6
10544733|NCT01491035|11697803|FG003|STARTED|Overall Study||6
10544734|NCT01491035|11697804|FG004|STARTED|Overall Study||6
10544735|NCT01491035|11697805|FG005|STARTED|Overall Study||6
10544736|NCT01491035|11697806|FG006|STARTED|Overall Study||6
10544737|NCT01491035|11697807|FG007|STARTED|Overall Study||6
10544738|NCT01491035|11697800|FG000|COMPLETED|Overall Study||6
10544739|NCT01491035|11697801|FG001|COMPLETED|Overall Study||6
10544740|NCT01491035|11697802|FG002|COMPLETED|Overall Study||6
10544741|NCT01491035|11697803|FG003|COMPLETED|Overall Study||6
10544742|NCT01491035|11697804|FG004|COMPLETED|Overall Study||5
10544743|NCT01491035|11697805|FG005|COMPLETED|Overall Study||6
10544744|NCT01491035|11697806|FG006|COMPLETED|Overall Study||6
10544745|NCT01491035|11697807|FG007|COMPLETED|Overall Study||6
10544746|NCT01491035|11697800|FG000|NOT COMPLETED|Overall Study||0
10544747|NCT01491035|11697801|FG001|NOT COMPLETED|Overall Study||0
10544748|NCT01491035|11697802|FG002|NOT COMPLETED|Overall Study||0
10544749|NCT01491035|11697803|FG003|NOT COMPLETED|Overall Study||0
10544750|NCT01491035|11697804|FG004|NOT COMPLETED|Overall Study||1
10544751|NCT01491035|11697805|FG005|NOT COMPLETED|Overall Study||0
10544752|NCT01491035|11697806|FG006|NOT COMPLETED|Overall Study||0
10544753|NCT01491035|11697807|FG007|NOT COMPLETED|Overall Study||0
10544754|NCT01491113|11697830|FG000|STARTED|Overall Study||6
10544755|NCT01491113|11697831|FG001|STARTED|Overall Study||6
10544756|NCT01491113|11697832|FG002|STARTED|Overall Study||6
10544757|NCT01491113|11697833|FG003|STARTED|Overall Study||6
10544758|NCT01491113|11697834|FG004|STARTED|Overall Study||6
10544759|NCT01491113|11697830|FG000|COMPLETED|Overall Study||6
10544760|NCT01491113|11697831|FG001|COMPLETED|Overall Study||6
10544761|NCT01491113|11697832|FG002|COMPLETED|Overall Study||6
10544762|NCT01491113|11697833|FG003|COMPLETED|Overall Study||6
10544763|NCT01491113|11697834|FG004|COMPLETED|Overall Study||6
10544764|NCT01491113|11697830|FG000|NOT COMPLETED|Overall Study||0
10544765|NCT01491113|11697831|FG001|NOT COMPLETED|Overall Study||0
10544766|NCT01491113|11697832|FG002|NOT COMPLETED|Overall Study||0
10544767|NCT01491113|11697833|FG003|NOT COMPLETED|Overall Study||0
10544768|NCT01491113|11697834|FG004|NOT COMPLETED|Overall Study||0
10544769|NCT01491178|11697848|FG000|STARTED|Overall Study|Started are the enrolled subjects who followed registration rule and for who eCRF was collected.|6443
10544770|NCT01491178|11697848|FG000|COMPLETED|Overall Study|Completed is defined as 104 weeks follow-up after enrollment.|3649
10544771|NCT01491178|11697848|FG000|NOT COMPLETED|Overall Study||2794
10544772|NCT01491490|11697854|FG000|STARTED|Overall Study||1
10544773|NCT01491490|11697855|FG001|STARTED|Overall Study||1
10544774|NCT01491490|11697854|FG000|COMPLETED|Overall Study||1
10544775|NCT01491490|11697855|FG001|COMPLETED|Overall Study||1
10544776|NCT01491490|11697854|FG000|NOT COMPLETED|Overall Study||0
10544777|NCT01491490|11697855|FG001|NOT COMPLETED|Overall Study||0
10544778|NCT01491607|11697865|FG000|STARTED|Overall Study||200
10544779|NCT01491607|11697865|FG000|COMPLETED|Overall Study||190
10544780|NCT01491607|11697865|FG000|NOT COMPLETED|Overall Study||10
10544781|NCT01491633|11697931|FG000|STARTED|Overall Study||5
10544782|NCT01491633|11697931|FG000|COMPLETED|Overall Study||0
10544783|NCT01491633|11697931|FG000|NOT COMPLETED|Overall Study||5
10548263|NCT01518699|11702085|FG000|NOT COMPLETED|Period 1||0
10548264|NCT01518699|11702086|FG001|NOT COMPLETED|Period 1||0
10548265|NCT01518699|11702087|FG002|NOT COMPLETED|Period 1||0
10548266|NCT01518699|11702088|FG003|NOT COMPLETED|Period 1||0
10548267|NCT01518699|11702089|FG004|NOT COMPLETED|Period 1||0
10548268|NCT01518699|11702090|FG005|NOT COMPLETED|Period 1||0
10548269|NCT01518699|11702085|FG000|STARTED|Period 2||10
10548270|NCT01518699|11702086|FG001|STARTED|Period 2||9
10548271|NCT01518699|11702087|FG002|STARTED|Period 2||9
10548272|NCT01518699|11702088|FG003|STARTED|Period 2||10
10548273|NCT01518699|11702089|FG004|STARTED|Period 2||10
10548274|NCT01518699|11702090|FG005|STARTED|Period 2||9
10548275|NCT01518699|11702085|FG000|COMPLETED|Period 2||8
10548276|NCT01518699|11702086|FG001|COMPLETED|Period 2||7
10548277|NCT01518699|11702087|FG002|COMPLETED|Period 2||9
10548278|NCT01518699|11702088|FG003|COMPLETED|Period 2||10
10548279|NCT01518699|11702089|FG004|COMPLETED|Period 2||10
10548280|NCT01518699|11702090|FG005|COMPLETED|Period 2||9
10548281|NCT01518699|11702085|FG000|NOT COMPLETED|Period 2||2
10548282|NCT01518699|11702086|FG001|NOT COMPLETED|Period 2||2
10548283|NCT01518699|11702087|FG002|NOT COMPLETED|Period 2||0
10548284|NCT01518699|11702088|FG003|NOT COMPLETED|Period 2||0
10548285|NCT01518699|11702089|FG004|NOT COMPLETED|Period 2||0
10744560|NCT02951780|11908538|FG004|COMPLETED|Period 1||2
10744561|NCT02951780|11908539|FG005|COMPLETED|Period 1||3
10744562|NCT02951780|11908540|FG006|COMPLETED|Period 1||2
10744563|NCT02951780|11908541|FG007|COMPLETED|Period 1||2
10744564|NCT02951780|11908542|FG008|COMPLETED|Period 1||2
10744565|NCT02951780|11908534|FG000|NOT COMPLETED|Period 1||0
10744566|NCT02951780|11908535|FG001|NOT COMPLETED|Period 1||0
10744567|NCT02951780|11908536|FG002|NOT COMPLETED|Period 1||0
10744568|NCT02951780|11908537|FG003|NOT COMPLETED|Period 1||1
10744569|NCT02951780|11908538|FG004|NOT COMPLETED|Period 1||0
10744570|NCT02951780|11908539|FG005|NOT COMPLETED|Period 1||0
10744571|NCT02951780|11908540|FG006|NOT COMPLETED|Period 1||0
10744572|NCT02951780|11908541|FG007|NOT COMPLETED|Period 1||1
10744573|NCT02951780|11908542|FG008|NOT COMPLETED|Period 1||0
10744574|NCT02951780|11908534|FG000|STARTED|Period 2||3
10744575|NCT02951780|11908535|FG001|STARTED|Period 2||2
10744576|NCT02951780|11908536|FG002|STARTED|Period 2||3
10744577|NCT02951780|11908537|FG003|STARTED|Period 2||2
10744578|NCT02951780|11908538|FG004|STARTED|Period 2||2
10744579|NCT02951780|11908539|FG005|STARTED|Period 2||3
10744580|NCT02951780|11908540|FG006|STARTED|Period 2||2
10744581|NCT02951780|11908541|FG007|STARTED|Period 2||2
10744582|NCT02951780|11908542|FG008|STARTED|Period 2||2
10744583|NCT02951780|11908534|FG000|COMPLETED|Period 2||3
10744584|NCT02951780|11908535|FG001|COMPLETED|Period 2||2
10744585|NCT02951780|11908536|FG002|COMPLETED|Period 2||3
10744586|NCT02951780|11908537|FG003|COMPLETED|Period 2||2
10744587|NCT02951780|11908538|FG004|COMPLETED|Period 2||2
10744588|NCT02951780|11908539|FG005|COMPLETED|Period 2||3
10744589|NCT02951780|11908540|FG006|COMPLETED|Period 2||2
10744590|NCT02951780|11908541|FG007|COMPLETED|Period 2||1
10744591|NCT02951780|11908542|FG008|COMPLETED|Period 2||2
10744592|NCT02951780|11908534|FG000|NOT COMPLETED|Period 2||0
10744593|NCT02951780|11908535|FG001|NOT COMPLETED|Period 2||0
10744594|NCT02951780|11908536|FG002|NOT COMPLETED|Period 2||0
10744595|NCT02951780|11908537|FG003|NOT COMPLETED|Period 2||0
10744596|NCT02951780|11908538|FG004|NOT COMPLETED|Period 2||0
10744597|NCT02951780|11908539|FG005|NOT COMPLETED|Period 2||0
10744598|NCT02951780|11908540|FG006|NOT COMPLETED|Period 2||0
10744599|NCT02951780|11908541|FG007|NOT COMPLETED|Period 2||1
10744600|NCT02951780|11908542|FG008|NOT COMPLETED|Period 2||0
10744601|NCT02951780|11908534|FG000|STARTED|Period 3||3
10744602|NCT02951780|11908535|FG001|STARTED|Period 3||2
10744603|NCT02951780|11908536|FG002|STARTED|Period 3||3
10744604|NCT02951780|11908537|FG003|STARTED|Period 3||2
10744605|NCT02951780|11908538|FG004|STARTED|Period 3||2
10744606|NCT02951780|11908539|FG005|STARTED|Period 3||3
10744607|NCT02951780|11908540|FG006|STARTED|Period 3||2
10548286|NCT01518699|11702090|FG005|NOT COMPLETED|Period 2||0
10548287|NCT01518699|11702085|FG000|STARTED|Period 3||8
10548288|NCT01518699|11702086|FG001|STARTED|Period 3||7
10548289|NCT01518699|11702087|FG002|STARTED|Period 3||9
10548290|NCT01518699|11702088|FG003|STARTED|Period 3||10
10548291|NCT01518699|11702089|FG004|STARTED|Period 3||10
10548292|NCT01518699|11702090|FG005|STARTED|Period 3||9
10548293|NCT01518699|11702085|FG000|COMPLETED|Period 3||8
10548294|NCT01518699|11702086|FG001|COMPLETED|Period 3||7
10744608|NCT02951780|11908541|FG007|STARTED|Period 3||1
10744609|NCT02951780|11908542|FG008|STARTED|Period 3||2
10744610|NCT02951780|11908534|FG000|COMPLETED|Period 3||3
10744611|NCT02951780|11908535|FG001|COMPLETED|Period 3||2
10744612|NCT02951780|11908536|FG002|COMPLETED|Period 3||3
10744613|NCT02951780|11908537|FG003|COMPLETED|Period 3||2
10744614|NCT02951780|11908538|FG004|COMPLETED|Period 3||2
10744615|NCT02951780|11908539|FG005|COMPLETED|Period 3||3
10744616|NCT02951780|11908540|FG006|COMPLETED|Period 3||2
10744617|NCT02951780|11908541|FG007|COMPLETED|Period 3||1
10744618|NCT02951780|11908542|FG008|COMPLETED|Period 3||2
10744619|NCT02951780|11908534|FG000|NOT COMPLETED|Period 3||0
10744620|NCT02951780|11908535|FG001|NOT COMPLETED|Period 3||0
10744621|NCT02951780|11908536|FG002|NOT COMPLETED|Period 3||0
10744622|NCT02951780|11908537|FG003|NOT COMPLETED|Period 3||0
10744623|NCT02951780|11908538|FG004|NOT COMPLETED|Period 3||0
10744624|NCT02951780|11908539|FG005|NOT COMPLETED|Period 3||0
10744625|NCT02951780|11908540|FG006|NOT COMPLETED|Period 3||0
10744626|NCT02951780|11908541|FG007|NOT COMPLETED|Period 3||0
10744627|NCT02951780|11908542|FG008|NOT COMPLETED|Period 3||0
10744628|NCT02951819|11908564|FG000|STARTED|Overall Study||87
10744629|NCT02951819|11908565|FG001|STARTED|Overall Study||14
10744630|NCT02951819|11908564|FG000|Treated|Overall Study||86
10744631|NCT02951819|11908565|FG001|Treated|Overall Study||14
10744632|NCT02951819|11908564|FG000|COMPLETED|Overall Study||59
10744633|NCT02951819|11908565|FG001|COMPLETED|Overall Study||7
10744634|NCT02951819|11908564|FG000|NOT COMPLETED|Overall Study||28
10744635|NCT02951819|11908565|FG001|NOT COMPLETED|Overall Study||7
10744636|NCT02951884|11908574|FG000|STARTED|Overall Study||0
10744637|NCT02951884|11908575|FG001|STARTED|Overall Study||1
10744638|NCT02951884|11908576|FG002|STARTED|Overall Study||1
10744639|NCT02951884|11908574|FG000|COMPLETED|Overall Study||0
10744640|NCT02951884|11908575|FG001|COMPLETED|Overall Study||1
10744641|NCT02951884|11908576|FG002|COMPLETED|Overall Study||1
10744642|NCT02951884|11908574|FG000|NOT COMPLETED|Overall Study||0
10744643|NCT02951884|11908575|FG001|NOT COMPLETED|Overall Study||0
10744644|NCT02951884|11908576|FG002|NOT COMPLETED|Overall Study||0
10744645|NCT02951988|11908587|FG000|STARTED|Open-Label Treatment Period||1304
10744646|NCT02951988|11908588|FG001|STARTED|Open-Label Treatment Period||0
10744647|NCT02951988|11908589|FG002|STARTED|Open-Label Treatment Period||0
10744648|NCT02951988|11908590|FG003|STARTED|Open-Label Treatment Period||0
10744649|NCT02951988|11908587|FG000|COMPLETED|Open-Label Treatment Period||1056
10744650|NCT02951988|11908588|FG001|COMPLETED|Open-Label Treatment Period||0
10744651|NCT02951988|11908589|FG002|COMPLETED|Open-Label Treatment Period||0
10744652|NCT02951988|11908590|FG003|COMPLETED|Open-Label Treatment Period||0
10744653|NCT02951988|11908587|FG000|NOT COMPLETED|Open-Label Treatment Period||248
10744654|NCT02951988|11908588|FG001|NOT COMPLETED|Open-Label Treatment Period||0
10744655|NCT02951988|11908589|FG002|NOT COMPLETED|Open-Label Treatment Period||0
10744656|NCT02951988|11908590|FG003|NOT COMPLETED|Open-Label Treatment Period||0
10744657|NCT02951988|11908587|FG000|STARTED|Double-Blind Treatment Period||0
10744658|NCT02951988|11908588|FG001|STARTED|Double-Blind Treatment Period||202
10744659|NCT02951988|11908589|FG002|STARTED|Double-Blind Treatment Period||202
10744660|NCT02951988|11908590|FG003|STARTED|Double-Blind Treatment Period||200
10744661|NCT02951988|11908587|FG000|COMPLETED|Double-Blind Treatment Period||0
10744662|NCT02951988|11908588|FG001|COMPLETED|Double-Blind Treatment Period||101
10744663|NCT02951988|11908589|FG002|COMPLETED|Double-Blind Treatment Period||101
10744664|NCT02951988|11908590|FG003|COMPLETED|Double-Blind Treatment Period||85
10744665|NCT02951988|11908587|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
10744666|NCT02951988|11908588|FG001|NOT COMPLETED|Double-Blind Treatment Period||101
10744667|NCT02951988|11908589|FG002|NOT COMPLETED|Double-Blind Treatment Period||101
10744668|NCT02951988|11908590|FG003|NOT COMPLETED|Double-Blind Treatment Period||115
10744669|NCT02952001|11908602|FG000|STARTED|Overall Study||28
10744670|NCT02952001|11908603|FG001|STARTED|Overall Study||5
10744671|NCT02952001|11908602|FG000|COMPLETED|Overall Study||14
10744672|NCT02952001|11908603|FG001|COMPLETED|Overall Study||2
10744673|NCT02952001|11908602|FG000|NOT COMPLETED|Overall Study||14
10744674|NCT02952001|11908603|FG001|NOT COMPLETED|Overall Study||3
10744675|NCT02952261|11908612|FG000|STARTED|Overall Study||100
10744676|NCT02952261|11908613|FG001|STARTED|Overall Study||100
10744677|NCT02952261|11908612|FG000|COMPLETED|Overall Study||95
10744678|NCT02952261|11908613|FG001|COMPLETED|Overall Study||95
10744679|NCT02952261|11908612|FG000|NOT COMPLETED|Overall Study||5
10744680|NCT02952261|11908613|FG001|NOT COMPLETED|Overall Study||5
10744681|NCT02952313|11908619|FG000|STARTED|Primary Endpoint||113
10744682|NCT02952313|11908619|FG000|6 Months|Primary Endpoint||106
10744683|NCT02952313|11908619|FG000|COMPLETED|Primary Endpoint||106
10744684|NCT02952313|11908619|FG000|NOT COMPLETED|Primary Endpoint||7
10744685|NCT02952313|11908619|FG000|STARTED|Long-term Follow-up||107
10744686|NCT02952313|11908619|FG000|12-Month|Long-term Follow-up||93
10744687|NCT02952313|11908619|FG000|18-Month|Long-term Follow-up||79
10744688|NCT02952313|11908619|FG000|COMPLETED|Long-term Follow-up||75
10744689|NCT02952313|11908619|FG000|NOT COMPLETED|Long-term Follow-up||32
10744690|NCT02952586|11908626|FG000|STARTED|Lead-In Phase (7 Days)||350
10744691|NCT02952586|11908627|FG001|STARTED|Lead-In Phase (7 Days)||347
10744692|NCT02952586|11908626|FG000|Safety Analysis Set|Lead-In Phase (7 Days)||348
10744693|NCT02952586|11908627|FG001|Safety Analysis Set|Lead-In Phase (7 Days)||344
10744694|NCT02952586|11908626|FG000|COMPLETED|Lead-In Phase (7 Days)||345
10744695|NCT02952586|11908627|FG001|COMPLETED|Lead-In Phase (7 Days)||343
10744696|NCT02952586|11908626|FG000|NOT COMPLETED|Lead-In Phase (7 Days)||5
10744697|NCT02952586|11908627|FG001|NOT COMPLETED|Lead-In Phase (7 Days)||4
10744698|NCT02952586|11908626|FG000|STARTED|CRT for Avelumab or Placebo (63 Days)||345
10778393|NCT03354637|11940320|FG000|NOT COMPLETED|Open Label Extension||0
10744699|NCT02952586|11908627|FG001|STARTED|CRT for Avelumab or Placebo (63 Days)|All participants who did not withdraw from study after Lead-In phase, entered into CRT phase.|340
10744700|NCT02952586|11908626|FG000|COMPLETED|CRT for Avelumab or Placebo (63 Days)||312
10744701|NCT02952586|11908627|FG001|COMPLETED|CRT for Avelumab or Placebo (63 Days)||313
10744702|NCT02952586|11908626|FG000|NOT COMPLETED|CRT for Avelumab or Placebo (63 Days)||33
10744703|NCT02952586|11908627|FG001|NOT COMPLETED|CRT for Avelumab or Placebo (63 Days)||27
10744704|NCT02952586|11908626|FG000|STARTED|CRT for Cisplatin (63 Days)|Avelumab, Cisplatin, and IMRT were treatments in CRT phase.|345
10744705|NCT02952586|11908627|FG001|STARTED|CRT for Cisplatin (63 Days)|Placebo, Cisplatin, and IMRT were treatments in CRT phase.|340
10744706|NCT02952586|11908626|FG000|COMPLETED|CRT for Cisplatin (63 Days)||234
10744707|NCT02952586|11908627|FG001|COMPLETED|CRT for Cisplatin (63 Days)||236
10744708|NCT02952586|11908626|FG000|NOT COMPLETED|CRT for Cisplatin (63 Days)||111
10744709|NCT02952586|11908627|FG001|NOT COMPLETED|CRT for Cisplatin (63 Days)||104
10744710|NCT02952586|11908626|FG000|STARTED|CRT for IMRT (63 Days)|Avelumab, Cisplatin, and IMRT were treatments in CRT phase.|345
10744711|NCT02952586|11908627|FG001|STARTED|CRT for IMRT (63 Days)|Placebo, Cisplatin, and IMRT were treatments in CRT phase.|340
10744712|NCT02952586|11908626|FG000|COMPLETED|CRT for IMRT (63 Days)||322
10744713|NCT02952586|11908627|FG001|COMPLETED|CRT for IMRT (63 Days)||320
10744714|NCT02952586|11908626|FG000|NOT COMPLETED|CRT for IMRT (63 Days)||23
10744715|NCT02952586|11908627|FG001|NOT COMPLETED|CRT for IMRT (63 Days)||20
10744716|NCT02952586|11908626|FG000|STARTED|Maintenance Phase (12 Months)|All participants who did not withdraw from study after CRT phases, entered into maintenance phase.|291
10744717|NCT02952586|11908627|FG001|STARTED|Maintenance Phase (12 Months)|All participants who did not withdraw from study after CRT phases, entered into maintenance phase.|304
10744718|NCT02952586|11908626|FG000|COMPLETED|Maintenance Phase (12 Months)||139
10744719|NCT02952586|11908627|FG001|COMPLETED|Maintenance Phase (12 Months)||177
10744720|NCT02952586|11908626|FG000|NOT COMPLETED|Maintenance Phase (12 Months)||152
10744721|NCT02952586|11908627|FG001|NOT COMPLETED|Maintenance Phase (12 Months)||127
10744722|NCT02952586|11908626|FG000|STARTED|Follow-Up Phase (90 Days)|Participants who did not withdraw study after previous phases, entered in short-term follow up phase.|266
10744723|NCT02952586|11908627|FG001|STARTED|Follow-Up Phase (90 Days)|Participants who did not withdraw study after previous phases, entered in short-term follow up phase.|284
10744724|NCT02952586|11908626|FG000|COMPLETED|Follow-Up Phase (90 Days)||208
10744725|NCT02952586|11908627|FG001|COMPLETED|Follow-Up Phase (90 Days)||216
10744726|NCT02952586|11908626|FG000|NOT COMPLETED|Follow-Up Phase (90 Days)||58
10744727|NCT02952586|11908627|FG001|NOT COMPLETED|Follow-Up Phase (90 Days)||68
10744728|NCT02952586|11908626|FG000|STARTED|LT Follow-up (up to 45 Months)|Participants who did not withdraw study after previous phases, entered in long-term follow up phase.|247
10744729|NCT02952586|11908627|FG001|STARTED|LT Follow-up (up to 45 Months)|Participants who did not withdraw study after previous phases, entered in long-term follow up phase.|237
10744730|NCT02952586|11908626|FG000|COMPLETED|LT Follow-up (up to 45 Months)||0
10744731|NCT02952586|11908627|FG001|COMPLETED|LT Follow-up (up to 45 Months)||0
10744732|NCT02952586|11908626|FG000|NOT COMPLETED|LT Follow-up (up to 45 Months)||247
10744733|NCT02952586|11908627|FG001|NOT COMPLETED|LT Follow-up (up to 45 Months)||237
10744734|NCT02952820|11908637|FG000|STARTED|Placebo-Controlled Treatment (6 Months)||325
10744735|NCT02952820|11908638|FG001|STARTED|Placebo-Controlled Treatment (6 Months)||323
10744736|NCT02952820|11908639|FG002|STARTED|Placebo-Controlled Treatment (6 Months)||323
10744737|NCT02952820|11908637|FG000|Treated|Placebo-Controlled Treatment (6 Months)||321
10744738|NCT02952820|11908638|FG001|Treated|Placebo-Controlled Treatment (6 Months)||319
10744739|NCT02952820|11908639|FG002|Treated|Placebo-Controlled Treatment (6 Months)||319
10744740|NCT02952820|11908637|FG000|Safety Analysis Set|Placebo-Controlled Treatment (6 Months)||319
10744741|NCT02952820|11908638|FG001|Safety Analysis Set|Placebo-Controlled Treatment (6 Months)||314
10744742|NCT02952820|11908639|FG002|Safety Analysis Set|Placebo-Controlled Treatment (6 Months)||314
10744743|NCT02952820|11908637|FG000|COMPLETED|Placebo-Controlled Treatment (6 Months)||261
10744744|NCT02952820|11908638|FG001|COMPLETED|Placebo-Controlled Treatment (6 Months)||254
10744745|NCT02952820|11908639|FG002|COMPLETED|Placebo-Controlled Treatment (6 Months)||235
10744746|NCT02952820|11908637|FG000|NOT COMPLETED|Placebo-Controlled Treatment (6 Months)||64
10744747|NCT02952820|11908638|FG001|NOT COMPLETED|Placebo-Controlled Treatment (6 Months)||69
10744748|NCT02952820|11908639|FG002|NOT COMPLETED|Placebo-Controlled Treatment (6 Months)||88
10744749|NCT02952820|11908637|FG000|STARTED|Active Treatment Period (6 Months)|Participants from Placebo were re-randomized to Lemborexant 5 mg and Lemborexant 10 mg.|0
10744750|NCT02952820|11908638|FG001|STARTED|Active Treatment Period (6 Months)||384
10744751|NCT02952820|11908639|FG002|STARTED|Active Treatment Period (6 Months)||352
10744752|NCT02952820|11908637|FG000|COMPLETED|Active Treatment Period (6 Months)||0
10744753|NCT02952820|11908638|FG001|COMPLETED|Active Treatment Period (6 Months)||346
10744754|NCT02952820|11908639|FG002|COMPLETED|Active Treatment Period (6 Months)||321
10744755|NCT02952820|11908637|FG000|NOT COMPLETED|Active Treatment Period (6 Months)||0
10744756|NCT02952820|11908638|FG001|NOT COMPLETED|Active Treatment Period (6 Months)||38
10744757|NCT02952820|11908639|FG002|NOT COMPLETED|Active Treatment Period (6 Months)||31
10744758|NCT02952872|11908666|FG000|STARTED|Overall Study||22
10744759|NCT02952872|11908667|FG001|STARTED|Overall Study||22
10744760|NCT02952872|11908668|FG002|STARTED|Overall Study||22
10744761|NCT02952872|11908669|FG003|STARTED|Overall Study||22
10744762|NCT02952872|11908670|FG004|STARTED|Overall Study||22
10744763|NCT02952872|11908671|FG005|STARTED|Overall Study||21
10744764|NCT02952872|11908672|FG006|STARTED|Overall Study||22
10744765|NCT02952872|11908673|FG007|STARTED|Overall Study||21
10744766|NCT02952872|11908674|FG008|STARTED|Overall Study||22
10744767|NCT02952872|11908675|FG009|STARTED|Overall Study||22
10744768|NCT02952872|11908676|FG010|STARTED|Overall Study||23
10744769|NCT02952872|11908677|FG011|STARTED|Overall Study||22
10744770|NCT02952872|11908678|FG012|STARTED|Overall Study||22
10744771|NCT02952872|11908679|FG013|STARTED|Overall Study||22
10817495|NCT01242020|11981310|FG000|STARTED|Overall Study||6
10817496|NCT01242020|11981311|FG001|STARTED|Overall Study||0
10817497|NCT01242020|11981310|FG000|COMPLETED|Overall Study||3
10817498|NCT01242020|11981311|FG001|COMPLETED|Overall Study||0
10817499|NCT01242020|11981310|FG000|NOT COMPLETED|Overall Study||3
10817500|NCT01242020|11981311|FG001|NOT COMPLETED|Overall Study||0
10817501|NCT01244620|11981317|FG000|STARTED|Overall Study||4
10817502|NCT01244620|11981318|FG001|STARTED|Overall Study||4
10817503|NCT01244620|11981319|FG002|STARTED|Overall Study||4
10817504|NCT01244620|11981320|FG003|STARTED|Overall Study||4
10817505|NCT01244620|11981317|FG000|COMPLETED|Overall Study||0
10817506|NCT01244620|11981318|FG001|COMPLETED|Overall Study||0
10817507|NCT01244620|11981319|FG002|COMPLETED|Overall Study||0
10744772|NCT02952872|11908680|FG014|STARTED|Overall Study||22
10744773|NCT02952872|11908681|FG015|STARTED|Overall Study||23
10744774|NCT02952872|11908666|FG000|COMPLETED|Overall Study||22
10744775|NCT02952872|11908667|FG001|COMPLETED|Overall Study||22
10744776|NCT02952872|11908668|FG002|COMPLETED|Overall Study||22
10744777|NCT02952872|11908669|FG003|COMPLETED|Overall Study||22
10744778|NCT02952872|11908670|FG004|COMPLETED|Overall Study||22
10744779|NCT02952872|11908671|FG005|COMPLETED|Overall Study||21
10744780|NCT02952872|11908672|FG006|COMPLETED|Overall Study||22
10744781|NCT02952872|11908673|FG007|COMPLETED|Overall Study||21
10744782|NCT02952872|11908674|FG008|COMPLETED|Overall Study||22
10744783|NCT02952872|11908675|FG009|COMPLETED|Overall Study||22
10744784|NCT02952872|11908676|FG010|COMPLETED|Overall Study||23
10744785|NCT02952872|11908677|FG011|COMPLETED|Overall Study||22
10744786|NCT02952872|11908678|FG012|COMPLETED|Overall Study||22
10744787|NCT02952872|11908679|FG013|COMPLETED|Overall Study||22
10744788|NCT02952872|11908680|FG014|COMPLETED|Overall Study||22
10744789|NCT02952872|11908681|FG015|COMPLETED|Overall Study||23
10744790|NCT02952872|11908666|FG000|NOT COMPLETED|Overall Study||0
10744791|NCT02952872|11908667|FG001|NOT COMPLETED|Overall Study||0
10744792|NCT02952872|11908668|FG002|NOT COMPLETED|Overall Study||0
10744793|NCT02952872|11908669|FG003|NOT COMPLETED|Overall Study||0
10744794|NCT02952872|11908670|FG004|NOT COMPLETED|Overall Study||0
10744795|NCT02952872|11908671|FG005|NOT COMPLETED|Overall Study||0
10744796|NCT02952872|11908672|FG006|NOT COMPLETED|Overall Study||0
10744797|NCT02952872|11908673|FG007|NOT COMPLETED|Overall Study||0
10744798|NCT02952872|11908674|FG008|NOT COMPLETED|Overall Study||0
10744799|NCT02952872|11908675|FG009|NOT COMPLETED|Overall Study||0
10744800|NCT02952872|11908676|FG010|NOT COMPLETED|Overall Study||0
10744801|NCT02952872|11908677|FG011|NOT COMPLETED|Overall Study||0
10744802|NCT02952872|11908678|FG012|NOT COMPLETED|Overall Study||0
10744803|NCT02952872|11908679|FG013|NOT COMPLETED|Overall Study||0
10744804|NCT02952872|11908680|FG014|NOT COMPLETED|Overall Study||0
10744805|NCT02952872|11908681|FG015|NOT COMPLETED|Overall Study||0
10744806|NCT02952898|11908718|FG000|STARTED|Overall Study||220
10744807|NCT02952898|11908719|FG001|STARTED|Overall Study||221
10744808|NCT02952898|11908720|FG002|STARTED|Overall Study||224
10744809|NCT02952898|11908718|FG000|COMPLETED|Overall Study||198
10744810|NCT02952898|11908719|FG001|COMPLETED|Overall Study||202
10744811|NCT02952898|11908720|FG002|COMPLETED|Overall Study||209
10744812|NCT02952898|11908718|FG000|NOT COMPLETED|Overall Study||22
10744813|NCT02952898|11908719|FG001|NOT COMPLETED|Overall Study||19
10744814|NCT02952898|11908720|FG002|NOT COMPLETED|Overall Study||15
10744815|NCT02953262|11908732|FG000|STARTED|Overall Study||68
10744816|NCT02953262|11908733|FG001|STARTED|Overall Study||69
10744817|NCT02953262|11908734|FG002|STARTED|Overall Study||68
10744818|NCT02953262|11908735|FG003|STARTED|Overall Study||70
10744819|NCT02953262|11908732|FG000|COMPLETED|Overall Study||65
10817508|NCT01244620|11981320|FG003|COMPLETED|Overall Study||0
10817509|NCT01244620|11981317|FG000|NOT COMPLETED|Overall Study||4
10817510|NCT01244620|11981318|FG001|NOT COMPLETED|Overall Study||4
10817511|NCT01244620|11981319|FG002|NOT COMPLETED|Overall Study||4
10817512|NCT01244620|11981320|FG003|NOT COMPLETED|Overall Study||4
10817513|NCT01240304|11981330|FG000|STARTED|Overall Study||10
10817514|NCT01240304|11981330|FG000|COMPLETED|Overall Study||0
10817515|NCT01240304|11981330|FG000|NOT COMPLETED|Overall Study||10
10817516|NCT01241279|11981336|FG000|STARTED|Overall Study||4
10817517|NCT01241279|11981337|FG001|STARTED|Overall Study||2
10817518|NCT01241279|11981336|FG000|COMPLETED|Overall Study||4
10817519|NCT01241279|11981337|FG001|COMPLETED|Overall Study||1
10817520|NCT01241279|11981336|FG000|NOT COMPLETED|Overall Study||0
10817521|NCT01241279|11981337|FG001|NOT COMPLETED|Overall Study||1
10817522|NCT01230788|11981343|FG000|STARTED|Overall Study||1
10817523|NCT01230788|11981343|FG000|COMPLETED|Overall Study||0
10744820|NCT02953262|11908733|FG001|COMPLETED|Overall Study||63
10744821|NCT02953262|11908734|FG002|COMPLETED|Overall Study||65
10744822|NCT02953262|11908735|FG003|COMPLETED|Overall Study||67
10817524|NCT01230788|11981343|FG000|NOT COMPLETED|Overall Study||1
10817525|NCT01239680|11981349|FG000|STARTED|Overall Study||3
10744823|NCT02953262|11908732|FG000|NOT COMPLETED|Overall Study||3
10744824|NCT02953262|11908733|FG001|NOT COMPLETED|Overall Study||6
10744825|NCT02953262|11908734|FG002|NOT COMPLETED|Overall Study||3
10817526|NCT01239680|11981350|FG001|STARTED|Overall Study||2
10817527|NCT01239680|11981349|FG000|COMPLETED|Overall Study||1
10744826|NCT02953262|11908735|FG003|NOT COMPLETED|Overall Study||3
10744827|NCT02953314|11908751|FG000|STARTED|Overall Study||13
10744828|NCT02953314|11908752|FG001|STARTED|Overall Study||70
10744829|NCT02953314|11908751|FG000|COMPLETED|Overall Study||13
10744830|NCT02953314|11908752|FG001|COMPLETED|Overall Study||67
10744831|NCT02953314|11908751|FG000|NOT COMPLETED|Overall Study||0
10744832|NCT02953314|11908752|FG001|NOT COMPLETED|Overall Study||3
10744833|NCT02953418|11908758|FG000|STARTED|Overall Study||34
10744834|NCT02953418|11908758|FG000|COMPLETED|Overall Study||34
10744835|NCT02953418|11908758|FG000|NOT COMPLETED|Overall Study||0
10744842|NCT02953561|11908770|FG000|STARTED|Overall Study||19
10744843|NCT02953561|11908770|FG000|COMPLETED|Overall Study||19
10744844|NCT02953561|11908770|FG000|NOT COMPLETED|Overall Study||0
10744845|NCT02953639|11908777|FG000|STARTED|Overall Study||81
10744846|NCT02953639|11908778|FG001|STARTED|Overall Study||54
10744847|NCT02953639|11908779|FG002|STARTED|Overall Study||78
10744848|NCT02953639|11908777|FG000|COMPLETED|Overall Study||61
10744849|NCT02953639|11908778|FG001|COMPLETED|Overall Study||40
10744850|NCT02953639|11908779|FG002|COMPLETED|Overall Study||62
10744851|NCT02953639|11908777|FG000|NOT COMPLETED|Overall Study||20
10744852|NCT02953639|11908778|FG001|NOT COMPLETED|Overall Study||14
10744853|NCT02953639|11908779|FG002|NOT COMPLETED|Overall Study||16
10744854|NCT02953678|11908789|FG000|STARTED|Overall Study||71
10744855|NCT02953678|11908789|FG000|COMPLETED|Overall Study||0
10744856|NCT02953678|11908789|FG000|NOT COMPLETED|Overall Study||71
10744857|NCT02953782|11908802|FG000|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||6
10744858|NCT02953782|11908803|FG001|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||3
10744859|NCT02953782|11908804|FG002|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||9
10744860|NCT02953782|11908805|FG003|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||8
10744861|NCT02953782|11908806|FG004|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||6
10744862|NCT02953782|11908807|FG005|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||0
10744863|NCT02953782|11908808|FG006|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||0
10744864|NCT02953782|11908809|FG007|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||0
10744865|NCT02953782|11908802|FG000|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
10744866|NCT02953782|11908803|FG001|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
10744867|NCT02953782|11908804|FG002|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
10744868|NCT02953782|11908805|FG003|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
10744869|NCT02953782|11908806|FG004|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
10744870|NCT02953782|11908807|FG005|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
10744871|NCT02953782|11908808|FG006|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
10744872|NCT02953782|11908809|FG007|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
10744873|NCT02953782|11908802|FG000|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||6
10744874|NCT02953782|11908803|FG001|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||3
10744875|NCT02953782|11908804|FG002|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||9
10744876|NCT02953782|11908805|FG003|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||8
10744877|NCT02953782|11908806|FG004|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||6
10744878|NCT02953782|11908807|FG005|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
10744879|NCT02953782|11908808|FG006|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
10744880|NCT02953782|11908809|FG007|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
10744881|NCT02953782|11908802|FG000|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0
10744882|NCT02953782|11908803|FG001|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0
10744883|NCT02953782|11908804|FG002|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0
10744884|NCT02953782|11908805|FG003|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0
10744885|NCT02953782|11908806|FG004|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0
10744886|NCT02953782|11908807|FG005|STARTED|Phase 2 (Maximum Duration: 11.1 Months)|11 participants were included in safety run-in to evaluate DLT. 9 out of 11 were evaluable for DLT.|16
10744887|NCT02953782|11908808|FG006|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||15
10744888|NCT02953782|11908809|FG007|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||15
10744889|NCT02953782|11908802|FG000|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
10744890|NCT02953782|11908803|FG001|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
10744891|NCT02953782|11908804|FG002|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
10744892|NCT02953782|11908805|FG003|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
10744893|NCT02953782|11908806|FG004|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
10744894|NCT02953782|11908807|FG005|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
10744895|NCT02953782|11908808|FG006|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
10744896|NCT02953782|11908809|FG007|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
10744897|NCT02953782|11908802|FG000|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
10744898|NCT02953782|11908803|FG001|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
10744899|NCT02953782|11908804|FG002|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
10744900|NCT02953782|11908805|FG003|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
10744901|NCT02953782|11908806|FG004|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
10744902|NCT02953782|11908807|FG005|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||16
10744903|NCT02953782|11908808|FG006|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||15
10744904|NCT02953782|11908809|FG007|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||15
10744905|NCT02953821|11908832|FG000|STARTED|Overall Study||86
10744906|NCT02953821|11908833|FG001|STARTED|Overall Study||86
10744907|NCT02953821|11908832|FG000|Safety Population|Overall Study||86
10744908|NCT02953821|11908833|FG001|Safety Population|Overall Study||86
10744909|NCT02953821|11908832|FG000|Modified Intent to Treat (mITT) Populati|Overall Study||85
10744910|NCT02953821|11908833|FG001|Modified Intent to Treat (mITT) Populati|Overall Study||84
10744911|NCT02953821|11908832|FG000|Per Protocol (PP) Population|Overall Study||72
10744912|NCT02953821|11908833|FG001|Per Protocol (PP) Population|Overall Study||75
10744913|NCT02953821|11908832|FG000|Completed Week 16 Visit|Overall Study||76
10744914|NCT02953821|11908833|FG001|Completed Week 16 Visit|Overall Study||77
10744915|NCT02953821|11908832|FG000|Completed Study Treatment (Week 24)|Overall Study||73
10744916|NCT02953821|11908833|FG001|Completed Study Treatment (Week 24)|Overall Study||76
10744917|NCT02953821|11908832|FG000|COMPLETED|Overall Study||71
10744918|NCT02953821|11908833|FG001|COMPLETED|Overall Study||73
10744919|NCT02953821|11908832|FG000|NOT COMPLETED|Overall Study||15
10744920|NCT02953821|11908833|FG001|NOT COMPLETED|Overall Study||13
10744921|NCT02953860|11908841|FG000|STARTED|Overall Study||32
10744922|NCT02953860|11908841|FG000|COMPLETED|Overall Study||32
10744923|NCT02953860|11908841|FG000|NOT COMPLETED|Overall Study||0
10744924|NCT02953873|11908845|FG000|STARTED|Overall Study||25
10744925|NCT02953873|11908845|FG000|COMPLETED|Overall Study||25
10744926|NCT02953873|11908845|FG000|NOT COMPLETED|Overall Study||0
10744927|NCT02953886|11908849|FG000|STARTED|Overall Study||20
10744928|NCT02953886|11908849|FG000|COMPLETED|Overall Study||20
10744929|NCT02953886|11908849|FG000|NOT COMPLETED|Overall Study||0
10744930|NCT02953938|11908855|FG000|STARTED|Overall Study||29
10744931|NCT02953938|11908856|FG001|STARTED|Overall Study||30
10744932|NCT02953938|11908855|FG000|COMPLETED|Overall Study||28
10744933|NCT02953938|11908856|FG001|COMPLETED|Overall Study||28
10744934|NCT02953938|11908855|FG000|NOT COMPLETED|Overall Study||1
10744935|NCT02953938|11908856|FG001|NOT COMPLETED|Overall Study||2
10744936|NCT02954172|11908865|FG000|STARTED|Overall Study||226
10744937|NCT02954172|11908866|FG001|STARTED|Overall Study||224
10744938|NCT02954172|11908865|FG000|COMPLETED|Overall Study||220
10744939|NCT02954172|11908866|FG001|COMPLETED|Overall Study||221
10744940|NCT02954172|11908865|FG000|NOT COMPLETED|Overall Study||6
10744941|NCT02954172|11908866|FG001|NOT COMPLETED|Overall Study||3
10744942|NCT02954198|11908875|FG000|STARTED|Overall Study||20
10744943|NCT02954198|11908876|FG001|STARTED|Overall Study||20
10744944|NCT02954198|11908875|FG000|COMPLETED|Overall Study||20
10744945|NCT02954198|11908876|FG001|COMPLETED|Overall Study||20
10744946|NCT02954198|11908875|FG000|NOT COMPLETED|Overall Study||0
10744947|NCT02954198|11908876|FG001|NOT COMPLETED|Overall Study||0
10744948|NCT02954354|11908885|FG000|STARTED|Overall Study||612
10744949|NCT02954354|11908886|FG001|STARTED|Overall Study||310
10744950|NCT02954354|11908887|FG002|STARTED|Overall Study||514
10744951|NCT02954354|11908885|FG000|Received Study Drug|Overall Study||610
10744952|NCT02954354|11908886|FG001|Received Study Drug|Overall Study||309
10744953|NCT02954354|11908887|FG002|Received Study Drug|Overall Study||513
10744954|NCT02954354|11908885|FG000|Intention to Treat Infected Population|Overall Study||456
10744955|NCT02954354|11908886|FG001|Intention to Treat Infected Population|Overall Study||231
10744956|NCT02954354|11908887|FG002|Intention to Treat Infected Population|Overall Study||377
10744957|NCT02954354|11908885|FG000|COMPLETED|Overall Study||578
10744958|NCT02954354|11908886|FG001|COMPLETED|Overall Study||290
10744959|NCT02954354|11908887|FG002|COMPLETED|Overall Study||498
10744960|NCT02954354|11908885|FG000|NOT COMPLETED|Overall Study||34
10744961|NCT02954354|11908886|FG001|NOT COMPLETED|Overall Study||20
10744962|NCT02954354|11908887|FG002|NOT COMPLETED|Overall Study||16
10744963|NCT02954458|11908901|FG000|STARTED|Overall Study||7
10744964|NCT02954458|11908902|FG001|STARTED|Overall Study||3
10744965|NCT02954458|11908903|FG002|STARTED|Overall Study||1
10744966|NCT02954458|11908904|FG003|STARTED|Overall Study||50
10744967|NCT02954458|11908901|FG000|COMPLETED|Overall Study||6
10744968|NCT02954458|11908902|FG001|COMPLETED|Overall Study||3
10744969|NCT02954458|11908903|FG002|COMPLETED|Overall Study||0
10744970|NCT02954458|11908904|FG003|COMPLETED|Overall Study||38
10744971|NCT02954458|11908901|FG000|NOT COMPLETED|Overall Study||1
10744972|NCT02954458|11908902|FG001|NOT COMPLETED|Overall Study||0
10744973|NCT02954458|11908903|FG002|NOT COMPLETED|Overall Study||1
10744974|NCT02954458|11908904|FG003|NOT COMPLETED|Overall Study||12
10817528|NCT01239680|11981350|FG001|COMPLETED|Overall Study||2
10744975|NCT02954575|11908918|FG000|STARTED|Overall Study||57
10744976|NCT02954575|11908918|FG000|Received Treatment|Overall Study||55
10744977|NCT02954575|11908918|FG000|SAF Population|Overall Study||55
10744978|NCT02954575|11908918|FG000|FAS Population|Overall Study||55
10744979|NCT02954575|11908918|FG000|PP Population|Overall Study||52
10744980|NCT02954575|11908918|FG000|PK Population|Overall Study||21
10744981|NCT02954575|11908918|FG000|SURG Population|Overall Study||1
10744982|NCT02954575|11908918|FG000|COMPLETED|Overall Study||54
10744983|NCT02954575|11908918|FG000|NOT COMPLETED|Overall Study||3
10744984|NCT02954601|11908930|FG000|STARTED|First Intervention (Five Days)||11
10744985|NCT02954601|11908931|FG001|STARTED|First Intervention (Five Days)||6
10744986|NCT02954601|11908932|FG002|STARTED|First Intervention (Five Days)||8
10744987|NCT02954601|11908933|FG003|STARTED|First Intervention (Five Days)||7
10744988|NCT02954601|11908930|FG000|COMPLETED|First Intervention (Five Days)||11
10744989|NCT02954601|11908931|FG001|COMPLETED|First Intervention (Five Days)||6
10744990|NCT02954601|11908932|FG002|COMPLETED|First Intervention (Five Days)||7
10744991|NCT02954601|11908933|FG003|COMPLETED|First Intervention (Five Days)||7
10744992|NCT02954601|11908930|FG000|NOT COMPLETED|First Intervention (Five Days)||0
10744993|NCT02954601|11908931|FG001|NOT COMPLETED|First Intervention (Five Days)||0
10744994|NCT02954601|11908932|FG002|NOT COMPLETED|First Intervention (Five Days)||1
10744995|NCT02954601|11908933|FG003|NOT COMPLETED|First Intervention (Five Days)||0
10744996|NCT02954601|11908930|FG000|STARTED|Second Intervention (Five Days)||11
10744997|NCT02954601|11908931|FG001|STARTED|Second Intervention (Five Days)||6
10744998|NCT02954601|11908932|FG002|STARTED|Second Intervention (Five Days)||8
10744999|NCT02954601|11908933|FG003|STARTED|Second Intervention (Five Days)||6
10745000|NCT02954601|11908930|FG000|COMPLETED|Second Intervention (Five Days)||11
10745001|NCT02954601|11908931|FG001|COMPLETED|Second Intervention (Five Days)||6
10745002|NCT02954601|11908932|FG002|COMPLETED|Second Intervention (Five Days)||8
10745003|NCT02954601|11908933|FG003|COMPLETED|Second Intervention (Five Days)||6
10745004|NCT02954601|11908930|FG000|NOT COMPLETED|Second Intervention (Five Days)||0
10745005|NCT02954601|11908931|FG001|NOT COMPLETED|Second Intervention (Five Days)||0
10745006|NCT02954601|11908932|FG002|NOT COMPLETED|Second Intervention (Five Days)||0
10745007|NCT02954601|11908933|FG003|NOT COMPLETED|Second Intervention (Five Days)||0
10745008|NCT02954601|11908930|FG000|STARTED|Third Intervention (Five Days)||9
10745009|NCT02954601|11908931|FG001|STARTED|Third Intervention (Five Days)||8
10745010|NCT02954601|11908932|FG002|STARTED|Third Intervention (Five Days)||6
10745011|NCT02954601|11908933|FG003|STARTED|Third Intervention (Five Days)||8
10745012|NCT02954601|11908930|FG000|COMPLETED|Third Intervention (Five Days)||9
10745013|NCT02954601|11908931|FG001|COMPLETED|Third Intervention (Five Days)||8
10745014|NCT02954601|11908932|FG002|COMPLETED|Third Intervention (Five Days)||6
10745015|NCT02954601|11908933|FG003|COMPLETED|Third Intervention (Five Days)||8
10745016|NCT02954601|11908930|FG000|NOT COMPLETED|Third Intervention (Five Days)||0
10745017|NCT02954601|11908931|FG001|NOT COMPLETED|Third Intervention (Five Days)||0
10745018|NCT02954601|11908932|FG002|NOT COMPLETED|Third Intervention (Five Days)||0
10745019|NCT02954601|11908933|FG003|NOT COMPLETED|Third Intervention (Five Days)||0
10745020|NCT02954653|11908945|FG000|STARTED|Overall Study||4
10745021|NCT02954653|11908946|FG001|STARTED|Overall Study||4
10745022|NCT02954653|11908947|FG002|STARTED|Overall Study|No participants were enrolled in this arm.|0
10745023|NCT02954653|11908948|FG003|STARTED|Overall Study|No participants were enrolled in this arm.|0
10745024|NCT02954653|11908949|FG004|STARTED|Overall Study|No participants were enrolled in this arm.|0
10745025|NCT02954653|11908950|FG005|STARTED|Overall Study|No participants were enrolled in this arm.|0
10745026|NCT02954653|11908951|FG006|STARTED|Overall Study|No participants were enrolled in this arm.|0
10745027|NCT02954653|11908952|FG007|STARTED|Overall Study|No participants were enrolled in this arm.|0
10745028|NCT02954653|11908953|FG008|STARTED|Overall Study|No participants were enrolled in this arm.|0
10745029|NCT02954653|11908945|FG000|Received Treatment|Overall Study||3
10745030|NCT02954653|11908946|FG001|Received Treatment|Overall Study||4
10745031|NCT02954653|11908947|FG002|Received Treatment|Overall Study||0
10745032|NCT02954653|11908948|FG003|Received Treatment|Overall Study||0
10745033|NCT02954653|11908949|FG004|Received Treatment|Overall Study||0
10745034|NCT02954653|11908950|FG005|Received Treatment|Overall Study||0
10745035|NCT02954653|11908951|FG006|Received Treatment|Overall Study||0
10745036|NCT02954653|11908952|FG007|Received Treatment|Overall Study||0
10745037|NCT02954653|11908953|FG008|Received Treatment|Overall Study||0
10745038|NCT02954653|11908945|FG000|COMPLETED|Overall Study||0
10745039|NCT02954653|11908946|FG001|COMPLETED|Overall Study||1
10745040|NCT02954653|11908947|FG002|COMPLETED|Overall Study||0
10745041|NCT02954653|11908948|FG003|COMPLETED|Overall Study||0
10745042|NCT02954653|11908949|FG004|COMPLETED|Overall Study||0
10745043|NCT02954653|11908950|FG005|COMPLETED|Overall Study||0
10745044|NCT02954653|11908951|FG006|COMPLETED|Overall Study||0
10745045|NCT02954653|11908952|FG007|COMPLETED|Overall Study||0
10745046|NCT02954653|11908953|FG008|COMPLETED|Overall Study||0
10745047|NCT02954653|11908945|FG000|NOT COMPLETED|Overall Study||4
10745048|NCT02954653|11908946|FG001|NOT COMPLETED|Overall Study||3
10745049|NCT02954653|11908947|FG002|NOT COMPLETED|Overall Study||0
10745050|NCT02954653|11908948|FG003|NOT COMPLETED|Overall Study||0
10745051|NCT02954653|11908949|FG004|NOT COMPLETED|Overall Study||0
10745052|NCT02954653|11908950|FG005|NOT COMPLETED|Overall Study||0
10817529|NCT01239680|11981349|FG000|NOT COMPLETED|Overall Study||2
10817530|NCT01239680|11981350|FG001|NOT COMPLETED|Overall Study||0
10817531|NCT01237613|11981356|FG000|STARTED|Overall Study||4
10817532|NCT01237613|11981356|FG000|COMPLETED|Overall Study||4
10817533|NCT01237613|11981356|FG000|NOT COMPLETED|Overall Study||0
10817534|NCT01234103|11981363|FG000|STARTED|Overall Study||542
10817535|NCT01234103|11981364|FG001|STARTED|Overall Study||391
10817536|NCT01234103|11981363|FG000|COMPLETED|Overall Study||542
10817537|NCT01234103|11981364|FG001|COMPLETED|Overall Study||391
10817538|NCT01234103|11981363|FG000|NOT COMPLETED|Overall Study||0
10745053|NCT02954653|11908951|FG006|NOT COMPLETED|Overall Study||0
10745054|NCT02954653|11908952|FG007|NOT COMPLETED|Overall Study||0
10745055|NCT02954653|11908953|FG008|NOT COMPLETED|Overall Study||0
10745056|NCT02954848|11908967|FG000|STARTED|Overall Study||245
10745057|NCT02954848|11908968|FG001|STARTED|Overall Study||239
10745058|NCT02954848|11908967|FG000|Treated|Overall Study||245
10745059|NCT02954848|11908968|FG001|Treated|Overall Study||238
10745060|NCT02954848|11908967|FG000|COMPLETED|Overall Study||243
10745061|NCT02954848|11908968|FG001|COMPLETED|Overall Study||234
10745062|NCT02954848|11908967|FG000|NOT COMPLETED|Overall Study||2
10817539|NCT01234103|11981364|FG001|NOT COMPLETED|Overall Study||0
10817540|NCT01231750|11981372|FG000|STARTED|Overall Study||3
10745063|NCT02954848|11908968|FG001|NOT COMPLETED|Overall Study||5
10745067|NCT02955069|11908980|FG000|STARTED|Overall Study||95
10745068|NCT02955069|11908981|FG001|STARTED|Overall Study||21
10745069|NCT02955069|11908980|FG000|Full Analysis Set (FAS)|Overall Study||95
10745070|NCT02955069|11908981|FG001|Full Analysis Set (FAS)|Overall Study||21
10745071|NCT02955069|11908980|FG000|Safety Set|Overall Study||95
10745072|NCT02955069|11908981|FG001|Safety Set|Overall Study||21
10745073|NCT02955069|11908980|FG000|Pharmacokinetic Analysis Set (PAS)|Overall Study||94
10745074|NCT02955069|11908981|FG001|Pharmacokinetic Analysis Set (PAS)|Overall Study||18
10745075|NCT02955069|11908980|FG000|Immunogenicity (IG) Prevalence Set|Overall Study||94
10745076|NCT02955069|11908981|FG001|Immunogenicity (IG) Prevalence Set|Overall Study||21
10745077|NCT02955069|11908980|FG000|IG Incidence Set|Overall Study||84
10745078|NCT02955069|11908981|FG001|IG Incidence Set|Overall Study||17
10745079|NCT02955069|11908980|FG000|COMPLETED|Overall Study||0
10745080|NCT02955069|11908981|FG001|COMPLETED|Overall Study||0
10745081|NCT02955069|11908980|FG000|NOT COMPLETED|Overall Study||95
10745082|NCT02955069|11908981|FG001|NOT COMPLETED|Overall Study||21
10745083|NCT02955147|11908989|FG000|STARTED|Overall Study||13
10745084|NCT02955147|11908989|FG000|COMPLETED|Overall Study||13
10745085|NCT02955147|11908989|FG000|NOT COMPLETED|Overall Study||0
10745086|NCT02955186|11908995|FG000|STARTED|Overall Study||33
10745087|NCT02955186|11908996|FG001|STARTED|Overall Study||17
10745088|NCT02955186|11908995|FG000|COMPLETED|Overall Study||26
10745089|NCT02955186|11908996|FG001|COMPLETED|Overall Study||15
10745090|NCT02955186|11908995|FG000|NOT COMPLETED|Overall Study||7
10745091|NCT02955186|11908996|FG001|NOT COMPLETED|Overall Study||2
10745092|NCT02955212|11909004|FG000|STARTED|Period 1: Double-blind Treatment Period||169
10745093|NCT02955212|11909005|FG001|STARTED|Period 1: Double-blind Treatment Period||169
10745094|NCT02955212|11909004|FG000|COMPLETED|Period 1: Double-blind Treatment Period||153
10745095|NCT02955212|11909005|FG001|COMPLETED|Period 1: Double-blind Treatment Period||157
10745096|NCT02955212|11909004|FG000|NOT COMPLETED|Period 1: Double-blind Treatment Period||16
10745097|NCT02955212|11909005|FG001|NOT COMPLETED|Period 1: Double-blind Treatment Period||12
10745098|NCT02955212|11909004|FG000|STARTED|Period 2: Open-label Extension||153
10745099|NCT02955212|11909005|FG001|STARTED|Period 2: Open-label Extension||157
10745100|NCT02955212|11909004|FG000|COMPLETED|Period 2: Open-label Extension||136
10745101|NCT02955212|11909005|FG001|COMPLETED|Period 2: Open-label Extension||139
10745102|NCT02955212|11909004|FG000|NOT COMPLETED|Period 2: Open-label Extension||17
10745103|NCT02955212|11909005|FG001|NOT COMPLETED|Period 2: Open-label Extension||18
10745104|NCT02955329|11909012|FG000|STARTED|Tobacco Arm||8
10745105|NCT02955329|11909012|FG000|COMPLETED|Tobacco Arm||8
10745106|NCT02955329|11909012|FG000|NOT COMPLETED|Tobacco Arm||0
10745107|NCT02955329|11909012|FG000|STARTED|Cannabis Arm||8
10745108|NCT02955329|11909012|FG000|COMPLETED|Cannabis Arm||8
10745109|NCT02955329|11909012|FG000|NOT COMPLETED|Cannabis Arm||0
10745110|NCT02955329|11909012|FG000|STARTED|Combined Cannabis and Tobacco Arm||8
10745111|NCT02955329|11909012|FG000|COMPLETED|Combined Cannabis and Tobacco Arm||8
10745112|NCT02955329|11909012|FG000|NOT COMPLETED|Combined Cannabis and Tobacco Arm||0
10745113|NCT02956044|11909023|FG000|STARTED|Overall Study||18
10745114|NCT02956044|11909024|FG001|STARTED|Overall Study||18
10745115|NCT02956044|11909025|FG002|STARTED|Overall Study||18
10745116|NCT02956044|11909023|FG000|COMPLETED|Overall Study||18
10745117|NCT02956044|11909024|FG001|COMPLETED|Overall Study||18
10745118|NCT02956044|11909025|FG002|COMPLETED|Overall Study||18
10745119|NCT02956044|11909023|FG000|NOT COMPLETED|Overall Study||0
10745120|NCT02956044|11909024|FG001|NOT COMPLETED|Overall Study||0
10745121|NCT02956044|11909025|FG002|NOT COMPLETED|Overall Study||0
10745122|NCT02956057|11909053|FG000|STARTED|Overall Study||174
10745123|NCT02956057|11909054|FG001|STARTED|Overall Study||174
10745124|NCT02956057|11909055|FG002|STARTED|Overall Study||174
10745125|NCT02956057|11909056|FG003|STARTED|Overall Study||174
10745126|NCT02956057|11909057|FG004|STARTED|Overall Study||174
10745127|NCT02956057|11909058|FG005|STARTED|Overall Study||174
10745128|NCT02956057|11909053|FG000|COMPLETED|Overall Study||160
10408716|NCT00756561|11552851|FG000|NOT COMPLETED|Overall Study||0
10408717|NCT00756600|11552858|FG000|STARTED|Overall Study||287
10408718|NCT00756600|11552859|FG001|STARTED|Overall Study||356
10408719|NCT00756600|11552858|FG000|COMPLETED|Overall Study||287
10408720|NCT00756600|11552859|FG001|COMPLETED|Overall Study||356
10408721|NCT00756600|11552858|FG000|NOT COMPLETED|Overall Study||0
10745129|NCT02956057|11909054|FG001|COMPLETED|Overall Study||162
10745130|NCT02956057|11909055|FG002|COMPLETED|Overall Study||166
10745131|NCT02956057|11909056|FG003|COMPLETED|Overall Study||159
10408722|NCT00756600|11552859|FG001|NOT COMPLETED|Overall Study||0
10408723|NCT00756613|11552868|FG000|STARTED|Overall Study||512
10745132|NCT02956057|11909057|FG004|COMPLETED|Overall Study||169
10745133|NCT02956057|11909058|FG005|COMPLETED|Overall Study||157
10408724|NCT00756613|11552869|FG001|STARTED|Overall Study||532
10745134|NCT02956057|11909053|FG000|NOT COMPLETED|Overall Study||14
10745135|NCT02956057|11909054|FG001|NOT COMPLETED|Overall Study||12
10745136|NCT02956057|11909055|FG002|NOT COMPLETED|Overall Study||8
10745137|NCT02956057|11909056|FG003|NOT COMPLETED|Overall Study||15
10408725|NCT00756613|11552868|FG000|COMPLETED|Overall Study||426
10745138|NCT02956057|11909057|FG004|NOT COMPLETED|Overall Study||5
10745139|NCT02956057|11909058|FG005|NOT COMPLETED|Overall Study||17
10745140|NCT02956070|11909074|FG000|STARTED|Overall Study||35
10745141|NCT02956070|11909075|FG001|STARTED|Overall Study||35
10745142|NCT02956070|11909074|FG000|COMPLETED|Overall Study||35
10745143|NCT02956070|11909075|FG001|COMPLETED|Overall Study||35
10745144|NCT02956070|11909074|FG000|NOT COMPLETED|Overall Study||0
10745145|NCT02956070|11909075|FG001|NOT COMPLETED|Overall Study||0
10745146|NCT02956122|11909081|FG000|STARTED|Overall Study||1
10745147|NCT02956122|11909081|FG000|COMPLETED|Overall Study||1
10745148|NCT02956122|11909081|FG000|NOT COMPLETED|Overall Study||0
10745149|NCT02956278|11909095|FG000|STARTED|Overall Study||15
10745150|NCT02956278|11909096|FG001|STARTED|Overall Study||9
10745151|NCT02956278|11909097|FG002|STARTED|Overall Study||3
10745152|NCT02956278|11909095|FG000|COMPLETED|Overall Study||9
10745153|NCT02956278|11909096|FG001|COMPLETED|Overall Study||7
10745154|NCT02956278|11909097|FG002|COMPLETED|Overall Study||3
10745155|NCT02956278|11909095|FG000|NOT COMPLETED|Overall Study||6
10745156|NCT02956278|11909096|FG001|NOT COMPLETED|Overall Study||2
10745157|NCT02956278|11909097|FG002|NOT COMPLETED|Overall Study||0
10745158|NCT02956460|11909107|FG000|STARTED|Lens 1||30
10745159|NCT02956460|11909108|FG001|STARTED|Lens 1||34
10745160|NCT02956460|11909107|FG000|COMPLETED|Lens 1||29
10745161|NCT02956460|11909108|FG001|COMPLETED|Lens 1||34
10745162|NCT02956460|11909107|FG000|NOT COMPLETED|Lens 1||1
10745163|NCT02956460|11909108|FG001|NOT COMPLETED|Lens 1||0
10745164|NCT02956460|11909107|FG000|STARTED|Lens 2||29
10745165|NCT02956460|11909108|FG001|STARTED|Lens 2||34
10745166|NCT02956460|11909107|FG000|COMPLETED|Lens 2||29
10745167|NCT02956460|11909108|FG001|COMPLETED|Lens 2||34
10745168|NCT02956460|11909107|FG000|NOT COMPLETED|Lens 2||0
10745169|NCT02956460|11909108|FG001|NOT COMPLETED|Lens 2||0
10745170|NCT02956486|11909116|FG000|STARTED|Core Phase||1108
10745171|NCT02956486|11909117|FG001|STARTED|Core Phase||1104
10745172|NCT02956486|11909118|FG002|STARTED|Core Phase||0
10745173|NCT02956486|11909116|FG000|Treated|Core Phase||1108
10745174|NCT02956486|11909117|FG001|Treated|Core Phase||1101
10745175|NCT02956486|11909118|FG002|Treated|Core Phase||0
10745176|NCT02956486|11909116|FG000|Safety Analysis Set (SAS)|Core Phase||1105
10745177|NCT02956486|11909117|FG001|Safety Analysis Set (SAS)|Core Phase||1099
10745178|NCT02956486|11909118|FG002|Safety Analysis Set (SAS)|Core Phase||0
10745179|NCT02956486|11909116|FG000|Full Analysis Set (FAS)|Core Phase||1084
10745180|NCT02956486|11909117|FG001|Full Analysis Set (FAS)|Core Phase||1062
10745181|NCT02956486|11909118|FG002|Full Analysis Set (FAS)|Core Phase||0
10745182|NCT02956486|11909116|FG000|COMPLETED|Core Phase||29
10745183|NCT02956486|11909117|FG001|COMPLETED|Core Phase||32
10745184|NCT02956486|11909118|FG002|COMPLETED|Core Phase||0
10745185|NCT02956486|11909116|FG000|NOT COMPLETED|Core Phase||1079
10745186|NCT02956486|11909117|FG001|NOT COMPLETED|Core Phase||1072
10745187|NCT02956486|11909118|FG002|NOT COMPLETED|Core Phase||0
10745188|NCT02956486|11909116|FG000|STARTED|Extension Phase||0
10745189|NCT02956486|11909117|FG001|STARTED|Extension Phase||0
10745190|NCT02956486|11909118|FG002|STARTED|Extension Phase|Eligible participants who completed core and consented for extension phase, entered extension phase.|19
10745191|NCT02956486|11909116|FG000|Treated|Extension Phase||0
10745192|NCT02956486|11909117|FG001|Treated|Extension Phase||0
10745193|NCT02956486|11909118|FG002|Treated|Extension Phase||18
10745194|NCT02956486|11909116|FG000|Safety Analysis Set (SAS)|Extension Phase||0
10745195|NCT02956486|11909117|FG001|Safety Analysis Set (SAS)|Extension Phase||0
10745196|NCT02956486|11909118|FG002|Safety Analysis Set (SAS)|Extension Phase||18
10745197|NCT02956486|11909116|FG000|COMPLETED|Extension Phase||0
10745198|NCT02956486|11909117|FG001|COMPLETED|Extension Phase||0
10745199|NCT02956486|11909118|FG002|COMPLETED|Extension Phase||0
10745200|NCT02956486|11909116|FG000|NOT COMPLETED|Extension Phase||0
10745201|NCT02956486|11909117|FG001|NOT COMPLETED|Extension Phase||0
10817541|NCT01231750|11981373|FG001|STARTED|Overall Study||4
10817542|NCT01231750|11981372|FG000|COMPLETED|Overall Study||3
10817543|NCT01231750|11981373|FG001|COMPLETED|Overall Study||4
10817544|NCT01231750|11981372|FG000|NOT COMPLETED|Overall Study||0
10817545|NCT01231750|11981373|FG001|NOT COMPLETED|Overall Study||0
10817546|NCT01230307|11981381|FG000|STARTED|Overall Study||6
10817547|NCT01230307|11981382|FG001|STARTED|Overall Study||6
10817548|NCT01230307|11981381|FG000|COMPLETED|Overall Study||6
10817549|NCT01230307|11981382|FG001|COMPLETED|Overall Study||4
10817550|NCT01230307|11981381|FG000|NOT COMPLETED|Overall Study||0
10817551|NCT01230307|11981382|FG001|NOT COMPLETED|Overall Study||2
10817552|NCT01230489|11981388|FG000|STARTED|Overall Study||13
10817553|NCT01230489|11981388|FG000|COMPLETED|Overall Study||8
10817554|NCT01230489|11981388|FG000|NOT COMPLETED|Overall Study||5
10817555|NCT01222871|11981394|FG000|STARTED|Overall Study||0
10817556|NCT01222871|11981395|FG001|STARTED|Overall Study||0
10817557|NCT01222871|11981394|FG000|COMPLETED|Overall Study||0
10745202|NCT02956486|11909118|FG002|NOT COMPLETED|Extension Phase||19
10745203|NCT02956616|11909129|FG000|STARTED|Overall Study||58
10745204|NCT02956616|11909130|FG001|STARTED|Overall Study||60
10745205|NCT02956616|11909129|FG000|COMPLETED|Overall Study||58
10745206|NCT02956616|11909130|FG001|COMPLETED|Overall Study||60
10745207|NCT02956616|11909129|FG000|NOT COMPLETED|Overall Study||0
10745208|NCT02956616|11909130|FG001|NOT COMPLETED|Overall Study||0
10817558|NCT01222871|11981395|FG001|COMPLETED|Overall Study||0
10817559|NCT01222871|11981394|FG000|NOT COMPLETED|Overall Study||0
10817560|NCT01222871|11981395|FG001|NOT COMPLETED|Overall Study||0
10817561|NCT01219673|11981410|FG000|STARTED|Overall Study||0
10817562|NCT01219673|11981411|FG001|STARTED|Overall Study||0
10817563|NCT01219673|11981412|FG002|STARTED|Overall Study||1
10817564|NCT01219673|11981413|FG003|STARTED|Overall Study||0
10817565|NCT01219673|11981414|FG004|STARTED|Overall Study||0
10817566|NCT01219673|11981415|FG005|STARTED|Overall Study||0
10745209|NCT02956629|11909142|FG000|STARTED|Overall Study||78
10745210|NCT02956629|11909143|FG001|STARTED|Overall Study||47
10745211|NCT02956629|11909144|FG002|STARTED|Overall Study||61
10745212|NCT02956629|11909145|FG003|STARTED|Overall Study||56
10745213|NCT02956629|11909146|FG004|STARTED|Overall Study||18
10745214|NCT02956629|11909147|FG005|STARTED|Overall Study||22
10745215|NCT02956629|11909142|FG000|COMPLETED|Overall Study||73
10745216|NCT02956629|11909143|FG001|COMPLETED|Overall Study||41
10745217|NCT02956629|11909144|FG002|COMPLETED|Overall Study||57
10745218|NCT02956629|11909145|FG003|COMPLETED|Overall Study||55
10745219|NCT02956629|11909146|FG004|COMPLETED|Overall Study||18
10745220|NCT02956629|11909147|FG005|COMPLETED|Overall Study||21
10745221|NCT02956629|11909142|FG000|NOT COMPLETED|Overall Study||5
10745222|NCT02956629|11909143|FG001|NOT COMPLETED|Overall Study||6
10745223|NCT02956629|11909144|FG002|NOT COMPLETED|Overall Study||4
10745224|NCT02956629|11909145|FG003|NOT COMPLETED|Overall Study||1
10745225|NCT02956629|11909146|FG004|NOT COMPLETED|Overall Study||0
10745226|NCT02956629|11909147|FG005|NOT COMPLETED|Overall Study||1
10745227|NCT02956746|11909165|FG000|STARTED|Overall Study||40
10745228|NCT02956746|11909166|FG001|STARTED|Overall Study||40
10745229|NCT02956746|11909167|FG002|STARTED|Overall Study||42
10817567|NCT01219673|11981416|FG006|STARTED|Overall Study||0
10817568|NCT01219673|11981417|FG007|STARTED|Overall Study||0
10817569|NCT01219673|11981410|FG000|COMPLETED|Overall Study||0
10817570|NCT01219673|11981411|FG001|COMPLETED|Overall Study||0
10817571|NCT01219673|11981412|FG002|COMPLETED|Overall Study||1
10817572|NCT01219673|11981413|FG003|COMPLETED|Overall Study||0
10817573|NCT01219673|11981414|FG004|COMPLETED|Overall Study||0
10817574|NCT01219673|11981415|FG005|COMPLETED|Overall Study||0
10817575|NCT01219673|11981416|FG006|COMPLETED|Overall Study||0
10817576|NCT01219673|11981417|FG007|COMPLETED|Overall Study||0
10817577|NCT01219673|11981410|FG000|NOT COMPLETED|Overall Study||0
10817578|NCT01219673|11981411|FG001|NOT COMPLETED|Overall Study||0
10817579|NCT01219673|11981412|FG002|NOT COMPLETED|Overall Study||0
10817580|NCT01219673|11981413|FG003|NOT COMPLETED|Overall Study||0
10817581|NCT01219673|11981414|FG004|NOT COMPLETED|Overall Study||0
10817582|NCT01219673|11981415|FG005|NOT COMPLETED|Overall Study||0
10817583|NCT01219673|11981416|FG006|NOT COMPLETED|Overall Study||0
10817584|NCT01219673|11981417|FG007|NOT COMPLETED|Overall Study||0
10817585|NCT01223001|11981437|FG000|STARTED|Overall Study||4
10817586|NCT01223001|11981438|FG001|STARTED|Overall Study||4
10817587|NCT01223001|11981437|FG000|COMPLETED|Overall Study||0
10817588|NCT01223001|11981438|FG001|COMPLETED|Overall Study||0
10817589|NCT01223001|11981437|FG000|NOT COMPLETED|Overall Study||4
10817590|NCT01223001|11981438|FG001|NOT COMPLETED|Overall Study||4
10817591|NCT01217060|11981444|FG000|STARTED|Overall Study||4
10817592|NCT01217060|11981444|FG000|COMPLETED|Overall Study||3
10817593|NCT01217060|11981444|FG000|NOT COMPLETED|Overall Study||1
10817594|NCT01217047|11981452|FG000|STARTED|Overall Study||3
10817595|NCT01217047|11981453|FG001|STARTED|Overall Study||4
10817596|NCT01217047|11981454|FG002|STARTED|Overall Study||3
10817597|NCT01217047|11981452|FG000|COMPLETED|Overall Study||3
10817598|NCT01217047|11981453|FG001|COMPLETED|Overall Study||3
10817599|NCT01217047|11981454|FG002|COMPLETED|Overall Study||3
10817600|NCT01217047|11981452|FG000|NOT COMPLETED|Overall Study||0
10817601|NCT01217047|11981453|FG001|NOT COMPLETED|Overall Study||1
10817602|NCT01217047|11981454|FG002|NOT COMPLETED|Overall Study||0
10817603|NCT01206101|11981465|FG000|STARTED|Overall Study||2
10817604|NCT01206101|11981466|FG001|STARTED|Overall Study||1
10817605|NCT01206101|11981465|FG000|COMPLETED|Overall Study||0
10745230|NCT02956746|11909168|FG003|STARTED|Overall Study||42
10745231|NCT02956746|11909165|FG000|COMPLETED|Overall Study||38
10745232|NCT02956746|11909166|FG001|COMPLETED|Overall Study||37
10745233|NCT02956746|11909167|FG002|COMPLETED|Overall Study||36
10745234|NCT02956746|11909168|FG003|COMPLETED|Overall Study||38
10312944|NCT00147082|11446470|FG002|STARTED|Overall Study||30
10312945|NCT00147082|11446468|FG000|COMPLETED|Overall Study||37
10312946|NCT00147082|11446469|FG001|COMPLETED|Overall Study||33
10312947|NCT00147082|11446470|FG002|COMPLETED|Overall Study||30
10745235|NCT02956746|11909165|FG000|NOT COMPLETED|Overall Study||2
10817606|NCT01206101|11981466|FG001|COMPLETED|Overall Study||0
10817607|NCT01206101|11981465|FG000|NOT COMPLETED|Overall Study||2
10817608|NCT01206101|11981466|FG001|NOT COMPLETED|Overall Study||1
10817609|NCT01216631|11981475|FG000|STARTED|Overall Study||0
10817610|NCT01216631|11981476|FG001|STARTED|Overall Study||0
10817611|NCT01216631|11981477|FG002|STARTED|Overall Study||1
10817612|NCT01216631|11981475|FG000|COMPLETED|Overall Study||0
10817613|NCT01216631|11981476|FG001|COMPLETED|Overall Study||0
10745236|NCT02956746|11909166|FG001|NOT COMPLETED|Overall Study||3
10745237|NCT02956746|11909167|FG002|NOT COMPLETED|Overall Study||6
10745238|NCT02956746|11909168|FG003|NOT COMPLETED|Overall Study||4
10745239|NCT02956837|11909183|FG000|STARTED|Overall Study||100
10745240|NCT02956837|11909184|FG001|STARTED|Overall Study||99
10745241|NCT02956837|11909185|FG002|STARTED|Overall Study||99
10745242|NCT02956837|11909186|FG003|STARTED|Overall Study||102
10745243|NCT02956837|11909183|FG000|COMPLETED|Overall Study||100
10745244|NCT02956837|11909184|FG001|COMPLETED|Overall Study||96
10745245|NCT02956837|11909185|FG002|COMPLETED|Overall Study||97
10745246|NCT02956837|11909186|FG003|COMPLETED|Overall Study||99
10745247|NCT02956837|11909183|FG000|NOT COMPLETED|Overall Study||0
10745248|NCT02956837|11909184|FG001|NOT COMPLETED|Overall Study||3
10745249|NCT02956837|11909185|FG002|NOT COMPLETED|Overall Study||2
10745250|NCT02956837|11909186|FG003|NOT COMPLETED|Overall Study||3
10745251|NCT02956967|11909199|FG000|STARTED|Overall Study||171
10745252|NCT02956967|11909199|FG000|COMPLETED|Overall Study||123
10745253|NCT02956967|11909199|FG000|NOT COMPLETED|Overall Study||48
10745254|NCT02957123|11909203|FG000|STARTED|Overall Study||30
10745255|NCT02957123|11909203|FG000|COMPLETED|Overall Study||30
10745256|NCT02957123|11909203|FG000|NOT COMPLETED|Overall Study||0
10745257|NCT02957136|11909209|FG000|STARTED|Overall Study||95
10745258|NCT02957136|11909210|FG001|STARTED|Overall Study||99
10745259|NCT02957136|11909209|FG000|COMPLETED|Overall Study||93
10745260|NCT02957136|11909210|FG001|COMPLETED|Overall Study||98
10745261|NCT02957136|11909209|FG000|NOT COMPLETED|Overall Study||2
10745262|NCT02957136|11909210|FG001|NOT COMPLETED|Overall Study||1
10745263|NCT02957305|11909218|FG000|STARTED|Overall Study||106
10745264|NCT02957305|11909219|FG001|STARTED|Overall Study||105
10745265|NCT02957305|11909218|FG000|COMPLETED|Overall Study||106
10745266|NCT02957305|11909219|FG001|COMPLETED|Overall Study||105
10745267|NCT02957305|11909218|FG000|NOT COMPLETED|Overall Study||0
10745268|NCT02957305|11909219|FG001|NOT COMPLETED|Overall Study||0
10745269|NCT02957331|11909227|FG000|STARTED|Overall Study||14
10745270|NCT02957331|11909228|FG001|STARTED|Overall Study||12
10745271|NCT02957331|11909227|FG000|COMPLETED|Overall Study||13
10745272|NCT02957331|11909228|FG001|COMPLETED|Overall Study||12
10745273|NCT02957331|11909227|FG000|NOT COMPLETED|Overall Study||1
10745274|NCT02957331|11909228|FG001|NOT COMPLETED|Overall Study||0
10745275|NCT02957357|11909236|FG000|STARTED|Overall Study||10479
10745276|NCT02957357|11909237|FG001|STARTED|Overall Study||835
10745277|NCT02957357|11909236|FG000|COMPLETED|Overall Study||10479
10745278|NCT02957357|11909237|FG001|COMPLETED|Overall Study||835
10745279|NCT02957357|11909236|FG000|NOT COMPLETED|Overall Study||0
10745280|NCT02957357|11909237|FG001|NOT COMPLETED|Overall Study||0
10745281|NCT02957682|11909252|FG000|STARTED|Overall Study||1088
10745282|NCT02957682|11909253|FG001|STARTED|Overall Study||1088
10745283|NCT02957682|11909252|FG000|Randomized and Treated|Overall Study||1085
10745284|NCT02957682|11909253|FG001|Randomized and Treated|Overall Study||1086
10745285|NCT02957682|11909252|FG000|COMPLETED|Overall Study||890
10745286|NCT02957682|11909253|FG001|COMPLETED|Overall Study||919
10745287|NCT02957682|11909252|FG000|NOT COMPLETED|Overall Study||198
10745288|NCT02957682|11909253|FG001|NOT COMPLETED|Overall Study||169
10745289|NCT02957747|11909261|FG000|STARTED|Overall Study||76
10745290|NCT02957747|11909262|FG001|STARTED|Overall Study||77
10745291|NCT02957747|11909261|FG000|COMPLETED|Overall Study||66
10745292|NCT02957747|11909262|FG001|COMPLETED|Overall Study||69
10745293|NCT02957747|11909261|FG000|NOT COMPLETED|Overall Study||10
10745294|NCT02957747|11909262|FG001|NOT COMPLETED|Overall Study||8
10745295|NCT02957942|11909271|FG000|STARTED|Overall Study||7
10745296|NCT02957942|11909272|FG001|STARTED|Overall Study|7 healthy individuals were recruited as control; 6 were recruited for practicing experiment details.|13
10745297|NCT02957942|11909271|FG000|COMPLETED|Overall Study||7
10745298|NCT02957942|11909272|FG001|COMPLETED|Overall Study||6
10745299|NCT02957942|11909271|FG000|NOT COMPLETED|Overall Study||0
10745300|NCT02957942|11909272|FG001|NOT COMPLETED|Overall Study||7
10745301|NCT02958267|11909280|FG000|STARTED|Enrollment||17
10745302|NCT02958267|11909281|FG001|STARTED|Enrollment||15
10745303|NCT02958267|11909280|FG000|COMPLETED|Enrollment||17
10544784|NCT01491672|11697938|FG000|STARTED|Overall Study||58
10544785|NCT01491672|11697939|FG001|STARTED|Overall Study|1 participant died prior to treatment initiation.|62
10745304|NCT02958267|11909281|FG001|COMPLETED|Enrollment||15
10745305|NCT02958267|11909280|FG000|NOT COMPLETED|Enrollment||0
10745306|NCT02958267|11909281|FG001|NOT COMPLETED|Enrollment||0
10745307|NCT02958267|11909280|FG000|STARTED|Enrollment to Actual Treatment Complete||17
10745308|NCT02958267|11909281|FG001|STARTED|Enrollment to Actual Treatment Complete||15
10745309|NCT02958267|11909280|FG000|COMPLETED|Enrollment to Actual Treatment Complete||15
10745310|NCT02958267|11909281|FG001|COMPLETED|Enrollment to Actual Treatment Complete||15
10745311|NCT02958267|11909280|FG000|NOT COMPLETED|Enrollment to Actual Treatment Complete||2
10745312|NCT02958267|11909281|FG001|NOT COMPLETED|Enrollment to Actual Treatment Complete||0
10745313|NCT02958267|11909280|FG000|STARTED|Follow-up Visits||15
10745314|NCT02958267|11909281|FG001|STARTED|Follow-up Visits||15
10745315|NCT02958267|11909280|FG000|3 Month Follow-up|Follow-up Visits||15
10745316|NCT02958267|11909281|FG001|3 Month Follow-up|Follow-up Visits||15
10745317|NCT02958267|11909280|FG000|6 Month Follow-up|Follow-up Visits||14
10745318|NCT02958267|11909281|FG001|6 Month Follow-up|Follow-up Visits||14
10745319|NCT02958267|11909280|FG000|12 Month Follow-up|Follow-up Visits||13
10745320|NCT02958267|11909281|FG001|12 Month Follow-up|Follow-up Visits||14
10745321|NCT02958267|11909280|FG000|COMPLETED|Follow-up Visits||13
10745322|NCT02958267|11909281|FG001|COMPLETED|Follow-up Visits||14
10745323|NCT02958267|11909280|FG000|NOT COMPLETED|Follow-up Visits||2
10745324|NCT02958267|11909281|FG001|NOT COMPLETED|Follow-up Visits||1
10745325|NCT02958345|11909289|FG000|STARTED|Overall Study||14
10745326|NCT02958345|11909290|FG001|STARTED|Overall Study||14
10745327|NCT02958345|11909289|FG000|COMPLETED|Overall Study||13
10745328|NCT02958345|11909290|FG001|COMPLETED|Overall Study||13
10745329|NCT02958345|11909289|FG000|NOT COMPLETED|Overall Study||1
10745330|NCT02958345|11909290|FG001|NOT COMPLETED|Overall Study||1
10745331|NCT02958527|11909296|FG000|STARTED|Overall Study||1408
10745332|NCT02958527|11909296|FG000|COMPLETED|Overall Study||1396
10745333|NCT02958527|11909296|FG000|NOT COMPLETED|Overall Study||12
10745334|NCT02958553|11909309|FG000|STARTED|Phase I, 1st Visit -Passive Prosthesis||8
10745335|NCT02958553|11909309|FG000|COMPLETED|Phase I, 1st Visit -Passive Prosthesis||8
10745336|NCT02958553|11909309|FG000|NOT COMPLETED|Phase I, 1st Visit -Passive Prosthesis||0
10745337|NCT02958553|11909309|FG000|STARTED|Phase I, 2nd Visit -Fitted With emPOWER||8
10745338|NCT02958553|11909309|FG000|COMPLETED|Phase I, 2nd Visit -Fitted With emPOWER||8
10745339|NCT02958553|11909309|FG000|NOT COMPLETED|Phase I, 2nd Visit -Fitted With emPOWER||0
10745340|NCT02958553|11909309|FG000|STARTED|Phase I, 3rd Visit -2 Week emPOWER FU||8
10745341|NCT02958553|11909309|FG000|COMPLETED|Phase I, 3rd Visit -2 Week emPOWER FU||7
10745342|NCT02958553|11909309|FG000|NOT COMPLETED|Phase I, 3rd Visit -2 Week emPOWER FU||1
10745343|NCT02958553|11909309|FG000|STARTED|Phase II, 4th Visit -3 Month emPOWER FU|Only 4 subjects started Phase II of the study. Phase II was optional per protocol.|7
10745344|NCT02958553|11909309|FG000|COMPLETED|Phase II, 4th Visit -3 Month emPOWER FU||4
10745345|NCT02958553|11909309|FG000|NOT COMPLETED|Phase II, 4th Visit -3 Month emPOWER FU||3
10745346|NCT02958553|11909309|FG000|STARTED|Phase II, 5th Visit -Crossover Visit||4
10745347|NCT02958553|11909309|FG000|COMPLETED|Phase II, 5th Visit -Crossover Visit||4
10745348|NCT02958553|11909309|FG000|NOT COMPLETED|Phase II, 5th Visit -Crossover Visit||0
10745349|NCT02958553|11909309|FG000|STARTED|Phase II, 6th Visit -6 Month emPOWER FU||4
10745350|NCT02958553|11909309|FG000|COMPLETED|Phase II, 6th Visit -6 Month emPOWER FU||2
10745351|NCT02958553|11909309|FG000|NOT COMPLETED|Phase II, 6th Visit -6 Month emPOWER FU||2
10745352|NCT02958553|11909309|FG000|STARTED|Phase II, 7th Visit -12 Month emPOWER FU||2
10745353|NCT02958553|11909309|FG000|COMPLETED|Phase II, 7th Visit -12 Month emPOWER FU||2
10745354|NCT02958553|11909309|FG000|NOT COMPLETED|Phase II, 7th Visit -12 Month emPOWER FU||0
10745355|NCT02958787|11909314|FG000|STARTED|Overall Study||135
10745356|NCT02958787|11909314|FG000|COMPLETED|Overall Study||135
10745357|NCT02958787|11909314|FG000|NOT COMPLETED|Overall Study||0
10745358|NCT02958826|11909320|FG000|STARTED|Overall Study||80
10745359|NCT02958826|11909321|FG001|STARTED|Overall Study||80
10745360|NCT02958826|11909320|FG000|COMPLETED|Overall Study||80
10745361|NCT02958826|11909321|FG001|COMPLETED|Overall Study||80
10745362|NCT02958826|11909320|FG000|NOT COMPLETED|Overall Study||0
10745363|NCT02958826|11909321|FG001|NOT COMPLETED|Overall Study||0
10745364|NCT02958956|11909331|FG000|STARTED|Overall Study||38190
10745365|NCT02958956|11909332|FG001|STARTED|Overall Study||198317
10745366|NCT02958956|11909331|FG000|COMPLETED|Overall Study||38190
10745367|NCT02958956|11909332|FG001|COMPLETED|Overall Study||198317
10745368|NCT02958956|11909331|FG000|NOT COMPLETED|Overall Study||0
10745369|NCT02958956|11909332|FG001|NOT COMPLETED|Overall Study||0
10745370|NCT02958969|11909339|FG000|STARTED|Overall Study||50
10745371|NCT02958969|11909339|FG000|COMPLETED|Overall Study||50
10745372|NCT02958969|11909339|FG000|NOT COMPLETED|Overall Study||0
10745373|NCT02958982|11909354|FG000|STARTED|Cohort 1: 25 mg in SAD Study||1
10745374|NCT02958982|11909355|FG001|STARTED|Cohort 1: 25 mg in SAD Study||3
10745375|NCT02958982|11909356|FG002|STARTED|Cohort 1: 25 mg in SAD Study||0
10745376|NCT02958982|11909357|FG003|STARTED|Cohort 1: 25 mg in SAD Study||0
10745377|NCT02958982|11909358|FG004|STARTED|Cohort 1: 25 mg in SAD Study||0
10745378|NCT02958982|11909359|FG005|STARTED|Cohort 1: 25 mg in SAD Study||0
10745379|NCT02958982|11909360|FG006|STARTED|Cohort 1: 25 mg in SAD Study||0
10745380|NCT02958982|11909361|FG007|STARTED|Cohort 1: 25 mg in SAD Study||0
10745381|NCT02958982|11909362|FG008|STARTED|Cohort 1: 25 mg in SAD Study||0
10745382|NCT02958982|11909363|FG009|STARTED|Cohort 1: 25 mg in SAD Study||0
10745383|NCT02958982|11909364|FG010|STARTED|Cohort 1: 25 mg in SAD Study||0
10745384|NCT02958982|11909354|FG000|COMPLETED|Cohort 1: 25 mg in SAD Study||1
10745385|NCT02958982|11909355|FG001|COMPLETED|Cohort 1: 25 mg in SAD Study||3
10745386|NCT02958982|11909356|FG002|COMPLETED|Cohort 1: 25 mg in SAD Study||0
10745387|NCT02958982|11909357|FG003|COMPLETED|Cohort 1: 25 mg in SAD Study||0
10745388|NCT02958982|11909358|FG004|COMPLETED|Cohort 1: 25 mg in SAD Study||0
10745389|NCT02958982|11909359|FG005|COMPLETED|Cohort 1: 25 mg in SAD Study||0
10745390|NCT02958982|11909360|FG006|COMPLETED|Cohort 1: 25 mg in SAD Study||0
10745391|NCT02958982|11909361|FG007|COMPLETED|Cohort 1: 25 mg in SAD Study||0
10745392|NCT02958982|11909362|FG008|COMPLETED|Cohort 1: 25 mg in SAD Study||0
10745393|NCT02958982|11909363|FG009|COMPLETED|Cohort 1: 25 mg in SAD Study||0
10745394|NCT02958982|11909364|FG010|COMPLETED|Cohort 1: 25 mg in SAD Study||0
10745395|NCT02958982|11909354|FG000|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
10745396|NCT02958982|11909355|FG001|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
10745397|NCT02958982|11909356|FG002|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
10745398|NCT02958982|11909357|FG003|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
10745399|NCT02958982|11909358|FG004|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
10745400|NCT02958982|11909359|FG005|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
10745401|NCT02958982|11909360|FG006|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
10745402|NCT02958982|11909361|FG007|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
10745403|NCT02958982|11909362|FG008|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
10745404|NCT02958982|11909363|FG009|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
10745405|NCT02958982|11909364|FG010|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
10745406|NCT02958982|11909354|FG000|STARTED|Cohort 2: 50 mg in SAD Study||2
10745407|NCT02958982|11909355|FG001|STARTED|Cohort 2: 50 mg in SAD Study||0
10745408|NCT02958982|11909356|FG002|STARTED|Cohort 2: 50 mg in SAD Study||4
10745409|NCT02958982|11909357|FG003|STARTED|Cohort 2: 50 mg in SAD Study||0
10745410|NCT02958982|11909358|FG004|STARTED|Cohort 2: 50 mg in SAD Study||0
10745411|NCT02958982|11909359|FG005|STARTED|Cohort 2: 50 mg in SAD Study||0
10745412|NCT02958982|11909360|FG006|STARTED|Cohort 2: 50 mg in SAD Study||0
10745413|NCT02958982|11909361|FG007|STARTED|Cohort 2: 50 mg in SAD Study||0
10745414|NCT02958982|11909362|FG008|STARTED|Cohort 2: 50 mg in SAD Study||0
10745415|NCT02958982|11909363|FG009|STARTED|Cohort 2: 50 mg in SAD Study||0
10745416|NCT02958982|11909364|FG010|STARTED|Cohort 2: 50 mg in SAD Study||0
10745417|NCT02958982|11909354|FG000|COMPLETED|Cohort 2: 50 mg in SAD Study||2
10745418|NCT02958982|11909355|FG001|COMPLETED|Cohort 2: 50 mg in SAD Study||0
10745419|NCT02958982|11909356|FG002|COMPLETED|Cohort 2: 50 mg in SAD Study||4
10745420|NCT02958982|11909357|FG003|COMPLETED|Cohort 2: 50 mg in SAD Study||0
10745421|NCT02958982|11909358|FG004|COMPLETED|Cohort 2: 50 mg in SAD Study||0
10745422|NCT02958982|11909359|FG005|COMPLETED|Cohort 2: 50 mg in SAD Study||0
10745423|NCT02958982|11909360|FG006|COMPLETED|Cohort 2: 50 mg in SAD Study||0
10745424|NCT02958982|11909361|FG007|COMPLETED|Cohort 2: 50 mg in SAD Study||0
10745425|NCT02958982|11909362|FG008|COMPLETED|Cohort 2: 50 mg in SAD Study||0
10745426|NCT02958982|11909363|FG009|COMPLETED|Cohort 2: 50 mg in SAD Study||0
10745427|NCT02958982|11909364|FG010|COMPLETED|Cohort 2: 50 mg in SAD Study||0
10745428|NCT02958982|11909354|FG000|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
10745429|NCT02958982|11909355|FG001|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
10745430|NCT02958982|11909356|FG002|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
10745431|NCT02958982|11909357|FG003|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
10745432|NCT02958982|11909358|FG004|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
10745433|NCT02958982|11909359|FG005|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
10745434|NCT02958982|11909360|FG006|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
10745435|NCT02958982|11909361|FG007|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
10745436|NCT02958982|11909362|FG008|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
10745437|NCT02958982|11909363|FG009|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
10745438|NCT02958982|11909364|FG010|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
10745439|NCT02958982|11909354|FG000|STARTED|Cohort 3: 100 mg in SAD Study||2
10745440|NCT02958982|11909355|FG001|STARTED|Cohort 3: 100 mg in SAD Study||0
10745441|NCT02958982|11909356|FG002|STARTED|Cohort 3: 100 mg in SAD Study||0
10745442|NCT02958982|11909357|FG003|STARTED|Cohort 3: 100 mg in SAD Study||4
10745443|NCT02958982|11909358|FG004|STARTED|Cohort 3: 100 mg in SAD Study||0
10745444|NCT02958982|11909359|FG005|STARTED|Cohort 3: 100 mg in SAD Study||0
10745445|NCT02958982|11909360|FG006|STARTED|Cohort 3: 100 mg in SAD Study||0
10745446|NCT02958982|11909361|FG007|STARTED|Cohort 3: 100 mg in SAD Study||0
10745447|NCT02958982|11909362|FG008|STARTED|Cohort 3: 100 mg in SAD Study||0
10745448|NCT02958982|11909363|FG009|STARTED|Cohort 3: 100 mg in SAD Study||0
10745449|NCT02958982|11909364|FG010|STARTED|Cohort 3: 100 mg in SAD Study||0
10745450|NCT02958982|11909354|FG000|COMPLETED|Cohort 3: 100 mg in SAD Study||2
10745451|NCT02958982|11909355|FG001|COMPLETED|Cohort 3: 100 mg in SAD Study||0
10745452|NCT02958982|11909356|FG002|COMPLETED|Cohort 3: 100 mg in SAD Study||0
10745453|NCT02958982|11909357|FG003|COMPLETED|Cohort 3: 100 mg in SAD Study||4
10745454|NCT02958982|11909358|FG004|COMPLETED|Cohort 3: 100 mg in SAD Study||0
10745455|NCT02958982|11909359|FG005|COMPLETED|Cohort 3: 100 mg in SAD Study||0
10745456|NCT02958982|11909360|FG006|COMPLETED|Cohort 3: 100 mg in SAD Study||0
10745457|NCT02958982|11909361|FG007|COMPLETED|Cohort 3: 100 mg in SAD Study||0
10745458|NCT02958982|11909362|FG008|COMPLETED|Cohort 3: 100 mg in SAD Study||0
10745459|NCT02958982|11909363|FG009|COMPLETED|Cohort 3: 100 mg in SAD Study||0
10745460|NCT02958982|11909364|FG010|COMPLETED|Cohort 3: 100 mg in SAD Study||0
10745461|NCT02958982|11909354|FG000|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
10745462|NCT02958982|11909355|FG001|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
10745463|NCT02958982|11909356|FG002|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
10745464|NCT02958982|11909357|FG003|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
10745465|NCT02958982|11909358|FG004|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
10745466|NCT02958982|11909359|FG005|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
10745467|NCT02958982|11909360|FG006|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
10745468|NCT02958982|11909361|FG007|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
10745469|NCT02958982|11909362|FG008|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
10745470|NCT02958982|11909363|FG009|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
10745471|NCT02958982|11909364|FG010|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
10745472|NCT02958982|11909354|FG000|STARTED|Cohort 4: 200 mg in SAD Study||2
10745473|NCT02958982|11909355|FG001|STARTED|Cohort 4: 200 mg in SAD Study||0
10745474|NCT02958982|11909356|FG002|STARTED|Cohort 4: 200 mg in SAD Study||0
10745475|NCT02958982|11909357|FG003|STARTED|Cohort 4: 200 mg in SAD Study||0
10745476|NCT02958982|11909358|FG004|STARTED|Cohort 4: 200 mg in SAD Study||6
10745477|NCT02958982|11909359|FG005|STARTED|Cohort 4: 200 mg in SAD Study||0
10745478|NCT02958982|11909360|FG006|STARTED|Cohort 4: 200 mg in SAD Study||0
10745479|NCT02958982|11909361|FG007|STARTED|Cohort 4: 200 mg in SAD Study||0
10745480|NCT02958982|11909362|FG008|STARTED|Cohort 4: 200 mg in SAD Study||0
10745481|NCT02958982|11909363|FG009|STARTED|Cohort 4: 200 mg in SAD Study||0
10745482|NCT02958982|11909364|FG010|STARTED|Cohort 4: 200 mg in SAD Study||0
10745483|NCT02958982|11909354|FG000|COMPLETED|Cohort 4: 200 mg in SAD Study||2
10745484|NCT02958982|11909355|FG001|COMPLETED|Cohort 4: 200 mg in SAD Study||0
10745485|NCT02958982|11909356|FG002|COMPLETED|Cohort 4: 200 mg in SAD Study||0
10745486|NCT02958982|11909357|FG003|COMPLETED|Cohort 4: 200 mg in SAD Study||0
10745487|NCT02958982|11909358|FG004|COMPLETED|Cohort 4: 200 mg in SAD Study||6
10745488|NCT02958982|11909359|FG005|COMPLETED|Cohort 4: 200 mg in SAD Study||0
10745489|NCT02958982|11909360|FG006|COMPLETED|Cohort 4: 200 mg in SAD Study||0
10745490|NCT02958982|11909361|FG007|COMPLETED|Cohort 4: 200 mg in SAD Study||0
10745491|NCT02958982|11909362|FG008|COMPLETED|Cohort 4: 200 mg in SAD Study||0
10745492|NCT02958982|11909363|FG009|COMPLETED|Cohort 4: 200 mg in SAD Study||0
10745493|NCT02958982|11909364|FG010|COMPLETED|Cohort 4: 200 mg in SAD Study||0
10745494|NCT02958982|11909354|FG000|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
10745495|NCT02958982|11909355|FG001|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
10745496|NCT02958982|11909356|FG002|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
10745497|NCT02958982|11909357|FG003|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
10745498|NCT02958982|11909358|FG004|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
10745499|NCT02958982|11909359|FG005|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
10745500|NCT02958982|11909360|FG006|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
10745501|NCT02958982|11909361|FG007|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
10745502|NCT02958982|11909362|FG008|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
10745503|NCT02958982|11909363|FG009|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
10745504|NCT02958982|11909364|FG010|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
10745505|NCT02958982|11909354|FG000|STARTED|Cohort 5: 400 mg in SAD Study||2
10745506|NCT02958982|11909355|FG001|STARTED|Cohort 5: 400 mg in SAD Study||0
10745507|NCT02958982|11909356|FG002|STARTED|Cohort 5: 400 mg in SAD Study||0
10745508|NCT02958982|11909357|FG003|STARTED|Cohort 5: 400 mg in SAD Study||0
10745509|NCT02958982|11909358|FG004|STARTED|Cohort 5: 400 mg in SAD Study||0
10745510|NCT02958982|11909359|FG005|STARTED|Cohort 5: 400 mg in SAD Study||6
10745511|NCT02958982|11909360|FG006|STARTED|Cohort 5: 400 mg in SAD Study||0
10745512|NCT02958982|11909361|FG007|STARTED|Cohort 5: 400 mg in SAD Study||0
10745513|NCT02958982|11909362|FG008|STARTED|Cohort 5: 400 mg in SAD Study||0
10745514|NCT02958982|11909363|FG009|STARTED|Cohort 5: 400 mg in SAD Study||0
10745515|NCT02958982|11909364|FG010|STARTED|Cohort 5: 400 mg in SAD Study||0
10745516|NCT02958982|11909354|FG000|COMPLETED|Cohort 5: 400 mg in SAD Study||2
10745517|NCT02958982|11909355|FG001|COMPLETED|Cohort 5: 400 mg in SAD Study||0
10745518|NCT02958982|11909356|FG002|COMPLETED|Cohort 5: 400 mg in SAD Study||0
10745519|NCT02958982|11909357|FG003|COMPLETED|Cohort 5: 400 mg in SAD Study||0
10745520|NCT02958982|11909358|FG004|COMPLETED|Cohort 5: 400 mg in SAD Study||0
10745521|NCT02958982|11909359|FG005|COMPLETED|Cohort 5: 400 mg in SAD Study||6
10745522|NCT02958982|11909360|FG006|COMPLETED|Cohort 5: 400 mg in SAD Study||0
10745523|NCT02958982|11909361|FG007|COMPLETED|Cohort 5: 400 mg in SAD Study||0
10745524|NCT02958982|11909362|FG008|COMPLETED|Cohort 5: 400 mg in SAD Study||0
10745525|NCT02958982|11909363|FG009|COMPLETED|Cohort 5: 400 mg in SAD Study||0
10745526|NCT02958982|11909364|FG010|COMPLETED|Cohort 5: 400 mg in SAD Study||0
10745527|NCT02958982|11909354|FG000|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
10745528|NCT02958982|11909355|FG001|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
10745529|NCT02958982|11909356|FG002|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
10745530|NCT02958982|11909357|FG003|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
10745531|NCT02958982|11909358|FG004|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
10745532|NCT02958982|11909359|FG005|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
10745533|NCT02958982|11909360|FG006|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
10745534|NCT02958982|11909361|FG007|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
10745535|NCT02958982|11909362|FG008|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
10745536|NCT02958982|11909363|FG009|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
10745537|NCT02958982|11909364|FG010|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
10745538|NCT02958982|11909354|FG000|STARTED|Cohort 1 : 25 mg in MAD Study||0
10745539|NCT02958982|11909355|FG001|STARTED|Cohort 1 : 25 mg in MAD Study||0
10745540|NCT02958982|11909356|FG002|STARTED|Cohort 1 : 25 mg in MAD Study||0
10745541|NCT02958982|11909357|FG003|STARTED|Cohort 1 : 25 mg in MAD Study||0
10745542|NCT02958982|11909358|FG004|STARTED|Cohort 1 : 25 mg in MAD Study||0
10745543|NCT02958982|11909359|FG005|STARTED|Cohort 1 : 25 mg in MAD Study||0
10745544|NCT02958982|11909360|FG006|STARTED|Cohort 1 : 25 mg in MAD Study||2
10745545|NCT02958982|11909361|FG007|STARTED|Cohort 1 : 25 mg in MAD Study||6
10745546|NCT02958982|11909362|FG008|STARTED|Cohort 1 : 25 mg in MAD Study||0
10745547|NCT02958982|11909363|FG009|STARTED|Cohort 1 : 25 mg in MAD Study||0
10745548|NCT02958982|11909364|FG010|STARTED|Cohort 1 : 25 mg in MAD Study||0
10745549|NCT02958982|11909354|FG000|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
10745550|NCT02958982|11909355|FG001|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
10745551|NCT02958982|11909356|FG002|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
10817614|NCT01216631|11981477|FG002|COMPLETED|Overall Study||1
10745552|NCT02958982|11909357|FG003|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
10745553|NCT02958982|11909358|FG004|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
10745554|NCT02958982|11909359|FG005|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
10745555|NCT02958982|11909360|FG006|COMPLETED|Cohort 1 : 25 mg in MAD Study||2
10745556|NCT02958982|11909361|FG007|COMPLETED|Cohort 1 : 25 mg in MAD Study||6
10745557|NCT02958982|11909362|FG008|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
10745558|NCT02958982|11909363|FG009|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
10745559|NCT02958982|11909364|FG010|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
10745560|NCT02958982|11909354|FG000|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
10745561|NCT02958982|11909355|FG001|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
10745562|NCT02958982|11909356|FG002|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
10745563|NCT02958982|11909357|FG003|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
10745564|NCT02958982|11909358|FG004|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
10745565|NCT02958982|11909359|FG005|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
10745566|NCT02958982|11909360|FG006|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
10745567|NCT02958982|11909361|FG007|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
10745568|NCT02958982|11909362|FG008|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
10745569|NCT02958982|11909363|FG009|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
10745570|NCT02958982|11909364|FG010|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
10745571|NCT02958982|11909354|FG000|STARTED|Cohort 2: 100 mg in MAD Study||0
10745572|NCT02958982|11909355|FG001|STARTED|Cohort 2: 100 mg in MAD Study||0
10745573|NCT02958982|11909356|FG002|STARTED|Cohort 2: 100 mg in MAD Study||0
10745574|NCT02958982|11909357|FG003|STARTED|Cohort 2: 100 mg in MAD Study||0
10745575|NCT02958982|11909358|FG004|STARTED|Cohort 2: 100 mg in MAD Study||0
10745576|NCT02958982|11909359|FG005|STARTED|Cohort 2: 100 mg in MAD Study||0
10745577|NCT02958982|11909360|FG006|STARTED|Cohort 2: 100 mg in MAD Study||2
10745578|NCT02958982|11909361|FG007|STARTED|Cohort 2: 100 mg in MAD Study||0
10745579|NCT02958982|11909362|FG008|STARTED|Cohort 2: 100 mg in MAD Study||6
10745580|NCT02958982|11909363|FG009|STARTED|Cohort 2: 100 mg in MAD Study||0
10745581|NCT02958982|11909364|FG010|STARTED|Cohort 2: 100 mg in MAD Study||0
10745582|NCT02958982|11909354|FG000|COMPLETED|Cohort 2: 100 mg in MAD Study||0
10745583|NCT02958982|11909355|FG001|COMPLETED|Cohort 2: 100 mg in MAD Study||0
10745584|NCT02958982|11909356|FG002|COMPLETED|Cohort 2: 100 mg in MAD Study||0
10745585|NCT02958982|11909357|FG003|COMPLETED|Cohort 2: 100 mg in MAD Study||0
10745586|NCT02958982|11909358|FG004|COMPLETED|Cohort 2: 100 mg in MAD Study||0
10745587|NCT02958982|11909359|FG005|COMPLETED|Cohort 2: 100 mg in MAD Study||0
10745588|NCT02958982|11909360|FG006|COMPLETED|Cohort 2: 100 mg in MAD Study||2
10745589|NCT02958982|11909361|FG007|COMPLETED|Cohort 2: 100 mg in MAD Study||0
10745590|NCT02958982|11909362|FG008|COMPLETED|Cohort 2: 100 mg in MAD Study||6
10745591|NCT02958982|11909363|FG009|COMPLETED|Cohort 2: 100 mg in MAD Study||0
10745592|NCT02958982|11909364|FG010|COMPLETED|Cohort 2: 100 mg in MAD Study||0
10745593|NCT02958982|11909354|FG000|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
10745594|NCT02958982|11909355|FG001|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
10745595|NCT02958982|11909356|FG002|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
10745596|NCT02958982|11909357|FG003|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
10745597|NCT02958982|11909358|FG004|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
10745598|NCT02958982|11909359|FG005|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
10745599|NCT02958982|11909360|FG006|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
10745600|NCT02958982|11909361|FG007|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
10745601|NCT02958982|11909362|FG008|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
10745602|NCT02958982|11909363|FG009|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
10745603|NCT02958982|11909364|FG010|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
10745604|NCT02958982|11909354|FG000|STARTED|Cohort 3: 400 mg in MAD Study||0
10745605|NCT02958982|11909355|FG001|STARTED|Cohort 3: 400 mg in MAD Study||0
10745606|NCT02958982|11909356|FG002|STARTED|Cohort 3: 400 mg in MAD Study||0
10745607|NCT02958982|11909357|FG003|STARTED|Cohort 3: 400 mg in MAD Study||0
10745608|NCT02958982|11909358|FG004|STARTED|Cohort 3: 400 mg in MAD Study||0
10745609|NCT02958982|11909359|FG005|STARTED|Cohort 3: 400 mg in MAD Study||0
10745610|NCT02958982|11909360|FG006|STARTED|Cohort 3: 400 mg in MAD Study||2
10745611|NCT02958982|11909361|FG007|STARTED|Cohort 3: 400 mg in MAD Study||0
10745612|NCT02958982|11909362|FG008|STARTED|Cohort 3: 400 mg in MAD Study||0
10745613|NCT02958982|11909363|FG009|STARTED|Cohort 3: 400 mg in MAD Study||6
10745614|NCT02958982|11909364|FG010|STARTED|Cohort 3: 400 mg in MAD Study||0
10745615|NCT02958982|11909354|FG000|COMPLETED|Cohort 3: 400 mg in MAD Study||0
10745616|NCT02958982|11909355|FG001|COMPLETED|Cohort 3: 400 mg in MAD Study||0
10745617|NCT02958982|11909356|FG002|COMPLETED|Cohort 3: 400 mg in MAD Study||0
10745618|NCT02958982|11909357|FG003|COMPLETED|Cohort 3: 400 mg in MAD Study||0
10745619|NCT02958982|11909358|FG004|COMPLETED|Cohort 3: 400 mg in MAD Study||0
10745620|NCT02958982|11909359|FG005|COMPLETED|Cohort 3: 400 mg in MAD Study||0
10745621|NCT02958982|11909360|FG006|COMPLETED|Cohort 3: 400 mg in MAD Study||2
10745622|NCT02958982|11909361|FG007|COMPLETED|Cohort 3: 400 mg in MAD Study||0
10745623|NCT02958982|11909362|FG008|COMPLETED|Cohort 3: 400 mg in MAD Study||0
10745624|NCT02958982|11909363|FG009|COMPLETED|Cohort 3: 400 mg in MAD Study||6
10745625|NCT02958982|11909364|FG010|COMPLETED|Cohort 3: 400 mg in MAD Study||0
10745626|NCT02958982|11909354|FG000|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
10745627|NCT02958982|11909355|FG001|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
10745628|NCT02958982|11909356|FG002|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
10745629|NCT02958982|11909357|FG003|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
10745630|NCT02958982|11909358|FG004|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
10745631|NCT02958982|11909359|FG005|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
10817615|NCT01216631|11981475|FG000|NOT COMPLETED|Overall Study||0
10817616|NCT01216631|11981476|FG001|NOT COMPLETED|Overall Study||0
10817617|NCT01216631|11981477|FG002|NOT COMPLETED|Overall Study||0
10817618|NCT01211756|11981485|FG000|STARTED|Overall Study||1
10745632|NCT02958982|11909360|FG006|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
10745633|NCT02958982|11909361|FG007|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
10745634|NCT02958982|11909362|FG008|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
10745635|NCT02958982|11909363|FG009|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
10745636|NCT02958982|11909364|FG010|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
10745637|NCT02958982|11909354|FG000|STARTED|Proof of Concept Study||0
10745638|NCT02958982|11909355|FG001|STARTED|Proof of Concept Study||0
10745639|NCT02958982|11909356|FG002|STARTED|Proof of Concept Study||0
10745640|NCT02958982|11909357|FG003|STARTED|Proof of Concept Study||0
10745641|NCT02958982|11909358|FG004|STARTED|Proof of Concept Study||0
10745642|NCT02958982|11909359|FG005|STARTED|Proof of Concept Study||0
10745643|NCT02958982|11909360|FG006|STARTED|Proof of Concept Study||0
10745644|NCT02958982|11909361|FG007|STARTED|Proof of Concept Study||0
10745645|NCT02958982|11909362|FG008|STARTED|Proof of Concept Study||0
10745646|NCT02958982|11909363|FG009|STARTED|Proof of Concept Study||0
10745647|NCT02958982|11909364|FG010|STARTED|Proof of Concept Study||1
10745648|NCT02958982|11909354|FG000|COMPLETED|Proof of Concept Study||0
10745649|NCT02958982|11909355|FG001|COMPLETED|Proof of Concept Study||0
10745650|NCT02958982|11909356|FG002|COMPLETED|Proof of Concept Study||0
10745651|NCT02958982|11909357|FG003|COMPLETED|Proof of Concept Study||0
10745652|NCT02958982|11909358|FG004|COMPLETED|Proof of Concept Study||0
10745653|NCT02958982|11909359|FG005|COMPLETED|Proof of Concept Study||0
10745654|NCT02958982|11909360|FG006|COMPLETED|Proof of Concept Study||0
10745655|NCT02958982|11909361|FG007|COMPLETED|Proof of Concept Study||0
10745656|NCT02958982|11909362|FG008|COMPLETED|Proof of Concept Study||0
10745657|NCT02958982|11909363|FG009|COMPLETED|Proof of Concept Study||0
10745658|NCT02958982|11909364|FG010|COMPLETED|Proof of Concept Study||1
10745659|NCT02958982|11909354|FG000|NOT COMPLETED|Proof of Concept Study||0
10745660|NCT02958982|11909355|FG001|NOT COMPLETED|Proof of Concept Study||0
10745661|NCT02958982|11909356|FG002|NOT COMPLETED|Proof of Concept Study||0
10745662|NCT02958982|11909357|FG003|NOT COMPLETED|Proof of Concept Study||0
10745663|NCT02958982|11909358|FG004|NOT COMPLETED|Proof of Concept Study||0
10745664|NCT02958982|11909359|FG005|NOT COMPLETED|Proof of Concept Study||0
10745665|NCT02958982|11909360|FG006|NOT COMPLETED|Proof of Concept Study||0
10745666|NCT02958982|11909361|FG007|NOT COMPLETED|Proof of Concept Study||0
10745667|NCT02958982|11909362|FG008|NOT COMPLETED|Proof of Concept Study||0
10745668|NCT02958982|11909363|FG009|NOT COMPLETED|Proof of Concept Study||0
10745669|NCT02958982|11909364|FG010|NOT COMPLETED|Proof of Concept Study||0
10745670|NCT02958995|11909399|FG000|STARTED|Overall Study||2630666
10745671|NCT02958995|11909400|FG001|STARTED|Overall Study||107495
10745672|NCT02958995|11909399|FG000|COMPLETED|Overall Study||2630666
10745673|NCT02958995|11909400|FG001|COMPLETED|Overall Study||107495
10745674|NCT02958995|11909399|FG000|NOT COMPLETED|Overall Study||0
10745675|NCT02958995|11909400|FG001|NOT COMPLETED|Overall Study||0
10745676|NCT02959138|11909409|FG000|STARTED|Overall Study||10
10745677|NCT02959138|11909410|FG001|STARTED|Overall Study||10
10745678|NCT02959138|11909411|FG002|STARTED|Overall Study||16
10745679|NCT02959138|11909409|FG000|COMPLETED|Overall Study||10
10745680|NCT02959138|11909410|FG001|COMPLETED|Overall Study||9
10745681|NCT02959138|11909411|FG002|COMPLETED|Overall Study||16
10745682|NCT02959138|11909409|FG000|NOT COMPLETED|Overall Study||0
10745683|NCT02959138|11909410|FG001|NOT COMPLETED|Overall Study||1
10745684|NCT02959138|11909411|FG002|NOT COMPLETED|Overall Study||0
10745685|NCT02959177|11909426|FG000|STARTED|Double-Blind Treatment Phase||115
10745686|NCT02959177|11909427|FG001|STARTED|Double-Blind Treatment Phase||114
10745687|NCT02959177|11909428|FG002|STARTED|Double-Blind Treatment Phase||230
10745688|NCT02959177|11909426|FG000|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||115
10745689|NCT02959177|11909427|FG001|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||114
10745690|NCT02959177|11909428|FG002|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||230
10745691|NCT02959177|11909426|FG000|COMPLETED|Double-Blind Treatment Phase||104
10745692|NCT02959177|11909427|FG001|COMPLETED|Double-Blind Treatment Phase||111
10745693|NCT02959177|11909428|FG002|COMPLETED|Double-Blind Treatment Phase||225
10745694|NCT02959177|11909426|FG000|NOT COMPLETED|Double-Blind Treatment Phase||11
10745695|NCT02959177|11909427|FG001|NOT COMPLETED|Double-Blind Treatment Phase||3
10745696|NCT02959177|11909428|FG002|NOT COMPLETED|Double-Blind Treatment Phase||5
10745697|NCT02959177|11909426|FG000|STARTED|Follow-up Post Treatment Phase|Not all participants entered Post Treatment Follow-up Phase|52
10745698|NCT02959177|11909427|FG001|STARTED|Follow-up Post Treatment Phase|Not all participants entered Post Treatment Follow-up Phase|52
10745699|NCT02959177|11909428|FG002|STARTED|Follow-up Post Treatment Phase|Not all participants entered Post Treatment Follow-up Phase|100
10745700|NCT02959177|11909426|FG000|COMPLETED|Follow-up Post Treatment Phase||51
10745701|NCT02959177|11909427|FG001|COMPLETED|Follow-up Post Treatment Phase||51
10745702|NCT02959177|11909428|FG002|COMPLETED|Follow-up Post Treatment Phase||98
10745703|NCT02959177|11909426|FG000|NOT COMPLETED|Follow-up Post Treatment Phase||1
10745704|NCT02959177|11909427|FG001|NOT COMPLETED|Follow-up Post Treatment Phase||1
10745705|NCT02959177|11909428|FG002|NOT COMPLETED|Follow-up Post Treatment Phase||2
10745706|NCT02959190|11909446|FG000|STARTED|Open Label||120
10745707|NCT02959190|11909447|FG001|STARTED|Open Label||126
10745708|NCT02959190|11909448|FG002|STARTED|Open Label||32
10745709|NCT02959190|11909449|FG003|STARTED|Open Label||33
10745710|NCT02959190|11909446|FG000|Received at Least 1 Dose of Study Drug|Open Label||120
10745711|NCT02959190|11909447|FG001|Received at Least 1 Dose of Study Drug|Open Label||126
10745712|NCT02959190|11909448|FG002|Received at Least 1 Dose of Study Drug|Open Label||32
10745713|NCT02959190|11909449|FG003|Received at Least 1 Dose of Study Drug|Open Label||33
10745714|NCT02959190|11909446|FG000|120mg/120mg Galcanezumab - EM|Open Label||58
10745715|NCT02959190|11909447|FG001|120mg/120mg Galcanezumab - EM|Open Label||0
10745716|NCT02959190|11909448|FG002|120mg/120mg Galcanezumab - EM|Open Label||0
10745717|NCT02959190|11909449|FG003|120mg/120mg Galcanezumab - EM|Open Label||0
10745718|NCT02959190|11909446|FG000|240mg/240mg Galcanezumab - EM|Open Label||0
10745719|NCT02959190|11909447|FG001|240mg/240mg Galcanezumab - EM|Open Label||62
10745720|NCT02959190|11909448|FG002|240mg/240mg Galcanezumab - EM|Open Label||0
10745721|NCT02959190|11909449|FG003|240mg/240mg Galcanezumab - EM|Open Label||0
10745722|NCT02959190|11909446|FG000|Placebo/ 120mg Galcanezumab - EM|Open Label||62
10745723|NCT02959190|11909447|FG001|Placebo/ 120mg Galcanezumab - EM|Open Label||0
10745724|NCT02959190|11909448|FG002|Placebo/ 120mg Galcanezumab - EM|Open Label||0
10745725|NCT02959190|11909449|FG003|Placebo/ 120mg Galcanezumab - EM|Open Label||0
10745726|NCT02959190|11909446|FG000|Placebo/ 240mg Galcanezumab - EM|Open Label||0
10745727|NCT02959190|11909447|FG001|Placebo/ 240mg Galcanezumab - EM|Open Label||64
10745728|NCT02959190|11909448|FG002|Placebo/ 240mg Galcanezumab - EM|Open Label||0
10745729|NCT02959190|11909449|FG003|Placebo/ 240mg Galcanezumab - EM|Open Label||0
10745730|NCT02959190|11909446|FG000|COMPLETED|Open Label||113
10745731|NCT02959190|11909447|FG001|COMPLETED|Open Label||110
10745732|NCT02959190|11909448|FG002|COMPLETED|Open Label||28
10745733|NCT02959190|11909449|FG003|COMPLETED|Open Label||27
10745734|NCT02959190|11909446|FG000|NOT COMPLETED|Open Label||7
10745735|NCT02959190|11909447|FG001|NOT COMPLETED|Open Label||16
10745736|NCT02959190|11909448|FG002|NOT COMPLETED|Open Label||4
10745737|NCT02959190|11909449|FG003|NOT COMPLETED|Open Label||6
10745738|NCT02959190|11909446|FG000|STARTED|Post Treatment Follow Up|Participants who discontinued open-label treatment phase had an option to enter post treatment phase|117
10745739|NCT02959190|11909447|FG001|STARTED|Post Treatment Follow Up|Participants who discontinued open-label treatment phase had an option to enter post treatment phase|120
10745740|NCT02959190|11909448|FG002|STARTED|Post Treatment Follow Up|Participants who discontinued open-label treatment phase had an option to enter post treatment phase|32
10745741|NCT02959190|11909449|FG003|STARTED|Post Treatment Follow Up|Participants who discontinued open-label treatment phase had an option to enter post treatment phase|32
10745742|NCT02959190|11909446|FG000|COMPLETED|Post Treatment Follow Up||114
10745743|NCT02959190|11909447|FG001|COMPLETED|Post Treatment Follow Up||119
10745744|NCT02959190|11909448|FG002|COMPLETED|Post Treatment Follow Up||31
10745745|NCT02959190|11909449|FG003|COMPLETED|Post Treatment Follow Up||32
10745746|NCT02959190|11909446|FG000|NOT COMPLETED|Post Treatment Follow Up||3
10745747|NCT02959190|11909447|FG001|NOT COMPLETED|Post Treatment Follow Up||1
10745748|NCT02959190|11909448|FG002|NOT COMPLETED|Post Treatment Follow Up||1
10745749|NCT02959190|11909449|FG003|NOT COMPLETED|Post Treatment Follow Up||0
10745750|NCT02959307|11909470|FG000|STARTED|Phase 1||18
10745751|NCT02959307|11909471|FG001|STARTED|Phase 1||31
10745752|NCT02959307|11909470|FG000|COMPLETED|Phase 1||15
10745753|NCT02959307|11909471|FG001|COMPLETED|Phase 1||23
10745754|NCT02959307|11909470|FG000|NOT COMPLETED|Phase 1||3
10745755|NCT02959307|11909471|FG001|NOT COMPLETED|Phase 1||8
10745756|NCT02959307|11909470|FG000|STARTED|Phase 2|This group is increased as those in sham were re-randomized to sham or NIR.|28
10745757|NCT02959307|11909471|FG001|STARTED|Phase 2|This group is decreased as those in sham were re-randomized to sham or NIR.|10
10745758|NCT02959307|11909470|FG000|COMPLETED|Phase 2||26
10745759|NCT02959307|11909471|FG001|COMPLETED|Phase 2||10
10745760|NCT02959307|11909470|FG000|NOT COMPLETED|Phase 2||2
10745761|NCT02959307|11909471|FG001|NOT COMPLETED|Phase 2||0
10745762|NCT02959437|11909481|FG000|STARTED|Overall Study||62
10745763|NCT02959437|11909482|FG001|STARTED|Overall Study||8
10745764|NCT02959437|11909483|FG002|STARTED|Overall Study|Due to early termination of the trial Treatment groups B and C were not dosed.|0
10745765|NCT02959437|11909484|FG003|STARTED|Overall Study|Due to early termination of the trial Treatment groups B and C were not dosed.|0
10745766|NCT02959437|11909481|FG000|COMPLETED|Overall Study||0
10745767|NCT02959437|11909482|FG001|COMPLETED|Overall Study||0
10745768|NCT02959437|11909483|FG002|COMPLETED|Overall Study||0
10745769|NCT02959437|11909484|FG003|COMPLETED|Overall Study||0
10745770|NCT02959437|11909481|FG000|NOT COMPLETED|Overall Study||62
10817619|NCT01211756|11981485|FG000|COMPLETED|Overall Study||1
10817620|NCT01211756|11981485|FG000|NOT COMPLETED|Overall Study||0
10817621|NCT01209520|11981489|FG000|STARTED|Overall Study||6
10817622|NCT01209520|11981489|FG000|COMPLETED|Overall Study||3
10817623|NCT01209520|11981489|FG000|NOT COMPLETED|Overall Study||3
10817624|NCT01207726|11981495|FG000|STARTED|Overall Study||7
10745771|NCT02959437|11909482|FG001|NOT COMPLETED|Overall Study||8
10745772|NCT02959437|11909483|FG002|NOT COMPLETED|Overall Study||0
10745773|NCT02959437|11909484|FG003|NOT COMPLETED|Overall Study||0
10817625|NCT01207726|11981496|FG001|STARTED|Overall Study||6
10817626|NCT01207726|11981495|FG000|COMPLETED|Overall Study||7
10817627|NCT01207726|11981496|FG001|COMPLETED|Overall Study||6
10817628|NCT01207726|11981495|FG000|NOT COMPLETED|Overall Study||0
10817629|NCT01207726|11981496|FG001|NOT COMPLETED|Overall Study||0
10817630|NCT01206296|11981506|FG000|STARTED|Overall Study||0
10817631|NCT01206296|11981506|FG000|COMPLETED|Overall Study||0
10817632|NCT01206296|11981506|FG000|NOT COMPLETED|Overall Study||0
10817633|NCT01207102|11981510|FG000|STARTED|Overall Study||10
10817634|NCT01207102|11981510|FG000|COMPLETED|Overall Study||0
10817635|NCT01207102|11981510|FG000|NOT COMPLETED|Overall Study||10
10817636|NCT01213329|11981516|FG000|STARTED|Screening||25
10817637|NCT01213329|11981517|FG001|STARTED|Screening||25
10817638|NCT01213329|11981516|FG000|COMPLETED|Screening||25
10745774|NCT02959671|11909495|FG000|STARTED|Overall Study||34
10745775|NCT02959671|11909495|FG000|COMPLETED|Overall Study||29
10745776|NCT02959671|11909495|FG000|NOT COMPLETED|Overall Study||5
10745777|NCT02959814|11909499|FG000|STARTED|Overall Study|22-02-2017|329
10745778|NCT02959814|11909499|FG000|COMPLETED|Overall Study|17-10-2017|272
10745779|NCT02959814|11909499|FG000|NOT COMPLETED|Overall Study||57
10745780|NCT02959827|11909504|FG000|STARTED|Overall Study||2320
10745781|NCT02959827|11909504|FG000|COMPLETED|Overall Study||2320
10745782|NCT02959827|11909504|FG000|NOT COMPLETED|Overall Study||0
10745783|NCT02959840|11909515|FG000|STARTED|Overall Study||60
10745784|NCT02959840|11909516|FG001|STARTED|Overall Study||60
10745785|NCT02959840|11909517|FG002|STARTED|Overall Study||60
10745786|NCT02959840|11909515|FG000|COMPLETED|Overall Study||60
10745787|NCT02959840|11909516|FG001|COMPLETED|Overall Study||60
10745788|NCT02959840|11909517|FG002|COMPLETED|Overall Study||60
10745789|NCT02959840|11909515|FG000|NOT COMPLETED|Overall Study||0
10745790|NCT02959840|11909516|FG001|NOT COMPLETED|Overall Study||0
10745791|NCT02959840|11909517|FG002|NOT COMPLETED|Overall Study||0
10745792|NCT02959853|11909527|FG000|STARTED|Overall Study||11
10745793|NCT02959853|11909528|FG001|STARTED|Overall Study||12
10745794|NCT02959853|11909527|FG000|COMPLETED|Overall Study||7
10745795|NCT02959853|11909528|FG001|COMPLETED|Overall Study||10
10745796|NCT02959853|11909527|FG000|NOT COMPLETED|Overall Study||4
10745797|NCT02959853|11909528|FG001|NOT COMPLETED|Overall Study||2
10745798|NCT02959866|11909535|FG000|STARTED|Overall Study||59
10745799|NCT02959866|11909535|FG000|Telephone Interview at 1 Month Follow-up|Overall Study||59
10745800|NCT02959866|11909535|FG000|COMPLETED|Overall Study||58
10745801|NCT02959866|11909535|FG000|NOT COMPLETED|Overall Study||1
10745802|NCT02959892|11909542|FG000|STARTED|Overall Study||6
10745803|NCT02959892|11909543|FG001|STARTED|Overall Study||6
10745804|NCT02959892|11909542|FG000|COMPLETED|Overall Study||5
10745805|NCT02959892|11909543|FG001|COMPLETED|Overall Study||5
10745806|NCT02959892|11909542|FG000|NOT COMPLETED|Overall Study||1
10745807|NCT02959892|11909543|FG001|NOT COMPLETED|Overall Study||1
10745808|NCT02959970|11909551|FG000|STARTED|Overall Study||17
10745809|NCT02959970|11909552|FG001|STARTED|Overall Study||83
10745810|NCT02959970|11909551|FG000|COMPLETED|Overall Study||15
10745811|NCT02959970|11909552|FG001|COMPLETED|Overall Study||76
10745812|NCT02959970|11909551|FG000|NOT COMPLETED|Overall Study||2
10745813|NCT02959970|11909552|FG001|NOT COMPLETED|Overall Study||7
10745814|NCT02959983|11909562|FG000|STARTED|Overall Study||172
10745815|NCT02959983|11909563|FG001|STARTED|Overall Study||174
10745816|NCT02959983|11909562|FG000|COMPLETED|Overall Study||146
10745817|NCT02959983|11909563|FG001|COMPLETED|Overall Study||149
10745818|NCT02959983|11909562|FG000|NOT COMPLETED|Overall Study||26
10745819|NCT02959983|11909563|FG001|NOT COMPLETED|Overall Study||25
10745820|NCT02959996|11909571|FG000|STARTED|Overall Study||40
10745821|NCT02959996|11909572|FG001|STARTED|Overall Study||39
10745822|NCT02959996|11909571|FG000|COMPLETED|Overall Study||40
10745823|NCT02959996|11909572|FG001|COMPLETED|Overall Study||39
10745824|NCT02959996|11909571|FG000|NOT COMPLETED|Overall Study||0
10745825|NCT02959996|11909572|FG001|NOT COMPLETED|Overall Study||0
10745826|NCT02960217|11909580|FG000|STARTED|Maintenance Phase: Treatment Period 1||22
10745827|NCT02960217|11909581|FG001|STARTED|Maintenance Phase: Treatment Period 1||21
10745828|NCT02960217|11909580|FG000|COMPLETED|Maintenance Phase: Treatment Period 1||21
10745829|NCT02960217|11909581|FG001|COMPLETED|Maintenance Phase: Treatment Period 1||21
10745830|NCT02960217|11909580|FG000|NOT COMPLETED|Maintenance Phase: Treatment Period 1||1
10745831|NCT02960217|11909581|FG001|NOT COMPLETED|Maintenance Phase: Treatment Period 1||0
10745832|NCT02960217|11909580|FG000|STARTED|Maintenance Phase: Crossover Washout||21
10745833|NCT02960217|11909581|FG001|STARTED|Maintenance Phase: Crossover Washout||21
10745834|NCT02960217|11909580|FG000|COMPLETED|Maintenance Phase: Crossover Washout||21
10745835|NCT02960217|11909581|FG001|COMPLETED|Maintenance Phase: Crossover Washout||21
10745836|NCT02960217|11909580|FG000|NOT COMPLETED|Maintenance Phase: Crossover Washout||0
10745837|NCT02960217|11909581|FG001|NOT COMPLETED|Maintenance Phase: Crossover Washout||0
10745838|NCT02960217|11909580|FG000|STARTED|Maintenance Phase: Treatment Period 2||21
10745839|NCT02960217|11909581|FG001|STARTED|Maintenance Phase: Treatment Period 2||21
10745840|NCT02960217|11909580|FG000|COMPLETED|Maintenance Phase: Treatment Period 2||20
10745841|NCT02960217|11909581|FG001|COMPLETED|Maintenance Phase: Treatment Period 2||18
10745842|NCT02960217|11909580|FG000|NOT COMPLETED|Maintenance Phase: Treatment Period 2||1
10745843|NCT02960217|11909581|FG001|NOT COMPLETED|Maintenance Phase: Treatment Period 2||3
10745844|NCT02960217|11909580|FG000|STARTED|Open-Label Extension Phase||20
10745845|NCT02960217|11909581|FG001|STARTED|Open-Label Extension Phase|5 participants completed the double blind period but did not continue in the open label period.|13
10745846|NCT02960217|11909580|FG000|COMPLETED|Open-Label Extension Phase||0
10745847|NCT02960217|11909581|FG001|COMPLETED|Open-Label Extension Phase||0
10745848|NCT02960217|11909580|FG000|NOT COMPLETED|Open-Label Extension Phase||20
10745849|NCT02960217|11909581|FG001|NOT COMPLETED|Open-Label Extension Phase||13
10745850|NCT02960295|11909591|FG000|STARTED|Overall Study||10
10745851|NCT02960295|11909591|FG000|COMPLETED|Overall Study||10
10745852|NCT02960295|11909591|FG000|NOT COMPLETED|Overall Study||0
10745853|NCT02960438|11909600|FG000|STARTED|Treatment Phase (Double-blind): 24 Weeks||56
10745854|NCT02960438|11909601|FG001|STARTED|Treatment Phase (Double-blind): 24 Weeks||29
10745855|NCT02960438|11909602|FG002|STARTED|Treatment Phase (Double-blind): 24 Weeks||54
10745856|NCT02960438|11909603|FG003|STARTED|Treatment Phase (Double-blind): 24 Weeks||55
10745857|NCT02960438|11909600|FG000|Treated Participants|Treatment Phase (Double-blind): 24 Weeks||54
10745858|NCT02960438|11909601|FG001|Treated Participants|Treatment Phase (Double-blind): 24 Weeks||28
10745859|NCT02960438|11909602|FG002|Treated Participants|Treatment Phase (Double-blind): 24 Weeks||54
10745860|NCT02960438|11909603|FG003|Treated Participants|Treatment Phase (Double-blind): 24 Weeks||54
10745861|NCT02960438|11909600|FG000|COMPLETED|Treatment Phase (Double-blind): 24 Weeks||47
10745862|NCT02960438|11909601|FG001|COMPLETED|Treatment Phase (Double-blind): 24 Weeks||26
10745863|NCT02960438|11909602|FG002|COMPLETED|Treatment Phase (Double-blind): 24 Weeks||50
10745864|NCT02960438|11909603|FG003|COMPLETED|Treatment Phase (Double-blind): 24 Weeks||46
10745865|NCT02960438|11909600|FG000|NOT COMPLETED|Treatment Phase (Double-blind): 24 Weeks||9
10745866|NCT02960438|11909601|FG001|NOT COMPLETED|Treatment Phase (Double-blind): 24 Weeks||3
10745867|NCT02960438|11909602|FG002|NOT COMPLETED|Treatment Phase (Double-blind): 24 Weeks||4
10745868|NCT02960438|11909603|FG003|NOT COMPLETED|Treatment Phase (Double-blind): 24 Weeks||9
10745869|NCT02960438|11909600|FG000|STARTED|Extension Phase (Open-label): 80 Weeks||47
10745870|NCT02960438|11909601|FG001|STARTED|Extension Phase (Open-label): 80 Weeks||26
10745871|NCT02960438|11909602|FG002|STARTED|Extension Phase (Open-label): 80 Weeks||50
10745872|NCT02960438|11909603|FG003|STARTED|Extension Phase (Open-label): 80 Weeks||46
10745873|NCT02960438|11909600|FG000|COMPLETED|Extension Phase (Open-label): 80 Weeks||36
10745874|NCT02960438|11909601|FG001|COMPLETED|Extension Phase (Open-label): 80 Weeks||17
10745875|NCT02960438|11909602|FG002|COMPLETED|Extension Phase (Open-label): 80 Weeks||36
10745876|NCT02960438|11909603|FG003|COMPLETED|Extension Phase (Open-label): 80 Weeks||35
10745877|NCT02960438|11909600|FG000|NOT COMPLETED|Extension Phase (Open-label): 80 Weeks||11
10745878|NCT02960438|11909601|FG001|NOT COMPLETED|Extension Phase (Open-label): 80 Weeks||9
10745879|NCT02960438|11909602|FG002|NOT COMPLETED|Extension Phase (Open-label): 80 Weeks||14
10745880|NCT02960438|11909603|FG003|NOT COMPLETED|Extension Phase (Open-label): 80 Weeks||11
10745881|NCT02960490|11909623|FG000|STARTED|Treatment Phase(Double-blind): 12 Weeks||34
10408726|NCT00756613|11552869|FG001|COMPLETED|Overall Study||462
10408727|NCT00756613|11552868|FG000|NOT COMPLETED|Overall Study||86
10408728|NCT00756613|11552869|FG001|NOT COMPLETED|Overall Study||70
10408729|NCT00756652|11552878|FG000|STARTED|Original Phase||41452
10408730|NCT00756652|11552879|FG001|STARTED|Original Phase||1039
10408731|NCT00756652|11552878|FG000|COMPLETED|Original Phase|At Year 7|6063
10408732|NCT00756652|11552879|FG001|COMPLETED|Original Phase||118
10408733|NCT00756652|11552878|FG000|NOT COMPLETED|Original Phase||35389
10408734|NCT00756652|11552879|FG001|NOT COMPLETED|Original Phase||921
10408735|NCT00756652|11552878|FG000|STARTED|Re-Op Phase||11101
10408736|NCT00756652|11552879|FG001|STARTED|Re-Op Phase|NA - The Re-Op Phase was limited in scope to data collection for only MemoryGel participants.|0
10408737|NCT00756652|11552878|FG000|COMPLETED|Re-Op Phase||8225
10408738|NCT00756652|11552879|FG001|COMPLETED|Re-Op Phase||0
10408739|NCT00756652|11552878|FG000|NOT COMPLETED|Re-Op Phase||2876
10408740|NCT00756652|11552879|FG001|NOT COMPLETED|Re-Op Phase||0
10408741|NCT00756678|11552883|FG000|STARTED|Overall Study||51
10408742|NCT00756678|11552883|FG000|COMPLETED|Overall Study||50
10408743|NCT00756678|11552883|FG000|NOT COMPLETED|Overall Study||1
10408744|NCT00756717|11552888|FG000|STARTED|Overall Study||22
10408745|NCT00756717|11552888|FG000|COMPLETED|Overall Study||20
10408746|NCT00756717|11552888|FG000|NOT COMPLETED|Overall Study||2
10408747|NCT00756730|11552894|FG000|STARTED|Overall Study||25
10408748|NCT00756730|11552895|FG001|STARTED|Overall Study||24
10408749|NCT00756730|11552894|FG000|COMPLETED|Overall Study||25
10408750|NCT00756730|11552895|FG001|COMPLETED|Overall Study||22
10408751|NCT00756730|11552894|FG000|NOT COMPLETED|Overall Study||0
10408752|NCT00756730|11552895|FG001|NOT COMPLETED|Overall Study||2
10408753|NCT00756886|11552903|FG000|STARTED|Overall Study||41
10408754|NCT00756886|11552904|FG001|STARTED|Overall Study||32
10408755|NCT00756886|11552903|FG000|COMPLETED|Overall Study||30
10408756|NCT00756886|11552904|FG001|COMPLETED|Overall Study||25
10408757|NCT00756886|11552903|FG000|NOT COMPLETED|Overall Study||11
10408758|NCT00756886|11552904|FG001|NOT COMPLETED|Overall Study||7
10408759|NCT00756964|11552912|FG000|STARTED|Overall Study||13
10408760|NCT00756964|11552913|FG001|STARTED|Overall Study||13
10408761|NCT00756964|11552912|FG000|COMPLETED|Overall Study||13
10408762|NCT00756964|11552913|FG001|COMPLETED|Overall Study||13
10408763|NCT00756964|11552912|FG000|NOT COMPLETED|Overall Study||0
10745882|NCT02960490|11909624|FG001|STARTED|Treatment Phase(Double-blind): 12 Weeks||32
10745883|NCT02960490|11909625|FG002|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
10745884|NCT02960490|11909626|FG003|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
10745885|NCT02960490|11909627|FG004|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
10745886|NCT02960490|11909628|FG005|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
10745887|NCT02960490|11909629|FG006|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
10745888|NCT02960490|11909630|FG007|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
10745889|NCT02960490|11909631|FG008|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
10745890|NCT02960490|11909632|FG009|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
10745891|NCT02960490|11909623|FG000|Treated|Treatment Phase(Double-blind): 12 Weeks||33
10745892|NCT02960490|11909624|FG001|Treated|Treatment Phase(Double-blind): 12 Weeks||31
10745893|NCT02960490|11909625|FG002|Treated|Treatment Phase(Double-blind): 12 Weeks||0
10745894|NCT02960490|11909626|FG003|Treated|Treatment Phase(Double-blind): 12 Weeks||0
10745895|NCT02960490|11909627|FG004|Treated|Treatment Phase(Double-blind): 12 Weeks||0
10745896|NCT02960490|11909628|FG005|Treated|Treatment Phase(Double-blind): 12 Weeks||0
10745897|NCT02960490|11909629|FG006|Treated|Treatment Phase(Double-blind): 12 Weeks||0
10745898|NCT02960490|11909630|FG007|Treated|Treatment Phase(Double-blind): 12 Weeks||0
10745899|NCT02960490|11909631|FG008|Treated|Treatment Phase(Double-blind): 12 Weeks||0
10745900|NCT02960490|11909632|FG009|Treated|Treatment Phase(Double-blind): 12 Weeks||0
10745901|NCT02960490|11909623|FG000|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||33
10745902|NCT02960490|11909624|FG001|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||31
10745903|NCT02960490|11909625|FG002|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
10745904|NCT02960490|11909626|FG003|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
10745905|NCT02960490|11909627|FG004|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
10745906|NCT02960490|11909628|FG005|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
10745907|NCT02960490|11909629|FG006|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
10745908|NCT02960490|11909630|FG007|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
10745909|NCT02960490|11909631|FG008|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
10745910|NCT02960490|11909632|FG009|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
10745911|NCT02960490|11909623|FG000|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||33
10745912|NCT02960490|11909624|FG001|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||31
10745913|NCT02960490|11909625|FG002|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
10745914|NCT02960490|11909626|FG003|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
10745915|NCT02960490|11909627|FG004|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
10745916|NCT02960490|11909628|FG005|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
10745917|NCT02960490|11909629|FG006|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
10745918|NCT02960490|11909630|FG007|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
10745919|NCT02960490|11909631|FG008|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
10745920|NCT02960490|11909632|FG009|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
10745921|NCT02960490|11909623|FG000|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||29
10745922|NCT02960490|11909624|FG001|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||26
10745923|NCT02960490|11909625|FG002|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
10745924|NCT02960490|11909626|FG003|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
10745925|NCT02960490|11909627|FG004|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
10745926|NCT02960490|11909628|FG005|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
10745927|NCT02960490|11909629|FG006|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
10745928|NCT02960490|11909630|FG007|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
10745929|NCT02960490|11909631|FG008|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
10745930|NCT02960490|11909632|FG009|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
10745931|NCT02960490|11909623|FG000|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||5
10745932|NCT02960490|11909624|FG001|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||6
10745933|NCT02960490|11909625|FG002|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
10745934|NCT02960490|11909626|FG003|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
10745935|NCT02960490|11909627|FG004|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
10745936|NCT02960490|11909628|FG005|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
10745937|NCT02960490|11909629|FG006|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
10745938|NCT02960490|11909630|FG007|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
10745939|NCT02960490|11909631|FG008|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
10745940|NCT02960490|11909632|FG009|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
10745941|NCT02960490|11909623|FG000|STARTED|Re-randomized Participants: 12 Weeks||0
10745942|NCT02960490|11909624|FG001|STARTED|Re-randomized Participants: 12 Weeks||0
10745943|NCT02960490|11909625|FG002|STARTED|Re-randomized Participants: 12 Weeks||15
10745944|NCT02960490|11909626|FG003|STARTED|Re-randomized Participants: 12 Weeks||14
10745945|NCT02960490|11909627|FG004|STARTED|Re-randomized Participants: 12 Weeks||14
10745946|NCT02960490|11909628|FG005|STARTED|Re-randomized Participants: 12 Weeks||12
10745947|NCT02960490|11909629|FG006|STARTED|Re-randomized Participants: 12 Weeks||0
10745948|NCT02960490|11909630|FG007|STARTED|Re-randomized Participants: 12 Weeks||0
10745949|NCT02960490|11909631|FG008|STARTED|Re-randomized Participants: 12 Weeks||0
10745950|NCT02960490|11909632|FG009|STARTED|Re-randomized Participants: 12 Weeks||0
10745951|NCT02960490|11909623|FG000|Treated|Re-randomized Participants: 12 Weeks||0
10745952|NCT02960490|11909624|FG001|Treated|Re-randomized Participants: 12 Weeks||0
10745953|NCT02960490|11909625|FG002|Treated|Re-randomized Participants: 12 Weeks||15
10745954|NCT02960490|11909626|FG003|Treated|Re-randomized Participants: 12 Weeks||14
10745955|NCT02960490|11909627|FG004|Treated|Re-randomized Participants: 12 Weeks||14
10745956|NCT02960490|11909628|FG005|Treated|Re-randomized Participants: 12 Weeks||12
10745957|NCT02960490|11909629|FG006|Treated|Re-randomized Participants: 12 Weeks||0
10745958|NCT02960490|11909630|FG007|Treated|Re-randomized Participants: 12 Weeks||0
10745959|NCT02960490|11909631|FG008|Treated|Re-randomized Participants: 12 Weeks||0
10745960|NCT02960490|11909632|FG009|Treated|Re-randomized Participants: 12 Weeks||0
10745961|NCT02960490|11909623|FG000|FAS|Re-randomized Participants: 12 Weeks||0
10745962|NCT02960490|11909624|FG001|FAS|Re-randomized Participants: 12 Weeks||0
10745963|NCT02960490|11909625|FG002|FAS|Re-randomized Participants: 12 Weeks||15
10745964|NCT02960490|11909626|FG003|FAS|Re-randomized Participants: 12 Weeks||14
10745965|NCT02960490|11909627|FG004|FAS|Re-randomized Participants: 12 Weeks||14
10745966|NCT02960490|11909628|FG005|FAS|Re-randomized Participants: 12 Weeks||12
10745967|NCT02960490|11909629|FG006|FAS|Re-randomized Participants: 12 Weeks||0
10745968|NCT02960490|11909630|FG007|FAS|Re-randomized Participants: 12 Weeks||0
10745969|NCT02960490|11909631|FG008|FAS|Re-randomized Participants: 12 Weeks||0
10745970|NCT02960490|11909632|FG009|FAS|Re-randomized Participants: 12 Weeks||0
10745971|NCT02960490|11909623|FG000|SAS|Re-randomized Participants: 12 Weeks||0
10745972|NCT02960490|11909624|FG001|SAS|Re-randomized Participants: 12 Weeks||0
10745973|NCT02960490|11909625|FG002|SAS|Re-randomized Participants: 12 Weeks||15
10745974|NCT02960490|11909626|FG003|SAS|Re-randomized Participants: 12 Weeks||14
10745975|NCT02960490|11909627|FG004|SAS|Re-randomized Participants: 12 Weeks||14
10745976|NCT02960490|11909628|FG005|SAS|Re-randomized Participants: 12 Weeks||12
10745977|NCT02960490|11909629|FG006|SAS|Re-randomized Participants: 12 Weeks||0
10745978|NCT02960490|11909630|FG007|SAS|Re-randomized Participants: 12 Weeks||0
10745979|NCT02960490|11909631|FG008|SAS|Re-randomized Participants: 12 Weeks||0
10745980|NCT02960490|11909632|FG009|SAS|Re-randomized Participants: 12 Weeks||0
10745981|NCT02960490|11909623|FG000|COMPLETED|Re-randomized Participants: 12 Weeks||0
10745982|NCT02960490|11909624|FG001|COMPLETED|Re-randomized Participants: 12 Weeks||0
10745983|NCT02960490|11909625|FG002|COMPLETED|Re-randomized Participants: 12 Weeks||13
10745984|NCT02960490|11909626|FG003|COMPLETED|Re-randomized Participants: 12 Weeks||12
10745985|NCT02960490|11909627|FG004|COMPLETED|Re-randomized Participants: 12 Weeks||13
10745986|NCT02960490|11909628|FG005|COMPLETED|Re-randomized Participants: 12 Weeks||10
10745987|NCT02960490|11909629|FG006|COMPLETED|Re-randomized Participants: 12 Weeks||0
10745988|NCT02960490|11909630|FG007|COMPLETED|Re-randomized Participants: 12 Weeks||0
10745989|NCT02960490|11909631|FG008|COMPLETED|Re-randomized Participants: 12 Weeks||0
10745990|NCT02960490|11909632|FG009|COMPLETED|Re-randomized Participants: 12 Weeks||0
10745991|NCT02960490|11909623|FG000|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0
10745992|NCT02960490|11909624|FG001|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0
10745993|NCT02960490|11909625|FG002|NOT COMPLETED|Re-randomized Participants: 12 Weeks||2
10745994|NCT02960490|11909626|FG003|NOT COMPLETED|Re-randomized Participants: 12 Weeks||2
10745995|NCT02960490|11909627|FG004|NOT COMPLETED|Re-randomized Participants: 12 Weeks||1
10745996|NCT02960490|11909628|FG005|NOT COMPLETED|Re-randomized Participants: 12 Weeks||2
10745997|NCT02960490|11909629|FG006|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0
10745998|NCT02960490|11909630|FG007|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0
10745999|NCT02960490|11909631|FG008|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0
10746000|NCT02960490|11909632|FG009|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0
10746001|NCT02960490|11909623|FG000|STARTED|Extension Phase(Open-label): 80 Weeks||0
10746002|NCT02960490|11909624|FG001|STARTED|Extension Phase(Open-label): 80 Weeks||0
10746003|NCT02960490|11909625|FG002|STARTED|Extension Phase(Open-label): 80 Weeks||0
10746004|NCT02960490|11909626|FG003|STARTED|Extension Phase(Open-label): 80 Weeks||0
10746005|NCT02960490|11909627|FG004|STARTED|Extension Phase(Open-label): 80 Weeks||0
10746006|NCT02960490|11909628|FG005|STARTED|Extension Phase(Open-label): 80 Weeks||0
10746007|NCT02960490|11909629|FG006|STARTED|Extension Phase(Open-label): 80 Weeks||13
10746008|NCT02960490|11909630|FG007|STARTED|Extension Phase(Open-label): 80 Weeks|One Participant who completed Core Treatment Phase (Placebo Then E6011 400 mg arm) had inadequate therapeutic effect at Week 24, hence did not started Extension phase.|11
10746009|NCT02960490|11909631|FG008|STARTED|Extension Phase(Open-label): 80 Weeks||13
10746010|NCT02960490|11909632|FG009|STARTED|Extension Phase(Open-label): 80 Weeks||10
10746011|NCT02960490|11909623|FG000|Treated|Extension Phase(Open-label): 80 Weeks||0
10746012|NCT02960490|11909624|FG001|Treated|Extension Phase(Open-label): 80 Weeks||0
10746013|NCT02960490|11909625|FG002|Treated|Extension Phase(Open-label): 80 Weeks||0
10746014|NCT02960490|11909626|FG003|Treated|Extension Phase(Open-label): 80 Weeks||0
10746015|NCT02960490|11909627|FG004|Treated|Extension Phase(Open-label): 80 Weeks||0
10746016|NCT02960490|11909628|FG005|Treated|Extension Phase(Open-label): 80 Weeks||0
10746017|NCT02960490|11909629|FG006|Treated|Extension Phase(Open-label): 80 Weeks||13
10746018|NCT02960490|11909630|FG007|Treated|Extension Phase(Open-label): 80 Weeks||11
10746019|NCT02960490|11909631|FG008|Treated|Extension Phase(Open-label): 80 Weeks||13
10746020|NCT02960490|11909632|FG009|Treated|Extension Phase(Open-label): 80 Weeks||10
10746021|NCT02960490|11909623|FG000|FAS|Extension Phase(Open-label): 80 Weeks||0
10746022|NCT02960490|11909624|FG001|FAS|Extension Phase(Open-label): 80 Weeks||0
10746023|NCT02960490|11909625|FG002|FAS|Extension Phase(Open-label): 80 Weeks||0
10746024|NCT02960490|11909626|FG003|FAS|Extension Phase(Open-label): 80 Weeks||0
10746025|NCT02960490|11909627|FG004|FAS|Extension Phase(Open-label): 80 Weeks||0
10817639|NCT01213329|11981517|FG001|COMPLETED|Screening||25
10746026|NCT02960490|11909628|FG005|FAS|Extension Phase(Open-label): 80 Weeks||0
10746027|NCT02960490|11909629|FG006|FAS|Extension Phase(Open-label): 80 Weeks||13
10746028|NCT02960490|11909630|FG007|FAS|Extension Phase(Open-label): 80 Weeks||11
10746029|NCT02960490|11909631|FG008|FAS|Extension Phase(Open-label): 80 Weeks||13
10746030|NCT02960490|11909632|FG009|FAS|Extension Phase(Open-label): 80 Weeks||10
10746031|NCT02960490|11909623|FG000|SAS|Extension Phase(Open-label): 80 Weeks||0
10746032|NCT02960490|11909624|FG001|SAS|Extension Phase(Open-label): 80 Weeks||0
10746033|NCT02960490|11909625|FG002|SAS|Extension Phase(Open-label): 80 Weeks||0
10746034|NCT02960490|11909626|FG003|SAS|Extension Phase(Open-label): 80 Weeks||0
10746035|NCT02960490|11909627|FG004|SAS|Extension Phase(Open-label): 80 Weeks||0
10746036|NCT02960490|11909628|FG005|SAS|Extension Phase(Open-label): 80 Weeks||0
10746037|NCT02960490|11909629|FG006|SAS|Extension Phase(Open-label): 80 Weeks||13
10746038|NCT02960490|11909630|FG007|SAS|Extension Phase(Open-label): 80 Weeks||11
10746039|NCT02960490|11909631|FG008|SAS|Extension Phase(Open-label): 80 Weeks||13
10746040|NCT02960490|11909632|FG009|SAS|Extension Phase(Open-label): 80 Weeks||10
10746041|NCT02960490|11909623|FG000|COMPLETED|Extension Phase(Open-label): 80 Weeks||0
10746042|NCT02960490|11909624|FG001|COMPLETED|Extension Phase(Open-label): 80 Weeks||0
10746043|NCT02960490|11909625|FG002|COMPLETED|Extension Phase(Open-label): 80 Weeks||0
10746044|NCT02960490|11909626|FG003|COMPLETED|Extension Phase(Open-label): 80 Weeks||0
10746045|NCT02960490|11909627|FG004|COMPLETED|Extension Phase(Open-label): 80 Weeks||0
10746046|NCT02960490|11909628|FG005|COMPLETED|Extension Phase(Open-label): 80 Weeks||0
10746047|NCT02960490|11909629|FG006|COMPLETED|Extension Phase(Open-label): 80 Weeks||4
10746048|NCT02960490|11909630|FG007|COMPLETED|Extension Phase(Open-label): 80 Weeks||5
10746049|NCT02960490|11909631|FG008|COMPLETED|Extension Phase(Open-label): 80 Weeks||9
10746050|NCT02960490|11909632|FG009|COMPLETED|Extension Phase(Open-label): 80 Weeks||3
10746051|NCT02960490|11909623|FG000|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0
10746052|NCT02960490|11909624|FG001|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0
10746053|NCT02960490|11909625|FG002|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0
10746054|NCT02960490|11909626|FG003|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0
10746055|NCT02960490|11909627|FG004|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0
10746056|NCT02960490|11909628|FG005|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0
10746057|NCT02960490|11909629|FG006|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||9
10746058|NCT02960490|11909630|FG007|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||6
10746059|NCT02960490|11909631|FG008|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||4
10746060|NCT02960490|11909632|FG009|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||7
10746061|NCT02960854|11909656|FG000|STARTED|Overall Study||15
10746062|NCT02960854|11909657|FG001|STARTED|Overall Study||16
10746063|NCT02960854|11909656|FG000|COMPLETED|Overall Study||8
10746064|NCT02960854|11909657|FG001|COMPLETED|Overall Study||7
10746065|NCT02960854|11909656|FG000|NOT COMPLETED|Overall Study||7
10746066|NCT02960854|11909657|FG001|NOT COMPLETED|Overall Study||9
10746067|NCT02961062|11909665|FG000|STARTED|Overall Study||20
10746068|NCT02961062|11909666|FG001|STARTED|Overall Study||20
10746069|NCT02961062|11909665|FG000|COMPLETED|Overall Study||20
10746070|NCT02961062|11909666|FG001|COMPLETED|Overall Study||20
10746071|NCT02961062|11909665|FG000|NOT COMPLETED|Overall Study||0
10746072|NCT02961062|11909666|FG001|NOT COMPLETED|Overall Study||0
10746073|NCT02961218|11909674|FG000|STARTED|Overall Study||25
10746074|NCT02961218|11909675|FG001|STARTED|Overall Study||24
10746075|NCT02961218|11909674|FG000|Safety Analysis Set|Overall Study||25
10746076|NCT02961218|11909675|FG001|Safety Analysis Set|Overall Study||24
10746077|NCT02961218|11909674|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study||25
10746078|NCT02961218|11909675|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study|Placebo patients were excluded from the PK analyses|0
10746079|NCT02961218|11909674|FG000|Primary PD Analysis Set|Overall Study||25
10746080|NCT02961218|11909675|FG001|Primary PD Analysis Set|Overall Study||24
10746081|NCT02961218|11909674|FG000|COMPLETED|Overall Study||22
10746082|NCT02961218|11909675|FG001|COMPLETED|Overall Study||19
10746083|NCT02961218|11909674|FG000|NOT COMPLETED|Overall Study||3
10746084|NCT02961218|11909675|FG001|NOT COMPLETED|Overall Study||5
10746085|NCT02961244|11909685|FG000|STARTED|Overall Study||64
10746086|NCT02961244|11909686|FG001|STARTED|Overall Study||64
10746087|NCT02961244|11909685|FG000|Patients Excluded During Randomization|Overall Study||0
10746088|NCT02961244|11909686|FG001|Patients Excluded During Randomization|Overall Study||1
10746089|NCT02961244|11909685|FG000|COMPLETED|Overall Study||63
10746090|NCT02961244|11909686|FG001|COMPLETED|Overall Study||55
10746091|NCT02961244|11909685|FG000|NOT COMPLETED|Overall Study||1
10746092|NCT02961244|11909686|FG001|NOT COMPLETED|Overall Study||9
10778394|NCT03354637|11940321|FG001|NOT COMPLETED|Open Label Extension||0
10778395|NCT03354637|11940322|FG002|NOT COMPLETED|Open Label Extension||28
10778396|NCT03354663|11940331|FG000|STARTED|Enrollment to Catheter Insertion||156
10778397|NCT03354663|11940331|FG000|COMPLETED|Enrollment to Catheter Insertion||151
10778398|NCT03354663|11940331|FG000|NOT COMPLETED|Enrollment to Catheter Insertion||5
10778399|NCT03354663|11940331|FG000|STARTED|Completed 30-day Visit||151
10778400|NCT03354663|11940331|FG000|COMPLETED|Completed 30-day Visit||149
10778401|NCT03354663|11940331|FG000|NOT COMPLETED|Completed 30-day Visit||2
10778402|NCT03354754|11940341|FG000|STARTED|Overall Study||2
10778403|NCT03354754|11940342|FG001|STARTED|Overall Study||1
10778404|NCT03354754|11940341|FG000|COMPLETED|Overall Study||2
10778405|NCT03354754|11940342|FG001|COMPLETED|Overall Study||1
10778406|NCT03354754|11940341|FG000|NOT COMPLETED|Overall Study||0
10778407|NCT03354754|11940342|FG001|NOT COMPLETED|Overall Study||0
10778408|NCT03355326|11940350|FG000|STARTED|Overall Study||9
10746093|NCT02961751|11909692|FG000|STARTED|Overall Study||211
10746094|NCT02961751|11909692|FG000|COMPLETED|Overall Study||196
10746095|NCT02961751|11909692|FG000|NOT COMPLETED|Overall Study||15
10746096|NCT02961764|11909698|FG000|STARTED|Overall Study||160
10746097|NCT02961764|11909699|FG001|STARTED|Overall Study||153
10746098|NCT02961764|11909698|FG000|COMPLETED|Overall Study||121
10746099|NCT02961764|11909699|FG001|COMPLETED|Overall Study||128
10746100|NCT02961764|11909698|FG000|NOT COMPLETED|Overall Study||39
10746101|NCT02961764|11909699|FG001|NOT COMPLETED|Overall Study||25
10746102|NCT02961790|11909709|FG000|STARTED|Overall Study||50
10746103|NCT02961790|11909710|FG001|STARTED|Overall Study||51
10746104|NCT02961790|11909711|FG002|STARTED|Overall Study||24
10746105|NCT02961790|11909712|FG003|STARTED|Overall Study||25
10817640|NCT01213329|11981516|FG000|NOT COMPLETED|Screening||0
10817641|NCT01213329|11981517|FG001|NOT COMPLETED|Screening||0
10817642|NCT01213329|11981516|FG000|STARTED|Phase 2|No subjects continued into phase 2.This is due to a loss of samples from a processing inconsistency.|0
10817643|NCT01213329|11981517|FG001|STARTED|Phase 2|No subjects continued into phase 2.This is due to a loss of samples from a processing inconsistency.|0
10817644|NCT01213329|11981516|FG000|COMPLETED|Phase 2||0
10817645|NCT01213329|11981517|FG001|COMPLETED|Phase 2||0
10817646|NCT01213329|11981516|FG000|NOT COMPLETED|Phase 2||0
10817647|NCT01213329|11981517|FG001|NOT COMPLETED|Phase 2||0
10817648|NCT01202110|11981523|FG000|STARTED|Overall Study||10
10817649|NCT01202110|11981524|FG001|STARTED|Overall Study||0
10817650|NCT01202110|11981523|FG000|COMPLETED|Overall Study||10
10817651|NCT01202110|11981524|FG001|COMPLETED|Overall Study||0
10817652|NCT01202110|11981523|FG000|NOT COMPLETED|Overall Study||0
10817653|NCT01202110|11981524|FG001|NOT COMPLETED|Overall Study||0
10817654|NCT01206439|11981528|FG000|STARTED|Overall Study||2
10817655|NCT01206439|11981528|FG000|COMPLETED|Overall Study||1
10817656|NCT01206439|11981528|FG000|NOT COMPLETED|Overall Study||1
10817657|NCT01204788|11981534|FG000|STARTED|Overall Study||1
10817658|NCT01204788|11981535|FG001|STARTED|Overall Study||3
10817659|NCT01204788|11981534|FG000|COMPLETED|Overall Study||0
10817660|NCT01204788|11981535|FG001|COMPLETED|Overall Study||0
10817661|NCT01204788|11981534|FG000|NOT COMPLETED|Overall Study||1
10817662|NCT01204788|11981535|FG001|NOT COMPLETED|Overall Study||3
10817663|NCT01200602|11981543|FG000|STARTED|Overall Study||0
10817664|NCT01200602|11981544|FG001|STARTED|Overall Study||0
10817665|NCT01200602|11981543|FG000|COMPLETED|Overall Study||0
10817666|NCT01200602|11981544|FG001|COMPLETED|Overall Study||0
10817667|NCT01200602|11981543|FG000|NOT COMPLETED|Overall Study||0
10817668|NCT01200602|11981544|FG001|NOT COMPLETED|Overall Study||0
10817669|NCT01198548|11981550|FG000|STARTED|Overall Study||10
10817670|NCT01198548|11981550|FG000|COMPLETED|Overall Study||0
10817671|NCT01198548|11981550|FG000|NOT COMPLETED|Overall Study||10
10817672|NCT01194908|11981554|FG000|STARTED|Overall Study||5
10817673|NCT01194908|11981554|FG000|COMPLETED|Overall Study||5
10817674|NCT01194908|11981554|FG000|NOT COMPLETED|Overall Study||0
10817675|NCT01194856|11981560|FG000|STARTED|Overall Study||1
10817676|NCT01194856|11981561|FG001|STARTED|Overall Study||0
10817677|NCT01194856|11981560|FG000|COMPLETED|Overall Study||0
10817678|NCT01194856|11981561|FG001|COMPLETED|Overall Study||0
10817679|NCT01194856|11981560|FG000|NOT COMPLETED|Overall Study||1
10817680|NCT01194856|11981561|FG001|NOT COMPLETED|Overall Study||0
10817681|NCT01194427|11981567|FG000|STARTED|Overall Study||2
10817682|NCT01194427|11981567|FG000|COMPLETED|Overall Study||2
10817683|NCT01194427|11981567|FG000|NOT COMPLETED|Overall Study||0
10817684|NCT01193556|11981573|FG000|STARTED|Overall Study||26
10817685|NCT01193556|11981574|FG001|STARTED|Overall Study||25
10817686|NCT01193556|11981573|FG000|COMPLETED|Overall Study||0
10817687|NCT01193556|11981574|FG001|COMPLETED|Overall Study||0
10817688|NCT01193556|11981573|FG000|NOT COMPLETED|Overall Study||26
10817689|NCT01193556|11981574|FG001|NOT COMPLETED|Overall Study||25
10817690|NCT01189435|11981580|FG000|STARTED|Overall Study||2
10817691|NCT01189435|11981580|FG000|COMPLETED|Overall Study||0
10817692|NCT01189435|11981580|FG000|NOT COMPLETED|Overall Study||2
10817693|NCT01193530|11981586|FG000|STARTED|Overall Study||4
10817694|NCT01193530|11981587|FG001|STARTED|Overall Study||8
10817695|NCT01193530|11981586|FG000|COMPLETED|Overall Study||1
10817696|NCT01193530|11981587|FG001|COMPLETED|Overall Study||3
10817697|NCT01193530|11981586|FG000|NOT COMPLETED|Overall Study||3
10817698|NCT01193530|11981587|FG001|NOT COMPLETED|Overall Study||5
10817699|NCT01182610|11981593|FG000|STARTED|Overall Study||1
10817700|NCT01182610|11981593|FG000|COMPLETED|Overall Study||1
10817701|NCT01182610|11981593|FG000|NOT COMPLETED|Overall Study||0
10817702|NCT01189071|11981599|FG000|STARTED|Overall Study||0
10817703|NCT01189071|11981600|FG001|STARTED|Overall Study||0
10817704|NCT01189071|11981599|FG000|COMPLETED|Overall Study||0
10817705|NCT01189071|11981600|FG001|COMPLETED|Overall Study||0
10817706|NCT01189071|11981599|FG000|NOT COMPLETED|Overall Study||0
10817707|NCT01189071|11981600|FG001|NOT COMPLETED|Overall Study||0
10817708|NCT01183416|11981606|FG000|STARTED|Overall Study||4
10746106|NCT02961790|11909709|FG000|COMPLETED|Overall Study||35
10817709|NCT01183416|11981606|FG000|COMPLETED|Overall Study||4
10817710|NCT01183416|11981606|FG000|NOT COMPLETED|Overall Study||0
10817711|NCT01184456|11981612|FG000|STARTED|Overall Study||0
10817712|NCT01184456|11981613|FG001|STARTED|Overall Study||0
10817713|NCT01184456|11981612|FG000|COMPLETED|Overall Study||0
10817714|NCT01184456|11981613|FG001|COMPLETED|Overall Study||0
10817715|NCT01184456|11981612|FG000|NOT COMPLETED|Overall Study||0
10817716|NCT01184456|11981613|FG001|NOT COMPLETED|Overall Study||0
10746107|NCT02961790|11909710|FG001|COMPLETED|Overall Study||40
10746108|NCT02961790|11909711|FG002|COMPLETED|Overall Study||18
10746109|NCT02961790|11909712|FG003|COMPLETED|Overall Study||20
10746110|NCT02961790|11909709|FG000|NOT COMPLETED|Overall Study||15
10746111|NCT02961790|11909710|FG001|NOT COMPLETED|Overall Study||11
10746112|NCT02961790|11909711|FG002|NOT COMPLETED|Overall Study||6
10746113|NCT02961790|11909712|FG003|NOT COMPLETED|Overall Study||5
10746114|NCT02961894|11909723|FG000|STARTED|Overall Study||121
10746115|NCT02961894|11909723|FG000|COMPLETED|Overall Study||121
10746116|NCT02961894|11909723|FG000|NOT COMPLETED|Overall Study||0
10746117|NCT02961920|11909729|FG000|STARTED|Overall Study||25
10746118|NCT02961920|11909730|FG001|STARTED|Overall Study||25
10746119|NCT02961920|11909729|FG000|COMPLETED|Overall Study||24
10746120|NCT02961920|11909730|FG001|COMPLETED|Overall Study||24
10746121|NCT02961920|11909729|FG000|NOT COMPLETED|Overall Study||1
10746122|NCT02961920|11909730|FG001|NOT COMPLETED|Overall Study||1
10746123|NCT02961946|11909739|FG000|STARTED|Overall Study||66
10746124|NCT02961946|11909740|FG001|STARTED|Overall Study||66
10817717|NCT01183221|11981621|FG000|STARTED|First Dose||15
10817718|NCT01183221|11981622|FG001|STARTED|First Dose||15
10817719|NCT01183221|11981621|FG000|COMPLETED|First Dose||15
10817720|NCT01183221|11981622|FG001|COMPLETED|First Dose||15
10817721|NCT01183221|11981621|FG000|NOT COMPLETED|First Dose||0
10817722|NCT01183221|11981622|FG001|NOT COMPLETED|First Dose||0
10817723|NCT01183221|11981621|FG000|STARTED|3 Weeks Wash Out||15
10817724|NCT01183221|11981622|FG001|STARTED|3 Weeks Wash Out||15
10817725|NCT01183221|11981621|FG000|COMPLETED|3 Weeks Wash Out||14
10817726|NCT01183221|11981622|FG001|COMPLETED|3 Weeks Wash Out||14
10817727|NCT01183221|11981621|FG000|NOT COMPLETED|3 Weeks Wash Out||1
10817728|NCT01183221|11981622|FG001|NOT COMPLETED|3 Weeks Wash Out||1
10817729|NCT01183221|11981621|FG000|STARTED|Second Dose||14
10817730|NCT01183221|11981622|FG001|STARTED|Second Dose||14
10817731|NCT01183221|11981621|FG000|COMPLETED|Second Dose||14
10817732|NCT01183221|11981622|FG001|COMPLETED|Second Dose||14
10817733|NCT01183221|11981621|FG000|NOT COMPLETED|Second Dose||0
10817734|NCT01183221|11981622|FG001|NOT COMPLETED|Second Dose||0
10817735|NCT01189227|11981630|FG000|STARTED|Overall Study||6
10817736|NCT01189227|11981631|FG001|STARTED|Overall Study||3
10817737|NCT01189227|11981630|FG000|COMPLETED|Overall Study||0
10817738|NCT01189227|11981631|FG001|COMPLETED|Overall Study||0
10817739|NCT01189227|11981630|FG000|NOT COMPLETED|Overall Study||6
10817740|NCT01189227|11981631|FG001|NOT COMPLETED|Overall Study||3
10817741|NCT01179737|11981641|FG000|STARTED|Cohort 1 & Cohort 2||12
10817742|NCT01179737|11981642|FG001|STARTED|Cohort 1 & Cohort 2|One patient was missing the end of study evaluation|3
10817743|NCT01179737|11981643|FG002|STARTED|Cohort 1 & Cohort 2||4
10817744|NCT01179737|11981644|FG003|STARTED|Cohort 1 & Cohort 2||4
10817745|NCT01179737|11981641|FG000|COMPLETED|Cohort 1 & Cohort 2||7
10817746|NCT01179737|11981642|FG001|COMPLETED|Cohort 1 & Cohort 2||1
10817747|NCT01179737|11981643|FG002|COMPLETED|Cohort 1 & Cohort 2||0
10817748|NCT01179737|11981644|FG003|COMPLETED|Cohort 1 & Cohort 2||0
10817749|NCT01179737|11981641|FG000|NOT COMPLETED|Cohort 1 & Cohort 2||5
10817750|NCT01179737|11981642|FG001|NOT COMPLETED|Cohort 1 & Cohort 2||2
10817751|NCT01179737|11981643|FG002|NOT COMPLETED|Cohort 1 & Cohort 2||4
10817752|NCT01179737|11981644|FG003|NOT COMPLETED|Cohort 1 & Cohort 2||4
10817753|NCT01179737|11981641|FG000|STARTED|Cohort 1 & Cohort 2 Expansion|2 participants did not enroll in extension|5
10817754|NCT01179737|11981642|FG001|STARTED|Cohort 1 & Cohort 2 Expansion||1
10817755|NCT01179737|11981643|FG002|STARTED|Cohort 1 & Cohort 2 Expansion||0
10817756|NCT01179737|11981644|FG003|STARTED|Cohort 1 & Cohort 2 Expansion||0
10817757|NCT01179737|11981641|FG000|COMPLETED|Cohort 1 & Cohort 2 Expansion||4
10817758|NCT01179737|11981642|FG001|COMPLETED|Cohort 1 & Cohort 2 Expansion||1
10817759|NCT01179737|11981643|FG002|COMPLETED|Cohort 1 & Cohort 2 Expansion||0
10817760|NCT01179737|11981644|FG003|COMPLETED|Cohort 1 & Cohort 2 Expansion||0
10817761|NCT01179737|11981641|FG000|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||1
10817762|NCT01179737|11981642|FG001|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
10817763|NCT01179737|11981643|FG002|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
10817764|NCT01179737|11981644|FG003|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
10817765|NCT01179737|11981641|FG000|STARTED|Extension|Two patients did not enrol in the extension|3
10817766|NCT01179737|11981642|FG001|STARTED|Extension|One patient did not enrol in the extension|0
10817767|NCT01179737|11981643|FG002|STARTED|Extension||0
10817768|NCT01179737|11981644|FG003|STARTED|Extension||0
10817769|NCT01179737|11981641|FG000|COMPLETED|Extension||0
10817770|NCT01179737|11981642|FG001|COMPLETED|Extension||0
10817771|NCT01179737|11981643|FG002|COMPLETED|Extension||0
10817772|NCT01179737|11981644|FG003|COMPLETED|Extension||0
10817773|NCT01179737|11981641|FG000|NOT COMPLETED|Extension||3
10817774|NCT01179737|11981642|FG001|NOT COMPLETED|Extension||0
10817775|NCT01179737|11981643|FG002|NOT COMPLETED|Extension||0
10817776|NCT01179737|11981644|FG003|NOT COMPLETED|Extension||0
10817777|NCT01183468|11981657|FG000|STARTED|Overall Study||8
10817778|NCT01183468|11981658|FG001|STARTED|Overall Study||9
10817779|NCT01183468|11981659|FG002|STARTED|Overall Study||0
10817780|NCT01183468|11981660|FG003|STARTED|Overall Study||0
10817781|NCT01183468|11981657|FG000|COMPLETED|Overall Study||5
10817782|NCT01183468|11981658|FG001|COMPLETED|Overall Study||7
10817783|NCT01183468|11981659|FG002|COMPLETED|Overall Study||0
10817784|NCT01183468|11981660|FG003|COMPLETED|Overall Study||0
10817785|NCT01183468|11981657|FG000|NOT COMPLETED|Overall Study||3
10817786|NCT01183468|11981658|FG001|NOT COMPLETED|Overall Study||2
10817787|NCT01183468|11981659|FG002|NOT COMPLETED|Overall Study||0
10746125|NCT02961946|11909741|FG002|STARTED|Overall Study||66
10746126|NCT02961946|11909739|FG000|COMPLETED|Overall Study||66
10746127|NCT02961946|11909740|FG001|COMPLETED|Overall Study||66
10746128|NCT02961946|11909741|FG002|COMPLETED|Overall Study||66
10746129|NCT02961946|11909739|FG000|NOT COMPLETED|Overall Study||0
10746130|NCT02961946|11909740|FG001|NOT COMPLETED|Overall Study||0
10746131|NCT02961946|11909741|FG002|NOT COMPLETED|Overall Study||0
10746132|NCT02962284|11909751|FG000|STARTED|Overall Study||9
10746133|NCT02962284|11909752|FG001|STARTED|Overall Study||11
10746134|NCT02962284|11909751|FG000|COMPLETED|Overall Study||4
10746135|NCT02962284|11909752|FG001|COMPLETED|Overall Study||8
10746136|NCT02962284|11909751|FG000|NOT COMPLETED|Overall Study||5
10746137|NCT02962284|11909752|FG001|NOT COMPLETED|Overall Study||3
10746138|NCT02962427|11909762|FG000|STARTED|Overall Study||3
10746139|NCT02962427|11909763|FG001|STARTED|Overall Study||1
10746140|NCT02962427|11909762|FG000|COMPLETED|Overall Study||3
10746141|NCT02962427|11909763|FG001|COMPLETED|Overall Study||1
10746142|NCT02962427|11909762|FG000|NOT COMPLETED|Overall Study||0
10746143|NCT02962427|11909763|FG001|NOT COMPLETED|Overall Study||0
10746144|NCT02962609|11909773|FG000|STARTED|Overall Study||38
10746145|NCT02962609|11909774|FG001|STARTED|Overall Study||42
10746146|NCT02962609|11909773|FG000|COMPLETED|Overall Study||38
10746147|NCT02962609|11909774|FG001|COMPLETED|Overall Study||42
10746148|NCT02962609|11909773|FG000|NOT COMPLETED|Overall Study||0
10746149|NCT02962609|11909774|FG001|NOT COMPLETED|Overall Study||0
10746150|NCT02962648|11909780|FG000|STARTED|Overall Study||103
10746151|NCT02962648|11909780|FG000|COMPLETED|Overall Study||94
10746152|NCT02962648|11909780|FG000|NOT COMPLETED|Overall Study||9
10746153|NCT02962674|11909784|FG000|STARTED|Overall Study|"Although a total of 49 subjects were consented to participate in the study, three (3) of those subjects are not included in the study analysis as they did not actually receive treatment. These 3 subjects could not be treated because of their anatomy and therefore are considered treatment attempts. The final enrollment number (treated subjects only)is 46 subjects."|49
10746154|NCT02962674|11909784|FG000|3 Month Endpoint|Overall Study|All treated subjects that completed the 3-month endpoint visit per protocol.|46
10746155|NCT02962674|11909784|FG000|12 Month Durability|Overall Study|All subjects that completed the 12-month follow-up visit per protocol.|46
10746156|NCT02962674|11909784|FG000|24 Month Durability|Overall Study|All subjects that completed the 24-month follow-up visit. Note that at the time of study termination, all subjects would have reached this milestone.|32
10746157|NCT02962674|11909784|FG000|36 Month Durability|Overall Study|All subjects that completed the 36-month follow-up visit. Note that at the time of study termination, not all subjects would have reached this milestone depending on time of enrollment.|18
10746158|NCT02962674|11909784|FG000|48 Month Durability|Overall Study|All subjects that completed the 48-month follow-up visit. Note that at the time of study termination, not all subjects would have reached this milestone depending on time of enrollment.|4
10746159|NCT02962674|11909784|FG000|COMPLETED|Overall Study|Study was terminated by sponsor prior to reaching 60 Month study completion mainly due to COVID-19 effects on subject follow-up.|0
10746160|NCT02962674|11909784|FG000|NOT COMPLETED|Overall Study||49
10746161|NCT02962687|11909792|FG000|STARTED|Overall Study|This number represents 20 dyads (1 Veteran and 1 caregiver in each dyad)|40
10746162|NCT02962687|11909793|FG001|STARTED|Overall Study|This number represents 20 dyads (1 Veteran and 1 caregiver in each dyad)|40
10746163|NCT02962687|11909792|FG000|COMPLETED|Overall Study|This number represents 15 dyads (1 Veteran and 1 caregiver in each dyad)|30
10746164|NCT02962687|11909793|FG001|COMPLETED|Overall Study|This number represents 16 dyads (1 Veteran and 1 caregiver in each dyad)|32
10746165|NCT02962687|11909792|FG000|NOT COMPLETED|Overall Study||10
10746166|NCT02962687|11909793|FG001|NOT COMPLETED|Overall Study||8
10746167|NCT02962739|11909801|FG000|STARTED|Overall Study||6
10746168|NCT02962739|11909802|FG001|STARTED|Overall Study||7
10746169|NCT02962739|11909803|FG002|STARTED|Overall Study||7
10746170|NCT02962739|11909804|FG003|STARTED|Overall Study||6
10746171|NCT02962739|11909805|FG004|STARTED|Overall Study||6
10817788|NCT01183468|11981660|FG003|NOT COMPLETED|Overall Study||0
10817789|NCT01181921|11981668|FG000|STARTED|Overall Study||1
10817790|NCT01181921|11981668|FG000|COMPLETED|Overall Study||0
10817791|NCT01181921|11981668|FG000|NOT COMPLETED|Overall Study||1
10817792|NCT01188798|11981674|FG000|STARTED|Overall Study||2
10746172|NCT02962739|11909806|FG005|STARTED|Overall Study||6
10746173|NCT02962739|11909801|FG000|COMPLETED|Overall Study||6
10746174|NCT02962739|11909802|FG001|COMPLETED|Overall Study||6
10746175|NCT02962739|11909803|FG002|COMPLETED|Overall Study||6
10746176|NCT02962739|11909804|FG003|COMPLETED|Overall Study||6
10746177|NCT02962739|11909805|FG004|COMPLETED|Overall Study||5
10746178|NCT02962739|11909806|FG005|COMPLETED|Overall Study||6
10746179|NCT02962739|11909801|FG000|NOT COMPLETED|Overall Study||0
10746180|NCT02962739|11909802|FG001|NOT COMPLETED|Overall Study||1
10746181|NCT02962739|11909803|FG002|NOT COMPLETED|Overall Study||1
10746182|NCT02962739|11909804|FG003|NOT COMPLETED|Overall Study||0
10746183|NCT02962739|11909805|FG004|NOT COMPLETED|Overall Study||1
10746184|NCT02962739|11909806|FG005|NOT COMPLETED|Overall Study||0
10817793|NCT01188798|11981675|FG001|STARTED|Overall Study||4
10817794|NCT01188798|11981674|FG000|COMPLETED|Overall Study||0
10817795|NCT01188798|11981675|FG001|COMPLETED|Overall Study||1
10408764|NCT00756964|11552913|FG001|NOT COMPLETED|Overall Study||0
10408765|NCT00756977|11552921|FG000|STARTED|Overall Study||196
10746185|NCT02962765|11909812|FG000|STARTED|Overall Study||78
10746186|NCT02962765|11909812|FG000|FAS Population|Overall Study||78
10746187|NCT02962765|11909812|FG000|SAF Population|Overall Study||78
10746188|NCT02962765|11909812|FG000|Prophylactic Treatment Group|Overall Study||77
10746189|NCT02962765|11909812|FG000|On Demand Treatment Group|Overall Study||2
10746190|NCT02962765|11909812|FG000|SURG Population|Overall Study||4
10746191|NCT02962765|11909812|FG000|COMPLETED|Overall Study||61
10746192|NCT02962765|11909812|FG000|NOT COMPLETED|Overall Study||17
10746193|NCT02962882|11909823|FG000|STARTED|Overall Study||50
10746194|NCT02962882|11909823|FG000|COMPLETED|Overall Study||14
10746195|NCT02962882|11909823|FG000|NOT COMPLETED|Overall Study||36
10746196|NCT02962908|11909832|FG000|STARTED|Overall Study||58
10746197|NCT02962908|11909833|FG001|STARTED|Overall Study||58
10746198|NCT02962908|11909834|FG002|STARTED|Overall Study||32
10746199|NCT02962908|11909835|FG003|STARTED|Overall Study||27
10746200|NCT02962908|11909832|FG000|COMPLETED|Overall Study||58
10746201|NCT02962908|11909833|FG001|COMPLETED|Overall Study||50
10746202|NCT02962908|11909834|FG002|COMPLETED|Overall Study||32
10746203|NCT02962908|11909835|FG003|COMPLETED|Overall Study||24
10746204|NCT02962908|11909832|FG000|NOT COMPLETED|Overall Study||0
10746205|NCT02962908|11909833|FG001|NOT COMPLETED|Overall Study||8
10746206|NCT02962908|11909834|FG002|NOT COMPLETED|Overall Study||0
10746207|NCT02962908|11909835|FG003|NOT COMPLETED|Overall Study||3
10746208|NCT02962934|11909853|FG000|STARTED|Overall Study||12
10746209|NCT02962934|11909854|FG001|STARTED|Overall Study||6
10746210|NCT02962934|11909853|FG000|COMPLETED|Overall Study||12
10746211|NCT02962934|11909854|FG001|COMPLETED|Overall Study||6
10746212|NCT02962934|11909853|FG000|NOT COMPLETED|Overall Study||0
10746213|NCT02962934|11909854|FG001|NOT COMPLETED|Overall Study||0
10746214|NCT02962960|11909863|FG000|STARTED|Overall Study||14
10746215|NCT02962960|11909864|FG001|STARTED|Overall Study||13
10746216|NCT02962960|11909865|FG002|STARTED|Overall Study||9
10746217|NCT02962960|11909863|FG000|COMPLETED|Overall Study||11
10746218|NCT02962960|11909864|FG001|COMPLETED|Overall Study||11
10746219|NCT02962960|11909865|FG002|COMPLETED|Overall Study||9
10746220|NCT02962960|11909863|FG000|NOT COMPLETED|Overall Study||3
10746221|NCT02962960|11909864|FG001|NOT COMPLETED|Overall Study||2
10746222|NCT02962960|11909865|FG002|NOT COMPLETED|Overall Study||0
10746223|NCT02963311|11909875|FG000|STARTED|Overall Study||9
10746224|NCT02963311|11909875|FG000|COMPLETED|Overall Study||4
10746225|NCT02963311|11909875|FG000|NOT COMPLETED|Overall Study||5
10746226|NCT02963376|11909883|FG000|STARTED|Overall Study||6
10746227|NCT02963376|11909884|FG001|STARTED|Overall Study||2
10746228|NCT02963376|11909885|FG002|STARTED|Overall Study||6
10746229|NCT02963376|11909886|FG003|STARTED|Overall Study||2
10746230|NCT02963376|11909887|FG004|STARTED|Overall Study||6
10746231|NCT02963376|11909888|FG005|STARTED|Overall Study||2
10746232|NCT02963376|11909883|FG000|COMPLETED|Overall Study||6
10746233|NCT02963376|11909884|FG001|COMPLETED|Overall Study||2
10746234|NCT02963376|11909885|FG002|COMPLETED|Overall Study||6
10746235|NCT02963376|11909886|FG003|COMPLETED|Overall Study||2
10746236|NCT02963376|11909887|FG004|COMPLETED|Overall Study||6
10746237|NCT02963376|11909888|FG005|COMPLETED|Overall Study||2
10746238|NCT02963376|11909883|FG000|NOT COMPLETED|Overall Study||0
10746239|NCT02963376|11909884|FG001|NOT COMPLETED|Overall Study||0
10746240|NCT02963376|11909885|FG002|NOT COMPLETED|Overall Study||0
10746241|NCT02963376|11909886|FG003|NOT COMPLETED|Overall Study||0
10746242|NCT02963376|11909887|FG004|NOT COMPLETED|Overall Study||0
10746243|NCT02963376|11909888|FG005|NOT COMPLETED|Overall Study||0
10746244|NCT02963441|11909910|FG000|STARTED|Overall Study||900
10746245|NCT02963441|11909910|FG000|COMPLETED|Overall Study||819
10746246|NCT02963441|11909910|FG000|NOT COMPLETED|Overall Study||81
10817796|NCT01188798|11981674|FG000|NOT COMPLETED|Overall Study||2
10817797|NCT01188798|11981675|FG001|NOT COMPLETED|Overall Study||3
10817798|NCT01174368|11981682|FG000|STARTED|Overall Study||1
10746351|NCT02963597|11909951|FG000|STARTED|Overall Study||10
10746352|NCT02963597|11909952|FG001|STARTED|Overall Study||11
10746353|NCT02963597|11909951|FG000|COMPLETED|Overall Study||10
10746354|NCT02963597|11909952|FG001|COMPLETED|Overall Study||11
10746355|NCT02963597|11909951|FG000|NOT COMPLETED|Overall Study||0
10746356|NCT02963597|11909952|FG001|NOT COMPLETED|Overall Study||0
10746357|NCT02963701|11909960|FG000|STARTED|Period 1 (Including Washout) (2 Days)||28
10746358|NCT02963701|11909961|FG001|STARTED|Period 1 (Including Washout) (2 Days)||28
10746359|NCT02963701|11909960|FG000|COMPLETED|Period 1 (Including Washout) (2 Days)|One subject withdrawn from the study after period 1|27
10746360|NCT02963701|11909961|FG001|COMPLETED|Period 1 (Including Washout) (2 Days)||28
10746361|NCT02963701|11909960|FG000|NOT COMPLETED|Period 1 (Including Washout) (2 Days)||1
10746362|NCT02963701|11909961|FG001|NOT COMPLETED|Period 1 (Including Washout) (2 Days)||0
10746363|NCT02963701|11909960|FG000|STARTED|Period 2 (2 Days)||27
10746364|NCT02963701|11909961|FG001|STARTED|Period 2 (2 Days)||28
10746365|NCT02963701|11909960|FG000|COMPLETED|Period 2 (2 Days)||27
10746366|NCT02963701|11909961|FG001|COMPLETED|Period 2 (2 Days)||28
10746367|NCT02963701|11909960|FG000|NOT COMPLETED|Period 2 (2 Days)||0
10746368|NCT02963701|11909961|FG001|NOT COMPLETED|Period 2 (2 Days)||0
10746369|NCT02963922|11909969|FG000|STARTED|Overall Study||198
10746370|NCT02963922|11909970|FG001|STARTED|Overall Study||198
10746371|NCT02963922|11909969|FG000|COMPLETED|Overall Study||166
10746372|NCT02963922|11909970|FG001|COMPLETED|Overall Study||168
10746373|NCT02963922|11909969|FG000|NOT COMPLETED|Overall Study||32
10746374|NCT02963922|11909970|FG001|NOT COMPLETED|Overall Study||30
10746375|NCT02963935|11909978|FG000|STARTED|Overall Study||142
10746376|NCT02963935|11909979|FG001|STARTED|Overall Study||140
10746377|NCT02963935|11909978|FG000|COMPLETED|Overall Study||114
10746378|NCT02963935|11909979|FG001|COMPLETED|Overall Study||103
10746379|NCT02963935|11909978|FG000|NOT COMPLETED|Overall Study||28
10746380|NCT02963935|11909979|FG001|NOT COMPLETED|Overall Study||37
10746381|NCT02963974|11909985|FG000|STARTED|Overall Study||20
10746382|NCT02963974|11909985|FG000|COMPLETED|Overall Study||19
10746383|NCT02963974|11909985|FG000|NOT COMPLETED|Overall Study||1
10746384|NCT02963987|11909989|FG000|STARTED|First Intervention Period||31
10746385|NCT02963987|11909990|FG001|STARTED|First Intervention Period||19
10746386|NCT02963987|11909989|FG000|COMPLETED|First Intervention Period||31
10746387|NCT02963987|11909990|FG001|COMPLETED|First Intervention Period||19
10746388|NCT02963987|11909989|FG000|NOT COMPLETED|First Intervention Period||0
10746389|NCT02963987|11909990|FG001|NOT COMPLETED|First Intervention Period||0
10746390|NCT02963987|11909989|FG000|STARTED|Second Intervention Period||31
10746391|NCT02963987|11909990|FG001|STARTED|Second Intervention Period||19
10746392|NCT02963987|11909989|FG000|COMPLETED|Second Intervention Period||31
10746393|NCT02963987|11909990|FG001|COMPLETED|Second Intervention Period||19
10746394|NCT02963987|11909989|FG000|NOT COMPLETED|Second Intervention Period||0
10746395|NCT02963987|11909990|FG001|NOT COMPLETED|Second Intervention Period||0
10746396|NCT02964234|11910000|FG000|STARTED|Overall Study||76
10746397|NCT02964234|11910001|FG001|STARTED|Overall Study||69
10746398|NCT02964234|11910000|FG000|COMPLETED|Overall Study||54
10746399|NCT02964234|11910001|FG001|COMPLETED|Overall Study||56
10746400|NCT02964234|11910000|FG000|NOT COMPLETED|Overall Study||22
10746401|NCT02964234|11910001|FG001|NOT COMPLETED|Overall Study||13
10746402|NCT02964247|11910009|FG000|STARTED|Overall Study||203
10746403|NCT02964247|11910010|FG001|STARTED|Overall Study||100
10746404|NCT02964247|11910009|FG000|Exposed to Trial Product|Overall Study||202
10746405|NCT02964247|11910010|FG001|Exposed to Trial Product|Overall Study||100
10746406|NCT02964247|11910009|FG000|COMPLETED|Overall Study||200
10746407|NCT02964247|11910010|FG001|COMPLETED|Overall Study||98
10746408|NCT02964247|11910009|FG000|NOT COMPLETED|Overall Study||3
10746409|NCT02964247|11910010|FG001|NOT COMPLETED|Overall Study||2
10746410|NCT02964312|11910016|FG000|STARTED|Overall Study||166
10746411|NCT02964312|11910016|FG000|1-Month Follow-up|Overall Study||164
10746412|NCT02964312|11910016|FG000|3-Month Follow-up|Overall Study||159
10746413|NCT02964312|11910016|FG000|6-Month Follow-up|Overall Study||152
10746414|NCT02964312|11910016|FG000|12-Month Follow-up|Overall Study||139
10746415|NCT02964312|11910016|FG000|18-Month Follow-up|Overall Study||112
10746416|NCT02964312|11910016|FG000|24-Month Follow-up|Overall Study||102
10746417|NCT02964312|11910016|FG000|COMPLETED|Overall Study||102
10746418|NCT02964312|11910016|FG000|NOT COMPLETED|Overall Study||64
10746419|NCT02964325|11910025|FG000|STARTED|Overall Study||164
10746420|NCT02964325|11910026|FG001|STARTED|Overall Study||166
10746421|NCT02964325|11910025|FG000|Full Analysis Set|Overall Study||164
10746422|NCT02964325|11910026|FG001|Full Analysis Set|Overall Study||166
10746423|NCT02964325|11910025|FG000|Modified Intent-to-Treat|Overall Study||145
10746424|NCT02964325|11910026|FG001|Modified Intent-to-Treat|Overall Study||152
10746425|NCT02964325|11910025|FG000|Safety Set|Overall Study||141
10746426|NCT02964325|11910026|FG001|Safety Set|Overall Study||161
10746427|NCT02964325|11910025|FG000|COMPLETED|Overall Study||143
10746428|NCT02964325|11910026|FG001|COMPLETED|Overall Study||143
10746429|NCT02964325|11910025|FG000|NOT COMPLETED|Overall Study||21
10746430|NCT02964325|11910026|FG001|NOT COMPLETED|Overall Study||23
10746431|NCT02964338|11910035|FG000|STARTED|Overall Study||84
10817799|NCT01174368|11981682|FG000|COMPLETED|Overall Study||0
10746432|NCT02964338|11910036|FG001|STARTED|Overall Study||88
10746433|NCT02964338|11910037|FG002|STARTED|Overall Study||87
10746434|NCT02964338|11910035|FG000|Safety Analysis Set|Overall Study||83
10746435|NCT02964338|11910036|FG001|Safety Analysis Set|Overall Study||88
10746436|NCT02964338|11910037|FG002|Safety Analysis Set|Overall Study||87
10746437|NCT02964338|11910035|FG000|Full Analysis Set|Overall Study||81
10746438|NCT02964338|11910036|FG001|Full Analysis Set|Overall Study||86
10746439|NCT02964338|11910037|FG002|Full Analysis Set|Overall Study||87
10746440|NCT02964338|11910035|FG000|COMPLETED|Overall Study||67
10746441|NCT02964338|11910036|FG001|COMPLETED|Overall Study||64
10746442|NCT02964338|11910037|FG002|COMPLETED|Overall Study||68
10746443|NCT02964338|11910035|FG000|NOT COMPLETED|Overall Study||17
10746444|NCT02964338|11910036|FG001|NOT COMPLETED|Overall Study||24
10746445|NCT02964338|11910037|FG002|NOT COMPLETED|Overall Study||19
10746446|NCT02964416|11910047|FG000|STARTED|Overall Study||39
10746447|NCT02964416|11910048|FG001|STARTED|Overall Study||41
10746448|NCT02964416|11910047|FG000|COMPLETED|Overall Study||38
10746449|NCT02964416|11910048|FG001|COMPLETED|Overall Study||41
10746450|NCT02964416|11910047|FG000|NOT COMPLETED|Overall Study||1
10746451|NCT02964416|11910048|FG001|NOT COMPLETED|Overall Study||0
10746452|NCT02964767|11910057|FG000|STARTED|Overall Study||171
10746453|NCT02964767|11910058|FG001|STARTED|Overall Study||48
10746454|NCT02964767|11910057|FG000|COMPLETED|Overall Study||171
10746455|NCT02964767|11910058|FG001|COMPLETED|Overall Study||48
10746456|NCT02964767|11910057|FG000|NOT COMPLETED|Overall Study||0
10746457|NCT02964767|11910058|FG001|NOT COMPLETED|Overall Study||0
10817800|NCT01174368|11981682|FG000|NOT COMPLETED|Overall Study||1
10817801|NCT01183897|11981686|FG000|STARTED|Overall Study||31
10817802|NCT01183897|11981686|FG000|COMPLETED|Overall Study||31
10817803|NCT01183897|11981686|FG000|NOT COMPLETED|Overall Study||0
10817804|NCT01183884|11981690|FG000|STARTED|Overall Study||46
10817805|NCT01183884|11981690|FG000|COMPLETED|Overall Study||8
10817806|NCT01183884|11981690|FG000|NOT COMPLETED|Overall Study||38
10817807|NCT01183429|11981694|FG000|STARTED|Overall Study||39
10817808|NCT01183429|11981694|FG000|COMPLETED|Overall Study||39
10817809|NCT01183429|11981694|FG000|NOT COMPLETED|Overall Study||0
10817810|NCT01166178|11981700|FG000|STARTED|Overall Study||21
10817811|NCT01166178|11981701|FG001|STARTED|Overall Study||8
10817812|NCT01166178|11981700|FG000|COMPLETED|Overall Study||0
10817813|NCT01166178|11981701|FG001|COMPLETED|Overall Study||0
10817814|NCT01166178|11981700|FG000|NOT COMPLETED|Overall Study||21
10817815|NCT01166178|11981701|FG001|NOT COMPLETED|Overall Study||8
10817816|NCT01176513|11981707|FG000|STARTED|Overall Study||25
10817817|NCT01176513|11981707|FG000|COMPLETED|Overall Study||22
10817818|NCT01176513|11981707|FG000|NOT COMPLETED|Overall Study||3
10817819|NCT01165450|11981711|FG000|STARTED|Overall Study||2
10817820|NCT01165450|11981711|FG000|COMPLETED|Overall Study||2
10817821|NCT01165450|11981711|FG000|NOT COMPLETED|Overall Study||0
10817822|NCT01179399|11981715|FG000|STARTED|Overall Study||32
10817823|NCT01179399|11981715|FG000|COMPLETED|Overall Study||0
10817824|NCT01179399|11981715|FG000|NOT COMPLETED|Overall Study||32
10817825|NCT01169753|11981721|FG000|STARTED|Overall Study||0
10817826|NCT01169753|11981722|FG001|STARTED|Overall Study||1
10817827|NCT01169753|11981721|FG000|COMPLETED|Overall Study||0
10817828|NCT01169753|11981722|FG001|COMPLETED|Overall Study||0
10817829|NCT01169753|11981721|FG000|NOT COMPLETED|Overall Study||0
10817830|NCT01169753|11981722|FG001|NOT COMPLETED|Overall Study||1
10817831|NCT01171534|11981730|FG000|STARTED|Overall Study|retrospective arm never performed on study|0
10817832|NCT01171534|11981731|FG001|STARTED|Overall Study||7
10817833|NCT01171534|11981730|FG000|COMPLETED|Overall Study||0
10817834|NCT01171534|11981731|FG001|COMPLETED|Overall Study||4
10817835|NCT01171534|11981730|FG000|NOT COMPLETED|Overall Study||0
10817836|NCT01171534|11981731|FG001|NOT COMPLETED|Overall Study||3
10817837|NCT01169610|11981737|FG000|STARTED|Overall Study||1
10817838|NCT01169610|11981737|FG000|COMPLETED|Overall Study||1
10817839|NCT01169610|11981737|FG000|NOT COMPLETED|Overall Study||0
10817840|NCT01163084|11981743|FG000|STARTED|Overall Study||4
10817841|NCT01163084|11981744|FG001|STARTED|Overall Study||5
10817842|NCT01163084|11981743|FG000|COMPLETED|Overall Study||4
10817843|NCT01163084|11981744|FG001|COMPLETED|Overall Study||5
10817844|NCT01163084|11981743|FG000|NOT COMPLETED|Overall Study||0
10817845|NCT01163084|11981744|FG001|NOT COMPLETED|Overall Study||0
10817846|NCT01166724|11981752|FG000|STARTED|Overall Study||7
10746458|NCT02964910|11910067|FG000|STARTED|Overall Study||235
10746459|NCT02964910|11910068|FG001|STARTED|Overall Study||240
10746460|NCT02964910|11910067|FG000|COMPLETED|Overall Study||192
10746461|NCT02964910|11910068|FG001|COMPLETED|Overall Study||196
10746462|NCT02964910|11910067|FG000|NOT COMPLETED|Overall Study||43
10746463|NCT02964910|11910068|FG001|NOT COMPLETED|Overall Study||44
10746464|NCT02965144|11910076|FG000|STARTED|Overall Study||13
10817847|NCT01166724|11981753|FG001|STARTED|Overall Study||5
10746465|NCT02965144|11910076|FG000|COMPLETED|Overall Study||13
10817848|NCT01166724|11981752|FG000|COMPLETED|Overall Study||0
10746466|NCT02965144|11910076|FG000|NOT COMPLETED|Overall Study||0
10746467|NCT02965378|11910085|FG000|STARTED|Overall Study||25
10746468|NCT02965378|11910086|FG001|STARTED|Overall Study||9
10746469|NCT02965378|11910085|FG000|Participants on Docetaxel Re-registered to AZD4547 After Progression.|Overall Study||0
10746470|NCT02965378|11910086|FG001|Participants on Docetaxel Re-registered to AZD4547 After Progression.|Overall Study||2
10746471|NCT02965378|11910085|FG000|COMPLETED|Overall Study||0
10746472|NCT02965378|11910086|FG001|COMPLETED|Overall Study||0
10746473|NCT02965378|11910085|FG000|NOT COMPLETED|Overall Study||25
10746474|NCT02965378|11910086|FG001|NOT COMPLETED|Overall Study||9
10746475|NCT02965456|11910094|FG000|STARTED|Overall Study||413
10746476|NCT02965456|11910095|FG001|STARTED|Overall Study||407
10746477|NCT02965456|11910094|FG000|Intent-to-treat (ITT) Population|Overall Study||413
10746478|NCT02965456|11910095|FG001|Intent-to-treat (ITT) Population|Overall Study||407
10746479|NCT02965456|11910094|FG000|Safety Population|Overall Study||389
10746480|NCT02965456|11910095|FG001|Safety Population|Overall Study||398
10746481|NCT02965456|11910094|FG000|COMPLETED|Overall Study||342
10746482|NCT02965456|11910095|FG001|COMPLETED|Overall Study||364
10746483|NCT02965456|11910094|FG000|NOT COMPLETED|Overall Study||71
10746484|NCT02965456|11910095|FG001|NOT COMPLETED|Overall Study||43
10746485|NCT02965534|11910101|FG000|STARTED|Overall Study|test period: 14 days with each test glasses|45
10746486|NCT02965534|11910102|FG001|STARTED|Overall Study|test period: 14 days with each test glasses|55
10746487|NCT02965534|11910101|FG000|COMPLETED|Overall Study||45
10746488|NCT02965534|11910102|FG001|COMPLETED|Overall Study||55
10746489|NCT02965534|11910101|FG000|NOT COMPLETED|Overall Study||0
10746490|NCT02965534|11910102|FG001|NOT COMPLETED|Overall Study||0
10746491|NCT02965573|11910111|FG000|STARTED|Overall Study||12
10746492|NCT02965573|11910112|FG001|STARTED|Overall Study||12
10746493|NCT02965573|11910111|FG000|COMPLETED|Overall Study||11
10746494|NCT02965573|11910112|FG001|COMPLETED|Overall Study||12
10746495|NCT02965573|11910111|FG000|NOT COMPLETED|Overall Study||1
10746496|NCT02965573|11910112|FG001|NOT COMPLETED|Overall Study||0
10746497|NCT02965599|11910120|FG000|STARTED|Overall Study||2
10746498|NCT02965599|11910121|FG001|STARTED|Overall Study||1
10746499|NCT02965599|11910120|FG000|COMPLETED|Overall Study||1
10746500|NCT02965599|11910121|FG001|COMPLETED|Overall Study||1
10746501|NCT02965599|11910120|FG000|NOT COMPLETED|Overall Study||1
10746502|NCT02965599|11910121|FG001|NOT COMPLETED|Overall Study||0
10746503|NCT02965781|11910131|FG000|STARTED|Overall Study||46
10746504|NCT02965781|11910132|FG001|STARTED|Overall Study||46
10746505|NCT02965781|11910133|FG002|STARTED|Overall Study||47
10746506|NCT02965781|11910131|FG000|COMPLETED|Overall Study||46
10746507|NCT02965781|11910132|FG001|COMPLETED|Overall Study||46
10746508|NCT02965781|11910133|FG002|COMPLETED|Overall Study||47
10746509|NCT02965781|11910131|FG000|NOT COMPLETED|Overall Study||0
10746510|NCT02965781|11910132|FG001|NOT COMPLETED|Overall Study||0
10746511|NCT02965781|11910133|FG002|NOT COMPLETED|Overall Study||0
10746512|NCT02965820|11910141|FG000|STARTED|Period 1, First 30 Days||59
10746513|NCT02965820|11910142|FG001|STARTED|Period 1, First 30 Days||62
10746514|NCT02965820|11910141|FG000|COMPLETED|Period 1, First 30 Days||59
10746515|NCT02965820|11910142|FG001|COMPLETED|Period 1, First 30 Days||62
10746516|NCT02965820|11910141|FG000|NOT COMPLETED|Period 1, First 30 Days||0
10746517|NCT02965820|11910142|FG001|NOT COMPLETED|Period 1, First 30 Days||0
10746518|NCT02965820|11910141|FG000|STARTED|Period 2, Second 30 Days|One subject discontinued due to an AE after completion of Period 1 but before beginning Period 2.|58
10746519|NCT02965820|11910142|FG001|STARTED|Period 2, Second 30 Days||62
10746520|NCT02965820|11910141|FG000|COMPLETED|Period 2, Second 30 Days||57
10746521|NCT02965820|11910142|FG001|COMPLETED|Period 2, Second 30 Days||61
10746522|NCT02965820|11910141|FG000|NOT COMPLETED|Period 2, Second 30 Days||1
10746523|NCT02965820|11910142|FG001|NOT COMPLETED|Period 2, Second 30 Days||1
10746524|NCT02965833|11910148|FG000|STARTED|Period 1, First 30 Days of Wear||67
10746525|NCT02965833|11910149|FG001|STARTED|Period 1, First 30 Days of Wear||54
10746526|NCT02965833|11910148|FG000|COMPLETED|Period 1, First 30 Days of Wear||64
10746527|NCT02965833|11910149|FG001|COMPLETED|Period 1, First 30 Days of Wear||52
10746528|NCT02965833|11910148|FG000|NOT COMPLETED|Period 1, First 30 Days of Wear||3
10746529|NCT02965833|11910149|FG001|NOT COMPLETED|Period 1, First 30 Days of Wear||2
10746530|NCT02965833|11910148|FG000|STARTED|Period 2, Second 30 Days of Wear||64
10746531|NCT02965833|11910149|FG001|STARTED|Period 2, Second 30 Days of Wear||52
10746532|NCT02965833|11910148|FG000|COMPLETED|Period 2, Second 30 Days of Wear||62
10746533|NCT02965833|11910149|FG001|COMPLETED|Period 2, Second 30 Days of Wear||52
10746534|NCT02965833|11910148|FG000|NOT COMPLETED|Period 2, Second 30 Days of Wear||2
10746535|NCT02965833|11910149|FG001|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
10746536|NCT02965924|11910155|FG000|STARTED|Overall Study||20
10746537|NCT02965924|11910155|FG000|COMPLETED|Overall Study||20
10746538|NCT02965924|11910155|FG000|NOT COMPLETED|Overall Study||0
10746539|NCT02965989|11910161|FG000|STARTED|Overall Study||26
10746540|NCT02965989|11910162|FG001|STARTED|Overall Study||22
10746541|NCT02965989|11910161|FG000|COMPLETED|Overall Study||26
10746542|NCT02965989|11910162|FG001|COMPLETED|Overall Study||22
10746543|NCT02965989|11910161|FG000|NOT COMPLETED|Overall Study||0
10746544|NCT02965989|11910162|FG001|NOT COMPLETED|Overall Study||0
10746545|NCT02966002|11910174|FG000|STARTED|Overall Study||9
10746546|NCT02966002|11910174|FG000|COMPLETED|Overall Study||5
10746547|NCT02966002|11910174|FG000|NOT COMPLETED|Overall Study||4
10746548|NCT02966015|11910180|FG000|STARTED|Inclusion Visit||95
10746549|NCT02966015|11910181|FG001|STARTED|Inclusion Visit||58
10746550|NCT02966015|11910180|FG000|COMPLETED|Inclusion Visit||87
10746551|NCT02966015|11910181|FG001|COMPLETED|Inclusion Visit||55
10746552|NCT02966015|11910180|FG000|NOT COMPLETED|Inclusion Visit||8
10746553|NCT02966015|11910181|FG001|NOT COMPLETED|Inclusion Visit||3
10746554|NCT02966015|11910180|FG000|STARTED|Test Period||87
10746555|NCT02966015|11910181|FG001|STARTED|Test Period||55
10746556|NCT02966015|11910180|FG000|COMPLETED|Test Period||87
10746557|NCT02966015|11910181|FG001|COMPLETED|Test Period||55
10746558|NCT02966015|11910180|FG000|NOT COMPLETED|Test Period||0
10746559|NCT02966015|11910181|FG001|NOT COMPLETED|Test Period||0
10746560|NCT02966028|11910190|FG000|STARTED|Overall Study||92
10746561|NCT02966028|11910191|FG001|STARTED|Overall Study||91
10746562|NCT02966028|11910192|FG002|STARTED|Overall Study||91
10746563|NCT02966028|11910190|FG000|COMPLETED|Overall Study||68
10746564|NCT02966028|11910191|FG001|COMPLETED|Overall Study||57
10746565|NCT02966028|11910192|FG002|COMPLETED|Overall Study||60
10746566|NCT02966028|11910190|FG000|NOT COMPLETED|Overall Study||24
10746567|NCT02966028|11910191|FG001|NOT COMPLETED|Overall Study||34
10746568|NCT02966028|11910192|FG002|NOT COMPLETED|Overall Study||31
10746569|NCT02966275|11910204|FG000|STARTED|Overall Study||10
10746570|NCT02966275|11910204|FG000|COMPLETED|Overall Study||10
10746571|NCT02966275|11910204|FG000|NOT COMPLETED|Overall Study||0
10746572|NCT02966314|11910213|FG000|STARTED|Overall Study||5
10746573|NCT02966314|11910214|FG001|STARTED|Overall Study||5
10746574|NCT02966314|11910213|FG000|COMPLETED|Overall Study||4
10746575|NCT02966314|11910214|FG001|COMPLETED|Overall Study||5
10746576|NCT02966314|11910213|FG000|NOT COMPLETED|Overall Study||1
10746577|NCT02966314|11910214|FG001|NOT COMPLETED|Overall Study||0
10746578|NCT02966340|11910220|FG000|STARTED|Overall Study||37
10746579|NCT02966340|11910221|FG001|STARTED|Overall Study||33
10746580|NCT02966340|11910220|FG000|COMPLETED|Overall Study||34
10746581|NCT02966340|11910221|FG001|COMPLETED|Overall Study||30
10746582|NCT02966340|11910220|FG000|NOT COMPLETED|Overall Study||3
10746583|NCT02966340|11910221|FG001|NOT COMPLETED|Overall Study||3
10746584|NCT02966353|11910227|FG000|STARTED|Overall Study||51
10746585|NCT02966353|11910227|FG000|Completed After Data Cutoff|Overall Study||1
10746586|NCT02966353|11910227|FG000|COMPLETED|Overall Study||29
10746587|NCT02966353|11910227|FG000|NOT COMPLETED|Overall Study||22
10746588|NCT02966509|11910233|FG000|STARTED|Baseline Satisfaction Survey||105
10746589|NCT02966509|11910234|FG001|STARTED|Baseline Satisfaction Survey||108
10746590|NCT02966509|11910233|FG000|COMPLETED|Baseline Satisfaction Survey||101
10746591|NCT02966509|11910234|FG001|COMPLETED|Baseline Satisfaction Survey||101
10746592|NCT02966509|11910233|FG000|NOT COMPLETED|Baseline Satisfaction Survey||4
10746593|NCT02966509|11910234|FG001|NOT COMPLETED|Baseline Satisfaction Survey||7
10746594|NCT02966509|11910233|FG000|STARTED|6 Month Satisfaction Decision Survey||105
10746595|NCT02966509|11910234|FG001|STARTED|6 Month Satisfaction Decision Survey||108
10746596|NCT02966509|11910233|FG000|COMPLETED|6 Month Satisfaction Decision Survey||80
10746597|NCT02966509|11910234|FG001|COMPLETED|6 Month Satisfaction Decision Survey||77
10746598|NCT02966509|11910233|FG000|NOT COMPLETED|6 Month Satisfaction Decision Survey||25
10746599|NCT02966509|11910234|FG001|NOT COMPLETED|6 Month Satisfaction Decision Survey||31
10746600|NCT02966509|11910233|FG000|STARTED|6 Month Satisfaction Survey||105
10746601|NCT02966509|11910234|FG001|STARTED|6 Month Satisfaction Survey||108
10746602|NCT02966509|11910233|FG000|COMPLETED|6 Month Satisfaction Survey||58
10746603|NCT02966509|11910234|FG001|COMPLETED|6 Month Satisfaction Survey||60
10746604|NCT02966509|11910233|FG000|NOT COMPLETED|6 Month Satisfaction Survey||47
10746605|NCT02966509|11910234|FG001|NOT COMPLETED|6 Month Satisfaction Survey||48
10746606|NCT02966509|11910233|FG000|STARTED|6-Month Utilization and Cost||105
10746607|NCT02966509|11910234|FG001|STARTED|6-Month Utilization and Cost||108
10746608|NCT02966509|11910233|FG000|COMPLETED|6-Month Utilization and Cost||105
10746609|NCT02966509|11910234|FG001|COMPLETED|6-Month Utilization and Cost||108
10746610|NCT02966509|11910233|FG000|NOT COMPLETED|6-Month Utilization and Cost||0
10746611|NCT02966509|11910234|FG001|NOT COMPLETED|6-Month Utilization and Cost||0
10746612|NCT02966509|11910233|FG000|STARTED|15-Month Utilization and Cost||105
10746613|NCT02966509|11910234|FG001|STARTED|15-Month Utilization and Cost||108
10746614|NCT02966509|11910233|FG000|COMPLETED|15-Month Utilization and Cost||105
10746615|NCT02966509|11910234|FG001|COMPLETED|15-Month Utilization and Cost||108
10746616|NCT02966509|11910233|FG000|NOT COMPLETED|15-Month Utilization and Cost||0
10746617|NCT02966509|11910234|FG001|NOT COMPLETED|15-Month Utilization and Cost||0
10746618|NCT02966509|11910233|FG000|STARTED|End of Life Utilization and Cost 6 Month||105
10746619|NCT02966509|11910234|FG001|STARTED|End of Life Utilization and Cost 6 Month||108
10746620|NCT02966509|11910233|FG000|COMPLETED|End of Life Utilization and Cost 6 Month||36
10746621|NCT02966509|11910234|FG001|COMPLETED|End of Life Utilization and Cost 6 Month||33
10746622|NCT02966509|11910233|FG000|NOT COMPLETED|End of Life Utilization and Cost 6 Month||69
10746623|NCT02966509|11910234|FG001|NOT COMPLETED|End of Life Utilization and Cost 6 Month||75
10746624|NCT02966509|11910233|FG000|STARTED|End of Life Utilization and Cost 15month||105
10746625|NCT02966509|11910234|FG001|STARTED|End of Life Utilization and Cost 15month||108
10746626|NCT02966509|11910233|FG000|COMPLETED|End of Life Utilization and Cost 15month||60
10746627|NCT02966509|11910234|FG001|COMPLETED|End of Life Utilization and Cost 15month||60
10746628|NCT02966509|11910233|FG000|NOT COMPLETED|End of Life Utilization and Cost 15month||45
10746629|NCT02966509|11910234|FG001|NOT COMPLETED|End of Life Utilization and Cost 15month||48
10746630|NCT02966795|11910242|FG000|STARTED|Overall Study||23
10746631|NCT02966795|11910243|FG001|STARTED|Overall Study||61
10746632|NCT02966795|11910242|FG000|COMPLETED|Overall Study||23
10746633|NCT02966795|11910243|FG001|COMPLETED|Overall Study||60
10746634|NCT02966795|11910242|FG000|NOT COMPLETED|Overall Study||0
10746635|NCT02966795|11910243|FG001|NOT COMPLETED|Overall Study||1
10746636|NCT02966834|11910254|FG000|STARTED|Main Study Period (Up to 12 Weeks)||36
10746637|NCT02966834|11910255|FG001|STARTED|Main Study Period (Up to 12 Weeks)||16
10746638|NCT02966834|11910256|FG002|STARTED|Main Study Period (Up to 12 Weeks)||23
10746639|NCT02966834|11910257|FG003|STARTED|Main Study Period (Up to 12 Weeks)||27
10746640|NCT02966834|11910258|FG004|STARTED|Main Study Period (Up to 12 Weeks)||23
10746641|NCT02966834|11910259|FG005|STARTED|Main Study Period (Up to 12 Weeks)||22
10746642|NCT02966834|11910254|FG000|COMPLETED|Main Study Period (Up to 12 Weeks)||35
10746643|NCT02966834|11910255|FG001|COMPLETED|Main Study Period (Up to 12 Weeks)||16
10746644|NCT02966834|11910256|FG002|COMPLETED|Main Study Period (Up to 12 Weeks)||19
10746645|NCT02966834|11910257|FG003|COMPLETED|Main Study Period (Up to 12 Weeks)||19
10746646|NCT02966834|11910258|FG004|COMPLETED|Main Study Period (Up to 12 Weeks)||22
10746647|NCT02966834|11910259|FG005|COMPLETED|Main Study Period (Up to 12 Weeks)||17
10746648|NCT02966834|11910254|FG000|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||1
10746649|NCT02966834|11910255|FG001|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||0
10746650|NCT02966834|11910256|FG002|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||4
10746651|NCT02966834|11910257|FG003|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||8
10746652|NCT02966834|11910258|FG004|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||1
10746653|NCT02966834|11910259|FG005|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||5
10746654|NCT02966834|11910254|FG000|STARTED|Final Study Period (Up to 4 Weeks)||35
10746655|NCT02966834|11910255|FG001|STARTED|Final Study Period (Up to 4 Weeks)||16
10746656|NCT02966834|11910256|FG002|STARTED|Final Study Period (Up to 4 Weeks)||19
10746657|NCT02966834|11910257|FG003|STARTED|Final Study Period (Up to 4 Weeks)||19
10746658|NCT02966834|11910258|FG004|STARTED|Final Study Period (Up to 4 Weeks)|One participant did not enter Final Study Period.|21
10746659|NCT02966834|11910259|FG005|STARTED|Final Study Period (Up to 4 Weeks)||17
10746660|NCT02966834|11910254|FG000|COMPLETED|Final Study Period (Up to 4 Weeks)||35
10746661|NCT02966834|11910255|FG001|COMPLETED|Final Study Period (Up to 4 Weeks)||16
10746662|NCT02966834|11910256|FG002|COMPLETED|Final Study Period (Up to 4 Weeks)||19
10746663|NCT02966834|11910257|FG003|COMPLETED|Final Study Period (Up to 4 Weeks)||19
10746664|NCT02966834|11910258|FG004|COMPLETED|Final Study Period (Up to 4 Weeks)||21
10746665|NCT02966834|11910259|FG005|COMPLETED|Final Study Period (Up to 4 Weeks)||17
10746666|NCT02966834|11910254|FG000|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0
10746667|NCT02966834|11910255|FG001|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0
10746668|NCT02966834|11910256|FG002|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0
10746669|NCT02966834|11910257|FG003|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0
10746670|NCT02966834|11910258|FG004|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0
10746671|NCT02966834|11910259|FG005|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0
10746672|NCT02966834|11910254|FG000|STARTED|Follow-up (Up to 4 Weeks)||35
10746673|NCT02966834|11910255|FG001|STARTED|Follow-up (Up to 4 Weeks)||16
10746674|NCT02966834|11910256|FG002|STARTED|Follow-up (Up to 4 Weeks)|4 participants discontinued study treatment in Main study period and directly entered follow-up.|23
10746675|NCT02966834|11910257|FG003|STARTED|Follow-up (Up to 4 Weeks)|8 participants discontinued study treatment in Main Study period and directly entered follow-up.|27
10746676|NCT02966834|11910258|FG004|STARTED|Follow-up (Up to 4 Weeks)|1 participant who completed main study period directly entered follow-up in this arm|22
10746677|NCT02966834|11910259|FG005|STARTED|Follow-up (Up to 4 Weeks)|5 participants discontinued study treatment in Main study period and directly entered follow-up|22
10746678|NCT02966834|11910254|FG000|COMPLETED|Follow-up (Up to 4 Weeks)||35
10746679|NCT02966834|11910255|FG001|COMPLETED|Follow-up (Up to 4 Weeks)||16
10746680|NCT02966834|11910256|FG002|COMPLETED|Follow-up (Up to 4 Weeks)||22
10746681|NCT02966834|11910257|FG003|COMPLETED|Follow-up (Up to 4 Weeks)||22
10746682|NCT02966834|11910258|FG004|COMPLETED|Follow-up (Up to 4 Weeks)||22
10746683|NCT02966834|11910259|FG005|COMPLETED|Follow-up (Up to 4 Weeks)||21
10746684|NCT02966834|11910254|FG000|NOT COMPLETED|Follow-up (Up to 4 Weeks)||0
10746685|NCT02966834|11910255|FG001|NOT COMPLETED|Follow-up (Up to 4 Weeks)||0
10746686|NCT02966834|11910256|FG002|NOT COMPLETED|Follow-up (Up to 4 Weeks)||1
10746687|NCT02966834|11910257|FG003|NOT COMPLETED|Follow-up (Up to 4 Weeks)||5
10746688|NCT02966834|11910258|FG004|NOT COMPLETED|Follow-up (Up to 4 Weeks)||0
10746689|NCT02966834|11910259|FG005|NOT COMPLETED|Follow-up (Up to 4 Weeks)||1
10746690|NCT02967016|11910310|FG000|STARTED|Overall Study||25
10746691|NCT02967016|11910311|FG001|STARTED|Overall Study||25
10746692|NCT02967016|11910310|FG000|COMPLETED|Overall Study||25
10746693|NCT02967016|11910311|FG001|COMPLETED|Overall Study||25
10746694|NCT02967016|11910310|FG000|NOT COMPLETED|Overall Study||0
10746695|NCT02967016|11910311|FG001|NOT COMPLETED|Overall Study||0
10746696|NCT02967055|11910317|FG000|STARTED|Overall Study|Assessed for eligibility|54
10746697|NCT02967055|11910317|FG000|In-person Screening|Overall Study||14
10746698|NCT02967055|11910317|FG000|Enrolled|Overall Study|Enrolled|9
10746699|NCT02967055|11910317|FG000|Completed 4 Week Follow-up Visit|Overall Study||8
10746700|NCT02967055|11910317|FG000|COMPLETED|Overall Study||5
10746701|NCT02967055|11910317|FG000|NOT COMPLETED|Overall Study||49
10746702|NCT02967354|11910326|FG000|STARTED|Overall Study||8
10746703|NCT02967354|11910327|FG001|STARTED|Overall Study||7
10746704|NCT02967354|11910328|FG002|STARTED|Overall Study||9
10746705|NCT02967354|11910329|FG003|STARTED|Overall Study||7
10746706|NCT02967354|11910330|FG004|STARTED|Overall Study||8
10746707|NCT02967354|11910326|FG000|COMPLETED|Overall Study||8
10746708|NCT02967354|11910327|FG001|COMPLETED|Overall Study||7
10746709|NCT02967354|11910328|FG002|COMPLETED|Overall Study||9
10746710|NCT02967354|11910329|FG003|COMPLETED|Overall Study||7
10746711|NCT02967354|11910330|FG004|COMPLETED|Overall Study||8
10746712|NCT02967354|11910326|FG000|NOT COMPLETED|Overall Study||0
10746713|NCT02967354|11910327|FG001|NOT COMPLETED|Overall Study||0
10746714|NCT02967354|11910328|FG002|NOT COMPLETED|Overall Study||0
10746715|NCT02967354|11910329|FG003|NOT COMPLETED|Overall Study||0
10746716|NCT02967354|11910330|FG004|NOT COMPLETED|Overall Study||0
10746717|NCT02967367|11910347|FG000|STARTED|Overall Study||36
10746718|NCT02967367|11910347|FG000|COMPLETED|Overall Study||22
10746719|NCT02967367|11910347|FG000|NOT COMPLETED|Overall Study||14
10746720|NCT02967393|11910353|FG000|STARTED|Overall Study||20
10746721|NCT02967393|11910354|FG001|STARTED|Overall Study||20
10746722|NCT02967393|11910353|FG000|COMPLETED|Overall Study||20
10746723|NCT02967393|11910354|FG001|COMPLETED|Overall Study||20
10746724|NCT02967393|11910353|FG000|NOT COMPLETED|Overall Study||0
10746725|NCT02967393|11910354|FG001|NOT COMPLETED|Overall Study||0
10746726|NCT02967458|11910362|FG000|STARTED|Overall Study||55
10746727|NCT02967458|11910362|FG000|COMPLETED|Overall Study||55
10746728|NCT02967458|11910362|FG000|NOT COMPLETED|Overall Study||0
10746729|NCT02967510|11910371|FG000|STARTED|Overall Study||70
10746730|NCT02967510|11910372|FG001|STARTED|Overall Study||70
10746731|NCT02967510|11910373|FG002|STARTED|Overall Study||72
10746732|NCT02967510|11910374|FG003|STARTED|Overall Study||71
10746733|NCT02967510|11910371|FG000|COMPLETED|Overall Study||66
10746734|NCT02967510|11910372|FG001|COMPLETED|Overall Study||67
10746735|NCT02967510|11910373|FG002|COMPLETED|Overall Study||65
10746736|NCT02967510|11910374|FG003|COMPLETED|Overall Study||63
10746737|NCT02967510|11910371|FG000|NOT COMPLETED|Overall Study||4
10746738|NCT02967510|11910372|FG001|NOT COMPLETED|Overall Study||3
10746739|NCT02967510|11910373|FG002|NOT COMPLETED|Overall Study||7
10746740|NCT02967510|11910374|FG003|NOT COMPLETED|Overall Study||8
10746741|NCT02967562|11910386|FG000|STARTED|Overall Study||32
10746742|NCT02967562|11910387|FG001|STARTED|Overall Study||31
10746743|NCT02967562|11910386|FG000|COMPLETED|Overall Study||30
10746744|NCT02967562|11910387|FG001|COMPLETED|Overall Study||30
10746745|NCT02967562|11910386|FG000|NOT COMPLETED|Overall Study||2
10746746|NCT02967562|11910387|FG001|NOT COMPLETED|Overall Study||1
10746747|NCT02967679|11910393|FG000|STARTED|Overall Study||15
10746748|NCT02967679|11910393|FG000|COMPLETED|Overall Study||14
10746749|NCT02967679|11910393|FG000|NOT COMPLETED|Overall Study||1
10746750|NCT02967991|11910397|FG000|STARTED|Overall Study|First Intervention: 10 minutes Washout: 1 minute Second Intervention: 10 minutes|10
10746751|NCT02967991|11910398|FG001|STARTED|Overall Study|First Intervention: 10 minutes Washout: 1 minute Second Intervention: 10 minutes|10
10746752|NCT02967991|11910397|FG000|COMPLETED|Overall Study||10
10746753|NCT02967991|11910398|FG001|COMPLETED|Overall Study||10
10746754|NCT02967991|11910397|FG000|NOT COMPLETED|Overall Study||0
10746755|NCT02967991|11910398|FG001|NOT COMPLETED|Overall Study||0
10746762|NCT02968134|11910417|FG000|STARTED|Overall Study||8
10746763|NCT02968134|11910417|FG000|COMPLETED|Overall Study||8
10746764|NCT02968134|11910417|FG000|NOT COMPLETED|Overall Study||0
10746765|NCT02968173|11910421|FG000|STARTED|Overall Study||50
10746766|NCT02968173|11910421|FG000|COMPLETED|Overall Study||49
10746767|NCT02968173|11910421|FG000|NOT COMPLETED|Overall Study||1
10746768|NCT02968277|11910429|FG000|STARTED|Overall Study||10
10746769|NCT02968277|11910430|FG001|STARTED|Overall Study||7
10746770|NCT02968277|11910431|FG002|STARTED|Overall Study||13
10746771|NCT02968277|11910429|FG000|COMPLETED|Overall Study||10
10746772|NCT02968277|11910430|FG001|COMPLETED|Overall Study||7
10746773|NCT02968277|11910431|FG002|COMPLETED|Overall Study||13
10746774|NCT02968277|11910429|FG000|NOT COMPLETED|Overall Study||0
10746775|NCT02968277|11910430|FG001|NOT COMPLETED|Overall Study||0
10746776|NCT02968277|11910431|FG002|NOT COMPLETED|Overall Study||0
10746777|NCT02968368|11910445|FG000|STARTED|Double Blind Phase||111
10817849|NCT01166724|11981753|FG001|COMPLETED|Overall Study||0
10817850|NCT01166724|11981752|FG000|NOT COMPLETED|Overall Study||7
10817851|NCT01166724|11981753|FG001|NOT COMPLETED|Overall Study||5
10817852|NCT01162382|11981759|FG000|STARTED|Overall Study||0
10817853|NCT01162382|11981759|FG000|COMPLETED|Overall Study||0
10817854|NCT01162382|11981759|FG000|NOT COMPLETED|Overall Study||0
10817855|NCT01157533|11981763|FG000|STARTED|Overall Study||1
10817856|NCT01157533|11981763|FG000|COMPLETED|Overall Study||1
10817857|NCT01157533|11981763|FG000|NOT COMPLETED|Overall Study||0
10817858|NCT01162304|11981767|FG000|STARTED|Overall Study||18
10817859|NCT01162304|11981767|FG000|COMPLETED|Overall Study||7
10817860|NCT01162304|11981767|FG000|NOT COMPLETED|Overall Study||11
10817861|NCT01151904|11981773|FG000|STARTED|Overall Study||17
10817862|NCT01151904|11981773|FG000|COMPLETED|Overall Study||17
10817863|NCT01151904|11981773|FG000|NOT COMPLETED|Overall Study||0
10817864|NCT01155518|11981783|FG000|STARTED|Overall Study||1
10817865|NCT01155518|11981784|FG001|STARTED|Overall Study||1
10817866|NCT01155518|11981785|FG002|STARTED|Overall Study||0
10817867|NCT01155518|11981786|FG003|STARTED|Overall Study||0
10817868|NCT01155518|11981787|FG004|STARTED|Overall Study||1
10817869|NCT01155518|11981788|FG005|STARTED|Overall Study||2
10817870|NCT01155518|11981783|FG000|COMPLETED|Overall Study||1
10746778|NCT02968368|11910446|FG001|STARTED|Double Blind Phase||56
10746779|NCT02968368|11910445|FG000|COMPLETED|Double Blind Phase||90
10746780|NCT02968368|11910446|FG001|COMPLETED|Double Blind Phase||39
10746781|NCT02968368|11910445|FG000|NOT COMPLETED|Double Blind Phase||21
10746782|NCT02968368|11910446|FG001|NOT COMPLETED|Double Blind Phase||17
10746783|NCT02968368|11910445|FG000|STARTED|Open Label Phase||86
10746784|NCT02968368|11910446|FG001|STARTED|Open Label Phase||39
10746785|NCT02968368|11910445|FG000|COMPLETED|Open Label Phase||67
10746786|NCT02968368|11910446|FG001|COMPLETED|Open Label Phase||25
10746787|NCT02968368|11910445|FG000|NOT COMPLETED|Open Label Phase||19
10746788|NCT02968368|11910446|FG001|NOT COMPLETED|Open Label Phase||14
10746789|NCT02968420|11910457|FG000|STARTED|Overall Study||6
10746790|NCT02968420|11910458|FG001|STARTED|Overall Study||6
10746791|NCT02968420|11910459|FG002|STARTED|Overall Study||6
10746792|NCT02968420|11910457|FG000|COMPLETED|Overall Study||6
10746793|NCT02968420|11910458|FG001|COMPLETED|Overall Study||6
10746794|NCT02968420|11910459|FG002|COMPLETED|Overall Study||6
10746795|NCT02968420|11910457|FG000|NOT COMPLETED|Overall Study||0
10746796|NCT02968420|11910458|FG001|NOT COMPLETED|Overall Study||0
10746797|NCT02968420|11910459|FG002|NOT COMPLETED|Overall Study||0
10746798|NCT02968433|11910467|FG000|STARTED|Overall Study||16
10746799|NCT02968433|11910467|FG000|COMPLETED|Overall Study||15
10746800|NCT02968433|11910467|FG000|NOT COMPLETED|Overall Study||1
10746801|NCT02968576|11910477|FG000|STARTED|Overall Study||11
10746802|NCT02968576|11910478|FG001|STARTED|Overall Study||14
10746803|NCT02968576|11910477|FG000|COMPLETED|Overall Study||11
10746804|NCT02968576|11910478|FG001|COMPLETED|Overall Study||13
10746805|NCT02968576|11910477|FG000|NOT COMPLETED|Overall Study||0
10746806|NCT02968576|11910478|FG001|NOT COMPLETED|Overall Study||1
10746807|NCT02968758|11910484|FG000|STARTED|Overall Study||797
10746808|NCT02968758|11910485|FG001|STARTED|Overall Study||1664
10746809|NCT02968758|11910484|FG000|COMPLETED|Overall Study||797
10746810|NCT02968758|11910485|FG001|COMPLETED|Overall Study||1664
10746811|NCT02968758|11910484|FG000|NOT COMPLETED|Overall Study||0
10746812|NCT02968758|11910485|FG001|NOT COMPLETED|Overall Study||0
10746813|NCT02968914|11910492|FG000|STARTED|Overall Study||90
10746814|NCT02968914|11910493|FG001|STARTED|Overall Study||90
10746815|NCT02968914|11910492|FG000|COMPLETED|Overall Study||90
10746816|NCT02968914|11910493|FG001|COMPLETED|Overall Study||90
10746817|NCT02968914|11910492|FG000|NOT COMPLETED|Overall Study||0
10746818|NCT02968914|11910493|FG001|NOT COMPLETED|Overall Study||0
10746819|NCT02968979|11910499|FG000|STARTED|Overall Study||539
10746820|NCT02968979|11910499|FG000|COMPLETED|Overall Study|This cross-sectional study had only 1 visit.|531
10746821|NCT02968979|11910499|FG000|NOT COMPLETED|Overall Study||8
10746822|NCT02968992|11910551|FG000|STARTED|Overall Study||18
10746823|NCT02968992|11910552|FG001|STARTED|Overall Study||18
10746824|NCT02968992|11910551|FG000|COMPLETED|Overall Study||18
10746825|NCT02968992|11910552|FG001|COMPLETED|Overall Study||17
10746826|NCT02968992|11910551|FG000|NOT COMPLETED|Overall Study||0
10746827|NCT02968992|11910552|FG001|NOT COMPLETED|Overall Study||1
10746828|NCT02969018|11910566|FG000|STARTED|Overall Study||25
10746829|NCT02969018|11910567|FG001|STARTED|Overall Study||29
10746830|NCT02969018|11910568|FG002|STARTED|Overall Study||26
10746831|NCT02969018|11910569|FG003|STARTED|Overall Study||25
10746832|NCT02969018|11910570|FG004|STARTED|Overall Study||29
10746833|NCT02969018|11910571|FG005|STARTED|Overall Study||25
10746834|NCT02969018|11910572|FG006|STARTED|Overall Study||30
10746835|NCT02969018|11910573|FG007|STARTED|Overall Study||23
10746836|NCT02969018|11910566|FG000|COMPLETED|Overall Study||21
10746837|NCT02969018|11910567|FG001|COMPLETED|Overall Study||21
10746838|NCT02969018|11910568|FG002|COMPLETED|Overall Study||20
10746839|NCT02969018|11910569|FG003|COMPLETED|Overall Study||20
10746840|NCT02969018|11910570|FG004|COMPLETED|Overall Study||27
10746841|NCT02969018|11910571|FG005|COMPLETED|Overall Study||17
10746842|NCT02969018|11910572|FG006|COMPLETED|Overall Study||22
10746843|NCT02969018|11910573|FG007|COMPLETED|Overall Study||16
10746844|NCT02969018|11910566|FG000|NOT COMPLETED|Overall Study||4
10746845|NCT02969018|11910567|FG001|NOT COMPLETED|Overall Study||8
10746846|NCT02969018|11910568|FG002|NOT COMPLETED|Overall Study||6
10746847|NCT02969018|11910569|FG003|NOT COMPLETED|Overall Study||5
10746848|NCT02969018|11910570|FG004|NOT COMPLETED|Overall Study||2
10746849|NCT02969018|11910571|FG005|NOT COMPLETED|Overall Study||8
10746850|NCT02969018|11910572|FG006|NOT COMPLETED|Overall Study||8
10746851|NCT02969018|11910573|FG007|NOT COMPLETED|Overall Study||7
10746852|NCT02969031|11910596|FG000|STARTED|Enrolled and Randomized||73
10746853|NCT02969031|11910597|FG001|STARTED|Enrolled and Randomized||75
10746854|NCT02969031|11910596|FG000|COMPLETED|Enrolled and Randomized||73
10746855|NCT02969031|11910597|FG001|COMPLETED|Enrolled and Randomized||75
10746856|NCT02969031|11910596|FG000|NOT COMPLETED|Enrolled and Randomized||0
10746857|NCT02969031|11910597|FG001|NOT COMPLETED|Enrolled and Randomized||0
10746858|NCT02969031|11910596|FG000|STARTED|Collection of Baseline Surveys||73
10746859|NCT02969031|11910597|FG001|STARTED|Collection of Baseline Surveys||75
10746860|NCT02969031|11910596|FG000|COMPLETED|Collection of Baseline Surveys||34
10746861|NCT02969031|11910597|FG001|COMPLETED|Collection of Baseline Surveys||23
10746862|NCT02969031|11910596|FG000|NOT COMPLETED|Collection of Baseline Surveys||39
10746863|NCT02969031|11910597|FG001|NOT COMPLETED|Collection of Baseline Surveys||52
10746864|NCT02969031|11910596|FG000|STARTED|Collection of Baseline Recordings||34
10746865|NCT02969031|11910597|FG001|STARTED|Collection of Baseline Recordings||23
10746866|NCT02969031|11910596|FG000|COMPLETED|Collection of Baseline Recordings||22
10746867|NCT02969031|11910597|FG001|COMPLETED|Collection of Baseline Recordings||18
10746868|NCT02969031|11910596|FG000|NOT COMPLETED|Collection of Baseline Recordings||12
10746869|NCT02969031|11910597|FG001|NOT COMPLETED|Collection of Baseline Recordings||5
10746870|NCT02969031|11910596|FG000|STARTED|Completed Intervention||22
10746871|NCT02969031|11910597|FG001|STARTED|Completed Intervention||18
10746872|NCT02969031|11910596|FG000|COMPLETED|Completed Intervention||15
10746873|NCT02969031|11910597|FG001|COMPLETED|Completed Intervention||14
10746874|NCT02969031|11910596|FG000|NOT COMPLETED|Completed Intervention||7
10746875|NCT02969031|11910597|FG001|NOT COMPLETED|Completed Intervention||4
10746876|NCT02969031|11910596|FG000|STARTED|Collection of Follow-Up Surveys||15
10746877|NCT02969031|11910597|FG001|STARTED|Collection of Follow-Up Surveys||14
10746878|NCT02969031|11910596|FG000|COMPLETED|Collection of Follow-Up Surveys||15
10746879|NCT02969031|11910597|FG001|COMPLETED|Collection of Follow-Up Surveys||12
10746880|NCT02969031|11910596|FG000|NOT COMPLETED|Collection of Follow-Up Surveys||0
10746881|NCT02969031|11910597|FG001|NOT COMPLETED|Collection of Follow-Up Surveys||2
10746882|NCT02969031|11910596|FG000|STARTED|Collection of Follow-Up Recordings||15
10746883|NCT02969031|11910597|FG001|STARTED|Collection of Follow-Up Recordings||12
10746884|NCT02969031|11910596|FG000|COMPLETED|Collection of Follow-Up Recordings||15
10746885|NCT02969031|11910597|FG001|COMPLETED|Collection of Follow-Up Recordings||12
10746886|NCT02969031|11910596|FG000|NOT COMPLETED|Collection of Follow-Up Recordings||0
10746887|NCT02969031|11910597|FG001|NOT COMPLETED|Collection of Follow-Up Recordings||0
10746888|NCT02969031|11910596|FG000|STARTED|Completed and Analyzed||15
10746889|NCT02969031|11910597|FG001|STARTED|Completed and Analyzed||12
10746890|NCT02969031|11910596|FG000|COMPLETED|Completed and Analyzed||15
10746891|NCT02969031|11910597|FG001|COMPLETED|Completed and Analyzed||12
10746892|NCT02969031|11910596|FG000|NOT COMPLETED|Completed and Analyzed||0
10746893|NCT02969031|11910597|FG001|NOT COMPLETED|Completed and Analyzed||0
10746894|NCT02969044|11910605|FG000|STARTED|Overall Study||42
10746895|NCT02969044|11910606|FG001|STARTED|Overall Study||28
10746896|NCT02969044|11910605|FG000|COMPLETED|Overall Study||37
10746897|NCT02969044|11910606|FG001|COMPLETED|Overall Study||22
10746898|NCT02969044|11910605|FG000|NOT COMPLETED|Overall Study||5
10746899|NCT02969044|11910606|FG001|NOT COMPLETED|Overall Study||6
10746900|NCT02969187|11910614|FG000|STARTED|Overall Study||63
10746901|NCT02969187|11910615|FG001|STARTED|Overall Study||63
10746902|NCT02969187|11910614|FG000|COMPLETED|Overall Study||51
10746903|NCT02969187|11910615|FG001|COMPLETED|Overall Study||50
10746904|NCT02969187|11910614|FG000|NOT COMPLETED|Overall Study||12
10746905|NCT02969187|11910615|FG001|NOT COMPLETED|Overall Study||13
10746906|NCT02969317|11910623|FG000|STARTED|Overall Study||12
10746907|NCT02969317|11910623|FG000|COMPLETED|Overall Study||12
10746908|NCT02969317|11910623|FG000|NOT COMPLETED|Overall Study||0
10746913|NCT02969382|11910634|FG000|STARTED|Overall Study||125
10746914|NCT02969382|11910635|FG001|STARTED|Overall Study||120
10746915|NCT02969382|11910634|FG000|Subjects Continued Into Extension Study|Overall Study||79
10746916|NCT02969382|11910635|FG001|Subjects Continued Into Extension Study|Overall Study||78
10746917|NCT02969382|11910634|FG000|COMPLETED|Overall Study||99
10746918|NCT02969382|11910635|FG001|COMPLETED|Overall Study||94
10746919|NCT02969382|11910634|FG000|NOT COMPLETED|Overall Study||26
10746920|NCT02969382|11910635|FG001|NOT COMPLETED|Overall Study||26
10746921|NCT02969408|11910641|FG000|STARTED|Overall Study||397
10746922|NCT02969408|11910641|FG000|Used ABS eMDPI at Least Once|Overall Study||370
10746923|NCT02969408|11910641|FG000|COMPLETED|Overall Study||381
10746924|NCT02969408|11910641|FG000|NOT COMPLETED|Overall Study||16
10746925|NCT02969421|11910647|FG000|STARTED|Overall Study||33
10746926|NCT02969421|11910648|FG001|STARTED|Overall Study||33
10746927|NCT02969421|11910647|FG000|COMPLETED|Overall Study||33
10746928|NCT02969421|11910648|FG001|COMPLETED|Overall Study||33
10746929|NCT02969421|11910647|FG000|NOT COMPLETED|Overall Study||0
10746930|NCT02969421|11910648|FG001|NOT COMPLETED|Overall Study||0
10746931|NCT02969499|11910654|FG000|STARTED|Overall Study||33
10746932|NCT02969499|11910654|FG000|COMPLETED|Overall Study||33
10746933|NCT02969499|11910654|FG000|NOT COMPLETED|Overall Study||0
10746934|NCT02969525|11910663|FG000|STARTED|Double-Blind Period||42
10746935|NCT02969525|11910664|FG001|STARTED|Double-Blind Period||41
10746936|NCT02969525|11910665|FG002|STARTED|Double-Blind Period||41
10746937|NCT02969525|11910666|FG003|STARTED|Double-Blind Period||41
10746938|NCT02969525|11910667|FG004|STARTED|Double-Blind Period||41
10746939|NCT02969525|11910668|FG005|STARTED|Double-Blind Period||0
10746940|NCT02969525|11910669|FG006|STARTED|Double-Blind Period||0
10746941|NCT02969525|11910670|FG007|STARTED|Double-Blind Period||0
10746942|NCT02969525|11910671|FG008|STARTED|Double-Blind Period||0
10746943|NCT02969525|11910672|FG009|STARTED|Double-Blind Period||0
10746944|NCT02969525|11910673|FG010|STARTED|Double-Blind Period||0
10746945|NCT02969525|11910674|FG011|STARTED|Double-Blind Period||0
10746946|NCT02969525|11910663|FG000|Completed Double-Blind Period|Double-Blind Period||42
10746947|NCT02969525|11910664|FG001|Completed Double-Blind Period|Double-Blind Period||41
10746948|NCT02969525|11910665|FG002|Completed Double-Blind Period|Double-Blind Period||40
10746949|NCT02969525|11910666|FG003|Completed Double-Blind Period|Double-Blind Period||39
10746950|NCT02969525|11910667|FG004|Completed Double-Blind Period|Double-Blind Period||41
10746951|NCT02969525|11910668|FG005|Completed Double-Blind Period|Double-Blind Period||0
10746952|NCT02969525|11910669|FG006|Completed Double-Blind Period|Double-Blind Period||0
10778409|NCT03355326|11940351|FG001|STARTED|Overall Study||7
10746953|NCT02969525|11910670|FG007|Completed Double-Blind Period|Double-Blind Period||0
10746954|NCT02969525|11910671|FG008|Completed Double-Blind Period|Double-Blind Period||0
10746955|NCT02969525|11910672|FG009|Completed Double-Blind Period|Double-Blind Period||0
10746956|NCT02969525|11910673|FG010|Completed Double-Blind Period|Double-Blind Period||0
10746957|NCT02969525|11910674|FG011|Completed Double-Blind Period|Double-Blind Period||0
10746958|NCT02969525|11910663|FG000|Completed Wk12 and Started Dose-Blind|Double-Blind Period||40
10746959|NCT02969525|11910664|FG001|Completed Wk12 and Started Dose-Blind|Double-Blind Period||41
10746960|NCT02969525|11910665|FG002|Completed Wk12 and Started Dose-Blind|Double-Blind Period||40
10746961|NCT02969525|11910666|FG003|Completed Wk12 and Started Dose-Blind|Double-Blind Period||37
10746962|NCT02969525|11910667|FG004|Completed Wk12 and Started Dose-Blind|Double-Blind Period||41
10746963|NCT02969525|11910668|FG005|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
10746964|NCT02969525|11910669|FG006|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
10746965|NCT02969525|11910670|FG007|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
10746966|NCT02969525|11910671|FG008|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
10746967|NCT02969525|11910672|FG009|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
10746968|NCT02969525|11910673|FG010|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
10746969|NCT02969525|11910674|FG011|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
10746970|NCT02969525|11910663|FG000|COMPLETED|Double-Blind Period||40
10746971|NCT02969525|11910664|FG001|COMPLETED|Double-Blind Period||41
10746972|NCT02969525|11910665|FG002|COMPLETED|Double-Blind Period||40
10746973|NCT02969525|11910666|FG003|COMPLETED|Double-Blind Period||37
10746974|NCT02969525|11910667|FG004|COMPLETED|Double-Blind Period||41
10746975|NCT02969525|11910668|FG005|COMPLETED|Double-Blind Period||0
10746976|NCT02969525|11910669|FG006|COMPLETED|Double-Blind Period||0
10746977|NCT02969525|11910670|FG007|COMPLETED|Double-Blind Period||0
10746978|NCT02969525|11910671|FG008|COMPLETED|Double-Blind Period||0
10746979|NCT02969525|11910672|FG009|COMPLETED|Double-Blind Period||0
10746980|NCT02969525|11910673|FG010|COMPLETED|Double-Blind Period||0
10746981|NCT02969525|11910674|FG011|COMPLETED|Double-Blind Period||0
10746982|NCT02969525|11910663|FG000|NOT COMPLETED|Double-Blind Period||2
10746983|NCT02969525|11910664|FG001|NOT COMPLETED|Double-Blind Period||0
10746984|NCT02969525|11910665|FG002|NOT COMPLETED|Double-Blind Period||1
10746985|NCT02969525|11910666|FG003|NOT COMPLETED|Double-Blind Period||4
10746986|NCT02969525|11910667|FG004|NOT COMPLETED|Double-Blind Period||0
10746987|NCT02969525|11910668|FG005|NOT COMPLETED|Double-Blind Period||0
10746988|NCT02969525|11910669|FG006|NOT COMPLETED|Double-Blind Period||0
10746989|NCT02969525|11910670|FG007|NOT COMPLETED|Double-Blind Period||0
10746990|NCT02969525|11910671|FG008|NOT COMPLETED|Double-Blind Period||0
10746991|NCT02969525|11910672|FG009|NOT COMPLETED|Double-Blind Period||0
10746992|NCT02969525|11910673|FG010|NOT COMPLETED|Double-Blind Period||0
10746993|NCT02969525|11910674|FG011|NOT COMPLETED|Double-Blind Period||0
10746994|NCT02969525|11910663|FG000|STARTED|Dose-Blind Period||0
10746995|NCT02969525|11910664|FG001|STARTED|Dose-Blind Period||0
10746996|NCT02969525|11910665|FG002|STARTED|Dose-Blind Period||0
10746997|NCT02969525|11910666|FG003|STARTED|Dose-Blind Period||0
10746998|NCT02969525|11910667|FG004|STARTED|Dose-Blind Period||0
10746999|NCT02969525|11910668|FG005|STARTED|Dose-Blind Period||20
10747000|NCT02969525|11910669|FG006|STARTED|Dose-Blind Period||20
10747001|NCT02969525|11910670|FG007|STARTED|Dose-Blind Period||22
10747002|NCT02969525|11910671|FG008|STARTED|Dose-Blind Period||19
10747003|NCT02969525|11910672|FG009|STARTED|Dose-Blind Period||37
10747004|NCT02969525|11910673|FG010|STARTED|Dose-Blind Period||40
10747005|NCT02969525|11910674|FG011|STARTED|Dose-Blind Period||41
10747006|NCT02969525|11910663|FG000|COMPLETED|Dose-Blind Period||0
10747007|NCT02969525|11910664|FG001|COMPLETED|Dose-Blind Period||0
10747008|NCT02969525|11910665|FG002|COMPLETED|Dose-Blind Period||0
10747009|NCT02969525|11910666|FG003|COMPLETED|Dose-Blind Period||0
10747010|NCT02969525|11910667|FG004|COMPLETED|Dose-Blind Period||0
10747011|NCT02969525|11910668|FG005|COMPLETED|Dose-Blind Period||20
10747012|NCT02969525|11910669|FG006|COMPLETED|Dose-Blind Period||18
10747013|NCT02969525|11910670|FG007|COMPLETED|Dose-Blind Period||22
10747014|NCT02969525|11910671|FG008|COMPLETED|Dose-Blind Period||18
10747015|NCT02969525|11910672|FG009|COMPLETED|Dose-Blind Period||34
10747016|NCT02969525|11910673|FG010|COMPLETED|Dose-Blind Period||38
10747017|NCT02969525|11910674|FG011|COMPLETED|Dose-Blind Period||39
10747018|NCT02969525|11910663|FG000|NOT COMPLETED|Dose-Blind Period||0
10747019|NCT02969525|11910664|FG001|NOT COMPLETED|Dose-Blind Period||0
10747020|NCT02969525|11910665|FG002|NOT COMPLETED|Dose-Blind Period||0
10747021|NCT02969525|11910666|FG003|NOT COMPLETED|Dose-Blind Period||0
10747022|NCT02969525|11910667|FG004|NOT COMPLETED|Dose-Blind Period||0
10817871|NCT01155518|11981784|FG001|COMPLETED|Overall Study|never started the study|0
10817872|NCT01155518|11981785|FG002|COMPLETED|Overall Study||0
10817873|NCT01155518|11981786|FG003|COMPLETED|Overall Study||0
10817874|NCT01155518|11981787|FG004|COMPLETED|Overall Study||1
10817875|NCT01155518|11981788|FG005|COMPLETED|Overall Study||2
10817876|NCT01155518|11981783|FG000|NOT COMPLETED|Overall Study||0
10747023|NCT02969525|11910668|FG005|NOT COMPLETED|Dose-Blind Period||0
10747024|NCT02969525|11910669|FG006|NOT COMPLETED|Dose-Blind Period||2
10747025|NCT02969525|11910670|FG007|NOT COMPLETED|Dose-Blind Period||0
10747026|NCT02969525|11910671|FG008|NOT COMPLETED|Dose-Blind Period||1
10747027|NCT02969525|11910672|FG009|NOT COMPLETED|Dose-Blind Period||3
10747028|NCT02969525|11910673|FG010|NOT COMPLETED|Dose-Blind Period||2
10817877|NCT01155518|11981784|FG001|NOT COMPLETED|Overall Study||1
10817878|NCT01155518|11981785|FG002|NOT COMPLETED|Overall Study||0
10817879|NCT01155518|11981786|FG003|NOT COMPLETED|Overall Study||0
10817880|NCT01155518|11981787|FG004|NOT COMPLETED|Overall Study||0
10817881|NCT01155518|11981788|FG005|NOT COMPLETED|Overall Study||0
10817882|NCT01150409|11981804|FG000|STARTED|Overall Study||11
10817883|NCT01150409|11981805|FG001|STARTED|Overall Study||0
10817884|NCT01150409|11981804|FG000|COMPLETED|Overall Study||11
10817885|NCT01150409|11981805|FG001|COMPLETED|Overall Study||0
10817886|NCT01150409|11981804|FG000|NOT COMPLETED|Overall Study||0
10817887|NCT01150409|11981805|FG001|NOT COMPLETED|Overall Study||0
10817888|NCT01151553|11981811|FG000|STARTED|Overall Study||5
10817889|NCT01151553|11981811|FG000|COMPLETED|Overall Study||5
10817890|NCT01151553|11981811|FG000|NOT COMPLETED|Overall Study||0
10817891|NCT01148056|11981815|FG000|STARTED|Overall Study||2
10817892|NCT01148056|11981815|FG000|COMPLETED|Overall Study||2
10817893|NCT01148056|11981815|FG000|NOT COMPLETED|Overall Study||0
10817894|NCT01147393|11981819|FG000|STARTED|Dose Level 1||3
10817895|NCT01147393|11981819|FG000|COMPLETED|Dose Level 1||1
10817896|NCT01147393|11981819|FG000|NOT COMPLETED|Dose Level 1||2
10817897|NCT01147393|11981819|FG000|STARTED|Dose Level -1||1
10817898|NCT01147393|11981819|FG000|COMPLETED|Dose Level -1||0
10817899|NCT01147393|11981819|FG000|NOT COMPLETED|Dose Level -1||1
10817900|NCT01147042|11981826|FG000|STARTED|Overall Study||2
10817901|NCT01147042|11981827|FG001|STARTED|Overall Study||0
10817902|NCT01147042|11981826|FG000|COMPLETED|Overall Study||2
10817903|NCT01147042|11981827|FG001|COMPLETED|Overall Study||0
10817904|NCT01147042|11981826|FG000|NOT COMPLETED|Overall Study||0
10817905|NCT01147042|11981827|FG001|NOT COMPLETED|Overall Study||0
10817906|NCT01147536|11981832|FG000|STARTED|Overall Study||12
10817907|NCT01147536|11981832|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12
10817908|NCT01147536|11981832|FG000|COMPLETED|Overall Study||9
10817909|NCT01147536|11981832|FG000|NOT COMPLETED|Overall Study||3
10817910|NCT01139996|11981838|FG000|STARTED|Overall Study||11
10817911|NCT01139996|11981839|FG001|STARTED|Overall Study||11
10817912|NCT01139996|11981838|FG000|COMPLETED|Overall Study||11
10817913|NCT01139996|11981839|FG001|COMPLETED|Overall Study||11
10817914|NCT01139996|11981838|FG000|NOT COMPLETED|Overall Study||0
10817915|NCT01139996|11981839|FG001|NOT COMPLETED|Overall Study||0
10817916|NCT01133288|11981845|FG000|STARTED|Eligibility Assessment||7
10817917|NCT01133288|11981845|FG000|COMPLETED|Eligibility Assessment||2
10817918|NCT01133288|11981845|FG000|NOT COMPLETED|Eligibility Assessment||5
10817919|NCT01133288|11981845|FG000|STARTED|Intervention Allocation||2
10817920|NCT01133288|11981845|FG000|COMPLETED|Intervention Allocation||0
10817921|NCT01133288|11981845|FG000|NOT COMPLETED|Intervention Allocation||2
10817922|NCT01142128|11981853|FG000|STARTED|Overall Study||8
10817923|NCT01142128|11981853|FG000|Nexium Alone|Overall Study||3
10817924|NCT01142128|11981853|FG000|Placebo to Nexium, Alone|Overall Study||3
10817925|NCT01142128|11981853|FG000|Viokase 16 Plus Nexium|Overall Study||2
10817926|NCT01142128|11981853|FG000|Viokase 16 Plus Placebo to Nexium|Overall Study||0
10817927|NCT01142128|11981853|FG000|COMPLETED|Overall Study||4
10817928|NCT01142128|11981853|FG000|NOT COMPLETED|Overall Study||4
10817929|NCT01131884|11981865|FG000|STARTED|Overall Study||1
10817930|NCT01131884|11981866|FG001|STARTED|Overall Study||0
10817931|NCT01131884|11981865|FG000|COMPLETED|Overall Study||1
10817932|NCT01131884|11981866|FG001|COMPLETED|Overall Study||0
10817933|NCT01131884|11981865|FG000|NOT COMPLETED|Overall Study||0
10817934|NCT01131884|11981866|FG001|NOT COMPLETED|Overall Study||0
10817935|NCT01128114|11981872|FG000|STARTED|Overall Study||32
10817936|NCT01128114|11981872|FG000|COMPLETED|Overall Study||24
10817937|NCT01128114|11981872|FG000|NOT COMPLETED|Overall Study||8
10817938|NCT01126879|11981878|FG000|STARTED|Overall Study||8
10817939|NCT01126879|11981879|FG001|STARTED|Overall Study||4
10817940|NCT01126879|11981878|FG000|Started 3 Months of Genistein/Placebo|Overall Study||8
10817941|NCT01126879|11981879|FG001|Started 3 Months of Genistein/Placebo|Overall Study||4
10817942|NCT01126879|11981878|FG000|Prostatectomy or Radiation|Overall Study||8
10817943|NCT01126879|11981879|FG001|Prostatectomy or Radiation|Overall Study||4
10817944|NCT01126879|11981878|FG000|Completed 3 Months Genistein/Placebo|Overall Study||4
10817945|NCT01126879|11981879|FG001|Completed 3 Months Genistein/Placebo|Overall Study||2
10817946|NCT01126879|11981878|FG000|COMPLETED|Overall Study||3
10817947|NCT01126879|11981879|FG001|COMPLETED|Overall Study||2
10817948|NCT01126879|11981878|FG000|NOT COMPLETED|Overall Study||5
10817949|NCT01126879|11981879|FG001|NOT COMPLETED|Overall Study||2
10817950|NCT01136811|11981885|FG000|STARTED|Overall Study||11
10817951|NCT01136811|11981885|FG000|COMPLETED|Overall Study||0
10817952|NCT01136811|11981885|FG000|NOT COMPLETED|Overall Study||11
10817953|NCT01139294|11981891|FG000|STARTED|Overall Study||0
10817954|NCT01139294|11981892|FG001|STARTED|Overall Study||0
10817955|NCT01139294|11981891|FG000|COMPLETED|Overall Study||0
10817956|NCT01139294|11981892|FG001|COMPLETED|Overall Study||0
10817957|NCT01139294|11981891|FG000|NOT COMPLETED|Overall Study||0
10817958|NCT01139294|11981892|FG001|NOT COMPLETED|Overall Study||0
10817959|NCT01139125|11981898|FG000|STARTED|Overall Study||3
10817960|NCT01139125|11981898|FG000|COMPLETED|Overall Study||2
10817961|NCT01139125|11981898|FG000|NOT COMPLETED|Overall Study||1
10817962|NCT01136668|11981904|FG000|STARTED|Overall Study||7
10817963|NCT01136668|11981905|FG001|STARTED|Overall Study||6
10817964|NCT01136668|11981904|FG000|COMPLETED|Overall Study||7
10817965|NCT01136668|11981905|FG001|COMPLETED|Overall Study||6
10817966|NCT01136668|11981904|FG000|NOT COMPLETED|Overall Study||0
10817967|NCT01136668|11981905|FG001|NOT COMPLETED|Overall Study||0
10747029|NCT02969525|11910674|FG011|NOT COMPLETED|Dose-Blind Period||2
10747030|NCT02969590|11910696|FG000|STARTED|Screening Period||5
10747031|NCT02969590|11910697|FG001|STARTED|Screening Period||0
10747032|NCT02969590|11910698|FG002|STARTED|Screening Period||0
10747033|NCT02969590|11910696|FG000|COMPLETED|Screening Period||4
10747034|NCT02969590|11910697|FG001|COMPLETED|Screening Period||0
10747035|NCT02969590|11910698|FG002|COMPLETED|Screening Period||0
10747036|NCT02969590|11910696|FG000|NOT COMPLETED|Screening Period||1
10747037|NCT02969590|11910697|FG001|NOT COMPLETED|Screening Period||0
10747038|NCT02969590|11910698|FG002|NOT COMPLETED|Screening Period||0
10747039|NCT02969590|11910696|FG000|STARTED|Treatment Period 1||0
10747040|NCT02969590|11910697|FG001|STARTED|Treatment Period 1||2
10747041|NCT02969590|11910698|FG002|STARTED|Treatment Period 1||2
10747042|NCT02969590|11910696|FG000|COMPLETED|Treatment Period 1||0
10747043|NCT02969590|11910697|FG001|COMPLETED|Treatment Period 1||2
10747044|NCT02969590|11910698|FG002|COMPLETED|Treatment Period 1||2
10747045|NCT02969590|11910696|FG000|NOT COMPLETED|Treatment Period 1||0
10747046|NCT02969590|11910697|FG001|NOT COMPLETED|Treatment Period 1||0
10747047|NCT02969590|11910698|FG002|NOT COMPLETED|Treatment Period 1||0
10747048|NCT02969590|11910696|FG000|STARTED|Treatment Period 2||0
10747049|NCT02969590|11910697|FG001|STARTED|Treatment Period 2||2
10747050|NCT02969590|11910698|FG002|STARTED|Treatment Period 2||2
10747051|NCT02969590|11910696|FG000|COMPLETED|Treatment Period 2||0
10747052|NCT02969590|11910697|FG001|COMPLETED|Treatment Period 2||2
10747053|NCT02969590|11910698|FG002|COMPLETED|Treatment Period 2||2
10747054|NCT02969590|11910696|FG000|NOT COMPLETED|Treatment Period 2||0
10747055|NCT02969590|11910697|FG001|NOT COMPLETED|Treatment Period 2||0
10747056|NCT02969590|11910698|FG002|NOT COMPLETED|Treatment Period 2||0
10747057|NCT02969655|11910710|FG000|STARTED|Overall Study||136
10747058|NCT02969655|11910711|FG001|STARTED|Overall Study||135
10747059|NCT02969655|11910710|FG000|COMPLETED|Overall Study||115
10747060|NCT02969655|11910711|FG001|COMPLETED|Overall Study||120
10747061|NCT02969655|11910710|FG000|NOT COMPLETED|Overall Study||21
10747062|NCT02969655|11910711|FG001|NOT COMPLETED|Overall Study||15
10747063|NCT02969707|11910720|FG000|STARTED|Overall Study||49
10747064|NCT02969707|11910721|FG001|STARTED|Overall Study||52
10747065|NCT02969707|11910720|FG000|COMPLETED|Overall Study||41
10747066|NCT02969707|11910721|FG001|COMPLETED|Overall Study||44
10747067|NCT02969707|11910720|FG000|NOT COMPLETED|Overall Study||8
10747068|NCT02969707|11910721|FG001|NOT COMPLETED|Overall Study||8
10747069|NCT02969863|11910732|FG000|STARTED|Overall Study||4
10747070|NCT02969863|11910733|FG001|STARTED|Overall Study||4
10747071|NCT02969863|11910734|FG002|STARTED|Overall Study||4
10747072|NCT02969863|11910735|FG003|STARTED|Overall Study||4
10747073|NCT02969863|11910736|FG004|STARTED|Overall Study||4
10747074|NCT02969863|11910737|FG005|STARTED|Overall Study||4
10747075|NCT02969863|11910732|FG000|COMPLETED|Overall Study||3
10747076|NCT02969863|11910733|FG001|COMPLETED|Overall Study||4
10747077|NCT02969863|11910734|FG002|COMPLETED|Overall Study||4
10747078|NCT02969863|11910735|FG003|COMPLETED|Overall Study||4
10747079|NCT02969863|11910736|FG004|COMPLETED|Overall Study||4
10747080|NCT02969863|11910737|FG005|COMPLETED|Overall Study||4
10747081|NCT02969863|11910732|FG000|NOT COMPLETED|Overall Study||1
10747082|NCT02969863|11910733|FG001|NOT COMPLETED|Overall Study||0
10747083|NCT02969863|11910734|FG002|NOT COMPLETED|Overall Study||0
10747084|NCT02969863|11910735|FG003|NOT COMPLETED|Overall Study||0
10747085|NCT02969863|11910736|FG004|NOT COMPLETED|Overall Study||0
10747086|NCT02969863|11910737|FG005|NOT COMPLETED|Overall Study||0
10747087|NCT02969876|11910751|FG000|STARTED|Overall Study||2
10747088|NCT02969876|11910751|FG000|COMPLETED|Overall Study||2
10747089|NCT02969876|11910751|FG000|NOT COMPLETED|Overall Study||0
10747090|NCT02970006|11910756|FG000|STARTED|Overall Study||15
10747091|NCT02970006|11910756|FG000|COMPLETED|Overall Study||14
10747092|NCT02970006|11910756|FG000|NOT COMPLETED|Overall Study||1
10747093|NCT02970032|11910760|FG000|STARTED|Standard Heparin Dose||20
10747094|NCT02970032|11910760|FG000|COMPLETED|Standard Heparin Dose||20
10747095|NCT02970032|11910760|FG000|NOT COMPLETED|Standard Heparin Dose||0
10747096|NCT02970032|11910760|FG000|STARTED|Real Time Heparin Dose Adjustment||20
10747097|NCT02970032|11910760|FG000|COMPLETED|Real Time Heparin Dose Adjustment||20
10747098|NCT02970032|11910760|FG000|NOT COMPLETED|Real Time Heparin Dose Adjustment||0
10747099|NCT02970162|11910767|FG000|STARTED|Overall Study||13
10747100|NCT02970162|11910768|FG001|STARTED|Overall Study||13
10747101|NCT02970162|11910767|FG000|COMPLETED|Overall Study||13
10747102|NCT02970162|11910768|FG001|COMPLETED|Overall Study||13
10747103|NCT02970162|11910767|FG000|NOT COMPLETED|Overall Study||0
10747104|NCT02970162|11910768|FG001|NOT COMPLETED|Overall Study||0
10747105|NCT02970292|11910776|FG000|STARTED|Overall Study||198
10747106|NCT02970292|11910777|FG001|STARTED|Overall Study||198
10747107|NCT02970292|11910776|FG000|COMPLETED|Overall Study||174
10747108|NCT02970292|11910777|FG001|COMPLETED|Overall Study||190
10747109|NCT02970292|11910776|FG000|NOT COMPLETED|Overall Study||24
10747110|NCT02970292|11910777|FG001|NOT COMPLETED|Overall Study||8
10747111|NCT02970305|11910785|FG000|STARTED|Overall Study||201
10747112|NCT02970305|11910786|FG001|STARTED|Overall Study||202
10747113|NCT02970305|11910785|FG000|COMPLETED|Overall Study||172
10747114|NCT02970305|11910786|FG001|COMPLETED|Overall Study||174
10747115|NCT02970305|11910785|FG000|NOT COMPLETED|Overall Study||29
10747116|NCT02970305|11910786|FG001|NOT COMPLETED|Overall Study||28
10778410|NCT03355326|11940350|FG000|COMPLETED|Overall Study||6
10778411|NCT03355326|11940351|FG001|COMPLETED|Overall Study||4
10778412|NCT03355326|11940350|FG000|NOT COMPLETED|Overall Study||3
10747117|NCT02970422|11910792|FG000|STARTED|Overall Study||200
10747118|NCT02970422|11910792|FG000|COMPLETED|Overall Study||200
10747119|NCT02970422|11910792|FG000|NOT COMPLETED|Overall Study||0
10747120|NCT02970552|11910817|FG000|STARTED|Overall Study||70
10747121|NCT02970552|11910818|FG001|STARTED|Overall Study||70
10747122|NCT02970552|11910817|FG000|COMPLETED|Overall Study||67
10747123|NCT02970552|11910818|FG001|COMPLETED|Overall Study||67
10747124|NCT02970552|11910817|FG000|NOT COMPLETED|Overall Study||3
10747125|NCT02970552|11910818|FG001|NOT COMPLETED|Overall Study||3
10747126|NCT02970669|11910830|FG000|STARTED|Double-blind Period||70
10747127|NCT02970669|11910831|FG001|STARTED|Double-blind Period||70
10747128|NCT02970669|11910830|FG000|COMPLETED|Double-blind Period||62
10747129|NCT02970669|11910831|FG001|COMPLETED|Double-blind Period||64
10747130|NCT02970669|11910830|FG000|NOT COMPLETED|Double-blind Period||8
10747131|NCT02970669|11910831|FG001|NOT COMPLETED|Double-blind Period||6
10747132|NCT02970669|11910830|FG000|STARTED|Open-label Period||62
10747133|NCT02970669|11910831|FG001|STARTED|Open-label Period||64
10747134|NCT02970669|11910830|FG000|COMPLETED|Open-label Period||58
10747135|NCT02970669|11910831|FG001|COMPLETED|Open-label Period||62
10747136|NCT02970669|11910830|FG000|NOT COMPLETED|Open-label Period||4
10747137|NCT02970669|11910831|FG001|NOT COMPLETED|Open-label Period||2
10747138|NCT02970812|11910841|FG000|STARTED|Overall Study||30
10747139|NCT02970812|11910842|FG001|STARTED|Overall Study||30
10747140|NCT02970812|11910841|FG000|COMPLETED|Overall Study||22
10747141|NCT02970812|11910842|FG001|COMPLETED|Overall Study||28
10747142|NCT02970812|11910841|FG000|NOT COMPLETED|Overall Study||8
10747143|NCT02970812|11910842|FG001|NOT COMPLETED|Overall Study||2
10747144|NCT02970942|11910852|FG000|STARTED|Overall Study||80
10747145|NCT02970942|11910853|FG001|STARTED|Overall Study||78
10747146|NCT02970942|11910854|FG002|STARTED|Overall Study||82
10747147|NCT02970942|11910855|FG003|STARTED|Overall Study||80
10747148|NCT02970942|11910852|FG000|Full Analysis Set|Overall Study||80
10747149|NCT02970942|11910853|FG001|Full Analysis Set|Overall Study||78
10747150|NCT02970942|11910854|FG002|Full Analysis Set|Overall Study||82
10747151|NCT02970942|11910855|FG003|Full Analysis Set|Overall Study||80
10747152|NCT02970942|11910852|FG000|Safety Analysis Set|Overall Study||80
10747153|NCT02970942|11910853|FG001|Safety Analysis Set|Overall Study||78
10747154|NCT02970942|11910854|FG002|Safety Analysis Set|Overall Study||81
10747155|NCT02970942|11910855|FG003|Safety Analysis Set|Overall Study||80
10747156|NCT02970942|11910852|FG000|Exposed|Overall Study||80
10747157|NCT02970942|11910853|FG001|Exposed|Overall Study||78
10747158|NCT02970942|11910854|FG002|Exposed|Overall Study||81
10747159|NCT02970942|11910855|FG003|Exposed|Overall Study||80
10747160|NCT02970942|11910852|FG000|COMPLETED|Overall Study||76
10747161|NCT02970942|11910853|FG001|COMPLETED|Overall Study||72
10747162|NCT02970942|11910854|FG002|COMPLETED|Overall Study||77
10747163|NCT02970942|11910855|FG003|COMPLETED|Overall Study||77
10747164|NCT02970942|11910852|FG000|NOT COMPLETED|Overall Study||4
10747165|NCT02970942|11910853|FG001|NOT COMPLETED|Overall Study||6
10747166|NCT02970942|11910854|FG002|NOT COMPLETED|Overall Study||5
10747167|NCT02970942|11910855|FG003|NOT COMPLETED|Overall Study||3
10747168|NCT02971007|11910868|FG000|STARTED|Overall Study||46
10747169|NCT02971007|11910869|FG001|STARTED|Overall Study||45
10747170|NCT02971007|11910870|FG002|STARTED|Overall Study||46
10747171|NCT02971007|11910868|FG000|COMPLETED|Overall Study||44
10747172|NCT02971007|11910869|FG001|COMPLETED|Overall Study||42
10817968|NCT01133639|11981913|FG000|STARTED|Overall Study|18 total subjects were enrolled, study was terminated prematurely and data was not analyzed|0
10817969|NCT01133639|11981914|FG001|STARTED|Overall Study|18 total subjects were enrolled, study was terminated prematurely and data was not analyzed|0
10817970|NCT01133639|11981913|FG000|COMPLETED|Overall Study|18 total subjects were enrolled, study was terminated prematurely and data was not analyzed|0
10817971|NCT01133639|11981914|FG001|COMPLETED|Overall Study|18 total subjects were enrolled,study was terminated prematurely and data was not analyzed|0
10817972|NCT01133639|11981913|FG000|NOT COMPLETED|Overall Study||0
10817973|NCT01133639|11981914|FG001|NOT COMPLETED|Overall Study||0
10817974|NCT01131455|11981922|FG000|STARTED|Overall Study||6
10817975|NCT01131455|11981923|FG001|STARTED|Overall Study||4
10817976|NCT01131455|11981924|FG002|STARTED|Overall Study||0
10817977|NCT01131455|11981922|FG000|COMPLETED|Overall Study||0
10817978|NCT01131455|11981923|FG001|COMPLETED|Overall Study||0
10817979|NCT01131455|11981924|FG002|COMPLETED|Overall Study||0
10817980|NCT01131455|11981922|FG000|NOT COMPLETED|Overall Study||6
10817981|NCT01131455|11981923|FG001|NOT COMPLETED|Overall Study||4
10817982|NCT01131455|11981924|FG002|NOT COMPLETED|Overall Study||0
10817983|NCT01126801|11981934|FG000|STARTED|Overall Study||1
10817984|NCT01126801|11981935|FG001|STARTED|Overall Study||1
10817985|NCT01126801|11981934|FG000|COMPLETED|Overall Study||1
10817986|NCT01126801|11981935|FG001|COMPLETED|Overall Study||1
10817987|NCT01126801|11981934|FG000|NOT COMPLETED|Overall Study||0
10817988|NCT01126801|11981935|FG001|NOT COMPLETED|Overall Study||0
10747173|NCT02971007|11910870|FG002|COMPLETED|Overall Study||45
10747174|NCT02971007|11910868|FG000|NOT COMPLETED|Overall Study||2
10747175|NCT02971007|11910869|FG001|NOT COMPLETED|Overall Study||3
10747176|NCT02971007|11910870|FG002|NOT COMPLETED|Overall Study||1
10747177|NCT02971163|11910880|FG000|STARTED|Overall Study||24
10747178|NCT02971163|11910881|FG001|STARTED|Overall Study||26
10747179|NCT02971163|11910880|FG000|COMPLETED|Overall Study||20
10747180|NCT02971163|11910881|FG001|COMPLETED|Overall Study||24
10747181|NCT02971163|11910880|FG000|NOT COMPLETED|Overall Study||4
10747182|NCT02971163|11910881|FG001|NOT COMPLETED|Overall Study||2
10747183|NCT02971202|11910890|FG000|STARTED|Overall Study||12
10747184|NCT02971202|11910891|FG001|STARTED|Overall Study||10
10747185|NCT02971202|11910892|FG002|STARTED|Overall Study||11
10747186|NCT02971202|11910890|FG000|Started Study|Overall Study||11
10747187|NCT02971202|11910891|FG001|Started Study|Overall Study||10
10747188|NCT02971202|11910892|FG002|Started Study|Overall Study||10
10747189|NCT02971202|11910890|FG000|COMPLETED|Overall Study||10
10747190|NCT02971202|11910891|FG001|COMPLETED|Overall Study||10
10747191|NCT02971202|11910892|FG002|COMPLETED|Overall Study||10
10747192|NCT02971202|11910890|FG000|NOT COMPLETED|Overall Study||2
10747193|NCT02971202|11910891|FG001|NOT COMPLETED|Overall Study||0
10747194|NCT02971202|11910892|FG002|NOT COMPLETED|Overall Study||1
10747195|NCT02971228|11910900|FG000|STARTED|Overall Study||1
10747196|NCT02971228|11910901|FG001|STARTED|Overall Study||7
10747197|NCT02971228|11910902|FG002|STARTED|Overall Study||5
10747198|NCT02971228|11910903|FG003|STARTED|Overall Study|Due to iLet unavailability, trial was stopped upon completion of Part 1. Part 2 was not conducted.|0
10747199|NCT02971228|11910904|FG004|STARTED|Overall Study|Due to iLet unavailability, trial was stopped upon completion of Part 1. Part 2 was not conducted.|0
10747200|NCT02971228|11910900|FG000|Randomized and Treated|Overall Study||0
10747201|NCT02971228|11910901|FG001|Randomized and Treated|Overall Study||7
10747202|NCT02971228|11910902|FG002|Randomized and Treated|Overall Study||5
10747203|NCT02971228|11910903|FG003|Randomized and Treated|Overall Study||0
10747204|NCT02971228|11910904|FG004|Randomized and Treated|Overall Study||0
10747205|NCT02971228|11910900|FG000|COMPLETED|Overall Study||0
10747206|NCT02971228|11910901|FG001|COMPLETED|Overall Study||5
10747207|NCT02971228|11910902|FG002|COMPLETED|Overall Study||5
10747295|NCT02972658|11911019|FG002|COMPLETED|Overall Study||0
10747208|NCT02971228|11910903|FG003|COMPLETED|Overall Study|Due to iLet unavailability, trial was stopped upon completion of Part 1. Part 2 was not conducted.|0
10747209|NCT02971228|11910904|FG004|COMPLETED|Overall Study|Due to iLet unavailability, trial was stopped upon completion of Part 1. Part 2 was not conducted.|0
10747210|NCT02971228|11910900|FG000|NOT COMPLETED|Overall Study||1
10747211|NCT02971228|11910901|FG001|NOT COMPLETED|Overall Study||2
10747212|NCT02971228|11910902|FG002|NOT COMPLETED|Overall Study||0
10747213|NCT02971228|11910903|FG003|NOT COMPLETED|Overall Study||0
10747214|NCT02971228|11910904|FG004|NOT COMPLETED|Overall Study||0
10747215|NCT02971293|11910915|FG000|STARTED|Overall Study||42
10747216|NCT02971293|11910915|FG000|COMPLETED|Overall Study||31
10747217|NCT02971293|11910915|FG000|NOT COMPLETED|Overall Study||11
10747218|NCT02971488|11910923|FG000|STARTED|Overall Study||529
10747219|NCT02971488|11910923|FG000|COMPLETED|Overall Study||529
10747220|NCT02971488|11910923|FG000|NOT COMPLETED|Overall Study||0
10747221|NCT02971605|11910930|FG000|STARTED|Overall Study||13
10747222|NCT02971605|11910930|FG000|COMPLETED|Overall Study||12
10747223|NCT02971605|11910930|FG000|NOT COMPLETED|Overall Study||1
10747224|NCT02971631|11910936|FG000|STARTED|First Intervention - One Day||3
10747225|NCT02971631|11910937|FG001|STARTED|First Intervention - One Day||2
10747226|NCT02971631|11910936|FG000|COMPLETED|First Intervention - One Day||3
10747227|NCT02971631|11910937|FG001|COMPLETED|First Intervention - One Day||2
10747228|NCT02971631|11910936|FG000|NOT COMPLETED|First Intervention - One Day||0
10747229|NCT02971631|11910937|FG001|NOT COMPLETED|First Intervention - One Day||0
10747230|NCT02971631|11910936|FG000|STARTED|Second Intervention - One Day||3
10747231|NCT02971631|11910937|FG001|STARTED|Second Intervention - One Day||2
10747232|NCT02971631|11910936|FG000|COMPLETED|Second Intervention - One Day||3
10747233|NCT02971631|11910937|FG001|COMPLETED|Second Intervention - One Day||2
10747234|NCT02971631|11910936|FG000|NOT COMPLETED|Second Intervention - One Day||0
10747235|NCT02971631|11910937|FG001|NOT COMPLETED|Second Intervention - One Day||0
10747236|NCT02971670|11910948|FG000|STARTED|Overall Study||13
10747237|NCT02971670|11910949|FG001|STARTED|Overall Study||2
10747238|NCT02971670|11910950|FG002|STARTED|Overall Study||5
10747239|NCT02971670|11910951|FG003|STARTED|Overall Study||3
10747240|NCT02971670|11910948|FG000|COMPLETED|Overall Study||9
10747241|NCT02971670|11910949|FG001|COMPLETED|Overall Study||1
10747242|NCT02971670|11910950|FG002|COMPLETED|Overall Study||4
10747243|NCT02971670|11910951|FG003|COMPLETED|Overall Study||1
10747244|NCT02971670|11910948|FG000|NOT COMPLETED|Overall Study||4
10747245|NCT02971670|11910949|FG001|NOT COMPLETED|Overall Study||1
10747246|NCT02971670|11910950|FG002|NOT COMPLETED|Overall Study||1
10747247|NCT02971670|11910951|FG003|NOT COMPLETED|Overall Study||2
10747248|NCT02971735|11910963|FG000|STARTED|Overall Study||30
10747249|NCT02971735|11910964|FG001|STARTED|Overall Study||30
10747250|NCT02971735|11910963|FG000|COMPLETED|Overall Study||30
10747251|NCT02971735|11910964|FG001|COMPLETED|Overall Study||30
10747252|NCT02971735|11910963|FG000|NOT COMPLETED|Overall Study||0
10747253|NCT02971735|11910964|FG001|NOT COMPLETED|Overall Study||0
10747254|NCT02971800|11910970|FG000|STARTED|Overall Study||37
10747255|NCT02971800|11910970|FG000|COMPLETED|Overall Study||30
10747256|NCT02971800|11910970|FG000|NOT COMPLETED|Overall Study||7
10747257|NCT02972242|11910976|FG000|STARTED|Overall Study||82
10747258|NCT02972242|11910977|FG001|STARTED|Overall Study||93
10747259|NCT02972242|11910976|FG000|COMPLETED|Overall Study||81
10747260|NCT02972242|11910977|FG001|COMPLETED|Overall Study||93
10747261|NCT02972242|11910976|FG000|NOT COMPLETED|Overall Study||1
10747262|NCT02972242|11910977|FG001|NOT COMPLETED|Overall Study||0
10747263|NCT02972359|11910983|FG000|STARTED|Overall Study||318
10747264|NCT02972359|11910983|FG000|COMPLETED|Overall Study||247
10747265|NCT02972359|11910983|FG000|NOT COMPLETED|Overall Study||71
10747266|NCT02972502|11910989|FG000|STARTED|Overall Study||35
10747267|NCT02972502|11910990|FG001|STARTED|Overall Study||31
10747268|NCT02972502|11910989|FG000|COMPLETED|Overall Study||31
10747269|NCT02972502|11910990|FG001|COMPLETED|Overall Study||29
10747270|NCT02972502|11910989|FG000|NOT COMPLETED|Overall Study||4
10747271|NCT02972502|11910990|FG001|NOT COMPLETED|Overall Study||2
10747272|NCT02972515|11910996|FG000|STARTED|Overall Study||166
10747273|NCT02972515|11910996|FG000|COMPLETED|Overall Study||88
10747274|NCT02972515|11910996|FG000|NOT COMPLETED|Overall Study||78
10747275|NCT02972554|11911002|FG000|STARTED|Overall Study||44
10747276|NCT02972554|11911003|FG001|STARTED|Overall Study||48
10747277|NCT02972554|11911002|FG000|COMPLETED|Overall Study||44
10747278|NCT02972554|11911003|FG001|COMPLETED|Overall Study||48
10747279|NCT02972554|11911002|FG000|NOT COMPLETED|Overall Study||0
10747280|NCT02972554|11911003|FG001|NOT COMPLETED|Overall Study||0
10747281|NCT02972632|11911009|FG000|STARTED|Overall Study||123
10747282|NCT02972632|11911009|FG000|Safety Analysis Set|Overall Study||122
10747283|NCT02972632|11911009|FG000|COMPLETED|Overall Study||106
10747284|NCT02972632|11911009|FG000|NOT COMPLETED|Overall Study||17
10747285|NCT02972658|11911017|FG000|STARTED|Overall Study||76
10747286|NCT02972658|11911018|FG001|STARTED|Overall Study||139
10747287|NCT02972658|11911019|FG002|STARTED|Overall Study||75
10747288|NCT02972658|11911020|FG003|STARTED|Overall Study||131
10747289|NCT02972658|11911017|FG000|Received at Least 1 Dose of Study Drug|Overall Study||76
10747290|NCT02972658|11911018|FG001|Received at Least 1 Dose of Study Drug|Overall Study||139
10747291|NCT02972658|11911019|FG002|Received at Least 1 Dose of Study Drug|Overall Study||74
10747292|NCT02972658|11911020|FG003|Received at Least 1 Dose of Study Drug|Overall Study||131
10747293|NCT02972658|11911017|FG000|COMPLETED|Overall Study||0
10747294|NCT02972658|11911018|FG001|COMPLETED|Overall Study|"1 participant was incorrectly marked as Completed rather than study terminated by Sponsor."|1
10747296|NCT02972658|11911020|FG003|COMPLETED|Overall Study||0
10747297|NCT02972658|11911017|FG000|NOT COMPLETED|Overall Study||76
10747298|NCT02972658|11911018|FG001|NOT COMPLETED|Overall Study||138
10747299|NCT02972658|11911019|FG002|NOT COMPLETED|Overall Study||75
10747300|NCT02972658|11911020|FG003|NOT COMPLETED|Overall Study||131
10747301|NCT02973048|11911032|FG000|STARTED|Overall Study||20
10747302|NCT02973048|11911033|FG001|STARTED|Overall Study||20
10747303|NCT02973048|11911032|FG000|COMPLETED|Overall Study||19
10747304|NCT02973048|11911033|FG001|COMPLETED|Overall Study||17
10747305|NCT02973048|11911032|FG000|NOT COMPLETED|Overall Study||1
10747306|NCT02973048|11911033|FG001|NOT COMPLETED|Overall Study||3
10747307|NCT02973087|11911041|FG000|STARTED|Overall Study||13
10747308|NCT02973087|11911042|FG001|STARTED|Overall Study||10
10747309|NCT02973087|11911041|FG000|COMPLETED|Overall Study||9
10747310|NCT02973087|11911042|FG001|COMPLETED|Overall Study||8
10747311|NCT02973087|11911041|FG000|NOT COMPLETED|Overall Study||4
10747312|NCT02973087|11911042|FG001|NOT COMPLETED|Overall Study||2
10747313|NCT02973100|11911053|FG000|STARTED|Overall Study||82
10747314|NCT02973100|11911054|FG001|STARTED|Overall Study||81
10747315|NCT02973100|11911055|FG002|STARTED|Overall Study||79
10747316|NCT02973100|11911056|FG003|STARTED|Overall Study||76
10747317|NCT02973100|11911053|FG000|Received at Least 1 Dose of Study Drug|Overall Study||81
10747318|NCT02973100|11911054|FG001|Received at Least 1 Dose of Study Drug|Overall Study||81
10747319|NCT02973100|11911055|FG002|Received at Least 1 Dose of Study Drug|Overall Study||79
10747320|NCT02973100|11911056|FG003|Received at Least 1 Dose of Study Drug|Overall Study||76
10747321|NCT02973100|11911053|FG000|COMPLETED|Overall Study||75
10747322|NCT02973100|11911054|FG001|COMPLETED|Overall Study||73
10747323|NCT02973100|11911055|FG002|COMPLETED|Overall Study||75
10747324|NCT02973100|11911056|FG003|COMPLETED|Overall Study||69
10747325|NCT02973100|11911053|FG000|NOT COMPLETED|Overall Study||7
10747326|NCT02973100|11911054|FG001|NOT COMPLETED|Overall Study||8
10747327|NCT02973100|11911055|FG002|NOT COMPLETED|Overall Study||4
10747328|NCT02973100|11911056|FG003|NOT COMPLETED|Overall Study||7
10747329|NCT02973438|11911073|FG000|STARTED|First Treatment Session (4 Days)||2
10747330|NCT02973438|11911074|FG001|STARTED|First Treatment Session (4 Days)||1
10747331|NCT02973438|11911075|FG002|STARTED|First Treatment Session (4 Days)||2
10747332|NCT02973438|11911076|FG003|STARTED|First Treatment Session (4 Days)||1
10747333|NCT02973438|11911073|FG000|COMPLETED|First Treatment Session (4 Days)||2
10747334|NCT02973438|11911074|FG001|COMPLETED|First Treatment Session (4 Days)||1
10747335|NCT02973438|11911075|FG002|COMPLETED|First Treatment Session (4 Days)||2
10747336|NCT02973438|11911076|FG003|COMPLETED|First Treatment Session (4 Days)||1
10747337|NCT02973438|11911073|FG000|NOT COMPLETED|First Treatment Session (4 Days)||0
10747338|NCT02973438|11911074|FG001|NOT COMPLETED|First Treatment Session (4 Days)||0
10747339|NCT02973438|11911075|FG002|NOT COMPLETED|First Treatment Session (4 Days)||0
10747340|NCT02973438|11911076|FG003|NOT COMPLETED|First Treatment Session (4 Days)||0
10747341|NCT02973438|11911073|FG000|STARTED|Washout (Three Weeks)||2
10747342|NCT02973438|11911074|FG001|STARTED|Washout (Three Weeks)||1
10747343|NCT02973438|11911075|FG002|STARTED|Washout (Three Weeks)||2
10747344|NCT02973438|11911076|FG003|STARTED|Washout (Three Weeks)||1
10747345|NCT02973438|11911073|FG000|COMPLETED|Washout (Three Weeks)||2
10747346|NCT02973438|11911074|FG001|COMPLETED|Washout (Three Weeks)||1
10747347|NCT02973438|11911075|FG002|COMPLETED|Washout (Three Weeks)||2
10747348|NCT02973438|11911076|FG003|COMPLETED|Washout (Three Weeks)||1
10747349|NCT02973438|11911073|FG000|NOT COMPLETED|Washout (Three Weeks)||0
10747350|NCT02973438|11911074|FG001|NOT COMPLETED|Washout (Three Weeks)||0
10747351|NCT02973438|11911075|FG002|NOT COMPLETED|Washout (Three Weeks)||0
10747352|NCT02973438|11911076|FG003|NOT COMPLETED|Washout (Three Weeks)||0
10747353|NCT02973438|11911073|FG000|STARTED|Second Treatment Session (4 Days)||2
10747354|NCT02973438|11911074|FG001|STARTED|Second Treatment Session (4 Days)||1
10747355|NCT02973438|11911075|FG002|STARTED|Second Treatment Session (4 Days)||2
10747356|NCT02973438|11911076|FG003|STARTED|Second Treatment Session (4 Days)||1
10747357|NCT02973438|11911073|FG000|COMPLETED|Second Treatment Session (4 Days)||2
10747358|NCT02973438|11911074|FG001|COMPLETED|Second Treatment Session (4 Days)||1
10747359|NCT02973438|11911075|FG002|COMPLETED|Second Treatment Session (4 Days)||2
10747360|NCT02973438|11911076|FG003|COMPLETED|Second Treatment Session (4 Days)||1
10747361|NCT02973438|11911073|FG000|NOT COMPLETED|Second Treatment Session (4 Days)||0
10747362|NCT02973438|11911074|FG001|NOT COMPLETED|Second Treatment Session (4 Days)||0
10747363|NCT02973438|11911075|FG002|NOT COMPLETED|Second Treatment Session (4 Days)||0
10747364|NCT02973438|11911076|FG003|NOT COMPLETED|Second Treatment Session (4 Days)||0
10747365|NCT02973477|11911089|FG000|STARTED|First Intervention||19
10747366|NCT02973477|11911090|FG001|STARTED|First Intervention||26
10747367|NCT02973477|11911089|FG000|COMPLETED|First Intervention||19
10747368|NCT02973477|11911090|FG001|COMPLETED|First Intervention||24
10747369|NCT02973477|11911089|FG000|NOT COMPLETED|First Intervention||0
10817989|NCT01123850|11981941|FG000|STARTED|Overall Study||45
10817990|NCT01123850|11981941|FG000|COMPLETED|Overall Study||0
10817991|NCT01123850|11981941|FG000|NOT COMPLETED|Overall Study||45
10817992|NCT01126957|11981945|FG000|STARTED|Overall Study||103
10817993|NCT01126957|11981945|FG000|COMPLETED|Overall Study||103
10747370|NCT02973477|11911090|FG001|NOT COMPLETED|First Intervention||2
10747371|NCT02973477|11911089|FG000|STARTED|Washout||19
10747372|NCT02973477|11911090|FG001|STARTED|Washout||24
10747373|NCT02973477|11911089|FG000|COMPLETED|Washout||18
10747374|NCT02973477|11911090|FG001|COMPLETED|Washout||24
10747375|NCT02973477|11911089|FG000|NOT COMPLETED|Washout||1
10747376|NCT02973477|11911090|FG001|NOT COMPLETED|Washout||0
10747377|NCT02973477|11911089|FG000|STARTED|Second Intervention||18
10747378|NCT02973477|11911090|FG001|STARTED|Second Intervention||24
10747379|NCT02973477|11911089|FG000|COMPLETED|Second Intervention||17
10747380|NCT02973477|11911090|FG001|COMPLETED|Second Intervention||24
10747381|NCT02973477|11911089|FG000|NOT COMPLETED|Second Intervention||1
10747382|NCT02973477|11911090|FG001|NOT COMPLETED|Second Intervention||0
10747383|NCT02973503|11911102|FG000|STARTED|Overall Study||117
10747384|NCT02973503|11911102|FG000|COMPLETED|Overall Study||117
10747385|NCT02973503|11911102|FG000|NOT COMPLETED|Overall Study||0
10747386|NCT02973516|11911113|FG000|STARTED|Overall Study||30
10747387|NCT02973516|11911114|FG001|STARTED|Overall Study||10
10747388|NCT02973516|11911113|FG000|COMPLETED|Overall Study||30
10747389|NCT02973516|11911114|FG001|COMPLETED|Overall Study||10
10747390|NCT02973516|11911113|FG000|NOT COMPLETED|Overall Study||0
10747391|NCT02973516|11911114|FG001|NOT COMPLETED|Overall Study||0
10747392|NCT02973802|11911120|FG000|STARTED|Overall Study||12
10747393|NCT02973802|11911120|FG000|COMPLETED|Overall Study||10
10747394|NCT02973802|11911120|FG000|NOT COMPLETED|Overall Study||2
10747395|NCT02974010|11911129|FG000|STARTED|Overall Study||12
10747396|NCT02974010|11911130|FG001|STARTED|Overall Study||5
10747397|NCT02974010|11911131|FG002|STARTED|Overall Study||4
10747398|NCT02974010|11911132|FG003|STARTED|Overall Study||1
10747399|NCT02974010|11911129|FG000|COMPLETED|Overall Study||6
10747400|NCT02974010|11911130|FG001|COMPLETED|Overall Study||2
10747401|NCT02974010|11911131|FG002|COMPLETED|Overall Study||2
10747402|NCT02974010|11911132|FG003|COMPLETED|Overall Study||1
10747403|NCT02974010|11911129|FG000|NOT COMPLETED|Overall Study||6
10747404|NCT02974010|11911130|FG001|NOT COMPLETED|Overall Study||3
10747405|NCT02974010|11911131|FG002|NOT COMPLETED|Overall Study||2
10747406|NCT02974010|11911132|FG003|NOT COMPLETED|Overall Study||0
10747407|NCT02974088|11911144|FG000|STARTED|Overall Study||23
10747408|NCT02974088|11911145|FG001|STARTED|Overall Study||24
10747409|NCT02974088|11911144|FG000|COMPLETED|Overall Study||23
10747410|NCT02974088|11911145|FG001|COMPLETED|Overall Study|Nurse left without notice and took CRFs and data for 2 subjects.|21
10747411|NCT02974088|11911144|FG000|NOT COMPLETED|Overall Study||0
10747412|NCT02974088|11911145|FG001|NOT COMPLETED|Overall Study||3
10747413|NCT02974114|11911154|FG000|STARTED|Overall Study||6
10747414|NCT02974114|11911155|FG001|STARTED|Overall Study||7
10747415|NCT02974114|11911156|FG002|STARTED|Overall Study||8
10747416|NCT02974114|11911154|FG000|COMPLETED|Overall Study||6
10747417|NCT02974114|11911155|FG001|COMPLETED|Overall Study||6
10747418|NCT02974114|11911156|FG002|COMPLETED|Overall Study||6
10747419|NCT02974114|11911154|FG000|NOT COMPLETED|Overall Study||0
10747420|NCT02974114|11911155|FG001|NOT COMPLETED|Overall Study||1
10747421|NCT02974114|11911156|FG002|NOT COMPLETED|Overall Study||2
10747422|NCT02974140|11911166|FG000|STARTED|Overall Study||39
10747423|NCT02974140|11911166|FG000|CRS (Left or Right Eye)|Overall Study||38
10747424|NCT02974140|11911166|FG000|Manual (Fellow Eye)|Overall Study||38
10747425|NCT02974140|11911166|FG000|COMPLETED|Overall Study||0
10747426|NCT02974140|11911166|FG000|NOT COMPLETED|Overall Study||39
10747427|NCT02974153|11911176|FG000|STARTED|Overall Study||374
10747428|NCT02974153|11911177|FG001|STARTED|Overall Study||372
10747429|NCT02974153|11911178|FG002|STARTED|Overall Study||375
10747430|NCT02974153|11911176|FG000|Participants Treated|Overall Study||350
10747431|NCT02974153|11911177|FG001|Participants Treated|Overall Study||356
10747432|NCT02974153|11911178|FG002|Participants Treated|Overall Study||366
10747433|NCT02974153|11911176|FG000|COMPLETED|Overall Study||322
10747434|NCT02974153|11911177|FG001|COMPLETED|Overall Study||324
10747435|NCT02974153|11911178|FG002|COMPLETED|Overall Study||325
10747436|NCT02974153|11911176|FG000|NOT COMPLETED|Overall Study||52
10747437|NCT02974153|11911177|FG001|NOT COMPLETED|Overall Study||48
10747438|NCT02974153|11911178|FG002|NOT COMPLETED|Overall Study||50
10817994|NCT01126957|11981945|FG000|NOT COMPLETED|Overall Study||0
10747439|NCT02974296|11911188|FG000|STARTED|Overall Study||10
10747440|NCT02974296|11911189|FG001|STARTED|Overall Study||23
10747441|NCT02974296|11911188|FG000|COMPLETED|Overall Study||10
10747442|NCT02974296|11911189|FG001|COMPLETED|Overall Study||22
10747443|NCT02974296|11911188|FG000|NOT COMPLETED|Overall Study||0
10747444|NCT02974296|11911189|FG001|NOT COMPLETED|Overall Study||1
10747445|NCT02974543|11911197|FG000|STARTED|Overall Study||11
10747446|NCT02974543|11911198|FG001|STARTED|Overall Study||10
10747447|NCT02974543|11911197|FG000|Began Washout Period|Overall Study||10
10747448|NCT02974543|11911198|FG001|Began Washout Period|Overall Study||10
10747449|NCT02974543|11911197|FG000|Began Crossover Assignment|Overall Study||10
10747450|NCT02974543|11911198|FG001|Began Crossover Assignment|Overall Study||10
10747451|NCT02974543|11911197|FG000|COMPLETED|Overall Study||10
10747452|NCT02974543|11911198|FG001|COMPLETED|Overall Study||10
10747453|NCT02974543|11911197|FG000|NOT COMPLETED|Overall Study||1
10747454|NCT02974543|11911198|FG001|NOT COMPLETED|Overall Study||0
10747455|NCT02974634|11911214|FG000|STARTED|Overall Study||106
10747456|NCT02974634|11911215|FG001|STARTED|Overall Study||110
10747457|NCT02974634|11911214|FG000|COMPLETED|Overall Study||78
10747458|NCT02974634|11911215|FG001|COMPLETED|Overall Study||89
10747459|NCT02974634|11911214|FG000|NOT COMPLETED|Overall Study||28
10747460|NCT02974634|11911215|FG001|NOT COMPLETED|Overall Study||21
10747461|NCT02974842|11911222|FG000|STARTED|Overall Study|Participants|50
10747462|NCT02974842|11911222|FG000|COMPLETED|Overall Study||42
10747463|NCT02974842|11911222|FG000|NOT COMPLETED|Overall Study||8
10747464|NCT02974855|11911230|FG000|STARTED|Overall Study||7
10747465|NCT02974855|11911231|FG001|STARTED|Overall Study||6
10747466|NCT02974855|11911232|FG002|STARTED|Overall Study||6
10747467|NCT02974855|11911233|FG003|STARTED|Overall Study||7
10747468|NCT02974855|11911230|FG000|COMPLETED|Overall Study||7
10747469|NCT02974855|11911231|FG001|COMPLETED|Overall Study||5
10747470|NCT02974855|11911232|FG002|COMPLETED|Overall Study||6
10747471|NCT02974855|11911233|FG003|COMPLETED|Overall Study||6
10747472|NCT02974855|11911230|FG000|NOT COMPLETED|Overall Study||0
10747473|NCT02974855|11911231|FG001|NOT COMPLETED|Overall Study||1
10747474|NCT02974855|11911232|FG002|NOT COMPLETED|Overall Study||0
10747475|NCT02974855|11911233|FG003|NOT COMPLETED|Overall Study||1
10747476|NCT02974868|11911250|FG000|STARTED|Initial 24-Week Treatment Period (TP)||24
10747477|NCT02974868|11911251|FG001|STARTED|Initial 24-Week Treatment Period (TP)||23
10747478|NCT02974868|11911252|FG002|STARTED|Initial 24-Week Treatment Period (TP)||48
10747479|NCT02974868|11911253|FG003|STARTED|Initial 24-Week Treatment Period (TP)||47
10747480|NCT02974868|11911250|FG000|COMPLETED|Initial 24-Week Treatment Period (TP)||20
10747481|NCT02974868|11911251|FG001|COMPLETED|Initial 24-Week Treatment Period (TP)||14
10747482|NCT02974868|11911252|FG002|COMPLETED|Initial 24-Week Treatment Period (TP)||45
10747483|NCT02974868|11911253|FG003|COMPLETED|Initial 24-Week Treatment Period (TP)||35
10747484|NCT02974868|11911250|FG000|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||4
10747485|NCT02974868|11911251|FG001|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||9
10747486|NCT02974868|11911252|FG002|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||3
10747487|NCT02974868|11911253|FG003|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||12
10747488|NCT02974868|11911250|FG000|STARTED|Single-Blind Extension (SBE) Period||17
10747489|NCT02974868|11911251|FG001|STARTED|Single-Blind Extension (SBE) Period||12
10747490|NCT02974868|11911252|FG002|STARTED|Single-Blind Extension (SBE) Period||38
10747491|NCT02974868|11911253|FG003|STARTED|Single-Blind Extension (SBE) Period||29
10747492|NCT02974868|11911250|FG000|COMPLETED|Single-Blind Extension (SBE) Period||15
10747493|NCT02974868|11911251|FG001|COMPLETED|Single-Blind Extension (SBE) Period||11
10747494|NCT02974868|11911252|FG002|COMPLETED|Single-Blind Extension (SBE) Period||27
10747495|NCT02974868|11911253|FG003|COMPLETED|Single-Blind Extension (SBE) Period||23
10747496|NCT02974868|11911250|FG000|NOT COMPLETED|Single-Blind Extension (SBE) Period||2
10747497|NCT02974868|11911251|FG001|NOT COMPLETED|Single-Blind Extension (SBE) Period||1
10747498|NCT02974868|11911252|FG002|NOT COMPLETED|Single-Blind Extension (SBE) Period||11
10747499|NCT02974868|11911253|FG003|NOT COMPLETED|Single-Blind Extension (SBE) Period||6
10747500|NCT02974868|11911250|FG000|STARTED|Cross-Over Extension (COE) Period||7
10747501|NCT02974868|11911251|FG001|STARTED|Cross-Over Extension (COE) Period||2
10747502|NCT02974868|11911252|FG002|STARTED|Cross-Over Extension (COE) Period||11
10747503|NCT02974868|11911253|FG003|STARTED|Cross-Over Extension (COE) Period||3
10747504|NCT02974868|11911250|FG000|COMPLETED|Cross-Over Extension (COE) Period||5
10747505|NCT02974868|11911251|FG001|COMPLETED|Cross-Over Extension (COE) Period||1
10747506|NCT02974868|11911252|FG002|COMPLETED|Cross-Over Extension (COE) Period||8
10747507|NCT02974868|11911253|FG003|COMPLETED|Cross-Over Extension (COE) Period||3
10747508|NCT02974868|11911250|FG000|NOT COMPLETED|Cross-Over Extension (COE) Period||2
10747509|NCT02974868|11911251|FG001|NOT COMPLETED|Cross-Over Extension (COE) Period||1
10747510|NCT02974868|11911252|FG002|NOT COMPLETED|Cross-Over Extension (COE) Period||3
10747511|NCT02974868|11911253|FG003|NOT COMPLETED|Cross-Over Extension (COE) Period||0
10747512|NCT02975206|11911297|FG000|STARTED|Overall Study||161
10747513|NCT02975206|11911298|FG001|STARTED|Overall Study||161
10747514|NCT02975206|11911299|FG002|STARTED|Overall Study||162
10747515|NCT02975206|11911297|FG000|COMPLETED|Overall Study||134
10747516|NCT02975206|11911298|FG001|COMPLETED|Overall Study||144
10747517|NCT02975206|11911299|FG002|COMPLETED|Overall Study||145
10747518|NCT02975206|11911297|FG000|NOT COMPLETED|Overall Study||27
10747519|NCT02975206|11911298|FG001|NOT COMPLETED|Overall Study||17
10747520|NCT02975206|11911299|FG002|NOT COMPLETED|Overall Study||17
10747521|NCT02975297|11911309|FG000|STARTED|Overall Study||41
10747522|NCT02975297|11911310|FG001|STARTED|Overall Study||41
10747523|NCT02975297|11911309|FG000|COMPLETED|Overall Study||34
10747524|NCT02975297|11911310|FG001|COMPLETED|Overall Study||35
10747525|NCT02975297|11911309|FG000|NOT COMPLETED|Overall Study||7
10747526|NCT02975297|11911310|FG001|NOT COMPLETED|Overall Study||6
10747527|NCT02975336|11911320|FG000|STARTED|DBPC (52 Weeks)||117
10747528|NCT02975336|11911321|FG001|STARTED|DBPC (52 Weeks)||118
10747529|NCT02975336|11911322|FG002|STARTED|DBPC (52 Weeks)||117
10747530|NCT02975336|11911323|FG003|STARTED|DBPC (52 Weeks)||117
10747531|NCT02975336|11911324|FG004|STARTED|DBPC (52 Weeks)||0
10747532|NCT02975336|11911325|FG005|STARTED|DBPC (52 Weeks)||0
10747533|NCT02975336|11911326|FG006|STARTED|DBPC (52 Weeks)||0
10747534|NCT02975336|11911327|FG007|STARTED|DBPC (52 Weeks)||0
10747535|NCT02975336|11911320|FG000|COMPLETED|DBPC (52 Weeks)||85
10747536|NCT02975336|11911321|FG001|COMPLETED|DBPC (52 Weeks)||89
10747537|NCT02975336|11911322|FG002|COMPLETED|DBPC (52 Weeks)||90
10747538|NCT02975336|11911323|FG003|COMPLETED|DBPC (52 Weeks)||84
10747539|NCT02975336|11911324|FG004|COMPLETED|DBPC (52 Weeks)||0
10747540|NCT02975336|11911325|FG005|COMPLETED|DBPC (52 Weeks)||0
10747541|NCT02975336|11911326|FG006|COMPLETED|DBPC (52 Weeks)||0
10747542|NCT02975336|11911327|FG007|COMPLETED|DBPC (52 Weeks)||0
10747543|NCT02975336|11911320|FG000|NOT COMPLETED|DBPC (52 Weeks)||32
10747544|NCT02975336|11911321|FG001|NOT COMPLETED|DBPC (52 Weeks)||29
10747545|NCT02975336|11911322|FG002|NOT COMPLETED|DBPC (52 Weeks)||27
10747546|NCT02975336|11911323|FG003|NOT COMPLETED|DBPC (52 Weeks)||33
10747547|NCT02975336|11911324|FG004|NOT COMPLETED|DBPC (52 Weeks)||0
10747548|NCT02975336|11911325|FG005|NOT COMPLETED|DBPC (52 Weeks)||0
10747549|NCT02975336|11911326|FG006|NOT COMPLETED|DBPC (52 Weeks)||0
10747550|NCT02975336|11911327|FG007|NOT COMPLETED|DBPC (52 Weeks)||0
10747551|NCT02975336|11911320|FG000|STARTED|LTE (104 Weeks)||0
10747552|NCT02975336|11911321|FG001|STARTED|LTE (104 Weeks)||0
10747553|NCT02975336|11911322|FG002|STARTED|LTE (104 Weeks)||0
10747554|NCT02975336|11911323|FG003|STARTED|LTE (104 Weeks)||0
10747555|NCT02975336|11911324|FG004|STARTED|LTE (104 Weeks)||62
10747556|NCT02975336|11911325|FG005|STARTED|LTE (104 Weeks)||69
10747557|NCT02975336|11911326|FG006|STARTED|LTE (104 Weeks)||80
10747558|NCT02975336|11911327|FG007|STARTED|LTE (104 Weeks)||72
10747559|NCT02975336|11911320|FG000|COMPLETED|LTE (104 Weeks)||0
10747560|NCT02975336|11911321|FG001|COMPLETED|LTE (104 Weeks)||0
10747561|NCT02975336|11911322|FG002|COMPLETED|LTE (104 Weeks)||0
10747562|NCT02975336|11911323|FG003|COMPLETED|LTE (104 Weeks)||0
10747563|NCT02975336|11911324|FG004|COMPLETED|LTE (104 Weeks)||0
10747564|NCT02975336|11911325|FG005|COMPLETED|LTE (104 Weeks)||0
10747565|NCT02975336|11911326|FG006|COMPLETED|LTE (104 Weeks)||0
10747566|NCT02975336|11911327|FG007|COMPLETED|LTE (104 Weeks)||0
10747567|NCT02975336|11911320|FG000|NOT COMPLETED|LTE (104 Weeks)||0
10747568|NCT02975336|11911321|FG001|NOT COMPLETED|LTE (104 Weeks)||0
10747569|NCT02975336|11911322|FG002|NOT COMPLETED|LTE (104 Weeks)||0
10747570|NCT02975336|11911323|FG003|NOT COMPLETED|LTE (104 Weeks)||0
10747571|NCT02975336|11911324|FG004|NOT COMPLETED|LTE (104 Weeks)||62
10747572|NCT02975336|11911325|FG005|NOT COMPLETED|LTE (104 Weeks)||69
10747573|NCT02975336|11911326|FG006|NOT COMPLETED|LTE (104 Weeks)||80
10747574|NCT02975336|11911327|FG007|NOT COMPLETED|LTE (104 Weeks)||72
10747575|NCT02975349|11911346|FG000|STARTED|Active Treatment Period (24 Weeks)||54
10747576|NCT02975349|11911347|FG001|STARTED|Active Treatment Period (24 Weeks)||0
10747577|NCT02975349|11911348|FG002|STARTED|Active Treatment Period (24 Weeks)||52
10747578|NCT02975349|11911349|FG003|STARTED|Active Treatment Period (24 Weeks)||53
10747579|NCT02975349|11911350|FG004|STARTED|Active Treatment Period (24 Weeks)||54
10747580|NCT02975349|11911351|FG005|STARTED|Active Treatment Period (24 Weeks)||54
10747581|NCT02975349|11911346|FG000|COMPLETED|Active Treatment Period (24 Weeks)||49
10747582|NCT02975349|11911347|FG001|COMPLETED|Active Treatment Period (24 Weeks)||0
10747583|NCT02975349|11911348|FG002|COMPLETED|Active Treatment Period (24 Weeks)||47
10747584|NCT02975349|11911349|FG003|COMPLETED|Active Treatment Period (24 Weeks)||48
10747585|NCT02975349|11911350|FG004|COMPLETED|Active Treatment Period (24 Weeks)||48
10747586|NCT02975349|11911351|FG005|COMPLETED|Active Treatment Period (24 Weeks)||52
10747587|NCT02975349|11911346|FG000|NOT COMPLETED|Active Treatment Period (24 Weeks)||5
10747588|NCT02975349|11911347|FG001|NOT COMPLETED|Active Treatment Period (24 Weeks)||0
10747589|NCT02975349|11911348|FG002|NOT COMPLETED|Active Treatment Period (24 Weeks)||5
10747590|NCT02975349|11911349|FG003|NOT COMPLETED|Active Treatment Period (24 Weeks)||5
10747591|NCT02975349|11911350|FG004|NOT COMPLETED|Active Treatment Period (24 Weeks)||6
10747592|NCT02975349|11911351|FG005|NOT COMPLETED|Active Treatment Period (24 Weeks)||2
10747593|NCT02975349|11911346|FG000|STARTED|Blinded Extension Period (24 Weeks)||0
10747594|NCT02975349|11911347|FG001|STARTED|Blinded Extension Period (24 Weeks)||49
10747595|NCT02975349|11911348|FG002|STARTED|Blinded Extension Period (24 Weeks)||47
10747596|NCT02975349|11911349|FG003|STARTED|Blinded Extension Period (24 Weeks)||48
10747597|NCT02975349|11911350|FG004|STARTED|Blinded Extension Period (24 Weeks)||48
10747598|NCT02975349|11911351|FG005|STARTED|Blinded Extension Period (24 Weeks)||52
10747599|NCT02975349|11911346|FG000|COMPLETED|Blinded Extension Period (24 Weeks)||0
10747600|NCT02975349|11911347|FG001|COMPLETED|Blinded Extension Period (24 Weeks)||42
10747601|NCT02975349|11911348|FG002|COMPLETED|Blinded Extension Period (24 Weeks)||43
10747602|NCT02975349|11911349|FG003|COMPLETED|Blinded Extension Period (24 Weeks)||44
10747603|NCT02975349|11911350|FG004|COMPLETED|Blinded Extension Period (24 Weeks)||46
10747604|NCT02975349|11911351|FG005|COMPLETED|Blinded Extension Period (24 Weeks)||52
10747605|NCT02975349|11911346|FG000|NOT COMPLETED|Blinded Extension Period (24 Weeks)||0
10747606|NCT02975349|11911347|FG001|NOT COMPLETED|Blinded Extension Period (24 Weeks)||7
10747607|NCT02975349|11911348|FG002|NOT COMPLETED|Blinded Extension Period (24 Weeks)||4
10747608|NCT02975349|11911349|FG003|NOT COMPLETED|Blinded Extension Period (24 Weeks)||4
10747609|NCT02975349|11911350|FG004|NOT COMPLETED|Blinded Extension Period (24 Weeks)||2
10747610|NCT02975349|11911351|FG005|NOT COMPLETED|Blinded Extension Period (24 Weeks)||0
10747611|NCT02975557|11911373|FG000|STARTED|Overall Study||4
10747612|NCT02975557|11911374|FG001|STARTED|Overall Study||5
10747613|NCT02975557|11911375|FG002|STARTED|Overall Study||6
10747614|NCT02975557|11911373|FG000|COMPLETED|Overall Study||3
10747615|NCT02975557|11911374|FG001|COMPLETED|Overall Study||2
10747616|NCT02975557|11911375|FG002|COMPLETED|Overall Study||5
10747617|NCT02975557|11911373|FG000|NOT COMPLETED|Overall Study||1
10747618|NCT02975557|11911374|FG001|NOT COMPLETED|Overall Study||3
10747619|NCT02975557|11911375|FG002|NOT COMPLETED|Overall Study||1
10747620|NCT02975804|11911385|FG000|STARTED|Overall Study||9
10747621|NCT02975804|11911386|FG001|STARTED|Overall Study||9
10747622|NCT02975804|11911385|FG000|COMPLETED|Overall Study||9
10747623|NCT02975804|11911386|FG001|COMPLETED|Overall Study||9
10747624|NCT02975804|11911385|FG000|NOT COMPLETED|Overall Study||0
10747625|NCT02975804|11911386|FG001|NOT COMPLETED|Overall Study||0
10747626|NCT02975973|11911396|FG000|STARTED|Overall Study||1
10747627|NCT02975973|11911397|FG001|STARTED|Overall Study||2
10747628|NCT02975973|11911398|FG002|STARTED|Overall Study||1
10747629|NCT02975973|11911399|FG003|STARTED|Overall Study||4
10747630|NCT02975973|11911396|FG000|COMPLETED|Overall Study||0
10747631|NCT02975973|11911397|FG001|COMPLETED|Overall Study||1
10747632|NCT02975973|11911398|FG002|COMPLETED|Overall Study||0
10747633|NCT02975973|11911399|FG003|COMPLETED|Overall Study||4
10747634|NCT02975973|11911396|FG000|NOT COMPLETED|Overall Study||1
10747635|NCT02975973|11911397|FG001|NOT COMPLETED|Overall Study||1
10747636|NCT02975973|11911398|FG002|NOT COMPLETED|Overall Study||1
10747637|NCT02975973|11911399|FG003|NOT COMPLETED|Overall Study||0
10747638|NCT02976103|11911411|FG000|STARTED|Overall Study||67
10747639|NCT02976103|11911412|FG001|STARTED|Overall Study||72
10747640|NCT02976103|11911411|FG000|COMPLETED|Overall Study|54 participants answered final (T3) questionnaire|54
10747641|NCT02976103|11911412|FG001|COMPLETED|Overall Study|64 participants answered final (T3 questionnaire)|64
10747642|NCT02976103|11911411|FG000|NOT COMPLETED|Overall Study||13
10747643|NCT02976103|11911412|FG001|NOT COMPLETED|Overall Study||8
10747644|NCT02976181|11911419|FG000|STARTED|Overall Study||113
10747645|NCT02976181|11911419|FG000|COMPLETED|Overall Study||112
10747646|NCT02976181|11911419|FG000|NOT COMPLETED|Overall Study||1
10747647|NCT02976519|11911431|FG000|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
10817995|NCT01127503|11981952|FG000|STARTED|Overall Study||1
10817996|NCT01127503|11981953|FG001|STARTED|Overall Study||1
10817997|NCT01127503|11981952|FG000|COMPLETED|Overall Study||1
10817998|NCT01127503|11981953|FG001|COMPLETED|Overall Study||1
10817999|NCT01127503|11981952|FG000|NOT COMPLETED|Overall Study||0
10818000|NCT01127503|11981953|FG001|NOT COMPLETED|Overall Study||0
10818001|NCT01122511|11981961|FG000|STARTED|Overall Study||2
10818002|NCT01122511|11981962|FG001|STARTED|Overall Study||2
10818003|NCT01122511|11981961|FG000|COMPLETED|Overall Study||0
10818004|NCT01122511|11981962|FG001|COMPLETED|Overall Study||0
10818005|NCT01122511|11981961|FG000|NOT COMPLETED|Overall Study||2
10818006|NCT01122511|11981962|FG001|NOT COMPLETED|Overall Study||2
10818007|NCT01118013|11981968|FG000|STARTED|Overall Study||6
10818008|NCT01118013|11981968|FG000|COMPLETED|Overall Study||6
10818009|NCT01118013|11981968|FG000|NOT COMPLETED|Overall Study||0
10818010|NCT01122381|11981974|FG000|STARTED|Overall Study||1
10818011|NCT01122381|11981975|FG001|STARTED|Overall Study||1
10818012|NCT01122381|11981974|FG000|COMPLETED|Overall Study|Subject never took the drug per review of ESX levels after unblinding|1
10818013|NCT01122381|11981975|FG001|COMPLETED|Overall Study||0
10818014|NCT01122381|11981974|FG000|NOT COMPLETED|Overall Study||0
10818015|NCT01122381|11981975|FG001|NOT COMPLETED|Overall Study||1
10818016|NCT01116232|11981981|FG000|STARTED|Overall Study||4
10818017|NCT01116232|11981981|FG000|COMPLETED|Overall Study||0
10818018|NCT01116232|11981981|FG000|NOT COMPLETED|Overall Study||4
10818019|NCT01110174|11981988|FG000|STARTED|Overall Study||8
10818020|NCT01110174|11981988|FG000|COMPLETED|Overall Study||8
10818021|NCT01110174|11981988|FG000|NOT COMPLETED|Overall Study||0
10747648|NCT02976519|11911432|FG001|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
10747649|NCT02976519|11911433|FG002|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
10747650|NCT02976519|11911434|FG003|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
10747651|NCT02976519|11911435|FG004|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
10747652|NCT02976519|11911436|FG005|STARTED|Treatment Period 1 (Part 1 and Part 2)||12
10747653|NCT02976519|11911437|FG006|STARTED|Treatment Period 1 (Part 1 and Part 2)||12
10747654|NCT02976519|11911431|FG000|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||8
10747655|NCT02976519|11911432|FG001|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||7
10747656|NCT02976519|11911433|FG002|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||8
10747657|NCT02976519|11911434|FG003|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||7
10747658|NCT02976519|11911435|FG004|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||8
10747659|NCT02976519|11911436|FG005|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||12
10747660|NCT02976519|11911437|FG006|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||12
10747661|NCT02976519|11911431|FG000|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
10747662|NCT02976519|11911432|FG001|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||1
10747663|NCT02976519|11911433|FG002|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
10747664|NCT02976519|11911434|FG003|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||1
10747665|NCT02976519|11911435|FG004|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
10747666|NCT02976519|11911436|FG005|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
10747667|NCT02976519|11911437|FG006|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
10747668|NCT02976519|11911431|FG000|STARTED|Wash-out Period (Part 2 Only)||0
10747669|NCT02976519|11911432|FG001|STARTED|Wash-out Period (Part 2 Only)||0
10747670|NCT02976519|11911433|FG002|STARTED|Wash-out Period (Part 2 Only)||0
10747671|NCT02976519|11911434|FG003|STARTED|Wash-out Period (Part 2 Only)||0
10747672|NCT02976519|11911435|FG004|STARTED|Wash-out Period (Part 2 Only)||0
10747673|NCT02976519|11911436|FG005|STARTED|Wash-out Period (Part 2 Only)||12
10747674|NCT02976519|11911437|FG006|STARTED|Wash-out Period (Part 2 Only)||12
10747675|NCT02976519|11911431|FG000|COMPLETED|Wash-out Period (Part 2 Only)||0
10747676|NCT02976519|11911432|FG001|COMPLETED|Wash-out Period (Part 2 Only)||0
10747677|NCT02976519|11911433|FG002|COMPLETED|Wash-out Period (Part 2 Only)||0
10747678|NCT02976519|11911434|FG003|COMPLETED|Wash-out Period (Part 2 Only)||0
10747679|NCT02976519|11911435|FG004|COMPLETED|Wash-out Period (Part 2 Only)||0
10747680|NCT02976519|11911436|FG005|COMPLETED|Wash-out Period (Part 2 Only)||12
10747681|NCT02976519|11911437|FG006|COMPLETED|Wash-out Period (Part 2 Only)||10
10747682|NCT02976519|11911431|FG000|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
10747683|NCT02976519|11911432|FG001|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
10747684|NCT02976519|11911433|FG002|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
10747685|NCT02976519|11911434|FG003|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
10747686|NCT02976519|11911435|FG004|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
10747687|NCT02976519|11911436|FG005|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
10747688|NCT02976519|11911437|FG006|NOT COMPLETED|Wash-out Period (Part 2 Only)||2
10747689|NCT02976519|11911431|FG000|STARTED|Treatment Period 2 (Part 2 Only)||0
10747690|NCT02976519|11911432|FG001|STARTED|Treatment Period 2 (Part 2 Only)||0
10747691|NCT02976519|11911433|FG002|STARTED|Treatment Period 2 (Part 2 Only)||0
10747692|NCT02976519|11911434|FG003|STARTED|Treatment Period 2 (Part 2 Only)||0
10747693|NCT02976519|11911435|FG004|STARTED|Treatment Period 2 (Part 2 Only)||0
10747694|NCT02976519|11911436|FG005|STARTED|Treatment Period 2 (Part 2 Only)||12
10747695|NCT02976519|11911437|FG006|STARTED|Treatment Period 2 (Part 2 Only)||10
10747696|NCT02976519|11911431|FG000|COMPLETED|Treatment Period 2 (Part 2 Only)||0
10747697|NCT02976519|11911432|FG001|COMPLETED|Treatment Period 2 (Part 2 Only)||0
10747698|NCT02976519|11911433|FG002|COMPLETED|Treatment Period 2 (Part 2 Only)||0
10747699|NCT02976519|11911434|FG003|COMPLETED|Treatment Period 2 (Part 2 Only)||0
10747700|NCT02976519|11911435|FG004|COMPLETED|Treatment Period 2 (Part 2 Only)||0
10747701|NCT02976519|11911436|FG005|COMPLETED|Treatment Period 2 (Part 2 Only)||12
10747702|NCT02976519|11911437|FG006|COMPLETED|Treatment Period 2 (Part 2 Only)||9
10747703|NCT02976519|11911431|FG000|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
10747704|NCT02976519|11911432|FG001|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
10747705|NCT02976519|11911433|FG002|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
10747706|NCT02976519|11911434|FG003|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
10747707|NCT02976519|11911435|FG004|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
10747708|NCT02976519|11911436|FG005|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
10747709|NCT02976519|11911437|FG006|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||1
10747710|NCT02977507|11911457|FG000|STARTED|Overall Study||8
10747711|NCT02977507|11911458|FG001|STARTED|Overall Study||10
10747712|NCT02977507|11911457|FG000|COMPLETED|Overall Study||6
10747713|NCT02977507|11911458|FG001|COMPLETED|Overall Study||10
10747714|NCT02977507|11911457|FG000|NOT COMPLETED|Overall Study||2
10747715|NCT02977507|11911458|FG001|NOT COMPLETED|Overall Study||0
10747716|NCT02977572|11911467|FG000|STARTED|Overall Study||58
10747717|NCT02977572|11911468|FG001|STARTED|Overall Study||56
10747718|NCT02977572|11911467|FG000|COMPLETED|Overall Study||56
10747719|NCT02977572|11911468|FG001|COMPLETED|Overall Study||54
10747720|NCT02977572|11911467|FG000|NOT COMPLETED|Overall Study||2
10747721|NCT02977572|11911468|FG001|NOT COMPLETED|Overall Study||2
10747722|NCT02978157|11911480|FG000|STARTED|Overall Study||52
10747723|NCT02978157|11911481|FG001|STARTED|Overall Study||50
10747724|NCT02978157|11911480|FG000|COMPLETED|Overall Study||52
10747725|NCT02978157|11911481|FG001|COMPLETED|Overall Study||50
10747726|NCT02978157|11911480|FG000|NOT COMPLETED|Overall Study||0
10747727|NCT02978157|11911481|FG001|NOT COMPLETED|Overall Study||0
10747728|NCT02978183|11911489|FG000|STARTED|Overall Study||34
10747729|NCT02978183|11911490|FG001|STARTED|Overall Study||36
10747730|NCT02978183|11911489|FG000|COMPLETED|Overall Study||34
10747731|NCT02978183|11911490|FG001|COMPLETED|Overall Study||36
10747732|NCT02978183|11911489|FG000|NOT COMPLETED|Overall Study||0
10747733|NCT02978183|11911490|FG001|NOT COMPLETED|Overall Study||0
10747734|NCT02978339|11911496|FG000|STARTED|Overall Study||15
10747735|NCT02978339|11911496|FG000|COMPLETED|Overall Study||15
10747736|NCT02978339|11911496|FG000|NOT COMPLETED|Overall Study||0
10747737|NCT02978417|11911502|FG000|STARTED|Overall Study||5
10818022|NCT01115699|11981992|FG000|STARTED|Overall Study||2
10818023|NCT01115699|11981992|FG000|COMPLETED|Overall Study||2
10818024|NCT01115699|11981992|FG000|NOT COMPLETED|Overall Study||0
10818025|NCT01108666|11981996|FG000|STARTED|Overall Study|Despite all possible efforts to contact the PI/study, data per dose-level are not available to be reported|7
10408766|NCT00756977|11552922|FG001|STARTED|Overall Study||198
10818026|NCT01108666|11981996|FG000|COMPLETED|Overall Study|Despite all possible efforts to contact the PI/study, data per dose-level are not available to be reported|7
10818027|NCT01108666|11981996|FG000|NOT COMPLETED|Overall Study||0
10818028|NCT01115244|11982002|FG000|STARTED|Overall Study||0
10818029|NCT01115244|11982003|FG001|STARTED|Overall Study||0
10818030|NCT01115244|11982002|FG000|COMPLETED|Overall Study||0
10818031|NCT01115244|11982003|FG001|COMPLETED|Overall Study||0
10818032|NCT01115244|11982002|FG000|NOT COMPLETED|Overall Study||0
10818033|NCT01115244|11982003|FG001|NOT COMPLETED|Overall Study||0
10818034|NCT01108523|11982009|FG000|STARTED|Overall Study||7
10818035|NCT01108523|11982009|FG000|COMPLETED|Overall Study||3
10818036|NCT01108523|11982009|FG000|NOT COMPLETED|Overall Study||4
10818037|NCT01107795|11982013|FG000|STARTED|Overall Study||41
10818038|NCT01107795|11982013|FG000|COMPLETED|Overall Study||41
10818039|NCT01107795|11982013|FG000|NOT COMPLETED|Overall Study||0
10818040|NCT01106534|11982017|FG000|STARTED|Overall Study||2997
10818041|NCT01106534|11982017|FG000|COMPLETED|Overall Study||2960
10818042|NCT01106534|11982017|FG000|NOT COMPLETED|Overall Study||37
10818043|NCT01104116|11982022|FG000|STARTED|Overall Study||1
10818044|NCT01104116|11982022|FG000|COMPLETED|Overall Study||1
10818045|NCT01104116|11982022|FG000|NOT COMPLETED|Overall Study||0
10818046|NCT01100658|11982026|FG000|STARTED|Overall Study||1
10818047|NCT01100658|11982026|FG000|COMPLETED|Overall Study||0
10818048|NCT01100658|11982026|FG000|NOT COMPLETED|Overall Study||1
10818049|NCT01103180|11982032|FG000|STARTED|Overall Study||35
10818050|NCT01103180|11982033|FG001|STARTED|Overall Study||35
10818051|NCT01103180|11982032|FG000|COMPLETED|Overall Study||13
10818052|NCT01103180|11982033|FG001|COMPLETED|Overall Study||14
10747738|NCT02978417|11911503|FG001|STARTED|Overall Study||5
10747739|NCT02978417|11911502|FG000|COMPLETED|Overall Study||3
10747740|NCT02978417|11911503|FG001|COMPLETED|Overall Study||3
10747741|NCT02978417|11911502|FG000|NOT COMPLETED|Overall Study||2
10747742|NCT02978417|11911503|FG001|NOT COMPLETED|Overall Study||2
10747743|NCT02978508|11911511|FG000|STARTED|Overall Study||70
10747744|NCT02978508|11911512|FG001|STARTED|Overall Study||70
10747745|NCT02978508|11911511|FG000|COMPLETED|Overall Study||70
10747746|NCT02978508|11911512|FG001|COMPLETED|Overall Study||70
10747747|NCT02978508|11911511|FG000|NOT COMPLETED|Overall Study||0
10747748|NCT02978508|11911512|FG001|NOT COMPLETED|Overall Study||0
10747749|NCT02979054|11911520|FG000|STARTED|Overall Study||71
10747750|NCT02979054|11911521|FG001|STARTED|Overall Study||64
10747751|NCT02979054|11911520|FG000|COMPLETED|Overall Study||71
10747752|NCT02979054|11911521|FG001|COMPLETED|Overall Study||64
10747753|NCT02979054|11911520|FG000|NOT COMPLETED|Overall Study||0
10747754|NCT02979054|11911521|FG001|NOT COMPLETED|Overall Study||0
10747755|NCT02979197|11911530|FG000|STARTED|Overall Study||48
10747756|NCT02979197|11911531|FG001|STARTED|Overall Study||49
10747757|NCT02979197|11911532|FG002|STARTED|Overall Study||8
10747758|NCT02979197|11911530|FG000|COMPLETED|Overall Study||44
10747759|NCT02979197|11911531|FG001|COMPLETED|Overall Study||45
10747760|NCT02979197|11911532|FG002|COMPLETED|Overall Study||8
10747761|NCT02979197|11911530|FG000|NOT COMPLETED|Overall Study||4
10747762|NCT02979197|11911531|FG001|NOT COMPLETED|Overall Study||4
10747763|NCT02979197|11911532|FG002|NOT COMPLETED|Overall Study||0
10747764|NCT02979249|11911540|FG000|STARTED|Overall Study||16
10747765|NCT02979249|11911540|FG000|COMPLETED|Overall Study||10
10747766|NCT02979249|11911540|FG000|NOT COMPLETED|Overall Study||6
10747767|NCT02979262|11911546|FG000|STARTED|Overall Study||33
10747768|NCT02979262|11911547|FG001|STARTED|Overall Study||29
10747769|NCT02979262|11911546|FG000|Received Allocated Intervention|Overall Study||30
10747770|NCT02979262|11911547|FG001|Received Allocated Intervention|Overall Study||27
10747771|NCT02979262|11911546|FG000|COMPLETED|Overall Study||21
10747772|NCT02979262|11911547|FG001|COMPLETED|Overall Study||20
10747773|NCT02979262|11911546|FG000|NOT COMPLETED|Overall Study||12
10747774|NCT02979262|11911547|FG001|NOT COMPLETED|Overall Study||9
10747775|NCT02979301|11911555|FG000|STARTED|Overall Study||11
10747776|NCT02979301|11911556|FG001|STARTED|Overall Study||11
10747777|NCT02979301|11911555|FG000|COMPLETED|Overall Study||10
10747778|NCT02979301|11911556|FG001|COMPLETED|Overall Study||11
10747779|NCT02979301|11911555|FG000|NOT COMPLETED|Overall Study||1
10747780|NCT02979301|11911556|FG001|NOT COMPLETED|Overall Study||0
10747781|NCT02979431|11911566|FG000|STARTED|Overall Study||44
10747782|NCT02979431|11911567|FG001|STARTED|Overall Study||46
10747783|NCT02979431|11911568|FG002|STARTED|Overall Study||45
10747784|NCT02979431|11911569|FG003|STARTED|Overall Study||45
10747785|NCT02979431|11911566|FG000|Included in the mITT Population|Overall Study||42
10747786|NCT02979431|11911567|FG001|Included in the mITT Population|Overall Study||45
10747787|NCT02979431|11911568|FG002|Included in the mITT Population|Overall Study||43
10747788|NCT02979431|11911569|FG003|Included in the mITT Population|Overall Study||45
10747789|NCT02979431|11911566|FG000|Included in the Safety Population|Overall Study||40
10747790|NCT02979431|11911567|FG001|Included in the Safety Population|Overall Study||45
10747791|NCT02979431|11911568|FG002|Included in the Safety Population|Overall Study|Includes a subject that was randomized to placebo but received a dose of ALX-0171 6.0 mg/kg|44
10747792|NCT02979431|11911569|FG003|Included in the Safety Population|Overall Study|Includes a subject that was randomized to placebo but received a dose of ALX-0171 9.0 mg/kg|46
10747793|NCT02979431|11911566|FG000|COMPLETED|Overall Study||40
10747794|NCT02979431|11911567|FG001|COMPLETED|Overall Study||44
10747795|NCT02979431|11911568|FG002|COMPLETED|Overall Study||43
10747796|NCT02979431|11911569|FG003|COMPLETED|Overall Study||44
10747797|NCT02979431|11911566|FG000|NOT COMPLETED|Overall Study||4
10747798|NCT02979431|11911567|FG001|NOT COMPLETED|Overall Study||2
10747799|NCT02979431|11911568|FG002|NOT COMPLETED|Overall Study||2
10747800|NCT02979431|11911569|FG003|NOT COMPLETED|Overall Study||1
10747801|NCT02979444|11911582|FG000|STARTED|Overall Study||405
10747802|NCT02979444|11911583|FG001|STARTED|Overall Study||310
10747803|NCT02979444|11911584|FG002|STARTED|Overall Study||159
10747804|NCT02979444|11911582|FG000|COMPLETED|Overall Study||382
10747805|NCT02979444|11911583|FG001|COMPLETED|Overall Study||293
10747806|NCT02979444|11911584|FG002|COMPLETED|Overall Study||149
10747807|NCT02979444|11911582|FG000|NOT COMPLETED|Overall Study||23
10747808|NCT02979444|11911583|FG001|NOT COMPLETED|Overall Study||17
10747809|NCT02979444|11911584|FG002|NOT COMPLETED|Overall Study||10
10747810|NCT02979613|11911594|FG000|STARTED|Double-Blind Phase||245
10747811|NCT02979613|11911595|FG001|STARTED|Double-Blind Phase||245
10747812|NCT02979613|11911594|FG000|COMPLETED|Double-Blind Phase||235
10747813|NCT02979613|11911595|FG001|COMPLETED|Double-Blind Phase||237
10747814|NCT02979613|11911594|FG000|NOT COMPLETED|Double-Blind Phase||10
10747815|NCT02979613|11911595|FG001|NOT COMPLETED|Double-Blind Phase||8
10747816|NCT02979613|11911594|FG000|STARTED|Open-Label Extension (OLE) Phase||235
10747817|NCT02979613|11911595|FG001|STARTED|Open-Label Extension (OLE) Phase||237
10747818|NCT02979613|11911594|FG000|COMPLETED|Open-Label Extension (OLE) Phase||232
10747819|NCT02979613|11911595|FG001|COMPLETED|Open-Label Extension (OLE) Phase||231
10747820|NCT02979613|11911594|FG000|NOT COMPLETED|Open-Label Extension (OLE) Phase||3
10747821|NCT02979613|11911595|FG001|NOT COMPLETED|Open-Label Extension (OLE) Phase||6
10747822|NCT02979626|11911605|FG000|STARTED|Overall Study||313
10747823|NCT02979626|11911606|FG001|STARTED|Overall Study||98
10747824|NCT02979626|11911605|FG000|COMPLETED|Overall Study||313
10747825|NCT02979626|11911606|FG001|COMPLETED|Overall Study||98
10747826|NCT02979626|11911605|FG000|NOT COMPLETED|Overall Study||0
10747827|NCT02979626|11911606|FG001|NOT COMPLETED|Overall Study||0
10747828|NCT02979639|11911612|FG000|STARTED|Overall Study||401
10747829|NCT02979639|11911612|FG000|COMPLETED|Overall Study||387
10747830|NCT02979639|11911612|FG000|NOT COMPLETED|Overall Study||14
10747831|NCT02979899|11911618|FG000|STARTED|Overall Study||64
10747832|NCT02979899|11911619|FG001|STARTED|Overall Study||64
10747833|NCT02979899|11911618|FG000|COMPLETED|Overall Study||64
10747834|NCT02979899|11911619|FG001|COMPLETED|Overall Study||64
10747835|NCT02979899|11911618|FG000|NOT COMPLETED|Overall Study||0
10747836|NCT02979899|11911619|FG001|NOT COMPLETED|Overall Study||0
10747837|NCT02979925|11911627|FG000|STARTED|Overall Study||28
10747838|NCT02979925|11911628|FG001|STARTED|Overall Study||29
10747839|NCT02979925|11911627|FG000|COMPLETED|Overall Study||28
10747840|NCT02979925|11911628|FG001|COMPLETED|Overall Study||23
10747841|NCT02979925|11911627|FG000|NOT COMPLETED|Overall Study||0
10747842|NCT02979925|11911628|FG001|NOT COMPLETED|Overall Study||6
10747843|NCT02980042|11911636|FG000|STARTED|Overall Study||100
10747844|NCT02980042|11911637|FG001|STARTED|Overall Study||100
10747845|NCT02980042|11911636|FG000|COMPLETED|Overall Study|All 100 subjects completed their Week 24 infusion. 7 subjects did not complete the 12 month visit.|93
10747846|NCT02980042|11911637|FG001|COMPLETED|Overall Study||100
10747847|NCT02980042|11911636|FG000|NOT COMPLETED|Overall Study||7
10747848|NCT02980042|11911637|FG001|NOT COMPLETED|Overall Study||0
10747849|NCT02980107|11911657|FG000|STARTED|Overall Study||105
10747850|NCT02980107|11911658|FG001|STARTED|Overall Study||107
10747851|NCT02980107|11911657|FG000|COMPLETED|Overall Study||54
10747852|NCT02980107|11911658|FG001|COMPLETED|Overall Study||45
10747853|NCT02980107|11911657|FG000|NOT COMPLETED|Overall Study||51
10747854|NCT02980107|11911658|FG001|NOT COMPLETED|Overall Study||62
10747855|NCT02980133|11911668|FG000|STARTED|Overall Study||209
10747856|NCT02980133|11911669|FG001|STARTED|Overall Study||211
10747857|NCT02980133|11911670|FG002|STARTED|Overall Study||210
10747858|NCT02980133|11911671|FG003|STARTED|Overall Study||211
10747859|NCT02980133|11911668|FG000|Received at Least 1 Dose of Study Drug|Overall Study||209
10747860|NCT02980133|11911669|FG001|Received at Least 1 Dose of Study Drug|Overall Study||211
10747861|NCT02980133|11911670|FG002|Received at Least 1 Dose of Study Drug|Overall Study||208
10747862|NCT02980133|11911671|FG003|Received at Least 1 Dose of Study Drug|Overall Study||211
10747863|NCT02980133|11911668|FG000|COMPLETED|Overall Study||202
10747864|NCT02980133|11911669|FG001|COMPLETED|Overall Study||206
10747865|NCT02980133|11911670|FG002|COMPLETED|Overall Study||203
10747866|NCT02980133|11911671|FG003|COMPLETED|Overall Study||205
10747867|NCT02980133|11911668|FG000|NOT COMPLETED|Overall Study||7
10747868|NCT02980133|11911669|FG001|NOT COMPLETED|Overall Study||5
10747869|NCT02980133|11911670|FG002|NOT COMPLETED|Overall Study||7
10747870|NCT02980133|11911671|FG003|NOT COMPLETED|Overall Study||6
10747871|NCT02980211|11911684|FG000|STARTED|Overall Study||17
10747872|NCT02980211|11911684|FG000|COMPLETED|Overall Study||17
10747873|NCT02980211|11911684|FG000|NOT COMPLETED|Overall Study||0
10747874|NCT02980224|11911690|FG000|STARTED|Overall Study||89
10747875|NCT02980224|11911691|FG001|STARTED|Overall Study||91
10747876|NCT02980224|11911690|FG000|COMPLETED|Overall Study||85
10747877|NCT02980224|11911691|FG001|COMPLETED|Overall Study||88
10747878|NCT02980224|11911690|FG000|NOT COMPLETED|Overall Study||4
10747879|NCT02980224|11911691|FG001|NOT COMPLETED|Overall Study||3
10747880|NCT02980523|11911702|FG000|STARTED|Overall Study||30
10747881|NCT02980523|11911703|FG001|STARTED|Overall Study||30
10747882|NCT02980523|11911704|FG002|STARTED|Overall Study||30
10747883|NCT02980523|11911705|FG003|STARTED|Overall Study||30
10747884|NCT02980523|11911706|FG004|STARTED|Overall Study||30
10747885|NCT02980523|11911702|FG000|COMPLETED|Overall Study||27
10747886|NCT02980523|11911703|FG001|COMPLETED|Overall Study||19
10747887|NCT02980523|11911704|FG002|COMPLETED|Overall Study||24
10747888|NCT02980523|11911705|FG003|COMPLETED|Overall Study||21
10747889|NCT02980523|11911706|FG004|COMPLETED|Overall Study||20
10747890|NCT02980523|11911702|FG000|NOT COMPLETED|Overall Study||3
10747891|NCT02980523|11911703|FG001|NOT COMPLETED|Overall Study||11
10747892|NCT02980523|11911704|FG002|NOT COMPLETED|Overall Study||6
10747893|NCT02980523|11911705|FG003|NOT COMPLETED|Overall Study||9
10747894|NCT02980523|11911706|FG004|NOT COMPLETED|Overall Study||10
10747895|NCT02980601|11911723|FG000|STARTED|Overall Study||6
10747896|NCT02980601|11911724|FG001|STARTED|Overall Study||4
10747897|NCT02980601|11911723|FG000|COMPLETED|Overall Study||1
10747898|NCT02980601|11911724|FG001|COMPLETED|Overall Study||1
10747899|NCT02980601|11911723|FG000|NOT COMPLETED|Overall Study||5
10747900|NCT02980601|11911724|FG001|NOT COMPLETED|Overall Study||3
10747901|NCT02980692|11911735|FG000|STARTED|Overall Study||78
10747902|NCT02980692|11911736|FG001|STARTED|Overall Study||79
10747903|NCT02980692|11911737|FG002|STARTED|Overall Study||77
10747904|NCT02980692|11911738|FG003|STARTED|Overall Study||78
10747905|NCT02980692|11911739|FG004|STARTED|Overall Study||79
10747906|NCT02980692|11911735|FG000|COMPLETED|Overall Study||69
10747907|NCT02980692|11911736|FG001|COMPLETED|Overall Study||73
10747908|NCT02980692|11911737|FG002|COMPLETED|Overall Study||65
10747909|NCT02980692|11911738|FG003|COMPLETED|Overall Study||69
10747910|NCT02980692|11911739|FG004|COMPLETED|Overall Study||68
10747911|NCT02980692|11911735|FG000|NOT COMPLETED|Overall Study||9
10747912|NCT02980692|11911736|FG001|NOT COMPLETED|Overall Study||6
10747913|NCT02980692|11911737|FG002|NOT COMPLETED|Overall Study||12
10747914|NCT02980692|11911738|FG003|NOT COMPLETED|Overall Study||9
10747915|NCT02980692|11911739|FG004|NOT COMPLETED|Overall Study||11
10747916|NCT02980705|11911754|FG000|STARTED|Overall Study||50
10747917|NCT02980705|11911755|FG001|STARTED|Overall Study||51
10747918|NCT02980705|11911754|FG000|COMPLETED|Overall Study||42
10818053|NCT01103180|11982032|FG000|NOT COMPLETED|Overall Study||22
10747919|NCT02980705|11911755|FG001|COMPLETED|Overall Study||40
10747920|NCT02980705|11911754|FG000|NOT COMPLETED|Overall Study||8
10747921|NCT02980705|11911755|FG001|NOT COMPLETED|Overall Study||11
10747922|NCT02980783|11911762|FG000|STARTED|Overall Study||53
10747923|NCT02980783|11911762|FG000|COMPLETED|Overall Study||52
10747924|NCT02980783|11911762|FG000|NOT COMPLETED|Overall Study||1
10747925|NCT02980874|11911768|FG000|STARTED|Overall Study||231
10747926|NCT02980874|11911769|FG001|STARTED|Overall Study||229
10747927|NCT02980874|11911768|FG000|COMPLETED|Overall Study||128
10747928|NCT02980874|11911769|FG001|COMPLETED|Overall Study||127
10747929|NCT02980874|11911768|FG000|NOT COMPLETED|Overall Study||103
10747930|NCT02980874|11911769|FG001|NOT COMPLETED|Overall Study||102
10747931|NCT02980978|11911777|FG000|STARTED|Overall Study||60
10747932|NCT02980978|11911778|FG001|STARTED|Overall Study||58
10747933|NCT02980978|11911777|FG000|COMPLETED|Overall Study||54
10747934|NCT02980978|11911778|FG001|COMPLETED|Overall Study||50
10747935|NCT02980978|11911777|FG000|NOT COMPLETED|Overall Study||6
10747936|NCT02980978|11911778|FG001|NOT COMPLETED|Overall Study||8
10747937|NCT02981342|11911788|FG000|STARTED|Overall Study||7
10747938|NCT02981342|11911789|FG001|STARTED|Overall Study||33
10747939|NCT02981342|11911790|FG002|STARTED|Overall Study||33
10747940|NCT02981342|11911791|FG003|STARTED|Overall Study||33
10747941|NCT02981342|11911788|FG000|Received at Least One Dose of Study Drug|Overall Study||7
10747942|NCT02981342|11911789|FG001|Received at Least One Dose of Study Drug|Overall Study||32
10747943|NCT02981342|11911790|FG002|Received at Least One Dose of Study Drug|Overall Study||33
10747944|NCT02981342|11911791|FG003|Received at Least One Dose of Study Drug|Overall Study||26
10747945|NCT02981342|11911788|FG000|COMPLETED|Overall Study||7
10747946|NCT02981342|11911789|FG001|COMPLETED|Overall Study||22
10747947|NCT02981342|11911790|FG002|COMPLETED|Overall Study||20
10747948|NCT02981342|11911791|FG003|COMPLETED|Overall Study||19
10747949|NCT02981342|11911788|FG000|NOT COMPLETED|Overall Study||0
10747950|NCT02981342|11911789|FG001|NOT COMPLETED|Overall Study||11
10747951|NCT02981342|11911790|FG002|NOT COMPLETED|Overall Study||13
10747952|NCT02981342|11911791|FG003|NOT COMPLETED|Overall Study||14
10747953|NCT02981368|11911805|FG000|STARTED|Overall Study||268
10747954|NCT02981368|11911806|FG001|STARTED|Overall Study||117
10747955|NCT02981368|11911805|FG000|COMPLETED|Overall Study||248
10747956|NCT02981368|11911806|FG001|COMPLETED|Overall Study||102
10747957|NCT02981368|11911805|FG000|NOT COMPLETED|Overall Study||20
10747958|NCT02981368|11911806|FG001|NOT COMPLETED|Overall Study||15
10747959|NCT02981524|11911839|FG000|STARTED|Overall Study||17
10747960|NCT02981524|11911839|FG000|COMPLETED|Overall Study||0
10747961|NCT02981524|11911839|FG000|NOT COMPLETED|Overall Study||17
10747962|NCT02981602|11911848|FG000|STARTED|Overall Study||6
10747963|NCT02981602|11911849|FG001|STARTED|Overall Study||12
10747964|NCT02981602|11911850|FG002|STARTED|Overall Study||6
10747965|NCT02981602|11911851|FG003|STARTED|Overall Study||5
10747966|NCT02981602|11911852|FG004|STARTED|Overall Study||2
10747967|NCT02981602|11911848|FG000|COMPLETED|Overall Study||6
10747968|NCT02981602|11911849|FG001|COMPLETED|Overall Study||12
10747969|NCT02981602|11911850|FG002|COMPLETED|Overall Study||6
10747970|NCT02981602|11911851|FG003|COMPLETED|Overall Study||4
10747971|NCT02981602|11911852|FG004|COMPLETED|Overall Study||2
10747972|NCT02981602|11911848|FG000|NOT COMPLETED|Overall Study||0
10747973|NCT02981602|11911849|FG001|NOT COMPLETED|Overall Study||0
10747974|NCT02981602|11911850|FG002|NOT COMPLETED|Overall Study||0
10747975|NCT02981602|11911851|FG003|NOT COMPLETED|Overall Study||1
10747976|NCT02981602|11911852|FG004|NOT COMPLETED|Overall Study||0
10747977|NCT02981953|11911865|FG000|STARTED|Overall Study||40
10747978|NCT02981953|11911865|FG000|COMPLETED|Overall Study||29
10747979|NCT02981953|11911865|FG000|NOT COMPLETED|Overall Study||11
10747980|NCT02982018|11911871|FG000|STARTED|Overall Study||67
10747981|NCT02982018|11911872|FG001|STARTED|Overall Study||64
10747982|NCT02982018|11911871|FG000|COMPLETED|Overall Study||62
10747983|NCT02982018|11911872|FG001|COMPLETED|Overall Study||61
10818054|NCT01103180|11982033|FG001|NOT COMPLETED|Overall Study||21
10818055|NCT01090141|11982041|FG000|STARTED|Overall Study||0
10818056|NCT01090141|11982042|FG001|STARTED|Overall Study||0
10818057|NCT01090141|11982041|FG000|COMPLETED|Overall Study||0
10818058|NCT01090141|11982042|FG001|COMPLETED|Overall Study||0
10818059|NCT01090141|11982041|FG000|NOT COMPLETED|Overall Study||0
10818060|NCT01090141|11982042|FG001|NOT COMPLETED|Overall Study||0
10818061|NCT01102140|11982050|FG000|STARTED|Overall Study||13
10747984|NCT02982018|11911871|FG000|NOT COMPLETED|Overall Study||5
10747985|NCT02982018|11911872|FG001|NOT COMPLETED|Overall Study||3
10747986|NCT02982187|11911880|FG000|STARTED|Overall Study||20
10747987|NCT02982187|11911881|FG001|STARTED|Overall Study||20
10747988|NCT02982187|11911882|FG002|STARTED|Overall Study||20
10747989|NCT02982187|11911883|FG003|STARTED|Overall Study||20
10747990|NCT02982187|11911884|FG004|STARTED|Overall Study||20
10747991|NCT02982187|11911885|FG005|STARTED|Overall Study||20
10747992|NCT02982187|11911886|FG006|STARTED|Overall Study||20
10747993|NCT02982187|11911887|FG007|STARTED|Overall Study||20
10747994|NCT02982187|11911880|FG000|COMPLETED|Overall Study||20
10747995|NCT02982187|11911881|FG001|COMPLETED|Overall Study||20
10747996|NCT02982187|11911882|FG002|COMPLETED|Overall Study||20
10747997|NCT02982187|11911883|FG003|COMPLETED|Overall Study||20
10747998|NCT02982187|11911884|FG004|COMPLETED|Overall Study||20
10747999|NCT02982187|11911885|FG005|COMPLETED|Overall Study||20
10748000|NCT02982187|11911886|FG006|COMPLETED|Overall Study||19
10748001|NCT02982187|11911887|FG007|COMPLETED|Overall Study||20
10748002|NCT02982187|11911880|FG000|NOT COMPLETED|Overall Study||0
10748003|NCT02982187|11911881|FG001|NOT COMPLETED|Overall Study||0
10748004|NCT02982187|11911882|FG002|NOT COMPLETED|Overall Study||0
10748005|NCT02982187|11911883|FG003|NOT COMPLETED|Overall Study||0
10748006|NCT02982187|11911884|FG004|NOT COMPLETED|Overall Study||0
10748007|NCT02982187|11911885|FG005|NOT COMPLETED|Overall Study||0
10748008|NCT02982187|11911886|FG006|NOT COMPLETED|Overall Study||1
10748009|NCT02982187|11911887|FG007|NOT COMPLETED|Overall Study||0
10748010|NCT02982213|11911899|FG000|STARTED|Overall Study||75
10748011|NCT02982213|11911900|FG001|STARTED|Overall Study||75
10748012|NCT02982213|11911899|FG000|COMPLETED|Overall Study||70
10748013|NCT02982213|11911900|FG001|COMPLETED|Overall Study||74
10748014|NCT02982213|11911899|FG000|NOT COMPLETED|Overall Study||5
10748015|NCT02982213|11911900|FG001|NOT COMPLETED|Overall Study||1
10748016|NCT02982239|11911908|FG000|STARTED|Overall Study||20
10748017|NCT02982239|11911909|FG001|STARTED|Overall Study||20
10748018|NCT02982239|11911908|FG000|COMPLETED|Overall Study||17
10748019|NCT02982239|11911909|FG001|COMPLETED|Overall Study||18
10748020|NCT02982239|11911908|FG000|NOT COMPLETED|Overall Study||3
10748021|NCT02982239|11911909|FG001|NOT COMPLETED|Overall Study||2
10748022|NCT02982590|11911918|FG000|STARTED|Overall Study||13
10748023|NCT02982590|11911919|FG001|STARTED|Overall Study||14
10748024|NCT02982590|11911918|FG000|COMPLETED|Overall Study||9
10748025|NCT02982590|11911919|FG001|COMPLETED|Overall Study||13
10748026|NCT02982590|11911918|FG000|NOT COMPLETED|Overall Study||4
10748027|NCT02982590|11911919|FG001|NOT COMPLETED|Overall Study||1
10748028|NCT02982772|11911927|FG000|STARTED|Enrollment||245
10748029|NCT02982772|11911928|FG001|STARTED|Enrollment||243
10748030|NCT02982772|11911927|FG000|COMPLETED|Enrollment||245
10748031|NCT02982772|11911928|FG001|COMPLETED|Enrollment||243
10748032|NCT02982772|11911927|FG000|NOT COMPLETED|Enrollment||0
10748033|NCT02982772|11911928|FG001|NOT COMPLETED|Enrollment||0
10748034|NCT02982772|11911927|FG000|STARTED|Intervention||245
10748035|NCT02982772|11911928|FG001|STARTED|Intervention||243
10748036|NCT02982772|11911927|FG000|COMPLETED|Intervention||226
10748037|NCT02982772|11911928|FG001|COMPLETED|Intervention||230
10748038|NCT02982772|11911927|FG000|NOT COMPLETED|Intervention||19
10748039|NCT02982772|11911928|FG001|NOT COMPLETED|Intervention||13
10748040|NCT02982772|11911927|FG000|STARTED|1M Follow-Up||226
10748041|NCT02982772|11911928|FG001|STARTED|1M Follow-Up||230
10818062|NCT01102140|11982051|FG001|STARTED|Overall Study||7
10818063|NCT01102140|11982050|FG000|COMPLETED|Overall Study||10
10818064|NCT01102140|11982051|FG001|COMPLETED|Overall Study||5
10818065|NCT01102140|11982050|FG000|NOT COMPLETED|Overall Study||3
10818066|NCT01102140|11982051|FG001|NOT COMPLETED|Overall Study||2
10818067|NCT01095250|11982063|FG000|STARTED|Overall Study||8
10818068|NCT01095250|11982064|FG001|STARTED|Overall Study||10
10818069|NCT01095250|11982065|FG002|STARTED|Overall Study||8
10818070|NCT01095250|11982066|FG003|STARTED|Overall Study||5
10818071|NCT01095250|11982063|FG000|COMPLETED|Overall Study||0
10818072|NCT01095250|11982064|FG001|COMPLETED|Overall Study||0
10818073|NCT01095250|11982065|FG002|COMPLETED|Overall Study||0
10818074|NCT01095250|11982066|FG003|COMPLETED|Overall Study||0
10818075|NCT01095250|11982063|FG000|NOT COMPLETED|Overall Study||8
10818076|NCT01095250|11982064|FG001|NOT COMPLETED|Overall Study||10
10818077|NCT01095250|11982065|FG002|NOT COMPLETED|Overall Study||8
10818078|NCT01095250|11982066|FG003|NOT COMPLETED|Overall Study||5
10818079|NCT01094561|11982076|FG000|STARTED|Overall Study||23
10818080|NCT01094561|11982076|FG000|COMPLETED|Overall Study||17
10818081|NCT01094561|11982076|FG000|NOT COMPLETED|Overall Study||6
10818082|NCT01093846|11982083|FG000|STARTED|Overall Study||19
10818083|NCT01093846|11982084|FG001|STARTED|Overall Study||18
10818084|NCT01093846|11982085|FG002|STARTED|Overall Study||22
10818085|NCT01093846|11982083|FG000|COMPLETED|Overall Study||0
10818086|NCT01093846|11982084|FG001|COMPLETED|Overall Study||0
10818087|NCT01093846|11982085|FG002|COMPLETED|Overall Study||1
10818088|NCT01093846|11982083|FG000|NOT COMPLETED|Overall Study||19
10818089|NCT01093846|11982084|FG001|NOT COMPLETED|Overall Study||18
10818090|NCT01093846|11982085|FG002|NOT COMPLETED|Overall Study||21
10818091|NCT01078844|11982091|FG000|STARTED|Overall Study||4
10818092|NCT01078844|11982091|FG000|COMPLETED|Overall Study||0
10818093|NCT01078844|11982091|FG000|NOT COMPLETED|Overall Study||4
10818094|NCT01081886|11982098|FG000|STARTED|Overall Study||11
10818095|NCT01081886|11982099|FG001|STARTED|Overall Study||13
10818096|NCT01081886|11982098|FG000|COMPLETED|Overall Study||0
10748042|NCT02982772|11911927|FG000|COMPLETED|1M Follow-Up||205
10748043|NCT02982772|11911928|FG001|COMPLETED|1M Follow-Up||212
10748044|NCT02982772|11911927|FG000|NOT COMPLETED|1M Follow-Up||21
10748045|NCT02982772|11911928|FG001|NOT COMPLETED|1M Follow-Up||18
10748046|NCT02982772|11911927|FG000|STARTED|3M Follow-Up||205
10748047|NCT02982772|11911928|FG001|STARTED|3M Follow-Up||212
10748048|NCT02982772|11911927|FG000|COMPLETED|3M Follow-Up||188
10748049|NCT02982772|11911928|FG001|COMPLETED|3M Follow-Up||201
10748050|NCT02982772|11911927|FG000|NOT COMPLETED|3M Follow-Up||17
10748051|NCT02982772|11911928|FG001|NOT COMPLETED|3M Follow-Up||11
10748052|NCT02982772|11911927|FG000|STARTED|6M Follow-Up||188
10748053|NCT02982772|11911928|FG001|STARTED|6M Follow-Up||201
10818097|NCT01081886|11982099|FG001|COMPLETED|Overall Study||0
10818098|NCT01081886|11982098|FG000|NOT COMPLETED|Overall Study||11
10818099|NCT01081886|11982099|FG001|NOT COMPLETED|Overall Study||13
10818100|NCT01085643|11982105|FG000|STARTED|Overall Study||4
10818101|NCT01085643|11982105|FG000|COMPLETED|Overall Study||4
10818102|NCT01085643|11982105|FG000|NOT COMPLETED|Overall Study||0
10748054|NCT02982772|11911927|FG000|COMPLETED|6M Follow-Up||177
10748055|NCT02982772|11911928|FG001|COMPLETED|6M Follow-Up||192
10748056|NCT02982772|11911927|FG000|NOT COMPLETED|6M Follow-Up||11
10748057|NCT02982772|11911928|FG001|NOT COMPLETED|6M Follow-Up||9
10748058|NCT02982772|11911927|FG000|STARTED|12M Follow-Up||177
10748059|NCT02982772|11911928|FG001|STARTED|12M Follow-Up||192
10748060|NCT02982772|11911927|FG000|COMPLETED|12M Follow-Up||166
10748061|NCT02982772|11911928|FG001|COMPLETED|12M Follow-Up||187
10748062|NCT02982772|11911927|FG000|NOT COMPLETED|12M Follow-Up||11
10748063|NCT02982772|11911928|FG001|NOT COMPLETED|12M Follow-Up||5
10748064|NCT02982863|11911941|FG000|STARTED|Overall Study||5745
10748065|NCT02982863|11911942|FG001|STARTED|Overall Study||16745
10748066|NCT02982863|11911943|FG002|STARTED|Overall Study||13238
10748067|NCT02982863|11911944|FG003|STARTED|Overall Study||10158
10748068|NCT02982863|11911945|FG004|STARTED|Overall Study||2760
10748069|NCT02982863|11911941|FG000|COMPLETED|Overall Study||4936
10748070|NCT02982863|11911942|FG001|COMPLETED|Overall Study||12484
10748071|NCT02982863|11911943|FG002|COMPLETED|Overall Study||11386
10748072|NCT02982863|11911944|FG003|COMPLETED|Overall Study||8758
10748073|NCT02982863|11911945|FG004|COMPLETED|Overall Study||2268
10748074|NCT02982863|11911941|FG000|NOT COMPLETED|Overall Study||809
10748075|NCT02982863|11911942|FG001|NOT COMPLETED|Overall Study||4261
10748076|NCT02982863|11911943|FG002|NOT COMPLETED|Overall Study||1852
10748077|NCT02982863|11911944|FG003|NOT COMPLETED|Overall Study||1400
10748078|NCT02982863|11911945|FG004|NOT COMPLETED|Overall Study||492
10748079|NCT02982928|11911961|FG000|STARTED|Overall Study||11
10748080|NCT02982928|11911961|FG000|COMPLETED|Overall Study||11
10748081|NCT02982928|11911961|FG000|NOT COMPLETED|Overall Study||0
10818103|NCT01083472|11982111|FG000|STARTED|Overall Study||18
10818104|NCT01083472|11982112|FG001|STARTED|Overall Study||19
10818105|NCT01083472|11982111|FG000|COMPLETED|Overall Study||18
10818106|NCT01083472|11982112|FG001|COMPLETED|Overall Study||19
10818107|NCT01083472|11982111|FG000|NOT COMPLETED|Overall Study||0
10818108|NCT01083472|11982112|FG001|NOT COMPLETED|Overall Study||0
10818109|NCT01080768|11982120|FG000|STARTED|Overall Study||14
10818110|NCT01080768|11982121|FG001|STARTED|Overall Study||17
10818111|NCT01080768|11982120|FG000|COMPLETED|Overall Study||12
10818112|NCT01080768|11982121|FG001|COMPLETED|Overall Study||16
10818113|NCT01080768|11982120|FG000|NOT COMPLETED|Overall Study||2
10818114|NCT01080768|11982121|FG001|NOT COMPLETED|Overall Study||1
10818115|NCT01079598|11982127|FG000|STARTED|Overall Study||8
10818116|NCT01079598|11982127|FG000|COMPLETED|Overall Study||8
10818117|NCT01079598|11982127|FG000|NOT COMPLETED|Overall Study||0
10818118|NCT01074502|11982131|FG000|STARTED|Overall Study||3
10818119|NCT01074502|11982131|FG000|COMPLETED|Overall Study||2
10818120|NCT01074502|11982131|FG000|NOT COMPLETED|Overall Study||1
10818121|NCT01074437|11982137|FG000|STARTED|Overall Study||4
10818122|NCT01074437|11982138|FG001|STARTED|Overall Study||5
10818123|NCT01074437|11982137|FG000|COMPLETED|Overall Study||4
10818124|NCT01074437|11982138|FG001|COMPLETED|Overall Study||5
10818125|NCT01074437|11982137|FG000|NOT COMPLETED|Overall Study||0
10818126|NCT01074437|11982138|FG001|NOT COMPLETED|Overall Study||0
10818127|NCT01069861|11982144|FG000|STARTED|Overall Study||4
10818128|NCT01069861|11982144|FG000|COMPLETED|Overall Study||1
10818129|NCT01069861|11982144|FG000|NOT COMPLETED|Overall Study||3
10818130|NCT01072526|11982148|FG000|STARTED|Overall Study|Study started in December 2007 (recruited 6 patients total of 20 anticipated)|6
10818131|NCT01072526|11982149|FG001|STARTED|Overall Study||0
10818132|NCT01072526|11982148|FG000|COMPLETED|Overall Study|Study completed in September 2008(recruited 6 patients total of 20 anticipated)|6
10818133|NCT01072526|11982149|FG001|COMPLETED|Overall Study||0
10818134|NCT01072526|11982148|FG000|NOT COMPLETED|Overall Study||0
10818135|NCT01072526|11982149|FG001|NOT COMPLETED|Overall Study||0
10818136|NCT01071993|11982159|FG000|STARTED|Overall Study||0
10818137|NCT01071993|11982160|FG001|STARTED|Overall Study||0
10818138|NCT01071993|11982159|FG000|COMPLETED|Overall Study||0
10818139|NCT01071993|11982160|FG001|COMPLETED|Overall Study||0
10818140|NCT01071993|11982159|FG000|NOT COMPLETED|Overall Study||0
10748082|NCT02983058|11911967|FG000|STARTED|Overall Study||7
10748083|NCT02983058|11911968|FG001|STARTED|Overall Study||5
10818141|NCT01071993|11982160|FG001|NOT COMPLETED|Overall Study||0
10818142|NCT01065051|11982168|FG000|STARTED|Overall Study||1
10818143|NCT01065051|11982169|FG001|STARTED|Overall Study||0
10818144|NCT01065051|11982168|FG000|COMPLETED|Overall Study||1
10818145|NCT01065051|11982169|FG001|COMPLETED|Overall Study||0
10818146|NCT01065051|11982168|FG000|NOT COMPLETED|Overall Study||0
10818147|NCT01065051|11982169|FG001|NOT COMPLETED|Overall Study||0
10818148|NCT01069120|11982177|FG000|STARTED|Overall Study||27
10818149|NCT01069120|11982177|FG000|COMPLETED|Overall Study||0
10818150|NCT01069120|11982177|FG000|NOT COMPLETED|Overall Study||27
10818151|NCT01066637|11982185|FG000|STARTED|Overall Study||16
10818152|NCT01066637|11982186|FG001|STARTED|Overall Study||10
10818153|NCT01066637|11982185|FG000|COMPLETED|Overall Study||16
10818154|NCT01066637|11982186|FG001|COMPLETED|Overall Study||10
10818155|NCT01066637|11982185|FG000|NOT COMPLETED|Overall Study||0
10818156|NCT01066637|11982186|FG001|NOT COMPLETED|Overall Study||0
10818157|NCT01058642|11982196|FG000|STARTED|Treatment Period 1||9
10818158|NCT01058642|11982197|FG001|STARTED|Treatment Period 1||12
10818159|NCT01058642|11982198|FG002|STARTED|Treatment Period 1||11
10818160|NCT01058642|11982199|FG003|STARTED|Treatment Period 1||9
10748084|NCT02983058|11911967|FG000|COMPLETED|Overall Study||2
10748085|NCT02983058|11911968|FG001|COMPLETED|Overall Study||2
10748086|NCT02983058|11911967|FG000|NOT COMPLETED|Overall Study||5
10748087|NCT02983058|11911968|FG001|NOT COMPLETED|Overall Study||3
10748088|NCT02983227|11911976|FG000|STARTED|Overall Study||410
10748089|NCT02983227|11911977|FG001|STARTED|Overall Study||86
10748090|NCT02983227|11911976|FG000|COMPLETED|Overall Study||351
10748091|NCT02983227|11911977|FG001|COMPLETED|Overall Study||72
10748092|NCT02983227|11911976|FG000|NOT COMPLETED|Overall Study||59
10748093|NCT02983227|11911977|FG001|NOT COMPLETED|Overall Study||14
10748094|NCT02983305|11911985|FG000|STARTED|Overall Study||12
10748095|NCT02983305|11911986|FG001|STARTED|Overall Study||10
10748096|NCT02983305|11911985|FG000|COMPLETED|Overall Study||10
10748097|NCT02983305|11911986|FG001|COMPLETED|Overall Study||10
10748098|NCT02983305|11911985|FG000|NOT COMPLETED|Overall Study||2
10748099|NCT02983305|11911986|FG001|NOT COMPLETED|Overall Study||0
10748100|NCT02983448|11911992|FG000|STARTED|Overall Study||12
10748101|NCT02983448|11911993|FG001|STARTED|Overall Study||12
10748102|NCT02983448|11911992|FG000|COMPLETED|Overall Study||12
10748103|NCT02983448|11911993|FG001|COMPLETED|Overall Study||12
10748104|NCT02983448|11911992|FG000|NOT COMPLETED|Overall Study||0
10748105|NCT02983448|11911993|FG001|NOT COMPLETED|Overall Study||0
10778413|NCT03355326|11940351|FG001|NOT COMPLETED|Overall Study||3
10778414|NCT03355742|11940357|FG000|STARTED|Overall Study||963
10778415|NCT03355742|11940357|FG000|COMPLETED|Overall Study||864
10778416|NCT03355742|11940357|FG000|NOT COMPLETED|Overall Study||99
10778417|NCT03355820|11940361|FG000|STARTED|Overall Study||227
10778418|NCT03355820|11940361|FG000|COMPLETED|Overall Study||227
10778419|NCT03355820|11940361|FG000|NOT COMPLETED|Overall Study||0
10778420|NCT03356145|11940367|FG000|STARTED|Overall Study||48
10778421|NCT03356145|11940368|FG001|STARTED|Overall Study||48
10778422|NCT03356145|11940367|FG000|Received Allocated Intervention|Overall Study||45
10778423|NCT03356145|11940368|FG001|Received Allocated Intervention|Overall Study||47
10778424|NCT03356145|11940367|FG000|COMPLETED|Overall Study||45
10778425|NCT03356145|11940368|FG001|COMPLETED|Overall Study||47
10778426|NCT03356145|11940367|FG000|NOT COMPLETED|Overall Study||3
10778427|NCT03356145|11940368|FG001|NOT COMPLETED|Overall Study||1
10778428|NCT03356977|11940374|FG000|STARTED|Overall Study||137
10778429|NCT03356977|11940374|FG000|COMPLETED|Overall Study||132
10778430|NCT03356977|11940374|FG000|NOT COMPLETED|Overall Study||5
10778431|NCT03357341|11940380|FG000|STARTED|Overall Study||96
10778432|NCT03357341|11940381|FG001|STARTED|Overall Study||98
10778433|NCT03357341|11940380|FG000|COMPLETED|Overall Study||89
10778434|NCT03357341|11940381|FG001|COMPLETED|Overall Study||86
10778435|NCT03357341|11940380|FG000|NOT COMPLETED|Overall Study||7
10778436|NCT03357341|11940381|FG001|NOT COMPLETED|Overall Study||12
10778437|NCT03357393|11940391|FG000|STARTED|Overall Study||50
10778438|NCT03357393|11940392|FG001|STARTED|Overall Study||50
10778439|NCT03357393|11940393|FG002|STARTED|Overall Study||50
10778440|NCT03357393|11940391|FG000|COMPLETED|Overall Study||50
10778441|NCT03357393|11940392|FG001|COMPLETED|Overall Study||50
10778442|NCT03357393|11940393|FG002|COMPLETED|Overall Study||50
10778443|NCT03357393|11940391|FG000|NOT COMPLETED|Overall Study||0
10778444|NCT03357393|11940392|FG001|NOT COMPLETED|Overall Study||0
10778445|NCT03357393|11940393|FG002|NOT COMPLETED|Overall Study||0
10778446|NCT03357471|11940403|FG000|STARTED|Overall Study||35
10778447|NCT03357471|11940404|FG001|STARTED|Overall Study||32
10778448|NCT03357471|11940403|FG000|COMPLETED|Overall Study||33
10778449|NCT03357471|11940404|FG001|COMPLETED|Overall Study||32
10778450|NCT03357471|11940403|FG000|NOT COMPLETED|Overall Study||2
10778451|NCT03357471|11940404|FG001|NOT COMPLETED|Overall Study||0
10778452|NCT03357614|11940412|FG000|STARTED|Overall Study||697
10778453|NCT03357614|11940413|FG001|STARTED|Overall Study||698
10778454|NCT03357614|11940412|FG000|COMPLETED|Overall Study||672
10778455|NCT03357614|11940413|FG001|COMPLETED|Overall Study||670
10778456|NCT03357614|11940412|FG000|NOT COMPLETED|Overall Study||25
10778457|NCT03357614|11940413|FG001|NOT COMPLETED|Overall Study||28
10778458|NCT03357731|11940419|FG000|STARTED|Overall Study||8
10778459|NCT03357731|11940420|FG001|STARTED|Overall Study||7
10778460|NCT03357731|11940421|FG002|STARTED|Overall Study||7
10778461|NCT03357731|11940422|FG003|STARTED|Overall Study||7
10778462|NCT03357731|11940423|FG004|STARTED|Overall Study||8
10778463|NCT03357731|11940424|FG005|STARTED|Overall Study||8
10778464|NCT03357731|11940419|FG000|Completed Period 1 (P1)|Overall Study|1 withdrew post-P1 completion/prior to P2 therapy due to acute cholecystitis, but returned for P2/P3|8
10778465|NCT03357731|11940420|FG001|Completed Period 1 (P1)|Overall Study||7
10778466|NCT03357731|11940421|FG002|Completed Period 1 (P1)|Overall Study||7
10778467|NCT03357731|11940422|FG003|Completed Period 1 (P1)|Overall Study|1 discontinued P1 due to acute bradycardia and hypotension|6
10778468|NCT03357731|11940423|FG004|Completed Period 1 (P1)|Overall Study|1 discontinued P1 due to hypotension but resumed P2/P3|7
10778469|NCT03357731|11940424|FG005|Completed Period 1 (P1)|Overall Study||8
10778470|NCT03357731|11940419|FG000|Completed Period 2 (P2)|Overall Study||8
10778471|NCT03357731|11940420|FG001|Completed Period 2 (P2)|Overall Study||7
10778472|NCT03357731|11940421|FG002|Completed Period 2 (P2)|Overall Study||7
10778473|NCT03357731|11940422|FG003|Completed Period 2 (P2)|Overall Study|"1 completed P1, did not proceed to P2/P3 (lost to follow-up);~1 discontinued P2 due to hypotension"|4
10778474|NCT03357731|11940423|FG004|Completed Period 2 (P2)|Overall Study|1 only completed P1, did not continue to P2/P3 (withdrew consent due to personal reasons)|7
10778475|NCT03357731|11940424|FG005|Completed Period 2 (P2)|Overall Study|1 discontinued P2 due to an Adverse Event (AE)|7
10778476|NCT03357731|11940419|FG000|COMPLETED|Overall Study||8
10748106|NCT02983552|11912005|FG000|STARTED|Overall Study||69
10748107|NCT02983552|11912006|FG001|STARTED|Overall Study||69
10748108|NCT02983552|11912007|FG002|STARTED|Overall Study||92
10748109|NCT02983552|11912008|FG003|STARTED|Overall Study||90
10748110|NCT02983552|11912005|FG000|4 Week Visit|Overall Study||69
10748111|NCT02983552|11912006|FG001|4 Week Visit|Overall Study||67
10748112|NCT02983552|11912007|FG002|4 Week Visit|Overall Study||85
10748113|NCT02983552|11912008|FG003|4 Week Visit|Overall Study||84
10748114|NCT02983552|11912005|FG000|8 Week Visit|Overall Study||67
10748115|NCT02983552|11912006|FG001|8 Week Visit|Overall Study||68
10748116|NCT02983552|11912007|FG002|8 Week Visit|Overall Study||85
10748117|NCT02983552|11912008|FG003|8 Week Visit|Overall Study||84
10748118|NCT02983552|11912005|FG000|16 Week Visit|Overall Study|The 16 week visit was elective for those who were originally assigned to continued spectacle correction. After completing 8 weeks of continued spectacle correction, participants were able to complete 8 weeks of binocular therapy. Values are not provided for the binocular computer game treatment cohorts as this visit was not applicable.|0
10748119|NCT02983552|11912006|FG001|16 Week Visit|Overall Study||66
10748120|NCT02983552|11912007|FG002|16 Week Visit|Overall Study|The 16 week visit was elective for those who were originally assigned to continued spectacle correction. After completing 8 weeks of continued spectacle correction, participants were able to complete 8 weeks of binocular therapy. Values are not provided for the binocular computer game treatment cohorts as this visit was not applicable.|0
10748121|NCT02983552|11912008|FG003|16 Week Visit|Overall Study||72
10818161|NCT01058642|11982196|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
10818162|NCT01058642|11982197|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1||12
10818163|NCT01058642|11982198|FG002|Received at Least 1 Dose of Study Drug|Treatment Period 1||11
10818164|NCT01058642|11982199|FG003|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
10818165|NCT01058642|11982196|FG000|COMPLETED|Treatment Period 1||7
10818166|NCT01058642|11982197|FG001|COMPLETED|Treatment Period 1||11
10818167|NCT01058642|11982198|FG002|COMPLETED|Treatment Period 1||9
10818168|NCT01058642|11982199|FG003|COMPLETED|Treatment Period 1||7
10818169|NCT01058642|11982196|FG000|NOT COMPLETED|Treatment Period 1||2
10818170|NCT01058642|11982197|FG001|NOT COMPLETED|Treatment Period 1||1
10818171|NCT01058642|11982198|FG002|NOT COMPLETED|Treatment Period 1||2
10818172|NCT01058642|11982199|FG003|NOT COMPLETED|Treatment Period 1||2
10818173|NCT01058642|11982196|FG000|STARTED|Washout Period||7
10818174|NCT01058642|11982197|FG001|STARTED|Washout Period||11
10818175|NCT01058642|11982198|FG002|STARTED|Washout Period||9
10818176|NCT01058642|11982199|FG003|STARTED|Washout Period||7
10818177|NCT01058642|11982196|FG000|COMPLETED|Washout Period||7
10818178|NCT01058642|11982197|FG001|COMPLETED|Washout Period||11
10818179|NCT01058642|11982198|FG002|COMPLETED|Washout Period||9
10818180|NCT01058642|11982199|FG003|COMPLETED|Washout Period||7
10818181|NCT01058642|11982196|FG000|NOT COMPLETED|Washout Period||0
10818182|NCT01058642|11982197|FG001|NOT COMPLETED|Washout Period||0
10818183|NCT01058642|11982198|FG002|NOT COMPLETED|Washout Period||0
10818184|NCT01058642|11982199|FG003|NOT COMPLETED|Washout Period||0
10818185|NCT01058642|11982196|FG000|STARTED|Treatment Period 2||7
10818186|NCT01058642|11982197|FG001|STARTED|Treatment Period 2||11
10818187|NCT01058642|11982198|FG002|STARTED|Treatment Period 2||9
10818188|NCT01058642|11982199|FG003|STARTED|Treatment Period 2||7
10818189|NCT01058642|11982196|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 2||7
10818190|NCT01058642|11982197|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 2||11
10818191|NCT01058642|11982198|FG002|Received at Least 1 Dose of Study Drug|Treatment Period 2||9
10818192|NCT01058642|11982199|FG003|Received at Least 1 Dose of Study Drug|Treatment Period 2||7
10818193|NCT01058642|11982196|FG000|COMPLETED|Treatment Period 2||7
10818194|NCT01058642|11982197|FG001|COMPLETED|Treatment Period 2||11
10818195|NCT01058642|11982198|FG002|COMPLETED|Treatment Period 2||9
10818196|NCT01058642|11982199|FG003|COMPLETED|Treatment Period 2||7
10818197|NCT01058642|11982196|FG000|NOT COMPLETED|Treatment Period 2||0
10818198|NCT01058642|11982197|FG001|NOT COMPLETED|Treatment Period 2||0
10818199|NCT01058642|11982198|FG002|NOT COMPLETED|Treatment Period 2||0
10818200|NCT01058642|11982199|FG003|NOT COMPLETED|Treatment Period 2||0
10818201|NCT01065818|11982207|FG000|STARTED|Overall Study||6
10818202|NCT01065818|11982207|FG000|COMPLETED|Overall Study||4
10818203|NCT01065818|11982207|FG000|NOT COMPLETED|Overall Study||2
10818204|NCT01051921|11982211|FG000|STARTED|Overall Study||67
10818205|NCT01051921|11982211|FG000|COMPLETED|Overall Study||37
10818206|NCT01051921|11982211|FG000|NOT COMPLETED|Overall Study||30
10818207|NCT01048125|11982217|FG000|STARTED|Overall Study||0
10818208|NCT01048125|11982218|FG001|STARTED|Overall Study||0
10818209|NCT01048125|11982217|FG000|COMPLETED|Overall Study||0
10818210|NCT01048125|11982218|FG001|COMPLETED|Overall Study||0
10818211|NCT01048125|11982217|FG000|NOT COMPLETED|Overall Study||0
10818212|NCT01048125|11982218|FG001|NOT COMPLETED|Overall Study||0
10818213|NCT01056315|11982226|FG000|STARTED|Overall Study||27
10818214|NCT01056315|11982227|FG001|STARTED|Overall Study||23
10818215|NCT01056315|11982226|FG000|COMPLETED|Overall Study||13
10748122|NCT02983552|11912005|FG000|COMPLETED|Overall Study||69
10748123|NCT02983552|11912006|FG001|COMPLETED|Overall Study||67
10748124|NCT02983552|11912007|FG002|COMPLETED|Overall Study||92
10748125|NCT02983552|11912008|FG003|COMPLETED|Overall Study||90
10748126|NCT02983552|11912005|FG000|NOT COMPLETED|Overall Study||0
10748127|NCT02983552|11912006|FG001|NOT COMPLETED|Overall Study||2
10748128|NCT02983552|11912007|FG002|NOT COMPLETED|Overall Study||0
10748129|NCT02983552|11912008|FG003|NOT COMPLETED|Overall Study||0
10748130|NCT02983604|11912026|FG000|STARTED|Overall Study||4
10748131|NCT02983604|11912027|FG001|STARTED|Overall Study||3
10748132|NCT02983604|11912028|FG002|STARTED|Overall Study||4
10748133|NCT02983604|11912029|FG003|STARTED|Overall Study||3
10748134|NCT02983604|11912026|FG000|COMPLETED|Overall Study||4
10748135|NCT02983604|11912027|FG001|COMPLETED|Overall Study||3
10748136|NCT02983604|11912028|FG002|COMPLETED|Overall Study||3
10748137|NCT02983604|11912029|FG003|COMPLETED|Overall Study||3
10748138|NCT02983604|11912026|FG000|NOT COMPLETED|Overall Study||0
10748139|NCT02983604|11912027|FG001|NOT COMPLETED|Overall Study||0
10748140|NCT02983604|11912028|FG002|NOT COMPLETED|Overall Study||1
10748141|NCT02983604|11912029|FG003|NOT COMPLETED|Overall Study||0
10748142|NCT02983825|11912039|FG000|STARTED|Overall Study|Of 21 enrolled subjects, 9 became ineligible for between consent and intervention|12
10748143|NCT02983825|11912039|FG000|COMPLETED|Overall Study|Of 12 subjects starting intervention, 3 met specified stopping critieria|9
10748144|NCT02983825|11912039|FG000|NOT COMPLETED|Overall Study||3
10748145|NCT02983877|11912043|FG000|STARTED|Overall Study||38
10748146|NCT02983877|11912043|FG000|COMPLETED|Overall Study||38
10748147|NCT02983877|11912043|FG000|NOT COMPLETED|Overall Study||0
10748148|NCT02983981|11912048|FG000|STARTED|Overall Study||20
10818216|NCT01056315|11982227|FG001|COMPLETED|Overall Study||12
10818217|NCT01056315|11982226|FG000|NOT COMPLETED|Overall Study||14
10818218|NCT01056315|11982227|FG001|NOT COMPLETED|Overall Study||11
10748149|NCT02983981|11912048|FG000|COMPLETED|Overall Study||20
10748150|NCT02983981|11912048|FG000|NOT COMPLETED|Overall Study||0
10748151|NCT02984267|11912054|FG000|STARTED|Overall Study||8
10748152|NCT02984267|11912055|FG001|STARTED|Overall Study||10
10748153|NCT02984267|11912054|FG000|COMPLETED|Overall Study||7
10748154|NCT02984267|11912055|FG001|COMPLETED|Overall Study||9
10748155|NCT02984267|11912054|FG000|NOT COMPLETED|Overall Study||1
10748156|NCT02984267|11912055|FG001|NOT COMPLETED|Overall Study||1
10748157|NCT02984644|11912063|FG000|STARTED|Overall Study||20
10748158|NCT02984644|11912064|FG001|STARTED|Overall Study||10
10748159|NCT02984644|11912063|FG000|COMPLETED|Overall Study||20
10748160|NCT02984644|11912064|FG001|COMPLETED|Overall Study||10
10748161|NCT02984644|11912063|FG000|NOT COMPLETED|Overall Study||0
10748162|NCT02984644|11912064|FG001|NOT COMPLETED|Overall Study||0
10748163|NCT02984683|11912093|FG000|STARTED|Overall Study||11
10748164|NCT02984683|11912094|FG001|STARTED|Overall Study||12
10748165|NCT02984683|11912093|FG000|COMPLETED|Overall Study||0
10748166|NCT02984683|11912094|FG001|COMPLETED|Overall Study||0
10748167|NCT02984683|11912093|FG000|NOT COMPLETED|Overall Study||11
10818219|NCT01058369|11982233|FG000|STARTED|Overall Study||2
10818220|NCT01058369|11982233|FG000|COMPLETED|Overall Study||0
10818221|NCT01058369|11982233|FG000|NOT COMPLETED|Overall Study||2
10818222|NCT01048723|11982237|FG000|STARTED|Overall Study||2
10818223|NCT01048723|11982237|FG000|COMPLETED|Overall Study||2
10818224|NCT01048723|11982237|FG000|NOT COMPLETED|Overall Study||0
10818225|NCT01053221|11982243|FG000|STARTED|Overall Study||5
10818226|NCT01053221|11982244|FG001|STARTED|Overall Study||9
10818227|NCT01053221|11982243|FG000|COMPLETED|Overall Study||0
10818228|NCT01053221|11982244|FG001|COMPLETED|Overall Study||0
10818229|NCT01053221|11982243|FG000|NOT COMPLETED|Overall Study||5
10818230|NCT01053221|11982244|FG001|NOT COMPLETED|Overall Study||9
10818231|NCT01038752|11982252|FG000|STARTED|Overall Study||8
10818232|NCT01038752|11982253|FG001|STARTED|Overall Study||6
10818233|NCT01038752|11982252|FG000|COMPLETED|Overall Study||3
10818234|NCT01038752|11982253|FG001|COMPLETED|Overall Study||1
10818235|NCT01038752|11982252|FG000|NOT COMPLETED|Overall Study||5
10818236|NCT01038752|11982253|FG001|NOT COMPLETED|Overall Study||5
10818237|NCT01050218|11982259|FG000|STARTED|Overall Study||237
10818238|NCT01050218|11982259|FG000|COMPLETED|Overall Study||142
10748168|NCT02984683|11912094|FG001|NOT COMPLETED|Overall Study||12
10748169|NCT02984709|11912102|FG000|STARTED|Overall Study|We enrolled 24 adolescent-parent dyads.|24
10748170|NCT02984709|11912103|FG001|STARTED|Overall Study|We enrolled 24 adolescent-parent dyads.|24
10748171|NCT02984709|11912102|FG000|COMPLETED|Overall Study||24
10748172|NCT02984709|11912103|FG001|COMPLETED|Overall Study||24
10748173|NCT02984709|11912102|FG000|NOT COMPLETED|Overall Study||0
10748174|NCT02984709|11912103|FG001|NOT COMPLETED|Overall Study||0
10748175|NCT02984878|11912113|FG000|STARTED|Overall Study||30
10748176|NCT02984878|11912114|FG001|STARTED|Overall Study||41
10748177|NCT02984878|11912113|FG000|COMPLETED|Overall Study||30
10748178|NCT02984878|11912114|FG001|COMPLETED|Overall Study||41
10748179|NCT02984878|11912113|FG000|NOT COMPLETED|Overall Study||0
10818239|NCT01050218|11982259|FG000|NOT COMPLETED|Overall Study||95
10818240|NCT01045694|11982263|FG000|STARTED|Overall Study||8
10818241|NCT01045694|11982263|FG000|COMPLETED|Overall Study||6
10748180|NCT02984878|11912114|FG001|NOT COMPLETED|Overall Study||0
10748181|NCT02984943|11912123|FG000|STARTED|Overall Study||14
10748182|NCT02984943|11912123|FG000|COMPLETED|Overall Study||10
10748183|NCT02984943|11912123|FG000|NOT COMPLETED|Overall Study||4
10748184|NCT02984982|11912129|FG000|STARTED|Overall Study||102
10818242|NCT01045694|11982263|FG000|NOT COMPLETED|Overall Study||2
10818243|NCT01035944|11982271|FG000|STARTED|Overall Study||14
10748185|NCT02984982|11912130|FG001|STARTED|Overall Study||104
10748186|NCT02984982|11912129|FG000|Treated|Overall Study||102
10748187|NCT02984982|11912130|FG001|Treated|Overall Study||103
10748188|NCT02984982|11912129|FG000|COMPLETED|Overall Study||94
10748189|NCT02984982|11912130|FG001|COMPLETED|Overall Study||94
10748190|NCT02984982|11912129|FG000|NOT COMPLETED|Overall Study||8
10748191|NCT02984982|11912130|FG001|NOT COMPLETED|Overall Study||10
10748192|NCT02984995|11912139|FG000|STARTED|Overall Study||34
10748193|NCT02984995|11912140|FG001|STARTED|Overall Study||3
10748194|NCT02984995|11912139|FG000|COMPLETED|Overall Study||9
10748195|NCT02984995|11912140|FG001|COMPLETED|Overall Study||0
10748196|NCT02984995|11912139|FG000|NOT COMPLETED|Overall Study||25
10748197|NCT02984995|11912140|FG001|NOT COMPLETED|Overall Study||3
10748198|NCT02985021|11912152|FG000|STARTED|Overall Study||2
10748199|NCT02985021|11912152|FG000|COMPLETED|Overall Study||1
10748200|NCT02985021|11912152|FG000|NOT COMPLETED|Overall Study||1
10748201|NCT02985398|11912156|FG000|STARTED|Overall Study||128
10748202|NCT02985398|11912156|FG000|Participants Treated|Overall Study||128
10748203|NCT02985398|11912156|FG000|COMPLETED|Overall Study||106
10748204|NCT02985398|11912156|FG000|NOT COMPLETED|Overall Study||22
10748205|NCT02985450|11912160|FG000|STARTED|Overall Study||82
10748206|NCT02985450|11912160|FG000|COMPLETED|Overall Study||75
10748207|NCT02985450|11912160|FG000|NOT COMPLETED|Overall Study||7
10748208|NCT02985710|11912169|FG000|STARTED|Overall Study||69
10748209|NCT02985710|11912170|FG001|STARTED|Overall Study||33
10748210|NCT02985710|11912169|FG000|COMPLETED|Overall Study||65
10748211|NCT02985710|11912170|FG001|COMPLETED|Overall Study||33
10748212|NCT02985710|11912169|FG000|NOT COMPLETED|Overall Study||4
10748213|NCT02985710|11912170|FG001|NOT COMPLETED|Overall Study||0
10748214|NCT02985827|11912178|FG000|STARTED|Overall Study||33
10748215|NCT02985827|11912179|FG001|STARTED|Overall Study||15
10748216|NCT02985827|11912178|FG000|COMPLETED|Overall Study||33
10748217|NCT02985827|11912179|FG001|COMPLETED|Overall Study||15
10748218|NCT02985827|11912178|FG000|NOT COMPLETED|Overall Study||0
10748219|NCT02985827|11912179|FG001|NOT COMPLETED|Overall Study||0
10748220|NCT02985879|11912188|FG000|STARTED|Overall Study||126
10748221|NCT02985879|11912189|FG001|STARTED|Overall Study||127
10748222|NCT02985879|11912190|FG002|STARTED|Overall Study||125
10748223|NCT02985879|11912188|FG000|COMPLETED|Overall Study||50
10748224|NCT02985879|11912189|FG001|COMPLETED|Overall Study||52
10748225|NCT02985879|11912190|FG002|COMPLETED|Overall Study||48
10748226|NCT02985879|11912188|FG000|NOT COMPLETED|Overall Study||76
10748227|NCT02985879|11912189|FG001|NOT COMPLETED|Overall Study||75
10748228|NCT02985879|11912190|FG002|NOT COMPLETED|Overall Study||77
10748229|NCT02985996|11912209|FG000|STARTED|Overall Study||5
10748230|NCT02985996|11912210|FG001|STARTED|Overall Study||8
10748231|NCT02985996|11912211|FG002|STARTED|Overall Study||10
10748232|NCT02985996|11912212|FG003|STARTED|Overall Study||7
10748233|NCT02985996|11912213|FG004|STARTED|Overall Study||9
10748234|NCT02985996|11912209|FG000|COMPLETED|Overall Study||5
10748235|NCT02985996|11912210|FG001|COMPLETED|Overall Study||7
10748236|NCT02985996|11912211|FG002|COMPLETED|Overall Study||9
10748237|NCT02985996|11912212|FG003|COMPLETED|Overall Study||7
10748238|NCT02985996|11912213|FG004|COMPLETED|Overall Study||9
10748239|NCT02985996|11912209|FG000|NOT COMPLETED|Overall Study||0
10748240|NCT02985996|11912210|FG001|NOT COMPLETED|Overall Study||1
10748241|NCT02985996|11912211|FG002|NOT COMPLETED|Overall Study||1
10748242|NCT02985996|11912212|FG003|NOT COMPLETED|Overall Study||0
10748243|NCT02985996|11912213|FG004|NOT COMPLETED|Overall Study||0
10748244|NCT02986074|11912229|FG000|STARTED|First Trial Period||26
10748245|NCT02986074|11912230|FG001|STARTED|First Trial Period||29
10748246|NCT02986074|11912231|FG002|STARTED|First Trial Period||0
10748247|NCT02986074|11912232|FG003|STARTED|First Trial Period||0
10748248|NCT02986074|11912229|FG000|COMPLETED|First Trial Period||25
10748249|NCT02986074|11912230|FG001|COMPLETED|First Trial Period||29
10748250|NCT02986074|11912231|FG002|COMPLETED|First Trial Period||0
10748251|NCT02986074|11912232|FG003|COMPLETED|First Trial Period||0
10748252|NCT02986074|11912229|FG000|NOT COMPLETED|First Trial Period||1
10748253|NCT02986074|11912230|FG001|NOT COMPLETED|First Trial Period||0
10748254|NCT02986074|11912231|FG002|NOT COMPLETED|First Trial Period||0
10748255|NCT02986074|11912232|FG003|NOT COMPLETED|First Trial Period||0
10748256|NCT02986074|11912229|FG000|STARTED|Second Trial Period||25
10748257|NCT02986074|11912230|FG001|STARTED|Second Trial Period||29
10748258|NCT02986074|11912231|FG002|STARTED|Second Trial Period||0
10748259|NCT02986074|11912232|FG003|STARTED|Second Trial Period||0
10748260|NCT02986074|11912229|FG000|COMPLETED|Second Trial Period||25
10748261|NCT02986074|11912230|FG001|COMPLETED|Second Trial Period||29
10748262|NCT02986074|11912231|FG002|COMPLETED|Second Trial Period||0
10748263|NCT02986074|11912232|FG003|COMPLETED|Second Trial Period||0
10818244|NCT01035944|11982272|FG001|STARTED|Overall Study||14
10818245|NCT01035944|11982273|FG002|STARTED|Overall Study||5
10818246|NCT01035944|11982274|FG003|STARTED|Overall Study||4
10818247|NCT01035944|11982271|FG000|COMPLETED|Overall Study||11
10748264|NCT02986074|11912229|FG000|NOT COMPLETED|Second Trial Period||0
10748265|NCT02986074|11912230|FG001|NOT COMPLETED|Second Trial Period||0
10748266|NCT02986074|11912231|FG002|NOT COMPLETED|Second Trial Period||0
10748267|NCT02986074|11912232|FG003|NOT COMPLETED|Second Trial Period||0
10748268|NCT02986074|11912229|FG000|STARTED|Follow up Period||0
10748269|NCT02986074|11912230|FG001|STARTED|Follow up Period||0
10748270|NCT02986074|11912231|FG002|STARTED|Follow up Period||21
10748271|NCT02986074|11912232|FG003|STARTED|Follow up Period||22
10748272|NCT02986074|11912229|FG000|3 Month Follow up|Follow up Period||0
10748273|NCT02986074|11912230|FG001|3 Month Follow up|Follow up Period||0
10748274|NCT02986074|11912231|FG002|3 Month Follow up|Follow up Period||21
10748275|NCT02986074|11912232|FG003|3 Month Follow up|Follow up Period||21
10748276|NCT02986074|11912229|FG000|6 Month Follow up|Follow up Period||0
10748277|NCT02986074|11912230|FG001|6 Month Follow up|Follow up Period||0
10748278|NCT02986074|11912231|FG002|6 Month Follow up|Follow up Period||21
10748279|NCT02986074|11912232|FG003|6 Month Follow up|Follow up Period||20
10748280|NCT02986074|11912229|FG000|COMPLETED|Follow up Period||0
10748281|NCT02986074|11912230|FG001|COMPLETED|Follow up Period||0
10748282|NCT02986074|11912231|FG002|COMPLETED|Follow up Period||20
10748283|NCT02986074|11912232|FG003|COMPLETED|Follow up Period||19
10748284|NCT02986074|11912229|FG000|NOT COMPLETED|Follow up Period||0
10748285|NCT02986074|11912230|FG001|NOT COMPLETED|Follow up Period||0
10748286|NCT02986074|11912231|FG002|NOT COMPLETED|Follow up Period||1
10748287|NCT02986074|11912232|FG003|NOT COMPLETED|Follow up Period||3
10748288|NCT02986139|11912239|FG000|STARTED|Overall Study||56
10748289|NCT02986139|11912240|FG001|STARTED|Overall Study||55
10748290|NCT02986139|11912239|FG000|Received Etanercept|Overall Study||56
10748291|NCT02986139|11912240|FG001|Received Etanercept|Overall Study||53
10748292|NCT02986139|11912239|FG000|COMPLETED|Overall Study||55
10748293|NCT02986139|11912240|FG001|COMPLETED|Overall Study||51
10748294|NCT02986139|11912239|FG000|NOT COMPLETED|Overall Study||1
10748295|NCT02986139|11912240|FG001|NOT COMPLETED|Overall Study||4
10748296|NCT02986282|11912250|FG000|STARTED|Overall Study||115
10748297|NCT02986282|11912250|FG000|COMPLETED|Overall Study||99
10748298|NCT02986282|11912250|FG000|NOT COMPLETED|Overall Study||16
10748299|NCT02986373|11912254|FG000|STARTED|Overall Study||145
10748300|NCT02986373|11912254|FG000|COMPLETED|Overall Study||106
10748301|NCT02986373|11912254|FG000|NOT COMPLETED|Overall Study||39
10748302|NCT02986711|11912260|FG000|STARTED|Overall Study||78
10748303|NCT02986711|11912261|FG001|STARTED|Overall Study||80
10748304|NCT02986711|11912260|FG000|COMPLETED|Overall Study||70
10748305|NCT02986711|11912261|FG001|COMPLETED|Overall Study||70
10748306|NCT02986711|11912260|FG000|NOT COMPLETED|Overall Study||8
10748307|NCT02986711|11912261|FG001|NOT COMPLETED|Overall Study||10
10748308|NCT02986802|11912271|FG000|STARTED|Overall Study||1360
10748309|NCT02986802|11912272|FG001|STARTED|Overall Study||2839
10748310|NCT02986802|11912273|FG002|STARTED|Overall Study||1873
10748311|NCT02986802|11912274|FG003|STARTED|Overall Study||83060
10748312|NCT02986802|11912271|FG000|COMPLETED|Overall Study||1360
10748313|NCT02986802|11912272|FG001|COMPLETED|Overall Study||2839
10748314|NCT02986802|11912273|FG002|COMPLETED|Overall Study||1873
10748315|NCT02986802|11912274|FG003|COMPLETED|Overall Study||83060
10748316|NCT02986802|11912271|FG000|NOT COMPLETED|Overall Study||0
10748317|NCT02986802|11912272|FG001|NOT COMPLETED|Overall Study||0
10748318|NCT02986802|11912273|FG002|NOT COMPLETED|Overall Study||0
10818248|NCT01035944|11982272|FG001|COMPLETED|Overall Study||13
10818249|NCT01035944|11982273|FG002|COMPLETED|Overall Study||4
10818250|NCT01035944|11982274|FG003|COMPLETED|Overall Study||4
10818251|NCT01035944|11982271|FG000|NOT COMPLETED|Overall Study||3
10818252|NCT01035944|11982272|FG001|NOT COMPLETED|Overall Study||1
10818253|NCT01035944|11982273|FG002|NOT COMPLETED|Overall Study||1
10818254|NCT01035944|11982274|FG003|NOT COMPLETED|Overall Study||0
10818255|NCT01031628|11982288|FG000|STARTED|Overall Study||0
10818256|NCT01031628|11982289|FG001|STARTED|Overall Study||1
10818257|NCT01031628|11982290|FG002|STARTED|Overall Study||3
10818258|NCT01031628|11982291|FG003|STARTED|Overall Study||0
10818259|NCT01031628|11982288|FG000|COMPLETED|Overall Study||0
10818260|NCT01031628|11982289|FG001|COMPLETED|Overall Study||0
10818261|NCT01031628|11982290|FG002|COMPLETED|Overall Study||0
10818262|NCT01031628|11982291|FG003|COMPLETED|Overall Study||0
10818263|NCT01031628|11982288|FG000|NOT COMPLETED|Overall Study||0
10818264|NCT01031628|11982289|FG001|NOT COMPLETED|Overall Study||1
10818265|NCT01031628|11982290|FG002|NOT COMPLETED|Overall Study||3
10818266|NCT01031628|11982291|FG003|NOT COMPLETED|Overall Study||0
10818267|NCT01030757|11982301|FG000|STARTED|Overall Study||2
10818268|NCT01030757|11982301|FG000|COMPLETED|Overall Study||2
10818269|NCT01030757|11982301|FG000|NOT COMPLETED|Overall Study||0
10818270|NCT01035073|11982305|FG000|STARTED|Overall Study||0
10818271|NCT01035073|11982305|FG000|COMPLETED|Overall Study||0
10818272|NCT01035073|11982305|FG000|NOT COMPLETED|Overall Study||0
10818273|NCT01031550|11982311|FG000|STARTED|Overall Study||5
10818274|NCT01031550|11982312|FG001|STARTED|Overall Study||3
10818275|NCT01031550|11982311|FG000|COMPLETED|Overall Study||5
10818276|NCT01031550|11982312|FG001|COMPLETED|Overall Study||3
10748319|NCT02986802|11912274|FG003|NOT COMPLETED|Overall Study||0
10748320|NCT02986854|11912287|FG000|STARTED|Overall Study||301
10748321|NCT02986854|11912288|FG001|STARTED|Overall Study||300
10748322|NCT02986854|11912289|FG002|STARTED|Overall Study||100
10748323|NCT02986854|11912287|FG000|COMPLETED|Overall Study||298
10748324|NCT02986854|11912288|FG001|COMPLETED|Overall Study||288
10748325|NCT02986854|11912289|FG002|COMPLETED|Overall Study||97
10748326|NCT02986854|11912287|FG000|NOT COMPLETED|Overall Study||3
10748327|NCT02986854|11912288|FG001|NOT COMPLETED|Overall Study||12
10748328|NCT02986854|11912289|FG002|NOT COMPLETED|Overall Study||3
10748329|NCT02986958|11912301|FG000|STARTED|Overall Study||49
10748330|NCT02986958|11912302|FG001|STARTED|Overall Study||44
10748331|NCT02986958|11912301|FG000|COMPLETED|Overall Study||49
10818277|NCT01031550|11982311|FG000|NOT COMPLETED|Overall Study||0
10748332|NCT02986958|11912302|FG001|COMPLETED|Overall Study||44
10748333|NCT02986958|11912301|FG000|NOT COMPLETED|Overall Study||0
10818278|NCT01031550|11982312|FG001|NOT COMPLETED|Overall Study||0
10748334|NCT02986958|11912302|FG001|NOT COMPLETED|Overall Study||0
10748335|NCT02987205|11912308|FG000|STARTED|Overall Study||163
10748336|NCT02987205|11912308|FG000|Treated - Bilateral NLF Injection|Overall Study||163
10748337|NCT02987205|11912308|FG000|COMPLETED|Overall Study|Treatment is bilateral, subject lost to Restylane AE was lost to further Revanesse Ultra treatment|159
10748338|NCT02987205|11912308|FG000|NOT COMPLETED|Overall Study||4
10748339|NCT02987231|11912316|FG000|STARTED|Overall Study||30
10748340|NCT02987231|11912317|FG001|STARTED|Overall Study||30
10748341|NCT02987231|11912316|FG000|COMPLETED|Overall Study||30
10748342|NCT02987231|11912317|FG001|COMPLETED|Overall Study||30
10748343|NCT02987231|11912316|FG000|NOT COMPLETED|Overall Study||0
10748344|NCT02987231|11912317|FG001|NOT COMPLETED|Overall Study||0
10748345|NCT02987374|11912323|FG000|STARTED|Overall Study||10
10748346|NCT02987374|11912323|FG000|COMPLETED|Overall Study||10
10748347|NCT02987374|11912323|FG000|NOT COMPLETED|Overall Study||0
10748348|NCT02987621|11912327|FG000|STARTED|Overall Study||7
10748349|NCT02987621|11912328|FG001|STARTED|Overall Study||7
10748350|NCT02987621|11912327|FG000|COMPLETED|Overall Study||7
10748351|NCT02987621|11912328|FG001|COMPLETED|Overall Study||7
10748352|NCT02987621|11912327|FG000|NOT COMPLETED|Overall Study||0
10748353|NCT02987621|11912328|FG001|NOT COMPLETED|Overall Study||0
10748354|NCT02987660|11912338|FG000|STARTED|Overall Study||10
10748355|NCT02987660|11912339|FG001|STARTED|Overall Study||10
10748356|NCT02987660|11912338|FG000|COMPLETED|Overall Study||0
10748357|NCT02987660|11912339|FG001|COMPLETED|Overall Study||0
10748358|NCT02987660|11912338|FG000|NOT COMPLETED|Overall Study||10
10748359|NCT02987660|11912339|FG001|NOT COMPLETED|Overall Study||10
10748360|NCT02987829|11912351|FG000|STARTED|Overall Study||1
10748361|NCT02987829|11912352|FG001|STARTED|Overall Study||1
10748362|NCT02987829|11912353|FG002|STARTED|Overall Study||2
10748363|NCT02987829|11912354|FG003|STARTED|Overall Study||7
10748364|NCT02987829|11912355|FG004|STARTED|Overall Study||51
10748365|NCT02987829|11912356|FG005|STARTED|Overall Study||10
10748366|NCT02987829|11912351|FG000|COMPLETED|Overall Study||1
10748367|NCT02987829|11912352|FG001|COMPLETED|Overall Study||1
10748368|NCT02987829|11912353|FG002|COMPLETED|Overall Study||2
10748369|NCT02987829|11912354|FG003|COMPLETED|Overall Study||7
10748370|NCT02987829|11912355|FG004|COMPLETED|Overall Study||51
10748371|NCT02987829|11912356|FG005|COMPLETED|Overall Study||10
10748372|NCT02987829|11912351|FG000|NOT COMPLETED|Overall Study||0
10748373|NCT02987829|11912352|FG001|NOT COMPLETED|Overall Study||0
10748374|NCT02987829|11912353|FG002|NOT COMPLETED|Overall Study||0
10748375|NCT02987829|11912354|FG003|NOT COMPLETED|Overall Study||0
10748376|NCT02987829|11912355|FG004|NOT COMPLETED|Overall Study||0
10748377|NCT02987829|11912356|FG005|NOT COMPLETED|Overall Study||0
10748378|NCT02987868|11912373|FG000|STARTED|First Intervention||8
10748379|NCT02987868|11912374|FG001|STARTED|First Intervention||8
10748380|NCT02987868|11912373|FG000|COMPLETED|First Intervention||8
10748381|NCT02987868|11912374|FG001|COMPLETED|First Intervention||8
10748382|NCT02987868|11912373|FG000|NOT COMPLETED|First Intervention||0
10748383|NCT02987868|11912374|FG001|NOT COMPLETED|First Intervention||0
10748384|NCT02987868|11912373|FG000|STARTED|Wash Out Period 1 Week||8
10748385|NCT02987868|11912374|FG001|STARTED|Wash Out Period 1 Week||8
10748386|NCT02987868|11912373|FG000|COMPLETED|Wash Out Period 1 Week||8
10748387|NCT02987868|11912374|FG001|COMPLETED|Wash Out Period 1 Week||8
10748388|NCT02987868|11912373|FG000|NOT COMPLETED|Wash Out Period 1 Week||0
10748389|NCT02987868|11912374|FG001|NOT COMPLETED|Wash Out Period 1 Week||0
10748390|NCT02987868|11912373|FG000|STARTED|Second Intervention||8
10748391|NCT02987868|11912374|FG001|STARTED|Second Intervention||8
10748392|NCT02987868|11912373|FG000|COMPLETED|Second Intervention||8
10748393|NCT02987868|11912374|FG001|COMPLETED|Second Intervention||8
10748394|NCT02987868|11912373|FG000|NOT COMPLETED|Second Intervention||0
10748395|NCT02987868|11912374|FG001|NOT COMPLETED|Second Intervention||0
10748396|NCT02987972|11912383|FG000|STARTED|Overall Study||351
10748397|NCT02987972|11912384|FG001|STARTED|Overall Study||350
10748398|NCT02987972|11912385|FG002|STARTED|Overall Study||350
10748399|NCT02987972|11912383|FG000|Vaccination 1|Overall Study||350
10748400|NCT02987972|11912384|FG001|Vaccination 1|Overall Study||347
10748401|NCT02987972|11912385|FG002|Vaccination 1|Overall Study||347
10748402|NCT02987972|11912383|FG000|Vaccination 2|Overall Study||333
10748403|NCT02987972|11912384|FG001|Vaccination 2|Overall Study||335
10748404|NCT02987972|11912385|FG002|Vaccination 2|Overall Study||335
10748405|NCT02987972|11912383|FG000|Vaccination 3|Overall Study||330
10748406|NCT02987972|11912384|FG001|Vaccination 3|Overall Study||331
10748407|NCT02987972|11912385|FG002|Vaccination 3|Overall Study||332
10748408|NCT02987972|11912383|FG000|Vaccination 4|Overall Study||310
10748409|NCT02987972|11912384|FG001|Vaccination 4|Overall Study||306
10748410|NCT02987972|11912385|FG002|Vaccination 4|Overall Study||311
10748411|NCT02987972|11912383|FG000|COMPLETED|Overall Study||308
10748412|NCT02987972|11912384|FG001|COMPLETED|Overall Study||305
10748413|NCT02987972|11912385|FG002|COMPLETED|Overall Study||308
10748414|NCT02987972|11912383|FG000|NOT COMPLETED|Overall Study||43
10748415|NCT02987972|11912384|FG001|NOT COMPLETED|Overall Study||45
10748416|NCT02987972|11912385|FG002|NOT COMPLETED|Overall Study||42
10748417|NCT02988050|11912395|FG000|STARTED|Overall Study||30
10748418|NCT02988050|11912396|FG001|STARTED|Overall Study||30
10748419|NCT02988050|11912395|FG000|COMPLETED|Overall Study||30
10748420|NCT02988050|11912396|FG001|COMPLETED|Overall Study||30
10748421|NCT02988050|11912395|FG000|NOT COMPLETED|Overall Study||0
10748422|NCT02988050|11912396|FG001|NOT COMPLETED|Overall Study||0
10748423|NCT02988115|11912404|FG000|STARTED|Overall Study||234
10748424|NCT02988115|11912405|FG001|STARTED|Overall Study||111
10748425|NCT02988115|11912404|FG000|COMPLETED|Overall Study||220
10748426|NCT02988115|11912405|FG001|COMPLETED|Overall Study||107
10748427|NCT02988115|11912404|FG000|NOT COMPLETED|Overall Study||14
10748428|NCT02988115|11912405|FG001|NOT COMPLETED|Overall Study||4
10748429|NCT02988193|11912413|FG000|STARTED|Overall Study||12
10748430|NCT02988193|11912414|FG001|STARTED|Overall Study||16
10748431|NCT02988193|11912413|FG000|COMPLETED|Overall Study||12
10748432|NCT02988193|11912414|FG001|COMPLETED|Overall Study||16
10748433|NCT02988193|11912413|FG000|NOT COMPLETED|Overall Study||0
10748434|NCT02988193|11912414|FG001|NOT COMPLETED|Overall Study||0
10748435|NCT02988219|11912422|FG000|STARTED|Overall Study||25
10748436|NCT02988219|11912423|FG001|STARTED|Overall Study||25
10748437|NCT02988219|11912422|FG000|COMPLETED|Overall Study||24
10748438|NCT02988219|11912423|FG001|COMPLETED|Overall Study||22
10748439|NCT02988219|11912422|FG000|NOT COMPLETED|Overall Study||1
10748440|NCT02988219|11912423|FG001|NOT COMPLETED|Overall Study||3
10748441|NCT02988349|11912431|FG000|STARTED|Overall Study||21
10748442|NCT02988349|11912432|FG001|STARTED|Overall Study||21
10748443|NCT02988349|11912431|FG000|COMPLETED|Overall Study||21
10748444|NCT02988349|11912432|FG001|COMPLETED|Overall Study||21
10748445|NCT02988349|11912431|FG000|NOT COMPLETED|Overall Study||0
10748446|NCT02988349|11912432|FG001|NOT COMPLETED|Overall Study||0
10748447|NCT02988622|11912438|FG000|STARTED|Overall Study||100
10748448|NCT02988622|11912438|FG000|COMPLETED|Overall Study||83
10748449|NCT02988622|11912438|FG000|NOT COMPLETED|Overall Study||17
10748450|NCT02988843|11912444|FG000|STARTED|Overall Study||1
10748451|NCT02988843|11912444|FG000|COMPLETED|Overall Study||1
10748452|NCT02988843|11912444|FG000|NOT COMPLETED|Overall Study||0
10748453|NCT02988856|11912448|FG000|STARTED|Overall Study||11
10748454|NCT02988856|11912448|FG000|COMPLETED|Overall Study||8
10748455|NCT02988856|11912448|FG000|NOT COMPLETED|Overall Study||3
10748456|NCT02988882|11912454|FG000|STARTED|Overall Study||44
10748457|NCT02988882|11912455|FG001|STARTED|Overall Study||42
10748458|NCT02988882|11912454|FG000|COMPLETED|Overall Study||41
10748459|NCT02988882|11912455|FG001|COMPLETED|Overall Study||40
10748460|NCT02988882|11912454|FG000|NOT COMPLETED|Overall Study||3
10748461|NCT02988882|11912455|FG001|NOT COMPLETED|Overall Study||2
10748462|NCT02988986|11912461|FG000|STARTED|Overall Study||28
10748463|NCT02988986|11912461|FG000|COMPLETED|Overall Study||25
10748464|NCT02988986|11912461|FG000|NOT COMPLETED|Overall Study||3
10748465|NCT02989168|11912468|FG000|STARTED|Overall Study||11
10748466|NCT02989168|11912469|FG001|STARTED|Overall Study||3
10748467|NCT02989168|11912468|FG000|COMPLETED|Overall Study||7
10748468|NCT02989168|11912469|FG001|COMPLETED|Overall Study||0
10748469|NCT02989168|11912468|FG000|NOT COMPLETED|Overall Study||4
10748470|NCT02989168|11912469|FG001|NOT COMPLETED|Overall Study||3
10748471|NCT02989246|11912477|FG000|STARTED|Overall Study||32
10748472|NCT02989246|11912477|FG000|COMPLETED|Overall Study||32
10748473|NCT02989246|11912477|FG000|NOT COMPLETED|Overall Study||0
10748474|NCT02989389|11912491|FG000|STARTED|Period 1||3
10748475|NCT02989389|11912492|FG001|STARTED|Period 1||4
10748476|NCT02989389|11912493|FG002|STARTED|Period 1||3
10748477|NCT02989389|11912494|FG003|STARTED|Period 1||3
10748478|NCT02989389|11912495|FG004|STARTED|Period 1||3
10748479|NCT02989389|11912496|FG005|STARTED|Period 1||3
10748480|NCT02989389|11912497|FG006|STARTED|Period 1||6
10748481|NCT02989389|11912498|FG007|STARTED|Period 1||5
10748482|NCT02989389|11912499|FG008|STARTED|Period 1||6
10748483|NCT02989389|11912500|FG009|STARTED|Period 1||6
10748484|NCT02989389|11912491|FG000|Received at Least 1 Dose of Study Drug|Period 1||3
10748485|NCT02989389|11912492|FG001|Received at Least 1 Dose of Study Drug|Period 1||4
10748486|NCT02989389|11912493|FG002|Received at Least 1 Dose of Study Drug|Period 1||3
10748487|NCT02989389|11912494|FG003|Received at Least 1 Dose of Study Drug|Period 1||3
10748488|NCT02989389|11912495|FG004|Received at Least 1 Dose of Study Drug|Period 1||3
10748489|NCT02989389|11912496|FG005|Received at Least 1 Dose of Study Drug|Period 1||3
10748490|NCT02989389|11912497|FG006|Received at Least 1 Dose of Study Drug|Period 1||6
10748491|NCT02989389|11912498|FG007|Received at Least 1 Dose of Study Drug|Period 1||5
10748492|NCT02989389|11912499|FG008|Received at Least 1 Dose of Study Drug|Period 1||6
10818279|NCT01030198|11982322|FG000|STARTED|Overall Study|None recruited|0
10818280|NCT01030198|11982323|FG001|STARTED|Overall Study||7
10818281|NCT01030198|11982322|FG000|COMPLETED|Overall Study|None recruited|0
10818282|NCT01030198|11982323|FG001|COMPLETED|Overall Study|Study terminated due to poor results and lack of enrollment|0
10818283|NCT01030198|11982322|FG000|NOT COMPLETED|Overall Study||0
10818284|NCT01030198|11982323|FG001|NOT COMPLETED|Overall Study||7
10818285|NCT01028300|11982329|FG000|STARTED|Overall Study||4
10818286|NCT01028300|11982329|FG000|COMPLETED|Overall Study||0
10818287|NCT01028300|11982329|FG000|NOT COMPLETED|Overall Study||4
10818288|NCT01025271|11982333|FG000|STARTED|Overall Study|unable to meet enrollment no data available. Study terminated early|2
10818289|NCT01025271|11982333|FG000|COMPLETED|Overall Study|unable to meet enrollment no data available. Study terminated early|2
10748493|NCT02989389|11912500|FG009|Received at Least 1 Dose of Study Drug|Period 1||6
10748494|NCT02989389|11912491|FG000|COMPLETED|Period 1||3
10748495|NCT02989389|11912492|FG001|COMPLETED|Period 1||3
10748496|NCT02989389|11912493|FG002|COMPLETED|Period 1||3
10748497|NCT02989389|11912494|FG003|COMPLETED|Period 1||3
10748498|NCT02989389|11912495|FG004|COMPLETED|Period 1||3
10748499|NCT02989389|11912496|FG005|COMPLETED|Period 1||3
10748500|NCT02989389|11912497|FG006|COMPLETED|Period 1||6
10748501|NCT02989389|11912498|FG007|COMPLETED|Period 1||5
10748502|NCT02989389|11912499|FG008|COMPLETED|Period 1||5
10748503|NCT02989389|11912500|FG009|COMPLETED|Period 1||6
10748504|NCT02989389|11912491|FG000|NOT COMPLETED|Period 1||0
10748505|NCT02989389|11912492|FG001|NOT COMPLETED|Period 1||1
10748506|NCT02989389|11912493|FG002|NOT COMPLETED|Period 1||0
10748507|NCT02989389|11912494|FG003|NOT COMPLETED|Period 1||0
10748508|NCT02989389|11912495|FG004|NOT COMPLETED|Period 1||0
10748509|NCT02989389|11912496|FG005|NOT COMPLETED|Period 1||0
10748510|NCT02989389|11912497|FG006|NOT COMPLETED|Period 1||0
10748511|NCT02989389|11912498|FG007|NOT COMPLETED|Period 1||0
10748512|NCT02989389|11912499|FG008|NOT COMPLETED|Period 1||1
10748513|NCT02989389|11912500|FG009|NOT COMPLETED|Period 1||0
10748514|NCT02989389|11912491|FG000|STARTED|Period 2||3
10748515|NCT02989389|11912492|FG001|STARTED|Period 2||3
10748516|NCT02989389|11912493|FG002|STARTED|Period 2||3
10748517|NCT02989389|11912494|FG003|STARTED|Period 2||3
10748518|NCT02989389|11912495|FG004|STARTED|Period 2||3
10748519|NCT02989389|11912496|FG005|STARTED|Period 2||3
10748520|NCT02989389|11912497|FG006|STARTED|Period 2|Part B was planned as a single period study.|0
10748521|NCT02989389|11912498|FG007|STARTED|Period 2|Part B was planned as a single period study.|0
10748522|NCT02989389|11912499|FG008|STARTED|Period 2|Part B was planned as a single period study.|0
10748523|NCT02989389|11912500|FG009|STARTED|Period 2|Part B was planned as a single period study.|0
10748524|NCT02989389|11912491|FG000|COMPLETED|Period 2||3
10748525|NCT02989389|11912492|FG001|COMPLETED|Period 2||3
10748526|NCT02989389|11912493|FG002|COMPLETED|Period 2||3
10748527|NCT02989389|11912494|FG003|COMPLETED|Period 2||3
10748528|NCT02989389|11912495|FG004|COMPLETED|Period 2||3
10748529|NCT02989389|11912496|FG005|COMPLETED|Period 2||3
10748530|NCT02989389|11912497|FG006|COMPLETED|Period 2||0
10748531|NCT02989389|11912498|FG007|COMPLETED|Period 2||0
10748532|NCT02989389|11912499|FG008|COMPLETED|Period 2||0
10748533|NCT02989389|11912500|FG009|COMPLETED|Period 2||0
10748534|NCT02989389|11912491|FG000|NOT COMPLETED|Period 2||0
10748535|NCT02989389|11912492|FG001|NOT COMPLETED|Period 2||0
10748536|NCT02989389|11912493|FG002|NOT COMPLETED|Period 2||0
10748537|NCT02989389|11912494|FG003|NOT COMPLETED|Period 2||0
10748538|NCT02989389|11912495|FG004|NOT COMPLETED|Period 2||0
10818290|NCT01025271|11982333|FG000|NOT COMPLETED|Overall Study||0
10818291|NCT01022398|11982340|FG000|STARTED|Overall Study||2
10818292|NCT01022398|11982341|FG001|STARTED|Overall Study||2
10818293|NCT01022398|11982340|FG000|COMPLETED|Overall Study||0
10818294|NCT01022398|11982341|FG001|COMPLETED|Overall Study||0
10818295|NCT01022398|11982340|FG000|NOT COMPLETED|Overall Study||2
10818296|NCT01022398|11982341|FG001|NOT COMPLETED|Overall Study||2
10818297|NCT01019980|11982348|FG000|STARTED|Overall Study|2 patients entered study but did not receive any drug since it was not available in the region.|2
10818298|NCT01019980|11982349|FG001|STARTED|Overall Study||0
10818299|NCT01019980|11982348|FG000|Discontinued|Overall Study||2
10818300|NCT01019980|11982349|FG001|Discontinued|Overall Study||0
10818301|NCT01019980|11982348|FG000|COMPLETED|Overall Study||0
10818302|NCT01019980|11982349|FG001|COMPLETED|Overall Study||0
10818303|NCT01019980|11982348|FG000|NOT COMPLETED|Overall Study||2
10818304|NCT01019980|11982349|FG001|NOT COMPLETED|Overall Study||0
10818305|NCT01025492|11982355|FG000|STARTED|Overall Study||24
10818306|NCT01025492|11982355|FG000|COMPLETED|Overall Study||24
10818307|NCT01025492|11982355|FG000|NOT COMPLETED|Overall Study||0
10818308|NCT01017263|11982359|FG000|STARTED|Overall Study||14
10818309|NCT01017263|11982359|FG000|COMPLETED|Overall Study|A total of 14 participants screened: 2 qualified and received drug the remaining 12 failed screen|2
10818310|NCT01017263|11982359|FG000|NOT COMPLETED|Overall Study||12
10818311|NCT01020903|11982365|FG000|STARTED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
10818312|NCT01020903|11982366|FG001|STARTED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
10818313|NCT01020903|11982365|FG000|COMPLETED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
10818314|NCT01020903|11982366|FG001|COMPLETED|Overall Study|Please be advised that the investigator of the study entitled left the institution in 2011.|100
10818315|NCT01020903|11982365|FG000|NOT COMPLETED|Overall Study||0
10818316|NCT01020903|11982366|FG001|NOT COMPLETED|Overall Study||0
10818317|NCT01023620|11982374|FG000|STARTED|Overall Study||0
10818318|NCT01023620|11982375|FG001|STARTED|Overall Study||0
10818319|NCT01023620|11982374|FG000|COMPLETED|Overall Study||0
10818320|NCT01023620|11982375|FG001|COMPLETED|Overall Study||0
10818321|NCT01023620|11982374|FG000|NOT COMPLETED|Overall Study||0
10818322|NCT01023620|11982375|FG001|NOT COMPLETED|Overall Study||0
10818323|NCT01018810|11982386|FG000|STARTED|Overall Study||4
10818324|NCT01018810|11982387|FG001|STARTED|Overall Study||1
10818325|NCT01018810|11982388|FG002|STARTED|Overall Study||1
10818326|NCT01018810|11982389|FG003|STARTED|Overall Study||1
10818327|NCT01018810|11982390|FG004|STARTED|Overall Study||1
10818328|NCT01018810|11982386|FG000|COMPLETED|Overall Study||2
10818329|NCT01018810|11982387|FG001|COMPLETED|Overall Study||0
10818330|NCT01018810|11982388|FG002|COMPLETED|Overall Study||0
10818331|NCT01018810|11982389|FG003|COMPLETED|Overall Study||0
10818332|NCT01018810|11982390|FG004|COMPLETED|Overall Study||0
10818333|NCT01018810|11982386|FG000|NOT COMPLETED|Overall Study||2
10818334|NCT01018810|11982387|FG001|NOT COMPLETED|Overall Study||1
10818335|NCT01018810|11982388|FG002|NOT COMPLETED|Overall Study||1
10818336|NCT01018810|11982389|FG003|NOT COMPLETED|Overall Study||1
10818337|NCT01018810|11982390|FG004|NOT COMPLETED|Overall Study||1
10818338|NCT01016561|11982402|FG000|STARTED|Overall Study|Despite all possible efforts to contact the PI/study team, no data are available to be reported|0
10748539|NCT02989389|11912496|FG005|NOT COMPLETED|Period 2||0
10748540|NCT02989389|11912497|FG006|NOT COMPLETED|Period 2||0
10748541|NCT02989389|11912498|FG007|NOT COMPLETED|Period 2||0
10748542|NCT02989389|11912499|FG008|NOT COMPLETED|Period 2||0
10748543|NCT02989389|11912500|FG009|NOT COMPLETED|Period 2||0
10748544|NCT02989389|11912491|FG000|STARTED|Period 3||3
10748545|NCT02989389|11912492|FG001|STARTED|Period 3||3
10748546|NCT02989389|11912493|FG002|STARTED|Period 3||3
10748547|NCT02989389|11912494|FG003|STARTED|Period 3||3
10748548|NCT02989389|11912495|FG004|STARTED|Period 3||3
10748549|NCT02989389|11912496|FG005|STARTED|Period 3||3
10748550|NCT02989389|11912497|FG006|STARTED|Period 3||0
10748551|NCT02989389|11912498|FG007|STARTED|Period 3||0
10748552|NCT02989389|11912499|FG008|STARTED|Period 3||0
10748553|NCT02989389|11912500|FG009|STARTED|Period 3||0
10748554|NCT02989389|11912491|FG000|COMPLETED|Period 3||3
10748555|NCT02989389|11912492|FG001|COMPLETED|Period 3||3
10748556|NCT02989389|11912493|FG002|COMPLETED|Period 3||3
10748557|NCT02989389|11912494|FG003|COMPLETED|Period 3||3
10748558|NCT02989389|11912495|FG004|COMPLETED|Period 3||3
10748559|NCT02989389|11912496|FG005|COMPLETED|Period 3||3
10748560|NCT02989389|11912497|FG006|COMPLETED|Period 3||0
10748561|NCT02989389|11912498|FG007|COMPLETED|Period 3||0
10748562|NCT02989389|11912499|FG008|COMPLETED|Period 3||0
10748563|NCT02989389|11912500|FG009|COMPLETED|Period 3||0
10748564|NCT02989389|11912491|FG000|NOT COMPLETED|Period 3||0
10748565|NCT02989389|11912492|FG001|NOT COMPLETED|Period 3||0
10748566|NCT02989389|11912493|FG002|NOT COMPLETED|Period 3||0
10748567|NCT02989389|11912494|FG003|NOT COMPLETED|Period 3||0
10748568|NCT02989389|11912495|FG004|NOT COMPLETED|Period 3||0
10748569|NCT02989389|11912496|FG005|NOT COMPLETED|Period 3||0
10748570|NCT02989389|11912497|FG006|NOT COMPLETED|Period 3||0
10748571|NCT02989389|11912498|FG007|NOT COMPLETED|Period 3||0
10748572|NCT02989389|11912499|FG008|NOT COMPLETED|Period 3||0
10748573|NCT02989389|11912500|FG009|NOT COMPLETED|Period 3||0
10748574|NCT02989493|11912542|FG000|STARTED|Overall Study||29
10748575|NCT02989493|11912543|FG001|STARTED|Overall Study||32
10748576|NCT02989493|11912542|FG000|COMPLETED|Overall Study||29
10748577|NCT02989493|11912543|FG001|COMPLETED|Overall Study||32
10748578|NCT02989493|11912542|FG000|NOT COMPLETED|Overall Study||0
10748579|NCT02989493|11912543|FG001|NOT COMPLETED|Overall Study||0
10748580|NCT02989545|11912549|FG000|STARTED|Control Period - no Intervention||20
10748581|NCT02989545|11912549|FG000|COMPLETED|Control Period - no Intervention||20
10748582|NCT02989545|11912549|FG000|NOT COMPLETED|Control Period - no Intervention||0
10748583|NCT02989545|11912549|FG000|STARTED|Treatment Period - Anal Tape Provided||20
10748584|NCT02989545|11912549|FG000|COMPLETED|Treatment Period - Anal Tape Provided||20
10748585|NCT02989545|11912549|FG000|NOT COMPLETED|Treatment Period - Anal Tape Provided||0
10748586|NCT02989610|11912557|FG000|STARTED|Overall Study||234
10748587|NCT02989610|11912557|FG000|COMPLETED|Overall Study||195
10748588|NCT02989610|11912557|FG000|NOT COMPLETED|Overall Study||39
10748589|NCT02989649|11912561|FG000|STARTED|Overall Study||593
10748590|NCT02989649|11912561|FG000|Started But Not Treated|Overall Study||84
10748591|NCT02989649|11912561|FG000|Eligible to Enter Into Treatment Period|Overall Study||509
10748592|NCT02989649|11912561|FG000|COMPLETED|Overall Study||173
10748593|NCT02989649|11912561|FG000|NOT COMPLETED|Overall Study||420
10748594|NCT02989714|11912565|FG000|STARTED|Overall Study||13
10748595|NCT02989714|11912565|FG000|Started Nivolumab|Overall Study||12
10748596|NCT02989714|11912565|FG000|COMPLETED|Overall Study||12
10748597|NCT02989714|11912565|FG000|NOT COMPLETED|Overall Study||1
10748598|NCT02989727|11912574|FG000|STARTED|Overall Study||46
10748599|NCT02989727|11912575|FG001|STARTED|Overall Study||44
10748600|NCT02989727|11912576|FG002|STARTED|Overall Study||30
10748601|NCT02989727|11912577|FG003|STARTED|Overall Study||30
10748602|NCT02989727|11912574|FG000|COMPLETED|Overall Study||46
10748603|NCT02989727|11912575|FG001|COMPLETED|Overall Study||44
10748604|NCT02989727|11912576|FG002|COMPLETED|Overall Study||30
10748605|NCT02989727|11912577|FG003|COMPLETED|Overall Study||30
10748606|NCT02989727|11912574|FG000|NOT COMPLETED|Overall Study||0
10748607|NCT02989727|11912575|FG001|NOT COMPLETED|Overall Study||0
10748608|NCT02989727|11912576|FG002|NOT COMPLETED|Overall Study||0
10748609|NCT02989727|11912577|FG003|NOT COMPLETED|Overall Study||0
10748610|NCT02989805|11912587|FG000|STARTED|Overall Study||160
10748611|NCT02989805|11912588|FG001|STARTED|Overall Study||166
10748612|NCT02989805|11912587|FG000|COMPLETED|Overall Study||154
10748613|NCT02989805|11912588|FG001|COMPLETED|Overall Study||162
10748614|NCT02989805|11912587|FG000|NOT COMPLETED|Overall Study||6
10748615|NCT02989805|11912588|FG001|NOT COMPLETED|Overall Study||4
10748616|NCT02990000|11912596|FG000|STARTED|Overall Study|155 patients were randomly assigned to the Pragmatic Match condition|155
10748617|NCT02990000|11912597|FG001|STARTED|Overall Study|133 patients were randomly assigned to the Scientific Match condition|133
10748618|NCT02990000|11912596|FG000|Begin Treatment|Overall Study|119 Pragmatic Match patients actually began treatment (attended at least 1 session)|119
10748619|NCT02990000|11912597|FG001|Begin Treatment|Overall Study|99 Scientifically Matched patients actually began treatment (attended at least one session)|99
10748620|NCT02990000|11912596|FG000|COMPLETED|Overall Study|119 patients provided naturalistic treatment data and were included in analyses|119
10748621|NCT02990000|11912597|FG001|COMPLETED|Overall Study|99 patients provided naturalistic treatment data and were included in analyses|99
10748622|NCT02990000|11912596|FG000|NOT COMPLETED|Overall Study||36
10748623|NCT02990000|11912597|FG001|NOT COMPLETED|Overall Study||34
10748624|NCT02990910|11912605|FG000|STARTED|Overall Study||140
10748625|NCT02990910|11912606|FG001|STARTED|Overall Study||140
10748626|NCT02990910|11912605|FG000|COMPLETED|Overall Study||134
10748627|NCT02990910|11912606|FG001|COMPLETED|Overall Study||130
10748628|NCT02990910|11912605|FG000|NOT COMPLETED|Overall Study||6
10748629|NCT02990910|11912606|FG001|NOT COMPLETED|Overall Study||10
10748630|NCT02991040|11912612|FG000|STARTED|Overall Study||100
10748631|NCT02991040|11912612|FG000|COMPLETED|Overall Study||96
10748632|NCT02991040|11912612|FG000|NOT COMPLETED|Overall Study||4
10748633|NCT02991118|11912620|FG000|STARTED|Overall Study||257
10748634|NCT02991118|11912621|FG001|STARTED|Overall Study||522
10748635|NCT02991118|11912620|FG000|COMPLETED|Overall Study||250
10748636|NCT02991118|11912621|FG001|COMPLETED|Overall Study||490
10748637|NCT02991118|11912620|FG000|NOT COMPLETED|Overall Study||7
10748638|NCT02991118|11912621|FG001|NOT COMPLETED|Overall Study||32
10748639|NCT02991729|11912629|FG000|STARTED|Overall Study||105
10748640|NCT02991729|11912630|FG001|STARTED|Overall Study||92
10748641|NCT02991729|11912629|FG000|COMPLETED|Overall Study||105
10748642|NCT02991729|11912630|FG001|COMPLETED|Overall Study||92
10748643|NCT02991729|11912629|FG000|NOT COMPLETED|Overall Study||0
10748644|NCT02991729|11912630|FG001|NOT COMPLETED|Overall Study||0
10748645|NCT02991820|11912640|FG000|STARTED|Overall Study||12
10748646|NCT02991820|11912641|FG001|STARTED|Overall Study||31
10748647|NCT02991820|11912640|FG000|COMPLETED|Overall Study||12
10748648|NCT02991820|11912641|FG001|COMPLETED|Overall Study||31
10748649|NCT02991820|11912640|FG000|NOT COMPLETED|Overall Study||0
10748650|NCT02991820|11912641|FG001|NOT COMPLETED|Overall Study||0
10748651|NCT02991859|11912666|FG000|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
10748652|NCT02991859|11912667|FG001|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
10748653|NCT02991859|11912668|FG002|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
10748654|NCT02991859|11912669|FG003|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
10748655|NCT02991859|11912670|FG004|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
10748656|NCT02991859|11912671|FG005|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
10748657|NCT02991859|11912672|FG006|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
10748658|NCT02991859|11912673|FG007|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
10748659|NCT02991859|11912674|FG008|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
10748660|NCT02991859|11912675|FG009|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
10748661|NCT02991859|11912676|FG010|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
10748662|NCT02991859|11912677|FG011|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
10748663|NCT02991859|11912678|FG012|STARTED|Period 1,Escalation Phase 1,Upto Day 7||7
10748664|NCT02991859|11912679|FG013|STARTED|Period 1,Escalation Phase 1,Upto Day 7||7
10748665|NCT02991859|11912680|FG014|STARTED|Period 1,Escalation Phase 1,Upto Day 7||6
10748666|NCT02991859|11912681|FG015|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
10748667|NCT02991859|11912682|FG016|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
10748668|NCT02991859|11912666|FG000|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
10748669|NCT02991859|11912667|FG001|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
10748670|NCT02991859|11912668|FG002|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
10748671|NCT02991859|11912669|FG003|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
10748672|NCT02991859|11912670|FG004|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
10748673|NCT02991859|11912671|FG005|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||3
10748674|NCT02991859|11912672|FG006|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
10748675|NCT02991859|11912673|FG007|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
10748676|NCT02991859|11912674|FG008|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
10748677|NCT02991859|11912675|FG009|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
10748678|NCT02991859|11912676|FG010|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
10748679|NCT02991859|11912677|FG011|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
10748680|NCT02991859|11912678|FG012|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||7
10748681|NCT02991859|11912679|FG013|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||7
10748682|NCT02991859|11912680|FG014|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||6
10748683|NCT02991859|11912681|FG015|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||3
10748684|NCT02991859|11912682|FG016|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||3
10748685|NCT02991859|11912666|FG000|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
10748686|NCT02991859|11912667|FG001|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||1
10748687|NCT02991859|11912668|FG002|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
10748688|NCT02991859|11912669|FG003|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
10748689|NCT02991859|11912670|FG004|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||1
10748690|NCT02991859|11912671|FG005|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
10748691|NCT02991859|11912672|FG006|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
10748692|NCT02991859|11912673|FG007|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
10748693|NCT02991859|11912674|FG008|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
10748694|NCT02991859|11912675|FG009|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
10748695|NCT02991859|11912676|FG010|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
10748696|NCT02991859|11912677|FG011|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
10748697|NCT02991859|11912678|FG012|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
10748698|NCT02991859|11912679|FG013|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
10748699|NCT02991859|11912680|FG014|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
10748700|NCT02991859|11912681|FG015|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
10748701|NCT02991859|11912682|FG016|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
10748702|NCT02991859|11912666|FG000|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
10748703|NCT02991859|11912667|FG001|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
10748704|NCT02991859|11912668|FG002|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
10748705|NCT02991859|11912669|FG003|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
10748706|NCT02991859|11912670|FG004|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
10748707|NCT02991859|11912671|FG005|STARTED|Period 1,Escalation Phase2,Upto Day 14||3
10748708|NCT02991859|11912672|FG006|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
10748709|NCT02991859|11912673|FG007|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
10748710|NCT02991859|11912674|FG008|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
10748711|NCT02991859|11912675|FG009|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
10748712|NCT02991859|11912676|FG010|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
10748713|NCT02991859|11912677|FG011|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
10748714|NCT02991859|11912678|FG012|STARTED|Period 1,Escalation Phase2,Upto Day 14||7
10748715|NCT02991859|11912679|FG013|STARTED|Period 1,Escalation Phase2,Upto Day 14||7
10748716|NCT02991859|11912680|FG014|STARTED|Period 1,Escalation Phase2,Upto Day 14||6
10748717|NCT02991859|11912681|FG015|STARTED|Period 1,Escalation Phase2,Upto Day 14||3
10748718|NCT02991859|11912682|FG016|STARTED|Period 1,Escalation Phase2,Upto Day 14||3
10748719|NCT02991859|11912666|FG000|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
10748720|NCT02991859|11912667|FG001|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
10748721|NCT02991859|11912668|FG002|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
10748722|NCT02991859|11912669|FG003|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
10748723|NCT02991859|11912670|FG004|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
10748724|NCT02991859|11912671|FG005|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||3
10748725|NCT02991859|11912672|FG006|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
10748726|NCT02991859|11912673|FG007|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
10748727|NCT02991859|11912674|FG008|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
10748728|NCT02991859|11912675|FG009|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
10748729|NCT02991859|11912676|FG010|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
10748730|NCT02991859|11912677|FG011|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
10748731|NCT02991859|11912678|FG012|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||7
10748732|NCT02991859|11912679|FG013|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||7
10748733|NCT02991859|11912680|FG014|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||6
10748734|NCT02991859|11912681|FG015|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||3
10748735|NCT02991859|11912682|FG016|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||3
10748736|NCT02991859|11912666|FG000|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
10748737|NCT02991859|11912667|FG001|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
10748738|NCT02991859|11912668|FG002|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
10748739|NCT02991859|11912669|FG003|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
10748740|NCT02991859|11912670|FG004|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
10748741|NCT02991859|11912671|FG005|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
10748742|NCT02991859|11912672|FG006|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
10748743|NCT02991859|11912673|FG007|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
10748744|NCT02991859|11912674|FG008|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
10748745|NCT02991859|11912675|FG009|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
10748746|NCT02991859|11912676|FG010|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
10748747|NCT02991859|11912677|FG011|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
10748748|NCT02991859|11912678|FG012|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
10748749|NCT02991859|11912679|FG013|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
10748750|NCT02991859|11912680|FG014|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
10748751|NCT02991859|11912681|FG015|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
10748752|NCT02991859|11912682|FG016|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
10748753|NCT02991859|11912666|FG000|STARTED|Period1, Escalation Phase3, Upto Day21||2
10748754|NCT02991859|11912667|FG001|STARTED|Period1, Escalation Phase3, Upto Day21||2
10748755|NCT02991859|11912668|FG002|STARTED|Period1, Escalation Phase3, Upto Day21||2
10748756|NCT02991859|11912669|FG003|STARTED|Period1, Escalation Phase3, Upto Day21||2
10748757|NCT02991859|11912670|FG004|STARTED|Period1, Escalation Phase3, Upto Day21||2
10748758|NCT02991859|11912671|FG005|STARTED|Period1, Escalation Phase3, Upto Day21||3
10748759|NCT02991859|11912672|FG006|STARTED|Period1, Escalation Phase3, Upto Day21||2
10748760|NCT02991859|11912673|FG007|STARTED|Period1, Escalation Phase3, Upto Day21||2
10748761|NCT02991859|11912674|FG008|STARTED|Period1, Escalation Phase3, Upto Day21||2
10748762|NCT02991859|11912675|FG009|STARTED|Period1, Escalation Phase3, Upto Day21||2
10748763|NCT02991859|11912676|FG010|STARTED|Period1, Escalation Phase3, Upto Day21||2
10748764|NCT02991859|11912677|FG011|STARTED|Period1, Escalation Phase3, Upto Day21||2
10748765|NCT02991859|11912678|FG012|STARTED|Period1, Escalation Phase3, Upto Day21||7
10748766|NCT02991859|11912679|FG013|STARTED|Period1, Escalation Phase3, Upto Day21||7
10748767|NCT02991859|11912680|FG014|STARTED|Period1, Escalation Phase3, Upto Day21||6
10748768|NCT02991859|11912681|FG015|STARTED|Period1, Escalation Phase3, Upto Day21||3
10748769|NCT02991859|11912682|FG016|STARTED|Period1, Escalation Phase3, Upto Day21||3
10748770|NCT02991859|11912666|FG000|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
10748771|NCT02991859|11912667|FG001|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
10748772|NCT02991859|11912668|FG002|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
10748773|NCT02991859|11912669|FG003|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
10748774|NCT02991859|11912670|FG004|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
10748775|NCT02991859|11912671|FG005|COMPLETED|Period1, Escalation Phase3, Upto Day21||3
10748776|NCT02991859|11912672|FG006|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
10748777|NCT02991859|11912673|FG007|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
10748778|NCT02991859|11912674|FG008|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
10748779|NCT02991859|11912675|FG009|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
10748780|NCT02991859|11912676|FG010|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
10748781|NCT02991859|11912677|FG011|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
10748782|NCT02991859|11912678|FG012|COMPLETED|Period1, Escalation Phase3, Upto Day21||6
10748783|NCT02991859|11912679|FG013|COMPLETED|Period1, Escalation Phase3, Upto Day21||6
10748784|NCT02991859|11912680|FG014|COMPLETED|Period1, Escalation Phase3, Upto Day21||6
10748785|NCT02991859|11912681|FG015|COMPLETED|Period1, Escalation Phase3, Upto Day21||3
10748786|NCT02991859|11912682|FG016|COMPLETED|Period1, Escalation Phase3, Upto Day21||3
10748787|NCT02991859|11912666|FG000|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
10748788|NCT02991859|11912667|FG001|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
10748789|NCT02991859|11912668|FG002|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
10748790|NCT02991859|11912669|FG003|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
10748791|NCT02991859|11912670|FG004|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
10748792|NCT02991859|11912671|FG005|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
10748793|NCT02991859|11912672|FG006|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
10748794|NCT02991859|11912673|FG007|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
10748795|NCT02991859|11912674|FG008|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
10748796|NCT02991859|11912675|FG009|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
10748797|NCT02991859|11912676|FG010|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
10748798|NCT02991859|11912677|FG011|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
10748799|NCT02991859|11912678|FG012|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||1
10748800|NCT02991859|11912679|FG013|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||1
10748801|NCT02991859|11912680|FG014|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
10748802|NCT02991859|11912681|FG015|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
10748803|NCT02991859|11912682|FG016|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
10748804|NCT02991859|11912666|FG000|STARTED|Period1, Escalation Phase4, Upto Day28||2
10748805|NCT02991859|11912667|FG001|STARTED|Period1, Escalation Phase4, Upto Day28||2
10748806|NCT02991859|11912668|FG002|STARTED|Period1, Escalation Phase4, Upto Day28||2
10748807|NCT02991859|11912669|FG003|STARTED|Period1, Escalation Phase4, Upto Day28||2
10748808|NCT02991859|11912670|FG004|STARTED|Period1, Escalation Phase4, Upto Day28||2
10748809|NCT02991859|11912671|FG005|STARTED|Period1, Escalation Phase4, Upto Day28|1 Par completed Phase 3 did not enter Phase 4|2
10748810|NCT02991859|11912672|FG006|STARTED|Period1, Escalation Phase4, Upto Day28||2
10818339|NCT01016561|11982402|FG000|COMPLETED|Overall Study|Despite all possible efforts to contact the PI/study team, no data are available to be reported|0
10818340|NCT01016561|11982402|FG000|NOT COMPLETED|Overall Study||0
10818341|NCT01016847|11982408|FG000|STARTED|Overall Study||1
10818342|NCT01016847|11982409|FG001|STARTED|Overall Study||2
10818343|NCT01016847|11982408|FG000|COMPLETED|Overall Study||1
10818344|NCT01016847|11982409|FG001|COMPLETED|Overall Study||2
10818345|NCT01016847|11982408|FG000|NOT COMPLETED|Overall Study||0
10818346|NCT01016847|11982409|FG001|NOT COMPLETED|Overall Study||0
10818347|NCT01014767|11982419|FG000|STARTED|Overall Study||12
10818348|NCT01014767|11982420|FG001|STARTED|Overall Study||1
10818349|NCT01014767|11982421|FG002|STARTED|Overall Study||4
10818350|NCT01014767|11982422|FG003|STARTED|Overall Study||1
10818351|NCT01014767|11982419|FG000|COMPLETED|Overall Study||0
10818352|NCT01014767|11982420|FG001|COMPLETED|Overall Study||0
10818353|NCT01014767|11982421|FG002|COMPLETED|Overall Study||0
10818354|NCT01014767|11982422|FG003|COMPLETED|Overall Study||0
10818355|NCT01014767|11982419|FG000|NOT COMPLETED|Overall Study||12
10818356|NCT01014767|11982420|FG001|NOT COMPLETED|Overall Study||1
10818357|NCT01014767|11982421|FG002|NOT COMPLETED|Overall Study||4
10818358|NCT01014767|11982422|FG003|NOT COMPLETED|Overall Study||1
10818359|NCT01013701|11982432|FG000|STARTED|Overall Study||7
10818360|NCT01013701|11982432|FG000|COMPLETED|Overall Study||0
10818361|NCT01013701|11982432|FG000|NOT COMPLETED|Overall Study||7
10818362|NCT01012414|11982437|FG000|STARTED|Overall Study||10
10818363|NCT01012414|11982437|FG000|COMPLETED|Overall Study|No subjects completed the study.|0
10818364|NCT01012414|11982437|FG000|NOT COMPLETED|Overall Study||10
10818365|NCT01011634|11982445|FG000|STARTED|Overall Study||9
10818366|NCT01011634|11982446|FG001|STARTED|Overall Study||9
10818367|NCT01011634|11982445|FG000|COMPLETED|Overall Study||9
10818368|NCT01011634|11982446|FG001|COMPLETED|Overall Study||8
10818369|NCT01011634|11982445|FG000|NOT COMPLETED|Overall Study||0
10818370|NCT01011634|11982446|FG001|NOT COMPLETED|Overall Study||1
10818371|NCT01009931|11982452|FG000|STARTED|Overall Study||1
10818372|NCT01009931|11982452|FG000|COMPLETED|Overall Study||0
10818373|NCT01009931|11982452|FG000|NOT COMPLETED|Overall Study||1
10818374|NCT01001390|11982456|FG000|STARTED|Overall Study||2
10818375|NCT01001390|11982457|FG001|STARTED|Overall Study||0
10748811|NCT02991859|11912673|FG007|STARTED|Period1, Escalation Phase4, Upto Day28||2
10748812|NCT02991859|11912674|FG008|STARTED|Period1, Escalation Phase4, Upto Day28||2
10748813|NCT02991859|11912675|FG009|STARTED|Period1, Escalation Phase4, Upto Day28||2
10818376|NCT01001390|11982456|FG000|COMPLETED|Overall Study||0
10818377|NCT01001390|11982457|FG001|COMPLETED|Overall Study||0
10818378|NCT01001390|11982456|FG000|NOT COMPLETED|Overall Study||2
10818379|NCT01001390|11982457|FG001|NOT COMPLETED|Overall Study||0
10818380|NCT01006018|11982465|FG000|STARTED|Overall Study||0
10748814|NCT02991859|11912676|FG010|STARTED|Period1, Escalation Phase4, Upto Day28||2
10748815|NCT02991859|11912677|FG011|STARTED|Period1, Escalation Phase4, Upto Day28||2
10748816|NCT02991859|11912678|FG012|STARTED|Period1, Escalation Phase4, Upto Day28||6
10748817|NCT02991859|11912679|FG013|STARTED|Period1, Escalation Phase4, Upto Day28||6
10748818|NCT02991859|11912680|FG014|STARTED|Period1, Escalation Phase4, Upto Day28||6
10748819|NCT02991859|11912681|FG015|STARTED|Period1, Escalation Phase4, Upto Day28||3
10748820|NCT02991859|11912682|FG016|STARTED|Period1, Escalation Phase4, Upto Day28||3
10748821|NCT02991859|11912666|FG000|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
10748822|NCT02991859|11912667|FG001|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
10748823|NCT02991859|11912668|FG002|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
10748824|NCT02991859|11912669|FG003|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
10748825|NCT02991859|11912670|FG004|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
10748826|NCT02991859|11912671|FG005|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
10748827|NCT02991859|11912672|FG006|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
10748828|NCT02991859|11912673|FG007|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
10748829|NCT02991859|11912674|FG008|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
10818381|NCT01006018|11982466|FG001|STARTED|Overall Study||0
10818382|NCT01006018|11982467|FG002|STARTED|Overall Study||0
10818383|NCT01006018|11982465|FG000|COMPLETED|Overall Study||0
10748830|NCT02991859|11912675|FG009|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
10748831|NCT02991859|11912676|FG010|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
10748832|NCT02991859|11912677|FG011|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
10748833|NCT02991859|11912678|FG012|COMPLETED|Period1, Escalation Phase4, Upto Day28||6
10748834|NCT02991859|11912679|FG013|COMPLETED|Period1, Escalation Phase4, Upto Day28||6
10748835|NCT02991859|11912680|FG014|COMPLETED|Period1, Escalation Phase4, Upto Day28||6
10748836|NCT02991859|11912681|FG015|COMPLETED|Period1, Escalation Phase4, Upto Day28||3
10748837|NCT02991859|11912682|FG016|COMPLETED|Period1, Escalation Phase4, Upto Day28||3
10748838|NCT02991859|11912666|FG000|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
10748839|NCT02991859|11912667|FG001|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
10748840|NCT02991859|11912668|FG002|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
10748841|NCT02991859|11912669|FG003|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
10748842|NCT02991859|11912670|FG004|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
10748843|NCT02991859|11912671|FG005|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
10748844|NCT02991859|11912672|FG006|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
10748845|NCT02991859|11912673|FG007|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
10748846|NCT02991859|11912674|FG008|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
10748847|NCT02991859|11912675|FG009|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
10748848|NCT02991859|11912676|FG010|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
10748849|NCT02991859|11912677|FG011|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
10748850|NCT02991859|11912678|FG012|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
10748851|NCT02991859|11912679|FG013|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
10748852|NCT02991859|11912680|FG014|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
10748853|NCT02991859|11912681|FG015|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
10748854|NCT02991859|11912682|FG016|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
10748855|NCT02991859|11912666|FG000|STARTED|Period1, Escalation Phase5, Upto Day35||2
10748856|NCT02991859|11912667|FG001|STARTED|Period1, Escalation Phase5, Upto Day35||2
10748857|NCT02991859|11912668|FG002|STARTED|Period1, Escalation Phase5, Upto Day35||2
10748858|NCT02991859|11912669|FG003|STARTED|Period1, Escalation Phase5, Upto Day35||2
10818384|NCT01006018|11982466|FG001|COMPLETED|Overall Study||0
10748859|NCT02991859|11912670|FG004|STARTED|Period1, Escalation Phase5, Upto Day35||2
10748860|NCT02991859|11912671|FG005|STARTED|Period1, Escalation Phase5, Upto Day35||2
10748861|NCT02991859|11912672|FG006|STARTED|Period1, Escalation Phase5, Upto Day35||2
10748862|NCT02991859|11912673|FG007|STARTED|Period1, Escalation Phase5, Upto Day35||2
10748863|NCT02991859|11912674|FG008|STARTED|Period1, Escalation Phase5, Upto Day35||2
10818385|NCT01006018|11982467|FG002|COMPLETED|Overall Study||0
10818386|NCT01006018|11982465|FG000|NOT COMPLETED|Overall Study||0
10748864|NCT02991859|11912675|FG009|STARTED|Period1, Escalation Phase5, Upto Day35||2
10748865|NCT02991859|11912676|FG010|STARTED|Period1, Escalation Phase5, Upto Day35|1 participant did not enter Esc Phase 5, and was not withdrawn|1
10748866|NCT02991859|11912677|FG011|STARTED|Period1, Escalation Phase5, Upto Day35||2
10748867|NCT02991859|11912678|FG012|STARTED|Period1, Escalation Phase5, Upto Day35||6
10748868|NCT02991859|11912679|FG013|STARTED|Period1, Escalation Phase5, Upto Day35||6
10748869|NCT02991859|11912680|FG014|STARTED|Period1, Escalation Phase5, Upto Day35||6
10748870|NCT02991859|11912681|FG015|STARTED|Period1, Escalation Phase5, Upto Day35||3
10748871|NCT02991859|11912682|FG016|STARTED|Period1, Escalation Phase5, Upto Day35||3
10748872|NCT02991859|11912666|FG000|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
10748873|NCT02991859|11912667|FG001|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
10748874|NCT02991859|11912668|FG002|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
10748875|NCT02991859|11912669|FG003|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
10748876|NCT02991859|11912670|FG004|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
10748877|NCT02991859|11912671|FG005|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
10748878|NCT02991859|11912672|FG006|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
10748879|NCT02991859|11912673|FG007|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
10748880|NCT02991859|11912674|FG008|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
10748881|NCT02991859|11912675|FG009|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
10748882|NCT02991859|11912676|FG010|COMPLETED|Period1, Escalation Phase5, Upto Day35||1
10748883|NCT02991859|11912677|FG011|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
10748884|NCT02991859|11912678|FG012|COMPLETED|Period1, Escalation Phase5, Upto Day35||6
10748885|NCT02991859|11912679|FG013|COMPLETED|Period1, Escalation Phase5, Upto Day35||6
10748886|NCT02991859|11912680|FG014|COMPLETED|Period1, Escalation Phase5, Upto Day35||6
10748887|NCT02991859|11912681|FG015|COMPLETED|Period1, Escalation Phase5, Upto Day35||3
10748888|NCT02991859|11912682|FG016|COMPLETED|Period1, Escalation Phase5, Upto Day35||3
10748889|NCT02991859|11912666|FG000|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
10748890|NCT02991859|11912667|FG001|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
10748891|NCT02991859|11912668|FG002|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
10748892|NCT02991859|11912669|FG003|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
10748893|NCT02991859|11912670|FG004|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
10748894|NCT02991859|11912671|FG005|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
10748895|NCT02991859|11912672|FG006|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
10748896|NCT02991859|11912673|FG007|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
10748897|NCT02991859|11912674|FG008|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
10748898|NCT02991859|11912675|FG009|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
10748899|NCT02991859|11912676|FG010|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
10748900|NCT02991859|11912677|FG011|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
10748901|NCT02991859|11912678|FG012|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
10748902|NCT02991859|11912679|FG013|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
10748903|NCT02991859|11912680|FG014|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
10748904|NCT02991859|11912681|FG015|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
10748905|NCT02991859|11912682|FG016|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
10748906|NCT02991859|11912666|FG000|STARTED|Wash Out, Up to Day 77||2
10748907|NCT02991859|11912667|FG001|STARTED|Wash Out, Up to Day 77||2
10748908|NCT02991859|11912668|FG002|STARTED|Wash Out, Up to Day 77||2
10748909|NCT02991859|11912669|FG003|STARTED|Wash Out, Up to Day 77||2
10748910|NCT02991859|11912670|FG004|STARTED|Wash Out, Up to Day 77||2
10748911|NCT02991859|11912671|FG005|STARTED|Wash Out, Up to Day 77||2
10748912|NCT02991859|11912672|FG006|STARTED|Wash Out, Up to Day 77||2
10748913|NCT02991859|11912673|FG007|STARTED|Wash Out, Up to Day 77||2
10748914|NCT02991859|11912674|FG008|STARTED|Wash Out, Up to Day 77||2
10748915|NCT02991859|11912675|FG009|STARTED|Wash Out, Up to Day 77||2
10748916|NCT02991859|11912676|FG010|STARTED|Wash Out, Up to Day 77||1
10748917|NCT02991859|11912677|FG011|STARTED|Wash Out, Up to Day 77||2
10748918|NCT02991859|11912678|FG012|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
10748919|NCT02991859|11912679|FG013|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
10748920|NCT02991859|11912680|FG014|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
10748921|NCT02991859|11912681|FG015|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
10748922|NCT02991859|11912682|FG016|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
10748923|NCT02991859|11912666|FG000|COMPLETED|Wash Out, Up to Day 77||2
10748924|NCT02991859|11912667|FG001|COMPLETED|Wash Out, Up to Day 77||2
10748925|NCT02991859|11912668|FG002|COMPLETED|Wash Out, Up to Day 77||2
10748926|NCT02991859|11912669|FG003|COMPLETED|Wash Out, Up to Day 77||2
10748927|NCT02991859|11912670|FG004|COMPLETED|Wash Out, Up to Day 77||2
10748928|NCT02991859|11912671|FG005|COMPLETED|Wash Out, Up to Day 77||1
10748929|NCT02991859|11912672|FG006|COMPLETED|Wash Out, Up to Day 77||2
10748930|NCT02991859|11912673|FG007|COMPLETED|Wash Out, Up to Day 77||2
10748931|NCT02991859|11912674|FG008|COMPLETED|Wash Out, Up to Day 77||2
10748932|NCT02991859|11912675|FG009|COMPLETED|Wash Out, Up to Day 77||1
10748933|NCT02991859|11912676|FG010|COMPLETED|Wash Out, Up to Day 77||1
10748934|NCT02991859|11912677|FG011|COMPLETED|Wash Out, Up to Day 77||2
10748935|NCT02991859|11912678|FG012|COMPLETED|Wash Out, Up to Day 77||0
10748936|NCT02991859|11912679|FG013|COMPLETED|Wash Out, Up to Day 77||0
10748937|NCT02991859|11912680|FG014|COMPLETED|Wash Out, Up to Day 77||0
10748938|NCT02991859|11912681|FG015|COMPLETED|Wash Out, Up to Day 77||0
10748939|NCT02991859|11912682|FG016|COMPLETED|Wash Out, Up to Day 77||0
10748940|NCT02991859|11912666|FG000|NOT COMPLETED|Wash Out, Up to Day 77||0
10748941|NCT02991859|11912667|FG001|NOT COMPLETED|Wash Out, Up to Day 77||0
10748942|NCT02991859|11912668|FG002|NOT COMPLETED|Wash Out, Up to Day 77||0
10748943|NCT02991859|11912669|FG003|NOT COMPLETED|Wash Out, Up to Day 77||0
10748944|NCT02991859|11912670|FG004|NOT COMPLETED|Wash Out, Up to Day 77||0
10748945|NCT02991859|11912671|FG005|NOT COMPLETED|Wash Out, Up to Day 77||1
10748946|NCT02991859|11912672|FG006|NOT COMPLETED|Wash Out, Up to Day 77||0
10748947|NCT02991859|11912673|FG007|NOT COMPLETED|Wash Out, Up to Day 77||0
10748948|NCT02991859|11912674|FG008|NOT COMPLETED|Wash Out, Up to Day 77||0
10748949|NCT02991859|11912675|FG009|NOT COMPLETED|Wash Out, Up to Day 77||1
10748950|NCT02991859|11912676|FG010|NOT COMPLETED|Wash Out, Up to Day 77||0
10748951|NCT02991859|11912677|FG011|NOT COMPLETED|Wash Out, Up to Day 77||0
10748952|NCT02991859|11912678|FG012|NOT COMPLETED|Wash Out, Up to Day 77||0
10748953|NCT02991859|11912679|FG013|NOT COMPLETED|Wash Out, Up to Day 77||0
10748954|NCT02991859|11912680|FG014|NOT COMPLETED|Wash Out, Up to Day 77||0
10748955|NCT02991859|11912681|FG015|NOT COMPLETED|Wash Out, Up to Day 77||0
10748956|NCT02991859|11912682|FG016|NOT COMPLETED|Wash Out, Up to Day 77||0
10748957|NCT02991859|11912666|FG000|STARTED|Period2, Escalation Phase1, Upto Day 84||2
10748958|NCT02991859|11912667|FG001|STARTED|Period2, Escalation Phase1, Upto Day 84||2
10748959|NCT02991859|11912668|FG002|STARTED|Period2, Escalation Phase1, Upto Day 84||2
10748960|NCT02991859|11912669|FG003|STARTED|Period2, Escalation Phase1, Upto Day 84||2
10748961|NCT02991859|11912670|FG004|STARTED|Period2, Escalation Phase1, Upto Day 84||2
10748962|NCT02991859|11912671|FG005|STARTED|Period2, Escalation Phase1, Upto Day 84||1
10748963|NCT02991859|11912672|FG006|STARTED|Period2, Escalation Phase1, Upto Day 84||2
10748964|NCT02991859|11912673|FG007|STARTED|Period2, Escalation Phase1, Upto Day 84||2
10818387|NCT01006018|11982466|FG001|NOT COMPLETED|Overall Study||0
10818388|NCT01006018|11982467|FG002|NOT COMPLETED|Overall Study||0
10818389|NCT01004510|11982475|FG000|STARTED|Overall Study||3
10818390|NCT01004510|11982475|FG000|COMPLETED|Overall Study||2
10818391|NCT01004510|11982475|FG000|NOT COMPLETED|Overall Study||1
10818392|NCT01005914|11982479|FG000|STARTED|Overall Study||11
10818393|NCT01005914|11982479|FG000|COMPLETED|Overall Study||1
10818394|NCT01005914|11982479|FG000|NOT COMPLETED|Overall Study||10
10818395|NCT00996333|11982483|FG000|STARTED|Overall Study||46
10818396|NCT00996333|11982483|FG000|COMPLETED|Overall Study||33
10818397|NCT00996333|11982483|FG000|NOT COMPLETED|Overall Study||13
10818398|NCT00998738|11982487|FG000|STARTED|Overall Study||1
10818399|NCT00998738|11982487|FG000|COMPLETED|Overall Study||0
10818400|NCT00998738|11982487|FG000|NOT COMPLETED|Overall Study||1
10818401|NCT00996502|11982491|FG000|STARTED|Overall Study||4
10818402|NCT00996502|11982491|FG000|COMPLETED|Overall Study||4
10818403|NCT00996502|11982491|FG000|NOT COMPLETED|Overall Study||0
10818404|NCT00997386|11982495|FG000|STARTED|Overall Study||16
10818405|NCT00997386|11982495|FG000|COMPLETED|Overall Study||9
10818406|NCT00997386|11982495|FG000|NOT COMPLETED|Overall Study||7
10818407|NCT00985738|11982501|FG000|STARTED|Overall Study||8
10818408|NCT00985738|11982502|FG001|STARTED|Overall Study||8
10818409|NCT00985738|11982501|FG000|COMPLETED|Overall Study||0
10818410|NCT00985738|11982502|FG001|COMPLETED|Overall Study||0
10818411|NCT00985738|11982501|FG000|NOT COMPLETED|Overall Study||8
10818412|NCT00985738|11982502|FG001|NOT COMPLETED|Overall Study||8
10818413|NCT00986999|11982508|FG000|STARTED|Overall Study||7
10818414|NCT00986999|11982508|FG000|COMPLETED|Overall Study||6
10818415|NCT00986999|11982508|FG000|NOT COMPLETED|Overall Study||1
10818416|NCT00989937|11982512|FG000|STARTED|Overall Study||0
10818417|NCT00989937|11982512|FG000|COMPLETED|Overall Study||0
10818418|NCT00989937|11982512|FG000|NOT COMPLETED|Overall Study||0
10818419|NCT00986947|11982516|FG000|STARTED|Overall Study||20
10818420|NCT00986947|11982516|FG000|COMPLETED|Overall Study||0
10818421|NCT00986947|11982516|FG000|NOT COMPLETED|Overall Study||20
10818422|NCT00982995|11982520|FG000|STARTED|Overall Study||3
10818423|NCT00982995|11982520|FG000|COMPLETED|Overall Study||3
10818424|NCT00982995|11982520|FG000|NOT COMPLETED|Overall Study||0
10818425|NCT00984490|11982524|FG000|STARTED|Overall Study||5
10818426|NCT00984490|11982524|FG000|COMPLETED|Overall Study||5
10818427|NCT00984490|11982524|FG000|NOT COMPLETED|Overall Study||0
10818428|NCT00986310|11982531|FG000|STARTED|Overall Study||0
10818429|NCT00986310|11982532|FG001|STARTED|Overall Study||0
10818430|NCT00986310|11982531|FG000|COMPLETED|Overall Study||0
10818431|NCT00986310|11982532|FG001|COMPLETED|Overall Study||0
10818432|NCT00986310|11982531|FG000|NOT COMPLETED|Overall Study||0
10818433|NCT00986310|11982532|FG001|NOT COMPLETED|Overall Study||0
10818434|NCT00978874|11982538|FG000|STARTED|Overall Study|The study was terminated and no data are available to be reported|0
10818435|NCT00978874|11982538|FG000|COMPLETED|Overall Study|The study was terminated and no data are available to be reported|0
10818436|NCT00978874|11982538|FG000|NOT COMPLETED|Overall Study||0
10818437|NCT00983645|11982544|FG000|STARTED|Overall Study||8
10748965|NCT02991859|11912674|FG008|STARTED|Period2, Escalation Phase1, Upto Day 84||2
10748966|NCT02991859|11912675|FG009|STARTED|Period2, Escalation Phase1, Upto Day 84|1 Par directly entered into Period 2, Esc 1|2
10748967|NCT02991859|11912676|FG010|STARTED|Period2, Escalation Phase1, Upto Day 84|1 Par cont in P2 Esc 1 insteadP1 Esc 5, was not withdrawn|2
10748968|NCT02991859|11912677|FG011|STARTED|Period2, Escalation Phase1, Upto Day 84||2
10748969|NCT02991859|11912678|FG012|STARTED|Period2, Escalation Phase1, Upto Day 84||0
10748970|NCT02991859|11912679|FG013|STARTED|Period2, Escalation Phase1, Upto Day 84||0
10818438|NCT00983645|11982545|FG001|STARTED|Overall Study||7
10748971|NCT02991859|11912680|FG014|STARTED|Period2, Escalation Phase1, Upto Day 84||0
10748972|NCT02991859|11912681|FG015|STARTED|Period2, Escalation Phase1, Upto Day 84||0
10748973|NCT02991859|11912682|FG016|STARTED|Period2, Escalation Phase1, Upto Day 84||0
10748974|NCT02991859|11912666|FG000|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
10748975|NCT02991859|11912667|FG001|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
10748976|NCT02991859|11912668|FG002|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
10748977|NCT02991859|11912669|FG003|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
10748978|NCT02991859|11912670|FG004|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
10748979|NCT02991859|11912671|FG005|COMPLETED|Period2, Escalation Phase1, Upto Day 84||1
10748980|NCT02991859|11912672|FG006|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
10818439|NCT00983645|11982544|FG000|COMPLETED|Overall Study||8
10818440|NCT00983645|11982545|FG001|COMPLETED|Overall Study||7
10818441|NCT00983645|11982544|FG000|NOT COMPLETED|Overall Study||0
10818442|NCT00983645|11982545|FG001|NOT COMPLETED|Overall Study||0
10818443|NCT00979147|11982553|FG000|STARTED|Overall Study||0
10818444|NCT00979147|11982554|FG001|STARTED|Overall Study||0
10818445|NCT00979147|11982553|FG000|COMPLETED|Overall Study||0
10818446|NCT00979147|11982554|FG001|COMPLETED|Overall Study||0
10818447|NCT00979147|11982553|FG000|NOT COMPLETED|Overall Study||0
10818448|NCT00979147|11982554|FG001|NOT COMPLETED|Overall Study||0
10818449|NCT00967447|11982560|FG000|STARTED|Overall Study|there are no collected data in CRF|2
10818450|NCT00967447|11982560|FG000|COMPLETED|Overall Study|there are no collected data in CRF|2
10818451|NCT00967447|11982560|FG000|NOT COMPLETED|Overall Study||0
10818452|NCT00970606|11982566|FG000|STARTED|Overall Study||4
10818453|NCT00970606|11982567|FG001|STARTED|Overall Study||3
10818454|NCT00970606|11982566|FG000|COMPLETED|Overall Study||4
10818455|NCT00970606|11982567|FG001|COMPLETED|Overall Study||3
10818456|NCT00970606|11982566|FG000|NOT COMPLETED|Overall Study||0
10818457|NCT00970606|11982567|FG001|NOT COMPLETED|Overall Study||0
10818458|NCT00979550|11982575|FG000|STARTED|Overall Study||4
10818459|NCT00979550|11982576|FG001|STARTED|Overall Study||3
10818460|NCT00979550|11982575|FG000|COMPLETED|Overall Study||4
10818461|NCT00979550|11982576|FG001|COMPLETED|Overall Study||3
10818462|NCT00979550|11982575|FG000|NOT COMPLETED|Overall Study||0
10818463|NCT00979550|11982576|FG001|NOT COMPLETED|Overall Study||0
10818464|NCT00966992|11982584|FG000|STARTED|Overall Study||3
10818465|NCT00966992|11982585|FG001|STARTED|Overall Study||0
10818466|NCT00966992|11982584|FG000|COMPLETED|Overall Study||3
10818467|NCT00966992|11982585|FG001|COMPLETED|Overall Study||0
10818468|NCT00966992|11982584|FG000|NOT COMPLETED|Overall Study||0
10818469|NCT00966992|11982585|FG001|NOT COMPLETED|Overall Study||0
10818470|NCT00981370|11982591|FG000|STARTED|Overall Study||0
10818471|NCT00981370|11982591|FG000|COMPLETED|Overall Study||0
10818472|NCT00981370|11982591|FG000|NOT COMPLETED|Overall Study||0
10818473|NCT00975611|11982595|FG000|STARTED|Overall Study||22
10818474|NCT00975611|11982595|FG000|COMPLETED|Overall Study||5
10818475|NCT00975611|11982595|FG000|NOT COMPLETED|Overall Study||17
10818476|NCT00978419|11982601|FG000|STARTED|Overall Study||0
10818477|NCT00978419|11982602|FG001|STARTED|Overall Study||0
10818478|NCT00978419|11982601|FG000|COMPLETED|Overall Study||0
10818479|NCT00978419|11982602|FG001|COMPLETED|Overall Study||0
10818480|NCT00978419|11982601|FG000|NOT COMPLETED|Overall Study||0
10818481|NCT00978419|11982602|FG001|NOT COMPLETED|Overall Study||0
10818482|NCT00973856|11982610|FG000|STARTED|Overall Study||3
10818483|NCT00973856|11982611|FG001|STARTED|Overall Study||2
10818484|NCT00973856|11982610|FG000|COMPLETED|Overall Study||3
10818485|NCT00973856|11982611|FG001|COMPLETED|Overall Study||2
10818486|NCT00973856|11982610|FG000|NOT COMPLETED|Overall Study||0
10818487|NCT00973856|11982611|FG001|NOT COMPLETED|Overall Study||0
10818488|NCT00979810|11982616|FG000|STARTED|Overall Study||11
10818489|NCT00979810|11982616|FG000|COMPLETED|Overall Study||11
10818490|NCT00979810|11982616|FG000|NOT COMPLETED|Overall Study||0
10818491|NCT00974922|11982620|FG000|STARTED|Overall Study||40
10818492|NCT00974922|11982620|FG000|COMPLETED|Overall Study||16
10818493|NCT00974922|11982620|FG000|NOT COMPLETED|Overall Study||24
10818494|NCT00976339|11982626|FG000|STARTED|Overall Study||10
10818495|NCT00976339|11982627|FG001|STARTED|Overall Study||10
10818496|NCT00976339|11982626|FG000|COMPLETED|Overall Study||10
10818497|NCT00976339|11982627|FG001|COMPLETED|Overall Study||10
10818498|NCT00976339|11982626|FG000|NOT COMPLETED|Overall Study||0
10818499|NCT00976339|11982627|FG001|NOT COMPLETED|Overall Study||0
10818500|NCT00965146|11982635|FG000|STARTED|Overall Study||210
10818501|NCT00965146|11982635|FG000|COMPLETED|Overall Study|Study was terminated prior to reaching 15 year endpoint.|0
10818502|NCT00965146|11982635|FG000|NOT COMPLETED|Overall Study||210
10818503|NCT00972023|11982639|FG000|STARTED|Overall Study||1
10818504|NCT00972023|11982639|FG000|COMPLETED|Overall Study||0
10748981|NCT02991859|11912673|FG007|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
10818505|NCT00972023|11982639|FG000|NOT COMPLETED|Overall Study||1
10818506|NCT00970736|11982645|FG000|STARTED|Overall Study||20
10818507|NCT00970736|11982645|FG000|COMPLETED|Overall Study||18
10818508|NCT00970736|11982645|FG000|NOT COMPLETED|Overall Study||2
10818509|NCT00957827|11982651|FG000|STARTED|Overall Study||2
10818510|NCT00957827|11982652|FG001|STARTED|Overall Study||2
10818511|NCT00957827|11982651|FG000|COMPLETED|Overall Study||2
10818512|NCT00957827|11982652|FG001|COMPLETED|Overall Study||2
10818513|NCT00957827|11982651|FG000|NOT COMPLETED|Overall Study||0
10818514|NCT00957827|11982652|FG001|NOT COMPLETED|Overall Study||0
10818515|NCT00953329|11982658|FG000|STARTED|Overall Study||1
10818516|NCT00953329|11982658|FG000|COMPLETED|Overall Study||0
10748982|NCT02991859|11912674|FG008|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
10748983|NCT02991859|11912675|FG009|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
10748984|NCT02991859|11912676|FG010|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
10748985|NCT02991859|11912677|FG011|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
10748986|NCT02991859|11912678|FG012|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
10748987|NCT02991859|11912679|FG013|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
10748988|NCT02991859|11912680|FG014|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
10748989|NCT02991859|11912681|FG015|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
10748990|NCT02991859|11912682|FG016|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
10748991|NCT02991859|11912666|FG000|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
10748992|NCT02991859|11912667|FG001|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
10748993|NCT02991859|11912668|FG002|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
10748994|NCT02991859|11912669|FG003|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
10748995|NCT02991859|11912670|FG004|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
10748996|NCT02991859|11912671|FG005|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
10748997|NCT02991859|11912672|FG006|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
10748998|NCT02991859|11912673|FG007|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
10748999|NCT02991859|11912674|FG008|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
10749000|NCT02991859|11912675|FG009|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
10749001|NCT02991859|11912676|FG010|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
10749002|NCT02991859|11912677|FG011|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
10749003|NCT02991859|11912678|FG012|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
10749004|NCT02991859|11912679|FG013|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
10749005|NCT02991859|11912680|FG014|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
10749006|NCT02991859|11912681|FG015|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
10749007|NCT02991859|11912682|FG016|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
10749008|NCT02991859|11912666|FG000|STARTED|Period2, Escalation Phase2, Upto Day 91||2
10749009|NCT02991859|11912667|FG001|STARTED|Period2, Escalation Phase2, Upto Day 91||2
10749010|NCT02991859|11912668|FG002|STARTED|Period2, Escalation Phase2, Upto Day 91||2
10749011|NCT02991859|11912669|FG003|STARTED|Period2, Escalation Phase2, Upto Day 91||2
10749012|NCT02991859|11912670|FG004|STARTED|Period2, Escalation Phase2, Upto Day 91||2
10749013|NCT02991859|11912671|FG005|STARTED|Period2, Escalation Phase2, Upto Day 91||1
10749014|NCT02991859|11912672|FG006|STARTED|Period2, Escalation Phase2, Upto Day 91||2
10749015|NCT02991859|11912673|FG007|STARTED|Period2, Escalation Phase2, Upto Day 91||2
10749016|NCT02991859|11912674|FG008|STARTED|Period2, Escalation Phase2, Upto Day 91||2
10749017|NCT02991859|11912675|FG009|STARTED|Period2, Escalation Phase2, Upto Day 91||2
10749018|NCT02991859|11912676|FG010|STARTED|Period2, Escalation Phase2, Upto Day 91||2
10749019|NCT02991859|11912677|FG011|STARTED|Period2, Escalation Phase2, Upto Day 91||2
10749020|NCT02991859|11912678|FG012|STARTED|Period2, Escalation Phase2, Upto Day 91||0
10749021|NCT02991859|11912679|FG013|STARTED|Period2, Escalation Phase2, Upto Day 91||0
10749022|NCT02991859|11912680|FG014|STARTED|Period2, Escalation Phase2, Upto Day 91||0
10749023|NCT02991859|11912681|FG015|STARTED|Period2, Escalation Phase2, Upto Day 91||0
10749024|NCT02991859|11912682|FG016|STARTED|Period2, Escalation Phase2, Upto Day 91||0
10749228|NCT02992197|11912781|FG001|STARTED|Overall Study||110
10749025|NCT02991859|11912666|FG000|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
10749026|NCT02991859|11912667|FG001|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
10749027|NCT02991859|11912668|FG002|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
10749028|NCT02991859|11912669|FG003|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
10749029|NCT02991859|11912670|FG004|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
10749030|NCT02991859|11912671|FG005|COMPLETED|Period2, Escalation Phase2, Upto Day 91||1
10749031|NCT02991859|11912672|FG006|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
10749032|NCT02991859|11912673|FG007|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
10749033|NCT02991859|11912674|FG008|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
10749034|NCT02991859|11912675|FG009|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
10749035|NCT02991859|11912676|FG010|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
10749036|NCT02991859|11912677|FG011|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
10749037|NCT02991859|11912678|FG012|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
10749038|NCT02991859|11912679|FG013|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
10749039|NCT02991859|11912680|FG014|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
10749040|NCT02991859|11912681|FG015|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
10749041|NCT02991859|11912682|FG016|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
10749042|NCT02991859|11912666|FG000|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
10749043|NCT02991859|11912667|FG001|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
10749044|NCT02991859|11912668|FG002|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
10749045|NCT02991859|11912669|FG003|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
10749046|NCT02991859|11912670|FG004|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
10749047|NCT02991859|11912671|FG005|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
10749048|NCT02991859|11912672|FG006|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
10749049|NCT02991859|11912673|FG007|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
10749050|NCT02991859|11912674|FG008|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
10749051|NCT02991859|11912675|FG009|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
10749052|NCT02991859|11912676|FG010|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
10749053|NCT02991859|11912677|FG011|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
10749054|NCT02991859|11912678|FG012|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
10749055|NCT02991859|11912679|FG013|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
10749056|NCT02991859|11912680|FG014|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
10749057|NCT02991859|11912681|FG015|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
10749058|NCT02991859|11912682|FG016|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
10749059|NCT02991859|11912666|FG000|STARTED|Period2, Escalation Phase3, Upto Day 98||2
10749060|NCT02991859|11912667|FG001|STARTED|Period2, Escalation Phase3, Upto Day 98||2
10749061|NCT02991859|11912668|FG002|STARTED|Period2, Escalation Phase3, Upto Day 98||2
10749062|NCT02991859|11912669|FG003|STARTED|Period2, Escalation Phase3, Upto Day 98||2
10749063|NCT02991859|11912670|FG004|STARTED|Period2, Escalation Phase3, Upto Day 98||2
10749064|NCT02991859|11912671|FG005|STARTED|Period2, Escalation Phase3, Upto Day 98||1
10749065|NCT02991859|11912672|FG006|STARTED|Period2, Escalation Phase3, Upto Day 98||2
10749066|NCT02991859|11912673|FG007|STARTED|Period2, Escalation Phase3, Upto Day 98||2
10749067|NCT02991859|11912674|FG008|STARTED|Period2, Escalation Phase3, Upto Day 98||2
10749068|NCT02991859|11912675|FG009|STARTED|Period2, Escalation Phase3, Upto Day 98||2
10749069|NCT02991859|11912676|FG010|STARTED|Period2, Escalation Phase3, Upto Day 98||2
10749070|NCT02991859|11912677|FG011|STARTED|Period2, Escalation Phase3, Upto Day 98||2
10749071|NCT02991859|11912678|FG012|STARTED|Period2, Escalation Phase3, Upto Day 98||0
10749072|NCT02991859|11912679|FG013|STARTED|Period2, Escalation Phase3, Upto Day 98||0
10749073|NCT02991859|11912680|FG014|STARTED|Period2, Escalation Phase3, Upto Day 98||0
10749074|NCT02991859|11912681|FG015|STARTED|Period2, Escalation Phase3, Upto Day 98||0
10749075|NCT02991859|11912682|FG016|STARTED|Period2, Escalation Phase3, Upto Day 98||0
10749076|NCT02991859|11912666|FG000|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
10749077|NCT02991859|11912667|FG001|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
10749078|NCT02991859|11912668|FG002|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
10749079|NCT02991859|11912669|FG003|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
10749080|NCT02991859|11912670|FG004|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
10749081|NCT02991859|11912671|FG005|COMPLETED|Period2, Escalation Phase3, Upto Day 98||1
10749082|NCT02991859|11912672|FG006|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
10749083|NCT02991859|11912673|FG007|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
10749084|NCT02991859|11912674|FG008|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
10749085|NCT02991859|11912675|FG009|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
10749086|NCT02991859|11912676|FG010|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
10749087|NCT02991859|11912677|FG011|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
10749088|NCT02991859|11912678|FG012|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
10749089|NCT02991859|11912679|FG013|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
10749090|NCT02991859|11912680|FG014|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
10749091|NCT02991859|11912681|FG015|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
10749092|NCT02991859|11912682|FG016|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
10749093|NCT02991859|11912666|FG000|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
10749094|NCT02991859|11912667|FG001|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
10749095|NCT02991859|11912668|FG002|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
10749096|NCT02991859|11912669|FG003|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
10749097|NCT02991859|11912670|FG004|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
10749229|NCT02992197|11912780|FG000|COMPLETED|Overall Study||99
10749098|NCT02991859|11912671|FG005|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
10749099|NCT02991859|11912672|FG006|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
10749100|NCT02991859|11912673|FG007|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
10749101|NCT02991859|11912674|FG008|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
10749102|NCT02991859|11912675|FG009|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
10749103|NCT02991859|11912676|FG010|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
10749104|NCT02991859|11912677|FG011|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
10749105|NCT02991859|11912678|FG012|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
10749106|NCT02991859|11912679|FG013|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
10749107|NCT02991859|11912680|FG014|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
10749108|NCT02991859|11912681|FG015|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
10749109|NCT02991859|11912682|FG016|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
10749110|NCT02991859|11912666|FG000|STARTED|Period2, Escalation Phase4, Upto Day 105||2
10749111|NCT02991859|11912667|FG001|STARTED|Period2, Escalation Phase4, Upto Day 105||2
10749112|NCT02991859|11912668|FG002|STARTED|Period2, Escalation Phase4, Upto Day 105||2
10749113|NCT02991859|11912669|FG003|STARTED|Period2, Escalation Phase4, Upto Day 105||2
10749114|NCT02991859|11912670|FG004|STARTED|Period2, Escalation Phase4, Upto Day 105||2
10749115|NCT02991859|11912671|FG005|STARTED|Period2, Escalation Phase4, Upto Day 105||1
10749116|NCT02991859|11912672|FG006|STARTED|Period2, Escalation Phase4, Upto Day 105||2
10749117|NCT02991859|11912673|FG007|STARTED|Period2, Escalation Phase4, Upto Day 105||2
10749118|NCT02991859|11912674|FG008|STARTED|Period2, Escalation Phase4, Upto Day 105||2
10749119|NCT02991859|11912675|FG009|STARTED|Period2, Escalation Phase4, Upto Day 105||2
10749120|NCT02991859|11912676|FG010|STARTED|Period2, Escalation Phase4, Upto Day 105||2
10749121|NCT02991859|11912677|FG011|STARTED|Period2, Escalation Phase4, Upto Day 105||2
10749122|NCT02991859|11912678|FG012|STARTED|Period2, Escalation Phase4, Upto Day 105||0
10749123|NCT02991859|11912679|FG013|STARTED|Period2, Escalation Phase4, Upto Day 105||0
10749124|NCT02991859|11912680|FG014|STARTED|Period2, Escalation Phase4, Upto Day 105||0
10749125|NCT02991859|11912681|FG015|STARTED|Period2, Escalation Phase4, Upto Day 105||0
10749126|NCT02991859|11912682|FG016|STARTED|Period2, Escalation Phase4, Upto Day 105||0
10749127|NCT02991859|11912666|FG000|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
10749128|NCT02991859|11912667|FG001|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
10749129|NCT02991859|11912668|FG002|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
10749130|NCT02991859|11912669|FG003|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
10749131|NCT02991859|11912670|FG004|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
10749132|NCT02991859|11912671|FG005|COMPLETED|Period2, Escalation Phase4, Upto Day 105||1
10749133|NCT02991859|11912672|FG006|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
10749134|NCT02991859|11912673|FG007|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
10818517|NCT00953329|11982658|FG000|NOT COMPLETED|Overall Study||1
10818518|NCT00965055|11982662|FG000|STARTED|Overall Study||2
10818519|NCT00965055|11982662|FG000|COMPLETED|Overall Study||2
10818520|NCT00965055|11982662|FG000|NOT COMPLETED|Overall Study||0
10818521|NCT00962429|11982668|FG000|STARTED|Overall Study||0
10818522|NCT00962429|11982669|FG001|STARTED|Overall Study||0
10818523|NCT00962429|11982668|FG000|COMPLETED|Overall Study||0
10818524|NCT00962429|11982669|FG001|COMPLETED|Overall Study||0
10818525|NCT00962429|11982668|FG000|NOT COMPLETED|Overall Study||0
10818526|NCT00962429|11982669|FG001|NOT COMPLETED|Overall Study||0
10818527|NCT00958893|11982675|FG000|STARTED|Overall Study||4
10818528|NCT00958893|11982675|FG000|COMPLETED|Overall Study||0
10818529|NCT00958893|11982675|FG000|NOT COMPLETED|Overall Study||4
10818530|NCT00966654|11982679|FG000|STARTED|Overall Study||12
10818531|NCT00966654|11982679|FG000|COMPLETED|Overall Study||0
10818532|NCT00966654|11982679|FG000|NOT COMPLETED|Overall Study||12
10818533|NCT00960154|11982687|FG000|STARTED|Overall Study||25
10818534|NCT00960154|11982688|FG001|STARTED|Overall Study||25
10818535|NCT00960154|11982687|FG000|COMPLETED|Overall Study||0
10818536|NCT00960154|11982688|FG001|COMPLETED|Overall Study||0
10818537|NCT00960154|11982687|FG000|NOT COMPLETED|Overall Study||25
10818538|NCT00960154|11982688|FG001|NOT COMPLETED|Overall Study||25
10778477|NCT03357731|11940420|FG001|COMPLETED|Overall Study||7
10749135|NCT02991859|11912674|FG008|COMPLETED|Period2, Escalation Phase4, Upto Day 105||1
10749136|NCT02991859|11912675|FG009|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
10749137|NCT02991859|11912676|FG010|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
10749138|NCT02991859|11912677|FG011|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
10749139|NCT02991859|11912678|FG012|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
10749140|NCT02991859|11912679|FG013|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
10749141|NCT02991859|11912680|FG014|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
10749142|NCT02991859|11912681|FG015|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
10749143|NCT02991859|11912682|FG016|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
10749144|NCT02991859|11912666|FG000|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
10749145|NCT02991859|11912667|FG001|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
10749146|NCT02991859|11912668|FG002|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
10749147|NCT02991859|11912669|FG003|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
10749148|NCT02991859|11912670|FG004|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
10749149|NCT02991859|11912671|FG005|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
10749150|NCT02991859|11912672|FG006|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
10749151|NCT02991859|11912673|FG007|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
10749152|NCT02991859|11912674|FG008|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||1
10749153|NCT02991859|11912675|FG009|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
10749154|NCT02991859|11912676|FG010|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
10749155|NCT02991859|11912677|FG011|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
10749156|NCT02991859|11912678|FG012|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
10749157|NCT02991859|11912679|FG013|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
10749158|NCT02991859|11912680|FG014|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
10749159|NCT02991859|11912681|FG015|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
10749160|NCT02991859|11912682|FG016|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
10749161|NCT02991859|11912666|FG000|STARTED|Period2,Escalation Phase5,Upto Day 112||2
10749162|NCT02991859|11912667|FG001|STARTED|Period2,Escalation Phase5,Upto Day 112||2
10749163|NCT02991859|11912668|FG002|STARTED|Period2,Escalation Phase5,Upto Day 112||2
10749164|NCT02991859|11912669|FG003|STARTED|Period2,Escalation Phase5,Upto Day 112||2
10749165|NCT02991859|11912670|FG004|STARTED|Period2,Escalation Phase5,Upto Day 112||2
10749166|NCT02991859|11912671|FG005|STARTED|Period2,Escalation Phase5,Upto Day 112||1
10749167|NCT02991859|11912672|FG006|STARTED|Period2,Escalation Phase5,Upto Day 112||2
10749168|NCT02991859|11912673|FG007|STARTED|Period2,Escalation Phase5,Upto Day 112||2
10749169|NCT02991859|11912674|FG008|STARTED|Period2,Escalation Phase5,Upto Day 112||1
10749170|NCT02991859|11912675|FG009|STARTED|Period2,Escalation Phase5,Upto Day 112||2
10749171|NCT02991859|11912676|FG010|STARTED|Period2,Escalation Phase5,Upto Day 112||2
10749172|NCT02991859|11912677|FG011|STARTED|Period2,Escalation Phase5,Upto Day 112||2
10749173|NCT02991859|11912678|FG012|STARTED|Period2,Escalation Phase5,Upto Day 112||0
10749174|NCT02991859|11912679|FG013|STARTED|Period2,Escalation Phase5,Upto Day 112||0
10749175|NCT02991859|11912680|FG014|STARTED|Period2,Escalation Phase5,Upto Day 112||0
10749176|NCT02991859|11912681|FG015|STARTED|Period2,Escalation Phase5,Upto Day 112||0
10749177|NCT02991859|11912682|FG016|STARTED|Period2,Escalation Phase5,Upto Day 112||0
10749178|NCT02991859|11912666|FG000|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
10749179|NCT02991859|11912667|FG001|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
10749180|NCT02991859|11912668|FG002|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
10749181|NCT02991859|11912669|FG003|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
10749182|NCT02991859|11912670|FG004|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
10749183|NCT02991859|11912671|FG005|COMPLETED|Period2,Escalation Phase5,Upto Day 112||1
10749184|NCT02991859|11912672|FG006|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
10749185|NCT02991859|11912673|FG007|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
10749186|NCT02991859|11912674|FG008|COMPLETED|Period2,Escalation Phase5,Upto Day 112||1
10749187|NCT02991859|11912675|FG009|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
10749188|NCT02991859|11912676|FG010|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
10749189|NCT02991859|11912677|FG011|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
10749190|NCT02991859|11912678|FG012|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
10749191|NCT02991859|11912679|FG013|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
10749192|NCT02991859|11912680|FG014|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
10749193|NCT02991859|11912681|FG015|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
10749194|NCT02991859|11912682|FG016|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
10749195|NCT02991859|11912666|FG000|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
10749196|NCT02991859|11912667|FG001|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
10749197|NCT02991859|11912668|FG002|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
10749198|NCT02991859|11912669|FG003|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
10749199|NCT02991859|11912670|FG004|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
10749200|NCT02991859|11912671|FG005|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
10749201|NCT02991859|11912672|FG006|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
10749202|NCT02991859|11912673|FG007|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
10749203|NCT02991859|11912674|FG008|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
10749204|NCT02991859|11912675|FG009|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
10749205|NCT02991859|11912676|FG010|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
10779389|NCT03365778|11940977|FG001|STARTED|Overall Study||17
10749206|NCT02991859|11912677|FG011|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
10749207|NCT02991859|11912678|FG012|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
10749208|NCT02991859|11912679|FG013|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
10749209|NCT02991859|11912680|FG014|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
10749210|NCT02991859|11912681|FG015|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
10749211|NCT02991859|11912682|FG016|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
10749212|NCT02991898|11912757|FG000|STARTED|Overall Study||3
10749213|NCT02991898|11912757|FG000|COMPLETED|Overall Study||3
10749214|NCT02991898|11912757|FG000|NOT COMPLETED|Overall Study||0
10749215|NCT02992067|11912761|FG000|STARTED|Overall Study||359
10749216|NCT02992067|11912761|FG000|COMPLETED|Overall Study||359
10749217|NCT02992067|11912761|FG000|NOT COMPLETED|Overall Study||0
10749218|NCT02992132|11912768|FG000|STARTED|Overall Study||40
10749219|NCT02992132|11912769|FG001|STARTED|Overall Study||35
10749220|NCT02992132|11912770|FG002|STARTED|Overall Study||36
10749221|NCT02992132|11912768|FG000|COMPLETED|Overall Study||27
10749222|NCT02992132|11912769|FG001|COMPLETED|Overall Study||27
10749223|NCT02992132|11912770|FG002|COMPLETED|Overall Study||29
10749224|NCT02992132|11912768|FG000|NOT COMPLETED|Overall Study||13
10749225|NCT02992132|11912769|FG001|NOT COMPLETED|Overall Study||8
10749226|NCT02992132|11912770|FG002|NOT COMPLETED|Overall Study||7
10749227|NCT02992197|11912780|FG000|STARTED|Overall Study||110
10818539|NCT00960752|11982697|FG000|STARTED|Overall Study||13
10818540|NCT00960752|11982698|FG001|STARTED|Overall Study||13
10818541|NCT00960752|11982699|FG002|STARTED|Overall Study||19
10818542|NCT00960752|11982697|FG000|COMPLETED|Overall Study||13
10818543|NCT00960752|11982698|FG001|COMPLETED|Overall Study||13
10749230|NCT02992197|11912781|FG001|COMPLETED|Overall Study||103
10749231|NCT02992197|11912780|FG000|NOT COMPLETED|Overall Study||11
10749232|NCT02992197|11912781|FG001|NOT COMPLETED|Overall Study||7
10749233|NCT02992236|11912789|FG000|STARTED|Overall Study||8
10749234|NCT02992236|11912790|FG001|STARTED|Overall Study||8
10749235|NCT02992236|11912789|FG000|COMPLETED|Overall Study||8
10749236|NCT02992236|11912790|FG001|COMPLETED|Overall Study||8
10749237|NCT02992236|11912789|FG000|NOT COMPLETED|Overall Study||0
10749238|NCT02992236|11912790|FG001|NOT COMPLETED|Overall Study||0
10749239|NCT02992288|11912804|FG000|STARTED|Overall Study||106
10749240|NCT02992288|11912805|FG001|STARTED|Overall Study||37
10749241|NCT02992288|11912806|FG002|STARTED|Overall Study||70
10749242|NCT02992288|11912807|FG003|STARTED|Overall Study||73
10749243|NCT02992288|11912808|FG004|STARTED|Overall Study||69
10749244|NCT02992288|11912809|FG005|STARTED|Overall Study||72
10749245|NCT02992288|11912804|FG000|Treated|Overall Study||106
10749246|NCT02992288|11912805|FG001|Treated|Overall Study||37
10749247|NCT02992288|11912806|FG002|Treated|Overall Study||70
10749248|NCT02992288|11912807|FG003|Treated|Overall Study||72
10749249|NCT02992288|11912808|FG004|Treated|Overall Study||69
10749250|NCT02992288|11912809|FG005|Treated|Overall Study||72
10749251|NCT02992288|11912804|FG000|COMPLETED|Overall Study||89
10749252|NCT02992288|11912805|FG001|COMPLETED|Overall Study||32
10749253|NCT02992288|11912806|FG002|COMPLETED|Overall Study||63
10749254|NCT02992288|11912807|FG003|COMPLETED|Overall Study||64
10749255|NCT02992288|11912808|FG004|COMPLETED|Overall Study||61
10749256|NCT02992288|11912809|FG005|COMPLETED|Overall Study||59
10749257|NCT02992288|11912804|FG000|NOT COMPLETED|Overall Study||17
10749258|NCT02992288|11912805|FG001|NOT COMPLETED|Overall Study||5
10749259|NCT02992288|11912806|FG002|NOT COMPLETED|Overall Study||7
10749260|NCT02992288|11912807|FG003|NOT COMPLETED|Overall Study||9
10749261|NCT02992288|11912808|FG004|NOT COMPLETED|Overall Study||8
10749262|NCT02992288|11912809|FG005|NOT COMPLETED|Overall Study||13
10749263|NCT02992691|11912823|FG000|STARTED|Overall Study||56
10749264|NCT02992691|11912823|FG000|Received Test Product 1|Overall Study||55
10749265|NCT02992691|11912823|FG000|Received Test Product 2|Overall Study||55
10749266|NCT02992691|11912823|FG000|Received Test Product 3|Overall Study||52
10749267|NCT02992691|11912823|FG000|Received Positive Control|Overall Study||55
10749268|NCT02992691|11912823|FG000|Received Negative Control|Overall Study||55
10749269|NCT02992691|11912823|FG000|COMPLETED|Overall Study||53
10749270|NCT02992691|11912823|FG000|NOT COMPLETED|Overall Study||3
10749271|NCT02992899|11912840|FG000|STARTED|Overall Study||27
10749272|NCT02992899|11912841|FG001|STARTED|Overall Study||29
10749273|NCT02992899|11912840|FG000|COMPLETED|Overall Study||25
10749274|NCT02992899|11912841|FG001|COMPLETED|Overall Study||26
10749275|NCT02992899|11912840|FG000|NOT COMPLETED|Overall Study||2
10749276|NCT02992899|11912841|FG001|NOT COMPLETED|Overall Study||3
10749277|NCT02993224|11912847|FG000|STARTED|Core Phase - Period 1||148
10749278|NCT02993224|11912847|FG000|COMPLETED|Core Phase - Period 1||140
10749279|NCT02993224|11912847|FG000|NOT COMPLETED|Core Phase - Period 1||8
10818544|NCT00960752|11982699|FG002|COMPLETED|Overall Study||17
10818545|NCT00960752|11982697|FG000|NOT COMPLETED|Overall Study||0
10818546|NCT00960752|11982698|FG001|NOT COMPLETED|Overall Study||0
10818547|NCT00960752|11982699|FG002|NOT COMPLETED|Overall Study||2
10749280|NCT02993224|11912847|FG000|STARTED|Core Phase- Period 2||140
10749281|NCT02993224|11912847|FG000|COMPLETED|Core Phase- Period 2||136
10749282|NCT02993224|11912847|FG000|NOT COMPLETED|Core Phase- Period 2||4
10749283|NCT02993224|11912847|FG000|STARTED|Extension Phase||116
10749284|NCT02993224|11912847|FG000|COMPLETED|Extension Phase||80
10749285|NCT02993224|11912847|FG000|NOT COMPLETED|Extension Phase||36
10818548|NCT00958347|11982707|FG000|STARTED|Overall Study||226
10818549|NCT00958347|11982707|FG000|COMPLETED|Overall Study|11 revisions total, one was a bilateral participant with the other hip counted as not completed.|0
10818550|NCT00958347|11982707|FG000|NOT COMPLETED|Overall Study||226
10818551|NCT00954187|11982713|FG000|STARTED|Overall Study|No subjects were assigned treatment and no study procedures were performed|0
10818552|NCT00954187|11982714|FG001|STARTED|Overall Study|No subjects were assigned treatment and no study procedures were performed|0
10818553|NCT00954187|11982713|FG000|COMPLETED|Overall Study||0
10818554|NCT00954187|11982714|FG001|COMPLETED|Overall Study||0
10749286|NCT02993250|11912855|FG000|STARTED|Overall Study||22
10749287|NCT02993250|11912856|FG001|STARTED|Overall Study||11
10408767|NCT00756977|11552921|FG000|COMPLETED|Overall Study||175
10408768|NCT00756977|11552922|FG001|COMPLETED|Overall Study||187
10408769|NCT00756977|11552921|FG000|NOT COMPLETED|Overall Study||21
10408770|NCT00756977|11552922|FG001|NOT COMPLETED|Overall Study||11
10408771|NCT00757003|11552928|FG000|STARTED|Overall Study||100
10408772|NCT00757003|11552928|FG000|COMPLETED|Overall Study||51
10818555|NCT00954187|11982713|FG000|NOT COMPLETED|Overall Study||0
10818556|NCT00954187|11982714|FG001|NOT COMPLETED|Overall Study||0
10818557|NCT00953615|11982720|FG000|STARTED|Overall Study||1
10818558|NCT00953615|11982720|FG000|COMPLETED|Overall Study||0
10818559|NCT00953615|11982720|FG000|NOT COMPLETED|Overall Study||1
10818560|NCT00947284|11982724|FG000|STARTED|Overall Study||0
10818561|NCT00947284|11982725|FG001|STARTED|Overall Study||3
10818562|NCT00947284|11982724|FG000|COMPLETED|Overall Study||0
10818563|NCT00947284|11982725|FG001|COMPLETED|Overall Study||0
10818564|NCT00947284|11982724|FG000|NOT COMPLETED|Overall Study||0
10408773|NCT00757003|11552928|FG000|NOT COMPLETED|Overall Study||49
10408774|NCT00757172|11552933|FG000|STARTED|Overall Study||65
10408775|NCT00757172|11552933|FG000|COMPLETED|Overall Study|Participants underwent surgery.|54
10408776|NCT00757172|11552933|FG000|NOT COMPLETED|Overall Study||11
10749288|NCT02993250|11912855|FG000|COMPLETED|Overall Study||22
10749289|NCT02993250|11912856|FG001|COMPLETED|Overall Study||10
10749290|NCT02993250|11912855|FG000|NOT COMPLETED|Overall Study||0
10749291|NCT02993250|11912856|FG001|NOT COMPLETED|Overall Study||1
10749292|NCT02993302|11912864|FG000|STARTED|Overall Study||13
10749293|NCT02993302|11912865|FG001|STARTED|Overall Study||12
10749294|NCT02993302|11912864|FG000|COMPLETED|Overall Study||13
10749295|NCT02993302|11912865|FG001|COMPLETED|Overall Study||12
10749296|NCT02993302|11912864|FG000|NOT COMPLETED|Overall Study||0
10749297|NCT02993302|11912865|FG001|NOT COMPLETED|Overall Study||0
10749298|NCT02993445|11912873|FG000|STARTED|First Intervention (5 Minutes)||6
10749299|NCT02993445|11912874|FG001|STARTED|First Intervention (5 Minutes)||5
10749300|NCT02993445|11912873|FG000|COMPLETED|First Intervention (5 Minutes)||6
10749301|NCT02993445|11912874|FG001|COMPLETED|First Intervention (5 Minutes)||5
10749302|NCT02993445|11912873|FG000|NOT COMPLETED|First Intervention (5 Minutes)||0
10749303|NCT02993445|11912874|FG001|NOT COMPLETED|First Intervention (5 Minutes)||0
10749304|NCT02993445|11912873|FG000|STARTED|Washout (2 Weeks)||6
10749305|NCT02993445|11912874|FG001|STARTED|Washout (2 Weeks)||5
10749306|NCT02993445|11912873|FG000|COMPLETED|Washout (2 Weeks)||6
10749307|NCT02993445|11912874|FG001|COMPLETED|Washout (2 Weeks)||5
10749308|NCT02993445|11912873|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10749309|NCT02993445|11912874|FG001|NOT COMPLETED|Washout (2 Weeks)||0
10749310|NCT02993445|11912873|FG000|STARTED|Second Intervention (5 Mins)||6
10749311|NCT02993445|11912874|FG001|STARTED|Second Intervention (5 Mins)||5
10749312|NCT02993445|11912873|FG000|COMPLETED|Second Intervention (5 Mins)||6
10749313|NCT02993445|11912874|FG001|COMPLETED|Second Intervention (5 Mins)||5
10749314|NCT02993445|11912873|FG000|NOT COMPLETED|Second Intervention (5 Mins)||0
10749315|NCT02993445|11912874|FG001|NOT COMPLETED|Second Intervention (5 Mins)||0
10749316|NCT02993471|11912880|FG000|STARTED|Period 1 (Drug Cocktail)||28
10749317|NCT02993471|11912880|FG000|Received at Least 1 Dose of Study Drug|Period 1 (Drug Cocktail)||28
10749318|NCT02993471|11912880|FG000|COMPLETED|Period 1 (Drug Cocktail)||28
10818565|NCT00947284|11982725|FG001|NOT COMPLETED|Overall Study||3
10818566|NCT00957034|11982732|FG000|STARTED|Overall Study||6
10818567|NCT00957034|11982733|FG001|STARTED|Overall Study||4
10818568|NCT00957034|11982734|FG002|STARTED|Overall Study||7
10408777|NCT00757237|11552939|FG000|STARTED|Overall Study||137
10749319|NCT02993471|11912880|FG000|NOT COMPLETED|Period 1 (Drug Cocktail)||0
10749320|NCT02993471|11912880|FG000|STARTED|Period 2 (Drug Cocktail + Ixekizumab)||28
10749321|NCT02993471|11912880|FG000|Received at Least 1 Dose of Study Drug|Period 2 (Drug Cocktail + Ixekizumab)||27
10749322|NCT02993471|11912880|FG000|COMPLETED|Period 2 (Drug Cocktail + Ixekizumab)||26
10749323|NCT02993471|11912880|FG000|NOT COMPLETED|Period 2 (Drug Cocktail + Ixekizumab)||2
10749324|NCT02993783|11912904|FG000|STARTED|Overall Study||8
10749325|NCT02993783|11912905|FG001|STARTED|Overall Study||9
10749326|NCT02993783|11912904|FG000|COMPLETED|Overall Study||2
10749327|NCT02993783|11912905|FG001|COMPLETED|Overall Study||0
10749328|NCT02993783|11912904|FG000|NOT COMPLETED|Overall Study||6
10749329|NCT02993783|11912905|FG001|NOT COMPLETED|Overall Study||9
10749330|NCT02994056|11912911|FG000|STARTED|Overall Study||32
10749331|NCT02994056|11912911|FG000|COMPLETED|Overall Study||23
10749332|NCT02994056|11912911|FG000|NOT COMPLETED|Overall Study||9
10749333|NCT02994108|11912926|FG000|STARTED|Intervention Messages||74
10749334|NCT02994108|11912927|FG001|STARTED|Intervention Messages||76
10749335|NCT02994108|11912926|FG000|COMPLETED|Intervention Messages||72
10749336|NCT02994108|11912927|FG001|COMPLETED|Intervention Messages||76
10749337|NCT02994108|11912926|FG000|NOT COMPLETED|Intervention Messages||2
10749338|NCT02994108|11912927|FG001|NOT COMPLETED|Intervention Messages||0
10749339|NCT02994108|11912926|FG000|STARTED|Phase 1 Assessment||72
10749340|NCT02994108|11912927|FG001|STARTED|Phase 1 Assessment||76
10749341|NCT02994108|11912926|FG000|COMPLETED|Phase 1 Assessment||67
10749342|NCT02994108|11912927|FG001|COMPLETED|Phase 1 Assessment||73
10749343|NCT02994108|11912926|FG000|NOT COMPLETED|Phase 1 Assessment||5
10818569|NCT00957034|11982732|FG000|COMPLETED|Overall Study||0
10818570|NCT00957034|11982733|FG001|COMPLETED|Overall Study||0
10818571|NCT00957034|11982734|FG002|COMPLETED|Overall Study||1
10818572|NCT00957034|11982732|FG000|NOT COMPLETED|Overall Study||6
10818573|NCT00957034|11982733|FG001|NOT COMPLETED|Overall Study||4
10818574|NCT00957034|11982734|FG002|NOT COMPLETED|Overall Study||6
10818575|NCT00949988|11982742|FG000|STARTED|Overall Study||3
10818576|NCT00949988|11982742|FG000|COMPLETED|Overall Study||0
10818577|NCT00949988|11982742|FG000|NOT COMPLETED|Overall Study||3
10818578|NCT00948194|11982748|FG000|STARTED|Overall Study||6
10818579|NCT00948194|11982749|FG001|STARTED|Overall Study||7
10818580|NCT00948194|11982748|FG000|COMPLETED|Overall Study||5
10818581|NCT00948194|11982749|FG001|COMPLETED|Overall Study||7
10818582|NCT00948194|11982748|FG000|NOT COMPLETED|Overall Study||1
10818583|NCT00948194|11982749|FG001|NOT COMPLETED|Overall Study||0
10818584|NCT00946985|11982755|FG000|STARTED|Stabilization Phase (25 Weeks)||162
10818585|NCT00946985|11982755|FG000|COMPLETED|Stabilization Phase (25 Weeks)||2
10818586|NCT00946985|11982755|FG000|NOT COMPLETED|Stabilization Phase (25 Weeks)||160
10818587|NCT00946985|11982755|FG000|STARTED|Relapse Prevention Phase (24 Months)|Both randomized patients were discontinued when the sponsor terminated the trial early.|2
10818588|NCT00946985|11982755|FG000|COMPLETED|Relapse Prevention Phase (24 Months)||0
10749386|NCT02994394|11912950|FG005|COMPLETED|Period 2 (Days 4 to 6)||14
10818589|NCT00946985|11982755|FG000|NOT COMPLETED|Relapse Prevention Phase (24 Months)||2
10818590|NCT00950183|11982759|FG000|STARTED|Overall Study||36
10818591|NCT00950183|11982759|FG000|COMPLETED|Overall Study||0
10818592|NCT00950183|11982759|FG000|NOT COMPLETED|Overall Study||36
10818593|NCT00950690|11982763|FG000|STARTED|Overall Study||1349
10818594|NCT00950690|11982763|FG000|COMPLETED|Overall Study||1105
10818595|NCT00950690|11982763|FG000|NOT COMPLETED|Overall Study||244
10818596|NCT00944229|11982767|FG000|STARTED|Overall Study||58
10818597|NCT00944229|11982767|FG000|COMPLETED|Overall Study||33
10818598|NCT00944229|11982767|FG000|NOT COMPLETED|Overall Study||25
10818599|NCT00941928|11982771|FG000|STARTED|Overall Study||2
10818600|NCT00941928|11982771|FG000|COMPLETED|Overall Study||0
10818601|NCT00941928|11982771|FG000|NOT COMPLETED|Overall Study||2
10818602|NCT00949403|11982775|FG000|STARTED|Overall Study||9
10818603|NCT00949403|11982775|FG000|COMPLETED|Overall Study||9
10818604|NCT00949403|11982775|FG000|NOT COMPLETED|Overall Study||0
10818605|NCT00947791|11982781|FG000|STARTED|Overall Study||0
10818606|NCT00947791|11982782|FG001|STARTED|Overall Study||1
10818607|NCT00947791|11982781|FG000|COMPLETED|Overall Study||0
10818608|NCT00947791|11982782|FG001|COMPLETED|Overall Study||1
10818609|NCT00947791|11982781|FG000|NOT COMPLETED|Overall Study||0
10818610|NCT00947791|11982782|FG001|NOT COMPLETED|Overall Study||0
10818611|NCT00947011|11982788|FG000|STARTED|Overall Study||12
10818612|NCT00947011|11982788|FG000|COMPLETED|Overall Study||0
10818613|NCT00947011|11982788|FG000|NOT COMPLETED|Overall Study||12
10818614|NCT00943605|11982796|FG000|STARTED|Overall Study|There were 10 total subjects (5/group) who were retrospectively unenrolled for deviations.|30
10818615|NCT00943605|11982797|FG001|STARTED|Overall Study|There were 10 total subjects (5/group) who were retrospectively unenrolled for deviations.|30
10818616|NCT00943605|11982796|FG000|COMPLETED|Overall Study||0
10818617|NCT00943605|11982797|FG001|COMPLETED|Overall Study||0
10818618|NCT00943605|11982796|FG000|NOT COMPLETED|Overall Study||30
10818619|NCT00943605|11982797|FG001|NOT COMPLETED|Overall Study||30
10818620|NCT00942409|11982803|FG000|STARTED|Overall Study||5
10818621|NCT00942409|11982803|FG000|COMPLETED|Overall Study||2
10818622|NCT00942409|11982803|FG000|NOT COMPLETED|Overall Study||3
10818623|NCT00936585|11982807|FG000|STARTED|Overall Study||2
10818624|NCT00936585|11982807|FG000|COMPLETED|Overall Study||2
10818625|NCT00936585|11982807|FG000|NOT COMPLETED|Overall Study||0
10818626|NCT00936598|11982813|FG000|STARTED|Overall Study||4
10818627|NCT00936598|11982814|FG001|STARTED|Overall Study||1
10818628|NCT00936598|11982813|FG000|COMPLETED|Overall Study||2
10818629|NCT00936598|11982814|FG001|COMPLETED|Overall Study||1
10818630|NCT00936598|11982813|FG000|NOT COMPLETED|Overall Study||2
10749344|NCT02994108|11912927|FG001|NOT COMPLETED|Phase 1 Assessment||3
10749345|NCT02994108|11912926|FG000|STARTED|Phase 2 Assessment||72
10749346|NCT02994108|11912927|FG001|STARTED|Phase 2 Assessment||76
10749347|NCT02994108|11912926|FG000|COMPLETED|Phase 2 Assessment||63
10749348|NCT02994108|11912927|FG001|COMPLETED|Phase 2 Assessment||69
10749349|NCT02994108|11912926|FG000|NOT COMPLETED|Phase 2 Assessment||9
10749350|NCT02994108|11912927|FG001|NOT COMPLETED|Phase 2 Assessment||7
10749351|NCT02994238|11912936|FG000|STARTED|Overall Study||125
10749352|NCT02994238|11912937|FG001|STARTED|Overall Study||127
10818631|NCT00936598|11982814|FG001|NOT COMPLETED|Overall Study||0
10818632|NCT00920309|11982822|FG000|STARTED|Overall Study||14
10818633|NCT00920309|11982823|FG001|STARTED|Overall Study||7
10818634|NCT00920309|11982822|FG000|COMPLETED|Overall Study||14
10818635|NCT00920309|11982823|FG001|COMPLETED|Overall Study||7
10749353|NCT02994238|11912936|FG000|COMPLETED|Overall Study||125
10749354|NCT02994238|11912937|FG001|COMPLETED|Overall Study||127
10749355|NCT02994238|11912936|FG000|NOT COMPLETED|Overall Study||0
10749356|NCT02994238|11912937|FG001|NOT COMPLETED|Overall Study||0
10749357|NCT02994394|11912945|FG000|STARTED|Period 1 (Days 1 to 3)||14
10749358|NCT02994394|11912946|FG001|STARTED|Period 1 (Days 1 to 3)||14
10749359|NCT02994394|11912947|FG002|STARTED|Period 1 (Days 1 to 3)||14
10749360|NCT02994394|11912948|FG003|STARTED|Period 1 (Days 1 to 3)||14
10749361|NCT02994394|11912949|FG004|STARTED|Period 1 (Days 1 to 3)||14
10749362|NCT02994394|11912950|FG005|STARTED|Period 1 (Days 1 to 3)||14
10749363|NCT02994394|11912945|FG000|COMPLETED|Period 1 (Days 1 to 3)||14
10749364|NCT02994394|11912946|FG001|COMPLETED|Period 1 (Days 1 to 3)||14
10749365|NCT02994394|11912947|FG002|COMPLETED|Period 1 (Days 1 to 3)||13
10749366|NCT02994394|11912948|FG003|COMPLETED|Period 1 (Days 1 to 3)||14
10749367|NCT02994394|11912949|FG004|COMPLETED|Period 1 (Days 1 to 3)||14
10749368|NCT02994394|11912950|FG005|COMPLETED|Period 1 (Days 1 to 3)||14
10749369|NCT02994394|11912945|FG000|NOT COMPLETED|Period 1 (Days 1 to 3)||0
10749370|NCT02994394|11912946|FG001|NOT COMPLETED|Period 1 (Days 1 to 3)||0
10749371|NCT02994394|11912947|FG002|NOT COMPLETED|Period 1 (Days 1 to 3)||1
10749372|NCT02994394|11912948|FG003|NOT COMPLETED|Period 1 (Days 1 to 3)||0
10749373|NCT02994394|11912949|FG004|NOT COMPLETED|Period 1 (Days 1 to 3)||0
10749374|NCT02994394|11912950|FG005|NOT COMPLETED|Period 1 (Days 1 to 3)||0
10749375|NCT02994394|11912945|FG000|STARTED|Period 2 (Days 4 to 6)||14
10749376|NCT02994394|11912946|FG001|STARTED|Period 2 (Days 4 to 6)||14
10749377|NCT02994394|11912947|FG002|STARTED|Period 2 (Days 4 to 6)||13
10749378|NCT02994394|11912948|FG003|STARTED|Period 2 (Days 4 to 6)||14
10749379|NCT02994394|11912949|FG004|STARTED|Period 2 (Days 4 to 6)||14
10749380|NCT02994394|11912950|FG005|STARTED|Period 2 (Days 4 to 6)||14
10749381|NCT02994394|11912945|FG000|COMPLETED|Period 2 (Days 4 to 6)||14
10749382|NCT02994394|11912946|FG001|COMPLETED|Period 2 (Days 4 to 6)||13
10749383|NCT02994394|11912947|FG002|COMPLETED|Period 2 (Days 4 to 6)||13
10749384|NCT02994394|11912948|FG003|COMPLETED|Period 2 (Days 4 to 6)||14
10749385|NCT02994394|11912949|FG004|COMPLETED|Period 2 (Days 4 to 6)||13
10749387|NCT02994394|11912945|FG000|NOT COMPLETED|Period 2 (Days 4 to 6)||0
10749388|NCT02994394|11912946|FG001|NOT COMPLETED|Period 2 (Days 4 to 6)||1
10749389|NCT02994394|11912947|FG002|NOT COMPLETED|Period 2 (Days 4 to 6)||0
10749390|NCT02994394|11912948|FG003|NOT COMPLETED|Period 2 (Days 4 to 6)||0
10749391|NCT02994394|11912949|FG004|NOT COMPLETED|Period 2 (Days 4 to 6)||1
10749392|NCT02994394|11912950|FG005|NOT COMPLETED|Period 2 (Days 4 to 6)||0
10749393|NCT02994394|11912945|FG000|STARTED|Period 3 (Days 7 and 8)||14
10749394|NCT02994394|11912946|FG001|STARTED|Period 3 (Days 7 and 8)||13
10749395|NCT02994394|11912947|FG002|STARTED|Period 3 (Days 7 and 8)||13
10749396|NCT02994394|11912948|FG003|STARTED|Period 3 (Days 7 and 8)||14
10749397|NCT02994394|11912949|FG004|STARTED|Period 3 (Days 7 and 8)||13
10749398|NCT02994394|11912950|FG005|STARTED|Period 3 (Days 7 and 8)||14
10749399|NCT02994394|11912945|FG000|COMPLETED|Period 3 (Days 7 and 8)||14
10818636|NCT00920309|11982822|FG000|NOT COMPLETED|Overall Study||0
10818637|NCT00920309|11982823|FG001|NOT COMPLETED|Overall Study||0
10818638|NCT00935649|11982830|FG000|STARTED|Overall Study||139
10818639|NCT00935649|11982830|FG000|COMPLETED|Overall Study||134
10818640|NCT00935649|11982830|FG000|NOT COMPLETED|Overall Study||5
10818641|NCT00934791|11982838|FG000|STARTED|Overall Study||1
10818642|NCT00934791|11982839|FG001|STARTED|Overall Study||0
10818643|NCT00934791|11982838|FG000|COMPLETED|Overall Study||0
10818644|NCT00934791|11982839|FG001|COMPLETED|Overall Study||0
10818645|NCT00934791|11982838|FG000|NOT COMPLETED|Overall Study||1
10818646|NCT00934791|11982839|FG001|NOT COMPLETED|Overall Study||0
10818647|NCT00932152|11982847|FG000|STARTED|Overall Study||1
10818648|NCT00932152|11982848|FG001|STARTED|Overall Study||2
10818649|NCT00932152|11982847|FG000|COMPLETED|Overall Study||0
10818650|NCT00932152|11982848|FG001|COMPLETED|Overall Study||0
10818651|NCT00932152|11982847|FG000|NOT COMPLETED|Overall Study||1
10818652|NCT00932152|11982848|FG001|NOT COMPLETED|Overall Study||2
10818653|NCT00928499|11982856|FG000|STARTED|Overall Study||18
10818654|NCT00928499|11982857|FG001|STARTED|Overall Study||14
10818655|NCT00928499|11982856|FG000|COMPLETED|Overall Study||18
10818656|NCT00928499|11982857|FG001|COMPLETED|Overall Study||14
10818657|NCT00928499|11982856|FG000|NOT COMPLETED|Overall Study||0
10818658|NCT00928499|11982857|FG001|NOT COMPLETED|Overall Study||0
10818659|NCT00924807|11982863|FG000|STARTED|Overall Study||4
10749400|NCT02994394|11912946|FG001|COMPLETED|Period 3 (Days 7 and 8)||13
10749401|NCT02994394|11912947|FG002|COMPLETED|Period 3 (Days 7 and 8)||13
10749402|NCT02994394|11912948|FG003|COMPLETED|Period 3 (Days 7 and 8)||14
10749403|NCT02994394|11912949|FG004|COMPLETED|Period 3 (Days 7 and 8)||13
10749404|NCT02994394|11912950|FG005|COMPLETED|Period 3 (Days 7 and 8)||14
10749405|NCT02994394|11912945|FG000|NOT COMPLETED|Period 3 (Days 7 and 8)||0
10749406|NCT02994394|11912946|FG001|NOT COMPLETED|Period 3 (Days 7 and 8)||0
10749407|NCT02994394|11912947|FG002|NOT COMPLETED|Period 3 (Days 7 and 8)||0
10749408|NCT02994394|11912948|FG003|NOT COMPLETED|Period 3 (Days 7 and 8)||0
10749409|NCT02994394|11912949|FG004|NOT COMPLETED|Period 3 (Days 7 and 8)||0
10749410|NCT02994394|11912950|FG005|NOT COMPLETED|Period 3 (Days 7 and 8)||0
10749411|NCT02994654|11912964|FG000|STARTED|Overall Study||12
10818660|NCT00924807|11982863|FG000|COMPLETED|Overall Study||4
10818661|NCT00924807|11982863|FG000|NOT COMPLETED|Overall Study||0
10818662|NCT00930787|11982869|FG000|STARTED|Overall Study||14
10818663|NCT00930787|11982870|FG001|STARTED|Overall Study||9
10818664|NCT00930787|11982869|FG000|COMPLETED|Overall Study||14
10818665|NCT00930787|11982870|FG001|COMPLETED|Overall Study||9
10818666|NCT00930787|11982869|FG000|NOT COMPLETED|Overall Study||0
10818667|NCT00930787|11982870|FG001|NOT COMPLETED|Overall Study||0
10818668|NCT00929474|11982878|FG000|STARTED|Overall Study||8
10818669|NCT00929474|11982879|FG001|STARTED|Overall Study||9
10818670|NCT00929474|11982878|FG000|COMPLETED|Overall Study||0
10818671|NCT00929474|11982879|FG001|COMPLETED|Overall Study||0
10818672|NCT00929474|11982878|FG000|NOT COMPLETED|Overall Study||8
10818673|NCT00929474|11982879|FG001|NOT COMPLETED|Overall Study||9
10818674|NCT00925548|11982887|FG000|STARTED|Overall Study||11
10818675|NCT00925548|11982888|FG001|STARTED|Overall Study||5
10818676|NCT00925548|11982887|FG000|COMPLETED|Overall Study||1
10818677|NCT00925548|11982888|FG001|COMPLETED|Overall Study||0
10818678|NCT00925548|11982887|FG000|NOT COMPLETED|Overall Study||10
10818679|NCT00925548|11982888|FG001|NOT COMPLETED|Overall Study||5
10818680|NCT00926575|11982897|FG000|STARTED|Overall Study||70
10818681|NCT00926575|11982898|FG001|STARTED|Overall Study||70
10818682|NCT00926575|11982897|FG000|COMPLETED|Overall Study||54
10818683|NCT00926575|11982898|FG001|COMPLETED|Overall Study||53
10818684|NCT00926575|11982897|FG000|NOT COMPLETED|Overall Study||16
10818685|NCT00926575|11982898|FG001|NOT COMPLETED|Overall Study||17
10818686|NCT00911053|11982909|FG000|STARTED|Overall Study||0
10818687|NCT00911053|11982910|FG001|STARTED|Overall Study||0
10818688|NCT00911053|11982911|FG002|STARTED|Overall Study||0
10818689|NCT00911053|11982912|FG003|STARTED|Overall Study||0
10818690|NCT00911053|11982913|FG004|STARTED|Overall Study||0
10818691|NCT00911053|11982909|FG000|COMPLETED|Overall Study||0
10818692|NCT00911053|11982910|FG001|COMPLETED|Overall Study||0
10818693|NCT00911053|11982911|FG002|COMPLETED|Overall Study||0
10818694|NCT00911053|11982912|FG003|COMPLETED|Overall Study||0
10818695|NCT00911053|11982913|FG004|COMPLETED|Overall Study||0
10818696|NCT00911053|11982909|FG000|NOT COMPLETED|Overall Study||0
10818697|NCT00911053|11982910|FG001|NOT COMPLETED|Overall Study||0
10818698|NCT00911053|11982911|FG002|NOT COMPLETED|Overall Study||0
10818699|NCT00911053|11982912|FG003|NOT COMPLETED|Overall Study||0
10818700|NCT00911053|11982913|FG004|NOT COMPLETED|Overall Study||0
10818701|NCT00918463|11982925|FG000|STARTED|Overall Study||2
10818702|NCT00918463|11982925|FG000|COMPLETED|Overall Study||0
10818703|NCT00918463|11982925|FG000|NOT COMPLETED|Overall Study||2
10818704|NCT00913692|11982929|FG000|STARTED|Screening (4 Months)||11
10818705|NCT00913692|11982929|FG000|COMPLETED|Screening (4 Months)||2
10818706|NCT00913692|11982929|FG000|NOT COMPLETED|Screening (4 Months)||9
10818707|NCT00913692|11982929|FG000|STARTED|Treatment Phase 1 (5 Months)||2
10818708|NCT00913692|11982929|FG000|COMPLETED|Treatment Phase 1 (5 Months)||1
10818709|NCT00913692|11982929|FG000|NOT COMPLETED|Treatment Phase 1 (5 Months)||1
10818710|NCT00913692|11982929|FG000|STARTED|Washout (2 Weeks)||1
10818711|NCT00913692|11982929|FG000|COMPLETED|Washout (2 Weeks)||1
10818712|NCT00913692|11982929|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10818713|NCT00913692|11982929|FG000|STARTED|Treatment Phase 2 (5 Months)||1
10818714|NCT00913692|11982929|FG000|COMPLETED|Treatment Phase 2 (5 Months)||1
10818715|NCT00913692|11982929|FG000|NOT COMPLETED|Treatment Phase 2 (5 Months)||0
10818716|NCT00918645|11982936|FG000|STARTED|Overall Study||13
10818717|NCT00918645|11982936|FG000|COMPLETED|Overall Study||12
10818718|NCT00918645|11982936|FG000|NOT COMPLETED|Overall Study||1
10818719|NCT00907218|11982940|FG000|STARTED|Overall Study||2
10818720|NCT00907218|11982940|FG000|COMPLETED|Overall Study||2
10749412|NCT02994654|11912964|FG000|COMPLETED|Overall Study||11
10749413|NCT02994654|11912964|FG000|NOT COMPLETED|Overall Study||1
10749414|NCT02994732|11912969|FG000|STARTED|Overall Study|All subjects entered clinic on January 11, 2017|6
10749415|NCT02994732|11912969|FG000|COMPLETED|Overall Study|All subjects were discharged from the clinic by Jan 24, 2017|6
10749416|NCT02994732|11912969|FG000|NOT COMPLETED|Overall Study||0
10749417|NCT02994940|11912976|FG000|STARTED|Overall Study||37
10749418|NCT02994940|11912977|FG001|STARTED|Overall Study||37
10749419|NCT02994940|11912976|FG000|COMPLETED|Overall Study||30
10749420|NCT02994940|11912977|FG001|COMPLETED|Overall Study||36
10818721|NCT00907218|11982940|FG000|NOT COMPLETED|Overall Study||0
10818722|NCT00895284|11982946|FG000|STARTED|Overall Study||3
10818723|NCT00895284|11982947|FG001|STARTED|Overall Study||0
10818724|NCT00895284|11982946|FG000|COMPLETED|Overall Study||3
10818725|NCT00895284|11982947|FG001|COMPLETED|Overall Study||0
10818726|NCT00895284|11982946|FG000|NOT COMPLETED|Overall Study||0
10818727|NCT00895284|11982947|FG001|NOT COMPLETED|Overall Study||0
10818728|NCT00897910|11982953|FG000|STARTED|Overall Study|None of the blood samples were analyzed due to lack of funding. No tissue sample was collected.|6
10818729|NCT00897910|11982953|FG000|COMPLETED|Overall Study|None of the blood samples were analyzed due to lack of funding. No tissue sample was collected|6
10818730|NCT00897910|11982953|FG000|NOT COMPLETED|Overall Study||0
10818731|NCT00901303|11982959|FG000|STARTED|Overall Study||5
10818732|NCT00901303|11982960|FG001|STARTED|Overall Study||1
10818733|NCT00901303|11982959|FG000|COMPLETED|Overall Study||5
10749421|NCT02994940|11912976|FG000|NOT COMPLETED|Overall Study||7
10749422|NCT02994940|11912977|FG001|NOT COMPLETED|Overall Study||1
10749423|NCT02994979|11912985|FG000|STARTED|Overall Study||114
10749424|NCT02994979|11912986|FG001|STARTED|Overall Study||105
10749425|NCT02994979|11912985|FG000|COMPLETED|Overall Study||114
10749426|NCT02994979|11912986|FG001|COMPLETED|Overall Study||105
10749427|NCT02994979|11912985|FG000|NOT COMPLETED|Overall Study||0
10749428|NCT02994979|11912986|FG001|NOT COMPLETED|Overall Study||0
10749429|NCT02995915|11912994|FG000|STARTED|Overall Study||30
10749430|NCT02995915|11912995|FG001|STARTED|Overall Study||15
10749431|NCT02995915|11912994|FG000|COMPLETED|Overall Study||30
10749432|NCT02995915|11912995|FG001|COMPLETED|Overall Study||15
10749433|NCT02995915|11912994|FG000|NOT COMPLETED|Overall Study||0
10749434|NCT02995915|11912995|FG001|NOT COMPLETED|Overall Study||0
10749435|NCT02995980|11913001|FG000|STARTED|Overall Study||128
10749436|NCT02995980|11913001|FG000|COMPLETED|Overall Study||114
10749437|NCT02995980|11913001|FG000|NOT COMPLETED|Overall Study||14
10749438|NCT02996097|11913006|FG000|STARTED|Overall Study||30
10749439|NCT02996097|11913007|FG001|STARTED|Overall Study||30
10749440|NCT02996097|11913006|FG000|Per Protocol Population|Overall Study||22
10749441|NCT02996097|11913007|FG001|Per Protocol Population|Overall Study||22
10749442|NCT02996097|11913006|FG000|COMPLETED|Overall Study||19
10749443|NCT02996097|11913007|FG001|COMPLETED|Overall Study||19
10749444|NCT02996097|11913006|FG000|NOT COMPLETED|Overall Study||11
10749445|NCT02996097|11913007|FG001|NOT COMPLETED|Overall Study||11
10749446|NCT02996448|11913012|FG000|STARTED|Overall Study||3
10749447|NCT02996448|11913012|FG000|COMPLETED|Overall Study||0
10749448|NCT02996448|11913012|FG000|NOT COMPLETED|Overall Study||3
10749449|NCT02996474|11913017|FG000|STARTED|Overall Study||10
10749450|NCT02996474|11913017|FG000|COMPLETED|Overall Study||5
10749451|NCT02996474|11913017|FG000|NOT COMPLETED|Overall Study||5
10749452|NCT02996500|11913027|FG000|STARTED|Overall Study||39
10749453|NCT02996500|11913028|FG001|STARTED|Overall Study||43
10749454|NCT02996500|11913029|FG002|STARTED|Overall Study||39
10749455|NCT02996500|11913030|FG003|STARTED|Overall Study||50
10749456|NCT02996500|11913031|FG004|STARTED|Overall Study||50
10749457|NCT02996500|11913032|FG005|STARTED|Overall Study||48
10749458|NCT02996500|11913027|FG000|COMPLETED|Overall Study||31
10749459|NCT02996500|11913028|FG001|COMPLETED|Overall Study||42
10749460|NCT02996500|11913029|FG002|COMPLETED|Overall Study||29
10749461|NCT02996500|11913030|FG003|COMPLETED|Overall Study||46
10749462|NCT02996500|11913031|FG004|COMPLETED|Overall Study||45
10749463|NCT02996500|11913032|FG005|COMPLETED|Overall Study||44
10749464|NCT02996500|11913027|FG000|NOT COMPLETED|Overall Study||8
10749465|NCT02996500|11913028|FG001|NOT COMPLETED|Overall Study||1
10749466|NCT02996500|11913029|FG002|NOT COMPLETED|Overall Study||10
10749467|NCT02996500|11913030|FG003|NOT COMPLETED|Overall Study||4
10749468|NCT02996500|11913031|FG004|NOT COMPLETED|Overall Study||5
10749469|NCT02996500|11913032|FG005|NOT COMPLETED|Overall Study||4
10749470|NCT02996591|11913052|FG000|STARTED|Overall Study||18
10749471|NCT02996591|11913053|FG001|STARTED|Overall Study||18
10749472|NCT02996591|11913052|FG000|COMPLETED|Overall Study||18
10749473|NCT02996591|11913053|FG001|COMPLETED|Overall Study||18
10749474|NCT02996591|11913052|FG000|NOT COMPLETED|Overall Study||0
10749475|NCT02996591|11913053|FG001|NOT COMPLETED|Overall Study||0
10749476|NCT02996682|11913061|FG000|STARTED|Overall Study||51
10749477|NCT02996682|11913062|FG001|STARTED|Overall Study||51
10818734|NCT00901303|11982960|FG001|COMPLETED|Overall Study||1
10818735|NCT00901303|11982959|FG000|NOT COMPLETED|Overall Study||0
10818736|NCT00901303|11982960|FG001|NOT COMPLETED|Overall Study||0
10818737|NCT00906035|11982969|FG000|STARTED|Overall Study||8
10818738|NCT00906035|11982970|FG001|STARTED|Overall Study||9
10818739|NCT00906035|11982971|FG002|STARTED|Overall Study||8
10818740|NCT00906035|11982969|FG000|COMPLETED|Overall Study|One Drop-Out; SAE day before Visit 1 and One subject Withrew prior to visit 1|6
10818741|NCT00906035|11982970|FG001|COMPLETED|Overall Study|2 subjects Withdrew after Visit 1 and 1 subject Withdrew shortly after Visit 1due to an AE|6
10818742|NCT00906035|11982971|FG002|COMPLETED|Overall Study||8
10818743|NCT00906035|11982969|FG000|NOT COMPLETED|Overall Study||2
10818744|NCT00906035|11982970|FG001|NOT COMPLETED|Overall Study||3
10818745|NCT00906035|11982971|FG002|NOT COMPLETED|Overall Study||0
10818746|NCT00904423|11982979|FG000|STARTED|Overall Study||8
10818747|NCT00904423|11982979|FG000|COMPLETED|Overall Study||8
10818748|NCT00904423|11982979|FG000|NOT COMPLETED|Overall Study||0
10818749|NCT00903396|11982987|FG000|STARTED|Overall Study||2
10818750|NCT00903396|11982988|FG001|STARTED|Overall Study||1
10818751|NCT00903396|11982989|FG002|STARTED|Overall Study||3
10818752|NCT00903396|11982990|FG003|STARTED|Overall Study||1
10749478|NCT02996682|11913061|FG000|COMPLETED|Overall Study||51
10749479|NCT02996682|11913062|FG001|COMPLETED|Overall Study||48
10749480|NCT02996682|11913061|FG000|NOT COMPLETED|Overall Study||0
10749481|NCT02996682|11913062|FG001|NOT COMPLETED|Overall Study||3
10749482|NCT02996864|11913070|FG000|STARTED|Overall Study||150
10749483|NCT02996864|11913071|FG001|STARTED|Overall Study||150
10749484|NCT02996864|11913070|FG000|COMPLETED|Overall Study||142
10749485|NCT02996864|11913071|FG001|COMPLETED|Overall Study||136
10749486|NCT02996864|11913070|FG000|NOT COMPLETED|Overall Study||8
10749487|NCT02996864|11913071|FG001|NOT COMPLETED|Overall Study||14
10749488|NCT02996968|11913079|FG000|STARTED|Overall Study||79
10749489|NCT02996968|11913080|FG001|STARTED|Overall Study||79
10749490|NCT02996968|11913079|FG000|COMPLETED|Overall Study||78
10749491|NCT02996968|11913080|FG001|COMPLETED|Overall Study||79
10749492|NCT02996968|11913079|FG000|NOT COMPLETED|Overall Study||1
10749493|NCT02996968|11913080|FG001|NOT COMPLETED|Overall Study||0
10749494|NCT02997085|11913089|FG000|STARTED|Overall Study||34
10749495|NCT02997085|11913090|FG001|STARTED|Overall Study||35
10749496|NCT02997085|11913091|FG002|STARTED|Overall Study||34
10749497|NCT02997085|11913089|FG000|COMPLETED|Overall Study||34
10749498|NCT02997085|11913090|FG001|COMPLETED|Overall Study||35
10749499|NCT02997085|11913091|FG002|COMPLETED|Overall Study||34
10749500|NCT02997085|11913089|FG000|NOT COMPLETED|Overall Study||0
10749501|NCT02997085|11913090|FG001|NOT COMPLETED|Overall Study||0
10749502|NCT02997085|11913091|FG002|NOT COMPLETED|Overall Study||0
10749503|NCT02997163|11913102|FG000|STARTED|Overall Study||9
10749504|NCT02997163|11913103|FG001|STARTED|Overall Study||9
10749505|NCT02997163|11913104|FG002|STARTED|Overall Study||8
10749506|NCT02997163|11913105|FG003|STARTED|Overall Study||8
10749507|NCT02997163|11913102|FG000|COMPLETED|Overall Study||8
10749508|NCT02997163|11913103|FG001|COMPLETED|Overall Study||9
10749509|NCT02997163|11913104|FG002|COMPLETED|Overall Study||8
10749510|NCT02997163|11913105|FG003|COMPLETED|Overall Study||7
10749511|NCT02997163|11913102|FG000|NOT COMPLETED|Overall Study||1
10749512|NCT02997163|11913103|FG001|NOT COMPLETED|Overall Study||0
10749513|NCT02997163|11913104|FG002|NOT COMPLETED|Overall Study||0
10749514|NCT02997163|11913105|FG003|NOT COMPLETED|Overall Study||1
10749515|NCT02997176|11913119|FG000|STARTED|Overall Study||7
10749516|NCT02997176|11913120|FG001|STARTED|Overall Study||10
10749517|NCT02997176|11913121|FG002|STARTED|Overall Study||5
10749518|NCT02997176|11913122|FG003|STARTED|Overall Study||16
10749519|NCT02997176|11913119|FG000|COMPLETED|Overall Study||6
10749520|NCT02997176|11913120|FG001|COMPLETED|Overall Study||8
10749521|NCT02997176|11913121|FG002|COMPLETED|Overall Study||3
10749522|NCT02997176|11913122|FG003|COMPLETED|Overall Study||5
10749523|NCT02997176|11913119|FG000|NOT COMPLETED|Overall Study||1
10749524|NCT02997176|11913120|FG001|NOT COMPLETED|Overall Study||2
10749525|NCT02997176|11913121|FG002|NOT COMPLETED|Overall Study||2
10749526|NCT02997176|11913122|FG003|NOT COMPLETED|Overall Study||11
10749527|NCT02997722|11913134|FG000|STARTED|Overall Study||3
10749528|NCT02997722|11913135|FG001|STARTED|Overall Study||1
10749529|NCT02997722|11913134|FG000|COMPLETED|Overall Study||3
10749530|NCT02997722|11913135|FG001|COMPLETED|Overall Study||1
10749531|NCT02997722|11913134|FG000|NOT COMPLETED|Overall Study||0
10749532|NCT02997722|11913135|FG001|NOT COMPLETED|Overall Study||0
10749533|NCT02997735|11913143|FG000|STARTED|Overall Study||233
10749534|NCT02997735|11913144|FG001|STARTED|Overall Study||251
10749535|NCT02997735|11913143|FG000|COMPLETED|Overall Study||233
10749536|NCT02997735|11913144|FG001|COMPLETED|Overall Study||251
10749537|NCT02997735|11913143|FG000|NOT COMPLETED|Overall Study||0
10749538|NCT02997735|11913144|FG001|NOT COMPLETED|Overall Study||0
10778478|NCT03357731|11940421|FG002|COMPLETED|Overall Study|1 discontinuation due to hypotension|6
10778479|NCT03357731|11940422|FG003|COMPLETED|Overall Study||4
10778480|NCT03357731|11940423|FG004|COMPLETED|Overall Study||7
10778481|NCT03357731|11940424|FG005|COMPLETED|Overall Study||7
10778482|NCT03357731|11940419|FG000|NOT COMPLETED|Overall Study||0
10778483|NCT03357731|11940420|FG001|NOT COMPLETED|Overall Study||0
10778484|NCT03357731|11940421|FG002|NOT COMPLETED|Overall Study||1
10778485|NCT03357731|11940422|FG003|NOT COMPLETED|Overall Study||3
10778486|NCT03357731|11940423|FG004|NOT COMPLETED|Overall Study||1
10778487|NCT03357731|11940424|FG005|NOT COMPLETED|Overall Study||1
10778488|NCT03358147|11940437|FG000|STARTED|Overall Study||235
10778489|NCT03358147|11940438|FG001|STARTED|Overall Study||240
10778490|NCT03358147|11940439|FG002|STARTED|Overall Study||240
10778491|NCT03358147|11940440|FG003|STARTED|Overall Study||237
10778492|NCT03358147|11940441|FG004|STARTED|Overall Study||119
10778493|NCT03358147|11940437|FG000|COMPLETED|Overall Study||201
10778494|NCT03358147|11940438|FG001|COMPLETED|Overall Study||201
10778495|NCT03358147|11940439|FG002|COMPLETED|Overall Study||206
10778496|NCT03358147|11940440|FG003|COMPLETED|Overall Study||201
10778497|NCT03358147|11940441|FG004|COMPLETED|Overall Study||105
10778498|NCT03358147|11940437|FG000|NOT COMPLETED|Overall Study||34
10778499|NCT03358147|11940438|FG001|NOT COMPLETED|Overall Study||39
10778500|NCT03358147|11940439|FG002|NOT COMPLETED|Overall Study||34
10778501|NCT03358147|11940440|FG003|NOT COMPLETED|Overall Study||36
10778502|NCT03358147|11940441|FG004|NOT COMPLETED|Overall Study||14
10778503|NCT03358238|11940455|FG000|STARTED|Overall Study||23
10778504|NCT03358238|11940456|FG001|STARTED|Overall Study||25
10778505|NCT03358238|11940455|FG000|COMPLETED|Overall Study||23
10778506|NCT03358238|11940456|FG001|COMPLETED|Overall Study||24
10778507|NCT03358238|11940455|FG000|NOT COMPLETED|Overall Study||0
10778508|NCT03358238|11940456|FG001|NOT COMPLETED|Overall Study||1
10778509|NCT03358251|11940466|FG000|STARTED|Overall Study||34
10778510|NCT03358251|11940466|FG000|COMPLETED|Overall Study||34
10778511|NCT03358251|11940466|FG000|NOT COMPLETED|Overall Study||0
10778512|NCT03358290|11940478|FG000|STARTED|Overall Study||2
10778513|NCT03358290|11940479|FG001|STARTED|Overall Study||3
10778514|NCT03358290|11940480|FG002|STARTED|Overall Study||3
10778515|NCT03358290|11940481|FG003|STARTED|Overall Study||3
10778516|NCT03358290|11940482|FG004|STARTED|Overall Study||2
10778517|NCT03358290|11940478|FG000|COMPLETED|Overall Study||2
10778518|NCT03358290|11940479|FG001|COMPLETED|Overall Study||2
10778519|NCT03358290|11940480|FG002|COMPLETED|Overall Study||1
10778520|NCT03358290|11940481|FG003|COMPLETED|Overall Study||1
10778521|NCT03358290|11940482|FG004|COMPLETED|Overall Study||1
10778522|NCT03358290|11940478|FG000|NOT COMPLETED|Overall Study||0
10778523|NCT03358290|11940479|FG001|NOT COMPLETED|Overall Study||1
10778524|NCT03358290|11940480|FG002|NOT COMPLETED|Overall Study||2
10778525|NCT03358290|11940481|FG003|NOT COMPLETED|Overall Study||2
10778526|NCT03358290|11940482|FG004|NOT COMPLETED|Overall Study||1
10778527|NCT03358329|11940494|FG000|STARTED|Overall Study||50
10778528|NCT03358329|11940494|FG000|COMPLETED|Overall Study||46
10749539|NCT02997904|11913152|FG000|STARTED|Overall Study||51
10749540|NCT02997904|11913153|FG001|STARTED|Overall Study||49
10749541|NCT02997904|11913152|FG000|COMPLETED|Overall Study||51
10749542|NCT02997904|11913153|FG001|COMPLETED|Overall Study||49
10749543|NCT02997904|11913152|FG000|NOT COMPLETED|Overall Study||0
10749544|NCT02997904|11913153|FG001|NOT COMPLETED|Overall Study||0
10749545|NCT02998021|11913165|FG000|STARTED|Overall Study||8
10749546|NCT02998021|11913166|FG001|STARTED|Overall Study||2
10749547|NCT02998021|11913165|FG000|COMPLETED|Overall Study||5
10749548|NCT02998021|11913166|FG001|COMPLETED|Overall Study||0
10749549|NCT02998021|11913165|FG000|NOT COMPLETED|Overall Study||3
10749550|NCT02998021|11913166|FG001|NOT COMPLETED|Overall Study||2
10749551|NCT02998151|11913172|FG000|STARTED|Overall Study||29
10749552|NCT02998151|11913172|FG000|Placebo|Overall Study|Two participants withdrew from the study before receiving placebo.|27
10749553|NCT02998151|11913172|FG000|Acamprosate|Overall Study|Every participant received acamprosate prior to acamprosate's discontinuance.|16
10749554|NCT02998151|11913172|FG000|Lovastatin|Overall Study|All participants received lovastatin.|29
10818753|NCT00903396|11982987|FG000|COMPLETED|Overall Study||2
10818754|NCT00903396|11982988|FG001|COMPLETED|Overall Study||1
10818755|NCT00903396|11982989|FG002|COMPLETED|Overall Study||3
10818756|NCT00903396|11982990|FG003|COMPLETED|Overall Study||1
10818757|NCT00903396|11982987|FG000|NOT COMPLETED|Overall Study||0
10818758|NCT00903396|11982988|FG001|NOT COMPLETED|Overall Study||0
10818759|NCT00903396|11982989|FG002|NOT COMPLETED|Overall Study||0
10818760|NCT00903396|11982990|FG003|NOT COMPLETED|Overall Study||0
10818761|NCT00894790|11983002|FG000|STARTED|Overall Study||4
10818762|NCT00894790|11983003|FG001|STARTED|Overall Study||4
10818763|NCT00894790|11983002|FG000|COMPLETED|Overall Study||3
10818764|NCT00894790|11983003|FG001|COMPLETED|Overall Study||2
10818765|NCT00894790|11983002|FG000|NOT COMPLETED|Overall Study||1
10818766|NCT00894790|11983003|FG001|NOT COMPLETED|Overall Study||2
10818767|NCT00902668|11983009|FG000|STARTED|Overall Study||3
10818768|NCT00902668|11983009|FG000|COMPLETED|Overall Study||0
10818769|NCT00902668|11983009|FG000|NOT COMPLETED|Overall Study||3
10818770|NCT00881205|11983015|FG000|STARTED|Overall Study||45
10818771|NCT00881205|11983016|FG001|STARTED|Overall Study||41
10818772|NCT00881205|11983015|FG000|COMPLETED|Overall Study||34
10818773|NCT00881205|11983016|FG001|COMPLETED|Overall Study||34
10818774|NCT00881205|11983015|FG000|NOT COMPLETED|Overall Study||11
10818775|NCT00881205|11983016|FG001|NOT COMPLETED|Overall Study||7
10818776|NCT00896025|11983023|FG000|STARTED|Overall Study||8
10818777|NCT00896025|11983023|FG000|COMPLETED|Overall Study||8
10818778|NCT00896025|11983023|FG000|NOT COMPLETED|Overall Study||0
10818779|NCT00903006|11983033|FG000|STARTED|Overall Study||2
10818780|NCT00903006|11983034|FG001|STARTED|Overall Study||3
10818781|NCT00903006|11983035|FG002|STARTED|Overall Study||1
10818782|NCT00903006|11983036|FG003|STARTED|Overall Study|Zero participants started due to smaller sample size.|0
10818783|NCT00903006|11983033|FG000|COMPLETED|Overall Study||0
10818784|NCT00903006|11983034|FG001|COMPLETED|Overall Study||0
10818785|NCT00903006|11983035|FG002|COMPLETED|Overall Study||0
10818786|NCT00903006|11983036|FG003|COMPLETED|Overall Study||0
10818787|NCT00903006|11983033|FG000|NOT COMPLETED|Overall Study||2
10818788|NCT00903006|11983034|FG001|NOT COMPLETED|Overall Study||3
10818789|NCT00903006|11983035|FG002|NOT COMPLETED|Overall Study||1
10818790|NCT00903006|11983036|FG003|NOT COMPLETED|Overall Study||0
10818791|NCT00904189|11983046|FG000|STARTED|Overall Study||2
10818792|NCT00904189|11983046|FG000|COMPLETED|Overall Study||2
10818793|NCT00904189|11983046|FG000|NOT COMPLETED|Overall Study||0
10818794|NCT00887315|11983053|FG000|STARTED|Overall Study||7
10818795|NCT00887315|11983054|FG001|STARTED|Overall Study||4
10818796|NCT00887315|11983053|FG000|COMPLETED|Overall Study||0
10818797|NCT00887315|11983054|FG001|COMPLETED|Overall Study||0
10818798|NCT00887315|11983053|FG000|NOT COMPLETED|Overall Study||7
10818799|NCT00887315|11983054|FG001|NOT COMPLETED|Overall Study||4
10818800|NCT00891904|11983060|FG000|STARTED|Overall Study||2
10818801|NCT00891904|11983060|FG000|COMPLETED|Overall Study||0
10818802|NCT00891904|11983060|FG000|NOT COMPLETED|Overall Study||2
10818803|NCT00881608|11983069|FG000|STARTED|Overall Study||11
10818804|NCT00881608|11983069|FG000|COMPLETED|Overall Study||0
10818805|NCT00881608|11983069|FG000|NOT COMPLETED|Overall Study||11
10818806|NCT00889421|11983081|FG000|STARTED|Overall Study||3
10818807|NCT00889421|11983081|FG000|COMPLETED|Overall Study||0
10818808|NCT00889421|11983081|FG000|NOT COMPLETED|Overall Study||3
10818809|NCT00875394|11983088|FG000|STARTED|Overall Study||36
10818810|NCT00875394|11983089|FG001|STARTED|Overall Study||23
10818811|NCT00875394|11983090|FG002|STARTED|Overall Study||9
10818812|NCT00875394|11983088|FG000|COMPLETED|Overall Study||36
10818813|NCT00875394|11983089|FG001|COMPLETED|Overall Study||23
10818814|NCT00875394|11983090|FG002|COMPLETED|Overall Study||9
10749555|NCT02998151|11913172|FG000|Minocycline|Overall Study|Two participants withdrew from the study before receiving minocycline.|27
10778529|NCT03358329|11940494|FG000|NOT COMPLETED|Overall Study||4
10818815|NCT00875394|11983088|FG000|NOT COMPLETED|Overall Study||0
10818816|NCT00875394|11983089|FG001|NOT COMPLETED|Overall Study||0
10818817|NCT00875394|11983090|FG002|NOT COMPLETED|Overall Study||0
10818818|NCT00882310|11983098|FG000|STARTED|Overall Study||37
10818819|NCT00882310|11983098|FG000|COMPLETED|Overall Study||15
10818820|NCT00882310|11983098|FG000|NOT COMPLETED|Overall Study||22
10818821|NCT00880542|11983102|FG000|STARTED|Treatment Period (Sorafenib+Ifosfamide)||7
10818822|NCT00880542|11983102|FG000|COMPLETED|Treatment Period (Sorafenib+Ifosfamide)||4
10818823|NCT00880542|11983102|FG000|NOT COMPLETED|Treatment Period (Sorafenib+Ifosfamide)||3
10749556|NCT02998151|11913172|FG000|Baclofen|Overall Study|All 13 remaining participants received baclofen after acamprosate was discontinued. Five participants were re-enrolled to receive baclofen.|18
10749557|NCT02998151|11913172|FG000|COMPLETED|Overall Study|Acamprosate was discontinued mid-study due to undetectable serum levels and replaced with baclofen. Participants who already completed acamprosate were given the option to re-enroll and receive baclofen. Five participants received all 5 interventions; 26 received 4+ interventions.|5
10749558|NCT02998151|11913172|FG000|NOT COMPLETED|Overall Study||24
10749559|NCT02998541|11913187|FG000|STARTED|Overall Study||86
10749560|NCT02998541|11913188|FG001|STARTED|Overall Study||90
10749561|NCT02998541|11913189|FG002|STARTED|Overall Study||43
10749562|NCT02998541|11913187|FG000|COMPLETED|Overall Study||78
10749563|NCT02998541|11913188|FG001|COMPLETED|Overall Study||81
10749564|NCT02998541|11913189|FG002|COMPLETED|Overall Study||37
10749565|NCT02998541|11913187|FG000|NOT COMPLETED|Overall Study||8
10749566|NCT02998541|11913188|FG001|NOT COMPLETED|Overall Study||9
10749567|NCT02998541|11913189|FG002|NOT COMPLETED|Overall Study||6
10749568|NCT02998554|11913199|FG000|STARTED|Overall Study||79
10749569|NCT02998554|11913200|FG001|STARTED|Overall Study||77
10749570|NCT02998554|11913199|FG000|COMPLETED|Overall Study||68
10749571|NCT02998554|11913200|FG001|COMPLETED|Overall Study||66
10749572|NCT02998554|11913199|FG000|NOT COMPLETED|Overall Study||11
10749573|NCT02998554|11913200|FG001|NOT COMPLETED|Overall Study||11
10749574|NCT02998684|11913210|FG000|STARTED|Overall Study||7
10749575|NCT02998684|11913211|FG001|STARTED|Overall Study||7
10749576|NCT02998684|11913210|FG000|COMPLETED|Overall Study||4
10749577|NCT02998684|11913211|FG001|COMPLETED|Overall Study||6
10749578|NCT02998684|11913210|FG000|NOT COMPLETED|Overall Study||3
10749579|NCT02998684|11913211|FG001|NOT COMPLETED|Overall Study||1
10749580|NCT02998996|11913223|FG000|STARTED|Overall Study||36
10818824|NCT00880542|11983102|FG000|STARTED|Response Evaluation Period(REP): PET/CT||4
10818825|NCT00880542|11983102|FG000|COMPLETED|Response Evaluation Period(REP): PET/CT||4
10818826|NCT00880542|11983102|FG000|NOT COMPLETED|Response Evaluation Period(REP): PET/CT||0
10818827|NCT00880542|11983102|FG000|STARTED|REP: Surgical Resection||4
10818828|NCT00880542|11983102|FG000|COMPLETED|REP: Surgical Resection||3
10818829|NCT00880542|11983102|FG000|NOT COMPLETED|REP: Surgical Resection||1
10818830|NCT00880542|11983102|FG000|STARTED|Post Surgical Evaluation||3
10818831|NCT00880542|11983102|FG000|COMPLETED|Post Surgical Evaluation|none of the 3 subjects met study criteria for continuation of therapy.|3
10818832|NCT00880542|11983102|FG000|NOT COMPLETED|Post Surgical Evaluation||0
10818833|NCT00880542|11983102|FG000|STARTED|Continued Treatment Period|None of the 3 subjects from previous period met study criteria for continuation of therapy.|0
10818834|NCT00880542|11983102|FG000|COMPLETED|Continued Treatment Period||0
10818835|NCT00880542|11983102|FG000|NOT COMPLETED|Continued Treatment Period||0
10818836|NCT00880542|11983102|FG000|STARTED|Follow-up Period|All 7 patients who started the treatment period completed the follow-up period.|7
10818837|NCT00880542|11983102|FG000|COMPLETED|Follow-up Period||7
10818838|NCT00880542|11983102|FG000|NOT COMPLETED|Follow-up Period||0
10818839|NCT00879619|11983106|FG000|STARTED|Overall Study||4
10818840|NCT00879619|11983106|FG000|COMPLETED|Overall Study||4
10818841|NCT00879619|11983106|FG000|NOT COMPLETED|Overall Study||0
10818842|NCT00874939|11983110|FG000|STARTED|Overall Study||4
10818843|NCT00874939|11983110|FG000|Treated|Overall Study||0
10818844|NCT00874939|11983110|FG000|COMPLETED|Overall Study||0
10818845|NCT00874939|11983110|FG000|NOT COMPLETED|Overall Study||4
10818846|NCT00878605|11983124|FG000|STARTED|Overall Study||10
10818847|NCT00878605|11983125|FG001|STARTED|Overall Study||10
10818848|NCT00878605|11983126|FG002|STARTED|Overall Study||9
10818849|NCT00878605|11983127|FG003|STARTED|Overall Study||9
10818850|NCT00878605|11983124|FG000|COMPLETED|Overall Study||7
10818851|NCT00878605|11983125|FG001|COMPLETED|Overall Study||7
10818852|NCT00878605|11983126|FG002|COMPLETED|Overall Study||8
10818853|NCT00878605|11983127|FG003|COMPLETED|Overall Study||6
10818854|NCT00878605|11983124|FG000|NOT COMPLETED|Overall Study||3
10818855|NCT00878605|11983125|FG001|NOT COMPLETED|Overall Study||3
10818856|NCT00878605|11983126|FG002|NOT COMPLETED|Overall Study||1
10818857|NCT00878605|11983127|FG003|NOT COMPLETED|Overall Study||3
10818858|NCT00877071|11983137|FG000|STARTED|Overall Study||2
10818859|NCT00877071|11983137|FG000|COMPLETED|Overall Study||0
10818860|NCT00877071|11983137|FG000|NOT COMPLETED|Overall Study||2
10818861|NCT00878969|11983144|FG000|STARTED|Overall Study||25
10818862|NCT00878969|11983145|FG001|STARTED|Overall Study||27
10818863|NCT00878969|11983146|FG002|STARTED|Overall Study||26
10818864|NCT00878969|11983144|FG000|COMPLETED|Overall Study||10
10818865|NCT00878969|11983145|FG001|COMPLETED|Overall Study||12
10818866|NCT00878969|11983146|FG002|COMPLETED|Overall Study||15
10818867|NCT00878969|11983144|FG000|NOT COMPLETED|Overall Study||15
10818868|NCT00878969|11983145|FG001|NOT COMPLETED|Overall Study||15
10818869|NCT00878969|11983146|FG002|NOT COMPLETED|Overall Study||11
10818870|NCT00865514|11983154|FG000|STARTED|Overall Study||2
10818871|NCT00865514|11983154|FG000|COMPLETED|Overall Study||0
10818872|NCT00865514|11983154|FG000|NOT COMPLETED|Overall Study||2
10818873|NCT00869414|11983159|FG000|STARTED|Overall Study||0
10818874|NCT00869414|11983160|FG001|STARTED|Overall Study||0
10818875|NCT00869414|11983161|FG002|STARTED|Overall Study||0
10818876|NCT00869414|11983159|FG000|COMPLETED|Overall Study||0
10749581|NCT02998996|11913224|FG001|STARTED|Overall Study||35
10818877|NCT00869414|11983160|FG001|COMPLETED|Overall Study||0
10818878|NCT00869414|11983161|FG002|COMPLETED|Overall Study||0
10818879|NCT00869414|11983159|FG000|NOT COMPLETED|Overall Study||0
10818880|NCT00869414|11983160|FG001|NOT COMPLETED|Overall Study||0
10818881|NCT00869414|11983161|FG002|NOT COMPLETED|Overall Study||0
10749582|NCT02998996|11913225|FG002|STARTED|Overall Study||36
10749583|NCT02998996|11913226|FG003|STARTED|Overall Study||18
10749584|NCT02998996|11913227|FG004|STARTED|Overall Study||18
10749585|NCT02998996|11913228|FG005|STARTED|Overall Study||19
10749586|NCT02998996|11913223|FG000|COMPLETED|Overall Study||36
10749587|NCT02998996|11913224|FG001|COMPLETED|Overall Study||34
10749588|NCT02998996|11913225|FG002|COMPLETED|Overall Study||35
10749589|NCT02998996|11913226|FG003|COMPLETED|Overall Study||18
10749590|NCT02998996|11913227|FG004|COMPLETED|Overall Study||17
10749591|NCT02998996|11913228|FG005|COMPLETED|Overall Study||19
10749592|NCT02998996|11913223|FG000|NOT COMPLETED|Overall Study||0
10749593|NCT02998996|11913224|FG001|NOT COMPLETED|Overall Study||1
10749594|NCT02998996|11913225|FG002|NOT COMPLETED|Overall Study||1
10749595|NCT02998996|11913226|FG003|NOT COMPLETED|Overall Study||0
10749596|NCT02998996|11913227|FG004|NOT COMPLETED|Overall Study||1
10749597|NCT02998996|11913228|FG005|NOT COMPLETED|Overall Study||0
10818882|NCT00863512|11983171|FG000|STARTED|Overall Study||17
10818883|NCT00863512|11983172|FG001|STARTED|Overall Study||17
10818884|NCT00863512|11983171|FG000|COMPLETED|Overall Study||3
10818885|NCT00863512|11983172|FG001|COMPLETED|Overall Study||17
10818886|NCT00863512|11983171|FG000|NOT COMPLETED|Overall Study||14
10818887|NCT00863512|11983172|FG001|NOT COMPLETED|Overall Study||0
10818888|NCT00868998|11983178|FG000|STARTED|Overall Study||5
10818889|NCT00868998|11983178|FG000|COMPLETED|Overall Study||0
10818890|NCT00868998|11983178|FG000|NOT COMPLETED|Overall Study||5
10818891|NCT00869258|11983182|FG000|STARTED|Overall Study||32
10818892|NCT00869258|11983182|FG000|COMPLETED|Overall Study||31
10818893|NCT00869258|11983182|FG000|NOT COMPLETED|Overall Study||1
10818894|NCT00863330|11983186|FG000|STARTED|Overall Study||6
10818895|NCT00863330|11983186|FG000|COMPLETED|Overall Study||0
10818896|NCT00863330|11983186|FG000|NOT COMPLETED|Overall Study||6
10818897|NCT00853229|11983192|FG000|STARTED|Phase 1: Initial Intervention||8
10818898|NCT00853229|11983193|FG001|STARTED|Phase 1: Initial Intervention||8
10818899|NCT00853229|11983192|FG000|COMPLETED|Phase 1: Initial Intervention||0
10818900|NCT00853229|11983193|FG001|COMPLETED|Phase 1: Initial Intervention||0
10818901|NCT00853229|11983192|FG000|NOT COMPLETED|Phase 1: Initial Intervention||8
10818902|NCT00853229|11983193|FG001|NOT COMPLETED|Phase 1: Initial Intervention||8
10818903|NCT00853229|11983192|FG000|STARTED|Phase 2: Cross Over||0
10818904|NCT00853229|11983193|FG001|STARTED|Phase 2: Cross Over||0
10818905|NCT00853229|11983192|FG000|COMPLETED|Phase 2: Cross Over||0
10818906|NCT00853229|11983193|FG001|COMPLETED|Phase 2: Cross Over||0
10818907|NCT00853229|11983192|FG000|NOT COMPLETED|Phase 2: Cross Over||0
10818908|NCT00853229|11983193|FG001|NOT COMPLETED|Phase 2: Cross Over||0
10818909|NCT00860249|11983204|FG000|STARTED|Overall Study||21
10818910|NCT00860249|11983205|FG001|STARTED|Overall Study||18
10818911|NCT00860249|11983206|FG002|STARTED|Overall Study||21
10818912|NCT00860249|11983204|FG000|COMPLETED|Overall Study||0
10818913|NCT00860249|11983205|FG001|COMPLETED|Overall Study||0
10818914|NCT00860249|11983206|FG002|COMPLETED|Overall Study||0
10818915|NCT00860249|11983204|FG000|NOT COMPLETED|Overall Study||21
10818916|NCT00860249|11983205|FG001|NOT COMPLETED|Overall Study||18
10818917|NCT00860249|11983206|FG002|NOT COMPLETED|Overall Study||21
10818918|NCT00860158|11983214|FG000|STARTED|Overall Study||1
10818919|NCT00860158|11983214|FG000|COMPLETED|Overall Study||0
10818920|NCT00860158|11983214|FG000|NOT COMPLETED|Overall Study||1
10818921|NCT00853567|11983221|FG000|STARTED|Overall Study||71
10818922|NCT00853567|11983221|FG000|COMPLETED|Overall Study||0
10818923|NCT00853567|11983221|FG000|NOT COMPLETED|Overall Study||71
10818924|NCT00849524|11983229|FG000|STARTED|Overall Study||6
10818925|NCT00849524|11983229|FG000|COMPLETED|Overall Study||3
10818926|NCT00849524|11983229|FG000|NOT COMPLETED|Overall Study||3
10818927|NCT00843986|11983235|FG000|STARTED|Overall Study||3
10818928|NCT00843986|11983236|FG001|STARTED|Overall Study||6
10818929|NCT00843986|11983235|FG000|Completed Treatment (Infusion)|Overall Study||2
10818930|NCT00843986|11983236|FG001|Completed Treatment (Infusion)|Overall Study||6
10818931|NCT00843986|11983235|FG000|COMPLETED|Overall Study||2
10818932|NCT00843986|11983236|FG001|COMPLETED|Overall Study||5
10818933|NCT00843986|11983235|FG000|NOT COMPLETED|Overall Study||1
10818934|NCT00843986|11983236|FG001|NOT COMPLETED|Overall Study||1
10818935|NCT00851682|11983244|FG000|STARTED|Overall Study||60
10818936|NCT00851682|11983245|FG001|STARTED|Overall Study||5
10818937|NCT00851682|11983244|FG000|COMPLETED|Overall Study||55
10818938|NCT00851682|11983245|FG001|COMPLETED|Overall Study||5
10818939|NCT00851682|11983244|FG000|NOT COMPLETED|Overall Study||5
10818940|NCT00851682|11983245|FG001|NOT COMPLETED|Overall Study||0
10818941|NCT00852124|11983253|FG000|STARTED|Overall Study||3
10818942|NCT00852124|11983254|FG001|STARTED|Overall Study||0
10818943|NCT00852124|11983253|FG000|COMPLETED|Overall Study||3
10818944|NCT00852124|11983254|FG001|COMPLETED|Overall Study||0
10749598|NCT02999100|11913248|FG000|STARTED|Part 1 (up to 15 Days)||9
10749599|NCT02999100|11913249|FG001|STARTED|Part 1 (up to 15 Days)||8
10749600|NCT02999100|11913250|FG002|STARTED|Part 1 (up to 15 Days)||0
10749601|NCT02999100|11913251|FG003|STARTED|Part 1 (up to 15 Days)||0
10818945|NCT00852124|11983253|FG000|NOT COMPLETED|Overall Study||0
10818946|NCT00852124|11983254|FG001|NOT COMPLETED|Overall Study||0
10818947|NCT00850421|11983259|FG000|STARTED|Overall Study||35
10749602|NCT02999100|11913252|FG004|STARTED|Part 1 (up to 15 Days)||0
10818948|NCT00850421|11983259|FG000|COMPLETED|Overall Study||18
10818949|NCT00850421|11983259|FG000|NOT COMPLETED|Overall Study||17
10818950|NCT00851747|11983267|FG000|STARTED|Overall Study||6
10818951|NCT00851747|11983268|FG001|STARTED|Overall Study||6
10749603|NCT02999100|11913253|FG005|STARTED|Part 1 (up to 15 Days)||0
10749604|NCT02999100|11913248|FG000|COMPLETED|Part 1 (up to 15 Days)||9
10749605|NCT02999100|11913249|FG001|COMPLETED|Part 1 (up to 15 Days)||7
10749606|NCT02999100|11913250|FG002|COMPLETED|Part 1 (up to 15 Days)||0
10818952|NCT00851747|11983269|FG002|STARTED|Overall Study||6
10818953|NCT00851747|11983267|FG000|COMPLETED|Overall Study||0
10818954|NCT00851747|11983268|FG001|COMPLETED|Overall Study||0
10818955|NCT00851747|11983269|FG002|COMPLETED|Overall Study||0
10749607|NCT02999100|11913251|FG003|COMPLETED|Part 1 (up to 15 Days)||0
10749608|NCT02999100|11913252|FG004|COMPLETED|Part 1 (up to 15 Days)||0
10749609|NCT02999100|11913253|FG005|COMPLETED|Part 1 (up to 15 Days)||0
10749610|NCT02999100|11913248|FG000|NOT COMPLETED|Part 1 (up to 15 Days)||0
10749611|NCT02999100|11913249|FG001|NOT COMPLETED|Part 1 (up to 15 Days)||1
10749612|NCT02999100|11913250|FG002|NOT COMPLETED|Part 1 (up to 15 Days)||0
10749613|NCT02999100|11913251|FG003|NOT COMPLETED|Part 1 (up to 15 Days)||0
10749614|NCT02999100|11913252|FG004|NOT COMPLETED|Part 1 (up to 15 Days)||0
10749615|NCT02999100|11913253|FG005|NOT COMPLETED|Part 1 (up to 15 Days)||0
10749616|NCT02999100|11913248|FG000|STARTED|Part 2 (Day 1): Dosing Session 1|Participants from Part 1 did not enter Part 2|0
10749617|NCT02999100|11913249|FG001|STARTED|Part 2 (Day 1): Dosing Session 1|Participants from Part 1 did not enter Part 2|0
10749618|NCT02999100|11913250|FG002|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|5
10749619|NCT02999100|11913251|FG003|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|3
10749620|NCT02999100|11913252|FG004|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|3
10749621|NCT02999100|11913253|FG005|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|3
10749622|NCT02999100|11913248|FG000|COMPLETED|Part 2 (Day 1): Dosing Session 1||0
10749623|NCT02999100|11913249|FG001|COMPLETED|Part 2 (Day 1): Dosing Session 1||0
10749624|NCT02999100|11913250|FG002|COMPLETED|Part 2 (Day 1): Dosing Session 1||4
10749625|NCT02999100|11913251|FG003|COMPLETED|Part 2 (Day 1): Dosing Session 1||3
10749626|NCT02999100|11913252|FG004|COMPLETED|Part 2 (Day 1): Dosing Session 1||3
10749627|NCT02999100|11913253|FG005|COMPLETED|Part 2 (Day 1): Dosing Session 1||2
10749628|NCT02999100|11913248|FG000|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0
10749629|NCT02999100|11913249|FG001|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0
10749630|NCT02999100|11913250|FG002|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||1
10749631|NCT02999100|11913251|FG003|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0
10749632|NCT02999100|11913252|FG004|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0
10749633|NCT02999100|11913253|FG005|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||1
10749634|NCT02999100|11913248|FG000|STARTED|Part 2 (Day 14): Dosing Session 2||0
10749635|NCT02999100|11913249|FG001|STARTED|Part 2 (Day 14): Dosing Session 2||0
10749636|NCT02999100|11913250|FG002|STARTED|Part 2 (Day 14): Dosing Session 2||4
10749637|NCT02999100|11913251|FG003|STARTED|Part 2 (Day 14): Dosing Session 2||3
10749638|NCT02999100|11913252|FG004|STARTED|Part 2 (Day 14): Dosing Session 2||3
10749639|NCT02999100|11913253|FG005|STARTED|Part 2 (Day 14): Dosing Session 2||2
10749640|NCT02999100|11913248|FG000|COMPLETED|Part 2 (Day 14): Dosing Session 2||0
10749641|NCT02999100|11913249|FG001|COMPLETED|Part 2 (Day 14): Dosing Session 2||0
10749642|NCT02999100|11913250|FG002|COMPLETED|Part 2 (Day 14): Dosing Session 2||4
10749643|NCT02999100|11913251|FG003|COMPLETED|Part 2 (Day 14): Dosing Session 2||3
10749644|NCT02999100|11913252|FG004|COMPLETED|Part 2 (Day 14): Dosing Session 2||3
10749645|NCT02999100|11913253|FG005|COMPLETED|Part 2 (Day 14): Dosing Session 2||2
10749646|NCT02999100|11913248|FG000|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
10749647|NCT02999100|11913249|FG001|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
10749648|NCT02999100|11913250|FG002|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
10749649|NCT02999100|11913251|FG003|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
10749650|NCT02999100|11913252|FG004|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
10749651|NCT02999100|11913253|FG005|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
10749652|NCT02999178|11913277|FG000|STARTED|Overall Study||332
10749653|NCT02999178|11913278|FG001|STARTED|Overall Study||331
10749654|NCT02999178|11913277|FG000|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12-August-2019|218
10749655|NCT02999178|11913278|FG001|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12-August-2019|231
10749656|NCT02999178|11913277|FG000|NOT COMPLETED|Overall Study||114
10749657|NCT02999178|11913278|FG001|NOT COMPLETED|Overall Study||100
10749658|NCT02999191|11913287|FG000|STARTED|Treatment Period 1 [1 Day]||6
10749659|NCT02999191|11913288|FG001|STARTED|Treatment Period 1 [1 Day]||6
10749660|NCT02999191|11913289|FG002|STARTED|Treatment Period 1 [1 Day]||6
10749661|NCT02999191|11913287|FG000|COMPLETED|Treatment Period 1 [1 Day]||6
10749662|NCT02999191|11913288|FG001|COMPLETED|Treatment Period 1 [1 Day]||6
10749663|NCT02999191|11913289|FG002|COMPLETED|Treatment Period 1 [1 Day]||6
10749664|NCT02999191|11913287|FG000|NOT COMPLETED|Treatment Period 1 [1 Day]||0
10749665|NCT02999191|11913288|FG001|NOT COMPLETED|Treatment Period 1 [1 Day]||0
10749666|NCT02999191|11913289|FG002|NOT COMPLETED|Treatment Period 1 [1 Day]||0
10749667|NCT02999191|11913287|FG000|STARTED|Wash-out Period 1 [21 Days]||6
10749668|NCT02999191|11913288|FG001|STARTED|Wash-out Period 1 [21 Days]||6
10749669|NCT02999191|11913289|FG002|STARTED|Wash-out Period 1 [21 Days]||6
10749670|NCT02999191|11913287|FG000|COMPLETED|Wash-out Period 1 [21 Days]||6
10818956|NCT00851747|11983267|FG000|NOT COMPLETED|Overall Study||6
10749671|NCT02999191|11913288|FG001|COMPLETED|Wash-out Period 1 [21 Days]||5
10749672|NCT02999191|11913289|FG002|COMPLETED|Wash-out Period 1 [21 Days]||6
10749673|NCT02999191|11913287|FG000|NOT COMPLETED|Wash-out Period 1 [21 Days]||0
10749674|NCT02999191|11913288|FG001|NOT COMPLETED|Wash-out Period 1 [21 Days]||1
10749675|NCT02999191|11913289|FG002|NOT COMPLETED|Wash-out Period 1 [21 Days]||0
10749676|NCT02999191|11913287|FG000|STARTED|Treatment Period 2 [1 Day]||6
10749677|NCT02999191|11913288|FG001|STARTED|Treatment Period 2 [1 Day]||5
10749678|NCT02999191|11913289|FG002|STARTED|Treatment Period 2 [1 Day]||6
10749679|NCT02999191|11913287|FG000|COMPLETED|Treatment Period 2 [1 Day]||6
10749680|NCT02999191|11913288|FG001|COMPLETED|Treatment Period 2 [1 Day]||5
10749681|NCT02999191|11913289|FG002|COMPLETED|Treatment Period 2 [1 Day]||6
10749682|NCT02999191|11913287|FG000|NOT COMPLETED|Treatment Period 2 [1 Day]||0
10749683|NCT02999191|11913288|FG001|NOT COMPLETED|Treatment Period 2 [1 Day]||0
10749684|NCT02999191|11913289|FG002|NOT COMPLETED|Treatment Period 2 [1 Day]||0
10749685|NCT02999191|11913287|FG000|STARTED|Wash-out Period 2 [21 Days]||6
10749686|NCT02999191|11913288|FG001|STARTED|Wash-out Period 2 [21 Days]||5
10749687|NCT02999191|11913289|FG002|STARTED|Wash-out Period 2 [21 Days]||6
10749688|NCT02999191|11913287|FG000|COMPLETED|Wash-out Period 2 [21 Days]||6
10749689|NCT02999191|11913288|FG001|COMPLETED|Wash-out Period 2 [21 Days]||5
10749690|NCT02999191|11913289|FG002|COMPLETED|Wash-out Period 2 [21 Days]||6
10749691|NCT02999191|11913287|FG000|NOT COMPLETED|Wash-out Period 2 [21 Days]||0
10749692|NCT02999191|11913288|FG001|NOT COMPLETED|Wash-out Period 2 [21 Days]||0
10749693|NCT02999191|11913289|FG002|NOT COMPLETED|Wash-out Period 2 [21 Days]||0
10749694|NCT02999191|11913287|FG000|STARTED|Treatment Period 3 [1 Day]||6
10749695|NCT02999191|11913288|FG001|STARTED|Treatment Period 3 [1 Day]||6
10749696|NCT02999191|11913289|FG002|STARTED|Treatment Period 3 [1 Day]||6
10749697|NCT02999191|11913287|FG000|COMPLETED|Treatment Period 3 [1 Day]||6
10749698|NCT02999191|11913288|FG001|COMPLETED|Treatment Period 3 [1 Day]||6
10818957|NCT00851747|11983268|FG001|NOT COMPLETED|Overall Study||6
10818958|NCT00851747|11983269|FG002|NOT COMPLETED|Overall Study||6
10818959|NCT00852241|11983276|FG000|STARTED|Overall Study||18
10818960|NCT00852241|11983276|FG000|COMPLETED|Overall Study||0
10818961|NCT00852241|11983276|FG000|NOT COMPLETED|Overall Study||18
10818962|NCT00851552|11983280|FG000|STARTED|Overall Study||9
10818963|NCT00851552|11983280|FG000|COMPLETED|Overall Study||2
10818964|NCT00851552|11983280|FG000|NOT COMPLETED|Overall Study||7
10818965|NCT00850720|11983284|FG000|STARTED|Overall Study||0
10818966|NCT00850720|11983284|FG000|COMPLETED|Overall Study||0
10818967|NCT00850720|11983284|FG000|NOT COMPLETED|Overall Study||0
10818968|NCT00845845|11983290|FG000|STARTED|Overall Study||3
10818969|NCT00845845|11983291|FG001|STARTED|Overall Study||6
10818970|NCT00845845|11983290|FG000|COMPLETED|Overall Study||3
10818971|NCT00845845|11983291|FG001|COMPLETED|Overall Study||2
10818972|NCT00845845|11983290|FG000|NOT COMPLETED|Overall Study||0
10818973|NCT00845845|11983291|FG001|NOT COMPLETED|Overall Study||4
10818974|NCT00851591|11983299|FG000|STARTED|Overall Study|These 2 participants did not receive treatment.|2
10818975|NCT00851591|11983300|FG001|STARTED|Overall Study|One received treatment.|1
10818976|NCT00851591|11983299|FG000|COMPLETED|Overall Study||0
10818977|NCT00851591|11983300|FG001|COMPLETED|Overall Study||1
10818978|NCT00851591|11983299|FG000|NOT COMPLETED|Overall Study||2
10818979|NCT00851591|11983300|FG001|NOT COMPLETED|Overall Study||0
10818980|NCT00847509|11983306|FG000|STARTED|Overall Study||49
10818981|NCT00847509|11983306|FG000|COMPLETED|Overall Study||38
10818982|NCT00847509|11983306|FG000|NOT COMPLETED|Overall Study||11
10818983|NCT00843310|11983310|FG000|STARTED|Overall Study||8
10818984|NCT00843310|11983310|FG000|COMPLETED|Overall Study||1
10818985|NCT00843310|11983310|FG000|NOT COMPLETED|Overall Study||7
10818986|NCT00847002|11983316|FG000|STARTED|Overall Study||4
10818987|NCT00847002|11983317|FG001|STARTED|Overall Study||4
10818988|NCT00847002|11983316|FG000|COMPLETED|Overall Study||4
10818989|NCT00847002|11983317|FG001|COMPLETED|Overall Study||4
10818990|NCT00847002|11983316|FG000|NOT COMPLETED|Overall Study||0
10818991|NCT00847002|11983317|FG001|NOT COMPLETED|Overall Study||0
10818992|NCT00845702|11983323|FG000|STARTED|TOF MRA||33
10818993|NCT00845702|11983323|FG000|COMPLETED|TOF MRA|One patient did not perform study MRA procedures.|32
10818994|NCT00845702|11983323|FG000|NOT COMPLETED|TOF MRA||1
10818995|NCT00845702|11983323|FG000|STARTED|Dotarem MRA||32
10818996|NCT00845702|11983323|FG000|COMPLETED|Dotarem MRA||32
10818997|NCT00845702|11983323|FG000|NOT COMPLETED|Dotarem MRA||0
10818998|NCT00843830|11983329|FG000|STARTED|Overall Study||4
10818999|NCT00843830|11983329|FG000|COMPLETED|Overall Study||4
10819000|NCT00843830|11983329|FG000|NOT COMPLETED|Overall Study||0
10819001|NCT00835679|11983337|FG000|STARTED|Overall Study||9
10819002|NCT00835679|11983338|FG001|STARTED|Overall Study|This study closed prematurely, thus no patients went on Cohort B, C or D.|0
10819003|NCT00835679|11983339|FG002|STARTED|Overall Study||0
10819004|NCT00835679|11983340|FG003|STARTED|Overall Study||0
10819005|NCT00835679|11983337|FG000|COMPLETED|Overall Study||8
10819006|NCT00835679|11983338|FG001|COMPLETED|Overall Study||0
10819007|NCT00835679|11983339|FG002|COMPLETED|Overall Study||0
10819008|NCT00835679|11983340|FG003|COMPLETED|Overall Study||0
10819009|NCT00835679|11983337|FG000|NOT COMPLETED|Overall Study||1
10749699|NCT02999191|11913289|FG002|COMPLETED|Treatment Period 3 [1 Day]||6
10749700|NCT02999191|11913287|FG000|NOT COMPLETED|Treatment Period 3 [1 Day]||0
10749701|NCT02999191|11913288|FG001|NOT COMPLETED|Treatment Period 3 [1 Day]||0
10819010|NCT00835679|11983338|FG001|NOT COMPLETED|Overall Study||0
10819011|NCT00835679|11983339|FG002|NOT COMPLETED|Overall Study||0
10749702|NCT02999191|11913289|FG002|NOT COMPLETED|Treatment Period 3 [1 Day]||0
10749703|NCT02999672|11913299|FG000|STARTED|Overall Study||13
10749704|NCT02999672|11913300|FG001|STARTED|Overall Study||7
10749705|NCT02999672|11913299|FG000|COMPLETED|Overall Study||0
10749706|NCT02999672|11913300|FG001|COMPLETED|Overall Study||0
10749707|NCT02999672|11913299|FG000|NOT COMPLETED|Overall Study||13
10749708|NCT02999672|11913300|FG001|NOT COMPLETED|Overall Study||7
10749709|NCT02999763|11913306|FG000|STARTED|Overall Study||70
10749710|NCT02999763|11913306|FG000|COMPLETED|Overall Study||58
10749711|NCT02999763|11913306|FG000|NOT COMPLETED|Overall Study||12
10749712|NCT03000010|11913312|FG000|STARTED|Overall Study||21
10749713|NCT03000010|11913313|FG001|STARTED|Overall Study||20
10749714|NCT03000010|11913312|FG000|COMPLETED|Overall Study||21
10749715|NCT03000010|11913313|FG001|COMPLETED|Overall Study||20
10749716|NCT03000010|11913312|FG000|NOT COMPLETED|Overall Study||0
10749717|NCT03000010|11913313|FG001|NOT COMPLETED|Overall Study||0
10749718|NCT03000075|11913322|FG000|STARTED|Part A||58
10749719|NCT03000075|11913323|FG001|STARTED|Part A||58
10749720|NCT03000075|11913324|FG002|STARTED|Part A||55
10749721|NCT03000075|11913325|FG003|STARTED|Part A||0
10749722|NCT03000075|11913326|FG004|STARTED|Part A||0
10749723|NCT03000075|11913327|FG005|STARTED|Part A||0
10749724|NCT03000075|11913328|FG006|STARTED|Part A||0
10749725|NCT03000075|11913322|FG000|COMPLETED|Part A||54
10749726|NCT03000075|11913323|FG001|COMPLETED|Part A||58
10819012|NCT00835679|11983340|FG003|NOT COMPLETED|Overall Study||0
10819013|NCT00841035|11983354|FG000|STARTED|Phase 1 Overall Study|2 phase enrollment,1st phase enrolled with cancer by fine needle aspiration in endoscopic ultrasound|19
10819014|NCT00841035|11983354|FG000|COMPLETED|Phase 1 Overall Study||6
10819015|NCT00841035|11983354|FG000|NOT COMPLETED|Phase 1 Overall Study||13
10819016|NCT00841035|11983354|FG000|STARTED|Phase 2 of Overall Study||6
10819017|NCT00841035|11983354|FG000|COMPLETED|Phase 2 of Overall Study||6
10819018|NCT00841035|11983354|FG000|NOT COMPLETED|Phase 2 of Overall Study||0
10819019|NCT00832520|11983359|FG000|STARTED|Overall Study||13
10819020|NCT00832520|11983359|FG000|COMPLETED|Overall Study||13
10819021|NCT00832520|11983359|FG000|NOT COMPLETED|Overall Study||0
10819022|NCT00833859|11983363|FG000|STARTED|Overall Study||2
10819023|NCT00833859|11983363|FG000|COMPLETED|Overall Study||2
10819024|NCT00833859|11983363|FG000|NOT COMPLETED|Overall Study||0
10819025|NCT00843050|11983367|FG000|STARTED|Overall Study||13
10819026|NCT00843050|11983367|FG000|COMPLETED|Overall Study||0
10819027|NCT00843050|11983367|FG000|NOT COMPLETED|Overall Study||13
10819028|NCT00840827|11983372|FG000|STARTED|Overall Study||6
10819029|NCT00840827|11983372|FG000|COMPLETED|Overall Study||0
10819030|NCT00840827|11983372|FG000|NOT COMPLETED|Overall Study||6
10819031|NCT00835328|11983380|FG000|STARTED|Cohort 1: Dose Level 1||5
10819032|NCT00835328|11983381|FG001|STARTED|Cohort 1: Dose Level 1||0
10819033|NCT00835328|11983382|FG002|STARTED|Cohort 1: Dose Level 1||0
10819034|NCT00835328|11983383|FG003|STARTED|Cohort 1: Dose Level 1||0
10819035|NCT00835328|11983380|FG000|COMPLETED|Cohort 1: Dose Level 1||5
10819036|NCT00835328|11983381|FG001|COMPLETED|Cohort 1: Dose Level 1||0
10819037|NCT00835328|11983382|FG002|COMPLETED|Cohort 1: Dose Level 1||0
10819038|NCT00835328|11983383|FG003|COMPLETED|Cohort 1: Dose Level 1||0
10819039|NCT00835328|11983380|FG000|NOT COMPLETED|Cohort 1: Dose Level 1||0
10819040|NCT00835328|11983381|FG001|NOT COMPLETED|Cohort 1: Dose Level 1||0
10819041|NCT00835328|11983382|FG002|NOT COMPLETED|Cohort 1: Dose Level 1||0
10819042|NCT00835328|11983383|FG003|NOT COMPLETED|Cohort 1: Dose Level 1||0
10819043|NCT00835328|11983380|FG000|STARTED|Cohort 2: Dose Level 2||0
10819044|NCT00835328|11983381|FG001|STARTED|Cohort 2: Dose Level 2||2
10819045|NCT00835328|11983382|FG002|STARTED|Cohort 2: Dose Level 2||0
10819046|NCT00835328|11983383|FG003|STARTED|Cohort 2: Dose Level 2||0
10819047|NCT00835328|11983380|FG000|COMPLETED|Cohort 2: Dose Level 2||0
10819048|NCT00835328|11983381|FG001|COMPLETED|Cohort 2: Dose Level 2||2
10819049|NCT00835328|11983382|FG002|COMPLETED|Cohort 2: Dose Level 2||0
10819050|NCT00835328|11983383|FG003|COMPLETED|Cohort 2: Dose Level 2||0
10819051|NCT00835328|11983380|FG000|NOT COMPLETED|Cohort 2: Dose Level 2||0
10819052|NCT00835328|11983381|FG001|NOT COMPLETED|Cohort 2: Dose Level 2||0
10819053|NCT00835328|11983382|FG002|NOT COMPLETED|Cohort 2: Dose Level 2||0
10819054|NCT00835328|11983383|FG003|NOT COMPLETED|Cohort 2: Dose Level 2||0
10819055|NCT00835328|11983380|FG000|STARTED|Cohort 3: Dose Level 3||0
10819056|NCT00835328|11983381|FG001|STARTED|Cohort 3: Dose Level 3||0
10819057|NCT00835328|11983382|FG002|STARTED|Cohort 3: Dose Level 3||2
10819058|NCT00835328|11983383|FG003|STARTED|Cohort 3: Dose Level 3||0
10819059|NCT00835328|11983380|FG000|COMPLETED|Cohort 3: Dose Level 3||0
10819060|NCT00835328|11983381|FG001|COMPLETED|Cohort 3: Dose Level 3||0
10819061|NCT00835328|11983382|FG002|COMPLETED|Cohort 3: Dose Level 3||2
10819062|NCT00835328|11983383|FG003|COMPLETED|Cohort 3: Dose Level 3||0
10819063|NCT00835328|11983380|FG000|NOT COMPLETED|Cohort 3: Dose Level 3||0
10819064|NCT00835328|11983381|FG001|NOT COMPLETED|Cohort 3: Dose Level 3||0
10819065|NCT00835328|11983382|FG002|NOT COMPLETED|Cohort 3: Dose Level 3||0
10819066|NCT00835328|11983383|FG003|NOT COMPLETED|Cohort 3: Dose Level 3||0
10819067|NCT00835328|11983380|FG000|STARTED|Cohort 4: Dose Level 4|Cohort#4 enrolled 4 subsequent subjects|0
10819068|NCT00835328|11983381|FG001|STARTED|Cohort 4: Dose Level 4||0
10819069|NCT00835328|11983382|FG002|STARTED|Cohort 4: Dose Level 4||0
10749727|NCT03000075|11913324|FG002|COMPLETED|Part A||55
10749728|NCT03000075|11913325|FG003|COMPLETED|Part A||0
10749729|NCT03000075|11913326|FG004|COMPLETED|Part A||0
10749730|NCT03000075|11913327|FG005|COMPLETED|Part A||0
10819070|NCT00835328|11983383|FG003|STARTED|Cohort 4: Dose Level 4||4
10819071|NCT00835328|11983380|FG000|COMPLETED|Cohort 4: Dose Level 4||0
10819072|NCT00835328|11983381|FG001|COMPLETED|Cohort 4: Dose Level 4||0
10819073|NCT00835328|11983382|FG002|COMPLETED|Cohort 4: Dose Level 4||0
10819074|NCT00835328|11983383|FG003|COMPLETED|Cohort 4: Dose Level 4||4
10819075|NCT00835328|11983380|FG000|NOT COMPLETED|Cohort 4: Dose Level 4||0
10749731|NCT03000075|11913328|FG006|COMPLETED|Part A||0
10749732|NCT03000075|11913322|FG000|NOT COMPLETED|Part A||4
10749733|NCT03000075|11913323|FG001|NOT COMPLETED|Part A||0
10749734|NCT03000075|11913324|FG002|NOT COMPLETED|Part A||0
10749735|NCT03000075|11913325|FG003|NOT COMPLETED|Part A||0
10749736|NCT03000075|11913326|FG004|NOT COMPLETED|Part A||0
10749737|NCT03000075|11913327|FG005|NOT COMPLETED|Part A||0
10749738|NCT03000075|11913328|FG006|NOT COMPLETED|Part A||0
10749739|NCT03000075|11913322|FG000|STARTED|Part B||0
10749740|NCT03000075|11913323|FG001|STARTED|Part B||0
10749741|NCT03000075|11913324|FG002|STARTED|Part B||0
10749742|NCT03000075|11913325|FG003|STARTED|Part B|Participants who received placebo in Part A received risankizumab 75 mg in Part B|27
10749743|NCT03000075|11913326|FG004|STARTED|Part B|Participants who received placebo in Part A received risankizumab 150 mg in Part B|27
10749744|NCT03000075|11913327|FG005|STARTED|Part B|Participants who received risankizumab 75 mg in Part A received risankizumab 75 mg in Part B|58
10749745|NCT03000075|11913328|FG006|STARTED|Part B|Participants who received risankizumab 150 mg in Part A received risankizumab 150 mg in Part B|55
10749746|NCT03000075|11913322|FG000|COMPLETED|Part B||0
10749747|NCT03000075|11913323|FG001|COMPLETED|Part B||0
10749748|NCT03000075|11913324|FG002|COMPLETED|Part B||0
10749749|NCT03000075|11913325|FG003|COMPLETED|Part B||27
10749750|NCT03000075|11913326|FG004|COMPLETED|Part B||26
10749751|NCT03000075|11913327|FG005|COMPLETED|Part B||56
10749752|NCT03000075|11913328|FG006|COMPLETED|Part B||54
10749753|NCT03000075|11913322|FG000|NOT COMPLETED|Part B||0
10749754|NCT03000075|11913323|FG001|NOT COMPLETED|Part B||0
10749755|NCT03000075|11913324|FG002|NOT COMPLETED|Part B||0
10749756|NCT03000075|11913325|FG003|NOT COMPLETED|Part B||0
10819076|NCT00835328|11983381|FG001|NOT COMPLETED|Cohort 4: Dose Level 4||0
10819077|NCT00835328|11983382|FG002|NOT COMPLETED|Cohort 4: Dose Level 4||0
10819078|NCT00835328|11983383|FG003|NOT COMPLETED|Cohort 4: Dose Level 4||0
10749757|NCT03000075|11913326|FG004|NOT COMPLETED|Part B||1
10749758|NCT03000075|11913327|FG005|NOT COMPLETED|Part B||2
10749759|NCT03000075|11913328|FG006|NOT COMPLETED|Part B||1
10749760|NCT03000088|11913346|FG000|STARTED|Overall Study||70
10749761|NCT03000088|11913347|FG001|STARTED|Overall Study||70
10749762|NCT03000088|11913346|FG000|COMPLETED|Overall Study||70
10749763|NCT03000088|11913347|FG001|COMPLETED|Overall Study||70
10749764|NCT03000088|11913346|FG000|NOT COMPLETED|Overall Study||0
10749765|NCT03000088|11913347|FG001|NOT COMPLETED|Overall Study||0
10749766|NCT03000166|11913355|FG000|STARTED|Overall Study||25
10749767|NCT03000166|11913356|FG001|STARTED|Overall Study||22
10749768|NCT03000166|11913355|FG000|COMPLETED|Overall Study||25
10749769|NCT03000166|11913356|FG001|COMPLETED|Overall Study||19
10749770|NCT03000166|11913355|FG000|NOT COMPLETED|Overall Study||0
10749771|NCT03000166|11913356|FG001|NOT COMPLETED|Overall Study||3
10749772|NCT03000283|11913363|FG000|STARTED|Overall Study||7
10749773|NCT03000283|11913363|FG000|COMPLETED|Overall Study||7
10749774|NCT03000283|11913363|FG000|NOT COMPLETED|Overall Study||0
10749775|NCT03000309|11913367|FG000|STARTED|Overall Study||20
10749776|NCT03000309|11913367|FG000|COMPLETED|Overall Study||19
10749777|NCT03000309|11913367|FG000|NOT COMPLETED|Overall Study||1
10749778|NCT03000348|11913377|FG000|STARTED|Overall Study||17
10749779|NCT03000348|11913378|FG001|STARTED|Overall Study||11
10749780|NCT03000348|11913379|FG002|STARTED|Overall Study||15
10749781|NCT03000348|11913380|FG003|STARTED|Overall Study||15
10749782|NCT03000348|11913381|FG004|STARTED|Overall Study||16
10749783|NCT03000348|11913382|FG005|STARTED|Overall Study||15
10819079|NCT00832572|11983397|FG000|STARTED|Period 1||3
10819080|NCT00832572|11983398|FG001|STARTED|Period 1||2
10819081|NCT00832572|11983397|FG000|COMPLETED|Period 1||3
10819082|NCT00832572|11983398|FG001|COMPLETED|Period 1||2
10819083|NCT00832572|11983397|FG000|NOT COMPLETED|Period 1||0
10819084|NCT00832572|11983398|FG001|NOT COMPLETED|Period 1||0
10819085|NCT00832572|11983397|FG000|STARTED|Period 2||3
10819086|NCT00832572|11983398|FG001|STARTED|Period 2||2
10749784|NCT03000348|11913377|FG000|Day 14 Treatment Period|Overall Study||17
10749785|NCT03000348|11913378|FG001|Day 14 Treatment Period|Overall Study||10
10749786|NCT03000348|11913379|FG002|Day 14 Treatment Period|Overall Study||13
10749787|NCT03000348|11913380|FG003|Day 14 Treatment Period|Overall Study||14
10749788|NCT03000348|11913381|FG004|Day 14 Treatment Period|Overall Study||13
10749789|NCT03000348|11913382|FG005|Day 14 Treatment Period|Overall Study||14
10749790|NCT03000348|11913377|FG000|COMPLETED|Overall Study||14
10749791|NCT03000348|11913378|FG001|COMPLETED|Overall Study||7
10749792|NCT03000348|11913379|FG002|COMPLETED|Overall Study||11
10749793|NCT03000348|11913380|FG003|COMPLETED|Overall Study||12
10749794|NCT03000348|11913381|FG004|COMPLETED|Overall Study||11
10819087|NCT00832572|11983397|FG000|COMPLETED|Period 2||3
10749795|NCT03000348|11913382|FG005|COMPLETED|Overall Study||13
10749796|NCT03000348|11913377|FG000|NOT COMPLETED|Overall Study||3
10749797|NCT03000348|11913378|FG001|NOT COMPLETED|Overall Study||4
10749798|NCT03000348|11913379|FG002|NOT COMPLETED|Overall Study||4
10749799|NCT03000348|11913380|FG003|NOT COMPLETED|Overall Study||3
10749800|NCT03000348|11913381|FG004|NOT COMPLETED|Overall Study||5
10819088|NCT00832572|11983398|FG001|COMPLETED|Period 2||2
10819089|NCT00832572|11983397|FG000|NOT COMPLETED|Period 2||0
10819090|NCT00832572|11983398|FG001|NOT COMPLETED|Period 2||0
10749801|NCT03000348|11913382|FG005|NOT COMPLETED|Overall Study||2
10749802|NCT03000452|11913399|FG000|STARTED|Treatment Period||18
10749803|NCT03000452|11913399|FG000|COMPLETED|Treatment Period||0
10749804|NCT03000452|11913399|FG000|NOT COMPLETED|Treatment Period||18
10749805|NCT03000452|11913399|FG000|STARTED|Follow-Up Period|1 participant died in Cycle 1 due to PD prior to evaluation.|17
10749806|NCT03000452|11913399|FG000|COMPLETED|Follow-Up Period||10
10749807|NCT03000452|11913399|FG000|NOT COMPLETED|Follow-Up Period||7
10749808|NCT03000608|11913405|FG000|STARTED|Overall Study||46
10749809|NCT03000608|11913406|FG001|STARTED|Overall Study||23
10749810|NCT03000608|11913405|FG000|COMPLETED|Overall Study||40
10749811|NCT03000608|11913406|FG001|COMPLETED|Overall Study||19
10749812|NCT03000608|11913405|FG000|NOT COMPLETED|Overall Study||6
10749813|NCT03000608|11913406|FG001|NOT COMPLETED|Overall Study||4
10749814|NCT03000673|11913416|FG000|STARTED|Overall Study||7
10749815|NCT03000673|11913417|FG001|STARTED|Overall Study||9
10749816|NCT03000673|11913418|FG002|STARTED|Overall Study||7
10749817|NCT03000673|11913419|FG003|STARTED|Overall Study||9
10749818|NCT03000673|11913416|FG000|COMPLETED|Overall Study||6
10749819|NCT03000673|11913417|FG001|COMPLETED|Overall Study||9
10749820|NCT03000673|11913418|FG002|COMPLETED|Overall Study||7
10749821|NCT03000673|11913419|FG003|COMPLETED|Overall Study||9
10749822|NCT03000673|11913416|FG000|NOT COMPLETED|Overall Study||1
10749823|NCT03000673|11913417|FG001|NOT COMPLETED|Overall Study||0
10749824|NCT03000673|11913418|FG002|NOT COMPLETED|Overall Study||0
10749825|NCT03000673|11913419|FG003|NOT COMPLETED|Overall Study||0
10749826|NCT03000686|11913432|FG000|STARTED|Part 1, Period 1 (1 Day)||5
10749827|NCT03000686|11913433|FG001|STARTED|Part 1, Period 1 (1 Day)||6
10749828|NCT03000686|11913434|FG002|STARTED|Part 1, Period 1 (1 Day)||0
10749829|NCT03000686|11913435|FG003|STARTED|Part 1, Period 1 (1 Day)||0
10749830|NCT03000686|11913432|FG000|COMPLETED|Part 1, Period 1 (1 Day)||5
10749831|NCT03000686|11913433|FG001|COMPLETED|Part 1, Period 1 (1 Day)||5
10749832|NCT03000686|11913434|FG002|COMPLETED|Part 1, Period 1 (1 Day)||0
10749833|NCT03000686|11913435|FG003|COMPLETED|Part 1, Period 1 (1 Day)||0
10749834|NCT03000686|11913432|FG000|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
10749835|NCT03000686|11913433|FG001|NOT COMPLETED|Part 1, Period 1 (1 Day)||1
10749836|NCT03000686|11913434|FG002|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
10749837|NCT03000686|11913435|FG003|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
10749838|NCT03000686|11913432|FG000|STARTED|Part 1, Wash-out (Up to 14 Days)||5
10749839|NCT03000686|11913433|FG001|STARTED|Part 1, Wash-out (Up to 14 Days)||5
10749840|NCT03000686|11913434|FG002|STARTED|Part 1, Wash-out (Up to 14 Days)||0
10749841|NCT03000686|11913435|FG003|STARTED|Part 1, Wash-out (Up to 14 Days)||0
10749842|NCT03000686|11913432|FG000|COMPLETED|Part 1, Wash-out (Up to 14 Days)||5
10749843|NCT03000686|11913433|FG001|COMPLETED|Part 1, Wash-out (Up to 14 Days)||5
10749844|NCT03000686|11913434|FG002|COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
10749845|NCT03000686|11913435|FG003|COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
10749846|NCT03000686|11913432|FG000|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
10749847|NCT03000686|11913433|FG001|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
10749848|NCT03000686|11913434|FG002|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
10749849|NCT03000686|11913435|FG003|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
10749850|NCT03000686|11913432|FG000|STARTED|Part 1, Period 2 (1 Day)||5
10749851|NCT03000686|11913433|FG001|STARTED|Part 1, Period 2 (1 Day)||5
10749852|NCT03000686|11913434|FG002|STARTED|Part 1, Period 2 (1 Day)||0
10749853|NCT03000686|11913435|FG003|STARTED|Part 1, Period 2 (1 Day)||0
10749854|NCT03000686|11913432|FG000|COMPLETED|Part 1, Period 2 (1 Day)||5
10749855|NCT03000686|11913433|FG001|COMPLETED|Part 1, Period 2 (1 Day)||5
10749856|NCT03000686|11913434|FG002|COMPLETED|Part 1, Period 2 (1 Day)||0
10749857|NCT03000686|11913435|FG003|COMPLETED|Part 1, Period 2 (1 Day)||0
10749858|NCT03000686|11913432|FG000|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
10749859|NCT03000686|11913433|FG001|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
10749860|NCT03000686|11913434|FG002|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
10749861|NCT03000686|11913435|FG003|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
10749862|NCT03000686|11913432|FG000|STARTED|Part 2, Period 1 (1 Day)||0
10749863|NCT03000686|11913433|FG001|STARTED|Part 2, Period 1 (1 Day)||0
10749864|NCT03000686|11913434|FG002|STARTED|Part 2, Period 1 (1 Day)||3
10749865|NCT03000686|11913435|FG003|STARTED|Part 2, Period 1 (1 Day)||3
10749866|NCT03000686|11913432|FG000|COMPLETED|Part 2, Period 1 (1 Day)||0
10749867|NCT03000686|11913433|FG001|COMPLETED|Part 2, Period 1 (1 Day)||0
10749868|NCT03000686|11913434|FG002|COMPLETED|Part 2, Period 1 (1 Day)||3
10749869|NCT03000686|11913435|FG003|COMPLETED|Part 2, Period 1 (1 Day)||3
10749870|NCT03000686|11913432|FG000|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
10749871|NCT03000686|11913433|FG001|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
10749872|NCT03000686|11913434|FG002|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
10749873|NCT03000686|11913435|FG003|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
10749874|NCT03000686|11913432|FG000|STARTED|Part 2, Wash-out (Up to 14 Days)||0
10819091|NCT00832624|11983406|FG000|STARTED|Overall Study||10
10819092|NCT00832624|11983406|FG000|COMPLETED|Overall Study||0
10819093|NCT00832624|11983406|FG000|NOT COMPLETED|Overall Study||10
10819094|NCT00832299|11983410|FG000|STARTED|Overall Study||2
10819095|NCT00832299|11983410|FG000|COMPLETED|Overall Study||2
10819096|NCT00832299|11983410|FG000|NOT COMPLETED|Overall Study||0
10819097|NCT00836355|11983418|FG000|STARTED|Overall Study||0
10819098|NCT00836355|11983419|FG001|STARTED|Overall Study||4
10749875|NCT03000686|11913433|FG001|STARTED|Part 2, Wash-out (Up to 14 Days)||0
10749876|NCT03000686|11913434|FG002|STARTED|Part 2, Wash-out (Up to 14 Days)||3
10749877|NCT03000686|11913435|FG003|STARTED|Part 2, Wash-out (Up to 14 Days)||3
10819099|NCT00836355|11983420|FG002|STARTED|Overall Study||0
10819100|NCT00836355|11983421|FG003|STARTED|Overall Study||2
10819101|NCT00836355|11983418|FG000|COMPLETED|Overall Study||0
10819102|NCT00836355|11983419|FG001|COMPLETED|Overall Study||4
10819103|NCT00836355|11983420|FG002|COMPLETED|Overall Study||0
10819104|NCT00836355|11983421|FG003|COMPLETED|Overall Study||2
10819105|NCT00836355|11983418|FG000|NOT COMPLETED|Overall Study||0
10749878|NCT03000686|11913432|FG000|COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
10749879|NCT03000686|11913433|FG001|COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
10749880|NCT03000686|11913434|FG002|COMPLETED|Part 2, Wash-out (Up to 14 Days)||3
10749881|NCT03000686|11913435|FG003|COMPLETED|Part 2, Wash-out (Up to 14 Days)||3
10749882|NCT03000686|11913432|FG000|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
10749883|NCT03000686|11913433|FG001|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
10819106|NCT00836355|11983419|FG001|NOT COMPLETED|Overall Study||0
10819107|NCT00836355|11983420|FG002|NOT COMPLETED|Overall Study||0
10819108|NCT00836355|11983421|FG003|NOT COMPLETED|Overall Study||0
10819109|NCT00832598|11983431|FG000|STARTED|Overall Study||13
10819110|NCT00832598|11983431|FG000|COMPLETED|Overall Study||13
10819111|NCT00832598|11983431|FG000|NOT COMPLETED|Overall Study||0
10819112|NCT00816777|11983437|FG000|STARTED|Overall Study||2
10819113|NCT00816777|11983438|FG001|STARTED|Overall Study||2
10819114|NCT00816777|11983437|FG000|COMPLETED|Overall Study||2
10819115|NCT00816777|11983438|FG001|COMPLETED|Overall Study||2
10819116|NCT00816777|11983437|FG000|NOT COMPLETED|Overall Study||0
10819117|NCT00816777|11983438|FG001|NOT COMPLETED|Overall Study||0
10819118|NCT00823095|11983444|FG000|STARTED|Overall Study||7
10819119|NCT00823095|11983444|FG000|COMPLETED|Overall Study||7
10819120|NCT00823095|11983444|FG000|NOT COMPLETED|Overall Study||0
10819121|NCT00827567|11983449|FG000|STARTED|Overall Study||4
10819122|NCT00827567|11983449|FG000|COMPLETED|Overall Study|2 screen failures, 4 withdrew from study to go on to other therapies|0
10819123|NCT00827567|11983449|FG000|NOT COMPLETED|Overall Study||4
10749884|NCT03000686|11913434|FG002|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
10749885|NCT03000686|11913435|FG003|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
10749886|NCT03000686|11913432|FG000|STARTED|Part 2, Period 2 (1 Day)||0
10749887|NCT03000686|11913433|FG001|STARTED|Part 2, Period 2 (1 Day)||0
10749888|NCT03000686|11913434|FG002|STARTED|Part 2, Period 2 (1 Day)||3
10749889|NCT03000686|11913435|FG003|STARTED|Part 2, Period 2 (1 Day)||3
10749890|NCT03000686|11913432|FG000|COMPLETED|Part 2, Period 2 (1 Day)||0
10749891|NCT03000686|11913433|FG001|COMPLETED|Part 2, Period 2 (1 Day)||0
10749892|NCT03000686|11913434|FG002|COMPLETED|Part 2, Period 2 (1 Day)||3
10749893|NCT03000686|11913435|FG003|COMPLETED|Part 2, Period 2 (1 Day)||3
10749894|NCT03000686|11913432|FG000|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
10749895|NCT03000686|11913433|FG001|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
10749896|NCT03000686|11913434|FG002|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
10749897|NCT03000686|11913435|FG003|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
10749898|NCT03001076|11913449|FG000|STARTED|Overall Study||88
10749899|NCT03001076|11913450|FG001|STARTED|Overall Study||181
10749900|NCT03001076|11913449|FG000|COMPLETED|Overall Study||81
10749901|NCT03001076|11913450|FG001|COMPLETED|Overall Study||176
10749902|NCT03001076|11913449|FG000|NOT COMPLETED|Overall Study||7
10749903|NCT03001076|11913450|FG001|NOT COMPLETED|Overall Study||5
10749904|NCT03001219|11913458|FG000|STARTED|Proof of Concept||37
10749905|NCT03001219|11913459|FG001|STARTED|Proof of Concept||72
10749906|NCT03001219|11913458|FG000|COMPLETED|Proof of Concept||35
10749907|NCT03001219|11913459|FG001|COMPLETED|Proof of Concept||65
10749908|NCT03001219|11913458|FG000|NOT COMPLETED|Proof of Concept||2
10749909|NCT03001219|11913459|FG001|NOT COMPLETED|Proof of Concept||7
10749910|NCT03001219|11913458|FG000|STARTED|Extension Period Analysis||9
10749911|NCT03001219|11913459|FG001|STARTED|Extension Period Analysis||97
10749912|NCT03001219|11913458|FG000|COMPLETED|Extension Period Analysis||4
10749913|NCT03001219|11913459|FG001|COMPLETED|Extension Period Analysis||52
10749914|NCT03001219|11913458|FG000|NOT COMPLETED|Extension Period Analysis||5
10819124|NCT00815633|11983453|FG000|STARTED|Overall Study||1
10819125|NCT00815633|11983453|FG000|COMPLETED|Overall Study||0
10819126|NCT00815633|11983453|FG000|NOT COMPLETED|Overall Study||1
10819127|NCT00814983|11983459|FG000|STARTED|Overall Study||15
10819128|NCT00814983|11983460|FG001|STARTED|Overall Study||0
10819129|NCT00814983|11983459|FG000|COMPLETED|Overall Study||12
10819130|NCT00814983|11983460|FG001|COMPLETED|Overall Study||0
10819131|NCT00814983|11983459|FG000|NOT COMPLETED|Overall Study||3
10819132|NCT00814983|11983460|FG001|NOT COMPLETED|Overall Study||0
10819133|NCT00825227|11983468|FG000|STARTED|Overall Study||6
10819134|NCT00825227|11983469|FG001|STARTED|Overall Study||4
10819135|NCT00825227|11983468|FG000|COMPLETED|Overall Study||6
10819136|NCT00825227|11983469|FG001|COMPLETED|Overall Study||4
10819137|NCT00825227|11983468|FG000|NOT COMPLETED|Overall Study||0
10819138|NCT00825227|11983469|FG001|NOT COMPLETED|Overall Study||0
10819139|NCT00819832|11983483|FG000|STARTED|Overall Study|No patient data analysis.|3
10819140|NCT00819832|11983484|FG001|STARTED|Overall Study||0
10819141|NCT00819832|11983485|FG002|STARTED|Overall Study||0
10819142|NCT00819832|11983486|FG003|STARTED|Overall Study||0
10819143|NCT00819832|11983487|FG004|STARTED|Overall Study||0
10819144|NCT00819832|11983488|FG005|STARTED|Overall Study||0
10819145|NCT00819832|11983483|FG000|COMPLETED|Overall Study||0
10819146|NCT00819832|11983484|FG001|COMPLETED|Overall Study||0
10819147|NCT00819832|11983485|FG002|COMPLETED|Overall Study||0
10819148|NCT00819832|11983486|FG003|COMPLETED|Overall Study||0
10819149|NCT00819832|11983487|FG004|COMPLETED|Overall Study||0
10819150|NCT00819832|11983488|FG005|COMPLETED|Overall Study||0
10819151|NCT00819832|11983483|FG000|NOT COMPLETED|Overall Study||3
10819152|NCT00819832|11983484|FG001|NOT COMPLETED|Overall Study||0
10819153|NCT00819832|11983485|FG002|NOT COMPLETED|Overall Study||0
10819154|NCT00819832|11983486|FG003|NOT COMPLETED|Overall Study||0
10819155|NCT00819832|11983487|FG004|NOT COMPLETED|Overall Study||0
10819156|NCT00819832|11983488|FG005|NOT COMPLETED|Overall Study||0
10819157|NCT00822679|11983504|FG000|STARTED|Overall Study||0
10819158|NCT00822679|11983505|FG001|STARTED|Overall Study||0
10819159|NCT00822679|11983504|FG000|COMPLETED|Overall Study||0
10819160|NCT00822679|11983505|FG001|COMPLETED|Overall Study||0
10819161|NCT00822679|11983504|FG000|NOT COMPLETED|Overall Study||0
10819162|NCT00822679|11983505|FG001|NOT COMPLETED|Overall Study||0
10819163|NCT00814892|11983511|FG000|STARTED|Overall Study||2
10819164|NCT00814892|11983511|FG000|COMPLETED|Overall Study||0
10819165|NCT00814892|11983511|FG000|NOT COMPLETED|Overall Study||2
10819166|NCT00809458|11983517|FG000|STARTED|Overall Study||9
10819167|NCT00809458|11983518|FG001|STARTED|Overall Study||6
10819168|NCT00809458|11983517|FG000|COMPLETED|Overall Study||8
10819169|NCT00809458|11983518|FG001|COMPLETED|Overall Study||5
10819170|NCT00809458|11983517|FG000|NOT COMPLETED|Overall Study||1
10819171|NCT00809458|11983518|FG001|NOT COMPLETED|Overall Study||1
10819172|NCT00802659|11983528|FG000|STARTED|Overall Study||0
10819173|NCT00802659|11983529|FG001|STARTED|Overall Study||2
10819174|NCT00802659|11983530|FG002|STARTED|Overall Study||0
10819175|NCT00802659|11983531|FG003|STARTED|Overall Study||0
10819176|NCT00802659|11983528|FG000|COMPLETED|Overall Study||0
10819177|NCT00802659|11983529|FG001|COMPLETED|Overall Study||1
10819178|NCT00802659|11983530|FG002|COMPLETED|Overall Study||0
10819179|NCT00802659|11983531|FG003|COMPLETED|Overall Study||0
10819180|NCT00802659|11983528|FG000|NOT COMPLETED|Overall Study||0
10819181|NCT00802659|11983529|FG001|NOT COMPLETED|Overall Study||1
10819182|NCT00802659|11983530|FG002|NOT COMPLETED|Overall Study||0
10819183|NCT00802659|11983531|FG003|NOT COMPLETED|Overall Study||0
10819184|NCT00807365|11983541|FG000|STARTED|Overall Study||5
10749915|NCT03001219|11913459|FG001|NOT COMPLETED|Extension Period Analysis||45
10749916|NCT03001258|11913473|FG000|STARTED|Overall Study||765
10819185|NCT00807365|11983541|FG000|COMPLETED|Overall Study||0
10819186|NCT00807365|11983541|FG000|NOT COMPLETED|Overall Study||5
10819187|NCT00814333|11983547|FG000|STARTED|Enrollment||1
10819188|NCT00814333|11983548|FG001|STARTED|Enrollment||0
10819189|NCT00814333|11983547|FG000|COMPLETED|Enrollment||0
10819190|NCT00814333|11983548|FG001|COMPLETED|Enrollment||0
10749917|NCT03001258|11913474|FG001|STARTED|Overall Study||751
10749918|NCT03001258|11913475|FG002|STARTED|Overall Study||485
10749919|NCT03001258|11913473|FG000|COMPLETED|Overall Study||765
10749920|NCT03001258|11913474|FG001|COMPLETED|Overall Study||751
10749921|NCT03001258|11913475|FG002|COMPLETED|Overall Study||485
10749922|NCT03001258|11913473|FG000|NOT COMPLETED|Overall Study||0
10749923|NCT03001258|11913474|FG001|NOT COMPLETED|Overall Study||0
10749924|NCT03001258|11913475|FG002|NOT COMPLETED|Overall Study||0
10749925|NCT03001453|11913485|FG000|STARTED|Overall Study||50
10749926|NCT03001453|11913486|FG001|STARTED|Overall Study||57
10749927|NCT03001453|11913485|FG000|COMPLETED|Overall Study||50
10749928|NCT03001453|11913486|FG001|COMPLETED|Overall Study||57
10749929|NCT03001453|11913485|FG000|NOT COMPLETED|Overall Study||0
10749930|NCT03001453|11913486|FG001|NOT COMPLETED|Overall Study||0
10749931|NCT03001557|11913497|FG000|STARTED|Core Phase||12
10749932|NCT03001557|11913498|FG001|STARTED|Core Phase||12
10749933|NCT03001557|11913499|FG002|STARTED|Core Phase||14
10749934|NCT03001557|11913500|FG003|STARTED|Core Phase||13
10749935|NCT03001557|11913501|FG004|STARTED|Core Phase||12
10749936|NCT03001557|11913502|FG005|STARTED|Core Phase||0
10749937|NCT03001557|11913503|FG006|STARTED|Core Phase||0
10749938|NCT03001557|11913504|FG007|STARTED|Core Phase||0
10749939|NCT03001557|11913497|FG000|Treated|Core Phase||12
10749940|NCT03001557|11913498|FG001|Treated|Core Phase||12
10749941|NCT03001557|11913499|FG002|Treated|Core Phase||13
10749942|NCT03001557|11913500|FG003|Treated|Core Phase||13
10749943|NCT03001557|11913501|FG004|Treated|Core Phase||12
10749944|NCT03001557|11913502|FG005|Treated|Core Phase||0
10749945|NCT03001557|11913503|FG006|Treated|Core Phase||0
10749946|NCT03001557|11913504|FG007|Treated|Core Phase||0
10749947|NCT03001557|11913497|FG000|COMPLETED|Core Phase||12
10749948|NCT03001557|11913498|FG001|COMPLETED|Core Phase||12
10749949|NCT03001557|11913499|FG002|COMPLETED|Core Phase||13
10749950|NCT03001557|11913500|FG003|COMPLETED|Core Phase||13
10749951|NCT03001557|11913501|FG004|COMPLETED|Core Phase||12
10749952|NCT03001557|11913502|FG005|COMPLETED|Core Phase||0
10749953|NCT03001557|11913503|FG006|COMPLETED|Core Phase||0
10749954|NCT03001557|11913504|FG007|COMPLETED|Core Phase||0
10749955|NCT03001557|11913497|FG000|NOT COMPLETED|Core Phase||0
10749956|NCT03001557|11913498|FG001|NOT COMPLETED|Core Phase||0
10749957|NCT03001557|11913499|FG002|NOT COMPLETED|Core Phase||1
10749958|NCT03001557|11913500|FG003|NOT COMPLETED|Core Phase||0
10749959|NCT03001557|11913501|FG004|NOT COMPLETED|Core Phase||0
10749960|NCT03001557|11913502|FG005|NOT COMPLETED|Core Phase||0
10749961|NCT03001557|11913503|FG006|NOT COMPLETED|Core Phase||0
10749962|NCT03001557|11913504|FG007|NOT COMPLETED|Core Phase||0
10749963|NCT03001557|11913497|FG000|STARTED|Extension Phase||0
10749964|NCT03001557|11913498|FG001|STARTED|Extension Phase||0
10749965|NCT03001557|11913499|FG002|STARTED|Extension Phase||0
10749966|NCT03001557|11913500|FG003|STARTED|Extension Phase||0
10749967|NCT03001557|11913501|FG004|STARTED|Extension Phase||0
10749968|NCT03001557|11913502|FG005|STARTED|Extension Phase||5
10749969|NCT03001557|11913503|FG006|STARTED|Extension Phase||14
10749970|NCT03001557|11913504|FG007|STARTED|Extension Phase||6
10749971|NCT03001557|11913497|FG000|COMPLETED|Extension Phase||0
10749972|NCT03001557|11913498|FG001|COMPLETED|Extension Phase||0
10749973|NCT03001557|11913499|FG002|COMPLETED|Extension Phase||0
10749974|NCT03001557|11913500|FG003|COMPLETED|Extension Phase||0
10749975|NCT03001557|11913501|FG004|COMPLETED|Extension Phase||0
10749976|NCT03001557|11913502|FG005|COMPLETED|Extension Phase||0
10749977|NCT03001557|11913503|FG006|COMPLETED|Extension Phase||0
10749978|NCT03001557|11913504|FG007|COMPLETED|Extension Phase||0
10749979|NCT03001557|11913497|FG000|NOT COMPLETED|Extension Phase||0
10749980|NCT03001557|11913498|FG001|NOT COMPLETED|Extension Phase||0
10749981|NCT03001557|11913499|FG002|NOT COMPLETED|Extension Phase||0
10749982|NCT03001557|11913500|FG003|NOT COMPLETED|Extension Phase||0
10749983|NCT03001557|11913501|FG004|NOT COMPLETED|Extension Phase||0
10819191|NCT00814333|11983547|FG000|NOT COMPLETED|Enrollment||1
10819192|NCT00814333|11983548|FG001|NOT COMPLETED|Enrollment||0
10819193|NCT00814333|11983547|FG000|STARTED|Treatment Period||0
10819194|NCT00814333|11983548|FG001|STARTED|Treatment Period||0
10819195|NCT00814333|11983547|FG000|COMPLETED|Treatment Period||0
10819196|NCT00814333|11983548|FG001|COMPLETED|Treatment Period||0
10819197|NCT00814333|11983547|FG000|NOT COMPLETED|Treatment Period||0
10819198|NCT00814333|11983548|FG001|NOT COMPLETED|Treatment Period||0
10749984|NCT03001557|11913502|FG005|NOT COMPLETED|Extension Phase||5
10749985|NCT03001557|11913503|FG006|NOT COMPLETED|Extension Phase||14
10819199|NCT00808080|11983554|FG000|STARTED|Overall Study||6
10819200|NCT00808080|11983554|FG000|COMPLETED|Overall Study||0
10749986|NCT03001557|11913504|FG007|NOT COMPLETED|Extension Phase||6
10749987|NCT03001674|11913528|FG000|STARTED|Overall Study||10
10749988|NCT03001674|11913529|FG001|STARTED|Overall Study||5
10749989|NCT03001674|11913528|FG000|COMPLETED|Overall Study||10
10749990|NCT03001674|11913529|FG001|COMPLETED|Overall Study||5
10749991|NCT03001674|11913528|FG000|NOT COMPLETED|Overall Study||0
10749992|NCT03001674|11913529|FG001|NOT COMPLETED|Overall Study||0
10749993|NCT03001778|11913537|FG000|STARTED|Overall Study||21
10819201|NCT00808080|11983554|FG000|NOT COMPLETED|Overall Study||6
10819202|NCT00802893|11983559|FG000|STARTED|Overall Study||3
10749994|NCT03001778|11913538|FG001|STARTED|Overall Study||46
10749995|NCT03001778|11913537|FG000|COMPLETED|Overall Study||21
10749996|NCT03001778|11913538|FG001|COMPLETED|Overall Study||46
10749997|NCT03001778|11913537|FG000|NOT COMPLETED|Overall Study||0
10749998|NCT03001778|11913538|FG001|NOT COMPLETED|Overall Study||0
10749999|NCT03001843|11913546|FG000|STARTED|Overall Study||27
10750000|NCT03001843|11913547|FG001|STARTED|Overall Study||27
10750001|NCT03001843|11913546|FG000|COMPLETED|Overall Study||27
10750002|NCT03001843|11913547|FG001|COMPLETED|Overall Study||27
10750003|NCT03001843|11913546|FG000|NOT COMPLETED|Overall Study||0
10750004|NCT03001843|11913547|FG001|NOT COMPLETED|Overall Study||0
10750005|NCT03002012|11913555|FG000|STARTED|Overall Study||11
10750006|NCT03002012|11913556|FG001|STARTED|Overall Study||11
10750007|NCT03002012|11913555|FG000|COMPLETED|Overall Study||11
10750008|NCT03002012|11913556|FG001|COMPLETED|Overall Study||11
10750009|NCT03002012|11913555|FG000|NOT COMPLETED|Overall Study||0
10750010|NCT03002012|11913556|FG001|NOT COMPLETED|Overall Study||0
10750011|NCT03002038|11913564|FG000|STARTED|Overall Study||46
10750012|NCT03002038|11913565|FG001|STARTED|Overall Study||40
10750013|NCT03002038|11913564|FG000|COMPLETED|Overall Study||35
10750014|NCT03002038|11913565|FG001|COMPLETED|Overall Study||33
10750015|NCT03002038|11913564|FG000|NOT COMPLETED|Overall Study||11
10750016|NCT03002038|11913565|FG001|NOT COMPLETED|Overall Study||7
10750017|NCT03002077|11913571|FG000|STARTED|Overall Study||617
10750018|NCT03002077|11913571|FG000|COMPLETED|Overall Study||179
10750019|NCT03002077|11913571|FG000|NOT COMPLETED|Overall Study||438
10750020|NCT03002194|11913575|FG000|STARTED|Overall Study||48
10750021|NCT03002194|11913575|FG000|COMPLETED|Overall Study||38
10750022|NCT03002194|11913575|FG000|NOT COMPLETED|Overall Study||10
10750023|NCT03002311|11913581|FG000|STARTED|Overall Study||147
10750024|NCT03002311|11913582|FG001|STARTED|Overall Study||180
10750025|NCT03002311|11913581|FG000|COMPLETED|Overall Study||128
10750026|NCT03002311|11913582|FG001|COMPLETED|Overall Study||150
10750027|NCT03002311|11913581|FG000|NOT COMPLETED|Overall Study||19
10750028|NCT03002311|11913582|FG001|NOT COMPLETED|Overall Study||30
10750029|NCT03002454|11913588|FG000|STARTED|Overall Study||4
10750030|NCT03002454|11913588|FG000|COMPLETED|Overall Study||4
10750031|NCT03002454|11913588|FG000|NOT COMPLETED|Overall Study||0
10750032|NCT03002506|11913593|FG000|STARTED|Overall Study||6
10750033|NCT03002506|11913593|FG000|COMPLETED|Overall Study||6
10750034|NCT03002506|11913593|FG000|NOT COMPLETED|Overall Study||0
10750035|NCT03002610|11913600|FG000|STARTED|Overall Study||24
10750036|NCT03002610|11913601|FG001|STARTED|Overall Study||50
10750037|NCT03002610|11913602|FG002|STARTED|Overall Study||34
10750038|NCT03002610|11913600|FG000|COMPLETED|Overall Study||18
10750039|NCT03002610|11913601|FG001|COMPLETED|Overall Study||25
10819203|NCT00802893|11983559|FG000|COMPLETED|Overall Study||0
10819204|NCT00802893|11983559|FG000|NOT COMPLETED|Overall Study||3
10819205|NCT00809341|11983565|FG000|STARTED|Overall Study||20
10819206|NCT00809341|11983566|FG001|STARTED|Overall Study||5
10819207|NCT00809341|11983565|FG000|COMPLETED|Overall Study||20
10819208|NCT00809341|11983566|FG001|COMPLETED|Overall Study||4
10819209|NCT00809341|11983565|FG000|NOT COMPLETED|Overall Study||0
10819210|NCT00809341|11983566|FG001|NOT COMPLETED|Overall Study||1
10819211|NCT00804349|11983574|FG000|STARTED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available.|0
10819212|NCT00804349|11983575|FG001|STARTED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available|0
10819213|NCT00804349|11983574|FG000|COMPLETED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available|0
10819214|NCT00804349|11983575|FG001|COMPLETED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available|0
10819215|NCT00804349|11983574|FG000|NOT COMPLETED|Overall Study||0
10819216|NCT00804349|11983575|FG001|NOT COMPLETED|Overall Study||0
10819217|NCT00803283|11983583|FG000|STARTED|Overall Study||1
10819218|NCT00803283|11983584|FG001|STARTED|Overall Study||1
10819219|NCT00803283|11983583|FG000|COMPLETED|Overall Study||1
10819220|NCT00803283|11983584|FG001|COMPLETED|Overall Study||1
10819221|NCT00803283|11983583|FG000|NOT COMPLETED|Overall Study||0
10819222|NCT00803283|11983584|FG001|NOT COMPLETED|Overall Study||0
10819223|NCT00811590|11983590|FG000|STARTED|Overall Study||3
10819224|NCT00811590|11983590|FG000|COMPLETED|Overall Study||3
10819225|NCT00811590|11983590|FG000|NOT COMPLETED|Overall Study||0
10819226|NCT00808899|11983594|FG000|STARTED|Overall Study||4
10819227|NCT00808899|11983594|FG000|COMPLETED|Overall Study||0
10819228|NCT00808899|11983594|FG000|NOT COMPLETED|Overall Study||4
10819229|NCT00808769|11983598|FG000|STARTED|First Intervention||15
10819230|NCT00808769|11983599|FG001|STARTED|First Intervention||15
10819231|NCT00808769|11983598|FG000|COMPLETED|First Intervention||15
10819232|NCT00808769|11983599|FG001|COMPLETED|First Intervention||15
10819233|NCT00808769|11983598|FG000|NOT COMPLETED|First Intervention||0
10819234|NCT00808769|11983599|FG001|NOT COMPLETED|First Intervention||0
10750040|NCT03002610|11913602|FG002|COMPLETED|Overall Study||21
10750041|NCT03002610|11913600|FG000|NOT COMPLETED|Overall Study||6
10750042|NCT03002610|11913601|FG001|NOT COMPLETED|Overall Study||25
10819235|NCT00808769|11983598|FG000|STARTED|Second Intervention||15
10750043|NCT03002610|11913602|FG002|NOT COMPLETED|Overall Study||13
10750044|NCT03002623|11913612|FG000|STARTED|Overall Study||4
10819236|NCT00808769|11983599|FG001|STARTED|Second Intervention||15
10819237|NCT00808769|11983598|FG000|COMPLETED|Second Intervention||15
10819238|NCT00808769|11983599|FG001|COMPLETED|Second Intervention||15
10819239|NCT00808769|11983598|FG000|NOT COMPLETED|Second Intervention||0
10750045|NCT03002623|11913613|FG001|STARTED|Overall Study||3
10750046|NCT03002623|11913612|FG000|COMPLETED|Overall Study||2
10750047|NCT03002623|11913613|FG001|COMPLETED|Overall Study||2
10750048|NCT03002623|11913612|FG000|NOT COMPLETED|Overall Study||2
10750049|NCT03002623|11913613|FG001|NOT COMPLETED|Overall Study||1
10750050|NCT03002753|11913623|FG000|STARTED|First Randomization||10
10750051|NCT03002753|11913624|FG001|STARTED|First Randomization||12
10750052|NCT03002753|11913625|FG002|STARTED|First Randomization||21
10750053|NCT03002753|11913623|FG000|COMPLETED|First Randomization||9
10750054|NCT03002753|11913624|FG001|COMPLETED|First Randomization||11
10750055|NCT03002753|11913625|FG002|COMPLETED|First Randomization||21
10750056|NCT03002753|11913623|FG000|NOT COMPLETED|First Randomization||1
10750057|NCT03002753|11913624|FG001|NOT COMPLETED|First Randomization||1
10750058|NCT03002753|11913625|FG002|NOT COMPLETED|First Randomization||0
10750059|NCT03002753|11913623|FG000|STARTED|Second Randomization (Re-randomization)||11
10750060|NCT03002753|11913624|FG001|STARTED|Second Randomization (Re-randomization)||10
10750061|NCT03002753|11913625|FG002|STARTED|Second Randomization (Re-randomization)||0
10750062|NCT03002753|11913623|FG000|COMPLETED|Second Randomization (Re-randomization)||11
10750063|NCT03002753|11913624|FG001|COMPLETED|Second Randomization (Re-randomization)||9
10750064|NCT03002753|11913625|FG002|COMPLETED|Second Randomization (Re-randomization)||0
10750065|NCT03002753|11913623|FG000|NOT COMPLETED|Second Randomization (Re-randomization)||0
10750066|NCT03002753|11913624|FG001|NOT COMPLETED|Second Randomization (Re-randomization)||1
10750067|NCT03002753|11913625|FG002|NOT COMPLETED|Second Randomization (Re-randomization)||0
10750068|NCT03002818|11913633|FG000|STARTED|Overall Study||41
10750069|NCT03002818|11913633|FG000|COMPLETED|Overall Study||40
10750070|NCT03002818|11913633|FG000|NOT COMPLETED|Overall Study||1
10750071|NCT03002974|11913640|FG000|STARTED|Overall Study||55
10750072|NCT03002974|11913641|FG001|STARTED|Overall Study||56
10750073|NCT03002974|11913642|FG002|STARTED|Overall Study||54
10750074|NCT03002974|11913640|FG000|Intention To Treat Populatio|Overall Study||55
10750075|NCT03002974|11913641|FG001|Intention To Treat Populatio|Overall Study||56
10750076|NCT03002974|11913642|FG002|Intention To Treat Populatio|Overall Study||54
10750077|NCT03002974|11913640|FG000|Safety Population|Overall Study||54
10750078|NCT03002974|11913641|FG001|Safety Population|Overall Study||55
10750079|NCT03002974|11913642|FG002|Safety Population|Overall Study||52
10750080|NCT03002974|11913640|FG000|COMPLETED|Overall Study||35
10750081|NCT03002974|11913641|FG001|COMPLETED|Overall Study||40
10750082|NCT03002974|11913642|FG002|COMPLETED|Overall Study||36
10750083|NCT03002974|11913640|FG000|NOT COMPLETED|Overall Study||20
10750084|NCT03002974|11913641|FG001|NOT COMPLETED|Overall Study||16
10750085|NCT03002974|11913642|FG002|NOT COMPLETED|Overall Study||18
10750086|NCT03003000|11913653|FG000|STARTED|Overall Study||126
10750087|NCT03003000|11913654|FG001|STARTED|Overall Study||253
10750088|NCT03003000|11913655|FG002|STARTED|Overall Study||256
10750089|NCT03003000|11913653|FG000|COMPLETED|Overall Study||121
10750090|NCT03003000|11913654|FG001|COMPLETED|Overall Study||249
10750091|NCT03003000|11913655|FG002|COMPLETED|Overall Study||251
10750092|NCT03003000|11913653|FG000|NOT COMPLETED|Overall Study||5
10750093|NCT03003000|11913654|FG001|NOT COMPLETED|Overall Study||4
10750094|NCT03003000|11913655|FG002|NOT COMPLETED|Overall Study||5
10819240|NCT00808769|11983599|FG001|NOT COMPLETED|Second Intervention||0
10750101|NCT03003390|11913674|FG000|STARTED|Overall Study||27
10750102|NCT03003390|11913675|FG001|STARTED|Overall Study||24
10750103|NCT03003390|11913674|FG000|COMPLETED|Overall Study||23
10750104|NCT03003390|11913675|FG001|COMPLETED|Overall Study||24
10750105|NCT03003390|11913674|FG000|NOT COMPLETED|Overall Study||4
10750106|NCT03003390|11913675|FG001|NOT COMPLETED|Overall Study||0
10750107|NCT03003494|11913686|FG000|STARTED|Overall Study||306
10750108|NCT03003494|11913686|FG000|COMPLETED|Overall Study||278
10750109|NCT03003494|11913686|FG000|NOT COMPLETED|Overall Study||28
10750110|NCT03003676|11913692|FG000|STARTED|Overall Study||9
10750111|NCT03003676|11913693|FG001|STARTED|Overall Study||12
10750112|NCT03003676|11913692|FG000|COMPLETED|Overall Study||3
10750113|NCT03003676|11913693|FG001|COMPLETED|Overall Study||4
10750114|NCT03003676|11913692|FG000|NOT COMPLETED|Overall Study||6
10750115|NCT03003676|11913693|FG001|NOT COMPLETED|Overall Study||8
10750116|NCT03003793|11913703|FG000|STARTED|Overall Study||16
10750117|NCT03003793|11913704|FG001|STARTED|Overall Study||16
10750118|NCT03003793|11913703|FG000|COMPLETED|Overall Study||16
10750119|NCT03003793|11913704|FG001|COMPLETED|Overall Study||16
10750120|NCT03003793|11913703|FG000|NOT COMPLETED|Overall Study||0
10750121|NCT03003793|11913704|FG001|NOT COMPLETED|Overall Study||0
10750122|NCT03003949|11913712|FG000|STARTED|Overall Study||40
10750123|NCT03003949|11913713|FG001|STARTED|Overall Study||42
10750124|NCT03003949|11913712|FG000|Week 8|Overall Study||40
10750125|NCT03003949|11913713|FG001|Week 8|Overall Study||42
10750126|NCT03003949|11913712|FG000|Week 16|Overall Study||38
10750127|NCT03003949|11913713|FG001|Week 16|Overall Study||35
10750128|NCT03003949|11913712|FG000|Week 20|Overall Study||35
10750129|NCT03003949|11913713|FG001|Week 20|Overall Study||33
10750130|NCT03003949|11913712|FG000|Week 24|Overall Study||35
10750131|NCT03003949|11913713|FG001|Week 24|Overall Study||32
10750132|NCT03003949|11913712|FG000|COMPLETED|Overall Study||35
10750133|NCT03003949|11913713|FG001|COMPLETED|Overall Study||32
10750134|NCT03003949|11913712|FG000|NOT COMPLETED|Overall Study||5
10750135|NCT03003949|11913713|FG001|NOT COMPLETED|Overall Study||10
10750136|NCT03004469|11913722|FG000|STARTED|Overall Study||189
10750137|NCT03004469|11913723|FG001|STARTED|Overall Study||184
10750138|NCT03004469|11913724|FG002|STARTED|Overall Study||85
10750139|NCT03004469|11913722|FG000|COMPLETED|Overall Study||128
10750140|NCT03004469|11913723|FG001|COMPLETED|Overall Study||135
10750141|NCT03004469|11913724|FG002|COMPLETED|Overall Study||60
10750142|NCT03004469|11913722|FG000|NOT COMPLETED|Overall Study||61
10750143|NCT03004469|11913723|FG001|NOT COMPLETED|Overall Study||49
10750144|NCT03004469|11913724|FG002|NOT COMPLETED|Overall Study||25
10750145|NCT03004534|11913733|FG000|STARTED|Overall Study||36
10750146|NCT03004534|11913733|FG000|COMPLETED|Overall Study||36
10750147|NCT03004534|11913733|FG000|NOT COMPLETED|Overall Study||0
10750148|NCT03004638|11913743|FG000|STARTED|Overall Study||6
10750149|NCT03004638|11913744|FG001|STARTED|Overall Study||6
10750150|NCT03004638|11913745|FG002|STARTED|Overall Study||6
10750151|NCT03004638|11913746|FG003|STARTED|Overall Study||6
10750152|NCT03004638|11913747|FG004|STARTED|Overall Study||1
10750153|NCT03004638|11913748|FG005|STARTED|Overall Study||7
10750154|NCT03004638|11913743|FG000|COMPLETED|Overall Study||6
10750155|NCT03004638|11913744|FG001|COMPLETED|Overall Study||6
10750156|NCT03004638|11913745|FG002|COMPLETED|Overall Study||6
10750157|NCT03004638|11913746|FG003|COMPLETED|Overall Study||6
10750158|NCT03004638|11913747|FG004|COMPLETED|Overall Study||1
10750159|NCT03004638|11913748|FG005|COMPLETED|Overall Study||7
10750160|NCT03004638|11913743|FG000|NOT COMPLETED|Overall Study||0
10750161|NCT03004638|11913744|FG001|NOT COMPLETED|Overall Study||0
10750162|NCT03004638|11913745|FG002|NOT COMPLETED|Overall Study||0
10750163|NCT03004638|11913746|FG003|NOT COMPLETED|Overall Study||0
10750164|NCT03004638|11913747|FG004|NOT COMPLETED|Overall Study||0
10750165|NCT03004638|11913748|FG005|NOT COMPLETED|Overall Study||0
10750166|NCT03004846|11913769|FG000|STARTED|Part A (Up to 14 Weeks)||8
10750167|NCT03004846|11913770|FG001|STARTED|Part A (Up to 14 Weeks)||0
10750168|NCT03004846|11913771|FG002|STARTED|Part A (Up to 14 Weeks)||0
10750169|NCT03004846|11913769|FG000|COMPLETED|Part A (Up to 14 Weeks)||8
10750170|NCT03004846|11913770|FG001|COMPLETED|Part A (Up to 14 Weeks)||0
10750171|NCT03004846|11913771|FG002|COMPLETED|Part A (Up to 14 Weeks)||0
10750172|NCT03004846|11913769|FG000|NOT COMPLETED|Part A (Up to 14 Weeks)||0
10750173|NCT03004846|11913770|FG001|NOT COMPLETED|Part A (Up to 14 Weeks)||0
10750174|NCT03004846|11913771|FG002|NOT COMPLETED|Part A (Up to 14 Weeks)||0
10750175|NCT03004846|11913769|FG000|STARTED|Part B (Up to 14 Weeks)||0
10750176|NCT03004846|11913770|FG001|STARTED|Part B (Up to 14 Weeks)||0
10750177|NCT03004846|11913771|FG002|STARTED|Part B (Up to 14 Weeks)||0
10750178|NCT03004846|11913769|FG000|COMPLETED|Part B (Up to 14 Weeks)||0
10750179|NCT03004846|11913770|FG001|COMPLETED|Part B (Up to 14 Weeks)||0
10750180|NCT03004846|11913771|FG002|COMPLETED|Part B (Up to 14 Weeks)||0
10750181|NCT03004846|11913769|FG000|NOT COMPLETED|Part B (Up to 14 Weeks)||0
10750182|NCT03004846|11913770|FG001|NOT COMPLETED|Part B (Up to 14 Weeks)||0
10750183|NCT03004846|11913771|FG002|NOT COMPLETED|Part B (Up to 14 Weeks)||0
10750184|NCT03004911|11913782|FG000|STARTED|Overall Study||20
10750185|NCT03004911|11913783|FG001|STARTED|Overall Study||20
10750186|NCT03004911|11913782|FG000|COMPLETED|Overall Study||19
10750187|NCT03004911|11913783|FG001|COMPLETED|Overall Study||17
10750188|NCT03004911|11913782|FG000|NOT COMPLETED|Overall Study||1
10750189|NCT03004911|11913783|FG001|NOT COMPLETED|Overall Study||3
10750190|NCT03004924|11913792|FG000|STARTED|Overall Study||324
10750191|NCT03004924|11913793|FG001|STARTED|Overall Study||108
10750192|NCT03004924|11913794|FG002|STARTED|Overall Study||321
10750193|NCT03004924|11913792|FG000|COMPLETED|Overall Study||297
10750194|NCT03004924|11913793|FG001|COMPLETED|Overall Study||94
10750195|NCT03004924|11913794|FG002|COMPLETED|Overall Study||293
10750196|NCT03004924|11913792|FG000|NOT COMPLETED|Overall Study||27
10750197|NCT03004924|11913793|FG001|NOT COMPLETED|Overall Study||14
10750198|NCT03004924|11913794|FG002|NOT COMPLETED|Overall Study||28
10750199|NCT03005041|11913803|FG000|STARTED|Period 1||28
10750200|NCT03005041|11913804|FG001|STARTED|Period 1||27
10750201|NCT03005041|11913803|FG000|COMPLETED|Period 1||28
10750202|NCT03005041|11913804|FG001|COMPLETED|Period 1||27
10750203|NCT03005041|11913803|FG000|NOT COMPLETED|Period 1||0
10750204|NCT03005041|11913804|FG001|NOT COMPLETED|Period 1||0
10750205|NCT03005041|11913803|FG000|STARTED|Washout Period 1||28
10750206|NCT03005041|11913804|FG001|STARTED|Washout Period 1||27
10750207|NCT03005041|11913803|FG000|COMPLETED|Washout Period 1||28
10750208|NCT03005041|11913804|FG001|COMPLETED|Washout Period 1||27
10750209|NCT03005041|11913803|FG000|NOT COMPLETED|Washout Period 1||0
10750210|NCT03005041|11913804|FG001|NOT COMPLETED|Washout Period 1||0
10750211|NCT03005041|11913803|FG000|STARTED|Period 2||28
10750212|NCT03005041|11913804|FG001|STARTED|Period 2||27
10750213|NCT03005041|11913803|FG000|COMPLETED|Period 2||28
10750214|NCT03005041|11913804|FG001|COMPLETED|Period 2||27
10750215|NCT03005041|11913803|FG000|NOT COMPLETED|Period 2||0
10750216|NCT03005041|11913804|FG001|NOT COMPLETED|Period 2||0
10750217|NCT03005054|11913810|FG000|STARTED|Overall Study||3
10750218|NCT03005054|11913810|FG000|COMPLETED|Overall Study||3
10750219|NCT03005054|11913810|FG000|NOT COMPLETED|Overall Study||0
10750220|NCT03005067|11913816|FG000|STARTED|Overall Study||90
10750221|NCT03005067|11913817|FG001|STARTED|Overall Study||81
10750222|NCT03005067|11913816|FG000|COMPLETED|Overall Study||80
10750223|NCT03005067|11913817|FG001|COMPLETED|Overall Study||74
10750224|NCT03005067|11913816|FG000|NOT COMPLETED|Overall Study||10
10750225|NCT03005067|11913817|FG001|NOT COMPLETED|Overall Study||7
10750226|NCT03005106|11913823|FG000|STARTED|Overall Study||71
10750227|NCT03005106|11913823|FG000|Completed Month 3 Visit|Overall Study||64
10750228|NCT03005106|11913823|FG000|Completed Month 12 Visit|Overall Study||51
10750229|NCT03005106|11913823|FG000|COMPLETED|Overall Study||51
10750230|NCT03005106|11913823|FG000|NOT COMPLETED|Overall Study||20
10750231|NCT03005288|11913829|FG000|STARTED|Overall Study||39
10750232|NCT03005288|11913830|FG001|STARTED|Overall Study||39
10750233|NCT03005288|11913829|FG000|Safety Analysis Set|Overall Study||37
10750234|NCT03005288|11913830|FG001|Safety Analysis Set|Overall Study||38
10750235|NCT03005288|11913829|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study|One subject was excluded due to a protocol deviation.|36
10750236|NCT03005288|11913830|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study|PK samples were only obtained and evaluated for subjects treated with BYM338.|0
10750237|NCT03005288|11913829|FG000|Pharmacodynamics (PD) Analysis Set|Overall Study|One subject was excluded due to a protocol deviation.|36
10750238|NCT03005288|11913830|FG001|Pharmacodynamics (PD) Analysis Set|Overall Study|Two subjects were excluded due to protocol deviations.|36
10750239|NCT03005288|11913829|FG000|COMPLETED|Overall Study||27
10750240|NCT03005288|11913830|FG001|COMPLETED|Overall Study||31
10750241|NCT03005288|11913829|FG000|NOT COMPLETED|Overall Study||12
10750242|NCT03005288|11913830|FG001|NOT COMPLETED|Overall Study||8
10750243|NCT03006341|11913840|FG000|STARTED|Overall Study||26199
10750244|NCT03006341|11913841|FG001|STARTED|Overall Study||70071
10750245|NCT03006341|11913842|FG002|STARTED|Overall Study||32595
10750246|NCT03006341|11913843|FG003|STARTED|Overall Study||11322
10750247|NCT03006341|11913840|FG000|COMPLETED|Overall Study||1130
10750248|NCT03006341|11913841|FG001|COMPLETED|Overall Study||2566
10750249|NCT03006341|11913842|FG002|COMPLETED|Overall Study||1602
10750250|NCT03006341|11913843|FG003|COMPLETED|Overall Study||637
10750251|NCT03006341|11913840|FG000|NOT COMPLETED|Overall Study||25069
10750252|NCT03006341|11913841|FG001|NOT COMPLETED|Overall Study||67505
10750253|NCT03006341|11913842|FG002|NOT COMPLETED|Overall Study||30993
10750254|NCT03006341|11913843|FG003|NOT COMPLETED|Overall Study||10685
10750255|NCT03006393|11913853|FG000|STARTED|Overall Study||21
10750256|NCT03006393|11913854|FG001|STARTED|Overall Study||21
10750257|NCT03006393|11913853|FG000|COMPLETED|Overall Study||20
10750258|NCT03006393|11913854|FG001|COMPLETED|Overall Study||18
10750259|NCT03006393|11913853|FG000|NOT COMPLETED|Overall Study||1
10750260|NCT03006393|11913854|FG001|NOT COMPLETED|Overall Study||3
10750261|NCT03006458|11913860|FG000|STARTED|First Intervention||14
10750262|NCT03006458|11913861|FG001|STARTED|First Intervention||10
10750263|NCT03006458|11913860|FG000|COMPLETED|First Intervention||14
10750264|NCT03006458|11913861|FG001|COMPLETED|First Intervention||7
10750265|NCT03006458|11913860|FG000|NOT COMPLETED|First Intervention||0
10750266|NCT03006458|11913861|FG001|NOT COMPLETED|First Intervention||3
10750267|NCT03006458|11913860|FG000|STARTED|Second Intervention||14
10750268|NCT03006458|11913861|FG001|STARTED|Second Intervention||10
10750269|NCT03006458|11913860|FG000|COMPLETED|Second Intervention||14
10750270|NCT03006458|11913861|FG001|COMPLETED|Second Intervention||10
10750271|NCT03006458|11913860|FG000|NOT COMPLETED|Second Intervention||0
10750272|NCT03006458|11913861|FG001|NOT COMPLETED|Second Intervention||0
10750273|NCT03006471|11913869|FG000|STARTED|Overall Study||15
10750274|NCT03006471|11913870|FG001|STARTED|Overall Study||15
10750275|NCT03006471|11913869|FG000|COMPLETED|Overall Study|Two patients did not complete the study due to early withdrawal|13
10750276|NCT03006471|11913870|FG001|COMPLETED|Overall Study|Two patients did not complete the study due to early withdrawal|13
10750277|NCT03006471|11913869|FG000|NOT COMPLETED|Overall Study||2
10750278|NCT03006471|11913870|FG001|NOT COMPLETED|Overall Study||2
10750279|NCT03006562|11913878|FG000|STARTED|Overall Study||251
10750280|NCT03006562|11913879|FG001|STARTED|Overall Study||250
10750281|NCT03006562|11913878|FG000|Voluntary Ultrasound at 30 Days|Overall Study||141
10750282|NCT03006562|11913879|FG001|Voluntary Ultrasound at 30 Days|Overall Study||137
10750283|NCT03006562|11913878|FG000|COMPLETED|Overall Study||251
10750284|NCT03006562|11913879|FG001|COMPLETED|Overall Study||249
10750285|NCT03006562|11913878|FG000|NOT COMPLETED|Overall Study||0
10750286|NCT03006562|11913879|FG001|NOT COMPLETED|Overall Study||1
10750290|NCT03006887|11913896|FG000|STARTED|Overall Study||6
10750291|NCT03006887|11913896|FG000|COMPLETED|Overall Study||5
10750292|NCT03006887|11913896|FG000|NOT COMPLETED|Overall Study||1
10750293|NCT03007225|11913902|FG000|STARTED|Overall Study|Followed up for at least 6 months after DEB TACE|25
10750294|NCT03007225|11913903|FG001|STARTED|Overall Study|followed up for at least 6 months after TACE|25
10750295|NCT03007225|11913902|FG000|COMPLETED|Overall Study||25
10750296|NCT03007225|11913903|FG001|COMPLETED|Overall Study||25
10750297|NCT03007225|11913902|FG000|NOT COMPLETED|Overall Study||0
10750298|NCT03007225|11913903|FG001|NOT COMPLETED|Overall Study||0
10750299|NCT03007394|11913911|FG000|STARTED|Overall Study||118
10750300|NCT03007394|11913912|FG001|STARTED|Overall Study||154
10750301|NCT03007394|11913911|FG000|COMPLETED|Overall Study||91
10750302|NCT03007394|11913912|FG001|COMPLETED|Overall Study||91
10750303|NCT03007394|11913911|FG000|NOT COMPLETED|Overall Study||27
10750304|NCT03007394|11913912|FG001|NOT COMPLETED|Overall Study||63
10750305|NCT03007472|11913918|FG000|STARTED|Overall Study||96
10750306|NCT03007472|11913918|FG000|COMPLETED|Overall Study||91
10750307|NCT03007472|11913918|FG000|NOT COMPLETED|Overall Study||5
10750308|NCT03007953|11913924|FG000|STARTED|Overall Study||73
10750309|NCT03007953|11913925|FG001|STARTED|Overall Study||78
10750310|NCT03007953|11913924|FG000|COMPLETED|Overall Study||57
10750311|NCT03007953|11913925|FG001|COMPLETED|Overall Study||65
10750312|NCT03007953|11913924|FG000|NOT COMPLETED|Overall Study||16
10750313|NCT03007953|11913925|FG001|NOT COMPLETED|Overall Study||13
10750314|NCT03007966|11913933|FG000|STARTED|Overall Study||30
10750315|NCT03007966|11913934|FG001|STARTED|Overall Study||30
10750316|NCT03007966|11913933|FG000|COMPLETED|Overall Study||29
10750317|NCT03007966|11913934|FG001|COMPLETED|Overall Study||30
10750318|NCT03007966|11913933|FG000|NOT COMPLETED|Overall Study||1
10750319|NCT03007966|11913934|FG001|NOT COMPLETED|Overall Study||0
10750320|NCT03008070|11913944|FG000|STARTED|Overall Study||83
10750321|NCT03008070|11913945|FG001|STARTED|Overall Study||83
10750322|NCT03008070|11913946|FG002|STARTED|Overall Study||81
10750323|NCT03008070|11913944|FG000|COMPLETED|Overall Study||77
10750324|NCT03008070|11913945|FG001|COMPLETED|Overall Study||77
10750325|NCT03008070|11913946|FG002|COMPLETED|Overall Study||74
10750326|NCT03008070|11913944|FG000|NOT COMPLETED|Overall Study||6
10750327|NCT03008070|11913945|FG001|NOT COMPLETED|Overall Study||6
10750328|NCT03008070|11913946|FG002|NOT COMPLETED|Overall Study||7
10750329|NCT03008174|11913958|FG000|STARTED|Overall Study||10
10750330|NCT03008174|11913959|FG001|STARTED|Overall Study||10
10750331|NCT03008174|11913958|FG000|COMPLETED|Overall Study||7
10750332|NCT03008174|11913959|FG001|COMPLETED|Overall Study||6
10750333|NCT03008174|11913958|FG000|NOT COMPLETED|Overall Study||3
10750334|NCT03008174|11913959|FG001|NOT COMPLETED|Overall Study||4
10750335|NCT03008213|11913965|FG000|STARTED|Overall Study||1
10750336|NCT03008213|11913965|FG000|COMPLETED|Overall Study||1
10750337|NCT03008213|11913965|FG000|NOT COMPLETED|Overall Study||0
10750338|NCT03008460|11913971|FG000|STARTED|Overall Study||126
10750339|NCT03008460|11913972|FG001|STARTED|Overall Study||124
10750340|NCT03008460|11913971|FG000|COMPLETED|Overall Study||119
10750341|NCT03008460|11913972|FG001|COMPLETED|Overall Study||110
10750342|NCT03008460|11913971|FG000|NOT COMPLETED|Overall Study||7
10750343|NCT03008460|11913972|FG001|NOT COMPLETED|Overall Study||14
10750344|NCT03008590|11913980|FG000|STARTED|Overall Study||14
10750345|NCT03008590|11913981|FG001|STARTED|Overall Study||15
10750346|NCT03008590|11913980|FG000|COMPLETED|Overall Study||11
10750347|NCT03008590|11913981|FG001|COMPLETED|Overall Study||12
10750348|NCT03008590|11913980|FG000|NOT COMPLETED|Overall Study||3
10750349|NCT03008590|11913981|FG001|NOT COMPLETED|Overall Study||3
10750350|NCT03008707|11913989|FG000|STARTED|Overall Study||28
10750351|NCT03008707|11913990|FG001|STARTED|Overall Study||38
10750352|NCT03008707|11913989|FG000|COMPLETED|Overall Study||28
10750353|NCT03008707|11913990|FG001|COMPLETED|Overall Study||38
10750354|NCT03008707|11913989|FG000|NOT COMPLETED|Overall Study||0
10750355|NCT03008707|11913990|FG001|NOT COMPLETED|Overall Study||0
10750356|NCT03008837|11913998|FG000|STARTED|Overall Study||12
10750357|NCT03008837|11913999|FG001|STARTED|Overall Study||9
10750358|NCT03008837|11913998|FG000|COMPLETED|Overall Study||9
10750359|NCT03008837|11913999|FG001|COMPLETED|Overall Study||5
10750360|NCT03008837|11913998|FG000|NOT COMPLETED|Overall Study||3
10750361|NCT03008837|11913999|FG001|NOT COMPLETED|Overall Study||4
10750362|NCT03008889|11914010|FG000|STARTED|Overall Study||1
10750363|NCT03008889|11914011|FG001|STARTED|Overall Study||1
10819241|NCT00803179|11983605|FG000|STARTED|Overall Study||5
10819242|NCT00803179|11983605|FG000|COMPLETED|Overall Study||2
10819243|NCT00803179|11983605|FG000|NOT COMPLETED|Overall Study||3
10819244|NCT00801931|11983609|FG000|STARTED|Overall Study||1
10819245|NCT00801931|11983609|FG000|COMPLETED|Overall Study||1
10819246|NCT00801931|11983609|FG000|NOT COMPLETED|Overall Study||0
10819247|NCT00793520|11983615|FG000|STARTED|Milnacipran Crossover to Placebo||1
10819248|NCT00793520|11983616|FG001|STARTED|Milnacipran Crossover to Placebo||0
10819249|NCT00793520|11983615|FG000|COMPLETED|Milnacipran Crossover to Placebo||0
10819250|NCT00793520|11983616|FG001|COMPLETED|Milnacipran Crossover to Placebo||0
10819251|NCT00793520|11983615|FG000|NOT COMPLETED|Milnacipran Crossover to Placebo||1
10819252|NCT00793520|11983616|FG001|NOT COMPLETED|Milnacipran Crossover to Placebo||0
10819253|NCT00793520|11983615|FG000|STARTED|Placebo Crossover to Milnacipran||0
10819254|NCT00793520|11983616|FG001|STARTED|Placebo Crossover to Milnacipran||1
10819255|NCT00793520|11983615|FG000|COMPLETED|Placebo Crossover to Milnacipran||0
10819256|NCT00793520|11983616|FG001|COMPLETED|Placebo Crossover to Milnacipran||0
10819257|NCT00793520|11983615|FG000|NOT COMPLETED|Placebo Crossover to Milnacipran||0
10819258|NCT00793520|11983616|FG001|NOT COMPLETED|Placebo Crossover to Milnacipran||1
10819259|NCT00795236|11983624|FG000|STARTED|Overall Study||0
10819260|NCT00795236|11983625|FG001|STARTED|Overall Study||0
10819261|NCT00795236|11983624|FG000|COMPLETED|Overall Study|Unable to consistently obtain saliva DLMO in subjects and thus couldn't measure circadian period|0
10819262|NCT00795236|11983625|FG001|COMPLETED|Overall Study||0
10819263|NCT00795236|11983624|FG000|NOT COMPLETED|Overall Study||0
10819264|NCT00795236|11983625|FG001|NOT COMPLETED|Overall Study||0
10819265|NCT00799773|11983635|FG000|STARTED|Overall Study||2
10819266|NCT00799773|11983636|FG001|STARTED|Overall Study||1
10819267|NCT00799773|11983635|FG000|COMPLETED|Overall Study||2
10819268|NCT00799773|11983636|FG001|COMPLETED|Overall Study||1
10819269|NCT00799773|11983635|FG000|NOT COMPLETED|Overall Study||0
10819270|NCT00799773|11983636|FG001|NOT COMPLETED|Overall Study||0
10819271|NCT00790452|11983644|FG000|STARTED|Overall Study||1
10819272|NCT00790452|11983645|FG001|STARTED|Overall Study||0
10819273|NCT00790452|11983644|FG000|COMPLETED|Overall Study||0
10819274|NCT00790452|11983645|FG001|COMPLETED|Overall Study||0
10819275|NCT00790452|11983644|FG000|NOT COMPLETED|Overall Study||1
10819276|NCT00790452|11983645|FG001|NOT COMPLETED|Overall Study||0
10819277|NCT00795665|11983651|FG000|STARTED|Overall Study||7
10819278|NCT00795665|11983651|FG000|COMPLETED|Overall Study||7
10819279|NCT00795665|11983651|FG000|NOT COMPLETED|Overall Study||0
10819280|NCT00787917|11983657|FG000|STARTED|Blinded Treatment||9
10819281|NCT00787917|11983658|FG001|STARTED|Blinded Treatment||5
10819282|NCT00787917|11983657|FG000|COMPLETED|Blinded Treatment||4
10819283|NCT00787917|11983658|FG001|COMPLETED|Blinded Treatment||3
10819284|NCT00787917|11983657|FG000|NOT COMPLETED|Blinded Treatment||5
10819285|NCT00787917|11983658|FG001|NOT COMPLETED|Blinded Treatment||2
10750364|NCT03008889|11914010|FG000|COMPLETED|Overall Study||1
10750365|NCT03008889|11914011|FG001|COMPLETED|Overall Study||1
10750366|NCT03008889|11914010|FG000|NOT COMPLETED|Overall Study||0
10750367|NCT03008889|11914011|FG001|NOT COMPLETED|Overall Study||0
10750368|NCT03008915|11914018|FG000|STARTED|Treatment 1||8
10750369|NCT03008915|11914019|FG001|STARTED|Treatment 1||7
10750370|NCT03008915|11914018|FG000|COMPLETED|Treatment 1||8
10819286|NCT00787917|11983657|FG000|STARTED|Open Label||7
10819287|NCT00787917|11983658|FG001|STARTED|Open Label|"Placebo was not an arm in open label treatment."|0
10819288|NCT00787917|11983657|FG000|COMPLETED|Open Label||3
10819289|NCT00787917|11983658|FG001|COMPLETED|Open Label||0
10819290|NCT00787917|11983657|FG000|NOT COMPLETED|Open Label||4
10750371|NCT03008915|11914019|FG001|COMPLETED|Treatment 1||6
10750372|NCT03008915|11914018|FG000|NOT COMPLETED|Treatment 1||0
10750373|NCT03008915|11914019|FG001|NOT COMPLETED|Treatment 1||1
10750374|NCT03008915|11914018|FG000|STARTED|Treatment 2||8
10750375|NCT03008915|11914019|FG001|STARTED|Treatment 2||6
10750376|NCT03008915|11914018|FG000|COMPLETED|Treatment 2||8
10750377|NCT03008915|11914019|FG001|COMPLETED|Treatment 2||6
10819291|NCT00787917|11983658|FG001|NOT COMPLETED|Open Label||0
10819292|NCT00798590|11983668|FG000|STARTED|Overall Study||11
10819293|NCT00798590|11983669|FG001|STARTED|Overall Study||8
10819294|NCT00798590|11983668|FG000|COMPLETED|Overall Study||0
10819295|NCT00798590|11983669|FG001|COMPLETED|Overall Study||0
10819296|NCT00798590|11983668|FG000|NOT COMPLETED|Overall Study||11
10750378|NCT03008915|11914018|FG000|NOT COMPLETED|Treatment 2||0
10750379|NCT03008915|11914019|FG001|NOT COMPLETED|Treatment 2||0
10750380|NCT03009162|11914028|FG000|STARTED|Overall Study||8
10750381|NCT03009162|11914029|FG001|STARTED|Overall Study||8
10750382|NCT03009162|11914028|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
10750383|NCT03009162|11914029|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
10750384|NCT03009162|11914028|FG000|COMPLETED|Overall Study||8
10750385|NCT03009162|11914029|FG001|COMPLETED|Overall Study||8
10750386|NCT03009162|11914028|FG000|NOT COMPLETED|Overall Study||0
10750387|NCT03009162|11914029|FG001|NOT COMPLETED|Overall Study||0
10750388|NCT03009396|11914035|FG000|STARTED|Overall Study||16
10750389|NCT03009396|11914036|FG001|STARTED|Overall Study||38
10750390|NCT03009396|11914035|FG000|COMPLETED|Overall Study||9
10750391|NCT03009396|11914036|FG001|COMPLETED|Overall Study||21
10750392|NCT03009396|11914035|FG000|NOT COMPLETED|Overall Study||7
10750393|NCT03009396|11914036|FG001|NOT COMPLETED|Overall Study||17
10750394|NCT03010137|11914045|FG000|STARTED|Overall Study||15
10750395|NCT03010137|11914046|FG001|STARTED|Overall Study||15
10750396|NCT03010137|11914045|FG000|COMPLETED|Overall Study||15
10750397|NCT03010137|11914046|FG001|COMPLETED|Overall Study||15
10750398|NCT03010137|11914045|FG000|NOT COMPLETED|Overall Study||0
10750399|NCT03010137|11914046|FG001|NOT COMPLETED|Overall Study||0
10750400|NCT03010254|11914054|FG000|STARTED|Overall Study||159
10750401|NCT03010254|11914055|FG001|STARTED|Overall Study||123
10750402|NCT03010254|11914054|FG000|Attempted Implantation|Overall Study||156
10750403|NCT03010254|11914055|FG001|Attempted Implantation|Overall Study||120
10750404|NCT03010254|11914054|FG000|Successful Implantation|Overall Study||156
10819297|NCT00798590|11983669|FG001|NOT COMPLETED|Overall Study||8
10819298|NCT00796510|11983677|FG000|STARTED|Overall Study||3
10819299|NCT00796510|11983678|FG001|STARTED|Overall Study||0
10819300|NCT00796510|11983677|FG000|COMPLETED|Overall Study||0
10819301|NCT00796510|11983678|FG001|COMPLETED|Overall Study||0
10819302|NCT00796510|11983677|FG000|NOT COMPLETED|Overall Study||3
10819303|NCT00796510|11983678|FG001|NOT COMPLETED|Overall Study||0
10819304|NCT00796861|11983684|FG000|STARTED|Overall Study||4
10819305|NCT00796861|11983684|FG000|COMPLETED|Overall Study||0
10819306|NCT00796861|11983684|FG000|NOT COMPLETED|Overall Study||4
10819307|NCT00791076|11983688|FG000|STARTED|Overall Study||8
10819308|NCT00791076|11983688|FG000|COMPLETED|Overall Study||0
10819309|NCT00791076|11983688|FG000|NOT COMPLETED|Overall Study||8
10819310|NCT00790478|11983696|FG000|STARTED|Overall Study||0
10819311|NCT00790478|11983697|FG001|STARTED|Overall Study||0
10819312|NCT00790478|11983696|FG000|COMPLETED|Overall Study||0
10819313|NCT00790478|11983697|FG001|COMPLETED|Overall Study||0
10819314|NCT00790478|11983696|FG000|NOT COMPLETED|Overall Study||0
10819315|NCT00790478|11983697|FG001|NOT COMPLETED|Overall Study||0
10819316|NCT00796107|11983703|FG000|STARTED|Overall Study||6
10819317|NCT00796107|11983703|FG000|COMPLETED|Overall Study||0
10819318|NCT00796107|11983703|FG000|NOT COMPLETED|Overall Study||6
10819319|NCT00791336|11983707|FG000|STARTED|Overall Study||1
10819320|NCT00791336|11983707|FG000|COMPLETED|Overall Study||1
10819321|NCT00791336|11983707|FG000|NOT COMPLETED|Overall Study||0
10819322|NCT00786682|11983711|FG000|STARTED|Overall Study||11
10819323|NCT00786682|11983711|FG000|COMPLETED|Overall Study||11
10819324|NCT00786682|11983711|FG000|NOT COMPLETED|Overall Study||0
10819325|NCT00787124|11983717|FG000|STARTED|Overall Study||4
10819326|NCT00787124|11983718|FG001|STARTED|Overall Study||4
10819327|NCT00787124|11983717|FG000|COMPLETED|Overall Study||4
10819328|NCT00787124|11983718|FG001|COMPLETED|Overall Study||4
10819329|NCT00787124|11983717|FG000|NOT COMPLETED|Overall Study||0
10819330|NCT00787124|11983718|FG001|NOT COMPLETED|Overall Study||0
10819331|NCT00785356|11983727|FG000|STARTED|Overall Study||8
10819332|NCT00785356|11983727|FG000|COMPLETED|Overall Study||0
10819333|NCT00785356|11983727|FG000|NOT COMPLETED|Overall Study||8
10819334|NCT00782483|11983735|FG000|STARTED|Overall Study|6 subjects enrolled beginning on 04/27/2009 with last enrollment on 04/13/2010.|6
10819335|NCT00782483|11983735|FG000|COMPLETED|Overall Study||0
10819336|NCT00782483|11983735|FG000|NOT COMPLETED|Overall Study||6
10819337|NCT00791843|11983739|FG000|STARTED|Overall Study|Data unavailable for the study|0
10819338|NCT00791843|11983739|FG000|COMPLETED|Overall Study|Data unavailable for the study|0
10819339|NCT00791843|11983739|FG000|NOT COMPLETED|Overall Study||0
10819340|NCT00784043|11983745|FG000|STARTED|Overall Study||31
10819341|NCT00784043|11983746|FG001|STARTED|Overall Study||6
10819342|NCT00784043|11983745|FG000|COMPLETED|Overall Study||0
10819343|NCT00784043|11983746|FG001|COMPLETED|Overall Study||0
10819344|NCT00784043|11983745|FG000|NOT COMPLETED|Overall Study||31
10819345|NCT00784043|11983746|FG001|NOT COMPLETED|Overall Study||6
10819346|NCT00787618|11983755|FG000|STARTED|Overall Study||3
10819347|NCT00787618|11983756|FG001|STARTED|Overall Study||0
10819348|NCT00787618|11983757|FG002|STARTED|Overall Study||3
10819349|NCT00787618|11983755|FG000|COMPLETED|Overall Study||3
10819350|NCT00787618|11983756|FG001|COMPLETED|Overall Study||0
10819351|NCT00787618|11983757|FG002|COMPLETED|Overall Study||3
10819352|NCT00787618|11983755|FG000|NOT COMPLETED|Overall Study||0
10819353|NCT00787618|11983756|FG001|NOT COMPLETED|Overall Study||0
10819354|NCT00787618|11983757|FG002|NOT COMPLETED|Overall Study||0
10819355|NCT00774306|11983769|FG000|STARTED|Overall Study||24
10819356|NCT00774306|11983770|FG001|STARTED|Overall Study||5
10819357|NCT00774306|11983771|FG002|STARTED|Overall Study||16
10750405|NCT03010254|11914055|FG001|Successful Implantation|Overall Study||120
10750406|NCT03010254|11914054|FG000|COMPLETED|Overall Study||152
10819358|NCT00774306|11983772|FG003|STARTED|Overall Study||7
10750407|NCT03010254|11914055|FG001|COMPLETED|Overall Study||118
10750408|NCT03010254|11914054|FG000|NOT COMPLETED|Overall Study||7
10750409|NCT03010254|11914055|FG001|NOT COMPLETED|Overall Study||5
10750410|NCT03010462|11914070|FG000|STARTED|Overall Study||31
10750411|NCT03010462|11914071|FG001|STARTED|Overall Study||29
10750412|NCT03010462|11914070|FG000|COMPLETED|Overall Study|1 subject withdrew consent before baseline visit. 2 subjects completed treatment but were lost during follow-up|28
10750413|NCT03010462|11914071|FG001|COMPLETED|Overall Study|1 subject withdrew consent prior to baseline visit|28
10750414|NCT03010462|11914070|FG000|NOT COMPLETED|Overall Study||3
10750415|NCT03010462|11914071|FG001|NOT COMPLETED|Overall Study||1
10750416|NCT03010488|11914079|FG000|STARTED|Overall Study||22
10750417|NCT03010488|11914080|FG001|STARTED|Overall Study||22
10750418|NCT03010488|11914079|FG000|COMPLETED|Overall Study||17
10750419|NCT03010488|11914080|FG001|COMPLETED|Overall Study||15
10750420|NCT03010488|11914079|FG000|NOT COMPLETED|Overall Study||5
10750421|NCT03010488|11914080|FG001|NOT COMPLETED|Overall Study||7
10750422|NCT03010501|11914086|FG000|STARTED|Study Week 1||9
10750423|NCT03010501|11914087|FG001|STARTED|Study Week 1||15
10750424|NCT03010501|11914088|FG002|STARTED|Study Week 1||7
10750425|NCT03010501|11914089|FG003|STARTED|Study Week 1||7
10750426|NCT03010501|11914090|FG004|STARTED|Study Week 1||7
10750427|NCT03010501|11914091|FG005|STARTED|Study Week 1||11
10750428|NCT03010501|11914086|FG000|COMPLETED|Study Week 1||7
10750429|NCT03010501|11914087|FG001|COMPLETED|Study Week 1||14
10750430|NCT03010501|11914088|FG002|COMPLETED|Study Week 1||7
10750431|NCT03010501|11914089|FG003|COMPLETED|Study Week 1||5
10750432|NCT03010501|11914090|FG004|COMPLETED|Study Week 1||7
10750433|NCT03010501|11914091|FG005|COMPLETED|Study Week 1||11
10750434|NCT03010501|11914086|FG000|NOT COMPLETED|Study Week 1||2
10750435|NCT03010501|11914087|FG001|NOT COMPLETED|Study Week 1||1
10750436|NCT03010501|11914088|FG002|NOT COMPLETED|Study Week 1||0
10750437|NCT03010501|11914089|FG003|NOT COMPLETED|Study Week 1||2
10819359|NCT00774306|11983769|FG000|COMPLETED|Overall Study||6
10819360|NCT00774306|11983770|FG001|COMPLETED|Overall Study||3
10819361|NCT00774306|11983771|FG002|COMPLETED|Overall Study||8
10819362|NCT00774306|11983772|FG003|COMPLETED|Overall Study||2
10819363|NCT00774306|11983769|FG000|NOT COMPLETED|Overall Study||18
10819364|NCT00774306|11983770|FG001|NOT COMPLETED|Overall Study||2
10819365|NCT00774306|11983771|FG002|NOT COMPLETED|Overall Study||8
10819366|NCT00774306|11983772|FG003|NOT COMPLETED|Overall Study||5
10819367|NCT00771602|11983785|FG000|STARTED|Overall Study||1
10819368|NCT00771602|11983786|FG001|STARTED|Overall Study||0
10819369|NCT00771602|11983787|FG002|STARTED|Overall Study||0
10819370|NCT00771602|11983785|FG000|COMPLETED|Overall Study||1
10819371|NCT00771602|11983786|FG001|COMPLETED|Overall Study||0
10819372|NCT00771602|11983787|FG002|COMPLETED|Overall Study||0
10819373|NCT00771602|11983785|FG000|NOT COMPLETED|Overall Study||0
10819374|NCT00771602|11983786|FG001|NOT COMPLETED|Overall Study||0
10819375|NCT00771602|11983787|FG002|NOT COMPLETED|Overall Study||0
10819376|NCT00779038|11983795|FG000|STARTED|Overall Study||13
10819377|NCT00779038|11983795|FG000|COMPLETED|Overall Study||0
10819378|NCT00779038|11983795|FG000|NOT COMPLETED|Overall Study||13
10819379|NCT00780455|11983801|FG000|STARTED|Overall Study||2
10819380|NCT00780455|11983802|FG001|STARTED|Overall Study||2
10819381|NCT00780455|11983801|FG000|COMPLETED|Overall Study||2
10819382|NCT00780455|11983802|FG001|COMPLETED|Overall Study||2
10819383|NCT00780455|11983801|FG000|NOT COMPLETED|Overall Study||0
10819384|NCT00780455|11983802|FG001|NOT COMPLETED|Overall Study||0
10819385|NCT00776100|11983810|FG000|STARTED|Overall Study||1
10819386|NCT00776100|11983811|FG001|STARTED|Overall Study||1
10819387|NCT00776100|11983810|FG000|COMPLETED|Overall Study||0
10819388|NCT00776100|11983811|FG001|COMPLETED|Overall Study||1
10819389|NCT00776100|11983810|FG000|NOT COMPLETED|Overall Study||1
10819390|NCT00776100|11983811|FG001|NOT COMPLETED|Overall Study||0
10819391|NCT00771316|11983819|FG000|STARTED|Overall Study||4
10819392|NCT00771316|11983820|FG001|STARTED|Overall Study||2
10819393|NCT00771316|11983819|FG000|COMPLETED|Overall Study||2
10819394|NCT00771316|11983820|FG001|COMPLETED|Overall Study||1
10819395|NCT00771316|11983819|FG000|NOT COMPLETED|Overall Study||2
10819396|NCT00771316|11983820|FG001|NOT COMPLETED|Overall Study||1
10819397|NCT00780481|11983826|FG000|STARTED|Overall Study||13
10819398|NCT00780481|11983826|FG000|COMPLETED|Overall Study||13
10819399|NCT00780481|11983826|FG000|NOT COMPLETED|Overall Study||0
10819400|NCT00769652|11983832|FG000|STARTED|Overall Study||6
10819401|NCT00769652|11983833|FG001|STARTED|Overall Study||1
10819402|NCT00769652|11983832|FG000|COMPLETED|Overall Study||6
10819403|NCT00769652|11983833|FG001|COMPLETED|Overall Study||1
10819404|NCT00769652|11983832|FG000|NOT COMPLETED|Overall Study||0
10819405|NCT00769652|11983833|FG001|NOT COMPLETED|Overall Study||0
10819406|NCT00768040|11983841|FG000|STARTED|Overall Study|"Started indicates randomized, safety and full analysis set."|20
10819407|NCT00768040|11983842|FG001|STARTED|Overall Study||19
10819408|NCT00768040|11983841|FG000|COMPLETED|Overall Study||16
10750438|NCT03010501|11914090|FG004|NOT COMPLETED|Study Week 1||0
10750439|NCT03010501|11914091|FG005|NOT COMPLETED|Study Week 1||0
10750440|NCT03010501|11914086|FG000|STARTED|Study Week 2||7
10819409|NCT00768040|11983842|FG001|COMPLETED|Overall Study||16
10819410|NCT00768040|11983841|FG000|NOT COMPLETED|Overall Study||4
10819411|NCT00768040|11983842|FG001|NOT COMPLETED|Overall Study||3
10819412|NCT00776555|11983850|FG000|STARTED|Overall Study||3
10819413|NCT00776555|11983851|FG001|STARTED|Overall Study||0
10819414|NCT00776555|11983850|FG000|COMPLETED|Overall Study||0
10819415|NCT00776555|11983851|FG001|COMPLETED|Overall Study||0
10750441|NCT03010501|11914087|FG001|STARTED|Study Week 2||14
10750442|NCT03010501|11914088|FG002|STARTED|Study Week 2||7
10750443|NCT03010501|11914089|FG003|STARTED|Study Week 2||5
10750444|NCT03010501|11914090|FG004|STARTED|Study Week 2||7
10750445|NCT03010501|11914091|FG005|STARTED|Study Week 2||11
10750446|NCT03010501|11914086|FG000|COMPLETED|Study Week 2||7
10750447|NCT03010501|11914087|FG001|COMPLETED|Study Week 2||14
10750448|NCT03010501|11914088|FG002|COMPLETED|Study Week 2||7
10750449|NCT03010501|11914089|FG003|COMPLETED|Study Week 2||5
10750450|NCT03010501|11914090|FG004|COMPLETED|Study Week 2||7
10750451|NCT03010501|11914091|FG005|COMPLETED|Study Week 2||11
10750452|NCT03010501|11914086|FG000|NOT COMPLETED|Study Week 2||0
10750453|NCT03010501|11914087|FG001|NOT COMPLETED|Study Week 2||0
10750454|NCT03010501|11914088|FG002|NOT COMPLETED|Study Week 2||0
10750455|NCT03010501|11914089|FG003|NOT COMPLETED|Study Week 2||0
10750456|NCT03010501|11914090|FG004|NOT COMPLETED|Study Week 2||0
10750457|NCT03010501|11914091|FG005|NOT COMPLETED|Study Week 2||0
10750458|NCT03010501|11914086|FG000|STARTED|Study Week 3||7
10750459|NCT03010501|11914087|FG001|STARTED|Study Week 3||14
10750460|NCT03010501|11914088|FG002|STARTED|Study Week 3||7
10750461|NCT03010501|11914089|FG003|STARTED|Study Week 3||5
10750462|NCT03010501|11914090|FG004|STARTED|Study Week 3||7
10750463|NCT03010501|11914091|FG005|STARTED|Study Week 3||11
10750464|NCT03010501|11914086|FG000|COMPLETED|Study Week 3||7
10750465|NCT03010501|11914087|FG001|COMPLETED|Study Week 3||14
10750466|NCT03010501|11914088|FG002|COMPLETED|Study Week 3||7
10750467|NCT03010501|11914089|FG003|COMPLETED|Study Week 3||4
10750468|NCT03010501|11914090|FG004|COMPLETED|Study Week 3||7
10819416|NCT00776555|11983850|FG000|NOT COMPLETED|Overall Study||3
10819417|NCT00776555|11983851|FG001|NOT COMPLETED|Overall Study||0
10819418|NCT00775190|11983859|FG000|STARTED|Overall Study||7
10819419|NCT00775190|11983860|FG001|STARTED|Overall Study||5
10819420|NCT00775190|11983859|FG000|COMPLETED|Overall Study||3
10819421|NCT00775190|11983860|FG001|COMPLETED|Overall Study||0
10819422|NCT00775190|11983859|FG000|NOT COMPLETED|Overall Study||4
10819423|NCT00775190|11983860|FG001|NOT COMPLETED|Overall Study||5
10819424|NCT00755261|11983866|FG000|STARTED|Overall Study||6
10819425|NCT00755261|11983866|FG000|COMPLETED|Overall Study||4
10819426|NCT00755261|11983866|FG000|NOT COMPLETED|Overall Study||2
10819427|NCT00762723|11983873|FG000|STARTED|Overall Study||5
10819428|NCT00762723|11983874|FG001|STARTED|Overall Study||11
10819429|NCT00762723|11983875|FG002|STARTED|Overall Study||3
10819430|NCT00762723|11983873|FG000|COMPLETED|Overall Study||0
10819431|NCT00762723|11983874|FG001|COMPLETED|Overall Study||6
10819432|NCT00762723|11983875|FG002|COMPLETED|Overall Study||0
10819433|NCT00762723|11983873|FG000|NOT COMPLETED|Overall Study||5
10819434|NCT00762723|11983874|FG001|NOT COMPLETED|Overall Study||5
10819435|NCT00762723|11983875|FG002|NOT COMPLETED|Overall Study||3
10819436|NCT00770965|11983887|FG000|STARTED|Safety Set||2
10819437|NCT00770965|11983888|FG001|STARTED|Safety Set||4
10819438|NCT00770965|11983889|FG002|STARTED|Safety Set||4
10819439|NCT00770965|11983890|FG003|STARTED|Safety Set||5
10819440|NCT00770965|11983887|FG000|COMPLETED|Safety Set||2
10819441|NCT00770965|11983888|FG001|COMPLETED|Safety Set||4
10819442|NCT00770965|11983889|FG002|COMPLETED|Safety Set||3
10819443|NCT00770965|11983890|FG003|COMPLETED|Safety Set||4
10819444|NCT00770965|11983887|FG000|NOT COMPLETED|Safety Set||0
10750469|NCT03010501|11914091|FG005|COMPLETED|Study Week 3||11
10750470|NCT03010501|11914086|FG000|NOT COMPLETED|Study Week 3||0
10819445|NCT00770965|11983888|FG001|NOT COMPLETED|Safety Set||0
10819446|NCT00770965|11983889|FG002|NOT COMPLETED|Safety Set||1
10819447|NCT00770965|11983890|FG003|NOT COMPLETED|Safety Set||1
10819448|NCT00770965|11983887|FG000|STARTED|Excluded Set||18
10819449|NCT00770965|11983888|FG001|STARTED|Excluded Set||16
10819450|NCT00770965|11983889|FG002|STARTED|Excluded Set||16
10819451|NCT00770965|11983890|FG003|STARTED|Excluded Set||15
10750471|NCT03010501|11914087|FG001|NOT COMPLETED|Study Week 3||0
10750472|NCT03010501|11914088|FG002|NOT COMPLETED|Study Week 3||0
10750473|NCT03010501|11914089|FG003|NOT COMPLETED|Study Week 3||1
10750474|NCT03010501|11914090|FG004|NOT COMPLETED|Study Week 3||0
10750475|NCT03010501|11914091|FG005|NOT COMPLETED|Study Week 3||0
10819452|NCT00770965|11983887|FG000|COMPLETED|Excluded Set||3
10819453|NCT00770965|11983888|FG001|COMPLETED|Excluded Set||3
10819454|NCT00770965|11983889|FG002|COMPLETED|Excluded Set||2
10750485|NCT03010631|11914125|FG000|STARTED|Cohort 1||18
10750486|NCT03010631|11914126|FG001|STARTED|Cohort 1||17
10750487|NCT03010631|11914127|FG002|STARTED|Cohort 1||0
10750488|NCT03010631|11914128|FG003|STARTED|Cohort 1||0
10750489|NCT03010631|11914125|FG000|COMPLETED|Cohort 1||14
10750490|NCT03010631|11914126|FG001|COMPLETED|Cohort 1||17
10750491|NCT03010631|11914127|FG002|COMPLETED|Cohort 1||0
10750492|NCT03010631|11914128|FG003|COMPLETED|Cohort 1||0
10750493|NCT03010631|11914125|FG000|NOT COMPLETED|Cohort 1||4
10750494|NCT03010631|11914126|FG001|NOT COMPLETED|Cohort 1||0
10750495|NCT03010631|11914127|FG002|NOT COMPLETED|Cohort 1||0
10750496|NCT03010631|11914128|FG003|NOT COMPLETED|Cohort 1||0
10750497|NCT03010631|11914125|FG000|STARTED|Cohort 2||0
10750498|NCT03010631|11914126|FG001|STARTED|Cohort 2||0
10750499|NCT03010631|11914127|FG002|STARTED|Cohort 2|New participants were enrolled for Cohort 2|7
10750500|NCT03010631|11914128|FG003|STARTED|Cohort 2||7
10750501|NCT03010631|11914125|FG000|COMPLETED|Cohort 2||0
10750502|NCT03010631|11914126|FG001|COMPLETED|Cohort 2||0
10750503|NCT03010631|11914127|FG002|COMPLETED|Cohort 2||7
10750504|NCT03010631|11914128|FG003|COMPLETED|Cohort 2||7
10750505|NCT03010631|11914125|FG000|NOT COMPLETED|Cohort 2||0
10750506|NCT03010631|11914126|FG001|NOT COMPLETED|Cohort 2||0
10750507|NCT03010631|11914127|FG002|NOT COMPLETED|Cohort 2||0
10750508|NCT03010631|11914128|FG003|NOT COMPLETED|Cohort 2||0
10750509|NCT03010683|11914144|FG000|STARTED|Overall Study||30
10750510|NCT03010683|11914145|FG001|STARTED|Overall Study||30
10750511|NCT03010683|11914144|FG000|COMPLETED|Overall Study||30
10750512|NCT03010683|11914145|FG001|COMPLETED|Overall Study||30
10750513|NCT03010683|11914144|FG000|NOT COMPLETED|Overall Study||0
10750514|NCT03010683|11914145|FG001|NOT COMPLETED|Overall Study||0
10750515|NCT03010800|11914153|FG000|STARTED|Initial Assignment||4
10750516|NCT03010800|11914154|FG001|STARTED|Initial Assignment||4
10750517|NCT03010800|11914153|FG000|COMPLETED|Initial Assignment||4
10750518|NCT03010800|11914154|FG001|COMPLETED|Initial Assignment||4
10750519|NCT03010800|11914153|FG000|NOT COMPLETED|Initial Assignment||0
10750520|NCT03010800|11914154|FG001|NOT COMPLETED|Initial Assignment||0
10750521|NCT03010800|11914153|FG000|STARTED|Cross Over||4
10750522|NCT03010800|11914154|FG001|STARTED|Cross Over||4
10750523|NCT03010800|11914153|FG000|COMPLETED|Cross Over||4
10750524|NCT03010800|11914154|FG001|COMPLETED|Cross Over||4
10750525|NCT03010800|11914153|FG000|NOT COMPLETED|Cross Over||0
10750526|NCT03010800|11914154|FG001|NOT COMPLETED|Cross Over||0
10750527|NCT03011099|11914162|FG000|STARTED|Overall Study||6
10750528|NCT03011099|11914163|FG001|STARTED|Overall Study||5
10750529|NCT03011099|11914162|FG000|COMPLETED|Overall Study||6
10750530|NCT03011099|11914163|FG001|COMPLETED|Overall Study||3
10750531|NCT03011099|11914162|FG000|NOT COMPLETED|Overall Study||0
10750532|NCT03011099|11914163|FG001|NOT COMPLETED|Overall Study||2
10750533|NCT03011333|11914178|FG000|STARTED|Overall Study||12
10750534|NCT03011333|11914179|FG001|STARTED|Overall Study||27
10750535|NCT03011333|11914180|FG002|STARTED|Overall Study||25
10750536|NCT03011333|11914181|FG003|STARTED|Overall Study||47
10750537|NCT03011333|11914182|FG004|STARTED|Overall Study||50
10750538|NCT03011333|11914183|FG005|STARTED|Overall Study||41
10750539|NCT03011333|11914184|FG006|STARTED|Overall Study||41
10750540|NCT03011333|11914178|FG000|COMPLETED|Overall Study||12
10750541|NCT03011333|11914179|FG001|COMPLETED|Overall Study||26
10750542|NCT03011333|11914180|FG002|COMPLETED|Overall Study||25
10750543|NCT03011333|11914181|FG003|COMPLETED|Overall Study||46
10750544|NCT03011333|11914182|FG004|COMPLETED|Overall Study||46
10750545|NCT03011333|11914183|FG005|COMPLETED|Overall Study||37
10750546|NCT03011333|11914184|FG006|COMPLETED|Overall Study||36
10750547|NCT03011333|11914178|FG000|NOT COMPLETED|Overall Study||0
10750548|NCT03011333|11914179|FG001|NOT COMPLETED|Overall Study||1
10750549|NCT03011333|11914180|FG002|NOT COMPLETED|Overall Study||0
10819455|NCT00770965|11983890|FG003|COMPLETED|Excluded Set||2
10819456|NCT00770965|11983887|FG000|NOT COMPLETED|Excluded Set||15
10819457|NCT00770965|11983888|FG001|NOT COMPLETED|Excluded Set||13
10819458|NCT00770965|11983889|FG002|NOT COMPLETED|Excluded Set||14
10819459|NCT00770965|11983890|FG003|NOT COMPLETED|Excluded Set||13
10819460|NCT00769002|11983904|FG000|STARTED|Overall Study||9
10819461|NCT00769002|11983905|FG001|STARTED|Overall Study||9
10819462|NCT00769002|11983904|FG000|COMPLETED|Overall Study||0
10819463|NCT00769002|11983905|FG001|COMPLETED|Overall Study||0
10819464|NCT00769002|11983904|FG000|NOT COMPLETED|Overall Study||9
10819465|NCT00769002|11983905|FG001|NOT COMPLETED|Overall Study||9
10750550|NCT03011333|11914181|FG003|NOT COMPLETED|Overall Study||1
10750551|NCT03011333|11914182|FG004|NOT COMPLETED|Overall Study||4
10819466|NCT00766636|11983912|FG000|STARTED|Overall Study||3
10819467|NCT00766636|11983913|FG001|STARTED|Overall Study||2
10819468|NCT00766636|11983912|FG000|COMPLETED|Overall Study|Number that completed pre- and post-operative therapy as well as surgery.|0
10819469|NCT00766636|11983913|FG001|COMPLETED|Overall Study||0
10819470|NCT00766636|11983912|FG000|NOT COMPLETED|Overall Study||3
10819471|NCT00766636|11983913|FG001|NOT COMPLETED|Overall Study||2
10750552|NCT03011333|11914183|FG005|NOT COMPLETED|Overall Study||4
10750553|NCT03011333|11914184|FG006|NOT COMPLETED|Overall Study||5
10750554|NCT03011840|11914202|FG000|STARTED|Overall Study||232
10750555|NCT03011840|11914203|FG001|STARTED|Overall Study||217
10750556|NCT03011840|11914202|FG000|COMPLETED|Overall Study||232
10750557|NCT03011840|11914203|FG001|COMPLETED|Overall Study||196
10750558|NCT03011840|11914202|FG000|NOT COMPLETED|Overall Study||0
10750559|NCT03011840|11914203|FG001|NOT COMPLETED|Overall Study||21
10750560|NCT03011892|11914215|FG000|STARTED|Double Blind (DB) Period||52
10750561|NCT03011892|11914216|FG001|STARTED|Double Blind (DB) Period||51
10750562|NCT03011892|11914217|FG002|STARTED|Double Blind (DB) Period||51
10750563|NCT03011892|11914218|FG003|STARTED|Double Blind (DB) Period||51
10750564|NCT03011892|11914219|FG004|STARTED|Double Blind (DB) Period||52
10750565|NCT03011892|11914220|FG005|STARTED|Double Blind (DB) Period||50
10750566|NCT03011892|11914221|FG006|STARTED|Double Blind (DB) Period||0
10750567|NCT03011892|11914222|FG007|STARTED|Double Blind (DB) Period||0
10750568|NCT03011892|11914223|FG008|STARTED|Double Blind (DB) Period||0
10750569|NCT03011892|11914224|FG009|STARTED|Double Blind (DB) Period||0
10750570|NCT03011892|11914225|FG010|STARTED|Double Blind (DB) Period||0
10750571|NCT03011892|11914226|FG011|STARTED|Double Blind (DB) Period||0
10750572|NCT03011892|11914215|FG000|Treated in DB Period|Double Blind (DB) Period||52
10750573|NCT03011892|11914216|FG001|Treated in DB Period|Double Blind (DB) Period||51
10750574|NCT03011892|11914217|FG002|Treated in DB Period|Double Blind (DB) Period||51
10750575|NCT03011892|11914218|FG003|Treated in DB Period|Double Blind (DB) Period||51
10750576|NCT03011892|11914219|FG004|Treated in DB Period|Double Blind (DB) Period||51
10750577|NCT03011892|11914220|FG005|Treated in DB Period|Double Blind (DB) Period||50
10750578|NCT03011892|11914221|FG006|Treated in DB Period|Double Blind (DB) Period||0
10750579|NCT03011892|11914222|FG007|Treated in DB Period|Double Blind (DB) Period||0
10819472|NCT00768248|11983921|FG000|STARTED|Overall Study||1
10819473|NCT00768248|11983922|FG001|STARTED|Overall Study||1
10819474|NCT00768248|11983921|FG000|COMPLETED|Overall Study||0
10819475|NCT00768248|11983922|FG001|COMPLETED|Overall Study||0
10819476|NCT00768248|11983921|FG000|NOT COMPLETED|Overall Study||1
10819477|NCT00768248|11983922|FG001|NOT COMPLETED|Overall Study||1
10819478|NCT00765765|11983928|FG000|STARTED|Overall Study||6
10819479|NCT00765765|11983928|FG000|COMPLETED|Overall Study||6
10819480|NCT00765765|11983928|FG000|NOT COMPLETED|Overall Study||0
10819481|NCT00764699|11983932|FG000|STARTED|Overall Study||3
10819482|NCT00764699|11983932|FG000|COMPLETED|Overall Study||0
10819483|NCT00764699|11983932|FG000|NOT COMPLETED|Overall Study||3
10819484|NCT00759577|11983936|FG000|STARTED|Overall Study||36
10819485|NCT00759577|11983936|FG000|COMPLETED|Overall Study||36
10819486|NCT00759577|11983936|FG000|NOT COMPLETED|Overall Study||0
10819487|NCT00763009|11983940|FG000|STARTED|Overall Study||8
10819488|NCT00763009|11983940|FG000|COMPLETED|Overall Study||7
10819489|NCT00763009|11983940|FG000|NOT COMPLETED|Overall Study||1
10819490|NCT00761176|11983947|FG000|STARTED|Overall Study||4
10819491|NCT00761176|11983948|FG001|STARTED|Overall Study||4
10819492|NCT00761176|11983947|FG000|COMPLETED|Overall Study||2
10819493|NCT00761176|11983948|FG001|COMPLETED|Overall Study||3
10819494|NCT00761176|11983947|FG000|NOT COMPLETED|Overall Study||2
10819495|NCT00761176|11983948|FG001|NOT COMPLETED|Overall Study||1
10819496|NCT00749476|11983954|FG000|STARTED|Overall Study||1
10819497|NCT00749476|11983954|FG000|COMPLETED|Overall Study||1
10819498|NCT00749476|11983954|FG000|NOT COMPLETED|Overall Study||0
10819499|NCT00760461|11983958|FG000|STARTED|Overall Study||44
10819500|NCT00760461|11983958|FG000|COMPLETED|Overall Study||0
10819501|NCT00760461|11983958|FG000|NOT COMPLETED|Overall Study||44
10819502|NCT00749658|11983964|FG000|STARTED|Overall Study||60
10819503|NCT00749658|11983965|FG001|STARTED|Overall Study||61
10819504|NCT00749658|11983964|FG000|COMPLETED|Overall Study||60
10819505|NCT00749658|11983965|FG001|COMPLETED|Overall Study||61
10819506|NCT00749658|11983964|FG000|NOT COMPLETED|Overall Study||0
10819507|NCT00749658|11983965|FG001|NOT COMPLETED|Overall Study||0
10819508|NCT00754793|11983973|FG000|STARTED|Overall Study||1
10819509|NCT00754793|11983974|FG001|STARTED|Overall Study||2
10819510|NCT00754793|11983973|FG000|COMPLETED|Overall Study||1
10819511|NCT00754793|11983974|FG001|COMPLETED|Overall Study||1
10819512|NCT00754793|11983973|FG000|NOT COMPLETED|Overall Study||0
10544786|NCT01491672|11697940|FG002|STARTED|Overall Study||14
10544787|NCT01491672|11697938|FG000|Safety Set|Overall Study||58
10544788|NCT01491672|11697939|FG001|Safety Set|Overall Study||61
10750580|NCT03011892|11914223|FG008|Treated in DB Period|Double Blind (DB) Period||0
10750581|NCT03011892|11914224|FG009|Treated in DB Period|Double Blind (DB) Period||0
10750582|NCT03011892|11914225|FG010|Treated in DB Period|Double Blind (DB) Period||0
10750583|NCT03011892|11914226|FG011|Treated in DB Period|Double Blind (DB) Period||0
10750584|NCT03011892|11914215|FG000|Completed Treatment Through Week 4|Double Blind (DB) Period||44
10750585|NCT03011892|11914216|FG001|Completed Treatment Through Week 4|Double Blind (DB) Period||46
10750586|NCT03011892|11914217|FG002|Completed Treatment Through Week 4|Double Blind (DB) Period||48
10819513|NCT00754793|11983974|FG001|NOT COMPLETED|Overall Study||1
10819514|NCT00754052|11983982|FG000|STARTED|Overall Study||5
10819515|NCT00754052|11983983|FG001|STARTED|Overall Study||3
10819516|NCT00754052|11983982|FG000|COMPLETED|Overall Study||0
10819517|NCT00754052|11983983|FG001|COMPLETED|Overall Study||0
10819518|NCT00754052|11983982|FG000|NOT COMPLETED|Overall Study||5
10819519|NCT00754052|11983983|FG001|NOT COMPLETED|Overall Study||3
10819520|NCT00750555|11983989|FG000|STARTED|Overall Study||0
10819521|NCT00750555|11983989|FG000|COMPLETED|Overall Study||0
10750587|NCT03011892|11914218|FG003|Completed Treatment Through Week 4|Double Blind (DB) Period||47
10750588|NCT03011892|11914219|FG004|Completed Treatment Through Week 4|Double Blind (DB) Period||49
10750589|NCT03011892|11914220|FG005|Completed Treatment Through Week 4|Double Blind (DB) Period||49
10750590|NCT03011892|11914221|FG006|Completed Treatment Through Week 4|Double Blind (DB) Period||0
10750591|NCT03011892|11914222|FG007|Completed Treatment Through Week 4|Double Blind (DB) Period||0
10750592|NCT03011892|11914223|FG008|Completed Treatment Through Week 4|Double Blind (DB) Period||0
10750593|NCT03011892|11914224|FG009|Completed Treatment Through Week 4|Double Blind (DB) Period||0
10750594|NCT03011892|11914225|FG010|Completed Treatment Through Week 4|Double Blind (DB) Period||0
10750595|NCT03011892|11914226|FG011|Completed Treatment Through Week 4|Double Blind (DB) Period||0
10750596|NCT03011892|11914215|FG000|COMPLETED|Double Blind (DB) Period||41
10750597|NCT03011892|11914216|FG001|COMPLETED|Double Blind (DB) Period||41
10750598|NCT03011892|11914217|FG002|COMPLETED|Double Blind (DB) Period||45
10750599|NCT03011892|11914218|FG003|COMPLETED|Double Blind (DB) Period||44
10750600|NCT03011892|11914219|FG004|COMPLETED|Double Blind (DB) Period||45
10750601|NCT03011892|11914220|FG005|COMPLETED|Double Blind (DB) Period||45
10750602|NCT03011892|11914221|FG006|COMPLETED|Double Blind (DB) Period||0
10750603|NCT03011892|11914222|FG007|COMPLETED|Double Blind (DB) Period||0
10750604|NCT03011892|11914223|FG008|COMPLETED|Double Blind (DB) Period||0
10750605|NCT03011892|11914224|FG009|COMPLETED|Double Blind (DB) Period||0
10750606|NCT03011892|11914225|FG010|COMPLETED|Double Blind (DB) Period||0
10750607|NCT03011892|11914226|FG011|COMPLETED|Double Blind (DB) Period||0
10750608|NCT03011892|11914215|FG000|NOT COMPLETED|Double Blind (DB) Period||11
10750609|NCT03011892|11914216|FG001|NOT COMPLETED|Double Blind (DB) Period||10
10750610|NCT03011892|11914217|FG002|NOT COMPLETED|Double Blind (DB) Period||6
10750611|NCT03011892|11914218|FG003|NOT COMPLETED|Double Blind (DB) Period||7
10750612|NCT03011892|11914219|FG004|NOT COMPLETED|Double Blind (DB) Period||7
10750613|NCT03011892|11914220|FG005|NOT COMPLETED|Double Blind (DB) Period||5
10750614|NCT03011892|11914221|FG006|NOT COMPLETED|Double Blind (DB) Period||0
10750615|NCT03011892|11914222|FG007|NOT COMPLETED|Double Blind (DB) Period||0
10750616|NCT03011892|11914223|FG008|NOT COMPLETED|Double Blind (DB) Period||0
10750617|NCT03011892|11914224|FG009|NOT COMPLETED|Double Blind (DB) Period||0
10750618|NCT03011892|11914225|FG010|NOT COMPLETED|Double Blind (DB) Period||0
10750619|NCT03011892|11914226|FG011|NOT COMPLETED|Double Blind (DB) Period||0
10750620|NCT03011892|11914215|FG000|STARTED|Open Label (OL) Period||0
10750621|NCT03011892|11914216|FG001|STARTED|Open Label (OL) Period||0
10750622|NCT03011892|11914217|FG002|STARTED|Open Label (OL) Period||0
10750623|NCT03011892|11914218|FG003|STARTED|Open Label (OL) Period||0
10750624|NCT03011892|11914219|FG004|STARTED|Open Label (OL) Period||0
10750625|NCT03011892|11914220|FG005|STARTED|Open Label (OL) Period||0
10750626|NCT03011892|11914221|FG006|STARTED|Open Label (OL) Period||41
10750627|NCT03011892|11914222|FG007|STARTED|Open Label (OL) Period||40
10750628|NCT03011892|11914223|FG008|STARTED|Open Label (OL) Period||45
10750629|NCT03011892|11914224|FG009|STARTED|Open Label (OL) Period||41
10750630|NCT03011892|11914225|FG010|STARTED|Open Label (OL) Period||42
10750631|NCT03011892|11914226|FG011|STARTED|Open Label (OL) Period||43
10750632|NCT03011892|11914215|FG000|COMPLETED|Open Label (OL) Period||0
10750633|NCT03011892|11914216|FG001|COMPLETED|Open Label (OL) Period||0
10750634|NCT03011892|11914217|FG002|COMPLETED|Open Label (OL) Period||0
10750635|NCT03011892|11914218|FG003|COMPLETED|Open Label (OL) Period||0
10750636|NCT03011892|11914219|FG004|COMPLETED|Open Label (OL) Period||0
10750637|NCT03011892|11914220|FG005|COMPLETED|Open Label (OL) Period||0
10750638|NCT03011892|11914221|FG006|COMPLETED|Open Label (OL) Period||34
10750639|NCT03011892|11914222|FG007|COMPLETED|Open Label (OL) Period||37
10819522|NCT00750555|11983989|FG000|NOT COMPLETED|Overall Study||0
10819523|NCT00754767|11983996|FG000|STARTED|Overall Study||2
10819524|NCT00754767|11983997|FG001|STARTED|Overall Study||0
10819525|NCT00754767|11983996|FG000|COMPLETED|Overall Study||2
10819526|NCT00754767|11983997|FG001|COMPLETED|Overall Study||0
10819527|NCT00754767|11983996|FG000|NOT COMPLETED|Overall Study||0
10819528|NCT00754767|11983997|FG001|NOT COMPLETED|Overall Study||0
10819529|NCT00750204|11984005|FG000|STARTED|Overall Study||1
10819530|NCT00750204|11984006|FG001|STARTED|Overall Study||1
10819531|NCT00750204|11984005|FG000|COMPLETED|Overall Study||0
10819532|NCT00750204|11984006|FG001|COMPLETED|Overall Study||0
10819533|NCT00750204|11984005|FG000|NOT COMPLETED|Overall Study||1
10819534|NCT00750204|11984006|FG001|NOT COMPLETED|Overall Study||1
10819535|NCT00748579|11984014|FG000|STARTED|Overall Study||2
10819536|NCT00748579|11984015|FG001|STARTED|Overall Study||0
10819537|NCT00748579|11984014|FG000|COMPLETED|Overall Study||2
10819538|NCT00748579|11984015|FG001|COMPLETED|Overall Study||0
10819539|NCT00748579|11984014|FG000|NOT COMPLETED|Overall Study||0
10819540|NCT00748579|11984015|FG001|NOT COMPLETED|Overall Study||0
10819541|NCT00748085|11984021|FG000|STARTED|Overall Study||5
10312948|NCT00147082|11446468|FG000|NOT COMPLETED|Overall Study||0
10312949|NCT00147082|11446469|FG001|NOT COMPLETED|Overall Study||0
10750640|NCT03011892|11914223|FG008|COMPLETED|Open Label (OL) Period||43
10750641|NCT03011892|11914224|FG009|COMPLETED|Open Label (OL) Period||41
10750642|NCT03011892|11914225|FG010|COMPLETED|Open Label (OL) Period||40
10750643|NCT03011892|11914226|FG011|COMPLETED|Open Label (OL) Period||40
10750644|NCT03011892|11914215|FG000|NOT COMPLETED|Open Label (OL) Period||0
10750645|NCT03011892|11914216|FG001|NOT COMPLETED|Open Label (OL) Period||0
10750646|NCT03011892|11914217|FG002|NOT COMPLETED|Open Label (OL) Period||0
10750647|NCT03011892|11914218|FG003|NOT COMPLETED|Open Label (OL) Period||0
10750648|NCT03011892|11914219|FG004|NOT COMPLETED|Open Label (OL) Period||0
10750649|NCT03011892|11914220|FG005|NOT COMPLETED|Open Label (OL) Period||0
10750650|NCT03011892|11914221|FG006|NOT COMPLETED|Open Label (OL) Period||7
10750651|NCT03011892|11914222|FG007|NOT COMPLETED|Open Label (OL) Period||3
10750652|NCT03011892|11914223|FG008|NOT COMPLETED|Open Label (OL) Period||2
10750653|NCT03011892|11914224|FG009|NOT COMPLETED|Open Label (OL) Period||0
10750654|NCT03011892|11914225|FG010|NOT COMPLETED|Open Label (OL) Period||2
10750655|NCT03011892|11914226|FG011|NOT COMPLETED|Open Label (OL) Period||3
10750656|NCT03012061|11914256|FG000|STARTED|Overall Study||143
10750657|NCT03012061|11914257|FG001|STARTED|Overall Study||139
10750658|NCT03012061|11914258|FG002|STARTED|Overall Study||139
10750659|NCT03012061|11914256|FG000|COMPLETED|Overall Study||137
10750660|NCT03012061|11914257|FG001|COMPLETED|Overall Study||130
10750661|NCT03012061|11914258|FG002|COMPLETED|Overall Study||131
10750662|NCT03012061|11914256|FG000|NOT COMPLETED|Overall Study||6
10750663|NCT03012061|11914257|FG001|NOT COMPLETED|Overall Study||9
10750664|NCT03012061|11914258|FG002|NOT COMPLETED|Overall Study||8
10750665|NCT03012191|11914269|FG000|STARTED|Overall Study||2
10750666|NCT03012191|11914270|FG001|STARTED|Overall Study||2
10750667|NCT03012191|11914271|FG002|STARTED|Overall Study||2
10750668|NCT03012191|11914269|FG000|COMPLETED|Overall Study||2
10750669|NCT03012191|11914270|FG001|COMPLETED|Overall Study||2
10750670|NCT03012191|11914271|FG002|COMPLETED|Overall Study||2
10750671|NCT03012191|11914269|FG000|NOT COMPLETED|Overall Study||0
10750672|NCT03012191|11914270|FG001|NOT COMPLETED|Overall Study||0
10750673|NCT03012191|11914271|FG002|NOT COMPLETED|Overall Study||0
10750674|NCT03012334|11914290|FG000|STARTED|Period 1||9
10750675|NCT03012334|11914291|FG001|STARTED|Period 1||9
10750676|NCT03012334|11914292|FG002|STARTED|Period 1||9
10750677|NCT03012334|11914293|FG003|STARTED|Period 1||9
10750678|NCT03012334|11914294|FG004|STARTED|Period 1||9
10750679|NCT03012334|11914295|FG005|STARTED|Period 1||9
10750680|NCT03012334|11914296|FG006|STARTED|Period 1||9
10750681|NCT03012334|11914297|FG007|STARTED|Period 1||9
10750682|NCT03012334|11914298|FG008|STARTED|Period 1||9
10750683|NCT03012334|11914299|FG009|STARTED|Period 1||9
10750684|NCT03012334|11914290|FG000|COMPLETED|Period 1||9
10750685|NCT03012334|11914291|FG001|COMPLETED|Period 1||9
10750686|NCT03012334|11914292|FG002|COMPLETED|Period 1||9
10750687|NCT03012334|11914293|FG003|COMPLETED|Period 1||9
10750688|NCT03012334|11914294|FG004|COMPLETED|Period 1||9
10750689|NCT03012334|11914295|FG005|COMPLETED|Period 1||9
10750690|NCT03012334|11914296|FG006|COMPLETED|Period 1||9
10750691|NCT03012334|11914297|FG007|COMPLETED|Period 1||9
10750692|NCT03012334|11914298|FG008|COMPLETED|Period 1||9
10750693|NCT03012334|11914299|FG009|COMPLETED|Period 1||8
10750694|NCT03012334|11914290|FG000|NOT COMPLETED|Period 1||0
10750695|NCT03012334|11914291|FG001|NOT COMPLETED|Period 1||0
10750696|NCT03012334|11914292|FG002|NOT COMPLETED|Period 1||0
10750697|NCT03012334|11914293|FG003|NOT COMPLETED|Period 1||0
10750698|NCT03012334|11914294|FG004|NOT COMPLETED|Period 1||0
10750699|NCT03012334|11914295|FG005|NOT COMPLETED|Period 1||0
10750700|NCT03012334|11914296|FG006|NOT COMPLETED|Period 1||0
10750701|NCT03012334|11914297|FG007|NOT COMPLETED|Period 1||0
10750702|NCT03012334|11914298|FG008|NOT COMPLETED|Period 1||0
10750703|NCT03012334|11914299|FG009|NOT COMPLETED|Period 1||1
10750704|NCT03012334|11914290|FG000|STARTED|Period 2||9
10750705|NCT03012334|11914291|FG001|STARTED|Period 2||9
10750706|NCT03012334|11914292|FG002|STARTED|Period 2||9
10819542|NCT00748085|11984021|FG000|COMPLETED|Overall Study|No analysis -study terminated for business reasons.|5
10819543|NCT00748085|11984021|FG000|NOT COMPLETED|Overall Study||0
10819544|NCT00752986|11984028|FG000|STARTED|Overall Study||16
10819545|NCT00752986|11984029|FG001|STARTED|Overall Study||12
10750707|NCT03012334|11914293|FG003|STARTED|Period 2||9
10750708|NCT03012334|11914294|FG004|STARTED|Period 2||9
10750709|NCT03012334|11914295|FG005|STARTED|Period 2||9
10750710|NCT03012334|11914296|FG006|STARTED|Period 2||9
10750711|NCT03012334|11914297|FG007|STARTED|Period 2||9
10750712|NCT03012334|11914298|FG008|STARTED|Period 2||9
10750713|NCT03012334|11914299|FG009|STARTED|Period 2||8
10750714|NCT03012334|11914290|FG000|COMPLETED|Period 2||9
10750715|NCT03012334|11914291|FG001|COMPLETED|Period 2||8
10750716|NCT03012334|11914292|FG002|COMPLETED|Period 2||8
10750717|NCT03012334|11914293|FG003|COMPLETED|Period 2||9
10750718|NCT03012334|11914294|FG004|COMPLETED|Period 2||9
10750719|NCT03012334|11914295|FG005|COMPLETED|Period 2||9
10750720|NCT03012334|11914296|FG006|COMPLETED|Period 2||9
10750721|NCT03012334|11914297|FG007|COMPLETED|Period 2||8
10750722|NCT03012334|11914298|FG008|COMPLETED|Period 2||9
10750723|NCT03012334|11914299|FG009|COMPLETED|Period 2||8
10750724|NCT03012334|11914290|FG000|NOT COMPLETED|Period 2||0
10750725|NCT03012334|11914291|FG001|NOT COMPLETED|Period 2||1
10750726|NCT03012334|11914292|FG002|NOT COMPLETED|Period 2||1
10750727|NCT03012334|11914293|FG003|NOT COMPLETED|Period 2||0
10750728|NCT03012334|11914294|FG004|NOT COMPLETED|Period 2||0
10750729|NCT03012334|11914295|FG005|NOT COMPLETED|Period 2||0
10750730|NCT03012334|11914296|FG006|NOT COMPLETED|Period 2||0
10750731|NCT03012334|11914297|FG007|NOT COMPLETED|Period 2||1
10750732|NCT03012334|11914298|FG008|NOT COMPLETED|Period 2||0
10750733|NCT03012334|11914299|FG009|NOT COMPLETED|Period 2||0
10750734|NCT03012334|11914290|FG000|STARTED|Period 3||9
10750735|NCT03012334|11914291|FG001|STARTED|Period 3||8
10750736|NCT03012334|11914292|FG002|STARTED|Period 3||8
10750737|NCT03012334|11914293|FG003|STARTED|Period 3||9
10750738|NCT03012334|11914294|FG004|STARTED|Period 3||9
10750739|NCT03012334|11914295|FG005|STARTED|Period 3||9
10750740|NCT03012334|11914296|FG006|STARTED|Period 3||9
10750741|NCT03012334|11914297|FG007|STARTED|Period 3||8
10750742|NCT03012334|11914298|FG008|STARTED|Period 3||9
10750743|NCT03012334|11914299|FG009|STARTED|Period 3||8
10750744|NCT03012334|11914290|FG000|COMPLETED|Period 3||9
10750745|NCT03012334|11914291|FG001|COMPLETED|Period 3||8
10750746|NCT03012334|11914292|FG002|COMPLETED|Period 3||8
10750747|NCT03012334|11914293|FG003|COMPLETED|Period 3||9
10750748|NCT03012334|11914294|FG004|COMPLETED|Period 3||9
10750749|NCT03012334|11914295|FG005|COMPLETED|Period 3||9
10750750|NCT03012334|11914296|FG006|COMPLETED|Period 3||9
10750751|NCT03012334|11914297|FG007|COMPLETED|Period 3||8
10750752|NCT03012334|11914298|FG008|COMPLETED|Period 3||9
10750753|NCT03012334|11914299|FG009|COMPLETED|Period 3||8
10750754|NCT03012334|11914290|FG000|NOT COMPLETED|Period 3||0
10750755|NCT03012334|11914291|FG001|NOT COMPLETED|Period 3||0
10750756|NCT03012334|11914292|FG002|NOT COMPLETED|Period 3||0
10750757|NCT03012334|11914293|FG003|NOT COMPLETED|Period 3||0
10750758|NCT03012334|11914294|FG004|NOT COMPLETED|Period 3||0
10750759|NCT03012334|11914295|FG005|NOT COMPLETED|Period 3||0
10750760|NCT03012334|11914296|FG006|NOT COMPLETED|Period 3||0
10750761|NCT03012334|11914297|FG007|NOT COMPLETED|Period 3||0
10750762|NCT03012334|11914298|FG008|NOT COMPLETED|Period 3||0
10750763|NCT03012334|11914299|FG009|NOT COMPLETED|Period 3||0
10750764|NCT03012334|11914290|FG000|STARTED|Period 4||9
10750765|NCT03012334|11914291|FG001|STARTED|Period 4||8
10750766|NCT03012334|11914292|FG002|STARTED|Period 4||8
10750767|NCT03012334|11914293|FG003|STARTED|Period 4||9
10750768|NCT03012334|11914294|FG004|STARTED|Period 4||9
10750769|NCT03012334|11914295|FG005|STARTED|Period 4||9
10750770|NCT03012334|11914296|FG006|STARTED|Period 4||9
10750771|NCT03012334|11914297|FG007|STARTED|Period 4||8
10750772|NCT03012334|11914298|FG008|STARTED|Period 4||9
10750773|NCT03012334|11914299|FG009|STARTED|Period 4||8
10750774|NCT03012334|11914290|FG000|COMPLETED|Period 4||9
10750775|NCT03012334|11914291|FG001|COMPLETED|Period 4||8
10750776|NCT03012334|11914292|FG002|COMPLETED|Period 4||8
10750777|NCT03012334|11914293|FG003|COMPLETED|Period 4||9
10750778|NCT03012334|11914294|FG004|COMPLETED|Period 4||9
10750779|NCT03012334|11914295|FG005|COMPLETED|Period 4||9
10750780|NCT03012334|11914296|FG006|COMPLETED|Period 4||8
10750781|NCT03012334|11914297|FG007|COMPLETED|Period 4||8
10750782|NCT03012334|11914298|FG008|COMPLETED|Period 4||8
10750783|NCT03012334|11914299|FG009|COMPLETED|Period 4||8
10750784|NCT03012334|11914290|FG000|NOT COMPLETED|Period 4||0
10750785|NCT03012334|11914291|FG001|NOT COMPLETED|Period 4||0
10750786|NCT03012334|11914292|FG002|NOT COMPLETED|Period 4||0
10750787|NCT03012334|11914293|FG003|NOT COMPLETED|Period 4||0
10750788|NCT03012334|11914294|FG004|NOT COMPLETED|Period 4||0
10750789|NCT03012334|11914295|FG005|NOT COMPLETED|Period 4||0
10750790|NCT03012334|11914296|FG006|NOT COMPLETED|Period 4||1
10750791|NCT03012334|11914297|FG007|NOT COMPLETED|Period 4||0
10750792|NCT03012334|11914298|FG008|NOT COMPLETED|Period 4||1
10750793|NCT03012334|11914299|FG009|NOT COMPLETED|Period 4||0
10750794|NCT03012334|11914290|FG000|STARTED|Period 5||9
10750795|NCT03012334|11914291|FG001|STARTED|Period 5||8
10750796|NCT03012334|11914292|FG002|STARTED|Period 5||8
10750797|NCT03012334|11914293|FG003|STARTED|Period 5||9
10819546|NCT00752986|11984030|FG002|STARTED|Overall Study||11
10819547|NCT00752986|11984028|FG000|COMPLETED|Overall Study||11
10750798|NCT03012334|11914294|FG004|STARTED|Period 5||9
10750799|NCT03012334|11914295|FG005|STARTED|Period 5||9
10750800|NCT03012334|11914296|FG006|STARTED|Period 5||8
10750801|NCT03012334|11914297|FG007|STARTED|Period 5||8
10819548|NCT00752986|11984029|FG001|COMPLETED|Overall Study||11
10819549|NCT00752986|11984030|FG002|COMPLETED|Overall Study||9
10750802|NCT03012334|11914298|FG008|STARTED|Period 5||8
10750803|NCT03012334|11914299|FG009|STARTED|Period 5||8
10750804|NCT03012334|11914290|FG000|COMPLETED|Period 5||9
10750805|NCT03012334|11914291|FG001|COMPLETED|Period 5||8
10750806|NCT03012334|11914292|FG002|COMPLETED|Period 5||8
10750807|NCT03012334|11914293|FG003|COMPLETED|Period 5||9
10750808|NCT03012334|11914294|FG004|COMPLETED|Period 5||9
10750809|NCT03012334|11914295|FG005|COMPLETED|Period 5||9
10750810|NCT03012334|11914296|FG006|COMPLETED|Period 5||8
10750811|NCT03012334|11914297|FG007|COMPLETED|Period 5||8
10750812|NCT03012334|11914298|FG008|COMPLETED|Period 5||8
10750813|NCT03012334|11914299|FG009|COMPLETED|Period 5||8
10750814|NCT03012334|11914290|FG000|NOT COMPLETED|Period 5||0
10750815|NCT03012334|11914291|FG001|NOT COMPLETED|Period 5||0
10750816|NCT03012334|11914292|FG002|NOT COMPLETED|Period 5||0
10750817|NCT03012334|11914293|FG003|NOT COMPLETED|Period 5||0
10750818|NCT03012334|11914294|FG004|NOT COMPLETED|Period 5||0
10750819|NCT03012334|11914295|FG005|NOT COMPLETED|Period 5||0
10750820|NCT03012334|11914296|FG006|NOT COMPLETED|Period 5||0
10750821|NCT03012334|11914297|FG007|NOT COMPLETED|Period 5||0
10750822|NCT03012334|11914298|FG008|NOT COMPLETED|Period 5||0
10819550|NCT00752986|11984028|FG000|NOT COMPLETED|Overall Study||5
10750823|NCT03012334|11914299|FG009|NOT COMPLETED|Period 5||0
10778530|NCT03358355|11940500|FG000|STARTED|Overall Study||9
10778531|NCT03358355|11940500|FG000|COMPLETED|Overall Study||9
10778532|NCT03358355|11940500|FG000|NOT COMPLETED|Overall Study||0
10778533|NCT03358407|11940519|FG000|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
10778534|NCT03358407|11940520|FG001|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
10778535|NCT03358407|11940521|FG002|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
10778536|NCT03358407|11940522|FG003|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
10778537|NCT03358407|11940523|FG004|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
10778538|NCT03358407|11940524|FG005|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
10778539|NCT03358407|11940525|FG006|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
10778540|NCT03358407|11940526|FG007|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
10778541|NCT03358407|11940527|FG008|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
10778542|NCT03358407|11940528|FG009|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
10778543|NCT03358407|11940519|FG000|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
10778544|NCT03358407|11940520|FG001|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
10778545|NCT03358407|11940521|FG002|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
10778546|NCT03358407|11940522|FG003|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
10778547|NCT03358407|11940523|FG004|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
10778548|NCT03358407|11940524|FG005|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
10778549|NCT03358407|11940525|FG006|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
10778550|NCT03358407|11940526|FG007|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
10778551|NCT03358407|11940527|FG008|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
10778552|NCT03358407|11940528|FG009|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
10778553|NCT03358407|11940519|FG000|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
10778554|NCT03358407|11940520|FG001|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
10778555|NCT03358407|11940521|FG002|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
10778556|NCT03358407|11940522|FG003|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
10778557|NCT03358407|11940523|FG004|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
10778558|NCT03358407|11940524|FG005|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
10778559|NCT03358407|11940525|FG006|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
10778560|NCT03358407|11940526|FG007|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
10778561|NCT03358407|11940527|FG008|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
10778562|NCT03358407|11940528|FG009|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
10778563|NCT03358407|11940519|FG000|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
10778564|NCT03358407|11940520|FG001|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
10778565|NCT03358407|11940521|FG002|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
10778566|NCT03358407|11940522|FG003|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
10778567|NCT03358407|11940523|FG004|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
10778568|NCT03358407|11940524|FG005|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
10778569|NCT03358407|11940525|FG006|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
10778570|NCT03358407|11940526|FG007|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
10778571|NCT03358407|11940527|FG008|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
10778572|NCT03358407|11940528|FG009|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
10778573|NCT03358407|11940519|FG000|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
10778574|NCT03358407|11940520|FG001|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
10778575|NCT03358407|11940521|FG002|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||1
10778576|NCT03358407|11940522|FG003|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
10778577|NCT03358407|11940523|FG004|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
10778578|NCT03358407|11940524|FG005|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
10778579|NCT03358407|11940525|FG006|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
10778580|NCT03358407|11940526|FG007|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
10778581|NCT03358407|11940527|FG008|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
10778582|NCT03358407|11940528|FG009|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
10778583|NCT03358407|11940519|FG000|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
10778584|NCT03358407|11940520|FG001|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
10778585|NCT03358407|11940521|FG002|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||1
10778586|NCT03358407|11940522|FG003|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
10778587|NCT03358407|11940523|FG004|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
10778588|NCT03358407|11940524|FG005|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
10778589|NCT03358407|11940525|FG006|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
10778590|NCT03358407|11940526|FG007|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
10778591|NCT03358407|11940527|FG008|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
10778592|NCT03358407|11940528|FG009|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
10778593|NCT03358407|11940519|FG000|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
10778594|NCT03358407|11940520|FG001|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
10778595|NCT03358407|11940521|FG002|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)|1 participant was added to Part A-Cohort 1: GSK 2mg/GSK 4mg/Placebo/GSK 30mg/GSK 100mg arm|2
10778596|NCT03358407|11940522|FG003|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
10778597|NCT03358407|11940523|FG004|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
10778598|NCT03358407|11940524|FG005|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
10778599|NCT03358407|11940525|FG006|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
10750824|NCT03012477|11914312|FG000|STARTED|Overall Study||34
10750825|NCT03012477|11914312|FG000|COMPLETED|Overall Study||34
10750826|NCT03012477|11914312|FG000|NOT COMPLETED|Overall Study||0
10750827|NCT03012594|11914316|FG000|STARTED|Overall Study||12
10750828|NCT03012594|11914316|FG000|COMPLETED|Overall Study||9
10750829|NCT03012594|11914316|FG000|NOT COMPLETED|Overall Study||3
10750830|NCT03012828|11914326|FG000|STARTED|Overall Study||10
10750831|NCT03012828|11914327|FG001|STARTED|Overall Study||10
10750832|NCT03012828|11914328|FG002|STARTED|Overall Study||10
10750833|NCT03012828|11914329|FG003|STARTED|Overall Study||10
10819551|NCT00752986|11984029|FG001|NOT COMPLETED|Overall Study||1
10819552|NCT00752986|11984030|FG002|NOT COMPLETED|Overall Study||2
10819553|NCT00751335|11984040|FG000|STARTED|Overall Study||0
10819554|NCT00751335|11984041|FG001|STARTED|Overall Study||0
10819555|NCT00751335|11984040|FG000|COMPLETED|Overall Study||0
10819556|NCT00751335|11984041|FG001|COMPLETED|Overall Study||0
10544789|NCT01491672|11697940|FG002|Safety Set|Overall Study||14
10544790|NCT01491672|11697938|FG000|COMPLETED|Overall Study||2
10544791|NCT01491672|11697939|FG001|COMPLETED|Overall Study||2
10544792|NCT01491672|11697940|FG002|COMPLETED|Overall Study||3
10544793|NCT01491672|11697938|FG000|NOT COMPLETED|Overall Study||56
10544794|NCT01491672|11697939|FG001|NOT COMPLETED|Overall Study||60
10544795|NCT01491672|11697940|FG002|NOT COMPLETED|Overall Study||11
10750834|NCT03012828|11914330|FG004|STARTED|Overall Study||10
10819557|NCT00751335|11984040|FG000|NOT COMPLETED|Overall Study||0
10819558|NCT00751335|11984041|FG001|NOT COMPLETED|Overall Study||0
10819559|NCT00746239|11984047|FG000|STARTED|Overall Study||11
10819560|NCT00746239|11984047|FG000|COMPLETED|Overall Study|11 subjects total were enrolled - 6 withdrew from study and 5 competed|5
10819561|NCT00746239|11984047|FG000|NOT COMPLETED|Overall Study||6
10819562|NCT00754013|11984053|FG000|STARTED|Overall Study||4
10819563|NCT00754013|11984054|FG001|STARTED|Overall Study||5
10819564|NCT00754013|11984053|FG000|COMPLETED|Overall Study||0
10819565|NCT00754013|11984054|FG001|COMPLETED|Overall Study||0
10819566|NCT00754013|11984053|FG000|NOT COMPLETED|Overall Study||4
10819567|NCT00754013|11984054|FG001|NOT COMPLETED|Overall Study||5
10819568|NCT00735553|11984063|FG000|STARTED|Overall Study||77
10819569|NCT00735553|11984063|FG000|COMPLETED|Overall Study||0
10819570|NCT00735553|11984063|FG000|NOT COMPLETED|Overall Study||77
10819571|NCT00751933|11984071|FG000|STARTED|Overall Study||0
10819572|NCT00751933|11984072|FG001|STARTED|Overall Study||1
10819573|NCT00751933|11984073|FG002|STARTED|Overall Study||1
10819574|NCT00751933|11984074|FG003|STARTED|Overall Study||1
10819575|NCT00751933|11984071|FG000|COMPLETED|Overall Study||0
10819576|NCT00751933|11984072|FG001|COMPLETED|Overall Study||0
10819577|NCT00751933|11984073|FG002|COMPLETED|Overall Study||0
10819578|NCT00751933|11984074|FG003|COMPLETED|Overall Study||0
10819579|NCT00751933|11984071|FG000|NOT COMPLETED|Overall Study||0
10819580|NCT00751933|11984072|FG001|NOT COMPLETED|Overall Study||1
10819581|NCT00751933|11984073|FG002|NOT COMPLETED|Overall Study||1
10819582|NCT00751933|11984074|FG003|NOT COMPLETED|Overall Study||1
10819583|NCT00747916|11984078|FG000|STARTED|Overall Study||3
10819584|NCT00747916|11984078|FG000|COMPLETED|Overall Study||3
10819585|NCT00747916|11984078|FG000|NOT COMPLETED|Overall Study||0
10819586|NCT00745030|11984084|FG000|STARTED|Overall Study||1
10819587|NCT00745030|11984085|FG001|STARTED|Overall Study||2
10819588|NCT00745030|11984084|FG000|COMPLETED|Overall Study||1
10819589|NCT00745030|11984085|FG001|COMPLETED|Overall Study||2
10819590|NCT00745030|11984084|FG000|NOT COMPLETED|Overall Study||0
10819591|NCT00745030|11984085|FG001|NOT COMPLETED|Overall Study||0
10819592|NCT00747461|11984091|FG000|STARTED|Overall Study||5
10819593|NCT00747461|11984091|FG000|COMPLETED|Overall Study||0
10819594|NCT00747461|11984091|FG000|NOT COMPLETED|Overall Study||5
10819595|NCT00746018|11984096|FG000|STARTED|Overall Study||39
10819596|NCT00746018|11984096|FG000|COMPLETED|Overall Study||39
10819597|NCT00746018|11984096|FG000|NOT COMPLETED|Overall Study||0
10819598|NCT00746603|11984100|FG000|STARTED|Overall Study||3
10819599|NCT00746603|11984100|FG000|COMPLETED|Overall Study||3
10819600|NCT00746603|11984100|FG000|NOT COMPLETED|Overall Study||0
10750835|NCT03012828|11914331|FG005|STARTED|Overall Study||10
10819601|NCT00736385|11984106|FG000|STARTED|Overall Study||4
10819602|NCT00736385|11984107|FG001|STARTED|Overall Study||5
10819603|NCT00736385|11984106|FG000|COMPLETED|Overall Study||2
10819604|NCT00736385|11984107|FG001|COMPLETED|Overall Study||2
10819605|NCT00736385|11984106|FG000|NOT COMPLETED|Overall Study||2
10819606|NCT00736385|11984107|FG001|NOT COMPLETED|Overall Study||3
10819607|NCT00738972|11984117|FG000|STARTED|Overall Study||3
10819608|NCT00738972|11984118|FG001|STARTED|Overall Study||3
10819609|NCT00738972|11984119|FG002|STARTED|Overall Study||3
10819610|NCT00738972|11984120|FG003|STARTED|Overall Study||3
10819611|NCT00738972|11984117|FG000|COMPLETED|Overall Study||3
10819612|NCT00738972|11984118|FG001|COMPLETED|Overall Study||3
10750836|NCT03012828|11914326|FG000|COMPLETED|Overall Study||9
10819613|NCT00738972|11984119|FG002|COMPLETED|Overall Study||3
10819614|NCT00738972|11984120|FG003|COMPLETED|Overall Study||2
10819615|NCT00738972|11984117|FG000|NOT COMPLETED|Overall Study||0
10819616|NCT00738972|11984118|FG001|NOT COMPLETED|Overall Study||0
10819617|NCT00738972|11984119|FG002|NOT COMPLETED|Overall Study||0
10819618|NCT00738972|11984120|FG003|NOT COMPLETED|Overall Study||1
10544796|NCT01491737|11697952|FG000|STARTED|Overall Study||129
10750837|NCT03012828|11914327|FG001|COMPLETED|Overall Study||10
10819619|NCT00739063|11984130|FG000|STARTED|Overall Study||11
10819620|NCT00739063|11984130|FG000|COMPLETED|Overall Study||3
10819621|NCT00739063|11984130|FG000|NOT COMPLETED|Overall Study||8
10750838|NCT03012828|11914328|FG002|COMPLETED|Overall Study||8
10750839|NCT03012828|11914329|FG003|COMPLETED|Overall Study||10
10750840|NCT03012828|11914330|FG004|COMPLETED|Overall Study||8
10750841|NCT03012828|11914331|FG005|COMPLETED|Overall Study||8
10750842|NCT03012828|11914326|FG000|NOT COMPLETED|Overall Study||1
10750843|NCT03012828|11914327|FG001|NOT COMPLETED|Overall Study||0
10750844|NCT03012828|11914328|FG002|NOT COMPLETED|Overall Study||2
10750845|NCT03012828|11914329|FG003|NOT COMPLETED|Overall Study||0
10750846|NCT03012828|11914330|FG004|NOT COMPLETED|Overall Study||2
10750847|NCT03012828|11914331|FG005|NOT COMPLETED|Overall Study||2
10750848|NCT03012841|11914347|FG000|STARTED|Overall Study||165
10750849|NCT03012841|11914348|FG001|STARTED|Overall Study||21
10750850|NCT03012841|11914347|FG000|COMPLETED|Overall Study||145
10750851|NCT03012841|11914348|FG001|COMPLETED|Overall Study||0
10750852|NCT03012841|11914347|FG000|NOT COMPLETED|Overall Study||20
10750853|NCT03012841|11914348|FG001|NOT COMPLETED|Overall Study||21
10750854|NCT03013985|11914355|FG000|STARTED|Overall Study||108
10750855|NCT03013985|11914356|FG001|STARTED|Overall Study||103
10750856|NCT03013985|11914355|FG000|COMPLETED|Overall Study||92
10750857|NCT03013985|11914356|FG001|COMPLETED|Overall Study||84
10750858|NCT03013985|11914355|FG000|NOT COMPLETED|Overall Study||16
10750859|NCT03013985|11914356|FG001|NOT COMPLETED|Overall Study||19
10750860|NCT03014011|11914362|FG000|STARTED|First Intervention||14
10750861|NCT03014011|11914363|FG001|STARTED|First Intervention||13
10750862|NCT03014011|11914362|FG000|COMPLETED|First Intervention||13
10750863|NCT03014011|11914363|FG001|COMPLETED|First Intervention||13
10750864|NCT03014011|11914362|FG000|NOT COMPLETED|First Intervention||1
10750865|NCT03014011|11914363|FG001|NOT COMPLETED|First Intervention||0
10750866|NCT03014011|11914362|FG000|STARTED|Washout||13
10750867|NCT03014011|11914363|FG001|STARTED|Washout||13
10750868|NCT03014011|11914362|FG000|COMPLETED|Washout||12
10750869|NCT03014011|11914363|FG001|COMPLETED|Washout||13
10750870|NCT03014011|11914362|FG000|NOT COMPLETED|Washout||1
10750871|NCT03014011|11914363|FG001|NOT COMPLETED|Washout||0
10750872|NCT03014011|11914362|FG000|STARTED|Second Intervention||12
10750873|NCT03014011|11914363|FG001|STARTED|Second Intervention||13
10750874|NCT03014011|11914362|FG000|COMPLETED|Second Intervention||12
10750875|NCT03014011|11914363|FG001|COMPLETED|Second Intervention||13
10750876|NCT03014011|11914362|FG000|NOT COMPLETED|Second Intervention||0
10750877|NCT03014011|11914363|FG001|NOT COMPLETED|Second Intervention||0
10750878|NCT03014180|11914369|FG000|STARTED|Overall Study||60
10750879|NCT03014180|11914369|FG000|COMPLETED|Overall Study||58
10750880|NCT03014180|11914369|FG000|NOT COMPLETED|Overall Study||2
10750881|NCT03014206|11914377|FG000|STARTED|Overall Study||696
10750882|NCT03014206|11914377|FG000|COMPLETED|Overall Study||684
10750883|NCT03014206|11914377|FG000|NOT COMPLETED|Overall Study||12
10750884|NCT03014453|11914381|FG000|STARTED|Overall Study||187
10750885|NCT03014453|11914381|FG000|COMPLETED|Overall Study||116
10750886|NCT03014453|11914381|FG000|NOT COMPLETED|Overall Study||71
10750887|NCT03014479|11914387|FG000|STARTED|Overall Study||110
10750888|NCT03014479|11914388|FG001|STARTED|Overall Study||109
10750889|NCT03014479|11914387|FG000|COMPLETED|Overall Study||110
10750890|NCT03014479|11914388|FG001|COMPLETED|Overall Study||105
10750891|NCT03014479|11914387|FG000|NOT COMPLETED|Overall Study||0
10750892|NCT03014479|11914388|FG001|NOT COMPLETED|Overall Study||4
10750893|NCT03014492|11914396|FG000|STARTED|Overall Study||44
10750894|NCT03014492|11914397|FG001|STARTED|Overall Study||28
10750895|NCT03014492|11914396|FG000|COMPLETED|Overall Study||44
10750896|NCT03014492|11914397|FG001|COMPLETED|Overall Study||28
10750897|NCT03014492|11914396|FG000|NOT COMPLETED|Overall Study||0
10750898|NCT03014492|11914397|FG001|NOT COMPLETED|Overall Study||0
10750899|NCT03014674|11914406|FG000|STARTED|Overall Study||85
10750900|NCT03014674|11914407|FG001|STARTED|Overall Study||79
10750901|NCT03014674|11914408|FG002|STARTED|Overall Study||80
10750902|NCT03014674|11914406|FG000|COMPLETED|Overall Study||84
10750903|NCT03014674|11914407|FG001|COMPLETED|Overall Study||79
10750904|NCT03014674|11914408|FG002|COMPLETED|Overall Study||80
10750905|NCT03014674|11914406|FG000|NOT COMPLETED|Overall Study||1
10750906|NCT03014674|11914407|FG001|NOT COMPLETED|Overall Study||0
10750907|NCT03014674|11914408|FG002|NOT COMPLETED|Overall Study||0
10750908|NCT03014700|11914418|FG000|STARTED|Overall Study||30
10750909|NCT03014700|11914419|FG001|STARTED|Overall Study||30
10750910|NCT03014700|11914418|FG000|COMPLETED|Overall Study||25
10750911|NCT03014700|11914419|FG001|COMPLETED|Overall Study||29
10750912|NCT03014700|11914418|FG000|NOT COMPLETED|Overall Study||5
10750913|NCT03014700|11914419|FG001|NOT COMPLETED|Overall Study||1
10750914|NCT03015116|11914428|FG000|STARTED|Overall Study||38
10750915|NCT03015116|11914429|FG001|STARTED|Overall Study||38
10819622|NCT00740597|11984134|FG000|STARTED|Overall Study||1
10819623|NCT00740597|11984134|FG000|COMPLETED|Overall Study||0
10819624|NCT00740597|11984134|FG000|NOT COMPLETED|Overall Study||1
10819625|NCT00737594|11984141|FG000|STARTED|Overall Study||0
10750916|NCT03015116|11914430|FG002|STARTED|Overall Study||38
10750917|NCT03015116|11914428|FG000|COMPLETED|Overall Study||31
10750918|NCT03015116|11914429|FG001|COMPLETED|Overall Study||36
10750919|NCT03015116|11914430|FG002|COMPLETED|Overall Study||36
10750920|NCT03015116|11914428|FG000|NOT COMPLETED|Overall Study||7
10750921|NCT03015116|11914429|FG001|NOT COMPLETED|Overall Study||2
10750922|NCT03015116|11914430|FG002|NOT COMPLETED|Overall Study||2
10750923|NCT03015181|11914447|FG000|STARTED|Overall Study||4
10750924|NCT03015181|11914448|FG001|STARTED|Overall Study||3
10750925|NCT03015181|11914449|FG002|STARTED|Overall Study||3
10750926|NCT03015181|11914450|FG003|STARTED|Overall Study||3
10750927|NCT03015181|11914451|FG004|STARTED|Overall Study||3
10750928|NCT03015181|11914452|FG005|STARTED|Overall Study||5
10750929|NCT03015181|11914453|FG006|STARTED|Overall Study||5
10750930|NCT03015181|11914447|FG000|Received VRC07-523LS Per Protocol|Overall Study||3
10750931|NCT03015181|11914448|FG001|Received VRC07-523LS Per Protocol|Overall Study||3
10750932|NCT03015181|11914449|FG002|Received VRC07-523LS Per Protocol|Overall Study||3
10750933|NCT03015181|11914450|FG003|Received VRC07-523LS Per Protocol|Overall Study||3
10750934|NCT03015181|11914451|FG004|Received VRC07-523LS Per Protocol|Overall Study||3
10750935|NCT03015181|11914452|FG005|Received VRC07-523LS Per Protocol|Overall Study||4
10750936|NCT03015181|11914453|FG006|Received VRC07-523LS Per Protocol|Overall Study||4
10750937|NCT03015181|11914447|FG000|Discontinued VRC07-523LS Administrations|Overall Study|One Group 1 subject decided not to receive the VRC07-523LS infusion|1
10750938|NCT03015181|11914448|FG001|Discontinued VRC07-523LS Administrations|Overall Study||0
10750939|NCT03015181|11914449|FG002|Discontinued VRC07-523LS Administrations|Overall Study||0
10750940|NCT03015181|11914450|FG003|Discontinued VRC07-523LS Administrations|Overall Study||0
10750941|NCT03015181|11914451|FG004|Discontinued VRC07-523LS Administrations|Overall Study||0
10750942|NCT03015181|11914452|FG005|Discontinued VRC07-523LS Administrations|Overall Study|One Group 6 subject received only 1 of 3 scheduled doses prior to withdrawing from the study|1
10750943|NCT03015181|11914453|FG006|Discontinued VRC07-523LS Administrations|Overall Study|One Group 7 subject received only 1 of 3 scheduled doses due to an unrelated intercurrent illness|1
10750944|NCT03015181|11914447|FG000|COMPLETED|Overall Study||3
10750945|NCT03015181|11914448|FG001|COMPLETED|Overall Study||3
10750946|NCT03015181|11914449|FG002|COMPLETED|Overall Study||3
10750947|NCT03015181|11914450|FG003|COMPLETED|Overall Study||3
10750948|NCT03015181|11914451|FG004|COMPLETED|Overall Study||3
10750949|NCT03015181|11914452|FG005|COMPLETED|Overall Study|Group 6 subject who received only 1 dose chose to withdraw from study after the first administration|4
10750950|NCT03015181|11914453|FG006|COMPLETED|Overall Study|Group 7 subject who received only 1 dose was withdrawn after unrelated intercurrent illness resolved|4
10750951|NCT03015181|11914447|FG000|NOT COMPLETED|Overall Study||1
10750952|NCT03015181|11914448|FG001|NOT COMPLETED|Overall Study||0
10750953|NCT03015181|11914449|FG002|NOT COMPLETED|Overall Study||0
10750954|NCT03015181|11914450|FG003|NOT COMPLETED|Overall Study||0
10750955|NCT03015181|11914451|FG004|NOT COMPLETED|Overall Study||0
10750956|NCT03015181|11914452|FG005|NOT COMPLETED|Overall Study||1
10750957|NCT03015181|11914453|FG006|NOT COMPLETED|Overall Study||1
10750958|NCT03015220|11914493|FG000|STARTED|Overall Study||131
10750959|NCT03015220|11914494|FG001|STARTED|Overall Study||132
10750960|NCT03015220|11914495|FG002|STARTED|Overall Study||130
10750961|NCT03015220|11914496|FG003|STARTED|Overall Study||65
10750962|NCT03015220|11914493|FG000|Full Analysis Set (FAS)|Overall Study||131
10750963|NCT03015220|11914494|FG001|Full Analysis Set (FAS)|Overall Study||132
10750964|NCT03015220|11914495|FG002|Full Analysis Set (FAS)|Overall Study||130
10750965|NCT03015220|11914496|FG003|Full Analysis Set (FAS)|Overall Study||65
10750966|NCT03015220|11914493|FG000|Safety Analysis Set (SAS)|Overall Study||131
10750967|NCT03015220|11914494|FG001|Safety Analysis Set (SAS)|Overall Study||132
10750968|NCT03015220|11914495|FG002|Safety Analysis Set (SAS)|Overall Study||130
10750969|NCT03015220|11914496|FG003|Safety Analysis Set (SAS)|Overall Study||65
10750970|NCT03015220|11914493|FG000|COMPLETED|Overall Study||128
10750971|NCT03015220|11914494|FG001|COMPLETED|Overall Study||130
10750972|NCT03015220|11914495|FG002|COMPLETED|Overall Study||127
10750973|NCT03015220|11914496|FG003|COMPLETED|Overall Study||63
10750974|NCT03015220|11914493|FG000|NOT COMPLETED|Overall Study||3
10750975|NCT03015220|11914494|FG001|NOT COMPLETED|Overall Study||2
10750976|NCT03015220|11914495|FG002|NOT COMPLETED|Overall Study||3
10750977|NCT03015220|11914496|FG003|NOT COMPLETED|Overall Study||2
10750978|NCT03015363|11914506|FG000|STARTED|Overall Study||37
10750979|NCT03015363|11914506|FG000|COMPLETED|Overall Study||20
10750980|NCT03015363|11914506|FG000|NOT COMPLETED|Overall Study||17
10750981|NCT03015532|11914518|FG000|STARTED|Overall Study||20
10750982|NCT03015532|11914519|FG001|STARTED|Overall Study||22
10750983|NCT03015532|11914520|FG002|STARTED|Overall Study||11
10750984|NCT03015532|11914521|FG003|STARTED|Overall Study||10
10750985|NCT03015532|11914522|FG004|STARTED|Overall Study||58
10750986|NCT03015532|11914523|FG005|STARTED|Overall Study||56
10750987|NCT03015532|11914524|FG006|STARTED|Overall Study||53
10750988|NCT03015532|11914525|FG007|STARTED|Overall Study||55
10750989|NCT03015532|11914518|FG000|COMPLETED|Overall Study||20
10819626|NCT00737594|11984142|FG001|STARTED|Overall Study||0
10819627|NCT00737594|11984143|FG002|STARTED|Overall Study||0
10819628|NCT00737594|11984141|FG000|COMPLETED|Overall Study||0
10819629|NCT00737594|11984142|FG001|COMPLETED|Overall Study||0
10819630|NCT00737594|11984143|FG002|COMPLETED|Overall Study||0
10819631|NCT00737594|11984141|FG000|NOT COMPLETED|Overall Study||0
10819632|NCT00737594|11984142|FG001|NOT COMPLETED|Overall Study||0
10819633|NCT00737594|11984143|FG002|NOT COMPLETED|Overall Study||0
10819634|NCT00737282|11984153|FG000|STARTED|Overall Study||175
10819635|NCT00737282|11984153|FG000|COMPLETED|Overall Study||0
10819636|NCT00737282|11984153|FG000|NOT COMPLETED|Overall Study||175
10819637|NCT00739882|11984161|FG000|STARTED|Double-blind Period||51
10819638|NCT00739882|11984162|FG001|STARTED|Double-blind Period||25
10819639|NCT00739882|11984161|FG000|COMPLETED|Double-blind Period||32
10819640|NCT00739882|11984162|FG001|COMPLETED|Double-blind Period||14
10819641|NCT00739882|11984161|FG000|NOT COMPLETED|Double-blind Period||19
10819642|NCT00739882|11984162|FG001|NOT COMPLETED|Double-blind Period||11
10819643|NCT00739882|11984161|FG000|STARTED|Open-label Period||17
10819644|NCT00739882|11984162|FG001|STARTED|Open-label Period||14
10750990|NCT03015532|11914519|FG001|COMPLETED|Overall Study||22
10750991|NCT03015532|11914520|FG002|COMPLETED|Overall Study||11
10750992|NCT03015532|11914521|FG003|COMPLETED|Overall Study||10
10750993|NCT03015532|11914522|FG004|COMPLETED|Overall Study||58
10750994|NCT03015532|11914523|FG005|COMPLETED|Overall Study||54
10750995|NCT03015532|11914524|FG006|COMPLETED|Overall Study||51
10750996|NCT03015532|11914525|FG007|COMPLETED|Overall Study||55
10750997|NCT03015532|11914518|FG000|NOT COMPLETED|Overall Study||0
10750998|NCT03015532|11914519|FG001|NOT COMPLETED|Overall Study||0
10750999|NCT03015532|11914520|FG002|NOT COMPLETED|Overall Study||0
10751000|NCT03015532|11914521|FG003|NOT COMPLETED|Overall Study||0
10751001|NCT03015532|11914522|FG004|NOT COMPLETED|Overall Study||0
10751002|NCT03015532|11914523|FG005|NOT COMPLETED|Overall Study||2
10751003|NCT03015532|11914524|FG006|NOT COMPLETED|Overall Study||2
10751004|NCT03015532|11914525|FG007|NOT COMPLETED|Overall Study||0
10751005|NCT03015649|11914545|FG000|STARTED|Overall Study||34
10751006|NCT03015649|11914545|FG000|COMPLETED|Overall Study||34
10751007|NCT03015649|11914545|FG000|NOT COMPLETED|Overall Study||0
10751008|NCT03015961|11914551|FG000|STARTED|Overall Study||18
10751009|NCT03015961|11914552|FG001|STARTED|Overall Study||20
10751010|NCT03015961|11914551|FG000|COMPLETED|Overall Study||18
10751011|NCT03015961|11914552|FG001|COMPLETED|Overall Study||18
10751012|NCT03015961|11914551|FG000|NOT COMPLETED|Overall Study||0
10751013|NCT03015961|11914552|FG001|NOT COMPLETED|Overall Study||2
10751014|NCT03016078|11914558|FG000|STARTED|Overall Study||21
10751015|NCT03016078|11914558|FG000|COMPLETED|Overall Study||19
10751016|NCT03016078|11914558|FG000|NOT COMPLETED|Overall Study||2
10751017|NCT03016325|11914570|FG000|STARTED|Treatment Period||48
10751018|NCT03016325|11914571|FG001|STARTED|Treatment Period||49
10751019|NCT03016325|11914572|FG002|STARTED|Treatment Period||71
10751020|NCT03016325|11914573|FG003|STARTED|Treatment Period||71
10751021|NCT03016325|11914574|FG004|STARTED|Treatment Period||72
10751022|NCT03016325|11914575|FG005|STARTED|Treatment Period||6
10751023|NCT03016325|11914576|FG006|STARTED|Treatment Period||6
10751024|NCT03016325|11914577|FG007|STARTED|Treatment Period||6
10751025|NCT03016325|11914570|FG000|COMPLETED|Treatment Period||48
10751026|NCT03016325|11914571|FG001|COMPLETED|Treatment Period||48
10751027|NCT03016325|11914572|FG002|COMPLETED|Treatment Period||70
10751028|NCT03016325|11914573|FG003|COMPLETED|Treatment Period||71
10751029|NCT03016325|11914574|FG004|COMPLETED|Treatment Period||70
10751030|NCT03016325|11914575|FG005|COMPLETED|Treatment Period||6
10751031|NCT03016325|11914576|FG006|COMPLETED|Treatment Period||6
10751032|NCT03016325|11914577|FG007|COMPLETED|Treatment Period||6
10751033|NCT03016325|11914570|FG000|NOT COMPLETED|Treatment Period||0
10751034|NCT03016325|11914571|FG001|NOT COMPLETED|Treatment Period||1
10751035|NCT03016325|11914572|FG002|NOT COMPLETED|Treatment Period||1
10751036|NCT03016325|11914573|FG003|NOT COMPLETED|Treatment Period||0
10751037|NCT03016325|11914574|FG004|NOT COMPLETED|Treatment Period||2
10751038|NCT03016325|11914575|FG005|NOT COMPLETED|Treatment Period||0
10751039|NCT03016325|11914576|FG006|NOT COMPLETED|Treatment Period||0
10751040|NCT03016325|11914577|FG007|NOT COMPLETED|Treatment Period||0
10751041|NCT03016325|11914570|FG000|STARTED|32-Day Follow-Up Period||48
10751042|NCT03016325|11914571|FG001|STARTED|32-Day Follow-Up Period||49
10751043|NCT03016325|11914572|FG002|STARTED|32-Day Follow-Up Period||71
10751044|NCT03016325|11914573|FG003|STARTED|32-Day Follow-Up Period||71
10751045|NCT03016325|11914574|FG004|STARTED|32-Day Follow-Up Period||72
10751046|NCT03016325|11914575|FG005|STARTED|32-Day Follow-Up Period||6
10751047|NCT03016325|11914576|FG006|STARTED|32-Day Follow-Up Period||6
10751048|NCT03016325|11914577|FG007|STARTED|32-Day Follow-Up Period||6
10751049|NCT03016325|11914570|FG000|COMPLETED|32-Day Follow-Up Period||44
10751050|NCT03016325|11914571|FG001|COMPLETED|32-Day Follow-Up Period||47
10751051|NCT03016325|11914572|FG002|COMPLETED|32-Day Follow-Up Period||62
10751052|NCT03016325|11914573|FG003|COMPLETED|32-Day Follow-Up Period||63
10819645|NCT00739882|11984161|FG000|COMPLETED|Open-label Period||7
10819646|NCT00739882|11984162|FG001|COMPLETED|Open-label Period||9
10819647|NCT00739882|11984161|FG000|NOT COMPLETED|Open-label Period||10
10819648|NCT00739882|11984162|FG001|NOT COMPLETED|Open-label Period||5
10819649|NCT00739024|11984172|FG000|STARTED|Overall Study||7
10819650|NCT00739024|11984173|FG001|STARTED|Overall Study||6
10819651|NCT00739024|11984172|FG000|COMPLETED|Overall Study||7
10819652|NCT00739024|11984173|FG001|COMPLETED|Overall Study||6
10819653|NCT00739024|11984172|FG000|NOT COMPLETED|Overall Study||0
10819654|NCT00739024|11984173|FG001|NOT COMPLETED|Overall Study||0
10819655|NCT00731770|11984181|FG000|STARTED|Overall Study||5
10819656|NCT00731770|11984182|FG001|STARTED|Overall Study||5
10819657|NCT00731770|11984181|FG000|COMPLETED|Overall Study||5
10819658|NCT00731770|11984182|FG001|COMPLETED|Overall Study||5
10819659|NCT00731770|11984181|FG000|NOT COMPLETED|Overall Study||0
10819660|NCT00731770|11984182|FG001|NOT COMPLETED|Overall Study||0
10819661|NCT00735254|11984194|FG000|STARTED|Overall Study||1
10819662|NCT00735254|11984195|FG001|STARTED|Overall Study||1
10819663|NCT00735254|11984196|FG002|STARTED|Overall Study||1
10819664|NCT00735254|11984197|FG003|STARTED|Overall Study||0
10819665|NCT00735254|11984194|FG000|COMPLETED|Overall Study||0
10819666|NCT00735254|11984195|FG001|COMPLETED|Overall Study||0
10819667|NCT00735254|11984196|FG002|COMPLETED|Overall Study||0
10751053|NCT03016325|11914574|FG004|COMPLETED|32-Day Follow-Up Period||64
10819668|NCT00735254|11984197|FG003|COMPLETED|Overall Study||0
10819669|NCT00735254|11984194|FG000|NOT COMPLETED|Overall Study||1
10819670|NCT00735254|11984195|FG001|NOT COMPLETED|Overall Study||1
10819671|NCT00735254|11984196|FG002|NOT COMPLETED|Overall Study||1
10751054|NCT03016325|11914575|FG005|COMPLETED|32-Day Follow-Up Period||6
10751055|NCT03016325|11914576|FG006|COMPLETED|32-Day Follow-Up Period||5
10751056|NCT03016325|11914577|FG007|COMPLETED|32-Day Follow-Up Period||6
10751057|NCT03016325|11914570|FG000|NOT COMPLETED|32-Day Follow-Up Period||4
10751058|NCT03016325|11914571|FG001|NOT COMPLETED|32-Day Follow-Up Period||2
10819672|NCT00735254|11984197|FG003|NOT COMPLETED|Overall Study||0
10819673|NCT00729365|11984210|FG000|STARTED|Overall Study||33
10819674|NCT00729365|11984211|FG001|STARTED|Overall Study||6
10819675|NCT00729365|11984212|FG002|STARTED|Overall Study||7
10819676|NCT00729365|11984210|FG000|COMPLETED|Overall Study|Study terminated|0
10819677|NCT00729365|11984211|FG001|COMPLETED|Overall Study|Study Terminated|0
10819678|NCT00729365|11984212|FG002|COMPLETED|Overall Study|Study terminated|0
10819679|NCT00729365|11984210|FG000|NOT COMPLETED|Overall Study||33
10819680|NCT00729365|11984211|FG001|NOT COMPLETED|Overall Study||6
10819681|NCT00729365|11984212|FG002|NOT COMPLETED|Overall Study||7
10819682|NCT00732680|11984222|FG000|STARTED|Overall Study||9
10819683|NCT00732680|11984222|FG000|COMPLETED|Overall Study||9
10819684|NCT00732680|11984222|FG000|NOT COMPLETED|Overall Study||0
10819685|NCT00726180|11984226|FG000|STARTED|Overall Study||1
10819686|NCT00726180|11984226|FG000|COMPLETED|Overall Study||1
10819687|NCT00726180|11984226|FG000|NOT COMPLETED|Overall Study||0
10819688|NCT00724282|11984230|FG000|STARTED|Overall Study||20
10819689|NCT00724282|11984230|FG000|COMPLETED|Overall Study||16
10819690|NCT00724282|11984230|FG000|NOT COMPLETED|Overall Study||4
10819691|NCT00730886|11984236|FG000|STARTED|Overall Study||2
10819692|NCT00730886|11984237|FG001|STARTED|Overall Study|no subjects enrolled in this arm. Study enrollment terminated early.|0
10819693|NCT00730886|11984236|FG000|COMPLETED|Overall Study||0
10819694|NCT00730886|11984237|FG001|COMPLETED|Overall Study|no subjects enrolled in this arm. Study enrollment terminated early.|0
10819695|NCT00730886|11984236|FG000|NOT COMPLETED|Overall Study||2
10819696|NCT00730886|11984237|FG001|NOT COMPLETED|Overall Study||0
10819697|NCT00728845|11984245|FG000|STARTED|Overall Study||8
10819698|NCT00728845|11984246|FG001|STARTED|Overall Study||0
10819699|NCT00728845|11984245|FG000|COMPLETED|Overall Study||8
10819700|NCT00728845|11984246|FG001|COMPLETED|Overall Study||0
10819701|NCT00728845|11984245|FG000|NOT COMPLETED|Overall Study||0
10819702|NCT00728845|11984246|FG001|NOT COMPLETED|Overall Study||0
10819703|NCT00726830|11984254|FG000|STARTED|Overall Study||1
10819704|NCT00726830|11984255|FG001|STARTED|Overall Study||0
10819705|NCT00726830|11984254|FG000|COMPLETED|Overall Study||1
10819706|NCT00726830|11984255|FG001|COMPLETED|Overall Study||0
10819707|NCT00726830|11984254|FG000|NOT COMPLETED|Overall Study||0
10819708|NCT00726830|11984255|FG001|NOT COMPLETED|Overall Study||0
10751059|NCT03016325|11914572|FG002|NOT COMPLETED|32-Day Follow-Up Period||9
10751060|NCT03016325|11914573|FG003|NOT COMPLETED|32-Day Follow-Up Period||8
10751061|NCT03016325|11914574|FG004|NOT COMPLETED|32-Day Follow-Up Period||8
10751062|NCT03016325|11914575|FG005|NOT COMPLETED|32-Day Follow-Up Period||0
10751063|NCT03016325|11914576|FG006|NOT COMPLETED|32-Day Follow-Up Period||1
10751064|NCT03016325|11914577|FG007|NOT COMPLETED|32-Day Follow-Up Period||0
10751065|NCT03016325|11914570|FG000|STARTED|182-Day Follow-Up Period||48
10751066|NCT03016325|11914571|FG001|STARTED|182-Day Follow-Up Period||49
10751067|NCT03016325|11914572|FG002|STARTED|182-Day Follow-Up Period||71
10751068|NCT03016325|11914573|FG003|STARTED|182-Day Follow-Up Period||71
10751069|NCT03016325|11914574|FG004|STARTED|182-Day Follow-Up Period||72
10751070|NCT03016325|11914575|FG005|STARTED|182-Day Follow-Up Period||6
10751071|NCT03016325|11914576|FG006|STARTED|182-Day Follow-Up Period||6
10751072|NCT03016325|11914577|FG007|STARTED|182-Day Follow-Up Period||6
10751073|NCT03016325|11914570|FG000|COMPLETED|182-Day Follow-Up Period||44
10751074|NCT03016325|11914571|FG001|COMPLETED|182-Day Follow-Up Period||45
10751075|NCT03016325|11914572|FG002|COMPLETED|182-Day Follow-Up Period||60
10751076|NCT03016325|11914573|FG003|COMPLETED|182-Day Follow-Up Period||58
10751077|NCT03016325|11914574|FG004|COMPLETED|182-Day Follow-Up Period||60
10751078|NCT03016325|11914575|FG005|COMPLETED|182-Day Follow-Up Period||1
10751079|NCT03016325|11914576|FG006|COMPLETED|182-Day Follow-Up Period||2
10751080|NCT03016325|11914577|FG007|COMPLETED|182-Day Follow-Up Period||1
10751081|NCT03016325|11914570|FG000|NOT COMPLETED|182-Day Follow-Up Period||4
10751082|NCT03016325|11914571|FG001|NOT COMPLETED|182-Day Follow-Up Period||4
10751083|NCT03016325|11914572|FG002|NOT COMPLETED|182-Day Follow-Up Period||11
10751084|NCT03016325|11914573|FG003|NOT COMPLETED|182-Day Follow-Up Period||13
10751085|NCT03016325|11914574|FG004|NOT COMPLETED|182-Day Follow-Up Period||12
10751086|NCT03016325|11914575|FG005|NOT COMPLETED|182-Day Follow-Up Period||5
10751087|NCT03016325|11914576|FG006|NOT COMPLETED|182-Day Follow-Up Period||4
10751088|NCT03016325|11914577|FG007|NOT COMPLETED|182-Day Follow-Up Period||5
10778600|NCT03358407|11940526|FG007|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
10778601|NCT03358407|11940527|FG008|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
10778602|NCT03358407|11940528|FG009|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
10778603|NCT03358407|11940519|FG000|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
10778604|NCT03358407|11940520|FG001|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
10778605|NCT03358407|11940521|FG002|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
10778606|NCT03358407|11940522|FG003|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
10778607|NCT03358407|11940523|FG004|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
10778608|NCT03358407|11940524|FG005|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
10778609|NCT03358407|11940525|FG006|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
10778610|NCT03358407|11940526|FG007|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
10778611|NCT03358407|11940527|FG008|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
10778612|NCT03358407|11940528|FG009|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
10778613|NCT03358407|11940519|FG000|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
10778614|NCT03358407|11940520|FG001|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
10778615|NCT03358407|11940521|FG002|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
10778616|NCT03358407|11940522|FG003|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
10778617|NCT03358407|11940523|FG004|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
10778618|NCT03358407|11940524|FG005|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
10778619|NCT03358407|11940525|FG006|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
10778620|NCT03358407|11940526|FG007|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
10778621|NCT03358407|11940527|FG008|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
10778622|NCT03358407|11940528|FG009|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
10778623|NCT03358407|11940519|FG000|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
10778624|NCT03358407|11940520|FG001|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
10778625|NCT03358407|11940521|FG002|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
10778626|NCT03358407|11940522|FG003|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
10778627|NCT03358407|11940523|FG004|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
10778628|NCT03358407|11940524|FG005|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
10778629|NCT03358407|11940525|FG006|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
10778630|NCT03358407|11940526|FG007|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
10778631|NCT03358407|11940527|FG008|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
10778632|NCT03358407|11940528|FG009|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
10778633|NCT03358407|11940519|FG000|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
10778634|NCT03358407|11940520|FG001|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
10778635|NCT03358407|11940521|FG002|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
10778636|NCT03358407|11940522|FG003|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
10778637|NCT03358407|11940523|FG004|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||1
10778638|NCT03358407|11940524|FG005|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
10778639|NCT03358407|11940525|FG006|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
10778640|NCT03358407|11940526|FG007|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
10778641|NCT03358407|11940527|FG008|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
10778642|NCT03358407|11940528|FG009|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
10778643|NCT03358407|11940519|FG000|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
10778644|NCT03358407|11940520|FG001|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
10778645|NCT03358407|11940521|FG002|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
10778646|NCT03358407|11940522|FG003|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
10778647|NCT03358407|11940523|FG004|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||1
10751089|NCT03016403|11914602|FG000|STARTED|Baseline||139
10751090|NCT03016403|11914603|FG001|STARTED|Baseline||147
10751091|NCT03016403|11914604|FG002|STARTED|Baseline||118
10751092|NCT03016403|11914605|FG003|STARTED|Baseline||131
10751093|NCT03016403|11914602|FG000|COMPLETED|Baseline||123
10751094|NCT03016403|11914603|FG001|COMPLETED|Baseline||120
10751095|NCT03016403|11914604|FG002|COMPLETED|Baseline||107
10751096|NCT03016403|11914605|FG003|COMPLETED|Baseline||97
10751097|NCT03016403|11914602|FG000|NOT COMPLETED|Baseline||16
10751098|NCT03016403|11914603|FG001|NOT COMPLETED|Baseline||27
10751099|NCT03016403|11914604|FG002|NOT COMPLETED|Baseline||11
10751100|NCT03016403|11914605|FG003|NOT COMPLETED|Baseline||34
10751101|NCT03016403|11914602|FG000|STARTED|6-week Follow-up|Anyone who had at least 1 follow-up after baseline.|123
10751102|NCT03016403|11914603|FG001|STARTED|6-week Follow-up||120
10751103|NCT03016403|11914604|FG002|STARTED|6-week Follow-up||107
10751104|NCT03016403|11914605|FG003|STARTED|6-week Follow-up||97
10751105|NCT03016403|11914602|FG000|COMPLETED|6-week Follow-up||120
10751106|NCT03016403|11914603|FG001|COMPLETED|6-week Follow-up||107
10751107|NCT03016403|11914604|FG002|COMPLETED|6-week Follow-up||103
10751108|NCT03016403|11914605|FG003|COMPLETED|6-week Follow-up||88
10751109|NCT03016403|11914602|FG000|NOT COMPLETED|6-week Follow-up||3
10751110|NCT03016403|11914603|FG001|NOT COMPLETED|6-week Follow-up||13
10751111|NCT03016403|11914604|FG002|NOT COMPLETED|6-week Follow-up||4
10751112|NCT03016403|11914605|FG003|NOT COMPLETED|6-week Follow-up||9
10751113|NCT03016403|11914602|FG000|STARTED|3-month Follow-up and 6-month Follow-up||120
10751114|NCT03016403|11914603|FG001|STARTED|3-month Follow-up and 6-month Follow-up||107
10751115|NCT03016403|11914604|FG002|STARTED|3-month Follow-up and 6-month Follow-up||103
10751116|NCT03016403|11914605|FG003|STARTED|3-month Follow-up and 6-month Follow-up||88
10751117|NCT03016403|11914602|FG000|COMPLETED|3-month Follow-up and 6-month Follow-up||108
10751118|NCT03016403|11914603|FG001|COMPLETED|3-month Follow-up and 6-month Follow-up||96
10751119|NCT03016403|11914604|FG002|COMPLETED|3-month Follow-up and 6-month Follow-up||95
10751120|NCT03016403|11914605|FG003|COMPLETED|3-month Follow-up and 6-month Follow-up||81
10751121|NCT03016403|11914602|FG000|NOT COMPLETED|3-month Follow-up and 6-month Follow-up||12
10751122|NCT03016403|11914603|FG001|NOT COMPLETED|3-month Follow-up and 6-month Follow-up||11
10751123|NCT03016403|11914604|FG002|NOT COMPLETED|3-month Follow-up and 6-month Follow-up||8
10751124|NCT03016403|11914605|FG003|NOT COMPLETED|3-month Follow-up and 6-month Follow-up||7
10751125|NCT03016598|11914619|FG000|STARTED|Overall Study||18
10751126|NCT03016598|11914620|FG001|STARTED|Overall Study||22
10751127|NCT03016598|11914619|FG000|COMPLETED|Overall Study||18
10751128|NCT03016598|11914620|FG001|COMPLETED|Overall Study||20
10751129|NCT03016598|11914619|FG000|NOT COMPLETED|Overall Study||0
10751130|NCT03016598|11914620|FG001|NOT COMPLETED|Overall Study||2
10751131|NCT03017079|11914628|FG000|STARTED|Overall Study||20
10751132|NCT03017079|11914629|FG001|STARTED|Overall Study||20
10751133|NCT03017079|11914628|FG000|COMPLETED|Overall Study||14
10819709|NCT00726037|11984261|FG000|STARTED|Overall Study||7
10819710|NCT00726037|11984261|FG000|COMPLETED|Overall Study||7
10819711|NCT00726037|11984261|FG000|NOT COMPLETED|Overall Study||0
10819712|NCT00729560|11984265|FG000|STARTED|Overall Study|Arm assignment can not be determined as study was ended prior to unblinding and no key found.|8
10819713|NCT00729560|11984265|FG000|COMPLETED|Overall Study||5
10819714|NCT00729560|11984265|FG000|NOT COMPLETED|Overall Study||3
10819715|NCT00716807|11984273|FG000|STARTED|Overall Study||8
10819716|NCT00716807|11984274|FG001|STARTED|Overall Study||5
10819717|NCT00716807|11984275|FG002|STARTED|Overall Study||18
10819718|NCT00716807|11984276|FG003|STARTED|Overall Study||15
10819719|NCT00716807|11984273|FG000|COMPLETED|Overall Study||8
10819720|NCT00716807|11984274|FG001|COMPLETED|Overall Study||5
10819721|NCT00716807|11984275|FG002|COMPLETED|Overall Study||18
10819722|NCT00716807|11984276|FG003|COMPLETED|Overall Study||15
10819723|NCT00716807|11984273|FG000|NOT COMPLETED|Overall Study||0
10819724|NCT00716807|11984274|FG001|NOT COMPLETED|Overall Study||0
10819725|NCT00716807|11984275|FG002|NOT COMPLETED|Overall Study||0
10819726|NCT00716807|11984276|FG003|NOT COMPLETED|Overall Study||0
10819727|NCT00714948|11984286|FG000|STARTED|Overall Study||2
10819728|NCT00714948|11984286|FG000|COMPLETED|Overall Study||0
10819729|NCT00714948|11984286|FG000|NOT COMPLETED|Overall Study||2
10819730|NCT00720343|11984290|FG000|STARTED|Overall Study||54
10819731|NCT00720343|11984290|FG000|COMPLETED|Overall Study|3 removed by physician. 3 unable to be determined; Columbia will never have access to this data.|48
10819732|NCT00720343|11984290|FG000|NOT COMPLETED|Overall Study||6
10819733|NCT00719914|11984298|FG000|STARTED|Overall Study||10
10819734|NCT00719914|11984299|FG001|STARTED|Overall Study||7
10819735|NCT00719914|11984298|FG000|COMPLETED|Overall Study||10
10819736|NCT00719914|11984299|FG001|COMPLETED|Overall Study||7
10819737|NCT00719914|11984298|FG000|NOT COMPLETED|Overall Study||0
10819738|NCT00719914|11984299|FG001|NOT COMPLETED|Overall Study||0
10819739|NCT00718640|11984305|FG000|STARTED|Overall Study||10
10819740|NCT00718640|11984305|FG000|COMPLETED|Overall Study||3
10819741|NCT00718640|11984305|FG000|NOT COMPLETED|Overall Study||7
10819742|NCT00720083|11984311|FG000|STARTED|Overall Study||17
10819743|NCT00720083|11984312|FG001|STARTED|Overall Study||15
10751134|NCT03017079|11914629|FG001|COMPLETED|Overall Study||14
10751135|NCT03017079|11914628|FG000|NOT COMPLETED|Overall Study||6
10819744|NCT00720083|11984311|FG000|COMPLETED|Overall Study|Subjects with data for the primary analysis are considered to have completed the study.|16
10819745|NCT00720083|11984312|FG001|COMPLETED|Overall Study||13
10819746|NCT00720083|11984311|FG000|NOT COMPLETED|Overall Study||1
10819747|NCT00720083|11984312|FG001|NOT COMPLETED|Overall Study||2
10819748|NCT00717275|11984318|FG000|STARTED|Overall Study||3
10751136|NCT03017079|11914629|FG001|NOT COMPLETED|Overall Study||6
10751137|NCT03017235|11914644|FG000|STARTED|Overall Study||456
10751138|NCT03017235|11914645|FG001|STARTED|Overall Study||461
10751139|NCT03017235|11914644|FG000|COMPLETED|Overall Study||444
10751140|NCT03017235|11914645|FG001|COMPLETED|Overall Study||447
10751141|NCT03017235|11914644|FG000|NOT COMPLETED|Overall Study||12
10751142|NCT03017235|11914645|FG001|NOT COMPLETED|Overall Study||14
10751143|NCT03017261|11914651|FG000|STARTED|6 Week Follow up||115
10751144|NCT03017261|11914651|FG000|COMPLETED|6 Week Follow up||115
10751145|NCT03017261|11914651|FG000|NOT COMPLETED|6 Week Follow up||0
10751146|NCT03017261|11914651|FG000|STARTED|3 Month Follow up||115
10751147|NCT03017261|11914651|FG000|COMPLETED|3 Month Follow up|1 failed to compete 3M imaging so only 114 have 3M data for tibial slope and KSS Objective Score.|115
10751148|NCT03017261|11914651|FG000|NOT COMPLETED|3 Month Follow up||0
10751149|NCT03017261|11914651|FG000|STARTED|6 Month Follow up||115
10751150|NCT03017261|11914651|FG000|COMPLETED|6 Month Follow up||106
10751151|NCT03017261|11914651|FG000|NOT COMPLETED|6 Month Follow up||9
10751152|NCT03017261|11914651|FG000|STARTED|12 Month Follow up||106
10751153|NCT03017261|11914651|FG000|COMPLETED|12 Month Follow up|1 failed to compete 12M imaging so only 58 have 12M data for KSS Objective Score.|59
10751154|NCT03017261|11914651|FG000|NOT COMPLETED|12 Month Follow up||47
10751155|NCT03017508|11914657|FG000|STARTED|Overall Study||12
10751156|NCT03017508|11914658|FG001|STARTED|Overall Study||10
10751157|NCT03017508|11914657|FG000|First Intervention (1 Day)|Overall Study||12
10751158|NCT03017508|11914658|FG001|First Intervention (1 Day)|Overall Study||10
10751159|NCT03017508|11914657|FG000|Washout (2-10 Days)|Overall Study||12
10751160|NCT03017508|11914658|FG001|Washout (2-10 Days)|Overall Study||10
10751161|NCT03017508|11914657|FG000|Second Intervention (1 Day)|Overall Study||12
10751162|NCT03017508|11914658|FG001|Second Intervention (1 Day)|Overall Study||10
10751163|NCT03017508|11914657|FG000|COMPLETED|Overall Study||12
10751164|NCT03017508|11914658|FG001|COMPLETED|Overall Study||10
10751165|NCT03017508|11914657|FG000|NOT COMPLETED|Overall Study||0
10751166|NCT03017508|11914658|FG001|NOT COMPLETED|Overall Study||0
10751167|NCT03017612|11914664|FG000|STARTED|Overall Study||13
10751168|NCT03017612|11914664|FG000|COMPLETED|Overall Study||11
10751169|NCT03017612|11914664|FG000|NOT COMPLETED|Overall Study||2
10751170|NCT03017846|11914668|FG000|STARTED|Overall Study||30
10751171|NCT03017846|11914668|FG000|COMPLETED|Overall Study||25
10751172|NCT03017846|11914668|FG000|NOT COMPLETED|Overall Study||5
10751173|NCT03017924|11914676|FG000|STARTED|Overall Study||12
10751174|NCT03017924|11914677|FG001|STARTED|Overall Study||11
10751175|NCT03017924|11914676|FG000|COMPLETED|Overall Study||10
10751176|NCT03017924|11914677|FG001|COMPLETED|Overall Study||8
10751177|NCT03017924|11914676|FG000|NOT COMPLETED|Overall Study||2
10751178|NCT03017924|11914677|FG001|NOT COMPLETED|Overall Study||3
10751179|NCT03017937|11914685|FG000|STARTED|Overall Study||155
10751180|NCT03017937|11914685|FG000|COMPLETED|Overall Study||155
10751181|NCT03017937|11914685|FG000|NOT COMPLETED|Overall Study||0
10751182|NCT03018028|11914695|FG000|STARTED|Overall Study||49
10751183|NCT03018028|11914696|FG001|STARTED|Overall Study||49
10751184|NCT03018028|11914697|FG002|STARTED|Overall Study||48
10751185|NCT03018028|11914698|FG003|STARTED|Overall Study||48
10751186|NCT03018028|11914699|FG004|STARTED|Overall Study||49
10751187|NCT03018028|11914695|FG000|Full Analysis Set (FAS)|Overall Study||49
10751188|NCT03018028|11914696|FG001|Full Analysis Set (FAS)|Overall Study||49
10751189|NCT03018028|11914697|FG002|Full Analysis Set (FAS)|Overall Study||48
10751190|NCT03018028|11914698|FG003|Full Analysis Set (FAS)|Overall Study||48
10751191|NCT03018028|11914699|FG004|Full Analysis Set (FAS)|Overall Study||49
10751192|NCT03018028|11914695|FG000|Safety Analysis Set (SAS)|Overall Study||49
10751193|NCT03018028|11914696|FG001|Safety Analysis Set (SAS)|Overall Study||49
10751194|NCT03018028|11914697|FG002|Safety Analysis Set (SAS)|Overall Study||48
10751195|NCT03018028|11914698|FG003|Safety Analysis Set (SAS)|Overall Study||48
10751196|NCT03018028|11914699|FG004|Safety Analysis Set (SAS)|Overall Study||49
10819749|NCT00717275|11984318|FG000|COMPLETED|Overall Study||0
10819750|NCT00717275|11984318|FG000|NOT COMPLETED|Overall Study||3
10819751|NCT00708734|11984322|FG000|STARTED|Overall Study|94 subjects were screened, 45 did not meet criteria, and 39 declined participation after screening.|10
10819752|NCT00708734|11984322|FG000|COMPLETED|Overall Study|Ten subjects enrolled, three completed the intervention and all follow up sessions.|3
10819753|NCT00708734|11984322|FG000|NOT COMPLETED|Overall Study||7
10819754|NCT00711087|11984328|FG000|STARTED|Overall Study||1
10819755|NCT00711087|11984329|FG001|STARTED|Overall Study||0
10819756|NCT00711087|11984328|FG000|COMPLETED|Overall Study||0
10819757|NCT00711087|11984329|FG001|COMPLETED|Overall Study||0
10819758|NCT00711087|11984328|FG000|NOT COMPLETED|Overall Study||1
10819759|NCT00711087|11984329|FG001|NOT COMPLETED|Overall Study||0
10819760|NCT00706797|11984337|FG000|STARTED|Overall Study||70
10819761|NCT00706797|11984338|FG001|STARTED|Overall Study||71
10819762|NCT00706797|11984337|FG000|Safety Population|Overall Study|Safety population=all randomly assigned subjects who had at least 1 dose of study treatment.|63
10819763|NCT00706797|11984338|FG001|Safety Population|Overall Study||71
10819764|NCT00706797|11984337|FG000|COMPLETED|Overall Study||1
10819765|NCT00706797|11984338|FG001|COMPLETED|Overall Study||0
10751197|NCT03018028|11914695|FG000|COMPLETED|Overall Study||46
10819766|NCT00706797|11984337|FG000|NOT COMPLETED|Overall Study||69
10819767|NCT00706797|11984338|FG001|NOT COMPLETED|Overall Study||71
10819768|NCT00713596|11984347|FG000|STARTED|Overall Study||9
10819769|NCT00713596|11984348|FG001|STARTED|Overall Study||8
10819770|NCT00713596|11984349|FG002|STARTED|Overall Study||8
10819771|NCT00713596|11984347|FG000|COMPLETED|Overall Study||7
10819772|NCT00713596|11984348|FG001|COMPLETED|Overall Study||5
10751198|NCT03018028|11914696|FG001|COMPLETED|Overall Study||49
10751199|NCT03018028|11914697|FG002|COMPLETED|Overall Study||47
10751200|NCT03018028|11914698|FG003|COMPLETED|Overall Study||46
10751201|NCT03018028|11914699|FG004|COMPLETED|Overall Study||49
10751202|NCT03018028|11914695|FG000|NOT COMPLETED|Overall Study||3
10819773|NCT00713596|11984349|FG002|COMPLETED|Overall Study||6
10819774|NCT00713596|11984347|FG000|NOT COMPLETED|Overall Study||2
10819775|NCT00713596|11984348|FG001|NOT COMPLETED|Overall Study||3
10819776|NCT00713596|11984349|FG002|NOT COMPLETED|Overall Study||2
10819777|NCT00703885|11984357|FG000|STARTED|Overall Study||16
10819778|NCT00703885|11984357|FG000|COMPLETED|Overall Study||16
10819779|NCT00703885|11984357|FG000|NOT COMPLETED|Overall Study||0
10819780|NCT00703092|11984362|FG000|STARTED|Overall Study||2
10819781|NCT00703092|11984362|FG000|COMPLETED|Overall Study||0
10819782|NCT00703092|11984362|FG000|NOT COMPLETED|Overall Study||2
10819783|NCT00713258|11984368|FG000|STARTED|Overall Study||41
10819784|NCT00713258|11984369|FG001|STARTED|Overall Study||34
10819785|NCT00713258|11984368|FG000|COMPLETED|Overall Study||36
10819786|NCT00713258|11984369|FG001|COMPLETED|Overall Study||28
10819787|NCT00713258|11984368|FG000|NOT COMPLETED|Overall Study||5
10819788|NCT00713258|11984369|FG001|NOT COMPLETED|Overall Study||6
10819789|NCT00706329|11984375|FG000|STARTED|Overall Study||25
10819790|NCT00706329|11984375|FG000|COMPLETED|Overall Study||25
10819791|NCT00706329|11984375|FG000|NOT COMPLETED|Overall Study||0
10819792|NCT00707434|11984379|FG000|STARTED|Overall Study||6
10819793|NCT00707434|11984379|FG000|COMPLETED|Overall Study||5
10819794|NCT00707434|11984379|FG000|NOT COMPLETED|Overall Study||1
10819795|NCT00707161|11984383|FG000|STARTED|Overall Study|3 deceased (1-Huntsman Cancer Institute, 2- LDS Hospital).|6
10819796|NCT00707161|11984383|FG000|COMPLETED|Overall Study||0
10819797|NCT00707161|11984383|FG000|NOT COMPLETED|Overall Study||6
10819798|NCT00704496|11984389|FG000|STARTED|Overall Study||0
10819799|NCT00704496|11984390|FG001|STARTED|Overall Study||0
10819800|NCT00704496|11984389|FG000|COMPLETED|Overall Study||0
10751203|NCT03018028|11914696|FG001|NOT COMPLETED|Overall Study||0
10751204|NCT03018028|11914697|FG002|NOT COMPLETED|Overall Study||1
10751205|NCT03018028|11914698|FG003|NOT COMPLETED|Overall Study||2
10751206|NCT03018028|11914699|FG004|NOT COMPLETED|Overall Study||0
10751207|NCT03018106|11914713|FG000|STARTED|Overall Study||0
10751208|NCT03018106|11914714|FG001|STARTED|Overall Study||1
10751209|NCT03018106|11914713|FG000|COMPLETED|Overall Study||0
10751210|NCT03018106|11914714|FG001|COMPLETED|Overall Study||0
10751211|NCT03018106|11914713|FG000|NOT COMPLETED|Overall Study||0
10751212|NCT03018106|11914714|FG001|NOT COMPLETED|Overall Study||1
10819801|NCT00704496|11984390|FG001|COMPLETED|Overall Study||0
10819802|NCT00704496|11984389|FG000|NOT COMPLETED|Overall Study||0
10819803|NCT00704496|11984390|FG001|NOT COMPLETED|Overall Study||0
10819804|NCT00708916|11984396|FG000|STARTED|Overall Study||12
10819805|NCT00708916|11984396|FG000|COMPLETED|Overall Study||8
10819806|NCT00708916|11984396|FG000|NOT COMPLETED|Overall Study||4
10751213|NCT03018223|11914718|FG000|STARTED|Overall Study||32
10819807|NCT00700778|11984401|FG000|STARTED|Overall Study||2
10819808|NCT00700778|11984401|FG000|COMPLETED|Overall Study||0
10819809|NCT00700778|11984401|FG000|NOT COMPLETED|Overall Study||2
10819810|NCT00699842|11984408|FG000|STARTED|Overall Study||3
10751214|NCT03018223|11914718|FG000|COMPLETED|Overall Study||32
10751215|NCT03018223|11914718|FG000|NOT COMPLETED|Overall Study||0
10751216|NCT03018249|11914724|FG000|STARTED|Overall Study||25
10751217|NCT03018249|11914725|FG001|STARTED|Overall Study||25
10751218|NCT03018249|11914724|FG000|COMPLETED|Overall Study||23
10751219|NCT03018249|11914725|FG001|COMPLETED|Overall Study||23
10819811|NCT00699842|11984409|FG001|STARTED|Overall Study||5
10819812|NCT00699842|11984410|FG002|STARTED|Overall Study||0
10819813|NCT00699842|11984408|FG000|COMPLETED|Overall Study||3
10819814|NCT00699842|11984409|FG001|COMPLETED|Overall Study||4
10819815|NCT00699842|11984410|FG002|COMPLETED|Overall Study||0
10819816|NCT00699842|11984408|FG000|NOT COMPLETED|Overall Study||0
10819817|NCT00699842|11984409|FG001|NOT COMPLETED|Overall Study||1
10819818|NCT00699842|11984410|FG002|NOT COMPLETED|Overall Study||0
10819819|NCT00702962|11984420|FG000|STARTED|Overall Study|One initiated treatment. Milestones not achieved due to premature closing due to low accrual.|1
10819820|NCT00702962|11984421|FG001|STARTED|Overall Study|Three treated. Milestone not met as Phase I closed prematurely as NCI research established the MTD.|3
10819821|NCT00702962|11984420|FG000|COMPLETED|Overall Study|The one participant off treatment after 2 doses due to concurrent health disorder.|0
10819822|NCT00702962|11984421|FG001|COMPLETED|Overall Study|Two completed all required cycles. One experienced progressive disease after 2 cycles|2
10819823|NCT00702962|11984420|FG000|NOT COMPLETED|Overall Study||1
10819824|NCT00702962|11984421|FG001|NOT COMPLETED|Overall Study||1
10819825|NCT00703534|11984431|FG000|STARTED|Overall Study||235
10819826|NCT00703534|11984432|FG001|STARTED|Overall Study||243
10819827|NCT00703534|11984431|FG000|COMPLETED|Overall Study||205
10819828|NCT00703534|11984432|FG001|COMPLETED|Overall Study||218
10819829|NCT00703534|11984431|FG000|NOT COMPLETED|Overall Study||30
10819830|NCT00703534|11984432|FG001|NOT COMPLETED|Overall Study||25
10819831|NCT00698009|11984438|FG000|STARTED|Overall Study||1
10819832|NCT00698009|11984438|FG000|COMPLETED|Overall Study||0
10819833|NCT00698009|11984438|FG000|NOT COMPLETED|Overall Study||1
10819834|NCT00703339|11984442|FG000|STARTED|Overall Study||1
10819835|NCT00703339|11984442|FG000|COMPLETED|Overall Study||1
10819836|NCT00703339|11984442|FG000|NOT COMPLETED|Overall Study||0
10819837|NCT00691444|11984449|FG000|STARTED|Overall Study||0
10819838|NCT00691444|11984450|FG001|STARTED|Overall Study||0
10819839|NCT00691444|11984451|FG002|STARTED|Overall Study||0
10819840|NCT00691444|11984449|FG000|COMPLETED|Overall Study||0
10819841|NCT00691444|11984450|FG001|COMPLETED|Overall Study||0
10819842|NCT00691444|11984451|FG002|COMPLETED|Overall Study||0
10819843|NCT00691444|11984449|FG000|NOT COMPLETED|Overall Study||0
10819844|NCT00691444|11984450|FG001|NOT COMPLETED|Overall Study||0
10819845|NCT00691444|11984451|FG002|NOT COMPLETED|Overall Study||0
10819846|NCT00702702|11984462|FG000|STARTED|Overall Study||56
10819847|NCT00702702|11984462|FG000|COMPLETED|Overall Study||0
10819848|NCT00702702|11984462|FG000|NOT COMPLETED|Overall Study||56
10819849|NCT00693628|11984472|FG000|STARTED|Overall Study|No data is available indicating to which group patients were assigned.|0
10819850|NCT00693628|11984473|FG001|STARTED|Overall Study|No data is available indicating to which group patients were assigned .|0
10819851|NCT00693628|11984472|FG000|COMPLETED|Overall Study|Only 4 patients enrolled in study. No data indicating their group assignment|0
10819852|NCT00693628|11984473|FG001|COMPLETED|Overall Study|Only 4 patients enrolled in study. No data indicating their group assignment.|0
10819853|NCT00693628|11984472|FG000|NOT COMPLETED|Overall Study||0
10819854|NCT00693628|11984473|FG001|NOT COMPLETED|Overall Study||0
10819855|NCT00699413|11984481|FG000|STARTED|Overall Study||4
10819856|NCT00699413|11984482|FG001|STARTED|Overall Study||4
10819857|NCT00699413|11984481|FG000|COMPLETED|Overall Study||0
10819858|NCT00699413|11984482|FG001|COMPLETED|Overall Study||0
10819859|NCT00699413|11984481|FG000|NOT COMPLETED|Overall Study||4
10819860|NCT00699413|11984482|FG001|NOT COMPLETED|Overall Study||4
10819861|NCT00691652|11984488|FG000|STARTED|Overall Study||2
10819862|NCT00691652|11984488|FG000|COMPLETED|Overall Study||1
10819863|NCT00691652|11984488|FG000|NOT COMPLETED|Overall Study||1
10819864|NCT00686972|11984492|FG000|STARTED|Overall Study||51
10819865|NCT00686972|11984492|FG000|COMPLETED|Overall Study||0
10819866|NCT00686972|11984492|FG000|NOT COMPLETED|Overall Study||51
10819867|NCT00693017|11984498|FG000|STARTED|Overall Study||2
10819868|NCT00693017|11984499|FG001|STARTED|Overall Study||2
10819869|NCT00693017|11984498|FG000|COMPLETED|Overall Study||0
10819870|NCT00693017|11984499|FG001|COMPLETED|Overall Study||0
10819871|NCT00693017|11984498|FG000|NOT COMPLETED|Overall Study||2
10819872|NCT00693017|11984499|FG001|NOT COMPLETED|Overall Study||2
10819873|NCT00691574|11984507|FG000|STARTED|Overall Study||0
10819874|NCT00691574|11984508|FG001|STARTED|Overall Study||0
10819875|NCT00691574|11984507|FG000|COMPLETED|Overall Study||0
10819876|NCT00691574|11984508|FG001|COMPLETED|Overall Study||0
10819877|NCT00691574|11984507|FG000|NOT COMPLETED|Overall Study||0
10751220|NCT03018249|11914724|FG000|NOT COMPLETED|Overall Study||2
10751221|NCT03018249|11914725|FG001|NOT COMPLETED|Overall Study||2
10751222|NCT03018340|11914733|FG000|STARTED|Overall Study||52
10751223|NCT03018340|11914734|FG001|STARTED|Overall Study||155
10751224|NCT03018340|11914733|FG000|COMPLETED|Overall Study||44
10751225|NCT03018340|11914734|FG001|COMPLETED|Overall Study||125
10751226|NCT03018340|11914733|FG000|NOT COMPLETED|Overall Study||8
10751227|NCT03018340|11914734|FG001|NOT COMPLETED|Overall Study||30
10751228|NCT03018691|11914747|FG000|STARTED|Overall Study||24
10751229|NCT03018691|11914748|FG001|STARTED|Overall Study||25
10751230|NCT03018691|11914749|FG002|STARTED|Overall Study||24
10751231|NCT03018691|11914747|FG000|COMPLETED|Overall Study||22
10751232|NCT03018691|11914748|FG001|COMPLETED|Overall Study||24
10751233|NCT03018691|11914749|FG002|COMPLETED|Overall Study||17
10751234|NCT03018691|11914747|FG000|NOT COMPLETED|Overall Study||2
10751235|NCT03018691|11914748|FG001|NOT COMPLETED|Overall Study||1
10751236|NCT03018691|11914749|FG002|NOT COMPLETED|Overall Study||7
10751237|NCT03018925|11914759|FG000|STARTED|Overall Study||15
10751238|NCT03018925|11914759|FG000|COMPLETED|Overall Study||15
10751239|NCT03018925|11914759|FG000|NOT COMPLETED|Overall Study||0
10751240|NCT03018938|11914786|FG000|STARTED|Overall Study||404
10751241|NCT03018938|11914787|FG001|STARTED|Overall Study||410
10751242|NCT03018938|11914786|FG000|Received at Least 1 Dose of Study Drug|Overall Study||404
10751243|NCT03018938|11914787|FG001|Received at Least 1 Dose of Study Drug|Overall Study||410
10751244|NCT03018938|11914786|FG000|COMPLETED|Overall Study||338
10751245|NCT03018938|11914787|FG001|COMPLETED|Overall Study||325
10751246|NCT03018938|11914786|FG000|NOT COMPLETED|Overall Study||66
10751247|NCT03018938|11914787|FG001|NOT COMPLETED|Overall Study||85
10751248|NCT03019055|11914797|FG000|STARTED|Overall Study||0
10751249|NCT03019055|11914798|FG001|STARTED|Overall Study||3
10751250|NCT03019055|11914799|FG002|STARTED|Overall Study||3
10751251|NCT03019055|11914800|FG003|STARTED|Overall Study||20
10751252|NCT03019055|11914797|FG000|COMPLETED|Overall Study||0
10751253|NCT03019055|11914798|FG001|COMPLETED|Overall Study||3
10751254|NCT03019055|11914799|FG002|COMPLETED|Overall Study||3
10751255|NCT03019055|11914800|FG003|COMPLETED|Overall Study||20
10751256|NCT03019055|11914797|FG000|NOT COMPLETED|Overall Study||0
10751257|NCT03019055|11914798|FG001|NOT COMPLETED|Overall Study||0
10751258|NCT03019055|11914799|FG002|NOT COMPLETED|Overall Study||0
10751259|NCT03019055|11914800|FG003|NOT COMPLETED|Overall Study||0
10751260|NCT03019107|11914812|FG000|STARTED|Overall Study||1
10751261|NCT03019107|11914813|FG001|STARTED|Overall Study||0
10751262|NCT03019107|11914812|FG000|COMPLETED|Overall Study||1
10751263|NCT03019107|11914813|FG001|COMPLETED|Overall Study||0
10751264|NCT03019107|11914812|FG000|NOT COMPLETED|Overall Study||0
10751265|NCT03019107|11914813|FG001|NOT COMPLETED|Overall Study||0
10751266|NCT03019289|11914828|FG000|STARTED|Overall Study||5
10751267|NCT03019289|11914829|FG001|STARTED|Overall Study||1
10751268|NCT03019289|11914830|FG002|STARTED|Overall Study||3
10751269|NCT03019289|11914831|FG003|STARTED|Overall Study||2
10751270|NCT03019289|11914832|FG004|STARTED|Overall Study||1
10751271|NCT03019289|11914833|FG005|STARTED|Overall Study||1
10751272|NCT03019289|11914834|FG006|STARTED|Overall Study||3
10751273|NCT03019289|11914835|FG007|STARTED|Overall Study||4
10751274|NCT03019289|11914836|FG008|STARTED|Overall Study||3
10751275|NCT03019289|11914828|FG000|COMPLETED|Overall Study||3
10751276|NCT03019289|11914829|FG001|COMPLETED|Overall Study||1
10751277|NCT03019289|11914830|FG002|COMPLETED|Overall Study||3
10751278|NCT03019289|11914831|FG003|COMPLETED|Overall Study||2
10751279|NCT03019289|11914832|FG004|COMPLETED|Overall Study||1
10751280|NCT03019289|11914833|FG005|COMPLETED|Overall Study||1
10751281|NCT03019289|11914834|FG006|COMPLETED|Overall Study||3
10751282|NCT03019289|11914835|FG007|COMPLETED|Overall Study||4
10751283|NCT03019289|11914836|FG008|COMPLETED|Overall Study||2
10751284|NCT03019289|11914828|FG000|NOT COMPLETED|Overall Study||2
10751285|NCT03019289|11914829|FG001|NOT COMPLETED|Overall Study||0
10751286|NCT03019289|11914830|FG002|NOT COMPLETED|Overall Study||0
10751287|NCT03019289|11914831|FG003|NOT COMPLETED|Overall Study||0
10751288|NCT03019289|11914832|FG004|NOT COMPLETED|Overall Study||0
10751289|NCT03019289|11914833|FG005|NOT COMPLETED|Overall Study||0
10751290|NCT03019289|11914834|FG006|NOT COMPLETED|Overall Study||0
10751291|NCT03019289|11914835|FG007|NOT COMPLETED|Overall Study||0
10751292|NCT03019289|11914836|FG008|NOT COMPLETED|Overall Study||1
10751293|NCT03019458|11914859|FG000|STARTED|Overall Study||24
10751294|NCT03019458|11914860|FG001|STARTED|Overall Study||26
10819878|NCT00691574|11984508|FG001|NOT COMPLETED|Overall Study||0
10819879|NCT00692094|11984518|FG000|STARTED|Overall Study||0
10751295|NCT03019458|11914859|FG000|COMPLETED|Overall Study||24
10751296|NCT03019458|11914860|FG001|COMPLETED|Overall Study||25
10751297|NCT03019458|11914859|FG000|NOT COMPLETED|Overall Study||0
10751298|NCT03019458|11914860|FG001|NOT COMPLETED|Overall Study||1
10751299|NCT03019549|11914868|FG000|STARTED|Period 1||42
10751300|NCT03019549|11914868|FG000|Received 1 Dose of Study Drug|Period 1||42
10751301|NCT03019549|11914868|FG000|COMPLETED|Period 1||42
10751302|NCT03019549|11914868|FG000|NOT COMPLETED|Period 1||0
10751303|NCT03019549|11914868|FG000|STARTED|Washout||42
10751304|NCT03019549|11914868|FG000|COMPLETED|Washout||31
10751305|NCT03019549|11914868|FG000|NOT COMPLETED|Washout||11
10751306|NCT03019549|11914868|FG000|STARTED|Period 2||31
10819880|NCT00692094|11984519|FG001|STARTED|Overall Study||0
10819881|NCT00692094|11984520|FG002|STARTED|Overall Study||0
10751307|NCT03019549|11914868|FG000|Received at Least 1 Dose of Study Drug|Period 2||29
10751308|NCT03019549|11914868|FG000|COMPLETED|Period 2||26
10751309|NCT03019549|11914868|FG000|NOT COMPLETED|Period 2||5
10751310|NCT03019627|11914879|FG000|STARTED|Overall Study||100
10751311|NCT03019627|11914880|FG001|STARTED|Overall Study||50
10751312|NCT03019627|11914879|FG000|COMPLETED|Overall Study||85
10751313|NCT03019627|11914880|FG001|COMPLETED|Overall Study||42
10751314|NCT03019627|11914879|FG000|NOT COMPLETED|Overall Study||15
10751315|NCT03019627|11914880|FG001|NOT COMPLETED|Overall Study||8
10751316|NCT03019744|11914888|FG000|STARTED|Overall Study||38
10751317|NCT03019744|11914889|FG001|STARTED|Overall Study||44
10751318|NCT03019744|11914888|FG000|COMPLETED|Overall Study||32
10751319|NCT03019744|11914889|FG001|COMPLETED|Overall Study||36
10751320|NCT03019744|11914888|FG000|NOT COMPLETED|Overall Study||6
10751321|NCT03019744|11914889|FG001|NOT COMPLETED|Overall Study||8
10751322|NCT03019783|11914897|FG000|STARTED|Overall Study||29
10751323|NCT03019783|11914898|FG001|STARTED|Overall Study||31
10751324|NCT03019783|11914897|FG000|COMPLETED|Overall Study||29
10751325|NCT03019783|11914898|FG001|COMPLETED|Overall Study||31
10751326|NCT03019783|11914897|FG000|NOT COMPLETED|Overall Study||0
10751327|NCT03019783|11914898|FG001|NOT COMPLETED|Overall Study||0
10751328|NCT03019796|11914904|FG000|STARTED|First Intervention Drug Tests||20
10751329|NCT03019796|11914905|FG001|STARTED|First Intervention Drug Tests||20
10751330|NCT03019796|11914904|FG000|COMPLETED|First Intervention Drug Tests||20
10751331|NCT03019796|11914905|FG001|COMPLETED|First Intervention Drug Tests||20
10751332|NCT03019796|11914904|FG000|NOT COMPLETED|First Intervention Drug Tests||0
10751333|NCT03019796|11914905|FG001|NOT COMPLETED|First Intervention Drug Tests||0
10751334|NCT03019796|11914904|FG000|STARTED|Second Intervention Training (4 Months)||20
10751335|NCT03019796|11914905|FG001|STARTED|Second Intervention Training (4 Months)||20
10751336|NCT03019796|11914904|FG000|COMPLETED|Second Intervention Training (4 Months)||19
10751337|NCT03019796|11914905|FG001|COMPLETED|Second Intervention Training (4 Months)||19
10751338|NCT03019796|11914904|FG000|NOT COMPLETED|Second Intervention Training (4 Months)||1
10751339|NCT03019796|11914905|FG001|NOT COMPLETED|Second Intervention Training (4 Months)||1
10751340|NCT03019796|11914904|FG000|STARTED|Third Intervention Drug Test||19
10751341|NCT03019796|11914905|FG001|STARTED|Third Intervention Drug Test||19
10751342|NCT03019796|11914904|FG000|COMPLETED|Third Intervention Drug Test||19
10751343|NCT03019796|11914905|FG001|COMPLETED|Third Intervention Drug Test||19
10751344|NCT03019796|11914904|FG000|NOT COMPLETED|Third Intervention Drug Test||0
10751345|NCT03019796|11914905|FG001|NOT COMPLETED|Third Intervention Drug Test||0
10751346|NCT03019887|11914912|FG000|STARTED|Overall Study||139
10751347|NCT03019887|11914912|FG000|COMPLETED|Overall Study||130
10751348|NCT03019887|11914912|FG000|NOT COMPLETED|Overall Study||9
10751349|NCT03019939|11914916|FG000|STARTED|Overall Study||65
10751350|NCT03019939|11914916|FG000|COMPLETED|Overall Study||65
10751351|NCT03019939|11914916|FG000|NOT COMPLETED|Overall Study||0
10751352|NCT03019965|11914922|FG000|STARTED|Overall Study||211
10751353|NCT03019965|11914923|FG001|STARTED|Overall Study||215
10751354|NCT03019965|11914922|FG000|COMPLETED|Overall Study||201
10751355|NCT03019965|11914923|FG001|COMPLETED|Overall Study||202
10751356|NCT03019965|11914922|FG000|NOT COMPLETED|Overall Study||10
10751357|NCT03019965|11914923|FG001|NOT COMPLETED|Overall Study||13
10751358|NCT03020004|11914929|FG000|STARTED|Overall Study||70
10751359|NCT03020004|11914929|FG000|COMPLETED|Overall Study||69
10751360|NCT03020004|11914929|FG000|NOT COMPLETED|Overall Study||1
10751361|NCT03020069|11914935|FG000|STARTED|Overall Study||9
10751362|NCT03020069|11914936|FG001|STARTED|Overall Study||4
10751363|NCT03020069|11914935|FG000|COMPLETED|Overall Study||9
10751364|NCT03020069|11914936|FG001|COMPLETED|Overall Study||3
10751365|NCT03020069|11914935|FG000|NOT COMPLETED|Overall Study||0
10751366|NCT03020069|11914936|FG001|NOT COMPLETED|Overall Study||1
10751367|NCT03020082|11914942|FG000|STARTED|Overall Study||141
10751368|NCT03020082|11914942|FG000|COMPLETED|Overall Study||138
10751369|NCT03020082|11914942|FG000|NOT COMPLETED|Overall Study||3
10751370|NCT03020095|11914946|FG000|STARTED|Overall Study||38
10751371|NCT03020095|11914946|FG000|COMPLETED|Overall Study||37
10751372|NCT03020095|11914946|FG000|NOT COMPLETED|Overall Study||1
10751373|NCT03020407|11914952|FG000|STARTED|Overall Study||105
10751374|NCT03020407|11914953|FG001|STARTED|Overall Study||106
10751375|NCT03020407|11914952|FG000|COMPLETED|Overall Study||101
10751376|NCT03020407|11914953|FG001|COMPLETED|Overall Study||101
10751377|NCT03020407|11914952|FG000|NOT COMPLETED|Overall Study||4
10751378|NCT03020407|11914953|FG001|NOT COMPLETED|Overall Study||5
10751379|NCT03020472|11914959|FG000|STARTED|Overall Study||6
10751380|NCT03020472|11914959|FG000|COMPLETED|Overall Study||6
10751381|NCT03020472|11914959|FG000|NOT COMPLETED|Overall Study||0
10751382|NCT03020498|11914966|FG000|STARTED|Overall Study||14
10751383|NCT03020498|11914967|FG001|STARTED|Overall Study||41
10751384|NCT03020498|11914968|FG002|STARTED|Overall Study||36
10751385|NCT03020498|11914966|FG000|COMPLETED|Overall Study||14
10819882|NCT00692094|11984521|FG003|STARTED|Overall Study||0
10751386|NCT03020498|11914967|FG001|COMPLETED|Overall Study||38
10751387|NCT03020498|11914968|FG002|COMPLETED|Overall Study||36
10751388|NCT03020498|11914966|FG000|NOT COMPLETED|Overall Study||0
10751389|NCT03020498|11914967|FG001|NOT COMPLETED|Overall Study||3
10751390|NCT03020498|11914968|FG002|NOT COMPLETED|Overall Study||0
10751391|NCT03020524|11914979|FG000|STARTED|Overall Study||3
10751392|NCT03020524|11914980|FG001|STARTED|Overall Study||3
10751393|NCT03020524|11914981|FG002|STARTED|Overall Study||3
10751394|NCT03020524|11914979|FG000|COMPLETED|Overall Study||3
10751395|NCT03020524|11914980|FG001|COMPLETED|Overall Study||3
10751396|NCT03020524|11914981|FG002|COMPLETED|Overall Study||3
10751397|NCT03020524|11914979|FG000|NOT COMPLETED|Overall Study||0
10751398|NCT03020524|11914980|FG001|NOT COMPLETED|Overall Study||0
10751399|NCT03020524|11914981|FG002|NOT COMPLETED|Overall Study||0
10751400|NCT03020537|11914991|FG000|STARTED|Overall Study||1
10751401|NCT03020537|11914992|FG001|STARTED|Overall Study||7
10751402|NCT03020537|11914991|FG000|COMPLETED|Overall Study||1
10819883|NCT00692094|11984518|FG000|COMPLETED|Overall Study||0
10819884|NCT00692094|11984519|FG001|COMPLETED|Overall Study||0
10819885|NCT00692094|11984520|FG002|COMPLETED|Overall Study||0
10751403|NCT03020537|11914992|FG001|COMPLETED|Overall Study||7
10819886|NCT00692094|11984521|FG003|COMPLETED|Overall Study||0
10751404|NCT03020537|11914991|FG000|NOT COMPLETED|Overall Study||0
10751405|NCT03020537|11914992|FG001|NOT COMPLETED|Overall Study||0
10751406|NCT03020550|11915000|FG000|STARTED|Overall Study||8
10751407|NCT03020550|11915001|FG001|STARTED|Overall Study||16
10751408|NCT03020550|11915000|FG000|COMPLETED|Overall Study||8
10751409|NCT03020550|11915001|FG001|COMPLETED|Overall Study||16
10751410|NCT03020550|11915000|FG000|NOT COMPLETED|Overall Study||0
10751411|NCT03020550|11915001|FG001|NOT COMPLETED|Overall Study||0
10751412|NCT03020576|11915009|FG000|STARTED|Overall Study||15
10751413|NCT03020576|11915010|FG001|STARTED|Overall Study||16
10751414|NCT03020576|11915009|FG000|COMPLETED|Overall Study||14
10751415|NCT03020576|11915010|FG001|COMPLETED|Overall Study||14
10751416|NCT03020576|11915009|FG000|NOT COMPLETED|Overall Study||1
10751417|NCT03020576|11915010|FG001|NOT COMPLETED|Overall Study||2
10819887|NCT00692094|11984518|FG000|NOT COMPLETED|Overall Study||0
10819888|NCT00692094|11984519|FG001|NOT COMPLETED|Overall Study||0
10819889|NCT00692094|11984520|FG002|NOT COMPLETED|Overall Study||0
10819890|NCT00692094|11984521|FG003|NOT COMPLETED|Overall Study||0
10819891|NCT00689884|11984531|FG000|STARTED|Overall Study||7
10819892|NCT00689884|11984531|FG000|COMPLETED|Overall Study||7
10819893|NCT00689884|11984531|FG000|NOT COMPLETED|Overall Study||0
10819894|NCT00692003|11984538|FG000|STARTED|Overall Study||5
10819895|NCT00692003|11984539|FG001|STARTED|Overall Study||1
10819896|NCT00692003|11984538|FG000|COMPLETED|Overall Study||0
10819897|NCT00692003|11984539|FG001|COMPLETED|Overall Study||0
10819898|NCT00692003|11984538|FG000|NOT COMPLETED|Overall Study||5
10819899|NCT00692003|11984539|FG001|NOT COMPLETED|Overall Study||1
10819900|NCT00678288|11984547|FG000|STARTED|Overall Study||10
10819901|NCT00678288|11984548|FG001|STARTED|Overall Study||6
10819902|NCT00678288|11984547|FG000|COMPLETED|Overall Study||0
10819903|NCT00678288|11984548|FG001|COMPLETED|Overall Study||0
10819904|NCT00678288|11984547|FG000|NOT COMPLETED|Overall Study||10
10819905|NCT00678288|11984548|FG001|NOT COMPLETED|Overall Study||6
10819906|NCT00676026|11984554|FG000|STARTED|Overall Study||8
10819907|NCT00676026|11984554|FG000|COMPLETED|Overall Study||8
10819908|NCT00676026|11984554|FG000|NOT COMPLETED|Overall Study||0
10819909|NCT00689052|11984560|FG000|STARTED|Overall Study||31
10819910|NCT00689052|11984561|FG001|STARTED|Overall Study||30
10819911|NCT00689052|11984560|FG000|COMPLETED|Overall Study||0
10819912|NCT00689052|11984561|FG001|COMPLETED|Overall Study||0
10819913|NCT00689052|11984560|FG000|NOT COMPLETED|Overall Study||31
10819914|NCT00689052|11984561|FG001|NOT COMPLETED|Overall Study||30
10819915|NCT00678574|11984571|FG000|STARTED|Overall Study||18
10819916|NCT00678574|11984572|FG001|STARTED|Overall Study||27
10819917|NCT00678574|11984571|FG000|COMPLETED|Overall Study||18
10819918|NCT00678574|11984572|FG001|COMPLETED|Overall Study||27
10819919|NCT00678574|11984571|FG000|NOT COMPLETED|Overall Study||0
10819920|NCT00678574|11984572|FG001|NOT COMPLETED|Overall Study||0
10819921|NCT00683917|11984581|FG000|STARTED|Overall Study||10
10819922|NCT00683917|11984581|FG000|COMPLETED|Overall Study||0
10819923|NCT00683917|11984581|FG000|NOT COMPLETED|Overall Study||10
10819924|NCT00688935|11984589|FG000|STARTED|Overall Study||0
10819925|NCT00688935|11984589|FG000|COMPLETED|Overall Study||0
10819926|NCT00688935|11984589|FG000|NOT COMPLETED|Overall Study||0
10819927|NCT00685880|11984595|FG000|STARTED|Overall Study||0
10819928|NCT00685880|11984596|FG001|STARTED|Overall Study||2
10819929|NCT00685880|11984595|FG000|COMPLETED|Overall Study||0
10819930|NCT00685880|11984596|FG001|COMPLETED|Overall Study||2
10819931|NCT00685880|11984595|FG000|NOT COMPLETED|Overall Study||0
10819932|NCT00685880|11984596|FG001|NOT COMPLETED|Overall Study||0
10819933|NCT00686036|11984604|FG000|STARTED|Overall Study||9
10819934|NCT00686036|11984605|FG001|STARTED|Overall Study||8
10819935|NCT00686036|11984604|FG000|COMPLETED|Overall Study||0
10819936|NCT00686036|11984605|FG001|COMPLETED|Overall Study||2
10819937|NCT00686036|11984604|FG000|NOT COMPLETED|Overall Study||9
10819938|NCT00686036|11984605|FG001|NOT COMPLETED|Overall Study||6
10819939|NCT00681044|11984611|FG000|STARTED|Overall Study||4
10819940|NCT00681044|11984611|FG000|COMPLETED|Overall Study||4
10819941|NCT00681044|11984611|FG000|NOT COMPLETED|Overall Study||0
10819942|NCT00676455|11984615|FG000|STARTED|Overall Study||14
10819943|NCT00676455|11984615|FG000|COMPLETED|Overall Study||14
10819944|NCT00676455|11984615|FG000|NOT COMPLETED|Overall Study||0
10819945|NCT00684255|11984619|FG000|STARTED|Overall Study||1
10819946|NCT00684255|11984619|FG000|COMPLETED|Overall Study||1
10819947|NCT00684255|11984619|FG000|NOT COMPLETED|Overall Study||0
10819948|NCT00683787|11984627|FG000|STARTED|Overall Study||3
10819949|NCT00683787|11984628|FG001|STARTED|Overall Study||3
10819950|NCT00683787|11984629|FG002|STARTED|Overall Study||2
10819951|NCT00683787|11984627|FG000|COMPLETED|Overall Study||0
10819952|NCT00683787|11984628|FG001|COMPLETED|Overall Study||0
10819953|NCT00683787|11984629|FG002|COMPLETED|Overall Study||0
10819954|NCT00683787|11984627|FG000|NOT COMPLETED|Overall Study||3
10819955|NCT00683787|11984628|FG001|NOT COMPLETED|Overall Study||3
10819956|NCT00683787|11984629|FG002|NOT COMPLETED|Overall Study||2
10819957|NCT00679926|11984637|FG000|STARTED|Overall Study||15
10819958|NCT00679926|11984637|FG000|COMPLETED|Overall Study||2
10751418|NCT03020615|11915019|FG000|STARTED|Overall Study||26
10751419|NCT03020615|11915020|FG001|STARTED|Overall Study||25
10751420|NCT03020615|11915021|FG002|STARTED|Overall Study||7
10751421|NCT03020615|11915019|FG000|COMPLETED|Overall Study||19
10751422|NCT03020615|11915020|FG001|COMPLETED|Overall Study||23
10751423|NCT03020615|11915021|FG002|COMPLETED|Overall Study||0
10819959|NCT00679926|11984637|FG000|NOT COMPLETED|Overall Study||13
10751424|NCT03020615|11915019|FG000|NOT COMPLETED|Overall Study||7
10751425|NCT03020615|11915020|FG001|NOT COMPLETED|Overall Study||2
10751426|NCT03020615|11915021|FG002|NOT COMPLETED|Overall Study||7
10751427|NCT03020641|11915034|FG000|STARTED|Overall Study||50
10751428|NCT03020641|11915035|FG001|STARTED|Overall Study||50
10751429|NCT03020641|11915034|FG000|COMPLETED|Overall Study||48
10751430|NCT03020641|11915035|FG001|COMPLETED|Overall Study||47
10751431|NCT03020641|11915034|FG000|NOT COMPLETED|Overall Study||2
10751432|NCT03020641|11915035|FG001|NOT COMPLETED|Overall Study||3
10819960|NCT00678041|11984644|FG000|STARTED|Overall Study||5
10819961|NCT00678041|11984645|FG001|STARTED|Overall Study||5
10819962|NCT00678041|11984644|FG000|COMPLETED|Overall Study||0
10819963|NCT00678041|11984645|FG001|COMPLETED|Overall Study||0
10819964|NCT00678041|11984644|FG000|NOT COMPLETED|Overall Study||5
10819965|NCT00678041|11984645|FG001|NOT COMPLETED|Overall Study||5
10819966|NCT00680316|11984654|FG000|STARTED|Overall Study||1
10819967|NCT00680316|11984655|FG001|STARTED|Overall Study||2
10819968|NCT00680316|11984654|FG000|COMPLETED|Overall Study||1
10819969|NCT00680316|11984655|FG001|COMPLETED|Overall Study||2
10819970|NCT00680316|11984654|FG000|NOT COMPLETED|Overall Study||0
10819971|NCT00680316|11984655|FG001|NOT COMPLETED|Overall Study||0
10819972|NCT00681629|11984663|FG000|STARTED|Overall Study|It was planned to recruit 100 patient|5
10819973|NCT00681629|11984664|FG001|STARTED|Overall Study|It was planned to recruit 100 patient|2
10819974|NCT00681629|11984663|FG000|COMPLETED|Overall Study||0
10819975|NCT00681629|11984664|FG001|COMPLETED|Overall Study||0
10819976|NCT00681629|11984663|FG000|NOT COMPLETED|Overall Study||5
10819977|NCT00681629|11984664|FG001|NOT COMPLETED|Overall Study||2
10819978|NCT00669461|11984670|FG000|STARTED|Overall Study||1
10819979|NCT00669461|11984670|FG000|COMPLETED|Overall Study||1
10819980|NCT00669461|11984670|FG000|NOT COMPLETED|Overall Study||0
10819981|NCT00671606|11984675|FG000|STARTED|Overall Study||5
10819982|NCT00671606|11984675|FG000|COMPLETED|Overall Study||5
10819983|NCT00671606|11984675|FG000|NOT COMPLETED|Overall Study||0
10819984|NCT00673309|11984689|FG000|STARTED|Overall Study||64
10819985|NCT00673309|11984690|FG001|STARTED|Overall Study||14
10819986|NCT00673309|11984691|FG002|STARTED|Overall Study||14
10819987|NCT00673309|11984692|FG003|STARTED|Overall Study||25
10819988|NCT00673309|11984693|FG004|STARTED|Overall Study||18
10819989|NCT00673309|11984694|FG005|STARTED|Overall Study||35
10819990|NCT00673309|11984695|FG006|STARTED|Overall Study||14
10819991|NCT00673309|11984696|FG007|STARTED|Overall Study||13
10819992|NCT00673309|11984697|FG008|STARTED|Overall Study||17
10819993|NCT00673309|11984698|FG009|STARTED|Overall Study||30
10819994|NCT00673309|11984689|FG000|COMPLETED|Overall Study||64
10819995|NCT00673309|11984690|FG001|COMPLETED|Overall Study||14
10819996|NCT00673309|11984691|FG002|COMPLETED|Overall Study||14
10819997|NCT00673309|11984692|FG003|COMPLETED|Overall Study||25
10819998|NCT00673309|11984693|FG004|COMPLETED|Overall Study||18
10819999|NCT00673309|11984694|FG005|COMPLETED|Overall Study||35
10820000|NCT00673309|11984695|FG006|COMPLETED|Overall Study||14
10820001|NCT00673309|11984696|FG007|COMPLETED|Overall Study||13
10820002|NCT00673309|11984697|FG008|COMPLETED|Overall Study||17
10820003|NCT00673309|11984698|FG009|COMPLETED|Overall Study||30
10820004|NCT00673309|11984689|FG000|NOT COMPLETED|Overall Study||0
10820005|NCT00673309|11984690|FG001|NOT COMPLETED|Overall Study||0
10820006|NCT00673309|11984691|FG002|NOT COMPLETED|Overall Study||0
10820007|NCT00673309|11984692|FG003|NOT COMPLETED|Overall Study||0
10820008|NCT00673309|11984693|FG004|NOT COMPLETED|Overall Study||0
10820009|NCT00673309|11984694|FG005|NOT COMPLETED|Overall Study||0
10820010|NCT00673309|11984695|FG006|NOT COMPLETED|Overall Study||0
10820011|NCT00673309|11984696|FG007|NOT COMPLETED|Overall Study||0
10820012|NCT00673309|11984697|FG008|NOT COMPLETED|Overall Study||0
10820013|NCT00673309|11984698|FG009|NOT COMPLETED|Overall Study||0
10820014|NCT00672178|11984711|FG000|STARTED|Overall Study||1
10820015|NCT00672178|11984711|FG000|COMPLETED|Overall Study||1
10820016|NCT00672178|11984711|FG000|NOT COMPLETED|Overall Study||0
10820017|NCT00673595|11984717|FG000|STARTED|Overall Study||8
10820018|NCT00673595|11984718|FG001|STARTED|Overall Study||11
10820019|NCT00673595|11984717|FG000|COMPLETED|Overall Study||8
10820020|NCT00673595|11984718|FG001|COMPLETED|Overall Study||11
10820021|NCT00673595|11984717|FG000|NOT COMPLETED|Overall Study||0
10820022|NCT00673595|11984718|FG001|NOT COMPLETED|Overall Study||0
10820023|NCT00673361|11984724|FG000|STARTED|Overall Study||9
10820024|NCT00673361|11984724|FG000|COMPLETED|Overall Study||7
10820025|NCT00673361|11984724|FG000|NOT COMPLETED|Overall Study||2
10820026|NCT00670631|11984728|FG000|STARTED|Overall Study||0
10820027|NCT00670631|11984728|FG000|COMPLETED|Overall Study||0
10820028|NCT00670631|11984728|FG000|NOT COMPLETED|Overall Study||0
10820029|NCT00668785|11984733|FG000|STARTED|Overall Study||6
10820030|NCT00668785|11984733|FG000|COMPLETED|Overall Study||6
10820031|NCT00668785|11984733|FG000|NOT COMPLETED|Overall Study||0
10820032|NCT00673179|11984741|FG000|STARTED|Overall Study||7
10820033|NCT00673179|11984742|FG001|STARTED|Overall Study||0
10820034|NCT00673179|11984741|FG000|COMPLETED|Overall Study||4
10751433|NCT03020719|11915046|FG000|STARTED|Overall Study||30
10751434|NCT03020719|11915047|FG001|STARTED|Overall Study||30
10751435|NCT03020719|11915046|FG000|COMPLETED|Overall Study||30
10751436|NCT03020719|11915047|FG001|COMPLETED|Overall Study||28
10751437|NCT03020719|11915046|FG000|NOT COMPLETED|Overall Study||0
10820035|NCT00673179|11984742|FG001|COMPLETED|Overall Study||0
10820036|NCT00673179|11984741|FG000|NOT COMPLETED|Overall Study||3
10820037|NCT00673179|11984742|FG001|NOT COMPLETED|Overall Study||0
10820038|NCT00668265|11984750|FG000|STARTED|Overall Study||9
10751438|NCT03020719|11915047|FG001|NOT COMPLETED|Overall Study||2
10751439|NCT03020745|11915061|FG000|STARTED|Part 1 (Up to 60 Days)||3
10751440|NCT03020745|11915062|FG001|STARTED|Part 1 (Up to 60 Days)||3
10751441|NCT03020745|11915063|FG002|STARTED|Part 1 (Up to 60 Days)|No participants were enrolled in this arm as per decision made by the dose escalation committee.|0
10751442|NCT03020745|11915064|FG003|STARTED|Part 1 (Up to 60 Days)||6
10751443|NCT03020745|11915065|FG004|STARTED|Part 1 (Up to 60 Days)|No participants were enrolled in this arm as per decision made by the dose escalation committee.|0
10751444|NCT03020745|11915066|FG005|STARTED|Part 1 (Up to 60 Days)||0
10751445|NCT03020745|11915067|FG006|STARTED|Part 1 (Up to 60 Days)||0
10751446|NCT03020745|11915068|FG007|STARTED|Part 1 (Up to 60 Days)||0
10751447|NCT03020745|11915069|FG008|STARTED|Part 1 (Up to 60 Days)||0
10751448|NCT03020745|11915070|FG009|STARTED|Part 1 (Up to 60 Days)||0
10751449|NCT03020745|11915061|FG000|COMPLETED|Part 1 (Up to 60 Days)||3
10751450|NCT03020745|11915062|FG001|COMPLETED|Part 1 (Up to 60 Days)||3
10751451|NCT03020745|11915063|FG002|COMPLETED|Part 1 (Up to 60 Days)||0
10751452|NCT03020745|11915064|FG003|COMPLETED|Part 1 (Up to 60 Days)||6
10751453|NCT03020745|11915065|FG004|COMPLETED|Part 1 (Up to 60 Days)||0
10751454|NCT03020745|11915066|FG005|COMPLETED|Part 1 (Up to 60 Days)||0
10751455|NCT03020745|11915067|FG006|COMPLETED|Part 1 (Up to 60 Days)||0
10751456|NCT03020745|11915068|FG007|COMPLETED|Part 1 (Up to 60 Days)||0
10751457|NCT03020745|11915069|FG008|COMPLETED|Part 1 (Up to 60 Days)||0
10751458|NCT03020745|11915070|FG009|COMPLETED|Part 1 (Up to 60 Days)||0
10751459|NCT03020745|11915061|FG000|NOT COMPLETED|Part 1 (Up to 60 Days)||0
10751460|NCT03020745|11915062|FG001|NOT COMPLETED|Part 1 (Up to 60 Days)||0
10751461|NCT03020745|11915063|FG002|NOT COMPLETED|Part 1 (Up to 60 Days)||0
10751462|NCT03020745|11915064|FG003|NOT COMPLETED|Part 1 (Up to 60 Days)||0
10751463|NCT03020745|11915065|FG004|NOT COMPLETED|Part 1 (Up to 60 Days)||0
10751464|NCT03020745|11915066|FG005|NOT COMPLETED|Part 1 (Up to 60 Days)||0
10751465|NCT03020745|11915067|FG006|NOT COMPLETED|Part 1 (Up to 60 Days)||0
10751466|NCT03020745|11915068|FG007|NOT COMPLETED|Part 1 (Up to 60 Days)||0
10751467|NCT03020745|11915069|FG008|NOT COMPLETED|Part 1 (Up to 60 Days)||0
10751468|NCT03020745|11915070|FG009|NOT COMPLETED|Part 1 (Up to 60 Days)||0
10751469|NCT03020745|11915061|FG000|STARTED|Part 2 (Up to 169 Days)||0
10751470|NCT03020745|11915062|FG001|STARTED|Part 2 (Up to 169 Days)||0
10751471|NCT03020745|11915063|FG002|STARTED|Part 2 (Up to 169 Days)||0
10751472|NCT03020745|11915064|FG003|STARTED|Part 2 (Up to 169 Days)||0
10751473|NCT03020745|11915065|FG004|STARTED|Part 2 (Up to 169 Days)||0
10751474|NCT03020745|11915066|FG005|STARTED|Part 2 (Up to 169 Days)||10
10751475|NCT03020745|11915067|FG006|STARTED|Part 2 (Up to 169 Days)||6
10751476|NCT03020745|11915068|FG007|STARTED|Part 2 (Up to 169 Days)||20
10751477|NCT03020745|11915069|FG008|STARTED|Part 2 (Up to 169 Days)||15
10751478|NCT03020745|11915070|FG009|STARTED|Part 2 (Up to 169 Days)||15
10751479|NCT03020745|11915061|FG000|COMPLETED|Part 2 (Up to 169 Days)||0
10751480|NCT03020745|11915062|FG001|COMPLETED|Part 2 (Up to 169 Days)||0
10820039|NCT00668265|11984751|FG001|STARTED|Overall Study||5
10820040|NCT00668265|11984750|FG000|COMPLETED|Overall Study|The PI left, no records avaialable; the number of subjects who completed the study is not known|0
10820041|NCT00668265|11984751|FG001|COMPLETED|Overall Study|The PI left, no records avaialable; the number of subjects who completed the study is not known|0
10820042|NCT00668265|11984750|FG000|NOT COMPLETED|Overall Study||9
10820043|NCT00668265|11984751|FG001|NOT COMPLETED|Overall Study||5
10820044|NCT00660348|11984761|FG000|STARTED|Overall Study||1
10820045|NCT00660348|11984762|FG001|STARTED|Overall Study||0
10820046|NCT00660348|11984761|FG000|COMPLETED|Overall Study||0
10820047|NCT00660348|11984762|FG001|COMPLETED|Overall Study||0
10820048|NCT00660348|11984761|FG000|NOT COMPLETED|Overall Study||1
10820049|NCT00660348|11984762|FG001|NOT COMPLETED|Overall Study||0
10820050|NCT00664066|11984768|FG000|STARTED|Overall Study||3
10820051|NCT00664066|11984768|FG000|COMPLETED|Overall Study||0
10820052|NCT00664066|11984768|FG000|NOT COMPLETED|Overall Study||3
10820053|NCT00667017|11984772|FG000|STARTED|Overall Study||1
10820054|NCT00667017|11984772|FG000|COMPLETED|Overall Study||0
10820055|NCT00667017|11984772|FG000|NOT COMPLETED|Overall Study||1
10820056|NCT00665444|11984776|FG000|STARTED|Overall Study||3
10820057|NCT00665444|11984776|FG000|COMPLETED|Overall Study||1
10820058|NCT00665444|11984776|FG000|NOT COMPLETED|Overall Study||2
10751481|NCT03020745|11915063|FG002|COMPLETED|Part 2 (Up to 169 Days)||0
10751482|NCT03020745|11915064|FG003|COMPLETED|Part 2 (Up to 169 Days)||0
10751483|NCT03020745|11915065|FG004|COMPLETED|Part 2 (Up to 169 Days)||0
10751484|NCT03020745|11915066|FG005|COMPLETED|Part 2 (Up to 169 Days)||10
10751485|NCT03020745|11915067|FG006|COMPLETED|Part 2 (Up to 169 Days)||6
10751486|NCT03020745|11915068|FG007|COMPLETED|Part 2 (Up to 169 Days)||19
10820059|NCT00656916|11984782|FG000|STARTED|Overall Study||1
10820060|NCT00656916|11984783|FG001|STARTED|Overall Study||0
10820061|NCT00656916|11984782|FG000|COMPLETED|Overall Study||1
10820062|NCT00656916|11984783|FG001|COMPLETED|Overall Study||0
10820063|NCT00656916|11984782|FG000|NOT COMPLETED|Overall Study||0
10820064|NCT00656916|11984783|FG001|NOT COMPLETED|Overall Study||0
10751487|NCT03020745|11915069|FG008|COMPLETED|Part 2 (Up to 169 Days)||14
10751488|NCT03020745|11915070|FG009|COMPLETED|Part 2 (Up to 169 Days)||15
10751489|NCT03020745|11915061|FG000|NOT COMPLETED|Part 2 (Up to 169 Days)||0
10751490|NCT03020745|11915062|FG001|NOT COMPLETED|Part 2 (Up to 169 Days)||0
10751491|NCT03020745|11915063|FG002|NOT COMPLETED|Part 2 (Up to 169 Days)||0
10751492|NCT03020745|11915064|FG003|NOT COMPLETED|Part 2 (Up to 169 Days)||0
10751493|NCT03020745|11915065|FG004|NOT COMPLETED|Part 2 (Up to 169 Days)||0
10751494|NCT03020745|11915066|FG005|NOT COMPLETED|Part 2 (Up to 169 Days)||0
10751495|NCT03020745|11915067|FG006|NOT COMPLETED|Part 2 (Up to 169 Days)||0
10751496|NCT03020745|11915068|FG007|NOT COMPLETED|Part 2 (Up to 169 Days)||1
10751497|NCT03020745|11915069|FG008|NOT COMPLETED|Part 2 (Up to 169 Days)||1
10751498|NCT03020745|11915070|FG009|NOT COMPLETED|Part 2 (Up to 169 Days)||0
10751499|NCT03020745|11915061|FG000|STARTED|Part 2:Optional FU (Up to 450 Days)||0
10751500|NCT03020745|11915062|FG001|STARTED|Part 2:Optional FU (Up to 450 Days)||0
10751501|NCT03020745|11915063|FG002|STARTED|Part 2:Optional FU (Up to 450 Days)||0
10751502|NCT03020745|11915064|FG003|STARTED|Part 2:Optional FU (Up to 450 Days)||0
10751503|NCT03020745|11915065|FG004|STARTED|Part 2:Optional FU (Up to 450 Days)||0
10751504|NCT03020745|11915066|FG005|STARTED|Part 2:Optional FU (Up to 450 Days)||10
10751505|NCT03020745|11915067|FG006|STARTED|Part 2:Optional FU (Up to 450 Days)|1 participant didn't enter into optional follow-up period.|5
10751506|NCT03020745|11915068|FG007|STARTED|Part 2:Optional FU (Up to 450 Days)|2 participants didn't enter into optional follow-up period.|17
10751507|NCT03020745|11915069|FG008|STARTED|Part 2:Optional FU (Up to 450 Days)|1 participant did not enter into optional follow-up period|13
10751508|NCT03020745|11915070|FG009|STARTED|Part 2:Optional FU (Up to 450 Days)||15
10751509|NCT03020745|11915061|FG000|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
10751510|NCT03020745|11915062|FG001|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
10751511|NCT03020745|11915063|FG002|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
10751512|NCT03020745|11915064|FG003|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
10751513|NCT03020745|11915065|FG004|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
10751514|NCT03020745|11915066|FG005|COMPLETED|Part 2:Optional FU (Up to 450 Days)||9
10751515|NCT03020745|11915067|FG006|COMPLETED|Part 2:Optional FU (Up to 450 Days)||5
10751516|NCT03020745|11915068|FG007|COMPLETED|Part 2:Optional FU (Up to 450 Days)||17
10751517|NCT03020745|11915069|FG008|COMPLETED|Part 2:Optional FU (Up to 450 Days)||10
10751518|NCT03020745|11915070|FG009|COMPLETED|Part 2:Optional FU (Up to 450 Days)||15
10751519|NCT03020745|11915061|FG000|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
10751520|NCT03020745|11915062|FG001|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
10751521|NCT03020745|11915063|FG002|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
10751522|NCT03020745|11915064|FG003|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
10751523|NCT03020745|11915065|FG004|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
10751524|NCT03020745|11915066|FG005|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||1
10751525|NCT03020745|11915067|FG006|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
10751526|NCT03020745|11915068|FG007|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
10751527|NCT03020745|11915069|FG008|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||3
10751528|NCT03020745|11915070|FG009|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
10751529|NCT03020888|11915094|FG000|STARTED|Overall Study||120
10751530|NCT03020888|11915094|FG000|COMPLETED|Overall Study||107
10751531|NCT03020888|11915094|FG000|NOT COMPLETED|Overall Study||13
10751532|NCT03020966|11915100|FG000|STARTED|Overall Study||77
10751533|NCT03020966|11915101|FG001|STARTED|Overall Study||77
10751534|NCT03020966|11915100|FG000|COMPLETED|Overall Study||75
10751535|NCT03020966|11915101|FG001|COMPLETED|Overall Study||77
10751536|NCT03020966|11915100|FG000|NOT COMPLETED|Overall Study||2
10751537|NCT03020966|11915101|FG001|NOT COMPLETED|Overall Study||0
10751538|NCT03020992|11915107|FG000|STARTED|Overall Study||89
10751539|NCT03020992|11915107|FG000|COMPLETED|Overall Study||83
10751540|NCT03020992|11915107|FG000|NOT COMPLETED|Overall Study||6
10751541|NCT03021005|11915114|FG000|STARTED|Overall Study||102
10751542|NCT03021005|11915115|FG001|STARTED|Overall Study||98
10751543|NCT03021005|11915114|FG000|COMPLETED|Overall Study||63
10751544|NCT03021005|11915115|FG001|COMPLETED|Overall Study||72
10751545|NCT03021005|11915114|FG000|NOT COMPLETED|Overall Study||39
10751546|NCT03021005|11915115|FG001|NOT COMPLETED|Overall Study||26
10751547|NCT03021018|11915124|FG000|STARTED|Overall Study||16
10751548|NCT03021018|11915125|FG001|STARTED|Overall Study||15
10751549|NCT03021018|11915126|FG002|STARTED|Overall Study||15
10751550|NCT03021018|11915124|FG000|COMPLETED|Overall Study||14
10751551|NCT03021018|11915125|FG001|COMPLETED|Overall Study||15
10751552|NCT03021018|11915126|FG002|COMPLETED|Overall Study||15
10751553|NCT03021018|11915124|FG000|NOT COMPLETED|Overall Study||2
10751554|NCT03021018|11915125|FG001|NOT COMPLETED|Overall Study||0
10751555|NCT03021018|11915126|FG002|NOT COMPLETED|Overall Study||0
10751556|NCT03021187|11915138|FG000|STARTED|Overall Study||184
10751557|NCT03021187|11915139|FG001|STARTED|Overall Study||182
10751558|NCT03021187|11915140|FG002|STARTED|Overall Study||181
10751559|NCT03021187|11915141|FG003|STARTED|Overall Study||184
10751560|NCT03021187|11915138|FG000|Exposed|Overall Study||184
10751561|NCT03021187|11915139|FG001|Exposed|Overall Study||181
10751562|NCT03021187|11915140|FG002|Exposed|Overall Study||181
10751563|NCT03021187|11915141|FG003|Exposed|Overall Study||184
10751564|NCT03021187|11915138|FG000|Full Analysis Set (FAS)|Overall Study||184
10751565|NCT03021187|11915139|FG001|Full Analysis Set (FAS)|Overall Study||182
10751566|NCT03021187|11915140|FG002|Full Analysis Set (FAS)|Overall Study||181
10751567|NCT03021187|11915141|FG003|Full Analysis Set (FAS)|Overall Study||184
10751568|NCT03021187|11915138|FG000|Safety Analysis Set (SAS)|Overall Study||184
10751569|NCT03021187|11915139|FG001|Safety Analysis Set (SAS)|Overall Study||181
10751570|NCT03021187|11915140|FG002|Safety Analysis Set (SAS)|Overall Study||181
10751571|NCT03021187|11915141|FG003|Safety Analysis Set (SAS)|Overall Study||184
10751572|NCT03021187|11915138|FG000|COMPLETED|Overall Study||174
10751573|NCT03021187|11915139|FG001|COMPLETED|Overall Study||173
10751574|NCT03021187|11915140|FG002|COMPLETED|Overall Study||175
10751575|NCT03021187|11915141|FG003|COMPLETED|Overall Study||175
10751576|NCT03021187|11915138|FG000|NOT COMPLETED|Overall Study||10
10820065|NCT00660595|11984791|FG000|STARTED|Overall Study||19
10751577|NCT03021187|11915139|FG001|NOT COMPLETED|Overall Study||9
10751578|NCT03021187|11915140|FG002|NOT COMPLETED|Overall Study||6
10751579|NCT03021187|11915141|FG003|NOT COMPLETED|Overall Study||9
10751580|NCT03021265|11915151|FG000|STARTED|Overall Study||676
10751581|NCT03021265|11915151|FG000|COMPLETED|Overall Study||554
10751582|NCT03021265|11915151|FG000|NOT COMPLETED|Overall Study||122
10751583|NCT03021304|11915155|FG000|STARTED|Overall Study||56
10751584|NCT03021304|11915155|FG000|COMPLETED|Overall Study||55
10751585|NCT03021304|11915155|FG000|NOT COMPLETED|Overall Study||1
10751586|NCT03021343|11915161|FG000|STARTED|Overall Study||179
10751587|NCT03021343|11915162|FG001|STARTED|Overall Study||181
10751588|NCT03021343|11915161|FG000|COMPLETED|Overall Study||174
10751589|NCT03021343|11915162|FG001|COMPLETED|Overall Study||174
10751590|NCT03021343|11915161|FG000|NOT COMPLETED|Overall Study||5
10751591|NCT03021343|11915162|FG001|NOT COMPLETED|Overall Study||7
10751592|NCT03021499|11915170|FG000|STARTED|Overall Study||179
10751593|NCT03021499|11915171|FG001|STARTED|Overall Study||178
10820066|NCT00660595|11984792|FG001|STARTED|Overall Study||10
10820067|NCT00660595|11984791|FG000|COMPLETED|Overall Study||1
10820068|NCT00660595|11984792|FG001|COMPLETED|Overall Study|One of the two was lost to follow-up|1
10820069|NCT00660595|11984791|FG000|NOT COMPLETED|Overall Study||18
10820070|NCT00660595|11984792|FG001|NOT COMPLETED|Overall Study||9
10820071|NCT00661466|11984800|FG000|STARTED|Overall Study|Participants|4
10820072|NCT00661466|11984801|FG001|STARTED|Overall Study|Participants|3
10820073|NCT00661466|11984800|FG000|COMPLETED|Overall Study|Participants|4
10820074|NCT00661466|11984801|FG001|COMPLETED|Overall Study|Participants|3
10820075|NCT00661466|11984800|FG000|NOT COMPLETED|Overall Study||0
10820076|NCT00661466|11984801|FG001|NOT COMPLETED|Overall Study||0
10820077|NCT00646282|11984809|FG000|STARTED|Overall Study||4
10820078|NCT00646282|11984810|FG001|STARTED|Overall Study||4
10820079|NCT00646282|11984809|FG000|COMPLETED|Overall Study||0
10820080|NCT00646282|11984810|FG001|COMPLETED|Overall Study||0
10820081|NCT00646282|11984809|FG000|NOT COMPLETED|Overall Study||4
10820082|NCT00646282|11984810|FG001|NOT COMPLETED|Overall Study||4
10820083|NCT00657553|11984818|FG000|STARTED|Overall Study||5
10820084|NCT00657553|11984819|FG001|STARTED|Overall Study||5
10820085|NCT00657553|11984818|FG000|COMPLETED|Overall Study||0
10820086|NCT00657553|11984819|FG001|COMPLETED|Overall Study||0
10820087|NCT00657553|11984818|FG000|NOT COMPLETED|Overall Study||5
10820088|NCT00657553|11984819|FG001|NOT COMPLETED|Overall Study||5
10820089|NCT00655057|11984828|FG000|STARTED|Overall Study||0
10820090|NCT00655057|11984829|FG001|STARTED|Overall Study||0
10820091|NCT00655057|11984830|FG002|STARTED|Overall Study||0
10820092|NCT00655057|11984828|FG000|COMPLETED|Overall Study||0
10820093|NCT00655057|11984829|FG001|COMPLETED|Overall Study||0
10820094|NCT00655057|11984830|FG002|COMPLETED|Overall Study||0
10820095|NCT00655057|11984828|FG000|NOT COMPLETED|Overall Study||0
10820096|NCT00655057|11984829|FG001|NOT COMPLETED|Overall Study||0
10820097|NCT00655057|11984830|FG002|NOT COMPLETED|Overall Study||0
10820098|NCT00648895|11984840|FG000|STARTED|Overall Study||6
10820099|NCT00648895|11984841|FG001|STARTED|Overall Study||6
10820100|NCT00648895|11984840|FG000|COMPLETED|Overall Study||6
10820101|NCT00648895|11984841|FG001|COMPLETED|Overall Study||5
10820102|NCT00648895|11984840|FG000|NOT COMPLETED|Overall Study||0
10820103|NCT00648895|11984841|FG001|NOT COMPLETED|Overall Study||1
10820104|NCT00647426|11984847|FG000|STARTED|Overall Study||7
10820105|NCT00647426|11984847|FG000|COMPLETED|Overall Study||5
10820106|NCT00647426|11984847|FG000|NOT COMPLETED|Overall Study||2
10820107|NCT00645567|11984852|FG000|STARTED|Overall Study||5
10820108|NCT00645567|11984852|FG000|COMPLETED|Overall Study|One individual provided consent & was dropped due to an unrelated injury to his hand at his home.|4
10820109|NCT00645567|11984852|FG000|NOT COMPLETED|Overall Study||1
10820110|NCT00637806|11984863|FG000|STARTED|Double-blind Phase||2
10820111|NCT00637806|11984864|FG001|STARTED|Double-blind Phase||0
10820112|NCT00637806|11984865|FG002|STARTED|Double-blind Phase||2
10820113|NCT00637806|11984866|FG003|STARTED|Double-blind Phase||0
10820114|NCT00637806|11984863|FG000|COMPLETED|Double-blind Phase||0
10820115|NCT00637806|11984864|FG001|COMPLETED|Double-blind Phase||0
10820116|NCT00637806|11984865|FG002|COMPLETED|Double-blind Phase||1
10820117|NCT00637806|11984866|FG003|COMPLETED|Double-blind Phase||0
10820118|NCT00637806|11984863|FG000|NOT COMPLETED|Double-blind Phase||2
10820119|NCT00637806|11984864|FG001|NOT COMPLETED|Double-blind Phase||0
10820120|NCT00637806|11984865|FG002|NOT COMPLETED|Double-blind Phase||1
10820121|NCT00637806|11984866|FG003|NOT COMPLETED|Double-blind Phase||0
10751594|NCT03021499|11915170|FG000|Week 24|Overall Study||167
10751595|NCT03021499|11915171|FG001|Week 24|Overall Study||162
10751596|NCT03021499|11915170|FG000|Week 52|Overall Study||162
10751597|NCT03021499|11915171|FG001|Week 52|Overall Study||147
10751598|NCT03021499|11915170|FG000|COMPLETED|Overall Study||163
10751599|NCT03021499|11915171|FG001|COMPLETED|Overall Study||147
10751600|NCT03021499|11915170|FG000|NOT COMPLETED|Overall Study||16
10820122|NCT00637806|11984863|FG000|STARTED|Extension Phase||0
10820123|NCT00637806|11984864|FG001|STARTED|Extension Phase||0
10820124|NCT00637806|11984865|FG002|STARTED|Extension Phase||0
10820125|NCT00637806|11984866|FG003|STARTED|Extension Phase||1
10820126|NCT00637806|11984863|FG000|COMPLETED|Extension Phase||0
10820127|NCT00637806|11984864|FG001|COMPLETED|Extension Phase||0
10820128|NCT00637806|11984865|FG002|COMPLETED|Extension Phase||0
10820129|NCT00637806|11984866|FG003|COMPLETED|Extension Phase||0
10820130|NCT00637806|11984863|FG000|NOT COMPLETED|Extension Phase||0
10751601|NCT03021499|11915171|FG001|NOT COMPLETED|Overall Study||31
10751602|NCT03021538|11915181|FG000|STARTED|Overall Study||6
10751603|NCT03021538|11915182|FG001|STARTED|Overall Study||7
10751604|NCT03021538|11915181|FG000|COMPLETED|Overall Study||6
10751605|NCT03021538|11915182|FG001|COMPLETED|Overall Study||7
10751606|NCT03021538|11915181|FG000|NOT COMPLETED|Overall Study||0
10751607|NCT03021538|11915182|FG001|NOT COMPLETED|Overall Study||0
10751608|NCT03021564|11915190|FG000|STARTED|Overall Study||120
10751609|NCT03021564|11915191|FG001|STARTED|Overall Study||557
10751610|NCT03021564|11915190|FG000|COMPLETED|Overall Study||36
10751611|NCT03021564|11915191|FG001|COMPLETED|Overall Study||89
10751612|NCT03021564|11915190|FG000|NOT COMPLETED|Overall Study||84
10751613|NCT03021564|11915191|FG001|NOT COMPLETED|Overall Study||468
10751632|NCT03021668|11915210|FG000|STARTED|Overall Study||62
10751633|NCT03021668|11915211|FG001|STARTED|Overall Study||62
10751634|NCT03021668|11915210|FG000|COMPLETED|Overall Study||62
10751635|NCT03021668|11915211|FG001|COMPLETED|Overall Study||61
10751636|NCT03021668|11915210|FG000|NOT COMPLETED|Overall Study||0
10751637|NCT03021668|11915211|FG001|NOT COMPLETED|Overall Study||1
10751638|NCT03021759|11915220|FG000|STARTED|Overall Study||1566
10751639|NCT03021759|11915221|FG001|STARTED|Overall Study||1743
10751640|NCT03021759|11915222|FG002|STARTED|Overall Study||1465
10751641|NCT03021759|11915220|FG000|COMPLETED|Overall Study|32 primary care physicians were randomized to this arm and analyzed.|1566
10751642|NCT03021759|11915221|FG001|COMPLETED|Overall Study|32 primary care physicians were randomized to this arm and analyzed.|1743
10751643|NCT03021759|11915222|FG002|COMPLETED|Overall Study|32 primary care physicians were randomized to this arm and analyzed.|1465
10751644|NCT03021759|11915220|FG000|NOT COMPLETED|Overall Study||0
10751645|NCT03021759|11915221|FG001|NOT COMPLETED|Overall Study||0
10751646|NCT03021759|11915222|FG002|NOT COMPLETED|Overall Study||0
10751647|NCT03022045|11915232|FG000|STARTED|Overall Study||9
10751648|NCT03022045|11915233|FG001|STARTED|Overall Study||8
10751649|NCT03022045|11915232|FG000|COMPLETED|Overall Study||8
10751650|NCT03022045|11915233|FG001|COMPLETED|Overall Study||6
10751651|NCT03022045|11915232|FG000|NOT COMPLETED|Overall Study||1
10751652|NCT03022045|11915233|FG001|NOT COMPLETED|Overall Study||2
10751653|NCT03022084|11915245|FG000|STARTED|Overall Study||29
10751654|NCT03022084|11915246|FG001|STARTED|Overall Study||32
10751655|NCT03022084|11915245|FG000|COMPLETED|Overall Study||27
10751656|NCT03022084|11915246|FG001|COMPLETED|Overall Study||29
10751657|NCT03022084|11915245|FG000|NOT COMPLETED|Overall Study||2
10751658|NCT03022084|11915246|FG001|NOT COMPLETED|Overall Study||3
10751659|NCT03022370|11915256|FG000|STARTED|Overall Study||677
10751660|NCT03022370|11915257|FG001|STARTED|Overall Study||674
10751661|NCT03022370|11915256|FG000|COMPLETED|Overall Study||497
10751662|NCT03022370|11915257|FG001|COMPLETED|Overall Study||553
10751663|NCT03022370|11915256|FG000|NOT COMPLETED|Overall Study||180
10751664|NCT03022370|11915257|FG001|NOT COMPLETED|Overall Study||121
10751665|NCT03022396|11915273|FG000|STARTED|Overall Study||16
10751666|NCT03022396|11915274|FG001|STARTED|Overall Study||14
10751667|NCT03022396|11915275|FG002|STARTED|Overall Study||10
10751668|NCT03022396|11915276|FG003|STARTED|Overall Study||20
10751669|NCT03022396|11915277|FG004|STARTED|Overall Study||14
10751670|NCT03022396|11915278|FG005|STARTED|Overall Study||8
10751671|NCT03022396|11915273|FG000|COMPLETED|Overall Study||16
10751672|NCT03022396|11915274|FG001|COMPLETED|Overall Study||14
10751673|NCT03022396|11915275|FG002|COMPLETED|Overall Study||10
10751674|NCT03022396|11915276|FG003|COMPLETED|Overall Study||20
10751675|NCT03022396|11915277|FG004|COMPLETED|Overall Study||14
10751676|NCT03022396|11915278|FG005|COMPLETED|Overall Study||8
10751677|NCT03022396|11915273|FG000|NOT COMPLETED|Overall Study||0
10751678|NCT03022396|11915274|FG001|NOT COMPLETED|Overall Study||0
10751679|NCT03022396|11915275|FG002|NOT COMPLETED|Overall Study||0
10751680|NCT03022396|11915276|FG003|NOT COMPLETED|Overall Study||0
10751681|NCT03022396|11915277|FG004|NOT COMPLETED|Overall Study||0
10751682|NCT03022396|11915278|FG005|NOT COMPLETED|Overall Study||0
10751683|NCT03022422|11915298|FG000|STARTED|Overall Study||8
10751684|NCT03022422|11915299|FG001|STARTED|Overall Study||10
10751685|NCT03022422|11915300|FG002|STARTED|Overall Study||23
10751686|NCT03022422|11915301|FG003|STARTED|Overall Study||12
10751687|NCT03022422|11915302|FG004|STARTED|Overall Study||5
10751688|NCT03022422|11915303|FG005|STARTED|Overall Study||5
10751689|NCT03022422|11915298|FG000|COMPLETED|Overall Study||8
10751690|NCT03022422|11915299|FG001|COMPLETED|Overall Study||10
10751691|NCT03022422|11915300|FG002|COMPLETED|Overall Study||20
10751692|NCT03022422|11915301|FG003|COMPLETED|Overall Study||12
10751693|NCT03022422|11915302|FG004|COMPLETED|Overall Study||5
10751694|NCT03022422|11915303|FG005|COMPLETED|Overall Study||5
10751695|NCT03022422|11915298|FG000|NOT COMPLETED|Overall Study||0
10751696|NCT03022422|11915299|FG001|NOT COMPLETED|Overall Study||0
10751697|NCT03022422|11915300|FG002|NOT COMPLETED|Overall Study||3
10751698|NCT03022422|11915301|FG003|NOT COMPLETED|Overall Study||0
10751699|NCT03022422|11915302|FG004|NOT COMPLETED|Overall Study||0
10751700|NCT03022422|11915303|FG005|NOT COMPLETED|Overall Study||0
10751701|NCT03022435|11915324|FG000|STARTED|Overall Study||5
10751702|NCT03022435|11915325|FG001|STARTED|Overall Study||5
10751703|NCT03022435|11915326|FG002|STARTED|Overall Study||6
10751704|NCT03022435|11915327|FG003|STARTED|Overall Study||3
10751705|NCT03022435|11915328|FG004|STARTED|Overall Study||3
10751706|NCT03022435|11915324|FG000|COMPLETED|Overall Study||5
10751707|NCT03022435|11915325|FG001|COMPLETED|Overall Study||5
10751708|NCT03022435|11915326|FG002|COMPLETED|Overall Study||6
10751709|NCT03022435|11915327|FG003|COMPLETED|Overall Study||3
10751710|NCT03022435|11915328|FG004|COMPLETED|Overall Study||3
10751711|NCT03022435|11915324|FG000|NOT COMPLETED|Overall Study||0
10751712|NCT03022435|11915325|FG001|NOT COMPLETED|Overall Study||0
10820131|NCT00637806|11984864|FG001|NOT COMPLETED|Extension Phase||0
10820132|NCT00637806|11984865|FG002|NOT COMPLETED|Extension Phase||0
10820133|NCT00637806|11984866|FG003|NOT COMPLETED|Extension Phase||1
10820134|NCT00652457|11984875|FG000|STARTED|Overall Study||23
10820135|NCT00652457|11984876|FG001|STARTED|Overall Study||27
10820136|NCT00652457|11984875|FG000|COMPLETED|Overall Study||23
10820137|NCT00652457|11984876|FG001|COMPLETED|Overall Study||27
10820138|NCT00652457|11984875|FG000|NOT COMPLETED|Overall Study||0
10820139|NCT00652457|11984876|FG001|NOT COMPLETED|Overall Study||0
10820140|NCT00642603|11984884|FG000|STARTED|Overall Study||21
10820141|NCT00642603|11984885|FG001|STARTED|Overall Study||20
10820142|NCT00642603|11984884|FG000|Safety Population|Overall Study||19
10820143|NCT00642603|11984885|FG001|Safety Population|Overall Study||20
10820144|NCT00642603|11984884|FG000|COMPLETED|Overall Study||0
10820145|NCT00642603|11984885|FG001|COMPLETED|Overall Study||2
10820146|NCT00642603|11984884|FG000|NOT COMPLETED|Overall Study||21
10820147|NCT00642603|11984885|FG001|NOT COMPLETED|Overall Study||18
10820148|NCT00629798|11984891|FG000|STARTED|Overall Study||64
10820149|NCT00629798|11984891|FG000|COMPLETED|Overall Study||60
10820150|NCT00629798|11984891|FG000|NOT COMPLETED|Overall Study||4
10820151|NCT00645359|11984895|FG000|STARTED|Overall Study||9
10820152|NCT00645359|11984895|FG000|COMPLETED|Overall Study||9
10820153|NCT00645359|11984895|FG000|NOT COMPLETED|Overall Study||0
10820154|NCT00637728|11984901|FG000|STARTED|Double-blind Phase||4
10820155|NCT00637728|11984902|FG001|STARTED|Double-blind Phase||1
10820156|NCT00637728|11984903|FG002|STARTED|Double-blind Phase||0
10820157|NCT00637728|11984901|FG000|COMPLETED|Double-blind Phase||0
10820158|NCT00637728|11984902|FG001|COMPLETED|Double-blind Phase||0
10820159|NCT00637728|11984903|FG002|COMPLETED|Double-blind Phase||0
10820160|NCT00637728|11984901|FG000|NOT COMPLETED|Double-blind Phase||4
10820161|NCT00637728|11984902|FG001|NOT COMPLETED|Double-blind Phase||1
10820162|NCT00637728|11984903|FG002|NOT COMPLETED|Double-blind Phase||0
10820163|NCT00637728|11984901|FG000|STARTED|Extension Phase||0
10820164|NCT00637728|11984902|FG001|STARTED|Extension Phase||0
10820165|NCT00637728|11984903|FG002|STARTED|Extension Phase||0
10820166|NCT00637728|11984901|FG000|COMPLETED|Extension Phase||0
10820167|NCT00637728|11984902|FG001|COMPLETED|Extension Phase||0
10820168|NCT00637728|11984903|FG002|COMPLETED|Extension Phase||0
10820169|NCT00637728|11984901|FG000|NOT COMPLETED|Extension Phase||0
10820170|NCT00637728|11984902|FG001|NOT COMPLETED|Extension Phase||0
10820171|NCT00637728|11984903|FG002|NOT COMPLETED|Extension Phase||0
10820172|NCT00639626|11984910|FG000|STARTED|Overall Study||0
10820173|NCT00639626|11984910|FG000|COMPLETED|Overall Study||0
10820174|NCT00639626|11984910|FG000|NOT COMPLETED|Overall Study||0
10820175|NCT00634582|11984914|FG000|STARTED|Overall Study||2
10751713|NCT03022435|11915326|FG002|NOT COMPLETED|Overall Study||0
10751714|NCT03022435|11915327|FG003|NOT COMPLETED|Overall Study||0
10751715|NCT03022435|11915328|FG004|NOT COMPLETED|Overall Study||0
10751716|NCT03022526|11915345|FG000|STARTED|Overall Study||31
10820176|NCT00634582|11984914|FG000|COMPLETED|Overall Study||2
10820177|NCT00634582|11984914|FG000|NOT COMPLETED|Overall Study||0
10820178|NCT00641108|11984920|FG000|STARTED|Overall Study||0
10820179|NCT00641108|11984921|FG001|STARTED|Overall Study||0
10820180|NCT00641108|11984920|FG000|COMPLETED|Overall Study||0
10820181|NCT00641108|11984921|FG001|COMPLETED|Overall Study||0
10751717|NCT03022526|11915346|FG001|STARTED|Overall Study||30
10751718|NCT03022526|11915345|FG000|COMPLETED|Overall Study||21
10751719|NCT03022526|11915346|FG001|COMPLETED|Overall Study||25
10751720|NCT03022526|11915345|FG000|NOT COMPLETED|Overall Study||10
10751721|NCT03022526|11915346|FG001|NOT COMPLETED|Overall Study||5
10751722|NCT03022617|11915352|FG000|STARTED|Overall Study||12
10751723|NCT03022617|11915352|FG000|COMPLETED|Overall Study||6
10751724|NCT03022617|11915352|FG000|NOT COMPLETED|Overall Study||6
10751725|NCT03022630|11915358|FG000|STARTED|Overall Study||31
10751726|NCT03022630|11915359|FG001|STARTED|Overall Study||32
10751727|NCT03022630|11915358|FG000|COMPLETED|Overall Study||22
10751728|NCT03022630|11915359|FG001|COMPLETED|Overall Study||20
10751729|NCT03022630|11915358|FG000|NOT COMPLETED|Overall Study||9
10751730|NCT03022630|11915359|FG001|NOT COMPLETED|Overall Study||12
10751731|NCT03022799|11915383|FG000|STARTED|Overall Study||6
10751732|NCT03022799|11915384|FG001|STARTED|Overall Study||6
10751733|NCT03022799|11915385|FG002|STARTED|Overall Study||6
10751734|NCT03022799|11915386|FG003|STARTED|Overall Study||6
10751735|NCT03022799|11915387|FG004|STARTED|Overall Study||6
10751736|NCT03022799|11915388|FG005|STARTED|Overall Study||6
10751737|NCT03022799|11915389|FG006|STARTED|Overall Study||12
10751738|NCT03022799|11915390|FG007|STARTED|Overall Study||6
10751739|NCT03022799|11915391|FG008|STARTED|Overall Study||6
10751740|NCT03022799|11915392|FG009|STARTED|Overall Study||6
10751741|NCT03022799|11915393|FG010|STARTED|Overall Study||6
10751742|NCT03022799|11915394|FG011|STARTED|Overall Study||6
10751743|NCT03022799|11915395|FG012|STARTED|Overall Study||10
10751744|NCT03022799|11915383|FG000|COMPLETED|Overall Study||6
10751745|NCT03022799|11915384|FG001|COMPLETED|Overall Study||6
10751746|NCT03022799|11915385|FG002|COMPLETED|Overall Study||6
10751747|NCT03022799|11915386|FG003|COMPLETED|Overall Study||6
10751748|NCT03022799|11915387|FG004|COMPLETED|Overall Study||6
10751749|NCT03022799|11915388|FG005|COMPLETED|Overall Study||6
10751750|NCT03022799|11915389|FG006|COMPLETED|Overall Study||12
10751751|NCT03022799|11915390|FG007|COMPLETED|Overall Study||6
10751752|NCT03022799|11915391|FG008|COMPLETED|Overall Study||6
10751753|NCT03022799|11915392|FG009|COMPLETED|Overall Study||5
10751754|NCT03022799|11915393|FG010|COMPLETED|Overall Study||5
10751755|NCT03022799|11915394|FG011|COMPLETED|Overall Study||6
10751756|NCT03022799|11915395|FG012|COMPLETED|Overall Study||10
10751757|NCT03022799|11915383|FG000|NOT COMPLETED|Overall Study||0
10751758|NCT03022799|11915384|FG001|NOT COMPLETED|Overall Study||0
10751759|NCT03022799|11915385|FG002|NOT COMPLETED|Overall Study||0
10751760|NCT03022799|11915386|FG003|NOT COMPLETED|Overall Study||0
10751761|NCT03022799|11915387|FG004|NOT COMPLETED|Overall Study||0
10751762|NCT03022799|11915388|FG005|NOT COMPLETED|Overall Study||0
10751763|NCT03022799|11915389|FG006|NOT COMPLETED|Overall Study||0
10751764|NCT03022799|11915390|FG007|NOT COMPLETED|Overall Study||0
10751765|NCT03022799|11915391|FG008|NOT COMPLETED|Overall Study||0
10751766|NCT03022799|11915392|FG009|NOT COMPLETED|Overall Study||1
10751767|NCT03022799|11915393|FG010|NOT COMPLETED|Overall Study||1
10751768|NCT03022799|11915394|FG011|NOT COMPLETED|Overall Study||0
10751769|NCT03022799|11915395|FG012|NOT COMPLETED|Overall Study||0
10751770|NCT03022916|11915440|FG000|STARTED|Overall Study||5
10751771|NCT03022916|11915441|FG001|STARTED|Overall Study||5
10751772|NCT03022916|11915442|FG002|STARTED|Overall Study||5
10751773|NCT03022916|11915443|FG003|STARTED|Overall Study||5
10751774|NCT03022916|11915440|FG000|Nail Polish|Overall Study||5
10751775|NCT03022916|11915441|FG001|Nail Polish|Overall Study||5
10751776|NCT03022916|11915442|FG002|Nail Polish|Overall Study||5
10751777|NCT03022916|11915443|FG003|Nail Polish|Overall Study||5
10751778|NCT03022916|11915440|FG000|Nail Polish, Base Coat|Overall Study||5
10751779|NCT03022916|11915441|FG001|Nail Polish, Base Coat|Overall Study||5
10751780|NCT03022916|11915442|FG002|Nail Polish, Base Coat|Overall Study||5
10751781|NCT03022916|11915443|FG003|Nail Polish, Base Coat|Overall Study||5
10751782|NCT03022916|11915440|FG000|Nail Polish, Top Coat|Overall Study||5
10751783|NCT03022916|11915441|FG001|Nail Polish, Top Coat|Overall Study||5
10751784|NCT03022916|11915442|FG002|Nail Polish, Top Coat|Overall Study||5
10751785|NCT03022916|11915443|FG003|Nail Polish, Top Coat|Overall Study||5
10751786|NCT03022916|11915440|FG000|COMPLETED|Overall Study||5
10751787|NCT03022916|11915441|FG001|COMPLETED|Overall Study||5
10751788|NCT03022916|11915442|FG002|COMPLETED|Overall Study||5
10751789|NCT03022916|11915443|FG003|COMPLETED|Overall Study||5
10751790|NCT03022916|11915440|FG000|NOT COMPLETED|Overall Study||0
10751791|NCT03022916|11915441|FG001|NOT COMPLETED|Overall Study||0
10751792|NCT03022916|11915442|FG002|NOT COMPLETED|Overall Study||0
10751793|NCT03022916|11915443|FG003|NOT COMPLETED|Overall Study||0
10751794|NCT03022981|11915453|FG000|STARTED|Overall Study||102
10751795|NCT03022981|11915454|FG001|STARTED|Overall Study||73
10751796|NCT03022981|11915455|FG002|STARTED|Overall Study||41
10751797|NCT03022981|11915453|FG000|Participated in PK Lead-in (PKL) Phase|Overall Study|All 17 participants completed treatment in the PK Lead-in phase and continued into treatment phase.|17
10751798|NCT03022981|11915454|FG001|Participated in PK Lead-in (PKL) Phase|Overall Study|All 20 participants completed treatment in the PK Lead-in phase and continued into treatment phase.|20
10751799|NCT03022981|11915455|FG002|Participated in PK Lead-in (PKL) Phase|Overall Study|All 19 participants completed treatment in the PK Lead-in phase and continued into treatment phase.|19
10751800|NCT03022981|11915453|FG000|COMPLETED|Overall Study||96
10751801|NCT03022981|11915454|FG001|COMPLETED|Overall Study||69
10751802|NCT03022981|11915455|FG002|COMPLETED|Overall Study||35
10751803|NCT03022981|11915453|FG000|NOT COMPLETED|Overall Study||6
10751804|NCT03022981|11915454|FG001|NOT COMPLETED|Overall Study||4
10751805|NCT03022981|11915455|FG002|NOT COMPLETED|Overall Study||6
10751806|NCT03023137|11915475|FG000|STARTED|Overall Study||178
10751807|NCT03023137|11915476|FG001|STARTED|Overall Study||171
10751808|NCT03023137|11915475|FG000|COMPLETED|Overall Study||174
10751809|NCT03023137|11915476|FG001|COMPLETED|Overall Study||162
10751810|NCT03023137|11915475|FG000|NOT COMPLETED|Overall Study||4
10751811|NCT03023137|11915476|FG001|NOT COMPLETED|Overall Study||9
10751812|NCT03023176|11915483|FG000|STARTED|Overall Study||20
10751813|NCT03023176|11915483|FG000|COMPLETED|Overall Study||20
10751814|NCT03023176|11915483|FG000|NOT COMPLETED|Overall Study||0
10751815|NCT03023397|11915490|FG000|STARTED|Run-In||8
10751816|NCT03023397|11915491|FG001|STARTED|Run-In||3
10751817|NCT03023397|11915492|FG002|STARTED|Run-In||1
10751818|NCT03023397|11915490|FG000|COMPLETED|Run-In||6
10751819|NCT03023397|11915491|FG001|COMPLETED|Run-In||3
10751820|NCT03023397|11915492|FG002|COMPLETED|Run-In||1
10751821|NCT03023397|11915490|FG000|NOT COMPLETED|Run-In||2
10751822|NCT03023397|11915491|FG001|NOT COMPLETED|Run-In||0
10751823|NCT03023397|11915492|FG002|NOT COMPLETED|Run-In||0
10751824|NCT03023397|11915490|FG000|STARTED|Main Study||6
10751825|NCT03023397|11915491|FG001|STARTED|Main Study||3
10751826|NCT03023397|11915492|FG002|STARTED|Main Study||1
10751827|NCT03023397|11915490|FG000|COMPLETED|Main Study||6
10751828|NCT03023397|11915491|FG001|COMPLETED|Main Study||3
10751829|NCT03023397|11915492|FG002|COMPLETED|Main Study||1
10751830|NCT03023397|11915490|FG000|NOT COMPLETED|Main Study||0
10751831|NCT03023397|11915491|FG001|NOT COMPLETED|Main Study||0
10751832|NCT03023397|11915492|FG002|NOT COMPLETED|Main Study||0
10751833|NCT03023423|11915504|FG000|STARTED|Overall Study||7
10820182|NCT00641108|11984920|FG000|NOT COMPLETED|Overall Study||0
10820183|NCT00641108|11984921|FG001|NOT COMPLETED|Overall Study||0
10820184|NCT00642382|11984929|FG000|STARTED|Overall Study||0
10820185|NCT00642382|11984930|FG001|STARTED|Overall Study||0
10820186|NCT00642382|11984929|FG000|COMPLETED|Overall Study||0
10820187|NCT00642382|11984930|FG001|COMPLETED|Overall Study||0
10820188|NCT00642382|11984929|FG000|NOT COMPLETED|Overall Study||0
10820189|NCT00642382|11984930|FG001|NOT COMPLETED|Overall Study||0
10820190|NCT00637416|11984938|FG000|STARTED|Overall Study||4
10820191|NCT00637416|11984939|FG001|STARTED|Overall Study||5
10820192|NCT00637416|11984938|FG000|COMPLETED|Overall Study||3
10820193|NCT00637416|11984939|FG001|COMPLETED|Overall Study||3
10820194|NCT00637416|11984938|FG000|NOT COMPLETED|Overall Study||1
10820195|NCT00637416|11984939|FG001|NOT COMPLETED|Overall Study||2
10820196|NCT00635167|11984945|FG000|STARTED|Overall Study||1
10820197|NCT00635167|11984945|FG000|COMPLETED|Overall Study||1
10820198|NCT00635167|11984945|FG000|NOT COMPLETED|Overall Study||0
10820199|NCT00637312|11984951|FG000|STARTED|Overall Study||72
10820200|NCT00637312|11984952|FG001|STARTED|Overall Study||36
10820201|NCT00637312|11984951|FG000|COMPLETED|Overall Study||30
10820202|NCT00637312|11984952|FG001|COMPLETED|Overall Study||19
10820203|NCT00637312|11984951|FG000|NOT COMPLETED|Overall Study||42
10820204|NCT00637312|11984952|FG001|NOT COMPLETED|Overall Study||17
10751834|NCT03023423|11915505|FG001|STARTED|Overall Study||46
10751835|NCT03023423|11915506|FG002|STARTED|Overall Study||46
10751836|NCT03023423|11915504|FG000|Treated|Overall Study||7
10751837|NCT03023423|11915505|FG001|Treated|Overall Study||44
10751838|NCT03023423|11915506|FG002|Treated|Overall Study||44
10751839|NCT03023423|11915504|FG000|Crossover From Atezo to Dara + Atezo|Overall Study||0
10820205|NCT00638222|11984961|FG000|STARTED|Overall Study||0
10820206|NCT00638222|11984962|FG001|STARTED|Overall Study||0
10820207|NCT00638222|11984963|FG002|STARTED|Overall Study||6
10820208|NCT00638222|11984961|FG000|COMPLETED|Overall Study||0
10820209|NCT00638222|11984962|FG001|COMPLETED|Overall Study||0
10820210|NCT00638222|11984963|FG002|COMPLETED|Overall Study||6
10820211|NCT00638222|11984961|FG000|NOT COMPLETED|Overall Study||0
10820212|NCT00638222|11984962|FG001|NOT COMPLETED|Overall Study||0
10820213|NCT00638222|11984963|FG002|NOT COMPLETED|Overall Study||0
10820214|NCT00634322|11984973|FG000|STARTED|Overall Study||1
10820215|NCT00634322|11984974|FG001|STARTED|Overall Study||1
10820216|NCT00634322|11984975|FG002|STARTED|Overall Study||5
10751840|NCT03023423|11915505|FG001|Crossover From Atezo to Dara + Atezo|Overall Study|Participants who met crossover eligibility criteria entered to Dara + Atezo arm.|8
10751841|NCT03023423|11915506|FG002|Crossover From Atezo to Dara + Atezo|Overall Study||0
10751842|NCT03023423|11915504|FG000|COMPLETED|Overall Study||0
10751843|NCT03023423|11915505|FG001|COMPLETED|Overall Study||0
10751844|NCT03023423|11915506|FG002|COMPLETED|Overall Study||0
10751845|NCT03023423|11915504|FG000|NOT COMPLETED|Overall Study||7
10751846|NCT03023423|11915505|FG001|NOT COMPLETED|Overall Study||46
10751847|NCT03023423|11915506|FG002|NOT COMPLETED|Overall Study||46
10751848|NCT03023488|11915518|FG000|STARTED|Overall Study||46
10751849|NCT03023488|11915518|FG000|COMPLETED|Overall Study||46
10751850|NCT03023488|11915518|FG000|NOT COMPLETED|Overall Study||0
10751851|NCT03023553|11915530|FG000|STARTED|Overall Study||4
10751852|NCT03023553|11915531|FG001|STARTED|Overall Study||9
10751853|NCT03023553|11915530|FG000|COMPLETED|Overall Study||4
10751854|NCT03023553|11915531|FG001|COMPLETED|Overall Study||8
10751855|NCT03023553|11915530|FG000|NOT COMPLETED|Overall Study||0
10751856|NCT03023553|11915531|FG001|NOT COMPLETED|Overall Study||1
10778648|NCT03358407|11940524|FG005|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
10778649|NCT03358407|11940525|FG006|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
10778650|NCT03358407|11940526|FG007|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
10778651|NCT03358407|11940527|FG008|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
10778652|NCT03358407|11940528|FG009|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
10778653|NCT03358407|11940519|FG000|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2
10778654|NCT03358407|11940520|FG001|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2
10778655|NCT03358407|11940521|FG002|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2
10778656|NCT03358407|11940522|FG003|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2
10778657|NCT03358407|11940523|FG004|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)|1 participant was added to Part A-Cohort 1: GSK 2mg/GSK 4mg/GSK 10mg/GSK 30mg/Placebo arm|2
10778658|NCT03358407|11940524|FG005|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
10778659|NCT03358407|11940525|FG006|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
10778660|NCT03358407|11940526|FG007|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
10778661|NCT03358407|11940527|FG008|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
10778662|NCT03358407|11940528|FG009|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
10778663|NCT03358407|11940519|FG000|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
10778664|NCT03358407|11940520|FG001|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
10778665|NCT03358407|11940521|FG002|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
10778666|NCT03358407|11940522|FG003|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
10778667|NCT03358407|11940523|FG004|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
10778668|NCT03358407|11940524|FG005|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
10778669|NCT03358407|11940525|FG006|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
10778670|NCT03358407|11940526|FG007|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
10820217|NCT00634322|11984973|FG000|COMPLETED|Overall Study||1
10820218|NCT00634322|11984974|FG001|COMPLETED|Overall Study||1
10820219|NCT00634322|11984975|FG002|COMPLETED|Overall Study||5
10820220|NCT00634322|11984973|FG000|NOT COMPLETED|Overall Study||0
10820221|NCT00634322|11984974|FG001|NOT COMPLETED|Overall Study||0
10820222|NCT00634322|11984975|FG002|NOT COMPLETED|Overall Study||0
10820223|NCT00633087|11984983|FG000|STARTED|Overall Study||12
10820224|NCT00633087|11984983|FG000|COMPLETED|Overall Study||12
10820225|NCT00633087|11984983|FG000|NOT COMPLETED|Overall Study||0
10820226|NCT00631137|11984989|FG000|STARTED|Overall Study||1
10820227|NCT00631137|11984990|FG001|STARTED|Overall Study||0
10820228|NCT00631137|11984989|FG000|COMPLETED|Overall Study||0
10820229|NCT00631137|11984990|FG001|COMPLETED|Overall Study||0
10820230|NCT00631137|11984989|FG000|NOT COMPLETED|Overall Study||1
10820231|NCT00631137|11984990|FG001|NOT COMPLETED|Overall Study||0
10820232|NCT00634972|11984998|FG000|STARTED|Overall Study||40
10820233|NCT00634972|11984999|FG001|STARTED|Overall Study||43
10820234|NCT00634972|11984998|FG000|COMPLETED|Overall Study||40
10820235|NCT00634972|11984999|FG001|COMPLETED|Overall Study||43
10820236|NCT00634972|11984998|FG000|NOT COMPLETED|Overall Study||0
10820237|NCT00634972|11984999|FG001|NOT COMPLETED|Overall Study||0
10820238|NCT00633061|11985007|FG000|STARTED|Overall Study|Study was on hold for 2 months for continuing review|136
10820239|NCT00633061|11985008|FG001|STARTED|Overall Study||0
10820240|NCT00633061|11985007|FG000|Met Criteria for Imaging|Overall Study||25
10820241|NCT00633061|11985008|FG001|Met Criteria for Imaging|Overall Study||0
10820242|NCT00633061|11985007|FG000|Had Prior Thrombosis Identified|Overall Study||25
10820243|NCT00633061|11985008|FG001|Had Prior Thrombosis Identified|Overall Study||0
10820244|NCT00633061|11985007|FG000|COMPLETED|Overall Study||50
10820245|NCT00633061|11985008|FG001|COMPLETED|Overall Study||0
10820246|NCT00633061|11985007|FG000|NOT COMPLETED|Overall Study||86
10820247|NCT00633061|11985008|FG001|NOT COMPLETED|Overall Study||0
10820248|NCT00626444|11985016|FG000|STARTED|Overall Study||2
10820249|NCT00626444|11985016|FG000|COMPLETED|Overall Study||2
10820250|NCT00626444|11985016|FG000|NOT COMPLETED|Overall Study||0
10820251|NCT00630292|11985020|FG000|STARTED|Overall Study||6
10820252|NCT00630292|11985020|FG000|COMPLETED|Overall Study||5
10820253|NCT00630292|11985020|FG000|NOT COMPLETED|Overall Study||1
10820254|NCT00634010|11985026|FG000|STARTED|Overall Study||18
10820255|NCT00634010|11985027|FG001|STARTED|Overall Study||18
10820256|NCT00634010|11985026|FG000|COMPLETED|Overall Study||8
10820257|NCT00634010|11985027|FG001|COMPLETED|Overall Study||4
10820258|NCT00634010|11985026|FG000|NOT COMPLETED|Overall Study||10
10751857|NCT03023683|11915539|FG000|STARTED|Overall Study||0
10751858|NCT03023683|11915540|FG001|STARTED|Overall Study||18
10751859|NCT03023683|11915539|FG000|COMPLETED|Overall Study||0
10751860|NCT03023683|11915540|FG001|COMPLETED|Overall Study||17
10751861|NCT03023683|11915539|FG000|NOT COMPLETED|Overall Study||0
10751862|NCT03023683|11915540|FG001|NOT COMPLETED|Overall Study||1
10751863|NCT03023709|11915548|FG000|STARTED|Overall Study||3
10751864|NCT03023709|11915549|FG001|STARTED|Overall Study||0
10751865|NCT03023709|11915548|FG000|COMPLETED|Overall Study||3
10751866|NCT03023709|11915549|FG001|COMPLETED|Overall Study||0
10751867|NCT03023709|11915548|FG000|NOT COMPLETED|Overall Study||0
10751868|NCT03023709|11915549|FG001|NOT COMPLETED|Overall Study||0
10751869|NCT03023722|11915557|FG000|STARTED|Overall Study||18
10751870|NCT03023722|11915557|FG000|COMPLETED|Overall Study||14
10751871|NCT03023722|11915557|FG000|NOT COMPLETED|Overall Study||4
10751872|NCT03023826|11915561|FG000|STARTED|Period 1||4
10751873|NCT03023826|11915562|FG001|STARTED|Period 1||4
10751874|NCT03023826|11915563|FG002|STARTED|Period 1||5
10751875|NCT03023826|11915564|FG003|STARTED|Period 1||4
10751876|NCT03023826|11915565|FG004|STARTED|Period 1||4
10751877|NCT03023826|11915566|FG005|STARTED|Period 1||5
10751878|NCT03023826|11915561|FG000|Received at Least One Dose of Study Drug|Period 1||4
10751879|NCT03023826|11915562|FG001|Received at Least One Dose of Study Drug|Period 1||4
10820259|NCT00634010|11985027|FG001|NOT COMPLETED|Overall Study||14
10820260|NCT00630487|11985035|FG000|STARTED|Overall Study||0
10820261|NCT00630487|11985036|FG001|STARTED|Overall Study||0
10820262|NCT00630487|11985035|FG000|COMPLETED|Overall Study||0
10820263|NCT00630487|11985036|FG001|COMPLETED|Overall Study||0
10820264|NCT00630487|11985035|FG000|NOT COMPLETED|Overall Study||0
10820265|NCT00630487|11985036|FG001|NOT COMPLETED|Overall Study||0
10751880|NCT03023826|11915563|FG002|Received at Least One Dose of Study Drug|Period 1||5
10751881|NCT03023826|11915564|FG003|Received at Least One Dose of Study Drug|Period 1||4
10751882|NCT03023826|11915565|FG004|Received at Least One Dose of Study Drug|Period 1||4
10751883|NCT03023826|11915566|FG005|Received at Least One Dose of Study Drug|Period 1||5
10751884|NCT03023826|11915561|FG000|COMPLETED|Period 1||4
10751885|NCT03023826|11915562|FG001|COMPLETED|Period 1||4
10751886|NCT03023826|11915563|FG002|COMPLETED|Period 1||5
10751887|NCT03023826|11915564|FG003|COMPLETED|Period 1||4
10751888|NCT03023826|11915565|FG004|COMPLETED|Period 1||3
10751889|NCT03023826|11915566|FG005|COMPLETED|Period 1||5
10751890|NCT03023826|11915561|FG000|NOT COMPLETED|Period 1||0
10751891|NCT03023826|11915562|FG001|NOT COMPLETED|Period 1||0
10751892|NCT03023826|11915563|FG002|NOT COMPLETED|Period 1||0
10751893|NCT03023826|11915564|FG003|NOT COMPLETED|Period 1||0
10751894|NCT03023826|11915565|FG004|NOT COMPLETED|Period 1||1
10751895|NCT03023826|11915566|FG005|NOT COMPLETED|Period 1||0
10751896|NCT03023826|11915561|FG000|STARTED|Period 2||4
10751897|NCT03023826|11915562|FG001|STARTED|Period 2||4
10820266|NCT00629850|11985044|FG000|STARTED|Overall Study||1
10820267|NCT00629850|11985045|FG001|STARTED|Overall Study||0
10820268|NCT00629850|11985044|FG000|COMPLETED|Overall Study||1
10820269|NCT00629850|11985045|FG001|COMPLETED|Overall Study||0
10820270|NCT00629850|11985044|FG000|NOT COMPLETED|Overall Study||0
10820271|NCT00629850|11985045|FG001|NOT COMPLETED|Overall Study||0
10820272|NCT00623974|11985055|FG000|STARTED|Overall Study||0
10820273|NCT00623974|11985056|FG001|STARTED|Overall Study||0
10820274|NCT00623974|11985057|FG002|STARTED|Overall Study||0
10820275|NCT00623974|11985058|FG003|STARTED|Overall Study||0
10820276|NCT00623974|11985055|FG000|COMPLETED|Overall Study||0
10820277|NCT00623974|11985056|FG001|COMPLETED|Overall Study||0
10820278|NCT00623974|11985057|FG002|COMPLETED|Overall Study||0
10820279|NCT00623974|11985058|FG003|COMPLETED|Overall Study||0
10820280|NCT00623974|11985055|FG000|NOT COMPLETED|Overall Study||0
10820281|NCT00623974|11985056|FG001|NOT COMPLETED|Overall Study||0
10820282|NCT00623974|11985057|FG002|NOT COMPLETED|Overall Study||0
10820283|NCT00623974|11985058|FG003|NOT COMPLETED|Overall Study||0
10820284|NCT00624650|11985070|FG000|STARTED|Overall Study||17
10820285|NCT00624650|11985071|FG001|STARTED|Overall Study||16
10820286|NCT00624650|11985070|FG000|COMPLETED|Overall Study||16
10820287|NCT00624650|11985071|FG001|COMPLETED|Overall Study||15
10820288|NCT00624650|11985070|FG000|NOT COMPLETED|Overall Study||1
10820289|NCT00624650|11985071|FG001|NOT COMPLETED|Overall Study||1
10820290|NCT00626561|11985077|FG000|STARTED|Overall Study||4
10820291|NCT00626561|11985077|FG000|COMPLETED|Overall Study||0
10820292|NCT00626561|11985077|FG000|NOT COMPLETED|Overall Study||4
10820293|NCT00613730|11985081|FG000|STARTED|Overall Study||3
10820294|NCT00613730|11985081|FG000|COMPLETED|Overall Study||0
10820295|NCT00613730|11985081|FG000|NOT COMPLETED|Overall Study||3
10820296|NCT00625586|11985085|FG000|STARTED|Overall Study||2
10820297|NCT00625586|11985085|FG000|COMPLETED|Overall Study||1
10820298|NCT00625586|11985085|FG000|NOT COMPLETED|Overall Study||1
10820299|NCT00625703|11985089|FG000|STARTED|Overall Study||0
10820300|NCT00625703|11985089|FG000|COMPLETED|Overall Study||0
10820301|NCT00625703|11985089|FG000|NOT COMPLETED|Overall Study||0
10820302|NCT00625742|11985093|FG000|STARTED|Overall Study||15
10820303|NCT00625742|11985093|FG000|COMPLETED|Overall Study||3
10820304|NCT00625742|11985093|FG000|NOT COMPLETED|Overall Study||12
10820305|NCT00619242|11985097|FG000|STARTED|Overall Study||3
10820306|NCT00619242|11985097|FG000|COMPLETED|Overall Study||3
10820307|NCT00619242|11985097|FG000|NOT COMPLETED|Overall Study||0
10820308|NCT00619151|11985103|FG000|STARTED|Overall Study||2
10820309|NCT00619151|11985104|FG001|STARTED|Overall Study||0
10820310|NCT00619151|11985103|FG000|COMPLETED|Overall Study||1
10820311|NCT00619151|11985104|FG001|COMPLETED|Overall Study||0
10820312|NCT00619151|11985103|FG000|NOT COMPLETED|Overall Study||1
10820313|NCT00619151|11985104|FG001|NOT COMPLETED|Overall Study||0
10820314|NCT00622167|11985110|FG000|STARTED|Overall Study||24
10820315|NCT00622167|11985110|FG000|COMPLETED|Overall Study||4
10820316|NCT00622167|11985110|FG000|NOT COMPLETED|Overall Study||20
10820317|NCT00616577|11985117|FG000|STARTED|Overall Study||6
10820318|NCT00616577|11985118|FG001|STARTED|Overall Study||9
10820319|NCT00616577|11985119|FG002|STARTED|Overall Study||7
10751898|NCT03023826|11915563|FG002|STARTED|Period 2||5
10751899|NCT03023826|11915564|FG003|STARTED|Period 2||4
10751900|NCT03023826|11915565|FG004|STARTED|Period 2||3
10751901|NCT03023826|11915566|FG005|STARTED|Period 2||5
10751902|NCT03023826|11915561|FG000|COMPLETED|Period 2||4
10820320|NCT00616577|11985117|FG000|COMPLETED|Overall Study||6
10820321|NCT00616577|11985118|FG001|COMPLETED|Overall Study||9
10820322|NCT00616577|11985119|FG002|COMPLETED|Overall Study||7
10820323|NCT00616577|11985117|FG000|NOT COMPLETED|Overall Study||0
10820324|NCT00616577|11985118|FG001|NOT COMPLETED|Overall Study||0
10820325|NCT00616577|11985119|FG002|NOT COMPLETED|Overall Study||0
10820326|NCT00616759|11985129|FG000|STARTED|Overall Study||10
10820327|NCT00616759|11985130|FG001|STARTED|Overall Study||10
10820328|NCT00616759|11985129|FG000|COMPLETED|Overall Study||7
10820329|NCT00616759|11985130|FG001|COMPLETED|Overall Study||8
10820330|NCT00616759|11985129|FG000|NOT COMPLETED|Overall Study||3
10820331|NCT00616759|11985130|FG001|NOT COMPLETED|Overall Study||2
10820332|NCT00616642|11985138|FG000|STARTED|Overall Study||0
10820333|NCT00616642|11985139|FG001|STARTED|Overall Study||1
10820334|NCT00616642|11985138|FG000|COMPLETED|Overall Study||0
10751903|NCT03023826|11915562|FG001|COMPLETED|Period 2||4
10751904|NCT03023826|11915563|FG002|COMPLETED|Period 2||5
10751905|NCT03023826|11915564|FG003|COMPLETED|Period 2||4
10751906|NCT03023826|11915565|FG004|COMPLETED|Period 2||3
10751907|NCT03023826|11915566|FG005|COMPLETED|Period 2||5
10751908|NCT03023826|11915561|FG000|NOT COMPLETED|Period 2||0
10751909|NCT03023826|11915562|FG001|NOT COMPLETED|Period 2||0
10751910|NCT03023826|11915563|FG002|NOT COMPLETED|Period 2||0
10751911|NCT03023826|11915564|FG003|NOT COMPLETED|Period 2||0
10751912|NCT03023826|11915565|FG004|NOT COMPLETED|Period 2||0
10751913|NCT03023826|11915566|FG005|NOT COMPLETED|Period 2||0
10820335|NCT00616642|11985139|FG001|COMPLETED|Overall Study||0
10820336|NCT00616642|11985138|FG000|NOT COMPLETED|Overall Study||0
10820337|NCT00616642|11985139|FG001|NOT COMPLETED|Overall Study||1
10820338|NCT00619515|11985145|FG000|STARTED|Overall Study||73
10820339|NCT00619515|11985145|FG000|COMPLETED|Overall Study||0
10820340|NCT00619515|11985145|FG000|NOT COMPLETED|Overall Study||73
10820341|NCT00616343|11985149|FG000|STARTED|Overall Study||9
10820342|NCT00616343|11985149|FG000|COMPLETED|Overall Study||9
10820343|NCT00616343|11985149|FG000|NOT COMPLETED|Overall Study||0
10820344|NCT00612677|11985153|FG000|STARTED|Overall Study||1
10820345|NCT00612677|11985153|FG000|COMPLETED|Overall Study||0
10820346|NCT00612677|11985153|FG000|NOT COMPLETED|Overall Study||1
10820347|NCT00616603|11985160|FG000|STARTED|Overall Study||14
10820348|NCT00616603|11985161|FG001|STARTED|Overall Study||14
10820349|NCT00616603|11985162|FG002|STARTED|Overall Study||15
10820350|NCT00616603|11985160|FG000|COMPLETED|Overall Study||12
10820351|NCT00616603|11985161|FG001|COMPLETED|Overall Study||14
10820352|NCT00616603|11985162|FG002|COMPLETED|Overall Study||13
10820353|NCT00616603|11985160|FG000|NOT COMPLETED|Overall Study||2
10820354|NCT00616603|11985161|FG001|NOT COMPLETED|Overall Study||0
10820355|NCT00616603|11985162|FG002|NOT COMPLETED|Overall Study||2
10820356|NCT00613886|11985170|FG000|STARTED|Overall Study||24
10820357|NCT00613886|11985170|FG000|COMPLETED|Overall Study||0
10820358|NCT00613886|11985170|FG000|NOT COMPLETED|Overall Study||24
10820359|NCT00610467|11985177|FG000|STARTED|Overall Study||1
10820360|NCT00610467|11985178|FG001|STARTED|Overall Study||1
10820361|NCT00610467|11985177|FG000|COMPLETED|Overall Study||1
10820362|NCT00610467|11985178|FG001|COMPLETED|Overall Study||1
10820363|NCT00610467|11985177|FG000|NOT COMPLETED|Overall Study||0
10820364|NCT00610467|11985178|FG001|NOT COMPLETED|Overall Study||0
10820365|NCT00610558|11985187|FG000|STARTED|Overall Study||20
10820366|NCT00610558|11985188|FG001|STARTED|Overall Study||20
10820367|NCT00610558|11985189|FG002|STARTED|Overall Study||20
10820368|NCT00610558|11985187|FG000|COMPLETED|Overall Study||15
10820369|NCT00610558|11985188|FG001|COMPLETED|Overall Study||14
10820370|NCT00610558|11985189|FG002|COMPLETED|Overall Study||14
10820371|NCT00610558|11985187|FG000|NOT COMPLETED|Overall Study||5
10820372|NCT00610558|11985188|FG001|NOT COMPLETED|Overall Study||6
10820373|NCT00610558|11985189|FG002|NOT COMPLETED|Overall Study||6
10820374|NCT00610532|11985197|FG000|STARTED|Intravenous Phenytoin Alone||8
10820375|NCT00610532|11985197|FG000|COMPLETED|Intravenous Phenytoin Alone||8
10820376|NCT00610532|11985197|FG000|NOT COMPLETED|Intravenous Phenytoin Alone||0
10820377|NCT00610532|11985197|FG000|STARTED|Intravenous Phenytoin Plus Probenecid|one participant dropped out between periods|7
10820378|NCT00610532|11985197|FG000|COMPLETED|Intravenous Phenytoin Plus Probenecid||7
10820379|NCT00610532|11985197|FG000|NOT COMPLETED|Intravenous Phenytoin Plus Probenecid||0
10820380|NCT00609765|11985203|FG000|STARTED|Overall Study||1
10820381|NCT00609765|11985203|FG000|COMPLETED|Overall Study||0
10820382|NCT00609765|11985203|FG000|NOT COMPLETED|Overall Study||1
10820383|NCT00608465|11985207|FG000|STARTED|Overall Study||4
10820384|NCT00608465|11985207|FG000|COMPLETED|Overall Study||4
10820385|NCT00608465|11985207|FG000|NOT COMPLETED|Overall Study||0
10820386|NCT00608777|11985211|FG000|STARTED|Overall Study||6
10820387|NCT00608777|11985211|FG000|COMPLETED|Overall Study||6
10820388|NCT00608777|11985211|FG000|NOT COMPLETED|Overall Study||0
10820389|NCT00601848|11985215|FG000|STARTED|Overall Study||9
10820390|NCT00601848|11985215|FG000|COMPLETED|Overall Study||0
10820391|NCT00601848|11985215|FG000|NOT COMPLETED|Overall Study||9
10820392|NCT00607477|11985221|FG000|STARTED|Overall Study||0
10820393|NCT00607477|11985222|FG001|STARTED|Overall Study||2
10820394|NCT00607477|11985221|FG000|COMPLETED|Overall Study||0
10820395|NCT00607477|11985222|FG001|COMPLETED|Overall Study||2
10820396|NCT00607477|11985221|FG000|NOT COMPLETED|Overall Study||0
10751914|NCT03023826|11915561|FG000|STARTED|Period 3||4
10820397|NCT00607477|11985222|FG001|NOT COMPLETED|Overall Study||0
10820398|NCT00595920|11985228|FG000|STARTED|Overall Study||116
10820399|NCT00595920|11985228|FG000|Patients Dosed|Overall Study|116 patients enrolled; however, only 38 received at least 1 dose.|38
10820400|NCT00595920|11985228|FG000|COMPLETED|Overall Study||0
10820401|NCT00595920|11985228|FG000|NOT COMPLETED|Overall Study||116
10820402|NCT00596947|11985234|FG000|STARTED|Overall Study||9
10820403|NCT00596947|11985235|FG001|STARTED|Overall Study||9
10820404|NCT00596947|11985234|FG000|COMPLETED|Overall Study||3
10820405|NCT00596947|11985235|FG001|COMPLETED|Overall Study||6
10820406|NCT00596947|11985234|FG000|NOT COMPLETED|Overall Study||6
10820407|NCT00596947|11985235|FG001|NOT COMPLETED|Overall Study||3
10820408|NCT00584012|11985241|FG000|STARTED|Overall Study||9
10820409|NCT00584012|11985241|FG000|COMPLETED|Overall Study||8
10820410|NCT00584012|11985241|FG000|NOT COMPLETED|Overall Study||1
10820411|NCT00599131|11985245|FG000|STARTED|Overall Study||4
10751915|NCT03023826|11915562|FG001|STARTED|Period 3||4
10820412|NCT00599131|11985245|FG000|COMPLETED|Overall Study||4
10820413|NCT00599131|11985245|FG000|NOT COMPLETED|Overall Study||0
10820414|NCT00597909|11985252|FG000|STARTED|Overall Study||0
10820415|NCT00597909|11985253|FG001|STARTED|Overall Study||0
10820416|NCT00597909|11985254|FG002|STARTED|Overall Study||0
10820417|NCT00597909|11985252|FG000|COMPLETED|Overall Study||0
10820418|NCT00597909|11985253|FG001|COMPLETED|Overall Study||0
10820419|NCT00597909|11985254|FG002|COMPLETED|Overall Study||0
10820420|NCT00597909|11985252|FG000|NOT COMPLETED|Overall Study||0
10290204|NCT04780919|11422887|FG000|STARTED|Overall Study||9
10290205|NCT04780919|11422888|FG001|STARTED|Overall Study||9
10290206|NCT04780919|11422887|FG000|COMPLETED|Overall Study||9
10290207|NCT04780919|11422888|FG001|COMPLETED|Overall Study||9
10290208|NCT04780919|11422887|FG000|NOT COMPLETED|Overall Study||0
10290209|NCT04780919|11422888|FG001|NOT COMPLETED|Overall Study||0
10820421|NCT00597909|11985253|FG001|NOT COMPLETED|Overall Study||0
10820422|NCT00597909|11985254|FG002|NOT COMPLETED|Overall Study||0
10820423|NCT00593320|11985264|FG000|STARTED|Overall Study||1
10820424|NCT00593320|11985265|FG001|STARTED|Overall Study||1
10820425|NCT00593320|11985264|FG000|COMPLETED|Overall Study||1
10820426|NCT00593320|11985265|FG001|COMPLETED|Overall Study||1
10820427|NCT00593320|11985264|FG000|NOT COMPLETED|Overall Study||0
10820428|NCT00593320|11985265|FG001|NOT COMPLETED|Overall Study||0
10820429|NCT00589550|11985271|FG000|STARTED|Overall Study||1
10820430|NCT00589550|11985271|FG000|Withdrew From Study|Overall Study||1
10820431|NCT00589550|11985271|FG000|COMPLETED|Overall Study||0
10820432|NCT00589550|11985271|FG000|NOT COMPLETED|Overall Study||1
10820433|NCT00577772|11985277|FG000|STARTED|Overall Study||10
10820434|NCT00577772|11985278|FG001|STARTED|Overall Study||7
10820435|NCT00577772|11985277|FG000|COMPLETED|Overall Study||10
10820436|NCT00577772|11985278|FG001|COMPLETED|Overall Study||6
10820437|NCT00577772|11985277|FG000|NOT COMPLETED|Overall Study||0
10820438|NCT00577772|11985278|FG001|NOT COMPLETED|Overall Study||1
10820439|NCT00592007|11985284|FG000|STARTED|Overall Study||7
10820440|NCT00592007|11985284|FG000|COMPLETED|Overall Study||5
10820441|NCT00592007|11985284|FG000|NOT COMPLETED|Overall Study||2
10820442|NCT00595582|11985288|FG000|STARTED|Overall Study||10
10820443|NCT00595582|11985288|FG000|COMPLETED|Overall Study||0
10820444|NCT00595582|11985288|FG000|NOT COMPLETED|Overall Study||10
10820445|NCT00588146|11985292|FG000|STARTED|First Intervention (Baseline to 6 mo)||5
10820446|NCT00588146|11985293|FG001|STARTED|First Intervention (Baseline to 6 mo)||5
10820447|NCT00588146|11985292|FG000|COMPLETED|First Intervention (Baseline to 6 mo)||1
10820448|NCT00588146|11985293|FG001|COMPLETED|First Intervention (Baseline to 6 mo)||2
10820449|NCT00588146|11985292|FG000|NOT COMPLETED|First Intervention (Baseline to 6 mo)||4
10820450|NCT00588146|11985293|FG001|NOT COMPLETED|First Intervention (Baseline to 6 mo)||3
10820451|NCT00588146|11985292|FG000|STARTED|Second Intervention (6 Months to 1 Year)||1
10820452|NCT00588146|11985293|FG001|STARTED|Second Intervention (6 Months to 1 Year)||2
10751916|NCT03023826|11915563|FG002|STARTED|Period 3||5
10751917|NCT03023826|11915564|FG003|STARTED|Period 3||4
10751918|NCT03023826|11915565|FG004|STARTED|Period 3||3
10751919|NCT03023826|11915566|FG005|STARTED|Period 3||5
10751920|NCT03023826|11915561|FG000|COMPLETED|Period 3||4
10751921|NCT03023826|11915562|FG001|COMPLETED|Period 3||4
10751922|NCT03023826|11915563|FG002|COMPLETED|Period 3||5
10751923|NCT03023826|11915564|FG003|COMPLETED|Period 3||4
10751924|NCT03023826|11915565|FG004|COMPLETED|Period 3||3
10751925|NCT03023826|11915566|FG005|COMPLETED|Period 3||5
10751926|NCT03023826|11915561|FG000|NOT COMPLETED|Period 3||0
10820453|NCT00588146|11985292|FG000|COMPLETED|Second Intervention (6 Months to 1 Year)||1
10820454|NCT00588146|11985293|FG001|COMPLETED|Second Intervention (6 Months to 1 Year)||2
10820455|NCT00588146|11985292|FG000|NOT COMPLETED|Second Intervention (6 Months to 1 Year)||0
10820456|NCT00588146|11985293|FG001|NOT COMPLETED|Second Intervention (6 Months to 1 Year)||0
10290222|NCT04773028|11422907|FG000|STARTED|Overall Study||24
10751927|NCT03023826|11915562|FG001|NOT COMPLETED|Period 3||0
10820457|NCT00586209|11985301|FG000|STARTED|Overall Study||5
10820458|NCT00586209|11985302|FG001|STARTED|Overall Study||10
10820459|NCT00586209|11985301|FG000|COMPLETED|Overall Study||5
10820460|NCT00586209|11985302|FG001|COMPLETED|Overall Study||10
10290223|NCT04773028|11422908|FG001|STARTED|Overall Study||24
10290224|NCT04773028|11422907|FG000|COMPLETED|Overall Study||24
10751928|NCT03023826|11915563|FG002|NOT COMPLETED|Period 3||0
10751929|NCT03023826|11915564|FG003|NOT COMPLETED|Period 3||0
10751930|NCT03023826|11915565|FG004|NOT COMPLETED|Period 3||0
10751931|NCT03023826|11915566|FG005|NOT COMPLETED|Period 3||0
10751932|NCT03023878|11915574|FG000|STARTED|Pre-Study Run-In Period||47
10751933|NCT03023878|11915574|FG000|COMPLETED|Pre-Study Run-In Period||30
10751934|NCT03023878|11915574|FG000|NOT COMPLETED|Pre-Study Run-In Period||17
10751935|NCT03023878|11915574|FG000|STARTED|Between Run-In and Treatment Periods||30
10751936|NCT03023878|11915574|FG000|COMPLETED|Between Run-In and Treatment Periods||28
10751937|NCT03023878|11915574|FG000|NOT COMPLETED|Between Run-In and Treatment Periods||2
10751938|NCT03023878|11915574|FG000|STARTED|Treatment Period||28
10751939|NCT03023878|11915574|FG000|Started Cycle 1|Treatment Period||28
10751940|NCT03023878|11915574|FG000|Started Cycle 2|Treatment Period||11
10751941|NCT03023878|11915574|FG000|COMPLETED|Treatment Period||25
10751942|NCT03023878|11915574|FG000|NOT COMPLETED|Treatment Period||3
10751943|NCT03023878|11915574|FG000|STARTED|Long Term Follow-Up Period||28
10751944|NCT03023878|11915574|FG000|COMPLETED|Long Term Follow-Up Period||26
10751945|NCT03023878|11915574|FG000|NOT COMPLETED|Long Term Follow-Up Period||2
10751946|NCT03023891|11915578|FG000|STARTED|Overall Study||18
10751947|NCT03023891|11915578|FG000|COMPLETED|Overall Study||18
10751948|NCT03023891|11915578|FG000|NOT COMPLETED|Overall Study||0
10751949|NCT03024112|11915584|FG000|STARTED|Overall Study||25
10751950|NCT03024112|11915585|FG001|STARTED|Overall Study||26
10751951|NCT03024112|11915584|FG000|COMPLETED|Overall Study||18
10751952|NCT03024112|11915585|FG001|COMPLETED|Overall Study||26
10751953|NCT03024112|11915584|FG000|NOT COMPLETED|Overall Study||7
10751954|NCT03024112|11915585|FG001|NOT COMPLETED|Overall Study||0
10751955|NCT03024606|11915593|FG000|STARTED|Overall Study||23
10751956|NCT03024606|11915594|FG001|STARTED|Overall Study||26
10751957|NCT03024606|11915593|FG000|COMPLETED|Overall Study||14
10751958|NCT03024606|11915594|FG001|COMPLETED|Overall Study||16
10751959|NCT03024606|11915593|FG000|NOT COMPLETED|Overall Study||9
10751960|NCT03024606|11915594|FG001|NOT COMPLETED|Overall Study||10
10751961|NCT03024970|11915600|FG000|STARTED|First Intervention||34
10751962|NCT03024970|11915601|FG001|STARTED|First Intervention||38
10751963|NCT03024970|11915600|FG000|COMPLETED|First Intervention||33
10751964|NCT03024970|11915601|FG001|COMPLETED|First Intervention||38
10751965|NCT03024970|11915600|FG000|NOT COMPLETED|First Intervention||1
10751966|NCT03024970|11915601|FG001|NOT COMPLETED|First Intervention||0
10751967|NCT03024970|11915600|FG000|STARTED|Second Intervention||33
10751968|NCT03024970|11915601|FG001|STARTED|Second Intervention||38
10751969|NCT03024970|11915600|FG000|COMPLETED|Second Intervention||32
10751970|NCT03024970|11915601|FG001|COMPLETED|Second Intervention||38
10751971|NCT03024970|11915600|FG000|NOT COMPLETED|Second Intervention||1
10751972|NCT03024970|11915601|FG001|NOT COMPLETED|Second Intervention||0
10751973|NCT03025217|11915607|FG000|STARTED|Overall Study||31
10751974|NCT03025217|11915607|FG000|COMPLETED|Overall Study||27
10751975|NCT03025217|11915607|FG000|NOT COMPLETED|Overall Study||4
10751976|NCT03025945|11915613|FG000|STARTED|Overall Study||331
10751977|NCT03025945|11915614|FG001|STARTED|Overall Study||331
10751978|NCT03025945|11915613|FG000|COMPLETED|Overall Study||331
10751979|NCT03025945|11915614|FG001|COMPLETED|Overall Study||331
10751980|NCT03025945|11915613|FG000|NOT COMPLETED|Overall Study||0
10751981|NCT03025945|11915614|FG001|NOT COMPLETED|Overall Study||0
10751982|NCT03026075|11915620|FG000|STARTED|Overall Study||47
10751983|NCT03026075|11915620|FG000|COMPLETED|Overall Study||46
10751984|NCT03026075|11915620|FG000|NOT COMPLETED|Overall Study||1
10751985|NCT03026088|11915624|FG000|STARTED|Overall Study||20
10751986|NCT03026088|11915624|FG000|COMPLETED|Overall Study||0
10751987|NCT03026088|11915624|FG000|NOT COMPLETED|Overall Study||20
10751988|NCT03026166|11915630|FG000|STARTED|Overall Study||30
10751989|NCT03026166|11915631|FG001|STARTED|Overall Study||12
10751990|NCT03026166|11915630|FG000|COMPLETED|Overall Study||0
10751991|NCT03026166|11915631|FG001|COMPLETED|Overall Study||0
10751992|NCT03026166|11915630|FG000|NOT COMPLETED|Overall Study||30
10751993|NCT03026166|11915631|FG001|NOT COMPLETED|Overall Study||12
10751994|NCT03026257|11915643|FG000|STARTED|Overall Study||60
10751995|NCT03026257|11915644|FG001|STARTED|Overall Study||64
10751996|NCT03026257|11915645|FG002|STARTED|Overall Study||34
10751997|NCT03026257|11915646|FG003|STARTED|Overall Study||25
10751998|NCT03026257|11915647|FG004|STARTED|Overall Study||23
10751999|NCT03026257|11915648|FG005|STARTED|Overall Study||46
10752000|NCT03026257|11915643|FG000|Treated|Overall Study||58
10752001|NCT03026257|11915644|FG001|Treated|Overall Study||65
10752002|NCT03026257|11915645|FG002|Treated|Overall Study||35
10752003|NCT03026257|11915646|FG003|Treated|Overall Study||24
10752004|NCT03026257|11915647|FG004|Treated|Overall Study||23
10752005|NCT03026257|11915648|FG005|Treated|Overall Study||47
10752006|NCT03026257|11915643|FG000|COMPLETED|Overall Study||54
10752007|NCT03026257|11915644|FG001|COMPLETED|Overall Study||63
10752008|NCT03026257|11915645|FG002|COMPLETED|Overall Study||34
10752009|NCT03026257|11915646|FG003|COMPLETED|Overall Study||24
10752010|NCT03026257|11915647|FG004|COMPLETED|Overall Study||22
10752011|NCT03026257|11915648|FG005|COMPLETED|Overall Study||46
10752012|NCT03026257|11915643|FG000|NOT COMPLETED|Overall Study||6
10752013|NCT03026257|11915644|FG001|NOT COMPLETED|Overall Study||1
10752014|NCT03026257|11915645|FG002|NOT COMPLETED|Overall Study||0
10752015|NCT03026257|11915646|FG003|NOT COMPLETED|Overall Study||1
10752016|NCT03026257|11915647|FG004|NOT COMPLETED|Overall Study||1
10752017|NCT03026257|11915648|FG005|NOT COMPLETED|Overall Study||0
10752018|NCT03026283|11915662|FG000|STARTED|CCTA Diagnosis||586
10752019|NCT03026283|11915663|FG001|STARTED|CCTA Diagnosis||0
10752020|NCT03026283|11915664|FG002|STARTED|CCTA Diagnosis||0
10752021|NCT03026283|11915665|FG003|STARTED|CCTA Diagnosis||0
10752022|NCT03026283|11915666|FG004|STARTED|CCTA Diagnosis||0
10752023|NCT03026283|11915667|FG005|STARTED|CCTA Diagnosis||0
10752024|NCT03026283|11915668|FG006|STARTED|CCTA Diagnosis||0
10752025|NCT03026283|11915669|FG007|STARTED|CCTA Diagnosis||0
10752026|NCT03026283|11915662|FG000|COMPLETED|CCTA Diagnosis||572
10752027|NCT03026283|11915663|FG001|COMPLETED|CCTA Diagnosis||0
10752028|NCT03026283|11915664|FG002|COMPLETED|CCTA Diagnosis||0
10752029|NCT03026283|11915665|FG003|COMPLETED|CCTA Diagnosis||0
10752030|NCT03026283|11915666|FG004|COMPLETED|CCTA Diagnosis||0
10752031|NCT03026283|11915667|FG005|COMPLETED|CCTA Diagnosis||0
10752032|NCT03026283|11915668|FG006|COMPLETED|CCTA Diagnosis||0
10752033|NCT03026283|11915669|FG007|COMPLETED|CCTA Diagnosis||0
10752034|NCT03026283|11915662|FG000|NOT COMPLETED|CCTA Diagnosis||14
10752035|NCT03026283|11915663|FG001|NOT COMPLETED|CCTA Diagnosis||0
10752036|NCT03026283|11915664|FG002|NOT COMPLETED|CCTA Diagnosis||0
10752037|NCT03026283|11915665|FG003|NOT COMPLETED|CCTA Diagnosis||0
10752038|NCT03026283|11915666|FG004|NOT COMPLETED|CCTA Diagnosis||0
10752039|NCT03026283|11915667|FG005|NOT COMPLETED|CCTA Diagnosis||0
10752040|NCT03026283|11915668|FG006|NOT COMPLETED|CCTA Diagnosis||0
10752041|NCT03026283|11915669|FG007|NOT COMPLETED|CCTA Diagnosis||0
10752042|NCT03026283|11915662|FG000|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
10752043|NCT03026283|11915663|FG001|STARTED|Optimal Medical Care/FFR-CT Diagnosis||289
10752044|NCT03026283|11915664|FG002|STARTED|Optimal Medical Care/FFR-CT Diagnosis||280
10752045|NCT03026283|11915665|FG003|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
10752046|NCT03026283|11915666|FG004|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
10752047|NCT03026283|11915667|FG005|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
10752048|NCT03026283|11915668|FG006|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
10752049|NCT03026283|11915669|FG007|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
10752050|NCT03026283|11915662|FG000|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
10752051|NCT03026283|11915663|FG001|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||286
10752052|NCT03026283|11915664|FG002|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||265
10752053|NCT03026283|11915665|FG003|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
10752054|NCT03026283|11915666|FG004|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
10752055|NCT03026283|11915667|FG005|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
10752056|NCT03026283|11915668|FG006|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
10752057|NCT03026283|11915669|FG007|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
10752058|NCT03026283|11915662|FG000|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
10752059|NCT03026283|11915663|FG001|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||3
10752060|NCT03026283|11915664|FG002|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||15
10752061|NCT03026283|11915665|FG003|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
10752062|NCT03026283|11915666|FG004|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
10752063|NCT03026283|11915667|FG005|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
10752064|NCT03026283|11915668|FG006|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
10752065|NCT03026283|11915669|FG007|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
10752066|NCT03026283|11915662|FG000|STARTED|Optimal Care/Stress Test/ICA||0
10752067|NCT03026283|11915663|FG001|STARTED|Optimal Care/Stress Test/ICA||0
10752068|NCT03026283|11915664|FG002|STARTED|Optimal Care/Stress Test/ICA||0
10752069|NCT03026283|11915665|FG003|STARTED|Optimal Care/Stress Test/ICA||128
10752070|NCT03026283|11915666|FG004|STARTED|Optimal Care/Stress Test/ICA||52
10752071|NCT03026283|11915667|FG005|STARTED|Optimal Care/Stress Test/ICA||101
10752072|NCT03026283|11915668|FG006|STARTED|Optimal Care/Stress Test/ICA||0
10752073|NCT03026283|11915669|FG007|STARTED|Optimal Care/Stress Test/ICA||0
10752074|NCT03026283|11915662|FG000|COMPLETED|Optimal Care/Stress Test/ICA||0
10752075|NCT03026283|11915663|FG001|COMPLETED|Optimal Care/Stress Test/ICA||0
10752076|NCT03026283|11915664|FG002|COMPLETED|Optimal Care/Stress Test/ICA||0
10752077|NCT03026283|11915665|FG003|COMPLETED|Optimal Care/Stress Test/ICA||108
10752078|NCT03026283|11915666|FG004|COMPLETED|Optimal Care/Stress Test/ICA||14
10752079|NCT03026283|11915667|FG005|COMPLETED|Optimal Care/Stress Test/ICA||73
10752080|NCT03026283|11915668|FG006|COMPLETED|Optimal Care/Stress Test/ICA||0
10752081|NCT03026283|11915669|FG007|COMPLETED|Optimal Care/Stress Test/ICA||0
10752082|NCT03026283|11915662|FG000|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
10752083|NCT03026283|11915663|FG001|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
10752084|NCT03026283|11915664|FG002|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
10752085|NCT03026283|11915665|FG003|NOT COMPLETED|Optimal Care/Stress Test/ICA||20
10752086|NCT03026283|11915666|FG004|NOT COMPLETED|Optimal Care/Stress Test/ICA||38
10752087|NCT03026283|11915667|FG005|NOT COMPLETED|Optimal Care/Stress Test/ICA||28
10752088|NCT03026283|11915668|FG006|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
10752089|NCT03026283|11915669|FG007|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
10752090|NCT03026283|11915662|FG000|STARTED|Optimal Care/ICA Diagnostic Cath||0
10752091|NCT03026283|11915663|FG001|STARTED|Optimal Care/ICA Diagnostic Cath||0
10752092|NCT03026283|11915664|FG002|STARTED|Optimal Care/ICA Diagnostic Cath||0
10752093|NCT03026283|11915665|FG003|STARTED|Optimal Care/ICA Diagnostic Cath||0
10752094|NCT03026283|11915666|FG004|STARTED|Optimal Care/ICA Diagnostic Cath||0
10752095|NCT03026283|11915667|FG005|STARTED|Optimal Care/ICA Diagnostic Cath||0
10752096|NCT03026283|11915668|FG006|STARTED|Optimal Care/ICA Diagnostic Cath||21
10752097|NCT03026283|11915669|FG007|STARTED|Optimal Care/ICA Diagnostic Cath||0
10752098|NCT03026283|11915662|FG000|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
10752099|NCT03026283|11915663|FG001|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
10752100|NCT03026283|11915664|FG002|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
10752101|NCT03026283|11915665|FG003|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
10752102|NCT03026283|11915666|FG004|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
10752103|NCT03026283|11915667|FG005|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
10752104|NCT03026283|11915668|FG006|COMPLETED|Optimal Care/ICA Diagnostic Cath||21
10752105|NCT03026283|11915669|FG007|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
10752106|NCT03026283|11915662|FG000|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
10752107|NCT03026283|11915663|FG001|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
10752108|NCT03026283|11915664|FG002|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
10752109|NCT03026283|11915665|FG003|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
10752110|NCT03026283|11915666|FG004|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
10752111|NCT03026283|11915667|FG005|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
10752112|NCT03026283|11915668|FG006|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
10752113|NCT03026283|11915669|FG007|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
10752114|NCT03026530|11915684|FG000|STARTED|Overall Study||100
10752115|NCT03026530|11915685|FG001|STARTED|Overall Study||100
10752116|NCT03026530|11915684|FG000|COMPLETED|Overall Study||79
10752117|NCT03026530|11915685|FG001|COMPLETED|Overall Study||71
10752118|NCT03026530|11915684|FG000|NOT COMPLETED|Overall Study||21
10752119|NCT03026530|11915685|FG001|NOT COMPLETED|Overall Study||29
10752120|NCT03026556|11915694|FG000|STARTED|Overall Study||12763
10752121|NCT03026556|11915695|FG001|STARTED|Overall Study||17177
10752122|NCT03026556|11915696|FG002|STARTED|Overall Study||12594
10752123|NCT03026556|11915694|FG000|COMPLETED|Overall Study||12763
10752124|NCT03026556|11915695|FG001|COMPLETED|Overall Study||17177
10752125|NCT03026556|11915696|FG002|COMPLETED|Overall Study||12594
10752126|NCT03026556|11915694|FG000|NOT COMPLETED|Overall Study||0
10752127|NCT03026556|11915695|FG001|NOT COMPLETED|Overall Study||0
10752128|NCT03026556|11915696|FG002|NOT COMPLETED|Overall Study||0
10752129|NCT03026777|11915707|FG000|STARTED|Overall Study||168
10752130|NCT03026777|11915708|FG001|STARTED|Overall Study||169
10752131|NCT03026777|11915707|FG000|COMPLETED|Overall Study||168
10752132|NCT03026777|11915708|FG001|COMPLETED|Overall Study||169
10752133|NCT03026777|11915707|FG000|NOT COMPLETED|Overall Study||0
10752134|NCT03026777|11915708|FG001|NOT COMPLETED|Overall Study||0
10752135|NCT03026803|11915714|FG000|STARTED|Overall Study||4
10752136|NCT03026803|11915714|FG000|COMPLETED|Overall Study||4
10752137|NCT03026803|11915714|FG000|NOT COMPLETED|Overall Study||0
10752138|NCT03027466|11915722|FG000|STARTED|Overall Study||2027
10752139|NCT03027466|11915723|FG001|STARTED|Overall Study||1984
10752140|NCT03027466|11915724|FG002|STARTED|Overall Study||1903
10752141|NCT03027466|11915725|FG003|STARTED|Overall Study||1985
10752142|NCT03027466|11915722|FG000|COMPLETED|Overall Study||158
10752143|NCT03027466|11915723|FG001|COMPLETED|Overall Study||165
10752144|NCT03027466|11915724|FG002|COMPLETED|Overall Study||160
10752145|NCT03027466|11915725|FG003|COMPLETED|Overall Study||164
10752146|NCT03027466|11915722|FG000|NOT COMPLETED|Overall Study||1869
10752147|NCT03027466|11915723|FG001|NOT COMPLETED|Overall Study||1819
10752148|NCT03027466|11915724|FG002|NOT COMPLETED|Overall Study||1743
10752149|NCT03027466|11915725|FG003|NOT COMPLETED|Overall Study||1821
10752150|NCT03027557|11915738|FG000|STARTED|Overall Study||15
10752151|NCT03027557|11915739|FG001|STARTED|Overall Study||16
10752152|NCT03027557|11915740|FG002|STARTED|Overall Study||15
10752153|NCT03027557|11915738|FG000|COMPLETED|Overall Study||14
10752154|NCT03027557|11915739|FG001|COMPLETED|Overall Study||16
10752155|NCT03027557|11915740|FG002|COMPLETED|Overall Study||15
10752156|NCT03027557|11915738|FG000|NOT COMPLETED|Overall Study||1
10752157|NCT03027557|11915739|FG001|NOT COMPLETED|Overall Study||0
10752158|NCT03027557|11915740|FG002|NOT COMPLETED|Overall Study||0
10752159|NCT03027661|11915750|FG000|STARTED|Overall Study||20
10752160|NCT03027661|11915751|FG001|STARTED|Overall Study||21
10752161|NCT03027661|11915750|FG000|COMPLETED|Overall Study||20
10752162|NCT03027661|11915751|FG001|COMPLETED|Overall Study||21
10752163|NCT03027661|11915750|FG000|NOT COMPLETED|Overall Study||0
10752164|NCT03027661|11915751|FG001|NOT COMPLETED|Overall Study||0
10752165|NCT03028012|11915760|FG000|STARTED|Overall Study||4
10752166|NCT03028012|11915761|FG001|STARTED|Overall Study||3
10752167|NCT03028012|11915762|FG002|STARTED|Overall Study||3
10752168|NCT03028012|11915760|FG000|COMPLETED|Overall Study||2
10752169|NCT03028012|11915761|FG001|COMPLETED|Overall Study||0
10752170|NCT03028012|11915762|FG002|COMPLETED|Overall Study||0
10752171|NCT03028012|11915760|FG000|NOT COMPLETED|Overall Study||2
10752172|NCT03028012|11915761|FG001|NOT COMPLETED|Overall Study||3
10752173|NCT03028012|11915762|FG002|NOT COMPLETED|Overall Study||3
10752174|NCT03028025|11915773|FG000|STARTED|Overall Study||90
10752175|NCT03028025|11915774|FG001|STARTED|Overall Study||94
10752176|NCT03028025|11915773|FG000|COMPLETED|Overall Study||87
10752177|NCT03028025|11915774|FG001|COMPLETED|Overall Study||93
10752178|NCT03028025|11915773|FG000|NOT COMPLETED|Overall Study||3
10752179|NCT03028025|11915774|FG001|NOT COMPLETED|Overall Study||1
10752180|NCT03028103|11915782|FG000|STARTED|Overall Study||16
10752181|NCT03028103|11915783|FG001|STARTED|Overall Study||16
10752182|NCT03028103|11915782|FG000|COMPLETED|Overall Study||16
10752183|NCT03028103|11915783|FG001|COMPLETED|Overall Study||16
10752184|NCT03028103|11915782|FG000|NOT COMPLETED|Overall Study||0
10752185|NCT03028103|11915783|FG001|NOT COMPLETED|Overall Study||0
10752186|NCT03028129|11915795|FG000|STARTED|Overall Study||258
10752187|NCT03028129|11915796|FG001|STARTED|Overall Study||209
10752188|NCT03028129|11915795|FG000|COMPLETED|Overall Study||132
10752189|NCT03028129|11915796|FG001|COMPLETED|Overall Study||122
10752190|NCT03028129|11915795|FG000|NOT COMPLETED|Overall Study||126
10820461|NCT00586209|11985301|FG000|NOT COMPLETED|Overall Study||0
10820462|NCT00586209|11985302|FG001|NOT COMPLETED|Overall Study||0
10820463|NCT00590538|11985308|FG000|STARTED|Overall Study|STUDY NOT UNBLINDED AT TIME OF TERMINATION; THEREFORE NUMBER ASSIGNED TO EACH GROUP IS NOT KNOWN.|9
10820464|NCT00590538|11985308|FG000|COMPLETED|Overall Study||7
10820465|NCT00590538|11985308|FG000|NOT COMPLETED|Overall Study||2
10820466|NCT00583115|11985312|FG000|STARTED|Overall Study||1
10820467|NCT00583115|11985312|FG000|COMPLETED|Overall Study||0
10820468|NCT00583115|11985312|FG000|NOT COMPLETED|Overall Study||1
10820469|NCT00582712|11985316|FG000|STARTED|Overall Study||5
10820470|NCT00582712|11985316|FG000|COMPLETED|Overall Study||1
10820471|NCT00582712|11985316|FG000|NOT COMPLETED|Overall Study||4
10820472|NCT00586716|11985322|FG000|STARTED|Overall Study||14
10820473|NCT00586716|11985323|FG001|STARTED|Overall Study||8
10820474|NCT00586716|11985322|FG000|COMPLETED|Overall Study||14
10820475|NCT00586716|11985323|FG001|COMPLETED|Overall Study||8
10820476|NCT00586716|11985322|FG000|NOT COMPLETED|Overall Study||0
10820477|NCT00586716|11985323|FG001|NOT COMPLETED|Overall Study||0
10820478|NCT00583466|11985330|FG000|STARTED|Overall Study||18
10820479|NCT00583466|11985330|FG000|COMPLETED|Overall Study||18
10820480|NCT00583466|11985330|FG000|NOT COMPLETED|Overall Study||0
10820481|NCT00588471|11985338|FG000|STARTED|Overall Study||28
10820482|NCT00588471|11985339|FG001|STARTED|Overall Study||29
10820483|NCT00588471|11985338|FG000|COMPLETED|Overall Study||28
10820484|NCT00588471|11985339|FG001|COMPLETED|Overall Study||29
10820485|NCT00588471|11985338|FG000|NOT COMPLETED|Overall Study||0
10820486|NCT00588471|11985339|FG001|NOT COMPLETED|Overall Study||0
10820487|NCT00587795|11985347|FG000|STARTED|Overall Study||1
10820488|NCT00587795|11985348|FG001|STARTED|Overall Study||0
10820489|NCT00587795|11985347|FG000|COMPLETED|Overall Study||0
10820490|NCT00587795|11985348|FG001|COMPLETED|Overall Study||0
10820491|NCT00587795|11985347|FG000|NOT COMPLETED|Overall Study||1
10820492|NCT00587795|11985348|FG001|NOT COMPLETED|Overall Study||0
10820493|NCT00590135|11985354|FG000|STARTED|Overall Study||59
10820494|NCT00590135|11985354|FG000|COMPLETED|Overall Study||0
10820495|NCT00590135|11985354|FG000|NOT COMPLETED|Overall Study||59
10820496|NCT00582036|11985361|FG000|STARTED|Overall Study||5
10820497|NCT00582036|11985362|FG001|STARTED|Overall Study||6
10820498|NCT00582036|11985361|FG000|COMPLETED|Overall Study||5
10820499|NCT00582036|11985362|FG001|COMPLETED|Overall Study|One patient withdrew consent|5
10820500|NCT00582036|11985361|FG000|NOT COMPLETED|Overall Study||0
10820501|NCT00582036|11985362|FG001|NOT COMPLETED|Overall Study||1
10820502|NCT00585585|11985368|FG000|STARTED|Overall Study||1
10820503|NCT00585585|11985368|FG000|Patients Receiving Drug|Overall Study||1
10820504|NCT00585585|11985368|FG000|COMPLETED|Overall Study||0
10820505|NCT00585585|11985368|FG000|NOT COMPLETED|Overall Study||1
10820506|NCT00585221|11985372|FG000|STARTED|Overall Study||8
10820507|NCT00585221|11985372|FG000|COMPLETED|Overall Study||0
10820508|NCT00585221|11985372|FG000|NOT COMPLETED|Overall Study||8
10820509|NCT00581113|11985378|FG000|STARTED|Overall Study||4
10820510|NCT00581113|11985379|FG001|STARTED|Overall Study||4
10820511|NCT00581113|11985378|FG000|COMPLETED|Overall Study||4
10820512|NCT00581113|11985379|FG001|COMPLETED|Overall Study||3
10820513|NCT00581113|11985378|FG000|NOT COMPLETED|Overall Study||0
10820514|NCT00581113|11985379|FG001|NOT COMPLETED|Overall Study||1
10820515|NCT00579254|11985385|FG000|STARTED|Overall Study||112
10820516|NCT00579254|11985385|FG000|COMPLETED|Overall Study||0
10820517|NCT00579254|11985385|FG000|NOT COMPLETED|Overall Study||112
10820518|NCT00587223|11985389|FG000|STARTED|Overall Study|Study design was within-subject control. Only 1 subject was enrolled in the study.|1
10820519|NCT00587223|11985389|FG000|COMPLETED|Overall Study|Subject withdrawn from study at Day 7.|0
10820520|NCT00587223|11985389|FG000|NOT COMPLETED|Overall Study||1
10820521|NCT00585611|11985398|FG000|STARTED|Overall Study||0
10752191|NCT03028129|11915796|FG001|NOT COMPLETED|Overall Study||87
10752192|NCT03028142|11915802|FG000|STARTED|Overall Study||5
10752193|NCT03028142|11915803|FG001|STARTED|Overall Study||5
10752194|NCT03028142|11915804|FG002|STARTED|Overall Study||6
10752195|NCT03028142|11915805|FG003|STARTED|Overall Study||4
10752196|NCT03028142|11915806|FG004|STARTED|Overall Study||6
10752197|NCT03028142|11915807|FG005|STARTED|Overall Study||4
10752198|NCT03028142|11915802|FG000|COMPLETED|Overall Study||4
10752199|NCT03028142|11915803|FG001|COMPLETED|Overall Study||4
10820522|NCT00585611|11985399|FG001|STARTED|Overall Study||0
10820523|NCT00585611|11985398|FG000|COMPLETED|Overall Study||0
10820524|NCT00585611|11985399|FG001|COMPLETED|Overall Study||0
10752200|NCT03028142|11915804|FG002|COMPLETED|Overall Study||6
10752201|NCT03028142|11915805|FG003|COMPLETED|Overall Study||4
10752202|NCT03028142|11915806|FG004|COMPLETED|Overall Study||5
10752203|NCT03028142|11915807|FG005|COMPLETED|Overall Study||3
10752204|NCT03028142|11915802|FG000|NOT COMPLETED|Overall Study||1
10820525|NCT00585611|11985398|FG000|NOT COMPLETED|Overall Study||0
10820526|NCT00585611|11985399|FG001|NOT COMPLETED|Overall Study||0
10820527|NCT00572260|11985405|FG000|STARTED|Overall Study||11
10820528|NCT00572260|11985405|FG000|COMPLETED|Overall Study||11
10820529|NCT00572260|11985405|FG000|NOT COMPLETED|Overall Study||0
10820530|NCT00571194|11985409|FG000|STARTED|Overall Study||7
10820531|NCT00571194|11985409|FG000|COMPLETED|Overall Study||7
10820532|NCT00571194|11985409|FG000|NOT COMPLETED|Overall Study||0
10752205|NCT03028142|11915803|FG001|NOT COMPLETED|Overall Study||1
10752206|NCT03028142|11915804|FG002|NOT COMPLETED|Overall Study||0
10752207|NCT03028142|11915805|FG003|NOT COMPLETED|Overall Study||0
10752208|NCT03028142|11915806|FG004|NOT COMPLETED|Overall Study||1
10752209|NCT03028142|11915807|FG005|NOT COMPLETED|Overall Study||1
10752210|NCT03028220|11915818|FG000|STARTED|Overall Study||20
10752211|NCT03028220|11915819|FG001|STARTED|Overall Study||20
10752212|NCT03028220|11915818|FG000|COMPLETED|Overall Study||20
10752213|NCT03028220|11915819|FG001|COMPLETED|Overall Study||20
10752214|NCT03028220|11915818|FG000|NOT COMPLETED|Overall Study||0
10752215|NCT03028220|11915819|FG001|NOT COMPLETED|Overall Study||0
10752216|NCT03028324|11915825|FG000|STARTED|Overall Study||4
10752217|NCT03028324|11915825|FG000|COMPLETED|Overall Study||4
10752218|NCT03028324|11915825|FG000|NOT COMPLETED|Overall Study||0
10752219|NCT03028363|11915831|FG000|STARTED|Overall Study||498
10752220|NCT03028363|11915832|FG001|STARTED|Overall Study||261
10752221|NCT03028363|11915831|FG000|COMPLETED|Overall Study||420
10752222|NCT03028363|11915832|FG001|COMPLETED|Overall Study||228
10752223|NCT03028363|11915831|FG000|NOT COMPLETED|Overall Study||78
10752224|NCT03028363|11915832|FG001|NOT COMPLETED|Overall Study||33
10752225|NCT03028415|11915840|FG000|STARTED|Overall Study||39
10752226|NCT03028415|11915841|FG001|STARTED|Overall Study||17
10752227|NCT03028415|11915840|FG000|Modified Intention-to-treat (mITT) Population|Overall Study||39
10752228|NCT03028415|11915841|FG001|Modified Intention-to-treat (mITT) Population|Overall Study||17
10752229|NCT03028415|11915840|FG000|COMPLETED|Overall Study||31
10752230|NCT03028415|11915841|FG001|COMPLETED|Overall Study||14
10752231|NCT03028415|11915840|FG000|NOT COMPLETED|Overall Study||8
10752232|NCT03028415|11915841|FG001|NOT COMPLETED|Overall Study||3
10752233|NCT03028467|11915852|FG000|STARTED|Overall Study||4
10752234|NCT03028467|11915853|FG001|STARTED|Overall Study||3
10752235|NCT03028467|11915854|FG002|STARTED|Overall Study||4
10752236|NCT03028467|11915855|FG003|STARTED|Overall Study||4
10752237|NCT03028467|11915852|FG000|COMPLETED|Overall Study||4
10752238|NCT03028467|11915853|FG001|COMPLETED|Overall Study||3
10752239|NCT03028467|11915854|FG002|COMPLETED|Overall Study||4
10752240|NCT03028467|11915855|FG003|COMPLETED|Overall Study||4
10752241|NCT03028467|11915852|FG000|NOT COMPLETED|Overall Study||0
10752242|NCT03028467|11915853|FG001|NOT COMPLETED|Overall Study||0
10752243|NCT03028467|11915854|FG002|NOT COMPLETED|Overall Study||0
10752244|NCT03028467|11915855|FG003|NOT COMPLETED|Overall Study||0
10752245|NCT03028636|11915868|FG000|STARTED|Overall Study||17
10752246|NCT03028636|11915868|FG000|COMPLETED|Overall Study||11
10752247|NCT03028636|11915868|FG000|NOT COMPLETED|Overall Study||6
10752248|NCT03028870|11915881|FG000|STARTED|Overall Study||74
10752249|NCT03028870|11915882|FG001|STARTED|Overall Study||67
10752250|NCT03028870|11915883|FG002|STARTED|Overall Study||76
10752251|NCT03028870|11915884|FG003|STARTED|Overall Study||74
10752252|NCT03028870|11915881|FG000|COMPLETED|Overall Study||57
10752253|NCT03028870|11915882|FG001|COMPLETED|Overall Study||57
10752254|NCT03028870|11915883|FG002|COMPLETED|Overall Study||60
10752255|NCT03028870|11915884|FG003|COMPLETED|Overall Study||65
10752256|NCT03028870|11915881|FG000|NOT COMPLETED|Overall Study||17
10752257|NCT03028870|11915882|FG001|NOT COMPLETED|Overall Study||10
10752258|NCT03028870|11915883|FG002|NOT COMPLETED|Overall Study||16
10752259|NCT03028870|11915884|FG003|NOT COMPLETED|Overall Study||9
10752260|NCT03028974|11915899|FG000|STARTED|2014-2015||1
10752261|NCT03028974|11915900|FG001|STARTED|2014-2015||0
10752262|NCT03028974|11915901|FG002|STARTED|2014-2015||0
10752263|NCT03028974|11915902|FG003|STARTED|2014-2015||3
10752264|NCT03028974|11915903|FG004|STARTED|2014-2015||0
10752265|NCT03028974|11915904|FG005|STARTED|2014-2015||11
10752266|NCT03028974|11915905|FG006|STARTED|2014-2015||13
10752267|NCT03028974|11915899|FG000|COMPLETED|2014-2015||1
10752268|NCT03028974|11915900|FG001|COMPLETED|2014-2015||0
10752269|NCT03028974|11915901|FG002|COMPLETED|2014-2015||0
10752270|NCT03028974|11915902|FG003|COMPLETED|2014-2015||3
10752271|NCT03028974|11915903|FG004|COMPLETED|2014-2015||0
10752272|NCT03028974|11915904|FG005|COMPLETED|2014-2015|2 participants did not continue to the next period.|11
10752273|NCT03028974|11915905|FG006|COMPLETED|2014-2015|13 participants did not continue to the next period.|13
10752274|NCT03028974|11915899|FG000|NOT COMPLETED|2014-2015||0
10752275|NCT03028974|11915900|FG001|NOT COMPLETED|2014-2015||0
10752276|NCT03028974|11915901|FG002|NOT COMPLETED|2014-2015||0
10752277|NCT03028974|11915902|FG003|NOT COMPLETED|2014-2015||0
10752278|NCT03028974|11915903|FG004|NOT COMPLETED|2014-2015||0
10752279|NCT03028974|11915904|FG005|NOT COMPLETED|2014-2015||0
10752280|NCT03028974|11915905|FG006|NOT COMPLETED|2014-2015||0
10752281|NCT03028974|11915899|FG000|STARTED|2015-2016||0
10752282|NCT03028974|11915900|FG001|STARTED|2015-2016||0
10752283|NCT03028974|11915901|FG002|STARTED|2015-2016||0
10752284|NCT03028974|11915902|FG003|STARTED|2015-2016|One participant joined from Group A, 2 new were enrolled.|6
10752285|NCT03028974|11915903|FG004|STARTED|2015-2016||0
10752286|NCT03028974|11915904|FG005|STARTED|2015-2016|10 new participants were enrolled; 4 subjects switched from Group G.|14
10752287|NCT03028974|11915905|FG006|STARTED|2015-2016|11 new participants were enrolled; 9 subjects switched from Group F.|20
10752288|NCT03028974|11915899|FG000|COMPLETED|2015-2016||0
10752289|NCT03028974|11915900|FG001|COMPLETED|2015-2016||0
10752290|NCT03028974|11915901|FG002|COMPLETED|2015-2016||0
10752291|NCT03028974|11915902|FG003|COMPLETED|2015-2016|3 participants did not continue to the next period. 1 Participant returned in period 4 (2017-2018).|6
10752292|NCT03028974|11915903|FG004|COMPLETED|2015-2016||0
10752293|NCT03028974|11915904|FG005|COMPLETED|2015-2016|14 participants did not continue to the next period.|14
10752294|NCT03028974|11915905|FG006|COMPLETED|2015-2016|20 participants did not continue to the next period.|20
10752295|NCT03028974|11915899|FG000|NOT COMPLETED|2015-2016||0
10752296|NCT03028974|11915900|FG001|NOT COMPLETED|2015-2016||0
10752297|NCT03028974|11915901|FG002|NOT COMPLETED|2015-2016||0
10752298|NCT03028974|11915902|FG003|NOT COMPLETED|2015-2016||0
10752299|NCT03028974|11915903|FG004|NOT COMPLETED|2015-2016||0
10752300|NCT03028974|11915904|FG005|NOT COMPLETED|2015-2016||0
10752301|NCT03028974|11915905|FG006|NOT COMPLETED|2015-2016||0
10752302|NCT03028974|11915899|FG000|STARTED|2016-2017||0
10752303|NCT03028974|11915900|FG001|STARTED|2016-2017||0
10752304|NCT03028974|11915901|FG002|STARTED|2016-2017||0
10752305|NCT03028974|11915902|FG003|STARTED|2016-2017|1 new participant was enrolled.|4
10752306|NCT03028974|11915903|FG004|STARTED|2016-2017|2 new participants were enrolled.|2
10752307|NCT03028974|11915904|FG005|STARTED|2016-2017||0
10752308|NCT03028974|11915905|FG006|STARTED|2016-2017|18 new participants were enrolled.|18
10752309|NCT03028974|11915899|FG000|COMPLETED|2016-2017||0
10752310|NCT03028974|11915900|FG001|COMPLETED|2016-2017||0
10752311|NCT03028974|11915901|FG002|COMPLETED|2016-2017||0
10752312|NCT03028974|11915902|FG003|COMPLETED|2016-2017||4
10752313|NCT03028974|11915903|FG004|COMPLETED|2016-2017|2 participants did not continue to the next period|2
10752314|NCT03028974|11915904|FG005|COMPLETED|2016-2017||0
10752315|NCT03028974|11915905|FG006|COMPLETED|2016-2017|18 participants did not continue to the next period.|18
10752316|NCT03028974|11915899|FG000|NOT COMPLETED|2016-2017||0
10752317|NCT03028974|11915900|FG001|NOT COMPLETED|2016-2017||0
10752318|NCT03028974|11915901|FG002|NOT COMPLETED|2016-2017||0
10752319|NCT03028974|11915902|FG003|NOT COMPLETED|2016-2017||0
10752320|NCT03028974|11915903|FG004|NOT COMPLETED|2016-2017||0
10752321|NCT03028974|11915904|FG005|NOT COMPLETED|2016-2017||0
10752322|NCT03028974|11915905|FG006|NOT COMPLETED|2016-2017||0
10752323|NCT03028974|11915899|FG000|STARTED|2017-2018||0
10752324|NCT03028974|11915900|FG001|STARTED|2017-2018||0
10752325|NCT03028974|11915901|FG002|STARTED|2017-2018||0
10752326|NCT03028974|11915902|FG003|STARTED|2017-2018||5
10752327|NCT03028974|11915903|FG004|STARTED|2017-2018||0
10752328|NCT03028974|11915904|FG005|STARTED|2017-2018||0
10752329|NCT03028974|11915905|FG006|STARTED|2017-2018|5 new participants were enrolled.|5
10752330|NCT03028974|11915899|FG000|COMPLETED|2017-2018||0
10752331|NCT03028974|11915900|FG001|COMPLETED|2017-2018||0
10752332|NCT03028974|11915901|FG002|COMPLETED|2017-2018||0
10752333|NCT03028974|11915902|FG003|COMPLETED|2017-2018||5
10752334|NCT03028974|11915903|FG004|COMPLETED|2017-2018||0
10752335|NCT03028974|11915904|FG005|COMPLETED|2017-2018||0
10752336|NCT03028974|11915905|FG006|COMPLETED|2017-2018||5
10752337|NCT03028974|11915899|FG000|NOT COMPLETED|2017-2018||0
10752338|NCT03028974|11915900|FG001|NOT COMPLETED|2017-2018||0
10752339|NCT03028974|11915901|FG002|NOT COMPLETED|2017-2018||0
10752340|NCT03028974|11915902|FG003|NOT COMPLETED|2017-2018||0
10752341|NCT03028974|11915903|FG004|NOT COMPLETED|2017-2018||0
10752342|NCT03028974|11915904|FG005|NOT COMPLETED|2017-2018||0
10752343|NCT03028974|11915905|FG006|NOT COMPLETED|2017-2018||0
10752344|NCT03028987|11915920|FG000|STARTED|Overall Study||5
10752345|NCT03028987|11915921|FG001|STARTED|Overall Study||5
10752346|NCT03028987|11915920|FG000|COMPLETED|Overall Study||5
10752347|NCT03028987|11915921|FG001|COMPLETED|Overall Study||5
10752348|NCT03028987|11915920|FG000|NOT COMPLETED|Overall Study||0
10752349|NCT03028987|11915921|FG001|NOT COMPLETED|Overall Study||0
10752350|NCT03029091|11915929|FG000|STARTED|Overall Study||8
10820533|NCT00584935|11985413|FG000|STARTED|Overall Study||3
10820534|NCT00584935|11985413|FG000|COMPLETED|Overall Study||3
10820535|NCT00584935|11985413|FG000|NOT COMPLETED|Overall Study||0
10820536|NCT00577395|11985420|FG000|STARTED|Overall Study|67 planned for Treatment 2, but due to enrollment difficulties this was not met.|7
10820537|NCT00577395|11985421|FG001|STARTED|Overall Study|67 were planned for Treatment 1, but due to enrollment difficulties this was not met.|6
10820538|NCT00577395|11985420|FG000|COMPLETED|Overall Study|The study was terminated early by the Sponsor for lack of enrollment|0
10820539|NCT00577395|11985421|FG001|COMPLETED|Overall Study|The study was terminated early by the Sponsor for lack of enrollment|0
10820540|NCT00577395|11985420|FG000|NOT COMPLETED|Overall Study||7
10820541|NCT00577395|11985421|FG001|NOT COMPLETED|Overall Study||6
10820542|NCT00573391|11985429|FG000|STARTED|Overall Study||3
10820543|NCT00573391|11985430|FG001|STARTED|Overall Study||2
10820544|NCT00573391|11985429|FG000|COMPLETED|Overall Study||0
10820545|NCT00573391|11985430|FG001|COMPLETED|Overall Study||0
10820546|NCT00573391|11985429|FG000|NOT COMPLETED|Overall Study||3
10820547|NCT00573391|11985430|FG001|NOT COMPLETED|Overall Study||2
10820548|NCT00570258|11985438|FG000|STARTED|Overall Study||12
10820549|NCT00570258|11985439|FG001|STARTED|Overall Study||15
10820550|NCT00570258|11985438|FG000|COMPLETED|Overall Study|Early termination due to a change in drug FDA approval.|0
10752351|NCT03029091|11915930|FG001|STARTED|Overall Study||7
10752352|NCT03029091|11915929|FG000|COMPLETED|Overall Study||8
10752353|NCT03029091|11915930|FG001|COMPLETED|Overall Study||7
10752354|NCT03029091|11915929|FG000|NOT COMPLETED|Overall Study||0
10752355|NCT03029091|11915930|FG001|NOT COMPLETED|Overall Study||0
10752356|NCT03029143|11915938|FG000|STARTED|Lead-in Period (6 Weeks)||278
10752357|NCT03029143|11915939|FG001|STARTED|Lead-in Period (6 Weeks)||0
10752358|NCT03029143|11915940|FG002|STARTED|Lead-in Period (6 Weeks)||0
10820551|NCT00570258|11985439|FG001|COMPLETED|Overall Study|Early termination due to a change in drug FDA approval.|0
10752359|NCT03029143|11915938|FG000|COMPLETED|Lead-in Period (6 Weeks)||109
10752360|NCT03029143|11915939|FG001|COMPLETED|Lead-in Period (6 Weeks)||0
10752361|NCT03029143|11915940|FG002|COMPLETED|Lead-in Period (6 Weeks)||0
10752362|NCT03029143|11915938|FG000|NOT COMPLETED|Lead-in Period (6 Weeks)||169
10752363|NCT03029143|11915939|FG001|NOT COMPLETED|Lead-in Period (6 Weeks)||0
10752364|NCT03029143|11915940|FG002|NOT COMPLETED|Lead-in Period (6 Weeks)||0
10752365|NCT03029143|11915938|FG000|STARTED|Randomized Treatment Period (24 Weeks)||0
10752366|NCT03029143|11915939|FG001|STARTED|Randomized Treatment Period (24 Weeks)||54
10752367|NCT03029143|11915940|FG002|STARTED|Randomized Treatment Period (24 Weeks)||55
10752368|NCT03029143|11915938|FG000|Not Treated Post Randomization|Randomized Treatment Period (24 Weeks)||0
10752369|NCT03029143|11915939|FG001|Not Treated Post Randomization|Randomized Treatment Period (24 Weeks)|One participant was randomized to Randomized Treatment Period: Standard Treatment Arm, but was not treated and was thus included in the Lead-in failure vedolizumab arm for the Safety Analysis Set (N=170).|1
10752370|NCT03029143|11915940|FG002|Not Treated Post Randomization|Randomized Treatment Period (24 Weeks)||0
10752371|NCT03029143|11915938|FG000|Safety Population|Randomized Treatment Period (24 Weeks)||0
10752372|NCT03029143|11915939|FG001|Safety Population|Randomized Treatment Period (24 Weeks)||53
10752373|NCT03029143|11915940|FG002|Safety Population|Randomized Treatment Period (24 Weeks)|Regimen A = 28 Regimen B = 27|55
10752374|NCT03029143|11915938|FG000|COMPLETED|Randomized Treatment Period (24 Weeks)||0
10752375|NCT03029143|11915939|FG001|COMPLETED|Randomized Treatment Period (24 Weeks)||31
10752376|NCT03029143|11915940|FG002|COMPLETED|Randomized Treatment Period (24 Weeks)||31
10752377|NCT03029143|11915938|FG000|NOT COMPLETED|Randomized Treatment Period (24 Weeks)||0
10752378|NCT03029143|11915939|FG001|NOT COMPLETED|Randomized Treatment Period (24 Weeks)||23
10752379|NCT03029143|11915940|FG002|NOT COMPLETED|Randomized Treatment Period (24 Weeks)||24
10752380|NCT03029208|11915951|FG000|STARTED|Overall Study||157
10752381|NCT03029208|11915952|FG001|STARTED|Overall Study||155
10752382|NCT03029208|11915951|FG000|COMPLETED|Overall Study||155
10752383|NCT03029208|11915952|FG001|COMPLETED|Overall Study||151
10752384|NCT03029208|11915951|FG000|NOT COMPLETED|Overall Study||2
10752385|NCT03029208|11915952|FG001|NOT COMPLETED|Overall Study||4
10752386|NCT03029247|11915969|FG000|STARTED|Acute Challenge 1 (Day 1)||45
10752387|NCT03029247|11915970|FG001|STARTED|Acute Challenge 1 (Day 1)||43
10752388|NCT03029247|11915969|FG000|COMPLETED|Acute Challenge 1 (Day 1)||45
10752389|NCT03029247|11915970|FG001|COMPLETED|Acute Challenge 1 (Day 1)||43
10752390|NCT03029247|11915969|FG000|NOT COMPLETED|Acute Challenge 1 (Day 1)||0
10752391|NCT03029247|11915970|FG001|NOT COMPLETED|Acute Challenge 1 (Day 1)||0
10752392|NCT03029247|11915969|FG000|STARTED|Hgb Maintenance Phase (8 Weeks)||45
10752393|NCT03029247|11915970|FG001|STARTED|Hgb Maintenance Phase (8 Weeks)||43
10752394|NCT03029247|11915969|FG000|COMPLETED|Hgb Maintenance Phase (8 Weeks)||32
10752395|NCT03029247|11915970|FG001|COMPLETED|Hgb Maintenance Phase (8 Weeks)||36
10752396|NCT03029247|11915969|FG000|NOT COMPLETED|Hgb Maintenance Phase (8 Weeks)||13
10752397|NCT03029247|11915970|FG001|NOT COMPLETED|Hgb Maintenance Phase (8 Weeks)||7
10752398|NCT03029247|11915969|FG000|STARTED|Acute Challenge 2 (Day 57)||32
10752399|NCT03029247|11915970|FG001|STARTED|Acute Challenge 2 (Day 57)||36
10752400|NCT03029247|11915969|FG000|COMPLETED|Acute Challenge 2 (Day 57)||32
10752401|NCT03029247|11915970|FG001|COMPLETED|Acute Challenge 2 (Day 57)||36
10752402|NCT03029247|11915969|FG000|NOT COMPLETED|Acute Challenge 2 (Day 57)||0
10752403|NCT03029247|11915970|FG001|NOT COMPLETED|Acute Challenge 2 (Day 57)||0
10752404|NCT03029247|11915969|FG000|STARTED|Follow-up Period (14 Days)||32
10752405|NCT03029247|11915970|FG001|STARTED|Follow-up Period (14 Days)||36
10752406|NCT03029247|11915969|FG000|COMPLETED|Follow-up Period (14 Days)||32
10752407|NCT03029247|11915970|FG001|COMPLETED|Follow-up Period (14 Days)||36
10752408|NCT03029247|11915969|FG000|NOT COMPLETED|Follow-up Period (14 Days)||0
10752409|NCT03029247|11915970|FG001|NOT COMPLETED|Follow-up Period (14 Days)||0
10752410|NCT03029585|11915978|FG000|STARTED|Overall Study||7
10752411|NCT03029585|11915979|FG001|STARTED|Overall Study||3
10752412|NCT03029585|11915978|FG000|COMPLETED|Overall Study||5
10752413|NCT03029585|11915979|FG001|COMPLETED|Overall Study||2
10752414|NCT03029585|11915978|FG000|NOT COMPLETED|Overall Study||2
10820552|NCT00570258|11985438|FG000|NOT COMPLETED|Overall Study||12
10820553|NCT00570258|11985439|FG001|NOT COMPLETED|Overall Study||15
10820554|NCT00568802|11985447|FG000|STARTED|Overall Study||27
10820555|NCT00568802|11985447|FG000|COMPLETED|Overall Study||24
10820556|NCT00568802|11985447|FG000|NOT COMPLETED|Overall Study||3
10820557|NCT00576524|11985455|FG000|STARTED|Overall Study||2
10290210|NCT04779606|11422898|FG000|STARTED|First Phase: Tolerability and Safety||16
10290211|NCT04779606|11422899|FG001|STARTED|First Phase: Tolerability and Safety||4
10290212|NCT04779606|11422898|FG000|COMPLETED|First Phase: Tolerability and Safety||16
10290213|NCT04779606|11422899|FG001|COMPLETED|First Phase: Tolerability and Safety||4
10290214|NCT04779606|11422898|FG000|NOT COMPLETED|First Phase: Tolerability and Safety||0
10290215|NCT04779606|11422899|FG001|NOT COMPLETED|First Phase: Tolerability and Safety||0
10290216|NCT04779606|11422898|FG000|STARTED|Second Phase: Efficacy||68
10290217|NCT04779606|11422899|FG001|STARTED|Second Phase: Efficacy||17
10290218|NCT04779606|11422898|FG000|COMPLETED|Second Phase: Efficacy||68
10290219|NCT04779606|11422899|FG001|COMPLETED|Second Phase: Efficacy||17
10290220|NCT04779606|11422898|FG000|NOT COMPLETED|Second Phase: Efficacy||0
10290221|NCT04779606|11422899|FG001|NOT COMPLETED|Second Phase: Efficacy||0
10290225|NCT04773028|11422908|FG001|COMPLETED|Overall Study||24
10290226|NCT04773028|11422907|FG000|NOT COMPLETED|Overall Study||0
10290227|NCT04773028|11422908|FG001|NOT COMPLETED|Overall Study||0
10312950|NCT00147082|11446470|FG002|NOT COMPLETED|Overall Study||0
10312951|NCT00147199|11446480|FG000|STARTED|Overall Study||115
10820558|NCT00576524|11985456|FG001|STARTED|Overall Study||0
10312952|NCT00147199|11446481|FG001|STARTED|Overall Study||120
10752415|NCT03029585|11915979|FG001|NOT COMPLETED|Overall Study||1
10752416|NCT03029624|11915985|FG000|STARTED|Overall Study||46
10752417|NCT03029624|11915985|FG000|Primary Endpoint (3 Months)|Overall Study||44
10752418|NCT03029624|11915985|FG000|COMPLETED|Overall Study||41
10752419|NCT03029624|11915985|FG000|NOT COMPLETED|Overall Study||5
10752420|NCT03029650|11915991|FG000|STARTED|First Intervention (3 - 6 Days)|More subjects not enrolled after consent in other group leaving uneven number.|14
10752421|NCT03029650|11915992|FG001|STARTED|First Intervention (3 - 6 Days)||12
10752422|NCT03029650|11915991|FG000|COMPLETED|First Intervention (3 - 6 Days)||14
10752423|NCT03029650|11915992|FG001|COMPLETED|First Intervention (3 - 6 Days)||12
10752424|NCT03029650|11915991|FG000|NOT COMPLETED|First Intervention (3 - 6 Days)||0
10752425|NCT03029650|11915992|FG001|NOT COMPLETED|First Intervention (3 - 6 Days)||0
10752426|NCT03029650|11915991|FG000|STARTED|Washout (1 Week)||14
10752427|NCT03029650|11915992|FG001|STARTED|Washout (1 Week)||12
10752428|NCT03029650|11915991|FG000|COMPLETED|Washout (1 Week)||13
10752429|NCT03029650|11915992|FG001|COMPLETED|Washout (1 Week)||10
10752430|NCT03029650|11915991|FG000|NOT COMPLETED|Washout (1 Week)||1
10752431|NCT03029650|11915992|FG001|NOT COMPLETED|Washout (1 Week)||2
10752432|NCT03029650|11915991|FG000|STARTED|2nd Intervention (3 - 6 Days)||13
10752433|NCT03029650|11915992|FG001|STARTED|2nd Intervention (3 - 6 Days)||10
10752434|NCT03029650|11915991|FG000|COMPLETED|2nd Intervention (3 - 6 Days)||13
10752435|NCT03029650|11915992|FG001|COMPLETED|2nd Intervention (3 - 6 Days)||10
10752436|NCT03029650|11915991|FG000|NOT COMPLETED|2nd Intervention (3 - 6 Days)||0
10752437|NCT03029650|11915992|FG001|NOT COMPLETED|2nd Intervention (3 - 6 Days)||0
10752438|NCT03029715|11916004|FG000|STARTED|Overall Study||50
10752439|NCT03029715|11916005|FG001|STARTED|Overall Study||50
10752440|NCT03029715|11916004|FG000|COMPLETED|Overall Study||50
10752441|NCT03029715|11916005|FG001|COMPLETED|Overall Study||50
10752442|NCT03029715|11916004|FG000|NOT COMPLETED|Overall Study||0
10752443|NCT03029715|11916005|FG001|NOT COMPLETED|Overall Study||0
10752444|NCT03029819|11916013|FG000|STARTED|Overall Study||33
10752445|NCT03029819|11916014|FG001|STARTED|Overall Study||39
10752446|NCT03029819|11916013|FG000|COMPLETED|Overall Study||30
10752447|NCT03029819|11916014|FG001|COMPLETED|Overall Study||33
10752448|NCT03029819|11916013|FG000|NOT COMPLETED|Overall Study||3
10752449|NCT03029819|11916014|FG001|NOT COMPLETED|Overall Study||6
10752450|NCT03029988|11916023|FG000|STARTED|Overall Study||3
10752451|NCT03029988|11916023|FG000|COMPLETED|Overall Study||3
10752452|NCT03029988|11916023|FG000|NOT COMPLETED|Overall Study||0
10752456|NCT03030599|11916032|FG000|STARTED|Open Label Treatment and Titration||201
10752457|NCT03030599|11916033|FG001|STARTED|Open Label Treatment and Titration||0
10752458|NCT03030599|11916034|FG002|STARTED|Open Label Treatment and Titration||0
10752459|NCT03030599|11916032|FG000|COMPLETED|Open Label Treatment and Titration||155
10752460|NCT03030599|11916033|FG001|COMPLETED|Open Label Treatment and Titration||0
10752461|NCT03030599|11916034|FG002|COMPLETED|Open Label Treatment and Titration||0
10752462|NCT03030599|11916032|FG000|NOT COMPLETED|Open Label Treatment and Titration||46
10752463|NCT03030599|11916033|FG001|NOT COMPLETED|Open Label Treatment and Titration||0
10752464|NCT03030599|11916034|FG002|NOT COMPLETED|Open Label Treatment and Titration||0
10752465|NCT03030599|11916032|FG000|STARTED|Stable Dose|149 subjects of the 201 entered the Stable Dose Period. Of those subjects, 136 were randomized.|149
10752466|NCT03030599|11916033|FG001|STARTED|Stable Dose||0
10752467|NCT03030599|11916034|FG002|STARTED|Stable Dose||0
10752468|NCT03030599|11916032|FG000|COMPLETED|Stable Dose||144
10752469|NCT03030599|11916033|FG001|COMPLETED|Stable Dose||0
10752470|NCT03030599|11916034|FG002|COMPLETED|Stable Dose||0
10752471|NCT03030599|11916032|FG000|NOT COMPLETED|Stable Dose||5
10752472|NCT03030599|11916033|FG001|NOT COMPLETED|Stable Dose||0
10752473|NCT03030599|11916034|FG002|NOT COMPLETED|Stable Dose||0
10752474|NCT03030599|11916032|FG000|STARTED|Double Blind Randomized Withdrawal||0
10752475|NCT03030599|11916033|FG001|STARTED|Double Blind Randomized Withdrawal|134 of the 136 subjects randomized received at least 1 dose of study drug in the DB RWP.|69
10752476|NCT03030599|11916034|FG002|STARTED|Double Blind Randomized Withdrawal|134 of the 136 subjects randomized received at least 1 dose of study drug in the DB RWP.|67
10752477|NCT03030599|11916032|FG000|COMPLETED|Double Blind Randomized Withdrawal||0
10752478|NCT03030599|11916033|FG001|COMPLETED|Double Blind Randomized Withdrawal||69
10752479|NCT03030599|11916034|FG002|COMPLETED|Double Blind Randomized Withdrawal||59
10290228|NCT04755595|11422914|FG000|STARTED|Overall Study||20
10290229|NCT04755595|11422914|FG000|COMPLETED|Overall Study||19
10820559|NCT00576524|11985455|FG000|COMPLETED|Overall Study||2
10820560|NCT00576524|11985456|FG001|COMPLETED|Overall Study||0
10820561|NCT00576524|11985455|FG000|NOT COMPLETED|Overall Study||0
10820562|NCT00576524|11985456|FG001|NOT COMPLETED|Overall Study||0
10820563|NCT00568698|11985466|FG000|STARTED|Overall Study||29
10820564|NCT00568698|11985466|FG000|COMPLETED|Overall Study||18
10820565|NCT00568698|11985466|FG000|NOT COMPLETED|Overall Study||11
10820566|NCT00574080|11985474|FG000|STARTED|Overall Study||10
10820567|NCT00574080|11985475|FG001|STARTED|Overall Study||10
10820568|NCT00574080|11985474|FG000|COMPLETED|Overall Study||0
10820569|NCT00574080|11985475|FG001|COMPLETED|Overall Study||0
10820570|NCT00574080|11985474|FG000|NOT COMPLETED|Overall Study||10
10820571|NCT00574080|11985475|FG001|NOT COMPLETED|Overall Study||10
10290230|NCT04755595|11422914|FG000|NOT COMPLETED|Overall Study||1
10752480|NCT03030599|11916032|FG000|NOT COMPLETED|Double Blind Randomized Withdrawal||0
10779390|NCT03365778|11940978|FG002|STARTED|Overall Study||53
10752481|NCT03030599|11916033|FG001|NOT COMPLETED|Double Blind Randomized Withdrawal||0
10752482|NCT03030599|11916034|FG002|NOT COMPLETED|Double Blind Randomized Withdrawal||8
10752483|NCT03030599|11916032|FG000|STARTED|Open-label Extension||74
10752484|NCT03030599|11916033|FG001|STARTED|Open-label Extension||0
10752485|NCT03030599|11916034|FG002|STARTED|Open-label Extension||0
10752486|NCT03030599|11916032|FG000|COMPLETED|Open-label Extension||67
10752487|NCT03030599|11916033|FG001|COMPLETED|Open-label Extension||0
10752488|NCT03030599|11916034|FG002|COMPLETED|Open-label Extension||0
10752489|NCT03030599|11916032|FG000|NOT COMPLETED|Open-label Extension||7
10752490|NCT03030599|11916033|FG001|NOT COMPLETED|Open-label Extension||0
10752491|NCT03030599|11916034|FG002|NOT COMPLETED|Open-label Extension||0
10752492|NCT03030638|11916048|FG000|STARTED|Overall Study||1386
10752493|NCT03030638|11916049|FG001|STARTED|Overall Study||1841
10752494|NCT03030638|11916050|FG002|STARTED|Overall Study||1712
10752495|NCT03030638|11916051|FG003|STARTED|Overall Study||6406
10752496|NCT03030638|11916052|FG004|STARTED|Overall Study||696
10752497|NCT03030638|11916053|FG005|STARTED|Overall Study||1592
10752498|NCT03030638|11916054|FG006|STARTED|Overall Study||364
10752499|NCT03030638|11916055|FG007|STARTED|Overall Study||127
10752500|NCT03030638|11916048|FG000|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||372
10752501|NCT03030638|11916049|FG001|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||636
10752502|NCT03030638|11916050|FG002|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
10752503|NCT03030638|11916051|FG003|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
10752504|NCT03030638|11916052|FG004|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
10752505|NCT03030638|11916053|FG005|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
10752506|NCT03030638|11916054|FG006|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
10752507|NCT03030638|11916055|FG007|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
10752508|NCT03030638|11916048|FG000|COMPLETED|Overall Study||1386
10752509|NCT03030638|11916049|FG001|COMPLETED|Overall Study||1841
10752510|NCT03030638|11916050|FG002|COMPLETED|Overall Study||1712
10752511|NCT03030638|11916051|FG003|COMPLETED|Overall Study||6406
10752512|NCT03030638|11916052|FG004|COMPLETED|Overall Study||696
10752513|NCT03030638|11916053|FG005|COMPLETED|Overall Study||1592
10752514|NCT03030638|11916054|FG006|COMPLETED|Overall Study||364
10752515|NCT03030638|11916055|FG007|COMPLETED|Overall Study||127
10752516|NCT03030638|11916048|FG000|NOT COMPLETED|Overall Study||0
10752517|NCT03030638|11916049|FG001|NOT COMPLETED|Overall Study||0
10752518|NCT03030638|11916050|FG002|NOT COMPLETED|Overall Study||0
10752519|NCT03030638|11916051|FG003|NOT COMPLETED|Overall Study||0
10752520|NCT03030638|11916052|FG004|NOT COMPLETED|Overall Study||0
10752521|NCT03030638|11916053|FG005|NOT COMPLETED|Overall Study||0
10752522|NCT03030638|11916054|FG006|NOT COMPLETED|Overall Study||0
10752523|NCT03030638|11916055|FG007|NOT COMPLETED|Overall Study||0
10752524|NCT03030989|11916077|FG000|STARTED|Overall Study||21
10752525|NCT03030989|11916078|FG001|STARTED|Overall Study||29
10752526|NCT03030989|11916077|FG000|COMPLETED|Overall Study||9
10752527|NCT03030989|11916078|FG001|COMPLETED|Overall Study||15
10752528|NCT03030989|11916077|FG000|NOT COMPLETED|Overall Study||12
10752529|NCT03030989|11916078|FG001|NOT COMPLETED|Overall Study||14
10752530|NCT03031431|11916084|FG000|STARTED|Overall Study||130
10752531|NCT03031431|11916084|FG000|COMPLETED|Overall Study||129
10752532|NCT03031431|11916084|FG000|NOT COMPLETED|Overall Study||1
10752533|NCT03031496|11916088|FG000|STARTED|Period 1||21
10752534|NCT03031496|11916089|FG001|STARTED|Period 1||21
10752535|NCT03031496|11916088|FG000|COMPLETED|Period 1||19
10752536|NCT03031496|11916089|FG001|COMPLETED|Period 1||19
10752537|NCT03031496|11916088|FG000|NOT COMPLETED|Period 1||2
10752538|NCT03031496|11916089|FG001|NOT COMPLETED|Period 1||2
10752539|NCT03031496|11916088|FG000|STARTED|Period 2||19
10752540|NCT03031496|11916089|FG001|STARTED|Period 2||19
10752541|NCT03031496|11916088|FG000|COMPLETED|Period 2||19
10752542|NCT03031496|11916089|FG001|COMPLETED|Period 2||19
10752543|NCT03031496|11916088|FG000|NOT COMPLETED|Period 2||0
10752544|NCT03031496|11916089|FG001|NOT COMPLETED|Period 2||0
10752545|NCT03031678|11916095|FG000|STARTED|Overall Study||50
10752546|NCT03031678|11916095|FG000|EAS Test Condition Complete|Overall Study||39
10752547|NCT03031678|11916095|FG000|CI Alone Test Condition Complete|Overall Study||10
10752548|NCT03031678|11916095|FG000|COMPLETED|Overall Study||49
10752549|NCT03031678|11916095|FG000|NOT COMPLETED|Overall Study||1
10752550|NCT03031795|11916105|FG000|STARTED|Overall Study||35
10752551|NCT03031795|11916106|FG001|STARTED|Overall Study||36
10752552|NCT03031795|11916105|FG000|COMPLETED|Overall Study||35
10752553|NCT03031795|11916106|FG001|COMPLETED|Overall Study||35
10752554|NCT03031795|11916105|FG000|NOT COMPLETED|Overall Study||0
10752555|NCT03031795|11916106|FG001|NOT COMPLETED|Overall Study||1
10752556|NCT03031899|11916112|FG000|STARTED|Overall Study||27
10752557|NCT03031899|11916112|FG000|COMPLETED|Overall Study||25
10752558|NCT03031899|11916112|FG000|NOT COMPLETED|Overall Study||2
10752559|NCT03031938|11916122|FG000|STARTED|Overall Study||2
10752560|NCT03031938|11916123|FG001|STARTED|Overall Study||2
10752561|NCT03031938|11916122|FG000|COMPLETED|Overall Study||1
10752562|NCT03031938|11916123|FG001|COMPLETED|Overall Study||2
10752563|NCT03031938|11916122|FG000|NOT COMPLETED|Overall Study||1
10752564|NCT03031938|11916123|FG001|NOT COMPLETED|Overall Study||0
10752565|NCT03032263|11916131|FG000|STARTED|Overall Study||6
10752566|NCT03032263|11916132|FG001|STARTED|Overall Study||6
10752567|NCT03032263|11916131|FG000|COMPLETED|Overall Study||6
10752568|NCT03032263|11916132|FG001|COMPLETED|Overall Study||6
10752569|NCT03032263|11916131|FG000|NOT COMPLETED|Overall Study||0
10752570|NCT03032263|11916132|FG001|NOT COMPLETED|Overall Study||0
10752571|NCT03032380|11916140|FG000|STARTED|Overall Study||148
10752572|NCT03032380|11916141|FG001|STARTED|Overall Study||152
10752573|NCT03032380|11916140|FG000|Received Treatment|Overall Study||148
10752574|NCT03032380|11916141|FG001|Received Treatment|Overall Study||150
10752575|NCT03032380|11916140|FG000|COMPLETED|Overall Study||106
10752576|NCT03032380|11916141|FG001|COMPLETED|Overall Study||112
10752577|NCT03032380|11916140|FG000|NOT COMPLETED|Overall Study||42
10752578|NCT03032380|11916141|FG001|NOT COMPLETED|Overall Study||40
10752579|NCT03032393|11916149|FG000|STARTED|Overall Study||15
10752580|NCT03032393|11916150|FG001|STARTED|Overall Study||15
10752581|NCT03032393|11916149|FG000|COMPLETED|Overall Study||15
10752582|NCT03032393|11916150|FG001|COMPLETED|Overall Study||15
10752583|NCT03032393|11916149|FG000|NOT COMPLETED|Overall Study||0
10752584|NCT03032393|11916150|FG001|NOT COMPLETED|Overall Study||0
10752585|NCT03032523|11916158|FG000|STARTED|Overall Study||15
10752586|NCT03032523|11916159|FG001|STARTED|Overall Study||6
10752587|NCT03032523|11916158|FG000|COMPLETED|Overall Study||12
10752588|NCT03032523|11916159|FG001|COMPLETED|Overall Study||4
10752589|NCT03032523|11916158|FG000|NOT COMPLETED|Overall Study||3
10752590|NCT03032523|11916159|FG001|NOT COMPLETED|Overall Study||2
10752591|NCT03032965|11916168|FG000|STARTED|Overall Study||61
10752592|NCT03032965|11916169|FG001|STARTED|Overall Study||68
10752593|NCT03032965|11916168|FG000|COMPLETED|Overall Study||61
10752594|NCT03032965|11916169|FG001|COMPLETED|Overall Study||68
10752595|NCT03032965|11916168|FG000|NOT COMPLETED|Overall Study||0
10752596|NCT03032965|11916169|FG001|NOT COMPLETED|Overall Study||0
10752597|NCT03033108|11916178|FG000|STARTED|Overall Study||7
10752598|NCT03033108|11916179|FG001|STARTED|Overall Study||9
10752599|NCT03033108|11916180|FG002|STARTED|Overall Study||7
10752600|NCT03033108|11916178|FG000|COMPLETED|Overall Study||7
10752601|NCT03033108|11916179|FG001|COMPLETED|Overall Study||8
10752602|NCT03033108|11916180|FG002|COMPLETED|Overall Study||7
10752603|NCT03033108|11916178|FG000|NOT COMPLETED|Overall Study||0
10752604|NCT03033108|11916179|FG001|NOT COMPLETED|Overall Study||1
10752605|NCT03033108|11916180|FG002|NOT COMPLETED|Overall Study||0
10752606|NCT03033134|11916190|FG000|STARTED|Overall Study||42
10752607|NCT03033134|11916191|FG001|STARTED|Overall Study||12
10752608|NCT03033134|11916190|FG000|6-month Primary Endpoints|Overall Study||42
10820572|NCT00558558|11985481|FG000|STARTED|Overall Study||6
10820573|NCT00558558|11985481|FG000|COMPLETED|Overall Study||0
10820574|NCT00558558|11985481|FG000|NOT COMPLETED|Overall Study||6
10820575|NCT00577356|11985485|FG000|STARTED|Overall Study||6
10820576|NCT00577356|11985485|FG000|COMPLETED|Overall Study||6
10820577|NCT00577356|11985485|FG000|NOT COMPLETED|Overall Study||0
10820578|NCT00573937|11985491|FG000|STARTED|Overall Study||0
10820579|NCT00573937|11985492|FG001|STARTED|Overall Study||1
10820580|NCT00573937|11985491|FG000|COMPLETED|Overall Study||0
10820581|NCT00573937|11985492|FG001|COMPLETED|Overall Study||0
10820582|NCT00573937|11985491|FG000|NOT COMPLETED|Overall Study||0
10820583|NCT00573937|11985492|FG001|NOT COMPLETED|Overall Study||1
10820584|NCT00577317|11985500|FG000|STARTED|Overall Study||0
10820585|NCT00577317|11985501|FG001|STARTED|Overall Study||2
10820586|NCT00577317|11985500|FG000|COMPLETED|Overall Study||0
10820587|NCT00577317|11985501|FG001|COMPLETED|Overall Study||0
10820588|NCT00577317|11985500|FG000|NOT COMPLETED|Overall Study||0
10820589|NCT00577317|11985501|FG001|NOT COMPLETED|Overall Study||2
10820590|NCT00571922|11985509|FG000|STARTED|Overall Study||36
10820591|NCT00571922|11985510|FG001|STARTED|Overall Study||36
10820592|NCT00571922|11985509|FG000|COMPLETED|Overall Study||0
10820593|NCT00571922|11985510|FG001|COMPLETED|Overall Study||0
10820594|NCT00571922|11985509|FG000|NOT COMPLETED|Overall Study||36
10820595|NCT00571922|11985510|FG001|NOT COMPLETED|Overall Study||36
10820596|NCT00569868|11985516|FG000|STARTED|Overall Study||11
10820597|NCT00569868|11985516|FG000|COMPLETED|Overall Study||11
10820598|NCT00569868|11985516|FG000|NOT COMPLETED|Overall Study||0
10820599|NCT00573157|11985522|FG000|STARTED|Overall Study||4
10820600|NCT00573157|11985523|FG001|STARTED|Overall Study||2
10820601|NCT00573157|11985522|FG000|COMPLETED|Overall Study||0
10820602|NCT00573157|11985523|FG001|COMPLETED|Overall Study||0
10820603|NCT00573157|11985522|FG000|NOT COMPLETED|Overall Study||4
10752609|NCT03033134|11916191|FG001|6-month Primary Endpoints|Overall Study||12
10752610|NCT03033134|11916190|FG000|COMPLETED|Overall Study||0
10752611|NCT03033134|11916191|FG001|COMPLETED|Overall Study||0
10752612|NCT03033134|11916190|FG000|NOT COMPLETED|Overall Study||42
10752613|NCT03033134|11916191|FG001|NOT COMPLETED|Overall Study||12
10752614|NCT03033394|11916199|FG000|STARTED|Completed Sampling||65
10752615|NCT03033394|11916199|FG000|COMPLETED|Completed Sampling||65
10820604|NCT00573157|11985523|FG001|NOT COMPLETED|Overall Study||2
10820605|NCT00570531|11985529|FG000|STARTED|Overall Study||6
10820606|NCT00570531|11985529|FG000|COMPLETED|Overall Study||6
10820607|NCT00570531|11985529|FG000|NOT COMPLETED|Overall Study||0
10820608|NCT00566462|11985535|FG000|STARTED|Overall Study||1
10820609|NCT00566462|11985536|FG001|STARTED|Overall Study||0
10820610|NCT00566462|11985535|FG000|COMPLETED|Overall Study||1
10820611|NCT00566462|11985536|FG001|COMPLETED|Overall Study||0
10820612|NCT00566462|11985535|FG000|NOT COMPLETED|Overall Study||0
10752616|NCT03033394|11916199|FG000|NOT COMPLETED|Completed Sampling||0
10752617|NCT03033394|11916199|FG000|STARTED|Completed Pharmacokinetic Analysis||65
10752618|NCT03033394|11916199|FG000|COMPLETED|Completed Pharmacokinetic Analysis||59
10779391|NCT03365778|11940976|FG000|COMPLETED|Overall Study||16
10752619|NCT03033394|11916199|FG000|NOT COMPLETED|Completed Pharmacokinetic Analysis||6
10752620|NCT03033394|11916199|FG000|STARTED|Completed Final Analysis||59
10752621|NCT03033394|11916199|FG000|COMPLETED|Completed Final Analysis||58
10752622|NCT03033394|11916199|FG000|NOT COMPLETED|Completed Final Analysis||1
10752623|NCT03033511|11916210|FG000|STARTED|Overall Study||376
10752624|NCT03033511|11916211|FG001|STARTED|Overall Study||372
10752625|NCT03033511|11916210|FG000|COMPLETED|Overall Study||376
10752626|NCT03033511|11916211|FG001|COMPLETED|Overall Study||372
10752627|NCT03033511|11916210|FG000|NOT COMPLETED|Overall Study||0
10752628|NCT03033511|11916211|FG001|NOT COMPLETED|Overall Study||0
10752629|NCT03033745|11916220|FG000|STARTED|Overall Study||15
10752630|NCT03033745|11916221|FG001|STARTED|Overall Study||18
10752631|NCT03033745|11916222|FG002|STARTED|Overall Study||16
10752632|NCT03033745|11916220|FG000|COMPLETED|Overall Study||14
10752633|NCT03033745|11916221|FG001|COMPLETED|Overall Study||17
10752634|NCT03033745|11916222|FG002|COMPLETED|Overall Study||14
10752635|NCT03033745|11916220|FG000|NOT COMPLETED|Overall Study||1
10752636|NCT03033745|11916221|FG001|NOT COMPLETED|Overall Study||1
10752637|NCT03033745|11916222|FG002|NOT COMPLETED|Overall Study||2
10752638|NCT03033784|11916239|FG000|STARTED|Overall Study||9
10752639|NCT03033784|11916240|FG001|STARTED|Overall Study||2
10752640|NCT03033784|11916241|FG002|STARTED|Overall Study||4
10752641|NCT03033784|11916242|FG003|STARTED|Overall Study||4
10752642|NCT03033784|11916243|FG004|STARTED|Overall Study||3
10752643|NCT03033784|11916244|FG005|STARTED|Overall Study||2
10752644|NCT03033784|11916245|FG006|STARTED|Overall Study||2
10752645|NCT03033784|11916246|FG007|STARTED|Overall Study||2
10752646|NCT03033784|11916247|FG008|STARTED|Overall Study||1
10752647|NCT03033784|11916248|FG009|STARTED|Overall Study||1
10752648|NCT03033784|11916249|FG010|STARTED|Overall Study||1
10752649|NCT03033784|11916250|FG011|STARTED|Overall Study||1
10752650|NCT03033784|11916251|FG012|STARTED|Overall Study||19
10752651|NCT03033784|11916239|FG000|Clinical Visit 2|Overall Study||9
10752652|NCT03033784|11916240|FG001|Clinical Visit 2|Overall Study||2
10752653|NCT03033784|11916241|FG002|Clinical Visit 2|Overall Study||4
10752654|NCT03033784|11916242|FG003|Clinical Visit 2|Overall Study||4
10752655|NCT03033784|11916243|FG004|Clinical Visit 2|Overall Study||3
10752656|NCT03033784|11916244|FG005|Clinical Visit 2|Overall Study||2
10752657|NCT03033784|11916245|FG006|Clinical Visit 2|Overall Study||2
10752658|NCT03033784|11916246|FG007|Clinical Visit 2|Overall Study||2
10752659|NCT03033784|11916247|FG008|Clinical Visit 2|Overall Study||1
10752660|NCT03033784|11916248|FG009|Clinical Visit 2|Overall Study||1
10752661|NCT03033784|11916249|FG010|Clinical Visit 2|Overall Study||1
10752662|NCT03033784|11916250|FG011|Clinical Visit 2|Overall Study||1
10752663|NCT03033784|11916251|FG012|Clinical Visit 2|Overall Study||17
10752664|NCT03033784|11916239|FG000|Clinical Visit 3|Overall Study||9
10752665|NCT03033784|11916240|FG001|Clinical Visit 3|Overall Study||1
10752666|NCT03033784|11916241|FG002|Clinical Visit 3|Overall Study||4
10752667|NCT03033784|11916242|FG003|Clinical Visit 3|Overall Study||4
10752668|NCT03033784|11916243|FG004|Clinical Visit 3|Overall Study||3
10752669|NCT03033784|11916244|FG005|Clinical Visit 3|Overall Study||2
10752670|NCT03033784|11916245|FG006|Clinical Visit 3|Overall Study||2
10752671|NCT03033784|11916246|FG007|Clinical Visit 3|Overall Study||2
10752672|NCT03033784|11916247|FG008|Clinical Visit 3|Overall Study||1
10752673|NCT03033784|11916248|FG009|Clinical Visit 3|Overall Study||1
10820613|NCT00566462|11985536|FG001|NOT COMPLETED|Overall Study||0
10820614|NCT00561912|11985542|FG000|STARTED|Overall Study||2
10820615|NCT00561912|11985542|FG000|COMPLETED|Overall Study||1
10820616|NCT00561912|11985542|FG000|NOT COMPLETED|Overall Study||1
10820617|NCT00561795|11985548|FG000|STARTED|Overall Study||6
10820618|NCT00561795|11985549|FG001|STARTED|Overall Study||6
10820619|NCT00561795|11985550|FG002|STARTED|Overall Study||0
10820620|NCT00561795|11985551|FG003|STARTED|Overall Study||0
10820621|NCT00561795|11985548|FG000|COMPLETED|Overall Study||2
10820622|NCT00561795|11985549|FG001|COMPLETED|Overall Study||0
10820623|NCT00561795|11985550|FG002|COMPLETED|Overall Study||0
10820624|NCT00561795|11985551|FG003|COMPLETED|Overall Study||0
10820625|NCT00561795|11985548|FG000|NOT COMPLETED|Overall Study||4
10820626|NCT00561795|11985549|FG001|NOT COMPLETED|Overall Study||6
10820627|NCT00561795|11985550|FG002|NOT COMPLETED|Overall Study||0
10820628|NCT00561795|11985551|FG003|NOT COMPLETED|Overall Study||0
10820629|NCT00564876|11985559|FG000|STARTED|Overall Study||2
10820630|NCT00564876|11985559|FG000|COMPLETED|Overall Study||2
10820631|NCT00564876|11985559|FG000|NOT COMPLETED|Overall Study||0
10752674|NCT03033784|11916249|FG010|Clinical Visit 3|Overall Study||1
10752675|NCT03033784|11916250|FG011|Clinical Visit 3|Overall Study||1
10752676|NCT03033784|11916251|FG012|Clinical Visit 3|Overall Study||0
10752677|NCT03033784|11916239|FG000|Clinical Visit 4|Overall Study||9
10752678|NCT03033784|11916240|FG001|Clinical Visit 4|Overall Study||1
10752679|NCT03033784|11916241|FG002|Clinical Visit 4|Overall Study||4
10752680|NCT03033784|11916242|FG003|Clinical Visit 4|Overall Study||4
10752681|NCT03033784|11916243|FG004|Clinical Visit 4|Overall Study||3
10820632|NCT00558870|11985565|FG000|STARTED|Overall Study||2
10820633|NCT00558870|11985566|FG001|STARTED|Overall Study||2
10752682|NCT03033784|11916244|FG005|Clinical Visit 4|Overall Study||2
10752683|NCT03033784|11916245|FG006|Clinical Visit 4|Overall Study||2
10752684|NCT03033784|11916246|FG007|Clinical Visit 4|Overall Study||2
10752685|NCT03033784|11916247|FG008|Clinical Visit 4|Overall Study||1
10752686|NCT03033784|11916248|FG009|Clinical Visit 4|Overall Study||1
10820634|NCT00558870|11985565|FG000|COMPLETED|Overall Study||2
10820635|NCT00558870|11985566|FG001|COMPLETED|Overall Study||2
10752687|NCT03033784|11916249|FG010|Clinical Visit 4|Overall Study||1
10752688|NCT03033784|11916250|FG011|Clinical Visit 4|Overall Study||1
10752689|NCT03033784|11916251|FG012|Clinical Visit 4|Overall Study||0
10752690|NCT03033784|11916239|FG000|COMPLETED|Overall Study||9
10752691|NCT03033784|11916240|FG001|COMPLETED|Overall Study||1
10752692|NCT03033784|11916241|FG002|COMPLETED|Overall Study||4
10752693|NCT03033784|11916242|FG003|COMPLETED|Overall Study||4
10752694|NCT03033784|11916243|FG004|COMPLETED|Overall Study||3
10752695|NCT03033784|11916244|FG005|COMPLETED|Overall Study||2
10752696|NCT03033784|11916245|FG006|COMPLETED|Overall Study||2
10752697|NCT03033784|11916246|FG007|COMPLETED|Overall Study||2
10752698|NCT03033784|11916247|FG008|COMPLETED|Overall Study||1
10752699|NCT03033784|11916248|FG009|COMPLETED|Overall Study||1
10752700|NCT03033784|11916249|FG010|COMPLETED|Overall Study||1
10752701|NCT03033784|11916250|FG011|COMPLETED|Overall Study||1
10820636|NCT00558870|11985565|FG000|NOT COMPLETED|Overall Study||0
10820637|NCT00558870|11985566|FG001|NOT COMPLETED|Overall Study||0
10820638|NCT00559897|11985572|FG000|STARTED|Overall Study||6
10820639|NCT00559897|11985572|FG000|COMPLETED|Overall Study||6
10820640|NCT00559897|11985572|FG000|NOT COMPLETED|Overall Study||0
10820641|NCT00556400|11985578|FG000|STARTED|Overall Study||1
10820642|NCT00556400|11985579|FG001|STARTED|Overall Study||0
10820643|NCT00556400|11985578|FG000|COMPLETED|Overall Study||1
10820644|NCT00556400|11985579|FG001|COMPLETED|Overall Study||0
10820645|NCT00556400|11985578|FG000|NOT COMPLETED|Overall Study||0
10820646|NCT00556400|11985579|FG001|NOT COMPLETED|Overall Study||0
10820647|NCT00556075|11985587|FG000|STARTED|Overall Study||22
10820648|NCT00556075|11985588|FG001|STARTED|Overall Study||22
10820649|NCT00556075|11985589|FG002|STARTED|Overall Study||23
10820650|NCT00556075|11985587|FG000|COMPLETED|Overall Study||9
10820651|NCT00556075|11985588|FG001|COMPLETED|Overall Study||13
10820652|NCT00556075|11985589|FG002|COMPLETED|Overall Study||15
10820653|NCT00556075|11985587|FG000|NOT COMPLETED|Overall Study||13
10820654|NCT00556075|11985588|FG001|NOT COMPLETED|Overall Study||9
10820655|NCT00556075|11985589|FG002|NOT COMPLETED|Overall Study||8
10820656|NCT00556166|11985601|FG000|STARTED|Overall Study||4
10820657|NCT00556166|11985601|FG000|COMPLETED|Overall Study||3
10820658|NCT00556166|11985601|FG000|NOT COMPLETED|Overall Study||1
10820659|NCT00521924|11985607|FG000|STARTED|Overall Study|Subjects randomized|4
10820660|NCT00521924|11985608|FG001|STARTED|Overall Study|Subjects randomized|4
10820661|NCT00521924|11985607|FG000|COMPLETED|Overall Study|At Early Termination, 1 patient completed Week 2 and 2 patients completed Week 6.|0
10820662|NCT00521924|11985608|FG001|COMPLETED|Overall Study|At Early Termination, 3 patients completed Week 6 and 1 completed Week 22.|0
10820663|NCT00521924|11985607|FG000|NOT COMPLETED|Overall Study||4
10820664|NCT00521924|11985608|FG001|NOT COMPLETED|Overall Study||4
10820665|NCT00548886|11985614|FG000|STARTED|Overall Study||7
10820666|NCT00548886|11985614|FG000|COMPLETED|Overall Study||7
10820667|NCT00548886|11985614|FG000|NOT COMPLETED|Overall Study||0
10820668|NCT00547456|11985618|FG000|STARTED|Overall Study||20
10820669|NCT00547456|11985618|FG000|COMPLETED|Overall Study||20
10820670|NCT00547456|11985618|FG000|NOT COMPLETED|Overall Study||0
10820671|NCT00539838|11985625|FG000|STARTED|Overall Study||12
10820672|NCT00539838|11985626|FG001|STARTED|Overall Study||11
10820673|NCT00539838|11985627|FG002|STARTED|Overall Study||10
10820674|NCT00539838|11985625|FG000|COMPLETED|Overall Study||5
10820675|NCT00539838|11985626|FG001|COMPLETED|Overall Study||5
10820676|NCT00539838|11985627|FG002|COMPLETED|Overall Study||1
10820677|NCT00539838|11985625|FG000|NOT COMPLETED|Overall Study||7
10820678|NCT00539838|11985626|FG001|NOT COMPLETED|Overall Study||6
10820679|NCT00539838|11985627|FG002|NOT COMPLETED|Overall Study||9
10820680|NCT00549328|11985637|FG000|STARTED|Overall Study||14
10820681|NCT00549328|11985637|FG000|COMPLETED|Overall Study||0
10820682|NCT00549328|11985637|FG000|NOT COMPLETED|Overall Study||14
10820683|NCT00548327|11985643|FG000|STARTED|Overall Study||6
10820684|NCT00548327|11985644|FG001|STARTED|Overall Study||5
10820685|NCT00548327|11985643|FG000|COMPLETED|Overall Study||6
10820686|NCT00548327|11985644|FG001|COMPLETED|Overall Study|Patient randomized to receive placebo first. While on placebo, Adverse Event lead to discontinuation|4
10820687|NCT00548327|11985643|FG000|NOT COMPLETED|Overall Study||0
10820688|NCT00548327|11985644|FG001|NOT COMPLETED|Overall Study||1
10820689|NCT00542542|11985657|FG000|STARTED|Overall Study||44
10820690|NCT00542542|11985658|FG001|STARTED|Overall Study||44
10820691|NCT00542542|11985657|FG000|COMPLETED|Overall Study||44
10820692|NCT00542542|11985658|FG001|COMPLETED|Overall Study||44
10820693|NCT00542542|11985657|FG000|NOT COMPLETED|Overall Study||0
10820694|NCT00542542|11985658|FG001|NOT COMPLETED|Overall Study||0
10544797|NCT01491737|11697953|FG001|STARTED|Overall Study||129
10544798|NCT01491737|11697952|FG000|Received at Least One Dose of Study Drug|Overall Study||127
10752702|NCT03033784|11916251|FG012|COMPLETED|Overall Study||17
10752703|NCT03033784|11916239|FG000|NOT COMPLETED|Overall Study||0
10752704|NCT03033784|11916240|FG001|NOT COMPLETED|Overall Study||1
10820695|NCT00545506|11985666|FG000|STARTED|Overall Study||3
10820696|NCT00545506|11985667|FG001|STARTED|Overall Study||3
10820697|NCT00545506|11985666|FG000|COMPLETED|Overall Study||3
10752705|NCT03033784|11916241|FG002|NOT COMPLETED|Overall Study||0
10752706|NCT03033784|11916242|FG003|NOT COMPLETED|Overall Study||0
10752707|NCT03033784|11916243|FG004|NOT COMPLETED|Overall Study||0
10820698|NCT00545506|11985667|FG001|COMPLETED|Overall Study||3
10820699|NCT00545506|11985666|FG000|NOT COMPLETED|Overall Study||0
10820700|NCT00545506|11985667|FG001|NOT COMPLETED|Overall Study||0
10820701|NCT00547300|11985675|FG000|STARTED|Overall Study||25
10752708|NCT03033784|11916244|FG005|NOT COMPLETED|Overall Study||0
10752709|NCT03033784|11916245|FG006|NOT COMPLETED|Overall Study||0
10752710|NCT03033784|11916246|FG007|NOT COMPLETED|Overall Study||0
10752711|NCT03033784|11916247|FG008|NOT COMPLETED|Overall Study||0
10752712|NCT03033784|11916248|FG009|NOT COMPLETED|Overall Study||0
10752713|NCT03033784|11916249|FG010|NOT COMPLETED|Overall Study||0
10752714|NCT03033784|11916250|FG011|NOT COMPLETED|Overall Study||0
10752715|NCT03033784|11916251|FG012|NOT COMPLETED|Overall Study||2
10752716|NCT03034044|11916262|FG000|STARTED|Overall Study||106
10752717|NCT03034044|11916262|FG000|Received Xyntha|Overall Study||105
10752718|NCT03034044|11916262|FG000|COMPLETED|Overall Study||105
10752719|NCT03034044|11916262|FG000|NOT COMPLETED|Overall Study||1
10752720|NCT03034057|11916266|FG000|STARTED|Overall Study||169
10752721|NCT03034057|11916266|FG000|COMPLETED|Overall Study||114
10752722|NCT03034057|11916266|FG000|NOT COMPLETED|Overall Study||55
10752723|NCT03034135|11916270|FG000|STARTED|Overall Study||23
10752724|NCT03034135|11916270|FG000|COMPLETED|Overall Study||21
10752725|NCT03034135|11916270|FG000|NOT COMPLETED|Overall Study||2
10752726|NCT03034460|11916276|FG000|STARTED|Overall Study||48
10752727|NCT03034460|11916277|FG001|STARTED|Overall Study||22
10752728|NCT03034460|11916276|FG000|COMPLETED|Overall Study||45
10752729|NCT03034460|11916277|FG001|COMPLETED|Overall Study||19
10752730|NCT03034460|11916276|FG000|NOT COMPLETED|Overall Study||3
10752731|NCT03034460|11916277|FG001|NOT COMPLETED|Overall Study||3
10752732|NCT03034577|11916289|FG000|STARTED|Overall Study||175
10752733|NCT03034577|11916290|FG001|STARTED|Overall Study||175
10752734|NCT03034577|11916289|FG000|COMPLETED|Overall Study||144
10752735|NCT03034577|11916290|FG001|COMPLETED|Overall Study||140
10752736|NCT03034577|11916289|FG000|NOT COMPLETED|Overall Study||31
10752737|NCT03034577|11916290|FG001|NOT COMPLETED|Overall Study||35
10752738|NCT03034772|11916300|FG000|STARTED|Overall Study||27
10752739|NCT03034772|11916301|FG001|STARTED|Overall Study||25
10752740|NCT03034772|11916300|FG000|COMPLETED|Overall Study||27
10752741|NCT03034772|11916301|FG001|COMPLETED|Overall Study||23
10752742|NCT03034772|11916300|FG000|NOT COMPLETED|Overall Study||0
10752743|NCT03034772|11916301|FG001|NOT COMPLETED|Overall Study||2
10752744|NCT03034915|11916310|FG000|STARTED|Overall Study||812
10752745|NCT03034915|11916311|FG001|STARTED|Overall Study||804
10752746|NCT03034915|11916312|FG002|STARTED|Overall Study||809
10752747|NCT03034915|11916310|FG000|COMPLETED|Overall Study||717
10752748|NCT03034915|11916311|FG001|COMPLETED|Overall Study||650
10752749|NCT03034915|11916312|FG002|COMPLETED|Overall Study||683
10752750|NCT03034915|11916310|FG000|NOT COMPLETED|Overall Study||95
10752751|NCT03034915|11916311|FG001|NOT COMPLETED|Overall Study||154
10752752|NCT03034915|11916312|FG002|NOT COMPLETED|Overall Study||126
10752753|NCT03034928|11916320|FG000|STARTED|Period 1, First 2 Hours of Wear||8
10820702|NCT00547300|11985676|FG001|STARTED|Overall Study|Two (2) patients were randomized in error, but no study medication taken.|26
10820703|NCT00547300|11985675|FG000|COMPLETED|Overall Study|No patients completed because the study was administratively terminated.|0
10544799|NCT01491737|11697953|FG001|Received at Least One Dose of Study Drug|Overall Study||124
10544800|NCT01491737|11697952|FG000|Entered Follow-Up (Post-Treatment)|Overall Study||120
10544801|NCT01491737|11697953|FG001|Entered Follow-Up (Post-Treatment)|Overall Study||116
10544802|NCT01491737|11697952|FG000|COMPLETED|Overall Study||0
10544803|NCT01491737|11697953|FG001|COMPLETED|Overall Study||0
10544804|NCT01491737|11697952|FG000|NOT COMPLETED|Overall Study||129
10544805|NCT01491737|11697953|FG001|NOT COMPLETED|Overall Study||129
10544806|NCT01491802|11697959|FG000|STARTED|Overall Study||9
10544807|NCT01491802|11697960|FG001|STARTED|Overall Study||8
10544808|NCT01491802|11697959|FG000|COMPLETED|Overall Study||8
10820704|NCT00547300|11985676|FG001|COMPLETED|Overall Study|No patients completed because the study was administratively terminated.|0
10820705|NCT00547300|11985675|FG000|NOT COMPLETED|Overall Study||25
10820706|NCT00547300|11985676|FG001|NOT COMPLETED|Overall Study||26
10820707|NCT00539617|11985682|FG000|STARTED|Pre-screening Period||7
10820708|NCT00539617|11985682|FG000|COMPLETED|Pre-screening Period||4
10820709|NCT00539617|11985682|FG000|NOT COMPLETED|Pre-screening Period||3
10820710|NCT00539617|11985682|FG000|STARTED|Run-In Period||4
10820711|NCT00539617|11985682|FG000|COMPLETED|Run-In Period||3
10820712|NCT00539617|11985682|FG000|NOT COMPLETED|Run-In Period||1
10820713|NCT00539617|11985682|FG000|STARTED|Treatment Period||3
10820714|NCT00539617|11985682|FG000|COMPLETED|Treatment Period||3
10820715|NCT00539617|11985682|FG000|NOT COMPLETED|Treatment Period||0
10820716|NCT00546455|11985688|FG000|STARTED|Overall Study||0
10820717|NCT00546455|11985689|FG001|STARTED|Overall Study||0
10820718|NCT00546455|11985688|FG000|COMPLETED|Overall Study||0
10820719|NCT00546455|11985689|FG001|COMPLETED|Overall Study||0
10820720|NCT00546455|11985688|FG000|NOT COMPLETED|Overall Study||0
10820721|NCT00546455|11985689|FG001|NOT COMPLETED|Overall Study||0
10820722|NCT00538980|11985695|FG000|STARTED|Overall Study||10
10820723|NCT00538980|11985695|FG000|COMPLETED|Overall Study||0
10820724|NCT00538980|11985695|FG000|NOT COMPLETED|Overall Study||10
10820725|NCT00540969|11985701|FG000|STARTED|Overall Study||2
10820726|NCT00540969|11985702|FG001|STARTED|Overall Study||1
10820727|NCT00540969|11985701|FG000|COMPLETED|Overall Study||2
10820728|NCT00540969|11985702|FG001|COMPLETED|Overall Study||1
10820729|NCT00540969|11985701|FG000|NOT COMPLETED|Overall Study||0
10820730|NCT00540969|11985702|FG001|NOT COMPLETED|Overall Study||0
10752754|NCT03034928|11916321|FG001|STARTED|Period 1, First 2 Hours of Wear||8
10752755|NCT03034928|11916322|FG002|STARTED|Period 1, First 2 Hours of Wear||9
10752756|NCT03034928|11916323|FG003|STARTED|Period 1, First 2 Hours of Wear||8
10752757|NCT03034928|11916320|FG000|COMPLETED|Period 1, First 2 Hours of Wear||8
10752758|NCT03034928|11916321|FG001|COMPLETED|Period 1, First 2 Hours of Wear||8
10752759|NCT03034928|11916322|FG002|COMPLETED|Period 1, First 2 Hours of Wear||9
10752760|NCT03034928|11916323|FG003|COMPLETED|Period 1, First 2 Hours of Wear||8
10752761|NCT03034928|11916320|FG000|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
10752762|NCT03034928|11916321|FG001|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
10752763|NCT03034928|11916322|FG002|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
10752764|NCT03034928|11916323|FG003|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
10752765|NCT03034928|11916320|FG000|STARTED|Washout Period Between Lens Wear||8
10752766|NCT03034928|11916321|FG001|STARTED|Washout Period Between Lens Wear||8
10752767|NCT03034928|11916322|FG002|STARTED|Washout Period Between Lens Wear||9
10752768|NCT03034928|11916323|FG003|STARTED|Washout Period Between Lens Wear||8
10752769|NCT03034928|11916320|FG000|COMPLETED|Washout Period Between Lens Wear||8
10752770|NCT03034928|11916321|FG001|COMPLETED|Washout Period Between Lens Wear||8
10752771|NCT03034928|11916322|FG002|COMPLETED|Washout Period Between Lens Wear||9
10820731|NCT00535262|11985708|FG000|STARTED|Overall Study|3 patients were enrolled in the study. Data was collected for only two weeks before funding expired.|3
10820732|NCT00535262|11985708|FG000|COMPLETED|Overall Study|Pharmaceutical company withdrew supply of EmSam prematurely before protocol was complete.|0
10820733|NCT00535262|11985708|FG000|NOT COMPLETED|Overall Study||3
10820734|NCT00529464|11985715|FG000|STARTED|Overall Study||0
10820735|NCT00529464|11985716|FG001|STARTED|Overall Study||0
10820736|NCT00529464|11985717|FG002|STARTED|Overall Study||0
10820737|NCT00529464|11985715|FG000|COMPLETED|Overall Study||0
10820738|NCT00529464|11985716|FG001|COMPLETED|Overall Study||0
10820739|NCT00529464|11985717|FG002|COMPLETED|Overall Study||0
10820740|NCT00529464|11985715|FG000|NOT COMPLETED|Overall Study||0
10820741|NCT00529464|11985716|FG001|NOT COMPLETED|Overall Study||0
10820742|NCT00529464|11985717|FG002|NOT COMPLETED|Overall Study||0
10820743|NCT00537199|11985725|FG000|STARTED|Overall Study||1
10820744|NCT00537199|11985725|FG000|COMPLETED|Overall Study||0
10820745|NCT00537199|11985725|FG000|NOT COMPLETED|Overall Study||1
10820746|NCT00537446|11985729|FG000|STARTED|Overall Study||8
10820747|NCT00537446|11985729|FG000|COMPLETED|Overall Study||8
10820748|NCT00537446|11985729|FG000|NOT COMPLETED|Overall Study||0
10820749|NCT00536978|11985735|FG000|STARTED|Overall Study||22
10820750|NCT00536978|11985735|FG000|COMPLETED|Overall Study||0
10820751|NCT00536978|11985735|FG000|NOT COMPLETED|Overall Study||22
10820752|NCT00524485|11985739|FG000|STARTED|Overall Study||12
10820753|NCT00524485|11985739|FG000|COMPLETED|Overall Study||7
10820754|NCT00524485|11985739|FG000|NOT COMPLETED|Overall Study||5
10752772|NCT03034928|11916323|FG003|COMPLETED|Washout Period Between Lens Wear||8
10752773|NCT03034928|11916320|FG000|NOT COMPLETED|Washout Period Between Lens Wear||0
10752774|NCT03034928|11916321|FG001|NOT COMPLETED|Washout Period Between Lens Wear||0
10752775|NCT03034928|11916322|FG002|NOT COMPLETED|Washout Period Between Lens Wear||0
10752776|NCT03034928|11916323|FG003|NOT COMPLETED|Washout Period Between Lens Wear||0
10752777|NCT03034928|11916320|FG000|STARTED|Period 2, Second 2 Hours of Wear||8
10752778|NCT03034928|11916321|FG001|STARTED|Period 2, Second 2 Hours of Wear||8
10752779|NCT03034928|11916322|FG002|STARTED|Period 2, Second 2 Hours of Wear||9
10752780|NCT03034928|11916323|FG003|STARTED|Period 2, Second 2 Hours of Wear||8
10752781|NCT03034928|11916320|FG000|COMPLETED|Period 2, Second 2 Hours of Wear||8
10752782|NCT03034928|11916321|FG001|COMPLETED|Period 2, Second 2 Hours of Wear||8
10752783|NCT03034928|11916322|FG002|COMPLETED|Period 2, Second 2 Hours of Wear||9
10752784|NCT03034928|11916323|FG003|COMPLETED|Period 2, Second 2 Hours of Wear||8
10752785|NCT03034928|11916320|FG000|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
10752786|NCT03034928|11916321|FG001|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
10752787|NCT03034928|11916322|FG002|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
10752788|NCT03034928|11916323|FG003|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
10752789|NCT03034954|11916334|FG000|STARTED|Overall Study||21
10752790|NCT03034954|11916335|FG001|STARTED|Overall Study||21
10752791|NCT03034954|11916334|FG000|COMPLETED|Overall Study||20
10752792|NCT03034954|11916335|FG001|COMPLETED|Overall Study||21
10752793|NCT03034954|11916334|FG000|NOT COMPLETED|Overall Study||1
10752794|NCT03034954|11916335|FG001|NOT COMPLETED|Overall Study||0
10752795|NCT03034967|11916347|FG000|STARTED|Overall Study||102
10752796|NCT03034967|11916348|FG001|STARTED|Overall Study||102
10752797|NCT03034967|11916349|FG002|STARTED|Overall Study||103
10752798|NCT03034967|11916350|FG003|STARTED|Overall Study||103
10752799|NCT03034967|11916351|FG004|STARTED|Overall Study||102
10752800|NCT03034967|11916352|FG005|STARTED|Overall Study||102
10752801|NCT03034967|11916347|FG000|COMPLETED|Overall Study||88
10820755|NCT00533351|11985745|FG000|STARTED|Period 1||7
10820756|NCT00533351|11985746|FG001|STARTED|Period 1||2
10820757|NCT00533351|11985745|FG000|COMPLETED|Period 1||5
10820758|NCT00533351|11985746|FG001|COMPLETED|Period 1||1
10820759|NCT00533351|11985745|FG000|NOT COMPLETED|Period 1||2
10820760|NCT00533351|11985746|FG001|NOT COMPLETED|Period 1||1
10752802|NCT03034967|11916348|FG001|COMPLETED|Overall Study||97
10752803|NCT03034967|11916349|FG002|COMPLETED|Overall Study||90
10752804|NCT03034967|11916350|FG003|COMPLETED|Overall Study||92
10752805|NCT03034967|11916351|FG004|COMPLETED|Overall Study||88
10752806|NCT03034967|11916352|FG005|COMPLETED|Overall Study||87
10752807|NCT03034967|11916347|FG000|NOT COMPLETED|Overall Study||14
10752808|NCT03034967|11916348|FG001|NOT COMPLETED|Overall Study||5
10820761|NCT00533351|11985745|FG000|STARTED|Period 2||5
10820762|NCT00533351|11985746|FG001|STARTED|Period 2||1
10820763|NCT00533351|11985745|FG000|COMPLETED|Period 2||5
10820764|NCT00533351|11985746|FG001|COMPLETED|Period 2||1
10820765|NCT00533351|11985745|FG000|NOT COMPLETED|Period 2||0
10820766|NCT00533351|11985746|FG001|NOT COMPLETED|Period 2||0
10820767|NCT00533351|11985745|FG000|STARTED|Period 3|Three out of the five patients who completed Period 2 continued to Period 3|3
10820768|NCT00533351|11985746|FG001|STARTED|Period 3|No patients continued to Period 3|0
10820769|NCT00533351|11985745|FG000|COMPLETED|Period 3||3
10820770|NCT00533351|11985746|FG001|COMPLETED|Period 3||0
10820771|NCT00533351|11985745|FG000|NOT COMPLETED|Period 3||0
10820772|NCT00533351|11985746|FG001|NOT COMPLETED|Period 3||0
10820773|NCT00529282|11985754|FG000|STARTED|Overall Study||0
10820774|NCT00529282|11985755|FG001|STARTED|Overall Study||2
10820775|NCT00529282|11985754|FG000|COMPLETED|Overall Study||0
10820776|NCT00529282|11985755|FG001|COMPLETED|Overall Study||2
10820777|NCT00529282|11985754|FG000|NOT COMPLETED|Overall Study||0
10820778|NCT00529282|11985755|FG001|NOT COMPLETED|Overall Study||0
10820779|NCT00524134|11985761|FG000|STARTED|Overall Study||6
10820780|NCT00524134|11985761|FG000|COMPLETED|Overall Study||4
10820781|NCT00524134|11985761|FG000|NOT COMPLETED|Overall Study||2
10820782|NCT00527748|11985765|FG000|STARTED|Overall Study||26
10820783|NCT00527748|11985765|FG000|COMPLETED|Overall Study||23
10820784|NCT00527748|11985765|FG000|NOT COMPLETED|Overall Study||3
10820785|NCT00517699|11985769|FG000|STARTED|Overall Study||5
10820786|NCT00517699|11985769|FG000|COMPLETED|Overall Study||0
10820787|NCT00517699|11985769|FG000|NOT COMPLETED|Overall Study||5
10820788|NCT00528775|11985773|FG000|STARTED|Overall Study||6
10820789|NCT00528775|11985773|FG000|COMPLETED|Overall Study||5
10820790|NCT00528775|11985773|FG000|NOT COMPLETED|Overall Study||1
10820791|NCT00528437|11985777|FG000|STARTED|Overall Study||46
10820792|NCT00528437|11985777|FG000|COMPLETED|Overall Study||46
10820793|NCT00528437|11985777|FG000|NOT COMPLETED|Overall Study||0
10820794|NCT00524511|11985783|FG000|STARTED|Overall Study||68
10820795|NCT00524511|11985784|FG001|STARTED|Overall Study||68
10820796|NCT00524511|11985783|FG000|COMPLETED|Overall Study||64
10820797|NCT00524511|11985784|FG001|COMPLETED|Overall Study||61
10820798|NCT00524511|11985783|FG000|NOT COMPLETED|Overall Study||4
10820799|NCT00524511|11985784|FG001|NOT COMPLETED|Overall Study||7
10820800|NCT00517075|11985794|FG000|STARTED|Overall Study||0
10820801|NCT00517075|11985795|FG001|STARTED|Overall Study||0
10820802|NCT00517075|11985796|FG002|STARTED|Overall Study||0
10820803|NCT00517075|11985797|FG003|STARTED|Overall Study||0
10820804|NCT00517075|11985794|FG000|COMPLETED|Overall Study||0
10820805|NCT00517075|11985795|FG001|COMPLETED|Overall Study||0
10820806|NCT00517075|11985796|FG002|COMPLETED|Overall Study||0
10820807|NCT00517075|11985797|FG003|COMPLETED|Overall Study||0
10752809|NCT03034967|11916349|FG002|NOT COMPLETED|Overall Study||13
10752810|NCT03034967|11916350|FG003|NOT COMPLETED|Overall Study||11
10752811|NCT03034967|11916351|FG004|NOT COMPLETED|Overall Study||14
10752812|NCT03034967|11916352|FG005|NOT COMPLETED|Overall Study||15
10752813|NCT03035032|11916371|FG000|STARTED|Overall Study||107
10752814|NCT03035032|11916371|FG000|COMPLETED|Overall Study||64
10752815|NCT03035032|11916371|FG000|NOT COMPLETED|Overall Study||43
10752816|NCT03035318|11916380|FG000|STARTED|Overall Study||24
10752817|NCT03035318|11916381|FG001|STARTED|Overall Study||25
10752818|NCT03035318|11916382|FG002|STARTED|Overall Study||25
10752819|NCT03035318|11916383|FG003|STARTED|Overall Study||25
10752820|NCT03035318|11916384|FG004|STARTED|Overall Study||27
10752821|NCT03035318|11916380|FG000|COMPLETED|Overall Study||22
10752822|NCT03035318|11916381|FG001|COMPLETED|Overall Study||21
10752823|NCT03035318|11916382|FG002|COMPLETED|Overall Study||21
10752824|NCT03035318|11916383|FG003|COMPLETED|Overall Study||23
10752825|NCT03035318|11916384|FG004|COMPLETED|Overall Study||20
10752826|NCT03035318|11916380|FG000|NOT COMPLETED|Overall Study||2
10752827|NCT03035318|11916381|FG001|NOT COMPLETED|Overall Study||4
10752828|NCT03035318|11916382|FG002|NOT COMPLETED|Overall Study||4
10752829|NCT03035318|11916383|FG003|NOT COMPLETED|Overall Study||2
10752830|NCT03035318|11916384|FG004|NOT COMPLETED|Overall Study||7
10752831|NCT03035487|11916396|FG000|STARTED|Overall Study||9
10752832|NCT03035487|11916396|FG000|COMPLETED|Overall Study||9
10752833|NCT03035487|11916396|FG000|NOT COMPLETED|Overall Study||0
10752834|NCT03035708|11916402|FG000|STARTED|Overall Study||23
10752835|NCT03035708|11916403|FG001|STARTED|Overall Study||24
10752836|NCT03035708|11916402|FG000|COMPLETED|Overall Study||19
10752837|NCT03035708|11916403|FG001|COMPLETED|Overall Study||13
10752838|NCT03035708|11916402|FG000|NOT COMPLETED|Overall Study||4
10752839|NCT03035708|11916403|FG001|NOT COMPLETED|Overall Study||11
10752840|NCT03035760|11916416|FG000|STARTED|First Intervention - 10/7 Days Follow-up||8
10752841|NCT03035760|11916417|FG001|STARTED|First Intervention - 10/7 Days Follow-up||8
10752842|NCT03035760|11916418|FG002|STARTED|First Intervention - 10/7 Days Follow-up||8
10752843|NCT03035760|11916419|FG003|STARTED|First Intervention - 10/7 Days Follow-up||6
10752844|NCT03035760|11916420|FG004|STARTED|First Intervention - 10/7 Days Follow-up||6
10752845|NCT03035760|11916416|FG000|COMPLETED|First Intervention - 10/7 Days Follow-up||8
10752846|NCT03035760|11916417|FG001|COMPLETED|First Intervention - 10/7 Days Follow-up||8
10752847|NCT03035760|11916418|FG002|COMPLETED|First Intervention - 10/7 Days Follow-up||8
10752848|NCT03035760|11916419|FG003|COMPLETED|First Intervention - 10/7 Days Follow-up||6
10752849|NCT03035760|11916420|FG004|COMPLETED|First Intervention - 10/7 Days Follow-up||6
10752850|NCT03035760|11916416|FG000|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
10752851|NCT03035760|11916417|FG001|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
10752852|NCT03035760|11916418|FG002|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
10752853|NCT03035760|11916419|FG003|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
10752854|NCT03035760|11916420|FG004|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
10752855|NCT03035760|11916416|FG000|STARTED|Second Intervention - 7 Days Follow-up||0
10752856|NCT03035760|11916417|FG001|STARTED|Second Intervention - 7 Days Follow-up||0
10752857|NCT03035760|11916418|FG002|STARTED|Second Intervention - 7 Days Follow-up||0
10752858|NCT03035760|11916419|FG003|STARTED|Second Intervention - 7 Days Follow-up||6
10752859|NCT03035760|11916420|FG004|STARTED|Second Intervention - 7 Days Follow-up||6
10752860|NCT03035760|11916416|FG000|COMPLETED|Second Intervention - 7 Days Follow-up||0
10752861|NCT03035760|11916417|FG001|COMPLETED|Second Intervention - 7 Days Follow-up||0
10752862|NCT03035760|11916418|FG002|COMPLETED|Second Intervention - 7 Days Follow-up||0
10752863|NCT03035760|11916419|FG003|COMPLETED|Second Intervention - 7 Days Follow-up||6
10752864|NCT03035760|11916420|FG004|COMPLETED|Second Intervention - 7 Days Follow-up||6
10752865|NCT03035760|11916416|FG000|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
10752866|NCT03035760|11916417|FG001|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
10752867|NCT03035760|11916418|FG002|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
10752868|NCT03035760|11916419|FG003|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
10752869|NCT03035760|11916420|FG004|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
10752870|NCT03035864|11916435|FG000|STARTED|Treatment Period||120
10752871|NCT03035864|11916436|FG001|STARTED|Treatment Period||60
10752872|NCT03035864|11916435|FG000|COMPLETED|Treatment Period||116
10752873|NCT03035864|11916436|FG001|COMPLETED|Treatment Period||59
10752874|NCT03035864|11916435|FG000|NOT COMPLETED|Treatment Period||4
10752875|NCT03035864|11916436|FG001|NOT COMPLETED|Treatment Period||1
10752876|NCT03035864|11916435|FG000|STARTED|Follow-up Period||116
10752877|NCT03035864|11916436|FG001|STARTED|Follow-up Period||59
10752878|NCT03035864|11916435|FG000|COMPLETED|Follow-up Period||105
10752879|NCT03035864|11916436|FG001|COMPLETED|Follow-up Period||55
10752880|NCT03035864|11916435|FG000|NOT COMPLETED|Follow-up Period||11
10752881|NCT03035864|11916436|FG001|NOT COMPLETED|Follow-up Period||4
10752882|NCT03035916|11916445|FG000|STARTED|Overall Study||30
10752883|NCT03035916|11916446|FG001|STARTED|Overall Study||30
10752884|NCT03035916|11916447|FG002|STARTED|Overall Study||31
10752885|NCT03035916|11916445|FG000|COMPLETED|Overall Study||30
10752886|NCT03035916|11916446|FG001|COMPLETED|Overall Study||28
10752887|NCT03035916|11916447|FG002|COMPLETED|Overall Study||31
10752888|NCT03035916|11916445|FG000|NOT COMPLETED|Overall Study||0
10752889|NCT03035916|11916446|FG001|NOT COMPLETED|Overall Study||2
10752890|NCT03035916|11916447|FG002|NOT COMPLETED|Overall Study||0
10752891|NCT03035929|11916455|FG000|STARTED|Overall Study||10
10752892|NCT03035929|11916455|FG000|COMPLETED|Overall Study||10
10752893|NCT03035929|11916455|FG000|NOT COMPLETED|Overall Study||0
10752894|NCT03035942|11916463|FG000|STARTED|Overall Study||45
10752895|NCT03035942|11916464|FG001|STARTED|Overall Study||45
10752896|NCT03035942|11916465|FG002|STARTED|Overall Study||45
10752897|NCT03035942|11916463|FG000|COMPLETED|Overall Study||37
10752898|NCT03035942|11916464|FG001|COMPLETED|Overall Study||41
10752899|NCT03035942|11916465|FG002|COMPLETED|Overall Study||40
10752900|NCT03035942|11916463|FG000|NOT COMPLETED|Overall Study||8
10752901|NCT03035942|11916464|FG001|NOT COMPLETED|Overall Study||4
10752902|NCT03035942|11916465|FG002|NOT COMPLETED|Overall Study||5
10752903|NCT03035955|11916477|FG000|STARTED|Overall Study||10
10752904|NCT03035955|11916478|FG001|STARTED|Overall Study||10
10752905|NCT03035955|11916477|FG000|COMPLETED|Overall Study||9
10752906|NCT03035955|11916478|FG001|COMPLETED|Overall Study||9
10752907|NCT03035955|11916477|FG000|NOT COMPLETED|Overall Study||1
10752908|NCT03035955|11916478|FG001|NOT COMPLETED|Overall Study||1
10752909|NCT03036072|11916486|FG000|STARTED|Overall Study||12
10752910|NCT03036072|11916487|FG001|STARTED|Overall Study||13
10752911|NCT03036072|11916486|FG000|COMPLETED|Overall Study||12
10752912|NCT03036072|11916487|FG001|COMPLETED|Overall Study||10
10752913|NCT03036072|11916486|FG000|NOT COMPLETED|Overall Study||0
10752914|NCT03036072|11916487|FG001|NOT COMPLETED|Overall Study||3
10752915|NCT03036124|11916495|FG000|STARTED|Overall Study||2373
10752916|NCT03036124|11916496|FG001|STARTED|Overall Study||2371
10752917|NCT03036124|11916495|FG000|COMPLETED|Overall Study||2368
10752918|NCT03036124|11916496|FG001|COMPLETED|Overall Study||2365
10752919|NCT03036124|11916495|FG000|NOT COMPLETED|Overall Study||5
10752920|NCT03036124|11916496|FG001|NOT COMPLETED|Overall Study||6
10752921|NCT03036150|11916504|FG000|STARTED|Overall Study||2152
10752922|NCT03036150|11916505|FG001|STARTED|Overall Study||2152
10752923|NCT03036150|11916504|FG000|COMPLETED|Overall Study||2142
10752924|NCT03036150|11916505|FG001|COMPLETED|Overall Study||2147
10752925|NCT03036150|11916504|FG000|NOT COMPLETED|Overall Study||10
10752926|NCT03036150|11916505|FG001|NOT COMPLETED|Overall Study||5
10752927|NCT03036163|11916518|FG000|STARTED|Overall Study||6
10752928|NCT03036163|11916519|FG001|STARTED|Overall Study||6
10752929|NCT03036163|11916520|FG002|STARTED|Overall Study||6
10752930|NCT03036163|11916521|FG003|STARTED|Overall Study||6
10752931|NCT03036163|11916522|FG004|STARTED|Overall Study||6
10752932|NCT03036163|11916523|FG005|STARTED|Overall Study||5
10752933|NCT03036163|11916524|FG006|STARTED|Overall Study||5
10752934|NCT03036163|11916518|FG000|COMPLETED|Overall Study||6
10752935|NCT03036163|11916519|FG001|COMPLETED|Overall Study||6
10752936|NCT03036163|11916520|FG002|COMPLETED|Overall Study||6
10752937|NCT03036163|11916521|FG003|COMPLETED|Overall Study||6
10752938|NCT03036163|11916522|FG004|COMPLETED|Overall Study||6
10752939|NCT03036163|11916523|FG005|COMPLETED|Overall Study||5
10752940|NCT03036163|11916524|FG006|COMPLETED|Overall Study||5
10752941|NCT03036163|11916518|FG000|NOT COMPLETED|Overall Study||0
10752942|NCT03036163|11916519|FG001|NOT COMPLETED|Overall Study||0
10752943|NCT03036163|11916520|FG002|NOT COMPLETED|Overall Study||0
10752944|NCT03036163|11916521|FG003|NOT COMPLETED|Overall Study||0
10752945|NCT03036163|11916522|FG004|NOT COMPLETED|Overall Study||0
10752946|NCT03036163|11916523|FG005|NOT COMPLETED|Overall Study||0
10752947|NCT03036163|11916524|FG006|NOT COMPLETED|Overall Study||0
10752948|NCT03036215|11916542|FG000|STARTED|Overall Study||41
10752949|NCT03036215|11916543|FG001|STARTED|Overall Study||39
10752950|NCT03036215|11916542|FG000|COMPLETED|Overall Study||39
10752951|NCT03036215|11916543|FG001|COMPLETED|Overall Study||36
10752952|NCT03036215|11916542|FG000|NOT COMPLETED|Overall Study||2
10752953|NCT03036215|11916543|FG001|NOT COMPLETED|Overall Study||3
10752954|NCT03036293|11916556|FG000|STARTED|Overall Study||127
10752955|NCT03036293|11916557|FG001|STARTED|Overall Study||67
10752956|NCT03036293|11916558|FG002|STARTED|Overall Study||131
10752957|NCT03036293|11916559|FG003|STARTED|Overall Study||65
10752958|NCT03036293|11916556|FG000|COMPLETED|Overall Study||126
10752959|NCT03036293|11916557|FG001|COMPLETED|Overall Study||64
10752960|NCT03036293|11916558|FG002|COMPLETED|Overall Study||130
10752961|NCT03036293|11916559|FG003|COMPLETED|Overall Study||64
10752962|NCT03036293|11916556|FG000|NOT COMPLETED|Overall Study||1
10752963|NCT03036293|11916557|FG001|NOT COMPLETED|Overall Study||3
10752964|NCT03036293|11916558|FG002|NOT COMPLETED|Overall Study||1
10752965|NCT03036293|11916559|FG003|NOT COMPLETED|Overall Study||1
10752966|NCT03036384|11916571|FG000|STARTED|Overall Study||4
10752967|NCT03036384|11916572|FG001|STARTED|Overall Study||4
10752968|NCT03036384|11916573|FG002|STARTED|Overall Study||4
10752969|NCT03036384|11916574|FG003|STARTED|Overall Study||4
10752970|NCT03036384|11916575|FG004|STARTED|Overall Study||4
10752971|NCT03036384|11916576|FG005|STARTED|Overall Study||4
10752972|NCT03036384|11916577|FG006|STARTED|Overall Study||4
10752973|NCT03036384|11916578|FG007|STARTED|Overall Study||4
10752974|NCT03036384|11916579|FG008|STARTED|Overall Study||4
10752975|NCT03036384|11916580|FG009|STARTED|Overall Study||4
10752976|NCT03036384|11916571|FG000|COMPLETED|Overall Study||4
10752977|NCT03036384|11916572|FG001|COMPLETED|Overall Study||4
10752978|NCT03036384|11916573|FG002|COMPLETED|Overall Study||4
10752979|NCT03036384|11916574|FG003|COMPLETED|Overall Study||4
10752980|NCT03036384|11916575|FG004|COMPLETED|Overall Study||4
10752981|NCT03036384|11916576|FG005|COMPLETED|Overall Study||4
10752982|NCT03036384|11916577|FG006|COMPLETED|Overall Study||4
10752983|NCT03036384|11916578|FG007|COMPLETED|Overall Study||4
10752984|NCT03036384|11916579|FG008|COMPLETED|Overall Study||4
10752985|NCT03036384|11916580|FG009|COMPLETED|Overall Study||4
10752986|NCT03036384|11916571|FG000|NOT COMPLETED|Overall Study||0
10752987|NCT03036384|11916572|FG001|NOT COMPLETED|Overall Study||0
10752988|NCT03036384|11916573|FG002|NOT COMPLETED|Overall Study||0
10752989|NCT03036384|11916574|FG003|NOT COMPLETED|Overall Study||0
10752990|NCT03036384|11916575|FG004|NOT COMPLETED|Overall Study||0
10752991|NCT03036384|11916576|FG005|NOT COMPLETED|Overall Study||0
10752992|NCT03036384|11916577|FG006|NOT COMPLETED|Overall Study||0
10752993|NCT03036384|11916578|FG007|NOT COMPLETED|Overall Study||0
10752994|NCT03036384|11916579|FG008|NOT COMPLETED|Overall Study||0
10752995|NCT03036384|11916580|FG009|NOT COMPLETED|Overall Study||0
10752996|NCT03036813|11916601|FG000|STARTED|Overall Study||92
10752997|NCT03036813|11916602|FG001|STARTED|Overall Study||90
10752998|NCT03036813|11916603|FG002|STARTED|Overall Study||92
10752999|NCT03036813|11916601|FG000|COMPLETED|Overall Study||70
10753000|NCT03036813|11916602|FG001|COMPLETED|Overall Study||63
10753001|NCT03036813|11916603|FG002|COMPLETED|Overall Study||66
10753002|NCT03036813|11916601|FG000|NOT COMPLETED|Overall Study||22
10753003|NCT03036813|11916602|FG001|NOT COMPLETED|Overall Study||27
10753004|NCT03036813|11916603|FG002|NOT COMPLETED|Overall Study||26
10753005|NCT03036839|11916617|FG000|STARTED|Overall Study||45
10753006|NCT03036839|11916618|FG001|STARTED|Overall Study||31
10753007|NCT03036839|11916619|FG002|STARTED|Overall Study||19
10753008|NCT03036839|11916617|FG000|COMPLETED|Overall Study||42
10753009|NCT03036839|11916618|FG001|COMPLETED|Overall Study||31
10753010|NCT03036839|11916619|FG002|COMPLETED|Overall Study||14
10753011|NCT03036839|11916617|FG000|NOT COMPLETED|Overall Study||3
10753012|NCT03036839|11916618|FG001|NOT COMPLETED|Overall Study||0
10753013|NCT03036839|11916619|FG002|NOT COMPLETED|Overall Study||5
10753014|NCT03036852|11916633|FG000|STARTED|Overall Study||59
10753015|NCT03036852|11916633|FG000|COMPLETED|Overall Study||53
10753016|NCT03036852|11916633|FG000|NOT COMPLETED|Overall Study||6
10753017|NCT03037203|11916647|FG000|STARTED|Overall Study||28
10753018|NCT03037203|11916648|FG001|STARTED|Overall Study||28
10753019|NCT03037203|11916649|FG002|STARTED|Overall Study||10
10753020|NCT03037203|11916647|FG000|COMPLETED|Overall Study||27
10753021|NCT03037203|11916648|FG001|COMPLETED|Overall Study||26
10753022|NCT03037203|11916649|FG002|COMPLETED|Overall Study||9
10753023|NCT03037203|11916647|FG000|NOT COMPLETED|Overall Study||1
10753024|NCT03037203|11916648|FG001|NOT COMPLETED|Overall Study||2
10753025|NCT03037203|11916649|FG002|NOT COMPLETED|Overall Study||1
10753026|NCT03037281|11916669|FG000|STARTED|Overall Study||6
10753027|NCT03037281|11916670|FG001|STARTED|Overall Study||8
10753028|NCT03037281|11916669|FG000|COMPLETED|Overall Study||6
10753029|NCT03037281|11916670|FG001|COMPLETED|Overall Study||8
10753030|NCT03037281|11916669|FG000|NOT COMPLETED|Overall Study||0
10753031|NCT03037281|11916670|FG001|NOT COMPLETED|Overall Study||0
10778671|NCT03358407|11940527|FG008|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
10778672|NCT03358407|11940528|FG009|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
10778673|NCT03358407|11940519|FG000|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
10778674|NCT03358407|11940520|FG001|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
10778675|NCT03358407|11940521|FG002|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
10778676|NCT03358407|11940522|FG003|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
10778677|NCT03358407|11940523|FG004|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
10778678|NCT03358407|11940524|FG005|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
10778679|NCT03358407|11940525|FG006|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
10778680|NCT03358407|11940526|FG007|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
10778681|NCT03358407|11940527|FG008|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
10778682|NCT03358407|11940528|FG009|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
10778683|NCT03358407|11940519|FG000|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
10778684|NCT03358407|11940520|FG001|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
10778685|NCT03358407|11940521|FG002|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
10778686|NCT03358407|11940522|FG003|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
10778687|NCT03358407|11940523|FG004|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
10778688|NCT03358407|11940524|FG005|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
10778689|NCT03358407|11940525|FG006|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
10778690|NCT03358407|11940526|FG007|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||6
10778691|NCT03358407|11940527|FG008|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
10778692|NCT03358407|11940528|FG009|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
10778693|NCT03358407|11940519|FG000|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
10778694|NCT03358407|11940520|FG001|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
10778695|NCT03358407|11940521|FG002|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
10778696|NCT03358407|11940522|FG003|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
10778697|NCT03358407|11940523|FG004|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
10778698|NCT03358407|11940524|FG005|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
10778699|NCT03358407|11940525|FG006|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||2
10778700|NCT03358407|11940526|FG007|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
10778701|NCT03358407|11940527|FG008|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
10778702|NCT03358407|11940528|FG009|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
10778703|NCT03358407|11940519|FG000|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
10778704|NCT03358407|11940520|FG001|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
10753032|NCT03037307|11916681|FG000|STARTED|Period 1||7
10753033|NCT03037307|11916682|FG001|STARTED|Period 1||7
10753034|NCT03037307|11916683|FG002|STARTED|Period 1||8
10753035|NCT03037307|11916684|FG003|STARTED|Period 1||7
10753036|NCT03037307|11916685|FG004|STARTED|Period 1||7
10753037|NCT03037307|11916686|FG005|STARTED|Period 1||8
10753038|NCT03037307|11916681|FG000|COMPLETED|Period 1||7
10753039|NCT03037307|11916682|FG001|COMPLETED|Period 1||7
10753040|NCT03037307|11916683|FG002|COMPLETED|Period 1||8
10753041|NCT03037307|11916684|FG003|COMPLETED|Period 1||6
10753042|NCT03037307|11916685|FG004|COMPLETED|Period 1||7
10753043|NCT03037307|11916686|FG005|COMPLETED|Period 1||8
10753044|NCT03037307|11916681|FG000|NOT COMPLETED|Period 1||0
10753045|NCT03037307|11916682|FG001|NOT COMPLETED|Period 1||0
10753046|NCT03037307|11916683|FG002|NOT COMPLETED|Period 1||0
10753047|NCT03037307|11916684|FG003|NOT COMPLETED|Period 1||1
10753048|NCT03037307|11916685|FG004|NOT COMPLETED|Period 1||0
10753049|NCT03037307|11916686|FG005|NOT COMPLETED|Period 1||0
10753050|NCT03037307|11916681|FG000|STARTED|Wash Out Period 1||7
10753051|NCT03037307|11916682|FG001|STARTED|Wash Out Period 1||7
10753052|NCT03037307|11916683|FG002|STARTED|Wash Out Period 1||8
10753053|NCT03037307|11916684|FG003|STARTED|Wash Out Period 1||6
10753054|NCT03037307|11916685|FG004|STARTED|Wash Out Period 1||7
10753055|NCT03037307|11916686|FG005|STARTED|Wash Out Period 1||8
10753056|NCT03037307|11916681|FG000|COMPLETED|Wash Out Period 1||7
10753057|NCT03037307|11916682|FG001|COMPLETED|Wash Out Period 1||7
10753058|NCT03037307|11916683|FG002|COMPLETED|Wash Out Period 1||8
10753059|NCT03037307|11916684|FG003|COMPLETED|Wash Out Period 1||6
10753060|NCT03037307|11916685|FG004|COMPLETED|Wash Out Period 1||7
10753061|NCT03037307|11916686|FG005|COMPLETED|Wash Out Period 1||8
10753062|NCT03037307|11916681|FG000|NOT COMPLETED|Wash Out Period 1||0
10753063|NCT03037307|11916682|FG001|NOT COMPLETED|Wash Out Period 1||0
10753064|NCT03037307|11916683|FG002|NOT COMPLETED|Wash Out Period 1||0
10753065|NCT03037307|11916684|FG003|NOT COMPLETED|Wash Out Period 1||0
10753066|NCT03037307|11916685|FG004|NOT COMPLETED|Wash Out Period 1||0
10753067|NCT03037307|11916686|FG005|NOT COMPLETED|Wash Out Period 1||0
10753068|NCT03037307|11916681|FG000|STARTED|Period 2||7
10753069|NCT03037307|11916682|FG001|STARTED|Period 2||7
10753070|NCT03037307|11916683|FG002|STARTED|Period 2||8
10753071|NCT03037307|11916684|FG003|STARTED|Period 2||6
10753072|NCT03037307|11916685|FG004|STARTED|Period 2||7
10753073|NCT03037307|11916686|FG005|STARTED|Period 2||8
10753074|NCT03037307|11916681|FG000|COMPLETED|Period 2||7
10753075|NCT03037307|11916682|FG001|COMPLETED|Period 2||7
10753076|NCT03037307|11916683|FG002|COMPLETED|Period 2||8
10753077|NCT03037307|11916684|FG003|COMPLETED|Period 2||6
10753078|NCT03037307|11916685|FG004|COMPLETED|Period 2||7
10753079|NCT03037307|11916686|FG005|COMPLETED|Period 2||8
10753080|NCT03037307|11916681|FG000|NOT COMPLETED|Period 2||0
10753081|NCT03037307|11916682|FG001|NOT COMPLETED|Period 2||0
10753082|NCT03037307|11916683|FG002|NOT COMPLETED|Period 2||0
10753083|NCT03037307|11916684|FG003|NOT COMPLETED|Period 2||0
10753084|NCT03037307|11916685|FG004|NOT COMPLETED|Period 2||0
10753085|NCT03037307|11916686|FG005|NOT COMPLETED|Period 2||0
10753086|NCT03037307|11916681|FG000|STARTED|Wash Out Period 2||7
10753087|NCT03037307|11916682|FG001|STARTED|Wash Out Period 2||7
10753088|NCT03037307|11916683|FG002|STARTED|Wash Out Period 2||8
10753089|NCT03037307|11916684|FG003|STARTED|Wash Out Period 2||6
10753090|NCT03037307|11916685|FG004|STARTED|Wash Out Period 2||7
10753091|NCT03037307|11916686|FG005|STARTED|Wash Out Period 2||8
10753092|NCT03037307|11916681|FG000|COMPLETED|Wash Out Period 2||7
10753093|NCT03037307|11916682|FG001|COMPLETED|Wash Out Period 2||7
10753094|NCT03037307|11916683|FG002|COMPLETED|Wash Out Period 2||8
10753095|NCT03037307|11916684|FG003|COMPLETED|Wash Out Period 2||6
10753096|NCT03037307|11916685|FG004|COMPLETED|Wash Out Period 2||7
10753097|NCT03037307|11916686|FG005|COMPLETED|Wash Out Period 2||8
10753098|NCT03037307|11916681|FG000|NOT COMPLETED|Wash Out Period 2||0
10753099|NCT03037307|11916682|FG001|NOT COMPLETED|Wash Out Period 2||0
10753100|NCT03037307|11916683|FG002|NOT COMPLETED|Wash Out Period 2||0
10753101|NCT03037307|11916684|FG003|NOT COMPLETED|Wash Out Period 2||0
10753102|NCT03037307|11916685|FG004|NOT COMPLETED|Wash Out Period 2||0
10753103|NCT03037307|11916686|FG005|NOT COMPLETED|Wash Out Period 2||0
10753104|NCT03037307|11916681|FG000|STARTED|Period 3||7
10753105|NCT03037307|11916682|FG001|STARTED|Period 3||7
10753106|NCT03037307|11916683|FG002|STARTED|Period 3||8
10753107|NCT03037307|11916684|FG003|STARTED|Period 3||6
10753108|NCT03037307|11916685|FG004|STARTED|Period 3||7
10753109|NCT03037307|11916686|FG005|STARTED|Period 3||8
10753110|NCT03037307|11916681|FG000|COMPLETED|Period 3||7
10753111|NCT03037307|11916682|FG001|COMPLETED|Period 3||7
10753112|NCT03037307|11916683|FG002|COMPLETED|Period 3||8
10753113|NCT03037307|11916684|FG003|COMPLETED|Period 3||6
10753114|NCT03037307|11916685|FG004|COMPLETED|Period 3||7
10753115|NCT03037307|11916686|FG005|COMPLETED|Period 3||8
10753116|NCT03037307|11916681|FG000|NOT COMPLETED|Period 3||0
10753117|NCT03037307|11916682|FG001|NOT COMPLETED|Period 3||0
10753118|NCT03037307|11916683|FG002|NOT COMPLETED|Period 3||0
10753119|NCT03037307|11916684|FG003|NOT COMPLETED|Period 3||0
10753120|NCT03037307|11916685|FG004|NOT COMPLETED|Period 3||0
10753121|NCT03037307|11916686|FG005|NOT COMPLETED|Period 3||0
10753122|NCT03037489|11916697|FG000|STARTED|Overall Study||46
10753123|NCT03037489|11916698|FG001|STARTED|Overall Study||4
10753124|NCT03037489|11916697|FG000|COMPLETED|Overall Study||39
10753125|NCT03037489|11916698|FG001|COMPLETED|Overall Study||4
10753126|NCT03037489|11916697|FG000|NOT COMPLETED|Overall Study||7
10753127|NCT03037489|11916698|FG001|NOT COMPLETED|Overall Study||0
10753128|NCT03037541|11916706|FG000|STARTED|Overall Study||30
10753129|NCT03037541|11916707|FG001|STARTED|Overall Study||30
10753130|NCT03037541|11916706|FG000|COMPLETED|Overall Study||30
10753131|NCT03037541|11916707|FG001|COMPLETED|Overall Study||30
10753132|NCT03037541|11916706|FG000|NOT COMPLETED|Overall Study||0
10753133|NCT03037541|11916707|FG001|NOT COMPLETED|Overall Study||0
10753134|NCT03037580|11916715|FG000|STARTED|Overall Study||41
10753135|NCT03037580|11916716|FG001|STARTED|Overall Study||43
10753136|NCT03037580|11916715|FG000|COMPLETED|Overall Study||25
10753137|NCT03037580|11916716|FG001|COMPLETED|Overall Study||27
10753138|NCT03037580|11916715|FG000|NOT COMPLETED|Overall Study||16
10753139|NCT03037580|11916716|FG001|NOT COMPLETED|Overall Study||16
10753140|NCT03037619|11916724|FG000|STARTED|Overall Study||8
10753141|NCT03037619|11916725|FG001|STARTED|Overall Study|8 participants and 7 buddies|15
10753142|NCT03037619|11916724|FG000|COMPLETED|Overall Study||8
10753143|NCT03037619|11916725|FG001|COMPLETED|Overall Study|7 participants and 7 buddies|14
10753144|NCT03037619|11916724|FG000|NOT COMPLETED|Overall Study||0
10753145|NCT03037619|11916725|FG001|NOT COMPLETED|Overall Study||1
10753146|NCT03037905|11916733|FG000|STARTED|Overall Study||50
10753147|NCT03037905|11916734|FG001|STARTED|Overall Study||50
10753148|NCT03037905|11916733|FG000|COMPLETED|Overall Study||50
10753149|NCT03037905|11916734|FG001|COMPLETED|Overall Study||50
10753150|NCT03037905|11916733|FG000|NOT COMPLETED|Overall Study||0
10753151|NCT03037905|11916734|FG001|NOT COMPLETED|Overall Study||0
10820808|NCT00517075|11985794|FG000|NOT COMPLETED|Overall Study||0
10820809|NCT00517075|11985795|FG001|NOT COMPLETED|Overall Study||0
10820810|NCT00517075|11985796|FG002|NOT COMPLETED|Overall Study||0
10820811|NCT00517075|11985797|FG003|NOT COMPLETED|Overall Study||0
10820812|NCT00527982|11985809|FG000|STARTED|Overall Study||1
10820813|NCT00527982|11985810|FG001|STARTED|Overall Study||0
10820814|NCT00527982|11985809|FG000|COMPLETED|Overall Study||0
10820815|NCT00527982|11985810|FG001|COMPLETED|Overall Study||0
10820816|NCT00527982|11985809|FG000|NOT COMPLETED|Overall Study||1
10820817|NCT00527982|11985810|FG001|NOT COMPLETED|Overall Study||0
10820818|NCT00524459|11985816|FG000|STARTED|Overall Study||6
10820819|NCT00524459|11985816|FG000|COMPLETED|Overall Study||4
10820820|NCT00524459|11985816|FG000|NOT COMPLETED|Overall Study||2
10820821|NCT00517361|11985820|FG000|STARTED|Overall Study||11
10820822|NCT00517361|11985820|FG000|COMPLETED|Overall Study|This study has been terminated due to poor accrual.|0
10820823|NCT00517361|11985820|FG000|NOT COMPLETED|Overall Study||11
10820824|NCT00523939|11985826|FG000|STARTED|Overall Study||2
10820825|NCT00523939|11985827|FG001|STARTED|Overall Study||2
10820826|NCT00523939|11985826|FG000|COMPLETED|Overall Study||2
10820827|NCT00523939|11985827|FG001|COMPLETED|Overall Study||2
10820828|NCT00523939|11985826|FG000|NOT COMPLETED|Overall Study||0
10820829|NCT00523939|11985827|FG001|NOT COMPLETED|Overall Study||0
10820830|NCT00522457|11985832|FG000|STARTED|Overall Study||19
10820831|NCT00522457|11985832|FG000|COMPLETED|Overall Study||1
10820832|NCT00522457|11985832|FG000|NOT COMPLETED|Overall Study||18
10820833|NCT00526331|11985836|FG000|STARTED|Overall Study||55
10820834|NCT00526331|11985836|FG000|COMPLETED|Overall Study||0
10820835|NCT00526331|11985836|FG000|NOT COMPLETED|Overall Study||55
10820836|NCT00519090|11985842|FG000|STARTED|Overall Study||2
10820837|NCT00519090|11985843|FG001|STARTED|Overall Study||4
10820838|NCT00519090|11985842|FG000|COMPLETED|Overall Study||2
10820839|NCT00519090|11985843|FG001|COMPLETED|Overall Study||4
10820840|NCT00519090|11985842|FG000|NOT COMPLETED|Overall Study||0
10820841|NCT00519090|11985843|FG001|NOT COMPLETED|Overall Study||0
10820842|NCT00524394|11985849|FG000|STARTED|Overall Study||2
10820843|NCT00524394|11985849|FG000|COMPLETED|Overall Study||1
10820844|NCT00524394|11985849|FG000|NOT COMPLETED|Overall Study||1
10820845|NCT00523809|11985853|FG000|STARTED|Overall Study||5
10820846|NCT00523809|11985853|FG000|COMPLETED|Overall Study||5
10820847|NCT00523809|11985853|FG000|NOT COMPLETED|Overall Study||0
10820848|NCT00522301|11985857|FG000|STARTED|Overall Study||6
10820849|NCT00522301|11985857|FG000|COMPLETED|Overall Study||0
10820850|NCT00522301|11985857|FG000|NOT COMPLETED|Overall Study||6
10820851|NCT00517192|11985863|FG000|STARTED|Overall Study||19
10820852|NCT00517192|11985864|FG001|STARTED|Overall Study||20
10820853|NCT00517192|11985863|FG000|COMPLETED|Overall Study||0
10820854|NCT00517192|11985864|FG001|COMPLETED|Overall Study||0
10820855|NCT00517192|11985863|FG000|NOT COMPLETED|Overall Study||19
10820856|NCT00517192|11985864|FG001|NOT COMPLETED|Overall Study||20
10820857|NCT00504985|11985870|FG000|STARTED|Overall Study||14
10820858|NCT00504985|11985870|FG000|COMPLETED|Overall Study||14
10820859|NCT00504985|11985870|FG000|NOT COMPLETED|Overall Study||0
10290231|NCT04749745|11422919|FG000|STARTED|Overall Study||5
10290232|NCT04749745|11422920|FG001|STARTED|Overall Study||6
10290233|NCT04749745|11422919|FG000|First Intervention|Overall Study||4
10290234|NCT04749745|11422920|FG001|First Intervention|Overall Study||6
10290235|NCT04749745|11422919|FG000|Washout|Overall Study||4
10290236|NCT04749745|11422920|FG001|Washout|Overall Study||6
10290237|NCT04749745|11422919|FG000|Second Intervention|Overall Study||4
10753152|NCT03037983|11916744|FG000|STARTED|Overall Study||5
10753153|NCT03037983|11916745|FG001|STARTED|Overall Study||4
10753154|NCT03037983|11916744|FG000|COMPLETED|Overall Study||5
10820860|NCT00503581|11985877|FG000|STARTED|Overall Study||3
10820861|NCT00503581|11985878|FG001|STARTED|Overall Study||4
10820862|NCT00503581|11985879|FG002|STARTED|Overall Study||2
10820863|NCT00503581|11985877|FG000|COMPLETED|Overall Study||0
10820864|NCT00503581|11985878|FG001|COMPLETED|Overall Study||0
10820865|NCT00503581|11985879|FG002|COMPLETED|Overall Study||0
10290238|NCT04749745|11422920|FG001|Second Intervention|Overall Study||6
10290239|NCT04749745|11422919|FG000|COMPLETED|Overall Study||4
10753155|NCT03037983|11916745|FG001|COMPLETED|Overall Study||4
10753156|NCT03037983|11916744|FG000|NOT COMPLETED|Overall Study||0
10753157|NCT03037983|11916745|FG001|NOT COMPLETED|Overall Study||0
10753158|NCT03038113|11916765|FG000|STARTED|Overall Study||8
10753159|NCT03038113|11916766|FG001|STARTED|Overall Study||8
10753160|NCT03038113|11916767|FG002|STARTED|Overall Study||8
10753161|NCT03038113|11916768|FG003|STARTED|Overall Study||8
10753162|NCT03038113|11916769|FG004|STARTED|Overall Study||8
10753163|NCT03038113|11916770|FG005|STARTED|Overall Study||8
10753164|NCT03038113|11916771|FG006|STARTED|Overall Study||12
10753165|NCT03038113|11916772|FG007|STARTED|Overall Study||6
10753166|NCT03038113|11916773|FG008|STARTED|Overall Study||7
10753167|NCT03038113|11916774|FG009|STARTED|Overall Study||6
10753168|NCT03038113|11916775|FG010|STARTED|Overall Study||14
10753169|NCT03038113|11916776|FG011|STARTED|Overall Study||7
10753170|NCT03038113|11916777|FG012|STARTED|Overall Study||4
10753171|NCT03038113|11916778|FG013|STARTED|Overall Study||15
10753172|NCT03038113|11916765|FG000|COMPLETED|Overall Study||8
10753173|NCT03038113|11916766|FG001|COMPLETED|Overall Study||8
10753174|NCT03038113|11916767|FG002|COMPLETED|Overall Study||7
10753175|NCT03038113|11916768|FG003|COMPLETED|Overall Study||8
10753176|NCT03038113|11916769|FG004|COMPLETED|Overall Study||8
10753177|NCT03038113|11916770|FG005|COMPLETED|Overall Study||8
10753178|NCT03038113|11916771|FG006|COMPLETED|Overall Study||11
10753179|NCT03038113|11916772|FG007|COMPLETED|Overall Study||6
10753180|NCT03038113|11916773|FG008|COMPLETED|Overall Study||7
10753181|NCT03038113|11916774|FG009|COMPLETED|Overall Study||6
10820866|NCT00503581|11985877|FG000|NOT COMPLETED|Overall Study||3
10820867|NCT00503581|11985878|FG001|NOT COMPLETED|Overall Study||4
10820868|NCT00503581|11985879|FG002|NOT COMPLETED|Overall Study||2
10820869|NCT00509600|11985887|FG000|STARTED|Overall Study||1
10820870|NCT00509600|11985887|FG000|COMPLETED|Overall Study||0
10820871|NCT00509600|11985887|FG000|NOT COMPLETED|Overall Study||1
10820872|NCT00515112|11985893|FG000|STARTED|Overall Study||3
10820873|NCT00515112|11985894|FG001|STARTED|Overall Study||3
10820874|NCT00515112|11985893|FG000|COMPLETED|Overall Study||0
10820875|NCT00515112|11985894|FG001|COMPLETED|Overall Study||0
10820876|NCT00515112|11985893|FG000|NOT COMPLETED|Overall Study||3
10820877|NCT00515112|11985894|FG001|NOT COMPLETED|Overall Study||3
10820878|NCT00508872|11985900|FG000|STARTED|Overall Study||2
10820879|NCT00508872|11985900|FG000|COMPLETED|Overall Study||0
10820880|NCT00508872|11985900|FG000|NOT COMPLETED|Overall Study||2
10820881|NCT00514813|11985908|FG000|STARTED|Overall Study||15
10820882|NCT00514813|11985909|FG001|STARTED|Overall Study||86
10820883|NCT00514813|11985910|FG002|STARTED|Overall Study||47
10820884|NCT00514813|11985911|FG003|STARTED|Overall Study||4
10820885|NCT00514813|11985908|FG000|COMPLETED|Overall Study||0
10820886|NCT00514813|11985909|FG001|COMPLETED|Overall Study||0
10820887|NCT00514813|11985910|FG002|COMPLETED|Overall Study||0
10820888|NCT00514813|11985911|FG003|COMPLETED|Overall Study||0
10820889|NCT00514813|11985908|FG000|NOT COMPLETED|Overall Study||15
10820890|NCT00514813|11985909|FG001|NOT COMPLETED|Overall Study||86
10820891|NCT00514813|11985910|FG002|NOT COMPLETED|Overall Study||47
10820892|NCT00514813|11985911|FG003|NOT COMPLETED|Overall Study||4
10820893|NCT00506064|11985923|FG000|STARTED|Overall Study||1
10820894|NCT00506064|11985924|FG001|STARTED|Overall Study||0
10820895|NCT00506064|11985923|FG000|COMPLETED|Overall Study||1
10820896|NCT00506064|11985924|FG001|COMPLETED|Overall Study||0
10820897|NCT00506064|11985923|FG000|NOT COMPLETED|Overall Study||0
10820898|NCT00506064|11985924|FG001|NOT COMPLETED|Overall Study||0
10820899|NCT00503880|11985930|FG000|STARTED|Overall Study||2
10820900|NCT00503880|11985931|FG001|STARTED|Overall Study||0
10820901|NCT00503880|11985932|FG002|STARTED|Overall Study||0
10820902|NCT00503880|11985933|FG003|STARTED|Overall Study||0
10820903|NCT00503880|11985934|FG004|STARTED|Overall Study||0
10820904|NCT00503880|11985930|FG000|COMPLETED|Overall Study||0
10820905|NCT00503880|11985931|FG001|COMPLETED|Overall Study||0
10820906|NCT00503880|11985932|FG002|COMPLETED|Overall Study||0
10820907|NCT00503880|11985933|FG003|COMPLETED|Overall Study||0
10820908|NCT00503880|11985934|FG004|COMPLETED|Overall Study||0
10820909|NCT00503880|11985930|FG000|NOT COMPLETED|Overall Study||2
10820910|NCT00503880|11985931|FG001|NOT COMPLETED|Overall Study||0
10820911|NCT00503880|11985932|FG002|NOT COMPLETED|Overall Study||0
10820912|NCT00503880|11985933|FG003|NOT COMPLETED|Overall Study||0
10820913|NCT00503880|11985934|FG004|NOT COMPLETED|Overall Study||0
10820914|NCT00511329|11985940|FG000|STARTED|Overall Study||0
10820915|NCT00511329|11985940|FG000|COMPLETED|Overall Study||0
10820916|NCT00511329|11985940|FG000|NOT COMPLETED|Overall Study||0
10820917|NCT00501228|11985944|FG000|STARTED|Overall Study||2
10820918|NCT00501228|11985944|FG000|COMPLETED|Overall Study||1
10753182|NCT03038113|11916775|FG010|COMPLETED|Overall Study||14
10753183|NCT03038113|11916776|FG011|COMPLETED|Overall Study||7
10820919|NCT00501228|11985944|FG000|NOT COMPLETED|Overall Study||1
10820920|NCT00496782|11985950|FG000|STARTED|Overall Study||9
10820921|NCT00496782|11985951|FG001|STARTED|Overall Study||7
10753184|NCT03038113|11916777|FG012|COMPLETED|Overall Study||4
10753185|NCT03038113|11916778|FG013|COMPLETED|Overall Study||14
10753186|NCT03038113|11916765|FG000|NOT COMPLETED|Overall Study||0
10820922|NCT00496782|11985950|FG000|COMPLETED|Overall Study||8
10820923|NCT00496782|11985951|FG001|COMPLETED|Overall Study||5
10753187|NCT03038113|11916766|FG001|NOT COMPLETED|Overall Study||0
10820924|NCT00496782|11985950|FG000|NOT COMPLETED|Overall Study||1
10753188|NCT03038113|11916767|FG002|NOT COMPLETED|Overall Study||1
10753189|NCT03038113|11916768|FG003|NOT COMPLETED|Overall Study||0
10753190|NCT03038113|11916769|FG004|NOT COMPLETED|Overall Study||0
10753191|NCT03038113|11916770|FG005|NOT COMPLETED|Overall Study||0
10753192|NCT03038113|11916771|FG006|NOT COMPLETED|Overall Study||1
10753193|NCT03038113|11916772|FG007|NOT COMPLETED|Overall Study||0
10820925|NCT00496782|11985951|FG001|NOT COMPLETED|Overall Study||2
10820926|NCT00506909|11985957|FG000|STARTED|Overall Study||0
10820927|NCT00506909|11985957|FG000|COMPLETED|Overall Study||0
10820928|NCT00506909|11985957|FG000|NOT COMPLETED|Overall Study||0
10820929|NCT00487578|11985963|FG000|STARTED|Overall Study||3
10820930|NCT00487578|11985964|FG001|STARTED|Overall Study||9
10820931|NCT00487578|11985963|FG000|COMPLETED|Overall Study||2
10820932|NCT00487578|11985964|FG001|COMPLETED|Overall Study||5
10820933|NCT00487578|11985963|FG000|NOT COMPLETED|Overall Study||1
10820934|NCT00487578|11985964|FG001|NOT COMPLETED|Overall Study||4
10820935|NCT00503009|11985973|FG000|STARTED|Overall Study||5
10820936|NCT00503009|11985974|FG001|STARTED|Overall Study||5
10820937|NCT00503009|11985975|FG002|STARTED|Overall Study||6
10820938|NCT00503009|11985973|FG000|COMPLETED|Overall Study||4
10820939|NCT00503009|11985974|FG001|COMPLETED|Overall Study||3
10820940|NCT00503009|11985975|FG002|COMPLETED|Overall Study||3
10820941|NCT00503009|11985973|FG000|NOT COMPLETED|Overall Study||1
10820942|NCT00503009|11985974|FG001|NOT COMPLETED|Overall Study||2
10820943|NCT00503009|11985975|FG002|NOT COMPLETED|Overall Study||3
10820944|NCT00500045|11985983|FG000|STARTED|Overall Study||0
10820945|NCT00500045|11985983|FG000|COMPLETED|Overall Study||0
10820946|NCT00500045|11985983|FG000|NOT COMPLETED|Overall Study||0
10820947|NCT00499590|11985990|FG000|STARTED|Overall Study||113
10820948|NCT00499590|11985991|FG001|STARTED|Overall Study||112
10820949|NCT00499590|11985992|FG002|STARTED|Overall Study||113
10820950|NCT00499590|11985990|FG000|COMPLETED|Overall Study||0
10820951|NCT00499590|11985991|FG001|COMPLETED|Overall Study||0
10820952|NCT00499590|11985992|FG002|COMPLETED|Overall Study||0
10820953|NCT00499590|11985990|FG000|NOT COMPLETED|Overall Study||113
10820954|NCT00499590|11985991|FG001|NOT COMPLETED|Overall Study||112
10820955|NCT00499590|11985992|FG002|NOT COMPLETED|Overall Study||113
10820956|NCT00501345|11986001|FG000|STARTED|Overall Study||5
10820957|NCT00501345|11986001|FG000|COMPLETED|Overall Study||5
10820958|NCT00501345|11986001|FG000|NOT COMPLETED|Overall Study||0
10820959|NCT00496756|11986005|FG000|STARTED|Overall Study||14
10820960|NCT00496756|11986005|FG000|COMPLETED|Overall Study||11
10820961|NCT00496756|11986005|FG000|NOT COMPLETED|Overall Study||3
10820962|NCT00495716|11986011|FG000|STARTED|Overall Study||35
10820963|NCT00495716|11986012|FG001|STARTED|Overall Study||37
10820964|NCT00495716|11986011|FG000|COMPLETED|Overall Study||20
10820965|NCT00495716|11986012|FG001|COMPLETED|Overall Study||24
10820966|NCT00495716|11986011|FG000|NOT COMPLETED|Overall Study||15
10820967|NCT00495716|11986012|FG001|NOT COMPLETED|Overall Study||13
10820968|NCT00500890|11986020|FG000|STARTED|Overall Study||1
10820969|NCT00500890|11986021|FG001|STARTED|Overall Study||1
10820970|NCT00500890|11986020|FG000|COMPLETED|Overall Study||1
10820971|NCT00500890|11986021|FG001|COMPLETED|Overall Study||1
10820972|NCT00500890|11986020|FG000|NOT COMPLETED|Overall Study||0
10820973|NCT00500890|11986021|FG001|NOT COMPLETED|Overall Study||0
10820974|NCT00503841|11986027|FG000|STARTED|Overall Study||44
10820975|NCT00503841|11986027|FG000|COMPLETED|Overall Study||0
10820976|NCT00503841|11986027|FG000|NOT COMPLETED|Overall Study||44
10820977|NCT00493025|11986033|FG000|STARTED|Overall Study||19
10820978|NCT00493025|11986033|FG000|COMPLETED|Overall Study|Trial stopped due to early stopping rule|0
10820979|NCT00493025|11986033|FG000|NOT COMPLETED|Overall Study||19
10820980|NCT00491400|11986040|FG000|STARTED|Overall Study||15
10820981|NCT00491400|11986041|FG001|STARTED|Overall Study||13
10820982|NCT00491400|11986040|FG000|Started First Treatment|Overall Study|1 withdrew prior to starting fenofibrate|14
10820983|NCT00491400|11986041|FG001|Started First Treatment|Overall Study|None withdrew prior to starting atorvastatin|13
10820984|NCT00491400|11986040|FG000|Completed First Treatment|Overall Study|None withdrew during fenofibrate treatment (first treatment)|14
10820985|NCT00491400|11986041|FG001|Completed First Treatment|Overall Study|4 withdrew during atorvastatin treatment (first treatment)|9
10820986|NCT00491400|11986040|FG000|Started Second Treatment|Overall Study|2 withdrew during washout period|12
10820987|NCT00491400|11986041|FG001|Started Second Treatment|Overall Study|None withdrew during the washout period|9
10820988|NCT00491400|11986040|FG000|Finished Second Treatment|Overall Study|2 withdrew during atorvastatin treatment (second treatment)|10
10820989|NCT00491400|11986041|FG001|Finished Second Treatment|Overall Study|None withdrew during fenofibrate treatment (second treatment)|9
10820990|NCT00491400|11986040|FG000|COMPLETED|Overall Study||10
10753194|NCT03038113|11916773|FG008|NOT COMPLETED|Overall Study||0
10753195|NCT03038113|11916774|FG009|NOT COMPLETED|Overall Study||0
10753196|NCT03038113|11916775|FG010|NOT COMPLETED|Overall Study||0
10753197|NCT03038113|11916776|FG011|NOT COMPLETED|Overall Study||0
10753198|NCT03038113|11916777|FG012|NOT COMPLETED|Overall Study||0
10753199|NCT03038113|11916778|FG013|NOT COMPLETED|Overall Study||1
10820991|NCT00491400|11986041|FG001|COMPLETED|Overall Study||9
10820992|NCT00491400|11986040|FG000|NOT COMPLETED|Overall Study||5
10820993|NCT00491400|11986041|FG001|NOT COMPLETED|Overall Study||4
10820994|NCT00490776|11986049|FG000|STARTED|Overall Study||9
10753200|NCT03038126|11916827|FG000|STARTED|Overall Study||63
10753201|NCT03038126|11916828|FG001|STARTED|Overall Study||55
10820995|NCT00490776|11986049|FG000|COMPLETED|Overall Study||0
10820996|NCT00490776|11986049|FG000|NOT COMPLETED|Overall Study||9
10753202|NCT03038126|11916827|FG000|COMPLETED|Overall Study||54
10753203|NCT03038126|11916828|FG001|COMPLETED|Overall Study||51
10753204|NCT03038126|11916827|FG000|NOT COMPLETED|Overall Study||9
10753205|NCT03038126|11916828|FG001|NOT COMPLETED|Overall Study||4
10753206|NCT03038308|11916834|FG000|STARTED|Overall Study||15
10753207|NCT03038308|11916834|FG000|COMPLETED|Overall Study||11
10753208|NCT03038308|11916834|FG000|NOT COMPLETED|Overall Study||4
10753209|NCT03038399|11916842|FG000|STARTED|Overall Study||11
10753210|NCT03038399|11916843|FG001|STARTED|Overall Study||12
10753211|NCT03038399|11916844|FG002|STARTED|Overall Study||12
10753212|NCT03038399|11916845|FG003|STARTED|Overall Study||11
10753213|NCT03038399|11916842|FG000|COMPLETED|Overall Study||10
10753214|NCT03038399|11916843|FG001|COMPLETED|Overall Study||11
10753215|NCT03038399|11916844|FG002|COMPLETED|Overall Study||11
10753216|NCT03038399|11916845|FG003|COMPLETED|Overall Study|Subjects escalated from lower dose groups|9
10753217|NCT03038399|11916842|FG000|NOT COMPLETED|Overall Study||1
10753218|NCT03038399|11916843|FG001|NOT COMPLETED|Overall Study||1
10753219|NCT03038399|11916844|FG002|NOT COMPLETED|Overall Study||1
10753220|NCT03038399|11916845|FG003|NOT COMPLETED|Overall Study||2
10753221|NCT03038620|11916859|FG000|STARTED|Overall Study||92
10753222|NCT03038620|11916860|FG001|STARTED|Overall Study||93
10753223|NCT03038620|11916859|FG000|COMPLETED|Overall Study||73
10753224|NCT03038620|11916860|FG001|COMPLETED|Overall Study||55
10753225|NCT03038620|11916859|FG000|NOT COMPLETED|Overall Study||19
10753226|NCT03038620|11916860|FG001|NOT COMPLETED|Overall Study||38
10753227|NCT03038815|11916868|FG000|STARTED|Controll Condition, 1 Hour||10
10753228|NCT03038815|11916869|FG001|STARTED|Controll Condition, 1 Hour||10
10753229|NCT03038815|11916868|FG000|COMPLETED|Controll Condition, 1 Hour||10
10753230|NCT03038815|11916869|FG001|COMPLETED|Controll Condition, 1 Hour||10
10753231|NCT03038815|11916868|FG000|NOT COMPLETED|Controll Condition, 1 Hour||0
10753232|NCT03038815|11916869|FG001|NOT COMPLETED|Controll Condition, 1 Hour||0
10753233|NCT03038815|11916868|FG000|STARTED|Intervention 1, 1 Hour||10
10753234|NCT03038815|11916869|FG001|STARTED|Intervention 1, 1 Hour||10
10753235|NCT03038815|11916868|FG000|COMPLETED|Intervention 1, 1 Hour||10
10753236|NCT03038815|11916869|FG001|COMPLETED|Intervention 1, 1 Hour||10
10753237|NCT03038815|11916868|FG000|NOT COMPLETED|Intervention 1, 1 Hour||0
10753238|NCT03038815|11916869|FG001|NOT COMPLETED|Intervention 1, 1 Hour||0
10753239|NCT03038815|11916868|FG000|STARTED|Intervention 2, 1 Hour||10
10753240|NCT03038815|11916869|FG001|STARTED|Intervention 2, 1 Hour||10
10753241|NCT03038815|11916868|FG000|COMPLETED|Intervention 2, 1 Hour||10
10753242|NCT03038815|11916869|FG001|COMPLETED|Intervention 2, 1 Hour||10
10753243|NCT03038815|11916868|FG000|NOT COMPLETED|Intervention 2, 1 Hour||0
10753244|NCT03038815|11916869|FG001|NOT COMPLETED|Intervention 2, 1 Hour||0
10753245|NCT03038867|11916878|FG000|STARTED|Overall Study||37
10753246|NCT03038867|11916879|FG001|STARTED|Overall Study||32
10753247|NCT03038867|11916878|FG000|COMPLETED|Overall Study||37
10753248|NCT03038867|11916879|FG001|COMPLETED|Overall Study||32
10753249|NCT03038867|11916878|FG000|NOT COMPLETED|Overall Study||0
10753250|NCT03038867|11916879|FG001|NOT COMPLETED|Overall Study||0
10753251|NCT03038880|11916888|FG000|STARTED|Overall Study||24
10753252|NCT03038880|11916889|FG001|STARTED|Overall Study||31
10753253|NCT03038880|11916890|FG002|STARTED|Overall Study||16
10753254|NCT03038880|11916888|FG000|COMPLETED|Overall Study||21
10753255|NCT03038880|11916889|FG001|COMPLETED|Overall Study||28
10753256|NCT03038880|11916890|FG002|COMPLETED|Overall Study||16
10753257|NCT03038880|11916888|FG000|NOT COMPLETED|Overall Study||3
10753258|NCT03038880|11916889|FG001|NOT COMPLETED|Overall Study||3
10753259|NCT03038880|11916890|FG002|NOT COMPLETED|Overall Study||0
10753260|NCT03039023|11916903|FG000|STARTED|Overall Study||19
10753261|NCT03039023|11916904|FG001|STARTED|Overall Study||20
10753262|NCT03039023|11916905|FG002|STARTED|Overall Study||17
10753263|NCT03039023|11916906|FG003|STARTED|Overall Study||20
10753264|NCT03039023|11916907|FG004|STARTED|Overall Study||10
10753265|NCT03039023|11916903|FG000|COMPLETED|Overall Study||18
10753266|NCT03039023|11916904|FG001|COMPLETED|Overall Study||20
10753267|NCT03039023|11916905|FG002|COMPLETED|Overall Study||16
10753268|NCT03039023|11916906|FG003|COMPLETED|Overall Study||18
10753269|NCT03039023|11916907|FG004|COMPLETED|Overall Study||10
10753270|NCT03039023|11916903|FG000|NOT COMPLETED|Overall Study||1
10753271|NCT03039023|11916904|FG001|NOT COMPLETED|Overall Study||0
10753272|NCT03039023|11916905|FG002|NOT COMPLETED|Overall Study||1
10753273|NCT03039023|11916906|FG003|NOT COMPLETED|Overall Study||2
10753274|NCT03039023|11916907|FG004|NOT COMPLETED|Overall Study||0
10753275|NCT03039088|11916921|FG000|STARTED|Overall Study||192
10753276|NCT03039088|11916922|FG001|STARTED|Overall Study||316
10753277|NCT03039088|11916921|FG000|COMPLETED|Overall Study||192
10753278|NCT03039088|11916922|FG001|COMPLETED|Overall Study||316
10753279|NCT03039088|11916921|FG000|NOT COMPLETED|Overall Study||0
10753280|NCT03039088|11916922|FG001|NOT COMPLETED|Overall Study||0
10753281|NCT03039179|11916930|FG000|STARTED|Overall Study||38
10753282|NCT03039179|11916931|FG001|STARTED|Overall Study||42
10753283|NCT03039179|11916930|FG000|COMPLETED|Overall Study||38
10753284|NCT03039179|11916931|FG001|COMPLETED|Overall Study||42
10753285|NCT03039179|11916930|FG000|NOT COMPLETED|Overall Study||0
10753286|NCT03039179|11916931|FG001|NOT COMPLETED|Overall Study||0
10753287|NCT03039192|11916939|FG000|STARTED|Overall Study||112
10753288|NCT03039192|11916940|FG001|STARTED|Overall Study||114
10753289|NCT03039192|11916939|FG000|Treated|Overall Study||112
10753290|NCT03039192|11916940|FG001|Treated|Overall Study||113
10753291|NCT03039192|11916939|FG000|COMPLETED|Overall Study||80
10290240|NCT04749745|11422920|FG001|COMPLETED|Overall Study||6
10753292|NCT03039192|11916940|FG001|COMPLETED|Overall Study||84
10753293|NCT03039192|11916939|FG000|NOT COMPLETED|Overall Study||32
10753294|NCT03039192|11916940|FG001|NOT COMPLETED|Overall Study||30
10753295|NCT03039283|11916946|FG000|STARTED|Overall Study||162
10753296|NCT03039283|11916946|FG000|COMPLETED|Overall Study||160
10753297|NCT03039283|11916946|FG000|NOT COMPLETED|Overall Study||2
10753298|NCT03039543|11916952|FG000|STARTED|Overall Study||54
10753299|NCT03039543|11916953|FG001|STARTED|Overall Study||54
10753300|NCT03039543|11916952|FG000|COMPLETED|Overall Study||53
10753301|NCT03039543|11916953|FG001|COMPLETED|Overall Study||51
10753302|NCT03039543|11916952|FG000|NOT COMPLETED|Overall Study||1
10753303|NCT03039543|11916953|FG001|NOT COMPLETED|Overall Study||3
10753304|NCT03039569|11916961|FG000|STARTED|Overall Study||40
10753305|NCT03039569|11916962|FG001|STARTED|Overall Study||39
10753306|NCT03039569|11916961|FG000|COMPLETED|Overall Study||35
10753307|NCT03039569|11916962|FG001|COMPLETED|Overall Study||35
10753308|NCT03039569|11916961|FG000|NOT COMPLETED|Overall Study||5
10753309|NCT03039569|11916962|FG001|NOT COMPLETED|Overall Study||4
10753310|NCT03039621|11916971|FG000|STARTED|Overall Study||143
10753311|NCT03039621|11916972|FG001|STARTED|Overall Study||144
10753312|NCT03039621|11916971|FG000|COMPLETED|Overall Study||131
10753313|NCT03039621|11916972|FG001|COMPLETED|Overall Study||128
10753314|NCT03039621|11916971|FG000|NOT COMPLETED|Overall Study||12
10753315|NCT03039621|11916972|FG001|NOT COMPLETED|Overall Study||16
10820997|NCT00487162|11986055|FG000|STARTED|Overall Study||30
10820998|NCT00487162|11986056|FG001|STARTED|Overall Study||26
10820999|NCT00487162|11986055|FG000|COMPLETED|Overall Study||28
10821000|NCT00487162|11986056|FG001|COMPLETED|Overall Study||21
10821001|NCT00487162|11986055|FG000|NOT COMPLETED|Overall Study||2
10821002|NCT00487162|11986056|FG001|NOT COMPLETED|Overall Study||5
10821003|NCT00487981|11986062|FG000|STARTED|Overall Study||1
10821004|NCT00487981|11986062|FG000|COMPLETED|Overall Study||0
10821005|NCT00487981|11986062|FG000|NOT COMPLETED|Overall Study||1
10821006|NCT00491387|11986066|FG000|STARTED|Overall Study||24
10821007|NCT00491387|11986066|FG000|Study Enrollment|Overall Study||24
10821008|NCT00491387|11986066|FG000|COMPLETED|Overall Study||4
10821009|NCT00491387|11986066|FG000|NOT COMPLETED|Overall Study||20
10821010|NCT00475332|11986070|FG000|STARTED|Overall Study||2
10821011|NCT00475332|11986070|FG000|COMPLETED|Overall Study||2
10821012|NCT00475332|11986070|FG000|NOT COMPLETED|Overall Study||0
10821013|NCT00483119|11986077|FG000|STARTED|Overall Study||5
10821014|NCT00483119|11986078|FG001|STARTED|Overall Study||4
10821015|NCT00483119|11986077|FG000|COMPLETED|Overall Study||4
10821016|NCT00483119|11986078|FG001|COMPLETED|Overall Study||3
10821017|NCT00483119|11986077|FG000|NOT COMPLETED|Overall Study||1
10821018|NCT00483119|11986078|FG001|NOT COMPLETED|Overall Study||1
10821019|NCT00487461|11986087|FG000|STARTED|Overall Study||2
10821020|NCT00487461|11986088|FG001|STARTED|Overall Study||12
10821021|NCT00487461|11986089|FG002|STARTED|Overall Study||11
10821022|NCT00487461|11986087|FG000|COMPLETED|Overall Study||2
10821023|NCT00487461|11986088|FG001|COMPLETED|Overall Study||10
10821024|NCT00487461|11986089|FG002|COMPLETED|Overall Study||7
10821025|NCT00487461|11986087|FG000|NOT COMPLETED|Overall Study||0
10821026|NCT00487461|11986088|FG001|NOT COMPLETED|Overall Study||2
10821027|NCT00487461|11986089|FG002|NOT COMPLETED|Overall Study||4
10821028|NCT00484718|11986097|FG000|STARTED|Treatment Period 1 (2 Weeks)||1
10821029|NCT00484718|11986098|FG001|STARTED|Treatment Period 1 (2 Weeks)||1
10821030|NCT00484718|11986099|FG002|STARTED|Treatment Period 1 (2 Weeks)||1
10821031|NCT00484718|11986100|FG003|STARTED|Treatment Period 1 (2 Weeks)||1
10821032|NCT00484718|11986101|FG004|STARTED|Treatment Period 1 (2 Weeks)||1
10821033|NCT00484718|11986102|FG005|STARTED|Treatment Period 1 (2 Weeks)||1
10821034|NCT00484718|11986097|FG000|COMPLETED|Treatment Period 1 (2 Weeks)||1
10821035|NCT00484718|11986098|FG001|COMPLETED|Treatment Period 1 (2 Weeks)||1
10821036|NCT00484718|11986099|FG002|COMPLETED|Treatment Period 1 (2 Weeks)||1
10821037|NCT00484718|11986100|FG003|COMPLETED|Treatment Period 1 (2 Weeks)||1
10821038|NCT00484718|11986101|FG004|COMPLETED|Treatment Period 1 (2 Weeks)||1
10821039|NCT00484718|11986102|FG005|COMPLETED|Treatment Period 1 (2 Weeks)||1
10821040|NCT00484718|11986097|FG000|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
10821041|NCT00484718|11986098|FG001|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
10290241|NCT04749745|11422919|FG000|NOT COMPLETED|Overall Study||1
10290242|NCT04749745|11422920|FG001|NOT COMPLETED|Overall Study||0
10290243|NCT04748341|11422928|FG000|STARTED|Overall Study||31
10290244|NCT04748341|11422929|FG001|STARTED|Overall Study||31
10753316|NCT03039686|11916981|FG000|STARTED|Double-blind Period||56
10753317|NCT03039686|11916982|FG001|STARTED|Double-blind Period||55
10753318|NCT03039686|11916983|FG002|STARTED|Double-blind Period||55
10753319|NCT03039686|11916981|FG000|COMPLETED|Double-blind Period||29
10753320|NCT03039686|11916982|FG001|COMPLETED|Double-blind Period||26
10753321|NCT03039686|11916983|FG002|COMPLETED|Double-blind Period||32
10753322|NCT03039686|11916981|FG000|NOT COMPLETED|Double-blind Period||27
10821042|NCT00484718|11986099|FG002|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
10821043|NCT00484718|11986100|FG003|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
10290245|NCT04748341|11422928|FG000|COMPLETED|Overall Study||30
10821044|NCT00484718|11986101|FG004|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
10821045|NCT00484718|11986102|FG005|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
10821046|NCT00484718|11986097|FG000|STARTED|Washout Period (2 Weeks)||1
10821047|NCT00484718|11986098|FG001|STARTED|Washout Period (2 Weeks)||1
10821048|NCT00484718|11986099|FG002|STARTED|Washout Period (2 Weeks)||1
10821049|NCT00484718|11986100|FG003|STARTED|Washout Period (2 Weeks)||1
10753323|NCT03039686|11916982|FG001|NOT COMPLETED|Double-blind Period||29
10753324|NCT03039686|11916983|FG002|NOT COMPLETED|Double-blind Period||23
10753325|NCT03039686|11916981|FG000|STARTED|Open Label Period|Double-blind (DB) placebo participants switched to RO7239361 (RO) for the open label phase.|0
10753326|NCT03039686|11916982|FG001|STARTED|Open Label Period|14 DB placebo participants switched to the RO Low Dose for the open-label phase.|38
10753327|NCT03039686|11916983|FG002|STARTED|Open Label Period|13 DB placebo participants switched to the RO High Dose for the open-label phase.|42
10753328|NCT03039686|11916981|FG000|Completed DB, Did Not Start OL|Open Label Period||2
10753329|NCT03039686|11916982|FG001|Completed DB, Did Not Start OL|Open Label Period||2
10753330|NCT03039686|11916983|FG002|Completed DB, Did Not Start OL|Open Label Period||3
10753331|NCT03039686|11916981|FG000|COMPLETED|Open Label Period||0
10753332|NCT03039686|11916982|FG001|COMPLETED|Open Label Period||0
10753333|NCT03039686|11916983|FG002|COMPLETED|Open Label Period||0
10753334|NCT03039686|11916981|FG000|NOT COMPLETED|Open Label Period||0
10753335|NCT03039686|11916982|FG001|NOT COMPLETED|Open Label Period||38
10753336|NCT03039686|11916983|FG002|NOT COMPLETED|Open Label Period||42
10753337|NCT03039699|11917003|FG000|STARTED|Overall Study||127
10753338|NCT03039699|11917004|FG001|STARTED|Overall Study||132
10753339|NCT03039699|11917003|FG000|COMPLETED|Overall Study||105
10753340|NCT03039699|11917004|FG001|COMPLETED|Overall Study||97
10753341|NCT03039699|11917003|FG000|NOT COMPLETED|Overall Study||22
10753342|NCT03039699|11917004|FG001|NOT COMPLETED|Overall Study||35
10753343|NCT03039738|11917012|FG000|STARTED|Overall Study||206
10753344|NCT03039738|11917013|FG001|STARTED|Overall Study|This arm did not initiate. The study was terminated following the completion of the telemetry phase.|0
10753345|NCT03039738|11917012|FG000|COMPLETED|Overall Study||152
10753346|NCT03039738|11917013|FG001|COMPLETED|Overall Study||0
10753347|NCT03039738|11917012|FG000|NOT COMPLETED|Overall Study||54
10753348|NCT03039738|11917013|FG001|NOT COMPLETED|Overall Study||0
10753349|NCT03040011|11917022|FG000|STARTED|Received Randomized Study Intervention||25
10753350|NCT03040011|11917023|FG001|STARTED|Received Randomized Study Intervention||25
10753351|NCT03040011|11917024|FG002|STARTED|Received Randomized Study Intervention||25
10753352|NCT03040011|11917022|FG000|COMPLETED|Received Randomized Study Intervention||25
10753353|NCT03040011|11917023|FG001|COMPLETED|Received Randomized Study Intervention||25
10753354|NCT03040011|11917024|FG002|COMPLETED|Received Randomized Study Intervention||25
10753355|NCT03040011|11917022|FG000|NOT COMPLETED|Received Randomized Study Intervention||0
10753356|NCT03040011|11917023|FG001|NOT COMPLETED|Received Randomized Study Intervention||0
10753357|NCT03040011|11917024|FG002|NOT COMPLETED|Received Randomized Study Intervention||0
10753358|NCT03040011|11917022|FG000|STARTED|Primary Outcome Follow Up||25
10753359|NCT03040011|11917023|FG001|STARTED|Primary Outcome Follow Up||25
10753360|NCT03040011|11917024|FG002|STARTED|Primary Outcome Follow Up||25
10753361|NCT03040011|11917022|FG000|COMPLETED|Primary Outcome Follow Up|Postoperative day one pain score not available for four patients|21
10753362|NCT03040011|11917023|FG001|COMPLETED|Primary Outcome Follow Up|Postoperative day one pain score not available for one patient|24
10753363|NCT03040011|11917024|FG002|COMPLETED|Primary Outcome Follow Up|Postoperative day one pain score not available for one patient|24
10753364|NCT03040011|11917022|FG000|NOT COMPLETED|Primary Outcome Follow Up||4
10753365|NCT03040011|11917023|FG001|NOT COMPLETED|Primary Outcome Follow Up||1
10753366|NCT03040011|11917024|FG002|NOT COMPLETED|Primary Outcome Follow Up||1
10753367|NCT03040024|11917035|FG000|STARTED|Overall Study||21
10753368|NCT03040024|11917036|FG001|STARTED|Overall Study||26
10753369|NCT03040024|11917037|FG002|STARTED|Overall Study||24
10753370|NCT03040024|11917035|FG000|COMPLETED|Overall Study||21
10753371|NCT03040024|11917036|FG001|COMPLETED|Overall Study||24
10753372|NCT03040024|11917037|FG002|COMPLETED|Overall Study||23
10753373|NCT03040024|11917035|FG000|NOT COMPLETED|Overall Study||0
10753374|NCT03040024|11917036|FG001|NOT COMPLETED|Overall Study||2
10753375|NCT03040024|11917037|FG002|NOT COMPLETED|Overall Study||1
10753376|NCT03040154|11917047|FG000|STARTED|Overall Study||110
10753377|NCT03040154|11917048|FG001|STARTED|Overall Study||105
10753378|NCT03040154|11917047|FG000|COMPLETED|Overall Study||110
10753379|NCT03040154|11917048|FG001|COMPLETED|Overall Study||105
10753380|NCT03040154|11917047|FG000|NOT COMPLETED|Overall Study||0
10753381|NCT03040154|11917048|FG001|NOT COMPLETED|Overall Study||0
10753382|NCT03040336|11917056|FG000|STARTED|Overall Study||10
10753383|NCT03040336|11917057|FG001|STARTED|Overall Study||7
10753384|NCT03040336|11917056|FG000|COMPLETED|Overall Study||7
10753385|NCT03040336|11917057|FG001|COMPLETED|Overall Study||4
10753386|NCT03040336|11917056|FG000|NOT COMPLETED|Overall Study||3
10753387|NCT03040336|11917057|FG001|NOT COMPLETED|Overall Study||3
10753388|NCT03040362|11917064|FG000|STARTED|Overall Study||8
10753389|NCT03040362|11917064|FG000|Received at Least 1dose of Study Drug|Overall Study||8
10753390|NCT03040362|11917064|FG000|COMPLETED|Overall Study||8
10753391|NCT03040362|11917064|FG000|NOT COMPLETED|Overall Study||0
10753392|NCT03040414|11917070|FG000|STARTED|Overall Study||57
10753393|NCT03040414|11917071|FG001|STARTED|Overall Study||56
10753394|NCT03040414|11917070|FG000|Completed Period 1|Overall Study||56
10753395|NCT03040414|11917071|FG001|Completed Period 1|Overall Study||55
10753396|NCT03040414|11917070|FG000|Started Period 2|Overall Study||56
10753397|NCT03040414|11917071|FG001|Started Period 2|Overall Study||55
10753398|NCT03040414|11917070|FG000|COMPLETED|Overall Study||56
10753399|NCT03040414|11917071|FG001|COMPLETED|Overall Study||55
10753400|NCT03040414|11917070|FG000|NOT COMPLETED|Overall Study||1
10753401|NCT03040414|11917071|FG001|NOT COMPLETED|Overall Study||1
10753402|NCT03040427|11917080|FG000|STARTED|Overall Study||2
10753403|NCT03040427|11917081|FG001|STARTED|Overall Study||6
10753404|NCT03040427|11917082|FG002|STARTED|Overall Study||4
10753405|NCT03040427|11917080|FG000|COMPLETED|Overall Study||2
10753406|NCT03040427|11917081|FG001|COMPLETED|Overall Study||6
10753407|NCT03040427|11917082|FG002|COMPLETED|Overall Study||4
10753408|NCT03040427|11917080|FG000|NOT COMPLETED|Overall Study||0
10753409|NCT03040427|11917081|FG001|NOT COMPLETED|Overall Study||0
10753410|NCT03040427|11917082|FG002|NOT COMPLETED|Overall Study||0
10753411|NCT03040466|11917092|FG000|STARTED|Overall Study||65
10753412|NCT03040466|11917093|FG001|STARTED|Overall Study||115
10753413|NCT03040466|11917092|FG000|COMPLETED|Overall Study||65
10753414|NCT03040466|11917093|FG001|COMPLETED|Overall Study||115
10753415|NCT03040466|11917092|FG000|NOT COMPLETED|Overall Study||0
10753416|NCT03040466|11917093|FG001|NOT COMPLETED|Overall Study||0
10753417|NCT03040479|11917102|FG000|STARTED|Overall Study||8
10753418|NCT03040479|11917103|FG001|STARTED|Overall Study||8
10753419|NCT03040479|11917104|FG002|STARTED|Overall Study||8
10753420|NCT03040479|11917102|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
10753421|NCT03040479|11917103|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
10753422|NCT03040479|11917104|FG002|Received at Least 1 Dose of Study Drug|Overall Study||8
10753423|NCT03040479|11917102|FG000|COMPLETED|Overall Study||8
10753424|NCT03040479|11917103|FG001|COMPLETED|Overall Study||8
10753425|NCT03040479|11917104|FG002|COMPLETED|Overall Study||8
10753426|NCT03040479|11917102|FG000|NOT COMPLETED|Overall Study||0
10753427|NCT03040479|11917103|FG001|NOT COMPLETED|Overall Study||0
10753428|NCT03040479|11917104|FG002|NOT COMPLETED|Overall Study||0
10753429|NCT03040674|11917114|FG000|STARTED|Overall Study||489
10753430|NCT03040674|11917114|FG000|Participants Completing 3 Month Survey|Overall Study||351
10753431|NCT03040674|11917114|FG000|Participants Completing 6 Month Survey|Overall Study||241
10753432|NCT03040674|11917114|FG000|COMPLETED|Overall Study||241
10753433|NCT03040674|11917114|FG000|NOT COMPLETED|Overall Study||248
10753434|NCT03040687|11917122|FG000|STARTED|Overall Study||20
10753435|NCT03040687|11917123|FG001|STARTED|Overall Study||20
10753436|NCT03040687|11917124|FG002|STARTED|Overall Study||20
10753437|NCT03040687|11917122|FG000|COMPLETED|Overall Study||19
10753438|NCT03040687|11917123|FG001|COMPLETED|Overall Study||20
10753439|NCT03040687|11917124|FG002|COMPLETED|Overall Study||20
10753440|NCT03040687|11917122|FG000|NOT COMPLETED|Overall Study||1
10753441|NCT03040687|11917123|FG001|NOT COMPLETED|Overall Study||0
10753442|NCT03040687|11917124|FG002|NOT COMPLETED|Overall Study||0
10753443|NCT03040713|11917132|FG000|STARTED|Overall Study||16
10753444|NCT03040713|11917132|FG000|COMPLETED|Overall Study||13
10753445|NCT03040713|11917132|FG000|NOT COMPLETED|Overall Study||3
10753446|NCT03040804|11917136|FG000|STARTED|Overall Study||2
10753447|NCT03040804|11917136|FG000|COMPLETED|Overall Study||2
10753448|NCT03040804|11917136|FG000|NOT COMPLETED|Overall Study||0
10821050|NCT00484718|11986101|FG004|STARTED|Washout Period (2 Weeks)||1
10821051|NCT00484718|11986102|FG005|STARTED|Washout Period (2 Weeks)||1
10290246|NCT04748341|11422929|FG001|COMPLETED|Overall Study||30
10290247|NCT04748341|11422928|FG000|NOT COMPLETED|Overall Study||1
10290248|NCT04748341|11422929|FG001|NOT COMPLETED|Overall Study||1
10312953|NCT00147199|11446480|FG000|COMPLETED|Overall Study||102
10312954|NCT00147199|11446481|FG001|COMPLETED|Overall Study||110
10312955|NCT00147199|11446480|FG000|NOT COMPLETED|Overall Study||13
10312956|NCT00147199|11446481|FG001|NOT COMPLETED|Overall Study||10
10312957|NCT00147212|11446487|FG000|STARTED|Overall Study||50
10312958|NCT00147212|11446487|FG000|COMPLETED|Overall Study||50
10312959|NCT00147212|11446487|FG000|NOT COMPLETED|Overall Study||0
10312960|NCT00147225|11446497|FG000|STARTED|Overall Study||7
10312961|NCT00147225|11446498|FG001|STARTED|Overall Study||6
10312962|NCT00147225|11446499|FG002|STARTED|Overall Study||8
10312963|NCT00147225|11446500|FG003|STARTED|Overall Study||11
10312964|NCT00147225|11446501|FG004|STARTED|Overall Study||11
10312965|NCT00147225|11446502|FG005|STARTED|Overall Study||12
10312966|NCT00147225|11446497|FG000|COMPLETED|Overall Study||6
10312967|NCT00147225|11446498|FG001|COMPLETED|Overall Study||6
10312968|NCT00147225|11446499|FG002|COMPLETED|Overall Study||6
10312969|NCT00147225|11446500|FG003|COMPLETED|Overall Study||10
10312970|NCT00147225|11446501|FG004|COMPLETED|Overall Study||10
10312971|NCT00147225|11446502|FG005|COMPLETED|Overall Study||10
10312972|NCT00147225|11446497|FG000|NOT COMPLETED|Overall Study||1
10312973|NCT00147225|11446498|FG001|NOT COMPLETED|Overall Study||0
10312974|NCT00147225|11446499|FG002|NOT COMPLETED|Overall Study||2
10312975|NCT00147225|11446500|FG003|NOT COMPLETED|Overall Study||1
10312976|NCT00147225|11446501|FG004|NOT COMPLETED|Overall Study||1
10312977|NCT00147225|11446502|FG005|NOT COMPLETED|Overall Study||2
10312978|NCT00147251|11446518|FG000|STARTED|Recruitment and Enrollment||271
10753449|NCT03040986|11917142|FG000|STARTED|Overall Study||6
10753450|NCT03040986|11917143|FG001|STARTED|Overall Study||2
10821052|NCT00484718|11986097|FG000|COMPLETED|Washout Period (2 Weeks)||1
10312979|NCT00147251|11446519|FG001|STARTED|Recruitment and Enrollment||277
10312980|NCT00147251|11446518|FG000|COMPLETED|Recruitment and Enrollment||247
10753451|NCT03040986|11917142|FG000|COMPLETED|Overall Study||0
10753452|NCT03040986|11917143|FG001|COMPLETED|Overall Study||0
10753453|NCT03040986|11917142|FG000|NOT COMPLETED|Overall Study||6
10753454|NCT03040986|11917143|FG001|NOT COMPLETED|Overall Study||2
10312981|NCT00147251|11446519|FG001|COMPLETED|Recruitment and Enrollment||252
10312982|NCT00147251|11446518|FG000|NOT COMPLETED|Recruitment and Enrollment||24
10312983|NCT00147251|11446519|FG001|NOT COMPLETED|Recruitment and Enrollment||25
10753455|NCT03041025|11917154|FG000|STARTED|Overall Study||8
10312984|NCT00147251|11446518|FG000|STARTED|Follow up||247
10753456|NCT03041025|11917155|FG001|STARTED|Overall Study||3
10753457|NCT03041025|11917156|FG002|STARTED|Overall Study||24
10753458|NCT03041025|11917154|FG000|COMPLETED|Overall Study||7
10753459|NCT03041025|11917155|FG001|COMPLETED|Overall Study||3
10753460|NCT03041025|11917156|FG002|COMPLETED|Overall Study||22
10753461|NCT03041025|11917154|FG000|NOT COMPLETED|Overall Study||1
10753462|NCT03041025|11917155|FG001|NOT COMPLETED|Overall Study||0
10753463|NCT03041025|11917156|FG002|NOT COMPLETED|Overall Study||2
10753464|NCT03041038|11917169|FG000|STARTED|Overall Study||11
10753465|NCT03041038|11917170|FG001|STARTED|Overall Study||9
10753466|NCT03041038|11917169|FG000|Week 16|Overall Study||10
10753467|NCT03041038|11917170|FG001|Week 16|Overall Study||8
10753468|NCT03041038|11917169|FG000|Week 32|Overall Study||9
10753469|NCT03041038|11917170|FG001|Week 32|Overall Study||8
10753470|NCT03041038|11917169|FG000|COMPLETED|Overall Study||5
10753471|NCT03041038|11917170|FG001|COMPLETED|Overall Study||7
10753472|NCT03041038|11917169|FG000|NOT COMPLETED|Overall Study||6
10753473|NCT03041038|11917170|FG001|NOT COMPLETED|Overall Study||2
10753474|NCT03041090|11917180|FG000|STARTED|Overall Study||109
10753475|NCT03041090|11917181|FG001|STARTED|Overall Study||24
10753476|NCT03041090|11917180|FG000|COMPLETED|Overall Study||109
10753477|NCT03041090|11917181|FG001|COMPLETED|Overall Study|3 consented subjects in the dynamic arm were not included in analysis due to technical errors.|21
10753478|NCT03041090|11917180|FG000|NOT COMPLETED|Overall Study||0
10753479|NCT03041090|11917181|FG001|NOT COMPLETED|Overall Study||3
10753480|NCT03041116|11917189|FG000|STARTED|Double-blind||41
10753481|NCT03041116|11917190|FG001|STARTED|Double-blind||43
10753482|NCT03041116|11917189|FG000|Received at Least 1 Dose of Study Drug|Double-blind||41
10753483|NCT03041116|11917190|FG001|Received at Least 1 Dose of Study Drug|Double-blind||43
10753484|NCT03041116|11917189|FG000|COMPLETED|Double-blind||41
10753485|NCT03041116|11917190|FG001|COMPLETED|Double-blind||37
10753486|NCT03041116|11917189|FG000|NOT COMPLETED|Double-blind||0
10753487|NCT03041116|11917190|FG001|NOT COMPLETED|Double-blind||6
10753488|NCT03041116|11917189|FG000|STARTED|Open-label||41
10753489|NCT03041116|11917190|FG001|STARTED|Open-label||37
10753490|NCT03041116|11917189|FG000|Received At Least 1 Dose of Study Drug|Open-label||41
10753491|NCT03041116|11917190|FG001|Received At Least 1 Dose of Study Drug|Open-label||37
10753492|NCT03041116|11917189|FG000|COMPLETED|Open-label||0
10753493|NCT03041116|11917190|FG001|COMPLETED|Open-label||0
10753494|NCT03041116|11917189|FG000|NOT COMPLETED|Open-label||41
10753495|NCT03041116|11917190|FG001|NOT COMPLETED|Open-label||37
10753496|NCT03041298|11917200|FG000|STARTED|Overall Study||1537
10753497|NCT03041298|11917200|FG000|COMPLETED|Overall Study||1537
10753498|NCT03041298|11917200|FG000|NOT COMPLETED|Overall Study||0
10753499|NCT03041441|11917204|FG000|STARTED|Overall Study||5
10753500|NCT03041441|11917204|FG000|COMPLETED|Overall Study||3
10753501|NCT03041441|11917204|FG000|NOT COMPLETED|Overall Study||2
10753508|NCT03041636|11917220|FG000|STARTED|Overall Study||1
10753509|NCT03041636|11917220|FG000|COMPLETED|Overall Study||1
10753510|NCT03041636|11917220|FG000|NOT COMPLETED|Overall Study||0
10753511|NCT03041792|11917226|FG000|STARTED|Overall Study||32
10753512|NCT03041792|11917227|FG001|STARTED|Overall Study||29
10753513|NCT03041792|11917226|FG000|Received Treatment|Overall Study||32
10753514|NCT03041792|11917227|FG001|Received Treatment|Overall Study||28
10753515|NCT03041792|11917226|FG000|COMPLETED|Overall Study||28
10753516|NCT03041792|11917227|FG001|COMPLETED|Overall Study||26
10753517|NCT03041792|11917226|FG000|NOT COMPLETED|Overall Study||4
10753518|NCT03041792|11917227|FG001|NOT COMPLETED|Overall Study||3
10753519|NCT03041896|11917237|FG000|STARTED|Overall Study||1486
10753520|NCT03041896|11917238|FG001|STARTED|Overall Study||1009
10753521|NCT03041896|11917239|FG002|STARTED|Overall Study||2299
10821053|NCT00484718|11986098|FG001|COMPLETED|Washout Period (2 Weeks)||1
10821054|NCT00484718|11986099|FG002|COMPLETED|Washout Period (2 Weeks)||1
10753522|NCT03041896|11917240|FG003|STARTED|Overall Study||256
10753523|NCT03041896|11917237|FG000|COMPLETED|Overall Study||1486
10753524|NCT03041896|11917238|FG001|COMPLETED|Overall Study||1009
10753525|NCT03041896|11917239|FG002|COMPLETED|Overall Study||2236
10753526|NCT03041896|11917240|FG003|COMPLETED|Overall Study||253
10753527|NCT03041896|11917237|FG000|NOT COMPLETED|Overall Study||0
10753528|NCT03041896|11917238|FG001|NOT COMPLETED|Overall Study||0
10753529|NCT03041896|11917239|FG002|NOT COMPLETED|Overall Study||63
10753530|NCT03041896|11917240|FG003|NOT COMPLETED|Overall Study||3
10753531|NCT03041909|11917257|FG000|STARTED|Overall Study||3
10753532|NCT03041909|11917258|FG001|STARTED|Overall Study||1
10753533|NCT03041909|11917259|FG002|STARTED|Overall Study||1
10753534|NCT03041909|11917257|FG000|COMPLETED|Overall Study||3
10821055|NCT00484718|11986100|FG003|COMPLETED|Washout Period (2 Weeks)||1
10753535|NCT03041909|11917258|FG001|COMPLETED|Overall Study||1
10753536|NCT03041909|11917259|FG002|COMPLETED|Overall Study||1
10753537|NCT03041909|11917257|FG000|NOT COMPLETED|Overall Study||0
10753538|NCT03041909|11917258|FG001|NOT COMPLETED|Overall Study||0
10753539|NCT03041909|11917259|FG002|NOT COMPLETED|Overall Study||0
10753540|NCT03042299|11917269|FG000|STARTED|Intervention Period 1 (6 Days)||7
10753541|NCT03042299|11917270|FG001|STARTED|Intervention Period 1 (6 Days)||7
10753542|NCT03042299|11917269|FG000|COMPLETED|Intervention Period 1 (6 Days)||7
10753543|NCT03042299|11917270|FG001|COMPLETED|Intervention Period 1 (6 Days)||7
10753544|NCT03042299|11917269|FG000|NOT COMPLETED|Intervention Period 1 (6 Days)||0
10753545|NCT03042299|11917270|FG001|NOT COMPLETED|Intervention Period 1 (6 Days)||0
10753546|NCT03042299|11917269|FG000|STARTED|Washout Period (at Least 6 Days)||7
10753547|NCT03042299|11917270|FG001|STARTED|Washout Period (at Least 6 Days)||7
10753548|NCT03042299|11917269|FG000|COMPLETED|Washout Period (at Least 6 Days)||7
10753549|NCT03042299|11917270|FG001|COMPLETED|Washout Period (at Least 6 Days)||7
10753550|NCT03042299|11917269|FG000|NOT COMPLETED|Washout Period (at Least 6 Days)||0
10753551|NCT03042299|11917270|FG001|NOT COMPLETED|Washout Period (at Least 6 Days)||0
10753552|NCT03042299|11917269|FG000|STARTED|Intervention Period 2 (6 Days)||7
10753553|NCT03042299|11917270|FG001|STARTED|Intervention Period 2 (6 Days)||7
10753554|NCT03042299|11917269|FG000|COMPLETED|Intervention Period 2 (6 Days)||7
10753555|NCT03042299|11917270|FG001|COMPLETED|Intervention Period 2 (6 Days)||7
10753556|NCT03042299|11917269|FG000|NOT COMPLETED|Intervention Period 2 (6 Days)||0
10821056|NCT00484718|11986101|FG004|COMPLETED|Washout Period (2 Weeks)||1
10821057|NCT00484718|11986102|FG005|COMPLETED|Washout Period (2 Weeks)||1
10821058|NCT00484718|11986097|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
10821059|NCT00484718|11986098|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0
10821060|NCT00484718|11986099|FG002|NOT COMPLETED|Washout Period (2 Weeks)||0
10821061|NCT00484718|11986100|FG003|NOT COMPLETED|Washout Period (2 Weeks)||0
10821062|NCT00484718|11986101|FG004|NOT COMPLETED|Washout Period (2 Weeks)||0
10821063|NCT00484718|11986102|FG005|NOT COMPLETED|Washout Period (2 Weeks)||0
10821064|NCT00484718|11986097|FG000|STARTED|Treatment Period 2 (2 Weeks)||1
10821065|NCT00484718|11986098|FG001|STARTED|Treatment Period 2 (2 Weeks)||1
10821066|NCT00484718|11986099|FG002|STARTED|Treatment Period 2 (2 Weeks)||1
10821067|NCT00484718|11986100|FG003|STARTED|Treatment Period 2 (2 Weeks)||1
10821068|NCT00484718|11986101|FG004|STARTED|Treatment Period 2 (2 Weeks)||1
10821069|NCT00484718|11986102|FG005|STARTED|Treatment Period 2 (2 Weeks)||1
10821070|NCT00484718|11986097|FG000|COMPLETED|Treatment Period 2 (2 Weeks)||1
10821071|NCT00484718|11986098|FG001|COMPLETED|Treatment Period 2 (2 Weeks)||1
10821072|NCT00484718|11986099|FG002|COMPLETED|Treatment Period 2 (2 Weeks)||1
10821073|NCT00484718|11986100|FG003|COMPLETED|Treatment Period 2 (2 Weeks)||1
10821074|NCT00484718|11986101|FG004|COMPLETED|Treatment Period 2 (2 Weeks)||1
10821075|NCT00484718|11986102|FG005|COMPLETED|Treatment Period 2 (2 Weeks)||1
10821076|NCT00484718|11986097|FG000|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
10821077|NCT00484718|11986098|FG001|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
10821078|NCT00484718|11986099|FG002|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
10821079|NCT00484718|11986100|FG003|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
10821080|NCT00484718|11986101|FG004|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
10821081|NCT00484718|11986102|FG005|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
10821082|NCT00484718|11986097|FG000|STARTED|Washout Period (2 Weeks)||1
10821083|NCT00484718|11986098|FG001|STARTED|Washout Period (2 Weeks)||1
10821084|NCT00484718|11986099|FG002|STARTED|Washout Period (2 Weeks)||1
10821085|NCT00484718|11986100|FG003|STARTED|Washout Period (2 Weeks)||1
10821086|NCT00484718|11986101|FG004|STARTED|Washout Period (2 Weeks)||1
10821087|NCT00484718|11986102|FG005|STARTED|Washout Period (2 Weeks)||1
10821088|NCT00484718|11986097|FG000|COMPLETED|Washout Period (2 Weeks)||1
10821089|NCT00484718|11986098|FG001|COMPLETED|Washout Period (2 Weeks)||1
10821090|NCT00484718|11986099|FG002|COMPLETED|Washout Period (2 Weeks)||1
10821091|NCT00484718|11986100|FG003|COMPLETED|Washout Period (2 Weeks)||1
10821092|NCT00484718|11986101|FG004|COMPLETED|Washout Period (2 Weeks)||1
10821093|NCT00484718|11986102|FG005|COMPLETED|Washout Period (2 Weeks)||1
10821094|NCT00484718|11986097|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
10821095|NCT00484718|11986098|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0
10821096|NCT00484718|11986099|FG002|NOT COMPLETED|Washout Period (2 Weeks)||0
10821097|NCT00484718|11986100|FG003|NOT COMPLETED|Washout Period (2 Weeks)||0
10821098|NCT00484718|11986101|FG004|NOT COMPLETED|Washout Period (2 Weeks)||0
10821099|NCT00484718|11986102|FG005|NOT COMPLETED|Washout Period (2 Weeks)||0
10821100|NCT00484718|11986097|FG000|STARTED|Treatment Period 3 (2 Weeks)||1
10821101|NCT00484718|11986098|FG001|STARTED|Treatment Period 3 (2 Weeks)||1
10821102|NCT00484718|11986099|FG002|STARTED|Treatment Period 3 (2 Weeks)||1
10821103|NCT00484718|11986100|FG003|STARTED|Treatment Period 3 (2 Weeks)||1
10821104|NCT00484718|11986101|FG004|STARTED|Treatment Period 3 (2 Weeks)||1
10821105|NCT00484718|11986102|FG005|STARTED|Treatment Period 3 (2 Weeks)||1
10821106|NCT00484718|11986097|FG000|COMPLETED|Treatment Period 3 (2 Weeks)||1
10821107|NCT00484718|11986098|FG001|COMPLETED|Treatment Period 3 (2 Weeks)||1
10821108|NCT00484718|11986099|FG002|COMPLETED|Treatment Period 3 (2 Weeks)||1
10821109|NCT00484718|11986100|FG003|COMPLETED|Treatment Period 3 (2 Weeks)||1
10821110|NCT00484718|11986101|FG004|COMPLETED|Treatment Period 3 (2 Weeks)||1
10821111|NCT00484718|11986102|FG005|COMPLETED|Treatment Period 3 (2 Weeks)||1
10821112|NCT00484718|11986097|FG000|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0
10821113|NCT00484718|11986098|FG001|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0
10821114|NCT00484718|11986099|FG002|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0
10821115|NCT00484718|11986100|FG003|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0
10753557|NCT03042299|11917270|FG001|NOT COMPLETED|Intervention Period 2 (6 Days)||0
10753558|NCT03042312|11917278|FG000|STARTED|Overall Study||28
10753559|NCT03042312|11917279|FG001|STARTED|Overall Study||43
10821116|NCT00484718|11986101|FG004|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0
10821117|NCT00484718|11986102|FG005|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0
10821118|NCT00477230|11986112|FG000|STARTED|Overall Study||32
10821119|NCT00477230|11986113|FG001|STARTED|Overall Study||32
10821120|NCT00477230|11986112|FG000|COMPLETED|Overall Study||12
10821121|NCT00477230|11986113|FG001|COMPLETED|Overall Study||1
10753560|NCT03042312|11917278|FG000|Safety Population|Overall Study||23
10753561|NCT03042312|11917279|FG001|Safety Population|Overall Study||41
10753562|NCT03042312|11917278|FG000|COMPLETED|Overall Study||18
10753563|NCT03042312|11917279|FG001|COMPLETED|Overall Study||31
10753564|NCT03042312|11917278|FG000|NOT COMPLETED|Overall Study||10
10753565|NCT03042312|11917279|FG001|NOT COMPLETED|Overall Study||12
10753566|NCT03042559|11917287|FG000|STARTED|Overall Study||22
10753567|NCT03042559|11917288|FG001|STARTED|Overall Study||21
10753568|NCT03042559|11917287|FG000|COMPLETED|Overall Study||21
10753569|NCT03042559|11917288|FG001|COMPLETED|Overall Study||20
10753570|NCT03042559|11917287|FG000|NOT COMPLETED|Overall Study||1
10753571|NCT03042559|11917288|FG001|NOT COMPLETED|Overall Study||1
10753572|NCT03042702|11917294|FG000|STARTED|Overall Study||2
10753573|NCT03042702|11917294|FG000|COMPLETED|Overall Study||2
10753574|NCT03042702|11917294|FG000|NOT COMPLETED|Overall Study||0
10753575|NCT03042715|11917299|FG000|STARTED|Overall Study||6
10753576|NCT03042715|11917299|FG000|COMPLETED|Overall Study||5
10753577|NCT03042715|11917299|FG000|NOT COMPLETED|Overall Study||1
10753578|NCT03042767|11917305|FG000|STARTED|Overall Study||12
10753579|NCT03042767|11917306|FG001|STARTED|Overall Study||13
10753580|NCT03042767|11917305|FG000|COMPLETED|Overall Study||11
10753581|NCT03042767|11917306|FG001|COMPLETED|Overall Study||11
10753582|NCT03042767|11917305|FG000|NOT COMPLETED|Overall Study||1
10753583|NCT03042767|11917306|FG001|NOT COMPLETED|Overall Study||2
10753584|NCT03042910|11917312|FG000|STARTED|Overall Study||38
10753585|NCT03042910|11917312|FG000|Treated|Overall Study||37
10753586|NCT03042910|11917312|FG000|COMPLETED|Overall Study||31
10753587|NCT03042910|11917312|FG000|NOT COMPLETED|Overall Study||7
10753588|NCT03043079|11917319|FG000|STARTED|Overall Study||21
10753589|NCT03043079|11917320|FG001|STARTED|Overall Study||14
10753590|NCT03043079|11917321|FG002|STARTED|Overall Study||10
10753591|NCT03043079|11917319|FG000|COMPLETED|Overall Study||21
10753592|NCT03043079|11917320|FG001|COMPLETED|Overall Study||14
10753593|NCT03043079|11917321|FG002|COMPLETED|Overall Study||10
10753594|NCT03043079|11917319|FG000|NOT COMPLETED|Overall Study||0
10753595|NCT03043079|11917320|FG001|NOT COMPLETED|Overall Study||0
10753596|NCT03043079|11917321|FG002|NOT COMPLETED|Overall Study||0
10753597|NCT03043105|11917330|FG000|STARTED|Overall Study||25
10753598|NCT03043105|11917330|FG000|COMPLETED|Overall Study||25
10753599|NCT03043105|11917330|FG000|NOT COMPLETED|Overall Study||0
10753600|NCT03043274|11917336|FG000|STARTED|Overall Study||13
10821122|NCT00477230|11986112|FG000|NOT COMPLETED|Overall Study||20
10821123|NCT00477230|11986113|FG001|NOT COMPLETED|Overall Study||31
10821124|NCT00470067|11986119|FG000|STARTED|Overall Study||9
10821125|NCT00470067|11986119|FG000|COMPLETED|Overall Study||2
10821126|NCT00470067|11986119|FG000|NOT COMPLETED|Overall Study||7
10821127|NCT00476827|11986129|FG000|STARTED|Overall Study||3
10821128|NCT00476827|11986130|FG001|STARTED|Overall Study||0
10821129|NCT00476827|11986131|FG002|STARTED|Overall Study||1
10821130|NCT00476827|11986132|FG003|STARTED|Overall Study||0
10821131|NCT00476827|11986133|FG004|STARTED|Overall Study||2
10821132|NCT00476827|11986134|FG005|STARTED|Overall Study||2
10821133|NCT00476827|11986129|FG000|COMPLETED|Overall Study||3
10821134|NCT00476827|11986130|FG001|COMPLETED|Overall Study||0
10821135|NCT00476827|11986131|FG002|COMPLETED|Overall Study||1
10821136|NCT00476827|11986132|FG003|COMPLETED|Overall Study||0
10821137|NCT00476827|11986133|FG004|COMPLETED|Overall Study||2
10821138|NCT00476827|11986134|FG005|COMPLETED|Overall Study||2
10821139|NCT00476827|11986129|FG000|NOT COMPLETED|Overall Study||0
10821140|NCT00476827|11986130|FG001|NOT COMPLETED|Overall Study||0
10821141|NCT00476827|11986131|FG002|NOT COMPLETED|Overall Study||0
10821142|NCT00476827|11986132|FG003|NOT COMPLETED|Overall Study||0
10821143|NCT00476827|11986133|FG004|NOT COMPLETED|Overall Study||0
10821144|NCT00476827|11986134|FG005|NOT COMPLETED|Overall Study||0
10821145|NCT00475657|11986146|FG000|STARTED|Overall Study||5
10821146|NCT00475657|11986146|FG000|COMPLETED|Overall Study||1
10821147|NCT00475657|11986146|FG000|NOT COMPLETED|Overall Study||4
10821148|NCT00472082|11986150|FG000|STARTED|Overall Study||5
10821149|NCT00472082|11986150|FG000|COMPLETED|Overall Study||0
10753601|NCT03043274|11917337|FG001|STARTED|Overall Study||10
10753602|NCT03043274|11917336|FG000|COMPLETED|Overall Study|The study was terminated because of slow recruitment.|13
10753603|NCT03043274|11917337|FG001|COMPLETED|Overall Study|The study was terminated because of slow recruitment.|9
10753604|NCT03043274|11917336|FG000|NOT COMPLETED|Overall Study||0
10753605|NCT03043274|11917337|FG001|NOT COMPLETED|Overall Study||1
10753606|NCT03043365|11917345|FG000|STARTED|Weeks 0 to Week 8||20
10753607|NCT03043365|11917346|FG001|STARTED|Weeks 0 to Week 8||17
10753608|NCT03043365|11917345|FG000|COMPLETED|Weeks 0 to Week 8||17
10753609|NCT03043365|11917346|FG001|COMPLETED|Weeks 0 to Week 8||14
10821150|NCT00472082|11986150|FG000|NOT COMPLETED|Overall Study||5
10821151|NCT00478062|11986154|FG000|STARTED|Overall Study||1
10821152|NCT00478062|11986154|FG000|COMPLETED|Overall Study||1
10821153|NCT00478062|11986154|FG000|NOT COMPLETED|Overall Study||0
10821154|NCT00470574|11986158|FG000|STARTED|Overall Study||7
10821155|NCT00470574|11986158|FG000|COMPLETED|Overall Study||7
10821156|NCT00470574|11986158|FG000|NOT COMPLETED|Overall Study||0
10821157|NCT00467753|11986164|FG000|STARTED|Overall Study||3
10821158|NCT00467753|11986165|FG001|STARTED|Overall Study||2
10821159|NCT00467753|11986164|FG000|COMPLETED|Overall Study||0
10821160|NCT00467753|11986165|FG001|COMPLETED|Overall Study||0
10753610|NCT03043365|11917345|FG000|NOT COMPLETED|Weeks 0 to Week 8||3
10753611|NCT03043365|11917346|FG001|NOT COMPLETED|Weeks 0 to Week 8||3
10753612|NCT03043365|11917345|FG000|STARTED|Week 8 to Week 16 - Washout Period||17
10753613|NCT03043365|11917346|FG001|STARTED|Week 8 to Week 16 - Washout Period||14
10753614|NCT03043365|11917345|FG000|COMPLETED|Week 8 to Week 16 - Washout Period||16
10753615|NCT03043365|11917346|FG001|COMPLETED|Week 8 to Week 16 - Washout Period||14
10753616|NCT03043365|11917345|FG000|NOT COMPLETED|Week 8 to Week 16 - Washout Period||1
10821161|NCT00467753|11986164|FG000|NOT COMPLETED|Overall Study||3
10821162|NCT00467753|11986165|FG001|NOT COMPLETED|Overall Study||2
10821163|NCT00456612|11986175|FG000|STARTED|Overall Study||4
10821164|NCT00456612|11986175|FG000|COMPLETED|Overall Study||1
10821165|NCT00456612|11986175|FG000|NOT COMPLETED|Overall Study||3
10821166|NCT00469612|11986182|FG000|STARTED|Overall Study||2
10821167|NCT00469612|11986183|FG001|STARTED|Overall Study||0
10821168|NCT00469612|11986182|FG000|COMPLETED|Overall Study|Subjects enrolled, but no data collected. Study terminated before data collection.|0
10821169|NCT00469612|11986183|FG001|COMPLETED|Overall Study||0
10821170|NCT00469612|11986182|FG000|NOT COMPLETED|Overall Study||2
10821171|NCT00469612|11986183|FG001|NOT COMPLETED|Overall Study||0
10821172|NCT00461812|11986189|FG000|STARTED|Overall Study||10
10821173|NCT00461812|11986189|FG000|COMPLETED|Overall Study||0
10821174|NCT00461812|11986189|FG000|NOT COMPLETED|Overall Study||10
10821175|NCT00459121|11986194|FG000|STARTED|Overall Study||2
10821176|NCT00459121|11986194|FG000|COMPLETED|Overall Study||2
10821177|NCT00459121|11986194|FG000|NOT COMPLETED|Overall Study||0
10821178|NCT00461682|11986199|FG000|STARTED|Overall Study||1
10821179|NCT00461682|11986199|FG000|COMPLETED|Overall Study||0
10821180|NCT00461682|11986199|FG000|NOT COMPLETED|Overall Study||1
10821181|NCT00462904|11986205|FG000|STARTED|Overall Study||4
10821182|NCT00462904|11986205|FG000|COMPLETED|Overall Study||3
10821183|NCT00462904|11986205|FG000|NOT COMPLETED|Overall Study||1
10821184|NCT00450333|11986213|FG000|STARTED|Overall Study||98
10821185|NCT00450333|11986214|FG001|STARTED|Overall Study||107
10821186|NCT00450333|11986215|FG002|STARTED|Overall Study||100
10821187|NCT00450333|11986216|FG003|STARTED|Overall Study||102
10821188|NCT00450333|11986213|FG000|COMPLETED|Overall Study||44
10821189|NCT00450333|11986214|FG001|COMPLETED|Overall Study||44
10821190|NCT00450333|11986215|FG002|COMPLETED|Overall Study||75
10821191|NCT00450333|11986216|FG003|COMPLETED|Overall Study||74
10821192|NCT00450333|11986213|FG000|NOT COMPLETED|Overall Study||54
10821193|NCT00450333|11986214|FG001|NOT COMPLETED|Overall Study||63
10821194|NCT00450333|11986215|FG002|NOT COMPLETED|Overall Study||25
10821195|NCT00450333|11986216|FG003|NOT COMPLETED|Overall Study||28
10821196|NCT00455143|11986226|FG000|STARTED|Overall Study||27
10544809|NCT01491802|11697960|FG001|COMPLETED|Overall Study||6
10544810|NCT01491802|11697959|FG000|NOT COMPLETED|Overall Study||1
10544811|NCT01491802|11697960|FG001|NOT COMPLETED|Overall Study||2
10544812|NCT01491841|11697967|FG000|STARTED|Overall Study||33
10544813|NCT01491841|11697967|FG000|COMPLETED|Overall Study||22
10753617|NCT03043365|11917346|FG001|NOT COMPLETED|Week 8 to Week 16 - Washout Period||0
10821197|NCT00455143|11986226|FG000|COMPLETED|Overall Study||21
10821198|NCT00455143|11986226|FG000|NOT COMPLETED|Overall Study||6
10821199|NCT00456989|11986231|FG000|STARTED|Overall Study||39
10821200|NCT00456989|11986231|FG000|COMPLETED|Overall Study||39
10821201|NCT00456989|11986231|FG000|NOT COMPLETED|Overall Study||0
10821202|NCT00448682|11986236|FG000|STARTED|Overall Study||25
10821203|NCT00448682|11986236|FG000|COMPLETED|Overall Study||25
10821204|NCT00448682|11986236|FG000|NOT COMPLETED|Overall Study||0
10821205|NCT00454571|11986242|FG000|STARTED|Overall Study||18
10821206|NCT00454571|11986243|FG001|STARTED|Overall Study||19
10821207|NCT00454571|11986242|FG000|COMPLETED|Overall Study||5
10821208|NCT00454571|11986243|FG001|COMPLETED|Overall Study||13
10821209|NCT00454571|11986242|FG000|NOT COMPLETED|Overall Study||13
10821210|NCT00454571|11986243|FG001|NOT COMPLETED|Overall Study||6
10821211|NCT00452361|11986251|FG000|STARTED|Overall Study||21
10821212|NCT00452361|11986252|FG001|STARTED|Overall Study||10
10821213|NCT00452361|11986251|FG000|COMPLETED|Overall Study||0
10821214|NCT00452361|11986252|FG001|COMPLETED|Overall Study||0
10821215|NCT00452361|11986251|FG000|NOT COMPLETED|Overall Study||21
10821216|NCT00452361|11986252|FG001|NOT COMPLETED|Overall Study||10
10821217|NCT00443040|11986261|FG000|STARTED|Overall Study||14
10821218|NCT00443040|11986262|FG001|STARTED|Overall Study||11
10821219|NCT00443040|11986263|FG002|STARTED|Overall Study||10
10821220|NCT00443040|11986261|FG000|COMPLETED|Overall Study||10
10821221|NCT00443040|11986262|FG001|COMPLETED|Overall Study||11
10544814|NCT01491841|11697967|FG000|NOT COMPLETED|Overall Study||11
10753618|NCT03043365|11917345|FG000|STARTED|Week 16 to Week 24||16
10821222|NCT00443040|11986263|FG002|COMPLETED|Overall Study||9
10821223|NCT00443040|11986261|FG000|NOT COMPLETED|Overall Study||4
10821224|NCT00443040|11986262|FG001|NOT COMPLETED|Overall Study||0
10821225|NCT00443040|11986263|FG002|NOT COMPLETED|Overall Study||1
10821226|NCT00447421|11986271|FG000|STARTED|Overall Study||9
10821227|NCT00447421|11986271|FG000|COMPLETED|Overall Study||3
10821228|NCT00447421|11986271|FG000|NOT COMPLETED|Overall Study||6
10821229|NCT00441272|11986277|FG000|STARTED|Overall Study||25
10821230|NCT00441272|11986278|FG001|STARTED|Overall Study||25
10821231|NCT00441272|11986277|FG000|COMPLETED|Overall Study|Study terminated prior to enrollment.|0
10821232|NCT00441272|11986278|FG001|COMPLETED|Overall Study|Study terminated prior to enrollment.|0
10821233|NCT00441272|11986277|FG000|NOT COMPLETED|Overall Study||25
10821234|NCT00441272|11986278|FG001|NOT COMPLETED|Overall Study||25
10821235|NCT00437398|11986284|FG000|STARTED|Overall Study||2
10753619|NCT03043365|11917346|FG001|STARTED|Week 16 to Week 24||14
10753620|NCT03043365|11917345|FG000|COMPLETED|Week 16 to Week 24||16
10753621|NCT03043365|11917346|FG001|COMPLETED|Week 16 to Week 24||14
10753622|NCT03043365|11917345|FG000|NOT COMPLETED|Week 16 to Week 24||0
10753623|NCT03043365|11917346|FG001|NOT COMPLETED|Week 16 to Week 24||0
10753624|NCT03043534|11917356|FG000|STARTED|Overall Study||15
10753625|NCT03043534|11917357|FG001|STARTED|Overall Study||14
10753626|NCT03043534|11917356|FG000|COMPLETED|Overall Study||15
10753627|NCT03043534|11917357|FG001|COMPLETED|Overall Study||14
10753628|NCT03043534|11917356|FG000|NOT COMPLETED|Overall Study||0
10753629|NCT03043534|11917357|FG001|NOT COMPLETED|Overall Study||0
10753630|NCT03043560|11917365|FG000|STARTED|Overall Study||21
10753631|NCT03043560|11917366|FG001|STARTED|Overall Study||24
10753632|NCT03043560|11917365|FG000|COMPLETED|Overall Study||20
10821236|NCT00437398|11986284|FG000|COMPLETED|Overall Study||2
10821237|NCT00437398|11986284|FG000|NOT COMPLETED|Overall Study||0
10821238|NCT00440271|11986290|FG000|STARTED|Overall Study||15
10821239|NCT00440271|11986291|FG001|STARTED|Overall Study||18
10821240|NCT00440271|11986290|FG000|COMPLETED|Overall Study||3
10821241|NCT00440271|11986291|FG001|COMPLETED|Overall Study||3
10821242|NCT00440271|11986290|FG000|NOT COMPLETED|Overall Study||12
10821243|NCT00440271|11986291|FG001|NOT COMPLETED|Overall Study||15
10821244|NCT00442260|11986297|FG000|STARTED|Overall Study||2
10821245|NCT00442260|11986297|FG000|COMPLETED|Overall Study||2
10821246|NCT00442260|11986297|FG000|NOT COMPLETED|Overall Study||0
10821247|NCT00429026|11986301|FG000|STARTED|Overall Study||40
10821248|NCT00429026|11986301|FG000|COMPLETED|Overall Study||0
10821249|NCT00429026|11986301|FG000|NOT COMPLETED|Overall Study||40
10821250|NCT00428207|11986305|FG000|STARTED|Overall Study||2
10821251|NCT00428207|11986306|FG001|STARTED|Overall Study||2
10821252|NCT00428207|11986305|FG000|COMPLETED|Overall Study||2
10821253|NCT00428207|11986306|FG001|COMPLETED|Overall Study||2
10821254|NCT00428207|11986305|FG000|NOT COMPLETED|Overall Study||0
10821255|NCT00428207|11986306|FG001|NOT COMPLETED|Overall Study||0
10821256|NCT00439569|11986312|FG000|STARTED|Cohort 1 (500 mg/kg/Day)||7
10821257|NCT00439569|11986312|FG000|COMPLETED|Cohort 1 (500 mg/kg/Day)||3
10821258|NCT00439569|11986312|FG000|NOT COMPLETED|Cohort 1 (500 mg/kg/Day)||4
10821259|NCT00439569|11986312|FG000|STARTED|Cohort 2 (500 mg/kg/Day)|2 new subjects in Cohort 2 were enrolled into the study after Cohort 1 completed the study.|2
10821260|NCT00439569|11986312|FG000|COMPLETED|Cohort 2 (500 mg/kg/Day)||1
10821261|NCT00439569|11986312|FG000|NOT COMPLETED|Cohort 2 (500 mg/kg/Day)||1
10821262|NCT00422669|11986319|FG000|STARTED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|98
10821263|NCT00422669|11986320|FG001|STARTED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|100
10821264|NCT00422669|11986321|FG002|STARTED|Overall Study||7
10821265|NCT00422669|11986319|FG000|COMPLETED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|0
10821266|NCT00422669|11986320|FG001|COMPLETED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|0
10821267|NCT00422669|11986321|FG002|COMPLETED|Overall Study||0
10821268|NCT00422669|11986319|FG000|NOT COMPLETED|Overall Study||98
10821269|NCT00422669|11986320|FG001|NOT COMPLETED|Overall Study||100
10821270|NCT00422669|11986321|FG002|NOT COMPLETED|Overall Study||7
10821271|NCT00432445|11986327|FG000|STARTED|Overall Study||2
10821272|NCT00432445|11986327|FG000|COMPLETED|Overall Study||2
10821273|NCT00432445|11986327|FG000|NOT COMPLETED|Overall Study||0
10821274|NCT00434590|11986333|FG000|STARTED|Overall Study||5
10821275|NCT00434590|11986334|FG001|STARTED|Overall Study||5
10821276|NCT00434590|11986333|FG000|COMPLETED|Overall Study|All patients randomized had study discontinued because of premature study termination.|0
10821277|NCT00434590|11986334|FG001|COMPLETED|Overall Study||0
10821278|NCT00434590|11986333|FG000|NOT COMPLETED|Overall Study||5
10821279|NCT00434590|11986334|FG001|NOT COMPLETED|Overall Study||5
10821280|NCT00424645|11986342|FG000|STARTED|Overall Study||3
10821281|NCT00424645|11986343|FG001|STARTED|Overall Study||0
10821282|NCT00424645|11986342|FG000|COMPLETED|Overall Study||2
10821283|NCT00424645|11986343|FG001|COMPLETED|Overall Study||0
10821284|NCT00424645|11986342|FG000|NOT COMPLETED|Overall Study||1
10821285|NCT00424645|11986343|FG001|NOT COMPLETED|Overall Study||0
10821286|NCT00430027|11986349|FG000|STARTED|Overall Study||8
10821287|NCT00430027|11986349|FG000|COMPLETED|Overall Study||0
10821288|NCT00430027|11986349|FG000|NOT COMPLETED|Overall Study||8
10821289|NCT00429858|11986353|FG000|STARTED|Overall Study||21
10821290|NCT00429858|11986353|FG000|COMPLETED|Overall Study||19
10821291|NCT00429858|11986353|FG000|NOT COMPLETED|Overall Study||2
10821292|NCT00425438|11986360|FG000|STARTED|Overall Study||25
10821293|NCT00425438|11986361|FG001|STARTED|Overall Study||27
10821294|NCT00425438|11986360|FG000|COMPLETED|Overall Study||0
10821295|NCT00425438|11986361|FG001|COMPLETED|Overall Study||0
10821296|NCT00425438|11986360|FG000|NOT COMPLETED|Overall Study||25
10821297|NCT00425438|11986361|FG001|NOT COMPLETED|Overall Study||27
10821298|NCT00421954|11986367|FG000|STARTED|Overall Study||0
10821299|NCT00421954|11986367|FG000|COMPLETED|Overall Study||0
10821300|NCT00421954|11986367|FG000|NOT COMPLETED|Overall Study||0
10821301|NCT00422942|11986371|FG000|STARTED|Overall Study||3
10821302|NCT00422942|11986371|FG000|COMPLETED|Overall Study||0
10821303|NCT00422942|11986371|FG000|NOT COMPLETED|Overall Study||3
10821304|NCT00409344|11986377|FG000|STARTED|Overall Study|No participants enrolled|0
10821305|NCT00409344|11986378|FG001|STARTED|Overall Study|No participants enrolled|0
10821306|NCT00409344|11986377|FG000|COMPLETED|Overall Study|No participants were enrolled to completion|0
10753633|NCT03043560|11917366|FG001|COMPLETED|Overall Study||21
10753634|NCT03043560|11917365|FG000|NOT COMPLETED|Overall Study||1
10753635|NCT03043560|11917366|FG001|NOT COMPLETED|Overall Study||3
10753636|NCT03043651|11917372|FG000|STARTED|Overall Study||48
10753637|NCT03043651|11917372|FG000|COMPLETED|Overall Study||0
10753638|NCT03043651|11917372|FG000|NOT COMPLETED|Overall Study||48
10753639|NCT03043885|11917380|FG000|STARTED|Overall Study||10
10753640|NCT03043885|11917381|FG001|STARTED|Overall Study||10
10753641|NCT03043885|11917382|FG002|STARTED|Overall Study||10
10753642|NCT03043885|11917383|FG003|STARTED|Overall Study||10
10753643|NCT03043885|11917380|FG000|COMPLETED|Overall Study||10
10753644|NCT03043885|11917381|FG001|COMPLETED|Overall Study||10
10753645|NCT03043885|11917382|FG002|COMPLETED|Overall Study||10
10753646|NCT03043885|11917383|FG003|COMPLETED|Overall Study||10
10753647|NCT03043885|11917380|FG000|NOT COMPLETED|Overall Study||0
10753648|NCT03043885|11917381|FG001|NOT COMPLETED|Overall Study||0
10753649|NCT03043885|11917382|FG002|NOT COMPLETED|Overall Study||0
10753650|NCT03043885|11917383|FG003|NOT COMPLETED|Overall Study||0
10753651|NCT03044028|11917396|FG000|STARTED|Overall Study||22
10753652|NCT03044028|11917397|FG001|STARTED|Overall Study||22
10753653|NCT03044028|11917398|FG002|STARTED|Overall Study||22
10753654|NCT03044028|11917396|FG000|COMPLETED|Overall Study||12
10753655|NCT03044028|11917397|FG001|COMPLETED|Overall Study||12
10753656|NCT03044028|11917398|FG002|COMPLETED|Overall Study||22
10753657|NCT03044028|11917396|FG000|NOT COMPLETED|Overall Study||10
10753658|NCT03044028|11917397|FG001|NOT COMPLETED|Overall Study||10
10753659|NCT03044028|11917398|FG002|NOT COMPLETED|Overall Study||0
10753660|NCT03044106|11917407|FG000|STARTED|Visit 1||22
10753661|NCT03044106|11917408|FG001|STARTED|Visit 1||22
10753662|NCT03044106|11917407|FG000|COMPLETED|Visit 1||22
10753663|NCT03044106|11917408|FG001|COMPLETED|Visit 1||22
10753664|NCT03044106|11917407|FG000|NOT COMPLETED|Visit 1||0
10753665|NCT03044106|11917408|FG001|NOT COMPLETED|Visit 1||0
10753666|NCT03044106|11917407|FG000|STARTED|Washout (1 Week)||22
10753667|NCT03044106|11917408|FG001|STARTED|Washout (1 Week)||22
10753668|NCT03044106|11917407|FG000|COMPLETED|Washout (1 Week)||22
10753669|NCT03044106|11917408|FG001|COMPLETED|Washout (1 Week)||20
10753670|NCT03044106|11917407|FG000|NOT COMPLETED|Washout (1 Week)||0
10753671|NCT03044106|11917408|FG001|NOT COMPLETED|Washout (1 Week)||2
10753672|NCT03044106|11917407|FG000|STARTED|Visit 2||22
10753673|NCT03044106|11917408|FG001|STARTED|Visit 2||20
10753674|NCT03044106|11917407|FG000|COMPLETED|Visit 2||22
10753675|NCT03044106|11917408|FG001|COMPLETED|Visit 2||20
10753676|NCT03044106|11917407|FG000|NOT COMPLETED|Visit 2||0
10753677|NCT03044106|11917408|FG001|NOT COMPLETED|Visit 2||0
10753678|NCT03044197|11917423|FG000|STARTED|Overall Study||12
10753679|NCT03044197|11917424|FG001|STARTED|Overall Study||12
10753680|NCT03044197|11917423|FG000|COMPLETED|Overall Study||9
10753681|NCT03044197|11917424|FG001|COMPLETED|Overall Study||11
10753682|NCT03044197|11917423|FG000|NOT COMPLETED|Overall Study||3
10753683|NCT03044197|11917424|FG001|NOT COMPLETED|Overall Study||1
10753684|NCT03044249|11917432|FG000|STARTED|Overall Study||42
10753685|NCT03044249|11917433|FG001|STARTED|Overall Study||39
10753686|NCT03044249|11917432|FG000|Received at Least One Dose of Study Drug|Overall Study||42
10753687|NCT03044249|11917433|FG001|Received at Least One Dose of Study Drug|Overall Study||39
10753688|NCT03044249|11917432|FG000|COMPLETED|Overall Study||32
10753689|NCT03044249|11917433|FG001|COMPLETED|Overall Study||25
10753690|NCT03044249|11917432|FG000|NOT COMPLETED|Overall Study||10
10753691|NCT03044249|11917433|FG001|NOT COMPLETED|Overall Study||14
10753692|NCT03044353|11917447|FG000|STARTED|Overall Study||6
10753693|NCT03044353|11917448|FG001|STARTED|Overall Study||1
10753694|NCT03044353|11917449|FG002|STARTED|Overall Study|No participant was enrolled in Group-3 due to early termination of the study.|0
10290249|NCT04737278|11422937|FG000|STARTED|Overall Study||28
10290250|NCT04737278|11422938|FG001|STARTED|Overall Study||28
10290251|NCT04737278|11422937|FG000|COMPLETED|Overall Study||24
10753695|NCT03044353|11917447|FG000|COMPLETED|Overall Study||6
10753696|NCT03044353|11917448|FG001|COMPLETED|Overall Study||0
10753697|NCT03044353|11917449|FG002|COMPLETED|Overall Study||0
10753698|NCT03044353|11917447|FG000|NOT COMPLETED|Overall Study||0
10290252|NCT04737278|11422938|FG001|COMPLETED|Overall Study||25
10290253|NCT04737278|11422937|FG000|NOT COMPLETED|Overall Study||4
10753699|NCT03044353|11917448|FG001|NOT COMPLETED|Overall Study||1
10753700|NCT03044353|11917449|FG002|NOT COMPLETED|Overall Study||0
10753701|NCT03044418|11917456|FG000|STARTED|Overall Study||30
10753702|NCT03044418|11917456|FG000|COMPLETED|Overall Study||30
10753703|NCT03044418|11917456|FG000|NOT COMPLETED|Overall Study||0
10753704|NCT03044431|11917460|FG000|STARTED|Overall Study||207
10753705|NCT03044431|11917460|FG000|COMPLETED|Overall Study||148
10753706|NCT03044431|11917460|FG000|NOT COMPLETED|Overall Study||59
10753707|NCT03044574|11917466|FG000|STARTED|Overall Study||204
10753708|NCT03044574|11917467|FG001|STARTED|Overall Study||203
10753709|NCT03044574|11917466|FG000|Inpatient Period|Overall Study||204
10753710|NCT03044574|11917467|FG001|Inpatient Period|Overall Study||203
10753711|NCT03044574|11917466|FG000|30 Days After Surgery|Overall Study||193
10753712|NCT03044574|11917467|FG001|30 Days After Surgery|Overall Study||194
10753713|NCT03044574|11917466|FG000|180 Days After Surgery|Overall Study||167
10753714|NCT03044574|11917467|FG001|180 Days After Surgery|Overall Study||158
10753715|NCT03044574|11917466|FG000|COMPLETED|Overall Study||167
10753716|NCT03044574|11917467|FG001|COMPLETED|Overall Study||158
10753717|NCT03044574|11917466|FG000|NOT COMPLETED|Overall Study||37
10753718|NCT03044574|11917467|FG001|NOT COMPLETED|Overall Study||45
10753719|NCT03044691|11917475|FG000|STARTED|Overall Study||0
10753720|NCT03044691|11917476|FG001|STARTED|Overall Study||84
10753721|NCT03044691|11917475|FG000|COMPLETED|Overall Study||0
10753722|NCT03044691|11917476|FG001|COMPLETED|Overall Study||84
10753723|NCT03044691|11917475|FG000|NOT COMPLETED|Overall Study||0
10753724|NCT03044691|11917476|FG001|NOT COMPLETED|Overall Study||0
10753725|NCT03044730|11917482|FG000|STARTED|3 Cycles of Pembro + Capecitab||30
10753726|NCT03044730|11917482|FG000|Attempted Cycle 1|3 Cycles of Pembro + Capecitab||30
10753727|NCT03044730|11917482|FG000|Attempted Cycle 2|3 Cycles of Pembro + Capecitab||28
10753728|NCT03044730|11917482|FG000|Attempted Cycle 3|3 Cycles of Pembro + Capecitab||26
10753729|NCT03044730|11917482|FG000|COMPLETED|3 Cycles of Pembro + Capecitab||26
10753730|NCT03044730|11917482|FG000|NOT COMPLETED|3 Cycles of Pembro + Capecitab||4
10753731|NCT03044730|11917482|FG000|STARTED|Cycles 4 and Beyond||26
10753732|NCT03044730|11917482|FG000|Assessed for Cycle 4|Cycles 4 and Beyond||26
10753733|NCT03044730|11917482|FG000|Started Cycle 4|Cycles 4 and Beyond||20
10753734|NCT03044730|11917482|FG000|Went on to Cycle 5 and Beyond|Cycles 4 and Beyond||16
10753735|NCT03044730|11917482|FG000|COMPLETED|Cycles 4 and Beyond||16
10753736|NCT03044730|11917482|FG000|NOT COMPLETED|Cycles 4 and Beyond||10
10753737|NCT03044730|11917482|FG000|STARTED|On Follow-up for 2 Years||29
10753738|NCT03044730|11917482|FG000|COMPLETED|On Follow-up for 2 Years||4
10753739|NCT03044730|11917482|FG000|NOT COMPLETED|On Follow-up for 2 Years||25
10753740|NCT03044886|11917490|FG000|STARTED|Overall Study||120
10753741|NCT03044886|11917491|FG001|STARTED|Overall Study||120
10753742|NCT03044886|11917492|FG002|STARTED|Overall Study||120
10753743|NCT03044886|11917490|FG000|COMPLETED|Overall Study||105
10753744|NCT03044886|11917491|FG001|COMPLETED|Overall Study||110
10753745|NCT03044886|11917492|FG002|COMPLETED|Overall Study||108
10753746|NCT03044886|11917490|FG000|NOT COMPLETED|Overall Study||15
10753747|NCT03044886|11917491|FG001|NOT COMPLETED|Overall Study||10
10753748|NCT03044886|11917492|FG002|NOT COMPLETED|Overall Study||12
10753749|NCT03045081|11917502|FG000|STARTED|Overall Study||51
10753750|NCT03045081|11917503|FG001|STARTED|Overall Study||48
10753751|NCT03045081|11917502|FG000|COMPLETED|Overall Study||45
10753752|NCT03045081|11917503|FG001|COMPLETED|Overall Study||37
10753753|NCT03045081|11917502|FG000|NOT COMPLETED|Overall Study||6
10753754|NCT03045081|11917503|FG001|NOT COMPLETED|Overall Study||11
10753755|NCT03045302|11917509|FG000|STARTED|Overall Study||4
10753756|NCT03045302|11917509|FG000|COMPLETED|Overall Study||3
10753757|NCT03045302|11917509|FG000|NOT COMPLETED|Overall Study||1
10753758|NCT03045328|11917513|FG000|STARTED|Overall Study||22
10753759|NCT03045328|11917513|FG000|COMPLETED|Overall Study||20
10753760|NCT03045328|11917513|FG000|NOT COMPLETED|Overall Study||2
10753761|NCT03045809|11917517|FG000|STARTED|Overall Study||705
10753762|NCT03045809|11917517|FG000|Attended an Additional Visit (if Needed)|Overall Study|(only if needed, for medical follow-up, to complete study procedures, or to report adverse events).|51
10753763|NCT03045809|11917517|FG000|COMPLETED|Overall Study||705
10753764|NCT03045809|11917517|FG000|NOT COMPLETED|Overall Study||0
10753765|NCT03045861|11917527|FG000|STARTED|Part A (Up to 10 Days)||0
10753766|NCT03045861|11917528|FG001|STARTED|Part A (Up to 10 Days)||0
10753767|NCT03045861|11917529|FG002|STARTED|Part A (Up to 10 Days)||10
10753768|NCT03045861|11917530|FG003|STARTED|Part A (Up to 10 Days)||0
10753769|NCT03045861|11917527|FG000|COMPLETED|Part A (Up to 10 Days)||0
10753770|NCT03045861|11917528|FG001|COMPLETED|Part A (Up to 10 Days)||0
10753771|NCT03045861|11917529|FG002|COMPLETED|Part A (Up to 10 Days)||10
10753772|NCT03045861|11917530|FG003|COMPLETED|Part A (Up to 10 Days)||0
10753773|NCT03045861|11917527|FG000|NOT COMPLETED|Part A (Up to 10 Days)||0
10753774|NCT03045861|11917528|FG001|NOT COMPLETED|Part A (Up to 10 Days)||0
10753775|NCT03045861|11917529|FG002|NOT COMPLETED|Part A (Up to 10 Days)||0
10753776|NCT03045861|11917530|FG003|NOT COMPLETED|Part A (Up to 10 Days)||0
10753777|NCT03045861|11917527|FG000|STARTED|Part B (Up to 10 Days)||7
10753778|NCT03045861|11917528|FG001|STARTED|Part B (Up to 10 Days)||8
10753779|NCT03045861|11917529|FG002|STARTED|Part B (Up to 10 Days)||0
10753780|NCT03045861|11917530|FG003|STARTED|Part B (Up to 10 Days)||8
10753781|NCT03045861|11917527|FG000|COMPLETED|Part B (Up to 10 Days)||7
10753782|NCT03045861|11917528|FG001|COMPLETED|Part B (Up to 10 Days)||8
10753783|NCT03045861|11917529|FG002|COMPLETED|Part B (Up to 10 Days)||0
10753784|NCT03045861|11917530|FG003|COMPLETED|Part B (Up to 10 Days)||8
10753785|NCT03045861|11917527|FG000|NOT COMPLETED|Part B (Up to 10 Days)||0
10753786|NCT03045861|11917528|FG001|NOT COMPLETED|Part B (Up to 10 Days)||0
10753787|NCT03045861|11917529|FG002|NOT COMPLETED|Part B (Up to 10 Days)||0
10821307|NCT00409344|11986378|FG001|COMPLETED|Overall Study|No participants were enrolled to completion|0
10821308|NCT00409344|11986377|FG000|NOT COMPLETED|Overall Study||0
10821309|NCT00409344|11986378|FG001|NOT COMPLETED|Overall Study||0
10821310|NCT00414453|11986384|FG000|STARTED|Overall Study||19
10821311|NCT00414453|11986384|FG000|COMPLETED|Overall Study||3
10821312|NCT00414453|11986384|FG000|NOT COMPLETED|Overall Study||16
10821313|NCT00417248|11986394|FG000|STARTED|Overall Study||8
10821314|NCT00417248|11986394|FG000|COMPLETED|Overall Study||0
10821315|NCT00417248|11986394|FG000|NOT COMPLETED|Overall Study||8
10821316|NCT00418145|11986399|FG000|STARTED|Overall Study||16
10821317|NCT00418145|11986399|FG000|COMPLETED|Overall Study||10
10821318|NCT00418145|11986399|FG000|NOT COMPLETED|Overall Study||6
10821319|NCT00409331|11986405|FG000|STARTED|Overall Study||1
10821320|NCT00409331|11986405|FG000|COMPLETED|Overall Study||0
10821321|NCT00409331|11986405|FG000|NOT COMPLETED|Overall Study||1
10821322|NCT00392860|11986411|FG000|STARTED|Overall Study||3
10753788|NCT03045861|11917530|FG003|NOT COMPLETED|Part B (Up to 10 Days)||0
10753789|NCT03045887|11917551|FG000|STARTED|Part A, Period (1 Day)||7
10753790|NCT03045887|11917552|FG001|STARTED|Part A, Period (1 Day)||4
10753791|NCT03045887|11917553|FG002|STARTED|Part A, Period (1 Day)||5
10753792|NCT03045887|11917554|FG003|STARTED|Part A, Period (1 Day)||5
10753793|NCT03045887|11917555|FG004|STARTED|Part A, Period (1 Day)||4
10753794|NCT03045887|11917556|FG005|STARTED|Part A, Period (1 Day)||4
10753795|NCT03045887|11917557|FG006|STARTED|Part A, Period (1 Day)||4
10753796|NCT03045887|11917558|FG007|STARTED|Part A, Period (1 Day)||4
10753797|NCT03045887|11917559|FG008|STARTED|Part A, Period (1 Day)||0
10753798|NCT03045887|11917560|FG009|STARTED|Part A, Period (1 Day)||0
10753799|NCT03045887|11917551|FG000|COMPLETED|Part A, Period (1 Day)||7
10821323|NCT00392860|11986412|FG001|STARTED|Overall Study||0
10821324|NCT00392860|11986413|FG002|STARTED|Overall Study||1
10821325|NCT00392860|11986411|FG000|COMPLETED|Overall Study||3
10821326|NCT00392860|11986412|FG001|COMPLETED|Overall Study||0
10821327|NCT00392860|11986413|FG002|COMPLETED|Overall Study||1
10821328|NCT00392860|11986411|FG000|NOT COMPLETED|Overall Study||0
10821329|NCT00392860|11986412|FG001|NOT COMPLETED|Overall Study||0
10821330|NCT00392860|11986413|FG002|NOT COMPLETED|Overall Study||0
10821331|NCT00391430|11986422|FG000|STARTED|Overall Study||8
10821332|NCT00391430|11986423|FG001|STARTED|Overall Study||0
10821333|NCT00391430|11986424|FG002|STARTED|Overall Study||31
10821334|NCT00391430|11986422|FG000|COMPLETED|Overall Study||5
10821335|NCT00391430|11986423|FG001|COMPLETED|Overall Study||0
10821336|NCT00391430|11986424|FG002|COMPLETED|Overall Study||19
10821337|NCT00391430|11986422|FG000|NOT COMPLETED|Overall Study||3
10821338|NCT00391430|11986423|FG001|NOT COMPLETED|Overall Study||0
10821339|NCT00391430|11986424|FG002|NOT COMPLETED|Overall Study||12
10821340|NCT00399841|11986432|FG000|STARTED|Overall Study||13
10821341|NCT00399841|11986433|FG001|STARTED|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
10821342|NCT00399841|11986434|FG002|STARTED|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
10821343|NCT00399841|11986432|FG000|Permanent Implant|Overall Study||6
10821344|NCT00399841|11986433|FG001|Permanent Implant|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
10821345|NCT00399841|11986434|FG002|Permanent Implant|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
10821346|NCT00399841|11986432|FG000|12-week|Overall Study||2
10821347|NCT00399841|11986433|FG001|12-week|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
10821348|NCT00399841|11986434|FG002|12-week|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
10821349|NCT00399841|11986432|FG000|COMPLETED|Overall Study||1
10821350|NCT00399841|11986433|FG001|COMPLETED|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
10821351|NCT00399841|11986434|FG002|COMPLETED|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
10821352|NCT00399841|11986432|FG000|NOT COMPLETED|Overall Study||12
10821353|NCT00399841|11986433|FG001|NOT COMPLETED|Overall Study||0
10821354|NCT00399841|11986434|FG002|NOT COMPLETED|Overall Study||0
10821355|NCT00387673|11986439|FG000|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
10821356|NCT00387673|11986440|FG001|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
10821357|NCT00387673|11986441|FG002|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
10821358|NCT00387673|11986439|FG000|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
10821359|NCT00387673|11986440|FG001|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
10821360|NCT00387673|11986441|FG002|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
10821361|NCT00387673|11986439|FG000|NOT COMPLETED|Overall Study||0
10821362|NCT00387673|11986440|FG001|NOT COMPLETED|Overall Study||0
10821363|NCT00387673|11986441|FG002|NOT COMPLETED|Overall Study||0
10821364|NCT00386724|11986447|FG000|STARTED|Overall Study||8
10821365|NCT00386724|11986447|FG000|3 Months Post-activation|Overall Study||4
10821366|NCT00386724|11986447|FG000|COMPLETED|Overall Study||3
10821367|NCT00386724|11986447|FG000|NOT COMPLETED|Overall Study||5
10821368|NCT00387244|11986451|FG000|STARTED|Overall Study||7
10821369|NCT00387244|11986451|FG000|End of Trial|Overall Study||0
10821370|NCT00387244|11986451|FG000|COMPLETED|Overall Study||0
10821371|NCT00387244|11986451|FG000|NOT COMPLETED|Overall Study||7
10753800|NCT03045887|11917552|FG001|COMPLETED|Part A, Period (1 Day)||4
10753801|NCT03045887|11917553|FG002|COMPLETED|Part A, Period (1 Day)||5
10753802|NCT03045887|11917554|FG003|COMPLETED|Part A, Period (1 Day)||5
10753803|NCT03045887|11917555|FG004|COMPLETED|Part A, Period (1 Day)||4
10753804|NCT03045887|11917556|FG005|COMPLETED|Part A, Period (1 Day)||4
10753805|NCT03045887|11917557|FG006|COMPLETED|Part A, Period (1 Day)||4
10753806|NCT03045887|11917558|FG007|COMPLETED|Part A, Period (1 Day)||4
10753807|NCT03045887|11917559|FG008|COMPLETED|Part A, Period (1 Day)||0
10753808|NCT03045887|11917560|FG009|COMPLETED|Part A, Period (1 Day)||0
10753809|NCT03045887|11917551|FG000|NOT COMPLETED|Part A, Period (1 Day)||0
10753810|NCT03045887|11917552|FG001|NOT COMPLETED|Part A, Period (1 Day)||0
10753811|NCT03045887|11917553|FG002|NOT COMPLETED|Part A, Period (1 Day)||0
10753812|NCT03045887|11917554|FG003|NOT COMPLETED|Part A, Period (1 Day)||0
10753813|NCT03045887|11917555|FG004|NOT COMPLETED|Part A, Period (1 Day)||0
10753814|NCT03045887|11917556|FG005|NOT COMPLETED|Part A, Period (1 Day)||0
10753815|NCT03045887|11917557|FG006|NOT COMPLETED|Part A, Period (1 Day)||0
10753816|NCT03045887|11917558|FG007|NOT COMPLETED|Part A, Period (1 Day)||0
10753817|NCT03045887|11917559|FG008|NOT COMPLETED|Part A, Period (1 Day)||0
10753818|NCT03045887|11917560|FG009|NOT COMPLETED|Part A, Period (1 Day)||0
10753819|NCT03045887|11917551|FG000|STARTED|Part A,Washout Period 1(4 Weeks)||7
10753820|NCT03045887|11917552|FG001|STARTED|Part A,Washout Period 1(4 Weeks)||4
10753821|NCT03045887|11917553|FG002|STARTED|Part A,Washout Period 1(4 Weeks)||5
10753822|NCT03045887|11917554|FG003|STARTED|Part A,Washout Period 1(4 Weeks)||5
10753823|NCT03045887|11917555|FG004|STARTED|Part A,Washout Period 1(4 Weeks)||4
10753824|NCT03045887|11917556|FG005|STARTED|Part A,Washout Period 1(4 Weeks)||4
10753825|NCT03045887|11917557|FG006|STARTED|Part A,Washout Period 1(4 Weeks)||4
10753826|NCT03045887|11917558|FG007|STARTED|Part A,Washout Period 1(4 Weeks)||4
10753827|NCT03045887|11917559|FG008|STARTED|Part A,Washout Period 1(4 Weeks)||0
10753828|NCT03045887|11917560|FG009|STARTED|Part A,Washout Period 1(4 Weeks)||0
10753829|NCT03045887|11917551|FG000|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
10753830|NCT03045887|11917552|FG001|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
10753831|NCT03045887|11917553|FG002|COMPLETED|Part A,Washout Period 1(4 Weeks)||5
10753832|NCT03045887|11917554|FG003|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
10753833|NCT03045887|11917555|FG004|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
10753834|NCT03045887|11917556|FG005|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
10753835|NCT03045887|11917557|FG006|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
10753836|NCT03045887|11917558|FG007|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
10753837|NCT03045887|11917559|FG008|COMPLETED|Part A,Washout Period 1(4 Weeks)||0
10753838|NCT03045887|11917560|FG009|COMPLETED|Part A,Washout Period 1(4 Weeks)||0
10753839|NCT03045887|11917551|FG000|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||3
10753840|NCT03045887|11917552|FG001|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
10753841|NCT03045887|11917553|FG002|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
10753842|NCT03045887|11917554|FG003|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||1
10753843|NCT03045887|11917555|FG004|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
10753844|NCT03045887|11917556|FG005|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
10753845|NCT03045887|11917557|FG006|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
10753846|NCT03045887|11917558|FG007|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
10753847|NCT03045887|11917559|FG008|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
10753848|NCT03045887|11917560|FG009|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
10753849|NCT03045887|11917551|FG000|STARTED|Part A, Period 2 (1 Day)||4
10753850|NCT03045887|11917552|FG001|STARTED|Part A, Period 2 (1 Day)||4
10753851|NCT03045887|11917553|FG002|STARTED|Part A, Period 2 (1 Day)||5
10753852|NCT03045887|11917554|FG003|STARTED|Part A, Period 2 (1 Day)||4
10753853|NCT03045887|11917555|FG004|STARTED|Part A, Period 2 (1 Day)||4
10821372|NCT00384293|11986457|FG000|STARTED|MK0524A Active Run-In, Pre-randomization||937
10821373|NCT00384293|11986458|FG001|STARTED|MK0524A Active Run-In, Pre-randomization||0
10821374|NCT00384293|11986459|FG002|STARTED|MK0524A Active Run-In, Pre-randomization||0
10821375|NCT00384293|11986457|FG000|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization|Entered active run-in period and received MK0524A 1 g|937
10821376|NCT00384293|11986458|FG001|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization||0
10821377|NCT00384293|11986459|FG002|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization||0
10821378|NCT00384293|11986457|FG000|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization|MK0524A dose increased to 2 g in active run-in period|813
10821379|NCT00384293|11986458|FG001|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization||0
10821380|NCT00384293|11986459|FG002|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization||0
10821381|NCT00384293|11986457|FG000|COMPLETED|MK0524A Active Run-In, Pre-randomization||433
10821382|NCT00384293|11986458|FG001|COMPLETED|MK0524A Active Run-In, Pre-randomization||0
10821383|NCT00384293|11986459|FG002|COMPLETED|MK0524A Active Run-In, Pre-randomization||0
10821384|NCT00384293|11986457|FG000|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||504
10821385|NCT00384293|11986458|FG001|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||0
10821386|NCT00384293|11986459|FG002|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||0
10821387|NCT00384293|11986457|FG000|STARTED|Post-randomization Period||0
10821388|NCT00384293|11986458|FG001|STARTED|Post-randomization Period||214
10821389|NCT00384293|11986459|FG002|STARTED|Post-randomization Period||219
10821390|NCT00384293|11986457|FG000|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period||0
10821391|NCT00384293|11986458|FG001|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period|Received at least one dose of randomized study drug (All Patients as Treated Population)|214
10821392|NCT00384293|11986459|FG002|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period||218
10821393|NCT00384293|11986457|FG000|COMPLETED|Post-randomization Period||0
10821394|NCT00384293|11986458|FG001|COMPLETED|Post-randomization Period||0
10753854|NCT03045887|11917556|FG005|STARTED|Part A, Period 2 (1 Day)||4
10753855|NCT03045887|11917557|FG006|STARTED|Part A, Period 2 (1 Day)||4
10821395|NCT00384293|11986459|FG002|COMPLETED|Post-randomization Period||0
10821396|NCT00384293|11986457|FG000|NOT COMPLETED|Post-randomization Period||0
10821397|NCT00384293|11986458|FG001|NOT COMPLETED|Post-randomization Period||214
10821398|NCT00384293|11986459|FG002|NOT COMPLETED|Post-randomization Period||219
10821399|NCT00383630|11986467|FG000|STARTED|Overall Study||1
10821400|NCT00383630|11986467|FG000|COMPLETED|Overall Study||1
10821401|NCT00383630|11986467|FG000|NOT COMPLETED|Overall Study||0
10821402|NCT00374543|11986473|FG000|STARTED|Overall Study||2
10821403|NCT00374543|11986474|FG001|STARTED|Overall Study||1
10821404|NCT00374543|11986473|FG000|COMPLETED|Overall Study||2
10821405|NCT00374543|11986474|FG001|COMPLETED|Overall Study||1
10821406|NCT00374543|11986473|FG000|NOT COMPLETED|Overall Study||0
10821407|NCT00374543|11986474|FG001|NOT COMPLETED|Overall Study||0
10821408|NCT00377455|11986480|FG000|STARTED|Overall Study||5
10821409|NCT00377455|11986480|FG000|COMPLETED|Overall Study||4
10821410|NCT00377455|11986480|FG000|NOT COMPLETED|Overall Study||1
10821411|NCT00371462|11986486|FG000|STARTED|Overall Study||35
10821412|NCT00371462|11986487|FG001|STARTED|Overall Study||35
10821413|NCT00371462|11986486|FG000|COMPLETED|Overall Study||27
10821414|NCT00371462|11986487|FG001|COMPLETED|Overall Study||27
10821415|NCT00371462|11986486|FG000|NOT COMPLETED|Overall Study||8
10821416|NCT00371462|11986487|FG001|NOT COMPLETED|Overall Study||8
10821417|NCT00369265|11986495|FG000|STARTED|Overall Study||4
10821418|NCT00369265|11986496|FG001|STARTED|Overall Study||7
10821419|NCT00369265|11986495|FG000|COMPLETED|Overall Study||0
10821420|NCT00369265|11986496|FG001|COMPLETED|Overall Study||0
10821421|NCT00369265|11986495|FG000|NOT COMPLETED|Overall Study||4
10821422|NCT00369265|11986496|FG001|NOT COMPLETED|Overall Study||7
10821423|NCT00370695|11986502|FG000|STARTED|Overall Study||15
10821424|NCT00370695|11986502|FG000|12 Weeks Post-activation|Overall Study||2
10821425|NCT00370695|11986502|FG000|COMPLETED|Overall Study||0
10753856|NCT03045887|11917558|FG007|STARTED|Part A, Period 2 (1 Day)||4
10753857|NCT03045887|11917559|FG008|STARTED|Part A, Period 2 (1 Day)||0
10753858|NCT03045887|11917560|FG009|STARTED|Part A, Period 2 (1 Day)||0
10753859|NCT03045887|11917551|FG000|COMPLETED|Part A, Period 2 (1 Day)||3
10753860|NCT03045887|11917552|FG001|COMPLETED|Part A, Period 2 (1 Day)||4
10753861|NCT03045887|11917553|FG002|COMPLETED|Part A, Period 2 (1 Day)||5
10753862|NCT03045887|11917554|FG003|COMPLETED|Part A, Period 2 (1 Day)||4
10753863|NCT03045887|11917555|FG004|COMPLETED|Part A, Period 2 (1 Day)||4
10821426|NCT00370695|11986502|FG000|NOT COMPLETED|Overall Study||15
10821427|NCT00364689|11986509|FG000|STARTED|Overall Study||13
10821428|NCT00364689|11986509|FG000|COMPLETED|Overall Study||12
10821429|NCT00364689|11986509|FG000|NOT COMPLETED|Overall Study||1
10821430|NCT00352118|11986515|FG000|STARTED|Overall Study||4
10821431|NCT00352118|11986515|FG000|COMPLETED|Overall Study||0
10821432|NCT00352118|11986515|FG000|NOT COMPLETED|Overall Study||4
10821433|NCT00368654|11986523|FG000|STARTED|Overall Study||3
10821434|NCT00368654|11986524|FG001|STARTED|Overall Study||3
10821435|NCT00368654|11986525|FG002|STARTED|Overall Study||3
10821436|NCT00368654|11986526|FG003|STARTED|Overall Study||3
10821437|NCT00368654|11986523|FG000|COMPLETED|Overall Study||0
10821438|NCT00368654|11986524|FG001|COMPLETED|Overall Study||0
10821439|NCT00368654|11986525|FG002|COMPLETED|Overall Study||0
10821440|NCT00368654|11986526|FG003|COMPLETED|Overall Study||0
10821441|NCT00368654|11986523|FG000|NOT COMPLETED|Overall Study||3
10821442|NCT00368654|11986524|FG001|NOT COMPLETED|Overall Study||3
10821443|NCT00368654|11986525|FG002|NOT COMPLETED|Overall Study||3
10821444|NCT00368654|11986526|FG003|NOT COMPLETED|Overall Study||3
10821445|NCT00356421|11986538|FG000|STARTED|Overall Study||38
10821446|NCT00356421|11986539|FG001|STARTED|Overall Study||20
10821447|NCT00356421|11986538|FG000|COMPLETED|Overall Study||6
10821448|NCT00356421|11986539|FG001|COMPLETED|Overall Study||3
10821449|NCT00356421|11986538|FG000|NOT COMPLETED|Overall Study||32
10821450|NCT00356421|11986539|FG001|NOT COMPLETED|Overall Study||17
10821451|NCT00350623|11986548|FG000|STARTED|Overall Study||71
10821452|NCT00350623|11986549|FG001|STARTED|Overall Study||71
10821453|NCT00350623|11986550|FG002|STARTED|Overall Study||68
10821454|NCT00350623|11986548|FG000|COMPLETED|Overall Study||63
10821455|NCT00350623|11986549|FG001|COMPLETED|Overall Study||67
10821456|NCT00350623|11986550|FG002|COMPLETED|Overall Study||62
10821457|NCT00350623|11986548|FG000|NOT COMPLETED|Overall Study||8
10821458|NCT00350623|11986549|FG001|NOT COMPLETED|Overall Study||4
10821459|NCT00350623|11986550|FG002|NOT COMPLETED|Overall Study||6
10821460|NCT00356187|11986560|FG000|STARTED|Overall Study||0
10821461|NCT00356187|11986561|FG001|STARTED|Overall Study||0
10821462|NCT00356187|11986560|FG000|COMPLETED|Overall Study||0
10821463|NCT00356187|11986561|FG001|COMPLETED|Overall Study||0
10821464|NCT00356187|11986560|FG000|NOT COMPLETED|Overall Study||0
10753864|NCT03045887|11917556|FG005|COMPLETED|Part A, Period 2 (1 Day)||4
10753865|NCT03045887|11917557|FG006|COMPLETED|Part A, Period 2 (1 Day)||4
10821465|NCT00356187|11986561|FG001|NOT COMPLETED|Overall Study||0
10821466|NCT00353275|11986571|FG000|STARTED|Overall Study||2
10821467|NCT00353275|11986572|FG001|STARTED|Overall Study||3
10821468|NCT00353275|11986571|FG000|COMPLETED|Overall Study||2
10821469|NCT00353275|11986572|FG001|COMPLETED|Overall Study||3
10821470|NCT00353275|11986571|FG000|NOT COMPLETED|Overall Study||0
10821471|NCT00353275|11986572|FG001|NOT COMPLETED|Overall Study||0
10821472|NCT00350844|11986578|FG000|STARTED|Overall Study||6
10753866|NCT03045887|11917558|FG007|COMPLETED|Part A, Period 2 (1 Day)||4
10753867|NCT03045887|11917559|FG008|COMPLETED|Part A, Period 2 (1 Day)||0
10753868|NCT03045887|11917560|FG009|COMPLETED|Part A, Period 2 (1 Day)||0
10753869|NCT03045887|11917551|FG000|NOT COMPLETED|Part A, Period 2 (1 Day)||1
10753870|NCT03045887|11917552|FG001|NOT COMPLETED|Part A, Period 2 (1 Day)||0
10753871|NCT03045887|11917553|FG002|NOT COMPLETED|Part A, Period 2 (1 Day)||0
10753872|NCT03045887|11917554|FG003|NOT COMPLETED|Part A, Period 2 (1 Day)||0
10753873|NCT03045887|11917555|FG004|NOT COMPLETED|Part A, Period 2 (1 Day)||0
10753874|NCT03045887|11917556|FG005|NOT COMPLETED|Part A, Period 2 (1 Day)||0
10753875|NCT03045887|11917557|FG006|NOT COMPLETED|Part A, Period 2 (1 Day)||0
10753876|NCT03045887|11917558|FG007|NOT COMPLETED|Part A, Period 2 (1 Day)||0
10753877|NCT03045887|11917559|FG008|NOT COMPLETED|Part A, Period 2 (1 Day)||0
10753878|NCT03045887|11917560|FG009|NOT COMPLETED|Part A, Period 2 (1 Day)||0
10753879|NCT03045887|11917551|FG000|STARTED|Part A,Washout Period 2 (4 Weeks)||3
10753880|NCT03045887|11917552|FG001|STARTED|Part A,Washout Period 2 (4 Weeks)||4
10753881|NCT03045887|11917553|FG002|STARTED|Part A,Washout Period 2 (4 Weeks)||5
10753882|NCT03045887|11917554|FG003|STARTED|Part A,Washout Period 2 (4 Weeks)||4
10753883|NCT03045887|11917555|FG004|STARTED|Part A,Washout Period 2 (4 Weeks)||4
10753884|NCT03045887|11917556|FG005|STARTED|Part A,Washout Period 2 (4 Weeks)||4
10753885|NCT03045887|11917557|FG006|STARTED|Part A,Washout Period 2 (4 Weeks)||4
10753886|NCT03045887|11917558|FG007|STARTED|Part A,Washout Period 2 (4 Weeks)||4
10753887|NCT03045887|11917559|FG008|STARTED|Part A,Washout Period 2 (4 Weeks)||0
10753888|NCT03045887|11917560|FG009|STARTED|Part A,Washout Period 2 (4 Weeks)||0
10753889|NCT03045887|11917551|FG000|COMPLETED|Part A,Washout Period 2 (4 Weeks)||3
10753890|NCT03045887|11917552|FG001|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
10753891|NCT03045887|11917553|FG002|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
10753892|NCT03045887|11917554|FG003|COMPLETED|Part A,Washout Period 2 (4 Weeks)||2
10753893|NCT03045887|11917555|FG004|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
10753894|NCT03045887|11917556|FG005|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
10753895|NCT03045887|11917557|FG006|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
10753896|NCT03045887|11917558|FG007|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
10753897|NCT03045887|11917559|FG008|COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
10753898|NCT03045887|11917560|FG009|COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
10753899|NCT03045887|11917551|FG000|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
10753900|NCT03045887|11917552|FG001|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
10753901|NCT03045887|11917553|FG002|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||1
10753902|NCT03045887|11917554|FG003|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||2
10753903|NCT03045887|11917555|FG004|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
10753904|NCT03045887|11917556|FG005|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
10753905|NCT03045887|11917557|FG006|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
10753906|NCT03045887|11917558|FG007|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
10753907|NCT03045887|11917559|FG008|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
10753908|NCT03045887|11917560|FG009|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
10753909|NCT03045887|11917551|FG000|STARTED|Part A, Period 3 (1 Day)||3
10753910|NCT03045887|11917552|FG001|STARTED|Part A, Period 3 (1 Day)||4
10753911|NCT03045887|11917553|FG002|STARTED|Part A, Period 3 (1 Day)||4
10753912|NCT03045887|11917554|FG003|STARTED|Part A, Period 3 (1 Day)||2
10753913|NCT03045887|11917555|FG004|STARTED|Part A, Period 3 (1 Day)||4
10753914|NCT03045887|11917556|FG005|STARTED|Part A, Period 3 (1 Day)||4
10753915|NCT03045887|11917557|FG006|STARTED|Part A, Period 3 (1 Day)||4
10753916|NCT03045887|11917558|FG007|STARTED|Part A, Period 3 (1 Day)||4
10753917|NCT03045887|11917559|FG008|STARTED|Part A, Period 3 (1 Day)||0
10753918|NCT03045887|11917560|FG009|STARTED|Part A, Period 3 (1 Day)||0
10753919|NCT03045887|11917551|FG000|COMPLETED|Part A, Period 3 (1 Day)||3
10753920|NCT03045887|11917552|FG001|COMPLETED|Part A, Period 3 (1 Day)||4
10753921|NCT03045887|11917553|FG002|COMPLETED|Part A, Period 3 (1 Day)||4
10753922|NCT03045887|11917554|FG003|COMPLETED|Part A, Period 3 (1 Day)||2
10753923|NCT03045887|11917555|FG004|COMPLETED|Part A, Period 3 (1 Day)||4
10753924|NCT03045887|11917556|FG005|COMPLETED|Part A, Period 3 (1 Day)||4
10753925|NCT03045887|11917557|FG006|COMPLETED|Part A, Period 3 (1 Day)||4
10753926|NCT03045887|11917558|FG007|COMPLETED|Part A, Period 3 (1 Day)||4
10753927|NCT03045887|11917559|FG008|COMPLETED|Part A, Period 3 (1 Day)||0
10753928|NCT03045887|11917560|FG009|COMPLETED|Part A, Period 3 (1 Day)||0
10753929|NCT03045887|11917551|FG000|NOT COMPLETED|Part A, Period 3 (1 Day)||0
10753930|NCT03045887|11917552|FG001|NOT COMPLETED|Part A, Period 3 (1 Day)||0
10753931|NCT03045887|11917553|FG002|NOT COMPLETED|Part A, Period 3 (1 Day)||0
10753932|NCT03045887|11917554|FG003|NOT COMPLETED|Part A, Period 3 (1 Day)||0
10753933|NCT03045887|11917555|FG004|NOT COMPLETED|Part A, Period 3 (1 Day)||0
10753934|NCT03045887|11917556|FG005|NOT COMPLETED|Part A, Period 3 (1 Day)||0
10753935|NCT03045887|11917557|FG006|NOT COMPLETED|Part A, Period 3 (1 Day)||0
10753936|NCT03045887|11917558|FG007|NOT COMPLETED|Part A, Period 3 (1 Day)||0
10753937|NCT03045887|11917559|FG008|NOT COMPLETED|Part A, Period 3 (1 Day)||0
10753938|NCT03045887|11917560|FG009|NOT COMPLETED|Part A, Period 3 (1 Day)||0
10753939|NCT03045887|11917551|FG000|STARTED|Part B (14 Days)||0
10753940|NCT03045887|11917552|FG001|STARTED|Part B (14 Days)||0
10753941|NCT03045887|11917553|FG002|STARTED|Part B (14 Days)||0
10753942|NCT03045887|11917554|FG003|STARTED|Part B (14 Days)||0
10753943|NCT03045887|11917555|FG004|STARTED|Part B (14 Days)||0
10753944|NCT03045887|11917556|FG005|STARTED|Part B (14 Days)||0
10753945|NCT03045887|11917557|FG006|STARTED|Part B (14 Days)||0
10753946|NCT03045887|11917558|FG007|STARTED|Part B (14 Days)||0
10753947|NCT03045887|11917559|FG008|STARTED|Part B (14 Days)||3
10753948|NCT03045887|11917560|FG009|STARTED|Part B (14 Days)||9
10753949|NCT03045887|11917551|FG000|COMPLETED|Part B (14 Days)||0
10753950|NCT03045887|11917552|FG001|COMPLETED|Part B (14 Days)||0
10753951|NCT03045887|11917553|FG002|COMPLETED|Part B (14 Days)||0
10753952|NCT03045887|11917554|FG003|COMPLETED|Part B (14 Days)||0
10753953|NCT03045887|11917555|FG004|COMPLETED|Part B (14 Days)||0
10753954|NCT03045887|11917556|FG005|COMPLETED|Part B (14 Days)||0
10753955|NCT03045887|11917557|FG006|COMPLETED|Part B (14 Days)||0
10753956|NCT03045887|11917558|FG007|COMPLETED|Part B (14 Days)||0
10753957|NCT03045887|11917559|FG008|COMPLETED|Part B (14 Days)||3
10753958|NCT03045887|11917560|FG009|COMPLETED|Part B (14 Days)||9
10753959|NCT03045887|11917551|FG000|NOT COMPLETED|Part B (14 Days)||0
10753960|NCT03045887|11917552|FG001|NOT COMPLETED|Part B (14 Days)||0
10753961|NCT03045887|11917553|FG002|NOT COMPLETED|Part B (14 Days)||0
10753962|NCT03045887|11917554|FG003|NOT COMPLETED|Part B (14 Days)||0
10753963|NCT03045887|11917555|FG004|NOT COMPLETED|Part B (14 Days)||0
10753964|NCT03045887|11917556|FG005|NOT COMPLETED|Part B (14 Days)||0
10753965|NCT03045887|11917557|FG006|NOT COMPLETED|Part B (14 Days)||0
10753966|NCT03045887|11917558|FG007|NOT COMPLETED|Part B (14 Days)||0
10753967|NCT03045887|11917559|FG008|NOT COMPLETED|Part B (14 Days)||0
10753968|NCT03045887|11917560|FG009|NOT COMPLETED|Part B (14 Days)||0
10753969|NCT03045926|11917587|FG000|STARTED|Overall Study||35
10753970|NCT03045926|11917587|FG000|COMPLETED|Overall Study||35
10753971|NCT03045926|11917587|FG000|NOT COMPLETED|Overall Study||0
10753972|NCT03046056|11917594|FG000|STARTED|Overall Study||28
10753973|NCT03046056|11917595|FG001|STARTED|Overall Study||32
10408778|NCT00757237|11552940|FG001|STARTED|Overall Study||136
10408779|NCT00757237|11552939|FG000|Treated|Overall Study||136
10408780|NCT00757237|11552940|FG001|Treated|Overall Study||132
10408781|NCT00757237|11552939|FG000|COMPLETED|Overall Study||124
10408782|NCT00757237|11552940|FG001|COMPLETED|Overall Study||111
10821473|NCT00350844|11986578|FG000|COMPLETED|Overall Study||5
10821474|NCT00350844|11986578|FG000|NOT COMPLETED|Overall Study||1
10821475|NCT00348556|11986582|FG000|STARTED|Overall Study||4
10821476|NCT00348556|11986582|FG000|COMPLETED|Overall Study||3
10821477|NCT00348556|11986582|FG000|NOT COMPLETED|Overall Study||1
10821478|NCT00319839|11986586|FG000|STARTED|Overall Study||7
10821479|NCT00319839|11986586|FG000|COMPLETED|Overall Study||1
10821480|NCT00319839|11986586|FG000|NOT COMPLETED|Overall Study||6
10821481|NCT00344019|11986593|FG000|STARTED|Overall Study||12
10821482|NCT00344019|11986594|FG001|STARTED|Overall Study||11
10821483|NCT00344019|11986595|FG002|STARTED|Overall Study||74
10821484|NCT00344019|11986593|FG000|COMPLETED|Overall Study||12
10821485|NCT00344019|11986594|FG001|COMPLETED|Overall Study||11
10821486|NCT00344019|11986595|FG002|COMPLETED|Overall Study||0
10821487|NCT00344019|11986593|FG000|NOT COMPLETED|Overall Study||0
10821488|NCT00344019|11986594|FG001|NOT COMPLETED|Overall Study||0
10821489|NCT00344019|11986595|FG002|NOT COMPLETED|Overall Study||74
10821490|NCT00338455|11986608|FG000|STARTED|Overall Study||9
10821491|NCT00338455|11986609|FG001|STARTED|Overall Study||7
10821492|NCT00338455|11986608|FG000|Administered Study Drug|Overall Study||8
10821493|NCT00338455|11986609|FG001|Administered Study Drug|Overall Study||7
10821494|NCT00338455|11986608|FG000|COMPLETED|Overall Study||6
10821495|NCT00338455|11986609|FG001|COMPLETED|Overall Study||6
10821496|NCT00338455|11986608|FG000|NOT COMPLETED|Overall Study||3
10821497|NCT00338455|11986609|FG001|NOT COMPLETED|Overall Study||1
10821498|NCT00329108|11986617|FG000|STARTED|Overall Study|study terminated due to poor recruitment|15
10821499|NCT00329108|11986618|FG001|STARTED|Overall Study|study terminated due to poor recruitment|14
10821500|NCT00329108|11986617|FG000|COMPLETED|Overall Study||5
10821501|NCT00329108|11986618|FG001|COMPLETED|Overall Study||2
10821502|NCT00329108|11986617|FG000|NOT COMPLETED|Overall Study||10
10821503|NCT00329108|11986618|FG001|NOT COMPLETED|Overall Study||12
10821504|NCT00325572|11986626|FG000|STARTED|PHASE I||45
10821505|NCT00325572|11986627|FG001|STARTED|PHASE I||44
10821506|NCT00325572|11986626|FG000|COMPLETED|PHASE I||45
10821507|NCT00325572|11986627|FG001|COMPLETED|PHASE I||44
10821508|NCT00325572|11986626|FG000|NOT COMPLETED|PHASE I||0
10821509|NCT00325572|11986627|FG001|NOT COMPLETED|PHASE I||0
10821510|NCT00325572|11986626|FG000|STARTED|PHASE ii||0
10821511|NCT00325572|11986627|FG001|STARTED|PHASE ii||0
10821512|NCT00325572|11986626|FG000|COMPLETED|PHASE ii||0
10821513|NCT00325572|11986627|FG001|COMPLETED|PHASE ii||0
10821514|NCT00325572|11986626|FG000|NOT COMPLETED|PHASE ii||0
10821515|NCT00325572|11986627|FG001|NOT COMPLETED|PHASE ii||0
10408783|NCT00757237|11552939|FG000|NOT COMPLETED|Overall Study||13
10821516|NCT00333762|11986633|FG000|STARTED|Overall Study||4
10821517|NCT00333762|11986633|FG000|COMPLETED|Overall Study||0
10821518|NCT00333762|11986633|FG000|NOT COMPLETED|Overall Study||4
10821519|NCT00333229|11986639|FG000|STARTED|Overall Study||6
10821520|NCT00333229|11986640|FG001|STARTED|Overall Study||5
10821521|NCT00333229|11986639|FG000|COMPLETED|Overall Study||6
10753974|NCT03046056|11917596|FG002|STARTED|Overall Study||18
10753975|NCT03046056|11917594|FG000|COMPLETED|Overall Study||16
10753976|NCT03046056|11917595|FG001|COMPLETED|Overall Study||16
10753977|NCT03046056|11917596|FG002|COMPLETED|Overall Study||11
10753978|NCT03046056|11917594|FG000|NOT COMPLETED|Overall Study||12
10821522|NCT00333229|11986640|FG001|COMPLETED|Overall Study||4
10821523|NCT00333229|11986639|FG000|NOT COMPLETED|Overall Study||0
10821524|NCT00333229|11986640|FG001|NOT COMPLETED|Overall Study||1
10821525|NCT00322855|11986646|FG000|STARTED|Overall Study||1
10821526|NCT00322855|11986646|FG000|COMPLETED|Overall Study||1
10753979|NCT03046056|11917595|FG001|NOT COMPLETED|Overall Study||16
10753980|NCT03046056|11917596|FG002|NOT COMPLETED|Overall Study||7
10753981|NCT03046212|11917606|FG000|STARTED|Overall Study||15
10753982|NCT03046212|11917607|FG001|STARTED|Overall Study||15
10753983|NCT03046212|11917606|FG000|COMPLETED|Overall Study||15
10753984|NCT03046212|11917607|FG001|COMPLETED|Overall Study||15
10753985|NCT03046212|11917606|FG000|NOT COMPLETED|Overall Study||0
10753986|NCT03046212|11917607|FG001|NOT COMPLETED|Overall Study||0
10753987|NCT03046225|11917615|FG000|STARTED|Overall Study||13
10753988|NCT03046225|11917616|FG001|STARTED|Overall Study||13
10753989|NCT03046225|11917615|FG000|COMPLETED|Overall Study||13
10753990|NCT03046225|11917616|FG001|COMPLETED|Overall Study||13
10753991|NCT03046225|11917615|FG000|NOT COMPLETED|Overall Study||0
10753992|NCT03046225|11917616|FG001|NOT COMPLETED|Overall Study||0
10753993|NCT03046446|11917622|FG000|STARTED|Overall Study||208
10753994|NCT03046446|11917622|FG000|Second Injection|Overall Study||179
10753995|NCT03046446|11917622|FG000|Completed at Week 12|Overall Study||10
10753996|NCT03046446|11917622|FG000|Completed at Week 24|Overall Study||6
10753997|NCT03046446|11917622|FG000|Completed at Week 52|Overall Study||133
10753998|NCT03046446|11917622|FG000|COMPLETED|Overall Study||149
10753999|NCT03046446|11917622|FG000|NOT COMPLETED|Overall Study||59
10754000|NCT03046472|11917628|FG000|STARTED|Overall Study||33
10754001|NCT03046472|11917629|FG001|STARTED|Overall Study||17
10754002|NCT03046472|11917628|FG000|COMPLETED|Overall Study||33
10754003|NCT03046472|11917629|FG001|COMPLETED|Overall Study||17
10754004|NCT03046472|11917628|FG000|NOT COMPLETED|Overall Study||0
10754005|NCT03046472|11917629|FG001|NOT COMPLETED|Overall Study||0
10754006|NCT03046966|11917637|FG000|STARTED|Overall Study||51
10754007|NCT03046966|11917638|FG001|STARTED|Overall Study||51
10754008|NCT03046966|11917637|FG000|COMPLETED|Overall Study||51
10754009|NCT03046966|11917638|FG001|COMPLETED|Overall Study||51
10754010|NCT03046966|11917637|FG000|NOT COMPLETED|Overall Study||0
10754011|NCT03046966|11917638|FG001|NOT COMPLETED|Overall Study||0
10754012|NCT03047174|11917646|FG000|STARTED|Overall Study||28
10754013|NCT03047174|11917647|FG001|STARTED|Overall Study||29
10754014|NCT03047174|11917646|FG000|COMPLETED|Overall Study||9
10754015|NCT03047174|11917647|FG001|COMPLETED|Overall Study||27
10754016|NCT03047174|11917646|FG000|NOT COMPLETED|Overall Study||19
10754017|NCT03047174|11917647|FG001|NOT COMPLETED|Overall Study||2
10754018|NCT03047447|11917670|FG000|STARTED|Overall Study||10
10754019|NCT03047447|11917671|FG001|STARTED|Overall Study||10
10754020|NCT03047447|11917672|FG002|STARTED|Overall Study||10
10754021|NCT03047447|11917670|FG000|COMPLETED|Overall Study||10
10754022|NCT03047447|11917671|FG001|COMPLETED|Overall Study||10
10754023|NCT03047447|11917672|FG002|COMPLETED|Overall Study||10
10754024|NCT03047447|11917670|FG000|NOT COMPLETED|Overall Study||0
10754025|NCT03047447|11917671|FG001|NOT COMPLETED|Overall Study||0
10754026|NCT03047447|11917672|FG002|NOT COMPLETED|Overall Study||0
10754027|NCT03047551|11917685|FG000|STARTED|Overall Study||319
10754028|NCT03047551|11917686|FG001|STARTED|Overall Study||315
10754029|NCT03047551|11917685|FG000|COMPLETED|Overall Study||317
10754030|NCT03047551|11917686|FG001|COMPLETED|Overall Study||312
10754031|NCT03047551|11917685|FG000|NOT COMPLETED|Overall Study||2
10754032|NCT03047551|11917686|FG001|NOT COMPLETED|Overall Study||3
10754033|NCT03047720|11917694|FG000|STARTED|First Intervention (6weeks)||12
10754034|NCT03047720|11917695|FG001|STARTED|First Intervention (6weeks)||0
10754035|NCT03047720|11917694|FG000|COMPLETED|First Intervention (6weeks)||5
10754036|NCT03047720|11917695|FG001|COMPLETED|First Intervention (6weeks)||0
10754037|NCT03047720|11917694|FG000|NOT COMPLETED|First Intervention (6weeks)||7
10754038|NCT03047720|11917695|FG001|NOT COMPLETED|First Intervention (6weeks)||0
10754039|NCT03047720|11917694|FG000|STARTED|Second Intervention (6weeks)||0
10754040|NCT03047720|11917695|FG001|STARTED|Second Intervention (6weeks)||0
10754041|NCT03047720|11917694|FG000|COMPLETED|Second Intervention (6weeks)||0
10754042|NCT03047720|11917695|FG001|COMPLETED|Second Intervention (6weeks)||0
10754043|NCT03047720|11917694|FG000|NOT COMPLETED|Second Intervention (6weeks)||0
10754044|NCT03047720|11917695|FG001|NOT COMPLETED|Second Intervention (6weeks)||0
10754045|NCT03047980|11917701|FG000|STARTED|Overall Study||10
10754046|NCT03047980|11917701|FG000|COMPLETED|Overall Study||9
10754047|NCT03047980|11917701|FG000|NOT COMPLETED|Overall Study||1
10754048|NCT03048006|11917705|FG000|STARTED|Overall Study||44456
10754049|NCT03048006|11917705|FG000|COMPLETED|Overall Study||44456
10754050|NCT03048006|11917705|FG000|NOT COMPLETED|Overall Study||0
10754051|NCT03048058|11917711|FG000|STARTED|Overall Study||10
10754052|NCT03048058|11917712|FG001|STARTED|Overall Study||10
10754053|NCT03048058|11917711|FG000|COMPLETED|Overall Study||6
10754054|NCT03048058|11917712|FG001|COMPLETED|Overall Study||6
10754055|NCT03048058|11917711|FG000|NOT COMPLETED|Overall Study||4
10754056|NCT03048058|11917712|FG001|NOT COMPLETED|Overall Study||4
10754057|NCT03048383|11917721|FG000|STARTED|Overall Study||28
10754058|NCT03048383|11917722|FG001|STARTED|Overall Study||21
10754059|NCT03048383|11917723|FG002|STARTED|Overall Study||22
10754060|NCT03048383|11917721|FG000|COMPLETED|Overall Study||15
10754061|NCT03048383|11917722|FG001|COMPLETED|Overall Study||13
10754062|NCT03048383|11917723|FG002|COMPLETED|Overall Study||10
10754063|NCT03048383|11917721|FG000|NOT COMPLETED|Overall Study||13
10754064|NCT03048383|11917722|FG001|NOT COMPLETED|Overall Study||8
10754065|NCT03048383|11917723|FG002|NOT COMPLETED|Overall Study||12
10754066|NCT03048500|11917731|FG000|STARTED|2 Cycles of Treatment||17
10754067|NCT03048500|11917731|FG000|Attempted 1st Cycle|2 Cycles of Treatment||17
10754068|NCT03048500|11917731|FG000|Attempted 2nd Cycle|2 Cycles of Treatment||16
10754069|NCT03048500|11917731|FG000|COMPLETED|2 Cycles of Treatment||16
10754070|NCT03048500|11917731|FG000|NOT COMPLETED|2 Cycles of Treatment||1
10754071|NCT03048500|11917731|FG000|STARTED|Reached 1st Response/Continued Treatment||16
10754072|NCT03048500|11917731|FG000|Assessed for First Response|Reached 1st Response/Continued Treatment||16
10754073|NCT03048500|11917731|FG000|Went on to Cycle 3 and Beyond|Reached 1st Response/Continued Treatment||9
10754074|NCT03048500|11917731|FG000|COMPLETED|Reached 1st Response/Continued Treatment||9
10754075|NCT03048500|11917731|FG000|NOT COMPLETED|Reached 1st Response/Continued Treatment||7
10754076|NCT03048500|11917731|FG000|STARTED|Follow up for 3 Years|1 patient died whilst on study.|16
10754077|NCT03048500|11917731|FG000|COMPLETED|Follow up for 3 Years||0
10754078|NCT03048500|11917731|FG000|NOT COMPLETED|Follow up for 3 Years||16
10754079|NCT03048747|11917735|FG000|STARTED|Overall Study||16
10754080|NCT03048747|11917735|FG000|COMPLETED|Overall Study||11
10754081|NCT03048747|11917735|FG000|NOT COMPLETED|Overall Study||5
10778705|NCT03358407|11940521|FG002|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
10778706|NCT03358407|11940522|FG003|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
10778707|NCT03358407|11940523|FG004|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
10778708|NCT03358407|11940524|FG005|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
10778709|NCT03358407|11940525|FG006|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||1
10778710|NCT03358407|11940526|FG007|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
10778711|NCT03358407|11940527|FG008|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
10778712|NCT03358407|11940528|FG009|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
10778713|NCT03358407|11940519|FG000|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
10778714|NCT03358407|11940520|FG001|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
10778715|NCT03358407|11940521|FG002|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
10778716|NCT03358407|11940522|FG003|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
10778717|NCT03358407|11940523|FG004|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
10778718|NCT03358407|11940524|FG005|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)|3 participants were added to Part A-Cohort 2: Placebo/GSK 400mg arm|3
10778719|NCT03358407|11940525|FG006|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)|1 participant was added to Part A-Cohort 2: GSK 200mg/ Placebo arm|3
10778720|NCT03358407|11940526|FG007|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)|3 participants were added to Part A-Cohort 2: GSK 200mg/GSK 400mg arm|6
10778721|NCT03358407|11940527|FG008|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
10778722|NCT03358407|11940528|FG009|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
10778723|NCT03358407|11940519|FG000|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
10778724|NCT03358407|11940520|FG001|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
10778725|NCT03358407|11940521|FG002|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
10778726|NCT03358407|11940522|FG003|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
10778727|NCT03358407|11940523|FG004|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
10778728|NCT03358407|11940524|FG005|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
10778729|NCT03358407|11940525|FG006|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
10778730|NCT03358407|11940526|FG007|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
10778731|NCT03358407|11940527|FG008|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
10778732|NCT03358407|11940528|FG009|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
10778733|NCT03358407|11940519|FG000|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
10778734|NCT03358407|11940520|FG001|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
10778735|NCT03358407|11940521|FG002|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
10778736|NCT03358407|11940522|FG003|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
10778737|NCT03358407|11940523|FG004|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
10778738|NCT03358407|11940524|FG005|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||3
10778739|NCT03358407|11940525|FG006|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||3
10778740|NCT03358407|11940526|FG007|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||6
10778741|NCT03358407|11940527|FG008|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
10778742|NCT03358407|11940528|FG009|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
10778743|NCT03358407|11940519|FG000|STARTED|Part B: Overall Period (11 Weeks)||0
10778744|NCT03358407|11940520|FG001|STARTED|Part B: Overall Period (11 Weeks)||0
10778745|NCT03358407|11940521|FG002|STARTED|Part B: Overall Period (11 Weeks)||0
10778746|NCT03358407|11940522|FG003|STARTED|Part B: Overall Period (11 Weeks)||0
10778747|NCT03358407|11940523|FG004|STARTED|Part B: Overall Period (11 Weeks)||0
10778748|NCT03358407|11940524|FG005|STARTED|Part B: Overall Period (11 Weeks)||0
10778749|NCT03358407|11940525|FG006|STARTED|Part B: Overall Period (11 Weeks)||0
10778750|NCT03358407|11940526|FG007|STARTED|Part B: Overall Period (11 Weeks)||0
10778751|NCT03358407|11940527|FG008|STARTED|Part B: Overall Period (11 Weeks)||0
10778752|NCT03358407|11940528|FG009|STARTED|Part B: Overall Period (11 Weeks)||0
10778753|NCT03358407|11940519|FG000|COMPLETED|Part B: Overall Period (11 Weeks)||0
10778754|NCT03358407|11940520|FG001|COMPLETED|Part B: Overall Period (11 Weeks)||0
10778755|NCT03358407|11940521|FG002|COMPLETED|Part B: Overall Period (11 Weeks)||0
10778756|NCT03358407|11940522|FG003|COMPLETED|Part B: Overall Period (11 Weeks)||0
10778757|NCT03358407|11940523|FG004|COMPLETED|Part B: Overall Period (11 Weeks)||0
10778758|NCT03358407|11940524|FG005|COMPLETED|Part B: Overall Period (11 Weeks)||0
10778759|NCT03358407|11940525|FG006|COMPLETED|Part B: Overall Period (11 Weeks)||0
10778760|NCT03358407|11940526|FG007|COMPLETED|Part B: Overall Period (11 Weeks)||0
10754082|NCT03049215|11917742|FG000|STARTED|Overall Study||1
10754083|NCT03049215|11917743|FG001|STARTED|Overall Study||0
10754084|NCT03049215|11917742|FG000|COMPLETED|Overall Study||1
10754085|NCT03049215|11917743|FG001|COMPLETED|Overall Study||0
10754086|NCT03049215|11917742|FG000|NOT COMPLETED|Overall Study||0
10754087|NCT03049215|11917743|FG001|NOT COMPLETED|Overall Study||0
10754088|NCT03049280|11917749|FG000|STARTED|Overall Study||33
10754089|NCT03049280|11917749|FG000|COMPLETED|Overall Study||32
10754090|NCT03049280|11917749|FG000|NOT COMPLETED|Overall Study||1
10754091|NCT03049488|11917761|FG000|STARTED|Overall Study||15
10754092|NCT03049488|11917762|FG001|STARTED|Overall Study||15
10754093|NCT03049488|11917763|FG002|STARTED|Overall Study||20
10754094|NCT03049488|11917764|FG003|STARTED|Overall Study||15
10754095|NCT03049488|11917765|FG004|STARTED|Overall Study||15
10754096|NCT03049488|11917766|FG005|STARTED|Overall Study||15
10754097|NCT03049488|11917761|FG000|Received First Product Administration|Overall Study||15
10754098|NCT03049488|11917762|FG001|Received First Product Administration|Overall Study||15
10754099|NCT03049488|11917763|FG002|Received First Product Administration|Overall Study||20
10754100|NCT03049488|11917764|FG003|Received First Product Administration|Overall Study||15
10754101|NCT03049488|11917765|FG004|Received First Product Administration|Overall Study||15
10754102|NCT03049488|11917766|FG005|Received First Product Administration|Overall Study||15
10754103|NCT03049488|11917761|FG000|Received Optional Second Dose|Overall Study||10
10754104|NCT03049488|11917762|FG001|Received Optional Second Dose|Overall Study||11
10754105|NCT03049488|11917763|FG002|Received Optional Second Dose|Overall Study||11
10754106|NCT03049488|11917764|FG003|Received Optional Second Dose|Overall Study||9
10754107|NCT03049488|11917765|FG004|Received Optional Second Dose|Overall Study||11
10754108|NCT03049488|11917766|FG005|Received Optional Second Dose|Overall Study||10
10754109|NCT03049488|11917761|FG000|COMPLETED|Overall Study||13
10754110|NCT03049488|11917762|FG001|COMPLETED|Overall Study||13
10754111|NCT03049488|11917763|FG002|COMPLETED|Overall Study||20
10754112|NCT03049488|11917764|FG003|COMPLETED|Overall Study||13
10754113|NCT03049488|11917765|FG004|COMPLETED|Overall Study||13
10754114|NCT03049488|11917766|FG005|COMPLETED|Overall Study||15
10754115|NCT03049488|11917761|FG000|NOT COMPLETED|Overall Study||2
10754116|NCT03049488|11917762|FG001|NOT COMPLETED|Overall Study||2
10754117|NCT03049488|11917763|FG002|NOT COMPLETED|Overall Study||0
10754118|NCT03049488|11917764|FG003|NOT COMPLETED|Overall Study||2
10754119|NCT03049488|11917765|FG004|NOT COMPLETED|Overall Study||2
10754120|NCT03049488|11917766|FG005|NOT COMPLETED|Overall Study||0
10754121|NCT03049501|11917783|FG000|STARTED|Overall Study||123
10754122|NCT03049501|11917784|FG001|STARTED|Overall Study||121
10754123|NCT03049501|11917783|FG000|6 Month Follow up|Overall Study||107
10821527|NCT00322855|11986646|FG000|NOT COMPLETED|Overall Study||0
10821528|NCT00323635|11986652|FG000|STARTED|Overall Study||10
10821529|NCT00323635|11986653|FG001|STARTED|Overall Study||9
10821530|NCT00323635|11986652|FG000|COMPLETED|Overall Study||10
10821531|NCT00323635|11986653|FG001|COMPLETED|Overall Study||9
10821532|NCT00323635|11986652|FG000|NOT COMPLETED|Overall Study||0
10821533|NCT00323635|11986653|FG001|NOT COMPLETED|Overall Study||0
10821534|NCT00329732|11986663|FG000|STARTED|Overall Study||2
10821535|NCT00329732|11986664|FG001|STARTED|Overall Study||0
10821536|NCT00329732|11986663|FG000|COMPLETED|Overall Study||2
10821537|NCT00329732|11986664|FG001|COMPLETED|Overall Study||0
10821538|NCT00329732|11986663|FG000|NOT COMPLETED|Overall Study||0
10821539|NCT00329732|11986664|FG001|NOT COMPLETED|Overall Study||0
10821540|NCT00320931|11986669|FG000|STARTED|Overall Study||30
10821541|NCT00320931|11986669|FG000|COMPLETED|Overall Study||30
10821542|NCT00320931|11986669|FG000|NOT COMPLETED|Overall Study||0
10821543|NCT00314353|11986675|FG000|STARTED|Protocol Therapy (8 Cycles)||4
10821544|NCT00314353|11986676|FG001|STARTED|Protocol Therapy (8 Cycles)||3
10821545|NCT00314353|11986675|FG000|COMPLETED|Protocol Therapy (8 Cycles)|COMPLETED refers to the participants completing 8 cycles of therapy.|2
10821546|NCT00314353|11986676|FG001|COMPLETED|Protocol Therapy (8 Cycles)|COMPLETED refers to the participants completing 8 cycles of therapy.|0
10821547|NCT00314353|11986675|FG000|NOT COMPLETED|Protocol Therapy (8 Cycles)||2
10821548|NCT00314353|11986676|FG001|NOT COMPLETED|Protocol Therapy (8 Cycles)||3
10821549|NCT00314353|11986675|FG000|STARTED|Follow-up|2 participants who completed 8 cycles plus 1 participant who did not complete 8 cycles therapy.|3
10821550|NCT00314353|11986676|FG001|STARTED|Follow-up||0
10821551|NCT00314353|11986675|FG000|COMPLETED|Follow-up||3
10821552|NCT00314353|11986676|FG001|COMPLETED|Follow-up||0
10821553|NCT00314353|11986675|FG000|NOT COMPLETED|Follow-up||0
10821554|NCT00314353|11986676|FG001|NOT COMPLETED|Follow-up||0
10821555|NCT00314093|11986682|FG000|STARTED|Overall Study||0
10821556|NCT00314093|11986682|FG000|COMPLETED|Overall Study||0
10821557|NCT00314093|11986682|FG000|NOT COMPLETED|Overall Study||0
10821558|NCT00314327|11986686|FG000|STARTED|Overall Study||1
10821559|NCT00314327|11986686|FG000|COMPLETED|Overall Study||0
10821560|NCT00314327|11986686|FG000|NOT COMPLETED|Overall Study||1
10821561|NCT00308113|11986694|FG000|STARTED|Overall Study||0
10821562|NCT00308113|11986695|FG001|STARTED|Overall Study||0
10821563|NCT00308113|11986696|FG002|STARTED|Overall Study||1
10821564|NCT00308113|11986697|FG003|STARTED|Overall Study||2
10754124|NCT03049501|11917784|FG001|6 Month Follow up|Overall Study||91
10754125|NCT03049501|11917783|FG000|12 Month Follow up|Overall Study||101
10821565|NCT00308113|11986694|FG000|COMPLETED|Overall Study||0
10821566|NCT00308113|11986695|FG001|COMPLETED|Overall Study||0
10821567|NCT00308113|11986696|FG002|COMPLETED|Overall Study||1
10821568|NCT00308113|11986697|FG003|COMPLETED|Overall Study||1
10821569|NCT00308113|11986694|FG000|NOT COMPLETED|Overall Study||0
10821570|NCT00308113|11986695|FG001|NOT COMPLETED|Overall Study||0
10821571|NCT00308113|11986696|FG002|NOT COMPLETED|Overall Study||0
10821572|NCT00308113|11986697|FG003|NOT COMPLETED|Overall Study||1
10821573|NCT00305643|11986709|FG000|STARTED|Overall Study||6
10821574|NCT00305643|11986710|FG001|STARTED|Overall Study||5
10821575|NCT00305643|11986709|FG000|COMPLETED|Overall Study||6
10821576|NCT00305643|11986710|FG001|COMPLETED|Overall Study||5
10821577|NCT00305643|11986709|FG000|NOT COMPLETED|Overall Study||0
10821578|NCT00305643|11986710|FG001|NOT COMPLETED|Overall Study||0
10821579|NCT00298740|11986717|FG000|STARTED|Overall Study||12
10821580|NCT00298740|11986717|FG000|COMPLETED|Overall Study||3
10821581|NCT00298740|11986717|FG000|NOT COMPLETED|Overall Study||9
10821582|NCT00301080|11986721|FG000|STARTED|Original Version (2 Arms & 4 Weeks)||4
10821583|NCT00301080|11986722|FG001|STARTED|Original Version (2 Arms & 4 Weeks)||3
10821584|NCT00301080|11986723|FG002|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
10821585|NCT00301080|11986724|FG003|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
10821586|NCT00301080|11986725|FG004|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
10821587|NCT00301080|11986721|FG000|Received an Intervention|Original Version (2 Arms & 4 Weeks)||3
10821588|NCT00301080|11986722|FG001|Received an Intervention|Original Version (2 Arms & 4 Weeks)||3
10821589|NCT00301080|11986723|FG002|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
10821590|NCT00301080|11986724|FG003|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
10821591|NCT00301080|11986725|FG004|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
10821592|NCT00301080|11986721|FG000|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||3
10821593|NCT00301080|11986722|FG001|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||3
10821594|NCT00301080|11986723|FG002|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
10821595|NCT00301080|11986724|FG003|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
10821596|NCT00301080|11986725|FG004|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
10821597|NCT00301080|11986721|FG000|COMPLETED|Original Version (2 Arms & 4 Weeks)||3
10821598|NCT00301080|11986722|FG001|COMPLETED|Original Version (2 Arms & 4 Weeks)||3
10821599|NCT00301080|11986723|FG002|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
10821600|NCT00301080|11986724|FG003|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
10821601|NCT00301080|11986725|FG004|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
10821602|NCT00301080|11986721|FG000|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||1
10821603|NCT00301080|11986722|FG001|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
10821604|NCT00301080|11986723|FG002|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
10821605|NCT00301080|11986724|FG003|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
10821606|NCT00301080|11986725|FG004|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
10821607|NCT00301080|11986721|FG000|STARTED|Revised Version (3 Arms & 12 Weeks)|This arm was not a part of the revised study design.|0
10821608|NCT00301080|11986722|FG001|STARTED|Revised Version (3 Arms & 12 Weeks)|This arm was not a part of the revised study design.|0
10821609|NCT00301080|11986723|FG002|STARTED|Revised Version (3 Arms & 12 Weeks)||0
10821610|NCT00301080|11986724|FG003|STARTED|Revised Version (3 Arms & 12 Weeks)||0
10821611|NCT00301080|11986725|FG004|STARTED|Revised Version (3 Arms & 12 Weeks)||0
10821612|NCT00301080|11986721|FG000|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
10821613|NCT00301080|11986722|FG001|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
10821614|NCT00301080|11986723|FG002|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
10821615|NCT00301080|11986724|FG003|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
10821616|NCT00301080|11986725|FG004|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
10821617|NCT00301080|11986721|FG000|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
10821618|NCT00301080|11986722|FG001|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
10821619|NCT00301080|11986723|FG002|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
10821620|NCT00301080|11986724|FG003|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
10821621|NCT00301080|11986725|FG004|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
10821622|NCT00299195|11986736|FG000|STARTED|Overall Study||30
10821623|NCT00299195|11986737|FG001|STARTED|Overall Study||33
10821624|NCT00299195|11986736|FG000|COMPLETED|Overall Study||30
10821625|NCT00299195|11986737|FG001|COMPLETED|Overall Study||33
10821626|NCT00299195|11986736|FG000|NOT COMPLETED|Overall Study||0
10821627|NCT00299195|11986737|FG001|NOT COMPLETED|Overall Study||0
10821628|NCT00290407|11986743|FG000|STARTED|Overall Study||2
10821629|NCT00290407|11986743|FG000|COMPLETED|Overall Study||0
10821630|NCT00290407|11986743|FG000|NOT COMPLETED|Overall Study||2
10821631|NCT00295490|11986751|FG000|STARTED|Overall Study||15
10821632|NCT00295490|11986752|FG001|STARTED|Overall Study||19
10821633|NCT00295490|11986753|FG002|STARTED|Overall Study||16
10821634|NCT00295490|11986754|FG003|STARTED|Overall Study||17
10821635|NCT00295490|11986751|FG000|COMPLETED|Overall Study||14
10821636|NCT00295490|11986752|FG001|COMPLETED|Overall Study||15
10821637|NCT00295490|11986753|FG002|COMPLETED|Overall Study||12
10821638|NCT00295490|11986754|FG003|COMPLETED|Overall Study||12
10821639|NCT00295490|11986751|FG000|NOT COMPLETED|Overall Study||1
10821640|NCT00295490|11986752|FG001|NOT COMPLETED|Overall Study||4
10821641|NCT00295490|11986753|FG002|NOT COMPLETED|Overall Study||4
10821642|NCT00295490|11986754|FG003|NOT COMPLETED|Overall Study||5
10821643|NCT00268463|11986766|FG000|STARTED|Overall Study||10
10821644|NCT00268463|11986767|FG001|STARTED|Overall Study||12
10821645|NCT00268463|11986766|FG000|COMPLETED|Overall Study||0
10821646|NCT00268463|11986767|FG001|COMPLETED|Overall Study||0
10821647|NCT00268463|11986766|FG000|NOT COMPLETED|Overall Study||10
10821648|NCT00268463|11986767|FG001|NOT COMPLETED|Overall Study||12
10821649|NCT00271102|11986775|FG000|STARTED|Overall Study||35
10821650|NCT00271102|11986776|FG001|STARTED|Overall Study||35
10821651|NCT00271102|11986775|FG000|COMPLETED|Overall Study||30
10821652|NCT00271102|11986776|FG001|COMPLETED|Overall Study||30
10821653|NCT00271102|11986775|FG000|NOT COMPLETED|Overall Study||5
10821654|NCT00271102|11986776|FG001|NOT COMPLETED|Overall Study||5
10821655|NCT00276419|11986784|FG000|STARTED|First Intervention||8
10821656|NCT00276419|11986785|FG001|STARTED|First Intervention||10
10821657|NCT00276419|11986784|FG000|COMPLETED|First Intervention||7
10821658|NCT00276419|11986785|FG001|COMPLETED|First Intervention||8
10821659|NCT00276419|11986784|FG000|NOT COMPLETED|First Intervention||1
10821660|NCT00276419|11986785|FG001|NOT COMPLETED|First Intervention||2
10821661|NCT00276419|11986784|FG000|STARTED|Wash-out Phase||7
10821662|NCT00276419|11986785|FG001|STARTED|Wash-out Phase||8
10821663|NCT00276419|11986784|FG000|COMPLETED|Wash-out Phase||7
10821664|NCT00276419|11986785|FG001|COMPLETED|Wash-out Phase||8
10821665|NCT00276419|11986784|FG000|NOT COMPLETED|Wash-out Phase||0
10821666|NCT00276419|11986785|FG001|NOT COMPLETED|Wash-out Phase||0
10821667|NCT00276419|11986784|FG000|STARTED|Second Intervention||7
10821668|NCT00276419|11986785|FG001|STARTED|Second Intervention||8
10821669|NCT00276419|11986784|FG000|COMPLETED|Second Intervention||7
10821670|NCT00276419|11986785|FG001|COMPLETED|Second Intervention||8
10821671|NCT00276419|11986784|FG000|NOT COMPLETED|Second Intervention||0
10821672|NCT00276419|11986785|FG001|NOT COMPLETED|Second Intervention||0
10821673|NCT00279409|11986793|FG000|STARTED|Overall Study||0
10821674|NCT00279409|11986794|FG001|STARTED|Overall Study||0
10821675|NCT00279409|11986793|FG000|COMPLETED|Overall Study||0
10821676|NCT00279409|11986794|FG001|COMPLETED|Overall Study||0
10821677|NCT00279409|11986793|FG000|NOT COMPLETED|Overall Study||0
10821678|NCT00279409|11986794|FG001|NOT COMPLETED|Overall Study||0
10821679|NCT00281879|11986808|FG000|STARTED|Overall Study||128
10821680|NCT00281879|11986809|FG001|STARTED|Overall Study||36
10821681|NCT00281879|11986810|FG002|STARTED|Overall Study||20
10821682|NCT00281879|11986811|FG003|STARTED|Overall Study||0
10821683|NCT00281879|11986812|FG004|STARTED|Overall Study||6
10821684|NCT00281879|11986813|FG005|STARTED|Overall Study||9
10821685|NCT00281879|11986814|FG006|STARTED|Overall Study||0
10821686|NCT00281879|11986815|FG007|STARTED|Overall Study||1
10821687|NCT00281879|11986808|FG000|COMPLETED|Overall Study||0
10821688|NCT00281879|11986809|FG001|COMPLETED|Overall Study||0
10821689|NCT00281879|11986810|FG002|COMPLETED|Overall Study||0
10821690|NCT00281879|11986811|FG003|COMPLETED|Overall Study||0
10821691|NCT00281879|11986812|FG004|COMPLETED|Overall Study||0
10821692|NCT00281879|11986813|FG005|COMPLETED|Overall Study||0
10821693|NCT00281879|11986814|FG006|COMPLETED|Overall Study||0
10821694|NCT00281879|11986815|FG007|COMPLETED|Overall Study||0
10821695|NCT00281879|11986808|FG000|NOT COMPLETED|Overall Study||128
10821696|NCT00281879|11986809|FG001|NOT COMPLETED|Overall Study||36
10821697|NCT00281879|11986810|FG002|NOT COMPLETED|Overall Study||20
10821698|NCT00281879|11986811|FG003|NOT COMPLETED|Overall Study||0
10821699|NCT00281879|11986812|FG004|NOT COMPLETED|Overall Study||6
10821700|NCT00281879|11986813|FG005|NOT COMPLETED|Overall Study||9
10821701|NCT00281879|11986814|FG006|NOT COMPLETED|Overall Study||0
10821702|NCT00281879|11986815|FG007|NOT COMPLETED|Overall Study||1
10821703|NCT00271947|11986833|FG000|STARTED|Overall Study||1
10821704|NCT00271947|11986833|FG000|COMPLETED|Overall Study||0
10821705|NCT00271947|11986833|FG000|NOT COMPLETED|Overall Study||1
10821706|NCT00271011|11986837|FG000|STARTED|Overall Study||13
10821707|NCT00271011|11986837|FG000|COMPLETED|Overall Study||13
10821708|NCT00271011|11986837|FG000|NOT COMPLETED|Overall Study||0
10821709|NCT00253981|11986843|FG000|STARTED|Overall Study||16
10821710|NCT00253981|11986844|FG001|STARTED|Overall Study||14
10821711|NCT00253981|11986843|FG000|COMPLETED|Overall Study||16
10821712|NCT00253981|11986844|FG001|COMPLETED|Overall Study||14
10821713|NCT00253981|11986843|FG000|NOT COMPLETED|Overall Study||0
10821714|NCT00253981|11986844|FG001|NOT COMPLETED|Overall Study||0
10821715|NCT00252174|11986853|FG000|STARTED|Overall Study|No subjects were randomized into Active Arm as only 2 subjects were randomized into the Control Arm.|0
10821801|NCT00205049|11986976|FG001|STARTED|Overall Study||0
10821716|NCT00252174|11986854|FG001|STARTED|Overall Study|2 subjects entered the control arm in total|2
10821717|NCT00252174|11986855|FG002|STARTED|Overall Study|No subjects entered Stage 2|0
10821718|NCT00252174|11986853|FG000|COMPLETED|Overall Study||0
10821719|NCT00252174|11986854|FG001|COMPLETED|Overall Study||1
10290254|NCT04737278|11422938|FG001|NOT COMPLETED|Overall Study||3
10312985|NCT00147251|11446519|FG001|STARTED|Follow up||252
10821720|NCT00252174|11986855|FG002|COMPLETED|Overall Study||0
10821721|NCT00252174|11986853|FG000|NOT COMPLETED|Overall Study||0
10821722|NCT00252174|11986854|FG001|NOT COMPLETED|Overall Study||1
10821723|NCT00252174|11986855|FG002|NOT COMPLETED|Overall Study||0
10821724|NCT00256295|11986863|FG000|STARTED|Overall Study|Of the 8 subjects consented, 1 withdrew prior to treatment.|7
10821725|NCT00256295|11986863|FG000|COMPLETED|Overall Study||3
10821726|NCT00256295|11986863|FG000|NOT COMPLETED|Overall Study||4
10821727|NCT00245128|11986867|FG000|STARTED|Overall Study||10
10821728|NCT00245128|11986867|FG000|COMPLETED|Overall Study||0
10312986|NCT00147251|11446518|FG000|COMPLETED|Follow up||247
10821729|NCT00245128|11986867|FG000|NOT COMPLETED|Overall Study||10
10821730|NCT00268450|11986871|FG000|STARTED|Overall Study||21
10821731|NCT00268450|11986871|FG000|COMPLETED|Overall Study||21
10821732|NCT00268450|11986871|FG000|NOT COMPLETED|Overall Study||0
10821733|NCT00239720|11986877|FG000|STARTED|Overall Study||3
10821734|NCT00239720|11986878|FG001|STARTED|Overall Study||1
10821735|NCT00239720|11986877|FG000|COMPLETED|Overall Study|One participant discontinued due to an adverse event|2
10821736|NCT00239720|11986878|FG001|COMPLETED|Overall Study|One participant lost to follow-up|0
10821737|NCT00239720|11986877|FG000|NOT COMPLETED|Overall Study||1
10821738|NCT00239720|11986878|FG001|NOT COMPLETED|Overall Study||1
10821739|NCT00250718|11986884|FG000|STARTED|Overall Study||17
10821740|NCT00250718|11986884|FG000|Received Treatment|Overall Study||16
10821741|NCT00250718|11986884|FG000|COMPLETED|Overall Study||14
10821742|NCT00250718|11986884|FG000|NOT COMPLETED|Overall Study||3
10821743|NCT00244010|11986890|FG000|STARTED|Overall Study||2
10821744|NCT00244010|11986891|FG001|STARTED|Overall Study||2
10821745|NCT00244010|11986890|FG000|COMPLETED|Overall Study||2
10821746|NCT00244010|11986891|FG001|COMPLETED|Overall Study||2
10821747|NCT00244010|11986890|FG000|NOT COMPLETED|Overall Study||0
10821748|NCT00244010|11986891|FG001|NOT COMPLETED|Overall Study||0
10821749|NCT00218036|11986902|FG000|STARTED|Overall Study||11
10821750|NCT00218036|11986903|FG001|STARTED|Overall Study||6
10821751|NCT00218036|11986904|FG002|STARTED|Overall Study||13
10821752|NCT00218036|11986905|FG003|STARTED|Overall Study||12
10821753|NCT00218036|11986906|FG004|STARTED|Overall Study||9
10821754|NCT00218036|11986902|FG000|COMPLETED|Overall Study||6
10821755|NCT00218036|11986903|FG001|COMPLETED|Overall Study||3
10821756|NCT00218036|11986904|FG002|COMPLETED|Overall Study||5
10821757|NCT00218036|11986905|FG003|COMPLETED|Overall Study||6
10821758|NCT00218036|11986906|FG004|COMPLETED|Overall Study||3
10821759|NCT00218036|11986902|FG000|NOT COMPLETED|Overall Study||5
10821760|NCT00218036|11986903|FG001|NOT COMPLETED|Overall Study||3
10821761|NCT00218036|11986904|FG002|NOT COMPLETED|Overall Study||8
10821762|NCT00218036|11986905|FG003|NOT COMPLETED|Overall Study||6
10821763|NCT00218036|11986906|FG004|NOT COMPLETED|Overall Study||6
10821764|NCT00240227|11986918|FG000|STARTED|Overall Study||8
10821765|NCT00240227|11986918|FG000|COMPLETED|Overall Study||8
10821766|NCT00240227|11986918|FG000|NOT COMPLETED|Overall Study||0
10821767|NCT00205868|11986925|FG000|STARTED|Overall Study||304
10821768|NCT00205868|11986925|FG000|COMPLETED|Overall Study||304
10821769|NCT00205868|11986925|FG000|NOT COMPLETED|Overall Study||0
10821770|NCT00206375|11986932|FG000|STARTED|Overall Study||6
10821771|NCT00206375|11986933|FG001|STARTED|Overall Study||3
10821772|NCT00206375|11986934|FG002|STARTED|Overall Study||7
10821773|NCT00206375|11986932|FG000|COMPLETED|Overall Study||3
10821774|NCT00206375|11986933|FG001|COMPLETED|Overall Study||1
10821775|NCT00206375|11986934|FG002|COMPLETED|Overall Study||3
10821776|NCT00206375|11986932|FG000|NOT COMPLETED|Overall Study||3
10821777|NCT00206375|11986933|FG001|NOT COMPLETED|Overall Study||2
10821778|NCT00206375|11986934|FG002|NOT COMPLETED|Overall Study||4
10821779|NCT00229931|11986944|FG000|STARTED|Overall Study||6
10821780|NCT00229931|11986945|FG001|STARTED|Overall Study||5
10821781|NCT00229931|11986944|FG000|COMPLETED|Overall Study||2
10821782|NCT00229931|11986945|FG001|COMPLETED|Overall Study||3
10821783|NCT00229931|11986944|FG000|NOT COMPLETED|Overall Study||4
10821784|NCT00229931|11986945|FG001|NOT COMPLETED|Overall Study||2
10821785|NCT00209131|11986953|FG000|STARTED|Overall Study|Patients enrolled for participation but did not complete the study.|15
10821786|NCT00209131|11986954|FG001|STARTED|Overall Study|Patients enrolled for participation but did not complete the study.|11
10821787|NCT00209131|11986953|FG000|COMPLETED|Overall Study|Lack of personnel for adequate followup and data collection.|0
10821788|NCT00209131|11986954|FG001|COMPLETED|Overall Study|Lack of personnel for adequate followup and data collection.|0
10821789|NCT00209131|11986953|FG000|NOT COMPLETED|Overall Study||15
10821790|NCT00209131|11986954|FG001|NOT COMPLETED|Overall Study||11
10821791|NCT00233090|11986962|FG000|STARTED|Overall Study||12
10821792|NCT00233090|11986963|FG001|STARTED|Overall Study||9
10821793|NCT00233090|11986962|FG000|COMPLETED|Overall Study||12
10821794|NCT00233090|11986963|FG001|COMPLETED|Overall Study||9
10821795|NCT00233090|11986962|FG000|NOT COMPLETED|Overall Study||0
10821796|NCT00233090|11986963|FG001|NOT COMPLETED|Overall Study||0
10821797|NCT00214149|11986969|FG000|STARTED|Overall Study||127
10821798|NCT00214149|11986969|FG000|COMPLETED|Overall Study|No data are available; study was terminated and PI has left the institution.|0
10821799|NCT00214149|11986969|FG000|NOT COMPLETED|Overall Study||127
10821800|NCT00205049|11986975|FG000|STARTED|Overall Study||0
10821802|NCT00205049|11986975|FG000|COMPLETED|Overall Study||0
10821803|NCT00205049|11986976|FG001|COMPLETED|Overall Study||0
10821804|NCT00205049|11986975|FG000|NOT COMPLETED|Overall Study||0
10821805|NCT00205049|11986976|FG001|NOT COMPLETED|Overall Study||0
10821806|NCT00209027|11986984|FG000|STARTED|Overall Study||10
10821807|NCT00209027|11986985|FG001|STARTED|Overall Study||10
10821808|NCT00209027|11986984|FG000|COMPLETED|Overall Study||0
10821809|NCT00209027|11986985|FG001|COMPLETED|Overall Study||10
10821810|NCT00209027|11986984|FG000|NOT COMPLETED|Overall Study||10
10821811|NCT00209027|11986985|FG001|NOT COMPLETED|Overall Study||0
10821812|NCT00182637|11986991|FG000|STARTED|Overall Study|active/on treatment date|5
10821813|NCT00182637|11986991|FG000|COMPLETED|Overall Study|off study date|2
10821814|NCT00182637|11986991|FG000|NOT COMPLETED|Overall Study||3
10821815|NCT00176488|11986996|FG000|STARTED|Overall Study||31
10821816|NCT00176488|11986996|FG000|COMPLETED|Overall Study||30
10821817|NCT00176488|11986996|FG000|NOT COMPLETED|Overall Study||1
10821818|NCT00179127|11987002|FG000|STARTED|Overall Study||0
10821819|NCT00179127|11987003|FG001|STARTED|Overall Study||0
10821820|NCT00179127|11987002|FG000|COMPLETED|Overall Study||0
10821821|NCT00179127|11987003|FG001|COMPLETED|Overall Study||0
10821822|NCT00179127|11987002|FG000|NOT COMPLETED|Overall Study||0
10821823|NCT00179127|11987003|FG001|NOT COMPLETED|Overall Study||0
10821824|NCT00183963|11987013|FG000|STARTED|Overall Study||1
10290255|NCT04736069|11422946|FG000|STARTED|Overall Study||30
10290256|NCT04736069|11422947|FG001|STARTED|Overall Study||30
10290257|NCT04736069|11422946|FG000|COMPLETED|Overall Study||30
10290258|NCT04736069|11422947|FG001|COMPLETED|Overall Study||22
10290259|NCT04736069|11422946|FG000|NOT COMPLETED|Overall Study||0
10290260|NCT04736069|11422947|FG001|NOT COMPLETED|Overall Study||8
10312987|NCT00147251|11446519|FG001|COMPLETED|Follow up||252
10312988|NCT00147251|11446518|FG000|NOT COMPLETED|Follow up||0
10312989|NCT00147251|11446519|FG001|NOT COMPLETED|Follow up||0
10312990|NCT00147316|11446527|FG000|STARTED|Overall Study||103
10312991|NCT00147316|11446527|FG000|COMPLETED|Overall Study||103
10312992|NCT00147316|11446527|FG000|NOT COMPLETED|Overall Study||0
10312993|NCT00147446|11446533|FG000|STARTED|Overall Study||60
10312994|NCT00147446|11446534|FG001|STARTED|Overall Study||61
10312995|NCT00147446|11446533|FG000|COMPLETED|Overall Study||60
10312996|NCT00147446|11446534|FG001|COMPLETED|Overall Study||61
10312997|NCT00147446|11446533|FG000|NOT COMPLETED|Overall Study||0
10312998|NCT00147446|11446534|FG001|NOT COMPLETED|Overall Study||0
10312999|NCT00147498|11446546|FG000|STARTED|Overall Study||61
10313000|NCT00147498|11446547|FG001|STARTED|Overall Study||69
10313001|NCT00147498|11446548|FG002|STARTED|Overall Study||69
10313002|NCT00147498|11446549|FG003|STARTED|Overall Study||65
10313003|NCT00147498|11446546|FG000|COMPLETED|Overall Study||58
10313004|NCT00147498|11446547|FG001|COMPLETED|Overall Study||60
10313005|NCT00147498|11446548|FG002|COMPLETED|Overall Study||52
10313006|NCT00147498|11446549|FG003|COMPLETED|Overall Study||48
10313007|NCT00147498|11446546|FG000|NOT COMPLETED|Overall Study||3
10313008|NCT00147498|11446547|FG001|NOT COMPLETED|Overall Study||9
10313009|NCT00147498|11446548|FG002|NOT COMPLETED|Overall Study||17
10313010|NCT00147498|11446549|FG003|NOT COMPLETED|Overall Study||17
10313011|NCT00147537|11446563|FG000|STARTED|Phase 1b||3
10313012|NCT00147537|11446564|FG001|STARTED|Phase 1b||2
10313013|NCT00147537|11446565|FG002|STARTED|Phase 1b||4
10313014|NCT00147537|11446566|FG003|STARTED|Phase 1b||3
10313015|NCT00147537|11446567|FG004|STARTED|Phase 1b||3
10313016|NCT00147537|11446568|FG005|STARTED|Phase 1b||3
10313017|NCT00147537|11446569|FG006|STARTED|Phase 1b|18 participants randomized; 17 participants treated|18
10313018|NCT00147537|11446570|FG007|STARTED|Phase 1b||7
10313019|NCT00147537|11446571|FG008|STARTED|Phase 1b|18 participants randomized; 17 participants treated|18
10313020|NCT00147537|11446572|FG009|STARTED|Phase 1b||0
10313021|NCT00147537|11446573|FG010|STARTED|Phase 1b||0
10313022|NCT00147537|11446563|FG000|COMPLETED|Phase 1b||1
10313023|NCT00147537|11446564|FG001|COMPLETED|Phase 1b||0
10313024|NCT00147537|11446565|FG002|COMPLETED|Phase 1b||0
10313025|NCT00147537|11446566|FG003|COMPLETED|Phase 1b||1
10313026|NCT00147537|11446567|FG004|COMPLETED|Phase 1b||0
10313027|NCT00147537|11446568|FG005|COMPLETED|Phase 1b||0
10313028|NCT00147537|11446569|FG006|COMPLETED|Phase 1b||0
10313029|NCT00147537|11446570|FG007|COMPLETED|Phase 1b||0
10313030|NCT00147537|11446571|FG008|COMPLETED|Phase 1b||1
10313031|NCT00147537|11446572|FG009|COMPLETED|Phase 1b||0
10313032|NCT00147537|11446573|FG010|COMPLETED|Phase 1b||0
10313033|NCT00147537|11446563|FG000|NOT COMPLETED|Phase 1b||2
10313034|NCT00147537|11446564|FG001|NOT COMPLETED|Phase 1b||2
10313035|NCT00147537|11446565|FG002|NOT COMPLETED|Phase 1b||4
10313036|NCT00147537|11446566|FG003|NOT COMPLETED|Phase 1b||2
10313037|NCT00147537|11446567|FG004|NOT COMPLETED|Phase 1b||3
10313038|NCT00147537|11446568|FG005|NOT COMPLETED|Phase 1b||3
10313039|NCT00147537|11446569|FG006|NOT COMPLETED|Phase 1b||18
10313040|NCT00147537|11446570|FG007|NOT COMPLETED|Phase 1b||7
10313041|NCT00147537|11446571|FG008|NOT COMPLETED|Phase 1b||17
10313042|NCT00147537|11446572|FG009|NOT COMPLETED|Phase 1b||0
10313043|NCT00147537|11446573|FG010|NOT COMPLETED|Phase 1b||0
10313044|NCT00147537|11446563|FG000|STARTED|Phase 2||0
10313045|NCT00147537|11446564|FG001|STARTED|Phase 2||0
10313046|NCT00147537|11446565|FG002|STARTED|Phase 2||0
10313047|NCT00147537|11446566|FG003|STARTED|Phase 2||0
10313048|NCT00147537|11446567|FG004|STARTED|Phase 2||0
10313049|NCT00147537|11446568|FG005|STARTED|Phase 2||0
10313050|NCT00147537|11446569|FG006|STARTED|Phase 2||0
10313051|NCT00147537|11446570|FG007|STARTED|Phase 2||0
10313052|NCT00147537|11446571|FG008|STARTED|Phase 2||0
10313053|NCT00147537|11446572|FG009|STARTED|Phase 2|166 particpants randomized; 163 participants treated|166
10313054|NCT00147537|11446573|FG010|STARTED|Phase 2|55 randomized; 56 treated-1 randomized but not treated, 2 randomized to F+P+C rec'd P+C|55
10313055|NCT00147537|11446563|FG000|COMPLETED|Phase 2||0
10313056|NCT00147537|11446564|FG001|COMPLETED|Phase 2||0
10313057|NCT00147537|11446565|FG002|COMPLETED|Phase 2||0
10313058|NCT00147537|11446566|FG003|COMPLETED|Phase 2||0
10313059|NCT00147537|11446567|FG004|COMPLETED|Phase 2||0
10821825|NCT00183963|11987014|FG001|STARTED|Overall Study||1
10313060|NCT00147537|11446568|FG005|COMPLETED|Phase 2||0
10313061|NCT00147537|11446569|FG006|COMPLETED|Phase 2||0
10313062|NCT00147537|11446570|FG007|COMPLETED|Phase 2||0
10313063|NCT00147537|11446571|FG008|COMPLETED|Phase 2||0
10313064|NCT00147537|11446572|FG009|COMPLETED|Phase 2||5
10313065|NCT00147537|11446573|FG010|COMPLETED|Phase 2||3
10313066|NCT00147537|11446563|FG000|NOT COMPLETED|Phase 2||0
10313067|NCT00147537|11446564|FG001|NOT COMPLETED|Phase 2||0
10313068|NCT00147537|11446565|FG002|NOT COMPLETED|Phase 2||0
10313069|NCT00147537|11446566|FG003|NOT COMPLETED|Phase 2||0
10313070|NCT00147537|11446567|FG004|NOT COMPLETED|Phase 2||0
10313071|NCT00147537|11446568|FG005|NOT COMPLETED|Phase 2||0
10313072|NCT00147537|11446569|FG006|NOT COMPLETED|Phase 2||0
10313073|NCT00147537|11446570|FG007|NOT COMPLETED|Phase 2||0
10313074|NCT00147537|11446571|FG008|NOT COMPLETED|Phase 2||0
10821826|NCT00183963|11987015|FG002|STARTED|Overall Study||1
10821827|NCT00183963|11987016|FG003|STARTED|Overall Study||1
10821828|NCT00183963|11987013|FG000|COMPLETED|Overall Study||0
10821829|NCT00183963|11987014|FG001|COMPLETED|Overall Study||0
10821830|NCT00183963|11987015|FG002|COMPLETED|Overall Study||0
10821831|NCT00183963|11987016|FG003|COMPLETED|Overall Study||0
10821832|NCT00183963|11987013|FG000|NOT COMPLETED|Overall Study||1
10821833|NCT00183963|11987014|FG001|NOT COMPLETED|Overall Study||1
10821834|NCT00183963|11987015|FG002|NOT COMPLETED|Overall Study||1
10821835|NCT00183963|11987016|FG003|NOT COMPLETED|Overall Study||1
10821836|NCT00178477|11987029|FG000|STARTED|Overall Study||10
10821837|NCT00178477|11987029|FG000|COMPLETED|Overall Study||5
10821838|NCT00178477|11987029|FG000|NOT COMPLETED|Overall Study||5
10821839|NCT00162773|11987033|FG000|STARTED|Overall Study||29
10821840|NCT00162773|11987033|FG000|COMPLETED|Overall Study||7
10821841|NCT00162773|11987033|FG000|NOT COMPLETED|Overall Study||22
10821842|NCT00176631|11987037|FG000|STARTED|Overall Study||10
10821843|NCT00176631|11987037|FG000|COMPLETED|Overall Study||10
10821844|NCT00176631|11987037|FG000|NOT COMPLETED|Overall Study||0
10821845|NCT00176501|11987041|FG000|STARTED|Overall Study||3
10821846|NCT00176501|11987041|FG000|COMPLETED|Overall Study||3
10821847|NCT00176501|11987041|FG000|NOT COMPLETED|Overall Study||0
10821848|NCT00177970|11987047|FG000|STARTED|Overall Study|No results available record destroyed due to age of study. no publications|0
10821849|NCT00177970|11987048|FG001|STARTED|Overall Study|No results available record destroyed due to age of study. no publications|0
10821850|NCT00177970|11987047|FG000|COMPLETED|Overall Study|No results available record destroyed due to age of study. no publications|0
10821851|NCT00177970|11987048|FG001|COMPLETED|Overall Study|No results available record destroyed due to age of study. no publications|0
10821852|NCT00177970|11987047|FG000|NOT COMPLETED|Overall Study||0
10821853|NCT00177970|11987048|FG001|NOT COMPLETED|Overall Study||0
10821854|NCT00177866|11987056|FG000|STARTED|Overall Study|No results or publication, data destroyed due to age of study.|0
10821855|NCT00177866|11987057|FG001|STARTED|Overall Study|No results or publication, data destroyed due to age of study.|0
10821856|NCT00177866|11987056|FG000|COMPLETED|Overall Study|No results or publication, data destroyed due to age of study.|0
10821857|NCT00177866|11987057|FG001|COMPLETED|Overall Study|No results or publication, data destroyed due to age of study.|0
10821858|NCT00177866|11987056|FG000|NOT COMPLETED|Overall Study||0
10821859|NCT00177866|11987057|FG001|NOT COMPLETED|Overall Study||0
10821860|NCT00147238|11987063|FG000|STARTED|Overall Study||10
10821861|NCT00147238|11987063|FG000|COMPLETED|Overall Study||2
10821862|NCT00147238|11987063|FG000|NOT COMPLETED|Overall Study||8
10821863|NCT00165503|11987067|FG000|STARTED|Overall Study||16
10821864|NCT00165503|11987067|FG000|COMPLETED|Overall Study||0
10821865|NCT00165503|11987067|FG000|NOT COMPLETED|Overall Study||16
10821866|NCT00160563|11987074|FG000|STARTED|Overall Study||59
10821867|NCT00160563|11987075|FG001|STARTED|Overall Study||47
10821868|NCT00160563|11987076|FG002|STARTED|Overall Study||101
10821869|NCT00160563|11987074|FG000|COMPLETED|Overall Study||8
10821870|NCT00160563|11987075|FG001|COMPLETED|Overall Study||2
10821871|NCT00160563|11987076|FG002|COMPLETED|Overall Study||11
10821872|NCT00160563|11987074|FG000|NOT COMPLETED|Overall Study||51
10821873|NCT00160563|11987075|FG001|NOT COMPLETED|Overall Study||45
10821874|NCT00160563|11987076|FG002|NOT COMPLETED|Overall Study||90
10821875|NCT00142519|11987087|FG000|STARTED|Overall Study||25
10821876|NCT00142519|11987088|FG001|STARTED|Overall Study||25
10821877|NCT00142519|11987087|FG000|COMPLETED|Overall Study||7
10821878|NCT00142519|11987088|FG001|COMPLETED|Overall Study||9
10821879|NCT00142519|11987087|FG000|NOT COMPLETED|Overall Study||18
10821880|NCT00142519|11987088|FG001|NOT COMPLETED|Overall Study||16
10821881|NCT00145704|11987096|FG000|STARTED|Overall Study||3
10821882|NCT00145704|11987097|FG001|STARTED|Overall Study||3
10821883|NCT00145704|11987096|FG000|COMPLETED|Overall Study||0
10821884|NCT00145704|11987097|FG001|COMPLETED|Overall Study||0
10821885|NCT00145704|11987096|FG000|NOT COMPLETED|Overall Study||3
10821886|NCT00145704|11987097|FG001|NOT COMPLETED|Overall Study||3
10821887|NCT00138073|11987103|FG000|STARTED|Overall Study||55
10821888|NCT00138073|11987103|FG000|Pre-intervention Testing|Overall Study||55
10821889|NCT00138073|11987103|FG000|COMPLETED|Overall Study||0
10821890|NCT00138073|11987103|FG000|NOT COMPLETED|Overall Study||55
10821891|NCT00113386|11987109|FG000|STARTED|Overall Study||10
10821892|NCT00113386|11987110|FG001|STARTED|Overall Study||9
10821893|NCT00113386|11987109|FG000|COMPLETED|Overall Study||3
10821894|NCT00113386|11987110|FG001|COMPLETED|Overall Study||5
10821895|NCT00113386|11987109|FG000|NOT COMPLETED|Overall Study||7
10821896|NCT00113386|11987110|FG001|NOT COMPLETED|Overall Study||4
10821897|NCT00138151|11987116|FG000|STARTED|Overall Study||33
10821898|NCT00138151|11987116|FG000|COMPLETED|Overall Study||29
10821899|NCT00138151|11987116|FG000|NOT COMPLETED|Overall Study||4
10821900|NCT00129974|11987120|FG000|STARTED|Overall Study||1
10821901|NCT00129974|11987120|FG000|COMPLETED|Overall Study||0
10290261|NCT04600375|11422961|FG000|STARTED|Overall Study||12
10821902|NCT00129974|11987120|FG000|NOT COMPLETED|Overall Study||1
10821903|NCT00126659|11987127|FG000|STARTED|Overall Study||3
10821904|NCT00126659|11987128|FG001|STARTED|Overall Study||3
10821905|NCT00126659|11987129|FG002|STARTED|Overall Study||4
10821906|NCT00126659|11987127|FG000|COMPLETED|Overall Study||3
10821907|NCT00126659|11987128|FG001|COMPLETED|Overall Study||3
10821908|NCT00126659|11987129|FG002|COMPLETED|Overall Study||2
10821909|NCT00126659|11987127|FG000|NOT COMPLETED|Overall Study||0
10821910|NCT00126659|11987128|FG001|NOT COMPLETED|Overall Study||0
10821911|NCT00126659|11987129|FG002|NOT COMPLETED|Overall Study||2
10821912|NCT00133679|11987137|FG000|STARTED|Overall Study||0
10821913|NCT00133679|11987138|FG001|STARTED|Overall Study||0
10821914|NCT00133679|11987137|FG000|COMPLETED|Overall Study||0
10821915|NCT00133679|11987138|FG001|COMPLETED|Overall Study||0
10821916|NCT00133679|11987137|FG000|NOT COMPLETED|Overall Study||0
10821917|NCT00133679|11987138|FG001|NOT COMPLETED|Overall Study||0
10821918|NCT00125268|11987146|FG000|STARTED|Overall Study||16
10821919|NCT00125268|11987147|FG001|STARTED|Overall Study||14
10821920|NCT00125268|11987146|FG000|COMPLETED|Overall Study||15
10821921|NCT00125268|11987147|FG001|COMPLETED|Overall Study||13
10821922|NCT00125268|11987146|FG000|NOT COMPLETED|Overall Study||1
10821923|NCT00125268|11987147|FG001|NOT COMPLETED|Overall Study||1
10821924|NCT00113399|11987155|FG000|STARTED|Overall Study||7
10821925|NCT00113399|11987156|FG001|STARTED|Overall Study||8
10821926|NCT00113399|11987155|FG000|COMPLETED|Overall Study||5
10821927|NCT00113399|11987156|FG001|COMPLETED|Overall Study||3
10821928|NCT00113399|11987155|FG000|NOT COMPLETED|Overall Study||2
10821929|NCT00113399|11987156|FG001|NOT COMPLETED|Overall Study||5
10821930|NCT00118053|11987162|FG000|STARTED|Overall Study||5
10821931|NCT00118053|11987162|FG000|COMPLETED|Overall Study||5
10821932|NCT00118053|11987162|FG000|NOT COMPLETED|Overall Study||0
10821933|NCT00107614|11987166|FG000|STARTED|Overall Study||12
10821934|NCT00107614|11987166|FG000|COMPLETED|Overall Study||0
10821935|NCT00107614|11987166|FG000|NOT COMPLETED|Overall Study||12
10821936|NCT00107315|11987170|FG000|STARTED|Overall Study||16
10821937|NCT00107315|11987170|FG000|COMPLETED|Overall Study||1
10821938|NCT00107315|11987170|FG000|NOT COMPLETED|Overall Study||15
10821939|NCT00108433|11987176|FG000|STARTED|Overall Study||30
10821940|NCT00108433|11987177|FG001|STARTED|Overall Study||31
10821941|NCT00108433|11987176|FG000|COMPLETED|Overall Study||9
10821942|NCT00108433|11987177|FG001|COMPLETED|Overall Study||14
10821943|NCT00108433|11987176|FG000|NOT COMPLETED|Overall Study||21
10821944|NCT00108433|11987177|FG001|NOT COMPLETED|Overall Study||17
10821945|NCT00113919|11987183|FG000|STARTED|Overall Study||14
10821946|NCT00113919|11987183|FG000|COMPLETED|Overall Study||0
10821947|NCT00113919|11987183|FG000|NOT COMPLETED|Overall Study||14
10821948|NCT00108342|11987189|FG000|STARTED|Overall Study||8
10821949|NCT00108342|11987190|FG001|STARTED|Overall Study||9
10821950|NCT00108342|11987189|FG000|COMPLETED|Overall Study||7
10821951|NCT00108342|11987190|FG001|COMPLETED|Overall Study||9
10821952|NCT00108342|11987189|FG000|NOT COMPLETED|Overall Study||1
10821953|NCT00108342|11987190|FG001|NOT COMPLETED|Overall Study||0
10821954|NCT00100828|11987196|FG000|STARTED|Overall Study||6
10821955|NCT00100828|11987196|FG000|COMPLETED|Overall Study||0
10821956|NCT00100828|11987196|FG000|NOT COMPLETED|Overall Study||6
10821957|NCT00104728|11987200|FG000|STARTED|Overall Study|42 consented on study|42
10821958|NCT00104728|11987200|FG000|COMPLETED|Overall Study||23
10821959|NCT00104728|11987200|FG000|NOT COMPLETED|Overall Study||19
10821960|NCT00089414|11987207|FG000|STARTED|Overall Study||2
10821961|NCT00089414|11987208|FG001|STARTED|Overall Study||1
10821962|NCT00089414|11987209|FG002|STARTED|Overall Study||2
10821963|NCT00089414|11987207|FG000|COMPLETED|Overall Study||2
10821964|NCT00089414|11987208|FG001|COMPLETED|Overall Study||1
10821965|NCT00089414|11987209|FG002|COMPLETED|Overall Study||2
10821966|NCT00089414|11987207|FG000|NOT COMPLETED|Overall Study||0
10821967|NCT00089414|11987208|FG001|NOT COMPLETED|Overall Study||0
10821968|NCT00089414|11987209|FG002|NOT COMPLETED|Overall Study||0
10821969|NCT00083915|11987219|FG000|STARTED|Overall Study||52
10821970|NCT00083915|11987220|FG001|STARTED|Overall Study||45
10821971|NCT00083915|11987219|FG000|COMPLETED|Overall Study||2
10821972|NCT00083915|11987220|FG001|COMPLETED|Overall Study||8
10821973|NCT00083915|11987219|FG000|NOT COMPLETED|Overall Study||50
10821974|NCT00083915|11987220|FG001|NOT COMPLETED|Overall Study||37
10821975|NCT00090870|11987226|FG000|STARTED|Overall Study||10
10821976|NCT00090870|11987226|FG000|COMPLETED|Overall Study||10
10821977|NCT00090870|11987226|FG000|NOT COMPLETED|Overall Study||0
10821978|NCT00088972|11987232|FG000|STARTED|Overall Study||3
10821979|NCT00088972|11987233|FG001|STARTED|Overall Study||5
10821980|NCT00088972|11987232|FG000|COMPLETED|Overall Study||1
10821981|NCT00088972|11987233|FG001|COMPLETED|Overall Study||1
10821982|NCT00088972|11987232|FG000|NOT COMPLETED|Overall Study||2
10821983|NCT00088972|11987233|FG001|NOT COMPLETED|Overall Study||4
10821984|NCT00088829|11987239|FG000|STARTED|Overall Study||22
10821985|NCT00088829|11987239|FG000|COMPLETED|Overall Study||0
10821986|NCT00088829|11987239|FG000|NOT COMPLETED|Overall Study||22
10821987|NCT00089128|11987243|FG000|STARTED|Overall Study||16
10821988|NCT00089128|11987243|FG000|COMPLETED|Overall Study||16
10821989|NCT00089128|11987243|FG000|NOT COMPLETED|Overall Study||0
10821990|NCT00075608|11987247|FG000|STARTED|Overall Study||12
10821991|NCT00075608|11987247|FG000|COMPLETED|Overall Study||12
10821992|NCT00075608|11987247|FG000|NOT COMPLETED|Overall Study||0
10821993|NCT00074724|11987255|FG000|STARTED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0
10821994|NCT00074724|11987256|FG001|STARTED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0
10821995|NCT00074724|11987255|FG000|COMPLETED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0
10821996|NCT00074724|11987256|FG001|COMPLETED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0
10821997|NCT00074724|11987255|FG000|NOT COMPLETED|Overall Study||0
10821998|NCT00074724|11987256|FG001|NOT COMPLETED|Overall Study||0
10821999|NCT00085631|11987262|FG000|STARTED|Overall Study||13
10822000|NCT00085631|11987263|FG001|STARTED|Overall Study||49
10822001|NCT00085631|11987264|FG002|STARTED|Overall Study||39
10822002|NCT00085631|11987262|FG000|COMPLETED|Overall Study||9
10822003|NCT00085631|11987263|FG001|COMPLETED|Overall Study||38
10822004|NCT00085631|11987264|FG002|COMPLETED|Overall Study||32
10822005|NCT00085631|11987262|FG000|NOT COMPLETED|Overall Study||4
10822006|NCT00085631|11987263|FG001|NOT COMPLETED|Overall Study||11
10822007|NCT00085631|11987264|FG002|NOT COMPLETED|Overall Study||7
10822008|NCT00062751|11987276|FG000|STARTED|Overall Study||33
10822009|NCT00062751|11987277|FG001|STARTED|Overall Study||30
10822010|NCT00062751|11987278|FG002|STARTED|Overall Study||33
10822011|NCT00062751|11987279|FG003|STARTED|Overall Study||6
10822012|NCT00062751|11987280|FG004|STARTED|Overall Study||6
10822013|NCT00062751|11987276|FG000|COMPLETED|Overall Study||0
10822014|NCT00062751|11987277|FG001|COMPLETED|Overall Study||0
10822015|NCT00062751|11987278|FG002|COMPLETED|Overall Study||3
10822016|NCT00062751|11987279|FG003|COMPLETED|Overall Study||1
10822017|NCT00062751|11987280|FG004|COMPLETED|Overall Study||0
10822018|NCT00062751|11987276|FG000|NOT COMPLETED|Overall Study||33
10822019|NCT00062751|11987277|FG001|NOT COMPLETED|Overall Study||30
10822020|NCT00062751|11987278|FG002|NOT COMPLETED|Overall Study||30
10822021|NCT00062751|11987279|FG003|NOT COMPLETED|Overall Study||5
10822022|NCT00062751|11987280|FG004|NOT COMPLETED|Overall Study||6
10822023|NCT00066807|11987295|FG000|STARTED|Overall Study||14
10822024|NCT00066807|11987296|FG001|STARTED|Overall Study||15
10822025|NCT00066807|11987295|FG000|COMPLETED|Overall Study||0
10822026|NCT00066807|11987296|FG001|COMPLETED|Overall Study||0
10822027|NCT00066807|11987295|FG000|NOT COMPLETED|Overall Study||14
10822028|NCT00066807|11987296|FG001|NOT COMPLETED|Overall Study||15
10822029|NCT00058188|11987304|FG000|STARTED|Overall Study||0
10822030|NCT00058188|11987305|FG001|STARTED|Overall Study||0
10822031|NCT00058188|11987304|FG000|COMPLETED|Overall Study||0
10822032|NCT00058188|11987305|FG001|COMPLETED|Overall Study||0
10822033|NCT00058188|11987304|FG000|NOT COMPLETED|Overall Study||0
10822034|NCT00058188|11987305|FG001|NOT COMPLETED|Overall Study||0
10290262|NCT04600375|11422962|FG001|STARTED|Overall Study||10
10290263|NCT04600375|11422961|FG000|COMPLETED|Overall Study||12
10290264|NCT04600375|11422962|FG001|COMPLETED|Overall Study||10
10290265|NCT04600375|11422961|FG000|NOT COMPLETED|Overall Study||0
10290266|NCT04600375|11422962|FG001|NOT COMPLETED|Overall Study||0
10822035|NCT00014560|11987311|FG000|STARTED|Overall Study||3
10822036|NCT00014560|11987311|FG000|COMPLETED|Overall Study||0
10822037|NCT00014560|11987311|FG000|NOT COMPLETED|Overall Study||3
10822038|NCT00038142|11987317|FG000|STARTED|Overall Study||32
10822039|NCT00038142|11987318|FG001|STARTED|Overall Study||14
10822040|NCT00038142|11987317|FG000|COMPLETED|Overall Study||10
10822041|NCT00038142|11987318|FG001|COMPLETED|Overall Study||7
10822042|NCT00038142|11987317|FG000|NOT COMPLETED|Overall Study||22
10822043|NCT00038142|11987318|FG001|NOT COMPLETED|Overall Study||7
10822044|NCT00020722|11987324|FG000|STARTED|Overall Study||7
10822045|NCT00020722|11987324|FG000|COMPLETED|Overall Study||7
10822046|NCT00020722|11987324|FG000|NOT COMPLETED|Overall Study||0
10822047|NCT00002975|11987329|FG000|STARTED|Overall Study||180
10822048|NCT00002975|11987329|FG000|Treated With Study Therapy|Overall Study||175
10822049|NCT00002975|11987329|FG000|COMPLETED|Overall Study||175
10822050|NCT00002975|11987329|FG000|NOT COMPLETED|Overall Study||5
10822051|NCT00006478|11987333|FG000|STARTED|Overall Study||19
10822052|NCT00006478|11987333|FG000|COMPLETED|Overall Study||12
10822053|NCT00006478|11987333|FG000|NOT COMPLETED|Overall Study||7
10822054|NCT00019747|11987339|FG000|STARTED|Overall Study||23
10822055|NCT00019747|11987340|FG001|STARTED|Overall Study||16
10822056|NCT00019747|11987339|FG000|COMPLETED|Overall Study||23
10822057|NCT00019747|11987340|FG001|COMPLETED|Overall Study||16
10822058|NCT00019747|11987339|FG000|NOT COMPLETED|Overall Study||0
10822059|NCT00019747|11987340|FG001|NOT COMPLETED|Overall Study||0
10822060|NCT00006916|11987346|FG000|STARTED|Overall Study||19
10822061|NCT00006916|11987346|FG000|COMPLETED|Overall Study|Subjects with survival data for the primary analysis are considered to have completed the study.|14
10822062|NCT00006916|11987346|FG000|NOT COMPLETED|Overall Study||5
10822063|NCT00003726|11987350|FG000|STARTED|Overall Study||1
10822064|NCT00003726|11987350|FG000|COMPLETED|Overall Study|Funding was pulled on the trial and therefore no other participants were enrolled|0
10822065|NCT00003726|11987350|FG000|NOT COMPLETED|Overall Study||1
10822066|NCT04051996|11987356|FG000|STARTED|Overall Study||1
10822067|NCT04051996|11987357|FG001|STARTED|Overall Study||0
10822068|NCT04051996|11987356|FG000|COMPLETED|Overall Study||1
10822069|NCT04051996|11987357|FG001|COMPLETED|Overall Study||0
10822070|NCT04051996|11987356|FG000|NOT COMPLETED|Overall Study||0
10822071|NCT04051996|11987357|FG001|NOT COMPLETED|Overall Study||0
10822072|NCT02970799|11987365|FG000|STARTED|Overall Study||0
10822073|NCT02970799|11987366|FG001|STARTED|Overall Study||0
10822074|NCT02970799|11987365|FG000|COMPLETED|Overall Study||0
10822075|NCT02970799|11987366|FG001|COMPLETED|Overall Study||0
10822076|NCT02970799|11987365|FG000|NOT COMPLETED|Overall Study||0
10822077|NCT02970799|11987366|FG001|NOT COMPLETED|Overall Study||0
10822078|NCT02385292|11987374|FG000|STARTED|Overall Study||0
10822079|NCT02385292|11987375|FG001|STARTED|Overall Study||0
10822080|NCT02385292|11987374|FG000|COMPLETED|Overall Study||0
10822081|NCT02385292|11987375|FG001|COMPLETED|Overall Study||0
10822082|NCT02385292|11987374|FG000|NOT COMPLETED|Overall Study||0
10822083|NCT02385292|11987375|FG001|NOT COMPLETED|Overall Study||0
10822084|NCT02126878|11987384|FG000|STARTED|Overall Study||0
10822085|NCT02126878|11987385|FG001|STARTED|Overall Study||0
10822086|NCT02126878|11987386|FG002|STARTED|Overall Study||0
10822087|NCT02126878|11987384|FG000|COMPLETED|Overall Study||0
10822088|NCT02126878|11987385|FG001|COMPLETED|Overall Study||0
10822089|NCT02126878|11987386|FG002|COMPLETED|Overall Study||0
10822090|NCT02126878|11987384|FG000|NOT COMPLETED|Overall Study||0
10822091|NCT02126878|11987385|FG001|NOT COMPLETED|Overall Study||0
10822092|NCT02126878|11987386|FG002|NOT COMPLETED|Overall Study||0
10822093|NCT02221817|11987396|FG000|STARTED|Overall Study||0
10822094|NCT02221817|11987397|FG001|STARTED|Overall Study||0
10822095|NCT02221817|11987396|FG000|COMPLETED|Overall Study||0
10822096|NCT02221817|11987397|FG001|COMPLETED|Overall Study||0
10822097|NCT02221817|11987396|FG000|NOT COMPLETED|Overall Study||0
10822098|NCT02221817|11987397|FG001|NOT COMPLETED|Overall Study||0
10822099|NCT02595996|11987403|FG000|STARTED|Overall Study||1
10822100|NCT02595996|11987403|FG000|COMPLETED|Overall Study||1
10822101|NCT02595996|11987403|FG000|NOT COMPLETED|Overall Study||0
10822102|NCT03879044|11987407|FG000|STARTED|Overall Study||30
10822103|NCT03879044|11987407|FG000|COMPLETED|Overall Study||26
10822104|NCT03879044|11987407|FG000|NOT COMPLETED|Overall Study||4
10822105|NCT03198156|11987413|FG000|STARTED|Overall Study||19
10822106|NCT03198156|11987414|FG001|STARTED|Overall Study||19
10822107|NCT03198156|11987413|FG000|COMPLETED|Overall Study||19
10822108|NCT03198156|11987414|FG001|COMPLETED|Overall Study||19
10822109|NCT03198156|11987413|FG000|NOT COMPLETED|Overall Study||0
10822110|NCT03198156|11987414|FG001|NOT COMPLETED|Overall Study||0
10822111|NCT02009384|11987420|FG000|STARTED|Overall Study|Study was Terminated due to low subject enrollment Data was not analyzed|2
10822112|NCT02009384|11987420|FG000|COMPLETED|Overall Study|Study was Terminated due to low subject enrollment Data was not analyzed|0
10822113|NCT02009384|11987420|FG000|NOT COMPLETED|Overall Study||2
10822114|NCT04558125|11987424|FG000|STARTED|Overall Study||2
10822115|NCT04558125|11987424|FG000|COMPLETED|Overall Study||1
10822116|NCT04558125|11987424|FG000|NOT COMPLETED|Overall Study||1
10822117|NCT02401308|11987430|FG000|STARTED|Overall Study||0
10822118|NCT02401308|11987431|FG001|STARTED|Overall Study||1
10822119|NCT02401308|11987430|FG000|COMPLETED|Overall Study||0
10822120|NCT02401308|11987431|FG001|COMPLETED|Overall Study||0
10822121|NCT02401308|11987430|FG000|NOT COMPLETED|Overall Study||0
10822122|NCT02401308|11987431|FG001|NOT COMPLETED|Overall Study||1
10822123|NCT04381988|11987439|FG000|STARTED|Overall Study||4
10822124|NCT04381988|11987440|FG001|STARTED|Overall Study||0
10822125|NCT04381988|11987439|FG000|COMPLETED|Overall Study||0
10822126|NCT04381988|11987440|FG001|COMPLETED|Overall Study||0
10822127|NCT04381988|11987439|FG000|NOT COMPLETED|Overall Study||4
10822128|NCT04381988|11987440|FG001|NOT COMPLETED|Overall Study||0
10822129|NCT00521885|11987448|FG000|STARTED|Overall Study||0
10822130|NCT00521885|11987449|FG001|STARTED|Overall Study||0
10822131|NCT00521885|11987448|FG000|COMPLETED|Overall Study||0
10822132|NCT00521885|11987449|FG001|COMPLETED|Overall Study||0
10822133|NCT00521885|11987448|FG000|NOT COMPLETED|Overall Study||0
10822134|NCT00521885|11987449|FG001|NOT COMPLETED|Overall Study||0
10822135|NCT02376946|11987457|FG000|STARTED|Overall Study|study terminated prior to being conducted|0
10822136|NCT02376946|11987458|FG001|STARTED|Overall Study|study terminated prior to being conducted|0
10822137|NCT02376946|11987457|FG000|COMPLETED|Overall Study|study terminated prior to being conducted|0
10822138|NCT02376946|11987458|FG001|COMPLETED|Overall Study|study terminated prior to being conducted|0
10822139|NCT02376946|11987457|FG000|NOT COMPLETED|Overall Study||0
10822140|NCT02376946|11987458|FG001|NOT COMPLETED|Overall Study||0
10822141|NCT01780636|11987464|FG000|STARTED|Overall Study||7
10822142|NCT01780636|11987464|FG000|COMPLETED|Overall Study||7
10822143|NCT01780636|11987464|FG000|NOT COMPLETED|Overall Study||0
10822144|NCT00479167|11987468|FG000|STARTED|Overall Study||1
10822145|NCT00479167|11987468|FG000|COMPLETED|Overall Study||0
10822146|NCT00479167|11987468|FG000|NOT COMPLETED|Overall Study||1
10822147|NCT03998189|11987475|FG000|STARTED|Overall Study||0
10822148|NCT03998189|11987476|FG001|STARTED|Overall Study||1
10822149|NCT03998189|11987475|FG000|COMPLETED|Overall Study||0
10822150|NCT03998189|11987476|FG001|COMPLETED|Overall Study|Samples were collected but were not analyzed as the analysis would have been done once a proper batch of samples were collected. This did not occur as the study was found to no longer be feasible and was terminated.|0
10822151|NCT03998189|11987475|FG000|NOT COMPLETED|Overall Study||0
10822152|NCT03998189|11987476|FG001|NOT COMPLETED|Overall Study||1
10822153|NCT02212574|11987482|FG000|STARTED|Overall Study||6
10822154|NCT02212574|11987482|FG000|COMPLETED|Overall Study||6
10822155|NCT02212574|11987482|FG000|NOT COMPLETED|Overall Study||0
10822156|NCT04422210|11987495|FG000|STARTED|Overall Study||0
10822157|NCT04422210|11987496|FG001|STARTED|Overall Study||0
10822158|NCT04422210|11987497|FG002|STARTED|Overall Study||0
10822159|NCT04422210|11987498|FG003|STARTED|Overall Study||0
10822160|NCT04422210|11987499|FG004|STARTED|Overall Study||0
10822161|NCT04422210|11987500|FG005|STARTED|Overall Study||0
10822162|NCT04422210|11987501|FG006|STARTED|Overall Study||0
10822163|NCT04422210|11987502|FG007|STARTED|Overall Study||0
10822164|NCT04422210|11987495|FG000|COMPLETED|Overall Study||0
10822165|NCT04422210|11987496|FG001|COMPLETED|Overall Study||0
10822166|NCT04422210|11987497|FG002|COMPLETED|Overall Study||0
10822167|NCT04422210|11987498|FG003|COMPLETED|Overall Study||0
10822168|NCT04422210|11987499|FG004|COMPLETED|Overall Study||0
10822169|NCT04422210|11987500|FG005|COMPLETED|Overall Study||0
10822170|NCT04422210|11987501|FG006|COMPLETED|Overall Study||0
10822171|NCT04422210|11987502|FG007|COMPLETED|Overall Study||0
10822172|NCT04422210|11987495|FG000|NOT COMPLETED|Overall Study||0
10822173|NCT04422210|11987496|FG001|NOT COMPLETED|Overall Study||0
10822174|NCT04422210|11987497|FG002|NOT COMPLETED|Overall Study||0
10822175|NCT04422210|11987498|FG003|NOT COMPLETED|Overall Study||0
10822176|NCT04422210|11987499|FG004|NOT COMPLETED|Overall Study||0
10822177|NCT04422210|11987500|FG005|NOT COMPLETED|Overall Study||0
10822178|NCT04422210|11987501|FG006|NOT COMPLETED|Overall Study||0
10822179|NCT04422210|11987502|FG007|NOT COMPLETED|Overall Study||0
10822180|NCT04298918|11987525|FG000|STARTED|Overall Study||0
10822181|NCT04298918|11987526|FG001|STARTED|Overall Study||0
10822182|NCT04298918|11987527|FG002|STARTED|Overall Study||0
10822183|NCT04298918|11987528|FG003|STARTED|Overall Study||0
10822184|NCT04298918|11987525|FG000|COMPLETED|Overall Study||0
10822185|NCT04298918|11987526|FG001|COMPLETED|Overall Study||0
10822186|NCT04298918|11987527|FG002|COMPLETED|Overall Study||0
10822187|NCT04298918|11987528|FG003|COMPLETED|Overall Study||0
10822188|NCT04298918|11987525|FG000|NOT COMPLETED|Overall Study||0
10822189|NCT04298918|11987526|FG001|NOT COMPLETED|Overall Study||0
10822190|NCT04298918|11987527|FG002|NOT COMPLETED|Overall Study||0
10822191|NCT04298918|11987528|FG003|NOT COMPLETED|Overall Study||0
10822192|NCT01996371|11987546|FG000|STARTED|Overall Study||5
10822193|NCT01996371|11987547|FG001|STARTED|Overall Study||4
10822194|NCT01996371|11987548|FG002|STARTED|Overall Study||6
10822195|NCT01996371|11987546|FG000|COMPLETED|Overall Study||5
10822196|NCT01996371|11987547|FG001|COMPLETED|Overall Study||4
10822197|NCT01996371|11987548|FG002|COMPLETED|Overall Study||6
10822198|NCT01996371|11987546|FG000|NOT COMPLETED|Overall Study||0
10822199|NCT01996371|11987547|FG001|NOT COMPLETED|Overall Study||0
10822200|NCT01996371|11987548|FG002|NOT COMPLETED|Overall Study||0
10822201|NCT01561378|11987561|FG000|STARTED|Overall Study||11
10822202|NCT01561378|11987562|FG001|STARTED|Overall Study||11
10822203|NCT01561378|11987561|FG000|COMPLETED|Overall Study||11
10822204|NCT01561378|11987562|FG001|COMPLETED|Overall Study||11
10822205|NCT01561378|11987561|FG000|NOT COMPLETED|Overall Study||0
10822206|NCT01561378|11987562|FG001|NOT COMPLETED|Overall Study||0
10822207|NCT00955929|11987571|FG000|STARTED|Overall Study||13
10822208|NCT00955929|11987572|FG001|STARTED|Overall Study||30
10822209|NCT00955929|11987573|FG002|STARTED|Overall Study||33
10822210|NCT00955929|11987571|FG000|COMPLETED|Overall Study||13
10822211|NCT00955929|11987572|FG001|COMPLETED|Overall Study||30
10822212|NCT00955929|11987573|FG002|COMPLETED|Overall Study||33
10822213|NCT00955929|11987571|FG000|NOT COMPLETED|Overall Study||0
10822214|NCT00955929|11987572|FG001|NOT COMPLETED|Overall Study||0
10822215|NCT00955929|11987573|FG002|NOT COMPLETED|Overall Study||0
10822216|NCT00402883|11987581|FG000|STARTED|Induction Therapy||5
10822217|NCT00402883|11987581|FG000|COMPLETED|Induction Therapy||5
10822218|NCT00402883|11987581|FG000|NOT COMPLETED|Induction Therapy||0
10822219|NCT00402883|11987581|FG000|STARTED|Consolidation Therapy||5
10822220|NCT00402883|11987581|FG000|COMPLETED|Consolidation Therapy||5
10822221|NCT00402883|11987581|FG000|NOT COMPLETED|Consolidation Therapy||0
10822222|NCT00402883|11987581|FG000|STARTED|Maintenance Therapy||5
10822223|NCT00402883|11987581|FG000|COMPLETED|Maintenance Therapy|All 5 patients received limited maintenance therapy due to early trial closure.|5
10822224|NCT00402883|11987581|FG000|NOT COMPLETED|Maintenance Therapy||0
10822225|NCT03482505|11987586|FG000|STARTED|Overall Study||10
10822226|NCT03482505|11987586|FG000|COMPLETED|Overall Study||10
10822227|NCT03482505|11987586|FG000|NOT COMPLETED|Overall Study||0
10822228|NCT02934503|11987590|FG000|STARTED|Overall Study||5
10822229|NCT02934503|11987590|FG000|COMPLETED|Overall Study||1
10822230|NCT02934503|11987590|FG000|NOT COMPLETED|Overall Study||4
10822231|NCT02137252|11987596|FG000|STARTED|Overall Study||2
10822232|NCT02137252|11987597|FG001|STARTED|Overall Study||1
10822233|NCT02137252|11987596|FG000|COMPLETED|Overall Study||0
10822234|NCT02137252|11987597|FG001|COMPLETED|Overall Study||0
10822235|NCT02137252|11987596|FG000|NOT COMPLETED|Overall Study||2
10822236|NCT02137252|11987597|FG001|NOT COMPLETED|Overall Study||1
10822237|NCT03863522|11987603|FG000|STARTED|Overall Study||116
10822238|NCT03863522|11987603|FG000|COMPLETED|Overall Study||116
10822239|NCT03863522|11987603|FG000|NOT COMPLETED|Overall Study||0
10822240|NCT01294670|11987612|FG000|STARTED|Overall Study||7
10822241|NCT01294670|11987613|FG001|STARTED|Overall Study||3
10822242|NCT01294670|11987614|FG002|STARTED|Overall Study||3
10822243|NCT01294670|11987615|FG003|STARTED|Overall Study||9
10822244|NCT01294670|11987616|FG004|STARTED|Overall Study||5
10822245|NCT01294670|11987612|FG000|COMPLETED|Overall Study||6
10822246|NCT01294670|11987613|FG001|COMPLETED|Overall Study||3
10822247|NCT01294670|11987614|FG002|COMPLETED|Overall Study||3
10822248|NCT01294670|11987615|FG003|COMPLETED|Overall Study||9
10822249|NCT01294670|11987616|FG004|COMPLETED|Overall Study||5
10822250|NCT01294670|11987612|FG000|NOT COMPLETED|Overall Study||1
10822251|NCT01294670|11987613|FG001|NOT COMPLETED|Overall Study||0
10822252|NCT01294670|11987614|FG002|NOT COMPLETED|Overall Study||0
10822253|NCT01294670|11987615|FG003|NOT COMPLETED|Overall Study||0
10822254|NCT01294670|11987616|FG004|NOT COMPLETED|Overall Study||0
10822255|NCT03095287|11987628|FG000|STARTED|Overall Study||2
10822256|NCT03095287|11987628|FG000|COMPLETED|Overall Study||0
10822257|NCT03095287|11987628|FG000|NOT COMPLETED|Overall Study||2
10822258|NCT03236662|11987632|FG000|STARTED|Overall Study||2
10822259|NCT03236662|11987632|FG000|COMPLETED|Overall Study||2
10822260|NCT03236662|11987632|FG000|NOT COMPLETED|Overall Study||0
10822261|NCT02930122|11987638|FG000|STARTED|Overall Study||3
10822262|NCT02930122|11987639|FG001|STARTED|Overall Study||3
10822263|NCT02930122|11987638|FG000|COMPLETED|Overall Study||0
10822264|NCT02930122|11987639|FG001|COMPLETED|Overall Study||0
10822265|NCT02930122|11987638|FG000|NOT COMPLETED|Overall Study||3
10822266|NCT02930122|11987639|FG001|NOT COMPLETED|Overall Study||3
10822267|NCT01444209|11987646|FG000|STARTED|Overall Study||2
10822268|NCT01444209|11987646|FG000|COMPLETED|Overall Study||2
10822269|NCT01444209|11987646|FG000|NOT COMPLETED|Overall Study||0
10822270|NCT04267380|11987652|FG000|STARTED|Overall Study||149
10822271|NCT04267380|11987653|FG001|STARTED|Overall Study||149
10822272|NCT04267380|11987652|FG000|COMPLETED|Overall Study||149
10822273|NCT04267380|11987653|FG001|COMPLETED|Overall Study||149
10822274|NCT04267380|11987652|FG000|NOT COMPLETED|Overall Study||0
10822275|NCT04267380|11987653|FG001|NOT COMPLETED|Overall Study||0
10822276|NCT04144166|11987659|FG000|STARTED|Overall Study||60
10822277|NCT04144166|11987659|FG000|COMPLETED|Overall Study||57
10822278|NCT04144166|11987659|FG000|NOT COMPLETED|Overall Study||3
10822279|NCT04090164|11987670|FG000|STARTED|Overall Study|Number of patients retrivied from the hospital files.|650
10822280|NCT04090164|11987671|FG001|STARTED|Overall Study||145
10822281|NCT04090164|11987670|FG000|COMPLETED|Overall Study|Number of patients analyzed.|405
10822282|NCT04090164|11987671|FG001|COMPLETED|Overall Study||145
10822283|NCT04090164|11987670|FG000|NOT COMPLETED|Overall Study||245
10822284|NCT04090164|11987671|FG001|NOT COMPLETED|Overall Study||0
10822285|NCT04047121|11987684|FG000|STARTED|Overall Study||310
10822286|NCT04047121|11987685|FG001|STARTED|Overall Study||299
10822287|NCT04047121|11987686|FG002|STARTED|Overall Study||79
10822288|NCT04047121|11987687|FG003|STARTED|Overall Study||287
10822289|NCT04047121|11987688|FG004|STARTED|Overall Study||112
10408784|NCT00757237|11552940|FG001|NOT COMPLETED|Overall Study||25
10822290|NCT04047121|11987689|FG005|STARTED|Overall Study||262
10822291|NCT04047121|11987684|FG000|COMPLETED|Overall Study||310
10822292|NCT04047121|11987685|FG001|COMPLETED|Overall Study||299
10822293|NCT04047121|11987686|FG002|COMPLETED|Overall Study||79
10822294|NCT04047121|11987687|FG003|COMPLETED|Overall Study||287
10822295|NCT04047121|11987688|FG004|COMPLETED|Overall Study||112
10822296|NCT04047121|11987689|FG005|COMPLETED|Overall Study||262
10822297|NCT04047121|11987684|FG000|NOT COMPLETED|Overall Study||0
10822298|NCT04047121|11987685|FG001|NOT COMPLETED|Overall Study||0
10822299|NCT04047121|11987686|FG002|NOT COMPLETED|Overall Study||0
10822300|NCT04047121|11987687|FG003|NOT COMPLETED|Overall Study||0
10822301|NCT04047121|11987688|FG004|NOT COMPLETED|Overall Study||0
10822302|NCT04047121|11987689|FG005|NOT COMPLETED|Overall Study||0
10822303|NCT04018001|11987705|FG000|STARTED|Overall Study||678
10822304|NCT04018001|11987706|FG001|STARTED|Overall Study||379
10822305|NCT04018001|11987705|FG000|COMPLETED|Overall Study||678
10822306|NCT04018001|11987706|FG001|COMPLETED|Overall Study||379
10822307|NCT04018001|11987705|FG000|NOT COMPLETED|Overall Study||0
10822308|NCT04018001|11987706|FG001|NOT COMPLETED|Overall Study||0
10822309|NCT04017754|11987712|FG000|STARTED|Overall Study||267
10822310|NCT04017754|11987713|FG001|STARTED|Overall Study||185
10822311|NCT04017754|11987712|FG000|COMPLETED|Overall Study||267
10822312|NCT04017754|11987713|FG001|COMPLETED|Overall Study||185
10822313|NCT04017754|11987712|FG000|NOT COMPLETED|Overall Study||0
10822314|NCT04017754|11987713|FG001|NOT COMPLETED|Overall Study||0
10822315|NCT04010370|11987756|FG000|STARTED|Overall Study||25
10822316|NCT04010370|11987756|FG000|COMPLETED|Overall Study||25
10822317|NCT04010370|11987756|FG000|NOT COMPLETED|Overall Study||0
10822318|NCT03997825|11987760|FG000|STARTED|Overall Study||117
10822319|NCT03997825|11987760|FG000|COMPLETED|Overall Study||100
10822320|NCT03997825|11987760|FG000|NOT COMPLETED|Overall Study||17
10822321|NCT03975790|11987767|FG000|STARTED|Overall Study||337
10822322|NCT03975790|11987768|FG001|STARTED|Overall Study||94
10822323|NCT03975790|11987769|FG002|STARTED|Overall Study||48
10822324|NCT03975790|11987767|FG000|COMPLETED|Overall Study||337
10822325|NCT03975790|11987768|FG001|COMPLETED|Overall Study||94
10822326|NCT03975790|11987769|FG002|COMPLETED|Overall Study||48
10822327|NCT03975790|11987767|FG000|NOT COMPLETED|Overall Study||0
10822328|NCT03975790|11987768|FG001|NOT COMPLETED|Overall Study||0
10822329|NCT03975790|11987769|FG002|NOT COMPLETED|Overall Study||0
10822330|NCT03979079|11987777|FG000|STARTED|Overall Study||2384
10822331|NCT03979079|11987777|FG000|COMPLETED|Overall Study||2384
10822332|NCT03979079|11987777|FG000|NOT COMPLETED|Overall Study||0
10822336|NCT03859622|11987786|FG000|STARTED|Overall Study||289
10822337|NCT03859622|11987786|FG000|COMPLETED|Overall Study||289
10822338|NCT03859622|11987786|FG000|NOT COMPLETED|Overall Study||0
10822339|NCT03764813|11987797|FG000|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving no transfusions before the age of 32 weeks|14
10822340|NCT03764813|11987798|FG001|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving only cord-RBC transfusions before the age of 32 weeks|3
10822341|NCT03764813|11987799|FG002|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving only adult-RBC transfusions before the age of 32 weeks|4
10822342|NCT03764813|11987800|FG003|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving both adult-RBC and cord-RBCs before the age of 32 weeks|4
10822343|NCT03764813|11987797|FG000|COMPLETED|From Enrollment to the Age of 32 Weeks||14
10822344|NCT03764813|11987798|FG001|COMPLETED|From Enrollment to the Age of 32 Weeks||2
10822345|NCT03764813|11987799|FG002|COMPLETED|From Enrollment to the Age of 32 Weeks||3
10822346|NCT03764813|11987800|FG003|COMPLETED|From Enrollment to the Age of 32 Weeks||4
10822347|NCT03764813|11987797|FG000|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||0
10822348|NCT03764813|11987798|FG001|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||1
10822349|NCT03764813|11987799|FG002|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||1
10822350|NCT03764813|11987800|FG003|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||0
10822351|NCT03764813|11987797|FG000|STARTED|From Enrollment to the Last HbF Test|Patients receiving no transfusions before last HbF test (occurring at 36 weeks,discharge or death)|13
10822352|NCT03764813|11987798|FG001|STARTED|From Enrollment to the Last HbF Test|Patients receiving only cord-RBCs before last HbF test (occurring at 36 wks,discharge or death)|3
10822353|NCT03764813|11987799|FG002|STARTED|From Enrollment to the Last HbF Test|Patients receiving only adult-RBC before last HbF test (occurring at 36 wks,discharge or death)|4
10822354|NCT03764813|11987800|FG003|STARTED|From Enrollment to the Last HbF Test|Patients receiving both cord and adult-RBCs before the last HbFtest(age of 36 wk,discharge or death)|5
10822355|NCT03764813|11987797|FG000|COMPLETED|From Enrollment to the Last HbF Test||13
10822356|NCT03764813|11987798|FG001|COMPLETED|From Enrollment to the Last HbF Test||3
10822357|NCT03764813|11987799|FG002|COMPLETED|From Enrollment to the Last HbF Test||4
10822358|NCT03764813|11987800|FG003|COMPLETED|From Enrollment to the Last HbF Test||5
10822359|NCT03764813|11987797|FG000|NOT COMPLETED|From Enrollment to the Last HbF Test||0
10822360|NCT03764813|11987798|FG001|NOT COMPLETED|From Enrollment to the Last HbF Test||0
10822361|NCT03764813|11987799|FG002|NOT COMPLETED|From Enrollment to the Last HbF Test||0
10822362|NCT03764813|11987800|FG003|NOT COMPLETED|From Enrollment to the Last HbF Test||0
10822363|NCT04941521|11987816|FG000|STARTED|Overall Study||3
10822364|NCT04941521|11987816|FG000|COMPLETED|Overall Study||3
10822365|NCT04941521|11987816|FG000|NOT COMPLETED|Overall Study||0
10822366|NCT04584788|11987820|FG000|STARTED|Overall Study||37
10822367|NCT04584788|11987820|FG000|COMPLETED|Overall Study||25
10822368|NCT04584788|11987820|FG000|NOT COMPLETED|Overall Study||12
10822369|NCT04219618|11987826|FG000|STARTED|Overall Study||1
10822370|NCT04219618|11987827|FG001|STARTED|Overall Study||1
10822371|NCT04219618|11987826|FG000|COMPLETED|Overall Study||1
10822372|NCT04219618|11987827|FG001|COMPLETED|Overall Study||1
10822373|NCT04219618|11987826|FG000|NOT COMPLETED|Overall Study||0
10822374|NCT04219618|11987827|FG001|NOT COMPLETED|Overall Study||0
10822375|NCT03783923|11987835|FG000|STARTED|Placebo-Controlled Period (26 Weeks)||5
10822376|NCT03783923|11987836|FG001|STARTED|Placebo-Controlled Period (26 Weeks)||6
10822377|NCT03783923|11987835|FG000|Safety Population|Placebo-Controlled Period (26 Weeks)||5
10822378|NCT03783923|11987836|FG001|Safety Population|Placebo-Controlled Period (26 Weeks)|2 participants who received placebo in placebo-controlled period transitioned to receive deflazacort in open-label extension.|2
10822379|NCT03783923|11987835|FG000|COMPLETED|Placebo-Controlled Period (26 Weeks)||1
10822380|NCT03783923|11987836|FG001|COMPLETED|Placebo-Controlled Period (26 Weeks)||2
10822381|NCT03783923|11987835|FG000|NOT COMPLETED|Placebo-Controlled Period (26 Weeks)||4
10822382|NCT03783923|11987836|FG001|NOT COMPLETED|Placebo-Controlled Period (26 Weeks)||4
10822383|NCT03783923|11987835|FG000|STARTED|Open-Label Extension (26 Weeks)||1
10822384|NCT03783923|11987836|FG001|STARTED|Open-Label Extension (26 Weeks)||2
10822385|NCT03783923|11987835|FG000|COMPLETED|Open-Label Extension (26 Weeks)||0
10822386|NCT03783923|11987836|FG001|COMPLETED|Open-Label Extension (26 Weeks)||0
10822387|NCT03783923|11987835|FG000|NOT COMPLETED|Open-Label Extension (26 Weeks)||1
10822388|NCT03783923|11987836|FG001|NOT COMPLETED|Open-Label Extension (26 Weeks)||2
10822389|NCT03718429|11987844|FG000|STARTED|Baseline Treatment||20
10822390|NCT03718429|11987845|FG001|STARTED|Baseline Treatment||21
10822391|NCT03718429|11987846|FG002|STARTED|Baseline Treatment||21
10822392|NCT03718429|11987847|FG003|STARTED|Baseline Treatment||20
10822393|NCT03718429|11987844|FG000|COMPLETED|Baseline Treatment||20
10822394|NCT03718429|11987845|FG001|COMPLETED|Baseline Treatment||21
10822395|NCT03718429|11987846|FG002|COMPLETED|Baseline Treatment||21
10822396|NCT03718429|11987847|FG003|COMPLETED|Baseline Treatment||20
10822397|NCT03718429|11987844|FG000|NOT COMPLETED|Baseline Treatment||0
10822398|NCT03718429|11987845|FG001|NOT COMPLETED|Baseline Treatment||0
10822399|NCT03718429|11987846|FG002|NOT COMPLETED|Baseline Treatment||0
10822400|NCT03718429|11987847|FG003|NOT COMPLETED|Baseline Treatment||0
10822401|NCT03718429|11987844|FG000|STARTED|Adjunctive Rivaroxaban 2.5 mg||20
10822402|NCT03718429|11987845|FG001|STARTED|Adjunctive Rivaroxaban 2.5 mg||21
10822403|NCT03718429|11987846|FG002|STARTED|Adjunctive Rivaroxaban 2.5 mg||21
10822404|NCT03718429|11987847|FG003|STARTED|Adjunctive Rivaroxaban 2.5 mg||0
10822405|NCT03718429|11987844|FG000|COMPLETED|Adjunctive Rivaroxaban 2.5 mg||20
10822406|NCT03718429|11987845|FG001|COMPLETED|Adjunctive Rivaroxaban 2.5 mg||20
10822407|NCT03718429|11987846|FG002|COMPLETED|Adjunctive Rivaroxaban 2.5 mg||20
10822408|NCT03718429|11987847|FG003|COMPLETED|Adjunctive Rivaroxaban 2.5 mg||0
10822409|NCT03718429|11987844|FG000|NOT COMPLETED|Adjunctive Rivaroxaban 2.5 mg||0
10822410|NCT03718429|11987845|FG001|NOT COMPLETED|Adjunctive Rivaroxaban 2.5 mg||1
10822411|NCT03718429|11987846|FG002|NOT COMPLETED|Adjunctive Rivaroxaban 2.5 mg||1
10822412|NCT03718429|11987847|FG003|NOT COMPLETED|Adjunctive Rivaroxaban 2.5 mg||0
10822413|NCT03718429|11987844|FG000|STARTED|Stopping Aspirin||20
10822414|NCT03718429|11987845|FG001|STARTED|Stopping Aspirin||20
10822415|NCT03718429|11987846|FG002|STARTED|Stopping Aspirin||20
10822416|NCT03718429|11987847|FG003|STARTED|Stopping Aspirin||0
10822417|NCT03718429|11987844|FG000|COMPLETED|Stopping Aspirin||20
10822418|NCT03718429|11987845|FG001|COMPLETED|Stopping Aspirin||20
10822419|NCT03718429|11987846|FG002|COMPLETED|Stopping Aspirin||20
10822420|NCT03718429|11987847|FG003|COMPLETED|Stopping Aspirin||0
10822421|NCT03718429|11987844|FG000|NOT COMPLETED|Stopping Aspirin||0
10822422|NCT03718429|11987845|FG001|NOT COMPLETED|Stopping Aspirin||0
10822423|NCT03718429|11987846|FG002|NOT COMPLETED|Stopping Aspirin||0
10822424|NCT03718429|11987847|FG003|NOT COMPLETED|Stopping Aspirin||0
10822461|NCT03206476|11987895|FG000|STARTED|Overall Study||54
10822462|NCT03206476|11987896|FG001|STARTED|Overall Study||53
10822463|NCT03206476|11987895|FG000|Completed Short-term Evaluation (4 Months)|Overall Study||48
10822464|NCT03206476|11987896|FG001|Completed Short-term Evaluation (4 Months)|Overall Study||40
10822465|NCT03206476|11987895|FG000|COMPLETED|Overall Study||42
10822466|NCT03206476|11987896|FG001|COMPLETED|Overall Study||37
10822467|NCT03206476|11987895|FG000|NOT COMPLETED|Overall Study||12
10822468|NCT03206476|11987896|FG001|NOT COMPLETED|Overall Study||16
10822469|NCT03057106|11987904|FG000|STARTED|Overall Study|1 patient refused the treatment|149
10822470|NCT03057106|11987905|FG001|STARTED|Overall Study|3 patients refused the treatment|148
10822471|NCT03057106|11987904|FG000|COMPLETED|Overall Study||149
10822472|NCT03057106|11987905|FG001|COMPLETED|Overall Study||148
10822473|NCT03057106|11987904|FG000|NOT COMPLETED|Overall Study||0
10822474|NCT03057106|11987905|FG001|NOT COMPLETED|Overall Study||0
10822475|NCT03022461|11987911|FG000|STARTED|Overall Study||25
10822476|NCT03022461|11987911|FG000|COMPLETED|Overall Study||22
10822477|NCT03022461|11987911|FG000|NOT COMPLETED|Overall Study||3
10822484|NCT02892955|11987925|FG000|STARTED|Overall Study||1685
10822485|NCT02892955|11987925|FG000|COMPLETED|Overall Study||1685
10822486|NCT02892955|11987925|FG000|NOT COMPLETED|Overall Study||0
10822487|NCT02689349|11987931|FG000|STARTED|Overall Study||59
10822488|NCT02689349|11987932|FG001|STARTED|Overall Study||58
10822489|NCT02689349|11987931|FG000|COMPLETED|Overall Study||46
10822490|NCT02689349|11987932|FG001|COMPLETED|Overall Study||58
10822491|NCT02689349|11987931|FG000|NOT COMPLETED|Overall Study||13
10822492|NCT02689349|11987932|FG001|NOT COMPLETED|Overall Study||0
10822493|NCT02680574|11987943|FG000|STARTED|Overall Study||862
10822494|NCT02680574|11987944|FG001|STARTED|Overall Study||863
10822495|NCT02680574|11987943|FG000|COMPLETED|Overall Study||704
10822496|NCT02680574|11987944|FG001|COMPLETED|Overall Study||711
10822497|NCT02680574|11987943|FG000|NOT COMPLETED|Overall Study||158
10822498|NCT02680574|11987944|FG001|NOT COMPLETED|Overall Study||152
10822499|NCT02648347|11987952|FG000|STARTED|Overall Study||879
10822500|NCT02648347|11987953|FG001|STARTED|Overall Study||872
10822501|NCT02648347|11987952|FG000|COMPLETED|Overall Study||670
10822502|NCT02648347|11987953|FG001|COMPLETED|Overall Study||675
10822503|NCT02648347|11987952|FG000|NOT COMPLETED|Overall Study||209
10822504|NCT02648347|11987953|FG001|NOT COMPLETED|Overall Study||197
10822505|NCT02396342|11987961|FG000|STARTED|Overall Study||5
10822506|NCT02396342|11987962|FG001|STARTED|Overall Study||5
10822507|NCT02396342|11987961|FG000|COMPLETED|Overall Study||5
10822508|NCT02396342|11987962|FG001|COMPLETED|Overall Study||5
10822509|NCT02396342|11987961|FG000|NOT COMPLETED|Overall Study||0
10822510|NCT02396342|11987962|FG001|NOT COMPLETED|Overall Study||0
10822511|NCT02307253|11987968|FG000|STARTED|Overall Study||246
10822512|NCT02307253|11987968|FG000|COMPLETED|Overall Study||246
10822513|NCT02307253|11987968|FG000|NOT COMPLETED|Overall Study||0
10822514|NCT02224755|11987974|FG000|STARTED|Randomization to Device Implant|Patients in the Full Study Cohort (n=1028) who were randomized to HeartMate II|512
10822515|NCT02224755|11987975|FG001|STARTED|Randomization to Device Implant|Patients in the Full Study Cohort (n=1028) who were randomized to HeartMate 3|516
10822516|NCT02224755|11987974|FG000|COMPLETED|Randomization to Device Implant|Patients who underwent HeartMate II LVAS implant|505
10822517|NCT02224755|11987975|FG001|COMPLETED|Randomization to Device Implant|Patients who underwent HeartMate 3 LVAS implant|515
10822518|NCT02224755|11987974|FG000|NOT COMPLETED|Randomization to Device Implant||7
10822519|NCT02224755|11987975|FG001|NOT COMPLETED|Randomization to Device Implant||1
10822520|NCT02224755|11987974|FG000|STARTED|Two Year Follow up Post-implant||505
10822521|NCT02224755|11987975|FG001|STARTED|Two Year Follow up Post-implant||515
10822522|NCT02224755|11987974|FG000|COMPLETED|Two Year Follow up Post-implant||247
10822523|NCT02224755|11987975|FG001|COMPLETED|Two Year Follow up Post-implant||289
10822524|NCT02224755|11987974|FG000|NOT COMPLETED|Two Year Follow up Post-implant||258
10822525|NCT02224755|11987975|FG001|NOT COMPLETED|Two Year Follow up Post-implant||226
10822526|NCT02170363|11987985|FG000|STARTED|Overall Study||50
10822527|NCT02170363|11987985|FG000|COMPLETED|Overall Study|Followed to the 6-Month Primary Endpoint|50
10822528|NCT02170363|11987985|FG000|NOT COMPLETED|Overall Study||0
10822529|NCT02090114|11987995|FG000|STARTED|Overall Study||30
10822530|NCT02090114|11987996|FG001|STARTED|Overall Study||29
10822531|NCT02090114|11987997|FG002|STARTED|Overall Study||29
10822532|NCT02090114|11987998|FG003|STARTED|Overall Study||8
10822533|NCT02090114|11987995|FG000|COMPLETED|Overall Study||0
10822534|NCT02090114|11987996|FG001|COMPLETED|Overall Study||0
10822535|NCT02090114|11987997|FG002|COMPLETED|Overall Study||0
10822536|NCT02090114|11987998|FG003|COMPLETED|Overall Study||0
10822537|NCT02090114|11987995|FG000|NOT COMPLETED|Overall Study||30
10822538|NCT02090114|11987996|FG001|NOT COMPLETED|Overall Study||29
10822539|NCT02090114|11987997|FG002|NOT COMPLETED|Overall Study||29
10822540|NCT02090114|11987998|FG003|NOT COMPLETED|Overall Study||8
10822541|NCT01568424|11988008|FG000|STARTED|Overall Study||25
10822542|NCT01568424|11988008|FG000|COMPLETED|Overall Study||25
10822543|NCT01568424|11988008|FG000|NOT COMPLETED|Overall Study||0
10822544|NCT00819793|11988012|FG000|STARTED|Overall Study||32
10822545|NCT00819793|11988012|FG000|COMPLETED|Overall Study||32
10822546|NCT00819793|11988012|FG000|NOT COMPLETED|Overall Study||0
10822547|NCT00121485|11988019|FG000|STARTED|Overall Study||134
10822548|NCT00121485|11988020|FG001|STARTED|Overall Study||66
10822549|NCT00121485|11988019|FG000|COMPLETED|Overall Study||133
10822550|NCT00121485|11988020|FG001|COMPLETED|Overall Study||59
10822551|NCT00121485|11988019|FG000|NOT COMPLETED|Overall Study||1
10822552|NCT00121485|11988020|FG001|NOT COMPLETED|Overall Study||7
10822553|NCT00121472|11988027|FG000|STARTED|Overall Study||194
10822554|NCT00121472|11988027|FG000|COMPLETED|Overall Study|Followed for at least 1 year after implantation of HM II LVAS.|194
10822555|NCT00121472|11988027|FG000|NOT COMPLETED|Overall Study||0
10822556|NCT00078806|11988035|FG000|STARTED|Part 1A||19
10822557|NCT00078806|11988036|FG001|STARTED|Part 1A||0
10822558|NCT00078806|11988037|FG002|STARTED|Part 1A||0
10822559|NCT00078806|11988038|FG003|STARTED|Part 1A||0
10822560|NCT00078806|11988035|FG000|COMPLETED|Part 1A||9
10822561|NCT00078806|11988036|FG001|COMPLETED|Part 1A||0
10822562|NCT00078806|11988037|FG002|COMPLETED|Part 1A||0
10822563|NCT00078806|11988038|FG003|COMPLETED|Part 1A||0
10822564|NCT00078806|11988035|FG000|NOT COMPLETED|Part 1A||10
10822565|NCT00078806|11988036|FG001|NOT COMPLETED|Part 1A||0
10822566|NCT00078806|11988037|FG002|NOT COMPLETED|Part 1A||0
10822567|NCT00078806|11988038|FG003|NOT COMPLETED|Part 1A||0
10822568|NCT00078806|11988035|FG000|STARTED|Part 1B||10
10822569|NCT00078806|11988036|FG001|STARTED|Part 1B||0
10822570|NCT00078806|11988037|FG002|STARTED|Part 1B||0
10822571|NCT00078806|11988038|FG003|STARTED|Part 1B||0
10822572|NCT00078806|11988035|FG000|COMPLETED|Part 1B||2
10822573|NCT00078806|11988036|FG001|COMPLETED|Part 1B||0
10822574|NCT00078806|11988037|FG002|COMPLETED|Part 1B||0
10822575|NCT00078806|11988038|FG003|COMPLETED|Part 1B||0
10822576|NCT00078806|11988035|FG000|NOT COMPLETED|Part 1B||8
10822577|NCT00078806|11988036|FG001|NOT COMPLETED|Part 1B||0
10822578|NCT00078806|11988037|FG002|NOT COMPLETED|Part 1B||0
10822579|NCT00078806|11988038|FG003|NOT COMPLETED|Part 1B||0
10822580|NCT00078806|11988035|FG000|STARTED|Part 2||0
10822581|NCT00078806|11988036|FG001|STARTED|Part 2||6
10822582|NCT00078806|11988037|FG002|STARTED|Part 2||4
10822583|NCT00078806|11988038|FG003|STARTED|Part 2||0
10822584|NCT00078806|11988035|FG000|Received Study Drug|Part 2||0
10822585|NCT00078806|11988036|FG001|Received Study Drug|Part 2||5
10822586|NCT00078806|11988037|FG002|Received Study Drug|Part 2||4
10822587|NCT00078806|11988038|FG003|Received Study Drug|Part 2||0
10822588|NCT00078806|11988035|FG000|COMPLETED|Part 2||0
10822589|NCT00078806|11988036|FG001|COMPLETED|Part 2||5
10822590|NCT00078806|11988037|FG002|COMPLETED|Part 2||4
10822591|NCT00078806|11988038|FG003|COMPLETED|Part 2||0
10822592|NCT00078806|11988035|FG000|NOT COMPLETED|Part 2||0
10822593|NCT00078806|11988036|FG001|NOT COMPLETED|Part 2||1
10822594|NCT00078806|11988037|FG002|NOT COMPLETED|Part 2||0
10822595|NCT00078806|11988038|FG003|NOT COMPLETED|Part 2||0
10822596|NCT00078806|11988035|FG000|STARTED|Part 3||0
10822597|NCT00078806|11988036|FG001|STARTED|Part 3||0
10822598|NCT00078806|11988037|FG002|STARTED|Part 3||0
10822599|NCT00078806|11988038|FG003|STARTED|Part 3||9
10822600|NCT00078806|11988035|FG000|COMPLETED|Part 3||0
10822601|NCT00078806|11988036|FG001|COMPLETED|Part 3||0
10822602|NCT00078806|11988037|FG002|COMPLETED|Part 3||0
10822603|NCT00078806|11988038|FG003|COMPLETED|Part 3||9
10822604|NCT00078806|11988035|FG000|NOT COMPLETED|Part 3||0
10822605|NCT00078806|11988036|FG001|NOT COMPLETED|Part 3||0
10822606|NCT00078806|11988037|FG002|NOT COMPLETED|Part 3||0
10822607|NCT00078806|11988038|FG003|NOT COMPLETED|Part 3||0
10822608|NCT00162370|11988053|FG000|STARTED|Completed Echocardiography Imaging|Received at least one dose of Definity|366
10822609|NCT00162370|11988053|FG000|COMPLETED|Completed Echocardiography Imaging|number of subjects who under went Definity-enhanced rest and stress echocardiogram|366
10822610|NCT00162370|11988053|FG000|NOT COMPLETED|Completed Echocardiography Imaging||0
10822611|NCT00162370|11988053|FG000|STARTED|Efficacy Population||366
10822612|NCT00162370|11988053|FG000|COMPLETED|Efficacy Population|Efficacy population, completed rest/stress echo with Definity & completed 2 and/or 5 year follow up|315
10822613|NCT00162370|11988053|FG000|NOT COMPLETED|Efficacy Population||51
10822614|NCT00204737|11988062|FG000|STARTED|Overall Study||6
10822615|NCT00204737|11988063|FG001|STARTED|Overall Study||6
10822616|NCT00204737|11988062|FG000|COMPLETED|Overall Study||6
10822617|NCT00204737|11988063|FG001|COMPLETED|Overall Study||6
10822618|NCT00204737|11988062|FG000|NOT COMPLETED|Overall Study||0
10822619|NCT00204737|11988063|FG001|NOT COMPLETED|Overall Study||0
10822620|NCT00214500|11988069|FG000|STARTED|Treatment Period|All eligible-enrolled participants who received at least 1 dose of study drug|9
10822621|NCT00214500|11988069|FG000|Safety Population|Treatment Period||9
10822622|NCT00214500|11988069|FG000|Pharmacokinetic (PK) Population|Treatment Period||9
10822623|NCT00214500|11988069|FG000|Pharmacodynamic (PD) Population|Treatment Period||9
10822624|NCT00214500|11988069|FG000|COMPLETED|Treatment Period||8
10822625|NCT00214500|11988069|FG000|NOT COMPLETED|Treatment Period||1
10822626|NCT00214500|11988069|FG000|STARTED|Extension Period||8
10822627|NCT00214500|11988069|FG000|COMPLETED|Extension Period||6
10822628|NCT00214500|11988069|FG000|NOT COMPLETED|Extension Period||2
10822629|NCT00278343|11988076|FG000|STARTED|Overall Study||74
10822630|NCT00278343|11988076|FG000|COMPLETED|Overall Study||74
10822631|NCT00278343|11988076|FG000|NOT COMPLETED|Overall Study||0
10822632|NCT00283959|11988081|FG000|STARTED|Treatment Period||4
10822633|NCT00283959|11988081|FG000|Safety Population|Treatment Period||4
10822634|NCT00283959|11988081|FG000|Pharmacodynamics (PD) Population|Treatment Period||4
10822635|NCT00283959|11988081|FG000|COMPLETED|Treatment Period||4
10822636|NCT00283959|11988081|FG000|NOT COMPLETED|Treatment Period||0
10822637|NCT00283959|11988081|FG000|STARTED|Extension Period||4
10822638|NCT00283959|11988081|FG000|COMPLETED|Extension Period||3
10822639|NCT00283959|11988081|FG000|NOT COMPLETED|Extension Period||1
10822640|NCT00290758|11988087|FG000|STARTED|Pre-Intervention rFNA Through Follow-Up||62
10822641|NCT00290758|11988088|FG001|STARTED|Pre-Intervention rFNA Through Follow-Up||64
10822642|NCT00290758|11988087|FG000|First rFNA Tissue Collection|Pre-Intervention rFNA Through Follow-Up||62
10822643|NCT00290758|11988088|FG001|First rFNA Tissue Collection|Pre-Intervention rFNA Through Follow-Up||64
10822644|NCT00290758|11988087|FG000|Randomization|Pre-Intervention rFNA Through Follow-Up||62
10822645|NCT00290758|11988088|FG001|Randomization|Pre-Intervention rFNA Through Follow-Up||62
10822646|NCT00290758|11988087|FG000|Treatment|Pre-Intervention rFNA Through Follow-Up||61
10822647|NCT00290758|11988088|FG001|Treatment|Pre-Intervention rFNA Through Follow-Up||64
10822648|NCT00290758|11988087|FG000|Post Intervention Follow-Up|Pre-Intervention rFNA Through Follow-Up||55
10822649|NCT00290758|11988088|FG001|Post Intervention Follow-Up|Pre-Intervention rFNA Through Follow-Up||54
10822650|NCT00290758|11988087|FG000|COMPLETED|Pre-Intervention rFNA Through Follow-Up||55
10822651|NCT00290758|11988088|FG001|COMPLETED|Pre-Intervention rFNA Through Follow-Up||54
10822652|NCT00290758|11988087|FG000|NOT COMPLETED|Pre-Intervention rFNA Through Follow-Up||7
10822653|NCT00290758|11988088|FG001|NOT COMPLETED|Pre-Intervention rFNA Through Follow-Up||10
10822654|NCT00290758|11988087|FG000|STARTED|Post Intervention rFNA||55
10822655|NCT00290758|11988088|FG001|STARTED|Post Intervention rFNA||54
10822656|NCT00290758|11988087|FG000|COMPLETED|Post Intervention rFNA||49
10822657|NCT00290758|11988088|FG001|COMPLETED|Post Intervention rFNA||49
10822658|NCT00290758|11988087|FG000|NOT COMPLETED|Post Intervention rFNA||6
10822659|NCT00290758|11988088|FG001|NOT COMPLETED|Post Intervention rFNA||5
10822660|NCT00310388|11988098|FG000|STARTED|Primary Reporting Phase||376
10822661|NCT00310388|11988099|FG001|STARTED|Primary Reporting Phase||0
10822662|NCT00310388|11988098|FG000|COMPLETED|Primary Reporting Phase||30
10754126|NCT03049501|11917784|FG001|12 Month Follow up|Overall Study||92
10754127|NCT03049501|11917783|FG000|COMPLETED|Overall Study||101
10754128|NCT03049501|11917784|FG001|COMPLETED|Overall Study||92
10408785|NCT00757484|11552946|FG000|STARTED|Overall Study||491
10408786|NCT00757484|11552946|FG000|COMPLETED|Overall Study||491
10408787|NCT00757484|11552946|FG000|NOT COMPLETED|Overall Study||0
10408788|NCT00757588|11552954|FG000|STARTED|Period 1: Short-term (24-week) Phase||304
10408789|NCT00757588|11552955|FG001|STARTED|Period 1: Short-term (24-week) Phase||151
10408790|NCT00757588|11552954|FG000|COMPLETED|Period 1: Short-term (24-week) Phase|Does not include 2 who completed Period 1 but were erroneously reported in the CSR as noncompleters.|268
10408791|NCT00757588|11552955|FG001|COMPLETED|Period 1: Short-term (24-week) Phase||134
10408792|NCT00757588|11552954|FG000|NOT COMPLETED|Period 1: Short-term (24-week) Phase||36
10408793|NCT00757588|11552955|FG001|NOT COMPLETED|Period 1: Short-term (24-week) Phase||17
10408794|NCT00757588|11552954|FG000|STARTED|Period 2: Long-term (52-week) Phase|270 participants completed short-term phase; 2 of these did not enter long-term phase.|268
10408795|NCT00757588|11552955|FG001|STARTED|Period 2: Long-term (52-week) Phase||134
10408796|NCT00757588|11552954|FG000|COMPLETED|Period 2: Long-term (52-week) Phase||246
10408797|NCT00757588|11552955|FG001|COMPLETED|Period 2: Long-term (52-week) Phase||125
10408798|NCT00757588|11552954|FG000|NOT COMPLETED|Period 2: Long-term (52-week) Phase||22
10408799|NCT00757588|11552955|FG001|NOT COMPLETED|Period 2: Long-term (52-week) Phase||9
10408800|NCT00757601|11552961|FG000|STARTED|Period 1||2
10408801|NCT00757601|11552962|FG001|STARTED|Period 1||2
10408802|NCT00757601|11552963|FG002|STARTED|Period 1||2
10408803|NCT00757601|11552964|FG003|STARTED|Period 1||2
10408804|NCT00757601|11552965|FG004|STARTED|Period 1||2
10408805|NCT00757601|11552966|FG005|STARTED|Period 1||2
10408806|NCT00757601|11552967|FG006|STARTED|Period 1||2
10408807|NCT00757601|11552968|FG007|STARTED|Period 1||2
10408808|NCT00757601|11552969|FG008|STARTED|Period 1||2
10408809|NCT00757601|11552970|FG009|STARTED|Period 1||2
10408810|NCT00757601|11552971|FG010|STARTED|Period 1||2
10408811|NCT00757601|11552972|FG011|STARTED|Period 1||3
10408812|NCT00757601|11552961|FG000|COMPLETED|Period 1||2
10754129|NCT03049501|11917783|FG000|NOT COMPLETED|Overall Study||22
10754130|NCT03049501|11917784|FG001|NOT COMPLETED|Overall Study||29
10754131|NCT03049748|11917792|FG000|STARTED|Overall Study||20
10754132|NCT03049748|11917793|FG001|STARTED|Overall Study||20
10754133|NCT03049748|11917792|FG000|COMPLETED|Overall Study||16
10754134|NCT03049748|11917793|FG001|COMPLETED|Overall Study||14
10754135|NCT03049748|11917792|FG000|NOT COMPLETED|Overall Study||4
10822663|NCT00310388|11988099|FG001|COMPLETED|Primary Reporting Phase||0
10822664|NCT00310388|11988098|FG000|NOT COMPLETED|Primary Reporting Phase||346
10822665|NCT00310388|11988099|FG001|NOT COMPLETED|Primary Reporting Phase||0
10822666|NCT00310388|11988098|FG000|STARTED|Safety Follow-up Continuation Phase||0
10822667|NCT00310388|11988099|FG001|STARTED|Safety Follow-up Continuation Phase||26
10822668|NCT00310388|11988098|FG000|COMPLETED|Safety Follow-up Continuation Phase||0
10822669|NCT00310388|11988099|FG001|COMPLETED|Safety Follow-up Continuation Phase||13
10822670|NCT00310388|11988098|FG000|NOT COMPLETED|Safety Follow-up Continuation Phase||0
10822671|NCT00310388|11988099|FG001|NOT COMPLETED|Safety Follow-up Continuation Phase||13
10822672|NCT04651114|11988104|FG000|STARTED|Overall Study||38
10822673|NCT04651114|11988104|FG000|COMPLETED|Overall Study||30
10822674|NCT04651114|11988104|FG000|NOT COMPLETED|Overall Study||8
10822685|NCT04346537|11988118|FG000|STARTED|Overall Study|8 subjects did not undergo the implant procedure and did not have the INGEVITY+ lead implanted or attempted.|109
10822686|NCT04346537|11988118|FG000|Implanted/Attempted With INGEVITY+ Lead|Overall Study||101
10822687|NCT04346537|11988118|FG000|COMPLETED|Overall Study||99
10822688|NCT04346537|11988118|FG000|NOT COMPLETED|Overall Study||10
10822689|NCT04344600|11988125|FG000|STARTED|Overall Study||2
10822690|NCT04344600|11988126|FG001|STARTED|Overall Study||4
10822691|NCT04344600|11988125|FG000|COMPLETED|Overall Study||2
10822692|NCT04344600|11988126|FG001|COMPLETED|Overall Study||4
10822693|NCT04344600|11988125|FG000|NOT COMPLETED|Overall Study||0
10754136|NCT03049748|11917793|FG001|NOT COMPLETED|Overall Study||6
10754137|NCT03049852|11917802|FG000|STARTED|Overall Study||24
10754138|NCT03049852|11917803|FG001|STARTED|Overall Study||25
10754139|NCT03049852|11917804|FG002|STARTED|Overall Study||26
10754140|NCT03049852|11917802|FG000|COMPLETED|Overall Study||24
10754141|NCT03049852|11917803|FG001|COMPLETED|Overall Study||24
10754142|NCT03049852|11917804|FG002|COMPLETED|Overall Study||26
10408813|NCT00757601|11552962|FG001|COMPLETED|Period 1||2
10408814|NCT00757601|11552963|FG002|COMPLETED|Period 1||2
10408815|NCT00757601|11552964|FG003|COMPLETED|Period 1||2
10754143|NCT03049852|11917802|FG000|NOT COMPLETED|Overall Study||0
10822694|NCT04344600|11988126|FG001|NOT COMPLETED|Overall Study||0
10822704|NCT03780387|11988140|FG000|STARTED|Overall Study||1
10822705|NCT03780387|11988140|FG000|COMPLETED|Overall Study||1
10822706|NCT03780387|11988140|FG000|NOT COMPLETED|Overall Study||0
10822707|NCT03768089|11988162|FG000|STARTED|Part A||8
10822708|NCT03768089|11988163|FG001|STARTED|Part A||5
10822709|NCT03768089|11988164|FG002|STARTED|Part A||6
10822710|NCT03768089|11988165|FG003|STARTED|Part A||6
10822711|NCT03768089|11988166|FG004|STARTED|Part A||6
10822712|NCT03768089|11988167|FG005|STARTED|Part A||6
10822713|NCT03768089|11988168|FG006|STARTED|Part A||8
10290317|NCT04334460|11422992|FG000|STARTED|Full Enrollment||81
10290318|NCT04334460|11422993|FG001|STARTED|Full Enrollment||39
10290319|NCT04334460|11422992|FG000|COMPLETED|Full Enrollment||81
10290320|NCT04334460|11422993|FG001|COMPLETED|Full Enrollment||39
10290321|NCT04334460|11422992|FG000|NOT COMPLETED|Full Enrollment||0
10290322|NCT04334460|11422993|FG001|NOT COMPLETED|Full Enrollment||0
10290323|NCT04334460|11422992|FG000|STARTED|Full Analysis Set (FAS)||81
10290324|NCT04334460|11422993|FG001|STARTED|Full Analysis Set (FAS)||39
10290325|NCT04334460|11422992|FG000|COMPLETED|Full Analysis Set (FAS)||77
10290326|NCT04334460|11422993|FG001|COMPLETED|Full Analysis Set (FAS)||38
10290327|NCT04334460|11422992|FG000|NOT COMPLETED|Full Analysis Set (FAS)||4
10290328|NCT04334460|11422993|FG001|NOT COMPLETED|Full Analysis Set (FAS)||1
10290329|NCT04334460|11422992|FG000|STARTED|Safety Analysis Population||81
10290330|NCT04334460|11422993|FG001|STARTED|Safety Analysis Population||39
10290331|NCT04334460|11422992|FG000|COMPLETED|Safety Analysis Population||77
10290332|NCT04334460|11422993|FG001|COMPLETED|Safety Analysis Population||38
10290333|NCT04334460|11422992|FG000|NOT COMPLETED|Safety Analysis Population||4
10290334|NCT04334460|11422993|FG001|NOT COMPLETED|Safety Analysis Population||1
10313075|NCT00147537|11446572|FG009|NOT COMPLETED|Phase 2||161
10313076|NCT00147537|11446573|FG010|NOT COMPLETED|Phase 2||52
10313077|NCT00147745|11446621|FG000|STARTED|Overall Study||16
10313078|NCT00147745|11446622|FG001|STARTED|Overall Study||14
10313079|NCT00147745|11446623|FG002|STARTED|Overall Study||6
10313080|NCT00147745|11446621|FG000|COMPLETED|Overall Study||15
10313081|NCT00147745|11446622|FG001|COMPLETED|Overall Study||14
10313082|NCT00147745|11446623|FG002|COMPLETED|Overall Study||6
10313083|NCT00147745|11446621|FG000|NOT COMPLETED|Overall Study||1
10313084|NCT00147745|11446622|FG001|NOT COMPLETED|Overall Study||0
10313085|NCT00147745|11446623|FG002|NOT COMPLETED|Overall Study||0
10313086|NCT00147823|11446633|FG000|STARTED|Overall Study||32
10313087|NCT00147823|11446634|FG001|STARTED|Overall Study||31
10313088|NCT00147823|11446633|FG000|Week 6 Visit|Overall Study||26
10313089|NCT00147823|11446634|FG001|Week 6 Visit|Overall Study||28
10313090|NCT00147823|11446633|FG000|Month 3 Visit|Overall Study||25
10313091|NCT00147823|11446634|FG001|Month 3 Visit|Overall Study||24
10313092|NCT00147823|11446633|FG000|Month 6 Visit|Overall Study||25
10313093|NCT00147823|11446634|FG001|Month 6 Visit|Overall Study||21
10313094|NCT00147823|11446633|FG000|Month 12 Visit|Overall Study||21
10313095|NCT00147823|11446634|FG001|Month 12 Visit|Overall Study|Subjects are counted at each milestone as that is when data is collectec|25
10313096|NCT00147823|11446633|FG000|Month 12 CT Scan|Overall Study||20
10313097|NCT00147823|11446634|FG001|Month 12 CT Scan|Overall Study||25
10313098|NCT00147823|11446633|FG000|Month 18 Visit|Overall Study|As stated previously ea. subject is counted at each milestone, as data is collected at ea. timepoint|21
10313099|NCT00147823|11446634|FG001|Month 18 Visit|Overall Study||20
10313100|NCT00147823|11446633|FG000|Month 24 Visit|Overall Study||21
10313101|NCT00147823|11446634|FG001|Month 24 Visit|Overall Study||18
10313102|NCT00147823|11446633|FG000|COMPLETED|Overall Study||19
10313103|NCT00147823|11446634|FG001|COMPLETED|Overall Study||16
10822714|NCT03768089|11988169|FG007|STARTED|Part A||0
10822715|NCT03768089|11988170|FG008|STARTED|Part A||0
10822716|NCT03768089|11988171|FG009|STARTED|Part A||0
10822717|NCT03768089|11988172|FG010|STARTED|Part A||0
10822718|NCT03768089|11988173|FG011|STARTED|Part A||0
10822719|NCT03768089|11988174|FG012|STARTED|Part A||0
10822720|NCT03768089|11988175|FG013|STARTED|Part A||0
10822721|NCT03768089|11988176|FG014|STARTED|Part A||0
10822722|NCT03768089|11988177|FG015|STARTED|Part A||0
10822723|NCT03768089|11988178|FG016|STARTED|Part A||0
10822724|NCT03768089|11988179|FG017|STARTED|Part A||0
10822725|NCT03768089|11988162|FG000|Safety Set|Part A||8
10822726|NCT03768089|11988163|FG001|Safety Set|Part A||5
10313104|NCT00147823|11446633|FG000|NOT COMPLETED|Overall Study||13
10822727|NCT03768089|11988164|FG002|Safety Set|Part A||6
10822728|NCT03768089|11988165|FG003|Safety Set|Part A||6
10822729|NCT03768089|11988166|FG004|Safety Set|Part A||6
10822730|NCT03768089|11988167|FG005|Safety Set|Part A||6
10822731|NCT03768089|11988168|FG006|Safety Set|Part A||8
10822732|NCT03768089|11988169|FG007|Safety Set|Part A||0
10822733|NCT03768089|11988170|FG008|Safety Set|Part A||0
10822734|NCT03768089|11988171|FG009|Safety Set|Part A||0
10822735|NCT03768089|11988172|FG010|Safety Set|Part A||0
10822736|NCT03768089|11988173|FG011|Safety Set|Part A||0
10822737|NCT03768089|11988174|FG012|Safety Set|Part A||0
10822738|NCT03768089|11988175|FG013|Safety Set|Part A||0
10822739|NCT03768089|11988176|FG014|Safety Set|Part A||0
10822740|NCT03768089|11988177|FG015|Safety Set|Part A||0
10822741|NCT03768089|11988178|FG016|Safety Set|Part A||0
10822742|NCT03768089|11988179|FG017|Safety Set|Part A||0
10822743|NCT03768089|11988162|FG000|COMPLETED|Part A||8
10822744|NCT03768089|11988163|FG001|COMPLETED|Part A||5
10822745|NCT03768089|11988164|FG002|COMPLETED|Part A||6
10822746|NCT03768089|11988165|FG003|COMPLETED|Part A||6
10822747|NCT03768089|11988166|FG004|COMPLETED|Part A||5
10822748|NCT03768089|11988167|FG005|COMPLETED|Part A||6
10822749|NCT03768089|11988168|FG006|COMPLETED|Part A||8
10822750|NCT03768089|11988169|FG007|COMPLETED|Part A||0
10822751|NCT03768089|11988170|FG008|COMPLETED|Part A||0
10822752|NCT03768089|11988171|FG009|COMPLETED|Part A||0
10822753|NCT03768089|11988172|FG010|COMPLETED|Part A||0
10822754|NCT03768089|11988173|FG011|COMPLETED|Part A||0
10822755|NCT03768089|11988174|FG012|COMPLETED|Part A||0
10822756|NCT03768089|11988175|FG013|COMPLETED|Part A||0
10822757|NCT03768089|11988176|FG014|COMPLETED|Part A||0
10822758|NCT03768089|11988177|FG015|COMPLETED|Part A||0
10822759|NCT03768089|11988178|FG016|COMPLETED|Part A||0
10822760|NCT03768089|11988179|FG017|COMPLETED|Part A||0
10822761|NCT03768089|11988162|FG000|NOT COMPLETED|Part A||0
10822762|NCT03768089|11988163|FG001|NOT COMPLETED|Part A||0
10822763|NCT03768089|11988164|FG002|NOT COMPLETED|Part A||0
10822764|NCT03768089|11988165|FG003|NOT COMPLETED|Part A||0
10822765|NCT03768089|11988166|FG004|NOT COMPLETED|Part A||1
10822766|NCT03768089|11988167|FG005|NOT COMPLETED|Part A||0
10822767|NCT03768089|11988168|FG006|NOT COMPLETED|Part A||0
10822768|NCT03768089|11988169|FG007|NOT COMPLETED|Part A||0
10822769|NCT03768089|11988170|FG008|NOT COMPLETED|Part A||0
10822770|NCT03768089|11988171|FG009|NOT COMPLETED|Part A||0
10822771|NCT03768089|11988172|FG010|NOT COMPLETED|Part A||0
10822772|NCT03768089|11988173|FG011|NOT COMPLETED|Part A||0
10822773|NCT03768089|11988174|FG012|NOT COMPLETED|Part A||0
10822774|NCT03768089|11988175|FG013|NOT COMPLETED|Part A||0
10822775|NCT03768089|11988176|FG014|NOT COMPLETED|Part A||0
10822776|NCT03768089|11988177|FG015|NOT COMPLETED|Part A||0
10822777|NCT03768089|11988178|FG016|NOT COMPLETED|Part A||0
10822778|NCT03768089|11988179|FG017|NOT COMPLETED|Part A||0
10822779|NCT03768089|11988162|FG000|STARTED|Part B||0
10822780|NCT03768089|11988163|FG001|STARTED|Part B||0
10822781|NCT03768089|11988164|FG002|STARTED|Part B||0
10822782|NCT03768089|11988165|FG003|STARTED|Part B||0
10822783|NCT03768089|11988166|FG004|STARTED|Part B||0
10822784|NCT03768089|11988167|FG005|STARTED|Part B||0
10822785|NCT03768089|11988168|FG006|STARTED|Part B||0
10822786|NCT03768089|11988169|FG007|STARTED|Part B||9
10822787|NCT03768089|11988170|FG008|STARTED|Part B||6
10822788|NCT03768089|11988171|FG009|STARTED|Part B||6
10822789|NCT03768089|11988172|FG010|STARTED|Part B|One participant who participated in A2 also participated in B3.|6
10822790|NCT03768089|11988173|FG011|STARTED|Part B||6
10822791|NCT03768089|11988174|FG012|STARTED|Part B||0
10822792|NCT03768089|11988175|FG013|STARTED|Part B||0
10822793|NCT03768089|11988176|FG014|STARTED|Part B||0
10822794|NCT03768089|11988177|FG015|STARTED|Part B||0
10822795|NCT03768089|11988178|FG016|STARTED|Part B||0
10822796|NCT03768089|11988179|FG017|STARTED|Part B||0
10822797|NCT03768089|11988162|FG000|Safety Set|Part B||0
10822798|NCT03768089|11988163|FG001|Safety Set|Part B||0
10822799|NCT03768089|11988164|FG002|Safety Set|Part B||0
10822800|NCT03768089|11988165|FG003|Safety Set|Part B||0
10822801|NCT03768089|11988166|FG004|Safety Set|Part B||0
10822802|NCT03768089|11988167|FG005|Safety Set|Part B||0
10822803|NCT03768089|11988168|FG006|Safety Set|Part B||0
10822804|NCT03768089|11988169|FG007|Safety Set|Part B||9
10822805|NCT03768089|11988170|FG008|Safety Set|Part B||6
10822806|NCT03768089|11988171|FG009|Safety Set|Part B||6
10822807|NCT03768089|11988172|FG010|Safety Set|Part B||6
10822808|NCT03768089|11988173|FG011|Safety Set|Part B||6
10822809|NCT03768089|11988174|FG012|Safety Set|Part B||0
10822810|NCT03768089|11988175|FG013|Safety Set|Part B||0
10822811|NCT03768089|11988176|FG014|Safety Set|Part B||0
10822812|NCT03768089|11988177|FG015|Safety Set|Part B||0
10822813|NCT03768089|11988178|FG016|Safety Set|Part B||0
10822814|NCT03768089|11988179|FG017|Safety Set|Part B||0
10822815|NCT03768089|11988162|FG000|COMPLETED|Part B||0
10822816|NCT03768089|11988163|FG001|COMPLETED|Part B||0
10822817|NCT03768089|11988164|FG002|COMPLETED|Part B||0
10822818|NCT03768089|11988165|FG003|COMPLETED|Part B||0
10822819|NCT03768089|11988166|FG004|COMPLETED|Part B||0
10822820|NCT03768089|11988167|FG005|COMPLETED|Part B||0
10822821|NCT03768089|11988168|FG006|COMPLETED|Part B||0
10822822|NCT03768089|11988169|FG007|COMPLETED|Part B||9
10822823|NCT03768089|11988170|FG008|COMPLETED|Part B||6
10822824|NCT03768089|11988171|FG009|COMPLETED|Part B||6
10822825|NCT03768089|11988172|FG010|COMPLETED|Part B||6
10822826|NCT03768089|11988173|FG011|COMPLETED|Part B||6
10822827|NCT03768089|11988174|FG012|COMPLETED|Part B||0
10822828|NCT03768089|11988175|FG013|COMPLETED|Part B||0
10822829|NCT03768089|11988176|FG014|COMPLETED|Part B||0
10822830|NCT03768089|11988177|FG015|COMPLETED|Part B||0
10822831|NCT03768089|11988178|FG016|COMPLETED|Part B||0
10822832|NCT03768089|11988179|FG017|COMPLETED|Part B||0
10822833|NCT03768089|11988162|FG000|NOT COMPLETED|Part B||0
10822834|NCT03768089|11988163|FG001|NOT COMPLETED|Part B||0
10822835|NCT03768089|11988164|FG002|NOT COMPLETED|Part B||0
10822836|NCT03768089|11988165|FG003|NOT COMPLETED|Part B||0
10822837|NCT03768089|11988166|FG004|NOT COMPLETED|Part B||0
10822838|NCT03768089|11988167|FG005|NOT COMPLETED|Part B||0
10822839|NCT03768089|11988168|FG006|NOT COMPLETED|Part B||0
10822840|NCT03768089|11988169|FG007|NOT COMPLETED|Part B||0
10822841|NCT03768089|11988170|FG008|NOT COMPLETED|Part B||0
10822842|NCT03768089|11988171|FG009|NOT COMPLETED|Part B||0
10822843|NCT03768089|11988172|FG010|NOT COMPLETED|Part B||0
10822844|NCT03768089|11988173|FG011|NOT COMPLETED|Part B||0
10822845|NCT03768089|11988174|FG012|NOT COMPLETED|Part B||0
10822846|NCT03768089|11988175|FG013|NOT COMPLETED|Part B||0
10822847|NCT03768089|11988176|FG014|NOT COMPLETED|Part B||0
10822848|NCT03768089|11988177|FG015|NOT COMPLETED|Part B||0
10822849|NCT03768089|11988178|FG016|NOT COMPLETED|Part B||0
10822850|NCT03768089|11988179|FG017|NOT COMPLETED|Part B||0
10822851|NCT03768089|11988162|FG000|STARTED|Part C||0
10822852|NCT03768089|11988163|FG001|STARTED|Part C||0
10822853|NCT03768089|11988164|FG002|STARTED|Part C||0
10822854|NCT03768089|11988165|FG003|STARTED|Part C||0
10822855|NCT03768089|11988166|FG004|STARTED|Part C||0
10822856|NCT03768089|11988167|FG005|STARTED|Part C||0
10822857|NCT03768089|11988168|FG006|STARTED|Part C||0
10822858|NCT03768089|11988169|FG007|STARTED|Part C||0
10822859|NCT03768089|11988170|FG008|STARTED|Part C||0
10822860|NCT03768089|11988171|FG009|STARTED|Part C||0
10822861|NCT03768089|11988172|FG010|STARTED|Part C||0
10822862|NCT03768089|11988173|FG011|STARTED|Part C||0
10822863|NCT03768089|11988174|FG012|STARTED|Part C||6
10822864|NCT03768089|11988175|FG013|STARTED|Part C||6
10822865|NCT03768089|11988176|FG014|STARTED|Part C||8
10822866|NCT03768089|11988177|FG015|STARTED|Part C||6
10822867|NCT03768089|11988178|FG016|STARTED|Part C||0
10822868|NCT03768089|11988179|FG017|STARTED|Part C||0
10822869|NCT03768089|11988162|FG000|Safety Set|Part C||0
10822870|NCT03768089|11988163|FG001|Safety Set|Part C||0
10822871|NCT03768089|11988164|FG002|Safety Set|Part C||0
10822872|NCT03768089|11988165|FG003|Safety Set|Part C||0
10822873|NCT03768089|11988166|FG004|Safety Set|Part C||0
10822874|NCT03768089|11988167|FG005|Safety Set|Part C||0
10822875|NCT03768089|11988168|FG006|Safety Set|Part C||0
10822876|NCT03768089|11988169|FG007|Safety Set|Part C||0
10822877|NCT03768089|11988170|FG008|Safety Set|Part C||0
10822878|NCT03768089|11988171|FG009|Safety Set|Part C||0
10822879|NCT03768089|11988172|FG010|Safety Set|Part C||0
10822880|NCT03768089|11988173|FG011|Safety Set|Part C||0
10822881|NCT03768089|11988174|FG012|Safety Set|Part C||6
10822882|NCT03768089|11988175|FG013|Safety Set|Part C||6
10822883|NCT03768089|11988176|FG014|Safety Set|Part C||7
10822884|NCT03768089|11988177|FG015|Safety Set|Part C||6
10822885|NCT03768089|11988178|FG016|Safety Set|Part C||0
10822886|NCT03768089|11988179|FG017|Safety Set|Part C||0
10822887|NCT03768089|11988162|FG000|COMPLETED|Part C||0
10822888|NCT03768089|11988163|FG001|COMPLETED|Part C||0
10822889|NCT03768089|11988164|FG002|COMPLETED|Part C||0
10822890|NCT03768089|11988165|FG003|COMPLETED|Part C||0
10822891|NCT03768089|11988166|FG004|COMPLETED|Part C||0
10822892|NCT03768089|11988167|FG005|COMPLETED|Part C||0
10822893|NCT03768089|11988168|FG006|COMPLETED|Part C||0
10822894|NCT03768089|11988169|FG007|COMPLETED|Part C||0
10822895|NCT03768089|11988170|FG008|COMPLETED|Part C||0
10822896|NCT03768089|11988171|FG009|COMPLETED|Part C||0
10822897|NCT03768089|11988172|FG010|COMPLETED|Part C||0
10822898|NCT03768089|11988173|FG011|COMPLETED|Part C||0
10822899|NCT03768089|11988174|FG012|COMPLETED|Part C||6
10822900|NCT03768089|11988175|FG013|COMPLETED|Part C||6
10822901|NCT03768089|11988176|FG014|COMPLETED|Part C||7
10822902|NCT03768089|11988177|FG015|COMPLETED|Part C||6
10822903|NCT03768089|11988178|FG016|COMPLETED|Part C||0
10822904|NCT03768089|11988179|FG017|COMPLETED|Part C||0
10822905|NCT03768089|11988162|FG000|NOT COMPLETED|Part C||0
10822906|NCT03768089|11988163|FG001|NOT COMPLETED|Part C||0
10822907|NCT03768089|11988164|FG002|NOT COMPLETED|Part C||0
10822908|NCT03768089|11988165|FG003|NOT COMPLETED|Part C||0
10822909|NCT03768089|11988166|FG004|NOT COMPLETED|Part C||0
10822910|NCT03768089|11988167|FG005|NOT COMPLETED|Part C||0
10822911|NCT03768089|11988168|FG006|NOT COMPLETED|Part C||0
10822912|NCT03768089|11988169|FG007|NOT COMPLETED|Part C||0
10822913|NCT03768089|11988170|FG008|NOT COMPLETED|Part C||0
10822914|NCT03768089|11988171|FG009|NOT COMPLETED|Part C||0
10822915|NCT03768089|11988172|FG010|NOT COMPLETED|Part C||0
10822916|NCT03768089|11988173|FG011|NOT COMPLETED|Part C||0
10822917|NCT03768089|11988174|FG012|NOT COMPLETED|Part C||0
10822918|NCT03768089|11988175|FG013|NOT COMPLETED|Part C||0
10822919|NCT03768089|11988176|FG014|NOT COMPLETED|Part C||1
10822920|NCT03768089|11988177|FG015|NOT COMPLETED|Part C||0
10822921|NCT03768089|11988178|FG016|NOT COMPLETED|Part C||0
10822922|NCT03768089|11988179|FG017|NOT COMPLETED|Part C||0
10822923|NCT03768089|11988162|FG000|STARTED|Part D||0
10822924|NCT03768089|11988163|FG001|STARTED|Part D||0
10822925|NCT03768089|11988164|FG002|STARTED|Part D||0
10822926|NCT03768089|11988165|FG003|STARTED|Part D||0
10822927|NCT03768089|11988166|FG004|STARTED|Part D||0
10822928|NCT03768089|11988167|FG005|STARTED|Part D||0
10822929|NCT03768089|11988168|FG006|STARTED|Part D||0
10822930|NCT03768089|11988169|FG007|STARTED|Part D||0
10822931|NCT03768089|11988170|FG008|STARTED|Part D||0
10822932|NCT03768089|11988171|FG009|STARTED|Part D||0
10822933|NCT03768089|11988172|FG010|STARTED|Part D||0
10822934|NCT03768089|11988173|FG011|STARTED|Part D||0
10822935|NCT03768089|11988174|FG012|STARTED|Part D||0
10822936|NCT03768089|11988175|FG013|STARTED|Part D||0
10822937|NCT03768089|11988176|FG014|STARTED|Part D||0
10822938|NCT03768089|11988177|FG015|STARTED|Part D||0
10822939|NCT03768089|11988178|FG016|STARTED|Part D||3
10822940|NCT03768089|11988179|FG017|STARTED|Part D||9
10822941|NCT03768089|11988162|FG000|Safety Set|Part D||0
10822942|NCT03768089|11988163|FG001|Safety Set|Part D||0
10822943|NCT03768089|11988164|FG002|Safety Set|Part D||0
10822944|NCT03768089|11988165|FG003|Safety Set|Part D||0
10822945|NCT03768089|11988166|FG004|Safety Set|Part D||0
10822946|NCT03768089|11988167|FG005|Safety Set|Part D||0
10822947|NCT03768089|11988168|FG006|Safety Set|Part D||0
10822948|NCT03768089|11988169|FG007|Safety Set|Part D||0
10822949|NCT03768089|11988170|FG008|Safety Set|Part D||0
10822950|NCT03768089|11988171|FG009|Safety Set|Part D||0
10822951|NCT03768089|11988172|FG010|Safety Set|Part D||0
10822952|NCT03768089|11988173|FG011|Safety Set|Part D||0
10822953|NCT03768089|11988174|FG012|Safety Set|Part D||0
10822954|NCT03768089|11988175|FG013|Safety Set|Part D||0
10822955|NCT03768089|11988176|FG014|Safety Set|Part D||0
10822956|NCT03768089|11988177|FG015|Safety Set|Part D||0
10822957|NCT03768089|11988178|FG016|Safety Set|Part D||3
10822958|NCT03768089|11988179|FG017|Safety Set|Part D||9
10822959|NCT03768089|11988162|FG000|COMPLETED|Part D||0
10822960|NCT03768089|11988163|FG001|COMPLETED|Part D||0
10822961|NCT03768089|11988164|FG002|COMPLETED|Part D||0
10822962|NCT03768089|11988165|FG003|COMPLETED|Part D||0
10822963|NCT03768089|11988166|FG004|COMPLETED|Part D||0
10822964|NCT03768089|11988167|FG005|COMPLETED|Part D||0
10822965|NCT03768089|11988168|FG006|COMPLETED|Part D||0
10822966|NCT03768089|11988169|FG007|COMPLETED|Part D||0
10822967|NCT03768089|11988170|FG008|COMPLETED|Part D||0
10822968|NCT03768089|11988171|FG009|COMPLETED|Part D||0
10822969|NCT03768089|11988172|FG010|COMPLETED|Part D||0
10822970|NCT03768089|11988173|FG011|COMPLETED|Part D||0
10822971|NCT03768089|11988174|FG012|COMPLETED|Part D||0
10822972|NCT03768089|11988175|FG013|COMPLETED|Part D||0
10822973|NCT03768089|11988176|FG014|COMPLETED|Part D||0
10822974|NCT03768089|11988177|FG015|COMPLETED|Part D||0
10822975|NCT03768089|11988178|FG016|COMPLETED|Part D||3
10822976|NCT03768089|11988179|FG017|COMPLETED|Part D||9
10822977|NCT03768089|11988162|FG000|NOT COMPLETED|Part D||0
10822978|NCT03768089|11988163|FG001|NOT COMPLETED|Part D||0
10822979|NCT03768089|11988164|FG002|NOT COMPLETED|Part D||0
10822980|NCT03768089|11988165|FG003|NOT COMPLETED|Part D||0
10822981|NCT03768089|11988166|FG004|NOT COMPLETED|Part D||0
10822982|NCT03768089|11988167|FG005|NOT COMPLETED|Part D||0
10822983|NCT03768089|11988168|FG006|NOT COMPLETED|Part D||0
10822984|NCT03768089|11988169|FG007|NOT COMPLETED|Part D||0
10822985|NCT03768089|11988170|FG008|NOT COMPLETED|Part D||0
10822986|NCT03768089|11988171|FG009|NOT COMPLETED|Part D||0
10822987|NCT03768089|11988172|FG010|NOT COMPLETED|Part D||0
10822988|NCT03768089|11988173|FG011|NOT COMPLETED|Part D||0
10822989|NCT03768089|11988174|FG012|NOT COMPLETED|Part D||0
10822990|NCT03768089|11988175|FG013|NOT COMPLETED|Part D||0
10822991|NCT03768089|11988176|FG014|NOT COMPLETED|Part D||0
10822992|NCT03768089|11988177|FG015|NOT COMPLETED|Part D||0
10822993|NCT03768089|11988178|FG016|NOT COMPLETED|Part D||0
10822994|NCT03768089|11988179|FG017|NOT COMPLETED|Part D||0
10822995|NCT03690544|11988234|FG000|STARTED|Overall Study||15
10822996|NCT03690544|11988234|FG000|COMPLETED|Overall Study||15
10822997|NCT03690544|11988234|FG000|NOT COMPLETED|Overall Study||0
10823019|NCT03446573|11988255|FG000|STARTED|Overall Study||369
10823020|NCT03446573|11988256|FG001|STARTED|Overall Study||372
10823021|NCT03446573|11988255|FG000|COMPLETED|Overall Study||0
10823022|NCT03446573|11988256|FG001|COMPLETED|Overall Study||0
10823023|NCT03446573|11988255|FG000|NOT COMPLETED|Overall Study||369
10823024|NCT03446573|11988256|FG001|NOT COMPLETED|Overall Study||372
10823025|NCT03409666|11988267|FG000|STARTED|Overall Study||25
10823026|NCT03409666|11988268|FG001|STARTED|Overall Study||25
10823027|NCT03409666|11988267|FG000|COMPLETED|Overall Study||25
10823028|NCT03409666|11988268|FG001|COMPLETED|Overall Study||21
10823029|NCT03409666|11988267|FG000|NOT COMPLETED|Overall Study||0
10823030|NCT03409666|11988268|FG001|NOT COMPLETED|Overall Study||4
10823043|NCT03325426|11988293|FG000|STARTED|Overall Study||21
10823044|NCT03325426|11988294|FG001|STARTED|Overall Study||42
10823045|NCT03325426|11988293|FG000|COMPLETED|Overall Study||11
10823046|NCT03325426|11988294|FG001|COMPLETED|Overall Study||18
10823047|NCT03325426|11988293|FG000|NOT COMPLETED|Overall Study||10
10823048|NCT03325426|11988294|FG001|NOT COMPLETED|Overall Study||24
10823049|NCT03195088|11988306|FG000|STARTED|Overall Study||4
10823050|NCT03195088|11988307|FG001|STARTED|Overall Study||6
10823051|NCT03195088|11988308|FG002|STARTED|Overall Study||6
10823052|NCT03195088|11988306|FG000|COMPLETED|Overall Study||4
10823053|NCT03195088|11988307|FG001|COMPLETED|Overall Study||6
10823054|NCT03195088|11988308|FG002|COMPLETED|Overall Study||6
10823055|NCT03195088|11988306|FG000|NOT COMPLETED|Overall Study||0
10823056|NCT03195088|11988307|FG001|NOT COMPLETED|Overall Study||0
10290335|NCT04247828|11423000|FG000|STARTED|Overall Study||30
10290336|NCT04247828|11423000|FG000|Started - Controls|Overall Study||19
10290337|NCT04247828|11423000|FG000|Started - Participants With SPI|Overall Study||11
10290338|NCT04247828|11423000|FG000|COMPLETED|Overall Study|16 controls and 5 participants with SPI completed the study|21
10290339|NCT04247828|11423000|FG000|NOT COMPLETED|Overall Study||9
10290340|NCT04084769|11423008|FG000|STARTED|Overall Study||191
10290341|NCT04084769|11423009|FG001|STARTED|Overall Study||190
10408816|NCT00757601|11552965|FG004|COMPLETED|Period 1||2
10408817|NCT00757601|11552966|FG005|COMPLETED|Period 1||2
10408818|NCT00757601|11552967|FG006|COMPLETED|Period 1||2
10408819|NCT00757601|11552968|FG007|COMPLETED|Period 1||2
10408820|NCT00757601|11552969|FG008|COMPLETED|Period 1||2
10408821|NCT00757601|11552970|FG009|COMPLETED|Period 1||2
10408822|NCT00757601|11552971|FG010|COMPLETED|Period 1||2
10408823|NCT00757601|11552972|FG011|COMPLETED|Period 1||3
10408824|NCT00757601|11552961|FG000|NOT COMPLETED|Period 1||0
10408825|NCT00757601|11552962|FG001|NOT COMPLETED|Period 1||0
10408826|NCT00757601|11552963|FG002|NOT COMPLETED|Period 1||0
10823057|NCT03195088|11988308|FG002|NOT COMPLETED|Overall Study||0
10823064|NCT03126019|11988341|FG000|STARTED|Overall Study||23
10823065|NCT03126019|11988342|FG001|STARTED|Overall Study||103
10823066|NCT03126019|11988341|FG000|COMPLETED|Overall Study||0
10823067|NCT03126019|11988342|FG001|COMPLETED|Overall Study||0
10823068|NCT03126019|11988341|FG000|NOT COMPLETED|Overall Study||23
10823069|NCT03126019|11988342|FG001|NOT COMPLETED|Overall Study||103
10823070|NCT03114059|11988349|FG000|STARTED|Overall Study||230
10823071|NCT03114059|11988349|FG000|COMPLETED|Overall Study||230
10823072|NCT03114059|11988349|FG000|NOT COMPLETED|Overall Study||0
10823083|NCT03089606|11988362|FG000|STARTED|Overall Study||27
10823084|NCT03089606|11988362|FG000|COMPLETED|Overall Study||26
10823085|NCT03089606|11988362|FG000|NOT COMPLETED|Overall Study||1
10823086|NCT03082391|11988374|FG000|STARTED|Overall Study||173
10823087|NCT03082391|11988375|FG001|STARTED|Overall Study||177
10823088|NCT03082391|11988374|FG000|COMPLETED|Overall Study||173
10823089|NCT03082391|11988375|FG001|COMPLETED|Overall Study||177
10823090|NCT03082391|11988374|FG000|NOT COMPLETED|Overall Study||0
10823091|NCT03082391|11988375|FG001|NOT COMPLETED|Overall Study||0
10823092|NCT03049111|11988381|FG000|STARTED|Overall Study||14
10290342|NCT04084769|11423010|FG002|STARTED|Overall Study||95
10823093|NCT03049111|11988381|FG000|COMPLETED|Overall Study||14
10290343|NCT04084769|11423011|FG003|STARTED|Overall Study||94
10290344|NCT04084769|11423008|FG000|Safety Analysis Set (SAfAS)|Overall Study||186
10290345|NCT04084769|11423009|FG001|Safety Analysis Set (SAfAS)|Overall Study||184
10823094|NCT03049111|11988381|FG000|NOT COMPLETED|Overall Study||0
10823095|NCT02955602|11988388|FG000|STARTED|Overall Study||11
10823096|NCT02955602|11988389|FG001|STARTED|Overall Study||53
10823097|NCT02955602|11988390|FG002|STARTED|Overall Study||55
10823098|NCT02955602|11988388|FG000|COMPLETED|Overall Study||10
10823099|NCT02955602|11988389|FG001|COMPLETED|Overall Study||46
10823100|NCT02955602|11988390|FG002|COMPLETED|Overall Study||49
10823101|NCT02955602|11988388|FG000|NOT COMPLETED|Overall Study||1
10823102|NCT02955602|11988389|FG001|NOT COMPLETED|Overall Study||7
10823103|NCT02955602|11988390|FG002|NOT COMPLETED|Overall Study||6
10823107|NCT02850016|11988405|FG000|STARTED|Overall Study||11
10823108|NCT02850016|11988406|FG001|STARTED|Overall Study||9
10823109|NCT02850016|11988405|FG000|COMPLETED|Overall Study||10
10823110|NCT02850016|11988406|FG001|COMPLETED|Overall Study||7
10823111|NCT02850016|11988405|FG000|NOT COMPLETED|Overall Study||1
10823112|NCT02850016|11988406|FG001|NOT COMPLETED|Overall Study||2
10823113|NCT02846545|11988414|FG000|STARTED|Active Treatment Period: Week 0-52||28
10823114|NCT02846545|11988415|FG001|STARTED|Active Treatment Period: Week 0-52||56
10823115|NCT02846545|11988414|FG000|COMPLETED|Active Treatment Period: Week 0-52||25
10823116|NCT02846545|11988415|FG001|COMPLETED|Active Treatment Period: Week 0-52||50
10823117|NCT02846545|11988414|FG000|NOT COMPLETED|Active Treatment Period: Week 0-52||3
10823118|NCT02846545|11988415|FG001|NOT COMPLETED|Active Treatment Period: Week 0-52||6
10823119|NCT02846545|11988414|FG000|STARTED|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60||25
10823120|NCT02846545|11988415|FG001|STARTED|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|1 participant from the golimumab treatment group terminated study participation on the day of the Week 52 visit.|49
10823121|NCT02846545|11988414|FG000|Participants Who Entered OLE Period|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60||0
10823122|NCT02846545|11988415|FG001|Participants Who Entered OLE Period|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60||5
10823123|NCT02846545|11988414|FG000|Participants Who Completed OLE Period|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60||0
10823124|NCT02846545|11988415|FG001|Participants Who Completed OLE Period|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60||1
10823125|NCT02846545|11988414|FG000|COMPLETED|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60||23
10823126|NCT02846545|11988415|FG001|COMPLETED|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60||47
10823127|NCT02846545|11988414|FG000|NOT COMPLETED|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60||2
10823128|NCT02846545|11988415|FG001|NOT COMPLETED|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60||2
10823129|NCT02841644|11988427|FG000|STARTED|Overall Study||60
10823130|NCT02841644|11988428|FG001|STARTED|Overall Study||120
10823131|NCT02841644|11988427|FG000|COMPLETED|Overall Study||60
10823132|NCT02841644|11988428|FG001|COMPLETED|Overall Study||120
10823133|NCT02841644|11988427|FG000|NOT COMPLETED|Overall Study||0
10823134|NCT02841644|11988428|FG001|NOT COMPLETED|Overall Study||0
10823135|NCT02838979|11988436|FG000|STARTED|Overall Study||6
10823136|NCT02838979|11988437|FG001|STARTED|Overall Study||5
10823137|NCT02838979|11988436|FG000|COMPLETED|Overall Study||6
10823138|NCT02838979|11988437|FG001|COMPLETED|Overall Study||5
10823139|NCT02838979|11988436|FG000|NOT COMPLETED|Overall Study||0
10823140|NCT02838979|11988437|FG001|NOT COMPLETED|Overall Study||0
10823147|NCT02808585|11988457|FG000|STARTED|Overall Study||3
10823148|NCT02808585|11988458|FG001|STARTED|Overall Study||6
10823149|NCT02808585|11988459|FG002|STARTED|Overall Study||7
10823150|NCT02808585|11988460|FG003|STARTED|Overall Study||6
10823151|NCT02808585|11988461|FG004|STARTED|Overall Study||7
10823152|NCT02808585|11988457|FG000|COMPLETED|Overall Study||3
10823153|NCT02808585|11988458|FG001|COMPLETED|Overall Study||6
10823154|NCT02808585|11988459|FG002|COMPLETED|Overall Study||6
10823155|NCT02808585|11988460|FG003|COMPLETED|Overall Study||4
10823156|NCT02808585|11988461|FG004|COMPLETED|Overall Study||7
10823157|NCT02808585|11988457|FG000|NOT COMPLETED|Overall Study||0
10823158|NCT02808585|11988458|FG001|NOT COMPLETED|Overall Study||0
10823159|NCT02808585|11988459|FG002|NOT COMPLETED|Overall Study||1
10823160|NCT02808585|11988460|FG003|NOT COMPLETED|Overall Study||2
10823161|NCT02808585|11988461|FG004|NOT COMPLETED|Overall Study||0
10823168|NCT02728726|11988486|FG000|STARTED|Overall Study||127
10823169|NCT02728726|11988487|FG001|STARTED|Overall Study||133
10823170|NCT02728726|11988486|FG000|COMPLETED|Overall Study||127
10823171|NCT02728726|11988487|FG001|COMPLETED|Overall Study||133
10823172|NCT02728726|11988486|FG000|NOT COMPLETED|Overall Study||0
10823173|NCT02728726|11988487|FG001|NOT COMPLETED|Overall Study||0
10823174|NCT02544750|11988495|FG000|STARTED|Overall Study||124
10823175|NCT02544750|11988496|FG001|STARTED|Overall Study||75
10823176|NCT02544750|11988495|FG000|COMPLETED|Overall Study||22
10823177|NCT02544750|11988496|FG001|COMPLETED|Overall Study||12
10823178|NCT02544750|11988495|FG000|NOT COMPLETED|Overall Study||102
10823179|NCT02544750|11988496|FG001|NOT COMPLETED|Overall Study||63
10823180|NCT02448771|11988502|FG000|STARTED|Overall Study||36
10823181|NCT02448771|11988502|FG000|COMPLETED|Overall Study||0
10823182|NCT02448771|11988502|FG000|NOT COMPLETED|Overall Study||36
10823183|NCT02337829|11988511|FG000|STARTED|Overall Study||18
10823184|NCT02337829|11988512|FG001|STARTED|Overall Study||14
10823185|NCT02337829|11988513|FG002|STARTED|Overall Study||6
10823186|NCT02337829|11988514|FG003|STARTED|Overall Study||10
10823187|NCT02337829|11988511|FG000|COMPLETED|Overall Study||0
10823188|NCT02337829|11988512|FG001|COMPLETED|Overall Study||0
10823189|NCT02337829|11988513|FG002|COMPLETED|Overall Study||0
10823190|NCT02337829|11988514|FG003|COMPLETED|Overall Study||0
10823191|NCT02337829|11988511|FG000|NOT COMPLETED|Overall Study||18
10823192|NCT02337829|11988512|FG001|NOT COMPLETED|Overall Study||14
10823193|NCT02337829|11988513|FG002|NOT COMPLETED|Overall Study||6
10823194|NCT02337829|11988514|FG003|NOT COMPLETED|Overall Study||10
10823195|NCT02062944|11988526|FG000|STARTED|Overall Study||21
10823196|NCT02062944|11988526|FG000|COMPLETED|Overall Study||15
10823197|NCT02062944|11988526|FG000|NOT COMPLETED|Overall Study||6
10823198|NCT02053792|11988533|FG000|STARTED|Overall Study||83
10823199|NCT02053792|11988534|FG001|STARTED|Overall Study||14
10823200|NCT02053792|11988533|FG000|COMPLETED|Overall Study||77
10823201|NCT02053792|11988534|FG001|COMPLETED|Overall Study||10
10823202|NCT02053792|11988533|FG000|NOT COMPLETED|Overall Study||6
10823203|NCT02053792|11988534|FG001|NOT COMPLETED|Overall Study||4
10823204|NCT01972217|11988544|FG000|STARTED|Part A: Open-label Safety Run-in Period||3
10823205|NCT01972217|11988545|FG001|STARTED|Part A: Open-label Safety Run-in Period||13
10823206|NCT01972217|11988546|FG002|STARTED|Part A: Open-label Safety Run-in Period||0
10823207|NCT01972217|11988547|FG003|STARTED|Part A: Open-label Safety Run-in Period||0
10823208|NCT01972217|11988544|FG000|COMPLETED|Part A: Open-label Safety Run-in Period||2
10823209|NCT01972217|11988545|FG001|COMPLETED|Part A: Open-label Safety Run-in Period||1
10823210|NCT01972217|11988546|FG002|COMPLETED|Part A: Open-label Safety Run-in Period||0
10823211|NCT01972217|11988547|FG003|COMPLETED|Part A: Open-label Safety Run-in Period||0
10823212|NCT01972217|11988544|FG000|NOT COMPLETED|Part A: Open-label Safety Run-in Period||1
10823213|NCT01972217|11988545|FG001|NOT COMPLETED|Part A: Open-label Safety Run-in Period||12
10823214|NCT01972217|11988546|FG002|NOT COMPLETED|Part A: Open-label Safety Run-in Period||0
10823215|NCT01972217|11988547|FG003|NOT COMPLETED|Part A: Open-label Safety Run-in Period||0
10823216|NCT01972217|11988544|FG000|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part A did not participate in Part B.|0
10823217|NCT01972217|11988545|FG001|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part A did not participate in Part B.|0
10823218|NCT01972217|11988546|FG002|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part B did not participate in Part A.|71
10823219|NCT01972217|11988547|FG003|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part B did not participate in Part A.|71
10823220|NCT01972217|11988544|FG000|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||0
10823221|NCT01972217|11988545|FG001|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||0
10823222|NCT01972217|11988546|FG002|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||71
10823223|NCT01972217|11988547|FG003|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||71
10823224|NCT01972217|11988544|FG000|Received Abiraterone|Part B Double-blind, Randomised Period||0
10823225|NCT01972217|11988545|FG001|Received Abiraterone|Part B Double-blind, Randomised Period||0
10823226|NCT01972217|11988546|FG002|Received Abiraterone|Part B Double-blind, Randomised Period||71
10823227|NCT01972217|11988547|FG003|Received Abiraterone|Part B Double-blind, Randomised Period||71
10823228|NCT01972217|11988544|FG000|COMPLETED|Part B Double-blind, Randomised Period||0
10823229|NCT01972217|11988545|FG001|COMPLETED|Part B Double-blind, Randomised Period||0
10823230|NCT01972217|11988546|FG002|COMPLETED|Part B Double-blind, Randomised Period||25
10823231|NCT01972217|11988547|FG003|COMPLETED|Part B Double-blind, Randomised Period||24
10823232|NCT01972217|11988544|FG000|NOT COMPLETED|Part B Double-blind, Randomised Period||0
10823233|NCT01972217|11988545|FG001|NOT COMPLETED|Part B Double-blind, Randomised Period||0
10823234|NCT01972217|11988546|FG002|NOT COMPLETED|Part B Double-blind, Randomised Period||46
10823235|NCT01972217|11988547|FG003|NOT COMPLETED|Part B Double-blind, Randomised Period||47
10823248|NCT01785459|11988572|FG000|STARTED|Overall Study||11
10823249|NCT01785459|11988573|FG001|STARTED|Overall Study||12
10823250|NCT01785459|11988572|FG000|COMPLETED|Overall Study||11
10823251|NCT01785459|11988573|FG001|COMPLETED|Overall Study||12
10823252|NCT01785459|11988572|FG000|NOT COMPLETED|Overall Study||0
10823253|NCT01785459|11988573|FG001|NOT COMPLETED|Overall Study||0
10823254|NCT01691833|11988582|FG000|STARTED|Overall Study||50
10823255|NCT01691833|11988583|FG001|STARTED|Overall Study||50
10823256|NCT01691833|11988584|FG002|STARTED|Overall Study||13
10823257|NCT01691833|11988582|FG000|COMPLETED|Overall Study||49
10823258|NCT01691833|11988583|FG001|COMPLETED|Overall Study||49
10823259|NCT01691833|11988584|FG002|COMPLETED|Overall Study||13
10823260|NCT01691833|11988582|FG000|NOT COMPLETED|Overall Study||1
10823261|NCT01691833|11988583|FG001|NOT COMPLETED|Overall Study||1
10823262|NCT01691833|11988584|FG002|NOT COMPLETED|Overall Study||0
10823263|NCT01640301|11988594|FG000|STARTED|Overall Study||13
10823264|NCT01640301|11988595|FG001|STARTED|Overall Study||15
10823265|NCT01640301|11988594|FG000|COMPLETED|Overall Study||13
10823266|NCT01640301|11988595|FG001|COMPLETED|Overall Study||7
10823267|NCT01640301|11988594|FG000|NOT COMPLETED|Overall Study||0
10823268|NCT01640301|11988595|FG001|NOT COMPLETED|Overall Study||8
10823269|NCT01589302|11988603|FG000|STARTED|Overall Study||154
10823270|NCT01589302|11988603|FG000|Del17p Patients|Overall Study||76
10823271|NCT01589302|11988603|FG000|Non-Del17p Patients|Overall Study||76
10823272|NCT01589302|11988603|FG000|COMPLETED|Overall Study||152
10823273|NCT01589302|11988603|FG000|NOT COMPLETED|Overall Study||2
10823274|NCT00554515|11988608|FG000|STARTED|Overall Study||123
10823275|NCT00554515|11988608|FG000|Treated|Overall Study||120
10823276|NCT00554515|11988608|FG000|COMPLETED|Overall Study||5
10823277|NCT00554515|11988608|FG000|NOT COMPLETED|Overall Study||118
10823278|NCT00107198|11988633|FG000|STARTED|Overall Study||188
10823279|NCT00107198|11988633|FG000|COMPLETED|Overall Study||136
10823280|NCT00107198|11988633|FG000|NOT COMPLETED|Overall Study||52
10823281|NCT00345358|11988641|FG000|STARTED|Primary Vaccination Phase||150
10823282|NCT00345358|11988642|FG001|STARTED|Primary Vaccination Phase||150
10823283|NCT00345358|11988643|FG002|STARTED|Primary Vaccination Phase||150
10823284|NCT00345358|11988644|FG003|STARTED|Primary Vaccination Phase||150
10823285|NCT00345358|11988641|FG000|COMPLETED|Primary Vaccination Phase||145
10823286|NCT00345358|11988642|FG001|COMPLETED|Primary Vaccination Phase||146
10823287|NCT00345358|11988643|FG002|COMPLETED|Primary Vaccination Phase||142
10823288|NCT00345358|11988644|FG003|COMPLETED|Primary Vaccination Phase||148
10823289|NCT00345358|11988641|FG000|NOT COMPLETED|Primary Vaccination Phase||5
10823290|NCT00345358|11988642|FG001|NOT COMPLETED|Primary Vaccination Phase||4
10823291|NCT00345358|11988643|FG002|NOT COMPLETED|Primary Vaccination Phase||8
10823292|NCT00345358|11988644|FG003|NOT COMPLETED|Primary Vaccination Phase||2
10823293|NCT00345358|11988641|FG000|STARTED|Booster Vaccination Phase||145
10823294|NCT00345358|11988642|FG001|STARTED|Booster Vaccination Phase||145
10823295|NCT00345358|11988643|FG002|STARTED|Booster Vaccination Phase||0
10823296|NCT00345358|11988644|FG003|STARTED|Booster Vaccination Phase||0
10823297|NCT00345358|11988641|FG000|COMPLETED|Booster Vaccination Phase||141
10823298|NCT00345358|11988642|FG001|COMPLETED|Booster Vaccination Phase||145
10823299|NCT00345358|11988643|FG002|COMPLETED|Booster Vaccination Phase||0
10823300|NCT00345358|11988644|FG003|COMPLETED|Booster Vaccination Phase||0
10823301|NCT00345358|11988641|FG000|NOT COMPLETED|Booster Vaccination Phase||4
10823302|NCT00345358|11988642|FG001|NOT COMPLETED|Booster Vaccination Phase||0
10823303|NCT00345358|11988643|FG002|NOT COMPLETED|Booster Vaccination Phase||0
10823304|NCT00345358|11988644|FG003|NOT COMPLETED|Booster Vaccination Phase||0
10823305|NCT00345800|11988654|FG000|STARTED|Overall Study||25
10823306|NCT00345800|11988654|FG000|COMPLETED|Overall Study||25
10823307|NCT00345800|11988654|FG000|NOT COMPLETED|Overall Study||0
10823308|NCT00372229|11988660|FG000|STARTED|Study Phase||148
10823309|NCT00372229|11988661|FG001|STARTED|Study Phase||151
10823310|NCT00372229|11988660|FG000|COMPLETED|Study Phase||117
10823311|NCT00372229|11988661|FG001|COMPLETED|Study Phase||122
10823312|NCT00372229|11988660|FG000|NOT COMPLETED|Study Phase||31
10823313|NCT00372229|11988661|FG001|NOT COMPLETED|Study Phase||29
10823314|NCT00372229|11988660|FG000|STARTED|Follow-Up Phase||117
10823315|NCT00372229|11988661|FG001|STARTED|Follow-Up Phase||122
10823316|NCT00372229|11988660|FG000|COMPLETED|Follow-Up Phase||71
10823317|NCT00372229|11988661|FG001|COMPLETED|Follow-Up Phase||70
10823318|NCT00372229|11988660|FG000|NOT COMPLETED|Follow-Up Phase||46
10823319|NCT00372229|11988661|FG001|NOT COMPLETED|Follow-Up Phase||52
10823329|NCT00413699|11988678|FG000|STARTED|Initial Period||1123
10823330|NCT00413699|11988679|FG001|STARTED|Initial Period||3358
10823331|NCT00413699|11988680|FG002|STARTED|Initial Period||0
10823332|NCT00413699|11988678|FG000|COMPLETED|Initial Period||484
10823333|NCT00413699|11988679|FG001|COMPLETED|Initial Period||1653
10823334|NCT00413699|11988680|FG002|COMPLETED|Initial Period||0
10823335|NCT00413699|11988678|FG000|NOT COMPLETED|Initial Period||639
10823336|NCT00413699|11988679|FG001|NOT COMPLETED|Initial Period||1705
10823337|NCT00413699|11988680|FG002|NOT COMPLETED|Initial Period||0
10823338|NCT00413699|11988678|FG000|STARTED|Extension Period||0
10823339|NCT00413699|11988679|FG001|STARTED|Extension Period||0
10823340|NCT00413699|11988680|FG002|STARTED|Extension Period||48
10823341|NCT00413699|11988678|FG000|COMPLETED|Extension Period||0
10823342|NCT00413699|11988679|FG001|COMPLETED|Extension Period||0
10823343|NCT00413699|11988680|FG002|COMPLETED|Extension Period||43
10823344|NCT00413699|11988678|FG000|NOT COMPLETED|Extension Period||0
10823345|NCT00413699|11988679|FG001|NOT COMPLETED|Extension Period||0
10823346|NCT00413699|11988680|FG002|NOT COMPLETED|Extension Period||5
10823347|NCT00435227|11988708|FG000|STARTED|Overall Study||5
10823348|NCT00435227|11988709|FG001|STARTED|Overall Study||7
10823349|NCT00435227|11988708|FG000|COMPLETED|Overall Study||5
10823350|NCT00435227|11988709|FG001|COMPLETED|Overall Study||7
10823351|NCT00435227|11988708|FG000|NOT COMPLETED|Overall Study||0
10823352|NCT00435227|11988709|FG001|NOT COMPLETED|Overall Study||0
10823407|NCT00442546|11988742|FG000|STARTED|Overall Study||103
10823408|NCT00442546|11988743|FG001|STARTED|Overall Study||100
10823409|NCT00442546|11988744|FG002|STARTED|Overall Study||104
10823410|NCT00442546|11988742|FG000|Received Treatment|Overall Study||98
10823411|NCT00442546|11988743|FG001|Received Treatment|Overall Study||96
10823412|NCT00442546|11988744|FG002|Received Treatment|Overall Study||98
10823413|NCT00442546|11988742|FG000|COMPLETED|Overall Study||77
10823414|NCT00442546|11988743|FG001|COMPLETED|Overall Study||63
10823415|NCT00442546|11988744|FG002|COMPLETED|Overall Study||71
10823416|NCT00442546|11988742|FG000|NOT COMPLETED|Overall Study||26
10823417|NCT00442546|11988743|FG001|NOT COMPLETED|Overall Study||37
10823418|NCT00442546|11988744|FG002|NOT COMPLETED|Overall Study||33
10823419|NCT04715932|11988756|FG000|STARTED|Overall Study||107
10823420|NCT04715932|11988757|FG001|STARTED|Overall Study||109
10823421|NCT04715932|11988756|FG000|COMPLETED|Overall Study||106
10823422|NCT04715932|11988757|FG001|COMPLETED|Overall Study||109
10823423|NCT04715932|11988756|FG000|NOT COMPLETED|Overall Study||1
10823353|NCT00436826|11988718|FG000|STARTED|Double Blind Period (DBP)||124
10823354|NCT00436826|11988719|FG001|STARTED|Double Blind Period (DBP)||48
10823355|NCT00436826|11988720|FG002|STARTED|Double Blind Period (DBP)||0
10823356|NCT00436826|11988721|FG003|STARTED|Double Blind Period (DBP)||0
10823357|NCT00436826|11988722|FG004|STARTED|Double Blind Period (DBP)||0
10823358|NCT00436826|11988723|FG005|STARTED|Double Blind Period (DBP)||0
10823359|NCT00436826|11988718|FG000|COMPLETED|Double Blind Period (DBP)||111
10823360|NCT00436826|11988719|FG001|COMPLETED|Double Blind Period (DBP)||37
10823361|NCT00436826|11988720|FG002|COMPLETED|Double Blind Period (DBP)||0
10823362|NCT00436826|11988721|FG003|COMPLETED|Double Blind Period (DBP)||0
10823363|NCT00436826|11988722|FG004|COMPLETED|Double Blind Period (DBP)||0
10823364|NCT00436826|11988723|FG005|COMPLETED|Double Blind Period (DBP)||0
10823365|NCT00436826|11988718|FG000|NOT COMPLETED|Double Blind Period (DBP)||13
10823366|NCT00436826|11988719|FG001|NOT COMPLETED|Double Blind Period (DBP)||11
10823367|NCT00436826|11988720|FG002|NOT COMPLETED|Double Blind Period (DBP)||0
10823368|NCT00436826|11988721|FG003|NOT COMPLETED|Double Blind Period (DBP)||0
10823369|NCT00436826|11988722|FG004|NOT COMPLETED|Double Blind Period (DBP)||0
10823370|NCT00436826|11988723|FG005|NOT COMPLETED|Double Blind Period (DBP)||0
10823371|NCT00436826|11988718|FG000|STARTED|Ext. Period (With Cladribine Treatment)||0
10823372|NCT00436826|11988719|FG001|STARTED|Ext. Period (With Cladribine Treatment)||0
10823373|NCT00436826|11988720|FG002|STARTED|Ext. Period (With Cladribine Treatment)||47
10823374|NCT00436826|11988721|FG003|STARTED|Ext. Period (With Cladribine Treatment)||28
10823375|NCT00436826|11988722|FG004|STARTED|Ext. Period (With Cladribine Treatment)||0
10823376|NCT00436826|11988723|FG005|STARTED|Ext. Period (With Cladribine Treatment)||0
10823377|NCT00436826|11988718|FG000|COMPLETED|Ext. Period (With Cladribine Treatment)||0
10823378|NCT00436826|11988719|FG001|COMPLETED|Ext. Period (With Cladribine Treatment)||0
10823379|NCT00436826|11988720|FG002|COMPLETED|Ext. Period (With Cladribine Treatment)||1
10823380|NCT00436826|11988721|FG003|COMPLETED|Ext. Period (With Cladribine Treatment)||2
10823381|NCT00436826|11988722|FG004|COMPLETED|Ext. Period (With Cladribine Treatment)||0
10823382|NCT00436826|11988723|FG005|COMPLETED|Ext. Period (With Cladribine Treatment)||0
10823383|NCT00436826|11988718|FG000|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
10823384|NCT00436826|11988719|FG001|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
10823385|NCT00436826|11988720|FG002|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||46
10823386|NCT00436826|11988721|FG003|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||26
10823387|NCT00436826|11988722|FG004|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
10823388|NCT00436826|11988723|FG005|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
10823389|NCT00436826|11988718|FG000|STARTED|Ext. Period (No Cladribine Treatment)||0
10823390|NCT00436826|11988719|FG001|STARTED|Ext. Period (No Cladribine Treatment)||0
10823391|NCT00436826|11988720|FG002|STARTED|Ext. Period (No Cladribine Treatment)||0
10823392|NCT00436826|11988721|FG003|STARTED|Ext. Period (No Cladribine Treatment)||0
10823393|NCT00436826|11988722|FG004|STARTED|Ext. Period (No Cladribine Treatment)||52
10823394|NCT00436826|11988723|FG005|STARTED|Ext. Period (No Cladribine Treatment)||7
10823395|NCT00436826|11988718|FG000|COMPLETED|Ext. Period (No Cladribine Treatment)||0
10823396|NCT00436826|11988719|FG001|COMPLETED|Ext. Period (No Cladribine Treatment)||0
10823397|NCT00436826|11988720|FG002|COMPLETED|Ext. Period (No Cladribine Treatment)||0
10823398|NCT00436826|11988721|FG003|COMPLETED|Ext. Period (No Cladribine Treatment)||0
10823399|NCT00436826|11988722|FG004|COMPLETED|Ext. Period (No Cladribine Treatment)||1
10823400|NCT00436826|11988723|FG005|COMPLETED|Ext. Period (No Cladribine Treatment)||0
10823401|NCT00436826|11988718|FG000|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
10823402|NCT00436826|11988719|FG001|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
10823403|NCT00436826|11988720|FG002|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
10823404|NCT00436826|11988721|FG003|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
10823405|NCT00436826|11988722|FG004|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||51
10823406|NCT00436826|11988723|FG005|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||7
10823424|NCT04715932|11988757|FG001|NOT COMPLETED|Overall Study||0
10823425|NCT04666441|11988771|FG000|STARTED|Overall Study||82
10823426|NCT04666441|11988772|FG001|STARTED|Overall Study||165
10823427|NCT04666441|11988773|FG002|STARTED|Overall Study||162
10823428|NCT04666441|11988774|FG003|STARTED|Overall Study||165
10823429|NCT04666441|11988775|FG004|STARTED|Overall Study||166
10823430|NCT04666441|11988776|FG005|STARTED|Overall Study||82
10823431|NCT04666441|11988777|FG006|STARTED|Overall Study||163
10823432|NCT04666441|11988778|FG007|STARTED|Overall Study||164
10823433|NCT04666441|11988771|FG000|COMPLETED|Overall Study||80
10823434|NCT04666441|11988772|FG001|COMPLETED|Overall Study||160
10823435|NCT04666441|11988773|FG002|COMPLETED|Overall Study||158
10823436|NCT04666441|11988774|FG003|COMPLETED|Overall Study||161
10823437|NCT04666441|11988775|FG004|COMPLETED|Overall Study||166
10823438|NCT04666441|11988776|FG005|COMPLETED|Overall Study||79
10823439|NCT04666441|11988777|FG006|COMPLETED|Overall Study||158
10823440|NCT04666441|11988778|FG007|COMPLETED|Overall Study||160
10823441|NCT04666441|11988771|FG000|NOT COMPLETED|Overall Study||2
10823442|NCT04666441|11988772|FG001|NOT COMPLETED|Overall Study||5
10823443|NCT04666441|11988773|FG002|NOT COMPLETED|Overall Study||4
10823444|NCT04666441|11988774|FG003|NOT COMPLETED|Overall Study||4
10823445|NCT04666441|11988775|FG004|NOT COMPLETED|Overall Study||0
10823446|NCT04666441|11988776|FG005|NOT COMPLETED|Overall Study||3
10823447|NCT04666441|11988777|FG006|NOT COMPLETED|Overall Study||5
10823448|NCT04666441|11988778|FG007|NOT COMPLETED|Overall Study||4
10823449|NCT04593641|11988809|FG000|STARTED|Overall Study||5
10823450|NCT04593641|11988810|FG001|STARTED|Overall Study||5
10823451|NCT04593641|11988811|FG002|STARTED|Overall Study||5
10823452|NCT04593641|11988812|FG003|STARTED|Overall Study||3
10823453|NCT04593641|11988809|FG000|COMPLETED|Overall Study||4
10823454|NCT04593641|11988810|FG001|COMPLETED|Overall Study||5
10823455|NCT04593641|11988811|FG002|COMPLETED|Overall Study||5
10823456|NCT04593641|11988812|FG003|COMPLETED|Overall Study||3
10823457|NCT04593641|11988809|FG000|NOT COMPLETED|Overall Study||1
10823458|NCT04593641|11988810|FG001|NOT COMPLETED|Overall Study||0
10823459|NCT04593641|11988811|FG002|NOT COMPLETED|Overall Study||0
10823460|NCT04593641|11988812|FG003|NOT COMPLETED|Overall Study||0
10823461|NCT04381052|11988824|FG000|STARTED|Overall Study||1
10823462|NCT04381052|11988824|FG000|COMPLETED|Overall Study||1
10823463|NCT04381052|11988824|FG000|NOT COMPLETED|Overall Study||0
10823464|NCT04259346|11988832|FG000|STARTED|Overall Study||126
10823465|NCT04259346|11988833|FG001|STARTED|Overall Study||119
10823466|NCT04259346|11988832|FG000|Received at Least One Dose of Study Drug|Overall Study||126
10823467|NCT04259346|11988833|FG001|Received at Least One Dose of Study Drug|Overall Study||119
10823468|NCT04259346|11988832|FG000|COMPLETED|Overall Study||122
10823469|NCT04259346|11988833|FG001|COMPLETED|Overall Study||115
10823470|NCT04259346|11988832|FG000|NOT COMPLETED|Overall Study||4
10823471|NCT04259346|11988833|FG001|NOT COMPLETED|Overall Study||4
10823472|NCT03959423|11988841|FG000|STARTED|Overall Study||160
10823473|NCT03959423|11988842|FG001|STARTED|Overall Study||128
10823474|NCT03959423|11988841|FG000|COMPLETED|Overall Study||151
10823475|NCT03959423|11988842|FG001|COMPLETED|Overall Study||124
10823476|NCT03959423|11988841|FG000|NOT COMPLETED|Overall Study||9
10823477|NCT03959423|11988842|FG001|NOT COMPLETED|Overall Study||4
10823478|NCT03713320|11988850|FG000|STARTED|Randomized Period||19
10823479|NCT03713320|11988851|FG001|STARTED|Randomized Period||18
10823480|NCT03713320|11988852|FG002|STARTED|Randomized Period||0
10823481|NCT03713320|11988850|FG000|COMPLETED|Randomized Period||4
10823482|NCT03713320|11988851|FG001|COMPLETED|Randomized Period||8
10823483|NCT03713320|11988852|FG002|COMPLETED|Randomized Period||0
10823484|NCT03713320|11988850|FG000|NOT COMPLETED|Randomized Period||15
10823485|NCT03713320|11988851|FG001|NOT COMPLETED|Randomized Period||10
10823486|NCT03713320|11988852|FG002|NOT COMPLETED|Randomized Period||0
10823487|NCT03713320|11988850|FG000|STARTED|Cobomarsen Crossover Period||0
10823488|NCT03713320|11988851|FG001|STARTED|Cobomarsen Crossover Period||0
10823489|NCT03713320|11988852|FG002|STARTED|Cobomarsen Crossover Period||7
10823490|NCT03713320|11988850|FG000|COMPLETED|Cobomarsen Crossover Period||0
10823491|NCT03713320|11988851|FG001|COMPLETED|Cobomarsen Crossover Period||0
10823492|NCT03713320|11988852|FG002|COMPLETED|Cobomarsen Crossover Period||0
10823493|NCT03713320|11988850|FG000|NOT COMPLETED|Cobomarsen Crossover Period||0
10823494|NCT03713320|11988851|FG001|NOT COMPLETED|Cobomarsen Crossover Period||0
10823495|NCT03713320|11988852|FG002|NOT COMPLETED|Cobomarsen Crossover Period||7
10823504|NCT03409731|11988868|FG000|STARTED|Overall Study||135
10823505|NCT03409731|11988868|FG000|COMPLETED|Overall Study||132
10823506|NCT03409731|11988868|FG000|NOT COMPLETED|Overall Study||3
10823507|NCT03283566|11988874|FG000|STARTED|Overall Study||4
10823508|NCT03283566|11988875|FG001|STARTED|Overall Study||5
10823509|NCT03283566|11988874|FG000|COMPLETED|Overall Study||3
10823510|NCT03283566|11988875|FG001|COMPLETED|Overall Study||3
10823511|NCT03283566|11988874|FG000|NOT COMPLETED|Overall Study||1
10823512|NCT03283566|11988875|FG001|NOT COMPLETED|Overall Study||2
10823513|NCT03077412|11988884|FG000|STARTED|Overall Study||17
10823514|NCT03077412|11988885|FG001|STARTED|Overall Study||25
10823515|NCT03077412|11988886|FG002|STARTED|Overall Study||15
10823516|NCT03077412|11988884|FG000|COMPLETED|Overall Study||14
10823517|NCT03077412|11988885|FG001|COMPLETED|Overall Study||12
10823518|NCT03077412|11988886|FG002|COMPLETED|Overall Study||6
10823519|NCT03077412|11988884|FG000|NOT COMPLETED|Overall Study||3
10823520|NCT03077412|11988885|FG001|NOT COMPLETED|Overall Study||13
10823521|NCT03077412|11988886|FG002|NOT COMPLETED|Overall Study||9
10823522|NCT03026504|11988894|FG000|STARTED|Overall Study||15
10823523|NCT03026504|11988894|FG000|COMPLETED|Overall Study||14
10823524|NCT03026504|11988894|FG000|NOT COMPLETED|Overall Study||1
10823525|NCT02971956|11988898|FG000|STARTED|Overall Study||49
10823526|NCT02971956|11988898|FG000|COMPLETED|Overall Study||49
10823527|NCT02971956|11988898|FG000|NOT COMPLETED|Overall Study||0
10823528|NCT02915367|11988904|FG000|STARTED|Overall Study||173
10823529|NCT02915367|11988905|FG001|STARTED|Overall Study||175
10823530|NCT02915367|11988904|FG000|COMPLETED|Overall Study||136
10823531|NCT02915367|11988905|FG001|COMPLETED|Overall Study||144
10823532|NCT02915367|11988904|FG000|NOT COMPLETED|Overall Study||37
10823533|NCT02915367|11988905|FG001|NOT COMPLETED|Overall Study||31
10823534|NCT02665143|11988911|FG000|STARTED|Phase 1||6
10823535|NCT02665143|11988911|FG000|COMPLETED|Phase 1||6
10823536|NCT02665143|11988911|FG000|NOT COMPLETED|Phase 1||0
10823537|NCT02665143|11988911|FG000|STARTED|Phase 2|19 Participants were enrolled in Phase 2.|19
10823538|NCT02665143|11988911|FG000|Completed 0 Cycles|Phase 2||1
10823539|NCT02665143|11988911|FG000|Completed 1 Cycle|Phase 2||12
10823540|NCT02665143|11988911|FG000|Completed 2 Cycles|Phase 2||3
10823541|NCT02665143|11988911|FG000|Completed 3 Cycles|Phase 2||3
10823542|NCT02665143|11988911|FG000|COMPLETED|Phase 2||19
10823543|NCT02665143|11988911|FG000|NOT COMPLETED|Phase 2||0
10823544|NCT02550470|11988919|FG000|STARTED|Overall Study|"time to reach FiO2 of 4 mm Hg was recorded for each absorbent in the anesthesia circuit~Absorbent units other than participants were assigned to Arms/Groups"|
10823545|NCT02550470|11988920|FG001|STARTED|Overall Study|"time to reach FiO2 of 4 mm Hg was recorded for each absorbent in the anesthesia circuit~Absorbent units other than participants were assigned to Arms/Groups"|
10823546|NCT02550470|11988921|FG002|STARTED|Overall Study|"time to reach FiO2 of 4 mm Hg was recorded for each absorbent in the anesthesia circuit~Absorbent units other than participants were assigned to Arms/Groups"|
10823547|NCT02550470|11988919|FG000|COMPLETED|Overall Study|"time to reach FiO2 of 4 mm Hg was recorded for each absorbent in the anesthesia circuit~Absorbent units other than participants were assigned to Arms/Groups"|
10823548|NCT02550470|11988920|FG001|COMPLETED|Overall Study|"time to reach FiO2 of 4 mm Hg was recorded for each absorbent in the anesthesia circuit~Absorbent units other than participants were assigned to Arms/Groups"|
10823549|NCT02550470|11988921|FG002|COMPLETED|Overall Study|"time to reach FiO2 of 4 mm Hg was recorded for each absorbent in the anesthesia circuit~Absorbent units other than participants were assigned to Arms/Groups"|
10823550|NCT02550470|11988919|FG000|NOT COMPLETED|Overall Study||
10823551|NCT02550470|11988920|FG001|NOT COMPLETED|Overall Study||
10823552|NCT02550470|11988921|FG002|NOT COMPLETED|Overall Study||
10823553|NCT02384850|11988931|FG000|STARTED|Overall Study||4
10823554|NCT02384850|11988932|FG001|STARTED|Overall Study||6
10823555|NCT02384850|11988931|FG000|COMPLETED|Overall Study||2
10823556|NCT02384850|11988932|FG001|COMPLETED|Overall Study||4
10823557|NCT02384850|11988931|FG000|NOT COMPLETED|Overall Study||2
10823558|NCT02384850|11988932|FG001|NOT COMPLETED|Overall Study||2
10408827|NCT00757601|11552964|FG003|NOT COMPLETED|Period 1||0
10408828|NCT00757601|11552965|FG004|NOT COMPLETED|Period 1||0
10408829|NCT00757601|11552966|FG005|NOT COMPLETED|Period 1||0
10408830|NCT00757601|11552967|FG006|NOT COMPLETED|Period 1||0
10408831|NCT00757601|11552968|FG007|NOT COMPLETED|Period 1||0
10408832|NCT00757601|11552969|FG008|NOT COMPLETED|Period 1||0
10408833|NCT00757601|11552970|FG009|NOT COMPLETED|Period 1||0
10408834|NCT00757601|11552971|FG010|NOT COMPLETED|Period 1||0
10408835|NCT00757601|11552972|FG011|NOT COMPLETED|Period 1||0
10408836|NCT00757601|11552961|FG000|STARTED|Period 2||2
10408837|NCT00757601|11552962|FG001|STARTED|Period 2||2
10408838|NCT00757601|11552963|FG002|STARTED|Period 2||2
10408839|NCT00757601|11552964|FG003|STARTED|Period 2||2
10408840|NCT00757601|11552965|FG004|STARTED|Period 2||2
10408841|NCT00757601|11552966|FG005|STARTED|Period 2||2
10408842|NCT00757601|11552967|FG006|STARTED|Period 2||2
10408843|NCT00757601|11552968|FG007|STARTED|Period 2||2
10408844|NCT00757601|11552969|FG008|STARTED|Period 2||2
10408845|NCT00757601|11552970|FG009|STARTED|Period 2||2
10408846|NCT00757601|11552971|FG010|STARTED|Period 2||2
10823601|NCT00971867|11988991|FG000|STARTED|Overall Study||11
10823602|NCT00971867|11988991|FG000|COMPLETED|Overall Study||0
10823603|NCT00971867|11988991|FG000|NOT COMPLETED|Overall Study||11
10823604|NCT00853307|11988997|FG000|STARTED|Overall Study||6
10823605|NCT00853307|11988998|FG001|STARTED|Overall Study||25
10823606|NCT00853307|11988997|FG000|COMPLETED|Overall Study|Completed = participants who completed the study treatment.|4
10823607|NCT00853307|11988998|FG001|COMPLETED|Overall Study||20
10823608|NCT00853307|11988997|FG000|NOT COMPLETED|Overall Study||2
10823609|NCT00853307|11988998|FG001|NOT COMPLETED|Overall Study||5
10823610|NCT00583804|11989004|FG000|STARTED|Overall Study||10
10823611|NCT00583804|11989004|FG000|COMPLETED|Overall Study|Subjects were considered enrolled when they underwent implantation of the device. All completed.|10
10823612|NCT00583804|11989004|FG000|NOT COMPLETED|Overall Study||0
10290346|NCT04084769|11423010|FG002|Safety Analysis Set (SAfAS)|Overall Study||93
10290347|NCT04084769|11423011|FG003|Safety Analysis Set (SAfAS)|Overall Study||92
10290348|NCT04084769|11423008|FG000|Full Analysis Set|Overall Study||191
10290349|NCT04084769|11423009|FG001|Full Analysis Set|Overall Study||190
10290350|NCT04084769|11423010|FG002|Full Analysis Set|Overall Study||95
10290351|NCT04084769|11423011|FG003|Full Analysis Set|Overall Study||94
10290352|NCT04084769|11423008|FG000|Per-Protocol Analysis Set 1 (PPAS1)|Overall Study||46
10290353|NCT04084769|11423009|FG001|Per-Protocol Analysis Set 1 (PPAS1)|Overall Study||45
10290354|NCT04084769|11423010|FG002|Per-Protocol Analysis Set 1 (PPAS1)|Overall Study||0
10290355|NCT04084769|11423011|FG003|Per-Protocol Analysis Set 1 (PPAS1)|Overall Study||0
10290356|NCT04084769|11423008|FG000|Per-Protocol Analysis Set 2 (PPAS2)|Overall Study||174
10290357|NCT04084769|11423009|FG001|Per-Protocol Analysis Set 2 (PPAS2)|Overall Study||176
10290358|NCT04084769|11423010|FG002|Per-Protocol Analysis Set 2 (PPAS2)|Overall Study||90
10290359|NCT04084769|11423011|FG003|Per-Protocol Analysis Set 2 (PPAS2)|Overall Study||89
10290360|NCT04084769|11423008|FG000|COMPLETED|Overall Study||187
10290361|NCT04084769|11423009|FG001|COMPLETED|Overall Study||186
10290362|NCT04084769|11423010|FG002|COMPLETED|Overall Study||95
10290363|NCT04084769|11423011|FG003|COMPLETED|Overall Study||92
10290364|NCT04084769|11423008|FG000|NOT COMPLETED|Overall Study||4
10290365|NCT04084769|11423009|FG001|NOT COMPLETED|Overall Study||4
10290366|NCT04084769|11423010|FG002|NOT COMPLETED|Overall Study||0
10290367|NCT04084769|11423011|FG003|NOT COMPLETED|Overall Study||2
10290368|NCT04024228|11423028|FG000|STARTED|Overall Study||774
10290369|NCT04024228|11423029|FG001|STARTED|Overall Study||765
10290370|NCT04024228|11423028|FG000|Vaccinated|Overall Study||772
10290371|NCT04024228|11423029|FG001|Vaccinated|Overall Study||761
10290372|NCT04024228|11423028|FG000|Full Analysis Set (FAS)|Overall Study|377 participants (60-64 years) and 392 participants (>=65 years).|769
10290373|NCT04024228|11423029|FG001|Full Analysis Set (FAS)|Overall Study|377 participants (60-64 years) and 381 participants (>=65 years).|758
10290374|NCT04024228|11423028|FG000|COMPLETED|Overall Study||770
10290375|NCT04024228|11423029|FG001|COMPLETED|Overall Study||759
10290376|NCT04024228|11423028|FG000|NOT COMPLETED|Overall Study||4
10290377|NCT04024228|11423029|FG001|NOT COMPLETED|Overall Study||6
10823613|NCT00545129|11989012|FG000|STARTED|Overall Study||29
10823614|NCT00545129|11989013|FG001|STARTED|Overall Study||30
10823615|NCT00545129|11989012|FG000|COMPLETED|Overall Study||12
10823616|NCT00545129|11989013|FG001|COMPLETED|Overall Study||6
10823617|NCT00545129|11989012|FG000|NOT COMPLETED|Overall Study||17
10823618|NCT00545129|11989013|FG001|NOT COMPLETED|Overall Study||24
10823625|NCT00554606|11989031|FG000|STARTED|Overall Study||115
10823626|NCT00554606|11989031|FG000|COMPLETED|Overall Study||30
10823627|NCT00554606|11989031|FG000|NOT COMPLETED|Overall Study||85
10823634|NCT00565461|11989050|FG000|STARTED|Overall Study||40
10823635|NCT00565461|11989051|FG001|STARTED|Overall Study||40
10823636|NCT00565461|11989052|FG002|STARTED|Overall Study||40
10823637|NCT00565461|11989053|FG003|STARTED|Overall Study||40
10823638|NCT00565461|11989050|FG000|COMPLETED|Overall Study||40
10823639|NCT00565461|11989051|FG001|COMPLETED|Overall Study||39
10823640|NCT00565461|11989052|FG002|COMPLETED|Overall Study||39
10823641|NCT00565461|11989053|FG003|COMPLETED|Overall Study||37
10823642|NCT00565461|11989050|FG000|NOT COMPLETED|Overall Study||0
10823643|NCT00565461|11989051|FG001|NOT COMPLETED|Overall Study||1
10823644|NCT00565461|11989052|FG002|NOT COMPLETED|Overall Study||1
10823645|NCT00565461|11989053|FG003|NOT COMPLETED|Overall Study||3
10823649|NCT00586924|11989079|FG000|STARTED|Overall Study||3
10823619|NCT00548093|11989021|FG000|STARTED|Overall Study||50
10823620|NCT00548093|11989022|FG001|STARTED|Overall Study||16
10823621|NCT00548093|11989021|FG000|COMPLETED|Overall Study||0
10823622|NCT00548093|11989022|FG001|COMPLETED|Overall Study||0
10823623|NCT00548093|11989021|FG000|NOT COMPLETED|Overall Study||50
10823624|NCT00548093|11989022|FG001|NOT COMPLETED|Overall Study||16
10823628|NCT00555009|11989039|FG000|STARTED|Overall Study||4
10823629|NCT00555009|11989040|FG001|STARTED|Overall Study||6
10823630|NCT00555009|11989039|FG000|COMPLETED|Overall Study||2
10823631|NCT00555009|11989040|FG001|COMPLETED|Overall Study||0
10823632|NCT00555009|11989039|FG000|NOT COMPLETED|Overall Study||2
10823633|NCT00555009|11989040|FG001|NOT COMPLETED|Overall Study||6
10823646|NCT00566995|11989069|FG000|STARTED|Overall Study||37
10823647|NCT00566995|11989069|FG000|COMPLETED|Overall Study||30
10823648|NCT00566995|11989069|FG000|NOT COMPLETED|Overall Study||7
10823650|NCT00586924|11989080|FG001|STARTED|Overall Study||3
10823651|NCT00586924|11989081|FG002|STARTED|Overall Study||3
10823652|NCT00586924|11989082|FG003|STARTED|Overall Study||3
10823653|NCT00586924|11989083|FG004|STARTED|Overall Study||4
10823654|NCT00586924|11989084|FG005|STARTED|Overall Study||33
10823655|NCT00586924|11989079|FG000|COMPLETED|Overall Study||0
10823656|NCT00586924|11989080|FG001|COMPLETED|Overall Study||0
10823657|NCT00586924|11989081|FG002|COMPLETED|Overall Study||0
10823658|NCT00586924|11989082|FG003|COMPLETED|Overall Study||0
10823659|NCT00586924|11989083|FG004|COMPLETED|Overall Study||0
10823660|NCT00586924|11989084|FG005|COMPLETED|Overall Study||0
10823661|NCT00586924|11989079|FG000|NOT COMPLETED|Overall Study||3
10823662|NCT00586924|11989080|FG001|NOT COMPLETED|Overall Study||3
10823663|NCT00586924|11989081|FG002|NOT COMPLETED|Overall Study||3
10823664|NCT00586924|11989082|FG003|NOT COMPLETED|Overall Study||3
10823665|NCT00586924|11989083|FG004|NOT COMPLETED|Overall Study||4
10823666|NCT00586924|11989084|FG005|NOT COMPLETED|Overall Study||33
10290378|NCT03996148|11423040|FG000|STARTED|Overall Study||7
10290379|NCT03996148|11423041|FG001|STARTED|Overall Study||7
10290380|NCT03996148|11423042|FG002|STARTED|Overall Study||7
10290381|NCT03996148|11423040|FG000|COMPLETED|Overall Study||7
10290382|NCT03996148|11423041|FG001|COMPLETED|Overall Study||6
10290383|NCT03996148|11423042|FG002|COMPLETED|Overall Study||7
10290384|NCT03996148|11423040|FG000|NOT COMPLETED|Overall Study||0
10290385|NCT03996148|11423041|FG001|NOT COMPLETED|Overall Study||1
10290386|NCT03996148|11423042|FG002|NOT COMPLETED|Overall Study||0
10290387|NCT03980938|11423052|FG000|STARTED|Treatment Period 1||7
10290388|NCT03980938|11423053|FG001|STARTED|Treatment Period 1||8
10290389|NCT03980938|11423052|FG000|COMPLETED|Treatment Period 1||6
10290390|NCT03980938|11423053|FG001|COMPLETED|Treatment Period 1||7
10290391|NCT03980938|11423052|FG000|NOT COMPLETED|Treatment Period 1||1
10290392|NCT03980938|11423053|FG001|NOT COMPLETED|Treatment Period 1||1
10290393|NCT03980938|11423052|FG000|STARTED|Treatment Period 2||3
10290394|NCT03980938|11423053|FG001|STARTED|Treatment Period 2||2
10313105|NCT00147823|11446634|FG001|NOT COMPLETED|Overall Study||15
10823667|NCT00588861|11989100|FG000|STARTED|Pre-Operative|202 Patients were enrolled, however only 107 contributed preop data.|202
10823668|NCT00588861|11989101|FG001|STARTED|Pre-Operative|200 patients were enrolled, however only 114 contributed preop data.|200
10823669|NCT00588861|11989100|FG000|COMPLETED|Pre-Operative||107
10823670|NCT00588861|11989101|FG001|COMPLETED|Pre-Operative||114
10823671|NCT00588861|11989100|FG000|NOT COMPLETED|Pre-Operative||95
10823672|NCT00588861|11989101|FG001|NOT COMPLETED|Pre-Operative||86
10823673|NCT00588861|11989100|FG000|STARTED|6 Months|107 cases were due at 6 Months, however only 9 returned for follow-up.|107
10823674|NCT00588861|11989101|FG001|STARTED|6 Months|114 cases were due at 6 Months, however only 41 returned for follow-up.|114
10823675|NCT00588861|11989100|FG000|COMPLETED|6 Months||9
10823676|NCT00588861|11989101|FG001|COMPLETED|6 Months||41
10823677|NCT00588861|11989100|FG000|NOT COMPLETED|6 Months||98
10823678|NCT00588861|11989101|FG001|NOT COMPLETED|6 Months||73
10823679|NCT00588861|11989100|FG000|STARTED|1 Year|107 cases were due at 1 Year, however only 18 returned for follow-up.|107
10823680|NCT00588861|11989101|FG001|STARTED|1 Year|114 cases were due at 1 Year, however only 32 returned for follow-up.|114
10823681|NCT00588861|11989100|FG000|COMPLETED|1 Year||18
10823682|NCT00588861|11989101|FG001|COMPLETED|1 Year||32
10823683|NCT00588861|11989100|FG000|NOT COMPLETED|1 Year||89
10823684|NCT00588861|11989101|FG001|NOT COMPLETED|1 Year||82
10823685|NCT00588861|11989100|FG000|STARTED|2 Years|107 cases were due at 2 Years, however only 15 returned for follow-up.|107
10823686|NCT00588861|11989101|FG001|STARTED|2 Years|114 cases were due at 2 Years, however only 27 returned for follow-up.|114
10823687|NCT00588861|11989100|FG000|COMPLETED|2 Years||15
10823688|NCT00588861|11989101|FG001|COMPLETED|2 Years||27
10823689|NCT00588861|11989100|FG000|NOT COMPLETED|2 Years||92
10823690|NCT00588861|11989101|FG001|NOT COMPLETED|2 Years||87
10823691|NCT00588861|11989100|FG000|STARTED|4 Years|107 cases were due at 4 Years, however only 16 returned for follow-up.|107
10823692|NCT00588861|11989101|FG001|STARTED|4 Years|114 cases were due at 4 Years, however only 11 returned for follow-up.|114
10823693|NCT00588861|11989100|FG000|COMPLETED|4 Years||16
10823694|NCT00588861|11989101|FG001|COMPLETED|4 Years||11
10823695|NCT00588861|11989100|FG000|NOT COMPLETED|4 Years||91
10823696|NCT00588861|11989101|FG001|NOT COMPLETED|4 Years||103
10823697|NCT00588861|11989100|FG000|STARTED|6 Years|107 cases were due at 6 Years, however only 3 returned for follow-up.|107
10823698|NCT00588861|11989101|FG001|STARTED|6 Years|114 cases were due at 6 Years, however only 5 returned for follow-up.|114
10823699|NCT00588861|11989100|FG000|COMPLETED|6 Years||3
10823700|NCT00588861|11989101|FG001|COMPLETED|6 Years||5
10823701|NCT00588861|11989100|FG000|NOT COMPLETED|6 Years||104
10823702|NCT00588861|11989101|FG001|NOT COMPLETED|6 Years||109
10823703|NCT00588861|11989100|FG000|STARTED|8 Years|107 cases were due at 8 Years, however only 2 returned for follow-up.|107
10823704|NCT00588861|11989101|FG001|STARTED|8 Years|114 cases were due at 8 Years, however no patients returned for follow-up.|114
10823705|NCT00588861|11989100|FG000|COMPLETED|8 Years||2
10823706|NCT00588861|11989101|FG001|COMPLETED|8 Years||0
10823707|NCT00588861|11989100|FG000|NOT COMPLETED|8 Years||105
10823708|NCT00588861|11989101|FG001|NOT COMPLETED|8 Years||114
10823709|NCT00588861|11989100|FG000|STARTED|10 Years|107 cases were due at 10 Years, however no patients returned for follow-up.|107
10290395|NCT03980938|11423052|FG000|COMPLETED|Treatment Period 2|One participant completed the study remotely. On-site visits were no longer permitted due to COVID-19 pandemic. Visits were conducted remotely for Weeks 8 and 10 of Treatment Period 2, and the follow-up visit.|1
10290396|NCT03980938|11423053|FG001|COMPLETED|Treatment Period 2||0
10290397|NCT03980938|11423052|FG000|NOT COMPLETED|Treatment Period 2||2
10290398|NCT03980938|11423053|FG001|NOT COMPLETED|Treatment Period 2||2
10290399|NCT03863353|11423061|FG000|STARTED|Overall Study||282
10290400|NCT03863353|11423062|FG001|STARTED|Overall Study||221
10290401|NCT03863353|11423061|FG000|COMPLETED|Overall Study||258
10290402|NCT03863353|11423062|FG001|COMPLETED|Overall Study||201
10290403|NCT03863353|11423061|FG000|NOT COMPLETED|Overall Study||24
10290404|NCT03863353|11423062|FG001|NOT COMPLETED|Overall Study||20
10313106|NCT00147966|11446640|FG000|STARTED|Overall Study||24
10313107|NCT00147966|11446640|FG000|COMPLETED|Overall Study||24
10313108|NCT00147966|11446640|FG000|NOT COMPLETED|Overall Study||0
10313109|NCT00148109|11446646|FG000|STARTED|Overall Study||15
10313110|NCT00148109|11446647|FG001|STARTED|Overall Study||21
10313111|NCT00148109|11446646|FG000|COMPLETED|Overall Study||3
10313112|NCT00148109|11446647|FG001|COMPLETED|Overall Study||1
10313113|NCT00148109|11446646|FG000|NOT COMPLETED|Overall Study||12
10313114|NCT00148109|11446647|FG001|NOT COMPLETED|Overall Study||20
10313115|NCT00148122|11446653|FG000|STARTED|Overall Study||40
10313116|NCT00148122|11446653|FG000|COMPLETED|Overall Study||38
10313117|NCT00148122|11446653|FG000|NOT COMPLETED|Overall Study||2
10313118|NCT00148317|11446657|FG000|STARTED|Consolidation (VEL + DEX)||38
10313119|NCT00148317|11446657|FG000|DOXIL Added at Cycle 3|Consolidation (VEL + DEX)||16
10408847|NCT00757601|11552972|FG011|STARTED|Period 2||3
10408848|NCT00757601|11552961|FG000|COMPLETED|Period 2||2
10313120|NCT00148317|11446657|FG000|DOXIL Added at Cycle 5|Consolidation (VEL + DEX)||12
10313121|NCT00148317|11446657|FG000|no DOXIL Added|Consolidation (VEL + DEX)||10
10313122|NCT00148317|11446657|FG000|COMPLETED|Consolidation (VEL + DEX)||38
10313123|NCT00148317|11446657|FG000|NOT COMPLETED|Consolidation (VEL + DEX)||0
10313124|NCT00148317|11446657|FG000|STARTED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||38
10313125|NCT00148317|11446657|FG000|COMPLETED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||27
10313126|NCT00148317|11446657|FG000|NOT COMPLETED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||11
10313127|NCT00148343|11446666|FG000|STARTED|Overall Study||54
10408849|NCT00757601|11552962|FG001|COMPLETED|Period 2||2
10823710|NCT00588861|11989101|FG001|STARTED|10 Years|114 cases were due at 10 Years, however no patients returned for follow-up.|114
10823711|NCT00588861|11989100|FG000|COMPLETED|10 Years||0
10823712|NCT00588861|11989101|FG001|COMPLETED|10 Years||0
10823713|NCT00588861|11989100|FG000|NOT COMPLETED|10 Years||107
10823714|NCT00588861|11989101|FG001|NOT COMPLETED|10 Years||114
10754144|NCT03049852|11917803|FG001|NOT COMPLETED|Overall Study||1
10754145|NCT03049852|11917804|FG002|NOT COMPLETED|Overall Study||0
10754146|NCT03049917|11917819|FG000|STARTED|Overall Study||90
10754147|NCT03049917|11917820|FG001|STARTED|Overall Study||89
10754148|NCT03049917|11917821|FG002|STARTED|Overall Study||93
10754149|NCT03049917|11917822|FG003|STARTED|Overall Study||92
10754150|NCT03049917|11917823|FG004|STARTED|Overall Study||88
10544815|NCT01491854|11697979|FG000|STARTED|Overall Study||130
10544816|NCT01491854|11697979|FG000|COMPLETED|Overall Study||0
10544817|NCT01491854|11697979|FG000|NOT COMPLETED|Overall Study||130
10544818|NCT01491919|11697986|FG000|STARTED|Overall Study||13
10544819|NCT01491919|11697987|FG001|STARTED|Overall Study||10
10544820|NCT01491919|11697988|FG002|STARTED|Overall Study||3
10544821|NCT01491919|11697986|FG000|COMPLETED|Overall Study||12
10544822|NCT01491919|11697987|FG001|COMPLETED|Overall Study||8
10544823|NCT01491919|11697988|FG002|COMPLETED|Overall Study||2
10544824|NCT01491919|11697986|FG000|NOT COMPLETED|Overall Study||1
10544825|NCT01491919|11697987|FG001|NOT COMPLETED|Overall Study||2
10544826|NCT01491919|11697988|FG002|NOT COMPLETED|Overall Study||1
10544827|NCT01491945|11697998|FG000|STARTED|Overall Study||76
10544828|NCT01491945|11697998|FG000|COMPLETED|Overall Study||25
10544829|NCT01491945|11697998|FG000|NOT COMPLETED|Overall Study||51
10544830|NCT01491958|11698005|FG000|STARTED|Overall Study||40
10544831|NCT01491958|11698006|FG001|STARTED|Overall Study||40
10544832|NCT01491958|11698005|FG000|COMPLETED|Overall Study||40
10544833|NCT01491958|11698006|FG001|COMPLETED|Overall Study||40
10544834|NCT01491958|11698005|FG000|NOT COMPLETED|Overall Study||0
10544835|NCT01491958|11698006|FG001|NOT COMPLETED|Overall Study||0
10544836|NCT01491984|11698013|FG000|STARTED|Overall Study||49
10754151|NCT03049917|11917819|FG000|COMPLETED|Overall Study||31
10754152|NCT03049917|11917820|FG001|COMPLETED|Overall Study||31
10754153|NCT03049917|11917821|FG002|COMPLETED|Overall Study||44
10754154|NCT03049917|11917822|FG003|COMPLETED|Overall Study||51
10754155|NCT03049917|11917823|FG004|COMPLETED|Overall Study||54
10754156|NCT03049917|11917819|FG000|NOT COMPLETED|Overall Study||59
10754157|NCT03049917|11917820|FG001|NOT COMPLETED|Overall Study||58
10823765|NCT03288142|11989129|FG000|STARTED|Overall Study||166
10823766|NCT03288142|11989130|FG001|STARTED|Overall Study||167
10823767|NCT03288142|11989129|FG000|COMPLETED|Overall Study||144
10823768|NCT03288142|11989130|FG001|COMPLETED|Overall Study||152
10823769|NCT03288142|11989129|FG000|NOT COMPLETED|Overall Study||22
10823770|NCT03288142|11989130|FG001|NOT COMPLETED|Overall Study||15
10823771|NCT03112603|11989140|FG000|STARTED|End of Randomization Period||165
10823772|NCT03112603|11989141|FG001|STARTED|End of Randomization Period||164
10823773|NCT03112603|11989142|FG002|STARTED|End of Randomization Period||0
10823774|NCT03112603|11989140|FG000|COMPLETED|End of Randomization Period||0
10823775|NCT03112603|11989141|FG001|COMPLETED|End of Randomization Period||0
10823776|NCT03112603|11989142|FG002|COMPLETED|End of Randomization Period||0
10823777|NCT03112603|11989140|FG000|NOT COMPLETED|End of Randomization Period||165
10823778|NCT03112603|11989141|FG001|NOT COMPLETED|End of Randomization Period||164
10823779|NCT03112603|11989142|FG002|NOT COMPLETED|End of Randomization Period||0
10823780|NCT03112603|11989140|FG000|STARTED|End of Cross Over Period||0
10823781|NCT03112603|11989141|FG001|STARTED|End of Cross Over Period||0
10823782|NCT03112603|11989142|FG002|STARTED|End of Cross Over Period||61
10823783|NCT03112603|11989140|FG000|COMPLETED|End of Cross Over Period||0
10823784|NCT03112603|11989141|FG001|COMPLETED|End of Cross Over Period||0
10823785|NCT03112603|11989142|FG002|COMPLETED|End of Cross Over Period||0
10823786|NCT03112603|11989140|FG000|NOT COMPLETED|End of Cross Over Period||0
10823787|NCT03112603|11989141|FG001|NOT COMPLETED|End of Cross Over Period||0
10823788|NCT03112603|11989142|FG002|NOT COMPLETED|End of Cross Over Period||61
10823795|NCT02767570|11989159|FG000|STARTED|Overall Study||34
10823796|NCT02767570|11989160|FG001|STARTED|Overall Study||34
10823797|NCT02767570|11989159|FG000|Per Protocol Week 6|Overall Study||31
10823798|NCT02767570|11989160|FG001|Per Protocol Week 6|Overall Study||33
10823799|NCT02767570|11989159|FG000|COMPLETED|Overall Study||25
10823800|NCT02767570|11989160|FG001|COMPLETED|Overall Study||24
10823801|NCT02767570|11989159|FG000|NOT COMPLETED|Overall Study||9
10823802|NCT02767570|11989160|FG001|NOT COMPLETED|Overall Study||10
10823803|NCT02702180|11989169|FG000|STARTED|Double-blind Treatment Period||46
10823804|NCT02702180|11989170|FG001|STARTED|Double-blind Treatment Period||45
10823805|NCT02702180|11989171|FG002|STARTED|Double-blind Treatment Period||47
10823806|NCT02702180|11989169|FG000|COMPLETED|Double-blind Treatment Period||45
10823807|NCT02702180|11989170|FG001|COMPLETED|Double-blind Treatment Period||44
10823808|NCT02702180|11989171|FG002|COMPLETED|Double-blind Treatment Period||43
10823809|NCT02702180|11989169|FG000|NOT COMPLETED|Double-blind Treatment Period||1
10823810|NCT02702180|11989170|FG001|NOT COMPLETED|Double-blind Treatment Period||1
10823811|NCT02702180|11989171|FG002|NOT COMPLETED|Double-blind Treatment Period||4
10823812|NCT02702180|11989169|FG000|STARTED|Open-label Treatment Period||45
10823813|NCT02702180|11989170|FG001|STARTED|Open-label Treatment Period||43
10823814|NCT02702180|11989171|FG002|STARTED|Open-label Treatment Period||43
10823815|NCT02702180|11989169|FG000|COMPLETED|Open-label Treatment Period||45
10823816|NCT02702180|11989170|FG001|COMPLETED|Open-label Treatment Period||42
10823817|NCT02702180|11989171|FG002|COMPLETED|Open-label Treatment Period||41
10823818|NCT02702180|11989169|FG000|NOT COMPLETED|Open-label Treatment Period||0
10823819|NCT02702180|11989170|FG001|NOT COMPLETED|Open-label Treatment Period||1
10823820|NCT02702180|11989171|FG002|NOT COMPLETED|Open-label Treatment Period||2
10823821|NCT02545049|11989182|FG000|STARTED|Overall Study||3723
10823822|NCT02545049|11989183|FG001|STARTED|Overall Study||3714
10823823|NCT02545049|11989182|FG000|Treated|Overall Study||3683
10823824|NCT02545049|11989183|FG001|Treated|Overall Study||3658
10823825|NCT02545049|11989182|FG000|Included in FAS|Overall Study||3686
10823826|NCT02545049|11989183|FG001|Included in FAS|Overall Study||3666
10823827|NCT02545049|11989182|FG000|COMPLETED|Overall Study||3681
10823828|NCT02545049|11989183|FG001|COMPLETED|Overall Study||3653
10823829|NCT02545049|11989182|FG000|NOT COMPLETED|Overall Study||42
10823830|NCT02545049|11989183|FG001|NOT COMPLETED|Overall Study||61
10823831|NCT02448381|11989191|FG000|STARTED|Overall Study||118
10823832|NCT02448381|11989192|FG001|STARTED|Overall Study||51
10823833|NCT02448381|11989191|FG000|Randomized, Not Treated|Overall Study||2
10823834|NCT02448381|11989192|FG001|Randomized, Not Treated|Overall Study||1
10823835|NCT02448381|11989191|FG000|Cycle 1|Overall Study||116
10823836|NCT02448381|11989192|FG001|Cycle 1|Overall Study||50
10823837|NCT02448381|11989191|FG000|Cycle 2|Overall Study||110
10823838|NCT02448381|11989192|FG001|Cycle 2|Overall Study||45
10823839|NCT02448381|11989191|FG000|Cycle 3|Overall Study||78
10823840|NCT02448381|11989192|FG001|Cycle 3|Overall Study||32
10823841|NCT02448381|11989191|FG000|Follow-up Period|Overall Study||98
10823842|NCT02448381|11989192|FG001|Follow-up Period|Overall Study||39
10823843|NCT02448381|11989191|FG000|COMPLETED|Overall Study||83
10823844|NCT02448381|11989192|FG001|COMPLETED|Overall Study||32
10823845|NCT02448381|11989191|FG000|NOT COMPLETED|Overall Study||35
10823846|NCT02448381|11989192|FG001|NOT COMPLETED|Overall Study||19
10823859|NCT01849874|11989215|FG000|STARTED|Overall Study||201
10823860|NCT01849874|11989216|FG001|STARTED|Overall Study||102
10823861|NCT01849874|11989215|FG000|Treated|Overall Study||200
10823862|NCT01849874|11989216|FG001|Treated|Overall Study||94
10823863|NCT01849874|11989215|FG000|COMPLETED|Overall Study||0
10823864|NCT01849874|11989216|FG001|COMPLETED|Overall Study||0
10823865|NCT01849874|11989215|FG000|NOT COMPLETED|Overall Study||201
10823866|NCT01849874|11989216|FG001|NOT COMPLETED|Overall Study||102
10823867|NCT01724866|11989226|FG000|STARTED|Overall Study||39
10823868|NCT01724866|11989227|FG001|STARTED|Overall Study||37
10823869|NCT01724866|11989228|FG002|STARTED|Overall Study||36
10823870|NCT01724866|11989229|FG003|STARTED|Overall Study||36
10823871|NCT01724866|11989226|FG000|Evaluable Population|Overall Study||39
10823872|NCT01724866|11989227|FG001|Evaluable Population|Overall Study||36
10823873|NCT01724866|11989228|FG002|Evaluable Population|Overall Study||36
10823874|NCT01724866|11989229|FG003|Evaluable Population|Overall Study||36
10823875|NCT01724866|11989226|FG000|COMPLETED|Overall Study||38
10823876|NCT01724866|11989227|FG001|COMPLETED|Overall Study||32
10823877|NCT01724866|11989228|FG002|COMPLETED|Overall Study||33
10823878|NCT01724866|11989229|FG003|COMPLETED|Overall Study||35
10823879|NCT01724866|11989226|FG000|NOT COMPLETED|Overall Study||1
10823880|NCT01724866|11989227|FG001|NOT COMPLETED|Overall Study||5
10823881|NCT01724866|11989228|FG002|NOT COMPLETED|Overall Study||3
10823882|NCT01724866|11989229|FG003|NOT COMPLETED|Overall Study||1
10823883|NCT01670877|11989243|FG000|STARTED|Part I and Part 2||16
10823884|NCT01670877|11989244|FG001|STARTED|Part I and Part 2||5
10823885|NCT01670877|11989245|FG002|STARTED|Part I and Part 2||11
10823886|NCT01670877|11989246|FG003|STARTED|Part I and Part 2||24
10823887|NCT01670877|11989247|FG004|STARTED|Part I and Part 2||0
10823888|NCT01670877|11989248|FG005|STARTED|Part I and Part 2||0
10823889|NCT01670877|11989243|FG000|COMPLETED|Part I and Part 2||16
10823890|NCT01670877|11989244|FG001|COMPLETED|Part I and Part 2||4
10823891|NCT01670877|11989245|FG002|COMPLETED|Part I and Part 2||10
10823892|NCT01670877|11989246|FG003|COMPLETED|Part I and Part 2||21
10823893|NCT01670877|11989247|FG004|COMPLETED|Part I and Part 2||0
10823894|NCT01670877|11989248|FG005|COMPLETED|Part I and Part 2||0
10823895|NCT01670877|11989243|FG000|NOT COMPLETED|Part I and Part 2||0
10823896|NCT01670877|11989244|FG001|NOT COMPLETED|Part I and Part 2||1
10823897|NCT01670877|11989245|FG002|NOT COMPLETED|Part I and Part 2||1
10823898|NCT01670877|11989246|FG003|NOT COMPLETED|Part I and Part 2||3
10823899|NCT01670877|11989247|FG004|NOT COMPLETED|Part I and Part 2||0
10823900|NCT01670877|11989248|FG005|NOT COMPLETED|Part I and Part 2||0
10823901|NCT01670877|11989243|FG000|STARTED|Crossover||0
10823902|NCT01670877|11989244|FG001|STARTED|Crossover||0
10823903|NCT01670877|11989245|FG002|STARTED|Crossover||0
10823904|NCT01670877|11989246|FG003|STARTED|Crossover||0
10823905|NCT01670877|11989247|FG004|STARTED|Crossover||3
10823906|NCT01670877|11989248|FG005|STARTED|Crossover||5
10823907|NCT01670877|11989243|FG000|COMPLETED|Crossover||0
10823908|NCT01670877|11989244|FG001|COMPLETED|Crossover||0
10823909|NCT01670877|11989245|FG002|COMPLETED|Crossover||0
10823910|NCT01670877|11989246|FG003|COMPLETED|Crossover||0
10823911|NCT01670877|11989247|FG004|COMPLETED|Crossover||3
10823912|NCT01670877|11989248|FG005|COMPLETED|Crossover||5
10823913|NCT01670877|11989243|FG000|NOT COMPLETED|Crossover||0
10823914|NCT01670877|11989244|FG001|NOT COMPLETED|Crossover||0
10823915|NCT01670877|11989245|FG002|NOT COMPLETED|Crossover||0
10823916|NCT01670877|11989246|FG003|NOT COMPLETED|Crossover||0
10823917|NCT01670877|11989247|FG004|NOT COMPLETED|Crossover||0
10823918|NCT01670877|11989248|FG005|NOT COMPLETED|Crossover||0
10823925|NCT00667628|11989273|FG000|STARTED|Overall Study||25
10823926|NCT00667628|11989274|FG001|STARTED|Overall Study||27
10823927|NCT00667628|11989273|FG000|COMPLETED|Overall Study||0
10823928|NCT00667628|11989274|FG001|COMPLETED|Overall Study||0
10823929|NCT00667628|11989273|FG000|NOT COMPLETED|Overall Study||25
10823930|NCT00667628|11989274|FG001|NOT COMPLETED|Overall Study||27
10313128|NCT00148343|11446667|FG001|STARTED|Overall Study||56
10823931|NCT04286529|11989284|FG000|STARTED|Overall Study||4
10823932|NCT04286529|11989285|FG001|STARTED|Overall Study||4
10823933|NCT04286529|11989286|FG002|STARTED|Overall Study||5
10823934|NCT04286529|11989287|FG003|STARTED|Overall Study||4
10823935|NCT04286529|11989284|FG000|COMPLETED|Overall Study||3
10823936|NCT04286529|11989285|FG001|COMPLETED|Overall Study||1
10823937|NCT04286529|11989286|FG002|COMPLETED|Overall Study||3
10823938|NCT04286529|11989287|FG003|COMPLETED|Overall Study||1
10823939|NCT04286529|11989284|FG000|NOT COMPLETED|Overall Study||1
10823940|NCT04286529|11989285|FG001|NOT COMPLETED|Overall Study||3
10823941|NCT04286529|11989286|FG002|NOT COMPLETED|Overall Study||2
10823942|NCT04286529|11989287|FG003|NOT COMPLETED|Overall Study||3
10823943|NCT03581786|11989299|FG000|STARTED|Overall Study||143
10823944|NCT03581786|11989300|FG001|STARTED|Overall Study||146
10823945|NCT03581786|11989299|FG000|COMPLETED|Overall Study||0
10823946|NCT03581786|11989300|FG001|COMPLETED|Overall Study||0
10823947|NCT03581786|11989299|FG000|NOT COMPLETED|Overall Study||143
10823948|NCT03581786|11989300|FG001|NOT COMPLETED|Overall Study||146
10823949|NCT03573518|11989310|FG000|STARTED|Overall Study||92
10823950|NCT03573518|11989311|FG001|STARTED|Overall Study||92
10823951|NCT03573518|11989312|FG002|STARTED|Overall Study||92
10823952|NCT03573518|11989313|FG003|STARTED|Overall Study||92
10823953|NCT03573518|11989310|FG000|COMPLETED|Overall Study||69
10823954|NCT03573518|11989311|FG001|COMPLETED|Overall Study||77
10823955|NCT03573518|11989312|FG002|COMPLETED|Overall Study||70
10823956|NCT03573518|11989313|FG003|COMPLETED|Overall Study||81
10823957|NCT03573518|11989310|FG000|NOT COMPLETED|Overall Study||23
10823958|NCT03573518|11989311|FG001|NOT COMPLETED|Overall Study||15
10823959|NCT03573518|11989312|FG002|NOT COMPLETED|Overall Study||22
10823960|NCT03573518|11989313|FG003|NOT COMPLETED|Overall Study||11
10823961|NCT03486314|11989323|FG000|STARTED|Part A||20
10823962|NCT03486314|11989324|FG001|STARTED|Part A||0
10823963|NCT03486314|11989325|FG002|STARTED|Part A||0
10823964|NCT03486314|11989323|FG000|COMPLETED|Part A||17
10823965|NCT03486314|11989324|FG001|COMPLETED|Part A||0
10823966|NCT03486314|11989325|FG002|COMPLETED|Part A||0
10823967|NCT03486314|11989323|FG000|NOT COMPLETED|Part A||3
10823968|NCT03486314|11989324|FG001|NOT COMPLETED|Part A||0
10823969|NCT03486314|11989325|FG002|NOT COMPLETED|Part A||0
10823970|NCT03486314|11989323|FG000|STARTED|Part B||0
10823971|NCT03486314|11989324|FG001|STARTED|Part B|These are the participants who completed Part A, met eligibility criteria, and provided consent for Part B.|9
10823972|NCT03486314|11989325|FG002|STARTED|Part B|These are the participants who completed Part A, met eligibility criteria, and provided consent for Part B.|8
10823973|NCT03486314|11989323|FG000|COMPLETED|Part B||0
10823974|NCT03486314|11989324|FG001|COMPLETED|Part B||9
10823975|NCT03486314|11989325|FG002|COMPLETED|Part B||8
10823976|NCT03486314|11989323|FG000|NOT COMPLETED|Part B||0
10823977|NCT03486314|11989324|FG001|NOT COMPLETED|Part B||0
10823978|NCT03486314|11989325|FG002|NOT COMPLETED|Part B||0
10823979|NCT02988713|11989333|FG000|STARTED|Overall Study||35
10823980|NCT02988713|11989333|FG000|COMPLETED|Overall Study||32
10823981|NCT02988713|11989333|FG000|NOT COMPLETED|Overall Study||3
10823982|NCT02794883|11989340|FG000|STARTED|Pre-Surgical Treatment||12
10823983|NCT02794883|11989341|FG001|STARTED|Pre-Surgical Treatment||12
10823984|NCT02794883|11989342|FG002|STARTED|Pre-Surgical Treatment||12
10823985|NCT02794883|11989340|FG000|Registered for Study|Pre-Surgical Treatment||12
10823986|NCT02794883|11989341|FG001|Registered for Study|Pre-Surgical Treatment||12
10823987|NCT02794883|11989342|FG002|Registered for Study|Pre-Surgical Treatment||12
10823988|NCT02794883|11989340|FG000|Received First Dose (Pre-surgical Dose) of Study Drug|Pre-Surgical Treatment||12
10823989|NCT02794883|11989341|FG001|Received First Dose (Pre-surgical Dose) of Study Drug|Pre-Surgical Treatment||11
10823990|NCT02794883|11989342|FG002|Received First Dose (Pre-surgical Dose) of Study Drug|Pre-Surgical Treatment||11
10823991|NCT02794883|11989340|FG000|COMPLETED|Pre-Surgical Treatment||12
10823992|NCT02794883|11989341|FG001|COMPLETED|Pre-Surgical Treatment||11
10823993|NCT02794883|11989342|FG002|COMPLETED|Pre-Surgical Treatment||11
10823994|NCT02794883|11989340|FG000|NOT COMPLETED|Pre-Surgical Treatment||0
10823995|NCT02794883|11989341|FG001|NOT COMPLETED|Pre-Surgical Treatment||1
10823996|NCT02794883|11989342|FG002|NOT COMPLETED|Pre-Surgical Treatment||1
10823997|NCT02794883|11989340|FG000|STARTED|Post-Surgery Treatment (Adjuvant)||12
10823998|NCT02794883|11989341|FG001|STARTED|Post-Surgery Treatment (Adjuvant)||11
10823999|NCT02794883|11989342|FG002|STARTED|Post-Surgery Treatment (Adjuvant)||11
10824000|NCT02794883|11989340|FG000|Started Cycle 1|Post-Surgery Treatment (Adjuvant)||11
10824001|NCT02794883|11989341|FG001|Started Cycle 1|Post-Surgery Treatment (Adjuvant)||8
10824002|NCT02794883|11989342|FG002|Started Cycle 1|Post-Surgery Treatment (Adjuvant)||11
10824003|NCT02794883|11989340|FG000|Started Cycle 2|Post-Surgery Treatment (Adjuvant)||7
10824004|NCT02794883|11989341|FG001|Started Cycle 2|Post-Surgery Treatment (Adjuvant)||8
10824005|NCT02794883|11989342|FG002|Started Cycle 2|Post-Surgery Treatment (Adjuvant)||11
10824006|NCT02794883|11989340|FG000|Started Cycle 3|Post-Surgery Treatment (Adjuvant)||3
10824007|NCT02794883|11989341|FG001|Started Cycle 3|Post-Surgery Treatment (Adjuvant)||7
10824008|NCT02794883|11989342|FG002|Started Cycle 3|Post-Surgery Treatment (Adjuvant)||4
10824009|NCT02794883|11989340|FG000|Started Cycle 4|Post-Surgery Treatment (Adjuvant)||2
10824010|NCT02794883|11989341|FG001|Started Cycle 4|Post-Surgery Treatment (Adjuvant)||5
10824011|NCT02794883|11989342|FG002|Started Cycle 4|Post-Surgery Treatment (Adjuvant)||2
10824012|NCT02794883|11989340|FG000|Started Cycle 5|Post-Surgery Treatment (Adjuvant)||2
10824013|NCT02794883|11989341|FG001|Started Cycle 5|Post-Surgery Treatment (Adjuvant)||3
10824014|NCT02794883|11989342|FG002|Started Cycle 5|Post-Surgery Treatment (Adjuvant)||2
10824015|NCT02794883|11989340|FG000|Started Cycle 6|Post-Surgery Treatment (Adjuvant)||0
10824016|NCT02794883|11989341|FG001|Started Cycle 6|Post-Surgery Treatment (Adjuvant)||3
10824017|NCT02794883|11989342|FG002|Started Cycle 6|Post-Surgery Treatment (Adjuvant)||2
10824018|NCT02794883|11989340|FG000|Started Cycle 7|Post-Surgery Treatment (Adjuvant)||0
10824019|NCT02794883|11989341|FG001|Started Cycle 7|Post-Surgery Treatment (Adjuvant)||3
10824020|NCT02794883|11989342|FG002|Started Cycle 7|Post-Surgery Treatment (Adjuvant)||1
10824021|NCT02794883|11989340|FG000|Started Cycle 8|Post-Surgery Treatment (Adjuvant)||0
10824022|NCT02794883|11989341|FG001|Started Cycle 8|Post-Surgery Treatment (Adjuvant)||3
10824023|NCT02794883|11989342|FG002|Started Cycle 8|Post-Surgery Treatment (Adjuvant)||1
10824024|NCT02794883|11989340|FG000|Started Cycle 9|Post-Surgery Treatment (Adjuvant)||0
10824025|NCT02794883|11989341|FG001|Started Cycle 9|Post-Surgery Treatment (Adjuvant)||3
10824026|NCT02794883|11989342|FG002|Started Cycle 9|Post-Surgery Treatment (Adjuvant)||1
10824027|NCT02794883|11989340|FG000|Started Cycle 10|Post-Surgery Treatment (Adjuvant)||0
10824028|NCT02794883|11989341|FG001|Started Cycle 10|Post-Surgery Treatment (Adjuvant)||2
10824029|NCT02794883|11989342|FG002|Started Cycle 10|Post-Surgery Treatment (Adjuvant)||1
10824030|NCT02794883|11989340|FG000|Started Cycle 11|Post-Surgery Treatment (Adjuvant)||0
10824031|NCT02794883|11989341|FG001|Started Cycle 11|Post-Surgery Treatment (Adjuvant)||2
10824032|NCT02794883|11989342|FG002|Started Cycle 11|Post-Surgery Treatment (Adjuvant)||1
10824033|NCT02794883|11989340|FG000|Started Cycle 12|Post-Surgery Treatment (Adjuvant)||0
10824034|NCT02794883|11989341|FG001|Started Cycle 12|Post-Surgery Treatment (Adjuvant)||1
10824035|NCT02794883|11989342|FG002|Started Cycle 12|Post-Surgery Treatment (Adjuvant)||1
10824036|NCT02794883|11989340|FG000|Started Cycle 13|Post-Surgery Treatment (Adjuvant)||0
10824037|NCT02794883|11989341|FG001|Started Cycle 13|Post-Surgery Treatment (Adjuvant)||1
10824038|NCT02794883|11989342|FG002|Started Cycle 13|Post-Surgery Treatment (Adjuvant)||1
10824039|NCT02794883|11989340|FG000|Started Cycle 14|Post-Surgery Treatment (Adjuvant)||0
10824040|NCT02794883|11989341|FG001|Started Cycle 14|Post-Surgery Treatment (Adjuvant)||1
10824041|NCT02794883|11989342|FG002|Started Cycle 14|Post-Surgery Treatment (Adjuvant)||1
10824042|NCT02794883|11989340|FG000|Started Cycle 15|Post-Surgery Treatment (Adjuvant)||0
10824043|NCT02794883|11989341|FG001|Started Cycle 15|Post-Surgery Treatment (Adjuvant)||0
10824044|NCT02794883|11989342|FG002|Started Cycle 15|Post-Surgery Treatment (Adjuvant)||1
10824045|NCT02794883|11989340|FG000|Started Cycle 16|Post-Surgery Treatment (Adjuvant)||0
10824046|NCT02794883|11989341|FG001|Started Cycle 16|Post-Surgery Treatment (Adjuvant)||0
10824047|NCT02794883|11989342|FG002|Started Cycle 16|Post-Surgery Treatment (Adjuvant)||1
10824048|NCT02794883|11989340|FG000|Started Cycle 17|Post-Surgery Treatment (Adjuvant)||0
10824049|NCT02794883|11989341|FG001|Started Cycle 17|Post-Surgery Treatment (Adjuvant)||0
10824050|NCT02794883|11989342|FG002|Started Cycle 17|Post-Surgery Treatment (Adjuvant)||0
10824051|NCT02794883|11989340|FG000|COMPLETED|Post-Surgery Treatment (Adjuvant)||0
10824052|NCT02794883|11989341|FG001|COMPLETED|Post-Surgery Treatment (Adjuvant)||0
10824053|NCT02794883|11989342|FG002|COMPLETED|Post-Surgery Treatment (Adjuvant)||0
10824054|NCT02794883|11989340|FG000|NOT COMPLETED|Post-Surgery Treatment (Adjuvant)||12
10824055|NCT02794883|11989341|FG001|NOT COMPLETED|Post-Surgery Treatment (Adjuvant)||11
10824056|NCT02794883|11989342|FG002|NOT COMPLETED|Post-Surgery Treatment (Adjuvant)||11
10824057|NCT02794883|11989340|FG000|STARTED|Follow-up Period (up to 2 Years)||12
10824058|NCT02794883|11989341|FG001|STARTED|Follow-up Period (up to 2 Years)||11
10824059|NCT02794883|11989342|FG002|STARTED|Follow-up Period (up to 2 Years)||11
10824060|NCT02794883|11989340|FG000|COMPLETED|Follow-up Period (up to 2 Years)||0
10824061|NCT02794883|11989341|FG001|COMPLETED|Follow-up Period (up to 2 Years)||1
10824062|NCT02794883|11989342|FG002|COMPLETED|Follow-up Period (up to 2 Years)||1
10824063|NCT02794883|11989340|FG000|NOT COMPLETED|Follow-up Period (up to 2 Years)||12
10824064|NCT02794883|11989341|FG001|NOT COMPLETED|Follow-up Period (up to 2 Years)||10
10824065|NCT02794883|11989342|FG002|NOT COMPLETED|Follow-up Period (up to 2 Years)||10
10824066|NCT02677987|11989352|FG000|STARTED|Overall Study||23
10824067|NCT02677987|11989353|FG001|STARTED|Overall Study||24
10824068|NCT02677987|11989352|FG000|COMPLETED|Overall Study||19
10824069|NCT02677987|11989353|FG001|COMPLETED|Overall Study||24
10824070|NCT02677987|11989352|FG000|NOT COMPLETED|Overall Study||4
10824071|NCT02677987|11989353|FG001|NOT COMPLETED|Overall Study||0
10824078|NCT01928394|11989396|FG000|STARTED|Treatment Period||18
10824079|NCT01928394|11989397|FG001|STARTED|Treatment Period||3
10824080|NCT01928394|11989398|FG002|STARTED|Treatment Period||18
10824081|NCT01928394|11989399|FG003|STARTED|Treatment Period||59
10824082|NCT01928394|11989400|FG004|STARTED|Treatment Period||3
10824083|NCT01928394|11989401|FG005|STARTED|Treatment Period||49
10824084|NCT01928394|11989402|FG006|STARTED|Treatment Period||52
10824085|NCT01928394|11989403|FG007|STARTED|Treatment Period||18
10824086|NCT01928394|11989404|FG008|STARTED|Treatment Period||3
10824087|NCT01928394|11989405|FG009|STARTED|Treatment Period||18
10824088|NCT01928394|11989406|FG010|STARTED|Treatment Period||30
10824089|NCT01928394|11989407|FG011|STARTED|Treatment Period||98
10824090|NCT01928394|11989408|FG012|STARTED|Treatment Period||61
10824091|NCT01928394|11989409|FG013|STARTED|Treatment Period||147
10824092|NCT01928394|11989410|FG014|STARTED|Treatment Period||96
10824093|NCT01928394|11989411|FG015|STARTED|Treatment Period||3
10824094|NCT01928394|11989412|FG016|STARTED|Treatment Period||55
10824095|NCT01928394|11989413|FG017|STARTED|Treatment Period||78
10824096|NCT01928394|11989414|FG018|STARTED|Treatment Period||92
10824097|NCT01928394|11989415|FG019|STARTED|Treatment Period||104
10824098|NCT01928394|11989416|FG020|STARTED|Treatment Period||41
10824099|NCT01928394|11989417|FG021|STARTED|Treatment Period||43
10824100|NCT01928394|11989418|FG022|STARTED|Treatment Period||42
10824101|NCT01928394|11989396|FG000|Transition|Treatment Period||3
10824102|NCT01928394|11989397|FG001|Transition|Treatment Period||0
10824103|NCT01928394|11989398|FG002|Transition|Treatment Period||0
10824104|NCT01928394|11989399|FG003|Transition|Treatment Period||9
10824105|NCT01928394|11989400|FG004|Transition|Treatment Period||0
10824106|NCT01928394|11989401|FG005|Transition|Treatment Period||0
10824107|NCT01928394|11989402|FG006|Transition|Treatment Period||0
10824108|NCT01928394|11989403|FG007|Transition|Treatment Period||2
10824109|NCT01928394|11989404|FG008|Transition|Treatment Period||0
10824110|NCT01928394|11989405|FG009|Transition|Treatment Period||0
10824111|NCT01928394|11989406|FG010|Transition|Treatment Period||0
10824112|NCT01928394|11989407|FG011|Transition|Treatment Period||17
10824113|NCT01928394|11989408|FG012|Transition|Treatment Period||0
10824114|NCT01928394|11989409|FG013|Transition|Treatment Period||2
10824115|NCT01928394|11989410|FG014|Transition|Treatment Period||0
10824116|NCT01928394|11989411|FG015|Transition|Treatment Period||0
10824117|NCT01928394|11989412|FG016|Transition|Treatment Period||0
10824118|NCT01928394|11989413|FG017|Transition|Treatment Period||20
10824119|NCT01928394|11989414|FG018|Transition|Treatment Period||0
10824120|NCT01928394|11989415|FG019|Transition|Treatment Period||0
10824121|NCT01928394|11989416|FG020|Transition|Treatment Period||0
10824122|NCT01928394|11989417|FG021|Transition|Treatment Period||0
10824123|NCT01928394|11989418|FG022|Transition|Treatment Period||0
10824124|NCT01928394|11989396|FG000|Transition- Continued|Treatment Period||0
10824125|NCT01928394|11989397|FG001|Transition- Continued|Treatment Period||0
10824126|NCT01928394|11989398|FG002|Transition- Continued|Treatment Period||3
10824127|NCT01928394|11989399|FG003|Transition- Continued|Treatment Period||0
10824128|NCT01928394|11989400|FG004|Transition- Continued|Treatment Period||0
10824129|NCT01928394|11989401|FG005|Transition- Continued|Treatment Period||3
10824130|NCT01928394|11989402|FG006|Transition- Continued|Treatment Period||6
10824131|NCT01928394|11989403|FG007|Transition- Continued|Treatment Period||0
10824132|NCT01928394|11989404|FG008|Transition- Continued|Treatment Period||1
10824133|NCT01928394|11989405|FG009|Transition- Continued|Treatment Period||1
10824134|NCT01928394|11989406|FG010|Transition- Continued|Treatment Period||0
10824135|NCT01928394|11989407|FG011|Transition- Continued|Treatment Period||0
10824136|NCT01928394|11989408|FG012|Transition- Continued|Treatment Period||17
10824137|NCT01928394|11989409|FG013|Transition- Continued|Treatment Period||0
10824138|NCT01928394|11989410|FG014|Transition- Continued|Treatment Period||2
10824139|NCT01928394|11989411|FG015|Transition- Continued|Treatment Period||0
10824140|NCT01928394|11989412|FG016|Transition- Continued|Treatment Period||0
10824141|NCT01928394|11989413|FG017|Transition- Continued|Treatment Period||0
10824142|NCT01928394|11989414|FG018|Transition- Continued|Treatment Period||1
10824143|NCT01928394|11989415|FG019|Transition- Continued|Treatment Period||19
10824144|NCT01928394|11989416|FG020|Transition- Continued|Treatment Period||0
10824145|NCT01928394|11989417|FG021|Transition- Continued|Treatment Period||0
10824146|NCT01928394|11989418|FG022|Transition- Continued|Treatment Period||0
10824147|NCT01928394|11989396|FG000|COMPLETED|Treatment Period||0
10824148|NCT01928394|11989397|FG001|COMPLETED|Treatment Period||0
10824149|NCT01928394|11989398|FG002|COMPLETED|Treatment Period||0
10824150|NCT01928394|11989399|FG003|COMPLETED|Treatment Period||3
10824151|NCT01928394|11989400|FG004|COMPLETED|Treatment Period||0
10824152|NCT01928394|11989401|FG005|COMPLETED|Treatment Period||6
10824153|NCT01928394|11989402|FG006|COMPLETED|Treatment Period||3
10824154|NCT01928394|11989403|FG007|COMPLETED|Treatment Period||0
10824155|NCT01928394|11989404|FG008|COMPLETED|Treatment Period||0
10824156|NCT01928394|11989405|FG009|COMPLETED|Treatment Period||0
10824157|NCT01928394|11989406|FG010|COMPLETED|Treatment Period||0
10824158|NCT01928394|11989407|FG011|COMPLETED|Treatment Period||5
10824159|NCT01928394|11989408|FG012|COMPLETED|Treatment Period||6
10824160|NCT01928394|11989409|FG013|COMPLETED|Treatment Period||8
10824161|NCT01928394|11989410|FG014|COMPLETED|Treatment Period||8
10824162|NCT01928394|11989411|FG015|COMPLETED|Treatment Period||1
10824163|NCT01928394|11989412|FG016|COMPLETED|Treatment Period||5
10824164|NCT01928394|11989413|FG017|COMPLETED|Treatment Period||7
10824165|NCT01928394|11989414|FG018|COMPLETED|Treatment Period||22
10824166|NCT01928394|11989415|FG019|COMPLETED|Treatment Period||8
10824167|NCT01928394|11989416|FG020|COMPLETED|Treatment Period||1
10824168|NCT01928394|11989417|FG021|COMPLETED|Treatment Period||1
10824169|NCT01928394|11989418|FG022|COMPLETED|Treatment Period||3
10824170|NCT01928394|11989396|FG000|NOT COMPLETED|Treatment Period||18
10824171|NCT01928394|11989397|FG001|NOT COMPLETED|Treatment Period||3
10824172|NCT01928394|11989398|FG002|NOT COMPLETED|Treatment Period||18
10824173|NCT01928394|11989399|FG003|NOT COMPLETED|Treatment Period||56
10824174|NCT01928394|11989400|FG004|NOT COMPLETED|Treatment Period||3
10824175|NCT01928394|11989401|FG005|NOT COMPLETED|Treatment Period||43
10824176|NCT01928394|11989402|FG006|NOT COMPLETED|Treatment Period||49
10824177|NCT01928394|11989403|FG007|NOT COMPLETED|Treatment Period||18
10824178|NCT01928394|11989404|FG008|NOT COMPLETED|Treatment Period||3
10824179|NCT01928394|11989405|FG009|NOT COMPLETED|Treatment Period||18
10824180|NCT01928394|11989406|FG010|NOT COMPLETED|Treatment Period||30
10824181|NCT01928394|11989407|FG011|NOT COMPLETED|Treatment Period||93
10824182|NCT01928394|11989408|FG012|NOT COMPLETED|Treatment Period||55
10824183|NCT01928394|11989409|FG013|NOT COMPLETED|Treatment Period||139
10824184|NCT01928394|11989410|FG014|NOT COMPLETED|Treatment Period||88
10824185|NCT01928394|11989411|FG015|NOT COMPLETED|Treatment Period||2
10824186|NCT01928394|11989412|FG016|NOT COMPLETED|Treatment Period||50
10824187|NCT01928394|11989413|FG017|NOT COMPLETED|Treatment Period||71
10824188|NCT01928394|11989414|FG018|NOT COMPLETED|Treatment Period||70
10824189|NCT01928394|11989415|FG019|NOT COMPLETED|Treatment Period||96
10824190|NCT01928394|11989416|FG020|NOT COMPLETED|Treatment Period||40
10824191|NCT01928394|11989417|FG021|NOT COMPLETED|Treatment Period||42
10824192|NCT01928394|11989418|FG022|NOT COMPLETED|Treatment Period||39
10824193|NCT01928394|11989396|FG000|STARTED|Follow-up Period||15
10824194|NCT01928394|11989397|FG001|STARTED|Follow-up Period||3
10824195|NCT01928394|11989398|FG002|STARTED|Follow-up Period||18
10824196|NCT01928394|11989399|FG003|STARTED|Follow-up Period||50
10824197|NCT01928394|11989400|FG004|STARTED|Follow-up Period||3
10824198|NCT01928394|11989401|FG005|STARTED|Follow-up Period||49
10824199|NCT01928394|11989402|FG006|STARTED|Follow-up Period||52
10824200|NCT01928394|11989403|FG007|STARTED|Follow-up Period||16
10824201|NCT01928394|11989404|FG008|STARTED|Follow-up Period||3
10824202|NCT01928394|11989405|FG009|STARTED|Follow-up Period||18
10824203|NCT01928394|11989406|FG010|STARTED|Follow-up Period||30
10824204|NCT01928394|11989407|FG011|STARTED|Follow-up Period||81
10824205|NCT01928394|11989408|FG012|STARTED|Follow-up Period||61
10824206|NCT01928394|11989409|FG013|STARTED|Follow-up Period||145
10824207|NCT01928394|11989410|FG014|STARTED|Follow-up Period||96
10824208|NCT01928394|11989411|FG015|STARTED|Follow-up Period||3
10824209|NCT01928394|11989412|FG016|STARTED|Follow-up Period||55
10824210|NCT01928394|11989413|FG017|STARTED|Follow-up Period||58
10824211|NCT01928394|11989414|FG018|STARTED|Follow-up Period||92
10824212|NCT01928394|11989415|FG019|STARTED|Follow-up Period||104
10824213|NCT01928394|11989416|FG020|STARTED|Follow-up Period||41
10824214|NCT01928394|11989417|FG021|STARTED|Follow-up Period||43
10824215|NCT01928394|11989418|FG022|STARTED|Follow-up Period||42
10824216|NCT01928394|11989396|FG000|COMPLETED|Follow-up Period||12
10824217|NCT01928394|11989397|FG001|COMPLETED|Follow-up Period||3
10824218|NCT01928394|11989398|FG002|COMPLETED|Follow-up Period||15
10824219|NCT01928394|11989399|FG003|COMPLETED|Follow-up Period||40
10824220|NCT01928394|11989400|FG004|COMPLETED|Follow-up Period||3
10824221|NCT01928394|11989401|FG005|COMPLETED|Follow-up Period||41
10824222|NCT01928394|11989402|FG006|COMPLETED|Follow-up Period||40
10824223|NCT01928394|11989403|FG007|COMPLETED|Follow-up Period||10
10824224|NCT01928394|11989404|FG008|COMPLETED|Follow-up Period||2
10824225|NCT01928394|11989405|FG009|COMPLETED|Follow-up Period||16
10824226|NCT01928394|11989406|FG010|COMPLETED|Follow-up Period||19
10824227|NCT01928394|11989407|FG011|COMPLETED|Follow-up Period||59
10824228|NCT01928394|11989408|FG012|COMPLETED|Follow-up Period||47
10824229|NCT01928394|11989409|FG013|COMPLETED|Follow-up Period||107
10824230|NCT01928394|11989410|FG014|COMPLETED|Follow-up Period||66
10824231|NCT01928394|11989411|FG015|COMPLETED|Follow-up Period||3
10824232|NCT01928394|11989412|FG016|COMPLETED|Follow-up Period||41
10824233|NCT01928394|11989413|FG017|COMPLETED|Follow-up Period||50
10824234|NCT01928394|11989414|FG018|COMPLETED|Follow-up Period||76
10824235|NCT01928394|11989415|FG019|COMPLETED|Follow-up Period||83
10824236|NCT01928394|11989416|FG020|COMPLETED|Follow-up Period||32
10824237|NCT01928394|11989417|FG021|COMPLETED|Follow-up Period||34
10824238|NCT01928394|11989418|FG022|COMPLETED|Follow-up Period||36
10824239|NCT01928394|11989396|FG000|NOT COMPLETED|Follow-up Period||3
10824240|NCT01928394|11989397|FG001|NOT COMPLETED|Follow-up Period||0
10824241|NCT01928394|11989398|FG002|NOT COMPLETED|Follow-up Period||3
10824242|NCT01928394|11989399|FG003|NOT COMPLETED|Follow-up Period||10
10824243|NCT01928394|11989400|FG004|NOT COMPLETED|Follow-up Period||0
10824244|NCT01928394|11989401|FG005|NOT COMPLETED|Follow-up Period||8
10824245|NCT01928394|11989402|FG006|NOT COMPLETED|Follow-up Period||12
10824246|NCT01928394|11989403|FG007|NOT COMPLETED|Follow-up Period||6
10824247|NCT01928394|11989404|FG008|NOT COMPLETED|Follow-up Period||1
10824248|NCT01928394|11989405|FG009|NOT COMPLETED|Follow-up Period||2
10824249|NCT01928394|11989406|FG010|NOT COMPLETED|Follow-up Period||11
10824250|NCT01928394|11989407|FG011|NOT COMPLETED|Follow-up Period||22
10824251|NCT01928394|11989408|FG012|NOT COMPLETED|Follow-up Period||14
10824252|NCT01928394|11989409|FG013|NOT COMPLETED|Follow-up Period||38
10824253|NCT01928394|11989410|FG014|NOT COMPLETED|Follow-up Period||30
10824254|NCT01928394|11989411|FG015|NOT COMPLETED|Follow-up Period||0
10824255|NCT01928394|11989412|FG016|NOT COMPLETED|Follow-up Period||14
10824256|NCT01928394|11989413|FG017|NOT COMPLETED|Follow-up Period||8
10824257|NCT01928394|11989414|FG018|NOT COMPLETED|Follow-up Period||16
10824258|NCT01928394|11989415|FG019|NOT COMPLETED|Follow-up Period||21
10824259|NCT01928394|11989416|FG020|NOT COMPLETED|Follow-up Period||9
10824260|NCT01928394|11989417|FG021|NOT COMPLETED|Follow-up Period||9
10824261|NCT01928394|11989418|FG022|NOT COMPLETED|Follow-up Period||6
10824262|NCT01657500|11989468|FG000|STARTED|Overall Study||32
10824263|NCT01657500|11989469|FG001|STARTED|Overall Study||32
10824264|NCT01657500|11989468|FG000|COMPLETED|Overall Study||27
10824265|NCT01657500|11989469|FG001|COMPLETED|Overall Study||27
10824266|NCT01657500|11989468|FG000|NOT COMPLETED|Overall Study||5
10824267|NCT01657500|11989469|FG001|NOT COMPLETED|Overall Study||5
10408850|NCT00757601|11552963|FG002|COMPLETED|Period 2||2
10408851|NCT00757601|11552964|FG003|COMPLETED|Period 2||2
10408852|NCT00757601|11552965|FG004|COMPLETED|Period 2||2
10408853|NCT00757601|11552966|FG005|COMPLETED|Period 2||2
10408854|NCT00757601|11552967|FG006|COMPLETED|Period 2||2
10408855|NCT00757601|11552968|FG007|COMPLETED|Period 2||2
10824268|NCT04810221|11989475|FG000|STARTED|Overall Study||16
10824269|NCT04810221|11989475|FG000|COMPLETED|Overall Study|"Included in the 13 subjects which completed the study, it is necessary to consider the case 0, a pilot test for the verification of study procedures. Data from this subject were not used in the statistical evaluation, which therefore included data from 12 eligible subjects that completed the study."|13
10824270|NCT04810221|11989475|FG000|NOT COMPLETED|Overall Study||3
10824271|NCT04575038|11989481|FG000|STARTED|Overall Study||56
10824272|NCT04575038|11989482|FG001|STARTED|Overall Study||59
10824273|NCT04575038|11989481|FG000|COMPLETED|Overall Study||55
10824274|NCT04575038|11989482|FG001|COMPLETED|Overall Study||58
10824275|NCT04575038|11989481|FG000|NOT COMPLETED|Overall Study||1
10824276|NCT04575038|11989482|FG001|NOT COMPLETED|Overall Study||1
10824277|NCT04545567|11989490|FG000|STARTED|Overall Study||10
10824278|NCT04545567|11989491|FG001|STARTED|Overall Study||11
10824279|NCT04545567|11989490|FG000|COMPLETED|Overall Study||9
10824280|NCT04545567|11989491|FG001|COMPLETED|Overall Study||9
10824281|NCT04545567|11989490|FG000|NOT COMPLETED|Overall Study||1
10824282|NCT04545567|11989491|FG001|NOT COMPLETED|Overall Study||2
10824283|NCT04425538|11989497|FG000|STARTED|Overall Study||17
10824284|NCT04425538|11989497|FG000|COMPLETED|Overall Study||17
10824285|NCT04425538|11989497|FG000|NOT COMPLETED|Overall Study||0
10824286|NCT04397757|11989503|FG000|STARTED|Overall Study||41
10824287|NCT04397757|11989504|FG001|STARTED|Overall Study||39
10824288|NCT04397757|11989503|FG000|Treated|Overall Study||39
10824289|NCT04397757|11989504|FG001|Treated|Overall Study||39
10824290|NCT04397757|11989503|FG000|COMPLETED|Overall Study||32
10824291|NCT04397757|11989504|FG001|COMPLETED|Overall Study||25
10824292|NCT04397757|11989503|FG000|NOT COMPLETED|Overall Study||9
10824293|NCT04397757|11989504|FG001|NOT COMPLETED|Overall Study||14
10824294|NCT04388683|11989517|FG000|STARTED|Overall Study||6
10824295|NCT04388683|11989518|FG001|STARTED|Overall Study||3
10824296|NCT04388683|11989517|FG000|COMPLETED|Overall Study||5
10824297|NCT04388683|11989518|FG001|COMPLETED|Overall Study||3
10824298|NCT04388683|11989517|FG000|NOT COMPLETED|Overall Study||1
10824299|NCT04388683|11989518|FG001|NOT COMPLETED|Overall Study||0
10824300|NCT04329832|11989526|FG000|STARTED|Overall Study||42
10824301|NCT04329832|11989527|FG001|STARTED|Overall Study||43
10544837|NCT01491984|11698014|FG001|STARTED|Overall Study||45
10544838|NCT01491984|11698013|FG000|COMPLETED|Overall Study||47
10544839|NCT01491984|11698014|FG001|COMPLETED|Overall Study||44
10544840|NCT01491984|11698013|FG000|NOT COMPLETED|Overall Study||2
10544841|NCT01491984|11698014|FG001|NOT COMPLETED|Overall Study||1
10824302|NCT04329832|11989526|FG000|COMPLETED|Overall Study||42
10290435|NCT03572634|11423098|FG000|STARTED|Overall Study||1
10290436|NCT03572634|11423099|FG001|STARTED|Overall Study||2
10290437|NCT03572634|11423098|FG000|COMPLETED|Overall Study||1
10290438|NCT03572634|11423099|FG001|COMPLETED|Overall Study||2
10290439|NCT03572634|11423098|FG000|NOT COMPLETED|Overall Study||0
10290440|NCT03572634|11423099|FG001|NOT COMPLETED|Overall Study||0
10290441|NCT03562156|11423108|FG000|STARTED|Overall Study||217
10290442|NCT03562156|11423109|FG001|STARTED|Overall Study||109
10290443|NCT03562156|11423108|FG000|COMPLETED|Overall Study||182
10290444|NCT03562156|11423109|FG001|COMPLETED|Overall Study||91
10290445|NCT03562156|11423108|FG000|NOT COMPLETED|Overall Study||35
10290446|NCT03562156|11423109|FG001|NOT COMPLETED|Overall Study||18
10290447|NCT03476135|11423117|FG000|STARTED|Overall Study||42
10290448|NCT03476135|11423118|FG001|STARTED|Overall Study||49
10290449|NCT03476135|11423117|FG000|COMPLETED|Overall Study||42
10290450|NCT03476135|11423118|FG001|COMPLETED|Overall Study||49
10824303|NCT04329832|11989527|FG001|COMPLETED|Overall Study||43
10824304|NCT04329832|11989526|FG000|NOT COMPLETED|Overall Study||0
10824305|NCT04329832|11989527|FG001|NOT COMPLETED|Overall Study||0
10824306|NCT04112303|11989541|FG000|STARTED|Overall Study||37
10824307|NCT04112303|11989541|FG000|COMPLETED|Overall Study||36
10824308|NCT04112303|11989541|FG000|NOT COMPLETED|Overall Study||1
10824309|NCT03896477|11989548|FG000|STARTED|Overall Study||220
10824310|NCT03896477|11989549|FG001|STARTED|Overall Study||220
10824311|NCT03896477|11989550|FG002|STARTED|Overall Study||220
10824312|NCT03896477|11989548|FG000|Received First Vaccination|Overall Study||220
10824313|NCT03896477|11989549|FG001|Received First Vaccination|Overall Study||220
10824314|NCT03896477|11989550|FG002|Received First Vaccination|Overall Study||220
10824315|NCT03896477|11989548|FG000|Received Second Vaccination|Overall Study||217
10824316|NCT03896477|11989549|FG001|Received Second Vaccination|Overall Study||213
10824317|NCT03896477|11989550|FG002|Received Second Vaccination|Overall Study||213
10824318|NCT03896477|11989548|FG000|Received Booster Vaccination|Overall Study||208
10824319|NCT03896477|11989549|FG001|Received Booster Vaccination|Overall Study||206
10824320|NCT03896477|11989550|FG002|Received Booster Vaccination|Overall Study||206
10824321|NCT03896477|11989548|FG000|COMPLETED|Overall Study||203
10824322|NCT03896477|11989549|FG001|COMPLETED|Overall Study||200
10824323|NCT03896477|11989550|FG002|COMPLETED|Overall Study||200
10824324|NCT03896477|11989548|FG000|NOT COMPLETED|Overall Study||17
10824325|NCT03896477|11989549|FG001|NOT COMPLETED|Overall Study||20
10824326|NCT03896477|11989550|FG002|NOT COMPLETED|Overall Study||20
10824327|NCT03760185|11989561|FG000|STARTED|Overall Study||13
10824328|NCT03760185|11989562|FG001|STARTED|Overall Study||13
10824329|NCT03760185|11989561|FG000|COMPLETED|Overall Study||12
10824330|NCT03760185|11989562|FG001|COMPLETED|Overall Study||12
10824331|NCT03760185|11989561|FG000|NOT COMPLETED|Overall Study||1
10824332|NCT03760185|11989562|FG001|NOT COMPLETED|Overall Study||1
10824333|NCT03732534|11989570|FG000|STARTED|Overall Study||6
10824334|NCT03732534|11989570|FG000|COMPLETED|Overall Study||0
10824335|NCT03732534|11989570|FG000|NOT COMPLETED|Overall Study||6
10290451|NCT03476135|11423117|FG000|NOT COMPLETED|Overall Study||0
10290452|NCT03476135|11423118|FG001|NOT COMPLETED|Overall Study||0
10290453|NCT03333928|11423127|FG000|STARTED|Initial Dosing Period (Period 1)||16
10290454|NCT03333928|11423128|FG001|STARTED|Initial Dosing Period (Period 1)||25
10290455|NCT03333928|11423129|FG002|STARTED|Initial Dosing Period (Period 1)||18
10290456|NCT03333928|11423127|FG000|COMPLETED|Initial Dosing Period (Period 1)||15
10290457|NCT03333928|11423128|FG001|COMPLETED|Initial Dosing Period (Period 1)||21
10290458|NCT03333928|11423129|FG002|COMPLETED|Initial Dosing Period (Period 1)||14
10290459|NCT03333928|11423127|FG000|NOT COMPLETED|Initial Dosing Period (Period 1)||1
10290460|NCT03333928|11423128|FG001|NOT COMPLETED|Initial Dosing Period (Period 1)||4
10290461|NCT03333928|11423129|FG002|NOT COMPLETED|Initial Dosing Period (Period 1)||4
10290462|NCT03333928|11423127|FG000|STARTED|Dose-controlled Extension (Period 2)||22
10290463|NCT03333928|11423128|FG001|STARTED|Dose-controlled Extension (Period 2)||29
10290464|NCT03333928|11423129|FG002|STARTED|Dose-controlled Extension (Period 2)||0
10290465|NCT03333928|11423127|FG000|COMPLETED|Dose-controlled Extension (Period 2)||19
10290466|NCT03333928|11423128|FG001|COMPLETED|Dose-controlled Extension (Period 2)||28
10290467|NCT03333928|11423129|FG002|COMPLETED|Dose-controlled Extension (Period 2)||0
10290468|NCT03333928|11423127|FG000|NOT COMPLETED|Dose-controlled Extension (Period 2)||3
10290469|NCT03333928|11423128|FG001|NOT COMPLETED|Dose-controlled Extension (Period 2)||1
10290470|NCT03333928|11423129|FG002|NOT COMPLETED|Dose-controlled Extension (Period 2)||0
10290471|NCT03333928|11423127|FG000|STARTED|Randomized Withdrawal (Period 3)||10
10290472|NCT03333928|11423128|FG001|STARTED|Randomized Withdrawal (Period 3)||14
10290473|NCT03333928|11423129|FG002|STARTED|Randomized Withdrawal (Period 3)||26
10290474|NCT03333928|11423127|FG000|COMPLETED|Randomized Withdrawal (Period 3)||8
10290475|NCT03333928|11423128|FG001|COMPLETED|Randomized Withdrawal (Period 3)||14
10290476|NCT03333928|11423129|FG002|COMPLETED|Randomized Withdrawal (Period 3)||25
10290477|NCT03333928|11423127|FG000|NOT COMPLETED|Randomized Withdrawal (Period 3)||2
10290478|NCT03333928|11423128|FG001|NOT COMPLETED|Randomized Withdrawal (Period 3)||0
10290479|NCT03333928|11423129|FG002|NOT COMPLETED|Randomized Withdrawal (Period 3)||1
10290480|NCT03298984|11423149|FG000|STARTED|Overall Study||3
10290481|NCT03298984|11423150|FG001|STARTED|Overall Study||3
10290482|NCT03298984|11423151|FG002|STARTED|Overall Study||3
10290483|NCT03298984|11423152|FG003|STARTED|Overall Study||23
10290484|NCT03298984|11423149|FG000|COMPLETED|Overall Study||2
10290485|NCT03298984|11423150|FG001|COMPLETED|Overall Study||2
10290486|NCT03298984|11423151|FG002|COMPLETED|Overall Study||1
10290487|NCT03298984|11423152|FG003|COMPLETED|Overall Study||8
10290488|NCT03298984|11423149|FG000|NOT COMPLETED|Overall Study||1
10290489|NCT03298984|11423150|FG001|NOT COMPLETED|Overall Study||1
10290490|NCT03298984|11423151|FG002|NOT COMPLETED|Overall Study||2
10290491|NCT03298984|11423152|FG003|NOT COMPLETED|Overall Study||15
10313129|NCT00148343|11446666|FG000|COMPLETED|Overall Study||39
10313130|NCT00148343|11446667|FG001|COMPLETED|Overall Study||45
10313131|NCT00148343|11446666|FG000|NOT COMPLETED|Overall Study||15
10313132|NCT00148343|11446667|FG001|NOT COMPLETED|Overall Study||11
10313133|NCT00148668|11446675|FG000|STARTED|Overall Study||41
10313134|NCT00148668|11446676|FG001|STARTED|Overall Study||40
10313135|NCT00148668|11446675|FG000|COMPLETED|Overall Study||41
10313136|NCT00148668|11446676|FG001|COMPLETED|Overall Study||40
10313137|NCT00148668|11446675|FG000|NOT COMPLETED|Overall Study||0
10313138|NCT00148668|11446676|FG001|NOT COMPLETED|Overall Study||0
10313139|NCT00148759|11446684|FG000|STARTED|Overall Study||11
10824336|NCT03692910|11989574|FG000|STARTED|Overall Study||35
10824337|NCT03692910|11989575|FG001|STARTED|Overall Study||0
10824338|NCT03692910|11989576|FG002|STARTED|Overall Study||0
10824339|NCT03692910|11989574|FG000|COMPLETED|Overall Study||29
10824340|NCT03692910|11989575|FG001|COMPLETED|Overall Study||0
10824341|NCT03692910|11989576|FG002|COMPLETED|Overall Study||0
10824342|NCT03692910|11989574|FG000|NOT COMPLETED|Overall Study||6
10824343|NCT03692910|11989575|FG001|NOT COMPLETED|Overall Study||0
10824344|NCT03692910|11989576|FG002|NOT COMPLETED|Overall Study||0
10824345|NCT03673956|11989586|FG000|STARTED|Overall Study||12
10824346|NCT03673956|11989587|FG001|STARTED|Overall Study||1
10824347|NCT03673956|11989588|FG002|STARTED|Overall Study||5
10824348|NCT03673956|11989589|FG003|STARTED|Overall Study||1
10824349|NCT03673956|11989586|FG000|COMPLETED|Overall Study||10
10824350|NCT03673956|11989587|FG001|COMPLETED|Overall Study||1
10824351|NCT03673956|11989588|FG002|COMPLETED|Overall Study||5
10824352|NCT03673956|11989589|FG003|COMPLETED|Overall Study||1
10824353|NCT03673956|11989586|FG000|NOT COMPLETED|Overall Study||2
10824354|NCT03673956|11989587|FG001|NOT COMPLETED|Overall Study||0
10824355|NCT03673956|11989588|FG002|NOT COMPLETED|Overall Study||0
10824356|NCT03673956|11989589|FG003|NOT COMPLETED|Overall Study||0
10824357|NCT03649347|11989603|FG000|STARTED|Overall Study||13
10824358|NCT03649347|11989604|FG001|STARTED|Overall Study||12
10824359|NCT03649347|11989605|FG002|STARTED|Overall Study||0
10824360|NCT03649347|11989606|FG003|STARTED|Overall Study||0
10824361|NCT03649347|11989603|FG000|COMPLETED|Overall Study||13
10824362|NCT03649347|11989604|FG001|COMPLETED|Overall Study||12
10824363|NCT03649347|11989605|FG002|COMPLETED|Overall Study||0
10824364|NCT03649347|11989606|FG003|COMPLETED|Overall Study||0
10824365|NCT03649347|11989603|FG000|NOT COMPLETED|Overall Study||0
10824366|NCT03649347|11989604|FG001|NOT COMPLETED|Overall Study||0
10824367|NCT03649347|11989605|FG002|NOT COMPLETED|Overall Study||0
10824368|NCT03649347|11989606|FG003|NOT COMPLETED|Overall Study||0
10824369|NCT03641326|11989616|FG000|STARTED|Overall Study||2
10824370|NCT03641326|11989617|FG001|STARTED|Overall Study||3
10824371|NCT03641326|11989616|FG000|COMPLETED|Overall Study||2
10824372|NCT03641326|11989617|FG001|COMPLETED|Overall Study||3
10824373|NCT03641326|11989616|FG000|NOT COMPLETED|Overall Study||0
10824374|NCT03641326|11989617|FG001|NOT COMPLETED|Overall Study||0
10824375|NCT03618420|11989628|FG000|STARTED|Overall Study||50
10824376|NCT03618420|11989628|FG000|COMPLETED|Overall Study||50
10824377|NCT03618420|11989628|FG000|NOT COMPLETED|Overall Study||0
10824378|NCT03411031|11989634|FG000|STARTED|Overall Study||9
10824379|NCT03411031|11989635|FG001|STARTED|Overall Study||9
10824380|NCT03411031|11989634|FG000|COMPLETED|Overall Study||9
10824381|NCT03411031|11989635|FG001|COMPLETED|Overall Study||9
10824382|NCT03411031|11989634|FG000|NOT COMPLETED|Overall Study||0
10824383|NCT03411031|11989635|FG001|NOT COMPLETED|Overall Study||0
10824384|NCT03365752|11989644|FG000|STARTED|Overall Study||13
10824385|NCT03365752|11989645|FG001|STARTED|Overall Study||13
10824386|NCT03365752|11989646|FG002|STARTED|Overall Study||13
10824387|NCT03365752|11989644|FG000|COMPLETED|Overall Study||13
10824388|NCT03365752|11989645|FG001|COMPLETED|Overall Study||13
10824389|NCT03365752|11989646|FG002|COMPLETED|Overall Study||13
10824390|NCT03365752|11989644|FG000|NOT COMPLETED|Overall Study||0
10824391|NCT03365752|11989645|FG001|NOT COMPLETED|Overall Study||0
10824392|NCT03365752|11989646|FG002|NOT COMPLETED|Overall Study||0
10824397|NCT03205163|11989660|FG000|STARTED|ATP (LDC: 3 Days; HDC: 4 Days)||7
10824398|NCT03205163|11989661|FG001|STARTED|ATP (LDC: 3 Days; HDC: 4 Days)||9
10824399|NCT03205163|11989660|FG000|Safety Population|ATP (LDC: 3 Days; HDC: 4 Days)||7
10824400|NCT03205163|11989661|FG001|Safety Population|ATP (LDC: 3 Days; HDC: 4 Days)||9
10824401|NCT03205163|11989660|FG000|COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||6
10824402|NCT03205163|11989661|FG001|COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||9
10824403|NCT03205163|11989660|FG000|NOT COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||1
10824404|NCT03205163|11989661|FG001|NOT COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||0
10824405|NCT03205163|11989660|FG000|STARTED|BTP (LDC: 28 Days; HDC: 28 Days)||6
10824406|NCT03205163|11989661|FG001|STARTED|BTP (LDC: 28 Days; HDC: 28 Days)||9
10824407|NCT03205163|11989660|FG000|Safety Population|BTP (LDC: 28 Days; HDC: 28 Days)||6
10824408|NCT03205163|11989661|FG001|Safety Population|BTP (LDC: 28 Days; HDC: 28 Days)||9
10824409|NCT03205163|11989660|FG000|COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||6
10824410|NCT03205163|11989661|FG001|COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||9
10824411|NCT03205163|11989660|FG000|NOT COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||0
10824412|NCT03205163|11989661|FG001|NOT COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||0
10824413|NCT03178045|11989678|FG000|STARTED|Overall Study||1396
10824414|NCT03178045|11989679|FG001|STARTED|Overall Study||1397
10824415|NCT03178045|11989678|FG000|COMPLETED|Overall Study||1310
10824416|NCT03178045|11989679|FG001|COMPLETED|Overall Study||1314
10824417|NCT03178045|11989678|FG000|NOT COMPLETED|Overall Study||86
10824418|NCT03178045|11989679|FG001|NOT COMPLETED|Overall Study||83
10824419|NCT03145766|11989691|FG000|STARTED|Active Vaccination Phase (Day 0-Day 56)||80
10824420|NCT03145766|11989692|FG001|STARTED|Active Vaccination Phase (Day 0-Day 56)||80
10824421|NCT03145766|11989693|FG002|STARTED|Active Vaccination Phase (Day 0-Day 56)||80
10824422|NCT03145766|11989694|FG003|STARTED|Active Vaccination Phase (Day 0-Day 56)||40
10824423|NCT03145766|11989695|FG004|STARTED|Active Vaccination Phase (Day 0-Day 56)||40
10824424|NCT03145766|11989691|FG000|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)||80
10824425|NCT03145766|11989692|FG001|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)||80
10824426|NCT03145766|11989693|FG002|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)||80
10824427|NCT03145766|11989694|FG003|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)|1 participant of this arm received Imovax Rabies, and counted in Group 5 for safety analysis.|39
10824428|NCT03145766|11989695|FG004|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)|1 participant of Group 4 received Imovax Rabies, and counted in Group 5 for safety analysis.|41
10824429|NCT03145766|11989691|FG000|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)|1 participant received Group 2 vaccine: counted in Group 2 for post-vaccination 2 safety analysis.|77
10824430|NCT03145766|11989692|FG001|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)|1 participant of Group 1 received Group 2 vaccine: counted in Group 2 for post-vaccination 2 safety.|81
10824431|NCT03145766|11989693|FG002|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)||80
10824432|NCT03145766|11989694|FG003|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)||39
10824433|NCT03145766|11989695|FG004|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)||39
10824434|NCT03145766|11989691|FG000|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||78
10824435|NCT03145766|11989692|FG001|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||79
10824436|NCT03145766|11989693|FG002|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||80
10824437|NCT03145766|11989694|FG003|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||39
10824438|NCT03145766|11989695|FG004|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||38
10824439|NCT03145766|11989691|FG000|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||78
10824440|NCT03145766|11989692|FG001|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||79
10824441|NCT03145766|11989693|FG002|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||80
10824442|NCT03145766|11989694|FG003|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||38
10824443|NCT03145766|11989695|FG004|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||38
10824444|NCT03145766|11989691|FG000|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||75
10824445|NCT03145766|11989692|FG001|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||78
10824446|NCT03145766|11989693|FG002|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||79
10824447|NCT03145766|11989694|FG003|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||34
10824448|NCT03145766|11989695|FG004|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||37
10824449|NCT03145766|11989691|FG000|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||74
10824450|NCT03145766|11989692|FG001|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||77
10824451|NCT03145766|11989693|FG002|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||78
10824452|NCT03145766|11989694|FG003|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||33
10824453|NCT03145766|11989695|FG004|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||37
10824454|NCT03145766|11989691|FG000|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||6
10824455|NCT03145766|11989692|FG001|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||3
10824456|NCT03145766|11989693|FG002|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||2
10824457|NCT03145766|11989694|FG003|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||7
10824458|NCT03145766|11989695|FG004|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||3
10824459|NCT03145766|11989691|FG000|STARTED|Follow-up Phase (Day 56 Till Month 7)||74
10824460|NCT03145766|11989692|FG001|STARTED|Follow-up Phase (Day 56 Till Month 7)||77
10824461|NCT03145766|11989693|FG002|STARTED|Follow-up Phase (Day 56 Till Month 7)||78
10824462|NCT03145766|11989694|FG003|STARTED|Follow-up Phase (Day 56 Till Month 7)||33
10824463|NCT03145766|11989695|FG004|STARTED|Follow-up Phase (Day 56 Till Month 7)||37
10824464|NCT03145766|11989691|FG000|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||67
10824465|NCT03145766|11989692|FG001|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||75
10824466|NCT03145766|11989693|FG002|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||73
10824467|NCT03145766|11989694|FG003|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||30
10824468|NCT03145766|11989695|FG004|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||34
10824469|NCT03145766|11989691|FG000|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||7
10824470|NCT03145766|11989692|FG001|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||2
10824471|NCT03145766|11989693|FG002|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||5
10824472|NCT03145766|11989694|FG003|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||3
10824473|NCT03145766|11989695|FG004|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||3
10824474|NCT03106987|11989712|FG000|STARTED|Overall Study||74
10824475|NCT03106987|11989713|FG001|STARTED|Overall Study||38
10824476|NCT03106987|11989714|FG002|STARTED|Overall Study||72
10824477|NCT03106987|11989715|FG003|STARTED|Overall Study||36
10824478|NCT03106987|11989712|FG000|COMPLETED|Overall Study||30
10824479|NCT03106987|11989713|FG001|COMPLETED|Overall Study||15
10824480|NCT03106987|11989714|FG002|COMPLETED|Overall Study||54
10824481|NCT03106987|11989715|FG003|COMPLETED|Overall Study||25
10824482|NCT03106987|11989712|FG000|NOT COMPLETED|Overall Study||44
10824483|NCT03106987|11989713|FG001|NOT COMPLETED|Overall Study||23
10824484|NCT03106987|11989714|FG002|NOT COMPLETED|Overall Study||18
10824485|NCT03106987|11989715|FG003|NOT COMPLETED|Overall Study||11
10824486|NCT03103087|11989728|FG000|STARTED|Overall Study||126
10824487|NCT03103087|11989729|FG001|STARTED|Overall Study||127
10824488|NCT03103087|11989730|FG002|STARTED|Overall Study||129
10824489|NCT03103087|11989728|FG000|COMPLETED|Overall Study||102
10824490|NCT03103087|11989729|FG001|COMPLETED|Overall Study||98
10824491|NCT03103087|11989730|FG002|COMPLETED|Overall Study||102
10824492|NCT03103087|11989728|FG000|NOT COMPLETED|Overall Study||24
10824493|NCT03103087|11989729|FG001|NOT COMPLETED|Overall Study||29
10824494|NCT03103087|11989730|FG002|NOT COMPLETED|Overall Study||27
10824495|NCT03049735|11989743|FG000|STARTED|Overall Study||128
10824496|NCT03049735|11989744|FG001|STARTED|Overall Study||132
10824497|NCT03049735|11989745|FG002|STARTED|Overall Study||128
10824498|NCT03049735|11989743|FG000|Received at Least 1 Dose of Study Drug|Overall Study||128
10824499|NCT03049735|11989744|FG001|Received at Least 1 Dose of Study Drug|Overall Study||132
10824500|NCT03049735|11989745|FG002|Received at Least 1 Dose of Study Drug|Overall Study||127
10824501|NCT03049735|11989743|FG000|COMPLETED|Overall Study||100
10824502|NCT03049735|11989744|FG001|COMPLETED|Overall Study||103
10824503|NCT03049735|11989745|FG002|COMPLETED|Overall Study||105
10824504|NCT03049735|11989743|FG000|NOT COMPLETED|Overall Study||28
10824505|NCT03049735|11989744|FG001|NOT COMPLETED|Overall Study||29
10824506|NCT03049735|11989745|FG002|NOT COMPLETED|Overall Study||23
10824507|NCT03021551|11989753|FG000|STARTED|Overall Study||80
10824508|NCT03021551|11989753|FG000|COMPLETED|Overall Study||77
10824509|NCT03021551|11989753|FG000|NOT COMPLETED|Overall Study||3
10824510|NCT02990338|11989759|FG000|STARTED|Overall Study||153
10824511|NCT02990338|11989760|FG001|STARTED|Overall Study||154
10824512|NCT02990338|11989759|FG000|Treated|Overall Study||149
10824513|NCT02990338|11989760|FG001|Treated|Overall Study||152
10824514|NCT02990338|11989759|FG000|Ongoing|Overall Study||35
10824515|NCT02990338|11989760|FG001|Ongoing|Overall Study||65
10824516|NCT02990338|11989759|FG000|COMPLETED|Overall Study||35
10824517|NCT02990338|11989760|FG001|COMPLETED|Overall Study||65
10824518|NCT02990338|11989759|FG000|NOT COMPLETED|Overall Study||118
10824519|NCT02990338|11989760|FG001|NOT COMPLETED|Overall Study||89
10824520|NCT02972996|11989769|FG000|STARTED|Overall Study||27
10824521|NCT02972996|11989770|FG001|STARTED|Overall Study||28
10824522|NCT02972996|11989769|FG000|COMPLETED|Overall Study||26
10824523|NCT02972996|11989770|FG001|COMPLETED|Overall Study||26
10824524|NCT02972996|11989769|FG000|NOT COMPLETED|Overall Study||1
10824525|NCT02972996|11989770|FG001|NOT COMPLETED|Overall Study||2
10824526|NCT02932332|11989780|FG000|STARTED|Overall Study||5
10824527|NCT02932332|11989781|FG001|STARTED|Overall Study||4
10824528|NCT02932332|11989782|FG002|STARTED|Overall Study||5
10824529|NCT02932332|11989783|FG003|STARTED|Overall Study||5
10824530|NCT02932332|11989780|FG000|Intervention 1|Overall Study||4
10824531|NCT02932332|11989781|FG001|Intervention 1|Overall Study||4
10824532|NCT02932332|11989782|FG002|Intervention 1|Overall Study||5
10824533|NCT02932332|11989783|FG003|Intervention 1|Overall Study||4
10824534|NCT02932332|11989780|FG000|Intervention 2|Overall Study||4
10824535|NCT02932332|11989781|FG001|Intervention 2|Overall Study||3
10824536|NCT02932332|11989782|FG002|Intervention 2|Overall Study||4
10824537|NCT02932332|11989783|FG003|Intervention 2|Overall Study||4
10824538|NCT02932332|11989780|FG000|Intervention 3|Overall Study||3
10824539|NCT02932332|11989781|FG001|Intervention 3|Overall Study||2
10824540|NCT02932332|11989782|FG002|Intervention 3|Overall Study||4
10824541|NCT02932332|11989783|FG003|Intervention 3|Overall Study||3
10824542|NCT02932332|11989780|FG000|Intervention 4|Overall Study||3
10824543|NCT02932332|11989781|FG001|Intervention 4|Overall Study||1
10824544|NCT02932332|11989782|FG002|Intervention 4|Overall Study||4
10824545|NCT02932332|11989783|FG003|Intervention 4|Overall Study||3
10824546|NCT02932332|11989780|FG000|COMPLETED|Overall Study||3
10824547|NCT02932332|11989781|FG001|COMPLETED|Overall Study||1
10824548|NCT02932332|11989782|FG002|COMPLETED|Overall Study||4
10824549|NCT02932332|11989783|FG003|COMPLETED|Overall Study||3
10824550|NCT02932332|11989780|FG000|NOT COMPLETED|Overall Study||2
10824551|NCT02932332|11989781|FG001|NOT COMPLETED|Overall Study||3
10824552|NCT02932332|11989782|FG002|NOT COMPLETED|Overall Study||1
10824553|NCT02932332|11989783|FG003|NOT COMPLETED|Overall Study||2
10824554|NCT02845440|11989798|FG000|STARTED|Overall Study||333
10824555|NCT02845440|11989799|FG001|STARTED|Overall Study||336
10824556|NCT02845440|11989800|FG002|STARTED|Overall Study||341
10824557|NCT02845440|11989801|FG003|STARTED|Overall Study||78
10824558|NCT02845440|11989802|FG004|STARTED|Overall Study||77
10824559|NCT02845440|11989798|FG000|COMPLETED|Overall Study||201
10824560|NCT02845440|11989799|FG001|COMPLETED|Overall Study||203
10824561|NCT02845440|11989800|FG002|COMPLETED|Overall Study||204
10824562|NCT02845440|11989801|FG003|COMPLETED|Overall Study||49
10824563|NCT02845440|11989802|FG004|COMPLETED|Overall Study||39
10824564|NCT02845440|11989798|FG000|NOT COMPLETED|Overall Study||132
10824565|NCT02845440|11989799|FG001|NOT COMPLETED|Overall Study||133
10824566|NCT02845440|11989800|FG002|NOT COMPLETED|Overall Study||137
10824567|NCT02845440|11989801|FG003|NOT COMPLETED|Overall Study||29
10824568|NCT02845440|11989802|FG004|NOT COMPLETED|Overall Study||38
10824569|NCT02786394|11989819|FG000|STARTED|Overall Study||11
10824570|NCT02786394|11989819|FG000|COMPLETED|Overall Study||10
10824571|NCT02786394|11989819|FG000|NOT COMPLETED|Overall Study||1
10824572|NCT02588248|11989826|FG000|STARTED|Overall Study||42
10824573|NCT02588248|11989827|FG001|STARTED|Overall Study||40
10824574|NCT02588248|11989826|FG000|COMPLETED|Overall Study||38
10824575|NCT02588248|11989827|FG001|COMPLETED|Overall Study||37
10824576|NCT02588248|11989826|FG000|NOT COMPLETED|Overall Study||4
10824577|NCT02588248|11989827|FG001|NOT COMPLETED|Overall Study||3
10824578|NCT02535065|11989838|FG000|STARTED|Overall Study||62
10824579|NCT02535065|11989838|FG000|1-Month Follow-up|Overall Study||62
10824580|NCT02535065|11989838|FG000|12-Month Follow-up|Overall Study||61
10824581|NCT02535065|11989838|FG000|COMPLETED|Overall Study||42
10824582|NCT02535065|11989838|FG000|NOT COMPLETED|Overall Study||20
10824583|NCT02510885|11989842|FG000|STARTED|Overall Study||39
10824584|NCT02510885|11989842|FG000|COMPLETED|Overall Study||39
10824585|NCT02510885|11989842|FG000|NOT COMPLETED|Overall Study||0
10824586|NCT02451358|11989850|FG000|STARTED|Overall Study||100
10824587|NCT02451358|11989851|FG001|STARTED|Overall Study||100
10824588|NCT02451358|11989852|FG002|STARTED|Overall Study||100
10824589|NCT02451358|11989853|FG003|STARTED|Overall Study||100
10824590|NCT02451358|11989850|FG000|Vaccinated at Day 0|Overall Study||100
10824591|NCT02451358|11989851|FG001|Vaccinated at Day 0|Overall Study||100
10824592|NCT02451358|11989852|FG002|Vaccinated at Day 0|Overall Study||100
10824593|NCT02451358|11989853|FG003|Vaccinated at Day 0|Overall Study||100
10824594|NCT02451358|11989850|FG000|Vaccinated at Day 28|Overall Study||99
10824595|NCT02451358|11989851|FG001|Vaccinated at Day 28|Overall Study||98
10824596|NCT02451358|11989852|FG002|Vaccinated at Day 28|Overall Study|Participants aged 9 years and older received only 1 dose of Quadrivalent Influenza Vaccine.|0
10824597|NCT02451358|11989853|FG003|Vaccinated at Day 28|Overall Study|Participants aged 9 years and older received only 1 dose of Quadrivalent Influenza Vaccine.|0
10824598|NCT02451358|11989850|FG000|COMPLETED|Overall Study||99
10824599|NCT02451358|11989851|FG001|COMPLETED|Overall Study||98
10824600|NCT02451358|11989852|FG002|COMPLETED|Overall Study||99
10824601|NCT02451358|11989853|FG003|COMPLETED|Overall Study||100
10824602|NCT02451358|11989850|FG000|NOT COMPLETED|Overall Study||1
10824603|NCT02451358|11989851|FG001|NOT COMPLETED|Overall Study||2
10824604|NCT02451358|11989852|FG002|NOT COMPLETED|Overall Study||1
10824605|NCT02451358|11989853|FG003|NOT COMPLETED|Overall Study||0
10824606|NCT02268175|11989865|FG000|STARTED|Overall Study||50
10824607|NCT02268175|11989866|FG001|STARTED|Overall Study||25
10824608|NCT02268175|11989865|FG000|COMPLETED|Overall Study||50
10824609|NCT02268175|11989866|FG001|COMPLETED|Overall Study||25
10824610|NCT02268175|11989865|FG000|NOT COMPLETED|Overall Study||0
10824611|NCT02268175|11989866|FG001|NOT COMPLETED|Overall Study||0
10824612|NCT02178709|11989872|FG000|STARTED|Overall Study||48
10824613|NCT02178709|11989872|FG000|COMPLETED|Overall Study||32
10824614|NCT02178709|11989872|FG000|NOT COMPLETED|Overall Study||16
10824615|NCT02163681|11989876|FG000|STARTED|Overall Study||45
10824616|NCT02163681|11989876|FG000|COMPLETED|Overall Study||44
10824617|NCT02163681|11989876|FG000|NOT COMPLETED|Overall Study||1
10824618|NCT01980017|11989882|FG000|STARTED|Overall Study||114
10824619|NCT01980017|11989883|FG001|STARTED|Overall Study||199
10824620|NCT01980017|11989882|FG000|COMPLETED|Overall Study||84
10824621|NCT01980017|11989883|FG001|COMPLETED|Overall Study||177
10824622|NCT01980017|11989882|FG000|NOT COMPLETED|Overall Study||30
10824623|NCT01980017|11989883|FG001|NOT COMPLETED|Overall Study||22
10824624|NCT01890759|11989894|FG000|STARTED|Overall Study||100
10824625|NCT01890759|11989895|FG001|STARTED|Overall Study||200
10824626|NCT01890759|11989894|FG000|COMPLETED|Overall Study||98
10824627|NCT01890759|11989895|FG001|COMPLETED|Overall Study||188
10824628|NCT01890759|11989894|FG000|NOT COMPLETED|Overall Study||2
10824629|NCT01890759|11989895|FG001|NOT COMPLETED|Overall Study||12
10824630|NCT01855867|11989901|FG000|STARTED|Overall Study||100
10824631|NCT01855867|11989901|FG000|COMPLETED|Overall Study||100
10824632|NCT01855867|11989901|FG000|NOT COMPLETED|Overall Study||0
10824633|NCT01721746|11989908|FG000|STARTED|Pre-Treatment||272
10824634|NCT01721746|11989909|FG001|STARTED|Pre-Treatment||133
10824635|NCT01721746|11989908|FG000|COMPLETED|Pre-Treatment||268
10824636|NCT01721746|11989909|FG001|COMPLETED|Pre-Treatment||102
10824637|NCT01721746|11989908|FG000|NOT COMPLETED|Pre-Treatment||4
10824638|NCT01721746|11989909|FG001|NOT COMPLETED|Pre-Treatment||31
10824639|NCT01721746|11989908|FG000|STARTED|Treatment||268
10824640|NCT01721746|11989909|FG001|STARTED|Treatment||102
10824641|NCT01721746|11989908|FG000|COMPLETED|Treatment||0
10824642|NCT01721746|11989909|FG001|COMPLETED|Treatment||0
10824643|NCT01721746|11989908|FG000|NOT COMPLETED|Treatment||268
10824644|NCT01721746|11989909|FG001|NOT COMPLETED|Treatment||102
10824645|NCT01587040|11989920|FG000|STARTED|Overall Study||17
10824646|NCT01587040|11989921|FG001|STARTED|Overall Study||3
10824647|NCT01587040|11989922|FG002|STARTED|Overall Study||37
10824648|NCT01587040|11989923|FG003|STARTED|Overall Study||4
10824649|NCT01587040|11989920|FG000|COMPLETED|Overall Study||0
10824650|NCT01587040|11989921|FG001|COMPLETED|Overall Study||0
10824651|NCT01587040|11989922|FG002|COMPLETED|Overall Study||0
10824652|NCT01587040|11989923|FG003|COMPLETED|Overall Study||0
10824653|NCT01587040|11989920|FG000|NOT COMPLETED|Overall Study||17
10824654|NCT01587040|11989921|FG001|NOT COMPLETED|Overall Study||3
10824655|NCT01587040|11989922|FG002|NOT COMPLETED|Overall Study||37
10824656|NCT01587040|11989923|FG003|NOT COMPLETED|Overall Study||4
10824657|NCT01293682|11989933|FG000|STARTED|Overall Study||12
10824658|NCT01293682|11989933|FG000|COMPLETED|Overall Study||12
10824659|NCT01293682|11989933|FG000|NOT COMPLETED|Overall Study||0
10824660|NCT01254409|11989941|FG000|STARTED|Overall Study||6
10824661|NCT01254409|11989942|FG001|STARTED|Overall Study||6
10824662|NCT01254409|11989943|FG002|STARTED|Overall Study||5
10824663|NCT01254409|11989944|FG003|STARTED|Overall Study||4
10824664|NCT01254409|11989941|FG000|COMPLETED|Overall Study||6
10824665|NCT01254409|11989942|FG001|COMPLETED|Overall Study||5
10824666|NCT01254409|11989943|FG002|COMPLETED|Overall Study||5
10824667|NCT01254409|11989944|FG003|COMPLETED|Overall Study||4
10824668|NCT01254409|11989941|FG000|NOT COMPLETED|Overall Study||0
10824669|NCT01254409|11989942|FG001|NOT COMPLETED|Overall Study||1
10824670|NCT01254409|11989943|FG002|NOT COMPLETED|Overall Study||0
10824671|NCT01254409|11989944|FG003|NOT COMPLETED|Overall Study||0
10824672|NCT01253161|11989957|FG000|STARTED|Overall Study||29
10824673|NCT01253161|11989957|FG000|COMPLETED|Overall Study||28
10824674|NCT01253161|11989957|FG000|NOT COMPLETED|Overall Study||1
10824675|NCT00867321|11989964|FG000|STARTED|Overall Study||4
10824676|NCT00867321|11989965|FG001|STARTED|Overall Study||3
10824677|NCT00867321|11989966|FG002|STARTED|Overall Study||3
10824678|NCT00867321|11989967|FG003|STARTED|Overall Study||6
10824679|NCT00867321|11989968|FG004|STARTED|Overall Study||5
10824680|NCT00867321|11989969|FG005|STARTED|Overall Study||3
10824681|NCT00867321|11989964|FG000|COMPLETED|Overall Study||4
10824682|NCT00867321|11989965|FG001|COMPLETED|Overall Study||2
10824683|NCT00867321|11989966|FG002|COMPLETED|Overall Study||3
10824684|NCT00867321|11989967|FG003|COMPLETED|Overall Study||6
10824685|NCT00867321|11989968|FG004|COMPLETED|Overall Study||5
10824686|NCT00867321|11989969|FG005|COMPLETED|Overall Study||3
10824687|NCT00867321|11989964|FG000|NOT COMPLETED|Overall Study||0
10824688|NCT00867321|11989965|FG001|NOT COMPLETED|Overall Study||1
10824689|NCT00867321|11989966|FG002|NOT COMPLETED|Overall Study||0
10824690|NCT00867321|11989967|FG003|NOT COMPLETED|Overall Study||0
10824691|NCT00867321|11989968|FG004|NOT COMPLETED|Overall Study||0
10824692|NCT00867321|11989969|FG005|NOT COMPLETED|Overall Study||0
10824693|NCT00728962|11989984|FG000|STARTED|Implant Placement Surgery||75
10824694|NCT00728962|11989984|FG000|COMPLETED|Implant Placement Surgery||65
10824695|NCT00728962|11989984|FG000|NOT COMPLETED|Implant Placement Surgery||10
10824696|NCT00728962|11989984|FG000|STARTED|Permanent Prosthesis Placement||65
10824697|NCT00728962|11989984|FG000|COMPLETED|Permanent Prosthesis Placement||62
10824698|NCT00728962|11989984|FG000|NOT COMPLETED|Permanent Prosthesis Placement||3
10824699|NCT00728962|11989984|FG000|STARTED|One Year Post Placement Follow-up||62
10824700|NCT00728962|11989984|FG000|COMPLETED|One Year Post Placement Follow-up||62
10824701|NCT00728962|11989984|FG000|NOT COMPLETED|One Year Post Placement Follow-up||0
10824702|NCT00728962|11989984|FG000|STARTED|Two Year Post Placement Follow-up||62
10824703|NCT00728962|11989984|FG000|COMPLETED|Two Year Post Placement Follow-up||59
10824704|NCT00728962|11989984|FG000|NOT COMPLETED|Two Year Post Placement Follow-up||3
10824705|NCT00728754|11989990|FG000|STARTED|Implant Placement Surgery|Individual test implant units is 75|29
10824706|NCT00728754|11989991|FG001|STARTED|Implant Placement Surgery|Individual control implant units is 78|32
10824707|NCT00728754|11989990|FG000|COMPLETED|Implant Placement Surgery|Individual test implant units completed = 75|29
10824708|NCT00728754|11989991|FG001|COMPLETED|Implant Placement Surgery|Individual control implant units completed = 78|32
10824709|NCT00728754|11989990|FG000|NOT COMPLETED|Implant Placement Surgery||0
10824710|NCT00728754|11989991|FG001|NOT COMPLETED|Implant Placement Surgery||0
10824711|NCT00728754|11989990|FG000|STARTED|Permanent Prosthesis Placement|Individual test implant units is 75|29
10824712|NCT00728754|11989991|FG001|STARTED|Permanent Prosthesis Placement|Individual control implant units is 78|32
10824713|NCT00728754|11989990|FG000|COMPLETED|Permanent Prosthesis Placement|Individual test implant units completed = 66|25
10824714|NCT00728754|11989991|FG001|COMPLETED|Permanent Prosthesis Placement|Individual control implant units completed = 68|28
10824715|NCT00728754|11989990|FG000|NOT COMPLETED|Permanent Prosthesis Placement||4
10824716|NCT00728754|11989991|FG001|NOT COMPLETED|Permanent Prosthesis Placement||4
10824717|NCT00728754|11989990|FG000|STARTED|One Year Post Placement Follow-up|individual test implant units is 66|25
10824718|NCT00728754|11989991|FG001|STARTED|One Year Post Placement Follow-up|individual control implant units is 68|28
10824719|NCT00728754|11989990|FG000|COMPLETED|One Year Post Placement Follow-up|individual test implant units completing is 65|24
10824720|NCT00728754|11989991|FG001|COMPLETED|One Year Post Placement Follow-up|individual control implant units completed= 68|28
10824721|NCT00728754|11989990|FG000|NOT COMPLETED|One Year Post Placement Follow-up||1
10824722|NCT00728754|11989991|FG001|NOT COMPLETED|One Year Post Placement Follow-up||0
10824723|NCT00728754|11989990|FG000|STARTED|Two Year Post Placement Follow-up|individual test implant units is 65|24
10824724|NCT00728754|11989991|FG001|STARTED|Two Year Post Placement Follow-up|individual control implant units is 68|28
10824725|NCT00728754|11989990|FG000|COMPLETED|Two Year Post Placement Follow-up|individual test implant units completed= 65|24
10824726|NCT00728754|11989991|FG001|COMPLETED|Two Year Post Placement Follow-up|individual test implant units completed= 68|28
10824727|NCT00728754|11989990|FG000|NOT COMPLETED|Two Year Post Placement Follow-up||0
10824728|NCT00728754|11989991|FG001|NOT COMPLETED|Two Year Post Placement Follow-up||0
10824729|NCT00723944|11989999|FG000|STARTED|Implant Placement Surgery|number of individual implant units is 148|52
10824730|NCT00723944|11990000|FG001|STARTED|Implant Placement Surgery|number of individual implant units is 138|50
10824731|NCT00723944|11989999|FG000|COMPLETED|Implant Placement Surgery|number of individual implant units completing is 148|52
10824732|NCT00723944|11990000|FG001|COMPLETED|Implant Placement Surgery|number of individual implant units completing is 138|50
10290492|NCT03175198|11423163|FG000|STARTED|Overall Study||5565
10290493|NCT03175198|11423163|FG000|Safety Set 1|Overall Study||5436
10290494|NCT03175198|11423163|FG000|COMPLETED|Overall Study||3238
10290495|NCT03175198|11423163|FG000|NOT COMPLETED|Overall Study||2327
10290496|NCT03158727|11423169|FG000|STARTED|Overall Study||42
10824733|NCT00723944|11989999|FG000|NOT COMPLETED|Implant Placement Surgery||0
10824734|NCT00723944|11990000|FG001|NOT COMPLETED|Implant Placement Surgery||0
10824735|NCT00723944|11989999|FG000|STARTED|Permanent Prosthesis Placement|number of individual implant units is 148|52
10824736|NCT00723944|11990000|FG001|STARTED|Permanent Prosthesis Placement|number of individual implant units is 138|50
10824737|NCT00723944|11989999|FG000|COMPLETED|Permanent Prosthesis Placement|number of individual implant units completing is 134|49
10824738|NCT00723944|11990000|FG001|COMPLETED|Permanent Prosthesis Placement|number of individual implant units completing is 112|41
10824739|NCT00723944|11989999|FG000|NOT COMPLETED|Permanent Prosthesis Placement||3
10824740|NCT00723944|11990000|FG001|NOT COMPLETED|Permanent Prosthesis Placement||9
10824741|NCT00723944|11989999|FG000|STARTED|One Year Post Placement Follow-up|number of individual implant units is 134|49
10824742|NCT00723944|11990000|FG001|STARTED|One Year Post Placement Follow-up|number of individual implant units is 112|41
10824743|NCT00723944|11989999|FG000|COMPLETED|One Year Post Placement Follow-up|number of individual implant units completing is 130|48
10824744|NCT00723944|11990000|FG001|COMPLETED|One Year Post Placement Follow-up|number of individual implant units completing is 108|37
10824745|NCT00723944|11989999|FG000|NOT COMPLETED|One Year Post Placement Follow-up||1
10824746|NCT00723944|11990000|FG001|NOT COMPLETED|One Year Post Placement Follow-up||4
10824747|NCT00723944|11989999|FG000|STARTED|Two Year Post Placement Follow-up|number of individual implant units is 130|48
10824748|NCT00723944|11990000|FG001|STARTED|Two Year Post Placement Follow-up|number of individual implant units is 108|37
10824749|NCT00723944|11989999|FG000|COMPLETED|Two Year Post Placement Follow-up|number of individual implant units completing is 130|48
10824750|NCT00723944|11990000|FG001|COMPLETED|Two Year Post Placement Follow-up|number of individual implant units completing is 108|37
10824751|NCT00723944|11989999|FG000|NOT COMPLETED|Two Year Post Placement Follow-up||0
10824752|NCT00723944|11990000|FG001|NOT COMPLETED|Two Year Post Placement Follow-up||0
10824753|NCT00467142|11990006|FG000|STARTED|Overall Study||62
10824754|NCT00467142|11990006|FG000|COMPLETED|Overall Study||59
10824755|NCT00467142|11990006|FG000|NOT COMPLETED|Overall Study||3
10290497|NCT03158727|11423170|FG001|STARTED|Overall Study||42
10290498|NCT03158727|11423169|FG000|Enrolled, Not Treated|Overall Study||1
10290499|NCT03158727|11423170|FG001|Enrolled, Not Treated|Overall Study||0
10290500|NCT03158727|11423169|FG000|COMPLETED|Overall Study||25
10290501|NCT03158727|11423170|FG001|COMPLETED|Overall Study||23
10290502|NCT03158727|11423169|FG000|NOT COMPLETED|Overall Study||17
10290503|NCT03158727|11423170|FG001|NOT COMPLETED|Overall Study||19
10290504|NCT03075826|11423176|FG000|STARTED|Overall Study||22
10290505|NCT03075826|11423176|FG000|COMPLETED|Overall Study||16
10290506|NCT03075826|11423176|FG000|NOT COMPLETED|Overall Study||6
10290507|NCT02993731|11423182|FG000|STARTED|Overall Study||565
10290508|NCT02993731|11423183|FG001|STARTED|Overall Study||569
10290509|NCT02993731|11423182|FG000|COMPLETED|Overall Study||464
10290510|NCT02993731|11423183|FG001|COMPLETED|Overall Study||464
10290511|NCT02993731|11423182|FG000|NOT COMPLETED|Overall Study||101
10290512|NCT02993731|11423183|FG001|NOT COMPLETED|Overall Study||105
10290513|NCT02826161|11423201|FG000|STARTED|Overall Study||1
10290514|NCT02826161|11423202|FG001|STARTED|Overall Study||3
10290515|NCT02826161|11423201|FG000|Discontinued Due to Treatment Related AE|Overall Study||1
10290516|NCT02826161|11423202|FG001|Discontinued Due to Treatment Related AE|Overall Study||0
10290517|NCT02826161|11423201|FG000|Discontinued Due to Death|Overall Study||0
10290518|NCT02826161|11423202|FG001|Discontinued Due to Death|Overall Study||1
10290519|NCT02826161|11423201|FG000|Discontinued Due to Patient Withdrawal|Overall Study||0
10290520|NCT02826161|11423202|FG001|Discontinued Due to Patient Withdrawal|Overall Study||1
10290521|NCT02826161|11423201|FG000|Discontinued Due to Withdrawal of ICF From Further FU|Overall Study||1
10290522|NCT02826161|11423202|FG001|Discontinued Due to Withdrawal of ICF From Further FU|Overall Study||1
10408856|NCT00757601|11552969|FG008|COMPLETED|Period 2||2
10408857|NCT00757601|11552970|FG009|COMPLETED|Period 2||2
10408858|NCT00757601|11552971|FG010|COMPLETED|Period 2||2
10408859|NCT00757601|11552972|FG011|COMPLETED|Period 2|One participant discontinued the study after Period 2 and was replaced by another participant.|2
10408860|NCT00757601|11552961|FG000|NOT COMPLETED|Period 2||0
10408861|NCT00757601|11552962|FG001|NOT COMPLETED|Period 2||0
10408862|NCT00757601|11552963|FG002|NOT COMPLETED|Period 2||0
10408863|NCT00757601|11552964|FG003|NOT COMPLETED|Period 2||0
10408864|NCT00757601|11552965|FG004|NOT COMPLETED|Period 2||0
10408865|NCT00757601|11552966|FG005|NOT COMPLETED|Period 2||0
10408866|NCT00757601|11552967|FG006|NOT COMPLETED|Period 2||0
10408867|NCT00757601|11552968|FG007|NOT COMPLETED|Period 2||0
10290523|NCT02826161|11423201|FG000|COMPLETED|Overall Study||1
10290524|NCT02826161|11423202|FG001|COMPLETED|Overall Study||3
10408868|NCT00757601|11552969|FG008|NOT COMPLETED|Period 2||0
10408869|NCT00757601|11552970|FG009|NOT COMPLETED|Period 2||0
10408870|NCT00757601|11552971|FG010|NOT COMPLETED|Period 2||0
10824756|NCT04878172|11990014|FG000|STARTED|Overall Study||2
10824757|NCT04878172|11990015|FG001|STARTED|Overall Study||2
10824758|NCT04878172|11990016|FG002|STARTED|Overall Study||2
10824759|NCT04878172|11990017|FG003|STARTED|Overall Study||3
10824760|NCT04878172|11990014|FG000|COMPLETED|Overall Study||2
10824761|NCT04878172|11990015|FG001|COMPLETED|Overall Study||2
10824762|NCT04878172|11990016|FG002|COMPLETED|Overall Study||2
10824763|NCT04878172|11990017|FG003|COMPLETED|Overall Study||3
10824764|NCT04878172|11990014|FG000|NOT COMPLETED|Overall Study||0
10824765|NCT04878172|11990015|FG001|NOT COMPLETED|Overall Study||0
10824766|NCT04878172|11990016|FG002|NOT COMPLETED|Overall Study||0
10824767|NCT04878172|11990017|FG003|NOT COMPLETED|Overall Study||0
10824768|NCT04671017|11990030|FG000|STARTED|Overall Study||51
10824769|NCT04671017|11990031|FG001|STARTED|Overall Study||51
10824770|NCT04671017|11990032|FG002|STARTED|Overall Study||51
10824771|NCT04671017|11990030|FG000|COMPLETED|Overall Study||51
10824772|NCT04671017|11990031|FG001|COMPLETED|Overall Study||51
10824773|NCT04671017|11990032|FG002|COMPLETED|Overall Study||51
10824774|NCT04671017|11990030|FG000|NOT COMPLETED|Overall Study||0
10824775|NCT04671017|11990031|FG001|NOT COMPLETED|Overall Study||0
10824776|NCT04671017|11990032|FG002|NOT COMPLETED|Overall Study||0
10824777|NCT04557371|11990043|FG000|STARTED|Overall Study||50
10824778|NCT04557371|11990044|FG001|STARTED|Overall Study||49
10824779|NCT04557371|11990045|FG002|STARTED|Overall Study||51
10824780|NCT04557371|11990043|FG000|COMPLETED|Overall Study||49
10824781|NCT04557371|11990044|FG001|COMPLETED|Overall Study||47
10824782|NCT04557371|11990045|FG002|COMPLETED|Overall Study||51
10824783|NCT04557371|11990043|FG000|NOT COMPLETED|Overall Study||1
10824784|NCT04557371|11990044|FG001|NOT COMPLETED|Overall Study||2
10824785|NCT04557371|11990045|FG002|NOT COMPLETED|Overall Study||0
10824786|NCT04540952|11990055|FG000|STARTED|Overall Study||34
10824787|NCT04540952|11990056|FG001|STARTED|Overall Study||34
10824788|NCT04540952|11990055|FG000|COMPLETED|Overall Study||34
10824789|NCT04540952|11990056|FG001|COMPLETED|Overall Study||34
10824790|NCT04540952|11990055|FG000|NOT COMPLETED|Overall Study||0
10824791|NCT04540952|11990056|FG001|NOT COMPLETED|Overall Study||0
10824792|NCT04369742|11990066|FG000|STARTED|Overall Study||67
10824793|NCT04369742|11990067|FG001|STARTED|Overall Study||61
10290525|NCT02826161|11423201|FG000|NOT COMPLETED|Overall Study||0
10290526|NCT02826161|11423202|FG001|NOT COMPLETED|Overall Study||0
10824794|NCT04369742|11990066|FG000|COMPLETED|Overall Study||53
10824795|NCT04369742|11990067|FG001|COMPLETED|Overall Study||50
10824796|NCT04369742|11990066|FG000|NOT COMPLETED|Overall Study||14
10824797|NCT04369742|11990067|FG001|NOT COMPLETED|Overall Study||11
10824798|NCT04115644|11990076|FG000|STARTED|Overall Study||26
10824799|NCT04115644|11990077|FG001|STARTED|Overall Study||30
10824800|NCT04115644|11990078|FG002|STARTED|Overall Study||26
10824801|NCT04115644|11990076|FG000|COMPLETED|Overall Study||26
10824802|NCT04115644|11990077|FG001|COMPLETED|Overall Study||30
10824803|NCT04115644|11990078|FG002|COMPLETED|Overall Study||25
10824804|NCT04115644|11990076|FG000|NOT COMPLETED|Overall Study||0
10824805|NCT04115644|11990077|FG001|NOT COMPLETED|Overall Study||0
10824806|NCT04115644|11990078|FG002|NOT COMPLETED|Overall Study||1
10824813|NCT03969589|11990097|FG000|STARTED|Overall Study||20
10824814|NCT03969589|11990098|FG001|STARTED|Overall Study||20
10824815|NCT03969589|11990097|FG000|COMPLETED|Overall Study||17
10824816|NCT03969589|11990098|FG001|COMPLETED|Overall Study||17
10824817|NCT03969589|11990097|FG000|NOT COMPLETED|Overall Study||3
10824818|NCT03969589|11990098|FG001|NOT COMPLETED|Overall Study||3
10824825|NCT03812588|11990117|FG000|STARTED|Overall Study||5
10824826|NCT03812588|11990118|FG001|STARTED|Overall Study||7
10824827|NCT03812588|11990119|FG002|STARTED|Overall Study||5
10824828|NCT03812588|11990120|FG003|STARTED|Overall Study||8
10824829|NCT03812588|11990117|FG000|COMPLETED|Overall Study||3
10824830|NCT03812588|11990118|FG001|COMPLETED|Overall Study||5
10824831|NCT03812588|11990119|FG002|COMPLETED|Overall Study||3
10824832|NCT03812588|11990120|FG003|COMPLETED|Overall Study||8
10824833|NCT03812588|11990117|FG000|NOT COMPLETED|Overall Study||2
10824834|NCT03812588|11990118|FG001|NOT COMPLETED|Overall Study||2
10824835|NCT03812588|11990119|FG002|NOT COMPLETED|Overall Study||2
10824836|NCT03812588|11990120|FG003|NOT COMPLETED|Overall Study||0
10824837|NCT03690674|11990130|FG000|STARTED|Overall Study||35
10824838|NCT03690674|11990131|FG001|STARTED|Overall Study||35
10824839|NCT03690674|11990130|FG000|COMPLETED|Overall Study||32
10824840|NCT03690674|11990131|FG001|COMPLETED|Overall Study||32
10824841|NCT03690674|11990130|FG000|NOT COMPLETED|Overall Study||3
10824842|NCT03690674|11990131|FG001|NOT COMPLETED|Overall Study||3
10824843|NCT03655691|11990141|FG000|STARTED|Overall Study||26
10824844|NCT03655691|11990142|FG001|STARTED|Overall Study||26
10824845|NCT03655691|11990143|FG002|STARTED|Overall Study||27
10824846|NCT03655691|11990141|FG000|COMPLETED|Overall Study||24
10824847|NCT03655691|11990142|FG001|COMPLETED|Overall Study||23
10824848|NCT03655691|11990143|FG002|COMPLETED|Overall Study||24
10824849|NCT03655691|11990141|FG000|NOT COMPLETED|Overall Study||2
10824850|NCT03655691|11990142|FG001|NOT COMPLETED|Overall Study||3
10824851|NCT03655691|11990143|FG002|NOT COMPLETED|Overall Study||3
10290555|NCT02520011|11423219|FG000|STARTED|Overall Study||11
10290556|NCT02520011|11423220|FG001|STARTED|Overall Study||79
10290557|NCT02520011|11423221|FG002|STARTED|Overall Study||14
10290558|NCT02520011|11423219|FG000|Stage 1|Overall Study||0
10290559|NCT02520011|11423220|FG001|Stage 1|Overall Study||32
10290560|NCT02520011|11423221|FG002|Stage 1|Overall Study||10
10290561|NCT02520011|11423219|FG000|Stage 2|Overall Study||11
10290562|NCT02520011|11423220|FG001|Stage 2|Overall Study||47
10290563|NCT02520011|11423221|FG002|Stage 2|Overall Study||4
10290564|NCT02520011|11423219|FG000|COMPLETED|Overall Study||6
10290565|NCT02520011|11423220|FG001|COMPLETED|Overall Study||33
10290566|NCT02520011|11423221|FG002|COMPLETED|Overall Study||5
10290567|NCT02520011|11423219|FG000|NOT COMPLETED|Overall Study||5
10290568|NCT02520011|11423220|FG001|NOT COMPLETED|Overall Study||46
10290569|NCT02520011|11423221|FG002|NOT COMPLETED|Overall Study||9
10290570|NCT02315534|11423236|FG000|STARTED|Overall Study||4
10290571|NCT02315534|11423237|FG001|STARTED|Overall Study||30
10290572|NCT02315534|11423236|FG000|Assessment of Dose-limiting Toxicity (DLT)|Overall Study||0
10290573|NCT02315534|11423237|FG001|Assessment of Dose-limiting Toxicity (DLT)|Overall Study||0
10290574|NCT02315534|11423236|FG000|Off Treatment Due to Radiologic Disease Progression (PD)|Overall Study||2
10290575|NCT02315534|11423237|FG001|Off Treatment Due to Radiologic Disease Progression (PD)|Overall Study||20
10290576|NCT02315534|11423236|FG000|Off Treatment Due to Clinically Unacceptable Toxicities|Overall Study||1
10290577|NCT02315534|11423237|FG001|Off Treatment Due to Clinically Unacceptable Toxicities|Overall Study||7
10290578|NCT02315534|11423236|FG000|Off Treatment Due to Patient Request|Overall Study||1
10290579|NCT02315534|11423237|FG001|Off Treatment Due to Patient Request|Overall Study||2
10290580|NCT02315534|11423236|FG000|Off Treatment Due to Clinical PD|Overall Study||0
10290581|NCT02315534|11423237|FG001|Off Treatment Due to Clinical PD|Overall Study||1
10290582|NCT02315534|11423236|FG000|COMPLETED|Overall Study||4
10290583|NCT02315534|11423237|FG001|COMPLETED|Overall Study||30
10290584|NCT02315534|11423236|FG000|NOT COMPLETED|Overall Study||0
10290585|NCT02315534|11423237|FG001|NOT COMPLETED|Overall Study||0
10290586|NCT02279719|11423258|FG000|STARTED|Overall Study||5
10824852|NCT03608670|11990151|FG000|STARTED|Overall Study||26
10824853|NCT03608670|11990151|FG000|Implant Attempted|Overall Study||21
10824854|NCT03608670|11990151|FG000|Successfully Implanted|Overall Study||17
10824855|NCT03608670|11990151|FG000|2-week Follow-up|Overall Study||17
10824856|NCT03608670|11990151|FG000|4-6 Weeks Follow-up|Overall Study||17
10824857|NCT03608670|11990151|FG000|COMPLETED|Overall Study||16
10824858|NCT03608670|11990151|FG000|NOT COMPLETED|Overall Study||10
10824859|NCT03364686|11990155|FG000|STARTED|Overall Study||6
10824860|NCT03364686|11990155|FG000|COMPLETED|Overall Study||4
10824861|NCT03364686|11990155|FG000|NOT COMPLETED|Overall Study||2
10824862|NCT03345771|11990161|FG000|STARTED|Overall Study||115
10824863|NCT03345771|11990162|FG001|STARTED|Overall Study||115
10824864|NCT03345771|11990161|FG000|COMPLETED|Overall Study||115
10824865|NCT03345771|11990162|FG001|COMPLETED|Overall Study||115
10824866|NCT03345771|11990161|FG000|NOT COMPLETED|Overall Study||0
10824867|NCT03345771|11990162|FG001|NOT COMPLETED|Overall Study||0
10824868|NCT03326856|11990173|FG000|STARTED|Overall Study||13
10824869|NCT03326856|11990174|FG001|STARTED|Overall Study||9
10824870|NCT03326856|11990175|FG002|STARTED|Overall Study||9
10824871|NCT03326856|11990176|FG003|STARTED|Overall Study||9
10824872|NCT03326856|11990177|FG004|STARTED|Overall Study||8
10824873|NCT03326856|11990173|FG000|COMPLETED|Overall Study||12
10824874|NCT03326856|11990174|FG001|COMPLETED|Overall Study||8
10824875|NCT03326856|11990175|FG002|COMPLETED|Overall Study||9
10824876|NCT03326856|11990176|FG003|COMPLETED|Overall Study||9
10824877|NCT03326856|11990177|FG004|COMPLETED|Overall Study||8
10824878|NCT03326856|11990173|FG000|NOT COMPLETED|Overall Study||1
10824879|NCT03326856|11990174|FG001|NOT COMPLETED|Overall Study||1
10824880|NCT03326856|11990175|FG002|NOT COMPLETED|Overall Study||0
10824881|NCT03326856|11990176|FG003|NOT COMPLETED|Overall Study||0
10824882|NCT03326856|11990177|FG004|NOT COMPLETED|Overall Study||0
10824892|NCT03240692|11990202|FG000|STARTED|Overall Study||23
10824893|NCT03240692|11990202|FG000|COMPLETED|Overall Study||21
10824894|NCT03240692|11990202|FG000|NOT COMPLETED|Overall Study||2
10824895|NCT03227029|11990209|FG000|STARTED|Overall Study||26
10824896|NCT03227029|11990210|FG001|STARTED|Overall Study||26
10824897|NCT03227029|11990211|FG002|STARTED|Overall Study||13
10824898|NCT03227029|11990209|FG000|Received Inoculation|Overall Study||26
10824899|NCT03227029|11990210|FG001|Received Inoculation|Overall Study||25
10824900|NCT03227029|11990211|FG002|Received Inoculation|Overall Study||12
10824901|NCT03227029|11990209|FG000|COMPLETED|Overall Study||22
10824902|NCT03227029|11990210|FG001|COMPLETED|Overall Study||22
10824903|NCT03227029|11990211|FG002|COMPLETED|Overall Study||9
10824904|NCT03227029|11990209|FG000|NOT COMPLETED|Overall Study||4
10824905|NCT03227029|11990210|FG001|NOT COMPLETED|Overall Study||4
10824906|NCT03227029|11990211|FG002|NOT COMPLETED|Overall Study||4
10824907|NCT03207776|11990221|FG000|STARTED|Overall Study||2479
10824908|NCT03207776|11990222|FG001|STARTED|Overall Study||2353
10824909|NCT03207776|11990221|FG000|COMPLETED|Overall Study||2479
10824910|NCT03207776|11990222|FG001|COMPLETED|Overall Study||2353
10824911|NCT03207776|11990221|FG000|NOT COMPLETED|Overall Study||0
10824912|NCT03207776|11990222|FG001|NOT COMPLETED|Overall Study||0
10824913|NCT03204643|11990230|FG000|STARTED|Overall Study||323
10824914|NCT03204643|11990231|FG001|STARTED|Overall Study||314
10824915|NCT03204643|11990230|FG000|COMPLETED|Overall Study||323
10824916|NCT03204643|11990231|FG001|COMPLETED|Overall Study||314
10824917|NCT03204643|11990230|FG000|NOT COMPLETED|Overall Study||0
10824918|NCT03204643|11990231|FG001|NOT COMPLETED|Overall Study||0
10824919|NCT03182829|11990239|FG000|STARTED|Overall Study||467
10824920|NCT03182829|11990240|FG001|STARTED|Overall Study||444
10824921|NCT03182829|11990239|FG000|COMPLETED|Overall Study||451
10824922|NCT03182829|11990240|FG001|COMPLETED|Overall Study||429
10824923|NCT03182829|11990239|FG000|NOT COMPLETED|Overall Study||16
10824924|NCT03182829|11990240|FG001|NOT COMPLETED|Overall Study||15
10824925|NCT03181789|11990250|FG000|STARTED|Overall Study||25
10824926|NCT03181789|11990251|FG001|STARTED|Overall Study||25
10824927|NCT03181789|11990252|FG002|STARTED|Overall Study||3
10824928|NCT03181789|11990253|FG003|STARTED|Overall Study||3
10824929|NCT03181789|11990250|FG000|Safety Population|Overall Study||25
10824930|NCT03181789|11990251|FG001|Safety Population|Overall Study||25
10824931|NCT03181789|11990252|FG002|Safety Population|Overall Study||3
10824932|NCT03181789|11990253|FG003|Safety Population|Overall Study||3
10824933|NCT03181789|11990250|FG000|COMPLETED|Overall Study||18
10824934|NCT03181789|11990251|FG001|COMPLETED|Overall Study||22
10824935|NCT03181789|11990252|FG002|COMPLETED|Overall Study||2
10824936|NCT03181789|11990253|FG003|COMPLETED|Overall Study||3
10824937|NCT03181789|11990250|FG000|NOT COMPLETED|Overall Study||7
10824938|NCT03181789|11990251|FG001|NOT COMPLETED|Overall Study||3
10824939|NCT03181789|11990252|FG002|NOT COMPLETED|Overall Study||1
10824940|NCT03181789|11990253|FG003|NOT COMPLETED|Overall Study||0
10824941|NCT03164356|11990268|FG000|STARTED|Overall Study||19
10824942|NCT03164356|11990269|FG001|STARTED|Overall Study||15
10824943|NCT03164356|11990270|FG002|STARTED|Overall Study||17
10824944|NCT03164356|11990271|FG003|STARTED|Overall Study||17
10824945|NCT03164356|11990268|FG000|COMPLETED|Overall Study||14
10824946|NCT03164356|11990269|FG001|COMPLETED|Overall Study||10
10824947|NCT03164356|11990270|FG002|COMPLETED|Overall Study||11
10824948|NCT03164356|11990271|FG003|COMPLETED|Overall Study||15
10824949|NCT03164356|11990268|FG000|NOT COMPLETED|Overall Study||5
10824950|NCT03164356|11990269|FG001|NOT COMPLETED|Overall Study||5
10824951|NCT03164356|11990270|FG002|NOT COMPLETED|Overall Study||6
10824952|NCT03164356|11990271|FG003|NOT COMPLETED|Overall Study||2
10824953|NCT02975700|11990291|FG000|STARTED|Overall Study||6
10824954|NCT02975700|11990291|FG000|COMPLETED|Overall Study||0
10824955|NCT02975700|11990291|FG000|NOT COMPLETED|Overall Study||6
10824956|NCT02941549|11990298|FG000|STARTED|Overall Study||31
10824957|NCT02941549|11990299|FG001|STARTED|Overall Study||32
10824958|NCT02941549|11990300|FG002|STARTED|Overall Study||33
10824959|NCT02941549|11990298|FG000|COMPLETED|Overall Study||28
10824960|NCT02941549|11990299|FG001|COMPLETED|Overall Study||31
10824961|NCT02941549|11990300|FG002|COMPLETED|Overall Study||31
10824962|NCT02941549|11990298|FG000|NOT COMPLETED|Overall Study||3
10824963|NCT02941549|11990299|FG001|NOT COMPLETED|Overall Study||1
10824964|NCT02941549|11990300|FG002|NOT COMPLETED|Overall Study||2
10824965|NCT02937766|11990313|FG000|STARTED|Overall Study||30
10824966|NCT02937766|11990314|FG001|STARTED|Overall Study||30
10824967|NCT02937766|11990313|FG000|COMPLETED|Overall Study||23
10824968|NCT02937766|11990314|FG001|COMPLETED|Overall Study||30
10824969|NCT02937766|11990313|FG000|NOT COMPLETED|Overall Study||7
10824970|NCT02937766|11990314|FG001|NOT COMPLETED|Overall Study||0
10824971|NCT02927938|11990324|FG000|STARTED|Overall Study||1
10824972|NCT02927938|11990325|FG001|STARTED|Overall Study||6
10824973|NCT02927938|11990326|FG002|STARTED|Overall Study||4
10824974|NCT02927938|11990327|FG003|STARTED|Overall Study||7
10824975|NCT02927938|11990324|FG000|COMPLETED|Overall Study||0
10824976|NCT02927938|11990325|FG001|COMPLETED|Overall Study||0
10824977|NCT02927938|11990326|FG002|COMPLETED|Overall Study||0
10824978|NCT02927938|11990327|FG003|COMPLETED|Overall Study||0
10824979|NCT02927938|11990324|FG000|NOT COMPLETED|Overall Study||1
10824980|NCT02927938|11990325|FG001|NOT COMPLETED|Overall Study||6
10290587|NCT02279719|11423259|FG001|STARTED|Overall Study||10
10290588|NCT02279719|11423260|FG002|STARTED|Overall Study||4
10290589|NCT02279719|11423261|FG003|STARTED|Overall Study||9
10290590|NCT02279719|11423262|FG004|STARTED|Overall Study||28
10290591|NCT02279719|11423263|FG005|STARTED|Overall Study||10
10290592|NCT02279719|11423264|FG006|STARTED|Overall Study||31
10290593|NCT02279719|11423258|FG000|COMPLETED|Overall Study||5
10290594|NCT02279719|11423259|FG001|COMPLETED|Overall Study||10
10290595|NCT02279719|11423260|FG002|COMPLETED|Overall Study||4
10290596|NCT02279719|11423261|FG003|COMPLETED|Overall Study||9
10290597|NCT02279719|11423262|FG004|COMPLETED|Overall Study||25
10290598|NCT02279719|11423263|FG005|COMPLETED|Overall Study||10
10290599|NCT02279719|11423264|FG006|COMPLETED|Overall Study||28
10290600|NCT02279719|11423258|FG000|NOT COMPLETED|Overall Study||0
10290601|NCT02279719|11423259|FG001|NOT COMPLETED|Overall Study||0
10290602|NCT02279719|11423260|FG002|NOT COMPLETED|Overall Study||0
10290603|NCT02279719|11423261|FG003|NOT COMPLETED|Overall Study||0
10290604|NCT02279719|11423262|FG004|NOT COMPLETED|Overall Study||3
10290605|NCT02279719|11423263|FG005|NOT COMPLETED|Overall Study||0
10290606|NCT02279719|11423264|FG006|NOT COMPLETED|Overall Study||3
10290607|NCT02178956|11423299|FG000|STARTED|Overall Study||357
10290608|NCT02178956|11423300|FG001|STARTED|Overall Study||357
10290609|NCT02178956|11423299|FG000|COMPLETED|Overall Study||286
10290610|NCT02178956|11423300|FG001|COMPLETED|Overall Study||279
10290611|NCT02178956|11423299|FG000|NOT COMPLETED|Overall Study||71
10290612|NCT02178956|11423300|FG001|NOT COMPLETED|Overall Study||78
10290616|NCT02097420|11423322|FG000|STARTED|Overall Study||20
10290617|NCT02097420|11423322|FG000|COMPLETED|Overall Study||6
10290618|NCT02097420|11423322|FG000|NOT COMPLETED|Overall Study||14
10290619|NCT02024607|11423333|FG000|STARTED|Overall Study||115
10290620|NCT02024607|11423334|FG001|STARTED|Overall Study||41
10290621|NCT02024607|11423335|FG002|STARTED|Overall Study||87
10290622|NCT02024607|11423336|FG003|STARTED|Overall Study||156
10290623|NCT02024607|11423337|FG004|STARTED|Overall Study||40
10290624|NCT02024607|11423338|FG005|STARTED|Overall Study||54
10290625|NCT02024607|11423339|FG006|STARTED|Overall Study||2
10290626|NCT02024607|11423333|FG000|COMPLETED|Overall Study||115
10290627|NCT02024607|11423334|FG001|COMPLETED|Overall Study||41
10290628|NCT02024607|11423335|FG002|COMPLETED|Overall Study||87
10290629|NCT02024607|11423336|FG003|COMPLETED|Overall Study||156
10290630|NCT02024607|11423337|FG004|COMPLETED|Overall Study||40
10290631|NCT02024607|11423338|FG005|COMPLETED|Overall Study||54
10824981|NCT02927938|11990326|FG002|NOT COMPLETED|Overall Study||4
10824982|NCT02927938|11990327|FG003|NOT COMPLETED|Overall Study||7
10824983|NCT02913131|11990337|FG000|STARTED|Overall Study||18
10824984|NCT02913131|11990338|FG001|STARTED|Overall Study|Two of the five participants enrolled in Part B were previously enrolled in Part A.|5
10824985|NCT02913131|11990337|FG000|COMPLETED|Overall Study||18
10290632|NCT02024607|11423339|FG006|COMPLETED|Overall Study||2
10290633|NCT02024607|11423333|FG000|NOT COMPLETED|Overall Study||0
10290634|NCT02024607|11423334|FG001|NOT COMPLETED|Overall Study||0
10290635|NCT02024607|11423335|FG002|NOT COMPLETED|Overall Study||0
10290636|NCT02024607|11423336|FG003|NOT COMPLETED|Overall Study||0
10290637|NCT02024607|11423337|FG004|NOT COMPLETED|Overall Study||0
10290638|NCT02024607|11423338|FG005|NOT COMPLETED|Overall Study||0
10290639|NCT02024607|11423339|FG006|NOT COMPLETED|Overall Study||0
10290640|NCT01925131|11423379|FG000|STARTED|Overall Study||5
10290641|NCT01925131|11423380|FG001|STARTED|Overall Study||4
10290642|NCT01925131|11423381|FG002|STARTED|Overall Study||10
10824986|NCT02913131|11990338|FG001|COMPLETED|Overall Study||5
10824987|NCT02913131|11990337|FG000|NOT COMPLETED|Overall Study||0
10824988|NCT02913131|11990338|FG001|NOT COMPLETED|Overall Study||0
10824989|NCT02883400|11990347|FG000|STARTED|Overall Study||22
10824990|NCT02883400|11990348|FG001|STARTED|Overall Study||8
10824991|NCT02883400|11990347|FG000|COMPLETED|Overall Study||22
10824992|NCT02883400|11990348|FG001|COMPLETED|Overall Study||8
10824993|NCT02883400|11990347|FG000|NOT COMPLETED|Overall Study||0
10824994|NCT02883400|11990348|FG001|NOT COMPLETED|Overall Study||0
10824995|NCT02855060|11990356|FG000|STARTED|Overall Study||22
10824996|NCT02855060|11990357|FG001|STARTED|Overall Study||28
10824997|NCT02855060|11990356|FG000|COMPLETED|Overall Study||20
10824998|NCT02855060|11990357|FG001|COMPLETED|Overall Study||23
10824999|NCT02855060|11990356|FG000|NOT COMPLETED|Overall Study||2
10825000|NCT02855060|11990357|FG001|NOT COMPLETED|Overall Study||5
10825001|NCT02823574|11990367|FG000|STARTED|Pre-Treatment Period||159
10825002|NCT02823574|11990368|FG001|STARTED|Pre-Treatment Period||82
10825003|NCT02823574|11990369|FG002|STARTED|Pre-Treatment Period||123
10825004|NCT02823574|11990370|FG003|STARTED|Pre-Treatment Period||61
10825005|NCT02823574|11990367|FG000|COMPLETED|Pre-Treatment Period||158
10825006|NCT02823574|11990368|FG001|COMPLETED|Pre-Treatment Period||82
10825007|NCT02823574|11990369|FG002|COMPLETED|Pre-Treatment Period||122
10825008|NCT02823574|11990370|FG003|COMPLETED|Pre-Treatment Period||61
10825009|NCT02823574|11990367|FG000|NOT COMPLETED|Pre-Treatment Period||1
10825010|NCT02823574|11990368|FG001|NOT COMPLETED|Pre-Treatment Period||0
10825011|NCT02823574|11990369|FG002|NOT COMPLETED|Pre-Treatment Period||1
10825012|NCT02823574|11990370|FG003|NOT COMPLETED|Pre-Treatment Period||0
10825013|NCT02823574|11990367|FG000|STARTED|Treatment Period||158
10825014|NCT02823574|11990368|FG001|STARTED|Treatment Period||82
10825015|NCT02823574|11990369|FG002|STARTED|Treatment Period||122
10825016|NCT02823574|11990370|FG003|STARTED|Treatment Period||61
10825017|NCT02823574|11990367|FG000|COMPLETED|Treatment Period||19
10825018|NCT02823574|11990368|FG001|COMPLETED|Treatment Period||16
10825019|NCT02823574|11990369|FG002|COMPLETED|Treatment Period||14
10825020|NCT02823574|11990370|FG003|COMPLETED|Treatment Period||10
10825021|NCT02823574|11990367|FG000|NOT COMPLETED|Treatment Period||139
10825022|NCT02823574|11990368|FG001|NOT COMPLETED|Treatment Period||66
10825023|NCT02823574|11990369|FG002|NOT COMPLETED|Treatment Period||108
10825024|NCT02823574|11990370|FG003|NOT COMPLETED|Treatment Period||51
10825025|NCT02771990|11990385|FG000|STARTED|Overall Study||11
10825026|NCT02771990|11990386|FG001|STARTED|Overall Study||10
10825027|NCT02771990|11990385|FG000|COMPLETED|Overall Study||11
10825028|NCT02771990|11990386|FG001|COMPLETED|Overall Study||10
10825029|NCT02771990|11990385|FG000|NOT COMPLETED|Overall Study||0
10825030|NCT02771990|11990386|FG001|NOT COMPLETED|Overall Study||0
10825031|NCT02743819|11990392|FG000|STARTED|Overall Study||70
10825032|NCT02743819|11990392|FG000|COMPLETED|Overall Study||62
10825033|NCT02743819|11990392|FG000|NOT COMPLETED|Overall Study||8
10825034|NCT02729753|11990398|FG000|STARTED|Overall Study|First patient enrolled April 2016|3
10825035|NCT02729753|11990399|FG001|STARTED|Overall Study|First patient enrolled April 2016|7
10825036|NCT02729753|11990398|FG000|COMPLETED|Overall Study|Study Complete on 30 Oct 2016|3
10825037|NCT02729753|11990399|FG001|COMPLETED|Overall Study|Study Complete on 30 Oct 2016|6
10825038|NCT02729753|11990398|FG000|NOT COMPLETED|Overall Study||0
10825039|NCT02729753|11990399|FG001|NOT COMPLETED|Overall Study||1
10825040|NCT02704130|11990410|FG000|STARTED|Overall Study||5
10825041|NCT02704130|11990411|FG001|STARTED|Overall Study||3
10825042|NCT02704130|11990410|FG000|COMPLETED|Overall Study||0
10825043|NCT02704130|11990411|FG001|COMPLETED|Overall Study||0
10825044|NCT02704130|11990410|FG000|NOT COMPLETED|Overall Study||5
10825045|NCT02704130|11990411|FG001|NOT COMPLETED|Overall Study||3
10825046|NCT02701192|11990417|FG000|STARTED|Overall Study||100
10825047|NCT02701192|11990417|FG000|COMPLETED|Overall Study||94
10825048|NCT02701192|11990417|FG000|NOT COMPLETED|Overall Study||6
10825049|NCT02685709|11990425|FG000|STARTED|Run-in Phase||146
10825050|NCT02685709|11990426|FG001|STARTED|Run-in Phase||0
10825051|NCT02685709|11990427|FG002|STARTED|Run-in Phase||0
10825052|NCT02685709|11990428|FG003|STARTED|Run-in Phase||0
10825053|NCT02685709|11990425|FG000|COMPLETED|Run-in Phase|30 patients early terminated the Run-in phase and 24 patient were not randomized to RCT|116
10825054|NCT02685709|11990426|FG001|COMPLETED|Run-in Phase||0
10825055|NCT02685709|11990427|FG002|COMPLETED|Run-in Phase||0
10825056|NCT02685709|11990428|FG003|COMPLETED|Run-in Phase||0
10825057|NCT02685709|11990425|FG000|NOT COMPLETED|Run-in Phase||30
10825058|NCT02685709|11990426|FG001|NOT COMPLETED|Run-in Phase||0
10825059|NCT02685709|11990427|FG002|NOT COMPLETED|Run-in Phase||0
10825060|NCT02685709|11990428|FG003|NOT COMPLETED|Run-in Phase||0
10825061|NCT02685709|11990425|FG000|STARTED|RCT Phase|116 patients completed the Run-in phase, out of which 92 were randomized to the RCT phase, and 24 were not randomized to the RCT phase. Out of these 24, 11 patients eneterd the combination phase.|0
10825062|NCT02685709|11990426|FG001|STARTED|RCT Phase||55
10825063|NCT02685709|11990427|FG002|STARTED|RCT Phase||37
10825064|NCT02685709|11990428|FG003|STARTED|RCT Phase||0
10825065|NCT02685709|11990425|FG000|COMPLETED|RCT Phase||0
10825066|NCT02685709|11990426|FG001|COMPLETED|RCT Phase||54
10825067|NCT02685709|11990427|FG002|COMPLETED|RCT Phase||35
10825068|NCT02685709|11990428|FG003|COMPLETED|RCT Phase||0
10825069|NCT02685709|11990425|FG000|NOT COMPLETED|RCT Phase||0
10825070|NCT02685709|11990426|FG001|NOT COMPLETED|RCT Phase||1
10825071|NCT02685709|11990427|FG002|NOT COMPLETED|RCT Phase||2
10825072|NCT02685709|11990428|FG003|NOT COMPLETED|RCT Phase||0
10825073|NCT02685709|11990425|FG000|STARTED|Combination Phase||0
10825074|NCT02685709|11990426|FG001|STARTED|Combination Phase||0
10825075|NCT02685709|11990427|FG002|STARTED|Combination Phase||0
10825076|NCT02685709|11990428|FG003|STARTED|Combination Phase|14 patients entered the combination phase (3 patients early discontinued the Run-in phase, and 11 patients completed Run-in and were not eligible to RCT phase).|14
10825077|NCT02685709|11990425|FG000|COMPLETED|Combination Phase||0
10825078|NCT02685709|11990426|FG001|COMPLETED|Combination Phase||0
10825079|NCT02685709|11990427|FG002|COMPLETED|Combination Phase||0
10825080|NCT02685709|11990428|FG003|COMPLETED|Combination Phase||8
10825081|NCT02685709|11990425|FG000|NOT COMPLETED|Combination Phase||0
10825082|NCT02685709|11990426|FG001|NOT COMPLETED|Combination Phase||0
10825083|NCT02685709|11990427|FG002|NOT COMPLETED|Combination Phase||0
10825084|NCT02685709|11990428|FG003|NOT COMPLETED|Combination Phase||6
10825085|NCT02684851|11990440|FG000|STARTED|Overall Study||42
10825086|NCT02684851|11990441|FG001|STARTED|Overall Study||45
10825087|NCT02684851|11990440|FG000|COMPLETED|Overall Study||42
10825088|NCT02684851|11990441|FG001|COMPLETED|Overall Study||45
10825089|NCT02684851|11990440|FG000|NOT COMPLETED|Overall Study||0
10825090|NCT02684851|11990441|FG001|NOT COMPLETED|Overall Study||0
10825091|NCT02653482|11990451|FG000|STARTED|Overall Study||131
10825092|NCT02653482|11990452|FG001|STARTED|Overall Study||132
10825093|NCT02653482|11990451|FG000|COMPLETED|Overall Study||130
10825094|NCT02653482|11990452|FG001|COMPLETED|Overall Study||131
10825095|NCT02653482|11990451|FG000|NOT COMPLETED|Overall Study||1
10825096|NCT02653482|11990452|FG001|NOT COMPLETED|Overall Study||1
10825097|NCT02632409|11990460|FG000|STARTED|Randomized||356
10825098|NCT02632409|11990461|FG001|STARTED|Randomized||353
10825099|NCT02632409|11990460|FG000|COMPLETED|Randomized||348
10825100|NCT02632409|11990461|FG001|COMPLETED|Randomized||351
10825101|NCT02632409|11990460|FG000|NOT COMPLETED|Randomized||8
10825102|NCT02632409|11990461|FG001|NOT COMPLETED|Randomized||2
10825103|NCT02632409|11990460|FG000|STARTED|Treatment Period||348
10825104|NCT02632409|11990461|FG001|STARTED|Treatment Period||351
10825105|NCT02632409|11990460|FG000|COMPLETED|Treatment Period||132
10825106|NCT02632409|11990461|FG001|COMPLETED|Treatment Period||143
10825107|NCT02632409|11990460|FG000|NOT COMPLETED|Treatment Period||216
10825108|NCT02632409|11990461|FG001|NOT COMPLETED|Treatment Period||208
10825109|NCT02612194|11990470|FG000|STARTED|Overall Study||6
10825110|NCT02612194|11990471|FG001|STARTED|Overall Study||0
10825111|NCT02612194|11990472|FG002|STARTED|Overall Study||2
10825112|NCT02612194|11990470|FG000|COMPLETED|Overall Study||0
10825113|NCT02612194|11990471|FG001|COMPLETED|Overall Study||0
10825114|NCT02612194|11990472|FG002|COMPLETED|Overall Study||0
10825115|NCT02612194|11990470|FG000|NOT COMPLETED|Overall Study||6
10825116|NCT02612194|11990471|FG001|NOT COMPLETED|Overall Study||0
10825117|NCT02612194|11990472|FG002|NOT COMPLETED|Overall Study||2
10825118|NCT02586207|11990479|FG000|STARTED|Overall Study||59
10825119|NCT02586207|11990479|FG000|COMPLETED|Overall Study||57
10825120|NCT02586207|11990479|FG000|NOT COMPLETED|Overall Study||2
10825121|NCT02542397|11990483|FG000|STARTED|Overall Study|75 subjects were enrolled to the study (i.e., submitted buccal swab).|75
10825122|NCT02542397|11990483|FG000|COMPLETED|Overall Study|54 enrolled subjects provided pain scores at baseline and final assessments within 30 +/- 7 days.|59
10825123|NCT02542397|11990483|FG000|NOT COMPLETED|Overall Study||16
10825124|NCT02519777|11990491|FG000|STARTED|Overall Study||63
10825125|NCT02519777|11990492|FG001|STARTED|Overall Study||67
10825126|NCT02519777|11990493|FG002|STARTED|Overall Study||61
10825127|NCT02519777|11990491|FG000|COMPLETED|Overall Study||57
10825128|NCT02519777|11990492|FG001|COMPLETED|Overall Study||59
10825129|NCT02519777|11990493|FG002|COMPLETED|Overall Study||57
10825130|NCT02519777|11990491|FG000|NOT COMPLETED|Overall Study||6
10825131|NCT02519777|11990492|FG001|NOT COMPLETED|Overall Study||8
10825132|NCT02519777|11990493|FG002|NOT COMPLETED|Overall Study||4
10825136|NCT02395666|11990507|FG000|STARTED|Overall Study||101
10825137|NCT02395666|11990508|FG001|STARTED|Overall Study||39
10825138|NCT02395666|11990507|FG000|COMPLETED|Overall Study||95
10825139|NCT02395666|11990508|FG001|COMPLETED|Overall Study||38
10825140|NCT02395666|11990507|FG000|NOT COMPLETED|Overall Study||6
10825141|NCT02395666|11990508|FG001|NOT COMPLETED|Overall Study||1
10825142|NCT02357810|11990518|FG000|STARTED|Registered and Started Treatment||178
10825143|NCT02357810|11990518|FG000|Signed Consent|Registered and Started Treatment||178
10825144|NCT02357810|11990518|FG000|Registered to Study|Registered and Started Treatment||152
10825145|NCT02357810|11990518|FG000|Initiated Treatment on Study|Registered and Started Treatment||151
10825146|NCT02357810|11990518|FG000|COMPLETED|Registered and Started Treatment||151
10825147|NCT02357810|11990518|FG000|NOT COMPLETED|Registered and Started Treatment||27
10825148|NCT02357810|11990518|FG000|STARTED|Reached 12 Weeks Response||151
10825149|NCT02357810|11990518|FG000|Completed 4 Weeks/1 Cycle|Reached 12 Weeks Response||151
10825150|NCT02357810|11990518|FG000|Reached 6 Week Response|Reached 12 Weeks Response||129
10825151|NCT02357810|11990518|FG000|Reached 12 Weeks/3 Cycles|Reached 12 Weeks Response||95
10825152|NCT02357810|11990518|FG000|COMPLETED|Reached 12 Weeks Response||95
10825153|NCT02357810|11990518|FG000|NOT COMPLETED|Reached 12 Weeks Response||56
10825154|NCT02357810|11990518|FG000|STARTED|12 Week Response and Further Treatment||95
10825155|NCT02357810|11990518|FG000|Assessed for 12 Week Response|12 Week Response and Further Treatment||95
10825156|NCT02357810|11990518|FG000|Went on to be Treated After Response|12 Week Response and Further Treatment||73
10825157|NCT02357810|11990518|FG000|COMPLETED|12 Week Response and Further Treatment||73
10825158|NCT02357810|11990518|FG000|NOT COMPLETED|12 Week Response and Further Treatment||22
10290643|NCT01925131|11423382|FG003|STARTED|Overall Study||5
10825159|NCT02357810|11990518|FG000|STARTED|Follow-up at Treatment Discontinuation|All patients that receive at least one dose of study treatment go into follow up phase of the study.|151
10825160|NCT02357810|11990518|FG000|COMPLETED|Follow-up at Treatment Discontinuation||144
10825161|NCT02357810|11990518|FG000|NOT COMPLETED|Follow-up at Treatment Discontinuation||7
10825162|NCT02343549|11990522|FG000|STARTED|Overall Study||13
10825163|NCT02343549|11990522|FG000|COMPLETED|Overall Study||0
10825164|NCT02343549|11990522|FG000|NOT COMPLETED|Overall Study||13
10825165|NCT02339233|11990526|FG000|STARTED|Overall Study||8
10825166|NCT02339233|11990526|FG000|COMPLETED|Overall Study||8
10825167|NCT02339233|11990526|FG000|NOT COMPLETED|Overall Study||0
10825171|NCT02315066|11990548|FG000|STARTED|Overall Study||2
10825172|NCT02315066|11990549|FG001|STARTED|Overall Study||10
10825173|NCT02315066|11990550|FG002|STARTED|Overall Study||11
10825174|NCT02315066|11990551|FG003|STARTED|Overall Study||12
10825175|NCT02315066|11990552|FG004|STARTED|Overall Study||13
10825176|NCT02315066|11990553|FG005|STARTED|Overall Study||4
10825177|NCT02315066|11990554|FG006|STARTED|Overall Study||16
10825178|NCT02315066|11990555|FG007|STARTED|Overall Study||19
10825179|NCT02315066|11990556|FG008|STARTED|Overall Study||11
10825180|NCT02315066|11990557|FG009|STARTED|Overall Study||12
10825181|NCT02315066|11990558|FG010|STARTED|Overall Study||12
10825182|NCT02315066|11990559|FG011|STARTED|Overall Study||11
10825183|NCT02315066|11990560|FG012|STARTED|Overall Study||11
10825184|NCT02315066|11990561|FG013|STARTED|Overall Study||30
10825185|NCT02315066|11990548|FG000|COMPLETED|Overall Study||0
10825186|NCT02315066|11990549|FG001|COMPLETED|Overall Study||0
10825187|NCT02315066|11990550|FG002|COMPLETED|Overall Study||2
10825188|NCT02315066|11990551|FG003|COMPLETED|Overall Study||1
10825189|NCT02315066|11990552|FG004|COMPLETED|Overall Study||2
10825190|NCT02315066|11990553|FG005|COMPLETED|Overall Study||1
10825191|NCT02315066|11990554|FG006|COMPLETED|Overall Study||3
10825192|NCT02315066|11990555|FG007|COMPLETED|Overall Study||5
10825193|NCT02315066|11990556|FG008|COMPLETED|Overall Study||0
10825194|NCT02315066|11990557|FG009|COMPLETED|Overall Study||1
10825195|NCT02315066|11990558|FG010|COMPLETED|Overall Study||0
10825196|NCT02315066|11990559|FG011|COMPLETED|Overall Study||0
10825197|NCT02315066|11990560|FG012|COMPLETED|Overall Study||1
10825198|NCT02315066|11990561|FG013|COMPLETED|Overall Study||0
10825199|NCT02315066|11990548|FG000|NOT COMPLETED|Overall Study||2
10825200|NCT02315066|11990549|FG001|NOT COMPLETED|Overall Study||10
10825201|NCT02315066|11990550|FG002|NOT COMPLETED|Overall Study||9
10825202|NCT02315066|11990551|FG003|NOT COMPLETED|Overall Study||11
10825203|NCT02315066|11990552|FG004|NOT COMPLETED|Overall Study||11
10825204|NCT02315066|11990553|FG005|NOT COMPLETED|Overall Study||3
10825205|NCT02315066|11990554|FG006|NOT COMPLETED|Overall Study||13
10825206|NCT02315066|11990555|FG007|NOT COMPLETED|Overall Study||14
10825207|NCT02315066|11990556|FG008|NOT COMPLETED|Overall Study||11
10825208|NCT02315066|11990557|FG009|NOT COMPLETED|Overall Study||11
10825209|NCT02315066|11990558|FG010|NOT COMPLETED|Overall Study||12
10825210|NCT02315066|11990559|FG011|NOT COMPLETED|Overall Study||11
10825211|NCT02315066|11990560|FG012|NOT COMPLETED|Overall Study||10
10825212|NCT02315066|11990561|FG013|NOT COMPLETED|Overall Study||30
10825213|NCT02265367|11990593|FG000|STARTED|Overall Study||28
10825214|NCT02265367|11990594|FG001|STARTED|Overall Study||28
10825215|NCT02265367|11990593|FG000|Completed First 3-week Period|Overall Study||24
10825216|NCT02265367|11990594|FG001|Completed First 3-week Period|Overall Study||26
10825217|NCT02265367|11990593|FG000|COMPLETED|Overall Study||18
10825218|NCT02265367|11990594|FG001|COMPLETED|Overall Study||22
10825219|NCT02265367|11990593|FG000|NOT COMPLETED|Overall Study||10
10825220|NCT02265367|11990594|FG001|NOT COMPLETED|Overall Study||6
10825221|NCT02256631|11990607|FG000|STARTED|Overall Study||13
10825222|NCT02256631|11990608|FG001|STARTED|Overall Study||14
10825223|NCT02256631|11990609|FG002|STARTED|Overall Study||13
10825224|NCT02256631|11990610|FG003|STARTED|Overall Study||10
10825225|NCT02256631|11990611|FG004|STARTED|Overall Study||11
10825226|NCT02256631|11990612|FG005|STARTED|Overall Study||11
10825227|NCT02256631|11990613|FG006|STARTED|Overall Study||11
10825228|NCT02256631|11990607|FG000|COMPLETED|Overall Study||12
10825229|NCT02256631|11990608|FG001|COMPLETED|Overall Study||11
10825230|NCT02256631|11990609|FG002|COMPLETED|Overall Study||13
10825231|NCT02256631|11990610|FG003|COMPLETED|Overall Study||6
10825232|NCT02256631|11990611|FG004|COMPLETED|Overall Study||10
10825233|NCT02256631|11990612|FG005|COMPLETED|Overall Study||9
10825234|NCT02256631|11990613|FG006|COMPLETED|Overall Study||7
10825235|NCT02256631|11990607|FG000|NOT COMPLETED|Overall Study||1
10825236|NCT02256631|11990608|FG001|NOT COMPLETED|Overall Study||3
10825237|NCT02256631|11990609|FG002|NOT COMPLETED|Overall Study||0
10825238|NCT02256631|11990610|FG003|NOT COMPLETED|Overall Study||4
10825239|NCT02256631|11990611|FG004|NOT COMPLETED|Overall Study||1
10825240|NCT02256631|11990612|FG005|NOT COMPLETED|Overall Study||2
10825241|NCT02256631|11990613|FG006|NOT COMPLETED|Overall Study||4
10825248|NCT02129348|11990641|FG000|STARTED|Overall Study||38
10825249|NCT02129348|11990642|FG001|STARTED|Overall Study||39
10290644|NCT01925131|11423383|FG004|STARTED|Overall Study||11
10825250|NCT02129348|11990641|FG000|COMPLETED|Overall Study||29
10825251|NCT02129348|11990642|FG001|COMPLETED|Overall Study||29
10825252|NCT02129348|11990641|FG000|NOT COMPLETED|Overall Study||9
10825253|NCT02129348|11990642|FG001|NOT COMPLETED|Overall Study||10
10825254|NCT02080260|11990648|FG000|STARTED|Overall Study||20
10825255|NCT02080260|11990648|FG000|COMPLETED|Overall Study|Defined as still alive in follow-up when the study was terminated and the database was locked.|1
10825256|NCT02080260|11990648|FG000|NOT COMPLETED|Overall Study||19
10825257|NCT02051933|11990654|FG000|STARTED|Overall Study||5
10825258|NCT02051933|11990655|FG001|STARTED|Overall Study||5
10825259|NCT02051933|11990654|FG000|COMPLETED|Overall Study||5
10825260|NCT02051933|11990655|FG001|COMPLETED|Overall Study||4
10825261|NCT02051933|11990654|FG000|NOT COMPLETED|Overall Study||0
10825262|NCT02051933|11990655|FG001|NOT COMPLETED|Overall Study||1
10825263|NCT02047929|11990669|FG000|STARTED|Overall Study||1503
10825264|NCT02047929|11990670|FG001|STARTED|Overall Study||2523
10825265|NCT02047929|11990671|FG002|STARTED|Overall Study||2248
10825266|NCT02047929|11990669|FG000|Practice Rollout|Overall Study||1503
10825267|NCT02047929|11990670|FG001|Practice Rollout|Overall Study||2523
10825268|NCT02047929|11990671|FG002|Practice Rollout|Overall Study|Per protocol, practice did not receive any intervention from practice facilitator|0
10825269|NCT02047929|11990669|FG000|Practice Refresher|Overall Study||1503
10825270|NCT02047929|11990670|FG001|Practice Refresher|Overall Study||2523
10825271|NCT02047929|11990671|FG002|Practice Refresher|Overall Study|Per protocol, practices did not receive any interaction from practice facilitator|0
10825272|NCT02047929|11990669|FG000|Surveys Collected|Overall Study||1503
10825273|NCT02047929|11990670|FG001|Surveys Collected|Overall Study||2523
10825274|NCT02047929|11990671|FG002|Surveys Collected|Overall Study|Per protocol, practice did not receive any interaction from practice facilitator|0
10825275|NCT02047929|11990669|FG000|COMPLETED|Overall Study||1503
10825276|NCT02047929|11990670|FG001|COMPLETED|Overall Study||2523
10825277|NCT02047929|11990671|FG002|COMPLETED|Overall Study||2248
10825278|NCT02047929|11990669|FG000|NOT COMPLETED|Overall Study||0
10825279|NCT02047929|11990670|FG001|NOT COMPLETED|Overall Study||0
10825280|NCT02047929|11990671|FG002|NOT COMPLETED|Overall Study||0
10825281|NCT01999569|11990682|FG000|STARTED|Control Cycle|First cycle no meds|10
10825282|NCT01999569|11990682|FG000|COMPLETED|Control Cycle||10
10825283|NCT01999569|11990682|FG000|NOT COMPLETED|Control Cycle||0
10825284|NCT01999569|11990682|FG000|STARTED|Letrozole Treatment Cycle||10
10825285|NCT01999569|11990682|FG000|COMPLETED|Letrozole Treatment Cycle||10
10825286|NCT01999569|11990682|FG000|NOT COMPLETED|Letrozole Treatment Cycle||0
10825287|NCT01969812|11990691|FG000|STARTED|Overall Study||12
10825288|NCT01969812|11990692|FG001|STARTED|Overall Study||10
10825289|NCT01969812|11990691|FG000|COMPLETED|Overall Study||12
10825290|NCT01969812|11990692|FG001|COMPLETED|Overall Study||10
10825291|NCT01969812|11990691|FG000|NOT COMPLETED|Overall Study||0
10825292|NCT01969812|11990692|FG001|NOT COMPLETED|Overall Study||0
10825293|NCT01959464|11990700|FG000|STARTED|Overall Study||10
10825294|NCT01959464|11990701|FG001|STARTED|Overall Study||10
10825295|NCT01959464|11990700|FG000|COMPLETED|Overall Study||9
10825296|NCT01959464|11990701|FG001|COMPLETED|Overall Study||10
10825297|NCT01959464|11990700|FG000|NOT COMPLETED|Overall Study||1
10825298|NCT01959464|11990701|FG001|NOT COMPLETED|Overall Study||0
10825299|NCT01921166|11990709|FG000|STARTED|Overall Study||8
10825300|NCT01921166|11990710|FG001|STARTED|Overall Study||15
10825301|NCT01921166|11990709|FG000|COMPLETED|Overall Study||8
10825302|NCT01921166|11990710|FG001|COMPLETED|Overall Study||15
10825303|NCT01921166|11990709|FG000|NOT COMPLETED|Overall Study||0
10825304|NCT01921166|11990710|FG001|NOT COMPLETED|Overall Study||0
10825305|NCT01886963|11990718|FG000|STARTED|Overall Study||57
10825306|NCT01886963|11990719|FG001|STARTED|Overall Study||58
10825307|NCT01886963|11990718|FG000|2 Week Follow Up|Overall Study||55
10825308|NCT01886963|11990719|FG001|2 Week Follow Up|Overall Study||55
10825309|NCT01886963|11990718|FG000|4 Week Follow Up|Overall Study||50
10825310|NCT01886963|11990719|FG001|4 Week Follow Up|Overall Study||51
10825311|NCT01886963|11990718|FG000|12 Week Follow Up|Overall Study||46
10825312|NCT01886963|11990719|FG001|12 Week Follow Up|Overall Study||49
10825313|NCT01886963|11990718|FG000|COMPLETED|Overall Study||46
10825314|NCT01886963|11990719|FG001|COMPLETED|Overall Study||49
10825315|NCT01886963|11990718|FG000|NOT COMPLETED|Overall Study||11
10825316|NCT01886963|11990719|FG001|NOT COMPLETED|Overall Study||9
10825329|NCT01774253|11990734|FG000|STARTED|Overall Study||9
10825330|NCT01774253|11990734|FG000|COMPLETED|Overall Study||0
10825331|NCT01774253|11990734|FG000|NOT COMPLETED|Overall Study||9
10825332|NCT01666145|11990738|FG000|STARTED|Overall Study||14
10825333|NCT01666145|11990738|FG000|COMPLETED|Overall Study||14
10825334|NCT01666145|11990738|FG000|NOT COMPLETED|Overall Study||0
10825335|NCT01505608|11990744|FG000|STARTED|Phase I|Randomization to Arm A began in Phase 2. All patients in Phase I were enrolled to receive TPI 287.|0
10825336|NCT01505608|11990745|FG001|STARTED|Phase I||8
10825337|NCT01505608|11990744|FG000|COMPLETED|Phase I||0
10825338|NCT01505608|11990745|FG001|COMPLETED|Phase I||2
10825339|NCT01505608|11990744|FG000|NOT COMPLETED|Phase I||0
10825340|NCT01505608|11990745|FG001|NOT COMPLETED|Phase I||6
10825341|NCT01505608|11990744|FG000|STARTED|Phase II|Phase 2 was new enrollment, not the same patients from Phase 1.|2
10825342|NCT01505608|11990745|FG001|STARTED|Phase II|Phase 2 was new enrollment, not the same patients from Phase 1.|4
10825343|NCT01505608|11990744|FG000|COMPLETED|Phase II||0
10825344|NCT01505608|11990745|FG001|COMPLETED|Phase II||2
10825345|NCT01505608|11990744|FG000|NOT COMPLETED|Phase II||2
10825346|NCT01505608|11990745|FG001|NOT COMPLETED|Phase II||2
10825347|NCT01483820|11990754|FG000|STARTED|Overall Study||8
10825348|NCT01483820|11990754|FG000|COMPLETED|Overall Study||0
10825349|NCT01483820|11990754|FG000|NOT COMPLETED|Overall Study||8
10825350|NCT01355679|11990758|FG000|STARTED|Overall Study||16
10825351|NCT01355679|11990758|FG000|COMPLETED|Overall Study||14
10825352|NCT01355679|11990758|FG000|NOT COMPLETED|Overall Study||2
10825353|NCT01227616|11990765|FG000|STARTED|Overall Study||196
10825354|NCT01227616|11990766|FG001|STARTED|Overall Study||97
10825355|NCT01227616|11990765|FG000|COMPLETED|Overall Study||142
10825356|NCT01227616|11990766|FG001|COMPLETED|Overall Study||74
10825357|NCT01227616|11990765|FG000|NOT COMPLETED|Overall Study||54
10825358|NCT01227616|11990766|FG001|NOT COMPLETED|Overall Study||23
10825359|NCT01192698|11990774|FG000|STARTED|Overall Study||10
10825360|NCT01192698|11990775|FG001|STARTED|Overall Study||5
10825361|NCT01192698|11990774|FG000|COMPLETED|Overall Study||10
10825362|NCT01192698|11990775|FG001|COMPLETED|Overall Study||5
10825363|NCT01192698|11990774|FG000|NOT COMPLETED|Overall Study||0
10825364|NCT01192698|11990775|FG001|NOT COMPLETED|Overall Study||0
10825365|NCT01166386|11990783|FG000|STARTED|Overall Study||82
10825366|NCT01166386|11990784|FG001|STARTED|Overall Study||83
10825367|NCT01166386|11990783|FG000|COMPLETED|Overall Study||79
10825368|NCT01166386|11990784|FG001|COMPLETED|Overall Study||78
10825369|NCT01166386|11990783|FG000|NOT COMPLETED|Overall Study||3
10825370|NCT01166386|11990784|FG001|NOT COMPLETED|Overall Study||5
10825371|NCT01114217|11990792|FG000|STARTED|Overall Study||337
10408871|NCT00757601|11552972|FG011|NOT COMPLETED|Period 2||1
10408872|NCT00757601|11552961|FG000|STARTED|Period 3||2
10408873|NCT00757601|11552962|FG001|STARTED|Period 3||2
10408874|NCT00757601|11552963|FG002|STARTED|Period 3||2
10408875|NCT00757601|11552964|FG003|STARTED|Period 3||2
10408876|NCT00757601|11552965|FG004|STARTED|Period 3||2
10408877|NCT00757601|11552966|FG005|STARTED|Period 3||2
10408878|NCT00757601|11552967|FG006|STARTED|Period 3||2
10408879|NCT00757601|11552968|FG007|STARTED|Period 3||2
10408880|NCT00757601|11552969|FG008|STARTED|Period 3||2
10408881|NCT00757601|11552970|FG009|STARTED|Period 3||2
10408882|NCT00757601|11552971|FG010|STARTED|Period 3||2
10408883|NCT00757601|11552972|FG011|STARTED|Period 3||2
10408884|NCT00757601|11552961|FG000|COMPLETED|Period 3||2
10408885|NCT00757601|11552962|FG001|COMPLETED|Period 3||2
10408886|NCT00757601|11552963|FG002|COMPLETED|Period 3||2
10408887|NCT00757601|11552964|FG003|COMPLETED|Period 3||2
10408888|NCT00757601|11552965|FG004|COMPLETED|Period 3||2
10408889|NCT00757601|11552966|FG005|COMPLETED|Period 3||2
10408890|NCT00757601|11552967|FG006|COMPLETED|Period 3||2
10408891|NCT00757601|11552968|FG007|COMPLETED|Period 3||2
10825372|NCT01114217|11990793|FG001|STARTED|Overall Study||297
10825373|NCT01114217|11990792|FG000|Received at Least 1 Dose of Ferumoxytol|Overall Study||337
10825374|NCT01114217|11990793|FG001|Received at Least 1 Dose of Ferumoxytol|Overall Study||0
10825375|NCT01114217|11990792|FG000|COMPLETED|Overall Study|Two participants lacked study completion data: one site stopped communicating during the study.|262
10825376|NCT01114217|11990793|FG001|COMPLETED|Overall Study||199
10825377|NCT01114217|11990792|FG000|NOT COMPLETED|Overall Study||75
10825378|NCT01114217|11990793|FG001|NOT COMPLETED|Overall Study||98
10825379|NCT01114204|11990799|FG000|STARTED|Overall Study||406
10825380|NCT01114204|11990800|FG001|STARTED|Overall Study||199
10825381|NCT01114204|11990799|FG000|Received at Least 1 Dose of Study Drug|Overall Study||406
10825382|NCT01114204|11990800|FG001|Received at Least 1 Dose of Study Drug|Overall Study||199
10825383|NCT01114204|11990799|FG000|COMPLETED|Overall Study||385
10825384|NCT01114204|11990800|FG001|COMPLETED|Overall Study||191
10825385|NCT01114204|11990799|FG000|NOT COMPLETED|Overall Study||21
10825386|NCT01114204|11990800|FG001|NOT COMPLETED|Overall Study||8
10825387|NCT01114139|11990808|FG000|STARTED|Overall Study||609
10825388|NCT01114139|11990809|FG001|STARTED|Overall Study||203
10825389|NCT01114139|11990808|FG000|Received at Least 1 Dose of Study Drug|Overall Study||608
10825390|NCT01114139|11990809|FG001|Received at Least 1 Dose of Study Drug|Overall Study||200
10825391|NCT01114139|11990808|FG000|COMPLETED|Overall Study||569
10825392|NCT01114139|11990809|FG001|COMPLETED|Overall Study||187
10825393|NCT01114139|11990808|FG000|NOT COMPLETED|Overall Study||40
10825394|NCT01114139|11990809|FG001|NOT COMPLETED|Overall Study||16
10825395|NCT01059071|11990815|FG000|STARTED|Overall Study||4
10825396|NCT01059071|11990816|FG001|STARTED|Overall Study||5
10825397|NCT01059071|11990817|FG002|STARTED|Overall Study||3
10825398|NCT01059071|11990818|FG003|STARTED|Overall Study||9
10825399|NCT01059071|11990815|FG000|COMPLETED|Overall Study||2
10825400|NCT01059071|11990816|FG001|COMPLETED|Overall Study||1
10825401|NCT01059071|11990817|FG002|COMPLETED|Overall Study||1
10825402|NCT01059071|11990818|FG003|COMPLETED|Overall Study||3
10825403|NCT01059071|11990815|FG000|NOT COMPLETED|Overall Study||2
10825404|NCT01059071|11990816|FG001|NOT COMPLETED|Overall Study||4
10825405|NCT01059071|11990817|FG002|NOT COMPLETED|Overall Study||2
10825406|NCT01059071|11990818|FG003|NOT COMPLETED|Overall Study||6
10825407|NCT01027702|11990826|FG000|STARTED|Overall Study||4
10825408|NCT01027702|11990827|FG001|STARTED|Overall Study||4
10408892|NCT00757601|11552969|FG008|COMPLETED|Period 3||2
10408893|NCT00757601|11552970|FG009|COMPLETED|Period 3||2
10408894|NCT00757601|11552971|FG010|COMPLETED|Period 3||2
10408895|NCT00757601|11552972|FG011|COMPLETED|Period 3||2
10408896|NCT00757601|11552961|FG000|NOT COMPLETED|Period 3||0
10408897|NCT00757601|11552962|FG001|NOT COMPLETED|Period 3||0
10408898|NCT00757601|11552963|FG002|NOT COMPLETED|Period 3||0
10408899|NCT00757601|11552964|FG003|NOT COMPLETED|Period 3||0
10408900|NCT00757601|11552965|FG004|NOT COMPLETED|Period 3||0
10408901|NCT00757601|11552966|FG005|NOT COMPLETED|Period 3||0
10825409|NCT01027702|11990828|FG002|STARTED|Overall Study||3
10825410|NCT01027702|11990829|FG003|STARTED|Overall Study||14
10825411|NCT01027702|11990830|FG004|STARTED|Overall Study||10
10825412|NCT01027702|11990831|FG005|STARTED|Overall Study||1
10825413|NCT01027702|11990832|FG006|STARTED|Overall Study||2
10825414|NCT01027702|11990826|FG000|COMPLETED|Overall Study||3
10825415|NCT01027702|11990827|FG001|COMPLETED|Overall Study||2
10825416|NCT01027702|11990828|FG002|COMPLETED|Overall Study||2
10825417|NCT01027702|11990829|FG003|COMPLETED|Overall Study||10
10825418|NCT01027702|11990830|FG004|COMPLETED|Overall Study||9
10825419|NCT01027702|11990831|FG005|COMPLETED|Overall Study||1
10825420|NCT01027702|11990832|FG006|COMPLETED|Overall Study||1
10825421|NCT01027702|11990826|FG000|NOT COMPLETED|Overall Study||1
10825422|NCT01027702|11990827|FG001|NOT COMPLETED|Overall Study||2
10825423|NCT01027702|11990828|FG002|NOT COMPLETED|Overall Study||1
10825424|NCT01027702|11990829|FG003|NOT COMPLETED|Overall Study||4
10825425|NCT01027702|11990830|FG004|NOT COMPLETED|Overall Study||1
10825426|NCT01027702|11990831|FG005|NOT COMPLETED|Overall Study||0
10825427|NCT01027702|11990832|FG006|NOT COMPLETED|Overall Study||1
10825428|NCT00991887|11990845|FG000|STARTED|Overall Study||26
10825429|NCT00991887|11990846|FG001|STARTED|Overall Study||22
10825430|NCT00991887|11990845|FG000|COMPLETED|Overall Study||24
10825431|NCT00991887|11990846|FG001|COMPLETED|Overall Study||21
10825432|NCT00991887|11990845|FG000|NOT COMPLETED|Overall Study||2
10825433|NCT00991887|11990846|FG001|NOT COMPLETED|Overall Study||1
10825434|NCT00968864|11990852|FG000|STARTED|Overall Study|One patient, FDA and IRB approved to enroll as an exception, was not evaluable for study endpoints.|53
10825435|NCT00968864|11990852|FG000|COMPLETED|Overall Study||52
10825436|NCT00968864|11990852|FG000|NOT COMPLETED|Overall Study||1
10825437|NCT00934700|11990863|FG000|STARTED|Overall Study||46
10825438|NCT00934700|11990864|FG001|STARTED|Overall Study||46
10825439|NCT00934700|11990863|FG000|COMPLETED|Overall Study||33
10825440|NCT00934700|11990864|FG001|COMPLETED|Overall Study||34
10825441|NCT00934700|11990863|FG000|NOT COMPLETED|Overall Study||13
10825442|NCT00934700|11990864|FG001|NOT COMPLETED|Overall Study||12
10825443|NCT00867568|11990871|FG000|STARTED|Overall Study||18
10825444|NCT00867568|11990871|FG000|COMPLETED|Overall Study||3
10825445|NCT00867568|11990871|FG000|NOT COMPLETED|Overall Study||15
10825455|NCT00782288|11990891|FG000|STARTED|Overall Study||8
10825456|NCT00782288|11990892|FG001|STARTED|Overall Study||8
10825457|NCT00782288|11990893|FG002|STARTED|Overall Study||8
10825458|NCT00782288|11990891|FG000|COMPLETED|Overall Study||8
10825459|NCT00782288|11990892|FG001|COMPLETED|Overall Study||8
10825460|NCT00782288|11990893|FG002|COMPLETED|Overall Study||8
10825461|NCT00782288|11990891|FG000|NOT COMPLETED|Overall Study||0
10825462|NCT00782288|11990892|FG001|NOT COMPLETED|Overall Study||0
10825463|NCT00782288|11990893|FG002|NOT COMPLETED|Overall Study||0
10825464|NCT00643864|11990903|FG000|STARTED|Pre-test Assessment||3
10825465|NCT00643864|11990903|FG000|COMPLETED|Pre-test Assessment||3
10825466|NCT00643864|11990903|FG000|NOT COMPLETED|Pre-test Assessment||0
10825467|NCT00643864|11990903|FG000|STARTED|Post-test Assessment||3
10825468|NCT00643864|11990903|FG000|COMPLETED|Post-test Assessment||3
10825469|NCT00643864|11990903|FG000|NOT COMPLETED|Post-test Assessment||0
10825470|NCT00628446|11990908|FG000|STARTED|Overall Study||45
10825471|NCT00628446|11990908|FG000|COMPLETED|Overall Study||38
10825472|NCT00628446|11990908|FG000|NOT COMPLETED|Overall Study||7
10825473|NCT00621751|11990915|FG000|STARTED|Overall Study||35
10825474|NCT00621751|11990916|FG001|STARTED|Overall Study||35
10825475|NCT00621751|11990915|FG000|COMPLETED|Overall Study||35
10825476|NCT00621751|11990916|FG001|COMPLETED|Overall Study||34
10825477|NCT00621751|11990915|FG000|NOT COMPLETED|Overall Study||0
10825478|NCT00621751|11990916|FG001|NOT COMPLETED|Overall Study||1
10825479|NCT00605215|11990925|FG000|STARTED|Overall Study||450
10825480|NCT00605215|11990926|FG001|STARTED|Overall Study||434
10825481|NCT00605215|11990927|FG002|STARTED|Overall Study||447
10825482|NCT00605215|11990925|FG000|Received at Least 1 Dose of Study Drug|Overall Study||449
10825483|NCT00605215|11990926|FG001|Received at Least 1 Dose of Study Drug|Overall Study||433
10825484|NCT00605215|11990927|FG002|Received at Least 1 Dose of Study Drug|Overall Study||442
10825485|NCT00605215|11990925|FG000|COMPLETED|Overall Study||359
10825486|NCT00605215|11990926|FG001|COMPLETED|Overall Study||353
10825487|NCT00605215|11990927|FG002|COMPLETED|Overall Study||378
10825488|NCT00605215|11990925|FG000|NOT COMPLETED|Overall Study||91
10825489|NCT00605215|11990926|FG001|NOT COMPLETED|Overall Study||81
10825490|NCT00605215|11990927|FG002|NOT COMPLETED|Overall Study||69
10825491|NCT00605150|11990935|FG000|STARTED|Overall Study|11 started|11
10825492|NCT00605150|11990935|FG000|COMPLETED|Overall Study||10
10825493|NCT00605150|11990935|FG000|NOT COMPLETED|Overall Study||1
10825494|NCT00552513|11990941|FG000|STARTED|Overall Study||1593
10825495|NCT00552513|11990942|FG001|STARTED|Overall Study||1438
10825496|NCT00552513|11990941|FG000|COMPLETED|Overall Study||1588
10825497|NCT00552513|11990942|FG001|COMPLETED|Overall Study||1437
10825498|NCT00552513|11990941|FG000|NOT COMPLETED|Overall Study||5
10825499|NCT00552513|11990942|FG001|NOT COMPLETED|Overall Study||1
10825500|NCT00368836|11990952|FG000|STARTED|Phase II||350
10825501|NCT00368836|11990952|FG000|COMPLETED|Phase II||329
10825502|NCT00368836|11990952|FG000|NOT COMPLETED|Phase II||21
10825503|NCT00368836|11990952|FG000|STARTED|Phase I Pre-op/Post-op|The phases consisted of unique subjects. Those enrolled in Phase I did not carry over to Phase II.|125
10825504|NCT00368836|11990952|FG000|COMPLETED|Phase I Pre-op/Post-op||104
10825505|NCT00368836|11990952|FG000|NOT COMPLETED|Phase I Pre-op/Post-op||21
10825506|NCT00290511|11990959|FG000|STARTED|Overall Study||49
10825507|NCT00290511|11990959|FG000|No Treatment Per Protocol|Overall Study||2
10825508|NCT00290511|11990959|FG000|Toxicity Assessment|Overall Study||47
10825509|NCT00290511|11990959|FG000|Response Assessment|Overall Study||45
10825510|NCT00290511|11990959|FG000|COMPLETED|Overall Study||45
10825511|NCT00290511|11990959|FG000|NOT COMPLETED|Overall Study||4
10825515|NCT00641537|11990972|FG000|STARTED|96-week Period||98
10825516|NCT00641537|11990973|FG001|STARTED|96-week Period||92
10825517|NCT00641537|11990974|FG002|STARTED|96-week Period||186
10825518|NCT00641537|11990975|FG003|STARTED|96-week Period||186
10825519|NCT00641537|11990976|FG004|STARTED|96-week Period||244
10825520|NCT00641537|11990977|FG005|STARTED|96-week Period||22
10825521|NCT00641537|11990978|FG006|STARTED|96-week Period||17
10825522|NCT00641537|11990979|FG007|STARTED|96-week Period||22
10825523|NCT00641537|11990972|FG000|COMPLETED|96-week Period||89
10825524|NCT00641537|11990973|FG001|COMPLETED|96-week Period||82
10825525|NCT00641537|11990974|FG002|COMPLETED|96-week Period||166
10825526|NCT00641537|11990975|FG003|COMPLETED|96-week Period||174
10825527|NCT00641537|11990976|FG004|COMPLETED|96-week Period||227
10825528|NCT00641537|11990977|FG005|COMPLETED|96-week Period||15
10825529|NCT00641537|11990978|FG006|COMPLETED|96-week Period||12
10825530|NCT00641537|11990979|FG007|COMPLETED|96-week Period||16
10825531|NCT00641537|11990972|FG000|NOT COMPLETED|96-week Period||9
10825532|NCT00641537|11990973|FG001|NOT COMPLETED|96-week Period||10
10825533|NCT00641537|11990974|FG002|NOT COMPLETED|96-week Period||20
10825534|NCT00641537|11990975|FG003|NOT COMPLETED|96-week Period||12
10825535|NCT00641537|11990976|FG004|NOT COMPLETED|96-week Period||17
10825536|NCT00641537|11990977|FG005|NOT COMPLETED|96-week Period||7
10825537|NCT00641537|11990978|FG006|NOT COMPLETED|96-week Period||5
10825538|NCT00641537|11990979|FG007|NOT COMPLETED|96-week Period||6
10825539|NCT00641537|11990972|FG000|STARTED|24-Week Supplemental Follow-up Period||75
10825540|NCT00641537|11990973|FG001|STARTED|24-Week Supplemental Follow-up Period||69
10825541|NCT00641537|11990974|FG002|STARTED|24-Week Supplemental Follow-up Period||143
10825542|NCT00641537|11990975|FG003|STARTED|24-Week Supplemental Follow-up Period||151
10825543|NCT00641537|11990976|FG004|STARTED|24-Week Supplemental Follow-up Period||198
10825544|NCT00641537|11990977|FG005|STARTED|24-Week Supplemental Follow-up Period||15
10825545|NCT00641537|11990978|FG006|STARTED|24-Week Supplemental Follow-up Period||9
10825546|NCT00641537|11990979|FG007|STARTED|24-Week Supplemental Follow-up Period||11
10825547|NCT00641537|11990972|FG000|COMPLETED|24-Week Supplemental Follow-up Period||75
10825548|NCT00641537|11990973|FG001|COMPLETED|24-Week Supplemental Follow-up Period||66
10825549|NCT00641537|11990974|FG002|COMPLETED|24-Week Supplemental Follow-up Period||140
10825550|NCT00641537|11990975|FG003|COMPLETED|24-Week Supplemental Follow-up Period||147
10825551|NCT00641537|11990976|FG004|COMPLETED|24-Week Supplemental Follow-up Period||193
10825552|NCT00641537|11990977|FG005|COMPLETED|24-Week Supplemental Follow-up Period||14
10825553|NCT00641537|11990978|FG006|COMPLETED|24-Week Supplemental Follow-up Period||8
10825554|NCT00641537|11990979|FG007|COMPLETED|24-Week Supplemental Follow-up Period||10
10825555|NCT00641537|11990972|FG000|NOT COMPLETED|24-Week Supplemental Follow-up Period||0
10825556|NCT00641537|11990973|FG001|NOT COMPLETED|24-Week Supplemental Follow-up Period||3
10825557|NCT00641537|11990974|FG002|NOT COMPLETED|24-Week Supplemental Follow-up Period||3
10825558|NCT00641537|11990975|FG003|NOT COMPLETED|24-Week Supplemental Follow-up Period||4
10825559|NCT00641537|11990976|FG004|NOT COMPLETED|24-Week Supplemental Follow-up Period||5
10825560|NCT00641537|11990977|FG005|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
10825561|NCT00641537|11990978|FG006|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
10825562|NCT00641537|11990979|FG007|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
10825563|NCT00655824|11990997|FG000|STARTED|Overall Study||92
10825564|NCT00655824|11990997|FG000|COMPLETED|Overall Study||8
10825565|NCT00655824|11990997|FG000|NOT COMPLETED|Overall Study||84
10825566|NCT00663052|11991003|FG000|STARTED|Overall Study||136
10825567|NCT00663052|11991004|FG001|STARTED|Overall Study||137
10825568|NCT00663052|11991003|FG000|COMPLETED|Overall Study||124
10825569|NCT00663052|11991004|FG001|COMPLETED|Overall Study||127
10825570|NCT00663052|11991003|FG000|NOT COMPLETED|Overall Study||12
10825571|NCT00663052|11991004|FG001|NOT COMPLETED|Overall Study||10
10825572|NCT00686374|11991010|FG000|STARTED|Overall Study||100
10825573|NCT00686374|11991010|FG000|COMPLETED|Overall Study||39
10825574|NCT00686374|11991010|FG000|NOT COMPLETED|Overall Study||61
10825575|NCT00698828|11991017|FG000|STARTED|Overall Study||76
10825576|NCT00698828|11991018|FG001|STARTED|Overall Study||75
10825577|NCT00698828|11991019|FG002|STARTED|Overall Study||76
10825578|NCT00698828|11991017|FG000|COMPLETED|Overall Study||67
10825579|NCT00698828|11991018|FG001|COMPLETED|Overall Study||60
10825580|NCT00698828|11991019|FG002|COMPLETED|Overall Study||65
10825581|NCT00698828|11991017|FG000|NOT COMPLETED|Overall Study||9
10825582|NCT00698828|11991018|FG001|NOT COMPLETED|Overall Study||15
10825583|NCT00698828|11991019|FG002|NOT COMPLETED|Overall Study||11
10825584|NCT00712933|11991027|FG000|STARTED|Overall Study||735
10825585|NCT00712933|11991027|FG000|COMPLETED|Overall Study||368
10825586|NCT00712933|11991027|FG000|NOT COMPLETED|Overall Study||367
10825596|NCT00725985|11991051|FG000|STARTED|ITP- Treatment Disposition||205
10825597|NCT00725985|11991052|FG001|STARTED|ITP- Treatment Disposition||206
10825598|NCT00725985|11991053|FG002|STARTED|ITP- Treatment Disposition||206
10825599|NCT00725985|11991054|FG003|STARTED|ITP- Treatment Disposition||0
10825600|NCT00725985|11991055|FG004|STARTED|ITP- Treatment Disposition||0
10825601|NCT00725985|11991056|FG005|STARTED|ITP- Treatment Disposition||0
10825602|NCT00725985|11991057|FG006|STARTED|ITP- Treatment Disposition||0
10825603|NCT00725985|11991058|FG007|STARTED|ITP- Treatment Disposition||0
10825604|NCT00725985|11991059|FG008|STARTED|ITP- Treatment Disposition||0
10825605|NCT00725985|11991060|FG009|STARTED|ITP- Treatment Disposition||0
10825606|NCT00725985|11991061|FG010|STARTED|ITP- Treatment Disposition||0
10825607|NCT00725985|11991062|FG011|STARTED|ITP- Treatment Disposition||0
10825608|NCT00725985|11991051|FG000|Treated|ITP- Treatment Disposition||204
10825587|NCT00715273|11991038|FG000|STARTED|Overall Study||71
10825588|NCT00715273|11991039|FG001|STARTED|Overall Study||73
10825589|NCT00715273|11991040|FG002|STARTED|Overall Study||73
10825590|NCT00715273|11991038|FG000|COMPLETED|Overall Study||63
10825591|NCT00715273|11991039|FG001|COMPLETED|Overall Study||65
10825592|NCT00715273|11991040|FG002|COMPLETED|Overall Study||68
10825593|NCT00715273|11991038|FG000|NOT COMPLETED|Overall Study||8
10825594|NCT00715273|11991039|FG001|NOT COMPLETED|Overall Study||8
10825595|NCT00715273|11991040|FG002|NOT COMPLETED|Overall Study||5
10825609|NCT00725985|11991052|FG001|Treated|ITP- Treatment Disposition||206
10825610|NCT00725985|11991053|FG002|Treated|ITP- Treatment Disposition||206
10825611|NCT00725985|11991054|FG003|Treated|ITP- Treatment Disposition||0
10825612|NCT00725985|11991055|FG004|Treated|ITP- Treatment Disposition||0
10825613|NCT00725985|11991056|FG005|Treated|ITP- Treatment Disposition||0
10825614|NCT00725985|11991057|FG006|Treated|ITP- Treatment Disposition||0
10825615|NCT00725985|11991058|FG007|Treated|ITP- Treatment Disposition||0
10825616|NCT00725985|11991059|FG008|Treated|ITP- Treatment Disposition||0
10825617|NCT00725985|11991060|FG009|Treated|ITP- Treatment Disposition||0
10825618|NCT00725985|11991061|FG010|Treated|ITP- Treatment Disposition||0
10825619|NCT00725985|11991062|FG011|Treated|ITP- Treatment Disposition||0
10825620|NCT00725985|11991051|FG000|COMPLETED|ITP- Treatment Disposition||104
10825621|NCT00725985|11991052|FG001|COMPLETED|ITP- Treatment Disposition||131
10825622|NCT00725985|11991053|FG002|COMPLETED|ITP- Treatment Disposition||104
10825623|NCT00725985|11991054|FG003|COMPLETED|ITP- Treatment Disposition||0
10825624|NCT00725985|11991055|FG004|COMPLETED|ITP- Treatment Disposition||0
10825625|NCT00725985|11991056|FG005|COMPLETED|ITP- Treatment Disposition||0
10825626|NCT00725985|11991057|FG006|COMPLETED|ITP- Treatment Disposition||0
10825627|NCT00725985|11991058|FG007|COMPLETED|ITP- Treatment Disposition||0
10825628|NCT00725985|11991059|FG008|COMPLETED|ITP- Treatment Disposition||0
10825629|NCT00725985|11991060|FG009|COMPLETED|ITP- Treatment Disposition||0
10825630|NCT00725985|11991061|FG010|COMPLETED|ITP- Treatment Disposition||0
10825631|NCT00725985|11991062|FG011|COMPLETED|ITP- Treatment Disposition||0
10825632|NCT00725985|11991051|FG000|NOT COMPLETED|ITP- Treatment Disposition||101
10825633|NCT00725985|11991052|FG001|NOT COMPLETED|ITP- Treatment Disposition||75
10825634|NCT00725985|11991053|FG002|NOT COMPLETED|ITP- Treatment Disposition||102
10825635|NCT00725985|11991054|FG003|NOT COMPLETED|ITP- Treatment Disposition||0
10825636|NCT00725985|11991055|FG004|NOT COMPLETED|ITP- Treatment Disposition||0
10825637|NCT00725985|11991056|FG005|NOT COMPLETED|ITP- Treatment Disposition||0
10825638|NCT00725985|11991057|FG006|NOT COMPLETED|ITP- Treatment Disposition||0
10825639|NCT00725985|11991058|FG007|NOT COMPLETED|ITP- Treatment Disposition||0
10825640|NCT00725985|11991059|FG008|NOT COMPLETED|ITP- Treatment Disposition||0
10825641|NCT00725985|11991060|FG009|NOT COMPLETED|ITP- Treatment Disposition||0
10825642|NCT00725985|11991061|FG010|NOT COMPLETED|ITP- Treatment Disposition||0
10825643|NCT00725985|11991062|FG011|NOT COMPLETED|ITP- Treatment Disposition||0
10825644|NCT00725985|11991051|FG000|STARTED|OLMP (Up to 96 Weeks)||0
10825645|NCT00725985|11991052|FG001|STARTED|OLMP (Up to 96 Weeks)||0
10825646|NCT00725985|11991053|FG002|STARTED|OLMP (Up to 96 Weeks)||0
10825647|NCT00725985|11991054|FG003|STARTED|OLMP (Up to 96 Weeks)||24
10825648|NCT00725985|11991055|FG004|STARTED|OLMP (Up to 96 Weeks)||25
10825649|NCT00725985|11991056|FG005|STARTED|OLMP (Up to 96 Weeks)||60
10825650|NCT00725985|11991057|FG006|STARTED|OLMP (Up to 96 Weeks)||0
10825651|NCT00725985|11991058|FG007|STARTED|OLMP (Up to 96 Weeks)||0
10825652|NCT00725985|11991059|FG008|STARTED|OLMP (Up to 96 Weeks)||0
10825653|NCT00725985|11991060|FG009|STARTED|OLMP (Up to 96 Weeks)||0
10825654|NCT00725985|11991061|FG010|STARTED|OLMP (Up to 96 Weeks)||0
10825655|NCT00725985|11991062|FG011|STARTED|OLMP (Up to 96 Weeks)||0
10825656|NCT00725985|11991051|FG000|COMPLETED|OLMP (Up to 96 Weeks)||0
10825657|NCT00725985|11991052|FG001|COMPLETED|OLMP (Up to 96 Weeks)||0
10825658|NCT00725985|11991053|FG002|COMPLETED|OLMP (Up to 96 Weeks)||0
10825659|NCT00725985|11991054|FG003|COMPLETED|OLMP (Up to 96 Weeks)||6
10825660|NCT00725985|11991055|FG004|COMPLETED|OLMP (Up to 96 Weeks)||2
10825661|NCT00725985|11991056|FG005|COMPLETED|OLMP (Up to 96 Weeks)||7
10825662|NCT00725985|11991057|FG006|COMPLETED|OLMP (Up to 96 Weeks)||0
10825663|NCT00725985|11991058|FG007|COMPLETED|OLMP (Up to 96 Weeks)||0
10825664|NCT00725985|11991059|FG008|COMPLETED|OLMP (Up to 96 Weeks)||0
10825665|NCT00725985|11991060|FG009|COMPLETED|OLMP (Up to 96 Weeks)||0
10825666|NCT00725985|11991061|FG010|COMPLETED|OLMP (Up to 96 Weeks)||0
10825667|NCT00725985|11991062|FG011|COMPLETED|OLMP (Up to 96 Weeks)||0
10825668|NCT00725985|11991051|FG000|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
10825669|NCT00725985|11991052|FG001|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
10825670|NCT00725985|11991053|FG002|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
10825671|NCT00725985|11991054|FG003|NOT COMPLETED|OLMP (Up to 96 Weeks)||18
10825672|NCT00725985|11991055|FG004|NOT COMPLETED|OLMP (Up to 96 Weeks)||23
10825673|NCT00725985|11991056|FG005|NOT COMPLETED|OLMP (Up to 96 Weeks)||53
10825674|NCT00725985|11991057|FG006|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
10825675|NCT00725985|11991058|FG007|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
10825676|NCT00725985|11991059|FG008|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
10825677|NCT00725985|11991060|FG009|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
10825678|NCT00725985|11991061|FG010|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
10825679|NCT00725985|11991062|FG011|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
10825680|NCT00725985|11991051|FG000|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825681|NCT00725985|11991052|FG001|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825682|NCT00725985|11991053|FG002|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825683|NCT00725985|11991054|FG003|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825684|NCT00725985|11991055|FG004|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825685|NCT00725985|11991056|FG005|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825686|NCT00725985|11991057|FG006|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||9
10825687|NCT00725985|11991058|FG007|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||9
10825688|NCT00725985|11991059|FG008|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||17
10825689|NCT00725985|11991060|FG009|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825690|NCT00725985|11991061|FG010|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825691|NCT00725985|11991062|FG011|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825692|NCT00725985|11991051|FG000|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825693|NCT00725985|11991052|FG001|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825694|NCT00725985|11991053|FG002|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825695|NCT00725985|11991054|FG003|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825696|NCT00725985|11991055|FG004|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825697|NCT00725985|11991056|FG005|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825698|NCT00725985|11991057|FG006|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825699|NCT00725985|11991058|FG007|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825700|NCT00725985|11991059|FG008|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825701|NCT00725985|11991060|FG009|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825702|NCT00725985|11991061|FG010|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825703|NCT00725985|11991062|FG011|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825704|NCT00725985|11991051|FG000|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825705|NCT00725985|11991052|FG001|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825706|NCT00725985|11991053|FG002|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825707|NCT00725985|11991054|FG003|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825708|NCT00725985|11991055|FG004|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825709|NCT00725985|11991056|FG005|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825710|NCT00725985|11991057|FG006|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||9
10825711|NCT00725985|11991058|FG007|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||9
10825712|NCT00725985|11991059|FG008|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||17
10825713|NCT00725985|11991060|FG009|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825714|NCT00725985|11991061|FG010|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825715|NCT00725985|11991062|FG011|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825716|NCT00725985|11991051|FG000|STARTED|LTFU (No Cladribine) (48 Weeks)||0
10825717|NCT00725985|11991052|FG001|STARTED|LTFU (No Cladribine) (48 Weeks)||0
10825718|NCT00725985|11991053|FG002|STARTED|LTFU (No Cladribine) (48 Weeks)||0
10825719|NCT00725985|11991054|FG003|STARTED|LTFU (No Cladribine) (48 Weeks)||0
10825720|NCT00725985|11991055|FG004|STARTED|LTFU (No Cladribine) (48 Weeks)||0
10825721|NCT00725985|11991056|FG005|STARTED|LTFU (No Cladribine) (48 Weeks)||0
10825722|NCT00725985|11991057|FG006|STARTED|LTFU (No Cladribine) (48 Weeks)||0
10825723|NCT00725985|11991058|FG007|STARTED|LTFU (No Cladribine) (48 Weeks)||0
10825724|NCT00725985|11991059|FG008|STARTED|LTFU (No Cladribine) (48 Weeks)||0
10825725|NCT00725985|11991060|FG009|STARTED|LTFU (No Cladribine) (48 Weeks)||34
10825726|NCT00725985|11991061|FG010|STARTED|LTFU (No Cladribine) (48 Weeks)||36
10825727|NCT00725985|11991062|FG011|STARTED|LTFU (No Cladribine) (48 Weeks)||14
10825728|NCT00725985|11991051|FG000|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10825729|NCT00725985|11991052|FG001|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10825730|NCT00725985|11991053|FG002|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10825731|NCT00725985|11991054|FG003|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10825732|NCT00725985|11991055|FG004|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10825733|NCT00725985|11991056|FG005|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10825734|NCT00725985|11991057|FG006|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10825735|NCT00725985|11991058|FG007|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10825736|NCT00725985|11991059|FG008|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10825737|NCT00725985|11991060|FG009|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10825738|NCT00725985|11991061|FG010|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10825739|NCT00725985|11991062|FG011|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10825740|NCT00725985|11991051|FG000|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10825741|NCT00725985|11991052|FG001|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10825742|NCT00725985|11991053|FG002|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10825743|NCT00725985|11991054|FG003|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10825744|NCT00725985|11991055|FG004|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10825745|NCT00725985|11991056|FG005|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10825746|NCT00725985|11991057|FG006|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10825747|NCT00725985|11991058|FG007|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10825748|NCT00725985|11991059|FG008|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10825749|NCT00725985|11991060|FG009|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||34
10825750|NCT00725985|11991061|FG010|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||36
10825751|NCT00725985|11991062|FG011|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||14
10408902|NCT00757601|11552967|FG006|NOT COMPLETED|Period 3||0
10408903|NCT00757601|11552968|FG007|NOT COMPLETED|Period 3||0
10408904|NCT00757601|11552969|FG008|NOT COMPLETED|Period 3||0
10408905|NCT00757601|11552970|FG009|NOT COMPLETED|Period 3||0
10408906|NCT00757601|11552971|FG010|NOT COMPLETED|Period 3||0
10408907|NCT00757601|11552972|FG011|NOT COMPLETED|Period 3||0
10408908|NCT00757601|11552961|FG000|STARTED|Period 4||2
10408909|NCT00757601|11552962|FG001|STARTED|Period 4||2
10408910|NCT00757601|11552963|FG002|STARTED|Period 4||2
10408911|NCT00757601|11552964|FG003|STARTED|Period 4||2
10408912|NCT00757601|11552965|FG004|STARTED|Period 4||2
10825752|NCT04860258|11991095|FG000|STARTED|Overall Study||1
10825753|NCT04860258|11991096|FG001|STARTED|Overall Study||1
10825754|NCT04860258|11991097|FG002|STARTED|Overall Study||52
10825755|NCT04860258|11991098|FG003|STARTED|Overall Study||33
10825756|NCT04860258|11991099|FG004|STARTED|Overall Study||33
10825757|NCT04860258|11991100|FG005|STARTED|Overall Study||7
10825758|NCT04860258|11991101|FG006|STARTED|Overall Study||2
10825759|NCT04860258|11991095|FG000|COMPLETED|Overall Study||1
10825760|NCT04860258|11991096|FG001|COMPLETED|Overall Study||1
10825761|NCT04860258|11991097|FG002|COMPLETED|Overall Study||48
10825762|NCT04860258|11991098|FG003|COMPLETED|Overall Study||32
10825763|NCT04860258|11991099|FG004|COMPLETED|Overall Study||29
10825764|NCT04860258|11991100|FG005|COMPLETED|Overall Study||6
10825765|NCT04860258|11991101|FG006|COMPLETED|Overall Study||2
10825766|NCT04860258|11991095|FG000|NOT COMPLETED|Overall Study||0
10825767|NCT04860258|11991096|FG001|NOT COMPLETED|Overall Study||0
10825768|NCT04860258|11991097|FG002|NOT COMPLETED|Overall Study||4
10825769|NCT04860258|11991098|FG003|NOT COMPLETED|Overall Study||1
10825770|NCT04860258|11991099|FG004|NOT COMPLETED|Overall Study||4
10825771|NCT04860258|11991100|FG005|NOT COMPLETED|Overall Study||1
10825772|NCT04860258|11991101|FG006|NOT COMPLETED|Overall Study||0
10825788|NCT04318210|11991121|FG000|STARTED|Overall Study||229
10825789|NCT04318210|11991121|FG000|COMPLETED|Overall Study||153
10825790|NCT04318210|11991121|FG000|NOT COMPLETED|Overall Study||76
10825791|NCT04237207|11991127|FG000|STARTED|Overall Study|Due to differences in speed of enrollment between the two cohorts and the delay in enrollment due to the Coronavirus (COVID-19) pandemic, enrollment for the electric only cohort was capped at 10 subjects, which exceeds the minimum sample size of 8 subjects per cohort.|10
10825792|NCT04237207|11991128|FG001|STARTED|Overall Study||12
10825793|NCT04237207|11991127|FG000|COMPLETED|Overall Study||10
10825794|NCT04237207|11991128|FG001|COMPLETED|Overall Study||12
10825795|NCT04237207|11991127|FG000|NOT COMPLETED|Overall Study||0
10825796|NCT04237207|11991128|FG001|NOT COMPLETED|Overall Study||0
10825797|NCT03787303|11991134|FG000|STARTED|Overall Study||7
10825798|NCT03787303|11991134|FG000|COMPLETED|Overall Study||5
10825799|NCT03787303|11991134|FG000|NOT COMPLETED|Overall Study||2
10825800|NCT03702283|11991138|FG000|STARTED|Overall Study|Recruitment and observation began on March 31, 2019|205
10825801|NCT03702283|11991138|FG000|COMPLETED|Overall Study|Recruitment and observation ended on March 31, 2021|205
10825802|NCT03702283|11991138|FG000|NOT COMPLETED|Overall Study||0
10825803|NCT03673098|11991144|FG000|STARTED|Overall Study||23
10825804|NCT03673098|11991145|FG001|STARTED|Overall Study||21
10825805|NCT03673098|11991144|FG000|COMPLETED|Overall Study||13
10825806|NCT03673098|11991145|FG001|COMPLETED|Overall Study||17
10825807|NCT03673098|11991144|FG000|NOT COMPLETED|Overall Study||10
10825808|NCT03673098|11991145|FG001|NOT COMPLETED|Overall Study||4
10825809|NCT03520569|11991158|FG000|STARTED|Overall Study||15
10825810|NCT03520569|11991158|FG000|Octreotide-Euglycemia|Overall Study||13
10825811|NCT03520569|11991158|FG000|Octreotide-Euglycemia-Insulin Clamp|Overall Study||14
10825812|NCT03520569|11991158|FG000|Octreotide-Hyperglycemia|Overall Study||10
10825813|NCT03520569|11991158|FG000|Octreotide-Hyperglycemia-Insulin Clamp|Overall Study||12
10825814|NCT03520569|11991158|FG000|COMPLETED|Overall Study||14
10825815|NCT03520569|11991158|FG000|NOT COMPLETED|Overall Study||1
10825816|NCT03499899|11991171|FG000|STARTED|Overall Study||20
10825817|NCT03499899|11991172|FG001|STARTED|Overall Study||34
10825818|NCT03499899|11991173|FG002|STARTED|Overall Study||34
10825819|NCT03499899|11991171|FG000|COMPLETED|Overall Study||0
10408913|NCT00757601|11552966|FG005|STARTED|Period 4||2
10825820|NCT03499899|11991172|FG001|COMPLETED|Overall Study||0
10825821|NCT03499899|11991173|FG002|COMPLETED|Overall Study||0
10825822|NCT03499899|11991171|FG000|NOT COMPLETED|Overall Study||20
10825823|NCT03499899|11991172|FG001|NOT COMPLETED|Overall Study||34
10825824|NCT03499899|11991173|FG002|NOT COMPLETED|Overall Study||34
10408914|NCT00757601|11552967|FG006|STARTED|Period 4||2
10408915|NCT00757601|11552968|FG007|STARTED|Period 4||2
10825831|NCT03419741|11991192|FG000|STARTED|Overall Study||5
10825832|NCT03419741|11991193|FG001|STARTED|Overall Study||6
10825833|NCT03419741|11991192|FG000|Treated|Overall Study||4
10825834|NCT03419741|11991193|FG001|Treated|Overall Study||4
10825835|NCT03419741|11991192|FG000|COMPLETED|Overall Study||3
10825836|NCT03419741|11991193|FG001|COMPLETED|Overall Study||4
10825837|NCT03419741|11991192|FG000|NOT COMPLETED|Overall Study||2
10825838|NCT03419741|11991193|FG001|NOT COMPLETED|Overall Study||2
10825839|NCT03401918|11991201|FG000|STARTED|Overall Study||25
10825840|NCT03401918|11991202|FG001|STARTED|Overall Study||16
10825841|NCT03401918|11991201|FG000|COMPLETED|Overall Study||25
10825842|NCT03401918|11991202|FG001|COMPLETED|Overall Study||16
10825843|NCT03401918|11991201|FG000|NOT COMPLETED|Overall Study||0
10825844|NCT03401918|11991202|FG001|NOT COMPLETED|Overall Study||0
10290645|NCT01925131|11423384|FG005|STARTED|Overall Study||13
10290646|NCT01925131|11423379|FG000|COMPLETED|Overall Study||0
10290647|NCT01925131|11423380|FG001|COMPLETED|Overall Study||2
10290648|NCT01925131|11423381|FG002|COMPLETED|Overall Study||1
10290649|NCT01925131|11423382|FG003|COMPLETED|Overall Study||0
10290650|NCT01925131|11423383|FG004|COMPLETED|Overall Study||0
10290651|NCT01925131|11423384|FG005|COMPLETED|Overall Study||3
10290652|NCT01925131|11423379|FG000|NOT COMPLETED|Overall Study||5
10290653|NCT01925131|11423380|FG001|NOT COMPLETED|Overall Study||2
10290654|NCT01925131|11423381|FG002|NOT COMPLETED|Overall Study||9
10290655|NCT01925131|11423382|FG003|NOT COMPLETED|Overall Study||5
10290656|NCT01925131|11423383|FG004|NOT COMPLETED|Overall Study||11
10290657|NCT01925131|11423384|FG005|NOT COMPLETED|Overall Study||10
10290658|NCT01776307|11423403|FG000|STARTED|Overall Study||49
10290659|NCT01776307|11423404|FG001|STARTED|Overall Study||75
10290660|NCT01776307|11423405|FG002|STARTED|Overall Study||76
10290661|NCT01776307|11423403|FG000|COMPLETED|Overall Study||49
10290662|NCT01776307|11423404|FG001|COMPLETED|Overall Study||75
10290663|NCT01776307|11423405|FG002|COMPLETED|Overall Study||75
10290664|NCT01776307|11423403|FG000|NOT COMPLETED|Overall Study||0
10290665|NCT01776307|11423404|FG001|NOT COMPLETED|Overall Study||0
10290666|NCT01776307|11423405|FG002|NOT COMPLETED|Overall Study||1
10290667|NCT01623167|11423437|FG000|STARTED|Overall Study||30
10290668|NCT01623167|11423438|FG001|STARTED|Overall Study||31
10290669|NCT01623167|11423439|FG002|STARTED|Overall Study||31
10408916|NCT00757601|11552969|FG008|STARTED|Period 4||2
10408917|NCT00757601|11552970|FG009|STARTED|Period 4||2
10290670|NCT01623167|11423437|FG000|COMPLETED|Overall Study||13
10290671|NCT01623167|11423438|FG001|COMPLETED|Overall Study||17
10290672|NCT01623167|11423439|FG002|COMPLETED|Overall Study||18
10290673|NCT01623167|11423437|FG000|NOT COMPLETED|Overall Study||17
10290674|NCT01623167|11423438|FG001|NOT COMPLETED|Overall Study||14
10290675|NCT01623167|11423439|FG002|NOT COMPLETED|Overall Study||13
10290676|NCT01535274|11423449|FG000|STARTED|Overall Study||28
10290677|NCT01535274|11423450|FG001|STARTED|Overall Study|"29 participants were initially randomized to receive desflurane treatment. One participant initially randomized to the desflurane arm was misallocated to the propofol arm and received propofol treatment, as shown in the reason not completed section below."|29
10290678|NCT01535274|11423449|FG000|Received Propofol|Overall Study||28
10290679|NCT01535274|11423450|FG001|Received Propofol|Overall Study|"Of the 29 participants initially randomized to receive desflurane treatment, one was misallocated to the propofol arm and received propofol treatment, as shown in the reason not completed section below. That participant is included in the baseline characteristics, outcome measures, and adverse events with the propofol arm."|1
10290680|NCT01535274|11423449|FG000|Received Desflurane|Overall Study||0
10290681|NCT01535274|11423450|FG001|Received Desflurane|Overall Study||28
10290682|NCT01535274|11423449|FG000|COMPLETED|Overall Study||28
10408918|NCT00757601|11552971|FG010|STARTED|Period 4||2
10825845|NCT02704156|11991210|FG000|STARTED|Overall Study||85
10825846|NCT02704156|11991211|FG001|STARTED|Overall Study||85
10825847|NCT02704156|11991210|FG000|COMPLETED|Overall Study||85
10825848|NCT02704156|11991211|FG001|COMPLETED|Overall Study||85
10825849|NCT02704156|11991210|FG000|NOT COMPLETED|Overall Study||0
10825850|NCT02704156|11991211|FG001|NOT COMPLETED|Overall Study||0
10825851|NCT02688530|11991221|FG000|STARTED|Overall Study||35
10825852|NCT02688530|11991222|FG001|STARTED|Overall Study||35
10825853|NCT02688530|11991223|FG002|STARTED|Overall Study||35
10825854|NCT02688530|11991224|FG003|STARTED|Overall Study||35
10825855|NCT02688530|11991221|FG000|COMPLETED|Overall Study||35
10825856|NCT02688530|11991222|FG001|COMPLETED|Overall Study||34
10825857|NCT02688530|11991223|FG002|COMPLETED|Overall Study||33
10825858|NCT02688530|11991224|FG003|COMPLETED|Overall Study||35
10825859|NCT02688530|11991221|FG000|NOT COMPLETED|Overall Study||0
10825860|NCT02688530|11991222|FG001|NOT COMPLETED|Overall Study||1
10825861|NCT02688530|11991223|FG002|NOT COMPLETED|Overall Study||2
10825862|NCT02688530|11991224|FG003|NOT COMPLETED|Overall Study||0
10825869|NCT02383966|11991250|FG000|STARTED|Overall Study||164
10825870|NCT02383966|11991251|FG001|STARTED|Overall Study||79
10825871|NCT02383966|11991250|FG000|COMPLETED|Overall Study||138
10825872|NCT02383966|11991251|FG001|COMPLETED|Overall Study||72
10825873|NCT02383966|11991250|FG000|NOT COMPLETED|Overall Study||26
10825874|NCT02383966|11991251|FG001|NOT COMPLETED|Overall Study||7
10825875|NCT02073565|11991259|FG000|STARTED|Intention-To-Treat Subjects-Cohorts AB&C||287
10825876|NCT02073565|11991260|FG001|STARTED|Intention-To-Treat Subjects-Cohorts AB&C||285
10825877|NCT02073565|11991259|FG000|COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||285
10825878|NCT02073565|11991260|FG001|COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||279
10825879|NCT02073565|11991259|FG000|NOT COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||2
10825880|NCT02073565|11991260|FG001|NOT COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||6
10825881|NCT02073565|11991259|FG000|STARTED|Cohort A||16
10825882|NCT02073565|11991260|FG001|STARTED|Cohort A||14
10825883|NCT02073565|11991259|FG000|COMPLETED|Cohort A||15
10825884|NCT02073565|11991260|FG001|COMPLETED|Cohort A||14
10825885|NCT02073565|11991259|FG000|NOT COMPLETED|Cohort A||1
10825886|NCT02073565|11991260|FG001|NOT COMPLETED|Cohort A||0
10825887|NCT02073565|11991259|FG000|STARTED|Cohort B||54
10825888|NCT02073565|11991260|FG001|STARTED|Cohort B||56
10825889|NCT02073565|11991259|FG000|COMPLETED|Cohort B||53
10825890|NCT02073565|11991260|FG001|COMPLETED|Cohort B||54
10825891|NCT02073565|11991259|FG000|NOT COMPLETED|Cohort B||1
10825892|NCT02073565|11991260|FG001|NOT COMPLETED|Cohort B||2
10825893|NCT02073565|11991259|FG000|STARTED|Cohort C||217
10825894|NCT02073565|11991260|FG001|STARTED|Cohort C||215
10825895|NCT02073565|11991259|FG000|COMPLETED|Cohort C||217
10825896|NCT02073565|11991260|FG001|COMPLETED|Cohort C||211
10825897|NCT02073565|11991259|FG000|NOT COMPLETED|Cohort C||0
10825898|NCT02073565|11991260|FG001|NOT COMPLETED|Cohort C||4
10825899|NCT02060487|11991269|FG000|STARTED|Overall Study||129
10825900|NCT02060487|11991270|FG001|STARTED|Overall Study||128
10825901|NCT02060487|11991271|FG002|STARTED|Overall Study||128
10825902|NCT02060487|11991269|FG000|COMPLETED|Overall Study||0
10825903|NCT02060487|11991270|FG001|COMPLETED|Overall Study||0
10825904|NCT02060487|11991271|FG002|COMPLETED|Overall Study||0
10825905|NCT02060487|11991269|FG000|NOT COMPLETED|Overall Study||129
10825906|NCT02060487|11991270|FG001|NOT COMPLETED|Overall Study||128
10825907|NCT02060487|11991271|FG002|NOT COMPLETED|Overall Study||128
10825908|NCT00732212|11991283|FG000|STARTED|Overall Study||112
10825909|NCT00732212|11991284|FG001|STARTED|Overall Study||123
10825910|NCT00732212|11991283|FG000|Temporarily Suspended|Overall Study|Study was suspended for a 9 month period by the VA DMC because of slow enrollment, then restarted.|50
10825911|NCT00732212|11991284|FG001|Temporarily Suspended|Overall Study||50
10825912|NCT00732212|11991283|FG000|COMPLETED|Overall Study||112
10825913|NCT00732212|11991284|FG001|COMPLETED|Overall Study||123
10825914|NCT00732212|11991283|FG000|NOT COMPLETED|Overall Study||0
10825915|NCT00732212|11991284|FG001|NOT COMPLETED|Overall Study||0
10825916|NCT00331773|11991316|FG000|STARTED|Overall Study||558
10825917|NCT00331773|11991317|FG001|STARTED|Overall Study||557
10825918|NCT00331773|11991316|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|542
10825919|NCT00331773|11991317|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|550
10825920|NCT00331773|11991316|FG000|NOT COMPLETED|Overall Study||16
10825921|NCT00331773|11991317|FG001|NOT COMPLETED|Overall Study||7
10825922|NCT00321698|11991329|FG000|STARTED|Phase I, Rad Only & Dose 1-3||3
10825923|NCT00321698|11991330|FG001|STARTED|Phase I, Rad Only & Dose 1-3||3
10825924|NCT00321698|11991331|FG002|STARTED|Phase I, Rad Only & Dose 1-3||3
10825925|NCT00321698|11991332|FG003|STARTED|Phase I, Rad Only & Dose 1-3||3
10825926|NCT00321698|11991333|FG004|STARTED|Phase I, Rad Only & Dose 1-3||0
10825927|NCT00321698|11991329|FG000|COMPLETED|Phase I, Rad Only & Dose 1-3||3
10825928|NCT00321698|11991330|FG001|COMPLETED|Phase I, Rad Only & Dose 1-3||3
10825929|NCT00321698|11991331|FG002|COMPLETED|Phase I, Rad Only & Dose 1-3||3
10825930|NCT00321698|11991332|FG003|COMPLETED|Phase I, Rad Only & Dose 1-3||3
10825931|NCT00321698|11991333|FG004|COMPLETED|Phase I, Rad Only & Dose 1-3||0
10825932|NCT00321698|11991329|FG000|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
10825933|NCT00321698|11991330|FG001|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
10825934|NCT00321698|11991331|FG002|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
10825935|NCT00321698|11991332|FG003|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
10825936|NCT00321698|11991333|FG004|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
10825937|NCT00321698|11991329|FG000|STARTED|Phase II, MTD Dose||0
10825938|NCT00321698|11991330|FG001|STARTED|Phase II, MTD Dose||0
10825939|NCT00321698|11991331|FG002|STARTED|Phase II, MTD Dose||0
10825940|NCT00321698|11991332|FG003|STARTED|Phase II, MTD Dose||0
10825941|NCT00321698|11991333|FG004|STARTED|Phase II, MTD Dose|+1 screen failure|13
10825942|NCT00321698|11991329|FG000|COMPLETED|Phase II, MTD Dose||0
10825943|NCT00321698|11991330|FG001|COMPLETED|Phase II, MTD Dose||0
10825944|NCT00321698|11991331|FG002|COMPLETED|Phase II, MTD Dose||0
10825945|NCT00321698|11991332|FG003|COMPLETED|Phase II, MTD Dose||0
10825946|NCT00321698|11991333|FG004|COMPLETED|Phase II, MTD Dose||13
10825947|NCT00321698|11991329|FG000|NOT COMPLETED|Phase II, MTD Dose||0
10825948|NCT00321698|11991330|FG001|NOT COMPLETED|Phase II, MTD Dose||0
10825949|NCT00321698|11991331|FG002|NOT COMPLETED|Phase II, MTD Dose||0
10825950|NCT00321698|11991332|FG003|NOT COMPLETED|Phase II, MTD Dose||0
10825951|NCT00321698|11991333|FG004|NOT COMPLETED|Phase II, MTD Dose||0
10825952|NCT05343156|11991347|FG000|STARTED|Overall Study||99
10825953|NCT05343156|11991348|FG001|STARTED|Overall Study||45
10825954|NCT05343156|11991347|FG000|COMPLETED|Overall Study||91
10825955|NCT05343156|11991348|FG001|COMPLETED|Overall Study||42
10825956|NCT05343156|11991347|FG000|NOT COMPLETED|Overall Study||8
10825957|NCT05343156|11991348|FG001|NOT COMPLETED|Overall Study||3
10825958|NCT04913636|11991356|FG000|STARTED|Overall Study||18
10825959|NCT04913636|11991357|FG001|STARTED|Overall Study||20
10825960|NCT04913636|11991356|FG000|COMPLETED|Overall Study||18
10825961|NCT04913636|11991357|FG001|COMPLETED|Overall Study||20
10825962|NCT04913636|11991356|FG000|NOT COMPLETED|Overall Study||0
10825963|NCT04913636|11991357|FG001|NOT COMPLETED|Overall Study||0
10825964|NCT04882995|11991365|FG000|STARTED|Overall Study||41
10825965|NCT04882995|11991366|FG001|STARTED|Overall Study||43
10825966|NCT04882995|11991365|FG000|COMPLETED|Overall Study||35
10825967|NCT04882995|11991366|FG001|COMPLETED|Overall Study||36
10825968|NCT04882995|11991365|FG000|NOT COMPLETED|Overall Study||6
10825969|NCT04882995|11991366|FG001|NOT COMPLETED|Overall Study||7
10825970|NCT04707573|11991374|FG000|STARTED|Overall Study||10
10825971|NCT04707573|11991375|FG001|STARTED|Overall Study||12
10825972|NCT04707573|11991374|FG000|COMPLETED|Overall Study||10
10825973|NCT04707573|11991375|FG001|COMPLETED|Overall Study||12
10825974|NCT04707573|11991374|FG000|NOT COMPLETED|Overall Study||0
10825975|NCT04707573|11991375|FG001|NOT COMPLETED|Overall Study||0
10825976|NCT04640168|11991383|FG000|STARTED|Overall Study||516
10825977|NCT04640168|11991384|FG001|STARTED|Overall Study||494
10825978|NCT04640168|11991383|FG000|Treated|Overall Study||503
10825979|NCT04640168|11991384|FG001|Treated|Overall Study||482
10825980|NCT04640168|11991383|FG000|ITT and Modified ITT Population|Overall Study||516
10825981|NCT04640168|11991384|FG001|ITT and Modified ITT Population|Overall Study||494
10825982|NCT04640168|11991383|FG000|As Treated Population|Overall Study||503
10825983|NCT04640168|11991384|FG001|As Treated Population|Overall Study||482
10825984|NCT04640168|11991383|FG000|COMPLETED|Overall Study||495
10825985|NCT04640168|11991384|FG001|COMPLETED|Overall Study||475
10825986|NCT04640168|11991383|FG000|NOT COMPLETED|Overall Study||21
10825987|NCT04640168|11991384|FG001|NOT COMPLETED|Overall Study||19
10825988|NCT04465630|11991390|FG000|STARTED|Overall Study||78
10825989|NCT04465630|11991390|FG000|COMPLETED|Overall Study||0
10825990|NCT04465630|11991390|FG000|NOT COMPLETED|Overall Study||78
10825991|NCT04459598|11991397|FG000|STARTED|Overall Study||16
10825992|NCT04459598|11991398|FG001|STARTED|Overall Study||16
10825993|NCT04459598|11991397|FG000|COMPLETED|Overall Study||15
10825994|NCT04459598|11991398|FG001|COMPLETED|Overall Study||15
10825995|NCT04459598|11991397|FG000|NOT COMPLETED|Overall Study||1
10825996|NCT04459598|11991398|FG001|NOT COMPLETED|Overall Study||1
10826015|NCT04387136|11991422|FG000|STARTED|Overall Study||26
10826016|NCT04387136|11991423|FG001|STARTED|Overall Study||27
10826017|NCT04387136|11991422|FG000|COMPLETED|Overall Study||25
10826018|NCT04387136|11991423|FG001|COMPLETED|Overall Study||25
10826019|NCT04387136|11991422|FG000|NOT COMPLETED|Overall Study||1
10826020|NCT04387136|11991423|FG001|NOT COMPLETED|Overall Study||2
10826021|NCT04351269|11991432|FG000|STARTED|Overall Study||237
10826022|NCT04351269|11991433|FG001|STARTED|Overall Study||260
10826023|NCT04351269|11991434|FG002|STARTED|Overall Study||100
10826024|NCT04351269|11991432|FG000|COMPLETED|Overall Study||165
10826025|NCT04351269|11991433|FG001|COMPLETED|Overall Study||219
10826026|NCT04351269|11991434|FG002|COMPLETED|Overall Study||71
10826027|NCT04351269|11991432|FG000|NOT COMPLETED|Overall Study||72
10826028|NCT04351269|11991433|FG001|NOT COMPLETED|Overall Study||41
10826029|NCT04351269|11991434|FG002|NOT COMPLETED|Overall Study||29
10826030|NCT04292301|11991445|FG000|STARTED|Overall Study||92
10826031|NCT04292301|11991445|FG000|COMPLETED|Overall Study||89
10826032|NCT04292301|11991445|FG000|NOT COMPLETED|Overall Study||3
10826033|NCT04285229|11991451|FG000|STARTED|Overall Study||73
10826034|NCT04285229|11991452|FG001|STARTED|Overall Study||74
10826035|NCT04285229|11991451|FG000|Received at Least One Dose of Study Drug|Overall Study||73
10826036|NCT04285229|11991452|FG001|Received at Least One Dose of Study Drug|Overall Study||74
10826037|NCT04285229|11991451|FG000|COMPLETED|Overall Study||70
10826038|NCT04285229|11991452|FG001|COMPLETED|Overall Study||72
10826039|NCT04285229|11991451|FG000|NOT COMPLETED|Overall Study||3
10826040|NCT04285229|11991452|FG001|NOT COMPLETED|Overall Study||2
10826041|NCT04148521|11991463|FG000|STARTED|Overall Study||534
10826042|NCT04148521|11991464|FG001|STARTED|Overall Study||555
10826043|NCT04148521|11991463|FG000|COMPLETED|Overall Study||534
10826044|NCT04148521|11991464|FG001|COMPLETED|Overall Study||555
10826045|NCT04148521|11991463|FG000|NOT COMPLETED|Overall Study||0
10826046|NCT04148521|11991464|FG001|NOT COMPLETED|Overall Study||0
10826047|NCT03897348|11991474|FG000|STARTED|ADP Session 1||1
10826048|NCT03897348|11991475|FG001|STARTED|ADP Session 1||1
10826049|NCT03897348|11991476|FG002|STARTED|ADP Session 1||1
10826050|NCT03897348|11991477|FG003|STARTED|ADP Session 1||1
10826051|NCT03897348|11991474|FG000|COMPLETED|ADP Session 1||1
10826052|NCT03897348|11991475|FG001|COMPLETED|ADP Session 1||1
10826053|NCT03897348|11991476|FG002|COMPLETED|ADP Session 1||1
10826054|NCT03897348|11991477|FG003|COMPLETED|ADP Session 1||1
10826055|NCT03897348|11991474|FG000|NOT COMPLETED|ADP Session 1||0
10826056|NCT03897348|11991475|FG001|NOT COMPLETED|ADP Session 1||0
10826057|NCT03897348|11991476|FG002|NOT COMPLETED|ADP Session 1||0
10826058|NCT03897348|11991477|FG003|NOT COMPLETED|ADP Session 1||0
10826059|NCT03897348|11991474|FG000|STARTED|ADP Session 2||1
10826060|NCT03897348|11991475|FG001|STARTED|ADP Session 2||1
10826061|NCT03897348|11991476|FG002|STARTED|ADP Session 2||1
10826062|NCT03897348|11991477|FG003|STARTED|ADP Session 2||1
10826063|NCT03897348|11991474|FG000|COMPLETED|ADP Session 2||1
10826064|NCT03897348|11991475|FG001|COMPLETED|ADP Session 2||1
10826065|NCT03897348|11991476|FG002|COMPLETED|ADP Session 2||1
10826066|NCT03897348|11991477|FG003|COMPLETED|ADP Session 2||1
10826067|NCT03897348|11991474|FG000|NOT COMPLETED|ADP Session 2||0
10826068|NCT03897348|11991475|FG001|NOT COMPLETED|ADP Session 2||0
10826069|NCT03897348|11991476|FG002|NOT COMPLETED|ADP Session 2||0
10826070|NCT03897348|11991477|FG003|NOT COMPLETED|ADP Session 2||0
10826071|NCT03897348|11991474|FG000|STARTED|ADP Session 3||1
10826072|NCT03897348|11991475|FG001|STARTED|ADP Session 3||1
10826073|NCT03897348|11991476|FG002|STARTED|ADP Session 3||0
10826074|NCT03897348|11991477|FG003|STARTED|ADP Session 3||1
10826075|NCT03897348|11991474|FG000|COMPLETED|ADP Session 3||1
10826076|NCT03897348|11991475|FG001|COMPLETED|ADP Session 3||1
10826077|NCT03897348|11991476|FG002|COMPLETED|ADP Session 3||0
10826078|NCT03897348|11991477|FG003|COMPLETED|ADP Session 3||1
10826079|NCT03897348|11991474|FG000|NOT COMPLETED|ADP Session 3||0
10826080|NCT03897348|11991475|FG001|NOT COMPLETED|ADP Session 3||0
10826081|NCT03897348|11991476|FG002|NOT COMPLETED|ADP Session 3||0
10826082|NCT03897348|11991477|FG003|NOT COMPLETED|ADP Session 3||0
10826092|NCT03668808|11991502|FG000|STARTED|First Intervention||13
10826093|NCT03668808|11991503|FG001|STARTED|First Intervention||12
10826094|NCT03668808|11991502|FG000|COMPLETED|First Intervention||11
10826095|NCT03668808|11991503|FG001|COMPLETED|First Intervention||10
10826096|NCT03668808|11991502|FG000|NOT COMPLETED|First Intervention||2
10826097|NCT03668808|11991503|FG001|NOT COMPLETED|First Intervention||2
10826098|NCT03668808|11991502|FG000|STARTED|Washout Period||11
10826099|NCT03668808|11991503|FG001|STARTED|Washout Period||10
10826100|NCT03668808|11991502|FG000|COMPLETED|Washout Period||11
10826101|NCT03668808|11991503|FG001|COMPLETED|Washout Period||10
10826102|NCT03668808|11991502|FG000|NOT COMPLETED|Washout Period||0
10826103|NCT03668808|11991503|FG001|NOT COMPLETED|Washout Period||0
10826104|NCT03668808|11991502|FG000|STARTED|Second Intervention||11
10826105|NCT03668808|11991503|FG001|STARTED|Second Intervention||10
10826106|NCT03668808|11991502|FG000|COMPLETED|Second Intervention||11
10826107|NCT03668808|11991503|FG001|COMPLETED|Second Intervention||10
10826108|NCT03668808|11991502|FG000|NOT COMPLETED|Second Intervention||0
10826109|NCT03668808|11991503|FG001|NOT COMPLETED|Second Intervention||0
10826110|NCT03658642|11991513|FG000|STARTED|Patients||2787
10826111|NCT03658642|11991514|FG001|STARTED|Patients||2260
10826112|NCT03658642|11991513|FG000|COMPLETED|Patients||2787
10826113|NCT03658642|11991514|FG001|COMPLETED|Patients||2260
10826114|NCT03658642|11991513|FG000|NOT COMPLETED|Patients||0
10826115|NCT03658642|11991514|FG001|NOT COMPLETED|Patients||0
10826116|NCT03658642|11991513|FG000|STARTED|Physicians|A total of 599 physicians were also included in the study.|340
10826117|NCT03658642|11991514|FG001|STARTED|Physicians|A total of 599 physicians were also included in the study.|259
10826118|NCT03658642|11991513|FG000|COMPLETED|Physicians||340
10826119|NCT03658642|11991514|FG001|COMPLETED|Physicians||259
10826120|NCT03658642|11991513|FG000|NOT COMPLETED|Physicians||0
10826121|NCT03658642|11991514|FG001|NOT COMPLETED|Physicians||0
10826122|NCT03656874|11991522|FG000|STARTED|Overall Study||13
10826123|NCT03656874|11991523|FG001|STARTED|Overall Study||43
10826124|NCT03656874|11991522|FG000|COMPLETED|Overall Study||10
10826125|NCT03656874|11991523|FG001|COMPLETED|Overall Study||26
10826126|NCT03656874|11991522|FG000|NOT COMPLETED|Overall Study||3
10826127|NCT03656874|11991523|FG001|NOT COMPLETED|Overall Study||17
10826128|NCT03584009|11991531|FG000|STARTED|Overall Study||51
10826129|NCT03584009|11991532|FG001|STARTED|Overall Study||52
10826130|NCT03584009|11991531|FG000|COMPLETED|Overall Study||0
10826131|NCT03584009|11991532|FG001|COMPLETED|Overall Study||0
10826132|NCT03584009|11991531|FG000|NOT COMPLETED|Overall Study||51
10826133|NCT03584009|11991532|FG001|NOT COMPLETED|Overall Study||52
10826134|NCT03583359|11991543|FG000|STARTED|Overall Study||123
10826135|NCT03583359|11991544|FG001|STARTED|Overall Study||57
10826136|NCT03583359|11991543|FG000|Treated Participants|Overall Study||122
10826137|NCT03583359|11991544|FG001|Treated Participants|Overall Study||53
10826138|NCT03583359|11991543|FG000|COMPLETED|Overall Study||94
10826139|NCT03583359|11991544|FG001|COMPLETED|Overall Study||45
10826140|NCT03583359|11991543|FG000|NOT COMPLETED|Overall Study||29
10826141|NCT03583359|11991544|FG001|NOT COMPLETED|Overall Study||12
10826160|NCT03557307|11991578|FG000|STARTED|To End of OCS Reduction Phase||598
10826161|NCT03557307|11991578|FG000|COMPLETED|To End of OCS Reduction Phase||563
10826162|NCT03557307|11991578|FG000|NOT COMPLETED|To End of OCS Reduction Phase||35
10826163|NCT03557307|11991578|FG000|STARTED|Maintenance Phase||563
10826164|NCT03557307|11991578|FG000|COMPLETED|Maintenance Phase||536
10826165|NCT03557307|11991578|FG000|NOT COMPLETED|Maintenance Phase||27
10826166|NCT03492463|11991586|FG000|STARTED|Overall Study||37
10826167|NCT03492463|11991587|FG001|STARTED|Overall Study||33
10826168|NCT03492463|11991588|FG002|STARTED|Overall Study||11
10826169|NCT03492463|11991589|FG003|STARTED|Overall Study||13
10826170|NCT03492463|11991586|FG000|COMPLETED|Overall Study||26
10826171|NCT03492463|11991587|FG001|COMPLETED|Overall Study||19
10826172|NCT03492463|11991588|FG002|COMPLETED|Overall Study||7
10826173|NCT03492463|11991589|FG003|COMPLETED|Overall Study||10
10826174|NCT03492463|11991586|FG000|NOT COMPLETED|Overall Study||11
10826175|NCT03492463|11991587|FG001|NOT COMPLETED|Overall Study||14
10826176|NCT03492463|11991588|FG002|NOT COMPLETED|Overall Study||4
10826177|NCT03492463|11991589|FG003|NOT COMPLETED|Overall Study||3
10826178|NCT03417687|11991601|FG000|STARTED|Overall Study|4 subjects were randomized to the 129Xe before 133Xe group but discontinued prior to receiving the first treatment.|18
10826179|NCT03417687|11991602|FG001|STARTED|Overall Study||20
10408919|NCT00757601|11552972|FG011|STARTED|Period 4||2
10408920|NCT00757601|11552961|FG000|COMPLETED|Period 4||2
10408921|NCT00757601|11552962|FG001|COMPLETED|Period 4||2
10408922|NCT00757601|11552963|FG002|COMPLETED|Period 4||2
10408923|NCT00757601|11552964|FG003|COMPLETED|Period 4||2
10408924|NCT00757601|11552965|FG004|COMPLETED|Period 4||2
10408925|NCT00757601|11552966|FG005|COMPLETED|Period 4||2
10826180|NCT03417687|11991601|FG000|Received 129Xe|Overall Study||14
10826181|NCT03417687|11991602|FG001|Received 129Xe|Overall Study||20
10826182|NCT03417687|11991601|FG000|Received 133Xe|Overall Study||13
10826183|NCT03417687|11991602|FG001|Received 133Xe|Overall Study||20
10826184|NCT03417687|11991601|FG000|COMPLETED|Overall Study||14
10826185|NCT03417687|11991602|FG001|COMPLETED|Overall Study||20
10826186|NCT03417687|11991601|FG000|NOT COMPLETED|Overall Study||4
10826187|NCT03417687|11991602|FG001|NOT COMPLETED|Overall Study||0
10826194|NCT03379675|11991625|FG000|STARTED|Overall Study||24
10826195|NCT03379675|11991626|FG001|STARTED|Overall Study||24
10826196|NCT03379675|11991627|FG002|STARTED|Overall Study||24
10826197|NCT03379675|11991625|FG000|COMPLETED|Overall Study||20
10826198|NCT03379675|11991626|FG001|COMPLETED|Overall Study||22
10826199|NCT03379675|11991627|FG002|COMPLETED|Overall Study||22
10408926|NCT00757601|11552967|FG006|COMPLETED|Period 4||2
10826200|NCT03379675|11991625|FG000|NOT COMPLETED|Overall Study||4
10826201|NCT03379675|11991626|FG001|NOT COMPLETED|Overall Study||2
10826202|NCT03379675|11991627|FG002|NOT COMPLETED|Overall Study||2
10408927|NCT00757601|11552968|FG007|COMPLETED|Period 4||2
10408928|NCT00757601|11552969|FG008|COMPLETED|Period 4||2
10826221|NCT03336619|11991648|FG000|STARTED|Overall Study||515
10826222|NCT03336619|11991649|FG001|STARTED|Overall Study||515
10826223|NCT03336619|11991648|FG000|Positive for Influenza by RT-PCR at Baseline (Intent-to-treat Infected [ITTI] Population)|Overall Study||314
10826224|NCT03336619|11991649|FG001|Positive for Influenza by RT-PCR at Baseline (Intent-to-treat Infected [ITTI] Population)|Overall Study||306
10826225|NCT03336619|11991648|FG000|COMPLETED|Overall Study||301
10826226|NCT03336619|11991649|FG001|COMPLETED|Overall Study||290
10826227|NCT03336619|11991648|FG000|NOT COMPLETED|Overall Study||214
10826228|NCT03336619|11991649|FG001|NOT COMPLETED|Overall Study||225
10826229|NCT03274687|11991660|FG000|STARTED|Overall Study||152
10826230|NCT03274687|11991661|FG001|STARTED|Overall Study||144
10826231|NCT03274687|11991660|FG000|Eligible|Overall Study||151
10826232|NCT03274687|11991661|FG001|Eligible|Overall Study||143
10826233|NCT03274687|11991660|FG000|Eligible With Adverse Event Data|Overall Study||148
10826234|NCT03274687|11991661|FG001|Eligible With Adverse Event Data|Overall Study||141
10826235|NCT03274687|11991660|FG000|COMPLETED|Overall Study||151
10826236|NCT03274687|11991661|FG001|COMPLETED|Overall Study||143
10826237|NCT03274687|11991660|FG000|NOT COMPLETED|Overall Study||1
10826238|NCT03274687|11991661|FG001|NOT COMPLETED|Overall Study||1
10826239|NCT03245450|11991674|FG000|STARTED|Overall Study||3
10826240|NCT03245450|11991675|FG001|STARTED|Overall Study||4
10826241|NCT03245450|11991676|FG002|STARTED|Overall Study||3
10826242|NCT03245450|11991677|FG003|STARTED|Overall Study||3
10826243|NCT03245450|11991678|FG004|STARTED|Overall Study||9
10826244|NCT03245450|11991679|FG005|STARTED|Overall Study||9
10826245|NCT03245450|11991680|FG006|STARTED|Overall Study||9
10826246|NCT03245450|11991674|FG000|COMPLETED|Overall Study||0
10826247|NCT03245450|11991675|FG001|COMPLETED|Overall Study||0
10826248|NCT03245450|11991676|FG002|COMPLETED|Overall Study||0
10826249|NCT03245450|11991677|FG003|COMPLETED|Overall Study||0
10826250|NCT03245450|11991678|FG004|COMPLETED|Overall Study||0
10826251|NCT03245450|11991679|FG005|COMPLETED|Overall Study||0
10826252|NCT03245450|11991680|FG006|COMPLETED|Overall Study||0
10826253|NCT03245450|11991674|FG000|NOT COMPLETED|Overall Study||3
10826254|NCT03245450|11991675|FG001|NOT COMPLETED|Overall Study||4
10826255|NCT03245450|11991676|FG002|NOT COMPLETED|Overall Study||3
10826256|NCT03245450|11991677|FG003|NOT COMPLETED|Overall Study||3
10826257|NCT03245450|11991678|FG004|NOT COMPLETED|Overall Study||9
10826258|NCT03245450|11991679|FG005|NOT COMPLETED|Overall Study||9
10826259|NCT03245450|11991680|FG006|NOT COMPLETED|Overall Study||9
10826260|NCT03086369|11991707|FG000|STARTED|Overall Study||3
10826261|NCT03086369|11991708|FG001|STARTED|Overall Study||7
10826262|NCT03086369|11991709|FG002|STARTED|Overall Study||12
10826263|NCT03086369|11991710|FG003|STARTED|Overall Study||82
10826264|NCT03086369|11991711|FG004|STARTED|Overall Study||80
10826265|NCT03086369|11991707|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
10826266|NCT03086369|11991708|FG001|Received at Least 1 Dose of Study Drug|Overall Study||7
10826267|NCT03086369|11991709|FG002|Received at Least 1 Dose of Study Drug|Overall Study||12
10826268|NCT03086369|11991710|FG003|Received at Least 1 Dose of Study Drug|Overall Study||81
10826269|NCT03086369|11991711|FG004|Received at Least 1 Dose of Study Drug|Overall Study||78
10826270|NCT03086369|11991707|FG000|COMPLETED|Overall Study||2
10826271|NCT03086369|11991708|FG001|COMPLETED|Overall Study||7
10826272|NCT03086369|11991709|FG002|COMPLETED|Overall Study||12
10826273|NCT03086369|11991710|FG003|COMPLETED|Overall Study||73
10826274|NCT03086369|11991711|FG004|COMPLETED|Overall Study||73
10826275|NCT03086369|11991707|FG000|NOT COMPLETED|Overall Study||1
10826276|NCT03086369|11991708|FG001|NOT COMPLETED|Overall Study||0
10826277|NCT03086369|11991709|FG002|NOT COMPLETED|Overall Study||0
10826278|NCT03086369|11991710|FG003|NOT COMPLETED|Overall Study||9
10826279|NCT03086369|11991711|FG004|NOT COMPLETED|Overall Study||7
10826280|NCT03083808|11991725|FG000|STARTED|Overall Study||35
10826281|NCT03083808|11991725|FG000|COMPLETED|Overall Study||35
10826282|NCT03083808|11991725|FG000|NOT COMPLETED|Overall Study||0
10826286|NCT02927847|11991735|FG000|STARTED|Overall Study||16
10826287|NCT02927847|11991736|FG001|STARTED|Overall Study||19
10826288|NCT02927847|11991735|FG000|COMPLETED|Overall Study||10
10826289|NCT02927847|11991736|FG001|COMPLETED|Overall Study||16
10826290|NCT02927847|11991735|FG000|NOT COMPLETED|Overall Study||6
10826291|NCT02927847|11991736|FG001|NOT COMPLETED|Overall Study||3
10826292|NCT02903355|11991744|FG000|STARTED|Overall Study||186
10826293|NCT02903355|11991745|FG001|STARTED|Overall Study||165
10826294|NCT02903355|11991744|FG000|COMPLETED|Overall Study||142
10826295|NCT02903355|11991745|FG001|COMPLETED|Overall Study||124
10826296|NCT02903355|11991744|FG000|NOT COMPLETED|Overall Study||44
10826297|NCT02903355|11991745|FG001|NOT COMPLETED|Overall Study||41
10826298|NCT02892149|11991753|FG000|STARTED|Overall Study||1777
10826299|NCT02892149|11991754|FG001|STARTED|Overall Study||1777
10826300|NCT02892149|11991753|FG000|COMPLETED|Overall Study||1425
10826301|NCT02892149|11991754|FG001|COMPLETED|Overall Study||1421
10826302|NCT02892149|11991753|FG000|NOT COMPLETED|Overall Study||352
10826303|NCT02892149|11991754|FG001|NOT COMPLETED|Overall Study||356
10826322|NCT02870920|11991779|FG000|STARTED|Overall Study||61
10826323|NCT02870920|11991780|FG001|STARTED|Overall Study||119
10826324|NCT02870920|11991779|FG000|COMPLETED|Overall Study||61
10826325|NCT02870920|11991780|FG001|COMPLETED|Overall Study||119
10826326|NCT02870920|11991779|FG000|NOT COMPLETED|Overall Study||0
10826327|NCT02870920|11991780|FG001|NOT COMPLETED|Overall Study||0
10826328|NCT02720523|11991790|FG000|STARTED|Period 1: Placebo-controlled Period||49
10826329|NCT02720523|11991791|FG001|STARTED|Period 1: Placebo-controlled Period||49
10826330|NCT02720523|11991792|FG002|STARTED|Period 1: Placebo-controlled Period||49
10826331|NCT02720523|11991793|FG003|STARTED|Period 1: Placebo-controlled Period||50
10826332|NCT02720523|11991794|FG004|STARTED|Period 1: Placebo-controlled Period||0
10826333|NCT02720523|11991795|FG005|STARTED|Period 1: Placebo-controlled Period||0
10826334|NCT02720523|11991796|FG006|STARTED|Period 1: Placebo-controlled Period||0
10826335|NCT02720523|11991790|FG000|COMPLETED|Period 1: Placebo-controlled Period||47
10826336|NCT02720523|11991791|FG001|COMPLETED|Period 1: Placebo-controlled Period||49
10826337|NCT02720523|11991792|FG002|COMPLETED|Period 1: Placebo-controlled Period||47
10826338|NCT02720523|11991793|FG003|COMPLETED|Period 1: Placebo-controlled Period||44
10826339|NCT02720523|11991794|FG004|COMPLETED|Period 1: Placebo-controlled Period||0
10826340|NCT02720523|11991795|FG005|COMPLETED|Period 1: Placebo-controlled Period||0
10826341|NCT02720523|11991796|FG006|COMPLETED|Period 1: Placebo-controlled Period||0
10826342|NCT02720523|11991790|FG000|NOT COMPLETED|Period 1: Placebo-controlled Period||2
10826343|NCT02720523|11991791|FG001|NOT COMPLETED|Period 1: Placebo-controlled Period||0
10826344|NCT02720523|11991792|FG002|NOT COMPLETED|Period 1: Placebo-controlled Period||2
10826345|NCT02720523|11991793|FG003|NOT COMPLETED|Period 1: Placebo-controlled Period||6
10826346|NCT02720523|11991794|FG004|NOT COMPLETED|Period 1: Placebo-controlled Period||0
10826347|NCT02720523|11991795|FG005|NOT COMPLETED|Period 1: Placebo-controlled Period||0
10826348|NCT02720523|11991796|FG006|NOT COMPLETED|Period 1: Placebo-controlled Period||0
10826349|NCT02720523|11991790|FG000|STARTED|Period 2: Long-term Extension Period||0
10826350|NCT02720523|11991791|FG001|STARTED|Period 2: Long-term Extension Period||0
10826351|NCT02720523|11991792|FG002|STARTED|Period 2: Long-term Extension Period||0
10826352|NCT02720523|11991793|FG003|STARTED|Period 2: Long-term Extension Period||0
10826353|NCT02720523|11991794|FG004|STARTED|Period 2: Long-term Extension Period|Includes participants originally randomized to placebo and upadacitinib 7.5 mg|65
10826354|NCT02720523|11991795|FG005|STARTED|Period 2: Long-term Extension Period|Includes participants originally randomized to placebo and upadacitinib 15 mg|62
10429144|NCT00862849|11575288|FG002|STARTED|Washout 2 (3 to 14 Days)||3
10826355|NCT02720523|11991796|FG006|STARTED|Period 2: Long-term Extension Period|Includes participants originally randomized to placebo and upadacitinib 30 mg|60
10826356|NCT02720523|11991790|FG000|COMPLETED|Period 2: Long-term Extension Period||0
10826357|NCT02720523|11991791|FG001|COMPLETED|Period 2: Long-term Extension Period||0
10826358|NCT02720523|11991792|FG002|COMPLETED|Period 2: Long-term Extension Period||0
10826359|NCT02720523|11991793|FG003|COMPLETED|Period 2: Long-term Extension Period||0
10826360|NCT02720523|11991794|FG004|COMPLETED|Period 2: Long-term Extension Period||0
10826361|NCT02720523|11991795|FG005|COMPLETED|Period 2: Long-term Extension Period||0
10826362|NCT02720523|11991796|FG006|COMPLETED|Period 2: Long-term Extension Period||0
10826363|NCT02720523|11991790|FG000|NOT COMPLETED|Period 2: Long-term Extension Period||0
10826364|NCT02720523|11991791|FG001|NOT COMPLETED|Period 2: Long-term Extension Period||0
10826365|NCT02720523|11991792|FG002|NOT COMPLETED|Period 2: Long-term Extension Period||0
10826366|NCT02720523|11991793|FG003|NOT COMPLETED|Period 2: Long-term Extension Period||0
10826367|NCT02720523|11991794|FG004|NOT COMPLETED|Period 2: Long-term Extension Period||65
10826368|NCT02720523|11991795|FG005|NOT COMPLETED|Period 2: Long-term Extension Period||62
10826369|NCT02720523|11991796|FG006|NOT COMPLETED|Period 2: Long-term Extension Period||60
10826370|NCT02625324|11991809|FG000|STARTED|30-Day Follow-up for Primary Endpoint|The 30-day primary endpoint was evaluated when 87 subjects completed 30-day follow-up.|87
10826371|NCT02625324|11991809|FG000|COMPLETED|30-Day Follow-up for Primary Endpoint||86
10826372|NCT02625324|11991809|FG000|NOT COMPLETED|30-Day Follow-up for Primary Endpoint||1
10826373|NCT02625324|11991809|FG000|STARTED|30-Day Follow-up for Secondary Endpoint|The 30-day secondary endpoint was evaluated when 100 subjects completed 30-day follow-up.|100
10826374|NCT02625324|11991809|FG000|COMPLETED|30-Day Follow-up for Secondary Endpoint||99
10826375|NCT02625324|11991809|FG000|NOT COMPLETED|30-Day Follow-up for Secondary Endpoint||1
10826376|NCT02625324|11991809|FG000|STARTED|6-Month Follow-up Subject Accountability|Note that 6-month follow up is not mandatory for OUS subjects|99
10826377|NCT02625324|11991809|FG000|COMPLETED|6-Month Follow-up Subject Accountability||91
10826378|NCT02625324|11991809|FG000|NOT COMPLETED|6-Month Follow-up Subject Accountability||8
10826379|NCT02625324|11991809|FG000|STARTED|12-Month Follow-up Secondary Endpoint||91
10826380|NCT02625324|11991809|FG000|COMPLETED|12-Month Follow-up Secondary Endpoint||87
10826381|NCT02625324|11991809|FG000|NOT COMPLETED|12-Month Follow-up Secondary Endpoint||4
10826382|NCT02625324|11991809|FG000|STARTED|24-Month Follow-up Secondary Endpoint||87
10826383|NCT02625324|11991809|FG000|COMPLETED|24-Month Follow-up Secondary Endpoint||53
10826384|NCT02625324|11991809|FG000|NOT COMPLETED|24-Month Follow-up Secondary Endpoint||34
10826385|NCT02625324|11991809|FG000|STARTED|36-Month Follow-up Secondary Endpoint||53
10826386|NCT02625324|11991809|FG000|COMPLETED|36-Month Follow-up Secondary Endpoint||49
10826387|NCT02625324|11991809|FG000|NOT COMPLETED|36-Month Follow-up Secondary Endpoint||4
10544842|NCT01492088|11698023|FG000|STARTED|Overall Study||3
10826409|NCT02468778|11991853|FG000|STARTED|Overall Study||18
10826410|NCT02468778|11991854|FG001|STARTED|Overall Study||26
10826411|NCT02468778|11991855|FG002|STARTED|Overall Study||10
10826412|NCT02468778|11991853|FG000|COMPLETED|Overall Study||15
10826413|NCT02468778|11991854|FG001|COMPLETED|Overall Study||22
10826414|NCT02468778|11991855|FG002|COMPLETED|Overall Study||7
10826415|NCT02468778|11991853|FG000|NOT COMPLETED|Overall Study||3
10826416|NCT02468778|11991854|FG001|NOT COMPLETED|Overall Study||4
10826417|NCT02468778|11991855|FG002|NOT COMPLETED|Overall Study||3
10826418|NCT02435849|11991863|FG000|STARTED|Overall Study||97
10826419|NCT02435849|11991863|FG000|Enrolled and Infused|Overall Study||79
10826420|NCT02435849|11991863|FG000|Enrolled But Not Infused|Overall Study||18
10826421|NCT02435849|11991863|FG000|Discontinued Study Follow-up|Overall Study||34
10826422|NCT02435849|11991863|FG000|COMPLETED|Overall Study||0
10826423|NCT02435849|11991863|FG000|NOT COMPLETED|Overall Study||97
10826473|NCT02311478|11991926|FG000|STARTED|Overall Study||79
10826474|NCT02311478|11991926|FG000|IUD Insertion|Overall Study||78
10826475|NCT02311478|11991926|FG000|COMPLETED|Overall Study||72
10826476|NCT02311478|11991926|FG000|NOT COMPLETED|Overall Study||7
10826477|NCT02292238|11991933|FG000|STARTED|Overall Study||34
10826478|NCT02292238|11991934|FG001|STARTED|Overall Study||37
10826479|NCT02292238|11991933|FG000|COMPLETED|Overall Study||30
10826480|NCT02292238|11991934|FG001|COMPLETED|Overall Study||33
10826481|NCT02292238|11991933|FG000|NOT COMPLETED|Overall Study||4
10826482|NCT02292238|11991934|FG001|NOT COMPLETED|Overall Study||4
10826483|NCT02287818|11991943|FG000|STARTED|Overall Study||60
10826484|NCT02287818|11991944|FG001|STARTED|Overall Study||67
10826485|NCT02287818|11991943|FG000|COMPLETED|Overall Study||53
10826486|NCT02287818|11991944|FG001|COMPLETED|Overall Study||54
10826487|NCT02287818|11991943|FG000|NOT COMPLETED|Overall Study||7
10826488|NCT02287818|11991944|FG001|NOT COMPLETED|Overall Study||13
10826489|NCT02277119|11991953|FG000|STARTED|Overall Study||58
10826490|NCT02277119|11991954|FG001|STARTED|Overall Study||24
10826491|NCT02277119|11991955|FG002|STARTED|Overall Study||27
10826492|NCT02277119|11991953|FG000|COMPLETED|Overall Study||55
10826493|NCT02277119|11991954|FG001|COMPLETED|Overall Study||20
10826494|NCT02277119|11991955|FG002|COMPLETED|Overall Study||19
10826495|NCT02277119|11991953|FG000|NOT COMPLETED|Overall Study||3
10826496|NCT02277119|11991954|FG001|NOT COMPLETED|Overall Study||4
10826497|NCT02277119|11991955|FG002|NOT COMPLETED|Overall Study||8
10826501|NCT02255097|11991967|FG000|STARTED|Overall Study||172
10826502|NCT02255097|11991967|FG000|Treated|Overall Study||171
10826503|NCT02255097|11991967|FG000|Received Second Course of Pembrolizumab|Overall Study||3
10826504|NCT02255097|11991967|FG000|COMPLETED|Overall Study||0
10826505|NCT02255097|11991967|FG000|NOT COMPLETED|Overall Study||172
10826506|NCT02218164|11991972|FG000|STARTED|Overall Study||8
10826507|NCT02218164|11991972|FG000|COMPLETED|Overall Study||8
10826508|NCT02218164|11991972|FG000|NOT COMPLETED|Overall Study||0
10826509|NCT02200614|11991978|FG000|STARTED|Double Blind Treatment||955
10826510|NCT02200614|11991979|FG001|STARTED|Double Blind Treatment||554
10826511|NCT02200614|11991978|FG000|COMPLETED|Double Blind Treatment||591
10826512|NCT02200614|11991979|FG001|COMPLETED|Double Blind Treatment||170
10826513|NCT02200614|11991978|FG000|NOT COMPLETED|Double Blind Treatment||364
10826514|NCT02200614|11991979|FG001|NOT COMPLETED|Double Blind Treatment||384
10826515|NCT02200614|11991978|FG000|STARTED|Open Label|Not all participants from treatment period entered follow-up|591
10826516|NCT02200614|11991979|FG001|STARTED|Open Label|Not all participants from treatment period entered follow-up|170
10826517|NCT02200614|11991978|FG000|COMPLETED|Open Label||295
10826518|NCT02200614|11991979|FG001|COMPLETED|Open Label||114
10826519|NCT02200614|11991978|FG000|NOT COMPLETED|Open Label||296
10826520|NCT02200614|11991979|FG001|NOT COMPLETED|Open Label||56
10826524|NCT02083081|11991993|FG000|STARTED|Overall Study||188
10826525|NCT02083081|11991994|FG001|STARTED|Overall Study||164
10826526|NCT02083081|11991993|FG000|COMPLETED|Overall Study||157
10826527|NCT02083081|11991994|FG001|COMPLETED|Overall Study||155
10826528|NCT02083081|11991993|FG000|NOT COMPLETED|Overall Study||31
10826529|NCT02083081|11991994|FG001|NOT COMPLETED|Overall Study||9
10826530|NCT02069899|11992003|FG000|STARTED|Overall Study||37
10826531|NCT02069899|11992004|FG001|STARTED|Overall Study||14
10826532|NCT02069899|11992005|FG002|STARTED|Overall Study||7
10826533|NCT02069899|11992003|FG000|Treated in Current Study|Overall Study||22
10826534|NCT02069899|11992004|FG001|Treated in Current Study|Overall Study||0
10826535|NCT02069899|11992005|FG002|Treated in Current Study|Overall Study||5
10826536|NCT02069899|11992003|FG000|COMPLETED|Overall Study||24
10826537|NCT02069899|11992004|FG001|COMPLETED|Overall Study||13
10826538|NCT02069899|11992005|FG002|COMPLETED|Overall Study||4
10826539|NCT02069899|11992003|FG000|NOT COMPLETED|Overall Study||13
10826540|NCT02069899|11992004|FG001|NOT COMPLETED|Overall Study||1
10826541|NCT02069899|11992005|FG002|NOT COMPLETED|Overall Study||3
10826545|NCT02018861|11992028|FG000|STARTED|Parsaclisib Monotherapy: 21-day Cycles||1
10826546|NCT02018861|11992029|FG001|STARTED|Parsaclisib Monotherapy: 21-day Cycles||3
10826547|NCT02018861|11992030|FG002|STARTED|Parsaclisib Monotherapy: 21-day Cycles||3
10826548|NCT02018861|11992031|FG003|STARTED|Parsaclisib Monotherapy: 21-day Cycles||34
10826549|NCT02018861|11992032|FG004|STARTED|Parsaclisib Monotherapy: 21-day Cycles||27
10826550|NCT02018861|11992033|FG005|STARTED|Parsaclisib Monotherapy: 21-day Cycles||4
10826551|NCT02018861|11992034|FG006|STARTED|Parsaclisib Monotherapy: 21-day Cycles||0
10826552|NCT02018861|11992035|FG007|STARTED|Parsaclisib Monotherapy: 21-day Cycles||0
10826553|NCT02018861|11992036|FG008|STARTED|Parsaclisib Monotherapy: 21-day Cycles||0
10826554|NCT02018861|11992037|FG009|STARTED|Parsaclisib Monotherapy: 21-day Cycles||0
10826555|NCT02018861|11992028|FG000|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0
10826556|NCT02018861|11992029|FG001|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0
10826557|NCT02018861|11992030|FG002|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0
10826558|NCT02018861|11992031|FG003|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||4
10826559|NCT02018861|11992032|FG004|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0
10826560|NCT02018861|11992033|FG005|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0
10826561|NCT02018861|11992034|FG006|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0
10826562|NCT02018861|11992035|FG007|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0
10826563|NCT02018861|11992036|FG008|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0
10826564|NCT02018861|11992037|FG009|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0
10826565|NCT02018861|11992028|FG000|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||1
10826566|NCT02018861|11992029|FG001|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||3
10826567|NCT02018861|11992030|FG002|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||3
10826568|NCT02018861|11992031|FG003|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||30
10826569|NCT02018861|11992032|FG004|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||27
10826570|NCT02018861|11992033|FG005|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||4
10826571|NCT02018861|11992034|FG006|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0
10826572|NCT02018861|11992035|FG007|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0
10826573|NCT02018861|11992036|FG008|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0
10826574|NCT02018861|11992037|FG009|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0
10826575|NCT02018861|11992028|FG000|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826576|NCT02018861|11992029|FG001|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826577|NCT02018861|11992030|FG002|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826578|NCT02018861|11992031|FG003|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826579|NCT02018861|11992032|FG004|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826580|NCT02018861|11992033|FG005|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826581|NCT02018861|11992034|FG006|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||8
10826582|NCT02018861|11992035|FG007|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||3
10826583|NCT02018861|11992036|FG008|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826584|NCT02018861|11992037|FG009|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826585|NCT02018861|11992028|FG000|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826586|NCT02018861|11992029|FG001|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826587|NCT02018861|11992030|FG002|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826588|NCT02018861|11992031|FG003|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826589|NCT02018861|11992032|FG004|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826590|NCT02018861|11992033|FG005|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826591|NCT02018861|11992034|FG006|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826592|NCT02018861|11992035|FG007|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826593|NCT02018861|11992036|FG008|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826594|NCT02018861|11992037|FG009|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826595|NCT02018861|11992028|FG000|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826596|NCT02018861|11992029|FG001|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826597|NCT02018861|11992030|FG002|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826598|NCT02018861|11992031|FG003|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826599|NCT02018861|11992032|FG004|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826600|NCT02018861|11992033|FG005|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826601|NCT02018861|11992034|FG006|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||8
10826602|NCT02018861|11992035|FG007|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||3
10826603|NCT02018861|11992036|FG008|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826604|NCT02018861|11992037|FG009|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826605|NCT02018861|11992028|FG000|STARTED|Parsaclisib + R-ICE; 21-day Cycles||0
10826606|NCT02018861|11992029|FG001|STARTED|Parsaclisib + R-ICE; 21-day Cycles||0
10826607|NCT02018861|11992030|FG002|STARTED|Parsaclisib + R-ICE; 21-day Cycles||0
10826608|NCT02018861|11992031|FG003|STARTED|Parsaclisib + R-ICE; 21-day Cycles||0
10826609|NCT02018861|11992032|FG004|STARTED|Parsaclisib + R-ICE; 21-day Cycles||0
10826610|NCT02018861|11992033|FG005|STARTED|Parsaclisib + R-ICE; 21-day Cycles||0
10826611|NCT02018861|11992034|FG006|STARTED|Parsaclisib + R-ICE; 21-day Cycles||0
10826612|NCT02018861|11992035|FG007|STARTED|Parsaclisib + R-ICE; 21-day Cycles||0
10826613|NCT02018861|11992036|FG008|STARTED|Parsaclisib + R-ICE; 21-day Cycles||4
10826614|NCT02018861|11992037|FG009|STARTED|Parsaclisib + R-ICE; 21-day Cycles||1
10826615|NCT02018861|11992028|FG000|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
10826616|NCT02018861|11992029|FG001|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
10826617|NCT02018861|11992030|FG002|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
10826618|NCT02018861|11992031|FG003|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
10290683|NCT01535274|11423450|FG001|COMPLETED|Overall Study||27
10290684|NCT01535274|11423449|FG000|NOT COMPLETED|Overall Study||0
10290685|NCT01535274|11423450|FG001|NOT COMPLETED|Overall Study||2
10313140|NCT00148759|11446685|FG001|STARTED|Overall Study||12
10313141|NCT00148759|11446684|FG000|24-hr PK Sampling|Overall Study||9
10313142|NCT00148759|11446685|FG001|24-hr PK Sampling|Overall Study||11
10313143|NCT00148759|11446684|FG000|COMPLETED|Overall Study||9
10313144|NCT00148759|11446685|FG001|COMPLETED|Overall Study||11
10313145|NCT00148759|11446684|FG000|NOT COMPLETED|Overall Study||2
10313146|NCT00148759|11446685|FG001|NOT COMPLETED|Overall Study||1
10313147|NCT00148798|11446693|FG000|STARTED|Overall Study|Intent To Treat (ITT) Population|557
10313148|NCT00148798|11446694|FG001|STARTED|Overall Study|ITT Population|568
10313149|NCT00148798|11446693|FG000|COMPLETED|Overall Study||557
10313150|NCT00148798|11446694|FG001|COMPLETED|Overall Study||568
10313151|NCT00148798|11446693|FG000|NOT COMPLETED|Overall Study||0
10313152|NCT00148798|11446694|FG001|NOT COMPLETED|Overall Study||0
10313153|NCT00148941|11446706|FG000|STARTED|Overall Study||1053
10313154|NCT00148941|11446707|FG001|STARTED|Overall Study||1051
10313155|NCT00148941|11446708|FG002|STARTED|Overall Study||1052
10313156|NCT00148941|11446709|FG003|STARTED|Overall Study||1053
10313157|NCT00148941|11446706|FG000|COMPLETED|Overall Study||1035
10313158|NCT00148941|11446707|FG001|COMPLETED|Overall Study||1027
10313159|NCT00148941|11446708|FG002|COMPLETED|Overall Study||1032
10408929|NCT00757601|11552970|FG009|COMPLETED|Period 4|One participant discontinued after receiving the 230 mg dose of MK1006 and was not replaced|1
10826619|NCT02018861|11992032|FG004|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
10826620|NCT02018861|11992033|FG005|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
10826621|NCT02018861|11992034|FG006|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
10826622|NCT02018861|11992035|FG007|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
10826623|NCT02018861|11992036|FG008|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||1
10826624|NCT02018861|11992037|FG009|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||1
10826625|NCT02018861|11992028|FG000|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
10826626|NCT02018861|11992029|FG001|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
10826627|NCT02018861|11992030|FG002|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
10826628|NCT02018861|11992031|FG003|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
10313160|NCT00148941|11446709|FG003|COMPLETED|Overall Study||1029
10826629|NCT02018861|11992032|FG004|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
10826630|NCT02018861|11992033|FG005|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
10826631|NCT02018861|11992034|FG006|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
10826632|NCT02018861|11992035|FG007|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
10826633|NCT02018861|11992036|FG008|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||3
10826634|NCT02018861|11992037|FG009|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
10826641|NCT01721759|11992075|FG000|STARTED|Treatment Period||117
10826642|NCT01721759|11992075|FG000|COMPLETED|Treatment Period||0
10826643|NCT01721759|11992075|FG000|NOT COMPLETED|Treatment Period||117
10826644|NCT01721759|11992075|FG000|STARTED|End of Study Period||117
10826645|NCT01721759|11992075|FG000|COMPLETED|End of Study Period||0
10826646|NCT01721759|11992075|FG000|NOT COMPLETED|End of Study Period||117
10826686|NCT01544335|11992144|FG000|STARTED|Overall Study||191
10826687|NCT01544335|11992144|FG000|COMPLETED|Overall Study||138
10826688|NCT01544335|11992144|FG000|NOT COMPLETED|Overall Study||53
10290686|NCT00544830|11423458|FG000|STARTED|Overall Study||29
10290687|NCT00544830|11423458|FG000|COMPLETED|Overall Study||29
10290688|NCT00544830|11423458|FG000|NOT COMPLETED|Overall Study||0
10290689|NCT00539981|11423464|FG000|STARTED|Overall Study||2344
10290690|NCT00539981|11423465|FG001|STARTED|Overall Study||2304
10290691|NCT00539981|11423464|FG000|COMPLETED|Overall Study||2049
10826704|NCT01451515|11992177|FG000|STARTED|Overall Study||12
10826705|NCT01451515|11992178|FG001|STARTED|Overall Study||7
10826706|NCT01451515|11992179|FG002|STARTED|Overall Study||4
10826707|NCT01451515|11992177|FG000|COMPLETED|Overall Study||11
10826708|NCT01451515|11992178|FG001|COMPLETED|Overall Study||4
10826709|NCT01451515|11992179|FG002|COMPLETED|Overall Study||3
10826710|NCT01451515|11992177|FG000|NOT COMPLETED|Overall Study||1
10826711|NCT01451515|11992178|FG001|NOT COMPLETED|Overall Study||3
10826712|NCT01451515|11992179|FG002|NOT COMPLETED|Overall Study||1
10826719|NCT01413399|11992201|FG000|STARTED|Overall Study||208
10826720|NCT01413399|11992202|FG001|STARTED|Overall Study||334
10826721|NCT01413399|11992201|FG000|COMPLETED|Overall Study||208
10826722|NCT01413399|11992202|FG001|COMPLETED|Overall Study||334
10826723|NCT01413399|11992201|FG000|NOT COMPLETED|Overall Study||0
10826724|NCT01413399|11992202|FG001|NOT COMPLETED|Overall Study||0
10826935|NCT01302834|11992273|FG000|STARTED|Overall Study||424
10826936|NCT01302834|11992274|FG001|STARTED|Overall Study||425
10826937|NCT01302834|11992273|FG000|Eligible|Overall Study||406
10826938|NCT01302834|11992274|FG001|Eligible|Overall Study||399
10826939|NCT01302834|11992273|FG000|Started Treatment|Overall Study||398
10826940|NCT01302834|11992274|FG001|Started Treatment|Overall Study||394
10826941|NCT01302834|11992273|FG000|AE Assessed 1 Month Post-treatment (PT)|Overall Study||369
10826942|NCT01302834|11992274|FG001|AE Assessed 1 Month Post-treatment (PT)|Overall Study||363
10826943|NCT01302834|11992273|FG000|AE Assessed 3 Months PT|Overall Study||359
10826944|NCT01302834|11992274|FG001|AE Assessed 3 Months PT|Overall Study||367
10826945|NCT01302834|11992273|FG000|AE Assessed 6 Months PT|Overall Study||361
10826946|NCT01302834|11992274|FG001|AE Assessed 6 Months PT|Overall Study||352
10826947|NCT01302834|11992273|FG000|AE Assessment 1 Year PT|Overall Study||360
10826948|NCT01302834|11992274|FG001|AE Assessment 1 Year PT|Overall Study||351
10826949|NCT01302834|11992273|FG000|AE Assessed 2 Years PT|Overall Study||311
10826950|NCT01302834|11992274|FG001|AE Assessed 2 Years PT|Overall Study||303
10826951|NCT01302834|11992273|FG000|AE Assessed 5 Years PT|Overall Study||92
10826952|NCT01302834|11992274|FG001|AE Assessed 5 Years PT|Overall Study||86
10826953|NCT01302834|11992273|FG000|Dental Health Assessed 1 Year PT|Overall Study||267
10826954|NCT01302834|11992274|FG001|Dental Health Assessed 1 Year PT|Overall Study||267
10826955|NCT01302834|11992273|FG000|Dental Health Assessed 2 Years PT|Overall Study||208
10826956|NCT01302834|11992274|FG001|Dental Health Assessed 2 Years PT|Overall Study||201
10826957|NCT01302834|11992273|FG000|Dental Health Assessed 5 Years PT|Overall Study||44
10826958|NCT01302834|11992274|FG001|Dental Health Assessed 5 Years PT|Overall Study||43
10826959|NCT01302834|11992273|FG000|Feeding Tube Assessed|Overall Study||368
10826960|NCT01302834|11992274|FG001|Feeding Tube Assessed|Overall Study||356
10826961|NCT01302834|11992273|FG000|Progressed|Overall Study||76
10826962|NCT01302834|11992274|FG001|Progressed|Overall Study||122
10826963|NCT01302834|11992273|FG000|COMPLETED|Overall Study||406
10826964|NCT01302834|11992274|FG001|COMPLETED|Overall Study||399
10826965|NCT01302834|11992273|FG000|NOT COMPLETED|Overall Study||18
10826966|NCT01302834|11992274|FG001|NOT COMPLETED|Overall Study||26
10826973|NCT01275313|11992291|FG000|STARTED|Overall Study||127
10826974|NCT01275313|11992292|FG001|STARTED|Overall Study||131
10826975|NCT01275313|11992291|FG000|COMPLETED|Overall Study||102
10826976|NCT01275313|11992292|FG001|COMPLETED|Overall Study||79
10826977|NCT01275313|11992291|FG000|NOT COMPLETED|Overall Study||25
10826978|NCT01275313|11992292|FG001|NOT COMPLETED|Overall Study||52
10826991|NCT01177540|11992313|FG000|STARTED|Overall Study||11
10826992|NCT01177540|11992314|FG001|STARTED|Overall Study||14
10826993|NCT01177540|11992313|FG000|COMPLETED|Overall Study||10
10826994|NCT01177540|11992314|FG001|COMPLETED|Overall Study||14
10826995|NCT01177540|11992313|FG000|NOT COMPLETED|Overall Study||1
10826996|NCT01177540|11992314|FG001|NOT COMPLETED|Overall Study||0
10290692|NCT00539981|11423465|FG001|COMPLETED|Overall Study||2022
10290693|NCT00539981|11423464|FG000|NOT COMPLETED|Overall Study||295
10290694|NCT00539981|11423465|FG001|NOT COMPLETED|Overall Study||282
10290695|NCT04732819|11423476|FG000|STARTED|Overall Study||12582
10290696|NCT04732819|11423477|FG001|STARTED|Overall Study||11186
10290697|NCT04732819|11423476|FG000|COMPLETED|Overall Study||12582
10290698|NCT04732819|11423477|FG001|COMPLETED|Overall Study||11186
10290699|NCT04732819|11423476|FG000|NOT COMPLETED|Overall Study||0
10290700|NCT04732819|11423477|FG001|NOT COMPLETED|Overall Study||0
10313161|NCT00148941|11446706|FG000|NOT COMPLETED|Overall Study||18
10313162|NCT00148941|11446707|FG001|NOT COMPLETED|Overall Study||24
10313163|NCT00148941|11446708|FG002|NOT COMPLETED|Overall Study||20
10313164|NCT00148941|11446709|FG003|NOT COMPLETED|Overall Study||24
10313165|NCT00148954|11446721|FG000|STARTED|Overall Study||985
10313166|NCT00148954|11446722|FG001|STARTED|Overall Study||977
10313167|NCT00148954|11446721|FG000|COMPLETED|Overall Study||678
10313168|NCT00148954|11446722|FG001|COMPLETED|Overall Study||677
10313169|NCT00148954|11446721|FG000|NOT COMPLETED|Overall Study||307
10313170|NCT00148954|11446722|FG001|NOT COMPLETED|Overall Study||300
10313171|NCT00149214|11446730|FG000|STARTED|Overall Study|One patient randomized to Pemetrexed (P) was treated with Cyclophosphamide (C).|135
10313172|NCT00149214|11446731|FG001|STARTED|Overall Study||122
10313173|NCT00149214|11446730|FG000|COMPLETED|Overall Study|The patient treated with Cyclophosphamide (C) was included in that arm (C) for safety analysis.|109
10313174|NCT00149214|11446731|FG001|COMPLETED|Overall Study||105
10313175|NCT00149214|11446730|FG000|NOT COMPLETED|Overall Study||26
10313176|NCT00149214|11446731|FG001|NOT COMPLETED|Overall Study||17
10313177|NCT00149227|11446739|FG000|STARTED|Overall Study||1517
10313178|NCT00149227|11446740|FG001|STARTED|Overall Study||1514
10313179|NCT00149227|11446739|FG000|COMPLETED|Overall Study||1517
10313180|NCT00149227|11446740|FG001|COMPLETED|Overall Study||1514
10827029|NCT00792259|11992372|FG000|STARTED|Overall Study||15
10827030|NCT00792259|11992373|FG001|STARTED|Overall Study||20
10827031|NCT00792259|11992374|FG002|STARTED|Overall Study||13
10827032|NCT00792259|11992372|FG000|COMPLETED|Overall Study||14
10827033|NCT00792259|11992373|FG001|COMPLETED|Overall Study||20
10827034|NCT00792259|11992374|FG002|COMPLETED|Overall Study||13
10827035|NCT00792259|11992372|FG000|NOT COMPLETED|Overall Study||1
10827036|NCT00792259|11992373|FG001|NOT COMPLETED|Overall Study||0
10827037|NCT00792259|11992374|FG002|NOT COMPLETED|Overall Study||0
10827038|NCT00662792|11992382|FG000|STARTED|Period 1||34
10827039|NCT00662792|11992383|FG001|STARTED|Period 1||38
10827040|NCT00662792|11992384|FG002|STARTED|Period 1||36
10827041|NCT00662792|11992385|FG003|STARTED|Period 1||39
10827042|NCT00662792|11992382|FG000|Treated|Period 1||34
10827043|NCT00662792|11992383|FG001|Treated|Period 1||37
10827044|NCT00662792|11992384|FG002|Treated|Period 1||36
10827045|NCT00662792|11992385|FG003|Treated|Period 1||39
10827046|NCT00662792|11992382|FG000|COMPLETED|Period 1||32
10827047|NCT00662792|11992383|FG001|COMPLETED|Period 1||31
10827048|NCT00662792|11992384|FG002|COMPLETED|Period 1||32
10827049|NCT00662792|11992385|FG003|COMPLETED|Period 1||39
10827050|NCT00662792|11992382|FG000|NOT COMPLETED|Period 1||2
10827051|NCT00662792|11992383|FG001|NOT COMPLETED|Period 1||7
10827052|NCT00662792|11992384|FG002|NOT COMPLETED|Period 1||4
10827053|NCT00662792|11992385|FG003|NOT COMPLETED|Period 1||0
10827054|NCT00662792|11992382|FG000|STARTED|Period 2||32
10827055|NCT00662792|11992383|FG001|STARTED|Period 2||31
10827056|NCT00662792|11992384|FG002|STARTED|Period 2||32
10827057|NCT00662792|11992385|FG003|STARTED|Period 2||39
10827058|NCT00662792|11992382|FG000|Treated|Period 2||32
10827059|NCT00662792|11992383|FG001|Treated|Period 2||31
10827060|NCT00662792|11992384|FG002|Treated|Period 2||32
10827061|NCT00662792|11992385|FG003|Treated|Period 2||39
10827062|NCT00662792|11992382|FG000|COMPLETED|Period 2||31
10827063|NCT00662792|11992383|FG001|COMPLETED|Period 2||31
10827064|NCT00662792|11992384|FG002|COMPLETED|Period 2||32
10827065|NCT00662792|11992385|FG003|COMPLETED|Period 2||36
10827066|NCT00662792|11992382|FG000|NOT COMPLETED|Period 2||1
10827067|NCT00662792|11992383|FG001|NOT COMPLETED|Period 2||0
10827068|NCT00662792|11992384|FG002|NOT COMPLETED|Period 2||0
10827069|NCT00662792|11992385|FG003|NOT COMPLETED|Period 2||3
10827070|NCT00662792|11992382|FG000|STARTED|Period 3||31
10827071|NCT00662792|11992383|FG001|STARTED|Period 3||31
10827072|NCT00662792|11992384|FG002|STARTED|Period 3||32
10827073|NCT00662792|11992385|FG003|STARTED|Period 3||36
10827074|NCT00662792|11992382|FG000|Treated|Period 3||31
10827075|NCT00662792|11992383|FG001|Treated|Period 3||31
10827076|NCT00662792|11992384|FG002|Treated|Period 3||32
10827077|NCT00662792|11992385|FG003|Treated|Period 3||36
10827078|NCT00662792|11992382|FG000|COMPLETED|Period 3||30
10827079|NCT00662792|11992383|FG001|COMPLETED|Period 3||31
10827080|NCT00662792|11992384|FG002|COMPLETED|Period 3||30
10827081|NCT00662792|11992385|FG003|COMPLETED|Period 3||35
10827082|NCT00662792|11992382|FG000|NOT COMPLETED|Period 3||1
10827083|NCT00662792|11992383|FG001|NOT COMPLETED|Period 3||0
10827084|NCT00662792|11992384|FG002|NOT COMPLETED|Period 3||2
10408930|NCT00757601|11552971|FG010|COMPLETED|Period 4||2
10429145|NCT00862849|11575289|FG003|STARTED|Washout 2 (3 to 14 Days)||4
10827085|NCT00662792|11992385|FG003|NOT COMPLETED|Period 3||1
10827086|NCT00662792|11992382|FG000|STARTED|Period 4||30
10827087|NCT00662792|11992383|FG001|STARTED|Period 4||31
10827088|NCT00662792|11992384|FG002|STARTED|Period 4||30
10827089|NCT00662792|11992385|FG003|STARTED|Period 4||35
10827090|NCT00662792|11992382|FG000|Treated|Period 4||30
10827091|NCT00662792|11992383|FG001|Treated|Period 4||31
10827092|NCT00662792|11992384|FG002|Treated|Period 4||30
10827093|NCT00662792|11992385|FG003|Treated|Period 4||35
10827094|NCT00662792|11992382|FG000|COMPLETED|Period 4||29
10827095|NCT00662792|11992383|FG001|COMPLETED|Period 4||30
10827096|NCT00662792|11992384|FG002|COMPLETED|Period 4||30
10827097|NCT00662792|11992385|FG003|COMPLETED|Period 4||34
10827098|NCT00662792|11992382|FG000|NOT COMPLETED|Period 4||1
10827099|NCT00662792|11992383|FG001|NOT COMPLETED|Period 4||1
10827100|NCT00662792|11992384|FG002|NOT COMPLETED|Period 4||0
10827101|NCT00662792|11992385|FG003|NOT COMPLETED|Period 4||1
10408931|NCT00757601|11552972|FG011|COMPLETED|Period 4|Replacement participant discontinued after receiving placebo to 230mg MK1006 and was not replaced|1
10408932|NCT00757601|11552961|FG000|NOT COMPLETED|Period 4||0
10408933|NCT00757601|11552962|FG001|NOT COMPLETED|Period 4||0
10408934|NCT00757601|11552963|FG002|NOT COMPLETED|Period 4||0
10408935|NCT00757601|11552964|FG003|NOT COMPLETED|Period 4||0
10408936|NCT00757601|11552965|FG004|NOT COMPLETED|Period 4||0
10408937|NCT00757601|11552966|FG005|NOT COMPLETED|Period 4||0
10408938|NCT00757601|11552967|FG006|NOT COMPLETED|Period 4||0
10827129|NCT00567580|11992427|FG000|STARTED|Overall Study||592
10827130|NCT00567580|11992428|FG001|STARTED|Overall Study||602
10827131|NCT00567580|11992429|FG002|STARTED|Overall Study||598
10827132|NCT00567580|11992427|FG000|Eligible|Overall Study||564
10827133|NCT00567580|11992428|FG001|Eligible|Overall Study||578
10827134|NCT00567580|11992429|FG002|Eligible|Overall Study||574
10827135|NCT00567580|11992427|FG000|Eligible, Started Study Treatment, and Have Adverse Event Data|Overall Study||547
10827136|NCT00567580|11992428|FG001|Eligible, Started Study Treatment, and Have Adverse Event Data|Overall Study||563
10827137|NCT00567580|11992429|FG002|Eligible, Started Study Treatment, and Have Adverse Event Data|Overall Study||563
10827138|NCT00567580|11992427|FG000|COMPLETED|Overall Study||564
10827139|NCT00567580|11992428|FG001|COMPLETED|Overall Study||578
10827140|NCT00567580|11992429|FG002|COMPLETED|Overall Study||574
10827141|NCT00567580|11992427|FG000|NOT COMPLETED|Overall Study||28
10827142|NCT00567580|11992428|FG001|NOT COMPLETED|Overall Study||24
10827143|NCT00567580|11992429|FG002|NOT COMPLETED|Overall Study||24
10827144|NCT00528021|11992444|FG000|STARTED|Overall Study||59
10827145|NCT00528021|11992445|FG001|STARTED|Overall Study||59
10827146|NCT00528021|11992446|FG002|STARTED|Overall Study||56
10827147|NCT00528021|11992447|FG003|STARTED|Overall Study||56
10827148|NCT00528021|11992444|FG000|COMPLETED|Overall Study||42
10827149|NCT00528021|11992445|FG001|COMPLETED|Overall Study||46
10827150|NCT00528021|11992446|FG002|COMPLETED|Overall Study||49
10827151|NCT00528021|11992447|FG003|COMPLETED|Overall Study||47
10827152|NCT00528021|11992444|FG000|NOT COMPLETED|Overall Study||17
10827153|NCT00528021|11992445|FG001|NOT COMPLETED|Overall Study||13
10827154|NCT00528021|11992446|FG002|NOT COMPLETED|Overall Study||7
10827155|NCT00528021|11992447|FG003|NOT COMPLETED|Overall Study||9
10827156|NCT00485693|11992459|FG000|STARTED|Overall Study||34
10827157|NCT00485693|11992460|FG001|STARTED|Overall Study||104
10827158|NCT00485693|11992459|FG000|COMPLETED|Overall Study||34
10827159|NCT00485693|11992460|FG001|COMPLETED|Overall Study||104
10827160|NCT00485693|11992459|FG000|NOT COMPLETED|Overall Study||0
10827161|NCT00485693|11992460|FG001|NOT COMPLETED|Overall Study||0
10408939|NCT00757601|11552968|FG007|NOT COMPLETED|Period 4||0
10408940|NCT00757601|11552969|FG008|NOT COMPLETED|Period 4||0
10408941|NCT00757601|11552970|FG009|NOT COMPLETED|Period 4||1
10408942|NCT00757601|11552971|FG010|NOT COMPLETED|Period 4||0
10408943|NCT00757601|11552972|FG011|NOT COMPLETED|Period 4||1
10408944|NCT00757601|11552961|FG000|STARTED|Period 5||2
10408945|NCT00757601|11552962|FG001|STARTED|Period 5||2
10408946|NCT00757601|11552963|FG002|STARTED|Period 5||2
10827195|NCT00799266|11992533|FG000|STARTED|Overall Study||18
10827196|NCT00799266|11992534|FG001|STARTED|Overall Study||16
10827197|NCT00799266|11992533|FG000|Modified Intention-to-treat (MITT)|Overall Study||17
10827198|NCT00799266|11992534|FG001|Modified Intention-to-treat (MITT)|Overall Study||16
10827199|NCT00799266|11992533|FG000|Safety Set|Overall Study||18
10827200|NCT00799266|11992534|FG001|Safety Set|Overall Study||16
10827201|NCT00799266|11992533|FG000|COMPLETED|Overall Study||15
10827202|NCT00799266|11992534|FG001|COMPLETED|Overall Study||15
10827203|NCT00799266|11992533|FG000|NOT COMPLETED|Overall Study||3
10827204|NCT00799266|11992534|FG001|NOT COMPLETED|Overall Study||1
10827205|NCT00810446|11992540|FG000|STARTED|Overall Study||72
10827206|NCT00810446|11992540|FG000|COMPLETED|Overall Study||72
10827207|NCT00810446|11992540|FG000|NOT COMPLETED|Overall Study||0
10827208|NCT00844480|11992546|FG000|STARTED|Overall Study||8
10827209|NCT00844480|11992547|FG001|STARTED|Overall Study||9
10827210|NCT00844480|11992546|FG000|COMPLETED|Overall Study||6
10827211|NCT00844480|11992547|FG001|COMPLETED|Overall Study||6
10827212|NCT00844480|11992546|FG000|NOT COMPLETED|Overall Study||2
10827213|NCT00844480|11992547|FG001|NOT COMPLETED|Overall Study||3
10827214|NCT00864474|11992553|FG000|STARTED|Overall Study||68
10827215|NCT00864474|11992553|FG000|COMPLETED|Overall Study||68
10827216|NCT00864474|11992553|FG000|NOT COMPLETED|Overall Study||0
10827217|NCT00873366|11992557|FG000|STARTED|Overall Study||77
10827218|NCT00873366|11992557|FG000|COMPLETED|Overall Study||71
10827219|NCT00873366|11992557|FG000|NOT COMPLETED|Overall Study||6
10827220|NCT00923247|11992563|FG000|STARTED|Overall Study||21
10827221|NCT00923247|11992564|FG001|STARTED|Overall Study||1
10827222|NCT00923247|11992563|FG000|COMPLETED|Overall Study||21
10827223|NCT00923247|11992564|FG001|COMPLETED|Overall Study||1
10827224|NCT00923247|11992563|FG000|NOT COMPLETED|Overall Study||0
10827225|NCT00923247|11992564|FG001|NOT COMPLETED|Overall Study||0
10827226|NCT00928226|11992580|FG000|STARTED|Overall Study||20
10827227|NCT00928226|11992581|FG001|STARTED|Overall Study||12
10827228|NCT00928226|11992582|FG002|STARTED|Overall Study||12
10827229|NCT00928226|11992583|FG003|STARTED|Overall Study||12
10827230|NCT00928226|11992580|FG000|Strata A: Small Tumor, Resected|Overall Study||6
10827231|NCT00928226|11992581|FG001|Strata A: Small Tumor, Resected|Overall Study||6
10827232|NCT00928226|11992582|FG002|Strata A: Small Tumor, Resected|Overall Study||6
10827233|NCT00928226|11992583|FG003|Strata A: Small Tumor, Resected|Overall Study||6
10827234|NCT00928226|11992580|FG000|Strata B: Small Tumor, Not Resected|Overall Study||5
10827235|NCT00928226|11992581|FG001|Strata B: Small Tumor, Not Resected|Overall Study||0
10827236|NCT00928226|11992582|FG002|Strata B: Small Tumor, Not Resected|Overall Study||0
10827237|NCT00928226|11992583|FG003|Strata B: Small Tumor, Not Resected|Overall Study||0
10827238|NCT00928226|11992580|FG000|Strata C: Large Tumor, Resected|Overall Study||8
10827239|NCT00928226|11992581|FG001|Strata C: Large Tumor, Resected|Overall Study||6
10827240|NCT00928226|11992582|FG002|Strata C: Large Tumor, Resected|Overall Study||6
10827241|NCT00928226|11992583|FG003|Strata C: Large Tumor, Resected|Overall Study||6
10827242|NCT00928226|11992580|FG000|Strata D: Large Tumor, Not Resected|Overall Study||1
10827243|NCT00928226|11992581|FG001|Strata D: Large Tumor, Not Resected|Overall Study||0
10827244|NCT00928226|11992582|FG002|Strata D: Large Tumor, Not Resected|Overall Study||0
10827245|NCT00928226|11992583|FG003|Strata D: Large Tumor, Not Resected|Overall Study||0
10827246|NCT00928226|11992580|FG000|COMPLETED|Overall Study||20
10827247|NCT00928226|11992581|FG001|COMPLETED|Overall Study||12
10827248|NCT00928226|11992582|FG002|COMPLETED|Overall Study||12
10827249|NCT00928226|11992583|FG003|COMPLETED|Overall Study||12
10827250|NCT00928226|11992580|FG000|NOT COMPLETED|Overall Study||0
10827251|NCT00928226|11992581|FG001|NOT COMPLETED|Overall Study||0
10827252|NCT00928226|11992582|FG002|NOT COMPLETED|Overall Study||0
10827253|NCT00928226|11992583|FG003|NOT COMPLETED|Overall Study||0
10827257|NCT00940498|11992605|FG000|STARTED|Overall Study||4
10827258|NCT00940498|11992606|FG001|STARTED|Overall Study||4
10827259|NCT00940498|11992607|FG002|STARTED|Overall Study||4
10827260|NCT00940498|11992608|FG003|STARTED|Overall Study||4
10827261|NCT00940498|11992609|FG004|STARTED|Overall Study||43
10827262|NCT00940498|11992610|FG005|STARTED|Overall Study||7
10827263|NCT00940498|11992611|FG006|STARTED|Overall Study||8
10827264|NCT00940498|11992612|FG007|STARTED|Overall Study||4
10827265|NCT00940498|11992605|FG000|COMPLETED|Overall Study||1
10827266|NCT00940498|11992606|FG001|COMPLETED|Overall Study||3
10827267|NCT00940498|11992607|FG002|COMPLETED|Overall Study||1
10827268|NCT00940498|11992608|FG003|COMPLETED|Overall Study||2
10827269|NCT00940498|11992609|FG004|COMPLETED|Overall Study||34
10827270|NCT00940498|11992610|FG005|COMPLETED|Overall Study||6
10827271|NCT00940498|11992611|FG006|COMPLETED|Overall Study||7
10827272|NCT00940498|11992612|FG007|COMPLETED|Overall Study||3
10827273|NCT00940498|11992605|FG000|NOT COMPLETED|Overall Study||3
10827274|NCT00940498|11992606|FG001|NOT COMPLETED|Overall Study||1
10827275|NCT00940498|11992607|FG002|NOT COMPLETED|Overall Study||3
10827276|NCT00940498|11992608|FG003|NOT COMPLETED|Overall Study||2
10827277|NCT00940498|11992609|FG004|NOT COMPLETED|Overall Study||9
10827278|NCT00940498|11992610|FG005|NOT COMPLETED|Overall Study||1
10290701|NCT04732338|11423485|FG000|STARTED|Overall Study||13
10827279|NCT00940498|11992611|FG006|NOT COMPLETED|Overall Study||1
10827280|NCT00940498|11992612|FG007|NOT COMPLETED|Overall Study||1
10827281|NCT04720547|11992638|FG000|STARTED|Overall Study||6
10827282|NCT04720547|11992639|FG001|STARTED|Overall Study||8
10827283|NCT04720547|11992638|FG000|COMPLETED|Overall Study||6
10827284|NCT04720547|11992639|FG001|COMPLETED|Overall Study||5
10827285|NCT04720547|11992638|FG000|NOT COMPLETED|Overall Study||0
10827254|NCT00930722|11992593|FG000|STARTED|Overall Study||329
10827255|NCT00930722|11992593|FG000|COMPLETED|Overall Study||302
10827256|NCT00930722|11992593|FG000|NOT COMPLETED|Overall Study||27
10827286|NCT04720547|11992639|FG001|NOT COMPLETED|Overall Study||3
10827287|NCT04553913|11992645|FG000|STARTED|Overall Study||15
10827288|NCT04553913|11992645|FG000|COMPLETED|Overall Study||9
10827289|NCT04553913|11992645|FG000|NOT COMPLETED|Overall Study||6
10827290|NCT04079452|11992650|FG000|STARTED|Overall Study||15
10827291|NCT04079452|11992650|FG000|COMPLETED|Overall Study||15
10827292|NCT04079452|11992650|FG000|NOT COMPLETED|Overall Study||0
10827293|NCT04009824|11992660|FG000|STARTED|Overall Study||10
10827294|NCT04009824|11992661|FG001|STARTED|Overall Study||10
10827295|NCT04009824|11992662|FG002|STARTED|Overall Study||11
10827296|NCT04009824|11992663|FG003|STARTED|Overall Study||10
10827297|NCT04009824|11992664|FG004|STARTED|Overall Study||10
10827298|NCT04009824|11992660|FG000|COMPLETED|Overall Study||8
10827299|NCT04009824|11992661|FG001|COMPLETED|Overall Study||7
10827300|NCT04009824|11992662|FG002|COMPLETED|Overall Study||6
10827301|NCT04009824|11992663|FG003|COMPLETED|Overall Study||8
10827302|NCT04009824|11992664|FG004|COMPLETED|Overall Study||7
10827303|NCT04009824|11992660|FG000|NOT COMPLETED|Overall Study||2
10827304|NCT04009824|11992661|FG001|NOT COMPLETED|Overall Study||3
10827305|NCT04009824|11992662|FG002|NOT COMPLETED|Overall Study||5
10827306|NCT04009824|11992663|FG003|NOT COMPLETED|Overall Study||2
10827307|NCT04009824|11992664|FG004|NOT COMPLETED|Overall Study||3
10827308|NCT03867383|11992678|FG000|STARTED|Overall Study||20
10827309|NCT03867383|11992679|FG001|STARTED|Overall Study||20
10827310|NCT03867383|11992678|FG000|COMPLETED|Overall Study||20
10290702|NCT04732338|11423486|FG001|STARTED|Overall Study||13
10290703|NCT04732338|11423485|FG000|COMPLETED|Overall Study||10
10290704|NCT04732338|11423486|FG001|COMPLETED|Overall Study||10
10290705|NCT04732338|11423485|FG000|NOT COMPLETED|Overall Study||3
10290706|NCT04732338|11423486|FG001|NOT COMPLETED|Overall Study||3
10313181|NCT00149227|11446739|FG000|NOT COMPLETED|Overall Study||0
10313182|NCT00149227|11446740|FG001|NOT COMPLETED|Overall Study||0
10313183|NCT00149396|11446746|FG000|STARTED|Overall Study||32
10313184|NCT00149396|11446746|FG000|Completed NV1020 Therapy|Overall Study||29
10313185|NCT00149396|11446746|FG000|Completed NV1020 and Chemotherapy|Overall Study||9
10313186|NCT00149396|11446746|FG000|COMPLETED|Overall Study||9
10313187|NCT00149396|11446746|FG000|NOT COMPLETED|Overall Study||23
10313188|NCT00149630|11446759|FG000|STARTED|Overall Study||34
10313189|NCT00149630|11446760|FG001|STARTED|Overall Study||40
10313190|NCT00149630|11446759|FG000|COMPLETED|Overall Study||26
10313191|NCT00149630|11446760|FG001|COMPLETED|Overall Study||35
10313192|NCT00149630|11446759|FG000|NOT COMPLETED|Overall Study||8
10313193|NCT00149630|11446760|FG001|NOT COMPLETED|Overall Study||5
10313194|NCT00149643|11446772|FG000|STARTED|Overall Study||34
10313195|NCT00149643|11446773|FG001|STARTED|Overall Study||36
10313196|NCT00149643|11446772|FG000|COMPLETED|Overall Study||0
10313197|NCT00149643|11446773|FG001|COMPLETED|Overall Study||0
10313198|NCT00149643|11446772|FG000|NOT COMPLETED|Overall Study||34
10313199|NCT00149643|11446773|FG001|NOT COMPLETED|Overall Study||36
10313200|NCT00149669|11446781|FG000|STARTED|Overall Study||32
10313201|NCT00149669|11446782|FG001|STARTED|Overall Study||35
10313202|NCT00149669|11446781|FG000|COMPLETED|Overall Study||29
10313203|NCT00149669|11446782|FG001|COMPLETED|Overall Study||30
10313204|NCT00149669|11446781|FG000|NOT COMPLETED|Overall Study||3
10313205|NCT00149669|11446782|FG001|NOT COMPLETED|Overall Study||5
10313206|NCT00149734|11446790|FG000|STARTED|Overall Study||4
10313207|NCT00149734|11446791|FG001|STARTED|Overall Study||4
10313208|NCT00149734|11446790|FG000|Started Intervention 2|Overall Study||4
10313209|NCT00149734|11446791|FG001|Started Intervention 2|Overall Study||4
10313210|NCT00149734|11446790|FG000|COMPLETED|Overall Study||4
10313211|NCT00149734|11446791|FG001|COMPLETED|Overall Study||4
10313212|NCT00149734|11446790|FG000|NOT COMPLETED|Overall Study||0
10313213|NCT00149734|11446791|FG001|NOT COMPLETED|Overall Study||0
10313214|NCT00149747|11446799|FG000|STARTED|Overall Study||36
10313215|NCT00149747|11446800|FG001|STARTED|Overall Study||30
10313216|NCT00149747|11446799|FG000|COMPLETED|Overall Study||32
10313217|NCT00149747|11446800|FG001|COMPLETED|Overall Study||27
10313218|NCT00149747|11446799|FG000|NOT COMPLETED|Overall Study||4
10313219|NCT00149747|11446800|FG001|NOT COMPLETED|Overall Study||3
10313220|NCT00149799|11446808|FG000|STARTED|Open Label Escitalopram (Phase I)||100
10313221|NCT00149799|11446809|FG001|STARTED|Open Label Escitalopram (Phase I)||0
10313222|NCT00149799|11446810|FG002|STARTED|Open Label Escitalopram (Phase I)||0
10313223|NCT00149799|11446808|FG000|COMPLETED|Open Label Escitalopram (Phase I)|14 completers were non-responders and 2 responders terminated the study after completing Phase I|74
10313224|NCT00149799|11446809|FG001|COMPLETED|Open Label Escitalopram (Phase I)||0
10313225|NCT00149799|11446810|FG002|COMPLETED|Open Label Escitalopram (Phase I)||0
10313226|NCT00149799|11446808|FG000|NOT COMPLETED|Open Label Escitalopram (Phase I)||26
10313227|NCT00149799|11446809|FG001|NOT COMPLETED|Open Label Escitalopram (Phase I)||0
10313228|NCT00149799|11446810|FG002|NOT COMPLETED|Open Label Escitalopram (Phase I)||0
10313229|NCT00149799|11446808|FG000|STARTED|Discontinuation (Phase II)||0
10313230|NCT00149799|11446809|FG001|STARTED|Discontinuation (Phase II)|Only responders who completed Phase I and were willing to continue were randomized in Phase II|28
10313231|NCT00149799|11446810|FG002|STARTED|Discontinuation (Phase II)|Only responders who completed Phase I and were willing to continue were randomized in Phase II|30
10313232|NCT00149799|11446808|FG000|COMPLETED|Discontinuation (Phase II)||0
10313233|NCT00149799|11446809|FG001|COMPLETED|Discontinuation (Phase II)||25
10313234|NCT00149799|11446810|FG002|COMPLETED|Discontinuation (Phase II)||21
10827311|NCT03867383|11992679|FG001|COMPLETED|Overall Study||20
10827312|NCT03867383|11992678|FG000|NOT COMPLETED|Overall Study||0
10827313|NCT03867383|11992679|FG001|NOT COMPLETED|Overall Study||0
10827314|NCT03449758|11992686|FG000|STARTED|Overall Study||84
10827315|NCT03449758|11992686|FG000|COMPLETED|Overall Study||65
10827316|NCT03449758|11992686|FG000|NOT COMPLETED|Overall Study||19
10827317|NCT03222973|11992693|FG000|STARTED|Part 1 (Week 0 to Week 72)||131
10827318|NCT03222973|11992694|FG001|STARTED|Part 1 (Week 0 to Week 72)||132
10827319|NCT03222973|11992695|FG002|STARTED|Part 1 (Week 0 to Week 72)||0
10827320|NCT03222973|11992696|FG003|STARTED|Part 1 (Week 0 to Week 72)||0
10827321|NCT03222973|11992693|FG000|Intent-to-treat (ITT) Population|Part 1 (Week 0 to Week 72)||131
10827322|NCT03222973|11992694|FG001|Intent-to-treat (ITT) Population|Part 1 (Week 0 to Week 72)||132
10827323|NCT03222973|11992695|FG002|Intent-to-treat (ITT) Population|Part 1 (Week 0 to Week 72)||0
10827324|NCT03222973|11992696|FG003|Intent-to-treat (ITT) Population|Part 1 (Week 0 to Week 72)||0
10827325|NCT03222973|11992693|FG000|Safety Population|Part 1 (Week 0 to Week 72)||131
10827326|NCT03222973|11992694|FG001|Safety Population|Part 1 (Week 0 to Week 72)||132
10827327|NCT03222973|11992695|FG002|Safety Population|Part 1 (Week 0 to Week 72)||0
10827328|NCT03222973|11992696|FG003|Safety Population|Part 1 (Week 0 to Week 72)||0
10827329|NCT03222973|11992693|FG000|COMPLETED|Part 1 (Week 0 to Week 72)||107
10827330|NCT03222973|11992694|FG001|COMPLETED|Part 1 (Week 0 to Week 72)||118
10827331|NCT03222973|11992695|FG002|COMPLETED|Part 1 (Week 0 to Week 72)||0
10827332|NCT03222973|11992696|FG003|COMPLETED|Part 1 (Week 0 to Week 72)||0
10827333|NCT03222973|11992693|FG000|NOT COMPLETED|Part 1 (Week 0 to Week 72)||24
10827334|NCT03222973|11992694|FG001|NOT COMPLETED|Part 1 (Week 0 to Week 72)||14
10827335|NCT03222973|11992695|FG002|NOT COMPLETED|Part 1 (Week 0 to Week 72)||0
10827336|NCT03222973|11992696|FG003|NOT COMPLETED|Part 1 (Week 0 to Week 72)||0
10827337|NCT03222973|11992693|FG000|STARTED|Part 2 (Week 73 to Week 168)||0
10827338|NCT03222973|11992694|FG001|STARTED|Part 2 (Week 73 to Week 168)||0
10827339|NCT03222973|11992695|FG002|STARTED|Part 2 (Week 73 to Week 168)|6 participants who completed Part 1 did not enter Part 2.|101
10827340|NCT03222973|11992696|FG003|STARTED|Part 2 (Week 73 to Week 168)|5 participants who completed Part 1 did not enter Part 2.|113
10827341|NCT03222973|11992693|FG000|ITT Population|Part 2 (Week 73 to Week 168)||0
10827342|NCT03222973|11992694|FG001|ITT Population|Part 2 (Week 73 to Week 168)||0
10827343|NCT03222973|11992695|FG002|ITT Population|Part 2 (Week 73 to Week 168)||100
10827344|NCT03222973|11992696|FG003|ITT Population|Part 2 (Week 73 to Week 168)||113
10827345|NCT03222973|11992693|FG000|Safety Population|Part 2 (Week 73 to Week 168)||0
10827346|NCT03222973|11992694|FG001|Safety Population|Part 2 (Week 73 to Week 168)||0
10827347|NCT03222973|11992695|FG002|Safety Population|Part 2 (Week 73 to Week 168)||100
10827348|NCT03222973|11992696|FG003|Safety Population|Part 2 (Week 73 to Week 168)||113
10827349|NCT03222973|11992693|FG000|COMPLETED|Part 2 (Week 73 to Week 168)||0
10827350|NCT03222973|11992694|FG001|COMPLETED|Part 2 (Week 73 to Week 168)||0
10827351|NCT03222973|11992695|FG002|COMPLETED|Part 2 (Week 73 to Week 168)||0
10827352|NCT03222973|11992696|FG003|COMPLETED|Part 2 (Week 73 to Week 168)||0
10827353|NCT03222973|11992693|FG000|NOT COMPLETED|Part 2 (Week 73 to Week 168)||0
10827354|NCT03222973|11992694|FG001|NOT COMPLETED|Part 2 (Week 73 to Week 168)||0
10827355|NCT03222973|11992695|FG002|NOT COMPLETED|Part 2 (Week 73 to Week 168)||101
10827356|NCT03222973|11992696|FG003|NOT COMPLETED|Part 2 (Week 73 to Week 168)||113
10827357|NCT03187262|11992706|FG000|STARTED|Induction||13
10827358|NCT03187262|11992706|FG000|COMPLETED|Induction||7
10827359|NCT03187262|11992706|FG000|NOT COMPLETED|Induction||6
10827360|NCT03187262|11992706|FG000|STARTED|Consolidation||7
10827361|NCT03187262|11992706|FG000|COMPLETED|Consolidation||2
10827362|NCT03187262|11992706|FG000|NOT COMPLETED|Consolidation||5
10827363|NCT03187262|11992706|FG000|STARTED|Maintenance||2
10827364|NCT03187262|11992706|FG000|COMPLETED|Maintenance||2
10827365|NCT03187262|11992706|FG000|NOT COMPLETED|Maintenance||0
10827366|NCT03137693|11992710|FG000|STARTED|Overall Study||20
10827367|NCT03137693|11992710|FG000|COMPLETED|Overall Study||20
10827368|NCT03137693|11992710|FG000|NOT COMPLETED|Overall Study||0
10827369|NCT02987959|11992714|FG000|STARTED|Overall Study||6
10827370|NCT02987959|11992714|FG000|COMPLETED|Overall Study||0
10827371|NCT02987959|11992714|FG000|NOT COMPLETED|Overall Study||6
10827372|NCT02985541|11992718|FG000|STARTED|Overall Study||364
10827373|NCT02985541|11992718|FG000|Valid for FAS|Overall Study||362
10827374|NCT02985541|11992718|FG000|Continued Into Year 7 of Mirena Use|Overall Study||305
10827375|NCT02985541|11992718|FG000|Continued Into Year 8 of Mirena Use|Overall Study||243
10827376|NCT02985541|11992718|FG000|COMPLETED|Overall Study||223
10827377|NCT02985541|11992718|FG000|NOT COMPLETED|Overall Study||141
10827378|NCT02960893|11992724|FG000|STARTED|Randomization Phase (8-week)||71
10827379|NCT02960893|11992725|FG001|STARTED|Randomization Phase (8-week)||70
10827380|NCT02960893|11992724|FG000|COMPLETED|Randomization Phase (8-week)||64
10827381|NCT02960893|11992725|FG001|COMPLETED|Randomization Phase (8-week)||68
10827382|NCT02960893|11992724|FG000|NOT COMPLETED|Randomization Phase (8-week)||7
10827383|NCT02960893|11992725|FG001|NOT COMPLETED|Randomization Phase (8-week)||2
10827384|NCT02960893|11992724|FG000|STARTED|Extension Phase (48-week)||64
10827385|NCT02960893|11992725|FG001|STARTED|Extension Phase (48-week)|One participant in placebo arm who completed Randomization Phase did not continue to Extension Phase|67
10827386|NCT02960893|11992724|FG000|COMPLETED|Extension Phase (48-week)||50
10827387|NCT02960893|11992725|FG001|COMPLETED|Extension Phase (48-week)||54
10827388|NCT02960893|11992724|FG000|NOT COMPLETED|Extension Phase (48-week)||14
10827389|NCT02960893|11992725|FG001|NOT COMPLETED|Extension Phase (48-week)||13
10827390|NCT02940522|11992740|FG000|STARTED|Overall Study||59
10827391|NCT02940522|11992741|FG001|STARTED|Overall Study||61
10827392|NCT02940522|11992740|FG000|COMPLETED|Overall Study||57
10827393|NCT02940522|11992741|FG001|COMPLETED|Overall Study||59
10827394|NCT02940522|11992740|FG000|NOT COMPLETED|Overall Study||2
10827395|NCT02940522|11992741|FG001|NOT COMPLETED|Overall Study||2
10827396|NCT02711137|11992762|FG000|STARTED|Overall Study||4
10827397|NCT02711137|11992763|FG001|STARTED|Overall Study||5
10827398|NCT02711137|11992764|FG002|STARTED|Overall Study||8
10827399|NCT02711137|11992765|FG003|STARTED|Overall Study||7
10827400|NCT02711137|11992766|FG004|STARTED|Overall Study||5
10827401|NCT02711137|11992767|FG005|STARTED|Overall Study||1
10827402|NCT02711137|11992768|FG006|STARTED|Overall Study||86
10827403|NCT02711137|11992769|FG007|STARTED|Overall Study||5
10827404|NCT02711137|11992770|FG008|STARTED|Overall Study||1
10827405|NCT02711137|11992771|FG009|STARTED|Overall Study||2
10827406|NCT02711137|11992772|FG010|STARTED|Overall Study||4
10827407|NCT02711137|11992773|FG011|STARTED|Overall Study||3
10827408|NCT02711137|11992774|FG012|STARTED|Overall Study||1
10827409|NCT02711137|11992775|FG013|STARTED|Overall Study||2
10827410|NCT02711137|11992776|FG014|STARTED|Overall Study||3
10827411|NCT02711137|11992762|FG000|COMPLETED|Overall Study||0
10827412|NCT02711137|11992763|FG001|COMPLETED|Overall Study||0
10827413|NCT02711137|11992764|FG002|COMPLETED|Overall Study||0
10827414|NCT02711137|11992765|FG003|COMPLETED|Overall Study||0
10827415|NCT02711137|11992766|FG004|COMPLETED|Overall Study||0
10290707|NCT04728802|11423494|FG000|STARTED|Overall Study||317
10290708|NCT04728802|11423495|FG001|STARTED|Overall Study||328
10290709|NCT04728802|11423494|FG000|COMPLETED|Overall Study||288
10290710|NCT04728802|11423495|FG001|COMPLETED|Overall Study||292
10290711|NCT04728802|11423494|FG000|NOT COMPLETED|Overall Study||29
10290712|NCT04728802|11423495|FG001|NOT COMPLETED|Overall Study||36
10290713|NCT04728594|11423504|FG000|STARTED|Overall Study|The number of participants who were sent a follow up email (delayed, three days after the other two arms) was used to see how many started.|3178
10290714|NCT04728594|11423505|FG001|STARTED|Overall Study||3198
10408947|NCT00757601|11552964|FG003|STARTED|Period 5||2
10408948|NCT00757601|11552965|FG004|STARTED|Period 5||2
10408949|NCT00757601|11552966|FG005|STARTED|Period 5||2
10408950|NCT00757601|11552967|FG006|STARTED|Period 5||2
10408951|NCT00757601|11552968|FG007|STARTED|Period 5||2
10408952|NCT00757601|11552969|FG008|STARTED|Period 5||2
10408953|NCT00757601|11552970|FG009|STARTED|Period 5||1
10408954|NCT00757601|11552971|FG010|STARTED|Period 5||2
10408955|NCT00757601|11552972|FG011|STARTED|Period 5||1
10408956|NCT00757601|11552961|FG000|COMPLETED|Period 5||2
10408957|NCT00757601|11552962|FG001|COMPLETED|Period 5||2
10408958|NCT00757601|11552963|FG002|COMPLETED|Period 5||2
10408959|NCT00757601|11552964|FG003|COMPLETED|Period 5||2
10408960|NCT00757601|11552965|FG004|COMPLETED|Period 5||2
10408961|NCT00757601|11552966|FG005|COMPLETED|Period 5||2
10408962|NCT00757601|11552967|FG006|COMPLETED|Period 5||2
10408963|NCT00757601|11552968|FG007|COMPLETED|Period 5||2
10408964|NCT00757601|11552969|FG008|COMPLETED|Period 5||2
10408965|NCT00757601|11552970|FG009|COMPLETED|Period 5||1
10408966|NCT00757601|11552971|FG010|COMPLETED|Period 5||2
10408967|NCT00757601|11552972|FG011|COMPLETED|Period 5||1
10408968|NCT00757601|11552961|FG000|NOT COMPLETED|Period 5||0
10408969|NCT00757601|11552962|FG001|NOT COMPLETED|Period 5||0
10408970|NCT00757601|11552963|FG002|NOT COMPLETED|Period 5||0
10408971|NCT00757601|11552964|FG003|NOT COMPLETED|Period 5||0
10408972|NCT00757601|11552965|FG004|NOT COMPLETED|Period 5||0
10408973|NCT00757601|11552966|FG005|NOT COMPLETED|Period 5||0
10408974|NCT00757601|11552967|FG006|NOT COMPLETED|Period 5||0
10544843|NCT01492088|11698024|FG001|STARTED|Overall Study||16
10544844|NCT01492088|11698025|FG002|STARTED|Overall Study||17
10544845|NCT01492088|11698023|FG000|COMPLETED|Overall Study||0
10544846|NCT01492088|11698024|FG001|COMPLETED|Overall Study||2
10544847|NCT01492088|11698025|FG002|COMPLETED|Overall Study||3
10544848|NCT01492088|11698023|FG000|NOT COMPLETED|Overall Study||3
10544849|NCT01492088|11698024|FG001|NOT COMPLETED|Overall Study||14
10544850|NCT01492088|11698025|FG002|NOT COMPLETED|Overall Study||14
10544851|NCT01492101|11698038|FG000|STARTED|Overall Study||429
10544852|NCT01492101|11698039|FG001|STARTED|Overall Study||423
10544853|NCT01492101|11698038|FG000|COMPLETED|Overall Study||92
10544854|NCT01492101|11698039|FG001|COMPLETED|Overall Study||81
10544855|NCT01492101|11698038|FG000|NOT COMPLETED|Overall Study||337
10544856|NCT01492101|11698039|FG001|NOT COMPLETED|Overall Study||342
10544857|NCT01492309|11698047|FG000|STARTED|Overall Study||11
10544858|NCT01492309|11698048|FG001|STARTED|Overall Study||11
10544859|NCT01492309|11698047|FG000|COMPLETED|Overall Study||11
10544860|NCT01492309|11698048|FG001|COMPLETED|Overall Study||11
10544861|NCT01492309|11698047|FG000|NOT COMPLETED|Overall Study||0
10544862|NCT01492309|11698048|FG001|NOT COMPLETED|Overall Study||0
10544863|NCT01492400|11698056|FG000|STARTED|Overall Study||181
10544864|NCT01492400|11698057|FG001|STARTED|Overall Study||182
10544865|NCT01492400|11698056|FG000|COMPLETED|Overall Study||165
10544866|NCT01492400|11698057|FG001|COMPLETED|Overall Study||166
10544867|NCT01492400|11698056|FG000|NOT COMPLETED|Overall Study||16
10827416|NCT02711137|11992767|FG005|COMPLETED|Overall Study||0
10408975|NCT00757601|11552968|FG007|NOT COMPLETED|Period 5||0
10408976|NCT00757601|11552969|FG008|NOT COMPLETED|Period 5||0
10544868|NCT01492400|11698057|FG001|NOT COMPLETED|Overall Study||16
10544869|NCT01492426|11698065|FG000|STARTED|Treatment||402
10827417|NCT02711137|11992768|FG006|COMPLETED|Overall Study||0
10827418|NCT02711137|11992769|FG007|COMPLETED|Overall Study||0
10408977|NCT00757601|11552970|FG009|NOT COMPLETED|Period 5||0
10408978|NCT00757601|11552971|FG010|NOT COMPLETED|Period 5||0
10408979|NCT00757601|11552972|FG011|NOT COMPLETED|Period 5||0
10408980|NCT00757666|11553004|FG000|STARTED|Overall Study||34
10544870|NCT01492426|11698066|FG001|STARTED|Treatment||200
10827419|NCT02711137|11992770|FG008|COMPLETED|Overall Study||0
10827420|NCT02711137|11992771|FG009|COMPLETED|Overall Study||0
10827421|NCT02711137|11992772|FG010|COMPLETED|Overall Study||0
10827422|NCT02711137|11992773|FG011|COMPLETED|Overall Study||0
10827423|NCT02711137|11992774|FG012|COMPLETED|Overall Study||0
10827424|NCT02711137|11992775|FG013|COMPLETED|Overall Study||0
10827425|NCT02711137|11992776|FG014|COMPLETED|Overall Study||0
10827426|NCT02711137|11992762|FG000|NOT COMPLETED|Overall Study||4
10827427|NCT02711137|11992763|FG001|NOT COMPLETED|Overall Study||5
10827428|NCT02711137|11992764|FG002|NOT COMPLETED|Overall Study||8
10827429|NCT02711137|11992765|FG003|NOT COMPLETED|Overall Study||7
10827430|NCT02711137|11992766|FG004|NOT COMPLETED|Overall Study||5
10827431|NCT02711137|11992767|FG005|NOT COMPLETED|Overall Study||1
10827432|NCT02711137|11992768|FG006|NOT COMPLETED|Overall Study||86
10827433|NCT02711137|11992769|FG007|NOT COMPLETED|Overall Study||5
10827434|NCT02711137|11992770|FG008|NOT COMPLETED|Overall Study||1
10827435|NCT02711137|11992771|FG009|NOT COMPLETED|Overall Study||2
10827436|NCT02711137|11992772|FG010|NOT COMPLETED|Overall Study||4
10827437|NCT02711137|11992773|FG011|NOT COMPLETED|Overall Study||3
10827438|NCT02711137|11992774|FG012|NOT COMPLETED|Overall Study||1
10827439|NCT02711137|11992775|FG013|NOT COMPLETED|Overall Study||2
10827440|NCT02711137|11992776|FG014|NOT COMPLETED|Overall Study||3
10290715|NCT04728594|11423506|FG002|STARTED|Overall Study||3190
10827557|NCT02575976|11992861|FG000|STARTED|Overall Study||37
10827558|NCT02575976|11992862|FG001|STARTED|Overall Study||39
10827559|NCT02575976|11992863|FG002|STARTED|Overall Study||39
10827560|NCT02575976|11992861|FG000|COMPLETED|Overall Study||32
10827561|NCT02575976|11992862|FG001|COMPLETED|Overall Study||31
10827562|NCT02575976|11992863|FG002|COMPLETED|Overall Study||30
10827563|NCT02575976|11992861|FG000|NOT COMPLETED|Overall Study||5
10827564|NCT02575976|11992862|FG001|NOT COMPLETED|Overall Study||8
10827565|NCT02575976|11992863|FG002|NOT COMPLETED|Overall Study||9
10827566|NCT02545868|11992874|FG000|STARTED|Immunization Study Period (ISP)||33
10827567|NCT02545868|11992875|FG001|STARTED|Immunization Study Period (ISP)||35
10827568|NCT02545868|11992876|FG002|STARTED|Immunization Study Period (ISP)||34
10827569|NCT02545868|11992874|FG000|COMPLETED|Immunization Study Period (ISP)||33
10290716|NCT04728594|11423504|FG000|COMPLETED|Overall Study||3178
10827570|NCT02545868|11992875|FG001|COMPLETED|Immunization Study Period (ISP)||35
10827571|NCT02545868|11992876|FG002|COMPLETED|Immunization Study Period (ISP)||34
10827572|NCT02545868|11992874|FG000|NOT COMPLETED|Immunization Study Period (ISP)||0
10827573|NCT02545868|11992875|FG001|NOT COMPLETED|Immunization Study Period (ISP)||0
10827574|NCT02545868|11992876|FG002|NOT COMPLETED|Immunization Study Period (ISP)||0
10827575|NCT02545868|11992874|FG000|STARTED|Optional Ocrelizumab Ext (OOE) Period||33
10827576|NCT02545868|11992875|FG001|STARTED|Optional Ocrelizumab Ext (OOE) Period||35
10827577|NCT02545868|11992876|FG002|STARTED|Optional Ocrelizumab Ext (OOE) Period||34
10827578|NCT02545868|11992874|FG000|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0
10827579|NCT02545868|11992875|FG001|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0
10827580|NCT02545868|11992876|FG002|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0
10827581|NCT02545868|11992874|FG000|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||33
10827582|NCT02545868|11992875|FG001|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||35
10827583|NCT02545868|11992876|FG002|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||34
10827584|NCT02470091|11992891|FG000|STARTED|Overall Study||16
10827585|NCT02470091|11992892|FG001|STARTED|Overall Study||40
10827586|NCT02470091|11992891|FG000|Follow-up Report|Overall Study||1
10827587|NCT02470091|11992892|FG001|Follow-up Report|Overall Study||10
10827588|NCT02470091|11992891|FG000|COMPLETED|Overall Study||15
10827589|NCT02470091|11992892|FG001|COMPLETED|Overall Study||38
10827590|NCT02470091|11992891|FG000|NOT COMPLETED|Overall Study||1
10827591|NCT02470091|11992892|FG001|NOT COMPLETED|Overall Study||2
10827592|NCT02440425|11992900|FG000|STARTED|Overall Study||42
10827593|NCT02440425|11992900|FG000|COMPLETED|Overall Study||37
10827594|NCT02440425|11992900|FG000|NOT COMPLETED|Overall Study||5
10827595|NCT02343120|11992909|FG000|STARTED|Part 1: Dose Escalation||3
10827596|NCT02343120|11992910|FG001|STARTED|Part 1: Dose Escalation||4
10827597|NCT02343120|11992911|FG002|STARTED|Part 1: Dose Escalation||5
10827598|NCT02343120|11992912|FG003|STARTED|Part 1: Dose Escalation||4
10827599|NCT02343120|11992913|FG004|STARTED|Part 1: Dose Escalation||1
10827600|NCT02343120|11992909|FG000|COMPLETED|Part 1: Dose Escalation||0
10827601|NCT02343120|11992910|FG001|COMPLETED|Part 1: Dose Escalation||0
10827602|NCT02343120|11992911|FG002|COMPLETED|Part 1: Dose Escalation||0
10827603|NCT02343120|11992912|FG003|COMPLETED|Part 1: Dose Escalation||0
10827604|NCT02343120|11992913|FG004|COMPLETED|Part 1: Dose Escalation||0
10827605|NCT02343120|11992909|FG000|NOT COMPLETED|Part 1: Dose Escalation||3
10827606|NCT02343120|11992910|FG001|NOT COMPLETED|Part 1: Dose Escalation||4
10827607|NCT02343120|11992911|FG002|NOT COMPLETED|Part 1: Dose Escalation||5
10827608|NCT02343120|11992912|FG003|NOT COMPLETED|Part 1: Dose Escalation||4
10827609|NCT02343120|11992913|FG004|NOT COMPLETED|Part 1: Dose Escalation||1
10827610|NCT02343120|11992909|FG000|STARTED|Part 2: Expansion||0
10827611|NCT02343120|11992910|FG001|STARTED|Part 2: Expansion||0
10827612|NCT02343120|11992911|FG002|STARTED|Part 2: Expansion||0
10827613|NCT02343120|11992912|FG003|STARTED|Part 2: Expansion||274
10827614|NCT02343120|11992913|FG004|STARTED|Part 2: Expansion||94
10827615|NCT02343120|11992909|FG000|COMPLETED|Part 2: Expansion||0
10827616|NCT02343120|11992910|FG001|COMPLETED|Part 2: Expansion||0
10827617|NCT02343120|11992911|FG002|COMPLETED|Part 2: Expansion||0
10827618|NCT02343120|11992912|FG003|COMPLETED|Part 2: Expansion||0
10827619|NCT02343120|11992913|FG004|COMPLETED|Part 2: Expansion||0
10827620|NCT02343120|11992909|FG000|NOT COMPLETED|Part 2: Expansion||0
10827621|NCT02343120|11992910|FG001|NOT COMPLETED|Part 2: Expansion||0
10827622|NCT02343120|11992911|FG002|NOT COMPLETED|Part 2: Expansion||0
10827623|NCT02343120|11992912|FG003|NOT COMPLETED|Part 2: Expansion||274
10827624|NCT02343120|11992913|FG004|NOT COMPLETED|Part 2: Expansion||94
10290717|NCT04728594|11423505|FG001|COMPLETED|Overall Study||3198
10290718|NCT04728594|11423506|FG002|COMPLETED|Overall Study||3190
10290719|NCT04728594|11423504|FG000|NOT COMPLETED|Overall Study||0
10290720|NCT04728594|11423505|FG001|NOT COMPLETED|Overall Study||0
10290721|NCT04728594|11423506|FG002|NOT COMPLETED|Overall Study||0
10313235|NCT00149799|11446808|FG000|NOT COMPLETED|Discontinuation (Phase II)||0
10313236|NCT00149799|11446809|FG001|NOT COMPLETED|Discontinuation (Phase II)||3
10544871|NCT01492426|11698065|FG000|COMPLETED|Treatment||319
10544872|NCT01492426|11698066|FG001|COMPLETED|Treatment||160
10544873|NCT01492426|11698065|FG000|NOT COMPLETED|Treatment||83
10544874|NCT01492426|11698066|FG001|NOT COMPLETED|Treatment||40
10544875|NCT01492426|11698065|FG000|STARTED|Follow-Up|This total number includes 319 who completed treatment plus 65 who rejoined for follow-up.|384
10544876|NCT01492426|11698066|FG001|STARTED|Follow-Up|This total number includes 160 who completed treatment plus 31 who rejoined for follow-up.|191
10544877|NCT01492426|11698065|FG000|COMPLETED|Follow-Up||359
10544878|NCT01492426|11698066|FG001|COMPLETED|Follow-Up||181
10544879|NCT01492426|11698065|FG000|NOT COMPLETED|Follow-Up||25
10544880|NCT01492426|11698066|FG001|NOT COMPLETED|Follow-Up||10
10544881|NCT01492439|11698078|FG000|STARTED|Overall Study||19
10544882|NCT01492439|11698079|FG001|STARTED|Overall Study||18
10544883|NCT01492439|11698078|FG000|Post-intervention|Overall Study||18
10544884|NCT01492439|11698079|FG001|Post-intervention|Overall Study||13
10544885|NCT01492439|11698078|FG000|COMPLETED|Overall Study||15
10544886|NCT01492439|11698079|FG001|COMPLETED|Overall Study||9
10544887|NCT01492439|11698078|FG000|NOT COMPLETED|Overall Study||4
10544888|NCT01492439|11698079|FG001|NOT COMPLETED|Overall Study||9
10544889|NCT01492582|11698087|FG000|STARTED|Overall Study|Consented to the vaccine arm (265 quadrivalent vaccine; 188 nonavalent vaccine)|453
10544890|NCT01492582|11698088|FG001|STARTED|Overall Study|Consented to the survey arm of the study|1046
10544891|NCT01492582|11698087|FG000|Received First Quadrivalent Vaccine Dose|Overall Study||254
10544892|NCT01492582|11698088|FG001|Received First Quadrivalent Vaccine Dose|Overall Study|Does not apply|0
10544893|NCT01492582|11698087|FG000|Received First Nonavalent Vaccine Dose|Overall Study||182
10544894|NCT01492582|11698088|FG001|Received First Nonavalent Vaccine Dose|Overall Study||0
10544895|NCT01492582|11698087|FG000|COMPLETED|Overall Study|Received 3 vaccine doses and completed Month 7 blood draw (224 quadrivalent; 160 nonavalent)|384
10544896|NCT01492582|11698088|FG001|COMPLETED|Overall Study|Returned evaluable survey|982
10544897|NCT01492582|11698087|FG000|NOT COMPLETED|Overall Study||69
10544898|NCT01492582|11698088|FG001|NOT COMPLETED|Overall Study||64
10544899|NCT01492673|11698111|FG000|STARTED|Overall Study||9
10544900|NCT01492673|11698111|FG000|COMPLETED|Overall Study||9
10544901|NCT01492673|11698111|FG000|NOT COMPLETED|Overall Study||0
10544902|NCT01492686|11698117|FG000|STARTED|Double-blind Phase||69
10544903|NCT01492686|11698118|FG001|STARTED|Double-blind Phase||68
10544904|NCT01492686|11698117|FG000|COMPLETED|Double-blind Phase||67
10544905|NCT01492686|11698118|FG001|COMPLETED|Double-blind Phase||60
10544906|NCT01492686|11698117|FG000|NOT COMPLETED|Double-blind Phase||2
10544907|NCT01492686|11698118|FG001|NOT COMPLETED|Double-blind Phase||8
10544908|NCT01492686|11698117|FG000|STARTED|Open-label Phase||65
10544909|NCT01492686|11698118|FG001|STARTED|Open-label Phase||58
10544910|NCT01492686|11698117|FG000|COMPLETED|Open-label Phase||53
10544911|NCT01492686|11698118|FG001|COMPLETED|Open-label Phase||40
10544912|NCT01492686|11698117|FG000|NOT COMPLETED|Open-label Phase||12
10544913|NCT01492686|11698118|FG001|NOT COMPLETED|Open-label Phase||18
10754158|NCT03049917|11917821|FG002|NOT COMPLETED|Overall Study||49
10754159|NCT03049917|11917822|FG003|NOT COMPLETED|Overall Study||41
10754160|NCT03049917|11917823|FG004|NOT COMPLETED|Overall Study||34
10754161|NCT03050203|11917859|FG000|STARTED|Overall Study||19
10754162|NCT03050203|11917860|FG001|STARTED|Overall Study||18
10754163|NCT03050203|11917859|FG000|COMPLETED|Overall Study||19
10754164|NCT03050203|11917860|FG001|COMPLETED|Overall Study||18
10754165|NCT03050203|11917859|FG000|NOT COMPLETED|Overall Study||0
10754166|NCT03050203|11917860|FG001|NOT COMPLETED|Overall Study||0
10754167|NCT03050216|11917866|FG000|STARTED|Overall Study||8
10754168|NCT03050216|11917866|FG000|COMPLETED|Overall Study||8
10754169|NCT03050216|11917866|FG000|NOT COMPLETED|Overall Study||0
10754170|NCT03050294|11917874|FG000|STARTED|Overall Study||6
10754171|NCT03050294|11917875|FG001|STARTED|Overall Study||6
10754172|NCT03050294|11917876|FG002|STARTED|Overall Study||6
10754173|NCT03050294|11917877|FG003|STARTED|Overall Study||6
10754174|NCT03050294|11917874|FG000|COMPLETED|Overall Study||6
10754175|NCT03050294|11917875|FG001|COMPLETED|Overall Study||6
10754176|NCT03050294|11917876|FG002|COMPLETED|Overall Study||6
10754177|NCT03050294|11917877|FG003|COMPLETED|Overall Study||6
10754178|NCT03050294|11917874|FG000|NOT COMPLETED|Overall Study||0
10754179|NCT03050294|11917875|FG001|NOT COMPLETED|Overall Study||0
10754180|NCT03050294|11917876|FG002|NOT COMPLETED|Overall Study||0
10754181|NCT03050294|11917877|FG003|NOT COMPLETED|Overall Study||0
10754182|NCT03050307|11917889|FG000|STARTED|Overall Study||115
10754183|NCT03050307|11917890|FG001|STARTED|Overall Study||119
10754184|NCT03050307|11917889|FG000|COMPLETED|Overall Study||107
10754185|NCT03050307|11917890|FG001|COMPLETED|Overall Study||110
10754186|NCT03050307|11917889|FG000|NOT COMPLETED|Overall Study||8
10754187|NCT03050307|11917890|FG001|NOT COMPLETED|Overall Study||9
10754188|NCT03050320|11917900|FG000|STARTED|Overall Study||21
10754189|NCT03050320|11917901|FG001|STARTED|Overall Study||22
10754190|NCT03050320|11917900|FG000|COMPLETED|Overall Study||20
10754191|NCT03050320|11917901|FG001|COMPLETED|Overall Study||21
10313237|NCT00149799|11446810|FG002|NOT COMPLETED|Discontinuation (Phase II)||9
10827721|NCT01659151|11992980|FG000|STARTED|Overall Study||17
10827722|NCT01659151|11992980|FG000|COMPLETED|Overall Study||16
10827723|NCT01659151|11992980|FG000|NOT COMPLETED|Overall Study||1
10827724|NCT01634048|11992986|FG000|STARTED|Overall Study||21
10827725|NCT01634048|11992987|FG001|STARTED|Overall Study||18
10827726|NCT01634048|11992986|FG000|COMPLETED|Overall Study||15
10827727|NCT01634048|11992987|FG001|COMPLETED|Overall Study||15
10827728|NCT01634048|11992986|FG000|NOT COMPLETED|Overall Study||6
10827729|NCT01634048|11992987|FG001|NOT COMPLETED|Overall Study||3
10827730|NCT01539863|11992995|FG000|STARTED|Overall Study||166
10827731|NCT01539863|11992996|FG001|STARTED|Overall Study||162
10827732|NCT01539863|11992995|FG000|COMPLETED|Overall Study||161
10827733|NCT01539863|11992996|FG001|COMPLETED|Overall Study||158
10827734|NCT01539863|11992995|FG000|NOT COMPLETED|Overall Study||5
10827735|NCT01539863|11992996|FG001|NOT COMPLETED|Overall Study||4
10827736|NCT01505062|11993005|FG000|STARTED|Overall Study||3
10827737|NCT01505062|11993006|FG001|STARTED|Overall Study||3
10827738|NCT01505062|11993007|FG002|STARTED|Overall Study||3
10827739|NCT01505062|11993005|FG000|COMPLETED|Overall Study||3
10827740|NCT01505062|11993006|FG001|COMPLETED|Overall Study||3
10827741|NCT01505062|11993007|FG002|COMPLETED|Overall Study||3
10827742|NCT01505062|11993005|FG000|NOT COMPLETED|Overall Study||0
10827743|NCT01505062|11993006|FG001|NOT COMPLETED|Overall Study||0
10827744|NCT01505062|11993007|FG002|NOT COMPLETED|Overall Study||0
10827745|NCT01439165|11993017|FG000|STARTED|Overall Study||1002
10827746|NCT01439165|11993018|FG001|STARTED|Overall Study||328
10827747|NCT01439165|11993017|FG000|COMPLETED|Overall Study||981
10827748|NCT01439165|11993018|FG001|COMPLETED|Overall Study||326
10827749|NCT01439165|11993017|FG000|NOT COMPLETED|Overall Study||21
10827750|NCT01439165|11993018|FG001|NOT COMPLETED|Overall Study||2
10827751|NCT01264679|11993024|FG000|STARTED|Overall Study||8
10827752|NCT01264679|11993024|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7
10827753|NCT01264679|11993024|FG000|COMPLETED|Overall Study||3
10827754|NCT01264679|11993024|FG000|NOT COMPLETED|Overall Study||5
10827755|NCT01155388|11993031|FG000|STARTED|Overall Study||8
10827756|NCT01155388|11993032|FG001|STARTED|Overall Study||6
10827757|NCT01155388|11993031|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
10827758|NCT01155388|11993032|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
10827759|NCT01155388|11993031|FG000|COMPLETED|Overall Study||7
10827760|NCT01155388|11993032|FG001|COMPLETED|Overall Study||6
10827761|NCT01155388|11993031|FG000|NOT COMPLETED|Overall Study||1
10827762|NCT01155388|11993032|FG001|NOT COMPLETED|Overall Study||0
10827763|NCT01137435|11993039|FG000|STARTED|Overall Study||687
10827764|NCT01137435|11993039|FG000|COMPLETED|Overall Study||659
10827765|NCT01137435|11993039|FG000|NOT COMPLETED|Overall Study||28
10827766|NCT01095003|11993045|FG000|STARTED|Overall Study||384
10827767|NCT01095003|11993046|FG001|STARTED|Overall Study||386
10827768|NCT01095003|11993045|FG000|COMPLETED|Overall Study||0
10827769|NCT01095003|11993046|FG001|COMPLETED|Overall Study||0
10827770|NCT01095003|11993045|FG000|NOT COMPLETED|Overall Study||384
10827771|NCT01095003|11993046|FG001|NOT COMPLETED|Overall Study||386
10827772|NCT01064817|11993056|FG000|STARTED|All Study Treatment Days 1-9||62
10827773|NCT01064817|11993057|FG001|STARTED|All Study Treatment Days 1-9||62
10827774|NCT01064817|11993056|FG000|COMPLETED|All Study Treatment Days 1-9||62
10827775|NCT01064817|11993057|FG001|COMPLETED|All Study Treatment Days 1-9||62
10827776|NCT01064817|11993056|FG000|NOT COMPLETED|All Study Treatment Days 1-9||0
10827777|NCT01064817|11993057|FG001|NOT COMPLETED|All Study Treatment Days 1-9||0
10827778|NCT01064817|11993056|FG000|STARTED|Study Completion||62
10827779|NCT01064817|11993057|FG001|STARTED|Study Completion||62
10827780|NCT01064817|11993056|FG000|COMPLETED|Study Completion||60
10827781|NCT01064817|11993057|FG001|COMPLETED|Study Completion||62
10827782|NCT01064817|11993056|FG000|NOT COMPLETED|Study Completion||2
10827783|NCT01064817|11993057|FG001|NOT COMPLETED|Study Completion||0
10827784|NCT01026220|11993063|FG000|STARTED|Induction||166
10827785|NCT01026220|11993064|FG001|STARTED|Induction||0
10827786|NCT01026220|11993065|FG002|STARTED|Induction||0
10827787|NCT01026220|11993063|FG000|COMPLETED|Induction||141
10827788|NCT01026220|11993064|FG001|COMPLETED|Induction||0
10827789|NCT01026220|11993065|FG002|COMPLETED|Induction||0
10827790|NCT01026220|11993063|FG000|NOT COMPLETED|Induction||25
10827791|NCT01026220|11993064|FG001|NOT COMPLETED|Induction||0
10827792|NCT01026220|11993065|FG002|NOT COMPLETED|Induction||0
10827793|NCT01026220|11993063|FG000|STARTED|Consolidation Maintenance||0
10827794|NCT01026220|11993064|FG001|STARTED|Consolidation Maintenance||81
10827795|NCT01026220|11993065|FG002|STARTED|Consolidation Maintenance||80
10827796|NCT01026220|11993063|FG000|COMPLETED|Consolidation Maintenance||0
10827797|NCT01026220|11993064|FG001|COMPLETED|Consolidation Maintenance||75
10827798|NCT01026220|11993065|FG002|COMPLETED|Consolidation Maintenance||66
10827799|NCT01026220|11993063|FG000|NOT COMPLETED|Consolidation Maintenance||0
10827800|NCT01026220|11993064|FG001|NOT COMPLETED|Consolidation Maintenance||6
10827801|NCT01026220|11993065|FG002|NOT COMPLETED|Consolidation Maintenance||14
10827802|NCT00961714|11993080|FG000|STARTED|Overall Study||15
10827803|NCT00961714|11993080|FG000|COMPLETED|Overall Study||13
10827804|NCT00961714|11993080|FG000|NOT COMPLETED|Overall Study||2
10827805|NCT00567567|11993087|FG000|STARTED|Overall Study||210
10827806|NCT00567567|11993088|FG001|STARTED|Overall Study||176
10827807|NCT00567567|11993089|FG002|STARTED|Overall Study||279
10827808|NCT00567567|11993087|FG000|COMPLETED|Overall Study||58
10827809|NCT00567567|11993088|FG001|COMPLETED|Overall Study||42
10827810|NCT00567567|11993089|FG002|COMPLETED|Overall Study||1
10827811|NCT00567567|11993087|FG000|NOT COMPLETED|Overall Study||152
10827812|NCT00567567|11993088|FG001|NOT COMPLETED|Overall Study||134
10827813|NCT00567567|11993089|FG002|NOT COMPLETED|Overall Study||278
10827814|NCT00450450|11993101|FG000|STARTED|Overall Study||13
10827815|NCT00450450|11993102|FG001|STARTED|Overall Study||14
10827816|NCT00450450|11993101|FG000|COMPLETED|Overall Study||8
10827817|NCT00450450|11993102|FG001|COMPLETED|Overall Study||11
10827818|NCT00450450|11993101|FG000|NOT COMPLETED|Overall Study||5
10827819|NCT00450450|11993102|FG001|NOT COMPLETED|Overall Study||3
10827820|NCT00346164|11993112|FG000|STARTED|Overall Study||222
10827821|NCT00346164|11993113|FG001|STARTED|Overall Study||21
10827822|NCT00346164|11993114|FG002|STARTED|Overall Study||122
10827823|NCT00346164|11993115|FG003|STARTED|Overall Study||223
10827824|NCT00346164|11993112|FG000|COMPLETED|Overall Study||205
10827825|NCT00346164|11993113|FG001|COMPLETED|Overall Study||14
10827826|NCT00346164|11993114|FG002|COMPLETED|Overall Study||96
10827827|NCT00346164|11993115|FG003|COMPLETED|Overall Study||117
10827828|NCT00346164|11993112|FG000|NOT COMPLETED|Overall Study||17
10827829|NCT00346164|11993113|FG001|NOT COMPLETED|Overall Study||7
10827830|NCT00346164|11993114|FG002|NOT COMPLETED|Overall Study||26
10827831|NCT00346164|11993115|FG003|NOT COMPLETED|Overall Study||106
10827853|NCT04360187|11993176|FG000|STARTED|Double-Blind Treatment||131
10827854|NCT04360187|11993177|FG001|STARTED|Double-Blind Treatment||260
10827855|NCT04360187|11993176|FG000|COMPLETED|Double-Blind Treatment||108
10827856|NCT04360187|11993177|FG001|COMPLETED|Double-Blind Treatment||245
10827857|NCT04360187|11993176|FG000|NOT COMPLETED|Double-Blind Treatment||23
10827858|NCT04360187|11993177|FG001|NOT COMPLETED|Double-Blind Treatment||15
10827859|NCT04360187|11993176|FG000|STARTED|Follow-Up||114
10827860|NCT04360187|11993177|FG001|STARTED|Follow-Up||232
10827861|NCT04360187|11993176|FG000|COMPLETED|Follow-Up||113
10827862|NCT04360187|11993177|FG001|COMPLETED|Follow-Up||232
10827863|NCT04360187|11993176|FG000|NOT COMPLETED|Follow-Up||1
10827864|NCT04360187|11993177|FG001|NOT COMPLETED|Follow-Up||0
10827879|NCT03978091|11993201|FG000|STARTED|Overall Study||8
10827880|NCT03978091|11993202|FG001|STARTED|Overall Study||8
10827881|NCT03978091|11993203|FG002|STARTED|Overall Study||8
10827882|NCT03978091|11993204|FG003|STARTED|Overall Study||8
10827883|NCT03978091|11993205|FG004|STARTED|Overall Study||8
10827884|NCT03978091|11993206|FG005|STARTED|Overall Study||8
10827885|NCT03978091|11993201|FG000|COMPLETED|Overall Study||8
10827886|NCT03978091|11993202|FG001|COMPLETED|Overall Study||8
10827887|NCT03978091|11993203|FG002|COMPLETED|Overall Study||7
10827888|NCT03978091|11993204|FG003|COMPLETED|Overall Study||7
10827889|NCT03978091|11993205|FG004|COMPLETED|Overall Study||7
10827890|NCT03978091|11993206|FG005|COMPLETED|Overall Study||8
10827891|NCT03978091|11993201|FG000|NOT COMPLETED|Overall Study||0
10827892|NCT03978091|11993202|FG001|NOT COMPLETED|Overall Study||0
10827893|NCT03978091|11993203|FG002|NOT COMPLETED|Overall Study||1
10827894|NCT03978091|11993204|FG003|NOT COMPLETED|Overall Study||1
10827895|NCT03978091|11993205|FG004|NOT COMPLETED|Overall Study||1
10827896|NCT03978091|11993206|FG005|NOT COMPLETED|Overall Study||0
10827897|NCT03903640|11993220|FG000|STARTED|Overall Study||2
10827898|NCT03903640|11993220|FG000|COMPLETED|Overall Study||2
10827899|NCT03903640|11993220|FG000|NOT COMPLETED|Overall Study||0
10827900|NCT03853291|11993230|FG000|STARTED|Overall Study||18
10827901|NCT03853291|11993231|FG001|STARTED|Overall Study||16
10827902|NCT03853291|11993232|FG002|STARTED|Overall Study||18
10827903|NCT03853291|11993233|FG003|STARTED|Overall Study||16
10827904|NCT03853291|11993234|FG004|STARTED|Overall Study||6
10827905|NCT03853291|11993235|FG005|STARTED|Overall Study||11
10827906|NCT03853291|11993230|FG000|COMPLETED|Overall Study||16
10827907|NCT03853291|11993231|FG001|COMPLETED|Overall Study||13
10827908|NCT03853291|11993232|FG002|COMPLETED|Overall Study||18
10827909|NCT03853291|11993233|FG003|COMPLETED|Overall Study||16
10827910|NCT03853291|11993234|FG004|COMPLETED|Overall Study||6
10827911|NCT03853291|11993235|FG005|COMPLETED|Overall Study||11
10827912|NCT03853291|11993230|FG000|NOT COMPLETED|Overall Study||2
10827913|NCT03853291|11993231|FG001|NOT COMPLETED|Overall Study||3
10827914|NCT03853291|11993232|FG002|NOT COMPLETED|Overall Study||0
10827915|NCT03853291|11993233|FG003|NOT COMPLETED|Overall Study||0
10827916|NCT03853291|11993234|FG004|NOT COMPLETED|Overall Study||0
10827917|NCT03853291|11993235|FG005|NOT COMPLETED|Overall Study||0
10827924|NCT03638011|11993257|FG000|STARTED|Overall Study||38
10827925|NCT03638011|11993258|FG001|STARTED|Overall Study||33
10827926|NCT03638011|11993257|FG000|COMPLETED|Overall Study||38
10827927|NCT03638011|11993258|FG001|COMPLETED|Overall Study||33
10827928|NCT03638011|11993257|FG000|NOT COMPLETED|Overall Study||0
10827929|NCT03638011|11993258|FG001|NOT COMPLETED|Overall Study||0
10827930|NCT03457129|11993266|FG000|STARTED|Overall Study||10
10827931|NCT03457129|11993267|FG001|STARTED|Overall Study||10
10827932|NCT03457129|11993266|FG000|COMPLETED|Overall Study||7
10827933|NCT03457129|11993267|FG001|COMPLETED|Overall Study||8
10827934|NCT03457129|11993266|FG000|NOT COMPLETED|Overall Study||3
10827935|NCT03457129|11993267|FG001|NOT COMPLETED|Overall Study||2
10827957|NCT03274804|11993295|FG000|STARTED|Overall Study||20
10827958|NCT03274804|11993295|FG000|COMPLETED|Overall Study||20
10827959|NCT03274804|11993295|FG000|NOT COMPLETED|Overall Study||0
10827966|NCT03190460|11993312|FG000|STARTED|Overall Study||40
10827967|NCT03190460|11993313|FG001|STARTED|Overall Study||20
10827968|NCT03190460|11993312|FG000|COMPLETED|Overall Study||3
10827969|NCT03190460|11993313|FG001|COMPLETED|Overall Study||2
10827970|NCT03190460|11993312|FG000|NOT COMPLETED|Overall Study||37
10827971|NCT03190460|11993313|FG001|NOT COMPLETED|Overall Study||18
10827984|NCT03120949|11993336|FG000|STARTED|Overall Study|One subject was randomized in error and did not receive any dose of study drug.|1058
10827985|NCT03120949|11993337|FG001|STARTED|Overall Study||1047
10827986|NCT03120949|11993336|FG000|mITT|Overall Study||1057
10827987|NCT03120949|11993337|FG001|mITT|Overall Study||1047
10827988|NCT03120949|11993336|FG000|Safety Population|Overall Study||1043
10827989|NCT03120949|11993337|FG001|Safety Population|Overall Study||1061
10827990|NCT03120949|11993336|FG000|COMPLETED|Overall Study||830
10827991|NCT03120949|11993337|FG001|COMPLETED|Overall Study||844
10827992|NCT03120949|11993336|FG000|NOT COMPLETED|Overall Study||228
10827993|NCT03120949|11993337|FG001|NOT COMPLETED|Overall Study||203
10827994|NCT03119766|11993349|FG000|STARTED|Overall Study||151
10827995|NCT03119766|11993350|FG001|STARTED|Overall Study||158
10827996|NCT03119766|11993349|FG000|COMPLETED|Overall Study||151
10827997|NCT03119766|11993350|FG001|COMPLETED|Overall Study||158
10827998|NCT03119766|11993349|FG000|NOT COMPLETED|Overall Study||0
10827999|NCT03119766|11993350|FG001|NOT COMPLETED|Overall Study||0
10828000|NCT03077698|11993358|FG000|STARTED|Progestin Monotherapy||16
10828001|NCT03077698|11993359|FG001|STARTED|Progestin Monotherapy||0
10828002|NCT03077698|11993358|FG000|COMPLETED|Progestin Monotherapy||6
10828003|NCT03077698|11993359|FG001|COMPLETED|Progestin Monotherapy||0
10828004|NCT03077698|11993358|FG000|NOT COMPLETED|Progestin Monotherapy||10
10828005|NCT03077698|11993359|FG001|NOT COMPLETED|Progestin Monotherapy||0
10828006|NCT03077698|11993358|FG000|STARTED|Sodium Cridanimod & Progestin Therapy|Subjects with disease progression after progestin monotherapy will roll over into treatment period 2, and receive combination treatment (Sodium Cridanimod and progestin) until documented disease progression.|6
10828007|NCT03077698|11993359|FG001|STARTED|Sodium Cridanimod & Progestin Therapy|Subjects determined to have PrR negative status from a tumor tissue sample at Screening will enroll directly into Treatment Period 2 and receive combination treatment (Sodium Cridanimod and progestin) until documented disease progression.|9
10828008|NCT03077698|11993358|FG000|COMPLETED|Sodium Cridanimod & Progestin Therapy||0
10828009|NCT03077698|11993359|FG001|COMPLETED|Sodium Cridanimod & Progestin Therapy||0
10828010|NCT03077698|11993358|FG000|NOT COMPLETED|Sodium Cridanimod & Progestin Therapy||6
10828011|NCT03077698|11993359|FG001|NOT COMPLETED|Sodium Cridanimod & Progestin Therapy||9
10828012|NCT03077698|11993358|FG000|STARTED|Safety Follow Up||6
10828013|NCT03077698|11993359|FG001|STARTED|Safety Follow Up||9
10828014|NCT03077698|11993358|FG000|COMPLETED|Safety Follow Up||3
10828015|NCT03077698|11993359|FG001|COMPLETED|Safety Follow Up||8
10828016|NCT03077698|11993358|FG000|NOT COMPLETED|Safety Follow Up||3
10828017|NCT03077698|11993359|FG001|NOT COMPLETED|Safety Follow Up||1
10828018|NCT02911935|11993366|FG000|STARTED|Overall Study||101
10828019|NCT02911935|11993367|FG001|STARTED|Overall Study||99
10828020|NCT02911935|11993366|FG000|COMPLETED|Overall Study||96
10828021|NCT02911935|11993367|FG001|COMPLETED|Overall Study||92
10828022|NCT02911935|11993366|FG000|NOT COMPLETED|Overall Study||5
10828023|NCT02911935|11993367|FG001|NOT COMPLETED|Overall Study||7
10828024|NCT02874742|11993376|FG000|STARTED|Overall Study||103
10828025|NCT02874742|11993377|FG001|STARTED|Overall Study||104
10828026|NCT02874742|11993378|FG002|STARTED|Overall Study||16
10828027|NCT02874742|11993376|FG000|Safety|Overall Study||102
10828028|NCT02874742|11993377|FG001|Safety|Overall Study||99
10828029|NCT02874742|11993378|FG002|Safety|Overall Study||16
10828030|NCT02874742|11993376|FG000|COMPLETED|Overall Study||0
10828031|NCT02874742|11993377|FG001|COMPLETED|Overall Study||0
10828032|NCT02874742|11993378|FG002|COMPLETED|Overall Study||0
10828033|NCT02874742|11993376|FG000|NOT COMPLETED|Overall Study||103
10828034|NCT02874742|11993377|FG001|NOT COMPLETED|Overall Study||104
10828035|NCT02874742|11993378|FG002|NOT COMPLETED|Overall Study||16
10828036|NCT02644525|11993390|FG000|STARTED|Group 1||2
10828037|NCT02644525|11993391|FG001|STARTED|Group 1||5
10828038|NCT02644525|11993392|FG002|STARTED|Group 1||0
10828039|NCT02644525|11993393|FG003|STARTED|Group 1||0
10828040|NCT02644525|11993390|FG000|COMPLETED|Group 1||2
10828041|NCT02644525|11993391|FG001|COMPLETED|Group 1||5
10290722|NCT04725500|11423516|FG000|STARTED|Screening||42
10290723|NCT04725500|11423516|FG000|COMPLETED|Screening||15
10290724|NCT04725500|11423516|FG000|NOT COMPLETED|Screening||27
10290725|NCT04725500|11423516|FG000|STARTED|Overnight Polysomnography (PSG)||15
10290726|NCT04725500|11423516|FG000|COMPLETED|Overnight Polysomnography (PSG)||15
10290727|NCT04725500|11423516|FG000|NOT COMPLETED|Overnight Polysomnography (PSG)||0
10290728|NCT04725500|11423516|FG000|STARTED|2 Week Take Home||15
10290729|NCT04725500|11423516|FG000|COMPLETED|2 Week Take Home||10
10290730|NCT04725500|11423516|FG000|NOT COMPLETED|2 Week Take Home||5
10290731|NCT04724538|11423522|FG000|STARTED|Overall Study||11
10290732|NCT04724538|11423523|FG001|STARTED|Overall Study||14
10290733|NCT04724538|11423522|FG000|COMPLETED|Overall Study||11
10290734|NCT04724538|11423523|FG001|COMPLETED|Overall Study||14
10290735|NCT04724538|11423522|FG000|NOT COMPLETED|Overall Study||0
10290736|NCT04724538|11423523|FG001|NOT COMPLETED|Overall Study||0
10313238|NCT00149825|11446820|FG000|STARTED|Overall Study||15
10313239|NCT00149825|11446821|FG001|STARTED|Overall Study||15
10313240|NCT00149825|11446820|FG000|COMPLETED|Overall Study||10
10313241|NCT00149825|11446821|FG001|COMPLETED|Overall Study||12
10313242|NCT00149825|11446820|FG000|NOT COMPLETED|Overall Study||5
10313243|NCT00149825|11446821|FG001|NOT COMPLETED|Overall Study||3
10313244|NCT00149838|11446829|FG000|STARTED|Phase I||92
10313245|NCT00149838|11446830|FG001|STARTED|Phase I||98
10313246|NCT00149838|11446831|FG002|STARTED|Phase I||0
10313247|NCT00149838|11446832|FG003|STARTED|Phase I||0
10313248|NCT00149838|11446829|FG000|COMPLETED|Phase I||72
10313249|NCT00149838|11446830|FG001|COMPLETED|Phase I||82
10313250|NCT00149838|11446831|FG002|COMPLETED|Phase I||0
10313251|NCT00149838|11446832|FG003|COMPLETED|Phase I||0
10313252|NCT00149838|11446829|FG000|NOT COMPLETED|Phase I||20
10313253|NCT00149838|11446830|FG001|NOT COMPLETED|Phase I||16
10313254|NCT00149838|11446831|FG002|NOT COMPLETED|Phase I||0
10313255|NCT00149838|11446832|FG003|NOT COMPLETED|Phase I||0
10313256|NCT00149838|11446829|FG000|STARTED|Phase II||0
10313257|NCT00149838|11446830|FG001|STARTED|Phase II||0
10313258|NCT00149838|11446831|FG002|STARTED|Phase II||144
10313259|NCT00149838|11446832|FG003|STARTED|Phase II||0
10313260|NCT00149838|11446829|FG000|COMPLETED|Phase II||0
10408981|NCT00757666|11553005|FG001|STARTED|Overall Study||34
10408982|NCT00757666|11553004|FG000|COMPLETED|Overall Study|Number of patients with complete CPX test results from 1 month and 2 month visits|12
10828042|NCT02644525|11993392|FG002|COMPLETED|Group 1||0
10828043|NCT02644525|11993393|FG003|COMPLETED|Group 1||0
10313261|NCT00149838|11446830|FG001|COMPLETED|Phase II||0
10828044|NCT02644525|11993390|FG000|NOT COMPLETED|Group 1||0
10828045|NCT02644525|11993391|FG001|NOT COMPLETED|Group 1||0
10828046|NCT02644525|11993392|FG002|NOT COMPLETED|Group 1||0
10828047|NCT02644525|11993393|FG003|NOT COMPLETED|Group 1||0
10828048|NCT02644525|11993390|FG000|STARTED|Group 2||2
10828049|NCT02644525|11993391|FG001|STARTED|Group 2||0
10828050|NCT02644525|11993392|FG002|STARTED|Group 2||5
10313262|NCT00149838|11446831|FG002|COMPLETED|Phase II||144
10313263|NCT00149838|11446832|FG003|COMPLETED|Phase II||0
10313264|NCT00149838|11446829|FG000|NOT COMPLETED|Phase II||0
10313265|NCT00149838|11446830|FG001|NOT COMPLETED|Phase II||0
10313266|NCT00149838|11446831|FG002|NOT COMPLETED|Phase II||0
10313267|NCT00149838|11446832|FG003|NOT COMPLETED|Phase II||0
10313268|NCT00149838|11446829|FG000|STARTED|Phase III||0
10313269|NCT00149838|11446830|FG001|STARTED|Phase III||0
10313270|NCT00149838|11446831|FG002|STARTED|Phase III||0
10313271|NCT00149838|11446832|FG003|STARTED|Phase III||61
10828051|NCT02644525|11993393|FG003|STARTED|Group 2||0
10828052|NCT02644525|11993390|FG000|COMPLETED|Group 2||2
10828053|NCT02644525|11993391|FG001|COMPLETED|Group 2||0
10828054|NCT02644525|11993392|FG002|COMPLETED|Group 2||5
10828055|NCT02644525|11993393|FG003|COMPLETED|Group 2||0
10828056|NCT02644525|11993390|FG000|NOT COMPLETED|Group 2||0
10828057|NCT02644525|11993391|FG001|NOT COMPLETED|Group 2||0
10828058|NCT02644525|11993392|FG002|NOT COMPLETED|Group 2||0
10828059|NCT02644525|11993393|FG003|NOT COMPLETED|Group 2||0
10828060|NCT02644525|11993390|FG000|STARTED|Group 3||1
10828061|NCT02644525|11993391|FG001|STARTED|Group 3||0
10828062|NCT02644525|11993392|FG002|STARTED|Group 3||0
10828063|NCT02644525|11993393|FG003|STARTED|Group 3||5
10828064|NCT02644525|11993390|FG000|COMPLETED|Group 3||1
10828065|NCT02644525|11993391|FG001|COMPLETED|Group 3||0
10828066|NCT02644525|11993392|FG002|COMPLETED|Group 3||0
10828067|NCT02644525|11993393|FG003|COMPLETED|Group 3||5
10828068|NCT02644525|11993390|FG000|NOT COMPLETED|Group 3||0
10828069|NCT02644525|11993391|FG001|NOT COMPLETED|Group 3||0
10828070|NCT02644525|11993392|FG002|NOT COMPLETED|Group 3||0
10828071|NCT02644525|11993393|FG003|NOT COMPLETED|Group 3||0
10828078|NCT02557672|11993414|FG000|STARTED|Overall Study||53
10828079|NCT02557672|11993415|FG001|STARTED|Overall Study||53
10828080|NCT02557672|11993414|FG000|COMPLETED|Overall Study||49
10828081|NCT02557672|11993415|FG001|COMPLETED|Overall Study||51
10828082|NCT02557672|11993414|FG000|NOT COMPLETED|Overall Study||4
10828083|NCT02557672|11993415|FG001|NOT COMPLETED|Overall Study||2
10828084|NCT02509312|11993423|FG000|STARTED|Overall Study||35
10828085|NCT02509312|11993424|FG001|STARTED|Overall Study||35
10828086|NCT02509312|11993423|FG000|Intraoperative Checkpoint|Overall Study||28
10828087|NCT02509312|11993424|FG001|Intraoperative Checkpoint|Overall Study||30
10828088|NCT02509312|11993423|FG000|COMPLETED|Overall Study||28
10828089|NCT02509312|11993424|FG001|COMPLETED|Overall Study||30
10828090|NCT02509312|11993423|FG000|NOT COMPLETED|Overall Study||7
10828091|NCT02509312|11993424|FG001|NOT COMPLETED|Overall Study||5
10290737|NCT04716426|11423531|FG000|STARTED|Overall Study||50
10290738|NCT04716426|11423532|FG001|STARTED|Overall Study||50
10290739|NCT04716426|11423531|FG000|COMPLETED|Overall Study||48
10290740|NCT04716426|11423532|FG001|COMPLETED|Overall Study||49
10290741|NCT04716426|11423531|FG000|NOT COMPLETED|Overall Study||2
10290742|NCT04716426|11423532|FG001|NOT COMPLETED|Overall Study||1
10290743|NCT04709068|11423538|FG000|STARTED|Overall Study||8
10290744|NCT04709068|11423538|FG000|COMPLETED|Overall Study||8
10290745|NCT04709068|11423538|FG000|NOT COMPLETED|Overall Study||0
10290746|NCT04704713|11423544|FG000|STARTED|Overall Study||15
10290747|NCT04704713|11423545|FG001|STARTED|Overall Study||16
10290748|NCT04704713|11423544|FG000|COMPLETED|Overall Study||11
10290749|NCT04704713|11423545|FG001|COMPLETED|Overall Study||12
10290750|NCT04704713|11423544|FG000|NOT COMPLETED|Overall Study||4
10290751|NCT04704713|11423545|FG001|NOT COMPLETED|Overall Study||4
10408983|NCT00757666|11553005|FG001|COMPLETED|Overall Study|Number of patients with complete CPX test results from 1 month and 2 month visits|11
10408984|NCT00757666|11553004|FG000|NOT COMPLETED|Overall Study||22
10408985|NCT00757666|11553005|FG001|NOT COMPLETED|Overall Study||23
10408986|NCT00757705|11553015|FG000|STARTED|Overall Study||299
10408987|NCT00757705|11553015|FG000|COMPLETED|Overall Study||178
10828092|NCT02379247|11993436|FG000|STARTED|Overall Study||3
10828093|NCT02379247|11993437|FG001|STARTED|Overall Study||3
10828094|NCT02379247|11993438|FG002|STARTED|Overall Study||7
10828095|NCT02379247|11993439|FG003|STARTED|Overall Study||30
10828096|NCT02379247|11993436|FG000|COMPLETED|Overall Study||3
10828097|NCT02379247|11993437|FG001|COMPLETED|Overall Study||3
10828098|NCT02379247|11993438|FG002|COMPLETED|Overall Study||7
10828099|NCT02379247|11993439|FG003|COMPLETED|Overall Study||30
10828100|NCT02379247|11993436|FG000|NOT COMPLETED|Overall Study||0
10828101|NCT02379247|11993437|FG001|NOT COMPLETED|Overall Study||0
10828102|NCT02379247|11993438|FG002|NOT COMPLETED|Overall Study||0
10828103|NCT02379247|11993439|FG003|NOT COMPLETED|Overall Study||0
10828104|NCT02360280|11993454|FG000|STARTED|Overall Study||28
10828105|NCT02360280|11993455|FG001|STARTED|Overall Study||30
10828106|NCT02360280|11993454|FG000|COMPLETED|Overall Study||25
10828107|NCT02360280|11993455|FG001|COMPLETED|Overall Study||29
10828108|NCT02360280|11993454|FG000|NOT COMPLETED|Overall Study||3
10828109|NCT02360280|11993455|FG001|NOT COMPLETED|Overall Study||1
10828110|NCT02163395|11993461|FG000|STARTED|Overall Study||44
10828111|NCT02163395|11993461|FG000|COMPLETED|Overall Study||39
10828112|NCT02163395|11993461|FG000|NOT COMPLETED|Overall Study||5
10828113|NCT02097134|11993465|FG000|STARTED|Overall Study||14
10828114|NCT02097134|11993465|FG000|COMPLETED|Overall Study||5
10828115|NCT02097134|11993465|FG000|NOT COMPLETED|Overall Study||9
10828116|NCT02096588|11993472|FG000|STARTED|Overall Study||15
10828117|NCT02096588|11993473|FG001|STARTED|Overall Study||16
10828118|NCT02096588|11993472|FG000|COMPLETED|Overall Study||13
10828119|NCT02096588|11993473|FG001|COMPLETED|Overall Study||15
10828120|NCT02096588|11993472|FG000|NOT COMPLETED|Overall Study||2
10828121|NCT02096588|11993473|FG001|NOT COMPLETED|Overall Study||1
10828122|NCT02053350|11993479|FG000|STARTED|Overall Study||7
10828123|NCT02053350|11993479|FG000|COMPLETED|Overall Study||2
10828124|NCT02053350|11993479|FG000|NOT COMPLETED|Overall Study||5
10828133|NCT01965704|11993499|FG000|STARTED|Overall Study||48
10828134|NCT01965704|11993500|FG001|STARTED|Overall Study||48
10828135|NCT01965704|11993501|FG002|STARTED|Overall Study||50
10828136|NCT01965704|11993502|FG003|STARTED|Overall Study||50
10828137|NCT01965704|11993499|FG000|Received Intervention|Overall Study||45
10828138|NCT01965704|11993500|FG001|Received Intervention|Overall Study||45
10828139|NCT01965704|11993501|FG002|Received Intervention|Overall Study||47
10828140|NCT01965704|11993502|FG003|Received Intervention|Overall Study||47
10828141|NCT01965704|11993499|FG000|Analyzable Population|Overall Study||45
10828142|NCT01965704|11993500|FG001|Analyzable Population|Overall Study||45
10828143|NCT01965704|11993501|FG002|Analyzable Population|Overall Study||41
10828144|NCT01965704|11993502|FG003|Analyzable Population|Overall Study||41
10828145|NCT01965704|11993499|FG000|COMPLETED|Overall Study||45
10828146|NCT01965704|11993500|FG001|COMPLETED|Overall Study||45
10828147|NCT01965704|11993501|FG002|COMPLETED|Overall Study||45
10828148|NCT01965704|11993502|FG003|COMPLETED|Overall Study||45
10828149|NCT01965704|11993499|FG000|NOT COMPLETED|Overall Study||3
10828150|NCT01965704|11993500|FG001|NOT COMPLETED|Overall Study||3
10828151|NCT01965704|11993501|FG002|NOT COMPLETED|Overall Study||5
10828152|NCT01965704|11993502|FG003|NOT COMPLETED|Overall Study||5
10828153|NCT01913795|11993514|FG000|STARTED|Overall Study||4
10828154|NCT01913795|11993515|FG001|STARTED|Overall Study||10
10828155|NCT01913795|11993516|FG002|STARTED|Overall Study||9
10828156|NCT01913795|11993517|FG003|STARTED|Overall Study||6
10828157|NCT01913795|11993514|FG000|COMPLETED|Overall Study||4
10828158|NCT01913795|11993515|FG001|COMPLETED|Overall Study||7
10828159|NCT01913795|11993516|FG002|COMPLETED|Overall Study||9
10828160|NCT01913795|11993517|FG003|COMPLETED|Overall Study||5
10828161|NCT01913795|11993514|FG000|NOT COMPLETED|Overall Study||0
10828162|NCT01913795|11993515|FG001|NOT COMPLETED|Overall Study||3
10828163|NCT01913795|11993516|FG002|NOT COMPLETED|Overall Study||0
10828164|NCT01913795|11993517|FG003|NOT COMPLETED|Overall Study||1
10828174|NCT01664182|11993548|FG000|STARTED|Overall Study||19
10828175|NCT01664182|11993549|FG001|STARTED|Overall Study||22
10828176|NCT01664182|11993548|FG000|COMPLETED|Overall Study||17
10828177|NCT01664182|11993549|FG001|COMPLETED|Overall Study||18
10828178|NCT01664182|11993548|FG000|NOT COMPLETED|Overall Study||2
10828179|NCT01664182|11993549|FG001|NOT COMPLETED|Overall Study||4
10828180|NCT01661881|11993555|FG000|STARTED|Overall Study||23
10828181|NCT01661881|11993555|FG000|COMPLETED|Overall Study||22
10828182|NCT01661881|11993555|FG000|NOT COMPLETED|Overall Study||1
10828183|NCT01646814|11993561|FG000|STARTED|Overall Study||121
10828184|NCT01646814|11993562|FG001|STARTED|Overall Study||126
10828185|NCT01646814|11993561|FG000|COMPLETED|Overall Study||110
10828186|NCT01646814|11993562|FG001|COMPLETED|Overall Study||120
10828187|NCT01646814|11993561|FG000|NOT COMPLETED|Overall Study||11
10828188|NCT01646814|11993562|FG001|NOT COMPLETED|Overall Study||6
10828189|NCT01621568|11993570|FG000|STARTED|Treatment Week 1-4||41
10828190|NCT01621568|11993571|FG001|STARTED|Treatment Week 1-4||15
10828191|NCT01621568|11993570|FG000|COMPLETED|Treatment Week 1-4||41
10828192|NCT01621568|11993571|FG001|COMPLETED|Treatment Week 1-4||15
10828193|NCT01621568|11993570|FG000|NOT COMPLETED|Treatment Week 1-4||0
10828194|NCT01621568|11993571|FG001|NOT COMPLETED|Treatment Week 1-4||0
10828195|NCT01621568|11993570|FG000|STARTED|Week 5-6 No Treatment||41
10828196|NCT01621568|11993571|FG001|STARTED|Week 5-6 No Treatment||15
10828197|NCT01621568|11993570|FG000|COMPLETED|Week 5-6 No Treatment||39
10828198|NCT01621568|11993571|FG001|COMPLETED|Week 5-6 No Treatment||15
10828199|NCT01621568|11993570|FG000|NOT COMPLETED|Week 5-6 No Treatment||2
10828200|NCT01621568|11993571|FG001|NOT COMPLETED|Week 5-6 No Treatment||0
10828201|NCT01416636|11993582|FG000|STARTED|Overall Study||53
10828202|NCT01416636|11993583|FG001|STARTED|Overall Study||52
10828203|NCT01416636|11993582|FG000|COMPLETED|Overall Study||45
10828204|NCT01416636|11993583|FG001|COMPLETED|Overall Study||46
10828205|NCT01416636|11993582|FG000|NOT COMPLETED|Overall Study||8
10828206|NCT01416636|11993583|FG001|NOT COMPLETED|Overall Study||6
10828207|NCT01070069|11993594|FG000|STARTED|Overall Study||50
10828208|NCT01070069|11993595|FG001|STARTED|Overall Study||50
10828209|NCT01070069|11993596|FG002|STARTED|Overall Study||51
10828210|NCT01070069|11993597|FG003|STARTED|Overall Study||19
10828211|NCT01070069|11993598|FG004|STARTED|Overall Study||22
10828212|NCT01070069|11993594|FG000|COMPLETED|Overall Study||44
10828213|NCT01070069|11993595|FG001|COMPLETED|Overall Study||48
10828214|NCT01070069|11993596|FG002|COMPLETED|Overall Study||45
10828215|NCT01070069|11993597|FG003|COMPLETED|Overall Study||19
10828216|NCT01070069|11993598|FG004|COMPLETED|Overall Study||18
10828217|NCT01070069|11993594|FG000|NOT COMPLETED|Overall Study||6
10828218|NCT01070069|11993595|FG001|NOT COMPLETED|Overall Study||2
10828219|NCT01070069|11993596|FG002|NOT COMPLETED|Overall Study||6
10828220|NCT01070069|11993597|FG003|NOT COMPLETED|Overall Study||0
10828221|NCT01070069|11993598|FG004|NOT COMPLETED|Overall Study||4
10828222|NCT00775684|11993616|FG000|STARTED|Overall Study||17
10828223|NCT00775684|11993617|FG001|STARTED|Overall Study||13
10828224|NCT00775684|11993618|FG002|STARTED|Overall Study||17
10828225|NCT00775684|11993616|FG000|COMPLETED|Overall Study||14
10828226|NCT00775684|11993617|FG001|COMPLETED|Overall Study||12
10828227|NCT00775684|11993618|FG002|COMPLETED|Overall Study||14
10828228|NCT00775684|11993616|FG000|NOT COMPLETED|Overall Study||3
10828229|NCT00775684|11993617|FG001|NOT COMPLETED|Overall Study||1
10828230|NCT00775684|11993618|FG002|NOT COMPLETED|Overall Study||3
10828231|NCT00501046|11993637|FG000|STARTED|Overall Study||508
10828232|NCT00501046|11993638|FG001|STARTED|Overall Study||507
10828233|NCT00501046|11993637|FG000|COMPLETED|Overall Study||238
10828234|NCT00501046|11993638|FG001|COMPLETED|Overall Study||213
10828235|NCT00501046|11993637|FG000|NOT COMPLETED|Overall Study||270
10828236|NCT00501046|11993638|FG001|NOT COMPLETED|Overall Study||294
10828237|NCT00500682|11993646|FG000|STARTED|Overall Study||510
10828238|NCT00500682|11993647|FG001|STARTED|Overall Study||510
10828239|NCT00500682|11993646|FG000|COMPLETED|Overall Study||204
10828240|NCT00500682|11993647|FG001|COMPLETED|Overall Study||223
10828241|NCT00500682|11993646|FG000|NOT COMPLETED|Overall Study||306
10828242|NCT00500682|11993647|FG001|NOT COMPLETED|Overall Study||287
10828249|NCT00001277|11993667|FG000|STARTED|Overall Study||634
10828250|NCT00001277|11993668|FG001|STARTED|Overall Study||900
10828251|NCT00001277|11993669|FG002|STARTED|Overall Study||19
10828252|NCT00001277|11993667|FG000|COMPLETED|Overall Study||634
10828253|NCT00001277|11993668|FG001|COMPLETED|Overall Study||900
10828254|NCT00001277|11993669|FG002|COMPLETED|Overall Study||16
10828255|NCT00001277|11993667|FG000|NOT COMPLETED|Overall Study||0
10828256|NCT00001277|11993668|FG001|NOT COMPLETED|Overall Study||0
10828257|NCT00001277|11993669|FG002|NOT COMPLETED|Overall Study||3
10828258|NCT01009294|11993678|FG000|STARTED|Overall Study||6
10828259|NCT01009294|11993678|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
10828260|NCT01009294|11993678|FG000|COMPLETED|Overall Study||0
10290752|NCT04698993|11423553|FG000|STARTED|Overall Study||275
10290753|NCT04698993|11423554|FG001|STARTED|Overall Study||113
10290754|NCT04698993|11423553|FG000|COMPLETED|Overall Study||272
10290755|NCT04698993|11423554|FG001|COMPLETED|Overall Study||106
10290756|NCT04698993|11423553|FG000|NOT COMPLETED|Overall Study||3
10290757|NCT04698993|11423554|FG001|NOT COMPLETED|Overall Study||7
10290758|NCT04697888|11423560|FG000|STARTED|Overall Study||2
10290759|NCT04697888|11423560|FG000|COMPLETED|Overall Study||2
10290760|NCT04697888|11423560|FG000|NOT COMPLETED|Overall Study||0
10313272|NCT00149838|11446829|FG000|COMPLETED|Phase III||0
10313273|NCT00149838|11446830|FG001|COMPLETED|Phase III||0
10313274|NCT00149838|11446831|FG002|COMPLETED|Phase III||0
10313275|NCT00149838|11446832|FG003|COMPLETED|Phase III||37
10313276|NCT00149838|11446829|FG000|NOT COMPLETED|Phase III||0
10313277|NCT00149838|11446830|FG001|NOT COMPLETED|Phase III||0
10313278|NCT00149838|11446831|FG002|NOT COMPLETED|Phase III||0
10313279|NCT00149838|11446832|FG003|NOT COMPLETED|Phase III||24
10315574|NCT00180323|11449484|FG000|COMPLETED|Overall Study||43
10315575|NCT00180323|11449484|FG000|NOT COMPLETED|Overall Study||0
10315576|NCT00180479|11449492|FG000|STARTED|Overall Study||669
10315577|NCT00180479|11449493|FG001|STARTED|Overall Study|1 patient randomized never signed consent, therefore no data collected. Analysis group = 332.|333
10315578|NCT00180479|11449492|FG000|COMPLETED|Overall Study||653
10315579|NCT00180479|11449493|FG001|COMPLETED|Overall Study||320
10315580|NCT00180479|11449492|FG000|NOT COMPLETED|Overall Study||16
10315581|NCT00180479|11449493|FG001|NOT COMPLETED|Overall Study||13
10315582|NCT00180661|11449501|FG000|STARTED|Overall Study||19
10315583|NCT00180661|11449502|FG001|STARTED|Overall Study||20
10315584|NCT00180661|11449501|FG000|COMPLETED|Overall Study||19
10315585|NCT00180661|11449502|FG001|COMPLETED|Overall Study||20
10315586|NCT00180661|11449501|FG000|NOT COMPLETED|Overall Study||0
10828261|NCT01009294|11993678|FG000|NOT COMPLETED|Overall Study||6
10315587|NCT00180661|11449502|FG001|NOT COMPLETED|Overall Study||0
10315588|NCT00180674|11449508|FG000|STARTED|Phase 1, Observation Period||14
10315589|NCT00180674|11449508|FG000|COMPLETED|Phase 1, Observation Period||10
10315590|NCT00180674|11449508|FG000|NOT COMPLETED|Phase 1, Observation Period||4
10315591|NCT00180674|11449508|FG000|STARTED|Phase 2, Warfarin Treatment Period||10
10828293|NCT01072175|11993715|FG012|COMPLETED|Part A (Drug-Drug Interaction)||0
10315592|NCT00180674|11449508|FG000|COMPLETED|Phase 2, Warfarin Treatment Period||9
10315593|NCT00180674|11449508|FG000|NOT COMPLETED|Phase 2, Warfarin Treatment Period||1
10315594|NCT00180687|11449520|FG000|STARTED|Overall Study||20
10315595|NCT00180687|11449521|FG001|STARTED|Overall Study||20
10315596|NCT00180687|11449522|FG002|STARTED|Overall Study||20
10315597|NCT00180687|11449523|FG003|STARTED|Overall Study||20
10315598|NCT00180687|11449520|FG000|COMPLETED|Overall Study||20
10315599|NCT00180687|11449521|FG001|COMPLETED|Overall Study||20
10315600|NCT00180687|11449522|FG002|COMPLETED|Overall Study||20
10315601|NCT00180687|11449523|FG003|COMPLETED|Overall Study||20
10315602|NCT00180687|11449520|FG000|NOT COMPLETED|Overall Study||0
10315603|NCT00180687|11449521|FG001|NOT COMPLETED|Overall Study||0
10315604|NCT00180687|11449522|FG002|NOT COMPLETED|Overall Study||0
10315605|NCT00180687|11449523|FG003|NOT COMPLETED|Overall Study||0
10315606|NCT00180713|11449535|FG000|STARTED|Overall Study||23
10315607|NCT00180713|11449536|FG001|STARTED|Overall Study||19
10315608|NCT00180713|11449535|FG000|COMPLETED|Overall Study||18
10315609|NCT00180713|11449536|FG001|COMPLETED|Overall Study||16
10315610|NCT00180713|11449535|FG000|NOT COMPLETED|Overall Study||5
10315611|NCT00180713|11449536|FG001|NOT COMPLETED|Overall Study||3
10315612|NCT00181155|11449542|FG000|STARTED|Overall Study||15
10315613|NCT00181155|11449543|FG001|STARTED|Overall Study||3
10315614|NCT00181155|11449542|FG000|COMPLETED|Overall Study||13
10315615|NCT00181155|11449543|FG001|COMPLETED|Overall Study||3
10315616|NCT00181155|11449542|FG000|NOT COMPLETED|Overall Study||2
10315617|NCT00181155|11449543|FG001|NOT COMPLETED|Overall Study||0
10315618|NCT00181168|11449552|FG000|STARTED|Overall Study||30
10315619|NCT00181168|11449553|FG001|STARTED|Overall Study||33
10315620|NCT00181168|11449552|FG000|COMPLETED|Overall Study||30
10315621|NCT00181168|11449553|FG001|COMPLETED|Overall Study||33
10315622|NCT00181168|11449552|FG000|NOT COMPLETED|Overall Study||0
10315623|NCT00181168|11449553|FG001|NOT COMPLETED|Overall Study||0
10315624|NCT00181207|11449561|FG000|STARTED|Overall Study||24
10315625|NCT00181207|11449562|FG001|STARTED|Overall Study||26
10315626|NCT00181207|11449561|FG000|COMPLETED|Overall Study||24
10315627|NCT00181207|11449562|FG001|COMPLETED|Overall Study||26
10315628|NCT00181207|11449561|FG000|NOT COMPLETED|Overall Study||0
10315629|NCT00181207|11449562|FG001|NOT COMPLETED|Overall Study||0
10315630|NCT00181285|11449570|FG000|STARTED|Overall Study||27
10315631|NCT00181285|11449571|FG001|STARTED|Overall Study||25
10315632|NCT00181285|11449570|FG000|COMPLETED|Overall Study||27
10315633|NCT00181285|11449571|FG001|COMPLETED|Overall Study||25
10315634|NCT00181285|11449570|FG000|NOT COMPLETED|Overall Study||0
10315635|NCT00181285|11449571|FG001|NOT COMPLETED|Overall Study||0
10315636|NCT00181363|11449577|FG000|STARTED|Overall Study|10|10
10315637|NCT00181363|11449577|FG000|COMPLETED|Overall Study||10
10315638|NCT00181363|11449577|FG000|NOT COMPLETED|Overall Study||0
10315639|NCT00181610|11449587|FG000|STARTED|Overall Study||4
10315640|NCT00181610|11449588|FG001|STARTED|Overall Study||4
10315641|NCT00181610|11449589|FG002|STARTED|Overall Study||3
10828262|NCT01053637|11993684|FG000|STARTED|Overall Study||43
10828263|NCT01053637|11993685|FG001|STARTED|Overall Study||42
10828264|NCT01053637|11993684|FG000|COMPLETED|Overall Study|2 with incomplete pain scores|43
10828265|NCT01053637|11993685|FG001|COMPLETED|Overall Study|4 incomplete pain scores 4 proceeded to procedural sedation|42
10828266|NCT01053637|11993684|FG000|NOT COMPLETED|Overall Study||0
10828267|NCT01053637|11993685|FG001|NOT COMPLETED|Overall Study||0
10290761|NCT04693078|11423564|FG000|STARTED|Overall Study||100
10290762|NCT04693078|11423564|FG000|COMPLETED|Overall Study||100
10290763|NCT04693078|11423564|FG000|NOT COMPLETED|Overall Study||0
10290764|NCT04688346|11423570|FG000|STARTED|Overall Study||6
10290765|NCT04688346|11423571|FG001|STARTED|Overall Study||7
10290766|NCT04688346|11423570|FG000|First Intervention|Overall Study||6
10290767|NCT04688346|11423571|FG001|First Intervention|Overall Study||7
10828268|NCT01072175|11993703|FG000|STARTED|Part A (Drug-Drug Interaction)||8
10828269|NCT01072175|11993704|FG001|STARTED|Part A (Drug-Drug Interaction)||0
10828270|NCT01072175|11993705|FG002|STARTED|Part A (Drug-Drug Interaction)||0
10828271|NCT01072175|11993706|FG003|STARTED|Part A (Drug-Drug Interaction)||0
10828272|NCT01072175|11993707|FG004|STARTED|Part A (Drug-Drug Interaction)||0
10828273|NCT01072175|11993708|FG005|STARTED|Part A (Drug-Drug Interaction)||0
10828274|NCT01072175|11993709|FG006|STARTED|Part A (Drug-Drug Interaction)||0
10828275|NCT01072175|11993710|FG007|STARTED|Part A (Drug-Drug Interaction)||0
10828276|NCT01072175|11993711|FG008|STARTED|Part A (Drug-Drug Interaction)||0
10828277|NCT01072175|11993712|FG009|STARTED|Part A (Drug-Drug Interaction)||0
10828278|NCT01072175|11993713|FG010|STARTED|Part A (Drug-Drug Interaction)||0
10828279|NCT01072175|11993714|FG011|STARTED|Part A (Drug-Drug Interaction)||0
10828280|NCT01072175|11993715|FG012|STARTED|Part A (Drug-Drug Interaction)||0
10828281|NCT01072175|11993703|FG000|COMPLETED|Part A (Drug-Drug Interaction)||0
10828282|NCT01072175|11993704|FG001|COMPLETED|Part A (Drug-Drug Interaction)||0
10828283|NCT01072175|11993705|FG002|COMPLETED|Part A (Drug-Drug Interaction)||0
10828284|NCT01072175|11993706|FG003|COMPLETED|Part A (Drug-Drug Interaction)||0
10828285|NCT01072175|11993707|FG004|COMPLETED|Part A (Drug-Drug Interaction)||0
10828286|NCT01072175|11993708|FG005|COMPLETED|Part A (Drug-Drug Interaction)||0
10828287|NCT01072175|11993709|FG006|COMPLETED|Part A (Drug-Drug Interaction)||0
10828288|NCT01072175|11993710|FG007|COMPLETED|Part A (Drug-Drug Interaction)||0
10828289|NCT01072175|11993711|FG008|COMPLETED|Part A (Drug-Drug Interaction)||0
10828290|NCT01072175|11993712|FG009|COMPLETED|Part A (Drug-Drug Interaction)||0
10828291|NCT01072175|11993713|FG010|COMPLETED|Part A (Drug-Drug Interaction)||0
10828292|NCT01072175|11993714|FG011|COMPLETED|Part A (Drug-Drug Interaction)||0
10828294|NCT01072175|11993703|FG000|NOT COMPLETED|Part A (Drug-Drug Interaction)||8
10828295|NCT01072175|11993704|FG001|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
10828296|NCT01072175|11993705|FG002|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
10828297|NCT01072175|11993706|FG003|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
10828298|NCT01072175|11993707|FG004|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
10828299|NCT01072175|11993708|FG005|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
10828300|NCT01072175|11993709|FG006|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
10828301|NCT01072175|11993710|FG007|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
10828302|NCT01072175|11993711|FG008|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
10828303|NCT01072175|11993712|FG009|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
10828304|NCT01072175|11993713|FG010|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
10828305|NCT01072175|11993714|FG011|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
10828306|NCT01072175|11993715|FG012|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
10828307|NCT01072175|11993703|FG000|STARTED|Part B (Dose Escalation and Expansion)||0
10828308|NCT01072175|11993704|FG001|STARTED|Part B (Dose Escalation and Expansion)||6
10828309|NCT01072175|11993705|FG002|STARTED|Part B (Dose Escalation and Expansion)||23
10828310|NCT01072175|11993706|FG003|STARTED|Part B (Dose Escalation and Expansion)||27
10828311|NCT01072175|11993707|FG004|STARTED|Part B (Dose Escalation and Expansion)||94
10828312|NCT01072175|11993708|FG005|STARTED|Part B (Dose Escalation and Expansion)||0
10828313|NCT01072175|11993709|FG006|STARTED|Part B (Dose Escalation and Expansion)||0
10828314|NCT01072175|11993710|FG007|STARTED|Part B (Dose Escalation and Expansion)||0
10828315|NCT01072175|11993711|FG008|STARTED|Part B (Dose Escalation and Expansion)||0
10828316|NCT01072175|11993712|FG009|STARTED|Part B (Dose Escalation and Expansion)||0
10828317|NCT01072175|11993713|FG010|STARTED|Part B (Dose Escalation and Expansion)||0
10828318|NCT01072175|11993714|FG011|STARTED|Part B (Dose Escalation and Expansion)||0
10828319|NCT01072175|11993715|FG012|STARTED|Part B (Dose Escalation and Expansion)||0
10828320|NCT01072175|11993703|FG000|COMPLETED|Part B (Dose Escalation and Expansion)||0
10828321|NCT01072175|11993704|FG001|COMPLETED|Part B (Dose Escalation and Expansion)||0
10828322|NCT01072175|11993705|FG002|COMPLETED|Part B (Dose Escalation and Expansion)||0
10828323|NCT01072175|11993706|FG003|COMPLETED|Part B (Dose Escalation and Expansion)||0
10828324|NCT01072175|11993707|FG004|COMPLETED|Part B (Dose Escalation and Expansion)||0
10828325|NCT01072175|11993708|FG005|COMPLETED|Part B (Dose Escalation and Expansion)||0
10828326|NCT01072175|11993709|FG006|COMPLETED|Part B (Dose Escalation and Expansion)||0
10828327|NCT01072175|11993710|FG007|COMPLETED|Part B (Dose Escalation and Expansion)||0
10828328|NCT01072175|11993711|FG008|COMPLETED|Part B (Dose Escalation and Expansion)||0
10828329|NCT01072175|11993712|FG009|COMPLETED|Part B (Dose Escalation and Expansion)||0
10828330|NCT01072175|11993713|FG010|COMPLETED|Part B (Dose Escalation and Expansion)||0
10828331|NCT01072175|11993714|FG011|COMPLETED|Part B (Dose Escalation and Expansion)||0
10828332|NCT01072175|11993715|FG012|COMPLETED|Part B (Dose Escalation and Expansion)||0
10828333|NCT01072175|11993703|FG000|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
10828334|NCT01072175|11993704|FG001|NOT COMPLETED|Part B (Dose Escalation and Expansion)||6
10828335|NCT01072175|11993705|FG002|NOT COMPLETED|Part B (Dose Escalation and Expansion)||23
10828336|NCT01072175|11993706|FG003|NOT COMPLETED|Part B (Dose Escalation and Expansion)||27
10828337|NCT01072175|11993707|FG004|NOT COMPLETED|Part B (Dose Escalation and Expansion)||94
10828338|NCT01072175|11993708|FG005|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
10828339|NCT01072175|11993709|FG006|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
10828340|NCT01072175|11993710|FG007|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
10828341|NCT01072175|11993711|FG008|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
10828342|NCT01072175|11993712|FG009|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
10828343|NCT01072175|11993713|FG010|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
10828344|NCT01072175|11993714|FG011|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
10828345|NCT01072175|11993715|FG012|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
10828346|NCT01072175|11993703|FG000|STARTED|Part C (Phase II: Randomized Phase)||0
10828347|NCT01072175|11993704|FG001|STARTED|Part C (Phase II: Randomized Phase)||0
10828348|NCT01072175|11993705|FG002|STARTED|Part C (Phase II: Randomized Phase)||0
10828349|NCT01072175|11993706|FG003|STARTED|Part C (Phase II: Randomized Phase)||0
10828350|NCT01072175|11993707|FG004|STARTED|Part C (Phase II: Randomized Phase)||0
10828351|NCT01072175|11993708|FG005|STARTED|Part C (Phase II: Randomized Phase)||54
10828352|NCT01072175|11993709|FG006|STARTED|Part C (Phase II: Randomized Phase)||54
10828353|NCT01072175|11993710|FG007|STARTED|Part C (Phase II: Randomized Phase)||54
10828354|NCT01072175|11993711|FG008|STARTED|Part C (Phase II: Randomized Phase)||0
10828355|NCT01072175|11993712|FG009|STARTED|Part C (Phase II: Randomized Phase)||0
10828356|NCT01072175|11993713|FG010|STARTED|Part C (Phase II: Randomized Phase)||0
10828357|NCT01072175|11993714|FG011|STARTED|Part C (Phase II: Randomized Phase)||0
10828358|NCT01072175|11993715|FG012|STARTED|Part C (Phase II: Randomized Phase)||0
10828359|NCT01072175|11993703|FG000|COMPLETED|Part C (Phase II: Randomized Phase)||0
10828360|NCT01072175|11993704|FG001|COMPLETED|Part C (Phase II: Randomized Phase)||0
10828361|NCT01072175|11993705|FG002|COMPLETED|Part C (Phase II: Randomized Phase)||0
10828362|NCT01072175|11993706|FG003|COMPLETED|Part C (Phase II: Randomized Phase)||0
10828363|NCT01072175|11993707|FG004|COMPLETED|Part C (Phase II: Randomized Phase)||0
10828364|NCT01072175|11993708|FG005|COMPLETED|Part C (Phase II: Randomized Phase)||0
10828365|NCT01072175|11993709|FG006|COMPLETED|Part C (Phase II: Randomized Phase)||0
10828366|NCT01072175|11993710|FG007|COMPLETED|Part C (Phase II: Randomized Phase)||0
10828367|NCT01072175|11993711|FG008|COMPLETED|Part C (Phase II: Randomized Phase)||0
10828368|NCT01072175|11993712|FG009|COMPLETED|Part C (Phase II: Randomized Phase)||0
10828369|NCT01072175|11993713|FG010|COMPLETED|Part C (Phase II: Randomized Phase)||0
10828370|NCT01072175|11993714|FG011|COMPLETED|Part C (Phase II: Randomized Phase)||0
10828371|NCT01072175|11993715|FG012|COMPLETED|Part C (Phase II: Randomized Phase)||0
10828372|NCT01072175|11993703|FG000|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
10828373|NCT01072175|11993704|FG001|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
10828374|NCT01072175|11993705|FG002|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
10828375|NCT01072175|11993706|FG003|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
10828376|NCT01072175|11993707|FG004|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
10828377|NCT01072175|11993708|FG005|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
10828378|NCT01072175|11993709|FG006|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
10828379|NCT01072175|11993710|FG007|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
10828380|NCT01072175|11993711|FG008|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
10828381|NCT01072175|11993712|FG009|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
10828382|NCT01072175|11993713|FG010|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
10828383|NCT01072175|11993714|FG011|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
10828384|NCT01072175|11993715|FG012|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
10828385|NCT01072175|11993703|FG000|STARTED|Part C (Phase II: Crossover Phase [CP])||0
10828386|NCT01072175|11993704|FG001|STARTED|Part C (Phase II: Crossover Phase [CP])||0
10828387|NCT01072175|11993705|FG002|STARTED|Part C (Phase II: Crossover Phase [CP])||0
10828388|NCT01072175|11993706|FG003|STARTED|Part C (Phase II: Crossover Phase [CP])||0
10828389|NCT01072175|11993707|FG004|STARTED|Part C (Phase II: Crossover Phase [CP])||0
10828390|NCT01072175|11993708|FG005|STARTED|Part C (Phase II: Crossover Phase [CP])||0
10828391|NCT01072175|11993709|FG006|STARTED|Part C (Phase II: Crossover Phase [CP])||0
10828392|NCT01072175|11993710|FG007|STARTED|Part C (Phase II: Crossover Phase [CP])||0
10828393|NCT01072175|11993711|FG008|STARTED|Part C (Phase II: Crossover Phase [CP])||45
10828394|NCT01072175|11993712|FG009|STARTED|Part C (Phase II: Crossover Phase [CP])||0
10828395|NCT01072175|11993713|FG010|STARTED|Part C (Phase II: Crossover Phase [CP])||0
10828396|NCT01072175|11993714|FG011|STARTED|Part C (Phase II: Crossover Phase [CP])||0
10828397|NCT01072175|11993715|FG012|STARTED|Part C (Phase II: Crossover Phase [CP])||0
10828398|NCT01072175|11993703|FG000|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828399|NCT01072175|11993704|FG001|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828400|NCT01072175|11993705|FG002|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828401|NCT01072175|11993706|FG003|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828402|NCT01072175|11993707|FG004|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828403|NCT01072175|11993708|FG005|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828404|NCT01072175|11993709|FG006|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828405|NCT01072175|11993710|FG007|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828406|NCT01072175|11993711|FG008|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828407|NCT01072175|11993712|FG009|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828408|NCT01072175|11993713|FG010|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828409|NCT01072175|11993714|FG011|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828410|NCT01072175|11993715|FG012|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828411|NCT01072175|11993703|FG000|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828412|NCT01072175|11993704|FG001|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828413|NCT01072175|11993705|FG002|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828414|NCT01072175|11993706|FG003|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828415|NCT01072175|11993707|FG004|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828416|NCT01072175|11993708|FG005|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828417|NCT01072175|11993709|FG006|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828418|NCT01072175|11993710|FG007|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828419|NCT01072175|11993711|FG008|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||45
10828420|NCT01072175|11993712|FG009|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828421|NCT01072175|11993713|FG010|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828422|NCT01072175|11993714|FG011|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828423|NCT01072175|11993715|FG012|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828424|NCT01072175|11993703|FG000|STARTED|Part D (HPMC Capsules)||0
10828425|NCT01072175|11993704|FG001|STARTED|Part D (HPMC Capsules)||0
10828426|NCT01072175|11993705|FG002|STARTED|Part D (HPMC Capsules)||0
10828427|NCT01072175|11993706|FG003|STARTED|Part D (HPMC Capsules)||0
10828428|NCT01072175|11993707|FG004|STARTED|Part D (HPMC Capsules)||0
10828429|NCT01072175|11993708|FG005|STARTED|Part D (HPMC Capsules)||0
10828430|NCT01072175|11993709|FG006|STARTED|Part D (HPMC Capsules)||0
10828431|NCT01072175|11993710|FG007|STARTED|Part D (HPMC Capsules)||0
10828432|NCT01072175|11993711|FG008|STARTED|Part D (HPMC Capsules)||0
10828433|NCT01072175|11993712|FG009|STARTED|Part D (HPMC Capsules)||12
10828434|NCT01072175|11993713|FG010|STARTED|Part D (HPMC Capsules)||16
10828435|NCT01072175|11993714|FG011|STARTED|Part D (HPMC Capsules)||43
10828436|NCT01072175|11993715|FG012|STARTED|Part D (HPMC Capsules)||39
10828437|NCT01072175|11993703|FG000|COMPLETED|Part D (HPMC Capsules)||0
10828438|NCT01072175|11993704|FG001|COMPLETED|Part D (HPMC Capsules)||0
10828439|NCT01072175|11993705|FG002|COMPLETED|Part D (HPMC Capsules)||0
10828440|NCT01072175|11993706|FG003|COMPLETED|Part D (HPMC Capsules)||0
10828441|NCT01072175|11993707|FG004|COMPLETED|Part D (HPMC Capsules)||0
10828442|NCT01072175|11993708|FG005|COMPLETED|Part D (HPMC Capsules)||0
10828443|NCT01072175|11993709|FG006|COMPLETED|Part D (HPMC Capsules)||0
10828444|NCT01072175|11993710|FG007|COMPLETED|Part D (HPMC Capsules)||0
10828445|NCT01072175|11993711|FG008|COMPLETED|Part D (HPMC Capsules)||0
10828446|NCT01072175|11993712|FG009|COMPLETED|Part D (HPMC Capsules)||0
10828447|NCT01072175|11993713|FG010|COMPLETED|Part D (HPMC Capsules)||0
10828448|NCT01072175|11993714|FG011|COMPLETED|Part D (HPMC Capsules)||0
10828449|NCT01072175|11993715|FG012|COMPLETED|Part D (HPMC Capsules)||0
10828450|NCT01072175|11993703|FG000|NOT COMPLETED|Part D (HPMC Capsules)||0
10828451|NCT01072175|11993704|FG001|NOT COMPLETED|Part D (HPMC Capsules)||0
10828452|NCT01072175|11993705|FG002|NOT COMPLETED|Part D (HPMC Capsules)||0
10828453|NCT01072175|11993706|FG003|NOT COMPLETED|Part D (HPMC Capsules)||0
10828454|NCT01072175|11993707|FG004|NOT COMPLETED|Part D (HPMC Capsules)||0
10828455|NCT01072175|11993708|FG005|NOT COMPLETED|Part D (HPMC Capsules)||0
10828456|NCT01072175|11993709|FG006|NOT COMPLETED|Part D (HPMC Capsules)||0
10828457|NCT01072175|11993710|FG007|NOT COMPLETED|Part D (HPMC Capsules)||0
10828458|NCT01072175|11993711|FG008|NOT COMPLETED|Part D (HPMC Capsules)||0
10828459|NCT01072175|11993712|FG009|NOT COMPLETED|Part D (HPMC Capsules)||12
10828460|NCT01072175|11993713|FG010|NOT COMPLETED|Part D (HPMC Capsules)||16
10828461|NCT01072175|11993714|FG011|NOT COMPLETED|Part D (HPMC Capsules)||43
10828462|NCT01072175|11993715|FG012|NOT COMPLETED|Part D (HPMC Capsules)||39
10828463|NCT01087203|11993749|FG000|STARTED|Overall Study||35
10828464|NCT01087203|11993750|FG001|STARTED|Overall Study||38
10828465|NCT01087203|11993749|FG000|COMPLETED|Overall Study||3
10828466|NCT01087203|11993750|FG001|COMPLETED|Overall Study||3
10828467|NCT01087203|11993749|FG000|NOT COMPLETED|Overall Study||32
10828468|NCT01087203|11993750|FG001|NOT COMPLETED|Overall Study||35
10828472|NCT01108055|11993761|FG000|STARTED|Overall Study||43
10828473|NCT01108055|11993761|FG000|Eligible and Started Treatment|Overall Study||32
10828474|NCT01108055|11993761|FG000|COMPLETED|Overall Study||28
10828475|NCT01108055|11993761|FG000|NOT COMPLETED|Overall Study||15
10828479|NCT01136967|11993771|FG000|STARTED|Overall Study||93
10828480|NCT01136967|11993772|FG001|STARTED|Overall Study||89
10828481|NCT01136967|11993771|FG000|Disease Progression|Overall Study||55
10828482|NCT01136967|11993772|FG001|Disease Progression|Overall Study||56
10828483|NCT01136967|11993771|FG000|Treatment Ongoing at Data Cutoff|Overall Study|Entered Extension Phase on treatment at data cut-off (18 January 2012)|14
10828484|NCT01136967|11993772|FG001|Treatment Ongoing at Data Cutoff|Overall Study|Entered Extension Phase on treatment at data cut-off (15 April 2013)|6
10828485|NCT01136967|11993771|FG000|COMPLETED|Overall Study|Disease Progression and treatment ongoing at data cutoff (18 January 2012)|69
10828486|NCT01136967|11993772|FG001|COMPLETED|Overall Study|Disease Progression and treatment ongoing at data cutoff (15 April 2013)|62
10828487|NCT01136967|11993771|FG000|NOT COMPLETED|Overall Study||24
10828488|NCT01136967|11993772|FG001|NOT COMPLETED|Overall Study||27
10828489|NCT01136980|11993780|FG000|STARTED|Overall Study||42
10828490|NCT01136980|11993781|FG001|STARTED|Overall Study||87
10828491|NCT01136980|11993780|FG000|COMPLETED|Overall Study||28
10828492|NCT01136980|11993781|FG001|COMPLETED|Overall Study||76
10828493|NCT01136980|11993780|FG000|NOT COMPLETED|Overall Study||14
10828494|NCT01136980|11993781|FG001|NOT COMPLETED|Overall Study||11
10828521|NCT01174563|11993807|FG000|STARTED|Overall Study||60
10828522|NCT01174563|11993807|FG000|Efficacy Set|Overall Study||59
10828523|NCT01174563|11993807|FG000|Safety Set|Overall Study||59
10828524|NCT01174563|11993807|FG000|COMPLETED|Overall Study||0
10828525|NCT01174563|11993807|FG000|NOT COMPLETED|Overall Study||60
10828526|NCT01190202|11993815|FG000|STARTED|Overall Study||6404
10828527|NCT01190202|11993816|FG001|STARTED|Overall Study||6414
10828528|NCT01190202|11993817|FG002|STARTED|Overall Study||6400
10828529|NCT01190202|11993818|FG003|STARTED|Overall Study||2400
10828530|NCT01190202|11993815|FG000|COMPLETED|Overall Study||6404
10828531|NCT01190202|11993816|FG001|COMPLETED|Overall Study||6414
10828532|NCT01190202|11993817|FG002|COMPLETED|Overall Study||6400
10828533|NCT01190202|11993818|FG003|COMPLETED|Overall Study||2400
10828534|NCT01190202|11993815|FG000|NOT COMPLETED|Overall Study||0
10828535|NCT01190202|11993816|FG001|NOT COMPLETED|Overall Study||0
10828536|NCT01190202|11993817|FG002|NOT COMPLETED|Overall Study||0
10828537|NCT01190202|11993818|FG003|NOT COMPLETED|Overall Study||0
10828538|NCT01200862|11993863|FG000|STARTED|Part 1||14
10828539|NCT01200862|11993864|FG001|STARTED|Part 1||0
10828540|NCT01200862|11993865|FG002|STARTED|Part 1||0
10828541|NCT01200862|11993863|FG000|COMPLETED|Part 1||13
10828542|NCT01200862|11993864|FG001|COMPLETED|Part 1||0
10828543|NCT01200862|11993865|FG002|COMPLETED|Part 1||0
10828544|NCT01200862|11993863|FG000|NOT COMPLETED|Part 1||1
10828545|NCT01200862|11993864|FG001|NOT COMPLETED|Part 1||0
10828546|NCT01200862|11993865|FG002|NOT COMPLETED|Part 1||0
10828547|NCT01200862|11993863|FG000|STARTED|Part 2||0
10828548|NCT01200862|11993864|FG001|STARTED|Part 2||7
10828549|NCT01200862|11993865|FG002|STARTED|Part 2||8
10828550|NCT01200862|11993863|FG000|COMPLETED|Part 2||0
10828551|NCT01200862|11993864|FG001|COMPLETED|Part 2||6
10828552|NCT01200862|11993865|FG002|COMPLETED|Part 2||8
10828553|NCT01200862|11993863|FG000|NOT COMPLETED|Part 2||0
10828554|NCT01200862|11993864|FG001|NOT COMPLETED|Part 2||1
10828555|NCT01200862|11993865|FG002|NOT COMPLETED|Part 2||0
10828556|NCT01225341|11993876|FG000|STARTED|Overall Study||0
10828557|NCT01225341|11993877|FG001|STARTED|Overall Study||0
10828558|NCT01225341|11993876|FG000|COMPLETED|Overall Study||0
10828559|NCT01225341|11993877|FG001|COMPLETED|Overall Study||0
10828560|NCT01225341|11993876|FG000|NOT COMPLETED|Overall Study||0
10828561|NCT01225341|11993877|FG001|NOT COMPLETED|Overall Study||0
10828562|NCT01235962|11993887|FG000|STARTED|Overall Study||198
10828563|NCT01235962|11993888|FG001|STARTED|Overall Study||205
10828564|NCT01235962|11993889|FG002|STARTED|Overall Study||571
10828565|NCT01235962|11993890|FG003|STARTED|Overall Study||564
10828566|NCT01235962|11993887|FG000|Prem. Withdrawn = Did Not Complete Study|Overall Study||46
10828567|NCT01235962|11993888|FG001|Prem. Withdrawn = Did Not Complete Study|Overall Study||35
10828568|NCT01235962|11993889|FG002|Prem. Withdrawn = Did Not Complete Study|Overall Study||118
10828569|NCT01235962|11993890|FG003|Prem. Withdrawn = Did Not Complete Study|Overall Study||86
10828570|NCT01235962|11993887|FG000|All Deaths|Overall Study||43
10828571|NCT01235962|11993888|FG001|All Deaths|Overall Study||46
10828572|NCT01235962|11993889|FG002|All Deaths|Overall Study||102
10828573|NCT01235962|11993890|FG003|All Deaths|Overall Study||104
10828574|NCT01235962|11993887|FG000|COMPLETED|Overall Study||152
10828575|NCT01235962|11993888|FG001|COMPLETED|Overall Study||170
10828576|NCT01235962|11993889|FG002|COMPLETED|Overall Study||453
10828577|NCT01235962|11993890|FG003|COMPLETED|Overall Study||478
10828578|NCT01235962|11993887|FG000|NOT COMPLETED|Overall Study||46
10828579|NCT01235962|11993888|FG001|NOT COMPLETED|Overall Study||35
10828580|NCT01235962|11993889|FG002|NOT COMPLETED|Overall Study||118
10828581|NCT01235962|11993890|FG003|NOT COMPLETED|Overall Study||86
10828582|NCT01239368|11993918|FG000|STARTED|Overall Study||2
10828583|NCT01239368|11993919|FG001|STARTED|Overall Study||1
10828584|NCT01239368|11993920|FG002|STARTED|Overall Study||1
10828469|NCT01088815|11993757|FG000|STARTED|Overall Study||72
10828470|NCT01088815|11993757|FG000|COMPLETED|Overall Study||72
10828471|NCT01088815|11993757|FG000|NOT COMPLETED|Overall Study||0
10828476|NCT01111019|11993765|FG000|STARTED|Overall Study||19
10828477|NCT01111019|11993765|FG000|COMPLETED|Overall Study||16
10828478|NCT01111019|11993765|FG000|NOT COMPLETED|Overall Study||3
10828495|NCT01137955|11993789|FG000|STARTED|Overall Study||25
10828496|NCT01137955|11993790|FG001|STARTED|Overall Study||25
10828497|NCT01137955|11993789|FG000|COMPLETED|Overall Study||20
10828498|NCT01137955|11993790|FG001|COMPLETED|Overall Study||21
10828499|NCT01137955|11993789|FG000|NOT COMPLETED|Overall Study||5
10828500|NCT01137955|11993790|FG001|NOT COMPLETED|Overall Study||4
10828585|NCT01239368|11993921|FG003|STARTED|Overall Study||2
10828586|NCT01239368|11993922|FG004|STARTED|Overall Study||7
10828587|NCT01239368|11993923|FG005|STARTED|Overall Study||5
10828588|NCT01239368|11993924|FG006|STARTED|Overall Study||7
10828589|NCT01239368|11993925|FG007|STARTED|Overall Study||0
10828590|NCT01239368|11993926|FG008|STARTED|Overall Study||1
10828591|NCT01239368|11993927|FG009|STARTED|Overall Study||5
10828592|NCT01239368|11993918|FG000|COMPLETED|Overall Study||0
10828593|NCT01239368|11993919|FG001|COMPLETED|Overall Study||0
10828594|NCT01239368|11993920|FG002|COMPLETED|Overall Study||0
10828595|NCT01239368|11993921|FG003|COMPLETED|Overall Study||1
10828596|NCT01239368|11993922|FG004|COMPLETED|Overall Study||2
10828597|NCT01239368|11993923|FG005|COMPLETED|Overall Study||1
10828598|NCT01239368|11993924|FG006|COMPLETED|Overall Study||1
10828599|NCT01239368|11993925|FG007|COMPLETED|Overall Study||0
10828600|NCT01239368|11993926|FG008|COMPLETED|Overall Study||1
10828601|NCT01239368|11993927|FG009|COMPLETED|Overall Study||1
10828602|NCT01239368|11993918|FG000|NOT COMPLETED|Overall Study||2
10828603|NCT01239368|11993919|FG001|NOT COMPLETED|Overall Study||1
10828604|NCT01239368|11993920|FG002|NOT COMPLETED|Overall Study||1
10828605|NCT01239368|11993921|FG003|NOT COMPLETED|Overall Study||1
10828606|NCT01239368|11993922|FG004|NOT COMPLETED|Overall Study||5
10828607|NCT01239368|11993923|FG005|NOT COMPLETED|Overall Study||4
10828608|NCT01239368|11993924|FG006|NOT COMPLETED|Overall Study||6
10828609|NCT01239368|11993925|FG007|NOT COMPLETED|Overall Study||0
10828610|NCT01239368|11993926|FG008|NOT COMPLETED|Overall Study||0
10828611|NCT01239368|11993927|FG009|NOT COMPLETED|Overall Study||4
10290768|NCT04688346|11423570|FG000|Second Intervention|Overall Study||6
10290769|NCT04688346|11423571|FG001|Second Intervention|Overall Study||7
10290770|NCT04688346|11423570|FG000|COMPLETED|Overall Study||6
10290771|NCT04688346|11423571|FG001|COMPLETED|Overall Study||7
10290772|NCT04688346|11423570|FG000|NOT COMPLETED|Overall Study||0
10290773|NCT04688346|11423571|FG001|NOT COMPLETED|Overall Study||0
10313280|NCT00149890|11446844|FG000|STARTED|Overall Study|"Started indicates all screened and treated participants."|39
10313281|NCT00149890|11446845|FG001|STARTED|Overall Study||38
10313282|NCT00149890|11446844|FG000|COMPLETED|Overall Study||26
10313283|NCT00149890|11446845|FG001|COMPLETED|Overall Study||20
10313284|NCT00149890|11446844|FG000|NOT COMPLETED|Overall Study||13
10313285|NCT00149890|11446845|FG001|NOT COMPLETED|Overall Study||18
10313286|NCT00149994|11446853|FG000|STARTED|Overall Study|"Started indicates Safety population."|85
10313287|NCT00149994|11446854|FG001|STARTED|Overall Study||86
10313288|NCT00149994|11446853|FG000|COMPLETED|Overall Study|"Completed indicates intention to treat (ITT) population."|84
10313289|NCT00149994|11446854|FG001|COMPLETED|Overall Study||85
10313290|NCT00149994|11446853|FG000|NOT COMPLETED|Overall Study||1
10313291|NCT00149994|11446854|FG001|NOT COMPLETED|Overall Study||1
10313292|NCT00150345|11446862|FG000|STARTED|Overall Study||81
10313293|NCT00150345|11446863|FG001|STARTED|Overall Study||66
10313294|NCT00150345|11446862|FG000|COMPLETED|Overall Study||47
10313295|NCT00150345|11446863|FG001|COMPLETED|Overall Study||34
10313296|NCT00150345|11446862|FG000|NOT COMPLETED|Overall Study||34
10313297|NCT00150345|11446863|FG001|NOT COMPLETED|Overall Study||32
10313298|NCT00150462|11446881|FG000|STARTED|Overall Study||3
10313299|NCT00150462|11446882|FG001|STARTED|Overall Study||3
10313300|NCT00150462|11446883|FG002|STARTED|Overall Study||4
10313301|NCT00150462|11446884|FG003|STARTED|Overall Study||3
10313302|NCT00150462|11446885|FG004|STARTED|Overall Study||3
10313303|NCT00150462|11446886|FG005|STARTED|Overall Study||4
10313304|NCT00150462|11446887|FG006|STARTED|Overall Study||3
10313305|NCT00150462|11446888|FG007|STARTED|Overall Study||8
10313306|NCT00150462|11446889|FG008|STARTED|Overall Study||6
10313307|NCT00150462|11446890|FG009|STARTED|Overall Study||7
10313308|NCT00150462|11446891|FG010|STARTED|Overall Study||4
10315642|NCT00181610|11449587|FG000|COMPLETED|Overall Study||4
10828501|NCT01140451|11993799|FG000|STARTED|Overall Study||95
10828502|NCT01140451|11993800|FG001|STARTED|Overall Study||96
10828503|NCT01140451|11993799|FG000|Completed 24 Weeks|Overall Study||89
10828504|NCT01140451|11993800|FG001|Completed 24 Weeks|Overall Study||86
10828505|NCT01140451|11993799|FG000|Completed 48 Weeks|Overall Study||78
10828506|NCT01140451|11993800|FG001|Completed 48 Weeks|Overall Study||70
10828507|NCT01140451|11993799|FG000|Completed 72 Weeks|Overall Study||63
10828508|NCT01140451|11993800|FG001|Completed 72 Weeks|Overall Study||62
10828509|NCT01140451|11993799|FG000|Completed 96 Weeks|Overall Study||57
10828510|NCT01140451|11993800|FG001|Completed 96 Weeks|Overall Study||54
10828511|NCT01140451|11993799|FG000|As-Treated Population|Overall Study||95
10828512|NCT01140451|11993800|FG001|As-Treated Population|Overall Study||96
10828513|NCT01140451|11993799|FG000|96-Week Completer Population|Overall Study||78
10828514|NCT01140451|11993800|FG001|96-Week Completer Population|Overall Study||70
10828515|NCT01140451|11993799|FG000|144-Week Completer Population|Overall Study||57
10828516|NCT01140451|11993800|FG001|144-Week Completer Population|Overall Study||54
10828517|NCT01140451|11993799|FG000|COMPLETED|Overall Study||57
10828518|NCT01140451|11993800|FG001|COMPLETED|Overall Study||54
10828519|NCT01140451|11993799|FG000|NOT COMPLETED|Overall Study||38
10828520|NCT01140451|11993800|FG001|NOT COMPLETED|Overall Study||42
10828612|NCT01247701|11993960|FG000|STARTED|Overall Study||16
10828613|NCT01247701|11993960|FG000|COMPLETED|Overall Study||6
10828614|NCT01247701|11993960|FG000|NOT COMPLETED|Overall Study||10
10828615|NCT01266031|11993967|FG000|STARTED|Overall Study||6
10828616|NCT01266031|11993968|FG001|STARTED|Overall Study||41
10828617|NCT01266031|11993969|FG002|STARTED|Overall Study||49
10828618|NCT01266031|11993967|FG000|COMPLETED|Overall Study||6
10828619|NCT01266031|11993968|FG001|COMPLETED|Overall Study||38
10828620|NCT01266031|11993969|FG002|COMPLETED|Overall Study||47
10828621|NCT01266031|11993967|FG000|NOT COMPLETED|Overall Study||0
10828622|NCT01266031|11993968|FG001|NOT COMPLETED|Overall Study||3
10828623|NCT01266031|11993969|FG002|NOT COMPLETED|Overall Study||2
10828624|NCT01287741|11993990|FG000|STARTED|Overall Study||712
10828625|NCT01287741|11993991|FG001|STARTED|Overall Study||706
10828626|NCT01287741|11993990|FG000|COMPLETED|Overall Study||86
10828627|NCT01287741|11993991|FG001|COMPLETED|Overall Study||91
10828628|NCT01287741|11993990|FG000|NOT COMPLETED|Overall Study||626
10828629|NCT01287741|11993991|FG001|NOT COMPLETED|Overall Study||615
10828630|NCT01304316|11993998|FG000|STARTED|Overall Study||12
10828631|NCT01304316|11993998|FG000|COMPLETED|Overall Study||12
10828632|NCT01304316|11993998|FG000|NOT COMPLETED|Overall Study||0
10828633|NCT01313689|11994008|FG000|STARTED|24-Week Randomization 1||79
10828634|NCT01313689|11994009|FG001|STARTED|24-Week Randomization 1|Of the 43 participants in the PC arm, 22 entered the OFA Salvage arm.|43
10828635|NCT01313689|11994010|FG002|STARTED|24-Week Randomization 1||0
10828636|NCT01313689|11994011|FG003|STARTED|24-Week Randomization 1||0
10828637|NCT01313689|11994012|FG004|STARTED|24-Week Randomization 1||0
10828638|NCT01313689|11994008|FG000|COMPLETED|24-Week Randomization 1|Par. not entering Randomization 2 continued visits for Follow-up and overall survival assessment|60
10828639|NCT01313689|11994009|FG001|COMPLETED|24-Week Randomization 1|Par. that did not receive OFA salvage continued visits for Follow-up and overall survival assessment|33
10828640|NCT01313689|11994010|FG002|COMPLETED|24-Week Randomization 1||0
10828641|NCT01313689|11994011|FG003|COMPLETED|24-Week Randomization 1||0
10828642|NCT01313689|11994012|FG004|COMPLETED|24-Week Randomization 1||0
10828643|NCT01313689|11994008|FG000|NOT COMPLETED|24-Week Randomization 1||19
10828644|NCT01313689|11994009|FG001|NOT COMPLETED|24-Week Randomization 1||10
10828645|NCT01313689|11994010|FG002|NOT COMPLETED|24-Week Randomization 1||0
10828646|NCT01313689|11994011|FG003|NOT COMPLETED|24-Week Randomization 1||0
10828647|NCT01313689|11994012|FG004|NOT COMPLETED|24-Week Randomization 1||0
10828648|NCT01313689|11994008|FG000|STARTED|24-Week Randomization 2||0
10828649|NCT01313689|11994009|FG001|STARTED|24-Week Randomization 2||0
10828650|NCT01313689|11994010|FG002|STARTED|24-Week Randomization 2|Not all participants from Randomization 1 continued to Randomization 2.|24
10828651|NCT01313689|11994011|FG003|STARTED|24-Week Randomization 2|Not all participants from Randomization 1 continued to Randomization 2.|13
10828652|NCT01313689|11994012|FG004|STARTED|24-Week Randomization 2|OFA Participants who did not enter Randomization 2.|42
10828653|NCT01313689|11994008|FG000|COMPLETED|24-Week Randomization 2||0
10828654|NCT01313689|11994009|FG001|COMPLETED|24-Week Randomization 2||0
10828655|NCT01313689|11994010|FG002|COMPLETED|24-Week Randomization 2||21
10828656|NCT01313689|11994011|FG003|COMPLETED|24-Week Randomization 2||12
10828657|NCT01313689|11994012|FG004|COMPLETED|24-Week Randomization 2||27
10828658|NCT01313689|11994008|FG000|NOT COMPLETED|24-Week Randomization 2||0
10828659|NCT01313689|11994009|FG001|NOT COMPLETED|24-Week Randomization 2||0
10828660|NCT01313689|11994010|FG002|NOT COMPLETED|24-Week Randomization 2||3
10828661|NCT01313689|11994011|FG003|NOT COMPLETED|24-Week Randomization 2||1
10828662|NCT01313689|11994012|FG004|NOT COMPLETED|24-Week Randomization 2||15
10828663|NCT01315353|11994034|FG000|STARTED|Overall Study||145
10828664|NCT01315353|11994035|FG001|STARTED|Overall Study||143
10828665|NCT01315353|11994036|FG002|STARTED|Overall Study||179
10828666|NCT01315353|11994034|FG000|COMPLETED|Overall Study||116
10828667|NCT01315353|11994035|FG001|COMPLETED|Overall Study||120
10290774|NCT04684992|11423577|FG000|STARTED|Overall Study||36
10290775|NCT04684992|11423577|FG000|COMPLETED|Overall Study||34
10290776|NCT04684992|11423577|FG000|NOT COMPLETED|Overall Study||2
10290777|NCT04674644|11423581|FG000|STARTED|Overall Study||850
10290778|NCT04674644|11423581|FG000|COMPLETED|Overall Study||813
10290779|NCT04674644|11423581|FG000|NOT COMPLETED|Overall Study||37
10290780|NCT04673214|11423588|FG000|STARTED|Overall Study||67
10290781|NCT04673214|11423589|FG001|STARTED|Overall Study||47
10290782|NCT04673214|11423588|FG000|Lost to Follow up|Overall Study|These patients were discontinued, given in the first days of their follow-up by video call, they presented major symptoms such as dyspnea of movement, dyspnea at rest, and chest pain; Following the protocol's follow-up criteria, patients were informed of their clinical care at the hospital level immediately, and the protocol was no longer followed. Subsequently, when capturing information in the data analysis, the clinical status of the patients is searched, registering their death.|2
10290783|NCT04673214|11423589|FG001|Lost to Follow up|Overall Study|This patient was stopped being followed up in the first days of his follow-up by video call. He presented major symptoms such as dyspnea of movement, dyspnea at rest, and chest pain; With the follow-up criteria of the protocol, the patient was informed of their clinical care at the hospital level immediately, and the protocol was no longer followed. Subsequently, when capturing information in the data analysis, the clinical status of the patient is searched, registering death.|1
10290784|NCT04673214|11423588|FG000|COMPLETED|Overall Study||65
10290785|NCT04673214|11423589|FG001|COMPLETED|Overall Study||46
10290786|NCT04673214|11423588|FG000|NOT COMPLETED|Overall Study||2
10290787|NCT04673214|11423589|FG001|NOT COMPLETED|Overall Study||1
10313309|NCT00150462|11446881|FG000|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
10313310|NCT00150462|11446882|FG001|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
10313311|NCT00150462|11446883|FG002|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
10313312|NCT00150462|11446884|FG003|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
10313313|NCT00150462|11446885|FG004|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
10313314|NCT00150462|11446886|FG005|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
10313315|NCT00150462|11446887|FG006|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
10313316|NCT00150462|11446888|FG007|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
10313317|NCT00150462|11446889|FG008|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
10313318|NCT00150462|11446890|FG009|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of treatment.|1
10313319|NCT00150462|11446891|FG010|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of treatment.|1
10313320|NCT00150462|11446881|FG000|NOT COMPLETED|Overall Study||3
10313321|NCT00150462|11446882|FG001|NOT COMPLETED|Overall Study||3
10313322|NCT00150462|11446883|FG002|NOT COMPLETED|Overall Study||4
10313323|NCT00150462|11446884|FG003|NOT COMPLETED|Overall Study||3
10313324|NCT00150462|11446885|FG004|NOT COMPLETED|Overall Study||3
10313325|NCT00150462|11446886|FG005|NOT COMPLETED|Overall Study||4
10313326|NCT00150462|11446887|FG006|NOT COMPLETED|Overall Study||3
10313327|NCT00150462|11446888|FG007|NOT COMPLETED|Overall Study||8
10313328|NCT00150462|11446889|FG008|NOT COMPLETED|Overall Study||6
10313329|NCT00150462|11446890|FG009|NOT COMPLETED|Overall Study||6
10313330|NCT00150462|11446891|FG010|NOT COMPLETED|Overall Study||3
10313331|NCT00150592|11446920|FG000|STARTED|Overall Study||121
10313332|NCT00150592|11446921|FG001|STARTED|Overall Study||57
10313333|NCT00150592|11446920|FG000|COMPLETED|Overall Study||114
10313334|NCT00150592|11446921|FG001|COMPLETED|Overall Study||54
10313335|NCT00150592|11446920|FG000|NOT COMPLETED|Overall Study||7
10313336|NCT00150592|11446921|FG001|NOT COMPLETED|Overall Study||3
10313337|NCT00150618|11446932|FG000|STARTED|Overall Study||62
10313338|NCT00150618|11446933|FG001|STARTED|Overall Study||65
10313339|NCT00150618|11446934|FG002|STARTED|Overall Study||65
10313340|NCT00150618|11446935|FG003|STARTED|Overall Study||66
10313341|NCT00150618|11446936|FG004|STARTED|Overall Study||66
10313342|NCT00150618|11446932|FG000|COMPLETED|Overall Study||45
10313343|NCT00150618|11446933|FG001|COMPLETED|Overall Study||47
10313344|NCT00150618|11446934|FG002|COMPLETED|Overall Study||38
10313345|NCT00150618|11446935|FG003|COMPLETED|Overall Study||40
10313346|NCT00150618|11446936|FG004|COMPLETED|Overall Study||41
10313347|NCT00150618|11446932|FG000|NOT COMPLETED|Overall Study||17
10313348|NCT00150618|11446933|FG001|NOT COMPLETED|Overall Study||18
10313349|NCT00150618|11446934|FG002|NOT COMPLETED|Overall Study||27
10313350|NCT00150618|11446935|FG003|NOT COMPLETED|Overall Study||26
10313351|NCT00150618|11446936|FG004|NOT COMPLETED|Overall Study||25
10313352|NCT00150800|11446948|FG000|STARTED|Overall Study||667
10313353|NCT00150800|11446948|FG000|COMPLETED|Overall Study||171
10313354|NCT00150800|11446948|FG000|NOT COMPLETED|Overall Study||496
10313355|NCT00150813|11446953|FG000|STARTED|Overall Study||66
10313356|NCT00150813|11446953|FG000|COMPLETED|Overall Study||48
10313357|NCT00150813|11446953|FG000|NOT COMPLETED|Overall Study||18
10313358|NCT00150969|11446959|FG000|STARTED|24 Month Main Study||217
10313359|NCT00150969|11446960|FG001|STARTED|24 Month Main Study||223
10408988|NCT00757705|11553015|FG000|NOT COMPLETED|Overall Study||121
10408989|NCT00757783|11553021|FG000|STARTED|Overall Study||34
10828668|NCT01315353|11994036|FG002|COMPLETED|Overall Study||166
10828669|NCT01315353|11994034|FG000|NOT COMPLETED|Overall Study||29
10828670|NCT01315353|11994035|FG001|NOT COMPLETED|Overall Study||23
10828671|NCT01315353|11994036|FG002|NOT COMPLETED|Overall Study||13
10828672|NCT01318993|11994044|FG000|STARTED|Overall Study||398
10828673|NCT01318993|11994044|FG000|COMPLETED|Overall Study||0
10828674|NCT01318993|11994044|FG000|NOT COMPLETED|Overall Study||398
10828675|NCT04764630|11994048|FG000|STARTED|Overall Study||3
10828676|NCT04764630|11994049|FG001|STARTED|Overall Study||4
10828677|NCT04764630|11994050|FG002|STARTED|Overall Study||3
10828678|NCT04764630|11994051|FG003|STARTED|Overall Study||4
10828679|NCT04764630|11994052|FG004|STARTED|Overall Study||3
10828680|NCT04764630|11994053|FG005|STARTED|Overall Study||4
10828681|NCT04764630|11994048|FG000|COMPLETED|Overall Study||3
10828682|NCT04764630|11994049|FG001|COMPLETED|Overall Study||3
10828683|NCT04764630|11994050|FG002|COMPLETED|Overall Study||3
10828684|NCT04764630|11994051|FG003|COMPLETED|Overall Study||3
10828685|NCT04764630|11994052|FG004|COMPLETED|Overall Study||3
10828686|NCT04764630|11994053|FG005|COMPLETED|Overall Study||3
10828687|NCT04764630|11994048|FG000|NOT COMPLETED|Overall Study||0
10828688|NCT04764630|11994049|FG001|NOT COMPLETED|Overall Study||1
10828689|NCT04764630|11994050|FG002|NOT COMPLETED|Overall Study||0
10828690|NCT04764630|11994051|FG003|NOT COMPLETED|Overall Study||1
10828691|NCT04764630|11994052|FG004|NOT COMPLETED|Overall Study||0
10828692|NCT04764630|11994053|FG005|NOT COMPLETED|Overall Study||1
10828693|NCT04480710|11994066|FG000|STARTED|Overall Study||6
10828694|NCT04480710|11994067|FG001|STARTED|Overall Study||15
10828695|NCT04480710|11994068|FG002|STARTED|Overall Study||9
10828696|NCT04480710|11994069|FG003|STARTED|Overall Study||17
10828697|NCT04480710|11994066|FG000|COMPLETED|Overall Study||6
10828698|NCT04480710|11994067|FG001|COMPLETED|Overall Study||12
10828699|NCT04480710|11994068|FG002|COMPLETED|Overall Study||8
10828700|NCT04480710|11994069|FG003|COMPLETED|Overall Study||17
10828701|NCT04480710|11994066|FG000|NOT COMPLETED|Overall Study||0
10828702|NCT04480710|11994067|FG001|NOT COMPLETED|Overall Study||3
10828703|NCT04480710|11994068|FG002|NOT COMPLETED|Overall Study||1
10828704|NCT04480710|11994069|FG003|NOT COMPLETED|Overall Study||0
10828708|NCT04225676|11994089|FG000|STARTED|Overall Study||5
10828709|NCT04225676|11994089|FG000|Full Analysis, Safety and Enrolled Sets|Overall Study||5
10828710|NCT04225676|11994089|FG000|COMPLETED|Overall Study||0
10828711|NCT04225676|11994089|FG000|NOT COMPLETED|Overall Study||5
10828712|NCT04045132|11994097|FG000|STARTED|Overall Study||37
10828713|NCT04045132|11994098|FG001|STARTED|Overall Study||38
10828714|NCT04045132|11994097|FG000|COMPLETED|Overall Study||34
10828715|NCT04045132|11994098|FG001|COMPLETED|Overall Study||32
10828716|NCT04045132|11994097|FG000|NOT COMPLETED|Overall Study||3
10828717|NCT04045132|11994098|FG001|NOT COMPLETED|Overall Study||6
10828718|NCT03985813|11994108|FG000|STARTED|Overall Study||27
10828719|NCT03985813|11994109|FG001|STARTED|Overall Study||26
10828720|NCT03985813|11994108|FG000|COMPLETED|Overall Study||27
10828721|NCT03985813|11994109|FG001|COMPLETED|Overall Study||26
10828722|NCT03985813|11994108|FG000|NOT COMPLETED|Overall Study||0
10828723|NCT03985813|11994109|FG001|NOT COMPLETED|Overall Study||0
10828724|NCT03891524|11994123|FG000|STARTED|Overall Study||34
10828725|NCT03891524|11994124|FG001|STARTED|Overall Study||150
10828726|NCT03891524|11994125|FG002|STARTED|Overall Study||153
10828727|NCT03891524|11994126|FG003|STARTED|Overall Study||150
10828728|NCT03891524|11994127|FG004|STARTED|Overall Study||149
10828729|NCT03891524|11994128|FG005|STARTED|Overall Study||152
10828730|NCT03891524|11994129|FG006|STARTED|Overall Study||153
10828731|NCT03891524|11994130|FG007|STARTED|Overall Study||301
10828732|NCT03891524|11994123|FG000|Safety Analysis Set|Overall Study||33
10828733|NCT03891524|11994124|FG001|Safety Analysis Set|Overall Study||150
10828734|NCT03891524|11994125|FG002|Safety Analysis Set|Overall Study||148
10828735|NCT03891524|11994126|FG003|Safety Analysis Set|Overall Study||148
10828736|NCT03891524|11994127|FG004|Safety Analysis Set|Overall Study||147
10828737|NCT03891524|11994128|FG005|Safety Analysis Set|Overall Study||149
10828738|NCT03891524|11994129|FG006|Safety Analysis Set|Overall Study||148
10828739|NCT03891524|11994130|FG007|Safety Analysis Set|Overall Study||296
10828740|NCT03891524|11994123|FG000|COMPLETED|Overall Study||34
10828741|NCT03891524|11994124|FG001|COMPLETED|Overall Study||149
10828742|NCT03891524|11994125|FG002|COMPLETED|Overall Study||151
10828743|NCT03891524|11994126|FG003|COMPLETED|Overall Study||149
10828744|NCT03891524|11994127|FG004|COMPLETED|Overall Study||147
10828745|NCT03891524|11994128|FG005|COMPLETED|Overall Study||150
10828746|NCT03891524|11994129|FG006|COMPLETED|Overall Study||151
10828747|NCT03891524|11994130|FG007|COMPLETED|Overall Study||299
10828748|NCT03891524|11994123|FG000|NOT COMPLETED|Overall Study||0
10828749|NCT03891524|11994124|FG001|NOT COMPLETED|Overall Study||1
10828750|NCT03891524|11994125|FG002|NOT COMPLETED|Overall Study||2
10828751|NCT03891524|11994126|FG003|NOT COMPLETED|Overall Study||1
10828752|NCT03891524|11994127|FG004|NOT COMPLETED|Overall Study||2
10828753|NCT03891524|11994128|FG005|NOT COMPLETED|Overall Study||2
10828754|NCT03891524|11994129|FG006|NOT COMPLETED|Overall Study||2
10828755|NCT03891524|11994130|FG007|NOT COMPLETED|Overall Study||2
10828756|NCT03796208|11994167|FG000|STARTED|Overall Study||40
10828757|NCT03796208|11994168|FG001|STARTED|Overall Study||38
10828758|NCT03796208|11994167|FG000|COMPLETED|Overall Study||16
10828759|NCT03796208|11994168|FG001|COMPLETED|Overall Study||16
10828760|NCT03796208|11994167|FG000|NOT COMPLETED|Overall Study||24
10828761|NCT03796208|11994168|FG001|NOT COMPLETED|Overall Study||22
10828762|NCT03672344|11994176|FG000|STARTED|Overall Study||25
10828763|NCT03672344|11994177|FG001|STARTED|Overall Study||29
10828764|NCT03672344|11994176|FG000|COMPLETED|Overall Study||25
10828765|NCT03672344|11994177|FG001|COMPLETED|Overall Study||29
10828766|NCT03672344|11994176|FG000|NOT COMPLETED|Overall Study||0
10828767|NCT03672344|11994177|FG001|NOT COMPLETED|Overall Study||0
10828768|NCT03611010|11994187|FG000|STARTED|Period 1: Lead-In||14
10828769|NCT03611010|11994188|FG001|STARTED|Period 1: Lead-In||14
10828770|NCT03611010|11994189|FG002|STARTED|Period 1: Lead-In||2
10828771|NCT03611010|11994190|FG003|STARTED|Period 1: Lead-In||10
10828772|NCT03611010|11994187|FG000|COMPLETED|Period 1: Lead-In||14
10828773|NCT03611010|11994188|FG001|COMPLETED|Period 1: Lead-In||14
10828774|NCT03611010|11994189|FG002|COMPLETED|Period 1: Lead-In||2
10828775|NCT03611010|11994190|FG003|COMPLETED|Period 1: Lead-In||10
10828776|NCT03611010|11994187|FG000|NOT COMPLETED|Period 1: Lead-In||0
10828777|NCT03611010|11994188|FG001|NOT COMPLETED|Period 1: Lead-In||0
10828778|NCT03611010|11994189|FG002|NOT COMPLETED|Period 1: Lead-In||0
10828779|NCT03611010|11994190|FG003|NOT COMPLETED|Period 1: Lead-In||0
10828780|NCT03611010|11994187|FG000|STARTED|Period 2: 15 Day Treatment||14
10828781|NCT03611010|11994188|FG001|STARTED|Period 2: 15 Day Treatment||14
10828782|NCT03611010|11994189|FG002|STARTED|Period 2: 15 Day Treatment||2
10828783|NCT03611010|11994190|FG003|STARTED|Period 2: 15 Day Treatment||10
10828784|NCT03611010|11994187|FG000|COMPLETED|Period 2: 15 Day Treatment||13
10828785|NCT03611010|11994188|FG001|COMPLETED|Period 2: 15 Day Treatment||14
10828786|NCT03611010|11994189|FG002|COMPLETED|Period 2: 15 Day Treatment||2
10828787|NCT03611010|11994190|FG003|COMPLETED|Period 2: 15 Day Treatment||10
10828788|NCT03611010|11994187|FG000|NOT COMPLETED|Period 2: 15 Day Treatment||1
10828789|NCT03611010|11994188|FG001|NOT COMPLETED|Period 2: 15 Day Treatment||0
10828790|NCT03611010|11994189|FG002|NOT COMPLETED|Period 2: 15 Day Treatment||0
10828791|NCT03611010|11994190|FG003|NOT COMPLETED|Period 2: 15 Day Treatment||0
10828792|NCT03542877|11994203|FG000|STARTED|Overall Study||44
10828793|NCT03542877|11994203|FG000|COMPLETED|Overall Study||23
10828794|NCT03542877|11994203|FG000|NOT COMPLETED|Overall Study||21
10828795|NCT03476798|11994211|FG000|STARTED|Overall Study||33
10828796|NCT03476798|11994211|FG000|COMPLETED|Overall Study||28
10828797|NCT03476798|11994211|FG000|NOT COMPLETED|Overall Study||5
10828810|NCT03355664|11994239|FG000|STARTED|Overall Study||154
10828811|NCT03355664|11994240|FG001|STARTED|Overall Study||156
10828812|NCT03355664|11994239|FG000|COMPLETED|Overall Study||139
10828813|NCT03355664|11994240|FG001|COMPLETED|Overall Study||144
10828814|NCT03355664|11994239|FG000|NOT COMPLETED|Overall Study||15
10828815|NCT03355664|11994240|FG001|NOT COMPLETED|Overall Study||12
10828819|NCT03290131|11994254|FG000|STARTED|Overall Study||179
10828820|NCT03290131|11994255|FG001|STARTED|Overall Study||179
10828821|NCT03290131|11994256|FG002|STARTED|Overall Study||178
10828822|NCT03290131|11994254|FG000|COMPLETED|Overall Study||137
10828823|NCT03290131|11994255|FG001|COMPLETED|Overall Study||107
10828824|NCT03290131|11994256|FG002|COMPLETED|Overall Study||159
10828825|NCT03290131|11994254|FG000|NOT COMPLETED|Overall Study||42
10828826|NCT03290131|11994255|FG001|NOT COMPLETED|Overall Study||72
10828827|NCT03290131|11994256|FG002|NOT COMPLETED|Overall Study||19
10828836|NCT03251326|11994274|FG000|STARTED|Overall Study||1
10828837|NCT03251326|11994275|FG001|STARTED|Overall Study||1
10828838|NCT03251326|11994276|FG002|STARTED|Overall Study||1
10828839|NCT03251326|11994277|FG003|STARTED|Overall Study||1
10828840|NCT03251326|11994274|FG000|COMPLETED|Overall Study||1
10828841|NCT03251326|11994275|FG001|COMPLETED|Overall Study||1
10828842|NCT03251326|11994276|FG002|COMPLETED|Overall Study||0
10828843|NCT03251326|11994277|FG003|COMPLETED|Overall Study||0
10828844|NCT03251326|11994274|FG000|NOT COMPLETED|Overall Study||0
10828845|NCT03251326|11994275|FG001|NOT COMPLETED|Overall Study||0
10828846|NCT03251326|11994276|FG002|NOT COMPLETED|Overall Study||1
10828847|NCT03251326|11994277|FG003|NOT COMPLETED|Overall Study||1
10290788|NCT04668989|11423599|FG000|STARTED|First Intervention||36
10290789|NCT04668989|11423600|FG001|STARTED|First Intervention||30
10290790|NCT04668989|11423599|FG000|COMPLETED|First Intervention||36
10290791|NCT04668989|11423600|FG001|COMPLETED|First Intervention||29
10290792|NCT04668989|11423599|FG000|NOT COMPLETED|First Intervention||0
10290793|NCT04668989|11423600|FG001|NOT COMPLETED|First Intervention||1
10290794|NCT04668989|11423599|FG000|STARTED|Second Intervention||36
10408990|NCT00757783|11553022|FG001|STARTED|Overall Study||31
10408991|NCT00757783|11553021|FG000|COMPLETED|Overall Study||29
10408992|NCT00757783|11553022|FG001|COMPLETED|Overall Study||25
10408993|NCT00757783|11553021|FG000|NOT COMPLETED|Overall Study||5
10408994|NCT00757783|11553022|FG001|NOT COMPLETED|Overall Study||6
10408995|NCT00757822|11553030|FG000|STARTED|Overall Study||92
10408996|NCT00757822|11553031|FG001|STARTED|Overall Study||88
10408997|NCT00757822|11553030|FG000|Day of Surgery (DOS) Assessment|Overall Study||92
10408998|NCT00757822|11553031|FG001|Day of Surgery (DOS) Assessment|Overall Study||88
10408999|NCT00757822|11553030|FG000|Withdrawal by Subject-no Intervention|Overall Study||1
10409000|NCT00757822|11553031|FG001|Withdrawal by Subject-no Intervention|Overall Study||3
10409001|NCT00757822|11553030|FG000|DOS Withdrawn by Investigator|Overall Study|No longer met inclusion criteria or developed exclusion criteria on DOS|6
10409002|NCT00757822|11553031|FG001|DOS Withdrawn by Investigator|Overall Study|No longer met inclusion criteria or developed exclusion criteria on DOS|11
10409003|NCT00757822|11553030|FG000|Received Study Intervention|Overall Study||85
10409004|NCT00757822|11553031|FG001|Received Study Intervention|Overall Study||74
10409005|NCT00757822|11553030|FG000|DOS: Post-operative Assessments|Overall Study||85
10409006|NCT00757822|11553031|FG001|DOS: Post-operative Assessments|Overall Study||74
10409007|NCT00757822|11553030|FG000|24-48 hr Telephone Assessment|Overall Study||85
10409008|NCT00757822|11553031|FG001|24-48 hr Telephone Assessment|Overall Study||74
10409009|NCT00757822|11553030|FG000|2-6 wk Post-op Assessment|Overall Study||85
10409010|NCT00757822|11553031|FG001|2-6 wk Post-op Assessment|Overall Study||74
10409011|NCT00757822|11553030|FG000|Data Entry, QC Assessment|Overall Study||85
10409012|NCT00757822|11553031|FG001|Data Entry, QC Assessment|Overall Study||74
10409013|NCT00757822|11553030|FG000|Withdrawn-low-risk for PONV|Overall Study|K score for PONV risk<2|12
10409014|NCT00757822|11553031|FG001|Withdrawn-low-risk for PONV|Overall Study|K score for PONV risk < 2|9
10409015|NCT00757822|11553030|FG000|Withdrawn-protocol Deviation|Overall Study||9
10409016|NCT00757822|11553031|FG001|Withdrawn-protocol Deviation|Overall Study||8
10409017|NCT00757822|11553030|FG000|Data Lock, Unblinding Analysis|Overall Study||64
10409018|NCT00757822|11553031|FG001|Data Lock, Unblinding Analysis|Overall Study||57
10409019|NCT00757822|11553030|FG000|COMPLETED|Overall Study||64
10409020|NCT00757822|11553031|FG001|COMPLETED|Overall Study||57
10409021|NCT00757822|11553030|FG000|NOT COMPLETED|Overall Study||28
10409022|NCT00757822|11553031|FG001|NOT COMPLETED|Overall Study||31
10409023|NCT00757848|11553042|FG000|STARTED|Overall Study||27
10409024|NCT00757848|11553043|FG001|STARTED|Overall Study||29
10409025|NCT00757848|11553042|FG000|COMPLETED|Overall Study||24
10409026|NCT00757848|11553043|FG001|COMPLETED|Overall Study||27
10409027|NCT00757848|11553042|FG000|NOT COMPLETED|Overall Study||3
10409028|NCT00757848|11553043|FG001|NOT COMPLETED|Overall Study||2
10409029|NCT00758043|11553053|FG000|STARTED|Overall Study||162
10409030|NCT00758043|11553054|FG001|STARTED|Overall Study||160
10409031|NCT00758043|11553055|FG002|STARTED|Overall Study||118
10409032|NCT00758043|11553056|FG003|STARTED|Overall Study||100
10409033|NCT00758043|11553053|FG000|COMPLETED|Overall Study||161
10409034|NCT00758043|11553054|FG001|COMPLETED|Overall Study||119
10409035|NCT00758043|11553055|FG002|COMPLETED|Overall Study||79
10409036|NCT00758043|11553056|FG003|COMPLETED|Overall Study||0
10409037|NCT00758043|11553053|FG000|NOT COMPLETED|Overall Study||1
10409038|NCT00758043|11553054|FG001|NOT COMPLETED|Overall Study||41
10409039|NCT00758043|11553055|FG002|NOT COMPLETED|Overall Study||39
10409040|NCT00758043|11553056|FG003|NOT COMPLETED|Overall Study||100
10409041|NCT00758069|11553075|FG000|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|27
10409042|NCT00758069|11553076|FG001|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|25
10409043|NCT00758069|11553077|FG002|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|28
10409044|NCT00758069|11553075|FG000|COMPLETED|Overall Study||26
10409045|NCT00758069|11553076|FG001|COMPLETED|Overall Study||25
10409046|NCT00758069|11553077|FG002|COMPLETED|Overall Study||27
10409047|NCT00758069|11553075|FG000|NOT COMPLETED|Overall Study||1
10409048|NCT00758069|11553076|FG001|NOT COMPLETED|Overall Study||0
10409049|NCT00758069|11553077|FG002|NOT COMPLETED|Overall Study||1
10409050|NCT00758160|11553085|FG000|STARTED|Overall Study||296
10409051|NCT00758160|11553085|FG000|COMPLETED|Overall Study||230
10409052|NCT00758160|11553085|FG000|NOT COMPLETED|Overall Study||66
10409053|NCT00758264|11553096|FG000|STARTED|Active Phase||182
10409054|NCT00758264|11553097|FG001|STARTED|Active Phase||91
10409055|NCT00758264|11553098|FG002|STARTED|Active Phase||90
10409056|NCT00758264|11553096|FG000|COMPLETED|Active Phase||181
10409057|NCT00758264|11553097|FG001|COMPLETED|Active Phase||91
10290795|NCT04668989|11423600|FG001|STARTED|Second Intervention||29
10409058|NCT00758264|11553098|FG002|COMPLETED|Active Phase||85
10409059|NCT00758264|11553096|FG000|NOT COMPLETED|Active Phase||1
10828860|NCT03119064|11994301|FG000|STARTED|Overall Study||9
10290796|NCT04668989|11423599|FG000|COMPLETED|Second Intervention||36
10290797|NCT04668989|11423600|FG001|COMPLETED|Second Intervention||28
10828861|NCT03119064|11994302|FG001|STARTED|Overall Study||3
10828862|NCT03119064|11994303|FG002|STARTED|Overall Study||0
10828863|NCT03119064|11994301|FG000|COMPLETED|Overall Study||9
10828864|NCT03119064|11994302|FG001|COMPLETED|Overall Study||3
10828865|NCT03119064|11994303|FG002|COMPLETED|Overall Study||0
10828866|NCT03119064|11994301|FG000|NOT COMPLETED|Overall Study||0
10828867|NCT03119064|11994302|FG001|NOT COMPLETED|Overall Study||0
10828868|NCT03119064|11994303|FG002|NOT COMPLETED|Overall Study||0
10828869|NCT03117049|11994312|FG000|STARTED|Overall Study||275
10828870|NCT03117049|11994313|FG001|STARTED|Overall Study||275
10828871|NCT03117049|11994312|FG000|COMPLETED|Overall Study||74
10828872|NCT03117049|11994313|FG001|COMPLETED|Overall Study||44
10828873|NCT03117049|11994312|FG000|NOT COMPLETED|Overall Study||201
10828874|NCT03117049|11994313|FG001|NOT COMPLETED|Overall Study||231
10828875|NCT02842086|11994321|FG000|STARTED|Overall Study||2700
10828876|NCT02842086|11994322|FG001|STARTED|Overall Study||2699
10828877|NCT02842086|11994321|FG000|COMPLETED|Overall Study||2156
10828878|NCT02842086|11994322|FG001|COMPLETED|Overall Study||2206
10828879|NCT02842086|11994321|FG000|NOT COMPLETED|Overall Study||544
10828880|NCT02842086|11994322|FG001|NOT COMPLETED|Overall Study||493
10828881|NCT02663622|11994332|FG000|STARTED|Overall Study||6
10828882|NCT02663622|11994333|FG001|STARTED|Overall Study||6
10828883|NCT02663622|11994334|FG002|STARTED|Overall Study||6
10828884|NCT02663622|11994335|FG003|STARTED|Overall Study||26
10828885|NCT02663622|11994332|FG000|COMPLETED|Overall Study||3
10828886|NCT02663622|11994333|FG001|COMPLETED|Overall Study||5
10828887|NCT02663622|11994334|FG002|COMPLETED|Overall Study||5
10828888|NCT02663622|11994335|FG003|COMPLETED|Overall Study||17
10828889|NCT02663622|11994332|FG000|NOT COMPLETED|Overall Study||3
10828890|NCT02663622|11994333|FG001|NOT COMPLETED|Overall Study||1
10828891|NCT02663622|11994334|FG002|NOT COMPLETED|Overall Study||1
10828892|NCT02663622|11994335|FG003|NOT COMPLETED|Overall Study||9
10828893|NCT02655016|11994348|FG000|STARTED|Overall Study||246
10828894|NCT02655016|11994349|FG001|STARTED|Overall Study||487
10828895|NCT02655016|11994348|FG000|Received Study Treatment|Overall Study|2 participants never received treatment due to screen failure after randomization.|244
10828896|NCT02655016|11994349|FG001|Received Study Treatment|Overall Study|3 participants never received treatment (2 failed screening & 1 withdrew consent before first dose).|484
10828897|NCT02655016|11994348|FG000|Ongoing With Treatment in the Study|Overall Study||69
10290798|NCT04668989|11423599|FG000|NOT COMPLETED|Second Intervention||0
10290799|NCT04668989|11423600|FG001|NOT COMPLETED|Second Intervention||1
10290800|NCT04668352|11423608|FG000|STARTED|Overall Study||511
10290801|NCT04668352|11423609|FG001|STARTED|Overall Study||513
10290802|NCT04668352|11423608|FG000|COMPLETED|Overall Study||510
10290803|NCT04668352|11423609|FG001|COMPLETED|Overall Study||511
10290804|NCT04668352|11423608|FG000|NOT COMPLETED|Overall Study||1
10290805|NCT04668352|11423609|FG001|NOT COMPLETED|Overall Study||2
10313360|NCT00150969|11446959|FG000|COMPLETED|24 Month Main Study||198
10313361|NCT00150969|11446960|FG001|COMPLETED|24 Month Main Study||202
10313362|NCT00150969|11446959|FG000|NOT COMPLETED|24 Month Main Study||19
10313363|NCT00150969|11446960|FG001|NOT COMPLETED|24 Month Main Study||21
10313364|NCT00150969|11446959|FG000|STARTED|24-48 Month Extension||121
10313365|NCT00150969|11446960|FG001|STARTED|24-48 Month Extension||140
10313366|NCT00150969|11446959|FG000|COMPLETED|24-48 Month Extension||33
10313367|NCT00150969|11446960|FG001|COMPLETED|24-48 Month Extension||40
10313368|NCT00150969|11446959|FG000|NOT COMPLETED|24-48 Month Extension||88
10313369|NCT00150969|11446960|FG001|NOT COMPLETED|24-48 Month Extension||100
10313370|NCT00151281|11446967|FG000|STARTED|Overall Study||25
10313371|NCT00151281|11446967|FG000|COMPLETED|Overall Study||22
10313372|NCT00151281|11446967|FG000|NOT COMPLETED|Overall Study||3
10313373|NCT00151320|11446974|FG000|STARTED|Overall Study||76
10313374|NCT00151320|11446974|FG000|COMPLETED|Overall Study||76
10313375|NCT00151320|11446974|FG000|NOT COMPLETED|Overall Study||0
10313376|NCT00151372|11446981|FG000|STARTED|Overall Study||67
10313377|NCT00151372|11446982|FG001|STARTED|Overall Study||74
10313378|NCT00151372|11446981|FG000|COMPLETED|Overall Study||38
10313379|NCT00151372|11446982|FG001|COMPLETED|Overall Study||45
10313380|NCT00151372|11446981|FG000|NOT COMPLETED|Overall Study||29
10313381|NCT00151372|11446982|FG001|NOT COMPLETED|Overall Study||29
10313382|NCT00151411|11446990|FG000|STARTED|Overall Study||55
10313383|NCT00151411|11446991|FG001|STARTED|Overall Study||59
10313384|NCT00151411|11446990|FG000|COMPLETED|Overall Study||22
10313385|NCT00151411|11446991|FG001|COMPLETED|Overall Study||16
10313386|NCT00151411|11446990|FG000|NOT COMPLETED|Overall Study||33
10313387|NCT00151411|11446991|FG001|NOT COMPLETED|Overall Study||43
10313388|NCT00151476|11447000|FG000|STARTED|FAP Identified Subjects||13
10313389|NCT00151476|11447001|FG001|STARTED|FAP Identified Subjects||55
10313390|NCT00151476|11447000|FG000|COMPLETED|FAP Identified Subjects||13
10313391|NCT00151476|11447001|FG001|COMPLETED|FAP Identified Subjects||54
10313392|NCT00151476|11447000|FG000|NOT COMPLETED|FAP Identified Subjects||0
10828898|NCT02655016|11994349|FG001|Ongoing With Treatment in the Study|Overall Study||177
10828899|NCT02655016|11994348|FG000|COMPLETED|Overall Study|69 participants are ongoing in the study.|191
10828900|NCT02655016|11994349|FG001|COMPLETED|Overall Study|177 participants are ongoing in the study.|397
10828901|NCT02655016|11994348|FG000|NOT COMPLETED|Overall Study||55
10828902|NCT02655016|11994349|FG001|NOT COMPLETED|Overall Study||90
10828903|NCT02636439|11994358|FG000|STARTED|Overall Study||44
10828904|NCT02636439|11994359|FG001|STARTED|Overall Study||44
10828905|NCT02636439|11994358|FG000|COMPLETED|Overall Study||38
10828906|NCT02636439|11994359|FG001|COMPLETED|Overall Study||41
10828907|NCT02636439|11994358|FG000|NOT COMPLETED|Overall Study||6
10828908|NCT02636439|11994359|FG001|NOT COMPLETED|Overall Study||3
10828909|NCT02567825|11994367|FG000|STARTED|Overall Study||129
10828910|NCT02567825|11994368|FG001|STARTED|Overall Study||121
10828911|NCT02567825|11994367|FG000|COMPLETED|Overall Study||108
10828912|NCT02567825|11994368|FG001|COMPLETED|Overall Study||100
10828913|NCT02567825|11994367|FG000|NOT COMPLETED|Overall Study||21
10828914|NCT02567825|11994368|FG001|NOT COMPLETED|Overall Study||21
10828918|NCT02536755|11994383|FG000|STARTED|Overall Study||31
10828919|NCT02536755|11994383|FG000|COMPLETED|Overall Study||27
10828920|NCT02536755|11994383|FG000|NOT COMPLETED|Overall Study||4
10828921|NCT02516241|11994393|FG000|STARTED|Overall Study||342
10828922|NCT02516241|11994394|FG001|STARTED|Overall Study||346
10828923|NCT02516241|11994395|FG002|STARTED|Overall Study||344
10828924|NCT02516241|11994393|FG000|Received Treatment|Overall Study||340
10828925|NCT02516241|11994394|FG001|Received Treatment|Overall Study||345
10828926|NCT02516241|11994395|FG002|Received Treatment|Overall Study||313
10828927|NCT02516241|11994393|FG000|COMPLETED|Overall Study||0
10828928|NCT02516241|11994394|FG001|COMPLETED|Overall Study||0
10828929|NCT02516241|11994395|FG002|COMPLETED|Overall Study||0
10828930|NCT02516241|11994393|FG000|NOT COMPLETED|Overall Study||342
10828931|NCT02516241|11994394|FG001|NOT COMPLETED|Overall Study||346
10828932|NCT02516241|11994395|FG002|NOT COMPLETED|Overall Study||344
10828933|NCT02442349|11994408|FG000|STARTED|Overall Study||171
10828934|NCT02442349|11994408|FG000|COMPLETED|Overall Study||0
10828935|NCT02442349|11994408|FG000|NOT COMPLETED|Overall Study||171
10828936|NCT02362035|11994412|FG000|STARTED|Overall Study||161
10828937|NCT02362035|11994412|FG000|COMPLETED|Overall Study||0
10828938|NCT02362035|11994412|FG000|NOT COMPLETED|Overall Study||161
10828939|NCT02359019|11994416|FG000|STARTED|Overall Study||45
10828940|NCT02359019|11994416|FG000|COMPLETED|Overall Study||45
10828941|NCT02359019|11994416|FG000|NOT COMPLETED|Overall Study||0
10828942|NCT02328014|11994424|FG000|STARTED|Overall Study||6
10828943|NCT02328014|11994425|FG001|STARTED|Overall Study||6
10828944|NCT02328014|11994426|FG002|STARTED|Overall Study||6
10828945|NCT02328014|11994427|FG003|STARTED|Overall Study||22
10828946|NCT02328014|11994424|FG000|COMPLETED|Overall Study||0
10828947|NCT02328014|11994425|FG001|COMPLETED|Overall Study||0
10828948|NCT02328014|11994426|FG002|COMPLETED|Overall Study||0
10828949|NCT02328014|11994427|FG003|COMPLETED|Overall Study||0
10828950|NCT02328014|11994424|FG000|NOT COMPLETED|Overall Study||6
10828951|NCT02328014|11994425|FG001|NOT COMPLETED|Overall Study||6
10828952|NCT02328014|11994426|FG002|NOT COMPLETED|Overall Study||6
10828953|NCT02328014|11994427|FG003|NOT COMPLETED|Overall Study||22
10290821|NCT04646291|11423648|FG000|STARTED|Overall Study||272
10290822|NCT04646291|11423649|FG001|STARTED|Overall Study||70
10290823|NCT04646291|11423650|FG002|STARTED|Overall Study||8
10290824|NCT04646291|11423648|FG000|COMPLETED|Overall Study||272
10290825|NCT04646291|11423649|FG001|COMPLETED|Overall Study||70
10290826|NCT04646291|11423650|FG002|COMPLETED|Overall Study||8
10290827|NCT04646291|11423648|FG000|NOT COMPLETED|Overall Study||0
10290828|NCT04646291|11423649|FG001|NOT COMPLETED|Overall Study||0
10290829|NCT04646291|11423650|FG002|NOT COMPLETED|Overall Study||0
10290830|NCT04646109|11423666|FG000|STARTED|Overall Study||30
10290831|NCT04646109|11423667|FG001|STARTED|Overall Study||36
10290832|NCT04646109|11423666|FG000|COMPLETED|Overall Study||30
10290833|NCT04646109|11423667|FG001|COMPLETED|Overall Study||30
10290834|NCT04646109|11423666|FG000|NOT COMPLETED|Overall Study||0
10290835|NCT04646109|11423667|FG001|NOT COMPLETED|Overall Study||6
10290836|NCT04637997|11423676|FG000|STARTED|Overall Study||9
10290837|NCT04637997|11423677|FG001|STARTED|Overall Study||9
10290838|NCT04637997|11423676|FG000|COMPLETED|Overall Study||9
10290839|NCT04637997|11423677|FG001|COMPLETED|Overall Study||9
10290840|NCT04637997|11423676|FG000|NOT COMPLETED|Overall Study||0
10290841|NCT04637997|11423677|FG001|NOT COMPLETED|Overall Study||0
10313393|NCT00151476|11447001|FG001|NOT COMPLETED|FAP Identified Subjects||1
10313394|NCT00151476|11447000|FG000|STARTED|FAP Analyzed Subjects||13
10828966|NCT02207569|11994450|FG000|STARTED|Implant|241 Attempted Implant|241
10828967|NCT02207569|11994450|FG000|COMPLETED|Implant|237 Implanted|241
10828968|NCT02207569|11994450|FG000|NOT COMPLETED|Implant||0
10828969|NCT02207569|11994450|FG000|STARTED|1-Month|241 Attempted Implant|241
10828970|NCT02207569|11994450|FG000|COMPLETED|1-Month||232
10828971|NCT02207569|11994450|FG000|NOT COMPLETED|1-Month||9
10828972|NCT02207569|11994450|FG000|STARTED|6-Month||232
10828973|NCT02207569|11994450|FG000|COMPLETED|6-Month||222
10828974|NCT02207569|11994450|FG000|NOT COMPLETED|6-Month||10
10828975|NCT02207569|11994450|FG000|STARTED|12-Month||213
10828976|NCT02207569|11994450|FG000|COMPLETED|12-Month||197
10828977|NCT02207569|11994450|FG000|NOT COMPLETED|12-Month||16
10828978|NCT02207569|11994450|FG000|STARTED|24-Month||197
10828979|NCT02207569|11994450|FG000|COMPLETED|24-Month||171
10828980|NCT02207569|11994450|FG000|NOT COMPLETED|24-Month||26
10828981|NCT02207569|11994450|FG000|STARTED|36-Month||171
10828982|NCT02207569|11994450|FG000|COMPLETED|36-Month||144
10828983|NCT02207569|11994450|FG000|NOT COMPLETED|36-Month||27
10828984|NCT02207569|11994450|FG000|STARTED|48-Month||144
10290842|NCT04634903|11423690|FG000|STARTED|Overall Study||818
10290843|NCT04634903|11423691|FG001|STARTED|Overall Study||821
10290844|NCT04634903|11423692|FG002|STARTED|Overall Study||813
10290845|NCT04634903|11423690|FG000|COMPLETED|Overall Study||669
10290846|NCT04634903|11423691|FG001|COMPLETED|Overall Study||732
10290847|NCT04634903|11423692|FG002|COMPLETED|Overall Study||653
10290848|NCT04634903|11423690|FG000|NOT COMPLETED|Overall Study||149
10290849|NCT04634903|11423691|FG001|NOT COMPLETED|Overall Study||89
10290850|NCT04634903|11423692|FG002|NOT COMPLETED|Overall Study||160
10313395|NCT00151476|11447001|FG001|STARTED|FAP Analyzed Subjects||54
10313396|NCT00151476|11447000|FG000|COMPLETED|FAP Analyzed Subjects||13
10313397|NCT00151476|11447001|FG001|COMPLETED|FAP Analyzed Subjects||51
10313398|NCT00151476|11447000|FG000|NOT COMPLETED|FAP Analyzed Subjects||0
10313399|NCT00151476|11447001|FG001|NOT COMPLETED|FAP Analyzed Subjects||3
10313400|NCT00151775|11447013|FG000|STARTED|Period 2 - Double-Blind Dose Response||95
10313401|NCT00151775|11447014|FG001|STARTED|Period 2 - Double-Blind Dose Response||95
10313402|NCT00151775|11447015|FG002|STARTED|Period 2 - Double-Blind Dose Response||0
10313403|NCT00151775|11447016|FG003|STARTED|Period 2 - Double-Blind Dose Response||0
10313404|NCT00151775|11447017|FG004|STARTED|Period 2 - Double-Blind Dose Response||0
10313405|NCT00151775|11447018|FG005|STARTED|Period 2 - Double-Blind Dose Response||56
10313406|NCT00151775|11447019|FG006|STARTED|Period 2 - Double-Blind Dose Response||56
10313407|NCT00151775|11447020|FG007|STARTED|Period 2 - Double-Blind Dose Response||0
10313408|NCT00151775|11447021|FG008|STARTED|Period 2 - Double-Blind Dose Response||0
10313409|NCT00151775|11447022|FG009|STARTED|Period 2 - Double-Blind Dose Response||0
10313410|NCT00151775|11447023|FG010|STARTED|Period 2 - Double-Blind Dose Response||60
10313411|NCT00151775|11447024|FG011|STARTED|Period 2 - Double-Blind Dose Response||0
10313412|NCT00151775|11447013|FG000|COMPLETED|Period 2 - Double-Blind Dose Response||93
10313413|NCT00151775|11447014|FG001|COMPLETED|Period 2 - Double-Blind Dose Response||89
10313414|NCT00151775|11447015|FG002|COMPLETED|Period 2 - Double-Blind Dose Response||0
10313415|NCT00151775|11447016|FG003|COMPLETED|Period 2 - Double-Blind Dose Response||0
10313416|NCT00151775|11447017|FG004|COMPLETED|Period 2 - Double-Blind Dose Response||0
10313417|NCT00151775|11447018|FG005|COMPLETED|Period 2 - Double-Blind Dose Response||54
10313418|NCT00151775|11447019|FG006|COMPLETED|Period 2 - Double-Blind Dose Response||53
10313419|NCT00151775|11447020|FG007|COMPLETED|Period 2 - Double-Blind Dose Response||0
10313420|NCT00151775|11447021|FG008|COMPLETED|Period 2 - Double-Blind Dose Response||0
10313421|NCT00151775|11447022|FG009|COMPLETED|Period 2 - Double-Blind Dose Response||0
10313422|NCT00151775|11447023|FG010|COMPLETED|Period 2 - Double-Blind Dose Response||59
10313423|NCT00151775|11447024|FG011|COMPLETED|Period 2 - Double-Blind Dose Response||0
10313424|NCT00151775|11447013|FG000|NOT COMPLETED|Period 2 - Double-Blind Dose Response||2
10313425|NCT00151775|11447014|FG001|NOT COMPLETED|Period 2 - Double-Blind Dose Response||6
10313426|NCT00151775|11447015|FG002|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
10313427|NCT00151775|11447016|FG003|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
10313428|NCT00151775|11447017|FG004|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
10313429|NCT00151775|11447018|FG005|NOT COMPLETED|Period 2 - Double-Blind Dose Response||2
10313430|NCT00151775|11447019|FG006|NOT COMPLETED|Period 2 - Double-Blind Dose Response||3
10313431|NCT00151775|11447020|FG007|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
10313432|NCT00151775|11447021|FG008|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
10313433|NCT00151775|11447022|FG009|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
10313434|NCT00151775|11447023|FG010|NOT COMPLETED|Period 2 - Double-Blind Dose Response||1
10313435|NCT00151775|11447024|FG011|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
10313436|NCT00151775|11447013|FG000|STARTED|Period 3: Double-blind, Withdrawal||48
10313437|NCT00151775|11447014|FG001|STARTED|Period 3: Double-blind, Withdrawal||45
10313438|NCT00151775|11447015|FG002|STARTED|Period 3: Double-blind, Withdrawal||45
10313439|NCT00151775|11447016|FG003|STARTED|Period 3: Double-blind, Withdrawal||44
10313440|NCT00151775|11447017|FG004|STARTED|Period 3: Double-blind, Withdrawal||0
10828985|NCT02207569|11994450|FG000|COMPLETED|48-Month||113
10828986|NCT02207569|11994450|FG000|NOT COMPLETED|48-Month||31
10828987|NCT02207569|11994450|FG000|STARTED|60-Month||113
10828988|NCT02207569|11994450|FG000|COMPLETED|60-Month||109
10828989|NCT02207569|11994450|FG000|NOT COMPLETED|60-Month||4
10828990|NCT02201108|11994456|FG000|STARTED|Double-blind Period (up to Week 96)||57
10828991|NCT02201108|11994457|FG001|STARTED|Double-blind Period (up to Week 96)||109
10828992|NCT02201108|11994456|FG000|COMPLETED|Double-blind Period (up to Week 96)||53
10828993|NCT02201108|11994457|FG001|COMPLETED|Double-blind Period (up to Week 96)||102
10828994|NCT02201108|11994456|FG000|NOT COMPLETED|Double-blind Period (up to Week 96)||4
10828995|NCT02201108|11994457|FG001|NOT COMPLETED|Double-blind Period (up to Week 96)||7
10828996|NCT02201108|11994456|FG000|STARTED|Open Label Period (up to Week 192)||52
10828997|NCT02201108|11994457|FG001|STARTED|Open Label Period (up to Week 192)||100
10828998|NCT02201108|11994456|FG000|COMPLETED|Open Label Period (up to Week 192)||31
10828999|NCT02201108|11994457|FG001|COMPLETED|Open Label Period (up to Week 192)||73
10829000|NCT02201108|11994456|FG000|NOT COMPLETED|Open Label Period (up to Week 192)||21
10829001|NCT02201108|11994457|FG001|NOT COMPLETED|Open Label Period (up to Week 192)||27
10829010|NCT02150967|11994487|FG000|STARTED|Overall Study||108
10829011|NCT02150967|11994488|FG001|STARTED|Overall Study||14
10829012|NCT02150967|11994487|FG000|Treatment Ongoing (Cohort 1 Only)|Overall Study||1
10829013|NCT02150967|11994488|FG001|Treatment Ongoing (Cohort 1 Only)|Overall Study||0
10829014|NCT02150967|11994487|FG000|Treatment Ended (Cohort 1 Only)|Overall Study||107
10829015|NCT02150967|11994488|FG001|Treatment Ended (Cohort 1 Only)|Overall Study||14
10829016|NCT02150967|11994487|FG000|COMPLETED|Overall Study|Cohort 1 (FGFR2 fusions): Primary efficacy outcome measures were prespecified only for this cohort.|108
10829017|NCT02150967|11994488|FG001|COMPLETED|Overall Study|Cohort 1 (Other FGFR Alterations): not the primary efficacy analysis population, thus efficacy results for this cohort are not reported.|14
10829018|NCT02150967|11994487|FG000|NOT COMPLETED|Overall Study||0
10829019|NCT02150967|11994488|FG001|NOT COMPLETED|Overall Study||0
10829056|NCT01759459|11994548|FG000|STARTED|Overall Study||50
10829057|NCT01759459|11994549|FG001|STARTED|Overall Study||50
10829058|NCT01759459|11994550|FG002|STARTED|Overall Study||50
10829059|NCT01759459|11994548|FG000|COMPLETED|Overall Study||50
10829060|NCT01759459|11994549|FG001|COMPLETED|Overall Study||50
10829061|NCT01759459|11994550|FG002|COMPLETED|Overall Study||50
10829062|NCT01759459|11994548|FG000|NOT COMPLETED|Overall Study||0
10829063|NCT01759459|11994549|FG001|NOT COMPLETED|Overall Study||0
10829064|NCT01759459|11994550|FG002|NOT COMPLETED|Overall Study||0
10829080|NCT01116648|11994597|FG000|STARTED|Phase 1 Dose Level 0||3
10829081|NCT01116648|11994598|FG001|STARTED|Phase 1 Dose Level 0||0
10829082|NCT01116648|11994599|FG002|STARTED|Phase 1 Dose Level 0||0
10829083|NCT01116648|11994600|FG003|STARTED|Phase 1 Dose Level 0||0
10829084|NCT01116648|11994601|FG004|STARTED|Phase 1 Dose Level 0||0
10829085|NCT01116648|11994602|FG005|STARTED|Phase 1 Dose Level 0||0
10829086|NCT01116648|11994603|FG006|STARTED|Phase 1 Dose Level 0||0
10829087|NCT01116648|11994604|FG007|STARTED|Phase 1 Dose Level 0||0
10829088|NCT01116648|11994605|FG008|STARTED|Phase 1 Dose Level 0||0
10829089|NCT01116648|11994606|FG009|STARTED|Phase 1 Dose Level 0||0
10829090|NCT01116648|11994607|FG010|STARTED|Phase 1 Dose Level 0||0
10829091|NCT01116648|11994608|FG011|STARTED|Phase 1 Dose Level 0||0
10829092|NCT01116648|11994609|FG012|STARTED|Phase 1 Dose Level 0||0
10829093|NCT01116648|11994610|FG013|STARTED|Phase 1 Dose Level 0||0
10829094|NCT01116648|11994611|FG014|STARTED|Phase 1 Dose Level 0||0
10829095|NCT01116648|11994597|FG000|COMPLETED|Phase 1 Dose Level 0||3
10829096|NCT01116648|11994598|FG001|COMPLETED|Phase 1 Dose Level 0||0
10829097|NCT01116648|11994599|FG002|COMPLETED|Phase 1 Dose Level 0||0
10829098|NCT01116648|11994600|FG003|COMPLETED|Phase 1 Dose Level 0||0
10829099|NCT01116648|11994601|FG004|COMPLETED|Phase 1 Dose Level 0||0
10829100|NCT01116648|11994602|FG005|COMPLETED|Phase 1 Dose Level 0||0
10829101|NCT01116648|11994603|FG006|COMPLETED|Phase 1 Dose Level 0||0
10829102|NCT01116648|11994604|FG007|COMPLETED|Phase 1 Dose Level 0||0
10829103|NCT01116648|11994605|FG008|COMPLETED|Phase 1 Dose Level 0||0
10829104|NCT01116648|11994606|FG009|COMPLETED|Phase 1 Dose Level 0||0
10829105|NCT01116648|11994607|FG010|COMPLETED|Phase 1 Dose Level 0||0
10829106|NCT01116648|11994608|FG011|COMPLETED|Phase 1 Dose Level 0||0
10829107|NCT01116648|11994609|FG012|COMPLETED|Phase 1 Dose Level 0||0
10829108|NCT01116648|11994610|FG013|COMPLETED|Phase 1 Dose Level 0||0
10829109|NCT01116648|11994611|FG014|COMPLETED|Phase 1 Dose Level 0||0
10829110|NCT01116648|11994597|FG000|NOT COMPLETED|Phase 1 Dose Level 0||0
10829111|NCT01116648|11994598|FG001|NOT COMPLETED|Phase 1 Dose Level 0||0
10829112|NCT01116648|11994599|FG002|NOT COMPLETED|Phase 1 Dose Level 0||0
10829113|NCT01116648|11994600|FG003|NOT COMPLETED|Phase 1 Dose Level 0||0
10829114|NCT01116648|11994601|FG004|NOT COMPLETED|Phase 1 Dose Level 0||0
10829115|NCT01116648|11994602|FG005|NOT COMPLETED|Phase 1 Dose Level 0||0
10829116|NCT01116648|11994603|FG006|NOT COMPLETED|Phase 1 Dose Level 0||0
10829117|NCT01116648|11994604|FG007|NOT COMPLETED|Phase 1 Dose Level 0||0
10829118|NCT01116648|11994605|FG008|NOT COMPLETED|Phase 1 Dose Level 0||0
10829119|NCT01116648|11994606|FG009|NOT COMPLETED|Phase 1 Dose Level 0||0
10829120|NCT01116648|11994607|FG010|NOT COMPLETED|Phase 1 Dose Level 0||0
10829121|NCT01116648|11994608|FG011|NOT COMPLETED|Phase 1 Dose Level 0||0
10829122|NCT01116648|11994609|FG012|NOT COMPLETED|Phase 1 Dose Level 0||0
10829123|NCT01116648|11994610|FG013|NOT COMPLETED|Phase 1 Dose Level 0||0
10829124|NCT01116648|11994611|FG014|NOT COMPLETED|Phase 1 Dose Level 0||0
10829125|NCT01116648|11994597|FG000|STARTED|Phase 1 Dose Level 1||0
10829126|NCT01116648|11994598|FG001|STARTED|Phase 1 Dose Level 1||3
10829127|NCT01116648|11994599|FG002|STARTED|Phase 1 Dose Level 1||0
10829128|NCT01116648|11994600|FG003|STARTED|Phase 1 Dose Level 1||0
10829129|NCT01116648|11994601|FG004|STARTED|Phase 1 Dose Level 1||0
10829130|NCT01116648|11994602|FG005|STARTED|Phase 1 Dose Level 1||0
10829131|NCT01116648|11994603|FG006|STARTED|Phase 1 Dose Level 1||0
10829132|NCT01116648|11994604|FG007|STARTED|Phase 1 Dose Level 1||0
10829133|NCT01116648|11994605|FG008|STARTED|Phase 1 Dose Level 1||0
10829134|NCT01116648|11994606|FG009|STARTED|Phase 1 Dose Level 1||0
10829135|NCT01116648|11994607|FG010|STARTED|Phase 1 Dose Level 1||0
10829136|NCT01116648|11994608|FG011|STARTED|Phase 1 Dose Level 1||0
10829137|NCT01116648|11994609|FG012|STARTED|Phase 1 Dose Level 1||0
10829138|NCT01116648|11994610|FG013|STARTED|Phase 1 Dose Level 1||0
10829139|NCT01116648|11994611|FG014|STARTED|Phase 1 Dose Level 1||0
10829140|NCT01116648|11994597|FG000|COMPLETED|Phase 1 Dose Level 1||0
10829141|NCT01116648|11994598|FG001|COMPLETED|Phase 1 Dose Level 1||3
10829142|NCT01116648|11994599|FG002|COMPLETED|Phase 1 Dose Level 1||0
10829143|NCT01116648|11994600|FG003|COMPLETED|Phase 1 Dose Level 1||0
10829144|NCT01116648|11994601|FG004|COMPLETED|Phase 1 Dose Level 1||0
10829145|NCT01116648|11994602|FG005|COMPLETED|Phase 1 Dose Level 1||0
10829146|NCT01116648|11994603|FG006|COMPLETED|Phase 1 Dose Level 1||0
10829147|NCT01116648|11994604|FG007|COMPLETED|Phase 1 Dose Level 1||0
10829148|NCT01116648|11994605|FG008|COMPLETED|Phase 1 Dose Level 1||0
10829149|NCT01116648|11994606|FG009|COMPLETED|Phase 1 Dose Level 1||0
10829150|NCT01116648|11994607|FG010|COMPLETED|Phase 1 Dose Level 1||0
10829151|NCT01116648|11994608|FG011|COMPLETED|Phase 1 Dose Level 1||0
10829152|NCT01116648|11994609|FG012|COMPLETED|Phase 1 Dose Level 1||0
10829153|NCT01116648|11994610|FG013|COMPLETED|Phase 1 Dose Level 1||0
10829154|NCT01116648|11994611|FG014|COMPLETED|Phase 1 Dose Level 1||0
10829155|NCT01116648|11994597|FG000|NOT COMPLETED|Phase 1 Dose Level 1||0
10829156|NCT01116648|11994598|FG001|NOT COMPLETED|Phase 1 Dose Level 1||0
10829157|NCT01116648|11994599|FG002|NOT COMPLETED|Phase 1 Dose Level 1||0
10829158|NCT01116648|11994600|FG003|NOT COMPLETED|Phase 1 Dose Level 1||0
10829159|NCT01116648|11994601|FG004|NOT COMPLETED|Phase 1 Dose Level 1||0
10829160|NCT01116648|11994602|FG005|NOT COMPLETED|Phase 1 Dose Level 1||0
10829161|NCT01116648|11994603|FG006|NOT COMPLETED|Phase 1 Dose Level 1||0
10829162|NCT01116648|11994604|FG007|NOT COMPLETED|Phase 1 Dose Level 1||0
10829163|NCT01116648|11994605|FG008|NOT COMPLETED|Phase 1 Dose Level 1||0
10829164|NCT01116648|11994606|FG009|NOT COMPLETED|Phase 1 Dose Level 1||0
10829165|NCT01116648|11994607|FG010|NOT COMPLETED|Phase 1 Dose Level 1||0
10829166|NCT01116648|11994608|FG011|NOT COMPLETED|Phase 1 Dose Level 1||0
10829167|NCT01116648|11994609|FG012|NOT COMPLETED|Phase 1 Dose Level 1||0
10829168|NCT01116648|11994610|FG013|NOT COMPLETED|Phase 1 Dose Level 1||0
10829169|NCT01116648|11994611|FG014|NOT COMPLETED|Phase 1 Dose Level 1||0
10829170|NCT01116648|11994597|FG000|STARTED|Phase 1 Dose Level 2||0
10829171|NCT01116648|11994598|FG001|STARTED|Phase 1 Dose Level 2||0
10829172|NCT01116648|11994599|FG002|STARTED|Phase 1 Dose Level 2||7
10829173|NCT01116648|11994600|FG003|STARTED|Phase 1 Dose Level 2||0
10829174|NCT01116648|11994601|FG004|STARTED|Phase 1 Dose Level 2||0
10829175|NCT01116648|11994602|FG005|STARTED|Phase 1 Dose Level 2||0
10829176|NCT01116648|11994603|FG006|STARTED|Phase 1 Dose Level 2||0
10829177|NCT01116648|11994604|FG007|STARTED|Phase 1 Dose Level 2||0
10829178|NCT01116648|11994605|FG008|STARTED|Phase 1 Dose Level 2||0
10829179|NCT01116648|11994606|FG009|STARTED|Phase 1 Dose Level 2||0
10829180|NCT01116648|11994607|FG010|STARTED|Phase 1 Dose Level 2||0
10829181|NCT01116648|11994608|FG011|STARTED|Phase 1 Dose Level 2||0
10829182|NCT01116648|11994609|FG012|STARTED|Phase 1 Dose Level 2||0
10829183|NCT01116648|11994610|FG013|STARTED|Phase 1 Dose Level 2||0
10829184|NCT01116648|11994611|FG014|STARTED|Phase 1 Dose Level 2||0
10829185|NCT01116648|11994597|FG000|COMPLETED|Phase 1 Dose Level 2||0
10829186|NCT01116648|11994598|FG001|COMPLETED|Phase 1 Dose Level 2||0
10829187|NCT01116648|11994599|FG002|COMPLETED|Phase 1 Dose Level 2||7
10829188|NCT01116648|11994600|FG003|COMPLETED|Phase 1 Dose Level 2||0
10829189|NCT01116648|11994601|FG004|COMPLETED|Phase 1 Dose Level 2||0
10829190|NCT01116648|11994602|FG005|COMPLETED|Phase 1 Dose Level 2||0
10829191|NCT01116648|11994603|FG006|COMPLETED|Phase 1 Dose Level 2||0
10829192|NCT01116648|11994604|FG007|COMPLETED|Phase 1 Dose Level 2||0
10829193|NCT01116648|11994605|FG008|COMPLETED|Phase 1 Dose Level 2||0
10829194|NCT01116648|11994606|FG009|COMPLETED|Phase 1 Dose Level 2||0
10829195|NCT01116648|11994607|FG010|COMPLETED|Phase 1 Dose Level 2||0
10829196|NCT01116648|11994608|FG011|COMPLETED|Phase 1 Dose Level 2||0
10829197|NCT01116648|11994609|FG012|COMPLETED|Phase 1 Dose Level 2||0
10829198|NCT01116648|11994610|FG013|COMPLETED|Phase 1 Dose Level 2||0
10829199|NCT01116648|11994611|FG014|COMPLETED|Phase 1 Dose Level 2||0
10829200|NCT01116648|11994597|FG000|NOT COMPLETED|Phase 1 Dose Level 2||0
10829201|NCT01116648|11994598|FG001|NOT COMPLETED|Phase 1 Dose Level 2||0
10829202|NCT01116648|11994599|FG002|NOT COMPLETED|Phase 1 Dose Level 2||0
10829203|NCT01116648|11994600|FG003|NOT COMPLETED|Phase 1 Dose Level 2||0
10829204|NCT01116648|11994601|FG004|NOT COMPLETED|Phase 1 Dose Level 2||0
10829205|NCT01116648|11994602|FG005|NOT COMPLETED|Phase 1 Dose Level 2||0
10829206|NCT01116648|11994603|FG006|NOT COMPLETED|Phase 1 Dose Level 2||0
10829207|NCT01116648|11994604|FG007|NOT COMPLETED|Phase 1 Dose Level 2||0
10829208|NCT01116648|11994605|FG008|NOT COMPLETED|Phase 1 Dose Level 2||0
10829209|NCT01116648|11994606|FG009|NOT COMPLETED|Phase 1 Dose Level 2||0
10829210|NCT01116648|11994607|FG010|NOT COMPLETED|Phase 1 Dose Level 2||0
10829211|NCT01116648|11994608|FG011|NOT COMPLETED|Phase 1 Dose Level 2||0
10829212|NCT01116648|11994609|FG012|NOT COMPLETED|Phase 1 Dose Level 2||0
10829213|NCT01116648|11994610|FG013|NOT COMPLETED|Phase 1 Dose Level 2||0
10829214|NCT01116648|11994611|FG014|NOT COMPLETED|Phase 1 Dose Level 2||0
10829215|NCT01116648|11994597|FG000|STARTED|Phase 1 Dose Level 3||0
10829216|NCT01116648|11994598|FG001|STARTED|Phase 1 Dose Level 3||0
10829217|NCT01116648|11994599|FG002|STARTED|Phase 1 Dose Level 3||0
10829218|NCT01116648|11994600|FG003|STARTED|Phase 1 Dose Level 3||6
10829219|NCT01116648|11994601|FG004|STARTED|Phase 1 Dose Level 3||0
10829220|NCT01116648|11994602|FG005|STARTED|Phase 1 Dose Level 3||0
10829221|NCT01116648|11994603|FG006|STARTED|Phase 1 Dose Level 3||0
10829222|NCT01116648|11994604|FG007|STARTED|Phase 1 Dose Level 3||0
10829223|NCT01116648|11994605|FG008|STARTED|Phase 1 Dose Level 3||0
10829224|NCT01116648|11994606|FG009|STARTED|Phase 1 Dose Level 3||0
10829225|NCT01116648|11994607|FG010|STARTED|Phase 1 Dose Level 3||0
10829226|NCT01116648|11994608|FG011|STARTED|Phase 1 Dose Level 3||0
10829227|NCT01116648|11994609|FG012|STARTED|Phase 1 Dose Level 3||0
10829228|NCT01116648|11994610|FG013|STARTED|Phase 1 Dose Level 3||0
10829229|NCT01116648|11994611|FG014|STARTED|Phase 1 Dose Level 3||0
10829230|NCT01116648|11994597|FG000|COMPLETED|Phase 1 Dose Level 3||0
10829231|NCT01116648|11994598|FG001|COMPLETED|Phase 1 Dose Level 3||0
10829232|NCT01116648|11994599|FG002|COMPLETED|Phase 1 Dose Level 3||0
10829233|NCT01116648|11994600|FG003|COMPLETED|Phase 1 Dose Level 3||4
10829234|NCT01116648|11994601|FG004|COMPLETED|Phase 1 Dose Level 3||0
10829235|NCT01116648|11994602|FG005|COMPLETED|Phase 1 Dose Level 3||0
10829236|NCT01116648|11994603|FG006|COMPLETED|Phase 1 Dose Level 3||0
10829237|NCT01116648|11994604|FG007|COMPLETED|Phase 1 Dose Level 3||0
10829238|NCT01116648|11994605|FG008|COMPLETED|Phase 1 Dose Level 3||0
10829239|NCT01116648|11994606|FG009|COMPLETED|Phase 1 Dose Level 3||0
10829240|NCT01116648|11994607|FG010|COMPLETED|Phase 1 Dose Level 3||0
10829241|NCT01116648|11994608|FG011|COMPLETED|Phase 1 Dose Level 3||0
10829242|NCT01116648|11994609|FG012|COMPLETED|Phase 1 Dose Level 3||0
10829243|NCT01116648|11994610|FG013|COMPLETED|Phase 1 Dose Level 3||0
10829244|NCT01116648|11994611|FG014|COMPLETED|Phase 1 Dose Level 3||0
10829245|NCT01116648|11994597|FG000|NOT COMPLETED|Phase 1 Dose Level 3||0
10829246|NCT01116648|11994598|FG001|NOT COMPLETED|Phase 1 Dose Level 3||0
10829247|NCT01116648|11994599|FG002|NOT COMPLETED|Phase 1 Dose Level 3||0
10829248|NCT01116648|11994600|FG003|NOT COMPLETED|Phase 1 Dose Level 3||2
10829249|NCT01116648|11994601|FG004|NOT COMPLETED|Phase 1 Dose Level 3||0
10829250|NCT01116648|11994602|FG005|NOT COMPLETED|Phase 1 Dose Level 3||0
10829251|NCT01116648|11994603|FG006|NOT COMPLETED|Phase 1 Dose Level 3||0
10829252|NCT01116648|11994604|FG007|NOT COMPLETED|Phase 1 Dose Level 3||0
10829253|NCT01116648|11994605|FG008|NOT COMPLETED|Phase 1 Dose Level 3||0
10829254|NCT01116648|11994606|FG009|NOT COMPLETED|Phase 1 Dose Level 3||0
10829255|NCT01116648|11994607|FG010|NOT COMPLETED|Phase 1 Dose Level 3||0
10829256|NCT01116648|11994608|FG011|NOT COMPLETED|Phase 1 Dose Level 3||0
10829257|NCT01116648|11994609|FG012|NOT COMPLETED|Phase 1 Dose Level 3||0
10829258|NCT01116648|11994610|FG013|NOT COMPLETED|Phase 1 Dose Level 3||0
10829259|NCT01116648|11994611|FG014|NOT COMPLETED|Phase 1 Dose Level 3||0
10829260|NCT01116648|11994597|FG000|STARTED|Expansion at Maximum Tolerated Dose||0
10829261|NCT01116648|11994598|FG001|STARTED|Expansion at Maximum Tolerated Dose||0
10829262|NCT01116648|11994599|FG002|STARTED|Expansion at Maximum Tolerated Dose||0
10829263|NCT01116648|11994600|FG003|STARTED|Expansion at Maximum Tolerated Dose||0
10829264|NCT01116648|11994601|FG004|STARTED|Expansion at Maximum Tolerated Dose||9
10829265|NCT01116648|11994602|FG005|STARTED|Expansion at Maximum Tolerated Dose||0
10829266|NCT01116648|11994603|FG006|STARTED|Expansion at Maximum Tolerated Dose||0
10829267|NCT01116648|11994604|FG007|STARTED|Expansion at Maximum Tolerated Dose||0
10829268|NCT01116648|11994605|FG008|STARTED|Expansion at Maximum Tolerated Dose||0
10829269|NCT01116648|11994606|FG009|STARTED|Expansion at Maximum Tolerated Dose||0
10829270|NCT01116648|11994607|FG010|STARTED|Expansion at Maximum Tolerated Dose||0
10829271|NCT01116648|11994608|FG011|STARTED|Expansion at Maximum Tolerated Dose||0
10829272|NCT01116648|11994609|FG012|STARTED|Expansion at Maximum Tolerated Dose||0
10829273|NCT01116648|11994610|FG013|STARTED|Expansion at Maximum Tolerated Dose||0
10829274|NCT01116648|11994611|FG014|STARTED|Expansion at Maximum Tolerated Dose||0
10829275|NCT01116648|11994597|FG000|COMPLETED|Expansion at Maximum Tolerated Dose||0
10829276|NCT01116648|11994598|FG001|COMPLETED|Expansion at Maximum Tolerated Dose||0
10829277|NCT01116648|11994599|FG002|COMPLETED|Expansion at Maximum Tolerated Dose||0
10829278|NCT01116648|11994600|FG003|COMPLETED|Expansion at Maximum Tolerated Dose||0
10829279|NCT01116648|11994601|FG004|COMPLETED|Expansion at Maximum Tolerated Dose||9
10829280|NCT01116648|11994602|FG005|COMPLETED|Expansion at Maximum Tolerated Dose||0
10829281|NCT01116648|11994603|FG006|COMPLETED|Expansion at Maximum Tolerated Dose||0
10829282|NCT01116648|11994604|FG007|COMPLETED|Expansion at Maximum Tolerated Dose||0
10829283|NCT01116648|11994605|FG008|COMPLETED|Expansion at Maximum Tolerated Dose||0
10829284|NCT01116648|11994606|FG009|COMPLETED|Expansion at Maximum Tolerated Dose||0
10829285|NCT01116648|11994607|FG010|COMPLETED|Expansion at Maximum Tolerated Dose||0
10829286|NCT01116648|11994608|FG011|COMPLETED|Expansion at Maximum Tolerated Dose||0
10829287|NCT01116648|11994609|FG012|COMPLETED|Expansion at Maximum Tolerated Dose||0
10829288|NCT01116648|11994610|FG013|COMPLETED|Expansion at Maximum Tolerated Dose||0
10829289|NCT01116648|11994611|FG014|COMPLETED|Expansion at Maximum Tolerated Dose||0
10829290|NCT01116648|11994597|FG000|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
10829291|NCT01116648|11994598|FG001|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
10829292|NCT01116648|11994599|FG002|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
10829293|NCT01116648|11994600|FG003|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
10829294|NCT01116648|11994601|FG004|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
10829295|NCT01116648|11994602|FG005|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
10829296|NCT01116648|11994603|FG006|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
10829297|NCT01116648|11994604|FG007|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
10829298|NCT01116648|11994605|FG008|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
10829299|NCT01116648|11994606|FG009|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
10829300|NCT01116648|11994607|FG010|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
10829301|NCT01116648|11994608|FG011|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
10829302|NCT01116648|11994609|FG012|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
10829303|NCT01116648|11994610|FG013|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
10829304|NCT01116648|11994611|FG014|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
10829305|NCT01116648|11994597|FG000|STARTED|Phase 2||0
10829306|NCT01116648|11994598|FG001|STARTED|Phase 2||0
10829307|NCT01116648|11994599|FG002|STARTED|Phase 2||0
10829308|NCT01116648|11994600|FG003|STARTED|Phase 2||0
10829309|NCT01116648|11994601|FG004|STARTED|Phase 2||0
10829310|NCT01116648|11994602|FG005|STARTED|Phase 2||46
10829311|NCT01116648|11994603|FG006|STARTED|Phase 2||44
10829312|NCT01116648|11994604|FG007|STARTED|Phase 2||0
10829313|NCT01116648|11994605|FG008|STARTED|Phase 2||0
10829314|NCT01116648|11994606|FG009|STARTED|Phase 2||0
10829315|NCT01116648|11994607|FG010|STARTED|Phase 2||0
10829316|NCT01116648|11994608|FG011|STARTED|Phase 2||0
10829317|NCT01116648|11994609|FG012|STARTED|Phase 2||0
10829318|NCT01116648|11994610|FG013|STARTED|Phase 2||0
10829319|NCT01116648|11994611|FG014|STARTED|Phase 2||0
10829320|NCT01116648|11994597|FG000|COMPLETED|Phase 2||0
10829321|NCT01116648|11994598|FG001|COMPLETED|Phase 2||0
10829322|NCT01116648|11994599|FG002|COMPLETED|Phase 2||0
10829323|NCT01116648|11994600|FG003|COMPLETED|Phase 2||0
10829324|NCT01116648|11994601|FG004|COMPLETED|Phase 2||0
10829325|NCT01116648|11994602|FG005|COMPLETED|Phase 2||46
10829326|NCT01116648|11994603|FG006|COMPLETED|Phase 2||44
10829327|NCT01116648|11994604|FG007|COMPLETED|Phase 2||0
10829328|NCT01116648|11994605|FG008|COMPLETED|Phase 2||0
10829329|NCT01116648|11994606|FG009|COMPLETED|Phase 2||0
10829330|NCT01116648|11994607|FG010|COMPLETED|Phase 2||0
10829331|NCT01116648|11994608|FG011|COMPLETED|Phase 2||0
10829332|NCT01116648|11994609|FG012|COMPLETED|Phase 2||0
10829333|NCT01116648|11994610|FG013|COMPLETED|Phase 2||0
10829334|NCT01116648|11994611|FG014|COMPLETED|Phase 2||0
10829335|NCT01116648|11994597|FG000|NOT COMPLETED|Phase 2||0
10829336|NCT01116648|11994598|FG001|NOT COMPLETED|Phase 2||0
10829337|NCT01116648|11994599|FG002|NOT COMPLETED|Phase 2||0
10829338|NCT01116648|11994600|FG003|NOT COMPLETED|Phase 2||0
10829339|NCT01116648|11994601|FG004|NOT COMPLETED|Phase 2||0
10829340|NCT01116648|11994602|FG005|NOT COMPLETED|Phase 2||0
10829341|NCT01116648|11994603|FG006|NOT COMPLETED|Phase 2||0
10829342|NCT01116648|11994604|FG007|NOT COMPLETED|Phase 2||0
10829343|NCT01116648|11994605|FG008|NOT COMPLETED|Phase 2||0
10829344|NCT01116648|11994606|FG009|NOT COMPLETED|Phase 2||0
10829345|NCT01116648|11994607|FG010|NOT COMPLETED|Phase 2||0
10829346|NCT01116648|11994608|FG011|NOT COMPLETED|Phase 2||0
10829347|NCT01116648|11994609|FG012|NOT COMPLETED|Phase 2||0
10829348|NCT01116648|11994610|FG013|NOT COMPLETED|Phase 2||0
10829349|NCT01116648|11994611|FG014|NOT COMPLETED|Phase 2||0
10829350|NCT01116648|11994597|FG000|STARTED|Phase 1-T Dose Level 0-TA||0
10829351|NCT01116648|11994598|FG001|STARTED|Phase 1-T Dose Level 0-TA||0
10829352|NCT01116648|11994599|FG002|STARTED|Phase 1-T Dose Level 0-TA||0
10829353|NCT01116648|11994600|FG003|STARTED|Phase 1-T Dose Level 0-TA||0
10829354|NCT01116648|11994601|FG004|STARTED|Phase 1-T Dose Level 0-TA||0
10829355|NCT01116648|11994602|FG005|STARTED|Phase 1-T Dose Level 0-TA||0
10829356|NCT01116648|11994603|FG006|STARTED|Phase 1-T Dose Level 0-TA||0
10829357|NCT01116648|11994604|FG007|STARTED|Phase 1-T Dose Level 0-TA||3
10829358|NCT01116648|11994605|FG008|STARTED|Phase 1-T Dose Level 0-TA||0
10829359|NCT01116648|11994606|FG009|STARTED|Phase 1-T Dose Level 0-TA||0
10829360|NCT01116648|11994607|FG010|STARTED|Phase 1-T Dose Level 0-TA||0
10829361|NCT01116648|11994608|FG011|STARTED|Phase 1-T Dose Level 0-TA||0
10829362|NCT01116648|11994609|FG012|STARTED|Phase 1-T Dose Level 0-TA||0
10829363|NCT01116648|11994610|FG013|STARTED|Phase 1-T Dose Level 0-TA||0
10829364|NCT01116648|11994611|FG014|STARTED|Phase 1-T Dose Level 0-TA||0
10829365|NCT01116648|11994597|FG000|COMPLETED|Phase 1-T Dose Level 0-TA||0
10829366|NCT01116648|11994598|FG001|COMPLETED|Phase 1-T Dose Level 0-TA||0
10829367|NCT01116648|11994599|FG002|COMPLETED|Phase 1-T Dose Level 0-TA||0
10829368|NCT01116648|11994600|FG003|COMPLETED|Phase 1-T Dose Level 0-TA||0
10829369|NCT01116648|11994601|FG004|COMPLETED|Phase 1-T Dose Level 0-TA||0
10829370|NCT01116648|11994602|FG005|COMPLETED|Phase 1-T Dose Level 0-TA||0
10829371|NCT01116648|11994603|FG006|COMPLETED|Phase 1-T Dose Level 0-TA||0
10829372|NCT01116648|11994604|FG007|COMPLETED|Phase 1-T Dose Level 0-TA||3
10829373|NCT01116648|11994605|FG008|COMPLETED|Phase 1-T Dose Level 0-TA||0
10829374|NCT01116648|11994606|FG009|COMPLETED|Phase 1-T Dose Level 0-TA||0
10829375|NCT01116648|11994607|FG010|COMPLETED|Phase 1-T Dose Level 0-TA||0
10829376|NCT01116648|11994608|FG011|COMPLETED|Phase 1-T Dose Level 0-TA||0
10829377|NCT01116648|11994609|FG012|COMPLETED|Phase 1-T Dose Level 0-TA||0
10829378|NCT01116648|11994610|FG013|COMPLETED|Phase 1-T Dose Level 0-TA||0
10829379|NCT01116648|11994611|FG014|COMPLETED|Phase 1-T Dose Level 0-TA||0
10829380|NCT01116648|11994597|FG000|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
10829381|NCT01116648|11994598|FG001|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
10829382|NCT01116648|11994599|FG002|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
10829383|NCT01116648|11994600|FG003|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
10829384|NCT01116648|11994601|FG004|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
10829385|NCT01116648|11994602|FG005|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
10829386|NCT01116648|11994603|FG006|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
10829387|NCT01116648|11994604|FG007|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
10829388|NCT01116648|11994605|FG008|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
10829389|NCT01116648|11994606|FG009|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
10829390|NCT01116648|11994607|FG010|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
10829391|NCT01116648|11994608|FG011|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
10829392|NCT01116648|11994609|FG012|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
10829393|NCT01116648|11994610|FG013|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
10829394|NCT01116648|11994611|FG014|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
10829395|NCT01116648|11994597|FG000|STARTED|Phase 1-T Dose Level 1-TA||0
10829396|NCT01116648|11994598|FG001|STARTED|Phase 1-T Dose Level 1-TA||0
10829397|NCT01116648|11994599|FG002|STARTED|Phase 1-T Dose Level 1-TA||0
10829398|NCT01116648|11994600|FG003|STARTED|Phase 1-T Dose Level 1-TA||0
10829399|NCT01116648|11994601|FG004|STARTED|Phase 1-T Dose Level 1-TA||0
10829400|NCT01116648|11994602|FG005|STARTED|Phase 1-T Dose Level 1-TA||0
10829401|NCT01116648|11994603|FG006|STARTED|Phase 1-T Dose Level 1-TA||0
10829402|NCT01116648|11994604|FG007|STARTED|Phase 1-T Dose Level 1-TA||0
10829403|NCT01116648|11994605|FG008|STARTED|Phase 1-T Dose Level 1-TA||6
10829404|NCT01116648|11994606|FG009|STARTED|Phase 1-T Dose Level 1-TA||0
10290851|NCT04633642|11423702|FG000|STARTED|Overall Study|27 participants|27
10829405|NCT01116648|11994607|FG010|STARTED|Phase 1-T Dose Level 1-TA||0
10829406|NCT01116648|11994608|FG011|STARTED|Phase 1-T Dose Level 1-TA||0
10829407|NCT01116648|11994609|FG012|STARTED|Phase 1-T Dose Level 1-TA||0
10829408|NCT01116648|11994610|FG013|STARTED|Phase 1-T Dose Level 1-TA||0
10829409|NCT01116648|11994611|FG014|STARTED|Phase 1-T Dose Level 1-TA||0
10829410|NCT01116648|11994597|FG000|COMPLETED|Phase 1-T Dose Level 1-TA||0
10829411|NCT01116648|11994598|FG001|COMPLETED|Phase 1-T Dose Level 1-TA||0
10829412|NCT01116648|11994599|FG002|COMPLETED|Phase 1-T Dose Level 1-TA||0
10829413|NCT01116648|11994600|FG003|COMPLETED|Phase 1-T Dose Level 1-TA||0
10829414|NCT01116648|11994601|FG004|COMPLETED|Phase 1-T Dose Level 1-TA||0
10290852|NCT04633642|11423703|FG001|STARTED|Overall Study|24 participants|24
10829415|NCT01116648|11994602|FG005|COMPLETED|Phase 1-T Dose Level 1-TA||0
10829416|NCT01116648|11994603|FG006|COMPLETED|Phase 1-T Dose Level 1-TA||0
10829417|NCT01116648|11994604|FG007|COMPLETED|Phase 1-T Dose Level 1-TA||0
10829418|NCT01116648|11994605|FG008|COMPLETED|Phase 1-T Dose Level 1-TA||6
10829419|NCT01116648|11994606|FG009|COMPLETED|Phase 1-T Dose Level 1-TA||0
10829420|NCT01116648|11994607|FG010|COMPLETED|Phase 1-T Dose Level 1-TA||0
10829421|NCT01116648|11994608|FG011|COMPLETED|Phase 1-T Dose Level 1-TA||0
10829422|NCT01116648|11994609|FG012|COMPLETED|Phase 1-T Dose Level 1-TA||0
10829423|NCT01116648|11994610|FG013|COMPLETED|Phase 1-T Dose Level 1-TA||0
10829424|NCT01116648|11994611|FG014|COMPLETED|Phase 1-T Dose Level 1-TA||0
10829425|NCT01116648|11994597|FG000|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
10829426|NCT01116648|11994598|FG001|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
10829427|NCT01116648|11994599|FG002|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
10829428|NCT01116648|11994600|FG003|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
10829429|NCT01116648|11994601|FG004|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
10829430|NCT01116648|11994602|FG005|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
10829431|NCT01116648|11994603|FG006|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
10829432|NCT01116648|11994604|FG007|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
10829433|NCT01116648|11994605|FG008|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
10829434|NCT01116648|11994606|FG009|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
10829435|NCT01116648|11994607|FG010|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
10829436|NCT01116648|11994608|FG011|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
10829437|NCT01116648|11994609|FG012|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
10829438|NCT01116648|11994610|FG013|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
10829439|NCT01116648|11994611|FG014|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
10829440|NCT01116648|11994597|FG000|STARTED|Phase 1-T Dose Level 2-TA||0
10829441|NCT01116648|11994598|FG001|STARTED|Phase 1-T Dose Level 2-TA||0
10829442|NCT01116648|11994599|FG002|STARTED|Phase 1-T Dose Level 2-TA||0
10829443|NCT01116648|11994600|FG003|STARTED|Phase 1-T Dose Level 2-TA||0
10829444|NCT01116648|11994601|FG004|STARTED|Phase 1-T Dose Level 2-TA||0
10829445|NCT01116648|11994602|FG005|STARTED|Phase 1-T Dose Level 2-TA||0
10829446|NCT01116648|11994603|FG006|STARTED|Phase 1-T Dose Level 2-TA||0
10829447|NCT01116648|11994604|FG007|STARTED|Phase 1-T Dose Level 2-TA||0
10829448|NCT01116648|11994605|FG008|STARTED|Phase 1-T Dose Level 2-TA||0
10829449|NCT01116648|11994606|FG009|STARTED|Phase 1-T Dose Level 2-TA||3
10829450|NCT01116648|11994607|FG010|STARTED|Phase 1-T Dose Level 2-TA||0
10829451|NCT01116648|11994608|FG011|STARTED|Phase 1-T Dose Level 2-TA||0
10829452|NCT01116648|11994609|FG012|STARTED|Phase 1-T Dose Level 2-TA||0
10829453|NCT01116648|11994610|FG013|STARTED|Phase 1-T Dose Level 2-TA||0
10829454|NCT01116648|11994611|FG014|STARTED|Phase 1-T Dose Level 2-TA||0
10829455|NCT01116648|11994597|FG000|COMPLETED|Phase 1-T Dose Level 2-TA||0
10829456|NCT01116648|11994598|FG001|COMPLETED|Phase 1-T Dose Level 2-TA||0
10829457|NCT01116648|11994599|FG002|COMPLETED|Phase 1-T Dose Level 2-TA||0
10829458|NCT01116648|11994600|FG003|COMPLETED|Phase 1-T Dose Level 2-TA||0
10829459|NCT01116648|11994601|FG004|COMPLETED|Phase 1-T Dose Level 2-TA||0
10829460|NCT01116648|11994602|FG005|COMPLETED|Phase 1-T Dose Level 2-TA||0
10829461|NCT01116648|11994603|FG006|COMPLETED|Phase 1-T Dose Level 2-TA||0
10829462|NCT01116648|11994604|FG007|COMPLETED|Phase 1-T Dose Level 2-TA||0
10829463|NCT01116648|11994605|FG008|COMPLETED|Phase 1-T Dose Level 2-TA||0
10829464|NCT01116648|11994606|FG009|COMPLETED|Phase 1-T Dose Level 2-TA||3
10829465|NCT01116648|11994607|FG010|COMPLETED|Phase 1-T Dose Level 2-TA||0
10829466|NCT01116648|11994608|FG011|COMPLETED|Phase 1-T Dose Level 2-TA||0
10829467|NCT01116648|11994609|FG012|COMPLETED|Phase 1-T Dose Level 2-TA||0
10829468|NCT01116648|11994610|FG013|COMPLETED|Phase 1-T Dose Level 2-TA||0
10829469|NCT01116648|11994611|FG014|COMPLETED|Phase 1-T Dose Level 2-TA||0
10829470|NCT01116648|11994597|FG000|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
10829471|NCT01116648|11994598|FG001|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
10829472|NCT01116648|11994599|FG002|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
10829473|NCT01116648|11994600|FG003|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
10829474|NCT01116648|11994601|FG004|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
10829475|NCT01116648|11994602|FG005|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
10829476|NCT01116648|11994603|FG006|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
10829477|NCT01116648|11994604|FG007|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
10829478|NCT01116648|11994605|FG008|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
10829479|NCT01116648|11994606|FG009|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
10829480|NCT01116648|11994607|FG010|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
10829481|NCT01116648|11994608|FG011|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
10829482|NCT01116648|11994609|FG012|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
10829483|NCT01116648|11994610|FG013|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
10829484|NCT01116648|11994611|FG014|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
10829485|NCT01116648|11994597|FG000|STARTED|Phase 1-T Dose Level 0-TB||0
10829486|NCT01116648|11994598|FG001|STARTED|Phase 1-T Dose Level 0-TB||0
10829487|NCT01116648|11994599|FG002|STARTED|Phase 1-T Dose Level 0-TB||0
10829488|NCT01116648|11994600|FG003|STARTED|Phase 1-T Dose Level 0-TB||0
10829489|NCT01116648|11994601|FG004|STARTED|Phase 1-T Dose Level 0-TB||0
10829490|NCT01116648|11994602|FG005|STARTED|Phase 1-T Dose Level 0-TB||0
10829491|NCT01116648|11994603|FG006|STARTED|Phase 1-T Dose Level 0-TB||0
10829492|NCT01116648|11994604|FG007|STARTED|Phase 1-T Dose Level 0-TB||0
10829493|NCT01116648|11994605|FG008|STARTED|Phase 1-T Dose Level 0-TB||0
10829494|NCT01116648|11994606|FG009|STARTED|Phase 1-T Dose Level 0-TB||0
10829495|NCT01116648|11994607|FG010|STARTED|Phase 1-T Dose Level 0-TB||3
10829496|NCT01116648|11994608|FG011|STARTED|Phase 1-T Dose Level 0-TB||0
10829497|NCT01116648|11994609|FG012|STARTED|Phase 1-T Dose Level 0-TB||0
10829498|NCT01116648|11994610|FG013|STARTED|Phase 1-T Dose Level 0-TB||0
10829499|NCT01116648|11994611|FG014|STARTED|Phase 1-T Dose Level 0-TB||0
10829500|NCT01116648|11994597|FG000|COMPLETED|Phase 1-T Dose Level 0-TB||0
10829501|NCT01116648|11994598|FG001|COMPLETED|Phase 1-T Dose Level 0-TB||0
10829502|NCT01116648|11994599|FG002|COMPLETED|Phase 1-T Dose Level 0-TB||0
10829503|NCT01116648|11994600|FG003|COMPLETED|Phase 1-T Dose Level 0-TB||0
10829504|NCT01116648|11994601|FG004|COMPLETED|Phase 1-T Dose Level 0-TB||0
10829505|NCT01116648|11994602|FG005|COMPLETED|Phase 1-T Dose Level 0-TB||0
10829506|NCT01116648|11994603|FG006|COMPLETED|Phase 1-T Dose Level 0-TB||0
10829507|NCT01116648|11994604|FG007|COMPLETED|Phase 1-T Dose Level 0-TB||0
10829508|NCT01116648|11994605|FG008|COMPLETED|Phase 1-T Dose Level 0-TB||0
10829509|NCT01116648|11994606|FG009|COMPLETED|Phase 1-T Dose Level 0-TB||0
10829510|NCT01116648|11994607|FG010|COMPLETED|Phase 1-T Dose Level 0-TB||3
10829511|NCT01116648|11994608|FG011|COMPLETED|Phase 1-T Dose Level 0-TB||0
10829512|NCT01116648|11994609|FG012|COMPLETED|Phase 1-T Dose Level 0-TB||0
10829513|NCT01116648|11994610|FG013|COMPLETED|Phase 1-T Dose Level 0-TB||0
10829514|NCT01116648|11994611|FG014|COMPLETED|Phase 1-T Dose Level 0-TB||0
10829515|NCT01116648|11994597|FG000|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
10829516|NCT01116648|11994598|FG001|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
10829517|NCT01116648|11994599|FG002|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
10829518|NCT01116648|11994600|FG003|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
10829519|NCT01116648|11994601|FG004|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
10829520|NCT01116648|11994602|FG005|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
10829521|NCT01116648|11994603|FG006|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
10829522|NCT01116648|11994604|FG007|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
10829523|NCT01116648|11994605|FG008|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
10829524|NCT01116648|11994606|FG009|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
10829525|NCT01116648|11994607|FG010|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
10829526|NCT01116648|11994608|FG011|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
10829527|NCT01116648|11994609|FG012|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
10829528|NCT01116648|11994610|FG013|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
10829529|NCT01116648|11994611|FG014|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
10829530|NCT01116648|11994597|FG000|STARTED|Phase 1-T Dose Level 1-TB||0
10829531|NCT01116648|11994598|FG001|STARTED|Phase 1-T Dose Level 1-TB||0
10829532|NCT01116648|11994599|FG002|STARTED|Phase 1-T Dose Level 1-TB||0
10829533|NCT01116648|11994600|FG003|STARTED|Phase 1-T Dose Level 1-TB||0
10829534|NCT01116648|11994601|FG004|STARTED|Phase 1-T Dose Level 1-TB||0
10829535|NCT01116648|11994602|FG005|STARTED|Phase 1-T Dose Level 1-TB||0
10829536|NCT01116648|11994603|FG006|STARTED|Phase 1-T Dose Level 1-TB||0
10829537|NCT01116648|11994604|FG007|STARTED|Phase 1-T Dose Level 1-TB||0
10829538|NCT01116648|11994605|FG008|STARTED|Phase 1-T Dose Level 1-TB||0
10829539|NCT01116648|11994606|FG009|STARTED|Phase 1-T Dose Level 1-TB||0
10829540|NCT01116648|11994607|FG010|STARTED|Phase 1-T Dose Level 1-TB||0
10829541|NCT01116648|11994608|FG011|STARTED|Phase 1-T Dose Level 1-TB||3
10829542|NCT01116648|11994609|FG012|STARTED|Phase 1-T Dose Level 1-TB||0
10829543|NCT01116648|11994610|FG013|STARTED|Phase 1-T Dose Level 1-TB||0
10829544|NCT01116648|11994611|FG014|STARTED|Phase 1-T Dose Level 1-TB||0
10829545|NCT01116648|11994597|FG000|COMPLETED|Phase 1-T Dose Level 1-TB||0
10829546|NCT01116648|11994598|FG001|COMPLETED|Phase 1-T Dose Level 1-TB||0
10829547|NCT01116648|11994599|FG002|COMPLETED|Phase 1-T Dose Level 1-TB||0
10829548|NCT01116648|11994600|FG003|COMPLETED|Phase 1-T Dose Level 1-TB||0
10829549|NCT01116648|11994601|FG004|COMPLETED|Phase 1-T Dose Level 1-TB||0
10829550|NCT01116648|11994602|FG005|COMPLETED|Phase 1-T Dose Level 1-TB||0
10829551|NCT01116648|11994603|FG006|COMPLETED|Phase 1-T Dose Level 1-TB||0
10829552|NCT01116648|11994604|FG007|COMPLETED|Phase 1-T Dose Level 1-TB||0
10829553|NCT01116648|11994605|FG008|COMPLETED|Phase 1-T Dose Level 1-TB||0
10829554|NCT01116648|11994606|FG009|COMPLETED|Phase 1-T Dose Level 1-TB||0
10829555|NCT01116648|11994607|FG010|COMPLETED|Phase 1-T Dose Level 1-TB||0
10829556|NCT01116648|11994608|FG011|COMPLETED|Phase 1-T Dose Level 1-TB||3
10829557|NCT01116648|11994609|FG012|COMPLETED|Phase 1-T Dose Level 1-TB||0
10829558|NCT01116648|11994610|FG013|COMPLETED|Phase 1-T Dose Level 1-TB||0
10829559|NCT01116648|11994611|FG014|COMPLETED|Phase 1-T Dose Level 1-TB||0
10829560|NCT01116648|11994597|FG000|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
10829561|NCT01116648|11994598|FG001|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
10829562|NCT01116648|11994599|FG002|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
10829563|NCT01116648|11994600|FG003|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
10829564|NCT01116648|11994601|FG004|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
10829565|NCT01116648|11994602|FG005|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
10829566|NCT01116648|11994603|FG006|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
10829567|NCT01116648|11994604|FG007|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
10829568|NCT01116648|11994605|FG008|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
10829569|NCT01116648|11994606|FG009|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
10829570|NCT01116648|11994607|FG010|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
10829571|NCT01116648|11994608|FG011|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
10829572|NCT01116648|11994609|FG012|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
10829573|NCT01116648|11994610|FG013|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
10829574|NCT01116648|11994611|FG014|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
10829575|NCT01116648|11994597|FG000|STARTED|Phase 1-T Dose Level 2-TB||0
10829576|NCT01116648|11994598|FG001|STARTED|Phase 1-T Dose Level 2-TB||0
10829577|NCT01116648|11994599|FG002|STARTED|Phase 1-T Dose Level 2-TB||0
10829578|NCT01116648|11994600|FG003|STARTED|Phase 1-T Dose Level 2-TB||0
10829579|NCT01116648|11994601|FG004|STARTED|Phase 1-T Dose Level 2-TB||0
10829580|NCT01116648|11994602|FG005|STARTED|Phase 1-T Dose Level 2-TB||0
10829581|NCT01116648|11994603|FG006|STARTED|Phase 1-T Dose Level 2-TB||0
10829582|NCT01116648|11994604|FG007|STARTED|Phase 1-T Dose Level 2-TB||0
10829583|NCT01116648|11994605|FG008|STARTED|Phase 1-T Dose Level 2-TB||0
10829584|NCT01116648|11994606|FG009|STARTED|Phase 1-T Dose Level 2-TB||0
10829585|NCT01116648|11994607|FG010|STARTED|Phase 1-T Dose Level 2-TB||0
10829586|NCT01116648|11994608|FG011|STARTED|Phase 1-T Dose Level 2-TB||0
10829587|NCT01116648|11994609|FG012|STARTED|Phase 1-T Dose Level 2-TB||6
10829588|NCT01116648|11994610|FG013|STARTED|Phase 1-T Dose Level 2-TB||0
10829589|NCT01116648|11994611|FG014|STARTED|Phase 1-T Dose Level 2-TB||0
10829590|NCT01116648|11994597|FG000|COMPLETED|Phase 1-T Dose Level 2-TB||0
10829591|NCT01116648|11994598|FG001|COMPLETED|Phase 1-T Dose Level 2-TB||0
10829592|NCT01116648|11994599|FG002|COMPLETED|Phase 1-T Dose Level 2-TB||0
10829593|NCT01116648|11994600|FG003|COMPLETED|Phase 1-T Dose Level 2-TB||0
10829594|NCT01116648|11994601|FG004|COMPLETED|Phase 1-T Dose Level 2-TB||0
10829595|NCT01116648|11994602|FG005|COMPLETED|Phase 1-T Dose Level 2-TB||0
10829596|NCT01116648|11994603|FG006|COMPLETED|Phase 1-T Dose Level 2-TB||0
10829597|NCT01116648|11994604|FG007|COMPLETED|Phase 1-T Dose Level 2-TB||0
10829598|NCT01116648|11994605|FG008|COMPLETED|Phase 1-T Dose Level 2-TB||0
10829599|NCT01116648|11994606|FG009|COMPLETED|Phase 1-T Dose Level 2-TB||0
10829600|NCT01116648|11994607|FG010|COMPLETED|Phase 1-T Dose Level 2-TB||0
10829601|NCT01116648|11994608|FG011|COMPLETED|Phase 1-T Dose Level 2-TB||0
10829602|NCT01116648|11994609|FG012|COMPLETED|Phase 1-T Dose Level 2-TB||6
10829603|NCT01116648|11994610|FG013|COMPLETED|Phase 1-T Dose Level 2-TB||0
10829604|NCT01116648|11994611|FG014|COMPLETED|Phase 1-T Dose Level 2-TB||0
10829605|NCT01116648|11994597|FG000|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
10829606|NCT01116648|11994598|FG001|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
10829607|NCT01116648|11994599|FG002|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
10829608|NCT01116648|11994600|FG003|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
10829609|NCT01116648|11994601|FG004|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
10829610|NCT01116648|11994602|FG005|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
10829611|NCT01116648|11994603|FG006|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
10829612|NCT01116648|11994604|FG007|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
10829613|NCT01116648|11994605|FG008|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
10829614|NCT01116648|11994606|FG009|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
10829615|NCT01116648|11994607|FG010|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
10829616|NCT01116648|11994608|FG011|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
10829617|NCT01116648|11994609|FG012|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
10829618|NCT01116648|11994610|FG013|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
10829619|NCT01116648|11994611|FG014|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
10829620|NCT01116648|11994597|FG000|STARTED|Phase 1-T PKOlap Expansion||0
10829621|NCT01116648|11994598|FG001|STARTED|Phase 1-T PKOlap Expansion||0
10290853|NCT04633642|11423702|FG000|COMPLETED|Overall Study|26 participants|26
10290854|NCT04633642|11423703|FG001|COMPLETED|Overall Study|22 participants|22
10290855|NCT04633642|11423702|FG000|NOT COMPLETED|Overall Study||1
10290856|NCT04633642|11423703|FG001|NOT COMPLETED|Overall Study||2
10290857|NCT04633174|11423709|FG000|STARTED|Overall Study||1
10290858|NCT04633174|11423709|FG000|COMPLETED|Overall Study||1
10290859|NCT04633174|11423709|FG000|NOT COMPLETED|Overall Study||0
10313441|NCT00151775|11447018|FG005|STARTED|Period 3: Double-blind, Withdrawal||26
10313442|NCT00151775|11447019|FG006|STARTED|Period 3: Double-blind, Withdrawal||27
10313443|NCT00151775|11447020|FG007|STARTED|Period 3: Double-blind, Withdrawal||28
10313444|NCT00151775|11447021|FG008|STARTED|Period 3: Double-blind, Withdrawal||26
10313445|NCT00151775|11447022|FG009|STARTED|Period 3: Double-blind, Withdrawal||0
10313446|NCT00151775|11447023|FG010|STARTED|Period 3: Double-blind, Withdrawal||29
10313447|NCT00151775|11447024|FG011|STARTED|Period 3: Double-blind, Withdrawal||29
10313448|NCT00151775|11447013|FG000|COMPLETED|Period 3: Double-blind, Withdrawal||48
10313449|NCT00151775|11447014|FG001|COMPLETED|Period 3: Double-blind, Withdrawal||45
10313450|NCT00151775|11447015|FG002|COMPLETED|Period 3: Double-blind, Withdrawal||42
10313451|NCT00151775|11447016|FG003|COMPLETED|Period 3: Double-blind, Withdrawal||44
10313452|NCT00151775|11447017|FG004|COMPLETED|Period 3: Double-blind, Withdrawal||0
10313453|NCT00151775|11447018|FG005|COMPLETED|Period 3: Double-blind, Withdrawal||25
10313454|NCT00151775|11447019|FG006|COMPLETED|Period 3: Double-blind, Withdrawal||26
10313455|NCT00151775|11447020|FG007|COMPLETED|Period 3: Double-blind, Withdrawal||27
10313456|NCT00151775|11447021|FG008|COMPLETED|Period 3: Double-blind, Withdrawal||26
10313457|NCT00151775|11447022|FG009|COMPLETED|Period 3: Double-blind, Withdrawal||0
10313458|NCT00151775|11447023|FG010|COMPLETED|Period 3: Double-blind, Withdrawal||29
10313459|NCT00151775|11447024|FG011|COMPLETED|Period 3: Double-blind, Withdrawal||28
10313460|NCT00151775|11447013|FG000|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
10313461|NCT00151775|11447014|FG001|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
10313462|NCT00151775|11447015|FG002|NOT COMPLETED|Period 3: Double-blind, Withdrawal||3
10313463|NCT00151775|11447016|FG003|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
10313464|NCT00151775|11447017|FG004|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
10313465|NCT00151775|11447018|FG005|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
10313466|NCT00151775|11447019|FG006|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
10313467|NCT00151775|11447020|FG007|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
10313468|NCT00151775|11447021|FG008|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
10313469|NCT00151775|11447022|FG009|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
10829622|NCT01116648|11994599|FG002|STARTED|Phase 1-T PKOlap Expansion||0
10829623|NCT01116648|11994600|FG003|STARTED|Phase 1-T PKOlap Expansion||0
10829624|NCT01116648|11994601|FG004|STARTED|Phase 1-T PKOlap Expansion||0
10829625|NCT01116648|11994602|FG005|STARTED|Phase 1-T PKOlap Expansion||0
10829626|NCT01116648|11994603|FG006|STARTED|Phase 1-T PKOlap Expansion||0
10829627|NCT01116648|11994604|FG007|STARTED|Phase 1-T PKOlap Expansion||0
10829628|NCT01116648|11994605|FG008|STARTED|Phase 1-T PKOlap Expansion||0
10829629|NCT01116648|11994606|FG009|STARTED|Phase 1-T PKOlap Expansion||0
10829630|NCT01116648|11994607|FG010|STARTED|Phase 1-T PKOlap Expansion||0
10829631|NCT01116648|11994608|FG011|STARTED|Phase 1-T PKOlap Expansion||0
10829632|NCT01116648|11994609|FG012|STARTED|Phase 1-T PKOlap Expansion||0
10829633|NCT01116648|11994610|FG013|STARTED|Phase 1-T PKOlap Expansion||6
10829634|NCT01116648|11994611|FG014|STARTED|Phase 1-T PKOlap Expansion||0
10829635|NCT01116648|11994597|FG000|COMPLETED|Phase 1-T PKOlap Expansion||0
10829636|NCT01116648|11994598|FG001|COMPLETED|Phase 1-T PKOlap Expansion||0
10829637|NCT01116648|11994599|FG002|COMPLETED|Phase 1-T PKOlap Expansion||0
10829638|NCT01116648|11994600|FG003|COMPLETED|Phase 1-T PKOlap Expansion||0
10829639|NCT01116648|11994601|FG004|COMPLETED|Phase 1-T PKOlap Expansion||0
10829640|NCT01116648|11994602|FG005|COMPLETED|Phase 1-T PKOlap Expansion||0
10829641|NCT01116648|11994603|FG006|COMPLETED|Phase 1-T PKOlap Expansion||0
10829642|NCT01116648|11994604|FG007|COMPLETED|Phase 1-T PKOlap Expansion||0
10829643|NCT01116648|11994605|FG008|COMPLETED|Phase 1-T PKOlap Expansion||0
10829644|NCT01116648|11994606|FG009|COMPLETED|Phase 1-T PKOlap Expansion||0
10829645|NCT01116648|11994607|FG010|COMPLETED|Phase 1-T PKOlap Expansion||0
10829646|NCT01116648|11994608|FG011|COMPLETED|Phase 1-T PKOlap Expansion||0
10829647|NCT01116648|11994609|FG012|COMPLETED|Phase 1-T PKOlap Expansion||0
10829648|NCT01116648|11994610|FG013|COMPLETED|Phase 1-T PKOlap Expansion||6
10829649|NCT01116648|11994611|FG014|COMPLETED|Phase 1-T PKOlap Expansion||0
10829650|NCT01116648|11994597|FG000|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
10829651|NCT01116648|11994598|FG001|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
10829652|NCT01116648|11994599|FG002|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
10829653|NCT01116648|11994600|FG003|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
10829654|NCT01116648|11994601|FG004|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
10829655|NCT01116648|11994602|FG005|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
10829656|NCT01116648|11994603|FG006|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
10829657|NCT01116648|11994604|FG007|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
10829658|NCT01116648|11994605|FG008|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
10829659|NCT01116648|11994606|FG009|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
10829660|NCT01116648|11994607|FG010|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
10829661|NCT01116648|11994608|FG011|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
10829662|NCT01116648|11994609|FG012|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
10290860|NCT04628221|11423714|FG000|STARTED|Overall Study||40
10290861|NCT04628221|11423714|FG000|COMPLETED|Overall Study||40
10290862|NCT04628221|11423714|FG000|NOT COMPLETED|Overall Study||0
10313470|NCT00151775|11447023|FG010|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
10313471|NCT00151775|11447024|FG011|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
10313472|NCT00151775|11447013|FG000|STARTED|Period 4: Open Label||0
10313473|NCT00151775|11447014|FG001|STARTED|Period 4: Open Label||0
10313474|NCT00151775|11447015|FG002|STARTED|Period 4: Open Label||0
10313475|NCT00151775|11447016|FG003|STARTED|Period 4: Open Label||0
10313476|NCT00151775|11447017|FG004|STARTED|Period 4: Open Label||179
10313477|NCT00151775|11447018|FG005|STARTED|Period 4: Open Label||0
10313478|NCT00151775|11447019|FG006|STARTED|Period 4: Open Label||0
10313479|NCT00151775|11447020|FG007|STARTED|Period 4: Open Label||0
10313480|NCT00151775|11447021|FG008|STARTED|Period 4: Open Label||0
10313481|NCT00151775|11447022|FG009|STARTED|Period 4: Open Label||104
10313482|NCT00151775|11447023|FG010|STARTED|Period 4: Open Label||57
10313483|NCT00151775|11447024|FG011|STARTED|Period 4: Open Label||0
10313484|NCT00151775|11447013|FG000|COMPLETED|Period 4: Open Label||0
10313485|NCT00151775|11447014|FG001|COMPLETED|Period 4: Open Label||0
10313486|NCT00151775|11447015|FG002|COMPLETED|Period 4: Open Label||0
10313487|NCT00151775|11447016|FG003|COMPLETED|Period 4: Open Label||0
10313488|NCT00151775|11447017|FG004|COMPLETED|Period 4: Open Label||149
10313489|NCT00151775|11447018|FG005|COMPLETED|Period 4: Open Label||0
10313490|NCT00151775|11447019|FG006|COMPLETED|Period 4: Open Label||0
10313491|NCT00151775|11447020|FG007|COMPLETED|Period 4: Open Label||0
10313492|NCT00151775|11447021|FG008|COMPLETED|Period 4: Open Label||0
10313493|NCT00151775|11447022|FG009|COMPLETED|Period 4: Open Label||83
10313494|NCT00151775|11447023|FG010|COMPLETED|Period 4: Open Label||57
10313495|NCT00151775|11447024|FG011|COMPLETED|Period 4: Open Label||0
10313496|NCT00151775|11447013|FG000|NOT COMPLETED|Period 4: Open Label||0
10313497|NCT00151775|11447014|FG001|NOT COMPLETED|Period 4: Open Label||0
10313498|NCT00151775|11447015|FG002|NOT COMPLETED|Period 4: Open Label||0
10829663|NCT01116648|11994610|FG013|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
10829664|NCT01116648|11994611|FG014|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
10829665|NCT01116648|11994597|FG000|STARTED|Phase 1-T PKCed Expansion||0
10829666|NCT01116648|11994598|FG001|STARTED|Phase 1-T PKCed Expansion||0
10829667|NCT01116648|11994599|FG002|STARTED|Phase 1-T PKCed Expansion||0
10829668|NCT01116648|11994600|FG003|STARTED|Phase 1-T PKCed Expansion||0
10829669|NCT01116648|11994601|FG004|STARTED|Phase 1-T PKCed Expansion||0
10829670|NCT01116648|11994602|FG005|STARTED|Phase 1-T PKCed Expansion||0
10829671|NCT01116648|11994603|FG006|STARTED|Phase 1-T PKCed Expansion||0
10829672|NCT01116648|11994604|FG007|STARTED|Phase 1-T PKCed Expansion||0
10829673|NCT01116648|11994605|FG008|STARTED|Phase 1-T PKCed Expansion||0
10829674|NCT01116648|11994606|FG009|STARTED|Phase 1-T PKCed Expansion||0
10829675|NCT01116648|11994607|FG010|STARTED|Phase 1-T PKCed Expansion||0
10829676|NCT01116648|11994608|FG011|STARTED|Phase 1-T PKCed Expansion||0
10829677|NCT01116648|11994609|FG012|STARTED|Phase 1-T PKCed Expansion||0
10829678|NCT01116648|11994610|FG013|STARTED|Phase 1-T PKCed Expansion||0
10829679|NCT01116648|11994611|FG014|STARTED|Phase 1-T PKCed Expansion||7
10829680|NCT01116648|11994597|FG000|COMPLETED|Phase 1-T PKCed Expansion||0
10829681|NCT01116648|11994598|FG001|COMPLETED|Phase 1-T PKCed Expansion||0
10829682|NCT01116648|11994599|FG002|COMPLETED|Phase 1-T PKCed Expansion||0
10829683|NCT01116648|11994600|FG003|COMPLETED|Phase 1-T PKCed Expansion||0
10829684|NCT01116648|11994601|FG004|COMPLETED|Phase 1-T PKCed Expansion||0
10829685|NCT01116648|11994602|FG005|COMPLETED|Phase 1-T PKCed Expansion||0
10829686|NCT01116648|11994603|FG006|COMPLETED|Phase 1-T PKCed Expansion||0
10829687|NCT01116648|11994604|FG007|COMPLETED|Phase 1-T PKCed Expansion||0
10829688|NCT01116648|11994605|FG008|COMPLETED|Phase 1-T PKCed Expansion||0
10829689|NCT01116648|11994606|FG009|COMPLETED|Phase 1-T PKCed Expansion||0
10829690|NCT01116648|11994607|FG010|COMPLETED|Phase 1-T PKCed Expansion||0
10829691|NCT01116648|11994608|FG011|COMPLETED|Phase 1-T PKCed Expansion||0
10829692|NCT01116648|11994609|FG012|COMPLETED|Phase 1-T PKCed Expansion||0
10829693|NCT01116648|11994610|FG013|COMPLETED|Phase 1-T PKCed Expansion||0
10829694|NCT01116648|11994611|FG014|COMPLETED|Phase 1-T PKCed Expansion||7
10829695|NCT01116648|11994597|FG000|NOT COMPLETED|Phase 1-T PKCed Expansion||0
10829696|NCT01116648|11994598|FG001|NOT COMPLETED|Phase 1-T PKCed Expansion||0
10829697|NCT01116648|11994599|FG002|NOT COMPLETED|Phase 1-T PKCed Expansion||0
10829698|NCT01116648|11994600|FG003|NOT COMPLETED|Phase 1-T PKCed Expansion||0
10829699|NCT01116648|11994601|FG004|NOT COMPLETED|Phase 1-T PKCed Expansion||0
10829700|NCT01116648|11994602|FG005|NOT COMPLETED|Phase 1-T PKCed Expansion||0
10829701|NCT01116648|11994603|FG006|NOT COMPLETED|Phase 1-T PKCed Expansion||0
10829702|NCT01116648|11994604|FG007|NOT COMPLETED|Phase 1-T PKCed Expansion||0
10829703|NCT01116648|11994605|FG008|NOT COMPLETED|Phase 1-T PKCed Expansion||0
10829704|NCT01116648|11994606|FG009|NOT COMPLETED|Phase 1-T PKCed Expansion||0
10829705|NCT01116648|11994607|FG010|NOT COMPLETED|Phase 1-T PKCed Expansion||0
10829706|NCT01116648|11994608|FG011|NOT COMPLETED|Phase 1-T PKCed Expansion||0
10829707|NCT01116648|11994609|FG012|NOT COMPLETED|Phase 1-T PKCed Expansion||0
10829708|NCT01116648|11994610|FG013|NOT COMPLETED|Phase 1-T PKCed Expansion||0
10829709|NCT01116648|11994611|FG014|NOT COMPLETED|Phase 1-T PKCed Expansion||0
10829710|NCT01078662|11994641|FG000|STARTED|Overall Study||62
10829711|NCT01078662|11994642|FG001|STARTED|Overall Study||193
10829712|NCT01078662|11994643|FG002|STARTED|Overall Study||23
10829713|NCT01078662|11994644|FG003|STARTED|Overall Study||8
10829714|NCT01078662|11994645|FG004|STARTED|Overall Study||12
10829715|NCT01078662|11994641|FG000|COMPLETED|Overall Study||4
10829716|NCT01078662|11994642|FG001|COMPLETED|Overall Study||25
10829717|NCT01078662|11994643|FG002|COMPLETED|Overall Study||2
10829718|NCT01078662|11994644|FG003|COMPLETED|Overall Study||1
10829719|NCT01078662|11994645|FG004|COMPLETED|Overall Study||1
10829720|NCT01078662|11994641|FG000|NOT COMPLETED|Overall Study||58
10829721|NCT01078662|11994642|FG001|NOT COMPLETED|Overall Study||168
10829722|NCT01078662|11994643|FG002|NOT COMPLETED|Overall Study||21
10829723|NCT01078662|11994644|FG003|NOT COMPLETED|Overall Study||7
10829724|NCT01078662|11994645|FG004|NOT COMPLETED|Overall Study||11
10829725|NCT00680901|11994656|FG000|STARTED|Overall Study||272
10829726|NCT00680901|11994657|FG001|STARTED|Overall Study||273
10829727|NCT00680901|11994656|FG000|Ongoing: On Study Treatment|Overall Study||16
10829728|NCT00680901|11994657|FG001|Ongoing: On Study Treatment|Overall Study||13
10829729|NCT00680901|11994656|FG000|Ongoing: In Follow Up|Overall Study||45
10829730|NCT00680901|11994657|FG001|Ongoing: In Follow Up|Overall Study||41
10829731|NCT00680901|11994656|FG000|COMPLETED|Overall Study||199
10829732|NCT00680901|11994657|FG001|COMPLETED|Overall Study||197
10829733|NCT00680901|11994656|FG000|NOT COMPLETED|Overall Study||73
10829734|NCT00680901|11994657|FG001|NOT COMPLETED|Overall Study||76
10290863|NCT04625426|11423721|FG000|STARTED|Overall Study||23
10290864|NCT04625426|11423722|FG001|STARTED|Overall Study||37
10290865|NCT04625426|11423723|FG002|STARTED|Overall Study||24
10829787|NCT01335685|11994691|FG000|STARTED|Overall Study||7
10829788|NCT01335685|11994692|FG001|STARTED|Overall Study||4
10829789|NCT01335685|11994693|FG002|STARTED|Overall Study||3
10829790|NCT01335685|11994694|FG003|STARTED|Overall Study||26
10829791|NCT01335685|11994695|FG004|STARTED|Overall Study||5
10829792|NCT01335685|11994696|FG005|STARTED|Overall Study||6
10829793|NCT01335685|11994697|FG006|STARTED|Overall Study||4
10829794|NCT01335685|11994698|FG007|STARTED|Overall Study||6
10829795|NCT01335685|11994691|FG000|COMPLETED|Overall Study||4
10829796|NCT01335685|11994692|FG001|COMPLETED|Overall Study||3
10829797|NCT01335685|11994693|FG002|COMPLETED|Overall Study||1
10829798|NCT01335685|11994694|FG003|COMPLETED|Overall Study||15
10829799|NCT01335685|11994695|FG004|COMPLETED|Overall Study||5
10829800|NCT01335685|11994696|FG005|COMPLETED|Overall Study||1
10829801|NCT01335685|11994697|FG006|COMPLETED|Overall Study||2
10829802|NCT01335685|11994698|FG007|COMPLETED|Overall Study||3
10829803|NCT01335685|11994691|FG000|NOT COMPLETED|Overall Study||3
10829804|NCT01335685|11994692|FG001|NOT COMPLETED|Overall Study||1
10829805|NCT01335685|11994693|FG002|NOT COMPLETED|Overall Study||2
10829806|NCT01335685|11994694|FG003|NOT COMPLETED|Overall Study||11
10829807|NCT01335685|11994695|FG004|NOT COMPLETED|Overall Study||0
10829808|NCT01335685|11994696|FG005|NOT COMPLETED|Overall Study||5
10829809|NCT01335685|11994697|FG006|NOT COMPLETED|Overall Study||2
10829810|NCT01335685|11994698|FG007|NOT COMPLETED|Overall Study||3
10829811|NCT01336621|11994721|FG000|STARTED|Primary Reporting Phase (Upto 5.8 Years)||98
10829812|NCT01336621|11994721|FG000|COMPLETED|Primary Reporting Phase (Upto 5.8 Years)||0
10829813|NCT01336621|11994721|FG000|NOT COMPLETED|Primary Reporting Phase (Upto 5.8 Years)||98
10829814|NCT01336621|11994721|FG000|STARTED|SFUCP (up to 2.6 Years)||9
10829815|NCT01336621|11994721|FG000|COMPLETED|SFUCP (up to 2.6 Years)||0
10829816|NCT01336621|11994721|FG000|NOT COMPLETED|SFUCP (up to 2.6 Years)||9
10829817|NCT04391036|11994730|FG000|STARTED|Overall Study||15
10829818|NCT04391036|11994731|FG001|STARTED|Overall Study||15
10829819|NCT04391036|11994730|FG000|COMPLETED|Overall Study||15
10829820|NCT04391036|11994731|FG001|COMPLETED|Overall Study||15
10829821|NCT04391036|11994730|FG000|NOT COMPLETED|Overall Study||0
10829822|NCT04391036|11994731|FG001|NOT COMPLETED|Overall Study||0
10829823|NCT04170296|11994741|FG000|STARTED|Overall Study||81
10829824|NCT04170296|11994742|FG001|STARTED|Overall Study||72
10829825|NCT04170296|11994741|FG000|COMPLETED|Overall Study||73
10829826|NCT04170296|11994742|FG001|COMPLETED|Overall Study||68
10829827|NCT04170296|11994741|FG000|NOT COMPLETED|Overall Study||8
10829828|NCT04170296|11994742|FG001|NOT COMPLETED|Overall Study||4
10829829|NCT04039217|11994754|FG000|STARTED|Overall Study||20
10829830|NCT04039217|11994754|FG000|Started Study Arm A.1|Overall Study||4
10829831|NCT04039217|11994754|FG000|Completed Study Arm A.1|Overall Study||4
10829832|NCT04039217|11994754|FG000|Started Study Arm A.2|Overall Study||4
10829833|NCT04039217|11994754|FG000|Completed Study Arm A.2|Overall Study||4
10829834|NCT04039217|11994754|FG000|Started Study Arm A.3|Overall Study||4
10829835|NCT04039217|11994754|FG000|Completed Study Arm A.3|Overall Study||4
10829836|NCT04039217|11994754|FG000|Started Study Arm B.1|Overall Study||4
10829837|NCT04039217|11994754|FG000|Completed Study Arm B.1|Overall Study||4
10829838|NCT04039217|11994754|FG000|Started Study Arm B.2|Overall Study||4
10829839|NCT04039217|11994754|FG000|Completed Study Arm B.2|Overall Study||4
10829840|NCT04039217|11994754|FG000|Started Study Arm C.1|Overall Study||5
10829841|NCT04039217|11994754|FG000|Completed Study Arm C.1|Overall Study||4
10829842|NCT04039217|11994754|FG000|Started Study Arm C.2|Overall Study||0
10829843|NCT04039217|11994754|FG000|Completed Study Arm C.2|Overall Study||0
10829844|NCT04039217|11994754|FG000|COMPLETED|Overall Study||19
10829845|NCT04039217|11994754|FG000|NOT COMPLETED|Overall Study||1
10829846|NCT03998046|11994764|FG000|STARTED|Overall Study||38
10829847|NCT03998046|11994765|FG001|STARTED|Overall Study||42
10829848|NCT03998046|11994764|FG000|COMPLETED|Overall Study||38
10829849|NCT03998046|11994765|FG001|COMPLETED|Overall Study||42
10829850|NCT03998046|11994764|FG000|NOT COMPLETED|Overall Study||0
10829851|NCT03998046|11994765|FG001|NOT COMPLETED|Overall Study||0
10829852|NCT03160521|11994775|FG000|STARTED|Overall Study|From 145 randomized patients in the 75 mg dose arm, one of them withdrew consent before receiving the study treatment. Due to, only 144 patients received allocated intervention.|144
10829853|NCT03160521|11994776|FG001|STARTED|Overall Study||146
10829854|NCT03160521|11994777|FG002|STARTED|Overall Study||147
10829855|NCT03160521|11994775|FG000|COMPLETED|Overall Study||107
10829856|NCT03160521|11994776|FG001|COMPLETED|Overall Study||95
10829857|NCT03160521|11994777|FG002|COMPLETED|Overall Study||88
10829858|NCT03160521|11994775|FG000|NOT COMPLETED|Overall Study||37
10829859|NCT03160521|11994776|FG001|NOT COMPLETED|Overall Study||51
10829860|NCT03160521|11994777|FG002|NOT COMPLETED|Overall Study||59
10829861|NCT03143816|11994793|FG000|STARTED|Overall Study||26
10829862|NCT03143816|11994794|FG001|STARTED|Overall Study||34
10829863|NCT03143816|11994793|FG000|COMPLETED|Overall Study||22
10829864|NCT03143816|11994794|FG001|COMPLETED|Overall Study||34
10829865|NCT03143816|11994793|FG000|NOT COMPLETED|Overall Study||4
10829866|NCT03143816|11994794|FG001|NOT COMPLETED|Overall Study||0
10829867|NCT03078192|11994808|FG000|STARTED|Overall Study||30
10829868|NCT03078192|11994809|FG001|STARTED|Overall Study||32
10829869|NCT03078192|11994808|FG000|COMPLETED|Overall Study||28
10829870|NCT03078192|11994809|FG001|COMPLETED|Overall Study||28
10829871|NCT03078192|11994808|FG000|NOT COMPLETED|Overall Study||2
10829872|NCT03078192|11994809|FG001|NOT COMPLETED|Overall Study||4
10829873|NCT02959944|11994817|FG000|STARTED|Overall Study||95
10829874|NCT02959944|11994818|FG001|STARTED|Overall Study||98
10829875|NCT02959944|11994817|FG000|Received at Least 1 Dose of Study Drug|Overall Study||94
10829876|NCT02959944|11994818|FG001|Received at Least 1 Dose of Study Drug|Overall Study||96
10829877|NCT02959944|11994817|FG000|COMPLETED|Overall Study||95
10829878|NCT02959944|11994818|FG001|COMPLETED|Overall Study||98
10290866|NCT04625426|11423721|FG000|COMPLETED|Overall Study||9
10290867|NCT04625426|11423722|FG001|COMPLETED|Overall Study||12
10290868|NCT04625426|11423723|FG002|COMPLETED|Overall Study||12
10290869|NCT04625426|11423721|FG000|NOT COMPLETED|Overall Study||14
10290870|NCT04625426|11423722|FG001|NOT COMPLETED|Overall Study||25
10290871|NCT04625426|11423723|FG002|NOT COMPLETED|Overall Study||12
10313499|NCT00151775|11447016|FG003|NOT COMPLETED|Period 4: Open Label||0
10313500|NCT00151775|11447017|FG004|NOT COMPLETED|Period 4: Open Label||30
10313501|NCT00151775|11447018|FG005|NOT COMPLETED|Period 4: Open Label||0
10313502|NCT00151775|11447019|FG006|NOT COMPLETED|Period 4: Open Label||0
10313503|NCT00151775|11447020|FG007|NOT COMPLETED|Period 4: Open Label||0
10313504|NCT00151775|11447021|FG008|NOT COMPLETED|Period 4: Open Label||0
10313505|NCT00151775|11447022|FG009|NOT COMPLETED|Period 4: Open Label||21
10313506|NCT00151775|11447023|FG010|NOT COMPLETED|Period 4: Open Label||0
10313507|NCT00151775|11447024|FG011|NOT COMPLETED|Period 4: Open Label||0
10313508|NCT00151814|11447068|FG000|STARTED|Overall Study||4
10313509|NCT00151814|11447069|FG001|STARTED|Overall Study||10
10313510|NCT00151814|11447070|FG002|STARTED|Overall Study||10
10313511|NCT00151814|11447068|FG000|COMPLETED|Overall Study||4
10313512|NCT00151814|11447069|FG001|COMPLETED|Overall Study||10
10313513|NCT00151814|11447070|FG002|COMPLETED|Overall Study||10
10313514|NCT00151814|11447068|FG000|NOT COMPLETED|Overall Study||0
10313515|NCT00151814|11447069|FG001|NOT COMPLETED|Overall Study||0
10313516|NCT00151814|11447070|FG002|NOT COMPLETED|Overall Study||0
10313517|NCT00151892|11447079|FG000|STARTED|Overall Study||416
10313518|NCT00151892|11447080|FG001|STARTED|Overall Study||413
10313519|NCT00151892|11447079|FG000|COMPLETED|Overall Study||340
10313520|NCT00151892|11447080|FG001|COMPLETED|Overall Study||330
10313521|NCT00151892|11447079|FG000|NOT COMPLETED|Overall Study||76
10313522|NCT00151892|11447080|FG001|NOT COMPLETED|Overall Study||83
10313523|NCT00151996|11447088|FG000|STARTED|Overall Study||42
10313524|NCT00151996|11447089|FG001|STARTED|Overall Study||33
10313525|NCT00151996|11447088|FG000|COMPLETED|Overall Study||37
10313526|NCT00151996|11447089|FG001|COMPLETED|Overall Study||26
10313527|NCT00151996|11447088|FG000|NOT COMPLETED|Overall Study||5
10313528|NCT00151996|11447089|FG001|NOT COMPLETED|Overall Study||7
10313529|NCT00152009|11447099|FG000|STARTED|Overall Study||87
10313530|NCT00152009|11447100|FG001|STARTED|Overall Study||86
10313531|NCT00152009|11447101|FG002|STARTED|Overall Study||86
10313532|NCT00152009|11447102|FG003|STARTED|Overall Study||86
10313533|NCT00152009|11447099|FG000|COMPLETED|Overall Study||58
10313534|NCT00152009|11447100|FG001|COMPLETED|Overall Study||55
10313535|NCT00152009|11447101|FG002|COMPLETED|Overall Study||49
10313536|NCT00152009|11447102|FG003|COMPLETED|Overall Study||53
10313537|NCT00152009|11447099|FG000|NOT COMPLETED|Overall Study||29
10313538|NCT00152009|11447100|FG001|NOT COMPLETED|Overall Study||31
10313539|NCT00152009|11447101|FG002|NOT COMPLETED|Overall Study||37
10313540|NCT00152009|11447102|FG003|NOT COMPLETED|Overall Study||33
10313541|NCT00152464|11447114|FG000|STARTED|Overall Study||255
10313542|NCT00152464|11447115|FG001|STARTED|Overall Study||255
10829879|NCT02959944|11994817|FG000|NOT COMPLETED|Overall Study||0
10829880|NCT02959944|11994818|FG001|NOT COMPLETED|Overall Study||0
10829881|NCT02903823|11994824|FG000|STARTED|Overall Study|First subject enrollment|27
10829882|NCT02903823|11994824|FG000|COMPLETED|Overall Study||20
10829883|NCT02903823|11994824|FG000|NOT COMPLETED|Overall Study||7
10829884|NCT02666183|11994832|FG000|STARTED|Overall Study||137
10829885|NCT02666183|11994833|FG001|STARTED|Overall Study||141
10829886|NCT02666183|11994834|FG002|STARTED|Overall Study||119
10829887|NCT02666183|11994832|FG000|COMPLETED|Overall Study||103
10829888|NCT02666183|11994833|FG001|COMPLETED|Overall Study||106
10313543|NCT00152464|11447114|FG000|COMPLETED|Overall Study||215
10313544|NCT00152464|11447115|FG001|COMPLETED|Overall Study||219
10313545|NCT00152464|11447114|FG000|NOT COMPLETED|Overall Study||40
10313546|NCT00152464|11447115|FG001|NOT COMPLETED|Overall Study||36
10313547|NCT00152516|11447121|FG000|STARTED|Overall Study|Subjects that were dispensed at least 1 dose of study medication|255
10313548|NCT00152516|11447121|FG000|COMPLETED|Overall Study|Subjects ongoing until study close-out|180
10313549|NCT00152516|11447121|FG000|NOT COMPLETED|Overall Study||75
10313550|NCT00152763|11447129|FG000|STARTED|Overall Study||77
10313551|NCT00152763|11447130|FG001|STARTED|Overall Study||19
10313552|NCT00152763|11447131|FG002|STARTED|Overall Study||20
10313553|NCT00152763|11447132|FG003|STARTED|Overall Study||77
10313554|NCT00152763|11447129|FG000|COMPLETED|Overall Study||67
10313555|NCT00152763|11447130|FG001|COMPLETED|Overall Study||14
10313556|NCT00152763|11447131|FG002|COMPLETED|Overall Study||16
10313557|NCT00152763|11447132|FG003|COMPLETED|Overall Study||63
10313558|NCT00152763|11447129|FG000|NOT COMPLETED|Overall Study||10
10313559|NCT00152763|11447130|FG001|NOT COMPLETED|Overall Study||5
10313560|NCT00152763|11447131|FG002|NOT COMPLETED|Overall Study||4
10313561|NCT00152763|11447132|FG003|NOT COMPLETED|Overall Study||14
10313562|NCT00152971|11447147|FG000|STARTED|Overall Study||857
10313563|NCT00152971|11447148|FG001|STARTED|Overall Study||871
10313564|NCT00152971|11447149|FG002|STARTED|Overall Study||868
10313565|NCT00152971|11447147|FG000|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|806
10315643|NCT00181610|11449588|FG001|COMPLETED|Overall Study||3
10829889|NCT02666183|11994834|FG002|COMPLETED|Overall Study||93
10829890|NCT02666183|11994832|FG000|NOT COMPLETED|Overall Study||34
10829891|NCT02666183|11994833|FG001|NOT COMPLETED|Overall Study||35
10829892|NCT02666183|11994834|FG002|NOT COMPLETED|Overall Study||26
10829893|NCT01547117|11994846|FG000|STARTED|Overall Study||12
10829894|NCT01547117|11994847|FG001|STARTED|Overall Study||5
10829895|NCT01547117|11994848|FG002|STARTED|Overall Study||10
10829896|NCT01547117|11994849|FG003|STARTED|Overall Study||11
10829897|NCT01547117|11994846|FG000|Phase 1 Baseline Labs|Overall Study||12
10829898|NCT01547117|11994847|FG001|Phase 1 Baseline Labs|Overall Study|1 healthy control was unable to find time to schedule study|4
10829899|NCT01547117|11994848|FG002|Phase 1 Baseline Labs|Overall Study|2 patients with POTS did not discontinue medication that was prohibited by protocol.|8
10829900|NCT01547117|11994849|FG003|Phase 1 Baseline Labs|Overall Study|1 patient with POTS did not discontinue medication that was prohibited by protocol, 1 patient was unable to find time to schedule the study, 1 was noted to be too old to participate, and 1 became pregnant between enrollment and the start of phase 1.|7
10829901|NCT01547117|11994846|FG000|Phase 1-150 mEq Sodium/Day|Overall Study||12
10829902|NCT01547117|11994847|FG001|Phase 1-150 mEq Sodium/Day|Overall Study||4
10829903|NCT01547117|11994848|FG002|Phase 1-150 mEq Sodium/Day|Overall Study||8
10829904|NCT01547117|11994849|FG003|Phase 1-150 mEq Sodium/Day|Overall Study||7
10829905|NCT01547117|11994846|FG000|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||12
10829906|NCT01547117|11994847|FG001|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||4
10829907|NCT01547117|11994848|FG002|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||8
10829908|NCT01547117|11994849|FG003|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||7
10829909|NCT01547117|11994846|FG000|Phase 1-finish|Overall Study|1 healthy control withdrew with migraines during phase 1 (low Na+).|11
10829910|NCT01547117|11994847|FG001|Phase 1-finish|Overall Study|2 healthy controls withdrew during phase 1 (high Na+): 1 unable to tolerate study diet and another with difficulty cooperating with investigators..|2
10829911|NCT01547117|11994848|FG002|Phase 1-finish|Overall Study||8
10829912|NCT01547117|11994849|FG003|Phase 1-finish|Overall Study|1 patient with POTS withdrew during phase 1 due to a family illness.|6
10829913|NCT01547117|11994846|FG000|Phase 2-150 mEq Sodium/Day|Overall Study||11
10829914|NCT01547117|11994847|FG001|Phase 2-150 mEq Sodium/Day|Overall Study||2
10829915|NCT01547117|11994848|FG002|Phase 2-150 mEq Sodium/Day|Overall Study||8
10829916|NCT01547117|11994849|FG003|Phase 2-150 mEq Sodium/Day|Overall Study||6
10829917|NCT01547117|11994846|FG000|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||11
10829918|NCT01547117|11994847|FG001|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||2
10829919|NCT01547117|11994848|FG002|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||8
10829920|NCT01547117|11994849|FG003|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||6
10829921|NCT01547117|11994846|FG000|Phase 2-finish|Overall Study||11
10829922|NCT01547117|11994847|FG001|Phase 2-finish|Overall Study||2
10829923|NCT01547117|11994848|FG002|Phase 2-finish|Overall Study||8
10829924|NCT01547117|11994849|FG003|Phase 2-finish|Overall Study||6
10829925|NCT01547117|11994846|FG000|COMPLETED|Overall Study||11
10829926|NCT01547117|11994847|FG001|COMPLETED|Overall Study||2
10829927|NCT01547117|11994848|FG002|COMPLETED|Overall Study||8
10829928|NCT01547117|11994849|FG003|COMPLETED|Overall Study||6
10829929|NCT01547117|11994846|FG000|NOT COMPLETED|Overall Study||1
10829930|NCT01547117|11994847|FG001|NOT COMPLETED|Overall Study||3
10829931|NCT01547117|11994848|FG002|NOT COMPLETED|Overall Study||2
10829932|NCT01547117|11994849|FG003|NOT COMPLETED|Overall Study||5
10829933|NCT01431508|11994875|FG000|STARTED|Overall Study||15
10829934|NCT01431508|11994875|FG000|COMPLETED|Overall Study||13
10829935|NCT01431508|11994875|FG000|NOT COMPLETED|Overall Study||2
10829936|NCT00871351|11994882|FG000|STARTED|Overall Study||47
10829937|NCT00871351|11994883|FG001|STARTED|Overall Study||46
10829938|NCT00871351|11994884|FG002|STARTED|Overall Study||32
10829939|NCT00871351|11994882|FG000|COMPLETED|Overall Study||43
10829940|NCT00871351|11994883|FG001|COMPLETED|Overall Study||45
10829941|NCT00871351|11994884|FG002|COMPLETED|Overall Study||32
10829942|NCT00871351|11994882|FG000|NOT COMPLETED|Overall Study||4
10829943|NCT00871351|11994883|FG001|NOT COMPLETED|Overall Study||1
10829944|NCT00871351|11994884|FG002|NOT COMPLETED|Overall Study||0
10829945|NCT00832455|11994892|FG000|STARTED|Overall Study|445 - number of patients that signed the informed consent form (Safety population)|445
10829946|NCT00832455|11994892|FG000|Baseline|Overall Study|420 -patients that received at least one dose of study medication and had 1 follow-up visit (ITT)|420
10829947|NCT00832455|11994892|FG000|Week 4|Overall Study||411
10829948|NCT00832455|11994892|FG000|Week 8 (Optional)|Overall Study||247
10829949|NCT00832455|11994892|FG000|Week 12|Overall Study||373
10829950|NCT00832455|11994892|FG000|COMPLETED|Overall Study||373
10829951|NCT00832455|11994892|FG000|NOT COMPLETED|Overall Study||72
10829952|NCT00812006|11994908|FG000|STARTED|Overall Study||36
10829953|NCT00812006|11994909|FG001|STARTED|Overall Study||36
10829954|NCT00812006|11994910|FG002|STARTED|Overall Study||36
10829955|NCT00812006|11994908|FG000|COMPLETED|Overall Study||30
10829956|NCT00812006|11994909|FG001|COMPLETED|Overall Study||33
10829957|NCT00812006|11994910|FG002|COMPLETED|Overall Study||30
10829958|NCT00812006|11994908|FG000|NOT COMPLETED|Overall Study||6
10829959|NCT00812006|11994909|FG001|NOT COMPLETED|Overall Study||3
10829960|NCT00812006|11994910|FG002|NOT COMPLETED|Overall Study||6
10829961|NCT00739050|11994916|FG000|STARTED|Overall Study||4
10829962|NCT00739050|11994917|FG001|STARTED|Overall Study||0
10829963|NCT00739050|11994916|FG000|COMPLETED|Overall Study|These 3 patients completing treatment did not complete the required procedures during the trial.|3
10829964|NCT00739050|11994917|FG001|COMPLETED|Overall Study||0
10829965|NCT00739050|11994916|FG000|NOT COMPLETED|Overall Study||1
10829966|NCT00739050|11994917|FG001|NOT COMPLETED|Overall Study||0
10829967|NCT00687531|11994923|FG000|STARTED|Overall Study|Completed screening procedures|385
10829968|NCT00687531|11994923|FG000|RECEIVED TREATMENT|Overall Study||281
10829969|NCT00687531|11994923|FG000|COMPLETED|Overall Study||250
10829970|NCT00687531|11994923|FG000|NOT COMPLETED|Overall Study||135
10829971|NCT00654628|11994927|FG000|STARTED|6-week Active Treatment Period||173
10829972|NCT00654628|11994927|FG000|COMPLETED|6-week Active Treatment Period||152
10829973|NCT00654628|11994927|FG000|NOT COMPLETED|6-week Active Treatment Period||21
10829974|NCT00654628|11994927|FG000|STARTED|6 -Week Extension Period (Single Site)|Subjects who completed the first 6-week period and participated in the second 6-week study period.|60
10829975|NCT00654628|11994927|FG000|COMPLETED|6 -Week Extension Period (Single Site)||55
10829976|NCT00654628|11994927|FG000|NOT COMPLETED|6 -Week Extension Period (Single Site)||5
10829977|NCT00604812|11994934|FG000|STARTED|Overall Study||9
10829978|NCT00604812|11994935|FG001|STARTED|Overall Study||3
10829979|NCT00604812|11994936|FG002|STARTED|Overall Study||10
10829980|NCT00604812|11994937|FG003|STARTED|Overall Study||3
10829981|NCT00604812|11994938|FG004|STARTED|Overall Study||5
10829982|NCT00604812|11994939|FG005|STARTED|Overall Study||1
10829983|NCT00604812|11994934|FG000|COMPLETED|Overall Study||9
10829984|NCT00604812|11994935|FG001|COMPLETED|Overall Study||3
10829985|NCT00604812|11994936|FG002|COMPLETED|Overall Study||10
10829986|NCT00604812|11994937|FG003|COMPLETED|Overall Study||3
10829987|NCT00604812|11994938|FG004|COMPLETED|Overall Study||5
10829988|NCT00604812|11994939|FG005|COMPLETED|Overall Study||1
10829989|NCT00604812|11994934|FG000|NOT COMPLETED|Overall Study||0
10829990|NCT00604812|11994935|FG001|NOT COMPLETED|Overall Study||0
10829991|NCT00604812|11994936|FG002|NOT COMPLETED|Overall Study||0
10829992|NCT00604812|11994937|FG003|NOT COMPLETED|Overall Study||0
10829993|NCT00604812|11994938|FG004|NOT COMPLETED|Overall Study||0
10829994|NCT00604812|11994939|FG005|NOT COMPLETED|Overall Study||0
10829995|NCT00536380|11994953|FG000|STARTED|Overall Study||106
10829996|NCT00536380|11994954|FG001|STARTED|Overall Study||104
10829997|NCT00536380|11994955|FG002|STARTED|Overall Study||104
10829998|NCT00536380|11994953|FG000|COMPLETED|Overall Study||94
10829999|NCT00536380|11994954|FG001|COMPLETED|Overall Study||95
10830000|NCT00536380|11994955|FG002|COMPLETED|Overall Study||94
10830001|NCT00536380|11994953|FG000|NOT COMPLETED|Overall Study||12
10830002|NCT00536380|11994954|FG001|NOT COMPLETED|Overall Study||9
10830003|NCT00536380|11994955|FG002|NOT COMPLETED|Overall Study||10
10830004|NCT00521599|11994966|FG000|STARTED|Overall Study||268
10830005|NCT00521599|11994967|FG001|STARTED|Overall Study||268
10830006|NCT00521599|11994968|FG002|STARTED|Overall Study||136
10830007|NCT00521599|11994966|FG000|COMPLETED|Overall Study||243
10830008|NCT00521599|11994967|FG001|COMPLETED|Overall Study||239
10830009|NCT00521599|11994968|FG002|COMPLETED|Overall Study||100
10830010|NCT00521599|11994966|FG000|NOT COMPLETED|Overall Study||25
10830011|NCT00521599|11994967|FG001|NOT COMPLETED|Overall Study||29
10830012|NCT00521599|11994968|FG002|NOT COMPLETED|Overall Study||36
10830013|NCT00496834|11994979|FG000|STARTED|Overall Study||101
10830014|NCT00496834|11994980|FG001|STARTED|Overall Study||100
10830015|NCT00496834|11994979|FG000|COMPLETED|Overall Study||83
10830016|NCT00496834|11994980|FG001|COMPLETED|Overall Study||87
10830017|NCT00496834|11994979|FG000|NOT COMPLETED|Overall Study||18
10830018|NCT00496834|11994980|FG001|NOT COMPLETED|Overall Study||13
10830019|NCT00442897|11994990|FG000|STARTED|Base Study (12 Week Follow-up)||118
10830020|NCT00442897|11994991|FG001|STARTED|Base Study (12 Week Follow-up)||111
10830021|NCT00442897|11994990|FG000|COMPLETED|Base Study (12 Week Follow-up)||101
10830022|NCT00442897|11994991|FG001|COMPLETED|Base Study (12 Week Follow-up)||99
10830023|NCT00442897|11994990|FG000|NOT COMPLETED|Base Study (12 Week Follow-up)||17
10830024|NCT00442897|11994991|FG001|NOT COMPLETED|Base Study (12 Week Follow-up)||12
10830025|NCT00442897|11994990|FG000|STARTED|24 Weeks Follow-up (3 Centers)|66 Patients did not continue in the additional 12 week extension, for the 24 weeks follow-up period.|35
10830026|NCT00442897|11994991|FG001|STARTED|24 Weeks Follow-up (3 Centers)|65 Patients did not continue in the additional 12 week extension, for the 24 weeks follow-up period.|34
10830027|NCT00442897|11994990|FG000|COMPLETED|24 Weeks Follow-up (3 Centers)||29
10830028|NCT00442897|11994991|FG001|COMPLETED|24 Weeks Follow-up (3 Centers)||28
10830029|NCT00442897|11994990|FG000|NOT COMPLETED|24 Weeks Follow-up (3 Centers)||6
10830030|NCT00442897|11994991|FG001|NOT COMPLETED|24 Weeks Follow-up (3 Centers)||6
10830031|NCT00423579|11994999|FG000|STARTED|Overall Study|61 enrolled, however one subject was ineligible and was removed.|60
10830032|NCT00423579|11995000|FG001|STARTED|Overall Study||60
10830033|NCT00423579|11994999|FG000|COMPLETED|Overall Study|These 56 subjects were the Intent-to-Treat population. Analysis based on ITT population.|56
10830034|NCT00423579|11995000|FG001|COMPLETED|Overall Study|These 56 subjects were the Intent-to-Treat population. Analysis based on ITT population.|56
10830035|NCT00423579|11994999|FG000|NOT COMPLETED|Overall Study||4
10830036|NCT00423579|11995000|FG001|NOT COMPLETED|Overall Study||4
10830037|NCT00394355|11995010|FG000|STARTED|Overall Study||140
10830038|NCT00394355|11995011|FG001|STARTED|Overall Study||137
10830039|NCT00394355|11995012|FG002|STARTED|Overall Study||147
10830040|NCT00394355|11995013|FG003|STARTED|Overall Study||142
10830041|NCT00394355|11995010|FG000|COMPLETED|Overall Study||105
10830042|NCT00394355|11995011|FG001|COMPLETED|Overall Study||103
10830043|NCT00394355|11995012|FG002|COMPLETED|Overall Study||109
10830044|NCT00394355|11995013|FG003|COMPLETED|Overall Study||111
10830045|NCT00394355|11995010|FG000|NOT COMPLETED|Overall Study||35
10830046|NCT00394355|11995011|FG001|NOT COMPLETED|Overall Study||34
10830047|NCT00394355|11995012|FG002|NOT COMPLETED|Overall Study||38
10830048|NCT00394355|11995013|FG003|NOT COMPLETED|Overall Study||31
10830049|NCT00359216|11995025|FG000|STARTED|Overall Study||20
10830050|NCT00359216|11995026|FG001|STARTED|Overall Study||10
10830051|NCT00359216|11995025|FG000|COMPLETED|Overall Study||20
10830052|NCT00359216|11995026|FG001|COMPLETED|Overall Study|Completed treatment but simultaneously partaking in other study,final study procedures not performed|9
10830053|NCT00359216|11995025|FG000|NOT COMPLETED|Overall Study||0
10830054|NCT00359216|11995026|FG001|NOT COMPLETED|Overall Study||1
10830055|NCT00166504|11995034|FG000|STARTED|Overall Study||108
10830056|NCT00166504|11995035|FG001|STARTED|Overall Study||95
10830057|NCT00166504|11995034|FG000|COMPLETED|Overall Study||103
10830058|NCT00166504|11995035|FG001|COMPLETED|Overall Study||91
10830059|NCT00166504|11995034|FG000|NOT COMPLETED|Overall Study||5
10830060|NCT00166504|11995035|FG001|NOT COMPLETED|Overall Study||4
10830061|NCT01345240|11995046|FG000|STARTED|Overall Study||142
10830062|NCT01345240|11995047|FG001|STARTED|Overall Study||142
10830063|NCT01345240|11995048|FG002|STARTED|Overall Study||141
10830064|NCT01345240|11995049|FG003|STARTED|Overall Study||141
10830065|NCT01345240|11995050|FG004|STARTED|Overall Study||139
10830066|NCT01345240|11995046|FG000|COMPLETED|Overall Study||131
10830067|NCT01345240|11995047|FG001|COMPLETED|Overall Study||128
10830068|NCT01345240|11995048|FG002|COMPLETED|Overall Study||123
10830069|NCT01345240|11995049|FG003|COMPLETED|Overall Study||132
10830070|NCT01345240|11995050|FG004|COMPLETED|Overall Study||129
10830071|NCT01345240|11995046|FG000|NOT COMPLETED|Overall Study||11
10830072|NCT01345240|11995047|FG001|NOT COMPLETED|Overall Study||14
10830073|NCT01345240|11995048|FG002|NOT COMPLETED|Overall Study||18
10830074|NCT01345240|11995049|FG003|NOT COMPLETED|Overall Study||9
10830075|NCT01345240|11995050|FG004|NOT COMPLETED|Overall Study||10
10830076|NCT01371305|11995077|FG000|STARTED|Overall Study||6
10830077|NCT01371305|11995078|FG001|STARTED|Overall Study||6
10830078|NCT01371305|11995079|FG002|STARTED|Overall Study||6
10830079|NCT01371305|11995080|FG003|STARTED|Overall Study||7
10830080|NCT01371305|11995081|FG004|STARTED|Overall Study||6
10830081|NCT01371305|11995082|FG005|STARTED|Overall Study||10
10830082|NCT01371305|11995077|FG000|COMPLETED|Overall Study||6
10830083|NCT01371305|11995078|FG001|COMPLETED|Overall Study||6
10830084|NCT01371305|11995079|FG002|COMPLETED|Overall Study||6
10830085|NCT01371305|11995080|FG003|COMPLETED|Overall Study||5
10830086|NCT01371305|11995081|FG004|COMPLETED|Overall Study||2
10830087|NCT01371305|11995082|FG005|COMPLETED|Overall Study||8
10830088|NCT01371305|11995077|FG000|NOT COMPLETED|Overall Study||0
10830089|NCT01371305|11995078|FG001|NOT COMPLETED|Overall Study||0
10830090|NCT01371305|11995079|FG002|NOT COMPLETED|Overall Study||0
10830091|NCT01371305|11995080|FG003|NOT COMPLETED|Overall Study||2
10830092|NCT01371305|11995081|FG004|NOT COMPLETED|Overall Study||4
10830093|NCT01371305|11995082|FG005|NOT COMPLETED|Overall Study||2
10830094|NCT01376323|11995102|FG000|STARTED|Overall Study||20
10830095|NCT01376323|11995103|FG001|STARTED|Overall Study||18
10830096|NCT01376323|11995104|FG002|STARTED|Overall Study||19
10830097|NCT01376323|11995105|FG003|STARTED|Overall Study||19
10830098|NCT01376323|11995106|FG004|STARTED|Overall Study||18
10830099|NCT01376323|11995102|FG000|COMPLETED|Overall Study||18
10830100|NCT01376323|11995103|FG001|COMPLETED|Overall Study||17
10830101|NCT01376323|11995104|FG002|COMPLETED|Overall Study||16
10830102|NCT01376323|11995105|FG003|COMPLETED|Overall Study||14
10830103|NCT01376323|11995106|FG004|COMPLETED|Overall Study||17
10830104|NCT01376323|11995102|FG000|NOT COMPLETED|Overall Study||2
10830105|NCT01376323|11995103|FG001|NOT COMPLETED|Overall Study||1
10830106|NCT01376323|11995104|FG002|NOT COMPLETED|Overall Study||3
10830107|NCT01376323|11995105|FG003|NOT COMPLETED|Overall Study||5
10830108|NCT01376323|11995106|FG004|NOT COMPLETED|Overall Study||1
10830109|NCT01386658|11995130|FG000|STARTED|Initial Icatibant Exposure||11
10830110|NCT01386658|11995131|FG001|STARTED|Initial Icatibant Exposure||21
10830111|NCT01386658|11995130|FG000|COMPLETED|Initial Icatibant Exposure||11
10830112|NCT01386658|11995131|FG001|COMPLETED|Initial Icatibant Exposure||9
10830113|NCT01386658|11995130|FG000|NOT COMPLETED|Initial Icatibant Exposure||0
10830114|NCT01386658|11995131|FG001|NOT COMPLETED|Initial Icatibant Exposure||12
10830115|NCT01386658|11995130|FG000|STARTED|Icatibant Exposure 2||0
10830116|NCT01386658|11995131|FG001|STARTED|Icatibant Exposure 2||9
10830117|NCT01386658|11995130|FG000|COMPLETED|Icatibant Exposure 2||0
10830118|NCT01386658|11995131|FG001|COMPLETED|Icatibant Exposure 2||9
10830119|NCT01386658|11995130|FG000|NOT COMPLETED|Icatibant Exposure 2||0
10830120|NCT01386658|11995131|FG001|NOT COMPLETED|Icatibant Exposure 2||0
10830121|NCT01386658|11995130|FG000|STARTED|Icatibant Exposure 3||0
10830122|NCT01386658|11995131|FG001|STARTED|Icatibant Exposure 3||9
10830123|NCT01386658|11995130|FG000|COMPLETED|Icatibant Exposure 3||0
10830124|NCT01386658|11995131|FG001|COMPLETED|Icatibant Exposure 3||9
10830125|NCT01386658|11995130|FG000|NOT COMPLETED|Icatibant Exposure 3||0
10830126|NCT01386658|11995131|FG001|NOT COMPLETED|Icatibant Exposure 3||0
10830127|NCT01386684|11995141|FG000|STARTED|Overall Study||552
10830128|NCT01386684|11995141|FG000|COMPLETED|Overall Study||259
10830129|NCT01386684|11995141|FG000|NOT COMPLETED|Overall Study||293
10830130|NCT01386879|11995148|FG000|STARTED|Overall Study||17
10830131|NCT01386879|11995149|FG001|STARTED|Overall Study||17
10830132|NCT01386879|11995150|FG002|STARTED|Overall Study||16
10830133|NCT01386879|11995148|FG000|COMPLETED|Overall Study||17
10830134|NCT01386879|11995149|FG001|COMPLETED|Overall Study||17
10830135|NCT01386879|11995150|FG002|COMPLETED|Overall Study||16
10830136|NCT01386879|11995148|FG000|NOT COMPLETED|Overall Study||0
10830137|NCT01386879|11995149|FG001|NOT COMPLETED|Overall Study||0
10830138|NCT01386879|11995150|FG002|NOT COMPLETED|Overall Study||0
10830139|NCT04980014|11995158|FG000|STARTED|Overall Study||730
10830140|NCT04980014|11995158|FG000|Safety Analysis Set|Overall Study||655
10830141|NCT04980014|11995158|FG000|Effectiveness Analysis Set|Overall Study||482
10830142|NCT04980014|11995158|FG000|COMPLETED|Overall Study||655
10830143|NCT04980014|11995158|FG000|NOT COMPLETED|Overall Study||75
10830144|NCT04503603|11995164|FG000|STARTED|Overall Study||9
10830145|NCT04503603|11995165|FG001|STARTED|Overall Study||3
10830146|NCT04503603|11995164|FG000|COMPLETED|Overall Study||9
10830147|NCT04503603|11995165|FG001|COMPLETED|Overall Study||3
10830148|NCT04503603|11995164|FG000|NOT COMPLETED|Overall Study||0
10830149|NCT04503603|11995165|FG001|NOT COMPLETED|Overall Study||0
10830150|NCT04454918|11995171|FG000|STARTED|Treatment Period 1 (Day 1)||6
10830151|NCT04454918|11995171|FG000|COMPLETED|Treatment Period 1 (Day 1)||6
10830152|NCT04454918|11995171|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10830153|NCT04454918|11995171|FG000|STARTED|Washout Period (Day 2 to 8)||6
10830154|NCT04454918|11995171|FG000|COMPLETED|Washout Period (Day 2 to 8)||6
10830155|NCT04454918|11995171|FG000|NOT COMPLETED|Washout Period (Day 2 to 8)||0
10830156|NCT04454918|11995171|FG000|STARTED|Treatment Period 2(Day9[Day1of Period2])||6
10830157|NCT04454918|11995171|FG000|COMPLETED|Treatment Period 2(Day9[Day1of Period2])||6
10830158|NCT04454918|11995171|FG000|NOT COMPLETED|Treatment Period 2(Day9[Day1of Period2])||0
10290872|NCT04617509|11423731|FG000|STARTED|Period 1: Part 1 Formulation A||14
10290873|NCT04617509|11423732|FG001|STARTED|Period 1: Part 1 Formulation A||0
10290874|NCT04617509|11423733|FG002|STARTED|Period 1: Part 1 Formulation A|Subjects were expected to participate in both Part I and Part II, seven visits in total. Subject 112 was prematurely withdrawn from the study due to self-reported Covid-19-like symptoms via phone after Visit 5, i.e. after receiving both GS-248 formulations but prior to the food interaction part. This means subject 112 was withdrawn after Part I Formulation B but before Part II which cannot be visualized in the Period section. The correct number of subjects started Part II is thus 13.|0
10290875|NCT04617509|11423731|FG000|COMPLETED|Period 1: Part 1 Formulation A||14
10290876|NCT04617509|11423732|FG001|COMPLETED|Period 1: Part 1 Formulation A||0
10290877|NCT04617509|11423733|FG002|COMPLETED|Period 1: Part 1 Formulation A||0
10290878|NCT04617509|11423731|FG000|NOT COMPLETED|Period 1: Part 1 Formulation A||0
10290879|NCT04617509|11423732|FG001|NOT COMPLETED|Period 1: Part 1 Formulation A||0
10290880|NCT04617509|11423733|FG002|NOT COMPLETED|Period 1: Part 1 Formulation A||0
10290881|NCT04617509|11423731|FG000|STARTED|Period 2: Part 1 Formulation B||0
10290882|NCT04617509|11423732|FG001|STARTED|Period 2: Part 1 Formulation B||14
10290883|NCT04617509|11423733|FG002|STARTED|Period 2: Part 1 Formulation B||0
10290884|NCT04617509|11423731|FG000|COMPLETED|Period 2: Part 1 Formulation B||0
10290885|NCT04617509|11423732|FG001|COMPLETED|Period 2: Part 1 Formulation B||14
10830219|NCT03735849|11995234|FG000|STARTED|Overall Study||11
10830220|NCT03735849|11995235|FG001|STARTED|Overall Study||13
10830221|NCT03735849|11995236|FG002|STARTED|Overall Study||4
10830222|NCT03735849|11995234|FG000|Safety Population|Overall Study||11
10830223|NCT03735849|11995235|FG001|Safety Population|Overall Study||13
10830224|NCT03735849|11995236|FG002|Safety Population|Overall Study||4
10830225|NCT03735849|11995234|FG000|COMPLETED|Overall Study||9
10830226|NCT03735849|11995235|FG001|COMPLETED|Overall Study||13
10830227|NCT03735849|11995236|FG002|COMPLETED|Overall Study||0
10830228|NCT03735849|11995234|FG000|NOT COMPLETED|Overall Study||2
10830229|NCT03735849|11995235|FG001|NOT COMPLETED|Overall Study||0
10830230|NCT03735849|11995236|FG002|NOT COMPLETED|Overall Study||4
10290886|NCT04617509|11423733|FG002|COMPLETED|Period 2: Part 1 Formulation B||0
10290887|NCT04617509|11423731|FG000|NOT COMPLETED|Period 2: Part 1 Formulation B||0
10290888|NCT04617509|11423732|FG001|NOT COMPLETED|Period 2: Part 1 Formulation B||0
10290889|NCT04617509|11423733|FG002|NOT COMPLETED|Period 2: Part 1 Formulation B||0
10290890|NCT04617509|11423731|FG000|STARTED|Period 3: Part 2 Formulation A Fed Cond.||0
10290891|NCT04617509|11423732|FG001|STARTED|Period 3: Part 2 Formulation A Fed Cond.||0
10290892|NCT04617509|11423733|FG002|STARTED|Period 3: Part 2 Formulation A Fed Cond.||14
10290893|NCT04617509|11423731|FG000|COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||0
10290894|NCT04617509|11423732|FG001|COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||0
10290895|NCT04617509|11423733|FG002|COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||13
10290896|NCT04617509|11423731|FG000|NOT COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||0
10290897|NCT04617509|11423732|FG001|NOT COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||0
10290898|NCT04617509|11423733|FG002|NOT COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||1
10313566|NCT00152971|11447148|FG001|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|823
10313567|NCT00152971|11447149|FG002|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|819
10313568|NCT00152971|11447147|FG000|NOT COMPLETED|Overall Study||51
10313569|NCT00152971|11447148|FG001|NOT COMPLETED|Overall Study||48
10313570|NCT00152971|11447149|FG002|NOT COMPLETED|Overall Study||49
10313571|NCT00152971|11447147|FG000|STARTED|Treatment||857
10313572|NCT00152971|11447148|FG001|STARTED|Treatment||871
10313573|NCT00152971|11447149|FG002|STARTED|Treatment||868
10313574|NCT00152971|11447147|FG000|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|786
10313575|NCT00152971|11447148|FG001|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|808
10313576|NCT00152971|11447149|FG002|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|788
10313577|NCT00152971|11447147|FG000|NOT COMPLETED|Treatment||71
10313578|NCT00152971|11447148|FG001|NOT COMPLETED|Treatment||63
10313579|NCT00152971|11447149|FG002|NOT COMPLETED|Treatment||80
10313580|NCT00153062|11447161|FG000|STARTED|Overall Study||5086
10313581|NCT00153062|11447162|FG001|STARTED|Overall Study||5095
10313582|NCT00153062|11447163|FG002|STARTED|Overall Study||5060
10313583|NCT00153062|11447164|FG003|STARTED|Overall Study||5091
10313584|NCT00153062|11447161|FG000|COMPLETED|Overall Study||4699
10313585|NCT00153062|11447162|FG001|COMPLETED|Overall Study||4689
10313586|NCT00153062|11447163|FG002|COMPLETED|Overall Study||4645
10313587|NCT00153062|11447164|FG003|COMPLETED|Overall Study||4680
10313588|NCT00153062|11447161|FG000|NOT COMPLETED|Overall Study||387
10313589|NCT00153062|11447162|FG001|NOT COMPLETED|Overall Study||406
10313590|NCT00153062|11447163|FG002|NOT COMPLETED|Overall Study||415
10830237|NCT03552393|11995252|FG000|STARTED|Core Period||40
10830238|NCT03552393|11995252|FG000|COMPLETED|Core Period||38
10830239|NCT03552393|11995252|FG000|NOT COMPLETED|Core Period||2
10830240|NCT03552393|11995252|FG000|STARTED|Safety Extension Period||25
10830241|NCT03552393|11995252|FG000|COMPLETED|Safety Extension Period||21
10830242|NCT03552393|11995252|FG000|NOT COMPLETED|Safety Extension Period||4
10830270|NCT03333382|11995281|FG000|STARTED|Overall Study||1
10830271|NCT03333382|11995282|FG001|STARTED|Overall Study||0
10830272|NCT03333382|11995281|FG000|COMPLETED|Overall Study||0
10830273|NCT03333382|11995282|FG001|COMPLETED|Overall Study||0
10830274|NCT03333382|11995281|FG000|NOT COMPLETED|Overall Study||1
10830275|NCT03333382|11995282|FG001|NOT COMPLETED|Overall Study||0
10830276|NCT03245827|11995292|FG000|STARTED|Overall Study||1
10830277|NCT03245827|11995293|FG001|STARTED|Overall Study||0
10830278|NCT03245827|11995294|FG002|STARTED|Overall Study||3
10830279|NCT03245827|11995295|FG003|STARTED|Overall Study||5
10830280|NCT03245827|11995292|FG000|COMPLETED|Overall Study||1
10830281|NCT03245827|11995293|FG001|COMPLETED|Overall Study||0
10830282|NCT03245827|11995294|FG002|COMPLETED|Overall Study||3
10830283|NCT03245827|11995295|FG003|COMPLETED|Overall Study||5
10830284|NCT03245827|11995292|FG000|NOT COMPLETED|Overall Study||0
10830285|NCT03245827|11995293|FG001|NOT COMPLETED|Overall Study||0
10830286|NCT03245827|11995294|FG002|NOT COMPLETED|Overall Study||0
10830287|NCT03245827|11995295|FG003|NOT COMPLETED|Overall Study||0
10830288|NCT03129321|11995306|FG000|STARTED|Overall Study||351
10830289|NCT03129321|11995307|FG001|STARTED|Overall Study||350
10830290|NCT03129321|11995308|FG002|STARTED|Overall Study||175
10830291|NCT03129321|11995306|FG000|COMPLETED|Overall Study||253
10830292|NCT03129321|11995307|FG001|COMPLETED|Overall Study||241
10830293|NCT03129321|11995308|FG002|COMPLETED|Overall Study||120
10830294|NCT03129321|11995306|FG000|NOT COMPLETED|Overall Study||98
10830295|NCT03129321|11995307|FG001|NOT COMPLETED|Overall Study||109
10830296|NCT03129321|11995308|FG002|NOT COMPLETED|Overall Study||55
10830297|NCT03107611|11995321|FG000|STARTED|Overall Study||217
10830298|NCT03107611|11995322|FG001|STARTED|Overall Study||216
10830299|NCT03107611|11995323|FG002|STARTED|Overall Study||221
10830300|NCT03107611|11995321|FG000|Dosed|Overall Study||215
10830301|NCT03107611|11995322|FG001|Dosed|Overall Study||214
10830302|NCT03107611|11995323|FG002|Dosed|Overall Study||220
10830303|NCT03107611|11995321|FG000|COMPLETED|Overall Study||210
10830304|NCT03107611|11995322|FG001|COMPLETED|Overall Study||212
10830305|NCT03107611|11995323|FG002|COMPLETED|Overall Study||212
10830306|NCT03107611|11995321|FG000|NOT COMPLETED|Overall Study||7
10830307|NCT03107611|11995322|FG001|NOT COMPLETED|Overall Study||4
10830308|NCT03107611|11995323|FG002|NOT COMPLETED|Overall Study||9
10830309|NCT02720016|11995334|FG000|STARTED|Overall Study||92
10830310|NCT02720016|11995335|FG001|STARTED|Overall Study||92
10830311|NCT02720016|11995336|FG002|STARTED|Overall Study||90
10830312|NCT02720016|11995334|FG000|Y1|Overall Study||26
10830313|NCT02720016|11995335|FG001|Y1|Overall Study||26
10830314|NCT02720016|11995336|FG002|Y1|Overall Study||28
10830315|NCT02720016|11995334|FG000|Y2|Overall Study||34
10830316|NCT02720016|11995335|FG001|Y2|Overall Study||32
10830317|NCT02720016|11995336|FG002|Y2|Overall Study||34
10830318|NCT02720016|11995334|FG000|Y3|Overall Study||28
10830319|NCT02720016|11995335|FG001|Y3|Overall Study||30
10830320|NCT02720016|11995336|FG002|Y3|Overall Study||24
10830321|NCT02720016|11995334|FG000|Y4|Overall Study||4
10830322|NCT02720016|11995335|FG001|Y4|Overall Study||4
10830323|NCT02720016|11995336|FG002|Y4|Overall Study||4
10830324|NCT02720016|11995334|FG000|Veteran Total|Overall Study||46
10830325|NCT02720016|11995335|FG001|Veteran Total|Overall Study||46
10830326|NCT02720016|11995336|FG002|Veteran Total|Overall Study||45
10830327|NCT02720016|11995334|FG000|Intimate Partner Total|Overall Study||46
10830328|NCT02720016|11995335|FG001|Intimate Partner Total|Overall Study||46
10830329|NCT02720016|11995336|FG002|Intimate Partner Total|Overall Study||45
10830330|NCT02720016|11995334|FG000|COMPLETED|Overall Study||72
10830331|NCT02720016|11995335|FG001|COMPLETED|Overall Study||72
10830332|NCT02720016|11995336|FG002|COMPLETED|Overall Study||70
10830333|NCT02720016|11995334|FG000|NOT COMPLETED|Overall Study||20
10830334|NCT02720016|11995335|FG001|NOT COMPLETED|Overall Study||20
10830335|NCT02720016|11995336|FG002|NOT COMPLETED|Overall Study||20
10830336|NCT02607956|11995347|FG000|STARTED|Double-Blinded Phase||327
10830337|NCT02607956|11995348|FG001|STARTED|Double-Blinded Phase||330
10830338|NCT02607956|11995349|FG002|STARTED|Double-Blinded Phase||0
10830339|NCT02607956|11995350|FG003|STARTED|Double-Blinded Phase||0
10830340|NCT02607956|11995347|FG000|COMPLETED|Double-Blinded Phase||266
10830341|NCT02607956|11995348|FG001|COMPLETED|Double-Blinded Phase||277
10830342|NCT02607956|11995349|FG002|COMPLETED|Double-Blinded Phase||0
10830343|NCT02607956|11995350|FG003|COMPLETED|Double-Blinded Phase||0
10830344|NCT02607956|11995347|FG000|NOT COMPLETED|Double-Blinded Phase||61
10830345|NCT02607956|11995348|FG001|NOT COMPLETED|Double-Blinded Phase||53
10830346|NCT02607956|11995349|FG002|NOT COMPLETED|Double-Blinded Phase||0
10830347|NCT02607956|11995350|FG003|NOT COMPLETED|Double-Blinded Phase||0
10830348|NCT02607956|11995347|FG000|STARTED|Open-Label Extension Phase|At the End of Blinded Treatment Visit, participants were given the option to receive B/F/TAF FDC in an OL extension phase for up to 96 weeks.|0
10830349|NCT02607956|11995348|FG001|STARTED|Open-Label Extension Phase|At the End of Blinded Treatment Visit, participants were given the option to receive B/F/TAF FDC in an OL extension phase for up to 96 weeks.|0
10830350|NCT02607956|11995349|FG002|STARTED|Open-Label Extension Phase|66 participants from the Double-Blinded Phase did not enter the Open-Label Extension Phase.|254
10830351|NCT02607956|11995350|FG003|STARTED|Open-Label Extension Phase|60 participants from the Double-Blinded Phase did not enter the Open-Label Extension Phase.|265
10830352|NCT02607956|11995347|FG000|COMPLETED|Open-Label Extension Phase||0
10830353|NCT02607956|11995348|FG001|COMPLETED|Open-Label Extension Phase||0
10830354|NCT02607956|11995349|FG002|COMPLETED|Open-Label Extension Phase||225
10830355|NCT02607956|11995350|FG003|COMPLETED|Open-Label Extension Phase||235
10830356|NCT02607956|11995347|FG000|NOT COMPLETED|Open-Label Extension Phase||0
10830357|NCT02607956|11995348|FG001|NOT COMPLETED|Open-Label Extension Phase||0
10830358|NCT02607956|11995349|FG002|NOT COMPLETED|Open-Label Extension Phase||29
10830359|NCT02607956|11995350|FG003|NOT COMPLETED|Open-Label Extension Phase||30
10830360|NCT02564523|11995380|FG000|STARTED|Overall Study||225
10830361|NCT02564523|11995381|FG001|STARTED|Overall Study||43
10830362|NCT02564523|11995382|FG002|STARTED|Overall Study||224
10830363|NCT02564523|11995383|FG003|STARTED|Overall Study||44
10830364|NCT02564523|11995384|FG004|STARTED|Overall Study||110
10830365|NCT02564523|11995385|FG005|STARTED|Overall Study||22
10830366|NCT02564523|11995386|FG006|STARTED|Overall Study||59
10830367|NCT02564523|11995387|FG007|STARTED|Overall Study||12
10830368|NCT02564523|11995388|FG008|STARTED|Overall Study||59
10830369|NCT02564523|11995389|FG009|STARTED|Overall Study||12
10830370|NCT02564523|11995390|FG010|STARTED|Overall Study||55
10830371|NCT02564523|11995391|FG011|STARTED|Overall Study||11
10830372|NCT02564523|11995392|FG012|STARTED|Overall Study||55
10830373|NCT02564523|11995393|FG013|STARTED|Overall Study||10
10830374|NCT02564523|11995394|FG014|STARTED|Overall Study||54
10830375|NCT02564523|11995395|FG015|STARTED|Overall Study||12
10830376|NCT02564523|11995396|FG016|STARTED|Overall Study||54
10830377|NCT02564523|11995397|FG017|STARTED|Overall Study||12
10830378|NCT02564523|11995380|FG000|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||34
10830379|NCT02564523|11995381|FG001|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||8
10830380|NCT02564523|11995382|FG002|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||39
10830381|NCT02564523|11995383|FG003|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||9
10830382|NCT02564523|11995384|FG004|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
10830383|NCT02564523|11995385|FG005|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
10830384|NCT02564523|11995386|FG006|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
10830385|NCT02564523|11995387|FG007|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
10830386|NCT02564523|11995388|FG008|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
10830387|NCT02564523|11995389|FG009|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
10830388|NCT02564523|11995390|FG010|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
10830389|NCT02564523|11995391|FG011|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
10830390|NCT02564523|11995392|FG012|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
10830391|NCT02564523|11995393|FG013|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
10830392|NCT02564523|11995394|FG014|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
10830393|NCT02564523|11995395|FG015|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
10830394|NCT02564523|11995396|FG016|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
10830395|NCT02564523|11995397|FG017|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
10830396|NCT02564523|11995380|FG000|COMPLETED|Overall Study||215
10830397|NCT02564523|11995381|FG001|COMPLETED|Overall Study||40
10830398|NCT02564523|11995382|FG002|COMPLETED|Overall Study||214
10830399|NCT02564523|11995383|FG003|COMPLETED|Overall Study||43
10830400|NCT02564523|11995384|FG004|COMPLETED|Overall Study||106
10830401|NCT02564523|11995385|FG005|COMPLETED|Overall Study||22
10830402|NCT02564523|11995386|FG006|COMPLETED|Overall Study||56
10830403|NCT02564523|11995387|FG007|COMPLETED|Overall Study||12
10830404|NCT02564523|11995388|FG008|COMPLETED|Overall Study||59
10830405|NCT02564523|11995389|FG009|COMPLETED|Overall Study||12
10830406|NCT02564523|11995390|FG010|COMPLETED|Overall Study||52
10830407|NCT02564523|11995391|FG011|COMPLETED|Overall Study||10
10830408|NCT02564523|11995392|FG012|COMPLETED|Overall Study||53
10290899|NCT04616430|11423746|FG000|STARTED|Overall Study||30
10290900|NCT04616430|11423747|FG001|STARTED|Overall Study||30
10290901|NCT04616430|11423748|FG002|STARTED|Overall Study||30
10290902|NCT04616430|11423746|FG000|COMPLETED|Overall Study||23
10290903|NCT04616430|11423747|FG001|COMPLETED|Overall Study||2
10290904|NCT04616430|11423748|FG002|COMPLETED|Overall Study||0
10290905|NCT04616430|11423746|FG000|NOT COMPLETED|Overall Study||7
10290906|NCT04616430|11423747|FG001|NOT COMPLETED|Overall Study||28
10290907|NCT04616430|11423748|FG002|NOT COMPLETED|Overall Study||30
10290908|NCT04615507|11423758|FG000|STARTED|Period 1||34
10290909|NCT04615507|11423759|FG001|STARTED|Period 1||34
10290910|NCT04615507|11423758|FG000|COMPLETED|Period 1||32
10290911|NCT04615507|11423759|FG001|COMPLETED|Period 1||33
10290912|NCT04615507|11423758|FG000|NOT COMPLETED|Period 1||2
10290913|NCT04615507|11423759|FG001|NOT COMPLETED|Period 1||1
10290914|NCT04615507|11423758|FG000|STARTED|Period 2||32
10290915|NCT04615507|11423759|FG001|STARTED|Period 2||33
10290916|NCT04615507|11423758|FG000|COMPLETED|Period 2||30
10290917|NCT04615507|11423759|FG001|COMPLETED|Period 2||31
10290918|NCT04615507|11423758|FG000|NOT COMPLETED|Period 2||2
10290919|NCT04615507|11423759|FG001|NOT COMPLETED|Period 2||2
10290920|NCT04615507|11423758|FG000|STARTED|Period 3||30
10290921|NCT04615507|11423759|FG001|STARTED|Period 3||31
10290922|NCT04615507|11423758|FG000|COMPLETED|Period 3||30
10290923|NCT04615507|11423759|FG001|COMPLETED|Period 3||30
10409060|NCT00758264|11553097|FG001|NOT COMPLETED|Active Phase||0
10409061|NCT00758264|11553098|FG002|NOT COMPLETED|Active Phase||5
10409062|NCT00758264|11553096|FG000|STARTED|Extended Safety Follow Up (ESFU) Phase||181
10409063|NCT00758264|11553097|FG001|STARTED|Extended Safety Follow Up (ESFU) Phase||90
10409064|NCT00758264|11553098|FG002|STARTED|Extended Safety Follow Up (ESFU) Phase||89
10409065|NCT00758264|11553096|FG000|COMPLETED|Extended Safety Follow Up (ESFU) Phase||181
10409066|NCT00758264|11553097|FG001|COMPLETED|Extended Safety Follow Up (ESFU) Phase||90
10409067|NCT00758264|11553098|FG002|COMPLETED|Extended Safety Follow Up (ESFU) Phase||89
10409068|NCT00758264|11553096|FG000|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
10409069|NCT00758264|11553097|FG001|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
10409070|NCT00758264|11553098|FG002|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
10409071|NCT00758342|11553108|FG000|STARTED|Overall Study||19
10409072|NCT00758342|11553109|FG001|STARTED|Overall Study||18
10409073|NCT00758342|11553108|FG000|COMPLETED|Overall Study||15
10409074|NCT00758342|11553109|FG001|COMPLETED|Overall Study||17
10409075|NCT00758342|11553108|FG000|NOT COMPLETED|Overall Study||4
10409076|NCT00758342|11553109|FG001|NOT COMPLETED|Overall Study||1
10409077|NCT00758394|11553119|FG000|STARTED|1st Intervention||8
10409078|NCT00758394|11553120|FG001|STARTED|1st Intervention||7
10409079|NCT00758394|11553121|FG002|STARTED|1st Intervention||6
10409080|NCT00758394|11553122|FG003|STARTED|1st Intervention||8
10409081|NCT00758394|11553119|FG000|COMPLETED|1st Intervention||8
10409082|NCT00758394|11553120|FG001|COMPLETED|1st Intervention||7
10409083|NCT00758394|11553121|FG002|COMPLETED|1st Intervention||6
10409084|NCT00758394|11553122|FG003|COMPLETED|1st Intervention||8
10409085|NCT00758394|11553119|FG000|NOT COMPLETED|1st Intervention||0
10409086|NCT00758394|11553120|FG001|NOT COMPLETED|1st Intervention||0
10409087|NCT00758394|11553121|FG002|NOT COMPLETED|1st Intervention||0
10409088|NCT00758394|11553122|FG003|NOT COMPLETED|1st Intervention||0
10409089|NCT00758394|11553119|FG000|STARTED|Washout After 1st Intervention||8
10409090|NCT00758394|11553120|FG001|STARTED|Washout After 1st Intervention||7
10409091|NCT00758394|11553121|FG002|STARTED|Washout After 1st Intervention||6
10409092|NCT00758394|11553122|FG003|STARTED|Washout After 1st Intervention||8
10409093|NCT00758394|11553119|FG000|COMPLETED|Washout After 1st Intervention||8
10409094|NCT00758394|11553120|FG001|COMPLETED|Washout After 1st Intervention||7
10409095|NCT00758394|11553121|FG002|COMPLETED|Washout After 1st Intervention||6
10830409|NCT02564523|11995393|FG013|COMPLETED|Overall Study||10
10290924|NCT04615507|11423758|FG000|NOT COMPLETED|Period 3||0
10290925|NCT04615507|11423759|FG001|NOT COMPLETED|Period 3||1
10313591|NCT00153062|11447164|FG003|NOT COMPLETED|Overall Study||411
10830410|NCT02564523|11995394|FG014|COMPLETED|Overall Study||54
10830411|NCT02564523|11995395|FG015|COMPLETED|Overall Study||12
10313592|NCT00153101|11447179|FG000|STARTED|Overall Study||8502
10313593|NCT00153101|11447180|FG001|STARTED|Overall Study||8542
10409096|NCT00758394|11553122|FG003|COMPLETED|Washout After 1st Intervention||8
10409097|NCT00758394|11553119|FG000|NOT COMPLETED|Washout After 1st Intervention||0
10830412|NCT02564523|11995396|FG016|COMPLETED|Overall Study||54
10830413|NCT02564523|11995397|FG017|COMPLETED|Overall Study||11
10830414|NCT02564523|11995380|FG000|NOT COMPLETED|Overall Study||10
10830415|NCT02564523|11995381|FG001|NOT COMPLETED|Overall Study||3
10830416|NCT02564523|11995382|FG002|NOT COMPLETED|Overall Study||10
10830417|NCT02564523|11995383|FG003|NOT COMPLETED|Overall Study||1
10830418|NCT02564523|11995384|FG004|NOT COMPLETED|Overall Study||4
10830419|NCT02564523|11995385|FG005|NOT COMPLETED|Overall Study||0
10830420|NCT02564523|11995386|FG006|NOT COMPLETED|Overall Study||3
10830421|NCT02564523|11995387|FG007|NOT COMPLETED|Overall Study||0
10830422|NCT02564523|11995388|FG008|NOT COMPLETED|Overall Study||0
10830423|NCT02564523|11995389|FG009|NOT COMPLETED|Overall Study||0
10830424|NCT02564523|11995390|FG010|NOT COMPLETED|Overall Study||3
10830425|NCT02564523|11995391|FG011|NOT COMPLETED|Overall Study||1
10830426|NCT02564523|11995392|FG012|NOT COMPLETED|Overall Study||2
10830427|NCT02564523|11995393|FG013|NOT COMPLETED|Overall Study||0
10830428|NCT02564523|11995394|FG014|NOT COMPLETED|Overall Study||0
10830429|NCT02564523|11995395|FG015|NOT COMPLETED|Overall Study||0
10830430|NCT02564523|11995396|FG016|NOT COMPLETED|Overall Study||0
10830431|NCT02564523|11995397|FG017|NOT COMPLETED|Overall Study||1
10830432|NCT02094716|11995454|FG000|STARTED|Overall Study||43
10830433|NCT02094716|11995455|FG001|STARTED|Overall Study||43
10830434|NCT02094716|11995456|FG002|STARTED|Overall Study||44
10830435|NCT02094716|11995454|FG000|Received Second Dose at Day 14|Overall Study||15
10830436|NCT02094716|11995455|FG001|Received Second Dose at Day 14|Overall Study||10
10830437|NCT02094716|11995456|FG002|Received Second Dose at Day 14|Overall Study||17
10830438|NCT02094716|11995454|FG000|COMPLETED|Overall Study||41
10830439|NCT02094716|11995455|FG001|COMPLETED|Overall Study||36
10830440|NCT02094716|11995456|FG002|COMPLETED|Overall Study||40
10830441|NCT02094716|11995454|FG000|NOT COMPLETED|Overall Study||2
10830442|NCT02094716|11995455|FG001|NOT COMPLETED|Overall Study||7
10830443|NCT02094716|11995456|FG002|NOT COMPLETED|Overall Study||4
10830469|NCT01868139|11995497|FG000|STARTED|Overall Study||1
10830470|NCT01868139|11995497|FG000|COMPLETED|Overall Study||0
10830471|NCT01868139|11995497|FG000|NOT COMPLETED|Overall Study||1
10830472|NCT01798004|11995502|FG000|STARTED|Overall Study||150
10830473|NCT01798004|11995502|FG000|COMPLETED|Overall Study||63
10830474|NCT01798004|11995502|FG000|NOT COMPLETED|Overall Study||87
10830475|NCT01620658|11995509|FG000|STARTED|Overall Study||59
10830476|NCT01620658|11995510|FG001|STARTED|Overall Study||74
10830477|NCT01620658|11995511|FG002|STARTED|Overall Study||64
10830478|NCT01620658|11995509|FG000|COMPLETED|Overall Study||35
10830479|NCT01620658|11995510|FG001|COMPLETED|Overall Study||45
10830480|NCT01620658|11995511|FG002|COMPLETED|Overall Study||44
10830481|NCT01620658|11995509|FG000|NOT COMPLETED|Overall Study||24
10830482|NCT01620658|11995510|FG001|NOT COMPLETED|Overall Study||29
10830483|NCT01620658|11995511|FG002|NOT COMPLETED|Overall Study||20
10830484|NCT01447628|11995529|FG000|STARTED|Week 0 to Week 12 (1st Intervention)||19
10830485|NCT01447628|11995530|FG001|STARTED|Week 0 to Week 12 (1st Intervention)||20
10830486|NCT01447628|11995531|FG002|STARTED|Week 0 to Week 12 (1st Intervention)|Randomisation error meant the arms were not balanced- refer to protocol description for full details|12
10830487|NCT01447628|11995532|FG003|STARTED|Week 0 to Week 12 (1st Intervention)|Randomisation error meant the arms were not balanced- refer to protocol description for full details|5
10830488|NCT01447628|11995529|FG000|COMPLETED|Week 0 to Week 12 (1st Intervention)||19
10830489|NCT01447628|11995530|FG001|COMPLETED|Week 0 to Week 12 (1st Intervention)||20
10830490|NCT01447628|11995531|FG002|COMPLETED|Week 0 to Week 12 (1st Intervention)||12
10830491|NCT01447628|11995532|FG003|COMPLETED|Week 0 to Week 12 (1st Intervention)||4
10830492|NCT01447628|11995529|FG000|NOT COMPLETED|Week 0 to Week 12 (1st Intervention)||0
10830493|NCT01447628|11995530|FG001|NOT COMPLETED|Week 0 to Week 12 (1st Intervention)||0
10830494|NCT01447628|11995531|FG002|NOT COMPLETED|Week 0 to Week 12 (1st Intervention)||0
10830495|NCT01447628|11995532|FG003|NOT COMPLETED|Week 0 to Week 12 (1st Intervention)||1
10830496|NCT01447628|11995529|FG000|STARTED|Week 12 to Week 24 (2nd Intervention)||19
10830497|NCT01447628|11995530|FG001|STARTED|Week 12 to Week 24 (2nd Intervention)||20
10830498|NCT01447628|11995531|FG002|STARTED|Week 12 to Week 24 (2nd Intervention)||12
10830499|NCT01447628|11995532|FG003|STARTED|Week 12 to Week 24 (2nd Intervention)||4
10830500|NCT01447628|11995529|FG000|COMPLETED|Week 12 to Week 24 (2nd Intervention)||19
10830501|NCT01447628|11995530|FG001|COMPLETED|Week 12 to Week 24 (2nd Intervention)||20
10830502|NCT01447628|11995531|FG002|COMPLETED|Week 12 to Week 24 (2nd Intervention)||12
10830503|NCT01447628|11995532|FG003|COMPLETED|Week 12 to Week 24 (2nd Intervention)||4
10830504|NCT01447628|11995529|FG000|NOT COMPLETED|Week 12 to Week 24 (2nd Intervention)||0
10830505|NCT01447628|11995530|FG001|NOT COMPLETED|Week 12 to Week 24 (2nd Intervention)||0
10830506|NCT01447628|11995531|FG002|NOT COMPLETED|Week 12 to Week 24 (2nd Intervention)||0
10830507|NCT01447628|11995532|FG003|NOT COMPLETED|Week 12 to Week 24 (2nd Intervention)||0
10830508|NCT01175356|11995552|FG000|STARTED|Overall Study||99
10830509|NCT01175356|11995552|FG000|COMPLETED|Overall Study||18
10830510|NCT01175356|11995552|FG000|NOT COMPLETED|Overall Study||81
10830511|NCT00515853|11995558|FG000|STARTED|Overall Study||61
10830512|NCT00515853|11995559|FG001|STARTED|Overall Study||60
10830513|NCT00515853|11995558|FG000|COMPLETED|Overall Study||46
10830514|NCT00515853|11995559|FG001|COMPLETED|Overall Study||43
10830515|NCT00515853|11995558|FG000|NOT COMPLETED|Overall Study||15
10830516|NCT00515853|11995559|FG001|NOT COMPLETED|Overall Study||17
10830517|NCT00003458|11995565|FG000|STARTED|Overall Study||34
10830518|NCT00003458|11995565|FG000|COMPLETED|Overall Study||30
10830519|NCT00003458|11995565|FG000|NOT COMPLETED|Overall Study||4
10544914|NCT01493024|11698130|FG000|STARTED|Overall Study||30
10830520|NCT04871815|11995570|FG000|STARTED|Baseline Day 1-7||22
10830521|NCT04871815|11995570|FG000|COMPLETED|Baseline Day 1-7||22
10830522|NCT04871815|11995570|FG000|NOT COMPLETED|Baseline Day 1-7||0
10830523|NCT04871815|11995570|FG000|STARTED|N115 Treatment Day 8-14||22
10830524|NCT04871815|11995570|FG000|COMPLETED|N115 Treatment Day 8-14||22
10830525|NCT04871815|11995570|FG000|NOT COMPLETED|N115 Treatment Day 8-14||0
10830526|NCT04772560|11995582|FG000|STARTED|Overall Study||11
10830527|NCT04772560|11995583|FG001|STARTED|Overall Study||12
10830528|NCT04772560|11995582|FG000|COMPLETED|Overall Study||11
10830529|NCT04772560|11995583|FG001|COMPLETED|Overall Study||12
10830530|NCT04772560|11995582|FG000|NOT COMPLETED|Overall Study||0
10830531|NCT04772560|11995583|FG001|NOT COMPLETED|Overall Study||0
10830532|NCT04613739|11995590|FG000|STARTED|Overall Study||19
10830533|NCT04613739|11995591|FG001|STARTED|Overall Study||37
10830534|NCT04613739|11995590|FG000|COMPLETED|Overall Study||12
10830535|NCT04613739|11995591|FG001|COMPLETED|Overall Study||25
10830536|NCT04613739|11995590|FG000|NOT COMPLETED|Overall Study||7
10830537|NCT04613739|11995591|FG001|NOT COMPLETED|Overall Study||12
10830538|NCT04573972|11995599|FG000|STARTED|Overall Study||88
10830539|NCT04573972|11995600|FG001|STARTED|Overall Study||84
10830540|NCT04573972|11995599|FG000|COMPLETED|Overall Study||56
10830541|NCT04573972|11995600|FG001|COMPLETED|Overall Study||70
10830542|NCT04573972|11995599|FG000|NOT COMPLETED|Overall Study||32
10830543|NCT04573972|11995600|FG001|NOT COMPLETED|Overall Study||14
10830544|NCT04432272|11995608|FG000|STARTED|Overall Study||43
10830545|NCT04432272|11995609|FG001|STARTED|Overall Study||28
10830546|NCT04432272|11995608|FG000|COMPLETED|Overall Study||43
10830547|NCT04432272|11995609|FG001|COMPLETED|Overall Study||28
10830548|NCT04432272|11995608|FG000|NOT COMPLETED|Overall Study||0
10830549|NCT04432272|11995609|FG001|NOT COMPLETED|Overall Study||0
10830550|NCT04407806|11995618|FG000|STARTED|Overall Study||3
10830551|NCT04407806|11995619|FG001|STARTED|Overall Study||3
10830552|NCT04407806|11995618|FG000|COMPLETED|Overall Study||2
10830553|NCT04407806|11995619|FG001|COMPLETED|Overall Study||1
10830554|NCT04407806|11995618|FG000|NOT COMPLETED|Overall Study||1
10830555|NCT04407806|11995619|FG001|NOT COMPLETED|Overall Study||2
10830569|NCT04186663|11995646|FG000|STARTED|Overall Study||59
10830570|NCT04186663|11995646|FG000|COMPLETED|Overall Study||55
10830571|NCT04186663|11995646|FG000|NOT COMPLETED|Overall Study||4
10830572|NCT04158219|11995650|FG000|STARTED|Overall Study||8
10830573|NCT04158219|11995650|FG000|COMPLETED|Overall Study||7
10830574|NCT04158219|11995650|FG000|NOT COMPLETED|Overall Study||1
10830575|NCT04131959|11995654|FG000|STARTED|Overall Study||5
10830576|NCT04131959|11995654|FG000|COMPLETED|Overall Study||5
10830577|NCT04131959|11995654|FG000|NOT COMPLETED|Overall Study||0
10830578|NCT04084990|11995661|FG000|STARTED|Overall Study||2
10830579|NCT04084990|11995662|FG001|STARTED|Overall Study||1
10830580|NCT04084990|11995661|FG000|COMPLETED|Overall Study||2
10830581|NCT04084990|11995662|FG001|COMPLETED|Overall Study||1
10830582|NCT04084990|11995661|FG000|NOT COMPLETED|Overall Study||0
10830583|NCT04084990|11995662|FG001|NOT COMPLETED|Overall Study||0
10830584|NCT04056299|11995670|FG000|STARTED|Overall Study||9
10830585|NCT04056299|11995671|FG001|STARTED|Overall Study||6
10830586|NCT04056299|11995670|FG000|COMPLETED|Overall Study||6
10830587|NCT04056299|11995671|FG001|COMPLETED|Overall Study||3
10830588|NCT04056299|11995670|FG000|NOT COMPLETED|Overall Study||3
10830589|NCT04056299|11995671|FG001|NOT COMPLETED|Overall Study||3
10830590|NCT04020718|11995679|FG000|STARTED|Pre-assessment and Adaptation||16
10830591|NCT04020718|11995680|FG001|STARTED|Pre-assessment and Adaptation||19
10830592|NCT04020718|11995681|FG002|STARTED|Pre-assessment and Adaptation||0
10830593|NCT04020718|11995682|FG003|STARTED|Pre-assessment and Adaptation||0
10830594|NCT04020718|11995683|FG004|STARTED|Pre-assessment and Adaptation||0
10830595|NCT04020718|11995684|FG005|STARTED|Pre-assessment and Adaptation||0
10830596|NCT04020718|11995685|FG006|STARTED|Pre-assessment and Adaptation||0
10830597|NCT04020718|11995686|FG007|STARTED|Pre-assessment and Adaptation||0
10830598|NCT04020718|11995679|FG000|COMPLETED|Pre-assessment and Adaptation||16
10830599|NCT04020718|11995680|FG001|COMPLETED|Pre-assessment and Adaptation||15
10830600|NCT04020718|11995681|FG002|COMPLETED|Pre-assessment and Adaptation||0
10830601|NCT04020718|11995682|FG003|COMPLETED|Pre-assessment and Adaptation||0
10830602|NCT04020718|11995683|FG004|COMPLETED|Pre-assessment and Adaptation||0
10290926|NCT04610489|11423765|FG000|STARTED|Overall Study||117
10290927|NCT04610489|11423765|FG000|COMPLETED|Overall Study||117
10290928|NCT04610489|11423765|FG000|NOT COMPLETED|Overall Study||0
10290944|NCT04599959|11423792|FG000|STARTED|Overall Study||151
10290945|NCT04599959|11423792|FG000|COMPLETED|Overall Study||151
10830603|NCT04020718|11995684|FG005|COMPLETED|Pre-assessment and Adaptation||0
10830604|NCT04020718|11995685|FG006|COMPLETED|Pre-assessment and Adaptation||0
10830605|NCT04020718|11995686|FG007|COMPLETED|Pre-assessment and Adaptation||0
10830606|NCT04020718|11995679|FG000|NOT COMPLETED|Pre-assessment and Adaptation||0
10830607|NCT04020718|11995680|FG001|NOT COMPLETED|Pre-assessment and Adaptation||4
10830608|NCT04020718|11995681|FG002|NOT COMPLETED|Pre-assessment and Adaptation||0
10830609|NCT04020718|11995682|FG003|NOT COMPLETED|Pre-assessment and Adaptation||0
10830610|NCT04020718|11995683|FG004|NOT COMPLETED|Pre-assessment and Adaptation||0
10830611|NCT04020718|11995684|FG005|NOT COMPLETED|Pre-assessment and Adaptation||0
10830612|NCT04020718|11995685|FG006|NOT COMPLETED|Pre-assessment and Adaptation||0
10830613|NCT04020718|11995686|FG007|NOT COMPLETED|Pre-assessment and Adaptation||0
10830614|NCT04020718|11995679|FG000|STARTED|Post-assessment and Adaptation||0
10830556|NCT04324021|11995628|FG000|STARTED|Overall Study||5
10830557|NCT04324021|11995629|FG001|STARTED|Overall Study||5
10830558|NCT04324021|11995630|FG002|STARTED|Overall Study||6
10830559|NCT04324021|11995628|FG000|COMPLETED|Overall Study||3
10830560|NCT04324021|11995629|FG001|COMPLETED|Overall Study||4
10830561|NCT04324021|11995630|FG002|COMPLETED|Overall Study||5
10830562|NCT04324021|11995628|FG000|NOT COMPLETED|Overall Study||2
10830563|NCT04324021|11995629|FG001|NOT COMPLETED|Overall Study||1
10830564|NCT04324021|11995630|FG002|NOT COMPLETED|Overall Study||1
10830565|NCT04209621|11995641|FG000|STARTED|Overall Study||3
10830566|NCT04209621|11995641|FG000|Dose Level 1|Overall Study||3
10830567|NCT04209621|11995641|FG000|COMPLETED|Overall Study||0
10830568|NCT04209621|11995641|FG000|NOT COMPLETED|Overall Study||3
10830615|NCT04020718|11995680|FG001|STARTED|Post-assessment and Adaptation||0
10830616|NCT04020718|11995681|FG002|STARTED|Post-assessment and Adaptation||8
10830617|NCT04020718|11995682|FG003|STARTED|Post-assessment and Adaptation||6
10830618|NCT04020718|11995683|FG004|STARTED|Post-assessment and Adaptation||8
10830619|NCT04020718|11995684|FG005|STARTED|Post-assessment and Adaptation||7
10830620|NCT04020718|11995685|FG006|STARTED|Post-assessment and Adaptation||2
10830621|NCT04020718|11995686|FG007|STARTED|Post-assessment and Adaptation||0
10830622|NCT04020718|11995679|FG000|COMPLETED|Post-assessment and Adaptation||0
10830623|NCT04020718|11995680|FG001|COMPLETED|Post-assessment and Adaptation||0
10830624|NCT04020718|11995681|FG002|COMPLETED|Post-assessment and Adaptation||8
10830625|NCT04020718|11995682|FG003|COMPLETED|Post-assessment and Adaptation||5
10830626|NCT04020718|11995683|FG004|COMPLETED|Post-assessment and Adaptation||8
10830627|NCT04020718|11995684|FG005|COMPLETED|Post-assessment and Adaptation||7
10830628|NCT04020718|11995685|FG006|COMPLETED|Post-assessment and Adaptation||2
10830629|NCT04020718|11995686|FG007|COMPLETED|Post-assessment and Adaptation||0
10290929|NCT04608500|11423772|FG000|STARTED|Overall Study||514
10290930|NCT04608500|11423773|FG001|STARTED|Overall Study||257
10290931|NCT04608500|11423772|FG000|COMPLETED|Overall Study||479
10290932|NCT04608500|11423773|FG001|COMPLETED|Overall Study||239
10290933|NCT04608500|11423772|FG000|NOT COMPLETED|Overall Study||35
10290934|NCT04608500|11423773|FG001|NOT COMPLETED|Overall Study||18
10290946|NCT04599959|11423792|FG000|NOT COMPLETED|Overall Study||0
10313594|NCT00153101|11447181|FG002|STARTED|Overall Study||8576
10313595|NCT00153101|11447182|FG003|STARTED|Overall Study||2954
10313596|NCT00153101|11447183|FG004|STARTED|Overall Study||2972
10313597|NCT00153101|11447179|FG000|COMPLETED|Overall Study||8485
10313598|NCT00153101|11447180|FG001|COMPLETED|Overall Study||8524
10313599|NCT00153101|11447181|FG002|COMPLETED|Overall Study||8561
10313600|NCT00153101|11447182|FG003|COMPLETED|Overall Study||2946
10313601|NCT00153101|11447183|FG004|COMPLETED|Overall Study||2962
10313602|NCT00153101|11447179|FG000|NOT COMPLETED|Overall Study||17
10313603|NCT00153101|11447180|FG001|NOT COMPLETED|Overall Study||18
10313604|NCT00153101|11447181|FG002|NOT COMPLETED|Overall Study||15
10313605|NCT00153101|11447182|FG003|NOT COMPLETED|Overall Study||8
10313606|NCT00153101|11447183|FG004|NOT COMPLETED|Overall Study||10
10313607|NCT00153166|11447200|FG000|STARTED|Overall Study||11
10313608|NCT00153166|11447201|FG001|STARTED|Overall Study||37
10313609|NCT00153166|11447202|FG002|STARTED|Overall Study||28
10313610|NCT00153166|11447200|FG000|Received Atorvastatin and Pioglitazone|Overall Study||3
10313611|NCT00153166|11447201|FG001|Received Atorvastatin and Pioglitazone|Overall Study||9
10313612|NCT00153166|11447202|FG002|Received Atorvastatin and Pioglitazone|Overall Study||7
10313613|NCT00153166|11447200|FG000|Received Atorvastatin and Placebo|Overall Study||2
10313614|NCT00153166|11447201|FG001|Received Atorvastatin and Placebo|Overall Study||9
10313615|NCT00153166|11447202|FG002|Received Atorvastatin and Placebo|Overall Study||7
10313616|NCT00153166|11447200|FG000|Received Placebo and Pioglitazone|Overall Study||3
10313617|NCT00153166|11447201|FG001|Received Placebo and Pioglitazone|Overall Study||10
10313618|NCT00153166|11447202|FG002|Received Placebo and Pioglitazone|Overall Study||7
10313619|NCT00153166|11447200|FG000|Received Placebo and Placebo|Overall Study||3
10313620|NCT00153166|11447201|FG001|Received Placebo and Placebo|Overall Study||9
10313621|NCT00153166|11447202|FG002|Received Placebo and Placebo|Overall Study||7
10313622|NCT00153166|11447200|FG000|COMPLETED|Overall Study||11
10313623|NCT00153166|11447201|FG001|COMPLETED|Overall Study||37
10313624|NCT00153166|11447202|FG002|COMPLETED|Overall Study||28
10313625|NCT00153166|11447200|FG000|NOT COMPLETED|Overall Study||0
10409098|NCT00758394|11553120|FG001|NOT COMPLETED|Washout After 1st Intervention||0
10409099|NCT00758394|11553121|FG002|NOT COMPLETED|Washout After 1st Intervention||0
10409100|NCT00758394|11553122|FG003|NOT COMPLETED|Washout After 1st Intervention||0
10409101|NCT00758394|11553119|FG000|STARTED|2nd Intervention Order||8
10409102|NCT00758394|11553120|FG001|STARTED|2nd Intervention Order||7
10409103|NCT00758394|11553121|FG002|STARTED|2nd Intervention Order||6
10409104|NCT00758394|11553122|FG003|STARTED|2nd Intervention Order||8
10409105|NCT00758394|11553119|FG000|COMPLETED|2nd Intervention Order||8
10409106|NCT00758394|11553120|FG001|COMPLETED|2nd Intervention Order||6
10313626|NCT00153166|11447201|FG001|NOT COMPLETED|Overall Study||0
10313627|NCT00153166|11447202|FG002|NOT COMPLETED|Overall Study||0
10313628|NCT00153179|11447213|FG000|STARTED|Study Visit Day 1||10
10313629|NCT00153179|11447214|FG001|STARTED|Study Visit Day 1||8
10313630|NCT00153179|11447215|FG002|STARTED|Study Visit Day 1||13
10313631|NCT00153179|11447216|FG003|STARTED|Study Visit Day 1||9
10313632|NCT00153179|11447213|FG000|COMPLETED|Study Visit Day 1||10
10313633|NCT00153179|11447214|FG001|COMPLETED|Study Visit Day 1||8
10409107|NCT00758394|11553121|FG002|COMPLETED|2nd Intervention Order||6
10313634|NCT00153179|11447215|FG002|COMPLETED|Study Visit Day 1||13
10830630|NCT04020718|11995679|FG000|NOT COMPLETED|Post-assessment and Adaptation||0
10830631|NCT04020718|11995680|FG001|NOT COMPLETED|Post-assessment and Adaptation||0
10830632|NCT04020718|11995681|FG002|NOT COMPLETED|Post-assessment and Adaptation||0
10830633|NCT04020718|11995682|FG003|NOT COMPLETED|Post-assessment and Adaptation||1
10830634|NCT04020718|11995683|FG004|NOT COMPLETED|Post-assessment and Adaptation||0
10830635|NCT04020718|11995684|FG005|NOT COMPLETED|Post-assessment and Adaptation||0
10830636|NCT04020718|11995685|FG006|NOT COMPLETED|Post-assessment and Adaptation||0
10830637|NCT04020718|11995686|FG007|NOT COMPLETED|Post-assessment and Adaptation||0
10830638|NCT03970109|11995707|FG000|STARTED|Overall Study||15
10830639|NCT03970109|11995708|FG001|STARTED|Overall Study||13
10830640|NCT03970109|11995709|FG002|STARTED|Overall Study||15
10830641|NCT03970109|11995707|FG000|COMPLETED|Overall Study||14
10830642|NCT03970109|11995708|FG001|COMPLETED|Overall Study||10
10830643|NCT03970109|11995709|FG002|COMPLETED|Overall Study||15
10830644|NCT03970109|11995707|FG000|NOT COMPLETED|Overall Study||1
10830645|NCT03970109|11995708|FG001|NOT COMPLETED|Overall Study||3
10830646|NCT03970109|11995709|FG002|NOT COMPLETED|Overall Study||0
10290935|NCT04607291|11423779|FG000|STARTED|Overall Study||183
10290936|NCT04607291|11423779|FG000|COMPLETED|Overall Study||183
10290937|NCT04607291|11423779|FG000|NOT COMPLETED|Overall Study||0
10290938|NCT04605588|11423785|FG000|STARTED|Overall Study||2
10290939|NCT04605588|11423786|FG001|STARTED|Overall Study||5
10290940|NCT04605588|11423785|FG000|COMPLETED|Overall Study||1
10290941|NCT04605588|11423786|FG001|COMPLETED|Overall Study||5
10290942|NCT04605588|11423785|FG000|NOT COMPLETED|Overall Study||1
10290943|NCT04605588|11423786|FG001|NOT COMPLETED|Overall Study||0
10290947|NCT04596085|11423800|FG000|STARTED|Overall Study||59
10290948|NCT04596085|11423801|FG001|STARTED|Overall Study||59
10290949|NCT04596085|11423800|FG000|COMPLETED|Overall Study||59
10290950|NCT04596085|11423801|FG001|COMPLETED|Overall Study||59
10290951|NCT04596085|11423800|FG000|NOT COMPLETED|Overall Study||0
10290952|NCT04596085|11423801|FG001|NOT COMPLETED|Overall Study||0
10290953|NCT04590027|11423811|FG000|STARTED|Overall Study||47
10290954|NCT04590027|11423812|FG001|STARTED|Overall Study||39
10290955|NCT04590027|11423811|FG000|COMPLETED|Overall Study||30
10290956|NCT04590027|11423812|FG001|COMPLETED|Overall Study||22
10830647|NCT03954743|11995719|FG000|STARTED|Overall Study||677
10830648|NCT03954743|11995720|FG001|STARTED|Overall Study||674
10830649|NCT03954743|11995719|FG000|COMPLETED|Overall Study||653
10830650|NCT03954743|11995720|FG001|COMPLETED|Overall Study||657
10830651|NCT03954743|11995719|FG000|NOT COMPLETED|Overall Study||24
10830652|NCT03954743|11995720|FG001|NOT COMPLETED|Overall Study||17
10830653|NCT03880565|11995728|FG000|STARTED|Overall Study||15
10830654|NCT03880565|11995729|FG001|STARTED|Overall Study||15
10830655|NCT03880565|11995728|FG000|COMPLETED|Overall Study||14
10830656|NCT03880565|11995729|FG001|COMPLETED|Overall Study||15
10830657|NCT03880565|11995728|FG000|NOT COMPLETED|Overall Study||1
10830658|NCT03880565|11995729|FG001|NOT COMPLETED|Overall Study||0
10830659|NCT03833661|11995735|FG000|STARTED|Overall Study||159
10830660|NCT03833661|11995735|FG000|COMPLETED|Overall Study||150
10830661|NCT03833661|11995735|FG000|NOT COMPLETED|Overall Study||9
10830662|NCT03809663|11995743|FG000|STARTED|Overall Study||63
10830663|NCT03809663|11995744|FG001|STARTED|Overall Study||62
10830664|NCT03809663|11995745|FG002|STARTED|Overall Study||63
10830665|NCT03809663|11995746|FG003|STARTED|Overall Study||63
10830666|NCT03809663|11995747|FG004|STARTED|Overall Study||0
10830667|NCT03809663|11995748|FG005|STARTED|Overall Study||0
10830668|NCT03809663|11995743|FG000|Participants Who Received Investigational Product|Overall Study||63
10830669|NCT03809663|11995744|FG001|Participants Who Received Investigational Product|Overall Study||61
10830670|NCT03809663|11995745|FG002|Participants Who Received Investigational Product|Overall Study||63
10830671|NCT03809663|11995746|FG003|Participants Who Received Investigational Product|Overall Study||63
10830672|NCT03809663|11995747|FG004|Participants Who Received Investigational Product|Overall Study||0
10830673|NCT03809663|11995748|FG005|Participants Who Received Investigational Product|Overall Study||0
10830674|NCT03809663|11995743|FG000|EASI 50 Non-responder at Week 16|Overall Study||40
10830675|NCT03809663|11995744|FG001|EASI 50 Non-responder at Week 16|Overall Study||26
10830676|NCT03809663|11995745|FG002|EASI 50 Non-responder at Week 16|Overall Study||30
10830677|NCT03809663|11995746|FG003|EASI 50 Non-responder at Week 16|Overall Study||38
10830678|NCT03809663|11995747|FG004|EASI 50 Non-responder at Week 16|Overall Study||0
10830679|NCT03809663|11995748|FG005|EASI 50 Non-responder at Week 16|Overall Study||0
10830680|NCT03809663|11995743|FG000|Switched to Tezepelumab 420 mg Q2W After Week 16|Overall Study||39
10830681|NCT03809663|11995744|FG001|Switched to Tezepelumab 420 mg Q2W After Week 16|Overall Study||24
10830682|NCT03809663|11995745|FG002|Switched to Tezepelumab 420 mg Q2W After Week 16|Overall Study||30
10830683|NCT03809663|11995746|FG003|Switched to Tezepelumab 420 mg Q2W After Week 16|Overall Study||38
10830684|NCT03809663|11995747|FG004|Switched to Tezepelumab 420 mg Q2W After Week 16|Overall Study||0
10830685|NCT03809663|11995748|FG005|Switched to Tezepelumab 420 mg Q2W After Week 16|Overall Study||0
10830686|NCT03809663|11995743|FG000|COMPLETED|Overall Study||12
10830687|NCT03809663|11995744|FG001|COMPLETED|Overall Study||18
10830688|NCT03809663|11995745|FG002|COMPLETED|Overall Study||15
10830689|NCT03809663|11995746|FG003|COMPLETED|Overall Study||16
10830690|NCT03809663|11995747|FG004|COMPLETED|Overall Study||0
10830691|NCT03809663|11995748|FG005|COMPLETED|Overall Study||0
10830692|NCT03809663|11995743|FG000|NOT COMPLETED|Overall Study||51
10830693|NCT03809663|11995744|FG001|NOT COMPLETED|Overall Study||44
10830694|NCT03809663|11995745|FG002|NOT COMPLETED|Overall Study||48
10830695|NCT03809663|11995746|FG003|NOT COMPLETED|Overall Study||47
10409108|NCT00758394|11553122|FG003|COMPLETED|2nd Intervention Order||8
10409109|NCT00758394|11553119|FG000|NOT COMPLETED|2nd Intervention Order||0
10409110|NCT00758394|11553120|FG001|NOT COMPLETED|2nd Intervention Order||1
10409111|NCT00758394|11553121|FG002|NOT COMPLETED|2nd Intervention Order||0
10830696|NCT03809663|11995747|FG004|NOT COMPLETED|Overall Study||0
10830697|NCT03809663|11995748|FG005|NOT COMPLETED|Overall Study||0
10830698|NCT03782792|11995775|FG000|STARTED|Overall Study||18
10830699|NCT03782792|11995776|FG001|STARTED|Overall Study||35
10830700|NCT03782792|11995775|FG000|Received Open Label Treatment With Spesolimab at Wk1/D8|Overall Study||15
10830701|NCT03782792|11995776|FG001|Received Open Label Treatment With Spesolimab at Wk1/D8|Overall Study||12
10830702|NCT03782792|11995775|FG000|Received Rescue Treatment With Spesolimab After Wk1|Overall Study||2
10830703|NCT03782792|11995776|FG001|Received Rescue Treatment With Spesolimab After Wk1|Overall Study||4
10830704|NCT03782792|11995775|FG000|COMPLETED|Overall Study||17
10830705|NCT03782792|11995776|FG001|COMPLETED|Overall Study||32
10830706|NCT03782792|11995775|FG000|NOT COMPLETED|Overall Study||1
10830707|NCT03782792|11995776|FG001|NOT COMPLETED|Overall Study||3
10830708|NCT03750461|11995786|FG000|STARTED|Overall Study||20
10830709|NCT03750461|11995787|FG001|STARTED|Overall Study||92
10830710|NCT03750461|11995786|FG000|Primary Endpoint|Overall Study||20
10830765|NCT03600142|11995847|FG001|COMPLETED|Overall Study||758
10830711|NCT03750461|11995787|FG001|Primary Endpoint|Overall Study|Considered study completion for the Historical Controls.|92
10830712|NCT03750461|11995786|FG000|Secondary Endpoint|Overall Study||19
10830713|NCT03750461|11995787|FG001|Secondary Endpoint|Overall Study|Not applicable for the historical controls.|0
10830714|NCT03750461|11995786|FG000|COMPLETED|Overall Study||19
10830715|NCT03750461|11995787|FG001|COMPLETED|Overall Study|Not applicable for the historical controls; no follow-up data was collected.|0
10830716|NCT03750461|11995786|FG000|NOT COMPLETED|Overall Study||1
10830717|NCT03750461|11995787|FG001|NOT COMPLETED|Overall Study||92
10830718|NCT03733119|11995795|FG000|STARTED|Overall Study||2
10830719|NCT03733119|11995796|FG001|STARTED|Overall Study||2
10830720|NCT03733119|11995795|FG000|Treated|Overall Study||2
10830721|NCT03733119|11995796|FG001|Treated|Overall Study||1
10830722|NCT03733119|11995795|FG000|Stopped Treatment After 1 Dose|Overall Study||1
10830723|NCT03733119|11995796|FG001|Stopped Treatment After 1 Dose|Overall Study||0
10830724|NCT03733119|11995795|FG000|Stopped Treatment After 3 Cycles|Overall Study||1
10830725|NCT03733119|11995796|FG001|Stopped Treatment After 3 Cycles|Overall Study||1
10830726|NCT03733119|11995795|FG000|COMPLETED|Overall Study||0
10830727|NCT03733119|11995796|FG001|COMPLETED|Overall Study||0
10830728|NCT03733119|11995795|FG000|NOT COMPLETED|Overall Study||2
10830729|NCT03733119|11995796|FG001|NOT COMPLETED|Overall Study||2
10830730|NCT03661996|11995807|FG000|STARTED|Overall Study||162
10830731|NCT03661996|11995808|FG001|STARTED|Overall Study||180
10830732|NCT03661996|11995809|FG002|STARTED|Overall Study||176
10830733|NCT03661996|11995810|FG003|STARTED|Overall Study||163
10830734|NCT03661996|11995811|FG004|STARTED|Overall Study||173
10830735|NCT03661996|11995807|FG000|Treated|Overall Study||162
10830736|NCT03661996|11995808|FG001|Treated|Overall Study||179
10830737|NCT03661996|11995809|FG002|Treated|Overall Study||175
10830738|NCT03661996|11995810|FG003|Treated|Overall Study||160
10830739|NCT03661996|11995811|FG004|Treated|Overall Study||172
10830740|NCT03661996|11995807|FG000|COMPLETED|Overall Study||150
10830741|NCT03661996|11995808|FG001|COMPLETED|Overall Study||172
10830742|NCT03661996|11995809|FG002|COMPLETED|Overall Study||170
10830743|NCT03661996|11995810|FG003|COMPLETED|Overall Study||150
10830744|NCT03661996|11995811|FG004|COMPLETED|Overall Study||159
10830745|NCT03661996|11995807|FG000|NOT COMPLETED|Overall Study||12
10830746|NCT03661996|11995808|FG001|NOT COMPLETED|Overall Study||8
10830747|NCT03661996|11995809|FG002|NOT COMPLETED|Overall Study||6
10830748|NCT03661996|11995810|FG003|NOT COMPLETED|Overall Study||13
10830749|NCT03661996|11995811|FG004|NOT COMPLETED|Overall Study||14
10830750|NCT03633461|11995828|FG000|STARTED|Overall Study||34
10830751|NCT03633461|11995829|FG001|STARTED|Overall Study||19
10830752|NCT03633461|11995828|FG000|COMPLETED|Overall Study||34
10830753|NCT03633461|11995829|FG001|COMPLETED|Overall Study||18
10830754|NCT03633461|11995828|FG000|NOT COMPLETED|Overall Study||0
10830755|NCT03633461|11995829|FG001|NOT COMPLETED|Overall Study||1
10830756|NCT03622658|11995837|FG000|STARTED|Overall Study||6
10830757|NCT03622658|11995838|FG001|STARTED|Overall Study||36
10830758|NCT03622658|11995837|FG000|COMPLETED|Overall Study||3
10830759|NCT03622658|11995838|FG001|COMPLETED|Overall Study||32
10830760|NCT03622658|11995837|FG000|NOT COMPLETED|Overall Study||3
10830761|NCT03622658|11995838|FG001|NOT COMPLETED|Overall Study||4
10290957|NCT04590027|11423811|FG000|NOT COMPLETED|Overall Study||17
10290958|NCT04590027|11423812|FG001|NOT COMPLETED|Overall Study||17
10313635|NCT00153179|11447216|FG003|COMPLETED|Study Visit Day 1||9
10313636|NCT00153179|11447213|FG000|NOT COMPLETED|Study Visit Day 1||0
10313637|NCT00153179|11447214|FG001|NOT COMPLETED|Study Visit Day 1||0
10313638|NCT00153179|11447215|FG002|NOT COMPLETED|Study Visit Day 1||0
10313639|NCT00153179|11447216|FG003|NOT COMPLETED|Study Visit Day 1||0
10313640|NCT00153179|11447213|FG000|STARTED|Study Visit Day 2||10
10313641|NCT00153179|11447214|FG001|STARTED|Study Visit Day 2||8
10313642|NCT00153179|11447215|FG002|STARTED|Study Visit Day 2||13
10313643|NCT00153179|11447216|FG003|STARTED|Study Visit Day 2||9
10313644|NCT00153179|11447213|FG000|COMPLETED|Study Visit Day 2||9
10313645|NCT00153179|11447214|FG001|COMPLETED|Study Visit Day 2||8
10313646|NCT00153179|11447215|FG002|COMPLETED|Study Visit Day 2||11
10313647|NCT00153179|11447216|FG003|COMPLETED|Study Visit Day 2||7
10313648|NCT00153179|11447213|FG000|NOT COMPLETED|Study Visit Day 2||1
10313649|NCT00153179|11447214|FG001|NOT COMPLETED|Study Visit Day 2||0
10313650|NCT00153179|11447215|FG002|NOT COMPLETED|Study Visit Day 2||2
10313651|NCT00153179|11447216|FG003|NOT COMPLETED|Study Visit Day 2||2
10313652|NCT00153803|11447226|FG000|STARTED|Concurrent Chemoradiation||123
10313653|NCT00153803|11447227|FG001|STARTED|Concurrent Chemoradiation||122
10313654|NCT00153803|11447226|FG000|Received Chemoradiation|Concurrent Chemoradiation||118
10313655|NCT00153803|11447227|FG001|Received Chemoradiation|Concurrent Chemoradiation||117
10313656|NCT00153803|11447226|FG000|COMPLETED|Concurrent Chemoradiation||118
10313657|NCT00153803|11447227|FG001|COMPLETED|Concurrent Chemoradiation||117
10313658|NCT00153803|11447226|FG000|NOT COMPLETED|Concurrent Chemoradiation||5
10313659|NCT00153803|11447227|FG001|NOT COMPLETED|Concurrent Chemoradiation||5
10313660|NCT00153803|11447226|FG000|STARTED|Investigational Drug||118
10313661|NCT00153803|11447227|FG001|STARTED|Investigational Drug||117
10313662|NCT00153803|11447226|FG000|Investigational Drug Dispensed|Investigational Drug||77
10313663|NCT00153803|11447227|FG001|Investigational Drug Dispensed|Investigational Drug||75
10313664|NCT00153803|11447226|FG000|COMPLETED|Investigational Drug||77
10313665|NCT00153803|11447227|FG001|COMPLETED|Investigational Drug||75
10830762|NCT03600142|11995846|FG000|STARTED|Overall Study||777
10830763|NCT03600142|11995847|FG001|STARTED|Overall Study||762
10313666|NCT00153803|11447226|FG000|NOT COMPLETED|Investigational Drug||41
10830764|NCT03600142|11995846|FG000|COMPLETED|Overall Study||773
10830766|NCT03600142|11995846|FG000|NOT COMPLETED|Overall Study||4
10830767|NCT03600142|11995847|FG001|NOT COMPLETED|Overall Study||4
10830768|NCT03517722|11995857|FG000|STARTED|Double Blind Period: Week 0-52||208
10830769|NCT03517722|11995858|FG001|STARTED|Double Blind Period: Week 0-52||308
10830770|NCT03517722|11995857|FG000|Treated|Double Blind Period: Week 0-52||208
10830771|NCT03517722|11995858|FG001|Treated|Double Blind Period: Week 0-52||307
10830772|NCT03517722|11995857|FG000|COMPLETED|Double Blind Period: Week 0-52||105
10830773|NCT03517722|11995858|FG001|COMPLETED|Double Blind Period: Week 0-52||153
10830774|NCT03517722|11995857|FG000|NOT COMPLETED|Double Blind Period: Week 0-52||103
10830775|NCT03517722|11995858|FG001|NOT COMPLETED|Double Blind Period: Week 0-52||155
10830776|NCT03517722|11995857|FG000|STARTED|Open-label Extension Period: Week 52-113||88
10830777|NCT03517722|11995858|FG001|STARTED|Open-label Extension Period: Week 52-113||137
10830778|NCT03517722|11995857|FG000|COMPLETED|Open-label Extension Period: Week 52-113||0
10830779|NCT03517722|11995858|FG001|COMPLETED|Open-label Extension Period: Week 52-113||0
10830780|NCT03517722|11995857|FG000|NOT COMPLETED|Open-label Extension Period: Week 52-113||88
10830781|NCT03517722|11995858|FG001|NOT COMPLETED|Open-label Extension Period: Week 52-113||137
10830782|NCT03499314|11995867|FG000|STARTED|Overall Study||33
10830783|NCT03499314|11995868|FG001|STARTED|Overall Study||32
10830784|NCT03499314|11995867|FG000|COMPLETED|Overall Study||31
10830785|NCT03499314|11995868|FG001|COMPLETED|Overall Study||29
10830786|NCT03499314|11995867|FG000|NOT COMPLETED|Overall Study||2
10830787|NCT03499314|11995868|FG001|NOT COMPLETED|Overall Study||3
10830788|NCT03439124|11995876|FG000|STARTED|Overall Study||94
10830789|NCT03439124|11995877|FG001|STARTED|Overall Study||44
10830790|NCT03439124|11995876|FG000|COMPLETED|Overall Study||90
10830791|NCT03439124|11995877|FG001|COMPLETED|Overall Study||44
10830792|NCT03439124|11995876|FG000|NOT COMPLETED|Overall Study||4
10830793|NCT03439124|11995877|FG001|NOT COMPLETED|Overall Study||0
10830794|NCT03369431|11995885|FG000|STARTED|Overall Study||35
10830795|NCT03369431|11995886|FG001|STARTED|Overall Study||34
10830796|NCT03369431|11995885|FG000|Taste Test (1 Week)|Overall Study||35
10754192|NCT03050320|11917900|FG000|NOT COMPLETED|Overall Study||1
10754193|NCT03050320|11917901|FG001|NOT COMPLETED|Overall Study||1
10754194|NCT03050359|11917909|FG000|STARTED|Overall Study||265
10830797|NCT03369431|11995886|FG001|Taste Test (1 Week)|Overall Study||34
10830798|NCT03369431|11995885|FG000|Part 1 Treatment (12 Weeks)|Overall Study||34
10830799|NCT03369431|11995886|FG001|Part 1 Treatment (12 Weeks)|Overall Study||34
10830800|NCT03369431|11995885|FG000|Washout (4 Weeks)|Overall Study||34
10830801|NCT03369431|11995886|FG001|Washout (4 Weeks)|Overall Study||32
10830802|NCT03369431|11995885|FG000|Part 2 Treatment (12 Weeks)|Overall Study||34
10830803|NCT03369431|11995886|FG001|Part 2 Treatment (12 Weeks)|Overall Study||32
10830804|NCT03369431|11995885|FG000|COMPLETED|Overall Study||31
10830805|NCT03369431|11995886|FG001|COMPLETED|Overall Study||27
10830806|NCT03369431|11995885|FG000|NOT COMPLETED|Overall Study||4
10830807|NCT03369431|11995886|FG001|NOT COMPLETED|Overall Study||7
10290959|NCT04578457|11423822|FG000|STARTED|Hearing Aid Without NR Enabled (0)||19
10754195|NCT03050359|11917910|FG001|STARTED|Overall Study||268
10754196|NCT03050359|11917909|FG000|COMPLETED|Overall Study||248
10754197|NCT03050359|11917910|FG001|COMPLETED|Overall Study||248
10754198|NCT03050359|11917909|FG000|NOT COMPLETED|Overall Study||17
10754199|NCT03050359|11917910|FG001|NOT COMPLETED|Overall Study||20
10754200|NCT03050372|11917918|FG000|STARTED|Adaptation Night (Night #1 PSG)||6
10754201|NCT03050372|11917919|FG001|STARTED|Adaptation Night (Night #1 PSG)||6
10754202|NCT03050372|11917918|FG000|COMPLETED|Adaptation Night (Night #1 PSG)|N=1 subject removed from study due to mild sleep apnea during adaptation night|5
10290960|NCT04578457|11423822|FG000|COMPLETED|Hearing Aid Without NR Enabled (0)||17
10290961|NCT04578457|11423822|FG000|NOT COMPLETED|Hearing Aid Without NR Enabled (0)||2
10290962|NCT04578457|11423822|FG000|STARTED|Hearing Aid With NR (1)||19
10290963|NCT04578457|11423822|FG000|COMPLETED|Hearing Aid With NR (1)||17
10290964|NCT04578457|11423822|FG000|NOT COMPLETED|Hearing Aid With NR (1)||2
10290965|NCT04578457|11423822|FG000|STARTED|Hearing Aid With NR (2)||19
10754203|NCT03050372|11917919|FG001|COMPLETED|Adaptation Night (Night #1 PSG)||6
10754204|NCT03050372|11917918|FG000|NOT COMPLETED|Adaptation Night (Night #1 PSG)||1
10754205|NCT03050372|11917919|FG001|NOT COMPLETED|Adaptation Night (Night #1 PSG)||0
10754206|NCT03050372|11917918|FG000|STARTED|First Intervention (Nights #2 and #3)||5
10754207|NCT03050372|11917919|FG001|STARTED|First Intervention (Nights #2 and #3)||6
10754208|NCT03050372|11917918|FG000|COMPLETED|First Intervention (Nights #2 and #3)||5
10754209|NCT03050372|11917919|FG001|COMPLETED|First Intervention (Nights #2 and #3)||6
10754210|NCT03050372|11917918|FG000|NOT COMPLETED|First Intervention (Nights #2 and #3)||0
10754211|NCT03050372|11917919|FG001|NOT COMPLETED|First Intervention (Nights #2 and #3)||0
10754212|NCT03050372|11917918|FG000|STARTED|Second Intervention (Nights #4 and #5)||5
10754213|NCT03050372|11917919|FG001|STARTED|Second Intervention (Nights #4 and #5)||6
10754214|NCT03050372|11917918|FG000|COMPLETED|Second Intervention (Nights #4 and #5)||5
10754215|NCT03050372|11917919|FG001|COMPLETED|Second Intervention (Nights #4 and #5)|N=1 subject (blind only broken after double-blind analysis) moved out off State; lost to study|5
10754216|NCT03050372|11917918|FG000|NOT COMPLETED|Second Intervention (Nights #4 and #5)||0
10754217|NCT03050372|11917919|FG001|NOT COMPLETED|Second Intervention (Nights #4 and #5)||1
10754218|NCT03050450|11917929|FG000|STARTED|Overall Study||6
10754219|NCT03050450|11917930|FG001|STARTED|Overall Study||0
10754220|NCT03050450|11917931|FG002|STARTED|Overall Study||0
10754221|NCT03050450|11917932|FG003|STARTED|Overall Study||0
10754222|NCT03050450|11917933|FG004|STARTED|Overall Study||0
10754223|NCT03050450|11917929|FG000|COMPLETED|Overall Study||5
10754224|NCT03050450|11917930|FG001|COMPLETED|Overall Study||0
10754225|NCT03050450|11917931|FG002|COMPLETED|Overall Study||0
10754226|NCT03050450|11917932|FG003|COMPLETED|Overall Study||0
10754227|NCT03050450|11917933|FG004|COMPLETED|Overall Study||0
10754228|NCT03050450|11917929|FG000|NOT COMPLETED|Overall Study||1
10754229|NCT03050450|11917930|FG001|NOT COMPLETED|Overall Study||0
10754230|NCT03050450|11917931|FG002|NOT COMPLETED|Overall Study||0
10754231|NCT03050450|11917932|FG003|NOT COMPLETED|Overall Study||0
10754232|NCT03050450|11917933|FG004|NOT COMPLETED|Overall Study||0
10754233|NCT03050541|11917948|FG000|STARTED|Overall Study||28
10754234|NCT03050541|11917949|FG001|STARTED|Overall Study||28
10754235|NCT03050541|11917950|FG002|STARTED|Overall Study||28
10754236|NCT03050541|11917948|FG000|COMPLETED|Overall Study||20
10754237|NCT03050541|11917949|FG001|COMPLETED|Overall Study||20
10754238|NCT03050541|11917950|FG002|COMPLETED|Overall Study||20
10754239|NCT03050541|11917948|FG000|NOT COMPLETED|Overall Study||8
10754240|NCT03050541|11917949|FG001|NOT COMPLETED|Overall Study||8
10754241|NCT03050541|11917950|FG002|NOT COMPLETED|Overall Study||8
10754242|NCT03050619|11917964|FG000|STARTED|Overall Study||129
10754243|NCT03050619|11917965|FG001|STARTED|Overall Study||3926
10754244|NCT03050619|11917966|FG002|STARTED|Overall Study||6416
10290966|NCT04578457|11423822|FG000|COMPLETED|Hearing Aid With NR (2)||17
10290967|NCT04578457|11423822|FG000|NOT COMPLETED|Hearing Aid With NR (2)||2
10830826|NCT03336866|11995909|FG000|STARTED|Overall Study||20
10830827|NCT03336866|11995910|FG001|STARTED|Overall Study||18
10830828|NCT03336866|11995911|FG002|STARTED|Overall Study||18
10830829|NCT03336866|11995909|FG000|COMPLETED|Overall Study||17
10830830|NCT03336866|11995910|FG001|COMPLETED|Overall Study||17
10830831|NCT03336866|11995911|FG002|COMPLETED|Overall Study||14
10830832|NCT03336866|11995909|FG000|NOT COMPLETED|Overall Study||3
10830833|NCT03336866|11995910|FG001|NOT COMPLETED|Overall Study||1
10830834|NCT03336866|11995911|FG002|NOT COMPLETED|Overall Study||4
10830835|NCT03332173|11995924|FG000|STARTED|Overall Study||44
10830836|NCT03332173|11995924|FG000|COMPLETED|Overall Study||0
10830837|NCT03332173|11995924|FG000|NOT COMPLETED|Overall Study||44
10830838|NCT03322293|11995931|FG000|STARTED|Overall Study||8
10830839|NCT03322293|11995932|FG001|STARTED|Overall Study||8
10830840|NCT03322293|11995933|FG002|STARTED|Overall Study||8
10830841|NCT03322293|11995931|FG000|COMPLETED|Overall Study||8
10830842|NCT03322293|11995932|FG001|COMPLETED|Overall Study||8
10830843|NCT03322293|11995933|FG002|COMPLETED|Overall Study||7
10830844|NCT03322293|11995931|FG000|NOT COMPLETED|Overall Study||0
10830845|NCT03322293|11995932|FG001|NOT COMPLETED|Overall Study||0
10830846|NCT03322293|11995933|FG002|NOT COMPLETED|Overall Study||1
10830847|NCT03315039|11995943|FG000|STARTED|Overall Study||4
10830848|NCT03315039|11995944|FG001|STARTED|Overall Study||3
10830849|NCT03315039|11995943|FG000|COMPLETED|Overall Study||4
10830850|NCT03315039|11995944|FG001|COMPLETED|Overall Study||3
10830851|NCT03315039|11995943|FG000|NOT COMPLETED|Overall Study||0
10830852|NCT03315039|11995944|FG001|NOT COMPLETED|Overall Study||0
10830853|NCT03254394|11995955|FG000|STARTED|Overall Study||12
10830854|NCT03254394|11995956|FG001|STARTED|Overall Study||14
10830855|NCT03254394|11995955|FG000|COMPLETED|Overall Study||12
10830856|NCT03254394|11995956|FG001|COMPLETED|Overall Study||12
10830857|NCT03254394|11995955|FG000|NOT COMPLETED|Overall Study||0
10830858|NCT03254394|11995956|FG001|NOT COMPLETED|Overall Study||2
10830859|NCT03253809|11995962|FG000|STARTED|Overall Study||14
10830860|NCT03253809|11995962|FG000|COMPLETED|Overall Study||0
10830861|NCT03253809|11995962|FG000|NOT COMPLETED|Overall Study||14
10290968|NCT04578457|11423822|FG000|STARTED|Hearing Aid With NR (4)||19
10290969|NCT04578457|11423822|FG000|COMPLETED|Hearing Aid With NR (4)||17
10290970|NCT04578457|11423822|FG000|NOT COMPLETED|Hearing Aid With NR (4)||2
10290971|NCT04578496|11423830|FG000|STARTED|Overall Study||16
10290972|NCT04578496|11423830|FG000|COMPLETED|Overall Study||12
10290973|NCT04578496|11423830|FG000|NOT COMPLETED|Overall Study||4
10313667|NCT00153803|11447227|FG001|NOT COMPLETED|Investigational Drug||42
10313668|NCT00153816|11447242|FG000|STARTED|Overall Study||415
10313669|NCT00153816|11447243|FG001|STARTED|Overall Study||419
10313670|NCT00153816|11447244|FG002|STARTED|Overall Study||420
10313671|NCT00153816|11447245|FG003|STARTED|Overall Study||421
10313672|NCT00153816|11447246|FG004|STARTED|Overall Study||295
10313673|NCT00153816|11447247|FG005|STARTED|Overall Study||289
10313674|NCT00153816|11447242|FG000|COMPLETED|Overall Study||383
10313675|NCT00153816|11447243|FG001|COMPLETED|Overall Study||387
10313676|NCT00153816|11447244|FG002|COMPLETED|Overall Study||388
10313677|NCT00153816|11447245|FG003|COMPLETED|Overall Study||390
10313678|NCT00153816|11447246|FG004|COMPLETED|Overall Study||278
10313679|NCT00153816|11447247|FG005|COMPLETED|Overall Study||262
10313680|NCT00153816|11447242|FG000|NOT COMPLETED|Overall Study||32
10313681|NCT00153816|11447243|FG001|NOT COMPLETED|Overall Study||32
10313682|NCT00153816|11447244|FG002|NOT COMPLETED|Overall Study||32
10313683|NCT00153816|11447245|FG003|NOT COMPLETED|Overall Study||31
10830862|NCT03180294|11995969|FG000|STARTED|Overall Study||79
10830863|NCT03180294|11995970|FG001|STARTED|Overall Study||74
10830864|NCT03180294|11995971|FG002|STARTED|Overall Study||77
10830865|NCT03180294|11995969|FG000|Eligible Population|Overall Study||79
10830866|NCT03180294|11995970|FG001|Eligible Population|Overall Study||74
10830867|NCT03180294|11995971|FG002|Eligible Population|Overall Study||77
10830868|NCT03180294|11995969|FG000|Adverse Event Population|Overall Study||77
10830869|NCT03180294|11995970|FG001|Adverse Event Population|Overall Study||73
10830870|NCT03180294|11995971|FG002|Adverse Event Population|Overall Study||76
10830871|NCT03180294|11995969|FG000|COMPLETED|Overall Study||79
10290974|NCT04577183|11423834|FG000|STARTED|Overall Study||13
10290975|NCT04577183|11423834|FG000|COMPLETED|Overall Study||7
10290976|NCT04577183|11423834|FG000|NOT COMPLETED|Overall Study||6
10313684|NCT00153816|11447246|FG004|NOT COMPLETED|Overall Study||17
10313685|NCT00153816|11447247|FG005|NOT COMPLETED|Overall Study||27
10313686|NCT00153842|11447263|FG000|STARTED|Overall Study||26
10830872|NCT03180294|11995970|FG001|COMPLETED|Overall Study||74
10830873|NCT03180294|11995971|FG002|COMPLETED|Overall Study||77
10830874|NCT03180294|11995969|FG000|NOT COMPLETED|Overall Study||0
10830875|NCT03180294|11995970|FG001|NOT COMPLETED|Overall Study||0
10830876|NCT03180294|11995971|FG002|NOT COMPLETED|Overall Study||0
10830877|NCT03151408|11995982|FG000|STARTED|Overall Study|Screened patients|203
10830878|NCT03151408|11995983|FG001|STARTED|Overall Study|Screened patients|203
10830879|NCT03151408|11995982|FG000|Treated|Overall Study||201
10830880|NCT03151408|11995983|FG001|Treated|Overall Study||201
10830881|NCT03151408|11995982|FG000|COMPLETED|Overall Study||0
10830882|NCT03151408|11995983|FG001|COMPLETED|Overall Study||0
10830883|NCT03151408|11995982|FG000|NOT COMPLETED|Overall Study||203
10830884|NCT03151408|11995983|FG001|NOT COMPLETED|Overall Study||203
10830885|NCT03137173|11995991|FG000|STARTED|Overall Study||335
10830886|NCT03137173|11995992|FG001|STARTED|Overall Study||344
10830887|NCT03137173|11995991|FG000|COMPLETED|Overall Study||309
10830888|NCT03137173|11995992|FG001|COMPLETED|Overall Study||308
10830889|NCT03137173|11995991|FG000|NOT COMPLETED|Overall Study||26
10830890|NCT03137173|11995992|FG001|NOT COMPLETED|Overall Study||36
10830891|NCT03111030|11996001|FG000|STARTED|Overall Study||14
10830892|NCT03111030|11996002|FG001|STARTED|Overall Study||14
10830893|NCT03111030|11996001|FG000|COMPLETED|Overall Study||14
10830894|NCT03111030|11996002|FG001|COMPLETED|Overall Study||14
10830895|NCT03111030|11996001|FG000|NOT COMPLETED|Overall Study||0
10830896|NCT03111030|11996002|FG001|NOT COMPLETED|Overall Study||0
10830897|NCT03081052|11996012|FG000|STARTED|Overall Study||98
10830898|NCT03081052|11996013|FG001|STARTED|Overall Study||103
10830899|NCT03081052|11996014|FG002|STARTED|Overall Study||111
10830900|NCT03081052|11996015|FG003|STARTED|Overall Study||120
10830901|NCT03081052|11996012|FG000|COMPLETED|Overall Study||98
10830902|NCT03081052|11996013|FG001|COMPLETED|Overall Study||103
10830903|NCT03081052|11996014|FG002|COMPLETED|Overall Study||111
10830904|NCT03081052|11996015|FG003|COMPLETED|Overall Study||120
10830905|NCT03081052|11996012|FG000|NOT COMPLETED|Overall Study||0
10830906|NCT03081052|11996013|FG001|NOT COMPLETED|Overall Study||0
10830907|NCT03081052|11996014|FG002|NOT COMPLETED|Overall Study||0
10830908|NCT03081052|11996015|FG003|NOT COMPLETED|Overall Study||0
10830909|NCT03028740|11996031|FG000|STARTED|Overall Study||593
10830910|NCT03028740|11996032|FG001|STARTED|Overall Study||1185
10830911|NCT03028740|11996031|FG000|Full Study Cohort: Received Study Drug|Overall Study||589
10830912|NCT03028740|11996032|FG001|Full Study Cohort: Received Study Drug|Overall Study||1180
10830913|NCT03028740|11996031|FG000|Participated in Part 1|Overall Study||432
10830914|NCT03028740|11996032|FG001|Participated in Part 1|Overall Study||861
10830915|NCT03028740|11996031|FG000|Part 1: Received Study Drug|Overall Study||429
10830916|NCT03028740|11996032|FG001|Part 1: Received Study Drug|Overall Study||859
10830917|NCT03028740|11996031|FG000|COMPLETED|Overall Study||0
10830918|NCT03028740|11996032|FG001|COMPLETED|Overall Study||0
10830919|NCT03028740|11996031|FG000|NOT COMPLETED|Overall Study||593
10830920|NCT03028740|11996032|FG001|NOT COMPLETED|Overall Study||1185
10830921|NCT03015142|11996041|FG000|STARTED|Overall Study||21
10830922|NCT03015142|11996041|FG000|COMPLETED|Overall Study||20
10830923|NCT03015142|11996041|FG000|NOT COMPLETED|Overall Study||1
10830924|NCT03012672|11996049|FG000|STARTED|Overall Study||20
10830925|NCT03012672|11996050|FG001|STARTED|Overall Study||30
10830926|NCT03012672|11996049|FG000|COMPLETED|Overall Study||20
10830927|NCT03012672|11996050|FG001|COMPLETED|Overall Study||30
10830928|NCT03012672|11996049|FG000|NOT COMPLETED|Overall Study||0
10830929|NCT03012672|11996050|FG001|NOT COMPLETED|Overall Study||0
10830930|NCT03011775|11996057|FG000|STARTED|Overall Study||20
10830931|NCT03011775|11996058|FG001|STARTED|Overall Study||23
10830932|NCT03011775|11996057|FG000|COMPLETED|Overall Study||20
10830933|NCT03011775|11996058|FG001|COMPLETED|Overall Study||23
10830934|NCT03011775|11996057|FG000|NOT COMPLETED|Overall Study||0
10313687|NCT00153842|11447264|FG001|STARTED|Overall Study||7
10830935|NCT03011775|11996058|FG001|NOT COMPLETED|Overall Study||0
10830936|NCT03007485|11996070|FG000|STARTED|Overall Study||98
10830937|NCT03007485|11996071|FG001|STARTED|Overall Study||111
10830938|NCT03007485|11996070|FG000|COMPLETED|Overall Study||28
10830939|NCT03007485|11996071|FG001|COMPLETED|Overall Study||57
10830940|NCT03007485|11996070|FG000|NOT COMPLETED|Overall Study||70
10830941|NCT03007485|11996071|FG001|NOT COMPLETED|Overall Study||54
10830942|NCT02998476|11996084|FG000|STARTED|Overall Study||55
10830943|NCT02998476|11996085|FG001|STARTED|Overall Study||5
10830944|NCT02998476|11996084|FG000|COMPLETED|Overall Study||0
10830945|NCT02998476|11996085|FG001|COMPLETED|Overall Study||0
10830946|NCT02998476|11996084|FG000|NOT COMPLETED|Overall Study||55
10830947|NCT02998476|11996085|FG001|NOT COMPLETED|Overall Study||5
10290977|NCT04574999|11423840|FG000|STARTED|Overall Study||114
10290978|NCT04574999|11423841|FG001|STARTED|Overall Study||53
10290979|NCT04574999|11423840|FG000|COMPLETED|Overall Study||105
10290980|NCT04574999|11423841|FG001|COMPLETED|Overall Study||48
10290981|NCT04574999|11423840|FG000|NOT COMPLETED|Overall Study||9
10290982|NCT04574999|11423841|FG001|NOT COMPLETED|Overall Study||5
10313688|NCT00153842|11447263|FG000|COMPLETED|Overall Study||26
10313689|NCT00153842|11447264|FG001|COMPLETED|Overall Study||7
10313690|NCT00153842|11447263|FG000|NOT COMPLETED|Overall Study||0
10313691|NCT00153842|11447264|FG001|NOT COMPLETED|Overall Study||0
10313692|NCT00153920|11447272|FG000|STARTED|Overall Study||66
10313693|NCT00153920|11447272|FG000|Eligible and Treated|Overall Study||64
10313694|NCT00153920|11447272|FG000|COMPLETED|Overall Study||36
10313695|NCT00153920|11447272|FG000|NOT COMPLETED|Overall Study||30
10313696|NCT00153985|11447276|FG000|STARTED|Overall Study||2
10313697|NCT00153985|11447276|FG000|COMPLETED|Overall Study||2
10313698|NCT00153985|11447276|FG000|NOT COMPLETED|Overall Study||0
10313699|NCT00154063|11447282|FG000|STARTED|Overall Study||104
10313700|NCT00154063|11447283|FG001|STARTED|Overall Study||102
10313701|NCT00154063|11447282|FG000|COMPLETED|Overall Study||92
10313702|NCT00154063|11447283|FG001|COMPLETED|Overall Study||80
10313703|NCT00154063|11447282|FG000|NOT COMPLETED|Overall Study||12
10313704|NCT00154063|11447283|FG001|NOT COMPLETED|Overall Study||22
10313705|NCT00154102|11447295|FG000|STARTED|Overall Study|Randomized and treated subjects; 1 additional subject was treated but not randomised|599
10313706|NCT00154102|11447296|FG001|STARTED|Overall Study|Randomized and treated subjects; 3 additional subjects were treated but not randomised|599
10313707|NCT00154102|11447295|FG000|COMPLETED|Overall Study||592
10313708|NCT00154102|11447296|FG001|COMPLETED|Overall Study||597
10313709|NCT00154102|11447295|FG000|NOT COMPLETED|Overall Study||7
10313710|NCT00154102|11447296|FG001|NOT COMPLETED|Overall Study||2
10313711|NCT00154284|11447304|FG000|STARTED|Overall Study|"Started indicates Safety Population (randomized patients and treated after randomization.)"|59
10313712|NCT00154284|11447305|FG001|STARTED|Overall Study||55
10313713|NCT00154284|11447304|FG000|Intent to Treat (ITT) Population|Overall Study||57
10313714|NCT00154284|11447305|FG001|Intent to Treat (ITT) Population|Overall Study||53
10313715|NCT00154284|11447304|FG000|COMPLETED|Overall Study|"Completed means patients completed on study medication.All patients of both arms completed study."|52
10313716|NCT00154284|11447305|FG001|COMPLETED|Overall Study||42
10313717|NCT00154284|11447304|FG000|NOT COMPLETED|Overall Study||7
10313718|NCT00154284|11447305|FG001|NOT COMPLETED|Overall Study||13
10313719|NCT00154297|11447315|FG000|STARTED|Overall Study|Randomized population.|65
10313720|NCT00154297|11447316|FG001|STARTED|Overall Study|Randomized population.|74
10313721|NCT00154297|11447315|FG000|COMPLETED|Overall Study|Completed study by 12 month.|57
10313722|NCT00154297|11447316|FG001|COMPLETED|Overall Study|Completed study by 12 month.|67
10313723|NCT00154297|11447315|FG000|NOT COMPLETED|Overall Study||8
10313724|NCT00154297|11447316|FG001|NOT COMPLETED|Overall Study||7
10313725|NCT00154310|11447324|FG000|STARTED|Overall Study|"Started indicates enrolled participants. Randomized participants for two arms are 154 and 146."|155
10313726|NCT00154310|11447325|FG001|STARTED|Overall Study||145
10313727|NCT00154310|11447324|FG000|COMPLETED|Overall Study||118
10313728|NCT00154310|11447325|FG001|COMPLETED|Overall Study||117
10313729|NCT00154310|11447324|FG000|NOT COMPLETED|Overall Study||37
10313730|NCT00154310|11447325|FG001|NOT COMPLETED|Overall Study||28
10313731|NCT00154375|11447333|FG000|STARTED|Overall Study||120
10313732|NCT00154375|11447334|FG001|STARTED|Overall Study||120
10313733|NCT00154375|11447333|FG000|Discontinued Study Treatment|Overall Study||111
10313734|NCT00154375|11447334|FG001|Discontinued Study Treatment|Overall Study||104
10313735|NCT00154375|11447333|FG000|Not Exposed to Study Treatment|Overall Study|4 randomized patients didn't receive study treatment were excluded from the safety analyses.|2
10313736|NCT00154375|11447334|FG001|Not Exposed to Study Treatment|Overall Study||2
10313737|NCT00154375|11447333|FG000|COMPLETED|Overall Study||7
10313738|NCT00154375|11447334|FG001|COMPLETED|Overall Study||14
10313739|NCT00154375|11447333|FG000|NOT COMPLETED|Overall Study||113
10313740|NCT00154375|11447334|FG001|NOT COMPLETED|Overall Study||106
10313741|NCT00154466|11447344|FG000|STARTED|Overall Study||20
10313742|NCT00154466|11447345|FG001|STARTED|Overall Study||19
10313743|NCT00154466|11447346|FG002|STARTED|Overall Study|Healthy controls underwent the test of myocardial perfusion only at baseline.|19
10313744|NCT00154466|11447344|FG000|COMPLETED|Overall Study||20
10313745|NCT00154466|11447345|FG001|COMPLETED|Overall Study||19
10313746|NCT00154466|11447346|FG002|COMPLETED|Overall Study||19
10313747|NCT00154466|11447344|FG000|NOT COMPLETED|Overall Study||0
10313748|NCT00154466|11447345|FG001|NOT COMPLETED|Overall Study||0
10313749|NCT00154466|11447346|FG002|NOT COMPLETED|Overall Study||0
10409112|NCT00758394|11553122|FG003|NOT COMPLETED|2nd Intervention Order||0
10409113|NCT00758394|11553119|FG000|STARTED|Washout After 2nd Intervention||8
10313750|NCT00156013|11447356|FG000|STARTED|Overall Study||33
10313751|NCT00156013|11447356|FG000|COMPLETED|Overall Study||31
10313752|NCT00156013|11447356|FG000|NOT COMPLETED|Overall Study||2
10313753|NCT00156247|11447362|FG000|STARTED|Overall Study||9
10313754|NCT00156247|11447362|FG000|COMPLETED|Overall Study||5
10313755|NCT00156247|11447362|FG000|NOT COMPLETED|Overall Study||4
10313756|NCT00156390|11447368|FG000|STARTED|Overall Study||110
10313757|NCT00156390|11447369|FG001|STARTED|Overall Study||77
10313758|NCT00156390|11447368|FG000|COMPLETED|Overall Study||96
10830948|NCT02960997|11996094|FG000|STARTED|First Intervention, 12 Weeks||4
10290983|NCT04572997|11423847|FG000|STARTED|Overall Study||21
10409114|NCT00758394|11553120|FG001|STARTED|Washout After 2nd Intervention||6
10409115|NCT00758394|11553121|FG002|STARTED|Washout After 2nd Intervention||6
10409116|NCT00758394|11553122|FG003|STARTED|Washout After 2nd Intervention||8
10409117|NCT00758394|11553119|FG000|COMPLETED|Washout After 2nd Intervention||8
10409118|NCT00758394|11553120|FG001|COMPLETED|Washout After 2nd Intervention||6
10409119|NCT00758394|11553121|FG002|COMPLETED|Washout After 2nd Intervention||6
10409120|NCT00758394|11553122|FG003|COMPLETED|Washout After 2nd Intervention||8
10409121|NCT00758394|11553119|FG000|NOT COMPLETED|Washout After 2nd Intervention||0
10409122|NCT00758394|11553120|FG001|NOT COMPLETED|Washout After 2nd Intervention||0
10409123|NCT00758394|11553121|FG002|NOT COMPLETED|Washout After 2nd Intervention||0
10409124|NCT00758394|11553122|FG003|NOT COMPLETED|Washout After 2nd Intervention||0
10409125|NCT00758394|11553119|FG000|STARTED|3rd Intervention||8
10409126|NCT00758394|11553120|FG001|STARTED|3rd Intervention||6
10409127|NCT00758394|11553121|FG002|STARTED|3rd Intervention||6
10409128|NCT00758394|11553122|FG003|STARTED|3rd Intervention||8
10409129|NCT00758394|11553119|FG000|COMPLETED|3rd Intervention||7
10409130|NCT00758394|11553120|FG001|COMPLETED|3rd Intervention||6
10409131|NCT00758394|11553121|FG002|COMPLETED|3rd Intervention||6
10409132|NCT00758394|11553122|FG003|COMPLETED|3rd Intervention||7
10409133|NCT00758394|11553119|FG000|NOT COMPLETED|3rd Intervention||1
10409134|NCT00758394|11553120|FG001|NOT COMPLETED|3rd Intervention||0
10409135|NCT00758394|11553121|FG002|NOT COMPLETED|3rd Intervention||0
10409136|NCT00758394|11553122|FG003|NOT COMPLETED|3rd Intervention||1
10409137|NCT00758394|11553119|FG000|STARTED|Washout After 3rd Intervention||7
10409138|NCT00758394|11553120|FG001|STARTED|Washout After 3rd Intervention||6
10409139|NCT00758394|11553121|FG002|STARTED|Washout After 3rd Intervention||6
10409140|NCT00758394|11553122|FG003|STARTED|Washout After 3rd Intervention||7
10409141|NCT00758394|11553119|FG000|COMPLETED|Washout After 3rd Intervention||7
10409142|NCT00758394|11553120|FG001|COMPLETED|Washout After 3rd Intervention||6
10409143|NCT00758394|11553121|FG002|COMPLETED|Washout After 3rd Intervention||6
10409144|NCT00758394|11553122|FG003|COMPLETED|Washout After 3rd Intervention||7
10409145|NCT00758394|11553119|FG000|NOT COMPLETED|Washout After 3rd Intervention||0
10409146|NCT00758394|11553120|FG001|NOT COMPLETED|Washout After 3rd Intervention||0
10409147|NCT00758394|11553121|FG002|NOT COMPLETED|Washout After 3rd Intervention||0
10409148|NCT00758394|11553122|FG003|NOT COMPLETED|Washout After 3rd Intervention||0
10409149|NCT00758394|11553119|FG000|STARTED|4th Intervention||7
10409150|NCT00758394|11553120|FG001|STARTED|4th Intervention||6
10409151|NCT00758394|11553121|FG002|STARTED|4th Intervention||6
10409152|NCT00758394|11553122|FG003|STARTED|4th Intervention||7
10409153|NCT00758394|11553119|FG000|COMPLETED|4th Intervention||7
10409154|NCT00758394|11553120|FG001|COMPLETED|4th Intervention||6
10409155|NCT00758394|11553121|FG002|COMPLETED|4th Intervention||6
10409156|NCT00758394|11553122|FG003|COMPLETED|4th Intervention||7
10830949|NCT02960997|11996095|FG001|STARTED|First Intervention, 12 Weeks||4
10830950|NCT02960997|11996094|FG000|COMPLETED|First Intervention, 12 Weeks||4
10830951|NCT02960997|11996095|FG001|COMPLETED|First Intervention, 12 Weeks||4
10830952|NCT02960997|11996094|FG000|NOT COMPLETED|First Intervention, 12 Weeks||0
10830953|NCT02960997|11996095|FG001|NOT COMPLETED|First Intervention, 12 Weeks||0
10830954|NCT02960997|11996094|FG000|STARTED|Washout Period, 4 Weeks||4
10830955|NCT02960997|11996095|FG001|STARTED|Washout Period, 4 Weeks||4
10830956|NCT02960997|11996094|FG000|COMPLETED|Washout Period, 4 Weeks||4
10830957|NCT02960997|11996095|FG001|COMPLETED|Washout Period, 4 Weeks||4
10830958|NCT02960997|11996094|FG000|NOT COMPLETED|Washout Period, 4 Weeks||0
10830959|NCT02960997|11996095|FG001|NOT COMPLETED|Washout Period, 4 Weeks||0
10830960|NCT02960997|11996094|FG000|STARTED|Second Treatment, 12 Weeks||4
10830961|NCT02960997|11996095|FG001|STARTED|Second Treatment, 12 Weeks||4
10830962|NCT02960997|11996094|FG000|COMPLETED|Second Treatment, 12 Weeks||4
10830963|NCT02960997|11996095|FG001|COMPLETED|Second Treatment, 12 Weeks||4
10290984|NCT04572997|11423847|FG000|COMPLETED|Overall Study||20
10290985|NCT04572997|11423847|FG000|NOT COMPLETED|Overall Study||1
10313759|NCT00156390|11447369|FG001|COMPLETED|Overall Study||69
10313760|NCT00156390|11447368|FG000|NOT COMPLETED|Overall Study||14
10313761|NCT00156390|11447369|FG001|NOT COMPLETED|Overall Study||8
10313762|NCT00156533|11447380|FG000|STARTED|Overall Study||5
10313763|NCT00156533|11447381|FG001|STARTED|Overall Study||5
10313764|NCT00156533|11447382|FG002|STARTED|Overall Study||5
10313765|NCT00156533|11447383|FG003|STARTED|Overall Study||5
10313766|NCT00156533|11447380|FG000|COMPLETED|Overall Study||3
10313767|NCT00156533|11447381|FG001|COMPLETED|Overall Study||3
10313768|NCT00156533|11447382|FG002|COMPLETED|Overall Study||3
10313769|NCT00156533|11447383|FG003|COMPLETED|Overall Study||3
10313770|NCT00156533|11447380|FG000|NOT COMPLETED|Overall Study||2
10313771|NCT00156533|11447381|FG001|NOT COMPLETED|Overall Study||2
10313772|NCT00156533|11447382|FG002|NOT COMPLETED|Overall Study||2
10313773|NCT00156533|11447383|FG003|NOT COMPLETED|Overall Study||2
10313774|NCT00156715|11447395|FG000|STARTED|Overall Study||23
10313775|NCT00156715|11447395|FG000|COMPLETED|Overall Study||16
10313776|NCT00156715|11447395|FG000|NOT COMPLETED|Overall Study||7
10313777|NCT00156819|11447402|FG000|STARTED|Overall Study||169
10313778|NCT00156819|11447403|FG001|STARTED|Overall Study||166
10313779|NCT00156819|11447404|FG002|STARTED|Overall Study||165
10313780|NCT00156819|11447402|FG000|COMPLETED|Overall Study||168
10409157|NCT00758394|11553119|FG000|NOT COMPLETED|4th Intervention||0
10409158|NCT00758394|11553120|FG001|NOT COMPLETED|4th Intervention||0
10830964|NCT02960997|11996094|FG000|NOT COMPLETED|Second Treatment, 12 Weeks||0
10830965|NCT02960997|11996095|FG001|NOT COMPLETED|Second Treatment, 12 Weeks||0
10830966|NCT02960997|11996094|FG000|STARTED|Follow-up Period, 4 Weeks||4
10830967|NCT02960997|11996095|FG001|STARTED|Follow-up Period, 4 Weeks||4
10830968|NCT02960997|11996094|FG000|COMPLETED|Follow-up Period, 4 Weeks||4
10830969|NCT02960997|11996095|FG001|COMPLETED|Follow-up Period, 4 Weeks||4
10830970|NCT02960997|11996094|FG000|NOT COMPLETED|Follow-up Period, 4 Weeks||0
10830971|NCT02960997|11996095|FG001|NOT COMPLETED|Follow-up Period, 4 Weeks||0
10830980|NCT02924064|11996107|FG000|STARTED|Overall Study||123
10830981|NCT02924064|11996108|FG001|STARTED|Overall Study||124
10830982|NCT02924064|11996107|FG000|FAS|Overall Study||122
10830983|NCT02924064|11996108|FG001|FAS|Overall Study||124
10830984|NCT02924064|11996107|FG000|COMPLETED|Overall Study||99
10830985|NCT02924064|11996108|FG001|COMPLETED|Overall Study||81
10830986|NCT02924064|11996107|FG000|NOT COMPLETED|Overall Study||24
10830987|NCT02924064|11996108|FG001|NOT COMPLETED|Overall Study||43
10830988|NCT02916706|11996116|FG000|STARTED|Overall Study||127
10830989|NCT02916706|11996117|FG001|STARTED|Overall Study||127
10830990|NCT02916706|11996116|FG000|FAS|Overall Study||125
10830991|NCT02916706|11996117|FG001|FAS|Overall Study||126
10830992|NCT02916706|11996116|FG000|COMPLETED|Overall Study||112
10830993|NCT02916706|11996117|FG001|COMPLETED|Overall Study||96
10830994|NCT02916706|11996116|FG000|NOT COMPLETED|Overall Study||15
10830995|NCT02916706|11996117|FG001|NOT COMPLETED|Overall Study||31
10830996|NCT02889900|11996123|FG000|STARTED|Overall Study||62
10830997|NCT02889900|11996123|FG000|Received Treatment|Overall Study||60
10830998|NCT02889900|11996123|FG000|COMPLETED|Overall Study|Patients ongoing in study at primary analysis data cut off (DCO)|5
10830999|NCT02889900|11996123|FG000|NOT COMPLETED|Overall Study||57
10831000|NCT02866695|11996127|FG000|STARTED|Overall Study||20
10831001|NCT02866695|11996127|FG000|COMPLETED|Overall Study||18
10831002|NCT02866695|11996127|FG000|NOT COMPLETED|Overall Study||2
10831003|NCT02834793|11996133|FG000|STARTED|Core Study (Up to 18 Weeks)||36
10831004|NCT02834793|11996134|FG001|STARTED|Core Study (Up to 18 Weeks)||34
10831005|NCT02834793|11996135|FG002|STARTED|Core Study (Up to 18 Weeks)||0
10831006|NCT02834793|11996136|FG003|STARTED|Core Study (Up to 18 Weeks)||0
10831007|NCT02834793|11996133|FG000|COMPLETED|Core Study (Up to 18 Weeks)||32
10831008|NCT02834793|11996134|FG001|COMPLETED|Core Study (Up to 18 Weeks)||29
10831009|NCT02834793|11996135|FG002|COMPLETED|Core Study (Up to 18 Weeks)||0
10831010|NCT02834793|11996136|FG003|COMPLETED|Core Study (Up to 18 Weeks)||0
10831011|NCT02834793|11996133|FG000|NOT COMPLETED|Core Study (Up to 18 Weeks)||4
10831012|NCT02834793|11996134|FG001|NOT COMPLETED|Core Study (Up to 18 Weeks)||5
10831013|NCT02834793|11996135|FG002|NOT COMPLETED|Core Study (Up to 18 Weeks)||0
10831014|NCT02834793|11996136|FG003|NOT COMPLETED|Core Study (Up to 18 Weeks)||0
10831015|NCT02834793|11996133|FG000|STARTED|Extension Phase A (up to 52 Weeks)||0
10831016|NCT02834793|11996134|FG001|STARTED|Extension Phase A (up to 52 Weeks)||0
10831017|NCT02834793|11996135|FG002|STARTED|Extension Phase A (up to 52 Weeks)|Only eligible participants who completed Core Study entered into Extension Phase A.|58
10831018|NCT02834793|11996136|FG003|STARTED|Extension Phase A (up to 52 Weeks)||0
10831019|NCT02834793|11996133|FG000|COMPLETED|Extension Phase A (up to 52 Weeks)||0
10831020|NCT02834793|11996134|FG001|COMPLETED|Extension Phase A (up to 52 Weeks)||0
10831021|NCT02834793|11996135|FG002|COMPLETED|Extension Phase A (up to 52 Weeks)||32
10831022|NCT02834793|11996136|FG003|COMPLETED|Extension Phase A (up to 52 Weeks)||0
10831023|NCT02834793|11996133|FG000|NOT COMPLETED|Extension Phase A (up to 52 Weeks)||0
10831024|NCT02834793|11996134|FG001|NOT COMPLETED|Extension Phase A (up to 52 Weeks)||0
10831025|NCT02834793|11996135|FG002|NOT COMPLETED|Extension Phase A (up to 52 Weeks)||26
10831026|NCT02834793|11996136|FG003|NOT COMPLETED|Extension Phase A (up to 52 Weeks)||0
10831027|NCT02834793|11996133|FG000|STARTED|Extension Phase B (up to 188 Weeks)||0
10831028|NCT02834793|11996134|FG001|STARTED|Extension Phase B (up to 188 Weeks)||0
10831029|NCT02834793|11996135|FG002|STARTED|Extension Phase B (up to 188 Weeks)||0
10831030|NCT02834793|11996136|FG003|STARTED|Extension Phase B (up to 188 Weeks)|Only eligible participants who completed Extension Phase A entered into Extension Phase B.|13
10290986|NCT04563767|11423855|FG000|STARTED|Overall Study||4
10290987|NCT04563767|11423855|FG000|COMPLETED|Overall Study||4
10290988|NCT04563767|11423855|FG000|NOT COMPLETED|Overall Study||0
10290995|NCT04555525|11423872|FG000|STARTED|Overall Study||75
10290996|NCT04555525|11423873|FG001|STARTED|Overall Study||25
10290997|NCT04555525|11423872|FG000|COMPLETED|Overall Study||72
10290998|NCT04555525|11423873|FG001|COMPLETED|Overall Study||25
10290999|NCT04555525|11423872|FG000|NOT COMPLETED|Overall Study||3
10409159|NCT00758394|11553121|FG002|NOT COMPLETED|4th Intervention||0
10409160|NCT00758394|11553122|FG003|NOT COMPLETED|4th Intervention||0
10831031|NCT02834793|11996133|FG000|COMPLETED|Extension Phase B (up to 188 Weeks)||0
10831032|NCT02834793|11996134|FG001|COMPLETED|Extension Phase B (up to 188 Weeks)||0
10291000|NCT04555525|11423873|FG001|NOT COMPLETED|Overall Study||0
10313781|NCT00156819|11447403|FG001|COMPLETED|Overall Study||165
10313782|NCT00156819|11447404|FG002|COMPLETED|Overall Study||162
10831033|NCT02834793|11996135|FG002|COMPLETED|Extension Phase B (up to 188 Weeks)||0
10831034|NCT02834793|11996136|FG003|COMPLETED|Extension Phase B (up to 188 Weeks)||1
10831035|NCT02834793|11996133|FG000|NOT COMPLETED|Extension Phase B (up to 188 Weeks)||0
10831036|NCT02834793|11996134|FG001|NOT COMPLETED|Extension Phase B (up to 188 Weeks)||0
10831037|NCT02834793|11996135|FG002|NOT COMPLETED|Extension Phase B (up to 188 Weeks)||0
10831038|NCT02834793|11996136|FG003|NOT COMPLETED|Extension Phase B (up to 188 Weeks)||12
10831039|NCT02810457|11996146|FG000|STARTED|Overall Study|362 patients received study treatment|364
10831040|NCT02810457|11996147|FG001|STARTED|Overall Study|366 patients received study treatment|367
10831041|NCT02810457|11996146|FG000|COMPLETED|Overall Study||37
10831042|NCT02810457|11996147|FG001|COMPLETED|Overall Study||38
10831043|NCT02810457|11996146|FG000|NOT COMPLETED|Overall Study||327
10831044|NCT02810457|11996147|FG001|NOT COMPLETED|Overall Study||329
10831045|NCT02797964|11996159|FG000|STARTED|Overall Study||32
10831046|NCT02797964|11996160|FG001|STARTED|Overall Study||37
10831047|NCT02797964|11996161|FG002|STARTED|Overall Study||10
10831048|NCT02797964|11996162|FG003|STARTED|Overall Study||16
10831049|NCT02797964|11996163|FG004|STARTED|Overall Study||4
10831050|NCT02797964|11996164|FG005|STARTED|Overall Study||8
10831051|NCT02797964|11996159|FG000|COMPLETED|Overall Study||32
10831052|NCT02797964|11996160|FG001|COMPLETED|Overall Study||37
10831053|NCT02797964|11996161|FG002|COMPLETED|Overall Study||10
10831054|NCT02797964|11996162|FG003|COMPLETED|Overall Study||16
10831055|NCT02797964|11996163|FG004|COMPLETED|Overall Study||4
10831056|NCT02797964|11996164|FG005|COMPLETED|Overall Study||8
10831057|NCT02797964|11996159|FG000|NOT COMPLETED|Overall Study||0
10831058|NCT02797964|11996160|FG001|NOT COMPLETED|Overall Study||0
10831059|NCT02797964|11996161|FG002|NOT COMPLETED|Overall Study||0
10831060|NCT02797964|11996162|FG003|NOT COMPLETED|Overall Study||0
10831061|NCT02797964|11996163|FG004|NOT COMPLETED|Overall Study||0
10831062|NCT02797964|11996164|FG005|NOT COMPLETED|Overall Study||0
10831063|NCT02746809|11996177|FG000|STARTED|Baseline- 30 Days||60
10831064|NCT02746809|11996177|FG000|COMPLETED|Baseline- 30 Days||59
10831065|NCT02746809|11996177|FG000|NOT COMPLETED|Baseline- 30 Days||1
10831066|NCT02746809|11996177|FG000|STARTED|Baseline-6 Months||59
10831067|NCT02746809|11996177|FG000|COMPLETED|Baseline-6 Months||54
10831068|NCT02746809|11996177|FG000|NOT COMPLETED|Baseline-6 Months||5
10831069|NCT02745535|11996183|FG000|STARTED|Overall Study||77
10831070|NCT02745535|11996183|FG000|Sustained Virologic Repsonse|Overall Study|Sustained Virologic response measured 24 weeks after completing study medication|70
10831071|NCT02745535|11996183|FG000|COMPLETED|Overall Study|Completed 12 weeks of study medication per protocol|71
10831072|NCT02745535|11996183|FG000|NOT COMPLETED|Overall Study||6
10831073|NCT02738853|11996187|FG000|STARTED|Baseline -30 Days||60
10831074|NCT02738853|11996187|FG000|COMPLETED|Baseline -30 Days||59
10831075|NCT02738853|11996187|FG000|NOT COMPLETED|Baseline -30 Days||1
10831076|NCT02738853|11996187|FG000|STARTED|30 Days- 6 Months||59
10831077|NCT02738853|11996187|FG000|COMPLETED|30 Days- 6 Months||57
10831078|NCT02738853|11996187|FG000|NOT COMPLETED|30 Days- 6 Months||2
10831079|NCT02729701|11996191|FG000|STARTED|Overall Study||28
10831080|NCT02729701|11996191|FG000|COMPLETED|Overall Study||28
10831081|NCT02729701|11996191|FG000|NOT COMPLETED|Overall Study||0
10831082|NCT02684253|11996197|FG000|STARTED|Overall Study||32
10831083|NCT02684253|11996198|FG001|STARTED|Overall Study||33
10831084|NCT02684253|11996197|FG000|COMPLETED|Overall Study||32
10831085|NCT02684253|11996198|FG001|COMPLETED|Overall Study||33
10831086|NCT02684253|11996197|FG000|NOT COMPLETED|Overall Study||0
10831087|NCT02684253|11996198|FG001|NOT COMPLETED|Overall Study||0
10831088|NCT02681406|11996208|FG000|STARTED|Overall Study||65
10831089|NCT02681406|11996209|FG001|STARTED|Overall Study||59
10831090|NCT02681406|11996210|FG002|STARTED|Overall Study||68
10831091|NCT02681406|11996211|FG003|STARTED|Overall Study||70
10831092|NCT02681406|11996208|FG000|COMPLETED|Overall Study||49
10831093|NCT02681406|11996209|FG001|COMPLETED|Overall Study||35
10831094|NCT02681406|11996210|FG002|COMPLETED|Overall Study||42
10831095|NCT02681406|11996211|FG003|COMPLETED|Overall Study||58
10831096|NCT02681406|11996208|FG000|NOT COMPLETED|Overall Study||16
10831097|NCT02681406|11996209|FG001|NOT COMPLETED|Overall Study||24
10831098|NCT02681406|11996210|FG002|NOT COMPLETED|Overall Study||26
10831099|NCT02681406|11996211|FG003|NOT COMPLETED|Overall Study||12
10831100|NCT02625090|11996221|FG000|STARTED|Overall Study||42
10831101|NCT02625090|11996221|FG000|COMPLETED|Overall Study||0
10831102|NCT02625090|11996221|FG000|NOT COMPLETED|Overall Study||42
10831103|NCT02539225|11996228|FG000|STARTED|Part A||97
10831104|NCT02539225|11996229|FG001|STARTED|Part A||94
10831105|NCT02539225|11996228|FG000|Received Any Quantity of Study Drug|Part A||96
10831106|NCT02539225|11996229|FG001|Received Any Quantity of Study Drug|Part A||93
10831107|NCT02539225|11996228|FG000|COMPLETED|Part A||77
10831108|NCT02539225|11996229|FG001|COMPLETED|Part A||78
10831109|NCT02539225|11996228|FG000|NOT COMPLETED|Part A||20
10831110|NCT02539225|11996229|FG001|NOT COMPLETED|Part A||16
10831111|NCT02539225|11996228|FG000|STARTED|Pre Treatment for Part B|Participants who met initiation criteria of Part B were allowed to pretreatment for part B.|63
10831200|NCT02284568|11996385|FG001|STARTED|Overall Study|Intent to treat (ITT) population|139
10831112|NCT02539225|11996229|FG001|STARTED|Pre Treatment for Part B|Participants who met initiation criteria of Part B were allowed to pretreatment for part B.|66
10831113|NCT02539225|11996228|FG000|COMPLETED|Pre Treatment for Part B||58
10831114|NCT02539225|11996229|FG001|COMPLETED|Pre Treatment for Part B||64
10831115|NCT02539225|11996228|FG000|NOT COMPLETED|Pre Treatment for Part B||5
10831116|NCT02539225|11996229|FG001|NOT COMPLETED|Pre Treatment for Part B||2
10831117|NCT02539225|11996228|FG000|STARTED|Part B||58
10831118|NCT02539225|11996229|FG001|STARTED|Part B||64
10831119|NCT02539225|11996228|FG000|COMPLETED|Part B||54
10831120|NCT02539225|11996229|FG001|COMPLETED|Part B||48
10831121|NCT02539225|11996228|FG000|NOT COMPLETED|Part B||4
10831122|NCT02539225|11996229|FG001|NOT COMPLETED|Part B||16
10831123|NCT02528500|11996240|FG000|STARTED|Overall Study||10
10831124|NCT02528500|11996240|FG000|COMPLETED|Overall Study||10
10831125|NCT02528500|11996240|FG000|NOT COMPLETED|Overall Study||0
10831126|NCT02527681|11996244|FG000|STARTED|Overall Study||15
10831127|NCT02527681|11996244|FG000|COMPLETED|Overall Study||15
10831128|NCT02527681|11996244|FG000|NOT COMPLETED|Overall Study||0
10831129|NCT02526017|11996257|FG000|STARTED|Overall Study||3
10831130|NCT02526017|11996258|FG001|STARTED|Overall Study||10
10831131|NCT02526017|11996259|FG002|STARTED|Overall Study||11
10831132|NCT02526017|11996260|FG003|STARTED|Overall Study||4
10831133|NCT02526017|11996261|FG004|STARTED|Overall Study||4
10831134|NCT02526017|11996262|FG005|STARTED|Overall Study||3
10831135|NCT02526017|11996263|FG006|STARTED|Overall Study||6
10831136|NCT02526017|11996264|FG007|STARTED|Overall Study||10
10831137|NCT02526017|11996265|FG008|STARTED|Overall Study||262
10831138|NCT02526017|11996257|FG000|Received Study Treatment|Overall Study||3
10831139|NCT02526017|11996258|FG001|Received Study Treatment|Overall Study||10
10831140|NCT02526017|11996259|FG002|Received Study Treatment|Overall Study||11
10831141|NCT02526017|11996260|FG003|Received Study Treatment|Overall Study||4
10831142|NCT02526017|11996261|FG004|Received Study Treatment|Overall Study||3
10831143|NCT02526017|11996262|FG005|Received Study Treatment|Overall Study||3
10831144|NCT02526017|11996263|FG006|Received Study Treatment|Overall Study||6
10831145|NCT02526017|11996264|FG007|Received Study Treatment|Overall Study||10
10831146|NCT02526017|11996265|FG008|Received Study Treatment|Overall Study||262
10831147|NCT02526017|11996257|FG000|COMPLETED|Overall Study||3
10831148|NCT02526017|11996258|FG001|COMPLETED|Overall Study||10
10831149|NCT02526017|11996259|FG002|COMPLETED|Overall Study||11
10831150|NCT02526017|11996260|FG003|COMPLETED|Overall Study||4
10831151|NCT02526017|11996261|FG004|COMPLETED|Overall Study||3
10831152|NCT02526017|11996262|FG005|COMPLETED|Overall Study||3
10831153|NCT02526017|11996263|FG006|COMPLETED|Overall Study||6
10831154|NCT02526017|11996264|FG007|COMPLETED|Overall Study||10
10831155|NCT02526017|11996265|FG008|COMPLETED|Overall Study||262
10831156|NCT02526017|11996257|FG000|NOT COMPLETED|Overall Study||0
10831157|NCT02526017|11996258|FG001|NOT COMPLETED|Overall Study||0
10831158|NCT02526017|11996259|FG002|NOT COMPLETED|Overall Study||0
10831159|NCT02526017|11996260|FG003|NOT COMPLETED|Overall Study||0
10831160|NCT02526017|11996261|FG004|NOT COMPLETED|Overall Study||1
10831161|NCT02526017|11996262|FG005|NOT COMPLETED|Overall Study||0
10831162|NCT02526017|11996263|FG006|NOT COMPLETED|Overall Study||0
10831163|NCT02526017|11996264|FG007|NOT COMPLETED|Overall Study||0
10831164|NCT02526017|11996265|FG008|NOT COMPLETED|Overall Study||0
10831165|NCT02482233|11996327|FG000|STARTED|Overall Study||10
10831166|NCT02482233|11996328|FG001|STARTED|Overall Study||20
10831167|NCT02482233|11996327|FG000|COMPLETED|Overall Study||9
10831168|NCT02482233|11996328|FG001|COMPLETED|Overall Study||19
10831169|NCT02482233|11996327|FG000|NOT COMPLETED|Overall Study||1
10831170|NCT02482233|11996328|FG001|NOT COMPLETED|Overall Study||1
10831171|NCT02417415|11996336|FG000|STARTED|Overall Study||13
10831172|NCT02417415|11996337|FG001|STARTED|Overall Study||9
10831173|NCT02417415|11996336|FG000|COMPLETED|Overall Study||13
10831174|NCT02417415|11996337|FG001|COMPLETED|Overall Study||9
10831175|NCT02417415|11996336|FG000|NOT COMPLETED|Overall Study||0
10831176|NCT02417415|11996337|FG001|NOT COMPLETED|Overall Study||0
10831177|NCT02400736|11996345|FG000|STARTED|Overall Study||58
10831178|NCT02400736|11996346|FG001|STARTED|Overall Study||61
10831179|NCT02400736|11996345|FG000|COMPLETED|Overall Study||47
10831180|NCT02400736|11996346|FG001|COMPLETED|Overall Study||53
10831181|NCT02400736|11996345|FG000|NOT COMPLETED|Overall Study||11
10831182|NCT02400736|11996346|FG001|NOT COMPLETED|Overall Study||8
10831183|NCT02369653|11996358|FG000|STARTED|Overall Study||256
10831184|NCT02369653|11996359|FG001|STARTED|Overall Study||256
10831185|NCT02369653|11996358|FG000|Adverse Event Analysis Population|Overall Study|Out of the 256 participants randomized to Apixaban only 250 participants received an apixaban dose.|250
10831186|NCT02369653|11996359|FG001|Adverse Event Analysis Population|Overall Study|The 6 subjects who were randomized to apixaban but received no dose were analyzed in Standard of Care.|262
10831187|NCT02369653|11996358|FG000|COMPLETED|Overall Study||242
10831188|NCT02369653|11996359|FG001|COMPLETED|Overall Study||249
10831189|NCT02369653|11996358|FG000|NOT COMPLETED|Overall Study||14
10831190|NCT02369653|11996359|FG001|NOT COMPLETED|Overall Study||7
10831195|NCT02326974|11996373|FG000|STARTED|Overall Study||164
10831196|NCT02326974|11996373|FG000|Treated|Overall Study||163
10831197|NCT02326974|11996373|FG000|COMPLETED|Overall Study||157
10831198|NCT02326974|11996373|FG000|NOT COMPLETED|Overall Study||7
10831199|NCT02284568|11996384|FG000|STARTED|Overall Study|Intent to treat (ITT) population|140
10831201|NCT02284568|11996386|FG002|STARTED|Overall Study|Intent to treat (ITT) population|95
10831202|NCT02284568|11996384|FG000|Safety Population|Overall Study||140
10831203|NCT02284568|11996385|FG001|Safety Population|Overall Study||138
10831204|NCT02284568|11996386|FG002|Safety Population|Overall Study||95
10831205|NCT02284568|11996384|FG000|Completed Week 48 MRI - on Treatment|Overall Study||113
10831206|NCT02284568|11996385|FG001|Completed Week 48 MRI - on Treatment|Overall Study||107
10831207|NCT02284568|11996386|FG002|Completed Week 48 MRI - on Treatment|Overall Study||0
10831208|NCT02284568|11996384|FG000|COMPLETED|Overall Study||109
10831209|NCT02284568|11996385|FG001|COMPLETED|Overall Study||93
10831210|NCT02284568|11996386|FG002|COMPLETED|Overall Study||0
10831211|NCT02284568|11996384|FG000|NOT COMPLETED|Overall Study||31
10831212|NCT02284568|11996385|FG001|NOT COMPLETED|Overall Study||46
10831213|NCT02284568|11996386|FG002|NOT COMPLETED|Overall Study||95
10831214|NCT02228525|11996394|FG000|STARTED|Overall Study||25
10831215|NCT02228525|11996394|FG000|COMPLETED|Overall Study||25
10831216|NCT02228525|11996394|FG000|NOT COMPLETED|Overall Study||0
10831217|NCT02227238|11996400|FG000|STARTED|Overall Study||312
10831218|NCT02227238|11996401|FG001|STARTED|Overall Study||312
10831219|NCT02227238|11996400|FG000|COMPLETED|Overall Study||275
10831220|NCT02227238|11996401|FG001|COMPLETED|Overall Study||245
10831221|NCT02227238|11996400|FG000|NOT COMPLETED|Overall Study||37
10831222|NCT02227238|11996401|FG001|NOT COMPLETED|Overall Study||67
10831223|NCT02195986|11996410|FG000|STARTED|Overall Study||146
10831224|NCT02195986|11996411|FG001|STARTED|Overall Study||147
10831225|NCT02195986|11996412|FG002|STARTED|Overall Study||73
10831226|NCT02195986|11996410|FG000|COMPLETED|Overall Study||143
10831227|NCT02195986|11996411|FG001|COMPLETED|Overall Study||142
10831228|NCT02195986|11996412|FG002|COMPLETED|Overall Study||71
10831229|NCT02195986|11996410|FG000|NOT COMPLETED|Overall Study||3
10831230|NCT02195986|11996411|FG001|NOT COMPLETED|Overall Study||5
10831231|NCT02195986|11996412|FG002|NOT COMPLETED|Overall Study||2
10831232|NCT02128958|11996422|FG000|STARTED|Overall Study||50
10831233|NCT02128958|11996423|FG001|STARTED|Overall Study||28
10831234|NCT02128958|11996422|FG000|COMPLETED|Overall Study||29
10831235|NCT02128958|11996423|FG001|COMPLETED|Overall Study||18
10831236|NCT02128958|11996422|FG000|NOT COMPLETED|Overall Study||21
10831237|NCT02128958|11996423|FG001|NOT COMPLETED|Overall Study||10
10831238|NCT02086448|11996433|FG000|STARTED|Overall Study||25
10831239|NCT02086448|11996434|FG001|STARTED|Overall Study||26
10831240|NCT02086448|11996435|FG002|STARTED|Overall Study||20
10831241|NCT02086448|11996436|FG003|STARTED|Overall Study||18
10831242|NCT02086448|11996433|FG000|COMPLETED|Overall Study||24
10831243|NCT02086448|11996434|FG001|COMPLETED|Overall Study||26
10831244|NCT02086448|11996435|FG002|COMPLETED|Overall Study||20
10831245|NCT02086448|11996436|FG003|COMPLETED|Overall Study||16
10831246|NCT02086448|11996433|FG000|NOT COMPLETED|Overall Study||1
10831247|NCT02086448|11996434|FG001|NOT COMPLETED|Overall Study||0
10831248|NCT02086448|11996435|FG002|NOT COMPLETED|Overall Study||0
10831249|NCT02086448|11996436|FG003|NOT COMPLETED|Overall Study||2
10831250|NCT01982630|11996454|FG000|STARTED|Overall Study||10
10831251|NCT01982630|11996455|FG001|STARTED|Overall Study||8
10831252|NCT01982630|11996456|FG002|STARTED|Overall Study||13
10831253|NCT01982630|11996457|FG003|STARTED|Overall Study||9
10831254|NCT01982630|11996458|FG004|STARTED|Overall Study||19
10831255|NCT01982630|11996459|FG005|STARTED|Overall Study||14
10831256|NCT01982630|11996460|FG006|STARTED|Overall Study||6
10831257|NCT01982630|11996461|FG007|STARTED|Overall Study||8
10831258|NCT01982630|11996454|FG000|Treated|Overall Study||9
10831259|NCT01982630|11996455|FG001|Treated|Overall Study||8
10831260|NCT01982630|11996456|FG002|Treated|Overall Study||11
10831261|NCT01982630|11996457|FG003|Treated|Overall Study||9
10831262|NCT01982630|11996458|FG004|Treated|Overall Study||18
10831263|NCT01982630|11996459|FG005|Treated|Overall Study||14
10831264|NCT01982630|11996460|FG006|Treated|Overall Study||6
10831265|NCT01982630|11996461|FG007|Treated|Overall Study||8
10831266|NCT01982630|11996454|FG000|COMPLETED|Overall Study||7
10831267|NCT01982630|11996455|FG001|COMPLETED|Overall Study||8
10831268|NCT01982630|11996456|FG002|COMPLETED|Overall Study||8
10831269|NCT01982630|11996457|FG003|COMPLETED|Overall Study||8
10831270|NCT01982630|11996458|FG004|COMPLETED|Overall Study||16
10831271|NCT01982630|11996459|FG005|COMPLETED|Overall Study||11
10831272|NCT01982630|11996460|FG006|COMPLETED|Overall Study||5
10831273|NCT01982630|11996461|FG007|COMPLETED|Overall Study||8
10831274|NCT01982630|11996454|FG000|NOT COMPLETED|Overall Study||3
10831275|NCT01982630|11996455|FG001|NOT COMPLETED|Overall Study||0
10831276|NCT01982630|11996456|FG002|NOT COMPLETED|Overall Study||5
10831277|NCT01982630|11996457|FG003|NOT COMPLETED|Overall Study||1
10831278|NCT01982630|11996458|FG004|NOT COMPLETED|Overall Study||3
10831279|NCT01982630|11996459|FG005|NOT COMPLETED|Overall Study||3
10831280|NCT01982630|11996460|FG006|NOT COMPLETED|Overall Study||1
10831281|NCT01982630|11996461|FG007|NOT COMPLETED|Overall Study||0
10831282|NCT01982448|11996516|FG000|STARTED|Preoperative Chemotherapy||75
10831283|NCT01982448|11996517|FG001|STARTED|Preoperative Chemotherapy||72
10831284|NCT01982448|11996516|FG000|Eligible & Treated|Preoperative Chemotherapy||72
10831285|NCT01982448|11996517|FG001|Eligible & Treated|Preoperative Chemotherapy||70
10831286|NCT01982448|11996516|FG000|Evaluable for Safety|Preoperative Chemotherapy||72
10409161|NCT00758420|11553134|FG000|STARTED|Overall Study||39
10831287|NCT01982448|11996517|FG001|Evaluable for Safety|Preoperative Chemotherapy||68
10831288|NCT01982448|11996516|FG000|COMPLETED|Preoperative Chemotherapy||72
10831289|NCT01982448|11996517|FG001|COMPLETED|Preoperative Chemotherapy||67
10831290|NCT01982448|11996516|FG000|NOT COMPLETED|Preoperative Chemotherapy||3
10831291|NCT01982448|11996517|FG001|NOT COMPLETED|Preoperative Chemotherapy||5
10831292|NCT01982448|11996516|FG000|STARTED|Definitive Breast Surgery||72
10831293|NCT01982448|11996517|FG001|STARTED|Definitive Breast Surgery||67
10831294|NCT01982448|11996516|FG000|Evaluable for Response by Homologous Recombination Deficiency (HRD)|Definitive Breast Surgery||56
10831295|NCT01982448|11996517|FG001|Evaluable for Response by Homologous Recombination Deficiency (HRD)|Definitive Breast Surgery||48
10831296|NCT01982448|11996516|FG000|COMPLETED|Definitive Breast Surgery||72
10831297|NCT01982448|11996517|FG001|COMPLETED|Definitive Breast Surgery||67
10831298|NCT01982448|11996516|FG000|NOT COMPLETED|Definitive Breast Surgery||0
10831299|NCT01982448|11996517|FG001|NOT COMPLETED|Definitive Breast Surgery||0
10831300|NCT01879228|11996529|FG000|STARTED|Overall Study||13
10831301|NCT01879228|11996530|FG001|STARTED|Overall Study||13
10831302|NCT01879228|11996529|FG000|COMPLETED|Overall Study||12
10831303|NCT01879228|11996530|FG001|COMPLETED|Overall Study||12
10831304|NCT01879228|11996529|FG000|NOT COMPLETED|Overall Study||1
10831305|NCT01879228|11996530|FG001|NOT COMPLETED|Overall Study||1
10831318|NCT01752920|11996549|FG000|STARTED|Overall Study||29
10831319|NCT01752920|11996550|FG001|STARTED|Overall Study||13
10831320|NCT01752920|11996551|FG002|STARTED|Overall Study||19
10831321|NCT01752920|11996552|FG003|STARTED|Overall Study||58
10831322|NCT01752920|11996549|FG000|COMPLETED|Overall Study||0
10831323|NCT01752920|11996550|FG001|COMPLETED|Overall Study||0
10831324|NCT01752920|11996551|FG002|COMPLETED|Overall Study||0
10831325|NCT01752920|11996552|FG003|COMPLETED|Overall Study||0
10831326|NCT01752920|11996549|FG000|NOT COMPLETED|Overall Study||29
10831327|NCT01752920|11996550|FG001|NOT COMPLETED|Overall Study||13
10831328|NCT01752920|11996551|FG002|NOT COMPLETED|Overall Study||19
10831329|NCT01752920|11996552|FG003|NOT COMPLETED|Overall Study||58
10831336|NCT01740297|11996584|FG000|STARTED|Overall Study||19
10831337|NCT01740297|11996585|FG001|STARTED|Overall Study||100
10831338|NCT01740297|11996586|FG002|STARTED|Overall Study||98
10831339|NCT01740297|11996584|FG000|Received Talimogene Laherparepvec|Overall Study||19
10831340|NCT01740297|11996585|FG001|Received Talimogene Laherparepvec|Overall Study||0
10831341|NCT01740297|11996586|FG002|Received Talimogene Laherparepvec|Overall Study||95
10831342|NCT01740297|11996584|FG000|Received Ipilimumab|Overall Study||18
10831343|NCT01740297|11996585|FG001|Received Ipilimumab|Overall Study||95
10831344|NCT01740297|11996586|FG002|Received Ipilimumab|Overall Study||92
10831345|NCT01740297|11996584|FG000|COMPLETED|Overall Study||6
10831346|NCT01740297|11996585|FG001|COMPLETED|Overall Study||36
10831347|NCT01740297|11996586|FG002|COMPLETED|Overall Study||37
10831348|NCT01740297|11996584|FG000|NOT COMPLETED|Overall Study||13
10831349|NCT01740297|11996585|FG001|NOT COMPLETED|Overall Study||64
10831350|NCT01740297|11996586|FG002|NOT COMPLETED|Overall Study||61
10831351|NCT01729754|11996600|FG000|STARTED|Part 1||20
10831352|NCT01729754|11996601|FG001|STARTED|Part 1||184
10831353|NCT01729754|11996602|FG002|STARTED|Part 1||110
10831354|NCT01729754|11996603|FG003|STARTED|Part 1||18
10831355|NCT01729754|11996604|FG004|STARTED|Part 1||21
10831356|NCT01729754|11996605|FG005|STARTED|Part 1||268
10831357|NCT01729754|11996606|FG006|STARTED|Part 1||14
10831358|NCT01729754|11996607|FG007|STARTED|Part 1||72
10831359|NCT01729754|11996608|FG008|STARTED|Part 1||70
10831360|NCT01729754|11996609|FG009|STARTED|Part 1||313
10831361|NCT01729754|11996600|FG000|COMPLETED|Part 1||6
10831362|NCT01729754|11996601|FG001|COMPLETED|Part 1||184
10831363|NCT01729754|11996602|FG002|COMPLETED|Part 1||110
10831364|NCT01729754|11996603|FG003|COMPLETED|Part 1||6
10831365|NCT01729754|11996604|FG004|COMPLETED|Part 1||21
10831366|NCT01729754|11996605|FG005|COMPLETED|Part 1||268
10831367|NCT01729754|11996606|FG006|COMPLETED|Part 1||0
10831368|NCT01729754|11996607|FG007|COMPLETED|Part 1||72
10831369|NCT01729754|11996608|FG008|COMPLETED|Part 1||70
10831370|NCT01729754|11996609|FG009|COMPLETED|Part 1||289
10831371|NCT01729754|11996600|FG000|NOT COMPLETED|Part 1||14
10831372|NCT01729754|11996601|FG001|NOT COMPLETED|Part 1||0
10831373|NCT01729754|11996602|FG002|NOT COMPLETED|Part 1||0
10831374|NCT01729754|11996603|FG003|NOT COMPLETED|Part 1||12
10831375|NCT01729754|11996604|FG004|NOT COMPLETED|Part 1||0
10831376|NCT01729754|11996605|FG005|NOT COMPLETED|Part 1||0
10831377|NCT01729754|11996606|FG006|NOT COMPLETED|Part 1||14
10831378|NCT01729754|11996607|FG007|NOT COMPLETED|Part 1||0
10831379|NCT01729754|11996608|FG008|NOT COMPLETED|Part 1||0
10831380|NCT01729754|11996609|FG009|NOT COMPLETED|Part 1||24
10831381|NCT01729754|11996600|FG000|STARTED|Part 2||6
10831382|NCT01729754|11996601|FG001|STARTED|Part 2||184
10831383|NCT01729754|11996602|FG002|STARTED|Part 2||110
10831384|NCT01729754|11996603|FG003|STARTED|Part 2|1 participant completed Part 1 but did not enter Part 2|5
10831385|NCT01729754|11996604|FG004|STARTED|Part 2||21
10831386|NCT01729754|11996605|FG005|STARTED|Part 2||268
10831387|NCT01729754|11996606|FG006|STARTED|Part 2||0
10831388|NCT01729754|11996607|FG007|STARTED|Part 2||72
10831389|NCT01729754|11996608|FG008|STARTED|Part 2||70
10831390|NCT01729754|11996609|FG009|STARTED|Part 2||289
10831391|NCT01729754|11996600|FG000|COMPLETED|Part 2||0
10831392|NCT01729754|11996601|FG001|COMPLETED|Part 2||184
10831393|NCT01729754|11996602|FG002|COMPLETED|Part 2||110
10831394|NCT01729754|11996603|FG003|COMPLETED|Part 2||0
10831395|NCT01729754|11996604|FG004|COMPLETED|Part 2||21
10831396|NCT01729754|11996605|FG005|COMPLETED|Part 2||268
10831397|NCT01729754|11996606|FG006|COMPLETED|Part 2||0
10831398|NCT01729754|11996607|FG007|COMPLETED|Part 2||69
10831399|NCT01729754|11996608|FG008|COMPLETED|Part 2||66
10831400|NCT01729754|11996609|FG009|COMPLETED|Part 2||277
10831401|NCT01729754|11996600|FG000|NOT COMPLETED|Part 2||6
10831402|NCT01729754|11996601|FG001|NOT COMPLETED|Part 2||0
10831403|NCT01729754|11996602|FG002|NOT COMPLETED|Part 2||0
10831404|NCT01729754|11996603|FG003|NOT COMPLETED|Part 2||5
10831405|NCT01729754|11996604|FG004|NOT COMPLETED|Part 2||0
10831406|NCT01729754|11996605|FG005|NOT COMPLETED|Part 2||0
10831407|NCT01729754|11996606|FG006|NOT COMPLETED|Part 2||0
10831408|NCT01729754|11996607|FG007|NOT COMPLETED|Part 2||3
10831409|NCT01729754|11996608|FG008|NOT COMPLETED|Part 2||4
10831410|NCT01729754|11996609|FG009|NOT COMPLETED|Part 2||12
10831411|NCT01729754|11996600|FG000|STARTED|Part 3||0
10831412|NCT01729754|11996601|FG001|STARTED|Part 3|14 participants completed Part 2 but did not enter Part 3|170
10831413|NCT01729754|11996602|FG002|STARTED|Part 3||110
10831414|NCT01729754|11996603|FG003|STARTED|Part 3||0
10831415|NCT01729754|11996604|FG004|STARTED|Part 3||21
10831416|NCT01729754|11996605|FG005|STARTED|Part 3|31 participants completed Part 2 but did not enter Part 3|237
10831417|NCT01729754|11996606|FG006|STARTED|Part 3||0
10831418|NCT01729754|11996607|FG007|STARTED|Part 3||69
10831419|NCT01729754|11996608|FG008|STARTED|Part 3||66
10831420|NCT01729754|11996609|FG009|STARTED|Part 3|156 participants completed Part 2 but did not enter Part 3|121
10831421|NCT01729754|11996600|FG000|COMPLETED|Part 3||0
10831422|NCT01729754|11996601|FG001|COMPLETED|Part 3||165
10831423|NCT01729754|11996602|FG002|COMPLETED|Part 3||105
10831424|NCT01729754|11996603|FG003|COMPLETED|Part 3||0
10831425|NCT01729754|11996604|FG004|COMPLETED|Part 3||17
10831426|NCT01729754|11996605|FG005|COMPLETED|Part 3||224
10831427|NCT01729754|11996606|FG006|COMPLETED|Part 3||0
10831428|NCT01729754|11996607|FG007|COMPLETED|Part 3||66
10831429|NCT01729754|11996608|FG008|COMPLETED|Part 3||65
10831430|NCT01729754|11996609|FG009|COMPLETED|Part 3||114
10831431|NCT01729754|11996600|FG000|NOT COMPLETED|Part 3||0
10831432|NCT01729754|11996601|FG001|NOT COMPLETED|Part 3||5
10831433|NCT01729754|11996602|FG002|NOT COMPLETED|Part 3||5
10831434|NCT01729754|11996603|FG003|NOT COMPLETED|Part 3||0
10831435|NCT01729754|11996604|FG004|NOT COMPLETED|Part 3||4
10831436|NCT01729754|11996605|FG005|NOT COMPLETED|Part 3||13
10831437|NCT01729754|11996606|FG006|NOT COMPLETED|Part 3||0
10831438|NCT01729754|11996607|FG007|NOT COMPLETED|Part 3||3
10831439|NCT01729754|11996608|FG008|NOT COMPLETED|Part 3||1
10831440|NCT01729754|11996609|FG009|NOT COMPLETED|Part 3||7
10831441|NCT01684826|11996639|FG000|STARTED|Overall Study||49
10831442|NCT01684826|11996639|FG000|Collected Dose and Image Information|Overall Study||39
10831443|NCT01684826|11996639|FG000|COMPLETED|Overall Study||39
10831444|NCT01684826|11996639|FG000|NOT COMPLETED|Overall Study||10
10831445|NCT01672242|11996643|FG000|STARTED|Period 1||4
10831446|NCT01672242|11996644|FG001|STARTED|Period 1||2
10831447|NCT01672242|11996643|FG000|COMPLETED|Period 1||4
10831448|NCT01672242|11996644|FG001|COMPLETED|Period 1||2
10831449|NCT01672242|11996643|FG000|NOT COMPLETED|Period 1||0
10831450|NCT01672242|11996644|FG001|NOT COMPLETED|Period 1||0
10831451|NCT01672242|11996643|FG000|STARTED|Period 2||4
10831452|NCT01672242|11996644|FG001|STARTED|Period 2||2
10831453|NCT01672242|11996643|FG000|COMPLETED|Period 2||4
10831454|NCT01672242|11996644|FG001|COMPLETED|Period 2||2
10831455|NCT01672242|11996643|FG000|NOT COMPLETED|Period 2||0
10831456|NCT01672242|11996644|FG001|NOT COMPLETED|Period 2||0
10831469|NCT01599741|11996659|FG000|STARTED|Overall Study||51
10831470|NCT01599741|11996659|FG000|Collected Dose and Image Information|Overall Study||48
10831471|NCT01599741|11996659|FG000|COMPLETED|Overall Study||48
10831472|NCT01599741|11996659|FG000|NOT COMPLETED|Overall Study||3
10831473|NCT01593852|11996665|FG000|STARTED|Overall Study||68
10831474|NCT01593852|11996666|FG001|STARTED|Overall Study||68
10831475|NCT01593852|11996665|FG000|COMPLETED|Overall Study||68
10831476|NCT01593852|11996666|FG001|COMPLETED|Overall Study||68
10831477|NCT01593852|11996665|FG000|NOT COMPLETED|Overall Study||0
10831478|NCT01593852|11996666|FG001|NOT COMPLETED|Overall Study||0
10831479|NCT01564537|11996674|FG000|STARTED|Overall Study||360
10831480|NCT01564537|11996675|FG001|STARTED|Overall Study||362
10831481|NCT01564537|11996674|FG000|Safety Population: Received Study Drug|Overall Study||360
10831482|NCT01564537|11996675|FG001|Safety Population: Received Study Drug|Overall Study||360
10831483|NCT01564537|11996674|FG000|COMPLETED|Overall Study|Completed=Participants who are ongoing as of 30 October 2014 or who have died on study.|354
10831484|NCT01564537|11996675|FG001|COMPLETED|Overall Study|Completed=Participants who are ongoing as of 30 October 2014 or who have died on study.|356
10831485|NCT01564537|11996674|FG000|NOT COMPLETED|Overall Study||6
10831486|NCT01564537|11996675|FG001|NOT COMPLETED|Overall Study||6
10831487|NCT01515306|11996684|FG000|STARTED|Overall Study||24
10831488|NCT01515306|11996685|FG001|STARTED|Overall Study||16
10831489|NCT01515306|11996684|FG000|Received at Least 1 Dose of Study Drug|Overall Study||24
10831490|NCT01515306|11996685|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16
10831491|NCT01515306|11996684|FG000|Cycle 1|Overall Study||24
10831492|NCT01515306|11996685|FG001|Cycle 1|Overall Study||16
10831493|NCT01515306|11996684|FG000|Cycle 2|Overall Study||21
10831494|NCT01515306|11996685|FG001|Cycle 2|Overall Study||15
10831495|NCT01515306|11996684|FG000|Drug-Drug Interaction Population|Overall Study|Completed Cycle 1 Day 1 and Cycle 2 Day 1 treatment.|21
10831496|NCT01515306|11996685|FG001|Drug-Drug Interaction Population|Overall Study|Drug-drug interaction was only assessed in Part A.|0
10831497|NCT01515306|11996684|FG000|COMPLETED|Overall Study||0
10831498|NCT01515306|11996685|FG001|COMPLETED|Overall Study||2
10831499|NCT01515306|11996684|FG000|NOT COMPLETED|Overall Study||24
10831500|NCT01515306|11996685|FG001|NOT COMPLETED|Overall Study||14
10831501|NCT01423851|11996706|FG000|STARTED|Whole Study||3
10831502|NCT01423851|11996707|FG001|STARTED|Whole Study||3
10831503|NCT01423851|11996708|FG002|STARTED|Whole Study||3
10831504|NCT01423851|11996709|FG003|STARTED|Whole Study||6
10831505|NCT01423851|11996710|FG004|STARTED|Whole Study||3
10831506|NCT01423851|11996711|FG005|STARTED|Whole Study||3
10831507|NCT01423851|11996712|FG006|STARTED|Whole Study||3
10831508|NCT01423851|11996713|FG007|STARTED|Whole Study||8
10831509|NCT01423851|11996714|FG008|STARTED|Whole Study||8
10831510|NCT01423851|11996715|FG009|STARTED|Whole Study||8
10831511|NCT01423851|11996716|FG010|STARTED|Whole Study||29
10831512|NCT01423851|11996706|FG000|COMPLETED|Whole Study||0
10831513|NCT01423851|11996707|FG001|COMPLETED|Whole Study||0
10831514|NCT01423851|11996708|FG002|COMPLETED|Whole Study||0
10831515|NCT01423851|11996709|FG003|COMPLETED|Whole Study||0
10831516|NCT01423851|11996710|FG004|COMPLETED|Whole Study||0
10831517|NCT01423851|11996711|FG005|COMPLETED|Whole Study||0
10831518|NCT01423851|11996712|FG006|COMPLETED|Whole Study||0
10831519|NCT01423851|11996713|FG007|COMPLETED|Whole Study||0
10831520|NCT01423851|11996714|FG008|COMPLETED|Whole Study||0
10831521|NCT01423851|11996715|FG009|COMPLETED|Whole Study||0
10831522|NCT01423851|11996716|FG010|COMPLETED|Whole Study||0
10831523|NCT01423851|11996706|FG000|NOT COMPLETED|Whole Study||3
10831524|NCT01423851|11996707|FG001|NOT COMPLETED|Whole Study||3
10831525|NCT01423851|11996708|FG002|NOT COMPLETED|Whole Study||3
10831526|NCT01423851|11996709|FG003|NOT COMPLETED|Whole Study||6
10831527|NCT01423851|11996710|FG004|NOT COMPLETED|Whole Study||3
10831528|NCT01423851|11996711|FG005|NOT COMPLETED|Whole Study||3
10831529|NCT01423851|11996712|FG006|NOT COMPLETED|Whole Study||3
10831530|NCT01423851|11996713|FG007|NOT COMPLETED|Whole Study||8
10831531|NCT01423851|11996714|FG008|NOT COMPLETED|Whole Study||8
10831532|NCT01423851|11996715|FG009|NOT COMPLETED|Whole Study||8
10831533|NCT01423851|11996716|FG010|NOT COMPLETED|Whole Study||29
10831534|NCT01423851|11996706|FG000|STARTED|Dose Finding Period - Escalation||0
10831535|NCT01423851|11996707|FG001|STARTED|Dose Finding Period - Escalation||1
10831536|NCT01423851|11996708|FG002|STARTED|Dose Finding Period - Escalation||4
10831537|NCT01423851|11996709|FG003|STARTED|Dose Finding Period - Escalation||4
10831538|NCT01423851|11996710|FG004|STARTED|Dose Finding Period - Escalation||0
10831539|NCT01423851|11996711|FG005|STARTED|Dose Finding Period - Escalation||0
10831540|NCT01423851|11996712|FG006|STARTED|Dose Finding Period - Escalation||2
10831541|NCT01423851|11996713|FG007|STARTED|Dose Finding Period - Escalation||0
10831542|NCT01423851|11996714|FG008|STARTED|Dose Finding Period - Escalation||1
10831543|NCT01423851|11996715|FG009|STARTED|Dose Finding Period - Escalation||0
10831544|NCT01423851|11996716|FG010|STARTED|Dose Finding Period - Escalation||0
10831545|NCT01423851|11996706|FG000|COMPLETED|Dose Finding Period - Escalation||0
10290989|NCT04560374|11423861|FG000|STARTED|Overall Study||50
10290990|NCT04560374|11423862|FG001|STARTED|Overall Study||50
10290991|NCT04560374|11423861|FG000|COMPLETED|Overall Study||50
10290992|NCT04560374|11423862|FG001|COMPLETED|Overall Study||50
10290993|NCT04560374|11423861|FG000|NOT COMPLETED|Overall Study||0
10290994|NCT04560374|11423862|FG001|NOT COMPLETED|Overall Study||0
10291001|NCT04553497|11423881|FG000|STARTED|Overall Study||17
10831546|NCT01423851|11996707|FG001|COMPLETED|Dose Finding Period - Escalation||0
10831547|NCT01423851|11996708|FG002|COMPLETED|Dose Finding Period - Escalation||0
10831548|NCT01423851|11996709|FG003|COMPLETED|Dose Finding Period - Escalation||0
10831549|NCT01423851|11996710|FG004|COMPLETED|Dose Finding Period - Escalation||0
10831550|NCT01423851|11996711|FG005|COMPLETED|Dose Finding Period - Escalation||0
10831551|NCT01423851|11996712|FG006|COMPLETED|Dose Finding Period - Escalation||0
10831552|NCT01423851|11996713|FG007|COMPLETED|Dose Finding Period - Escalation||0
10831553|NCT01423851|11996714|FG008|COMPLETED|Dose Finding Period - Escalation||0
10831554|NCT01423851|11996715|FG009|COMPLETED|Dose Finding Period - Escalation||0
10831555|NCT01423851|11996716|FG010|COMPLETED|Dose Finding Period - Escalation||0
10831556|NCT01423851|11996706|FG000|NOT COMPLETED|Dose Finding Period - Escalation||0
10831557|NCT01423851|11996707|FG001|NOT COMPLETED|Dose Finding Period - Escalation||1
10291002|NCT04553497|11423882|FG001|STARTED|Overall Study||18
10291003|NCT04553497|11423881|FG000|COMPLETED|Overall Study||15
10291004|NCT04553497|11423882|FG001|COMPLETED|Overall Study||17
10831635|NCT01317875|11996789|FG001|COMPLETED|Overall Study||1
10831558|NCT01423851|11996708|FG002|NOT COMPLETED|Dose Finding Period - Escalation||4
10831559|NCT01423851|11996709|FG003|NOT COMPLETED|Dose Finding Period - Escalation||4
10831560|NCT01423851|11996710|FG004|NOT COMPLETED|Dose Finding Period - Escalation||0
10831561|NCT01423851|11996711|FG005|NOT COMPLETED|Dose Finding Period - Escalation||0
10831562|NCT01423851|11996712|FG006|NOT COMPLETED|Dose Finding Period - Escalation||2
10831563|NCT01423851|11996713|FG007|NOT COMPLETED|Dose Finding Period - Escalation||0
10831564|NCT01423851|11996714|FG008|NOT COMPLETED|Dose Finding Period - Escalation||1
10831565|NCT01423851|11996715|FG009|NOT COMPLETED|Dose Finding Period - Escalation||0
10831566|NCT01423851|11996716|FG010|NOT COMPLETED|Dose Finding Period - Escalation||0
10831567|NCT01423851|11996706|FG000|STARTED|Dose Finding Period - Reduction||0
10831568|NCT01423851|11996707|FG001|STARTED|Dose Finding Period - Reduction||0
10831569|NCT01423851|11996708|FG002|STARTED|Dose Finding Period - Reduction||3
10831570|NCT01423851|11996709|FG003|STARTED|Dose Finding Period - Reduction||5
10831571|NCT01423851|11996710|FG004|STARTED|Dose Finding Period - Reduction||1
10831572|NCT01423851|11996711|FG005|STARTED|Dose Finding Period - Reduction||2
10831573|NCT01423851|11996712|FG006|STARTED|Dose Finding Period - Reduction||8
10831574|NCT01423851|11996713|FG007|STARTED|Dose Finding Period - Reduction||0
10831575|NCT01423851|11996714|FG008|STARTED|Dose Finding Period - Reduction||3
10831576|NCT01423851|11996715|FG009|STARTED|Dose Finding Period - Reduction||0
10831577|NCT01423851|11996716|FG010|STARTED|Dose Finding Period - Reduction||0
10831578|NCT01423851|11996706|FG000|COMPLETED|Dose Finding Period - Reduction||0
10831579|NCT01423851|11996707|FG001|COMPLETED|Dose Finding Period - Reduction||0
10831580|NCT01423851|11996708|FG002|COMPLETED|Dose Finding Period - Reduction||0
10831581|NCT01423851|11996709|FG003|COMPLETED|Dose Finding Period - Reduction||0
10831582|NCT01423851|11996710|FG004|COMPLETED|Dose Finding Period - Reduction||0
10831583|NCT01423851|11996711|FG005|COMPLETED|Dose Finding Period - Reduction||0
10831584|NCT01423851|11996712|FG006|COMPLETED|Dose Finding Period - Reduction||0
10831585|NCT01423851|11996713|FG007|COMPLETED|Dose Finding Period - Reduction||0
10831586|NCT01423851|11996714|FG008|COMPLETED|Dose Finding Period - Reduction||0
10831587|NCT01423851|11996715|FG009|COMPLETED|Dose Finding Period - Reduction||0
10831588|NCT01423851|11996716|FG010|COMPLETED|Dose Finding Period - Reduction||0
10831589|NCT01423851|11996706|FG000|NOT COMPLETED|Dose Finding Period - Reduction||0
10831590|NCT01423851|11996707|FG001|NOT COMPLETED|Dose Finding Period - Reduction||0
10831591|NCT01423851|11996708|FG002|NOT COMPLETED|Dose Finding Period - Reduction||3
10831592|NCT01423851|11996709|FG003|NOT COMPLETED|Dose Finding Period - Reduction||5
10831593|NCT01423851|11996710|FG004|NOT COMPLETED|Dose Finding Period - Reduction||1
10831594|NCT01423851|11996711|FG005|NOT COMPLETED|Dose Finding Period - Reduction||2
10831595|NCT01423851|11996712|FG006|NOT COMPLETED|Dose Finding Period - Reduction||8
10831596|NCT01423851|11996713|FG007|NOT COMPLETED|Dose Finding Period - Reduction||0
10831597|NCT01423851|11996714|FG008|NOT COMPLETED|Dose Finding Period - Reduction||3
10831598|NCT01423851|11996715|FG009|NOT COMPLETED|Dose Finding Period - Reduction||0
10831599|NCT01423851|11996716|FG010|NOT COMPLETED|Dose Finding Period - Reduction||0
10831612|NCT01360593|11996759|FG000|STARTED|Overall Study||35
10831613|NCT01360593|11996759|FG000|COMPLETED|Overall Study||35
10831614|NCT01360593|11996759|FG000|NOT COMPLETED|Overall Study||0
10831615|NCT01354977|11996765|FG000|STARTED|Overall Study||12
10831616|NCT01354977|11996766|FG001|STARTED|Overall Study||8
10831617|NCT01354977|11996765|FG000|COMPLETED|Overall Study||12
10831618|NCT01354977|11996766|FG001|COMPLETED|Overall Study||8
10831619|NCT01354977|11996765|FG000|NOT COMPLETED|Overall Study||0
10831620|NCT01354977|11996766|FG001|NOT COMPLETED|Overall Study||0
10831621|NCT01334606|11996772|FG000|STARTED|Overall Study||21
10831622|NCT01334606|11996772|FG000|COMPLETED|Overall Study||3
10831623|NCT01334606|11996772|FG000|NOT COMPLETED|Overall Study||18
10831624|NCT01317875|11996788|FG000|STARTED|Overall Study||5
10831625|NCT01317875|11996789|FG001|STARTED|Overall Study||3
10831626|NCT01317875|11996790|FG002|STARTED|Overall Study||20
10831627|NCT01317875|11996791|FG003|STARTED|Overall Study||4
10831628|NCT01317875|11996792|FG004|STARTED|Overall Study||12
10831629|NCT01317875|11996793|FG005|STARTED|Overall Study||3
10831630|NCT01317875|11996794|FG006|STARTED|Overall Study||4
10831631|NCT01317875|11996795|FG007|STARTED|Overall Study||18
10831632|NCT01317875|11996796|FG008|STARTED|Overall Study|No participants enrolled in Stratum 2 : Cohort 4|0
10831633|NCT01317875|11996797|FG009|STARTED|Overall Study|No participants enrolled in Stratum 2 : Cohort 5|0
10831634|NCT01317875|11996788|FG000|COMPLETED|Overall Study||2
10831636|NCT01317875|11996790|FG002|COMPLETED|Overall Study||11
10831637|NCT01317875|11996791|FG003|COMPLETED|Overall Study||2
10831638|NCT01317875|11996792|FG004|COMPLETED|Overall Study||3
10831639|NCT01317875|11996793|FG005|COMPLETED|Overall Study||1
10831640|NCT01317875|11996794|FG006|COMPLETED|Overall Study||2
10831641|NCT01317875|11996795|FG007|COMPLETED|Overall Study||3
10831642|NCT01317875|11996796|FG008|COMPLETED|Overall Study||0
10831643|NCT01317875|11996797|FG009|COMPLETED|Overall Study||0
10831644|NCT01317875|11996788|FG000|NOT COMPLETED|Overall Study||3
10831645|NCT01317875|11996789|FG001|NOT COMPLETED|Overall Study||2
10831646|NCT01317875|11996790|FG002|NOT COMPLETED|Overall Study||9
10831647|NCT01317875|11996791|FG003|NOT COMPLETED|Overall Study||2
10831648|NCT01317875|11996792|FG004|NOT COMPLETED|Overall Study||9
10831649|NCT01317875|11996793|FG005|NOT COMPLETED|Overall Study||2
10831650|NCT01317875|11996794|FG006|NOT COMPLETED|Overall Study||2
10831651|NCT01317875|11996795|FG007|NOT COMPLETED|Overall Study||15
10831652|NCT01317875|11996796|FG008|NOT COMPLETED|Overall Study||0
10831653|NCT01317875|11996797|FG009|NOT COMPLETED|Overall Study||0
10831654|NCT01226732|11996833|FG000|STARTED|Overall Study||3
10831655|NCT01226732|11996834|FG001|STARTED|Overall Study||3
10291005|NCT04553497|11423881|FG000|NOT COMPLETED|Overall Study||2
10291006|NCT04553497|11423882|FG001|NOT COMPLETED|Overall Study||1
10313783|NCT00156819|11447402|FG000|NOT COMPLETED|Overall Study||1
10313784|NCT00156819|11447403|FG001|NOT COMPLETED|Overall Study||1
10313785|NCT00156819|11447404|FG002|NOT COMPLETED|Overall Study||3
10313786|NCT00156910|11447414|FG000|STARTED|Double-Blind Phase (DB)||341
10831656|NCT01226732|11996835|FG002|STARTED|Overall Study||3
10831657|NCT01226732|11996836|FG003|STARTED|Overall Study||5
10831658|NCT01226732|11996837|FG004|STARTED|Overall Study||3
10831659|NCT01226732|11996838|FG005|STARTED|Overall Study||6
10831660|NCT01226732|11996833|FG000|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
10831661|NCT01226732|11996834|FG001|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
10831662|NCT01226732|11996835|FG002|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
10831663|NCT01226732|11996836|FG003|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
10831664|NCT01226732|11996837|FG004|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
10831665|NCT01226732|11996838|FG005|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
10831666|NCT01226732|11996833|FG000|NOT COMPLETED|Overall Study||3
10831667|NCT01226732|11996834|FG001|NOT COMPLETED|Overall Study||3
10831668|NCT01226732|11996835|FG002|NOT COMPLETED|Overall Study||3
10831669|NCT01226732|11996836|FG003|NOT COMPLETED|Overall Study||5
10831670|NCT01226732|11996837|FG004|NOT COMPLETED|Overall Study||3
10831671|NCT01226732|11996838|FG005|NOT COMPLETED|Overall Study||6
10831672|NCT01216683|11996862|FG000|STARTED|Induction||65
10831673|NCT01216683|11996863|FG001|STARTED|Induction||99
10831674|NCT01216683|11996864|FG002|STARTED|Induction||125
10831675|NCT01216683|11996862|FG000|Received Treatment and Assessed for Toxicities|Induction||65
10831676|NCT01216683|11996863|FG001|Received Treatment and Assessed for Toxicities|Induction||93
10831677|NCT01216683|11996864|FG002|Received Treatment and Assessed for Toxicities|Induction||122
10831678|NCT01216683|11996862|FG000|Eligible and Treated|Induction||59
10831679|NCT01216683|11996863|FG001|Eligible and Treated|Induction||85
10831680|NCT01216683|11996864|FG002|Eligible and Treated|Induction||114
10831681|NCT01216683|11996862|FG000|Included in the Primary Analysis of Complete Remission Rate During Induction Treatment|Induction||48
10831682|NCT01216683|11996863|FG001|Included in the Primary Analysis of Complete Remission Rate During Induction Treatment|Induction||85
10831683|NCT01216683|11996864|FG002|Included in the Primary Analysis of Complete Remission Rate During Induction Treatment|Induction||89
10831684|NCT01216683|11996862|FG000|COMPLETED|Induction||61
10831685|NCT01216683|11996863|FG001|COMPLETED|Induction||80
10831686|NCT01216683|11996864|FG002|COMPLETED|Induction||104
10831687|NCT01216683|11996862|FG000|NOT COMPLETED|Induction||4
10831688|NCT01216683|11996863|FG001|NOT COMPLETED|Induction||19
10831689|NCT01216683|11996864|FG002|NOT COMPLETED|Induction||21
10831690|NCT01216683|11996862|FG000|STARTED|Continuation||59
10831691|NCT01216683|11996863|FG001|STARTED|Continuation||71
10831692|NCT01216683|11996864|FG002|STARTED|Continuation||94
10831693|NCT01216683|11996862|FG000|Received Continuation Treatment|Continuation||59
10831694|NCT01216683|11996863|FG001|Received Continuation Treatment|Continuation||70
10831695|NCT01216683|11996864|FG002|Received Continuation Treatment|Continuation||89
10831696|NCT01216683|11996862|FG000|COMPLETED|Continuation||44
10831697|NCT01216683|11996863|FG001|COMPLETED|Continuation||56
10831698|NCT01216683|11996864|FG002|COMPLETED|Continuation||51
10831699|NCT01216683|11996862|FG000|NOT COMPLETED|Continuation||15
10831700|NCT01216683|11996863|FG001|NOT COMPLETED|Continuation||15
10831701|NCT01216683|11996864|FG002|NOT COMPLETED|Continuation||43
10831702|NCT01085097|11996888|FG000|STARTED|Overall Study||15
10831703|NCT01085097|11996889|FG001|STARTED|Overall Study||16
10831704|NCT01085097|11996890|FG002|STARTED|Overall Study||15
10831705|NCT01085097|11996888|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
10831706|NCT01085097|11996889|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16
10831707|NCT01085097|11996890|FG002|Received at Least 1 Dose of Study Drug|Overall Study||15
10831708|NCT01085097|11996888|FG000|COMPLETED|Overall Study||13
10313787|NCT00156910|11447415|FG001|STARTED|Double-Blind Phase (DB)||338
10313788|NCT00156910|11447414|FG000|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|296
10313789|NCT00156910|11447415|FG001|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|295
10313790|NCT00156910|11447414|FG000|NOT COMPLETED|Double-Blind Phase (DB)||45
10313791|NCT00156910|11447415|FG001|NOT COMPLETED|Double-Blind Phase (DB)||43
10315644|NCT00181610|11449589|FG002|COMPLETED|Overall Study||3
10831709|NCT01085097|11996889|FG001|COMPLETED|Overall Study||16
10831710|NCT01085097|11996890|FG002|COMPLETED|Overall Study||13
10831711|NCT01085097|11996888|FG000|NOT COMPLETED|Overall Study||2
10831712|NCT01085097|11996889|FG001|NOT COMPLETED|Overall Study||0
10831713|NCT01085097|11996890|FG002|NOT COMPLETED|Overall Study||2
10831714|NCT00920621|11996902|FG000|STARTED|Overall Study||440
10831715|NCT00920621|11996903|FG001|STARTED|Overall Study||436
10831716|NCT00920621|11996904|FG002|STARTED|Overall Study||440
10831717|NCT00920621|11996905|FG003|STARTED|Overall Study||436
10831718|NCT00920621|11996902|FG000|COMPLETED|Overall Study||386
10831719|NCT00920621|11996903|FG001|COMPLETED|Overall Study||391
10831720|NCT00920621|11996904|FG002|COMPLETED|Overall Study||405
10831721|NCT00920621|11996905|FG003|COMPLETED|Overall Study||401
10831722|NCT00920621|11996902|FG000|NOT COMPLETED|Overall Study||54
10831723|NCT00920621|11996903|FG001|NOT COMPLETED|Overall Study||45
10831724|NCT00920621|11996904|FG002|NOT COMPLETED|Overall Study||35
10831725|NCT00920621|11996905|FG003|NOT COMPLETED|Overall Study||35
10831726|NCT00828308|11996916|FG000|STARTED|Overall Study||16
10831727|NCT00828308|11996916|FG000|COMPLETED|Overall Study||16
10831728|NCT00828308|11996916|FG000|NOT COMPLETED|Overall Study||0
10831729|NCT00600015|11996922|FG000|STARTED|Overall Study||111
10831730|NCT00600015|11996923|FG001|STARTED|Overall Study||55
10831731|NCT00600015|11996922|FG000|COMPLETED|Overall Study|Completed >=2 cycles|51
10831732|NCT00600015|11996923|FG001|COMPLETED|Overall Study|Completed >=2 cycles|20
10831733|NCT00600015|11996922|FG000|NOT COMPLETED|Overall Study||60
10831734|NCT00600015|11996923|FG001|NOT COMPLETED|Overall Study||35
10831735|NCT00500071|11996930|FG000|STARTED|Screening and Washout Phase||318
10831736|NCT00500071|11996930|FG000|COMPLETED|Screening and Washout Phase||317
10831737|NCT00500071|11996930|FG000|NOT COMPLETED|Screening and Washout Phase||1
10831738|NCT00500071|11996930|FG000|STARTED|Dose-optimization and Maintenance Phase|Safety population (i.e., received at least one dose of study medication)|317
10831739|NCT00500071|11996930|FG000|COMPLETED|Dose-optimization and Maintenance Phase||295
10831740|NCT00500071|11996930|FG000|NOT COMPLETED|Dose-optimization and Maintenance Phase||22
10831741|NCT00500071|11996930|FG000|STARTED|30-day Safety Follow-up||295
10831742|NCT00500071|11996930|FG000|COMPLETED|30-day Safety Follow-up||278
10831743|NCT00500071|11996930|FG000|NOT COMPLETED|30-day Safety Follow-up||17
10831744|NCT00447122|11996938|FG000|STARTED|Overall Study||3
10831745|NCT00447122|11996939|FG001|STARTED|Overall Study||11
10831746|NCT00447122|11996940|FG002|STARTED|Overall Study||6
10831747|NCT00447122|11996941|FG003|STARTED|Overall Study||5
10831748|NCT00447122|11996938|FG000|COMPLETED|Overall Study||3
10831749|NCT00447122|11996939|FG001|COMPLETED|Overall Study||10
10831750|NCT00447122|11996940|FG002|COMPLETED|Overall Study||6
10831751|NCT00447122|11996941|FG003|COMPLETED|Overall Study||5
10831752|NCT00447122|11996938|FG000|NOT COMPLETED|Overall Study||0
10831753|NCT00447122|11996939|FG001|NOT COMPLETED|Overall Study||1
10831754|NCT00447122|11996940|FG002|NOT COMPLETED|Overall Study||0
10831755|NCT00447122|11996941|FG003|NOT COMPLETED|Overall Study||0
10831756|NCT00382252|11996951|FG000|STARTED|Overall Study||89
10831757|NCT00382252|11996951|FG000|COMPLETED|Overall Study||76
10831758|NCT00382252|11996951|FG000|NOT COMPLETED|Overall Study||13
10831791|NCT00309985|11996983|FG000|STARTED|Overall Study||397
10831792|NCT00309985|11996984|FG001|STARTED|Overall Study||393
10831793|NCT00309985|11996983|FG000|Toxicity Analysis|Overall Study||390
10831794|NCT00309985|11996984|FG001|Toxicity Analysis|Overall Study||392
10831795|NCT00309985|11996983|FG000|Both Baseline and 3-month FACT-P Evals|Overall Study||334
10831796|NCT00309985|11996984|FG001|Both Baseline and 3-month FACT-P Evals|Overall Study||299
10831797|NCT00309985|11996983|FG000|COMPLETED|Overall Study||335
10831798|NCT00309985|11996984|FG001|COMPLETED|Overall Study|"Arm B tx info was not collected so only 1 patient w/o follow-up data was considered not completed."|392
10831799|NCT00309985|11996983|FG000|NOT COMPLETED|Overall Study||62
10831800|NCT00309985|11996984|FG001|NOT COMPLETED|Overall Study||1
10831801|NCT00290251|11996993|FG000|STARTED|Baseline (Month 1)||14
10831802|NCT00290251|11996994|FG001|STARTED|Baseline (Month 1)||14
10831803|NCT00290251|11996995|FG002|STARTED|Baseline (Month 1)||14
10831804|NCT00290251|11996996|FG003|STARTED|Baseline (Month 1)||0
10409162|NCT00758420|11553135|FG001|STARTED|Overall Study||38
10409163|NCT00758420|11553134|FG000|COMPLETED|Overall Study||39
10831805|NCT00290251|11996997|FG004|STARTED|Baseline (Month 1)||0
10831806|NCT00290251|11996998|FG005|STARTED|Baseline (Month 1)||0
10831807|NCT00290251|11996993|FG000|COMPLETED|Baseline (Month 1)||14
10831808|NCT00290251|11996994|FG001|COMPLETED|Baseline (Month 1)||14
10831809|NCT00290251|11996995|FG002|COMPLETED|Baseline (Month 1)||14
10831810|NCT00290251|11996996|FG003|COMPLETED|Baseline (Month 1)||0
10831811|NCT00290251|11996997|FG004|COMPLETED|Baseline (Month 1)||0
10831812|NCT00290251|11996998|FG005|COMPLETED|Baseline (Month 1)||0
10831813|NCT00290251|11996993|FG000|NOT COMPLETED|Baseline (Month 1)||0
10831814|NCT00290251|11996994|FG001|NOT COMPLETED|Baseline (Month 1)||0
10831815|NCT00290251|11996995|FG002|NOT COMPLETED|Baseline (Month 1)||0
10831816|NCT00290251|11996996|FG003|NOT COMPLETED|Baseline (Month 1)||0
10831817|NCT00290251|11996997|FG004|NOT COMPLETED|Baseline (Month 1)||0
10831818|NCT00290251|11996998|FG005|NOT COMPLETED|Baseline (Month 1)||0
10831819|NCT00290251|11996993|FG000|STARTED|Treatment 1 (Months 2-4)|Subjects crossed over from no intervention baseline to treatment assignment|0
10409164|NCT00758420|11553135|FG001|COMPLETED|Overall Study||38
10409165|NCT00758420|11553134|FG000|NOT COMPLETED|Overall Study||0
10409166|NCT00758420|11553135|FG001|NOT COMPLETED|Overall Study||0
10409167|NCT00758459|11553143|FG000|STARTED|Overall Study||35
10291007|NCT04548622|11423891|FG000|STARTED|Overall Study||15
10291008|NCT04548622|11423891|FG000|COMPLETED|Overall Study||15
10291009|NCT04548622|11423891|FG000|NOT COMPLETED|Overall Study||0
10291064|NCT04534764|11423962|FG000|STARTED|Period 1||18
10291065|NCT04534764|11423963|FG001|STARTED|Period 1||17
10291066|NCT04534764|11423962|FG000|COMPLETED|Period 1||18
10291067|NCT04534764|11423963|FG001|COMPLETED|Period 1||17
10291068|NCT04534764|11423962|FG000|NOT COMPLETED|Period 1||0
10291069|NCT04534764|11423963|FG001|NOT COMPLETED|Period 1||0
10291070|NCT04534764|11423962|FG000|STARTED|Period 2||18
10291071|NCT04534764|11423963|FG001|STARTED|Period 2||17
10291072|NCT04534764|11423962|FG000|COMPLETED|Period 2||18
10291073|NCT04534764|11423963|FG001|COMPLETED|Period 2||17
10291074|NCT04534764|11423962|FG000|NOT COMPLETED|Period 2||0
10291075|NCT04534764|11423963|FG001|NOT COMPLETED|Period 2||0
10291076|NCT04534491|11423969|FG000|STARTED|Overall Study||855
10291077|NCT04534491|11423969|FG000|Treated|Overall Study||727
10291078|NCT04534491|11423969|FG000|COMPLETED|Overall Study||703
10291079|NCT04534491|11423969|FG000|NOT COMPLETED|Overall Study||152
10291080|NCT04534465|11423973|FG000|STARTED|Overall Study||10
10291081|NCT04534465|11423974|FG001|STARTED|Overall Study||10
10291082|NCT04534465|11423975|FG002|STARTED|Overall Study||10
10291083|NCT04534465|11423976|FG003|STARTED|Overall Study||10
10291084|NCT04534465|11423977|FG004|STARTED|Overall Study||10
10291085|NCT04534465|11423973|FG000|COMPLETED|Overall Study||10
10291086|NCT04534465|11423974|FG001|COMPLETED|Overall Study||10
10291087|NCT04534465|11423975|FG002|COMPLETED|Overall Study||10
10291088|NCT04534465|11423976|FG003|COMPLETED|Overall Study||10
10291089|NCT04534465|11423977|FG004|COMPLETED|Overall Study||10
10291090|NCT04534465|11423973|FG000|NOT COMPLETED|Overall Study||0
10291091|NCT04534465|11423974|FG001|NOT COMPLETED|Overall Study||0
10291092|NCT04534465|11423975|FG002|NOT COMPLETED|Overall Study||0
10291093|NCT04534465|11423976|FG003|NOT COMPLETED|Overall Study||0
10291094|NCT04534465|11423977|FG004|NOT COMPLETED|Overall Study||0
10313792|NCT00156910|11447414|FG000|STARTED|Open-Label Phase (OL)|Number of DB Botulinum toxin type A patients who rolled into OL phase|285
10313793|NCT00156910|11447415|FG001|STARTED|Open-Label Phase (OL)|Number of DB Placebo patients who rolled into OL Phase|286
10313794|NCT00156910|11447414|FG000|COMPLETED|Open-Label Phase (OL)||252
10313795|NCT00156910|11447415|FG001|COMPLETED|Open-Label Phase (OL)||231
10313796|NCT00156910|11447414|FG000|NOT COMPLETED|Open-Label Phase (OL)||33
10313797|NCT00156910|11447415|FG001|NOT COMPLETED|Open-Label Phase (OL)||55
10313798|NCT00156923|11447423|FG000|STARTED|Overall Study||56
10313799|NCT00156923|11447424|FG001|STARTED|Overall Study||52
10313800|NCT00156923|11447423|FG000|COMPLETED|Overall Study||22
10313801|NCT00156923|11447424|FG001|COMPLETED|Overall Study||20
10313802|NCT00156923|11447423|FG000|NOT COMPLETED|Overall Study||34
10313803|NCT00156923|11447424|FG001|NOT COMPLETED|Overall Study||32
10313804|NCT00156936|11447432|FG000|STARTED|Overall Study||92
10313805|NCT00156936|11447433|FG001|STARTED|Overall Study||16
10313806|NCT00156936|11447432|FG000|COMPLETED|Overall Study||20
10313807|NCT00156936|11447433|FG001|COMPLETED|Overall Study||5
10313808|NCT00156936|11447432|FG000|NOT COMPLETED|Overall Study||72
10313809|NCT00156936|11447433|FG001|NOT COMPLETED|Overall Study||11
10313810|NCT00157014|11447443|FG000|STARTED|Overall Study||52
10313811|NCT00157014|11447444|FG001|STARTED|Overall Study||46
10313812|NCT00157014|11447445|FG002|STARTED|Overall Study||5
10313813|NCT00157014|11447446|FG003|STARTED|Overall Study||6
10313814|NCT00157014|11447443|FG000|COMPLETED|Overall Study||45
10313815|NCT00157014|11447444|FG001|COMPLETED|Overall Study||41
10313816|NCT00157014|11447445|FG002|COMPLETED|Overall Study||4
10313817|NCT00157014|11447446|FG003|COMPLETED|Overall Study||5
10313818|NCT00157014|11447443|FG000|NOT COMPLETED|Overall Study||7
10409168|NCT00758459|11553144|FG001|STARTED|Overall Study||39
10831820|NCT00290251|11996994|FG001|STARTED|Treatment 1 (Months 2-4)|Subjects crossed over from no intervention baseline to treatment assignment|0
10409169|NCT00758459|11553143|FG000|COMPLETED|Overall Study||32
10313819|NCT00157014|11447444|FG001|NOT COMPLETED|Overall Study||5
10313820|NCT00157014|11447445|FG002|NOT COMPLETED|Overall Study||1
10313821|NCT00157014|11447446|FG003|NOT COMPLETED|Overall Study||1
10313822|NCT00157157|11447456|FG000|STARTED|Overall Study||55
10313823|NCT00157157|11447456|FG000|COMPLETED|Overall Study||44
10313824|NCT00157157|11447456|FG000|NOT COMPLETED|Overall Study||11
10313825|NCT00157196|11447467|FG000|STARTED|Overall Study||22
10313826|NCT00157196|11447467|FG000|COMPLETED|Overall Study||13
10313827|NCT00157196|11447467|FG000|NOT COMPLETED|Overall Study||9
10313828|NCT00157209|11447473|FG000|STARTED|Overall Study||88
10313829|NCT00157209|11447474|FG001|STARTED|Overall Study||83
10313830|NCT00157209|11447473|FG000|COMPLETED|Overall Study||78
10313831|NCT00157209|11447474|FG001|COMPLETED|Overall Study||83
10313832|NCT00157209|11447473|FG000|NOT COMPLETED|Overall Study||10
10313833|NCT00157209|11447474|FG001|NOT COMPLETED|Overall Study||0
10831821|NCT00290251|11996995|FG002|STARTED|Treatment 1 (Months 2-4)|Subjects crossed over from no intervention baseline to treatment assignment|0
10831822|NCT00290251|11996996|FG003|STARTED|Treatment 1 (Months 2-4)|Subjects crossed over from no intervention baseline to treatment assignment|14
10831823|NCT00290251|11996997|FG004|STARTED|Treatment 1 (Months 2-4)|Subjects crossed over from no intervention baseline to treatment assignment|14
10831824|NCT00290251|11996998|FG005|STARTED|Treatment 1 (Months 2-4)|Subjects crossed over from no intervention baseline to treatment assignment|14
10831825|NCT00290251|11996993|FG000|COMPLETED|Treatment 1 (Months 2-4)||0
10831826|NCT00290251|11996994|FG001|COMPLETED|Treatment 1 (Months 2-4)||0
10831827|NCT00290251|11996995|FG002|COMPLETED|Treatment 1 (Months 2-4)||0
10831828|NCT00290251|11996996|FG003|COMPLETED|Treatment 1 (Months 2-4)||13
10831829|NCT00290251|11996997|FG004|COMPLETED|Treatment 1 (Months 2-4)||13
10831830|NCT00290251|11996998|FG005|COMPLETED|Treatment 1 (Months 2-4)||12
10831831|NCT00290251|11996993|FG000|NOT COMPLETED|Treatment 1 (Months 2-4)||0
10831832|NCT00290251|11996994|FG001|NOT COMPLETED|Treatment 1 (Months 2-4)||0
10831833|NCT00290251|11996995|FG002|NOT COMPLETED|Treatment 1 (Months 2-4)||0
10831834|NCT00290251|11996996|FG003|NOT COMPLETED|Treatment 1 (Months 2-4)||1
10831835|NCT00290251|11996997|FG004|NOT COMPLETED|Treatment 1 (Months 2-4)||1
10831836|NCT00290251|11996998|FG005|NOT COMPLETED|Treatment 1 (Months 2-4)||2
10831837|NCT00066963|11997014|FG000|STARTED|Overall Study||126
10831838|NCT00066963|11997015|FG001|STARTED|Overall Study||124
10831839|NCT00066963|11997016|FG002|STARTED|Overall Study||126
10831840|NCT00066963|11997014|FG000|COMPLETED|Overall Study|any follow-up|100
10831841|NCT00066963|11997015|FG001|COMPLETED|Overall Study||93
10831842|NCT00066963|11997016|FG002|COMPLETED|Overall Study||87
10831843|NCT00066963|11997014|FG000|NOT COMPLETED|Overall Study||26
10831844|NCT00066963|11997015|FG001|NOT COMPLETED|Overall Study||31
10831845|NCT00066963|11997016|FG002|NOT COMPLETED|Overall Study||39
10291010|NCT04547036|11423895|FG000|STARTED|Overall Study||129
10291011|NCT04547036|11423895|FG000|COMPLETED|Overall Study||129
10291012|NCT04547036|11423895|FG000|NOT COMPLETED|Overall Study||0
10291095|NCT04533204|11423991|FG000|STARTED|Overall Study||29
10291096|NCT04533204|11423992|FG001|STARTED|Overall Study||30
10291097|NCT04533204|11423991|FG000|COMPLETED|Overall Study||28
10291098|NCT04533204|11423992|FG001|COMPLETED|Overall Study||29
10291099|NCT04533204|11423991|FG000|NOT COMPLETED|Overall Study||1
10291100|NCT04533204|11423992|FG001|NOT COMPLETED|Overall Study||1
10291101|NCT04532164|11423998|FG000|STARTED|Overall Study||137
10291102|NCT04532164|11423998|FG000|Treated|Overall Study||132
10291103|NCT04532164|11423998|FG000|COMPLETED|Overall Study||113
10291104|NCT04532164|11423998|FG000|NOT COMPLETED|Overall Study||24
10313834|NCT00157248|11447484|FG000|STARTED|Overall Study|Started: Participant completed previous trial on Dabigatran and took study drug of present trial.|98
10313835|NCT00157248|11447485|FG001|STARTED|Overall Study||89
10313836|NCT00157248|11447486|FG002|STARTED|Overall Study||50
10313837|NCT00157248|11447487|FG003|STARTED|Overall Study||124
10313838|NCT00157248|11447484|FG000|COMPLETED|Overall Study|Completed: Participant without premature discontinuation of study medication.|50
10313839|NCT00157248|11447485|FG001|COMPLETED|Overall Study||52
10313840|NCT00157248|11447486|FG002|COMPLETED|Overall Study||29
10313841|NCT00157248|11447487|FG003|COMPLETED|Overall Study||77
10313842|NCT00157248|11447484|FG000|NOT COMPLETED|Overall Study||48
10313843|NCT00157248|11447485|FG001|NOT COMPLETED|Overall Study||37
10313844|NCT00157248|11447486|FG002|NOT COMPLETED|Overall Study||21
10313845|NCT00157248|11447487|FG003|NOT COMPLETED|Overall Study||47
10313846|NCT00157573|11447501|FG000|STARTED|Overall Study||35
10313847|NCT00157573|11447502|FG001|STARTED|Overall Study||37
10313848|NCT00157573|11447501|FG000|COMPLETED|Overall Study||35
10409170|NCT00758459|11553144|FG001|COMPLETED|Overall Study||35
10313849|NCT00157573|11447502|FG001|COMPLETED|Overall Study||37
10313850|NCT00157573|11447501|FG000|NOT COMPLETED|Overall Study||0
10313851|NCT00157573|11447502|FG001|NOT COMPLETED|Overall Study||0
10313852|NCT00157755|11447509|FG000|STARTED|Overall Study||26
10313853|NCT00157755|11447510|FG001|STARTED|Overall Study||19
10313854|NCT00157755|11447511|FG002|STARTED|Overall Study||10
10313855|NCT00157755|11447512|FG003|STARTED|Overall Study||15
10313856|NCT00157755|11447513|FG004|STARTED|Overall Study||12
10313857|NCT00157755|11447514|FG005|STARTED|Overall Study||5
10313858|NCT00157755|11447509|FG000|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|24
10313859|NCT00157755|11447510|FG001|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|15
10831846|NCT01403948|11997034|FG000|STARTED|Overall Study||1
10831847|NCT01403948|11997035|FG001|STARTED|Overall Study||4
10831848|NCT01403948|11997036|FG002|STARTED|Overall Study||3
10831849|NCT01403948|11997037|FG003|STARTED|Overall Study||4
10831850|NCT01403948|11997038|FG004|STARTED|Overall Study||6
10831851|NCT01403948|11997039|FG005|STARTED|Overall Study||7
10831852|NCT01403948|11997040|FG006|STARTED|Overall Study||6
10831853|NCT01403948|11997041|FG007|STARTED|Overall Study||4
10831854|NCT01403948|11997042|FG008|STARTED|Overall Study||6
10831855|NCT01403948|11997043|FG009|STARTED|Overall Study||7
10831856|NCT01403948|11997034|FG000|COMPLETED|Overall Study||0
10831857|NCT01403948|11997035|FG001|COMPLETED|Overall Study||0
10831858|NCT01403948|11997036|FG002|COMPLETED|Overall Study||0
10831859|NCT01403948|11997037|FG003|COMPLETED|Overall Study||0
10831860|NCT01403948|11997038|FG004|COMPLETED|Overall Study||0
10831861|NCT01403948|11997039|FG005|COMPLETED|Overall Study||0
10831862|NCT01403948|11997040|FG006|COMPLETED|Overall Study||0
10831863|NCT01403948|11997041|FG007|COMPLETED|Overall Study||0
10831864|NCT01403948|11997042|FG008|COMPLETED|Overall Study||0
10831865|NCT01403948|11997043|FG009|COMPLETED|Overall Study||0
10831866|NCT01403948|11997034|FG000|NOT COMPLETED|Overall Study||1
10831867|NCT01403948|11997035|FG001|NOT COMPLETED|Overall Study||4
10831868|NCT01403948|11997036|FG002|NOT COMPLETED|Overall Study||3
10831869|NCT01403948|11997037|FG003|NOT COMPLETED|Overall Study||4
10831870|NCT01403948|11997038|FG004|NOT COMPLETED|Overall Study||6
10831871|NCT01403948|11997039|FG005|NOT COMPLETED|Overall Study||7
10831872|NCT01403948|11997040|FG006|NOT COMPLETED|Overall Study||6
10831873|NCT01403948|11997041|FG007|NOT COMPLETED|Overall Study||4
10831874|NCT01403948|11997042|FG008|NOT COMPLETED|Overall Study||6
10831875|NCT01403948|11997043|FG009|NOT COMPLETED|Overall Study||7
10831882|NCT01425008|11997098|FG000|STARTED|Dose Escalation Phase||4
10831883|NCT01425008|11997099|FG001|STARTED|Dose Escalation Phase||3
10831884|NCT01425008|11997100|FG002|STARTED|Dose Escalation Phase||3
10831885|NCT01425008|11997101|FG003|STARTED|Dose Escalation Phase||3
10831886|NCT01425008|11997102|FG004|STARTED|Dose Escalation Phase||7
10831887|NCT01425008|11997103|FG005|STARTED|Dose Escalation Phase||7
10831888|NCT01425008|11997104|FG006|STARTED|Dose Escalation Phase||3
10831889|NCT01425008|11997105|FG007|STARTED|Dose Escalation Phase||3
10831890|NCT01425008|11997106|FG008|STARTED|Dose Escalation Phase||13
10831891|NCT01425008|11997107|FG009|STARTED|Dose Escalation Phase||4
10831892|NCT01425008|11997108|FG010|STARTED|Dose Escalation Phase||0
10831893|NCT01425008|11997109|FG011|STARTED|Dose Escalation Phase||0
10831894|NCT01425008|11997110|FG012|STARTED|Dose Escalation Phase||0
10831895|NCT01425008|11997111|FG013|STARTED|Dose Escalation Phase||0
10831896|NCT01425008|11997112|FG014|STARTED|Dose Escalation Phase||0
10831897|NCT01425008|11997113|FG015|STARTED|Dose Escalation Phase||0
10831898|NCT01425008|11997114|FG016|STARTED|Dose Escalation Phase||0
10831899|NCT01425008|11997115|FG017|STARTED|Dose Escalation Phase||0
10831900|NCT01425008|11997116|FG018|STARTED|Dose Escalation Phase||0
10831901|NCT01425008|11997098|FG000|COMPLETED|Dose Escalation Phase||0
10831902|NCT01425008|11997099|FG001|COMPLETED|Dose Escalation Phase||0
10831903|NCT01425008|11997100|FG002|COMPLETED|Dose Escalation Phase||0
10831904|NCT01425008|11997101|FG003|COMPLETED|Dose Escalation Phase||0
10831905|NCT01425008|11997102|FG004|COMPLETED|Dose Escalation Phase||0
10291013|NCT04544566|11423905|FG000|STARTED|Overall Study||2
10291014|NCT04544566|11423906|FG001|STARTED|Overall Study||2
10291015|NCT04544566|11423907|FG002|STARTED|Overall Study||2
10291016|NCT04544566|11423908|FG003|STARTED|Overall Study||2
10291017|NCT04544566|11423909|FG004|STARTED|Overall Study||2
10291018|NCT04544566|11423910|FG005|STARTED|Overall Study||2
10291019|NCT04544566|11423905|FG000|COMPLETED|Overall Study||2
10291020|NCT04544566|11423906|FG001|COMPLETED|Overall Study||2
10291021|NCT04544566|11423907|FG002|COMPLETED|Overall Study||2
10291022|NCT04544566|11423908|FG003|COMPLETED|Overall Study||2
10291023|NCT04544566|11423909|FG004|COMPLETED|Overall Study||2
10291024|NCT04544566|11423910|FG005|COMPLETED|Overall Study||2
10291025|NCT04544566|11423905|FG000|NOT COMPLETED|Overall Study||0
10291026|NCT04544566|11423906|FG001|NOT COMPLETED|Overall Study||0
10291027|NCT04544566|11423907|FG002|NOT COMPLETED|Overall Study||0
10291028|NCT04544566|11423908|FG003|NOT COMPLETED|Overall Study||0
10291029|NCT04544566|11423909|FG004|NOT COMPLETED|Overall Study||0
10291030|NCT04544566|11423910|FG005|NOT COMPLETED|Overall Study||0
10291031|NCT04542694|11423926|FG000|STARTED|Overall Study||100
10291032|NCT04542694|11423927|FG001|STARTED|Overall Study||100
10291033|NCT04542694|11423926|FG000|COMPLETED|Overall Study||96
10291034|NCT04542694|11423927|FG001|COMPLETED|Overall Study||100
10291035|NCT04542694|11423926|FG000|NOT COMPLETED|Overall Study||4
10291036|NCT04542694|11423927|FG001|NOT COMPLETED|Overall Study||0
10291105|NCT04531813|11424003|FG000|STARTED|Overall Study||32
10291106|NCT04531813|11424003|FG000|Treated|Overall Study||31
10291107|NCT04531813|11424003|FG000|COMPLETED|Overall Study||30
10291108|NCT04531813|11424003|FG000|NOT COMPLETED|Overall Study||2
10291109|NCT04531527|11424007|FG000|STARTED|Overall Study||32
10831906|NCT01425008|11997103|FG005|COMPLETED|Dose Escalation Phase||0
10831907|NCT01425008|11997104|FG006|COMPLETED|Dose Escalation Phase||0
10831908|NCT01425008|11997105|FG007|COMPLETED|Dose Escalation Phase||0
10831909|NCT01425008|11997106|FG008|COMPLETED|Dose Escalation Phase||0
10831910|NCT01425008|11997107|FG009|COMPLETED|Dose Escalation Phase||0
10831911|NCT01425008|11997108|FG010|COMPLETED|Dose Escalation Phase||0
10831912|NCT01425008|11997109|FG011|COMPLETED|Dose Escalation Phase||0
10831913|NCT01425008|11997110|FG012|COMPLETED|Dose Escalation Phase||0
10291037|NCT04542226|11423933|FG000|STARTED|Overall Study||81
10291038|NCT04542226|11423933|FG000|COMPLETED|Overall Study||81
10291039|NCT04542226|11423933|FG000|NOT COMPLETED|Overall Study||0
10291040|NCT04540627|11423940|FG000|STARTED|Open-label Treatment: PK Sentinel|Participants were not enrolled in this arm in the double-blind period.|6
10291041|NCT04540627|11423941|FG001|STARTED|Open-label Treatment: PK Sentinel|Participants were not enrolled in this arm in the open-label period.|0
10831916|NCT01425008|11997113|FG015|COMPLETED|Dose Escalation Phase||0
10291042|NCT04540627|11423942|FG002|STARTED|Open-label Treatment: PK Sentinel|Participants were not enrolled in this arm in the open-label period.|0
10291043|NCT04540627|11423940|FG000|COMPLETED|Open-label Treatment: PK Sentinel||6
10291044|NCT04540627|11423941|FG001|COMPLETED|Open-label Treatment: PK Sentinel||0
10291045|NCT04540627|11423942|FG002|COMPLETED|Open-label Treatment: PK Sentinel||0
10291046|NCT04540627|11423940|FG000|NOT COMPLETED|Open-label Treatment: PK Sentinel||0
10291047|NCT04540627|11423941|FG001|NOT COMPLETED|Open-label Treatment: PK Sentinel||0
10291048|NCT04540627|11423942|FG002|NOT COMPLETED|Open-label Treatment: PK Sentinel||0
10291049|NCT04540627|11423940|FG000|STARTED|Double-blind Treatment: Viral Challenge|Participants were not enrolled in this arm in the double-blind period.|0
10291050|NCT04540627|11423941|FG001|STARTED|Double-blind Treatment: Viral Challenge|Participants were not enrolled in this arm in the open-label period.|25
10291051|NCT04540627|11423942|FG002|STARTED|Double-blind Treatment: Viral Challenge|Participants were not enrolled in this arm in the open-label period.|25
10291052|NCT04540627|11423940|FG000|COMPLETED|Double-blind Treatment: Viral Challenge||0
10291053|NCT04540627|11423941|FG001|COMPLETED|Double-blind Treatment: Viral Challenge||25
10291054|NCT04540627|11423942|FG002|COMPLETED|Double-blind Treatment: Viral Challenge||25
10291055|NCT04540627|11423940|FG000|NOT COMPLETED|Double-blind Treatment: Viral Challenge||0
10291056|NCT04540627|11423941|FG001|NOT COMPLETED|Double-blind Treatment: Viral Challenge||0
10291057|NCT04540627|11423942|FG002|NOT COMPLETED|Double-blind Treatment: Viral Challenge||0
10291058|NCT04540510|11423955|FG000|STARTED|Overall Study||5
10291059|NCT04540510|11423956|FG001|STARTED|Overall Study||6
10291060|NCT04540510|11423955|FG000|COMPLETED|Overall Study||5
10291061|NCT04540510|11423956|FG001|COMPLETED|Overall Study||6
10291062|NCT04540510|11423955|FG000|NOT COMPLETED|Overall Study||0
10291063|NCT04540510|11423956|FG001|NOT COMPLETED|Overall Study||0
10291110|NCT04531527|11424007|FG000|Treated|Overall Study||29
10291111|NCT04531527|11424007|FG000|COMPLETED|Overall Study||29
10291112|NCT04531527|11424007|FG000|NOT COMPLETED|Overall Study||3
10291113|NCT04531540|11424011|FG000|STARTED|Overall Study||225
10291114|NCT04531540|11424011|FG000|Treated|Overall Study||222
10409171|NCT00758459|11553143|FG000|NOT COMPLETED|Overall Study||3
10409172|NCT00758459|11553144|FG001|NOT COMPLETED|Overall Study||4
10409173|NCT00758485|11553152|FG000|STARTED|Overall Study||70
10409174|NCT00758485|11553153|FG001|STARTED|Overall Study||70
10291115|NCT04531540|11424011|FG000|COMPLETED|Overall Study||216
10291116|NCT04531540|11424011|FG000|NOT COMPLETED|Overall Study||9
10291117|NCT04530591|11424015|FG000|STARTED|Overall Study||97
10291118|NCT04530591|11424015|FG000|COMPLETED|Overall Study||97
10291119|NCT04530591|11424015|FG000|NOT COMPLETED|Overall Study||0
10313860|NCT00157755|11447511|FG002|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|3
10313861|NCT00157755|11447512|FG003|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|11
10313862|NCT00157755|11447513|FG004|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|10
10313863|NCT00157755|11447514|FG005|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|0
10313864|NCT00157755|11447509|FG000|NOT COMPLETED|Overall Study||2
10313865|NCT00157755|11447510|FG001|NOT COMPLETED|Overall Study||4
10313866|NCT00157755|11447511|FG002|NOT COMPLETED|Overall Study||7
10313867|NCT00157755|11447512|FG003|NOT COMPLETED|Overall Study||4
10313868|NCT00157755|11447513|FG004|NOT COMPLETED|Overall Study||2
10313869|NCT00157755|11447514|FG005|NOT COMPLETED|Overall Study||5
10313870|NCT00157820|11447523|FG000|STARTED|Randomized||118
10313871|NCT00157820|11447524|FG001|STARTED|Randomized||116
10313872|NCT00157820|11447525|FG002|STARTED|Randomized||120
10313873|NCT00157820|11447523|FG000|COMPLETED|Randomized||111
10313874|NCT00157820|11447524|FG001|COMPLETED|Randomized||111
10313875|NCT00157820|11447525|FG002|COMPLETED|Randomized||112
10313876|NCT00157820|11447523|FG000|NOT COMPLETED|Randomized||7
10313877|NCT00157820|11447524|FG001|NOT COMPLETED|Randomized||5
10313878|NCT00157820|11447525|FG002|NOT COMPLETED|Randomized||8
10313879|NCT00157820|11447523|FG000|STARTED|1st 8 Month||111
10313880|NCT00157820|11447524|FG001|STARTED|1st 8 Month||111
10313881|NCT00157820|11447525|FG002|STARTED|1st 8 Month||112
10313882|NCT00157820|11447523|FG000|COMPLETED|1st 8 Month||103
10313883|NCT00157820|11447524|FG001|COMPLETED|1st 8 Month||99
10313884|NCT00157820|11447525|FG002|COMPLETED|1st 8 Month||106
10313885|NCT00157820|11447523|FG000|NOT COMPLETED|1st 8 Month||8
10313886|NCT00157820|11447524|FG001|NOT COMPLETED|1st 8 Month||12
10313887|NCT00157820|11447525|FG002|NOT COMPLETED|1st 8 Month||6
10313888|NCT00157820|11447523|FG000|STARTED|1 Month Wash Out Period||103
10313889|NCT00157820|11447524|FG001|STARTED|1 Month Wash Out Period|2 patients had crossed over prematurely in SC sim period, that are now carried to DC true period|101
10313890|NCT00157820|11447525|FG002|STARTED|1 Month Wash Out Period|2 patients had crossed over prematurely in DC true period, that are now carried to SC sim period|108
10313891|NCT00157820|11447523|FG000|COMPLETED|1 Month Wash Out Period||103
10313892|NCT00157820|11447524|FG001|COMPLETED|1 Month Wash Out Period||101
10313893|NCT00157820|11447525|FG002|COMPLETED|1 Month Wash Out Period||108
10313894|NCT00157820|11447523|FG000|NOT COMPLETED|1 Month Wash Out Period||0
10313895|NCT00157820|11447524|FG001|NOT COMPLETED|1 Month Wash Out Period||0
10313896|NCT00157820|11447525|FG002|NOT COMPLETED|1 Month Wash Out Period||0
10409175|NCT00758485|11553152|FG000|TREATED|Overall Study||69
10831876|NCT01404312|11997071|FG000|STARTED|Overall Study||1496
10831877|NCT01404312|11997072|FG001|STARTED|Overall Study||1504
10831878|NCT01404312|11997071|FG000|COMPLETED|Overall Study||1198
10831879|NCT01404312|11997072|FG001|COMPLETED|Overall Study||1193
10831880|NCT01404312|11997071|FG000|NOT COMPLETED|Overall Study||298
10831881|NCT01404312|11997072|FG001|NOT COMPLETED|Overall Study||311
10831914|NCT01425008|11997111|FG013|COMPLETED|Dose Escalation Phase||0
10831915|NCT01425008|11997112|FG014|COMPLETED|Dose Escalation Phase||0
10831917|NCT01425008|11997114|FG016|COMPLETED|Dose Escalation Phase||0
10831918|NCT01425008|11997115|FG017|COMPLETED|Dose Escalation Phase||0
10831919|NCT01425008|11997116|FG018|COMPLETED|Dose Escalation Phase||0
10831920|NCT01425008|11997098|FG000|NOT COMPLETED|Dose Escalation Phase||4
10831921|NCT01425008|11997099|FG001|NOT COMPLETED|Dose Escalation Phase||3
10831922|NCT01425008|11997100|FG002|NOT COMPLETED|Dose Escalation Phase||3
10831923|NCT01425008|11997101|FG003|NOT COMPLETED|Dose Escalation Phase||3
10831924|NCT01425008|11997102|FG004|NOT COMPLETED|Dose Escalation Phase||7
10831925|NCT01425008|11997103|FG005|NOT COMPLETED|Dose Escalation Phase||7
10831926|NCT01425008|11997104|FG006|NOT COMPLETED|Dose Escalation Phase||3
10831927|NCT01425008|11997105|FG007|NOT COMPLETED|Dose Escalation Phase||3
10831928|NCT01425008|11997106|FG008|NOT COMPLETED|Dose Escalation Phase||13
10831929|NCT01425008|11997107|FG009|NOT COMPLETED|Dose Escalation Phase||4
10831930|NCT01425008|11997108|FG010|NOT COMPLETED|Dose Escalation Phase||0
10831931|NCT01425008|11997109|FG011|NOT COMPLETED|Dose Escalation Phase||0
10831932|NCT01425008|11997110|FG012|NOT COMPLETED|Dose Escalation Phase||0
10831933|NCT01425008|11997111|FG013|NOT COMPLETED|Dose Escalation Phase||0
10831934|NCT01425008|11997112|FG014|NOT COMPLETED|Dose Escalation Phase||0
10831935|NCT01425008|11997113|FG015|NOT COMPLETED|Dose Escalation Phase||0
10831936|NCT01425008|11997114|FG016|NOT COMPLETED|Dose Escalation Phase||0
10831937|NCT01425008|11997115|FG017|NOT COMPLETED|Dose Escalation Phase||0
10831938|NCT01425008|11997116|FG018|NOT COMPLETED|Dose Escalation Phase||0
10831939|NCT01425008|11997098|FG000|STARTED|Dose Expansion Phase||0
10831940|NCT01425008|11997099|FG001|STARTED|Dose Expansion Phase||0
10831941|NCT01425008|11997100|FG002|STARTED|Dose Expansion Phase||0
10831942|NCT01425008|11997101|FG003|STARTED|Dose Expansion Phase||0
10831943|NCT01425008|11997102|FG004|STARTED|Dose Expansion Phase||0
10831944|NCT01425008|11997103|FG005|STARTED|Dose Expansion Phase||0
10831945|NCT01425008|11997104|FG006|STARTED|Dose Expansion Phase||0
10831946|NCT01425008|11997105|FG007|STARTED|Dose Expansion Phase||0
10831947|NCT01425008|11997106|FG008|STARTED|Dose Expansion Phase||0
10831948|NCT01425008|11997107|FG009|STARTED|Dose Expansion Phase||0
10831949|NCT01425008|11997108|FG010|STARTED|Dose Expansion Phase||16
10831950|NCT01425008|11997109|FG011|STARTED|Dose Expansion Phase||8
10831951|NCT01425008|11997110|FG012|STARTED|Dose Expansion Phase||16
10831952|NCT01425008|11997111|FG013|STARTED|Dose Expansion Phase||1
10831953|NCT01425008|11997112|FG014|STARTED|Dose Expansion Phase||6
10831954|NCT01425008|11997113|FG015|STARTED|Dose Expansion Phase||11
10831955|NCT01425008|11997114|FG016|STARTED|Dose Expansion Phase||20
10831956|NCT01425008|11997115|FG017|STARTED|Dose Expansion Phase||2
10831957|NCT01425008|11997116|FG018|STARTED|Dose Expansion Phase||19
10831958|NCT01425008|11997098|FG000|COMPLETED|Dose Expansion Phase||0
10831959|NCT01425008|11997099|FG001|COMPLETED|Dose Expansion Phase||0
10831960|NCT01425008|11997100|FG002|COMPLETED|Dose Expansion Phase||0
10831961|NCT01425008|11997101|FG003|COMPLETED|Dose Expansion Phase||0
10831962|NCT01425008|11997102|FG004|COMPLETED|Dose Expansion Phase||0
10831963|NCT01425008|11997103|FG005|COMPLETED|Dose Expansion Phase||0
10831964|NCT01425008|11997104|FG006|COMPLETED|Dose Expansion Phase||0
10831965|NCT01425008|11997105|FG007|COMPLETED|Dose Expansion Phase||0
10831966|NCT01425008|11997106|FG008|COMPLETED|Dose Expansion Phase||0
10831967|NCT01425008|11997107|FG009|COMPLETED|Dose Expansion Phase||0
10831968|NCT01425008|11997108|FG010|COMPLETED|Dose Expansion Phase||1
10831969|NCT01425008|11997109|FG011|COMPLETED|Dose Expansion Phase||0
10831970|NCT01425008|11997110|FG012|COMPLETED|Dose Expansion Phase||0
10831971|NCT01425008|11997111|FG013|COMPLETED|Dose Expansion Phase||0
10831972|NCT01425008|11997112|FG014|COMPLETED|Dose Expansion Phase||0
10831973|NCT01425008|11997113|FG015|COMPLETED|Dose Expansion Phase||0
10831974|NCT01425008|11997114|FG016|COMPLETED|Dose Expansion Phase||0
10831975|NCT01425008|11997115|FG017|COMPLETED|Dose Expansion Phase||0
10831976|NCT01425008|11997116|FG018|COMPLETED|Dose Expansion Phase||0
10831977|NCT01425008|11997098|FG000|NOT COMPLETED|Dose Expansion Phase||0
10831978|NCT01425008|11997099|FG001|NOT COMPLETED|Dose Expansion Phase||0
10831979|NCT01425008|11997100|FG002|NOT COMPLETED|Dose Expansion Phase||0
10831980|NCT01425008|11997101|FG003|NOT COMPLETED|Dose Expansion Phase||0
10831981|NCT01425008|11997102|FG004|NOT COMPLETED|Dose Expansion Phase||0
10831982|NCT01425008|11997103|FG005|NOT COMPLETED|Dose Expansion Phase||0
10831983|NCT01425008|11997104|FG006|NOT COMPLETED|Dose Expansion Phase||0
10831984|NCT01425008|11997105|FG007|NOT COMPLETED|Dose Expansion Phase||0
10831985|NCT01425008|11997106|FG008|NOT COMPLETED|Dose Expansion Phase||0
10831986|NCT01425008|11997107|FG009|NOT COMPLETED|Dose Expansion Phase||0
10831987|NCT01425008|11997108|FG010|NOT COMPLETED|Dose Expansion Phase||15
10831988|NCT01425008|11997109|FG011|NOT COMPLETED|Dose Expansion Phase||8
10831989|NCT01425008|11997110|FG012|NOT COMPLETED|Dose Expansion Phase||16
10831990|NCT01425008|11997111|FG013|NOT COMPLETED|Dose Expansion Phase||1
10831991|NCT01425008|11997112|FG014|NOT COMPLETED|Dose Expansion Phase||6
10831992|NCT01425008|11997113|FG015|NOT COMPLETED|Dose Expansion Phase||11
10831993|NCT01425008|11997114|FG016|NOT COMPLETED|Dose Expansion Phase||20
10831994|NCT01425008|11997115|FG017|NOT COMPLETED|Dose Expansion Phase||2
10831995|NCT01425008|11997116|FG018|NOT COMPLETED|Dose Expansion Phase||19
10291120|NCT04615832|11424019|FG000|STARTED|Overall Study||44
10291121|NCT04615832|11424019|FG000|COMPLETED|Overall Study||44
10291122|NCT04615832|11424019|FG000|NOT COMPLETED|Overall Study||0
10291123|NCT04093258|11424023|FG000|STARTED|Period 1||21
10291124|NCT04093258|11424024|FG001|STARTED|Period 1||20
10291125|NCT04093258|11424023|FG000|COMPLETED|Period 1||21
10831996|NCT04425902|11997169|FG000|STARTED|Treatment Period 1 (Days 1 to 10)||20
10831997|NCT04425902|11997169|FG000|COMPLETED|Treatment Period 1 (Days 1 to 10)||20
10831998|NCT04425902|11997169|FG000|NOT COMPLETED|Treatment Period 1 (Days 1 to 10)||0
10831999|NCT04425902|11997169|FG000|STARTED|Treatment Period 2 (Days 11 to 20)||20
10832000|NCT04425902|11997169|FG000|COMPLETED|Treatment Period 2 (Days 11 to 20)||19
10832001|NCT04425902|11997169|FG000|NOT COMPLETED|Treatment Period 2 (Days 11 to 20)||1
10832002|NCT04425902|11997169|FG000|STARTED|Treatment Period 3 (Days 21 to 26)||19
10832003|NCT04425902|11997169|FG000|COMPLETED|Treatment Period 3 (Days 21 to 26)||19
10832004|NCT04425902|11997169|FG000|NOT COMPLETED|Treatment Period 3 (Days 21 to 26)||0
10832005|NCT04072146|11997182|FG000|STARTED|Overall Study||11
10832006|NCT04072146|11997183|FG001|STARTED|Overall Study||11
10832007|NCT04072146|11997182|FG000|COMPLETED|Overall Study||11
10832008|NCT04072146|11997183|FG001|COMPLETED|Overall Study||10
10832009|NCT04072146|11997182|FG000|NOT COMPLETED|Overall Study||0
10832010|NCT04072146|11997183|FG001|NOT COMPLETED|Overall Study||1
10832011|NCT03861481|11997197|FG000|STARTED|Overall Study||17
10832012|NCT03861481|11997198|FG001|STARTED|Overall Study||17
10832013|NCT03861481|11997197|FG000|COMPLETED|Overall Study||11
10832014|NCT03861481|11997198|FG001|COMPLETED|Overall Study||10
10832015|NCT03861481|11997197|FG000|NOT COMPLETED|Overall Study||6
10832016|NCT03861481|11997198|FG001|NOT COMPLETED|Overall Study||7
10832017|NCT03708198|11997204|FG000|STARTED|Overall Study||15
10832018|NCT03708198|11997204|FG000|COMPLETED|Overall Study||15
10832019|NCT03708198|11997204|FG000|NOT COMPLETED|Overall Study||0
10832026|NCT03648476|11997214|FG000|STARTED|Overall Study||10
10832027|NCT03648476|11997215|FG001|STARTED|Overall Study||14
10832028|NCT03648476|11997214|FG000|COMPLETED|Overall Study||8
10832029|NCT03648476|11997215|FG001|COMPLETED|Overall Study||13
10832030|NCT03648476|11997214|FG000|NOT COMPLETED|Overall Study||2
10832031|NCT03648476|11997215|FG001|NOT COMPLETED|Overall Study||1
10832032|NCT03375203|11997227|FG000|STARTED|Overall Study||75
10832033|NCT03375203|11997228|FG001|STARTED|Overall Study||72
10832034|NCT03375203|11997229|FG002|STARTED|Overall Study||74
10832035|NCT03375203|11997230|FG003|STARTED|Overall Study||71
10832036|NCT03375203|11997231|FG004|STARTED|Overall Study||73
10832037|NCT03375203|11997227|FG000|COMPLETED|Overall Study||69
10832038|NCT03375203|11997228|FG001|COMPLETED|Overall Study||68
10832039|NCT03375203|11997229|FG002|COMPLETED|Overall Study||72
10832040|NCT03375203|11997230|FG003|COMPLETED|Overall Study||69
10832041|NCT03375203|11997231|FG004|COMPLETED|Overall Study||69
10832042|NCT03375203|11997227|FG000|NOT COMPLETED|Overall Study||6
10832043|NCT03375203|11997228|FG001|NOT COMPLETED|Overall Study||4
10832044|NCT03375203|11997229|FG002|NOT COMPLETED|Overall Study||2
10832045|NCT03375203|11997230|FG003|NOT COMPLETED|Overall Study||2
10832046|NCT03375203|11997231|FG004|NOT COMPLETED|Overall Study||4
10832047|NCT02926833|11997248|FG000|STARTED|Overall Study||3
10832048|NCT02926833|11997249|FG001|STARTED|Overall Study||4
10832049|NCT02926833|11997250|FG002|STARTED|Overall Study||7
10832050|NCT02926833|11997251|FG003|STARTED|Overall Study||23
10832051|NCT02926833|11997248|FG000|COMPLETED|Overall Study||0
10832052|NCT02926833|11997249|FG001|COMPLETED|Overall Study||0
10832053|NCT02926833|11997250|FG002|COMPLETED|Overall Study||0
10832054|NCT02926833|11997251|FG003|COMPLETED|Overall Study||0
10832055|NCT02926833|11997248|FG000|NOT COMPLETED|Overall Study||3
10832056|NCT02926833|11997249|FG001|NOT COMPLETED|Overall Study||4
10832057|NCT02926833|11997250|FG002|NOT COMPLETED|Overall Study||7
10832058|NCT02926833|11997251|FG003|NOT COMPLETED|Overall Study||23
10832071|NCT02547662|11997271|FG000|STARTED|Overall Study||17
10832072|NCT02547662|11997271|FG000|COMPLETED|Overall Study||17
10832073|NCT02547662|11997271|FG000|NOT COMPLETED|Overall Study||0
10832074|NCT02348216|11997282|FG000|STARTED|Overall Study||8
10832075|NCT02348216|11997283|FG001|STARTED|Overall Study||81
10832076|NCT02348216|11997284|FG002|STARTED|Overall Study||30
10832077|NCT02348216|11997285|FG003|STARTED|Overall Study||42
10832078|NCT02348216|11997286|FG004|STARTED|Overall Study||46
10832079|NCT02348216|11997287|FG005|STARTED|Overall Study||58
10832080|NCT02348216|11997288|FG006|STARTED|Overall Study||42
10832081|NCT02348216|11997282|FG000|COMPLETED|Overall Study||0
10832082|NCT02348216|11997283|FG001|COMPLETED|Overall Study||0
10832083|NCT02348216|11997284|FG002|COMPLETED|Overall Study||0
10832084|NCT02348216|11997285|FG003|COMPLETED|Overall Study||0
10832085|NCT02348216|11997286|FG004|COMPLETED|Overall Study||0
10832086|NCT02348216|11997287|FG005|COMPLETED|Overall Study||0
10832087|NCT02348216|11997288|FG006|COMPLETED|Overall Study||0
10832088|NCT02348216|11997282|FG000|NOT COMPLETED|Overall Study||8
10832089|NCT02348216|11997283|FG001|NOT COMPLETED|Overall Study||81
10832090|NCT02348216|11997284|FG002|NOT COMPLETED|Overall Study||30
10832091|NCT02348216|11997285|FG003|NOT COMPLETED|Overall Study||42
10832092|NCT02348216|11997286|FG004|NOT COMPLETED|Overall Study||46
10832093|NCT02348216|11997287|FG005|NOT COMPLETED|Overall Study||58
10832094|NCT02348216|11997288|FG006|NOT COMPLETED|Overall Study||42
10832095|NCT02275559|11997328|FG000|STARTED|Overall Study||115
10832096|NCT02275559|11997329|FG001|STARTED|Overall Study||118
10832097|NCT02275559|11997328|FG000|COMPLETED|Overall Study||115
10832098|NCT02275559|11997329|FG001|COMPLETED|Overall Study||118
10832099|NCT02275559|11997328|FG000|NOT COMPLETED|Overall Study||0
10832100|NCT02275559|11997329|FG001|NOT COMPLETED|Overall Study||0
10754245|NCT03050619|11917967|FG003|STARTED|Overall Study||14007
10754246|NCT03050619|11917968|FG004|STARTED|Overall Study||6079
10754247|NCT03050619|11917969|FG005|STARTED|Overall Study||1351
10754248|NCT03050619|11917964|FG000|COMPLETED|Overall Study||129
10754249|NCT03050619|11917965|FG001|COMPLETED|Overall Study||3926
10754250|NCT03050619|11917966|FG002|COMPLETED|Overall Study||6416
10754251|NCT03050619|11917967|FG003|COMPLETED|Overall Study||14007
10754252|NCT03050619|11917968|FG004|COMPLETED|Overall Study||6079
10754253|NCT03050619|11917969|FG005|COMPLETED|Overall Study||1351
10754254|NCT03050619|11917964|FG000|NOT COMPLETED|Overall Study||0
10754255|NCT03050619|11917965|FG001|NOT COMPLETED|Overall Study||0
10754256|NCT03050619|11917966|FG002|NOT COMPLETED|Overall Study||0
10754257|NCT03050619|11917967|FG003|NOT COMPLETED|Overall Study||0
10754258|NCT03050619|11917968|FG004|NOT COMPLETED|Overall Study||0
10754259|NCT03050619|11917969|FG005|NOT COMPLETED|Overall Study||0
10754260|NCT03050697|11917983|FG000|STARTED|Overall Study||12
10754261|NCT03050697|11917983|FG000|COMPLETED|Overall Study||12
10754262|NCT03050697|11917983|FG000|NOT COMPLETED|Overall Study||0
10754263|NCT03050775|11918001|FG000|STARTED|Overall Study||35
10291126|NCT04093258|11424024|FG001|COMPLETED|Period 1||20
10291127|NCT04093258|11424023|FG000|NOT COMPLETED|Period 1||0
10291128|NCT04093258|11424024|FG001|NOT COMPLETED|Period 1||0
10291129|NCT04093258|11424023|FG000|STARTED|Period 2||21
10291130|NCT04093258|11424024|FG001|STARTED|Period 2||20
10291131|NCT04093258|11424023|FG000|COMPLETED|Period 2||20
10291132|NCT04093258|11424024|FG001|COMPLETED|Period 2||20
10291133|NCT04093258|11424023|FG000|NOT COMPLETED|Period 2||1
10291134|NCT04093258|11424024|FG001|NOT COMPLETED|Period 2||0
10291135|NCT04011826|11424030|FG000|STARTED|Overall Study||45
10291136|NCT04011826|11424030|FG000|COMPLETED|Overall Study||45
10291137|NCT04011826|11424030|FG000|NOT COMPLETED|Overall Study||0
10291138|NCT03993379|11424038|FG000|STARTED|Overall Study||0
10291139|NCT03993379|11424039|FG001|STARTED|Overall Study||3
10291140|NCT03993379|11424040|FG002|STARTED|Overall Study||0
10291141|NCT03993379|11424041|FG003|STARTED|Overall Study||0
10291142|NCT03993379|11424038|FG000|COMPLETED|Overall Study|No subjects enrolled in this arm/group.|0
10291143|NCT03993379|11424039|FG001|COMPLETED|Overall Study|Subjects did not complete due to early termination of the study due to business reasons.|0
10291144|NCT03993379|11424040|FG002|COMPLETED|Overall Study|No subjects enrolled in this arm/group.|0
10291145|NCT03993379|11424041|FG003|COMPLETED|Overall Study|No subjects enrolled in this arm/group.|0
10291146|NCT03993379|11424038|FG000|NOT COMPLETED|Overall Study||0
10291147|NCT03993379|11424039|FG001|NOT COMPLETED|Overall Study||3
10291148|NCT03993379|11424040|FG002|NOT COMPLETED|Overall Study||0
10409176|NCT00758485|11553153|FG001|TREATED|Overall Study||68
10409177|NCT00758485|11553152|FG000|COMPLETED|Overall Study||69
10409178|NCT00758485|11553153|FG001|COMPLETED|Overall Study||67
10409179|NCT00758485|11553152|FG000|NOT COMPLETED|Overall Study||1
10409180|NCT00758485|11553153|FG001|NOT COMPLETED|Overall Study||3
10409181|NCT00758498|11553163|FG000|STARTED|Overall Study||142
10409182|NCT00758498|11553164|FG001|STARTED|Overall Study||143
10409183|NCT00758498|11553165|FG002|STARTED|Overall Study||142
10409184|NCT00758498|11553163|FG000|COMPLETED|Overall Study||139
10409185|NCT00758498|11553164|FG001|COMPLETED|Overall Study||141
10409186|NCT00758498|11553165|FG002|COMPLETED|Overall Study||137
10409187|NCT00758498|11553163|FG000|NOT COMPLETED|Overall Study||3
10409188|NCT00758498|11553164|FG001|NOT COMPLETED|Overall Study||2
10409189|NCT00758498|11553165|FG002|NOT COMPLETED|Overall Study||5
10754264|NCT03050775|11918002|FG001|STARTED|Overall Study||35
10754265|NCT03050775|11918001|FG000|COMPLETED|Overall Study||35
10754266|NCT03050775|11918002|FG001|COMPLETED|Overall Study||35
10754267|NCT03050775|11918001|FG000|NOT COMPLETED|Overall Study||0
10291149|NCT03993379|11424041|FG003|NOT COMPLETED|Overall Study||0
10291150|NCT03956615|11424051|FG000|STARTED|Overall Study||10
10291151|NCT03956615|11424051|FG000|COMPLETED|Overall Study||3
10291152|NCT03956615|11424051|FG000|NOT COMPLETED|Overall Study||7
10291153|NCT03803059|11424055|FG000|STARTED|Overall Study||35
10291154|NCT03803059|11424055|FG000|COMPLETED|Overall Study||32
10291155|NCT03803059|11424055|FG000|NOT COMPLETED|Overall Study||3
10409190|NCT00758524|11553179|FG000|STARTED|Core Period (Week 0 to Week 8)||92
10832173|NCT01231906|11997356|FG000|STARTED|Overall Study||319
10832174|NCT01231906|11997357|FG001|STARTED|Overall Study||323
10832175|NCT01231906|11997356|FG000|Received Therapy|Overall Study||308
10832176|NCT01231906|11997357|FG001|Received Therapy|Overall Study||318
10832177|NCT01231906|11997356|FG000|COMPLETED|Overall Study||198
10832178|NCT01231906|11997357|FG001|COMPLETED|Overall Study||222
10832179|NCT01231906|11997356|FG000|NOT COMPLETED|Overall Study||121
10832180|NCT01231906|11997357|FG001|NOT COMPLETED|Overall Study||101
10291156|NCT03723590|11424060|FG000|STARTED|Overall Study||5
10291157|NCT03723590|11424060|FG000|COMPLETED|Overall Study||2
10291158|NCT03723590|11424060|FG000|NOT COMPLETED|Overall Study||3
10291159|NCT03720392|11424066|FG000|STARTED|Overall Study||3
10291160|NCT03720392|11424067|FG001|STARTED|Overall Study||3
10291161|NCT03720392|11424066|FG000|COMPLETED|Overall Study||3
10832181|NCT01470326|11997363|FG000|STARTED|Overall Study||3187
10832182|NCT01470326|11997363|FG000|COMPLETED|Overall Study||3034
10832183|NCT01470326|11997363|FG000|NOT COMPLETED|Overall Study||153
10832184|NCT01480180|11997369|FG000|STARTED|Main Phase||174
10832185|NCT01480180|11997370|FG001|STARTED|Main Phase||12
10832186|NCT01480180|11997371|FG002|STARTED|Main Phase|Not applicable for this phase|0
10832187|NCT01480180|11997372|FG003|STARTED|Main Phase|Not applicable for this phase|0
10832188|NCT01480180|11997373|FG004|STARTED|Main Phase|Not applicable for this phase|0
10832189|NCT01480180|11997374|FG005|STARTED|Main Phase|Not applicable for this phase|0
10832190|NCT01480180|11997369|FG000|Max. Participants After Switching|Main Phase||175
10832191|NCT01480180|11997370|FG001|Max. Participants After Switching|Main Phase||11
10832192|NCT01480180|11997371|FG002|Max. Participants After Switching|Main Phase||0
10832193|NCT01480180|11997372|FG003|Max. Participants After Switching|Main Phase||0
10832194|NCT01480180|11997373|FG004|Max. Participants After Switching|Main Phase||0
10832195|NCT01480180|11997374|FG005|Max. Participants After Switching|Main Phase||0
10832196|NCT01480180|11997369|FG000|COMPLETED|Main Phase||155
10832197|NCT01480180|11997370|FG001|COMPLETED|Main Phase||11
10832198|NCT01480180|11997371|FG002|COMPLETED|Main Phase|Not applicable for this phase|0
10832199|NCT01480180|11997372|FG003|COMPLETED|Main Phase|Not applicable for this phase|0
10832200|NCT01480180|11997373|FG004|COMPLETED|Main Phase|Not applicable for this phase|0
10832201|NCT01480180|11997374|FG005|COMPLETED|Main Phase|Not applicable for this phase|0
10832202|NCT01480180|11997369|FG000|NOT COMPLETED|Main Phase||19
10832203|NCT01480180|11997370|FG001|NOT COMPLETED|Main Phase||1
10832204|NCT01480180|11997371|FG002|NOT COMPLETED|Main Phase||0
10832205|NCT01480180|11997372|FG003|NOT COMPLETED|Main Phase||0
10832206|NCT01480180|11997373|FG004|NOT COMPLETED|Main Phase||0
10832207|NCT01480180|11997374|FG005|NOT COMPLETED|Main Phase||0
10832208|NCT01480180|11997369|FG000|STARTED|Extension Phase, Part 1||0
10832209|NCT01480180|11997370|FG001|STARTED|Extension Phase, Part 1||0
10832210|NCT01480180|11997371|FG002|STARTED|Extension Phase, Part 1||105
10832211|NCT01480180|11997372|FG003|STARTED|Extension Phase, Part 1||38
10832212|NCT01480180|11997373|FG004|STARTED|Extension Phase, Part 1||7
10832213|NCT01480180|11997374|FG005|STARTED|Extension Phase, Part 1||0
10832214|NCT01480180|11997369|FG000|COMPLETED|Extension Phase, Part 1||0
10832215|NCT01480180|11997370|FG001|COMPLETED|Extension Phase, Part 1||0
10832216|NCT01480180|11997371|FG002|COMPLETED|Extension Phase, Part 1||95
10832217|NCT01480180|11997372|FG003|COMPLETED|Extension Phase, Part 1||28
10832218|NCT01480180|11997373|FG004|COMPLETED|Extension Phase, Part 1||7
10832219|NCT01480180|11997374|FG005|COMPLETED|Extension Phase, Part 1||0
10832220|NCT01480180|11997369|FG000|NOT COMPLETED|Extension Phase, Part 1||0
10832221|NCT01480180|11997370|FG001|NOT COMPLETED|Extension Phase, Part 1||0
10832222|NCT01480180|11997371|FG002|NOT COMPLETED|Extension Phase, Part 1||10
10832223|NCT01480180|11997372|FG003|NOT COMPLETED|Extension Phase, Part 1||10
10832224|NCT01480180|11997373|FG004|NOT COMPLETED|Extension Phase, Part 1||0
10832225|NCT01480180|11997374|FG005|NOT COMPLETED|Extension Phase, Part 1||0
10832226|NCT01480180|11997369|FG000|STARTED|Extension Phase, Part 2||0
10832227|NCT01480180|11997370|FG001|STARTED|Extension Phase, Part 2||0
10832228|NCT01480180|11997371|FG002|STARTED|Extension Phase, Part 2||94
10832229|NCT01480180|11997372|FG003|STARTED|Extension Phase, Part 2||40
10832230|NCT01480180|11997373|FG004|STARTED|Extension Phase, Part 2||5
10832231|NCT01480180|11997374|FG005|STARTED|Extension Phase, Part 2||0
10832232|NCT01480180|11997369|FG000|COMPLETED|Extension Phase, Part 2||0
10832233|NCT01480180|11997370|FG001|COMPLETED|Extension Phase, Part 2||0
10832234|NCT01480180|11997371|FG002|COMPLETED|Extension Phase, Part 2||77
10832235|NCT01480180|11997372|FG003|COMPLETED|Extension Phase, Part 2||33
10832236|NCT01480180|11997373|FG004|COMPLETED|Extension Phase, Part 2||3
10832237|NCT01480180|11997374|FG005|COMPLETED|Extension Phase, Part 2||0
10832238|NCT01480180|11997369|FG000|NOT COMPLETED|Extension Phase, Part 2||0
10832239|NCT01480180|11997370|FG001|NOT COMPLETED|Extension Phase, Part 2||0
10832240|NCT01480180|11997371|FG002|NOT COMPLETED|Extension Phase, Part 2||17
10832241|NCT01480180|11997372|FG003|NOT COMPLETED|Extension Phase, Part 2||7
10832242|NCT01480180|11997373|FG004|NOT COMPLETED|Extension Phase, Part 2||2
10832243|NCT01480180|11997374|FG005|NOT COMPLETED|Extension Phase, Part 2||0
10832244|NCT01504438|11997397|FG000|STARTED|Overall Study||48
10832245|NCT01504438|11997398|FG001|STARTED|Overall Study||50
10832246|NCT01504438|11997397|FG000|COMPLETED|Overall Study||22
10832247|NCT01504438|11997398|FG001|COMPLETED|Overall Study||25
10832248|NCT01504438|11997397|FG000|NOT COMPLETED|Overall Study||26
10832249|NCT01504438|11997398|FG001|NOT COMPLETED|Overall Study||25
10832250|NCT01545050|11997410|FG000|STARTED|Overall Study||18
10832251|NCT01545050|11997411|FG001|STARTED|Overall Study||9
10832252|NCT01545050|11997412|FG002|STARTED|Overall Study||9
10832253|NCT01545050|11997413|FG003|STARTED|Overall Study||18
10832254|NCT01545050|11997414|FG004|STARTED|Overall Study||18
10832255|NCT01545050|11997410|FG000|COMPLETED|Overall Study||11
10832256|NCT01545050|11997411|FG001|COMPLETED|Overall Study||4
10832257|NCT01545050|11997412|FG002|COMPLETED|Overall Study||4
10832258|NCT01545050|11997413|FG003|COMPLETED|Overall Study||6
10832259|NCT01545050|11997414|FG004|COMPLETED|Overall Study||9
10832260|NCT01545050|11997410|FG000|NOT COMPLETED|Overall Study||7
10832261|NCT01545050|11997411|FG001|NOT COMPLETED|Overall Study||5
10832262|NCT01545050|11997412|FG002|NOT COMPLETED|Overall Study||5
10832263|NCT01545050|11997413|FG003|NOT COMPLETED|Overall Study||12
10832264|NCT01545050|11997414|FG004|NOT COMPLETED|Overall Study||9
10832265|NCT01550302|11997432|FG000|STARTED|Overall Study||5
10832266|NCT01550302|11997433|FG001|STARTED|Overall Study||5
10832267|NCT01550302|11997432|FG000|COMPLETED|Overall Study||5
10832268|NCT01550302|11997433|FG001|COMPLETED|Overall Study||5
10832269|NCT01550302|11997432|FG000|NOT COMPLETED|Overall Study||0
10832270|NCT01550302|11997433|FG001|NOT COMPLETED|Overall Study||0
10291162|NCT03720392|11424067|FG001|COMPLETED|Overall Study||3
10291163|NCT03720392|11424066|FG000|NOT COMPLETED|Overall Study||0
10291164|NCT03720392|11424067|FG001|NOT COMPLETED|Overall Study||0
10291171|NCT03430895|11424083|FG000|STARTED|Overall Study||15
10291172|NCT03430895|11424083|FG000|COMPLETED|Overall Study||13
10291173|NCT03430895|11424083|FG000|NOT COMPLETED|Overall Study||2
10291174|NCT03321617|11424091|FG000|STARTED|Overall Study||3
10291175|NCT03321617|11424092|FG001|STARTED|Overall Study||3
10291176|NCT03321617|11424093|FG002|STARTED|Overall Study||2
10291177|NCT03321617|11424094|FG003|STARTED|Overall Study||3
10291178|NCT03321617|11424091|FG000|COMPLETED|Overall Study||2
10291179|NCT03321617|11424092|FG001|COMPLETED|Overall Study||3
10291180|NCT03321617|11424093|FG002|COMPLETED|Overall Study||2
10291181|NCT03321617|11424094|FG003|COMPLETED|Overall Study||2
10291182|NCT03321617|11424091|FG000|NOT COMPLETED|Overall Study||1
10291183|NCT03321617|11424092|FG001|NOT COMPLETED|Overall Study||0
10291184|NCT03321617|11424093|FG002|NOT COMPLETED|Overall Study||0
10291185|NCT03321617|11424094|FG003|NOT COMPLETED|Overall Study||1
10291186|NCT03230838|11424106|FG000|STARTED|Overall Study||101
10291187|NCT03230838|11424107|FG001|STARTED|Overall Study||33
10291188|NCT03230838|11424106|FG000|Treated|Overall Study||100
10291189|NCT03230838|11424107|FG001|Treated|Overall Study||33
10291190|NCT03230838|11424106|FG000|COMPLETED|Overall Study||97
10291191|NCT03230838|11424107|FG001|COMPLETED|Overall Study||33
10291192|NCT03230838|11424106|FG000|NOT COMPLETED|Overall Study||4
10291193|NCT03230838|11424107|FG001|NOT COMPLETED|Overall Study||0
10291194|NCT03183778|11424113|FG000|STARTED|Overall Study||3
10291195|NCT03183778|11424113|FG000|COMPLETED|Overall Study||2
10291196|NCT03183778|11424113|FG000|NOT COMPLETED|Overall Study||1
10313897|NCT00157820|11447523|FG000|STARTED|2nd 8 Months||103
10313898|NCT00157820|11447524|FG001|STARTED|2nd 8 Months||101
10313899|NCT00157820|11447525|FG002|STARTED|2nd 8 Months||108
10313900|NCT00157820|11447523|FG000|COMPLETED|2nd 8 Months||98
10313901|NCT00157820|11447524|FG001|COMPLETED|2nd 8 Months||88
10313902|NCT00157820|11447525|FG002|COMPLETED|2nd 8 Months||94
10313903|NCT00157820|11447523|FG000|NOT COMPLETED|2nd 8 Months||5
10313904|NCT00157820|11447524|FG001|NOT COMPLETED|2nd 8 Months||13
10313905|NCT00157820|11447525|FG002|NOT COMPLETED|2nd 8 Months||14
10313906|NCT00157950|11447536|FG000|STARTED|Overall Study||117
10313907|NCT00157950|11447537|FG001|STARTED|Overall Study||59
10313908|NCT00157950|11447536|FG000|Vaccinated at Dose 1|Overall Study||117
10313909|NCT00157950|11447537|FG001|Vaccinated at Dose 1|Overall Study||59
10313910|NCT00157950|11447536|FG000|Vaccinated at Dose 2|Overall Study||117
10313911|NCT00157950|11447537|FG001|Vaccinated at Dose 2|Overall Study||59
10313912|NCT00157950|11447536|FG000|Vaccinated at Dose 3|Overall Study||116
10313913|NCT00157950|11447537|FG001|Vaccinated at Dose 3|Overall Study||59
10313914|NCT00157950|11447536|FG000|COMPLETED|Overall Study||116
10313915|NCT00157950|11447537|FG001|COMPLETED|Overall Study||59
10313916|NCT00157950|11447536|FG000|NOT COMPLETED|Overall Study||1
10313917|NCT00157950|11447537|FG001|NOT COMPLETED|Overall Study||0
10313918|NCT00158054|11447545|FG000|STARTED|Overall Study||80
10313919|NCT00158054|11447546|FG001|STARTED|Overall Study||77
10313920|NCT00158054|11447545|FG000|COMPLETED|Overall Study||70
10313921|NCT00158054|11447546|FG001|COMPLETED|Overall Study||74
10313922|NCT00158054|11447545|FG000|NOT COMPLETED|Overall Study||10
10313923|NCT00158054|11447546|FG001|NOT COMPLETED|Overall Study||3
10313924|NCT00158184|11447554|FG000|STARTED|Overall Study||16
10313925|NCT00158184|11447555|FG001|STARTED|Overall Study||11
10313926|NCT00158184|11447554|FG000|COMPLETED|Overall Study||10
10313927|NCT00158184|11447555|FG001|COMPLETED|Overall Study||9
10313928|NCT00158184|11447554|FG000|NOT COMPLETED|Overall Study||6
10313929|NCT00158184|11447555|FG001|NOT COMPLETED|Overall Study||2
10313930|NCT00158197|11447567|FG000|STARTED|Overall Study||32
10313931|NCT00158197|11447568|FG001|STARTED|Overall Study||30
10832271|NCT01555021|11997441|FG000|STARTED|Overall Study||2
10832272|NCT01555021|11997442|FG001|STARTED|Overall Study||2
10832273|NCT01555021|11997441|FG000|COMPLETED|Overall Study|One treatment as usual subject completed 1 month, 3 month, and 6 month follow up visits|1
10832274|NCT01555021|11997442|FG001|COMPLETED|Overall Study|None of the AGT subjects competed month 1, month 3, or month 6 follow up visits.|0
10832275|NCT01555021|11997441|FG000|NOT COMPLETED|Overall Study||1
10832276|NCT01555021|11997442|FG001|NOT COMPLETED|Overall Study||2
10832277|NCT01561430|11997458|FG000|STARTED|Overall Study||9
10832278|NCT01561430|11997459|FG001|STARTED|Overall Study||23
10832279|NCT01561430|11997460|FG002|STARTED|Overall Study||18
10832280|NCT01561430|11997461|FG003|STARTED|Overall Study||20
10832281|NCT01561430|11997458|FG000|Received at Least One Dose of Study Drug|Overall Study||9
10832282|NCT01561430|11997459|FG001|Received at Least One Dose of Study Drug|Overall Study||23
10832283|NCT01561430|11997460|FG002|Received at Least One Dose of Study Drug|Overall Study||18
10832284|NCT01561430|11997461|FG003|Received at Least One Dose of Study Drug|Overall Study||20
10832285|NCT01561430|11997458|FG000|COMPLETED|Overall Study||8
10832286|NCT01561430|11997459|FG001|COMPLETED|Overall Study||8
10832287|NCT01561430|11997460|FG002|COMPLETED|Overall Study||1
10832288|NCT01561430|11997461|FG003|COMPLETED|Overall Study||7
10409191|NCT00758524|11553180|FG001|STARTED|Core Period (Week 0 to Week 8)||88
10409192|NCT00758524|11553181|FG002|STARTED|Core Period (Week 0 to Week 8)||86
10409193|NCT00758524|11553182|FG003|STARTED|Core Period (Week 0 to Week 8)|One participant in this arm group was randomized twice and was excluded from Full Analysis Set.|97
10409194|NCT00758524|11553183|FG004|STARTED|Core Period (Week 0 to Week 8)||84
10409195|NCT00758524|11553184|FG005|STARTED|Core Period (Week 0 to Week 8)||77
10409196|NCT00758524|11553185|FG006|STARTED|Core Period (Week 0 to Week 8)||0
10409197|NCT00758524|11553186|FG007|STARTED|Core Period (Week 0 to Week 8)||0
10409198|NCT00758524|11553187|FG008|STARTED|Core Period (Week 0 to Week 8)||0
10409199|NCT00758524|11553188|FG009|STARTED|Core Period (Week 0 to Week 8)||0
10832289|NCT01561430|11997458|FG000|NOT COMPLETED|Overall Study||1
10832290|NCT01561430|11997459|FG001|NOT COMPLETED|Overall Study||15
10832291|NCT01561430|11997460|FG002|NOT COMPLETED|Overall Study||17
10832292|NCT01561430|11997461|FG003|NOT COMPLETED|Overall Study||13
10832293|NCT01580813|11997472|FG000|STARTED|Overall Study||4
10832294|NCT01580813|11997473|FG001|STARTED|Overall Study||3
10832295|NCT01580813|11997472|FG000|Completed First Intervention|Overall Study||4
10832296|NCT01580813|11997473|FG001|Completed First Intervention|Overall Study||3
10832297|NCT01580813|11997472|FG000|Completed 1 Week Washout|Overall Study||4
10832298|NCT01580813|11997473|FG001|Completed 1 Week Washout|Overall Study||3
10832299|NCT01580813|11997472|FG000|Started Second Intervention|Overall Study||4
10832300|NCT01580813|11997473|FG001|Started Second Intervention|Overall Study||3
10832301|NCT01580813|11997472|FG000|COMPLETED|Overall Study||4
10832302|NCT01580813|11997473|FG001|COMPLETED|Overall Study||3
10832303|NCT01580813|11997472|FG000|NOT COMPLETED|Overall Study||0
10832304|NCT01580813|11997473|FG001|NOT COMPLETED|Overall Study||0
10832305|NCT01595009|11997481|FG000|STARTED|Core||126
10832306|NCT01595009|11997482|FG001|STARTED|Core||120
10832307|NCT01595009|11997483|FG002|STARTED|Core||0
10832308|NCT01595009|11997484|FG003|STARTED|Core||0
10832309|NCT01595009|11997481|FG000|COMPLETED|Core||0
10832310|NCT01595009|11997482|FG001|COMPLETED|Core||0
10832311|NCT01595009|11997483|FG002|COMPLETED|Core||0
10832312|NCT01595009|11997484|FG003|COMPLETED|Core||0
10832313|NCT01595009|11997481|FG000|NOT COMPLETED|Core||126
10832314|NCT01595009|11997482|FG001|NOT COMPLETED|Core||120
10832315|NCT01595009|11997483|FG002|NOT COMPLETED|Core||0
10832316|NCT01595009|11997484|FG003|NOT COMPLETED|Core||0
10832317|NCT01595009|11997481|FG000|STARTED|Extension||0
10832318|NCT01595009|11997482|FG001|STARTED|Extension||0
10832319|NCT01595009|11997483|FG002|STARTED|Extension||4
10832320|NCT01595009|11997484|FG003|STARTED|Extension||11
10832321|NCT01595009|11997481|FG000|COMPLETED|Extension||0
10832322|NCT01595009|11997482|FG001|COMPLETED|Extension||0
10832323|NCT01595009|11997483|FG002|COMPLETED|Extension||0
10832324|NCT01595009|11997484|FG003|COMPLETED|Extension||0
10832325|NCT01595009|11997481|FG000|NOT COMPLETED|Extension||0
10832326|NCT01595009|11997482|FG001|NOT COMPLETED|Extension||0
10832327|NCT01595009|11997483|FG002|NOT COMPLETED|Extension||4
10832328|NCT01595009|11997484|FG003|NOT COMPLETED|Extension||11
10832329|NCT01613807|11997501|FG000|STARTED|Overall Study||20
10832330|NCT01613807|11997502|FG001|STARTED|Overall Study||20
10832331|NCT01613807|11997501|FG000|COMPLETED|Overall Study||20
10832332|NCT01613807|11997502|FG001|COMPLETED|Overall Study||20
10832333|NCT01613807|11997501|FG000|NOT COMPLETED|Overall Study||0
10832334|NCT01613807|11997502|FG001|NOT COMPLETED|Overall Study||0
10832335|NCT01620944|11997512|FG000|STARTED|Overall Study||2
10832336|NCT01620944|11997513|FG001|STARTED|Overall Study||1
10832337|NCT01620944|11997512|FG000|COMPLETED|Overall Study||0
10832338|NCT01620944|11997513|FG001|COMPLETED|Overall Study||0
10832339|NCT01620944|11997512|FG000|NOT COMPLETED|Overall Study||2
10832340|NCT01620944|11997513|FG001|NOT COMPLETED|Overall Study||1
10832341|NCT01627561|11997521|FG000|STARTED|Overall Study||74
10832342|NCT01627561|11997522|FG001|STARTED|Overall Study||74
10832343|NCT01627561|11997521|FG000|COMPLETED|Overall Study||73
10832344|NCT01627561|11997522|FG001|COMPLETED|Overall Study||71
10832345|NCT01627561|11997521|FG000|NOT COMPLETED|Overall Study||1
10832346|NCT01627561|11997522|FG001|NOT COMPLETED|Overall Study||3
10832359|NCT01652534|11997547|FG000|STARTED|Overall Study||2
10832360|NCT01652534|11997548|FG001|STARTED|Overall Study||1
10832361|NCT01652534|11997547|FG000|COMPLETED|Overall Study||1
10832347|NCT01629511|11997532|FG000|STARTED|Overall Study||4
10832348|NCT01629511|11997533|FG001|STARTED|Overall Study||0
10832349|NCT01629511|11997534|FG002|STARTED|Overall Study||8
10832350|NCT01629511|11997535|FG003|STARTED|Overall Study||3
10832351|NCT01629511|11997532|FG000|COMPLETED|Overall Study||4
10832352|NCT01629511|11997533|FG001|COMPLETED|Overall Study||0
10832353|NCT01629511|11997534|FG002|COMPLETED|Overall Study||8
10832354|NCT01629511|11997535|FG003|COMPLETED|Overall Study||3
10832355|NCT01629511|11997532|FG000|NOT COMPLETED|Overall Study||0
10832356|NCT01629511|11997533|FG001|NOT COMPLETED|Overall Study||0
10832357|NCT01629511|11997534|FG002|NOT COMPLETED|Overall Study||0
10832358|NCT01629511|11997535|FG003|NOT COMPLETED|Overall Study||0
10832362|NCT01652534|11997548|FG001|COMPLETED|Overall Study||1
10832363|NCT01652534|11997547|FG000|NOT COMPLETED|Overall Study||1
10832364|NCT01652534|11997548|FG001|NOT COMPLETED|Overall Study||0
10832365|NCT01670565|11997556|FG000|STARTED|Overall Study||10
10832366|NCT01670565|11997557|FG001|STARTED|Overall Study||10
10832367|NCT01670565|11997556|FG000|COMPLETED|Overall Study||9
10832368|NCT01670565|11997557|FG001|COMPLETED|Overall Study||9
10832369|NCT01670565|11997556|FG000|NOT COMPLETED|Overall Study||1
10832370|NCT01670565|11997557|FG001|NOT COMPLETED|Overall Study||1
10832371|NCT04871425|11997567|FG000|STARTED|Overall Study||57
10832372|NCT04871425|11997568|FG001|STARTED|Overall Study||53
10832373|NCT04871425|11997567|FG000|COMPLETED|Overall Study||42
10832374|NCT04871425|11997568|FG001|COMPLETED|Overall Study||45
10832375|NCT04871425|11997567|FG000|NOT COMPLETED|Overall Study||15
10832376|NCT04871425|11997568|FG001|NOT COMPLETED|Overall Study||8
10832377|NCT04799405|11997574|FG000|STARTED|Phase 1 - Acute Stimulation, Daily tDCS||5
10832378|NCT04799405|11997574|FG000|COMPLETED|Phase 1 - Acute Stimulation, Daily tDCS||3
10832379|NCT04799405|11997574|FG000|NOT COMPLETED|Phase 1 - Acute Stimulation, Daily tDCS||2
10832380|NCT04799405|11997574|FG000|STARTED|Phase 2 - Tapered Stimulation Schedule||3
10832381|NCT04799405|11997574|FG000|COMPLETED|Phase 2 - Tapered Stimulation Schedule||3
10832382|NCT04799405|11997574|FG000|NOT COMPLETED|Phase 2 - Tapered Stimulation Schedule||0
10832383|NCT04799405|11997574|FG000|STARTED|Phase 3 - Follow up Phase||3
10832384|NCT04799405|11997574|FG000|COMPLETED|Phase 3 - Follow up Phase||3
10832385|NCT04799405|11997574|FG000|NOT COMPLETED|Phase 3 - Follow up Phase||0
10832386|NCT04748458|11997578|FG000|STARTED|Overall Study||85
10832387|NCT04748458|11997578|FG000|COMPLETED|Overall Study||85
10832388|NCT04748458|11997578|FG000|NOT COMPLETED|Overall Study||0
10832389|NCT04529499|11997584|FG000|STARTED|Overall Study||175
10832390|NCT04529499|11997585|FG001|STARTED|Overall Study||178
10832391|NCT04529499|11997584|FG000|Discharged From Hospital Before Day 28|Overall Study||136
10832392|NCT04529499|11997585|FG001|Discharged From Hospital Before Day 28|Overall Study||136
10832393|NCT04529499|11997584|FG000|Completed 10-day Treatment Course of IMP|Overall Study||150
10832394|NCT04529499|11997585|FG001|Completed 10-day Treatment Course of IMP|Overall Study||147
10832395|NCT04529499|11997584|FG000|Completed Day 14 Telephonic Visit|Overall Study||107
10832396|NCT04529499|11997585|FG001|Completed Day 14 Telephonic Visit|Overall Study||102
10832397|NCT04529499|11997584|FG000|Completed Day 21 Telephonic Visit|Overall Study||119
10832398|NCT04529499|11997585|FG001|Completed Day 21 Telephonic Visit|Overall Study||120
10832399|NCT04529499|11997584|FG000|Completed Day 28 Telephonic Visit|Overall Study||134
10832400|NCT04529499|11997585|FG001|Completed Day 28 Telephonic Visit|Overall Study||131
10832401|NCT04529499|11997584|FG000|Completed Days 14, 21 and 28 Telephonic Visits in Stage I|Overall Study||98
10832402|NCT04529499|11997585|FG001|Completed Days 14, 21 and 28 Telephonic Visits in Stage I|Overall Study||94
10832403|NCT04529499|11997584|FG000|Continue to be in Hospital as of Day 28|Overall Study||6
10832404|NCT04529499|11997585|FG001|Continue to be in Hospital as of Day 28|Overall Study||4
10832405|NCT04529499|11997584|FG000|Completed Day 42 Telephonic Visit|Overall Study||136
10832406|NCT04529499|11997585|FG001|Completed Day 42 Telephonic Visit|Overall Study||135
10832407|NCT04529499|11997584|FG000|Completed Day 60 Telephonic Visit|Overall Study||129
10832408|NCT04529499|11997585|FG001|Completed Day 60 Telephonic Visit|Overall Study||132
10832409|NCT04529499|11997584|FG000|Completed Days 42 and 60 Telephonic Visits in Stage II|Overall Study||126
10832410|NCT04529499|11997585|FG001|Completed Days 42 and 60 Telephonic Visits in Stage II|Overall Study||130
10832411|NCT04529499|11997584|FG000|Continued to be in Hospital When Study Was Terminated|Overall Study||11
10832412|NCT04529499|11997585|FG001|Continued to be in Hospital When Study Was Terminated|Overall Study||17
10832413|NCT04529499|11997584|FG000|COMPLETED|Overall Study||139
10832414|NCT04529499|11997585|FG001|COMPLETED|Overall Study||138
10832415|NCT04529499|11997584|FG000|NOT COMPLETED|Overall Study||36
10832416|NCT04529499|11997585|FG001|NOT COMPLETED|Overall Study||40
10832417|NCT04501094|11997593|FG000|STARTED|Overall Study||1
10832418|NCT04501094|11997594|FG001|STARTED|Overall Study||1
10832419|NCT04501094|11997593|FG000|COMPLETED|Overall Study||0
10832420|NCT04501094|11997594|FG001|COMPLETED|Overall Study||1
10832421|NCT04501094|11997593|FG000|NOT COMPLETED|Overall Study||1
10832422|NCT04501094|11997594|FG001|NOT COMPLETED|Overall Study||0
10832423|NCT04414618|11997602|FG000|STARTED|Overall Study||23
10832424|NCT04414618|11997603|FG001|STARTED|Overall Study||19
10832425|NCT04414618|11997602|FG000|COMPLETED|Overall Study||15
10832426|NCT04414618|11997603|FG001|COMPLETED|Overall Study||12
10832427|NCT04414618|11997602|FG000|NOT COMPLETED|Overall Study||8
10832428|NCT04414618|11997603|FG001|NOT COMPLETED|Overall Study||7
10832429|NCT04412057|11997612|FG000|STARTED|Overall Study||41
10832430|NCT04412057|11997613|FG001|STARTED|Overall Study||42
10832431|NCT04412057|11997612|FG000|Randomized Analysis Set|Overall Study||41
10832432|NCT04412057|11997613|FG001|Randomized Analysis Set|Overall Study||42
10832433|NCT04412057|11997612|FG000|Safety Analysis Set|Overall Study||40
10832434|NCT04412057|11997613|FG001|Safety Analysis Set|Overall Study||42
10832435|NCT04412057|11997612|FG000|Full Analysis Set|Overall Study||40
10832436|NCT04412057|11997613|FG001|Full Analysis Set|Overall Study||42
10832437|NCT04412057|11997612|FG000|Primary Analysis Set|Overall Study||31
10832438|NCT04412057|11997613|FG001|Primary Analysis Set|Overall Study||31
10832439|NCT04412057|11997612|FG000|COMPLETED|Overall Study||37
10832440|NCT04412057|11997613|FG001|COMPLETED|Overall Study||35
10832441|NCT04412057|11997612|FG000|NOT COMPLETED|Overall Study||4
10832442|NCT04412057|11997613|FG001|NOT COMPLETED|Overall Study||7
10832443|NCT04402060|11997622|FG000|STARTED|Overall Study||6
10832444|NCT04402060|11997623|FG001|STARTED|Overall Study||34
10832445|NCT04402060|11997624|FG002|STARTED|Overall Study||32
10832446|NCT04402060|11997622|FG000|Received Treatment|Overall Study||6
10832447|NCT04402060|11997623|FG001|Received Treatment|Overall Study||33
10832448|NCT04402060|11997624|FG002|Received Treatment|Overall Study||32
10832449|NCT04402060|11997622|FG000|COMPLETED|Overall Study||5
10832450|NCT04402060|11997623|FG001|COMPLETED|Overall Study||18
10832451|NCT04402060|11997624|FG002|COMPLETED|Overall Study||21
10832452|NCT04402060|11997622|FG000|NOT COMPLETED|Overall Study||1
10832453|NCT04402060|11997623|FG001|NOT COMPLETED|Overall Study||16
10832454|NCT04402060|11997624|FG002|NOT COMPLETED|Overall Study||11
10832455|NCT04396626|11997637|FG000|STARTED|Overall Study||975
10832456|NCT04396626|11997637|FG000|COMPLETED|Overall Study||0
10832457|NCT04396626|11997637|FG000|NOT COMPLETED|Overall Study||975
10832458|NCT04391179|11997643|FG000|STARTED|Overall Study||49
10832459|NCT04391179|11997644|FG001|STARTED|Overall Study||50
10832460|NCT04391179|11997643|FG000|COMPLETED|Overall Study||34
10832461|NCT04391179|11997644|FG001|COMPLETED|Overall Study||34
10832462|NCT04391179|11997643|FG000|NOT COMPLETED|Overall Study||15
10291197|NCT03113955|11424117|FG000|STARTED|Overall Study||109
10291198|NCT03113955|11424117|FG000|COMPLETED|Overall Study||92
10291199|NCT03113955|11424117|FG000|NOT COMPLETED|Overall Study||17
10291200|NCT02995694|11424124|FG000|STARTED|Overall Study||215
10291201|NCT02995694|11424125|FG001|STARTED|Overall Study||211
10291202|NCT02995694|11424126|FG002|STARTED|Overall Study||109
10291203|NCT02995694|11424124|FG000|COMPLETED|Overall Study||181
10291204|NCT02995694|11424125|FG001|COMPLETED|Overall Study||183
10291205|NCT02995694|11424126|FG002|COMPLETED|Overall Study||94
10291206|NCT02995694|11424124|FG000|NOT COMPLETED|Overall Study||34
10291207|NCT02995694|11424125|FG001|NOT COMPLETED|Overall Study||28
10291208|NCT02995694|11424126|FG002|NOT COMPLETED|Overall Study||15
10291209|NCT02700698|11424139|FG000|STARTED|Overall Study||17
10291210|NCT02700698|11424140|FG001|STARTED|Overall Study||18
10291211|NCT02700698|11424139|FG000|COMPLETED|Overall Study||16
10291212|NCT02700698|11424140|FG001|COMPLETED|Overall Study||18
10291213|NCT02700698|11424139|FG000|NOT COMPLETED|Overall Study||1
10291214|NCT02700698|11424140|FG001|NOT COMPLETED|Overall Study||0
10291215|NCT02699086|11424146|FG000|STARTED|Overall Study||0
10291216|NCT02699086|11424147|FG001|STARTED|Overall Study||6
10291217|NCT02699086|11424146|FG000|COMPLETED|Overall Study||0
10291218|NCT02699086|11424147|FG001|COMPLETED|Overall Study||6
10291219|NCT02699086|11424146|FG000|NOT COMPLETED|Overall Study||0
10291220|NCT02699086|11424147|FG001|NOT COMPLETED|Overall Study||0
10291221|NCT02698865|11424157|FG000|STARTED|Overall Study||140
10291222|NCT02698865|11424158|FG001|STARTED|Overall Study||80
10291223|NCT02698865|11424157|FG000|Treated|Overall Study||140
10291224|NCT02698865|11424158|FG001|Treated|Overall Study||80
10291225|NCT02698865|11424157|FG000|COMPLETED|Overall Study||105
10291226|NCT02698865|11424158|FG001|COMPLETED|Overall Study||47
10291227|NCT02698865|11424157|FG000|NOT COMPLETED|Overall Study||35
10291228|NCT02698865|11424158|FG001|NOT COMPLETED|Overall Study||33
10291229|NCT02660086|11424166|FG000|STARTED|Overall Study- 12-month||299
10291230|NCT02660086|11424167|FG001|STARTED|Overall Study- 12-month||303
10291231|NCT02660086|11424166|FG000|COMPLETED|Overall Study- 12-month||273
10291232|NCT02660086|11424167|FG001|COMPLETED|Overall Study- 12-month||274
10291233|NCT02660086|11424166|FG000|NOT COMPLETED|Overall Study- 12-month||26
10291234|NCT02660086|11424167|FG001|NOT COMPLETED|Overall Study- 12-month||29
10291235|NCT02660086|11424166|FG000|STARTED|Overall Study: 24-month Follow-up||281
10291236|NCT02660086|11424167|FG001|STARTED|Overall Study: 24-month Follow-up||278
10291237|NCT02660086|11424166|FG000|COMPLETED|Overall Study: 24-month Follow-up||255
10291238|NCT02660086|11424167|FG001|COMPLETED|Overall Study: 24-month Follow-up||254
10291239|NCT02660086|11424166|FG000|NOT COMPLETED|Overall Study: 24-month Follow-up||26
10291240|NCT02660086|11424167|FG001|NOT COMPLETED|Overall Study: 24-month Follow-up||24
10291241|NCT02335749|11424173|FG000|STARTED|Overall Study||40
10291242|NCT02335749|11424173|FG000|COMPLETED|Overall Study||40
10291243|NCT02335749|11424173|FG000|NOT COMPLETED|Overall Study||0
10291244|NCT02129647|11424177|FG000|STARTED|Overall Study||13
10291245|NCT02129647|11424177|FG000|COMPLETED|Overall Study||10
10291246|NCT02129647|11424177|FG000|NOT COMPLETED|Overall Study||3
10291247|NCT02071901|11424181|FG000|STARTED|Overall Study||31
10291248|NCT02071901|11424181|FG000|COMPLETED|Overall Study||31
10291249|NCT02071901|11424181|FG000|NOT COMPLETED|Overall Study||0
10291250|NCT01959139|11424189|FG000|STARTED|Phase I: Cohort 1||5
10291251|NCT01959139|11424190|FG001|STARTED|Phase I: Cohort 1||0
10291252|NCT01959139|11424191|FG002|STARTED|Phase I: Cohort 1||0
10291253|NCT01959139|11424192|FG003|STARTED|Phase I: Cohort 1||0
10291254|NCT01959139|11424189|FG000|COMPLETED|Phase I: Cohort 1||5
10291255|NCT01959139|11424190|FG001|COMPLETED|Phase I: Cohort 1||0
10291256|NCT01959139|11424191|FG002|COMPLETED|Phase I: Cohort 1||0
10291257|NCT01959139|11424192|FG003|COMPLETED|Phase I: Cohort 1||0
10291258|NCT01959139|11424189|FG000|NOT COMPLETED|Phase I: Cohort 1||0
10291259|NCT01959139|11424190|FG001|NOT COMPLETED|Phase I: Cohort 1||0
10291260|NCT01959139|11424191|FG002|NOT COMPLETED|Phase I: Cohort 1||0
10291261|NCT01959139|11424192|FG003|NOT COMPLETED|Phase I: Cohort 1||0
10291262|NCT01959139|11424189|FG000|STARTED|Phase I: Cohort 2||0
10291263|NCT01959139|11424190|FG001|STARTED|Phase I: Cohort 2||6
10291264|NCT01959139|11424191|FG002|STARTED|Phase I: Cohort 2||0
10832463|NCT04391179|11997644|FG001|NOT COMPLETED|Overall Study||16
10291265|NCT01959139|11424192|FG003|STARTED|Phase I: Cohort 2||0
10291266|NCT01959139|11424189|FG000|COMPLETED|Phase I: Cohort 2||0
10291267|NCT01959139|11424190|FG001|COMPLETED|Phase I: Cohort 2||6
10832464|NCT04386096|11997652|FG000|STARTED|Overall Study||20
10832465|NCT04386096|11997653|FG001|STARTED|Overall Study||20
10832466|NCT04386096|11997652|FG000|COMPLETED|Overall Study||20
10832467|NCT04386096|11997653|FG001|COMPLETED|Overall Study||20
10832468|NCT04386096|11997652|FG000|NOT COMPLETED|Overall Study||0
10832469|NCT04386096|11997653|FG001|NOT COMPLETED|Overall Study||0
10832470|NCT04376684|11997663|FG000|STARTED|Part 1 (Up to Day 60)||403
10832471|NCT04376684|11997664|FG001|STARTED|Part 1 (Up to Day 60)||403
10291268|NCT01959139|11424191|FG002|COMPLETED|Phase I: Cohort 2||0
10291269|NCT01959139|11424192|FG003|COMPLETED|Phase I: Cohort 2||0
10291270|NCT01959139|11424189|FG000|NOT COMPLETED|Phase I: Cohort 2||0
10291271|NCT01959139|11424190|FG001|NOT COMPLETED|Phase I: Cohort 2||0
10291272|NCT01959139|11424191|FG002|NOT COMPLETED|Phase I: Cohort 2||0
10291273|NCT01959139|11424192|FG003|NOT COMPLETED|Phase I: Cohort 2||0
10291274|NCT01959139|11424189|FG000|STARTED|Phase II||0
10291275|NCT01959139|11424190|FG001|STARTED|Phase II||0
10291276|NCT01959139|11424191|FG002|STARTED|Phase II||56
10291277|NCT01959139|11424192|FG003|STARTED|Phase II||55
10291278|NCT01959139|11424189|FG000|Assessed for AEs|Phase II||0
10291279|NCT01959139|11424190|FG001|Assessed for AEs|Phase II||0
10291280|NCT01959139|11424191|FG002|Assessed for AEs|Phase II||54
10291281|NCT01959139|11424192|FG003|Assessed for AEs|Phase II||51
10291282|NCT01959139|11424189|FG000|COMPLETED|Phase II||0
10291283|NCT01959139|11424190|FG001|COMPLETED|Phase II||0
10291284|NCT01959139|11424191|FG002|COMPLETED|Phase II||0
10291285|NCT01959139|11424192|FG003|COMPLETED|Phase II||0
10291286|NCT01959139|11424189|FG000|NOT COMPLETED|Phase II||0
10291287|NCT01959139|11424190|FG001|NOT COMPLETED|Phase II||0
10291288|NCT01959139|11424191|FG002|NOT COMPLETED|Phase II||56
10291289|NCT01959139|11424192|FG003|NOT COMPLETED|Phase II||55
10291290|NCT01597778|11424209|FG000|STARTED|Overall Study||186
10291291|NCT01597778|11424210|FG001|STARTED|Overall Study||182
10291292|NCT01597778|11424209|FG000|COMPLETED|Overall Study||172
10291293|NCT01597778|11424210|FG001|COMPLETED|Overall Study||153
10291294|NCT01597778|11424209|FG000|NOT COMPLETED|Overall Study||14
10291295|NCT01597778|11424210|FG001|NOT COMPLETED|Overall Study||29
10291296|NCT01134601|11424216|FG000|STARTED|Overall Study||1
10291297|NCT01134601|11424216|FG000|COMPLETED|Overall Study||1
10291298|NCT01134601|11424216|FG000|NOT COMPLETED|Overall Study||0
10291299|NCT01118026|11424220|FG000|STARTED|Overall Study||101
10291300|NCT01118026|11424220|FG000|COMPLETED|Overall Study||101
10291301|NCT01118026|11424220|FG000|NOT COMPLETED|Overall Study||0
10291302|NCT00879086|11424227|FG000|STARTED|Overall Study||52
10291303|NCT00879086|11424228|FG001|STARTED|Overall Study||52
10291304|NCT00879086|11424227|FG000|Safety Analysis Set (SAS)|Overall Study||51
10291305|NCT00879086|11424228|FG001|Safety Analysis Set (SAS)|Overall Study||50
10291306|NCT00879086|11424227|FG000|COMPLETED|Overall Study||0
10291307|NCT00879086|11424228|FG001|COMPLETED|Overall Study||0
10291308|NCT00879086|11424227|FG000|NOT COMPLETED|Overall Study||52
10291309|NCT00879086|11424228|FG001|NOT COMPLETED|Overall Study||52
10291310|NCT00864227|11424234|FG000|STARTED|Overall Study||54
10291311|NCT00864227|11424234|FG000|COMPLETED|Overall Study||50
10291312|NCT00864227|11424234|FG000|NOT COMPLETED|Overall Study||4
10291313|NCT00685360|11424241|FG000|STARTED|Overall Study||161
10291314|NCT00685360|11424242|FG001|STARTED|Overall Study||160
10291315|NCT00685360|11424243|FG002|STARTED|Overall Study||160
10291316|NCT00685360|11424241|FG000|Modified Intent-to-Treat (MITT)|Overall Study||141
10291317|NCT00685360|11424242|FG001|Modified Intent-to-Treat (MITT)|Overall Study||136
10291318|NCT00685360|11424243|FG002|Modified Intent-to-Treat (MITT)|Overall Study||125
10291319|NCT00685360|11424241|FG000|MITT (Solid Culture)|Overall Study||119
10291320|NCT00685360|11424242|FG001|MITT (Solid Culture)|Overall Study||115
10291321|NCT00685360|11424243|FG002|MITT (Solid Culture)|Overall Study||113
10291322|NCT00685360|11424241|FG000|COMPLETED|Overall Study||143
10291323|NCT00685360|11424242|FG001|COMPLETED|Overall Study||146
10291324|NCT00685360|11424243|FG002|COMPLETED|Overall Study||145
10291325|NCT00685360|11424241|FG000|NOT COMPLETED|Overall Study||18
10291326|NCT00685360|11424242|FG001|NOT COMPLETED|Overall Study||14
10291327|NCT00685360|11424243|FG002|NOT COMPLETED|Overall Study||15
10291328|NCT00299728|11424253|FG000|STARTED|Overall Study||11
10291329|NCT00299728|11424254|FG001|STARTED|Overall Study||11
10291330|NCT00299728|11424253|FG000|COMPLETED|Overall Study||11
10291331|NCT00299728|11424254|FG001|COMPLETED|Overall Study||8
10291332|NCT00299728|11424253|FG000|NOT COMPLETED|Overall Study||0
10291333|NCT00299728|11424254|FG001|NOT COMPLETED|Overall Study||3
10313932|NCT00158197|11447569|FG002|STARTED|Overall Study||28
10832472|NCT04376684|11997665|FG002|STARTED|Part 1 (Up to Day 60)||0
10832473|NCT04376684|11997666|FG003|STARTED|Part 1 (Up to Day 60)||0
10832474|NCT04376684|11997663|FG000|COMPLETED|Part 1 (Up to Day 60)||388
10832475|NCT04376684|11997664|FG001|COMPLETED|Part 1 (Up to Day 60)||379
10313933|NCT00158197|11447570|FG003|STARTED|Overall Study||29
10313934|NCT00158197|11447567|FG000|COMPLETED|Overall Study||32
10313935|NCT00158197|11447568|FG001|COMPLETED|Overall Study||30
10313936|NCT00158197|11447569|FG002|COMPLETED|Overall Study||28
10313937|NCT00158197|11447570|FG003|COMPLETED|Overall Study||29
10313938|NCT00158197|11447567|FG000|NOT COMPLETED|Overall Study||0
10313939|NCT00158197|11447568|FG001|NOT COMPLETED|Overall Study||0
10313940|NCT00158197|11447569|FG002|NOT COMPLETED|Overall Study||0
10313941|NCT00158197|11447570|FG003|NOT COMPLETED|Overall Study||0
10313942|NCT00158223|11447582|FG000|STARTED|Overall Study||28
10313943|NCT00158223|11447583|FG001|STARTED|Overall Study||25
10313944|NCT00158223|11447582|FG000|COMPLETED|Overall Study||23
10313945|NCT00158223|11447583|FG001|COMPLETED|Overall Study||22
10313946|NCT00158223|11447582|FG000|NOT COMPLETED|Overall Study||5
10313947|NCT00158223|11447583|FG001|NOT COMPLETED|Overall Study||3
10832476|NCT04376684|11997665|FG002|COMPLETED|Part 1 (Up to Day 60)||0
10832477|NCT04376684|11997666|FG003|COMPLETED|Part 1 (Up to Day 60)||0
10832478|NCT04376684|11997663|FG000|NOT COMPLETED|Part 1 (Up to Day 60)||15
10832479|NCT04376684|11997664|FG001|NOT COMPLETED|Part 1 (Up to Day 60)||24
10832480|NCT04376684|11997665|FG002|NOT COMPLETED|Part 1 (Up to Day 60)||0
10832481|NCT04376684|11997666|FG003|NOT COMPLETED|Part 1 (Up to Day 60)||0
10832482|NCT04376684|11997663|FG000|STARTED|Part 2 (Up to Day 60)||0
10832483|NCT04376684|11997664|FG001|STARTED|Part 2 (Up to Day 60)||0
10832484|NCT04376684|11997665|FG002|STARTED|Part 2 (Up to Day 60)||175
10832485|NCT04376684|11997666|FG003|STARTED|Part 2 (Up to Day 60)||175
10832486|NCT04376684|11997663|FG000|COMPLETED|Part 2 (Up to Day 60)||0
10832487|NCT04376684|11997664|FG001|COMPLETED|Part 2 (Up to Day 60)||0
10832488|NCT04376684|11997665|FG002|COMPLETED|Part 2 (Up to Day 60)||170
10832489|NCT04376684|11997666|FG003|COMPLETED|Part 2 (Up to Day 60)||171
10832490|NCT04376684|11997663|FG000|NOT COMPLETED|Part 2 (Up to Day 60)||0
10832491|NCT04376684|11997664|FG001|NOT COMPLETED|Part 2 (Up to Day 60)||0
10832492|NCT04376684|11997665|FG002|NOT COMPLETED|Part 2 (Up to Day 60)||5
10832493|NCT04376684|11997666|FG003|NOT COMPLETED|Part 2 (Up to Day 60)||4
10832494|NCT04353284|11997678|FG000|STARTED|Overall Study||35
10832495|NCT04353284|11997679|FG001|STARTED|Overall Study||35
10832496|NCT04353284|11997678|FG000|COMPLETED|Overall Study||33
10832497|NCT04353284|11997679|FG001|COMPLETED|Overall Study||34
10832498|NCT04353284|11997678|FG000|NOT COMPLETED|Overall Study||2
10832499|NCT04353284|11997679|FG001|NOT COMPLETED|Overall Study||1
10832500|NCT04294147|11997687|FG000|STARTED|Overall Study||32
10832501|NCT04294147|11997688|FG001|STARTED|Overall Study||33
10832502|NCT04294147|11997687|FG000|Received at Least One Dose of Study Drug|Overall Study||32
10832503|NCT04294147|11997688|FG001|Received at Least One Dose of Study Drug|Overall Study||33
10832504|NCT04294147|11997687|FG000|COMPLETED|Overall Study||30
10832505|NCT04294147|11997688|FG001|COMPLETED|Overall Study||33
10832506|NCT04294147|11997687|FG000|NOT COMPLETED|Overall Study||2
10832507|NCT04294147|11997688|FG001|NOT COMPLETED|Overall Study||0
10832508|NCT04269707|11997694|FG000|STARTED|Overall Study||7
10832509|NCT04269707|11997694|FG000|COMPLETED|Overall Study||7
10832510|NCT04269707|11997694|FG000|NOT COMPLETED|Overall Study||0
10832511|NCT04231825|11997700|FG000|STARTED|Overall Study||23
10832512|NCT04231825|11997701|FG001|STARTED|Overall Study||24
10832513|NCT04231825|11997700|FG000|COMPLETED|Overall Study||20
10832514|NCT04231825|11997701|FG001|COMPLETED|Overall Study||20
10832515|NCT04231825|11997700|FG000|NOT COMPLETED|Overall Study||3
10832516|NCT04231825|11997701|FG001|NOT COMPLETED|Overall Study||4
10832517|NCT04196686|11997707|FG000|STARTED|First Treatment (4 Minutes)||78
10832518|NCT04196686|11997708|FG001|STARTED|First Treatment (4 Minutes)||78
10832519|NCT04196686|11997707|FG000|COMPLETED|First Treatment (4 Minutes)||78
10832520|NCT04196686|11997708|FG001|COMPLETED|First Treatment (4 Minutes)||75
10832521|NCT04196686|11997707|FG000|NOT COMPLETED|First Treatment (4 Minutes)||0
10832522|NCT04196686|11997708|FG001|NOT COMPLETED|First Treatment (4 Minutes)||3
10832523|NCT04196686|11997707|FG000|STARTED|Second Treatment (4 Minutes)||78
10832524|NCT04196686|11997708|FG001|STARTED|Second Treatment (4 Minutes)||75
10832525|NCT04196686|11997707|FG000|COMPLETED|Second Treatment (4 Minutes)||78
10832526|NCT04196686|11997708|FG001|COMPLETED|Second Treatment (4 Minutes)||75
10832527|NCT04196686|11997707|FG000|NOT COMPLETED|Second Treatment (4 Minutes)||0
10832528|NCT04196686|11997708|FG001|NOT COMPLETED|Second Treatment (4 Minutes)||0
10832529|NCT04178772|11997714|FG000|STARTED|Overall Study||27
10832530|NCT04178772|11997714|FG000|COMPLETED|Overall Study||19
10832531|NCT04178772|11997714|FG000|NOT COMPLETED|Overall Study||8
10832532|NCT04148651|11997718|FG000|STARTED|Overall Study||12
10832533|NCT04148651|11997718|FG000|COMPLETED|Overall Study|2 subjects did not complete the final follow-up due to COVID-19 pandemic|10
10832534|NCT04148651|11997718|FG000|NOT COMPLETED|Overall Study||2
10291334|NCT04450823|11424260|FG000|STARTED|Overall Study||61
10291335|NCT04450823|11424260|FG000|COMPLETED|Overall Study||58
10291336|NCT04450823|11424260|FG000|NOT COMPLETED|Overall Study||3
10291337|NCT04446247|11424264|FG000|STARTED|Overall Study||14
10291338|NCT04446247|11424264|FG000|COMPLETED|Overall Study||14
10291339|NCT04446247|11424264|FG000|NOT COMPLETED|Overall Study||0
10832535|NCT04113304|11997723|FG000|STARTED|Overall Study||6
10832536|NCT04113304|11997723|FG000|COMPLETED|Overall Study||6
10832537|NCT04113304|11997723|FG000|NOT COMPLETED|Overall Study||0
10832538|NCT03929588|11997727|FG000|STARTED|Overall Study||230
10832539|NCT03929588|11997727|FG000|COMPLETED|Overall Study||143
10832540|NCT03929588|11997727|FG000|NOT COMPLETED|Overall Study||87
10291340|NCT04386785|11424270|FG000|STARTED|Overall Study||27
10291341|NCT04386785|11424270|FG000|COMPLETED|Overall Study||27
10291342|NCT04386785|11424270|FG000|NOT COMPLETED|Overall Study||0
10291343|NCT04347564|11424274|FG000|STARTED|Overall Study||45
10291344|NCT04347564|11424274|FG000|COMPLETED|Overall Study||45
10291345|NCT04347564|11424274|FG000|NOT COMPLETED|Overall Study||0
10313948|NCT00158249|11447591|FG000|STARTED|Overall Study||11
10313949|NCT00158249|11447592|FG001|STARTED|Overall Study||10
10313950|NCT00158249|11447591|FG000|COMPLETED|Overall Study||9
10313951|NCT00158249|11447592|FG001|COMPLETED|Overall Study||10
10313952|NCT00158249|11447591|FG000|NOT COMPLETED|Overall Study||2
10313953|NCT00158249|11447592|FG001|NOT COMPLETED|Overall Study||0
10313954|NCT00158262|11447600|FG000|STARTED|Overall Study||21
10313955|NCT00158262|11447601|FG001|STARTED|Overall Study||22
10313956|NCT00158262|11447600|FG000|COMPLETED|Overall Study||20
10313957|NCT00158262|11447601|FG001|COMPLETED|Overall Study||21
10313958|NCT00158262|11447600|FG000|NOT COMPLETED|Overall Study||1
10313959|NCT00158262|11447601|FG001|NOT COMPLETED|Overall Study||1
10313960|NCT00158379|11447607|FG000|STARTED|Overall Study||105
10313961|NCT00158379|11447607|FG000|COMPLETED|Overall Study||105
10313962|NCT00158379|11447607|FG000|NOT COMPLETED|Overall Study||0
10313963|NCT00158600|11447613|FG000|STARTED|Overall Study||60
10313964|NCT00158600|11447614|FG001|STARTED|Overall Study||30
10313965|NCT00158600|11447613|FG000|COMPLETED|Overall Study||55
10313966|NCT00158600|11447614|FG001|COMPLETED|Overall Study||26
10313967|NCT00158600|11447613|FG000|NOT COMPLETED|Overall Study||5
10313968|NCT00158600|11447614|FG001|NOT COMPLETED|Overall Study||4
10313969|NCT00158743|11447623|FG000|STARTED|Overall Study||24
10313970|NCT00158743|11447624|FG001|STARTED|Overall Study||27
10313971|NCT00158743|11447623|FG000|COMPLETED|Overall Study||15
10313972|NCT00158743|11447624|FG001|COMPLETED|Overall Study||20
10313973|NCT00158743|11447623|FG000|NOT COMPLETED|Overall Study||9
10313974|NCT00158743|11447624|FG001|NOT COMPLETED|Overall Study||7
10313975|NCT00158756|11447635|FG000|STARTED|Overall Study||80
10313976|NCT00158756|11447636|FG001|STARTED|Overall Study||25
10313977|NCT00158756|11447637|FG002|STARTED|Overall Study||81
10313978|NCT00158756|11447638|FG003|STARTED|Overall Study||23
10313979|NCT00158756|11447639|FG004|STARTED|Overall Study||99
10313980|NCT00158756|11447635|FG000|COMPLETED|Overall Study||75
10313981|NCT00158756|11447636|FG001|COMPLETED|Overall Study||25
10313982|NCT00158756|11447637|FG002|COMPLETED|Overall Study||73
10313983|NCT00158756|11447638|FG003|COMPLETED|Overall Study||22
10313984|NCT00158756|11447639|FG004|COMPLETED|Overall Study||96
10832541|NCT03893448|11997733|FG000|STARTED|Overall Study||860
10832542|NCT03893448|11997734|FG001|STARTED|Overall Study||860
10832543|NCT03893448|11997733|FG000|Treated|Overall Study||858
10832544|NCT03893448|11997734|FG001|Treated|Overall Study||856
10832545|NCT03893448|11997733|FG000|COMPLETED|Overall Study||758
10832546|NCT03893448|11997734|FG001|COMPLETED|Overall Study||734
10832547|NCT03893448|11997733|FG000|NOT COMPLETED|Overall Study||102
10832548|NCT03893448|11997734|FG001|NOT COMPLETED|Overall Study||126
10832549|NCT03870880|11997747|FG000|STARTED|Overall Study||27
10832550|NCT03870880|11997748|FG001|STARTED|Overall Study||58
10832551|NCT03870880|11997749|FG002|STARTED|Overall Study||31
10832552|NCT03870880|11997750|FG003|STARTED|Overall Study||28
10832553|NCT03870880|11997751|FG004|STARTED|Overall Study||61
10832554|NCT03870880|11997752|FG005|STARTED|Overall Study||10
10832555|NCT03870880|11997747|FG000|COMPLETED|Overall Study||21
10832556|NCT03870880|11997748|FG001|COMPLETED|Overall Study||43
10832557|NCT03870880|11997749|FG002|COMPLETED|Overall Study||26
10832558|NCT03870880|11997750|FG003|COMPLETED|Overall Study||20
10832559|NCT03870880|11997751|FG004|COMPLETED|Overall Study||44
10832560|NCT03870880|11997752|FG005|COMPLETED|Overall Study||7
10832561|NCT03870880|11997747|FG000|NOT COMPLETED|Overall Study||6
10832562|NCT03870880|11997748|FG001|NOT COMPLETED|Overall Study||15
10291346|NCT04330157|11424281|FG000|STARTED|Overall Study||50
10291347|NCT04330157|11424281|FG000|COMPLETED|Overall Study||43
10291348|NCT04330157|11424281|FG000|NOT COMPLETED|Overall Study||7
10313985|NCT00158756|11447635|FG000|NOT COMPLETED|Overall Study||5
10313986|NCT00158756|11447636|FG001|NOT COMPLETED|Overall Study||0
10313987|NCT00158756|11447637|FG002|NOT COMPLETED|Overall Study||8
10313988|NCT00158756|11447638|FG003|NOT COMPLETED|Overall Study||1
10313989|NCT00158756|11447639|FG004|NOT COMPLETED|Overall Study||3
10313990|NCT00158860|11447653|FG000|STARTED|Overall Study||128
10313991|NCT00158860|11447654|FG001|STARTED|Overall Study||255
10313992|NCT00158860|11447653|FG000|COMPLETED|Overall Study||93
10313993|NCT00158860|11447654|FG001|COMPLETED|Overall Study||184
10313994|NCT00158860|11447653|FG000|NOT COMPLETED|Overall Study||35
10313995|NCT00158860|11447654|FG001|NOT COMPLETED|Overall Study||71
10313996|NCT00158925|11447661|FG000|STARTED|Overall Study|96 subjects were implanted or attempted with the study lead|96
10313997|NCT00158925|11447661|FG000|COMPLETED|Overall Study||84
10313998|NCT00158925|11447661|FG000|NOT COMPLETED|Overall Study||12
10313999|NCT00159250|11447667|FG000|STARTED|Overall Study||2
10314000|NCT00159250|11447668|FG001|STARTED|Overall Study||5
10314001|NCT00159250|11447667|FG000|COMPLETED|Overall Study||2
10314002|NCT00159250|11447668|FG001|COMPLETED|Overall Study||5
10314003|NCT00159250|11447667|FG000|NOT COMPLETED|Overall Study||0
10314004|NCT00159250|11447668|FG001|NOT COMPLETED|Overall Study||0
10314005|NCT00159263|11447674|FG000|STARTED|First Intervention||1
10314006|NCT00159263|11447675|FG001|STARTED|First Intervention||1
10314007|NCT00159263|11447676|FG002|STARTED|First Intervention||2
10314008|NCT00159263|11447677|FG003|STARTED|First Intervention||2
10314009|NCT00159263|11447678|FG004|STARTED|First Intervention||2
10314010|NCT00159263|11447679|FG005|STARTED|First Intervention||2
10314011|NCT00159263|11447674|FG000|COMPLETED|First Intervention||1
10314012|NCT00159263|11447675|FG001|COMPLETED|First Intervention||1
10314013|NCT00159263|11447676|FG002|COMPLETED|First Intervention||2
10314014|NCT00159263|11447677|FG003|COMPLETED|First Intervention||2
10314015|NCT00159263|11447678|FG004|COMPLETED|First Intervention||2
10314016|NCT00159263|11447679|FG005|COMPLETED|First Intervention||2
10314017|NCT00159263|11447674|FG000|NOT COMPLETED|First Intervention||0
10314018|NCT00159263|11447675|FG001|NOT COMPLETED|First Intervention||0
10314019|NCT00159263|11447676|FG002|NOT COMPLETED|First Intervention||0
10314020|NCT00159263|11447677|FG003|NOT COMPLETED|First Intervention||0
10314021|NCT00159263|11447678|FG004|NOT COMPLETED|First Intervention||0
10314022|NCT00159263|11447679|FG005|NOT COMPLETED|First Intervention||0
10314023|NCT00159263|11447674|FG000|STARTED|Washout||1
10314024|NCT00159263|11447675|FG001|STARTED|Washout||1
10314025|NCT00159263|11447676|FG002|STARTED|Washout||2
10314026|NCT00159263|11447677|FG003|STARTED|Washout||2
10314027|NCT00159263|11447678|FG004|STARTED|Washout||2
10409200|NCT00758524|11553189|FG010|STARTED|Core Period (Week 0 to Week 8)||0
10832563|NCT03870880|11997749|FG002|NOT COMPLETED|Overall Study||5
10832564|NCT03870880|11997750|FG003|NOT COMPLETED|Overall Study||8
10832565|NCT03870880|11997751|FG004|NOT COMPLETED|Overall Study||17
10832566|NCT03870880|11997752|FG005|NOT COMPLETED|Overall Study||3
10832567|NCT03831347|11997771|FG000|STARTED|Overall Study||11
10832568|NCT03831347|11997771|FG000|COMPLETED|Overall Study||9
10832569|NCT03831347|11997771|FG000|NOT COMPLETED|Overall Study||2
10314028|NCT00159263|11447679|FG005|STARTED|Washout||2
10314029|NCT00159263|11447674|FG000|COMPLETED|Washout||1
10314030|NCT00159263|11447675|FG001|COMPLETED|Washout||1
10314031|NCT00159263|11447676|FG002|COMPLETED|Washout||2
10314032|NCT00159263|11447677|FG003|COMPLETED|Washout||2
10314033|NCT00159263|11447678|FG004|COMPLETED|Washout||2
10314034|NCT00159263|11447679|FG005|COMPLETED|Washout||2
10314035|NCT00159263|11447674|FG000|NOT COMPLETED|Washout||0
10409201|NCT00758524|11553190|FG011|STARTED|Core Period (Week 0 to Week 8)||0
10832612|NCT03811574|11997845|FG000|STARTED|Overall Study||101
10832613|NCT03811574|11997846|FG001|STARTED|Overall Study||199
10832614|NCT03811574|11997847|FG002|STARTED|Overall Study||101
10832615|NCT03811574|11997845|FG000|Full Analysis Set (FAS)|Overall Study||101
10832616|NCT03811574|11997846|FG001|Full Analysis Set (FAS)|Overall Study||199
10832617|NCT03811574|11997847|FG002|Full Analysis Set (FAS)|Overall Study||101
10832618|NCT03811574|11997845|FG000|Safety Analysis Set (SAS)|Overall Study||100
10832619|NCT03811574|11997846|FG001|Safety Analysis Set (SAS)|Overall Study||199
10832620|NCT03811574|11997847|FG002|Safety Analysis Set (SAS)|Overall Study||101
10832621|NCT03811574|11997845|FG000|Treated|Overall Study||100
10832622|NCT03811574|11997846|FG001|Treated|Overall Study||199
10832623|NCT03811574|11997847|FG002|Treated|Overall Study||101
10832624|NCT03811574|11997845|FG000|COMPLETED|Overall Study||99
10832625|NCT03811574|11997846|FG001|COMPLETED|Overall Study||195
10832626|NCT03811574|11997847|FG002|COMPLETED|Overall Study||101
10832627|NCT03811574|11997845|FG000|NOT COMPLETED|Overall Study||2
10832628|NCT03811574|11997846|FG001|NOT COMPLETED|Overall Study||4
10832629|NCT03811574|11997847|FG002|NOT COMPLETED|Overall Study||0
10832630|NCT03800420|11997857|FG000|STARTED|Overall Study||12
10832631|NCT03800420|11997858|FG001|STARTED|Overall Study||4
10832632|NCT03800420|11997857|FG000|COMPLETED|Overall Study||10
10832633|NCT03800420|11997858|FG001|COMPLETED|Overall Study||3
10832634|NCT03800420|11997857|FG000|NOT COMPLETED|Overall Study||2
10832635|NCT03800420|11997858|FG001|NOT COMPLETED|Overall Study||1
10409202|NCT00758524|11553191|FG012|STARTED|Core Period (Week 0 to Week 8)||0
10832636|NCT03759184|11997868|FG000|STARTED|Overall Study||1
10832637|NCT03759184|11997868|FG000|COMPLETED|Overall Study||1
10832638|NCT03759184|11997868|FG000|NOT COMPLETED|Overall Study||0
10832639|NCT03747640|11997874|FG000|STARTED|Overall Study||15
10832640|NCT03747640|11997875|FG001|STARTED|Overall Study||15
10832641|NCT03747640|11997874|FG000|COMPLETED|Overall Study||15
10832642|NCT03747640|11997875|FG001|COMPLETED|Overall Study||15
10832643|NCT03747640|11997874|FG000|NOT COMPLETED|Overall Study||0
10832644|NCT03747640|11997875|FG001|NOT COMPLETED|Overall Study||0
10832645|NCT03727750|11997883|FG000|STARTED|Overall Study||51
10832646|NCT03727750|11997883|FG000|Safety Set|Overall Study||50
10832647|NCT03727750|11997883|FG000|COMPLETED|Overall Study||2
10832648|NCT03727750|11997883|FG000|NOT COMPLETED|Overall Study||49
10832649|NCT03715829|11997893|FG000|STARTED|Dose Ranging Period||65
10832650|NCT03715829|11997894|FG001|STARTED|Dose Ranging Period||67
10832651|NCT03715829|11997895|FG002|STARTED|Dose Ranging Period||67
10832652|NCT03715829|11997896|FG003|STARTED|Dose Ranging Period||50
10832653|NCT03715829|11997897|FG004|STARTED|Dose Ranging Period||49
10832654|NCT03715829|11997898|FG005|STARTED|Dose Ranging Period||66
10832655|NCT03715829|11997899|FG006|STARTED|Dose Ranging Period||0
10832656|NCT03715829|11997900|FG007|STARTED|Dose Ranging Period||0
10832657|NCT03715829|11997901|FG008|STARTED|Dose Ranging Period||0
10832658|NCT03715829|11997902|FG009|STARTED|Dose Ranging Period||0
10832659|NCT03715829|11997903|FG010|STARTED|Dose Ranging Period||0
10832660|NCT03715829|11997893|FG000|COMPLETED|Dose Ranging Period||53
10832661|NCT03715829|11997894|FG001|COMPLETED|Dose Ranging Period||58
10832662|NCT03715829|11997895|FG002|COMPLETED|Dose Ranging Period||54
10832663|NCT03715829|11997896|FG003|COMPLETED|Dose Ranging Period||36
10832664|NCT03715829|11997897|FG004|COMPLETED|Dose Ranging Period||42
10832665|NCT03715829|11997898|FG005|COMPLETED|Dose Ranging Period||55
10832666|NCT03715829|11997899|FG006|COMPLETED|Dose Ranging Period||0
10832667|NCT03715829|11997900|FG007|COMPLETED|Dose Ranging Period||0
10832668|NCT03715829|11997901|FG008|COMPLETED|Dose Ranging Period||0
10832669|NCT03715829|11997902|FG009|COMPLETED|Dose Ranging Period||0
10832670|NCT03715829|11997903|FG010|COMPLETED|Dose Ranging Period||0
10832671|NCT03715829|11997893|FG000|NOT COMPLETED|Dose Ranging Period||12
10832672|NCT03715829|11997894|FG001|NOT COMPLETED|Dose Ranging Period||9
10832673|NCT03715829|11997895|FG002|NOT COMPLETED|Dose Ranging Period||13
10832674|NCT03715829|11997896|FG003|NOT COMPLETED|Dose Ranging Period||14
10832675|NCT03715829|11997897|FG004|NOT COMPLETED|Dose Ranging Period||7
10832676|NCT03715829|11997898|FG005|NOT COMPLETED|Dose Ranging Period||11
10832677|NCT03715829|11997899|FG006|NOT COMPLETED|Dose Ranging Period||0
10832678|NCT03715829|11997900|FG007|NOT COMPLETED|Dose Ranging Period||0
10832679|NCT03715829|11997901|FG008|NOT COMPLETED|Dose Ranging Period||0
10832680|NCT03715829|11997902|FG009|NOT COMPLETED|Dose Ranging Period||0
10832681|NCT03715829|11997903|FG010|NOT COMPLETED|Dose Ranging Period||0
10832682|NCT03715829|11997893|FG000|STARTED|Extension Period||0
10832683|NCT03715829|11997894|FG001|STARTED|Extension Period||0
10832684|NCT03715829|11997895|FG002|STARTED|Extension Period||0
10832685|NCT03715829|11997896|FG003|STARTED|Extension Period||0
10832686|NCT03715829|11997897|FG004|STARTED|Extension Period||0
10832687|NCT03715829|11997898|FG005|STARTED|Extension Period||0
10832688|NCT03715829|11997899|FG006|STARTED|Extension Period||55
10832689|NCT03715829|11997900|FG007|STARTED|Extension Period||43
10832690|NCT03715829|11997901|FG008|STARTED|Extension Period||187
10832691|NCT03715829|11997902|FG009|STARTED|Extension Period||6
10832692|NCT03715829|11997903|FG010|STARTED|Extension Period||2
10832693|NCT03715829|11997893|FG000|COMPLETED|Extension Period||0
10832694|NCT03715829|11997894|FG001|COMPLETED|Extension Period||0
10832695|NCT03715829|11997895|FG002|COMPLETED|Extension Period||0
10832696|NCT03715829|11997896|FG003|COMPLETED|Extension Period||0
10832697|NCT03715829|11997897|FG004|COMPLETED|Extension Period||0
10832698|NCT03715829|11997898|FG005|COMPLETED|Extension Period||0
10832699|NCT03715829|11997899|FG006|COMPLETED|Extension Period||47
10832700|NCT03715829|11997900|FG007|COMPLETED|Extension Period||27
10832701|NCT03715829|11997901|FG008|COMPLETED|Extension Period||158
10832702|NCT03715829|11997902|FG009|COMPLETED|Extension Period||3
10832703|NCT03715829|11997903|FG010|COMPLETED|Extension Period||2
10832704|NCT03715829|11997893|FG000|NOT COMPLETED|Extension Period||0
10832705|NCT03715829|11997894|FG001|NOT COMPLETED|Extension Period||0
10832706|NCT03715829|11997895|FG002|NOT COMPLETED|Extension Period||0
10832707|NCT03715829|11997896|FG003|NOT COMPLETED|Extension Period||0
10832708|NCT03715829|11997897|FG004|NOT COMPLETED|Extension Period||0
10832709|NCT03715829|11997898|FG005|NOT COMPLETED|Extension Period||0
10832710|NCT03715829|11997899|FG006|NOT COMPLETED|Extension Period||8
10832711|NCT03715829|11997900|FG007|NOT COMPLETED|Extension Period||16
10832712|NCT03715829|11997901|FG008|NOT COMPLETED|Extension Period||29
10832713|NCT03715829|11997902|FG009|NOT COMPLETED|Extension Period||3
10832714|NCT03715829|11997903|FG010|NOT COMPLETED|Extension Period||0
10832715|NCT03693430|11997931|FG000|STARTED|Overall Study||152
10832716|NCT03693430|11997932|FG001|STARTED|Overall Study||152
10832717|NCT03693430|11997931|FG000|Full Analysis Set (FAS)|Overall Study||152
10832718|NCT03693430|11997932|FG001|Full Analysis Set (FAS)|Overall Study||152
10832719|NCT03693430|11997931|FG000|Safety Analysis Set (SAS)|Overall Study||152
10832720|NCT03693430|11997932|FG001|Safety Analysis Set (SAS)|Overall Study||152
10832721|NCT03693430|11997931|FG000|COMPLETED|Overall Study||148
10832722|NCT03693430|11997932|FG001|COMPLETED|Overall Study||134
10832723|NCT03693430|11997931|FG000|NOT COMPLETED|Overall Study||4
10832724|NCT03693430|11997932|FG001|NOT COMPLETED|Overall Study||18
10832725|NCT03677934|11997940|FG000|STARTED|Overall Study||248
10832726|NCT03677934|11997941|FG001|STARTED|Overall Study||167
10832727|NCT03677934|11997940|FG000|COMPLETED|Overall Study||0
10832728|NCT03677934|11997941|FG001|COMPLETED|Overall Study||0
10832729|NCT03677934|11997940|FG000|NOT COMPLETED|Overall Study||248
10832730|NCT03677934|11997941|FG001|NOT COMPLETED|Overall Study||167
10832731|NCT03660839|11997951|FG000|STARTED|Overall Study||35
10832732|NCT03660839|11997952|FG001|STARTED|Overall Study||36
10832733|NCT03660839|11997953|FG002|STARTED|Overall Study||36
10832734|NCT03660839|11997954|FG003|STARTED|Overall Study||33
10832735|NCT03660839|11997951|FG000|COMPLETED|Overall Study||35
10832736|NCT03660839|11997952|FG001|COMPLETED|Overall Study||36
10832737|NCT03660839|11997953|FG002|COMPLETED|Overall Study||36
10832738|NCT03660839|11997954|FG003|COMPLETED|Overall Study||33
10832739|NCT03660839|11997951|FG000|NOT COMPLETED|Overall Study||0
10832740|NCT03660839|11997952|FG001|NOT COMPLETED|Overall Study||0
10832741|NCT03660839|11997953|FG002|NOT COMPLETED|Overall Study||0
10832742|NCT03660839|11997954|FG003|NOT COMPLETED|Overall Study||0
10832743|NCT03660241|11997970|FG000|STARTED|Overall Study||8
10832744|NCT03660241|11997971|FG001|STARTED|Overall Study||7
10832745|NCT03660241|11997972|FG002|STARTED|Overall Study||8
10832746|NCT03660241|11997970|FG000|COMPLETED|Overall Study||8
10832747|NCT03660241|11997971|FG001|COMPLETED|Overall Study||7
10832748|NCT03660241|11997972|FG002|COMPLETED|Overall Study||8
10832749|NCT03660241|11997970|FG000|NOT COMPLETED|Overall Study||0
10832750|NCT03660241|11997971|FG001|NOT COMPLETED|Overall Study||0
10832751|NCT03660241|11997972|FG002|NOT COMPLETED|Overall Study||0
10832752|NCT03575104|11997983|FG000|STARTED|Overall Study||307
10832753|NCT03575104|11997984|FG001|STARTED|Overall Study||309
10832754|NCT03575104|11997985|FG002|STARTED|Overall Study||308
10832755|NCT03575104|11997983|FG000|COMPLETED|Overall Study||283
10832756|NCT03575104|11997984|FG001|COMPLETED|Overall Study||280
10832757|NCT03575104|11997985|FG002|COMPLETED|Overall Study||286
10291349|NCT04317690|11424295|FG000|STARTED|Overall Study||100
10291350|NCT04317690|11424296|FG001|STARTED|Overall Study||100
10409203|NCT00758524|11553192|FG013|STARTED|Core Period (Week 0 to Week 8)||0
10832758|NCT03575104|11997983|FG000|NOT COMPLETED|Overall Study||24
10832759|NCT03575104|11997984|FG001|NOT COMPLETED|Overall Study||29
10832760|NCT03575104|11997985|FG002|NOT COMPLETED|Overall Study||22
10832761|NCT03569475|11997996|FG000|STARTED|Double-blind Treatment Period (8 Weeks)||164
10832762|NCT03569475|11997997|FG001|STARTED|Double-blind Treatment Period (8 Weeks)||169
10832763|NCT03569475|11997998|FG002|STARTED|Double-blind Treatment Period (8 Weeks)||168
10832764|NCT03569475|11997996|FG000|Safety Population|Double-blind Treatment Period (8 Weeks)||160
10832765|NCT03569475|11997997|FG001|Safety Population|Double-blind Treatment Period (8 Weeks)||166
10832766|NCT03569475|11997998|FG002|Safety Population|Double-blind Treatment Period (8 Weeks)||166
10832767|NCT03569475|11997996|FG000|COMPLETED|Double-blind Treatment Period (8 Weeks)||146
10832768|NCT03569475|11997997|FG001|COMPLETED|Double-blind Treatment Period (8 Weeks)||146
10832769|NCT03569475|11997998|FG002|COMPLETED|Double-blind Treatment Period (8 Weeks)||144
10832770|NCT03569475|11997996|FG000|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||18
10832771|NCT03569475|11997997|FG001|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||23
10832772|NCT03569475|11997998|FG002|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||24
10832773|NCT03569475|11997996|FG000|STARTED|Double-blind Down-taper Period (1 Week)||140
10832774|NCT03569475|11997997|FG001|STARTED|Double-blind Down-taper Period (1 Week)||141
10832775|NCT03569475|11997998|FG002|STARTED|Double-blind Down-taper Period (1 Week)||140
10832776|NCT03569475|11997996|FG000|COMPLETED|Double-blind Down-taper Period (1 Week)||140
10832777|NCT03569475|11997997|FG001|COMPLETED|Double-blind Down-taper Period (1 Week)||139
10832778|NCT03569475|11997998|FG002|COMPLETED|Double-blind Down-taper Period (1 Week)||138
10832779|NCT03569475|11997996|FG000|NOT COMPLETED|Double-blind Down-taper Period (1 Week)||0
10832780|NCT03569475|11997997|FG001|NOT COMPLETED|Double-blind Down-taper Period (1 Week)||2
10832781|NCT03569475|11997998|FG002|NOT COMPLETED|Double-blind Down-taper Period (1 Week)||2
10832782|NCT03554798|11998018|FG000|STARTED|Overall Study||50
10832783|NCT03554798|11998019|FG001|STARTED|Overall Study||50
10832784|NCT03554798|11998020|FG002|STARTED|Overall Study||51
10832785|NCT03554798|11998021|FG003|STARTED|Overall Study||156
10832786|NCT03554798|11998022|FG004|STARTED|Overall Study||144
10832787|NCT03554798|11998023|FG005|STARTED|Overall Study||138
10832788|NCT03554798|11998024|FG006|STARTED|Overall Study||150
10832789|NCT03554798|11998025|FG007|STARTED|Overall Study||135
10832790|NCT03554798|11998026|FG008|STARTED|Overall Study||151
10832791|NCT03554798|11998018|FG000|COMPLETED|Overall Study||45
10832792|NCT03554798|11998019|FG001|COMPLETED|Overall Study||47
10832793|NCT03554798|11998020|FG002|COMPLETED|Overall Study||48
10832794|NCT03554798|11998021|FG003|COMPLETED|Overall Study||154
10832795|NCT03554798|11998022|FG004|COMPLETED|Overall Study||141
10832796|NCT03554798|11998023|FG005|COMPLETED|Overall Study||137
10832797|NCT03554798|11998024|FG006|COMPLETED|Overall Study||149
10832798|NCT03554798|11998025|FG007|COMPLETED|Overall Study||133
10832799|NCT03554798|11998026|FG008|COMPLETED|Overall Study||149
10832800|NCT03554798|11998018|FG000|NOT COMPLETED|Overall Study||5
10832801|NCT03554798|11998019|FG001|NOT COMPLETED|Overall Study||3
10832802|NCT03554798|11998020|FG002|NOT COMPLETED|Overall Study||3
10832803|NCT03554798|11998021|FG003|NOT COMPLETED|Overall Study||2
10832804|NCT03554798|11998022|FG004|NOT COMPLETED|Overall Study||3
10832805|NCT03554798|11998023|FG005|NOT COMPLETED|Overall Study||1
10832806|NCT03554798|11998024|FG006|NOT COMPLETED|Overall Study||1
10832807|NCT03554798|11998025|FG007|NOT COMPLETED|Overall Study||2
10832808|NCT03554798|11998026|FG008|NOT COMPLETED|Overall Study||2
10832809|NCT03545191|11998052|FG000|STARTED|Overall Study||310
10832810|NCT03545191|11998053|FG001|STARTED|Overall Study||310
10832811|NCT03545191|11998054|FG002|STARTED|Overall Study||310
10832812|NCT03545191|11998052|FG000|COMPLETED|Overall Study||288
10832813|NCT03545191|11998053|FG001|COMPLETED|Overall Study||285
10832814|NCT03545191|11998054|FG002|COMPLETED|Overall Study||280
10832815|NCT03545191|11998052|FG000|NOT COMPLETED|Overall Study||22
10832816|NCT03545191|11998053|FG001|NOT COMPLETED|Overall Study||25
10832817|NCT03545191|11998054|FG002|NOT COMPLETED|Overall Study||30
10832818|NCT03500549|11998064|FG000|STARTED|Run-in Period (Day -28 to ≤Day 1)||41
10832819|NCT03500549|11998065|FG001|STARTED|Run-in Period (Day -28 to ≤Day 1)||39
10832820|NCT03500549|11998064|FG000|COMPLETED|Run-in Period (Day -28 to ≤Day 1)||41
10832821|NCT03500549|11998065|FG001|COMPLETED|Run-in Period (Day -28 to ≤Day 1)||39
10832822|NCT03500549|11998064|FG000|NOT COMPLETED|Run-in Period (Day -28 to ≤Day 1)||0
10832823|NCT03500549|11998065|FG001|NOT COMPLETED|Run-in Period (Day -28 to ≤Day 1)||0
10291351|NCT04317690|11424297|FG002|STARTED|Overall Study||140
10291352|NCT04317690|11424298|FG003|STARTED|Overall Study||100
10832824|NCT03500549|11998064|FG000|STARTED|RCP (Day 1 - Week 16)||41
10832825|NCT03500549|11998065|FG001|STARTED|RCP (Day 1 - Week 16)||39
10832826|NCT03500549|11998064|FG000|COMPLETED|RCP (Day 1 - Week 16)||38
10832827|NCT03500549|11998065|FG001|COMPLETED|RCP (Day 1 - Week 16)||39
10832828|NCT03500549|11998064|FG000|NOT COMPLETED|RCP (Day 1 - Week 16)||3
10832829|NCT03500549|11998065|FG001|NOT COMPLETED|RCP (Day 1 - Week 16)||0
10832830|NCT03500549|11998064|FG000|STARTED|Open-label Period (Week 17 to Week 48)||38
10832831|NCT03500549|11998065|FG001|STARTED|Open-label Period (Week 17 to Week 48)||39
10832832|NCT03500549|11998064|FG000|COMPLETED|Open-label Period (Week 17 to Week 48)||35
10832833|NCT03500549|11998065|FG001|COMPLETED|Open-label Period (Week 17 to Week 48)||32
10832834|NCT03500549|11998064|FG000|NOT COMPLETED|Open-label Period (Week 17 to Week 48)||3
10832835|NCT03500549|11998065|FG001|NOT COMPLETED|Open-label Period (Week 17 to Week 48)||7
10832836|NCT03456700|11998076|FG000|STARTED|Overall Study||22
10832837|NCT03456700|11998076|FG000|COMPLETED|Overall Study||21
10832838|NCT03456700|11998076|FG000|NOT COMPLETED|Overall Study||1
10832839|NCT03435185|11998082|FG000|STARTED|Overall Study||44
10832840|NCT03435185|11998083|FG001|STARTED|Overall Study||43
10832841|NCT03435185|11998082|FG000|COMPLETED|Overall Study||43
10832842|NCT03435185|11998083|FG001|COMPLETED|Overall Study||28
10832843|NCT03435185|11998082|FG000|NOT COMPLETED|Overall Study||1
10832844|NCT03435185|11998083|FG001|NOT COMPLETED|Overall Study||15
10832845|NCT03427411|11998091|FG000|STARTED|Overall Study||30
10832846|NCT03427411|11998092|FG001|STARTED|Overall Study||27
10832847|NCT03427411|11998091|FG000|COMPLETED|Overall Study||30
10832848|NCT03427411|11998092|FG001|COMPLETED|Overall Study||26
10832849|NCT03427411|11998091|FG000|NOT COMPLETED|Overall Study||0
10832850|NCT03427411|11998092|FG001|NOT COMPLETED|Overall Study||1
10832851|NCT03387150|11998105|FG000|STARTED|Overall Study||19
10832852|NCT03387150|11998106|FG001|STARTED|Overall Study||19
10832853|NCT03387150|11998107|FG002|STARTED|Overall Study||21
10832854|NCT03387150|11998108|FG003|STARTED|Overall Study||21
10832855|NCT03387150|11998109|FG004|STARTED|Overall Study||20
10832856|NCT03387150|11998110|FG005|STARTED|Overall Study||21
10832857|NCT03387150|11998111|FG006|STARTED|Overall Study||3
10832858|NCT03387150|11998105|FG000|Safety Population|Overall Study||19
10832859|NCT03387150|11998106|FG001|Safety Population|Overall Study||19
10832860|NCT03387150|11998107|FG002|Safety Population|Overall Study||21
10832861|NCT03387150|11998108|FG003|Safety Population|Overall Study||21
10832862|NCT03387150|11998109|FG004|Safety Population|Overall Study||20
10832863|NCT03387150|11998110|FG005|Safety Population|Overall Study||21
10832864|NCT03387150|11998111|FG006|Safety Population|Overall Study||3
10832865|NCT03387150|11998105|FG000|COMPLETED|Overall Study||13
10832866|NCT03387150|11998106|FG001|COMPLETED|Overall Study||16
10832867|NCT03387150|11998107|FG002|COMPLETED|Overall Study||16
10832868|NCT03387150|11998108|FG003|COMPLETED|Overall Study||14
10832869|NCT03387150|11998109|FG004|COMPLETED|Overall Study||14
10832870|NCT03387150|11998110|FG005|COMPLETED|Overall Study||14
10832871|NCT03387150|11998111|FG006|COMPLETED|Overall Study||3
10291353|NCT04317690|11424299|FG004|STARTED|Overall Study||99
10291354|NCT04317690|11424295|FG000|COMPLETED|Overall Study||100
10291355|NCT04317690|11424296|FG001|COMPLETED|Overall Study||96
10291356|NCT04317690|11424297|FG002|COMPLETED|Overall Study||140
10291357|NCT04317690|11424298|FG003|COMPLETED|Overall Study||98
10291358|NCT04317690|11424299|FG004|COMPLETED|Overall Study||99
10291359|NCT04317690|11424295|FG000|NOT COMPLETED|Overall Study||0
10291360|NCT04317690|11424296|FG001|NOT COMPLETED|Overall Study||4
10291361|NCT04317690|11424297|FG002|NOT COMPLETED|Overall Study||0
10291362|NCT04317690|11424298|FG003|NOT COMPLETED|Overall Study||2
10291363|NCT04317690|11424299|FG004|NOT COMPLETED|Overall Study||0
10409204|NCT00758524|11553193|FG014|STARTED|Core Period (Week 0 to Week 8)||0
10409205|NCT00758524|11553194|FG015|STARTED|Core Period (Week 0 to Week 8)||0
10409206|NCT00758524|11553195|FG016|STARTED|Core Period (Week 0 to Week 8)||0
10409207|NCT00758524|11553179|FG000|Treated|Core Period (Week 0 to Week 8)||92
10409208|NCT00758524|11553180|FG001|Treated|Core Period (Week 0 to Week 8)||87
10409209|NCT00758524|11553181|FG002|Treated|Core Period (Week 0 to Week 8)|One participant from LCI699 0.5 mg QD was randomized to LCI699 1.0 mg QD and received LCI699 1.0 mg QD, thus was included in this arm in the Safety Set.|87
10409210|NCT00758524|11553182|FG003|Treated|Core Period (Week 0 to Week 8)||97
10314036|NCT00159263|11447675|FG001|NOT COMPLETED|Washout||0
10314037|NCT00159263|11447676|FG002|NOT COMPLETED|Washout||0
10314038|NCT00159263|11447677|FG003|NOT COMPLETED|Washout||0
10314039|NCT00159263|11447678|FG004|NOT COMPLETED|Washout||0
10314040|NCT00159263|11447679|FG005|NOT COMPLETED|Washout||0
10314041|NCT00159263|11447674|FG000|STARTED|Second Intervention||1
10314042|NCT00159263|11447675|FG001|STARTED|Second Intervention||1
10314043|NCT00159263|11447676|FG002|STARTED|Second Intervention||2
10314044|NCT00159263|11447677|FG003|STARTED|Second Intervention||2
10314045|NCT00159263|11447678|FG004|STARTED|Second Intervention||2
10314046|NCT00159263|11447679|FG005|STARTED|Second Intervention||2
10409211|NCT00758524|11553183|FG004|Treated|Core Period (Week 0 to Week 8)||84
10409212|NCT00758524|11553184|FG005|Treated|Core Period (Week 0 to Week 8)||76
10409213|NCT00758524|11553185|FG006|Treated|Core Period (Week 0 to Week 8)||0
10314047|NCT00159263|11447674|FG000|COMPLETED|Second Intervention||1
10314048|NCT00159263|11447675|FG001|COMPLETED|Second Intervention||1
10314049|NCT00159263|11447676|FG002|COMPLETED|Second Intervention||2
10314050|NCT00159263|11447677|FG003|COMPLETED|Second Intervention||2
10314051|NCT00159263|11447678|FG004|COMPLETED|Second Intervention||2
10314052|NCT00159263|11447679|FG005|COMPLETED|Second Intervention||2
10409214|NCT00758524|11553186|FG007|Treated|Core Period (Week 0 to Week 8)||0
10832872|NCT03387150|11998105|FG000|NOT COMPLETED|Overall Study||6
10832873|NCT03387150|11998106|FG001|NOT COMPLETED|Overall Study||3
10832874|NCT03387150|11998107|FG002|NOT COMPLETED|Overall Study||5
10832875|NCT03387150|11998108|FG003|NOT COMPLETED|Overall Study||7
10832876|NCT03387150|11998109|FG004|NOT COMPLETED|Overall Study||6
10832877|NCT03387150|11998110|FG005|NOT COMPLETED|Overall Study||7
10832878|NCT03387150|11998111|FG006|NOT COMPLETED|Overall Study||0
10409215|NCT00758524|11553187|FG008|Treated|Core Period (Week 0 to Week 8)||0
10409216|NCT00758524|11553188|FG009|Treated|Core Period (Week 0 to Week 8)||0
10409217|NCT00758524|11553189|FG010|Treated|Core Period (Week 0 to Week 8)||0
10409218|NCT00758524|11553190|FG011|Treated|Core Period (Week 0 to Week 8)||0
10409219|NCT00758524|11553191|FG012|Treated|Core Period (Week 0 to Week 8)||0
10544915|NCT01493024|11698131|FG001|STARTED|Overall Study||12
10544916|NCT01493024|11698132|FG002|STARTED|Overall Study||24
10544917|NCT01493024|11698133|FG003|STARTED|Overall Study||24
10544918|NCT01493024|11698130|FG000|COMPLETED|Overall Study||30
10544919|NCT01493024|11698131|FG001|COMPLETED|Overall Study||12
10544920|NCT01493024|11698132|FG002|COMPLETED|Overall Study||24
10544921|NCT01493024|11698133|FG003|COMPLETED|Overall Study||24
10544922|NCT01493024|11698130|FG000|NOT COMPLETED|Overall Study||0
10544923|NCT01493024|11698131|FG001|NOT COMPLETED|Overall Study||0
10544924|NCT01493024|11698132|FG002|NOT COMPLETED|Overall Study||0
10544925|NCT01493024|11698133|FG003|NOT COMPLETED|Overall Study||0
10544926|NCT01493089|11698146|FG000|STARTED|Overall Study||122
10544927|NCT01493089|11698147|FG001|STARTED|Overall Study||117
10544928|NCT01493089|11698146|FG000|COMPLETED|Overall Study||119
10544929|NCT01493089|11698147|FG001|COMPLETED|Overall Study||114
10544930|NCT01493089|11698146|FG000|NOT COMPLETED|Overall Study||3
10544931|NCT01493089|11698147|FG001|NOT COMPLETED|Overall Study||3
10544932|NCT01493167|11698155|FG000|STARTED|Overall Study||97
10544933|NCT01493167|11698155|FG000|COMPLETED|Overall Study||97
10544934|NCT01493167|11698155|FG000|NOT COMPLETED|Overall Study||0
10544935|NCT01493180|11698161|FG000|STARTED|Overall Study||51
10544936|NCT01493180|11698162|FG001|STARTED|Overall Study||51
10544937|NCT01493180|11698161|FG000|COMPLETED|Overall Study||48
10544938|NCT01493180|11698162|FG001|COMPLETED|Overall Study||49
10544939|NCT01493180|11698161|FG000|NOT COMPLETED|Overall Study||3
10544940|NCT01493180|11698162|FG001|NOT COMPLETED|Overall Study||2
10544941|NCT01493284|11698168|FG000|STARTED|Overall Study||222
10544942|NCT01493284|11698168|FG000|COMPLETED|Overall Study||161
10544943|NCT01493284|11698168|FG000|NOT COMPLETED|Overall Study||61
10544944|NCT01493414|11698172|FG000|STARTED|Overall Study||2233
10544945|NCT01493414|11698172|FG000|COMPLETED|Overall Study||1283
10544946|NCT01493414|11698172|FG000|NOT COMPLETED|Overall Study||950
10544947|NCT01493427|11698180|FG000|STARTED|Overall Study||199
10544948|NCT01493427|11698180|FG000|COMPLETED|Overall Study||179
10544949|NCT01493427|11698180|FG000|NOT COMPLETED|Overall Study||20
10544950|NCT01493531|11698187|FG000|STARTED|Overall Study||204
10544951|NCT01493531|11698188|FG001|STARTED|Overall Study||200
10544952|NCT01493531|11698189|FG002|STARTED|Overall Study||206
10544953|NCT01493531|11698187|FG000|COMPLETED|Overall Study||163
10544954|NCT01493531|11698188|FG001|COMPLETED|Overall Study||150
10544955|NCT01493531|11698189|FG002|COMPLETED|Overall Study||158
10544956|NCT01493531|11698187|FG000|NOT COMPLETED|Overall Study||41
10544957|NCT01493531|11698188|FG001|NOT COMPLETED|Overall Study||50
10544958|NCT01493531|11698189|FG002|NOT COMPLETED|Overall Study||48
10544959|NCT01493557|11698200|FG000|STARTED|Not Randomized to Management Strategies||0
10544960|NCT01493557|11698201|FG001|STARTED|Not Randomized to Management Strategies||0
10544961|NCT01493557|11698202|FG002|STARTED|Not Randomized to Management Strategies||950
10544962|NCT01493557|11698200|FG000|Without Experiencing GIS|Not Randomized to Management Strategies||0
10544963|NCT01493557|11698201|FG001|Without Experiencing GIS|Not Randomized to Management Strategies||0
10544964|NCT01493557|11698202|FG002|Without Experiencing GIS|Not Randomized to Management Strategies|754 patients completed the trial.|854
10544965|NCT01493557|11698200|FG000|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies||0
10544966|NCT01493557|11698201|FG001|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies||0
10544967|NCT01493557|11698202|FG002|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies|32 patients completed the trial.|48
10544968|NCT01493557|11698200|FG000|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies||0
10544969|NCT01493557|11698201|FG001|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies||0
10544970|NCT01493557|11698202|FG002|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies|26 patients completed (GIS resolved ) and 4 patients completed (GIS not resolved ) the trial.|48
10544971|NCT01493557|11698200|FG000|COMPLETED|Not Randomized to Management Strategies||0
10544972|NCT01493557|11698201|FG001|COMPLETED|Not Randomized to Management Strategies||0
10544973|NCT01493557|11698202|FG002|COMPLETED|Not Randomized to Management Strategies||816
10544974|NCT01493557|11698200|FG000|NOT COMPLETED|Not Randomized to Management Strategies||0
10544975|NCT01493557|11698201|FG001|NOT COMPLETED|Not Randomized to Management Strategies||0
10544976|NCT01493557|11698202|FG002|NOT COMPLETED|Not Randomized to Management Strategies||134
10544977|NCT01493557|11698200|FG000|STARTED|Randomized to Management Strategies||59
10544978|NCT01493557|11698201|FG001|STARTED|Randomized to Management Strategies||58
10544979|NCT01493557|11698202|FG002|STARTED|Randomized to Management Strategies||0
10544980|NCT01493557|11698200|FG000|COMPLETED|Randomized to Management Strategies||44
10544981|NCT01493557|11698201|FG001|COMPLETED|Randomized to Management Strategies||47
10544982|NCT01493557|11698202|FG002|COMPLETED|Randomized to Management Strategies||0
10544983|NCT01493557|11698200|FG000|NOT COMPLETED|Randomized to Management Strategies||15
10544984|NCT01493557|11698201|FG001|NOT COMPLETED|Randomized to Management Strategies||11
10544985|NCT01493557|11698202|FG002|NOT COMPLETED|Randomized to Management Strategies||0
10409220|NCT00758524|11553192|FG013|Treated|Core Period (Week 0 to Week 8)||0
10409221|NCT00758524|11553193|FG014|Treated|Core Period (Week 0 to Week 8)||0
10409222|NCT00758524|11553194|FG015|Treated|Core Period (Week 0 to Week 8)||0
10409223|NCT00758524|11553195|FG016|Treated|Core Period (Week 0 to Week 8)||0
10409224|NCT00758524|11553179|FG000|COMPLETED|Core Period (Week 0 to Week 8)||84
10409225|NCT00758524|11553180|FG001|COMPLETED|Core Period (Week 0 to Week 8)||81
10409226|NCT00758524|11553181|FG002|COMPLETED|Core Period (Week 0 to Week 8)||77
10409227|NCT00758524|11553182|FG003|COMPLETED|Core Period (Week 0 to Week 8)||90
10409228|NCT00758524|11553183|FG004|COMPLETED|Core Period (Week 0 to Week 8)||75
10409229|NCT00758524|11553184|FG005|COMPLETED|Core Period (Week 0 to Week 8)||67
10409230|NCT00758524|11553185|FG006|COMPLETED|Core Period (Week 0 to Week 8)||0
10409231|NCT00758524|11553186|FG007|COMPLETED|Core Period (Week 0 to Week 8)||0
10409232|NCT00758524|11553187|FG008|COMPLETED|Core Period (Week 0 to Week 8)||0
10409233|NCT00758524|11553188|FG009|COMPLETED|Core Period (Week 0 to Week 8)||0
10409234|NCT00758524|11553189|FG010|COMPLETED|Core Period (Week 0 to Week 8)||0
10409235|NCT00758524|11553190|FG011|COMPLETED|Core Period (Week 0 to Week 8)||0
10409236|NCT00758524|11553191|FG012|COMPLETED|Core Period (Week 0 to Week 8)||0
10409237|NCT00758524|11553192|FG013|COMPLETED|Core Period (Week 0 to Week 8)||0
10409238|NCT00758524|11553193|FG014|COMPLETED|Core Period (Week 0 to Week 8)||0
10409239|NCT00758524|11553194|FG015|COMPLETED|Core Period (Week 0 to Week 8)||0
10409240|NCT00758524|11553195|FG016|COMPLETED|Core Period (Week 0 to Week 8)||0
10409241|NCT00758524|11553179|FG000|NOT COMPLETED|Core Period (Week 0 to Week 8)||8
10409242|NCT00758524|11553180|FG001|NOT COMPLETED|Core Period (Week 0 to Week 8)||7
10409243|NCT00758524|11553181|FG002|NOT COMPLETED|Core Period (Week 0 to Week 8)||9
10409244|NCT00758524|11553182|FG003|NOT COMPLETED|Core Period (Week 0 to Week 8)||7
10409245|NCT00758524|11553183|FG004|NOT COMPLETED|Core Period (Week 0 to Week 8)||9
10409246|NCT00758524|11553184|FG005|NOT COMPLETED|Core Period (Week 0 to Week 8)||10
10409247|NCT00758524|11553185|FG006|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
10409248|NCT00758524|11553186|FG007|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
10291364|NCT04274556|11424311|FG000|STARTED|Overall Study||86
10291365|NCT04274556|11424311|FG000|COMPLETED|Overall Study||86
10291366|NCT04274556|11424311|FG000|NOT COMPLETED|Overall Study||0
10291367|NCT04270292|11424315|FG000|STARTED|Overall Study||164
10291368|NCT04270292|11424315|FG000|COMPLETED|Overall Study||164
10291369|NCT04270292|11424315|FG000|NOT COMPLETED|Overall Study||0
10291370|NCT04182217|11424319|FG000|STARTED|Overall Study||91
10291371|NCT04182217|11424319|FG000|COMPLETED|Overall Study||91
10291372|NCT04182217|11424319|FG000|NOT COMPLETED|Overall Study||0
10291376|NCT04083404|11424328|FG000|STARTED|Overall Study||202
10291377|NCT04083404|11424328|FG000|COMPLETED|Overall Study||202
10291378|NCT04083404|11424328|FG000|NOT COMPLETED|Overall Study||0
10291379|NCT04079114|11424332|FG000|STARTED|Overall Study||166
10291380|NCT04079114|11424332|FG000|COMPLETED|Overall Study|Study prematurely terminated.|0
10291381|NCT04079114|11424332|FG000|NOT COMPLETED|Overall Study||166
10291382|NCT04075279|11424336|FG000|STARTED|Overall Study||19
10291383|NCT04075279|11424336|FG000|COMPLETED|Overall Study||19
10291384|NCT04075279|11424336|FG000|NOT COMPLETED|Overall Study||0
10291407|NCT03977818|11424365|FG000|STARTED|Overall Study||2165
10291408|NCT03977818|11424365|FG000|COMPLETED|Overall Study||2165
10291409|NCT03977818|11424365|FG000|NOT COMPLETED|Overall Study||0
10291410|NCT03976531|11424369|FG000|STARTED|Overall Study||42
10291411|NCT03976531|11424369|FG000|COMPLETED|Overall Study||42
10291412|NCT03976531|11424369|FG000|NOT COMPLETED|Overall Study||0
10291413|NCT03964649|11424383|FG000|STARTED|Overall Study||349
10291414|NCT03964649|11424384|FG001|STARTED|Overall Study||304
10291415|NCT03964649|11424385|FG002|STARTED|Overall Study||2728
10291416|NCT03964649|11424386|FG003|STARTED|Overall Study||192
10291417|NCT03964649|11424387|FG004|STARTED|Overall Study||1948
10291418|NCT03964649|11424388|FG005|STARTED|Overall Study||349
10291419|NCT03964649|11424389|FG006|STARTED|Overall Study||376
10291420|NCT03964649|11424390|FG007|STARTED|Overall Study||325
10291421|NCT03964649|11424391|FG008|STARTED|Overall Study||204
10291422|NCT03964649|11424392|FG009|STARTED|Overall Study||533
10291423|NCT03964649|11424383|FG000|COMPLETED|Overall Study||349
10291424|NCT03964649|11424384|FG001|COMPLETED|Overall Study||304
10291425|NCT03964649|11424385|FG002|COMPLETED|Overall Study||2728
10291426|NCT03964649|11424386|FG003|COMPLETED|Overall Study||192
10409249|NCT00758524|11553187|FG008|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
10429146|NCT00862849|11575290|FG004|STARTED|Washout 2 (3 to 14 Days)||4
10291427|NCT03964649|11424387|FG004|COMPLETED|Overall Study||1948
10291428|NCT03964649|11424388|FG005|COMPLETED|Overall Study||349
10291429|NCT03964649|11424389|FG006|COMPLETED|Overall Study||376
10291430|NCT03964649|11424390|FG007|COMPLETED|Overall Study||325
10832915|NCT03366792|11998153|FG000|STARTED|Overall Study||46
10832916|NCT03366792|11998153|FG000|COMPLETED|Overall Study||31
10832917|NCT03366792|11998153|FG000|NOT COMPLETED|Overall Study||15
10832918|NCT03366337|11998161|FG000|STARTED|Overall Study||31
10832919|NCT03366337|11998162|FG001|STARTED|Overall Study||26
10832920|NCT03366337|11998163|FG002|STARTED|Overall Study||28
10832921|NCT03366337|11998164|FG003|STARTED|Overall Study||18
10832922|NCT03366337|11998161|FG000|COMPLETED|Overall Study||28
10832923|NCT03366337|11998162|FG001|COMPLETED|Overall Study||26
10832924|NCT03366337|11998163|FG002|COMPLETED|Overall Study||26
10291373|NCT04160988|11424323|FG000|STARTED|Overall Study||703
10291374|NCT04160988|11424323|FG000|COMPLETED|Overall Study||675
10291375|NCT04160988|11424323|FG000|NOT COMPLETED|Overall Study||28
10291385|NCT04066686|11424342|FG000|STARTED|Overall Study||14
10291386|NCT04066686|11424343|FG001|STARTED|Overall Study||13
10291387|NCT04066686|11424342|FG000|COMPLETED|Overall Study||12
10291388|NCT04066686|11424343|FG001|COMPLETED|Overall Study||13
10291389|NCT04066686|11424342|FG000|NOT COMPLETED|Overall Study||2
10291390|NCT04066686|11424343|FG001|NOT COMPLETED|Overall Study||0
10291391|NCT04058626|11424349|FG000|STARTED|Overall Study||305
10291392|NCT04058626|11424349|FG000|COMPLETED|Overall Study||305
10291393|NCT04058626|11424349|FG000|NOT COMPLETED|Overall Study||0
10291394|NCT04057235|11424353|FG000|STARTED|Overall Study||129
10291395|NCT04057235|11424353|FG000|Had Radiographic Data|Overall Study||58
10291396|NCT04057235|11424353|FG000|Had ODI Data|Overall Study||43
10291397|NCT04057235|11424353|FG000|Had VAS Back Data|Overall Study||45
10291398|NCT04057235|11424353|FG000|Had VAS Leg Data|Overall Study||45
10291399|NCT04057235|11424353|FG000|COMPLETED|Overall Study|All 129 participants had data for at least one of the primary/secondary outcomes or adverse events|129
10291400|NCT04057235|11424353|FG000|NOT COMPLETED|Overall Study||0
10291431|NCT03964649|11424391|FG008|COMPLETED|Overall Study||204
10291432|NCT03964649|11424392|FG009|COMPLETED|Overall Study||533
10291433|NCT03964649|11424383|FG000|NOT COMPLETED|Overall Study||0
10409250|NCT00758524|11553188|FG009|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
10409251|NCT00758524|11553189|FG010|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
10409252|NCT00758524|11553190|FG011|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
10832925|NCT03366337|11998164|FG003|COMPLETED|Overall Study||17
10832926|NCT03366337|11998161|FG000|NOT COMPLETED|Overall Study||3
10409253|NCT00758524|11553191|FG012|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
10409254|NCT00758524|11553192|FG013|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
10409255|NCT00758524|11553193|FG014|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
10409256|NCT00758524|11553194|FG015|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
10409257|NCT00758524|11553195|FG016|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
10409258|NCT00758524|11553179|FG000|STARTED|Withdrawal Period (Week 8 to Week 9)||0
10409259|NCT00758524|11553180|FG001|STARTED|Withdrawal Period (Week 8 to Week 9)||0
10409260|NCT00758524|11553181|FG002|STARTED|Withdrawal Period (Week 8 to Week 9)||0
10409261|NCT00758524|11553182|FG003|STARTED|Withdrawal Period (Week 8 to Week 9)||0
10409262|NCT00758524|11553183|FG004|STARTED|Withdrawal Period (Week 8 to Week 9)||0
10409263|NCT00758524|11553184|FG005|STARTED|Withdrawal Period (Week 8 to Week 9)||0
10409264|NCT00758524|11553185|FG006|STARTED|Withdrawal Period (Week 8 to Week 9)||46
10409265|NCT00758524|11553186|FG007|STARTED|Withdrawal Period (Week 8 to Week 9)||38
10409266|NCT00758524|11553187|FG008|STARTED|Withdrawal Period (Week 8 to Week 9)||44
10409267|NCT00758524|11553188|FG009|STARTED|Withdrawal Period (Week 8 to Week 9)|One participant randomized to Placebo arm in Withdrawal Period received LCI699 0.5 mg QD and was counted in LCI699 0.5 mg QD arm in the Randomized Withdrawal Safety Set.|37
10409268|NCT00758524|11553189|FG010|STARTED|Withdrawal Period (Week 8 to Week 9)||41
10409269|NCT00758524|11553190|FG011|STARTED|Withdrawal Period (Week 8 to Week 9)|One participant randomized to LCI699 0.5 mg BID in the core period received LCI699 1.0 mg QD and was considered in the LCI699 1.0 mg QD arm in Randomized Withdrawal Safety Set.|37
10409270|NCT00758524|11553191|FG012|STARTED|Withdrawal Period (Week 8 to Week 9)||45
10409271|NCT00758524|11553192|FG013|STARTED|Withdrawal Period (Week 8 to Week 9)||45
10409272|NCT00758524|11553193|FG014|STARTED|Withdrawal Period (Week 8 to Week 9)||39
10409273|NCT00758524|11553194|FG015|STARTED|Withdrawal Period (Week 8 to Week 9)||36
10409274|NCT00758524|11553195|FG016|STARTED|Withdrawal Period (Week 8 to Week 9)||66
10409275|NCT00758524|11553179|FG000|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0
10409276|NCT00758524|11553180|FG001|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0
10409277|NCT00758524|11553181|FG002|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0
10409278|NCT00758524|11553182|FG003|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0
10409279|NCT00758524|11553183|FG004|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0
10409280|NCT00758524|11553184|FG005|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0
10409281|NCT00758524|11553185|FG006|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||45
10409282|NCT00758524|11553186|FG007|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||38
10409283|NCT00758524|11553187|FG008|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||43
10409284|NCT00758524|11553188|FG009|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||37
10409285|NCT00758524|11553189|FG010|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||41
10832927|NCT03366337|11998162|FG001|NOT COMPLETED|Overall Study||0
10832928|NCT03366337|11998163|FG002|NOT COMPLETED|Overall Study||2
10832929|NCT03366337|11998164|FG003|NOT COMPLETED|Overall Study||1
10291434|NCT03964649|11424384|FG001|NOT COMPLETED|Overall Study||0
10291435|NCT03964649|11424385|FG002|NOT COMPLETED|Overall Study||0
10832930|NCT03342053|11998176|FG000|STARTED|Overall Study||23
10832931|NCT03342053|11998177|FG001|STARTED|Overall Study||23
10832932|NCT03342053|11998176|FG000|COMPLETED|Overall Study||21
10832933|NCT03342053|11998177|FG001|COMPLETED|Overall Study||22
10832934|NCT03342053|11998176|FG000|NOT COMPLETED|Overall Study||2
10832935|NCT03342053|11998177|FG001|NOT COMPLETED|Overall Study||1
10832936|NCT03283241|11998185|FG000|STARTED|Overall Study||32
10832937|NCT03283241|11998186|FG001|STARTED|Overall Study||30
10832938|NCT03283241|11998185|FG000|Completed 12 Weeks|Overall Study|Completed 12 weeks|29
10832939|NCT03283241|11998186|FG001|Completed 12 Weeks|Overall Study|Completed 12 weeks|29
10832940|NCT03283241|11998185|FG000|COMPLETED|Overall Study|Completed 24 month|28
10832941|NCT03283241|11998186|FG001|COMPLETED|Overall Study|Completed 24 month|27
10832942|NCT03283241|11998185|FG000|NOT COMPLETED|Overall Study||4
10832943|NCT03283241|11998186|FG001|NOT COMPLETED|Overall Study||3
10832944|NCT03242772|11998194|FG000|STARTED|Overall Study||9
10832945|NCT03242772|11998195|FG001|STARTED|Overall Study||9
10832946|NCT03242772|11998194|FG000|COMPLETED|Overall Study||6
10832947|NCT03242772|11998195|FG001|COMPLETED|Overall Study||8
10832948|NCT03242772|11998194|FG000|NOT COMPLETED|Overall Study||3
10832949|NCT03242772|11998195|FG001|NOT COMPLETED|Overall Study||1
10832950|NCT03236311|11998203|FG000|STARTED|Overall Study||5
10832951|NCT03236311|11998204|FG001|STARTED|Overall Study||5
10832952|NCT03236311|11998203|FG000|COMPLETED|Overall Study||5
10832953|NCT03236311|11998204|FG001|COMPLETED|Overall Study||2
10832954|NCT03236311|11998203|FG000|NOT COMPLETED|Overall Study||0
10832955|NCT03236311|11998204|FG001|NOT COMPLETED|Overall Study||3
10832956|NCT03192046|11998212|FG000|STARTED|Overall Study||5
10832957|NCT03192046|11998213|FG001|STARTED|Overall Study||4
10832958|NCT03192046|11998212|FG000|COMPLETED|Overall Study||4
10832959|NCT03192046|11998213|FG001|COMPLETED|Overall Study||3
10832960|NCT03192046|11998212|FG000|NOT COMPLETED|Overall Study||1
10832961|NCT03192046|11998213|FG001|NOT COMPLETED|Overall Study||1
10832962|NCT03190369|11998221|FG000|STARTED|Overall Study||220
10832963|NCT03190369|11998222|FG001|STARTED|Overall Study||220
10832964|NCT03190369|11998221|FG000|Treated|Overall Study||220
10832965|NCT03190369|11998222|FG001|Treated|Overall Study||218
10832966|NCT03190369|11998221|FG000|COMPLETED|Overall Study||219
10832967|NCT03190369|11998222|FG001|COMPLETED|Overall Study||212
10832968|NCT03190369|11998221|FG000|NOT COMPLETED|Overall Study||1
10832969|NCT03190369|11998222|FG001|NOT COMPLETED|Overall Study||8
10832970|NCT04657198|11998231|FG000|STARTED|Overall Study||40
10832971|NCT04657198|11998232|FG001|STARTED|Overall Study||39
10832972|NCT04657198|11998233|FG002|STARTED|Overall Study||43
10832973|NCT04657198|11998231|FG000|COMPLETED|Overall Study||39
10832974|NCT04657198|11998232|FG001|COMPLETED|Overall Study||39
10832975|NCT04657198|11998233|FG002|COMPLETED|Overall Study||43
10832976|NCT04657198|11998231|FG000|NOT COMPLETED|Overall Study||1
10832977|NCT04657198|11998232|FG001|NOT COMPLETED|Overall Study||0
10832978|NCT04657198|11998233|FG002|NOT COMPLETED|Overall Study||0
10832979|NCT04590586|11998247|FG000|STARTED|Overall Study||28
10832980|NCT04590586|11998248|FG001|STARTED|Overall Study||1
10832981|NCT04590586|11998249|FG002|STARTED|Overall Study||194
10832982|NCT04590586|11998250|FG003|STARTED|Overall Study||184
10832983|NCT04590586|11998251|FG004|STARTED|Overall Study||100
10832984|NCT04590586|11998252|FG005|STARTED|Overall Study||8
10832985|NCT04590586|11998247|FG000|Received Study Drug|Overall Study||27
10832986|NCT04590586|11998248|FG001|Received Study Drug|Overall Study||1
10832987|NCT04590586|11998249|FG002|Received Study Drug|Overall Study||189
10832988|NCT04590586|11998250|FG003|Received Study Drug|Overall Study||182
10832989|NCT04590586|11998251|FG004|Received Study Drug|Overall Study||95
10832990|NCT04590586|11998252|FG005|Received Study Drug|Overall Study||7
10832991|NCT04590586|11998247|FG000|Full Analysis Set|Overall Study||28
10832992|NCT04590586|11998248|FG001|Full Analysis Set|Overall Study|Includes participants randomized to this arm (1) and 32 participants from Apremilast Placebo + SOC group and 1 participant from Zilucoplan Placebo + SOC group.|34
10832993|NCT04590586|11998249|FG002|Full Analysis Set|Overall Study||194
10832994|NCT04590586|11998250|FG003|Full Analysis Set|Overall Study|Includes participants randomized to this arm (184) and 1 participant from Lanadelumab Placebo + SOC group and 5 participants from Zilucoplan Placebo + SOC group.|190
10832995|NCT04590586|11998251|FG004|Full Analysis Set|Overall Study||100
10832996|NCT04590586|11998252|FG005|Full Analysis Set|Overall Study|Includes participants randomized to this arm (8) and 1 participant from Lanadelumab Placebo + SOC group and 66 participants from the Apremilast Placebo + SOC group.|75
10832997|NCT04590586|11998247|FG000|COMPLETED|Overall Study||15
10832998|NCT04590586|11998248|FG001|COMPLETED|Overall Study||0
10832999|NCT04590586|11998249|FG002|COMPLETED|Overall Study||139
10833000|NCT04590586|11998250|FG003|COMPLETED|Overall Study||138
10833001|NCT04590586|11998251|FG004|COMPLETED|Overall Study||70
10833002|NCT04590586|11998252|FG005|COMPLETED|Overall Study||4
10833003|NCT04590586|11998247|FG000|NOT COMPLETED|Overall Study||13
10833004|NCT04590586|11998248|FG001|NOT COMPLETED|Overall Study||1
10833005|NCT04590586|11998249|FG002|NOT COMPLETED|Overall Study||55
10833006|NCT04590586|11998250|FG003|NOT COMPLETED|Overall Study||46
10833007|NCT04590586|11998251|FG004|NOT COMPLETED|Overall Study||30
10833008|NCT04590586|11998252|FG005|NOT COMPLETED|Overall Study||4
10833009|NCT04312009|11998278|FG000|STARTED|Overall Study||104
10833010|NCT04312009|11998279|FG001|STARTED|Overall Study||101
10833011|NCT04312009|11998278|FG000|COMPLETED|Overall Study||102
10833012|NCT04312009|11998279|FG001|COMPLETED|Overall Study||100
10833013|NCT04312009|11998278|FG000|NOT COMPLETED|Overall Study||2
10833014|NCT04312009|11998279|FG001|NOT COMPLETED|Overall Study||1
10833015|NCT04191382|11998288|FG000|STARTED|Overall Study||34
10833016|NCT04191382|11998289|FG001|STARTED|Overall Study||36
10833017|NCT04191382|11998290|FG002|STARTED|Overall Study||35
10833018|NCT04191382|11998288|FG000|Treated|Overall Study||33
10833019|NCT04191382|11998289|FG001|Treated|Overall Study||36
10833020|NCT04191382|11998290|FG002|Treated|Overall Study||35
10833021|NCT04191382|11998288|FG000|COMPLETED|Overall Study||33
10833022|NCT04191382|11998289|FG001|COMPLETED|Overall Study||36
10833023|NCT04191382|11998290|FG002|COMPLETED|Overall Study||35
10291401|NCT04041037|11424357|FG000|STARTED|Overall Study||2
10291402|NCT04041037|11424357|FG000|COMPLETED|Overall Study||2
10291403|NCT04041037|11424357|FG000|NOT COMPLETED|Overall Study||0
10291404|NCT04034043|11424361|FG000|STARTED|Overall Study||68
10291405|NCT04034043|11424361|FG000|COMPLETED|Overall Study||68
10291406|NCT04034043|11424361|FG000|NOT COMPLETED|Overall Study||0
10291436|NCT03964649|11424386|FG003|NOT COMPLETED|Overall Study||0
10291437|NCT03964649|11424387|FG004|NOT COMPLETED|Overall Study||0
10291438|NCT03964649|11424388|FG005|NOT COMPLETED|Overall Study||0
10291439|NCT03964649|11424389|FG006|NOT COMPLETED|Overall Study||0
10291440|NCT03964649|11424390|FG007|NOT COMPLETED|Overall Study||0
10291441|NCT03964649|11424391|FG008|NOT COMPLETED|Overall Study||0
10833024|NCT04191382|11998288|FG000|NOT COMPLETED|Overall Study||1
10833025|NCT04191382|11998289|FG001|NOT COMPLETED|Overall Study||0
10833026|NCT04191382|11998290|FG002|NOT COMPLETED|Overall Study||0
10833027|NCT03964337|11998300|FG000|STARTED|Overall Study||3
10833028|NCT03964337|11998301|FG001|STARTED|Overall Study||0
10833029|NCT03964337|11998300|FG000|COMPLETED|Overall Study||3
10833030|NCT03964337|11998301|FG001|COMPLETED|Overall Study||0
10833031|NCT03964337|11998300|FG000|NOT COMPLETED|Overall Study||0
10833032|NCT03964337|11998301|FG001|NOT COMPLETED|Overall Study||0
10833033|NCT03937466|11998307|FG000|STARTED|Overall Study||38
10833034|NCT03937466|11998307|FG000|COMPLETED|Overall Study||15
10833035|NCT03937466|11998307|FG000|NOT COMPLETED|Overall Study||23
10833036|NCT03850483|11998320|FG000|STARTED|Treatment for Stage 1||37
10833037|NCT03850483|11998321|FG001|STARTED|Treatment for Stage 1||37
10833038|NCT03850483|11998322|FG002|STARTED|Treatment for Stage 1||37
10291442|NCT03964649|11424392|FG009|NOT COMPLETED|Overall Study||0
10314053|NCT00159263|11447674|FG000|NOT COMPLETED|Second Intervention||0
10314054|NCT00159263|11447675|FG001|NOT COMPLETED|Second Intervention||0
10314055|NCT00159263|11447676|FG002|NOT COMPLETED|Second Intervention||0
10314056|NCT00159263|11447677|FG003|NOT COMPLETED|Second Intervention||0
10833039|NCT03850483|11998323|FG003|STARTED|Treatment for Stage 1||36
10833040|NCT03850483|11998324|FG004|STARTED|Treatment for Stage 1||37
10833041|NCT03850483|11998325|FG005|STARTED|Treatment for Stage 1||38
10833042|NCT03850483|11998326|FG006|STARTED|Treatment for Stage 1||36
10833043|NCT03850483|11998327|FG007|STARTED|Treatment for Stage 1||36
10833044|NCT03850483|11998328|FG008|STARTED|Treatment for Stage 1||0
10833045|NCT03850483|11998329|FG009|STARTED|Treatment for Stage 1||0
10833046|NCT03850483|11998320|FG000|Treated|Treatment for Stage 1||37
10833047|NCT03850483|11998321|FG001|Treated|Treatment for Stage 1||37
10833048|NCT03850483|11998322|FG002|Treated|Treatment for Stage 1||37
10833049|NCT03850483|11998323|FG003|Treated|Treatment for Stage 1||36
10833050|NCT03850483|11998324|FG004|Treated|Treatment for Stage 1||37
10833051|NCT03850483|11998325|FG005|Treated|Treatment for Stage 1||37
10833052|NCT03850483|11998326|FG006|Treated|Treatment for Stage 1||36
10833053|NCT03850483|11998327|FG007|Treated|Treatment for Stage 1||36
10833054|NCT03850483|11998328|FG008|Treated|Treatment for Stage 1||0
10833055|NCT03850483|11998329|FG009|Treated|Treatment for Stage 1||0
10833056|NCT03850483|11998320|FG000|COMPLETED|Treatment for Stage 1||29
10833057|NCT03850483|11998321|FG001|COMPLETED|Treatment for Stage 1||29
10833058|NCT03850483|11998322|FG002|COMPLETED|Treatment for Stage 1||26
10833059|NCT03850483|11998323|FG003|COMPLETED|Treatment for Stage 1||30
10833060|NCT03850483|11998324|FG004|COMPLETED|Treatment for Stage 1||28
10833061|NCT03850483|11998325|FG005|COMPLETED|Treatment for Stage 1||27
10833062|NCT03850483|11998326|FG006|COMPLETED|Treatment for Stage 1||25
10833063|NCT03850483|11998327|FG007|COMPLETED|Treatment for Stage 1||30
10291443|NCT03941015|11424416|FG000|STARTED|Overall Study||38
10291444|NCT03941015|11424417|FG001|STARTED|Overall Study||207
10291445|NCT03941015|11424416|FG000|COMPLETED|Overall Study||38
10291446|NCT03941015|11424417|FG001|COMPLETED|Overall Study||204
10291447|NCT03941015|11424416|FG000|NOT COMPLETED|Overall Study||0
10291448|NCT03941015|11424417|FG001|NOT COMPLETED|Overall Study||3
10314057|NCT00159263|11447678|FG004|NOT COMPLETED|Second Intervention||0
10314058|NCT00159263|11447679|FG005|NOT COMPLETED|Second Intervention||0
10314059|NCT00159263|11447674|FG000|STARTED|Washout||1
10314060|NCT00159263|11447675|FG001|STARTED|Washout||1
10314061|NCT00159263|11447676|FG002|STARTED|Washout||2
10314062|NCT00159263|11447677|FG003|STARTED|Washout||2
10314063|NCT00159263|11447678|FG004|STARTED|Washout||2
10314064|NCT00159263|11447679|FG005|STARTED|Washout||2
10314065|NCT00159263|11447674|FG000|COMPLETED|Washout||1
10314066|NCT00159263|11447675|FG001|COMPLETED|Washout||1
10314067|NCT00159263|11447676|FG002|COMPLETED|Washout||2
10314068|NCT00159263|11447677|FG003|COMPLETED|Washout||2
10314069|NCT00159263|11447678|FG004|COMPLETED|Washout||2
10314070|NCT00159263|11447679|FG005|COMPLETED|Washout||2
10314071|NCT00159263|11447674|FG000|NOT COMPLETED|Washout||0
10314072|NCT00159263|11447675|FG001|NOT COMPLETED|Washout||0
10314073|NCT00159263|11447676|FG002|NOT COMPLETED|Washout||0
10314074|NCT00159263|11447677|FG003|NOT COMPLETED|Washout||0
10314075|NCT00159263|11447678|FG004|NOT COMPLETED|Washout||0
10314076|NCT00159263|11447679|FG005|NOT COMPLETED|Washout||0
10314077|NCT00159263|11447674|FG000|STARTED|Third Intervention||1
10314078|NCT00159263|11447675|FG001|STARTED|Third Intervention||1
10314079|NCT00159263|11447676|FG002|STARTED|Third Intervention||2
10314080|NCT00159263|11447677|FG003|STARTED|Third Intervention||2
10314081|NCT00159263|11447678|FG004|STARTED|Third Intervention||2
10314082|NCT00159263|11447679|FG005|STARTED|Third Intervention||2
10314083|NCT00159263|11447674|FG000|COMPLETED|Third Intervention||1
10314084|NCT00159263|11447675|FG001|COMPLETED|Third Intervention||1
10314085|NCT00159263|11447676|FG002|COMPLETED|Third Intervention||2
10314086|NCT00159263|11447677|FG003|COMPLETED|Third Intervention||2
10314087|NCT00159263|11447678|FG004|COMPLETED|Third Intervention||2
10314088|NCT00159263|11447679|FG005|COMPLETED|Third Intervention||2
10314089|NCT00159263|11447674|FG000|NOT COMPLETED|Third Intervention||0
10833064|NCT03850483|11998328|FG008|COMPLETED|Treatment for Stage 1||0
10833065|NCT03850483|11998329|FG009|COMPLETED|Treatment for Stage 1||0
10833066|NCT03850483|11998320|FG000|NOT COMPLETED|Treatment for Stage 1||8
10833067|NCT03850483|11998321|FG001|NOT COMPLETED|Treatment for Stage 1||8
10833068|NCT03850483|11998322|FG002|NOT COMPLETED|Treatment for Stage 1||11
10833069|NCT03850483|11998323|FG003|NOT COMPLETED|Treatment for Stage 1||6
10833070|NCT03850483|11998324|FG004|NOT COMPLETED|Treatment for Stage 1||9
10833071|NCT03850483|11998325|FG005|NOT COMPLETED|Treatment for Stage 1||11
10833072|NCT03850483|11998326|FG006|NOT COMPLETED|Treatment for Stage 1||11
10833073|NCT03850483|11998327|FG007|NOT COMPLETED|Treatment for Stage 1||6
10833074|NCT03850483|11998328|FG008|NOT COMPLETED|Treatment for Stage 1||0
10833075|NCT03850483|11998329|FG009|NOT COMPLETED|Treatment for Stage 1||0
10314090|NCT00159263|11447675|FG001|NOT COMPLETED|Third Intervention||0
10314091|NCT00159263|11447676|FG002|NOT COMPLETED|Third Intervention||0
10314092|NCT00159263|11447677|FG003|NOT COMPLETED|Third Intervention||0
10314093|NCT00159263|11447678|FG004|NOT COMPLETED|Third Intervention||0
10314094|NCT00159263|11447679|FG005|NOT COMPLETED|Third Intervention||0
10314095|NCT00159263|11447674|FG000|STARTED|Washout||1
10314096|NCT00159263|11447675|FG001|STARTED|Washout||1
10314097|NCT00159263|11447676|FG002|STARTED|Washout||2
10314098|NCT00159263|11447677|FG003|STARTED|Washout||2
10314099|NCT00159263|11447678|FG004|STARTED|Washout||2
10314100|NCT00159263|11447679|FG005|STARTED|Washout||2
10314101|NCT00159263|11447674|FG000|COMPLETED|Washout||1
10833076|NCT03850483|11998320|FG000|STARTED|Follow-up for Stage 1||37
10833077|NCT03850483|11998321|FG001|STARTED|Follow-up for Stage 1||37
10833078|NCT03850483|11998322|FG002|STARTED|Follow-up for Stage 1||37
10833079|NCT03850483|11998323|FG003|STARTED|Follow-up for Stage 1||36
10833080|NCT03850483|11998324|FG004|STARTED|Follow-up for Stage 1||37
10833081|NCT03850483|11998325|FG005|STARTED|Follow-up for Stage 1||37
10833082|NCT03850483|11998326|FG006|STARTED|Follow-up for Stage 1||36
10833083|NCT03850483|11998327|FG007|STARTED|Follow-up for Stage 1||36
10833084|NCT03850483|11998328|FG008|STARTED|Follow-up for Stage 1||0
10833085|NCT03850483|11998329|FG009|STARTED|Follow-up for Stage 1||0
10833086|NCT03850483|11998320|FG000|COMPLETED|Follow-up for Stage 1||37
10833087|NCT03850483|11998321|FG001|COMPLETED|Follow-up for Stage 1||34
10833088|NCT03850483|11998322|FG002|COMPLETED|Follow-up for Stage 1||35
10833089|NCT03850483|11998323|FG003|COMPLETED|Follow-up for Stage 1||34
10833090|NCT03850483|11998324|FG004|COMPLETED|Follow-up for Stage 1||34
10833091|NCT03850483|11998325|FG005|COMPLETED|Follow-up for Stage 1||33
10833092|NCT03850483|11998326|FG006|COMPLETED|Follow-up for Stage 1||34
10833093|NCT03850483|11998327|FG007|COMPLETED|Follow-up for Stage 1||33
10833094|NCT03850483|11998328|FG008|COMPLETED|Follow-up for Stage 1||0
10833095|NCT03850483|11998329|FG009|COMPLETED|Follow-up for Stage 1||0
10833096|NCT03850483|11998320|FG000|NOT COMPLETED|Follow-up for Stage 1||0
10833097|NCT03850483|11998321|FG001|NOT COMPLETED|Follow-up for Stage 1||3
10833098|NCT03850483|11998322|FG002|NOT COMPLETED|Follow-up for Stage 1||2
10833099|NCT03850483|11998323|FG003|NOT COMPLETED|Follow-up for Stage 1||2
10833100|NCT03850483|11998324|FG004|NOT COMPLETED|Follow-up for Stage 1||3
10833101|NCT03850483|11998325|FG005|NOT COMPLETED|Follow-up for Stage 1||4
10833102|NCT03850483|11998326|FG006|NOT COMPLETED|Follow-up for Stage 1||2
10833103|NCT03850483|11998327|FG007|NOT COMPLETED|Follow-up for Stage 1||3
10833104|NCT03850483|11998328|FG008|NOT COMPLETED|Follow-up for Stage 1||0
10833105|NCT03850483|11998329|FG009|NOT COMPLETED|Follow-up for Stage 1||0
10833106|NCT03850483|11998320|FG000|STARTED|Treatment for Stage 2|Stage 1 enrolment was different from Stage 2.|0
10833107|NCT03850483|11998321|FG001|STARTED|Treatment for Stage 2|Stage 1 enrolment was different from Stage 2.|0
10833108|NCT03850483|11998322|FG002|STARTED|Treatment for Stage 2|Stage 1 enrolment was different from Stage 2.|0
10833109|NCT03850483|11998323|FG003|STARTED|Treatment for Stage 2|Stage 1 enrolment was different from Stage 2.|0
10833110|NCT03850483|11998324|FG004|STARTED|Treatment for Stage 2|Stage 1 enrolment was different from Stage 2.|0
10833111|NCT03850483|11998325|FG005|STARTED|Treatment for Stage 2|Stage 1 enrolment was different from Stage 2.|0
10833112|NCT03850483|11998326|FG006|STARTED|Treatment for Stage 2|Stage 1 enrolment was different from Stage 2.|0
10833113|NCT03850483|11998327|FG007|STARTED|Treatment for Stage 2|Stage 1 enrolment was different from Stage 2.|0
10833114|NCT03850483|11998328|FG008|STARTED|Treatment for Stage 2|Stage 1 enrolment was different from Stage 2.|12
10833115|NCT03850483|11998329|FG009|STARTED|Treatment for Stage 2|Stage 1 enrolment was different from Stage 2.|38
10833116|NCT03850483|11998320|FG000|COMPLETED|Treatment for Stage 2||0
10833117|NCT03850483|11998321|FG001|COMPLETED|Treatment for Stage 2||0
10833118|NCT03850483|11998322|FG002|COMPLETED|Treatment for Stage 2||0
10833119|NCT03850483|11998323|FG003|COMPLETED|Treatment for Stage 2||0
10833120|NCT03850483|11998324|FG004|COMPLETED|Treatment for Stage 2||0
10833121|NCT03850483|11998325|FG005|COMPLETED|Treatment for Stage 2||0
10833122|NCT03850483|11998326|FG006|COMPLETED|Treatment for Stage 2||0
10833123|NCT03850483|11998327|FG007|COMPLETED|Treatment for Stage 2||0
10833124|NCT03850483|11998328|FG008|COMPLETED|Treatment for Stage 2||7
10833125|NCT03850483|11998329|FG009|COMPLETED|Treatment for Stage 2||27
10833126|NCT03850483|11998320|FG000|NOT COMPLETED|Treatment for Stage 2||0
10833127|NCT03850483|11998321|FG001|NOT COMPLETED|Treatment for Stage 2||0
10833128|NCT03850483|11998322|FG002|NOT COMPLETED|Treatment for Stage 2||0
10833129|NCT03850483|11998323|FG003|NOT COMPLETED|Treatment for Stage 2||0
10833130|NCT03850483|11998324|FG004|NOT COMPLETED|Treatment for Stage 2||0
10833131|NCT03850483|11998325|FG005|NOT COMPLETED|Treatment for Stage 2||0
10833132|NCT03850483|11998326|FG006|NOT COMPLETED|Treatment for Stage 2||0
10833133|NCT03850483|11998327|FG007|NOT COMPLETED|Treatment for Stage 2||0
10833134|NCT03850483|11998328|FG008|NOT COMPLETED|Treatment for Stage 2||5
10833135|NCT03850483|11998329|FG009|NOT COMPLETED|Treatment for Stage 2||11
10833136|NCT03850483|11998320|FG000|STARTED|Follow-up For Stage 2||0
10833137|NCT03850483|11998321|FG001|STARTED|Follow-up For Stage 2||0
10833138|NCT03850483|11998322|FG002|STARTED|Follow-up For Stage 2||0
10833139|NCT03850483|11998323|FG003|STARTED|Follow-up For Stage 2||0
10833140|NCT03850483|11998324|FG004|STARTED|Follow-up For Stage 2||0
10833141|NCT03850483|11998325|FG005|STARTED|Follow-up For Stage 2||0
10833142|NCT03850483|11998326|FG006|STARTED|Follow-up For Stage 2||0
10833143|NCT03850483|11998327|FG007|STARTED|Follow-up For Stage 2||0
10833144|NCT03850483|11998328|FG008|STARTED|Follow-up For Stage 2||12
10833145|NCT03850483|11998329|FG009|STARTED|Follow-up For Stage 2||38
10833146|NCT03850483|11998320|FG000|COMPLETED|Follow-up For Stage 2||0
10833147|NCT03850483|11998321|FG001|COMPLETED|Follow-up For Stage 2||0
10833148|NCT03850483|11998322|FG002|COMPLETED|Follow-up For Stage 2||0
10833149|NCT03850483|11998323|FG003|COMPLETED|Follow-up For Stage 2||0
10833150|NCT03850483|11998324|FG004|COMPLETED|Follow-up For Stage 2||0
10833151|NCT03850483|11998325|FG005|COMPLETED|Follow-up For Stage 2||0
10833152|NCT03850483|11998326|FG006|COMPLETED|Follow-up For Stage 2||0
10833153|NCT03850483|11998327|FG007|COMPLETED|Follow-up For Stage 2||0
10833154|NCT03850483|11998328|FG008|COMPLETED|Follow-up For Stage 2||12
10833155|NCT03850483|11998329|FG009|COMPLETED|Follow-up For Stage 2||36
10833156|NCT03850483|11998320|FG000|NOT COMPLETED|Follow-up For Stage 2||0
10833157|NCT03850483|11998321|FG001|NOT COMPLETED|Follow-up For Stage 2||0
10833158|NCT03850483|11998322|FG002|NOT COMPLETED|Follow-up For Stage 2||0
10833159|NCT03850483|11998323|FG003|NOT COMPLETED|Follow-up For Stage 2||0
10833160|NCT03850483|11998324|FG004|NOT COMPLETED|Follow-up For Stage 2||0
10833161|NCT03850483|11998325|FG005|NOT COMPLETED|Follow-up For Stage 2||0
10833162|NCT03850483|11998326|FG006|NOT COMPLETED|Follow-up For Stage 2||0
10833163|NCT03850483|11998327|FG007|NOT COMPLETED|Follow-up For Stage 2||0
10833164|NCT03850483|11998328|FG008|NOT COMPLETED|Follow-up For Stage 2||0
10833165|NCT03850483|11998329|FG009|NOT COMPLETED|Follow-up For Stage 2||2
10833176|NCT03804684|11998361|FG000|STARTED|Overall Study||28
10833177|NCT03804684|11998362|FG001|STARTED|Overall Study||44
10833178|NCT03804684|11998361|FG000|COMPLETED|Overall Study||25
10833179|NCT03804684|11998362|FG001|COMPLETED|Overall Study||26
10833180|NCT03804684|11998361|FG000|NOT COMPLETED|Overall Study||3
10833181|NCT03804684|11998362|FG001|NOT COMPLETED|Overall Study||18
10833190|NCT03537014|11998381|FG000|STARTED|Overall Study||46
10833191|NCT03537014|11998382|FG001|STARTED|Overall Study||45
10833192|NCT03537014|11998381|FG000|Withdrew Consent Before Dosing|Overall Study||0
10833193|NCT03537014|11998382|FG001|Withdrew Consent Before Dosing|Overall Study||1
10833194|NCT03537014|11998381|FG000|Completed First Experimental Session|Overall Study||46
10833195|NCT03537014|11998382|FG001|Completed First Experimental Session|Overall Study||44
10833196|NCT03537014|11998381|FG000|Completed Second Experimental Session|Overall Study||43
10833197|NCT03537014|11998382|FG001|Completed Second Experimental Session|Overall Study||41
10833198|NCT03537014|11998381|FG000|COMPLETED|Overall Study||42
10833199|NCT03537014|11998382|FG001|COMPLETED|Overall Study||40
10833200|NCT03537014|11998381|FG000|NOT COMPLETED|Overall Study||4
10833201|NCT03537014|11998382|FG001|NOT COMPLETED|Overall Study||5
10833202|NCT03529799|11998390|FG000|STARTED|Overall Study||14
10833203|NCT03529799|11998391|FG001|STARTED|Overall Study||26
10833204|NCT03529799|11998390|FG000|COMPLETED|Overall Study||14
10833205|NCT03529799|11998391|FG001|COMPLETED|Overall Study||26
10833206|NCT03529799|11998390|FG000|NOT COMPLETED|Overall Study||0
10833207|NCT03529799|11998391|FG001|NOT COMPLETED|Overall Study||0
10833208|NCT03485287|11998397|FG000|STARTED|Overall Study||4
10833209|NCT03485287|11998397|FG000|COMPLETED|Overall Study||3
10833210|NCT03485287|11998397|FG000|NOT COMPLETED|Overall Study||1
10833211|NCT03473925|11998403|FG000|STARTED|Overall Study||52
10833212|NCT03473925|11998404|FG001|STARTED|Overall Study||55
10833213|NCT03473925|11998403|FG000|Treated|Overall Study||51
10833214|NCT03473925|11998404|FG001|Treated|Overall Study||54
10833215|NCT03473925|11998403|FG000|COMPLETED|Overall Study||0
10833216|NCT03473925|11998404|FG001|COMPLETED|Overall Study||0
10833217|NCT03473925|11998403|FG000|NOT COMPLETED|Overall Study||52
10833218|NCT03473925|11998404|FG001|NOT COMPLETED|Overall Study||55
10291449|NCT03889028|11424426|FG000|STARTED|Overall Study||144
10833241|NCT03230097|11998432|FG000|STARTED|Overall Study||24
10291450|NCT03889028|11424427|FG001|STARTED|Overall Study||422
10291451|NCT03889028|11424428|FG002|STARTED|Overall Study||312
10833242|NCT03230097|11998433|FG001|STARTED|Overall Study||26
10833243|NCT03230097|11998432|FG000|COMPLETED|Overall Study||9
10833244|NCT03230097|11998433|FG001|COMPLETED|Overall Study||10
10833245|NCT03230097|11998432|FG000|NOT COMPLETED|Overall Study||15
10291452|NCT03889028|11424426|FG000|COMPLETED|Overall Study||144
10833246|NCT03230097|11998433|FG001|NOT COMPLETED|Overall Study||16
10833247|NCT03226067|11998442|FG000|STARTED|Overall Study||36
10833248|NCT03226067|11998443|FG001|STARTED|Overall Study||38
10833249|NCT03226067|11998444|FG002|STARTED|Overall Study||37
10833250|NCT03226067|11998442|FG000|COMPLETED|Overall Study||36
10833251|NCT03226067|11998443|FG001|COMPLETED|Overall Study||38
10833252|NCT03226067|11998444|FG002|COMPLETED|Overall Study||37
10833253|NCT03226067|11998442|FG000|NOT COMPLETED|Overall Study||0
10833254|NCT03226067|11998443|FG001|NOT COMPLETED|Overall Study||0
10833255|NCT03226067|11998444|FG002|NOT COMPLETED|Overall Study||0
10833256|NCT03029780|11998454|FG000|STARTED|Overall Study||52
10833257|NCT03029780|11998455|FG001|STARTED|Overall Study||52
10833258|NCT03029780|11998454|FG000|COMPLETED|Overall Study||1
10833259|NCT03029780|11998455|FG001|COMPLETED|Overall Study||1
10833260|NCT03029780|11998454|FG000|NOT COMPLETED|Overall Study||51
10833261|NCT03029780|11998455|FG001|NOT COMPLETED|Overall Study||51
10833265|NCT02968940|11998469|FG000|STARTED|Overall Study||6
10833266|NCT02968940|11998469|FG000|COMPLETED|Overall Study||6
10833267|NCT02968940|11998469|FG000|NOT COMPLETED|Overall Study||0
10833292|NCT02803593|11998503|FG000|STARTED|Overall Study||95
10833293|NCT02803593|11998504|FG001|STARTED|Overall Study||104
10833294|NCT02803593|11998503|FG000|Completed Month 1 Assessment|Overall Study||83
10833295|NCT02803593|11998504|FG001|Completed Month 1 Assessment|Overall Study||76
10833296|NCT02803593|11998503|FG000|COMPLETED|Overall Study||78
10833297|NCT02803593|11998504|FG001|COMPLETED|Overall Study||69
10833298|NCT02803593|11998503|FG000|NOT COMPLETED|Overall Study||17
10833299|NCT02803593|11998504|FG001|NOT COMPLETED|Overall Study||35
10833300|NCT02663908|11998512|FG000|STARTED|Overall Study||276
10833301|NCT02663908|11998513|FG001|STARTED|Overall Study||269
10833302|NCT02663908|11998512|FG000|Full Analysis Set (FAS)|Overall Study||275
10833303|NCT02663908|11998513|FG001|Full Analysis Set (FAS)|Overall Study||269
10833304|NCT02663908|11998512|FG000|COMPLETED|Overall Study||244
10833305|NCT02663908|11998513|FG001|COMPLETED|Overall Study||245
10833306|NCT02663908|11998512|FG000|NOT COMPLETED|Overall Study||32
10833307|NCT02663908|11998513|FG001|NOT COMPLETED|Overall Study||24
10833308|NCT02650284|11998521|FG000|STARTED|Overall Study||8
10833309|NCT02650284|11998522|FG001|STARTED|Overall Study||9
10833310|NCT02650284|11998521|FG000|COMPLETED|Overall Study||5
10833311|NCT02650284|11998522|FG001|COMPLETED|Overall Study||5
10833312|NCT02650284|11998521|FG000|NOT COMPLETED|Overall Study||3
10833313|NCT02650284|11998522|FG001|NOT COMPLETED|Overall Study||4
10754268|NCT03050775|11918002|FG001|NOT COMPLETED|Overall Study||0
10754269|NCT03050801|11918014|FG000|STARTED|Experiment 1||3
10754270|NCT03050801|11918015|FG001|STARTED|Experiment 1||13
10754271|NCT03050801|11918016|FG002|STARTED|Experiment 1||8
10754272|NCT03050801|11918017|FG003|STARTED|Experiment 1||0
10754273|NCT03050801|11918018|FG004|STARTED|Experiment 1||0
10833317|NCT02535338|11998534|FG000|STARTED|Overall Study||3
10833318|NCT02535338|11998535|FG001|STARTED|Overall Study||8
10833319|NCT02535338|11998534|FG000|COMPLETED|Overall Study||3
10833320|NCT02535338|11998535|FG001|COMPLETED|Overall Study||8
10833321|NCT02535338|11998534|FG000|NOT COMPLETED|Overall Study||0
10833322|NCT02535338|11998535|FG001|NOT COMPLETED|Overall Study||0
10833323|NCT02500797|11998555|FG000|STARTED|Overall Study||43
10833324|NCT02500797|11998556|FG001|STARTED|Overall Study||42
10833325|NCT02500797|11998557|FG002|STARTED|Overall Study||15
10833326|NCT02500797|11998558|FG003|STARTED|Overall Study||14
10833327|NCT02500797|11998559|FG004|STARTED|Overall Study||14
10833328|NCT02500797|11998560|FG005|STARTED|Overall Study||15
10833329|NCT02500797|11998561|FG006|STARTED|Overall Study||10
10833330|NCT02500797|11998562|FG007|STARTED|Overall Study||11
10833331|NCT02500797|11998555|FG000|Arm I Crossover|Overall Study||4
10833332|NCT02500797|11998556|FG001|Arm I Crossover|Overall Study||0
10833333|NCT02500797|11998557|FG002|Arm I Crossover|Overall Study||6
10833334|NCT02500797|11998558|FG003|Arm I Crossover|Overall Study||0
10833335|NCT02500797|11998559|FG004|Arm I Crossover|Overall Study||1
10833336|NCT02500797|11998560|FG005|Arm I Crossover|Overall Study||0
10833337|NCT02500797|11998561|FG006|Arm I Crossover|Overall Study||2
10754274|NCT03050801|11918019|FG005|STARTED|Experiment 1||0
10754275|NCT03050801|11918014|FG000|COMPLETED|Experiment 1||3
10754276|NCT03050801|11918015|FG001|COMPLETED|Experiment 1||6
10754277|NCT03050801|11918016|FG002|COMPLETED|Experiment 1||6
10754278|NCT03050801|11918017|FG003|COMPLETED|Experiment 1||0
10833338|NCT02500797|11998562|FG007|Arm I Crossover|Overall Study||0
10754279|NCT03050801|11918018|FG004|COMPLETED|Experiment 1||0
10754280|NCT03050801|11918019|FG005|COMPLETED|Experiment 1||0
10754281|NCT03050801|11918014|FG000|NOT COMPLETED|Experiment 1||0
10833339|NCT02500797|11998555|FG000|COMPLETED|Overall Study||42
10833340|NCT02500797|11998556|FG001|COMPLETED|Overall Study||42
10833341|NCT02500797|11998557|FG002|COMPLETED|Overall Study||15
10833342|NCT02500797|11998558|FG003|COMPLETED|Overall Study||14
10833343|NCT02500797|11998559|FG004|COMPLETED|Overall Study||13
10833344|NCT02500797|11998560|FG005|COMPLETED|Overall Study||14
10833345|NCT02500797|11998561|FG006|COMPLETED|Overall Study||10
10833346|NCT02500797|11998562|FG007|COMPLETED|Overall Study||11
10833347|NCT02500797|11998555|FG000|NOT COMPLETED|Overall Study||1
10833348|NCT02500797|11998556|FG001|NOT COMPLETED|Overall Study||0
10833349|NCT02500797|11998557|FG002|NOT COMPLETED|Overall Study||0
10833350|NCT02500797|11998558|FG003|NOT COMPLETED|Overall Study||0
10833351|NCT02500797|11998559|FG004|NOT COMPLETED|Overall Study||1
10833352|NCT02500797|11998560|FG005|NOT COMPLETED|Overall Study||1
10833353|NCT02500797|11998561|FG006|NOT COMPLETED|Overall Study||0
10833354|NCT02500797|11998562|FG007|NOT COMPLETED|Overall Study||0
10833355|NCT02447133|11998587|FG000|STARTED|Overall Study||12
10833356|NCT02447133|11998587|FG000|COMPLETED|Overall Study||12
10833357|NCT02447133|11998587|FG000|NOT COMPLETED|Overall Study||0
10833456|NCT02017717|11998674|FG008|COMPLETED|Before Treatment Period||28
10833370|NCT02426658|11998610|FG000|STARTED|Overall Study||16
10833371|NCT02426658|11998610|FG000|COMPLETED|Overall Study||13
10833372|NCT02426658|11998610|FG000|NOT COMPLETED|Overall Study||3
10833385|NCT02277106|11998631|FG000|STARTED|Stage 1: Treatment Period 1||13
10833386|NCT02277106|11998632|FG001|STARTED|Stage 1: Treatment Period 1||12
10833387|NCT02277106|11998633|FG002|STARTED|Stage 1: Treatment Period 1||0
10833388|NCT02277106|11998631|FG000|COMPLETED|Stage 1: Treatment Period 1||13
10833389|NCT02277106|11998632|FG001|COMPLETED|Stage 1: Treatment Period 1||12
10833390|NCT02277106|11998633|FG002|COMPLETED|Stage 1: Treatment Period 1||0
10833391|NCT02277106|11998631|FG000|NOT COMPLETED|Stage 1: Treatment Period 1||0
10833392|NCT02277106|11998632|FG001|NOT COMPLETED|Stage 1: Treatment Period 1||0
10833393|NCT02277106|11998633|FG002|NOT COMPLETED|Stage 1: Treatment Period 1||0
10833394|NCT02277106|11998631|FG000|STARTED|Washout||13
10833395|NCT02277106|11998632|FG001|STARTED|Washout||12
10833396|NCT02277106|11998633|FG002|STARTED|Washout||0
10833397|NCT02277106|11998631|FG000|COMPLETED|Washout||13
10833398|NCT02277106|11998632|FG001|COMPLETED|Washout||12
10833399|NCT02277106|11998633|FG002|COMPLETED|Washout||0
10833400|NCT02277106|11998631|FG000|NOT COMPLETED|Washout||0
10833401|NCT02277106|11998632|FG001|NOT COMPLETED|Washout||0
10833402|NCT02277106|11998633|FG002|NOT COMPLETED|Washout||0
10833403|NCT02277106|11998631|FG000|STARTED|Stage 1: Treatment Period 2||13
10833404|NCT02277106|11998632|FG001|STARTED|Stage 1: Treatment Period 2||12
10833405|NCT02277106|11998633|FG002|STARTED|Stage 1: Treatment Period 2||0
10833406|NCT02277106|11998631|FG000|COMPLETED|Stage 1: Treatment Period 2||13
10833407|NCT02277106|11998632|FG001|COMPLETED|Stage 1: Treatment Period 2||12
10833408|NCT02277106|11998633|FG002|COMPLETED|Stage 1: Treatment Period 2||0
10833409|NCT02277106|11998631|FG000|NOT COMPLETED|Stage 1: Treatment Period 2||0
10833410|NCT02277106|11998632|FG001|NOT COMPLETED|Stage 1: Treatment Period 2||0
10833411|NCT02277106|11998633|FG002|NOT COMPLETED|Stage 1: Treatment Period 2||0
10833412|NCT02277106|11998631|FG000|STARTED|Stage 2||0
10833413|NCT02277106|11998632|FG001|STARTED|Stage 2||0
10833414|NCT02277106|11998633|FG002|STARTED|Stage 2|Out of 25, 17 participants entered Stage 2 after Screening at Stage 2.|17
10833415|NCT02277106|11998631|FG000|COMPLETED|Stage 2||0
10833416|NCT02277106|11998632|FG001|COMPLETED|Stage 2||0
10833417|NCT02277106|11998633|FG002|COMPLETED|Stage 2||16
10833418|NCT02277106|11998631|FG000|NOT COMPLETED|Stage 2||0
10833419|NCT02277106|11998632|FG001|NOT COMPLETED|Stage 2||0
10833420|NCT02277106|11998633|FG002|NOT COMPLETED|Stage 2||1
10833421|NCT02175030|11998646|FG000|STARTED|Overall Study||356
10833422|NCT02175030|11998647|FG001|STARTED|Overall Study||355
10833423|NCT02175030|11998646|FG000|COMPLETED|Overall Study||321
10833424|NCT02175030|11998647|FG001|COMPLETED|Overall Study||317
10833425|NCT02175030|11998646|FG000|NOT COMPLETED|Overall Study||35
10833426|NCT02175030|11998647|FG001|NOT COMPLETED|Overall Study||38
10833430|NCT02017717|11998666|FG000|STARTED|Before Treatment Period||10
10833431|NCT02017717|11998667|FG001|STARTED|Before Treatment Period||10
10833432|NCT02017717|11998668|FG002|STARTED|Before Treatment Period||20
10833433|NCT02017717|11998669|FG003|STARTED|Before Treatment Period||184
10833434|NCT02017717|11998670|FG004|STARTED|Before Treatment Period||185
10833435|NCT02017717|11998671|FG005|STARTED|Before Treatment Period||31
10833436|NCT02017717|11998672|FG006|STARTED|Before Treatment Period||30
10833437|NCT02017717|11998673|FG007|STARTED|Before Treatment Period||29
10833438|NCT02017717|11998674|FG008|STARTED|Before Treatment Period||30
10833439|NCT02017717|11998666|FG000|Randomized|Before Treatment Period||10
10833440|NCT02017717|11998667|FG001|Randomized|Before Treatment Period||10
10833441|NCT02017717|11998668|FG002|Randomized|Before Treatment Period||0
10833442|NCT02017717|11998669|FG003|Randomized|Before Treatment Period||184
10833443|NCT02017717|11998670|FG004|Randomized|Before Treatment Period||185
10833444|NCT02017717|11998671|FG005|Randomized|Before Treatment Period||0
10833445|NCT02017717|11998672|FG006|Randomized|Before Treatment Period||0
10833446|NCT02017717|11998673|FG007|Randomized|Before Treatment Period||29
10833447|NCT02017717|11998674|FG008|Randomized|Before Treatment Period||30
10833448|NCT02017717|11998666|FG000|COMPLETED|Before Treatment Period||10
10833449|NCT02017717|11998667|FG001|COMPLETED|Before Treatment Period||10
10833450|NCT02017717|11998668|FG002|COMPLETED|Before Treatment Period||20
10833451|NCT02017717|11998669|FG003|COMPLETED|Before Treatment Period||182
10833452|NCT02017717|11998670|FG004|COMPLETED|Before Treatment Period||165
10833453|NCT02017717|11998671|FG005|COMPLETED|Before Treatment Period||31
10833454|NCT02017717|11998672|FG006|COMPLETED|Before Treatment Period||30
10833455|NCT02017717|11998673|FG007|COMPLETED|Before Treatment Period||28
10833457|NCT02017717|11998666|FG000|NOT COMPLETED|Before Treatment Period||0
10833458|NCT02017717|11998667|FG001|NOT COMPLETED|Before Treatment Period||0
10833459|NCT02017717|11998668|FG002|NOT COMPLETED|Before Treatment Period||0
10833460|NCT02017717|11998669|FG003|NOT COMPLETED|Before Treatment Period||2
10833461|NCT02017717|11998670|FG004|NOT COMPLETED|Before Treatment Period||20
10833462|NCT02017717|11998671|FG005|NOT COMPLETED|Before Treatment Period||0
10833463|NCT02017717|11998672|FG006|NOT COMPLETED|Before Treatment Period||0
10833464|NCT02017717|11998673|FG007|NOT COMPLETED|Before Treatment Period||1
10833465|NCT02017717|11998674|FG008|NOT COMPLETED|Before Treatment Period||2
10833466|NCT02017717|11998666|FG000|STARTED|Treatment Period||10
10833467|NCT02017717|11998667|FG001|STARTED|Treatment Period||10
10833468|NCT02017717|11998668|FG002|STARTED|Treatment Period||20
10833469|NCT02017717|11998669|FG003|STARTED|Treatment Period||182
10833470|NCT02017717|11998670|FG004|STARTED|Treatment Period||165
10833471|NCT02017717|11998671|FG005|STARTED|Treatment Period||31
10833472|NCT02017717|11998672|FG006|STARTED|Treatment Period||30
10833473|NCT02017717|11998673|FG007|STARTED|Treatment Period||28
10833474|NCT02017717|11998674|FG008|STARTED|Treatment Period||28
10833475|NCT02017717|11998666|FG000|COMPLETED|Treatment Period||0
10833476|NCT02017717|11998667|FG001|COMPLETED|Treatment Period||1
10833477|NCT02017717|11998668|FG002|COMPLETED|Treatment Period||0
10833478|NCT02017717|11998669|FG003|COMPLETED|Treatment Period||1
10833479|NCT02017717|11998670|FG004|COMPLETED|Treatment Period||1
10833480|NCT02017717|11998671|FG005|COMPLETED|Treatment Period||2
10833481|NCT02017717|11998672|FG006|COMPLETED|Treatment Period||0
10833482|NCT02017717|11998673|FG007|COMPLETED|Treatment Period||0
10833483|NCT02017717|11998674|FG008|COMPLETED|Treatment Period||0
10833484|NCT02017717|11998666|FG000|NOT COMPLETED|Treatment Period||10
10833485|NCT02017717|11998667|FG001|NOT COMPLETED|Treatment Period||9
10833486|NCT02017717|11998668|FG002|NOT COMPLETED|Treatment Period||20
10833487|NCT02017717|11998669|FG003|NOT COMPLETED|Treatment Period||181
10833488|NCT02017717|11998670|FG004|NOT COMPLETED|Treatment Period||164
10833489|NCT02017717|11998671|FG005|NOT COMPLETED|Treatment Period||29
10833490|NCT02017717|11998672|FG006|NOT COMPLETED|Treatment Period||30
10833491|NCT02017717|11998673|FG007|NOT COMPLETED|Treatment Period||28
10833492|NCT02017717|11998674|FG008|NOT COMPLETED|Treatment Period||28
10291453|NCT03889028|11424427|FG001|COMPLETED|Overall Study||422
10291454|NCT03889028|11424428|FG002|COMPLETED|Overall Study||312
10291455|NCT03889028|11424426|FG000|NOT COMPLETED|Overall Study||0
10291456|NCT03889028|11424427|FG001|NOT COMPLETED|Overall Study||0
10291457|NCT03889028|11424428|FG002|NOT COMPLETED|Overall Study||0
10291458|NCT03842683|11424435|FG000|STARTED|Overall Study||472
10291459|NCT03842683|11424435|FG000|COMPLETED|Overall Study||472
10291460|NCT03842683|11424435|FG000|NOT COMPLETED|Overall Study||0
10314102|NCT00159263|11447675|FG001|COMPLETED|Washout||1
10314103|NCT00159263|11447676|FG002|COMPLETED|Washout||2
10314104|NCT00159263|11447677|FG003|COMPLETED|Washout||2
10314105|NCT00159263|11447678|FG004|COMPLETED|Washout||2
10314106|NCT00159263|11447679|FG005|COMPLETED|Washout||2
10314107|NCT00159263|11447674|FG000|NOT COMPLETED|Washout||0
10314108|NCT00159263|11447675|FG001|NOT COMPLETED|Washout||0
10314109|NCT00159263|11447676|FG002|NOT COMPLETED|Washout||0
10314110|NCT00159263|11447677|FG003|NOT COMPLETED|Washout||0
10314111|NCT00159263|11447678|FG004|NOT COMPLETED|Washout||0
10314112|NCT00159263|11447679|FG005|NOT COMPLETED|Washout||0
10314113|NCT00159263|11447674|FG000|STARTED|Fourth Intervention||1
10314114|NCT00159263|11447675|FG001|STARTED|Fourth Intervention||1
10314115|NCT00159263|11447676|FG002|STARTED|Fourth Intervention||2
10314116|NCT00159263|11447677|FG003|STARTED|Fourth Intervention||2
10314117|NCT00159263|11447678|FG004|STARTED|Fourth Intervention||2
10314118|NCT00159263|11447679|FG005|STARTED|Fourth Intervention||2
10314119|NCT00159263|11447674|FG000|COMPLETED|Fourth Intervention||1
10314120|NCT00159263|11447675|FG001|COMPLETED|Fourth Intervention||1
10314121|NCT00159263|11447676|FG002|COMPLETED|Fourth Intervention||2
10314122|NCT00159263|11447677|FG003|COMPLETED|Fourth Intervention||2
10314123|NCT00159263|11447678|FG004|COMPLETED|Fourth Intervention||2
10314124|NCT00159263|11447679|FG005|COMPLETED|Fourth Intervention||2
10314125|NCT00159263|11447674|FG000|NOT COMPLETED|Fourth Intervention||0
10314126|NCT00159263|11447675|FG001|NOT COMPLETED|Fourth Intervention||0
10314127|NCT00159263|11447676|FG002|NOT COMPLETED|Fourth Intervention||0
10314128|NCT00159263|11447677|FG003|NOT COMPLETED|Fourth Intervention||0
10314129|NCT00159263|11447678|FG004|NOT COMPLETED|Fourth Intervention||0
10314130|NCT00159263|11447679|FG005|NOT COMPLETED|Fourth Intervention||0
10314131|NCT00159263|11447674|FG000|STARTED|Washout||1
10314132|NCT00159263|11447675|FG001|STARTED|Washout||1
10314133|NCT00159263|11447676|FG002|STARTED|Washout||2
10314134|NCT00159263|11447677|FG003|STARTED|Washout||2
10314135|NCT00159263|11447678|FG004|STARTED|Washout||2
10314136|NCT00159263|11447679|FG005|STARTED|Washout||2
10314137|NCT00159263|11447674|FG000|COMPLETED|Washout||1
10314138|NCT00159263|11447675|FG001|COMPLETED|Washout||1
10314139|NCT00159263|11447676|FG002|COMPLETED|Washout||2
10314140|NCT00159263|11447677|FG003|COMPLETED|Washout||2
10314141|NCT00159263|11447678|FG004|COMPLETED|Washout||2
10314142|NCT00159263|11447679|FG005|COMPLETED|Washout||2
10314143|NCT00159263|11447674|FG000|NOT COMPLETED|Washout||0
10314144|NCT00159263|11447675|FG001|NOT COMPLETED|Washout||0
10314145|NCT00159263|11447676|FG002|NOT COMPLETED|Washout||0
10314146|NCT00159263|11447677|FG003|NOT COMPLETED|Washout||0
10314147|NCT00159263|11447678|FG004|NOT COMPLETED|Washout||0
10314148|NCT00159263|11447679|FG005|NOT COMPLETED|Washout||0
10314149|NCT00159263|11447674|FG000|STARTED|Fifth Intervention||1
10314150|NCT00159263|11447675|FG001|STARTED|Fifth Intervention||1
10314151|NCT00159263|11447676|FG002|STARTED|Fifth Intervention||2
10314152|NCT00159263|11447677|FG003|STARTED|Fifth Intervention||2
10314153|NCT00159263|11447678|FG004|STARTED|Fifth Intervention||2
10314154|NCT00159263|11447679|FG005|STARTED|Fifth Intervention||2
10314155|NCT00159263|11447674|FG000|COMPLETED|Fifth Intervention||1
10314156|NCT00159263|11447675|FG001|COMPLETED|Fifth Intervention||1
10314157|NCT00159263|11447676|FG002|COMPLETED|Fifth Intervention||2
10314158|NCT00159263|11447677|FG003|COMPLETED|Fifth Intervention||2
10314159|NCT00159263|11447678|FG004|COMPLETED|Fifth Intervention||2
10314160|NCT00159263|11447679|FG005|COMPLETED|Fifth Intervention||2
10314161|NCT00159263|11447674|FG000|NOT COMPLETED|Fifth Intervention||0
10314162|NCT00159263|11447675|FG001|NOT COMPLETED|Fifth Intervention||0
10314163|NCT00159263|11447676|FG002|NOT COMPLETED|Fifth Intervention||0
10314164|NCT00159263|11447677|FG003|NOT COMPLETED|Fifth Intervention||0
10314165|NCT00159263|11447678|FG004|NOT COMPLETED|Fifth Intervention||0
10314166|NCT00159263|11447679|FG005|NOT COMPLETED|Fifth Intervention||0
10314167|NCT00159263|11447674|FG000|STARTED|Washout||1
10314168|NCT00159263|11447675|FG001|STARTED|Washout||1
10409286|NCT00758524|11553190|FG011|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||36
10409287|NCT00758524|11553191|FG012|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||45
10409288|NCT00758524|11553192|FG013|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||44
10409289|NCT00758524|11553193|FG014|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||39
10409290|NCT00758524|11553194|FG015|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||36
10429147|NCT00862849|11575291|FG005|STARTED|Washout 2 (3 to 14 Days)||3
10429148|NCT00862849|11575286|FG000|COMPLETED|Washout 2 (3 to 14 Days)||3
10429149|NCT00862849|11575287|FG001|COMPLETED|Washout 2 (3 to 14 Days)||3
10429150|NCT00862849|11575288|FG002|COMPLETED|Washout 2 (3 to 14 Days)||3
10314169|NCT00159263|11447676|FG002|STARTED|Washout||2
10314170|NCT00159263|11447677|FG003|STARTED|Washout||2
10314171|NCT00159263|11447678|FG004|STARTED|Washout||2
10314172|NCT00159263|11447679|FG005|STARTED|Washout||2
10314173|NCT00159263|11447674|FG000|COMPLETED|Washout||1
10314174|NCT00159263|11447675|FG001|COMPLETED|Washout||1
10314175|NCT00159263|11447676|FG002|COMPLETED|Washout||2
10314176|NCT00159263|11447677|FG003|COMPLETED|Washout||2
10314177|NCT00159263|11447678|FG004|COMPLETED|Washout||2
10314178|NCT00159263|11447679|FG005|COMPLETED|Washout||2
10314179|NCT00159263|11447674|FG000|NOT COMPLETED|Washout||0
10314180|NCT00159263|11447675|FG001|NOT COMPLETED|Washout||0
10314181|NCT00159263|11447676|FG002|NOT COMPLETED|Washout||0
10833527|NCT01746173|11998739|FG000|STARTED|Overall Study||5
10833528|NCT01746173|11998739|FG000|COMPLETED|Overall Study||3
10833529|NCT01746173|11998739|FG000|NOT COMPLETED|Overall Study||2
10833530|NCT01734512|11998743|FG000|STARTED|Overall Study||65
10833531|NCT01734512|11998743|FG000|COMPLETED|Overall Study||65
10833532|NCT01734512|11998743|FG000|NOT COMPLETED|Overall Study||0
10833576|NCT01555541|11998778|FG000|STARTED|Salvage Response Assessment||19
10833577|NCT01555541|11998778|FG000|COMPLETED|Salvage Response Assessment||19
10833578|NCT01555541|11998778|FG000|NOT COMPLETED|Salvage Response Assessment||0
10833579|NCT01555541|11998778|FG000|STARTED|OVA Treatment||19
10833580|NCT01555541|11998778|FG000|COMPLETED|OVA Treatment||19
10833581|NCT01555541|11998778|FG000|NOT COMPLETED|OVA Treatment||0
10833582|NCT01555541|11998778|FG000|STARTED|Autologous Stem Cell Transplantation|7 patients did not move forward due to non-response/progression on last line of therapy prior to Autologous Stem Cell Transplantation (ASCT)|12
10833583|NCT01555541|11998778|FG000|COMPLETED|Autologous Stem Cell Transplantation||12
10833584|NCT01555541|11998778|FG000|NOT COMPLETED|Autologous Stem Cell Transplantation||0
10833585|NCT01398852|11998782|FG000|STARTED|Overall Study|Due to termination of the study the exact number of participants enrolled is unknown at this time.|372
10833586|NCT01398852|11998782|FG000|COMPLETED|Overall Study||0
10833587|NCT01398852|11998782|FG000|NOT COMPLETED|Overall Study||372
10833588|NCT01398839|11998788|FG000|STARTED|Overall Study||35
10833589|NCT01398839|11998789|FG001|STARTED|Overall Study||37
10833590|NCT01398839|11998788|FG000|COMPLETED|Overall Study|The study was terminated. The exact number of patients completing all visits is unknown.|35
10833591|NCT01398839|11998789|FG001|COMPLETED|Overall Study|The study was terminated. The exact number of patients completing all visits is unknown.|37
10833592|NCT01398839|11998788|FG000|NOT COMPLETED|Overall Study||0
10833593|NCT01398839|11998789|FG001|NOT COMPLETED|Overall Study||0
10833594|NCT01349959|11998795|FG000|STARTED|Overall Study||40
10833595|NCT01349959|11998795|FG000|COMPLETED|Overall Study||33
10833596|NCT01349959|11998795|FG000|NOT COMPLETED|Overall Study||7
10291461|NCT03839511|11424440|FG000|STARTED|Overall Study||4
10291462|NCT03839511|11424440|FG000|COMPLETED|Overall Study||4
10291463|NCT03839511|11424440|FG000|NOT COMPLETED|Overall Study||0
10291464|NCT03835546|11424447|FG000|STARTED|Overall Study||15
10291465|NCT03835546|11424448|FG001|STARTED|Overall Study||15
10291466|NCT03835546|11424449|FG002|STARTED|Overall Study||15
10291467|NCT03835546|11424447|FG000|COMPLETED|Overall Study||12
10291468|NCT03835546|11424448|FG001|COMPLETED|Overall Study||15
10291469|NCT03835546|11424449|FG002|COMPLETED|Overall Study||15
10291470|NCT03835546|11424447|FG000|NOT COMPLETED|Overall Study||3
10291471|NCT03835546|11424448|FG001|NOT COMPLETED|Overall Study||0
10544986|NCT01493557|11698200|FG000|STARTED|Adding the Second Strategy||14
10544987|NCT01493557|11698201|FG001|STARTED|Adding the Second Strategy||15
10544988|NCT01493557|11698202|FG002|STARTED|Adding the Second Strategy||0
10544989|NCT01493557|11698200|FG000|COMPLETED|Adding the Second Strategy||12
10544990|NCT01493557|11698201|FG001|COMPLETED|Adding the Second Strategy||11
10544991|NCT01493557|11698202|FG002|COMPLETED|Adding the Second Strategy||0
10544992|NCT01493557|11698200|FG000|NOT COMPLETED|Adding the Second Strategy||2
10544993|NCT01493557|11698201|FG001|NOT COMPLETED|Adding the Second Strategy||4
10544994|NCT01493557|11698202|FG002|NOT COMPLETED|Adding the Second Strategy||0
10544995|NCT01493596|11698216|FG000|STARTED|Overall Study||8
10544996|NCT01493596|11698217|FG001|STARTED|Overall Study||8
10544997|NCT01493596|11698218|FG002|STARTED|Overall Study|Repeat of dose cohort because of incidences of hyperkalemia observed in cohort 2(a).|7
10833761|NCT00700882|11998960|FG000|STARTED|Overall Study||81
10833762|NCT00700882|11998960|FG000|Received Protocol Therapy|Overall Study||75
10833763|NCT00700882|11998960|FG000|Eligible and Treated Patients|Overall Study||73
10833764|NCT00700882|11998960|FG000|Eligible, Treated and KIT+ Patients|Overall Study||22
10833765|NCT00700882|11998960|FG000|COMPLETED|Overall Study||22
10833766|NCT00700882|11998960|FG000|NOT COMPLETED|Overall Study||59
10833793|NCT00644228|11998979|FG000|STARTED|Randomization & Eligibility||261
10833794|NCT00644228|11998980|FG001|STARTED|Randomization & Eligibility||264
10833795|NCT00644228|11998979|FG000|Eligible and Analyzable|Randomization & Eligibility||229
10833796|NCT00644228|11998980|FG001|Eligible and Analyzable|Randomization & Eligibility||242
10833797|NCT00644228|11998979|FG000|COMPLETED|Randomization & Eligibility||229
10833798|NCT00644228|11998980|FG001|COMPLETED|Randomization & Eligibility||242
10833799|NCT00644228|11998979|FG000|NOT COMPLETED|Randomization & Eligibility||32
10833800|NCT00644228|11998980|FG001|NOT COMPLETED|Randomization & Eligibility||22
10833801|NCT00644228|11998979|FG000|STARTED|Induction Therapy||229
10833802|NCT00644228|11998980|FG001|STARTED|Induction Therapy||242
10833803|NCT00644228|11998979|FG000|COMPLETED|Induction Therapy||146
10833804|NCT00644228|11998980|FG001|COMPLETED|Induction Therapy||137
10833805|NCT00644228|11998979|FG000|NOT COMPLETED|Induction Therapy||83
10833806|NCT00644228|11998980|FG001|NOT COMPLETED|Induction Therapy||105
10833807|NCT00644228|11998979|FG000|STARTED|Maintenance|3 patients who completed induction did not continue on to maintenance due to refusal (1), other (2).|143
10833808|NCT00644228|11998980|FG001|STARTED|Maintenance|2 patients who completed induction did not continue on to maintenance due to other (2).|135
10833809|NCT00644228|11998979|FG000|COMPLETED|Maintenance||0
10833810|NCT00644228|11998980|FG001|COMPLETED|Maintenance||0
10833811|NCT00644228|11998979|FG000|NOT COMPLETED|Maintenance||143
10833812|NCT00644228|11998980|FG001|NOT COMPLETED|Maintenance||135
10291472|NCT03835546|11424449|FG002|NOT COMPLETED|Overall Study||0
10314182|NCT00159263|11447677|FG003|NOT COMPLETED|Washout||0
10314183|NCT00159263|11447678|FG004|NOT COMPLETED|Washout||0
10314184|NCT00159263|11447679|FG005|NOT COMPLETED|Washout||0
10314185|NCT00159263|11447674|FG000|STARTED|Sixth Intervention||1
10314186|NCT00159263|11447675|FG001|STARTED|Sixth Intervention||1
10314187|NCT00159263|11447676|FG002|STARTED|Sixth Intervention||2
10314188|NCT00159263|11447677|FG003|STARTED|Sixth Intervention||2
10314189|NCT00159263|11447678|FG004|STARTED|Sixth Intervention||2
10314190|NCT00159263|11447679|FG005|STARTED|Sixth Intervention||2
10314191|NCT00159263|11447674|FG000|COMPLETED|Sixth Intervention||1
10314192|NCT00159263|11447675|FG001|COMPLETED|Sixth Intervention||1
10314193|NCT00159263|11447676|FG002|COMPLETED|Sixth Intervention||2
10314194|NCT00159263|11447677|FG003|COMPLETED|Sixth Intervention||2
10314195|NCT00159263|11447678|FG004|COMPLETED|Sixth Intervention||2
10314196|NCT00159263|11447679|FG005|COMPLETED|Sixth Intervention||2
10314197|NCT00159263|11447674|FG000|NOT COMPLETED|Sixth Intervention||0
10314198|NCT00159263|11447675|FG001|NOT COMPLETED|Sixth Intervention||0
10314199|NCT00159263|11447676|FG002|NOT COMPLETED|Sixth Intervention||0
10314200|NCT00159263|11447677|FG003|NOT COMPLETED|Sixth Intervention||0
10314201|NCT00159263|11447678|FG004|NOT COMPLETED|Sixth Intervention||0
10314202|NCT00159263|11447679|FG005|NOT COMPLETED|Sixth Intervention||0
10314203|NCT00159419|11447695|FG000|STARTED|Overall Study||9
10314204|NCT00159419|11447696|FG001|STARTED|Overall Study||9
10314205|NCT00159419|11447695|FG000|COMPLETED|Overall Study||9
10314206|NCT00159419|11447696|FG001|COMPLETED|Overall Study||9
10314207|NCT00159419|11447695|FG000|NOT COMPLETED|Overall Study||0
10314208|NCT00159419|11447696|FG001|NOT COMPLETED|Overall Study||0
10314209|NCT00159432|11447702|FG000|STARTED|Overall Study||63
10314210|NCT00159432|11447702|FG000|COMPLETED|Overall Study||53
10409291|NCT00758524|11553195|FG016|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)|One participant randomized to Placebo arm in Withdrawal Period received LCI699 0.5 mg QD and was counted in LCI699 0.5 mg QD arm in the Randomized Withdrawal Safety Set. However, this participant was counted in the Placebo arm (N=67) in the Randomized Withdrawal Set.|67
10409292|NCT00758524|11553179|FG000|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
10409293|NCT00758524|11553180|FG001|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
10409294|NCT00758524|11553181|FG002|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
10409295|NCT00758524|11553182|FG003|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
10409296|NCT00758524|11553183|FG004|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
10409297|NCT00758524|11553184|FG005|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
10409298|NCT00758524|11553185|FG006|COMPLETED|Withdrawal Period (Week 8 to Week 9)||45
10409299|NCT00758524|11553186|FG007|COMPLETED|Withdrawal Period (Week 8 to Week 9)||38
10409300|NCT00758524|11553187|FG008|COMPLETED|Withdrawal Period (Week 8 to Week 9)||42
10409301|NCT00758524|11553188|FG009|COMPLETED|Withdrawal Period (Week 8 to Week 9)||37
10409302|NCT00758524|11553189|FG010|COMPLETED|Withdrawal Period (Week 8 to Week 9)||41
10409303|NCT00758524|11553190|FG011|COMPLETED|Withdrawal Period (Week 8 to Week 9)||37
10314211|NCT00159432|11447702|FG000|NOT COMPLETED|Overall Study||10
10314212|NCT00159822|11447706|FG000|STARTED|Voriconazole Treatment Period||48
10314213|NCT00159822|11447706|FG000|COMPLETED|Voriconazole Treatment Period|Number of subjects completed treatment: 36 up to month 6 (M6); 26 after M6.|26
10314214|NCT00159822|11447706|FG000|NOT COMPLETED|Voriconazole Treatment Period||22
10314215|NCT00159822|11447706|FG000|STARTED|Post-treatment Follow-up Period||26
10291473|NCT04461795|11424457|FG000|STARTED|Overall Study||40
10291474|NCT04461795|11424457|FG000|COMPLETED|Overall Study||35
10833933|NCT00378482|11999024|FG000|STARTED|Overall Study||37
10833934|NCT00378482|11999024|FG000|COMPLETED|Overall Study||6
10833935|NCT00378482|11999024|FG000|NOT COMPLETED|Overall Study||31
10833936|NCT00316888|11999030|FG000|STARTED|Overall Study||28
10833937|NCT00316888|11999031|FG001|STARTED|Overall Study||35
10833938|NCT00316888|11999030|FG000|Eligible|Overall Study||28
10833939|NCT00316888|11999031|FG001|Eligible|Overall Study||35
10833940|NCT00316888|11999030|FG000|Treated|Overall Study|Received induction and/or chemo+radiation therapy|28
10833941|NCT00316888|11999031|FG001|Treated|Overall Study||34
10833942|NCT00316888|11999030|FG000|Started Induction Chemotherapy|Overall Study||28
10833943|NCT00316888|11999031|FG001|Started Induction Chemotherapy|Overall Study|Induction chemotherapy was removed for patients on this arm|0
10833944|NCT00316888|11999030|FG000|Started Chemo+Radiation+Cetuximab|Overall Study|One patient did not start chemo+radiation therapy after completing induction therapy|27
10833945|NCT00316888|11999031|FG001|Started Chemo+Radiation+Cetuximab|Overall Study||34
10833946|NCT00316888|11999030|FG000|COMPLETED|Overall Study||22
10833947|NCT00316888|11999031|FG001|COMPLETED|Overall Study||27
10833948|NCT00316888|11999030|FG000|NOT COMPLETED|Overall Study||6
10833949|NCT00316888|11999031|FG001|NOT COMPLETED|Overall Study||8
10833950|NCT00095784|11999037|FG000|STARTED|Overall Study||21
10833951|NCT00095784|11999037|FG000|COMPLETED|Overall Study||21
10833952|NCT00095784|11999037|FG000|NOT COMPLETED|Overall Study||0
10833973|NCT03178487|11999069|FG000|STARTED|Overall Study||94
10833974|NCT03178487|11999070|FG001|STARTED|Overall Study||93
10833975|NCT03178487|11999069|FG000|Received Treatment|Overall Study||94
10833976|NCT03178487|11999070|FG001|Received Treatment|Overall Study||93
10833977|NCT03178487|11999069|FG000|COMPLETED|Overall Study||90
10833978|NCT03178487|11999070|FG001|COMPLETED|Overall Study||89
10833979|NCT03178487|11999069|FG000|NOT COMPLETED|Overall Study||4
10833980|NCT03178487|11999070|FG001|NOT COMPLETED|Overall Study||4
10833981|NCT03155932|11999076|FG000|STARTED|Overall Study||2
10833982|NCT03155932|11999076|FG000|Participants Escalated to 2 mg Dose of APD334 at Week 12 to Week 24|Overall Study||2
10833983|NCT03155932|11999076|FG000|COMPLETED|Overall Study||2
10833984|NCT03155932|11999076|FG000|NOT COMPLETED|Overall Study||0
10833985|NCT03096834|11999083|FG000|STARTED|Double-Blind Treatment Epoch||121
10833986|NCT03096834|11999084|FG001|STARTED|Double-Blind Treatment Epoch||125
10833987|NCT03096834|11999085|FG002|STARTED|Double-Blind Treatment Epoch||0
10833988|NCT03096834|11999086|FG003|STARTED|Double-Blind Treatment Epoch||0
10833989|NCT03096834|11999083|FG000|COMPLETED|Double-Blind Treatment Epoch||118
10833990|NCT03096834|11999084|FG001|COMPLETED|Double-Blind Treatment Epoch||122
10833991|NCT03096834|11999085|FG002|COMPLETED|Double-Blind Treatment Epoch||0
10833992|NCT03096834|11999086|FG003|COMPLETED|Double-Blind Treatment Epoch||0
10833993|NCT03096834|11999083|FG000|NOT COMPLETED|Double-Blind Treatment Epoch||3
10833994|NCT03096834|11999084|FG001|NOT COMPLETED|Double-Blind Treatment Epoch||3
10833995|NCT03096834|11999085|FG002|NOT COMPLETED|Double-Blind Treatment Epoch||0
10833996|NCT03096834|11999086|FG003|NOT COMPLETED|Double-Blind Treatment Epoch||0
10833997|NCT03096834|11999083|FG000|STARTED|Open-Label Treatment Epoch||0
10833998|NCT03096834|11999084|FG001|STARTED|Open-Label Treatment Epoch||0
10833999|NCT03096834|11999085|FG002|STARTED|Open-Label Treatment Epoch||118
10834000|NCT03096834|11999086|FG003|STARTED|Open-Label Treatment Epoch||122
10834001|NCT03096834|11999083|FG000|COMPLETED|Open-Label Treatment Epoch||0
10834002|NCT03096834|11999084|FG001|COMPLETED|Open-Label Treatment Epoch||0
10834003|NCT03096834|11999085|FG002|COMPLETED|Open-Label Treatment Epoch||86
10834004|NCT03096834|11999086|FG003|COMPLETED|Open-Label Treatment Epoch||83
10834005|NCT03096834|11999083|FG000|NOT COMPLETED|Open-Label Treatment Epoch||0
10834006|NCT03096834|11999084|FG001|NOT COMPLETED|Open-Label Treatment Epoch||0
10834007|NCT03096834|11999085|FG002|NOT COMPLETED|Open-Label Treatment Epoch||32
10834008|NCT03096834|11999086|FG003|NOT COMPLETED|Open-Label Treatment Epoch||39
10834009|NCT03096834|11999083|FG000|STARTED|Safety Follow-Up Epoch||0
10834010|NCT03096834|11999084|FG001|STARTED|Safety Follow-Up Epoch||0
10834011|NCT03096834|11999085|FG002|STARTED|Safety Follow-Up Epoch||66
10834012|NCT03096834|11999086|FG003|STARTED|Safety Follow-Up Epoch||61
10834013|NCT03096834|11999083|FG000|COMPLETED|Safety Follow-Up Epoch||0
10834014|NCT03096834|11999084|FG001|COMPLETED|Safety Follow-Up Epoch||0
10834015|NCT03096834|11999085|FG002|COMPLETED|Safety Follow-Up Epoch||65
10834016|NCT03096834|11999086|FG003|COMPLETED|Safety Follow-Up Epoch||59
10834017|NCT03096834|11999083|FG000|NOT COMPLETED|Safety Follow-Up Epoch||0
10834018|NCT03096834|11999084|FG001|NOT COMPLETED|Safety Follow-Up Epoch||0
10834019|NCT03096834|11999085|FG002|NOT COMPLETED|Safety Follow-Up Epoch||1
10834020|NCT03096834|11999086|FG003|NOT COMPLETED|Safety Follow-Up Epoch||2
10834021|NCT03096834|11999083|FG000|STARTED|Post-Trial Access Epoch||0
10834022|NCT03096834|11999084|FG001|STARTED|Post-Trial Access Epoch||0
10834023|NCT03096834|11999085|FG002|STARTED|Post-Trial Access Epoch||21
10834024|NCT03096834|11999086|FG003|STARTED|Post-Trial Access Epoch||15
10834025|NCT03096834|11999083|FG000|COMPLETED|Post-Trial Access Epoch||0
10834026|NCT03096834|11999084|FG001|COMPLETED|Post-Trial Access Epoch||0
10834027|NCT03096834|11999085|FG002|COMPLETED|Post-Trial Access Epoch||21
10834028|NCT03096834|11999086|FG003|COMPLETED|Post-Trial Access Epoch||15
10834029|NCT03096834|11999083|FG000|NOT COMPLETED|Post-Trial Access Epoch||0
10834030|NCT03096834|11999084|FG001|NOT COMPLETED|Post-Trial Access Epoch||0
10834031|NCT03096834|11999085|FG002|NOT COMPLETED|Post-Trial Access Epoch||0
10834032|NCT03096834|11999086|FG003|NOT COMPLETED|Post-Trial Access Epoch||0
10834033|NCT03089853|11999097|FG000|STARTED|Overall Study||4
10834034|NCT03089853|11999098|FG001|STARTED|Overall Study||3
10834035|NCT03089853|11999097|FG000|COMPLETED|Overall Study||2
10834036|NCT03089853|11999098|FG001|COMPLETED|Overall Study||2
10834037|NCT03089853|11999097|FG000|NOT COMPLETED|Overall Study||2
10834038|NCT03089853|11999098|FG001|NOT COMPLETED|Overall Study||1
10834039|NCT03070392|11999106|FG000|STARTED|Overall Study||252
10834040|NCT03070392|11999107|FG001|STARTED|Overall Study||7
10834041|NCT03070392|11999108|FG002|STARTED|Overall Study||16
10834042|NCT03070392|11999109|FG003|STARTED|Overall Study||103
10834043|NCT03070392|11999106|FG000|COMPLETED|Overall Study||0
10834044|NCT03070392|11999107|FG001|COMPLETED|Overall Study||0
10834045|NCT03070392|11999108|FG002|COMPLETED|Overall Study||10
10834046|NCT03070392|11999109|FG003|COMPLETED|Overall Study||0
10834047|NCT03070392|11999106|FG000|NOT COMPLETED|Overall Study||252
10834048|NCT03070392|11999107|FG001|NOT COMPLETED|Overall Study||7
10834049|NCT03070392|11999108|FG002|NOT COMPLETED|Overall Study||6
10834050|NCT03070392|11999109|FG003|NOT COMPLETED|Overall Study||103
10834051|NCT03048578|11999117|FG000|STARTED|Overall Study||89
10834052|NCT03048578|11999118|FG001|STARTED|Overall Study||43
10834053|NCT03048578|11999117|FG000|COMPLETED|Overall Study||58
10834054|NCT03048578|11999118|FG001|COMPLETED|Overall Study||23
10834055|NCT03048578|11999117|FG000|NOT COMPLETED|Overall Study||31
10834056|NCT03048578|11999118|FG001|NOT COMPLETED|Overall Study||20
10834057|NCT03015194|11999124|FG000|STARTED|Overall Study||30
10834058|NCT03015194|11999124|FG000|COMPLETED|Overall Study||18
10834059|NCT03015194|11999124|FG000|NOT COMPLETED|Overall Study||12
10834060|NCT03012815|11999131|FG000|STARTED|Overall Study||46
10834061|NCT03012815|11999132|FG001|STARTED|Overall Study||42
10834062|NCT03012815|11999131|FG000|COMPLETED|Overall Study||41
10834063|NCT03012815|11999132|FG001|COMPLETED|Overall Study||40
10834064|NCT03012815|11999131|FG000|NOT COMPLETED|Overall Study||5
10834065|NCT03012815|11999132|FG001|NOT COMPLETED|Overall Study||2
10834066|NCT03001011|11999141|FG000|STARTED|Overall Study||101
10834067|NCT03001011|11999142|FG001|STARTED|Overall Study||101
10834068|NCT03001011|11999141|FG000|COMPLETED|Overall Study||74
10834069|NCT03001011|11999142|FG001|COMPLETED|Overall Study||80
10834070|NCT03001011|11999141|FG000|NOT COMPLETED|Overall Study||27
10834071|NCT03001011|11999142|FG001|NOT COMPLETED|Overall Study||21
10834072|NCT02999633|11999149|FG000|STARTED|Overall Study||14
10834073|NCT02999633|11999149|FG000|COMPLETED|Overall Study||0
10834074|NCT02999633|11999149|FG000|NOT COMPLETED|Overall Study||14
10834075|NCT02993757|11999155|FG000|STARTED|Overall Study||266
10834076|NCT02993757|11999156|FG001|STARTED|Overall Study||262
10834077|NCT02993757|11999155|FG000|Safety Analysis Set (SafAS)|Overall Study||263
10834078|NCT02993757|11999156|FG001|Safety Analysis Set (SafAS)|Overall Study||260
10834079|NCT02993757|11999155|FG000|COMPLETED|Overall Study||102
10834080|NCT02993757|11999156|FG001|COMPLETED|Overall Study||84
10834081|NCT02993757|11999155|FG000|NOT COMPLETED|Overall Study||164
10834082|NCT02993757|11999156|FG001|NOT COMPLETED|Overall Study||178
10834083|NCT02992418|11999164|FG000|STARTED|Overall Study||346
10834084|NCT02992418|11999165|FG001|STARTED|Overall Study||342
10834085|NCT02992418|11999164|FG000|Safety Analysis Set (SafAS)|Overall Study||338
10834086|NCT02992418|11999165|FG001|Safety Analysis Set (SafAS)|Overall Study||342
10834087|NCT02992418|11999164|FG000|COMPLETED|Overall Study||0
10834088|NCT02992418|11999165|FG001|COMPLETED|Overall Study||0
10834089|NCT02992418|11999164|FG000|NOT COMPLETED|Overall Study||346
10834090|NCT02992418|11999165|FG001|NOT COMPLETED|Overall Study||342
10834091|NCT02979535|11999173|FG000|STARTED|Overall Study||239
10834092|NCT02979535|11999174|FG001|STARTED|Overall Study||241
10834093|NCT02979535|11999173|FG000|Safety Analysis Set|Overall Study||237
10834094|NCT02979535|11999174|FG001|Safety Analysis Set|Overall Study||241
10834095|NCT02979535|11999173|FG000|COMPLETED|Overall Study||144
10834096|NCT02979535|11999174|FG001|COMPLETED|Overall Study||140
10834097|NCT02979535|11999173|FG000|NOT COMPLETED|Overall Study||95
10834098|NCT02979535|11999174|FG001|NOT COMPLETED|Overall Study||101
10834099|NCT02978716|11999183|FG000|STARTED|Overall Study||34
10834100|NCT02978716|11999184|FG001|STARTED|Overall Study||33
10834101|NCT02978716|11999185|FG002|STARTED|Overall Study||35
10834102|NCT02978716|11999183|FG000|ITT Population|Overall Study||34
10834103|NCT02978716|11999184|FG001|ITT Population|Overall Study||33
10834104|NCT02978716|11999185|FG002|ITT Population|Overall Study||35
10834105|NCT02978716|11999183|FG000|Safety Analysis Set|Overall Study||30
10834106|NCT02978716|11999184|FG001|Safety Analysis Set|Overall Study||33
10834107|NCT02978716|11999185|FG002|Safety Analysis Set|Overall Study||35
10834108|NCT02978716|11999183|FG000|Treated|Overall Study||30
10834109|NCT02978716|11999184|FG001|Treated|Overall Study||33
10834110|NCT02978716|11999185|FG002|Treated|Overall Study||35
10834111|NCT02978716|11999183|FG000|COMPLETED|Overall Study||0
10834112|NCT02978716|11999184|FG001|COMPLETED|Overall Study||0
10834113|NCT02978716|11999185|FG002|COMPLETED|Overall Study||0
10834114|NCT02978716|11999183|FG000|NOT COMPLETED|Overall Study||34
10834115|NCT02978716|11999184|FG001|NOT COMPLETED|Overall Study||33
10834116|NCT02978716|11999185|FG002|NOT COMPLETED|Overall Study||35
10834117|NCT02973321|11999200|FG000|STARTED|Overall Study||33
10834118|NCT02973321|11999201|FG001|STARTED|Overall Study||66
10291475|NCT04461795|11424457|FG000|NOT COMPLETED|Overall Study||5
10291476|NCT04405999|11424464|FG000|STARTED|Overall Study||25
10291477|NCT04405999|11424465|FG001|STARTED|Overall Study||25
10291478|NCT04405999|11424464|FG000|COMPLETED|Overall Study||25
10291479|NCT04405999|11424465|FG001|COMPLETED|Overall Study||25
10291480|NCT04405999|11424464|FG000|NOT COMPLETED|Overall Study||0
10291481|NCT04405999|11424465|FG001|NOT COMPLETED|Overall Study||0
10291482|NCT04383587|11424471|FG000|STARTED|Overall Study||300
10291483|NCT04383587|11424471|FG000|COMPLETED|Overall Study||292
10291484|NCT04383587|11424471|FG000|NOT COMPLETED|Overall Study||8
10314216|NCT00159822|11447706|FG000|COMPLETED|Post-treatment Follow-up Period||23
10314217|NCT00159822|11447706|FG000|NOT COMPLETED|Post-treatment Follow-up Period||3
10314218|NCT00159861|11447712|FG000|STARTED|Core Study - 16 Weeks||133
10314219|NCT00159861|11447713|FG001|STARTED|Core Study - 16 Weeks||134
10314220|NCT00159861|11447712|FG000|Treated|Core Study - 16 Weeks||131
10314221|NCT00159861|11447713|FG001|Treated|Core Study - 16 Weeks||134
10314222|NCT00159861|11447712|FG000|COMPLETED|Core Study - 16 Weeks|Entered A1481153: 115; Did not enter A1481153: 16|108
10314223|NCT00159861|11447713|FG001|COMPLETED|Core Study - 16 Weeks|Entered A1481153: 127; Did not enter A1481153: 7|122
10314224|NCT00159861|11447712|FG000|NOT COMPLETED|Core Study - 16 Weeks||25
10314225|NCT00159861|11447713|FG001|NOT COMPLETED|Core Study - 16 Weeks||12
10314226|NCT00159861|11447712|FG000|STARTED|Extension Study - up to 3 Years|Subjects may have entered extension study after 4 weeks in core study (prior to completion).|115
10314227|NCT00159861|11447713|FG001|STARTED|Extension Study - up to 3 Years|Subjects may have entered extension study after 4 weeks in core study (prior to completion).|127
10314228|NCT00159861|11447712|FG000|Treated|Extension Study - up to 3 Years||115
10314229|NCT00159861|11447713|FG001|Treated|Extension Study - up to 3 Years||127
10314230|NCT00159861|11447712|FG000|COMPLETED|Extension Study - up to 3 Years||53
10314231|NCT00159861|11447713|FG001|COMPLETED|Extension Study - up to 3 Years||56
10314232|NCT00159861|11447712|FG000|NOT COMPLETED|Extension Study - up to 3 Years||62
10314233|NCT00159861|11447713|FG001|NOT COMPLETED|Extension Study - up to 3 Years||71
10314234|NCT00159874|11447731|FG000|STARTED|Overall Study||42
10314235|NCT00159874|11447732|FG001|STARTED|Overall Study||55
10314236|NCT00159874|11447733|FG002|STARTED|Overall Study||77
10314237|NCT00159874|11447734|FG003|STARTED|Overall Study||13
10834119|NCT02973321|11999202|FG002|STARTED|Overall Study||66
10834120|NCT02973321|11999203|FG003|STARTED|Overall Study||64
10834121|NCT02973321|11999204|FG004|STARTED|Overall Study||67
10834122|NCT02973321|11999200|FG000|COMPLETED|Overall Study||32
10834123|NCT02973321|11999201|FG001|COMPLETED|Overall Study||51
10314238|NCT00159874|11447735|FG004|STARTED|Overall Study||19
10834124|NCT02973321|11999202|FG002|COMPLETED|Overall Study||52
10834125|NCT02973321|11999203|FG003|COMPLETED|Overall Study||48
10834126|NCT02973321|11999204|FG004|COMPLETED|Overall Study||62
10834127|NCT02973321|11999200|FG000|NOT COMPLETED|Overall Study||1
10834128|NCT02973321|11999201|FG001|NOT COMPLETED|Overall Study||15
10834129|NCT02973321|11999202|FG002|NOT COMPLETED|Overall Study||14
10834130|NCT02973321|11999203|FG003|NOT COMPLETED|Overall Study||16
10834131|NCT02973321|11999204|FG004|NOT COMPLETED|Overall Study||5
10834132|NCT02943785|11999219|FG000|STARTED|Overall Study||713
10834133|NCT02943785|11999220|FG001|STARTED|Overall Study||713
10834134|NCT02943785|11999219|FG000|COMPLETED|Overall Study||431
10834135|NCT02943785|11999220|FG001|COMPLETED|Overall Study||350
10834136|NCT02943785|11999219|FG000|NOT COMPLETED|Overall Study||282
10834137|NCT02943785|11999220|FG001|NOT COMPLETED|Overall Study||363
10834138|NCT02923674|11999229|FG000|STARTED|Overall Study||60
10834139|NCT02923674|11999230|FG001|STARTED|Overall Study||60
10834140|NCT02923674|11999231|FG002|STARTED|Overall Study||63
10834141|NCT02923674|11999229|FG000|COMPLETED|Overall Study||32
10834142|NCT02923674|11999230|FG001|COMPLETED|Overall Study||32
10834143|NCT02923674|11999231|FG002|COMPLETED|Overall Study||38
10834144|NCT02923674|11999229|FG000|NOT COMPLETED|Overall Study||28
10834145|NCT02923674|11999230|FG001|NOT COMPLETED|Overall Study||28
10834146|NCT02923674|11999231|FG002|NOT COMPLETED|Overall Study||25
10834147|NCT02921971|11999241|FG000|STARTED|Overall Study||49
10834148|NCT02921971|11999242|FG001|STARTED|Overall Study||48
10834149|NCT02921971|11999241|FG000|COMPLETED|Overall Study||43
10834150|NCT02921971|11999242|FG001|COMPLETED|Overall Study||44
10834151|NCT02921971|11999241|FG000|NOT COMPLETED|Overall Study||6
10834152|NCT02921971|11999242|FG001|NOT COMPLETED|Overall Study||4
10834153|NCT02886286|11999250|FG000|STARTED|Overall Study||8
10834154|NCT02886286|11999251|FG001|STARTED|Overall Study||9
10834155|NCT02886286|11999250|FG000|COMPLETED|Overall Study||8
10834156|NCT02886286|11999251|FG001|COMPLETED|Overall Study||8
10834157|NCT02886286|11999250|FG000|NOT COMPLETED|Overall Study||0
10834158|NCT02886286|11999251|FG001|NOT COMPLETED|Overall Study||1
10834159|NCT02865187|11999259|FG000|STARTED|Overall Study||33
10834160|NCT02865187|11999260|FG001|STARTED|Overall Study||14
10834161|NCT02865187|11999259|FG000|Visit 2 - at 3 Months|Overall Study||23
10834162|NCT02865187|11999260|FG001|Visit 2 - at 3 Months|Overall Study||7
10834163|NCT02865187|11999259|FG000|COMPLETED|Overall Study||20
10834164|NCT02865187|11999260|FG001|COMPLETED|Overall Study||7
10834165|NCT02865187|11999259|FG000|NOT COMPLETED|Overall Study||13
10834166|NCT02865187|11999260|FG001|NOT COMPLETED|Overall Study||7
10834176|NCT02824198|11999281|FG000|STARTED|Overall Study||89
10834177|NCT02824198|11999282|FG001|STARTED|Overall Study||29
10834178|NCT02824198|11999281|FG000|COMPLETED|Overall Study||74
10834179|NCT02824198|11999282|FG001|COMPLETED|Overall Study||26
10834180|NCT02824198|11999281|FG000|NOT COMPLETED|Overall Study||15
10834181|NCT02824198|11999282|FG001|NOT COMPLETED|Overall Study||3
10834182|NCT02821754|11999293|FG000|STARTED|Overall Study||36
10834183|NCT02821754|11999294|FG001|STARTED|Overall Study||16
10834184|NCT02821754|11999295|FG002|STARTED|Overall Study|No results data were collected for these participants.|2
10834185|NCT02821754|11999293|FG000|COMPLETED|Overall Study||20
10834186|NCT02821754|11999294|FG001|COMPLETED|Overall Study||4
10834187|NCT02821754|11999295|FG002|COMPLETED|Overall Study||0
10834188|NCT02821754|11999293|FG000|NOT COMPLETED|Overall Study||16
10834189|NCT02821754|11999294|FG001|NOT COMPLETED|Overall Study||12
10834190|NCT02821754|11999295|FG002|NOT COMPLETED|Overall Study||2
10834191|NCT02787551|11999303|FG000|STARTED|Core Period: 26 Weeks||257
10834192|NCT02787551|11999304|FG001|STARTED|Core Period: 26 Weeks||257
10834193|NCT02787551|11999303|FG000|Treated|Core Period: 26 Weeks||255
10834194|NCT02787551|11999304|FG001|Treated|Core Period: 26 Weeks||256
10834195|NCT02787551|11999303|FG000|COMPLETED|Core Period: 26 Weeks|Out of 230 participants, 206 participants entered in single arm extension period.|230
10834196|NCT02787551|11999304|FG001|COMPLETED|Core Period: 26 Weeks||246
10834197|NCT02787551|11999303|FG000|NOT COMPLETED|Core Period: 26 Weeks||27
10834198|NCT02787551|11999304|FG001|NOT COMPLETED|Core Period: 26 Weeks||11
10834199|NCT02787551|11999303|FG000|STARTED|Extension Period:26 Weeks(Upto 52 Weeks)|Participants who completed core period and met eligibility criteria for extension period.|206
10834200|NCT02787551|11999304|FG001|STARTED|Extension Period:26 Weeks(Upto 52 Weeks)||0
10834201|NCT02787551|11999303|FG000|COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||197
10834202|NCT02787551|11999304|FG001|COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||0
10834203|NCT02787551|11999303|FG000|NOT COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||9
10834204|NCT02787551|11999304|FG001|NOT COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||0
10834205|NCT02747121|11999315|FG000|STARTED|Overall Study||3594
10834206|NCT02747121|11999316|FG001|STARTED|Overall Study||3813
10834207|NCT02747121|11999315|FG000|COMPLETED|Overall Study||3594
10834208|NCT02747121|11999316|FG001|COMPLETED|Overall Study||3813
10834209|NCT02747121|11999315|FG000|NOT COMPLETED|Overall Study||0
10834210|NCT02747121|11999316|FG001|NOT COMPLETED|Overall Study||0
10834211|NCT02735044|11999324|FG000|STARTED|Overall Study||233
10834212|NCT02735044|11999325|FG001|STARTED|Overall Study||230
10834213|NCT02735044|11999324|FG000|Treated|Overall Study||233
10834214|NCT02735044|11999325|FG001|Treated|Overall Study||228
10834215|NCT02735044|11999324|FG000|COMPLETED|Overall Study||217
10834216|NCT02735044|11999325|FG001|COMPLETED|Overall Study||207
10834217|NCT02735044|11999324|FG000|NOT COMPLETED|Overall Study||16
10834218|NCT02735044|11999325|FG001|NOT COMPLETED|Overall Study||23
10834219|NCT02720744|11999333|FG000|STARTED|Overall Study||107
10834220|NCT02720744|11999334|FG001|STARTED|Overall Study||105
10834221|NCT02720744|11999333|FG000|COMPLETED|Overall Study||69
10834222|NCT02720744|11999334|FG001|COMPLETED|Overall Study||79
10834223|NCT02720744|11999333|FG000|NOT COMPLETED|Overall Study||38
10834224|NCT02720744|11999334|FG001|NOT COMPLETED|Overall Study||26
10834225|NCT02713867|11999342|FG000|STARTED|Randomization||180
10834226|NCT02713867|11999343|FG001|STARTED|Randomization||183
10834227|NCT02713867|11999342|FG000|COMPLETED|Randomization||178
10834228|NCT02713867|11999343|FG001|COMPLETED|Randomization||180
10834229|NCT02713867|11999342|FG000|NOT COMPLETED|Randomization||2
10834230|NCT02713867|11999343|FG001|NOT COMPLETED|Randomization||3
10834231|NCT02713867|11999342|FG000|STARTED|Treatment Period||178
10834232|NCT02713867|11999343|FG001|STARTED|Treatment Period||180
10834233|NCT02713867|11999342|FG000|COMPLETED|Treatment Period||31
10834234|NCT02713867|11999343|FG001|COMPLETED|Treatment Period||30
10834235|NCT02713867|11999342|FG000|NOT COMPLETED|Treatment Period||147
10834236|NCT02713867|11999343|FG001|NOT COMPLETED|Treatment Period||150
10834237|NCT02704403|11999351|FG000|STARTED|Overall Study||1437
10834238|NCT02704403|11999352|FG001|STARTED|Overall Study||720
10834239|NCT02704403|11999351|FG000|Full Intent-to-Treat Population|Overall Study||1437
10834240|NCT02704403|11999352|FG001|Full Intent-to-Treat Population|Overall Study||720
10834241|NCT02704403|11999351|FG000|Full Safety Population|Overall Study||1433
10834242|NCT02704403|11999352|FG001|Full Safety Population|Overall Study||717
10834243|NCT02704403|11999351|FG000|COMPLETED|Overall Study||0
10834244|NCT02704403|11999352|FG001|COMPLETED|Overall Study||0
10834245|NCT02704403|11999351|FG000|NOT COMPLETED|Overall Study||1437
10834246|NCT02704403|11999352|FG001|NOT COMPLETED|Overall Study||720
10834247|NCT02694185|11999360|FG000|STARTED|Overall Study||476
10834248|NCT02694185|11999361|FG001|STARTED|Overall Study||4793
10834249|NCT02694185|11999360|FG000|COMPLETED|Overall Study||431
10834250|NCT02694185|11999361|FG001|COMPLETED|Overall Study||4793
10834251|NCT02694185|11999360|FG000|NOT COMPLETED|Overall Study||45
10834252|NCT02694185|11999361|FG001|NOT COMPLETED|Overall Study||0
10834253|NCT02692651|11999369|FG000|STARTED|Study Treatment||70
10834254|NCT02692651|11999370|FG001|STARTED|Study Treatment||74
10834255|NCT02692651|11999369|FG000|COMPLETED|Study Treatment||54
10834256|NCT02692651|11999370|FG001|COMPLETED|Study Treatment||64
10834257|NCT02692651|11999369|FG000|NOT COMPLETED|Study Treatment||16
10834258|NCT02692651|11999370|FG001|NOT COMPLETED|Study Treatment||10
10834259|NCT02692651|11999369|FG000|STARTED|Post Study Treatment Follow-up||54
10834260|NCT02692651|11999370|FG001|STARTED|Post Study Treatment Follow-up||64
10834261|NCT02692651|11999369|FG000|COMPLETED|Post Study Treatment Follow-up||50
10834262|NCT02692651|11999370|FG001|COMPLETED|Post Study Treatment Follow-up||60
10834263|NCT02692651|11999369|FG000|NOT COMPLETED|Post Study Treatment Follow-up||4
10834264|NCT02692651|11999370|FG001|NOT COMPLETED|Post Study Treatment Follow-up||4
10834265|NCT02674061|11999378|FG000|STARTED|Overall Study||285
10834266|NCT02674061|11999379|FG001|STARTED|Overall Study||91
10834267|NCT02674061|11999378|FG000|COMPLETED|Overall Study||0
10834268|NCT02674061|11999379|FG001|COMPLETED|Overall Study||0
10834269|NCT02674061|11999378|FG000|NOT COMPLETED|Overall Study||285
10834270|NCT02674061|11999379|FG001|NOT COMPLETED|Overall Study||91
10834271|NCT02656706|11999387|FG000|STARTED|Overall Study||22
10834272|NCT02656706|11999387|FG000|COMPLETED|Overall Study||21
10834273|NCT02656706|11999387|FG000|NOT COMPLETED|Overall Study||1
10834274|NCT02654314|11999393|FG000|STARTED|Overall Study||136
10834275|NCT02654314|11999394|FG001|STARTED|Overall Study||141
10834276|NCT02654314|11999393|FG000|COMPLETED|Overall Study||136
10834277|NCT02654314|11999394|FG001|COMPLETED|Overall Study||141
10834278|NCT02654314|11999393|FG000|NOT COMPLETED|Overall Study||0
10834279|NCT02654314|11999394|FG001|NOT COMPLETED|Overall Study||0
10834280|NCT02628444|11999403|FG000|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||350
10834281|NCT02628444|11999404|FG001|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||348
10834282|NCT02628444|11999405|FG002|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||352
10834283|NCT02628444|11999406|FG003|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834284|NCT02628444|11999407|FG004|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834285|NCT02628444|11999408|FG005|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834286|NCT02628444|11999409|FG006|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834287|NCT02628444|11999410|FG007|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834288|NCT02628444|11999411|FG008|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834289|NCT02628444|11999403|FG000|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||348
10834290|NCT02628444|11999404|FG001|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||348
10834291|NCT02628444|11999405|FG002|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||352
10834292|NCT02628444|11999406|FG003|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834293|NCT02628444|11999407|FG004|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834294|NCT02628444|11999408|FG005|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834295|NCT02628444|11999409|FG006|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834296|NCT02628444|11999410|FG007|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834297|NCT02628444|11999411|FG008|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834298|NCT02628444|11999403|FG000|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||333
10834299|NCT02628444|11999404|FG001|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||328
10834300|NCT02628444|11999405|FG002|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||332
10834301|NCT02628444|11999406|FG003|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834302|NCT02628444|11999407|FG004|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834303|NCT02628444|11999408|FG005|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834304|NCT02628444|11999409|FG006|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834305|NCT02628444|11999410|FG007|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834306|NCT02628444|11999411|FG008|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834307|NCT02628444|11999403|FG000|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||314
10834308|NCT02628444|11999404|FG001|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||309
10834309|NCT02628444|11999405|FG002|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||310
10834310|NCT02628444|11999406|FG003|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834311|NCT02628444|11999407|FG004|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834312|NCT02628444|11999408|FG005|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834313|NCT02628444|11999409|FG006|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834314|NCT02628444|11999410|FG007|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834315|NCT02628444|11999411|FG008|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834316|NCT02628444|11999403|FG000|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||36
10834317|NCT02628444|11999404|FG001|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||39
10834318|NCT02628444|11999405|FG002|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||42
10834319|NCT02628444|11999406|FG003|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834320|NCT02628444|11999407|FG004|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834321|NCT02628444|11999408|FG005|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834322|NCT02628444|11999409|FG006|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834323|NCT02628444|11999410|FG007|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834324|NCT02628444|11999411|FG008|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834325|NCT02628444|11999403|FG000|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
10834326|NCT02628444|11999404|FG001|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
10834327|NCT02628444|11999405|FG002|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
10834328|NCT02628444|11999406|FG003|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||145
10834329|NCT02628444|11999407|FG004|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||152
10834330|NCT02628444|11999408|FG005|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||157
10834331|NCT02628444|11999409|FG006|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||149
10834332|NCT02628444|11999410|FG007|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||152
10834333|NCT02628444|11999411|FG008|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||151
10834334|NCT02628444|11999403|FG000|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||0
10834335|NCT02628444|11999404|FG001|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||0
10834336|NCT02628444|11999405|FG002|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||0
10834337|NCT02628444|11999406|FG003|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||55
10834338|NCT02628444|11999407|FG004|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||59
10834339|NCT02628444|11999408|FG005|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||62
10834340|NCT02628444|11999409|FG006|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||53
10834341|NCT02628444|11999410|FG007|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||56
10834342|NCT02628444|11999411|FG008|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||53
10834343|NCT02628444|11999403|FG000|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
10834344|NCT02628444|11999404|FG001|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
10834345|NCT02628444|11999405|FG002|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
10834346|NCT02628444|11999406|FG003|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||55
10834347|NCT02628444|11999407|FG004|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||59
10834348|NCT02628444|11999408|FG005|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||62
10834349|NCT02628444|11999409|FG006|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||53
10834350|NCT02628444|11999410|FG007|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||54
10834351|NCT02628444|11999411|FG008|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||52
10834352|NCT02628444|11999403|FG000|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
10834353|NCT02628444|11999404|FG001|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
10834354|NCT02628444|11999405|FG002|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
10834355|NCT02628444|11999406|FG003|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||90
10834356|NCT02628444|11999407|FG004|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||93
10834357|NCT02628444|11999408|FG005|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||95
10834358|NCT02628444|11999409|FG006|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||96
10834359|NCT02628444|11999410|FG007|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||98
10834360|NCT02628444|11999411|FG008|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||99
10834361|NCT02623998|11999438|FG000|STARTED|Overall Study||50
10834362|NCT02623998|11999439|FG001|STARTED|Overall Study||52
10834363|NCT02623998|11999438|FG000|COMPLETED|Overall Study||48
10834364|NCT02623998|11999439|FG001|COMPLETED|Overall Study||51
10834365|NCT02623998|11999438|FG000|NOT COMPLETED|Overall Study||2
10834366|NCT02623998|11999439|FG001|NOT COMPLETED|Overall Study||1
10834367|NCT02623725|11999447|FG000|STARTED|Overall Study||187
10834368|NCT02623725|11999448|FG001|STARTED|Overall Study||64
10834369|NCT02623725|11999447|FG000|COMPLETED|Overall Study||171
10834370|NCT02623725|11999448|FG001|COMPLETED|Overall Study||58
10834371|NCT02623725|11999447|FG000|NOT COMPLETED|Overall Study||16
10834372|NCT02623725|11999448|FG001|NOT COMPLETED|Overall Study||6
10834373|NCT02608684|11999456|FG000|STARTED|Overall Study||21
10834374|NCT02608684|11999456|FG000|COMPLETED|Overall Study||18
10834375|NCT02608684|11999456|FG000|NOT COMPLETED|Overall Study||3
10834376|NCT02603887|11999460|FG000|STARTED|Stage 1||12
10834377|NCT02603887|11999460|FG000|Cycle 1|Stage 1||12
10834378|NCT02603887|11999460|FG000|Cycle 8|Stage 1||7
10834379|NCT02603887|11999460|FG000|COMPLETED|Stage 1||7
10834380|NCT02603887|11999460|FG000|NOT COMPLETED|Stage 1||5
10834381|NCT02603887|11999460|FG000|STARTED|Stage 2||1
10834382|NCT02603887|11999460|FG000|Cycle 1|Stage 2||1
10834383|NCT02603887|11999460|FG000|Cycle 8|Stage 2||0
10834384|NCT02603887|11999460|FG000|COMPLETED|Stage 2||0
10834385|NCT02603887|11999460|FG000|NOT COMPLETED|Stage 2||1
10834386|NCT02587520|11999482|FG000|STARTED|Overall Study||80
10834387|NCT02587520|11999483|FG001|STARTED|Overall Study||71
10834388|NCT02587520|11999484|FG002|STARTED|Overall Study||78
10834389|NCT02587520|11999485|FG003|STARTED|Overall Study||79
10834390|NCT02587520|11999486|FG004|STARTED|Overall Study||75
10834391|NCT02587520|11999487|FG005|STARTED|Overall Study||75
10834392|NCT02587520|11999488|FG006|STARTED|Overall Study||76
10834393|NCT02587520|11999489|FG007|STARTED|Overall Study||73
10834394|NCT02587520|11999490|FG008|STARTED|Overall Study||76
10834395|NCT02587520|11999491|FG009|STARTED|Overall Study||76
10834396|NCT02587520|11999492|FG010|STARTED|Overall Study||76
10834397|NCT02587520|11999493|FG011|STARTED|Overall Study||73
10834398|NCT02587520|11999494|FG012|STARTED|Overall Study||77
10834399|NCT02587520|11999495|FG013|STARTED|Overall Study||74
10834400|NCT02587520|11999496|FG014|STARTED|Overall Study||78
10834401|NCT02587520|11999497|FG015|STARTED|Overall Study||72
10834402|NCT02587520|11999498|FG016|STARTED|Overall Study||76
10834403|NCT02587520|11999499|FG017|STARTED|Overall Study||78
10834404|NCT02587520|11999482|FG000|Safety Analysis Set (SafAS)|Overall Study||79
10834405|NCT02587520|11999483|FG001|Safety Analysis Set (SafAS)|Overall Study||71
10834406|NCT02587520|11999484|FG002|Safety Analysis Set (SafAS)|Overall Study||77
10834407|NCT02587520|11999485|FG003|Safety Analysis Set (SafAS)|Overall Study||77
10834408|NCT02587520|11999486|FG004|Safety Analysis Set (SafAS)|Overall Study||75
10834409|NCT02587520|11999487|FG005|Safety Analysis Set (SafAS)|Overall Study||75
10834410|NCT02587520|11999488|FG006|Safety Analysis Set (SafAS)|Overall Study||76
10834411|NCT02587520|11999489|FG007|Safety Analysis Set (SafAS)|Overall Study||73
10834412|NCT02587520|11999490|FG008|Safety Analysis Set (SafAS)|Overall Study||76
10834413|NCT02587520|11999491|FG009|Safety Analysis Set (SafAS)|Overall Study||76
10834414|NCT02587520|11999492|FG010|Safety Analysis Set (SafAS)|Overall Study||76
10834415|NCT02587520|11999493|FG011|Safety Analysis Set (SafAS)|Overall Study||72
10834416|NCT02587520|11999494|FG012|Safety Analysis Set (SafAS)|Overall Study||77
10834417|NCT02587520|11999495|FG013|Safety Analysis Set (SafAS)|Overall Study||73
10834418|NCT02587520|11999496|FG014|Safety Analysis Set (SafAS)|Overall Study||78
10834419|NCT02587520|11999497|FG015|Safety Analysis Set (SafAS)|Overall Study||72
10834420|NCT02587520|11999498|FG016|Safety Analysis Set (SafAS)|Overall Study||76
10834421|NCT02587520|11999499|FG017|Safety Analysis Set (SafAS)|Overall Study||78
10834422|NCT02587520|11999482|FG000|COMPLETED|Overall Study||78
10834423|NCT02587520|11999483|FG001|COMPLETED|Overall Study||69
10834424|NCT02587520|11999484|FG002|COMPLETED|Overall Study||77
10834425|NCT02587520|11999485|FG003|COMPLETED|Overall Study||74
10834426|NCT02587520|11999486|FG004|COMPLETED|Overall Study||75
10834427|NCT02587520|11999487|FG005|COMPLETED|Overall Study||72
10834428|NCT02587520|11999488|FG006|COMPLETED|Overall Study||73
10834429|NCT02587520|11999489|FG007|COMPLETED|Overall Study||71
10834430|NCT02587520|11999490|FG008|COMPLETED|Overall Study||73
10834431|NCT02587520|11999491|FG009|COMPLETED|Overall Study||71
10834432|NCT02587520|11999492|FG010|COMPLETED|Overall Study||73
10834433|NCT02587520|11999493|FG011|COMPLETED|Overall Study||69
10834434|NCT02587520|11999494|FG012|COMPLETED|Overall Study||77
10834435|NCT02587520|11999495|FG013|COMPLETED|Overall Study||73
10834436|NCT02587520|11999496|FG014|COMPLETED|Overall Study||78
10834437|NCT02587520|11999497|FG015|COMPLETED|Overall Study||72
10834438|NCT02587520|11999498|FG016|COMPLETED|Overall Study||76
10834439|NCT02587520|11999499|FG017|COMPLETED|Overall Study||78
10834440|NCT02587520|11999482|FG000|NOT COMPLETED|Overall Study||2
10834441|NCT02587520|11999483|FG001|NOT COMPLETED|Overall Study||2
10834442|NCT02587520|11999484|FG002|NOT COMPLETED|Overall Study||1
10834443|NCT02587520|11999485|FG003|NOT COMPLETED|Overall Study||5
10834444|NCT02587520|11999486|FG004|NOT COMPLETED|Overall Study||0
10834445|NCT02587520|11999487|FG005|NOT COMPLETED|Overall Study||3
10834446|NCT02587520|11999488|FG006|NOT COMPLETED|Overall Study||3
10834447|NCT02587520|11999489|FG007|NOT COMPLETED|Overall Study||2
10834448|NCT02587520|11999490|FG008|NOT COMPLETED|Overall Study||3
10834449|NCT02587520|11999491|FG009|NOT COMPLETED|Overall Study||5
10834450|NCT02587520|11999492|FG010|NOT COMPLETED|Overall Study||3
10834451|NCT02587520|11999493|FG011|NOT COMPLETED|Overall Study||4
10834452|NCT02587520|11999494|FG012|NOT COMPLETED|Overall Study||0
10834453|NCT02587520|11999495|FG013|NOT COMPLETED|Overall Study||1
10834454|NCT02587520|11999496|FG014|NOT COMPLETED|Overall Study||0
10834455|NCT02587520|11999497|FG015|NOT COMPLETED|Overall Study||0
10834456|NCT02587520|11999498|FG016|NOT COMPLETED|Overall Study||0
10834457|NCT02587520|11999499|FG017|NOT COMPLETED|Overall Study||0
10834458|NCT02584829|11999539|FG000|STARTED|Overall Study||1
10834459|NCT02584829|11999540|FG001|STARTED|Overall Study||7
10834460|NCT02584829|11999539|FG000|COMPLETED|Overall Study||0
10834461|NCT02584829|11999540|FG001|COMPLETED|Overall Study||3
10834462|NCT02584829|11999539|FG000|NOT COMPLETED|Overall Study||1
10834463|NCT02584829|11999540|FG001|NOT COMPLETED|Overall Study||4
10834464|NCT02570308|11999553|FG000|STARTED|Overall Study||3
10834465|NCT02570308|11999554|FG001|STARTED|Overall Study||6
10834466|NCT02570308|11999555|FG002|STARTED|Overall Study||4
10834467|NCT02570308|11999556|FG003|STARTED|Overall Study||6
10834468|NCT02570308|11999557|FG004|STARTED|Overall Study||127
10834469|NCT02570308|11999553|FG000|COMPLETED|Overall Study||2
10834470|NCT02570308|11999554|FG001|COMPLETED|Overall Study||1
10834471|NCT02570308|11999555|FG002|COMPLETED|Overall Study||0
10834472|NCT02570308|11999556|FG003|COMPLETED|Overall Study||2
10834473|NCT02570308|11999557|FG004|COMPLETED|Overall Study||53
10834474|NCT02570308|11999553|FG000|NOT COMPLETED|Overall Study||1
10834475|NCT02570308|11999554|FG001|NOT COMPLETED|Overall Study||5
10834476|NCT02570308|11999555|FG002|NOT COMPLETED|Overall Study||4
10834477|NCT02570308|11999556|FG003|NOT COMPLETED|Overall Study||4
10834478|NCT02570308|11999557|FG004|NOT COMPLETED|Overall Study||74
10834479|NCT02514083|11999575|FG000|STARTED|Overall Study||29
10834480|NCT02514083|11999575|FG000|COMPLETED|Overall Study||28
10834481|NCT02514083|11999575|FG000|NOT COMPLETED|Overall Study||1
10834482|NCT02497612|11999583|FG000|STARTED|Overall Study||93
10834483|NCT02497612|11999584|FG001|STARTED|Overall Study||94
10834484|NCT02497612|11999585|FG002|STARTED|Overall Study||97
10834485|NCT02497612|11999586|FG003|STARTED|Overall Study||93
10834486|NCT02497612|11999583|FG000|Treated|Overall Study||92
10834487|NCT02497612|11999584|FG001|Treated|Overall Study||94
10834488|NCT02497612|11999585|FG002|Treated|Overall Study||96
10834489|NCT02497612|11999586|FG003|Treated|Overall Study||91
10834490|NCT02497612|11999583|FG000|Cohort 1: >14 Years to <70 Years|Overall Study||14
10834491|NCT02497612|11999584|FG001|Cohort 1: >14 Years to <70 Years|Overall Study||15
10834492|NCT02497612|11999585|FG002|Cohort 1: >14 Years to <70 Years|Overall Study||18
10834493|NCT02497612|11999586|FG003|Cohort 1: >14 Years to <70 Years|Overall Study||16
10834494|NCT02497612|11999583|FG000|Cohort 2: >5 Years to <=14 Years|Overall Study||6
10834495|NCT02497612|11999584|FG001|Cohort 2: >5 Years to <=14 Years|Overall Study||5
10834496|NCT02497612|11999585|FG002|Cohort 2: >5 Years to <=14 Years|Overall Study||6
10834497|NCT02497612|11999586|FG003|Cohort 2: >5 Years to <=14 Years|Overall Study||5
10834498|NCT02497612|11999583|FG000|Cohort 3: >2 Years to <=5 Years|Overall Study||66
10834499|NCT02497612|11999584|FG001|Cohort 3: >2 Years to <=5 Years|Overall Study||66
10291485|NCT04035473|11424478|FG000|STARTED|Screening/Baseline||20
10291486|NCT04035473|11424479|FG001|STARTED|Screening/Baseline||22
10291487|NCT04035473|11424478|FG000|COMPLETED|Screening/Baseline||20
10291488|NCT04035473|11424479|FG001|COMPLETED|Screening/Baseline||20
10291489|NCT04035473|11424478|FG000|NOT COMPLETED|Screening/Baseline||0
10291490|NCT04035473|11424479|FG001|NOT COMPLETED|Screening/Baseline||2
10291491|NCT04035473|11424478|FG000|STARTED|Treatment Period 1||20
10291492|NCT04035473|11424479|FG001|STARTED|Treatment Period 1||20
10291493|NCT04035473|11424478|FG000|COMPLETED|Treatment Period 1||20
10291494|NCT04035473|11424479|FG001|COMPLETED|Treatment Period 1||20
10291495|NCT04035473|11424478|FG000|NOT COMPLETED|Treatment Period 1||0
10291496|NCT04035473|11424479|FG001|NOT COMPLETED|Treatment Period 1||0
10291497|NCT04035473|11424478|FG000|STARTED|Treatment Period 2|2 subjects withdrew before starting treatment period 2 due to diease progression and withdrawal from study treatment and procedure.|18
10291498|NCT04035473|11424479|FG001|STARTED|Treatment Period 2|1 subject withdrew before starting treatment period 2 due to SAE and investigator's decision.|19
10291499|NCT04035473|11424478|FG000|COMPLETED|Treatment Period 2||18
10291500|NCT04035473|11424479|FG001|COMPLETED|Treatment Period 2||19
10291501|NCT04035473|11424478|FG000|NOT COMPLETED|Treatment Period 2||0
10291502|NCT04035473|11424479|FG001|NOT COMPLETED|Treatment Period 2||0
10291503|NCT04035473|11424478|FG000|STARTED|Follow-up Period||18
10291504|NCT04035473|11424479|FG001|STARTED|Follow-up Period||19
10291505|NCT04035473|11424478|FG000|COMPLETED|Follow-up Period||16
10291506|NCT04035473|11424479|FG001|COMPLETED|Follow-up Period||19
10291507|NCT04035473|11424478|FG000|NOT COMPLETED|Follow-up Period||2
10291508|NCT04035473|11424479|FG001|NOT COMPLETED|Follow-up Period||0
10291509|NCT03796676|11424488|FG000|STARTED|Overall Study||96
10291510|NCT03796676|11424489|FG001|STARTED|Overall Study||95
10291511|NCT03796676|11424490|FG002|STARTED|Overall Study||94
10291512|NCT03796676|11424488|FG000|COMPLETED|Overall Study||90
10291513|NCT03796676|11424489|FG001|COMPLETED|Overall Study||92
10291514|NCT03796676|11424490|FG002|COMPLETED|Overall Study||91
10291515|NCT03796676|11424488|FG000|NOT COMPLETED|Overall Study||6
10291516|NCT03796676|11424489|FG001|NOT COMPLETED|Overall Study||3
10291517|NCT03796676|11424490|FG002|NOT COMPLETED|Overall Study||3
10291518|NCT03366220|11424503|FG000|STARTED|Overall Study||4
10291519|NCT03366220|11424504|FG001|STARTED|Overall Study||4
10291520|NCT03366220|11424503|FG000|COMPLETED|Overall Study||4
10291521|NCT03366220|11424504|FG001|COMPLETED|Overall Study||4
10291522|NCT03366220|11424503|FG000|NOT COMPLETED|Overall Study||0
10291523|NCT03366220|11424504|FG001|NOT COMPLETED|Overall Study||0
10291524|NCT02989857|11424512|FG000|STARTED|Randomization Phase||126
10291525|NCT02989857|11424513|FG001|STARTED|Randomization Phase||61
10291526|NCT02989857|11424514|FG002|STARTED|Randomization Phase||0
10291527|NCT02989857|11424512|FG000|COMPLETED|Randomization Phase|Completed implies the participants who completed the study treatment.|0
10291528|NCT02989857|11424513|FG001|COMPLETED|Randomization Phase|Completed implies the participants who completed the study treatment.|0
10291529|NCT02989857|11424514|FG002|COMPLETED|Randomization Phase||0
10291530|NCT02989857|11424512|FG000|NOT COMPLETED|Randomization Phase||126
10291531|NCT02989857|11424513|FG001|NOT COMPLETED|Randomization Phase||61
10291532|NCT02989857|11424514|FG002|NOT COMPLETED|Randomization Phase||0
10291533|NCT02989857|11424512|FG000|STARTED|Cross Over Phase||0
10291534|NCT02989857|11424513|FG001|STARTED|Cross Over Phase||0
10291535|NCT02989857|11424514|FG002|STARTED|Cross Over Phase|Participants who had experienced disease progression and received placebo were allowed to cross over to receive AG-120.|43
10291536|NCT02989857|11424512|FG000|COMPLETED|Cross Over Phase||0
10291537|NCT02989857|11424513|FG001|COMPLETED|Cross Over Phase||0
10291538|NCT02989857|11424514|FG002|COMPLETED|Cross Over Phase|Completed implies the participants who completed the study treatment.|0
10291539|NCT02989857|11424512|FG000|NOT COMPLETED|Cross Over Phase||0
10291540|NCT02989857|11424513|FG001|NOT COMPLETED|Cross Over Phase||0
10291541|NCT02989857|11424514|FG002|NOT COMPLETED|Cross Over Phase||43
10291542|NCT02983799|11424526|FG000|STARTED|Overall Study||75
10291543|NCT02983799|11424527|FG001|STARTED|Overall Study||26
10291544|NCT02983799|11424528|FG002|STARTED|Overall Study||68
10834500|NCT02497612|11999585|FG002|Cohort 3: >2 Years to <=5 Years|Overall Study||67
10834501|NCT02497612|11999586|FG003|Cohort 3: >2 Years to <=5 Years|Overall Study||65
10291545|NCT02983799|11424529|FG003|STARTED|Overall Study||90
10291546|NCT02983799|11424530|FG004|STARTED|Overall Study||13
10834502|NCT02497612|11999583|FG000|Cohort 4: >6 Months to <=2 Years|Overall Study||7
10834503|NCT02497612|11999584|FG001|Cohort 4: >6 Months to <=2 Years|Overall Study||8
10834504|NCT02497612|11999585|FG002|Cohort 4: >6 Months to <=2 Years|Overall Study||6
10834505|NCT02497612|11999586|FG003|Cohort 4: >6 Months to <=2 Years|Overall Study||7
10834506|NCT02497612|11999583|FG000|COMPLETED|Overall Study||27
10834507|NCT02497612|11999584|FG001|COMPLETED|Overall Study||37
10834508|NCT02497612|11999585|FG002|COMPLETED|Overall Study||48
10834509|NCT02497612|11999586|FG003|COMPLETED|Overall Study||46
10834510|NCT02497612|11999583|FG000|NOT COMPLETED|Overall Study||66
10834511|NCT02497612|11999584|FG001|NOT COMPLETED|Overall Study||57
10834512|NCT02497612|11999585|FG002|NOT COMPLETED|Overall Study||49
10834513|NCT02497612|11999586|FG003|NOT COMPLETED|Overall Study||47
10834514|NCT02460458|11999596|FG000|STARTED|Retrospective Phase||265
10834515|NCT02460458|11999596|FG000|COMPLETED|Retrospective Phase||265
10834516|NCT02460458|11999596|FG000|NOT COMPLETED|Retrospective Phase||0
10834517|NCT02460458|11999596|FG000|STARTED|Confirmatory Phase||265
10834518|NCT02460458|11999596|FG000|COMPLETED|Confirmatory Phase||177
10834519|NCT02460458|11999596|FG000|NOT COMPLETED|Confirmatory Phase||88
10834520|NCT02460458|11999596|FG000|STARTED|First Prospective Phase||177
10409304|NCT00758524|11553191|FG012|COMPLETED|Withdrawal Period (Week 8 to Week 9)||45
10754282|NCT03050801|11918015|FG001|NOT COMPLETED|Experiment 1||7
10754283|NCT03050801|11918016|FG002|NOT COMPLETED|Experiment 1||2
10754284|NCT03050801|11918017|FG003|NOT COMPLETED|Experiment 1||0
10754285|NCT03050801|11918018|FG004|NOT COMPLETED|Experiment 1||0
10834521|NCT02460458|11999596|FG000|COMPLETED|First Prospective Phase||161
10834522|NCT02460458|11999596|FG000|NOT COMPLETED|First Prospective Phase||16
10834523|NCT02460458|11999596|FG000|STARTED|Confirmation of Clinical Phase Data||161
10834524|NCT02460458|11999596|FG000|COMPLETED|Confirmation of Clinical Phase Data||152
10834525|NCT02460458|11999596|FG000|NOT COMPLETED|Confirmation of Clinical Phase Data||9
10834526|NCT02460458|11999596|FG000|STARTED|Second Prospective Phase||152
10834527|NCT02460458|11999596|FG000|COMPLETED|Second Prospective Phase|Information not available yet, anticipated date is december 2022|0
10834528|NCT02460458|11999596|FG000|NOT COMPLETED|Second Prospective Phase||152
10834529|NCT02457559|11999611|FG000|STARTED|Overall Study||2
10834530|NCT02457559|11999612|FG001|STARTED|Overall Study||3
10834531|NCT02457559|11999613|FG002|STARTED|Overall Study||7
10834532|NCT02457559|11999614|FG003|STARTED|Overall Study||2
10834533|NCT02457559|11999615|FG004|STARTED|Overall Study||1
10834534|NCT02457559|11999616|FG005|STARTED|Overall Study||2
10834535|NCT02457559|11999617|FG006|STARTED|Overall Study||2
10834536|NCT02457559|11999618|FG007|STARTED|Overall Study||1
10834537|NCT02457559|11999619|FG008|STARTED|Overall Study||3
10834538|NCT02457559|11999620|FG009|STARTED|Overall Study||4
10834539|NCT02457559|11999621|FG010|STARTED|Overall Study||2
10834540|NCT02457559|11999611|FG000|COMPLETED|Overall Study||0
10834541|NCT02457559|11999612|FG001|COMPLETED|Overall Study||0
10834542|NCT02457559|11999613|FG002|COMPLETED|Overall Study||0
10834543|NCT02457559|11999614|FG003|COMPLETED|Overall Study||2
10834544|NCT02457559|11999615|FG004|COMPLETED|Overall Study||0
10834545|NCT02457559|11999616|FG005|COMPLETED|Overall Study||0
10834546|NCT02457559|11999617|FG006|COMPLETED|Overall Study||0
10834547|NCT02457559|11999618|FG007|COMPLETED|Overall Study||1
10834548|NCT02457559|11999619|FG008|COMPLETED|Overall Study||0
10834549|NCT02457559|11999620|FG009|COMPLETED|Overall Study||0
10834550|NCT02457559|11999621|FG010|COMPLETED|Overall Study||0
10834551|NCT02457559|11999611|FG000|NOT COMPLETED|Overall Study||2
10834552|NCT02457559|11999612|FG001|NOT COMPLETED|Overall Study||3
10834553|NCT02457559|11999613|FG002|NOT COMPLETED|Overall Study||7
10834554|NCT02457559|11999614|FG003|NOT COMPLETED|Overall Study||0
10834555|NCT02457559|11999615|FG004|NOT COMPLETED|Overall Study||1
10834556|NCT02457559|11999616|FG005|NOT COMPLETED|Overall Study||2
10834557|NCT02457559|11999617|FG006|NOT COMPLETED|Overall Study||2
10834558|NCT02457559|11999618|FG007|NOT COMPLETED|Overall Study||0
10834559|NCT02457559|11999619|FG008|NOT COMPLETED|Overall Study||3
10834560|NCT02457559|11999620|FG009|NOT COMPLETED|Overall Study||4
10834561|NCT02457559|11999621|FG010|NOT COMPLETED|Overall Study||2
10834562|NCT02417974|11999661|FG000|STARTED|Overall Study||15
10834563|NCT02417974|11999662|FG001|STARTED|Overall Study||9
10834564|NCT02417974|11999661|FG000|COMPLETED|Overall Study||15
10834565|NCT02417974|11999662|FG001|COMPLETED|Overall Study||9
10834566|NCT02417974|11999661|FG000|NOT COMPLETED|Overall Study||0
10754286|NCT03050801|11918019|FG005|NOT COMPLETED|Experiment 1||0
10754287|NCT03050801|11918014|FG000|STARTED|Experiment 2||0
10754288|NCT03050801|11918015|FG001|STARTED|Experiment 2||0
10754289|NCT03050801|11918016|FG002|STARTED|Experiment 2||0
10754290|NCT03050801|11918017|FG003|STARTED|Experiment 2||21
10834567|NCT02417974|11999662|FG001|NOT COMPLETED|Overall Study||0
10834568|NCT02381652|11999671|FG000|STARTED|Overall Study|Cingal injection in 13-01 study; receiving a 2nd Cingal injection in 13-02|94
10834569|NCT02381652|11999672|FG001|STARTED|Overall Study|Monovisc injection in 13-01 study; receiving a Cingal injection in 13-02|98
10834570|NCT02381652|11999673|FG002|STARTED|Overall Study|Saline injection in 13-01 study; receiving a Cingal injection in 13-02|50
10834571|NCT02381652|11999671|FG000|COMPLETED|Overall Study||94
10834572|NCT02381652|11999672|FG001|COMPLETED|Overall Study||98
10834573|NCT02381652|11999673|FG002|COMPLETED|Overall Study||49
10834574|NCT02381652|11999671|FG000|NOT COMPLETED|Overall Study||0
10834575|NCT02381652|11999672|FG001|NOT COMPLETED|Overall Study||0
10834576|NCT02381652|11999673|FG002|NOT COMPLETED|Overall Study||1
10754291|NCT03050801|11918018|FG004|STARTED|Experiment 2||19
10834577|NCT02367794|11999682|FG000|STARTED|Overall Study||340
10834578|NCT02367794|11999683|FG001|STARTED|Overall Study||343
10834579|NCT02367794|11999684|FG002|STARTED|Overall Study||338
10834580|NCT02367794|11999682|FG000|COMPLETED|Overall Study||0
10834581|NCT02367794|11999683|FG001|COMPLETED|Overall Study||0
10834582|NCT02367794|11999684|FG002|COMPLETED|Overall Study||0
10834583|NCT02367794|11999682|FG000|NOT COMPLETED|Overall Study||340
10834584|NCT02367794|11999683|FG001|NOT COMPLETED|Overall Study||343
10834585|NCT02367794|11999684|FG002|NOT COMPLETED|Overall Study||338
10834586|NCT02363998|11999697|FG000|STARTED|Overall Study||286
10834587|NCT02363998|11999697|FG000|COMPLETED|Overall Study|A subject was defined as completed if at least one dose was taken on Day 7.|168
10834588|NCT02363998|11999697|FG000|NOT COMPLETED|Overall Study||118
10834589|NCT02353832|11999717|FG000|STARTED|Overall Study||44
10834590|NCT02353832|11999717|FG000|COMPLETED|Overall Study||42
10834591|NCT02353832|11999717|FG000|NOT COMPLETED|Overall Study||2
10834592|NCT02353728|11999721|FG000|STARTED|Overall Study||16
10834593|NCT02353728|11999721|FG000|COMPLETED|Overall Study||15
10834594|NCT02353728|11999721|FG000|NOT COMPLETED|Overall Study||1
10834595|NCT02345070|11999728|FG000|STARTED|Overall Study||110
10834596|NCT02345070|11999729|FG001|STARTED|Overall Study||109
10834597|NCT02345070|11999730|FG002|STARTED|Overall Study||108
10834598|NCT02345070|11999728|FG000|Treated|Overall Study||109
10834599|NCT02345070|11999729|FG001|Treated|Overall Study||108
10834600|NCT02345070|11999730|FG002|Treated|Overall Study||108
10834601|NCT02345070|11999728|FG000|COMPLETED|Overall Study||90
10834602|NCT02345070|11999729|FG001|COMPLETED|Overall Study||98
10834603|NCT02345070|11999730|FG002|COMPLETED|Overall Study||85
10834604|NCT02345070|11999728|FG000|NOT COMPLETED|Overall Study||20
10834605|NCT02345070|11999729|FG001|NOT COMPLETED|Overall Study||11
10834606|NCT02345070|11999730|FG002|NOT COMPLETED|Overall Study||23
10834607|NCT02325466|11999738|FG000|STARTED|Period 1 Timeframe - Baseline to Week 4||23
10834608|NCT02325466|11999739|FG001|STARTED|Period 1 Timeframe - Baseline to Week 4||23
10834609|NCT02325466|11999740|FG002|STARTED|Period 1 Timeframe - Baseline to Week 4||24
10834610|NCT02325466|11999738|FG000|COMPLETED|Period 1 Timeframe - Baseline to Week 4||22
10834611|NCT02325466|11999739|FG001|COMPLETED|Period 1 Timeframe - Baseline to Week 4||21
10834612|NCT02325466|11999740|FG002|COMPLETED|Period 1 Timeframe - Baseline to Week 4||21
10834613|NCT02325466|11999738|FG000|NOT COMPLETED|Period 1 Timeframe - Baseline to Week 4||1
10834614|NCT02325466|11999739|FG001|NOT COMPLETED|Period 1 Timeframe - Baseline to Week 4||2
10834615|NCT02325466|11999740|FG002|NOT COMPLETED|Period 1 Timeframe - Baseline to Week 4||3
10834616|NCT02325466|11999738|FG000|STARTED|Period 2 - Timeframe Week 4 to Week 10||22
10834617|NCT02325466|11999739|FG001|STARTED|Period 2 - Timeframe Week 4 to Week 10||21
10834618|NCT02325466|11999740|FG002|STARTED|Period 2 - Timeframe Week 4 to Week 10||21
10834619|NCT02325466|11999738|FG000|COMPLETED|Period 2 - Timeframe Week 4 to Week 10||19
10834620|NCT02325466|11999739|FG001|COMPLETED|Period 2 - Timeframe Week 4 to Week 10||20
10834621|NCT02325466|11999740|FG002|COMPLETED|Period 2 - Timeframe Week 4 to Week 10||21
10834622|NCT02325466|11999738|FG000|NOT COMPLETED|Period 2 - Timeframe Week 4 to Week 10||3
10834623|NCT02325466|11999739|FG001|NOT COMPLETED|Period 2 - Timeframe Week 4 to Week 10||1
10834624|NCT02325466|11999740|FG002|NOT COMPLETED|Period 2 - Timeframe Week 4 to Week 10||0
10834625|NCT02325466|11999738|FG000|STARTED|3rd Crossover - Week 10 to Week 16||19
10834626|NCT02325466|11999739|FG001|STARTED|3rd Crossover - Week 10 to Week 16||20
10834627|NCT02325466|11999740|FG002|STARTED|3rd Crossover - Week 10 to Week 16||21
10834628|NCT02325466|11999738|FG000|COMPLETED|3rd Crossover - Week 10 to Week 16||18
10834629|NCT02325466|11999739|FG001|COMPLETED|3rd Crossover - Week 10 to Week 16||18
10834630|NCT02325466|11999740|FG002|COMPLETED|3rd Crossover - Week 10 to Week 16||21
10834631|NCT02325466|11999738|FG000|NOT COMPLETED|3rd Crossover - Week 10 to Week 16||1
10834632|NCT02325466|11999739|FG001|NOT COMPLETED|3rd Crossover - Week 10 to Week 16||2
10834633|NCT02325466|11999740|FG002|NOT COMPLETED|3rd Crossover - Week 10 to Week 16||0
10834634|NCT02322710|11999751|FG000|STARTED|Overall Study||105
10834635|NCT02322710|11999752|FG001|STARTED|Overall Study||99
10834636|NCT02322710|11999751|FG000|Safety Population|Overall Study||105
10834637|NCT02322710|11999752|FG001|Safety Population|Overall Study||99
10834638|NCT02322710|11999751|FG000|Full Analysis Population|Overall Study||105
10834639|NCT02322710|11999752|FG001|Full Analysis Population|Overall Study||98
10834640|NCT02322710|11999751|FG000|COMPLETED|Overall Study||85
10834641|NCT02322710|11999752|FG001|COMPLETED|Overall Study||73
10834642|NCT02322710|11999751|FG000|NOT COMPLETED|Overall Study||20
10834643|NCT02322710|11999752|FG001|NOT COMPLETED|Overall Study||26
10834644|NCT02303548|11999760|FG000|STARTED|Overall Study||25
10834645|NCT02303548|11999761|FG001|STARTED|Overall Study||25
10834646|NCT02303548|11999760|FG000|COMPLETED|Overall Study||25
10834647|NCT02303548|11999761|FG001|COMPLETED|Overall Study||25
10834648|NCT02303548|11999760|FG000|NOT COMPLETED|Overall Study||0
10834649|NCT02303548|11999761|FG001|NOT COMPLETED|Overall Study||0
10834650|NCT02292654|11999770|FG000|STARTED|Overall Study||4
10834651|NCT02292654|11999771|FG001|STARTED|Overall Study||9
10834652|NCT02292654|11999772|FG002|STARTED|Overall Study||7
10834653|NCT02292654|11999770|FG000|COMPLETED|Overall Study||4
10834654|NCT02292654|11999771|FG001|COMPLETED|Overall Study||9
10834655|NCT02292654|11999772|FG002|COMPLETED|Overall Study||7
10834656|NCT02292654|11999770|FG000|NOT COMPLETED|Overall Study||0
10834657|NCT02292654|11999771|FG001|NOT COMPLETED|Overall Study||0
10834658|NCT02292654|11999772|FG002|NOT COMPLETED|Overall Study||0
10834659|NCT02251548|11999786|FG000|STARTED|Overall Study||85
10834660|NCT02251548|11999786|FG000|COMPLETED|Overall Study||0
10834661|NCT02251548|11999786|FG000|NOT COMPLETED|Overall Study||85
10834662|NCT02239354|11999793|FG000|STARTED|Overall Study||19
10834663|NCT02239354|11999794|FG001|STARTED|Overall Study||0
10834664|NCT02239354|11999793|FG000|COMPLETED|Overall Study||9
10834665|NCT02239354|11999794|FG001|COMPLETED|Overall Study||0
10834666|NCT02239354|11999793|FG000|NOT COMPLETED|Overall Study||10
10834667|NCT02239354|11999794|FG001|NOT COMPLETED|Overall Study||0
10834668|NCT02234310|11999800|FG000|STARTED|Overall Study||33
10834669|NCT02234310|11999800|FG000|Episodic Treatment Regimen|Overall Study|Participants were treated in more than one regimen and counted in all categories wherever applicable|22
10834670|NCT02234310|11999800|FG000|Prophylactic Treatment Regimen|Overall Study|17 participants among the 22 who started in episodic regimen, switched to the prophylactic regimen.|28
10834671|NCT02234310|11999800|FG000|COMPLETED|Overall Study||27
10834672|NCT02234310|11999800|FG000|NOT COMPLETED|Overall Study||6
10834673|NCT02212015|11999804|FG000|STARTED|Overall Study||26
10834674|NCT02212015|11999804|FG000|COMPLETED|Overall Study||25
10834675|NCT02212015|11999804|FG000|NOT COMPLETED|Overall Study||1
10834676|NCT02158091|11999814|FG000|STARTED|Overall Study||6
10834677|NCT02158091|11999815|FG001|STARTED|Overall Study||6
10834678|NCT02158091|11999816|FG002|STARTED|Overall Study||20
10834679|NCT02158091|11999814|FG000|COMPLETED|Overall Study||4
10834680|NCT02158091|11999815|FG001|COMPLETED|Overall Study||5
10834681|NCT02158091|11999816|FG002|COMPLETED|Overall Study||20
10834682|NCT02158091|11999814|FG000|NOT COMPLETED|Overall Study||2
10834683|NCT02158091|11999815|FG001|NOT COMPLETED|Overall Study||1
10834684|NCT02158091|11999816|FG002|NOT COMPLETED|Overall Study||0
10834685|NCT02139436|11999827|FG000|STARTED|Overall Study||41
10834686|NCT02139436|11999828|FG001|STARTED|Overall Study||14
10834687|NCT02139436|11999829|FG002|STARTED|Overall Study||13
10834688|NCT02139436|11999827|FG000|COMPLETED|Overall Study||41
10834689|NCT02139436|11999828|FG001|COMPLETED|Overall Study||14
10834690|NCT02139436|11999829|FG002|COMPLETED|Overall Study||13
10834691|NCT02139436|11999827|FG000|NOT COMPLETED|Overall Study||0
10834692|NCT02139436|11999828|FG001|NOT COMPLETED|Overall Study||0
10834693|NCT02139436|11999829|FG002|NOT COMPLETED|Overall Study||0
10834694|NCT02120079|11999845|FG000|STARTED|Baseline||17
10834695|NCT02120079|11999846|FG001|STARTED|Baseline||20
10834696|NCT02120079|11999845|FG000|COMPLETED|Baseline||17
10834697|NCT02120079|11999846|FG001|COMPLETED|Baseline||20
10834698|NCT02120079|11999845|FG000|NOT COMPLETED|Baseline||0
10834699|NCT02120079|11999846|FG001|NOT COMPLETED|Baseline||0
10834700|NCT02120079|11999845|FG000|STARTED|2 Weeks||17
10834701|NCT02120079|11999846|FG001|STARTED|2 Weeks||20
10834702|NCT02120079|11999845|FG000|COMPLETED|2 Weeks||17
10834703|NCT02120079|11999846|FG001|COMPLETED|2 Weeks||20
10834704|NCT02120079|11999845|FG000|NOT COMPLETED|2 Weeks||0
10834705|NCT02120079|11999846|FG001|NOT COMPLETED|2 Weeks||0
10834706|NCT02120079|11999845|FG000|STARTED|6 Weeks||17
10834707|NCT02120079|11999846|FG001|STARTED|6 Weeks||20
10834708|NCT02120079|11999845|FG000|COMPLETED|6 Weeks||17
10834709|NCT02120079|11999846|FG001|COMPLETED|6 Weeks||20
10834710|NCT02120079|11999845|FG000|NOT COMPLETED|6 Weeks||0
10834711|NCT02120079|11999846|FG001|NOT COMPLETED|6 Weeks||0
10834712|NCT02106195|11999853|FG000|STARTED|Overall Study||8
10834713|NCT02106195|11999853|FG000|COMPLETED|Overall Study|Includes all 3 periods of study: Screening, Treatment, Post-treatment|5
10834714|NCT02106195|11999853|FG000|NOT COMPLETED|Overall Study||3
10834715|NCT02104180|11999865|FG000|STARTED|Overall Study||31
10834716|NCT02104180|11999866|FG001|STARTED|Overall Study||31
10834717|NCT02104180|11999865|FG000|COMPLETED|Overall Study||30
10834718|NCT02104180|11999866|FG001|COMPLETED|Overall Study||31
10834719|NCT02104180|11999865|FG000|NOT COMPLETED|Overall Study||1
10834720|NCT02104180|11999866|FG001|NOT COMPLETED|Overall Study||0
10834721|NCT02050919|11999872|FG000|STARTED|Overall Study||20
10834722|NCT02050919|11999872|FG000|COMPLETED|Overall Study||20
10834723|NCT02050919|11999872|FG000|NOT COMPLETED|Overall Study||0
10834724|NCT02040857|11999876|FG000|STARTED|Overall Study||162
10834725|NCT02040857|11999876|FG000|Treatment Discontinuation Evaluable|Overall Study|Evaluable population excludes participants who discontinue early for reasons unrelated to treatment.|152
10834726|NCT02040857|11999876|FG000|COMPLETED|Overall Study||102
10834727|NCT02040857|11999876|FG000|NOT COMPLETED|Overall Study||60
10834728|NCT01997463|11999885|FG000|STARTED|Overall Study||192
10834729|NCT01997463|11999886|FG001|STARTED|Overall Study||250
10834730|NCT01997463|11999885|FG000|COMPLETED|Overall Study||107
10834731|NCT01997463|11999886|FG001|COMPLETED|Overall Study||147
10834732|NCT01997463|11999885|FG000|NOT COMPLETED|Overall Study||85
10834733|NCT01997463|11999886|FG001|NOT COMPLETED|Overall Study||103
10834734|NCT01943825|11999896|FG000|STARTED|Overall Study||25
10834735|NCT01943825|11999897|FG001|STARTED|Overall Study||15
10834736|NCT01943825|11999898|FG002|STARTED|Overall Study||25
10834737|NCT01943825|11999899|FG003|STARTED|Overall Study||25
10834738|NCT01943825|11999896|FG000|COMPLETED|Overall Study||15
10834739|NCT01943825|11999897|FG001|COMPLETED|Overall Study||11
10834740|NCT01943825|11999898|FG002|COMPLETED|Overall Study||10
10834741|NCT01943825|11999899|FG003|COMPLETED|Overall Study||14
10834742|NCT01943825|11999896|FG000|NOT COMPLETED|Overall Study||10
10834743|NCT01943825|11999897|FG001|NOT COMPLETED|Overall Study||4
10834744|NCT01943825|11999898|FG002|NOT COMPLETED|Overall Study||15
10834745|NCT01943825|11999899|FG003|NOT COMPLETED|Overall Study||11
10834770|NCT01863186|11999943|FG000|STARTED|Double-blind Phase|Original number of 230. One participant was randomly assigned into the study, but not dosed.|229
10834771|NCT01863186|11999944|FG001|STARTED|Double-blind Phase||222
10834772|NCT01863186|11999945|FG002|STARTED|Double-blind Phase||151
10834773|NCT01863186|11999946|FG003|STARTED|Double-blind Phase||0
10834774|NCT01863186|11999943|FG000|COMPLETED|Double-blind Phase||95
10834775|NCT01863186|11999944|FG001|COMPLETED|Double-blind Phase||88
10834776|NCT01863186|11999945|FG002|COMPLETED|Double-blind Phase||42
10834777|NCT01863186|11999946|FG003|COMPLETED|Double-blind Phase||0
10834778|NCT01863186|11999943|FG000|NOT COMPLETED|Double-blind Phase||134
10834779|NCT01863186|11999944|FG001|NOT COMPLETED|Double-blind Phase||134
10834780|NCT01863186|11999945|FG002|NOT COMPLETED|Double-blind Phase||109
10834781|NCT01863186|11999946|FG003|NOT COMPLETED|Double-blind Phase||0
10834782|NCT01863186|11999943|FG000|STARTED|Open-label Phase||0
10834783|NCT01863186|11999944|FG001|STARTED|Open-label Phase||0
10834784|NCT01863186|11999945|FG002|STARTED|Open-label Phase|No placebo group in the Open-label Phase.|0
10291547|NCT02983799|11424526|FG000|COMPLETED|Overall Study||25
10291548|NCT02983799|11424527|FG001|COMPLETED|Overall Study||8
10291549|NCT02983799|11424528|FG002|COMPLETED|Overall Study||18
10291550|NCT02983799|11424529|FG003|COMPLETED|Overall Study||14
10291551|NCT02983799|11424530|FG004|COMPLETED|Overall Study||3
10291552|NCT02983799|11424526|FG000|NOT COMPLETED|Overall Study||50
10291553|NCT02983799|11424527|FG001|NOT COMPLETED|Overall Study||18
10291554|NCT02983799|11424528|FG002|NOT COMPLETED|Overall Study||50
10291555|NCT02983799|11424529|FG003|NOT COMPLETED|Overall Study||76
10291556|NCT02983799|11424530|FG004|NOT COMPLETED|Overall Study||10
10291563|NCT02682992|11424555|FG000|STARTED|Overall Study||47
10291564|NCT02682992|11424555|FG000|COMPLETED|Overall Study||47
10291565|NCT02682992|11424555|FG000|NOT COMPLETED|Overall Study||0
10291566|NCT02631577|11424561|FG000|STARTED|Overall Study||4
10291567|NCT02631577|11424562|FG001|STARTED|Overall Study||34
10291568|NCT02631577|11424561|FG000|COMPLETED|Overall Study||3
10291569|NCT02631577|11424562|FG001|COMPLETED|Overall Study||24
10291570|NCT02631577|11424561|FG000|NOT COMPLETED|Overall Study||1
10291571|NCT02631577|11424562|FG001|NOT COMPLETED|Overall Study||10
10291572|NCT02573779|11424570|FG000|STARTED|Overall Study||74
10291573|NCT02573779|11424571|FG001|STARTED|Overall Study||43
10291574|NCT02573779|11424570|FG000|COMPLETED|Overall Study||74
10291575|NCT02573779|11424571|FG001|COMPLETED|Overall Study||43
10291576|NCT02573779|11424570|FG000|NOT COMPLETED|Overall Study||0
10291577|NCT02573779|11424571|FG001|NOT COMPLETED|Overall Study||0
10291578|NCT02408315|11424579|FG000|STARTED|Overall Study||148
10291579|NCT02408315|11424580|FG001|STARTED|Overall Study||152
10291580|NCT02408315|11424579|FG000|COMPLETED|Overall Study||148
10291581|NCT02408315|11424580|FG001|COMPLETED|Overall Study||152
10291582|NCT02408315|11424579|FG000|NOT COMPLETED|Overall Study||0
10291583|NCT02408315|11424580|FG001|NOT COMPLETED|Overall Study||0
10291584|NCT02300233|11424589|FG000|STARTED|Overall Study||38
10291585|NCT02300233|11424590|FG001|STARTED|Overall Study||25
10291586|NCT02300233|11424591|FG002|STARTED|Overall Study||50
10291587|NCT02300233|11424589|FG000|COMPLETED|Overall Study||34
10291588|NCT02300233|11424590|FG001|COMPLETED|Overall Study||24
10291589|NCT02300233|11424591|FG002|COMPLETED|Overall Study||27
10291590|NCT02300233|11424589|FG000|NOT COMPLETED|Overall Study||4
10291591|NCT02300233|11424590|FG001|NOT COMPLETED|Overall Study||1
10291592|NCT02300233|11424591|FG002|NOT COMPLETED|Overall Study||23
10291593|NCT02211209|11424602|FG000|STARTED|Overall Study||34
10291594|NCT02211209|11424603|FG001|STARTED|Overall Study||33
10834785|NCT01863186|11999946|FG003|STARTED|Open-label Phase|36 from 2.4 mg group, 28 from 3.2mg group, and 19 from Placebo continued to the Open-label phase.|83
10834786|NCT01863186|11999943|FG000|COMPLETED|Open-label Phase||0
10834787|NCT01863186|11999944|FG001|COMPLETED|Open-label Phase||0
10834788|NCT01863186|11999945|FG002|COMPLETED|Open-label Phase||0
10834789|NCT01863186|11999946|FG003|COMPLETED|Open-label Phase||70
10291595|NCT02211209|11424602|FG000|Dosed|Overall Study||33
10291596|NCT02211209|11424603|FG001|Dosed|Overall Study||33
10291597|NCT02211209|11424602|FG000|COMPLETED|Overall Study||32
10291598|NCT02211209|11424603|FG001|COMPLETED|Overall Study||19
10291599|NCT02211209|11424602|FG000|NOT COMPLETED|Overall Study||2
10291600|NCT02211209|11424603|FG001|NOT COMPLETED|Overall Study||14
10834790|NCT01863186|11999943|FG000|NOT COMPLETED|Open-label Phase||0
10834791|NCT01863186|11999944|FG001|NOT COMPLETED|Open-label Phase||0
10834792|NCT01863186|11999945|FG002|NOT COMPLETED|Open-label Phase||0
10834793|NCT01863186|11999946|FG003|NOT COMPLETED|Open-label Phase||13
10834794|NCT01853748|11999957|FG000|STARTED|Allocation||384
10834795|NCT01853748|11999958|FG001|STARTED|Allocation||128
10834796|NCT01853748|11999957|FG000|COMPLETED|Allocation||383
10834797|NCT01853748|11999958|FG001|COMPLETED|Allocation||114
10834798|NCT01853748|11999957|FG000|NOT COMPLETED|Allocation||1
10834799|NCT01853748|11999958|FG001|NOT COMPLETED|Allocation||14
10834800|NCT01853748|11999957|FG000|STARTED|Follow-Up||383
10834801|NCT01853748|11999958|FG001|STARTED|Follow-Up||114
10834802|NCT01853748|11999957|FG000|COMPLETED|Follow-Up||293
10834803|NCT01853748|11999958|FG001|COMPLETED|Follow-Up||97
10834804|NCT01853748|11999957|FG000|NOT COMPLETED|Follow-Up||90
10834805|NCT01853748|11999958|FG001|NOT COMPLETED|Follow-Up||17
10834806|NCT01817751|11999973|FG000|STARTED|Overall Study||47
10834807|NCT01817751|11999973|FG000|COMPLETED|Overall Study||46
10834808|NCT01817751|11999973|FG000|NOT COMPLETED|Overall Study||1
10834809|NCT01722331|11999980|FG000|STARTED|Part 1||308
10834810|NCT01722331|11999981|FG001|STARTED|Part 1||249
10834811|NCT01722331|11999982|FG002|STARTED|Part 1||41
10834812|NCT01722331|11999983|FG003|STARTED|Part 1||19
10834813|NCT01722331|11999984|FG004|STARTED|Part 1||9
10834814|NCT01722331|11999985|FG005|STARTED|Part 1||72
10834815|NCT01722331|11999986|FG006|STARTED|Part 1||74
10834816|NCT01722331|11999980|FG000|COMPLETED|Part 1||298
10834817|NCT01722331|11999981|FG001|COMPLETED|Part 1||249
10834818|NCT01722331|11999982|FG002|COMPLETED|Part 1||32
10834819|NCT01722331|11999983|FG003|COMPLETED|Part 1||19
10834820|NCT01722331|11999984|FG004|COMPLETED|Part 1||0
10834821|NCT01722331|11999985|FG005|COMPLETED|Part 1||72
10834822|NCT01722331|11999986|FG006|COMPLETED|Part 1||74
10834823|NCT01722331|11999980|FG000|NOT COMPLETED|Part 1||10
10834824|NCT01722331|11999981|FG001|NOT COMPLETED|Part 1||0
10834825|NCT01722331|11999982|FG002|NOT COMPLETED|Part 1||9
10834826|NCT01722331|11999983|FG003|NOT COMPLETED|Part 1||0
10834827|NCT01722331|11999984|FG004|NOT COMPLETED|Part 1||9
10834828|NCT01722331|11999985|FG005|NOT COMPLETED|Part 1||0
10834829|NCT01722331|11999986|FG006|NOT COMPLETED|Part 1||0
10834830|NCT01722331|11999980|FG000|STARTED|Part 2||298
10834831|NCT01722331|11999981|FG001|STARTED|Part 2||249
10834832|NCT01722331|11999982|FG002|STARTED|Part 2|1 participant who completed Part 1 did not enter Part 2|31
10834833|NCT01722331|11999983|FG003|STARTED|Part 2||19
10834834|NCT01722331|11999984|FG004|STARTED|Part 2||0
10834835|NCT01722331|11999985|FG005|STARTED|Part 2||72
10834836|NCT01722331|11999986|FG006|STARTED|Part 2||74
10834837|NCT01722331|11999980|FG000|COMPLETED|Part 2||279
10834838|NCT01722331|11999981|FG001|COMPLETED|Part 2||249
10834839|NCT01722331|11999982|FG002|COMPLETED|Part 2||0
10834840|NCT01722331|11999983|FG003|COMPLETED|Part 2||19
10834841|NCT01722331|11999984|FG004|COMPLETED|Part 2||0
10834842|NCT01722331|11999985|FG005|COMPLETED|Part 2||62
10834843|NCT01722331|11999986|FG006|COMPLETED|Part 2||67
10834844|NCT01722331|11999980|FG000|NOT COMPLETED|Part 2||19
10834845|NCT01722331|11999981|FG001|NOT COMPLETED|Part 2||0
10834846|NCT01722331|11999982|FG002|NOT COMPLETED|Part 2||31
10834847|NCT01722331|11999983|FG003|NOT COMPLETED|Part 2||0
10834848|NCT01722331|11999984|FG004|NOT COMPLETED|Part 2||0
10834849|NCT01722331|11999985|FG005|NOT COMPLETED|Part 2||10
10834850|NCT01722331|11999986|FG006|NOT COMPLETED|Part 2||7
10834851|NCT01722331|11999980|FG000|STARTED|Part 3||279
10834852|NCT01722331|11999981|FG001|STARTED|Part 3||249
10834853|NCT01722331|11999982|FG002|STARTED|Part 3||0
10834854|NCT01722331|11999983|FG003|STARTED|Part 3||19
10834855|NCT01722331|11999984|FG004|STARTED|Part 3||0
10834856|NCT01722331|11999985|FG005|STARTED|Part 3||62
10834857|NCT01722331|11999986|FG006|STARTED|Part 3||67
10834858|NCT01722331|11999980|FG000|COMPLETED|Part 3||264
10834859|NCT01722331|11999981|FG001|COMPLETED|Part 3||232
10834860|NCT01722331|11999982|FG002|COMPLETED|Part 3||0
10834861|NCT01722331|11999983|FG003|COMPLETED|Part 3||18
10834862|NCT01722331|11999984|FG004|COMPLETED|Part 3||0
10834863|NCT01722331|11999985|FG005|COMPLETED|Part 3||59
10834864|NCT01722331|11999986|FG006|COMPLETED|Part 3||65
10834865|NCT01722331|11999980|FG000|NOT COMPLETED|Part 3||15
10834866|NCT01722331|11999981|FG001|NOT COMPLETED|Part 3||17
10834867|NCT01722331|11999982|FG002|NOT COMPLETED|Part 3||0
10834868|NCT01722331|11999983|FG003|NOT COMPLETED|Part 3||1
10834869|NCT01722331|11999984|FG004|NOT COMPLETED|Part 3||0
10834870|NCT01722331|11999985|FG005|NOT COMPLETED|Part 3||3
10834871|NCT01722331|11999986|FG006|NOT COMPLETED|Part 3||2
10834872|NCT01716117|12000000|FG000|STARTED|Overall Study||180
10834873|NCT01716117|12000001|FG001|STARTED|Overall Study||33
10834874|NCT01716117|12000000|FG000|Discharge|Overall Study||177
10834875|NCT01716117|12000001|FG001|Discharge|Overall Study||33
10834876|NCT01716117|12000000|FG000|1-Month Visit|Overall Study||176
10834877|NCT01716117|12000001|FG001|1-Month Visit|Overall Study||33
10834878|NCT01716117|12000000|FG000|6-Month Visit|Overall Study||174
10834879|NCT01716117|12000001|FG001|6-Month Visit|Overall Study||32
10834880|NCT01716117|12000000|FG000|COMPLETED|Overall Study||173
10834881|NCT01716117|12000001|FG001|COMPLETED|Overall Study||31
10834882|NCT01716117|12000000|FG000|NOT COMPLETED|Overall Study||7
10834883|NCT01716117|12000001|FG001|NOT COMPLETED|Overall Study||2
10834884|NCT01698905|12000015|FG000|STARTED|Overall Study||163
10834885|NCT01698905|12000015|FG000|Still on Study Phase|Overall Study||0
10834886|NCT01698905|12000015|FG000|TFR Phase|Overall Study||126
10834887|NCT01698905|12000015|FG000|NTRI Phase|Overall Study||51
10834888|NCT01698905|12000015|FG000|NTCT Phase|Overall Study||26
10834889|NCT01698905|12000015|FG000|TFR-2 Phase|Overall Study||2
10834890|NCT01698905|12000015|FG000|NTRI-2 Phase|Overall Study||1
10834891|NCT01698905|12000015|FG000|NTCT-P Phase Phase|Overall Study||6
10834892|NCT01698905|12000015|FG000|COMPLETED|Overall Study||152
10834893|NCT01698905|12000015|FG000|NOT COMPLETED|Overall Study||11
10834894|NCT01676350|12000028|FG000|STARTED|Overall Study||11
10834895|NCT01676350|12000029|FG001|STARTED|Overall Study||11
10834896|NCT01676350|12000028|FG000|COMPLETED|Overall Study||11
10834897|NCT01676350|12000029|FG001|COMPLETED|Overall Study||11
10834898|NCT01676350|12000028|FG000|NOT COMPLETED|Overall Study||0
10834899|NCT01676350|12000029|FG001|NOT COMPLETED|Overall Study||0
10834900|NCT01630590|12000036|FG000|STARTED|Overall Study||62
10834901|NCT01630590|12000036|FG000|COMPLETED|Overall Study||5
10834902|NCT01630590|12000036|FG000|NOT COMPLETED|Overall Study||57
10834903|NCT01619085|12000040|FG000|STARTED|Overall Study||752
10834904|NCT01619085|12000040|FG000|Treated|Overall Study||751
10834905|NCT01619085|12000040|FG000|COMPLETED|Overall Study||227
10834906|NCT01619085|12000040|FG000|NOT COMPLETED|Overall Study||525
10834907|NCT01499095|12000053|FG000|STARTED|Overall Study||404
10834908|NCT01499095|12000054|FG001|STARTED|Overall Study||407
10834909|NCT01499095|12000053|FG000|Treated|Overall Study||403
10834910|NCT01499095|12000054|FG001|Treated|Overall Study||406
10834911|NCT01499095|12000053|FG000|Participated in Substudy|Overall Study|45 participants received adaptable dosing regimen and 44 participants received fixed dosing regimen|89
10834912|NCT01499095|12000054|FG001|Participated in Substudy|Overall Study||0
10834913|NCT01499095|12000053|FG000|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|403
10834914|NCT01499095|12000054|FG001|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|405
10834915|NCT01499095|12000053|FG000|COMPLETED|Overall Study||315
10834916|NCT01499095|12000054|FG001|COMPLETED|Overall Study||314
10834917|NCT01499095|12000053|FG000|NOT COMPLETED|Overall Study||89
10834918|NCT01499095|12000054|FG001|NOT COMPLETED|Overall Study||93
10834919|NCT01499082|12000065|FG000|STARTED|Overall Study||404
10834920|NCT01499082|12000066|FG001|STARTED|Overall Study||403
10834921|NCT01499082|12000065|FG000|Treated|Overall Study||404
10834922|NCT01499082|12000066|FG001|Treated|Overall Study||402
10834923|NCT01499082|12000065|FG000|Participated in Substudy|Overall Study|56 participants received adaptable dosing regimen and 53 participants received fixed dosing regimen|109
10834924|NCT01499082|12000066|FG001|Participated in Substudy|Overall Study||0
10834925|NCT01499082|12000065|FG000|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|404
10834926|NCT01499082|12000066|FG001|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|400
10834927|NCT01499082|12000065|FG000|COMPLETED|Overall Study||359
10834928|NCT01499082|12000066|FG001|COMPLETED|Overall Study||355
10834929|NCT01499082|12000065|FG000|NOT COMPLETED|Overall Study||45
10834930|NCT01499082|12000066|FG001|NOT COMPLETED|Overall Study||48
10834934|NCT01488890|12000082|FG000|STARTED|Overall Study||120
10834935|NCT01488890|12000083|FG001|STARTED|Overall Study||120
10834936|NCT01488890|12000084|FG002|STARTED|Overall Study||120
10834937|NCT01488890|12000085|FG003|STARTED|Overall Study||30
10834938|NCT01488890|12000082|FG000|Treated|Overall Study||120
10834939|NCT01488890|12000083|FG001|Treated|Overall Study||120
10834940|NCT01488890|12000084|FG002|Treated|Overall Study||119
10834941|NCT01488890|12000085|FG003|Treated|Overall Study||30
10834942|NCT01488890|12000082|FG000|COMPLETED|Overall Study||88
10834943|NCT01488890|12000083|FG001|COMPLETED|Overall Study||100
10834944|NCT01488890|12000084|FG002|COMPLETED|Overall Study||85
10834945|NCT01488890|12000085|FG003|COMPLETED|Overall Study||25
10834946|NCT01488890|12000082|FG000|NOT COMPLETED|Overall Study||32
10834947|NCT01488890|12000083|FG001|NOT COMPLETED|Overall Study||20
10834948|NCT01488890|12000084|FG002|NOT COMPLETED|Overall Study||35
10834949|NCT01488890|12000085|FG003|NOT COMPLETED|Overall Study||5
10834950|NCT01436396|12000101|FG000|STARTED|Overall Study||396
10834951|NCT01436396|12000102|FG001|STARTED|Overall Study||396
10834952|NCT01436396|12000101|FG000|Vaccinated|Overall Study||394
10834953|NCT01436396|12000102|FG001|Vaccinated|Overall Study||393
10834954|NCT01436396|12000101|FG000|COMPLETED|Overall Study||364
10834955|NCT01436396|12000102|FG001|COMPLETED|Overall Study||354
10834956|NCT01436396|12000101|FG000|NOT COMPLETED|Overall Study||32
10834957|NCT01436396|12000102|FG001|NOT COMPLETED|Overall Study||42
10834958|NCT01411241|12000110|FG000|STARTED|Overall Study||309
10834959|NCT01411241|12000111|FG001|STARTED|Overall Study||315
10834960|NCT01411241|12000110|FG000|COMPLETED|Overall Study||298
10834961|NCT01411241|12000111|FG001|COMPLETED|Overall Study||293
10834962|NCT01411241|12000110|FG000|NOT COMPLETED|Overall Study||11
10834963|NCT01411241|12000111|FG001|NOT COMPLETED|Overall Study||22
10834964|NCT01374516|12000119|FG000|STARTED|Vaccination Phase (Up to 25 Months)||13920
10834965|NCT01374516|12000120|FG001|STARTED|Vaccination Phase (Up to 25 Months)||6949
10834966|NCT01374516|12000119|FG000|COMPLETED|Vaccination Phase (Up to 25 Months)||13281
10834967|NCT01374516|12000120|FG001|COMPLETED|Vaccination Phase (Up to 25 Months)||6640
10834968|NCT01374516|12000119|FG000|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||639
10834969|NCT01374516|12000120|FG001|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||309
10834970|NCT01374516|12000119|FG000|STARTED|Surveillance Expansion Period||13281
10834971|NCT01374516|12000120|FG001|STARTED|Surveillance Expansion Period||6640
10834972|NCT01374516|12000119|FG000|COMPLETED|Surveillance Expansion Period||10932
10834973|NCT01374516|12000120|FG001|COMPLETED|Surveillance Expansion Period||5387
10834974|NCT01374516|12000119|FG000|NOT COMPLETED|Surveillance Expansion Period||2349
10834975|NCT01374516|12000120|FG001|NOT COMPLETED|Surveillance Expansion Period||1253
10834976|NCT01373281|12000135|FG000|STARTED|Vaccination Phase (Up to 25 Months)||6851
10834977|NCT01373281|12000136|FG001|STARTED|Vaccination Phase (Up to 25 Months)||3424
10834978|NCT01373281|12000135|FG000|COMPLETED|Vaccination Phase (Up to 25 Months)||6797
10834979|NCT01373281|12000136|FG001|COMPLETED|Vaccination Phase (Up to 25 Months)||3397
10834980|NCT01373281|12000135|FG000|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||54
10834981|NCT01373281|12000136|FG001|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||27
10834982|NCT01373281|12000135|FG000|STARTED|Surveillance Expansion Period||6797
10834983|NCT01373281|12000136|FG001|STARTED|Surveillance Expansion Period||3397
10834984|NCT01373281|12000135|FG000|COMPLETED|Surveillance Expansion Period||6595
10834985|NCT01373281|12000136|FG001|COMPLETED|Surveillance Expansion Period||3279
10834986|NCT01373281|12000135|FG000|NOT COMPLETED|Surveillance Expansion Period||202
10834987|NCT01373281|12000136|FG001|NOT COMPLETED|Surveillance Expansion Period||118
10834988|NCT01302847|12000157|FG000|STARTED|Overall Study||23
10834989|NCT01302847|12000158|FG001|STARTED|Overall Study||23
10834990|NCT01302847|12000159|FG002|STARTED|Overall Study||17
10834991|NCT01302847|12000160|FG003|STARTED|Overall Study||15
10834992|NCT01302847|12000161|FG004|STARTED|Overall Study||7
10834993|NCT01302847|12000162|FG005|STARTED|Overall Study||36
10834994|NCT01302847|12000163|FG006|STARTED|Overall Study||35
10834995|NCT01302847|12000164|FG007|STARTED|Overall Study||25
10834996|NCT01302847|12000157|FG000|COMPLETED|Overall Study||10
10834997|NCT01302847|12000158|FG001|COMPLETED|Overall Study||16
10291615|NCT02000115|11424621|FG000|STARTED|Overall Study||381
10291616|NCT02000115|11424622|FG001|STARTED|Overall Study||369
10291617|NCT02000115|11424623|FG002|STARTED|Overall Study||100
10291618|NCT02000115|11424624|FG003|STARTED|Overall Study||53
10291619|NCT02000115|11424621|FG000|COMPLETED|Overall Study|6 subjects missed the One-year follow-up visit|302
10291620|NCT02000115|11424622|FG001|COMPLETED|Overall Study|8 subjects missed the One-year follow-up visit|301
10291621|NCT02000115|11424623|FG002|COMPLETED|Overall Study|1 subject missed the 30 day follow-up visit|99
10291622|NCT02000115|11424624|FG003|COMPLETED|Overall Study||0
10291623|NCT02000115|11424621|FG000|NOT COMPLETED|Overall Study||79
10291624|NCT02000115|11424622|FG001|NOT COMPLETED|Overall Study||68
10291625|NCT02000115|11424623|FG002|NOT COMPLETED|Overall Study||1
10291626|NCT02000115|11424624|FG003|NOT COMPLETED|Overall Study||53
10291627|NCT01888653|11424635|FG000|STARTED|Overall Study||24
10291628|NCT01888653|11424636|FG001|STARTED|Overall Study||26
10291629|NCT01888653|11424635|FG000|COMPLETED|Overall Study||24
10291630|NCT01888653|11424636|FG001|COMPLETED|Overall Study||26
10291631|NCT01888653|11424635|FG000|NOT COMPLETED|Overall Study||0
10291632|NCT01888653|11424636|FG001|NOT COMPLETED|Overall Study||0
10291633|NCT01813227|11424642|FG000|STARTED|Overall Study||7
10291634|NCT01813227|11424642|FG000|COMPLETED|Overall Study||7
10291635|NCT01813227|11424642|FG000|NOT COMPLETED|Overall Study||0
10291636|NCT01695317|11424648|FG000|STARTED|Period 1 in the Cross-over Design||36
10291637|NCT01695317|11424649|FG001|STARTED|Period 1 in the Cross-over Design||36
10291638|NCT01695317|11424648|FG000|COMPLETED|Period 1 in the Cross-over Design||34
10291639|NCT01695317|11424649|FG001|COMPLETED|Period 1 in the Cross-over Design||35
10291640|NCT01695317|11424648|FG000|NOT COMPLETED|Period 1 in the Cross-over Design||2
10409305|NCT00758524|11553192|FG013|COMPLETED|Withdrawal Period (Week 8 to Week 9)||45
10409306|NCT00758524|11553193|FG014|COMPLETED|Withdrawal Period (Week 8 to Week 9)||39
10409307|NCT00758524|11553194|FG015|COMPLETED|Withdrawal Period (Week 8 to Week 9)||36
10409308|NCT00758524|11553195|FG016|COMPLETED|Withdrawal Period (Week 8 to Week 9)||66
10409309|NCT00758524|11553179|FG000|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
10409310|NCT00758524|11553180|FG001|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
10409311|NCT00758524|11553181|FG002|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
10409312|NCT00758524|11553182|FG003|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
10409313|NCT00758524|11553183|FG004|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
10834998|NCT01302847|12000159|FG002|COMPLETED|Overall Study||15
10834999|NCT01302847|12000160|FG003|COMPLETED|Overall Study||14
10291641|NCT01695317|11424649|FG001|NOT COMPLETED|Period 1 in the Cross-over Design||1
10409314|NCT00758524|11553184|FG005|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
10409315|NCT00758524|11553185|FG006|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||1
10835000|NCT01302847|12000161|FG004|COMPLETED|Overall Study||5
10291642|NCT01695317|11424648|FG000|STARTED|Cross-over to Period 2||34
10291643|NCT01695317|11424649|FG001|STARTED|Cross-over to Period 2||35
10835001|NCT01302847|12000162|FG005|COMPLETED|Overall Study||6
10835002|NCT01302847|12000163|FG006|COMPLETED|Overall Study||9
10835003|NCT01302847|12000164|FG007|COMPLETED|Overall Study||3
10835004|NCT01302847|12000157|FG000|NOT COMPLETED|Overall Study||13
10835005|NCT01302847|12000158|FG001|NOT COMPLETED|Overall Study||7
10835006|NCT01302847|12000159|FG002|NOT COMPLETED|Overall Study||2
10835007|NCT01302847|12000160|FG003|NOT COMPLETED|Overall Study||1
10835008|NCT01302847|12000161|FG004|NOT COMPLETED|Overall Study||2
10835009|NCT01302847|12000162|FG005|NOT COMPLETED|Overall Study||30
10835010|NCT01302847|12000163|FG006|NOT COMPLETED|Overall Study||26
10835011|NCT01302847|12000164|FG007|NOT COMPLETED|Overall Study||22
10835012|NCT01287611|12000193|FG000|STARTED|Overall Study||84
10835013|NCT01287611|12000194|FG001|STARTED|Overall Study||84
10835014|NCT01287611|12000193|FG000|The Number of Patients Who Underwent C/S|Overall Study||84
10835015|NCT01287611|12000194|FG001|The Number of Patients Who Underwent C/S|Overall Study||84
10835016|NCT01287611|12000193|FG000|COMPLETED|Overall Study||51
10835017|NCT01287611|12000194|FG001|COMPLETED|Overall Study||65
10835018|NCT01287611|12000193|FG000|NOT COMPLETED|Overall Study||33
10835019|NCT01287611|12000194|FG001|NOT COMPLETED|Overall Study||19
10835020|NCT01254422|12000204|FG000|STARTED|Overall Study||199
10835021|NCT01254422|12000205|FG001|STARTED|Overall Study||51
10835022|NCT01254422|12000204|FG000|COMPLETED|Overall Study||196
10835023|NCT01254422|12000205|FG001|COMPLETED|Overall Study||50
10835024|NCT01254422|12000204|FG000|NOT COMPLETED|Overall Study||3
10835025|NCT01254422|12000205|FG001|NOT COMPLETED|Overall Study||1
10835026|NCT01187433|12000213|FG000|STARTED|Overall Study||100
10835027|NCT01187433|12000214|FG001|STARTED|Overall Study||50
10835028|NCT01187433|12000213|FG000|COMPLETED|Overall Study||89
10835029|NCT01187433|12000214|FG001|COMPLETED|Overall Study||46
10835030|NCT01187433|12000213|FG000|NOT COMPLETED|Overall Study||11
10835031|NCT01187433|12000214|FG001|NOT COMPLETED|Overall Study||4
10835032|NCT01150045|12000224|FG000|STARTED|Overall Study||615
10835033|NCT01150045|12000225|FG001|STARTED|Overall Study||647
10835034|NCT01150045|12000226|FG002|STARTED|Overall Study||646
10835035|NCT01150045|12000227|FG003|STARTED|Overall Study||618
10835036|NCT01150045|12000224|FG000|COMPLETED|Overall Study||615
10835037|NCT01150045|12000225|FG001|COMPLETED|Overall Study||646
10835038|NCT01150045|12000226|FG002|COMPLETED|Overall Study||646
10835039|NCT01150045|12000227|FG003|COMPLETED|Overall Study||617
10835040|NCT01150045|12000224|FG000|NOT COMPLETED|Overall Study||0
10835041|NCT01150045|12000225|FG001|NOT COMPLETED|Overall Study||1
10291644|NCT01695317|11424648|FG000|COMPLETED|Cross-over to Period 2||30
10291645|NCT01695317|11424649|FG001|COMPLETED|Cross-over to Period 2||1
10291646|NCT01695317|11424648|FG000|NOT COMPLETED|Cross-over to Period 2||4
10291647|NCT01695317|11424649|FG001|NOT COMPLETED|Cross-over to Period 2||34
10291648|NCT01683825|11424658|FG000|STARTED|Overall Study||10
10291649|NCT01683825|11424659|FG001|STARTED|Overall Study||6
10291650|NCT01683825|11424660|FG002|STARTED|Overall Study||7
10291651|NCT01683825|11424658|FG000|COMPLETED|Overall Study||10
10291652|NCT01683825|11424659|FG001|COMPLETED|Overall Study||6
10291653|NCT01683825|11424660|FG002|COMPLETED|Overall Study||7
10291654|NCT01683825|11424658|FG000|NOT COMPLETED|Overall Study||0
10291655|NCT01683825|11424659|FG001|NOT COMPLETED|Overall Study||0
10291656|NCT01683825|11424660|FG002|NOT COMPLETED|Overall Study||0
10291657|NCT01196936|11424671|FG000|STARTED|Overall Study||34
10291658|NCT01196936|11424672|FG001|STARTED|Overall Study||38
10291659|NCT01196936|11424671|FG000|Year One Post Treatment|Overall Study||27
10291660|NCT01196936|11424672|FG001|Year One Post Treatment|Overall Study||28
10291661|NCT01196936|11424671|FG000|COMPLETED|Overall Study||23
10291662|NCT01196936|11424672|FG001|COMPLETED|Overall Study||21
10291663|NCT01196936|11424671|FG000|NOT COMPLETED|Overall Study||11
10291664|NCT01196936|11424672|FG001|NOT COMPLETED|Overall Study||17
10291665|NCT01127451|11424680|FG000|STARTED|Overall Study||43
10291666|NCT01127451|11424681|FG001|STARTED|Overall Study||32
10291667|NCT01127451|11424680|FG000|Safety Analysis Set|Overall Study||43
10291668|NCT01127451|11424681|FG001|Safety Analysis Set|Overall Study||32
10291669|NCT01127451|11424680|FG000|Modified Intent-to-Treat (MITT)|Overall Study||42
10291670|NCT01127451|11424681|FG001|Modified Intent-to-Treat (MITT)|Overall Study||32
10291671|NCT01127451|11424680|FG000|COMPLETED|Overall Study||0
10291672|NCT01127451|11424681|FG001|COMPLETED|Overall Study||0
10291673|NCT01127451|11424680|FG000|NOT COMPLETED|Overall Study||43
10291674|NCT01127451|11424681|FG001|NOT COMPLETED|Overall Study||32
10314239|NCT00159874|11447736|FG005|STARTED|Overall Study||23
10314240|NCT00159874|11447737|FG006|STARTED|Overall Study||5
10314241|NCT00159874|11447731|FG000|Treated|Overall Study||42
10314242|NCT00159874|11447732|FG001|Treated|Overall Study||55
10314243|NCT00159874|11447733|FG002|Treated|Overall Study||77
10314244|NCT00159874|11447734|FG003|Treated|Overall Study||13
10314245|NCT00159874|11447735|FG004|Treated|Overall Study||19
10314246|NCT00159874|11447736|FG005|Treated|Overall Study||23
10314247|NCT00159874|11447737|FG006|Treated|Overall Study||5
10314248|NCT00159874|11447731|FG000|COMPLETED|Overall Study||22
10314249|NCT00159874|11447732|FG001|COMPLETED|Overall Study||25
10314250|NCT00159874|11447733|FG002|COMPLETED|Overall Study||34
10429151|NCT00862849|11575289|FG003|COMPLETED|Washout 2 (3 to 14 Days)||4
10835042|NCT01150045|12000226|FG002|NOT COMPLETED|Overall Study||0
10835043|NCT01150045|12000227|FG003|NOT COMPLETED|Overall Study||1
10835044|NCT01098032|12000237|FG000|STARTED|Overall Study|1 patient di not receive the treatment. Therefore this patient was excluded from the analysis.|147
10835045|NCT01098032|12000238|FG001|STARTED|Overall Study|1 patient di not receive the treatment. Therefore this patient was excluded from the analysis.|147
10835046|NCT01098032|12000237|FG000|COMPLETED|Overall Study||146
10835047|NCT01098032|12000238|FG001|COMPLETED|Overall Study||146
10835048|NCT01098032|12000237|FG000|NOT COMPLETED|Overall Study||1
10835049|NCT01098032|12000238|FG001|NOT COMPLETED|Overall Study||1
10835050|NCT01034306|12000246|FG000|STARTED|Overall Study||42
10835051|NCT01034306|12000247|FG001|STARTED|Overall Study||37
10835052|NCT01034306|12000246|FG000|COMPLETED|Overall Study||37
10835053|NCT01034306|12000247|FG001|COMPLETED|Overall Study||34
10835054|NCT01034306|12000246|FG000|NOT COMPLETED|Overall Study||5
10835055|NCT01034306|12000247|FG001|NOT COMPLETED|Overall Study||3
10835059|NCT00993447|12000259|FG000|STARTED|Overall Study||401
10835060|NCT00993447|12000260|FG001|STARTED|Overall Study||199
10835061|NCT00993447|12000259|FG000|COMPLETED|Overall Study||364
10835062|NCT00993447|12000260|FG001|COMPLETED|Overall Study||180
10835063|NCT00993447|12000259|FG000|NOT COMPLETED|Overall Study||37
10835064|NCT00993447|12000260|FG001|NOT COMPLETED|Overall Study||19
10835065|NCT00945009|12000269|FG000|STARTED|Overall Study||201
10835066|NCT00945009|12000270|FG001|STARTED|Overall Study||39
10835067|NCT00945009|12000271|FG002|STARTED|Overall Study||9
10835068|NCT00945009|12000269|FG000|COMPLETED|Overall Study||156
10835069|NCT00945009|12000270|FG001|COMPLETED|Overall Study||32
10835070|NCT00945009|12000271|FG002|COMPLETED|Overall Study||6
10835071|NCT00945009|12000269|FG000|NOT COMPLETED|Overall Study||45
10835072|NCT00945009|12000270|FG001|NOT COMPLETED|Overall Study||7
10835073|NCT00945009|12000271|FG002|NOT COMPLETED|Overall Study||3
10835074|NCT00942877|12000281|FG000|STARTED|Overall Study||46
10835075|NCT00942877|12000282|FG001|STARTED|Overall Study||7
10835076|NCT00942877|12000281|FG000|COMPLETED|Overall Study||1
10835077|NCT00942877|12000282|FG001|COMPLETED|Overall Study||3
10835078|NCT00942877|12000281|FG000|NOT COMPLETED|Overall Study||45
10835079|NCT00942877|12000282|FG001|NOT COMPLETED|Overall Study||4
10835080|NCT00896389|12000289|FG000|STARTED|Salt Loading||124
10835081|NCT00896389|12000289|FG000|COMPLETED|Salt Loading||124
10835082|NCT00896389|12000289|FG000|NOT COMPLETED|Salt Loading||0
10835083|NCT00896389|12000289|FG000|STARTED|HCTZ Low Dose|Only subjects with SBP > 120 mmHg and agreeable to the HCTZ protocol continued to the next period.|28
10835084|NCT00896389|12000289|FG000|COMPLETED|HCTZ Low Dose||28
10835085|NCT00896389|12000289|FG000|NOT COMPLETED|HCTZ Low Dose||0
10835086|NCT00896389|12000289|FG000|STARTED|HCTZ High Dose||25
10835087|NCT00896389|12000289|FG000|COMPLETED|HCTZ High Dose||25
10835088|NCT00896389|12000289|FG000|NOT COMPLETED|HCTZ High Dose||0
10835089|NCT00880893|12000297|FG000|STARTED|Overall Study||898
10835090|NCT00880893|12000298|FG001|STARTED|Overall Study||300
10835091|NCT00880893|12000297|FG000|COMPLETED|Overall Study||791
10835092|NCT00880893|12000298|FG001|COMPLETED|Overall Study||255
10835093|NCT00880893|12000297|FG000|NOT COMPLETED|Overall Study||107
10835094|NCT00880893|12000298|FG001|NOT COMPLETED|Overall Study||45
10835095|NCT00866918|12000306|FG000|STARTED|Overall Study||69
10835096|NCT00866918|12000307|FG001|STARTED|Overall Study||39
10835097|NCT00866918|12000306|FG000|COMPLETED|Overall Study||53
10835098|NCT00866918|12000307|FG001|COMPLETED|Overall Study||27
10835099|NCT00866918|12000306|FG000|NOT COMPLETED|Overall Study||16
10835100|NCT00866918|12000307|FG001|NOT COMPLETED|Overall Study||12
10835101|NCT00587301|12000313|FG000|STARTED|Overall Study||119
10835102|NCT00587301|12000313|FG000|COMPLETED|Overall Study||74
10835103|NCT00587301|12000313|FG000|NOT COMPLETED|Overall Study||45
10835104|NCT00579527|12000317|FG000|STARTED|Overall Study||14
10835105|NCT00579527|12000317|FG000|COMPLETED|Overall Study||10
10835106|NCT00579527|12000317|FG000|NOT COMPLETED|Overall Study||4
10835107|NCT00576836|12000322|FG000|STARTED|Overall Study||0
10835108|NCT00576836|12000323|FG001|STARTED|Overall Study||7
10835109|NCT00576836|12000322|FG000|COMPLETED|Overall Study||0
10835110|NCT00576836|12000323|FG001|COMPLETED|Overall Study||5
10835111|NCT00576836|12000322|FG000|NOT COMPLETED|Overall Study||0
10835112|NCT00576836|12000323|FG001|NOT COMPLETED|Overall Study||2
10835113|NCT00576407|12000327|FG000|STARTED|Overall Study||26
10835114|NCT00576407|12000327|FG000|COMPLETED|Overall Study||18
10835115|NCT00576407|12000327|FG000|NOT COMPLETED|Overall Study||8
10291675|NCT01004874|11424687|FG000|STARTED|Overall Study||80
10291676|NCT01004874|11424687|FG000|COMPLETED|Overall Study||80
10291677|NCT01004874|11424687|FG000|NOT COMPLETED|Overall Study||0
10291684|NCT04748120|11424702|FG000|STARTED|Overall Study||1
10291685|NCT04748120|11424703|FG001|STARTED|Overall Study||1
10291686|NCT04748120|11424702|FG000|COMPLETED|Overall Study||1
10291687|NCT04748120|11424703|FG001|COMPLETED|Overall Study||1
10291688|NCT04748120|11424702|FG000|NOT COMPLETED|Overall Study||0
10291689|NCT04748120|11424703|FG001|NOT COMPLETED|Overall Study||0
10314251|NCT00159874|11447734|FG003|COMPLETED|Overall Study||7
10314252|NCT00159874|11447735|FG004|COMPLETED|Overall Study||11
10314253|NCT00159874|11447736|FG005|COMPLETED|Overall Study||11
10314254|NCT00159874|11447737|FG006|COMPLETED|Overall Study||0
10314255|NCT00159874|11447731|FG000|NOT COMPLETED|Overall Study||20
10314256|NCT00159874|11447732|FG001|NOT COMPLETED|Overall Study||30
10314257|NCT00159874|11447733|FG002|NOT COMPLETED|Overall Study||43
10314258|NCT00159874|11447734|FG003|NOT COMPLETED|Overall Study||6
10314259|NCT00159874|11447735|FG004|NOT COMPLETED|Overall Study||8
10314260|NCT00159874|11447736|FG005|NOT COMPLETED|Overall Study||12
10314261|NCT00159874|11447737|FG006|NOT COMPLETED|Overall Study||5
10409316|NCT00758524|11553186|FG007|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
10314262|NCT00159913|11447757|FG000|STARTED|Overall Study||42
10314263|NCT00159913|11447758|FG001|STARTED|Overall Study||55
10314264|NCT00159913|11447759|FG002|STARTED|Overall Study||77
10314265|NCT00159913|11447760|FG003|STARTED|Overall Study||60
10314266|NCT00159913|11447757|FG000|COMPLETED|Overall Study||40
10835152|NCT00547339|12000366|FG000|STARTED|Overall Study||15
10835153|NCT00547339|12000367|FG001|STARTED|Overall Study||15
10835154|NCT00547339|12000368|FG002|STARTED|Overall Study||15
10835155|NCT00547339|12000369|FG003|STARTED|Overall Study||47
10314267|NCT00159913|11447758|FG001|COMPLETED|Overall Study||55
10835156|NCT00547339|12000366|FG000|COMPLETED|Overall Study||15
10835157|NCT00547339|12000367|FG001|COMPLETED|Overall Study||15
10835158|NCT00547339|12000368|FG002|COMPLETED|Overall Study||14
10835159|NCT00547339|12000369|FG003|COMPLETED|Overall Study||47
10835160|NCT00547339|12000366|FG000|NOT COMPLETED|Overall Study||0
10835161|NCT00547339|12000367|FG001|NOT COMPLETED|Overall Study||0
10835162|NCT00547339|12000368|FG002|NOT COMPLETED|Overall Study||1
10409317|NCT00758524|11553187|FG008|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||2
10409318|NCT00758524|11553188|FG009|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
10409319|NCT00758524|11553189|FG010|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
10409320|NCT00758524|11553190|FG011|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
10835163|NCT00547339|12000369|FG003|NOT COMPLETED|Overall Study||0
10835164|NCT00531232|12000391|FG000|STARTED|Overall Study||4
10835165|NCT00531232|12000392|FG001|STARTED|Overall Study||9
10835166|NCT00531232|12000393|FG002|STARTED|Overall Study||25
10835167|NCT00531232|12000391|FG000|Treated|Overall Study||4
10835168|NCT00531232|12000392|FG001|Treated|Overall Study||8
10835169|NCT00531232|12000393|FG002|Treated|Overall Study||24
10835170|NCT00531232|12000391|FG000|COMPLETED|Overall Study||0
10835171|NCT00531232|12000392|FG001|COMPLETED|Overall Study||0
10835172|NCT00531232|12000393|FG002|COMPLETED|Overall Study||0
10835173|NCT00531232|12000391|FG000|NOT COMPLETED|Overall Study||4
10835174|NCT00531232|12000392|FG001|NOT COMPLETED|Overall Study||9
10835175|NCT00531232|12000393|FG002|NOT COMPLETED|Overall Study||25
10835176|NCT00379340|12000409|FG000|STARTED|Overall Study||120
10835177|NCT00379340|12000410|FG001|STARTED|Overall Study||135
10835178|NCT00379340|12000411|FG002|STARTED|Overall Study||52
10835179|NCT00379340|12000412|FG003|STARTED|Overall Study||50
10835180|NCT00379340|12000413|FG004|STARTED|Overall Study||23
10835181|NCT00379340|12000409|FG000|COMPLETED|Overall Study||107
10835182|NCT00379340|12000410|FG001|COMPLETED|Overall Study||132
10835183|NCT00379340|12000411|FG002|COMPLETED|Overall Study||50
10835184|NCT00379340|12000412|FG003|COMPLETED|Overall Study||37
10835185|NCT00379340|12000413|FG004|COMPLETED|Overall Study||9
10835186|NCT00379340|12000409|FG000|NOT COMPLETED|Overall Study||13
10835187|NCT00379340|12000410|FG001|NOT COMPLETED|Overall Study||3
10835188|NCT00379340|12000411|FG002|NOT COMPLETED|Overall Study||2
10835189|NCT00379340|12000412|FG003|NOT COMPLETED|Overall Study||13
10835190|NCT00379340|12000413|FG004|NOT COMPLETED|Overall Study||14
10835191|NCT00304070|12000429|FG000|STARTED|Overall Study||24
10835192|NCT00304070|12000430|FG001|STARTED|Overall Study||15
10835193|NCT00304070|12000431|FG002|STARTED|Overall Study||39
10835194|NCT00304070|12000429|FG000|COMPLETED|Overall Study||21
10835195|NCT00304070|12000430|FG001|COMPLETED|Overall Study||8
10835196|NCT00304070|12000431|FG002|COMPLETED|Overall Study||27
10835197|NCT00304070|12000429|FG000|NOT COMPLETED|Overall Study||3
10835198|NCT00304070|12000430|FG001|NOT COMPLETED|Overall Study||7
10835199|NCT00304070|12000431|FG002|NOT COMPLETED|Overall Study||12
10835200|NCT00001322|12000443|FG000|STARTED|Phase 1 - Lupron Only||92
10835201|NCT00001322|12000444|FG001|STARTED|Phase 1 - Lupron Only||0
10835202|NCT00001322|12000445|FG002|STARTED|Phase 1 - Lupron Only||0
10835203|NCT00001322|12000443|FG000|COMPLETED|Phase 1 - Lupron Only||92
10835204|NCT00001322|12000444|FG001|COMPLETED|Phase 1 - Lupron Only||0
10835205|NCT00001322|12000445|FG002|COMPLETED|Phase 1 - Lupron Only||0
10835206|NCT00001322|12000443|FG000|NOT COMPLETED|Phase 1 - Lupron Only||0
10835207|NCT00001322|12000444|FG001|NOT COMPLETED|Phase 1 - Lupron Only||0
10835208|NCT00001322|12000445|FG002|NOT COMPLETED|Phase 1 - Lupron Only||0
10835209|NCT00001322|12000443|FG000|STARTED|Phase 2, Period 1 - Crossover Phase||0
10835210|NCT00001322|12000444|FG001|STARTED|Phase 2, Period 1 - Crossover Phase||42
10835211|NCT00001322|12000445|FG002|STARTED|Phase 2, Period 1 - Crossover Phase||40
10835212|NCT00001322|12000443|FG000|COMPLETED|Phase 2, Period 1 - Crossover Phase||0
10835213|NCT00001322|12000444|FG001|COMPLETED|Phase 2, Period 1 - Crossover Phase||42
10835214|NCT00001322|12000445|FG002|COMPLETED|Phase 2, Period 1 - Crossover Phase||40
10835215|NCT00001322|12000443|FG000|NOT COMPLETED|Phase 2, Period 1 - Crossover Phase||0
10835216|NCT00001322|12000444|FG001|NOT COMPLETED|Phase 2, Period 1 - Crossover Phase||0
10835217|NCT00001322|12000445|FG002|NOT COMPLETED|Phase 2, Period 1 - Crossover Phase||0
10835218|NCT00001322|12000443|FG000|STARTED|Phase 2, Period 2 - Crossover Phase||0
10835219|NCT00001322|12000444|FG001|STARTED|Phase 2, Period 2 - Crossover Phase||42
10835220|NCT00001322|12000445|FG002|STARTED|Phase 2, Period 2 - Crossover Phase||40
10835221|NCT00001322|12000443|FG000|COMPLETED|Phase 2, Period 2 - Crossover Phase||0
10835222|NCT00001322|12000444|FG001|COMPLETED|Phase 2, Period 2 - Crossover Phase||42
10835223|NCT00001322|12000445|FG002|COMPLETED|Phase 2, Period 2 - Crossover Phase||40
10835224|NCT00001322|12000443|FG000|NOT COMPLETED|Phase 2, Period 2 - Crossover Phase||0
10835225|NCT00001322|12000444|FG001|NOT COMPLETED|Phase 2, Period 2 - Crossover Phase||0
10835226|NCT00001322|12000445|FG002|NOT COMPLETED|Phase 2, Period 2 - Crossover Phase||0
10429152|NCT00862849|11575290|FG004|COMPLETED|Washout 2 (3 to 14 Days)||4
10835227|NCT01701583|12000455|FG000|STARTED|Overall Study||7
10835228|NCT01701583|12000456|FG001|STARTED|Overall Study||3
10835229|NCT01701583|12000455|FG000|COMPLETED|Overall Study||5
10835230|NCT01701583|12000456|FG001|COMPLETED|Overall Study||3
10835231|NCT01701583|12000455|FG000|NOT COMPLETED|Overall Study||2
10835232|NCT01701583|12000456|FG001|NOT COMPLETED|Overall Study||0
10835233|NCT01714817|12000465|FG000|STARTED|Year 1 Period||203
10835234|NCT01714817|12000466|FG001|STARTED|Year 1 Period||203
10835235|NCT01714817|12000465|FG000|Treated|Year 1 Period||202
10835236|NCT01714817|12000466|FG001|Treated|Year 1 Period||203
10835237|NCT01714817|12000465|FG000|COMPLETED|Year 1 Period|Completed = continued study through Year 1|155
10835238|NCT01714817|12000466|FG001|COMPLETED|Year 1 Period|Completed = continued study through Year 1|161
10835239|NCT01714817|12000465|FG000|NOT COMPLETED|Year 1 Period||48
10835240|NCT01714817|12000466|FG001|NOT COMPLETED|Year 1 Period||42
10835241|NCT01714817|12000465|FG000|STARTED|Year 2 Period|Started = Completed Year 1|155
10835242|NCT01714817|12000466|FG001|STARTED|Year 2 Period|Started = Completed Year 1|161
10835243|NCT01714817|12000465|FG000|COMPLETED|Year 2 Period|Completed = Continued study through Year 2|129
10835244|NCT01714817|12000466|FG001|COMPLETED|Year 2 Period|Completed = Continued study through Year 2|123
10835245|NCT01714817|12000465|FG000|NOT COMPLETED|Year 2 Period||26
10835246|NCT01714817|12000466|FG001|NOT COMPLETED|Year 2 Period||38
10835247|NCT01714817|12000465|FG000|STARTED|Long-Term Extension (LTE) Period|Started = Completed Year 2|129
10835248|NCT01714817|12000466|FG001|STARTED|Long-Term Extension (LTE) Period|Started = Completed Year 2|123
10835249|NCT01714817|12000465|FG000|COMPLETED|Long-Term Extension (LTE) Period|Completed = Continued study through LTE|62
10835250|NCT01714817|12000466|FG001|COMPLETED|Long-Term Extension (LTE) Period|Completed = Continued study through LTE|53
10835251|NCT01714817|12000465|FG000|NOT COMPLETED|Long-Term Extension (LTE) Period||67
10835252|NCT01714817|12000466|FG001|NOT COMPLETED|Long-Term Extension (LTE) Period||70
10835253|NCT01755689|12000479|FG000|STARTED|Overall Study||259
10835254|NCT01755689|12000480|FG001|STARTED|Overall Study||259
10835255|NCT01755689|12000481|FG002|STARTED|Overall Study||261
10835256|NCT01755689|12000482|FG003|STARTED|Overall Study||260
10835257|NCT01755689|12000483|FG004|STARTED|Overall Study||261
10835258|NCT01755689|12000479|FG000|COMPLETED|Overall Study||256
10835259|NCT01755689|12000480|FG001|COMPLETED|Overall Study||254
10835260|NCT01755689|12000481|FG002|COMPLETED|Overall Study||255
10835261|NCT01755689|12000482|FG003|COMPLETED|Overall Study||254
10835262|NCT01755689|12000483|FG004|COMPLETED|Overall Study||255
10835263|NCT01755689|12000479|FG000|NOT COMPLETED|Overall Study||3
10835264|NCT01755689|12000480|FG001|NOT COMPLETED|Overall Study||5
10835265|NCT01755689|12000481|FG002|NOT COMPLETED|Overall Study||6
10835266|NCT01755689|12000482|FG003|NOT COMPLETED|Overall Study||6
10835267|NCT01755689|12000483|FG004|NOT COMPLETED|Overall Study||6
10835268|NCT01762761|12000505|FG000|STARTED|Overall Study||51
10835269|NCT01762761|12000506|FG001|STARTED|Overall Study||104
10835270|NCT01762761|12000505|FG000|COMPLETED|Overall Study||12
10835271|NCT01762761|12000506|FG001|COMPLETED|Overall Study||39
10835272|NCT01762761|12000505|FG000|NOT COMPLETED|Overall Study||39
10835273|NCT01762761|12000506|FG001|NOT COMPLETED|Overall Study||65
10835290|NCT01774370|12000530|FG000|STARTED|Overall Study||3182
10835291|NCT01774370|12000530|FG000|COMPLETED|Overall Study||3053
10835292|NCT01774370|12000530|FG000|NOT COMPLETED|Overall Study||129
10835299|NCT01787552|12000557|FG000|STARTED|Overall Study||8
10835300|NCT01787552|12000558|FG001|STARTED|Overall Study||10
10835301|NCT01787552|12000559|FG002|STARTED|Overall Study||5
10835302|NCT01787552|12000560|FG003|STARTED|Overall Study||27
10835303|NCT01787552|12000557|FG000|COMPLETED|Overall Study||0
10835304|NCT01787552|12000558|FG001|COMPLETED|Overall Study||1
10835305|NCT01787552|12000559|FG002|COMPLETED|Overall Study||0
10835306|NCT01787552|12000560|FG003|COMPLETED|Overall Study||0
10835307|NCT01787552|12000557|FG000|NOT COMPLETED|Overall Study||8
10835308|NCT01787552|12000558|FG001|NOT COMPLETED|Overall Study||9
10835309|NCT01787552|12000559|FG002|NOT COMPLETED|Overall Study||5
10835310|NCT01787552|12000560|FG003|NOT COMPLETED|Overall Study||27
10835311|NCT01807117|12000575|FG000|STARTED|Overall Study||15
10835312|NCT01807117|12000575|FG000|COMPLETED|Overall Study||12
10835313|NCT01807117|12000575|FG000|NOT COMPLETED|Overall Study||3
10835320|NCT01814826|12000603|FG000|STARTED|Overall Study|6 participants were enrolled into the dose escalation phase and 26 in the MTD expansion phase.|32
10835321|NCT01814826|12000604|FG001|STARTED|Overall Study|29 participants were enrolled into the MTD expansion phase.|29
10835322|NCT01814826|12000605|FG002|STARTED|Overall Study|3 participants were enrolled into the dose escalation phase.|3
10835323|NCT01814826|12000603|FG000|COMPLETED|Overall Study||0
10835324|NCT01814826|12000604|FG001|COMPLETED|Overall Study||0
10835325|NCT01814826|12000605|FG002|COMPLETED|Overall Study||0
10835326|NCT01814826|12000603|FG000|NOT COMPLETED|Overall Study||32
10835327|NCT01814826|12000604|FG001|NOT COMPLETED|Overall Study||29
10835328|NCT01814826|12000605|FG002|NOT COMPLETED|Overall Study||3
10835329|NCT01829711|12000614|FG000|STARTED|Overall Study||80
10835330|NCT01829711|12000614|FG000|COMPLETED|Overall Study||37
10835331|NCT01829711|12000614|FG000|NOT COMPLETED|Overall Study||43
10835332|NCT01846273|12000621|FG000|STARTED|Overall Study||168
10835333|NCT01846273|12000622|FG001|STARTED|Overall Study||113
10835334|NCT01846273|12000623|FG002|STARTED|Overall Study||41
10835335|NCT01846273|12000621|FG000|Safety Analysis Set|Overall Study||172
10835336|NCT01846273|12000622|FG001|Safety Analysis Set|Overall Study||135
10835337|NCT01846273|12000623|FG002|Safety Analysis Set|Overall Study||14
10835338|NCT01846273|12000621|FG000|COMPLETED|Overall Study||146
10835339|NCT01846273|12000622|FG001|COMPLETED|Overall Study||87
10835274|NCT01763788|12000517|FG000|STARTED|Overall Study||3
10835275|NCT01763788|12000518|FG001|STARTED|Overall Study||6
10835276|NCT01763788|12000519|FG002|STARTED|Overall Study||91
10835277|NCT01763788|12000520|FG003|STARTED|Overall Study||92
10835278|NCT01763788|12000517|FG000|Received at Least 1dose of Study Drug|Overall Study||3
10835279|NCT01763788|12000518|FG001|Received at Least 1dose of Study Drug|Overall Study||6
10835280|NCT01763788|12000519|FG002|Received at Least 1dose of Study Drug|Overall Study||90
10835281|NCT01763788|12000520|FG003|Received at Least 1dose of Study Drug|Overall Study||91
10835282|NCT01763788|12000517|FG000|COMPLETED|Overall Study||3
10835283|NCT01763788|12000518|FG001|COMPLETED|Overall Study||6
10835284|NCT01763788|12000519|FG002|COMPLETED|Overall Study||90
10835285|NCT01763788|12000520|FG003|COMPLETED|Overall Study||92
10835286|NCT01763788|12000517|FG000|NOT COMPLETED|Overall Study||0
10835287|NCT01763788|12000518|FG001|NOT COMPLETED|Overall Study||0
10835288|NCT01763788|12000519|FG002|NOT COMPLETED|Overall Study||1
10835289|NCT01763788|12000520|FG003|NOT COMPLETED|Overall Study||0
10835293|NCT01777295|12000536|FG000|STARTED|Overall Study||40
10835294|NCT01777295|12000537|FG001|STARTED|Overall Study||41
10835295|NCT01777295|12000536|FG000|COMPLETED|Overall Study||36
10835296|NCT01777295|12000537|FG001|COMPLETED|Overall Study||38
10835297|NCT01777295|12000536|FG000|NOT COMPLETED|Overall Study||4
10835298|NCT01777295|12000537|FG001|NOT COMPLETED|Overall Study||3
10835314|NCT01808261|12000583|FG000|STARTED|Overall Study||68
10835315|NCT01808261|12000584|FG001|STARTED|Overall Study||65
10835316|NCT01808261|12000583|FG000|COMPLETED|Overall Study||32
10835317|NCT01808261|12000584|FG001|COMPLETED|Overall Study||32
10835318|NCT01808261|12000583|FG000|NOT COMPLETED|Overall Study||36
10835319|NCT01808261|12000584|FG001|NOT COMPLETED|Overall Study||33
10835340|NCT01846273|12000623|FG002|COMPLETED|Overall Study||41
10835341|NCT01846273|12000621|FG000|NOT COMPLETED|Overall Study||22
10835342|NCT01846273|12000622|FG001|NOT COMPLETED|Overall Study||26
10835343|NCT01846273|12000623|FG002|NOT COMPLETED|Overall Study||0
10291690|NCT04559698|11424713|FG000|STARTED|Overall Study||61
10291691|NCT04559698|11424714|FG001|STARTED|Overall Study||60
10291692|NCT04559698|11424713|FG000|Four-month Pre-intervention|Overall Study|Participants in this arm started training immediately after randomization, and therefore, did not have a four-month waiting period prior to receiving the training.|0
10291693|NCT04559698|11424714|FG001|Four-month Pre-intervention|Overall Study||60
10291694|NCT04559698|11424713|FG000|Immediate Pre-intervention|Overall Study||61
10291695|NCT04559698|11424714|FG001|Immediate Pre-intervention|Overall Study||55
10291696|NCT04559698|11424713|FG000|Immediate Post-intervention|Overall Study||52
10291697|NCT04559698|11424714|FG001|Immediate Post-intervention|Overall Study||44
10291698|NCT04559698|11424713|FG000|Four-month Post-intervention|Overall Study||47
10291699|NCT04559698|11424714|FG001|Four-month Post-intervention|Overall Study|Participants in this arm started training four months after randomization (waitlist) and therefore, were not assessed at the four-month follow-up time point due to completion of the study.|0
10291700|NCT04559698|11424713|FG000|COMPLETED|Overall Study||47
10291701|NCT04559698|11424714|FG001|COMPLETED|Overall Study||44
10291702|NCT04559698|11424713|FG000|NOT COMPLETED|Overall Study||14
10291703|NCT04559698|11424714|FG001|NOT COMPLETED|Overall Study||16
10291704|NCT04492475|11424722|FG000|STARTED|Overall Study||487
10291705|NCT04492475|11424723|FG001|STARTED|Overall Study||482
10291706|NCT04492475|11424722|FG000|ITT and Modified ITT Population|Overall Study||487
10291707|NCT04492475|11424723|FG001|ITT and Modified ITT Population|Overall Study||482
10291708|NCT04492475|11424722|FG000|As Treated Population|Overall Study||477
10291709|NCT04492475|11424723|FG001|As Treated Population|Overall Study||468
10291710|NCT04492475|11424722|FG000|COMPLETED|Overall Study||473
10291711|NCT04492475|11424723|FG001|COMPLETED|Overall Study||474
10291712|NCT04492475|11424722|FG000|NOT COMPLETED|Overall Study||14
10835344|NCT01875185|12000633|FG000|STARTED|Overall Study||52
10835345|NCT01875185|12000634|FG001|STARTED|Overall Study||48
10835346|NCT01875185|12000633|FG000|COMPLETED|Overall Study||0
10835347|NCT01875185|12000634|FG001|COMPLETED|Overall Study||0
10835348|NCT01875185|12000633|FG000|NOT COMPLETED|Overall Study||52
10835349|NCT01875185|12000634|FG001|NOT COMPLETED|Overall Study||48
10835350|NCT01887743|12000647|FG000|STARTED|Overall Study||20
10835351|NCT01887743|12000648|FG001|STARTED|Overall Study||19
10835352|NCT01887743|12000649|FG002|STARTED|Overall Study||32
10835353|NCT01887743|12000647|FG000|COMPLETED|Overall Study||19
10835354|NCT01887743|12000648|FG001|COMPLETED|Overall Study||17
10835355|NCT01887743|12000649|FG002|COMPLETED|Overall Study||29
10835356|NCT01887743|12000647|FG000|NOT COMPLETED|Overall Study||1
10835357|NCT01887743|12000648|FG001|NOT COMPLETED|Overall Study||2
10835358|NCT01887743|12000649|FG002|NOT COMPLETED|Overall Study||3
10835359|NCT01891643|12000660|FG000|STARTED|Overall Study||13
10835360|NCT01891643|12000661|FG001|STARTED|Overall Study||10
10835361|NCT01891643|12000660|FG000|COMPLETED|Overall Study||3
10835362|NCT01891643|12000661|FG001|COMPLETED|Overall Study||0
10835363|NCT01891643|12000660|FG000|NOT COMPLETED|Overall Study||10
10835364|NCT01891643|12000661|FG001|NOT COMPLETED|Overall Study||10
10835394|NCT01917318|12000712|FG000|STARTED|First Treatment||0
10835395|NCT01917318|12000713|FG001|STARTED|First Treatment||1
10835396|NCT01917318|12000712|FG000|COMPLETED|First Treatment||0
10835397|NCT01917318|12000713|FG001|COMPLETED|First Treatment||0
10835398|NCT01917318|12000712|FG000|NOT COMPLETED|First Treatment||0
10835399|NCT01917318|12000713|FG001|NOT COMPLETED|First Treatment||1
10835400|NCT01917318|12000712|FG000|STARTED|Second Treatment||0
10835401|NCT01917318|12000713|FG001|STARTED|Second Treatment||0
10835402|NCT01917318|12000712|FG000|COMPLETED|Second Treatment||0
10835403|NCT01917318|12000713|FG001|COMPLETED|Second Treatment||0
10835404|NCT01917318|12000712|FG000|NOT COMPLETED|Second Treatment||0
10835405|NCT01917318|12000713|FG001|NOT COMPLETED|Second Treatment||0
10835406|NCT01921218|12000721|FG000|STARTED|Overall Study||6
10291713|NCT04492475|11424723|FG001|NOT COMPLETED|Overall Study||8
10291714|NCT04401579|11424738|FG000|STARTED|Overall Study||515
10291715|NCT04401579|11424739|FG001|STARTED|Overall Study||518
10291716|NCT04401579|11424738|FG000|Treated|Overall Study||507
10291717|NCT04401579|11424739|FG001|Treated|Overall Study||509
10291718|NCT04401579|11424738|FG000|COMPLETED|Overall Study||431
10291719|NCT04401579|11424739|FG001|COMPLETED|Overall Study||408
10291720|NCT04401579|11424738|FG000|NOT COMPLETED|Overall Study||84
10291721|NCT04401579|11424739|FG001|NOT COMPLETED|Overall Study||110
10291722|NCT04321460|11424747|FG000|STARTED|Overall Study||260
10291723|NCT04321460|11424748|FG001|STARTED|Overall Study||260
10291724|NCT04321460|11424747|FG000|Intention to Treat (ITT) Population|Overall Study||260
10291725|NCT04321460|11424748|FG001|Intention to Treat (ITT) Population|Overall Study||260
10291726|NCT04321460|11424747|FG000|Per-protocol (PP) Population|Overall Study||252
10291727|NCT04321460|11424748|FG001|Per-protocol (PP) Population|Overall Study||248
10291728|NCT04321460|11424747|FG000|COMPLETED|Overall Study||259
10291729|NCT04321460|11424748|FG001|COMPLETED|Overall Study||259
10291730|NCT04321460|11424747|FG000|NOT COMPLETED|Overall Study||1
10291731|NCT04321460|11424748|FG001|NOT COMPLETED|Overall Study||1
10291732|NCT04280705|11424756|FG000|STARTED|Overall Study||521
10291733|NCT04280705|11424757|FG001|STARTED|Overall Study||541
10291734|NCT04280705|11424756|FG000|Received Treatment|Overall Study||517
10291735|NCT04280705|11424757|FG001|Received Treatment|Overall Study||531
10291736|NCT04280705|11424756|FG000|COMPLETED|Overall Study||508
10291737|NCT04280705|11424757|FG001|COMPLETED|Overall Study||517
10291738|NCT04280705|11424756|FG000|NOT COMPLETED|Overall Study||13
10291739|NCT04280705|11424757|FG001|NOT COMPLETED|Overall Study||24
10291740|NCT04208750|11424765|FG000|STARTED|Overall Study||58
10291741|NCT04208750|11424766|FG001|STARTED|Overall Study||61
10291742|NCT04208750|11424765|FG000|Visit 2|Overall Study||58
10291743|NCT04208750|11424766|FG001|Visit 2|Overall Study||61
10291744|NCT04208750|11424765|FG000|Visit 3|Overall Study||58
10291745|NCT04208750|11424766|FG001|Visit 3|Overall Study||53
10291746|NCT04208750|11424765|FG000|Visit 4|Overall Study||43
10291747|NCT04208750|11424766|FG001|Visit 4|Overall Study||47
10291748|NCT04208750|11424765|FG000|COMPLETED|Overall Study||42
10291749|NCT04208750|11424766|FG001|COMPLETED|Overall Study||46
10835407|NCT01921218|12000722|FG001|STARTED|Overall Study||7
10291750|NCT04208750|11424765|FG000|NOT COMPLETED|Overall Study||16
10291751|NCT04208750|11424766|FG001|NOT COMPLETED|Overall Study||15
10314268|NCT00159913|11447759|FG002|COMPLETED|Overall Study||75
10314269|NCT00159913|11447760|FG003|COMPLETED|Overall Study||58
10314270|NCT00159913|11447757|FG000|NOT COMPLETED|Overall Study||2
10314271|NCT00159913|11447758|FG001|NOT COMPLETED|Overall Study||0
10409321|NCT00758524|11553191|FG012|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
10409322|NCT00758524|11553192|FG013|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
10835408|NCT01921218|12000721|FG000|COMPLETED|Overall Study||3
10835409|NCT01921218|12000722|FG001|COMPLETED|Overall Study||3
10314272|NCT00159913|11447759|FG002|NOT COMPLETED|Overall Study||2
10314273|NCT00159913|11447760|FG003|NOT COMPLETED|Overall Study||2
10314274|NCT00159965|11447774|FG000|STARTED|Overall Study||19
10835410|NCT01921218|12000721|FG000|NOT COMPLETED|Overall Study||3
10835411|NCT01921218|12000722|FG001|NOT COMPLETED|Overall Study||4
10835457|NCT01931098|12000763|FG000|STARTED|Overall Study||9
10835458|NCT01931098|12000764|FG001|STARTED|Overall Study||26
10835368|NCT01901432|12000677|FG000|STARTED|Overall Study||3
10835369|NCT01901432|12000678|FG001|STARTED|Overall Study||3
10835370|NCT01901432|12000679|FG002|STARTED|Overall Study||3
10835371|NCT01901432|12000680|FG003|STARTED|Overall Study||3
10835372|NCT01901432|12000681|FG004|STARTED|Overall Study||36
10835373|NCT01901432|12000677|FG000|Received Study Drug|Overall Study||3
10835374|NCT01901432|12000678|FG001|Received Study Drug|Overall Study||3
10835375|NCT01901432|12000679|FG002|Received Study Drug|Overall Study||3
10835376|NCT01901432|12000680|FG003|Received Study Drug|Overall Study||3
10835377|NCT01901432|12000681|FG004|Received Study Drug|Overall Study||35
10835378|NCT01901432|12000677|FG000|COMPLETED|Overall Study||3
10835379|NCT01901432|12000678|FG001|COMPLETED|Overall Study||2
10835380|NCT01901432|12000679|FG002|COMPLETED|Overall Study||1
10835381|NCT01901432|12000680|FG003|COMPLETED|Overall Study||3
10835382|NCT01901432|12000681|FG004|COMPLETED|Overall Study||27
10835383|NCT01901432|12000677|FG000|NOT COMPLETED|Overall Study||0
10835384|NCT01901432|12000678|FG001|NOT COMPLETED|Overall Study||1
10835385|NCT01901432|12000679|FG002|NOT COMPLETED|Overall Study||2
10835386|NCT01901432|12000680|FG003|NOT COMPLETED|Overall Study||0
10835387|NCT01901432|12000681|FG004|NOT COMPLETED|Overall Study||9
10835412|NCT01923168|12000731|FG000|STARTED|Overall Study||131
10835413|NCT01923168|12000732|FG001|STARTED|Overall Study||83
10835414|NCT01923168|12000733|FG002|STARTED|Overall Study||126
10835415|NCT01923168|12000731|FG000|COMPLETED|Overall Study||94
10835416|NCT01923168|12000732|FG001|COMPLETED|Overall Study||44
10835417|NCT01923168|12000733|FG002|COMPLETED|Overall Study||109
10835418|NCT01923168|12000731|FG000|NOT COMPLETED|Overall Study||37
10835419|NCT01923168|12000732|FG001|NOT COMPLETED|Overall Study||39
10835420|NCT01923168|12000733|FG002|NOT COMPLETED|Overall Study||17
10835421|NCT01923480|12000744|FG000|STARTED|Period 1 (Hours 1-7)||1
10835422|NCT01923480|12000745|FG001|STARTED|Period 1 (Hours 1-7)||2
10835423|NCT01923480|12000746|FG002|STARTED|Period 1 (Hours 1-7)||2
10835424|NCT01923480|12000747|FG003|STARTED|Period 1 (Hours 1-7)||2
10835425|NCT01923480|12000748|FG004|STARTED|Period 1 (Hours 1-7)||2
10835426|NCT01923480|12000749|FG005|STARTED|Period 1 (Hours 1-7)||2
10835427|NCT01923480|12000744|FG000|COMPLETED|Period 1 (Hours 1-7)||1
10835428|NCT01923480|12000745|FG001|COMPLETED|Period 1 (Hours 1-7)|One subject completed Period 1, but withdrew from the study prior to the start of Period 2.|2
10835429|NCT01923480|12000746|FG002|COMPLETED|Period 1 (Hours 1-7)||2
10835430|NCT01923480|12000747|FG003|COMPLETED|Period 1 (Hours 1-7)||2
10835431|NCT01923480|12000748|FG004|COMPLETED|Period 1 (Hours 1-7)||2
10835432|NCT01923480|12000749|FG005|COMPLETED|Period 1 (Hours 1-7)||2
10835433|NCT01923480|12000744|FG000|NOT COMPLETED|Period 1 (Hours 1-7)||0
10835434|NCT01923480|12000745|FG001|NOT COMPLETED|Period 1 (Hours 1-7)||0
10835435|NCT01923480|12000746|FG002|NOT COMPLETED|Period 1 (Hours 1-7)||0
10835436|NCT01923480|12000747|FG003|NOT COMPLETED|Period 1 (Hours 1-7)||0
10835437|NCT01923480|12000748|FG004|NOT COMPLETED|Period 1 (Hours 1-7)||0
10835438|NCT01923480|12000749|FG005|NOT COMPLETED|Period 1 (Hours 1-7)||0
10835439|NCT01923480|12000744|FG000|STARTED|Period 2 (Hours 1-7)||1
10835440|NCT01923480|12000745|FG001|STARTED|Period 2 (Hours 1-7)|One subject completed Period 1, but withdrew from the study prior to the start of Period 2.|1
10835441|NCT01923480|12000746|FG002|STARTED|Period 2 (Hours 1-7)||2
10835442|NCT01923480|12000747|FG003|STARTED|Period 2 (Hours 1-7)||2
10835443|NCT01923480|12000748|FG004|STARTED|Period 2 (Hours 1-7)||2
10835444|NCT01923480|12000749|FG005|STARTED|Period 2 (Hours 1-7)||2
10835445|NCT01923480|12000744|FG000|COMPLETED|Period 2 (Hours 1-7)||1
10835446|NCT01923480|12000745|FG001|COMPLETED|Period 2 (Hours 1-7)||1
10835447|NCT01923480|12000746|FG002|COMPLETED|Period 2 (Hours 1-7)||2
10835448|NCT01923480|12000747|FG003|COMPLETED|Period 2 (Hours 1-7)||2
10835449|NCT01923480|12000748|FG004|COMPLETED|Period 2 (Hours 1-7)||2
10835450|NCT01923480|12000749|FG005|COMPLETED|Period 2 (Hours 1-7)||2
10835451|NCT01923480|12000744|FG000|NOT COMPLETED|Period 2 (Hours 1-7)||0
10835452|NCT01923480|12000745|FG001|NOT COMPLETED|Period 2 (Hours 1-7)||0
10835453|NCT01923480|12000746|FG002|NOT COMPLETED|Period 2 (Hours 1-7)||0
10835454|NCT01923480|12000747|FG003|NOT COMPLETED|Period 2 (Hours 1-7)||0
10835455|NCT01923480|12000748|FG004|NOT COMPLETED|Period 2 (Hours 1-7)||0
10835456|NCT01923480|12000749|FG005|NOT COMPLETED|Period 2 (Hours 1-7)||0
10835459|NCT01931098|12000763|FG000|COMPLETED|Overall Study||9
10835460|NCT01931098|12000764|FG001|COMPLETED|Overall Study||22
10291752|NCT03713281|11424772|FG000|STARTED|Overall Study||28
10835461|NCT01931098|12000763|FG000|NOT COMPLETED|Overall Study||0
10835462|NCT01931098|12000764|FG001|NOT COMPLETED|Overall Study||4
10835388|NCT01904279|12000702|FG000|STARTED|Overall Study||27
10835389|NCT01904279|12000703|FG001|STARTED|Overall Study||25
10835390|NCT01904279|12000702|FG000|COMPLETED|Overall Study||24
10835391|NCT01904279|12000703|FG001|COMPLETED|Overall Study||22
10835392|NCT01904279|12000702|FG000|NOT COMPLETED|Overall Study||3
10835393|NCT01904279|12000703|FG001|NOT COMPLETED|Overall Study||3
10835463|NCT01945021|12000772|FG000|STARTED|Overall Study||127
10835464|NCT01945021|12000772|FG000|Safety Population|Overall Study|Received at least 1 dose of study medication.|127
10835465|NCT01945021|12000772|FG000|Response Evaluable Population|Overall Study|Received at least 1 dose of study drug and an adequate baseline tumor assessment.|127
10835466|NCT01945021|12000772|FG000|Patient Reported Outcome Evaluable|Overall Study|Received at least 1 dose of study drug, completed baseline with at least 1 post-baseline assessment.|123
10835467|NCT01945021|12000772|FG000|COMPLETED|Overall Study||44
10835468|NCT01945021|12000772|FG000|NOT COMPLETED|Overall Study||83
10835469|NCT04747808|12000776|FG000|STARTED|Overall Study||5
10835470|NCT04747808|12000776|FG000|COMPLETED|Overall Study||5
10835471|NCT04747808|12000776|FG000|NOT COMPLETED|Overall Study||0
10835472|NCT04411953|12000782|FG000|STARTED|Treatment Period 1 (8 Days)||16
10835473|NCT04411953|12000783|FG001|STARTED|Treatment Period 1 (8 Days)||16
10835474|NCT04411953|12000782|FG000|COMPLETED|Treatment Period 1 (8 Days)||16
10835475|NCT04411953|12000783|FG001|COMPLETED|Treatment Period 1 (8 Days)||16
10835476|NCT04411953|12000782|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10835477|NCT04411953|12000783|FG001|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10835478|NCT04411953|12000782|FG000|STARTED|Washout Period (14 Days)||16
10835479|NCT04411953|12000783|FG001|STARTED|Washout Period (14 Days)||16
10835480|NCT04411953|12000782|FG000|COMPLETED|Washout Period (14 Days)||16
10835481|NCT04411953|12000783|FG001|COMPLETED|Washout Period (14 Days)||15
10835482|NCT04411953|12000782|FG000|NOT COMPLETED|Washout Period (14 Days)||0
10835483|NCT04411953|12000783|FG001|NOT COMPLETED|Washout Period (14 Days)||1
10835484|NCT04411953|12000782|FG000|STARTED|Treatment Period 2 (8 Days)||16
10835485|NCT04411953|12000783|FG001|STARTED|Treatment Period 2 (8 Days)||15
10835486|NCT04411953|12000782|FG000|COMPLETED|Treatment Period 2 (8 Days)||16
10835487|NCT04411953|12000783|FG001|COMPLETED|Treatment Period 2 (8 Days)||15
10835488|NCT04411953|12000782|FG000|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10835489|NCT04411953|12000783|FG001|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10835490|NCT04411940|12000791|FG000|STARTED|Treatment Period 1 (8 Days)||16
10835491|NCT04411940|12000792|FG001|STARTED|Treatment Period 1 (8 Days)||16
10835492|NCT04411940|12000791|FG000|COMPLETED|Treatment Period 1 (8 Days)||16
10835493|NCT04411940|12000792|FG001|COMPLETED|Treatment Period 1 (8 Days)||16
10835494|NCT04411940|12000791|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10835495|NCT04411940|12000792|FG001|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10835496|NCT04411940|12000791|FG000|STARTED|Washout Period (14 Days)||16
10835497|NCT04411940|12000792|FG001|STARTED|Washout Period (14 Days)||16
10835498|NCT04411940|12000791|FG000|COMPLETED|Washout Period (14 Days)||16
10835499|NCT04411940|12000792|FG001|COMPLETED|Washout Period (14 Days)||16
10835500|NCT04411940|12000791|FG000|NOT COMPLETED|Washout Period (14 Days)||0
10835501|NCT04411940|12000792|FG001|NOT COMPLETED|Washout Period (14 Days)||0
10835502|NCT04411940|12000791|FG000|STARTED|Treatment Period 2 (8 Days)||16
10835503|NCT04411940|12000792|FG001|STARTED|Treatment Period 2 (8 Days)||16
10835504|NCT04411940|12000791|FG000|COMPLETED|Treatment Period 2 (8 Days)||16
10835505|NCT04411940|12000792|FG001|COMPLETED|Treatment Period 2 (8 Days)||16
10835506|NCT04411940|12000791|FG000|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10835507|NCT04411940|12000792|FG001|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10835508|NCT04068792|12000800|FG000|STARTED|Overall Study||11
10835509|NCT04068792|12000801|FG001|STARTED|Overall Study||11
10835510|NCT04068792|12000800|FG000|COMPLETED|Overall Study||11
10835511|NCT04068792|12000801|FG001|COMPLETED|Overall Study||11
10835512|NCT04068792|12000800|FG000|NOT COMPLETED|Overall Study||0
10835513|NCT04068792|12000801|FG001|NOT COMPLETED|Overall Study||0
10835514|NCT03960541|12000809|FG000|STARTED|Overall Study||4
10835515|NCT03960541|12000810|FG001|STARTED|Overall Study||4
10835516|NCT03960541|12000809|FG000|COMPLETED|Overall Study||4
10835517|NCT03960541|12000810|FG001|COMPLETED|Overall Study||4
10835518|NCT03960541|12000809|FG000|NOT COMPLETED|Overall Study||0
10835519|NCT03960541|12000810|FG001|NOT COMPLETED|Overall Study||0
10835520|NCT03951077|12000822|FG000|STARTED|Overall Study||27
10835521|NCT03951077|12000823|FG001|STARTED|Overall Study||18
10835522|NCT03951077|12000824|FG002|STARTED|Overall Study||18
10835523|NCT03951077|12000825|FG003|STARTED|Overall Study||18
10835524|NCT03951077|12000826|FG004|STARTED|Overall Study||19
10835525|NCT03951077|12000827|FG005|STARTED|Overall Study||18
10835526|NCT03951077|12000822|FG000|Randomized and Treated|Overall Study||26
10835527|NCT03951077|12000823|FG001|Randomized and Treated|Overall Study||18
10835528|NCT03951077|12000824|FG002|Randomized and Treated|Overall Study||17
10835529|NCT03951077|12000825|FG003|Randomized and Treated|Overall Study||17
10835530|NCT03951077|12000826|FG004|Randomized and Treated|Overall Study||18
10835531|NCT03951077|12000827|FG005|Randomized and Treated|Overall Study||18
10835532|NCT03951077|12000822|FG000|COMPLETED|Overall Study||9
10835533|NCT03951077|12000823|FG001|COMPLETED|Overall Study||4
10835534|NCT03951077|12000824|FG002|COMPLETED|Overall Study||5
10835535|NCT03951077|12000825|FG003|COMPLETED|Overall Study||6
10835536|NCT03951077|12000826|FG004|COMPLETED|Overall Study||3
10835537|NCT03951077|12000827|FG005|COMPLETED|Overall Study||7
10835538|NCT03951077|12000822|FG000|NOT COMPLETED|Overall Study||18
10835539|NCT03951077|12000823|FG001|NOT COMPLETED|Overall Study||14
10835540|NCT03951077|12000824|FG002|NOT COMPLETED|Overall Study||13
10835541|NCT03951077|12000825|FG003|NOT COMPLETED|Overall Study||12
10835542|NCT03951077|12000826|FG004|NOT COMPLETED|Overall Study||16
10835543|NCT03951077|12000827|FG005|NOT COMPLETED|Overall Study||11
10835544|NCT03873246|12000844|FG000|STARTED|Overall Study||41
10835545|NCT03873246|12000845|FG001|STARTED|Overall Study||41
10835546|NCT03873246|12000846|FG002|STARTED|Overall Study||41
10835547|NCT03873246|12000844|FG000|COMPLETED|Overall Study||36
10835548|NCT03873246|12000845|FG001|COMPLETED|Overall Study||29
10835549|NCT03873246|12000846|FG002|COMPLETED|Overall Study||32
10835550|NCT03873246|12000844|FG000|NOT COMPLETED|Overall Study||5
10835551|NCT03873246|12000845|FG001|NOT COMPLETED|Overall Study||12
10835552|NCT03873246|12000846|FG002|NOT COMPLETED|Overall Study||9
10835553|NCT03807349|12000855|FG000|STARTED|Overall Study||12
10835554|NCT03807349|12000855|FG000|COMPLETED|Overall Study||3
10835555|NCT03807349|12000855|FG000|NOT COMPLETED|Overall Study||9
10835556|NCT03769649|12000859|FG000|STARTED|Overall Study||15
10835557|NCT03769649|12000859|FG000|COMPLETED|Overall Study||11
10835558|NCT03769649|12000859|FG000|NOT COMPLETED|Overall Study||4
10835559|NCT03714880|12000865|FG000|STARTED|Overall Study||20
10835560|NCT03714880|12000866|FG001|STARTED|Overall Study||24
10835561|NCT03714880|12000865|FG000|COMPLETED|Overall Study||19
10835562|NCT03714880|12000866|FG001|COMPLETED|Overall Study||22
10835563|NCT03714880|12000865|FG000|NOT COMPLETED|Overall Study||1
10835564|NCT03714880|12000866|FG001|NOT COMPLETED|Overall Study||2
10835565|NCT03645941|12000876|FG000|STARTED|Overall Study||30
10835566|NCT03645941|12000877|FG001|STARTED|Overall Study||31
10835567|NCT03645941|12000876|FG000|COMPLETED|Overall Study||16
10835568|NCT03645941|12000877|FG001|COMPLETED|Overall Study||19
10835569|NCT03645941|12000876|FG000|NOT COMPLETED|Overall Study||14
10835570|NCT03645941|12000877|FG001|NOT COMPLETED|Overall Study||12
10835571|NCT03598088|12000883|FG000|STARTED|Screening/Baseline PCT Visits 1-4||38
10835572|NCT03598088|12000883|FG000|COMPLETED|Screening/Baseline PCT Visits 1-4||38
10835573|NCT03598088|12000883|FG000|NOT COMPLETED|Screening/Baseline PCT Visits 1-4||0
10835574|NCT03598088|12000883|FG000|STARTED|Caya PCT Cycle, Visit 5 & 6||38
10835575|NCT03598088|12000883|FG000|COMPLETED|Caya PCT Cycle, Visit 5 & 6||35
10835576|NCT03598088|12000883|FG000|NOT COMPLETED|Caya PCT Cycle, Visit 5 & 6||3
10835577|NCT03598088|12000883|FG000|STARTED|OVP Safety Cycle Visits 7-11||33
10835578|NCT03598088|12000883|FG000|Used the OVP Device During the Study|OVP Safety Cycle Visits 7-11|Any subject that used the OVP device at least one time during the study.|33
10835579|NCT03598088|12000883|FG000|COMPLETED|OVP Safety Cycle Visits 7-11||28
10835580|NCT03598088|12000883|FG000|NOT COMPLETED|OVP Safety Cycle Visits 7-11||5
10835581|NCT03598088|12000883|FG000|STARTED|OVP PCT Cycle A Visits 12-16||28
10835582|NCT03598088|12000883|FG000|Completed 1 OVP PCT Cycle|OVP PCT Cycle A Visits 12-16|Subjects Completed One PCT Visit|26
10835583|NCT03598088|12000883|FG000|COMPLETED|OVP PCT Cycle A Visits 12-16||24
10835584|NCT03598088|12000883|FG000|NOT COMPLETED|OVP PCT Cycle A Visits 12-16||4
10835585|NCT03598088|12000883|FG000|STARTED|OVP PCT Cycle B Visits 17-21||24
10835586|NCT03598088|12000883|FG000|COMPLETED|OVP PCT Cycle B Visits 17-21||23
10835587|NCT03598088|12000883|FG000|NOT COMPLETED|OVP PCT Cycle B Visits 17-21||1
10835588|NCT03408444|12000924|FG000|STARTED|Overall Study||50
10835589|NCT03408444|12000925|FG001|STARTED|Overall Study||48
10835590|NCT03408444|12000926|FG002|STARTED|Overall Study||50
10835591|NCT03408444|12000927|FG003|STARTED|Overall Study||51
10835592|NCT03408444|12000924|FG000|COMPLETED|Overall Study||49
10835593|NCT03408444|12000925|FG001|COMPLETED|Overall Study||45
10835594|NCT03408444|12000926|FG002|COMPLETED|Overall Study||44
10835595|NCT03408444|12000927|FG003|COMPLETED|Overall Study||47
10835596|NCT03408444|12000924|FG000|NOT COMPLETED|Overall Study||1
10835597|NCT03408444|12000925|FG001|NOT COMPLETED|Overall Study||3
10835598|NCT03408444|12000926|FG002|NOT COMPLETED|Overall Study||6
10835599|NCT03408444|12000927|FG003|NOT COMPLETED|Overall Study||4
10835615|NCT02862548|12000961|FG000|STARTED|Randomized Phase (Up to Week 48)||26
10835616|NCT02862548|12000962|FG001|STARTED|Randomized Phase (Up to Week 48)||25
10835617|NCT02862548|12000961|FG000|COMPLETED|Randomized Phase (Up to Week 48)||26
10835618|NCT02862548|12000962|FG001|COMPLETED|Randomized Phase (Up to Week 48)||24
10835619|NCT02862548|12000961|FG000|NOT COMPLETED|Randomized Phase (Up to Week 48)||0
10835620|NCT02862548|12000962|FG001|NOT COMPLETED|Randomized Phase (Up to Week 48)||1
10835621|NCT02862548|12000961|FG000|STARTED|OLE Phase (Week 49 to Week 192)||26
10835622|NCT02862548|12000962|FG001|STARTED|OLE Phase (Week 49 to Week 192)||24
10835623|NCT02862548|12000961|FG000|COMPLETED|OLE Phase (Week 49 to Week 192)||23
10835624|NCT02862548|12000962|FG001|COMPLETED|OLE Phase (Week 49 to Week 192)||23
10835625|NCT02862548|12000961|FG000|NOT COMPLETED|OLE Phase (Week 49 to Week 192)||3
10835626|NCT02862548|12000962|FG001|NOT COMPLETED|OLE Phase (Week 49 to Week 192)||1
10835627|NCT02377089|12000972|FG000|STARTED|Overall Study||31
10835628|NCT02377089|12000973|FG001|STARTED|Overall Study||29
10835629|NCT02377089|12000972|FG000|COMPLETED|Overall Study||22
10835630|NCT02377089|12000973|FG001|COMPLETED|Overall Study||24
10835631|NCT02377089|12000972|FG000|NOT COMPLETED|Overall Study||9
10835632|NCT02377089|12000973|FG001|NOT COMPLETED|Overall Study||5
10835633|NCT02335099|12000981|FG000|STARTED|Treatment||22
10835634|NCT02335099|12000982|FG001|STARTED|Treatment||22
10835635|NCT02335099|12000981|FG000|COMPLETED|Treatment||17
10835636|NCT02335099|12000982|FG001|COMPLETED|Treatment||17
10835637|NCT02335099|12000981|FG000|NOT COMPLETED|Treatment||5
10835638|NCT02335099|12000982|FG001|NOT COMPLETED|Treatment||5
10835639|NCT02335099|12000981|FG000|STARTED|Follow-up||17
10835640|NCT02335099|12000982|FG001|STARTED|Follow-up||17
10835641|NCT02335099|12000981|FG000|COMPLETED|Follow-up||17
10835642|NCT02335099|12000982|FG001|COMPLETED|Follow-up||16
10835643|NCT02335099|12000981|FG000|NOT COMPLETED|Follow-up||0
10835644|NCT02335099|12000982|FG001|NOT COMPLETED|Follow-up||1
10835645|NCT02330562|12000999|FG000|STARTED|Overall Study||6
10835646|NCT02330562|12001000|FG001|STARTED|Overall Study||3
10835647|NCT02330562|12001001|FG002|STARTED|Overall Study||27
10835648|NCT02330562|12001002|FG003|STARTED|Overall Study||30
10835649|NCT02330562|12001003|FG004|STARTED|Overall Study||31
10835650|NCT02330562|12001004|FG005|STARTED|Overall Study||10
10835651|NCT02330562|12001005|FG006|STARTED|Overall Study||1
10835652|NCT02330562|12001006|FG007|STARTED|Overall Study||1
10835653|NCT02330562|12001007|FG008|STARTED|Overall Study||1
10835654|NCT02330562|12001008|FG009|STARTED|Overall Study||5
10835655|NCT02330562|12001009|FG010|STARTED|Overall Study||6
10835656|NCT02330562|12000999|FG000|COMPLETED|Overall Study||0
10835657|NCT02330562|12001000|FG001|COMPLETED|Overall Study||0
10835658|NCT02330562|12001001|FG002|COMPLETED|Overall Study||0
10835659|NCT02330562|12001002|FG003|COMPLETED|Overall Study||0
10835660|NCT02330562|12001003|FG004|COMPLETED|Overall Study||0
10835661|NCT02330562|12001004|FG005|COMPLETED|Overall Study||0
10835662|NCT02330562|12001005|FG006|COMPLETED|Overall Study||0
10835663|NCT02330562|12001006|FG007|COMPLETED|Overall Study||0
10835664|NCT02330562|12001007|FG008|COMPLETED|Overall Study||0
10835665|NCT02330562|12001008|FG009|COMPLETED|Overall Study||0
10835666|NCT02330562|12001009|FG010|COMPLETED|Overall Study||0
10835667|NCT02330562|12000999|FG000|NOT COMPLETED|Overall Study||6
10835668|NCT02330562|12001000|FG001|NOT COMPLETED|Overall Study||3
10835669|NCT02330562|12001001|FG002|NOT COMPLETED|Overall Study||27
10835670|NCT02330562|12001002|FG003|NOT COMPLETED|Overall Study||30
10835671|NCT02330562|12001003|FG004|NOT COMPLETED|Overall Study||31
10835672|NCT02330562|12001004|FG005|NOT COMPLETED|Overall Study||10
10835673|NCT02330562|12001005|FG006|NOT COMPLETED|Overall Study||1
10835674|NCT02330562|12001006|FG007|NOT COMPLETED|Overall Study||1
10835675|NCT02330562|12001007|FG008|NOT COMPLETED|Overall Study||1
10835676|NCT02330562|12001008|FG009|NOT COMPLETED|Overall Study||5
10835677|NCT02330562|12001009|FG010|NOT COMPLETED|Overall Study||6
10835678|NCT02053363|12001056|FG000|STARTED|Overall Study||25
10835679|NCT02053363|12001057|FG001|STARTED|Overall Study||27
10835680|NCT02053363|12001056|FG000|COMPLETED|Overall Study||25
10835681|NCT02053363|12001057|FG001|COMPLETED|Overall Study||27
10835682|NCT02053363|12001056|FG000|NOT COMPLETED|Overall Study||0
10835683|NCT02053363|12001057|FG001|NOT COMPLETED|Overall Study||0
10835684|NCT02035137|12001066|FG000|STARTED|Overall Study||38
10835685|NCT02035137|12001067|FG001|STARTED|Overall Study||37
10835686|NCT02035137|12001068|FG002|STARTED|Overall Study||39
10835687|NCT02035137|12001066|FG000|COMPLETED|Overall Study||36
10835688|NCT02035137|12001067|FG001|COMPLETED|Overall Study||35
10835689|NCT02035137|12001068|FG002|COMPLETED|Overall Study||34
10835690|NCT02035137|12001066|FG000|NOT COMPLETED|Overall Study||2
10835691|NCT02035137|12001067|FG001|NOT COMPLETED|Overall Study||2
10835692|NCT02035137|12001068|FG002|NOT COMPLETED|Overall Study||5
10835693|NCT01975571|12001079|FG000|STARTED|Overall Study||15
10835694|NCT01975571|12001080|FG001|STARTED|Overall Study||5
10835695|NCT01975571|12001081|FG002|STARTED|Overall Study||0
10835696|NCT01975571|12001079|FG000|COMPLETED|Overall Study||14
10835697|NCT01975571|12001080|FG001|COMPLETED|Overall Study||3
10835698|NCT01975571|12001081|FG002|COMPLETED|Overall Study||0
10835699|NCT01975571|12001079|FG000|NOT COMPLETED|Overall Study||1
10835700|NCT01975571|12001080|FG001|NOT COMPLETED|Overall Study||2
10835701|NCT01975571|12001081|FG002|NOT COMPLETED|Overall Study||0
10835702|NCT01589523|12001089|FG000|STARTED|Overall Study||5
10835703|NCT01589523|12001089|FG000|COMPLETED|Overall Study||4
10835704|NCT01589523|12001089|FG000|NOT COMPLETED|Overall Study||1
10835705|NCT01157091|12001095|FG000|STARTED|Overall Study||28
10835706|NCT01157091|12001095|FG000|COMPLETED|Overall Study||28
10835707|NCT01157091|12001095|FG000|NOT COMPLETED|Overall Study||0
10835708|NCT01100775|12001099|FG000|STARTED|Overall Study||6
10835709|NCT01100775|12001100|FG001|STARTED|Overall Study||6
10835710|NCT01100775|12001099|FG000|COMPLETED|Overall Study||6
10835711|NCT01100775|12001100|FG001|COMPLETED|Overall Study||6
10835712|NCT01100775|12001099|FG000|NOT COMPLETED|Overall Study||0
10835713|NCT01100775|12001100|FG001|NOT COMPLETED|Overall Study||0
10835714|NCT00777036|12001109|FG000|STARTED|On Treatment||29
10835715|NCT00777036|12001110|FG001|STARTED|On Treatment||17
10835716|NCT00777036|12001111|FG002|STARTED|On Treatment||84
10835717|NCT00777036|12001109|FG000|COMPLETED|On Treatment|Completed = Still on treatment|14
10835718|NCT00777036|12001110|FG001|COMPLETED|On Treatment|Completed = Still on treatment|1
10835719|NCT00777036|12001111|FG002|COMPLETED|On Treatment|Completed = Still on treatment|61
10835720|NCT00777036|12001109|FG000|NOT COMPLETED|On Treatment||15
10835721|NCT00777036|12001110|FG001|NOT COMPLETED|On Treatment||16
10835722|NCT00777036|12001111|FG002|NOT COMPLETED|On Treatment||23
10835723|NCT00777036|12001109|FG000|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|14
10835724|NCT00777036|12001110|FG001|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|13
10835725|NCT00777036|12001111|FG002|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|23
10835726|NCT00777036|12001109|FG000|COMPLETED|Follow-Up|Completed = Still in Follow-up|9
10835727|NCT00777036|12001110|FG001|COMPLETED|Follow-Up|Completed = Still in Follow-up|5
10835728|NCT00777036|12001111|FG002|COMPLETED|Follow-Up|Completed = Still in Follow-up|19
10835729|NCT00777036|12001109|FG000|NOT COMPLETED|Follow-Up||5
10835730|NCT00777036|12001110|FG001|NOT COMPLETED|Follow-Up||8
10835731|NCT00777036|12001111|FG002|NOT COMPLETED|Follow-Up||4
10835732|NCT00504712|12001128|FG000|STARTED|Overall Study||11
10835733|NCT00504712|12001129|FG001|STARTED|Overall Study||13
10835734|NCT00504712|12001128|FG000|COMPLETED|Overall Study||11
10835735|NCT00504712|12001129|FG001|COMPLETED|Overall Study||13
10835736|NCT00504712|12001128|FG000|NOT COMPLETED|Overall Study||0
10835737|NCT00504712|12001129|FG001|NOT COMPLETED|Overall Study||0
10835738|NCT05097157|12001135|FG000|STARTED|Overall Study||79
10835739|NCT05097157|12001135|FG000|COMPLETED|Overall Study||56
10835740|NCT05097157|12001135|FG000|NOT COMPLETED|Overall Study||23
10835741|NCT04331795|12001141|FG000|STARTED|Overall Study||12
10835742|NCT04331795|12001142|FG001|STARTED|Overall Study||20
10835743|NCT04331795|12001141|FG000|COMPLETED|Overall Study||12
10835744|NCT04331795|12001142|FG001|COMPLETED|Overall Study||20
10835745|NCT04331795|12001141|FG000|NOT COMPLETED|Overall Study||0
10835746|NCT04331795|12001142|FG001|NOT COMPLETED|Overall Study||0
10835784|NCT03395704|12001195|FG000|STARTED|Overall Study||34
10835785|NCT03395704|12001196|FG001|STARTED|Overall Study||36
10835786|NCT03395704|12001195|FG000|Safety Population|Overall Study||34
10835787|NCT03395704|12001196|FG001|Safety Population|Overall Study||35
10835788|NCT03395704|12001195|FG000|Analysis Population|Overall Study||21
10835789|NCT03395704|12001196|FG001|Analysis Population|Overall Study||28
10835790|NCT03395704|12001195|FG000|COMPLETED|Overall Study||30
10835791|NCT03395704|12001196|FG001|COMPLETED|Overall Study||33
10835792|NCT03395704|12001195|FG000|NOT COMPLETED|Overall Study||4
10835793|NCT03395704|12001196|FG001|NOT COMPLETED|Overall Study||3
10835794|NCT03335813|12001202|FG000|STARTED|Overall Study||7
10835795|NCT03335813|12001202|FG000|COMPLETED|Overall Study||6
10835796|NCT03335813|12001202|FG000|NOT COMPLETED|Overall Study||1
10835797|NCT03246503|12001206|FG000|STARTED|Overall Study||203
10835798|NCT03246503|12001206|FG000|COMPLETED|Overall Study||150
10835799|NCT03246503|12001206|FG000|NOT COMPLETED|Overall Study||53
10835800|NCT03039595|12001210|FG000|STARTED|Overall Study||150
10835801|NCT03039595|12001210|FG000|COMPLETED|Overall Study||143
10835802|NCT03039595|12001210|FG000|NOT COMPLETED|Overall Study||7
10835803|NCT02864368|12001219|FG000|STARTED|Overall Study||4
10835804|NCT02864368|12001220|FG001|STARTED|Overall Study||1
10835805|NCT02864368|12001221|FG002|STARTED|Overall Study||6
10835806|NCT02864368|12001222|FG003|STARTED|Overall Study||8
10835807|NCT02864368|12001223|FG004|STARTED|Overall Study||8
10835808|NCT02864368|12001219|FG000|COMPLETED|Overall Study||4
10835809|NCT02864368|12001220|FG001|COMPLETED|Overall Study||1
10835810|NCT02864368|12001221|FG002|COMPLETED|Overall Study||6
10835811|NCT02864368|12001222|FG003|COMPLETED|Overall Study||8
10835812|NCT02864368|12001223|FG004|COMPLETED|Overall Study||8
10835813|NCT02864368|12001219|FG000|NOT COMPLETED|Overall Study||0
10835814|NCT02864368|12001220|FG001|NOT COMPLETED|Overall Study||0
10835815|NCT02864368|12001221|FG002|NOT COMPLETED|Overall Study||0
10835816|NCT02864368|12001222|FG003|NOT COMPLETED|Overall Study||0
10835817|NCT02864368|12001223|FG004|NOT COMPLETED|Overall Study||0
10835818|NCT02856698|12001242|FG000|STARTED|Overall Study||55
10835819|NCT02856698|12001243|FG001|STARTED|Overall Study||56
10835820|NCT02856698|12001242|FG000|COMPLETED|Overall Study||48
10835821|NCT02856698|12001243|FG001|COMPLETED|Overall Study||46
10835822|NCT02856698|12001242|FG000|NOT COMPLETED|Overall Study||7
10835823|NCT02856698|12001243|FG001|NOT COMPLETED|Overall Study||10
10835824|NCT02625610|12001251|FG000|STARTED|Overall Study||250
10835825|NCT02625610|12001252|FG001|STARTED|Overall Study||249
10835826|NCT02625610|12001251|FG000|Safety-Maintenance Analysis Set|Overall Study||238
10835827|NCT02625610|12001252|FG001|Safety-Maintenance Analysis Set|Overall Study||243
10835828|NCT02625610|12001251|FG000|COMPLETED|Overall Study||250
10835829|NCT02625610|12001252|FG001|COMPLETED|Overall Study||249
10835830|NCT02625610|12001251|FG000|NOT COMPLETED|Overall Study||0
10835831|NCT02625610|12001252|FG001|NOT COMPLETED|Overall Study||0
10835832|NCT02514447|12001267|FG000|STARTED|Overall Study||29
10835833|NCT02514447|12001268|FG001|STARTED|Overall Study||30
10835834|NCT02514447|12001269|FG002|STARTED|Overall Study||32
10835835|NCT02514447|12001270|FG003|STARTED|Overall Study||2
10835836|NCT02514447|12001271|FG004|STARTED|Overall Study||3
10835837|NCT02514447|12001272|FG005|STARTED|Overall Study||4
10835838|NCT02514447|12001273|FG006|STARTED|Overall Study||8
10835839|NCT02514447|12001274|FG007|STARTED|Overall Study||7
10835840|NCT02514447|12001275|FG008|STARTED|Overall Study||8
10835841|NCT02514447|12001267|FG000|COMPLETED|Overall Study||0
10835842|NCT02514447|12001268|FG001|COMPLETED|Overall Study||0
10835843|NCT02514447|12001269|FG002|COMPLETED|Overall Study||0
10835844|NCT02514447|12001270|FG003|COMPLETED|Overall Study||0
10835845|NCT02514447|12001271|FG004|COMPLETED|Overall Study||0
10835846|NCT02514447|12001272|FG005|COMPLETED|Overall Study||0
10835847|NCT02514447|12001273|FG006|COMPLETED|Overall Study||0
10835848|NCT02514447|12001274|FG007|COMPLETED|Overall Study||0
10835849|NCT02514447|12001275|FG008|COMPLETED|Overall Study||0
10835850|NCT02514447|12001267|FG000|NOT COMPLETED|Overall Study||29
10835851|NCT02514447|12001268|FG001|NOT COMPLETED|Overall Study||30
10835852|NCT02514447|12001269|FG002|NOT COMPLETED|Overall Study||32
10835853|NCT02514447|12001270|FG003|NOT COMPLETED|Overall Study||2
10835854|NCT02514447|12001271|FG004|NOT COMPLETED|Overall Study||3
10835855|NCT02514447|12001272|FG005|NOT COMPLETED|Overall Study||4
10835856|NCT02514447|12001273|FG006|NOT COMPLETED|Overall Study||8
10835857|NCT02514447|12001274|FG007|NOT COMPLETED|Overall Study||7
10835858|NCT02514447|12001275|FG008|NOT COMPLETED|Overall Study||8
10835859|NCT02031978|12001315|FG000|STARTED|Overall Study||4367
10835860|NCT02031978|12001315|FG000|COMPLETED|Overall Study||4367
10835861|NCT02031978|12001315|FG000|NOT COMPLETED|Overall Study||0
10835862|NCT01785563|12001319|FG000|STARTED|Overall Study||40
10835863|NCT01785563|12001319|FG000|COMPLETED|Overall Study||27
10835864|NCT01785563|12001319|FG000|NOT COMPLETED|Overall Study||13
10835865|NCT01732120|12001325|FG000|STARTED|Overall Study||40
10835866|NCT01732120|12001326|FG001|STARTED|Overall Study||40
10835867|NCT01732120|12001325|FG000|COMPLETED|Overall Study||40
10835747|NCT04175730|12001150|FG000|STARTED|Overall Study||27
10835748|NCT04175730|12001151|FG001|STARTED|Overall Study||21
10835749|NCT04175730|12001150|FG000|COMPLETED|Overall Study||27
10835750|NCT04175730|12001151|FG001|COMPLETED|Overall Study||21
10835751|NCT04175730|12001150|FG000|NOT COMPLETED|Overall Study||0
10835752|NCT04175730|12001151|FG001|NOT COMPLETED|Overall Study||0
10835759|NCT03703102|12001172|FG000|STARTED|Overall Study||54
10835760|NCT03703102|12001173|FG001|STARTED|Overall Study||53
10835761|NCT03703102|12001174|FG002|STARTED|Overall Study||55
10835762|NCT03703102|12001175|FG003|STARTED|Overall Study||54
10835763|NCT03703102|12001176|FG004|STARTED|Overall Study||57
10835764|NCT03703102|12001172|FG000|Completed Treatment Period A|Overall Study||42
10835765|NCT03703102|12001173|FG001|Completed Treatment Period A|Overall Study||41
10835766|NCT03703102|12001174|FG002|Completed Treatment Period A|Overall Study||42
10835767|NCT03703102|12001175|FG003|Completed Treatment Period A|Overall Study||46
10835768|NCT03703102|12001176|FG004|Completed Treatment Period A|Overall Study||34
10835769|NCT03703102|12001172|FG000|Completed Treatment Period B|Overall Study||33
10835770|NCT03703102|12001173|FG001|Completed Treatment Period B|Overall Study||39
10835771|NCT03703102|12001174|FG002|Completed Treatment Period B|Overall Study||37
10835772|NCT03703102|12001175|FG003|Completed Treatment Period B|Overall Study||38
10835773|NCT03703102|12001176|FG004|Completed Treatment Period B|Overall Study||26
10835774|NCT03703102|12001172|FG000|COMPLETED|Overall Study||32
10835775|NCT03703102|12001173|FG001|COMPLETED|Overall Study||38
10835776|NCT03703102|12001174|FG002|COMPLETED|Overall Study||33
10835777|NCT03703102|12001175|FG003|COMPLETED|Overall Study||37
10291753|NCT03713281|11424772|FG000|COMPLETED|Overall Study||25
10291754|NCT03713281|11424772|FG000|NOT COMPLETED|Overall Study||3
10291755|NCT03608254|11424776|FG000|STARTED|Overall Study||11
10291756|NCT03608254|11424776|FG000|COMPLETED|Overall Study||8
10291757|NCT03608254|11424776|FG000|NOT COMPLETED|Overall Study||3
10291758|NCT03512275|11424782|FG000|STARTED|Overall Study||24
10291759|NCT03512275|11424783|FG001|STARTED|Overall Study||18
10291760|NCT03512275|11424782|FG000|COMPLETED|Overall Study||22
10291761|NCT03512275|11424783|FG001|COMPLETED|Overall Study||11
10291762|NCT03512275|11424782|FG000|NOT COMPLETED|Overall Study||2
10291763|NCT03512275|11424783|FG001|NOT COMPLETED|Overall Study||7
10291764|NCT03414983|11424791|FG000|STARTED|Pre-Treatment||127
10291765|NCT03414983|11424792|FG001|STARTED|Pre-Treatment||68
10291766|NCT03414983|11424791|FG000|COMPLETED|Pre-Treatment||123
10291767|NCT03414983|11424792|FG001|COMPLETED|Pre-Treatment||62
10291768|NCT03414983|11424791|FG000|NOT COMPLETED|Pre-Treatment||4
10291769|NCT03414983|11424792|FG001|NOT COMPLETED|Pre-Treatment||6
10291770|NCT03414983|11424791|FG000|STARTED|Treatment||123
10291771|NCT03414983|11424792|FG001|STARTED|Treatment||62
10291772|NCT03414983|11424791|FG000|COMPLETED|Treatment||4
10291773|NCT03414983|11424792|FG001|COMPLETED|Treatment||2
10291774|NCT03414983|11424791|FG000|NOT COMPLETED|Treatment||119
10291775|NCT03414983|11424792|FG001|NOT COMPLETED|Treatment||60
10291776|NCT03383692|11424800|FG000|STARTED|Overall Study||17
10291777|NCT03383692|11424801|FG001|STARTED|Overall Study||23
10291778|NCT03383692|11424800|FG000|COMPLETED|Overall Study||11
10291779|NCT03383692|11424801|FG001|COMPLETED|Overall Study||19
10291780|NCT03383692|11424800|FG000|NOT COMPLETED|Overall Study||6
10291781|NCT03383692|11424801|FG001|NOT COMPLETED|Overall Study||4
10291782|NCT03371251|11424815|FG000|STARTED|Overall Study||7
10291783|NCT03371251|11424816|FG001|STARTED|Overall Study||5
10835778|NCT03703102|12001176|FG004|COMPLETED|Overall Study||24
10835779|NCT03703102|12001172|FG000|NOT COMPLETED|Overall Study||22
10835780|NCT03703102|12001173|FG001|NOT COMPLETED|Overall Study||15
10835781|NCT03703102|12001174|FG002|NOT COMPLETED|Overall Study||22
10835782|NCT03703102|12001175|FG003|NOT COMPLETED|Overall Study||17
10835783|NCT03703102|12001176|FG004|NOT COMPLETED|Overall Study||33
10835868|NCT01732120|12001326|FG001|COMPLETED|Overall Study||40
10835869|NCT01732120|12001325|FG000|NOT COMPLETED|Overall Study||0
10835870|NCT01732120|12001326|FG001|NOT COMPLETED|Overall Study||0
10835871|NCT01434290|12001334|FG000|STARTED|Overall Study||127
10291784|NCT03371251|11424817|FG002|STARTED|Overall Study||9
10291785|NCT03371251|11424818|FG003|STARTED|Overall Study||9
10291786|NCT03371251|11424819|FG004|STARTED|Overall Study||37
10291787|NCT03371251|11424820|FG005|STARTED|Overall Study||76
10291788|NCT03371251|11424815|FG000|COMPLETED|Overall Study||5
10291789|NCT03371251|11424816|FG001|COMPLETED|Overall Study||5
10291790|NCT03371251|11424817|FG002|COMPLETED|Overall Study||8
10291791|NCT03371251|11424818|FG003|COMPLETED|Overall Study||9
10291792|NCT03371251|11424819|FG004|COMPLETED|Overall Study||30
10291793|NCT03371251|11424820|FG005|COMPLETED|Overall Study||71
10835872|NCT01434290|12001335|FG001|STARTED|Overall Study||128
10835873|NCT01434290|12001334|FG000|COMPLETED|Overall Study|Eligible subjects included in analysis|119
10835874|NCT01434290|12001335|FG001|COMPLETED|Overall Study|Eligible subjects included in analysis|121
10835875|NCT01434290|12001334|FG000|NOT COMPLETED|Overall Study||8
10835876|NCT01434290|12001335|FG001|NOT COMPLETED|Overall Study||7
10835877|NCT01062399|12001347|FG000|STARTED|Overall Study||8
10835878|NCT01062399|12001348|FG001|STARTED|Overall Study||10
10835879|NCT01062399|12001349|FG002|STARTED|Overall Study||8
10835880|NCT01062399|12001350|FG003|STARTED|Overall Study||89
10835881|NCT01062399|12001351|FG004|STARTED|Overall Study||92
10835882|NCT01062399|12001347|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analyses are considered to have completed the study.|8
10835883|NCT01062399|12001348|FG001|COMPLETED|Overall Study||9
10835884|NCT01062399|12001349|FG002|COMPLETED|Overall Study||8
10835885|NCT01062399|12001350|FG003|COMPLETED|Overall Study||83
10291794|NCT03371251|11424815|FG000|NOT COMPLETED|Overall Study||2
10291795|NCT03371251|11424816|FG001|NOT COMPLETED|Overall Study||0
10291796|NCT03371251|11424817|FG002|NOT COMPLETED|Overall Study||1
10291797|NCT03371251|11424818|FG003|NOT COMPLETED|Overall Study||0
10291798|NCT03371251|11424819|FG004|NOT COMPLETED|Overall Study||7
10291799|NCT03371251|11424820|FG005|NOT COMPLETED|Overall Study||5
10291800|NCT03349268|11424840|FG000|STARTED|Overall Study||9117
10291801|NCT03349268|11424841|FG001|STARTED|Overall Study||10296
10291802|NCT03349268|11424842|FG002|STARTED|Overall Study||6319
10291803|NCT03349268|11424840|FG000|COMPLETED|Overall Study||9117
10291804|NCT03349268|11424841|FG001|COMPLETED|Overall Study||10296
10291805|NCT03349268|11424842|FG002|COMPLETED|Overall Study||6319
10291806|NCT03349268|11424840|FG000|NOT COMPLETED|Overall Study||0
10291807|NCT03349268|11424841|FG001|NOT COMPLETED|Overall Study||0
10291808|NCT03349268|11424842|FG002|NOT COMPLETED|Overall Study||0
10754292|NCT03050801|11918019|FG005|STARTED|Experiment 2|Experiment 2 (Prefrontal Cortex Stimulation) was terminated early due to adverse events (intolerance of stimulation) in 2 of 4 participants.|4
10754293|NCT03050801|11918014|FG000|COMPLETED|Experiment 2||0
10754294|NCT03050801|11918015|FG001|COMPLETED|Experiment 2||0
10754295|NCT03050801|11918016|FG002|COMPLETED|Experiment 2||0
10754296|NCT03050801|11918017|FG003|COMPLETED|Experiment 2||15
10754297|NCT03050801|11918018|FG004|COMPLETED|Experiment 2||15
10754298|NCT03050801|11918019|FG005|COMPLETED|Experiment 2||2
10754299|NCT03050801|11918014|FG000|NOT COMPLETED|Experiment 2||0
10754300|NCT03050801|11918015|FG001|NOT COMPLETED|Experiment 2||0
10754301|NCT03050801|11918016|FG002|NOT COMPLETED|Experiment 2||0
10754302|NCT03050801|11918017|FG003|NOT COMPLETED|Experiment 2||6
10754303|NCT03050801|11918018|FG004|NOT COMPLETED|Experiment 2||4
10754304|NCT03050801|11918019|FG005|NOT COMPLETED|Experiment 2||2
10754305|NCT03050918|11918038|FG000|STARTED|Overall Study||1534
10754306|NCT03050918|11918039|FG001|STARTED|Overall Study||1520
10754307|NCT03050918|11918038|FG000|COMPLETED|Overall Study||1534
10754308|NCT03050918|11918039|FG001|COMPLETED|Overall Study||1520
10754309|NCT03050918|11918038|FG000|NOT COMPLETED|Overall Study||0
10754310|NCT03050918|11918039|FG001|NOT COMPLETED|Overall Study||0
10754311|NCT03051100|11918047|FG000|STARTED|Overall Study||20
10754312|NCT03051100|11918048|FG001|STARTED|Overall Study||43
10754313|NCT03051100|11918047|FG000|COMPLETED|Overall Study||19
10754314|NCT03051100|11918048|FG001|COMPLETED|Overall Study||43
10754315|NCT03051100|11918047|FG000|NOT COMPLETED|Overall Study||1
10754316|NCT03051100|11918048|FG001|NOT COMPLETED|Overall Study||0
10754317|NCT03051165|11918054|FG000|STARTED|Overall Study||13
10754318|NCT03051165|11918054|FG000|Completed Some Baseline Assessments|Overall Study||1
10754319|NCT03051165|11918054|FG000|Completed Some Day 105 Assessments|Overall Study||1
10754320|NCT03051165|11918054|FG000|Began HGNS Treatment Withdrawal|Overall Study||0
10754321|NCT03051165|11918054|FG000|Completed Some Day 137 Assessments|Overall Study||0
10754322|NCT03051165|11918054|FG000|COMPLETED|Overall Study||0
10835886|NCT01062399|12001351|FG004|COMPLETED|Overall Study||88
10835887|NCT01062399|12001347|FG000|NOT COMPLETED|Overall Study||0
10409323|NCT00758524|11553193|FG014|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
10409324|NCT00758524|11553194|FG015|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
10409325|NCT00758524|11553195|FG016|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
10409326|NCT00758550|11553235|FG000|STARTED|Overall Study||30
10409327|NCT00758550|11553236|FG001|STARTED|Overall Study||30
10409328|NCT00758550|11553235|FG000|COMPLETED|Overall Study||30
10409329|NCT00758550|11553236|FG001|COMPLETED|Overall Study||30
10409330|NCT00758550|11553235|FG000|NOT COMPLETED|Overall Study||0
10409331|NCT00758550|11553236|FG001|NOT COMPLETED|Overall Study||0
10409332|NCT00758576|11553242|FG000|STARTED|Overall Study||64
10409333|NCT00758576|11553242|FG000|COMPLETED|Overall Study||63
10409334|NCT00758576|11553242|FG000|NOT COMPLETED|Overall Study||1
10544998|NCT01493596|11698219|FG003|STARTED|Overall Study||8
10754323|NCT03051165|11918054|FG000|NOT COMPLETED|Overall Study||13
10754324|NCT03051256|11918061|FG000|STARTED|Overall Study||19
10754325|NCT03051256|11918062|FG001|STARTED|Overall Study||21
10409335|NCT00758589|11553250|FG000|STARTED|Overall Study||95
10409336|NCT00758589|11553251|FG001|STARTED|Overall Study||90
10835888|NCT01062399|12001348|FG001|NOT COMPLETED|Overall Study||1
10835889|NCT01062399|12001349|FG002|NOT COMPLETED|Overall Study||0
10835890|NCT01062399|12001350|FG003|NOT COMPLETED|Overall Study||6
10835891|NCT01062399|12001351|FG004|NOT COMPLETED|Overall Study||4
10835892|NCT00750269|12001368|FG000|STARTED|Overall Study||8
10835893|NCT00750269|12001369|FG001|STARTED|Overall Study||8
10835894|NCT00750269|12001370|FG002|STARTED|Overall Study||18
10835895|NCT00750269|12001371|FG003|STARTED|Overall Study||43
10409337|NCT00758589|11553252|FG002|STARTED|Overall Study||92
10409338|NCT00758589|11553253|FG003|STARTED|Overall Study||91
10409339|NCT00758589|11553250|FG000|COMPLETED|Overall Study||92
10409340|NCT00758589|11553251|FG001|COMPLETED|Overall Study||87
10409341|NCT00758589|11553252|FG002|COMPLETED|Overall Study||86
10409342|NCT00758589|11553253|FG003|COMPLETED|Overall Study||85
10409343|NCT00758589|11553250|FG000|NOT COMPLETED|Overall Study||3
10409344|NCT00758589|11553251|FG001|NOT COMPLETED|Overall Study||3
10409345|NCT00758589|11553252|FG002|NOT COMPLETED|Overall Study||6
10409346|NCT00758589|11553253|FG003|NOT COMPLETED|Overall Study||6
10409347|NCT00758602|11553265|FG000|STARTED|Overall Study||104
10409348|NCT00758602|11553266|FG001|STARTED|Overall Study||106
10409349|NCT00758602|11553265|FG000|COMPLETED|Overall Study||85
10409350|NCT00758602|11553266|FG001|COMPLETED|Overall Study||84
10409351|NCT00758602|11553265|FG000|NOT COMPLETED|Overall Study||19
10409352|NCT00758602|11553266|FG001|NOT COMPLETED|Overall Study||22
10409353|NCT00758667|11553275|FG000|STARTED|Overall Study||9
10409354|NCT00758667|11553276|FG001|STARTED|Overall Study||11
10409355|NCT00758667|11553275|FG000|COMPLETED|Overall Study||9
10409356|NCT00758667|11553276|FG001|COMPLETED|Overall Study||11
10409357|NCT00758667|11553275|FG000|NOT COMPLETED|Overall Study||0
10409358|NCT00758667|11553276|FG001|NOT COMPLETED|Overall Study||0
10409359|NCT00758680|11553283|FG000|STARTED|Overall Study||6
10409360|NCT00758680|11553284|FG001|STARTED|Overall Study||6
10409361|NCT00758680|11553285|FG002|STARTED|Overall Study||6
10409362|NCT00758680|11553286|FG003|STARTED|Overall Study||6
10409363|NCT00758680|11553287|FG004|STARTED|Overall Study||6
10409364|NCT00758680|11553288|FG005|STARTED|Overall Study||6
10409365|NCT00758680|11553289|FG006|STARTED|Overall Study||7
10409366|NCT00758680|11553290|FG007|STARTED|Overall Study||20
10409367|NCT00758680|11553291|FG008|STARTED|Overall Study||20
10409368|NCT00758680|11553292|FG009|STARTED|Overall Study||29
10409369|NCT00758680|11553283|FG000|COMPLETED|Overall Study||6
10409370|NCT00758680|11553284|FG001|COMPLETED|Overall Study||6
10409371|NCT00758680|11553285|FG002|COMPLETED|Overall Study||6
10409372|NCT00758680|11553286|FG003|COMPLETED|Overall Study||6
10409373|NCT00758680|11553287|FG004|COMPLETED|Overall Study||6
10409374|NCT00758680|11553288|FG005|COMPLETED|Overall Study||6
10409375|NCT00758680|11553289|FG006|COMPLETED|Overall Study||6
10409376|NCT00758680|11553290|FG007|COMPLETED|Overall Study||19
10409377|NCT00758680|11553291|FG008|COMPLETED|Overall Study||18
10409378|NCT00758680|11553292|FG009|COMPLETED|Overall Study||28
10409379|NCT00758680|11553283|FG000|NOT COMPLETED|Overall Study||0
10409380|NCT00758680|11553284|FG001|NOT COMPLETED|Overall Study||0
10409381|NCT00758680|11553285|FG002|NOT COMPLETED|Overall Study||0
10409382|NCT00758680|11553286|FG003|NOT COMPLETED|Overall Study||0
10409383|NCT00758680|11553287|FG004|NOT COMPLETED|Overall Study||0
10409384|NCT00758680|11553288|FG005|NOT COMPLETED|Overall Study||0
10409385|NCT00758680|11553289|FG006|NOT COMPLETED|Overall Study||1
10409386|NCT00758680|11553290|FG007|NOT COMPLETED|Overall Study||1
10409387|NCT00758680|11553291|FG008|NOT COMPLETED|Overall Study||2
10409388|NCT00758680|11553292|FG009|NOT COMPLETED|Overall Study||1
10835896|NCT00750269|12001372|FG004|STARTED|Overall Study||43
10409389|NCT00758706|11553317|FG000|STARTED|Overall Study||26
10409390|NCT00758706|11553318|FG001|STARTED|Overall Study||29
10409391|NCT00758706|11553317|FG000|COMPLETED|Overall Study||22
10409392|NCT00758706|11553318|FG001|COMPLETED|Overall Study||25
10409393|NCT00758706|11553317|FG000|NOT COMPLETED|Overall Study||4
10409394|NCT00758706|11553318|FG001|NOT COMPLETED|Overall Study||4
10409395|NCT00758745|11553326|FG000|STARTED|Overall Study||81
10409396|NCT00758745|11553327|FG001|STARTED|Overall Study||81
10409397|NCT00758745|11553326|FG000|COMPLETED|Overall Study||60
10409398|NCT00758745|11553327|FG001|COMPLETED|Overall Study||60
10409399|NCT00758745|11553326|FG000|NOT COMPLETED|Overall Study||21
10409400|NCT00758745|11553327|FG001|NOT COMPLETED|Overall Study||21
10409401|NCT00758758|11553341|FG000|STARTED|Overall Study||14
10409402|NCT00758758|11553342|FG001|STARTED|Overall Study||74
10409403|NCT00758758|11553343|FG002|STARTED|Overall Study||53
10409404|NCT00758758|11553344|FG003|STARTED|Overall Study||6
10409405|NCT00758758|11553345|FG004|STARTED|Overall Study||3
10835897|NCT00750269|12001368|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study|8
10835898|NCT00750269|12001369|FG001|COMPLETED|Overall Study||7
10835899|NCT00750269|12001370|FG002|COMPLETED|Overall Study||14
10835900|NCT00750269|12001371|FG003|COMPLETED|Overall Study||38
10835901|NCT00750269|12001372|FG004|COMPLETED|Overall Study||33
10835902|NCT00750269|12001368|FG000|NOT COMPLETED|Overall Study||0
10835903|NCT00750269|12001369|FG001|NOT COMPLETED|Overall Study||1
10835904|NCT00750269|12001370|FG002|NOT COMPLETED|Overall Study||4
10835905|NCT00750269|12001371|FG003|NOT COMPLETED|Overall Study||5
10835906|NCT00750269|12001372|FG004|NOT COMPLETED|Overall Study||10
10835907|NCT00712322|12001394|FG000|STARTED|Overall Study||12
10835908|NCT00712322|12001395|FG001|STARTED|Overall Study||14
10835909|NCT00712322|12001396|FG002|STARTED|Overall Study||9
10835910|NCT00712322|12001394|FG000|COMPLETED|Overall Study||12
10835911|NCT00712322|12001395|FG001|COMPLETED|Overall Study||13
10835912|NCT00712322|12001396|FG002|COMPLETED|Overall Study||9
10835913|NCT00712322|12001394|FG000|NOT COMPLETED|Overall Study||0
10835914|NCT00712322|12001395|FG001|NOT COMPLETED|Overall Study||1
10835915|NCT00712322|12001396|FG002|NOT COMPLETED|Overall Study||0
10835916|NCT00323856|12001404|FG000|STARTED|Overall Study||50
10835917|NCT00323856|12001404|FG000|COMPLETED|Overall Study||45
10835918|NCT00323856|12001404|FG000|NOT COMPLETED|Overall Study||5
10835919|NCT00103038|12001408|FG000|STARTED|Overall Study||155
10835920|NCT00103038|12001408|FG000|COMPLETED|Overall Study||142
10835921|NCT00103038|12001408|FG000|NOT COMPLETED|Overall Study||13
10835922|NCT05086835|12001415|FG000|STARTED|Overall Study||10
10835923|NCT05086835|12001415|FG000|COMPLETED|Overall Study||10
10835924|NCT05086835|12001415|FG000|NOT COMPLETED|Overall Study||0
10835925|NCT04524663|12001424|FG000|STARTED|Overall Study||25
10835926|NCT04524663|12001425|FG001|STARTED|Overall Study||24
10835927|NCT04524663|12001424|FG000|COMPLETED|Overall Study||25
10835928|NCT04524663|12001425|FG001|COMPLETED|Overall Study||22
10835929|NCT04524663|12001424|FG000|NOT COMPLETED|Overall Study||0
10835930|NCT04524663|12001425|FG001|NOT COMPLETED|Overall Study||2
10835972|NCT03738423|12001481|FG000|STARTED|Overall Study||25
10835973|NCT03738423|12001482|FG001|STARTED|Overall Study||26
10835974|NCT03738423|12001483|FG002|STARTED|Overall Study||27
10835975|NCT03738423|12001484|FG003|STARTED|Overall Study||25
10835976|NCT03738423|12001485|FG004|STARTED|Overall Study||26
10835977|NCT03738423|12001481|FG000|Treated|Overall Study||25
10835978|NCT03738423|12001482|FG001|Treated|Overall Study||26
10835979|NCT03738423|12001483|FG002|Treated|Overall Study||26
10835980|NCT03738423|12001484|FG003|Treated|Overall Study||24
10835981|NCT03738423|12001485|FG004|Treated|Overall Study||26
10835982|NCT03738423|12001481|FG000|COMPLETED|Overall Study||11
10835983|NCT03738423|12001482|FG001|COMPLETED|Overall Study||13
10835984|NCT03738423|12001483|FG002|COMPLETED|Overall Study||14
10835985|NCT03738423|12001484|FG003|COMPLETED|Overall Study||10
10835986|NCT03738423|12001485|FG004|COMPLETED|Overall Study||11
10835987|NCT03738423|12001481|FG000|NOT COMPLETED|Overall Study||14
10835988|NCT03738423|12001482|FG001|NOT COMPLETED|Overall Study||13
10835989|NCT03738423|12001483|FG002|NOT COMPLETED|Overall Study||13
10835990|NCT03738423|12001484|FG003|NOT COMPLETED|Overall Study||15
10835991|NCT03738423|12001485|FG004|NOT COMPLETED|Overall Study||15
10835992|NCT03600818|12001499|FG000|STARTED|Overall Study||58
10835993|NCT03600818|12001500|FG001|STARTED|Overall Study||60
10835994|NCT03600818|12001499|FG000|Safety Population|Overall Study||58
10835995|NCT03600818|12001500|FG001|Safety Population|Overall Study||59
10835996|NCT03600818|12001499|FG000|COMPLETED|Overall Study||36
10835997|NCT03600818|12001500|FG001|COMPLETED|Overall Study||42
10409406|NCT00758758|11553346|FG005|STARTED|Overall Study||50
10409407|NCT00758758|11553347|FG006|STARTED|Overall Study||31
10409408|NCT00758758|11553348|FG007|STARTED|Overall Study||0
10409409|NCT00758758|11553341|FG000|COMPLETED|Overall Study||11
10409410|NCT00758758|11553342|FG001|COMPLETED|Overall Study||49
10409411|NCT00758758|11553343|FG002|COMPLETED|Overall Study||35
10409412|NCT00758758|11553344|FG003|COMPLETED|Overall Study||4
10409413|NCT00758758|11553345|FG004|COMPLETED|Overall Study||1
10409414|NCT00758758|11553346|FG005|COMPLETED|Overall Study||36
10409415|NCT00758758|11553347|FG006|COMPLETED|Overall Study||17
10409416|NCT00758758|11553348|FG007|COMPLETED|Overall Study||0
10409417|NCT00758758|11553341|FG000|NOT COMPLETED|Overall Study||3
10409418|NCT00758758|11553342|FG001|NOT COMPLETED|Overall Study||25
10409419|NCT00758758|11553343|FG002|NOT COMPLETED|Overall Study||18
10409420|NCT00758758|11553344|FG003|NOT COMPLETED|Overall Study||2
10409421|NCT00758758|11553345|FG004|NOT COMPLETED|Overall Study||2
10409422|NCT00758758|11553346|FG005|NOT COMPLETED|Overall Study||14
10409423|NCT00758758|11553347|FG006|NOT COMPLETED|Overall Study||14
10409424|NCT00758758|11553348|FG007|NOT COMPLETED|Overall Study||0
10409425|NCT00758771|11553376|FG000|STARTED|Overall Study||18
10409426|NCT00758771|11553377|FG001|STARTED|Overall Study||20
10409427|NCT00758771|11553376|FG000|COMPLETED|Overall Study||15
10409428|NCT00758771|11553377|FG001|COMPLETED|Overall Study||15
10409429|NCT00758771|11553376|FG000|NOT COMPLETED|Overall Study||3
10409430|NCT00758771|11553377|FG001|NOT COMPLETED|Overall Study||5
10409431|NCT00758784|11553383|FG000|STARTED|Overall Study||38
10409432|NCT00758784|11553383|FG000|COMPLETED|Overall Study||36
10409433|NCT00758784|11553383|FG000|NOT COMPLETED|Overall Study||2
10409434|NCT00758836|11553391|FG000|STARTED|Overall Study||171
10835998|NCT03600818|12001499|FG000|NOT COMPLETED|Overall Study||22
10835999|NCT03600818|12001500|FG001|NOT COMPLETED|Overall Study||18
10836000|NCT03578276|12001509|FG000|STARTED|Overall Study||35
10836001|NCT03578276|12001510|FG001|STARTED|Overall Study||35
10836002|NCT03578276|12001509|FG000|COMPLETED|Overall Study||33
10836003|NCT03578276|12001510|FG001|COMPLETED|Overall Study||33
10836004|NCT03578276|12001509|FG000|NOT COMPLETED|Overall Study||2
10836005|NCT03578276|12001510|FG001|NOT COMPLETED|Overall Study||2
10836006|NCT03257696|12001518|FG000|STARTED|Overall Study||123
10836007|NCT03257696|12001519|FG001|STARTED|Overall Study||29
10836008|NCT03257696|12001518|FG000|COMPLETED|Overall Study||123
10836009|NCT03257696|12001519|FG001|COMPLETED|Overall Study||29
10836010|NCT03257696|12001518|FG000|NOT COMPLETED|Overall Study||0
10836011|NCT03257696|12001519|FG001|NOT COMPLETED|Overall Study||0
10836012|NCT03035409|12001525|FG000|STARTED|Overall Study||45
10835931|NCT04435795|12001433|FG000|STARTED|Overall Study||108
10835932|NCT04435795|12001434|FG001|STARTED|Overall Study||107
10835933|NCT04435795|12001433|FG000|COMPLETED|Overall Study||105
10835934|NCT04435795|12001434|FG001|COMPLETED|Overall Study||98
10835935|NCT04435795|12001433|FG000|NOT COMPLETED|Overall Study||3
10835936|NCT04435795|12001434|FG001|NOT COMPLETED|Overall Study||9
10835937|NCT04350593|12001442|FG000|STARTED|Overall Study||625
10835938|NCT04350593|12001443|FG001|STARTED|Overall Study||625
10835939|NCT04350593|12001442|FG000|COMPLETED|Overall Study||617
10835940|NCT04350593|12001443|FG001|COMPLETED|Overall Study||620
10835941|NCT04350593|12001442|FG000|NOT COMPLETED|Overall Study||8
10835942|NCT04350593|12001443|FG001|NOT COMPLETED|Overall Study||5
10835943|NCT04208243|12001449|FG000|STARTED|Overall Study||83
10835944|NCT04208243|12001449|FG000|COMPLETED|Overall Study||83
10835945|NCT04208243|12001449|FG000|NOT COMPLETED|Overall Study||0
10836013|NCT03035409|12001525|FG000|Day 15|Overall Study||28
10836014|NCT03035409|12001525|FG000|Day 29|Overall Study||28
10836015|NCT03035409|12001525|FG000|Day 43|Overall Study||28
10836016|NCT03035409|12001525|FG000|COMPLETED|Overall Study||28
10836017|NCT03035409|12001525|FG000|NOT COMPLETED|Overall Study||17
10836018|NCT02971761|12001529|FG000|STARTED|Overall Study||18
10836019|NCT02971761|12001529|FG000|COMPLETED|Overall Study||16
10836020|NCT02971761|12001529|FG000|NOT COMPLETED|Overall Study||2
10836021|NCT02900560|12001537|FG000|STARTED|Overall Study||9
10836022|NCT02900560|12001538|FG001|STARTED|Overall Study||10
10836023|NCT02900560|12001539|FG002|STARTED|Overall Study||7
10836024|NCT02900560|12001540|FG003|STARTED|Overall Study||8
10836025|NCT02900560|12001537|FG000|COMPLETED|Overall Study||7
10836026|NCT02900560|12001538|FG001|COMPLETED|Overall Study||10
10836027|NCT02900560|12001539|FG002|COMPLETED|Overall Study||7
10836028|NCT02900560|12001540|FG003|COMPLETED|Overall Study||8
10836029|NCT02900560|12001537|FG000|NOT COMPLETED|Overall Study||2
10836030|NCT02900560|12001538|FG001|NOT COMPLETED|Overall Study||0
10836031|NCT02900560|12001539|FG002|NOT COMPLETED|Overall Study||0
10836032|NCT02900560|12001540|FG003|NOT COMPLETED|Overall Study||0
10836055|NCT01968213|12001570|FG000|STARTED|Overall Study||375
10836056|NCT01968213|12001571|FG001|STARTED|Overall Study||189
10836057|NCT01968213|12001570|FG000|COMPLETED|Overall Study||285
10836058|NCT01968213|12001571|FG001|COMPLETED|Overall Study||180
10836059|NCT01968213|12001570|FG000|NOT COMPLETED|Overall Study||90
10836060|NCT01968213|12001571|FG001|NOT COMPLETED|Overall Study||9
10836069|NCT01656486|12001589|FG000|STARTED|Overall Study||1
10836070|NCT01656486|12001589|FG000|COMPLETED|Overall Study||1
10836071|NCT01656486|12001589|FG000|NOT COMPLETED|Overall Study||0
10836072|NCT01627574|12001595|FG000|STARTED|Overall Study||142
10836073|NCT01627574|12001596|FG001|STARTED|Overall Study||130
10836074|NCT01627574|12001595|FG000|COMPLETED|Overall Study||121
10836075|NCT01627574|12001596|FG001|COMPLETED|Overall Study||112
10836076|NCT01627574|12001595|FG000|NOT COMPLETED|Overall Study||21
10836077|NCT01627574|12001596|FG001|NOT COMPLETED|Overall Study||18
10836078|NCT01498458|12001602|FG000|STARTED|Overall Study|9 patients took part in the study of which 8 received pazopanib.|8
10836079|NCT01498458|12001602|FG000|COMPLETED|Overall Study|only 1 patient was in the study at the end. 7 left due to Adverse Events or Investigators Decision.|1
10836080|NCT01498458|12001602|FG000|NOT COMPLETED|Overall Study||7
10836081|NCT01427712|12001611|FG000|STARTED|Overall Study||24
10836082|NCT01427712|12001611|FG000|Collected CRFs|Overall Study||21
10836083|NCT01427712|12001611|FG000|Safety Analysis Set|Overall Study||21
10836084|NCT01427712|12001611|FG000|COMPLETED|Overall Study||17
10836085|NCT01427712|12001611|FG000|NOT COMPLETED|Overall Study||7
10836086|NCT01369147|12001618|FG000|STARTED|Overall Study||3
10836087|NCT01369147|12001619|FG001|STARTED|Overall Study||5
10836088|NCT01369147|12001620|FG002|STARTED|Overall Study||4
10836089|NCT01369147|12001618|FG000|COMPLETED|Overall Study||3
10836090|NCT01369147|12001619|FG001|COMPLETED|Overall Study||4
10836091|NCT01369147|12001620|FG002|COMPLETED|Overall Study||4
10836092|NCT01369147|12001618|FG000|NOT COMPLETED|Overall Study||0
10836093|NCT01369147|12001619|FG001|NOT COMPLETED|Overall Study||1
10836094|NCT01369147|12001620|FG002|NOT COMPLETED|Overall Study||0
10836095|NCT01097746|12001628|FG000|STARTED|Overall Study||33
10836096|NCT01097746|12001628|FG000|COMPLETED|Overall Study||28
10836097|NCT01097746|12001628|FG000|NOT COMPLETED|Overall Study||5
10836098|NCT01079780|12001635|FG000|STARTED|Overall Study||70
10836099|NCT01079780|12001636|FG001|STARTED|Overall Study||16
10836100|NCT01079780|12001637|FG002|STARTED|Overall Study||50
10836101|NCT01079780|12001635|FG000|Started Protocol Therapy|Overall Study||69
10836102|NCT01079780|12001636|FG001|Started Protocol Therapy|Overall Study||16
10836103|NCT01079780|12001637|FG002|Started Protocol Therapy|Overall Study||48
10836104|NCT01079780|12001635|FG000|Treated Patients With Toxicity Data Available|Overall Study||68
10836105|NCT01079780|12001636|FG001|Treated Patients With Toxicity Data Available|Overall Study||16
10836106|NCT01079780|12001637|FG002|Treated Patients With Toxicity Data Available|Overall Study||48
10544999|NCT01493596|11698220|FG004|STARTED|Overall Study||8
10836107|NCT01079780|12001635|FG000|Eligible and Treated|Overall Study||62
10836108|NCT01079780|12001636|FG001|Eligible and Treated|Overall Study||16
10836109|NCT01079780|12001637|FG002|Eligible and Treated|Overall Study||45
10836110|NCT01079780|12001635|FG000|Analyzable Patients for Efficacy Analysis|Overall Study||44
10836111|NCT01079780|12001636|FG001|Analyzable Patients for Efficacy Analysis|Overall Study||0
10836112|NCT01079780|12001637|FG002|Analyzable Patients for Efficacy Analysis|Overall Study||45
10836113|NCT01079780|12001635|FG000|COMPLETED|Overall Study||0
10836114|NCT01079780|12001636|FG001|COMPLETED|Overall Study||0
10836115|NCT01079780|12001637|FG002|COMPLETED|Overall Study||0
10836116|NCT01079780|12001635|FG000|NOT COMPLETED|Overall Study||70
10836117|NCT01079780|12001636|FG001|NOT COMPLETED|Overall Study||16
10836118|NCT01079780|12001637|FG002|NOT COMPLETED|Overall Study||50
10836119|NCT00075946|12001649|FG000|STARTED|Overall Study||148
10836120|NCT00075946|12001650|FG001|STARTED|Overall Study||151
10836121|NCT00075946|12001651|FG002|STARTED|Overall Study||28
10836122|NCT00075946|12001652|FG003|STARTED|Overall Study||30
10836123|NCT00075946|12001653|FG004|STARTED|Overall Study||188
10836124|NCT00075946|12001649|FG000|Treated and With Toxicity Data Available|Overall Study||142
10836125|NCT00075946|12001650|FG001|Treated and With Toxicity Data Available|Overall Study||148
10836126|NCT00075946|12001651|FG002|Treated and With Toxicity Data Available|Overall Study||27
10836127|NCT00075946|12001652|FG003|Treated and With Toxicity Data Available|Overall Study||29
10836128|NCT00075946|12001653|FG004|Treated and With Toxicity Data Available|Overall Study||154
10836129|NCT00075946|12001649|FG000|Included in Primary Analysis|Overall Study||143
10836130|NCT00075946|12001650|FG001|Included in Primary Analysis|Overall Study||146
10836131|NCT00075946|12001651|FG002|Included in Primary Analysis|Overall Study||23
10836132|NCT00075946|12001652|FG003|Included in Primary Analysis|Overall Study||29
10836133|NCT00075946|12001653|FG004|Included in Primary Analysis|Overall Study||0
10836134|NCT00075946|12001649|FG000|COMPLETED|Overall Study||0
10836135|NCT00075946|12001650|FG001|COMPLETED|Overall Study||0
10836136|NCT00075946|12001651|FG002|COMPLETED|Overall Study||0
10836137|NCT00075946|12001652|FG003|COMPLETED|Overall Study||0
10836138|NCT00075946|12001653|FG004|COMPLETED|Overall Study||0
10836139|NCT00075946|12001649|FG000|NOT COMPLETED|Overall Study||148
10836140|NCT00075946|12001650|FG001|NOT COMPLETED|Overall Study||151
10836141|NCT00075946|12001651|FG002|NOT COMPLETED|Overall Study||28
10836142|NCT00075946|12001652|FG003|NOT COMPLETED|Overall Study||30
10836143|NCT00075946|12001653|FG004|NOT COMPLETED|Overall Study||188
10836144|NCT00003641|12001666|FG000|STARTED|Overall Study||569
10836145|NCT00003641|12001667|FG001|STARTED|Overall Study||581
10836146|NCT00003641|12001666|FG000|Treated|Overall Study|Patients on arm I should undergo observation, but 2 patients received interferon therapy|2
10836147|NCT00003641|12001667|FG001|Treated|Overall Study||569
10836148|NCT00003641|12001666|FG000|Toxicity Assessed|Overall Study|439 patients on arm I had their toxicity assessed even though they did not receive any treatment|439
10836149|NCT00003641|12001667|FG001|Toxicity Assessed|Overall Study||568
10836150|NCT00003641|12001666|FG000|COMPLETED|Overall Study||0
10836151|NCT00003641|12001667|FG001|COMPLETED|Overall Study||407
10836152|NCT00003641|12001666|FG000|NOT COMPLETED|Overall Study||569
10836153|NCT00003641|12001667|FG001|NOT COMPLETED|Overall Study||174
10836154|NCT01956669|12001680|FG000|STARTED|Overall Study||12
10836155|NCT01956669|12001681|FG001|STARTED|Overall Study||11
10836156|NCT01956669|12001682|FG002|STARTED|Overall Study||10
10836157|NCT01956669|12001683|FG003|STARTED|Overall Study||10
10836158|NCT01956669|12001684|FG004|STARTED|Overall Study||4
10836159|NCT01956669|12001685|FG005|STARTED|Overall Study||4
10836160|NCT01956669|12001686|FG006|STARTED|Overall Study||6
10836161|NCT01956669|12001680|FG000|PK Set|Overall Study||11
10836162|NCT01956669|12001681|FG001|PK Set|Overall Study||11
10836163|NCT01956669|12001682|FG002|PK Set|Overall Study||10
10836164|NCT01956669|12001683|FG003|PK Set|Overall Study||10
10836165|NCT01956669|12001684|FG004|PK Set|Overall Study||4
10836166|NCT01956669|12001685|FG005|PK Set|Overall Study||4
10836167|NCT01956669|12001686|FG006|PK Set|Overall Study||6
10836168|NCT01956669|12001680|FG000|PKES Set|Overall Study||4
10836169|NCT01956669|12001681|FG001|PKES Set|Overall Study||0
10836170|NCT01956669|12001682|FG002|PKES Set|Overall Study||3
10836171|NCT01956669|12001683|FG003|PKES Set|Overall Study||0
10836172|NCT01956669|12001684|FG004|PKES Set|Overall Study||1
10836173|NCT01956669|12001685|FG005|PKES Set|Overall Study||1
10836174|NCT01956669|12001686|FG006|PKES Set|Overall Study||5
10836175|NCT01956669|12001680|FG000|Biomarker Set|Overall Study||12
10836176|NCT01956669|12001681|FG001|Biomarker Set|Overall Study||11
10836177|NCT01956669|12001682|FG002|Biomarker Set|Overall Study||9
10836178|NCT01956669|12001683|FG003|Biomarker Set|Overall Study||9
10836179|NCT01956669|12001684|FG004|Biomarker Set|Overall Study||3
10836180|NCT01956669|12001685|FG005|Biomarker Set|Overall Study||4
10836181|NCT01956669|12001686|FG006|Biomarker Set|Overall Study||3
10836182|NCT01956669|12001680|FG000|Per Protocol Set (PP Set)|Overall Study||9
10836183|NCT01956669|12001681|FG001|Per Protocol Set (PP Set)|Overall Study||10
10836184|NCT01956669|12001682|FG002|Per Protocol Set (PP Set)|Overall Study||6
10836185|NCT01956669|12001683|FG003|Per Protocol Set (PP Set)|Overall Study||9
10836186|NCT01956669|12001684|FG004|Per Protocol Set (PP Set)|Overall Study||4
10836187|NCT01956669|12001685|FG005|Per Protocol Set (PP Set)|Overall Study||4
10836188|NCT01956669|12001686|FG006|Per Protocol Set (PP Set)|Overall Study||5
10836189|NCT01956669|12001680|FG000|COMPLETED|Overall Study||0
10836190|NCT01956669|12001681|FG001|COMPLETED|Overall Study||0
10836191|NCT01956669|12001682|FG002|COMPLETED|Overall Study||0
10836192|NCT01956669|12001683|FG003|COMPLETED|Overall Study||0
10836193|NCT01956669|12001684|FG004|COMPLETED|Overall Study||0
10409435|NCT00758836|11553392|FG001|STARTED|Overall Study||171
10409436|NCT00758836|11553393|FG002|STARTED|Overall Study||171
10409437|NCT00758836|11553394|FG003|STARTED|Overall Study||170
10409438|NCT00758836|11553391|FG000|Treated|Overall Study||147
10409439|NCT00758836|11553392|FG001|Treated|Overall Study||145
10409440|NCT00758836|11553393|FG002|Treated|Overall Study||133
10409441|NCT00758836|11553394|FG003|Treated|Overall Study||138
10409442|NCT00758836|11553391|FG000|COMPLETED|Overall Study||147
10409443|NCT00758836|11553392|FG001|COMPLETED|Overall Study||145
10409444|NCT00758836|11553393|FG002|COMPLETED|Overall Study||133
10409445|NCT00758836|11553394|FG003|COMPLETED|Overall Study||138
10409446|NCT00758836|11553391|FG000|NOT COMPLETED|Overall Study||24
10409447|NCT00758836|11553392|FG001|NOT COMPLETED|Overall Study||26
10409448|NCT00758836|11553393|FG002|NOT COMPLETED|Overall Study||38
10409449|NCT00758836|11553394|FG003|NOT COMPLETED|Overall Study||32
10409450|NCT00758862|11553404|FG000|STARTED|Overall Study||20
10409451|NCT00758862|11553404|FG000|COMPLETED|Overall Study||19
10409452|NCT00758862|11553404|FG000|NOT COMPLETED|Overall Study||1
10409453|NCT00759031|11553410|FG000|STARTED|First Intervention (1 Day)||10
10409454|NCT00759031|11553411|FG001|STARTED|First Intervention (1 Day)||9
10409455|NCT00759031|11553410|FG000|COMPLETED|First Intervention (1 Day)||8
10409456|NCT00759031|11553411|FG001|COMPLETED|First Intervention (1 Day)||8
10409457|NCT00759031|11553410|FG000|NOT COMPLETED|First Intervention (1 Day)||2
10409458|NCT00759031|11553411|FG001|NOT COMPLETED|First Intervention (1 Day)||1
10409459|NCT00759031|11553410|FG000|STARTED|Washout After 1st Intervention (1 Week)||8
10409460|NCT00759031|11553411|FG001|STARTED|Washout After 1st Intervention (1 Week)||8
10409461|NCT00759031|11553410|FG000|COMPLETED|Washout After 1st Intervention (1 Week)||8
10409462|NCT00759031|11553411|FG001|COMPLETED|Washout After 1st Intervention (1 Week)||8
10409463|NCT00759031|11553410|FG000|NOT COMPLETED|Washout After 1st Intervention (1 Week)||0
10409464|NCT00759031|11553411|FG001|NOT COMPLETED|Washout After 1st Intervention (1 Week)||0
10409465|NCT00759031|11553410|FG000|STARTED|Second Intervention (1 Day)||8
10409466|NCT00759031|11553411|FG001|STARTED|Second Intervention (1 Day)||8
10409467|NCT00759031|11553410|FG000|COMPLETED|Second Intervention (1 Day)||8
10409468|NCT00759031|11553411|FG001|COMPLETED|Second Intervention (1 Day)||8
10409469|NCT00759031|11553410|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
10409470|NCT00759031|11553411|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
10409471|NCT00759096|11553417|FG000|STARTED|Overall Study||30
10409472|NCT00759096|11553417|FG000|COMPLETED|Overall Study||30
10409473|NCT00759096|11553417|FG000|NOT COMPLETED|Overall Study||0
10409474|NCT00759109|11553423|FG000|STARTED|Overall Study||74
10409475|NCT00759109|11553424|FG001|STARTED|Overall Study||76
10409476|NCT00759109|11553423|FG000|COMPLETED|Overall Study|From both arms combined, 7 discontinued due to death and there were 8 deaths during follow up.|35
10409477|NCT00759109|11553424|FG001|COMPLETED|Overall Study|From both arms combined, 7 discontinued due to death and there were 8 deaths during follow up.|41
10409478|NCT00759109|11553423|FG000|NOT COMPLETED|Overall Study||39
10409479|NCT00759109|11553424|FG001|NOT COMPLETED|Overall Study||35
10409480|NCT00759148|11553432|FG000|STARTED|Overall Study||593
10409481|NCT00759148|11553433|FG001|STARTED|Overall Study||586
10409482|NCT00759148|11553432|FG000|COMPLETED|Overall Study||579
10409483|NCT00759148|11553433|FG001|COMPLETED|Overall Study||554
10409484|NCT00759148|11553432|FG000|NOT COMPLETED|Overall Study||14
10409485|NCT00759148|11553433|FG001|NOT COMPLETED|Overall Study||32
10409486|NCT00759161|11553439|FG000|STARTED|Overall Study||35
10409487|NCT00759161|11553439|FG000|COMPLETED|Overall Study||35
10409488|NCT00759161|11553439|FG000|NOT COMPLETED|Overall Study||0
10409489|NCT00759174|11553448|FG000|STARTED|Overall Study||76
10409490|NCT00759174|11553449|FG001|STARTED|Overall Study||597
10409491|NCT00759174|11553448|FG000|COMPLETED|Overall Study||76
10409492|NCT00759174|11553449|FG001|COMPLETED|Overall Study||595
10409493|NCT00759174|11553448|FG000|NOT COMPLETED|Overall Study||0
10409494|NCT00759174|11553449|FG001|NOT COMPLETED|Overall Study||2
10409495|NCT00759187|11553459|FG000|STARTED|Overall Study||8
10409496|NCT00759187|11553460|FG001|STARTED|Overall Study||8
10409497|NCT00759187|11553461|FG002|STARTED|Overall Study||9
10409498|NCT00759187|11553459|FG000|COMPLETED|Overall Study||8
10836194|NCT01956669|12001685|FG005|COMPLETED|Overall Study||0
10836195|NCT01956669|12001686|FG006|COMPLETED|Overall Study||0
10836196|NCT01956669|12001680|FG000|NOT COMPLETED|Overall Study||12
10836197|NCT01956669|12001681|FG001|NOT COMPLETED|Overall Study||11
10836198|NCT01956669|12001682|FG002|NOT COMPLETED|Overall Study||10
10836199|NCT01956669|12001683|FG003|NOT COMPLETED|Overall Study||10
10836200|NCT01956669|12001684|FG004|NOT COMPLETED|Overall Study||4
10836201|NCT01956669|12001685|FG005|NOT COMPLETED|Overall Study||4
10836202|NCT01956669|12001686|FG006|NOT COMPLETED|Overall Study||6
10836203|NCT01967823|12001711|FG000|STARTED|Overall Study||11
10836204|NCT01967823|12001711|FG000|COMPLETED|Overall Study||10
10836205|NCT01967823|12001711|FG000|NOT COMPLETED|Overall Study||1
10836206|NCT01989676|12001721|FG000|STARTED|Overall Study||352
10836207|NCT01989676|12001722|FG001|STARTED|Overall Study||355
10836208|NCT01989676|12001721|FG000|Treated|Overall Study||349
10836209|NCT01989676|12001722|FG001|Treated|Overall Study||353
10836210|NCT01989676|12001721|FG000|COMPLETED|Overall Study||234
10836211|NCT01989676|12001722|FG001|COMPLETED|Overall Study||217
10836212|NCT01989676|12001721|FG000|NOT COMPLETED|Overall Study||118
10836213|NCT01989676|12001722|FG001|NOT COMPLETED|Overall Study||138
10836214|NCT01992653|12001737|FG000|STARTED|Overall Study||3
10836215|NCT01992653|12001738|FG001|STARTED|Overall Study||3
10836216|NCT01992653|12001739|FG002|STARTED|Overall Study||6
10836217|NCT01992653|12001740|FG003|STARTED|Overall Study||1
10836218|NCT01992653|12001741|FG004|STARTED|Overall Study||6
10836219|NCT01992653|12001742|FG005|STARTED|Overall Study||6
10836220|NCT01992653|12001743|FG006|STARTED|Overall Study||40
10836221|NCT01992653|12001744|FG007|STARTED|Overall Study||17
10836222|NCT01992653|12001737|FG000|COMPLETED|Overall Study||3
10836223|NCT01992653|12001738|FG001|COMPLETED|Overall Study||3
10836224|NCT01992653|12001739|FG002|COMPLETED|Overall Study||5
10836225|NCT01992653|12001740|FG003|COMPLETED|Overall Study||1
10836226|NCT01992653|12001741|FG004|COMPLETED|Overall Study||5
10836227|NCT01992653|12001742|FG005|COMPLETED|Overall Study||6
10836228|NCT01992653|12001743|FG006|COMPLETED|Overall Study||32
10836229|NCT01992653|12001744|FG007|COMPLETED|Overall Study||13
10836230|NCT01992653|12001737|FG000|NOT COMPLETED|Overall Study||0
10836231|NCT01992653|12001738|FG001|NOT COMPLETED|Overall Study||0
10836232|NCT01992653|12001739|FG002|NOT COMPLETED|Overall Study||1
10836233|NCT01992653|12001740|FG003|NOT COMPLETED|Overall Study||0
10836234|NCT01992653|12001741|FG004|NOT COMPLETED|Overall Study||1
10836235|NCT01992653|12001742|FG005|NOT COMPLETED|Overall Study||0
10836236|NCT01992653|12001743|FG006|NOT COMPLETED|Overall Study||8
10836237|NCT01992653|12001744|FG007|NOT COMPLETED|Overall Study||4
10836238|NCT02001974|12001765|FG000|STARTED|Run-in Period||4
10836239|NCT02001974|12001766|FG001|STARTED|Run-in Period||3
10836240|NCT02001974|12001767|FG002|STARTED|Run-in Period||26
10836241|NCT02001974|12001765|FG000|COMPLETED|Run-in Period||4
10836242|NCT02001974|12001766|FG001|COMPLETED|Run-in Period||3
10836243|NCT02001974|12001767|FG002|COMPLETED|Run-in Period||26
10836244|NCT02001974|12001765|FG000|NOT COMPLETED|Run-in Period||0
10836245|NCT02001974|12001766|FG001|NOT COMPLETED|Run-in Period||0
10836246|NCT02001974|12001767|FG002|NOT COMPLETED|Run-in Period||0
10836247|NCT02001974|12001765|FG000|STARTED|Reparixin + Paclitaxel (28-day Cycles)||4
10836248|NCT02001974|12001766|FG001|STARTED|Reparixin + Paclitaxel (28-day Cycles)||3
10836249|NCT02001974|12001767|FG002|STARTED|Reparixin + Paclitaxel (28-day Cycles)||26
10836250|NCT02001974|12001765|FG000|COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||0
10836251|NCT02001974|12001766|FG001|COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||0
10836252|NCT02001974|12001767|FG002|COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||0
10836253|NCT02001974|12001765|FG000|NOT COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||4
10836254|NCT02001974|12001766|FG001|NOT COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||3
10836255|NCT02001974|12001767|FG002|NOT COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||26
10836256|NCT02014558|12001788|FG000|STARTED|Overall Study||5
10836257|NCT02014558|12001789|FG001|STARTED|Overall Study||3
10836258|NCT02014558|12001790|FG002|STARTED|Overall Study||3
10836259|NCT02014558|12001791|FG003|STARTED|Overall Study||3
10836260|NCT02014558|12001792|FG004|STARTED|Overall Study||4
10836261|NCT02014558|12001793|FG005|STARTED|Overall Study||3
10836262|NCT02014558|12001794|FG006|STARTED|Overall Study||4
10836263|NCT02014558|12001795|FG007|STARTED|Overall Study||11
10836264|NCT02014558|12001796|FG008|STARTED|Overall Study||15
10836265|NCT02014558|12001797|FG009|STARTED|Overall Study||21
10836266|NCT02014558|12001798|FG010|STARTED|Overall Study||69
10836267|NCT02014558|12001799|FG011|STARTED|Overall Study||102
10836268|NCT02014558|12001800|FG012|STARTED|Overall Study||17
10836269|NCT02014558|12001788|FG000|Treated|Overall Study||5
10836270|NCT02014558|12001789|FG001|Treated|Overall Study||3
10836271|NCT02014558|12001790|FG002|Treated|Overall Study||3
10836272|NCT02014558|12001791|FG003|Treated|Overall Study||3
10836273|NCT02014558|12001792|FG004|Treated|Overall Study||3
10836274|NCT02014558|12001793|FG005|Treated|Overall Study||3
10836275|NCT02014558|12001794|FG006|Treated|Overall Study||3
10836276|NCT02014558|12001795|FG007|Treated|Overall Study|A participant randomized to the 120 mg was treated with an initial dose of 20 mg by mistake.|12
10836277|NCT02014558|12001796|FG008|Treated|Overall Study||13
10836278|NCT02014558|12001797|FG009|Treated|Overall Study||21
10836279|NCT02014558|12001798|FG010|Treated|Overall Study|A participant randomized to the 120 mg was treated with an initial dose of 20 mg by mistake.|66
10836280|NCT02014558|12001799|FG011|Treated|Overall Study||100
10836281|NCT02014558|12001800|FG012|Treated|Overall Study||17
10836282|NCT02014558|12001788|FG000|COMPLETED|Overall Study||0
10836283|NCT02014558|12001789|FG001|COMPLETED|Overall Study||0
10836284|NCT02014558|12001790|FG002|COMPLETED|Overall Study||0
10836285|NCT02014558|12001791|FG003|COMPLETED|Overall Study||0
10836286|NCT02014558|12001792|FG004|COMPLETED|Overall Study||0
10836287|NCT02014558|12001793|FG005|COMPLETED|Overall Study||0
10836288|NCT02014558|12001794|FG006|COMPLETED|Overall Study||0
10836289|NCT02014558|12001795|FG007|COMPLETED|Overall Study||0
10836290|NCT02014558|12001796|FG008|COMPLETED|Overall Study||0
10836291|NCT02014558|12001797|FG009|COMPLETED|Overall Study||0
10836292|NCT02014558|12001798|FG010|COMPLETED|Overall Study||0
10836293|NCT02014558|12001799|FG011|COMPLETED|Overall Study||0
10836294|NCT02014558|12001800|FG012|COMPLETED|Overall Study||0
10836295|NCT02014558|12001788|FG000|NOT COMPLETED|Overall Study||5
10836296|NCT02014558|12001789|FG001|NOT COMPLETED|Overall Study||3
10836297|NCT02014558|12001790|FG002|NOT COMPLETED|Overall Study||3
10836298|NCT02014558|12001791|FG003|NOT COMPLETED|Overall Study||3
10836299|NCT02014558|12001792|FG004|NOT COMPLETED|Overall Study||4
10836300|NCT02014558|12001793|FG005|NOT COMPLETED|Overall Study||3
10836301|NCT02014558|12001794|FG006|NOT COMPLETED|Overall Study||4
10836302|NCT02014558|12001795|FG007|NOT COMPLETED|Overall Study||11
10836303|NCT02014558|12001796|FG008|NOT COMPLETED|Overall Study||15
10836304|NCT02014558|12001797|FG009|NOT COMPLETED|Overall Study||21
10836305|NCT02014558|12001798|FG010|NOT COMPLETED|Overall Study||69
10836306|NCT02014558|12001799|FG011|NOT COMPLETED|Overall Study||102
10836307|NCT02014558|12001800|FG012|NOT COMPLETED|Overall Study||17
10836308|NCT02015455|12001844|FG000|STARTED|Step 0 - Oct 2013 to Mar 2014||48233
10836309|NCT02015455|12001845|FG001|STARTED|Step 0 - Oct 2013 to Mar 2014||0
10836310|NCT02015455|12001844|FG000|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 0 - Oct 2013 to Mar 2014||135
10836311|NCT02015455|12001845|FG001|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 0 - Oct 2013 to Mar 2014||0
10836312|NCT02015455|12001844|FG000|COMPLETED|Step 0 - Oct 2013 to Mar 2014||48233
10836313|NCT02015455|12001845|FG001|COMPLETED|Step 0 - Oct 2013 to Mar 2014||0
10836314|NCT02015455|12001844|FG000|NOT COMPLETED|Step 0 - Oct 2013 to Mar 2014||0
10836315|NCT02015455|12001845|FG001|NOT COMPLETED|Step 0 - Oct 2013 to Mar 2014||0
10836316|NCT02015455|12001844|FG000|STARTED|Step 1 - Apr 2014 to Sep 2014||24074
10836317|NCT02015455|12001845|FG001|STARTED|Step 1 - Apr 2014 to Sep 2014||6455
10836318|NCT02015455|12001844|FG000|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 1 - Apr 2014 to Sep 2014||390
10836319|NCT02015455|12001845|FG001|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 1 - Apr 2014 to Sep 2014||2208
10836320|NCT02015455|12001844|FG000|COMPLETED|Step 1 - Apr 2014 to Sep 2014||24074
10836321|NCT02015455|12001845|FG001|COMPLETED|Step 1 - Apr 2014 to Sep 2014||6455
10836322|NCT02015455|12001844|FG000|NOT COMPLETED|Step 1 - Apr 2014 to Sep 2014||0
10836323|NCT02015455|12001845|FG001|NOT COMPLETED|Step 1 - Apr 2014 to Sep 2014||0
10836324|NCT02015455|12001844|FG000|STARTED|Step 2 - Oct 2014 to Mar 2015||23139
10836325|NCT02015455|12001845|FG001|STARTED|Step 2 - Oct 2014 to Mar 2015||16285
10836326|NCT02015455|12001844|FG000|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 2 - Oct 2014 to Mar 2015||98
10836327|NCT02015455|12001845|FG001|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 2 - Oct 2014 to Mar 2015||1511
10836328|NCT02015455|12001844|FG000|COMPLETED|Step 2 - Oct 2014 to Mar 2015||23139
10836329|NCT02015455|12001845|FG001|COMPLETED|Step 2 - Oct 2014 to Mar 2015||16285
10836330|NCT02015455|12001844|FG000|NOT COMPLETED|Step 2 - Oct 2014 to Mar 2015||0
10836331|NCT02015455|12001845|FG001|NOT COMPLETED|Step 2 - Oct 2014 to Mar 2015||0
10836332|NCT02015455|12001844|FG000|STARTED|Step 3 - Apr 2015 to Sep 2015||14135
10836333|NCT02015455|12001845|FG001|STARTED|Step 3 - Apr 2015 to Sep 2015||27661
10836334|NCT02015455|12001844|FG000|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 3 - Apr 2015 to Sep 2015||72
10836335|NCT02015455|12001845|FG001|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 3 - Apr 2015 to Sep 2015||4915
10836336|NCT02015455|12001844|FG000|COMPLETED|Step 3 - Apr 2015 to Sep 2015||14135
10836337|NCT02015455|12001845|FG001|COMPLETED|Step 3 - Apr 2015 to Sep 2015||27661
10836338|NCT02015455|12001844|FG000|NOT COMPLETED|Step 3 - Apr 2015 to Sep 2015||0
10836339|NCT02015455|12001845|FG001|NOT COMPLETED|Step 3 - Apr 2015 to Sep 2015||0
10836340|NCT02015455|12001844|FG000|STARTED|Step 4 - Oct 2015 to Mar 2016||7874
10836341|NCT02015455|12001845|FG001|STARTED|Step 4 - Oct 2015 to Mar 2016||31316
10836342|NCT02015455|12001844|FG000|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 4 - Oct 2015 to Mar 2016||76
10836343|NCT02015455|12001845|FG001|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 4 - Oct 2015 to Mar 2016||3742
10836344|NCT02015455|12001844|FG000|COMPLETED|Step 4 - Oct 2015 to Mar 2016||7874
10836345|NCT02015455|12001845|FG001|COMPLETED|Step 4 - Oct 2015 to Mar 2016||31316
10836346|NCT02015455|12001844|FG000|NOT COMPLETED|Step 4 - Oct 2015 to Mar 2016||0
10836347|NCT02015455|12001845|FG001|NOT COMPLETED|Step 4 - Oct 2015 to Mar 2016||0
10836348|NCT02015455|12001844|FG000|STARTED|Step 5 - Apr 2016 to Sep 2016||0
10836349|NCT02015455|12001845|FG001|STARTED|Step 5 - Apr 2016 to Sep 2016||39714
10836350|NCT02015455|12001844|FG000|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 5 - Apr 2016 to Sep 2016||0
10836351|NCT02015455|12001845|FG001|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 5 - Apr 2016 to Sep 2016||3512
10836352|NCT02015455|12001844|FG000|COMPLETED|Step 5 - Apr 2016 to Sep 2016||0
10836353|NCT02015455|12001845|FG001|COMPLETED|Step 5 - Apr 2016 to Sep 2016||39714
10836354|NCT02015455|12001844|FG000|NOT COMPLETED|Step 5 - Apr 2016 to Sep 2016||0
10836355|NCT02015455|12001845|FG001|NOT COMPLETED|Step 5 - Apr 2016 to Sep 2016||0
10836356|NCT02024555|12001855|FG000|STARTED|Overall Study||49
10836357|NCT02024555|12001856|FG001|STARTED|Overall Study||48
10836358|NCT02024555|12001855|FG000|COMPLETED|Overall Study||43
10836359|NCT02024555|12001856|FG001|COMPLETED|Overall Study||46
10836360|NCT02024555|12001855|FG000|NOT COMPLETED|Overall Study||6
10836361|NCT02024555|12001856|FG001|NOT COMPLETED|Overall Study||2
10836362|NCT02034123|12001880|FG000|STARTED|Part1(Median of 7.286 Weeks of Exposure)||1
10836363|NCT02034123|12001881|FG001|STARTED|Part1(Median of 7.286 Weeks of Exposure)||1
10836364|NCT02034123|12001882|FG002|STARTED|Part1(Median of 7.286 Weeks of Exposure)||5
10836365|NCT02034123|12001883|FG003|STARTED|Part1(Median of 7.286 Weeks of Exposure)||3
10836366|NCT02034123|12001884|FG004|STARTED|Part1(Median of 7.286 Weeks of Exposure)||7
10836367|NCT02034123|12001885|FG005|STARTED|Part1(Median of 7.286 Weeks of Exposure)||3
10836368|NCT02034123|12001886|FG006|STARTED|Part1(Median of 7.286 Weeks of Exposure)||2
10836369|NCT02034123|12001887|FG007|STARTED|Part1(Median of 7.286 Weeks of Exposure)||5
10836370|NCT02034123|12001888|FG008|STARTED|Part1(Median of 7.286 Weeks of Exposure)||2
10836371|NCT02034123|12001889|FG009|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
10836372|NCT02034123|12001890|FG010|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
10836373|NCT02034123|12001891|FG011|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
10836374|NCT02034123|12001892|FG012|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
10836375|NCT02034123|12001893|FG013|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
10836376|NCT02034123|12001894|FG014|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
10836377|NCT02034123|12001895|FG015|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
10836378|NCT02034123|12001896|FG016|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
10836379|NCT02034123|12001897|FG017|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
10836380|NCT02034123|12001880|FG000|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
10836381|NCT02034123|12001881|FG001|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
10836382|NCT02034123|12001882|FG002|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||5
10836383|NCT02034123|12001883|FG003|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
10836384|NCT02034123|12001884|FG004|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||5
10836385|NCT02034123|12001885|FG005|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||3
10836386|NCT02034123|12001886|FG006|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
10836387|NCT02034123|12001887|FG007|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||4
10836388|NCT02034123|12001888|FG008|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10836389|NCT02034123|12001889|FG009|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10836390|NCT02034123|12001890|FG010|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10836391|NCT02034123|12001891|FG011|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10836392|NCT02034123|12001892|FG012|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10836393|NCT02034123|12001893|FG013|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10836394|NCT02034123|12001894|FG014|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10836395|NCT02034123|12001895|FG015|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10836396|NCT02034123|12001896|FG016|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10836397|NCT02034123|12001897|FG017|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10836398|NCT02034123|12001880|FG000|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10836399|NCT02034123|12001881|FG001|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10836400|NCT02034123|12001882|FG002|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10836401|NCT02034123|12001883|FG003|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
10836402|NCT02034123|12001884|FG004|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
10836403|NCT02034123|12001885|FG005|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10836404|NCT02034123|12001886|FG006|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10836405|NCT02034123|12001887|FG007|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
10836406|NCT02034123|12001888|FG008|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
10836407|NCT02034123|12001889|FG009|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10836408|NCT02034123|12001890|FG010|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10836409|NCT02034123|12001891|FG011|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10836410|NCT02034123|12001892|FG012|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10836411|NCT02034123|12001893|FG013|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10836412|NCT02034123|12001894|FG014|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10836413|NCT02034123|12001895|FG015|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10836414|NCT02034123|12001896|FG016|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10836415|NCT02034123|12001897|FG017|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10836416|NCT02034123|12001880|FG000|STARTED|Part2(Up to 2 Years)||0
10836417|NCT02034123|12001881|FG001|STARTED|Part2(Up to 2 Years)||0
10836418|NCT02034123|12001882|FG002|STARTED|Part2(Up to 2 Years)||0
10836419|NCT02034123|12001883|FG003|STARTED|Part2(Up to 2 Years)||0
10836420|NCT02034123|12001884|FG004|STARTED|Part2(Up to 2 Years)||0
10836421|NCT02034123|12001885|FG005|STARTED|Part2(Up to 2 Years)||0
10836422|NCT02034123|12001886|FG006|STARTED|Part2(Up to 2 Years)||0
10836423|NCT02034123|12001887|FG007|STARTED|Part2(Up to 2 Years)||0
10836424|NCT02034123|12001888|FG008|STARTED|Part2(Up to 2 Years)||0
10836425|NCT02034123|12001889|FG009|STARTED|Part2(Up to 2 Years)||0
10836426|NCT02034123|12001890|FG010|STARTED|Part2(Up to 2 Years)||0
10836427|NCT02034123|12001891|FG011|STARTED|Part2(Up to 2 Years)||0
10836428|NCT02034123|12001892|FG012|STARTED|Part2(Up to 2 Years)||0
10836429|NCT02034123|12001893|FG013|STARTED|Part2(Up to 2 Years)||0
10836430|NCT02034123|12001894|FG014|STARTED|Part2(Up to 2 Years)||0
10836431|NCT02034123|12001895|FG015|STARTED|Part2(Up to 2 Years)||0
10836432|NCT02034123|12001896|FG016|STARTED|Part2(Up to 2 Years)||0
10836433|NCT02034123|12001897|FG017|STARTED|Part2(Up to 2 Years)||0
10836434|NCT02034123|12001880|FG000|COMPLETED|Part2(Up to 2 Years)||0
10836435|NCT02034123|12001881|FG001|COMPLETED|Part2(Up to 2 Years)||0
10836436|NCT02034123|12001882|FG002|COMPLETED|Part2(Up to 2 Years)||0
10836437|NCT02034123|12001883|FG003|COMPLETED|Part2(Up to 2 Years)||0
10836438|NCT02034123|12001884|FG004|COMPLETED|Part2(Up to 2 Years)||0
10836439|NCT02034123|12001885|FG005|COMPLETED|Part2(Up to 2 Years)||0
10836440|NCT02034123|12001886|FG006|COMPLETED|Part2(Up to 2 Years)||0
10836441|NCT02034123|12001887|FG007|COMPLETED|Part2(Up to 2 Years)||0
10836442|NCT02034123|12001888|FG008|COMPLETED|Part2(Up to 2 Years)||0
10836443|NCT02034123|12001889|FG009|COMPLETED|Part2(Up to 2 Years)||0
10836444|NCT02034123|12001890|FG010|COMPLETED|Part2(Up to 2 Years)||0
10836445|NCT02034123|12001891|FG011|COMPLETED|Part2(Up to 2 Years)||0
10836446|NCT02034123|12001892|FG012|COMPLETED|Part2(Up to 2 Years)||0
10836447|NCT02034123|12001893|FG013|COMPLETED|Part2(Up to 2 Years)||0
10836448|NCT02034123|12001894|FG014|COMPLETED|Part2(Up to 2 Years)||0
10836449|NCT02034123|12001895|FG015|COMPLETED|Part2(Up to 2 Years)||0
10836450|NCT02034123|12001896|FG016|COMPLETED|Part2(Up to 2 Years)||0
10836451|NCT02034123|12001897|FG017|COMPLETED|Part2(Up to 2 Years)||0
10836452|NCT02034123|12001880|FG000|NOT COMPLETED|Part2(Up to 2 Years)||0
10836453|NCT02034123|12001881|FG001|NOT COMPLETED|Part2(Up to 2 Years)||0
10836454|NCT02034123|12001882|FG002|NOT COMPLETED|Part2(Up to 2 Years)||0
10836455|NCT02034123|12001883|FG003|NOT COMPLETED|Part2(Up to 2 Years)||0
10836456|NCT02034123|12001884|FG004|NOT COMPLETED|Part2(Up to 2 Years)||0
10836457|NCT02034123|12001885|FG005|NOT COMPLETED|Part2(Up to 2 Years)||0
10836458|NCT02034123|12001886|FG006|NOT COMPLETED|Part2(Up to 2 Years)||0
10836459|NCT02034123|12001887|FG007|NOT COMPLETED|Part2(Up to 2 Years)||0
10836460|NCT02034123|12001888|FG008|NOT COMPLETED|Part2(Up to 2 Years)||0
10836461|NCT02034123|12001889|FG009|NOT COMPLETED|Part2(Up to 2 Years)||0
10836462|NCT02034123|12001890|FG010|NOT COMPLETED|Part2(Up to 2 Years)||0
10836463|NCT02034123|12001891|FG011|NOT COMPLETED|Part2(Up to 2 Years)||0
10836464|NCT02034123|12001892|FG012|NOT COMPLETED|Part2(Up to 2 Years)||0
10836465|NCT02034123|12001893|FG013|NOT COMPLETED|Part2(Up to 2 Years)||0
10836466|NCT02034123|12001894|FG014|NOT COMPLETED|Part2(Up to 2 Years)||0
10836467|NCT02034123|12001895|FG015|NOT COMPLETED|Part2(Up to 2 Years)||0
10836468|NCT02034123|12001896|FG016|NOT COMPLETED|Part2(Up to 2 Years)||0
10836469|NCT02034123|12001897|FG017|NOT COMPLETED|Part2(Up to 2 Years)||0
10409499|NCT00759187|11553460|FG001|COMPLETED|Overall Study||8
10409500|NCT00759187|11553461|FG002|COMPLETED|Overall Study||9
10409501|NCT00759187|11553459|FG000|NOT COMPLETED|Overall Study||0
10409502|NCT00759187|11553460|FG001|NOT COMPLETED|Overall Study||0
10409503|NCT00759187|11553461|FG002|NOT COMPLETED|Overall Study||0
10409504|NCT00759330|11553473|FG000|STARTED|Overall Study||20
10409505|NCT00759330|11553474|FG001|STARTED|Overall Study||42
10409506|NCT00759330|11553475|FG002|STARTED|Overall Study||22
10409507|NCT00759330|11553476|FG003|STARTED|Overall Study||43
10409508|NCT00759330|11553473|FG000|COMPLETED|Overall Study||19
10409509|NCT00759330|11553474|FG001|COMPLETED|Overall Study||41
10409510|NCT00759330|11553475|FG002|COMPLETED|Overall Study||22
10409511|NCT00759330|11553476|FG003|COMPLETED|Overall Study||41
10409512|NCT00759330|11553473|FG000|NOT COMPLETED|Overall Study||1
10409513|NCT00759330|11553474|FG001|NOT COMPLETED|Overall Study||1
10409514|NCT00759330|11553475|FG002|NOT COMPLETED|Overall Study||0
10409515|NCT00759330|11553476|FG003|NOT COMPLETED|Overall Study||2
10409516|NCT00759356|11553489|FG000|STARTED|Overall Study||18
10409517|NCT00759356|11553490|FG001|STARTED|Overall Study||18
10409518|NCT00759356|11553489|FG000|COMPLETED|Overall Study||17
10409519|NCT00759356|11553490|FG001|COMPLETED|Overall Study||15
10409520|NCT00759356|11553489|FG000|NOT COMPLETED|Overall Study||1
10409521|NCT00759356|11553490|FG001|NOT COMPLETED|Overall Study||3
10409522|NCT00759395|11553498|FG000|STARTED|Overall Study||13
10409523|NCT00759395|11553499|FG001|STARTED|Overall Study||9
10409524|NCT00759395|11553498|FG000|COMPLETED|Overall Study||11
10409525|NCT00759395|11553499|FG001|COMPLETED|Overall Study||7
10409526|NCT00759395|11553498|FG000|NOT COMPLETED|Overall Study||2
10409527|NCT00759395|11553499|FG001|NOT COMPLETED|Overall Study||2
10409528|NCT00759408|11553505|FG000|STARTED|Overall Study||38
10409529|NCT00759408|11553505|FG000|COMPLETED|Overall Study||19
10409530|NCT00759408|11553505|FG000|NOT COMPLETED|Overall Study||19
10409531|NCT00759473|11553514|FG000|STARTED|Overall Study||10
10409532|NCT00759473|11553515|FG001|STARTED|Overall Study||10
10409533|NCT00759473|11553516|FG002|STARTED|Overall Study||12
10409534|NCT00759473|11553517|FG003|STARTED|Overall Study||23
10409535|NCT00759473|11553518|FG004|STARTED|Overall Study||24
10409536|NCT00759473|11553514|FG000|COMPLETED|Overall Study||10
10409537|NCT00759473|11553515|FG001|COMPLETED|Overall Study||10
10836470|NCT02040584|12001942|FG000|STARTED|Overall Study||105
10836471|NCT02040584|12001943|FG001|STARTED|Overall Study||106
10836472|NCT02040584|12001942|FG000|COMPLETED|Overall Study||70
10409538|NCT00759473|11553516|FG002|COMPLETED|Overall Study||12
10409539|NCT00759473|11553517|FG003|COMPLETED|Overall Study||23
10409540|NCT00759473|11553518|FG004|COMPLETED|Overall Study||24
10409541|NCT00759473|11553514|FG000|NOT COMPLETED|Overall Study||0
10409542|NCT00759473|11553515|FG001|NOT COMPLETED|Overall Study||0
10409543|NCT00759473|11553516|FG002|NOT COMPLETED|Overall Study||0
10409544|NCT00759473|11553517|FG003|NOT COMPLETED|Overall Study||0
10409545|NCT00759473|11553518|FG004|NOT COMPLETED|Overall Study||0
10409546|NCT00759525|11553530|FG000|STARTED|First Intervention (14 Days)||7
10409547|NCT00759525|11553531|FG001|STARTED|First Intervention (14 Days)||8
10409548|NCT00759525|11553530|FG000|COMPLETED|First Intervention (14 Days)||7
10409549|NCT00759525|11553531|FG001|COMPLETED|First Intervention (14 Days)||8
10409550|NCT00759525|11553530|FG000|NOT COMPLETED|First Intervention (14 Days)||0
10409551|NCT00759525|11553531|FG001|NOT COMPLETED|First Intervention (14 Days)||0
10409552|NCT00759525|11553530|FG000|STARTED|Washout (14 Days)||7
10409553|NCT00759525|11553531|FG001|STARTED|Washout (14 Days)||8
10409554|NCT00759525|11553530|FG000|COMPLETED|Washout (14 Days)||7
10409555|NCT00759525|11553531|FG001|COMPLETED|Washout (14 Days)||8
10409556|NCT00759525|11553530|FG000|NOT COMPLETED|Washout (14 Days)||0
10409557|NCT00759525|11553531|FG001|NOT COMPLETED|Washout (14 Days)||0
10409558|NCT00759525|11553530|FG000|STARTED|Second Intervention (14 Days)||7
10409559|NCT00759525|11553531|FG001|STARTED|Second Intervention (14 Days)||8
10409560|NCT00759525|11553530|FG000|COMPLETED|Second Intervention (14 Days)||7
10409561|NCT00759525|11553531|FG001|COMPLETED|Second Intervention (14 Days)||8
10409562|NCT00759525|11553530|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
10409563|NCT00759525|11553531|FG001|NOT COMPLETED|Second Intervention (14 Days)||0
10409564|NCT00759564|11553542|FG000|STARTED|First Intervention Period (4 Days)||8
10409565|NCT00759564|11553543|FG001|STARTED|First Intervention Period (4 Days)||8
10409566|NCT00759564|11553544|FG002|STARTED|First Intervention Period (4 Days)||8
10409567|NCT00759564|11553545|FG003|STARTED|First Intervention Period (4 Days)||1
10409568|NCT00759564|11553546|FG004|STARTED|First Intervention Period (4 Days)||4
10409569|NCT00759564|11553542|FG000|COMPLETED|First Intervention Period (4 Days)||8
10409570|NCT00759564|11553543|FG001|COMPLETED|First Intervention Period (4 Days)||8
10409571|NCT00759564|11553544|FG002|COMPLETED|First Intervention Period (4 Days)||8
10409572|NCT00759564|11553545|FG003|COMPLETED|First Intervention Period (4 Days)||1
10409573|NCT00759564|11553546|FG004|COMPLETED|First Intervention Period (4 Days)||4
10409574|NCT00759564|11553542|FG000|NOT COMPLETED|First Intervention Period (4 Days)||0
10409575|NCT00759564|11553543|FG001|NOT COMPLETED|First Intervention Period (4 Days)||0
10409576|NCT00759564|11553544|FG002|NOT COMPLETED|First Intervention Period (4 Days)||0
10409577|NCT00759564|11553545|FG003|NOT COMPLETED|First Intervention Period (4 Days)||0
10409578|NCT00759564|11553546|FG004|NOT COMPLETED|First Intervention Period (4 Days)||0
10409579|NCT00759564|11553542|FG000|STARTED|Washout Period (at Least 14 Days)||8
10409580|NCT00759564|11553543|FG001|STARTED|Washout Period (at Least 14 Days)||8
10409581|NCT00759564|11553544|FG002|STARTED|Washout Period (at Least 14 Days)||8
10409582|NCT00759564|11553545|FG003|STARTED|Washout Period (at Least 14 Days)||1
10409583|NCT00759564|11553546|FG004|STARTED|Washout Period (at Least 14 Days)||4
10409584|NCT00759564|11553542|FG000|COMPLETED|Washout Period (at Least 14 Days)||8
10409585|NCT00759564|11553543|FG001|COMPLETED|Washout Period (at Least 14 Days)||8
10409586|NCT00759564|11553544|FG002|COMPLETED|Washout Period (at Least 14 Days)||8
10409587|NCT00759564|11553545|FG003|COMPLETED|Washout Period (at Least 14 Days)||1
10409588|NCT00759564|11553546|FG004|COMPLETED|Washout Period (at Least 14 Days)||3
10409589|NCT00759564|11553542|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10409590|NCT00759564|11553543|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10409591|NCT00759564|11553544|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10409592|NCT00759564|11553545|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0
10409593|NCT00759564|11553546|FG004|NOT COMPLETED|Washout Period (at Least 14 Days)||1
10409594|NCT00759564|11553542|FG000|STARTED|Second Intervention Period (4 Days)||8
10409595|NCT00759564|11553543|FG001|STARTED|Second Intervention Period (4 Days)||8
10409596|NCT00759564|11553544|FG002|STARTED|Second Intervention Period (4 Days)||8
10409597|NCT00759564|11553545|FG003|STARTED|Second Intervention Period (4 Days)||1
10409598|NCT00759564|11553546|FG004|STARTED|Second Intervention Period (4 Days)||3
10409599|NCT00759564|11553542|FG000|COMPLETED|Second Intervention Period (4 Days)||8
10409600|NCT00759564|11553543|FG001|COMPLETED|Second Intervention Period (4 Days)||8
10409601|NCT00759564|11553544|FG002|COMPLETED|Second Intervention Period (4 Days)||8
10409602|NCT00759564|11553545|FG003|COMPLETED|Second Intervention Period (4 Days)||1
10409603|NCT00759564|11553546|FG004|COMPLETED|Second Intervention Period (4 Days)||3
10409604|NCT00759564|11553542|FG000|NOT COMPLETED|Second Intervention Period (4 Days)||0
10409605|NCT00759564|11553543|FG001|NOT COMPLETED|Second Intervention Period (4 Days)||0
10409606|NCT00759564|11553544|FG002|NOT COMPLETED|Second Intervention Period (4 Days)||0
10409607|NCT00759564|11553545|FG003|NOT COMPLETED|Second Intervention Period (4 Days)||0
10409608|NCT00759564|11553546|FG004|NOT COMPLETED|Second Intervention Period (4 Days)||0
10409609|NCT00759603|11553578|FG000|STARTED|Overall Study||59
10409610|NCT00759603|11553578|FG000|COMPLETED|Overall Study||59
10409611|NCT00759603|11553578|FG000|NOT COMPLETED|Overall Study||0
10836473|NCT02040584|12001943|FG001|COMPLETED|Overall Study||74
10836474|NCT02040584|12001942|FG000|NOT COMPLETED|Overall Study||35
10836475|NCT02040584|12001943|FG001|NOT COMPLETED|Overall Study||32
10836476|NCT02045797|12001962|FG000|STARTED|Overall Study||58
10836477|NCT02045797|12001963|FG001|STARTED|Overall Study||39
10836478|NCT02045797|12001964|FG002|STARTED|Overall Study||25
10836479|NCT02045797|12001962|FG000|COMPLETED|Overall Study||51
10836480|NCT02045797|12001963|FG001|COMPLETED|Overall Study||32
10836481|NCT02045797|12001964|FG002|COMPLETED|Overall Study||24
10836482|NCT02045797|12001962|FG000|NOT COMPLETED|Overall Study||7
10836483|NCT02045797|12001963|FG001|NOT COMPLETED|Overall Study||7
10836484|NCT02045797|12001964|FG002|NOT COMPLETED|Overall Study||1
10545000|NCT01493596|11698221|FG005|STARTED|Overall Study||8
10545001|NCT01493596|11698222|FG006|STARTED|Overall Study||8
10545002|NCT01493596|11698216|FG000|COMPLETED|Overall Study||8
10545003|NCT01493596|11698217|FG001|COMPLETED|Overall Study||8
10836485|NCT02049710|12001974|FG000|STARTED|Overall Study||653
10836486|NCT02049710|12001975|FG001|STARTED|Overall Study||664
10836487|NCT02049710|12001974|FG000|COMPLETED|Overall Study||334
10836488|NCT02049710|12001975|FG001|COMPLETED|Overall Study||340
10836489|NCT02049710|12001974|FG000|NOT COMPLETED|Overall Study||319
10836490|NCT02049710|12001975|FG001|NOT COMPLETED|Overall Study||324
10836491|NCT02055547|12001981|FG000|STARTED|Overall Study||2
10836492|NCT02055547|12001982|FG001|STARTED|Overall Study||2
10836493|NCT02055547|12001983|FG002|STARTED|Overall Study||5
10836494|NCT02055547|12001984|FG003|STARTED|Overall Study||2
10836495|NCT02055547|12001985|FG004|STARTED|Overall Study||2
10836496|NCT02055547|12001986|FG005|STARTED|Overall Study||2
10836497|NCT02055547|12001987|FG006|STARTED|Overall Study||2
10836498|NCT02055547|12001988|FG007|STARTED|Overall Study||6
10836499|NCT02055547|12001989|FG008|STARTED|Overall Study||6
10836500|NCT02055547|12001990|FG009|STARTED|Overall Study||6
10836501|NCT02055547|12001991|FG010|STARTED|Overall Study||6
10836502|NCT02055547|12001992|FG011|STARTED|Overall Study||6
10836503|NCT02055547|12001993|FG012|STARTED|Overall Study||2
10836504|NCT02055547|12001994|FG013|STARTED|Overall Study||2
10836505|NCT02055547|12001995|FG014|STARTED|Overall Study||2
10836506|NCT02055547|12001996|FG015|STARTED|Overall Study||2
10836507|NCT02055547|12001997|FG016|STARTED|Overall Study||2
10836508|NCT02055547|12001998|FG017|STARTED|Overall Study||2
10836509|NCT02055547|12001999|FG018|STARTED|Overall Study||2
10836510|NCT02055547|12001981|FG000|COMPLETED|Overall Study||2
10836511|NCT02055547|12001982|FG001|COMPLETED|Overall Study||1
10836512|NCT02055547|12001983|FG002|COMPLETED|Overall Study||2
10836513|NCT02055547|12001984|FG003|COMPLETED|Overall Study||2
10836514|NCT02055547|12001985|FG004|COMPLETED|Overall Study||1
10836515|NCT02055547|12001986|FG005|COMPLETED|Overall Study||1
10836516|NCT02055547|12001987|FG006|COMPLETED|Overall Study||0
10836517|NCT02055547|12001988|FG007|COMPLETED|Overall Study||6
10836518|NCT02055547|12001989|FG008|COMPLETED|Overall Study||4
10836519|NCT02055547|12001990|FG009|COMPLETED|Overall Study||5
10836520|NCT02055547|12001991|FG010|COMPLETED|Overall Study||5
10836521|NCT02055547|12001992|FG011|COMPLETED|Overall Study||6
10836522|NCT02055547|12001993|FG012|COMPLETED|Overall Study||2
10836523|NCT02055547|12001994|FG013|COMPLETED|Overall Study||1
10836524|NCT02055547|12001995|FG014|COMPLETED|Overall Study||2
10836525|NCT02055547|12001996|FG015|COMPLETED|Overall Study||1
10836526|NCT02055547|12001997|FG016|COMPLETED|Overall Study||2
10836527|NCT02055547|12001998|FG017|COMPLETED|Overall Study||2
10836528|NCT02055547|12001999|FG018|COMPLETED|Overall Study||2
10836529|NCT02055547|12001981|FG000|NOT COMPLETED|Overall Study||0
10836530|NCT02055547|12001982|FG001|NOT COMPLETED|Overall Study||1
10836531|NCT02055547|12001983|FG002|NOT COMPLETED|Overall Study||3
10836532|NCT02055547|12001984|FG003|NOT COMPLETED|Overall Study||0
10836533|NCT02055547|12001985|FG004|NOT COMPLETED|Overall Study||1
10836534|NCT02055547|12001986|FG005|NOT COMPLETED|Overall Study||1
10836535|NCT02055547|12001987|FG006|NOT COMPLETED|Overall Study||2
10836536|NCT02055547|12001988|FG007|NOT COMPLETED|Overall Study||0
10836537|NCT02055547|12001989|FG008|NOT COMPLETED|Overall Study||2
10836538|NCT02055547|12001990|FG009|NOT COMPLETED|Overall Study||1
10836539|NCT02055547|12001991|FG010|NOT COMPLETED|Overall Study||1
10836540|NCT02055547|12001992|FG011|NOT COMPLETED|Overall Study||0
10836541|NCT02055547|12001993|FG012|NOT COMPLETED|Overall Study||0
10836542|NCT02055547|12001994|FG013|NOT COMPLETED|Overall Study||1
10836543|NCT02055547|12001995|FG014|NOT COMPLETED|Overall Study||0
10836544|NCT02055547|12001996|FG015|NOT COMPLETED|Overall Study||1
10836545|NCT02055547|12001997|FG016|NOT COMPLETED|Overall Study||0
10836546|NCT02055547|12001998|FG017|NOT COMPLETED|Overall Study||0
10836547|NCT02055547|12001999|FG018|NOT COMPLETED|Overall Study||0
10836548|NCT02064387|12002045|FG000|STARTED|Part 1 Max 23.5 Months Followup Duration||1
10836549|NCT02064387|12002046|FG001|STARTED|Part 1 Max 23.5 Months Followup Duration||1
10836550|NCT02064387|12002047|FG002|STARTED|Part 1 Max 23.5 Months Followup Duration||4
10836551|NCT02064387|12002048|FG003|STARTED|Part 1 Max 23.5 Months Followup Duration||4
10836552|NCT02064387|12002049|FG004|STARTED|Part 1 Max 23.5 Months Followup Duration||4
10836553|NCT02064387|12002050|FG005|STARTED|Part 1 Max 23.5 Months Followup Duration||3
10836554|NCT02064387|12002051|FG006|STARTED|Part 1 Max 23.5 Months Followup Duration||4
10754386|NCT03052517|11918145|FG001|NOT COMPLETED|Overall Study||1014
10836555|NCT02064387|12002052|FG007|STARTED|Part 1 Max 23.5 Months Followup Duration||8
10836556|NCT02064387|12002053|FG008|STARTED|Part 1 Max 23.5 Months Followup Duration||3
10836557|NCT02064387|12002054|FG009|STARTED|Part 1 Max 23.5 Months Followup Duration||6
10836558|NCT02064387|12002055|FG010|STARTED|Part 1 Max 23.5 Months Followup Duration||0
10836559|NCT02064387|12002056|FG011|STARTED|Part 1 Max 23.5 Months Followup Duration||0
10836560|NCT02064387|12002045|FG000|COMPLETED|Part 1 Max 23.5 Months Followup Duration||1
10836561|NCT02064387|12002046|FG001|COMPLETED|Part 1 Max 23.5 Months Followup Duration||1
10836562|NCT02064387|12002047|FG002|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4
10836563|NCT02064387|12002048|FG003|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4
10836564|NCT02064387|12002049|FG004|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4
10836565|NCT02064387|12002050|FG005|COMPLETED|Part 1 Max 23.5 Months Followup Duration||3
10836566|NCT02064387|12002051|FG006|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4
10836567|NCT02064387|12002052|FG007|COMPLETED|Part 1 Max 23.5 Months Followup Duration||6
10836568|NCT02064387|12002053|FG008|COMPLETED|Part 1 Max 23.5 Months Followup Duration||2
10836569|NCT02064387|12002054|FG009|COMPLETED|Part 1 Max 23.5 Months Followup Duration||5
10836570|NCT02064387|12002055|FG010|COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
10836571|NCT02064387|12002056|FG011|COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
10836572|NCT02064387|12002045|FG000|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
10836573|NCT02064387|12002046|FG001|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
10836574|NCT02064387|12002047|FG002|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
10836575|NCT02064387|12002048|FG003|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
10836576|NCT02064387|12002049|FG004|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
10836577|NCT02064387|12002050|FG005|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
10754326|NCT03051256|11918063|FG002|STARTED|Overall Study||22
10754327|NCT03051256|11918061|FG000|COMPLETED|Overall Study||19
10754328|NCT03051256|11918062|FG001|COMPLETED|Overall Study||21
10754329|NCT03051256|11918063|FG002|COMPLETED|Overall Study||21
10754330|NCT03051256|11918061|FG000|NOT COMPLETED|Overall Study||0
10754331|NCT03051256|11918062|FG001|NOT COMPLETED|Overall Study||0
10754332|NCT03051256|11918063|FG002|NOT COMPLETED|Overall Study||1
10754333|NCT03051607|11918072|FG000|STARTED|Overall Study||66
10754334|NCT03051607|11918072|FG000|COMPLETED|Overall Study||0
10754335|NCT03051607|11918072|FG000|NOT COMPLETED|Overall Study||66
10754336|NCT03051620|11918076|FG000|STARTED|Overall Study||142
10754337|NCT03051620|11918076|FG000|COMPLETED|Overall Study||124
10754338|NCT03051620|11918076|FG000|NOT COMPLETED|Overall Study||18
10754339|NCT03051633|11918082|FG000|STARTED|Overall Study||342
10754340|NCT03051633|11918083|FG001|STARTED|Overall Study||186
10754341|NCT03051633|11918082|FG000|COMPLETED|Overall Study||249
10754342|NCT03051633|11918083|FG001|COMPLETED|Overall Study||179
10754343|NCT03051633|11918082|FG000|NOT COMPLETED|Overall Study||93
10754344|NCT03051633|11918083|FG001|NOT COMPLETED|Overall Study||7
10754345|NCT03051646|11918091|FG000|STARTED|Overall Study||6
10754346|NCT03051646|11918092|FG001|STARTED|Overall Study||6
10754347|NCT03051646|11918091|FG000|COMPLETED|Overall Study||6
10754348|NCT03051646|11918092|FG001|COMPLETED|Overall Study||6
10754349|NCT03051646|11918091|FG000|NOT COMPLETED|Overall Study||0
10754350|NCT03051646|11918092|FG001|NOT COMPLETED|Overall Study||0
10754351|NCT03051672|11918100|FG000|STARTED|Overall Study||8
10754352|NCT03051672|11918100|FG000|Began Treatment|Overall Study||8
10754353|NCT03051672|11918100|FG000|COMPLETED|Overall Study||8
10754354|NCT03051672|11918100|FG000|NOT COMPLETED|Overall Study||0
10754355|NCT03052257|11918107|FG000|STARTED|Overall Study||100
10754356|NCT03052257|11918108|FG001|STARTED|Overall Study||100
10754357|NCT03052257|11918107|FG000|COMPLETED|Overall Study||95
10754358|NCT03052257|11918108|FG001|COMPLETED|Overall Study||97
10754359|NCT03052257|11918107|FG000|NOT COMPLETED|Overall Study||5
10754360|NCT03052257|11918108|FG001|NOT COMPLETED|Overall Study||3
10754361|NCT03052322|11918116|FG000|STARTED|Overall Study||143
10754362|NCT03052322|11918117|FG001|STARTED|Overall Study||145
10754363|NCT03052322|11918116|FG000|COMPLETED|Overall Study||122
10754364|NCT03052322|11918117|FG001|COMPLETED|Overall Study||113
10754365|NCT03052322|11918116|FG000|NOT COMPLETED|Overall Study||21
10754366|NCT03052322|11918117|FG001|NOT COMPLETED|Overall Study||32
10754367|NCT03052426|11918126|FG000|STARTED|Overall Study||6
10754368|NCT03052426|11918127|FG001|STARTED|Overall Study||6
10754369|NCT03052426|11918128|FG002|STARTED|Overall Study||6
10754370|NCT03052426|11918126|FG000|COMPLETED|Overall Study||4
10754371|NCT03052426|11918127|FG001|COMPLETED|Overall Study||5
10754372|NCT03052426|11918128|FG002|COMPLETED|Overall Study||5
10754373|NCT03052426|11918126|FG000|NOT COMPLETED|Overall Study||2
10754374|NCT03052426|11918127|FG001|NOT COMPLETED|Overall Study||1
10754375|NCT03052426|11918128|FG002|NOT COMPLETED|Overall Study||1
10754376|NCT03052517|11918144|FG000|STARTED|Overall Study||1093
10754377|NCT03052517|11918145|FG001|STARTED|Overall Study||1085
10754378|NCT03052517|11918146|FG002|STARTED|Overall Study||360
10754379|NCT03052517|11918144|FG000|Safety Set (SAF)|Overall Study|One patient received placebo. This patient was not included in QAW039 150 mg group in the SAF|1092
10754380|NCT03052517|11918145|FG001|Safety Set (SAF)|Overall Study|One patient had no treatment administered and thus was excluded from the SAF|1084
10754381|NCT03052517|11918146|FG002|Safety Set (SAF)|Overall Study|One patient in QAW039 150 mg group received placebo and was included in the placebo group in the SAF|361
10754382|NCT03052517|11918144|FG000|COMPLETED|Overall Study||76
10754383|NCT03052517|11918145|FG001|COMPLETED|Overall Study||71
10754384|NCT03052517|11918146|FG002|COMPLETED|Overall Study||32
10754385|NCT03052517|11918144|FG000|NOT COMPLETED|Overall Study||1017
10754387|NCT03052517|11918146|FG002|NOT COMPLETED|Overall Study||328
10754388|NCT03052530|11918154|FG000|STARTED|Overall Study||61
10754389|NCT03052530|11918154|FG000|COMPLETED|Overall Study||61
10754390|NCT03052530|11918154|FG000|NOT COMPLETED|Overall Study||0
10754391|NCT03052725|11918160|FG000|STARTED|Overall Study||194
10754392|NCT03052725|11918161|FG001|STARTED|Overall Study||197
10754393|NCT03052725|11918160|FG000|Safety Analysis Set|Overall Study||194
10754394|NCT03052725|11918161|FG001|Safety Analysis Set|Overall Study||196
10754395|NCT03052725|11918160|FG000|COMPLETED|Overall Study||46
10754396|NCT03052725|11918161|FG001|COMPLETED|Overall Study||47
10836578|NCT02064387|12002051|FG006|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
10836579|NCT02064387|12002052|FG007|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||2
10836580|NCT02064387|12002053|FG008|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||1
10836581|NCT02064387|12002054|FG009|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||1
10836582|NCT02064387|12002055|FG010|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
10836583|NCT02064387|12002056|FG011|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
10836584|NCT02064387|12002045|FG000|STARTED|Part 2 Max 35 Months Followup Duration||0
10836585|NCT02064387|12002046|FG001|STARTED|Part 2 Max 35 Months Followup Duration||0
10836586|NCT02064387|12002047|FG002|STARTED|Part 2 Max 35 Months Followup Duration||0
10836587|NCT02064387|12002048|FG003|STARTED|Part 2 Max 35 Months Followup Duration||0
10836588|NCT02064387|12002049|FG004|STARTED|Part 2 Max 35 Months Followup Duration||0
10836589|NCT02064387|12002050|FG005|STARTED|Part 2 Max 35 Months Followup Duration||0
10836590|NCT02064387|12002051|FG006|STARTED|Part 2 Max 35 Months Followup Duration||0
10836591|NCT02064387|12002052|FG007|STARTED|Part 2 Max 35 Months Followup Duration||0
10836592|NCT02064387|12002053|FG008|STARTED|Part 2 Max 35 Months Followup Duration||0
10836593|NCT02064387|12002054|FG009|STARTED|Part 2 Max 35 Months Followup Duration||0
10836594|NCT02064387|12002055|FG010|STARTED|Part 2 Max 35 Months Followup Duration||35
10836595|NCT02064387|12002056|FG011|STARTED|Part 2 Max 35 Months Followup Duration||6
10836596|NCT02064387|12002045|FG000|COMPLETED|Part 2 Max 35 Months Followup Duration||0
10836597|NCT02064387|12002046|FG001|COMPLETED|Part 2 Max 35 Months Followup Duration||0
10836598|NCT02064387|12002047|FG002|COMPLETED|Part 2 Max 35 Months Followup Duration||0
10836599|NCT02064387|12002048|FG003|COMPLETED|Part 2 Max 35 Months Followup Duration||0
10836600|NCT02064387|12002049|FG004|COMPLETED|Part 2 Max 35 Months Followup Duration||0
10836601|NCT02064387|12002050|FG005|COMPLETED|Part 2 Max 35 Months Followup Duration||0
10836602|NCT02064387|12002051|FG006|COMPLETED|Part 2 Max 35 Months Followup Duration||0
10836603|NCT02064387|12002052|FG007|COMPLETED|Part 2 Max 35 Months Followup Duration||0
10836604|NCT02064387|12002053|FG008|COMPLETED|Part 2 Max 35 Months Followup Duration||0
10836605|NCT02064387|12002054|FG009|COMPLETED|Part 2 Max 35 Months Followup Duration||0
10836606|NCT02064387|12002055|FG010|COMPLETED|Part 2 Max 35 Months Followup Duration||29
10836607|NCT02064387|12002056|FG011|COMPLETED|Part 2 Max 35 Months Followup Duration||3
10836608|NCT02064387|12002045|FG000|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
10836609|NCT02064387|12002046|FG001|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
10836610|NCT02064387|12002047|FG002|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
10836611|NCT02064387|12002048|FG003|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
10836612|NCT02064387|12002049|FG004|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
10836613|NCT02064387|12002050|FG005|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
10836614|NCT02064387|12002051|FG006|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
10836615|NCT02064387|12002052|FG007|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
10836616|NCT02064387|12002053|FG008|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
10836617|NCT02064387|12002054|FG009|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
10836618|NCT02064387|12002055|FG010|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||6
10836619|NCT02064387|12002056|FG011|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||3
10754397|NCT03052725|11918160|FG000|NOT COMPLETED|Overall Study||148
10754398|NCT03052725|11918161|FG001|NOT COMPLETED|Overall Study||150
10836620|NCT02076178|12002097|FG000|STARTED|Oral Phase||21
10836621|NCT02076178|12002098|FG001|STARTED|Oral Phase||106
10836622|NCT02076178|12002097|FG000|COMPLETED|Oral Phase||21
10836623|NCT02076178|12002098|FG001|COMPLETED|Oral Phase||94
10836624|NCT02076178|12002097|FG000|NOT COMPLETED|Oral Phase||0
10836625|NCT02076178|12002098|FG001|NOT COMPLETED|Oral Phase||12
10836626|NCT02076178|12002097|FG000|STARTED|Injection Phase||21
10836627|NCT02076178|12002098|FG001|STARTED|Injection Phase||94
10836628|NCT02076178|12002097|FG000|COMPLETED|Injection Phase||20
10836629|NCT02076178|12002098|FG001|COMPLETED|Injection Phase||87
10836630|NCT02076178|12002097|FG000|NOT COMPLETED|Injection Phase||1
10836631|NCT02076178|12002098|FG001|NOT COMPLETED|Injection Phase||7
10836632|NCT02079766|12002108|FG000|STARTED|Overall Study||30
10836633|NCT02079766|12002109|FG001|STARTED|Overall Study||11
10836634|NCT02079766|12002108|FG000|COMPLETED|Overall Study||28
10836635|NCT02079766|12002109|FG001|COMPLETED|Overall Study||11
10836636|NCT02079766|12002108|FG000|NOT COMPLETED|Overall Study||2
10836637|NCT02079766|12002109|FG001|NOT COMPLETED|Overall Study||0
10836662|NCT02087189|12002142|FG000|STARTED|Overall Study||30
10836663|NCT02087189|12002142|FG000|COMPLETED|Overall Study||28
10836664|NCT02087189|12002142|FG000|NOT COMPLETED|Overall Study||2
10836665|NCT02096055|12002150|FG000|STARTED|Overall Study||13
10836666|NCT02096055|12002151|FG001|STARTED|Overall Study||9
10836667|NCT02096055|12002152|FG002|STARTED|Overall Study||13
10836668|NCT02096055|12002153|FG003|STARTED|Overall Study||9
10836669|NCT02096055|12002150|FG000|COMPLETED|Overall Study||13
10836670|NCT02096055|12002151|FG001|COMPLETED|Overall Study||9
10836671|NCT02096055|12002152|FG002|COMPLETED|Overall Study||13
10836672|NCT02096055|12002153|FG003|COMPLETED|Overall Study||9
10836673|NCT02096055|12002150|FG000|NOT COMPLETED|Overall Study||0
10836674|NCT02096055|12002151|FG001|NOT COMPLETED|Overall Study||0
10836675|NCT02096055|12002152|FG002|NOT COMPLETED|Overall Study||0
10836676|NCT02096055|12002153|FG003|NOT COMPLETED|Overall Study||0
10836677|NCT02112916|12002167|FG000|STARTED|Overall Study||312
10836678|NCT02112916|12002168|FG001|STARTED|Overall Study||315
10836679|NCT02112916|12002169|FG002|STARTED|Overall Study||111
10836680|NCT02112916|12002170|FG003|STARTED|Overall Study||109
10836681|NCT02112916|12002167|FG000|COMPLETED|Overall Study||108
10836682|NCT02112916|12002168|FG001|COMPLETED|Overall Study||123
10836683|NCT02112916|12002169|FG002|COMPLETED|Overall Study||52
10836684|NCT02112916|12002170|FG003|COMPLETED|Overall Study||62
10836685|NCT02112916|12002167|FG000|NOT COMPLETED|Overall Study||204
10836686|NCT02112916|12002168|FG001|NOT COMPLETED|Overall Study||192
10836687|NCT02112916|12002169|FG002|NOT COMPLETED|Overall Study||59
10836688|NCT02112916|12002170|FG003|NOT COMPLETED|Overall Study||47
10836697|NCT02134717|12002194|FG000|STARTED|Overall Study||3
10836698|NCT02134717|12002194|FG000|COMPLETED|Overall Study||3
10836699|NCT02134717|12002194|FG000|NOT COMPLETED|Overall Study||0
10836700|NCT02135029|12002201|FG000|STARTED|Overall Study||73
10836701|NCT02135029|12002202|FG001|STARTED|Overall Study||74
10836702|NCT02135029|12002203|FG002|STARTED|Overall Study||37
10836703|NCT02135029|12002201|FG000|Treated|Overall Study||73
10836704|NCT02135029|12002202|FG001|Treated|Overall Study||74
10836705|NCT02135029|12002203|FG002|Treated|Overall Study||36
10409612|NCT00759642|11553582|FG000|STARTED|Overall Study||33
10409613|NCT00759642|11553582|FG000|COMPLETED|Overall Study||33
10409614|NCT00759642|11553582|FG000|NOT COMPLETED|Overall Study||0
10409615|NCT00759668|11553588|FG000|STARTED|Overall Study||17
10409616|NCT00759668|11553589|FG001|STARTED|Overall Study||18
10409617|NCT00759668|11553588|FG000|COMPLETED|Overall Study||16
10409618|NCT00759668|11553589|FG001|COMPLETED|Overall Study||15
10409619|NCT00759668|11553588|FG000|NOT COMPLETED|Overall Study||1
10409620|NCT00759668|11553589|FG001|NOT COMPLETED|Overall Study||3
10409621|NCT00759681|11553597|FG000|STARTED|Overall Study||107
10409622|NCT00759681|11553598|FG001|STARTED|Overall Study||110
10409623|NCT00759681|11553597|FG000|COMPLETED|Overall Study||97
10409624|NCT00759681|11553598|FG001|COMPLETED|Overall Study||100
10409625|NCT00759681|11553597|FG000|NOT COMPLETED|Overall Study||10
10409626|NCT00759681|11553598|FG001|NOT COMPLETED|Overall Study||10
10409627|NCT00759707|11553605|FG000|STARTED|Overall Study||19
10409628|NCT00759707|11553605|FG000|COMPLETED|Overall Study||19
10409629|NCT00759707|11553605|FG000|NOT COMPLETED|Overall Study||0
10409630|NCT00759759|11553611|FG000|STARTED|Overall Study||18
10409631|NCT00759759|11553612|FG001|STARTED|Overall Study||18
10409632|NCT00759759|11553611|FG000|COMPLETED|Overall Study||14
10409633|NCT00759759|11553612|FG001|COMPLETED|Overall Study||17
10409634|NCT00759759|11553611|FG000|NOT COMPLETED|Overall Study||4
10409635|NCT00759759|11553612|FG001|NOT COMPLETED|Overall Study||1
10429153|NCT00862849|11575291|FG005|COMPLETED|Washout 2 (3 to 14 Days)||3
10429154|NCT00862849|11575286|FG000|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
10429155|NCT00862849|11575287|FG001|NOT COMPLETED|Washout 2 (3 to 14 Days)||1
10429156|NCT00862849|11575288|FG002|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
10429157|NCT00862849|11575289|FG003|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
10429158|NCT00862849|11575290|FG004|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
10429159|NCT00862849|11575291|FG005|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
10429160|NCT00862849|11575286|FG000|STARTED|Intervention 3||3
10429161|NCT00862849|11575287|FG001|STARTED|Intervention 3||3
10429162|NCT00862849|11575288|FG002|STARTED|Intervention 3||3
10429163|NCT00862849|11575289|FG003|STARTED|Intervention 3||4
10429164|NCT00862849|11575290|FG004|STARTED|Intervention 3||4
10429165|NCT00862849|11575291|FG005|STARTED|Intervention 3||3
10836706|NCT02135029|12002201|FG000|COMPLETED|Overall Study||69
10836707|NCT02135029|12002202|FG001|COMPLETED|Overall Study||69
10409636|NCT00759772|11553620|FG000|STARTED|Overall Study||12
10409637|NCT00759772|11553621|FG001|STARTED|Overall Study||11
10409638|NCT00759772|11553620|FG000|COMPLETED|Overall Study||12
10409639|NCT00759772|11553621|FG001|COMPLETED|Overall Study||11
10409640|NCT00759772|11553620|FG000|NOT COMPLETED|Overall Study||0
10409641|NCT00759772|11553621|FG001|NOT COMPLETED|Overall Study||0
10409642|NCT00759785|11553629|FG000|STARTED|Overall Study||26
10409643|NCT00759785|11553630|FG001|STARTED|Overall Study||22
10409644|NCT00759785|11553629|FG000|Treated|Overall Study||25
10409645|NCT00759785|11553630|FG001|Treated|Overall Study||20
10409646|NCT00759785|11553629|FG000|COMPLETED|Overall Study||14
10409647|NCT00759785|11553630|FG001|COMPLETED|Overall Study||17
10409648|NCT00759785|11553629|FG000|NOT COMPLETED|Overall Study||12
10409649|NCT00759785|11553630|FG001|NOT COMPLETED|Overall Study||5
10836638|NCT02081391|12002119|FG000|STARTED|12-hour Treatment||108
10836639|NCT02081391|12002120|FG001|STARTED|12-hour Treatment||52
10836640|NCT02081391|12002121|FG002|STARTED|12-hour Treatment||11
10836641|NCT02081391|12002122|FG003|STARTED|12-hour Treatment||4
10836642|NCT02081391|12002119|FG000|COMPLETED|12-hour Treatment||90
10836643|NCT02081391|12002120|FG001|COMPLETED|12-hour Treatment||46
10836644|NCT02081391|12002121|FG002|COMPLETED|12-hour Treatment||10
10836645|NCT02081391|12002122|FG003|COMPLETED|12-hour Treatment||4
10836646|NCT02081391|12002119|FG000|NOT COMPLETED|12-hour Treatment||18
10836647|NCT02081391|12002120|FG001|NOT COMPLETED|12-hour Treatment||6
10836648|NCT02081391|12002121|FG002|NOT COMPLETED|12-hour Treatment||1
10836649|NCT02081391|12002122|FG003|NOT COMPLETED|12-hour Treatment||0
10836650|NCT02081391|12002119|FG000|STARTED|24-hour Treatment and Trial Completion||90
10836651|NCT02081391|12002120|FG001|STARTED|24-hour Treatment and Trial Completion||46
10836652|NCT02081391|12002121|FG002|STARTED|24-hour Treatment and Trial Completion||10
10836653|NCT02081391|12002122|FG003|STARTED|24-hour Treatment and Trial Completion||4
10836654|NCT02081391|12002119|FG000|COMPLETED|24-hour Treatment and Trial Completion||63
10836655|NCT02081391|12002120|FG001|COMPLETED|24-hour Treatment and Trial Completion||28
10836656|NCT02081391|12002121|FG002|COMPLETED|24-hour Treatment and Trial Completion||9
10836657|NCT02081391|12002122|FG003|COMPLETED|24-hour Treatment and Trial Completion||4
10836658|NCT02081391|12002119|FG000|NOT COMPLETED|24-hour Treatment and Trial Completion||27
10836659|NCT02081391|12002120|FG001|NOT COMPLETED|24-hour Treatment and Trial Completion||18
10836660|NCT02081391|12002121|FG002|NOT COMPLETED|24-hour Treatment and Trial Completion||1
10836661|NCT02081391|12002122|FG003|NOT COMPLETED|24-hour Treatment and Trial Completion||0
10836689|NCT02114697|12002187|FG000|STARTED|Overall Study||5
10836690|NCT02114697|12002188|FG001|STARTED|Overall Study||4
10836691|NCT02114697|12002187|FG000|Completed Month 18 Visit|Overall Study||0
10836692|NCT02114697|12002188|FG001|Completed Month 18 Visit|Overall Study||1
10836693|NCT02114697|12002187|FG000|COMPLETED|Overall Study||0
10836694|NCT02114697|12002188|FG001|COMPLETED|Overall Study||0
10836695|NCT02114697|12002187|FG000|NOT COMPLETED|Overall Study||5
10836696|NCT02114697|12002188|FG001|NOT COMPLETED|Overall Study||4
10836708|NCT02135029|12002203|FG002|COMPLETED|Overall Study||34
10836709|NCT02135029|12002201|FG000|NOT COMPLETED|Overall Study||4
10836710|NCT02135029|12002202|FG001|NOT COMPLETED|Overall Study||5
10836711|NCT02135029|12002203|FG002|NOT COMPLETED|Overall Study||3
10409650|NCT00759798|11553636|FG000|STARTED|Overall Study||289
10409651|NCT00759798|11553636|FG000|COMPLETED|Overall Study||289
10409652|NCT00759798|11553636|FG000|NOT COMPLETED|Overall Study||0
10409653|NCT00759811|11553642|FG000|STARTED|Overall Study||25
10836712|NCT02137239|12002214|FG000|STARTED|Overall Study||26
10836713|NCT02137239|12002215|FG001|STARTED|Overall Study||32
10836714|NCT02137239|12002214|FG000|COMPLETED|Overall Study||23
10836715|NCT02137239|12002215|FG001|COMPLETED|Overall Study||26
10836716|NCT02137239|12002214|FG000|NOT COMPLETED|Overall Study||3
10409654|NCT00759811|11553643|FG001|STARTED|Overall Study||25
10836717|NCT02137239|12002215|FG001|NOT COMPLETED|Overall Study||6
10409655|NCT00759811|11553642|FG000|COMPLETED|Overall Study||23
10409656|NCT00759811|11553643|FG001|COMPLETED|Overall Study||24
10409657|NCT00759811|11553642|FG000|NOT COMPLETED|Overall Study||2
10836718|NCT02148133|12002221|FG000|STARTED|Overall Study||21
10836719|NCT02148133|12002221|FG000|Safety Set (SS)|Overall Study||21
10836720|NCT02148133|12002221|FG000|Pharmacokinetic Analysis Set (PAS)|Overall Study||21
10836721|NCT02148133|12002221|FG000|COMPLETED|Overall Study||16
10836722|NCT02148133|12002221|FG000|NOT COMPLETED|Overall Study||5
10836723|NCT02151383|12002228|FG000|STARTED|Overall Study||8
10836724|NCT02151383|12002229|FG001|STARTED|Overall Study||3
10836725|NCT02151383|12002230|FG002|STARTED|Overall Study||1
10836726|NCT02151383|12002228|FG000|Low-dose|Overall Study||2
10836727|NCT02151383|12002229|FG001|Low-dose|Overall Study||3
10836728|NCT02151383|12002230|FG002|Low-dose|Overall Study||1
10836729|NCT02151383|12002228|FG000|High-dose|Overall Study||6
10836730|NCT02151383|12002229|FG001|High-dose|Overall Study||0
10836731|NCT02151383|12002230|FG002|High-dose|Overall Study||0
10836732|NCT02151383|12002228|FG000|COMPLETED|Overall Study||8
10836733|NCT02151383|12002229|FG001|COMPLETED|Overall Study||3
10836734|NCT02151383|12002230|FG002|COMPLETED|Overall Study||1
10836735|NCT02151383|12002228|FG000|NOT COMPLETED|Overall Study||0
10836736|NCT02151383|12002229|FG001|NOT COMPLETED|Overall Study||0
10836737|NCT02151383|12002230|FG002|NOT COMPLETED|Overall Study||0
10836738|NCT02165215|12002241|FG000|STARTED|Induction Phase||359
10836739|NCT02165215|12002242|FG001|STARTED|Induction Phase||0
10836740|NCT02165215|12002243|FG002|STARTED|Induction Phase||0
10836741|NCT02165215|12002241|FG000|Dosed|Induction Phase||358
10836742|NCT02165215|12002242|FG001|Dosed|Induction Phase||0
10836743|NCT02165215|12002243|FG002|Dosed|Induction Phase||0
10836744|NCT02165215|12002241|FG000|COMPLETED|Induction Phase||336
10836745|NCT02165215|12002242|FG001|COMPLETED|Induction Phase||0
10836746|NCT02165215|12002243|FG002|COMPLETED|Induction Phase||0
10836747|NCT02165215|12002241|FG000|NOT COMPLETED|Induction Phase||23
10836748|NCT02165215|12002242|FG001|NOT COMPLETED|Induction Phase||0
10836749|NCT02165215|12002243|FG002|NOT COMPLETED|Induction Phase||0
10836750|NCT02165215|12002241|FG000|STARTED|Maintenance Phase||0
10836751|NCT02165215|12002242|FG001|STARTED|Maintenance Phase||108
10836752|NCT02165215|12002243|FG002|STARTED|Maintenance Phase||106
10836753|NCT02165215|12002241|FG000|Dosed|Maintenance Phase||0
10836754|NCT02165215|12002242|FG001|Dosed|Maintenance Phase||108
10836755|NCT02165215|12002243|FG002|Dosed|Maintenance Phase||102
10836756|NCT02165215|12002241|FG000|COMPLETED|Maintenance Phase||0
10836757|NCT02165215|12002242|FG001|COMPLETED|Maintenance Phase||96
10836758|NCT02165215|12002243|FG002|COMPLETED|Maintenance Phase||101
10836759|NCT02165215|12002241|FG000|NOT COMPLETED|Maintenance Phase||0
10836760|NCT02165215|12002242|FG001|NOT COMPLETED|Maintenance Phase||12
10836761|NCT02165215|12002243|FG002|NOT COMPLETED|Maintenance Phase||5
10836762|NCT02180217|12002257|FG000|STARTED|Overall Study||36
10836763|NCT02180217|12002258|FG001|STARTED|Overall Study||35
10836764|NCT02180217|12002259|FG002|STARTED|Overall Study||66
10836765|NCT02180217|12002257|FG000|Discontinued at/Prior to Week 12 (W12)|Overall Study||0
10836766|NCT02180217|12002258|FG001|Discontinued at/Prior to Week 12 (W12)|Overall Study||0
10836767|NCT02180217|12002259|FG002|Discontinued at/Prior to Week 12 (W12)|Overall Study||7
10836768|NCT02180217|12002257|FG000|Discont. at/Prior to W26 But After W12|Overall Study||0
10836769|NCT02180217|12002258|FG001|Discont. at/Prior to W26 But After W12|Overall Study||0
10836770|NCT02180217|12002259|FG002|Discont. at/Prior to W26 But After W12|Overall Study||12
10836771|NCT02180217|12002257|FG000|Discontinued Prior to W48 But After W26|Overall Study||0
10836772|NCT02180217|12002258|FG001|Discontinued Prior to W48 But After W26|Overall Study||2
10836773|NCT02180217|12002259|FG002|Discontinued Prior to W48 But After W26|Overall Study||3
10836774|NCT02180217|12002257|FG000|Completed Week 48 (Core Phase)|Overall Study||36
10836775|NCT02180217|12002258|FG001|Completed Week 48 (Core Phase)|Overall Study||33
10836776|NCT02180217|12002259|FG002|Completed Week 48 (Core Phase)|Overall Study||44
10836777|NCT02180217|12002257|FG000|Completed W48, Did Not Enter Ext. Phase|Overall Study||1
10836778|NCT02180217|12002258|FG001|Completed W48, Did Not Enter Ext. Phase|Overall Study||3
10836779|NCT02180217|12002259|FG002|Completed W48, Did Not Enter Ext. Phase|Overall Study||3
10836780|NCT02180217|12002257|FG000|Completed W48, Entered Ext. Phase|Overall Study||35
10836781|NCT02180217|12002258|FG001|Completed W48, Entered Ext. Phase|Overall Study||30
10836782|NCT02180217|12002259|FG002|Completed W48, Entered Ext. Phase|Overall Study||41
10836783|NCT02180217|12002257|FG000|Discontinued Extension Phase|Overall Study||12
10836784|NCT02180217|12002258|FG001|Discontinued Extension Phase|Overall Study||6
10836785|NCT02180217|12002259|FG002|Discontinued Extension Phase|Overall Study||16
10836786|NCT02180217|12002257|FG000|Completed Ext. Phase|Overall Study||23
10836787|NCT02180217|12002258|FG001|Completed Ext. Phase|Overall Study||24
10836788|NCT02180217|12002259|FG002|Completed Ext. Phase|Overall Study||25
10836789|NCT02180217|12002257|FG000|COMPLETED|Overall Study||24
10836790|NCT02180217|12002258|FG001|COMPLETED|Overall Study||27
10836791|NCT02180217|12002259|FG002|COMPLETED|Overall Study||28
10836792|NCT02180217|12002257|FG000|NOT COMPLETED|Overall Study||12
10836793|NCT02180217|12002258|FG001|NOT COMPLETED|Overall Study||8
10836794|NCT02180217|12002259|FG002|NOT COMPLETED|Overall Study||38
10836795|NCT02186457|12002276|FG000|STARTED|Overall Study||95
10836796|NCT02186457|12002277|FG001|STARTED|Overall Study||95
10836797|NCT02186457|12002276|FG000|COMPLETED|Overall Study||95
10836798|NCT02186457|12002277|FG001|COMPLETED|Overall Study||95
10836799|NCT02186457|12002276|FG000|NOT COMPLETED|Overall Study||0
10836800|NCT02186457|12002277|FG001|NOT COMPLETED|Overall Study||0
10836801|NCT02193867|12002283|FG000|STARTED|Overall Study||10
10836802|NCT02193867|12002283|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||10
10836803|NCT02193867|12002283|FG000|Completed 18 Months Of Treatment|Overall Study||8
10836804|NCT02193867|12002283|FG000|COMPLETED|Overall Study||6
10836805|NCT02193867|12002283|FG000|NOT COMPLETED|Overall Study||4
10836806|NCT02215096|12002290|FG000|STARTED|Run-In Period (Up to Week 2)||37
10836807|NCT02215096|12002291|FG001|STARTED|Run-In Period (Up to Week 2)||0
10836808|NCT02215096|12002292|FG002|STARTED|Run-In Period (Up to Week 2)||0
10836809|NCT02215096|12002293|FG003|STARTED|Run-In Period (Up to Week 2)||0
10836810|NCT02215096|12002294|FG004|STARTED|Run-In Period (Up to Week 2)||0
10836811|NCT02215096|12002290|FG000|COMPLETED|Run-In Period (Up to Week 2)||36
10836812|NCT02215096|12002291|FG001|COMPLETED|Run-In Period (Up to Week 2)||0
10836813|NCT02215096|12002292|FG002|COMPLETED|Run-In Period (Up to Week 2)||0
10836814|NCT02215096|12002293|FG003|COMPLETED|Run-In Period (Up to Week 2)||0
10836815|NCT02215096|12002294|FG004|COMPLETED|Run-In Period (Up to Week 2)||0
10836816|NCT02215096|12002290|FG000|NOT COMPLETED|Run-In Period (Up to Week 2)||1
10836817|NCT02215096|12002291|FG001|NOT COMPLETED|Run-In Period (Up to Week 2)||0
10836818|NCT02215096|12002292|FG002|NOT COMPLETED|Run-In Period (Up to Week 2)||0
10836819|NCT02215096|12002293|FG003|NOT COMPLETED|Run-In Period (Up to Week 2)||0
10836820|NCT02215096|12002294|FG004|NOT COMPLETED|Run-In Period (Up to Week 2)||0
10836821|NCT02215096|12002290|FG000|STARTED|Combination TP (Up to Maximum 654 Days)||0
10836822|NCT02215096|12002291|FG001|STARTED|Combination TP (Up to Maximum 654 Days)||11
10836823|NCT02215096|12002292|FG002|STARTED|Combination TP (Up to Maximum 654 Days)||11
10409658|NCT00759811|11553643|FG001|NOT COMPLETED|Overall Study||1
10409659|NCT00759863|11553651|FG000|STARTED|Overall Study||144
10409660|NCT00759863|11553652|FG001|STARTED|Overall Study||98
10409661|NCT00759863|11553651|FG000|COMPLETED|Overall Study||124
10409662|NCT00759863|11553652|FG001|COMPLETED|Overall Study||80
10409663|NCT00759863|11553651|FG000|NOT COMPLETED|Overall Study||20
10409664|NCT00759863|11553652|FG001|NOT COMPLETED|Overall Study||18
10409665|NCT00759876|11553658|FG000|STARTED|Overall Study||36
10409666|NCT00759876|11553658|FG000|As-Treated Population|Overall Study||36
10409667|NCT00759876|11553658|FG000|Evaluable Population|Overall Study||35
10409668|NCT00759876|11553658|FG000|Ambulatory Evaluable Population|Overall Study||24
10409669|NCT00759876|11553658|FG000|COMPLETED|Overall Study||0
10409670|NCT00759876|11553658|FG000|NOT COMPLETED|Overall Study||36
10409671|NCT00759902|11553664|FG000|STARTED|Overall Study||18
10409672|NCT00759902|11553665|FG001|STARTED|Overall Study||18
10409673|NCT00759902|11553664|FG000|COMPLETED|Overall Study||18
10409674|NCT00759902|11553665|FG001|COMPLETED|Overall Study||17
10409675|NCT00759902|11553664|FG000|NOT COMPLETED|Overall Study||0
10409676|NCT00759902|11553665|FG001|NOT COMPLETED|Overall Study||1
10409677|NCT00759915|11553673|FG000|STARTED|Overall Study||18
10409678|NCT00759915|11553674|FG001|STARTED|Overall Study||18
10409679|NCT00759915|11553673|FG000|COMPLETED|Overall Study||17
10409680|NCT00759915|11553674|FG001|COMPLETED|Overall Study||17
10409681|NCT00759915|11553673|FG000|NOT COMPLETED|Overall Study||1
10409682|NCT00759915|11553674|FG001|NOT COMPLETED|Overall Study||1
10409683|NCT00759941|11553682|FG000|STARTED|Overall Study||42
10409684|NCT00759941|11553683|FG001|STARTED|Overall Study||44
10409685|NCT00759941|11553682|FG000|COMPLETED|Overall Study||39
10409686|NCT00759941|11553683|FG001|COMPLETED|Overall Study||43
10409687|NCT00759941|11553682|FG000|NOT COMPLETED|Overall Study||3
10409688|NCT00759941|11553683|FG001|NOT COMPLETED|Overall Study||1
10409689|NCT00759954|11553691|FG000|STARTED|Overall Study|All assigned participants entered trial|18
10409690|NCT00759954|11553692|FG001|STARTED|Overall Study|All assigned participants entered trial|18
10409691|NCT00759954|11553691|FG000|COMPLETED|Overall Study|One participant(#225) did not enter Period 2 and one participant (#203)dropped out during Period 2|16
10409692|NCT00759954|11553692|FG001|COMPLETED|Overall Study|Two participants (#202 and #228) did not enter Period 2.|16
10409693|NCT00759954|11553691|FG000|NOT COMPLETED|Overall Study||2
10409694|NCT00759954|11553692|FG001|NOT COMPLETED|Overall Study||2
10409695|NCT00759967|11553698|FG000|STARTED|First Intervention||10
10409696|NCT00759967|11553699|FG001|STARTED|First Intervention||9
10409697|NCT00759967|11553698|FG000|COMPLETED|First Intervention||10
10409698|NCT00759967|11553699|FG001|COMPLETED|First Intervention||9
10409699|NCT00759967|11553698|FG000|NOT COMPLETED|First Intervention||0
10409700|NCT00759967|11553699|FG001|NOT COMPLETED|First Intervention||0
10409701|NCT00759967|11553698|FG000|STARTED|Second Intervention||10
10409702|NCT00759967|11553699|FG001|STARTED|Second Intervention||9
10409703|NCT00759967|11553698|FG000|COMPLETED|Second Intervention||8
10409704|NCT00759967|11553699|FG001|COMPLETED|Second Intervention||9
10409705|NCT00759967|11553698|FG000|NOT COMPLETED|Second Intervention||2
10409706|NCT00759967|11553699|FG001|NOT COMPLETED|Second Intervention||0
10409707|NCT00760006|11553711|FG000|STARTED|Overall Study||86
10409708|NCT00760006|11553712|FG001|STARTED|Overall Study||138
10409709|NCT00760006|11553711|FG000|COMPLETED|Overall Study||86
10409710|NCT00760006|11553712|FG001|COMPLETED|Overall Study||138
10409711|NCT00760006|11553711|FG000|NOT COMPLETED|Overall Study||0
10409712|NCT00760006|11553712|FG001|NOT COMPLETED|Overall Study||0
10409713|NCT00760019|11553720|FG000|STARTED|Overall Study||15
10409714|NCT00760019|11553721|FG001|STARTED|Overall Study||15
10409715|NCT00760019|11553722|FG002|STARTED|Overall Study||14
10409716|NCT00760019|11553723|FG003|STARTED|Overall Study||14
10409717|NCT00760019|11553720|FG000|COMPLETED|Overall Study||15
10836824|NCT02215096|12002293|FG003|STARTED|Combination TP (Up to Maximum 654 Days)||12
10836825|NCT02215096|12002294|FG004|STARTED|Combination TP (Up to Maximum 654 Days)||2
10836826|NCT02215096|12002290|FG000|COMPLETED|Combination TP (Up to Maximum 654 Days)||0
10836827|NCT02215096|12002291|FG001|COMPLETED|Combination TP (Up to Maximum 654 Days)||9
10836828|NCT02215096|12002292|FG002|COMPLETED|Combination TP (Up to Maximum 654 Days)||10
10409718|NCT00760019|11553721|FG001|COMPLETED|Overall Study||15
10409719|NCT00760019|11553722|FG002|COMPLETED|Overall Study||14
10409720|NCT00760019|11553723|FG003|COMPLETED|Overall Study||14
10409721|NCT00760019|11553720|FG000|NOT COMPLETED|Overall Study||0
10409722|NCT00760019|11553721|FG001|NOT COMPLETED|Overall Study||0
10836829|NCT02215096|12002293|FG003|COMPLETED|Combination TP (Up to Maximum 654 Days)||10
10836830|NCT02215096|12002294|FG004|COMPLETED|Combination TP (Up to Maximum 654 Days)||1
10836831|NCT02215096|12002290|FG000|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||0
10836832|NCT02215096|12002291|FG001|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||2
10836833|NCT02215096|12002292|FG002|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||1
10836834|NCT02215096|12002293|FG003|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||2
10836835|NCT02215096|12002294|FG004|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||1
10836836|NCT02218697|12002312|FG000|STARTED|Overall Study||179
10836837|NCT02218697|12002313|FG001|STARTED|Overall Study||177
10836838|NCT02218697|12002312|FG000|COMPLETED|Overall Study||177
10836839|NCT02218697|12002313|FG001|COMPLETED|Overall Study||171
10836840|NCT02218697|12002312|FG000|NOT COMPLETED|Overall Study||2
10836841|NCT02218697|12002313|FG001|NOT COMPLETED|Overall Study||6
10836842|NCT02221037|12002323|FG000|STARTED|Overall Study||5
10836843|NCT02221037|12002324|FG001|STARTED|Overall Study||11
10836844|NCT02221037|12002325|FG002|STARTED|Overall Study||8
10836845|NCT02221037|12002326|FG003|STARTED|Overall Study||9
10836846|NCT02221037|12002323|FG000|COMPLETED|Overall Study||5
10836847|NCT02221037|12002324|FG001|COMPLETED|Overall Study||11
10836848|NCT02221037|12002325|FG002|COMPLETED|Overall Study||7
10836849|NCT02221037|12002326|FG003|COMPLETED|Overall Study||9
10836850|NCT02221037|12002323|FG000|NOT COMPLETED|Overall Study||0
10836851|NCT02221037|12002324|FG001|NOT COMPLETED|Overall Study||0
10836852|NCT02221037|12002325|FG002|NOT COMPLETED|Overall Study||1
10836853|NCT02221037|12002326|FG003|NOT COMPLETED|Overall Study||0
10836854|NCT02224456|12002340|FG000|STARTED|Overall Study||197
10836855|NCT02224456|12002340|FG000|COMPLETED|Overall Study||161
10836856|NCT02224456|12002340|FG000|NOT COMPLETED|Overall Study||36
10836857|NCT02231762|12002344|FG000|STARTED|Combination Phase||57
10836858|NCT02231762|12002345|FG001|STARTED|Combination Phase|This arm was not included in period 1 (combination phase).|0
10836859|NCT02231762|12002346|FG002|STARTED|Combination Phase|This arm was not included in period 1 (combination phase).|0
10836860|NCT02231762|12002347|FG003|STARTED|Combination Phase|This arm was not included in period 1 (combination phase).|0
10836861|NCT02231762|12002344|FG000|COMPLETED|Combination Phase||37
10836862|NCT02231762|12002345|FG001|COMPLETED|Combination Phase||0
10836863|NCT02231762|12002346|FG002|COMPLETED|Combination Phase||0
10836864|NCT02231762|12002347|FG003|COMPLETED|Combination Phase||0
10409723|NCT00760019|11553722|FG002|NOT COMPLETED|Overall Study||0
10409724|NCT00760019|11553723|FG003|NOT COMPLETED|Overall Study||0
10409725|NCT00760084|11553729|FG000|STARTED|Overall Study||10
10409726|NCT00760084|11553729|FG000|COMPLETED|Overall Study||0
10409727|NCT00760084|11553729|FG000|NOT COMPLETED|Overall Study||10
10409728|NCT00760214|11553736|FG000|STARTED|Overall Study||295
10409729|NCT00760214|11553737|FG001|STARTED|Overall Study||294
10409730|NCT00760214|11553738|FG002|STARTED|Overall Study||296
10409731|NCT00760214|11553736|FG000|COMPLETED|Overall Study||265
10409732|NCT00760214|11553737|FG001|COMPLETED|Overall Study||264
10409733|NCT00760214|11553738|FG002|COMPLETED|Overall Study||255
10409734|NCT00760214|11553736|FG000|NOT COMPLETED|Overall Study||30
10409735|NCT00760214|11553737|FG001|NOT COMPLETED|Overall Study||30
10409736|NCT00760214|11553738|FG002|NOT COMPLETED|Overall Study||41
10409737|NCT00760266|11553748|FG000|STARTED|Overall Study||228
10836865|NCT02231762|12002344|FG000|NOT COMPLETED|Combination Phase||20
10409738|NCT00760266|11553749|FG001|STARTED|Overall Study||223
10409739|NCT00760266|11553748|FG000|COMPLETED|Overall Study||204
10836866|NCT02231762|12002345|FG001|NOT COMPLETED|Combination Phase||0
10836867|NCT02231762|12002346|FG002|NOT COMPLETED|Combination Phase||0
10836868|NCT02231762|12002347|FG003|NOT COMPLETED|Combination Phase||0
10836869|NCT02231762|12002344|FG000|STARTED|Maintenance Phase|This arm was not included in period 2 (maintenance phase).|0
10836870|NCT02231762|12002345|FG001|STARTED|Maintenance Phase|The 37 subjects completing period 1 were split between the 3 arms in period 2.|11
10836871|NCT02231762|12002346|FG002|STARTED|Maintenance Phase|The 37 subjects completing period 1 were split between the 3 arms in period 2.|14
10836872|NCT02231762|12002347|FG003|STARTED|Maintenance Phase|The 37 subjects completing period 1 were split between the 3 arms in period 2.|12
10836873|NCT02231762|12002344|FG000|COMPLETED|Maintenance Phase||0
10836874|NCT02231762|12002345|FG001|COMPLETED|Maintenance Phase||8
10836875|NCT02231762|12002346|FG002|COMPLETED|Maintenance Phase||9
10836876|NCT02231762|12002347|FG003|COMPLETED|Maintenance Phase||7
10836877|NCT02231762|12002344|FG000|NOT COMPLETED|Maintenance Phase||0
10836878|NCT02231762|12002345|FG001|NOT COMPLETED|Maintenance Phase||3
10836879|NCT02231762|12002346|FG002|NOT COMPLETED|Maintenance Phase||5
10836880|NCT02231762|12002347|FG003|NOT COMPLETED|Maintenance Phase||5
10836881|NCT02234843|12002371|FG000|STARTED|Overall Study||184
10836882|NCT02234843|12002372|FG001|STARTED|Overall Study||67
10836883|NCT02234843|12002373|FG002|STARTED|Overall Study||47
10836884|NCT02234843|12002374|FG003|STARTED|Overall Study||21
10836885|NCT02234843|12002375|FG004|STARTED|Overall Study||16
10836886|NCT02234843|12002376|FG005|STARTED|Overall Study||92
10836887|NCT02234843|12002377|FG006|STARTED|Overall Study||34
10836888|NCT02234843|12002378|FG007|STARTED|Overall Study||22
10836889|NCT02234843|12002379|FG008|STARTED|Overall Study||9
10836890|NCT02234843|12002380|FG009|STARTED|Overall Study||8
10836891|NCT02234843|12002371|FG000|COMPLETED|Overall Study||162
10836892|NCT02234843|12002372|FG001|COMPLETED|Overall Study||61
10836893|NCT02234843|12002373|FG002|COMPLETED|Overall Study||44
10836894|NCT02234843|12002374|FG003|COMPLETED|Overall Study||16
10836895|NCT02234843|12002375|FG004|COMPLETED|Overall Study||14
10836896|NCT02234843|12002376|FG005|COMPLETED|Overall Study||79
10836897|NCT02234843|12002377|FG006|COMPLETED|Overall Study||32
10836898|NCT02234843|12002378|FG007|COMPLETED|Overall Study||20
10836899|NCT02234843|12002379|FG008|COMPLETED|Overall Study||8
10836900|NCT02234843|12002380|FG009|COMPLETED|Overall Study||8
10836901|NCT02234843|12002371|FG000|NOT COMPLETED|Overall Study||22
10836902|NCT02234843|12002372|FG001|NOT COMPLETED|Overall Study||6
10836903|NCT02234843|12002373|FG002|NOT COMPLETED|Overall Study||3
10836904|NCT02234843|12002374|FG003|NOT COMPLETED|Overall Study||5
10836905|NCT02234843|12002375|FG004|NOT COMPLETED|Overall Study||2
10836906|NCT02234843|12002376|FG005|NOT COMPLETED|Overall Study||13
10836907|NCT02234843|12002377|FG006|NOT COMPLETED|Overall Study||2
10836908|NCT02234843|12002378|FG007|NOT COMPLETED|Overall Study||2
10836909|NCT02234843|12002379|FG008|NOT COMPLETED|Overall Study||1
10836910|NCT02234843|12002380|FG009|NOT COMPLETED|Overall Study||0
10836911|NCT02243306|12002415|FG000|STARTED|Overall Study||1
10836912|NCT02243306|12002416|FG001|STARTED|Overall Study||7
10836913|NCT02243306|12002415|FG000|COMPLETED|Overall Study||1
10836914|NCT02243306|12002416|FG001|COMPLETED|Overall Study||4
10836915|NCT02243306|12002415|FG000|NOT COMPLETED|Overall Study||0
10836916|NCT02243306|12002416|FG001|NOT COMPLETED|Overall Study||3
10409740|NCT00760266|11553749|FG001|COMPLETED|Overall Study||205
10409741|NCT00760266|11553748|FG000|NOT COMPLETED|Overall Study||24
10409742|NCT00760266|11553749|FG001|NOT COMPLETED|Overall Study||18
10409743|NCT00760383|11553757|FG000|STARTED|Overall Study||21
10409744|NCT00760383|11553758|FG001|STARTED|Overall Study||19
10409745|NCT00760383|11553757|FG000|COMPLETED|Overall Study||16
10409746|NCT00760383|11553758|FG001|COMPLETED|Overall Study||12
10409747|NCT00760383|11553757|FG000|NOT COMPLETED|Overall Study||5
10409748|NCT00760383|11553758|FG001|NOT COMPLETED|Overall Study||7
10409749|NCT00760435|11553766|FG000|STARTED|Overall Study||98
10409750|NCT00760435|11553767|FG001|STARTED|Overall Study||98
10409751|NCT00760435|11553766|FG000|COMPLETED|Overall Study||94
10409752|NCT00760435|11553767|FG001|COMPLETED|Overall Study||93
10409753|NCT00760435|11553766|FG000|NOT COMPLETED|Overall Study||4
10409754|NCT00760435|11553767|FG001|NOT COMPLETED|Overall Study||5
10409755|NCT00760474|11553773|FG000|STARTED|Period 1 (P1)||13
10409756|NCT00760474|11553774|FG001|STARTED|Period 1 (P1)||14
10409757|NCT00760474|11553773|FG000|Treated|Period 1 (P1)|1 participant discontinued in P1; re-entered with new identification number and completed P1, P2.|13
10409758|NCT00760474|11553774|FG001|Treated|Period 1 (P1)|1 participant discontinued in P1; re-entered with new identification number and completed P1, P2.|14
10409759|NCT00760474|11553773|FG000|Overall Number of Unique Participants|Period 1 (P1)||12
10409760|NCT00760474|11553774|FG001|Overall Number of Unique Participants|Period 1 (P1)||13
10409761|NCT00760474|11553773|FG000|COMPLETED|Period 1 (P1)||12
10409762|NCT00760474|11553774|FG001|COMPLETED|Period 1 (P1)||13
10409763|NCT00760474|11553773|FG000|NOT COMPLETED|Period 1 (P1)||1
10409764|NCT00760474|11553774|FG001|NOT COMPLETED|Period 1 (P1)||1
10409765|NCT00760474|11553773|FG000|STARTED|Placebo Washout Period||12
10409766|NCT00760474|11553774|FG001|STARTED|Placebo Washout Period||13
10409767|NCT00760474|11553773|FG000|COMPLETED|Placebo Washout Period||12
10409768|NCT00760474|11553774|FG001|COMPLETED|Placebo Washout Period||12
10409769|NCT00760474|11553773|FG000|NOT COMPLETED|Placebo Washout Period||0
10409770|NCT00760474|11553774|FG001|NOT COMPLETED|Placebo Washout Period||1
10409771|NCT00760474|11553773|FG000|STARTED|Period 2 (P2)||12
10409772|NCT00760474|11553774|FG001|STARTED|Period 2 (P2)||12
10409773|NCT00760474|11553773|FG000|COMPLETED|Period 2 (P2)||11
10409774|NCT00760474|11553774|FG001|COMPLETED|Period 2 (P2)||11
10409775|NCT00760474|11553773|FG000|NOT COMPLETED|Period 2 (P2)||1
10409776|NCT00760474|11553774|FG001|NOT COMPLETED|Period 2 (P2)||1
10409777|NCT00760487|11553781|FG000|STARTED|Overall Study||120
10409778|NCT00760487|11553781|FG000|COMPLETED|Overall Study||117
10409779|NCT00760487|11553781|FG000|NOT COMPLETED|Overall Study||3
10409780|NCT00760513|11553787|FG000|STARTED|Overall Study||51
10409781|NCT00760513|11553788|FG001|STARTED|Overall Study||52
10409782|NCT00760513|11553787|FG000|COMPLETED|Overall Study||46
10409783|NCT00760513|11553788|FG001|COMPLETED|Overall Study||45
10409784|NCT00760513|11553787|FG000|NOT COMPLETED|Overall Study||5
10409785|NCT00760513|11553788|FG001|NOT COMPLETED|Overall Study||7
10409786|NCT00760526|11553798|FG000|STARTED|Overall Study||74
10409787|NCT00760526|11553799|FG001|STARTED|Overall Study||72
10409788|NCT00760526|11553798|FG000|COMPLETED|Overall Study||69
10409789|NCT00760526|11553799|FG001|COMPLETED|Overall Study||68
10409790|NCT00760526|11553798|FG000|NOT COMPLETED|Overall Study||5
10409791|NCT00760526|11553799|FG001|NOT COMPLETED|Overall Study||4
10409792|NCT00760552|11553814|FG000|STARTED|Overall Study||61
10409793|NCT00760552|11553815|FG001|STARTED|Overall Study||62
10409794|NCT00760552|11553814|FG000|COMPLETED|Overall Study||48
10545004|NCT01493596|11698218|FG002|COMPLETED|Overall Study||7
10545005|NCT01493596|11698219|FG003|COMPLETED|Overall Study||8
10545006|NCT01493596|11698220|FG004|COMPLETED|Overall Study||8
10545007|NCT01493596|11698221|FG005|COMPLETED|Overall Study||8
10545008|NCT01493596|11698222|FG006|COMPLETED|Overall Study||8
10545009|NCT01493596|11698216|FG000|NOT COMPLETED|Overall Study||0
10409795|NCT00760552|11553815|FG001|COMPLETED|Overall Study||52
10409796|NCT00760552|11553814|FG000|NOT COMPLETED|Overall Study||13
10409797|NCT00760552|11553815|FG001|NOT COMPLETED|Overall Study||10
10545010|NCT01493596|11698217|FG001|NOT COMPLETED|Overall Study||0
10409798|NCT00760578|11553825|FG000|STARTED|Overall Study||22
10409799|NCT00760578|11553826|FG001|STARTED|Overall Study||21
10836925|NCT04093843|12002432|FG000|STARTED|Overall Study||6
10836926|NCT04093843|12002432|FG000|COMPLETED|Overall Study||6
10836927|NCT04093843|12002432|FG000|NOT COMPLETED|Overall Study||0
10836928|NCT03926611|12002443|FG000|STARTED|Overall Study||44
10836929|NCT03926611|12002444|FG001|STARTED|Overall Study||44
10836930|NCT03926611|12002445|FG002|STARTED|Overall Study||47
10836931|NCT03926611|12002446|FG003|STARTED|Overall Study||44
10836932|NCT03926611|12002447|FG004|STARTED|Overall Study||44
10836933|NCT03926611|12002448|FG005|STARTED|Overall Study||45
10836934|NCT03926611|12002449|FG006|STARTED|Overall Study||43
10836935|NCT03926611|12002443|FG000|Randomized Set (RAN)|Overall Study||44
10836936|NCT03926611|12002444|FG001|Randomized Set (RAN)|Overall Study||44
10836937|NCT03926611|12002445|FG002|Randomized Set (RAN)|Overall Study||47
10836938|NCT03926611|12002446|FG003|Randomized Set (RAN)|Overall Study||44
10836939|NCT03926611|12002447|FG004|Randomized Set (RAN)|Overall Study||44
10836940|NCT03926611|12002448|FG005|Randomized Set (RAN)|Overall Study||45
10836941|NCT03926611|12002449|FG006|Randomized Set (RAN)|Overall Study||43
10836942|NCT03926611|12002443|FG000|Full Analysis Set (FAS)|Overall Study||44
10836943|NCT03926611|12002444|FG001|Full Analysis Set (FAS)|Overall Study||44
10836944|NCT03926611|12002445|FG002|Full Analysis Set (FAS)|Overall Study||47
10836945|NCT03926611|12002446|FG003|Full Analysis Set (FAS)|Overall Study||44
10836946|NCT03926611|12002447|FG004|Full Analysis Set (FAS)|Overall Study||43
10836947|NCT03926611|12002448|FG005|Full Analysis Set (FAS)|Overall Study||45
10836948|NCT03926611|12002449|FG006|Full Analysis Set (FAS)|Overall Study||42
10836949|NCT03926611|12002443|FG000|Safety Set (SAF)|Overall Study||44
10836950|NCT03926611|12002444|FG001|Safety Set (SAF)|Overall Study||44
10836951|NCT03926611|12002445|FG002|Safety Set (SAF)|Overall Study||47
10836952|NCT03926611|12002446|FG003|Safety Set (SAF)|Overall Study||44
10836953|NCT03926611|12002447|FG004|Safety Set (SAF)|Overall Study||43
10836954|NCT03926611|12002448|FG005|Safety Set (SAF)|Overall Study||45
10836955|NCT03926611|12002449|FG006|Safety Set (SAF)|Overall Study||42
10836956|NCT03926611|12002443|FG000|COMPLETED|Overall Study||41
10836957|NCT03926611|12002444|FG001|COMPLETED|Overall Study||41
10836958|NCT03926611|12002445|FG002|COMPLETED|Overall Study||45
10836959|NCT03926611|12002446|FG003|COMPLETED|Overall Study||40
10836960|NCT03926611|12002447|FG004|COMPLETED|Overall Study||40
10836961|NCT03926611|12002448|FG005|COMPLETED|Overall Study||36
10836962|NCT03926611|12002449|FG006|COMPLETED|Overall Study||38
10836963|NCT03926611|12002443|FG000|NOT COMPLETED|Overall Study||3
10836964|NCT03926611|12002444|FG001|NOT COMPLETED|Overall Study||3
10836965|NCT03926611|12002445|FG002|NOT COMPLETED|Overall Study||2
10836966|NCT03926611|12002446|FG003|NOT COMPLETED|Overall Study||4
10836967|NCT03926611|12002447|FG004|NOT COMPLETED|Overall Study||4
10836968|NCT03926611|12002448|FG005|NOT COMPLETED|Overall Study||9
10836969|NCT03926611|12002449|FG006|NOT COMPLETED|Overall Study||5
10836970|NCT03838484|12002473|FG000|STARTED|Overall Study||5
10836971|NCT03838484|12002474|FG001|STARTED|Overall Study||5
10836972|NCT03838484|12002475|FG002|STARTED|Overall Study||4
10836973|NCT03838484|12002476|FG003|STARTED|Overall Study||4
10836974|NCT03838484|12002473|FG000|COMPLETED|Overall Study||5
10836975|NCT03838484|12002474|FG001|COMPLETED|Overall Study||4
10836976|NCT03838484|12002475|FG002|COMPLETED|Overall Study||4
10836977|NCT03838484|12002476|FG003|COMPLETED|Overall Study||4
10836978|NCT03838484|12002473|FG000|NOT COMPLETED|Overall Study||0
10836979|NCT03838484|12002474|FG001|NOT COMPLETED|Overall Study||1
10836980|NCT03838484|12002475|FG002|NOT COMPLETED|Overall Study||0
10836981|NCT03838484|12002476|FG003|NOT COMPLETED|Overall Study||0
10836982|NCT03814720|12002497|FG000|STARTED|Overall Study||5
10836983|NCT03814720|12002498|FG001|STARTED|Overall Study||12
10836984|NCT03814720|12002499|FG002|STARTED|Overall Study||12
10836985|NCT03814720|12002500|FG003|STARTED|Overall Study||12
10836986|NCT03814720|12002501|FG004|STARTED|Overall Study||11
10836987|NCT03814720|12002497|FG000|Received First Product Administration|Overall Study||5
10836988|NCT03814720|12002498|FG001|Received First Product Administration|Overall Study||12
10836989|NCT03814720|12002499|FG002|Received First Product Administration|Overall Study||12
10836990|NCT03814720|12002500|FG003|Received First Product Administration|Overall Study||12
10836991|NCT03814720|12002501|FG004|Received First Product Administration|Overall Study||11
10836992|NCT03814720|12002497|FG000|Received All Product Administrations|Overall Study||5
10836993|NCT03814720|12002498|FG001|Received All Product Administrations|Overall Study||12
10836994|NCT03814720|12002499|FG002|Received All Product Administrations|Overall Study|One participant did not receive the second dose due to moving out of area and 4 participants did not receive the second dose due to the COVID-19 pandemic|7
10836995|NCT03814720|12002500|FG003|Received All Product Administrations|Overall Study|Three (3) participants did not receive the second dose due to the COVID-19 pandemic|9
10836996|NCT03814720|12002501|FG004|Received All Product Administrations|Overall Study|Four (4) participants did not receive the second dose due to the COVID-19 pandemic|7
10836997|NCT03814720|12002497|FG000|COMPLETED|Overall Study||5
10836998|NCT03814720|12002498|FG001|COMPLETED|Overall Study||11
10836999|NCT03814720|12002499|FG002|COMPLETED|Overall Study||12
10837000|NCT03814720|12002500|FG003|COMPLETED|Overall Study||12
10837001|NCT03814720|12002501|FG004|COMPLETED|Overall Study||11
10837002|NCT03814720|12002497|FG000|NOT COMPLETED|Overall Study||0
10837003|NCT03814720|12002498|FG001|NOT COMPLETED|Overall Study||1
10837004|NCT03814720|12002499|FG002|NOT COMPLETED|Overall Study||0
10837005|NCT03814720|12002500|FG003|NOT COMPLETED|Overall Study||0
10837006|NCT03814720|12002501|FG004|NOT COMPLETED|Overall Study||0
10837007|NCT03635424|12002515|FG000|STARTED|Overall Study||150
10837008|NCT03635424|12002515|FG000|COMPLETED|Overall Study||147
10837009|NCT03635424|12002515|FG000|NOT COMPLETED|Overall Study||3
10837010|NCT03529110|12002521|FG000|STARTED|Overall Study||261
10837011|NCT03529110|12002522|FG001|STARTED|Overall Study||263
10837012|NCT03529110|12002521|FG000|COMPLETED|Overall Study||136
10837013|NCT03529110|12002522|FG001|COMPLETED|Overall Study||49
10837014|NCT03529110|12002521|FG000|NOT COMPLETED|Overall Study||125
10837015|NCT03529110|12002522|FG001|NOT COMPLETED|Overall Study||214
10837016|NCT03517540|12002532|FG000|STARTED|Overall Study||50
10837017|NCT03517540|12002533|FG001|STARTED|Overall Study||48
10837018|NCT03517540|12002534|FG002|STARTED|Overall Study||47
10837019|NCT03517540|12002535|FG003|STARTED|Overall Study||48
10837020|NCT03517540|12002532|FG000|COMPLETED|Overall Study||36
10837021|NCT03517540|12002533|FG001|COMPLETED|Overall Study||41
10837022|NCT03517540|12002534|FG002|COMPLETED|Overall Study||38
10837023|NCT03517540|12002535|FG003|COMPLETED|Overall Study||43
10837024|NCT03517540|12002532|FG000|NOT COMPLETED|Overall Study||14
10837025|NCT03517540|12002533|FG001|NOT COMPLETED|Overall Study||7
10837026|NCT03517540|12002534|FG002|NOT COMPLETED|Overall Study||9
10837027|NCT03517540|12002535|FG003|NOT COMPLETED|Overall Study||5
10837028|NCT03443635|12002547|FG000|STARTED|Overall Study||2616
10837029|NCT03443635|12002548|FG001|STARTED|Overall Study||4576
10837030|NCT03443635|12002547|FG000|COMPLETED|Overall Study||2127
10837031|NCT03443635|12002548|FG001|COMPLETED|Overall Study||3720
10837032|NCT03443635|12002547|FG000|NOT COMPLETED|Overall Study||489
10837033|NCT03443635|12002548|FG001|NOT COMPLETED|Overall Study||856
10837034|NCT03437278|12002557|FG000|STARTED|Overall Study||24
10837035|NCT03437278|12002558|FG001|STARTED|Overall Study||13
10837036|NCT03437278|12002559|FG002|STARTED|Overall Study||12
10837037|NCT03437278|12002557|FG000|COMPLETED|Overall Study||22
10837038|NCT03437278|12002558|FG001|COMPLETED|Overall Study||13
10837039|NCT03437278|12002559|FG002|COMPLETED|Overall Study||10
10837040|NCT03437278|12002557|FG000|NOT COMPLETED|Overall Study||2
10837041|NCT03437278|12002558|FG001|NOT COMPLETED|Overall Study||0
10837042|NCT03437278|12002559|FG002|NOT COMPLETED|Overall Study||2
10837043|NCT03350815|12002569|FG000|STARTED|Period 1||322
10837044|NCT03350815|12002570|FG001|STARTED|Period 1||0
10837045|NCT03350815|12002571|FG002|STARTED|Period 1||0
10837046|NCT03350815|12002572|FG003|STARTED|Period 1||0
10837047|NCT03350815|12002569|FG000|Non-responders|Period 1||50
10837048|NCT03350815|12002570|FG001|Non-responders|Period 1||0
10837049|NCT03350815|12002571|FG002|Non-responders|Period 1||0
10837050|NCT03350815|12002572|FG003|Non-responders|Period 1||0
10837051|NCT03350815|12002569|FG000|Inadequate Responders|Period 1||207
10837052|NCT03350815|12002570|FG001|Inadequate Responders|Period 1||0
10837053|NCT03350815|12002571|FG002|Inadequate Responders|Period 1||0
10837054|NCT03350815|12002572|FG003|Inadequate Responders|Period 1||0
10837055|NCT03350815|12002569|FG000|Responders|Period 1||22
10837056|NCT03350815|12002570|FG001|Responders|Period 1||0
10837057|NCT03350815|12002571|FG002|Responders|Period 1||0
10837058|NCT03350815|12002572|FG003|Responders|Period 1||0
10837059|NCT03350815|12002569|FG000|COMPLETED|Period 1||279
10837060|NCT03350815|12002570|FG001|COMPLETED|Period 1||0
10837061|NCT03350815|12002571|FG002|COMPLETED|Period 1||0
10837062|NCT03350815|12002572|FG003|COMPLETED|Period 1||0
10837063|NCT03350815|12002569|FG000|NOT COMPLETED|Period 1||43
10837064|NCT03350815|12002570|FG001|NOT COMPLETED|Period 1||0
10837065|NCT03350815|12002571|FG002|NOT COMPLETED|Period 1||0
10837066|NCT03350815|12002572|FG003|NOT COMPLETED|Period 1||0
10837067|NCT03350815|12002569|FG000|STARTED|Period 2||0
10837068|NCT03350815|12002570|FG001|STARTED|Period 2||102
10837069|NCT03350815|12002571|FG002|STARTED|Period 2||105
10837070|NCT03350815|12002572|FG003|STARTED|Period 2||22
10837071|NCT03350815|12002569|FG000|COMPLETED|Period 2||0
10837072|NCT03350815|12002570|FG001|COMPLETED|Period 2||86
10837073|NCT03350815|12002571|FG002|COMPLETED|Period 2||88
10837074|NCT03350815|12002572|FG003|COMPLETED|Period 2||22
10837075|NCT03350815|12002569|FG000|NOT COMPLETED|Period 2||0
10837076|NCT03350815|12002570|FG001|NOT COMPLETED|Period 2||16
10837077|NCT03350815|12002571|FG002|NOT COMPLETED|Period 2||17
10837078|NCT03350815|12002572|FG003|NOT COMPLETED|Period 2||0
10837079|NCT03249714|12002585|FG000|STARTED|Double-blind Treatment (Core Part)||43
10837080|NCT03249714|12002586|FG001|STARTED|Double-blind Treatment (Core Part)||21
10837081|NCT03249714|12002585|FG000|COMPLETED|Double-blind Treatment (Core Part)||40
10837082|NCT03249714|12002586|FG001|COMPLETED|Double-blind Treatment (Core Part)||19
10837083|NCT03249714|12002585|FG000|NOT COMPLETED|Double-blind Treatment (Core Part)||3
10837084|NCT03249714|12002586|FG001|NOT COMPLETED|Double-blind Treatment (Core Part)||2
10837085|NCT03249714|12002585|FG000|STARTED|Open-label Treatment (Extension Part)||40
10837086|NCT03249714|12002586|FG001|STARTED|Open-label Treatment (Extension Part)||19
10837087|NCT03249714|12002585|FG000|COMPLETED|Open-label Treatment (Extension Part)||38
10837088|NCT03249714|12002586|FG001|COMPLETED|Open-label Treatment (Extension Part)||19
10837089|NCT03249714|12002585|FG000|NOT COMPLETED|Open-label Treatment (Extension Part)||2
10837090|NCT03249714|12002586|FG001|NOT COMPLETED|Open-label Treatment (Extension Part)||0
10837091|NCT03170882|12002610|FG000|STARTED|Overall Study||49
10837092|NCT03170882|12002611|FG001|STARTED|Overall Study||73
10837093|NCT03170882|12002610|FG000|Treated: Safety Population|Overall Study||47
10837094|NCT03170882|12002611|FG001|Treated: Safety Population|Overall Study||72
10837095|NCT03170882|12002610|FG000|ITT PRO Population|Overall Study||45
10837096|NCT03170882|12002611|FG001|ITT PRO Population|Overall Study||70
10837097|NCT03170882|12002610|FG000|COMPLETED|Overall Study||20
10837098|NCT03170882|12002611|FG001|COMPLETED|Overall Study||22
10837099|NCT03170882|12002610|FG000|NOT COMPLETED|Overall Study||29
10837100|NCT03170882|12002611|FG001|NOT COMPLETED|Overall Study||51
10837101|NCT03074318|12002621|FG000|STARTED|Overall Study||6
10837102|NCT03074318|12002622|FG001|STARTED|Overall Study||7
10837103|NCT03074318|12002623|FG002|STARTED|Overall Study||6
10837104|NCT03074318|12002624|FG003|STARTED|Overall Study||16
10837105|NCT03074318|12002621|FG000|COMPLETED|Overall Study||2
10837106|NCT03074318|12002622|FG001|COMPLETED|Overall Study||2
10837107|NCT03074318|12002623|FG002|COMPLETED|Overall Study||0
10837108|NCT03074318|12002624|FG003|COMPLETED|Overall Study||0
10837109|NCT03074318|12002621|FG000|NOT COMPLETED|Overall Study||4
10837110|NCT03074318|12002622|FG001|NOT COMPLETED|Overall Study||5
10837111|NCT03074318|12002623|FG002|NOT COMPLETED|Overall Study||6
10837112|NCT03074318|12002624|FG003|NOT COMPLETED|Overall Study||16
10837113|NCT03010319|12002645|FG000|STARTED|Overall Study||110
10837114|NCT03010319|12002646|FG001|STARTED|Overall Study||116
10837115|NCT03010319|12002645|FG000|COMPLETED|Overall Study||84
10837116|NCT03010319|12002646|FG001|COMPLETED|Overall Study||87
10837117|NCT03010319|12002645|FG000|NOT COMPLETED|Overall Study||26
10837118|NCT03010319|12002646|FG001|NOT COMPLETED|Overall Study||29
10837119|NCT02915016|12002660|FG000|STARTED|Overall Study||30
10837120|NCT02915016|12002661|FG001|STARTED|Overall Study||50
10837121|NCT02915016|12002662|FG002|STARTED|Overall Study||50
10837122|NCT02915016|12002663|FG003|STARTED|Overall Study||30
10837123|NCT02915016|12002664|FG004|STARTED|Overall Study||50
10837124|NCT02915016|12002665|FG005|STARTED|Overall Study||50
10837125|NCT02915016|12002666|FG006|STARTED|Overall Study||50
10837126|NCT02915016|12002667|FG007|STARTED|Overall Study||24
10837127|NCT02915016|12002660|FG000|Month 6.5 Immunogenicity Timepoint|Overall Study||23
10837128|NCT02915016|12002661|FG001|Month 6.5 Immunogenicity Timepoint|Overall Study||49
10837129|NCT02915016|12002662|FG002|Month 6.5 Immunogenicity Timepoint|Overall Study||46
10837130|NCT02915016|12002663|FG003|Month 6.5 Immunogenicity Timepoint|Overall Study||26
10837131|NCT02915016|12002664|FG004|Month 6.5 Immunogenicity Timepoint|Overall Study||43
10837132|NCT02915016|12002665|FG005|Month 6.5 Immunogenicity Timepoint|Overall Study||42
10837133|NCT02915016|12002666|FG006|Month 6.5 Immunogenicity Timepoint|Overall Study||42
10837134|NCT02915016|12002667|FG007|Month 6.5 Immunogenicity Timepoint|Overall Study||21
10837135|NCT02915016|12002660|FG000|COMPLETED|Overall Study||23
10837136|NCT02915016|12002661|FG001|COMPLETED|Overall Study||47
10837137|NCT02915016|12002662|FG002|COMPLETED|Overall Study||42
10837138|NCT02915016|12002663|FG003|COMPLETED|Overall Study||26
10837139|NCT02915016|12002664|FG004|COMPLETED|Overall Study||43
10837140|NCT02915016|12002665|FG005|COMPLETED|Overall Study||44
10837141|NCT02915016|12002666|FG006|COMPLETED|Overall Study||38
10837142|NCT02915016|12002667|FG007|COMPLETED|Overall Study||20
10837143|NCT02915016|12002660|FG000|NOT COMPLETED|Overall Study||7
10837144|NCT02915016|12002661|FG001|NOT COMPLETED|Overall Study||3
10837145|NCT02915016|12002662|FG002|NOT COMPLETED|Overall Study||8
10837146|NCT02915016|12002663|FG003|NOT COMPLETED|Overall Study||4
10837147|NCT02915016|12002664|FG004|NOT COMPLETED|Overall Study||7
10837148|NCT02915016|12002665|FG005|NOT COMPLETED|Overall Study||6
10837149|NCT02915016|12002666|FG006|NOT COMPLETED|Overall Study||12
10837150|NCT02915016|12002667|FG007|NOT COMPLETED|Overall Study||4
10837151|NCT02871401|12002687|FG000|STARTED|Overall Study||20
10837152|NCT02871401|12002688|FG001|STARTED|Overall Study||11
10837153|NCT02871401|12002687|FG000|COMPLETED|Overall Study||19
10837154|NCT02871401|12002688|FG001|COMPLETED|Overall Study||11
10837155|NCT02871401|12002687|FG000|NOT COMPLETED|Overall Study||1
10837156|NCT02871401|12002688|FG001|NOT COMPLETED|Overall Study||0
10837157|NCT02811913|12002694|FG000|STARTED|Overall Study||20
10837158|NCT02811913|12002694|FG000|COMPLETED|Overall Study||16
10837159|NCT02811913|12002694|FG000|NOT COMPLETED|Overall Study||4
10837160|NCT02701283|12002706|FG000|STARTED|Overall Study||737
10837161|NCT02701283|12002707|FG001|STARTED|Overall Study||741
10837162|NCT02701283|12002708|FG002|STARTED|Overall Study||745
10837163|NCT02701283|12002706|FG000|As Treated (Attempted Implant)|Overall Study||730
10837164|NCT02701283|12002707|FG001|As Treated (Attempted Implant)|Overall Study||684
10837165|NCT02701283|12002708|FG002|As Treated (Attempted Implant)|Overall Study||745
10837166|NCT02701283|12002706|FG000|Implanted|Overall Study||727
10837167|NCT02701283|12002707|FG001|Implanted|Overall Study||686
10837168|NCT02701283|12002708|FG002|Implanted|Overall Study||745
10837169|NCT02701283|12002706|FG000|COMPLETED|Overall Study||668
10837170|NCT02701283|12002707|FG001|COMPLETED|Overall Study||579
10837171|NCT02701283|12002708|FG002|COMPLETED|Overall Study||724
10837172|NCT02701283|12002706|FG000|NOT COMPLETED|Overall Study||69
10837173|NCT02701283|12002707|FG001|NOT COMPLETED|Overall Study||162
10837174|NCT02701283|12002708|FG002|NOT COMPLETED|Overall Study||21
10837175|NCT02696031|12002722|FG000|STARTED|Up to Week 24||185
10837176|NCT02696031|12002723|FG001|STARTED|Up to Week 24||184
10837177|NCT02696031|12002724|FG002|STARTED|Up to Week 24||186
10837178|NCT02696031|12002725|FG003|STARTED|Up to Week 24||0
10837179|NCT02696031|12002726|FG004|STARTED|Up to Week 24||0
10837180|NCT02696031|12002727|FG005|STARTED|Up to Week 24||0
10837181|NCT02696031|12002722|FG000|COMPLETED|Up to Week 24||175
10837182|NCT02696031|12002723|FG001|COMPLETED|Up to Week 24||177
10837183|NCT02696031|12002724|FG002|COMPLETED|Up to Week 24||175
10837184|NCT02696031|12002725|FG003|COMPLETED|Up to Week 24||0
10837185|NCT02696031|12002726|FG004|COMPLETED|Up to Week 24||0
10837186|NCT02696031|12002727|FG005|COMPLETED|Up to Week 24||0
10837187|NCT02696031|12002722|FG000|NOT COMPLETED|Up to Week 24||10
10837188|NCT02696031|12002723|FG001|NOT COMPLETED|Up to Week 24||7
10837189|NCT02696031|12002724|FG002|NOT COMPLETED|Up to Week 24||11
10837190|NCT02696031|12002725|FG003|NOT COMPLETED|Up to Week 24||0
10837191|NCT02696031|12002726|FG004|NOT COMPLETED|Up to Week 24||0
10837192|NCT02696031|12002727|FG005|NOT COMPLETED|Up to Week 24||0
10837193|NCT02696031|12002722|FG000|STARTED|Up to Week 52||185
10837194|NCT02696031|12002723|FG001|STARTED|Up to Week 52||184
10837195|NCT02696031|12002724|FG002|STARTED|Up to Week 52||186
10837196|NCT02696031|12002725|FG003|STARTED|Up to Week 52||0
10837197|NCT02696031|12002726|FG004|STARTED|Up to Week 52||0
10837198|NCT02696031|12002727|FG005|STARTED|Up to Week 52||0
10837199|NCT02696031|12002722|FG000|COMPLETED|Up to Week 52||156
10837200|NCT02696031|12002723|FG001|COMPLETED|Up to Week 52||165
10837201|NCT02696031|12002724|FG002|COMPLETED|Up to Week 52||160
10837202|NCT02696031|12002725|FG003|COMPLETED|Up to Week 52||0
10837203|NCT02696031|12002726|FG004|COMPLETED|Up to Week 52||0
10837204|NCT02696031|12002727|FG005|COMPLETED|Up to Week 52||0
10837205|NCT02696031|12002722|FG000|NOT COMPLETED|Up to Week 52||29
10837206|NCT02696031|12002723|FG001|NOT COMPLETED|Up to Week 52||19
10837207|NCT02696031|12002724|FG002|NOT COMPLETED|Up to Week 52||26
10837208|NCT02696031|12002725|FG003|NOT COMPLETED|Up to Week 52||0
10837209|NCT02696031|12002726|FG004|NOT COMPLETED|Up to Week 52||0
10837210|NCT02696031|12002727|FG005|NOT COMPLETED|Up to Week 52||0
10837211|NCT02696031|12002722|FG000|STARTED|Up to Week 104||185
10837212|NCT02696031|12002723|FG001|STARTED|Up to Week 104||184
10837213|NCT02696031|12002724|FG002|STARTED|Up to Week 104||186
10837214|NCT02696031|12002725|FG003|STARTED|Up to Week 104||0
10837215|NCT02696031|12002726|FG004|STARTED|Up to Week 104||0
10837216|NCT02696031|12002727|FG005|STARTED|Up to Week 104||0
10837217|NCT02696031|12002722|FG000|COMPLETED|Up to Week 104||146
10837218|NCT02696031|12002723|FG001|COMPLETED|Up to Week 104||143
10837219|NCT02696031|12002724|FG002|COMPLETED|Up to Week 104||149
10314275|NCT00159965|11447775|FG001|STARTED|Overall Study||19
10314276|NCT00159965|11447774|FG000|COMPLETED|Overall Study||12
10314277|NCT00159965|11447775|FG001|COMPLETED|Overall Study||14
10314278|NCT00159965|11447774|FG000|NOT COMPLETED|Overall Study||7
10314279|NCT00159965|11447775|FG001|NOT COMPLETED|Overall Study||5
10314280|NCT00160199|11447783|FG000|STARTED|Overall Study||122
10314281|NCT00160199|11447784|FG001|STARTED|Overall Study||118
10409800|NCT00760578|11553827|FG002|STARTED|Overall Study||21
10409801|NCT00760578|11553828|FG003|STARTED|Overall Study||22
10837220|NCT02696031|12002725|FG003|COMPLETED|Up to Week 104||0
10837221|NCT02696031|12002726|FG004|COMPLETED|Up to Week 104||0
10837222|NCT02696031|12002727|FG005|COMPLETED|Up to Week 104||0
10837223|NCT02696031|12002722|FG000|NOT COMPLETED|Up to Week 104||39
10837224|NCT02696031|12002723|FG001|NOT COMPLETED|Up to Week 104||41
10837225|NCT02696031|12002724|FG002|NOT COMPLETED|Up to Week 104||37
10837226|NCT02696031|12002725|FG003|NOT COMPLETED|Up to Week 104||0
10837227|NCT02696031|12002726|FG004|NOT COMPLETED|Up to Week 104||0
10314282|NCT00160199|11447783|FG000|COMPLETED|Overall Study||98
10314283|NCT00160199|11447784|FG001|COMPLETED|Overall Study||81
10314284|NCT00160199|11447783|FG000|NOT COMPLETED|Overall Study||24
10837228|NCT02696031|12002727|FG005|NOT COMPLETED|Up to Week 104||0
10837229|NCT02696031|12002722|FG000|STARTED|Extension Phase From wk 104 to wk 208||0
10837230|NCT02696031|12002723|FG001|STARTED|Extension Phase From wk 104 to wk 208||0
10837231|NCT02696031|12002724|FG002|STARTED|Extension Phase From wk 104 to wk 208||0
10837232|NCT02696031|12002725|FG003|STARTED|Extension Phase From wk 104 to wk 208||147
10837233|NCT02696031|12002726|FG004|STARTED|Extension Phase From wk 104 to wk 208||147
10837234|NCT02696031|12002727|FG005|STARTED|Extension Phase From wk 104 to wk 208||78
10837235|NCT02696031|12002722|FG000|COMPLETED|Extension Phase From wk 104 to wk 208||0
10837236|NCT02696031|12002723|FG001|COMPLETED|Extension Phase From wk 104 to wk 208||0
10837237|NCT02696031|12002724|FG002|COMPLETED|Extension Phase From wk 104 to wk 208||0
10837238|NCT02696031|12002725|FG003|COMPLETED|Extension Phase From wk 104 to wk 208||137
10837239|NCT02696031|12002726|FG004|COMPLETED|Extension Phase From wk 104 to wk 208||132
10837240|NCT02696031|12002727|FG005|COMPLETED|Extension Phase From wk 104 to wk 208||72
10837241|NCT02696031|12002722|FG000|NOT COMPLETED|Extension Phase From wk 104 to wk 208||0
10837242|NCT02696031|12002723|FG001|NOT COMPLETED|Extension Phase From wk 104 to wk 208||0
10837243|NCT02696031|12002724|FG002|NOT COMPLETED|Extension Phase From wk 104 to wk 208||0
10837244|NCT02696031|12002725|FG003|NOT COMPLETED|Extension Phase From wk 104 to wk 208||10
10837245|NCT02696031|12002726|FG004|NOT COMPLETED|Extension Phase From wk 104 to wk 208||15
10837246|NCT02696031|12002727|FG005|NOT COMPLETED|Extension Phase From wk 104 to wk 208||6
10409802|NCT00760578|11553825|FG000|Entered Drug Treatment Period|Overall Study||21
10409803|NCT00760578|11553826|FG001|Entered Drug Treatment Period|Overall Study||20
10409804|NCT00760578|11553827|FG002|Entered Drug Treatment Period|Overall Study||19
10409805|NCT00760578|11553828|FG003|Entered Drug Treatment Period|Overall Study||22
10409806|NCT00760578|11553825|FG000|COMPLETED|Overall Study||19
10409807|NCT00760578|11553826|FG001|COMPLETED|Overall Study||19
10409808|NCT00760578|11553827|FG002|COMPLETED|Overall Study||16
10409809|NCT00760578|11553828|FG003|COMPLETED|Overall Study||18
10409810|NCT00760578|11553825|FG000|NOT COMPLETED|Overall Study||3
10409811|NCT00760578|11553826|FG001|NOT COMPLETED|Overall Study||2
10409812|NCT00760578|11553827|FG002|NOT COMPLETED|Overall Study||5
10409813|NCT00760578|11553828|FG003|NOT COMPLETED|Overall Study||4
10409814|NCT00760617|11553846|FG000|STARTED|Overall Study||266
10409815|NCT00760617|11553847|FG001|STARTED|Overall Study||144
10409816|NCT00760617|11553848|FG002|STARTED|Overall Study||116
10409817|NCT00760617|11553846|FG000|COMPLETED|Overall Study||261
10409818|NCT00760617|11553847|FG001|COMPLETED|Overall Study||142
10409819|NCT00760617|11553848|FG002|COMPLETED|Overall Study||111
10409820|NCT00760617|11553846|FG000|NOT COMPLETED|Overall Study||5
10409821|NCT00760617|11553847|FG001|NOT COMPLETED|Overall Study||2
10409822|NCT00760617|11553848|FG002|NOT COMPLETED|Overall Study||5
10409823|NCT00760669|11553856|FG000|STARTED|Overall Study||1061
10409824|NCT00760669|11553856|FG000|COMPLETED|Overall Study||1031
10409825|NCT00760669|11553856|FG000|NOT COMPLETED|Overall Study||30
10409826|NCT00760747|11553862|FG000|STARTED|Study Period II||57
10409827|NCT00760747|11553863|FG001|STARTED|Study Period II||55
10409828|NCT00760747|11553862|FG000|Received at Least One Dose of Study Drug|Study Period II||57
10409829|NCT00760747|11553863|FG001|Received at Least One Dose of Study Drug|Study Period II||54
10409830|NCT00760747|11553862|FG000|COMPLETED|Study Period II||44
10409831|NCT00760747|11553863|FG001|COMPLETED|Study Period II||41
10409832|NCT00760747|11553862|FG000|NOT COMPLETED|Study Period II||13
10409833|NCT00760747|11553863|FG001|NOT COMPLETED|Study Period II||14
10409834|NCT00760747|11553862|FG000|STARTED|Study Period III||44
10409835|NCT00760747|11553863|FG001|STARTED|Study Period III||41
10409836|NCT00760747|11553862|FG000|COMPLETED|Study Period III||41
10409837|NCT00760747|11553863|FG001|COMPLETED|Study Period III||38
10409838|NCT00760747|11553862|FG000|NOT COMPLETED|Study Period III||3
10837247|NCT02689453|12002739|FG000|STARTED|Overall Study||3
10837248|NCT02689453|12002740|FG001|STARTED|Overall Study||4
10837249|NCT02689453|12002741|FG002|STARTED|Overall Study||4
10837250|NCT02689453|12002739|FG000|COMPLETED|Overall Study||3
10837251|NCT02689453|12002740|FG001|COMPLETED|Overall Study||3
10837252|NCT02689453|12002741|FG002|COMPLETED|Overall Study||3
10837253|NCT02689453|12002739|FG000|NOT COMPLETED|Overall Study||0
10837254|NCT02689453|12002740|FG001|NOT COMPLETED|Overall Study||1
10837255|NCT02689453|12002741|FG002|NOT COMPLETED|Overall Study||1
10837256|NCT02476851|12002753|FG000|STARTED|Overall Study||31
10837257|NCT02476851|12002754|FG001|STARTED|Overall Study||31
10837258|NCT02476851|12002753|FG000|COMPLETED|Overall Study||30
10837259|NCT02476851|12002754|FG001|COMPLETED|Overall Study||30
10837260|NCT02476851|12002753|FG000|NOT COMPLETED|Overall Study||1
10837261|NCT02476851|12002754|FG001|NOT COMPLETED|Overall Study||1
10837268|NCT02310919|12002771|FG000|STARTED|Overall Study||54
10837269|NCT02310919|12002772|FG001|STARTED|Overall Study||51
10409839|NCT00760747|11553863|FG001|NOT COMPLETED|Study Period III||3
10409840|NCT00760838|11553871|FG000|STARTED|Overall Study||54
10409841|NCT00760838|11553872|FG001|STARTED|Overall Study||55
10409842|NCT00760838|11553871|FG000|COMPLETED|Overall Study||49
10409843|NCT00760838|11553872|FG001|COMPLETED|Overall Study||53
10409844|NCT00760838|11553871|FG000|NOT COMPLETED|Overall Study||5
10409845|NCT00760838|11553872|FG001|NOT COMPLETED|Overall Study||2
10409846|NCT00760877|11553880|FG000|STARTED|Overall Study||104
10409847|NCT00760877|11553881|FG001|STARTED|Overall Study||103
10409848|NCT00760877|11553880|FG000|Cross-over to Nilotinib|Overall Study|Not applicable: cross-over occurred from imatinib to nilotinib only.|0
10409849|NCT00760877|11553881|FG001|Cross-over to Nilotinib|Overall Study||46
10409850|NCT00760877|11553880|FG000|Safety Set|Overall Study||101
10409851|NCT00760877|11553881|FG001|Safety Set|Overall Study||103
10409852|NCT00760877|11553880|FG000|COMPLETED|Overall Study||59
10409853|NCT00760877|11553881|FG001|COMPLETED|Overall Study||77
10409854|NCT00760877|11553880|FG000|NOT COMPLETED|Overall Study||45
10409855|NCT00760877|11553881|FG001|NOT COMPLETED|Overall Study||26
10409856|NCT00760929|11553892|FG000|STARTED|Overall Study||26
10409857|NCT00760929|11553893|FG001|STARTED|Overall Study||29
10409858|NCT00760929|11553894|FG002|STARTED|Overall Study||59
10409859|NCT00760929|11553895|FG003|STARTED|Overall Study||57
10409860|NCT00760929|11553892|FG000|COMPLETED|Overall Study||0
10409861|NCT00760929|11553893|FG001|COMPLETED|Overall Study||1
10409862|NCT00760929|11553894|FG002|COMPLETED|Overall Study||1
10409863|NCT00760929|11553895|FG003|COMPLETED|Overall Study||2
10409864|NCT00760929|11553892|FG000|NOT COMPLETED|Overall Study||26
10409865|NCT00760929|11553893|FG001|NOT COMPLETED|Overall Study||28
10409866|NCT00760929|11553894|FG002|NOT COMPLETED|Overall Study||58
10409867|NCT00760929|11553895|FG003|NOT COMPLETED|Overall Study||55
10409868|NCT00760994|11553907|FG000|STARTED|Overall Study||29
10409869|NCT00760994|11553908|FG001|STARTED|Overall Study||31
10409870|NCT00760994|11553909|FG002|STARTED|Overall Study||20
10409871|NCT00760994|11553907|FG000|COMPLETED|Overall Study||25
10409872|NCT00760994|11553908|FG001|COMPLETED|Overall Study||27
10409873|NCT00760994|11553909|FG002|COMPLETED|Overall Study||17
10409874|NCT00760994|11553907|FG000|NOT COMPLETED|Overall Study||4
10409875|NCT00760994|11553908|FG001|NOT COMPLETED|Overall Study||4
10409876|NCT00760994|11553909|FG002|NOT COMPLETED|Overall Study||3
10409877|NCT00761007|11553923|FG000|STARTED|Overall Study||142
10409878|NCT00761007|11553924|FG001|STARTED|Overall Study||135
10409879|NCT00761007|11553925|FG002|STARTED|Overall Study||139
10409880|NCT00761007|11553926|FG003|STARTED|Overall Study||138
10409881|NCT00761007|11553923|FG000|Safety (>=1 Dose of Study Medication)|Overall Study||140
10409882|NCT00761007|11553924|FG001|Safety (>=1 Dose of Study Medication)|Overall Study||135
10409883|NCT00761007|11553925|FG002|Safety (>=1 Dose of Study Medication)|Overall Study||139
10409884|NCT00761007|11553926|FG003|Safety (>=1 Dose of Study Medication)|Overall Study||137
10409885|NCT00761007|11553923|FG000|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||140
10409886|NCT00761007|11553924|FG001|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||133
10409887|NCT00761007|11553925|FG002|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||135
10409888|NCT00761007|11553926|FG003|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||136
10409889|NCT00761007|11553923|FG000|COMPLETED|Overall Study||129
10409890|NCT00761007|11553924|FG001|COMPLETED|Overall Study||124
10409891|NCT00761007|11553925|FG002|COMPLETED|Overall Study||121
10409892|NCT00761007|11553926|FG003|COMPLETED|Overall Study||131
10409893|NCT00761007|11553923|FG000|NOT COMPLETED|Overall Study||13
10409894|NCT00761007|11553924|FG001|NOT COMPLETED|Overall Study||11
10409895|NCT00761007|11553925|FG002|NOT COMPLETED|Overall Study||18
10409896|NCT00761007|11553926|FG003|NOT COMPLETED|Overall Study||7
10409897|NCT00761085|11553940|FG000|STARTED|Overall Study||12
10409898|NCT00761085|11553941|FG001|STARTED|Overall Study||12
10409899|NCT00761085|11553942|FG002|STARTED|Overall Study||11
10409900|NCT00761085|11553943|FG003|STARTED|Overall Study||12
10409901|NCT00761085|11553940|FG000|COMPLETED|Overall Study||12
10409902|NCT00761085|11553941|FG001|COMPLETED|Overall Study||6
10837270|NCT02310919|12002771|FG000|COMPLETED|Overall Study|Four participants receiving the study trigger deviated from protocol. One patient was randomized before her E2 resulted >5,000 pg/ml. Another elected to convert to intrauterine insemination while another underwent oocyte cryopreservation as their male partner was unable to produce a fresh sperm sample for fertilization. The 4th patient inadvertently spilled a portion of the trigger prior to injection. Since her post-trigger hCG was <18 IU/L, she was unblinded and re-triggered with 10,000 IU hCG.|54
10837271|NCT02310919|12002772|FG001|COMPLETED|Overall Study|Two participants that received the standard trigger requested exclusionary embryo co-culture to be added post-trigger.|51
10837272|NCT02310919|12002771|FG000|NOT COMPLETED|Overall Study||0
10837273|NCT02310919|12002772|FG001|NOT COMPLETED|Overall Study||0
10837274|NCT02208024|12002779|FG000|STARTED|Overall Study||18
10837275|NCT02208024|12002779|FG000|COMPLETED|Overall Study||17
10837276|NCT02208024|12002779|FG000|NOT COMPLETED|Overall Study||1
10837277|NCT01866111|12002787|FG000|STARTED|Double-blind Period of Study YKP3089C017||108
10837278|NCT01866111|12002788|FG001|STARTED|Double-blind Period of Study YKP3089C017||108
10837279|NCT01866111|12002789|FG002|STARTED|Double-blind Period of Study YKP3089C017||110
10837280|NCT01866111|12002790|FG003|STARTED|Double-blind Period of Study YKP3089C017||111
10837281|NCT01866111|12002787|FG000|COMPLETED|Double-blind Period of Study YKP3089C017||94
10837282|NCT01866111|12002788|FG001|COMPLETED|Double-blind Period of Study YKP3089C017||95
10837283|NCT01866111|12002789|FG002|COMPLETED|Double-blind Period of Study YKP3089C017||90
10837284|NCT01866111|12002790|FG003|COMPLETED|Double-blind Period of Study YKP3089C017||81
10837285|NCT01866111|12002787|FG000|NOT COMPLETED|Double-blind Period of Study YKP3089C017||14
10837286|NCT01866111|12002788|FG001|NOT COMPLETED|Double-blind Period of Study YKP3089C017||13
10837287|NCT01866111|12002789|FG002|NOT COMPLETED|Double-blind Period of Study YKP3089C017||20
10837288|NCT01866111|12002790|FG003|NOT COMPLETED|Double-blind Period of Study YKP3089C017||30
10837289|NCT01866111|12002787|FG000|STARTED|Open-label Extension Study YKP3089C017|Not all patients from double-blind rolled over to open-label|91
10837290|NCT01866111|12002788|FG001|STARTED|Open-label Extension Study YKP3089C017||95
10837291|NCT01866111|12002789|FG002|STARTED|Open-label Extension Study YKP3089C017||90
10837292|NCT01866111|12002790|FG003|STARTED|Open-label Extension Study YKP3089C017|Not all patients from double-blind rolled over to open-label|80
10409903|NCT00761085|11553942|FG002|COMPLETED|Overall Study||11
10409904|NCT00761085|11553943|FG003|COMPLETED|Overall Study||8
10409905|NCT00761085|11553940|FG000|NOT COMPLETED|Overall Study||0
10409906|NCT00761085|11553941|FG001|NOT COMPLETED|Overall Study||6
10409907|NCT00761085|11553942|FG002|NOT COMPLETED|Overall Study||0
10409908|NCT00761085|11553943|FG003|NOT COMPLETED|Overall Study||4
10409909|NCT00761137|11553953|FG000|STARTED|Overall Study||19
10409910|NCT00761137|11553953|FG000|Placebo|Overall Study||19
10409911|NCT00761137|11553953|FG000|0.3 mg Tropicamide|Overall Study||19
10409912|NCT00761137|11553953|FG000|1 mg Tropicamide|Overall Study||19
10409913|NCT00761137|11553953|FG000|3 mg Tropicamide|Overall Study||19
10409914|NCT00761137|11553953|FG000|COMPLETED|Overall Study||19
10409915|NCT00761137|11553953|FG000|NOT COMPLETED|Overall Study||0
10409916|NCT00761150|11553963|FG000|STARTED|Open-label Period||308
10409917|NCT00761150|11553964|FG001|STARTED|Open-label Period||0
10409918|NCT00761150|11553965|FG002|STARTED|Open-label Period||0
10409919|NCT00761150|11553963|FG000|COMPLETED|Open-label Period||238
10409920|NCT00761150|11553964|FG001|COMPLETED|Open-label Period||0
10409921|NCT00761150|11553965|FG002|COMPLETED|Open-label Period||0
10409922|NCT00761150|11553963|FG000|NOT COMPLETED|Open-label Period||70
10409923|NCT00761150|11553964|FG001|NOT COMPLETED|Open-label Period||0
10409924|NCT00761150|11553965|FG002|NOT COMPLETED|Open-label Period||0
10409925|NCT00761150|11553963|FG000|STARTED|Double-blind Period||0
10409926|NCT00761150|11553964|FG001|STARTED|Double-blind Period||120
10409927|NCT00761150|11553965|FG002|STARTED|Double-blind Period||118
10409928|NCT00761150|11553963|FG000|COMPLETED|Double-blind Period||0
10409929|NCT00761150|11553964|FG001|COMPLETED|Double-blind Period||106
10409930|NCT00761150|11553965|FG002|COMPLETED|Double-blind Period||89
10409931|NCT00761150|11553963|FG000|NOT COMPLETED|Double-blind Period||0
10409932|NCT00761150|11553964|FG001|NOT COMPLETED|Double-blind Period||14
10409933|NCT00761150|11553965|FG002|NOT COMPLETED|Double-blind Period||29
10409934|NCT00761189|11553972|FG000|STARTED|Overall Study||491
10409935|NCT00761189|11553972|FG000|COMPLETED|Overall Study||306
10409936|NCT00761189|11553972|FG000|NOT COMPLETED|Overall Study||185
10409937|NCT00761202|11553978|FG000|STARTED|Overall Study||22
10409938|NCT00761202|11553979|FG001|STARTED|Overall Study||28
10409939|NCT00761202|11553978|FG000|COMPLETED|Overall Study||21
10409940|NCT00761202|11553979|FG001|COMPLETED|Overall Study||26
10409941|NCT00761202|11553978|FG000|NOT COMPLETED|Overall Study||1
10409942|NCT00761202|11553979|FG001|NOT COMPLETED|Overall Study||2
10409943|NCT00761215|11553988|FG000|STARTED|Overall Study||64
10409944|NCT00761215|11553989|FG001|STARTED|Overall Study||64
10409945|NCT00761215|11553990|FG002|STARTED|Overall Study||64
10409946|NCT00761215|11553988|FG000|COMPLETED|Overall Study||55
10409947|NCT00761215|11553989|FG001|COMPLETED|Overall Study||60
10409948|NCT00761215|11553990|FG002|COMPLETED|Overall Study||56
10409949|NCT00761215|11553988|FG000|NOT COMPLETED|Overall Study||9
10409950|NCT00761215|11553989|FG001|NOT COMPLETED|Overall Study||4
10409951|NCT00761215|11553990|FG002|NOT COMPLETED|Overall Study||8
10409952|NCT00761267|11554004|FG000|STARTED|Overall Study||20
10409953|NCT00761267|11554005|FG001|STARTED|Overall Study||20
10409954|NCT00761267|11554006|FG002|STARTED|Overall Study||30
10409955|NCT00761267|11554004|FG000|Treated|Overall Study||19
10409956|NCT00761267|11554005|FG001|Treated|Overall Study||19
10409957|NCT00761267|11554006|FG002|Treated|Overall Study||30
10837293|NCT01866111|12002787|FG000|COMPLETED|Open-label Extension Study YKP3089C017||26
10837294|NCT01866111|12002788|FG001|COMPLETED|Open-label Extension Study YKP3089C017||28
10837295|NCT01866111|12002789|FG002|COMPLETED|Open-label Extension Study YKP3089C017||27
10837296|NCT01866111|12002790|FG003|COMPLETED|Open-label Extension Study YKP3089C017||28
10837297|NCT01866111|12002787|FG000|NOT COMPLETED|Open-label Extension Study YKP3089C017||65
10837298|NCT01866111|12002788|FG001|NOT COMPLETED|Open-label Extension Study YKP3089C017||67
10837299|NCT01866111|12002789|FG002|NOT COMPLETED|Open-label Extension Study YKP3089C017||63
10837300|NCT01866111|12002790|FG003|NOT COMPLETED|Open-label Extension Study YKP3089C017||52
10837301|NCT01767129|12002800|FG000|STARTED|Treatment Period 1 (14 Days)||7
10837302|NCT01767129|12002801|FG001|STARTED|Treatment Period 1 (14 Days)||7
10837303|NCT01767129|12002800|FG000|COMPLETED|Treatment Period 1 (14 Days)||6
10837304|NCT01767129|12002801|FG001|COMPLETED|Treatment Period 1 (14 Days)||7
10837305|NCT01767129|12002800|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||1
10837306|NCT01767129|12002801|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||0
10837307|NCT01767129|12002800|FG000|STARTED|Treatment Period 2 (14 Days)||6
10837308|NCT01767129|12002801|FG001|STARTED|Treatment Period 2 (14 Days)||7
10837309|NCT01767129|12002800|FG000|COMPLETED|Treatment Period 2 (14 Days)||6
10837310|NCT01767129|12002801|FG001|COMPLETED|Treatment Period 2 (14 Days)||7
10837311|NCT01767129|12002800|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||0
10837312|NCT01767129|12002801|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||0
10409958|NCT00761267|11554004|FG000|COMPLETED|Overall Study||18
10409959|NCT00761267|11554005|FG001|COMPLETED|Overall Study||16
10409960|NCT00761267|11554006|FG002|COMPLETED|Overall Study||24
10409961|NCT00761267|11554004|FG000|NOT COMPLETED|Overall Study||2
10409962|NCT00761267|11554005|FG001|NOT COMPLETED|Overall Study||4
10409963|NCT00761267|11554006|FG002|NOT COMPLETED|Overall Study||6
10409964|NCT00761280|11554027|FG000|STARTED|Randomization to First Dose||14
10409965|NCT00761280|11554028|FG001|STARTED|Randomization to First Dose||13
10409966|NCT00761280|11554027|FG000|Catheter Surgery|Randomization to First Dose|Safety population|13
10409967|NCT00761280|11554028|FG001|Catheter Surgery|Randomization to First Dose|Not applicable to control group|0
10409968|NCT00761280|11554027|FG000|First Dose of Study Drug / Chemotherapy|Randomization to First Dose||12
10409969|NCT00761280|11554028|FG001|First Dose of Study Drug / Chemotherapy|Randomization to First Dose|Safety population|11
10409970|NCT00761280|11554027|FG000|COMPLETED|Randomization to First Dose||12
10409971|NCT00761280|11554028|FG001|COMPLETED|Randomization to First Dose||11
10409972|NCT00761280|11554027|FG000|NOT COMPLETED|Randomization to First Dose||2
10409973|NCT00761280|11554028|FG001|NOT COMPLETED|Randomization to First Dose||2
10409974|NCT00761280|11554027|FG000|STARTED|First Dose to End of Study||12
10409975|NCT00761280|11554028|FG001|STARTED|First Dose to End of Study||11
10409976|NCT00761280|11554027|FG000|COMPLETED|First Dose to End of Study|Study was discontinued early due to the inability to recruit a sufficient number of participants.|0
10409977|NCT00761280|11554028|FG001|COMPLETED|First Dose to End of Study|Study was discontinued early due to the inability to recruit a sufficient number of participants.|0
10409978|NCT00761280|11554027|FG000|NOT COMPLETED|First Dose to End of Study||12
10409979|NCT00761280|11554028|FG001|NOT COMPLETED|First Dose to End of Study||11
10409980|NCT00761306|11554034|FG000|STARTED|Overall Study||74
10409981|NCT00761306|11554034|FG000|COMPLETED|Overall Study||54
10409982|NCT00761306|11554034|FG000|NOT COMPLETED|Overall Study||20
10409983|NCT00761319|11554040|FG000|STARTED|Overall Study||353
10409984|NCT00761319|11554041|FG001|STARTED|Overall Study||352
10409985|NCT00761319|11554040|FG000|COMPLETED|Overall Study||305
10409986|NCT00761319|11554041|FG001|COMPLETED|Overall Study||318
10409987|NCT00761319|11554040|FG000|NOT COMPLETED|Overall Study||48
10409988|NCT00761319|11554041|FG001|NOT COMPLETED|Overall Study||34
10409989|NCT00761345|11554047|FG000|STARTED|Overall Study||27
10409990|NCT00761345|11554047|FG000|COMPLETED|Overall Study||24
10409991|NCT00761345|11554047|FG000|NOT COMPLETED|Overall Study||3
10409992|NCT00761462|11554053|FG000|STARTED|Treatment|Patients enrolled in study group|510
10409993|NCT00761462|11554054|FG001|STARTED|Treatment|Patients enrolled in study group|519
10409994|NCT00761462|11554053|FG000|COMPLETED|Treatment|Patients with confirmed intake of study drug|487
10409995|NCT00761462|11554054|FG001|COMPLETED|Treatment|Patients with confirmed intake of study drug|507
10409996|NCT00761462|11554053|FG000|NOT COMPLETED|Treatment||23
10409997|NCT00761462|11554054|FG001|NOT COMPLETED|Treatment||12
10409998|NCT00761462|11554053|FG000|STARTED|2 or 5 Years Long-term Safety Follow-up|Patients with confirmed intake of study drug entering long-term safety evaluation|487
10409999|NCT00761462|11554054|FG001|STARTED|2 or 5 Years Long-term Safety Follow-up|Patients with confirmed intake of study drug entering long-term safety evaluation|507
10410000|NCT00761462|11554053|FG000|4-6 Weeks Post Treatment|2 or 5 Years Long-term Safety Follow-up||487
10410001|NCT00761462|11554054|FG001|4-6 Weeks Post Treatment|2 or 5 Years Long-term Safety Follow-up||507
10410002|NCT00761462|11554053|FG000|1 Year Follow-up|2 or 5 Years Long-term Safety Follow-up||485
10410003|NCT00761462|11554054|FG001|1 Year Follow-up|2 or 5 Years Long-term Safety Follow-up||507
10410004|NCT00761462|11554053|FG000|COMPLETED|2 or 5 Years Long-term Safety Follow-up|Patients under safety evaluation at end of 5 year safety Follow-up.|333
10429166|NCT00862849|11575286|FG000|COMPLETED|Intervention 3||3
10837332|NCT01586910|12002832|FG000|STARTED|Overall Study||879
10837333|NCT01586910|12002833|FG001|STARTED|Overall Study||867
10837334|NCT01586910|12002832|FG000|COMPLETED|Overall Study||864
10837335|NCT01586910|12002833|FG001|COMPLETED|Overall Study||796
10837336|NCT01586910|12002832|FG000|NOT COMPLETED|Overall Study||15
10837337|NCT01586910|12002833|FG001|NOT COMPLETED|Overall Study||71
10837392|NCT00559936|12002893|FG000|STARTED|Overall Study||24
10837393|NCT00559936|12002893|FG000|COMPLETED|Overall Study||20
10837394|NCT00559936|12002893|FG000|NOT COMPLETED|Overall Study||4
10837395|NCT00504582|12002900|FG000|STARTED|Overall Study||47
10837396|NCT00504582|12002901|FG001|STARTED|Overall Study||45
10837397|NCT00504582|12002902|FG002|STARTED|Overall Study||20
10837398|NCT00504582|12002900|FG000|COMPLETED|Overall Study||46
10837399|NCT00504582|12002901|FG001|COMPLETED|Overall Study||45
10837400|NCT00504582|12002902|FG002|COMPLETED|Overall Study||20
10837401|NCT00504582|12002900|FG000|NOT COMPLETED|Overall Study||1
10837402|NCT00504582|12002901|FG001|NOT COMPLETED|Overall Study||0
10837403|NCT00504582|12002902|FG002|NOT COMPLETED|Overall Study||0
10837404|NCT02255487|12002912|FG000|STARTED|Overall Study||309
10837405|NCT02255487|12002913|FG001|STARTED|Overall Study||308
10837406|NCT02255487|12002912|FG000|Modified Intent to Treat (mITT)|Overall Study|"Within the ITT population, subjects with unknown age entries (modified ITT or mITT) were considered non-evaluable and excluded from the analysis. The mITT population was defined as patients 18 years of age or older."|293
10837407|NCT02255487|12002913|FG001|Modified Intent to Treat (mITT)|Overall Study|"Within the ITT population, subjects with unknown age entries (modified ITT or mITT) were considered non-evaluable and excluded from the analysis. The mITT population was defined as patients 18 years of age or older."|291
10837408|NCT02255487|12002912|FG000|COMPLETED|Overall Study||218
10837409|NCT02255487|12002913|FG001|COMPLETED|Overall Study||230
10837410|NCT02255487|12002912|FG000|NOT COMPLETED|Overall Study||91
10837411|NCT02255487|12002913|FG001|NOT COMPLETED|Overall Study||78
10837444|NCT02290431|12002968|FG000|STARTED|Overall Study||31
10837445|NCT02290431|12002968|FG000|Subjects. Discont. Prematurely|Overall Study||27
10837446|NCT02290431|12002968|FG000|Subjects Completed Study Per Protocol|Overall Study||8
10837447|NCT02290431|12002968|FG000|Subjs. Ntered Post-treatment Eval. Phase|Overall Study||31
10837448|NCT02290431|12002968|FG000|Subjects Entered Survival f/u Phase|Overall Study||24
10837449|NCT02290431|12002968|FG000|Entered Treatment Phase 2|Overall Study||17
10837450|NCT02290431|12002968|FG000|COMPLETED|Overall Study||4
10837451|NCT02290431|12002968|FG000|NOT COMPLETED|Overall Study||27
10837452|NCT02314923|12002982|FG000|STARTED|Overall Study||64
10837453|NCT02314923|12002983|FG001|STARTED|Overall Study||64
10837454|NCT02314923|12002984|FG002|STARTED|Overall Study||64
10837455|NCT02314923|12002985|FG003|STARTED|Overall Study||64
10837456|NCT02314923|12002986|FG004|STARTED|Overall Study||74
10837457|NCT02314923|12002987|FG005|STARTED|Overall Study||20
10837458|NCT02314923|12002988|FG006|STARTED|Overall Study||48
10837459|NCT02314923|12002989|FG007|STARTED|Overall Study||47
10837460|NCT02314923|12002990|FG008|STARTED|Overall Study||48
10837461|NCT02314923|12002991|FG009|STARTED|Overall Study||20
10837462|NCT02314923|12002982|FG000|Treated|Overall Study||64
10837463|NCT02314923|12002983|FG001|Treated|Overall Study||64
10837464|NCT02314923|12002984|FG002|Treated|Overall Study||64
10837465|NCT02314923|12002985|FG003|Treated|Overall Study||64
10837466|NCT02314923|12002986|FG004|Treated|Overall Study||74
10837467|NCT02314923|12002987|FG005|Treated|Overall Study||20
10837468|NCT02314923|12002988|FG006|Treated|Overall Study|One participant did not receive vaccination due to missing blood sample at randomization.|47
10837469|NCT02314923|12002989|FG007|Treated|Overall Study||47
10837470|NCT02314923|12002990|FG008|Treated|Overall Study||48
10837471|NCT02314923|12002991|FG009|Treated|Overall Study||20
10837472|NCT02314923|12002982|FG000|COMPLETED|Overall Study||61
10837473|NCT02314923|12002983|FG001|COMPLETED|Overall Study||60
10837474|NCT02314923|12002984|FG002|COMPLETED|Overall Study||62
10837475|NCT02314923|12002985|FG003|COMPLETED|Overall Study||63
10837476|NCT02314923|12002986|FG004|COMPLETED|Overall Study||73
10837477|NCT02314923|12002987|FG005|COMPLETED|Overall Study||19
10837478|NCT02314923|12002988|FG006|COMPLETED|Overall Study||43
10837479|NCT02314923|12002989|FG007|COMPLETED|Overall Study||42
10837480|NCT02314923|12002990|FG008|COMPLETED|Overall Study||46
10837481|NCT02314923|12002991|FG009|COMPLETED|Overall Study||20
10837482|NCT02314923|12002982|FG000|NOT COMPLETED|Overall Study||3
10837483|NCT02314923|12002983|FG001|NOT COMPLETED|Overall Study||4
10837484|NCT02314923|12002984|FG002|NOT COMPLETED|Overall Study||2
10837485|NCT02314923|12002985|FG003|NOT COMPLETED|Overall Study||1
10837486|NCT02314923|12002986|FG004|NOT COMPLETED|Overall Study||1
10837487|NCT02314923|12002987|FG005|NOT COMPLETED|Overall Study||1
10837488|NCT02314923|12002988|FG006|NOT COMPLETED|Overall Study||5
10837489|NCT02314923|12002989|FG007|NOT COMPLETED|Overall Study||5
10837490|NCT02314923|12002990|FG008|NOT COMPLETED|Overall Study||2
10837491|NCT02314923|12002991|FG009|NOT COMPLETED|Overall Study||0
10837492|NCT04821362|12003017|FG000|STARTED|Overall Study||90
10837493|NCT04821362|12003018|FG001|STARTED|Overall Study||90
10837494|NCT04821362|12003019|FG002|STARTED|Overall Study||90
10837495|NCT04821362|12003017|FG000|COMPLETED|Overall Study||90
10837496|NCT04821362|12003018|FG001|COMPLETED|Overall Study||90
10837497|NCT04821362|12003019|FG002|COMPLETED|Overall Study||90
10837498|NCT04821362|12003017|FG000|NOT COMPLETED|Overall Study||0
10837499|NCT04821362|12003018|FG001|NOT COMPLETED|Overall Study||0
10837500|NCT04821362|12003019|FG002|NOT COMPLETED|Overall Study||0
10837501|NCT04524507|12003032|FG000|STARTED|Overall Study||15
10837502|NCT04524507|12003033|FG001|STARTED|Overall Study||41
10837503|NCT04524507|12003032|FG000|Received Intervention|Overall Study||14
10837504|NCT04524507|12003033|FG001|Received Intervention|Overall Study||41
10837505|NCT04524507|12003032|FG000|Hospital Discharge|Overall Study||13
10837506|NCT04524507|12003033|FG001|Hospital Discharge|Overall Study||27
10837507|NCT04524507|12003032|FG000|COMPLETED|Overall Study||9
10837508|NCT04524507|12003033|FG001|COMPLETED|Overall Study||18
10837509|NCT04524507|12003032|FG000|NOT COMPLETED|Overall Study||6
10837510|NCT04524507|12003033|FG001|NOT COMPLETED|Overall Study||23
10837511|NCT04382924|12003042|FG000|STARTED|Overall Study||52
10837512|NCT04382924|12003043|FG001|STARTED|Overall Study||56
10837513|NCT04382924|12003044|FG002|STARTED|Overall Study||60
10837514|NCT04382924|12003042|FG000|COMPLETED|Overall Study||44
10837515|NCT04382924|12003043|FG001|COMPLETED|Overall Study||46
10837516|NCT04382924|12003044|FG002|COMPLETED|Overall Study||48
10837517|NCT04382924|12003042|FG000|NOT COMPLETED|Overall Study||8
10837518|NCT04382924|12003043|FG001|NOT COMPLETED|Overall Study||10
10837519|NCT04382924|12003044|FG002|NOT COMPLETED|Overall Study||12
10837520|NCT04166214|12003054|FG000|STARTED|Overall Study||12
10837412|NCT02257918|12002923|FG000|STARTED|Overall Study||72
10837413|NCT02257918|12002924|FG001|STARTED|Overall Study||67
10837414|NCT02257918|12002925|FG002|STARTED|Overall Study||41
10837415|NCT02257918|12002923|FG000|Test of Cure Visit|Overall Study||72
10837416|NCT02257918|12002924|FG001|Test of Cure Visit|Overall Study||67
10837417|NCT02257918|12002925|FG002|Test of Cure Visit|Overall Study||40
10837418|NCT02257918|12002923|FG000|COMPLETED|Overall Study||68
10837419|NCT02257918|12002924|FG001|COMPLETED|Overall Study||66
10837420|NCT02257918|12002925|FG002|COMPLETED|Overall Study||39
10837421|NCT02257918|12002923|FG000|NOT COMPLETED|Overall Study||4
10837422|NCT02257918|12002924|FG001|NOT COMPLETED|Overall Study||1
10837423|NCT02257918|12002925|FG002|NOT COMPLETED|Overall Study||2
10837521|NCT04166214|12003055|FG001|STARTED|Overall Study||39
10837522|NCT04166214|12003054|FG000|COMPLETED|Overall Study||12
10837523|NCT04166214|12003055|FG001|COMPLETED|Overall Study||39
10837524|NCT04166214|12003054|FG000|NOT COMPLETED|Overall Study||0
10837525|NCT04166214|12003055|FG001|NOT COMPLETED|Overall Study||0
10837526|NCT03947788|12003063|FG000|STARTED|Overall Study||69
10837527|NCT03947788|12003064|FG001|STARTED|Overall Study||74
10837528|NCT03947788|12003063|FG000|COMPLETED|Overall Study||69
10837529|NCT03947788|12003064|FG001|COMPLETED|Overall Study||74
10837530|NCT03947788|12003063|FG000|NOT COMPLETED|Overall Study||0
10837531|NCT03947788|12003064|FG001|NOT COMPLETED|Overall Study||0
10837532|NCT03842436|12003075|FG000|STARTED|Overall Study||16
10837533|NCT03842436|12003075|FG000|COMPLETED|Overall Study||15
10837534|NCT03842436|12003075|FG000|NOT COMPLETED|Overall Study||1
10837535|NCT03646162|12003082|FG000|STARTED|Overall Study||31
10837536|NCT03646162|12003083|FG001|STARTED|Overall Study||31
10837537|NCT03646162|12003084|FG002|STARTED|Overall Study||31
10837538|NCT03646162|12003082|FG000|COMPLETED|Overall Study||26
10837539|NCT03646162|12003083|FG001|COMPLETED|Overall Study||27
10837540|NCT03646162|12003084|FG002|COMPLETED|Overall Study||30
10837541|NCT03646162|12003082|FG000|NOT COMPLETED|Overall Study||5
10837542|NCT03646162|12003083|FG001|NOT COMPLETED|Overall Study||4
10837543|NCT03646162|12003084|FG002|NOT COMPLETED|Overall Study||1
10837544|NCT03462030|12003096|FG000|STARTED|Overall Study||15
10837545|NCT03462030|12003097|FG001|STARTED|Overall Study||15
10837546|NCT03462030|12003096|FG000|End of Build-up|Overall Study||14
10837547|NCT03462030|12003097|FG001|End of Build-up|Overall Study||14
10837548|NCT03462030|12003096|FG000|Month 12 Food Challenge|Overall Study||14
10837549|NCT03462030|12003097|FG001|Month 12 Food Challenge|Overall Study||14
10837550|NCT03462030|12003096|FG000|COMPLETED|Overall Study||14
10837551|NCT03462030|12003097|FG001|COMPLETED|Overall Study||14
10837552|NCT03462030|12003096|FG000|NOT COMPLETED|Overall Study||1
10837553|NCT03462030|12003097|FG001|NOT COMPLETED|Overall Study||1
10837554|NCT03446768|12003105|FG000|STARTED|Overall Study||141
10837555|NCT03446768|12003106|FG001|STARTED|Overall Study||153
10837556|NCT03446768|12003105|FG000|COMPLETED|Overall Study||141
10837557|NCT03446768|12003106|FG001|COMPLETED|Overall Study||152
10837558|NCT03446768|12003105|FG000|NOT COMPLETED|Overall Study||0
10837559|NCT03446768|12003106|FG001|NOT COMPLETED|Overall Study||1
10837560|NCT03348514|12003120|FG000|STARTED|Overall Study||1
10837561|NCT03348514|12003121|FG001|STARTED|Overall Study||1
10837562|NCT03348514|12003122|FG002|STARTED|Overall Study||1
10837563|NCT03348514|12003123|FG003|STARTED|Overall Study||1
10837564|NCT03348514|12003124|FG004|STARTED|Overall Study||3
10837565|NCT03348514|12003125|FG005|STARTED|Overall Study||4
10837566|NCT03348514|12003126|FG006|STARTED|Overall Study||6
10837567|NCT03348514|12003127|FG007|STARTED|Overall Study||2
10837568|NCT03348514|12003120|FG000|COMPLETED|Overall Study||1
10837569|NCT03348514|12003121|FG001|COMPLETED|Overall Study||1
10837570|NCT03348514|12003122|FG002|COMPLETED|Overall Study||1
10837571|NCT03348514|12003123|FG003|COMPLETED|Overall Study||1
10837572|NCT03348514|12003124|FG004|COMPLETED|Overall Study||3
10837573|NCT03348514|12003125|FG005|COMPLETED|Overall Study||4
10837574|NCT03348514|12003126|FG006|COMPLETED|Overall Study||6
10837575|NCT03348514|12003127|FG007|COMPLETED|Overall Study||2
10837576|NCT03348514|12003120|FG000|NOT COMPLETED|Overall Study||0
10837577|NCT03348514|12003121|FG001|NOT COMPLETED|Overall Study||0
10837578|NCT03348514|12003122|FG002|NOT COMPLETED|Overall Study||0
10837579|NCT03348514|12003123|FG003|NOT COMPLETED|Overall Study||0
10837580|NCT03348514|12003124|FG004|NOT COMPLETED|Overall Study||0
10837581|NCT03348514|12003125|FG005|NOT COMPLETED|Overall Study||0
10837582|NCT03348514|12003126|FG006|NOT COMPLETED|Overall Study||0
10837583|NCT03348514|12003127|FG007|NOT COMPLETED|Overall Study||0
10837584|NCT03253393|12003151|FG000|STARTED|First Intervention||12
10837585|NCT03253393|12003152|FG001|STARTED|First Intervention||13
10837586|NCT03253393|12003153|FG002|STARTED|First Intervention||0
10837587|NCT03253393|12003151|FG000|COMPLETED|First Intervention||12
10837588|NCT03253393|12003152|FG001|COMPLETED|First Intervention||13
10837589|NCT03253393|12003153|FG002|COMPLETED|First Intervention||0
10837590|NCT03253393|12003151|FG000|NOT COMPLETED|First Intervention||0
10837591|NCT03253393|12003152|FG001|NOT COMPLETED|First Intervention||0
10837592|NCT03253393|12003153|FG002|NOT COMPLETED|First Intervention||0
10837593|NCT03253393|12003151|FG000|STARTED|Washout (Minimum 48 Hours)||12
10837594|NCT03253393|12003152|FG001|STARTED|Washout (Minimum 48 Hours)||13
10837595|NCT03253393|12003153|FG002|STARTED|Washout (Minimum 48 Hours)|Participants in this group were only assigned to one visit/intervention|0
10837596|NCT03253393|12003151|FG000|COMPLETED|Washout (Minimum 48 Hours)||12
10837597|NCT03253393|12003152|FG001|COMPLETED|Washout (Minimum 48 Hours)||13
10837598|NCT03253393|12003153|FG002|COMPLETED|Washout (Minimum 48 Hours)|Participants in this group were only assigned to one visit/intervention|0
10837424|NCT02258542|12002937|FG000|STARTED|Overall Study||953
10837425|NCT02258542|12002938|FG001|STARTED|Overall Study||973
10837426|NCT02258542|12002939|FG002|STARTED|Overall Study||100
10837427|NCT02258542|12002940|FG003|STARTED|Overall Study||97
10837428|NCT02258542|12002937|FG000|Treated|Overall Study||953
10837429|NCT02258542|12002938|FG001|Treated|Overall Study||971
10837430|NCT02258542|12002939|FG002|Treated|Overall Study||100
10837431|NCT02258542|12002940|FG003|Treated|Overall Study||97
10837432|NCT02258542|12002937|FG000|Adolescents Only|Overall Study||25
10837433|NCT02258542|12002938|FG001|Adolescents Only|Overall Study||61
10837434|NCT02258542|12002939|FG002|Adolescents Only|Overall Study||0
10837435|NCT02258542|12002940|FG003|Adolescents Only|Overall Study||0
10837436|NCT02258542|12002937|FG000|COMPLETED|Overall Study|170 enrolled into study MELTEMI|911
10837437|NCT02258542|12002938|FG001|COMPLETED|Overall Study|178 enrolled into study MELTEMI|924
10837438|NCT02258542|12002939|FG002|COMPLETED|Overall Study|51 enrolled into study MELTEMI|92
10837439|NCT02258542|12002940|FG003|COMPLETED|Overall Study|48 enrolled into study MELTEMI|92
10837440|NCT02258542|12002937|FG000|NOT COMPLETED|Overall Study||42
10837441|NCT02258542|12002938|FG001|NOT COMPLETED|Overall Study||49
10837442|NCT02258542|12002939|FG002|NOT COMPLETED|Overall Study||8
10837443|NCT02258542|12002940|FG003|NOT COMPLETED|Overall Study||5
10837599|NCT03253393|12003151|FG000|NOT COMPLETED|Washout (Minimum 48 Hours)||0
10837600|NCT03253393|12003152|FG001|NOT COMPLETED|Washout (Minimum 48 Hours)||0
10837601|NCT03253393|12003153|FG002|NOT COMPLETED|Washout (Minimum 48 Hours)||0
10837602|NCT03253393|12003151|FG000|STARTED|Second Intervention||12
10837603|NCT03253393|12003152|FG001|STARTED|Second Intervention||13
10410005|NCT00761462|11554054|FG001|COMPLETED|2 or 5 Years Long-term Safety Follow-up|Patients under safety evaluation at end of 2 year safety Follow-up.|456
10410006|NCT00761462|11554053|FG000|NOT COMPLETED|2 or 5 Years Long-term Safety Follow-up||154
10410007|NCT00761462|11554054|FG001|NOT COMPLETED|2 or 5 Years Long-term Safety Follow-up||51
10410008|NCT00761514|11554060|FG000|STARTED|Overall Study||14
10410009|NCT00761514|11554060|FG000|COMPLETED|Overall Study||7
10410010|NCT00761514|11554060|FG000|NOT COMPLETED|Overall Study||7
10410011|NCT00761579|11554064|FG000|STARTED|Overall Study||190
10410012|NCT00761579|11554064|FG000|COMPLETED|Overall Study||98
10410013|NCT00761579|11554064|FG000|NOT COMPLETED|Overall Study||92
10410014|NCT00761592|11554072|FG000|STARTED|Overall Study||32
10410015|NCT00761592|11554073|FG001|STARTED|Overall Study||33
10410016|NCT00761592|11554072|FG000|COMPLETED|Overall Study||31
10410017|NCT00761592|11554073|FG001|COMPLETED|Overall Study||32
10410018|NCT00761592|11554072|FG000|NOT COMPLETED|Overall Study||1
10410019|NCT00761592|11554073|FG001|NOT COMPLETED|Overall Study||1
10410020|NCT00761605|11554079|FG000|STARTED|Overall Study||387
10410021|NCT00761605|11554079|FG000|COMPLETED|Overall Study||246
10410022|NCT00761605|11554079|FG000|NOT COMPLETED|Overall Study||141
10410023|NCT00761631|11554091|FG000|STARTED|Overall Study||126
10410024|NCT00761631|11554092|FG001|STARTED|Overall Study||181
10410025|NCT00761631|11554093|FG002|STARTED|Overall Study||176
10410026|NCT00761631|11554094|FG003|STARTED|Overall Study||119
10410027|NCT00761631|11554095|FG004|STARTED|Overall Study||299
10410028|NCT00761631|11554096|FG005|STARTED|Overall Study||299
10837604|NCT03253393|12003153|FG002|STARTED|Second Intervention|Participants in this group were only assigned to one visit/intervention|0
10837605|NCT03253393|12003151|FG000|COMPLETED|Second Intervention||12
10837606|NCT03253393|12003152|FG001|COMPLETED|Second Intervention||13
10837607|NCT03253393|12003153|FG002|COMPLETED|Second Intervention|Participants in this group were only assigned to one visit/intervention|0
10410029|NCT00761631|11554091|FG000|Vaccinated Dose 1|Overall Study||124
10410030|NCT00761631|11554092|FG001|Vaccinated Dose 1|Overall Study||179
10410031|NCT00761631|11554093|FG002|Vaccinated Dose 1|Overall Study||175
10410032|NCT00761631|11554094|FG003|Vaccinated Dose 1|Overall Study||118
10410033|NCT00761631|11554095|FG004|Vaccinated Dose 1|Overall Study||294
10410034|NCT00761631|11554096|FG005|Vaccinated Dose 1|Overall Study||298
10410035|NCT00761631|11554091|FG000|Vaccinated Dose 2|Overall Study||112
10410036|NCT00761631|11554092|FG001|Vaccinated Dose 2|Overall Study||0
10410037|NCT00761631|11554093|FG002|Vaccinated Dose 2|Overall Study||165
10410038|NCT00761631|11554094|FG003|Vaccinated Dose 2|Overall Study||0
10410039|NCT00761631|11554095|FG004|Vaccinated Dose 2|Overall Study||0
10410040|NCT00761631|11554096|FG005|Vaccinated Dose 2|Overall Study||0
10410041|NCT00761631|11554091|FG000|COMPLETED|Overall Study||111
10410042|NCT00761631|11554092|FG001|COMPLETED|Overall Study||174
10410043|NCT00761631|11554093|FG002|COMPLETED|Overall Study||160
10410044|NCT00761631|11554094|FG003|COMPLETED|Overall Study||116
10410045|NCT00761631|11554095|FG004|COMPLETED|Overall Study||277
10410046|NCT00761631|11554096|FG005|COMPLETED|Overall Study||294
10410047|NCT00761631|11554091|FG000|NOT COMPLETED|Overall Study||15
10837608|NCT03253393|12003151|FG000|NOT COMPLETED|Second Intervention||0
10837609|NCT03253393|12003152|FG001|NOT COMPLETED|Second Intervention||0
10837610|NCT03253393|12003153|FG002|NOT COMPLETED|Second Intervention||0
10410048|NCT00761631|11554092|FG001|NOT COMPLETED|Overall Study||7
10410049|NCT00761631|11554093|FG002|NOT COMPLETED|Overall Study||16
10410050|NCT00761631|11554094|FG003|NOT COMPLETED|Overall Study||3
10410051|NCT00761631|11554095|FG004|NOT COMPLETED|Overall Study||22
10410052|NCT00761631|11554096|FG005|NOT COMPLETED|Overall Study||5
10410053|NCT00761657|11554128|FG000|STARTED|Part 1 (up to Day 57)||0
10410054|NCT00761657|11554129|FG001|STARTED|Part 1 (up to Day 57)||0
10410055|NCT00761657|11554130|FG002|STARTED|Part 1 (up to Day 57)||12
10410056|NCT00761657|11554131|FG003|STARTED|Part 1 (up to Day 57)||10
10410057|NCT00761657|11554132|FG004|STARTED|Part 1 (up to Day 57)||0
10410058|NCT00761657|11554133|FG005|STARTED|Part 1 (up to Day 57)||0
10837611|NCT03253393|12003151|FG000|STARTED|Washout (Minimum 48 Hours)||12
10837612|NCT03253393|12003152|FG001|STARTED|Washout (Minimum 48 Hours)||13
10837613|NCT03253393|12003153|FG002|STARTED|Washout (Minimum 48 Hours)|Participants in this group were only assigned to one visit/intervention|0
10837614|NCT03253393|12003151|FG000|COMPLETED|Washout (Minimum 48 Hours)||6
10837615|NCT03253393|12003152|FG001|COMPLETED|Washout (Minimum 48 Hours)||6
10837616|NCT03253393|12003153|FG002|COMPLETED|Washout (Minimum 48 Hours)|Participants in this group were only assigned to one visit/intervention|0
10837617|NCT03253393|12003151|FG000|NOT COMPLETED|Washout (Minimum 48 Hours)||6
10837618|NCT03253393|12003152|FG001|NOT COMPLETED|Washout (Minimum 48 Hours)||7
10837619|NCT03253393|12003153|FG002|NOT COMPLETED|Washout (Minimum 48 Hours)||0
10837620|NCT03253393|12003151|FG000|STARTED|Third Intervention||6
10837621|NCT03253393|12003152|FG001|STARTED|Third Intervention||6
10837622|NCT03253393|12003153|FG002|STARTED|Third Intervention|Participants in this group were only assigned to one visit/intervention|13
10837623|NCT03253393|12003151|FG000|COMPLETED|Third Intervention||6
10837624|NCT03253393|12003152|FG001|COMPLETED|Third Intervention||6
10837625|NCT03253393|12003153|FG002|COMPLETED|Third Intervention|Participants in this group were only assigned to one visit/intervention|13
10837626|NCT03253393|12003151|FG000|NOT COMPLETED|Third Intervention||0
10837627|NCT03253393|12003152|FG001|NOT COMPLETED|Third Intervention||0
10837628|NCT03253393|12003153|FG002|NOT COMPLETED|Third Intervention||0
10837629|NCT03188822|12003167|FG000|STARTED|Overall Study||9
10837630|NCT03188822|12003167|FG000|COMPLETED|Overall Study||2
10837631|NCT03188822|12003167|FG000|NOT COMPLETED|Overall Study||7
10837632|NCT03128671|12003173|FG000|STARTED|Enrollment||89
10837633|NCT03128671|12003174|FG001|STARTED|Enrollment||89
10837634|NCT03128671|12003173|FG000|COMPLETED|Enrollment||89
10837635|NCT03128671|12003174|FG001|COMPLETED|Enrollment||89
10837636|NCT03128671|12003173|FG000|NOT COMPLETED|Enrollment||0
10837637|NCT03128671|12003174|FG001|NOT COMPLETED|Enrollment||0
10837638|NCT03128671|12003173|FG000|STARTED|Allocation||89
10837639|NCT03128671|12003174|FG001|STARTED|Allocation||89
10837640|NCT03128671|12003173|FG000|COMPLETED|Allocation||80
10837641|NCT03128671|12003174|FG001|COMPLETED|Allocation||89
10837642|NCT03128671|12003173|FG000|NOT COMPLETED|Allocation||9
10837643|NCT03128671|12003174|FG001|NOT COMPLETED|Allocation||0
10837644|NCT03128671|12003173|FG000|STARTED|Intervention||80
10837645|NCT03128671|12003174|FG001|STARTED|Intervention||89
10837646|NCT03128671|12003173|FG000|COMPLETED|Intervention||44
10837647|NCT03128671|12003174|FG001|COMPLETED|Intervention||55
10837648|NCT03128671|12003173|FG000|NOT COMPLETED|Intervention||36
10837649|NCT03128671|12003174|FG001|NOT COMPLETED|Intervention||34
10837650|NCT03111732|12003180|FG000|STARTED|Overall Study||11
10837651|NCT03111732|12003180|FG000|COMPLETED|Overall Study||6
10837652|NCT03111732|12003180|FG000|NOT COMPLETED|Overall Study||5
10837653|NCT03065244|12003191|FG000|STARTED|Overall Study||50
10837654|NCT03065244|12003192|FG001|STARTED|Overall Study||55
10837655|NCT03065244|12003191|FG000|Participants Who Failed 1st Treatment and Crossed Over to Receive Other Treatment|Overall Study||22
10837656|NCT03065244|12003192|FG001|Participants Who Failed 1st Treatment and Crossed Over to Receive Other Treatment|Overall Study||9
10837657|NCT03065244|12003191|FG000|COMPLETED|Overall Study||47
10837658|NCT03065244|12003192|FG001|COMPLETED|Overall Study||51
10837659|NCT03065244|12003191|FG000|NOT COMPLETED|Overall Study||3
10837660|NCT03065244|12003192|FG001|NOT COMPLETED|Overall Study||4
10837661|NCT02879305|12003200|FG000|STARTED|Overall Study||1487
10837662|NCT02879305|12003201|FG001|STARTED|Overall Study||1477
10837663|NCT02879305|12003200|FG000|COMPLETED|Overall Study||1370
10837664|NCT02879305|12003201|FG001|COMPLETED|Overall Study||1366
10837665|NCT02879305|12003200|FG000|NOT COMPLETED|Overall Study||117
10837666|NCT02879305|12003201|FG001|NOT COMPLETED|Overall Study||111
10837667|NCT02816736|12003209|FG000|STARTED|Overall Study||179
10837668|NCT02816736|12003210|FG001|STARTED|Overall Study||186
10837669|NCT02816736|12003209|FG000|COMPLETED|Overall Study||164
10837670|NCT02816736|12003210|FG001|COMPLETED|Overall Study||166
10837671|NCT02816736|12003209|FG000|NOT COMPLETED|Overall Study||15
10837672|NCT02816736|12003210|FG001|NOT COMPLETED|Overall Study||20
10837673|NCT02787850|12003218|FG000|STARTED|Overall Study||10
10837674|NCT02787850|12003219|FG001|STARTED|Overall Study||10
10837675|NCT02787850|12003218|FG000|COMPLETED|Overall Study||10
10837676|NCT02787850|12003219|FG001|COMPLETED|Overall Study||9
10837677|NCT02787850|12003218|FG000|NOT COMPLETED|Overall Study||0
10837678|NCT02787850|12003219|FG001|NOT COMPLETED|Overall Study||1
10837682|NCT02676284|12003238|FG000|STARTED|Overall Study||36
10837683|NCT02676284|12003238|FG000|COMPLETED|Overall Study||35
10837684|NCT02676284|12003238|FG000|NOT COMPLETED|Overall Study||1
10837685|NCT02431702|12003242|FG000|STARTED|Part 1: 2-Month Oral Run-in Phase||273
10837686|NCT02431702|12003243|FG001|STARTED|Part 1: 2-Month Oral Run-in Phase||0
10837687|NCT02431702|12003244|FG002|STARTED|Part 1: 2-Month Oral Run-in Phase||0
10837688|NCT02431702|12003245|FG003|STARTED|Part 1: 2-Month Oral Run-in Phase||0
10837689|NCT02431702|12003246|FG004|STARTED|Part 1: 2-Month Oral Run-in Phase||0
10837690|NCT02431702|12003247|FG005|STARTED|Part 1: 2-Month Oral Run-in Phase||0
10837691|NCT02431702|12003248|FG006|STARTED|Part 1: 2-Month Oral Run-in Phase||64
10837692|NCT02431702|12003242|FG000|COMPLETED|Part 1: 2-Month Oral Run-in Phase||239
10837693|NCT02431702|12003243|FG001|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
10837694|NCT02431702|12003244|FG002|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
10837695|NCT02431702|12003245|FG003|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
10837696|NCT02431702|12003246|FG004|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
10837697|NCT02431702|12003247|FG005|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
10837698|NCT02431702|12003248|FG006|COMPLETED|Part 1: 2-Month Oral Run-in Phase||32
10837699|NCT02431702|12003242|FG000|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||34
10837700|NCT02431702|12003243|FG001|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
10837701|NCT02431702|12003244|FG002|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
10837702|NCT02431702|12003245|FG003|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
10837703|NCT02431702|12003246|FG004|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
10837704|NCT02431702|12003247|FG005|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
10837705|NCT02431702|12003248|FG006|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||32
10837706|NCT02431702|12003242|FG000|STARTED|Part 2: 9Month Disease Progression Phase||0
10410059|NCT00761657|11554134|FG006|STARTED|Part 1 (up to Day 57)||1
10410060|NCT00761657|11554135|FG007|STARTED|Part 1 (up to Day 57)||2
10410061|NCT00761657|11554136|FG008|STARTED|Part 1 (up to Day 57)||10
10410062|NCT00761657|11554128|FG000|Safety Population|Part 1 (up to Day 57)||0
10410063|NCT00761657|11554129|FG001|Safety Population|Part 1 (up to Day 57)||0
10410064|NCT00761657|11554130|FG002|Safety Population|Part 1 (up to Day 57)||12
10410065|NCT00761657|11554131|FG003|Safety Population|Part 1 (up to Day 57)||9
10410066|NCT00761657|11554132|FG004|Safety Population|Part 1 (up to Day 57)||0
10410067|NCT00761657|11554133|FG005|Safety Population|Part 1 (up to Day 57)||0
10410068|NCT00761657|11554134|FG006|Safety Population|Part 1 (up to Day 57)||1
10410069|NCT00761657|11554135|FG007|Safety Population|Part 1 (up to Day 57)||2
10410070|NCT00761657|11554136|FG008|Safety Population|Part 1 (up to Day 57)||10
10410071|NCT00761657|11554128|FG000|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||0
10410072|NCT00761657|11554129|FG001|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||0
10410073|NCT00761657|11554130|FG002|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||5
10410074|NCT00761657|11554131|FG003|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||5
10410075|NCT00761657|11554132|FG004|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||0
10410076|NCT00761657|11554133|FG005|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||0
10410077|NCT00761657|11554134|FG006|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||0
10410078|NCT00761657|11554135|FG007|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||1
10410079|NCT00761657|11554136|FG008|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||6
10410080|NCT00761657|11554128|FG000|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||0
10410081|NCT00761657|11554129|FG001|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||0
10410082|NCT00761657|11554130|FG002|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||5
10410083|NCT00761657|11554131|FG003|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||3
10410084|NCT00761657|11554132|FG004|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||0
10410085|NCT00761657|11554133|FG005|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||0
10410086|NCT00761657|11554134|FG006|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||1
10410087|NCT00761657|11554135|FG007|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||2
10410088|NCT00761657|11554136|FG008|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||0
10410089|NCT00761657|11554128|FG000|COMPLETED|Part 1 (up to Day 57)||0
10410090|NCT00761657|11554129|FG001|COMPLETED|Part 1 (up to Day 57)||0
10410091|NCT00761657|11554130|FG002|COMPLETED|Part 1 (up to Day 57)||8
10410092|NCT00761657|11554131|FG003|COMPLETED|Part 1 (up to Day 57)||4
10410093|NCT00761657|11554132|FG004|COMPLETED|Part 1 (up to Day 57)||0
10410094|NCT00761657|11554133|FG005|COMPLETED|Part 1 (up to Day 57)||0
10410095|NCT00761657|11554134|FG006|COMPLETED|Part 1 (up to Day 57)||0
10410096|NCT00761657|11554135|FG007|COMPLETED|Part 1 (up to Day 57)||1
10410097|NCT00761657|11554136|FG008|COMPLETED|Part 1 (up to Day 57)||9
10410098|NCT00761657|11554128|FG000|NOT COMPLETED|Part 1 (up to Day 57)||0
10410099|NCT00761657|11554129|FG001|NOT COMPLETED|Part 1 (up to Day 57)||0
10410100|NCT00761657|11554130|FG002|NOT COMPLETED|Part 1 (up to Day 57)||4
10410101|NCT00761657|11554131|FG003|NOT COMPLETED|Part 1 (up to Day 57)||6
10410102|NCT00761657|11554132|FG004|NOT COMPLETED|Part 1 (up to Day 57)||0
10410103|NCT00761657|11554133|FG005|NOT COMPLETED|Part 1 (up to Day 57)||0
10410104|NCT00761657|11554134|FG006|NOT COMPLETED|Part 1 (up to Day 57)||1
10410105|NCT00761657|11554135|FG007|NOT COMPLETED|Part 1 (up to Day 57)||1
10410106|NCT00761657|11554136|FG008|NOT COMPLETED|Part 1 (up to Day 57)||1
10410107|NCT00761657|11554128|FG000|STARTED|Part 2 (up to Day 114)||10
10410108|NCT00761657|11554129|FG001|STARTED|Part 2 (up to Day 114)||13
10410109|NCT00761657|11554130|FG002|STARTED|Part 2 (up to Day 114)||0
10410110|NCT00761657|11554131|FG003|STARTED|Part 2 (up to Day 114)||0
10410111|NCT00761657|11554132|FG004|STARTED|Part 2 (up to Day 114)||10
10410112|NCT00761657|11554133|FG005|STARTED|Part 2 (up to Day 114)||11
10410113|NCT00761657|11554134|FG006|STARTED|Part 2 (up to Day 114)||10
10410114|NCT00761657|11554135|FG007|STARTED|Part 2 (up to Day 114)||10
10410115|NCT00761657|11554136|FG008|STARTED|Part 2 (up to Day 114)||18
10410116|NCT00761657|11554128|FG000|Safety Population|Part 2 (up to Day 114)||10
10410117|NCT00761657|11554129|FG001|Safety Population|Part 2 (up to Day 114)||13
10410118|NCT00761657|11554130|FG002|Safety Population|Part 2 (up to Day 114)||0
10410119|NCT00761657|11554131|FG003|Safety Population|Part 2 (up to Day 114)||0
10410120|NCT00761657|11554132|FG004|Safety Population|Part 2 (up to Day 114)||10
10410121|NCT00761657|11554133|FG005|Safety Population|Part 2 (up to Day 114)||11
10410122|NCT00761657|11554134|FG006|Safety Population|Part 2 (up to Day 114)||10
10410123|NCT00761657|11554135|FG007|Safety Population|Part 2 (up to Day 114)||10
10410124|NCT00761657|11554136|FG008|Safety Population|Part 2 (up to Day 114)||18
10837707|NCT02431702|12003243|FG001|STARTED|Part 2: 9Month Disease Progression Phase|Participants who completed Part 1 and were eligible to be randomized in this group.|78
10837708|NCT02431702|12003244|FG002|STARTED|Part 2: 9Month Disease Progression Phase|Participants who completed Part 1 and were eligible to be randomized in this group.|157
10837709|NCT02431702|12003245|FG003|STARTED|Part 2: 9Month Disease Progression Phase||0
10837710|NCT02431702|12003246|FG004|STARTED|Part 2: 9Month Disease Progression Phase||0
10837711|NCT02431702|12003247|FG005|STARTED|Part 2: 9Month Disease Progression Phase||0
10837712|NCT02431702|12003248|FG006|STARTED|Part 2: 9Month Disease Progression Phase||0
10837713|NCT02431702|12003242|FG000|COMPLETED|Part 2: 9Month Disease Progression Phase||0
10837714|NCT02431702|12003243|FG001|COMPLETED|Part 2: 9Month Disease Progression Phase||52
10837715|NCT02431702|12003244|FG002|COMPLETED|Part 2: 9Month Disease Progression Phase||128
10837716|NCT02431702|12003245|FG003|COMPLETED|Part 2: 9Month Disease Progression Phase||0
10837717|NCT02431702|12003246|FG004|COMPLETED|Part 2: 9Month Disease Progression Phase||0
10837718|NCT02431702|12003247|FG005|COMPLETED|Part 2: 9Month Disease Progression Phase||0
10837719|NCT02431702|12003248|FG006|COMPLETED|Part 2: 9Month Disease Progression Phase||0
10837720|NCT02431702|12003242|FG000|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0
10837721|NCT02431702|12003243|FG001|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||26
10837722|NCT02431702|12003244|FG002|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||29
10837723|NCT02431702|12003245|FG003|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0
10837724|NCT02431702|12003246|FG004|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0
10837725|NCT02431702|12003247|FG005|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0
10837726|NCT02431702|12003248|FG006|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0
10837727|NCT02431702|12003242|FG000|STARTED|Part 3: 9 Month of Additional Treatment||0
10837728|NCT02431702|12003243|FG001|STARTED|Part 3: 9 Month of Additional Treatment||0
10837729|NCT02431702|12003244|FG002|STARTED|Part 3: 9 Month of Additional Treatment||0
10837730|NCT02431702|12003245|FG003|STARTED|Part 3: 9 Month of Additional Treatment|Participants who completed Part 2 and were eligible to continue treatment in this group.|49
10837731|NCT02431702|12003246|FG004|STARTED|Part 3: 9 Month of Additional Treatment|Participants who completed Part 2 and were eligible to be re-randomized in this group.|57
10837732|NCT02431702|12003247|FG005|STARTED|Part 3: 9 Month of Additional Treatment|Participants who completed Part 2 and were eligible to be re-randomized in this group.|63
10837733|NCT02431702|12003248|FG006|STARTED|Part 3: 9 Month of Additional Treatment||0
10837734|NCT02431702|12003242|FG000|COMPLETED|Part 3: 9 Month of Additional Treatment||0
10837735|NCT02431702|12003243|FG001|COMPLETED|Part 3: 9 Month of Additional Treatment||0
10837736|NCT02431702|12003244|FG002|COMPLETED|Part 3: 9 Month of Additional Treatment||0
10837737|NCT02431702|12003245|FG003|COMPLETED|Part 3: 9 Month of Additional Treatment||40
10837738|NCT02431702|12003246|FG004|COMPLETED|Part 3: 9 Month of Additional Treatment||47
10837739|NCT02431702|12003247|FG005|COMPLETED|Part 3: 9 Month of Additional Treatment||46
10837740|NCT02431702|12003248|FG006|COMPLETED|Part 3: 9 Month of Additional Treatment||0
10837741|NCT02431702|12003242|FG000|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||0
10837742|NCT02431702|12003243|FG001|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||0
10837743|NCT02431702|12003244|FG002|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||0
10837744|NCT02431702|12003245|FG003|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||9
10837745|NCT02431702|12003246|FG004|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||10
10837746|NCT02431702|12003247|FG005|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||17
10837747|NCT02431702|12003248|FG006|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||0
10837748|NCT02368002|12003268|FG000|STARTED|Stage 1 Intervention (Up to 20 Weeks)||233
10837749|NCT02368002|12003269|FG001|STARTED|Stage 1 Intervention (Up to 20 Weeks)||0
10837750|NCT02368002|12003270|FG002|STARTED|Stage 1 Intervention (Up to 20 Weeks)||0
10837751|NCT02368002|12003271|FG003|STARTED|Stage 1 Intervention (Up to 20 Weeks)||235
10837752|NCT02368002|12003272|FG004|STARTED|Stage 1 Intervention (Up to 20 Weeks)||0
10837753|NCT02368002|12003273|FG005|STARTED|Stage 1 Intervention (Up to 20 Weeks)||0
10837754|NCT02368002|12003268|FG000|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||228
10837755|NCT02368002|12003269|FG001|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
10837756|NCT02368002|12003270|FG002|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
10837757|NCT02368002|12003271|FG003|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||214
10837758|NCT02368002|12003272|FG004|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
10837759|NCT02368002|12003273|FG005|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
10837760|NCT02368002|12003268|FG000|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||5
10837761|NCT02368002|12003269|FG001|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
10837762|NCT02368002|12003270|FG002|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
10837763|NCT02368002|12003271|FG003|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||21
10837764|NCT02368002|12003272|FG004|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
10837765|NCT02368002|12003273|FG005|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
10837766|NCT02368002|12003268|FG000|STARTED|Stage 2 Intervention (Up to 17 Weeks)||88
10837767|NCT02368002|12003269|FG001|STARTED|Stage 2 Intervention (Up to 17 Weeks)||70
10837768|NCT02368002|12003270|FG002|STARTED|Stage 2 Intervention (Up to 17 Weeks)||70
10837769|NCT02368002|12003271|FG003|STARTED|Stage 2 Intervention (Up to 17 Weeks)||0
10837770|NCT02368002|12003272|FG004|STARTED|Stage 2 Intervention (Up to 17 Weeks)||0
10837771|NCT02368002|12003273|FG005|STARTED|Stage 2 Intervention (Up to 17 Weeks)||0
10837772|NCT02368002|12003268|FG000|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||86
10837773|NCT02368002|12003269|FG001|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||60
10837774|NCT02368002|12003270|FG002|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||64
10754399|NCT03052751|11918168|FG000|STARTED|Dosing Period 1||22
10754400|NCT03052751|11918169|FG001|STARTED|Dosing Period 1||21
10754401|NCT03052751|11918170|FG002|STARTED|Dosing Period 1||0
10754402|NCT03052751|11918171|FG003|STARTED|Dosing Period 1||0
10754403|NCT03052751|11918172|FG004|STARTED|Dosing Period 1||0
10754404|NCT03052751|11918173|FG005|STARTED|Dosing Period 1||0
10754405|NCT03052751|11918168|FG000|Completed Period 1|Dosing Period 1||22
10754406|NCT03052751|11918169|FG001|Completed Period 1|Dosing Period 1||21
10754407|NCT03052751|11918170|FG002|Completed Period 1|Dosing Period 1||0
10754408|NCT03052751|11918171|FG003|Completed Period 1|Dosing Period 1||0
10754409|NCT03052751|11918172|FG004|Completed Period 1|Dosing Period 1||0
10754410|NCT03052751|11918173|FG005|Completed Period 1|Dosing Period 1||0
10754411|NCT03052751|11918168|FG000|Completed Period 1 and Started Period 2|Dosing Period 1||22
10754412|NCT03052751|11918169|FG001|Completed Period 1 and Started Period 2|Dosing Period 1||20
10754413|NCT03052751|11918170|FG002|Completed Period 1 and Started Period 2|Dosing Period 1||0
10754414|NCT03052751|11918171|FG003|Completed Period 1 and Started Period 2|Dosing Period 1||0
10754415|NCT03052751|11918172|FG004|Completed Period 1 and Started Period 2|Dosing Period 1||0
10754416|NCT03052751|11918173|FG005|Completed Period 1 and Started Period 2|Dosing Period 1||0
10754417|NCT03052751|11918168|FG000|COMPLETED|Dosing Period 1||22
10410125|NCT00761657|11554128|FG000|EE Population|Part 2 (up to Day 114)||10
10410126|NCT00761657|11554129|FG001|EE Population|Part 2 (up to Day 114)||12
10410127|NCT00761657|11554130|FG002|EE Population|Part 2 (up to Day 114)||0
10410128|NCT00761657|11554131|FG003|EE Population|Part 2 (up to Day 114)||0
10754418|NCT03052751|11918169|FG001|COMPLETED|Dosing Period 1||20
10837775|NCT02368002|12003271|FG003|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0
10837776|NCT02368002|12003272|FG004|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0
10837777|NCT02368002|12003273|FG005|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0
10837778|NCT02368002|12003268|FG000|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||2
10837779|NCT02368002|12003269|FG001|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||10
10837780|NCT02368002|12003270|FG002|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||6
10837781|NCT02368002|12003271|FG003|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0
10837782|NCT02368002|12003272|FG004|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0
10837783|NCT02368002|12003273|FG005|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0
10837784|NCT02368002|12003268|FG000|STARTED|Stage 2 Intervention (Up to 13 Weeks)||0
10837785|NCT02368002|12003269|FG001|STARTED|Stage 2 Intervention (Up to 13 Weeks)||0
10837786|NCT02368002|12003270|FG002|STARTED|Stage 2 Intervention (Up to 13 Weeks)||0
10837787|NCT02368002|12003271|FG003|STARTED|Stage 2 Intervention (Up to 13 Weeks)||95
10837788|NCT02368002|12003272|FG004|STARTED|Stage 2 Intervention (Up to 13 Weeks)||57
10837789|NCT02368002|12003273|FG005|STARTED|Stage 2 Intervention (Up to 13 Weeks)||62
10837790|NCT02368002|12003268|FG000|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0
10837791|NCT02368002|12003269|FG001|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0
10837792|NCT02368002|12003270|FG002|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0
10837793|NCT02368002|12003271|FG003|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||94
10837794|NCT02368002|12003272|FG004|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||53
10837795|NCT02368002|12003273|FG005|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||59
10837796|NCT02368002|12003268|FG000|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0
10837797|NCT02368002|12003269|FG001|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0
10837798|NCT02368002|12003270|FG002|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0
10837799|NCT02368002|12003271|FG003|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||1
10837800|NCT02368002|12003272|FG004|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||4
10837801|NCT02368002|12003273|FG005|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||3
10292106|NCT03088826|11424893|FG000|STARTED|Overall Study||40
10292107|NCT03088826|11424894|FG001|STARTED|Overall Study||40
10292108|NCT03088826|11424893|FG000|COMPLETED|Overall Study||40
10292109|NCT03088826|11424894|FG001|COMPLETED|Overall Study||40
10292110|NCT03088826|11424893|FG000|NOT COMPLETED|Overall Study||0
10292111|NCT03088826|11424894|FG001|NOT COMPLETED|Overall Study||0
10837802|NCT02200770|12003285|FG000|STARTED|Randomized-controlled Period (RCP)||56
10837803|NCT02200770|12003286|FG001|STARTED|Randomized-controlled Period (RCP)||175
10837804|NCT02200770|12003285|FG000|Treated|Randomized-controlled Period (RCP)||56
10837805|NCT02200770|12003286|FG001|Treated|Randomized-controlled Period (RCP)||174
10837806|NCT02200770|12003285|FG000|COMPLETED|Randomized-controlled Period (RCP)||54
10837807|NCT02200770|12003286|FG001|COMPLETED|Randomized-controlled Period (RCP)||169
10837808|NCT02200770|12003285|FG000|NOT COMPLETED|Randomized-controlled Period (RCP)||2
10837809|NCT02200770|12003286|FG001|NOT COMPLETED|Randomized-controlled Period (RCP)||6
10837810|NCT02200770|12003285|FG000|STARTED|Open-label Period (OLP)|3 participants completed RCP but did not roll over to OLP.|51
10837811|NCT02200770|12003286|FG001|STARTED|Open-label Period (OLP)|4 participants completed RCP but did not roll over to OLP.|165
10837812|NCT02200770|12003285|FG000|COMPLETED|Open-label Period (OLP)||43
10837813|NCT02200770|12003286|FG001|COMPLETED|Open-label Period (OLP)||131
10837814|NCT02200770|12003285|FG000|NOT COMPLETED|Open-label Period (OLP)||8
10837815|NCT02200770|12003286|FG001|NOT COMPLETED|Open-label Period (OLP)||34
10837816|NCT02136069|12003296|FG000|STARTED|Overall Study||199
10837817|NCT02136069|12003297|FG001|STARTED|Overall Study||198
10837818|NCT02136069|12003296|FG000|COMPLETED|Overall Study||165
10837819|NCT02136069|12003297|FG001|COMPLETED|Overall Study||170
10837820|NCT02136069|12003296|FG000|NOT COMPLETED|Overall Study||34
10837821|NCT02136069|12003297|FG001|NOT COMPLETED|Overall Study||28
10837822|NCT02086552|12003303|FG000|STARTED|Overall Study||28
10837823|NCT02086552|12003303|FG000|COMPLETED|Overall Study||27
10837824|NCT02086552|12003303|FG000|NOT COMPLETED|Overall Study||1
10837825|NCT01517659|12003307|FG000|STARTED|Overall Study||45
10837826|NCT01517659|12003307|FG000|COMPLETED|Overall Study||45
10837827|NCT01517659|12003307|FG000|NOT COMPLETED|Overall Study||0
10837828|NCT01209767|12003312|FG000|STARTED|Overall Study||22
10837829|NCT01209767|12003312|FG000|COMPLETED|Overall Study||18
10837830|NCT01209767|12003312|FG000|NOT COMPLETED|Overall Study||4
10837831|NCT01186848|12003320|FG000|STARTED|Overall Study||30
10837832|NCT01186848|12003320|FG000|COMPLETED|Overall Study||22
10837833|NCT01186848|12003320|FG000|NOT COMPLETED|Overall Study||8
10837834|NCT01040624|12003328|FG000|STARTED|Overall Study||58
10837835|NCT01040624|12003329|FG001|STARTED|Overall Study||19
10837836|NCT01040624|12003328|FG000|COMPLETED|Overall Study||58
10837837|NCT01040624|12003329|FG001|COMPLETED|Overall Study||19
10837838|NCT01040624|12003328|FG000|NOT COMPLETED|Overall Study||0
10837839|NCT01040624|12003329|FG001|NOT COMPLETED|Overall Study||0
10837840|NCT01024608|12003337|FG000|STARTED|Overall Study||169
10837841|NCT01024608|12003338|FG001|STARTED|Overall Study||171
10837842|NCT01024608|12003337|FG000|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|167
10837843|NCT01024608|12003338|FG001|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|171
10837844|NCT01024608|12003337|FG000|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|167
10837845|NCT01024608|12003338|FG001|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|171
10837846|NCT01024608|12003337|FG000|COMPLETED|Overall Study||165
10837847|NCT01024608|12003338|FG001|COMPLETED|Overall Study||167
10837848|NCT01024608|12003337|FG000|NOT COMPLETED|Overall Study||4
10837849|NCT01024608|12003338|FG001|NOT COMPLETED|Overall Study||4
10837850|NCT00988247|12003346|FG000|STARTED|Overall Study||418
10837851|NCT00988247|12003347|FG001|STARTED|Overall Study||111
10837852|NCT00988247|12003346|FG000|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|415
10837853|NCT00988247|12003347|FG001|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|111
10837854|NCT00988247|12003346|FG000|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|414
10837855|NCT00988247|12003347|FG001|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|110
10837856|NCT00988247|12003346|FG000|COMPLETED|Overall Study||335
10837857|NCT00988247|12003347|FG001|COMPLETED|Overall Study||85
10837858|NCT00988247|12003346|FG000|NOT COMPLETED|Overall Study||83
10837859|NCT00988247|12003347|FG001|NOT COMPLETED|Overall Study||26
10837860|NCT00838981|12003357|FG000|STARTED|Week 1 Days 1-3||26
10837861|NCT00838981|12003358|FG001|STARTED|Week 1 Days 1-3||19
10837862|NCT00838981|12003359|FG002|STARTED|Week 1 Days 1-3||27
10837863|NCT00838981|12003360|FG003|STARTED|Week 1 Days 1-3||19
10837864|NCT00838981|12003357|FG000|COMPLETED|Week 1 Days 1-3||26
10837865|NCT00838981|12003358|FG001|COMPLETED|Week 1 Days 1-3||19
10837866|NCT00838981|12003359|FG002|COMPLETED|Week 1 Days 1-3||27
10837867|NCT00838981|12003360|FG003|COMPLETED|Week 1 Days 1-3||19
10837868|NCT00838981|12003357|FG000|NOT COMPLETED|Week 1 Days 1-3||0
10837869|NCT00838981|12003358|FG001|NOT COMPLETED|Week 1 Days 1-3||0
10837870|NCT00838981|12003359|FG002|NOT COMPLETED|Week 1 Days 1-3||0
10837871|NCT00838981|12003360|FG003|NOT COMPLETED|Week 1 Days 1-3||0
10837872|NCT00838981|12003357|FG000|STARTED|Day 4 to Week 11||26
10837873|NCT00838981|12003358|FG001|STARTED|Day 4 to Week 11||19
10837874|NCT00838981|12003359|FG002|STARTED|Day 4 to Week 11||27
10837875|NCT00838981|12003360|FG003|STARTED|Day 4 to Week 11||19
10837876|NCT00838981|12003357|FG000|Completed Main Treatment on 400mg|Day 4 to Week 11||22
10837877|NCT00838981|12003358|FG001|Completed Main Treatment on 400mg|Day 4 to Week 11||13
10837878|NCT00838981|12003359|FG002|Completed Main Treatment on 400mg|Day 4 to Week 11||17
10837879|NCT00838981|12003360|FG003|Completed Main Treatment on 400mg|Day 4 to Week 11||14
10837880|NCT00838981|12003357|FG000|COMPLETED|Day 4 to Week 11||19
10837881|NCT00838981|12003358|FG001|COMPLETED|Day 4 to Week 11||11
10837882|NCT00838981|12003359|FG002|COMPLETED|Day 4 to Week 11||16
10837883|NCT00838981|12003360|FG003|COMPLETED|Day 4 to Week 11||12
10837884|NCT00838981|12003357|FG000|NOT COMPLETED|Day 4 to Week 11||7
10837885|NCT00838981|12003358|FG001|NOT COMPLETED|Day 4 to Week 11||8
10837886|NCT00838981|12003359|FG002|NOT COMPLETED|Day 4 to Week 11||11
10837887|NCT00838981|12003360|FG003|NOT COMPLETED|Day 4 to Week 11||7
10837888|NCT00730639|12003379|FG000|STARTED|Overall Study||17
10837889|NCT00730639|12003380|FG001|STARTED|Overall Study||18
10837890|NCT00730639|12003381|FG002|STARTED|Overall Study||86
10837891|NCT00730639|12003382|FG003|STARTED|Overall Study||54
10837892|NCT00730639|12003383|FG004|STARTED|Overall Study||131
10837893|NCT00730639|12003379|FG000|COMPLETED|Overall Study||0
10837894|NCT00730639|12003380|FG001|COMPLETED|Overall Study||0
10837895|NCT00730639|12003381|FG002|COMPLETED|Overall Study||0
10837896|NCT00730639|12003382|FG003|COMPLETED|Overall Study||0
10837897|NCT00730639|12003383|FG004|COMPLETED|Overall Study||0
10837898|NCT00730639|12003379|FG000|NOT COMPLETED|Overall Study||17
10837899|NCT00730639|12003380|FG001|NOT COMPLETED|Overall Study||18
10837900|NCT00730639|12003381|FG002|NOT COMPLETED|Overall Study||86
10837901|NCT00730639|12003382|FG003|NOT COMPLETED|Overall Study||54
10837902|NCT00730639|12003383|FG004|NOT COMPLETED|Overall Study||131
10837903|NCT00363038|12003406|FG000|STARTED|Overall Study||16
10837904|NCT00363038|12003406|FG000|COMPLETED|Overall Study||16
10837905|NCT00363038|12003406|FG000|NOT COMPLETED|Overall Study||0
10837906|NCT04834362|12003412|FG000|STARTED|Overall Study||53
10837907|NCT04834362|12003413|FG001|STARTED|Overall Study||52
10837908|NCT04834362|12003412|FG000|COMPLETED|Overall Study||52
10837909|NCT04834362|12003413|FG001|COMPLETED|Overall Study||50
10837910|NCT04834362|12003412|FG000|NOT COMPLETED|Overall Study||1
10837911|NCT04834362|12003413|FG001|NOT COMPLETED|Overall Study||2
10837912|NCT04681482|12003423|FG000|STARTED|Overall Study||35051
10837913|NCT04681482|12003424|FG001|STARTED|Overall Study||38756
10837914|NCT04681482|12003425|FG002|STARTED|Overall Study||12148
10837915|NCT04681482|12003426|FG003|STARTED|Overall Study||21428
10837916|NCT04681482|12003423|FG000|COMPLETED|Overall Study||35051
10837917|NCT04681482|12003424|FG001|COMPLETED|Overall Study||38756
10837918|NCT04681482|12003425|FG002|COMPLETED|Overall Study||12148
10837919|NCT04681482|12003426|FG003|COMPLETED|Overall Study||21428
10837920|NCT04681482|12003423|FG000|NOT COMPLETED|Overall Study||0
10837921|NCT04681482|12003424|FG001|NOT COMPLETED|Overall Study||0
10837922|NCT04681482|12003425|FG002|NOT COMPLETED|Overall Study||0
10837923|NCT04681482|12003426|FG003|NOT COMPLETED|Overall Study||0
10837924|NCT04611789|12003439|FG000|STARTED|Overall Study||4
10837925|NCT04611789|12003440|FG001|STARTED|Overall Study||7
10837926|NCT04611789|12003441|FG002|STARTED|Overall Study||7
10837927|NCT04611789|12003439|FG000|COMPLETED|Overall Study||3
10837928|NCT04611789|12003440|FG001|COMPLETED|Overall Study||7
10837929|NCT04611789|12003441|FG002|COMPLETED|Overall Study||7
10837930|NCT04611789|12003439|FG000|NOT COMPLETED|Overall Study||1
10837931|NCT04611789|12003440|FG001|NOT COMPLETED|Overall Study||0
10837932|NCT04611789|12003441|FG002|NOT COMPLETED|Overall Study||0
10837933|NCT04537910|12003452|FG000|STARTED|Overall Study||6
10837934|NCT04537910|12003453|FG001|STARTED|Overall Study||5
10837935|NCT04537910|12003454|FG002|STARTED|Overall Study||7
10837936|NCT04537910|12003455|FG003|STARTED|Overall Study||7
10837937|NCT04537910|12003452|FG000|Received at Least One Dose of Study Drug|Overall Study||6
10837938|NCT04537910|12003453|FG001|Received at Least One Dose of Study Drug|Overall Study||5
10837939|NCT04537910|12003454|FG002|Received at Least One Dose of Study Drug|Overall Study||7
10837940|NCT04537910|12003455|FG003|Received at Least One Dose of Study Drug|Overall Study||7
10837941|NCT04537910|12003452|FG000|COMPLETED|Overall Study||6
10837942|NCT04537910|12003453|FG001|COMPLETED|Overall Study||5
10837943|NCT04537910|12003454|FG002|COMPLETED|Overall Study||7
10837944|NCT04537910|12003455|FG003|COMPLETED|Overall Study||7
10837945|NCT04537910|12003452|FG000|NOT COMPLETED|Overall Study||0
10837946|NCT04537910|12003453|FG001|NOT COMPLETED|Overall Study||0
10837947|NCT04537910|12003454|FG002|NOT COMPLETED|Overall Study||0
10837948|NCT04537910|12003455|FG003|NOT COMPLETED|Overall Study||0
10837949|NCT04441931|12003468|FG000|STARTED|Overall Study||6
10837950|NCT04441931|12003469|FG001|STARTED|Overall Study||7
10837951|NCT04441931|12003470|FG002|STARTED|Overall Study||7
10837952|NCT04441931|12003471|FG003|STARTED|Overall Study||6
10837953|NCT04441931|12003468|FG000|Received at Least One Dose of Study Drug|Overall Study||6
10410129|NCT00761657|11554132|FG004|EE Population|Part 2 (up to Day 114)||10
10410130|NCT00761657|11554133|FG005|EE Population|Part 2 (up to Day 114)||11
10410131|NCT00761657|11554134|FG006|EE Population|Part 2 (up to Day 114)||10
10410132|NCT00761657|11554135|FG007|EE Population|Part 2 (up to Day 114)||10
10410133|NCT00761657|11554136|FG008|EE Population|Part 2 (up to Day 114)||11
10410134|NCT00761657|11554128|FG000|PK Population|Part 2 (up to Day 114)||10
10410135|NCT00761657|11554129|FG001|PK Population|Part 2 (up to Day 114)||13
10410136|NCT00761657|11554130|FG002|PK Population|Part 2 (up to Day 114)||0
10410137|NCT00761657|11554131|FG003|PK Population|Part 2 (up to Day 114)||0
10410138|NCT00761657|11554132|FG004|PK Population|Part 2 (up to Day 114)||10
10410139|NCT00761657|11554133|FG005|PK Population|Part 2 (up to Day 114)||11
10410140|NCT00761657|11554134|FG006|PK Population|Part 2 (up to Day 114)||10
10410141|NCT00761657|11554135|FG007|PK Population|Part 2 (up to Day 114)||10
10410142|NCT00761657|11554136|FG008|PK Population|Part 2 (up to Day 114)||0
10410143|NCT00761657|11554128|FG000|COMPLETED|Part 2 (up to Day 114)||10
10410144|NCT00761657|11554129|FG001|COMPLETED|Part 2 (up to Day 114)||13
10410145|NCT00761657|11554130|FG002|COMPLETED|Part 2 (up to Day 114)||0
10410146|NCT00761657|11554131|FG003|COMPLETED|Part 2 (up to Day 114)||0
10410147|NCT00761657|11554132|FG004|COMPLETED|Part 2 (up to Day 114)||10
10410148|NCT00761657|11554133|FG005|COMPLETED|Part 2 (up to Day 114)||11
10410149|NCT00761657|11554134|FG006|COMPLETED|Part 2 (up to Day 114)||10
10410150|NCT00761657|11554135|FG007|COMPLETED|Part 2 (up to Day 114)||10
10410151|NCT00761657|11554136|FG008|COMPLETED|Part 2 (up to Day 114)||17
10410152|NCT00761657|11554128|FG000|NOT COMPLETED|Part 2 (up to Day 114)||0
10410153|NCT00761657|11554129|FG001|NOT COMPLETED|Part 2 (up to Day 114)||0
10837954|NCT04441931|12003469|FG001|Received at Least One Dose of Study Drug|Overall Study||7
10837955|NCT04441931|12003470|FG002|Received at Least One Dose of Study Drug|Overall Study||7
10837956|NCT04441931|12003471|FG003|Received at Least One Dose of Study Drug|Overall Study||6
10837957|NCT04441931|12003468|FG000|COMPLETED|Overall Study||6
10837958|NCT04441931|12003469|FG001|COMPLETED|Overall Study||7
10837959|NCT04441931|12003470|FG002|COMPLETED|Overall Study||7
10837960|NCT04441931|12003471|FG003|COMPLETED|Overall Study||6
10837961|NCT04441931|12003468|FG000|NOT COMPLETED|Overall Study||0
10837962|NCT04441931|12003469|FG001|NOT COMPLETED|Overall Study||0
10837963|NCT04441931|12003470|FG002|NOT COMPLETED|Overall Study||0
10837964|NCT04441931|12003471|FG003|NOT COMPLETED|Overall Study||0
10837965|NCT04355728|12003486|FG000|STARTED|Overall Study||12
10837966|NCT04355728|12003487|FG001|STARTED|Overall Study||12
10837967|NCT04355728|12003486|FG000|COMPLETED|Overall Study||12
10837968|NCT04355728|12003487|FG001|COMPLETED|Overall Study||12
10837969|NCT04355728|12003486|FG000|NOT COMPLETED|Overall Study||0
10837970|NCT04355728|12003487|FG001|NOT COMPLETED|Overall Study||0
10837971|NCT04344535|12003495|FG000|STARTED|Overall Study||59
10837972|NCT04344535|12003496|FG001|STARTED|Overall Study||15
10837973|NCT04344535|12003495|FG000|COMPLETED|Overall Study||59
10837974|NCT04344535|12003496|FG001|COMPLETED|Overall Study||15
10837975|NCT04344535|12003495|FG000|NOT COMPLETED|Overall Study||0
10837976|NCT04344535|12003496|FG001|NOT COMPLETED|Overall Study||0
10837977|NCT04254809|12003504|FG000|STARTED|Overall Study||48
10837978|NCT04254809|12003505|FG001|STARTED|Overall Study||48
10837979|NCT04254809|12003504|FG000|COMPLETED|Overall Study||43
10837980|NCT04254809|12003505|FG001|COMPLETED|Overall Study||38
10837981|NCT04254809|12003504|FG000|NOT COMPLETED|Overall Study||5
10837982|NCT04254809|12003505|FG001|NOT COMPLETED|Overall Study||10
10837983|NCT04230122|12003513|FG000|STARTED|Overall Study||3
10837984|NCT04230122|12003514|FG001|STARTED|Overall Study||1
10837985|NCT04230122|12003513|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
10837986|NCT04230122|12003514|FG001|Received at Least 1 Dose of Study Drug|Overall Study||1
10837987|NCT04230122|12003513|FG000|COMPLETED|Overall Study||2
10837988|NCT04230122|12003514|FG001|COMPLETED|Overall Study||1
10837989|NCT04230122|12003513|FG000|NOT COMPLETED|Overall Study||1
10837990|NCT04230122|12003514|FG001|NOT COMPLETED|Overall Study||0
10837991|NCT04110366|12003522|FG000|STARTED|Overall Study||40
10837992|NCT04110366|12003523|FG001|STARTED|Overall Study||8
10837993|NCT04110366|12003522|FG000|COMPLETED|Overall Study||40
10837994|NCT04110366|12003523|FG001|COMPLETED|Overall Study||8
10837995|NCT04110366|12003522|FG000|NOT COMPLETED|Overall Study||0
10837996|NCT04110366|12003523|FG001|NOT COMPLETED|Overall Study||0
10837997|NCT04086693|12003532|FG000|STARTED|Overall Study||175
10410154|NCT00761657|11554130|FG002|NOT COMPLETED|Part 2 (up to Day 114)||0
10410155|NCT00761657|11554131|FG003|NOT COMPLETED|Part 2 (up to Day 114)||0
10410156|NCT00761657|11554132|FG004|NOT COMPLETED|Part 2 (up to Day 114)||0
10410157|NCT00761657|11554133|FG005|NOT COMPLETED|Part 2 (up to Day 114)||0
10410158|NCT00761657|11554134|FG006|NOT COMPLETED|Part 2 (up to Day 114)||0
10410159|NCT00761657|11554135|FG007|NOT COMPLETED|Part 2 (up to Day 114)||0
10410160|NCT00761657|11554136|FG008|NOT COMPLETED|Part 2 (up to Day 114)||1
10410161|NCT00761735|11554166|FG000|STARTED|Overall Study||94
10410162|NCT00761735|11554166|FG000|COMPLETED|Overall Study||80
10410163|NCT00761735|11554166|FG000|NOT COMPLETED|Overall Study||14
10410164|NCT00761748|11554174|FG000|STARTED|First Intervention (21 +/- 3 Days)||20
10410165|NCT00761748|11554175|FG001|STARTED|First Intervention (21 +/- 3 Days)||10
10410166|NCT00761748|11554174|FG000|COMPLETED|First Intervention (21 +/- 3 Days)||17
10410167|NCT00761748|11554175|FG001|COMPLETED|First Intervention (21 +/- 3 Days)||7
10410168|NCT00761748|11554174|FG000|NOT COMPLETED|First Intervention (21 +/- 3 Days)||3
10410169|NCT00761748|11554175|FG001|NOT COMPLETED|First Intervention (21 +/- 3 Days)||3
10410170|NCT00761748|11554174|FG000|STARTED|Second Intervention (21 +/- 3 Days)||17
10410171|NCT00761748|11554175|FG001|STARTED|Second Intervention (21 +/- 3 Days)||7
10410172|NCT00761748|11554174|FG000|COMPLETED|Second Intervention (21 +/- 3 Days)||17
10410173|NCT00761748|11554175|FG001|COMPLETED|Second Intervention (21 +/- 3 Days)||7
10410174|NCT00761748|11554174|FG000|NOT COMPLETED|Second Intervention (21 +/- 3 Days)||0
10410175|NCT00761748|11554175|FG001|NOT COMPLETED|Second Intervention (21 +/- 3 Days)||0
10410176|NCT00761761|11554183|FG000|STARTED|Overall Study||30
10410177|NCT00761761|11554184|FG001|STARTED|Overall Study||30
10410178|NCT00761761|11554183|FG000|COMPLETED|Overall Study||24
10410179|NCT00761761|11554184|FG001|COMPLETED|Overall Study||29
10410180|NCT00761761|11554183|FG000|NOT COMPLETED|Overall Study||6
10410181|NCT00761761|11554184|FG001|NOT COMPLETED|Overall Study||1
10410182|NCT00761774|11554192|FG000|STARTED|Overall Study||108
10410183|NCT00761774|11554192|FG000|COMPLETED|Overall Study||29
10410184|NCT00761774|11554192|FG000|NOT COMPLETED|Overall Study||79
10410185|NCT00761813|11554200|FG000|STARTED|Overall Study||557
10410186|NCT00761813|11554201|FG001|STARTED|Overall Study||551
10410187|NCT00761813|11554200|FG000|COMPLETED|Overall Study||542
10410188|NCT00761813|11554201|FG001|COMPLETED|Overall Study||537
10410189|NCT00761813|11554200|FG000|NOT COMPLETED|Overall Study||15
10410190|NCT00761813|11554201|FG001|NOT COMPLETED|Overall Study||14
10410191|NCT00761865|11554209|FG000|STARTED|Overall Study||16
10410192|NCT00761865|11554210|FG001|STARTED|Overall Study||18
10410193|NCT00761865|11554209|FG000|COMPLETED|Overall Study||8
10410194|NCT00761865|11554210|FG001|COMPLETED|Overall Study||11
10410195|NCT00761865|11554209|FG000|NOT COMPLETED|Overall Study||8
10410196|NCT00761865|11554210|FG001|NOT COMPLETED|Overall Study||7
10837998|NCT04086693|12003533|FG001|STARTED|Overall Study||175
10410197|NCT00761891|11554216|FG000|STARTED|Overall Study||64
10410198|NCT00761891|11554216|FG000|COMPLETED|Overall Study||54
10410199|NCT00761891|11554216|FG000|NOT COMPLETED|Overall Study||10
10837999|NCT04086693|12003532|FG000|COMPLETED|Overall Study||174
10838000|NCT04086693|12003533|FG001|COMPLETED|Overall Study||171
10838001|NCT04086693|12003532|FG000|NOT COMPLETED|Overall Study||1
10838002|NCT04086693|12003533|FG001|NOT COMPLETED|Overall Study||4
10838003|NCT04033068|12003543|FG000|STARTED|Overall Study||14
10838004|NCT04033068|12003544|FG001|STARTED|Overall Study||14
10838005|NCT04033068|12003545|FG002|STARTED|Overall Study||12
10838006|NCT04033068|12003546|FG003|STARTED|Overall Study||8
10838007|NCT04033068|12003543|FG000|First Dose|Overall Study||14
10838008|NCT04033068|12003544|FG001|First Dose|Overall Study||14
10838009|NCT04033068|12003545|FG002|First Dose|Overall Study||12
10838010|NCT04033068|12003546|FG003|First Dose|Overall Study||8
10838011|NCT04033068|12003543|FG000|Second Dose|Overall Study||14
10838012|NCT04033068|12003544|FG001|Second Dose|Overall Study||14
10838013|NCT04033068|12003545|FG002|Second Dose|Overall Study||11
10838014|NCT04033068|12003546|FG003|Second Dose|Overall Study||7
10838015|NCT04033068|12003543|FG000|COMPLETED|Overall Study||14
10838016|NCT04033068|12003544|FG001|COMPLETED|Overall Study||13
10838017|NCT04033068|12003545|FG002|COMPLETED|Overall Study||11
10838018|NCT04033068|12003546|FG003|COMPLETED|Overall Study||7
10838019|NCT04033068|12003543|FG000|NOT COMPLETED|Overall Study||0
10838020|NCT04033068|12003544|FG001|NOT COMPLETED|Overall Study||1
10838021|NCT04033068|12003545|FG002|NOT COMPLETED|Overall Study||1
10838022|NCT04033068|12003546|FG003|NOT COMPLETED|Overall Study||1
10838023|NCT03561597|12003556|FG000|STARTED|Overall Study|Recruited|40
10838024|NCT03561597|12003556|FG000|3 Month Follow up|Overall Study|Attended 3 month follow up|21
10838025|NCT03561597|12003556|FG000|COMPLETED|Overall Study|Attend month 6 follow up|20
10838026|NCT03561597|12003556|FG000|NOT COMPLETED|Overall Study||20
10838027|NCT03350984|12003562|FG000|STARTED|Overall Study||39
10838028|NCT03350984|12003563|FG001|STARTED|Overall Study||36
10838029|NCT03350984|12003562|FG000|COMPLETED|Overall Study||31
10838030|NCT03350984|12003563|FG001|COMPLETED|Overall Study||28
10838031|NCT03350984|12003562|FG000|NOT COMPLETED|Overall Study||8
10838032|NCT03350984|12003563|FG001|NOT COMPLETED|Overall Study||8
10838033|NCT03277261|12003571|FG000|STARTED|Overall Study||274
10838034|NCT03277261|12003572|FG001|STARTED|Overall Study||275
10838035|NCT03277261|12003571|FG000|COMPLETED|Overall Study||240
10838036|NCT03277261|12003572|FG001|COMPLETED|Overall Study||252
10838037|NCT03277261|12003571|FG000|NOT COMPLETED|Overall Study||34
10838038|NCT03277261|12003572|FG001|NOT COMPLETED|Overall Study||23
10838039|NCT03277248|12003581|FG000|STARTED|Overall Study||272
10838040|NCT03277248|12003582|FG001|STARTED|Overall Study||273
10838041|NCT03277248|12003581|FG000|COMPLETED|Overall Study||254
10838042|NCT03277248|12003582|FG001|COMPLETED|Overall Study||239
10838043|NCT03277248|12003581|FG000|NOT COMPLETED|Overall Study||18
10838044|NCT03277248|12003582|FG001|NOT COMPLETED|Overall Study||34
10838045|NCT03179462|12003591|FG000|STARTED|Overall Study||9
10838046|NCT03179462|12003592|FG001|STARTED|Overall Study||10
10838047|NCT03179462|12003593|FG002|STARTED|Overall Study||8
10838048|NCT03179462|12003591|FG000|COMPLETED|Overall Study||8
10410200|NCT00761930|11554224|FG000|STARTED|Overall Study||34
10410201|NCT00761930|11554225|FG001|STARTED|Overall Study||34
10410202|NCT00761930|11554226|FG002|STARTED|Overall Study||35
10410203|NCT00761930|11554224|FG000|COMPLETED|Overall Study||34
10410204|NCT00761930|11554225|FG001|COMPLETED|Overall Study||34
10410205|NCT00761930|11554226|FG002|COMPLETED|Overall Study||35
10410206|NCT00761930|11554224|FG000|NOT COMPLETED|Overall Study||0
10410207|NCT00761930|11554225|FG001|NOT COMPLETED|Overall Study||0
10410208|NCT00761930|11554226|FG002|NOT COMPLETED|Overall Study||0
10410209|NCT00761956|11554236|FG000|STARTED|Overall Study||87
10410210|NCT00761956|11554237|FG001|STARTED|Overall Study||102
10410211|NCT00761956|11554236|FG000|COMPLETED|Overall Study||52
10410212|NCT00761956|11554237|FG001|COMPLETED|Overall Study||48
10410213|NCT00761956|11554236|FG000|NOT COMPLETED|Overall Study||35
10410214|NCT00761956|11554237|FG001|NOT COMPLETED|Overall Study||54
10410215|NCT00761969|11554245|FG000|STARTED|Overall Study||742
10410216|NCT00761969|11554246|FG001|STARTED|Overall Study||713
10410217|NCT00761969|11554245|FG000|COMPLETED|Overall Study||542
10410218|NCT00761969|11554246|FG001|COMPLETED|Overall Study||573
10410219|NCT00761969|11554245|FG000|NOT COMPLETED|Overall Study||200
10410220|NCT00761969|11554246|FG001|NOT COMPLETED|Overall Study||140
10410221|NCT00762021|11554254|FG000|STARTED|Overall Study||52
10410222|NCT00762021|11554255|FG001|STARTED|Overall Study||52
10410223|NCT00762021|11554254|FG000|COMPLETED|Overall Study||44
10410224|NCT00762021|11554255|FG001|COMPLETED|Overall Study||44
10410225|NCT00762021|11554254|FG000|NOT COMPLETED|Overall Study||8
10410226|NCT00762021|11554255|FG001|NOT COMPLETED|Overall Study||8
10410227|NCT00762034|11554263|FG000|STARTED|Induction Period||472
10410228|NCT00762034|11554264|FG001|STARTED|Induction Period||467
10410229|NCT00762034|11554263|FG000|Received at Least 1 Dose of Study Drug|Induction Period||442
10410230|NCT00762034|11554264|FG001|Received at Least 1 Dose of Study Drug|Induction Period||443
10410231|NCT00762034|11554263|FG000|COMPLETED|Induction Period||294
10410232|NCT00762034|11554264|FG001|COMPLETED|Induction Period||298
10410233|NCT00762034|11554263|FG000|NOT COMPLETED|Induction Period||178
10410234|NCT00762034|11554264|FG001|NOT COMPLETED|Induction Period||169
10410235|NCT00762034|11554263|FG000|STARTED|Maintenance Period||294
10410236|NCT00762034|11554264|FG001|STARTED|Maintenance Period||298
10410237|NCT00762034|11554263|FG000|Received at Least 1 Dose of Study Drug|Maintenance Period||294
10410238|NCT00762034|11554264|FG001|Received at Least 1 Dose of Study Drug|Maintenance Period||298
10410239|NCT00762034|11554263|FG000|COMPLETED|Maintenance Period||0
10410240|NCT00762034|11554264|FG001|COMPLETED|Maintenance Period||0
10410241|NCT00762034|11554263|FG000|NOT COMPLETED|Maintenance Period||294
10410242|NCT00762034|11554264|FG001|NOT COMPLETED|Maintenance Period||298
10410243|NCT00762073|11554282|FG000|STARTED|Overall Study||21
10410244|NCT00762073|11554283|FG001|STARTED|Overall Study||21
10410245|NCT00762073|11554284|FG002|STARTED|Overall Study||20
10410246|NCT00762073|11554285|FG003|STARTED|Overall Study||20
10410247|NCT00762073|11554282|FG000|COMPLETED|Overall Study||17
10410248|NCT00762073|11554283|FG001|COMPLETED|Overall Study||17
10410249|NCT00762073|11554284|FG002|COMPLETED|Overall Study|One participant was enrolled and randomized then withdrew consent and did not receive study drug.|18
10410250|NCT00762073|11554285|FG003|COMPLETED|Overall Study||17
10838049|NCT03179462|12003592|FG001|COMPLETED|Overall Study||8
10838050|NCT03179462|12003593|FG002|COMPLETED|Overall Study||8
10838051|NCT03179462|12003591|FG000|NOT COMPLETED|Overall Study||1
10545011|NCT01493596|11698218|FG002|NOT COMPLETED|Overall Study||0
10545012|NCT01493596|11698219|FG003|NOT COMPLETED|Overall Study||0
10545013|NCT01493596|11698220|FG004|NOT COMPLETED|Overall Study||0
10545014|NCT01493596|11698221|FG005|NOT COMPLETED|Overall Study||0
10545015|NCT01493596|11698222|FG006|NOT COMPLETED|Overall Study||0
10838052|NCT03179462|12003592|FG001|NOT COMPLETED|Overall Study||2
10410251|NCT00762073|11554282|FG000|NOT COMPLETED|Overall Study||4
10410252|NCT00762073|11554283|FG001|NOT COMPLETED|Overall Study||4
10838053|NCT03179462|12003593|FG002|NOT COMPLETED|Overall Study||0
10838054|NCT03099707|12003603|FG000|STARTED|Overall Study||43
10838055|NCT03099707|12003604|FG001|STARTED|Overall Study||41
10838056|NCT03099707|12003603|FG000|COMPLETED|Overall Study||43
10838057|NCT03099707|12003604|FG001|COMPLETED|Overall Study||37
10838058|NCT03099707|12003603|FG000|NOT COMPLETED|Overall Study||0
10838059|NCT03099707|12003604|FG001|NOT COMPLETED|Overall Study||4
10838060|NCT03064763|12003610|FG000|STARTED|Overall Study||18
10838061|NCT03064763|12003610|FG000|Received Treatment|Overall Study||18
10838062|NCT03064763|12003610|FG000|COMPLETED|Overall Study||0
10838063|NCT03064763|12003610|FG000|NOT COMPLETED|Overall Study||18
10838064|NCT03036267|12003614|FG000|STARTED|Overall Study||46
10838065|NCT03036267|12003614|FG000|COMPLETED|Overall Study||46
10838066|NCT03036267|12003614|FG000|NOT COMPLETED|Overall Study||0
10838067|NCT02941146|12003618|FG000|STARTED|Overall Study||15
10838068|NCT02941146|12003618|FG000|COMPLETED|Overall Study||15
10838069|NCT02941146|12003618|FG000|NOT COMPLETED|Overall Study||0
10838070|NCT02922985|12003624|FG000|STARTED|Overall Study||60
10838071|NCT02922985|12003625|FG001|STARTED|Overall Study||60
10838072|NCT02922985|12003624|FG000|COMPLETED|Overall Study||60
10838073|NCT02922985|12003625|FG001|COMPLETED|Overall Study||60
10838074|NCT02922985|12003624|FG000|NOT COMPLETED|Overall Study||0
10838075|NCT02922985|12003625|FG001|NOT COMPLETED|Overall Study||0
10838076|NCT02906033|12003635|FG000|STARTED|Baseline||231
10838077|NCT02906033|12003636|FG001|STARTED|Baseline||222
10838078|NCT02906033|12003635|FG000|15 D at Baseline|Baseline||211
10838079|NCT02906033|12003636|FG001|15 D at Baseline|Baseline||189
10838080|NCT02906033|12003635|FG000|STATE at Baseline|Baseline||199
10838081|NCT02906033|12003636|FG001|STATE at Baseline|Baseline||190
10838082|NCT02906033|12003635|FG000|TRAIT at Baseline|Baseline||194
10838083|NCT02906033|12003636|FG001|TRAIT at Baseline|Baseline||189
10838084|NCT02906033|12003635|FG000|COMPLETED|Baseline|Analyzed at baseline for 15 D and STATE anxiety and TRAIT anxiety|194
10838085|NCT02906033|12003636|FG001|COMPLETED|Baseline|Analyzed at baseline for 15 D and STATE anxiety and TRAIT anxiety.|189
10838086|NCT02906033|12003635|FG000|NOT COMPLETED|Baseline||37
10838087|NCT02906033|12003636|FG001|NOT COMPLETED|Baseline||33
10838088|NCT02906033|12003635|FG000|STARTED|Follow-up||194
10838089|NCT02906033|12003636|FG001|STARTED|Follow-up||189
10838090|NCT02906033|12003635|FG000|15 D at Follow-up|Follow-up||151
10838091|NCT02906033|12003636|FG001|15 D at Follow-up|Follow-up||135
10838092|NCT02906033|12003635|FG000|STATE at Follow-up|Follow-up||154
10838093|NCT02906033|12003636|FG001|STATE at Follow-up|Follow-up||135
10838094|NCT02906033|12003635|FG000|TRAIT at Follow-up|Follow-up||148
10838095|NCT02906033|12003636|FG001|TRAIT at Follow-up|Follow-up||127
10838096|NCT02906033|12003635|FG000|COMPLETED|Follow-up|Analyzed for 15 D and STATE anxiety and TRAIT anxiety at follow-up|148
10838097|NCT02906033|12003636|FG001|COMPLETED|Follow-up|Analyzed at follow-up 15 D and STATE anxiety and TRAIT anxiety.|127
10838098|NCT02906033|12003635|FG000|NOT COMPLETED|Follow-up||46
10838099|NCT02906033|12003636|FG001|NOT COMPLETED|Follow-up||62
10838100|NCT02837783|12003644|FG000|STARTED|Overall Study||9
10838101|NCT02837783|12003645|FG001|STARTED|Overall Study||11
10838102|NCT02837783|12003644|FG000|Received >= 1 Dose of Study Drug|Overall Study||9
10838103|NCT02837783|12003645|FG001|Received >= 1 Dose of Study Drug|Overall Study||10
10838104|NCT02837783|12003644|FG000|COMPLETED|Overall Study||7
10838105|NCT02837783|12003645|FG001|COMPLETED|Overall Study||9
10838106|NCT02837783|12003644|FG000|NOT COMPLETED|Overall Study||2
10838107|NCT02837783|12003645|FG001|NOT COMPLETED|Overall Study||2
10838108|NCT02786537|12003657|FG000|STARTED|As Randomized||56
10838109|NCT02786537|12003658|FG001|STARTED|As Randomized||644
10838110|NCT02786537|12003659|FG002|STARTED|As Randomized||15
10838111|NCT02786537|12003660|FG003|STARTED|As Randomized||413
10838112|NCT02786537|12003661|FG004|STARTED|As Randomized||99
10838113|NCT02786537|12003662|FG005|STARTED|As Randomized||48
10838114|NCT02786537|12003657|FG000|COMPLETED|As Randomized||50
10410253|NCT00762073|11554284|FG002|NOT COMPLETED|Overall Study||2
10410254|NCT00762073|11554285|FG003|NOT COMPLETED|Overall Study||3
10410255|NCT00762086|11554304|FG000|STARTED|Overall Study||39
10410256|NCT00762086|11554305|FG001|STARTED|Overall Study||28
10410257|NCT00762086|11554304|FG000|COMPLETED|Overall Study||33
10410258|NCT00762086|11554305|FG001|COMPLETED|Overall Study||24
10410259|NCT00762086|11554304|FG000|NOT COMPLETED|Overall Study||6
10410260|NCT00762086|11554305|FG001|NOT COMPLETED|Overall Study||4
10410261|NCT00762164|11554313|FG000|STARTED|Overall Study||17
10410262|NCT00762164|11554314|FG001|STARTED|Overall Study||17
10410263|NCT00762164|11554313|FG000|COMPLETED|Overall Study||14
10410264|NCT00762164|11554314|FG001|COMPLETED|Overall Study||15
10410265|NCT00762164|11554313|FG000|NOT COMPLETED|Overall Study||3
10410266|NCT00762164|11554314|FG001|NOT COMPLETED|Overall Study||2
10410267|NCT00762177|11554323|FG000|STARTED|1st Treatment Period||8
10410268|NCT00762177|11554324|FG001|STARTED|1st Treatment Period||8
10410269|NCT00762177|11554325|FG002|STARTED|1st Treatment Period||8
10410270|NCT00762177|11554323|FG000|COMPLETED|1st Treatment Period||8
10410271|NCT00762177|11554324|FG001|COMPLETED|1st Treatment Period||8
10838115|NCT02786537|12003658|FG001|COMPLETED|As Randomized||582
10838116|NCT02786537|12003659|FG002|COMPLETED|As Randomized||15
10838117|NCT02786537|12003660|FG003|COMPLETED|As Randomized||378
10838118|NCT02786537|12003661|FG004|COMPLETED|As Randomized||87
10838119|NCT02786537|12003662|FG005|COMPLETED|As Randomized||41
10838120|NCT02786537|12003657|FG000|NOT COMPLETED|As Randomized||6
10838121|NCT02786537|12003658|FG001|NOT COMPLETED|As Randomized||62
10838122|NCT02786537|12003659|FG002|NOT COMPLETED|As Randomized||0
10410272|NCT00762177|11554325|FG002|COMPLETED|1st Treatment Period||8
10410273|NCT00762177|11554323|FG000|NOT COMPLETED|1st Treatment Period||0
10410274|NCT00762177|11554324|FG001|NOT COMPLETED|1st Treatment Period||0
10838123|NCT02786537|12003660|FG003|NOT COMPLETED|As Randomized||35
10838124|NCT02786537|12003661|FG004|NOT COMPLETED|As Randomized||12
10838125|NCT02786537|12003662|FG005|NOT COMPLETED|As Randomized||7
10838126|NCT02786537|12003657|FG000|STARTED|As Treated||56
10838127|NCT02786537|12003658|FG001|STARTED|As Treated||664
10838128|NCT02786537|12003659|FG002|STARTED|As Treated||15
10838129|NCT02786537|12003660|FG003|STARTED|As Treated||394
10838130|NCT02786537|12003661|FG004|STARTED|As Treated||99
10838131|NCT02786537|12003662|FG005|STARTED|As Treated||47
10838132|NCT02786537|12003657|FG000|COMPLETED|As Treated||50
10838133|NCT02786537|12003658|FG001|COMPLETED|As Treated||602
10838134|NCT02786537|12003659|FG002|COMPLETED|As Treated||15
10838135|NCT02786537|12003660|FG003|COMPLETED|As Treated||359
10838136|NCT02786537|12003661|FG004|COMPLETED|As Treated||87
10838137|NCT02786537|12003662|FG005|COMPLETED|As Treated||40
10838138|NCT02786537|12003657|FG000|NOT COMPLETED|As Treated||6
10838139|NCT02786537|12003658|FG001|NOT COMPLETED|As Treated||62
10838140|NCT02786537|12003659|FG002|NOT COMPLETED|As Treated||0
10838141|NCT02786537|12003660|FG003|NOT COMPLETED|As Treated||35
10838142|NCT02786537|12003661|FG004|NOT COMPLETED|As Treated||12
10838143|NCT02786537|12003662|FG005|NOT COMPLETED|As Treated||7
10838144|NCT02740231|12003772|FG000|STARTED|Overall Study||41
10838145|NCT02740231|12003773|FG001|STARTED|Overall Study||41
10838146|NCT02740231|12003774|FG002|STARTED|Overall Study||41
10838147|NCT02740231|12003775|FG003|STARTED|Overall Study||41
10838148|NCT02740231|12003772|FG000|COMPLETED|Overall Study||39
10838149|NCT02740231|12003773|FG001|COMPLETED|Overall Study||35
10838150|NCT02740231|12003774|FG002|COMPLETED|Overall Study||40
10838151|NCT02740231|12003775|FG003|COMPLETED|Overall Study||33
10838152|NCT02740231|12003772|FG000|NOT COMPLETED|Overall Study||2
10838153|NCT02740231|12003773|FG001|NOT COMPLETED|Overall Study||6
10838154|NCT02740231|12003774|FG002|NOT COMPLETED|Overall Study||1
10838155|NCT02740231|12003775|FG003|NOT COMPLETED|Overall Study||8
10838156|NCT02710084|12003787|FG000|STARTED|First Phase - 12 Weeks||10
10838157|NCT02710084|12003788|FG001|STARTED|First Phase - 12 Weeks||8
10838158|NCT02710084|12003787|FG000|COMPLETED|First Phase - 12 Weeks||7
10838159|NCT02710084|12003788|FG001|COMPLETED|First Phase - 12 Weeks||7
10838160|NCT02710084|12003787|FG000|NOT COMPLETED|First Phase - 12 Weeks||3
10838161|NCT02710084|12003788|FG001|NOT COMPLETED|First Phase - 12 Weeks||1
10838162|NCT02710084|12003787|FG000|STARTED|Open Label Phase: Week 12 to 24||7
10838163|NCT02710084|12003788|FG001|STARTED|Open Label Phase: Week 12 to 24||7
10838164|NCT02710084|12003787|FG000|COMPLETED|Open Label Phase: Week 12 to 24||7
10838165|NCT02710084|12003788|FG001|COMPLETED|Open Label Phase: Week 12 to 24||7
10838166|NCT02710084|12003787|FG000|NOT COMPLETED|Open Label Phase: Week 12 to 24||0
10838167|NCT02710084|12003788|FG001|NOT COMPLETED|Open Label Phase: Week 12 to 24||0
10838168|NCT02660034|12003809|FG000|STARTED|Overall Study||12
10838169|NCT02660034|12003810|FG001|STARTED|Overall Study||12
10838170|NCT02660034|12003811|FG002|STARTED|Overall Study||6
10838171|NCT02660034|12003812|FG003|STARTED|Overall Study||13
10838172|NCT02660034|12003813|FG004|STARTED|Overall Study||6
10838173|NCT02660034|12003814|FG005|STARTED|Overall Study||23
10838174|NCT02660034|12003815|FG006|STARTED|Overall Study||23
10838175|NCT02660034|12003816|FG007|STARTED|Overall Study||19
10838176|NCT02660034|12003817|FG008|STARTED|Overall Study||20
10838177|NCT02660034|12003818|FG009|STARTED|Overall Study||23
10838178|NCT02660034|12003819|FG010|STARTED|Overall Study||20
10838179|NCT02660034|12003820|FG011|STARTED|Overall Study||21
10838180|NCT02660034|12003821|FG012|STARTED|Overall Study||21
10838181|NCT02660034|12003822|FG013|STARTED|Overall Study||10
10838182|NCT02660034|12003809|FG000|Received At Least 1 Dose of Study Drug(s)|Overall Study||12
10838183|NCT02660034|12003810|FG001|Received At Least 1 Dose of Study Drug(s)|Overall Study||12
10838184|NCT02660034|12003811|FG002|Received At Least 1 Dose of Study Drug(s)|Overall Study||6
10838185|NCT02660034|12003812|FG003|Received At Least 1 Dose of Study Drug(s)|Overall Study||13
10838186|NCT02660034|12003813|FG004|Received At Least 1 Dose of Study Drug(s)|Overall Study||6
10838187|NCT02660034|12003814|FG005|Received At Least 1 Dose of Study Drug(s)|Overall Study||23
10838188|NCT02660034|12003815|FG006|Received At Least 1 Dose of Study Drug(s)|Overall Study||23
10838189|NCT02660034|12003816|FG007|Received At Least 1 Dose of Study Drug(s)|Overall Study||19
10838190|NCT02660034|12003817|FG008|Received At Least 1 Dose of Study Drug(s)|Overall Study||20
10838191|NCT02660034|12003818|FG009|Received At Least 1 Dose of Study Drug(s)|Overall Study||23
10838192|NCT02660034|12003819|FG010|Received At Least 1 Dose of Study Drug(s)|Overall Study||20
10838193|NCT02660034|12003820|FG011|Received At Least 1 Dose of Study Drug(s)|Overall Study||21
10838194|NCT02660034|12003821|FG012|Received At Least 1 Dose of Study Drug(s)|Overall Study||21
10838195|NCT02660034|12003822|FG013|Received At Least 1 Dose of Study Drug(s)|Overall Study||10
10838196|NCT02660034|12003809|FG000|COMPLETED|Overall Study||0
10410275|NCT00762177|11554325|FG002|NOT COMPLETED|1st Treatment Period||0
10838197|NCT02660034|12003810|FG001|COMPLETED|Overall Study||0
10838198|NCT02660034|12003811|FG002|COMPLETED|Overall Study||0
10838199|NCT02660034|12003812|FG003|COMPLETED|Overall Study||0
10838200|NCT02660034|12003813|FG004|COMPLETED|Overall Study||0
10838201|NCT02660034|12003814|FG005|COMPLETED|Overall Study||0
10838202|NCT02660034|12003815|FG006|COMPLETED|Overall Study||0
10838203|NCT02660034|12003816|FG007|COMPLETED|Overall Study||0
10838204|NCT02660034|12003817|FG008|COMPLETED|Overall Study||0
10838205|NCT02660034|12003818|FG009|COMPLETED|Overall Study||0
10838206|NCT02660034|12003819|FG010|COMPLETED|Overall Study||0
10838207|NCT02660034|12003820|FG011|COMPLETED|Overall Study||0
10838208|NCT02660034|12003821|FG012|COMPLETED|Overall Study||0
10410276|NCT00762177|11554323|FG000|STARTED|Washout After 1st Treatment||8
10838209|NCT02660034|12003822|FG013|COMPLETED|Overall Study||0
10838210|NCT02660034|12003809|FG000|NOT COMPLETED|Overall Study||12
10838211|NCT02660034|12003810|FG001|NOT COMPLETED|Overall Study||12
10838212|NCT02660034|12003811|FG002|NOT COMPLETED|Overall Study||6
10838213|NCT02660034|12003812|FG003|NOT COMPLETED|Overall Study||13
10838214|NCT02660034|12003813|FG004|NOT COMPLETED|Overall Study||6
10838215|NCT02660034|12003814|FG005|NOT COMPLETED|Overall Study||23
10838216|NCT02660034|12003815|FG006|NOT COMPLETED|Overall Study||23
10838217|NCT02660034|12003816|FG007|NOT COMPLETED|Overall Study||19
10838218|NCT02660034|12003817|FG008|NOT COMPLETED|Overall Study||20
10838219|NCT02660034|12003818|FG009|NOT COMPLETED|Overall Study||23
10838220|NCT02660034|12003819|FG010|NOT COMPLETED|Overall Study||20
10838221|NCT02660034|12003820|FG011|NOT COMPLETED|Overall Study||21
10838222|NCT02660034|12003821|FG012|NOT COMPLETED|Overall Study||21
10838223|NCT02660034|12003822|FG013|NOT COMPLETED|Overall Study||10
10838224|NCT02640625|12003856|FG000|STARTED|Overall Study||20
10838225|NCT02640625|12003856|FG000|COMPLETED|Overall Study||19
10838226|NCT02640625|12003856|FG000|NOT COMPLETED|Overall Study||1
10838227|NCT02561962|12003870|FG000|STARTED|Overall Study||3
10838228|NCT02561962|12003871|FG001|STARTED|Overall Study||3
10838229|NCT02561962|12003872|FG002|STARTED|Overall Study||3
10838230|NCT02561962|12003873|FG003|STARTED|Overall Study||3
10838231|NCT02561962|12003874|FG004|STARTED|Overall Study||6
10838232|NCT02561962|12003875|FG005|STARTED|Overall Study||6
10838233|NCT02561962|12003876|FG006|STARTED|Overall Study||5
10838234|NCT02561962|12003877|FG007|STARTED|Overall Study||11
10838235|NCT02561962|12003878|FG008|STARTED|Overall Study||2
10838236|NCT02561962|12003870|FG000|Received Treatment|Overall Study||3
10838237|NCT02561962|12003871|FG001|Received Treatment|Overall Study||3
10410277|NCT00762177|11554324|FG001|STARTED|Washout After 1st Treatment||8
10410278|NCT00762177|11554325|FG002|STARTED|Washout After 1st Treatment||8
10410279|NCT00762177|11554323|FG000|COMPLETED|Washout After 1st Treatment||8
10410280|NCT00762177|11554324|FG001|COMPLETED|Washout After 1st Treatment||8
10410281|NCT00762177|11554325|FG002|COMPLETED|Washout After 1st Treatment||8
10410282|NCT00762177|11554323|FG000|NOT COMPLETED|Washout After 1st Treatment||0
10410283|NCT00762177|11554324|FG001|NOT COMPLETED|Washout After 1st Treatment||0
10410284|NCT00762177|11554325|FG002|NOT COMPLETED|Washout After 1st Treatment||0
10410285|NCT00762177|11554323|FG000|STARTED|2nd Treatment Period||8
10410286|NCT00762177|11554324|FG001|STARTED|2nd Treatment Period||8
10410287|NCT00762177|11554325|FG002|STARTED|2nd Treatment Period||8
10410288|NCT00762177|11554323|FG000|COMPLETED|2nd Treatment Period||8
10410289|NCT00762177|11554324|FG001|COMPLETED|2nd Treatment Period||8
10410290|NCT00762177|11554325|FG002|COMPLETED|2nd Treatment Period||8
10410291|NCT00762177|11554323|FG000|NOT COMPLETED|2nd Treatment Period||0
10410292|NCT00762177|11554324|FG001|NOT COMPLETED|2nd Treatment Period||0
10410293|NCT00762177|11554325|FG002|NOT COMPLETED|2nd Treatment Period||0
10410294|NCT00762177|11554323|FG000|STARTED|Washout After 2nd Treatment||8
10410295|NCT00762177|11554324|FG001|STARTED|Washout After 2nd Treatment||8
10410296|NCT00762177|11554325|FG002|STARTED|Washout After 2nd Treatment||8
10410297|NCT00762177|11554323|FG000|COMPLETED|Washout After 2nd Treatment||8
10410298|NCT00762177|11554324|FG001|COMPLETED|Washout After 2nd Treatment||8
10410299|NCT00762177|11554325|FG002|COMPLETED|Washout After 2nd Treatment||8
10410300|NCT00762177|11554323|FG000|NOT COMPLETED|Washout After 2nd Treatment||0
10410301|NCT00762177|11554324|FG001|NOT COMPLETED|Washout After 2nd Treatment||0
10410302|NCT00762177|11554325|FG002|NOT COMPLETED|Washout After 2nd Treatment||0
10410303|NCT00762177|11554323|FG000|STARTED|3rd Treatment Period||8
10410304|NCT00762177|11554324|FG001|STARTED|3rd Treatment Period||8
10410305|NCT00762177|11554325|FG002|STARTED|3rd Treatment Period||8
10410306|NCT00762177|11554323|FG000|COMPLETED|3rd Treatment Period||8
10410307|NCT00762177|11554324|FG001|COMPLETED|3rd Treatment Period||8
10410308|NCT00762177|11554325|FG002|COMPLETED|3rd Treatment Period||8
10410309|NCT00762177|11554323|FG000|NOT COMPLETED|3rd Treatment Period||0
10410310|NCT00762177|11554324|FG001|NOT COMPLETED|3rd Treatment Period||0
10410311|NCT00762177|11554325|FG002|NOT COMPLETED|3rd Treatment Period||0
10410312|NCT00762216|11554336|FG000|STARTED|Overall Study||71
10410313|NCT00762216|11554336|FG000|COMPLETED|Overall Study||71
10410314|NCT00762216|11554336|FG000|NOT COMPLETED|Overall Study||0
10838238|NCT02561962|12003872|FG002|Received Treatment|Overall Study||3
10838239|NCT02561962|12003873|FG003|Received Treatment|Overall Study||3
10838240|NCT02561962|12003874|FG004|Received Treatment|Overall Study||6
10838241|NCT02561962|12003875|FG005|Received Treatment|Overall Study||6
10838242|NCT02561962|12003876|FG006|Received Treatment|Overall Study||5
10838243|NCT02561962|12003877|FG007|Received Treatment|Overall Study||9
10838244|NCT02561962|12003878|FG008|Received Treatment|Overall Study||2
10838245|NCT02561962|12003870|FG000|COMPLETED|Overall Study||1
10838246|NCT02561962|12003871|FG001|COMPLETED|Overall Study||3
10838247|NCT02561962|12003872|FG002|COMPLETED|Overall Study||3
10838248|NCT02561962|12003873|FG003|COMPLETED|Overall Study||2
10838249|NCT02561962|12003874|FG004|COMPLETED|Overall Study||4
10410315|NCT00762229|11554342|FG000|STARTED|Overall Study||15
10410316|NCT00762229|11554343|FG001|STARTED|Overall Study||24
10410317|NCT00762229|11554342|FG000|COMPLETED|Overall Study||14
10410318|NCT00762229|11554343|FG001|COMPLETED|Overall Study||22
10410319|NCT00762229|11554342|FG000|NOT COMPLETED|Overall Study||1
10410320|NCT00762229|11554343|FG001|NOT COMPLETED|Overall Study||2
10410321|NCT00762268|11554351|FG000|STARTED|Overall Study||12
10410322|NCT00762268|11554352|FG001|STARTED|Overall Study||11
10410323|NCT00762268|11554351|FG000|COMPLETED|Overall Study||9
10838250|NCT02561962|12003875|FG005|COMPLETED|Overall Study||2
10838251|NCT02561962|12003876|FG006|COMPLETED|Overall Study||3
10838252|NCT02561962|12003877|FG007|COMPLETED|Overall Study||3
10838253|NCT02561962|12003878|FG008|COMPLETED|Overall Study||1
10838254|NCT02561962|12003870|FG000|NOT COMPLETED|Overall Study||2
10838255|NCT02561962|12003871|FG001|NOT COMPLETED|Overall Study||0
10838256|NCT02561962|12003872|FG002|NOT COMPLETED|Overall Study||0
10838257|NCT02561962|12003873|FG003|NOT COMPLETED|Overall Study||1
10838258|NCT02561962|12003874|FG004|NOT COMPLETED|Overall Study||2
10838259|NCT02561962|12003875|FG005|NOT COMPLETED|Overall Study||4
10838260|NCT02561962|12003876|FG006|NOT COMPLETED|Overall Study||2
10838261|NCT02561962|12003877|FG007|NOT COMPLETED|Overall Study||8
10838262|NCT02561962|12003878|FG008|NOT COMPLETED|Overall Study||1
10838263|NCT02500589|12003900|FG000|STARTED|Overall Study||175
10838264|NCT02500589|12003901|FG001|STARTED|Overall Study||175
10838265|NCT02500589|12003900|FG000|COMPLETED|Overall Study||147
10838266|NCT02500589|12003901|FG001|COMPLETED|Overall Study||143
10838267|NCT02500589|12003900|FG000|NOT COMPLETED|Overall Study||28
10838268|NCT02500589|12003901|FG001|NOT COMPLETED|Overall Study||32
10838269|NCT02474329|12003911|FG000|STARTED|Overall Study|Participants (People with Parkinson's Disease) who signed a consent form.|304
10838270|NCT02474329|12003911|FG000|COMPLETED|Overall Study|Participants (People with Parkinson's Disease) who contributed data for 13 weeks.|291
10838271|NCT02474329|12003911|FG000|NOT COMPLETED|Overall Study||13
10838272|NCT01976273|12003918|FG000|STARTED|Overall Study||10
10838273|NCT01976273|12003919|FG001|STARTED|Overall Study||10
10838274|NCT01976273|12003918|FG000|COMPLETED|Overall Study||9
10838275|NCT01976273|12003919|FG001|COMPLETED|Overall Study||9
10838276|NCT01976273|12003918|FG000|NOT COMPLETED|Overall Study||1
10838277|NCT01976273|12003919|FG001|NOT COMPLETED|Overall Study||1
10838278|NCT01722929|12003925|FG000|STARTED|Overall Study||4
10838279|NCT01722929|12003925|FG000|COMPLETED|Overall Study||4
10838280|NCT01722929|12003925|FG000|NOT COMPLETED|Overall Study||0
10838281|NCT01500733|12003932|FG000|STARTED|Overall Study||35
10838282|NCT01500733|12003933|FG001|STARTED|Overall Study||51
10838283|NCT01500733|12003932|FG000|COMPLETED|Overall Study||33
10838284|NCT01500733|12003933|FG001|COMPLETED|Overall Study||48
10838285|NCT01500733|12003932|FG000|NOT COMPLETED|Overall Study||2
10838286|NCT01500733|12003933|FG001|NOT COMPLETED|Overall Study||3
10838287|NCT01388491|12003941|FG000|STARTED|Overall Study|number randomized|150
10838288|NCT01388491|12003942|FG001|STARTED|Overall Study||143
10838289|NCT01388491|12003941|FG000|Safety Population|Overall Study|Safety: all randomized participants who took 1 or more doses of study drug|145
10838290|NCT01388491|12003942|FG001|Safety Population|Overall Study||142
10838291|NCT01388491|12003941|FG000|Intent-to-Treat (ITT) Population|Overall Study|ITT:participants in safety population with baseline (BL) + ≥1 post-BL prothrombin fragment 1+2 value|140
10838292|NCT01388491|12003942|FG001|Intent-to-Treat (ITT) Population|Overall Study||136
10838293|NCT01388491|12003941|FG000|Per Protocol (PP) Population|Overall Study|PP: all data from ITT participants obtained prior to any major protocol violations|125
10838294|NCT01388491|12003942|FG001|Per Protocol (PP) Population|Overall Study||121
10838295|NCT01388491|12003941|FG000|COMPLETED|Overall Study||116
10838296|NCT01388491|12003942|FG001|COMPLETED|Overall Study||114
10838297|NCT01388491|12003941|FG000|NOT COMPLETED|Overall Study||34
10838298|NCT01388491|12003942|FG001|NOT COMPLETED|Overall Study||29
10838299|NCT01373151|12003955|FG000|STARTED|Period 1||61
10838300|NCT01373151|12003956|FG001|STARTED|Period 1||59
10838301|NCT01373151|12003957|FG002|STARTED|Period 1||60
10838302|NCT01373151|12003958|FG003|STARTED|Period 1||60
10838303|NCT01373151|12003959|FG004|STARTED|Period 1||59
10838304|NCT01373151|12003960|FG005|STARTED|Period 1||60
10838305|NCT01373151|12003961|FG006|STARTED|Period 1||59
10838306|NCT01373151|12003955|FG000|COMPLETED|Period 1||56
10838307|NCT01373151|12003956|FG001|COMPLETED|Period 1||59
10410324|NCT00762268|11554352|FG001|COMPLETED|Overall Study||8
10410325|NCT00762268|11554351|FG000|NOT COMPLETED|Overall Study||3
10410326|NCT00762268|11554352|FG001|NOT COMPLETED|Overall Study||3
10410327|NCT00762307|11554362|FG000|STARTED|Overall Study||28
10410328|NCT00762307|11554363|FG001|STARTED|Overall Study||11
10410329|NCT00762307|11554364|FG002|STARTED|Overall Study||11
10410330|NCT00762307|11554365|FG003|STARTED|Overall Study||10
10410331|NCT00762307|11554362|FG000|COMPLETED|Overall Study||26
10410332|NCT00762307|11554363|FG001|COMPLETED|Overall Study||11
10410333|NCT00762307|11554364|FG002|COMPLETED|Overall Study||11
10410334|NCT00762307|11554365|FG003|COMPLETED|Overall Study||9
10410335|NCT00762307|11554362|FG000|NOT COMPLETED|Overall Study||2
10410336|NCT00762307|11554363|FG001|NOT COMPLETED|Overall Study||0
10410337|NCT00762307|11554364|FG002|NOT COMPLETED|Overall Study||0
10410338|NCT00762307|11554365|FG003|NOT COMPLETED|Overall Study||1
10410339|NCT00762320|11554386|FG000|STARTED|Overall Study||8
10410340|NCT00762320|11554386|FG000|COMPLETED|Overall Study||8
10410341|NCT00762320|11554386|FG000|NOT COMPLETED|Overall Study||0
10838308|NCT01373151|12003957|FG002|COMPLETED|Period 1||56
10838309|NCT01373151|12003958|FG003|COMPLETED|Period 1||59
10838310|NCT01373151|12003959|FG004|COMPLETED|Period 1||54
10410342|NCT00762359|11554397|FG000|STARTED|Overall Study||226
10410343|NCT00762359|11554398|FG001|STARTED|Overall Study||235
10410344|NCT00762359|11554397|FG000|COMPLETED|Overall Study||167
10410345|NCT00762359|11554398|FG001|COMPLETED|Overall Study||178
10410346|NCT00762359|11554397|FG000|NOT COMPLETED|Overall Study||59
10410347|NCT00762359|11554398|FG001|NOT COMPLETED|Overall Study||57
10410348|NCT00762372|11554407|FG000|STARTED|Overall Study|N=114 enrolled but 3 participant's discontinued before start of study drug administration.|111
10838311|NCT01373151|12003960|FG005|COMPLETED|Period 1||56
10838312|NCT01373151|12003961|FG006|COMPLETED|Period 1||59
10838313|NCT01373151|12003955|FG000|NOT COMPLETED|Period 1||5
10838314|NCT01373151|12003956|FG001|NOT COMPLETED|Period 1||0
10838315|NCT01373151|12003957|FG002|NOT COMPLETED|Period 1||4
10838316|NCT01373151|12003958|FG003|NOT COMPLETED|Period 1||1
10838317|NCT01373151|12003959|FG004|NOT COMPLETED|Period 1||5
10838318|NCT01373151|12003960|FG005|NOT COMPLETED|Period 1||4
10838319|NCT01373151|12003961|FG006|NOT COMPLETED|Period 1||0
10838320|NCT01373151|12003955|FG000|STARTED|Period 2||56
10838321|NCT01373151|12003956|FG001|STARTED|Period 2||58
10838322|NCT01373151|12003957|FG002|STARTED|Period 2||56
10838323|NCT01373151|12003958|FG003|STARTED|Period 2||59
10838324|NCT01373151|12003959|FG004|STARTED|Period 2||54
10838325|NCT01373151|12003960|FG005|STARTED|Period 2||55
10838326|NCT01373151|12003961|FG006|STARTED|Period 2||59
10838327|NCT01373151|12003955|FG000|COMPLETED|Period 2||47
10838328|NCT01373151|12003956|FG001|COMPLETED|Period 2||57
10838329|NCT01373151|12003957|FG002|COMPLETED|Period 2||52
10838330|NCT01373151|12003958|FG003|COMPLETED|Period 2||54
10838331|NCT01373151|12003959|FG004|COMPLETED|Period 2||52
10838332|NCT01373151|12003960|FG005|COMPLETED|Period 2||55
10838333|NCT01373151|12003961|FG006|COMPLETED|Period 2||54
10838334|NCT01373151|12003955|FG000|NOT COMPLETED|Period 2||9
10838335|NCT01373151|12003956|FG001|NOT COMPLETED|Period 2||1
10838336|NCT01373151|12003957|FG002|NOT COMPLETED|Period 2||4
10838337|NCT01373151|12003958|FG003|NOT COMPLETED|Period 2||5
10838338|NCT01373151|12003959|FG004|NOT COMPLETED|Period 2||2
10838339|NCT01373151|12003960|FG005|NOT COMPLETED|Period 2||0
10838340|NCT01373151|12003961|FG006|NOT COMPLETED|Period 2||5
10838341|NCT01328587|12003977|FG000|STARTED|Overall Study||34
10838342|NCT01328587|12003977|FG000|COMPLETED|Overall Study||34
10838343|NCT01328587|12003977|FG000|NOT COMPLETED|Overall Study||0
10838344|NCT01285947|12003983|FG000|STARTED|Overall Study||10
10838345|NCT01285947|12003984|FG001|STARTED|Overall Study||10
10838346|NCT01285947|12003983|FG000|COMPLETED|Overall Study||10
10838347|NCT01285947|12003984|FG001|COMPLETED|Overall Study||10
10838348|NCT01285947|12003983|FG000|NOT COMPLETED|Overall Study||0
10838349|NCT01285947|12003984|FG001|NOT COMPLETED|Overall Study||0
10838350|NCT01281644|12003990|FG000|STARTED|Overall Study||23
10838351|NCT01281644|12003990|FG000|COMPLETED|Overall Study||18
10838352|NCT01281644|12003990|FG000|NOT COMPLETED|Overall Study||5
10838353|NCT01274611|12003996|FG000|STARTED|Overall Study||20
10838354|NCT01274611|12003996|FG000|COMPLETED|Overall Study||20
10838355|NCT01274611|12003996|FG000|NOT COMPLETED|Overall Study||0
10838356|NCT00960297|12004002|FG000|STARTED|Overall Study||4
10838357|NCT00960297|12004002|FG000|COMPLETED|Overall Study||1
10838358|NCT00960297|12004002|FG000|NOT COMPLETED|Overall Study||3
10838359|NCT00910650|12004006|FG000|STARTED|Overall Study||14
10838360|NCT00910650|12004006|FG000|COMPLETED|Overall Study||12
10838361|NCT00910650|12004006|FG000|NOT COMPLETED|Overall Study||2
10838362|NCT00793169|12004010|FG000|STARTED|Overall Study||19
10838363|NCT00793169|12004010|FG000|COMPLETED|Overall Study||19
10838364|NCT00793169|12004010|FG000|NOT COMPLETED|Overall Study||0
10838365|NCT00703326|12004016|FG000|STARTED|Overall Study||759
10838366|NCT00703326|12004017|FG001|STARTED|Overall Study||385
10838367|NCT00703326|12004016|FG000|Received at Least 1 Dose of Study Drug|Overall Study||752
10838368|NCT00703326|12004017|FG001|Received at Least 1 Dose of Study Drug|Overall Study||382
10838369|NCT00703326|12004016|FG000|COMPLETED|Overall Study||657
10838370|NCT00703326|12004017|FG001|COMPLETED|Overall Study||347
10838371|NCT00703326|12004016|FG000|NOT COMPLETED|Overall Study||102
10838372|NCT00703326|12004017|FG001|NOT COMPLETED|Overall Study||38
10838373|NCT00602667|12004027|FG000|STARTED|Overall Study||57
10838374|NCT00602667|12004028|FG001|STARTED|Overall Study||156
10838375|NCT00602667|12004029|FG002|STARTED|Overall Study||77
10838376|NCT00602667|12004027|FG000|COMPLETED|Overall Study||38
10838377|NCT00602667|12004028|FG001|COMPLETED|Overall Study||75
10838378|NCT00602667|12004029|FG002|COMPLETED|Overall Study||14
10838379|NCT00602667|12004027|FG000|NOT COMPLETED|Overall Study||19
10838380|NCT00602667|12004028|FG001|NOT COMPLETED|Overall Study||81
10838381|NCT00602667|12004029|FG002|NOT COMPLETED|Overall Study||63
10838382|NCT00535990|12004064|FG000|STARTED|Overall Study||250
10838383|NCT00535990|12004064|FG000|COMPLETED|Overall Study||250
10838384|NCT00535990|12004064|FG000|NOT COMPLETED|Overall Study||0
10838385|NCT00472186|12004070|FG000|STARTED|Overall Study||2
10838386|NCT00472186|12004071|FG001|STARTED|Overall Study||0
10838387|NCT00472186|12004070|FG000|COMPLETED|Overall Study||1
10838388|NCT00472186|12004071|FG001|COMPLETED|Overall Study||0
10838389|NCT00472186|12004070|FG000|NOT COMPLETED|Overall Study||1
10838390|NCT00472186|12004071|FG001|NOT COMPLETED|Overall Study||0
10754419|NCT03052751|11918170|FG002|COMPLETED|Dosing Period 1||0
10754420|NCT03052751|11918171|FG003|COMPLETED|Dosing Period 1||0
10754421|NCT03052751|11918172|FG004|COMPLETED|Dosing Period 1||0
10754422|NCT03052751|11918173|FG005|COMPLETED|Dosing Period 1||0
10754423|NCT03052751|11918168|FG000|NOT COMPLETED|Dosing Period 1||0
10754424|NCT03052751|11918169|FG001|NOT COMPLETED|Dosing Period 1||1
10754425|NCT03052751|11918170|FG002|NOT COMPLETED|Dosing Period 1||0
10754426|NCT03052751|11918171|FG003|NOT COMPLETED|Dosing Period 1||0
10754427|NCT03052751|11918172|FG004|NOT COMPLETED|Dosing Period 1||0
10754428|NCT03052751|11918173|FG005|NOT COMPLETED|Dosing Period 1||0
10754429|NCT03052751|11918168|FG000|STARTED|Dosing Period 2||0
10410349|NCT00762372|11554408|FG001|STARTED|Overall Study|N=57 enrolled but 2 participant's discontinued before start of study drug administration.|55
10754430|NCT03052751|11918169|FG001|STARTED|Dosing Period 2||0
10754431|NCT03052751|11918170|FG002|STARTED|Dosing Period 2||11
10754432|NCT03052751|11918171|FG003|STARTED|Dosing Period 2||11
10838391|NCT03996876|12004081|FG000|STARTED|Overall Study||14
10838392|NCT03996876|12004082|FG001|STARTED|Overall Study||14
10838393|NCT03996876|12004081|FG000|COMPLETED|Overall Study||12
10838394|NCT03996876|12004082|FG001|COMPLETED|Overall Study||10
10838395|NCT03996876|12004081|FG000|NOT COMPLETED|Overall Study||2
10838396|NCT03996876|12004082|FG001|NOT COMPLETED|Overall Study||4
10838471|NCT02740972|12004202|FG002|STARTED|20-week Open Label Treatment Period||0
10838472|NCT02740972|12004203|FG003|STARTED|20-week Open Label Treatment Period||8
10838473|NCT02740972|12004204|FG004|STARTED|20-week Open Label Treatment Period||8
10838474|NCT02740972|12004200|FG000|COMPLETED|20-week Open Label Treatment Period||0
10838475|NCT02740972|12004201|FG001|COMPLETED|20-week Open Label Treatment Period||0
10838476|NCT02740972|12004202|FG002|COMPLETED|20-week Open Label Treatment Period||0
10838477|NCT02740972|12004203|FG003|COMPLETED|20-week Open Label Treatment Period||8
10838478|NCT02740972|12004204|FG004|COMPLETED|20-week Open Label Treatment Period||8
10838479|NCT02740972|12004200|FG000|NOT COMPLETED|20-week Open Label Treatment Period||0
10838480|NCT02740972|12004201|FG001|NOT COMPLETED|20-week Open Label Treatment Period||0
10838481|NCT02740972|12004202|FG002|NOT COMPLETED|20-week Open Label Treatment Period||0
10838482|NCT02740972|12004203|FG003|NOT COMPLETED|20-week Open Label Treatment Period||0
10838483|NCT02740972|12004204|FG004|NOT COMPLETED|20-week Open Label Treatment Period||0
10838484|NCT02662985|12004223|FG000|STARTED|Treatment Period 1||83
10838485|NCT02662985|12004224|FG001|STARTED|Treatment Period 1||83
10838486|NCT02662985|12004223|FG000|COMPLETED|Treatment Period 1||82
10838487|NCT02662985|12004224|FG001|COMPLETED|Treatment Period 1||79
10838488|NCT02662985|12004223|FG000|NOT COMPLETED|Treatment Period 1||1
10838489|NCT02662985|12004224|FG001|NOT COMPLETED|Treatment Period 1||4
10838490|NCT02662985|12004223|FG000|STARTED|Treatment Period 2||82
10838491|NCT02662985|12004224|FG001|STARTED|Treatment Period 2||79
10838492|NCT02662985|12004223|FG000|COMPLETED|Treatment Period 2||81
10838493|NCT02662985|12004224|FG001|COMPLETED|Treatment Period 2||78
10838494|NCT02662985|12004223|FG000|NOT COMPLETED|Treatment Period 2||1
10838495|NCT02662985|12004224|FG001|NOT COMPLETED|Treatment Period 2||1
10838496|NCT02662985|12004223|FG000|STARTED|Treatment Period 3 (Extension Period)||81
10838497|NCT02662985|12004224|FG001|STARTED|Treatment Period 3 (Extension Period)||78
10838498|NCT02662985|12004223|FG000|COMPLETED|Treatment Period 3 (Extension Period)||75
10838499|NCT02662985|12004224|FG001|COMPLETED|Treatment Period 3 (Extension Period)||69
10838500|NCT02662985|12004223|FG000|NOT COMPLETED|Treatment Period 3 (Extension Period)||6
10838501|NCT02662985|12004224|FG001|NOT COMPLETED|Treatment Period 3 (Extension Period)||9
10838502|NCT02606461|12004234|FG000|STARTED|Overall Study||27
10838503|NCT02606461|12004235|FG001|STARTED|Overall Study||30
10838504|NCT02606461|12004236|FG002|STARTED|Overall Study||188
10838505|NCT02606461|12004237|FG003|STARTED|Overall Study||97
10838506|NCT02606461|12004234|FG000|Treated|Overall Study||27
10838507|NCT02606461|12004235|FG001|Treated|Overall Study||30
10838508|NCT02606461|12004236|FG002|Treated|Overall Study||187
10838509|NCT02606461|12004237|FG003|Treated|Overall Study||97
10838510|NCT02606461|12004234|FG000|Open Label|Overall Study||0
10838511|NCT02606461|12004235|FG001|Open Label|Overall Study|Participants in the placebo group who had PD during the Phase 2 double-blinded treatment, switched to open-label selinexor.|24
10838512|NCT02606461|12004236|FG002|Open Label|Overall Study||0
10838513|NCT02606461|12004237|FG003|Open Label|Overall Study|Participants in the placebo group who had PD during the Phase 3 double-blinded treatment, switched to open-label selinexor.|57
10838514|NCT02606461|12004234|FG000|COMPLETED|Overall Study||0
10838515|NCT02606461|12004235|FG001|COMPLETED|Overall Study||0
10838516|NCT02606461|12004236|FG002|COMPLETED|Overall Study||0
10838517|NCT02606461|12004237|FG003|COMPLETED|Overall Study||0
10838518|NCT02606461|12004234|FG000|NOT COMPLETED|Overall Study||27
10838519|NCT02606461|12004235|FG001|NOT COMPLETED|Overall Study||30
10838520|NCT02606461|12004236|FG002|NOT COMPLETED|Overall Study||188
10838521|NCT02606461|12004237|FG003|NOT COMPLETED|Overall Study||97
10838522|NCT02536339|12004250|FG000|STARTED|Overall Study||40
10838523|NCT02536339|12004250|FG000|Received at Least One Dose of Study Drug|Overall Study||39
10838524|NCT02536339|12004250|FG000|Efficacy-Evaluable Population|Overall Study|2 participants did not have post-baseline assessments and were not evaluable for efficacy.|37
10838525|NCT02536339|12004250|FG000|COMPLETED|Overall Study||12
10838526|NCT02536339|12004250|FG000|NOT COMPLETED|Overall Study||28
10838527|NCT02323295|12004256|FG000|STARTED|Overall Study||2
10838528|NCT02323295|12004257|FG001|STARTED|Overall Study||10
10838529|NCT02323295|12004256|FG000|COMPLETED|Overall Study||2
10838530|NCT02323295|12004257|FG001|COMPLETED|Overall Study||7
10838531|NCT02323295|12004256|FG000|NOT COMPLETED|Overall Study||0
10838532|NCT02323295|12004257|FG001|NOT COMPLETED|Overall Study||3
10410350|NCT00762372|11554409|FG002|STARTED|Overall Study|N=53 enrolled but 3 participant's discontinued before start of study drug administration.|50
10410351|NCT00762372|11554407|FG000|COMPLETED|Overall Study||110
10410352|NCT00762372|11554408|FG001|COMPLETED|Overall Study||55
10410353|NCT00762372|11554409|FG002|COMPLETED|Overall Study||50
10410354|NCT00762372|11554407|FG000|NOT COMPLETED|Overall Study||1
10838533|NCT02050308|12004265|FG000|STARTED|Overall Study||127
10838534|NCT02050308|12004266|FG001|STARTED|Overall Study||124
10838535|NCT02050308|12004265|FG000|COMPLETED|Overall Study||28
10838536|NCT02050308|12004266|FG001|COMPLETED|Overall Study||22
10838537|NCT02050308|12004265|FG000|NOT COMPLETED|Overall Study||99
10838538|NCT02050308|12004266|FG001|NOT COMPLETED|Overall Study||102
10838539|NCT02036970|12004287|FG000|STARTED|Part 1: Day 1 Through Week 16||6
10838540|NCT02036970|12004288|FG001|STARTED|Part 1: Day 1 Through Week 16||12
10410355|NCT00762372|11554408|FG001|NOT COMPLETED|Overall Study||0
10838397|NCT03589976|12004091|FG000|STARTED|Overall Study||35
10838398|NCT03589976|12004092|FG001|STARTED|Overall Study||12
10838399|NCT03589976|12004091|FG000|COMPLETED|Overall Study||16
10838400|NCT03589976|12004092|FG001|COMPLETED|Overall Study||6
10838401|NCT03589976|12004091|FG000|NOT COMPLETED|Overall Study||19
10838402|NCT03589976|12004092|FG001|NOT COMPLETED|Overall Study||6
10838403|NCT03490227|12004098|FG000|STARTED|Overall Study||10
10838404|NCT03490227|12004098|FG000|COMPLETED|Overall Study||10
10838405|NCT03490227|12004098|FG000|NOT COMPLETED|Overall Study||0
10838406|NCT03401190|12004107|FG000|STARTED|Overall Study||8
10838407|NCT03401190|12004108|FG001|STARTED|Overall Study||6
10838408|NCT03401190|12004109|FG002|STARTED|Overall Study||7
10838409|NCT03401190|12004107|FG000|COMPLETED|Overall Study||8
10838410|NCT03401190|12004108|FG001|COMPLETED|Overall Study||4
10838411|NCT03401190|12004109|FG002|COMPLETED|Overall Study||7
10838412|NCT03401190|12004107|FG000|NOT COMPLETED|Overall Study||0
10838413|NCT03401190|12004108|FG001|NOT COMPLETED|Overall Study||2
10838414|NCT03401190|12004109|FG002|NOT COMPLETED|Overall Study||0
10838421|NCT03212963|12004130|FG000|STARTED|Overall Study||16
10838422|NCT03212963|12004130|FG000|COMPLETED|Overall Study||16
10838423|NCT03212963|12004130|FG000|NOT COMPLETED|Overall Study||0
10838424|NCT03135262|12004139|FG000|STARTED|Overall Study||9
10838425|NCT03135262|12004140|FG001|STARTED|Overall Study||6
10838426|NCT03135262|12004141|FG002|STARTED|Overall Study||7
10838427|NCT03135262|12004142|FG003|STARTED|Overall Study||6
10838428|NCT03135262|12004143|FG004|STARTED|Overall Study||1
10838429|NCT03135262|12004139|FG000|COMPLETED|Overall Study|The study was terminated after escalation phase. The planned expansion phase did not take place due to the early termination.|0
10838430|NCT03135262|12004140|FG001|COMPLETED|Overall Study|The study was terminated after escalation phase. The planned expansion phase did not take place due to the early termination.|0
10838431|NCT03135262|12004141|FG002|COMPLETED|Overall Study|The study was terminated after escalation phase. The planned expansion phase did not take place due to the early termination.|0
10838432|NCT03135262|12004142|FG003|COMPLETED|Overall Study|The study was terminated after escalation phase. The planned expansion phase did not take place due to the early termination.|0
10838433|NCT03135262|12004143|FG004|COMPLETED|Overall Study|The study was terminated after escalation phase. The planned expansion phase did not take place due to the early termination.|0
10838434|NCT03135262|12004139|FG000|NOT COMPLETED|Overall Study||9
10838435|NCT03135262|12004140|FG001|NOT COMPLETED|Overall Study||6
10838436|NCT03135262|12004141|FG002|NOT COMPLETED|Overall Study||7
10838437|NCT03135262|12004142|FG003|NOT COMPLETED|Overall Study||6
10838438|NCT03135262|12004143|FG004|NOT COMPLETED|Overall Study||1
10838439|NCT03104075|12004175|FG000|STARTED|Overall Study||20
10838440|NCT03104075|12004176|FG001|STARTED|Overall Study||20
10838441|NCT03104075|12004175|FG000|COMPLETED|Overall Study||19
10838442|NCT03104075|12004176|FG001|COMPLETED|Overall Study||20
10838443|NCT03104075|12004175|FG000|NOT COMPLETED|Overall Study||1
10838444|NCT03104075|12004176|FG001|NOT COMPLETED|Overall Study||0
10838445|NCT03038087|12004183|FG000|STARTED|Overall Study||10
10838446|NCT03038087|12004183|FG000|COMPLETED|Overall Study||9
10838447|NCT03038087|12004183|FG000|NOT COMPLETED|Overall Study||1
10838448|NCT02880540|12004191|FG000|STARTED|Overall Study||13
10838449|NCT02880540|12004192|FG001|STARTED|Overall Study||13
10838450|NCT02880540|12004191|FG000|COMPLETED|Overall Study||13
10838451|NCT02880540|12004192|FG001|COMPLETED|Overall Study||13
10838452|NCT02880540|12004191|FG000|NOT COMPLETED|Overall Study||0
10838453|NCT02880540|12004192|FG001|NOT COMPLETED|Overall Study||0
10838454|NCT02740972|12004200|FG000|STARTED|4-week Double-blinded Placebo-controlled||5
10838455|NCT02740972|12004201|FG001|STARTED|4-week Double-blinded Placebo-controlled||6
10838456|NCT02740972|12004202|FG002|STARTED|4-week Double-blinded Placebo-controlled||5
10838457|NCT02740972|12004203|FG003|STARTED|4-week Double-blinded Placebo-controlled||0
10838458|NCT02740972|12004204|FG004|STARTED|4-week Double-blinded Placebo-controlled||0
10838459|NCT02740972|12004200|FG000|COMPLETED|4-week Double-blinded Placebo-controlled||5
10838460|NCT02740972|12004201|FG001|COMPLETED|4-week Double-blinded Placebo-controlled||6
10838461|NCT02740972|12004202|FG002|COMPLETED|4-week Double-blinded Placebo-controlled||5
10838462|NCT02740972|12004203|FG003|COMPLETED|4-week Double-blinded Placebo-controlled||0
10838463|NCT02740972|12004204|FG004|COMPLETED|4-week Double-blinded Placebo-controlled||0
10838464|NCT02740972|12004200|FG000|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0
10838465|NCT02740972|12004201|FG001|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0
10838466|NCT02740972|12004202|FG002|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0
10410356|NCT00762372|11554409|FG002|NOT COMPLETED|Overall Study||0
10410357|NCT00762385|11554423|FG000|STARTED|First Intervention||51
10410358|NCT00762385|11554424|FG001|STARTED|First Intervention||46
10410359|NCT00762385|11554423|FG000|COMPLETED|First Intervention||49
10410360|NCT00762385|11554424|FG001|COMPLETED|First Intervention||42
10838467|NCT02740972|12004203|FG003|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0
10838468|NCT02740972|12004204|FG004|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0
10838469|NCT02740972|12004200|FG000|STARTED|20-week Open Label Treatment Period||0
10838470|NCT02740972|12004201|FG001|STARTED|20-week Open Label Treatment Period||0
10410361|NCT00762385|11554423|FG000|NOT COMPLETED|First Intervention||2
10838541|NCT02036970|12004289|FG002|STARTED|Part 1: Day 1 Through Week 16||11
10838542|NCT02036970|12004290|FG003|STARTED|Part 1: Day 1 Through Week 16||12
10838543|NCT02036970|12004291|FG004|STARTED|Part 1: Day 1 Through Week 16||2
10838544|NCT02036970|12004292|FG005|STARTED|Part 1: Day 1 Through Week 16||4
10838545|NCT02036970|12004293|FG006|STARTED|Part 1: Day 1 Through Week 16||3
10838546|NCT02036970|12004294|FG007|STARTED|Part 1: Day 1 Through Week 16||4
10838547|NCT02036970|12004295|FG008|STARTED|Part 1: Day 1 Through Week 16||74
10838548|NCT02036970|12004296|FG009|STARTED|Part 1: Day 1 Through Week 16||38
10838549|NCT02036970|12004287|FG000|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||6
10838550|NCT02036970|12004288|FG001|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||6
10838551|NCT02036970|12004289|FG002|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||11
10838552|NCT02036970|12004290|FG003|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||6
10838553|NCT02036970|12004291|FG004|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||2
10838554|NCT02036970|12004292|FG005|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||2
10838555|NCT02036970|12004293|FG006|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||3
10838556|NCT02036970|12004294|FG007|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||2
10838557|NCT02036970|12004295|FG008|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||0
10838558|NCT02036970|12004296|FG009|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||0
10838559|NCT02036970|12004287|FG000|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0
10838560|NCT02036970|12004288|FG001|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||6
10838561|NCT02036970|12004289|FG002|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0
10838562|NCT02036970|12004290|FG003|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||6
10838563|NCT02036970|12004291|FG004|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0
10838564|NCT02036970|12004292|FG005|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||2
10838565|NCT02036970|12004293|FG006|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0
10838566|NCT02036970|12004294|FG007|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||2
10838567|NCT02036970|12004295|FG008|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0
10838568|NCT02036970|12004296|FG009|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0
10838569|NCT02036970|12004287|FG000|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
10838570|NCT02036970|12004288|FG001|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
10838571|NCT02036970|12004289|FG002|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
10838572|NCT02036970|12004290|FG003|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
10838573|NCT02036970|12004291|FG004|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
10838574|NCT02036970|12004292|FG005|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
10838575|NCT02036970|12004293|FG006|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
10838576|NCT02036970|12004294|FG007|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
10838577|NCT02036970|12004295|FG008|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||14
10838578|NCT02036970|12004296|FG009|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||8
10838579|NCT02036970|12004287|FG000|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
10838580|NCT02036970|12004288|FG001|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
10838581|NCT02036970|12004289|FG002|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
10838582|NCT02036970|12004290|FG003|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
10410362|NCT00762385|11554424|FG001|NOT COMPLETED|First Intervention||4
10410363|NCT00762385|11554423|FG000|STARTED|Second Intervention||49
10410364|NCT00762385|11554424|FG001|STARTED|Second Intervention||42
10410365|NCT00762385|11554423|FG000|COMPLETED|Second Intervention||46
10410366|NCT00762385|11554424|FG001|COMPLETED|Second Intervention||39
10410367|NCT00762385|11554423|FG000|NOT COMPLETED|Second Intervention||3
10410368|NCT00762385|11554424|FG001|NOT COMPLETED|Second Intervention||3
10410369|NCT00762411|11554435|FG000|STARTED|Initial Treatment||556
10410370|NCT00762411|11554436|FG001|STARTED|Initial Treatment||555
10410371|NCT00762411|11554435|FG000|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants(pts) who received at least 1 dose of study drug.|555
10410372|NCT00762411|11554436|FG001|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who received at least 1 dose of study drug.|553
10410373|NCT00762411|11554435|FG000|COMPLETED|Initial Treatment||22
10410374|NCT00762411|11554436|FG001|COMPLETED|Initial Treatment||34
10410375|NCT00762411|11554435|FG000|NOT COMPLETED|Initial Treatment||534
10410376|NCT00762411|11554436|FG001|NOT COMPLETED|Initial Treatment||521
10410377|NCT00762411|11554435|FG000|STARTED|Delayed Start||22
10410378|NCT00762411|11554436|FG001|STARTED|Delayed Start||34
10410379|NCT00762411|11554435|FG000|COMPLETED|Delayed Start||5
10410380|NCT00762411|11554436|FG001|COMPLETED|Delayed Start||8
10410381|NCT00762411|11554435|FG000|NOT COMPLETED|Delayed Start||17
10410382|NCT00762411|11554436|FG001|NOT COMPLETED|Delayed Start||26
10410383|NCT00762411|11554435|FG000|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|312
10410384|NCT00762411|11554436|FG001|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|430
10410385|NCT00762411|11554435|FG000|COMPLETED|Safety Follow Up (SFU)-Optional||228
10838583|NCT02036970|12004291|FG004|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
10838584|NCT02036970|12004292|FG005|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
10838585|NCT02036970|12004293|FG006|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
10410386|NCT00762411|11554436|FG001|COMPLETED|Safety Follow Up (SFU)-Optional||312
10838586|NCT02036970|12004294|FG007|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
10838587|NCT02036970|12004295|FG008|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||16
10838588|NCT02036970|12004296|FG009|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||9
10838589|NCT02036970|12004287|FG000|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
10838590|NCT02036970|12004288|FG001|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
10838591|NCT02036970|12004289|FG002|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
10838592|NCT02036970|12004290|FG003|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
10838593|NCT02036970|12004291|FG004|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
10838594|NCT02036970|12004292|FG005|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
10838595|NCT02036970|12004293|FG006|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
10838596|NCT02036970|12004294|FG007|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
10838597|NCT02036970|12004295|FG008|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||17
10838598|NCT02036970|12004296|FG009|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||8
10410387|NCT00762411|11554435|FG000|NOT COMPLETED|Safety Follow Up (SFU)-Optional||84
10410388|NCT00762411|11554436|FG001|NOT COMPLETED|Safety Follow Up (SFU)-Optional||118
10410389|NCT00762424|11554448|FG000|STARTED|Overall Study||28
10410390|NCT00762424|11554449|FG001|STARTED|Overall Study||25
10410391|NCT00762424|11554448|FG000|COMPLETED|Overall Study||28
10410392|NCT00762424|11554449|FG001|COMPLETED|Overall Study||25
10410393|NCT00762424|11554448|FG000|NOT COMPLETED|Overall Study||0
10410394|NCT00762424|11554449|FG001|NOT COMPLETED|Overall Study||0
10410395|NCT00762450|11554458|FG000|STARTED|1st Treatment Period||2
10410396|NCT00762450|11554459|FG001|STARTED|1st Treatment Period||2
10410397|NCT00762450|11554460|FG002|STARTED|1st Treatment Period||2
10410398|NCT00762450|11554458|FG000|COMPLETED|1st Treatment Period||2
10410399|NCT00762450|11554459|FG001|COMPLETED|1st Treatment Period||2
10410400|NCT00762450|11554460|FG002|COMPLETED|1st Treatment Period||2
10410401|NCT00762450|11554458|FG000|NOT COMPLETED|1st Treatment Period||0
10410402|NCT00762450|11554459|FG001|NOT COMPLETED|1st Treatment Period||0
10410403|NCT00762450|11554460|FG002|NOT COMPLETED|1st Treatment Period||0
10410404|NCT00762450|11554458|FG000|STARTED|Washout After 1st Treatment Period||2
10410405|NCT00762450|11554459|FG001|STARTED|Washout After 1st Treatment Period||2
10410406|NCT00762450|11554460|FG002|STARTED|Washout After 1st Treatment Period||2
10410407|NCT00762450|11554458|FG000|COMPLETED|Washout After 1st Treatment Period||2
10410408|NCT00762450|11554459|FG001|COMPLETED|Washout After 1st Treatment Period||2
10410409|NCT00762450|11554460|FG002|COMPLETED|Washout After 1st Treatment Period||2
10410410|NCT00762450|11554458|FG000|NOT COMPLETED|Washout After 1st Treatment Period||0
10410411|NCT00762450|11554459|FG001|NOT COMPLETED|Washout After 1st Treatment Period||0
10410412|NCT00762450|11554460|FG002|NOT COMPLETED|Washout After 1st Treatment Period||0
10410413|NCT00762450|11554458|FG000|STARTED|2nd Treatment Period||2
10410414|NCT00762450|11554459|FG001|STARTED|2nd Treatment Period||2
10410415|NCT00762450|11554460|FG002|STARTED|2nd Treatment Period||2
10410416|NCT00762450|11554458|FG000|COMPLETED|2nd Treatment Period||2
10410417|NCT00762450|11554459|FG001|COMPLETED|2nd Treatment Period||2
10410418|NCT00762450|11554460|FG002|COMPLETED|2nd Treatment Period||2
10410419|NCT00762450|11554458|FG000|NOT COMPLETED|2nd Treatment Period||0
10410420|NCT00762450|11554459|FG001|NOT COMPLETED|2nd Treatment Period||0
10410421|NCT00762450|11554460|FG002|NOT COMPLETED|2nd Treatment Period||0
10410422|NCT00762450|11554458|FG000|STARTED|Washout After 2nd Treatment Period||2
10410423|NCT00762450|11554459|FG001|STARTED|Washout After 2nd Treatment Period||2
10410424|NCT00762450|11554460|FG002|STARTED|Washout After 2nd Treatment Period||2
10410425|NCT00762450|11554458|FG000|COMPLETED|Washout After 2nd Treatment Period||2
10410426|NCT00762450|11554459|FG001|COMPLETED|Washout After 2nd Treatment Period||2
10410427|NCT00762450|11554460|FG002|COMPLETED|Washout After 2nd Treatment Period||2
10410428|NCT00762450|11554458|FG000|NOT COMPLETED|Washout After 2nd Treatment Period||0
10410429|NCT00762450|11554459|FG001|NOT COMPLETED|Washout After 2nd Treatment Period||0
10410430|NCT00762450|11554460|FG002|NOT COMPLETED|Washout After 2nd Treatment Period||0
10410431|NCT00762450|11554458|FG000|STARTED|3rd Treatment Period||2
10410432|NCT00762450|11554459|FG001|STARTED|3rd Treatment Period||2
10410433|NCT00762450|11554460|FG002|STARTED|3rd Treatment Period||2
10410434|NCT00762450|11554458|FG000|COMPLETED|3rd Treatment Period||2
10410435|NCT00762450|11554459|FG001|COMPLETED|3rd Treatment Period||2
10410436|NCT00762450|11554460|FG002|COMPLETED|3rd Treatment Period||2
10410437|NCT00762450|11554458|FG000|NOT COMPLETED|3rd Treatment Period||0
10410438|NCT00762450|11554459|FG001|NOT COMPLETED|3rd Treatment Period||0
10410439|NCT00762450|11554460|FG002|NOT COMPLETED|3rd Treatment Period||0
10410440|NCT00762463|11554470|FG000|STARTED|Double-blind Phase (Baseline to Week 6)||120
10410441|NCT00762463|11554471|FG001|STARTED|Double-blind Phase (Baseline to Week 6)||120
10410442|NCT00762463|11554472|FG002|STARTED|Double-blind Phase (Baseline to Week 6)||0
10410443|NCT00762463|11554473|FG003|STARTED|Double-blind Phase (Baseline to Week 6)||0
10410444|NCT00762463|11554470|FG000|COMPLETED|Double-blind Phase (Baseline to Week 6)||113
10410445|NCT00762463|11554471|FG001|COMPLETED|Double-blind Phase (Baseline to Week 6)||110
10410446|NCT00762463|11554472|FG002|COMPLETED|Double-blind Phase (Baseline to Week 6)||0
10410447|NCT00762463|11554473|FG003|COMPLETED|Double-blind Phase (Baseline to Week 6)||0
10410448|NCT00762463|11554470|FG000|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||7
10410449|NCT00762463|11554471|FG001|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||10
10410503|NCT00762515|11554510|FG001|COMPLETED|Overall Study||22
10410450|NCT00762463|11554472|FG002|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||0
10410451|NCT00762463|11554473|FG003|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||0
10838599|NCT02036970|12004287|FG000|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
10838600|NCT02036970|12004288|FG001|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
10838601|NCT02036970|12004289|FG002|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
10838602|NCT02036970|12004290|FG003|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
10838603|NCT02036970|12004291|FG004|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
10838604|NCT02036970|12004292|FG005|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
10838605|NCT02036970|12004293|FG006|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
10838606|NCT02036970|12004294|FG007|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
10838607|NCT02036970|12004295|FG008|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||6
10838608|NCT02036970|12004296|FG009|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||2
10838609|NCT02036970|12004287|FG000|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
10838610|NCT02036970|12004288|FG001|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
10838611|NCT02036970|12004289|FG002|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
10838612|NCT02036970|12004290|FG003|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
10838613|NCT02036970|12004291|FG004|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
10838614|NCT02036970|12004292|FG005|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
10838615|NCT02036970|12004293|FG006|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
10838616|NCT02036970|12004294|FG007|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
10838617|NCT02036970|12004295|FG008|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||4
10838618|NCT02036970|12004296|FG009|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||1
10838619|NCT02036970|12004287|FG000|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
10838620|NCT02036970|12004288|FG001|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
10838621|NCT02036970|12004289|FG002|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
10410452|NCT00762463|11554470|FG000|STARTED|Enrollment in Extension Phase (Week 6)||113
10410453|NCT00762463|11554471|FG001|STARTED|Enrollment in Extension Phase (Week 6)||110
10410454|NCT00762463|11554472|FG002|STARTED|Enrollment in Extension Phase (Week 6)||0
10410455|NCT00762463|11554473|FG003|STARTED|Enrollment in Extension Phase (Week 6)||0
10410456|NCT00762463|11554470|FG000|COMPLETED|Enrollment in Extension Phase (Week 6)||109
10410457|NCT00762463|11554471|FG001|COMPLETED|Enrollment in Extension Phase (Week 6)||109
10410458|NCT00762463|11554472|FG002|COMPLETED|Enrollment in Extension Phase (Week 6)||0
10410459|NCT00762463|11554473|FG003|COMPLETED|Enrollment in Extension Phase (Week 6)||0
10410460|NCT00762463|11554470|FG000|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||4
10410461|NCT00762463|11554471|FG001|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||1
10410462|NCT00762463|11554472|FG002|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||0
10410463|NCT00762463|11554473|FG003|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||0
10410464|NCT00762463|11554470|FG000|STARTED|Extension Phase (Week 6 to Week 12)||55
10410465|NCT00762463|11554471|FG001|STARTED|Extension Phase (Week 6 to Week 12)||55
10410466|NCT00762463|11554472|FG002|STARTED|Extension Phase (Week 6 to Week 12)||54
10410467|NCT00762463|11554473|FG003|STARTED|Extension Phase (Week 6 to Week 12)||54
10410468|NCT00762463|11554470|FG000|COMPLETED|Extension Phase (Week 6 to Week 12)||52
10410469|NCT00762463|11554471|FG001|COMPLETED|Extension Phase (Week 6 to Week 12)||54
10410470|NCT00762463|11554472|FG002|COMPLETED|Extension Phase (Week 6 to Week 12)||50
10410471|NCT00762463|11554473|FG003|COMPLETED|Extension Phase (Week 6 to Week 12)||52
10410472|NCT00762463|11554470|FG000|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||3
10410473|NCT00762463|11554471|FG001|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||1
10410474|NCT00762463|11554472|FG002|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||4
10410475|NCT00762463|11554473|FG003|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||2
10410476|NCT00762476|11554488|FG000|STARTED|Overall Study||206
10410477|NCT00762476|11554489|FG001|STARTED|Overall Study||205
10410478|NCT00762476|11554488|FG000|COMPLETED|Overall Study||183
10410479|NCT00762476|11554489|FG001|COMPLETED|Overall Study||169
10410480|NCT00762476|11554488|FG000|NOT COMPLETED|Overall Study||23
10410481|NCT00762476|11554489|FG001|NOT COMPLETED|Overall Study||36
10410482|NCT00762502|11554499|FG000|STARTED|Baseline to Month 3 (Period 1)||36
10410483|NCT00762502|11554500|FG001|STARTED|Baseline to Month 3 (Period 1)||25
10410484|NCT00762502|11554501|FG002|STARTED|Baseline to Month 3 (Period 1)||51
10410485|NCT00762502|11554499|FG000|COMPLETED|Baseline to Month 3 (Period 1)||26
10410486|NCT00762502|11554500|FG001|COMPLETED|Baseline to Month 3 (Period 1)||19
10410487|NCT00762502|11554501|FG002|COMPLETED|Baseline to Month 3 (Period 1)||32
10410488|NCT00762502|11554499|FG000|NOT COMPLETED|Baseline to Month 3 (Period 1)||10
10410489|NCT00762502|11554500|FG001|NOT COMPLETED|Baseline to Month 3 (Period 1)||6
10410490|NCT00762502|11554501|FG002|NOT COMPLETED|Baseline to Month 3 (Period 1)||19
10410491|NCT00762502|11554499|FG000|STARTED|Month 3 to Month 6 (Period 2)||9
10410492|NCT00762502|11554500|FG001|STARTED|Month 3 to Month 6 (Period 2)||5
10410493|NCT00762502|11554501|FG002|STARTED|Month 3 to Month 6 (Period 2)||23
10410494|NCT00762502|11554499|FG000|COMPLETED|Month 3 to Month 6 (Period 2)||9
10410495|NCT00762502|11554500|FG001|COMPLETED|Month 3 to Month 6 (Period 2)||4
10410496|NCT00762502|11554501|FG002|COMPLETED|Month 3 to Month 6 (Period 2)||23
10410497|NCT00762502|11554499|FG000|NOT COMPLETED|Month 3 to Month 6 (Period 2)||0
10410498|NCT00762502|11554500|FG001|NOT COMPLETED|Month 3 to Month 6 (Period 2)||1
10410499|NCT00762502|11554501|FG002|NOT COMPLETED|Month 3 to Month 6 (Period 2)||0
10410500|NCT00762515|11554509|FG000|STARTED|Overall Study||22
10410501|NCT00762515|11554510|FG001|STARTED|Overall Study||22
10410502|NCT00762515|11554509|FG000|COMPLETED|Overall Study||22
10838622|NCT02036970|12004290|FG003|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
10838623|NCT02036970|12004291|FG004|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
10838624|NCT02036970|12004292|FG005|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
10838625|NCT02036970|12004293|FG006|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
10838626|NCT02036970|12004294|FG007|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
10838627|NCT02036970|12004295|FG008|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||17
10838628|NCT02036970|12004296|FG009|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||1
10838629|NCT02036970|12004287|FG000|COMPLETED|Part 1: Day 1 Through Week 16||5
10838630|NCT02036970|12004288|FG001|COMPLETED|Part 1: Day 1 Through Week 16||12
10838631|NCT02036970|12004289|FG002|COMPLETED|Part 1: Day 1 Through Week 16||7
10838632|NCT02036970|12004290|FG003|COMPLETED|Part 1: Day 1 Through Week 16||9
10838633|NCT02036970|12004291|FG004|COMPLETED|Part 1: Day 1 Through Week 16||1
10838634|NCT02036970|12004292|FG005|COMPLETED|Part 1: Day 1 Through Week 16||3
10838635|NCT02036970|12004293|FG006|COMPLETED|Part 1: Day 1 Through Week 16||3
10838636|NCT02036970|12004294|FG007|COMPLETED|Part 1: Day 1 Through Week 16||3
10838637|NCT02036970|12004295|FG008|COMPLETED|Part 1: Day 1 Through Week 16||66
10838638|NCT02036970|12004296|FG009|COMPLETED|Part 1: Day 1 Through Week 16||33
10838639|NCT02036970|12004287|FG000|NOT COMPLETED|Part 1: Day 1 Through Week 16||1
10838640|NCT02036970|12004288|FG001|NOT COMPLETED|Part 1: Day 1 Through Week 16||0
10838641|NCT02036970|12004289|FG002|NOT COMPLETED|Part 1: Day 1 Through Week 16||4
10838642|NCT02036970|12004290|FG003|NOT COMPLETED|Part 1: Day 1 Through Week 16||3
10838643|NCT02036970|12004291|FG004|NOT COMPLETED|Part 1: Day 1 Through Week 16||1
10838644|NCT02036970|12004292|FG005|NOT COMPLETED|Part 1: Day 1 Through Week 16||1
10838645|NCT02036970|12004293|FG006|NOT COMPLETED|Part 1: Day 1 Through Week 16||0
10838646|NCT02036970|12004294|FG007|NOT COMPLETED|Part 1: Day 1 Through Week 16||1
10838647|NCT02036970|12004295|FG008|NOT COMPLETED|Part 1: Day 1 Through Week 16||8
10838648|NCT02036970|12004296|FG009|NOT COMPLETED|Part 1: Day 1 Through Week 16||5
10838649|NCT02036970|12004287|FG000|STARTED|Part 2: Week 16 Onwards||5
10838650|NCT02036970|12004288|FG001|STARTED|Part 2: Week 16 Onwards|One patient who completed Part 1 elected not to continue to Part 2.|11
10838651|NCT02036970|12004289|FG002|STARTED|Part 2: Week 16 Onwards|One patient who completed Part 1 elected not to continue to Part 2.|6
10838652|NCT02036970|12004290|FG003|STARTED|Part 2: Week 16 Onwards||9
10838653|NCT02036970|12004291|FG004|STARTED|Part 2: Week 16 Onwards||1
10838654|NCT02036970|12004292|FG005|STARTED|Part 2: Week 16 Onwards||3
10838655|NCT02036970|12004293|FG006|STARTED|Part 2: Week 16 Onwards||3
10838656|NCT02036970|12004294|FG007|STARTED|Part 2: Week 16 Onwards||3
10838657|NCT02036970|12004295|FG008|STARTED|Part 2: Week 16 Onwards|Three patients who completed Part 1 elected not to continue to Part 2.|63
10838658|NCT02036970|12004296|FG009|STARTED|Part 2: Week 16 Onwards||33
10838659|NCT02036970|12004287|FG000|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||5
10838660|NCT02036970|12004288|FG001|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||5
10838661|NCT02036970|12004289|FG002|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||6
10838662|NCT02036970|12004290|FG003|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||5
10838663|NCT02036970|12004291|FG004|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||1
10838664|NCT02036970|12004292|FG005|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||1
10838665|NCT02036970|12004293|FG006|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||3
10838666|NCT02036970|12004294|FG007|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||2
10838667|NCT02036970|12004295|FG008|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||0
10838668|NCT02036970|12004296|FG009|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||0
10292142|NCT03034018|11424925|FG000|STARTED|Overall Study||30
10292143|NCT03034018|11424926|FG001|STARTED|Overall Study||30
10292144|NCT03034018|11424925|FG000|Initiated Assigned Treatment|Overall Study||27
10292145|NCT03034018|11424926|FG001|Initiated Assigned Treatment|Overall Study||29
10292146|NCT03034018|11424925|FG000|COMPLETED|Overall Study||25
10292147|NCT03034018|11424926|FG001|COMPLETED|Overall Study||28
10292148|NCT03034018|11424925|FG000|NOT COMPLETED|Overall Study||5
10292149|NCT03034018|11424926|FG001|NOT COMPLETED|Overall Study||2
10292150|NCT02750215|11424932|FG000|STARTED|Overall Study||20
10292151|NCT02750215|11424932|FG000|COMPLETED|Overall Study||20
10292152|NCT02750215|11424932|FG000|NOT COMPLETED|Overall Study||0
10410504|NCT00762515|11554509|FG000|NOT COMPLETED|Overall Study||0
10292153|NCT02673333|11424936|FG000|STARTED|Overall Study||39
10292154|NCT02673333|11424936|FG000|COMPLETED|Overall Study||39
10838669|NCT02036970|12004287|FG000|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0
10838670|NCT02036970|12004288|FG001|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||6
10838671|NCT02036970|12004289|FG002|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0
10838672|NCT02036970|12004290|FG003|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||4
10838673|NCT02036970|12004291|FG004|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0
10838674|NCT02036970|12004292|FG005|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||2
10838675|NCT02036970|12004293|FG006|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0
10838676|NCT02036970|12004294|FG007|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||1
10838677|NCT02036970|12004295|FG008|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0
10838678|NCT02036970|12004296|FG009|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0
10838679|NCT02036970|12004287|FG000|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
10838680|NCT02036970|12004288|FG001|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
10838681|NCT02036970|12004289|FG002|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
10838682|NCT02036970|12004290|FG003|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
10838683|NCT02036970|12004291|FG004|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
10838684|NCT02036970|12004292|FG005|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
10838685|NCT02036970|12004293|FG006|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
10838686|NCT02036970|12004294|FG007|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
10838687|NCT02036970|12004295|FG008|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||12
10838688|NCT02036970|12004296|FG009|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||8
10838689|NCT02036970|12004287|FG000|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
10838690|NCT02036970|12004288|FG001|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
10838691|NCT02036970|12004289|FG002|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
10838692|NCT02036970|12004290|FG003|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
10838693|NCT02036970|12004291|FG004|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
10838694|NCT02036970|12004292|FG005|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
10838695|NCT02036970|12004293|FG006|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
10838696|NCT02036970|12004294|FG007|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
10838697|NCT02036970|12004295|FG008|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||12
10838698|NCT02036970|12004296|FG009|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||7
10838699|NCT02036970|12004287|FG000|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
10838700|NCT02036970|12004288|FG001|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
10838701|NCT02036970|12004289|FG002|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
10838702|NCT02036970|12004290|FG003|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
10838703|NCT02036970|12004291|FG004|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
10838704|NCT02036970|12004292|FG005|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
10838705|NCT02036970|12004293|FG006|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
10838706|NCT02036970|12004294|FG007|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
10838707|NCT02036970|12004295|FG008|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||16
10838708|NCT02036970|12004296|FG009|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||7
10838709|NCT02036970|12004287|FG000|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
10838710|NCT02036970|12004288|FG001|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
10838711|NCT02036970|12004289|FG002|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
10838712|NCT02036970|12004290|FG003|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
10838713|NCT02036970|12004291|FG004|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
10838714|NCT02036970|12004292|FG005|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
10838715|NCT02036970|12004293|FG006|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
10838716|NCT02036970|12004294|FG007|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
10838717|NCT02036970|12004295|FG008|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||5
10838718|NCT02036970|12004296|FG009|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||2
10838719|NCT02036970|12004287|FG000|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
10838720|NCT02036970|12004288|FG001|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
10838721|NCT02036970|12004289|FG002|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
10838722|NCT02036970|12004290|FG003|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
10838723|NCT02036970|12004291|FG004|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
10838724|NCT02036970|12004292|FG005|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
10838725|NCT02036970|12004293|FG006|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
10838726|NCT02036970|12004294|FG007|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
10838727|NCT02036970|12004295|FG008|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||3
10838728|NCT02036970|12004296|FG009|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||1
10838729|NCT02036970|12004287|FG000|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
10838730|NCT02036970|12004288|FG001|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
10838731|NCT02036970|12004289|FG002|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
10838732|NCT02036970|12004290|FG003|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
10838733|NCT02036970|12004291|FG004|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
10838734|NCT02036970|12004292|FG005|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
10838735|NCT02036970|12004293|FG006|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
10838736|NCT02036970|12004294|FG007|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
10838737|NCT02036970|12004295|FG008|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||15
10838738|NCT02036970|12004296|FG009|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||8
10838739|NCT02036970|12004287|FG000|COMPLETED|Part 2: Week 16 Onwards||5
10838740|NCT02036970|12004288|FG001|COMPLETED|Part 2: Week 16 Onwards||6
10838741|NCT02036970|12004289|FG002|COMPLETED|Part 2: Week 16 Onwards||3
10838742|NCT02036970|12004290|FG003|COMPLETED|Part 2: Week 16 Onwards||7
10838743|NCT02036970|12004291|FG004|COMPLETED|Part 2: Week 16 Onwards||0
10838744|NCT02036970|12004292|FG005|COMPLETED|Part 2: Week 16 Onwards||3
10838745|NCT02036970|12004293|FG006|COMPLETED|Part 2: Week 16 Onwards||2
10838746|NCT02036970|12004294|FG007|COMPLETED|Part 2: Week 16 Onwards||2
10838747|NCT02036970|12004295|FG008|COMPLETED|Part 2: Week 16 Onwards||54
10838748|NCT02036970|12004296|FG009|COMPLETED|Part 2: Week 16 Onwards||28
10838749|NCT02036970|12004287|FG000|NOT COMPLETED|Part 2: Week 16 Onwards||0
10838750|NCT02036970|12004288|FG001|NOT COMPLETED|Part 2: Week 16 Onwards||5
10838751|NCT02036970|12004289|FG002|NOT COMPLETED|Part 2: Week 16 Onwards||3
10838752|NCT02036970|12004290|FG003|NOT COMPLETED|Part 2: Week 16 Onwards||2
10838753|NCT02036970|12004291|FG004|NOT COMPLETED|Part 2: Week 16 Onwards||1
10838754|NCT02036970|12004292|FG005|NOT COMPLETED|Part 2: Week 16 Onwards||0
10838755|NCT02036970|12004293|FG006|NOT COMPLETED|Part 2: Week 16 Onwards||1
10838756|NCT02036970|12004294|FG007|NOT COMPLETED|Part 2: Week 16 Onwards||1
10838757|NCT02036970|12004295|FG008|NOT COMPLETED|Part 2: Week 16 Onwards||9
10838758|NCT02036970|12004296|FG009|NOT COMPLETED|Part 2: Week 16 Onwards||5
10838759|NCT01941719|12004330|FG000|STARTED|Overall Study||48
10838760|NCT01941719|12004331|FG001|STARTED|Overall Study||51
10838761|NCT01941719|12004330|FG000|Month 1|Overall Study||43
10838762|NCT01941719|12004331|FG001|Month 1|Overall Study||48
10838763|NCT01941719|12004330|FG000|Month 3|Overall Study||38
10838764|NCT01941719|12004331|FG001|Month 3|Overall Study||44
10838765|NCT01941719|12004330|FG000|Month 6|Overall Study||34
10838766|NCT01941719|12004331|FG001|Month 6|Overall Study||42
10838767|NCT01941719|12004330|FG000|Month 9|Overall Study||29
10838768|NCT01941719|12004331|FG001|Month 9|Overall Study||37
10838769|NCT01941719|12004330|FG000|Month 12|Overall Study||28
10838770|NCT01941719|12004331|FG001|Month 12|Overall Study||32
10838771|NCT01941719|12004330|FG000|COMPLETED|Overall Study||28
10838772|NCT01941719|12004331|FG001|COMPLETED|Overall Study||32
10838773|NCT01941719|12004330|FG000|NOT COMPLETED|Overall Study||20
10838774|NCT01941719|12004331|FG001|NOT COMPLETED|Overall Study||19
10838775|NCT01578967|12004338|FG000|STARTED|Overall Study||41
10838776|NCT01578967|12004338|FG000|COMPLETED|Overall Study||41
10838777|NCT01578967|12004338|FG000|NOT COMPLETED|Overall Study||0
10838778|NCT01186003|12004347|FG000|STARTED|Overall Study||14
10838779|NCT01186003|12004348|FG001|STARTED|Overall Study||16
10838780|NCT01186003|12004347|FG000|COMPLETED|Overall Study||14
10838781|NCT01186003|12004348|FG001|COMPLETED|Overall Study||16
10838782|NCT01186003|12004347|FG000|NOT COMPLETED|Overall Study||0
10838783|NCT01186003|12004348|FG001|NOT COMPLETED|Overall Study||0
10838784|NCT00943618|12004357|FG000|STARTED|Overall Study||163
10838785|NCT00943618|12004358|FG001|STARTED|Overall Study||166
10838786|NCT00943618|12004359|FG002|STARTED|Overall Study||56
10838787|NCT00943618|12004357|FG000|COMPLETED|Overall Study||108
10838788|NCT00943618|12004358|FG001|COMPLETED|Overall Study||89
10838789|NCT00943618|12004359|FG002|COMPLETED|Overall Study||25
10838790|NCT00943618|12004357|FG000|NOT COMPLETED|Overall Study||55
10838791|NCT00943618|12004358|FG001|NOT COMPLETED|Overall Study||77
10838792|NCT00943618|12004359|FG002|NOT COMPLETED|Overall Study||31
10545016|NCT01493687|11698238|FG000|STARTED|Part A Vehicle Control (12 Weeks)||451
10545017|NCT01493687|11698239|FG001|STARTED|Part A Vehicle Control (12 Weeks)||232
10545018|NCT01493687|11698238|FG000|COMPLETED|Part A Vehicle Control (12 Weeks)||414
10545019|NCT01493687|11698239|FG001|COMPLETED|Part A Vehicle Control (12 Weeks)||210
10545020|NCT01493687|11698238|FG000|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||37
10838793|NCT03938272|12004369|FG000|STARTED|Overall Study||11
10838794|NCT03938272|12004370|FG001|STARTED|Overall Study||11
10838795|NCT03938272|12004369|FG000|COMPLETED|Overall Study||0
10838796|NCT03938272|12004370|FG001|COMPLETED|Overall Study||1
10838797|NCT03938272|12004369|FG000|NOT COMPLETED|Overall Study||11
10838798|NCT03938272|12004370|FG001|NOT COMPLETED|Overall Study||10
10838799|NCT03641339|12004382|FG000|STARTED|Overall Study||16
10838800|NCT03641339|12004383|FG001|STARTED|Overall Study||17
10838801|NCT03641339|12004384|FG002|STARTED|Overall Study||15
10838802|NCT03641339|12004385|FG003|STARTED|Overall Study||16
10838803|NCT03641339|12004386|FG004|STARTED|Overall Study||15
10838804|NCT03641339|12004387|FG005|STARTED|Overall Study||16
10838805|NCT03641339|12004382|FG000|COMPLETED|Overall Study||15
10838806|NCT03641339|12004383|FG001|COMPLETED|Overall Study||15
10838807|NCT03641339|12004384|FG002|COMPLETED|Overall Study||15
10838808|NCT03641339|12004385|FG003|COMPLETED|Overall Study||14
10838809|NCT03641339|12004386|FG004|COMPLETED|Overall Study||15
10838810|NCT03641339|12004387|FG005|COMPLETED|Overall Study||15
10838811|NCT03641339|12004382|FG000|NOT COMPLETED|Overall Study||1
10838812|NCT03641339|12004383|FG001|NOT COMPLETED|Overall Study||2
10838813|NCT03641339|12004384|FG002|NOT COMPLETED|Overall Study||0
10838814|NCT03641339|12004385|FG003|NOT COMPLETED|Overall Study||2
10838815|NCT03641339|12004386|FG004|NOT COMPLETED|Overall Study||0
10838816|NCT03641339|12004387|FG005|NOT COMPLETED|Overall Study||1
10838817|NCT03625466|12004403|FG000|STARTED|Overall Study||16
10838818|NCT03625466|12004404|FG001|STARTED|Overall Study||35
10838819|NCT03625466|12004403|FG000|COMPLETED|Overall Study||16
10838820|NCT03625466|12004404|FG001|COMPLETED|Overall Study||33
10838821|NCT03625466|12004403|FG000|NOT COMPLETED|Overall Study||0
10838822|NCT03625466|12004404|FG001|NOT COMPLETED|Overall Study||2
10838823|NCT03317795|12004412|FG000|STARTED|Overall Study||9
10838824|NCT03317795|12004413|FG001|STARTED|Overall Study||9
10838825|NCT03317795|12004412|FG000|COMPLETED|Overall Study||7
10838826|NCT03317795|12004413|FG001|COMPLETED|Overall Study||2
10838827|NCT03317795|12004412|FG000|NOT COMPLETED|Overall Study||2
10838828|NCT03317795|12004413|FG001|NOT COMPLETED|Overall Study||7
10838829|NCT03287245|12004423|FG000|STARTED|Overall Study||15
10838830|NCT03287245|12004424|FG001|STARTED|Overall Study||5
10838831|NCT03287245|12004425|FG002|STARTED|Overall Study||6
10838832|NCT03287245|12004426|FG003|STARTED|Overall Study||1
10838833|NCT03287245|12004423|FG000|COMPLETED|Overall Study||0
10838834|NCT03287245|12004424|FG001|COMPLETED|Overall Study||0
10838835|NCT03287245|12004425|FG002|COMPLETED|Overall Study||0
10838836|NCT03287245|12004426|FG003|COMPLETED|Overall Study||0
10838837|NCT03287245|12004423|FG000|NOT COMPLETED|Overall Study||15
10838838|NCT03287245|12004424|FG001|NOT COMPLETED|Overall Study||5
10838839|NCT03287245|12004425|FG002|NOT COMPLETED|Overall Study||6
10838840|NCT03287245|12004426|FG003|NOT COMPLETED|Overall Study||1
10838841|NCT03165916|12004458|FG000|STARTED|Overall Study||58
10838842|NCT03165916|12004459|FG001|STARTED|Overall Study||57
10838843|NCT03165916|12004458|FG000|Reconstruction Interventions|Overall Study||59
10838844|NCT03165916|12004459|FG001|Reconstruction Interventions|Overall Study||57
10838845|NCT03165916|12004458|FG000|COMPLETED|Overall Study||58
10838846|NCT03165916|12004459|FG001|COMPLETED|Overall Study||57
10838847|NCT03165916|12004458|FG000|NOT COMPLETED|Overall Study||0
10838848|NCT03165916|12004459|FG001|NOT COMPLETED|Overall Study||0
10838849|NCT03092219|12004467|FG000|STARTED|Overall Study||150
10838850|NCT03092219|12004468|FG001|STARTED|Overall Study||52
10838851|NCT03092219|12004467|FG000|Baseline / ITT Population|Overall Study||150
10838852|NCT03092219|12004468|FG001|Baseline / ITT Population|Overall Study|Subject randomized to No Treatment group but received treatment at Visit 1.|51
10838853|NCT03092219|12004467|FG000|Primary Analysis Endpoint|Overall Study||150
10838854|NCT03092219|12004468|FG001|Primary Analysis Endpoint|Overall Study||51
10838855|NCT03092219|12004467|FG000|Pooled SAFT Population|Overall Study||150
10838856|NCT03092219|12004468|FG001|Pooled SAFT Population|Overall Study|2 subjects did not receive treatment at Visit 1b.|50
10838857|NCT03092219|12004467|FG000|COMPLETED|Overall Study||143
10838858|NCT03092219|12004468|FG001|COMPLETED|Overall Study||48
10838859|NCT03092219|12004467|FG000|NOT COMPLETED|Overall Study||7
10838860|NCT03092219|12004468|FG001|NOT COMPLETED|Overall Study||4
10838861|NCT03033069|12004481|FG000|STARTED|Overall Study||82
10838862|NCT03033069|12004482|FG001|STARTED|Overall Study||75
10838863|NCT03033069|12004483|FG002|STARTED|Overall Study||81
10838864|NCT03033069|12004484|FG003|STARTED|Overall Study||83
10838865|NCT03033069|12004481|FG000|Safety Sample|Overall Study||80
10838866|NCT03033069|12004482|FG001|Safety Sample|Overall Study||75
10838867|NCT03033069|12004483|FG002|Safety Sample|Overall Study||79
10410505|NCT00762515|11554510|FG001|NOT COMPLETED|Overall Study||0
10838868|NCT03033069|12004484|FG003|Safety Sample|Overall Study||82
10838869|NCT03033069|12004481|FG000|Intent to Treat (ITT) Sample|Overall Study||79
10838870|NCT03033069|12004482|FG001|Intent to Treat (ITT) Sample|Overall Study||72
10838871|NCT03033069|12004483|FG002|Intent to Treat (ITT) Sample|Overall Study||77
10838872|NCT03033069|12004484|FG003|Intent to Treat (ITT) Sample|Overall Study||80
10838873|NCT03033069|12004481|FG000|COMPLETED|Overall Study||58
10410506|NCT00762528|11554518|FG000|STARTED|Overall Study||24
10838874|NCT03033069|12004482|FG001|COMPLETED|Overall Study||50
10838875|NCT03033069|12004483|FG002|COMPLETED|Overall Study||59
10838876|NCT03033069|12004484|FG003|COMPLETED|Overall Study||64
10838877|NCT03033069|12004481|FG000|NOT COMPLETED|Overall Study||24
10838878|NCT03033069|12004482|FG001|NOT COMPLETED|Overall Study||25
10838879|NCT03033069|12004483|FG002|NOT COMPLETED|Overall Study||22
10838880|NCT03033069|12004484|FG003|NOT COMPLETED|Overall Study||19
10838881|NCT02956434|12004498|FG000|STARTED|Overall Study||10
10838882|NCT02956434|12004499|FG001|STARTED|Overall Study||10
10838883|NCT02956434|12004500|FG002|STARTED|Overall Study||10
10838884|NCT02956434|12004501|FG003|STARTED|Overall Study||10
10838885|NCT02956434|12004498|FG000|COMPLETED|Overall Study||10
10838886|NCT02956434|12004499|FG001|COMPLETED|Overall Study||10
10838887|NCT02956434|12004500|FG002|COMPLETED|Overall Study||10
10838888|NCT02956434|12004501|FG003|COMPLETED|Overall Study||10
10838889|NCT02956434|12004498|FG000|NOT COMPLETED|Overall Study||0
10838890|NCT02956434|12004499|FG001|NOT COMPLETED|Overall Study||0
10838891|NCT02956434|12004500|FG002|NOT COMPLETED|Overall Study||0
10838892|NCT02956434|12004501|FG003|NOT COMPLETED|Overall Study||0
10838893|NCT02609503|12004509|FG000|STARTED|Overall Study||29
10838894|NCT02609503|12004509|FG000|COMPLETED|Overall Study||25
10838895|NCT02609503|12004509|FG000|NOT COMPLETED|Overall Study||4
10838896|NCT02587598|12004527|FG000|STARTED|Overall Study||4
10838897|NCT02587598|12004528|FG001|STARTED|Overall Study||11
10838898|NCT02587598|12004529|FG002|STARTED|Overall Study||4
10838899|NCT02587598|12004530|FG003|STARTED|Overall Study||21
10838900|NCT02587598|12004531|FG004|STARTED|Overall Study||12
10838901|NCT02587598|12004532|FG005|STARTED|Overall Study||6
10838902|NCT02587598|12004533|FG006|STARTED|Overall Study||6
10838903|NCT02587598|12004534|FG007|STARTED|Overall Study||7
10838904|NCT02587598|12004535|FG008|STARTED|Overall Study||9
10838905|NCT02587598|12004536|FG009|STARTED|Overall Study||3
10838906|NCT02587598|12004537|FG010|STARTED|Overall Study||14
10838907|NCT02587598|12004527|FG000|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
10838908|NCT02587598|12004528|FG001|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
10838909|NCT02587598|12004529|FG002|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
10838910|NCT02587598|12004530|FG003|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
10838911|NCT02587598|12004531|FG004|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
10838912|NCT02587598|12004532|FG005|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
10838913|NCT02587598|12004533|FG006|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
10838914|NCT02587598|12004534|FG007|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
10838915|NCT02587598|12004535|FG008|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
10838916|NCT02587598|12004536|FG009|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
10838917|NCT02587598|12004537|FG010|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
10838918|NCT02587598|12004527|FG000|NOT COMPLETED|Overall Study||4
10838919|NCT02587598|12004528|FG001|NOT COMPLETED|Overall Study||11
10838920|NCT02587598|12004529|FG002|NOT COMPLETED|Overall Study||4
10838921|NCT02587598|12004530|FG003|NOT COMPLETED|Overall Study||21
10838922|NCT02587598|12004531|FG004|NOT COMPLETED|Overall Study||12
10838923|NCT02587598|12004532|FG005|NOT COMPLETED|Overall Study||6
10838924|NCT02587598|12004533|FG006|NOT COMPLETED|Overall Study||6
10838925|NCT02587598|12004534|FG007|NOT COMPLETED|Overall Study||7
10838926|NCT02587598|12004535|FG008|NOT COMPLETED|Overall Study||9
10838927|NCT02587598|12004536|FG009|NOT COMPLETED|Overall Study||3
10838928|NCT02587598|12004537|FG010|NOT COMPLETED|Overall Study||14
10838929|NCT02485574|12004573|FG000|STARTED|Overall Study||69
10838930|NCT02485574|12004573|FG000|COMPLETED|Overall Study||65
10838931|NCT02485574|12004573|FG000|NOT COMPLETED|Overall Study||4
10838941|NCT01899261|12004599|FG000|STARTED|Overall Study||20
10838942|NCT01899261|12004599|FG000|COMPLETED|Overall Study||20
10838943|NCT01899261|12004599|FG000|NOT COMPLETED|Overall Study||0
10838944|NCT01595503|12004603|FG000|STARTED|Overall Study||5
10838945|NCT01595503|12004603|FG000|COMPLETED|Overall Study||5
10838946|NCT01595503|12004603|FG000|NOT COMPLETED|Overall Study||0
10838947|NCT01460160|12004607|FG000|STARTED|Treatment Phase||106
10838948|NCT01460160|12004607|FG000|COMPLETED|Treatment Phase||78
10838949|NCT01460160|12004607|FG000|NOT COMPLETED|Treatment Phase||28
10838950|NCT01460160|12004607|FG000|STARTED|Follow-up Phase|Some of the participants who did not completed the Treatment Phase were still moved to the Follow-up Phase|100
10838951|NCT01460160|12004607|FG000|COMPLETED|Follow-up Phase||0
10410507|NCT00762528|11554519|FG001|STARTED|Overall Study||25
10410508|NCT00762528|11554518|FG000|COMPLETED|Overall Study||24
10410509|NCT00762528|11554519|FG001|COMPLETED|Overall Study||25
10410510|NCT00762528|11554518|FG000|NOT COMPLETED|Overall Study||0
10410511|NCT00762528|11554519|FG001|NOT COMPLETED|Overall Study||0
10410512|NCT00762606|11554527|FG000|STARTED|Overall Study||55
10410513|NCT00762606|11554528|FG001|STARTED|Overall Study||51
10410514|NCT00762606|11554527|FG000|COMPLETED|Overall Study||37
10410515|NCT00762606|11554528|FG001|COMPLETED|Overall Study||38
10410516|NCT00762606|11554527|FG000|NOT COMPLETED|Overall Study||18
10410517|NCT00762606|11554528|FG001|NOT COMPLETED|Overall Study||13
10410518|NCT00762619|11554536|FG000|STARTED|Overall Study||55
10410519|NCT00762619|11554537|FG001|STARTED|Overall Study||50
10410520|NCT00762619|11554536|FG000|COMPLETED|Overall Study||55
10410521|NCT00762619|11554537|FG001|COMPLETED|Overall Study||50
10410522|NCT00762619|11554536|FG000|NOT COMPLETED|Overall Study||0
10410523|NCT00762619|11554537|FG001|NOT COMPLETED|Overall Study||0
10410524|NCT00762645|11554547|FG000|STARTED|Overall Study||16
10410525|NCT00762645|11554548|FG001|STARTED|Overall Study||14
10410526|NCT00762645|11554547|FG000|COMPLETED|Overall Study||12
10410527|NCT00762645|11554548|FG001|COMPLETED|Overall Study||12
10410528|NCT00762645|11554547|FG000|NOT COMPLETED|Overall Study||4
10410529|NCT00762645|11554548|FG001|NOT COMPLETED|Overall Study||2
10410530|NCT00762710|11554556|FG000|STARTED|Overall Study||48
10410531|NCT00762710|11554557|FG001|STARTED|Overall Study||44
10410532|NCT00762710|11554556|FG000|COMPLETED|Overall Study||27
10410533|NCT00762710|11554557|FG001|COMPLETED|Overall Study||29
10410534|NCT00762710|11554556|FG000|NOT COMPLETED|Overall Study||21
10410535|NCT00762710|11554557|FG001|NOT COMPLETED|Overall Study||15
10410536|NCT00762762|11554565|FG000|STARTED|Overall Study||30
10410537|NCT00762762|11554566|FG001|STARTED|Overall Study||30
10410538|NCT00762762|11554565|FG000|COMPLETED|Overall Study||22
10410539|NCT00762762|11554566|FG001|COMPLETED|Overall Study||20
10410540|NCT00762762|11554565|FG000|NOT COMPLETED|Overall Study||8
10410541|NCT00762762|11554566|FG001|NOT COMPLETED|Overall Study||10
10410542|NCT00762788|11554578|FG000|STARTED|Overall Study||55
10410543|NCT00762788|11554579|FG001|STARTED|Overall Study||58
10410544|NCT00762788|11554580|FG002|STARTED|Overall Study||42
10410545|NCT00762788|11554581|FG003|STARTED|Overall Study||64
10410546|NCT00762788|11554582|FG004|STARTED|Overall Study||43
10410547|NCT00762788|11554583|FG005|STARTED|Overall Study||52
10410548|NCT00762788|11554578|FG000|COMPLETED|Overall Study||29
10410549|NCT00762788|11554579|FG001|COMPLETED|Overall Study||21
10410550|NCT00762788|11554580|FG002|COMPLETED|Overall Study||21
10410551|NCT00762788|11554581|FG003|COMPLETED|Overall Study||38
10410552|NCT00762788|11554582|FG004|COMPLETED|Overall Study||30
10410553|NCT00762788|11554583|FG005|COMPLETED|Overall Study||31
10410554|NCT00762788|11554578|FG000|NOT COMPLETED|Overall Study||26
10410555|NCT00762788|11554579|FG001|NOT COMPLETED|Overall Study||37
10410556|NCT00762788|11554580|FG002|NOT COMPLETED|Overall Study||21
10410557|NCT00762788|11554581|FG003|NOT COMPLETED|Overall Study||26
10410558|NCT00762788|11554582|FG004|NOT COMPLETED|Overall Study||13
10410559|NCT00762788|11554583|FG005|NOT COMPLETED|Overall Study||21
10410560|NCT00762853|11554599|FG000|STARTED|First Treatment Period||10
10410561|NCT00762853|11554600|FG001|STARTED|First Treatment Period||10
10410562|NCT00762853|11554599|FG000|COMPLETED|First Treatment Period||10
10410563|NCT00762853|11554600|FG001|COMPLETED|First Treatment Period||10
10410564|NCT00762853|11554599|FG000|NOT COMPLETED|First Treatment Period||0
10410565|NCT00762853|11554600|FG001|NOT COMPLETED|First Treatment Period||0
10410566|NCT00762853|11554599|FG000|STARTED|1 Week Washout After Treatment 1||10
10410567|NCT00762853|11554600|FG001|STARTED|1 Week Washout After Treatment 1||10
10410568|NCT00762853|11554599|FG000|COMPLETED|1 Week Washout After Treatment 1||10
10410569|NCT00762853|11554600|FG001|COMPLETED|1 Week Washout After Treatment 1||10
10410570|NCT00762853|11554599|FG000|NOT COMPLETED|1 Week Washout After Treatment 1||0
10410571|NCT00762853|11554600|FG001|NOT COMPLETED|1 Week Washout After Treatment 1||0
10838952|NCT01460160|12004607|FG000|NOT COMPLETED|Follow-up Phase||100
10410572|NCT00762853|11554599|FG000|STARTED|Second Treatment Period||10
10410573|NCT00762853|11554600|FG001|STARTED|Second Treatment Period||10
10410574|NCT00762853|11554599|FG000|COMPLETED|Second Treatment Period||10
10410575|NCT00762853|11554600|FG001|COMPLETED|Second Treatment Period||10
10410576|NCT00762853|11554599|FG000|NOT COMPLETED|Second Treatment Period||0
10410577|NCT00762853|11554600|FG001|NOT COMPLETED|Second Treatment Period||0
10410578|NCT00762892|11554608|FG000|STARTED|Overall Study||14
10410579|NCT00762892|11554609|FG001|STARTED|Overall Study||14
10410580|NCT00762892|11554608|FG000|COMPLETED|Overall Study||9
10410581|NCT00762892|11554609|FG001|COMPLETED|Overall Study||8
10410582|NCT00762892|11554608|FG000|NOT COMPLETED|Overall Study||5
10410583|NCT00762892|11554609|FG001|NOT COMPLETED|Overall Study||6
10410584|NCT00762931|11554615|FG000|STARTED|Overall Study||25
10838953|NCT01170702|12004615|FG000|STARTED|Overall Study||34
10838954|NCT01170702|12004616|FG001|STARTED|Overall Study||32
10838955|NCT01170702|12004617|FG002|STARTED|Overall Study||25
10838956|NCT01170702|12004618|FG003|STARTED|Overall Study||29
10838957|NCT01170702|12004615|FG000|COMPLETED|Overall Study||33
10838958|NCT01170702|12004616|FG001|COMPLETED|Overall Study||30
10838959|NCT01170702|12004617|FG002|COMPLETED|Overall Study||25
10838960|NCT01170702|12004618|FG003|COMPLETED|Overall Study||27
10838961|NCT01170702|12004615|FG000|NOT COMPLETED|Overall Study||1
10838962|NCT01170702|12004616|FG001|NOT COMPLETED|Overall Study||2
10838963|NCT01170702|12004617|FG002|NOT COMPLETED|Overall Study||0
10838964|NCT01170702|12004618|FG003|NOT COMPLETED|Overall Study||2
10838965|NCT01018563|12004628|FG000|STARTED|Overall Study||2
10838966|NCT01018563|12004629|FG001|STARTED|Overall Study||1
10838967|NCT01018563|12004628|FG000|COMPLETED|Overall Study||0
10838968|NCT01018563|12004629|FG001|COMPLETED|Overall Study||0
10838969|NCT01018563|12004628|FG000|NOT COMPLETED|Overall Study||2
10838970|NCT01018563|12004629|FG001|NOT COMPLETED|Overall Study||1
10838971|NCT00805961|12004639|FG000|STARTED|Modality Therapy||68
10838972|NCT00805961|12004639|FG000|COMPLETED|Modality Therapy||64
10838973|NCT00805961|12004639|FG000|NOT COMPLETED|Modality Therapy||4
10838974|NCT00805961|12004639|FG000|STARTED|Treatment-Free Interval||64
10838975|NCT00805961|12004639|FG000|COMPLETED|Treatment-Free Interval||57
10838976|NCT00805961|12004639|FG000|NOT COMPLETED|Treatment-Free Interval||7
10838977|NCT00805961|12004639|FG000|STARTED|Maintenance Treatment||57
10838978|NCT00805961|12004639|FG000|COMPLETED|Maintenance Treatment||23
10838979|NCT00805961|12004639|FG000|NOT COMPLETED|Maintenance Treatment||34
10838980|NCT04056182|12004643|FG000|STARTED|Overall Study||20
10838981|NCT04056182|12004643|FG000|COMPLETED|Overall Study||3
10838982|NCT04056182|12004643|FG000|NOT COMPLETED|Overall Study||17
10838983|NCT03954106|12004649|FG000|STARTED|Part 1: Safety Lead In Phase||4
10838984|NCT03954106|12004650|FG001|STARTED|Part 1: Safety Lead In Phase||0
10838985|NCT03954106|12004649|FG000|COMPLETED|Part 1: Safety Lead In Phase||4
10838986|NCT03954106|12004650|FG001|COMPLETED|Part 1: Safety Lead In Phase||0
10838987|NCT03954106|12004649|FG000|NOT COMPLETED|Part 1: Safety Lead In Phase||0
10838988|NCT03954106|12004650|FG001|NOT COMPLETED|Part 1: Safety Lead In Phase||0
10838989|NCT03954106|12004649|FG000|STARTED|Phase 2: Treatment at RP2D||0
10838990|NCT03954106|12004650|FG001|STARTED|Phase 2: Treatment at RP2D||21
10838991|NCT03954106|12004649|FG000|COMPLETED|Phase 2: Treatment at RP2D||0
10838992|NCT03954106|12004650|FG001|COMPLETED|Phase 2: Treatment at RP2D||21
10838993|NCT03954106|12004649|FG000|NOT COMPLETED|Phase 2: Treatment at RP2D||0
10838994|NCT03954106|12004650|FG001|NOT COMPLETED|Phase 2: Treatment at RP2D||0
10838995|NCT03921424|12004660|FG000|STARTED|Overall Study||203
10838996|NCT03921424|12004661|FG001|STARTED|Overall Study||204
10838997|NCT03921424|12004660|FG000|Vaccination 1 - (Day 1)|Overall Study||203
10838998|NCT03921424|12004661|FG001|Vaccination 1 - (Day 1)|Overall Study||204
10838999|NCT03921424|12004660|FG000|Vaccination 2 - (Week 8)|Overall Study||203
10839000|NCT03921424|12004661|FG001|Vaccination 2 - (Week 8)|Overall Study|Two participants did not receive Vaccination 2.|202
10839001|NCT03921424|12004660|FG000|COMPLETED|Overall Study||203
10839002|NCT03921424|12004661|FG001|COMPLETED|Overall Study||201
10839003|NCT03921424|12004660|FG000|NOT COMPLETED|Overall Study||0
10839004|NCT03921424|12004661|FG001|NOT COMPLETED|Overall Study||3
10839005|NCT03598777|12004674|FG000|STARTED|Overall Study||13
10839006|NCT03598777|12004675|FG001|STARTED|Overall Study||8
10839007|NCT03598777|12004676|FG002|STARTED|Overall Study||8
10839008|NCT03598777|12004677|FG003|STARTED|Overall Study||14
10839009|NCT03598777|12004678|FG004|STARTED|Overall Study||17
10839010|NCT03598777|12004674|FG000|Received Treatment in Cycle 1 DB Treatment Period|Overall Study||13
10839011|NCT03598777|12004675|FG001|Received Treatment in Cycle 1 DB Treatment Period|Overall Study||8
10839012|NCT03598777|12004676|FG002|Received Treatment in Cycle 1 DB Treatment Period|Overall Study||8
10839013|NCT03598777|12004677|FG003|Received Treatment in Cycle 1 DB Treatment Period|Overall Study||14
10839014|NCT03598777|12004678|FG004|Received Treatment in Cycle 1 DB Treatment Period|Overall Study||17
10839015|NCT03598777|12004674|FG000|Retreated in Cycle 2 OL Treatment Period|Overall Study||13
10839016|NCT03598777|12004675|FG001|Retreated in Cycle 2 OL Treatment Period|Overall Study||7
10839017|NCT03598777|12004676|FG002|Retreated in Cycle 2 OL Treatment Period|Overall Study||8
10839018|NCT03598777|12004677|FG003|Retreated in Cycle 2 OL Treatment Period|Overall Study||13
10839019|NCT03598777|12004678|FG004|Retreated in Cycle 2 OL Treatment Period|Overall Study||11
10839020|NCT03598777|12004674|FG000|Retreated in Cycle 3 OL Treatment Period|Overall Study||8
10839021|NCT03598777|12004675|FG001|Retreated in Cycle 3 OL Treatment Period|Overall Study||6
10839022|NCT03598777|12004676|FG002|Retreated in Cycle 3 OL Treatment Period|Overall Study||6
10839023|NCT03598777|12004677|FG003|Retreated in Cycle 3 OL Treatment Period|Overall Study||12
10839024|NCT03598777|12004678|FG004|Retreated in Cycle 3 OL Treatment Period|Overall Study||2
10839025|NCT03598777|12004674|FG000|Retreated in Cycle 4 OL Treatment Period|Overall Study||1
10839026|NCT03598777|12004675|FG001|Retreated in Cycle 4 OL Treatment Period|Overall Study||0
10839027|NCT03598777|12004676|FG002|Retreated in Cycle 4 OL Treatment Period|Overall Study||1
10839028|NCT03598777|12004677|FG003|Retreated in Cycle 4 OL Treatment Period|Overall Study||3
10839029|NCT03598777|12004678|FG004|Retreated in Cycle 4 OL Treatment Period|Overall Study||0
10839030|NCT03598777|12004674|FG000|COMPLETED|Overall Study||7
10839031|NCT03598777|12004675|FG001|COMPLETED|Overall Study||7
10839032|NCT03598777|12004676|FG002|COMPLETED|Overall Study||8
10839033|NCT03598777|12004677|FG003|COMPLETED|Overall Study||14
10839034|NCT03598777|12004678|FG004|COMPLETED|Overall Study||2
10839035|NCT03598777|12004674|FG000|NOT COMPLETED|Overall Study||6
10839036|NCT03598777|12004675|FG001|NOT COMPLETED|Overall Study||1
10839037|NCT03598777|12004676|FG002|NOT COMPLETED|Overall Study||0
10839038|NCT03598777|12004677|FG003|NOT COMPLETED|Overall Study||0
10839039|NCT03598777|12004678|FG004|NOT COMPLETED|Overall Study||15
10839040|NCT03406078|12004695|FG000|STARTED|Overall Study||74
10839041|NCT03406078|12004696|FG001|STARTED|Overall Study||76
10839042|NCT03406078|12004695|FG000|COMPLETED|Overall Study||68
10839043|NCT03406078|12004696|FG001|COMPLETED|Overall Study||73
10839044|NCT03406078|12004695|FG000|NOT COMPLETED|Overall Study||6
10839045|NCT03406078|12004696|FG001|NOT COMPLETED|Overall Study||3
10839046|NCT03397589|12004704|FG000|STARTED|Overall Study||211
10839047|NCT03397589|12004705|FG001|STARTED|Overall Study||209
10839048|NCT03397589|12004704|FG000|COMPLETED|Overall Study||175
10839049|NCT03397589|12004705|FG001|COMPLETED|Overall Study||187
10839050|NCT03397589|12004704|FG000|NOT COMPLETED|Overall Study||36
10839051|NCT03397589|12004705|FG001|NOT COMPLETED|Overall Study||22
10839052|NCT03368066|12004711|FG000|STARTED|Overall Study||58
10839053|NCT03368066|12004712|FG001|STARTED|Overall Study||37
10839054|NCT03368066|12004711|FG000|COMPLETED|Overall Study||58
10839055|NCT03368066|12004712|FG001|COMPLETED|Overall Study||37
10839056|NCT03368066|12004711|FG000|NOT COMPLETED|Overall Study||0
10839057|NCT03368066|12004712|FG001|NOT COMPLETED|Overall Study||0
10839058|NCT03345342|12004718|FG000|STARTED|Open-Label Phase||838
10839059|NCT03345342|12004719|FG001|STARTED|Open-Label Phase||0
10839060|NCT03345342|12004720|FG002|STARTED|Open-Label Phase||0
10839061|NCT03345342|12004721|FG003|STARTED|Open-Label Phase||0
10839062|NCT03345342|12004722|FG004|STARTED|Open-Label Phase||0
10839063|NCT03345342|12004718|FG000|COMPLETED|Open-Label Phase||702
10839064|NCT03345342|12004719|FG001|COMPLETED|Open-Label Phase||0
10839065|NCT03345342|12004720|FG002|COMPLETED|Open-Label Phase||0
10839066|NCT03345342|12004721|FG003|COMPLETED|Open-Label Phase||0
10839067|NCT03345342|12004722|FG004|COMPLETED|Open-Label Phase||0
10839068|NCT03345342|12004718|FG000|NOT COMPLETED|Open-Label Phase||136
10839069|NCT03345342|12004719|FG001|NOT COMPLETED|Open-Label Phase||0
10839070|NCT03345342|12004720|FG002|NOT COMPLETED|Open-Label Phase||0
10839071|NCT03345342|12004721|FG003|NOT COMPLETED|Open-Label Phase||0
10839072|NCT03345342|12004722|FG004|NOT COMPLETED|Open-Label Phase||0
10839073|NCT03345342|12004718|FG000|STARTED|Double-Blind Phase||0
10839074|NCT03345342|12004719|FG001|STARTED|Double-Blind Phase|Participants from the OL phase have continued in the DB phase.|224
10839075|NCT03345342|12004720|FG002|STARTED|Double-Blind Phase|Participants from the OL phase have continued in the DB phase.|478
10839076|NCT03345342|12004721|FG003|STARTED|Double-Blind Phase||0
10839077|NCT03345342|12004722|FG004|STARTED|Double-Blind Phase||0
10839078|NCT03345342|12004718|FG000|COMPLETED|Double-Blind Phase||0
10839079|NCT03345342|12004719|FG001|COMPLETED|Double-Blind Phase||202
10839080|NCT03345342|12004720|FG002|COMPLETED|Double-Blind Phase||416
10410585|NCT00762931|11554615|FG000|COMPLETED|Overall Study||23
10410586|NCT00762931|11554615|FG000|NOT COMPLETED|Overall Study||2
10410587|NCT00762970|11554622|FG000|STARTED|Overall Study||46
10839081|NCT03345342|12004721|FG003|COMPLETED|Double-Blind Phase||0
10839082|NCT03345342|12004722|FG004|COMPLETED|Double-Blind Phase||0
10839083|NCT03345342|12004718|FG000|NOT COMPLETED|Double-Blind Phase||0
10839084|NCT03345342|12004719|FG001|NOT COMPLETED|Double-Blind Phase||22
10839085|NCT03345342|12004720|FG002|NOT COMPLETED|Double-Blind Phase||62
10839086|NCT03345342|12004721|FG003|NOT COMPLETED|Double-Blind Phase||0
10839087|NCT03345342|12004722|FG004|NOT COMPLETED|Double-Blind Phase||0
10839088|NCT03345342|12004718|FG000|STARTED|Follow-Up Phase||0
10839089|NCT03345342|12004719|FG001|STARTED|Follow-Up Phase||0
10839090|NCT03345342|12004720|FG002|STARTED|Follow-Up Phase||0
10839091|NCT03345342|12004721|FG003|STARTED|Follow-Up Phase|Participants from the DB phase have continued in the FU phase.|42
10839092|NCT03345342|12004722|FG004|STARTED|Follow-Up Phase|Participants from the DB phase have continued in the FU phase.|109
10839093|NCT03345342|12004718|FG000|COMPLETED|Follow-Up Phase||0
10839094|NCT03345342|12004719|FG001|COMPLETED|Follow-Up Phase||0
10839095|NCT03345342|12004720|FG002|COMPLETED|Follow-Up Phase||0
10839096|NCT03345342|12004721|FG003|COMPLETED|Follow-Up Phase||34
10839097|NCT03345342|12004722|FG004|COMPLETED|Follow-Up Phase||78
10839098|NCT03345342|12004718|FG000|NOT COMPLETED|Follow-Up Phase||0
10839099|NCT03345342|12004719|FG001|NOT COMPLETED|Follow-Up Phase||0
10839100|NCT03345342|12004720|FG002|NOT COMPLETED|Follow-Up Phase||0
10839101|NCT03345342|12004721|FG003|NOT COMPLETED|Follow-Up Phase||8
10839102|NCT03345342|12004722|FG004|NOT COMPLETED|Follow-Up Phase||31
10839103|NCT03218995|12004734|FG000|STARTED|Overall Study||15
10839104|NCT03218995|12004734|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
10839105|NCT03218995|12004734|FG000|COMPLETED|Overall Study||15
10839106|NCT03218995|12004734|FG000|NOT COMPLETED|Overall Study||0
10839107|NCT03030222|12004742|FG000|STARTED|Overall Study||33
10839108|NCT03030222|12004743|FG001|STARTED|Overall Study||32
10839109|NCT03030222|12004742|FG000|COMPLETED|Overall Study||33
10839110|NCT03030222|12004743|FG001|COMPLETED|Overall Study||32
10839111|NCT03030222|12004742|FG000|NOT COMPLETED|Overall Study||0
10839112|NCT03030222|12004743|FG001|NOT COMPLETED|Overall Study||0
10839113|NCT02880241|12004755|FG000|STARTED|Overall Study|Study terminated|8
10839114|NCT02880241|12004756|FG001|STARTED|Overall Study|Study terminated|0
10839115|NCT02880241|12004757|FG002|STARTED|Overall Study|Study terminated|0
10839116|NCT02880241|12004758|FG003|STARTED|Overall Study|Study terminated|0
10839117|NCT02880241|12004759|FG004|STARTED|Overall Study|Study terminated|0
10839118|NCT02880241|12004760|FG005|STARTED|Overall Study|Study terminated|0
10839119|NCT02880241|12004755|FG000|COMPLETED|Overall Study|Study terminated|7
10839120|NCT02880241|12004756|FG001|COMPLETED|Overall Study|Study terminated|0
10839121|NCT02880241|12004757|FG002|COMPLETED|Overall Study|Study terminated|0
10839122|NCT02880241|12004758|FG003|COMPLETED|Overall Study|Study terminated|0
10839123|NCT02880241|12004759|FG004|COMPLETED|Overall Study|Study terminated|0
10839124|NCT02880241|12004760|FG005|COMPLETED|Overall Study|Study terminated|0
10839125|NCT02880241|12004755|FG000|NOT COMPLETED|Overall Study||1
10839126|NCT02880241|12004756|FG001|NOT COMPLETED|Overall Study||0
10839127|NCT02880241|12004757|FG002|NOT COMPLETED|Overall Study||0
10839128|NCT02880241|12004758|FG003|NOT COMPLETED|Overall Study||0
10839129|NCT02880241|12004759|FG004|NOT COMPLETED|Overall Study||0
10839130|NCT02880241|12004760|FG005|NOT COMPLETED|Overall Study||0
10839131|NCT02832687|12004778|FG000|STARTED|Overall Study||41
10839132|NCT02832687|12004779|FG001|STARTED|Overall Study||47
10839133|NCT02832687|12004778|FG000|Participants Who Were Included in the Analysis|Overall Study||31
10839134|NCT02832687|12004779|FG001|Participants Who Were Included in the Analysis|Overall Study||34
10839135|NCT02832687|12004778|FG000|COMPLETED|Overall Study||41
10839136|NCT02832687|12004779|FG001|COMPLETED|Overall Study||45
10839137|NCT02832687|12004778|FG000|NOT COMPLETED|Overall Study||0
10839138|NCT02832687|12004779|FG001|NOT COMPLETED|Overall Study||2
10839139|NCT02568449|12004785|FG000|STARTED|Overall Study||20
10839140|NCT02568449|12004785|FG000|COMPLETED|Overall Study||20
10839141|NCT02568449|12004785|FG000|NOT COMPLETED|Overall Study||0
10839142|NCT02499900|12004791|FG000|STARTED|Core Study Period||430
10839143|NCT02499900|12004792|FG001|STARTED|Core Study Period||431
10839144|NCT02499900|12004791|FG000|Safety Analysis Set|Core Study Period||427
10839145|NCT02499900|12004792|FG001|Safety Analysis Set|Core Study Period||430
10839146|NCT02499900|12004791|FG000|COMPLETED|Core Study Period||395
10839147|NCT02499900|12004792|FG001|COMPLETED|Core Study Period||399
10839148|NCT02499900|12004791|FG000|NOT COMPLETED|Core Study Period||35
10839149|NCT02499900|12004792|FG001|NOT COMPLETED|Core Study Period||32
10839150|NCT02499900|12004791|FG000|STARTED|Completed Core, Continued Into Extension||395
10839151|NCT02499900|12004792|FG001|STARTED|Completed Core, Continued Into Extension||399
10839152|NCT02499900|12004791|FG000|COMPLETED|Completed Core, Continued Into Extension||392
10839153|NCT02499900|12004792|FG001|COMPLETED|Completed Core, Continued Into Extension||397
10839154|NCT02499900|12004791|FG000|NOT COMPLETED|Completed Core, Continued Into Extension||3
10839155|NCT02499900|12004792|FG001|NOT COMPLETED|Completed Core, Continued Into Extension||2
10839156|NCT02499900|12004791|FG000|STARTED|Extension Study Period||392
10839157|NCT02499900|12004792|FG001|STARTED|Extension Study Period||397
10839158|NCT02499900|12004791|FG000|Safety Analysis Set|Extension Study Period||392
10839159|NCT02499900|12004792|FG001|Safety Analysis Set|Extension Study Period|One participant was not treated in the Extension Study Period|396
10839160|NCT02499900|12004791|FG000|COMPLETED|Extension Study Period||380
10839161|NCT02499900|12004792|FG001|COMPLETED|Extension Study Period||377
10839162|NCT02499900|12004791|FG000|NOT COMPLETED|Extension Study Period||12
10839163|NCT02499900|12004792|FG001|NOT COMPLETED|Extension Study Period||20
10839164|NCT02481986|12004806|FG000|STARTED|Overall Study||108
10839165|NCT02481986|12004807|FG001|STARTED|Overall Study||115
10839166|NCT02481986|12004806|FG000|COMPLETED|Overall Study||103
10839167|NCT02481986|12004807|FG001|COMPLETED|Overall Study||106
10839168|NCT02481986|12004806|FG000|NOT COMPLETED|Overall Study||5
10839169|NCT02481986|12004807|FG001|NOT COMPLETED|Overall Study||9
10839170|NCT02394548|12004813|FG000|STARTED|Overall Study||26
10839171|NCT02394548|12004813|FG000|COMPLETED|Overall Study||25
10839172|NCT02394548|12004813|FG000|NOT COMPLETED|Overall Study||1
10839173|NCT02269917|12004819|FG000|STARTED|BL to EOE-Test and BL to Switch-Control||766
10839174|NCT02269917|12004820|FG001|STARTED|BL to EOE-Test and BL to Switch-Control||383
10839175|NCT02269917|12004821|FG002|STARTED|BL to EOE-Test and BL to Switch-Control||0
10839176|NCT02269917|12004819|FG000|Treated|BL to EOE-Test and BL to Switch-Control||763
10839177|NCT02269917|12004820|FG001|Treated|BL to EOE-Test and BL to Switch-Control||378
10839178|NCT02269917|12004821|FG002|Treated|BL to EOE-Test and BL to Switch-Control||0
10839179|NCT02269917|12004819|FG000|COMPLETED|BL to EOE-Test and BL to Switch-Control||649
10839180|NCT02269917|12004820|FG001|COMPLETED|BL to EOE-Test and BL to Switch-Control||352
10839181|NCT02269917|12004821|FG002|COMPLETED|BL to EOE-Test and BL to Switch-Control||0
10839182|NCT02269917|12004819|FG000|NOT COMPLETED|BL to EOE-Test and BL to Switch-Control||117
10839183|NCT02269917|12004820|FG001|NOT COMPLETED|BL to EOE-Test and BL to Switch-Control||31
10839184|NCT02269917|12004821|FG002|NOT COMPLETED|BL to EOE-Test and BL to Switch-Control||0
10839185|NCT02269917|12004819|FG000|STARTED|Switch to D/C/F/TAF (Until EOE)||0
10839186|NCT02269917|12004820|FG001|STARTED|Switch to D/C/F/TAF (Until EOE)||0
10839187|NCT02269917|12004821|FG002|STARTED|Switch to D/C/F/TAF (Until EOE)||352
10839188|NCT02269917|12004819|FG000|COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
10839189|NCT02269917|12004820|FG001|COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
10839190|NCT02269917|12004821|FG002|COMPLETED|Switch to D/C/F/TAF (Until EOE)||314
10839191|NCT02269917|12004819|FG000|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
10839192|NCT02269917|12004820|FG001|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
10839193|NCT02269917|12004821|FG002|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||38
10839194|NCT02225366|12004832|FG000|STARTED|Overall Study||2
10839195|NCT02225366|12004833|FG001|STARTED|Overall Study||1
10839196|NCT02225366|12004832|FG000|COMPLETED|Overall Study||1
10839197|NCT02225366|12004833|FG001|COMPLETED|Overall Study||1
10839198|NCT02225366|12004832|FG000|NOT COMPLETED|Overall Study||1
10839199|NCT02225366|12004833|FG001|NOT COMPLETED|Overall Study||0
10839200|NCT01530997|12004839|FG000|STARTED|Overall Study||45
10839201|NCT01530997|12004839|FG000|COMPLETED|Overall Study||43
10839202|NCT01530997|12004839|FG000|NOT COMPLETED|Overall Study||2
10839203|NCT01109004|12004853|FG000|STARTED|Overall Study||247
10839204|NCT01109004|12004854|FG001|STARTED|Overall Study||254
10839205|NCT01109004|12004855|FG002|STARTED|Overall Study||257
10839206|NCT01109004|12004853|FG000|COMPLETED|Overall Study||247
10839207|NCT01109004|12004854|FG001|COMPLETED|Overall Study||254
10839208|NCT01109004|12004855|FG002|COMPLETED|Overall Study||257
10410588|NCT00762970|11554623|FG001|STARTED|Overall Study||44
10410589|NCT00762970|11554624|FG002|STARTED|Overall Study||47
10410590|NCT00762970|11554622|FG000|COMPLETED|Overall Study||34
10410591|NCT00762970|11554623|FG001|COMPLETED|Overall Study||35
10410592|NCT00762970|11554624|FG002|COMPLETED|Overall Study||46
10410593|NCT00762970|11554622|FG000|NOT COMPLETED|Overall Study||12
10410594|NCT00762970|11554623|FG001|NOT COMPLETED|Overall Study||9
10410595|NCT00762970|11554624|FG002|NOT COMPLETED|Overall Study||1
10410596|NCT00762996|11554632|FG000|STARTED|Period One||15
10410597|NCT00762996|11554633|FG001|STARTED|Period One||16
10410598|NCT00762996|11554634|FG002|STARTED|Period One||17
10410599|NCT00762996|11554635|FG003|STARTED|Period One||17
10410600|NCT00762996|11554632|FG000|COMPLETED|Period One||15
10410601|NCT00762996|11554633|FG001|COMPLETED|Period One||16
10410602|NCT00762996|11554634|FG002|COMPLETED|Period One||13
10410603|NCT00762996|11554635|FG003|COMPLETED|Period One||16
10410604|NCT00762996|11554632|FG000|NOT COMPLETED|Period One||0
10410605|NCT00762996|11554633|FG001|NOT COMPLETED|Period One||0
10410606|NCT00762996|11554634|FG002|NOT COMPLETED|Period One||4
10410607|NCT00762996|11554635|FG003|NOT COMPLETED|Period One||1
10410608|NCT00762996|11554632|FG000|STARTED|Period Two||15
10410609|NCT00762996|11554633|FG001|STARTED|Period Two||16
10410610|NCT00762996|11554634|FG002|STARTED|Period Two||13
10410611|NCT00762996|11554635|FG003|STARTED|Period Two||16
10410612|NCT00762996|11554632|FG000|COMPLETED|Period Two||15
10410613|NCT00762996|11554633|FG001|COMPLETED|Period Two||16
10410614|NCT00762996|11554634|FG002|COMPLETED|Period Two||13
10410615|NCT00762996|11554635|FG003|COMPLETED|Period Two||16
10410616|NCT00762996|11554632|FG000|NOT COMPLETED|Period Two||0
10410617|NCT00762996|11554633|FG001|NOT COMPLETED|Period Two||0
10410618|NCT00762996|11554634|FG002|NOT COMPLETED|Period Two||0
10410619|NCT00762996|11554635|FG003|NOT COMPLETED|Period Two||0
10410620|NCT00763035|11554643|FG000|STARTED|First Intervention||10
10410621|NCT00763035|11554644|FG001|STARTED|First Intervention||4
10410622|NCT00763035|11554643|FG000|COMPLETED|First Intervention||9
10410623|NCT00763035|11554644|FG001|COMPLETED|First Intervention||3
10410624|NCT00763035|11554643|FG000|NOT COMPLETED|First Intervention||1
10410625|NCT00763035|11554644|FG001|NOT COMPLETED|First Intervention||1
10410626|NCT00763035|11554643|FG000|STARTED|Second Intervention||9
10410627|NCT00763035|11554644|FG001|STARTED|Second Intervention||3
10410628|NCT00763035|11554643|FG000|COMPLETED|Second Intervention||6
10410629|NCT00763035|11554644|FG001|COMPLETED|Second Intervention||3
10410630|NCT00763035|11554643|FG000|NOT COMPLETED|Second Intervention||3
10410631|NCT00763035|11554644|FG001|NOT COMPLETED|Second Intervention||0
10410632|NCT00763048|11554652|FG000|STARTED|Overall Study||21
10410633|NCT00763048|11554653|FG001|STARTED|Overall Study||18
10410634|NCT00763048|11554652|FG000|COMPLETED|Overall Study||21
10410635|NCT00763048|11554653|FG001|COMPLETED|Overall Study||18
10410636|NCT00763048|11554652|FG000|NOT COMPLETED|Overall Study||0
10410637|NCT00763048|11554653|FG001|NOT COMPLETED|Overall Study||0
10410638|NCT00763061|11554661|FG000|STARTED|Overall Study||54
10410639|NCT00763061|11554662|FG001|STARTED|Overall Study||57
10410640|NCT00763061|11554661|FG000|COMPLETED|Overall Study||49
10410641|NCT00763061|11554662|FG001|COMPLETED|Overall Study||44
10410642|NCT00763061|11554661|FG000|NOT COMPLETED|Overall Study||5
10545021|NCT01493687|11698239|FG001|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||22
10545022|NCT01493687|11698238|FG000|STARTED|Part B Long Term Active Control 40 Weeks|414 completed Part A. Then 2 discontinued (lack of efficacy, subject request) prior to Part B.|412
10545023|NCT01493687|11698239|FG001|STARTED|Part B Long Term Active Control 40 Weeks||210
10545024|NCT01493687|11698238|FG000|COMPLETED|Part B Long Term Active Control 40 Weeks||351
10545025|NCT01493687|11698239|FG001|COMPLETED|Part B Long Term Active Control 40 Weeks||175
10545026|NCT01493687|11698238|FG000|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||61
10545027|NCT01493687|11698239|FG001|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||35
10548295|NCT01518699|11702087|FG002|COMPLETED|Period 3||9
10548296|NCT01518699|11702088|FG003|COMPLETED|Period 3||10
10839209|NCT01109004|12004853|FG000|NOT COMPLETED|Overall Study||0
10839210|NCT01109004|12004854|FG001|NOT COMPLETED|Overall Study||0
10839211|NCT01109004|12004855|FG002|NOT COMPLETED|Overall Study||0
10839212|NCT01067521|12004865|FG000|STARTED|Double-Blind Placebo-Controlled Period||943
10839213|NCT01067521|12004866|FG001|STARTED|Double-Blind Placebo-Controlled Period||461
10839214|NCT01067521|12004865|FG000|COMPLETED|Double-Blind Placebo-Controlled Period||859
10839215|NCT01067521|12004866|FG001|COMPLETED|Double-Blind Placebo-Controlled Period||430
10839216|NCT01067521|12004865|FG000|NOT COMPLETED|Double-Blind Placebo-Controlled Period||84
10839217|NCT01067521|12004866|FG001|NOT COMPLETED|Double-Blind Placebo-Controlled Period||31
10839218|NCT01067521|12004865|FG000|STARTED|Open-Label Period|Some participants did not continue into the open-label period.|834
10839219|NCT01067521|12004866|FG001|STARTED|Open-Label Period|Some participants did not continue into the open-label period.|419
10839220|NCT01067521|12004865|FG000|COMPLETED|Open-Label Period||580
10839221|NCT01067521|12004866|FG001|COMPLETED|Open-Label Period||261
10839222|NCT01067521|12004865|FG000|NOT COMPLETED|Open-Label Period||254
10839223|NCT01067521|12004866|FG001|NOT COMPLETED|Open-Label Period||158
10839224|NCT01047319|12004880|FG000|STARTED|Overall Study||345
10839225|NCT01047319|12004881|FG001|STARTED|Overall Study||350
10839226|NCT01047319|12004882|FG002|STARTED|Overall Study||352
10839227|NCT01047319|12004880|FG000|COMPLETED|Overall Study||0
10839228|NCT01047319|12004881|FG001|COMPLETED|Overall Study||0
10839229|NCT01047319|12004882|FG002|COMPLETED|Overall Study||0
10839230|NCT01047319|12004880|FG000|NOT COMPLETED|Overall Study||345
10839231|NCT01047319|12004881|FG001|NOT COMPLETED|Overall Study||350
10839232|NCT01047319|12004882|FG002|NOT COMPLETED|Overall Study||352
10839233|NCT00988052|12004892|FG000|STARTED|Overall Study||423
10839234|NCT00988052|12004893|FG001|STARTED|Overall Study||416
10839235|NCT00988052|12004892|FG000|COMPLETED|Overall Study||0
10839236|NCT00988052|12004893|FG001|COMPLETED|Overall Study||0
10839237|NCT00988052|12004892|FG000|NOT COMPLETED|Overall Study||423
10839238|NCT00988052|12004893|FG001|NOT COMPLETED|Overall Study||416
10839239|NCT02021773|12004902|FG000|STARTED|Overall Study||89
10839240|NCT02021773|12004903|FG001|STARTED|Overall Study||88
10839241|NCT02021773|12004904|FG002|STARTED|Overall Study||87
10410643|NCT00763061|11554662|FG001|NOT COMPLETED|Overall Study||13
10410644|NCT00763139|11554668|FG000|STARTED|Overall Study||17
10410645|NCT00763139|11554669|FG001|STARTED|Overall Study||17
10410646|NCT00763139|11554668|FG000|COMPLETED|Overall Study||12
10410647|NCT00763139|11554669|FG001|COMPLETED|Overall Study||14
10410648|NCT00763139|11554668|FG000|NOT COMPLETED|Overall Study||5
10410649|NCT00763139|11554669|FG001|NOT COMPLETED|Overall Study||3
10410650|NCT00763243|11554680|FG000|STARTED|Waiting Period||9
10410651|NCT00763243|11554680|FG000|COMPLETED|Waiting Period||9
10410652|NCT00763243|11554680|FG000|NOT COMPLETED|Waiting Period||0
10410653|NCT00763243|11554680|FG000|STARTED|Training Period||9
10410654|NCT00763243|11554680|FG000|COMPLETED|Training Period||9
10410655|NCT00763243|11554680|FG000|NOT COMPLETED|Training Period||0
10410656|NCT00763243|11554680|FG000|STARTED|1-Month Follow-Up Period||9
10410657|NCT00763243|11554680|FG000|COMPLETED|1-Month Follow-Up Period||9
10410658|NCT00763243|11554680|FG000|NOT COMPLETED|1-Month Follow-Up Period||0
10410659|NCT00763243|11554680|FG000|STARTED|6-Month Follow-Up Period||9
10410660|NCT00763243|11554680|FG000|COMPLETED|6-Month Follow-Up Period||9
10410661|NCT00763243|11554680|FG000|NOT COMPLETED|6-Month Follow-Up Period||0
10410662|NCT00763256|11554694|FG000|STARTED|Overall Study||15
10410663|NCT00763256|11554695|FG001|STARTED|Overall Study||18
10410664|NCT00763256|11554694|FG000|COMPLETED|Overall Study||8
10410665|NCT00763256|11554695|FG001|COMPLETED|Overall Study||8
10410666|NCT00763256|11554694|FG000|NOT COMPLETED|Overall Study||7
10754433|NCT03052751|11918172|FG004|STARTED|Dosing Period 2||10
10754434|NCT03052751|11918173|FG005|STARTED|Dosing Period 2||10
10754435|NCT03052751|11918168|FG000|COMPLETED|Dosing Period 2||0
10754436|NCT03052751|11918169|FG001|COMPLETED|Dosing Period 2||0
10754437|NCT03052751|11918170|FG002|COMPLETED|Dosing Period 2||8
10754438|NCT03052751|11918171|FG003|COMPLETED|Dosing Period 2||11
10410667|NCT00763256|11554695|FG001|NOT COMPLETED|Overall Study||10
10410668|NCT00763269|11554703|FG000|STARTED|Overall Study||314
10754439|NCT03052751|11918172|FG004|COMPLETED|Dosing Period 2||10
10754440|NCT03052751|11918173|FG005|COMPLETED|Dosing Period 2||10
10754441|NCT03052751|11918168|FG000|NOT COMPLETED|Dosing Period 2||0
10754442|NCT03052751|11918169|FG001|NOT COMPLETED|Dosing Period 2||0
10754443|NCT03052751|11918170|FG002|NOT COMPLETED|Dosing Period 2||3
10754444|NCT03052751|11918171|FG003|NOT COMPLETED|Dosing Period 2||0
10754445|NCT03052751|11918172|FG004|NOT COMPLETED|Dosing Period 2||0
10754446|NCT03052751|11918173|FG005|NOT COMPLETED|Dosing Period 2||0
10754447|NCT03052751|11918168|FG000|STARTED|Observation Period||22
10754448|NCT03052751|11918169|FG001|STARTED|Observation Period||21
10754449|NCT03052751|11918170|FG002|STARTED|Observation Period||11
10754450|NCT03052751|11918171|FG003|STARTED|Observation Period||11
10754451|NCT03052751|11918172|FG004|STARTED|Observation Period||10
10754452|NCT03052751|11918173|FG005|STARTED|Observation Period||10
10754453|NCT03052751|11918168|FG000|COMPLETED|Observation Period||22
10754454|NCT03052751|11918169|FG001|COMPLETED|Observation Period||21
10754455|NCT03052751|11918170|FG002|COMPLETED|Observation Period||11
10754456|NCT03052751|11918171|FG003|COMPLETED|Observation Period||11
10754457|NCT03052751|11918172|FG004|COMPLETED|Observation Period||9
10754458|NCT03052751|11918173|FG005|COMPLETED|Observation Period||10
10754459|NCT03052751|11918168|FG000|NOT COMPLETED|Observation Period||0
10754460|NCT03052751|11918169|FG001|NOT COMPLETED|Observation Period||0
10754461|NCT03052751|11918170|FG002|NOT COMPLETED|Observation Period||0
10754462|NCT03052751|11918171|FG003|NOT COMPLETED|Observation Period||0
10754463|NCT03052751|11918172|FG004|NOT COMPLETED|Observation Period||1
10839242|NCT02021773|12004902|FG000|Safety Analysis Set|Overall Study||89
10839243|NCT02021773|12004903|FG001|Safety Analysis Set|Overall Study||88
10839244|NCT02021773|12004904|FG002|Safety Analysis Set|Overall Study||86
10839245|NCT02021773|12004902|FG000|Intent-to-treat (ITT)|Overall Study||89
10839246|NCT02021773|12004903|FG001|Intent-to-treat (ITT)|Overall Study||87
10839247|NCT02021773|12004904|FG002|Intent-to-treat (ITT)|Overall Study||85
10839248|NCT02021773|12004902|FG000|COMPLETED|Overall Study||77
10839249|NCT02021773|12004903|FG001|COMPLETED|Overall Study||72
10839250|NCT02021773|12004904|FG002|COMPLETED|Overall Study||76
10839251|NCT02021773|12004902|FG000|NOT COMPLETED|Overall Study||12
10839252|NCT02021773|12004903|FG001|NOT COMPLETED|Overall Study||16
10839253|NCT02021773|12004904|FG002|NOT COMPLETED|Overall Study||11
10754464|NCT03052751|11918173|FG005|NOT COMPLETED|Observation Period||0
10754465|NCT03052764|11918185|FG000|STARTED|Double-Blind Treatment Period||80
10754466|NCT03052764|11918186|FG001|STARTED|Double-Blind Treatment Period||40
10754467|NCT03052764|11918185|FG000|mITT|Double-Blind Treatment Period||78
10754468|NCT03052764|11918186|FG001|mITT|Double-Blind Treatment Period||39
10754469|NCT03052764|11918185|FG000|COMPLETED|Double-Blind Treatment Period||70
10754470|NCT03052764|11918186|FG001|COMPLETED|Double-Blind Treatment Period||37
10754471|NCT03052764|11918185|FG000|NOT COMPLETED|Double-Blind Treatment Period||10
10754472|NCT03052764|11918186|FG001|NOT COMPLETED|Double-Blind Treatment Period||3
10754473|NCT03052764|11918185|FG000|STARTED|Open-Label Re-Treatment Period||58
10754474|NCT03052764|11918186|FG001|STARTED|Open-Label Re-Treatment Period||33
10754475|NCT03052764|11918185|FG000|COMPLETED|Open-Label Re-Treatment Period||58
10754476|NCT03052764|11918186|FG001|COMPLETED|Open-Label Re-Treatment Period||33
10754477|NCT03052764|11918185|FG000|NOT COMPLETED|Open-Label Re-Treatment Period||0
10754478|NCT03052764|11918186|FG001|NOT COMPLETED|Open-Label Re-Treatment Period||0
10754479|NCT03052816|11918196|FG000|STARTED|Overall Study||33
10754480|NCT03052816|11918197|FG001|STARTED|Overall Study||33
10754481|NCT03052816|11918196|FG000|COMPLETED|Overall Study||30
10754482|NCT03052816|11918197|FG001|COMPLETED|Overall Study||33
10754483|NCT03052816|11918196|FG000|NOT COMPLETED|Overall Study||3
10754484|NCT03052816|11918197|FG001|NOT COMPLETED|Overall Study||0
10754485|NCT03052959|11918207|FG000|STARTED|Overall Study||59
10754486|NCT03052959|11918208|FG001|STARTED|Overall Study||66
10754487|NCT03052959|11918207|FG000|COMPLETED|Overall Study||55
10754488|NCT03052959|11918208|FG001|COMPLETED|Overall Study||61
10754489|NCT03052959|11918207|FG000|NOT COMPLETED|Overall Study||4
10754490|NCT03052959|11918208|FG001|NOT COMPLETED|Overall Study||5
10754491|NCT03052972|11918217|FG000|STARTED|Overall Study||18
10754492|NCT03052972|11918218|FG001|STARTED|Overall Study||5
10754493|NCT03052972|11918217|FG000|COMPLETED|Overall Study||18
10754494|NCT03052972|11918218|FG001|COMPLETED|Overall Study||5
10754495|NCT03052972|11918217|FG000|NOT COMPLETED|Overall Study||0
10754496|NCT03052972|11918218|FG001|NOT COMPLETED|Overall Study||0
10754497|NCT03053050|11918228|FG000|STARTED|Randomized Phase||324
10754498|NCT03053050|11918229|FG001|STARTED|Randomized Phase||323
10754499|NCT03053050|11918230|FG002|STARTED|Randomized Phase||161
10754500|NCT03053050|11918231|FG003|STARTED|Randomized Phase||0
10754501|NCT03053050|11918228|FG000|COMPLETED|Randomized Phase||0
10754502|NCT03053050|11918229|FG001|COMPLETED|Randomized Phase||0
10754503|NCT03053050|11918230|FG002|COMPLETED|Randomized Phase||0
10754504|NCT03053050|11918231|FG003|COMPLETED|Randomized Phase||0
10754505|NCT03053050|11918228|FG000|NOT COMPLETED|Randomized Phase||324
10754506|NCT03053050|11918229|FG001|NOT COMPLETED|Randomized Phase||323
10754507|NCT03053050|11918230|FG002|NOT COMPLETED|Randomized Phase||161
10754508|NCT03053050|11918231|FG003|NOT COMPLETED|Randomized Phase||0
10754509|NCT03053050|11918228|FG000|STARTED|Open-label Phase||0
10754510|NCT03053050|11918229|FG001|STARTED|Open-label Phase||0
10754511|NCT03053050|11918230|FG002|STARTED|Open-label Phase||0
10754512|NCT03053050|11918231|FG003|STARTED|Open-label Phase|Participants with hepatic clinical event or progression to cirrhosis had option to go into OL Phase.|99
10754513|NCT03053050|11918228|FG000|COMPLETED|Open-label Phase||0
10754514|NCT03053050|11918229|FG001|COMPLETED|Open-label Phase||0
10754515|NCT03053050|11918230|FG002|COMPLETED|Open-label Phase||0
10754516|NCT03053050|11918231|FG003|COMPLETED|Open-label Phase||0
10754517|NCT03053050|11918228|FG000|NOT COMPLETED|Open-label Phase||0
10754518|NCT03053050|11918229|FG001|NOT COMPLETED|Open-label Phase||0
10754519|NCT03053050|11918230|FG002|NOT COMPLETED|Open-label Phase||0
10754520|NCT03053050|11918231|FG003|NOT COMPLETED|Open-label Phase||99
10754521|NCT03053063|11918243|FG000|STARTED|Randomized Phase||355
10754522|NCT03053063|11918244|FG001|STARTED|Randomized Phase||354
10754523|NCT03053063|11918245|FG002|STARTED|Randomized Phase||174
10754524|NCT03053063|11918246|FG003|STARTED|Randomized Phase||0
10754525|NCT03053063|11918243|FG000|COMPLETED|Randomized Phase||0
10754526|NCT03053063|11918244|FG001|COMPLETED|Randomized Phase||0
10754527|NCT03053063|11918245|FG002|COMPLETED|Randomized Phase||0
10754528|NCT03053063|11918246|FG003|COMPLETED|Randomized Phase||0
10754529|NCT03053063|11918243|FG000|NOT COMPLETED|Randomized Phase||355
10754530|NCT03053063|11918244|FG001|NOT COMPLETED|Randomized Phase||354
10754531|NCT03053063|11918245|FG002|NOT COMPLETED|Randomized Phase||174
10754532|NCT03053063|11918246|FG003|NOT COMPLETED|Randomized Phase||0
10754533|NCT03053063|11918243|FG000|STARTED|Open-Label Phase||0
10754534|NCT03053063|11918244|FG001|STARTED|Open-Label Phase||0
10754535|NCT03053063|11918245|FG002|STARTED|Open-Label Phase||0
10754536|NCT03053063|11918246|FG003|STARTED|Open-Label Phase|Participants who experienced a hepatic clinical event had the option to roll over into the OL Phase.|23
10754537|NCT03053063|11918243|FG000|COMPLETED|Open-Label Phase||0
10839254|NCT04689932|12004912|FG000|STARTED|Overall Study||12
10839255|NCT04689932|12004912|FG000|COMPLETED|Overall Study||12
10839256|NCT04689932|12004912|FG000|NOT COMPLETED|Overall Study||0
10839257|NCT04635579|12004919|FG000|STARTED|Overall Study||20
10839258|NCT04635579|12004920|FG001|STARTED|Overall Study||20
10839259|NCT04635579|12004919|FG000|COMPLETED|Overall Study||20
10839260|NCT04635579|12004920|FG001|COMPLETED|Overall Study||20
10839261|NCT04635579|12004919|FG000|NOT COMPLETED|Overall Study||0
10839262|NCT04635579|12004920|FG001|NOT COMPLETED|Overall Study||0
10839263|NCT04553406|12004928|FG000|STARTED|Overall Study||1
10839264|NCT04553406|12004929|FG001|STARTED|Overall Study||1
10839265|NCT04553406|12004928|FG000|COMPLETED|Overall Study||1
10839266|NCT04553406|12004929|FG001|COMPLETED|Overall Study||0
10839267|NCT04553406|12004928|FG000|NOT COMPLETED|Overall Study||0
10839268|NCT04553406|12004929|FG001|NOT COMPLETED|Overall Study||1
10839269|NCT03792750|12004935|FG000|STARTED|Overall Study||12
10839270|NCT03792750|12004935|FG000|COMPLETED|Overall Study||9
10839271|NCT03792750|12004935|FG000|NOT COMPLETED|Overall Study||3
10839272|NCT03739593|12004943|FG000|STARTED|Overall Study||5
10839273|NCT03739593|12004944|FG001|STARTED|Overall Study||22
10839274|NCT03739593|12004945|FG002|STARTED|Overall Study||22
10839275|NCT03739593|12004943|FG000|COMPLETED|Overall Study||2
10839276|NCT03739593|12004944|FG001|COMPLETED|Overall Study||16
10839277|NCT03739593|12004945|FG002|COMPLETED|Overall Study||14
10839278|NCT03739593|12004943|FG000|NOT COMPLETED|Overall Study||3
10839279|NCT03739593|12004944|FG001|NOT COMPLETED|Overall Study||6
10839280|NCT03739593|12004945|FG002|NOT COMPLETED|Overall Study||8
10839281|NCT03739138|12004956|FG000|STARTED|Overall Study||0
10839282|NCT03739138|12004957|FG001|STARTED|Overall Study||7
10839283|NCT03739138|12004958|FG002|STARTED|Overall Study||5
10839284|NCT03739138|12004959|FG003|STARTED|Overall Study||18
10839285|NCT03739138|12004960|FG004|STARTED|Overall Study||0
10839286|NCT03739138|12004956|FG000|COMPLETED|Overall Study||0
10839287|NCT03739138|12004957|FG001|COMPLETED|Overall Study||0
10839288|NCT03739138|12004958|FG002|COMPLETED|Overall Study||0
10839289|NCT03739138|12004959|FG003|COMPLETED|Overall Study||0
10839290|NCT03739138|12004960|FG004|COMPLETED|Overall Study||0
10839291|NCT03739138|12004956|FG000|NOT COMPLETED|Overall Study||0
10839292|NCT03739138|12004957|FG001|NOT COMPLETED|Overall Study||7
10839293|NCT03739138|12004958|FG002|NOT COMPLETED|Overall Study||5
10839294|NCT03739138|12004959|FG003|NOT COMPLETED|Overall Study||18
10839295|NCT03739138|12004960|FG004|NOT COMPLETED|Overall Study||0
10839312|NCT03468309|12004980|FG000|STARTED|Overall Study||53
10839313|NCT03468309|12004980|FG000|COMPLETED|Overall Study||47
10839314|NCT03468309|12004980|FG000|NOT COMPLETED|Overall Study||6
10839315|NCT03347123|12004986|FG000|STARTED|Overall Study||5
10839316|NCT03347123|12004987|FG001|STARTED|Overall Study||6
10839317|NCT03347123|12004988|FG002|STARTED|Overall Study||0
10839318|NCT03347123|12004989|FG003|STARTED|Overall Study||0
10839319|NCT03347123|12004990|FG004|STARTED|Overall Study||0
10839320|NCT03347123|12004991|FG005|STARTED|Overall Study||0
10839321|NCT03347123|12004992|FG006|STARTED|Overall Study||0
10839322|NCT03347123|12004986|FG000|COMPLETED|Overall Study||0
10839323|NCT03347123|12004987|FG001|COMPLETED|Overall Study||0
10839324|NCT03347123|12004988|FG002|COMPLETED|Overall Study||0
10839325|NCT03347123|12004989|FG003|COMPLETED|Overall Study||0
10839326|NCT03347123|12004990|FG004|COMPLETED|Overall Study||0
10839327|NCT03347123|12004991|FG005|COMPLETED|Overall Study||0
10839328|NCT03347123|12004992|FG006|COMPLETED|Overall Study||0
10839329|NCT03347123|12004986|FG000|NOT COMPLETED|Overall Study||5
10839330|NCT03347123|12004987|FG001|NOT COMPLETED|Overall Study||6
10839331|NCT03347123|12004988|FG002|NOT COMPLETED|Overall Study||0
10839332|NCT03347123|12004989|FG003|NOT COMPLETED|Overall Study||0
10839333|NCT03347123|12004990|FG004|NOT COMPLETED|Overall Study||0
10839334|NCT03347123|12004991|FG005|NOT COMPLETED|Overall Study||0
10839335|NCT03347123|12004992|FG006|NOT COMPLETED|Overall Study||0
10839336|NCT03318523|12005007|FG000|STARTED|PC Period: Up to Year 1||100
10839337|NCT03318523|12005008|FG001|STARTED|PC Period: Up to Year 1||55
10839338|NCT03318523|12005009|FG002|STARTED|PC Period: Up to Year 1||102
10839339|NCT03318523|12005010|FG003|STARTED|PC Period: Up to Year 1||100
10839340|NCT03318523|12005011|FG004|STARTED|PC Period: Up to Year 1||0
10839341|NCT03318523|12005012|FG005|STARTED|PC Period: Up to Year 1||0
10839342|NCT03318523|12005013|FG006|STARTED|PC Period: Up to Year 1||0
10839343|NCT03318523|12005014|FG007|STARTED|PC Period: Up to Year 1||0
10839344|NCT03318523|12005015|FG008|STARTED|PC Period: Up to Year 1||0
10839345|NCT03318523|12005016|FG009|STARTED|PC Period: Up to Year 1||0
10839346|NCT03318523|12005007|FG000|COMPLETED|PC Period: Up to Year 1||96
10839347|NCT03318523|12005008|FG001|COMPLETED|PC Period: Up to Year 1||53
10839348|NCT03318523|12005009|FG002|COMPLETED|PC Period: Up to Year 1||100
10839349|NCT03318523|12005010|FG003|COMPLETED|PC Period: Up to Year 1||96
10839350|NCT03318523|12005011|FG004|COMPLETED|PC Period: Up to Year 1||0
10839351|NCT03318523|12005012|FG005|COMPLETED|PC Period: Up to Year 1||0
10839352|NCT03318523|12005013|FG006|COMPLETED|PC Period: Up to Year 1||0
10839353|NCT03318523|12005014|FG007|COMPLETED|PC Period: Up to Year 1||0
10839354|NCT03318523|12005015|FG008|COMPLETED|PC Period: Up to Year 1||0
10839355|NCT03318523|12005016|FG009|COMPLETED|PC Period: Up to Year 1||0
10839356|NCT03318523|12005007|FG000|NOT COMPLETED|PC Period: Up to Year 1||4
10839357|NCT03318523|12005008|FG001|NOT COMPLETED|PC Period: Up to Year 1||2
10839358|NCT03318523|12005009|FG002|NOT COMPLETED|PC Period: Up to Year 1||2
10839359|NCT03318523|12005010|FG003|NOT COMPLETED|PC Period: Up to Year 1||4
10839360|NCT03318523|12005011|FG004|NOT COMPLETED|PC Period: Up to Year 1||0
10839361|NCT03318523|12005012|FG005|NOT COMPLETED|PC Period: Up to Year 1||0
10839362|NCT03318523|12005013|FG006|NOT COMPLETED|PC Period: Up to Year 1||0
10839363|NCT03318523|12005014|FG007|NOT COMPLETED|PC Period: Up to Year 1||0
10839364|NCT03318523|12005015|FG008|NOT COMPLETED|PC Period: Up to Year 1||0
10839365|NCT03318523|12005016|FG009|NOT COMPLETED|PC Period: Up to Year 1||0
10839366|NCT03318523|12005007|FG000|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10839367|NCT03318523|12005008|FG001|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10839368|NCT03318523|12005009|FG002|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10839369|NCT03318523|12005010|FG003|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10839370|NCT03318523|12005011|FG004|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||20
10839371|NCT03318523|12005012|FG005|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||37
10839372|NCT03318523|12005013|FG006|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||39
10839373|NCT03318523|12005014|FG007|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||52
10839374|NCT03318523|12005015|FG008|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||100
10839375|NCT03318523|12005016|FG009|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||96
10839376|NCT03318523|12005007|FG000|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10839377|NCT03318523|12005008|FG001|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10839378|NCT03318523|12005009|FG002|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10839379|NCT03318523|12005010|FG003|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10839380|NCT03318523|12005011|FG004|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||20
10839381|NCT03318523|12005012|FG005|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||37
10839382|NCT03318523|12005013|FG006|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||39
10839383|NCT03318523|12005014|FG007|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||52
10839384|NCT03318523|12005015|FG008|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||100
10839385|NCT03318523|12005016|FG009|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||94
10839386|NCT03318523|12005007|FG000|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10839387|NCT03318523|12005008|FG001|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10839388|NCT03318523|12005009|FG002|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10839389|NCT03318523|12005010|FG003|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10839390|NCT03318523|12005011|FG004|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10839391|NCT03318523|12005012|FG005|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10839392|NCT03318523|12005013|FG006|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10839393|NCT03318523|12005014|FG007|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10839394|NCT03318523|12005015|FG008|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10839395|NCT03318523|12005016|FG009|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10839396|NCT03318523|12005007|FG000|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10839397|NCT03318523|12005008|FG001|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10839398|NCT03318523|12005009|FG002|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10839399|NCT03318523|12005010|FG003|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10839400|NCT03318523|12005011|FG004|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||20
10839401|NCT03318523|12005012|FG005|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||37
10839402|NCT03318523|12005013|FG006|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||39
10839403|NCT03318523|12005014|FG007|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||52
10839404|NCT03318523|12005015|FG008|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||100
10839405|NCT03318523|12005016|FG009|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||96
10839406|NCT02906020|12005050|FG000|STARTED|Part 1: Dose Escalation Period||4
10839407|NCT02906020|12005051|FG001|STARTED|Part 1: Dose Escalation Period||4
10839408|NCT02906020|12005052|FG002|STARTED|Part 1: Dose Escalation Period||5
10839409|NCT02906020|12005053|FG003|STARTED|Part 1: Dose Escalation Period||4
10839410|NCT02906020|12005054|FG004|STARTED|Part 1: Dose Escalation Period||3
10839411|NCT02906020|12005055|FG005|STARTED|Part 1: Dose Escalation Period||3
10839412|NCT02906020|12005056|FG006|STARTED|Part 1: Dose Escalation Period||3
10839413|NCT02906020|12005057|FG007|STARTED|Part 1: Dose Escalation Period||3
10839414|NCT02906020|12005058|FG008|STARTED|Part 1: Dose Escalation Period||0
10839415|NCT02906020|12005059|FG009|STARTED|Part 1: Dose Escalation Period||0
10839416|NCT02906020|12005060|FG010|STARTED|Part 1: Dose Escalation Period||0
10839417|NCT02906020|12005061|FG011|STARTED|Part 1: Dose Escalation Period||0
10839418|NCT02906020|12005062|FG012|STARTED|Part 1: Dose Escalation Period||0
10839419|NCT02906020|12005063|FG013|STARTED|Part 1: Dose Escalation Period||0
10839420|NCT02906020|12005064|FG014|STARTED|Part 1: Dose Escalation Period||0
10839421|NCT02906020|12005065|FG015|STARTED|Part 1: Dose Escalation Period||0
10839422|NCT02906020|12005050|FG000|Treated|Part 1: Dose Escalation Period||4
10839423|NCT02906020|12005051|FG001|Treated|Part 1: Dose Escalation Period||4
10839424|NCT02906020|12005052|FG002|Treated|Part 1: Dose Escalation Period||5
10839425|NCT02906020|12005053|FG003|Treated|Part 1: Dose Escalation Period||4
10839426|NCT02906020|12005054|FG004|Treated|Part 1: Dose Escalation Period||3
10839427|NCT02906020|12005055|FG005|Treated|Part 1: Dose Escalation Period||3
10839428|NCT02906020|12005056|FG006|Treated|Part 1: Dose Escalation Period||3
10839429|NCT02906020|12005057|FG007|Treated|Part 1: Dose Escalation Period||3
10839430|NCT02906020|12005058|FG008|Treated|Part 1: Dose Escalation Period||0
10839431|NCT02906020|12005059|FG009|Treated|Part 1: Dose Escalation Period||0
10839432|NCT02906020|12005060|FG010|Treated|Part 1: Dose Escalation Period||0
10839433|NCT02906020|12005061|FG011|Treated|Part 1: Dose Escalation Period||0
10839434|NCT02906020|12005062|FG012|Treated|Part 1: Dose Escalation Period||0
10839435|NCT02906020|12005063|FG013|Treated|Part 1: Dose Escalation Period||0
10839436|NCT02906020|12005064|FG014|Treated|Part 1: Dose Escalation Period||0
10839437|NCT02906020|12005065|FG015|Treated|Part 1: Dose Escalation Period||0
10839438|NCT02906020|12005050|FG000|COMPLETED|Part 1: Dose Escalation Period||4
10839439|NCT02906020|12005051|FG001|COMPLETED|Part 1: Dose Escalation Period||3
10839440|NCT02906020|12005052|FG002|COMPLETED|Part 1: Dose Escalation Period||5
10839441|NCT02906020|12005053|FG003|COMPLETED|Part 1: Dose Escalation Period||3
10839442|NCT02906020|12005054|FG004|COMPLETED|Part 1: Dose Escalation Period||3
10839443|NCT02906020|12005055|FG005|COMPLETED|Part 1: Dose Escalation Period||3
10839444|NCT02906020|12005056|FG006|COMPLETED|Part 1: Dose Escalation Period||3
10839445|NCT02906020|12005057|FG007|COMPLETED|Part 1: Dose Escalation Period||3
10839446|NCT02906020|12005058|FG008|COMPLETED|Part 1: Dose Escalation Period||0
10839447|NCT02906020|12005059|FG009|COMPLETED|Part 1: Dose Escalation Period||0
10839448|NCT02906020|12005060|FG010|COMPLETED|Part 1: Dose Escalation Period||0
10839449|NCT02906020|12005061|FG011|COMPLETED|Part 1: Dose Escalation Period||0
10839450|NCT02906020|12005062|FG012|COMPLETED|Part 1: Dose Escalation Period||0
10839451|NCT02906020|12005063|FG013|COMPLETED|Part 1: Dose Escalation Period||0
10839452|NCT02906020|12005064|FG014|COMPLETED|Part 1: Dose Escalation Period||0
10839453|NCT02906020|12005065|FG015|COMPLETED|Part 1: Dose Escalation Period||0
10839454|NCT02906020|12005050|FG000|NOT COMPLETED|Part 1: Dose Escalation Period||0
10839455|NCT02906020|12005051|FG001|NOT COMPLETED|Part 1: Dose Escalation Period||1
10839456|NCT02906020|12005052|FG002|NOT COMPLETED|Part 1: Dose Escalation Period||0
10839457|NCT02906020|12005053|FG003|NOT COMPLETED|Part 1: Dose Escalation Period||1
10839458|NCT02906020|12005054|FG004|NOT COMPLETED|Part 1: Dose Escalation Period||0
10839459|NCT02906020|12005055|FG005|NOT COMPLETED|Part 1: Dose Escalation Period||0
10839460|NCT02906020|12005056|FG006|NOT COMPLETED|Part 1: Dose Escalation Period||0
10839461|NCT02906020|12005057|FG007|NOT COMPLETED|Part 1: Dose Escalation Period||0
10839462|NCT02906020|12005058|FG008|NOT COMPLETED|Part 1: Dose Escalation Period||0
10839463|NCT02906020|12005059|FG009|NOT COMPLETED|Part 1: Dose Escalation Period||0
10839464|NCT02906020|12005060|FG010|NOT COMPLETED|Part 1: Dose Escalation Period||0
10839465|NCT02906020|12005061|FG011|NOT COMPLETED|Part 1: Dose Escalation Period||0
10839466|NCT02906020|12005062|FG012|NOT COMPLETED|Part 1: Dose Escalation Period||0
10839467|NCT02906020|12005063|FG013|NOT COMPLETED|Part 1: Dose Escalation Period||0
10839468|NCT02906020|12005064|FG014|NOT COMPLETED|Part 1: Dose Escalation Period||0
10839469|NCT02906020|12005065|FG015|NOT COMPLETED|Part 1: Dose Escalation Period||0
10839470|NCT02906020|12005050|FG000|STARTED|Part 2: Double-blind Treatment Period||0
10839471|NCT02906020|12005051|FG001|STARTED|Part 2: Double-blind Treatment Period||0
10839472|NCT02906020|12005052|FG002|STARTED|Part 2: Double-blind Treatment Period||0
10839473|NCT02906020|12005053|FG003|STARTED|Part 2: Double-blind Treatment Period||0
10839474|NCT02906020|12005054|FG004|STARTED|Part 2: Double-blind Treatment Period||0
10839475|NCT02906020|12005055|FG005|STARTED|Part 2: Double-blind Treatment Period||0
10839476|NCT02906020|12005056|FG006|STARTED|Part 2: Double-blind Treatment Period||0
10839477|NCT02906020|12005057|FG007|STARTED|Part 2: Double-blind Treatment Period||0
10839478|NCT02906020|12005058|FG008|STARTED|Part 2: Double-blind Treatment Period||111
10839479|NCT02906020|12005059|FG009|STARTED|Part 2: Double-blind Treatment Period||110
10839480|NCT02906020|12005060|FG010|STARTED|Part 2: Double-blind Treatment Period||10
10839481|NCT02906020|12005061|FG011|STARTED|Part 2: Double-blind Treatment Period||13
10839482|NCT02906020|12005062|FG012|STARTED|Part 2: Double-blind Treatment Period||0
10839483|NCT02906020|12005063|FG013|STARTED|Part 2: Double-blind Treatment Period||0
10839484|NCT02906020|12005064|FG014|STARTED|Part 2: Double-blind Treatment Period||0
10839485|NCT02906020|12005065|FG015|STARTED|Part 2: Double-blind Treatment Period||0
10839486|NCT02906020|12005050|FG000|Treated|Part 2: Double-blind Treatment Period||0
10839487|NCT02906020|12005051|FG001|Treated|Part 2: Double-blind Treatment Period||0
10839488|NCT02906020|12005052|FG002|Treated|Part 2: Double-blind Treatment Period||0
10839489|NCT02906020|12005053|FG003|Treated|Part 2: Double-blind Treatment Period||0
10839490|NCT02906020|12005054|FG004|Treated|Part 2: Double-blind Treatment Period||0
10839491|NCT02906020|12005055|FG005|Treated|Part 2: Double-blind Treatment Period||0
10839492|NCT02906020|12005056|FG006|Treated|Part 2: Double-blind Treatment Period||0
10839493|NCT02906020|12005057|FG007|Treated|Part 2: Double-blind Treatment Period||0
10839494|NCT02906020|12005058|FG008|Treated|Part 2: Double-blind Treatment Period||111
10839495|NCT02906020|12005059|FG009|Treated|Part 2: Double-blind Treatment Period||110
10839496|NCT02906020|12005060|FG010|Treated|Part 2: Double-blind Treatment Period||10
10839497|NCT02906020|12005061|FG011|Treated|Part 2: Double-blind Treatment Period||13
10839498|NCT02906020|12005062|FG012|Treated|Part 2: Double-blind Treatment Period||0
10839499|NCT02906020|12005063|FG013|Treated|Part 2: Double-blind Treatment Period||0
10839500|NCT02906020|12005064|FG014|Treated|Part 2: Double-blind Treatment Period||0
10839501|NCT02906020|12005065|FG015|Treated|Part 2: Double-blind Treatment Period||0
10839502|NCT02906020|12005050|FG000|COMPLETED|Part 2: Double-blind Treatment Period||0
10292155|NCT02673333|11424936|FG000|NOT COMPLETED|Overall Study||0
10839503|NCT02906020|12005051|FG001|COMPLETED|Part 2: Double-blind Treatment Period||0
10839504|NCT02906020|12005052|FG002|COMPLETED|Part 2: Double-blind Treatment Period||0
10839505|NCT02906020|12005053|FG003|COMPLETED|Part 2: Double-blind Treatment Period||0
10839506|NCT02906020|12005054|FG004|COMPLETED|Part 2: Double-blind Treatment Period||0
10839507|NCT02906020|12005055|FG005|COMPLETED|Part 2: Double-blind Treatment Period||0
10839508|NCT02906020|12005056|FG006|COMPLETED|Part 2: Double-blind Treatment Period||0
10839509|NCT02906020|12005057|FG007|COMPLETED|Part 2: Double-blind Treatment Period||0
10839510|NCT02906020|12005058|FG008|COMPLETED|Part 2: Double-blind Treatment Period||99
10839511|NCT02906020|12005059|FG009|COMPLETED|Part 2: Double-blind Treatment Period||85
10839512|NCT02906020|12005060|FG010|COMPLETED|Part 2: Double-blind Treatment Period||10
10839513|NCT02906020|12005061|FG011|COMPLETED|Part 2: Double-blind Treatment Period||13
10839514|NCT02906020|12005062|FG012|COMPLETED|Part 2: Double-blind Treatment Period||0
10839515|NCT02906020|12005063|FG013|COMPLETED|Part 2: Double-blind Treatment Period||0
10839516|NCT02906020|12005064|FG014|COMPLETED|Part 2: Double-blind Treatment Period||0
10839517|NCT02906020|12005065|FG015|COMPLETED|Part 2: Double-blind Treatment Period||0
10839518|NCT02906020|12005050|FG000|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
10839519|NCT02906020|12005051|FG001|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
10839520|NCT02906020|12005052|FG002|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
10839521|NCT02906020|12005053|FG003|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
10839522|NCT02906020|12005054|FG004|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
10839523|NCT02906020|12005055|FG005|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
10839524|NCT02906020|12005056|FG006|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
10839525|NCT02906020|12005057|FG007|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
10292179|NCT01353118|11424964|FG000|STARTED|Overall Study||21
10292180|NCT01353118|11424965|FG001|STARTED|Overall Study||20
10292181|NCT01353118|11424964|FG000|COMPLETED|Overall Study||21
10292182|NCT01353118|11424965|FG001|COMPLETED|Overall Study||20
10292183|NCT01353118|11424964|FG000|NOT COMPLETED|Overall Study||0
10292184|NCT01353118|11424965|FG001|NOT COMPLETED|Overall Study||0
10292185|NCT01252953|11424973|FG000|STARTED|Overall Study||15225
10292186|NCT01252953|11424974|FG001|STARTED|Overall Study||15224
10292187|NCT01252953|11424973|FG000|COMPLETED|Overall Study||15187
10292188|NCT01252953|11424974|FG001|COMPLETED|Overall Study||15186
10292189|NCT01252953|11424973|FG000|NOT COMPLETED|Overall Study||38
10292190|NCT01252953|11424974|FG001|NOT COMPLETED|Overall Study||38
10292191|NCT01012609|11424983|FG000|STARTED|Overall Study||21
10292192|NCT01012609|11424984|FG001|STARTED|Overall Study||26
10292193|NCT01012609|11424983|FG000|COMPLETED|Overall Study||20
10292194|NCT01012609|11424984|FG001|COMPLETED|Overall Study||25
10292195|NCT01012609|11424983|FG000|NOT COMPLETED|Overall Study||1
10292196|NCT01012609|11424984|FG001|NOT COMPLETED|Overall Study||1
10839526|NCT02906020|12005058|FG008|NOT COMPLETED|Part 2: Double-blind Treatment Period||12
10839527|NCT02906020|12005059|FG009|NOT COMPLETED|Part 2: Double-blind Treatment Period||25
10410669|NCT00763269|11554704|FG001|STARTED|Overall Study||312
10410670|NCT00763269|11554703|FG000|COMPLETED|Overall Study||302
10410671|NCT00763269|11554704|FG001|COMPLETED|Overall Study||299
10410672|NCT00763269|11554703|FG000|NOT COMPLETED|Overall Study||12
10410673|NCT00763269|11554704|FG001|NOT COMPLETED|Overall Study||13
10429167|NCT00862849|11575287|FG001|COMPLETED|Intervention 3||3
10429168|NCT00862849|11575288|FG002|COMPLETED|Intervention 3||3
10429169|NCT00862849|11575289|FG003|COMPLETED|Intervention 3||4
10429170|NCT00862849|11575290|FG004|COMPLETED|Intervention 3||4
10429171|NCT00862849|11575291|FG005|COMPLETED|Intervention 3||3
10429172|NCT00862849|11575286|FG000|NOT COMPLETED|Intervention 3||0
10429173|NCT00862849|11575287|FG001|NOT COMPLETED|Intervention 3||0
10429174|NCT00862849|11575288|FG002|NOT COMPLETED|Intervention 3||0
10429175|NCT00862849|11575289|FG003|NOT COMPLETED|Intervention 3||0
10429176|NCT00862849|11575290|FG004|NOT COMPLETED|Intervention 3||0
10429177|NCT00862849|11575291|FG005|NOT COMPLETED|Intervention 3||0
10429178|NCT00862849|11575286|FG000|STARTED|Washout 3 (3 to 14 Days)||3
10429179|NCT00862849|11575287|FG001|STARTED|Washout 3 (3 to 14 Days)||3
10429180|NCT00862849|11575288|FG002|STARTED|Washout 3 (3 to 14 Days)||3
10429181|NCT00862849|11575289|FG003|STARTED|Washout 3 (3 to 14 Days)||4
10429182|NCT00862849|11575290|FG004|STARTED|Washout 3 (3 to 14 Days)||4
10429183|NCT00862849|11575291|FG005|STARTED|Washout 3 (3 to 14 Days)||3
10429184|NCT00862849|11575286|FG000|COMPLETED|Washout 3 (3 to 14 Days)||3
10429185|NCT00862849|11575287|FG001|COMPLETED|Washout 3 (3 to 14 Days)||3
10429186|NCT00862849|11575288|FG002|COMPLETED|Washout 3 (3 to 14 Days)||3
10429187|NCT00862849|11575289|FG003|COMPLETED|Washout 3 (3 to 14 Days)||4
10429188|NCT00862849|11575290|FG004|COMPLETED|Washout 3 (3 to 14 Days)||4
10429189|NCT00862849|11575291|FG005|COMPLETED|Washout 3 (3 to 14 Days)||3
10839528|NCT02906020|12005060|FG010|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
10839529|NCT02906020|12005061|FG011|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
10839530|NCT02906020|12005062|FG012|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
10839531|NCT02906020|12005063|FG013|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
10839532|NCT02906020|12005064|FG014|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
10839533|NCT02906020|12005065|FG015|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
10839534|NCT02906020|12005050|FG000|STARTED|Part 2: Long-term Follow-up Period||0
10839535|NCT02906020|12005051|FG001|STARTED|Part 2: Long-term Follow-up Period||0
10839536|NCT02906020|12005052|FG002|STARTED|Part 2: Long-term Follow-up Period||0
10839537|NCT02906020|12005053|FG003|STARTED|Part 2: Long-term Follow-up Period||0
10839538|NCT02906020|12005054|FG004|STARTED|Part 2: Long-term Follow-up Period||0
10839539|NCT02906020|12005055|FG005|STARTED|Part 2: Long-term Follow-up Period||0
10839540|NCT02906020|12005056|FG006|STARTED|Part 2: Long-term Follow-up Period||0
10839541|NCT02906020|12005057|FG007|STARTED|Part 2: Long-term Follow-up Period||0
10839542|NCT02906020|12005058|FG008|STARTED|Part 2: Long-term Follow-up Period||0
10839543|NCT02906020|12005059|FG009|STARTED|Part 2: Long-term Follow-up Period||0
10839544|NCT02906020|12005060|FG010|STARTED|Part 2: Long-term Follow-up Period||0
10839545|NCT02906020|12005061|FG011|STARTED|Part 2: Long-term Follow-up Period||0
10839546|NCT02906020|12005062|FG012|STARTED|Part 2: Long-term Follow-up Period||99
10839547|NCT02906020|12005063|FG013|STARTED|Part 2: Long-term Follow-up Period||85
10839548|NCT02906020|12005064|FG014|STARTED|Part 2: Long-term Follow-up Period||10
10839549|NCT02906020|12005065|FG015|STARTED|Part 2: Long-term Follow-up Period|Out of 13 completed participants in the previous part 2 DB period-arm, 2 didn't enter LTFU period.|11
10839550|NCT02906020|12005050|FG000|Treated|Part 2: Long-term Follow-up Period||0
10839551|NCT02906020|12005051|FG001|Treated|Part 2: Long-term Follow-up Period||0
10839552|NCT02906020|12005052|FG002|Treated|Part 2: Long-term Follow-up Period||0
10839553|NCT02906020|12005053|FG003|Treated|Part 2: Long-term Follow-up Period||0
10839554|NCT02906020|12005054|FG004|Treated|Part 2: Long-term Follow-up Period||0
10839555|NCT02906020|12005055|FG005|Treated|Part 2: Long-term Follow-up Period||0
10839556|NCT02906020|12005056|FG006|Treated|Part 2: Long-term Follow-up Period||0
10839557|NCT02906020|12005057|FG007|Treated|Part 2: Long-term Follow-up Period||0
10410674|NCT00763282|11554712|FG000|STARTED|Overall Study||72
10410675|NCT00763282|11554713|FG001|STARTED|Overall Study||72
10410676|NCT00763282|11554712|FG000|COMPLETED|Overall Study||40
10410677|NCT00763282|11554713|FG001|COMPLETED|Overall Study||38
10410678|NCT00763282|11554712|FG000|NOT COMPLETED|Overall Study||32
10410679|NCT00763282|11554713|FG001|NOT COMPLETED|Overall Study||34
10410680|NCT00763321|11554724|FG000|STARTED|Open-label Period||285
10410681|NCT00763321|11554725|FG001|STARTED|Open-label Period||0
10410682|NCT00763321|11554726|FG002|STARTED|Open-label Period||0
10410683|NCT00763321|11554724|FG000|COMPLETED|Open-label Period||222
10410684|NCT00763321|11554725|FG001|COMPLETED|Open-label Period||0
10839558|NCT02906020|12005058|FG008|Treated|Part 2: Long-term Follow-up Period||0
10839559|NCT02906020|12005059|FG009|Treated|Part 2: Long-term Follow-up Period||0
10839560|NCT02906020|12005060|FG010|Treated|Part 2: Long-term Follow-up Period||0
10839561|NCT02906020|12005061|FG011|Treated|Part 2: Long-term Follow-up Period||0
10839562|NCT02906020|12005062|FG012|Treated|Part 2: Long-term Follow-up Period||87
10839563|NCT02906020|12005063|FG013|Treated|Part 2: Long-term Follow-up Period||75
10839564|NCT02906020|12005064|FG014|Treated|Part 2: Long-term Follow-up Period||10
10839565|NCT02906020|12005065|FG015|Treated|Part 2: Long-term Follow-up Period||11
10839566|NCT02906020|12005050|FG000|COMPLETED|Part 2: Long-term Follow-up Period||0
10839567|NCT02906020|12005051|FG001|COMPLETED|Part 2: Long-term Follow-up Period||0
10839568|NCT02906020|12005052|FG002|COMPLETED|Part 2: Long-term Follow-up Period||0
10839569|NCT02906020|12005053|FG003|COMPLETED|Part 2: Long-term Follow-up Period||0
10839570|NCT02906020|12005054|FG004|COMPLETED|Part 2: Long-term Follow-up Period||0
10839571|NCT02906020|12005055|FG005|COMPLETED|Part 2: Long-term Follow-up Period||0
10839572|NCT02906020|12005056|FG006|COMPLETED|Part 2: Long-term Follow-up Period||0
10839573|NCT02906020|12005057|FG007|COMPLETED|Part 2: Long-term Follow-up Period||0
10839574|NCT02906020|12005058|FG008|COMPLETED|Part 2: Long-term Follow-up Period||0
10839575|NCT02906020|12005059|FG009|COMPLETED|Part 2: Long-term Follow-up Period||0
10839576|NCT02906020|12005060|FG010|COMPLETED|Part 2: Long-term Follow-up Period||0
10839577|NCT02906020|12005061|FG011|COMPLETED|Part 2: Long-term Follow-up Period||0
10839578|NCT02906020|12005062|FG012|COMPLETED|Part 2: Long-term Follow-up Period||0
10839579|NCT02906020|12005063|FG013|COMPLETED|Part 2: Long-term Follow-up Period||0
10839580|NCT02906020|12005064|FG014|COMPLETED|Part 2: Long-term Follow-up Period||0
10839581|NCT02906020|12005065|FG015|COMPLETED|Part 2: Long-term Follow-up Period||0
10839582|NCT02906020|12005050|FG000|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
10839583|NCT02906020|12005051|FG001|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
10839584|NCT02906020|12005052|FG002|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
10839585|NCT02906020|12005053|FG003|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
10839586|NCT02906020|12005054|FG004|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
10839587|NCT02906020|12005055|FG005|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
10839588|NCT02906020|12005056|FG006|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
10839589|NCT02906020|12005057|FG007|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
10839590|NCT02906020|12005058|FG008|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
10839591|NCT02906020|12005059|FG009|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
10410685|NCT00763321|11554726|FG002|COMPLETED|Open-label Period||0
10410686|NCT00763321|11554724|FG000|NOT COMPLETED|Open-label Period||63
10410687|NCT00763321|11554725|FG001|NOT COMPLETED|Open-label Period||0
10410688|NCT00763321|11554726|FG002|NOT COMPLETED|Open-label Period||0
10410689|NCT00763321|11554724|FG000|STARTED|Double-blind Period||0
10839592|NCT02906020|12005060|FG010|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
10839593|NCT02906020|12005061|FG011|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
10839594|NCT02906020|12005062|FG012|NOT COMPLETED|Part 2: Long-term Follow-up Period||99
10839595|NCT02906020|12005063|FG013|NOT COMPLETED|Part 2: Long-term Follow-up Period||85
10839596|NCT02906020|12005064|FG014|NOT COMPLETED|Part 2: Long-term Follow-up Period||10
10839597|NCT02906020|12005065|FG015|NOT COMPLETED|Part 2: Long-term Follow-up Period||11
10410690|NCT00763321|11554725|FG001|STARTED|Double-blind Period||109
10410691|NCT00763321|11554726|FG002|STARTED|Double-blind Period||113
10410692|NCT00763321|11554724|FG000|COMPLETED|Double-blind Period||0
10410693|NCT00763321|11554725|FG001|COMPLETED|Double-blind Period||88
10410694|NCT00763321|11554726|FG002|COMPLETED|Double-blind Period||84
10410695|NCT00763321|11554724|FG000|NOT COMPLETED|Double-blind Period||0
10410696|NCT00763321|11554725|FG001|NOT COMPLETED|Double-blind Period||21
10410697|NCT00763321|11554726|FG002|NOT COMPLETED|Double-blind Period||29
10410698|NCT00763360|11554736|FG000|STARTED|Overall Study||61
10410699|NCT00763360|11554737|FG001|STARTED|Overall Study||60
10410700|NCT00763360|11554738|FG002|STARTED|Overall Study||63
10410701|NCT00763360|11554736|FG000|COMPLETED|Overall Study||61
10410702|NCT00763360|11554737|FG001|COMPLETED|Overall Study||58
10410703|NCT00763360|11554738|FG002|COMPLETED|Overall Study||63
10410704|NCT00763360|11554736|FG000|NOT COMPLETED|Overall Study||0
10410705|NCT00763360|11554737|FG001|NOT COMPLETED|Overall Study||2
10410706|NCT00763360|11554738|FG002|NOT COMPLETED|Overall Study||0
10410707|NCT00763386|11554748|FG000|STARTED|Overall Study||164
10410708|NCT00763386|11554749|FG001|STARTED|Overall Study||167
10410709|NCT00763386|11554748|FG000|COMPLETED|Overall Study||116
10410710|NCT00763386|11554749|FG001|COMPLETED|Overall Study||127
10410711|NCT00763386|11554748|FG000|NOT COMPLETED|Overall Study||48
10410712|NCT00763386|11554749|FG001|NOT COMPLETED|Overall Study||40
10410713|NCT00763412|11554757|FG000|STARTED|Overall Study||8
10410714|NCT00763412|11554758|FG001|STARTED|Overall Study||8
10410715|NCT00763412|11554757|FG000|COMPLETED|Overall Study||4
10410716|NCT00763412|11554758|FG001|COMPLETED|Overall Study||4
10410717|NCT00763412|11554757|FG000|NOT COMPLETED|Overall Study||4
10410718|NCT00763412|11554758|FG001|NOT COMPLETED|Overall Study||4
10410719|NCT00763451|11554768|FG000|STARTED|Overall Study|Randomized.|80
10410720|NCT00763451|11554769|FG001|STARTED|Overall Study||82
10410721|NCT00763451|11554770|FG002|STARTED|Overall Study||161
10410722|NCT00763451|11554771|FG003|STARTED|Overall Study||161
10410723|NCT00763451|11554768|FG000|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|79
10410724|NCT00763451|11554769|FG001|Treated/Safety Population|Overall Study||81
10410725|NCT00763451|11554770|FG002|Treated/Safety Population|Overall Study||161
10410726|NCT00763451|11554771|FG003|Treated/Safety Population|Overall Study||161
10410727|NCT00763451|11554768|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|79
10410728|NCT00763451|11554769|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||80
10410729|NCT00763451|11554770|FG002|Modified Intent-to-Treat(mITT)Population|Overall Study||160
10410730|NCT00763451|11554771|FG003|Modified Intent-to-Treat(mITT)Population|Overall Study||160
10410731|NCT00763451|11554768|FG000|COMPLETED|Overall Study||67
10410732|NCT00763451|11554769|FG001|COMPLETED|Overall Study||60
10410733|NCT00763451|11554770|FG002|COMPLETED|Overall Study||121
10410734|NCT00763451|11554771|FG003|COMPLETED|Overall Study||131
10410735|NCT00763451|11554768|FG000|NOT COMPLETED|Overall Study||13
10410736|NCT00763451|11554769|FG001|NOT COMPLETED|Overall Study||22
10410737|NCT00763451|11554770|FG002|NOT COMPLETED|Overall Study||40
10410738|NCT00763451|11554771|FG003|NOT COMPLETED|Overall Study||30
10410739|NCT00763490|11554782|FG000|STARTED|Overall Study||20
10410740|NCT00763490|11554782|FG000|COMPLETED|Overall Study||20
10410741|NCT00763490|11554782|FG000|NOT COMPLETED|Overall Study||0
10410742|NCT00763698|11554786|FG000|STARTED|Overall Study||86
10410743|NCT00763698|11554786|FG000|COMPLETED|Overall Study||76
10410744|NCT00763698|11554786|FG000|NOT COMPLETED|Overall Study||10
10410745|NCT00763750|11554791|FG000|STARTED|Overall Study||25
10410746|NCT00763750|11554791|FG000|COMPLETED|Overall Study||25
10410747|NCT00763750|11554791|FG000|NOT COMPLETED|Overall Study||0
10410748|NCT00763815|11554797|FG000|STARTED|Overall Study|Randomized.|161
10839806|NCT02703480|12005136|FG000|STARTED|Overall Study||11
10839807|NCT02703480|12005137|FG001|STARTED|Overall Study||11
10839808|NCT02703480|12005136|FG000|COMPLETED|Overall Study||10
10839809|NCT02703480|12005137|FG001|COMPLETED|Overall Study||10
10839810|NCT02703480|12005136|FG000|NOT COMPLETED|Overall Study||1
10839811|NCT02703480|12005137|FG001|NOT COMPLETED|Overall Study||1
10839812|NCT02549092|12005145|FG000|STARTED|Treatment Period||44
10839813|NCT02549092|12005146|FG001|STARTED|Treatment Period||45
10839814|NCT02549092|12005145|FG000|COMPLETED|Treatment Period||41
10839815|NCT02549092|12005146|FG001|COMPLETED|Treatment Period||38
10839816|NCT02549092|12005145|FG000|NOT COMPLETED|Treatment Period||3
10839817|NCT02549092|12005146|FG001|NOT COMPLETED|Treatment Period||7
10839818|NCT02549092|12005145|FG000|STARTED|Extension/Transition Period||10
10839819|NCT02549092|12005146|FG001|STARTED|Extension/Transition Period||14
10839820|NCT02549092|12005145|FG000|COMPLETED|Extension/Transition Period||5
10839821|NCT02549092|12005146|FG001|COMPLETED|Extension/Transition Period||5
10839822|NCT02549092|12005145|FG000|NOT COMPLETED|Extension/Transition Period||5
10839823|NCT02549092|12005146|FG001|NOT COMPLETED|Extension/Transition Period||9
10839824|NCT02506465|12005157|FG000|STARTED|Overall Study||128
10839825|NCT02506465|12005158|FG001|STARTED|Overall Study||57
10839826|NCT02506465|12005157|FG000|COMPLETED|Overall Study|78 patients reached 12 months FU visit.|78
10839827|NCT02506465|12005158|FG001|COMPLETED|Overall Study|The Sham arm was analyzed up to 3 months FU visit as primary endpoint timeframe in accordance with the FDA guideline for BPH treatments, published in 2010, the most recent guidance available at the time of the study.|57
10839828|NCT02506465|12005157|FG000|NOT COMPLETED|Overall Study||50
10839829|NCT02506465|12005158|FG001|NOT COMPLETED|Overall Study||0
10839830|NCT02323126|12005167|FG000|STARTED|Overall Study||18
10839831|NCT02323126|12005168|FG001|STARTED|Overall Study||16
10839832|NCT02323126|12005169|FG002|STARTED|Overall Study||30
10839833|NCT02323126|12005167|FG000|COMPLETED|Overall Study||0
10839834|NCT02323126|12005168|FG001|COMPLETED|Overall Study||0
10839835|NCT02323126|12005169|FG002|COMPLETED|Overall Study||0
10839836|NCT02323126|12005167|FG000|NOT COMPLETED|Overall Study||18
10839837|NCT02323126|12005168|FG001|NOT COMPLETED|Overall Study||16
10839838|NCT02323126|12005169|FG002|NOT COMPLETED|Overall Study||30
10839847|NCT01126749|12005194|FG000|STARTED|Phase 1b||3
10839848|NCT01126749|12005195|FG001|STARTED|Phase 1b||6
10839849|NCT01126749|12005196|FG002|STARTED|Phase 1b||0
10839850|NCT01126749|12005197|FG003|STARTED|Phase 1b||0
10839851|NCT01126749|12005194|FG000|COMPLETED|Phase 1b||0
10839852|NCT01126749|12005195|FG001|COMPLETED|Phase 1b||0
10839853|NCT01126749|12005196|FG002|COMPLETED|Phase 1b||0
10839854|NCT01126749|12005197|FG003|COMPLETED|Phase 1b||0
10839855|NCT01126749|12005194|FG000|NOT COMPLETED|Phase 1b||3
10839856|NCT01126749|12005195|FG001|NOT COMPLETED|Phase 1b||6
10839857|NCT01126749|12005196|FG002|NOT COMPLETED|Phase 1b||0
10839858|NCT01126749|12005197|FG003|NOT COMPLETED|Phase 1b||0
10839859|NCT01126749|12005194|FG000|STARTED|Phase 2||0
10839860|NCT01126749|12005195|FG001|STARTED|Phase 2||0
10839861|NCT01126749|12005196|FG002|STARTED|Phase 2||42
10839862|NCT01126749|12005197|FG003|STARTED|Phase 2||41
10839863|NCT01126749|12005194|FG000|Safety Analysis Set (SAS)/Treated|Phase 2||0
10839864|NCT01126749|12005195|FG001|Safety Analysis Set (SAS)/Treated|Phase 2||0
10839865|NCT01126749|12005196|FG002|Safety Analysis Set (SAS)/Treated|Phase 2||41
10839866|NCT01126749|12005197|FG003|Safety Analysis Set (SAS)/Treated|Phase 2||39
10839867|NCT01126749|12005194|FG000|Modified-intent-to-treat (MITT)|Phase 2||0
10839868|NCT01126749|12005195|FG001|Modified-intent-to-treat (MITT)|Phase 2||0
10839869|NCT01126749|12005196|FG002|Modified-intent-to-treat (MITT)|Phase 2||40
10839870|NCT01126749|12005197|FG003|Modified-intent-to-treat (MITT)|Phase 2||39
10839871|NCT01126749|12005194|FG000|COMPLETED|Phase 2||0
10839872|NCT01126749|12005195|FG001|COMPLETED|Phase 2||0
10839873|NCT01126749|12005196|FG002|COMPLETED|Phase 2||0
10839874|NCT01126749|12005197|FG003|COMPLETED|Phase 2||0
10839875|NCT01126749|12005194|FG000|NOT COMPLETED|Phase 2||0
10839876|NCT01126749|12005195|FG001|NOT COMPLETED|Phase 2||0
10839877|NCT01126749|12005196|FG002|NOT COMPLETED|Phase 2||42
10839878|NCT01126749|12005197|FG003|NOT COMPLETED|Phase 2||41
10839879|NCT01111110|12005209|FG000|STARTED|Overall Study||3
10839880|NCT01111110|12005210|FG001|STARTED|Overall Study||4
10839881|NCT01111110|12005209|FG000|COMPLETED|Overall Study||3
10839882|NCT01111110|12005210|FG001|COMPLETED|Overall Study||4
10839883|NCT01111110|12005209|FG000|NOT COMPLETED|Overall Study||0
10839884|NCT01111110|12005210|FG001|NOT COMPLETED|Overall Study||0
10839885|NCT01059448|12005220|FG000|STARTED|Overall Study||49
10839886|NCT01059448|12005221|FG001|STARTED|Overall Study||55
10839887|NCT01059448|12005222|FG002|STARTED|Overall Study||53
10839888|NCT01059448|12005223|FG003|STARTED|Overall Study||54
10839889|NCT01059448|12005220|FG000|COMPLETED|Overall Study||0
10839890|NCT01059448|12005221|FG001|COMPLETED|Overall Study||0
10839891|NCT01059448|12005222|FG002|COMPLETED|Overall Study||0
10839892|NCT01059448|12005223|FG003|COMPLETED|Overall Study||0
10839893|NCT01059448|12005220|FG000|NOT COMPLETED|Overall Study||49
10839894|NCT01059448|12005221|FG001|NOT COMPLETED|Overall Study||55
10839895|NCT01059448|12005222|FG002|NOT COMPLETED|Overall Study||53
10839896|NCT01059448|12005223|FG003|NOT COMPLETED|Overall Study||54
10839897|NCT00821587|12005235|FG000|STARTED|Overall Study||20
10839898|NCT00821587|12005236|FG001|STARTED|Overall Study||19
10839899|NCT00821587|12005235|FG000|COMPLETED|Overall Study||20
10839900|NCT00821587|12005236|FG001|COMPLETED|Overall Study||18
10839901|NCT00821587|12005235|FG000|NOT COMPLETED|Overall Study||0
10839902|NCT00821587|12005236|FG001|NOT COMPLETED|Overall Study||1
10839903|NCT00585195|12005263|FG000|STARTED|Overall Study||3
10839904|NCT00585195|12005264|FG001|STARTED|Overall Study||4
10839905|NCT00585195|12005265|FG002|STARTED|Overall Study||9
10839906|NCT00585195|12005266|FG003|STARTED|Overall Study||7
10545028|NCT01493687|11698238|FG000|STARTED|Part C Safety Follow up (4 Weeks)|351 completed Part B. Then 1 discontinued (subject request) prior to Part C.|350
10545029|NCT01493687|11698239|FG001|STARTED|Part C Safety Follow up (4 Weeks)||175
10545030|NCT01493687|11698238|FG000|COMPLETED|Part C Safety Follow up (4 Weeks)||350
10839907|NCT00585195|12005267|FG004|STARTED|Overall Study||9
10839908|NCT00585195|12005268|FG005|STARTED|Overall Study||6
10839909|NCT00585195|12005269|FG006|STARTED|Overall Study||7
10839910|NCT00585195|12005270|FG007|STARTED|Overall Study||5
10839911|NCT00585195|12005271|FG008|STARTED|Overall Study||3
10839912|NCT00585195|12005272|FG009|STARTED|Overall Study||6
10839913|NCT00585195|12005273|FG010|STARTED|Overall Study||11
10839914|NCT00585195|12005274|FG011|STARTED|Overall Study||53
10839915|NCT00585195|12005275|FG012|STARTED|Overall Study||85
10839916|NCT00585195|12005276|FG013|STARTED|Overall Study||41
10839917|NCT00585195|12005277|FG014|STARTED|Overall Study||48
10839918|NCT00585195|12005278|FG015|STARTED|Overall Study||19
10839919|NCT00585195|12005279|FG016|STARTED|Overall Study||154
10839920|NCT00585195|12005280|FG017|STARTED|Overall Study||67
10839921|NCT00585195|12005281|FG018|STARTED|Overall Study||21
10839922|NCT00585195|12005282|FG019|STARTED|Overall Study||18
10839923|NCT00585195|12005283|FG020|STARTED|Overall Study||14
10839924|NCT00585195|12005263|FG000|Treated|Overall Study||3
10839925|NCT00585195|12005264|FG001|Treated|Overall Study||4
10839926|NCT00585195|12005265|FG002|Treated|Overall Study||8
10839927|NCT00585195|12005266|FG003|Treated|Overall Study||7
10839928|NCT00585195|12005267|FG004|Treated|Overall Study||8
10839929|NCT00585195|12005268|FG005|Treated|Overall Study||6
10839930|NCT00585195|12005269|FG006|Treated|Overall Study||6
10839931|NCT00585195|12005270|FG007|Treated|Overall Study||5
10839932|NCT00585195|12005271|FG008|Treated|Overall Study||3
10839933|NCT00585195|12005272|FG009|Treated|Overall Study||6
10839934|NCT00585195|12005273|FG010|Treated|Overall Study||9
10839935|NCT00585195|12005274|FG011|Treated|Overall Study||53
10839936|NCT00585195|12005275|FG012|Treated|Overall Study||85
10839937|NCT00585195|12005276|FG013|Treated|Overall Study||41
10839938|NCT00585195|12005277|FG014|Treated|Overall Study||48
10839939|NCT00585195|12005278|FG015|Treated|Overall Study||18
10839940|NCT00585195|12005279|FG016|Treated|Overall Study||154
10839941|NCT00585195|12005280|FG017|Treated|Overall Study||66
10839942|NCT00585195|12005281|FG018|Treated|Overall Study||18
10839943|NCT00585195|12005282|FG019|Treated|Overall Study||18
10839944|NCT00585195|12005283|FG020|Treated|Overall Study||12
10839945|NCT00585195|12005263|FG000|COMPLETED|Overall Study||0
10839946|NCT00585195|12005264|FG001|COMPLETED|Overall Study||0
10839947|NCT00585195|12005265|FG002|COMPLETED|Overall Study||0
10839948|NCT00585195|12005266|FG003|COMPLETED|Overall Study||0
10839949|NCT00585195|12005267|FG004|COMPLETED|Overall Study||0
10839950|NCT00585195|12005268|FG005|COMPLETED|Overall Study||0
10839951|NCT00585195|12005269|FG006|COMPLETED|Overall Study||0
10839952|NCT00585195|12005270|FG007|COMPLETED|Overall Study||0
10839953|NCT00585195|12005271|FG008|COMPLETED|Overall Study||0
10839954|NCT00585195|12005272|FG009|COMPLETED|Overall Study||0
10839955|NCT00585195|12005273|FG010|COMPLETED|Overall Study||0
10839956|NCT00585195|12005274|FG011|COMPLETED|Overall Study||0
10839957|NCT00585195|12005275|FG012|COMPLETED|Overall Study||0
10839958|NCT00585195|12005276|FG013|COMPLETED|Overall Study||0
10839959|NCT00585195|12005277|FG014|COMPLETED|Overall Study||0
10839960|NCT00585195|12005278|FG015|COMPLETED|Overall Study||0
10839961|NCT00585195|12005279|FG016|COMPLETED|Overall Study||0
10839962|NCT00585195|12005280|FG017|COMPLETED|Overall Study||0
10839963|NCT00585195|12005281|FG018|COMPLETED|Overall Study||0
10839964|NCT00585195|12005282|FG019|COMPLETED|Overall Study||0
10839965|NCT00585195|12005283|FG020|COMPLETED|Overall Study||0
10839966|NCT00585195|12005263|FG000|NOT COMPLETED|Overall Study||3
10839967|NCT00585195|12005264|FG001|NOT COMPLETED|Overall Study||4
10839968|NCT00585195|12005265|FG002|NOT COMPLETED|Overall Study||9
10839969|NCT00585195|12005266|FG003|NOT COMPLETED|Overall Study||7
10545031|NCT01493687|11698239|FG001|COMPLETED|Part C Safety Follow up (4 Weeks)||174
10839970|NCT00585195|12005267|FG004|NOT COMPLETED|Overall Study||9
10839971|NCT00585195|12005268|FG005|NOT COMPLETED|Overall Study||6
10839972|NCT00585195|12005269|FG006|NOT COMPLETED|Overall Study||7
10839973|NCT00585195|12005270|FG007|NOT COMPLETED|Overall Study||5
10839974|NCT00585195|12005271|FG008|NOT COMPLETED|Overall Study||3
10839975|NCT00585195|12005272|FG009|NOT COMPLETED|Overall Study||6
10839976|NCT00585195|12005273|FG010|NOT COMPLETED|Overall Study||11
10839977|NCT00585195|12005274|FG011|NOT COMPLETED|Overall Study||53
10839978|NCT00585195|12005275|FG012|NOT COMPLETED|Overall Study||85
10839979|NCT00585195|12005276|FG013|NOT COMPLETED|Overall Study||41
10839980|NCT00585195|12005277|FG014|NOT COMPLETED|Overall Study||48
10839981|NCT00585195|12005278|FG015|NOT COMPLETED|Overall Study||19
10839982|NCT00585195|12005279|FG016|NOT COMPLETED|Overall Study||154
10839983|NCT00585195|12005280|FG017|NOT COMPLETED|Overall Study||67
10839984|NCT00585195|12005281|FG018|NOT COMPLETED|Overall Study||21
10839985|NCT00585195|12005282|FG019|NOT COMPLETED|Overall Study||18
10839986|NCT00585195|12005283|FG020|NOT COMPLETED|Overall Study||14
10839987|NCT04446429|12005368|FG000|STARTED|Overall Study||134
10839988|NCT04446429|12005369|FG001|STARTED|Overall Study||134
10839989|NCT04446429|12005368|FG000|COMPLETED|Overall Study|In placebo group, 6 patients were lost to follow-up but were included in intention-to-treat analysis.|128
10839990|NCT04446429|12005369|FG001|COMPLETED|Overall Study||134
10839991|NCT04446429|12005368|FG000|NOT COMPLETED|Overall Study||6
10839992|NCT04446429|12005369|FG001|NOT COMPLETED|Overall Study||0
10839993|NCT04372017|12005379|FG000|STARTED|Overall Study||1
10839994|NCT04372017|12005380|FG001|STARTED|Overall Study||0
10839995|NCT04372017|12005381|FG002|STARTED|Overall Study||0
10839996|NCT04372017|12005382|FG003|STARTED|Overall Study||0
10839997|NCT04372017|12005379|FG000|COMPLETED|Overall Study||1
10839998|NCT04372017|12005380|FG001|COMPLETED|Overall Study||0
10839999|NCT04372017|12005381|FG002|COMPLETED|Overall Study||0
10840000|NCT04372017|12005382|FG003|COMPLETED|Overall Study||0
10840001|NCT04372017|12005379|FG000|NOT COMPLETED|Overall Study||0
10840002|NCT04372017|12005380|FG001|NOT COMPLETED|Overall Study||0
10840003|NCT04372017|12005381|FG002|NOT COMPLETED|Overall Study||0
10840004|NCT04372017|12005382|FG003|NOT COMPLETED|Overall Study||0
10840005|NCT04194528|12005392|FG000|STARTED|Overall Study||2
10840006|NCT04194528|12005392|FG000|COMPLETED|Overall Study||1
10840007|NCT04194528|12005392|FG000|NOT COMPLETED|Overall Study||1
10840008|NCT04147650|12005400|FG000|STARTED|Overall Study||127
10840009|NCT04147650|12005401|FG001|STARTED|Overall Study||126
10840010|NCT04147650|12005402|FG002|STARTED|Overall Study||128
10840011|NCT04147650|12005403|FG003|STARTED|Overall Study||127
10840012|NCT04147650|12005400|FG000|Modified Intent to Treat (mITT)|Overall Study||120
10840013|NCT04147650|12005401|FG001|Modified Intent to Treat (mITT)|Overall Study||119
10840014|NCT04147650|12005402|FG002|Modified Intent to Treat (mITT)|Overall Study||122
10840015|NCT04147650|12005403|FG003|Modified Intent to Treat (mITT)|Overall Study||121
10840016|NCT04147650|12005400|FG000|COMPLETED|Overall Study||116
10840017|NCT04147650|12005401|FG001|COMPLETED|Overall Study||107
10840018|NCT04147650|12005402|FG002|COMPLETED|Overall Study||121
10840019|NCT04147650|12005403|FG003|COMPLETED|Overall Study||120
10840020|NCT04147650|12005400|FG000|NOT COMPLETED|Overall Study||11
10840021|NCT04147650|12005401|FG001|NOT COMPLETED|Overall Study||19
10840022|NCT04147650|12005402|FG002|NOT COMPLETED|Overall Study||7
10840023|NCT04147650|12005403|FG003|NOT COMPLETED|Overall Study||7
10840024|NCT03527238|12005415|FG000|STARTED|Overall Study||31
10840025|NCT03527238|12005416|FG001|STARTED|Overall Study||31
10840026|NCT03527238|12005415|FG000|COMPLETED|Overall Study||29
10840027|NCT03527238|12005416|FG001|COMPLETED|Overall Study||27
10840028|NCT03527238|12005415|FG000|NOT COMPLETED|Overall Study||2
10840029|NCT03527238|12005416|FG001|NOT COMPLETED|Overall Study||4
10840030|NCT03116685|12005424|FG000|STARTED|Overall Study||13
10840031|NCT03116685|12005425|FG001|STARTED|Overall Study||12
10840032|NCT03116685|12005424|FG000|COMPLETED|Overall Study||13
10840033|NCT03116685|12005425|FG001|COMPLETED|Overall Study||11
10840034|NCT03116685|12005424|FG000|NOT COMPLETED|Overall Study||0
10840035|NCT03116685|12005425|FG001|NOT COMPLETED|Overall Study||1
10840036|NCT03099304|12005436|FG000|STARTED|DB Period Day 1 to Week 24||32
10840037|NCT03099304|12005437|FG001|STARTED|DB Period Day 1 to Week 24||31
10840038|NCT03099304|12005438|FG002|STARTED|DB Period Day 1 to Week 24||31
10840039|NCT03099304|12005439|FG003|STARTED|DB Period Day 1 to Week 24||30
10410749|NCT00763815|11554798|FG001|STARTED|Overall Study||323
10410750|NCT00763815|11554797|FG000|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|161
10410751|NCT00763815|11554798|FG001|Treated/Safety Population|Overall Study||323
10410752|NCT00763815|11554797|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|159
10410753|NCT00763815|11554798|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||320
10410754|NCT00763815|11554797|FG000|COMPLETED|Overall Study||109
10410755|NCT00763815|11554798|FG001|COMPLETED|Overall Study||239
10410756|NCT00763815|11554797|FG000|NOT COMPLETED|Overall Study||52
10410757|NCT00763815|11554798|FG001|NOT COMPLETED|Overall Study||84
10410758|NCT00763867|11554806|FG000|STARTED|Overall Study||103
10410759|NCT00763867|11554807|FG001|STARTED|Overall Study||113
10410760|NCT00763867|11554806|FG000|COMPLETED|Overall Study||98
10410761|NCT00763867|11554807|FG001|COMPLETED|Overall Study||101
10410762|NCT00763867|11554806|FG000|NOT COMPLETED|Overall Study||5
10410763|NCT00763867|11554807|FG001|NOT COMPLETED|Overall Study||12
10410764|NCT00763919|11554813|FG000|STARTED|Overall Study||43
10410765|NCT00763919|11554813|FG000|COMPLETED|Overall Study||30
10410766|NCT00763919|11554813|FG000|NOT COMPLETED|Overall Study||13
10410767|NCT00763958|11554819|FG000|STARTED|Overall Study||28
10410768|NCT00763958|11554820|FG001|STARTED|Overall Study||16
10410769|NCT00763958|11554819|FG000|COMPLETED|Overall Study||14
10410770|NCT00763958|11554820|FG001|COMPLETED|Overall Study||5
10410771|NCT00763958|11554819|FG000|NOT COMPLETED|Overall Study||14
10410772|NCT00763958|11554820|FG001|NOT COMPLETED|Overall Study||11
10410773|NCT00763971|11554830|FG000|STARTED|Overall Study||113
10410774|NCT00763971|11554831|FG001|STARTED|Overall Study||112
10410775|NCT00763971|11554832|FG002|STARTED|Overall Study||111
10410776|NCT00763971|11554830|FG000|COMPLETED|Overall Study||80
10410777|NCT00763971|11554831|FG001|COMPLETED|Overall Study||74
10410778|NCT00763971|11554832|FG002|COMPLETED|Overall Study||42
10410779|NCT00763971|11554830|FG000|NOT COMPLETED|Overall Study||33
10410780|NCT00763971|11554831|FG001|NOT COMPLETED|Overall Study||38
10410781|NCT00763971|11554832|FG002|NOT COMPLETED|Overall Study||69
10410782|NCT00764309|11554840|FG000|STARTED|Overall Study|Number of participants treated.|31
10410783|NCT00764309|11554840|FG000|COMPLETED|Overall Study|Completed=off study. Major Reasons for off study: AE-13; withdrawn by sponsor-10; Lack of efficacy-3|31
10410784|NCT00764309|11554840|FG000|NOT COMPLETED|Overall Study||0
10410785|NCT00764322|11554846|FG000|STARTED|Overall Study||500
10410786|NCT00764322|11554846|FG000|COMPLETED|Overall Study||480
10410787|NCT00764322|11554846|FG000|NOT COMPLETED|Overall Study||20
10410788|NCT00764361|11554865|FG000|STARTED|Overall Study||8
10410789|NCT00764361|11554866|FG001|STARTED|Overall Study||7
10410790|NCT00764361|11554865|FG000|COMPLETED|Overall Study||6
10410791|NCT00764361|11554866|FG001|COMPLETED|Overall Study||3
10410792|NCT00764361|11554865|FG000|NOT COMPLETED|Overall Study||2
10410793|NCT00764361|11554866|FG001|NOT COMPLETED|Overall Study||4
10410794|NCT00764465|11554878|FG000|STARTED|Overall Study||9
10410795|NCT00764465|11554879|FG001|STARTED|Overall Study||7
10410796|NCT00764465|11554880|FG002|STARTED|Overall Study||7
10410797|NCT00764465|11554881|FG003|STARTED|Overall Study||7
10410798|NCT00764465|11554882|FG004|STARTED|Overall Study||7
10410799|NCT00764465|11554883|FG005|STARTED|Overall Study||8
10410800|NCT00764465|11554878|FG000|COMPLETED|Overall Study||7
10410801|NCT00764465|11554879|FG001|COMPLETED|Overall Study||6
10410802|NCT00764465|11554880|FG002|COMPLETED|Overall Study||6
10410803|NCT00764465|11554881|FG003|COMPLETED|Overall Study||6
10410804|NCT00764465|11554882|FG004|COMPLETED|Overall Study||6
10840040|NCT03099304|12005440|FG004|STARTED|DB Period Day 1 to Week 24||33
10840041|NCT03099304|12005436|FG000|COMPLETED|DB Period Day 1 to Week 24||27
10840042|NCT03099304|12005437|FG001|COMPLETED|DB Period Day 1 to Week 24||26
10410805|NCT00764465|11554883|FG005|COMPLETED|Overall Study||7
10410806|NCT00764465|11554878|FG000|NOT COMPLETED|Overall Study||2
10410807|NCT00764465|11554879|FG001|NOT COMPLETED|Overall Study||1
10410808|NCT00764465|11554880|FG002|NOT COMPLETED|Overall Study||1
10410809|NCT00764465|11554881|FG003|NOT COMPLETED|Overall Study||1
10410810|NCT00764465|11554882|FG004|NOT COMPLETED|Overall Study||1
10410811|NCT00764465|11554883|FG005|NOT COMPLETED|Overall Study||1
10410812|NCT00764491|11554902|FG000|STARTED|Overall Study||123
10840043|NCT03099304|12005438|FG002|COMPLETED|DB Period Day 1 to Week 24||30
10840044|NCT03099304|12005439|FG003|COMPLETED|DB Period Day 1 to Week 24||26
10840045|NCT03099304|12005440|FG004|COMPLETED|DB Period Day 1 to Week 24||30
10840046|NCT03099304|12005436|FG000|NOT COMPLETED|DB Period Day 1 to Week 24||5
10840047|NCT03099304|12005437|FG001|NOT COMPLETED|DB Period Day 1 to Week 24||5
10840048|NCT03099304|12005438|FG002|NOT COMPLETED|DB Period Day 1 to Week 24||1
10840049|NCT03099304|12005439|FG003|NOT COMPLETED|DB Period Day 1 to Week 24||4
10840050|NCT03099304|12005440|FG004|NOT COMPLETED|DB Period Day 1 to Week 24||3
10840051|NCT03099304|12005436|FG000|STARTED|DB Period Weeks 24 to 52|Vehicle cream was not used after Week 24. After DB 24 week period, participants who met criteria were rerandomized to 1 of the 3 higher active blinded treatment groups.|0
10840052|NCT03099304|12005437|FG001|STARTED|DB Period Weeks 24 to 52|These subjects continued on the initial .15% QD treatment.|11
10840053|NCT03099304|12005438|FG002|STARTED|DB Period Weeks 24 to 52|Total participants include those initially randomized to 0.5% QD and those re-randomized from vehicle cream and .15% QD to 0.5% QD.|45
10840054|NCT03099304|12005439|FG003|STARTED|DB Period Weeks 24 to 52|Total participants include those initially randomized to 1.5% QD and those re-randomized from vehicle cream and .15% QD to 1.5% QD.|44
10840055|NCT03099304|12005440|FG004|STARTED|DB Period Weeks 24 to 52|Total participants include those initially randomized to 1.5% BID and those re-randomized from vehicle cream and .15% QD to 1.5% BID|47
10840056|NCT03099304|12005436|FG000|COMPLETED|DB Period Weeks 24 to 52||0
10840057|NCT03099304|12005437|FG001|COMPLETED|DB Period Weeks 24 to 52||10
10840058|NCT03099304|12005438|FG002|COMPLETED|DB Period Weeks 24 to 52||43
10840059|NCT03099304|12005439|FG003|COMPLETED|DB Period Weeks 24 to 52||37
10840060|NCT03099304|12005440|FG004|COMPLETED|DB Period Weeks 24 to 52||45
10840061|NCT03099304|12005436|FG000|NOT COMPLETED|DB Period Weeks 24 to 52||0
10840062|NCT03099304|12005437|FG001|NOT COMPLETED|DB Period Weeks 24 to 52||1
10840063|NCT03099304|12005438|FG002|NOT COMPLETED|DB Period Weeks 24 to 52||2
10840064|NCT03099304|12005439|FG003|NOT COMPLETED|DB Period Weeks 24 to 52||7
10840065|NCT03099304|12005440|FG004|NOT COMPLETED|DB Period Weeks 24 to 52||2
10840066|NCT03034863|12005461|FG000|STARTED|Overall Study||38
10840067|NCT03034863|12005462|FG001|STARTED|Overall Study||40
10840068|NCT03034863|12005461|FG000|Veterans|Overall Study||19
10840069|NCT03034863|12005462|FG001|Veterans|Overall Study||20
10410813|NCT00764491|11554903|FG001|STARTED|Overall Study||33
10410814|NCT00764491|11554902|FG000|COMPLETED|Overall Study||88
10410815|NCT00764491|11554903|FG001|COMPLETED|Overall Study||16
10410816|NCT00764491|11554902|FG000|NOT COMPLETED|Overall Study||35
10410817|NCT00764491|11554903|FG001|NOT COMPLETED|Overall Study||17
10410818|NCT00764504|11554912|FG000|STARTED|Overall Study||141
10410819|NCT00764504|11554913|FG001|STARTED|Overall Study||141
10410820|NCT00764504|11554914|FG002|STARTED|Overall Study||234
10410821|NCT00764504|11554912|FG000|COMPLETED|Overall Study||75
10410822|NCT00764504|11554913|FG001|COMPLETED|Overall Study||71
10754538|NCT03053063|11918244|FG001|COMPLETED|Open-Label Phase||0
10754539|NCT03053063|11918245|FG002|COMPLETED|Open-Label Phase||0
10754540|NCT03053063|11918246|FG003|COMPLETED|Open-Label Phase||0
10754541|NCT03053063|11918243|FG000|NOT COMPLETED|Open-Label Phase||0
10754542|NCT03053063|11918244|FG001|NOT COMPLETED|Open-Label Phase||0
10754543|NCT03053063|11918245|FG002|NOT COMPLETED|Open-Label Phase||0
10754544|NCT03053063|11918246|FG003|NOT COMPLETED|Open-Label Phase||23
10754545|NCT03053180|11918255|FG000|STARTED|Overall Study||60
10754546|NCT03053180|11918255|FG000|COMPLETED|Overall Study||59
10754547|NCT03053180|11918255|FG000|NOT COMPLETED|Overall Study||1
10840070|NCT03034863|12005461|FG000|Supporting Partners|Overall Study||19
10840071|NCT03034863|12005462|FG001|Supporting Partners|Overall Study||20
10840072|NCT03034863|12005461|FG000|COMPLETED|Overall Study||28
10840073|NCT03034863|12005462|FG001|COMPLETED|Overall Study||28
10840074|NCT03034863|12005461|FG000|NOT COMPLETED|Overall Study||10
10840075|NCT03034863|12005462|FG001|NOT COMPLETED|Overall Study||12
10840076|NCT02819050|12005475|FG000|STARTED|Overall Study||40
10840077|NCT02819050|12005476|FG001|STARTED|Overall Study||40
10840078|NCT02819050|12005475|FG000|COMPLETED|Overall Study||40
10840079|NCT02819050|12005476|FG001|COMPLETED|Overall Study||40
10840080|NCT02819050|12005475|FG000|NOT COMPLETED|Overall Study||0
10840081|NCT02819050|12005476|FG001|NOT COMPLETED|Overall Study||0
10840082|NCT02682901|12005486|FG000|STARTED|Overall Study||43
10840083|NCT02682901|12005487|FG001|STARTED|Overall Study||41
10840084|NCT02682901|12005486|FG000|Completed 4 Weeks|Overall Study||38
10840085|NCT02682901|12005487|FG001|Completed 4 Weeks|Overall Study||39
10840086|NCT02682901|12005486|FG000|Completed 12 Weeks|Overall Study||36
10840087|NCT02682901|12005487|FG001|Completed 12 Weeks|Overall Study||37
10840088|NCT02682901|12005486|FG000|COMPLETED|Overall Study||33
10840089|NCT02682901|12005487|FG001|COMPLETED|Overall Study||37
10840090|NCT02682901|12005486|FG000|NOT COMPLETED|Overall Study||10
10840091|NCT02682901|12005487|FG001|NOT COMPLETED|Overall Study||4
10840092|NCT02555657|12005495|FG000|STARTED|Overall Study||312
10840093|NCT02555657|12005496|FG001|STARTED|Overall Study||310
10840094|NCT02555657|12005495|FG000|Treated|Overall Study||309
10840095|NCT02555657|12005496|FG001|Treated|Overall Study||292
10840096|NCT02555657|12005495|FG000|COMPLETED|Overall Study||0
10840097|NCT02555657|12005496|FG001|COMPLETED|Overall Study||0
10840098|NCT02555657|12005495|FG000|NOT COMPLETED|Overall Study||312
10840099|NCT02555657|12005496|FG001|NOT COMPLETED|Overall Study||310
10840100|NCT02190721|12005506|FG000|STARTED|Overall Study||2
10840101|NCT02190721|12005507|FG001|STARTED|Overall Study||30
10840102|NCT02190721|12005508|FG002|STARTED|Overall Study||18
10840103|NCT02190721|12005506|FG000|Completed Treatment|Overall Study||2
10840104|NCT02190721|12005507|FG001|Completed Treatment|Overall Study||30
10410823|NCT00764504|11554914|FG002|COMPLETED|Overall Study||131
10410824|NCT00764504|11554912|FG000|NOT COMPLETED|Overall Study||66
10410825|NCT00764504|11554913|FG001|NOT COMPLETED|Overall Study||70
10840105|NCT02190721|12005508|FG002|Completed Treatment|Overall Study||18
10840106|NCT02190721|12005506|FG000|Completed 30 Day Follow-up|Overall Study||2
10840107|NCT02190721|12005507|FG001|Completed 30 Day Follow-up|Overall Study||29
10840108|NCT02190721|12005508|FG002|Completed 30 Day Follow-up|Overall Study||18
10840109|NCT02190721|12005506|FG000|Completed 90 Day Follow-up|Overall Study||2
10840110|NCT02190721|12005507|FG001|Completed 90 Day Follow-up|Overall Study||29
10840111|NCT02190721|12005508|FG002|Completed 90 Day Follow-up|Overall Study||18
10840112|NCT02190721|12005506|FG000|COMPLETED|Overall Study||2
10840113|NCT02190721|12005507|FG001|COMPLETED|Overall Study||29
10840114|NCT02190721|12005508|FG002|COMPLETED|Overall Study||18
10840115|NCT02190721|12005506|FG000|NOT COMPLETED|Overall Study||0
10840116|NCT02190721|12005507|FG001|NOT COMPLETED|Overall Study||1
10840117|NCT02190721|12005508|FG002|NOT COMPLETED|Overall Study||0
10840118|NCT00908687|12005522|FG000|STARTED|Overall Study||50
10840119|NCT00908687|12005523|FG001|STARTED|Overall Study||100
10840120|NCT00908687|12005524|FG002|STARTED|Overall Study||102
10840121|NCT00908687|12005525|FG003|STARTED|Overall Study||50
10840122|NCT00908687|12005526|FG004|STARTED|Overall Study||98
10840123|NCT00908687|12005527|FG005|STARTED|Overall Study||100
10840124|NCT00908687|12005522|FG000|COMPLETED|Overall Study||49
10840125|NCT00908687|12005523|FG001|COMPLETED|Overall Study||99
10840126|NCT00908687|12005524|FG002|COMPLETED|Overall Study||99
10840127|NCT00908687|12005525|FG003|COMPLETED|Overall Study||47
10840128|NCT00908687|12005526|FG004|COMPLETED|Overall Study||94
10840129|NCT00908687|12005527|FG005|COMPLETED|Overall Study||94
10840130|NCT00908687|12005522|FG000|NOT COMPLETED|Overall Study||1
10840131|NCT00908687|12005523|FG001|NOT COMPLETED|Overall Study||1
10840132|NCT00908687|12005524|FG002|NOT COMPLETED|Overall Study||3
10840133|NCT00908687|12005525|FG003|NOT COMPLETED|Overall Study||3
10840134|NCT00908687|12005526|FG004|NOT COMPLETED|Overall Study||4
10840135|NCT00908687|12005527|FG005|NOT COMPLETED|Overall Study||6
10840136|NCT00739401|12005541|FG000|STARTED|Overall Study||44
10840137|NCT00739401|12005541|FG000|COMPLETED|Overall Study||3
10840138|NCT00739401|12005541|FG000|NOT COMPLETED|Overall Study||41
10840139|NCT00651742|12005545|FG000|STARTED|Overall Study||28
10840140|NCT00651742|12005545|FG000|Treated|Overall Study||27
10840141|NCT00651742|12005545|FG000|Efficacy Analysis Per Investigator|Overall Study||21
10840142|NCT00651742|12005545|FG000|Efficacy Analysis Per Independent Reader|Overall Study||25
10840143|NCT00651742|12005545|FG000|COMPLETED|Overall Study||0
10840144|NCT00651742|12005545|FG000|NOT COMPLETED|Overall Study||28
10840145|NCT00308516|12005551|FG000|STARTED|Overall Study||35
10840146|NCT00308516|12005552|FG001|STARTED|Overall Study||31
10840147|NCT00308516|12005551|FG000|COMPLETED|Overall Study||6
10840148|NCT00308516|12005552|FG001|COMPLETED|Overall Study||10
10840149|NCT00308516|12005551|FG000|NOT COMPLETED|Overall Study||29
10840150|NCT00308516|12005552|FG001|NOT COMPLETED|Overall Study||21
10840151|NCT04331366|12005558|FG000|STARTED|Overall Study||2
10840152|NCT04331366|12005558|FG000|COMPLETED|Overall Study||2
10840153|NCT04331366|12005558|FG000|NOT COMPLETED|Overall Study||0
10840154|NCT04930263|12005564|FG000|STARTED|Overall Study||33
10840155|NCT04930263|12005565|FG001|STARTED|Overall Study||33
10840156|NCT04930263|12005564|FG000|COMPLETED|Overall Study||30
10840157|NCT04930263|12005565|FG001|COMPLETED|Overall Study||28
10840158|NCT04930263|12005564|FG000|NOT COMPLETED|Overall Study||3
10840159|NCT04930263|12005565|FG001|NOT COMPLETED|Overall Study||5
10840160|NCT04321252|12005580|FG000|STARTED|Overall Study||6
10840161|NCT04321252|12005581|FG001|STARTED|Overall Study||6
10840162|NCT04321252|12005582|FG002|STARTED|Overall Study||6
10840163|NCT04321252|12005583|FG003|STARTED|Overall Study||6
10840164|NCT04321252|12005584|FG004|STARTED|Overall Study||6
10840165|NCT04321252|12005585|FG005|STARTED|Overall Study||9
10840166|NCT04321252|12005586|FG006|STARTED|Overall Study||6
10840167|NCT04321252|12005587|FG007|STARTED|Overall Study||6
10840168|NCT04321252|12005588|FG008|STARTED|Overall Study||6
10840169|NCT04321252|12005580|FG000|PK Analysis Set|Overall Study||6
10840170|NCT04321252|12005581|FG001|PK Analysis Set|Overall Study||6
10840171|NCT04321252|12005582|FG002|PK Analysis Set|Overall Study||6
10840172|NCT04321252|12005583|FG003|PK Analysis Set|Overall Study||6
10840173|NCT04321252|12005584|FG004|PK Analysis Set|Overall Study||6
10840174|NCT04321252|12005585|FG005|PK Analysis Set|Overall Study||0
10840175|NCT04321252|12005586|FG006|PK Analysis Set|Overall Study||6
10840176|NCT04321252|12005587|FG007|PK Analysis Set|Overall Study||6
10840177|NCT04321252|12005588|FG008|PK Analysis Set|Overall Study||0
10840178|NCT04321252|12005580|FG000|COMPLETED|Overall Study||6
10840179|NCT04321252|12005581|FG001|COMPLETED|Overall Study||6
10840180|NCT04321252|12005582|FG002|COMPLETED|Overall Study||6
10840181|NCT04321252|12005583|FG003|COMPLETED|Overall Study||6
10840182|NCT04321252|12005584|FG004|COMPLETED|Overall Study||6
10840183|NCT04321252|12005585|FG005|COMPLETED|Overall Study||8
10840184|NCT04321252|12005586|FG006|COMPLETED|Overall Study||6
10840185|NCT04321252|12005587|FG007|COMPLETED|Overall Study||6
10840186|NCT04321252|12005588|FG008|COMPLETED|Overall Study||6
10840187|NCT04321252|12005580|FG000|NOT COMPLETED|Overall Study||0
10840188|NCT04321252|12005581|FG001|NOT COMPLETED|Overall Study||0
10840189|NCT04321252|12005582|FG002|NOT COMPLETED|Overall Study||0
10840190|NCT04321252|12005583|FG003|NOT COMPLETED|Overall Study||0
10840191|NCT04321252|12005584|FG004|NOT COMPLETED|Overall Study||0
10840192|NCT04321252|12005585|FG005|NOT COMPLETED|Overall Study||1
10840193|NCT04321252|12005586|FG006|NOT COMPLETED|Overall Study||0
10840194|NCT04321252|12005587|FG007|NOT COMPLETED|Overall Study||0
10840195|NCT04321252|12005588|FG008|NOT COMPLETED|Overall Study||0
10840196|NCT04285684|12005614|FG000|STARTED|Overall Study||4
10840197|NCT04285684|12005614|FG000|COMPLETED|Overall Study||4
10840198|NCT04285684|12005614|FG000|NOT COMPLETED|Overall Study||0
10840199|NCT04176445|12005618|FG000|STARTED|Overall Study||12
10840200|NCT04176445|12005619|FG001|STARTED|Overall Study||7
10840201|NCT04176445|12005618|FG000|COMPLETED|Overall Study||12
10840202|NCT04176445|12005619|FG001|COMPLETED|Overall Study||5
10840203|NCT04176445|12005618|FG000|NOT COMPLETED|Overall Study||0
10840204|NCT04176445|12005619|FG001|NOT COMPLETED|Overall Study||2
10840205|NCT04126213|12005631|FG000|STARTED|Overall Study||70
10840206|NCT04126213|12005632|FG001|STARTED|Overall Study||75
10840207|NCT04126213|12005633|FG002|STARTED|Overall Study||68
10840208|NCT04126213|12005634|FG003|STARTED|Overall Study||67
10840209|NCT04126213|12005635|FG004|STARTED|Overall Study||73
10840210|NCT04126213|12005636|FG005|STARTED|Overall Study||66
10840211|NCT04126213|12005631|FG000|COMPLETED|Overall Study||58
10840212|NCT04126213|12005632|FG001|COMPLETED|Overall Study||70
10840213|NCT04126213|12005633|FG002|COMPLETED|Overall Study||59
10840214|NCT04126213|12005634|FG003|COMPLETED|Overall Study||54
10840215|NCT04126213|12005635|FG004|COMPLETED|Overall Study||67
10840216|NCT04126213|12005636|FG005|COMPLETED|Overall Study||55
10840217|NCT04126213|12005631|FG000|NOT COMPLETED|Overall Study||12
10840218|NCT04126213|12005632|FG001|NOT COMPLETED|Overall Study||5
10840219|NCT04126213|12005633|FG002|NOT COMPLETED|Overall Study||9
10840220|NCT04126213|12005634|FG003|NOT COMPLETED|Overall Study||13
10840221|NCT04126213|12005635|FG004|NOT COMPLETED|Overall Study||6
10840222|NCT04126213|12005636|FG005|NOT COMPLETED|Overall Study||11
10840223|NCT03916458|12005653|FG000|STARTED|Overall Study||62
10840224|NCT03916458|12005653|FG000|COMPLETED|Overall Study|Out of these 62 participants, 2 participants died. But data available before censoring date for these 2 participants were observed and included in results.|62
10840225|NCT03916458|12005653|FG000|NOT COMPLETED|Overall Study||0
10840226|NCT03672188|12005672|FG000|STARTED|Overall Study||6
10840227|NCT03672188|12005673|FG001|STARTED|Overall Study||6
10840228|NCT03672188|12005674|FG002|STARTED|Overall Study||6
10840229|NCT03672188|12005675|FG003|STARTED|Overall Study||8
10840230|NCT03672188|12005676|FG004|STARTED|Overall Study||6
10840231|NCT03672188|12005677|FG005|STARTED|Overall Study||6
10840232|NCT03672188|12005678|FG006|STARTED|Overall Study||12
10840233|NCT03672188|12005679|FG007|STARTED|Overall Study||3
10840234|NCT03672188|12005680|FG008|STARTED|Overall Study||6
10840235|NCT03672188|12005681|FG009|STARTED|Overall Study||6
10840236|NCT03672188|12005682|FG010|STARTED|Overall Study||3
10840237|NCT03672188|12005683|FG011|STARTED|Overall Study||3
10840238|NCT03672188|12005684|FG012|STARTED|Overall Study||3
10840239|NCT03672188|12005685|FG013|STARTED|Overall Study||6
10840240|NCT03672188|12005686|FG014|STARTED|Overall Study||2
10840241|NCT03672188|12005672|FG000|Dosed|Overall Study||6
10840242|NCT03672188|12005673|FG001|Dosed|Overall Study||6
10840243|NCT03672188|12005674|FG002|Dosed|Overall Study||6
10840244|NCT03672188|12005675|FG003|Dosed|Overall Study|1 subject was not dosed and therefore not included in any analyses.|7
10840245|NCT03672188|12005676|FG004|Dosed|Overall Study||6
10840246|NCT03672188|12005677|FG005|Dosed|Overall Study||6
10840247|NCT03672188|12005678|FG006|Dosed|Overall Study||12
10840248|NCT03672188|12005679|FG007|Dosed|Overall Study||3
10840249|NCT03672188|12005680|FG008|Dosed|Overall Study||6
10840250|NCT03672188|12005681|FG009|Dosed|Overall Study||6
10840251|NCT03672188|12005682|FG010|Dosed|Overall Study||3
10840252|NCT03672188|12005683|FG011|Dosed|Overall Study||3
10840253|NCT03672188|12005684|FG012|Dosed|Overall Study||3
10840254|NCT03672188|12005685|FG013|Dosed|Overall Study||6
10840255|NCT03672188|12005686|FG014|Dosed|Overall Study||2
10840256|NCT03672188|12005672|FG000|COMPLETED|Overall Study||6
10840257|NCT03672188|12005673|FG001|COMPLETED|Overall Study||6
10840258|NCT03672188|12005674|FG002|COMPLETED|Overall Study|1 Subject could not attend last follow up (Week 12 visit)|5
10840259|NCT03672188|12005675|FG003|COMPLETED|Overall Study||5
10840260|NCT03672188|12005676|FG004|COMPLETED|Overall Study||6
10840261|NCT03672188|12005677|FG005|COMPLETED|Overall Study||6
10840262|NCT03672188|12005678|FG006|COMPLETED|Overall Study||12
10840263|NCT03672188|12005679|FG007|COMPLETED|Overall Study||3
10840264|NCT03672188|12005680|FG008|COMPLETED|Overall Study||6
10840265|NCT03672188|12005681|FG009|COMPLETED|Overall Study||6
10840266|NCT03672188|12005682|FG010|COMPLETED|Overall Study||3
10840267|NCT03672188|12005683|FG011|COMPLETED|Overall Study||3
10840268|NCT03672188|12005684|FG012|COMPLETED|Overall Study|1 non-treatment related SAE of suicide during follow up period|2
10840269|NCT03672188|12005685|FG013|COMPLETED|Overall Study||6
10840270|NCT03672188|12005686|FG014|COMPLETED|Overall Study||2
10840271|NCT03672188|12005672|FG000|NOT COMPLETED|Overall Study||0
10840272|NCT03672188|12005673|FG001|NOT COMPLETED|Overall Study||0
10840273|NCT03672188|12005674|FG002|NOT COMPLETED|Overall Study||1
10840274|NCT03672188|12005675|FG003|NOT COMPLETED|Overall Study||3
10840275|NCT03672188|12005676|FG004|NOT COMPLETED|Overall Study||0
10840276|NCT03672188|12005677|FG005|NOT COMPLETED|Overall Study||0
10840277|NCT03672188|12005678|FG006|NOT COMPLETED|Overall Study||0
10840278|NCT03672188|12005679|FG007|NOT COMPLETED|Overall Study||0
10840279|NCT03672188|12005680|FG008|NOT COMPLETED|Overall Study||0
10840280|NCT03672188|12005681|FG009|NOT COMPLETED|Overall Study||0
10840281|NCT03672188|12005682|FG010|NOT COMPLETED|Overall Study||0
10840282|NCT03672188|12005683|FG011|NOT COMPLETED|Overall Study||0
10840283|NCT03672188|12005684|FG012|NOT COMPLETED|Overall Study||1
10840284|NCT03672188|12005685|FG013|NOT COMPLETED|Overall Study||0
10840285|NCT03672188|12005686|FG014|NOT COMPLETED|Overall Study||0
10840286|NCT03637959|12005752|FG000|STARTED|Overall Study||270
10840287|NCT03637959|12005752|FG000|COMPLETED|Overall Study||270
10840288|NCT03637959|12005752|FG000|NOT COMPLETED|Overall Study||0
10840289|NCT03230916|12005767|FG000|STARTED|Overall Study||7
10840290|NCT03230916|12005768|FG001|STARTED|Overall Study||6
10840291|NCT03230916|12005769|FG002|STARTED|Overall Study||6
10840292|NCT03230916|12005770|FG003|STARTED|Overall Study||4
10840293|NCT03230916|12005771|FG004|STARTED|Overall Study||4
10840294|NCT03230916|12005772|FG005|STARTED|Overall Study||6
10840295|NCT03230916|12005773|FG006|STARTED|Overall Study||3
10840296|NCT03230916|12005774|FG007|STARTED|Overall Study||2
10840297|NCT03230916|12005775|FG008|STARTED|Overall Study||2
10840298|NCT03230916|12005776|FG009|STARTED|Overall Study||3
10840299|NCT03230916|12005777|FG010|STARTED|Overall Study||4
10840300|NCT03230916|12005767|FG000|Treated|Overall Study||7
10840301|NCT03230916|12005768|FG001|Treated|Overall Study||6
10840302|NCT03230916|12005769|FG002|Treated|Overall Study||6
10840303|NCT03230916|12005770|FG003|Treated|Overall Study||4
10840304|NCT03230916|12005771|FG004|Treated|Overall Study||4
10840305|NCT03230916|12005772|FG005|Treated|Overall Study||5
10840306|NCT03230916|12005773|FG006|Treated|Overall Study||3
10840307|NCT03230916|12005774|FG007|Treated|Overall Study||2
10840308|NCT03230916|12005775|FG008|Treated|Overall Study||2
10840309|NCT03230916|12005776|FG009|Treated|Overall Study||3
10840310|NCT03230916|12005777|FG010|Treated|Overall Study||4
10840311|NCT03230916|12005767|FG000|COMPLETED|Overall Study||7
10840312|NCT03230916|12005768|FG001|COMPLETED|Overall Study||6
10840313|NCT03230916|12005769|FG002|COMPLETED|Overall Study||6
10840314|NCT03230916|12005770|FG003|COMPLETED|Overall Study||4
10840315|NCT03230916|12005771|FG004|COMPLETED|Overall Study||4
10840316|NCT03230916|12005772|FG005|COMPLETED|Overall Study||5
10840317|NCT03230916|12005773|FG006|COMPLETED|Overall Study||3
10840318|NCT03230916|12005774|FG007|COMPLETED|Overall Study||2
10840319|NCT03230916|12005775|FG008|COMPLETED|Overall Study||2
10840320|NCT03230916|12005776|FG009|COMPLETED|Overall Study||3
10840321|NCT03230916|12005777|FG010|COMPLETED|Overall Study||4
10840322|NCT03230916|12005767|FG000|NOT COMPLETED|Overall Study||0
10840323|NCT03230916|12005768|FG001|NOT COMPLETED|Overall Study||0
10840324|NCT03230916|12005769|FG002|NOT COMPLETED|Overall Study||0
10840325|NCT03230916|12005770|FG003|NOT COMPLETED|Overall Study||0
10840326|NCT03230916|12005771|FG004|NOT COMPLETED|Overall Study||0
10292215|NCT00458835|11425008|FG000|STARTED|Overall Study||5
10292216|NCT00458835|11425009|FG001|STARTED|Overall Study||5
10292217|NCT00458835|11425010|FG002|STARTED|Overall Study||5
10292218|NCT00458835|11425011|FG003|STARTED|Overall Study||5
10292219|NCT00458835|11425012|FG004|STARTED|Overall Study||5
10292220|NCT00458835|11425013|FG005|STARTED|Overall Study||5
10292221|NCT00458835|11425008|FG000|COMPLETED|Overall Study||5
10292222|NCT00458835|11425009|FG001|COMPLETED|Overall Study||5
10292223|NCT00458835|11425010|FG002|COMPLETED|Overall Study||5
10292224|NCT00458835|11425011|FG003|COMPLETED|Overall Study||5
10292225|NCT00458835|11425012|FG004|COMPLETED|Overall Study||5
10292226|NCT00458835|11425013|FG005|COMPLETED|Overall Study||4
10292227|NCT00458835|11425008|FG000|NOT COMPLETED|Overall Study||0
10292228|NCT00458835|11425009|FG001|NOT COMPLETED|Overall Study||0
10292229|NCT00458835|11425010|FG002|NOT COMPLETED|Overall Study||0
10292230|NCT00458835|11425011|FG003|NOT COMPLETED|Overall Study||0
10292231|NCT00458835|11425012|FG004|NOT COMPLETED|Overall Study||0
10292232|NCT00458835|11425013|FG005|NOT COMPLETED|Overall Study||1
10292233|NCT00403559|11425023|FG000|STARTED|Overall Study||56
10292234|NCT00403559|11425024|FG001|STARTED|Overall Study||56
10292235|NCT00403559|11425023|FG000|COMPLETED|Overall Study||52
10292236|NCT00403559|11425024|FG001|COMPLETED|Overall Study||52
10292237|NCT00403559|11425023|FG000|NOT COMPLETED|Overall Study||4
10292238|NCT00403559|11425024|FG001|NOT COMPLETED|Overall Study||4
10840327|NCT03230916|12005772|FG005|NOT COMPLETED|Overall Study||1
10840328|NCT03230916|12005773|FG006|NOT COMPLETED|Overall Study||0
10840329|NCT03230916|12005774|FG007|NOT COMPLETED|Overall Study||0
10840330|NCT03230916|12005775|FG008|NOT COMPLETED|Overall Study||0
10840331|NCT03230916|12005776|FG009|NOT COMPLETED|Overall Study||0
10840332|NCT03230916|12005777|FG010|NOT COMPLETED|Overall Study||0
10840333|NCT03195894|12005820|FG000|STARTED|Overall Study||59
10840334|NCT03195894|12005821|FG001|STARTED|Overall Study||56
10840335|NCT03195894|12005820|FG000|COMPLETED|Overall Study||26
10840336|NCT03195894|12005821|FG001|COMPLETED|Overall Study||28
10840337|NCT03195894|12005820|FG000|NOT COMPLETED|Overall Study||33
10840338|NCT03195894|12005821|FG001|NOT COMPLETED|Overall Study||28
10840339|NCT03032705|12005832|FG000|STARTED|Overall Study|"Number of participants are same (repeated) for both groups~unit = teeth"|51
10840340|NCT03032705|12005833|FG001|STARTED|Overall Study|"Number of participants are same (repeated) for both groups~unit = teeth"|51
10840341|NCT03032705|12005832|FG000|Completion of Restorations (V2)|Overall Study|"Number of participants are same (repeated) for both groups~unit = teeth"|45
10840342|NCT03032705|12005833|FG001|Completion of Restorations (V2)|Overall Study|"Number of participants are same (repeated) for both groups~unit = teeth"|45
10840343|NCT03032705|12005832|FG000|COMPLETED|Overall Study|"Number of participants are same (repeated) for both groups~unit = teeth"|29
10840344|NCT03032705|12005833|FG001|COMPLETED|Overall Study|"Number of participants are same (repeated) for both groups~unit = teeth"|28
10840345|NCT03032705|12005832|FG000|NOT COMPLETED|Overall Study||22
10840346|NCT03032705|12005833|FG001|NOT COMPLETED|Overall Study||23
10292275|NCT00176436|11425047|FG000|STARTED|Overall Study||20
10292276|NCT00176436|11425048|FG001|STARTED|Overall Study||17
10292277|NCT00176436|11425047|FG000|COMPLETED|Overall Study||14
10840347|NCT02573259|12005846|FG000|STARTED|Overall Study||2
10840348|NCT02573259|12005847|FG001|STARTED|Overall Study||8
10840349|NCT02573259|12005848|FG002|STARTED|Overall Study||8
10840350|NCT02573259|12005849|FG003|STARTED|Overall Study||7
10840351|NCT02573259|12005850|FG004|STARTED|Overall Study||15
10840352|NCT02573259|12005851|FG005|STARTED|Overall Study||68
10840353|NCT02573259|12005852|FG006|STARTED|Overall Study||39
10840354|NCT02573259|12005846|FG000|Treated|Overall Study||2
10840355|NCT02573259|12005847|FG001|Treated|Overall Study||8
10840356|NCT02573259|12005848|FG002|Treated|Overall Study||8
10840357|NCT02573259|12005849|FG003|Treated|Overall Study||7
10840358|NCT02573259|12005850|FG004|Treated|Overall Study||15
10840359|NCT02573259|12005851|FG005|Treated|Overall Study||68
10840360|NCT02573259|12005852|FG006|Treated|Overall Study||38
10840361|NCT02573259|12005846|FG000|COMPLETED|Overall Study||1
10840362|NCT02573259|12005847|FG001|COMPLETED|Overall Study||0
10840363|NCT02573259|12005848|FG002|COMPLETED|Overall Study||2
10840364|NCT02573259|12005849|FG003|COMPLETED|Overall Study||1
10840365|NCT02573259|12005850|FG004|COMPLETED|Overall Study||2
10840366|NCT02573259|12005851|FG005|COMPLETED|Overall Study||10
10840367|NCT02573259|12005852|FG006|COMPLETED|Overall Study||5
10840368|NCT02573259|12005846|FG000|NOT COMPLETED|Overall Study||1
10840369|NCT02573259|12005847|FG001|NOT COMPLETED|Overall Study||8
10840370|NCT02573259|12005848|FG002|NOT COMPLETED|Overall Study||6
10840371|NCT02573259|12005849|FG003|NOT COMPLETED|Overall Study||6
10840372|NCT02573259|12005850|FG004|NOT COMPLETED|Overall Study||13
10840373|NCT02573259|12005851|FG005|NOT COMPLETED|Overall Study||58
10840374|NCT02573259|12005852|FG006|NOT COMPLETED|Overall Study||34
10840375|NCT02318329|12005894|FG000|STARTED|Overall Study||3
10840376|NCT02318329|12005895|FG001|STARTED|Overall Study||4
10840377|NCT02318329|12005896|FG002|STARTED|Overall Study||3
10840378|NCT02318329|12005897|FG003|STARTED|Overall Study||3
10840379|NCT02318329|12005898|FG004|STARTED|Overall Study||3
10840380|NCT02318329|12005899|FG005|STARTED|Overall Study||3
10840381|NCT02318329|12005900|FG006|STARTED|Overall Study||1
10840382|NCT02318329|12005901|FG007|STARTED|Overall Study||1
10840383|NCT02318329|12005902|FG008|STARTED|Overall Study||6
10840384|NCT02318329|12005903|FG009|STARTED|Overall Study||52
10840385|NCT02318329|12005894|FG000|COMPLETED|Overall Study||0
10840386|NCT02318329|12005895|FG001|COMPLETED|Overall Study||0
10840387|NCT02318329|12005896|FG002|COMPLETED|Overall Study||0
10840388|NCT02318329|12005897|FG003|COMPLETED|Overall Study||0
10840389|NCT02318329|12005898|FG004|COMPLETED|Overall Study||0
10840390|NCT02318329|12005899|FG005|COMPLETED|Overall Study||0
10840391|NCT02318329|12005900|FG006|COMPLETED|Overall Study||0
10840392|NCT02318329|12005901|FG007|COMPLETED|Overall Study||0
10840393|NCT02318329|12005902|FG008|COMPLETED|Overall Study||0
10840394|NCT02318329|12005903|FG009|COMPLETED|Overall Study||0
10840395|NCT02318329|12005894|FG000|NOT COMPLETED|Overall Study||3
10840396|NCT02318329|12005895|FG001|NOT COMPLETED|Overall Study||4
10840397|NCT02318329|12005896|FG002|NOT COMPLETED|Overall Study||3
10840398|NCT02318329|12005897|FG003|NOT COMPLETED|Overall Study||3
10840399|NCT02318329|12005898|FG004|NOT COMPLETED|Overall Study||3
10840400|NCT02318329|12005899|FG005|NOT COMPLETED|Overall Study||3
10840401|NCT02318329|12005900|FG006|NOT COMPLETED|Overall Study||1
10840402|NCT02318329|12005901|FG007|NOT COMPLETED|Overall Study||1
10840403|NCT02318329|12005902|FG008|NOT COMPLETED|Overall Study||6
10840404|NCT02318329|12005903|FG009|NOT COMPLETED|Overall Study||52
10840405|NCT01602666|12005946|FG000|STARTED|Induction Chemotherapy||107
10840406|NCT01602666|12005947|FG001|STARTED|Induction Chemotherapy||137
10840407|NCT01602666|12005946|FG000|COMPLETED|Induction Chemotherapy||70
10840408|NCT01602666|12005947|FG001|COMPLETED|Induction Chemotherapy||113
10840409|NCT01602666|12005946|FG000|NOT COMPLETED|Induction Chemotherapy||37
10840410|NCT01602666|12005947|FG001|NOT COMPLETED|Induction Chemotherapy||24
10840411|NCT01602666|12005946|FG000|STARTED|Radiation Therapy on Protocol||70
10840412|NCT01602666|12005947|FG001|STARTED|Radiation Therapy on Protocol||113
10840413|NCT01602666|12005946|FG000|Evaluable for Reduced Dose (30Gy)|Radiation Therapy on Protocol||66
10840414|NCT01602666|12005947|FG001|Evaluable for Reduced Dose (30Gy)|Radiation Therapy on Protocol||0
10840415|NCT01602666|12005946|FG000|Evaluable for Reduced Dose (18 Gy)|Radiation Therapy on Protocol||0
10840416|NCT01602666|12005947|FG001|Evaluable for Reduced Dose (18 Gy)|Radiation Therapy on Protocol||74
10840417|NCT01602666|12005946|FG000|Evaluable for RT Dose (24Gy)|Radiation Therapy on Protocol||0
10840418|NCT01602666|12005947|FG001|Evaluable for RT Dose (24Gy)|Radiation Therapy on Protocol||16
10840419|NCT01602666|12005946|FG000|COMPLETED|Radiation Therapy on Protocol||60
10840420|NCT01602666|12005947|FG001|COMPLETED|Radiation Therapy on Protocol||82
10840421|NCT01602666|12005946|FG000|NOT COMPLETED|Radiation Therapy on Protocol||10
10840422|NCT01602666|12005947|FG001|NOT COMPLETED|Radiation Therapy on Protocol||31
10840423|NCT01375959|12005957|FG000|STARTED|First Intervention (6 Weeks)||17
10840424|NCT01375959|12005958|FG001|STARTED|First Intervention (6 Weeks)||21
10840425|NCT01375959|12005957|FG000|Received Invertention|First Intervention (6 Weeks)||17
10840426|NCT01375959|12005958|FG001|Received Invertention|First Intervention (6 Weeks)||21
10840427|NCT01375959|12005957|FG000|COMPLETED|First Intervention (6 Weeks)|Two participants were withdrawn due to adverse events.|15
10840428|NCT01375959|12005958|FG001|COMPLETED|First Intervention (6 Weeks)|Three participants were withdrawn due to adverse events.|18
10840429|NCT01375959|12005957|FG000|NOT COMPLETED|First Intervention (6 Weeks)||2
10840430|NCT01375959|12005958|FG001|NOT COMPLETED|First Intervention (6 Weeks)||3
10840431|NCT01375959|12005957|FG000|STARTED|Wash-Out (3 Weeks)||15
10840432|NCT01375959|12005958|FG001|STARTED|Wash-Out (3 Weeks)||18
10840433|NCT01375959|12005957|FG000|COMPLETED|Wash-Out (3 Weeks)||15
10840434|NCT01375959|12005958|FG001|COMPLETED|Wash-Out (3 Weeks)||18
10840435|NCT01375959|12005957|FG000|NOT COMPLETED|Wash-Out (3 Weeks)||0
10840436|NCT01375959|12005958|FG001|NOT COMPLETED|Wash-Out (3 Weeks)||0
10840437|NCT01375959|12005957|FG000|STARTED|Second Intervention (6 Weeks)||15
10840438|NCT01375959|12005958|FG001|STARTED|Second Intervention (6 Weeks)||18
10840439|NCT01375959|12005957|FG000|COMPLETED|Second Intervention (6 Weeks)||15
10840440|NCT01375959|12005958|FG001|COMPLETED|Second Intervention (6 Weeks)||15
10840441|NCT01375959|12005957|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
10840442|NCT01375959|12005958|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||3
10840443|NCT01224106|12005969|FG000|STARTED|Double-Blind Treatment Phase||266
10840444|NCT01224106|12005970|FG001|STARTED|Double-Blind Treatment Phase||271
10840445|NCT01224106|12005971|FG002|STARTED|Double-Blind Treatment Phase||260
10840446|NCT01224106|12005972|FG003|STARTED|Double-Blind Treatment Phase||0
10840447|NCT01224106|12005973|FG004|STARTED|Double-Blind Treatment Phase||0
10840448|NCT01224106|12005969|FG000|COMPLETED|Double-Blind Treatment Phase||187
10840449|NCT01224106|12005970|FG001|COMPLETED|Double-Blind Treatment Phase||185
10840450|NCT01224106|12005971|FG002|COMPLETED|Double-Blind Treatment Phase||180
10840451|NCT01224106|12005972|FG003|COMPLETED|Double-Blind Treatment Phase||0
10840452|NCT01224106|12005973|FG004|COMPLETED|Double-Blind Treatment Phase||0
10840453|NCT01224106|12005969|FG000|NOT COMPLETED|Double-Blind Treatment Phase||79
10840454|NCT01224106|12005970|FG001|NOT COMPLETED|Double-Blind Treatment Phase||86
10840455|NCT01224106|12005971|FG002|NOT COMPLETED|Double-Blind Treatment Phase||80
10840456|NCT01224106|12005972|FG003|NOT COMPLETED|Double-Blind Treatment Phase||0
10840457|NCT01224106|12005973|FG004|NOT COMPLETED|Double-Blind Treatment Phase||0
10840458|NCT01224106|12005969|FG000|STARTED|Open-Label Extension (OLE) Phase||0
10840459|NCT01224106|12005970|FG001|STARTED|Open-Label Extension (OLE) Phase||0
10840460|NCT01224106|12005971|FG002|STARTED|Open-Label Extension (OLE) Phase||0
10840461|NCT01224106|12005972|FG003|STARTED|Open-Label Extension (OLE) Phase||49
10840462|NCT01224106|12005973|FG004|STARTED|Open-Label Extension (OLE) Phase||105
10840463|NCT01224106|12005969|FG000|COMPLETED|Open-Label Extension (OLE) Phase||0
10840464|NCT01224106|12005970|FG001|COMPLETED|Open-Label Extension (OLE) Phase||0
10840465|NCT01224106|12005971|FG002|COMPLETED|Open-Label Extension (OLE) Phase||0
10840466|NCT01224106|12005972|FG003|COMPLETED|Open-Label Extension (OLE) Phase||33
10840467|NCT01224106|12005973|FG004|COMPLETED|Open-Label Extension (OLE) Phase||71
10840468|NCT01224106|12005969|FG000|NOT COMPLETED|Open-Label Extension (OLE) Phase||0
10840469|NCT01224106|12005970|FG001|NOT COMPLETED|Open-Label Extension (OLE) Phase||0
10840470|NCT01224106|12005971|FG002|NOT COMPLETED|Open-Label Extension (OLE) Phase||0
10840471|NCT01224106|12005972|FG003|NOT COMPLETED|Open-Label Extension (OLE) Phase||16
10840472|NCT01224106|12005973|FG004|NOT COMPLETED|Open-Label Extension (OLE) Phase||34
10410826|NCT00764504|11554914|FG002|NOT COMPLETED|Overall Study||103
10410827|NCT00764517|11554924|FG000|STARTED|Overall Study||39
10410828|NCT00764517|11554925|FG001|STARTED|Overall Study||18
10410829|NCT00764517|11554924|FG000|COMPLETED|Overall Study||24
10410830|NCT00764517|11554925|FG001|COMPLETED|Overall Study||4
10410831|NCT00764517|11554924|FG000|NOT COMPLETED|Overall Study||15
10410832|NCT00764517|11554925|FG001|NOT COMPLETED|Overall Study||14
10410833|NCT00764660|11554933|FG000|STARTED|Overall Study||75
10410834|NCT00764660|11554934|FG001|STARTED|Overall Study||66
10410835|NCT00764660|11554933|FG000|COMPLETED|Overall Study||53
10410836|NCT00764660|11554934|FG001|COMPLETED|Overall Study||55
10410837|NCT00764660|11554933|FG000|NOT COMPLETED|Overall Study||22
10410838|NCT00764660|11554934|FG001|NOT COMPLETED|Overall Study||11
10410839|NCT00764673|11554940|FG000|STARTED|Overall Study||71
10410840|NCT00764673|11554940|FG000|COMPLETED|Overall Study||59
10410841|NCT00764673|11554940|FG000|NOT COMPLETED|Overall Study||12
10410842|NCT00764738|11554948|FG000|STARTED|Overall Study||24
10410843|NCT00764738|11554949|FG001|STARTED|Overall Study||28
10410844|NCT00764738|11554950|FG002|STARTED|Overall Study||15
10410845|NCT00764738|11554951|FG003|STARTED|Overall Study||24
10410846|NCT00764738|11554948|FG000|COMPLETED|Overall Study||22
10410847|NCT00764738|11554949|FG001|COMPLETED|Overall Study||25
10410848|NCT00764738|11554950|FG002|COMPLETED|Overall Study||12
10410849|NCT00764738|11554951|FG003|COMPLETED|Overall Study||18
10410850|NCT00764738|11554948|FG000|NOT COMPLETED|Overall Study||2
10410851|NCT00764738|11554949|FG001|NOT COMPLETED|Overall Study||3
10410852|NCT00764738|11554950|FG002|NOT COMPLETED|Overall Study||3
10410853|NCT00764738|11554951|FG003|NOT COMPLETED|Overall Study||6
10410854|NCT00764751|11554963|FG000|STARTED|Overall Study||39
10410855|NCT00764751|11554964|FG001|STARTED|Overall Study||12
10410856|NCT00764751|11554963|FG000|COMPLETED|Overall Study||37
10410857|NCT00764751|11554964|FG001|COMPLETED|Overall Study||11
10410858|NCT00764751|11554963|FG000|NOT COMPLETED|Overall Study||2
10410859|NCT00764751|11554964|FG001|NOT COMPLETED|Overall Study||1
10840473|NCT00999609|12005993|FG000|STARTED|Overall Study|Before intervention|21
10410860|NCT00764790|11554978|FG000|STARTED|Overall Study||1107
10410861|NCT00764790|11554979|FG001|STARTED|Overall Study||1106
10410862|NCT00764790|11554980|FG002|STARTED|Overall Study||1104
10410863|NCT00764790|11554978|FG000|COMPLETED|Overall Study||1069
10410864|NCT00764790|11554979|FG001|COMPLETED|Overall Study||1065
10410865|NCT00764790|11554980|FG002|COMPLETED|Overall Study||1074
10410866|NCT00764790|11554978|FG000|NOT COMPLETED|Overall Study||38
10840474|NCT00999609|12005994|FG001|STARTED|Overall Study||10
10410867|NCT00764790|11554979|FG001|NOT COMPLETED|Overall Study||41
10410868|NCT00764790|11554980|FG002|NOT COMPLETED|Overall Study||30
10410869|NCT00764868|11554988|FG000|STARTED|Overall Study||269
10840475|NCT00999609|12005993|FG000|COMPLETED|Overall Study|1 year post intervention|20
10840476|NCT00999609|12005994|FG001|COMPLETED|Overall Study|1 year post intervention|9
10840477|NCT00999609|12005993|FG000|NOT COMPLETED|Overall Study||1
10840478|NCT00999609|12005994|FG001|NOT COMPLETED|Overall Study||1
10840479|NCT00354835|12006002|FG000|STARTED|Overall Study||239
10840480|NCT00354835|12006003|FG001|STARTED|Overall Study||242
10840481|NCT00354835|12006002|FG000|COMPLETED|Overall Study||187
10840482|NCT00354835|12006003|FG001|COMPLETED|Overall Study||181
10840483|NCT00354835|12006002|FG000|NOT COMPLETED|Overall Study||52
10840484|NCT00354835|12006003|FG001|NOT COMPLETED|Overall Study||61
10840485|NCT04531241|12006024|FG000|STARTED|Period 1||68
10840486|NCT04531241|12006025|FG001|STARTED|Period 1||67
10840487|NCT04531241|12006024|FG000|COMPLETED|Period 1||64
10840488|NCT04531241|12006025|FG001|COMPLETED|Period 1||65
10840489|NCT04531241|12006024|FG000|NOT COMPLETED|Period 1||4
10840490|NCT04531241|12006025|FG001|NOT COMPLETED|Period 1||2
10840491|NCT04531241|12006024|FG000|STARTED|Period 2||64
10840492|NCT04531241|12006025|FG001|STARTED|Period 2||65
10840493|NCT04531241|12006024|FG000|COMPLETED|Period 2||63
10840494|NCT04531241|12006025|FG001|COMPLETED|Period 2||64
10840495|NCT04531241|12006024|FG000|NOT COMPLETED|Period 2||1
10840496|NCT04531241|12006025|FG001|NOT COMPLETED|Period 2||1
10840497|NCT04456153|12006033|FG000|STARTED|Overall Study||19
10840498|NCT04456153|12006034|FG001|STARTED|Overall Study||41
10292278|NCT00176436|11425048|FG001|COMPLETED|Overall Study||12
10410870|NCT00764868|11554988|FG000|COMPLETED|Overall Study||156
10410871|NCT00764868|11554988|FG000|NOT COMPLETED|Overall Study||113
10410872|NCT00764881|11554994|FG000|STARTED|Overall Study||108
10410873|NCT00764881|11554995|FG001|STARTED|Overall Study||109
10410874|NCT00764881|11554994|FG000|Subjects Received Treatment|Overall Study|Full Analysis Set (FAS)|106
10410875|NCT00764881|11554995|FG001|Subjects Received Treatment|Overall Study|Full Analysis Set (FAS)|107
10410876|NCT00764881|11554994|FG000|COMPLETED|Overall Study||92
10410877|NCT00764881|11554995|FG001|COMPLETED|Overall Study||99
10410878|NCT00764881|11554994|FG000|NOT COMPLETED|Overall Study||16
10410879|NCT00764881|11554995|FG001|NOT COMPLETED|Overall Study||10
10410880|NCT00764946|11555004|FG000|STARTED|Overall Study||98
10410881|NCT00764946|11555005|FG001|STARTED|Overall Study||89
10410882|NCT00764946|11555006|FG002|STARTED|Overall Study||22
10410883|NCT00764946|11555004|FG000|TREATED|Overall Study||97
10410884|NCT00764946|11555005|FG001|TREATED|Overall Study||88
10410885|NCT00764946|11555006|FG002|TREATED|Overall Study||21
10410886|NCT00764946|11555004|FG000|COMPLETED|Overall Study||85
10410887|NCT00764946|11555005|FG001|COMPLETED|Overall Study||72
10410888|NCT00764946|11555006|FG002|COMPLETED|Overall Study||18
10410889|NCT00764946|11555004|FG000|NOT COMPLETED|Overall Study||13
10410890|NCT00764946|11555005|FG001|NOT COMPLETED|Overall Study||17
10545032|NCT01493687|11698238|FG000|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
10840499|NCT04456153|12006033|FG000|COMPLETED|Overall Study||19
10840500|NCT04456153|12006034|FG001|COMPLETED|Overall Study||41
10840501|NCT04456153|12006033|FG000|NOT COMPLETED|Overall Study||0
10292279|NCT00176436|11425047|FG000|NOT COMPLETED|Overall Study||6
10292280|NCT00176436|11425048|FG001|NOT COMPLETED|Overall Study||5
10314285|NCT00160199|11447784|FG001|NOT COMPLETED|Overall Study||37
10314286|NCT00160251|11447796|FG000|STARTED|Prior to Amendment 2||15
10314287|NCT00160251|11447797|FG001|STARTED|Prior to Amendment 2||34
10314288|NCT00160251|11447798|FG002|STARTED|Prior to Amendment 2||48
10314289|NCT00160251|11447799|FG003|STARTED|Prior to Amendment 2||49
10314290|NCT00160251|11447800|FG004|STARTED|Prior to Amendment 2||49
10314291|NCT00160251|11447801|FG005|STARTED|Prior to Amendment 2||97
10314292|NCT00160251|11447802|FG006|STARTED|Prior to Amendment 2||65
10314293|NCT00160251|11447803|FG007|STARTED|Prior to Amendment 2||0
10314294|NCT00160251|11447796|FG000|COMPLETED|Prior to Amendment 2||6
10314295|NCT00160251|11447797|FG001|COMPLETED|Prior to Amendment 2||28
10314296|NCT00160251|11447798|FG002|COMPLETED|Prior to Amendment 2||4
10314297|NCT00160251|11447799|FG003|COMPLETED|Prior to Amendment 2||9
10314298|NCT00160251|11447800|FG004|COMPLETED|Prior to Amendment 2||21
10314299|NCT00160251|11447801|FG005|COMPLETED|Prior to Amendment 2||14
10314300|NCT00160251|11447802|FG006|COMPLETED|Prior to Amendment 2||61
10314301|NCT00160251|11447803|FG007|COMPLETED|Prior to Amendment 2||0
10314302|NCT00160251|11447796|FG000|NOT COMPLETED|Prior to Amendment 2||9
10314303|NCT00160251|11447797|FG001|NOT COMPLETED|Prior to Amendment 2||6
10314304|NCT00160251|11447798|FG002|NOT COMPLETED|Prior to Amendment 2||44
10314305|NCT00160251|11447799|FG003|NOT COMPLETED|Prior to Amendment 2||40
10314306|NCT00160251|11447800|FG004|NOT COMPLETED|Prior to Amendment 2||28
10314307|NCT00160251|11447801|FG005|NOT COMPLETED|Prior to Amendment 2||83
10314308|NCT00160251|11447802|FG006|NOT COMPLETED|Prior to Amendment 2||4
10314309|NCT00160251|11447803|FG007|NOT COMPLETED|Prior to Amendment 2||0
10314310|NCT00160251|11447796|FG000|STARTED|Post-amendment 2||0
10314311|NCT00160251|11447797|FG001|STARTED|Post-amendment 2||0
10314312|NCT00160251|11447798|FG002|STARTED|Post-amendment 2||0
10314313|NCT00160251|11447799|FG003|STARTED|Post-amendment 2||0
10314314|NCT00160251|11447800|FG004|STARTED|Post-amendment 2||0
10314315|NCT00160251|11447801|FG005|STARTED|Post-amendment 2||0
10314316|NCT00160251|11447802|FG006|STARTED|Post-amendment 2||0
10314317|NCT00160251|11447803|FG007|STARTED|Post-amendment 2||143
10314318|NCT00160251|11447796|FG000|COMPLETED|Post-amendment 2||0
10314319|NCT00160251|11447797|FG001|COMPLETED|Post-amendment 2||0
10314320|NCT00160251|11447798|FG002|COMPLETED|Post-amendment 2||0
10314321|NCT00160251|11447799|FG003|COMPLETED|Post-amendment 2||0
10314322|NCT00160251|11447800|FG004|COMPLETED|Post-amendment 2||0
10314323|NCT00160251|11447801|FG005|COMPLETED|Post-amendment 2||0
10314324|NCT00160251|11447802|FG006|COMPLETED|Post-amendment 2||0
10314325|NCT00160251|11447803|FG007|COMPLETED|Post-amendment 2||88
10314326|NCT00160251|11447796|FG000|NOT COMPLETED|Post-amendment 2||0
10314327|NCT00160251|11447797|FG001|NOT COMPLETED|Post-amendment 2||0
10314328|NCT00160251|11447798|FG002|NOT COMPLETED|Post-amendment 2||0
10314329|NCT00160251|11447799|FG003|NOT COMPLETED|Post-amendment 2||0
10314330|NCT00160251|11447800|FG004|NOT COMPLETED|Post-amendment 2||0
10840502|NCT04456153|12006034|FG001|NOT COMPLETED|Overall Study||0
10840503|NCT04351243|12006056|FG000|STARTED|Overall Study||114
10840504|NCT04351243|12006057|FG001|STARTED|Overall Study||113
10840505|NCT04351243|12006056|FG000|Completed Baseline Assessment|Overall Study||113
10840506|NCT04351243|12006057|FG001|Completed Baseline Assessment|Overall Study||112
10840507|NCT04351243|12006056|FG000|COMPLETED|Overall Study||74
10840508|NCT04351243|12006057|FG001|COMPLETED|Overall Study||75
10840509|NCT04351243|12006056|FG000|NOT COMPLETED|Overall Study||40
10840510|NCT04351243|12006057|FG001|NOT COMPLETED|Overall Study||38
10840511|NCT04312256|12006063|FG000|STARTED|Overall Study||81
10840512|NCT04312256|12006063|FG000|COMPLETED|Overall Study||81
10840513|NCT04312256|12006063|FG000|NOT COMPLETED|Overall Study||0
10840514|NCT04185220|12006070|FG000|STARTED|Dose Escalation||3
10840515|NCT04185220|12006071|FG001|STARTED|Dose Escalation||3
10840516|NCT04185220|12006070|FG000|COMPLETED|Dose Escalation||3
10840517|NCT04185220|12006071|FG001|COMPLETED|Dose Escalation||1
10840518|NCT04185220|12006070|FG000|NOT COMPLETED|Dose Escalation||0
10840519|NCT04185220|12006071|FG001|NOT COMPLETED|Dose Escalation||2
10840520|NCT04185220|12006070|FG000|STARTED|Dose Expansion||0
10840521|NCT04185220|12006071|FG001|STARTED|Dose Expansion||0
10840522|NCT04185220|12006070|FG000|COMPLETED|Dose Expansion||0
10840523|NCT04185220|12006071|FG001|COMPLETED|Dose Expansion||0
10840524|NCT04185220|12006070|FG000|NOT COMPLETED|Dose Expansion||0
10840525|NCT04185220|12006071|FG001|NOT COMPLETED|Dose Expansion||0
10840526|NCT03851107|12006078|FG000|STARTED|Overall Study||9
10840527|NCT03851107|12006078|FG000|COMPLETED|Overall Study||7
10840528|NCT03851107|12006078|FG000|NOT COMPLETED|Overall Study||2
10840529|NCT03600714|12006088|FG000|STARTED|Overall Study||26
10840530|NCT03600714|12006088|FG000|COMPLETED|Overall Study||25
10840531|NCT03600714|12006088|FG000|NOT COMPLETED|Overall Study||1
10840532|NCT03479307|12006095|FG000|STARTED|Overall Study||91
10840533|NCT03479307|12006096|FG001|STARTED|Overall Study||90
10840534|NCT03479307|12006097|FG002|STARTED|Overall Study||47
10840535|NCT03479307|12006095|FG000|COMPLETED|Overall Study||90
10840536|NCT03479307|12006096|FG001|COMPLETED|Overall Study||89
10840537|NCT03479307|12006097|FG002|COMPLETED|Overall Study||47
10840538|NCT03479307|12006095|FG000|NOT COMPLETED|Overall Study||1
10840539|NCT03479307|12006096|FG001|NOT COMPLETED|Overall Study||1
10840540|NCT03479307|12006097|FG002|NOT COMPLETED|Overall Study||0
10840541|NCT03470441|12006109|FG000|STARTED|Overall Study||29
10840542|NCT03470441|12006110|FG001|STARTED|Overall Study||31
10840543|NCT03470441|12006111|FG002|STARTED|Overall Study||31
10840544|NCT03470441|12006112|FG003|STARTED|Overall Study||29
10840545|NCT03470441|12006109|FG000|COMPLETED|Overall Study||28
10840546|NCT03470441|12006110|FG001|COMPLETED|Overall Study||26
10840547|NCT03470441|12006111|FG002|COMPLETED|Overall Study||29
10840548|NCT03470441|12006112|FG003|COMPLETED|Overall Study||25
10840549|NCT03470441|12006109|FG000|NOT COMPLETED|Overall Study||1
10840550|NCT03470441|12006110|FG001|NOT COMPLETED|Overall Study||5
10840551|NCT03470441|12006111|FG002|NOT COMPLETED|Overall Study||2
10840552|NCT03470441|12006112|FG003|NOT COMPLETED|Overall Study||4
10840553|NCT03452397|12006126|FG000|STARTED|Overall Study||41
10840554|NCT03452397|12006127|FG001|STARTED|Overall Study||41
10840555|NCT03452397|12006128|FG002|STARTED|Overall Study||41
10840556|NCT03452397|12006129|FG003|STARTED|Overall Study||42
10840557|NCT03452397|12006126|FG000|COMPLETED|Overall Study||40
10840558|NCT03452397|12006127|FG001|COMPLETED|Overall Study||41
10840559|NCT03452397|12006128|FG002|COMPLETED|Overall Study||39
10840560|NCT03452397|12006129|FG003|COMPLETED|Overall Study||41
10840561|NCT03452397|12006126|FG000|NOT COMPLETED|Overall Study||1
10840562|NCT03452397|12006127|FG001|NOT COMPLETED|Overall Study||0
10840563|NCT03452397|12006128|FG002|NOT COMPLETED|Overall Study||2
10840564|NCT03452397|12006129|FG003|NOT COMPLETED|Overall Study||1
10840565|NCT03448939|12006143|FG000|STARTED|Overall Study||243
10840566|NCT03448939|12006144|FG001|STARTED|Overall Study||118
10840567|NCT03448939|12006143|FG000|Received at Least 1 Dose of Study Drug|Overall Study||239
10840568|NCT03448939|12006144|FG001|Received at Least 1 Dose of Study Drug|Overall Study||113
10840569|NCT03448939|12006143|FG000|COMPLETED|Overall Study||222
10840570|NCT03448939|12006144|FG001|COMPLETED|Overall Study||107
10840571|NCT03448939|12006143|FG000|NOT COMPLETED|Overall Study||21
10840572|NCT03448939|12006144|FG001|NOT COMPLETED|Overall Study||11
10840573|NCT03377803|12006152|FG000|STARTED|Overall Study||150
10840574|NCT03377803|12006153|FG001|STARTED|Overall Study||112
10840575|NCT03377803|12006152|FG000|COMPLETED|Overall Study||139
10840576|NCT03377803|12006153|FG001|COMPLETED|Overall Study||108
10840577|NCT03377803|12006152|FG000|NOT COMPLETED|Overall Study||11
10840578|NCT03377803|12006153|FG001|NOT COMPLETED|Overall Study||4
10840579|NCT03283371|12006161|FG000|STARTED|Placebo-controlled||34
10840580|NCT03283371|12006162|FG001|STARTED|Placebo-controlled||33
10840581|NCT03283371|12006163|FG002|STARTED|Placebo-controlled||0
10840582|NCT03283371|12006164|FG003|STARTED|Placebo-controlled||0
10840583|NCT03283371|12006161|FG000|Number of Participants Dosed|Placebo-controlled||34
10840584|NCT03283371|12006162|FG001|Number of Participants Dosed|Placebo-controlled||32
10840585|NCT03283371|12006163|FG002|Number of Participants Dosed|Placebo-controlled||0
10840586|NCT03283371|12006164|FG003|Number of Participants Dosed|Placebo-controlled||0
10840587|NCT03283371|12006161|FG000|COMPLETED|Placebo-controlled||31
10840588|NCT03283371|12006162|FG001|COMPLETED|Placebo-controlled||30
10840589|NCT03283371|12006163|FG002|COMPLETED|Placebo-controlled||0
10840590|NCT03283371|12006164|FG003|COMPLETED|Placebo-controlled||0
10840591|NCT03283371|12006161|FG000|NOT COMPLETED|Placebo-controlled||3
10840592|NCT03283371|12006162|FG001|NOT COMPLETED|Placebo-controlled||3
10840593|NCT03283371|12006163|FG002|NOT COMPLETED|Placebo-controlled||0
10840594|NCT03283371|12006164|FG003|NOT COMPLETED|Placebo-controlled||0
10840595|NCT03283371|12006161|FG000|STARTED|Open-label Phase||0
10840596|NCT03283371|12006162|FG001|STARTED|Open-label Phase||0
10840597|NCT03283371|12006163|FG002|STARTED|Open-label Phase||31
10840598|NCT03283371|12006164|FG003|STARTED|Open-label Phase||30
10840599|NCT03283371|12006161|FG000|COMPLETED|Open-label Phase||0
10840600|NCT03283371|12006162|FG001|COMPLETED|Open-label Phase||0
10840601|NCT03283371|12006163|FG002|COMPLETED|Open-label Phase||27
10840602|NCT03283371|12006164|FG003|COMPLETED|Open-label Phase||29
10840603|NCT03283371|12006161|FG000|NOT COMPLETED|Open-label Phase||0
10840604|NCT03283371|12006162|FG001|NOT COMPLETED|Open-label Phase||0
10840605|NCT03283371|12006163|FG002|NOT COMPLETED|Open-label Phase||4
10840606|NCT03283371|12006164|FG003|NOT COMPLETED|Open-label Phase||1
10840607|NCT03257254|12006174|FG000|STARTED|Overall Study||76
10840608|NCT03257254|12006174|FG000|COMPLETED|Overall Study||55
10840609|NCT03257254|12006174|FG000|NOT COMPLETED|Overall Study||21
10840610|NCT03084718|12006183|FG000|STARTED|Overall Study||120
10840611|NCT03084718|12006184|FG001|STARTED|Overall Study||120
10840612|NCT03084718|12006185|FG002|STARTED|Overall Study||122
10840613|NCT03084718|12006186|FG003|STARTED|Overall Study||124
10840614|NCT03084718|12006187|FG004|STARTED|Overall Study||124
10840615|NCT03084718|12006183|FG000|COMPLETED|Overall Study||109
10840616|NCT03084718|12006184|FG001|COMPLETED|Overall Study||110
10840617|NCT03084718|12006185|FG002|COMPLETED|Overall Study||110
10840618|NCT03084718|12006186|FG003|COMPLETED|Overall Study||110
10840619|NCT03084718|12006187|FG004|COMPLETED|Overall Study||120
10840620|NCT03084718|12006183|FG000|NOT COMPLETED|Overall Study||11
10840621|NCT03084718|12006184|FG001|NOT COMPLETED|Overall Study||10
10840622|NCT03084718|12006185|FG002|NOT COMPLETED|Overall Study||12
10840623|NCT03084718|12006186|FG003|NOT COMPLETED|Overall Study||14
10840624|NCT03084718|12006187|FG004|NOT COMPLETED|Overall Study||4
10840625|NCT03069417|12006204|FG000|STARTED|Overall Study||14
10840626|NCT03069417|12006205|FG001|STARTED|Overall Study||9
10410891|NCT00764946|11555006|FG002|NOT COMPLETED|Overall Study||4
10410892|NCT00765037|11555020|FG000|STARTED|Overall Study|Original number of eligible subjects who signed a consent form.|19
10410893|NCT00765037|11555020|FG000|COMPLETED|Overall Study|Subjects who came in for 1 year visit.|13
10410894|NCT00765037|11555020|FG000|NOT COMPLETED|Overall Study||6
10410895|NCT00765063|11555024|FG000|STARTED|Overall Study||62
10410896|NCT00765063|11555024|FG000|COMPLETED|Overall Study||30
10410897|NCT00765063|11555024|FG000|NOT COMPLETED|Overall Study||32
10410898|NCT00765076|11555031|FG000|STARTED|Overall Study||69
10410899|NCT00765076|11555032|FG001|STARTED|Overall Study||73
10410900|NCT00765076|11555033|FG002|STARTED|Overall Study||50
10410901|NCT00765076|11555031|FG000|COMPLETED|Overall Study||68
10410902|NCT00765076|11555032|FG001|COMPLETED|Overall Study||73
10410903|NCT00765076|11555033|FG002|COMPLETED|Overall Study||49
10410904|NCT00765076|11555031|FG000|NOT COMPLETED|Overall Study||1
10410905|NCT00765076|11555032|FG001|NOT COMPLETED|Overall Study||0
10410906|NCT00765076|11555033|FG002|NOT COMPLETED|Overall Study||1
10410907|NCT00765102|11555041|FG000|STARTED|Overall Study||32
10410908|NCT00765102|11555041|FG000|COMPLETED|Overall Study|Completed 8 cycles of treatment|1
10410909|NCT00765102|11555041|FG000|NOT COMPLETED|Overall Study||31
10410910|NCT00765128|11555049|FG000|STARTED|Overall Study||8
10410911|NCT00765128|11555050|FG001|STARTED|Overall Study||9
10410912|NCT00765128|11555049|FG000|COMPLETED|Overall Study||8
10410913|NCT00765128|11555050|FG001|COMPLETED|Overall Study||9
10410914|NCT00765128|11555049|FG000|NOT COMPLETED|Overall Study||0
10410915|NCT00765128|11555050|FG001|NOT COMPLETED|Overall Study||0
10410916|NCT00765193|11555056|FG000|STARTED|Problem Area Examination||14381
10410917|NCT00765193|11555056|FG000|COMPLETED|Problem Area Examination||14381
10410918|NCT00765193|11555056|FG000|NOT COMPLETED|Problem Area Examination||0
10410919|NCT00765193|11555056|FG000|STARTED|Full Body Examination||14381
10410920|NCT00765193|11555056|FG000|COMPLETED|Full Body Examination||14381
10410921|NCT00765193|11555056|FG000|NOT COMPLETED|Full Body Examination||0
10410922|NCT00765206|11555061|FG000|STARTED|First Intervention||15
10410923|NCT00765206|11555062|FG001|STARTED|First Intervention||15
10410924|NCT00765206|11555063|FG002|STARTED|First Intervention||15
10410925|NCT00765206|11555064|FG003|STARTED|First Intervention||15
10410926|NCT00765206|11555061|FG000|COMPLETED|First Intervention||15
10410927|NCT00765206|11555062|FG001|COMPLETED|First Intervention||15
10410928|NCT00765206|11555063|FG002|COMPLETED|First Intervention||15
10410929|NCT00765206|11555064|FG003|COMPLETED|First Intervention||15
10410930|NCT00765206|11555061|FG000|NOT COMPLETED|First Intervention||0
10410931|NCT00765206|11555062|FG001|NOT COMPLETED|First Intervention||0
10410932|NCT00765206|11555063|FG002|NOT COMPLETED|First Intervention||0
10410933|NCT00765206|11555064|FG003|NOT COMPLETED|First Intervention||0
10410934|NCT00765206|11555061|FG000|STARTED|Washout Period of 14 Days||15
10410935|NCT00765206|11555062|FG001|STARTED|Washout Period of 14 Days||15
10410936|NCT00765206|11555063|FG002|STARTED|Washout Period of 14 Days||15
10410937|NCT00765206|11555064|FG003|STARTED|Washout Period of 14 Days||15
10410938|NCT00765206|11555061|FG000|COMPLETED|Washout Period of 14 Days||15
10410939|NCT00765206|11555062|FG001|COMPLETED|Washout Period of 14 Days||15
10410940|NCT00765206|11555063|FG002|COMPLETED|Washout Period of 14 Days||15
10410941|NCT00765206|11555064|FG003|COMPLETED|Washout Period of 14 Days||15
10410942|NCT00765206|11555061|FG000|NOT COMPLETED|Washout Period of 14 Days||0
10410943|NCT00765206|11555062|FG001|NOT COMPLETED|Washout Period of 14 Days||0
10410944|NCT00765206|11555063|FG002|NOT COMPLETED|Washout Period of 14 Days||0
10410945|NCT00765206|11555064|FG003|NOT COMPLETED|Washout Period of 14 Days||0
10410946|NCT00765206|11555061|FG000|STARTED|Second Intervention||15
10410947|NCT00765206|11555062|FG001|STARTED|Second Intervention||15
10410948|NCT00765206|11555063|FG002|STARTED|Second Intervention||15
10410949|NCT00765206|11555064|FG003|STARTED|Second Intervention||15
10410950|NCT00765206|11555061|FG000|COMPLETED|Second Intervention||15
10410951|NCT00765206|11555062|FG001|COMPLETED|Second Intervention||15
10410952|NCT00765206|11555063|FG002|COMPLETED|Second Intervention||15
10410953|NCT00765206|11555064|FG003|COMPLETED|Second Intervention||15
10410954|NCT00765206|11555061|FG000|NOT COMPLETED|Second Intervention||0
10410955|NCT00765206|11555062|FG001|NOT COMPLETED|Second Intervention||0
10410956|NCT00765206|11555063|FG002|NOT COMPLETED|Second Intervention||0
10410957|NCT00765206|11555064|FG003|NOT COMPLETED|Second Intervention||0
10410958|NCT00765232|11555072|FG000|STARTED|Overall Study||57
10410959|NCT00765232|11555073|FG001|STARTED|Overall Study||54
10410960|NCT00765232|11555072|FG000|COMPLETED|Overall Study||57
10410961|NCT00765232|11555073|FG001|COMPLETED|Overall Study||54
10410962|NCT00765232|11555072|FG000|NOT COMPLETED|Overall Study||0
10840627|NCT03069417|12006204|FG000|Post-Treatment Assessment|Overall Study||12
10840628|NCT03069417|12006205|FG001|Post-Treatment Assessment|Overall Study||6
10410963|NCT00765232|11555073|FG001|NOT COMPLETED|Overall Study||0
10840629|NCT03069417|12006204|FG000|COMPLETED|Overall Study||8
10840630|NCT03069417|12006205|FG001|COMPLETED|Overall Study||2
10840631|NCT03069417|12006204|FG000|NOT COMPLETED|Overall Study||6
10840632|NCT03069417|12006205|FG001|NOT COMPLETED|Overall Study||7
10840633|NCT03063164|12006212|FG000|STARTED|Overall Study||7
10840634|NCT03063164|12006213|FG001|STARTED|Overall Study||7
10840635|NCT03063164|12006212|FG000|COMPLETED|Overall Study||7
10840636|NCT03063164|12006213|FG001|COMPLETED|Overall Study||7
10840637|NCT03063164|12006212|FG000|NOT COMPLETED|Overall Study||0
10840638|NCT03063164|12006213|FG001|NOT COMPLETED|Overall Study||0
10840639|NCT02952365|12006220|FG000|STARTED|Overall Study||2
10840640|NCT02952365|12006220|FG000|COMPLETED|Overall Study||2
10840641|NCT02952365|12006220|FG000|NOT COMPLETED|Overall Study||0
10840642|NCT02936323|12006234|FG000|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|2
10840643|NCT02936323|12006235|FG001|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|3
10840644|NCT02936323|12006236|FG002|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|3
10840645|NCT02936323|12006237|FG003|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|3
10840646|NCT02936323|12006238|FG004|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|3
10840647|NCT02936323|12006239|FG005|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|6
10840648|NCT02936323|12006240|FG006|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|3
10840649|NCT02936323|12006241|FG007|STARTED|Phase 1 Dose Escalation||0
10840650|NCT02936323|12006242|FG008|STARTED|Phase 1 Dose Escalation||0
10840651|NCT02936323|12006243|FG009|STARTED|Phase 1 Dose Escalation||0
10840652|NCT02936323|12006234|FG000|COMPLETED|Phase 1 Dose Escalation||0
10840653|NCT02936323|12006235|FG001|COMPLETED|Phase 1 Dose Escalation||1
10840654|NCT02936323|12006236|FG002|COMPLETED|Phase 1 Dose Escalation||0
10840655|NCT02936323|12006237|FG003|COMPLETED|Phase 1 Dose Escalation||1
10840656|NCT02936323|12006238|FG004|COMPLETED|Phase 1 Dose Escalation||0
10840657|NCT02936323|12006239|FG005|COMPLETED|Phase 1 Dose Escalation||1
10840658|NCT02936323|12006240|FG006|COMPLETED|Phase 1 Dose Escalation||0
10840659|NCT02936323|12006241|FG007|COMPLETED|Phase 1 Dose Escalation||0
10840660|NCT02936323|12006242|FG008|COMPLETED|Phase 1 Dose Escalation||0
10840661|NCT02936323|12006243|FG009|COMPLETED|Phase 1 Dose Escalation||0
10840662|NCT02936323|12006234|FG000|NOT COMPLETED|Phase 1 Dose Escalation||2
10840663|NCT02936323|12006235|FG001|NOT COMPLETED|Phase 1 Dose Escalation||2
10840664|NCT02936323|12006236|FG002|NOT COMPLETED|Phase 1 Dose Escalation||3
10840665|NCT02936323|12006237|FG003|NOT COMPLETED|Phase 1 Dose Escalation||2
10840666|NCT02936323|12006238|FG004|NOT COMPLETED|Phase 1 Dose Escalation||3
10840667|NCT02936323|12006239|FG005|NOT COMPLETED|Phase 1 Dose Escalation||5
10840668|NCT02936323|12006240|FG006|NOT COMPLETED|Phase 1 Dose Escalation||3
10840669|NCT02936323|12006241|FG007|NOT COMPLETED|Phase 1 Dose Escalation||0
10840670|NCT02936323|12006242|FG008|NOT COMPLETED|Phase 1 Dose Escalation||0
10840671|NCT02936323|12006243|FG009|NOT COMPLETED|Phase 1 Dose Escalation||0
10840672|NCT02936323|12006234|FG000|STARTED|Phase 2a Dose Expansion||0
10840673|NCT02936323|12006235|FG001|STARTED|Phase 2a Dose Expansion||0
10840674|NCT02936323|12006236|FG002|STARTED|Phase 2a Dose Expansion||0
10840675|NCT02936323|12006237|FG003|STARTED|Phase 2a Dose Expansion||0
10840676|NCT02936323|12006238|FG004|STARTED|Phase 2a Dose Expansion||0
10840677|NCT02936323|12006239|FG005|STARTED|Phase 2a Dose Expansion||0
10840678|NCT02936323|12006240|FG006|STARTED|Phase 2a Dose Expansion||0
10840679|NCT02936323|12006241|FG007|STARTED|Phase 2a Dose Expansion|Participants in Phase 2a did not participate in Phase 1|32
10840680|NCT02936323|12006242|FG008|STARTED|Phase 2a Dose Expansion|Participants in Phase 2a did not participate in Phase 1|15
10840681|NCT02936323|12006243|FG009|STARTED|Phase 2a Dose Expansion|Participants in Phase 2a did not participate in Phase 1|19
10840682|NCT02936323|12006234|FG000|COMPLETED|Phase 2a Dose Expansion||0
10840683|NCT02936323|12006235|FG001|COMPLETED|Phase 2a Dose Expansion||0
10840684|NCT02936323|12006236|FG002|COMPLETED|Phase 2a Dose Expansion||0
10840685|NCT02936323|12006237|FG003|COMPLETED|Phase 2a Dose Expansion||0
10840686|NCT02936323|12006238|FG004|COMPLETED|Phase 2a Dose Expansion||0
10840687|NCT02936323|12006239|FG005|COMPLETED|Phase 2a Dose Expansion||0
10840688|NCT02936323|12006240|FG006|COMPLETED|Phase 2a Dose Expansion||0
10840689|NCT02936323|12006241|FG007|COMPLETED|Phase 2a Dose Expansion||15
10840690|NCT02936323|12006242|FG008|COMPLETED|Phase 2a Dose Expansion||2
10840691|NCT02936323|12006243|FG009|COMPLETED|Phase 2a Dose Expansion||5
10840692|NCT02936323|12006234|FG000|NOT COMPLETED|Phase 2a Dose Expansion||0
10840693|NCT02936323|12006235|FG001|NOT COMPLETED|Phase 2a Dose Expansion||0
10840694|NCT02936323|12006236|FG002|NOT COMPLETED|Phase 2a Dose Expansion||0
10840695|NCT02936323|12006237|FG003|NOT COMPLETED|Phase 2a Dose Expansion||0
10840696|NCT02936323|12006238|FG004|NOT COMPLETED|Phase 2a Dose Expansion||0
10840697|NCT02936323|12006239|FG005|NOT COMPLETED|Phase 2a Dose Expansion||0
10840698|NCT02936323|12006240|FG006|NOT COMPLETED|Phase 2a Dose Expansion||0
10410964|NCT00765245|11555081|FG000|STARTED|Overall Study||22
10410965|NCT00765245|11555082|FG001|STARTED|Overall Study||22
10410966|NCT00765245|11555081|FG000|COMPLETED|Overall Study||9
10410967|NCT00765245|11555082|FG001|COMPLETED|Overall Study||20
10410968|NCT00765245|11555081|FG000|NOT COMPLETED|Overall Study||13
10410969|NCT00765245|11555082|FG001|NOT COMPLETED|Overall Study||2
10410970|NCT00765336|11555090|FG000|STARTED|Overall Study||91
10410971|NCT00765336|11555091|FG001|STARTED|Overall Study||89
10410972|NCT00765336|11555090|FG000|COMPLETED|Overall Study||72
10410973|NCT00765336|11555091|FG001|COMPLETED|Overall Study||73
10410974|NCT00765336|11555090|FG000|NOT COMPLETED|Overall Study||19
10410975|NCT00765336|11555091|FG001|NOT COMPLETED|Overall Study||16
10410976|NCT00765362|11555097|FG000|STARTED|Overall Study||419
10840699|NCT02936323|12006241|FG007|NOT COMPLETED|Phase 2a Dose Expansion||17
10840700|NCT02936323|12006242|FG008|NOT COMPLETED|Phase 2a Dose Expansion||13
10840701|NCT02936323|12006243|FG009|NOT COMPLETED|Phase 2a Dose Expansion||14
10840702|NCT02631837|12006277|FG000|STARTED|Overall Study||35
10840703|NCT02631837|12006278|FG001|STARTED|Overall Study||35
10840704|NCT02631837|12006277|FG000|COMPLETED|Overall Study||35
10840705|NCT02631837|12006278|FG001|COMPLETED|Overall Study||35
10840706|NCT02631837|12006277|FG000|NOT COMPLETED|Overall Study||0
10840707|NCT02631837|12006278|FG001|NOT COMPLETED|Overall Study||0
10292281|NCT04749459|11425054|FG000|STARTED|Overall Study||14
10292282|NCT04749459|11425054|FG000|CSM Classic|Overall Study||12
10292283|NCT04749459|11425054|FG000|CSM Strawberry Flavor|Overall Study||10
10292284|NCT04749459|11425054|FG000|P2 Control Standard|Overall Study||14
10292285|NCT04749459|11425054|FG000|COMPLETED|Overall Study||14
10292286|NCT04749459|11425054|FG000|NOT COMPLETED|Overall Study||0
10292287|NCT04702984|11425065|FG000|STARTED|Overall Study||39
10292288|NCT04702984|11425065|FG000|COMPLETED|Overall Study||38
10292289|NCT04702984|11425065|FG000|NOT COMPLETED|Overall Study||1
10292290|NCT04633564|11425073|FG000|STARTED|Period 1||335
10292291|NCT04633564|11425074|FG001|STARTED|Period 1||329
10292292|NCT04633564|11425073|FG000|COMPLETED|Period 1||227
10292293|NCT04633564|11425074|FG001|COMPLETED|Period 1||220
10840718|NCT02429791|12006295|FG000|STARTED|Early Switch Phase (Up to Week 52)||252
10840719|NCT02429791|12006296|FG001|STARTED|Early Switch Phase (Up to Week 52)||256
10840720|NCT02429791|12006295|FG000|COMPLETED|Early Switch Phase (Up to Week 52)||239
10840721|NCT02429791|12006296|FG001|COMPLETED|Early Switch Phase (Up to Week 52)||238
10840722|NCT02429791|12006295|FG000|NOT COMPLETED|Early Switch Phase (Up to Week 52)||13
10840723|NCT02429791|12006296|FG001|NOT COMPLETED|Early Switch Phase (Up to Week 52)||18
10840724|NCT02429791|12006295|FG000|STARTED|Late Switch Phase (Week 52 to Week 148)||239
10840725|NCT02429791|12006296|FG001|STARTED|Late Switch Phase (Week 52 to Week 148)||238
10840726|NCT02429791|12006295|FG000|COMPLETED|Late Switch Phase (Week 52 to Week 148)||214
10840727|NCT02429791|12006296|FG001|COMPLETED|Late Switch Phase (Week 52 to Week 148)||210
10840728|NCT02429791|12006295|FG000|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||25
10840729|NCT02429791|12006296|FG001|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||28
10840730|NCT02422797|12006311|FG000|STARTED|Early Switch Phase (Up to Week 52)||261
10840731|NCT02422797|12006312|FG001|STARTED|Early Switch Phase (Up to Week 52)||255
10840732|NCT02422797|12006311|FG000|COMPLETED|Early Switch Phase (Up to Week 52)||245
10840733|NCT02422797|12006312|FG001|COMPLETED|Early Switch Phase (Up to Week 52)||239
10840734|NCT02422797|12006311|FG000|NOT COMPLETED|Early Switch Phase (Up to Week 52)||16
10840735|NCT02422797|12006312|FG001|NOT COMPLETED|Early Switch Phase (Up to Week 52)||16
10840736|NCT02422797|12006311|FG000|STARTED|Late Switch Phase (Week 52 to Week 148)||245
10840737|NCT02422797|12006312|FG001|STARTED|Late Switch Phase (Week 52 to Week 148)||239
10840738|NCT02422797|12006311|FG000|COMPLETED|Late Switch Phase (Week 52 to Week 148)||222
10840739|NCT02422797|12006312|FG001|COMPLETED|Late Switch Phase (Week 52 to Week 148)||221
10840740|NCT02422797|12006311|FG000|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||23
10840741|NCT02422797|12006312|FG001|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||18
10840742|NCT02287493|12006330|FG000|STARTED|Overall Study||19
10840743|NCT02287493|12006331|FG001|STARTED|Overall Study||16
10840744|NCT02287493|12006330|FG000|COMPLETED|Overall Study||19
10840745|NCT02287493|12006331|FG001|COMPLETED|Overall Study||16
10840746|NCT02287493|12006330|FG000|NOT COMPLETED|Overall Study||0
10840747|NCT02287493|12006331|FG001|NOT COMPLETED|Overall Study||0
10840748|NCT02132611|12006341|FG000|STARTED|Overall Study||100
10840749|NCT02132611|12006341|FG000|COMPLETED|Overall Study||98
10840750|NCT02132611|12006341|FG000|NOT COMPLETED|Overall Study||2
10840751|NCT01147822|12006347|FG000|STARTED|Overall Study||188
10840752|NCT01147822|12006348|FG001|STARTED|Overall Study||179
10840753|NCT01147822|12006347|FG000|Not Completed/Ongoing|Overall Study||111
10840754|NCT01147822|12006348|FG001|Not Completed/Ongoing|Overall Study||102
10840755|NCT01147822|12006347|FG000|COMPLETED|Overall Study||0
10840756|NCT01147822|12006348|FG001|COMPLETED|Overall Study||0
10840757|NCT01147822|12006347|FG000|NOT COMPLETED|Overall Study||188
10840758|NCT01147822|12006348|FG001|NOT COMPLETED|Overall Study||179
10840759|NCT00328653|12006357|FG000|STARTED|Period I||40
10840760|NCT00328653|12006358|FG001|STARTED|Period I||39
10840761|NCT00328653|12006359|FG002|STARTED|Period I||39
10840762|NCT00328653|12006357|FG000|COMPLETED|Period I||36
10840763|NCT00328653|12006358|FG001|COMPLETED|Period I||39
10840764|NCT00328653|12006359|FG002|COMPLETED|Period I||36
10840765|NCT00328653|12006357|FG000|NOT COMPLETED|Period I||4
10840766|NCT00328653|12006358|FG001|NOT COMPLETED|Period I||0
10840767|NCT00328653|12006359|FG002|NOT COMPLETED|Period I||3
10840768|NCT00328653|12006357|FG000|STARTED|Period II|Following completion of the first period of the trial, all patients were to be administered NOVA22007 (i.e. CsA 0.05% or 0.1%) as four times or twice daily instillations in both eyes for an additional 3 month period.|0
10840769|NCT00328653|12006358|FG001|STARTED|Period II||58
10840770|NCT00328653|12006359|FG002|STARTED|Period II||53
10840771|NCT00328653|12006357|FG000|COMPLETED|Period II||0
10840772|NCT00328653|12006358|FG001|COMPLETED|Period II||50
10840773|NCT00328653|12006359|FG002|COMPLETED|Period II||49
10840774|NCT00328653|12006357|FG000|NOT COMPLETED|Period II||0
10840775|NCT00328653|12006358|FG001|NOT COMPLETED|Period II||8
10840776|NCT00328653|12006359|FG002|NOT COMPLETED|Period II||4
10292294|NCT04633564|11425073|FG000|NOT COMPLETED|Period 1||108
10292295|NCT04633564|11425074|FG001|NOT COMPLETED|Period 1||109
10840777|NCT04476251|12006369|FG000|STARTED|Overall Study||1
10840778|NCT04476251|12006369|FG000|COMPLETED|Overall Study||0
10840779|NCT04476251|12006369|FG000|NOT COMPLETED|Overall Study||1
10840780|NCT03924765|12006373|FG000|STARTED|Overall Study||5
10840781|NCT03924765|12006373|FG000|COMPLETED|Overall Study||5
10840782|NCT03924765|12006373|FG000|NOT COMPLETED|Overall Study||0
10840783|NCT03915860|12006377|FG000|STARTED|Overall Study||47
10840784|NCT03915860|12006377|FG000|Treated|Overall Study||46
10840785|NCT03915860|12006377|FG000|COMPLETED|Overall Study||33
10840786|NCT03915860|12006377|FG000|NOT COMPLETED|Overall Study||14
10840787|NCT03817606|12006383|FG000|STARTED|Overall Study||2
10840788|NCT03817606|12006384|FG001|STARTED|Overall Study||2
10840789|NCT03817606|12006383|FG000|COMPLETED|Overall Study||0
10840790|NCT03817606|12006384|FG001|COMPLETED|Overall Study||0
10840791|NCT03817606|12006383|FG000|NOT COMPLETED|Overall Study||2
10840792|NCT03817606|12006384|FG001|NOT COMPLETED|Overall Study||2
10840793|NCT03795233|12006396|FG000|STARTED|Overall Study||4
10840794|NCT03795233|12006397|FG001|STARTED|Overall Study||1
10840795|NCT03795233|12006396|FG000|COMPLETED|Overall Study||0
10840796|NCT03795233|12006397|FG001|COMPLETED|Overall Study||0
10840797|NCT03795233|12006396|FG000|NOT COMPLETED|Overall Study||4
10840798|NCT03795233|12006397|FG001|NOT COMPLETED|Overall Study||1
10840799|NCT03786380|12006408|FG000|STARTED|Overall Study||35
10840800|NCT03786380|12006409|FG001|STARTED|Overall Study||22
10840801|NCT03786380|12006410|FG002|STARTED|Overall Study||54
10840802|NCT03786380|12006411|FG003|STARTED|Overall Study||63
10840803|NCT03786380|12006412|FG004|STARTED|Overall Study||28
10840804|NCT03786380|12006408|FG000|Safety Population|Overall Study||35
10840805|NCT03786380|12006409|FG001|Safety Population|Overall Study||22
10840806|NCT03786380|12006410|FG002|Safety Population|Overall Study||54
10840807|NCT03786380|12006411|FG003|Safety Population|Overall Study||62
10840808|NCT03786380|12006412|FG004|Safety Population|Overall Study||28
10840809|NCT03786380|12006408|FG000|COMPLETED|Overall Study||0
10840810|NCT03786380|12006409|FG001|COMPLETED|Overall Study||0
10840811|NCT03786380|12006410|FG002|COMPLETED|Overall Study||0
10840812|NCT03786380|12006411|FG003|COMPLETED|Overall Study||0
10840813|NCT03786380|12006412|FG004|COMPLETED|Overall Study||0
10840814|NCT03786380|12006408|FG000|NOT COMPLETED|Overall Study||35
10840815|NCT03786380|12006409|FG001|NOT COMPLETED|Overall Study||22
10840816|NCT03786380|12006410|FG002|NOT COMPLETED|Overall Study||54
10840817|NCT03786380|12006411|FG003|NOT COMPLETED|Overall Study||63
10840818|NCT03786380|12006412|FG004|NOT COMPLETED|Overall Study||28
10840819|NCT03769376|12006426|FG000|STARTED|Overall Study||20
10840820|NCT03769376|12006427|FG001|STARTED|Overall Study||18
10840821|NCT03769376|12006426|FG000|COMPLETED|Overall Study||13
10840822|NCT03769376|12006427|FG001|COMPLETED|Overall Study||11
10840823|NCT03769376|12006426|FG000|NOT COMPLETED|Overall Study||7
10840824|NCT03769376|12006427|FG001|NOT COMPLETED|Overall Study||7
10840825|NCT03645863|12006436|FG000|STARTED|Overall Study||21
10840826|NCT03645863|12006437|FG001|STARTED|Overall Study||20
10840827|NCT03645863|12006438|FG002|STARTED|Overall Study||20
10840828|NCT03645863|12006436|FG000|COMPLETED|Overall Study||20
10840829|NCT03645863|12006437|FG001|COMPLETED|Overall Study||20
10840830|NCT03645863|12006438|FG002|COMPLETED|Overall Study||20
10840831|NCT03645863|12006436|FG000|NOT COMPLETED|Overall Study||1
10840832|NCT03645863|12006437|FG001|NOT COMPLETED|Overall Study||0
10840833|NCT03645863|12006438|FG002|NOT COMPLETED|Overall Study||0
10840834|NCT03564145|12006446|FG000|STARTED|Overall Study||547
10840835|NCT03564145|12006446|FG000|Received at Least 1 Dose of Study Drug|Overall Study||535
10840836|NCT03564145|12006446|FG000|COMPLETED|Overall Study||323
10840837|NCT03564145|12006446|FG000|NOT COMPLETED|Overall Study||224
10840838|NCT03564119|12006452|FG000|STARTED|Overall Study||250
10840839|NCT03564119|12006453|FG001|STARTED|Overall Study||122
10840840|NCT03564119|12006452|FG000|Received at Least 1 Dose of Study Drug|Overall Study||249
10840841|NCT03564119|12006453|FG001|Received at Least 1 Dose of Study Drug|Overall Study||120
10840842|NCT03564119|12006452|FG000|COMPLETED|Overall Study||235
10840843|NCT03564119|12006453|FG001|COMPLETED|Overall Study||113
10840844|NCT03564119|12006452|FG000|NOT COMPLETED|Overall Study||15
10840845|NCT03564119|12006453|FG001|NOT COMPLETED|Overall Study||9
10840846|NCT03365635|12006465|FG000|STARTED|Overall Study||3
10840847|NCT03365635|12006466|FG001|STARTED|Overall Study||0
10840848|NCT03365635|12006467|FG002|STARTED|Overall Study||1
10840849|NCT03365635|12006468|FG003|STARTED|Overall Study||0
10840850|NCT03365635|12006469|FG004|STARTED|Overall Study||0
10840851|NCT03365635|12006470|FG005|STARTED|Overall Study||0
10840852|NCT03365635|12006465|FG000|COMPLETED|Overall Study||3
10840853|NCT03365635|12006466|FG001|COMPLETED|Overall Study||0
10840854|NCT03365635|12006467|FG002|COMPLETED|Overall Study||1
10840855|NCT03365635|12006468|FG003|COMPLETED|Overall Study||0
10840856|NCT03365635|12006469|FG004|COMPLETED|Overall Study||0
10840857|NCT03365635|12006470|FG005|COMPLETED|Overall Study||0
10840858|NCT03365635|12006465|FG000|NOT COMPLETED|Overall Study||0
10840859|NCT03365635|12006466|FG001|NOT COMPLETED|Overall Study||0
10840860|NCT03365635|12006467|FG002|NOT COMPLETED|Overall Study||0
10840861|NCT03365635|12006468|FG003|NOT COMPLETED|Overall Study||0
10840862|NCT03365635|12006469|FG004|NOT COMPLETED|Overall Study||0
10840863|NCT03365635|12006470|FG005|NOT COMPLETED|Overall Study||0
10840864|NCT03287050|12006484|FG000|STARTED|Overall Study||6
10840865|NCT03287050|12006484|FG000|COMPLETED|Overall Study||6
10840866|NCT03287050|12006484|FG000|NOT COMPLETED|Overall Study||0
10840867|NCT03223350|12006490|FG000|STARTED|Overall Study||17
10840868|NCT03223350|12006491|FG001|STARTED|Overall Study||13
10840869|NCT03223350|12006490|FG000|COMPLETED|Overall Study||17
10840870|NCT03223350|12006491|FG001|COMPLETED|Overall Study||13
10840871|NCT03223350|12006490|FG000|NOT COMPLETED|Overall Study||0
10840872|NCT03223350|12006491|FG001|NOT COMPLETED|Overall Study||0
10840873|NCT03181828|12006499|FG000|STARTED|Overall Study||2
10840874|NCT03181828|12006500|FG001|STARTED|Overall Study||2
10840875|NCT03181828|12006499|FG000|COMPLETED|Overall Study||2
10840876|NCT03181828|12006500|FG001|COMPLETED|Overall Study||2
10840877|NCT03181828|12006499|FG000|NOT COMPLETED|Overall Study||0
10840878|NCT03181828|12006500|FG001|NOT COMPLETED|Overall Study||0
10840879|NCT03181529|12006508|FG000|STARTED|Overall Study||15
10840880|NCT03181529|12006509|FG001|STARTED|Overall Study||12
10840881|NCT03181529|12006508|FG000|COMPLETED|Overall Study||13
10840882|NCT03181529|12006509|FG001|COMPLETED|Overall Study||11
10840883|NCT03181529|12006508|FG000|NOT COMPLETED|Overall Study||2
10840884|NCT03181529|12006509|FG001|NOT COMPLETED|Overall Study||1
10840889|NCT02779556|12006521|FG000|STARTED|Baseline||394
10840890|NCT02779556|12006522|FG001|STARTED|Baseline||362
10840891|NCT02779556|12006521|FG000|COMPLETED|Baseline||393
10840892|NCT02779556|12006522|FG001|COMPLETED|Baseline||362
10840893|NCT02779556|12006521|FG000|NOT COMPLETED|Baseline||1
10840894|NCT02779556|12006522|FG001|NOT COMPLETED|Baseline||0
10840895|NCT02779556|12006521|FG000|STARTED|3 Months||393
10840896|NCT02779556|12006522|FG001|STARTED|3 Months||362
10840897|NCT02779556|12006521|FG000|COMPLETED|3 Months||326
10840898|NCT02779556|12006522|FG001|COMPLETED|3 Months||314
10840899|NCT02779556|12006521|FG000|NOT COMPLETED|3 Months||67
10840900|NCT02779556|12006522|FG001|NOT COMPLETED|3 Months||48
10840901|NCT02779556|12006521|FG000|STARTED|6 Month|Those who were not lost to follow-up but missed the visit from the previous period were allowed to continue in the study and complete future interviews (314+19=333 Enhanced Usual Care).|353
10840902|NCT02779556|12006522|FG001|STARTED|6 Month|Those who were not lost to follow-up but missed the visit from the previous period were allowed to continue in the study and complete future interviews (326+27=353 Intervention).|333
10840903|NCT02779556|12006521|FG000|COMPLETED|6 Month||320
10840904|NCT02779556|12006522|FG001|COMPLETED|6 Month||294
10840905|NCT02779556|12006521|FG000|NOT COMPLETED|6 Month||33
10840906|NCT02779556|12006522|FG001|NOT COMPLETED|6 Month||39
10840907|NCT02779556|12006521|FG000|STARTED|6 Month HbA1c|All enrolled participants were eligible for the analysis of clinical values regardless of completion of 3 and 6 month interviews.|394
10840908|NCT02779556|12006522|FG001|STARTED|6 Month HbA1c|All enrolled participants were eligible for the analysis of clinical values regardless of completion of 3 and 6 month interviews.|362
10840909|NCT02779556|12006521|FG000|COMPLETED|6 Month HbA1c||325
10840910|NCT02779556|12006522|FG001|COMPLETED|6 Month HbA1c||312
10840911|NCT02779556|12006521|FG000|NOT COMPLETED|6 Month HbA1c||69
10840912|NCT02779556|12006522|FG001|NOT COMPLETED|6 Month HbA1c||50
10840913|NCT02779556|12006521|FG000|STARTED|12 Month HbA1c|All enrolled participants were eligible for the analysis of clinical values regardless of completion of 3 and 6 month interviews.|394
10840914|NCT02779556|12006522|FG001|STARTED|12 Month HbA1c|All enrolled participants were eligible for the analysis of clinical values regardless of completion of 3 and 6 month interviews.|362
10840915|NCT02779556|12006521|FG000|COMPLETED|12 Month HbA1c||256
10840916|NCT02779556|12006522|FG001|COMPLETED|12 Month HbA1c||260
10840917|NCT02779556|12006521|FG000|NOT COMPLETED|12 Month HbA1c||138
10840918|NCT02779556|12006522|FG001|NOT COMPLETED|12 Month HbA1c||102
10840919|NCT02724774|12006530|FG000|STARTED|Overall Study||127
10840920|NCT02724774|12006531|FG001|STARTED|Overall Study||125
10840921|NCT02724774|12006530|FG000|Infant 6 Months|Overall Study||122
10840922|NCT02724774|12006531|FG001|Infant 6 Months|Overall Study||122
10840923|NCT02724774|12006530|FG000|Infant 12 Months|Overall Study||120
10840924|NCT02724774|12006531|FG001|Infant 12 Months|Overall Study||123
10840925|NCT02724774|12006530|FG000|COMPLETED|Overall Study||120
10840926|NCT02724774|12006531|FG001|COMPLETED|Overall Study||123
10840927|NCT02724774|12006530|FG000|NOT COMPLETED|Overall Study||7
10840928|NCT02724774|12006531|FG001|NOT COMPLETED|Overall Study||2
10840929|NCT02675751|12006537|FG000|STARTED|Overall Study||167
10840930|NCT02675751|12006537|FG000|COMPLETED|Overall Study||151
10840931|NCT02675751|12006537|FG000|NOT COMPLETED|Overall Study||16
10840932|NCT02643381|12006543|FG000|STARTED|Overall Study||400
10840933|NCT02643381|12006544|FG001|STARTED|Overall Study||401
10840934|NCT02643381|12006543|FG000|COMPLETED|Overall Study||396
10840935|NCT02643381|12006544|FG001|COMPLETED|Overall Study||395
10840936|NCT02643381|12006543|FG000|NOT COMPLETED|Overall Study||4
10840937|NCT02643381|12006544|FG001|NOT COMPLETED|Overall Study||6
10840938|NCT02621424|12006552|FG000|STARTED|Overall Study||14
10840939|NCT02621424|12006553|FG001|STARTED|Overall Study||18
10840940|NCT02621424|12006552|FG000|COMPLETED|Overall Study||13
10840941|NCT02621424|12006553|FG001|COMPLETED|Overall Study||16
10840942|NCT02621424|12006552|FG000|NOT COMPLETED|Overall Study||1
10840943|NCT02621424|12006553|FG001|NOT COMPLETED|Overall Study||2
10840944|NCT02595372|12006559|FG000|STARTED|Overall Study||42
10840945|NCT02595372|12006559|FG000|COMPLETED|Overall Study||33
10840946|NCT02595372|12006559|FG000|NOT COMPLETED|Overall Study||9
10840947|NCT02334722|12006565|FG000|STARTED|Overall Study||40
10840948|NCT02334722|12006566|FG001|STARTED|Overall Study||41
10840949|NCT02334722|12006565|FG000|COMPLETED|Overall Study||33
10840950|NCT02334722|12006566|FG001|COMPLETED|Overall Study||34
10840951|NCT02334722|12006565|FG000|NOT COMPLETED|Overall Study||7
10840952|NCT02334722|12006566|FG001|NOT COMPLETED|Overall Study||7
10840953|NCT02259725|12006572|FG000|STARTED|Overall Study||3
10840954|NCT02259725|12006572|FG000|COMPLETED|Overall Study||3
10840955|NCT02259725|12006572|FG000|NOT COMPLETED|Overall Study||0
10840956|NCT01966731|12006576|FG000|STARTED|Overall Study||635
10840957|NCT01966731|12006576|FG000|Initiated Hydroxyurea|Overall Study||606
10840958|NCT01966731|12006576|FG000|Completed 3 Months of Treatment|Overall Study||600
10840959|NCT01966731|12006576|FG000|Completed Study|Overall Study||0
10840960|NCT01966731|12006576|FG000|COMPLETED|Overall Study||0
10840961|NCT01966731|12006576|FG000|NOT COMPLETED|Overall Study||635
10840962|NCT01952288|12006582|FG000|STARTED|Overall Study||3
10840963|NCT01952288|12006583|FG001|STARTED|Overall Study||2
10840964|NCT01952288|12006582|FG000|COMPLETED|Overall Study||3
10840965|NCT01952288|12006583|FG001|COMPLETED|Overall Study||2
10840966|NCT01952288|12006582|FG000|NOT COMPLETED|Overall Study||0
10840967|NCT01952288|12006583|FG001|NOT COMPLETED|Overall Study||0
10840968|NCT01850082|12006591|FG000|STARTED|Overall Study||576
10292296|NCT04633564|11425073|FG000|STARTED|Period 2||200
10292297|NCT04633564|11425074|FG001|STARTED|Period 2||199
10292298|NCT04633564|11425073|FG000|COMPLETED|Period 2||107
10292299|NCT04633564|11425074|FG001|COMPLETED|Period 2||102
10292300|NCT04633564|11425073|FG000|NOT COMPLETED|Period 2||93
10292301|NCT04633564|11425074|FG001|NOT COMPLETED|Period 2||97
10314331|NCT00160251|11447801|FG005|NOT COMPLETED|Post-amendment 2||0
10314332|NCT00160251|11447802|FG006|NOT COMPLETED|Post-amendment 2||0
10314333|NCT00160251|11447803|FG007|NOT COMPLETED|Post-amendment 2||55
10314334|NCT00160524|11447860|FG000|STARTED|Overall Study|One subject was enrolled erroneously and has no data in the database.|595
10314335|NCT00160524|11447860|FG000|COMPLETED|Overall Study||117
10314336|NCT00160524|11447860|FG000|NOT COMPLETED|Overall Study||478
10314337|NCT00160615|11447866|FG000|STARTED|Overall Study||50
10314338|NCT00160615|11447867|FG001|STARTED|Overall Study||101
10314339|NCT00160615|11447866|FG000|COMPLETED|Overall Study||32
10314340|NCT00160615|11447867|FG001|COMPLETED|Overall Study||56
10314341|NCT00160615|11447866|FG000|NOT COMPLETED|Overall Study||18
10314342|NCT00160615|11447867|FG001|NOT COMPLETED|Overall Study||45
10314343|NCT00160641|11447875|FG000|STARTED|Overall Study||567
10314344|NCT00160641|11447875|FG000|COMPLETED|Overall Study||346
10314345|NCT00160641|11447875|FG000|NOT COMPLETED|Overall Study||221
10314346|NCT00160654|11447879|FG000|STARTED|Overall Study||251
10314347|NCT00160654|11447879|FG000|COMPLETED|Overall Study||218
10314348|NCT00160654|11447879|FG000|NOT COMPLETED|Overall Study||33
10314349|NCT00160667|11447886|FG000|STARTED|Overall Study||50
10314350|NCT00160667|11447887|FG001|STARTED|Overall Study||51
10314351|NCT00160667|11447888|FG002|STARTED|Overall Study||51
10314352|NCT00160667|11447886|FG000|COMPLETED|Overall Study||45
10314353|NCT00160667|11447887|FG001|COMPLETED|Overall Study||48
10314354|NCT00160667|11447888|FG002|COMPLETED|Overall Study||45
10314355|NCT00160667|11447886|FG000|NOT COMPLETED|Overall Study||5
10840969|NCT01850082|12006592|FG001|STARTED|Overall Study||574
10840970|NCT01850082|12006591|FG000|COMPLETED|Overall Study||576
10840971|NCT01850082|12006592|FG001|COMPLETED|Overall Study||574
10840972|NCT01850082|12006591|FG000|NOT COMPLETED|Overall Study||0
10840973|NCT01850082|12006592|FG001|NOT COMPLETED|Overall Study||0
10840980|NCT01675479|12006610|FG000|STARTED|Overall Study||69
10840981|NCT01675479|12006610|FG000|COMPLETED|Overall Study||58
10840982|NCT01675479|12006610|FG000|NOT COMPLETED|Overall Study||11
10840983|NCT00812708|12006614|FG000|STARTED|Overall Study|6 patients withdrew from the study before being taken to the operating room.|72
10840984|NCT00812708|12006614|FG000|Taken to Surgery for Device Implantation|Overall Study|2 patients could not be implanted because of intraoperative complications.|66
10840985|NCT00812708|12006614|FG000|COMPLETED|Overall Study||64
10840986|NCT00812708|12006614|FG000|NOT COMPLETED|Overall Study||8
10840987|NCT00741988|12006621|FG000|STARTED|Overall Study||42
10840988|NCT00741988|12006622|FG001|STARTED|Overall Study||40
10840989|NCT00741988|12006621|FG000|COMPLETED|Overall Study||38
10840990|NCT00741988|12006622|FG001|COMPLETED|Overall Study||36
10840991|NCT00741988|12006621|FG000|NOT COMPLETED|Overall Study||4
10840992|NCT00741988|12006622|FG001|NOT COMPLETED|Overall Study||4
10840993|NCT00563576|12006630|FG000|STARTED|Overall Study||35
10840994|NCT00563576|12006631|FG001|STARTED|Overall Study||36
10314356|NCT00160667|11447887|FG001|NOT COMPLETED|Overall Study||3
10314357|NCT00160667|11447888|FG002|NOT COMPLETED|Overall Study||6
10314358|NCT00160680|11447899|FG000|STARTED|Overall Study||31
10314359|NCT00160680|11447900|FG001|STARTED|Overall Study||31
10314360|NCT00160680|11447899|FG000|COMPLETED|Overall Study||22
10314361|NCT00160680|11447900|FG001|COMPLETED|Overall Study||18
10314362|NCT00160680|11447899|FG000|NOT COMPLETED|Overall Study||9
10314363|NCT00160680|11447900|FG001|NOT COMPLETED|Overall Study||13
10840995|NCT00563576|12006630|FG000|COMPLETED|Overall Study||21
10840996|NCT00563576|12006631|FG001|COMPLETED|Overall Study||22
10840997|NCT00563576|12006630|FG000|NOT COMPLETED|Overall Study||14
10840998|NCT00563576|12006631|FG001|NOT COMPLETED|Overall Study||14
10840999|NCT00515671|12006639|FG000|STARTED|Overall Study||60
10841000|NCT00515671|12006640|FG001|STARTED|Overall Study||58
10841001|NCT00515671|12006639|FG000|COMPLETED|Overall Study||43
10841002|NCT00515671|12006640|FG001|COMPLETED|Overall Study||41
10841003|NCT00515671|12006639|FG000|NOT COMPLETED|Overall Study||17
10841004|NCT00515671|12006640|FG001|NOT COMPLETED|Overall Study||17
10841005|NCT00455403|12006648|FG000|STARTED|Overall Study||59
10841006|NCT00455403|12006649|FG001|STARTED|Overall Study||57
10841007|NCT00455403|12006648|FG000|COMPLETED|Overall Study||56
10841008|NCT00455403|12006649|FG001|COMPLETED|Overall Study||51
10841009|NCT00455403|12006648|FG000|NOT COMPLETED|Overall Study||3
10841010|NCT00455403|12006649|FG001|NOT COMPLETED|Overall Study||6
10841017|NCT04328961|12006666|FG000|STARTED|Overall Study||422
10841018|NCT04328961|12006667|FG001|STARTED|Overall Study||407
10841019|NCT04328961|12006666|FG000|COMPLETED|Overall Study||336
10841020|NCT04328961|12006667|FG001|COMPLETED|Overall Study||353
10841021|NCT04328961|12006666|FG000|NOT COMPLETED|Overall Study||86
10841022|NCT04328961|12006667|FG001|NOT COMPLETED|Overall Study||54
10841080|NCT02896855|12006734|FG001|NOT COMPLETED|Overall Study||53
10841081|NCT02871778|12006747|FG000|STARTED|Part A: Treatment Period 1||43
10841082|NCT02871778|12006748|FG001|STARTED|Part A: Treatment Period 1||41
10841083|NCT02871778|12006749|FG002|STARTED|Part A: Treatment Period 1||21
10841084|NCT02871778|12006750|FG003|STARTED|Part A: Treatment Period 1||18
10841085|NCT02871778|12006751|FG004|STARTED|Part A: Treatment Period 1||0
10841086|NCT02871778|12006752|FG005|STARTED|Part A: Treatment Period 1||0
10841087|NCT02871778|12006753|FG006|STARTED|Part A: Treatment Period 1||0
10841088|NCT02871778|12006754|FG007|STARTED|Part A: Treatment Period 1||0
10841089|NCT02871778|12006747|FG000|Safety Analysis Set|Part A: Treatment Period 1|1 participant was randomized to receive HS in Period 1, but instead received VX-371 in HS in Period 1.|44
10841090|NCT02871778|12006748|FG001|Safety Analysis Set|Part A: Treatment Period 1||40
10841091|NCT02871778|12006749|FG002|Safety Analysis Set|Part A: Treatment Period 1||21
10841092|NCT02871778|12006750|FG003|Safety Analysis Set|Part A: Treatment Period 1||18
10841093|NCT02871778|12006751|FG004|Safety Analysis Set|Part A: Treatment Period 1||0
10841094|NCT02871778|12006752|FG005|Safety Analysis Set|Part A: Treatment Period 1||0
10841095|NCT02871778|12006753|FG006|Safety Analysis Set|Part A: Treatment Period 1||0
10841096|NCT02871778|12006754|FG007|Safety Analysis Set|Part A: Treatment Period 1||0
10841097|NCT02871778|12006747|FG000|COMPLETED|Part A: Treatment Period 1||40
10841098|NCT02871778|12006748|FG001|COMPLETED|Part A: Treatment Period 1||37
10841099|NCT02871778|12006749|FG002|COMPLETED|Part A: Treatment Period 1||18
10841100|NCT02871778|12006750|FG003|COMPLETED|Part A: Treatment Period 1||16
10841101|NCT02871778|12006751|FG004|COMPLETED|Part A: Treatment Period 1||0
10841102|NCT02871778|12006752|FG005|COMPLETED|Part A: Treatment Period 1||0
10841103|NCT02871778|12006753|FG006|COMPLETED|Part A: Treatment Period 1||0
10841104|NCT02871778|12006754|FG007|COMPLETED|Part A: Treatment Period 1||0
10841105|NCT02871778|12006747|FG000|NOT COMPLETED|Part A: Treatment Period 1||3
10841106|NCT02871778|12006748|FG001|NOT COMPLETED|Part A: Treatment Period 1||4
10841107|NCT02871778|12006749|FG002|NOT COMPLETED|Part A: Treatment Period 1||3
10841108|NCT02871778|12006750|FG003|NOT COMPLETED|Part A: Treatment Period 1||2
10841109|NCT02871778|12006751|FG004|NOT COMPLETED|Part A: Treatment Period 1||0
10841110|NCT02871778|12006752|FG005|NOT COMPLETED|Part A: Treatment Period 1||0
10841111|NCT02871778|12006753|FG006|NOT COMPLETED|Part A: Treatment Period 1||0
10841112|NCT02871778|12006754|FG007|NOT COMPLETED|Part A: Treatment Period 1||0
10841113|NCT02871778|12006747|FG000|STARTED|Part A: Treatment Period 2||40
10841114|NCT02871778|12006748|FG001|STARTED|Part A: Treatment Period 2||37
10841115|NCT02871778|12006749|FG002|STARTED|Part A: Treatment Period 2||18
10841116|NCT02871778|12006750|FG003|STARTED|Part A: Treatment Period 2||16
10841117|NCT02871778|12006751|FG004|STARTED|Part A: Treatment Period 2||0
10841118|NCT02871778|12006752|FG005|STARTED|Part A: Treatment Period 2||0
10841119|NCT02871778|12006753|FG006|STARTED|Part A: Treatment Period 2||0
10841120|NCT02871778|12006754|FG007|STARTED|Part A: Treatment Period 2||0
10841121|NCT02871778|12006747|FG000|Safety Analysis Set|Part A: Treatment Period 2||40
10841122|NCT02871778|12006748|FG001|Safety Analysis Set|Part A: Treatment Period 2||37
10841123|NCT02871778|12006749|FG002|Safety Analysis Set|Part A: Treatment Period 2||18
10841124|NCT02871778|12006750|FG003|Safety Analysis Set|Part A: Treatment Period 2||16
10841125|NCT02871778|12006751|FG004|Safety Analysis Set|Part A: Treatment Period 2||0
10841126|NCT02871778|12006752|FG005|Safety Analysis Set|Part A: Treatment Period 2||0
10841127|NCT02871778|12006753|FG006|Safety Analysis Set|Part A: Treatment Period 2||0
10841128|NCT02871778|12006754|FG007|Safety Analysis Set|Part A: Treatment Period 2||0
10841129|NCT02871778|12006747|FG000|COMPLETED|Part A: Treatment Period 2||37
10841130|NCT02871778|12006748|FG001|COMPLETED|Part A: Treatment Period 2||35
10841131|NCT02871778|12006749|FG002|COMPLETED|Part A: Treatment Period 2||17
10841132|NCT02871778|12006750|FG003|COMPLETED|Part A: Treatment Period 2||15
10841133|NCT02871778|12006751|FG004|COMPLETED|Part A: Treatment Period 2||0
10841134|NCT02871778|12006752|FG005|COMPLETED|Part A: Treatment Period 2||0
10841135|NCT02871778|12006753|FG006|COMPLETED|Part A: Treatment Period 2||0
10841136|NCT02871778|12006754|FG007|COMPLETED|Part A: Treatment Period 2||0
10841137|NCT02871778|12006747|FG000|NOT COMPLETED|Part A: Treatment Period 2||3
10841138|NCT02871778|12006748|FG001|NOT COMPLETED|Part A: Treatment Period 2||2
10841139|NCT02871778|12006749|FG002|NOT COMPLETED|Part A: Treatment Period 2||1
10841140|NCT02871778|12006750|FG003|NOT COMPLETED|Part A: Treatment Period 2||1
10841141|NCT02871778|12006751|FG004|NOT COMPLETED|Part A: Treatment Period 2||0
10841142|NCT02871778|12006752|FG005|NOT COMPLETED|Part A: Treatment Period 2||0
10841143|NCT02871778|12006753|FG006|NOT COMPLETED|Part A: Treatment Period 2||0
10841144|NCT02871778|12006754|FG007|NOT COMPLETED|Part A: Treatment Period 2||0
10841145|NCT02871778|12006747|FG000|STARTED|Part B: Treatment Period 3||0
10841146|NCT02871778|12006748|FG001|STARTED|Part B: Treatment Period 3||0
10841147|NCT02871778|12006749|FG002|STARTED|Part B: Treatment Period 3||0
10841148|NCT02871778|12006750|FG003|STARTED|Part B: Treatment Period 3||0
10841149|NCT02871778|12006751|FG004|STARTED|Part B: Treatment Period 3|Out of 35 participants who were on VX-371 in HS in Treatment period 2 and completed Part A, 11 participants rolled-over to Part B.|11
10841150|NCT02871778|12006752|FG005|STARTED|Part B: Treatment Period 3|Out of 37 participants who were on HS in Treatment period 2 and completed Part A, 27 participants rolled-over to Part B.|27
10841023|NCT04128319|12006673|FG000|STARTED|Overall Study||3
10841024|NCT04128319|12006673|FG000|Initiated T-Guard Treatment|Overall Study||3
10841025|NCT04128319|12006673|FG000|COMPLETED|Overall Study||0
10841026|NCT04128319|12006673|FG000|NOT COMPLETED|Overall Study||3
10841027|NCT03761810|12006679|FG000|STARTED|Overall Study||290
10841028|NCT03761810|12006680|FG001|STARTED|Overall Study||144
10841029|NCT03761810|12006679|FG000|Received at Least 1 Dose of Study Drug|Overall Study||281
10841030|NCT03761810|12006680|FG001|Received at Least 1 Dose of Study Drug|Overall Study||138
10841031|NCT03761810|12006679|FG000|COMPLETED|Overall Study||242
10841032|NCT03761810|12006680|FG001|COMPLETED|Overall Study||132
10841033|NCT03761810|12006679|FG000|NOT COMPLETED|Overall Study||48
10841034|NCT03761810|12006680|FG001|NOT COMPLETED|Overall Study||12
10841035|NCT03761784|12006688|FG000|STARTED|Overall Study||281
10841036|NCT03761784|12006689|FG001|STARTED|Overall Study||143
10841037|NCT03761784|12006688|FG000|Received at Least 1 Dose of Study Drug|Overall Study||274
10841038|NCT03761784|12006689|FG001|Received at Least 1 Dose of Study Drug|Overall Study||139
10841039|NCT03761784|12006688|FG000|COMPLETED|Overall Study||249
10841040|NCT03761784|12006689|FG001|COMPLETED|Overall Study||131
10841041|NCT03761784|12006688|FG000|NOT COMPLETED|Overall Study||32
10841042|NCT03761784|12006689|FG001|NOT COMPLETED|Overall Study||12
10841043|NCT03361865|12006697|FG000|STARTED|Overall Study||44
10841044|NCT03361865|12006698|FG001|STARTED|Overall Study||49
10841045|NCT03361865|12006697|FG000|Intention-to-Treat (ITT)|Overall Study||44
10841046|NCT03361865|12006698|FG001|Intention-to-Treat (ITT)|Overall Study||49
10841047|NCT03361865|12006697|FG000|All Participants as Treated (APaT)|Overall Study||43
10410977|NCT00765362|11555097|FG000|COMPLETED|Overall Study||282
10841048|NCT03361865|12006698|FG001|All Participants as Treated (APaT)|Overall Study||49
10841049|NCT03361865|12006697|FG000|COMPLETED|Overall Study||25
10841050|NCT03361865|12006698|FG001|COMPLETED|Overall Study||22
10841051|NCT03361865|12006697|FG000|NOT COMPLETED|Overall Study||19
10841052|NCT03361865|12006698|FG001|NOT COMPLETED|Overall Study||27
10841053|NCT03294304|12006705|FG000|STARTED|Overall Study||43
10841054|NCT03294304|12006705|FG000|COMPLETED|Overall Study||43
10841055|NCT03294304|12006705|FG000|NOT COMPLETED|Overall Study||0
10841056|NCT03122431|12006712|FG000|STARTED|Overall Study||41
10841057|NCT03122431|12006713|FG001|STARTED|Overall Study||32
10841058|NCT03122431|12006714|FG002|STARTED|Overall Study||20
10841059|NCT03122431|12006712|FG000|COMPLETED|Overall Study||41
10841060|NCT03122431|12006713|FG001|COMPLETED|Overall Study||32
10841061|NCT03122431|12006714|FG002|COMPLETED|Overall Study||9
10841062|NCT03122431|12006712|FG000|NOT COMPLETED|Overall Study||0
10841063|NCT03122431|12006713|FG001|NOT COMPLETED|Overall Study||0
10841064|NCT03122431|12006714|FG002|NOT COMPLETED|Overall Study||11
10841065|NCT02929056|12006724|FG000|STARTED|Overall Study||1
10841066|NCT02929056|12006725|FG001|STARTED|Overall Study||1
10841067|NCT02929056|12006724|FG000|COMPLETED|Overall Study||1
10841068|NCT02929056|12006725|FG001|COMPLETED|Overall Study||0
10841069|NCT02929056|12006724|FG000|NOT COMPLETED|Overall Study||0
10841070|NCT02929056|12006725|FG001|NOT COMPLETED|Overall Study||1
10841071|NCT02896855|12006733|FG000|STARTED|Overall Study||121
10841072|NCT02896855|12006734|FG001|STARTED|Overall Study||122
10841073|NCT02896855|12006733|FG000|Received Any Study Treatment|Overall Study||120
10841074|NCT02896855|12006734|FG001|Received Any Study Treatment|Overall Study||122
10841075|NCT02896855|12006733|FG000|Crossed Over From Placebo to Receive Pertuzumab|Overall Study|From 07-March-2020, 12 participants randomized to the Placebo arm crossed over to open-label pertuzumab.|12
10841076|NCT02896855|12006734|FG001|Crossed Over From Placebo to Receive Pertuzumab|Overall Study||0
10841077|NCT02896855|12006733|FG000|COMPLETED|Overall Study||49
10841078|NCT02896855|12006734|FG001|COMPLETED|Overall Study||69
10841079|NCT02896855|12006733|FG000|NOT COMPLETED|Overall Study||72
10410978|NCT00765362|11555097|FG000|NOT COMPLETED|Overall Study||137
10410979|NCT00765375|11555101|FG000|STARTED|Overall Study||5
10410980|NCT00765375|11555101|FG000|COMPLETED|Overall Study||5
10410981|NCT00765375|11555101|FG000|NOT COMPLETED|Overall Study||0
10410982|NCT00765388|11555107|FG000|STARTED|Period 1|A cross-over study|16
10292314|NCT04195958|11425089|FG000|STARTED|Overall Study||3
10410983|NCT00765388|11555108|FG001|STARTED|Period 1||11
10292315|NCT04195958|11425089|FG000|COMPLETED|Overall Study||1
10410984|NCT00765388|11555107|FG000|COMPLETED|Period 1||15
10410985|NCT00765388|11555108|FG001|COMPLETED|Period 1||6
10410986|NCT00765388|11555107|FG000|NOT COMPLETED|Period 1||1
10410987|NCT00765388|11555108|FG001|NOT COMPLETED|Period 1||5
10410988|NCT00765388|11555107|FG000|STARTED|Period 2||15
10410989|NCT00765388|11555108|FG001|STARTED|Period 2||6
10410990|NCT00765388|11555107|FG000|COMPLETED|Period 2||15
10410991|NCT00765388|11555108|FG001|COMPLETED|Period 2||6
10410992|NCT00765388|11555107|FG000|NOT COMPLETED|Period 2||0
10410993|NCT00765388|11555108|FG001|NOT COMPLETED|Period 2||0
10410994|NCT00765570|11555116|FG000|STARTED|Overall Study||9
10410995|NCT00765570|11555117|FG001|STARTED|Overall Study||3
10410996|NCT00765570|11555116|FG000|COMPLETED|Overall Study||7
10410997|NCT00765570|11555117|FG001|COMPLETED|Overall Study||3
10754548|NCT03053271|11918259|FG000|STARTED|Overall Study||4
10754549|NCT03053271|11918259|FG000|COMPLETED|Overall Study|All completed the open-label dose escalation, but did not meet criteria for randomization|0
10410998|NCT00765570|11555116|FG000|NOT COMPLETED|Overall Study||2
10410999|NCT00765570|11555117|FG001|NOT COMPLETED|Overall Study||0
10411000|NCT00765648|11555125|FG000|STARTED|Overall Study||110
10411001|NCT00765648|11555126|FG001|STARTED|Overall Study||116
10411002|NCT00765648|11555125|FG000|COMPLETED|Overall Study||109
10411003|NCT00765648|11555126|FG001|COMPLETED|Overall Study||114
10411004|NCT00765648|11555125|FG000|NOT COMPLETED|Overall Study||1
10411005|NCT00765648|11555126|FG001|NOT COMPLETED|Overall Study||2
10411006|NCT00765661|11555134|FG000|STARTED|Overall Study||32
10411007|NCT00765661|11555135|FG001|STARTED|Overall Study||31
10411008|NCT00765661|11555134|FG000|COMPLETED|Overall Study||32
10411009|NCT00765661|11555135|FG001|COMPLETED|Overall Study||31
10411010|NCT00765661|11555134|FG000|NOT COMPLETED|Overall Study||0
10411011|NCT00765661|11555135|FG001|NOT COMPLETED|Overall Study||0
10411012|NCT00765674|11555145|FG000|STARTED|Overall Study||287
10411013|NCT00765674|11555146|FG001|STARTED|Overall Study|1 patient was randomized in error and discontinued without taking any double-blind study medication.|298
10411014|NCT00765674|11555147|FG002|STARTED|Overall Study||296
10411015|NCT00765674|11555148|FG003|STARTED|Overall Study|1 patient was randomized in error and discontinued without taking any double-blind study medication.|310
10411016|NCT00765674|11555145|FG000|COMPLETED|Overall Study||266
10411017|NCT00765674|11555146|FG001|COMPLETED|Overall Study||276
10411018|NCT00765674|11555147|FG002|COMPLETED|Overall Study||279
10411019|NCT00765674|11555148|FG003|COMPLETED|Overall Study||285
10411020|NCT00765674|11555145|FG000|NOT COMPLETED|Overall Study||21
10411021|NCT00765674|11555146|FG001|NOT COMPLETED|Overall Study||22
10411022|NCT00765674|11555147|FG002|NOT COMPLETED|Overall Study||17
10411023|NCT00765674|11555148|FG003|NOT COMPLETED|Overall Study||25
10411024|NCT00765726|11555158|FG000|STARTED|Overall Study||12
10411025|NCT00765726|11555158|FG000|COMPLETED|Overall Study||3
10411026|NCT00765726|11555158|FG000|NOT COMPLETED|Overall Study||9
10411027|NCT00765817|11555164|FG000|STARTED|Overall Study|One subject withdrew prior to receiving study medication, not included in analysis set|138
10411028|NCT00765817|11555165|FG001|STARTED|Overall Study|One subject withdrew prior to receiving study medication, not included in analysis set|123
10411029|NCT00765817|11555164|FG000|COMPLETED|Overall Study||112
10411030|NCT00765817|11555165|FG001|COMPLETED|Overall Study||101
10411031|NCT00765817|11555164|FG000|NOT COMPLETED|Overall Study||26
10411032|NCT00765817|11555165|FG001|NOT COMPLETED|Overall Study||22
10411033|NCT00765843|11555174|FG000|STARTED|Overall Study||26
10411034|NCT00765843|11555175|FG001|STARTED|Overall Study||25
10411035|NCT00765843|11555176|FG002|STARTED|Overall Study||26
10411036|NCT00765843|11555174|FG000|COMPLETED|Overall Study||25
10411037|NCT00765843|11555175|FG001|COMPLETED|Overall Study||21
10411038|NCT00765843|11555176|FG002|COMPLETED|Overall Study||23
10411039|NCT00765843|11555174|FG000|NOT COMPLETED|Overall Study||1
10411040|NCT00765843|11555175|FG001|NOT COMPLETED|Overall Study||4
10411041|NCT00765843|11555176|FG002|NOT COMPLETED|Overall Study||3
10411042|NCT00765856|11555184|FG000|STARTED|Titration Period||27
10411043|NCT00765856|11555184|FG000|COMPLETED|Titration Period||24
10411044|NCT00765856|11555184|FG000|NOT COMPLETED|Titration Period||3
10754550|NCT03053271|11918259|FG000|NOT COMPLETED|Overall Study||4
10754551|NCT03053401|11918265|FG000|STARTED|Overall Study||26
10754552|NCT03053401|11918266|FG001|STARTED|Overall Study||26
10754553|NCT03053401|11918265|FG000|COMPLETED|Overall Study||26
10754554|NCT03053401|11918266|FG001|COMPLETED|Overall Study||26
10754555|NCT03053401|11918265|FG000|NOT COMPLETED|Overall Study||0
10754556|NCT03053401|11918266|FG001|NOT COMPLETED|Overall Study||0
10754557|NCT03053427|11918275|FG000|STARTED|Overall Study||186
10754558|NCT03053427|11918276|FG001|STARTED|Overall Study||189
10754559|NCT03053427|11918275|FG000|COMPLETED|Overall Study||173
10754560|NCT03053427|11918276|FG001|COMPLETED|Overall Study||173
10411045|NCT00765856|11555184|FG000|STARTED|Maintenance Period||24
10411046|NCT00765856|11555184|FG000|COMPLETED|Maintenance Period||18
10411047|NCT00765856|11555184|FG000|NOT COMPLETED|Maintenance Period||6
10411048|NCT00765882|11555194|FG000|STARTED|Overall Study||215
10411049|NCT00765882|11555195|FG001|STARTED|Overall Study||213
10411050|NCT00765882|11555196|FG002|STARTED|Overall Study||205
10411051|NCT00765882|11555194|FG000|COMPLETED|Overall Study||191
10411052|NCT00765882|11555195|FG001|COMPLETED|Overall Study||173
10411053|NCT00765882|11555196|FG002|COMPLETED|Overall Study||169
10411054|NCT00765882|11555194|FG000|NOT COMPLETED|Overall Study||24
10411055|NCT00765882|11555195|FG001|NOT COMPLETED|Overall Study||40
10411056|NCT00765882|11555196|FG002|NOT COMPLETED|Overall Study||36
10411057|NCT00765895|11555206|FG000|STARTED|Overall Study||65
10411058|NCT00765895|11555207|FG001|STARTED|Overall Study||65
10411059|NCT00765895|11555206|FG000|COMPLETED|Overall Study||65
10841151|NCT02871778|12006753|FG006|STARTED|Part B: Treatment Period 3|Out of 15 participants who were on VX-371 in Treatment period 2 and completed Part A, 7 participants rolled-over to Part B.|7
10841152|NCT02871778|12006754|FG007|STARTED|Part B: Treatment Period 3|Out of 17 participants who were on Placebo in Treatment period 2 and completed Part A, 12 participants rolled-over to Part B.|12
10841153|NCT02871778|12006747|FG000|Safety Analysis Set|Part B: Treatment Period 3||0
10841154|NCT02871778|12006748|FG001|Safety Analysis Set|Part B: Treatment Period 3||0
10841155|NCT02871778|12006749|FG002|Safety Analysis Set|Part B: Treatment Period 3||0
10841156|NCT02871778|12006750|FG003|Safety Analysis Set|Part B: Treatment Period 3||0
10841157|NCT02871778|12006751|FG004|Safety Analysis Set|Part B: Treatment Period 3||11
10841158|NCT02871778|12006752|FG005|Safety Analysis Set|Part B: Treatment Period 3||27
10841159|NCT02871778|12006753|FG006|Safety Analysis Set|Part B: Treatment Period 3||7
10841160|NCT02871778|12006754|FG007|Safety Analysis Set|Part B: Treatment Period 3||12
10841161|NCT02871778|12006747|FG000|COMPLETED|Part B: Treatment Period 3||0
10841162|NCT02871778|12006748|FG001|COMPLETED|Part B: Treatment Period 3||0
10841163|NCT02871778|12006749|FG002|COMPLETED|Part B: Treatment Period 3||0
10841164|NCT02871778|12006750|FG003|COMPLETED|Part B: Treatment Period 3||0
10841165|NCT02871778|12006751|FG004|COMPLETED|Part B: Treatment Period 3||10
10841166|NCT02871778|12006752|FG005|COMPLETED|Part B: Treatment Period 3||26
10841167|NCT02871778|12006753|FG006|COMPLETED|Part B: Treatment Period 3||6
10841168|NCT02871778|12006754|FG007|COMPLETED|Part B: Treatment Period 3||12
10841169|NCT02871778|12006747|FG000|NOT COMPLETED|Part B: Treatment Period 3||0
10841170|NCT02871778|12006748|FG001|NOT COMPLETED|Part B: Treatment Period 3||0
10841171|NCT02871778|12006749|FG002|NOT COMPLETED|Part B: Treatment Period 3||0
10841172|NCT02871778|12006750|FG003|NOT COMPLETED|Part B: Treatment Period 3||0
10841173|NCT02871778|12006751|FG004|NOT COMPLETED|Part B: Treatment Period 3||1
10841174|NCT02871778|12006752|FG005|NOT COMPLETED|Part B: Treatment Period 3||1
10841175|NCT02871778|12006753|FG006|NOT COMPLETED|Part B: Treatment Period 3||1
10841176|NCT02871778|12006754|FG007|NOT COMPLETED|Part B: Treatment Period 3||0
10841177|NCT02769000|12006778|FG000|STARTED|Overall Study||5
10841178|NCT02769000|12006779|FG001|STARTED|Overall Study||0
10411060|NCT00765895|11555207|FG001|COMPLETED|Overall Study||65
10411061|NCT00765895|11555206|FG000|NOT COMPLETED|Overall Study||0
10411062|NCT00765895|11555207|FG001|NOT COMPLETED|Overall Study||0
10411063|NCT00765947|11555213|FG000|STARTED|Overall Study||256
10411064|NCT00765947|11555213|FG000|COMPLETED|Overall Study||232
10411065|NCT00765947|11555213|FG000|NOT COMPLETED|Overall Study||24
10411066|NCT00765999|11555219|FG000|STARTED|Overall Study||1554
10411067|NCT00765999|11555219|FG000|COMPLETED|Overall Study||770
10411068|NCT00765999|11555219|FG000|NOT COMPLETED|Overall Study||784
10411069|NCT00766038|11555227|FG000|STARTED|Overall Study||31
10411070|NCT00766038|11555228|FG001|STARTED|Overall Study||32
10411071|NCT00766038|11555227|FG000|COMPLETED|Overall Study||16
10841179|NCT02769000|12006778|FG000|COMPLETED|Overall Study||5
10841180|NCT02769000|12006779|FG001|COMPLETED|Overall Study||0
10841181|NCT02769000|12006778|FG000|NOT COMPLETED|Overall Study||0
10841182|NCT02769000|12006779|FG001|NOT COMPLETED|Overall Study||0
10841183|NCT02756208|12006787|FG000|STARTED|Overall Study||18
10841184|NCT02756208|12006788|FG001|STARTED|Overall Study||16
10841185|NCT02756208|12006789|FG002|STARTED|Overall Study||15
10841186|NCT02756208|12006790|FG003|STARTED|Overall Study||16
10841187|NCT02756208|12006787|FG000|COMPLETED|Overall Study||13
10841188|NCT02756208|12006788|FG001|COMPLETED|Overall Study||14
10411072|NCT00766038|11555228|FG001|COMPLETED|Overall Study||18
10411073|NCT00766038|11555227|FG000|NOT COMPLETED|Overall Study||15
10411074|NCT00766038|11555228|FG001|NOT COMPLETED|Overall Study||14
10411075|NCT00766051|11555238|FG000|STARTED|Overall Study||12
10411076|NCT00766051|11555239|FG001|STARTED|Overall Study||10
10754561|NCT03053427|11918275|FG000|NOT COMPLETED|Overall Study||13
10754562|NCT03053427|11918276|FG001|NOT COMPLETED|Overall Study||16
10754563|NCT03053492|11918284|FG000|STARTED|Overall Study||33
10411077|NCT00766051|11555238|FG000|COMPLETED|Overall Study||10
10411078|NCT00766051|11555239|FG001|COMPLETED|Overall Study||10
10411079|NCT00766051|11555238|FG000|NOT COMPLETED|Overall Study||2
10411080|NCT00766051|11555239|FG001|NOT COMPLETED|Overall Study||0
10411081|NCT00766090|11555249|FG000|STARTED|Treatment Period 1 (28 Days)||25
10411082|NCT00766090|11555250|FG001|STARTED|Treatment Period 1 (28 Days)||27
10411083|NCT00766090|11555251|FG002|STARTED|Treatment Period 1 (28 Days)||23
10411084|NCT00766090|11555252|FG003|STARTED|Treatment Period 1 (28 Days)||26
10411085|NCT00766090|11555253|FG004|STARTED|Treatment Period 1 (28 Days)||23
10411086|NCT00766090|11555254|FG005|STARTED|Treatment Period 1 (28 Days)||23
10411087|NCT00766090|11555255|FG006|STARTED|Treatment Period 1 (28 Days)||6
10411088|NCT00766090|11555256|FG007|STARTED|Treatment Period 1 (28 Days)||8
10754564|NCT03053492|11918285|FG001|STARTED|Overall Study||33
10754565|NCT03053492|11918284|FG000|COMPLETED|Overall Study||25
10754566|NCT03053492|11918285|FG001|COMPLETED|Overall Study||27
10754567|NCT03053492|11918284|FG000|NOT COMPLETED|Overall Study||8
10754568|NCT03053492|11918285|FG001|NOT COMPLETED|Overall Study||6
10754569|NCT03054051|11918293|FG000|STARTED|Overall Study||30
10754570|NCT03054051|11918294|FG001|STARTED|Overall Study||30
10754571|NCT03054051|11918293|FG000|COMPLETED|Overall Study||30
10754572|NCT03054051|11918294|FG001|COMPLETED|Overall Study||30
10411089|NCT00766090|11555257|FG008|STARTED|Treatment Period 1 (28 Days)||7
10411090|NCT00766090|11555258|FG009|STARTED|Treatment Period 1 (28 Days)||8
10411091|NCT00766090|11555259|FG010|STARTED|Treatment Period 1 (28 Days)||7
10411092|NCT00766090|11555260|FG011|STARTED|Treatment Period 1 (28 Days)||7
10754573|NCT03054051|11918293|FG000|NOT COMPLETED|Overall Study||0
10841189|NCT02756208|12006789|FG002|COMPLETED|Overall Study||13
10841190|NCT02756208|12006790|FG003|COMPLETED|Overall Study||12
10841191|NCT02756208|12006787|FG000|NOT COMPLETED|Overall Study||5
10841192|NCT02756208|12006788|FG001|NOT COMPLETED|Overall Study||2
10841193|NCT02756208|12006789|FG002|NOT COMPLETED|Overall Study||2
10841194|NCT02756208|12006790|FG003|NOT COMPLETED|Overall Study||4
10841195|NCT02149121|12006807|FG000|STARTED|Main Study Period||161
10841196|NCT02149121|12006808|FG001|STARTED|Main Study Period||151
10841197|NCT02149121|12006809|FG002|STARTED|Main Study Period||60
10841198|NCT02149121|12006810|FG003|STARTED|Main Study Period||0
10841199|NCT02149121|12006811|FG004|STARTED|Main Study Period||0
10841200|NCT02149121|12006812|FG005|STARTED|Main Study Period||0
10841201|NCT02149121|12006813|FG006|STARTED|Main Study Period||0
10841202|NCT02149121|12006807|FG000|COMPLETED|Main Study Period||140
10841203|NCT02149121|12006808|FG001|COMPLETED|Main Study Period||134
10841204|NCT02149121|12006809|FG002|COMPLETED|Main Study Period||56
10841205|NCT02149121|12006810|FG003|COMPLETED|Main Study Period||0
10841206|NCT02149121|12006811|FG004|COMPLETED|Main Study Period||0
10841207|NCT02149121|12006812|FG005|COMPLETED|Main Study Period||0
10841208|NCT02149121|12006813|FG006|COMPLETED|Main Study Period||0
10841209|NCT02149121|12006807|FG000|NOT COMPLETED|Main Study Period||21
10841210|NCT02149121|12006808|FG001|NOT COMPLETED|Main Study Period||17
10841211|NCT02149121|12006809|FG002|NOT COMPLETED|Main Study Period||4
10841212|NCT02149121|12006810|FG003|NOT COMPLETED|Main Study Period||0
10841213|NCT02149121|12006811|FG004|NOT COMPLETED|Main Study Period||0
10841214|NCT02149121|12006812|FG005|NOT COMPLETED|Main Study Period||0
10841215|NCT02149121|12006813|FG006|NOT COMPLETED|Main Study Period||0
10841216|NCT02149121|12006807|FG000|STARTED|Extension Study Period|This group is for the Main Study Period, not for the Extension Study Period.|0
10841217|NCT02149121|12006808|FG001|STARTED|Extension Study Period|This group is for the Main Study Period, not for the Extension Study Period.|0
10841218|NCT02149121|12006809|FG002|STARTED|Extension Study Period|This group is for the Main Study Period, not for the Extension Study Period.|0
10841219|NCT02149121|12006810|FG003|STARTED|Extension Study Period|"Some participants did not initiate the Extension Study Period (CT-P10: 19, Rituxan: 8, MabThera: 9).~From 19 patients in CT-P10 who did not initiate the extension study period, one patient did not initiate the treatment course but had been included to extension period and was monitored up to week 48"|122
10841220|NCT02149121|12006811|FG004|STARTED|Extension Study Period|Some participants did not initiate the Extension Study Period (CT-P10: 19, Rituxan: 8, MabThera: 9)|64
10841221|NCT02149121|12006812|FG005|STARTED|Extension Study Period|Some participants did not initiate the Extension Study Period (CT-P10: 19, Rituxan: 8, MabThera: 9)|62
10841234|NCT02149121|12006811|FG004|NOT COMPLETED|Extension Study Period||0
10841222|NCT02149121|12006813|FG006|STARTED|Extension Study Period|Some participants did not initiate the Extension Study Period (CT-P10: 19, Rituxan: 8, MabThera: 9)|47
10841223|NCT02149121|12006807|FG000|COMPLETED|Extension Study Period||0
10411093|NCT00766090|11555249|FG000|COMPLETED|Treatment Period 1 (28 Days)||22
10411094|NCT00766090|11555250|FG001|COMPLETED|Treatment Period 1 (28 Days)||27
10411095|NCT00766090|11555251|FG002|COMPLETED|Treatment Period 1 (28 Days)||23
10411096|NCT00766090|11555252|FG003|COMPLETED|Treatment Period 1 (28 Days)||25
10411097|NCT00766090|11555253|FG004|COMPLETED|Treatment Period 1 (28 Days)||23
10411098|NCT00766090|11555254|FG005|COMPLETED|Treatment Period 1 (28 Days)||23
10411099|NCT00766090|11555255|FG006|COMPLETED|Treatment Period 1 (28 Days)||6
10411100|NCT00766090|11555256|FG007|COMPLETED|Treatment Period 1 (28 Days)||8
10411101|NCT00766090|11555257|FG008|COMPLETED|Treatment Period 1 (28 Days)||6
10411102|NCT00766090|11555258|FG009|COMPLETED|Treatment Period 1 (28 Days)||8
10411103|NCT00766090|11555259|FG010|COMPLETED|Treatment Period 1 (28 Days)||7
10411104|NCT00766090|11555260|FG011|COMPLETED|Treatment Period 1 (28 Days)||7
10411105|NCT00766090|11555249|FG000|NOT COMPLETED|Treatment Period 1 (28 Days)||3
10411106|NCT00766090|11555250|FG001|NOT COMPLETED|Treatment Period 1 (28 Days)||0
10411107|NCT00766090|11555251|FG002|NOT COMPLETED|Treatment Period 1 (28 Days)||0
10411108|NCT00766090|11555252|FG003|NOT COMPLETED|Treatment Period 1 (28 Days)||1
10411109|NCT00766090|11555253|FG004|NOT COMPLETED|Treatment Period 1 (28 Days)||0
10411110|NCT00766090|11555254|FG005|NOT COMPLETED|Treatment Period 1 (28 Days)||0
10411111|NCT00766090|11555255|FG006|NOT COMPLETED|Treatment Period 1 (28 Days)||0
10411112|NCT00766090|11555256|FG007|NOT COMPLETED|Treatment Period 1 (28 Days)||0
10411113|NCT00766090|11555257|FG008|NOT COMPLETED|Treatment Period 1 (28 Days)||1
10411114|NCT00766090|11555258|FG009|NOT COMPLETED|Treatment Period 1 (28 Days)||0
10411115|NCT00766090|11555259|FG010|NOT COMPLETED|Treatment Period 1 (28 Days)||0
10411116|NCT00766090|11555260|FG011|NOT COMPLETED|Treatment Period 1 (28 Days)||0
10411117|NCT00766090|11555249|FG000|STARTED|Washout Period 1 (14 Days)||22
10411118|NCT00766090|11555250|FG001|STARTED|Washout Period 1 (14 Days)||27
10411119|NCT00766090|11555251|FG002|STARTED|Washout Period 1 (14 Days)||23
10411120|NCT00766090|11555252|FG003|STARTED|Washout Period 1 (14 Days)||25
10411121|NCT00766090|11555253|FG004|STARTED|Washout Period 1 (14 Days)||23
10411122|NCT00766090|11555254|FG005|STARTED|Washout Period 1 (14 Days)||23
10411123|NCT00766090|11555255|FG006|STARTED|Washout Period 1 (14 Days)||6
10411124|NCT00766090|11555256|FG007|STARTED|Washout Period 1 (14 Days)||8
10411125|NCT00766090|11555257|FG008|STARTED|Washout Period 1 (14 Days)||6
10411126|NCT00766090|11555258|FG009|STARTED|Washout Period 1 (14 Days)||8
10411127|NCT00766090|11555259|FG010|STARTED|Washout Period 1 (14 Days)||7
10411128|NCT00766090|11555260|FG011|STARTED|Washout Period 1 (14 Days)||7
10411129|NCT00766090|11555249|FG000|COMPLETED|Washout Period 1 (14 Days)||22
10411130|NCT00766090|11555250|FG001|COMPLETED|Washout Period 1 (14 Days)||27
10411131|NCT00766090|11555251|FG002|COMPLETED|Washout Period 1 (14 Days)||22
10411132|NCT00766090|11555252|FG003|COMPLETED|Washout Period 1 (14 Days)||25
10411133|NCT00766090|11555253|FG004|COMPLETED|Washout Period 1 (14 Days)||23
10411134|NCT00766090|11555254|FG005|COMPLETED|Washout Period 1 (14 Days)||23
10411135|NCT00766090|11555255|FG006|COMPLETED|Washout Period 1 (14 Days)||6
10411136|NCT00766090|11555256|FG007|COMPLETED|Washout Period 1 (14 Days)||8
10411137|NCT00766090|11555257|FG008|COMPLETED|Washout Period 1 (14 Days)||6
10411138|NCT00766090|11555258|FG009|COMPLETED|Washout Period 1 (14 Days)||8
10411139|NCT00766090|11555259|FG010|COMPLETED|Washout Period 1 (14 Days)||7
10411140|NCT00766090|11555260|FG011|COMPLETED|Washout Period 1 (14 Days)||7
10411141|NCT00766090|11555249|FG000|NOT COMPLETED|Washout Period 1 (14 Days)||0
10411142|NCT00766090|11555250|FG001|NOT COMPLETED|Washout Period 1 (14 Days)||0
10411143|NCT00766090|11555251|FG002|NOT COMPLETED|Washout Period 1 (14 Days)||1
10411144|NCT00766090|11555252|FG003|NOT COMPLETED|Washout Period 1 (14 Days)||0
10411145|NCT00766090|11555253|FG004|NOT COMPLETED|Washout Period 1 (14 Days)||0
10411146|NCT00766090|11555254|FG005|NOT COMPLETED|Washout Period 1 (14 Days)||0
10411147|NCT00766090|11555255|FG006|NOT COMPLETED|Washout Period 1 (14 Days)||0
10411148|NCT00766090|11555256|FG007|NOT COMPLETED|Washout Period 1 (14 Days)||0
10411149|NCT00766090|11555257|FG008|NOT COMPLETED|Washout Period 1 (14 Days)||0
10411150|NCT00766090|11555258|FG009|NOT COMPLETED|Washout Period 1 (14 Days)||0
10411151|NCT00766090|11555259|FG010|NOT COMPLETED|Washout Period 1 (14 Days)||0
10411152|NCT00766090|11555260|FG011|NOT COMPLETED|Washout Period 1 (14 Days)||0
10411153|NCT00766090|11555249|FG000|STARTED|Treatment Period 2 (28 Days)||22
10411154|NCT00766090|11555250|FG001|STARTED|Treatment Period 2 (28 Days)||27
10411155|NCT00766090|11555251|FG002|STARTED|Treatment Period 2 (28 Days)||22
10411156|NCT00766090|11555252|FG003|STARTED|Treatment Period 2 (28 Days)||25
10411157|NCT00766090|11555253|FG004|STARTED|Treatment Period 2 (28 Days)||23
10411158|NCT00766090|11555254|FG005|STARTED|Treatment Period 2 (28 Days)||23
10411159|NCT00766090|11555255|FG006|STARTED|Treatment Period 2 (28 Days)||6
10411160|NCT00766090|11555256|FG007|STARTED|Treatment Period 2 (28 Days)||8
10841224|NCT02149121|12006808|FG001|COMPLETED|Extension Study Period||0
10841225|NCT02149121|12006809|FG002|COMPLETED|Extension Study Period||0
10841226|NCT02149121|12006810|FG003|COMPLETED|Extension Study Period||121
10841227|NCT02149121|12006811|FG004|COMPLETED|Extension Study Period||64
10841228|NCT02149121|12006812|FG005|COMPLETED|Extension Study Period||60
10841229|NCT02149121|12006813|FG006|COMPLETED|Extension Study Period||47
10841230|NCT02149121|12006807|FG000|NOT COMPLETED|Extension Study Period||0
10841231|NCT02149121|12006808|FG001|NOT COMPLETED|Extension Study Period||0
10841232|NCT02149121|12006809|FG002|NOT COMPLETED|Extension Study Period||0
10841233|NCT02149121|12006810|FG003|NOT COMPLETED|Extension Study Period||1
10841235|NCT02149121|12006812|FG005|NOT COMPLETED|Extension Study Period||2
10841236|NCT02149121|12006813|FG006|NOT COMPLETED|Extension Study Period||0
10841237|NCT01889186|12006836|FG000|STARTED|Overall Study||107
10841238|NCT01889186|12006837|FG001|STARTED|Overall Study||51
10841239|NCT01889186|12006836|FG000|COMPLETED|Overall Study||0
10841240|NCT01889186|12006837|FG001|COMPLETED|Overall Study||0
10841241|NCT01889186|12006836|FG000|NOT COMPLETED|Overall Study||107
10841242|NCT01889186|12006837|FG001|NOT COMPLETED|Overall Study||51
10841243|NCT01850004|12006845|FG000|STARTED|Overall Study||84
10841244|NCT01850004|12006845|FG000|COMPLETED|Overall Study||76
10841245|NCT01850004|12006845|FG000|NOT COMPLETED|Overall Study||8
10841246|NCT01510184|12006852|FG000|STARTED|Overall Study||36
10841247|NCT01510184|12006853|FG001|STARTED|Overall Study||43
10841248|NCT01510184|12006852|FG000|COMPLETED|Overall Study||6
10841249|NCT01510184|12006853|FG001|COMPLETED|Overall Study||8
10841250|NCT01510184|12006852|FG000|NOT COMPLETED|Overall Study||30
10841251|NCT01510184|12006853|FG001|NOT COMPLETED|Overall Study||35
10841252|NCT01471444|12006861|FG000|STARTED|Overall Study||133
10841253|NCT01471444|12006862|FG001|STARTED|Overall Study||123
10841254|NCT01471444|12006861|FG000|COMPLETED|Overall Study||130
10841255|NCT01471444|12006862|FG001|COMPLETED|Overall Study||120
10841256|NCT01471444|12006861|FG000|NOT COMPLETED|Overall Study||3
10841257|NCT01471444|12006862|FG001|NOT COMPLETED|Overall Study||3
10411161|NCT00766090|11555257|FG008|STARTED|Treatment Period 2 (28 Days)||6
10411162|NCT00766090|11555258|FG009|STARTED|Treatment Period 2 (28 Days)||8
10411163|NCT00766090|11555259|FG010|STARTED|Treatment Period 2 (28 Days)||7
10411164|NCT00766090|11555260|FG011|STARTED|Treatment Period 2 (28 Days)||7
10411165|NCT00766090|11555249|FG000|COMPLETED|Treatment Period 2 (28 Days)||22
10411166|NCT00766090|11555250|FG001|COMPLETED|Treatment Period 2 (28 Days)||27
10411167|NCT00766090|11555251|FG002|COMPLETED|Treatment Period 2 (28 Days)||21
10411168|NCT00766090|11555252|FG003|COMPLETED|Treatment Period 2 (28 Days)||25
10411169|NCT00766090|11555253|FG004|COMPLETED|Treatment Period 2 (28 Days)||21
10411170|NCT00766090|11555254|FG005|COMPLETED|Treatment Period 2 (28 Days)||23
10411171|NCT00766090|11555255|FG006|COMPLETED|Treatment Period 2 (28 Days)||6
10411172|NCT00766090|11555256|FG007|COMPLETED|Treatment Period 2 (28 Days)||8
10411173|NCT00766090|11555257|FG008|COMPLETED|Treatment Period 2 (28 Days)||6
10411174|NCT00766090|11555258|FG009|COMPLETED|Treatment Period 2 (28 Days)||8
10411175|NCT00766090|11555259|FG010|COMPLETED|Treatment Period 2 (28 Days)||7
10411176|NCT00766090|11555260|FG011|COMPLETED|Treatment Period 2 (28 Days)||7
10411177|NCT00766090|11555249|FG000|NOT COMPLETED|Treatment Period 2 (28 Days)||0
10411178|NCT00766090|11555250|FG001|NOT COMPLETED|Treatment Period 2 (28 Days)||0
10411179|NCT00766090|11555251|FG002|NOT COMPLETED|Treatment Period 2 (28 Days)||1
10429190|NCT00862849|11575286|FG000|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
10841258|NCT00545766|12006869|FG000|STARTED|Overall Study||41
10841259|NCT00545766|12006869|FG000|COMPLETED|Overall Study||36
10841260|NCT00545766|12006869|FG000|NOT COMPLETED|Overall Study||5
10841261|NCT04101890|12006873|FG000|STARTED|Routine Diaper Care||5
10841262|NCT04101890|12006873|FG000|COMPLETED|Routine Diaper Care||5
10841263|NCT04101890|12006873|FG000|NOT COMPLETED|Routine Diaper Care||0
10841264|NCT04101890|12006873|FG000|STARTED|Diaper Care With Theraworx||5
10841265|NCT04101890|12006873|FG000|COMPLETED|Diaper Care With Theraworx||5
10841266|NCT04101890|12006873|FG000|NOT COMPLETED|Diaper Care With Theraworx||0
10841267|NCT03993314|12006881|FG000|STARTED|Overall Study||9
10841268|NCT03993314|12006882|FG001|STARTED|Overall Study||6
10841269|NCT03993314|12006881|FG000|COMPLETED|Overall Study||9
10841270|NCT03993314|12006882|FG001|COMPLETED|Overall Study||6
10841271|NCT03993314|12006881|FG000|NOT COMPLETED|Overall Study||0
10841272|NCT03993314|12006882|FG001|NOT COMPLETED|Overall Study||0
10841273|NCT03874351|12006890|FG000|STARTED|Overall Study||11
10841274|NCT03874351|12006891|FG001|STARTED|Overall Study||11
10841275|NCT03874351|12006890|FG000|COMPLETED|Overall Study||7
10841276|NCT03874351|12006891|FG001|COMPLETED|Overall Study||9
10841277|NCT03874351|12006890|FG000|NOT COMPLETED|Overall Study||4
10841278|NCT03874351|12006891|FG001|NOT COMPLETED|Overall Study||2
10841279|NCT03856359|12006897|FG000|STARTED|Overall Study||10
10292316|NCT04195958|11425089|FG000|NOT COMPLETED|Overall Study||2
10292317|NCT04191148|11425095|FG000|STARTED|Overall Study||24
10292318|NCT04191148|11425096|FG001|STARTED|Overall Study||12
10292319|NCT04191148|11425095|FG000|COMPLETED|Overall Study||22
10292320|NCT04191148|11425096|FG001|COMPLETED|Overall Study||12
10292321|NCT04191148|11425095|FG000|NOT COMPLETED|Overall Study||2
10292322|NCT04191148|11425096|FG001|NOT COMPLETED|Overall Study||0
10314364|NCT00160693|11447906|FG000|STARTED|Overall Study||402
10314365|NCT00160693|11447906|FG000|COMPLETED|Overall Study||167
10314366|NCT00160693|11447906|FG000|NOT COMPLETED|Overall Study||235
10314367|NCT00160706|11447910|FG000|STARTED|Overall Study||310
10314368|NCT00160706|11447910|FG000|COMPLETED|Overall Study||24
10314369|NCT00160706|11447910|FG000|NOT COMPLETED|Overall Study||286
10314370|NCT00161213|11447914|FG000|STARTED|Overall Study||44
10314371|NCT00161213|11447914|FG000|COMPLETED|Overall Study||42
10314372|NCT00161213|11447914|FG000|NOT COMPLETED|Overall Study||2
10314373|NCT00161382|11447920|FG000|STARTED|Overall Study|Number of students allocated to intervention group|598
10314374|NCT00161382|11447921|FG001|STARTED|Overall Study|Number of students allocated to comparison group|847
10314375|NCT00161382|11447920|FG000|COMPLETED|Overall Study|Number of intervention students included in the analyzed cohort (i.e., completed 9th-grade survey)|349
10314376|NCT00161382|11447921|FG001|COMPLETED|Overall Study|Number of control students included in the analyzed cohort (i.e., completed 9th-grade survey)|558
10314377|NCT00161382|11447920|FG000|NOT COMPLETED|Overall Study||249
10314378|NCT00161382|11447921|FG001|NOT COMPLETED|Overall Study||289
10314379|NCT00161473|11447929|FG000|STARTED|Overall Study||12
10314380|NCT00161473|11447930|FG001|STARTED|Overall Study||12
10314381|NCT00161473|11447929|FG000|COMPLETED|Overall Study||7
10314382|NCT00161473|11447930|FG001|COMPLETED|Overall Study||6
10314383|NCT00161473|11447929|FG000|NOT COMPLETED|Overall Study||5
10314384|NCT00161473|11447930|FG001|NOT COMPLETED|Overall Study||6
10314385|NCT00161616|11447938|FG000|STARTED|Overall Study||139
10314386|NCT00161616|11447939|FG001|STARTED|Overall Study||138
10314387|NCT00161616|11447938|FG000|COMPLETED|Overall Study||113
10314388|NCT00161616|11447939|FG001|COMPLETED|Overall Study||119
10314389|NCT00161616|11447938|FG000|NOT COMPLETED|Overall Study||26
10314390|NCT00161616|11447939|FG001|NOT COMPLETED|Overall Study||19
10314391|NCT00162032|11447947|FG000|STARTED|Overall Study||329
10314392|NCT00162032|11447948|FG001|STARTED|Overall Study||116
10314393|NCT00162032|11447947|FG000|COMPLETED|Overall Study|Completed is all subjects who completed 3 yr FU whether or not they were seen in the previous year.|324
10314394|NCT00162032|11447948|FG001|COMPLETED|Overall Study|Completed is all subjects who completed 3 yr FU whether or not they were seen in the previous year.|114
10314395|NCT00162032|11447947|FG000|NOT COMPLETED|Overall Study||5
10314396|NCT00162032|11447948|FG001|NOT COMPLETED|Overall Study||2
10314397|NCT00162097|11447963|FG000|STARTED|Overall Study|Treated on Day 1|6
10314398|NCT00162097|11447964|FG001|STARTED|Overall Study|Treated on Day 1|2
10314399|NCT00162097|11447965|FG002|STARTED|Overall Study|Treated on Day 1|1
10314400|NCT00162097|11447966|FG003|STARTED|Overall Study|Treated on Day 1. One participant enrolled twice in the study and is hence counted twice|7
10314401|NCT00162097|11447963|FG000|COMPLETED|Overall Study||6
10314402|NCT00162097|11447964|FG001|COMPLETED|Overall Study||2
10314403|NCT00162097|11447965|FG002|COMPLETED|Overall Study||1
10314404|NCT00162097|11447966|FG003|COMPLETED|Overall Study||6
10314405|NCT00162097|11447963|FG000|NOT COMPLETED|Overall Study||0
10314406|NCT00162097|11447964|FG001|NOT COMPLETED|Overall Study||0
10314407|NCT00162097|11447965|FG002|NOT COMPLETED|Overall Study||0
10314408|NCT00162097|11447966|FG003|NOT COMPLETED|Overall Study||1
10314409|NCT00162123|11447990|FG000|STARTED|Overall Study|Enrolled|53
10314410|NCT00162123|11447991|FG001|STARTED|Overall Study|Enrolled|34
10314411|NCT00162123|11447992|FG002|STARTED|Overall Study|Enrolled|24
10314412|NCT00162123|11447993|FG003|STARTED|Overall Study|Enrolled|11
10314413|NCT00162123|11447994|FG004|STARTED|Overall Study|Enrolled|45
10314414|NCT00162123|11447995|FG005|STARTED|Overall Study|Enrolled|13
10314415|NCT00162123|11447996|FG006|STARTED|Overall Study|Enrolled|4
10314416|NCT00162123|11447997|FG007|STARTED|Overall Study|Enrolled|58
10314417|NCT00162123|11447990|FG000|Received Treatment|Overall Study||53
10314418|NCT00162123|11447991|FG001|Received Treatment|Overall Study||34
10314419|NCT00162123|11447992|FG002|Received Treatment|Overall Study||24
10314420|NCT00162123|11447993|FG003|Received Treatment|Overall Study||11
10314421|NCT00162123|11447994|FG004|Received Treatment|Overall Study||33
10314422|NCT00162123|11447995|FG005|Received Treatment|Overall Study||12
10314423|NCT00162123|11447996|FG006|Received Treatment|Overall Study||4
10314424|NCT00162123|11447997|FG007|Received Treatment|Overall Study||0
10314425|NCT00162123|11447990|FG000|COMPLETED|Overall Study|Still on treatment|9
10841280|NCT03856359|12006897|FG000|COMPLETED|Overall Study||9
10314426|NCT00162123|11447991|FG001|COMPLETED|Overall Study|Still on treatment|5
10841281|NCT03856359|12006897|FG000|NOT COMPLETED|Overall Study||1
10841282|NCT03769519|12006903|FG000|STARTED|Overall Study||14
10841283|NCT03769519|12006904|FG001|STARTED|Overall Study||15
10841284|NCT03769519|12006903|FG000|COMPLETED|Overall Study||14
10841285|NCT03769519|12006904|FG001|COMPLETED|Overall Study||14
10841286|NCT03769519|12006903|FG000|NOT COMPLETED|Overall Study||0
10841287|NCT03769519|12006904|FG001|NOT COMPLETED|Overall Study||1
10841288|NCT03745651|12006913|FG000|STARTED|Vehicle Control Period (Day 1 to Week 8)||124
10841289|NCT03745651|12006914|FG001|STARTED|Vehicle Control Period (Day 1 to Week 8)||248
10841290|NCT03745651|12006915|FG002|STARTED|Vehicle Control Period (Day 1 to Week 8)||246
10841291|NCT03745651|12006916|FG003|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
10841292|NCT03745651|12006917|FG004|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
10841293|NCT03745651|12006918|FG005|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
10841294|NCT03745651|12006919|FG006|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
10841295|NCT03745651|12006913|FG000|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||105
10841296|NCT03745651|12006914|FG001|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||209
10841297|NCT03745651|12006915|FG002|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||224
10841298|NCT03745651|12006916|FG003|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
10841299|NCT03745651|12006917|FG004|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
10841300|NCT03745651|12006918|FG005|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
10841301|NCT03745651|12006919|FG006|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
10841302|NCT03745651|12006913|FG000|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||19
10841303|NCT03745651|12006914|FG001|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||39
10841304|NCT03745651|12006915|FG002|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||22
10841305|NCT03745651|12006916|FG003|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
10841306|NCT03745651|12006917|FG004|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
10841307|NCT03745651|12006918|FG005|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
10841308|NCT03745651|12006919|FG006|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
10841309|NCT03745651|12006913|FG000|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0
10841310|NCT03745651|12006914|FG001|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0
10841311|NCT03745651|12006915|FG002|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0
10841312|NCT03745651|12006916|FG003|STARTED|Long-Term Safety Period (Weeks 8 to 52)||53
10841313|NCT03745651|12006917|FG004|STARTED|Long-Term Safety Period (Weeks 8 to 52)||52
10841314|NCT03745651|12006918|FG005|STARTED|Long-Term Safety Period (Weeks 8 to 52)||204
10841315|NCT03745651|12006919|FG006|STARTED|Long-Term Safety Period (Weeks 8 to 52)||221
10841316|NCT03745651|12006913|FG000|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
10841317|NCT03745651|12006914|FG001|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
10841318|NCT03745651|12006915|FG002|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
10841319|NCT03745651|12006916|FG003|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||33
10841320|NCT03745651|12006917|FG004|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||41
10841321|NCT03745651|12006918|FG005|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||151
10841322|NCT03745651|12006919|FG006|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||170
10841323|NCT03745651|12006913|FG000|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
10841324|NCT03745651|12006914|FG001|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
10841325|NCT03745651|12006915|FG002|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
10841326|NCT03745651|12006916|FG003|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||20
10841327|NCT03745651|12006917|FG004|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||11
10841328|NCT03745651|12006918|FG005|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||53
10841329|NCT03745651|12006919|FG006|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||51
10841330|NCT03745638|12006938|FG000|STARTED|Vehicle Control Period (Day 1 to Week 8)||126
10841331|NCT03745638|12006939|FG001|STARTED|Vehicle Control Period (Day 1 to Week 8)||252
10841332|NCT03745638|12006940|FG002|STARTED|Vehicle Control Period (Day 1 to Week 8)||253
10841333|NCT03745638|12006941|FG003|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
10841334|NCT03745638|12006942|FG004|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
10841335|NCT03745638|12006943|FG005|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
10841336|NCT03745638|12006944|FG006|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
10841337|NCT03745638|12006938|FG000|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||95
10841338|NCT03745638|12006939|FG001|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||222
10841339|NCT03745638|12006940|FG002|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||225
10841340|NCT03745638|12006941|FG003|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
10841341|NCT03745638|12006942|FG004|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
10841342|NCT03745638|12006943|FG005|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
10841343|NCT03745638|12006944|FG006|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
10841344|NCT03745638|12006938|FG000|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||31
10841345|NCT03745638|12006939|FG001|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||30
10841346|NCT03745638|12006940|FG002|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||28
10841347|NCT03745638|12006941|FG003|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
10841348|NCT03745638|12006942|FG004|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
10841349|NCT03745638|12006943|FG005|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
10841350|NCT03745638|12006944|FG006|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
10841351|NCT03745638|12006938|FG000|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0
10841352|NCT03745638|12006939|FG001|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0
10841353|NCT03745638|12006940|FG002|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0
10841354|NCT03745638|12006941|FG003|STARTED|Long-Term Safety Period (Weeks 8 to 52)||48
10841355|NCT03745638|12006942|FG004|STARTED|Long-Term Safety Period (Weeks 8 to 52)||47
10841356|NCT03745638|12006943|FG005|STARTED|Long-Term Safety Period (Weeks 8 to 52)||222
10841357|NCT03745638|12006944|FG006|STARTED|Long-Term Safety Period (Weeks 8 to 52)||225
10841358|NCT03745638|12006938|FG000|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
10841359|NCT03745638|12006939|FG001|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
10841360|NCT03745638|12006940|FG002|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
10841361|NCT03745638|12006941|FG003|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||37
10841362|NCT03745638|12006942|FG004|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||38
10841363|NCT03745638|12006943|FG005|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||176
10841364|NCT03745638|12006944|FG006|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||174
10841365|NCT03745638|12006938|FG000|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
10841366|NCT03745638|12006939|FG001|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
10841367|NCT03745638|12006940|FG002|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
10841368|NCT03745638|12006941|FG003|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||11
10841369|NCT03745638|12006942|FG004|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||9
10841370|NCT03745638|12006943|FG005|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||46
10841371|NCT03745638|12006944|FG006|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||51
10841372|NCT03715764|12006963|FG000|STARTED|Baseline (Randomized (n=69)||35
10841373|NCT03715764|12006964|FG001|STARTED|Baseline (Randomized (n=69)||34
10841374|NCT03715764|12006963|FG000|COMPLETED|Baseline (Randomized (n=69)||33
10841375|NCT03715764|12006964|FG001|COMPLETED|Baseline (Randomized (n=69)||31
10841376|NCT03715764|12006963|FG000|NOT COMPLETED|Baseline (Randomized (n=69)||2
10841377|NCT03715764|12006964|FG001|NOT COMPLETED|Baseline (Randomized (n=69)||3
10841378|NCT03715764|12006963|FG000|STARTED|3 Month Follow-up||33
10841379|NCT03715764|12006964|FG001|STARTED|3 Month Follow-up||31
10841380|NCT03715764|12006963|FG000|COMPLETED|3 Month Follow-up||30
10841381|NCT03715764|12006964|FG001|COMPLETED|3 Month Follow-up||28
10841382|NCT03715764|12006963|FG000|NOT COMPLETED|3 Month Follow-up||3
10841383|NCT03715764|12006964|FG001|NOT COMPLETED|3 Month Follow-up||3
10841384|NCT03715764|12006963|FG000|STARTED|6 Month Follow-up||30
10841385|NCT03715764|12006964|FG001|STARTED|6 Month Follow-up||28
10841386|NCT03715764|12006963|FG000|COMPLETED|6 Month Follow-up||27
10841387|NCT03715764|12006964|FG001|COMPLETED|6 Month Follow-up||28
10841388|NCT03715764|12006963|FG000|NOT COMPLETED|6 Month Follow-up||3
10841389|NCT03715764|12006964|FG001|NOT COMPLETED|6 Month Follow-up||0
10841390|NCT03715764|12006963|FG000|STARTED|12 Month Follow-up||27
10841391|NCT03715764|12006964|FG001|STARTED|12 Month Follow-up||28
10841392|NCT03715764|12006963|FG000|COMPLETED|12 Month Follow-up||21
10841393|NCT03715764|12006964|FG001|COMPLETED|12 Month Follow-up||23
10841394|NCT03715764|12006963|FG000|NOT COMPLETED|12 Month Follow-up||6
10841395|NCT03715764|12006964|FG001|NOT COMPLETED|12 Month Follow-up||5
10841396|NCT03663855|12006970|FG000|STARTED|Overall Study||10
10841397|NCT03663855|12006970|FG000|COMPLETED|Overall Study||10
10841398|NCT03663855|12006970|FG000|NOT COMPLETED|Overall Study||0
10841399|NCT03654729|12006977|FG000|STARTED|Overall Study||97
10841400|NCT03654729|12006978|FG001|STARTED|Overall Study||96
10841401|NCT03654729|12006979|FG002|STARTED|Overall Study||98
10841402|NCT03654729|12006977|FG000|Treated|Overall Study||96
10841403|NCT03654729|12006978|FG001|Treated|Overall Study||93
10841404|NCT03654729|12006979|FG002|Treated|Overall Study||96
10841405|NCT03654729|12006977|FG000|COMPLETED|Overall Study||66
10841406|NCT03654729|12006978|FG001|COMPLETED|Overall Study||70
10841407|NCT03654729|12006979|FG002|COMPLETED|Overall Study||69
10841408|NCT03654729|12006977|FG000|NOT COMPLETED|Overall Study||31
10841409|NCT03654729|12006978|FG001|NOT COMPLETED|Overall Study||26
10841410|NCT03654729|12006979|FG002|NOT COMPLETED|Overall Study||29
10841411|NCT03531112|12006989|FG000|STARTED|Overall Study||20
10841412|NCT03531112|12006990|FG001|STARTED|Overall Study||0
10841413|NCT03531112|12006989|FG000|Month 4|Overall Study||17
10841414|NCT03531112|12006990|FG001|Month 4|Overall Study||0
10292323|NCT04130802|11425107|FG000|STARTED|Overall Study||51
10292324|NCT04130802|11425108|FG001|STARTED|Overall Study||51
10292325|NCT04130802|11425109|FG002|STARTED|Overall Study||51
10292326|NCT04130802|11425107|FG000|COMPLETED|Overall Study||50
10292327|NCT04130802|11425108|FG001|COMPLETED|Overall Study||50
10292328|NCT04130802|11425109|FG002|COMPLETED|Overall Study||48
10292329|NCT04130802|11425107|FG000|NOT COMPLETED|Overall Study||1
10292330|NCT04130802|11425108|FG001|NOT COMPLETED|Overall Study||1
10292331|NCT04130802|11425109|FG002|NOT COMPLETED|Overall Study||3
10292332|NCT04105738|11425120|FG000|STARTED|Overall Study||13
10292333|NCT04105738|11425121|FG001|STARTED|Overall Study||0
10292334|NCT04105738|11425120|FG000|COMPLETED|Overall Study||13
10292335|NCT04105738|11425121|FG001|COMPLETED|Overall Study||0
10292336|NCT04105738|11425120|FG000|NOT COMPLETED|Overall Study||0
10292337|NCT04105738|11425121|FG001|NOT COMPLETED|Overall Study||0
10292338|NCT04022733|11425129|FG000|STARTED|Overall Study||67
10292339|NCT04022733|11425130|FG001|STARTED|Overall Study||67
10292340|NCT04022733|11425129|FG000|COMPLETED|Overall Study||64
10841415|NCT03531112|12006989|FG000|Month 6 (Follow-Up)|Overall Study||13
10841416|NCT03531112|12006990|FG001|Month 6 (Follow-Up)|Overall Study||0
10841417|NCT03531112|12006989|FG000|COMPLETED|Overall Study||13
10292341|NCT04022733|11425130|FG001|COMPLETED|Overall Study||64
10292342|NCT04022733|11425129|FG000|NOT COMPLETED|Overall Study||3
10292343|NCT04022733|11425130|FG001|NOT COMPLETED|Overall Study||3
10292344|NCT04021524|11425138|FG000|STARTED|Overall Study||25
10292345|NCT04021524|11425139|FG001|STARTED|Overall Study||25
10841418|NCT03531112|12006990|FG001|COMPLETED|Overall Study||0
10841419|NCT03531112|12006989|FG000|NOT COMPLETED|Overall Study||7
10841420|NCT03531112|12006990|FG001|NOT COMPLETED|Overall Study||0
10841421|NCT03112902|12007006|FG000|STARTED|Overall Study||2
10841422|NCT03112902|12007007|FG001|STARTED|Overall Study||2
10841423|NCT03112902|12007008|FG002|STARTED|Overall Study||3
10841424|NCT03112902|12007009|FG003|STARTED|Overall Study||1
10841425|NCT03112902|12007010|FG004|STARTED|Overall Study||1
10841426|NCT03112902|12007011|FG005|STARTED|Overall Study||3
10841427|NCT03112902|12007012|FG006|STARTED|Overall Study||9
10841428|NCT03112902|12007013|FG007|STARTED|Overall Study||3
10841429|NCT03112902|12007014|FG008|STARTED|Overall Study||0
10841430|NCT03112902|12007015|FG009|STARTED|Overall Study||0
10841431|NCT03112902|12007006|FG000|COMPLETED|Overall Study||0
10841432|NCT03112902|12007007|FG001|COMPLETED|Overall Study||2
10841433|NCT03112902|12007008|FG002|COMPLETED|Overall Study||2
10841434|NCT03112902|12007009|FG003|COMPLETED|Overall Study||0
10841435|NCT03112902|12007010|FG004|COMPLETED|Overall Study||1
10841436|NCT03112902|12007011|FG005|COMPLETED|Overall Study||0
10841437|NCT03112902|12007012|FG006|COMPLETED|Overall Study||1
10841438|NCT03112902|12007013|FG007|COMPLETED|Overall Study||1
10841439|NCT03112902|12007014|FG008|COMPLETED|Overall Study||0
10841440|NCT03112902|12007015|FG009|COMPLETED|Overall Study||0
10841441|NCT03112902|12007006|FG000|NOT COMPLETED|Overall Study||2
10841442|NCT03112902|12007007|FG001|NOT COMPLETED|Overall Study||0
10841443|NCT03112902|12007008|FG002|NOT COMPLETED|Overall Study||1
10841444|NCT03112902|12007009|FG003|NOT COMPLETED|Overall Study||1
10841445|NCT03112902|12007010|FG004|NOT COMPLETED|Overall Study||0
10841446|NCT03112902|12007011|FG005|NOT COMPLETED|Overall Study||3
10841447|NCT03112902|12007012|FG006|NOT COMPLETED|Overall Study||8
10841448|NCT03112902|12007013|FG007|NOT COMPLETED|Overall Study||2
10841449|NCT03112902|12007014|FG008|NOT COMPLETED|Overall Study||0
10841450|NCT03112902|12007015|FG009|NOT COMPLETED|Overall Study||0
10841451|NCT02976038|12007031|FG000|STARTED|Overall Study||28
10841452|NCT02976038|12007031|FG000|COMPLETED|Overall Study||0
10841453|NCT02976038|12007031|FG000|NOT COMPLETED|Overall Study||28
10841454|NCT02631070|12007047|FG000|STARTED|Overall Study||153
10841455|NCT02631070|12007048|FG001|STARTED|Overall Study||76
10841456|NCT02631070|12007047|FG000|COMPLETED|Overall Study||4
10841457|NCT02631070|12007048|FG001|COMPLETED|Overall Study||12
10841458|NCT02631070|12007047|FG000|NOT COMPLETED|Overall Study||149
10841459|NCT02631070|12007048|FG001|NOT COMPLETED|Overall Study||64
10841460|NCT02281955|12007054|FG000|STARTED|Overall Study||114
10841461|NCT02281955|12007054|FG000|COMPLETED|Overall Study||113
10841462|NCT02281955|12007054|FG000|NOT COMPLETED|Overall Study||1
10841463|NCT02202434|12007062|FG000|STARTED|Overall Study||607
10841464|NCT02202434|12007063|FG001|STARTED|Overall Study||305
10841465|NCT02202434|12007064|FG002|STARTED|Overall Study||102
10841466|NCT02202434|12007065|FG003|STARTED|Overall Study||295
10841467|NCT02202434|12007062|FG000|COMPLETED|Overall Study||498
10841468|NCT02202434|12007063|FG001|COMPLETED|Overall Study||236
10841469|NCT02202434|12007064|FG002|COMPLETED|Overall Study||87
10841470|NCT02202434|12007065|FG003|COMPLETED|Overall Study||258
10841471|NCT02202434|12007062|FG000|NOT COMPLETED|Overall Study||109
10841472|NCT02202434|12007063|FG001|NOT COMPLETED|Overall Study||69
10841473|NCT02202434|12007064|FG002|NOT COMPLETED|Overall Study||15
10841474|NCT02202434|12007065|FG003|NOT COMPLETED|Overall Study||37
10841475|NCT01727011|12007075|FG000|STARTED|Overall Study||31
10841476|NCT01727011|12007075|FG000|COMPLETED|Overall Study||26
10841477|NCT01727011|12007075|FG000|NOT COMPLETED|Overall Study||5
10841478|NCT01230242|12007079|FG000|STARTED|Overall Study||4
10841479|NCT01230242|12007079|FG000|COMPLETED|Overall Study||1
10841480|NCT01230242|12007079|FG000|NOT COMPLETED|Overall Study||3
10841481|NCT00983437|12007083|FG000|STARTED|Overall Study||47
10841482|NCT00983437|12007083|FG000|Safety Analysis Set (SAS)|Overall Study|Participants who received at least 1 dose of study drug were evaluable for safety.|47
10841483|NCT00983437|12007083|FG000|Full Analysis Set (FAS)|Overall Study|Participants had to have at least 1 postbaseline efficacy assessment to be evaluable for efficacy.|45
10841484|NCT00983437|12007083|FG000|COMPLETED|Overall Study|Completed 12 months of treatment with armodafinil.|0
10841485|NCT00983437|12007083|FG000|NOT COMPLETED|Overall Study||47
10841486|NCT00965757|12007089|FG000|STARTED|Double-blind Phase||165
10841487|NCT00965757|12007090|FG001|STARTED|Double-blind Phase||88
10841488|NCT00965757|12007091|FG002|STARTED|Double-blind Phase||0
10841489|NCT00965757|12007092|FG003|STARTED|Double-blind Phase||0
10841490|NCT00965757|12007089|FG000|COMPLETED|Double-blind Phase||148
10841491|NCT00965757|12007090|FG001|COMPLETED|Double-blind Phase||70
10841492|NCT00965757|12007091|FG002|COMPLETED|Double-blind Phase||0
10841493|NCT00965757|12007092|FG003|COMPLETED|Double-blind Phase||0
10841494|NCT00965757|12007089|FG000|NOT COMPLETED|Double-blind Phase||17
10841495|NCT00965757|12007090|FG001|NOT COMPLETED|Double-blind Phase||18
10841496|NCT00965757|12007091|FG002|NOT COMPLETED|Double-blind Phase||0
10841497|NCT00965757|12007092|FG003|NOT COMPLETED|Double-blind Phase||0
10841498|NCT00965757|12007089|FG000|STARTED|Extension Phase||0
10841499|NCT00965757|12007090|FG001|STARTED|Extension Phase||0
10841500|NCT00965757|12007091|FG002|STARTED|Extension Phase||165
10841501|NCT00965757|12007092|FG003|STARTED|Extension Phase||88
10841502|NCT00965757|12007089|FG000|COMPLETED|Extension Phase||0
10841503|NCT00965757|12007090|FG001|COMPLETED|Extension Phase||0
10841504|NCT00965757|12007091|FG002|COMPLETED|Extension Phase||132
10841505|NCT00965757|12007092|FG003|COMPLETED|Extension Phase||64
10841506|NCT00965757|12007089|FG000|NOT COMPLETED|Extension Phase||0
10841507|NCT00965757|12007090|FG001|NOT COMPLETED|Extension Phase||0
10841508|NCT00965757|12007091|FG002|NOT COMPLETED|Extension Phase||33
10841509|NCT00965757|12007092|FG003|NOT COMPLETED|Extension Phase||24
10841510|NCT00928447|12007100|FG000|STARTED|Overall Study||22
10841511|NCT00928447|12007100|FG000|Received at Least 1 Dose of rHuPH20|Overall Study||21
10841512|NCT00928447|12007100|FG000|Received at Least 1 Dose of Placebo|Overall Study||21
10841513|NCT00928447|12007100|FG000|COMPLETED|Overall Study||20
10841514|NCT00928447|12007100|FG000|NOT COMPLETED|Overall Study||2
10841515|NCT00893789|12007108|FG000|STARTED|Overall Study||29
10841516|NCT00893789|12007109|FG001|STARTED|Overall Study||30
10841517|NCT00893789|12007110|FG002|STARTED|Overall Study||29
10841518|NCT00893789|12007111|FG003|STARTED|Overall Study||29
10841519|NCT00893789|12007108|FG000|Safety Analysis Set (SAS)|Overall Study|SAS = all participants who received 1 or more doses of study drug.|29
10841520|NCT00893789|12007109|FG001|Safety Analysis Set (SAS)|Overall Study||30
10841521|NCT00893789|12007110|FG002|Safety Analysis Set (SAS)|Overall Study||29
10841522|NCT00893789|12007111|FG003|Safety Analysis Set (SAS)|Overall Study||29
10841523|NCT00893789|12007108|FG000|Full Analysis Set (FAS)|Overall Study|FAS = participants in the safety analysis set with ≥1 postbaseline primary efficacy assessment.|29
10841524|NCT00893789|12007109|FG001|Full Analysis Set (FAS)|Overall Study||29
10841525|NCT00893789|12007110|FG002|Full Analysis Set (FAS)|Overall Study||28
10841526|NCT00893789|12007111|FG003|Full Analysis Set (FAS)|Overall Study||27
10841527|NCT00893789|12007108|FG000|COMPLETED|Overall Study||23
10841528|NCT00893789|12007109|FG001|COMPLETED|Overall Study||26
10841529|NCT00893789|12007110|FG002|COMPLETED|Overall Study||22
10841530|NCT00893789|12007111|FG003|COMPLETED|Overall Study||16
10841531|NCT00893789|12007108|FG000|NOT COMPLETED|Overall Study||6
10841532|NCT00893789|12007109|FG001|NOT COMPLETED|Overall Study||4
10841533|NCT00893789|12007110|FG002|NOT COMPLETED|Overall Study||7
10841534|NCT00893789|12007111|FG003|NOT COMPLETED|Overall Study||13
10841535|NCT04349150|12007121|FG000|STARTED|Overall Study||31
10841536|NCT04349150|12007121|FG000|COMPLETED|Overall Study||27
10411180|NCT00766090|11555252|FG003|NOT COMPLETED|Treatment Period 2 (28 Days)||0
10411181|NCT00766090|11555253|FG004|NOT COMPLETED|Treatment Period 2 (28 Days)||2
10411182|NCT00766090|11555254|FG005|NOT COMPLETED|Treatment Period 2 (28 Days)||0
10411183|NCT00766090|11555255|FG006|NOT COMPLETED|Treatment Period 2 (28 Days)||0
10411184|NCT00766090|11555256|FG007|NOT COMPLETED|Treatment Period 2 (28 Days)||0
10411185|NCT00766090|11555257|FG008|NOT COMPLETED|Treatment Period 2 (28 Days)||0
10411186|NCT00766090|11555258|FG009|NOT COMPLETED|Treatment Period 2 (28 Days)||0
10411187|NCT00766090|11555259|FG010|NOT COMPLETED|Treatment Period 2 (28 Days)||0
10841537|NCT04349150|12007121|FG000|NOT COMPLETED|Overall Study||4
10841541|NCT03901144|12007129|FG000|STARTED|Overall Study||50
10841542|NCT03901144|12007130|FG001|STARTED|Overall Study||50
10841543|NCT03901144|12007131|FG002|STARTED|Overall Study||50
10841544|NCT03901144|12007132|FG003|STARTED|Overall Study||50
10411188|NCT00766090|11555260|FG011|NOT COMPLETED|Treatment Period 2 (28 Days)||0
10841545|NCT03901144|12007129|FG000|COMPLETED|Overall Study||49
10841546|NCT03901144|12007130|FG001|COMPLETED|Overall Study||49
10841547|NCT03901144|12007131|FG002|COMPLETED|Overall Study||49
10841548|NCT03901144|12007132|FG003|COMPLETED|Overall Study||49
10841549|NCT03901144|12007129|FG000|NOT COMPLETED|Overall Study||1
10841550|NCT03901144|12007130|FG001|NOT COMPLETED|Overall Study||1
10841551|NCT03901144|12007131|FG002|NOT COMPLETED|Overall Study||1
10841552|NCT03901144|12007132|FG003|NOT COMPLETED|Overall Study||1
10411189|NCT00766090|11555249|FG000|STARTED|Washout Period 2 (14 Days)||22
10411190|NCT00766090|11555250|FG001|STARTED|Washout Period 2 (14 Days)||27
10411191|NCT00766090|11555251|FG002|STARTED|Washout Period 2 (14 Days)||21
10411192|NCT00766090|11555252|FG003|STARTED|Washout Period 2 (14 Days)||25
10411193|NCT00766090|11555253|FG004|STARTED|Washout Period 2 (14 Days)||21
10411194|NCT00766090|11555254|FG005|STARTED|Washout Period 2 (14 Days)||23
10411195|NCT00766090|11555255|FG006|STARTED|Washout Period 2 (14 Days)||6
10411196|NCT00766090|11555256|FG007|STARTED|Washout Period 2 (14 Days)||8
10411197|NCT00766090|11555257|FG008|STARTED|Washout Period 2 (14 Days)||6
10411198|NCT00766090|11555258|FG009|STARTED|Washout Period 2 (14 Days)||8
10411199|NCT00766090|11555259|FG010|STARTED|Washout Period 2 (14 Days)||7
10411200|NCT00766090|11555260|FG011|STARTED|Washout Period 2 (14 Days)||7
10411201|NCT00766090|11555249|FG000|COMPLETED|Washout Period 2 (14 Days)||22
10411202|NCT00766090|11555250|FG001|COMPLETED|Washout Period 2 (14 Days)||27
10411203|NCT00766090|11555251|FG002|COMPLETED|Washout Period 2 (14 Days)||20
10411204|NCT00766090|11555252|FG003|COMPLETED|Washout Period 2 (14 Days)||25
10411205|NCT00766090|11555253|FG004|COMPLETED|Washout Period 2 (14 Days)||21
10411206|NCT00766090|11555254|FG005|COMPLETED|Washout Period 2 (14 Days)||23
10411207|NCT00766090|11555255|FG006|COMPLETED|Washout Period 2 (14 Days)||6
10411208|NCT00766090|11555256|FG007|COMPLETED|Washout Period 2 (14 Days)||8
10411209|NCT00766090|11555257|FG008|COMPLETED|Washout Period 2 (14 Days)||6
10411210|NCT00766090|11555258|FG009|COMPLETED|Washout Period 2 (14 Days)||8
10411211|NCT00766090|11555259|FG010|COMPLETED|Washout Period 2 (14 Days)||7
10411212|NCT00766090|11555260|FG011|COMPLETED|Washout Period 2 (14 Days)||7
10411213|NCT00766090|11555249|FG000|NOT COMPLETED|Washout Period 2 (14 Days)||0
10411214|NCT00766090|11555250|FG001|NOT COMPLETED|Washout Period 2 (14 Days)||0
10411215|NCT00766090|11555251|FG002|NOT COMPLETED|Washout Period 2 (14 Days)||1
10411216|NCT00766090|11555252|FG003|NOT COMPLETED|Washout Period 2 (14 Days)||0
10411217|NCT00766090|11555253|FG004|NOT COMPLETED|Washout Period 2 (14 Days)||0
10411218|NCT00766090|11555254|FG005|NOT COMPLETED|Washout Period 2 (14 Days)||0
10411219|NCT00766090|11555255|FG006|NOT COMPLETED|Washout Period 2 (14 Days)||0
10411220|NCT00766090|11555256|FG007|NOT COMPLETED|Washout Period 2 (14 Days)||0
10411221|NCT00766090|11555257|FG008|NOT COMPLETED|Washout Period 2 (14 Days)||0
10411222|NCT00766090|11555258|FG009|NOT COMPLETED|Washout Period 2 (14 Days)||0
10411223|NCT00766090|11555259|FG010|NOT COMPLETED|Washout Period 2 (14 Days)||0
10411224|NCT00766090|11555260|FG011|NOT COMPLETED|Washout Period 2 (14 Days)||0
10411225|NCT00766090|11555249|FG000|STARTED|Treatment Period 3 (28 Days)||22
10411226|NCT00766090|11555250|FG001|STARTED|Treatment Period 3 (28 Days)||27
10411227|NCT00766090|11555251|FG002|STARTED|Treatment Period 3 (28 Days)||20
10411228|NCT00766090|11555252|FG003|STARTED|Treatment Period 3 (28 Days)||25
10411229|NCT00766090|11555253|FG004|STARTED|Treatment Period 3 (28 Days)||21
10411230|NCT00766090|11555254|FG005|STARTED|Treatment Period 3 (28 Days)||23
10411231|NCT00766090|11555255|FG006|STARTED|Treatment Period 3 (28 Days)||6
10411232|NCT00766090|11555256|FG007|STARTED|Treatment Period 3 (28 Days)||8
10411233|NCT00766090|11555257|FG008|STARTED|Treatment Period 3 (28 Days)||6
10411234|NCT00766090|11555258|FG009|STARTED|Treatment Period 3 (28 Days)||8
10411235|NCT00766090|11555259|FG010|STARTED|Treatment Period 3 (28 Days)||7
10411236|NCT00766090|11555260|FG011|STARTED|Treatment Period 3 (28 Days)||7
10411237|NCT00766090|11555249|FG000|COMPLETED|Treatment Period 3 (28 Days)||22
10411238|NCT00766090|11555250|FG001|COMPLETED|Treatment Period 3 (28 Days)||26
10411239|NCT00766090|11555251|FG002|COMPLETED|Treatment Period 3 (28 Days)||20
10411240|NCT00766090|11555252|FG003|COMPLETED|Treatment Period 3 (28 Days)||24
10411241|NCT00766090|11555253|FG004|COMPLETED|Treatment Period 3 (28 Days)||20
10411242|NCT00766090|11555254|FG005|COMPLETED|Treatment Period 3 (28 Days)||22
10411243|NCT00766090|11555255|FG006|COMPLETED|Treatment Period 3 (28 Days)||6
10411244|NCT00766090|11555256|FG007|COMPLETED|Treatment Period 3 (28 Days)||8
10411245|NCT00766090|11555257|FG008|COMPLETED|Treatment Period 3 (28 Days)||6
10841553|NCT03561701|12007144|FG000|STARTED|Overall Study||220
10841554|NCT03561701|12007145|FG001|STARTED|Overall Study||110
10841555|NCT03561701|12007144|FG000|COMPLETED|Overall Study||191
10841556|NCT03561701|12007145|FG001|COMPLETED|Overall Study||91
10841557|NCT03561701|12007144|FG000|NOT COMPLETED|Overall Study||29
10841558|NCT03561701|12007145|FG001|NOT COMPLETED|Overall Study||19
10841559|NCT03525808|12007151|FG000|STARTED|Overall Study||40
10841560|NCT03525808|12007151|FG000|COMPLETED|Overall Study||34
10841561|NCT03525808|12007151|FG000|NOT COMPLETED|Overall Study||6
10841562|NCT03461211|12007157|FG000|STARTED|Overall Study||37
10841563|NCT03461211|12007158|FG001|STARTED|Overall Study||14
10841564|NCT03461211|12007157|FG000|Proptosis Non-Responders in OPTIC|Overall Study||36
10841565|NCT03461211|12007158|FG001|Proptosis Non-Responders in OPTIC|Overall Study||5
10841566|NCT03461211|12007157|FG000|Relapsed During Follow-Up Period of OPTIC|Overall Study||1
10841567|NCT03461211|12007158|FG001|Relapsed During Follow-Up Period of OPTIC|Overall Study||9
10841568|NCT03461211|12007157|FG000|COMPLETED|Overall Study||36
10841569|NCT03461211|12007158|FG001|COMPLETED|Overall Study||12
10841570|NCT03461211|12007157|FG000|NOT COMPLETED|Overall Study||1
10841571|NCT03461211|12007158|FG001|NOT COMPLETED|Overall Study||2
10754574|NCT03054051|11918294|FG001|NOT COMPLETED|Overall Study||0
10754575|NCT03054064|11918302|FG000|STARTED|Overall Study||48
10754576|NCT03054064|11918302|FG000|Screen Failure|Overall Study||2
10754577|NCT03054064|11918302|FG000|COMPLETED|Overall Study||42
10754578|NCT03054064|11918302|FG000|NOT COMPLETED|Overall Study||6
10754579|NCT03054077|11918308|FG000|STARTED|Overall Study||12
10841572|NCT03276780|12007168|FG000|STARTED|Overall Study||41
10841573|NCT03276780|12007169|FG001|STARTED|Overall Study||39
10841574|NCT03276780|12007168|FG000|COMPLETED|Overall Study||23
10841575|NCT03276780|12007169|FG001|COMPLETED|Overall Study||29
10841576|NCT03276780|12007168|FG000|NOT COMPLETED|Overall Study||18
10841577|NCT03276780|12007169|FG001|NOT COMPLETED|Overall Study||10
10841578|NCT03205553|12007179|FG000|STARTED|Overall Study||2
10841579|NCT03205553|12007180|FG001|STARTED|Overall Study||1
10841580|NCT03205553|12007179|FG000|COMPLETED|Overall Study||2
10841581|NCT03205553|12007180|FG001|COMPLETED|Overall Study||1
10841582|NCT03205553|12007179|FG000|NOT COMPLETED|Overall Study||0
10841583|NCT03205553|12007180|FG001|NOT COMPLETED|Overall Study||0
10841584|NCT03104205|12007186|FG000|STARTED|Overall Study||53
10841585|NCT03104205|12007186|FG000|COMPLETED|Overall Study||44
10841586|NCT03104205|12007186|FG000|NOT COMPLETED|Overall Study||9
10841587|NCT03050814|12007193|FG000|STARTED|Overall Study||10
10841588|NCT03050814|12007194|FG001|STARTED|Overall Study||16
10841589|NCT03050814|12007195|FG002|STARTED|Overall Study||4
10841590|NCT03050814|12007193|FG000|COMPLETED|Overall Study||10
10841591|NCT03050814|12007194|FG001|COMPLETED|Overall Study||16
10841592|NCT03050814|12007195|FG002|COMPLETED|Overall Study||0
10841593|NCT03050814|12007193|FG000|NOT COMPLETED|Overall Study||0
10841594|NCT03050814|12007194|FG001|NOT COMPLETED|Overall Study||0
10841595|NCT03050814|12007195|FG002|NOT COMPLETED|Overall Study||4
10841596|NCT02797262|12007203|FG000|STARTED|Overall Study||65
10841597|NCT02797262|12007204|FG001|STARTED|Overall Study||65
10841598|NCT02797262|12007203|FG000|Baseline|Overall Study||54
10841599|NCT02797262|12007204|FG001|Baseline|Overall Study||58
10841600|NCT02797262|12007203|FG000|COMPLETED|Overall Study||45
10841601|NCT02797262|12007204|FG001|COMPLETED|Overall Study||54
10841602|NCT02797262|12007203|FG000|NOT COMPLETED|Overall Study||20
10841603|NCT02797262|12007204|FG001|NOT COMPLETED|Overall Study||11
10841604|NCT02639910|12007212|FG000|STARTED|Overall Study||11
10841605|NCT02639910|12007213|FG001|STARTED|Overall Study||13
10841606|NCT02639910|12007212|FG000|COMPLETED|Overall Study||7
10841607|NCT02639910|12007213|FG001|COMPLETED|Overall Study||5
10841608|NCT02639910|12007212|FG000|NOT COMPLETED|Overall Study||4
10841609|NCT02639910|12007213|FG001|NOT COMPLETED|Overall Study||8
10841610|NCT02409368|12007222|FG000|STARTED|Overall Study||173
10841611|NCT02409368|12007223|FG001|STARTED|Overall Study||534
10841612|NCT02409368|12007224|FG002|STARTED|Overall Study||103
10841613|NCT02409368|12007222|FG000|COMPLETED|Overall Study||25
10841614|NCT02409368|12007223|FG001|COMPLETED|Overall Study||45
10841615|NCT02409368|12007224|FG002|COMPLETED|Overall Study||4
10841616|NCT02409368|12007222|FG000|NOT COMPLETED|Overall Study||148
10841617|NCT02409368|12007223|FG001|NOT COMPLETED|Overall Study||489
10841618|NCT02409368|12007224|FG002|NOT COMPLETED|Overall Study||99
10841619|NCT02322593|12007235|FG000|STARTED|Overall Study||356
10754580|NCT03054077|11918309|FG001|STARTED|Overall Study||12
10754581|NCT03054077|11918308|FG000|COMPLETED|Overall Study||12
10754582|NCT03054077|11918309|FG001|COMPLETED|Overall Study||12
10754583|NCT03054077|11918308|FG000|NOT COMPLETED|Overall Study||0
10754584|NCT03054077|11918309|FG001|NOT COMPLETED|Overall Study||0
10754585|NCT03054103|11918318|FG000|STARTED|Overall Study||41
10754586|NCT03054103|11918319|FG001|STARTED|Overall Study||29
10754587|NCT03054103|11918320|FG002|STARTED|Overall Study||35
10754588|NCT03054103|11918318|FG000|COMPLETED|Overall Study||41
10841620|NCT02322593|12007236|FG001|STARTED|Overall Study||355
10841621|NCT02322593|12007235|FG000|COMPLETED|Overall Study||356
10841622|NCT02322593|12007236|FG001|COMPLETED|Overall Study||355
10841623|NCT02322593|12007235|FG000|NOT COMPLETED|Overall Study||0
10841624|NCT02322593|12007236|FG001|NOT COMPLETED|Overall Study||0
10841625|NCT02124824|12007244|FG000|STARTED|Overall Study||15
10841626|NCT02124824|12007245|FG001|STARTED|Overall Study||15
10841627|NCT02124824|12007244|FG000|COMPLETED|Overall Study||15
10841628|NCT02124824|12007245|FG001|COMPLETED|Overall Study||15
10841629|NCT02124824|12007244|FG000|NOT COMPLETED|Overall Study||0
10411246|NCT00766090|11555258|FG009|COMPLETED|Treatment Period 3 (28 Days)||8
10411247|NCT00766090|11555259|FG010|COMPLETED|Treatment Period 3 (28 Days)||7
10411248|NCT00766090|11555260|FG011|COMPLETED|Treatment Period 3 (28 Days)||6
10411249|NCT00766090|11555249|FG000|NOT COMPLETED|Treatment Period 3 (28 Days)||0
10411250|NCT00766090|11555250|FG001|NOT COMPLETED|Treatment Period 3 (28 Days)||1
10411251|NCT00766090|11555251|FG002|NOT COMPLETED|Treatment Period 3 (28 Days)||0
10411252|NCT00766090|11555252|FG003|NOT COMPLETED|Treatment Period 3 (28 Days)||1
10411253|NCT00766090|11555253|FG004|NOT COMPLETED|Treatment Period 3 (28 Days)||1
10411254|NCT00766090|11555254|FG005|NOT COMPLETED|Treatment Period 3 (28 Days)||1
10411255|NCT00766090|11555255|FG006|NOT COMPLETED|Treatment Period 3 (28 Days)||0
10411256|NCT00766090|11555256|FG007|NOT COMPLETED|Treatment Period 3 (28 Days)||0
10411257|NCT00766090|11555257|FG008|NOT COMPLETED|Treatment Period 3 (28 Days)||0
10411258|NCT00766090|11555258|FG009|NOT COMPLETED|Treatment Period 3 (28 Days)||0
10754589|NCT03054103|11918319|FG001|COMPLETED|Overall Study||29
10754590|NCT03054103|11918320|FG002|COMPLETED|Overall Study||35
10754591|NCT03054103|11918318|FG000|NOT COMPLETED|Overall Study||0
10754592|NCT03054103|11918319|FG001|NOT COMPLETED|Overall Study||0
10754593|NCT03054103|11918320|FG002|NOT COMPLETED|Overall Study||0
10754594|NCT03054337|11918334|FG000|STARTED|Primary Efficacy Period (6 Weeks)||12
10754595|NCT03054337|11918335|FG001|STARTED|Primary Efficacy Period (6 Weeks)||12
10754596|NCT03054337|11918336|FG002|STARTED|Primary Efficacy Period (6 Weeks)||13
10754597|NCT03054337|11918337|FG003|STARTED|Primary Efficacy Period (6 Weeks)||5
10754598|NCT03054337|11918338|FG004|STARTED|Primary Efficacy Period (6 Weeks)||4
10754599|NCT03054337|11918339|FG005|STARTED|Primary Efficacy Period (6 Weeks)||5
10754600|NCT03054337|11918334|FG000|COMPLETED|Primary Efficacy Period (6 Weeks)||12
10754601|NCT03054337|11918335|FG001|COMPLETED|Primary Efficacy Period (6 Weeks)||12
10754602|NCT03054337|11918336|FG002|COMPLETED|Primary Efficacy Period (6 Weeks)||13
10754603|NCT03054337|11918337|FG003|COMPLETED|Primary Efficacy Period (6 Weeks)||5
10754604|NCT03054337|11918338|FG004|COMPLETED|Primary Efficacy Period (6 Weeks)||4
10754605|NCT03054337|11918339|FG005|COMPLETED|Primary Efficacy Period (6 Weeks)||5
10779392|NCT03365778|11940977|FG001|COMPLETED|Overall Study||17
10841630|NCT02124824|12007245|FG001|NOT COMPLETED|Overall Study||0
10841631|NCT01772004|12007274|FG000|STARTED|Dose Escalation Phase||4
10841632|NCT01772004|12007275|FG001|STARTED|Dose Escalation Phase||13
10841633|NCT01772004|12007276|FG002|STARTED|Dose Escalation Phase||15
10841634|NCT01772004|12007277|FG003|STARTED|Dose Escalation Phase||21
10841635|NCT01772004|12007278|FG004|STARTED|Dose Escalation Phase||8
10841636|NCT01772004|12007279|FG005|STARTED|Dose Escalation Phase||0
10841637|NCT01772004|12007280|FG006|STARTED|Dose Escalation Phase||0
10841638|NCT01772004|12007281|FG007|STARTED|Dose Escalation Phase||0
10841639|NCT01772004|12007282|FG008|STARTED|Dose Escalation Phase||0
10841640|NCT01772004|12007283|FG009|STARTED|Dose Escalation Phase||0
10841641|NCT01772004|12007284|FG010|STARTED|Dose Escalation Phase||0
10841642|NCT01772004|12007285|FG011|STARTED|Dose Escalation Phase||0
10841643|NCT01772004|12007286|FG012|STARTED|Dose Escalation Phase||0
10841644|NCT01772004|12007287|FG013|STARTED|Dose Escalation Phase||0
10841645|NCT01772004|12007288|FG014|STARTED|Dose Escalation Phase||0
10841646|NCT01772004|12007289|FG015|STARTED|Dose Escalation Phase||0
10841647|NCT01772004|12007290|FG016|STARTED|Dose Escalation Phase||0
10841648|NCT01772004|12007291|FG017|STARTED|Dose Escalation Phase||0
10841649|NCT01772004|12007292|FG018|STARTED|Dose Escalation Phase||0
10841650|NCT01772004|12007293|FG019|STARTED|Dose Escalation Phase||0
10841651|NCT01772004|12007294|FG020|STARTED|Dose Escalation Phase||0
10841652|NCT01772004|12007295|FG021|STARTED|Dose Escalation Phase||0
10841653|NCT01772004|12007296|FG022|STARTED|Dose Escalation Phase||0
10841654|NCT01772004|12007274|FG000|COMPLETED|Dose Escalation Phase||4
10841655|NCT01772004|12007275|FG001|COMPLETED|Dose Escalation Phase||13
10841656|NCT01772004|12007276|FG002|COMPLETED|Dose Escalation Phase||15
10841657|NCT01772004|12007277|FG003|COMPLETED|Dose Escalation Phase||21
10841658|NCT01772004|12007278|FG004|COMPLETED|Dose Escalation Phase||8
10841659|NCT01772004|12007279|FG005|COMPLETED|Dose Escalation Phase||0
10841660|NCT01772004|12007280|FG006|COMPLETED|Dose Escalation Phase||0
10841661|NCT01772004|12007281|FG007|COMPLETED|Dose Escalation Phase||0
10841662|NCT01772004|12007282|FG008|COMPLETED|Dose Escalation Phase||0
10841663|NCT01772004|12007283|FG009|COMPLETED|Dose Escalation Phase||0
10841664|NCT01772004|12007284|FG010|COMPLETED|Dose Escalation Phase||0
10841665|NCT01772004|12007285|FG011|COMPLETED|Dose Escalation Phase||0
10841666|NCT01772004|12007286|FG012|COMPLETED|Dose Escalation Phase||0
10841667|NCT01772004|12007287|FG013|COMPLETED|Dose Escalation Phase||0
10841668|NCT01772004|12007288|FG014|COMPLETED|Dose Escalation Phase||0
10841669|NCT01772004|12007289|FG015|COMPLETED|Dose Escalation Phase||0
10841670|NCT01772004|12007290|FG016|COMPLETED|Dose Escalation Phase||0
10841671|NCT01772004|12007291|FG017|COMPLETED|Dose Escalation Phase||0
10841672|NCT01772004|12007292|FG018|COMPLETED|Dose Escalation Phase||0
10841673|NCT01772004|12007293|FG019|COMPLETED|Dose Escalation Phase||0
10841674|NCT01772004|12007294|FG020|COMPLETED|Dose Escalation Phase||0
10841675|NCT01772004|12007295|FG021|COMPLETED|Dose Escalation Phase||0
10841676|NCT01772004|12007296|FG022|COMPLETED|Dose Escalation Phase||0
10841677|NCT01772004|12007274|FG000|NOT COMPLETED|Dose Escalation Phase||0
10841678|NCT01772004|12007275|FG001|NOT COMPLETED|Dose Escalation Phase||0
10841679|NCT01772004|12007276|FG002|NOT COMPLETED|Dose Escalation Phase||0
10841680|NCT01772004|12007277|FG003|NOT COMPLETED|Dose Escalation Phase||0
10411259|NCT00766090|11555259|FG010|NOT COMPLETED|Treatment Period 3 (28 Days)||0
10411260|NCT00766090|11555260|FG011|NOT COMPLETED|Treatment Period 3 (28 Days)||1
10411261|NCT00766116|11555274|FG000|STARTED|Overall Study||50
10411262|NCT00766116|11555274|FG000|COMPLETED|Overall Study||50
10411263|NCT00766116|11555274|FG000|NOT COMPLETED|Overall Study||0
10411264|NCT00766142|11555281|FG000|STARTED|Overall Study||18
10411265|NCT00766142|11555281|FG000|COMPLETED|Overall Study||14
10411266|NCT00766142|11555281|FG000|NOT COMPLETED|Overall Study||4
10545033|NCT01493687|11698239|FG001|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||1
10545034|NCT01493778|11698251|FG000|STARTED|Overall Study||60
10545035|NCT01493778|11698251|FG000|COMPLETED|Overall Study||52
10545036|NCT01493778|11698251|FG000|NOT COMPLETED|Overall Study||8
10545037|NCT01493947|11698266|FG000|STARTED|Period A Efficacy and Safety Data||478
10545038|NCT01493947|11698267|FG001|STARTED|Period A Efficacy and Safety Data||484
10545039|NCT01493947|11698266|FG000|COMPLETED|Period A Efficacy and Safety Data||446
10545040|NCT01493947|11698267|FG001|COMPLETED|Period A Efficacy and Safety Data||456
10545041|NCT01493947|11698266|FG000|NOT COMPLETED|Period A Efficacy and Safety Data||32
10545042|NCT01493947|11698267|FG001|NOT COMPLETED|Period A Efficacy and Safety Data||28
10545043|NCT01493947|11698266|FG000|STARTED|Period B Extension Period|Only 399 /446 subjects were eligible to enter in Period B (i.e IGA=0 or1 at end of Period A).|399
10545044|NCT01493947|11698267|FG001|STARTED|Period B Extension Period|358 / 456 subjects were eligible to enter in Period B (i.e IGA =0 or 1 at end of Period A).|358
10545045|NCT01493947|11698266|FG000|COMPLETED|Period B Extension Period||366
10545046|NCT01493947|11698267|FG001|COMPLETED|Period B Extension Period||326
10545047|NCT01493947|11698266|FG000|NOT COMPLETED|Period B Extension Period||33
10545048|NCT01493947|11698267|FG001|NOT COMPLETED|Period B Extension Period||32
10545049|NCT01493960|11698278|FG000|STARTED|Overall Study||87
10545050|NCT01493960|11698279|FG001|STARTED|Overall Study||44
10661192|NCT02257541|11823077|FG000|STARTED|Overall Study||3
10661193|NCT02257541|11823078|FG001|STARTED|Overall Study||8
10661194|NCT02257541|11823079|FG002|STARTED|Overall Study||1
10661195|NCT02257541|11823080|FG003|STARTED|Overall Study||3
10661196|NCT02257541|11823081|FG004|STARTED|Overall Study||1
10661197|NCT02257541|11823077|FG000|COMPLETED|Overall Study||3
10661198|NCT02257541|11823078|FG001|COMPLETED|Overall Study||8
10661199|NCT02257541|11823079|FG002|COMPLETED|Overall Study||1
10661200|NCT02257541|11823080|FG003|COMPLETED|Overall Study||3
10661201|NCT02257541|11823081|FG004|COMPLETED|Overall Study||1
10661202|NCT02257541|11823077|FG000|NOT COMPLETED|Overall Study||0
10661203|NCT02257541|11823078|FG001|NOT COMPLETED|Overall Study||0
10661204|NCT02257541|11823079|FG002|NOT COMPLETED|Overall Study||0
10661205|NCT02257541|11823080|FG003|NOT COMPLETED|Overall Study||0
10661206|NCT02257541|11823081|FG004|NOT COMPLETED|Overall Study||0
10661207|NCT02257632|11823094|FG000|STARTED|Overall Study||19
10661208|NCT02257632|11823095|FG001|STARTED|Overall Study||22
10661209|NCT02257632|11823094|FG000|Full Analysis Set (FAS)|Overall Study||19
10661210|NCT02257632|11823095|FG001|Full Analysis Set (FAS)|Overall Study||21
10661211|NCT02257632|11823094|FG000|Safety Set (SAF)|Overall Study||19
10661212|NCT02257632|11823095|FG001|Safety Set (SAF)|Overall Study||21
10661213|NCT02257632|11823094|FG000|Per-Protocol Set (PPS)|Overall Study||17
10661214|NCT02257632|11823095|FG001|Per-Protocol Set (PPS)|Overall Study||20
10661215|NCT02257632|11823094|FG000|COMPLETED|Overall Study||18
10661216|NCT02257632|11823095|FG001|COMPLETED|Overall Study||19
10661217|NCT02257632|11823094|FG000|NOT COMPLETED|Overall Study||1
10661218|NCT02257632|11823095|FG001|NOT COMPLETED|Overall Study||3
10661219|NCT02257684|11823103|FG000|STARTED|Overall Study||4
10661220|NCT02257684|11823103|FG000|COMPLETED|Overall Study||0
10661221|NCT02257684|11823103|FG000|NOT COMPLETED|Overall Study||4
10661222|NCT02257957|11823109|FG000|STARTED|Overall Study||15
10661223|NCT02257957|11823110|FG001|STARTED|Overall Study||15
10411267|NCT00766363|11555289|FG000|STARTED|Overall Study||12
10411268|NCT00766363|11555290|FG001|STARTED|Overall Study||13
10661224|NCT02257957|11823109|FG000|COMPLETED|Overall Study||15
10661225|NCT02257957|11823110|FG001|COMPLETED|Overall Study||15
10661226|NCT02257957|11823109|FG000|NOT COMPLETED|Overall Study||0
10661227|NCT02257957|11823110|FG001|NOT COMPLETED|Overall Study||0
10661228|NCT02257970|11823120|FG000|STARTED|Part 1||50
10411269|NCT00766363|11555291|FG002|STARTED|Overall Study|Number randomized.|12
10661229|NCT02257970|11823121|FG001|STARTED|Part 1||0
10411270|NCT00766363|11555292|FG003|STARTED|Overall Study|Number randomized.|12
10411271|NCT00766363|11555289|FG000|SAFETY POPULATION|Overall Study||12
10411272|NCT00766363|11555290|FG001|SAFETY POPULATION|Overall Study||13
10411273|NCT00766363|11555291|FG002|SAFETY POPULATION|Overall Study|Decreased by one subject who took placebo instead due to treatment assignment error.|11
10411274|NCT00766363|11555292|FG003|SAFETY POPULATION|Overall Study|Increased by one subject who took placebo due to treatment assignment error.|13
10411275|NCT00766363|11555289|FG000|PK POPULATION|Overall Study||12
10411276|NCT00766363|11555290|FG001|PK POPULATION|Overall Study||13
10411277|NCT00766363|11555291|FG002|PK POPULATION|Overall Study||10
10411278|NCT00766363|11555292|FG003|PK POPULATION|Overall Study||13
10411279|NCT00766363|11555289|FG000|COMPLETED|Overall Study||11
10411280|NCT00766363|11555290|FG001|COMPLETED|Overall Study||12
10411281|NCT00766363|11555291|FG002|COMPLETED|Overall Study||12
10411282|NCT00766363|11555292|FG003|COMPLETED|Overall Study||12
10411283|NCT00766363|11555289|FG000|NOT COMPLETED|Overall Study||1
10411284|NCT00766363|11555290|FG001|NOT COMPLETED|Overall Study||1
10411285|NCT00766363|11555291|FG002|NOT COMPLETED|Overall Study||0
10411286|NCT00766363|11555292|FG003|NOT COMPLETED|Overall Study||0
10411287|NCT00766376|11555303|FG000|STARTED|Overall Study||151
10411288|NCT00766376|11555303|FG000|COMPLETED|Overall Study||124
10411289|NCT00766376|11555303|FG000|NOT COMPLETED|Overall Study||27
10411290|NCT00766415|11555309|FG000|STARTED|Overall Study||25
10411291|NCT00766415|11555310|FG001|STARTED|Overall Study||27
10411292|NCT00766415|11555309|FG000|COMPLETED|Overall Study||25
10411293|NCT00766415|11555310|FG001|COMPLETED|Overall Study||26
10411294|NCT00766415|11555309|FG000|NOT COMPLETED|Overall Study||0
10411295|NCT00766415|11555310|FG001|NOT COMPLETED|Overall Study||1
10411296|NCT00766467|11555318|FG000|STARTED|Overall Study||42
10411297|NCT00766467|11555319|FG001|STARTED|Overall Study||39
10411298|NCT00766467|11555318|FG000|Initiated Treatment|Overall Study||39
10411299|NCT00766467|11555319|FG001|Initiated Treatment|Overall Study||38
10411300|NCT00766467|11555318|FG000|COMPLETED|Overall Study||31
10411301|NCT00766467|11555319|FG001|COMPLETED|Overall Study||31
10411302|NCT00766467|11555318|FG000|NOT COMPLETED|Overall Study||11
10411303|NCT00766467|11555319|FG001|NOT COMPLETED|Overall Study||8
10411304|NCT00766493|11555325|FG000|STARTED|Pre-Discharge||250
10411305|NCT00766493|11555325|FG000|COMPLETED|Pre-Discharge||250
10411306|NCT00766493|11555325|FG000|NOT COMPLETED|Pre-Discharge||0
10411307|NCT00766493|11555325|FG000|STARTED|30 Days Post-Procedure||250
10411308|NCT00766493|11555325|FG000|COMPLETED|30 Days Post-Procedure||238
10411309|NCT00766493|11555325|FG000|NOT COMPLETED|30 Days Post-Procedure||12
10411310|NCT00766506|11555331|FG000|STARTED|Overall Study||58
10411311|NCT00766506|11555332|FG001|STARTED|Overall Study||50
10411312|NCT00766506|11555331|FG000|COMPLETED|Overall Study||53
10411313|NCT00766506|11555332|FG001|COMPLETED|Overall Study||48
10411314|NCT00766506|11555331|FG000|NOT COMPLETED|Overall Study||5
10411315|NCT00766506|11555332|FG001|NOT COMPLETED|Overall Study||2
10754606|NCT03054337|11918334|FG000|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0
10754607|NCT03054337|11918335|FG001|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0
10754608|NCT03054337|11918336|FG002|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0
10754609|NCT03054337|11918337|FG003|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0
10754610|NCT03054337|11918338|FG004|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0
10754611|NCT03054337|11918339|FG005|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0
10754612|NCT03054337|11918334|FG000|STARTED|Dose Adjustment and Maintenance Period||12
10754613|NCT03054337|11918335|FG001|STARTED|Dose Adjustment and Maintenance Period||12
10754614|NCT03054337|11918336|FG002|STARTED|Dose Adjustment and Maintenance Period||13
10754615|NCT03054337|11918337|FG003|STARTED|Dose Adjustment and Maintenance Period||5
10754616|NCT03054337|11918338|FG004|STARTED|Dose Adjustment and Maintenance Period||4
10754617|NCT03054337|11918339|FG005|STARTED|Dose Adjustment and Maintenance Period||5
10754618|NCT03054337|11918334|FG000|COMPLETED|Dose Adjustment and Maintenance Period||11
10754619|NCT03054337|11918335|FG001|COMPLETED|Dose Adjustment and Maintenance Period||10
10754620|NCT03054337|11918336|FG002|COMPLETED|Dose Adjustment and Maintenance Period||12
10754621|NCT03054337|11918337|FG003|COMPLETED|Dose Adjustment and Maintenance Period||5
10754622|NCT03054337|11918338|FG004|COMPLETED|Dose Adjustment and Maintenance Period||4
10754623|NCT03054337|11918339|FG005|COMPLETED|Dose Adjustment and Maintenance Period||4
10754624|NCT03054337|11918334|FG000|NOT COMPLETED|Dose Adjustment and Maintenance Period||1
10754625|NCT03054337|11918335|FG001|NOT COMPLETED|Dose Adjustment and Maintenance Period||2
10754626|NCT03054337|11918336|FG002|NOT COMPLETED|Dose Adjustment and Maintenance Period||1
10754627|NCT03054337|11918337|FG003|NOT COMPLETED|Dose Adjustment and Maintenance Period||0
10779393|NCT03365778|11940978|FG002|COMPLETED|Overall Study||53
10411316|NCT00766532|11555338|FG000|STARTED|Overall Study||12
10411317|NCT00766532|11555338|FG000|COMPLETED|Overall Study||10
10411318|NCT00766532|11555338|FG000|NOT COMPLETED|Overall Study||2
10411319|NCT00766597|11555342|FG000|STARTED|Overall Study|Screened participants who were evaluated for co-receptor tropism|9
10411320|NCT00766597|11555342|FG000|With CCR5-tropic Virus|Overall Study|Evaluable participants, received the study drug|4
10411321|NCT00766597|11555342|FG000|Without CCR5-tropic Virus|Overall Study|Not evaluable participants, did not receive the study drug|5
10411322|NCT00766597|11555342|FG000|Completed Week 24|Overall Study|Week 24 is the first primary time point of analysis|1
10411323|NCT00766597|11555342|FG000|Completed Week 48|Overall Study|Week 48 is the second primary time point of analysis|0
10411324|NCT00766597|11555342|FG000|COMPLETED|Overall Study|Treatment duration is 48 weeks plus 5 years of follow-up|0
10411325|NCT00766597|11555342|FG000|NOT COMPLETED|Overall Study||9
10411326|NCT00766649|11555348|FG000|STARTED|Overall Study||11
10411327|NCT00766649|11555348|FG000|COMPLETED|Overall Study||1
10411328|NCT00766649|11555348|FG000|NOT COMPLETED|Overall Study||10
10411329|NCT00766675|11555352|FG000|STARTED|Overall Study||80
10411330|NCT00766675|11555352|FG000|COMPLETED|Overall Study||40
10411331|NCT00766675|11555352|FG000|NOT COMPLETED|Overall Study||40
10411332|NCT00766727|11555356|FG000|STARTED|Overall Study||12
10411333|NCT00766727|11555356|FG000|COMPLETED|Overall Study||9
10411334|NCT00766727|11555356|FG000|NOT COMPLETED|Overall Study||3
10411335|NCT00766753|11555364|FG000|STARTED|Overall Study||11
10411336|NCT00766753|11555365|FG001|STARTED|Overall Study||11
10411337|NCT00766753|11555364|FG000|Received at Least One Vaccine|Overall Study||11
10411338|NCT00766753|11555365|FG001|Received at Least One Vaccine|Overall Study||11
10411339|NCT00766753|11555364|FG000|Completed at Least Four Vaccines|Overall Study||10
10411340|NCT00766753|11555365|FG001|Completed at Least Four Vaccines|Overall Study||9
10411341|NCT00766753|11555364|FG000|COMPLETED|Overall Study||11
10411342|NCT00766753|11555365|FG001|COMPLETED|Overall Study||11
10411343|NCT00766753|11555364|FG000|NOT COMPLETED|Overall Study||0
10411344|NCT00766753|11555365|FG001|NOT COMPLETED|Overall Study||0
10411345|NCT00766831|11555372|FG000|STARTED|Overall Study||190
10411346|NCT00766831|11555372|FG000|COMPLETED|Overall Study||75
10411347|NCT00766831|11555372|FG000|NOT COMPLETED|Overall Study||115
10411348|NCT00767000|11555381|FG000|STARTED|54-week Study||119
10411349|NCT00767000|11555382|FG001|STARTED|54-week Study||117
10411350|NCT00767000|11555383|FG002|STARTED|54-week Study||117
10411351|NCT00767000|11555384|FG003|STARTED|54-week Study|Includes additional participants enrolled to enhance evaluation of the safety profile of MK-0941|229
10411352|NCT00767000|11555385|FG004|STARTED|54-week Study|Includes additional participants enrolled to enhance evaluation of the safety profile of MK-0941|231
10411353|NCT00767000|11555381|FG000|COMPLETED|54-week Study||11
10411354|NCT00767000|11555382|FG001|COMPLETED|54-week Study||4
10411355|NCT00767000|11555383|FG002|COMPLETED|54-week Study||8
10411356|NCT00767000|11555384|FG003|COMPLETED|54-week Study||4
10411357|NCT00767000|11555385|FG004|COMPLETED|54-week Study||7
10411358|NCT00767000|11555381|FG000|NOT COMPLETED|54-week Study||108
10411359|NCT00767000|11555382|FG001|NOT COMPLETED|54-week Study||113
10411360|NCT00767000|11555383|FG002|NOT COMPLETED|54-week Study||109
10411361|NCT00767000|11555384|FG003|NOT COMPLETED|54-week Study||225
10411362|NCT00767000|11555385|FG004|NOT COMPLETED|54-week Study||224
10411363|NCT00767000|11555381|FG000|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|7
10411364|NCT00767000|11555382|FG001|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|3
10411365|NCT00767000|11555383|FG002|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|7
10411366|NCT00767000|11555384|FG003|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|2
10411367|NCT00767000|11555385|FG004|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|4
10411368|NCT00767000|11555381|FG000|COMPLETED|Optional 104-week Extension||0
10411369|NCT00767000|11555382|FG001|COMPLETED|Optional 104-week Extension||0
10411370|NCT00767000|11555383|FG002|COMPLETED|Optional 104-week Extension||0
10411371|NCT00767000|11555384|FG003|COMPLETED|Optional 104-week Extension||0
10411372|NCT00767000|11555385|FG004|COMPLETED|Optional 104-week Extension||0
10411373|NCT00767000|11555381|FG000|NOT COMPLETED|Optional 104-week Extension||7
10411374|NCT00767000|11555382|FG001|NOT COMPLETED|Optional 104-week Extension||3
10411375|NCT00767000|11555383|FG002|NOT COMPLETED|Optional 104-week Extension||7
10411376|NCT00767000|11555384|FG003|NOT COMPLETED|Optional 104-week Extension||2
10411377|NCT00767000|11555385|FG004|NOT COMPLETED|Optional 104-week Extension||4
10411378|NCT00767039|11555399|FG000|STARTED|Overall Study|Two early deaths and 3 late deaths occurred in this group|27
10411379|NCT00767039|11555400|FG001|STARTED|Overall Study||25
10411380|NCT00767039|11555399|FG000|COMPLETED|Overall Study||22
10411381|NCT00767039|11555400|FG001|COMPLETED|Overall Study||23
10411382|NCT00767039|11555399|FG000|NOT COMPLETED|Overall Study||5
10411383|NCT00767039|11555400|FG001|NOT COMPLETED|Overall Study||2
10411384|NCT00767104|11555408|FG000|STARTED|Overall Study||20
10411385|NCT00767104|11555409|FG001|STARTED|Overall Study||20
10411386|NCT00767104|11555408|FG000|COMPLETED|Overall Study||19
10411387|NCT00767104|11555409|FG001|COMPLETED|Overall Study||18
10411388|NCT00767104|11555408|FG000|NOT COMPLETED|Overall Study||1
10411389|NCT00767104|11555409|FG001|NOT COMPLETED|Overall Study||2
10411390|NCT00767325|11555417|FG000|STARTED|Overall Study||104
10411391|NCT00767325|11555417|FG000|COMPLETED|Overall Study||89
10411392|NCT00767325|11555417|FG000|NOT COMPLETED|Overall Study||15
10411393|NCT00767338|11555425|FG000|STARTED|Overall Study||1
10411394|NCT00767338|11555426|FG001|STARTED|Overall Study||2
10411395|NCT00767338|11555427|FG002|STARTED|Overall Study||0
10411396|NCT00767338|11555428|FG003|STARTED|Overall Study||0
10411397|NCT00767338|11555425|FG000|COMPLETED|Overall Study||0
10411398|NCT00767338|11555426|FG001|COMPLETED|Overall Study||0
10411399|NCT00767338|11555427|FG002|COMPLETED|Overall Study||0
10411400|NCT00767338|11555428|FG003|COMPLETED|Overall Study||0
10411401|NCT00767338|11555425|FG000|NOT COMPLETED|Overall Study||1
10411402|NCT00767338|11555426|FG001|NOT COMPLETED|Overall Study||2
10411403|NCT00767338|11555427|FG002|NOT COMPLETED|Overall Study||0
10411404|NCT00767338|11555428|FG003|NOT COMPLETED|Overall Study||0
10411405|NCT00767364|11555440|FG000|STARTED|Overall Study||5
10411406|NCT00767364|11555441|FG001|STARTED|Overall Study||3
10411407|NCT00767364|11555440|FG000|COMPLETED|Overall Study||5
10411408|NCT00767364|11555441|FG001|COMPLETED|Overall Study||3
10411409|NCT00767364|11555440|FG000|NOT COMPLETED|Overall Study||0
10411410|NCT00767364|11555441|FG001|NOT COMPLETED|Overall Study||0
10411411|NCT00767455|11555447|FG000|STARTED|Overall Study||59
10411412|NCT00767455|11555447|FG000|COMPLETED|Overall Study||40
10411413|NCT00767455|11555447|FG000|NOT COMPLETED|Overall Study||19
10411414|NCT00767507|11555457|FG000|STARTED|Overall Study||5
10411415|NCT00767507|11555458|FG001|STARTED|Overall Study||6
10411416|NCT00767507|11555459|FG002|STARTED|Overall Study||106
10411417|NCT00767507|11555460|FG003|STARTED|Overall Study||104
10411418|NCT00767507|11555457|FG000|COMPLETED|Overall Study||5
10411419|NCT00767507|11555458|FG001|COMPLETED|Overall Study||6
10411420|NCT00767507|11555459|FG002|COMPLETED|Overall Study||106
10411421|NCT00767507|11555460|FG003|COMPLETED|Overall Study||101
10411422|NCT00767507|11555457|FG000|NOT COMPLETED|Overall Study||0
10411423|NCT00767507|11555458|FG001|NOT COMPLETED|Overall Study||0
10411424|NCT00767507|11555459|FG002|NOT COMPLETED|Overall Study||0
10411425|NCT00767507|11555460|FG003|NOT COMPLETED|Overall Study||3
10411426|NCT00767520|11555479|FG000|STARTED|Overall Study||79
10411427|NCT00767520|11555480|FG001|STARTED|Overall Study||78
10411428|NCT00767520|11555479|FG000|COMPLETED|Overall Study|Completed=Off-treatment; Major reasons: disease progression-50, study drug toxicity-10,AE-3,Death-2|68
10411429|NCT00767520|11555480|FG001|COMPLETED|Overall Study|Completed=Off-treatment; Major reasons: disease progression-56, study drug toxicity-2,AE-1,Death-1|61
10411430|NCT00767520|11555479|FG000|NOT COMPLETED|Overall Study||11
10411431|NCT00767520|11555480|FG001|NOT COMPLETED|Overall Study||17
10411432|NCT00767572|11555486|FG000|STARTED|First Intervention (12 Weeks)||12
10411433|NCT00767572|11555486|FG000|COMPLETED|First Intervention (12 Weeks)||12
10411434|NCT00767572|11555486|FG000|NOT COMPLETED|First Intervention (12 Weeks)||0
10411435|NCT00767572|11555486|FG000|STARTED|Washout (4 Weeks)||12
10411436|NCT00767572|11555486|FG000|COMPLETED|Washout (4 Weeks)||12
10411437|NCT00767572|11555486|FG000|NOT COMPLETED|Washout (4 Weeks)||0
10411438|NCT00767572|11555486|FG000|STARTED|Second Intervention (12 Weeks)||12
10411439|NCT00767572|11555486|FG000|COMPLETED|Second Intervention (12 Weeks)||12
10411440|NCT00767572|11555486|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0
10411441|NCT00767624|11555494|FG000|STARTED|Overall Study||75
10411442|NCT00767624|11555495|FG001|STARTED|Overall Study||75
10411443|NCT00767624|11555494|FG000|COMPLETED|Overall Study||51
10411444|NCT00767624|11555495|FG001|COMPLETED|Overall Study||58
10411445|NCT00767624|11555494|FG000|NOT COMPLETED|Overall Study||24
10411446|NCT00767624|11555495|FG001|NOT COMPLETED|Overall Study||17
10411447|NCT00767676|11555501|FG000|STARTED|Overall Study||259
10411448|NCT00767676|11555501|FG000|COMPLETED|Overall Study||205
10411449|NCT00767676|11555501|FG000|NOT COMPLETED|Overall Study||54
10411450|NCT00767767|11555510|FG000|STARTED|Overall Study||21
10411451|NCT00767767|11555511|FG001|STARTED|Overall Study||20
10411452|NCT00767767|11555512|FG002|STARTED|Overall Study||20
10545051|NCT01493960|11698278|FG000|Received Study Drug|Overall Study||87
10841681|NCT01772004|12007278|FG004|NOT COMPLETED|Dose Escalation Phase||0
10841682|NCT01772004|12007279|FG005|NOT COMPLETED|Dose Escalation Phase||0
10841683|NCT01772004|12007280|FG006|NOT COMPLETED|Dose Escalation Phase||0
10841684|NCT01772004|12007281|FG007|NOT COMPLETED|Dose Escalation Phase||0
10841685|NCT01772004|12007282|FG008|NOT COMPLETED|Dose Escalation Phase||0
10841686|NCT01772004|12007283|FG009|NOT COMPLETED|Dose Escalation Phase||0
10841687|NCT01772004|12007284|FG010|NOT COMPLETED|Dose Escalation Phase||0
10841688|NCT01772004|12007285|FG011|NOT COMPLETED|Dose Escalation Phase||0
10841689|NCT01772004|12007286|FG012|NOT COMPLETED|Dose Escalation Phase||0
10841690|NCT01772004|12007287|FG013|NOT COMPLETED|Dose Escalation Phase||0
10841691|NCT01772004|12007288|FG014|NOT COMPLETED|Dose Escalation Phase||0
10841692|NCT01772004|12007289|FG015|NOT COMPLETED|Dose Escalation Phase||0
10411453|NCT00767767|11555513|FG003|STARTED|Overall Study||3
10411454|NCT00767767|11555514|FG004|STARTED|Overall Study||3
10411455|NCT00767767|11555510|FG000|COMPLETED|Overall Study||21
10411456|NCT00767767|11555511|FG001|COMPLETED|Overall Study||20
10411457|NCT00767767|11555512|FG002|COMPLETED|Overall Study||20
10411458|NCT00767767|11555513|FG003|COMPLETED|Overall Study||3
10545052|NCT01493960|11698279|FG001|Received Study Drug|Overall Study||43
10545053|NCT01493960|11698278|FG000|COMPLETED|Overall Study||55
10545054|NCT01493960|11698279|FG001|COMPLETED|Overall Study||26
10545055|NCT01493960|11698278|FG000|NOT COMPLETED|Overall Study||32
10545056|NCT01493960|11698279|FG001|NOT COMPLETED|Overall Study||18
10545057|NCT01494038|11698287|FG000|STARTED|Overall Study||477
10545058|NCT01494038|11698288|FG001|STARTED|Overall Study||479
10545059|NCT01494038|11698287|FG000|COMPLETED|Overall Study||389
10545060|NCT01494038|11698288|FG001|COMPLETED|Overall Study||396
10545061|NCT01494038|11698287|FG000|NOT COMPLETED|Overall Study||88
10545062|NCT01494038|11698288|FG001|NOT COMPLETED|Overall Study||83
10545063|NCT01494051|11698311|FG000|STARTED|Overall Study||6
10545064|NCT01494051|11698312|FG001|STARTED|Overall Study||7
10545065|NCT01494051|11698311|FG000|COMPLETED|Overall Study||6
10545066|NCT01494051|11698312|FG001|COMPLETED|Overall Study||7
10545067|NCT01494051|11698311|FG000|NOT COMPLETED|Overall Study||0
10545068|NCT01494051|11698312|FG001|NOT COMPLETED|Overall Study||0
10545069|NCT01494298|11698320|FG000|STARTED|Overall Study||56
10545070|NCT01494298|11698321|FG001|STARTED|Overall Study||55
10545071|NCT01494298|11698320|FG000|COMPLETED|Overall Study||54
10545072|NCT01494298|11698321|FG001|COMPLETED|Overall Study||47
10545073|NCT01494298|11698320|FG000|NOT COMPLETED|Overall Study||2
10545074|NCT01494298|11698321|FG001|NOT COMPLETED|Overall Study||8
10545075|NCT01494350|11698329|FG000|STARTED|Overall Study||50
10841693|NCT01772004|12007290|FG016|NOT COMPLETED|Dose Escalation Phase||0
10841694|NCT01772004|12007291|FG017|NOT COMPLETED|Dose Escalation Phase||0
10841695|NCT01772004|12007292|FG018|NOT COMPLETED|Dose Escalation Phase||0
10841696|NCT01772004|12007293|FG019|NOT COMPLETED|Dose Escalation Phase||0
10841697|NCT01772004|12007294|FG020|NOT COMPLETED|Dose Escalation Phase||0
10841698|NCT01772004|12007295|FG021|NOT COMPLETED|Dose Escalation Phase||0
10841699|NCT01772004|12007296|FG022|NOT COMPLETED|Dose Escalation Phase||0
10841700|NCT01772004|12007274|FG000|STARTED|Dose Expansion Phase||0
10841701|NCT01772004|12007275|FG001|STARTED|Dose Expansion Phase||0
10841702|NCT01772004|12007276|FG002|STARTED|Dose Expansion Phase||0
10841703|NCT01772004|12007277|FG003|STARTED|Dose Expansion Phase||0
10841704|NCT01772004|12007278|FG004|STARTED|Dose Expansion Phase||0
10841705|NCT01772004|12007279|FG005|STARTED|Dose Expansion Phase||184
10841706|NCT01772004|12007280|FG006|STARTED|Dose Expansion Phase||156
10841707|NCT01772004|12007281|FG007|STARTED|Dose Expansion Phase||168
10841708|NCT01772004|12007282|FG008|STARTED|Dose Expansion Phase||60
10841709|NCT01772004|12007283|FG009|STARTED|Dose Expansion Phase||90
10841710|NCT01772004|12007284|FG010|STARTED|Dose Expansion Phase||21
10841711|NCT01772004|12007285|FG011|STARTED|Dose Expansion Phase||18
10841712|NCT01772004|12007286|FG012|STARTED|Dose Expansion Phase||50
10841713|NCT01772004|12007287|FG013|STARTED|Dose Expansion Phase||51
10841714|NCT01772004|12007288|FG014|STARTED|Dose Expansion Phase||53
10841715|NCT01772004|12007289|FG015|STARTED|Dose Expansion Phase||44
10841716|NCT01772004|12007290|FG016|STARTED|Dose Expansion Phase||125
10841717|NCT01772004|12007291|FG017|STARTED|Dose Expansion Phase||62
10841718|NCT01772004|12007292|FG018|STARTED|Dose Expansion Phase||20
10841719|NCT01772004|12007293|FG019|STARTED|Dose Expansion Phase||103
10841720|NCT01772004|12007294|FG020|STARTED|Dose Expansion Phase||205
10841721|NCT01772004|12007295|FG021|STARTED|Dose Expansion Phase||132
10841722|NCT01772004|12007296|FG022|STARTED|Dose Expansion Phase||153
10841723|NCT01772004|12007274|FG000|COMPLETED|Dose Expansion Phase||0
10841724|NCT01772004|12007275|FG001|COMPLETED|Dose Expansion Phase||0
10841725|NCT01772004|12007276|FG002|COMPLETED|Dose Expansion Phase||0
10411459|NCT00767767|11555514|FG004|COMPLETED|Overall Study||3
10411460|NCT00767767|11555510|FG000|NOT COMPLETED|Overall Study||0
10411461|NCT00767767|11555511|FG001|NOT COMPLETED|Overall Study||0
10411462|NCT00767767|11555512|FG002|NOT COMPLETED|Overall Study||0
10411463|NCT00767767|11555513|FG003|NOT COMPLETED|Overall Study||0
10411464|NCT00767767|11555514|FG004|NOT COMPLETED|Overall Study||0
10411465|NCT00767806|11555528|FG000|STARTED|Overall Study||198
10411466|NCT00767806|11555529|FG001|STARTED|Overall Study||203
10411467|NCT00767806|11555528|FG000|COMPLETED|Overall Study||147
10411468|NCT00767806|11555529|FG001|COMPLETED|Overall Study||156
10411469|NCT00767806|11555528|FG000|NOT COMPLETED|Overall Study||51
10411470|NCT00767806|11555529|FG001|NOT COMPLETED|Overall Study||47
10411471|NCT00767819|11555538|FG000|STARTED|Overall Study||37
10411472|NCT00767819|11555539|FG001|STARTED|Overall Study||24
10411473|NCT00767819|11555540|FG002|STARTED|Overall Study||10
10411474|NCT00767819|11555538|FG000|Intent to Treat (ITT) Analysis Set|Overall Study||37
10411475|NCT00767819|11555539|FG001|Intent to Treat (ITT) Analysis Set|Overall Study||24
10411476|NCT00767819|11555540|FG002|Intent to Treat (ITT) Analysis Set|Overall Study||10
10411477|NCT00767819|11555538|FG000|Safety Analysis Set (SAF)|Overall Study||37
10411478|NCT00767819|11555539|FG001|Safety Analysis Set (SAF)|Overall Study||24
10411479|NCT00767819|11555540|FG002|Safety Analysis Set (SAF)|Overall Study||10
10411480|NCT00767819|11555538|FG000|COMPLETED|Overall Study||12
10411481|NCT00767819|11555539|FG001|COMPLETED|Overall Study||5
10411482|NCT00767819|11555540|FG002|COMPLETED|Overall Study||10
10411483|NCT00767819|11555538|FG000|NOT COMPLETED|Overall Study||25
10411484|NCT00767819|11555539|FG001|NOT COMPLETED|Overall Study||19
10411485|NCT00767819|11555540|FG002|NOT COMPLETED|Overall Study||0
10411486|NCT00768053|11555548|FG000|STARTED|Overall Study||108
10411487|NCT00768053|11555548|FG000|COMPLETED|Overall Study||97
10411488|NCT00768053|11555548|FG000|NOT COMPLETED|Overall Study||11
10411489|NCT00768066|11555555|FG000|STARTED|Overall Study||22
10411490|NCT00768066|11555556|FG001|STARTED|Overall Study||22
10411491|NCT00768066|11555557|FG002|STARTED|Overall Study||21
10411492|NCT00768066|11555555|FG000|COMPLETED|Overall Study||19
10411493|NCT00768066|11555556|FG001|COMPLETED|Overall Study||19
10411494|NCT00768066|11555557|FG002|COMPLETED|Overall Study||21
10411495|NCT00768066|11555555|FG000|NOT COMPLETED|Overall Study||3
10411496|NCT00768066|11555556|FG001|NOT COMPLETED|Overall Study||3
10411497|NCT00768066|11555557|FG002|NOT COMPLETED|Overall Study||0
10411498|NCT00768079|11555568|FG000|STARTED|Overall Study||38
10411499|NCT00768079|11555569|FG001|STARTED|Overall Study||36
10411500|NCT00768079|11555570|FG002|STARTED|Overall Study||36
10411501|NCT00768079|11555568|FG000|COMPLETED|Overall Study||36
10411502|NCT00768079|11555569|FG001|COMPLETED|Overall Study||35
10411503|NCT00768079|11555570|FG002|COMPLETED|Overall Study||32
10411504|NCT00768079|11555568|FG000|NOT COMPLETED|Overall Study||2
10411505|NCT00768079|11555569|FG001|NOT COMPLETED|Overall Study||1
10411506|NCT00768079|11555570|FG002|NOT COMPLETED|Overall Study||4
10411507|NCT00768118|11555580|FG000|STARTED|Overall Study||11
10411508|NCT00768118|11555580|FG000|COMPLETED|Overall Study||11
10411509|NCT00768118|11555580|FG000|NOT COMPLETED|Overall Study||0
10411510|NCT00768144|11555584|FG000|STARTED|Overall Study||36
10841726|NCT01772004|12007277|FG003|COMPLETED|Dose Expansion Phase||0
10841727|NCT01772004|12007278|FG004|COMPLETED|Dose Expansion Phase||0
10841728|NCT01772004|12007279|FG005|COMPLETED|Dose Expansion Phase||184
10841729|NCT01772004|12007280|FG006|COMPLETED|Dose Expansion Phase||156
10841730|NCT01772004|12007281|FG007|COMPLETED|Dose Expansion Phase||168
10841731|NCT01772004|12007282|FG008|COMPLETED|Dose Expansion Phase||60
10841732|NCT01772004|12007283|FG009|COMPLETED|Dose Expansion Phase||90
10841733|NCT01772004|12007284|FG010|COMPLETED|Dose Expansion Phase||21
10841734|NCT01772004|12007285|FG011|COMPLETED|Dose Expansion Phase||18
10841735|NCT01772004|12007286|FG012|COMPLETED|Dose Expansion Phase||50
10841736|NCT01772004|12007287|FG013|COMPLETED|Dose Expansion Phase||51
10841737|NCT01772004|12007288|FG014|COMPLETED|Dose Expansion Phase||53
10841738|NCT01772004|12007289|FG015|COMPLETED|Dose Expansion Phase||44
10841739|NCT01772004|12007290|FG016|COMPLETED|Dose Expansion Phase||125
10841740|NCT01772004|12007291|FG017|COMPLETED|Dose Expansion Phase||62
10841741|NCT01772004|12007292|FG018|COMPLETED|Dose Expansion Phase||20
10841742|NCT01772004|12007293|FG019|COMPLETED|Dose Expansion Phase||103
10841743|NCT01772004|12007294|FG020|COMPLETED|Dose Expansion Phase||205
10841744|NCT01772004|12007295|FG021|COMPLETED|Dose Expansion Phase||132
10841745|NCT01772004|12007296|FG022|COMPLETED|Dose Expansion Phase||153
10841746|NCT01772004|12007274|FG000|NOT COMPLETED|Dose Expansion Phase||0
10841747|NCT01772004|12007275|FG001|NOT COMPLETED|Dose Expansion Phase||0
10841748|NCT01772004|12007276|FG002|NOT COMPLETED|Dose Expansion Phase||0
10841749|NCT01772004|12007277|FG003|NOT COMPLETED|Dose Expansion Phase||0
10841750|NCT01772004|12007278|FG004|NOT COMPLETED|Dose Expansion Phase||0
10841751|NCT01772004|12007279|FG005|NOT COMPLETED|Dose Expansion Phase||0
10841752|NCT01772004|12007280|FG006|NOT COMPLETED|Dose Expansion Phase||0
10841753|NCT01772004|12007281|FG007|NOT COMPLETED|Dose Expansion Phase||0
10841754|NCT01772004|12007282|FG008|NOT COMPLETED|Dose Expansion Phase||0
10841755|NCT01772004|12007283|FG009|NOT COMPLETED|Dose Expansion Phase||0
10841756|NCT01772004|12007284|FG010|NOT COMPLETED|Dose Expansion Phase||0
10841757|NCT01772004|12007285|FG011|NOT COMPLETED|Dose Expansion Phase||0
10841758|NCT01772004|12007286|FG012|NOT COMPLETED|Dose Expansion Phase||0
10841759|NCT01772004|12007287|FG013|NOT COMPLETED|Dose Expansion Phase||0
10841760|NCT01772004|12007288|FG014|NOT COMPLETED|Dose Expansion Phase||0
10841761|NCT01772004|12007289|FG015|NOT COMPLETED|Dose Expansion Phase||0
10841762|NCT01772004|12007290|FG016|NOT COMPLETED|Dose Expansion Phase||0
10841763|NCT01772004|12007291|FG017|NOT COMPLETED|Dose Expansion Phase||0
10841764|NCT01772004|12007292|FG018|NOT COMPLETED|Dose Expansion Phase||0
10841765|NCT01772004|12007293|FG019|NOT COMPLETED|Dose Expansion Phase||0
10841766|NCT01772004|12007294|FG020|NOT COMPLETED|Dose Expansion Phase||0
10841767|NCT01772004|12007295|FG021|NOT COMPLETED|Dose Expansion Phase||0
10841768|NCT01772004|12007296|FG022|NOT COMPLETED|Dose Expansion Phase||0
10841769|NCT01322971|12007393|FG000|STARTED|Overall Study||1
10841770|NCT01322971|12007394|FG001|STARTED|Overall Study||1
10841771|NCT01322971|12007393|FG000|COMPLETED|Overall Study||0
10841772|NCT01322971|12007394|FG001|COMPLETED|Overall Study||0
10841773|NCT01322971|12007393|FG000|NOT COMPLETED|Overall Study||1
10841774|NCT01322971|12007394|FG001|NOT COMPLETED|Overall Study||1
10841775|NCT01285102|12007400|FG000|STARTED|Overall Study||4
10841776|NCT01285102|12007400|FG000|COMPLETED|Overall Study||0
10841777|NCT01285102|12007400|FG000|NOT COMPLETED|Overall Study||4
10841778|NCT00952692|12007404|FG000|STARTED|Overall Study||12
10841779|NCT00952692|12007404|FG000|COMPLETED|Overall Study||12
10841780|NCT00952692|12007404|FG000|NOT COMPLETED|Overall Study||0
10841781|NCT00804713|12007408|FG000|STARTED|Overall Study||1978
10841782|NCT00804713|12007408|FG000|COMPLETED|Overall Study||1978
10841783|NCT00804713|12007408|FG000|NOT COMPLETED|Overall Study||0
10841784|NCT00677560|12007419|FG000|STARTED|Overall Study||20
10841785|NCT00677560|12007420|FG001|STARTED|Overall Study||23
10841786|NCT00677560|12007421|FG002|STARTED|Overall Study||29
10841787|NCT00677560|12007422|FG003|STARTED|Overall Study||20
10841788|NCT00677560|12007423|FG004|STARTED|Overall Study||34
10841789|NCT00677560|12007419|FG000|COMPLETED|Overall Study||5
10841790|NCT00677560|12007420|FG001|COMPLETED|Overall Study||13
10841791|NCT00677560|12007421|FG002|COMPLETED|Overall Study||6
10841792|NCT00677560|12007422|FG003|COMPLETED|Overall Study||3
10841793|NCT00677560|12007423|FG004|COMPLETED|Overall Study||21
10841794|NCT00677560|12007419|FG000|NOT COMPLETED|Overall Study||15
10841795|NCT00677560|12007420|FG001|NOT COMPLETED|Overall Study||10
10841796|NCT00677560|12007421|FG002|NOT COMPLETED|Overall Study||23
10841797|NCT00677560|12007422|FG003|NOT COMPLETED|Overall Study||17
10841798|NCT00677560|12007423|FG004|NOT COMPLETED|Overall Study||13
10841799|NCT00389649|12007448|FG000|STARTED|Overall Study||2
10841800|NCT00389649|12007449|FG001|STARTED|Overall Study||2
10841801|NCT00389649|12007450|FG002|STARTED|Overall Study||3
10841802|NCT00389649|12007451|FG003|STARTED|Overall Study||2
10841803|NCT00389649|12007452|FG004|STARTED|Overall Study||2
10841804|NCT00389649|12007453|FG005|STARTED|Overall Study||2
10841805|NCT00389649|12007448|FG000|COMPLETED|Overall Study||2
10841806|NCT00389649|12007449|FG001|COMPLETED|Overall Study||2
10841807|NCT00389649|12007450|FG002|COMPLETED|Overall Study||3
10841808|NCT00389649|12007451|FG003|COMPLETED|Overall Study||2
10841809|NCT00389649|12007452|FG004|COMPLETED|Overall Study||2
10841810|NCT00389649|12007453|FG005|COMPLETED|Overall Study||2
10841811|NCT00389649|12007448|FG000|NOT COMPLETED|Overall Study||0
10841812|NCT00389649|12007449|FG001|NOT COMPLETED|Overall Study||0
10841813|NCT00389649|12007450|FG002|NOT COMPLETED|Overall Study||0
10841814|NCT00389649|12007451|FG003|NOT COMPLETED|Overall Study||0
10841815|NCT00389649|12007452|FG004|NOT COMPLETED|Overall Study||0
10841816|NCT00389649|12007453|FG005|NOT COMPLETED|Overall Study||0
10841817|NCT04644328|12007463|FG000|STARTED|Thanksgiving Period|"Two separate, sequential experiments were run within the study using the same counties (with differences in exclusion criteria explained in the pre-assignment details).~Thanksgiving experiment: 410 counties were assigned to high-intensity treatment. A total of 3,545 ZCTAs (of which 2,702 were in high-intensity counties) were treated.~Counties randomized to intervention, data collected at the population level, actual number of participants unknown."|
10841818|NCT04644328|12007464|FG001|STARTED|Thanksgiving Period|"Two separate, sequential experiments were run within the study using the same counties (with differences in exclusion criteria explained in the pre-assignment details).~Thanksgiving experiment: 410 counties were assigned to low-intensity treatment. A total of 3,453 ZCTAs (of which 2,549 were in low-intensity counties) were not treated.~Counties randomized to intervention, data collected at the population level, actual number of participants unknown."|
10841899|NCT03181542|12007573|FG001|STARTED|Overall Study||80
10841819|NCT04644328|12007463|FG000|COMPLETED|Thanksgiving Period|Counties randomized to intervention, data collected at the population level, actual number of participants unknown.|
10841820|NCT04644328|12007464|FG001|COMPLETED|Thanksgiving Period|Counties randomized to intervention, data collected at the population level, actual number of participants unknown.|
10841821|NCT04644328|12007463|FG000|NOT COMPLETED|Thanksgiving Period||
10841822|NCT04644328|12007464|FG001|NOT COMPLETED|Thanksgiving Period||
10841823|NCT04644328|12007463|FG000|STARTED|Christmas Period|"Two separate, sequential experiments were run within the study using the same counties (with differences in exclusion criteria explained in the pre-assignment details).~Christmas experiment: 386 counties were assigned to high-intensity treatment. A total of 5,077 ZCTAs (of which 3,818 were in high-intensity counties) were treated.~Counties randomized to intervention, data collected at the population level, actual number of participants unknown."|
10841824|NCT04644328|12007464|FG001|STARTED|Christmas Period|"Two separate, sequential experiments were run within the study using the same counties (with differences in exclusion criteria explained in the pre-assignment details).~Christmas experiment: 381 counties were assigned to low-intensity treatment. A total of 5,102 ZCTAs (of which 3,833 were in low-intensity counties) were not treated.~Counties randomized to intervention, data collected at the population level, actual number of participants unknown."|
10841825|NCT04644328|12007463|FG000|COMPLETED|Christmas Period|Counties randomized to intervention, data collected at the population level, actual number of participants unknown.|
10841826|NCT04644328|12007464|FG001|COMPLETED|Christmas Period|Counties randomized to intervention, data collected at the population level, actual number of participants unknown.|
10841827|NCT04644328|12007463|FG000|NOT COMPLETED|Christmas Period||
10841828|NCT04644328|12007464|FG001|NOT COMPLETED|Christmas Period||
10841829|NCT04246554|12007474|FG000|STARTED|Overall Study||26
10841830|NCT04246554|12007475|FG001|STARTED|Overall Study||23
10411511|NCT00768144|11555584|FG000|COMPLETED|Overall Study||0
10411512|NCT00768144|11555584|FG000|NOT COMPLETED|Overall Study||36
10411513|NCT00768222|11555590|FG000|STARTED|Overall Study||50
10411514|NCT00768222|11555591|FG001|STARTED|Overall Study||51
10411515|NCT00768222|11555590|FG000|COMPLETED|Overall Study||46
10411516|NCT00768222|11555591|FG001|COMPLETED|Overall Study||47
10411517|NCT00768222|11555590|FG000|NOT COMPLETED|Overall Study||4
10411518|NCT00768222|11555591|FG001|NOT COMPLETED|Overall Study||4
10411519|NCT00768261|11555601|FG000|STARTED|Overall Study||14
10411520|NCT00768261|11555602|FG001|STARTED|Overall Study||18
10411521|NCT00768261|11555603|FG002|STARTED|Overall Study||39
10411522|NCT00768261|11555604|FG003|STARTED|Overall Study||56
10411523|NCT00768261|11555601|FG000|COMPLETED|Overall Study||14
10411524|NCT00768261|11555602|FG001|COMPLETED|Overall Study||18
10411525|NCT00768261|11555603|FG002|COMPLETED|Overall Study||14
10411526|NCT00768261|11555604|FG003|COMPLETED|Overall Study||56
10411527|NCT00768261|11555601|FG000|NOT COMPLETED|Overall Study||0
10411528|NCT00768261|11555602|FG001|NOT COMPLETED|Overall Study||0
10411529|NCT00768261|11555603|FG002|NOT COMPLETED|Overall Study||25
10411530|NCT00768261|11555604|FG003|NOT COMPLETED|Overall Study||0
10411531|NCT00768287|11555617|FG000|STARTED|Pharmacokinetic Study||16
10411532|NCT00768287|11555618|FG001|STARTED|Pharmacokinetic Study||16
10411533|NCT00768287|11555619|FG002|STARTED|Pharmacokinetic Study||0
10411534|NCT00768287|11555620|FG003|STARTED|Pharmacokinetic Study||0
10411535|NCT00768287|11555621|FG004|STARTED|Pharmacokinetic Study||0
10411536|NCT00768287|11555622|FG005|STARTED|Pharmacokinetic Study||0
10411537|NCT00768287|11555617|FG000|COMPLETED|Pharmacokinetic Study||16
10411538|NCT00768287|11555618|FG001|COMPLETED|Pharmacokinetic Study||16
10411539|NCT00768287|11555619|FG002|COMPLETED|Pharmacokinetic Study||0
10411540|NCT00768287|11555620|FG003|COMPLETED|Pharmacokinetic Study||0
10411541|NCT00768287|11555621|FG004|COMPLETED|Pharmacokinetic Study||0
10411542|NCT00768287|11555622|FG005|COMPLETED|Pharmacokinetic Study||0
10411543|NCT00768287|11555617|FG000|NOT COMPLETED|Pharmacokinetic Study||0
10411544|NCT00768287|11555618|FG001|NOT COMPLETED|Pharmacokinetic Study||0
10411545|NCT00768287|11555619|FG002|NOT COMPLETED|Pharmacokinetic Study||0
10411546|NCT00768287|11555620|FG003|NOT COMPLETED|Pharmacokinetic Study||0
10411547|NCT00768287|11555621|FG004|NOT COMPLETED|Pharmacokinetic Study||0
10411548|NCT00768287|11555622|FG005|NOT COMPLETED|Pharmacokinetic Study||0
10411549|NCT00768287|11555617|FG000|STARTED|Repeat Pharmacokinetic Study||0
10411550|NCT00768287|11555618|FG001|STARTED|Repeat Pharmacokinetic Study||0
10411551|NCT00768287|11555619|FG002|STARTED|Repeat Pharmacokinetic Study|Eight subjects were part of the IB1001 first group; 6 were from the nonacog alfa first group.|14
10411552|NCT00768287|11555620|FG003|STARTED|Repeat Pharmacokinetic Study||0
10411553|NCT00768287|11555621|FG004|STARTED|Repeat Pharmacokinetic Study||0
10411554|NCT00768287|11555622|FG005|STARTED|Repeat Pharmacokinetic Study||0
10411555|NCT00768287|11555617|FG000|COMPLETED|Repeat Pharmacokinetic Study||0
10411556|NCT00768287|11555618|FG001|COMPLETED|Repeat Pharmacokinetic Study||0
10411557|NCT00768287|11555619|FG002|COMPLETED|Repeat Pharmacokinetic Study||14
10411558|NCT00768287|11555620|FG003|COMPLETED|Repeat Pharmacokinetic Study||0
10411559|NCT00768287|11555621|FG004|COMPLETED|Repeat Pharmacokinetic Study||0
10411560|NCT00768287|11555622|FG005|COMPLETED|Repeat Pharmacokinetic Study||0
10411561|NCT00768287|11555617|FG000|NOT COMPLETED|Repeat Pharmacokinetic Study||0
10411562|NCT00768287|11555618|FG001|NOT COMPLETED|Repeat Pharmacokinetic Study||0
10411563|NCT00768287|11555619|FG002|NOT COMPLETED|Repeat Pharmacokinetic Study||0
10411564|NCT00768287|11555620|FG003|NOT COMPLETED|Repeat Pharmacokinetic Study||0
10411565|NCT00768287|11555621|FG004|NOT COMPLETED|Repeat Pharmacokinetic Study||0
10411566|NCT00768287|11555622|FG005|NOT COMPLETED|Repeat Pharmacokinetic Study||0
10411567|NCT00768287|11555617|FG000|STARTED|Treatment Study||0
10411568|NCT00768287|11555618|FG001|STARTED|Treatment Study||0
10411569|NCT00768287|11555619|FG002|STARTED|Treatment Study||0
10841900|NCT03181542|12007572|FG000|COMPLETED|Overall Study||79
10411570|NCT00768287|11555620|FG003|STARTED|Treatment Study|1 subject was not assigned a regimen at the start of the study.|58
10411571|NCT00768287|11555621|FG004|STARTED|Treatment Study|1 subject was not assigned a regimen at the start of the study.|9
10411572|NCT00768287|11555622|FG005|STARTED|Treatment Study||0
10411573|NCT00768287|11555617|FG000|Treated|Treatment Study||0
10411574|NCT00768287|11555618|FG001|Treated|Treatment Study||0
10411575|NCT00768287|11555619|FG002|Treated|Treatment Study||0
10411576|NCT00768287|11555620|FG003|Treated|Treatment Study|Subjects could switch treatment regimens. 3 subjects switched from On Demand to Prophylaxis.|61
10411577|NCT00768287|11555621|FG004|Treated|Treatment Study|Subjects could switch treatment regimens. 3 subjects switched from Prophylaxis to On Demand.|12
10411578|NCT00768287|11555622|FG005|Treated|Treatment Study||0
10411579|NCT00768287|11555617|FG000|COMPLETED|Treatment Study||0
10411580|NCT00768287|11555618|FG001|COMPLETED|Treatment Study||0
10411581|NCT00768287|11555619|FG002|COMPLETED|Treatment Study||0
10411582|NCT00768287|11555620|FG003|COMPLETED|Treatment Study||58
10411583|NCT00768287|11555621|FG004|COMPLETED|Treatment Study||9
10411584|NCT00768287|11555622|FG005|COMPLETED|Treatment Study||0
10411585|NCT00768287|11555617|FG000|NOT COMPLETED|Treatment Study||0
10411586|NCT00768287|11555618|FG001|NOT COMPLETED|Treatment Study||0
10411587|NCT00768287|11555619|FG002|NOT COMPLETED|Treatment Study||0
10411588|NCT00768287|11555620|FG003|NOT COMPLETED|Treatment Study||0
10841831|NCT04246554|12007474|FG000|COMPLETED|Overall Study||26
10841832|NCT04246554|12007475|FG001|COMPLETED|Overall Study||22
10411589|NCT00768287|11555621|FG004|NOT COMPLETED|Treatment Study||0
10841833|NCT04246554|12007474|FG000|NOT COMPLETED|Overall Study||0
10841834|NCT04246554|12007475|FG001|NOT COMPLETED|Overall Study||1
10841835|NCT03877926|12007485|FG000|STARTED|Overall Study||1103
10841836|NCT03877926|12007486|FG001|STARTED|Overall Study||1103
10841837|NCT03877926|12007487|FG002|STARTED|Overall Study||1098
10841838|NCT03877926|12007488|FG003|STARTED|Overall Study||558
10841839|NCT03877926|12007485|FG000|Received at Least One Study Vaccination|Overall Study||1100
10841840|NCT03877926|12007486|FG001|Received at Least One Study Vaccination|Overall Study||1102
10841841|NCT03877926|12007487|FG002|Received at Least One Study Vaccination|Overall Study||1097
10841842|NCT03877926|12007488|FG003|Received at Least One Study Vaccination|Overall Study||558
10841843|NCT03877926|12007485|FG000|Did Not Receive Any Study Vaccination|Overall Study||3
10841844|NCT03877926|12007486|FG001|Did Not Receive Any Study Vaccination|Overall Study||1
10841845|NCT03877926|12007487|FG002|Did Not Receive Any Study Vaccination|Overall Study||1
10841846|NCT03877926|12007488|FG003|Did Not Receive Any Study Vaccination|Overall Study||0
10841847|NCT03877926|12007485|FG000|COMPLETED|Overall Study||1032
10841848|NCT03877926|12007486|FG001|COMPLETED|Overall Study||1026
10841849|NCT03877926|12007487|FG002|COMPLETED|Overall Study||1035
10841850|NCT03877926|12007488|FG003|COMPLETED|Overall Study||537
10841851|NCT03877926|12007485|FG000|NOT COMPLETED|Overall Study||71
10841852|NCT03877926|12007486|FG001|NOT COMPLETED|Overall Study||77
10841853|NCT03877926|12007487|FG002|NOT COMPLETED|Overall Study||63
10841854|NCT03877926|12007488|FG003|NOT COMPLETED|Overall Study||21
10841855|NCT03862807|12007511|FG000|STARTED|Overall Study||24
10841856|NCT03862807|12007511|FG000|Treated|Overall Study||23
10841857|NCT03862807|12007511|FG000|Completed Treatment|Overall Study||22
10841858|NCT03862807|12007511|FG000|COMPLETED|Overall Study||23
10841859|NCT03862807|12007511|FG000|NOT COMPLETED|Overall Study||1
10841860|NCT03857867|12007515|FG000|STARTED|Overall Study||7
10841861|NCT03857867|12007515|FG000|COMPLETED|Overall Study||6
10841862|NCT03857867|12007515|FG000|NOT COMPLETED|Overall Study||1
10841863|NCT03691571|12007522|FG000|STARTED|Overall Study||31
10841864|NCT03691571|12007523|FG001|STARTED|Overall Study||24
10841865|NCT03691571|12007522|FG000|COMPLETED|Overall Study||22
10841866|NCT03691571|12007523|FG001|COMPLETED|Overall Study||22
10841867|NCT03691571|12007522|FG000|NOT COMPLETED|Overall Study||9
10841868|NCT03691571|12007523|FG001|NOT COMPLETED|Overall Study||2
10841869|NCT03436199|12007533|FG000|STARTED|Overall Study||187
10841870|NCT03436199|12007534|FG001|STARTED|Overall Study||185
10841871|NCT03436199|12007535|FG002|STARTED|Overall Study||186
10841872|NCT03436199|12007533|FG000|COMPLETED|Overall Study||165
10841873|NCT03436199|12007534|FG001|COMPLETED|Overall Study||132
10841874|NCT03436199|12007535|FG002|COMPLETED|Overall Study||174
10841875|NCT03436199|12007533|FG000|NOT COMPLETED|Overall Study||22
10841876|NCT03436199|12007534|FG001|NOT COMPLETED|Overall Study||53
10841877|NCT03436199|12007535|FG002|NOT COMPLETED|Overall Study||12
10841878|NCT03353233|12007545|FG000|STARTED|Overall Study||25
10841879|NCT03353233|12007546|FG001|STARTED|Overall Study||25
10841880|NCT03353233|12007545|FG000|COMPLETED|Overall Study||25
10841881|NCT03353233|12007546|FG001|COMPLETED|Overall Study||25
10841882|NCT03353233|12007545|FG000|NOT COMPLETED|Overall Study||0
10841883|NCT03353233|12007546|FG001|NOT COMPLETED|Overall Study||0
10841890|NCT03217136|12007563|FG000|STARTED|Overall Study||71
10841891|NCT03217136|12007564|FG001|STARTED|Overall Study||23
10841892|NCT03217136|12007563|FG000|Treated|Overall Study||70
10841893|NCT03217136|12007564|FG001|Treated|Overall Study||21
10841894|NCT03217136|12007563|FG000|COMPLETED|Overall Study||67
10841895|NCT03217136|12007564|FG001|COMPLETED|Overall Study||20
10841896|NCT03217136|12007563|FG000|NOT COMPLETED|Overall Study||4
10841897|NCT03217136|12007564|FG001|NOT COMPLETED|Overall Study||3
10841898|NCT03181542|12007572|FG000|STARTED|Overall Study||80
10841901|NCT03181542|12007573|FG001|COMPLETED|Overall Study||80
10841902|NCT03181542|12007572|FG000|NOT COMPLETED|Overall Study||1
10841903|NCT03181542|12007573|FG001|NOT COMPLETED|Overall Study||0
10841904|NCT04458467|12007581|FG000|STARTED|Overall Study||35
10841905|NCT04458467|12007582|FG001|STARTED|Overall Study||35
10841906|NCT04458467|12007581|FG000|COMPLETED|Overall Study||35
10841907|NCT04458467|12007582|FG001|COMPLETED|Overall Study||35
10841908|NCT04458467|12007581|FG000|NOT COMPLETED|Overall Study||0
10841909|NCT04458467|12007582|FG001|NOT COMPLETED|Overall Study||0
10841910|NCT04411082|12007594|FG000|STARTED|Overall Study||29
10841911|NCT04411082|12007595|FG001|STARTED|Overall Study||25
10841912|NCT04411082|12007596|FG002|STARTED|Overall Study||20
10841913|NCT04411082|12007597|FG003|STARTED|Overall Study||24
10841914|NCT04411082|12007598|FG004|STARTED|Overall Study||12
10841915|NCT04411082|12007599|FG005|STARTED|Overall Study||12
10841916|NCT04411082|12007594|FG000|COMPLETED|Overall Study||18
10841917|NCT04411082|12007595|FG001|COMPLETED|Overall Study||16
10841918|NCT04411082|12007596|FG002|COMPLETED|Overall Study||16
10841919|NCT04411082|12007597|FG003|COMPLETED|Overall Study||10
10841920|NCT04411082|12007598|FG004|COMPLETED|Overall Study||8
10411590|NCT00768287|11555622|FG005|NOT COMPLETED|Treatment Study||0
10411591|NCT00768287|11555617|FG000|STARTED|Surgical Sub-study||0
10411592|NCT00768287|11555618|FG001|STARTED|Surgical Sub-study||0
10411593|NCT00768287|11555619|FG002|STARTED|Surgical Sub-study||0
10411594|NCT00768287|11555620|FG003|STARTED|Surgical Sub-study||0
10411595|NCT00768287|11555621|FG004|STARTED|Surgical Sub-study||0
10411596|NCT00768287|11555622|FG005|STARTED|Surgical Sub-study|1 female subject was excluded from the efficacy analysis. She was included in the safety population.|17
10411597|NCT00768287|11555617|FG000|COMPLETED|Surgical Sub-study||0
10411598|NCT00768287|11555618|FG001|COMPLETED|Surgical Sub-study||0
10411599|NCT00768287|11555619|FG002|COMPLETED|Surgical Sub-study||0
10411600|NCT00768287|11555620|FG003|COMPLETED|Surgical Sub-study||0
10411601|NCT00768287|11555621|FG004|COMPLETED|Surgical Sub-study||0
10411602|NCT00768287|11555622|FG005|COMPLETED|Surgical Sub-study||17
10411603|NCT00768287|11555617|FG000|NOT COMPLETED|Surgical Sub-study||0
10411604|NCT00768287|11555618|FG001|NOT COMPLETED|Surgical Sub-study||0
10411605|NCT00768287|11555619|FG002|NOT COMPLETED|Surgical Sub-study||0
10411606|NCT00768287|11555620|FG003|NOT COMPLETED|Surgical Sub-study||0
10411607|NCT00768287|11555621|FG004|NOT COMPLETED|Surgical Sub-study||0
10411608|NCT00768287|11555622|FG005|NOT COMPLETED|Surgical Sub-study||0
10411609|NCT00768300|11555636|FG000|STARTED|Overall Study||330
10411610|NCT00768300|11555637|FG001|STARTED|Overall Study||164
10411611|NCT00768300|11555636|FG000|Randomized and Treated|Overall Study||329
10411612|NCT00768300|11555637|FG001|Randomized and Treated|Overall Study||163
10411613|NCT00768300|11555636|FG000|COMPLETED|Overall Study||1
10411614|NCT00768300|11555637|FG001|COMPLETED|Overall Study||1
10411615|NCT00768300|11555636|FG000|NOT COMPLETED|Overall Study||329
10411616|NCT00768300|11555637|FG001|NOT COMPLETED|Overall Study||163
10411617|NCT00768430|11555645|FG000|STARTED|24 Hour Endpoint||48
10411618|NCT00768430|11555646|FG001|STARTED|24 Hour Endpoint||25
10411619|NCT00768430|11555645|FG000|COMPLETED|24 Hour Endpoint||47
10411620|NCT00768430|11555646|FG001|COMPLETED|24 Hour Endpoint||25
10411621|NCT00768430|11555645|FG000|NOT COMPLETED|24 Hour Endpoint||1
10411622|NCT00768430|11555646|FG001|NOT COMPLETED|24 Hour Endpoint||0
10411623|NCT00768430|11555645|FG000|STARTED|7 Day Endpoint||47
10411624|NCT00768430|11555646|FG001|STARTED|7 Day Endpoint||25
10841921|NCT04411082|12007599|FG005|COMPLETED|Overall Study||6
10841922|NCT04411082|12007594|FG000|NOT COMPLETED|Overall Study||11
10841923|NCT04411082|12007595|FG001|NOT COMPLETED|Overall Study||9
10841924|NCT04411082|12007596|FG002|NOT COMPLETED|Overall Study||4
10841925|NCT04411082|12007597|FG003|NOT COMPLETED|Overall Study||14
10841926|NCT04411082|12007598|FG004|NOT COMPLETED|Overall Study||4
10841927|NCT04411082|12007599|FG005|NOT COMPLETED|Overall Study||6
10841928|NCT04100590|12007616|FG000|STARTED|Overall Study||1
10411625|NCT00768430|11555645|FG000|COMPLETED|7 Day Endpoint||45
10841929|NCT04100590|12007616|FG000|COMPLETED|Overall Study||1
10841930|NCT04100590|12007616|FG000|NOT COMPLETED|Overall Study||0
10841931|NCT03985293|12007628|FG000|STARTED|DOUBLE-BLIND TREATMENT||66
10841932|NCT03985293|12007629|FG001|STARTED|DOUBLE-BLIND TREATMENT||68
10841933|NCT03985293|12007630|FG002|STARTED|DOUBLE-BLIND TREATMENT||68
10841934|NCT03985293|12007631|FG003|STARTED|DOUBLE-BLIND TREATMENT||71
10841935|NCT03985293|12007632|FG004|STARTED|DOUBLE-BLIND TREATMENT||67
10841936|NCT03985293|12007633|FG005|STARTED|DOUBLE-BLIND TREATMENT||71
10841937|NCT03985293|12007628|FG000|COMPLETED|DOUBLE-BLIND TREATMENT||57
10841938|NCT03985293|12007629|FG001|COMPLETED|DOUBLE-BLIND TREATMENT||54
10841939|NCT03985293|12007630|FG002|COMPLETED|DOUBLE-BLIND TREATMENT||63
10841940|NCT03985293|12007631|FG003|COMPLETED|DOUBLE-BLIND TREATMENT||57
10841941|NCT03985293|12007632|FG004|COMPLETED|DOUBLE-BLIND TREATMENT||47
10841942|NCT03985293|12007633|FG005|COMPLETED|DOUBLE-BLIND TREATMENT||38
10841943|NCT03985293|12007628|FG000|NOT COMPLETED|DOUBLE-BLIND TREATMENT||9
10841944|NCT03985293|12007629|FG001|NOT COMPLETED|DOUBLE-BLIND TREATMENT||14
10841945|NCT03985293|12007630|FG002|NOT COMPLETED|DOUBLE-BLIND TREATMENT||5
10841946|NCT03985293|12007631|FG003|NOT COMPLETED|DOUBLE-BLIND TREATMENT||14
10841947|NCT03985293|12007632|FG004|NOT COMPLETED|DOUBLE-BLIND TREATMENT||20
10841948|NCT03985293|12007633|FG005|NOT COMPLETED|DOUBLE-BLIND TREATMENT||33
10841949|NCT03985293|12007628|FG000|STARTED|FOLLOW-UP||57
10841950|NCT03985293|12007629|FG001|STARTED|FOLLOW-UP||54
10841951|NCT03985293|12007630|FG002|STARTED|FOLLOW-UP||63
10841952|NCT03985293|12007631|FG003|STARTED|FOLLOW-UP||57
10841953|NCT03985293|12007632|FG004|STARTED|FOLLOW-UP||47
10841954|NCT03985293|12007633|FG005|STARTED|FOLLOW-UP||38
10841955|NCT03985293|12007628|FG000|COMPLETED|FOLLOW-UP||57
10841956|NCT03985293|12007629|FG001|COMPLETED|FOLLOW-UP||54
10841957|NCT03985293|12007630|FG002|COMPLETED|FOLLOW-UP||62
10841958|NCT03985293|12007631|FG003|COMPLETED|FOLLOW-UP||57
10841959|NCT03985293|12007632|FG004|COMPLETED|FOLLOW-UP||47
10841960|NCT03985293|12007633|FG005|COMPLETED|FOLLOW-UP||38
10841961|NCT03985293|12007628|FG000|NOT COMPLETED|FOLLOW-UP||0
10841962|NCT03985293|12007629|FG001|NOT COMPLETED|FOLLOW-UP||0
10841963|NCT03985293|12007630|FG002|NOT COMPLETED|FOLLOW-UP||1
10841964|NCT03985293|12007631|FG003|NOT COMPLETED|FOLLOW-UP||0
10841965|NCT03985293|12007632|FG004|NOT COMPLETED|FOLLOW-UP||0
10841966|NCT03985293|12007633|FG005|NOT COMPLETED|FOLLOW-UP||0
10841967|NCT03846427|12007647|FG000|STARTED|Overall Study||68
10841968|NCT03846427|12007647|FG000|COMPLETED|Overall Study||0
10841969|NCT03846427|12007647|FG000|NOT COMPLETED|Overall Study||68
10841978|NCT03776357|12007660|FG000|STARTED|Overall Study||9
10841979|NCT03776357|12007660|FG000|COMPLETED|Overall Study||6
10841980|NCT03776357|12007660|FG000|NOT COMPLETED|Overall Study||3
10841981|NCT03656068|12007664|FG000|STARTED|Overall Study||21
10841982|NCT03656068|12007664|FG000|COMPLETED|Overall Study||16
10841983|NCT03656068|12007664|FG000|NOT COMPLETED|Overall Study||5
10841984|NCT03595982|12007670|FG000|STARTED|Overall Study||3
10841985|NCT03595982|12007671|FG001|STARTED|Overall Study||2
10841986|NCT03595982|12007670|FG000|COMPLETED|Overall Study||3
10841987|NCT03595982|12007671|FG001|COMPLETED|Overall Study||2
10841988|NCT03595982|12007670|FG000|NOT COMPLETED|Overall Study||0
10841989|NCT03595982|12007671|FG001|NOT COMPLETED|Overall Study||0
10841990|NCT03400956|12007680|FG000|STARTED|Treatment Period 1||35
10841991|NCT03400956|12007681|FG001|STARTED|Treatment Period 1||34
10841992|NCT03400956|12007682|FG002|STARTED|Treatment Period 1||34
10841993|NCT03400956|12007680|FG000|Treated|Treatment Period 1||31
10841994|NCT03400956|12007681|FG001|Treated|Treatment Period 1||30
10841995|NCT03400956|12007682|FG002|Treated|Treatment Period 1||30
10841996|NCT03400956|12007680|FG000|FAS|Treatment Period 1||32
10841997|NCT03400956|12007681|FG001|FAS|Treatment Period 1||33
10841998|NCT03400956|12007682|FG002|FAS|Treatment Period 1||31
10841999|NCT03400956|12007680|FG000|COMPLETED|Treatment Period 1||31
10842000|NCT03400956|12007681|FG001|COMPLETED|Treatment Period 1||26
10842001|NCT03400956|12007682|FG002|COMPLETED|Treatment Period 1||25
10842002|NCT03400956|12007680|FG000|NOT COMPLETED|Treatment Period 1||4
10842003|NCT03400956|12007681|FG001|NOT COMPLETED|Treatment Period 1||8
10842004|NCT03400956|12007682|FG002|NOT COMPLETED|Treatment Period 1||9
10842005|NCT03400956|12007680|FG000|STARTED|Post-treatment Period 1||31
10842006|NCT03400956|12007681|FG001|STARTED|Post-treatment Period 1||26
10842007|NCT03400956|12007682|FG002|STARTED|Post-treatment Period 1||25
10842008|NCT03400956|12007680|FG000|COMPLETED|Post-treatment Period 1||9
10842009|NCT03400956|12007681|FG001|COMPLETED|Post-treatment Period 1||10
10842010|NCT03400956|12007682|FG002|COMPLETED|Post-treatment Period 1||9
10842011|NCT03400956|12007680|FG000|NOT COMPLETED|Post-treatment Period 1||22
10842012|NCT03400956|12007681|FG001|NOT COMPLETED|Post-treatment Period 1||16
10842013|NCT03400956|12007682|FG002|NOT COMPLETED|Post-treatment Period 1||16
10842014|NCT03400956|12007680|FG000|STARTED|Treatment Period 2||9
10842015|NCT03400956|12007681|FG001|STARTED|Treatment Period 2||10
10842016|NCT03400956|12007682|FG002|STARTED|Treatment Period 2||9
10842017|NCT03400956|12007680|FG000|COMPLETED|Treatment Period 2||5
10842018|NCT03400956|12007681|FG001|COMPLETED|Treatment Period 2||7
10842019|NCT03400956|12007682|FG002|COMPLETED|Treatment Period 2||5
10842020|NCT03400956|12007680|FG000|NOT COMPLETED|Treatment Period 2||4
10842021|NCT03400956|12007681|FG001|NOT COMPLETED|Treatment Period 2||3
10842022|NCT03400956|12007682|FG002|NOT COMPLETED|Treatment Period 2||4
10842023|NCT03400956|12007680|FG000|STARTED|Follow-up Period||6
10842024|NCT03400956|12007681|FG001|STARTED|Follow-up Period||9
10842025|NCT03400956|12007682|FG002|STARTED|Follow-up Period||7
10842026|NCT03400956|12007680|FG000|COMPLETED|Follow-up Period||6
10842027|NCT03400956|12007681|FG001|COMPLETED|Follow-up Period||9
10842028|NCT03400956|12007682|FG002|COMPLETED|Follow-up Period||5
10842029|NCT03400956|12007680|FG000|NOT COMPLETED|Follow-up Period||0
10842030|NCT03400956|12007681|FG001|NOT COMPLETED|Follow-up Period||0
10842031|NCT03400956|12007682|FG002|NOT COMPLETED|Follow-up Period||2
10842032|NCT03126539|12007695|FG000|STARTED|Overall Study||9
10842033|NCT03126539|12007696|FG001|STARTED|Overall Study||9
10842034|NCT03126539|12007697|FG002|STARTED|Overall Study||9
10842035|NCT03126539|12007698|FG003|STARTED|Overall Study|Group B was not done|0
10842036|NCT03126539|12007699|FG004|STARTED|Overall Study||0
10842037|NCT03126539|12007695|FG000|COMPLETED|Overall Study||8
10842038|NCT03126539|12007696|FG001|COMPLETED|Overall Study||8
10842039|NCT03126539|12007697|FG002|COMPLETED|Overall Study||8
10842040|NCT03126539|12007698|FG003|COMPLETED|Overall Study||0
10842041|NCT03126539|12007699|FG004|COMPLETED|Overall Study||0
10842042|NCT03126539|12007695|FG000|NOT COMPLETED|Overall Study||1
10842043|NCT03126539|12007696|FG001|NOT COMPLETED|Overall Study||1
10842044|NCT03126539|12007697|FG002|NOT COMPLETED|Overall Study||1
10842045|NCT03126539|12007698|FG003|NOT COMPLETED|Overall Study||0
10842046|NCT03126539|12007699|FG004|NOT COMPLETED|Overall Study||0
10842047|NCT03057613|12007712|FG000|STARTED|Overall Study||18
10842048|NCT03057613|12007712|FG000|COMPLETED|Overall Study||18
10842049|NCT03057613|12007712|FG000|NOT COMPLETED|Overall Study||0
10842065|NCT02830594|12007738|FG000|STARTED|Overall Study||14
10842066|NCT02830594|12007738|FG000|COMPLETED|Overall Study||14
10842067|NCT02830594|12007738|FG000|NOT COMPLETED|Overall Study||0
10842068|NCT02819635|12007750|FG000|STARTED|Substudy 1 and Substudy 2, Part 1||46
10842069|NCT02819635|12007751|FG001|STARTED|Substudy 1 and Substudy 2, Part 1||47
10842070|NCT02819635|12007752|FG002|STARTED|Substudy 1 and Substudy 2, Part 1||49
10842071|NCT02819635|12007753|FG003|STARTED|Substudy 1 and Substudy 2, Part 1||117
10842072|NCT02819635|12007754|FG004|STARTED|Substudy 1 and Substudy 2, Part 1||123
10842073|NCT02819635|12007755|FG005|STARTED|Substudy 1 and Substudy 2, Part 1||155
10842074|NCT02819635|12007756|FG006|STARTED|Substudy 1 and Substudy 2, Part 1||319
10842075|NCT02819635|12007757|FG007|STARTED|Substudy 1 and Substudy 2, Part 1||446
10842076|NCT02819635|12007758|FG008|STARTED|Substudy 1 and Substudy 2, Part 1||0
10842077|NCT02819635|12007759|FG009|STARTED|Substudy 1 and Substudy 2, Part 1||0
10842078|NCT02819635|12007760|FG010|STARTED|Substudy 1 and Substudy 2, Part 1||0
10842079|NCT02819635|12007761|FG011|STARTED|Substudy 1 and Substudy 2, Part 1||0
10842080|NCT02819635|12007750|FG000|COMPLETED|Substudy 1 and Substudy 2, Part 1||41
10842081|NCT02819635|12007751|FG001|COMPLETED|Substudy 1 and Substudy 2, Part 1||45
10842082|NCT02819635|12007752|FG002|COMPLETED|Substudy 1 and Substudy 2, Part 1||45
10842083|NCT02819635|12007753|FG003|COMPLETED|Substudy 1 and Substudy 2, Part 1||105
10842084|NCT02819635|12007754|FG004|COMPLETED|Substudy 1 and Substudy 2, Part 1||113
10842085|NCT02819635|12007755|FG005|COMPLETED|Substudy 1 and Substudy 2, Part 1||135
10842086|NCT02819635|12007756|FG006|COMPLETED|Substudy 1 and Substudy 2, Part 1||306
10842087|NCT02819635|12007757|FG007|COMPLETED|Substudy 1 and Substudy 2, Part 1||446
10842088|NCT02819635|12007758|FG008|COMPLETED|Substudy 1 and Substudy 2, Part 1||0
10842089|NCT02819635|12007759|FG009|COMPLETED|Substudy 1 and Substudy 2, Part 1||0
10842090|NCT02819635|12007760|FG010|COMPLETED|Substudy 1 and Substudy 2, Part 1||0
10842091|NCT02819635|12007761|FG011|COMPLETED|Substudy 1 and Substudy 2, Part 1||0
10842092|NCT02819635|12007750|FG000|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||5
10842093|NCT02819635|12007751|FG001|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||2
10842094|NCT02819635|12007752|FG002|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||4
10842095|NCT02819635|12007753|FG003|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||12
10842096|NCT02819635|12007754|FG004|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||10
10842097|NCT02819635|12007755|FG005|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||20
10842098|NCT02819635|12007756|FG006|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||13
10842099|NCT02819635|12007757|FG007|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||0
10842100|NCT02819635|12007758|FG008|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||0
10842101|NCT02819635|12007759|FG009|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||0
10842102|NCT02819635|12007760|FG010|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||0
10842103|NCT02819635|12007761|FG011|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||0
10842104|NCT02819635|12007750|FG000|STARTED|Substudy 2, Part 2||0
10842105|NCT02819635|12007751|FG001|STARTED|Substudy 2, Part 2||0
10842106|NCT02819635|12007752|FG002|STARTED|Substudy 2, Part 2||0
10842107|NCT02819635|12007753|FG003|STARTED|Substudy 2, Part 2||0
10842108|NCT02819635|12007754|FG004|STARTED|Substudy 2, Part 2||0
10842109|NCT02819635|12007755|FG005|STARTED|Substudy 2, Part 2||85
10842110|NCT02819635|12007756|FG006|STARTED|Substudy 2, Part 2||59
10842111|NCT02819635|12007757|FG007|STARTED|Substudy 2, Part 2||0
10842112|NCT02819635|12007758|FG008|STARTED|Substudy 2, Part 2||0
10842113|NCT02819635|12007759|FG009|STARTED|Substudy 2, Part 2||0
10842114|NCT02819635|12007760|FG010|STARTED|Substudy 2, Part 2||0
10842115|NCT02819635|12007761|FG011|STARTED|Substudy 2, Part 2||0
10842116|NCT02819635|12007750|FG000|COMPLETED|Substudy 2, Part 2||0
10842117|NCT02819635|12007751|FG001|COMPLETED|Substudy 2, Part 2||0
10842118|NCT02819635|12007752|FG002|COMPLETED|Substudy 2, Part 2||0
10842119|NCT02819635|12007753|FG003|COMPLETED|Substudy 2, Part 2||0
10842120|NCT02819635|12007754|FG004|COMPLETED|Substudy 2, Part 2||0
10842121|NCT02819635|12007755|FG005|COMPLETED|Substudy 2, Part 2||74
10842122|NCT02819635|12007756|FG006|COMPLETED|Substudy 2, Part 2||47
10842123|NCT02819635|12007757|FG007|COMPLETED|Substudy 2, Part 2||0
10842124|NCT02819635|12007758|FG008|COMPLETED|Substudy 2, Part 2||0
10842125|NCT02819635|12007759|FG009|COMPLETED|Substudy 2, Part 2||0
10842126|NCT02819635|12007760|FG010|COMPLETED|Substudy 2, Part 2||0
10842127|NCT02819635|12007761|FG011|COMPLETED|Substudy 2, Part 2||0
10842128|NCT02819635|12007750|FG000|NOT COMPLETED|Substudy 2, Part 2||0
10842129|NCT02819635|12007751|FG001|NOT COMPLETED|Substudy 2, Part 2||0
10842130|NCT02819635|12007752|FG002|NOT COMPLETED|Substudy 2, Part 2||0
10842131|NCT02819635|12007753|FG003|NOT COMPLETED|Substudy 2, Part 2||0
10842132|NCT02819635|12007754|FG004|NOT COMPLETED|Substudy 2, Part 2||0
10842133|NCT02819635|12007755|FG005|NOT COMPLETED|Substudy 2, Part 2||11
10842134|NCT02819635|12007756|FG006|NOT COMPLETED|Substudy 2, Part 2||12
10842135|NCT02819635|12007757|FG007|NOT COMPLETED|Substudy 2, Part 2||0
10842136|NCT02819635|12007758|FG008|NOT COMPLETED|Substudy 2, Part 2||0
10842137|NCT02819635|12007759|FG009|NOT COMPLETED|Substudy 2, Part 2||0
10842138|NCT02819635|12007760|FG010|NOT COMPLETED|Substudy 2, Part 2||0
10842139|NCT02819635|12007761|FG011|NOT COMPLETED|Substudy 2, Part 2||0
10842140|NCT02819635|12007750|FG000|STARTED|Substudy 3||0
10842141|NCT02819635|12007751|FG001|STARTED|Substudy 3||0
10842142|NCT02819635|12007752|FG002|STARTED|Substudy 3||0
10842143|NCT02819635|12007753|FG003|STARTED|Substudy 3||0
10842144|NCT02819635|12007754|FG004|STARTED|Substudy 3||0
10842145|NCT02819635|12007755|FG005|STARTED|Substudy 3||0
10842146|NCT02819635|12007756|FG006|STARTED|Substudy 3||0
10842147|NCT02819635|12007757|FG007|STARTED|Substudy 3||0
10842148|NCT02819635|12007758|FG008|STARTED|Substudy 3||386
10842149|NCT02819635|12007759|FG009|STARTED|Substudy 3||20
10842150|NCT02819635|12007760|FG010|STARTED|Substudy 3||324
10842151|NCT02819635|12007761|FG011|STARTED|Substudy 3||316
10842152|NCT02819635|12007750|FG000|COMPLETED|Substudy 3||0
10842153|NCT02819635|12007751|FG001|COMPLETED|Substudy 3||0
10842154|NCT02819635|12007752|FG002|COMPLETED|Substudy 3||0
10842155|NCT02819635|12007753|FG003|COMPLETED|Substudy 3||0
10842156|NCT02819635|12007754|FG004|COMPLETED|Substudy 3||0
10842157|NCT02819635|12007755|FG005|COMPLETED|Substudy 3||0
10842158|NCT02819635|12007756|FG006|COMPLETED|Substudy 3||0
10842159|NCT02819635|12007757|FG007|COMPLETED|Substudy 3||0
10842160|NCT02819635|12007758|FG008|COMPLETED|Substudy 3||140
10842161|NCT02819635|12007759|FG009|COMPLETED|Substudy 3||11
10842162|NCT02819635|12007760|FG010|COMPLETED|Substudy 3||218
10842163|NCT02819635|12007761|FG011|COMPLETED|Substudy 3||248
10842164|NCT02819635|12007750|FG000|NOT COMPLETED|Substudy 3||0
10842165|NCT02819635|12007751|FG001|NOT COMPLETED|Substudy 3||0
10842166|NCT02819635|12007752|FG002|NOT COMPLETED|Substudy 3||0
10842167|NCT02819635|12007753|FG003|NOT COMPLETED|Substudy 3||0
10842168|NCT02819635|12007754|FG004|NOT COMPLETED|Substudy 3||0
10842169|NCT02819635|12007755|FG005|NOT COMPLETED|Substudy 3||0
10842170|NCT02819635|12007756|FG006|NOT COMPLETED|Substudy 3||0
10842171|NCT02819635|12007757|FG007|NOT COMPLETED|Substudy 3||0
10411626|NCT00768430|11555646|FG001|COMPLETED|7 Day Endpoint||22
10411627|NCT00768430|11555645|FG000|NOT COMPLETED|7 Day Endpoint||2
10411628|NCT00768430|11555646|FG001|NOT COMPLETED|7 Day Endpoint||3
10411629|NCT00768469|11555654|FG000|STARTED|Overall Study||3
10411630|NCT00768469|11555655|FG001|STARTED|Overall Study||7
10411631|NCT00768469|11555654|FG000|COMPLETED|Overall Study||0
10842172|NCT02819635|12007758|FG008|NOT COMPLETED|Substudy 3||246
10842173|NCT02819635|12007759|FG009|NOT COMPLETED|Substudy 3||9
10842174|NCT02819635|12007760|FG010|NOT COMPLETED|Substudy 3||106
10842175|NCT02819635|12007761|FG011|NOT COMPLETED|Substudy 3||68
10842176|NCT02756013|12007789|FG000|STARTED|Overall Study||3
10842177|NCT02756013|12007789|FG000|COMPLETED|Overall Study||1
10842178|NCT02756013|12007789|FG000|NOT COMPLETED|Overall Study||2
10842179|NCT02681614|12007793|FG000|STARTED|Overall Study||5
10842180|NCT02681614|12007793|FG000|COMPLETED|Overall Study||5
10842181|NCT02681614|12007793|FG000|NOT COMPLETED|Overall Study||0
10842182|NCT02667067|12007800|FG000|STARTED|Overall Study||117
10842183|NCT02667067|12007801|FG001|STARTED|Overall Study||150
10842184|NCT02667067|12007800|FG000|COMPLETED|Overall Study||96
10842185|NCT02667067|12007801|FG001|COMPLETED|Overall Study||139
10842186|NCT02667067|12007800|FG000|NOT COMPLETED|Overall Study||21
10842187|NCT02667067|12007801|FG001|NOT COMPLETED|Overall Study||11
10411632|NCT00768469|11555655|FG001|COMPLETED|Overall Study||0
10411633|NCT00768469|11555654|FG000|NOT COMPLETED|Overall Study||3
10411634|NCT00768469|11555655|FG001|NOT COMPLETED|Overall Study||7
10411635|NCT00768521|11555662|FG000|STARTED|Period 1||9
10411636|NCT00768521|11555663|FG001|STARTED|Period 1||11
10411637|NCT00768521|11555662|FG000|COMPLETED|Period 1||9
10411638|NCT00768521|11555663|FG001|COMPLETED|Period 1||11
10411639|NCT00768521|11555662|FG000|NOT COMPLETED|Period 1||0
10411640|NCT00768521|11555663|FG001|NOT COMPLETED|Period 1||0
10411641|NCT00768521|11555662|FG000|STARTED|Period 2||9
10661230|NCT02257970|11823122|FG002|STARTED|Part 1||0
10661231|NCT02257970|11823123|FG003|STARTED|Part 1||0
10661232|NCT02257970|11823120|FG000|COMPLETED|Part 1||50
10661233|NCT02257970|11823121|FG001|COMPLETED|Part 1||0
10661234|NCT02257970|11823122|FG002|COMPLETED|Part 1||0
10661235|NCT02257970|11823123|FG003|COMPLETED|Part 1||0
10545076|NCT01494350|11698329|FG000|COMPLETED|Overall Study||49
10545077|NCT01494350|11698329|FG000|NOT COMPLETED|Overall Study||1
10545078|NCT01494467|11698335|FG000|STARTED|Part A Vehicle Control (12 Weeks)||459
10545079|NCT01494467|11698336|FG001|STARTED|Part A Vehicle Control (12 Weeks)||229
10545080|NCT01494467|11698335|FG000|COMPLETED|Part A Vehicle Control (12 Weeks)||429
10545081|NCT01494467|11698336|FG001|COMPLETED|Part A Vehicle Control (12 Weeks)||208
10545082|NCT01494467|11698335|FG000|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||30
10545083|NCT01494467|11698336|FG001|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||21
10545084|NCT01494467|11698335|FG000|STARTED|Part B Long Term Active Control 40 Weeks|429 completed Part A. Subsequently, one subject discontinued so only 428 entered Part B|428
10545085|NCT01494467|11698336|FG001|STARTED|Part B Long Term Active Control 40 Weeks||208
10545086|NCT01494467|11698335|FG000|COMPLETED|Part B Long Term Active Control 40 Weeks||353
10545087|NCT01494467|11698336|FG001|COMPLETED|Part B Long Term Active Control 40 Weeks||159
10545088|NCT01494467|11698335|FG000|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||75
10545089|NCT01494467|11698336|FG001|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||49
10411642|NCT00768521|11555663|FG001|STARTED|Period 2||11
10411643|NCT00768521|11555662|FG000|COMPLETED|Period 2||9
10411644|NCT00768521|11555663|FG001|COMPLETED|Period 2||11
10411645|NCT00768521|11555662|FG000|NOT COMPLETED|Period 2||0
10411646|NCT00768521|11555663|FG001|NOT COMPLETED|Period 2||0
10292346|NCT04021524|11425138|FG000|COMPLETED|Overall Study||25
10292347|NCT04021524|11425139|FG001|COMPLETED|Overall Study||24
10292348|NCT04021524|11425138|FG000|NOT COMPLETED|Overall Study||0
10292349|NCT04021524|11425139|FG001|NOT COMPLETED|Overall Study||1
10314427|NCT00162123|11447992|FG002|COMPLETED|Overall Study|Still on treatment|3
10314428|NCT00162123|11447993|FG003|COMPLETED|Overall Study|Still on treatment|3
10314429|NCT00162123|11447994|FG004|COMPLETED|Overall Study|Still on treatment|14
10314430|NCT00162123|11447995|FG005|COMPLETED|Overall Study|Still on treatment|4
10314431|NCT00162123|11447996|FG006|COMPLETED|Overall Study|Still on treatment|0
10314432|NCT00162123|11447997|FG007|COMPLETED|Overall Study|Still on treatment|0
10314433|NCT00162123|11447990|FG000|NOT COMPLETED|Overall Study||44
10314434|NCT00162123|11447991|FG001|NOT COMPLETED|Overall Study||29
10314435|NCT00162123|11447992|FG002|NOT COMPLETED|Overall Study||21
10314436|NCT00162123|11447993|FG003|NOT COMPLETED|Overall Study||8
10314437|NCT00162123|11447994|FG004|NOT COMPLETED|Overall Study||31
10314438|NCT00162123|11447995|FG005|NOT COMPLETED|Overall Study||9
10314439|NCT00162123|11447996|FG006|NOT COMPLETED|Overall Study||4
10314440|NCT00162123|11447997|FG007|NOT COMPLETED|Overall Study||58
10314441|NCT00162136|11448022|FG000|STARTED|Overall Study||35
10314442|NCT00162136|11448022|FG000|COMPLETED|Overall Study|Number of Participants still on treatment at study termination|0
10314443|NCT00162136|11448022|FG000|NOT COMPLETED|Overall Study||35
10314444|NCT00162266|11448049|FG000|STARTED|Double-Blind Period||115
10314445|NCT00162266|11448050|FG001|STARTED|Double-Blind Period||105
10314446|NCT00162266|11448051|FG002|STARTED|Double-Blind Period||119
10314447|NCT00162266|11448052|FG003|STARTED|Double-Blind Period||0
10314448|NCT00162266|11448049|FG000|Completed Day 1 to Day 181|Double-Blind Period||98
10314449|NCT00162266|11448050|FG001|Completed Day 1 to Day 181|Double-Blind Period||80
10314450|NCT00162266|11448051|FG002|Completed Day 1 to Day 181|Double-Blind Period||78
10314451|NCT00162266|11448052|FG003|Completed Day 1 to Day 181|Double-Blind Period||0
10314452|NCT00162266|11448049|FG000|COMPLETED|Double-Blind Period||90
10314453|NCT00162266|11448050|FG001|COMPLETED|Double-Blind Period||74
10314454|NCT00162266|11448051|FG002|COMPLETED|Double-Blind Period||71
10314455|NCT00162266|11448052|FG003|COMPLETED|Double-Blind Period||0
10314456|NCT00162266|11448049|FG000|NOT COMPLETED|Double-Blind Period||25
10314457|NCT00162266|11448050|FG001|NOT COMPLETED|Double-Blind Period||31
10314458|NCT00162266|11448051|FG002|NOT COMPLETED|Double-Blind Period||48
10411647|NCT00768560|11555675|FG000|STARTED|Intervention Set 1|3-period/treatment crossover|5
10411648|NCT00768560|11555676|FG001|STARTED|Intervention Set 1|3-period/treatment crossover|6
10411649|NCT00768560|11555677|FG002|STARTED|Intervention Set 1|3-period/treatment crossover|6
10411650|NCT00768560|11555678|FG003|STARTED|Intervention Set 1|3-period/treatment crossover|6
10411651|NCT00768560|11555679|FG004|STARTED|Intervention Set 1|3-period/treatment crossover|6
10411652|NCT00768560|11555680|FG005|STARTED|Intervention Set 1|3-period/treatment crossover|6
10411653|NCT00768560|11555675|FG000|Subjects Received Treatment|Intervention Set 1|40 mg OD for 2 weeks|5
10411654|NCT00768560|11555676|FG001|Subjects Received Treatment|Intervention Set 1|40 mg OD for 2 weeks|6
10411655|NCT00768560|11555677|FG002|Subjects Received Treatment|Intervention Set 1|40 mg twice daily (BID) for 2 weeks|6
10411656|NCT00768560|11555678|FG003|Subjects Received Treatment|Intervention Set 1|40 mg BID for 2 weeks|6
10411657|NCT00768560|11555679|FG004|Subjects Received Treatment|Intervention Set 1|80 mg OD for 2 weeks|6
10411658|NCT00768560|11555680|FG005|Subjects Received Treatment|Intervention Set 1|80 mg OD for 2 weeks|6
10411659|NCT00768560|11555675|FG000|COMPLETED|Intervention Set 1||5
10411660|NCT00768560|11555676|FG001|COMPLETED|Intervention Set 1||5
10411661|NCT00768560|11555677|FG002|COMPLETED|Intervention Set 1||6
10411662|NCT00768560|11555678|FG003|COMPLETED|Intervention Set 1||6
10411663|NCT00768560|11555679|FG004|COMPLETED|Intervention Set 1||6
10411664|NCT00768560|11555680|FG005|COMPLETED|Intervention Set 1||6
10411665|NCT00768560|11555675|FG000|NOT COMPLETED|Intervention Set 1||0
10411666|NCT00768560|11555676|FG001|NOT COMPLETED|Intervention Set 1||1
10411667|NCT00768560|11555677|FG002|NOT COMPLETED|Intervention Set 1||0
10411668|NCT00768560|11555678|FG003|NOT COMPLETED|Intervention Set 1||0
10411669|NCT00768560|11555679|FG004|NOT COMPLETED|Intervention Set 1||0
10411670|NCT00768560|11555680|FG005|NOT COMPLETED|Intervention Set 1||0
10411671|NCT00768560|11555675|FG000|STARTED|Intervention Set 2|40 mg BID for 2 weeks|5
10314459|NCT00162266|11448052|FG003|NOT COMPLETED|Double-Blind Period||0
10314460|NCT00162266|11448049|FG000|STARTED|Open-Label Period||0
10314461|NCT00162266|11448050|FG001|STARTED|Open-Label Period||0
10314462|NCT00162266|11448051|FG002|STARTED|Open-Label Period||0
10314463|NCT00162266|11448052|FG003|STARTED|Open-Label Period||219
10411672|NCT00768560|11555676|FG001|STARTED|Intervention Set 2|80 mg OD for 2 weeks|5
10411673|NCT00768560|11555677|FG002|STARTED|Intervention Set 2|80 mg OD for 2 weeks|6
10411674|NCT00768560|11555678|FG003|STARTED|Intervention Set 2|40 mg OD for 2 weeks|6
10411675|NCT00768560|11555679|FG004|STARTED|Intervention Set 2|40 mg OD for 2 weeks|6
10411676|NCT00768560|11555680|FG005|STARTED|Intervention Set 2|40 mg BID for 2 weeks|6
10411677|NCT00768560|11555675|FG000|COMPLETED|Intervention Set 2||5
10411678|NCT00768560|11555676|FG001|COMPLETED|Intervention Set 2||5
10411679|NCT00768560|11555677|FG002|COMPLETED|Intervention Set 2||6
10842242|NCT02551718|12007837|FG000|STARTED|Overall Study||34
10842243|NCT02551718|12007837|FG000|COMPLETED|Overall Study||34
10842244|NCT02551718|12007837|FG000|NOT COMPLETED|Overall Study||0
10842245|NCT02419807|12007842|FG000|STARTED|Overall Study||102
10842246|NCT02419807|12007842|FG000|COMPLETED|Overall Study||92
10842247|NCT02419807|12007842|FG000|NOT COMPLETED|Overall Study||10
10842254|NCT02242942|12007858|FG000|STARTED|Overall Study||216
10842255|NCT02242942|12007859|FG001|STARTED|Overall Study||216
10842256|NCT02242942|12007860|FG002|STARTED|Overall Study||13
10842257|NCT02242942|12007858|FG000|Treated|Overall Study||214
10842258|NCT02242942|12007859|FG001|Treated|Overall Study||212
10842259|NCT02242942|12007860|FG002|Treated|Overall Study||13
10842260|NCT02242942|12007858|FG000|COMPLETED|Overall Study||0
10842261|NCT02242942|12007859|FG001|COMPLETED|Overall Study||0
10842262|NCT02242942|12007860|FG002|COMPLETED|Overall Study||0
10842263|NCT02242942|12007858|FG000|NOT COMPLETED|Overall Study||216
10842264|NCT02242942|12007859|FG001|NOT COMPLETED|Overall Study||216
10842265|NCT02242942|12007860|FG002|NOT COMPLETED|Overall Study||13
10842266|NCT02231749|12007872|FG000|STARTED|Overall Study||550
10842267|NCT02231749|12007873|FG001|STARTED|Overall Study||546
10842268|NCT02231749|12007872|FG000|Received Treatment|Overall Study||547
10842269|NCT02231749|12007873|FG001|Received Treatment|Overall Study||535
10842270|NCT02231749|12007872|FG000|COMPLETED|Overall Study||128
10842271|NCT02231749|12007873|FG001|COMPLETED|Overall Study||97
10842272|NCT02231749|12007872|FG000|NOT COMPLETED|Overall Study||422
10842273|NCT02231749|12007873|FG001|NOT COMPLETED|Overall Study||449
10842274|NCT02227199|12007882|FG000|STARTED|Overall Study||3
10842275|NCT02227199|12007883|FG001|STARTED|Overall Study||3
10842276|NCT02227199|12007884|FG002|STARTED|Overall Study||39
10842277|NCT02227199|12007882|FG000|COMPLETED|Overall Study||3
10842278|NCT02227199|12007883|FG001|COMPLETED|Overall Study||3
10842279|NCT02227199|12007884|FG002|COMPLETED|Overall Study||35
10842280|NCT02227199|12007882|FG000|NOT COMPLETED|Overall Study||0
10842281|NCT02227199|12007883|FG001|NOT COMPLETED|Overall Study||0
10842282|NCT02227199|12007884|FG002|NOT COMPLETED|Overall Study||4
10842283|NCT02181413|12007898|FG000|STARTED|Overall Study||261
10842284|NCT02181413|12007899|FG001|STARTED|Overall Study||395
10842285|NCT02181413|12007898|FG000|Intent-to-Treat (ITT) Population|Overall Study||261
10842286|NCT02181413|12007899|FG001|Intent-to-Treat (ITT) Population|Overall Study||395
10842287|NCT02181413|12007898|FG000|Safety Population|Overall Study||259
10842288|NCT02181413|12007899|FG001|Safety Population|Overall Study||394
10842289|NCT02181413|12007898|FG000|Per Protocol (PP) Population|Overall Study||256
10842290|NCT02181413|12007899|FG001|Per Protocol (PP) Population|Overall Study||387
10842291|NCT02181413|12007898|FG000|COMPLETED|Overall Study||109
10842292|NCT02181413|12007899|FG001|COMPLETED|Overall Study||198
10842293|NCT02181413|12007898|FG000|NOT COMPLETED|Overall Study||152
10842294|NCT02181413|12007899|FG001|NOT COMPLETED|Overall Study||197
10842295|NCT02095678|12007907|FG000|STARTED|Overall Study||34
10842296|NCT02095678|12007908|FG001|STARTED|Overall Study||18
10842297|NCT02095678|12007907|FG000|COMPLETED|Overall Study||17
10842298|NCT02095678|12007908|FG001|COMPLETED|Overall Study||0
10842299|NCT02095678|12007907|FG000|NOT COMPLETED|Overall Study||17
10842300|NCT02095678|12007908|FG001|NOT COMPLETED|Overall Study||18
10842301|NCT01990209|12007919|FG000|STARTED|Overall Study|One participant was found to be ineligible after starting with study treatment and hence excluded from further analyses|27
10842302|NCT01990209|12007920|FG001|STARTED|Overall Study||44
10842303|NCT01990209|12007919|FG000|COMPLETED|Overall Study||0
10842304|NCT01990209|12007920|FG001|COMPLETED|Overall Study||0
10842305|NCT01990209|12007919|FG000|NOT COMPLETED|Overall Study||27
10842306|NCT01990209|12007920|FG001|NOT COMPLETED|Overall Study||44
10411680|NCT00768560|11555678|FG003|COMPLETED|Intervention Set 2||6
10842317|NCT01955109|12007937|FG000|STARTED|Overall Study||123
10842318|NCT01955109|12007938|FG001|STARTED|Overall Study||48
10842319|NCT01955109|12007937|FG000|Completed Study Until Month 12|Overall Study||103
10842320|NCT01955109|12007938|FG001|Completed Study Until Month 12|Overall Study||46
10842321|NCT01955109|12007937|FG000|COMPLETED|Overall Study||78
10842322|NCT01955109|12007938|FG001|COMPLETED|Overall Study||39
10842323|NCT01955109|12007937|FG000|NOT COMPLETED|Overall Study||45
10842324|NCT01955109|12007938|FG001|NOT COMPLETED|Overall Study||9
10411681|NCT00768560|11555679|FG004|COMPLETED|Intervention Set 2||6
10292350|NCT03830359|11425145|FG000|STARTED|Overall Study||62
10292351|NCT03830359|11425145|FG000|COMPLETED|Overall Study||62
10292352|NCT03830359|11425145|FG000|NOT COMPLETED|Overall Study||0
10292353|NCT03675516|11425151|FG000|STARTED|Overall Study||6591
10292354|NCT03675516|11425152|FG001|STARTED|Overall Study||6591
10292355|NCT03675516|11425151|FG000|COMPLETED|Overall Study||6591
10292356|NCT03675516|11425152|FG001|COMPLETED|Overall Study||6591
10292357|NCT03675516|11425151|FG000|NOT COMPLETED|Overall Study||0
10292358|NCT03675516|11425152|FG001|NOT COMPLETED|Overall Study||0
10292359|NCT03605680|11425163|FG000|STARTED|SB Placebo Run-in Period (1 Week)||604
10292360|NCT03605680|11425164|FG001|STARTED|SB Placebo Run-in Period (1 Week)||0
10292361|NCT03605680|11425165|FG002|STARTED|SB Placebo Run-in Period (1 Week)||0
10292362|NCT03605680|11425166|FG003|STARTED|SB Placebo Run-in Period (1 Week)||0
10292363|NCT03605680|11425163|FG000|Treated|SB Placebo Run-in Period (1 Week)||584
10292364|NCT03605680|11425164|FG001|Treated|SB Placebo Run-in Period (1 Week)||0
10292365|NCT03605680|11425165|FG002|Treated|SB Placebo Run-in Period (1 Week)||0
10292366|NCT03605680|11425166|FG003|Treated|SB Placebo Run-in Period (1 Week)||0
10292367|NCT03605680|11425163|FG000|COMPLETED|SB Placebo Run-in Period (1 Week)||466
10292368|NCT03605680|11425164|FG001|COMPLETED|SB Placebo Run-in Period (1 Week)||0
10292369|NCT03605680|11425165|FG002|COMPLETED|SB Placebo Run-in Period (1 Week)||0
10292370|NCT03605680|11425166|FG003|COMPLETED|SB Placebo Run-in Period (1 Week)||0
10292371|NCT03605680|11425163|FG000|NOT COMPLETED|SB Placebo Run-in Period (1 Week)||138
10292372|NCT03605680|11425164|FG001|NOT COMPLETED|SB Placebo Run-in Period (1 Week)||0
10292373|NCT03605680|11425165|FG002|NOT COMPLETED|SB Placebo Run-in Period (1 Week)||0
10292374|NCT03605680|11425166|FG003|NOT COMPLETED|SB Placebo Run-in Period (1 Week)||0
10292375|NCT03605680|11425163|FG000|STARTED|Double-blind Treatment Period (6 Weeks)||0
10292376|NCT03605680|11425164|FG001|STARTED|Double-blind Treatment Period (6 Weeks)||154
10292377|NCT03605680|11425165|FG002|STARTED|Double-blind Treatment Period (6 Weeks)||156
10292378|NCT03605680|11425166|FG003|STARTED|Double-blind Treatment Period (6 Weeks)||156
10292379|NCT03605680|11425163|FG000|COMPLETED|Double-blind Treatment Period (6 Weeks)||0
10292380|NCT03605680|11425164|FG001|COMPLETED|Double-blind Treatment Period (6 Weeks)||110
10292381|NCT03605680|11425165|FG002|COMPLETED|Double-blind Treatment Period (6 Weeks)||117
10292382|NCT03605680|11425166|FG003|COMPLETED|Double-blind Treatment Period (6 Weeks)||121
10292383|NCT03605680|11425163|FG000|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||0
10292384|NCT03605680|11425164|FG001|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||44
10292385|NCT03605680|11425165|FG002|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||39
10292386|NCT03605680|11425166|FG003|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||35
10292387|NCT03485950|11425177|FG000|STARTED|Overall Study||50
10292388|NCT03485950|11425178|FG001|STARTED|Overall Study||50
10292389|NCT03485950|11425177|FG000|COMPLETED|Overall Study||43
10292390|NCT03485950|11425178|FG001|COMPLETED|Overall Study||48
10292391|NCT03485950|11425177|FG000|NOT COMPLETED|Overall Study||7
10292392|NCT03485950|11425178|FG001|NOT COMPLETED|Overall Study||2
10292393|NCT03404518|11425186|FG000|STARTED|Overall Study||97
10292394|NCT03404518|11425187|FG001|STARTED|Overall Study||88
10292395|NCT03404518|11425186|FG000|COMPLETED|Overall Study||56
10292396|NCT03404518|11425187|FG001|COMPLETED|Overall Study||52
10292397|NCT03404518|11425186|FG000|NOT COMPLETED|Overall Study||41
10292398|NCT03404518|11425187|FG001|NOT COMPLETED|Overall Study||36
10292399|NCT03370757|11425195|FG000|STARTED|Overall Study||20
10292400|NCT03370757|11425196|FG001|STARTED|Overall Study||28
10292401|NCT03370757|11425195|FG000|COMPLETED|Overall Study||20
10292402|NCT03370757|11425196|FG001|COMPLETED|Overall Study||26
10292403|NCT03370757|11425195|FG000|NOT COMPLETED|Overall Study||0
10292404|NCT03370757|11425196|FG001|NOT COMPLETED|Overall Study||2
10292405|NCT03303989|11425206|FG000|STARTED|Overall Study||24
10292406|NCT03303989|11425207|FG001|STARTED|Overall Study||11
10292407|NCT03303989|11425206|FG000|COMPLETED|Overall Study||22
10292408|NCT03303989|11425207|FG001|COMPLETED|Overall Study||10
10292409|NCT03303989|11425206|FG000|NOT COMPLETED|Overall Study||2
10292410|NCT03303989|11425207|FG001|NOT COMPLETED|Overall Study||1
10292411|NCT03289143|11425217|FG000|STARTED|Overall Study||135
10292412|NCT03289143|11425218|FG001|STARTED|Overall Study||94
10292413|NCT03289143|11425219|FG002|STARTED|Overall Study||136
10292414|NCT03289143|11425220|FG003|STARTED|Overall Study||92
10292415|NCT03289143|11425217|FG000|COMPLETED|Overall Study||1
10292416|NCT03289143|11425218|FG001|COMPLETED|Overall Study||0
10292417|NCT03289143|11425219|FG002|COMPLETED|Overall Study||2
10292418|NCT03289143|11425220|FG003|COMPLETED|Overall Study||0
10842457|NCT01854775|12007987|FG000|STARTED|Treatment Phase (48 Weeks)||50
10842458|NCT01854775|12007988|FG001|STARTED|Treatment Phase (48 Weeks)||52
10842459|NCT01854775|12007989|FG002|STARTED|Treatment Phase (48 Weeks)||27
10842460|NCT01854775|12007987|FG000|COMPLETED|Treatment Phase (48 Weeks)||48
10842461|NCT01854775|12007988|FG001|COMPLETED|Treatment Phase (48 Weeks)||51
10842462|NCT01854775|12007989|FG002|COMPLETED|Treatment Phase (48 Weeks)||18
10842463|NCT01854775|12007987|FG000|NOT COMPLETED|Treatment Phase (48 Weeks)||2
10842464|NCT01854775|12007988|FG001|NOT COMPLETED|Treatment Phase (48 Weeks)||1
10842465|NCT01854775|12007989|FG002|NOT COMPLETED|Treatment Phase (48 Weeks)||9
10842466|NCT01854775|12007987|FG000|STARTED|Extension Phase||48
10842467|NCT01854775|12007988|FG001|STARTED|Extension Phase||50
10842468|NCT01854775|12007989|FG002|STARTED|Extension Phase||18
10842469|NCT01854775|12007987|FG000|COMPLETED|Extension Phase||9
10842470|NCT01854775|12007988|FG001|COMPLETED|Extension Phase||3
10842471|NCT01854775|12007989|FG002|COMPLETED|Extension Phase||0
10842472|NCT01854775|12007987|FG000|NOT COMPLETED|Extension Phase||39
10842473|NCT01854775|12007988|FG001|NOT COMPLETED|Extension Phase||47
10842474|NCT01854775|12007989|FG002|NOT COMPLETED|Extension Phase||18
10842486|NCT01839331|12008015|FG000|STARTED|Overall Study||83
10842487|NCT01839331|12008016|FG001|STARTED|Overall Study||83
10842488|NCT01839331|12008017|FG002|STARTED|Overall Study||82
10842489|NCT01839331|12008018|FG003|STARTED|Overall Study||81
10842490|NCT01839331|12008015|FG000|Week 6|Overall Study||83
10842491|NCT01839331|12008016|FG001|Week 6|Overall Study||83
10842492|NCT01839331|12008017|FG002|Week 6|Overall Study||82
10842493|NCT01839331|12008018|FG003|Week 6|Overall Study||81
10842494|NCT01839331|12008015|FG000|COMPLETED|Overall Study||79
10842495|NCT01839331|12008016|FG001|COMPLETED|Overall Study||77
10842496|NCT01839331|12008017|FG002|COMPLETED|Overall Study||77
10842497|NCT01839331|12008018|FG003|COMPLETED|Overall Study||76
10842498|NCT01839331|12008015|FG000|NOT COMPLETED|Overall Study||4
10842499|NCT01839331|12008016|FG001|NOT COMPLETED|Overall Study||6
10842500|NCT01839331|12008017|FG002|NOT COMPLETED|Overall Study||5
10842501|NCT01839331|12008018|FG003|NOT COMPLETED|Overall Study||5
10411682|NCT00768560|11555680|FG005|COMPLETED|Intervention Set 2||6
10411683|NCT00768560|11555675|FG000|NOT COMPLETED|Intervention Set 2||0
10411684|NCT00768560|11555676|FG001|NOT COMPLETED|Intervention Set 2||0
10411685|NCT00768560|11555677|FG002|NOT COMPLETED|Intervention Set 2||0
10411686|NCT00768560|11555678|FG003|NOT COMPLETED|Intervention Set 2||0
10411687|NCT00768560|11555679|FG004|NOT COMPLETED|Intervention Set 2||0
10411688|NCT00768560|11555680|FG005|NOT COMPLETED|Intervention Set 2||0
10411689|NCT00768560|11555675|FG000|STARTED|Intervention Set 3|80 mg OD for 2 weeks|5
10411690|NCT00768560|11555676|FG001|STARTED|Intervention Set 3|40 mg BID for 2 weeks|5
10411691|NCT00768560|11555677|FG002|STARTED|Intervention Set 3|40 mg OD for 2 weeks|6
10842508|NCT01709123|12008047|FG000|STARTED|Overall Study||31
10842509|NCT01709123|12008048|FG001|STARTED|Overall Study||31
10842510|NCT01709123|12008047|FG000|COMPLETED|Overall Study||22
10842511|NCT01709123|12008048|FG001|COMPLETED|Overall Study||22
10842512|NCT01709123|12008047|FG000|NOT COMPLETED|Overall Study||9
10842513|NCT01709123|12008048|FG001|NOT COMPLETED|Overall Study||9
10842514|NCT01235234|12008057|FG000|STARTED|Overall Study||77
10842515|NCT01235234|12008058|FG001|STARTED|Overall Study||78
10842516|NCT01235234|12008059|FG002|STARTED|Overall Study||81
10842517|NCT01235234|12008057|FG000|COMPLETED|Overall Study||75
10842518|NCT01235234|12008058|FG001|COMPLETED|Overall Study||76
10842519|NCT01235234|12008059|FG002|COMPLETED|Overall Study||80
10842520|NCT01235234|12008057|FG000|NOT COMPLETED|Overall Study||2
10842521|NCT01235234|12008058|FG001|NOT COMPLETED|Overall Study||2
10842522|NCT01235234|12008059|FG002|NOT COMPLETED|Overall Study||1
10411692|NCT00768560|11555678|FG003|STARTED|Intervention Set 3|80 mg OD for 2 weeks|6
10411693|NCT00768560|11555679|FG004|STARTED|Intervention Set 3|40 mg BID for 2 weeks|6
10411694|NCT00768560|11555680|FG005|STARTED|Intervention Set 3|40 mg OD for 2 weeks|6
10411695|NCT00768560|11555675|FG000|COMPLETED|Intervention Set 3||5
10842523|NCT01160211|12008070|FG000|STARTED|Overall Study||120
10842524|NCT01160211|12008071|FG001|STARTED|Overall Study||118
10842525|NCT01160211|12008072|FG002|STARTED|Overall Study||117
10842526|NCT01160211|12008070|FG000|Ongoing|Overall Study||90
10842527|NCT01160211|12008071|FG001|Ongoing|Overall Study||75
10842528|NCT01160211|12008072|FG002|Ongoing|Overall Study||79
10842529|NCT01160211|12008070|FG000|COMPLETED|Overall Study||21
10842530|NCT01160211|12008071|FG001|COMPLETED|Overall Study||31
10842531|NCT01160211|12008072|FG002|COMPLETED|Overall Study||30
10842532|NCT01160211|12008070|FG000|NOT COMPLETED|Overall Study||99
10842533|NCT01160211|12008071|FG001|NOT COMPLETED|Overall Study||87
10842534|NCT01160211|12008072|FG002|NOT COMPLETED|Overall Study||87
10842535|NCT01093573|12008084|FG000|STARTED|Overall Study||3
10842536|NCT01093573|12008085|FG001|STARTED|Overall Study||3
10842537|NCT01093573|12008086|FG002|STARTED|Overall Study||28
10842538|NCT01093573|12008084|FG000|COMPLETED|Overall Study||3
10842539|NCT01093573|12008085|FG001|COMPLETED|Overall Study||3
10842540|NCT01093573|12008086|FG002|COMPLETED|Overall Study||26
10842541|NCT01093573|12008084|FG000|NOT COMPLETED|Overall Study||0
10842542|NCT01093573|12008085|FG001|NOT COMPLETED|Overall Study||0
10842543|NCT01093573|12008086|FG002|NOT COMPLETED|Overall Study||2
10842544|NCT00828854|12008097|FG000|STARTED|Overall Study||27
10842545|NCT00828854|12008097|FG000|COMPLETED|Overall Study||0
10842546|NCT00828854|12008097|FG000|NOT COMPLETED|Overall Study||27
10842547|NCT00753545|12008103|FG000|STARTED|Overall Study|Patients randomized|136
10842548|NCT00753545|12008104|FG001|STARTED|Overall Study|Patients randomized|129
10842549|NCT00753545|12008103|FG000|COMPLETED|Overall Study|Patients completing the Study|28
10842550|NCT00753545|12008104|FG001|COMPLETED|Overall Study|Patients completing the Study|11
10842551|NCT00753545|12008103|FG000|NOT COMPLETED|Overall Study||108
10842552|NCT00753545|12008104|FG001|NOT COMPLETED|Overall Study||118
10842553|NCT00494234|12008112|FG000|STARTED|Overall Study||27
10842554|NCT00494234|12008113|FG001|STARTED|Overall Study||27
10842555|NCT00494234|12008112|FG000|COMPLETED|Overall Study||12
10842556|NCT00494234|12008113|FG001|COMPLETED|Overall Study||17
10842557|NCT00494234|12008112|FG000|NOT COMPLETED|Overall Study||15
10842558|NCT00494234|12008113|FG001|NOT COMPLETED|Overall Study||10
10842559|NCT04884191|12008126|FG000|STARTED|Overall Study||55
10842560|NCT04884191|12008127|FG001|STARTED|Overall Study||55
10842561|NCT04884191|12008128|FG002|STARTED|Overall Study||55
10842562|NCT04884191|12008126|FG000|COMPLETED|Overall Study||52
10842563|NCT04884191|12008127|FG001|COMPLETED|Overall Study||55
10842564|NCT04884191|12008128|FG002|COMPLETED|Overall Study||54
10842565|NCT04884191|12008126|FG000|NOT COMPLETED|Overall Study||3
10842566|NCT04884191|12008127|FG001|NOT COMPLETED|Overall Study||0
10842567|NCT04884191|12008128|FG002|NOT COMPLETED|Overall Study||1
10842568|NCT04881175|12008136|FG000|STARTED|Overall Study||3
10842569|NCT04881175|12008136|FG000|COMPLETED|Overall Study||3
10842570|NCT04881175|12008136|FG000|NOT COMPLETED|Overall Study||0
10842571|NCT04881149|12008140|FG000|STARTED|Overall Study||7
10842572|NCT04881149|12008140|FG000|Control Biopsy|Overall Study||7
10842573|NCT04881149|12008140|FG000|Treatment Biopsy|Overall Study||7
10842574|NCT04881149|12008140|FG000|COMPLETED|Overall Study||7
10842575|NCT04881149|12008140|FG000|NOT COMPLETED|Overall Study||0
10842576|NCT04600076|12008145|FG000|STARTED|Overall Study||22
10842577|NCT04600076|12008145|FG000|COMPLETED|Overall Study||19
10842578|NCT04600076|12008145|FG000|NOT COMPLETED|Overall Study||3
10842579|NCT04375397|12008151|FG000|STARTED|Overall Study||22
10842580|NCT04375397|12008152|FG001|STARTED|Overall Study||24
10842581|NCT04375397|12008151|FG000|COMPLETED|Overall Study||13
10842582|NCT04375397|12008152|FG001|COMPLETED|Overall Study||18
10842583|NCT04375397|12008151|FG000|NOT COMPLETED|Overall Study||9
10842584|NCT04375397|12008152|FG001|NOT COMPLETED|Overall Study||6
10842607|NCT04048343|12008188|FG000|STARTED|Overall Study||65
10842608|NCT04048343|12008188|FG000|COMPLETED|Overall Study||65
10842609|NCT04048343|12008188|FG000|NOT COMPLETED|Overall Study||0
10842619|NCT03915470|12008207|FG000|STARTED|Overall Study||63
10842620|NCT03915470|12008208|FG001|STARTED|Overall Study||61
10842621|NCT03915470|12008207|FG000|COMPLETED|Overall Study|63 - 6 (discontinued intervention)|57
10842622|NCT03915470|12008208|FG001|COMPLETED|Overall Study|61-2 (discontinued intervention)|59
10842623|NCT03915470|12008207|FG000|NOT COMPLETED|Overall Study||6
10842624|NCT03915470|12008208|FG001|NOT COMPLETED|Overall Study||2
10842625|NCT03892642|12008214|FG000|STARTED|Overall Study||18
10842626|NCT03892642|12008214|FG000|COMPLETED|Overall Study||18
10842627|NCT03892642|12008214|FG000|NOT COMPLETED|Overall Study||0
10842628|NCT03881553|12008221|FG000|STARTED|Overall Study||11
10842629|NCT03881553|12008222|FG001|STARTED|Overall Study||2
10842630|NCT03881553|12008223|FG002|STARTED|Overall Study||4
10842631|NCT03881553|12008221|FG000|COMPLETED|Overall Study||10
10842585|NCT04327518|12008158|FG000|STARTED|Overall Study||125
10842586|NCT04327518|12008158|FG000|COMPLETED|Overall Study||124
10842587|NCT04327518|12008158|FG000|NOT COMPLETED|Overall Study||1
10842588|NCT04273737|12008162|FG000|STARTED|Overall Study||11
10842589|NCT04273737|12008162|FG000|COMPLETED|Overall Study||11
10842590|NCT04273737|12008162|FG000|NOT COMPLETED|Overall Study||0
10842591|NCT04267276|12008166|FG000|STARTED|Overall Study||7
10842592|NCT04267276|12008166|FG000|Treated|Overall Study||7
10842593|NCT04267276|12008166|FG000|COMPLETED|Overall Study||7
10842594|NCT04267276|12008166|FG000|NOT COMPLETED|Overall Study||0
10842595|NCT04255381|12008170|FG000|STARTED|Overall Study||20
10842596|NCT04255381|12008170|FG000|COMPLETED|Overall Study||20
10842597|NCT04255381|12008170|FG000|NOT COMPLETED|Overall Study||0
10842598|NCT04075734|12008177|FG000|STARTED|Overall Study||25
10842599|NCT04075734|12008178|FG001|STARTED|Overall Study||25
10842600|NCT04075734|12008179|FG002|STARTED|Overall Study||10
10842601|NCT04075734|12008177|FG000|COMPLETED|Overall Study||21
10842602|NCT04075734|12008178|FG001|COMPLETED|Overall Study||24
10842603|NCT04075734|12008179|FG002|COMPLETED|Overall Study||10
10842604|NCT04075734|12008177|FG000|NOT COMPLETED|Overall Study||4
10842605|NCT04075734|12008178|FG001|NOT COMPLETED|Overall Study||1
10842606|NCT04075734|12008179|FG002|NOT COMPLETED|Overall Study||0
10842632|NCT03881553|12008222|FG001|COMPLETED|Overall Study||1
10842633|NCT03881553|12008223|FG002|COMPLETED|Overall Study||3
10842634|NCT03881553|12008221|FG000|NOT COMPLETED|Overall Study||1
10842635|NCT03881553|12008222|FG001|NOT COMPLETED|Overall Study||1
10842636|NCT03881553|12008223|FG002|NOT COMPLETED|Overall Study||1
10842637|NCT03874325|12008231|FG000|STARTED|Overall Study||17
10842638|NCT03874325|12008232|FG001|STARTED|Overall Study||0
10842639|NCT03874325|12008231|FG000|COMPLETED|Overall Study||17
10842640|NCT03874325|12008232|FG001|COMPLETED|Overall Study||0
10842641|NCT03874325|12008231|FG000|NOT COMPLETED|Overall Study||0
10842642|NCT03874325|12008232|FG001|NOT COMPLETED|Overall Study||0
10842643|NCT03861611|12008239|FG000|STARTED|Overall Study||66
10842644|NCT03861611|12008240|FG001|STARTED|Overall Study||66
10842645|NCT03861611|12008241|FG002|STARTED|Overall Study||66
10842646|NCT03861611|12008239|FG000|COMPLETED|Overall Study||59
10842647|NCT03861611|12008240|FG001|COMPLETED|Overall Study||61
10842648|NCT03861611|12008241|FG002|COMPLETED|Overall Study||62
10842649|NCT03861611|12008239|FG000|NOT COMPLETED|Overall Study||7
10842650|NCT03861611|12008240|FG001|NOT COMPLETED|Overall Study||5
10842651|NCT03861611|12008241|FG002|NOT COMPLETED|Overall Study||4
10842652|NCT03860311|12008254|FG000|STARTED|Overall Study||22
10842653|NCT03860311|12008255|FG001|STARTED|Overall Study||23
10842654|NCT03860311|12008254|FG000|COMPLETED|Overall Study||22
10842655|NCT03860311|12008255|FG001|COMPLETED|Overall Study||23
10842656|NCT03860311|12008254|FG000|NOT COMPLETED|Overall Study||0
10842657|NCT03860311|12008255|FG001|NOT COMPLETED|Overall Study||0
10842658|NCT03795116|12008264|FG000|STARTED|Overall Study||10
10842659|NCT03795116|12008265|FG001|STARTED|Overall Study||10
10842660|NCT03795116|12008266|FG002|STARTED|Overall Study||10
10842661|NCT03795116|12008267|FG003|STARTED|Overall Study||10
10842662|NCT03795116|12008268|FG004|STARTED|Overall Study||10
10842663|NCT03795116|12008269|FG005|STARTED|Overall Study||10
10842664|NCT03795116|12008264|FG000|COMPLETED|Overall Study||6
10842665|NCT03795116|12008265|FG001|COMPLETED|Overall Study||6
10842666|NCT03795116|12008266|FG002|COMPLETED|Overall Study||9
10842667|NCT03795116|12008267|FG003|COMPLETED|Overall Study||9
10842668|NCT03795116|12008268|FG004|COMPLETED|Overall Study||9
10842669|NCT03795116|12008269|FG005|COMPLETED|Overall Study||9
10842670|NCT03795116|12008264|FG000|NOT COMPLETED|Overall Study||4
10842671|NCT03795116|12008265|FG001|NOT COMPLETED|Overall Study||4
10842672|NCT03795116|12008266|FG002|NOT COMPLETED|Overall Study||1
10842673|NCT03795116|12008267|FG003|NOT COMPLETED|Overall Study||1
10842674|NCT03795116|12008268|FG004|NOT COMPLETED|Overall Study||1
10842675|NCT03795116|12008269|FG005|NOT COMPLETED|Overall Study||1
10842676|NCT03750292|12008290|FG000|STARTED|First Intervention (Baseline to 8 Weeks)||5
10842677|NCT03750292|12008291|FG001|STARTED|First Intervention (Baseline to 8 Weeks)||4
10842678|NCT03750292|12008290|FG000|COMPLETED|First Intervention (Baseline to 8 Weeks)||5
10842679|NCT03750292|12008291|FG001|COMPLETED|First Intervention (Baseline to 8 Weeks)||4
10842680|NCT03750292|12008290|FG000|NOT COMPLETED|First Intervention (Baseline to 8 Weeks)||0
10842681|NCT03750292|12008291|FG001|NOT COMPLETED|First Intervention (Baseline to 8 Weeks)||0
10842682|NCT03750292|12008290|FG000|STARTED|Washout (3 Weeks)||5
10842683|NCT03750292|12008291|FG001|STARTED|Washout (3 Weeks)||4
10842684|NCT03750292|12008290|FG000|COMPLETED|Washout (3 Weeks)||5
10842685|NCT03750292|12008291|FG001|COMPLETED|Washout (3 Weeks)||4
10842686|NCT03750292|12008290|FG000|NOT COMPLETED|Washout (3 Weeks)||0
10842687|NCT03750292|12008291|FG001|NOT COMPLETED|Washout (3 Weeks)||0
10842688|NCT03750292|12008290|FG000|STARTED|Second Intervention (11 to 19 Weeks)||5
10842689|NCT03750292|12008291|FG001|STARTED|Second Intervention (11 to 19 Weeks)||4
10842690|NCT03750292|12008290|FG000|COMPLETED|Second Intervention (11 to 19 Weeks)||5
10842691|NCT03750292|12008291|FG001|COMPLETED|Second Intervention (11 to 19 Weeks)||4
10842692|NCT03750292|12008290|FG000|NOT COMPLETED|Second Intervention (11 to 19 Weeks)||0
10842693|NCT03750292|12008291|FG001|NOT COMPLETED|Second Intervention (11 to 19 Weeks)||0
10842694|NCT03749252|12008300|FG000|STARTED|Overall Study||26
10842695|NCT03749252|12008301|FG001|STARTED|Overall Study||23
10842696|NCT03749252|12008302|FG002|STARTED|Overall Study||31
10842697|NCT03749252|12008300|FG000|COMPLETED|Overall Study||26
10842698|NCT03749252|12008301|FG001|COMPLETED|Overall Study||23
10842699|NCT03749252|12008302|FG002|COMPLETED|Overall Study||31
10842700|NCT03749252|12008300|FG000|NOT COMPLETED|Overall Study||0
10842701|NCT03749252|12008301|FG001|NOT COMPLETED|Overall Study||0
10842702|NCT03749252|12008302|FG002|NOT COMPLETED|Overall Study||0
10842703|NCT03718000|12008312|FG000|STARTED|Overall Study||55
10842704|NCT03718000|12008313|FG001|STARTED|Overall Study||56
10842705|NCT03718000|12008312|FG000|COMPLETED|Overall Study||53
10842706|NCT03718000|12008313|FG001|COMPLETED|Overall Study||51
10842707|NCT03718000|12008312|FG000|NOT COMPLETED|Overall Study||2
10842708|NCT03718000|12008313|FG001|NOT COMPLETED|Overall Study||5
10842730|NCT03698409|12008349|FG000|STARTED|Overall Study||39
10842731|NCT03698409|12008350|FG001|STARTED|Overall Study||29
10842732|NCT03698409|12008349|FG000|COMPLETED|Overall Study||39
10842733|NCT03698409|12008350|FG001|COMPLETED|Overall Study||29
10842734|NCT03698409|12008349|FG000|NOT COMPLETED|Overall Study||0
10842735|NCT03698409|12008350|FG001|NOT COMPLETED|Overall Study||0
10842736|NCT03654651|12008358|FG000|STARTED|First Intervention (6 Weeks)||26
10842737|NCT03654651|12008359|FG001|STARTED|First Intervention (6 Weeks)||25
10842738|NCT03654651|12008358|FG000|COMPLETED|First Intervention (6 Weeks)||25
10842739|NCT03654651|12008359|FG001|COMPLETED|First Intervention (6 Weeks)||25
10842740|NCT03654651|12008358|FG000|NOT COMPLETED|First Intervention (6 Weeks)||1
10842741|NCT03654651|12008359|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
10842742|NCT03654651|12008358|FG000|STARTED|Washout Period (2-weeks)||25
10842743|NCT03654651|12008359|FG001|STARTED|Washout Period (2-weeks)||25
10842744|NCT03654651|12008358|FG000|COMPLETED|Washout Period (2-weeks)||25
10842745|NCT03654651|12008359|FG001|COMPLETED|Washout Period (2-weeks)||25
10842746|NCT03654651|12008358|FG000|NOT COMPLETED|Washout Period (2-weeks)||0
10842747|NCT03654651|12008359|FG001|NOT COMPLETED|Washout Period (2-weeks)||0
10842748|NCT03654651|12008358|FG000|STARTED|Second Intervention (6 Weeks)||25
10842749|NCT03654651|12008359|FG001|STARTED|Second Intervention (6 Weeks)||25
10842750|NCT03654651|12008358|FG000|COMPLETED|Second Intervention (6 Weeks)||25
10842751|NCT03654651|12008359|FG001|COMPLETED|Second Intervention (6 Weeks)||25
10842752|NCT03654651|12008358|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
10842753|NCT03654651|12008359|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
10842754|NCT03633396|12008368|FG000|STARTED|Overall Study||29
10842755|NCT03633396|12008369|FG001|STARTED|Overall Study||30
10842756|NCT03633396|12008368|FG000|COMPLETED|Overall Study||23
10842757|NCT03633396|12008369|FG001|COMPLETED|Overall Study||24
10842758|NCT03633396|12008368|FG000|NOT COMPLETED|Overall Study||6
10842759|NCT03633396|12008369|FG001|NOT COMPLETED|Overall Study||6
10842760|NCT03612856|12008378|FG000|STARTED|Pre-dose Period||8
10842761|NCT03612856|12008379|FG001|STARTED|Pre-dose Period||10
10842762|NCT03612856|12008380|FG002|STARTED|Pre-dose Period||9
10842763|NCT03612856|12008378|FG000|COMPLETED|Pre-dose Period||8
10842764|NCT03612856|12008379|FG001|COMPLETED|Pre-dose Period||8
10842765|NCT03612856|12008380|FG002|COMPLETED|Pre-dose Period||8
10842766|NCT03612856|12008378|FG000|NOT COMPLETED|Pre-dose Period||0
10842767|NCT03612856|12008379|FG001|NOT COMPLETED|Pre-dose Period||2
10842768|NCT03612856|12008380|FG002|NOT COMPLETED|Pre-dose Period||1
10842769|NCT03612856|12008378|FG000|STARTED|Post-dose Period||8
10842770|NCT03612856|12008379|FG001|STARTED|Post-dose Period||8
10842771|NCT03612856|12008380|FG002|STARTED|Post-dose Period||8
10842772|NCT03612856|12008378|FG000|COMPLETED|Post-dose Period||8
10842773|NCT03612856|12008379|FG001|COMPLETED|Post-dose Period||8
10842774|NCT03612856|12008380|FG002|COMPLETED|Post-dose Period||8
10842775|NCT03612856|12008378|FG000|NOT COMPLETED|Post-dose Period||0
10842776|NCT03612856|12008379|FG001|NOT COMPLETED|Post-dose Period||0
10842777|NCT03612856|12008380|FG002|NOT COMPLETED|Post-dose Period||0
10842778|NCT03607994|12008390|FG000|STARTED|Overall Study||10
10842779|NCT03607994|12008391|FG001|STARTED|Overall Study||12
10842780|NCT03607994|12008390|FG000|COMPLETED|Overall Study||9
10842781|NCT03607994|12008391|FG001|COMPLETED|Overall Study||11
10842782|NCT03607994|12008390|FG000|NOT COMPLETED|Overall Study||1
10842783|NCT03607994|12008391|FG001|NOT COMPLETED|Overall Study||1
10411696|NCT00768560|11555676|FG001|COMPLETED|Intervention Set 3||5
10411697|NCT00768560|11555677|FG002|COMPLETED|Intervention Set 3||6
10411698|NCT00768560|11555678|FG003|COMPLETED|Intervention Set 3||6
10411699|NCT00768560|11555679|FG004|COMPLETED|Intervention Set 3||6
10411700|NCT00768560|11555680|FG005|COMPLETED|Intervention Set 3||6
10411701|NCT00768560|11555675|FG000|NOT COMPLETED|Intervention Set 3||0
10411702|NCT00768560|11555676|FG001|NOT COMPLETED|Intervention Set 3||0
10411703|NCT00768560|11555677|FG002|NOT COMPLETED|Intervention Set 3||0
10411704|NCT00768560|11555678|FG003|NOT COMPLETED|Intervention Set 3||0
10411705|NCT00768560|11555679|FG004|NOT COMPLETED|Intervention Set 3||0
10411706|NCT00768560|11555680|FG005|NOT COMPLETED|Intervention Set 3||0
10429191|NCT00862849|11575287|FG001|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
10429192|NCT00862849|11575288|FG002|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
10429193|NCT00862849|11575289|FG003|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
10429194|NCT00862849|11575290|FG004|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
10429195|NCT00862849|11575291|FG005|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
10429196|NCT00862849|11575286|FG000|STARTED|Intervention 4||3
10429197|NCT00862849|11575287|FG001|STARTED|Intervention 4||3
10429198|NCT00862849|11575288|FG002|STARTED|Intervention 4||3
10429199|NCT00862849|11575289|FG003|STARTED|Intervention 4||4
10429200|NCT00862849|11575290|FG004|STARTED|Intervention 4||4
10429201|NCT00862849|11575291|FG005|STARTED|Intervention 4||3
10429202|NCT00862849|11575286|FG000|COMPLETED|Intervention 4||3
10429203|NCT00862849|11575287|FG001|COMPLETED|Intervention 4||3
10429204|NCT00862849|11575288|FG002|COMPLETED|Intervention 4||3
10429205|NCT00862849|11575289|FG003|COMPLETED|Intervention 4||4
10429206|NCT00862849|11575290|FG004|COMPLETED|Intervention 4||4
10429207|NCT00862849|11575291|FG005|COMPLETED|Intervention 4||3
10429208|NCT00862849|11575286|FG000|NOT COMPLETED|Intervention 4||0
10429209|NCT00862849|11575287|FG001|NOT COMPLETED|Intervention 4||0
10429210|NCT00862849|11575288|FG002|NOT COMPLETED|Intervention 4||0
10429211|NCT00862849|11575289|FG003|NOT COMPLETED|Intervention 4||0
10429212|NCT00862849|11575290|FG004|NOT COMPLETED|Intervention 4||0
10429213|NCT00862849|11575291|FG005|NOT COMPLETED|Intervention 4||0
10842803|NCT03505671|12008425|FG000|STARTED|Overall Study||11
10842804|NCT03505671|12008426|FG001|STARTED|Overall Study||12
10842805|NCT03505671|12008425|FG000|COMPLETED|Overall Study||8
10842806|NCT03505671|12008426|FG001|COMPLETED|Overall Study||11
10842807|NCT03505671|12008425|FG000|NOT COMPLETED|Overall Study||3
10842808|NCT03505671|12008426|FG001|NOT COMPLETED|Overall Study||1
10842809|NCT03469999|12008432|FG000|STARTED|Overall Study||12
10842810|NCT03469999|12008432|FG000|COMPLETED|Overall Study||10
10842811|NCT03469999|12008432|FG000|NOT COMPLETED|Overall Study||2
10842812|NCT03463993|12008439|FG000|STARTED|Overall Study||253
10842813|NCT03463993|12008440|FG001|STARTED|Overall Study||253
10842814|NCT03463993|12008439|FG000|COMPLETED|Overall Study||224
10842815|NCT03463993|12008440|FG001|COMPLETED|Overall Study||227
10842816|NCT03463993|12008439|FG000|NOT COMPLETED|Overall Study||29
10842817|NCT03463993|12008440|FG001|NOT COMPLETED|Overall Study||26
10411707|NCT00768599|11555691|FG000|STARTED|Overall Study||45
10411708|NCT00768599|11555692|FG001|STARTED|Overall Study||43
10411709|NCT00768599|11555693|FG002|STARTED|Overall Study||47
10411710|NCT00768599|11555691|FG000|COMPLETED|Overall Study||34
10411711|NCT00768599|11555692|FG001|COMPLETED|Overall Study||27
10411712|NCT00768599|11555693|FG002|COMPLETED|Overall Study||35
10411713|NCT00768599|11555691|FG000|NOT COMPLETED|Overall Study||11
10411714|NCT00768599|11555692|FG001|NOT COMPLETED|Overall Study||16
10411715|NCT00768599|11555693|FG002|NOT COMPLETED|Overall Study||12
10411716|NCT00768651|11555701|FG000|STARTED|Overall Study||8
10411717|NCT00768651|11555701|FG000|COMPLETED|Overall Study||7
10411718|NCT00768651|11555701|FG000|NOT COMPLETED|Overall Study||1
10411719|NCT00768664|11555706|FG000|STARTED|Overall Study||69
10411720|NCT00768664|11555706|FG000|COMPLETED|Overall Study||0
10411721|NCT00768664|11555706|FG000|NOT COMPLETED|Overall Study||69
10411722|NCT00768716|11555712|FG000|STARTED|Overall Study||54
10411723|NCT00768716|11555713|FG001|STARTED|Overall Study||41
10411724|NCT00768716|11555712|FG000|COMPLETED|Overall Study||54
10411725|NCT00768716|11555713|FG001|COMPLETED|Overall Study||41
10411726|NCT00768716|11555712|FG000|NOT COMPLETED|Overall Study||0
10411727|NCT00768716|11555713|FG001|NOT COMPLETED|Overall Study||0
10411728|NCT00768755|11555726|FG000|STARTED|Phase 1||10
10411729|NCT00768755|11555727|FG001|STARTED|Phase 1||0
10411730|NCT00768755|11555728|FG002|STARTED|Phase 1||0
10411731|NCT00768755|11555729|FG003|STARTED|Phase 1||0
10411732|NCT00768755|11555726|FG000|COMPLETED|Phase 1||0
10411733|NCT00768755|11555727|FG001|COMPLETED|Phase 1||0
10842818|NCT03390101|12008449|FG000|STARTED|Weeks 0-12||85
10842819|NCT03390101|12008450|FG001|STARTED|Weeks 0-12||84
10842820|NCT03390101|12008451|FG002|STARTED|Weeks 0-12||44
10842821|NCT03390101|12008449|FG000|COMPLETED|Weeks 0-12||85
10842822|NCT03390101|12008450|FG001|COMPLETED|Weeks 0-12||82
10842823|NCT03390101|12008451|FG002|COMPLETED|Weeks 0-12||43
10842824|NCT03390101|12008449|FG000|NOT COMPLETED|Weeks 0-12||0
10842825|NCT03390101|12008450|FG001|NOT COMPLETED|Weeks 0-12||2
10842826|NCT03390101|12008451|FG002|NOT COMPLETED|Weeks 0-12||1
10842827|NCT03390101|12008449|FG000|STARTED|Weeks 12-54||85
10842828|NCT03390101|12008450|FG001|STARTED|Weeks 12-54||82
10842829|NCT03390101|12008451|FG002|STARTED|Weeks 12-54||43
10842830|NCT03390101|12008449|FG000|COMPLETED|Weeks 12-54||82
10842831|NCT03390101|12008450|FG001|COMPLETED|Weeks 12-54||78
10842832|NCT03390101|12008451|FG002|COMPLETED|Weeks 12-54||41
10842833|NCT03390101|12008449|FG000|NOT COMPLETED|Weeks 12-54||3
10842834|NCT03390101|12008450|FG001|NOT COMPLETED|Weeks 12-54||4
10842835|NCT03390101|12008451|FG002|NOT COMPLETED|Weeks 12-54||2
10842836|NCT03213158|12008459|FG000|STARTED|Overall Study||10
10842837|NCT03213158|12008459|FG000|COMPLETED|Overall Study||7
10842838|NCT03213158|12008459|FG000|NOT COMPLETED|Overall Study||3
10842839|NCT03179605|12008463|FG000|STARTED|Overall Study||22
10842840|NCT03179605|12008463|FG000|COMPLETED|Overall Study||21
10842841|NCT03179605|12008463|FG000|NOT COMPLETED|Overall Study||1
10842842|NCT03159195|12008469|FG000|STARTED|Overall Study||360
10842843|NCT03159195|12008470|FG001|STARTED|Overall Study||292
10842844|NCT03159195|12008469|FG000|COMPLETED|Overall Study||360
10842845|NCT03159195|12008470|FG001|COMPLETED|Overall Study||292
10842846|NCT03159195|12008469|FG000|NOT COMPLETED|Overall Study||0
10842847|NCT03159195|12008470|FG001|NOT COMPLETED|Overall Study||0
10842848|NCT03150862|12008484|FG000|STARTED|Overall Study||3
10842849|NCT03150862|12008485|FG001|STARTED|Overall Study||8
10842850|NCT03150862|12008486|FG002|STARTED|Overall Study||9
10842851|NCT03150862|12008487|FG003|STARTED|Overall Study||40
10842852|NCT03150862|12008488|FG004|STARTED|Overall Study||9
10842853|NCT03150862|12008489|FG005|STARTED|Overall Study||9
10842854|NCT03150862|12008490|FG006|STARTED|Overall Study||8
10842855|NCT03150862|12008491|FG007|STARTED|Overall Study||30
10842856|NCT03150862|12008484|FG000|COMPLETED|Overall Study||0
10842857|NCT03150862|12008485|FG001|COMPLETED|Overall Study||0
10842858|NCT03150862|12008486|FG002|COMPLETED|Overall Study||0
10842859|NCT03150862|12008487|FG003|COMPLETED|Overall Study||0
10842860|NCT03150862|12008488|FG004|COMPLETED|Overall Study||0
10842861|NCT03150862|12008489|FG005|COMPLETED|Overall Study||0
10842862|NCT03150862|12008490|FG006|COMPLETED|Overall Study||0
10842863|NCT03150862|12008491|FG007|COMPLETED|Overall Study||0
10842864|NCT03150862|12008484|FG000|NOT COMPLETED|Overall Study||3
10842865|NCT03150862|12008485|FG001|NOT COMPLETED|Overall Study||8
10842866|NCT03150862|12008486|FG002|NOT COMPLETED|Overall Study||9
10842867|NCT03150862|12008487|FG003|NOT COMPLETED|Overall Study||40
10842868|NCT03150862|12008488|FG004|NOT COMPLETED|Overall Study||9
10842869|NCT03150862|12008489|FG005|NOT COMPLETED|Overall Study||9
10842870|NCT03150862|12008490|FG006|NOT COMPLETED|Overall Study||8
10842871|NCT03150862|12008491|FG007|NOT COMPLETED|Overall Study||30
10842872|NCT03074695|12008520|FG000|STARTED|Overall Study||70
10842873|NCT03074695|12008521|FG001|STARTED|Overall Study||71
10842874|NCT03074695|12008520|FG000|COMPLETED|Overall Study||66
10842875|NCT03074695|12008521|FG001|COMPLETED|Overall Study||66
10842876|NCT03074695|12008520|FG000|NOT COMPLETED|Overall Study||4
10842877|NCT03074695|12008521|FG001|NOT COMPLETED|Overall Study||5
10842878|NCT03052608|12008529|FG000|STARTED|Treatment Phase||149
10842879|NCT03052608|12008530|FG001|STARTED|Treatment Phase||147
10411734|NCT00768755|11555728|FG002|COMPLETED|Phase 1||0
10411735|NCT00768755|11555729|FG003|COMPLETED|Phase 1||0
10411736|NCT00768755|11555726|FG000|NOT COMPLETED|Phase 1||10
10411737|NCT00768755|11555727|FG001|NOT COMPLETED|Phase 1||0
10411738|NCT00768755|11555728|FG002|NOT COMPLETED|Phase 1||0
10411739|NCT00768755|11555729|FG003|NOT COMPLETED|Phase 1||0
10411740|NCT00768755|11555726|FG000|STARTED|Phase 2||0
10411741|NCT00768755|11555727|FG001|STARTED|Phase 2||55
10411742|NCT00768755|11555728|FG002|STARTED|Phase 2||58
10411743|NCT00768755|11555729|FG003|STARTED|Phase 2||57
10411744|NCT00768755|11555726|FG000|Treated|Phase 2||0
10411745|NCT00768755|11555727|FG001|Treated|Phase 2||55
10411746|NCT00768755|11555728|FG002|Treated|Phase 2||58
10411747|NCT00768755|11555729|FG003|Treated|Phase 2||55
10842880|NCT03052608|12008529|FG000|COMPLETED|Treatment Phase||26
10842881|NCT03052608|12008530|FG001|COMPLETED|Treatment Phase||83
10842882|NCT03052608|12008529|FG000|NOT COMPLETED|Treatment Phase||123
10842883|NCT03052608|12008530|FG001|NOT COMPLETED|Treatment Phase||64
10842884|NCT03052608|12008529|FG000|STARTED|Long-Term Follow-up Phase||149
10842885|NCT03052608|12008530|FG001|STARTED|Long-Term Follow-up Phase||147
10842886|NCT03052608|12008529|FG000|COMPLETED|Long-Term Follow-up Phase||0
10842887|NCT03052608|12008530|FG001|COMPLETED|Long-Term Follow-up Phase||0
10842888|NCT03052608|12008529|FG000|NOT COMPLETED|Long-Term Follow-up Phase||149
10842889|NCT03052608|12008530|FG001|NOT COMPLETED|Long-Term Follow-up Phase||147
10411748|NCT00768755|11555726|FG000|COMPLETED|Phase 2||0
10411749|NCT00768755|11555727|FG001|COMPLETED|Phase 2||0
10411750|NCT00768755|11555728|FG002|COMPLETED|Phase 2||0
10411751|NCT00768755|11555729|FG003|COMPLETED|Phase 2||0
10411752|NCT00768755|11555726|FG000|NOT COMPLETED|Phase 2||0
10842896|NCT02922725|12008551|FG000|STARTED|Overall Study||12
10842897|NCT02922725|12008552|FG001|STARTED|Overall Study||12
10842898|NCT02922725|12008553|FG002|STARTED|Overall Study||8
10842899|NCT02922725|12008551|FG000|COMPLETED|Overall Study||11
10842900|NCT02922725|12008552|FG001|COMPLETED|Overall Study||12
10842901|NCT02922725|12008553|FG002|COMPLETED|Overall Study||8
10842902|NCT02922725|12008551|FG000|NOT COMPLETED|Overall Study||1
10842903|NCT02922725|12008552|FG001|NOT COMPLETED|Overall Study||0
10842904|NCT02922725|12008553|FG002|NOT COMPLETED|Overall Study||0
10842905|NCT02886572|12008560|FG000|STARTED|Overall Study||40
10842906|NCT02886572|12008560|FG000|Survival Analysis Population|Overall Study||40
10842907|NCT02886572|12008560|FG000|Distant Brain Recurrence|Overall Study||32
10842908|NCT02886572|12008560|FG000|Local Recurrence|Overall Study||32
10842909|NCT02886572|12008560|FG000|Time to Neurologic Death|Overall Study||32
10842910|NCT02886572|12008560|FG000|SRS Related Adverse Events|Overall Study||32
10842911|NCT02886572|12008560|FG000|COMPLETED|Overall Study||32
10842912|NCT02886572|12008560|FG000|NOT COMPLETED|Overall Study||8
10545090|NCT01494467|11698335|FG000|STARTED|Part C Safety Follow up (4 Weeks)||353
10545091|NCT01494467|11698336|FG001|STARTED|Part C Safety Follow up (4 Weeks)||159
10545092|NCT01494467|11698335|FG000|COMPLETED|Part C Safety Follow up (4 Weeks)||353
10545093|NCT01494467|11698336|FG001|COMPLETED|Part C Safety Follow up (4 Weeks)||159
10545094|NCT01494467|11698335|FG000|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
10545095|NCT01494467|11698336|FG001|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
10545096|NCT01494506|11698351|FG000|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|151
10545097|NCT01494506|11698352|FG001|STARTED|Overall Study||149
10545098|NCT01494506|11698353|FG002|STARTED|Overall Study||117
10548297|NCT01518699|11702089|FG004|COMPLETED|Period 3||10
10842913|NCT02805257|12008566|FG000|STARTED|Overall Study||60
10842914|NCT02805257|12008567|FG001|STARTED|Overall Study||59
10842915|NCT02805257|12008566|FG000|COMPLETED|Overall Study||53
10842916|NCT02805257|12008567|FG001|COMPLETED|Overall Study||52
10842917|NCT02805257|12008566|FG000|NOT COMPLETED|Overall Study||7
10842918|NCT02805257|12008567|FG001|NOT COMPLETED|Overall Study||7
10842919|NCT02780609|12008577|FG000|STARTED|Overall Study||3
10842920|NCT02780609|12008578|FG001|STARTED|Overall Study||3
10842921|NCT02780609|12008579|FG002|STARTED|Overall Study||6
10842922|NCT02780609|12008580|FG003|STARTED|Overall Study||10
10842923|NCT02780609|12008577|FG000|COMPLETED|Overall Study||3
10842924|NCT02780609|12008578|FG001|COMPLETED|Overall Study||3
10842925|NCT02780609|12008579|FG002|COMPLETED|Overall Study||6
10842926|NCT02780609|12008580|FG003|COMPLETED|Overall Study||10
10842927|NCT02780609|12008577|FG000|NOT COMPLETED|Overall Study||0
10842928|NCT02780609|12008578|FG001|NOT COMPLETED|Overall Study||0
10842929|NCT02780609|12008579|FG002|NOT COMPLETED|Overall Study||0
10842930|NCT02780609|12008580|FG003|NOT COMPLETED|Overall Study||0
10842931|NCT02747433|12008594|FG000|STARTED|Overall Study||5
10842932|NCT02747433|12008595|FG001|STARTED|Overall Study||5
10842933|NCT02747433|12008594|FG000|COMPLETED|Overall Study||5
10842934|NCT02747433|12008595|FG001|COMPLETED|Overall Study||5
10842935|NCT02747433|12008594|FG000|NOT COMPLETED|Overall Study||0
10842936|NCT02747433|12008595|FG001|NOT COMPLETED|Overall Study||0
10842937|NCT02696564|12008606|FG000|STARTED|Overall Study||108
10842938|NCT02696564|12008607|FG001|STARTED|Overall Study||112
10842939|NCT02696564|12008606|FG000|COMPLETED|Overall Study||94
10842940|NCT02696564|12008607|FG001|COMPLETED|Overall Study||99
10842941|NCT02696564|12008606|FG000|NOT COMPLETED|Overall Study||14
10842942|NCT02696564|12008607|FG001|NOT COMPLETED|Overall Study||13
10842952|NCT02640950|12008626|FG000|STARTED|Overall Study||31
10842953|NCT02640950|12008626|FG000|COMPLETED|Overall Study||29
10842954|NCT02640950|12008626|FG000|NOT COMPLETED|Overall Study||2
10842955|NCT02639065|12008630|FG000|STARTED|Study Treatment||37
10842956|NCT02639065|12008630|FG000|COMPLETED|Study Treatment||17
10842957|NCT02639065|12008630|FG000|NOT COMPLETED|Study Treatment||20
10842958|NCT02639065|12008630|FG000|STARTED|Follow up||37
10842959|NCT02639065|12008630|FG000|COMPLETED|Follow up||28
10842960|NCT02639065|12008630|FG000|NOT COMPLETED|Follow up||9
10842961|NCT02564263|12008636|FG000|STARTED|Overall Study||314
10842962|NCT02564263|12008637|FG001|STARTED|Overall Study||314
10842963|NCT02564263|12008636|FG000|Treated|Overall Study||314
10842964|NCT02564263|12008637|FG001|Treated|Overall Study||296
10842965|NCT02564263|12008636|FG000|COMPLETED|Overall Study||0
10842966|NCT02564263|12008637|FG001|COMPLETED|Overall Study||0
10842967|NCT02564263|12008636|FG000|NOT COMPLETED|Overall Study||314
10842968|NCT02564263|12008637|FG001|NOT COMPLETED|Overall Study||314
10842977|NCT02372136|12008654|FG000|STARTED|Overall Study||62
10842978|NCT02372136|12008655|FG001|STARTED|Overall Study||58
10842979|NCT02372136|12008654|FG000|COMPLETED|Overall Study||59
10842980|NCT02372136|12008655|FG001|COMPLETED|Overall Study||57
10842981|NCT02372136|12008654|FG000|NOT COMPLETED|Overall Study||3
10842982|NCT02372136|12008655|FG001|NOT COMPLETED|Overall Study||1
10842983|NCT02367456|12008666|FG000|STARTED|Overall Study||12
10842984|NCT02367456|12008667|FG001|STARTED|Overall Study||30
10842985|NCT02367456|12008668|FG002|STARTED|Overall Study||30
10842986|NCT02367456|12008666|FG000|COMPLETED|Overall Study||0
10842987|NCT02367456|12008667|FG001|COMPLETED|Overall Study||0
10842988|NCT02367456|12008668|FG002|COMPLETED|Overall Study||0
10842989|NCT02367456|12008666|FG000|NOT COMPLETED|Overall Study||12
10842990|NCT02367456|12008667|FG001|NOT COMPLETED|Overall Study||30
10842991|NCT02367456|12008668|FG002|NOT COMPLETED|Overall Study||30
10842996|NCT02022033|12008685|FG000|STARTED|Overall Study||25
10842997|NCT02022033|12008685|FG000|COMPLETED|Overall Study||24
10842998|NCT02022033|12008685|FG000|NOT COMPLETED|Overall Study||1
10843005|NCT01434602|12008703|FG000|STARTED|Phase I Dose Escalation||6
10843006|NCT01434602|12008704|FG001|STARTED|Phase I Dose Escalation||7
10843007|NCT01434602|12008705|FG002|STARTED|Phase I Dose Escalation||0
10843008|NCT01434602|12008706|FG003|STARTED|Phase I Dose Escalation||0
10843009|NCT01434602|12008707|FG004|STARTED|Phase I Dose Escalation||0
10843010|NCT01434602|12008703|FG000|COMPLETED|Phase I Dose Escalation||6
10843011|NCT01434602|12008704|FG001|COMPLETED|Phase I Dose Escalation||6
10843012|NCT01434602|12008705|FG002|COMPLETED|Phase I Dose Escalation||0
10843013|NCT01434602|12008706|FG003|COMPLETED|Phase I Dose Escalation||0
10411753|NCT00768755|11555727|FG001|NOT COMPLETED|Phase 2||55
10411754|NCT00768755|11555728|FG002|NOT COMPLETED|Phase 2||58
10411755|NCT00768755|11555729|FG003|NOT COMPLETED|Phase 2||57
10411756|NCT00768898|11555738|FG000|STARTED|Overall Study||30
10411757|NCT00768898|11555738|FG000|COMPLETED|Overall Study||28
10411758|NCT00768898|11555738|FG000|NOT COMPLETED|Overall Study||2
10411759|NCT00768989|11555749|FG000|STARTED|Prior to Week 24||63
10411760|NCT00768989|11555750|FG001|STARTED|Prior to Week 24||30
10411761|NCT00768989|11555749|FG000|COMPLETED|Prior to Week 24||59
10411762|NCT00768989|11555750|FG001|COMPLETED|Prior to Week 24||27
10411763|NCT00768989|11555749|FG000|NOT COMPLETED|Prior to Week 24||4
10411764|NCT00768989|11555750|FG001|NOT COMPLETED|Prior to Week 24||3
10411765|NCT00768989|11555749|FG000|STARTED|Week 24 to Prior to Week 36||59
10411766|NCT00768989|11555750|FG001|STARTED|Week 24 to Prior to Week 36||27
10411767|NCT00768989|11555749|FG000|COMPLETED|Week 24 to Prior to Week 36||51
10411768|NCT00768989|11555750|FG001|COMPLETED|Week 24 to Prior to Week 36||27
10411769|NCT00768989|11555749|FG000|NOT COMPLETED|Week 24 to Prior to Week 36||8
10411770|NCT00768989|11555750|FG001|NOT COMPLETED|Week 24 to Prior to Week 36||0
10411771|NCT00768989|11555749|FG000|STARTED|On or After Week 36||51
10411772|NCT00768989|11555750|FG001|STARTED|On or After Week 36||27
10411773|NCT00768989|11555749|FG000|COMPLETED|On or After Week 36||0
10411774|NCT00768989|11555750|FG001|COMPLETED|On or After Week 36||0
10411775|NCT00768989|11555749|FG000|NOT COMPLETED|On or After Week 36||51
10411776|NCT00768989|11555750|FG001|NOT COMPLETED|On or After Week 36||27
10411777|NCT00769015|11555760|FG000|STARTED|Overall Study||96
10411778|NCT00769015|11555761|FG001|STARTED|Overall Study||92
10411779|NCT00769015|11555760|FG000|COMPLETED|Overall Study||87
10411780|NCT00769015|11555761|FG001|COMPLETED|Overall Study||76
10411781|NCT00769015|11555760|FG000|NOT COMPLETED|Overall Study||9
10411782|NCT00769015|11555761|FG001|NOT COMPLETED|Overall Study||16
10411783|NCT00769067|11555769|FG000|STARTED|Overall Study||94
10411784|NCT00769067|11555770|FG001|STARTED|Overall Study||94
10411785|NCT00769067|11555769|FG000|Treated|Overall Study||94
10411786|NCT00769067|11555770|FG001|Treated|Overall Study|One participant was not treated: refused treatment for reason other than an adverse event (AE).|93
10411787|NCT00769067|11555769|FG000|COMPLETED|Overall Study||0
10411788|NCT00769067|11555770|FG001|COMPLETED|Overall Study||0
10411789|NCT00769067|11555769|FG000|NOT COMPLETED|Overall Study||94
10411790|NCT00769067|11555770|FG001|NOT COMPLETED|Overall Study||94
10411791|NCT00769119|11555779|FG000|STARTED|Overall Study||22
10411792|NCT00769119|11555780|FG001|STARTED|Overall Study||16
10411793|NCT00769119|11555779|FG000|COMPLETED|Overall Study||20
10411794|NCT00769119|11555780|FG001|COMPLETED|Overall Study||13
10411795|NCT00769119|11555779|FG000|NOT COMPLETED|Overall Study||2
10411796|NCT00769119|11555780|FG001|NOT COMPLETED|Overall Study||3
10411797|NCT00769132|11555786|FG000|STARTED|Period 1||7
10411798|NCT00769132|11555787|FG001|STARTED|Period 1||6
10411799|NCT00769132|11555788|FG002|STARTED|Period 1||6
10411800|NCT00769132|11555789|FG003|STARTED|Period 1||7
10411801|NCT00769132|11555786|FG000|COMPLETED|Period 1||6
10411802|NCT00769132|11555787|FG001|COMPLETED|Period 1||6
10411803|NCT00769132|11555788|FG002|COMPLETED|Period 1||6
10411804|NCT00769132|11555789|FG003|COMPLETED|Period 1||6
10411805|NCT00769132|11555786|FG000|NOT COMPLETED|Period 1||1
10411806|NCT00769132|11555787|FG001|NOT COMPLETED|Period 1||0
10411807|NCT00769132|11555788|FG002|NOT COMPLETED|Period 1||0
10411808|NCT00769132|11555789|FG003|NOT COMPLETED|Period 1||1
10411809|NCT00769132|11555786|FG000|STARTED|Period 2||6
10411810|NCT00769132|11555787|FG001|STARTED|Period 2||6
10411811|NCT00769132|11555788|FG002|STARTED|Period 2||6
10411812|NCT00769132|11555789|FG003|STARTED|Period 2||6
10411813|NCT00769132|11555786|FG000|COMPLETED|Period 2||6
10411814|NCT00769132|11555787|FG001|COMPLETED|Period 2||6
10411815|NCT00769132|11555788|FG002|COMPLETED|Period 2||6
10411816|NCT00769132|11555789|FG003|COMPLETED|Period 2||5
10411817|NCT00769132|11555786|FG000|NOT COMPLETED|Period 2||0
10411818|NCT00769132|11555787|FG001|NOT COMPLETED|Period 2||0
10411819|NCT00769132|11555788|FG002|NOT COMPLETED|Period 2||0
10411820|NCT00769132|11555789|FG003|NOT COMPLETED|Period 2||1
10411821|NCT00769132|11555786|FG000|STARTED|Period 3||6
10411822|NCT00769132|11555787|FG001|STARTED|Period 3||6
10411823|NCT00769132|11555788|FG002|STARTED|Period 3||6
10843014|NCT01434602|12008707|FG004|COMPLETED|Phase I Dose Escalation||0
10411824|NCT00769132|11555789|FG003|STARTED|Period 3||5
10411825|NCT00769132|11555786|FG000|COMPLETED|Period 3||5
10411826|NCT00769132|11555787|FG001|COMPLETED|Period 3||6
10411827|NCT00769132|11555788|FG002|COMPLETED|Period 3||6
10411828|NCT00769132|11555789|FG003|COMPLETED|Period 3||5
10411829|NCT00769132|11555786|FG000|NOT COMPLETED|Period 3||1
10411830|NCT00769132|11555787|FG001|NOT COMPLETED|Period 3||0
10411831|NCT00769132|11555788|FG002|NOT COMPLETED|Period 3||0
10411832|NCT00769132|11555789|FG003|NOT COMPLETED|Period 3||0
10411833|NCT00769132|11555786|FG000|STARTED|Period 4||5
10411834|NCT00769132|11555787|FG001|STARTED|Period 4||6
10411835|NCT00769132|11555788|FG002|STARTED|Period 4||6
10411836|NCT00769132|11555789|FG003|STARTED|Period 4||5
10843015|NCT01434602|12008703|FG000|NOT COMPLETED|Phase I Dose Escalation||0
10843016|NCT01434602|12008704|FG001|NOT COMPLETED|Phase I Dose Escalation||1
10843017|NCT01434602|12008705|FG002|NOT COMPLETED|Phase I Dose Escalation||0
10843018|NCT01434602|12008706|FG003|NOT COMPLETED|Phase I Dose Escalation||0
10843019|NCT01434602|12008707|FG004|NOT COMPLETED|Phase I Dose Escalation||0
10843020|NCT01434602|12008703|FG000|STARTED|Phase II Recommended Phase 2 Dose||0
10843021|NCT01434602|12008704|FG001|STARTED|Phase II Recommended Phase 2 Dose||0
10843022|NCT01434602|12008705|FG002|STARTED|Phase II Recommended Phase 2 Dose||12
10843023|NCT01434602|12008706|FG003|STARTED|Phase II Recommended Phase 2 Dose||40
10545099|NCT01494506|11698351|FG000|Treated Population|Overall Study|Treated population: Patients who received at least 1 dose of study drug.|147
10545100|NCT01494506|11698352|FG001|Treated Population|Overall Study||134
10545101|NCT01494506|11698353|FG002|Treated Population|Overall Study|2 randomized Arm C patients did not receive study drug. 1 patient each in A and B received Arm C.|117
10545102|NCT01494506|11698351|FG000|COMPLETED|Overall Study|Completed = Subjects remaining on treatment at the time of the primary analysis data cut off.|3
10545103|NCT01494506|11698352|FG001|COMPLETED|Overall Study||6
10545104|NCT01494506|11698353|FG002|COMPLETED|Overall Study||14
10545105|NCT01494506|11698351|FG000|NOT COMPLETED|Overall Study||148
10545106|NCT01494506|11698352|FG001|NOT COMPLETED|Overall Study||143
10545107|NCT01494506|11698353|FG002|NOT COMPLETED|Overall Study||103
10545108|NCT01494532|11698369|FG000|STARTED|Overall Study||75
10843024|NCT01434602|12008707|FG004|STARTED|Phase II Recommended Phase 2 Dose||21
10843025|NCT01434602|12008703|FG000|COMPLETED|Phase II Recommended Phase 2 Dose||0
10843026|NCT01434602|12008704|FG001|COMPLETED|Phase II Recommended Phase 2 Dose||0
10843027|NCT01434602|12008705|FG002|COMPLETED|Phase II Recommended Phase 2 Dose||12
10843028|NCT01434602|12008706|FG003|COMPLETED|Phase II Recommended Phase 2 Dose||31
10843029|NCT01434602|12008707|FG004|COMPLETED|Phase II Recommended Phase 2 Dose||19
10843030|NCT01434602|12008703|FG000|NOT COMPLETED|Phase II Recommended Phase 2 Dose||0
10843031|NCT01434602|12008704|FG001|NOT COMPLETED|Phase II Recommended Phase 2 Dose||0
10843032|NCT01434602|12008705|FG002|NOT COMPLETED|Phase II Recommended Phase 2 Dose||0
10843033|NCT01434602|12008706|FG003|NOT COMPLETED|Phase II Recommended Phase 2 Dose||9
10843034|NCT01434602|12008707|FG004|NOT COMPLETED|Phase II Recommended Phase 2 Dose||2
10843035|NCT01358877|12008731|FG000|STARTED|Overall Study||2400
10843036|NCT01358877|12008732|FG001|STARTED|Overall Study||2404
10843037|NCT01358877|12008731|FG000|Did Not Receive Study Drug|Overall Study||22
10843038|NCT01358877|12008732|FG001|Did Not Receive Study Drug|Overall Study||13
10843039|NCT01358877|12008731|FG000|Received Study Drug (Safety Population)|Overall Study|24 placebo participants received at least 1 dose of pertuzumab and were included in pertuzumab arm.|2364
10843040|NCT01358877|12008732|FG001|Received Study Drug (Safety Population)|Overall Study|38 pertuzumab participants did not receive pertuzumab and were included in placebo arm.|2405
10843041|NCT01358877|12008731|FG000|COMPLETED|Overall Study||0
10843042|NCT01358877|12008732|FG001|COMPLETED|Overall Study||0
10843043|NCT01358877|12008731|FG000|NOT COMPLETED|Overall Study||2400
10843044|NCT01358877|12008732|FG001|NOT COMPLETED|Overall Study||2404
10292419|NCT03289143|11425217|FG000|NOT COMPLETED|Overall Study||134
10292420|NCT03289143|11425218|FG001|NOT COMPLETED|Overall Study||94
10292421|NCT03289143|11425219|FG002|NOT COMPLETED|Overall Study||134
10292422|NCT03289143|11425220|FG003|NOT COMPLETED|Overall Study||92
10411837|NCT00769132|11555786|FG000|COMPLETED|Period 4||5
10411838|NCT00769132|11555787|FG001|COMPLETED|Period 4||5
10411839|NCT00769132|11555788|FG002|COMPLETED|Period 4||6
10411840|NCT00769132|11555789|FG003|COMPLETED|Period 4||5
10411841|NCT00769132|11555786|FG000|NOT COMPLETED|Period 4||0
10411842|NCT00769132|11555787|FG001|NOT COMPLETED|Period 4||1
10411843|NCT00769132|11555788|FG002|NOT COMPLETED|Period 4||0
10411844|NCT00769132|11555789|FG003|NOT COMPLETED|Period 4||0
10411845|NCT00769184|11555799|FG000|STARTED|Corticosteroid + LCD/ +Placebo (2 Weeks)||7
10411846|NCT00769184|11555800|FG001|STARTED|Corticosteroid + LCD/ +Placebo (2 Weeks)||8
10411847|NCT00769184|11555799|FG000|COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||6
10411848|NCT00769184|11555800|FG001|COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||7
10411849|NCT00769184|11555799|FG000|NOT COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||1
10411850|NCT00769184|11555800|FG001|NOT COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||1
10411851|NCT00769184|11555799|FG000|STARTED|+LCD / +Placebo Only (4 Weeks)||6
10411852|NCT00769184|11555800|FG001|STARTED|+LCD / +Placebo Only (4 Weeks)||7
10411853|NCT00769184|11555799|FG000|COMPLETED|+LCD / +Placebo Only (4 Weeks)||6
10545109|NCT01494532|11698370|FG001|STARTED|Overall Study||25
10843045|NCT01239797|12008740|FG000|STARTED|Randomized Participants||321
10843046|NCT01239797|12008741|FG001|STARTED|Randomized Participants||325
10843047|NCT01239797|12008740|FG000|COMPLETED|Randomized Participants||319
10292423|NCT03156504|11425235|FG000|STARTED|Overall Study||75
10292424|NCT03156504|11425235|FG000|COMPLETED|Overall Study||74
10292425|NCT03156504|11425235|FG000|NOT COMPLETED|Overall Study||1
10314464|NCT00162266|11448049|FG000|COMPLETED|Open-Label Period||0
10314465|NCT00162266|11448050|FG001|COMPLETED|Open-Label Period||0
10314466|NCT00162266|11448051|FG002|COMPLETED|Open-Label Period||0
10314467|NCT00162266|11448052|FG003|COMPLETED|Open-Label Period||82
10314468|NCT00162266|11448049|FG000|NOT COMPLETED|Open-Label Period||0
10314469|NCT00162266|11448050|FG001|NOT COMPLETED|Open-Label Period||0
10314470|NCT00162266|11448051|FG002|NOT COMPLETED|Open-Label Period||0
10314471|NCT00162266|11448052|FG003|NOT COMPLETED|Open-Label Period||137
10314472|NCT00162981|11448106|FG000|STARTED|Overall Study||32
10314473|NCT00162981|11448107|FG001|STARTED|Overall Study||36
10314474|NCT00162981|11448106|FG000|COMPLETED|Overall Study||28
10843048|NCT01239797|12008741|FG001|COMPLETED|Randomized Participants||316
10843049|NCT01239797|12008740|FG000|NOT COMPLETED|Randomized Participants||2
10843050|NCT01239797|12008741|FG001|NOT COMPLETED|Randomized Participants||9
10843051|NCT01239797|12008740|FG000|STARTED|Treated Participants|1 participant was randomized to treatment E-Ld but received treatment Ld|318
10843052|NCT01239797|12008741|FG001|STARTED|Treated Participants|1 participant was randomized to treatment E-Ld but received treatment Ld|317
10843053|NCT01239797|12008740|FG000|COMPLETED|Treated Participants||0
10843054|NCT01239797|12008741|FG001|COMPLETED|Treated Participants||0
10843055|NCT01239797|12008740|FG000|NOT COMPLETED|Treated Participants||318
10843056|NCT01239797|12008741|FG001|NOT COMPLETED|Treated Participants||317
10843057|NCT01236521|12008749|FG000|STARTED|Overall Study||131
10843058|NCT01236521|12008750|FG001|STARTED|Overall Study||130
10843059|NCT01236521|12008749|FG000|3-month Completed|Overall Study||122
10843060|NCT01236521|12008750|FG001|3-month Completed|Overall Study||118
10843061|NCT01236521|12008749|FG000|6-month Completed|Overall Study||121
10843062|NCT01236521|12008750|FG001|6-month Completed|Overall Study||114
10843063|NCT01236521|12008749|FG000|9-month Completed|Overall Study||105
10843064|NCT01236521|12008750|FG001|9-month Completed|Overall Study||98
10843065|NCT01236521|12008749|FG000|12-moth Completed|Overall Study||108
10843066|NCT01236521|12008750|FG001|12-moth Completed|Overall Study||105
10843067|NCT01236521|12008749|FG000|COMPLETED|Overall Study||108
10843068|NCT01236521|12008750|FG001|COMPLETED|Overall Study||105
10843069|NCT01236521|12008749|FG000|NOT COMPLETED|Overall Study||23
10843070|NCT01236521|12008750|FG001|NOT COMPLETED|Overall Study||25
10843071|NCT01103349|12008759|FG000|STARTED|Overall Study||95
10843072|NCT01103349|12008760|FG001|STARTED|Overall Study||81
10843073|NCT01103349|12008761|FG002|STARTED|Overall Study||67
10843074|NCT01103349|12008759|FG000|COMPLETED|Overall Study||84
10843075|NCT01103349|12008760|FG001|COMPLETED|Overall Study||74
10843076|NCT01103349|12008761|FG002|COMPLETED|Overall Study||63
10843077|NCT01103349|12008759|FG000|NOT COMPLETED|Overall Study||11
10843078|NCT01103349|12008760|FG001|NOT COMPLETED|Overall Study||7
10843079|NCT01103349|12008761|FG002|NOT COMPLETED|Overall Study||4
10843080|NCT01092143|12008774|FG000|STARTED|Overall Study||78
10843081|NCT01092143|12008775|FG001|STARTED|Overall Study||77
10843082|NCT01092143|12008776|FG002|STARTED|Overall Study||84
10843083|NCT01092143|12008777|FG003|STARTED|Overall Study||79
10843084|NCT01092143|12008778|FG004|STARTED|Overall Study||71
10843085|NCT01092143|12008774|FG000|Treated|Overall Study||78
10843086|NCT01092143|12008775|FG001|Treated|Overall Study||77
10843087|NCT01092143|12008776|FG002|Treated|Overall Study||83
10843088|NCT01092143|12008777|FG003|Treated|Overall Study||79
10843089|NCT01092143|12008778|FG004|Treated|Overall Study||71
10843090|NCT01092143|12008774|FG000|COMPLETED|Overall Study||63
10843091|NCT01092143|12008775|FG001|COMPLETED|Overall Study||70
10843092|NCT01092143|12008776|FG002|COMPLETED|Overall Study||80
10843093|NCT01092143|12008777|FG003|COMPLETED|Overall Study||72
10843094|NCT01092143|12008778|FG004|COMPLETED|Overall Study||63
10843095|NCT01092143|12008774|FG000|NOT COMPLETED|Overall Study||15
10843096|NCT01092143|12008775|FG001|NOT COMPLETED|Overall Study||7
10843097|NCT01092143|12008776|FG002|NOT COMPLETED|Overall Study||4
10843098|NCT01092143|12008777|FG003|NOT COMPLETED|Overall Study||7
10843099|NCT01092143|12008778|FG004|NOT COMPLETED|Overall Study||8
10843100|NCT01004029|12008792|FG000|STARTED|Overall Study||578
10843101|NCT01004029|12008793|FG001|STARTED|Overall Study||1130
10843102|NCT01004029|12008792|FG000|Safety Population|Overall Study||578
10843103|NCT01004029|12008793|FG001|Safety Population|Overall Study||1128
10843104|NCT01004029|12008792|FG000|COMPLETED|Overall Study||530
10843105|NCT01004029|12008793|FG001|COMPLETED|Overall Study||1057
10843106|NCT01004029|12008792|FG000|NOT COMPLETED|Overall Study||48
10843107|NCT01004029|12008793|FG001|NOT COMPLETED|Overall Study||73
10843108|NCT00640133|12008802|FG000|STARTED|Randomization Phase (Baseline-Month 3)||15
10843109|NCT00640133|12008803|FG001|STARTED|Randomization Phase (Baseline-Month 3)||12
10411854|NCT00769184|11555800|FG001|COMPLETED|+LCD / +Placebo Only (4 Weeks)||7
10411855|NCT00769184|11555799|FG000|NOT COMPLETED|+LCD / +Placebo Only (4 Weeks)||0
10411856|NCT00769184|11555800|FG001|NOT COMPLETED|+LCD / +Placebo Only (4 Weeks)||0
10411857|NCT00769184|11555799|FG000|STARTED|No Treatment (6 Weeks)||6
10411858|NCT00769184|11555800|FG001|STARTED|No Treatment (6 Weeks)||7
10411859|NCT00769184|11555799|FG000|COMPLETED|No Treatment (6 Weeks)||5
10411860|NCT00769184|11555800|FG001|COMPLETED|No Treatment (6 Weeks)||6
10411861|NCT00769184|11555799|FG000|NOT COMPLETED|No Treatment (6 Weeks)||1
10411862|NCT00769184|11555800|FG001|NOT COMPLETED|No Treatment (6 Weeks)||1
10411863|NCT00769314|11555810|FG000|STARTED|Overall Study|The number of participants started is defined as those that were randomized and received treatment.|378
10411864|NCT00769314|11555811|FG001|STARTED|Overall Study|The number of participants started is defined as those that were randomized and received treatment.|397
10411865|NCT00769314|11555810|FG000|COMPLETED|Overall Study||361
10411866|NCT00769314|11555811|FG001|COMPLETED|Overall Study||384
10411867|NCT00769314|11555810|FG000|NOT COMPLETED|Overall Study||17
10843110|NCT00640133|12008802|FG000|COMPLETED|Randomization Phase (Baseline-Month 3)||15
10843111|NCT00640133|12008803|FG001|COMPLETED|Randomization Phase (Baseline-Month 3)||12
10843112|NCT00640133|12008802|FG000|NOT COMPLETED|Randomization Phase (Baseline-Month 3)||0
10843113|NCT00640133|12008803|FG001|NOT COMPLETED|Randomization Phase (Baseline-Month 3)||0
10843114|NCT00640133|12008802|FG000|STARTED|Open Label Phase (Month 4-12)||27
10843115|NCT00640133|12008803|FG001|STARTED|Open Label Phase (Month 4-12)||0
10843116|NCT00640133|12008802|FG000|COMPLETED|Open Label Phase (Month 4-12)||24
10843117|NCT00640133|12008803|FG001|COMPLETED|Open Label Phase (Month 4-12)||0
10843118|NCT00640133|12008802|FG000|NOT COMPLETED|Open Label Phase (Month 4-12)||3
10843119|NCT00640133|12008803|FG001|NOT COMPLETED|Open Label Phase (Month 4-12)||0
10843120|NCT00593567|12008813|FG000|STARTED|Overall Study||48
10843121|NCT00593567|12008814|FG001|STARTED|Overall Study||22
10843122|NCT00593567|12008813|FG000|COMPLETED|Overall Study||28
10843123|NCT00593567|12008814|FG001|COMPLETED|Overall Study||12
10843124|NCT00593567|12008813|FG000|NOT COMPLETED|Overall Study||20
10843125|NCT00593567|12008814|FG001|NOT COMPLETED|Overall Study||10
10843136|NCT02983617|12008831|FG000|STARTED|Overall Study||6
10843137|NCT02983617|12008832|FG001|STARTED|Overall Study||30
10843138|NCT02983617|12008831|FG000|COMPLETED|Overall Study||6
10843139|NCT02983617|12008832|FG001|COMPLETED|Overall Study||21
10843140|NCT02983617|12008831|FG000|NOT COMPLETED|Overall Study||0
10843141|NCT02983617|12008832|FG001|NOT COMPLETED|Overall Study||9
10843142|NCT02964377|12008841|FG000|STARTED|Overall Study||5
10843143|NCT02964377|12008842|FG001|STARTED|Overall Study||5
10843144|NCT02964377|12008843|FG002|STARTED|Overall Study||5
10843145|NCT02964377|12008841|FG000|COMPLETED|Overall Study||5
10843146|NCT02964377|12008842|FG001|COMPLETED|Overall Study||5
10843147|NCT02964377|12008843|FG002|COMPLETED|Overall Study||5
10843148|NCT02964377|12008841|FG000|NOT COMPLETED|Overall Study||0
10843149|NCT02964377|12008842|FG001|NOT COMPLETED|Overall Study||0
10843150|NCT02964377|12008843|FG002|NOT COMPLETED|Overall Study||0
10843151|NCT02790034|12008854|FG000|STARTED|Overall Study||33
10843152|NCT02790034|12008855|FG001|STARTED|Overall Study||56
10843153|NCT02790034|12008856|FG002|STARTED|Overall Study||40
10843154|NCT02790034|12008854|FG000|COMPLETED|Overall Study||27
10843155|NCT02790034|12008855|FG001|COMPLETED|Overall Study||46
10843156|NCT02790034|12008856|FG002|COMPLETED|Overall Study||36
10843157|NCT02790034|12008854|FG000|NOT COMPLETED|Overall Study||6
10843158|NCT02790034|12008855|FG001|NOT COMPLETED|Overall Study||10
10843159|NCT02790034|12008856|FG002|NOT COMPLETED|Overall Study||4
10843160|NCT02649946|12008866|FG000|STARTED|Overall Study||142
10843161|NCT02649946|12008867|FG001|STARTED|Overall Study||138
10843162|NCT02649946|12008866|FG000|COMPLETED|Overall Study||130
10843163|NCT02649946|12008867|FG001|COMPLETED|Overall Study||123
10843164|NCT02649946|12008866|FG000|NOT COMPLETED|Overall Study||12
10843165|NCT02649946|12008867|FG001|NOT COMPLETED|Overall Study||15
10843184|NCT02345850|12008892|FG000|STARTED|Overall Study||114
10843185|NCT02345850|12008893|FG001|STARTED|Overall Study||114
10843186|NCT02345850|12008894|FG002|STARTED|Overall Study||118
10843187|NCT02345850|12008892|FG000|COMPLETED|Overall Study||101
10843188|NCT02345850|12008893|FG001|COMPLETED|Overall Study||106
10843189|NCT02345850|12008894|FG002|COMPLETED|Overall Study||112
10843190|NCT02345850|12008892|FG000|NOT COMPLETED|Overall Study||13
10843191|NCT02345850|12008893|FG001|NOT COMPLETED|Overall Study||8
10843192|NCT02345850|12008894|FG002|NOT COMPLETED|Overall Study||6
10843193|NCT02343302|12008904|FG000|STARTED|Overall Study||1
10843194|NCT02343302|12008905|FG001|STARTED|Overall Study||1
10843195|NCT02343302|12008904|FG000|COMPLETED|Overall Study||0
10843196|NCT02343302|12008905|FG001|COMPLETED|Overall Study||0
10843197|NCT02343302|12008904|FG000|NOT COMPLETED|Overall Study||1
10843198|NCT02343302|12008905|FG001|NOT COMPLETED|Overall Study||1
10843199|NCT02053584|12008911|FG000|STARTED|Overall Study||230
10843200|NCT02053584|12008911|FG000|COMPLETED|Overall Study|68 subjects (day one participants) were excluded from the final analysis.|230
10843201|NCT02053584|12008911|FG000|NOT COMPLETED|Overall Study||0
10843202|NCT01962792|12008922|FG000|STARTED|Overall Study||3
10843203|NCT01962792|12008923|FG001|STARTED|Overall Study||5
10843204|NCT01962792|12008924|FG002|STARTED|Overall Study||17
10843205|NCT01962792|12008925|FG003|STARTED|Overall Study||59
10843206|NCT01962792|12008922|FG000|COMPLETED|Overall Study||3
10843207|NCT01962792|12008923|FG001|COMPLETED|Overall Study||5
10843208|NCT01962792|12008924|FG002|COMPLETED|Overall Study||17
10843209|NCT01962792|12008925|FG003|COMPLETED|Overall Study||59
10843210|NCT01962792|12008922|FG000|NOT COMPLETED|Overall Study||0
10843211|NCT01962792|12008923|FG001|NOT COMPLETED|Overall Study||0
10843212|NCT01962792|12008924|FG002|NOT COMPLETED|Overall Study||0
10843213|NCT01962792|12008925|FG003|NOT COMPLETED|Overall Study||0
10843214|NCT01878500|12008936|FG000|STARTED|Overall Study||47
10843215|NCT01878500|12008936|FG000|COMPLETED|Overall Study||47
10843216|NCT01878500|12008936|FG000|NOT COMPLETED|Overall Study||0
10843217|NCT01464164|12008947|FG000|STARTED|Overall Study||3
10843218|NCT01464164|12008948|FG001|STARTED|Overall Study||4
10843219|NCT01464164|12008949|FG002|STARTED|Overall Study||4
10843220|NCT01464164|12008950|FG003|STARTED|Overall Study||2
10843221|NCT01464164|12008951|FG004|STARTED|Overall Study||3
10843222|NCT01464164|12008952|FG005|STARTED|Overall Study||0
10843223|NCT01464164|12008953|FG006|STARTED|Overall Study||3
10843224|NCT01464164|12008947|FG000|COMPLETED|Overall Study||3
10843225|NCT01464164|12008948|FG001|COMPLETED|Overall Study||3
10843226|NCT01464164|12008949|FG002|COMPLETED|Overall Study||2
10843227|NCT01464164|12008950|FG003|COMPLETED|Overall Study||2
10843228|NCT01464164|12008951|FG004|COMPLETED|Overall Study||3
10843229|NCT01464164|12008952|FG005|COMPLETED|Overall Study||0
10843230|NCT01464164|12008953|FG006|COMPLETED|Overall Study||1
10843231|NCT01464164|12008947|FG000|NOT COMPLETED|Overall Study||0
10843232|NCT01464164|12008948|FG001|NOT COMPLETED|Overall Study||1
10843233|NCT01464164|12008949|FG002|NOT COMPLETED|Overall Study||2
10843234|NCT01464164|12008950|FG003|NOT COMPLETED|Overall Study||0
10843235|NCT01464164|12008951|FG004|NOT COMPLETED|Overall Study||0
10843236|NCT01464164|12008952|FG005|NOT COMPLETED|Overall Study||0
10843237|NCT01464164|12008953|FG006|NOT COMPLETED|Overall Study||2
10843247|NCT01111565|12008983|FG000|STARTED|Phase B (Weeks 0 to 8)||137
10843248|NCT01111565|12008984|FG001|STARTED|Phase B (Weeks 0 to 8)||0
10843249|NCT01111565|12008985|FG002|STARTED|Phase B (Weeks 0 to 8)||0
10843250|NCT01111565|12008986|FG003|STARTED|Phase B (Weeks 0 to 8)||0
10843251|NCT01111565|12008987|FG004|STARTED|Phase B (Weeks 0 to 8)||0
10843252|NCT01111565|12008983|FG000|COMPLETED|Phase B (Weeks 0 to 8)||71
10843253|NCT01111565|12008984|FG001|COMPLETED|Phase B (Weeks 0 to 8)||0
10843254|NCT01111565|12008985|FG002|COMPLETED|Phase B (Weeks 0 to 8)||0
10843255|NCT01111565|12008986|FG003|COMPLETED|Phase B (Weeks 0 to 8)||0
10843256|NCT01111565|12008987|FG004|COMPLETED|Phase B (Weeks 0 to 8)||0
10843257|NCT01111565|12008983|FG000|NOT COMPLETED|Phase B (Weeks 0 to 8)||66
10843258|NCT01111565|12008984|FG001|NOT COMPLETED|Phase B (Weeks 0 to 8)||0
10843259|NCT01111565|12008985|FG002|NOT COMPLETED|Phase B (Weeks 0 to 8)||0
10843260|NCT01111565|12008986|FG003|NOT COMPLETED|Phase B (Weeks 0 to 8)||0
10843261|NCT01111565|12008987|FG004|NOT COMPLETED|Phase B (Weeks 0 to 8)||0
10843262|NCT01111565|12008983|FG000|STARTED|Phase B + and Phase C (Weeks 9 to 14)||0
10843263|NCT01111565|12008984|FG001|STARTED|Phase B + and Phase C (Weeks 9 to 14)||26
10843264|NCT01111565|12008985|FG002|STARTED|Phase B + and Phase C (Weeks 9 to 14)||16
10843265|NCT01111565|12008986|FG003|STARTED|Phase B + and Phase C (Weeks 9 to 14)||14
10843266|NCT01111565|12008987|FG004|STARTED|Phase B + and Phase C (Weeks 9 to 14)||15
10843267|NCT01111565|12008983|FG000|COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||0
10843268|NCT01111565|12008984|FG001|COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||19
10843269|NCT01111565|12008985|FG002|COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||11
10843270|NCT01111565|12008986|FG003|COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||10
10843271|NCT01111565|12008987|FG004|COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||11
10843272|NCT01111565|12008983|FG000|NOT COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||0
10843273|NCT01111565|12008984|FG001|NOT COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||7
10843274|NCT01111565|12008985|FG002|NOT COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||5
10843275|NCT01111565|12008986|FG003|NOT COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||4
10843276|NCT01111565|12008987|FG004|NOT COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||4
10843277|NCT01092117|12008997|FG000|STARTED|Index Procedure to 1 Month||161
10843278|NCT01092117|12008997|FG000|COMPLETED|Index Procedure to 1 Month||160
10843279|NCT01092117|12008997|FG000|NOT COMPLETED|Index Procedure to 1 Month||1
10843280|NCT01092117|12008997|FG000|STARTED|1 Month||160
10843281|NCT01092117|12008997|FG000|COMPLETED|1 Month||157
10843282|NCT01092117|12008997|FG000|NOT COMPLETED|1 Month||3
10843283|NCT01092117|12008997|FG000|STARTED|6 Months||157
10843284|NCT01092117|12008997|FG000|COMPLETED|6 Months||152
10843285|NCT01092117|12008997|FG000|NOT COMPLETED|6 Months||5
10843286|NCT01092117|12008997|FG000|STARTED|12 Month||152
10843287|NCT01092117|12008997|FG000|COMPLETED|12 Month||138
10843288|NCT01092117|12008997|FG000|NOT COMPLETED|12 Month||14
10843289|NCT01092117|12008997|FG000|STARTED|Year 2||138
10843290|NCT01092117|12008997|FG000|COMPLETED|Year 2||128
10843291|NCT01092117|12008997|FG000|NOT COMPLETED|Year 2||10
10843292|NCT01092117|12008997|FG000|STARTED|Year 3||128
10843293|NCT01092117|12008997|FG000|COMPLETED|Year 3||109
10843294|NCT01092117|12008997|FG000|NOT COMPLETED|Year 3||19
10843295|NCT01092117|12008997|FG000|STARTED|Year 4||109
10843296|NCT01092117|12008997|FG000|COMPLETED|Year 4||93
10843297|NCT01092117|12008997|FG000|NOT COMPLETED|Year 4||16
10843298|NCT00950989|12009005|FG000|STARTED|Overall Study||63
10843299|NCT00950989|12009006|FG001|STARTED|Overall Study||63
10843300|NCT00950989|12009007|FG002|STARTED|Overall Study||63
10843301|NCT00950989|12009008|FG003|STARTED|Overall Study||63
10843302|NCT00950989|12009005|FG000|COMPLETED|Overall Study||59
10843303|NCT00950989|12009006|FG001|COMPLETED|Overall Study||60
10843304|NCT00950989|12009007|FG002|COMPLETED|Overall Study||60
10843305|NCT00950989|12009008|FG003|COMPLETED|Overall Study||63
10843306|NCT00950989|12009005|FG000|NOT COMPLETED|Overall Study||4
10843307|NCT00950989|12009006|FG001|NOT COMPLETED|Overall Study||3
10843308|NCT00950989|12009007|FG002|NOT COMPLETED|Overall Study||3
10843309|NCT00950989|12009008|FG003|NOT COMPLETED|Overall Study||0
10843310|NCT00489307|12009023|FG000|STARTED|Overall Study||67
10843311|NCT00489307|12009024|FG001|STARTED|Overall Study||65
10843312|NCT00489307|12009023|FG000|COMPLETED|Overall Study||43
10843313|NCT00489307|12009024|FG001|COMPLETED|Overall Study||41
10843314|NCT00489307|12009023|FG000|NOT COMPLETED|Overall Study||24
10843315|NCT00489307|12009024|FG001|NOT COMPLETED|Overall Study||24
10843316|NCT00072410|12009032|FG000|STARTED|Overall Study||3
10843317|NCT00072410|12009033|FG001|STARTED|Overall Study||4
10843318|NCT00072410|12009032|FG000|COMPLETED|Overall Study||3
10843319|NCT00072410|12009033|FG001|COMPLETED|Overall Study||1
10843320|NCT00072410|12009032|FG000|NOT COMPLETED|Overall Study||0
10843321|NCT00072410|12009033|FG001|NOT COMPLETED|Overall Study||3
10843322|NCT05057923|12009039|FG000|STARTED|Overall Study||6
10843323|NCT05057923|12009039|FG000|COMPLETED|Overall Study||6
10843324|NCT05057923|12009039|FG000|NOT COMPLETED|Overall Study||0
10843325|NCT04632706|12009047|FG000|STARTED|Overall Study||6
10843326|NCT04632706|12009048|FG001|STARTED|Overall Study||6
10843327|NCT04632706|12009049|FG002|STARTED|Overall Study||6
10843328|NCT04632706|12009050|FG003|STARTED|Overall Study||6
10843329|NCT04632706|12009047|FG000|COMPLETED|Overall Study||6
10843330|NCT04632706|12009048|FG001|COMPLETED|Overall Study||6
10843331|NCT04632706|12009049|FG002|COMPLETED|Overall Study||5
10843332|NCT04632706|12009050|FG003|COMPLETED|Overall Study||6
10843333|NCT04632706|12009047|FG000|NOT COMPLETED|Overall Study||0
10843334|NCT04632706|12009048|FG001|NOT COMPLETED|Overall Study||0
10843335|NCT04632706|12009049|FG002|NOT COMPLETED|Overall Study||1
10843336|NCT04632706|12009050|FG003|NOT COMPLETED|Overall Study||0
10843337|NCT04544358|12009064|FG000|STARTED|Overall Study||12
10843338|NCT04544358|12009065|FG001|STARTED|Overall Study||10
10843339|NCT04544358|12009064|FG000|COMPLETED|Overall Study||12
10843340|NCT04544358|12009065|FG001|COMPLETED|Overall Study||10
10843341|NCT04544358|12009064|FG000|NOT COMPLETED|Overall Study||0
10843342|NCT04544358|12009065|FG001|NOT COMPLETED|Overall Study||0
10843343|NCT04498247|12009080|FG000|STARTED|Overall Study||21
10843344|NCT04498247|12009081|FG001|STARTED|Overall Study||80
10843345|NCT04498247|12009082|FG002|STARTED|Overall Study||4
10843346|NCT04498247|12009083|FG003|STARTED|Overall Study||81
10843347|NCT04498247|12009084|FG004|STARTED|Overall Study||4
10843348|NCT04498247|12009085|FG005|STARTED|Overall Study||20
10843349|NCT04498247|12009086|FG006|STARTED|Overall Study||51
10843350|NCT04498247|12009087|FG007|STARTED|Overall Study||2
10843351|NCT04498247|12009080|FG000|Vaccination 1|Overall Study||20
10843352|NCT04498247|12009081|FG001|Vaccination 1|Overall Study||80
10843353|NCT04498247|12009082|FG002|Vaccination 1|Overall Study||4
10843354|NCT04498247|12009083|FG003|Vaccination 1|Overall Study||81
10843355|NCT04498247|12009084|FG004|Vaccination 1|Overall Study||4
10843356|NCT04498247|12009085|FG005|Vaccination 1|Overall Study||20
10843357|NCT04498247|12009086|FG006|Vaccination 1|Overall Study||51
10843358|NCT04498247|12009087|FG007|Vaccination 1|Overall Study||2
10843359|NCT04498247|12009080|FG000|Vaccination 2|Overall Study||0
10843360|NCT04498247|12009081|FG001|Vaccination 2|Overall Study||0
10843361|NCT04498247|12009082|FG002|Vaccination 2|Overall Study||4
10843362|NCT04498247|12009083|FG003|Vaccination 2|Overall Study||0
10843363|NCT04498247|12009084|FG004|Vaccination 2|Overall Study||4
10843364|NCT04498247|12009085|FG005|Vaccination 2|Overall Study||0
10843365|NCT04498247|12009086|FG006|Vaccination 2|Overall Study||0
10843366|NCT04498247|12009087|FG007|Vaccination 2|Overall Study||2
10843367|NCT04498247|12009080|FG000|COMPLETED|Overall Study||20
10843368|NCT04498247|12009081|FG001|COMPLETED|Overall Study||68
10843369|NCT04498247|12009082|FG002|COMPLETED|Overall Study||4
10843370|NCT04498247|12009083|FG003|COMPLETED|Overall Study||70
10843371|NCT04498247|12009084|FG004|COMPLETED|Overall Study||4
10843372|NCT04498247|12009085|FG005|COMPLETED|Overall Study||20
10843373|NCT04498247|12009086|FG006|COMPLETED|Overall Study||43
10843374|NCT04498247|12009087|FG007|COMPLETED|Overall Study||2
10843375|NCT04498247|12009080|FG000|NOT COMPLETED|Overall Study||1
10843376|NCT04498247|12009081|FG001|NOT COMPLETED|Overall Study||12
10843377|NCT04498247|12009082|FG002|NOT COMPLETED|Overall Study||0
10843378|NCT04498247|12009083|FG003|NOT COMPLETED|Overall Study||11
10843379|NCT04498247|12009084|FG004|NOT COMPLETED|Overall Study||0
10843380|NCT04498247|12009085|FG005|NOT COMPLETED|Overall Study||0
10843381|NCT04498247|12009086|FG006|NOT COMPLETED|Overall Study||8
10843382|NCT04498247|12009087|FG007|NOT COMPLETED|Overall Study||0
10843383|NCT04472650|12009104|FG000|STARTED|Period 1 (Up to 15 Days)||13
10843384|NCT04472650|12009105|FG001|STARTED|Period 1 (Up to 15 Days)||13
10843385|NCT04472650|12009104|FG000|COMPLETED|Period 1 (Up to 15 Days)||13
10843386|NCT04472650|12009105|FG001|COMPLETED|Period 1 (Up to 15 Days)||13
10843387|NCT04472650|12009104|FG000|NOT COMPLETED|Period 1 (Up to 15 Days)||0
10843388|NCT04472650|12009105|FG001|NOT COMPLETED|Period 1 (Up to 15 Days)||0
10843389|NCT04472650|12009104|FG000|STARTED|Washout Period (Minimum 14 Days)||13
10843390|NCT04472650|12009105|FG001|STARTED|Washout Period (Minimum 14 Days)||13
10843391|NCT04472650|12009104|FG000|COMPLETED|Washout Period (Minimum 14 Days)||12
10843392|NCT04472650|12009105|FG001|COMPLETED|Washout Period (Minimum 14 Days)||13
10843393|NCT04472650|12009104|FG000|NOT COMPLETED|Washout Period (Minimum 14 Days)||1
10843394|NCT04472650|12009105|FG001|NOT COMPLETED|Washout Period (Minimum 14 Days)||0
10843395|NCT04472650|12009104|FG000|STARTED|Period 2 (Up to 15 Days)||12
10843396|NCT04472650|12009105|FG001|STARTED|Period 2 (Up to 15 Days)||13
10843397|NCT04472650|12009104|FG000|COMPLETED|Period 2 (Up to 15 Days)||12
10843398|NCT04472650|12009105|FG001|COMPLETED|Period 2 (Up to 15 Days)||13
10843399|NCT04472650|12009104|FG000|NOT COMPLETED|Period 2 (Up to 15 Days)||0
10843400|NCT04472650|12009105|FG001|NOT COMPLETED|Period 2 (Up to 15 Days)||0
10843401|NCT04359797|12009115|FG000|STARTED|Overall Study||243
10843402|NCT04359797|12009116|FG001|STARTED|Overall Study||258
10843403|NCT04359797|12009115|FG000|COMPLETED|Overall Study||243
10843404|NCT04359797|12009116|FG001|COMPLETED|Overall Study||258
10843405|NCT04359797|12009115|FG000|NOT COMPLETED|Overall Study||0
10843406|NCT04359797|12009116|FG001|NOT COMPLETED|Overall Study||0
10843407|NCT04151290|12009122|FG000|STARTED|Overall Study||711
10843408|NCT04151290|12009122|FG000|COMPLETED|Overall Study||425
10843409|NCT04151290|12009122|FG000|NOT COMPLETED|Overall Study||286
10843410|NCT04038385|12009128|FG000|STARTED|Overall Study||160
10843411|NCT04038385|12009129|FG001|STARTED|Overall Study||137
10843412|NCT04038385|12009128|FG000|COMPLETED|Overall Study||143
10843413|NCT04038385|12009129|FG001|COMPLETED|Overall Study||130
10843414|NCT04038385|12009128|FG000|NOT COMPLETED|Overall Study||17
10843415|NCT04038385|12009129|FG001|NOT COMPLETED|Overall Study||7
10545110|NCT01494532|11698371|FG002|STARTED|Overall Study||76
10545111|NCT01494532|11698372|FG003|STARTED|Overall Study||75
10545112|NCT01494532|11698373|FG004|STARTED|Overall Study||76
10545113|NCT01494532|11698374|FG005|STARTED|Overall Study||25
10545114|NCT01494532|11698369|FG000|COMPLETED|Overall Study||65
10545115|NCT01494532|11698370|FG001|COMPLETED|Overall Study||21
10545116|NCT01494532|11698371|FG002|COMPLETED|Overall Study||59
10843416|NCT03923738|12009135|FG000|STARTED|Period 1||24
10843417|NCT03923738|12009135|FG000|COMPLETED|Period 1||22
10843418|NCT03923738|12009135|FG000|NOT COMPLETED|Period 1||2
10843419|NCT03923738|12009135|FG000|STARTED|Period 2||22
10843420|NCT03923738|12009135|FG000|COMPLETED|Period 2||22
10843421|NCT03923738|12009135|FG000|NOT COMPLETED|Period 2||0
10843422|NCT03887117|12009145|FG000|STARTED|Overall Study||25
10843423|NCT03887117|12009146|FG001|STARTED|Overall Study||15
10843424|NCT03887117|12009147|FG002|STARTED|Overall Study||26
10843425|NCT03887117|12009148|FG003|STARTED|Overall Study||27
10843426|NCT03887117|12009145|FG000|COMPLETED|Overall Study||25
10843427|NCT03887117|12009146|FG001|COMPLETED|Overall Study||14
10843428|NCT03887117|12009147|FG002|COMPLETED|Overall Study||25
10843429|NCT03887117|12009148|FG003|COMPLETED|Overall Study||25
10843430|NCT03887117|12009145|FG000|NOT COMPLETED|Overall Study||0
10843431|NCT03887117|12009146|FG001|NOT COMPLETED|Overall Study||1
10843432|NCT03887117|12009147|FG002|NOT COMPLETED|Overall Study||1
10843433|NCT03887117|12009148|FG003|NOT COMPLETED|Overall Study||2
10843434|NCT03858634|12009169|FG000|STARTED|Overall Study||39
10843435|NCT03858634|12009170|FG001|STARTED|Overall Study||19
10843436|NCT03858634|12009169|FG000|Participants With Chronic Idiopathic Urticaria (CIU)|Overall Study||4
10843437|NCT03858634|12009170|FG001|Participants With Chronic Idiopathic Urticaria (CIU)|Overall Study||2
10843438|NCT03858634|12009169|FG000|Participants With Chronic Idiopathic Pruritus (CIP)|Overall Study||14
10843439|NCT03858634|12009170|FG001|Participants With Chronic Idiopathic Pruritus (CIP)|Overall Study||9
10843440|NCT03858634|12009169|FG000|Participants With Lichen Planus (LP)|Overall Study||3
10843441|NCT03858634|12009170|FG001|Participants With Lichen Planus (LP)|Overall Study||0
10843442|NCT03858634|12009169|FG000|Participants With Lichen Simplex Chronicus (LSC)|Overall Study||4
10843443|NCT03858634|12009170|FG001|Participants With Lichen Simplex Chronicus (LSC)|Overall Study||1
10843444|NCT03858634|12009169|FG000|Participants With Plaque Psoriasis (PPs)|Overall Study||14
10843445|NCT03858634|12009170|FG001|Participants With Plaque Psoriasis (PPs)|Overall Study||7
10843446|NCT03858634|12009169|FG000|COMPLETED|Overall Study||36
10843447|NCT03858634|12009170|FG001|COMPLETED|Overall Study||17
10843448|NCT03858634|12009169|FG000|NOT COMPLETED|Overall Study||3
10411868|NCT00769314|11555811|FG001|NOT COMPLETED|Overall Study||13
10411869|NCT00769392|11555817|FG000|STARTED|Overall Study||28
10411870|NCT00769392|11555817|FG000|COMPLETED|Overall Study||24
10411871|NCT00769392|11555817|FG000|NOT COMPLETED|Overall Study||4
10411872|NCT00769483|11555827|FG000|STARTED|Overall Study||9
10411873|NCT00769483|11555828|FG001|STARTED|Overall Study||13
10411874|NCT00769483|11555829|FG002|STARTED|Overall Study||15
10411875|NCT00769483|11555830|FG003|STARTED|Overall Study||15
10411876|NCT00769483|11555831|FG004|STARTED|Overall Study||16
10411877|NCT00769483|11555832|FG005|STARTED|Overall Study||9
10411878|NCT00769483|11555827|FG000|COMPLETED|Overall Study||9
10411879|NCT00769483|11555828|FG001|COMPLETED|Overall Study||12
10411880|NCT00769483|11555829|FG002|COMPLETED|Overall Study||15
10411881|NCT00769483|11555830|FG003|COMPLETED|Overall Study||15
10411882|NCT00769483|11555831|FG004|COMPLETED|Overall Study||15
10411883|NCT00769483|11555832|FG005|COMPLETED|Overall Study||9
10411884|NCT00769483|11555827|FG000|NOT COMPLETED|Overall Study||0
10411885|NCT00769483|11555828|FG001|NOT COMPLETED|Overall Study||1
10411886|NCT00769483|11555829|FG002|NOT COMPLETED|Overall Study||0
10411887|NCT00769483|11555830|FG003|NOT COMPLETED|Overall Study||0
10411888|NCT00769483|11555831|FG004|NOT COMPLETED|Overall Study||1
10411889|NCT00769483|11555832|FG005|NOT COMPLETED|Overall Study||0
10411890|NCT00769561|11555850|FG000|STARTED|Overall Study||29
10411891|NCT00769561|11555851|FG001|STARTED|Overall Study||29
10411892|NCT00769561|11555850|FG000|COMPLETED|Overall Study||26
10411893|NCT00769561|11555851|FG001|COMPLETED|Overall Study||24
10411894|NCT00769561|11555850|FG000|NOT COMPLETED|Overall Study||3
10411895|NCT00769561|11555851|FG001|NOT COMPLETED|Overall Study||5
10411896|NCT00769600|11555859|FG000|STARTED|Overall Study||15
10411897|NCT00769600|11555860|FG001|STARTED|Overall Study||8
10411898|NCT00769600|11555859|FG000|COMPLETED|Overall Study||15
10411899|NCT00769600|11555860|FG001|COMPLETED|Overall Study||8
10411900|NCT00769600|11555859|FG000|NOT COMPLETED|Overall Study||0
10411901|NCT00769600|11555860|FG001|NOT COMPLETED|Overall Study||0
10411902|NCT00769704|11555871|FG000|STARTED|Overall Study||141
10411903|NCT00769704|11555872|FG001|STARTED|Overall Study||296
10411904|NCT00769704|11555871|FG000|Intent-to-treat Population|Overall Study|All participants who were randomized once to study treatment|141
10411905|NCT00769704|11555872|FG001|Intent-to-treat Population|Overall Study|Participants who were randomized once to study treatment; excludes 1 participant randomized 3 times|295
10411906|NCT00769704|11555871|FG000|Received Treatment|Overall Study||127
10411907|NCT00769704|11555872|FG001|Received Treatment|Overall Study||292
10411908|NCT00769704|11555871|FG000|COMPLETED|Overall Study||30
10411909|NCT00769704|11555872|FG001|COMPLETED|Overall Study||97
10411910|NCT00769704|11555871|FG000|NOT COMPLETED|Overall Study||111
10411911|NCT00769704|11555872|FG001|NOT COMPLETED|Overall Study||199
10411912|NCT00769808|11555879|FG000|STARTED|Overall Study||72
10411913|NCT00769808|11555879|FG000|COMPLETED|Overall Study||64
10545117|NCT01494532|11698372|FG003|COMPLETED|Overall Study||60
10843449|NCT03858634|12009170|FG001|NOT COMPLETED|Overall Study||2
10843450|NCT03819114|12009188|FG000|STARTED|Overall Study||17
10843451|NCT03819114|12009189|FG001|STARTED|Overall Study||36
10843452|NCT03819114|12009190|FG002|STARTED|Overall Study||35
10843453|NCT03819114|12009191|FG003|STARTED|Overall Study||34
10843454|NCT03819114|12009188|FG000|Received LNG Treatment|Overall Study||17
10843455|NCT03819114|12009189|FG001|Received LNG Treatment|Overall Study||36
10843456|NCT03819114|12009190|FG002|Received LNG Treatment|Overall Study||35
10843457|NCT03819114|12009191|FG003|Received LNG Treatment|Overall Study||34
10843458|NCT03819114|12009188|FG000|COMPLETED|Overall Study||17
10843459|NCT03819114|12009189|FG001|COMPLETED|Overall Study||35
10843460|NCT03819114|12009190|FG002|COMPLETED|Overall Study||33
10843461|NCT03819114|12009191|FG003|COMPLETED|Overall Study||34
10843462|NCT03819114|12009188|FG000|NOT COMPLETED|Overall Study||0
10843463|NCT03819114|12009189|FG001|NOT COMPLETED|Overall Study||1
10843464|NCT03819114|12009190|FG002|NOT COMPLETED|Overall Study||2
10843465|NCT03819114|12009191|FG003|NOT COMPLETED|Overall Study||0
10843466|NCT03804268|12009205|FG000|STARTED|Overall Study||160
10843467|NCT03804268|12009206|FG001|STARTED|Overall Study||163
10843468|NCT03804268|12009205|FG000|COMPLETED|Overall Study||153
10843469|NCT03804268|12009206|FG001|COMPLETED|Overall Study||161
10843470|NCT03804268|12009205|FG000|NOT COMPLETED|Overall Study||7
10843471|NCT03804268|12009206|FG001|NOT COMPLETED|Overall Study||2
10843472|NCT04435808|12009215|FG000|STARTED|Overall Study||0
10843473|NCT04435808|12009216|FG001|STARTED|Overall Study||1
10843474|NCT04435808|12009215|FG000|COMPLETED|Overall Study||0
10843475|NCT04435808|12009216|FG001|COMPLETED|Overall Study|Study stopped prior to any data collection for this lone participant|0
10843476|NCT04435808|12009215|FG000|NOT COMPLETED|Overall Study||0
10843477|NCT04435808|12009216|FG001|NOT COMPLETED|Overall Study||1
10843478|NCT04409262|12009224|FG000|STARTED|Overall Study||215
10843479|NCT04409262|12009225|FG001|STARTED|Overall Study||434
10843480|NCT04409262|12009224|FG000|COMPLETED|Overall Study||140
10843481|NCT04409262|12009225|FG001|COMPLETED|Overall Study||300
10843482|NCT04409262|12009224|FG000|NOT COMPLETED|Overall Study||75
10843483|NCT04409262|12009225|FG001|NOT COMPLETED|Overall Study||134
10843484|NCT04305912|12009234|FG000|STARTED|First Intervention||26
10843485|NCT04305912|12009235|FG001|STARTED|First Intervention||25
10843486|NCT04305912|12009234|FG000|COMPLETED|First Intervention||24
10843487|NCT04305912|12009235|FG001|COMPLETED|First Intervention||24
10843488|NCT04305912|12009234|FG000|NOT COMPLETED|First Intervention||2
10843489|NCT04305912|12009235|FG001|NOT COMPLETED|First Intervention||1
10843490|NCT04305912|12009234|FG000|STARTED|Second Intervention||24
10843491|NCT04305912|12009235|FG001|STARTED|Second Intervention||24
10843492|NCT04305912|12009234|FG000|COMPLETED|Second Intervention||24
10843493|NCT04305912|12009235|FG001|COMPLETED|Second Intervention||23
10843494|NCT04305912|12009234|FG000|NOT COMPLETED|Second Intervention||0
10843495|NCT04305912|12009235|FG001|NOT COMPLETED|Second Intervention||1
10843496|NCT04030416|12009241|FG000|STARTED|Overall Study||120
10843497|NCT04030416|12009241|FG000|COMPLETED|Overall Study||119
10843498|NCT04030416|12009241|FG000|NOT COMPLETED|Overall Study||1
10843499|NCT04028648|12009245|FG000|STARTED|Overall Study||150
10843500|NCT04028648|12009245|FG000|COMPLETED|Overall Study||150
10843501|NCT04028648|12009245|FG000|NOT COMPLETED|Overall Study||0
10843502|NCT03987919|12009254|FG000|STARTED|Overall Study||471
10843503|NCT03987919|12009255|FG001|STARTED|Overall Study||469
10843504|NCT03987919|12009256|FG002|STARTED|Overall Study||470
10843505|NCT03987919|12009257|FG003|STARTED|Overall Study||469
10843506|NCT03987919|12009254|FG000|Received at Least One Dose of Study Drug|Overall Study||470
10843507|NCT03987919|12009255|FG001|Received at Least One Dose of Study Drug|Overall Study||469
10843508|NCT03987919|12009256|FG002|Received at Least One Dose of Study Drug|Overall Study||470
10843509|NCT03987919|12009257|FG003|Received at Least One Dose of Study Drug|Overall Study||469
10843510|NCT03987919|12009254|FG000|COMPLETED|Overall Study||452
10843511|NCT03987919|12009255|FG001|COMPLETED|Overall Study||442
10843512|NCT03987919|12009256|FG002|COMPLETED|Overall Study||446
10843513|NCT03987919|12009257|FG003|COMPLETED|Overall Study||443
10843514|NCT03987919|12009254|FG000|NOT COMPLETED|Overall Study||19
10843515|NCT03987919|12009255|FG001|NOT COMPLETED|Overall Study||27
10843516|NCT03987919|12009256|FG002|NOT COMPLETED|Overall Study||24
10843517|NCT03987919|12009257|FG003|NOT COMPLETED|Overall Study||26
10843518|NCT03980145|12009274|FG000|STARTED|Overall Study||7
10843519|NCT03980145|12009275|FG001|STARTED|Overall Study||8
10843520|NCT03980145|12009274|FG000|COMPLETED|Overall Study||7
10843521|NCT03980145|12009275|FG001|COMPLETED|Overall Study||8
10843522|NCT03980145|12009274|FG000|NOT COMPLETED|Overall Study||0
10843523|NCT03980145|12009275|FG001|NOT COMPLETED|Overall Study||0
10843524|NCT03861039|12009286|FG000|STARTED|Overall Study||148
10843525|NCT03861039|12009287|FG001|STARTED|Overall Study||147
10843526|NCT03861039|12009288|FG002|STARTED|Overall Study||148
10843527|NCT03861039|12009286|FG000|Received at Least One Dose of Study Drug|Overall Study||148
10843528|NCT03861039|12009287|FG001|Received at Least One Dose of Study Drug|Overall Study||147
10843529|NCT03861039|12009288|FG002|Received at Least One Dose of Study Drug|Overall Study||148
10843530|NCT03861039|12009286|FG000|COMPLETED|Overall Study||145
10843531|NCT03861039|12009287|FG001|COMPLETED|Overall Study||139
10843532|NCT03861039|12009288|FG002|COMPLETED|Overall Study||133
10843533|NCT03861039|12009286|FG000|NOT COMPLETED|Overall Study||3
10843534|NCT03861039|12009287|FG001|NOT COMPLETED|Overall Study||8
10843535|NCT03861039|12009288|FG002|NOT COMPLETED|Overall Study||15
10843536|NCT03759587|12009298|FG000|STARTED|Overall Study||19
10843537|NCT03759587|12009298|FG000|COMPLETED|Overall Study||0
10843538|NCT03759587|12009298|FG000|NOT COMPLETED|Overall Study||19
10843539|NCT03730662|12009306|FG000|STARTED|Treatment Period (52 Weeks)||329
10843540|NCT03730662|12009307|FG001|STARTED|Treatment Period (52 Weeks)||330
10843541|NCT03730662|12009308|FG002|STARTED|Treatment Period (52 Weeks)||338
10843542|NCT03730662|12009309|FG003|STARTED|Treatment Period (52 Weeks)||1005
10843543|NCT03730662|12009306|FG000|Received at Least One Dose of Study Drug|Treatment Period (52 Weeks)||329
10843544|NCT03730662|12009307|FG001|Received at Least One Dose of Study Drug|Treatment Period (52 Weeks)||328
10843545|NCT03730662|12009308|FG002|Received at Least One Dose of Study Drug|Treatment Period (52 Weeks)||338
10843546|NCT03730662|12009309|FG003|Received at Least One Dose of Study Drug|Treatment Period (52 Weeks)||1000
10843547|NCT03730662|12009306|FG000|COMPLETED|Treatment Period (52 Weeks)||308
10843548|NCT03730662|12009307|FG001|COMPLETED|Treatment Period (52 Weeks)||319
10843549|NCT03730662|12009308|FG002|COMPLETED|Treatment Period (52 Weeks)||329
10843550|NCT03730662|12009309|FG003|COMPLETED|Treatment Period (52 Weeks)||953
10843551|NCT03730662|12009306|FG000|NOT COMPLETED|Treatment Period (52 Weeks)||21
10843552|NCT03730662|12009307|FG001|NOT COMPLETED|Treatment Period (52 Weeks)||11
10843553|NCT03730662|12009308|FG002|NOT COMPLETED|Treatment Period (52 Weeks)||9
10843554|NCT03730662|12009309|FG003|NOT COMPLETED|Treatment Period (52 Weeks)||52
10843555|NCT03730662|12009306|FG000|STARTED|Variable Treatment Period||308
10843556|NCT03730662|12009307|FG001|STARTED|Variable Treatment Period||319
10843557|NCT03730662|12009308|FG002|STARTED|Variable Treatment Period||329
10843558|NCT03730662|12009309|FG003|STARTED|Variable Treatment Period||953
10843559|NCT03730662|12009306|FG000|COMPLETED|Variable Treatment Period||294
10843560|NCT03730662|12009307|FG001|COMPLETED|Variable Treatment Period||312
10843561|NCT03730662|12009308|FG002|COMPLETED|Variable Treatment Period||313
10843562|NCT03730662|12009309|FG003|COMPLETED|Variable Treatment Period||882
10843563|NCT03730662|12009306|FG000|NOT COMPLETED|Variable Treatment Period||14
10843564|NCT03730662|12009307|FG001|NOT COMPLETED|Variable Treatment Period||7
10843565|NCT03730662|12009308|FG002|NOT COMPLETED|Variable Treatment Period||16
10843566|NCT03730662|12009309|FG003|NOT COMPLETED|Variable Treatment Period||71
10843567|NCT03538444|12009325|FG000|STARTED|Overall Study||4
10843568|NCT03538444|12009326|FG001|STARTED|Overall Study||3
10843569|NCT03538444|12009325|FG000|COMPLETED|Overall Study||3
10411914|NCT00769808|11555879|FG000|NOT COMPLETED|Overall Study||8
10411915|NCT00769860|11555885|FG000|STARTED|Overall Study||16
10411916|NCT00769860|11555886|FG001|STARTED|Overall Study||8
10411917|NCT00769860|11555885|FG000|Month 4|Overall Study||16
10411918|NCT00769860|11555886|FG001|Month 4|Overall Study||8
10411919|NCT00769860|11555885|FG000|Month 8|Overall Study||14
10411920|NCT00769860|11555886|FG001|Month 8|Overall Study||8
10411921|NCT00769860|11555885|FG000|COMPLETED|Overall Study||14
10411922|NCT00769860|11555886|FG001|COMPLETED|Overall Study||8
10411923|NCT00769860|11555885|FG000|NOT COMPLETED|Overall Study||2
10411924|NCT00769860|11555886|FG001|NOT COMPLETED|Overall Study||0
10411925|NCT00769886|11555896|FG000|STARTED|Overall Study||36
10411926|NCT00769886|11555897|FG001|STARTED|Overall Study||36
10411927|NCT00769886|11555898|FG002|STARTED|Overall Study||35
10411928|NCT00769886|11555899|FG003|STARTED|Overall Study||37
10411929|NCT00769886|11555896|FG000|COMPLETED|Overall Study||31
10411930|NCT00769886|11555897|FG001|COMPLETED|Overall Study||32
10411931|NCT00769886|11555898|FG002|COMPLETED|Overall Study||34
10411932|NCT00769886|11555899|FG003|COMPLETED|Overall Study||35
10411933|NCT00769886|11555896|FG000|NOT COMPLETED|Overall Study||5
10411934|NCT00769886|11555897|FG001|NOT COMPLETED|Overall Study||4
10411935|NCT00769886|11555898|FG002|NOT COMPLETED|Overall Study||1
10411936|NCT00769886|11555899|FG003|NOT COMPLETED|Overall Study||2
10411937|NCT00770029|11555911|FG000|STARTED|Overall Study||184
10411938|NCT00770029|11555912|FG001|STARTED|Overall Study||92
10411939|NCT00770029|11555911|FG000|COMPLETED|Overall Study||178
10411940|NCT00770029|11555912|FG001|COMPLETED|Overall Study||89
10411941|NCT00770029|11555911|FG000|NOT COMPLETED|Overall Study||6
10411942|NCT00770029|11555912|FG001|NOT COMPLETED|Overall Study||3
10411943|NCT00770120|11555918|FG000|STARTED|Overall Study||61
10411944|NCT00770120|11555918|FG000|Eligible|Overall Study||60
10411945|NCT00770120|11555918|FG000|Not Analyzable|Overall Study||1
10411946|NCT00770120|11555918|FG000|COMPLETED|Overall Study||0
10411947|NCT00770120|11555918|FG000|NOT COMPLETED|Overall Study||61
10411948|NCT00770133|11555927|FG000|STARTED|Overall Study||35
10411949|NCT00770133|11555928|FG001|STARTED|Overall Study||36
10411950|NCT00770133|11555929|FG002|STARTED|Overall Study||35
10411951|NCT00770133|11555930|FG003|STARTED|Overall Study||35
10411952|NCT00770133|11555927|FG000|COMPLETED|Overall Study||32
10411953|NCT00770133|11555928|FG001|COMPLETED|Overall Study||35
10411954|NCT00770133|11555929|FG002|COMPLETED|Overall Study||32
10411955|NCT00770133|11555930|FG003|COMPLETED|Overall Study||32
10411956|NCT00770133|11555927|FG000|NOT COMPLETED|Overall Study||3
10411957|NCT00770133|11555928|FG001|NOT COMPLETED|Overall Study||1
10411958|NCT00770133|11555929|FG002|NOT COMPLETED|Overall Study||3
10411959|NCT00770133|11555930|FG003|NOT COMPLETED|Overall Study||3
10411960|NCT00770146|11555942|FG000|STARTED|Treatment Period||53
10411961|NCT00770146|11555943|FG001|STARTED|Treatment Period||105
10411962|NCT00770146|11555942|FG000|Treated|Treatment Period||52
10411963|NCT00770146|11555943|FG001|Treated|Treatment Period||105
10411964|NCT00770146|11555942|FG000|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|50
10411965|NCT00770146|11555943|FG001|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|101
10411966|NCT00770146|11555942|FG000|COMPLETED|Treatment Period||44
10411967|NCT00770146|11555943|FG001|COMPLETED|Treatment Period||60
10411968|NCT00770146|11555942|FG000|NOT COMPLETED|Treatment Period||9
10411969|NCT00770146|11555943|FG001|NOT COMPLETED|Treatment Period||45
10411970|NCT00770146|11555942|FG000|STARTED|Follow-up Period||53
10411971|NCT00770146|11555943|FG001|STARTED|Follow-up Period||105
10411972|NCT00770146|11555942|FG000|COMPLETED|Follow-up Period||42
10411973|NCT00770146|11555943|FG001|COMPLETED|Follow-up Period||85
10411974|NCT00770146|11555942|FG000|NOT COMPLETED|Follow-up Period||11
10411975|NCT00770146|11555943|FG001|NOT COMPLETED|Follow-up Period||20
10411976|NCT00770211|11555951|FG000|STARTED|Overall Study||182
10411977|NCT00770211|11555952|FG001|STARTED|Overall Study||89
10411978|NCT00770211|11555951|FG000|COMPLETED|Overall Study||181
10411979|NCT00770211|11555952|FG001|COMPLETED|Overall Study||87
10411980|NCT00770211|11555951|FG000|NOT COMPLETED|Overall Study||1
10411981|NCT00770211|11555952|FG001|NOT COMPLETED|Overall Study||2
10411982|NCT00770224|11555958|FG000|STARTED|Step 1: Induction||87
10843570|NCT03538444|12009326|FG001|COMPLETED|Overall Study||3
10843571|NCT03538444|12009325|FG000|NOT COMPLETED|Overall Study||1
10843572|NCT03538444|12009326|FG001|NOT COMPLETED|Overall Study||0
10411983|NCT00770224|11555959|FG001|STARTED|Step 1: Induction||0
10411984|NCT00770224|11555958|FG000|Eligible and Evaluable|Step 1: Induction||84
10411985|NCT00770224|11555959|FG001|Eligible and Evaluable|Step 1: Induction||0
10843591|NCT03252925|12009362|FG000|STARTED|Overall Study||80
10843592|NCT03252925|12009363|FG001|STARTED|Overall Study||80
10843593|NCT03252925|12009362|FG000|COMPLETED|Overall Study||66
10843594|NCT03252925|12009363|FG001|COMPLETED|Overall Study||74
10843595|NCT03252925|12009362|FG000|NOT COMPLETED|Overall Study||14
10843596|NCT03252925|12009363|FG001|NOT COMPLETED|Overall Study||6
10843597|NCT03185832|12009373|FG000|STARTED|Overall Study||69
10843598|NCT03185832|12009374|FG001|STARTED|Overall Study||102
10843599|NCT03185832|12009375|FG002|STARTED|Overall Study||68
10843600|NCT03185832|12009376|FG003|STARTED|Overall Study||115
10843601|NCT03185832|12009373|FG000|COMPLETED|Overall Study||60
10843602|NCT03185832|12009374|FG001|COMPLETED|Overall Study||87
10843603|NCT03185832|12009375|FG002|COMPLETED|Overall Study||58
10843604|NCT03185832|12009376|FG003|COMPLETED|Overall Study||104
10843605|NCT03185832|12009373|FG000|NOT COMPLETED|Overall Study||9
10843606|NCT03185832|12009374|FG001|NOT COMPLETED|Overall Study||15
10843607|NCT03185832|12009375|FG002|NOT COMPLETED|Overall Study||10
10843608|NCT03185832|12009376|FG003|NOT COMPLETED|Overall Study||11
10843609|NCT02963714|12009386|FG000|STARTED|Overall Study||176
10843610|NCT02963714|12009387|FG001|STARTED|Overall Study||176
10843611|NCT02963714|12009386|FG000|COMPLETED|Overall Study||126
10843612|NCT02963714|12009387|FG001|COMPLETED|Overall Study||126
10843613|NCT02963714|12009386|FG000|NOT COMPLETED|Overall Study||50
10843614|NCT02963714|12009387|FG001|NOT COMPLETED|Overall Study||50
10843615|NCT02959918|12009407|FG000|STARTED|Overall Study||3
10843616|NCT02959918|12009408|FG001|STARTED|Overall Study||3
10843617|NCT02959918|12009409|FG002|STARTED|Overall Study||9
10843618|NCT02959918|12009410|FG003|STARTED|Overall Study||10
10843619|NCT02959918|12009411|FG004|STARTED|Overall Study||6
10843620|NCT02959918|12009412|FG005|STARTED|Overall Study||11
10843621|NCT02959918|12009413|FG006|STARTED|Overall Study||11
10843622|NCT02959918|12009414|FG007|STARTED|Overall Study||12
10843623|NCT02959918|12009415|FG008|STARTED|Overall Study||14
10843624|NCT02959918|12009416|FG009|STARTED|Overall Study||13
10843625|NCT02959918|12009417|FG010|STARTED|Overall Study||14
10843626|NCT02959918|12009418|FG011|STARTED|Overall Study||23
10843627|NCT02959918|12009419|FG012|STARTED|Overall Study||11
10843628|NCT02959918|12009420|FG013|STARTED|Overall Study||12
10843629|NCT02959918|12009407|FG000|COMPLETED|Overall Study||0
10843630|NCT02959918|12009408|FG001|COMPLETED|Overall Study||0
10843631|NCT02959918|12009409|FG002|COMPLETED|Overall Study||1
10843632|NCT02959918|12009410|FG003|COMPLETED|Overall Study||1
10843633|NCT02959918|12009411|FG004|COMPLETED|Overall Study||1
10843634|NCT02959918|12009412|FG005|COMPLETED|Overall Study||5
10843635|NCT02959918|12009413|FG006|COMPLETED|Overall Study||6
10843636|NCT02959918|12009414|FG007|COMPLETED|Overall Study||6
10843637|NCT02959918|12009415|FG008|COMPLETED|Overall Study||7
10843638|NCT02959918|12009416|FG009|COMPLETED|Overall Study||7
10843639|NCT02959918|12009417|FG010|COMPLETED|Overall Study||8
10843640|NCT02959918|12009418|FG011|COMPLETED|Overall Study||11
10843641|NCT02959918|12009419|FG012|COMPLETED|Overall Study||4
10843642|NCT02959918|12009420|FG013|COMPLETED|Overall Study||6
10843643|NCT02959918|12009407|FG000|NOT COMPLETED|Overall Study||3
10843644|NCT02959918|12009408|FG001|NOT COMPLETED|Overall Study||3
10843645|NCT02959918|12009409|FG002|NOT COMPLETED|Overall Study||8
10843646|NCT02959918|12009410|FG003|NOT COMPLETED|Overall Study||9
10843647|NCT02959918|12009411|FG004|NOT COMPLETED|Overall Study||5
10843648|NCT02959918|12009412|FG005|NOT COMPLETED|Overall Study||6
10843649|NCT02959918|12009413|FG006|NOT COMPLETED|Overall Study||5
10843650|NCT02959918|12009414|FG007|NOT COMPLETED|Overall Study||6
10843651|NCT02959918|12009415|FG008|NOT COMPLETED|Overall Study||7
10843652|NCT02959918|12009416|FG009|NOT COMPLETED|Overall Study||6
10843653|NCT02959918|12009417|FG010|NOT COMPLETED|Overall Study||6
10843654|NCT02959918|12009418|FG011|NOT COMPLETED|Overall Study||12
10843655|NCT02959918|12009419|FG012|NOT COMPLETED|Overall Study||7
10843656|NCT02959918|12009420|FG013|NOT COMPLETED|Overall Study||6
10843657|NCT02472964|12009455|FG000|STARTED|Part 1 (up to Week 24)||246
10843658|NCT02472964|12009456|FG001|STARTED|Part 1 (up to Week 24)||247
10843659|NCT02472964|12009455|FG000|COMPLETED|Part 1 (up to Week 24)||171
10843660|NCT02472964|12009456|FG001|COMPLETED|Part 1 (up to Week 24)||185
10843661|NCT02472964|12009455|FG000|NOT COMPLETED|Part 1 (up to Week 24)||75
10843662|NCT02472964|12009456|FG001|NOT COMPLETED|Part 1 (up to Week 24)||62
10843663|NCT02472964|12009455|FG000|STARTED|Part 2 (Week 24-week 48)||163
10843664|NCT02472964|12009456|FG001|STARTED|Part 2 (Week 24-week 48)||179
10843665|NCT02472964|12009455|FG000|COMPLETED|Part 2 (Week 24-week 48)||98
10843666|NCT02472964|12009456|FG001|COMPLETED|Part 2 (Week 24-week 48)||116
10843667|NCT02472964|12009455|FG000|NOT COMPLETED|Part 2 (Week 24-week 48)||65
10843668|NCT02472964|12009456|FG001|NOT COMPLETED|Part 2 (Week 24-week 48)||63
10843669|NCT02178722|12009467|FG000|STARTED|Overall Study||4
10843670|NCT02178722|12009468|FG001|STARTED|Overall Study||20
10843671|NCT02178722|12009469|FG002|STARTED|Overall Study||18
10843672|NCT02178722|12009470|FG003|STARTED|Overall Study||20
10843673|NCT02178722|12009471|FG004|STARTED|Overall Study||382
10843674|NCT02178722|12009467|FG000|COMPLETED|Overall Study||0
10843675|NCT02178722|12009468|FG001|COMPLETED|Overall Study||0
10843676|NCT02178722|12009469|FG002|COMPLETED|Overall Study||0
10843677|NCT02178722|12009470|FG003|COMPLETED|Overall Study||0
10843678|NCT02178722|12009471|FG004|COMPLETED|Overall Study||0
10843679|NCT02178722|12009467|FG000|NOT COMPLETED|Overall Study||4
10843680|NCT02178722|12009468|FG001|NOT COMPLETED|Overall Study||20
10843681|NCT02178722|12009469|FG002|NOT COMPLETED|Overall Study||18
10843682|NCT02178722|12009470|FG003|NOT COMPLETED|Overall Study||20
10843683|NCT02178722|12009471|FG004|NOT COMPLETED|Overall Study||382
10843684|NCT01258803|12009486|FG000|STARTED|Treatment Period 1 (1 Dose)||15
10843685|NCT01258803|12009487|FG001|STARTED|Treatment Period 1 (1 Dose)||16
10843686|NCT01258803|12009488|FG002|STARTED|Treatment Period 1 (1 Dose)||15
10843687|NCT01258803|12009489|FG003|STARTED|Treatment Period 1 (1 Dose)||15
10843688|NCT01258803|12009490|FG004|STARTED|Treatment Period 1 (1 Dose)||15
10411986|NCT00770224|11555958|FG000|COMPLETED|Step 1: Induction||73
10411987|NCT00770224|11555959|FG001|COMPLETED|Step 1: Induction||0
10411988|NCT00770224|11555958|FG000|NOT COMPLETED|Step 1: Induction||14
10411989|NCT00770224|11555959|FG001|NOT COMPLETED|Step 1: Induction||0
10411990|NCT00770224|11555958|FG000|STARTED|Step 2: Maintenance||0
10411991|NCT00770224|11555959|FG001|STARTED|Step 2: Maintenance||71
10411992|NCT00770224|11555958|FG000|Eligible and Evaluable|Step 2: Maintenance||0
10411993|NCT00770224|11555959|FG001|Eligible and Evaluable|Step 2: Maintenance||69
10411994|NCT00770224|11555958|FG000|COMPLETED|Step 2: Maintenance||0
10411995|NCT00770224|11555959|FG001|COMPLETED|Step 2: Maintenance||41
10411996|NCT00770224|11555958|FG000|NOT COMPLETED|Step 2: Maintenance||0
10411997|NCT00770224|11555959|FG001|NOT COMPLETED|Step 2: Maintenance||30
10411998|NCT00770289|11555966|FG000|STARTED|Overall Study||851
10411999|NCT00770289|11555966|FG000|COMPLETED|Overall Study||845
10412000|NCT00770289|11555966|FG000|NOT COMPLETED|Overall Study||6
10412001|NCT00770315|11555979|FG000|STARTED|Overall Study||197
10412002|NCT00770315|11555980|FG001|STARTED|Overall Study||195
10412003|NCT00770315|11555981|FG002|STARTED|Overall Study||194
10412004|NCT00770315|11555982|FG003|STARTED|Overall Study||198
10412005|NCT00770315|11555979|FG000|COMPLETED|Overall Study||157
10412006|NCT00770315|11555980|FG001|COMPLETED|Overall Study||152
10412007|NCT00770315|11555981|FG002|COMPLETED|Overall Study||137
10412008|NCT00770315|11555982|FG003|COMPLETED|Overall Study||160
10412009|NCT00770315|11555979|FG000|NOT COMPLETED|Overall Study||40
10412010|NCT00770315|11555980|FG001|NOT COMPLETED|Overall Study||43
10412011|NCT00770315|11555981|FG002|NOT COMPLETED|Overall Study||57
10412012|NCT00770315|11555982|FG003|NOT COMPLETED|Overall Study||38
10412013|NCT00770328|11555994|FG000|STARTED|Overall Study||22
10412014|NCT00770328|11555995|FG001|STARTED|Overall Study||15
10412015|NCT00770328|11555994|FG000|COMPLETED|Overall Study||9
10412016|NCT00770328|11555995|FG001|COMPLETED|Overall Study||11
10412017|NCT00770328|11555994|FG000|NOT COMPLETED|Overall Study||13
10412018|NCT00770328|11555995|FG001|NOT COMPLETED|Overall Study||4
10412019|NCT00770341|11556004|FG000|STARTED|Overall Study|Number randomized|89
10412020|NCT00770341|11556005|FG001|STARTED|Overall Study|Number randomized|22
10412021|NCT00770341|11556006|FG002|STARTED|Overall Study|Number randomized|11
10412022|NCT00770341|11556004|FG000|COMPLETED|Overall Study||77
10412023|NCT00770341|11556005|FG001|COMPLETED|Overall Study||17
10412024|NCT00770341|11556006|FG002|COMPLETED|Overall Study||8
10412025|NCT00770341|11556004|FG000|NOT COMPLETED|Overall Study||12
10412026|NCT00770341|11556005|FG001|NOT COMPLETED|Overall Study||5
10412027|NCT00770341|11556006|FG002|NOT COMPLETED|Overall Study||3
10412028|NCT00770367|11556017|FG000|STARTED|First Intervention||18
10412029|NCT00770367|11556018|FG001|STARTED|First Intervention||18
10412030|NCT00770367|11556017|FG000|COMPLETED|First Intervention||18
10412031|NCT00770367|11556018|FG001|COMPLETED|First Intervention||16
10843689|NCT01258803|12009491|FG005|STARTED|Treatment Period 1 (1 Dose)||16
10843690|NCT01258803|12009486|FG000|COMPLETED|Treatment Period 1 (1 Dose)||15
10843691|NCT01258803|12009487|FG001|COMPLETED|Treatment Period 1 (1 Dose)||16
10412032|NCT00770367|11556017|FG000|NOT COMPLETED|First Intervention||0
10412033|NCT00770367|11556018|FG001|NOT COMPLETED|First Intervention||2
10412034|NCT00770367|11556017|FG000|STARTED|Washout Period of 4 Weeks||18
10412035|NCT00770367|11556018|FG001|STARTED|Washout Period of 4 Weeks||16
10412036|NCT00770367|11556017|FG000|COMPLETED|Washout Period of 4 Weeks||18
10412037|NCT00770367|11556018|FG001|COMPLETED|Washout Period of 4 Weeks||15
10412038|NCT00770367|11556017|FG000|NOT COMPLETED|Washout Period of 4 Weeks||0
10412039|NCT00770367|11556018|FG001|NOT COMPLETED|Washout Period of 4 Weeks||1
10412040|NCT00770367|11556017|FG000|STARTED|Second Intervention||18
10545118|NCT01494532|11698373|FG004|COMPLETED|Overall Study||64
10843692|NCT01258803|12009488|FG002|COMPLETED|Treatment Period 1 (1 Dose)||15
10843693|NCT01258803|12009489|FG003|COMPLETED|Treatment Period 1 (1 Dose)||15
10843694|NCT01258803|12009490|FG004|COMPLETED|Treatment Period 1 (1 Dose)||15
10843695|NCT01258803|12009491|FG005|COMPLETED|Treatment Period 1 (1 Dose)||16
10843696|NCT01258803|12009486|FG000|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
10843697|NCT01258803|12009487|FG001|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
10843698|NCT01258803|12009488|FG002|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
10843699|NCT01258803|12009489|FG003|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
10843700|NCT01258803|12009490|FG004|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
10843701|NCT01258803|12009491|FG005|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
10843702|NCT01258803|12009486|FG000|STARTED|Treatment Period 2 (1 Dose)||15
10843703|NCT01258803|12009487|FG001|STARTED|Treatment Period 2 (1 Dose)||16
10843704|NCT01258803|12009488|FG002|STARTED|Treatment Period 2 (1 Dose)||15
10843705|NCT01258803|12009489|FG003|STARTED|Treatment Period 2 (1 Dose)||15
10843706|NCT01258803|12009490|FG004|STARTED|Treatment Period 2 (1 Dose)||15
10843707|NCT01258803|12009491|FG005|STARTED|Treatment Period 2 (1 Dose)||16
10843708|NCT01258803|12009486|FG000|COMPLETED|Treatment Period 2 (1 Dose)||14
10843709|NCT01258803|12009487|FG001|COMPLETED|Treatment Period 2 (1 Dose)||14
10843710|NCT01258803|12009488|FG002|COMPLETED|Treatment Period 2 (1 Dose)||15
10843711|NCT01258803|12009489|FG003|COMPLETED|Treatment Period 2 (1 Dose)||15
10843712|NCT01258803|12009490|FG004|COMPLETED|Treatment Period 2 (1 Dose)||15
10843713|NCT01258803|12009491|FG005|COMPLETED|Treatment Period 2 (1 Dose)||15
10843714|NCT01258803|12009486|FG000|NOT COMPLETED|Treatment Period 2 (1 Dose)||1
10843715|NCT01258803|12009487|FG001|NOT COMPLETED|Treatment Period 2 (1 Dose)||2
10843716|NCT01258803|12009488|FG002|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
10843717|NCT01258803|12009489|FG003|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
10843718|NCT01258803|12009490|FG004|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
10843719|NCT01258803|12009491|FG005|NOT COMPLETED|Treatment Period 2 (1 Dose)||1
10843720|NCT01258803|12009486|FG000|STARTED|Treatment Period 3 (1 Dose)||14
10843721|NCT01258803|12009487|FG001|STARTED|Treatment Period 3 (1 Dose)||14
10843722|NCT01258803|12009488|FG002|STARTED|Treatment Period 3 (1 Dose)||15
10843723|NCT01258803|12009489|FG003|STARTED|Treatment Period 3 (1 Dose)||15
10843724|NCT01258803|12009490|FG004|STARTED|Treatment Period 3 (1 Dose)||15
10843725|NCT01258803|12009491|FG005|STARTED|Treatment Period 3 (1 Dose)||15
10843726|NCT01258803|12009486|FG000|COMPLETED|Treatment Period 3 (1 Dose)||14
10843727|NCT01258803|12009487|FG001|COMPLETED|Treatment Period 3 (1 Dose)||14
10843728|NCT01258803|12009488|FG002|COMPLETED|Treatment Period 3 (1 Dose)||14
10843729|NCT01258803|12009489|FG003|COMPLETED|Treatment Period 3 (1 Dose)||15
10843730|NCT01258803|12009490|FG004|COMPLETED|Treatment Period 3 (1 Dose)||15
10843731|NCT01258803|12009491|FG005|COMPLETED|Treatment Period 3 (1 Dose)||15
10843732|NCT01258803|12009486|FG000|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
10843733|NCT01258803|12009487|FG001|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
10843734|NCT01258803|12009488|FG002|NOT COMPLETED|Treatment Period 3 (1 Dose)||1
10843735|NCT01258803|12009489|FG003|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
10843736|NCT01258803|12009490|FG004|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
10843737|NCT01258803|12009491|FG005|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
10843738|NCT01258803|12009486|FG000|STARTED|Treatment Period 4 (1 Dose)||14
10843739|NCT01258803|12009487|FG001|STARTED|Treatment Period 4 (1 Dose)||14
10843740|NCT01258803|12009488|FG002|STARTED|Treatment Period 4 (1 Dose)||14
10843741|NCT01258803|12009489|FG003|STARTED|Treatment Period 4 (1 Dose)||15
10843742|NCT01258803|12009490|FG004|STARTED|Treatment Period 4 (1 Dose)||15
10843743|NCT01258803|12009491|FG005|STARTED|Treatment Period 4 (1 Dose)||15
10843744|NCT01258803|12009486|FG000|COMPLETED|Treatment Period 4 (1 Dose)||14
10843745|NCT01258803|12009487|FG001|COMPLETED|Treatment Period 4 (1 Dose)||14
10843746|NCT01258803|12009488|FG002|COMPLETED|Treatment Period 4 (1 Dose)||14
10843747|NCT01258803|12009489|FG003|COMPLETED|Treatment Period 4 (1 Dose)||15
10843748|NCT01258803|12009490|FG004|COMPLETED|Treatment Period 4 (1 Dose)||15
10843749|NCT01258803|12009491|FG005|COMPLETED|Treatment Period 4 (1 Dose)||15
10843750|NCT01258803|12009486|FG000|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
10843751|NCT01258803|12009487|FG001|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
10843752|NCT01258803|12009488|FG002|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
10843753|NCT01258803|12009489|FG003|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
10843754|NCT01258803|12009490|FG004|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
10843755|NCT01258803|12009491|FG005|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
10843756|NCT01104922|12009505|FG000|STARTED|Overall Study||48
10843757|NCT01104922|12009505|FG000|COMPLETED|Overall Study||48
10843758|NCT01104922|12009505|FG000|NOT COMPLETED|Overall Study||0
10843759|NCT00862251|12009512|FG000|STARTED|Overall Study||322
10843760|NCT00862251|12009513|FG001|STARTED|Overall Study||162
10843761|NCT00862251|12009514|FG002|STARTED|Overall Study||324
10843762|NCT00862251|12009512|FG000|COMPLETED|Overall Study||303
10843763|NCT00862251|12009513|FG001|COMPLETED|Overall Study||157
10843764|NCT00862251|12009514|FG002|COMPLETED|Overall Study||315
10843765|NCT00862251|12009512|FG000|NOT COMPLETED|Overall Study||19
10843766|NCT00862251|12009513|FG001|NOT COMPLETED|Overall Study||5
10843767|NCT00862251|12009514|FG002|NOT COMPLETED|Overall Study||9
10843768|NCT00783263|12009529|FG000|STARTED|Overall Study||99
10843769|NCT00783263|12009530|FG001|STARTED|Overall Study||98
10843770|NCT00783263|12009531|FG002|STARTED|Overall Study||122
10843771|NCT00783263|12009532|FG003|STARTED|Overall Study||121
10843772|NCT00783263|12009529|FG000|COMPLETED|Overall Study||95
10843773|NCT00783263|12009530|FG001|COMPLETED|Overall Study||96
10843774|NCT00783263|12009531|FG002|COMPLETED|Overall Study||119
10843775|NCT00783263|12009532|FG003|COMPLETED|Overall Study||118
10843776|NCT00783263|12009529|FG000|NOT COMPLETED|Overall Study||4
10843777|NCT00783263|12009530|FG001|NOT COMPLETED|Overall Study||2
10843778|NCT00783263|12009531|FG002|NOT COMPLETED|Overall Study||3
10843779|NCT00783263|12009532|FG003|NOT COMPLETED|Overall Study||3
10843780|NCT00782184|12009557|FG000|STARTED|Overall Study||120
10843781|NCT00782184|12009558|FG001|STARTED|Overall Study||130
10843782|NCT00782184|12009557|FG000|COMPLETED|Overall Study||116
10843783|NCT00782184|12009558|FG001|COMPLETED|Overall Study||125
10843784|NCT00782184|12009557|FG000|NOT COMPLETED|Overall Study||4
10843785|NCT00782184|12009558|FG001|NOT COMPLETED|Overall Study||5
10843786|NCT00635882|12009571|FG000|STARTED|Overall Study||20
10843787|NCT00635882|12009572|FG001|STARTED|Overall Study||17
10843788|NCT00635882|12009573|FG002|STARTED|Overall Study||12
10843789|NCT00635882|12009574|FG003|STARTED|Overall Study||15
10843790|NCT00635882|12009575|FG004|STARTED|Overall Study||16
10843791|NCT00635882|12009576|FG005|STARTED|Overall Study||13
10843792|NCT00635882|12009571|FG000|COMPLETED|Overall Study||19
10843793|NCT00635882|12009572|FG001|COMPLETED|Overall Study||17
10843794|NCT00635882|12009573|FG002|COMPLETED|Overall Study||12
10843795|NCT00635882|12009574|FG003|COMPLETED|Overall Study||15
10843796|NCT00635882|12009575|FG004|COMPLETED|Overall Study||16
10843797|NCT00635882|12009576|FG005|COMPLETED|Overall Study||13
10843798|NCT00635882|12009571|FG000|NOT COMPLETED|Overall Study||1
10843799|NCT00635882|12009572|FG001|NOT COMPLETED|Overall Study||0
10843800|NCT00635882|12009573|FG002|NOT COMPLETED|Overall Study||0
10843801|NCT00635882|12009574|FG003|NOT COMPLETED|Overall Study||0
10843802|NCT00635882|12009575|FG004|NOT COMPLETED|Overall Study||0
10412041|NCT00770367|11556018|FG001|STARTED|Second Intervention||15
10412042|NCT00770367|11556017|FG000|COMPLETED|Second Intervention||16
10412043|NCT00770367|11556018|FG001|COMPLETED|Second Intervention||15
10412044|NCT00770367|11556017|FG000|NOT COMPLETED|Second Intervention||2
10412045|NCT00770367|11556018|FG001|NOT COMPLETED|Second Intervention||0
10412046|NCT00770432|11556028|FG000|STARTED|Overall Study||102
10412047|NCT00770432|11556029|FG001|STARTED|Overall Study||101
10412048|NCT00770432|11556028|FG000|COMPLETED|Overall Study||98
10412049|NCT00770432|11556029|FG001|COMPLETED|Overall Study||94
10412050|NCT00770432|11556028|FG000|NOT COMPLETED|Overall Study||4
10412051|NCT00770432|11556029|FG001|NOT COMPLETED|Overall Study||7
10412052|NCT00770484|11556037|FG000|STARTED|Overall Study||8
10412053|NCT00770484|11556038|FG001|STARTED|Overall Study||4
10412054|NCT00770484|11556037|FG000|COMPLETED|Overall Study||7
10412055|NCT00770484|11556038|FG001|COMPLETED|Overall Study||4
10412056|NCT00770484|11556037|FG000|NOT COMPLETED|Overall Study||1
10412057|NCT00770484|11556038|FG001|NOT COMPLETED|Overall Study||0
10412058|NCT00770510|11556044|FG000|STARTED|Overall Study||72
10412059|NCT00770510|11556044|FG000|COMPLETED|Overall Study||67
10412060|NCT00770510|11556044|FG000|NOT COMPLETED|Overall Study||5
10412061|NCT00770562|11556058|FG000|STARTED|Overall Study||53
10412062|NCT00770562|11556059|FG001|STARTED|Overall Study||50
10412063|NCT00770562|11556058|FG000|COMPLETED|Overall Study||52
10412064|NCT00770562|11556059|FG001|COMPLETED|Overall Study||49
10412065|NCT00770562|11556058|FG000|NOT COMPLETED|Overall Study||1
10412066|NCT00770562|11556059|FG001|NOT COMPLETED|Overall Study||1
10412067|NCT00770588|11556068|FG000|STARTED|Overall Study||148
10412068|NCT00770588|11556069|FG001|STARTED|Overall Study||148
10412069|NCT00770588|11556068|FG000|COMPLETED|Overall Study||67
10412070|NCT00770588|11556069|FG001|COMPLETED|Overall Study||53
10412071|NCT00770588|11556068|FG000|NOT COMPLETED|Overall Study||81
10412072|NCT00770588|11556069|FG001|NOT COMPLETED|Overall Study||95
10412073|NCT00770601|11556076|FG000|STARTED|Overall Study||7
10412074|NCT00770601|11556076|FG000|COMPLETED|Overall Study||6
10412075|NCT00770601|11556076|FG000|NOT COMPLETED|Overall Study||1
10412076|NCT00770653|11556082|FG000|STARTED|Overall Study||155
10412077|NCT00770653|11556083|FG001|STARTED|Overall Study||150
10412078|NCT00770653|11556082|FG000|COMPLETED|Overall Study||123
10412079|NCT00770653|11556083|FG001|COMPLETED|Overall Study||121
10412080|NCT00770653|11556082|FG000|NOT COMPLETED|Overall Study||32
10412081|NCT00770653|11556083|FG001|NOT COMPLETED|Overall Study||29
10412082|NCT00770679|11556089|FG000|STARTED|Overall Study||16
10412083|NCT00770679|11556089|FG000|COMPLETED|Overall Study||10
10412084|NCT00770679|11556089|FG000|NOT COMPLETED|Overall Study||6
10412085|NCT00770692|11556097|FG000|STARTED|Overall Study|"1 participant whose compliance was unknown, was regarded as a treatment compliance unknown"|81
10412086|NCT00770692|11556098|FG001|STARTED|Overall Study||83
10412087|NCT00770692|11556099|FG002|STARTED|Overall Study||84
10412088|NCT00770692|11556100|FG003|STARTED|Overall Study||77
10412089|NCT00770692|11556097|FG000|COMPLETED|Overall Study||69
10412090|NCT00770692|11556098|FG001|COMPLETED|Overall Study||74
10412091|NCT00770692|11556099|FG002|COMPLETED|Overall Study||70
10412092|NCT00770692|11556100|FG003|COMPLETED|Overall Study||66
10412093|NCT00770692|11556097|FG000|NOT COMPLETED|Overall Study||12
10412094|NCT00770692|11556098|FG001|NOT COMPLETED|Overall Study||9
10412095|NCT00770692|11556099|FG002|NOT COMPLETED|Overall Study||14
10412096|NCT00770692|11556100|FG003|NOT COMPLETED|Overall Study||11
10412097|NCT00770757|11556110|FG000|STARTED|Overall Study||13
10412098|NCT00770757|11556110|FG000|COMPLETED|Overall Study||13
10412099|NCT00770757|11556110|FG000|NOT COMPLETED|Overall Study||0
10412100|NCT00770770|11556116|FG000|STARTED|Overall Study||14
10412101|NCT00770770|11556117|FG001|STARTED|Overall Study||6
10843803|NCT00635882|12009576|FG005|NOT COMPLETED|Overall Study||0
10843804|NCT00594620|12009592|FG000|STARTED|Overall Study|Study was terminated early due to low accrual. Study was blinded and no data was collected|0
10843805|NCT00594620|12009593|FG001|STARTED|Overall Study|Study was terminated early due to low accrual. Study was blinded and no data was collected|0
10843806|NCT00594620|12009592|FG000|COMPLETED|Overall Study||0
10412102|NCT00770770|11556116|FG000|COMPLETED|Overall Study||4
10412103|NCT00770770|11556117|FG001|COMPLETED|Overall Study||5
10843807|NCT00594620|12009593|FG001|COMPLETED|Overall Study||0
10843808|NCT00594620|12009592|FG000|NOT COMPLETED|Overall Study||0
10843809|NCT00594620|12009593|FG001|NOT COMPLETED|Overall Study||0
10843810|NCT00535405|12009604|FG000|STARTED|Overall Study||257
10843811|NCT00535405|12009605|FG001|STARTED|Overall Study||259
10843812|NCT00535405|12009606|FG002|STARTED|Overall Study||259
10843813|NCT00535405|12009607|FG003|STARTED|Overall Study||257
10843814|NCT00535405|12009608|FG004|STARTED|Overall Study||257
10843815|NCT00535405|12009604|FG000|COMPLETED|Overall Study||240
10843816|NCT00535405|12009605|FG001|COMPLETED|Overall Study||233
10843817|NCT00535405|12009606|FG002|COMPLETED|Overall Study||241
10843818|NCT00535405|12009607|FG003|COMPLETED|Overall Study||235
10843819|NCT00535405|12009608|FG004|COMPLETED|Overall Study||241
10843820|NCT00535405|12009604|FG000|NOT COMPLETED|Overall Study||17
10843821|NCT00535405|12009605|FG001|NOT COMPLETED|Overall Study||26
10843822|NCT00535405|12009606|FG002|NOT COMPLETED|Overall Study||18
10843823|NCT00535405|12009607|FG003|NOT COMPLETED|Overall Study||22
10843824|NCT00535405|12009608|FG004|NOT COMPLETED|Overall Study||16
10843825|NCT00496730|12009622|FG000|STARTED|Overall Study||130
10843826|NCT00496730|12009623|FG001|STARTED|Overall Study||126
10843827|NCT00496730|12009622|FG000|COMPLETED|Overall Study||124
10843828|NCT00496730|12009623|FG001|COMPLETED|Overall Study||121
10843829|NCT00496730|12009622|FG000|NOT COMPLETED|Overall Study||6
10843830|NCT00496730|12009623|FG001|NOT COMPLETED|Overall Study||5
10843831|NCT00462748|12009632|FG000|STARTED|Overall Study||261
10843832|NCT00462748|12009633|FG001|STARTED|Overall Study||263
10843833|NCT00462748|12009634|FG002|STARTED|Overall Study||262
10843834|NCT00462748|12009632|FG000|COMPLETED|Overall Study||249
10843835|NCT00462748|12009633|FG001|COMPLETED|Overall Study||252
10843836|NCT00462748|12009634|FG002|COMPLETED|Overall Study||251
10843837|NCT00462748|12009632|FG000|NOT COMPLETED|Overall Study||12
10843838|NCT00462748|12009633|FG001|NOT COMPLETED|Overall Study||11
10843839|NCT00462748|12009634|FG002|NOT COMPLETED|Overall Study||11
10843840|NCT00418834|12009644|FG000|STARTED|Overall Study||526
10843841|NCT00418834|12009645|FG001|STARTED|Overall Study||527
10843842|NCT00418834|12009644|FG000|COMPLETED|Overall Study||503
10843843|NCT00418834|12009645|FG001|COMPLETED|Overall Study||507
10843844|NCT00418834|12009644|FG000|NOT COMPLETED|Overall Study||23
10843845|NCT00418834|12009645|FG001|NOT COMPLETED|Overall Study||20
10843846|NCT00409773|12009656|FG000|STARTED|Overall Study||229
10843847|NCT00409773|12009657|FG001|STARTED|Overall Study||229
10843848|NCT00409773|12009658|FG002|STARTED|Overall Study||229
10843849|NCT00409773|12009659|FG003|STARTED|Overall Study||228
10843850|NCT00409773|12009660|FG004|STARTED|Overall Study||228
10843851|NCT00409773|12009656|FG000|COMPLETED|Overall Study||220
10843852|NCT00409773|12009657|FG001|COMPLETED|Overall Study||222
10843853|NCT00409773|12009658|FG002|COMPLETED|Overall Study||220
10843854|NCT00409773|12009659|FG003|COMPLETED|Overall Study||216
10843855|NCT00409773|12009660|FG004|COMPLETED|Overall Study||218
10843856|NCT00409773|12009656|FG000|NOT COMPLETED|Overall Study||9
10843857|NCT00409773|12009657|FG001|NOT COMPLETED|Overall Study||7
10843858|NCT00409773|12009658|FG002|NOT COMPLETED|Overall Study||9
10843859|NCT00409773|12009659|FG003|NOT COMPLETED|Overall Study||12
10843860|NCT00409773|12009660|FG004|NOT COMPLETED|Overall Study||10
10843861|NCT00276484|12009674|FG000|STARTED|Overall Study||288
10843862|NCT00276484|12009675|FG001|STARTED|Overall Study||291
10843863|NCT00276484|12009674|FG000|COMPLETED|Overall Study||279
10843864|NCT00276484|12009675|FG001|COMPLETED|Overall Study||278
10843865|NCT00276484|12009674|FG000|NOT COMPLETED|Overall Study||9
10843866|NCT00276484|12009675|FG001|NOT COMPLETED|Overall Study||13
10843867|NCT00276458|12009683|FG000|STARTED|Overall Study||98
10843868|NCT00276458|12009684|FG001|STARTED|Overall Study||98
10843869|NCT00276458|12009683|FG000|COMPLETED|Overall Study||92
10843870|NCT00276458|12009684|FG001|COMPLETED|Overall Study||91
10843871|NCT00276458|12009683|FG000|NOT COMPLETED|Overall Study||6
10843872|NCT00276458|12009684|FG001|NOT COMPLETED|Overall Study||7
10843873|NCT00271817|12009693|FG000|STARTED|Part 1||272
10843874|NCT00271817|12009694|FG001|STARTED|Part 1||272
10843875|NCT00271817|12009695|FG002|STARTED|Part 1||676
10843876|NCT00271817|12009693|FG000|COMPLETED|Part 1|6 patients who completed Part 1 did not continue to Part 2; 1 patient never received drug in Part 2|166
10843877|NCT00271817|12009694|FG001|COMPLETED|Part 1|1 patient who completed Part 1 did not continue to Part 2|213
10843878|NCT00271817|12009695|FG002|COMPLETED|Part 1|11 patients who completed Part 1 did not continue to Part 2|391
10843879|NCT00271817|12009693|FG000|NOT COMPLETED|Part 1||106
10843880|NCT00271817|12009694|FG001|NOT COMPLETED|Part 1||59
10843881|NCT00271817|12009695|FG002|NOT COMPLETED|Part 1||285
10843882|NCT00271817|12009693|FG000|STARTED|Part 2|Patients completing the niacin group in Part 1, were re-allocated to one of the two arms in Part 2|0
10843883|NCT00271817|12009694|FG001|STARTED|Part 2|Includes 54 patients re-allocated from the niacin group in Part 1|266
10843884|NCT00271817|12009695|FG002|STARTED|Part 2|Includes 105 patients re-allocated from the niacin group in Part 1|485
10843885|NCT00271817|12009693|FG000|COMPLETED|Part 2||0
10843886|NCT00271817|12009694|FG001|COMPLETED|Part 2||234
10843887|NCT00271817|12009695|FG002|COMPLETED|Part 2||401
10843888|NCT00271817|12009693|FG000|NOT COMPLETED|Part 2||0
10843889|NCT00271817|12009694|FG001|NOT COMPLETED|Part 2||32
10843890|NCT00271817|12009695|FG002|NOT COMPLETED|Part 2||84
10843891|NCT03660865|12009709|FG000|STARTED|Overall Study||105
10843892|NCT03660865|12009710|FG001|STARTED|Overall Study||105
10843893|NCT03660865|12009709|FG000|COMPLETED|Overall Study||105
10843894|NCT03660865|12009710|FG001|COMPLETED|Overall Study||105
10843895|NCT03660865|12009709|FG000|NOT COMPLETED|Overall Study||0
10843896|NCT03660865|12009710|FG001|NOT COMPLETED|Overall Study||0
10843897|NCT03493126|12009718|FG000|STARTED|Overall Study||31
10843898|NCT03493126|12009719|FG001|STARTED|Overall Study||28
10843899|NCT03493126|12009718|FG000|COMPLETED|Overall Study||28
10843900|NCT03493126|12009719|FG001|COMPLETED|Overall Study||28
10843901|NCT03493126|12009718|FG000|NOT COMPLETED|Overall Study||3
10843902|NCT03493126|12009719|FG001|NOT COMPLETED|Overall Study||0
10843903|NCT03420781|12009727|FG000|STARTED|Treatment Period (40 Weeks)||236
10843904|NCT03420781|12009728|FG001|STARTED|Treatment Period (40 Weeks)||231
10843905|NCT03420781|12009729|FG002|STARTED|Treatment Period (40 Weeks)||0
10843906|NCT03420781|12009730|FG003|STARTED|Treatment Period (40 Weeks)||0
10843907|NCT03420781|12009731|FG004|STARTED|Treatment Period (40 Weeks)||0
10843908|NCT03420781|12009727|FG000|Safety Population|Treatment Period (40 Weeks)||235
10843909|NCT03420781|12009728|FG001|Safety Population|Treatment Period (40 Weeks)||231
10843910|NCT03420781|12009729|FG002|Safety Population|Treatment Period (40 Weeks)||0
10843911|NCT03420781|12009730|FG003|Safety Population|Treatment Period (40 Weeks)||0
10292432|NCT02993926|11425250|FG000|STARTED|Enantone Treatment Phase||108
10292433|NCT02993926|11425251|FG001|STARTED|Enantone Treatment Phase||0
10292434|NCT02993926|11425252|FG002|STARTED|Enantone Treatment Phase||0
10292435|NCT02993926|11425250|FG000|COMPLETED|Enantone Treatment Phase||76
10292436|NCT02993926|11425251|FG001|COMPLETED|Enantone Treatment Phase||0
10292437|NCT02993926|11425252|FG002|COMPLETED|Enantone Treatment Phase||0
10292438|NCT02993926|11425250|FG000|NOT COMPLETED|Enantone Treatment Phase||32
10292439|NCT02993926|11425251|FG001|NOT COMPLETED|Enantone Treatment Phase||0
10292440|NCT02993926|11425252|FG002|NOT COMPLETED|Enantone Treatment Phase||0
10292441|NCT02993926|11425250|FG000|STARTED|Follow-Up Phase||0
10292442|NCT02993926|11425251|FG001|STARTED|Follow-Up Phase||44
10292443|NCT02993926|11425252|FG002|STARTED|Follow-Up Phase||26
10292444|NCT02993926|11425250|FG000|COMPLETED|Follow-Up Phase||0
10292445|NCT02993926|11425251|FG001|COMPLETED|Follow-Up Phase||44
10292446|NCT02993926|11425252|FG002|COMPLETED|Follow-Up Phase||26
10292447|NCT02993926|11425250|FG000|NOT COMPLETED|Follow-Up Phase||0
10292448|NCT02993926|11425251|FG001|NOT COMPLETED|Follow-Up Phase||0
10292449|NCT02993926|11425252|FG002|NOT COMPLETED|Follow-Up Phase||0
10292450|NCT02932579|11425264|FG000|STARTED|Overall Study||33
10292451|NCT02932579|11425265|FG001|STARTED|Overall Study||26
10292452|NCT02932579|11425264|FG000|COMPLETED|Overall Study||29
10292453|NCT02932579|11425265|FG001|COMPLETED|Overall Study||25
10292454|NCT02932579|11425264|FG000|NOT COMPLETED|Overall Study||4
10292455|NCT02932579|11425265|FG001|NOT COMPLETED|Overall Study||1
10292468|NCT02858154|11425293|FG000|STARTED|HFNC 3-4 Hours||9
10292469|NCT02858154|11425293|FG000|COMPLETED|HFNC 3-4 Hours||9
10292470|NCT02858154|11425293|FG000|NOT COMPLETED|HFNC 3-4 Hours||0
10292471|NCT02858154|11425293|FG000|STARTED|Clinically Ordered PSG/Low Flow Oxygen||9
10292472|NCT02858154|11425293|FG000|COMPLETED|Clinically Ordered PSG/Low Flow Oxygen||9
10292473|NCT02858154|11425293|FG000|NOT COMPLETED|Clinically Ordered PSG/Low Flow Oxygen||0
10292474|NCT02852967|11425303|FG000|STARTED|Overall Study||23
10292475|NCT02852967|11425304|FG001|STARTED|Overall Study||22
10292476|NCT02852967|11425305|FG002|STARTED|Overall Study||21
10292477|NCT02852967|11425306|FG003|STARTED|Overall Study||26
10292478|NCT02852967|11425307|FG004|STARTED|Overall Study||18
10292479|NCT02852967|11425303|FG000|Completed Period 1: Double-blind|Overall Study||14
10292480|NCT02852967|11425304|FG001|Completed Period 1: Double-blind|Overall Study||15
10412104|NCT00770770|11556116|FG000|NOT COMPLETED|Overall Study||10
10412105|NCT00770770|11556117|FG001|NOT COMPLETED|Overall Study||1
10412106|NCT00770861|11556125|FG000|STARTED|Overall Study||141
10412107|NCT00770861|11556126|FG001|STARTED|Overall Study||136
10412108|NCT00770861|11556125|FG000|COMPLETED|Overall Study||131
10412109|NCT00770861|11556126|FG001|COMPLETED|Overall Study||120
10843912|NCT03420781|12009731|FG004|Safety Population|Treatment Period (40 Weeks)||0
10843913|NCT03420781|12009727|FG000|COMPLETED|Treatment Period (40 Weeks)||92
10843914|NCT03420781|12009728|FG001|COMPLETED|Treatment Period (40 Weeks)||105
10843915|NCT03420781|12009729|FG002|COMPLETED|Treatment Period (40 Weeks)||0
10292481|NCT02852967|11425305|FG002|Completed Period 1: Double-blind|Overall Study||17
10292482|NCT02852967|11425306|FG003|Completed Period 1: Double-blind|Overall Study||16
10292483|NCT02852967|11425307|FG004|Completed Period 1: Double-blind|Overall Study||10
10292484|NCT02852967|11425303|FG000|Completed Period 2: Open-label|Overall Study||11
10292485|NCT02852967|11425304|FG001|Completed Period 2: Open-label|Overall Study||8
10292486|NCT02852967|11425305|FG002|Completed Period 2: Open-label|Overall Study||13
10292487|NCT02852967|11425306|FG003|Completed Period 2: Open-label|Overall Study||11
10412110|NCT00770861|11556125|FG000|NOT COMPLETED|Overall Study||10
10412111|NCT00770861|11556126|FG001|NOT COMPLETED|Overall Study||16
10412112|NCT00770874|11556134|FG000|STARTED|Overall Study||188
10843916|NCT03420781|12009730|FG003|COMPLETED|Treatment Period (40 Weeks)||0
10843917|NCT03420781|12009731|FG004|COMPLETED|Treatment Period (40 Weeks)||0
10843918|NCT03420781|12009727|FG000|NOT COMPLETED|Treatment Period (40 Weeks)||144
10843919|NCT03420781|12009728|FG001|NOT COMPLETED|Treatment Period (40 Weeks)||126
10843920|NCT03420781|12009729|FG002|NOT COMPLETED|Treatment Period (40 Weeks)||0
10843921|NCT03420781|12009730|FG003|NOT COMPLETED|Treatment Period (40 Weeks)||0
10843922|NCT03420781|12009731|FG004|NOT COMPLETED|Treatment Period (40 Weeks)||0
10843923|NCT03420781|12009727|FG000|STARTED|RW Period: 6 Weeks (Week 41 to Week 46)||0
10843924|NCT03420781|12009728|FG001|STARTED|RW Period: 6 Weeks (Week 41 to Week 46)||0
10843925|NCT03420781|12009729|FG002|STARTED|RW Period: 6 Weeks (Week 41 to Week 46)||91
10843926|NCT03420781|12009730|FG003|STARTED|RW Period: 6 Weeks (Week 41 to Week 46)||59
10843927|NCT03420781|12009731|FG004|STARTED|RW Period: 6 Weeks (Week 41 to Week 46)||43
10843928|NCT03420781|12009727|FG000|COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||0
10843929|NCT03420781|12009728|FG001|COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||0
10843930|NCT03420781|12009729|FG002|COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||85
10843931|NCT03420781|12009730|FG003|COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||54
10843932|NCT03420781|12009731|FG004|COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||38
10843933|NCT03420781|12009727|FG000|NOT COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||0
10843934|NCT03420781|12009728|FG001|NOT COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||0
10843935|NCT03420781|12009729|FG002|NOT COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||6
10843936|NCT03420781|12009730|FG003|NOT COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||5
10843937|NCT03420781|12009731|FG004|NOT COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||5
10843938|NCT03316586|12009747|FG000|STARTED|Overall Study||18
10843939|NCT03316586|12009747|FG000|COMPLETED|Overall Study||0
10843940|NCT03316586|12009747|FG000|NOT COMPLETED|Overall Study||18
10843941|NCT03277066|12009754|FG000|STARTED|Overall Study||71
10843942|NCT03277066|12009755|FG001|STARTED|Overall Study||72
10843943|NCT03277066|12009756|FG002|STARTED|Overall Study||146
10843944|NCT03277066|12009754|FG000|COMPLETED|Overall Study||69
10843945|NCT03277066|12009755|FG001|COMPLETED|Overall Study||71
10843946|NCT03277066|12009756|FG002|COMPLETED|Overall Study||143
10843947|NCT03277066|12009754|FG000|NOT COMPLETED|Overall Study||2
10843948|NCT03277066|12009755|FG001|NOT COMPLETED|Overall Study||1
10843949|NCT03277066|12009756|FG002|NOT COMPLETED|Overall Study||3
10843950|NCT03269695|12009766|FG000|STARTED|Overall Study||10
10412113|NCT00770874|11556135|FG001|STARTED|Overall Study||176
10412114|NCT00770874|11556134|FG000|COMPLETED|Overall Study||188
10412115|NCT00770874|11556135|FG001|COMPLETED|Overall Study||176
10412116|NCT00770874|11556134|FG000|NOT COMPLETED|Overall Study||0
10412117|NCT00770874|11556135|FG001|NOT COMPLETED|Overall Study||0
10412118|NCT00770913|11556144|FG000|STARTED|Overall Study||113
10412119|NCT00770913|11556145|FG001|STARTED|Overall Study||111
10412120|NCT00770913|11556146|FG002|STARTED|Overall Study||113
10412121|NCT00770913|11556144|FG000|COMPLETED|Overall Study||102
10412122|NCT00770913|11556145|FG001|COMPLETED|Overall Study||103
10412123|NCT00770913|11556146|FG002|COMPLETED|Overall Study||100
10412124|NCT00770913|11556144|FG000|NOT COMPLETED|Overall Study||11
10412125|NCT00770913|11556145|FG001|NOT COMPLETED|Overall Study||8
10412126|NCT00770913|11556146|FG002|NOT COMPLETED|Overall Study||13
10412127|NCT00770991|11556156|FG000|STARTED|Overall Study|34 participants enrolled (signed informed consent). 24 subjects were eligible to be randomized.|12
10412128|NCT00770991|11556157|FG001|STARTED|Overall Study|We anticipated 26-30 subjects with FAP 18 year or olders would need to be enrolled to randomize 18|12
10412129|NCT00770991|11556156|FG000|COMPLETED|Overall Study|7 subjects completed 36 weeks (+/- 10 days)of treatment|7
10412130|NCT00770991|11556157|FG001|COMPLETED|Overall Study|7 subjects completed 36 weeks (+/- 10 days)of treatment|7
10412131|NCT00770991|11556156|FG000|NOT COMPLETED|Overall Study||5
10412132|NCT00770991|11556157|FG001|NOT COMPLETED|Overall Study||5
10412133|NCT00771030|11556175|FG000|STARTED|Overall Study||6
10412134|NCT00771030|11556176|FG001|STARTED|Overall Study||4
10412135|NCT00771030|11556177|FG002|STARTED|Overall Study||6
10412136|NCT00771030|11556178|FG003|STARTED|Overall Study||6
10412137|NCT00771030|11556179|FG004|STARTED|Overall Study||6
10412138|NCT00771030|11556180|FG005|STARTED|Overall Study||6
10412139|NCT00771030|11556181|FG006|STARTED|Overall Study||6
10412140|NCT00771030|11556175|FG000|Received Study Drug|Overall Study||6
10412141|NCT00771030|11556176|FG001|Received Study Drug|Overall Study||4
10412142|NCT00771030|11556177|FG002|Received Study Drug|Overall Study||6
10412143|NCT00771030|11556178|FG003|Received Study Drug|Overall Study||6
10412144|NCT00771030|11556179|FG004|Received Study Drug|Overall Study||6
10412145|NCT00771030|11556180|FG005|Received Study Drug|Overall Study||6
10412146|NCT00771030|11556181|FG006|Received Study Drug|Overall Study||6
10412147|NCT00771030|11556175|FG000|COMPLETED|Overall Study||6
10412148|NCT00771030|11556176|FG001|COMPLETED|Overall Study||3
10412149|NCT00771030|11556177|FG002|COMPLETED|Overall Study||6
10412150|NCT00771030|11556178|FG003|COMPLETED|Overall Study||6
10412151|NCT00771030|11556179|FG004|COMPLETED|Overall Study||6
10412152|NCT00771030|11556180|FG005|COMPLETED|Overall Study||6
10412153|NCT00771030|11556181|FG006|COMPLETED|Overall Study||6
10412154|NCT00771030|11556175|FG000|NOT COMPLETED|Overall Study||0
10412155|NCT00771030|11556176|FG001|NOT COMPLETED|Overall Study||1
10412156|NCT00771030|11556177|FG002|NOT COMPLETED|Overall Study||0
10412157|NCT00771030|11556178|FG003|NOT COMPLETED|Overall Study||0
10412158|NCT00771030|11556179|FG004|NOT COMPLETED|Overall Study||0
10412159|NCT00771030|11556180|FG005|NOT COMPLETED|Overall Study||0
10412160|NCT00771030|11556181|FG006|NOT COMPLETED|Overall Study||0
10412161|NCT00771056|11556202|FG000|STARTED|Overall Study||23
10412162|NCT00771056|11556202|FG000|COMPLETED|Overall Study||18
10412163|NCT00771056|11556202|FG000|NOT COMPLETED|Overall Study||5
10412164|NCT00771173|11556208|FG000|STARTED|Overall Study||129
10412165|NCT00771173|11556209|FG001|STARTED|Overall Study||129
10412166|NCT00771173|11556208|FG000|COMPLETED|Overall Study||107
10412167|NCT00771173|11556209|FG001|COMPLETED|Overall Study||112
10412168|NCT00771173|11556208|FG000|NOT COMPLETED|Overall Study||22
10412169|NCT00771173|11556209|FG001|NOT COMPLETED|Overall Study||17
10412170|NCT00771238|11556217|FG000|STARTED|Overall Study||31
10412171|NCT00771238|11556218|FG001|STARTED|Overall Study||21
10412172|NCT00771238|11556217|FG000|COMPLETED|Overall Study||31
10412173|NCT00771238|11556218|FG001|COMPLETED|Overall Study||21
10843951|NCT03269695|12009767|FG001|STARTED|Overall Study||10
10843952|NCT03269695|12009766|FG000|Treated|Overall Study||10
10412174|NCT00771238|11556217|FG000|NOT COMPLETED|Overall Study||0
10412175|NCT00771238|11556218|FG001|NOT COMPLETED|Overall Study||0
10412176|NCT00771264|11556226|FG000|STARTED|Overall Study||110
10412177|NCT00771264|11556227|FG001|STARTED|Overall Study||110
10412178|NCT00771264|11556226|FG000|COMPLETED|Overall Study||103
10412179|NCT00771264|11556227|FG001|COMPLETED|Overall Study||105
10412180|NCT00771264|11556226|FG000|NOT COMPLETED|Overall Study||7
10412181|NCT00771264|11556227|FG001|NOT COMPLETED|Overall Study||5
10412182|NCT00771277|11556233|FG000|STARTED|Overall Study||6
10412183|NCT00771277|11556233|FG000|COMPLETED|Overall Study||6
10412184|NCT00771277|11556233|FG000|NOT COMPLETED|Overall Study||0
10412185|NCT00771407|11556239|FG000|STARTED|Overall Study||60
10412186|NCT00771407|11556240|FG001|STARTED|Overall Study||60
10412187|NCT00771407|11556239|FG000|COMPLETED|Overall Study||40
10412188|NCT00771407|11556240|FG001|COMPLETED|Overall Study||35
10843953|NCT03269695|12009767|FG001|Treated|Overall Study||10
10843954|NCT03269695|12009766|FG000|COMPLETED|Overall Study||8
10843955|NCT03269695|12009767|FG001|COMPLETED|Overall Study||7
10843956|NCT03269695|12009766|FG000|NOT COMPLETED|Overall Study||2
10843957|NCT03269695|12009767|FG001|NOT COMPLETED|Overall Study||3
10843958|NCT03268811|12009776|FG000|STARTED|Overall Study||7
10843959|NCT03268811|12009777|FG001|STARTED|Overall Study||2
10843960|NCT03268811|12009776|FG000|COMPLETED|Overall Study||7
10843961|NCT03268811|12009777|FG001|COMPLETED|Overall Study||1
10843962|NCT03268811|12009776|FG000|NOT COMPLETED|Overall Study||0
10843963|NCT03268811|12009777|FG001|NOT COMPLETED|Overall Study||1
10843964|NCT03227757|12009784|FG000|STARTED|Overall Study||85
10843965|NCT03227757|12009784|FG000|COMPLETED|Overall Study||69
10843966|NCT03227757|12009784|FG000|NOT COMPLETED|Overall Study||16
10843967|NCT03222128|12009788|FG000|STARTED|Overall Study||1074
10843968|NCT03222128|12009788|FG000|Valve-Implanted|Overall Study||1069
10843969|NCT03222128|12009788|FG000|COMPLETED|Overall Study||968
10843970|NCT03222128|12009788|FG000|NOT COMPLETED|Overall Study||106
10843971|NCT03142334|12009794|FG000|STARTED|Overall Study||496
10843972|NCT03142334|12009795|FG001|STARTED|Overall Study||498
10412189|NCT00771407|11556239|FG000|NOT COMPLETED|Overall Study||20
10412190|NCT00771407|11556240|FG001|NOT COMPLETED|Overall Study||25
10412191|NCT00771472|11556246|FG000|STARTED|Overall Study||6
10412192|NCT00771472|11556247|FG001|STARTED|Overall Study||4
10412193|NCT00771472|11556246|FG000|COMPLETED|Overall Study||0
10412194|NCT00771472|11556247|FG001|COMPLETED|Overall Study||0
10412195|NCT00771472|11556246|FG000|NOT COMPLETED|Overall Study||6
10412196|NCT00771472|11556247|FG001|NOT COMPLETED|Overall Study||4
10412197|NCT00771537|11556268|FG000|STARTED|Overall Study||135
10412198|NCT00771537|11556269|FG001|STARTED|Overall Study||124
10412199|NCT00771537|11556270|FG002|STARTED|Overall Study||151
10412200|NCT00771537|11556271|FG003|STARTED|Overall Study||114
10412201|NCT00771537|11556272|FG004|STARTED|Overall Study||127
10412202|NCT00771537|11556273|FG005|STARTED|Overall Study||118
10412203|NCT00771537|11556274|FG006|STARTED|Overall Study||128
10412204|NCT00771537|11556275|FG007|STARTED|Overall Study||132
10412205|NCT00771537|11556276|FG008|STARTED|Overall Study||115
10412206|NCT00771537|11556277|FG009|STARTED|Overall Study||119
10412207|NCT00771537|11556278|FG010|STARTED|Overall Study||133
10412208|NCT00771537|11556279|FG011|STARTED|Overall Study||137
10412209|NCT00771537|11556280|FG012|STARTED|Overall Study||128
10412210|NCT00771537|11556281|FG013|STARTED|Overall Study||124
10412211|NCT00771537|11556282|FG014|STARTED|Overall Study||124
10843973|NCT03142334|12009794|FG000|Treated|Overall Study||488
10843974|NCT03142334|12009795|FG001|Treated|Overall Study||496
10843975|NCT03142334|12009794|FG000|Continuing Study Treatment|Overall Study||0
10843976|NCT03142334|12009795|FG001|Continuing Study Treatment|Overall Study||1
10843977|NCT03142334|12009794|FG000|Completed Study Treatment|Overall Study||298
10843978|NCT03142334|12009795|FG001|Completed Study Treatment|Overall Study||365
10843979|NCT03142334|12009794|FG000|Discontinued Study Treatment|Overall Study||190
10843980|NCT03142334|12009795|FG001|Discontinued Study Treatment|Overall Study||130
10843981|NCT03142334|12009794|FG000|COMPLETED|Overall Study||0
10843982|NCT03142334|12009795|FG001|COMPLETED|Overall Study||0
10843983|NCT03142334|12009794|FG000|NOT COMPLETED|Overall Study||496
10843984|NCT03142334|12009795|FG001|NOT COMPLETED|Overall Study||498
10843985|NCT03093701|12009804|FG000|STARTED|Overall Study||10
10843986|NCT03093701|12009805|FG001|STARTED|Overall Study||10
10843987|NCT03093701|12009806|FG002|STARTED|Overall Study||11
10843988|NCT03093701|12009807|FG003|STARTED|Overall Study||0
10843989|NCT03093701|12009804|FG000|COMPLETED|Overall Study||10
10843990|NCT03093701|12009805|FG001|COMPLETED|Overall Study||7
10843991|NCT03093701|12009806|FG002|COMPLETED|Overall Study||11
10843992|NCT03093701|12009807|FG003|COMPLETED|Overall Study||0
10843993|NCT03093701|12009804|FG000|NOT COMPLETED|Overall Study||0
10843994|NCT03093701|12009805|FG001|NOT COMPLETED|Overall Study||3
10843995|NCT03093701|12009806|FG002|NOT COMPLETED|Overall Study||0
10843996|NCT03093701|12009807|FG003|NOT COMPLETED|Overall Study||0
10843997|NCT03093246|12009817|FG000|STARTED|Overall Study||19
10843998|NCT03093246|12009818|FG001|STARTED|Overall Study||19
10843999|NCT03093246|12009817|FG000|COMPLETED|Overall Study||19
10844000|NCT03093246|12009818|FG001|COMPLETED|Overall Study||19
10844001|NCT03093246|12009817|FG000|NOT COMPLETED|Overall Study||0
10844002|NCT03093246|12009818|FG001|NOT COMPLETED|Overall Study||0
10844003|NCT02991599|12009826|FG000|STARTED|Overall Study||98
10844004|NCT02991599|12009827|FG001|STARTED|Overall Study||98
10844005|NCT02991599|12009826|FG000|COMPLETED|Overall Study||60
10844006|NCT02991599|12009827|FG001|COMPLETED|Overall Study||61
10844007|NCT02991599|12009826|FG000|NOT COMPLETED|Overall Study||38
10844008|NCT02991599|12009827|FG001|NOT COMPLETED|Overall Study||37
10844009|NCT02976129|12009835|FG000|STARTED|Overall Study||82
10844010|NCT02976129|12009836|FG001|STARTED|Overall Study||43
10844011|NCT02976129|12009835|FG000|COMPLETED|Overall Study||77
10844012|NCT02976129|12009836|FG001|COMPLETED|Overall Study||41
10844013|NCT02976129|12009835|FG000|NOT COMPLETED|Overall Study||5
10844014|NCT02976129|12009836|FG001|NOT COMPLETED|Overall Study||2
10844015|NCT02970136|12009844|FG000|STARTED|Overall Study||377
10844016|NCT02970136|12009845|FG001|STARTED|Overall Study||377
10844017|NCT02970136|12009844|FG000|COMPLETED|Overall Study||297
10844018|NCT02970136|12009845|FG001|COMPLETED|Overall Study||282
10844019|NCT02970136|12009844|FG000|NOT COMPLETED|Overall Study||80
10844020|NCT02970136|12009845|FG001|NOT COMPLETED|Overall Study||95
10844021|NCT02969928|12009853|FG000|STARTED|Overall Study||23
10844022|NCT02969928|12009854|FG001|STARTED|Overall Study||23
10844023|NCT02969928|12009853|FG000|COMPLETED|Overall Study||23
10844024|NCT02969928|12009854|FG001|COMPLETED|Overall Study||23
10844025|NCT02969928|12009853|FG000|NOT COMPLETED|Overall Study||0
10844026|NCT02969928|12009854|FG001|NOT COMPLETED|Overall Study||0
10844027|NCT02949297|12009860|FG000|STARTED|1 Month||75
10844028|NCT02949297|12009860|FG000|COMPLETED|1 Month||75
10844029|NCT02949297|12009860|FG000|NOT COMPLETED|1 Month||0
10844030|NCT02949297|12009860|FG000|STARTED|6 Months||75
10844031|NCT02949297|12009860|FG000|COMPLETED|6 Months||72
10844032|NCT02949297|12009860|FG000|NOT COMPLETED|6 Months||3
10844033|NCT02949297|12009860|FG000|STARTED|12 Months||72
10844034|NCT02949297|12009860|FG000|COMPLETED|12 Months||67
10844035|NCT02949297|12009860|FG000|NOT COMPLETED|12 Months||5
10844036|NCT02945787|12009866|FG000|STARTED|Overall Study||714
10844037|NCT02945787|12009867|FG001|STARTED|Overall Study||703
10844038|NCT02945787|12009866|FG000|COMPLETED|Overall Study||714
10844039|NCT02945787|12009867|FG001|COMPLETED|Overall Study||703
10844040|NCT02945787|12009866|FG000|NOT COMPLETED|Overall Study||0
10844041|NCT02945787|12009867|FG001|NOT COMPLETED|Overall Study||0
10844042|NCT02857426|12009875|FG000|STARTED|Overall Study||47
10844043|NCT02857426|12009876|FG001|STARTED|Overall Study||19
10844044|NCT02857426|12009875|FG000|COMPLETED|Overall Study||0
10844045|NCT02857426|12009876|FG001|COMPLETED|Overall Study||0
10844046|NCT02857426|12009875|FG000|NOT COMPLETED|Overall Study||47
10844047|NCT02857426|12009876|FG001|NOT COMPLETED|Overall Study||19
10844048|NCT02855125|12009884|FG000|STARTED|Overall Study||64
10844049|NCT02855125|12009885|FG001|STARTED|Overall Study||64
10844050|NCT02855125|12009884|FG000|Treated|Overall Study||64
10844051|NCT02855125|12009885|FG001|Treated|Overall Study||63
10844052|NCT02855125|12009884|FG000|COMPLETED|Overall Study||0
10844053|NCT02855125|12009885|FG001|COMPLETED|Overall Study||0
10844054|NCT02855125|12009884|FG000|NOT COMPLETED|Overall Study||64
10844055|NCT02855125|12009885|FG001|NOT COMPLETED|Overall Study||64
10844056|NCT02728752|12009893|FG000|STARTED|First Period||48
10844057|NCT02728752|12009894|FG001|STARTED|First Period||47
10844058|NCT02728752|12009893|FG000|COMPLETED|First Period||46
10844059|NCT02728752|12009894|FG001|COMPLETED|First Period||45
10844060|NCT02728752|12009893|FG000|NOT COMPLETED|First Period||2
10844061|NCT02728752|12009894|FG001|NOT COMPLETED|First Period||2
10844062|NCT02728752|12009893|FG000|STARTED|Extension Period||46
10844063|NCT02728752|12009894|FG001|STARTED|Extension Period||45
10844064|NCT02728752|12009893|FG000|COMPLETED|Extension Period||35
10844065|NCT02728752|12009894|FG001|COMPLETED|Extension Period||34
10844066|NCT02728752|12009893|FG000|NOT COMPLETED|Extension Period||11
10844067|NCT02728752|12009894|FG001|NOT COMPLETED|Extension Period||11
10844074|NCT02667639|12009916|FG000|STARTED|Overall Study||25
10844075|NCT02667639|12009917|FG001|STARTED|Overall Study||10
10844076|NCT02667639|12009916|FG000|COMPLETED|Overall Study||25
10844077|NCT02667639|12009917|FG001|COMPLETED|Overall Study||10
10844078|NCT02667639|12009916|FG000|NOT COMPLETED|Overall Study||0
10844079|NCT02667639|12009917|FG001|NOT COMPLETED|Overall Study||0
10844080|NCT02527798|12009931|FG000|STARTED|Overall Study||32
10844081|NCT02527798|12009932|FG001|STARTED|Overall Study||10
10844082|NCT02527798|12009933|FG002|STARTED|Overall Study||30
10844083|NCT02527798|12009934|FG003|STARTED|Overall Study||10
10844084|NCT02527798|12009935|FG004|STARTED|Overall Study||0
10844085|NCT02527798|12009936|FG005|STARTED|Overall Study||0
10844086|NCT02527798|12009931|FG000|Randomized, Not Dosed|Overall Study||31
10844087|NCT02527798|12009932|FG001|Randomized, Not Dosed|Overall Study||9
10844088|NCT02527798|12009933|FG002|Randomized, Not Dosed|Overall Study||30
10844089|NCT02527798|12009934|FG003|Randomized, Not Dosed|Overall Study||10
10844090|NCT02527798|12009935|FG004|Randomized, Not Dosed|Overall Study||0
10844091|NCT02527798|12009936|FG005|Randomized, Not Dosed|Overall Study||0
10844092|NCT02527798|12009931|FG000|Pharmacokinetic (PK) Population|Overall Study||20
10844093|NCT02527798|12009932|FG001|Pharmacokinetic (PK) Population|Overall Study||0
10844094|NCT02527798|12009933|FG002|Pharmacokinetic (PK) Population|Overall Study||19
10844095|NCT02527798|12009934|FG003|Pharmacokinetic (PK) Population|Overall Study||0
10844096|NCT02527798|12009935|FG004|Pharmacokinetic (PK) Population|Overall Study||0
10844097|NCT02527798|12009936|FG005|Pharmacokinetic (PK) Population|Overall Study||0
10844098|NCT02527798|12009931|FG000|COMPLETED|Overall Study||29
10844099|NCT02527798|12009932|FG001|COMPLETED|Overall Study||8
10844100|NCT02527798|12009933|FG002|COMPLETED|Overall Study||25
10844101|NCT02527798|12009934|FG003|COMPLETED|Overall Study||9
10844102|NCT02527798|12009935|FG004|COMPLETED|Overall Study||0
10844103|NCT02527798|12009936|FG005|COMPLETED|Overall Study||0
10844104|NCT02527798|12009931|FG000|NOT COMPLETED|Overall Study||3
10844105|NCT02527798|12009932|FG001|NOT COMPLETED|Overall Study||2
10844106|NCT02527798|12009933|FG002|NOT COMPLETED|Overall Study||5
10844107|NCT02527798|12009934|FG003|NOT COMPLETED|Overall Study||1
10844108|NCT02527798|12009935|FG004|NOT COMPLETED|Overall Study||0
10844109|NCT02527798|12009936|FG005|NOT COMPLETED|Overall Study||0
10844110|NCT02416492|12009967|FG000|STARTED|Overall Study||15
10844111|NCT02416492|12009968|FG001|STARTED|Overall Study||15
10844112|NCT02416492|12009969|FG002|STARTED|Overall Study||16
10844113|NCT02416492|12009970|FG003|STARTED|Overall Study||15
10844114|NCT02416492|12009967|FG000|COMPLETED|Overall Study||15
10844115|NCT02416492|12009968|FG001|COMPLETED|Overall Study||15
10844116|NCT02416492|12009969|FG002|COMPLETED|Overall Study||16
10844117|NCT02416492|12009970|FG003|COMPLETED|Overall Study||15
10844118|NCT02416492|12009967|FG000|NOT COMPLETED|Overall Study||0
10844119|NCT02416492|12009968|FG001|NOT COMPLETED|Overall Study||0
10844120|NCT02416492|12009969|FG002|NOT COMPLETED|Overall Study||0
10844121|NCT02416492|12009970|FG003|NOT COMPLETED|Overall Study||0
10844122|NCT02324816|12009983|FG000|STARTED|Overall Study||19
10844123|NCT02324816|12009983|FG000|COMPLETED|Overall Study||19
10844124|NCT02324816|12009983|FG000|NOT COMPLETED|Overall Study||0
10844125|NCT02279745|12009987|FG000|STARTED|Overall Study||45
10844126|NCT02279745|12009987|FG000|COMPLETED|Overall Study||25
10844127|NCT02279745|12009987|FG000|NOT COMPLETED|Overall Study||20
10844128|NCT02067975|12009993|FG000|STARTED|Overall Study||20
10844129|NCT02067975|12009994|FG001|STARTED|Overall Study||18
10844130|NCT02067975|12009995|FG002|STARTED|Overall Study||21
10844131|NCT02067975|12009996|FG003|STARTED|Overall Study||18
10844132|NCT02067975|12009997|FG004|STARTED|Overall Study||8
10844133|NCT02067975|12009998|FG005|STARTED|Overall Study||8
10844134|NCT02067975|12009993|FG000|COMPLETED|Overall Study||16
10844135|NCT02067975|12009994|FG001|COMPLETED|Overall Study||16
10844136|NCT02067975|12009995|FG002|COMPLETED|Overall Study||19
10844137|NCT02067975|12009996|FG003|COMPLETED|Overall Study||14
10844138|NCT02067975|12009997|FG004|COMPLETED|Overall Study||0
10844139|NCT02067975|12009998|FG005|COMPLETED|Overall Study||0
10844140|NCT02067975|12009993|FG000|NOT COMPLETED|Overall Study||4
10844141|NCT02067975|12009994|FG001|NOT COMPLETED|Overall Study||2
10844142|NCT02067975|12009995|FG002|NOT COMPLETED|Overall Study||2
10844143|NCT02067975|12009996|FG003|NOT COMPLETED|Overall Study||4
10844144|NCT02067975|12009997|FG004|NOT COMPLETED|Overall Study||8
10844145|NCT02067975|12009998|FG005|NOT COMPLETED|Overall Study||8
10844146|NCT02030938|12010010|FG000|STARTED|Overall Study||34
10844147|NCT02030938|12010010|FG000|COMPLETED|Overall Study||29
10844148|NCT02030938|12010010|FG000|NOT COMPLETED|Overall Study||5
10844149|NCT02006147|12010022|FG000|STARTED|Overall Study||5
10844150|NCT02006147|12010023|FG001|STARTED|Overall Study||9
10844151|NCT02006147|12010024|FG002|STARTED|Overall Study||0
10844152|NCT02006147|12010025|FG003|STARTED|Overall Study||0
10844153|NCT02006147|12010022|FG000|COMPLETED|Overall Study||3
10844154|NCT02006147|12010023|FG001|COMPLETED|Overall Study||7
10844155|NCT02006147|12010024|FG002|COMPLETED|Overall Study||0
10844156|NCT02006147|12010025|FG003|COMPLETED|Overall Study||0
10844157|NCT02006147|12010022|FG000|NOT COMPLETED|Overall Study||2
10844158|NCT02006147|12010023|FG001|NOT COMPLETED|Overall Study||2
10844159|NCT02006147|12010024|FG002|NOT COMPLETED|Overall Study||0
10844160|NCT02006147|12010025|FG003|NOT COMPLETED|Overall Study||0
10844161|NCT01925794|12010031|FG000|STARTED|30 Days||296
10844162|NCT01925794|12010031|FG000|COMPLETED|30 Days||296
10844163|NCT01925794|12010031|FG000|NOT COMPLETED|30 Days||0
10844164|NCT01925794|12010031|FG000|STARTED|180 Days||296
10844165|NCT01925794|12010031|FG000|COMPLETED|180 Days||292
10844166|NCT01925794|12010031|FG000|NOT COMPLETED|180 Days||4
10844167|NCT01925794|12010031|FG000|STARTED|270 Days||292
10844168|NCT01925794|12010031|FG000|COMPLETED|270 Days||287
10844169|NCT01925794|12010031|FG000|NOT COMPLETED|270 Days||5
10844170|NCT01907360|12010041|FG000|STARTED|Overall Study||18
10844171|NCT01907360|12010042|FG001|STARTED|Overall Study||11
10844172|NCT01907360|12010041|FG000|COMPLETED|Overall Study||18
10844173|NCT01907360|12010042|FG001|COMPLETED|Overall Study||11
10844174|NCT01907360|12010041|FG000|NOT COMPLETED|Overall Study||0
10844175|NCT01907360|12010042|FG001|NOT COMPLETED|Overall Study||0
10844176|NCT01856868|12010048|FG000|STARTED|Overall Study||7
10844177|NCT01856868|12010048|FG000|COMPLETED|Overall Study||7
10844178|NCT01856868|12010048|FG000|NOT COMPLETED|Overall Study||0
10844179|NCT01849250|12010054|FG000|STARTED|Overall Study||32
10844180|NCT01849250|12010055|FG001|STARTED|Overall Study||32
10844181|NCT01849250|12010054|FG000|COMPLETED|Overall Study||25
10844182|NCT01849250|12010055|FG001|COMPLETED|Overall Study||29
10844183|NCT01849250|12010054|FG000|NOT COMPLETED|Overall Study||7
10844184|NCT01849250|12010055|FG001|NOT COMPLETED|Overall Study||3
10844185|NCT01592643|12010062|FG000|STARTED|Overall Study||30
10844186|NCT01592643|12010062|FG000|COMPLETED|Overall Study||30
10844187|NCT01592643|12010062|FG000|NOT COMPLETED|Overall Study||0
10844188|NCT01441115|12010066|FG000|STARTED|Overall Study||2
10844189|NCT01441115|12010066|FG000|COMPLETED|Overall Study||1
10844190|NCT01441115|12010066|FG000|NOT COMPLETED|Overall Study||1
10844191|NCT01199302|12010077|FG000|STARTED|Overall Study||20
10844192|NCT01199302|12010078|FG001|STARTED|Overall Study||16
10844193|NCT01199302|12010079|FG002|STARTED|Overall Study||20
10844194|NCT01199302|12010080|FG003|STARTED|Overall Study||11
10844195|NCT01199302|12010077|FG000|COMPLETED|Overall Study||0
10844196|NCT01199302|12010078|FG001|COMPLETED|Overall Study||0
10844197|NCT01199302|12010079|FG002|COMPLETED|Overall Study||0
10844198|NCT01199302|12010080|FG003|COMPLETED|Overall Study||0
10844199|NCT01199302|12010077|FG000|NOT COMPLETED|Overall Study||20
10844200|NCT01199302|12010078|FG001|NOT COMPLETED|Overall Study||16
10844201|NCT01199302|12010079|FG002|NOT COMPLETED|Overall Study||20
10844202|NCT01199302|12010080|FG003|NOT COMPLETED|Overall Study||11
10844203|NCT01123707|12010091|FG000|STARTED|Overall Study||44
10844204|NCT01123707|12010092|FG001|STARTED|Overall Study||41
10844205|NCT01123707|12010093|FG002|STARTED|Overall Study||38
10844206|NCT01123707|12010094|FG003|STARTED|Overall Study||50
10844207|NCT01123707|12010091|FG000|Safety Sample|Overall Study||44
10844208|NCT01123707|12010092|FG001|Safety Sample|Overall Study||41
10844209|NCT01123707|12010093|FG002|Safety Sample|Overall Study||36
10844210|NCT01123707|12010094|FG003|Safety Sample|Overall Study||49
10844211|NCT01123707|12010091|FG000|COMPLETED|Overall Study||0
10844212|NCT01123707|12010092|FG001|COMPLETED|Overall Study||0
10844213|NCT01123707|12010093|FG002|COMPLETED|Overall Study||0
10844214|NCT01123707|12010094|FG003|COMPLETED|Overall Study||0
10844215|NCT01123707|12010091|FG000|NOT COMPLETED|Overall Study||44
10844216|NCT01123707|12010092|FG001|NOT COMPLETED|Overall Study||41
10844217|NCT01123707|12010093|FG002|NOT COMPLETED|Overall Study||38
10844218|NCT01123707|12010094|FG003|NOT COMPLETED|Overall Study||50
10844219|NCT00894244|12010104|FG000|STARTED|Overall Study||25
10844220|NCT00894244|12010104|FG000|COMPLETED|Overall Study||24
10844221|NCT00894244|12010104|FG000|NOT COMPLETED|Overall Study||1
10844222|NCT00462943|12010111|FG000|STARTED|Overall Study||46
10844223|NCT00462943|12010112|FG001|STARTED|Overall Study||31
10844224|NCT00462943|12010113|FG002|STARTED|Overall Study||23
10844225|NCT00462943|12010111|FG000|COMPLETED|Overall Study||1
10844226|NCT00462943|12010112|FG001|COMPLETED|Overall Study||1
10844227|NCT00462943|12010113|FG002|COMPLETED|Overall Study||0
10412212|NCT00771537|11556283|FG015|STARTED|Overall Study||122
10412213|NCT00771537|11556268|FG000|COMPLETED|Overall Study||135
10412214|NCT00771537|11556269|FG001|COMPLETED|Overall Study||124
10412215|NCT00771537|11556270|FG002|COMPLETED|Overall Study||151
10412216|NCT00771537|11556271|FG003|COMPLETED|Overall Study||114
10412217|NCT00771537|11556272|FG004|COMPLETED|Overall Study||127
10412218|NCT00771537|11556273|FG005|COMPLETED|Overall Study||118
10412219|NCT00771537|11556274|FG006|COMPLETED|Overall Study||128
10412220|NCT00771537|11556275|FG007|COMPLETED|Overall Study||132
10412221|NCT00771537|11556276|FG008|COMPLETED|Overall Study||115
10412222|NCT00771537|11556277|FG009|COMPLETED|Overall Study||119
10412223|NCT00771537|11556278|FG010|COMPLETED|Overall Study||133
10412224|NCT00771537|11556279|FG011|COMPLETED|Overall Study||137
10412225|NCT00771537|11556280|FG012|COMPLETED|Overall Study||128
10412226|NCT00771537|11556281|FG013|COMPLETED|Overall Study||124
10412227|NCT00771537|11556282|FG014|COMPLETED|Overall Study||124
10412228|NCT00771537|11556283|FG015|COMPLETED|Overall Study||122
10412229|NCT00771537|11556268|FG000|NOT COMPLETED|Overall Study||0
10412230|NCT00771537|11556269|FG001|NOT COMPLETED|Overall Study||0
10412231|NCT00771537|11556270|FG002|NOT COMPLETED|Overall Study||0
10412232|NCT00771537|11556271|FG003|NOT COMPLETED|Overall Study||0
10412233|NCT00771537|11556272|FG004|NOT COMPLETED|Overall Study||0
10412234|NCT00771537|11556273|FG005|NOT COMPLETED|Overall Study||0
10412235|NCT00771537|11556274|FG006|NOT COMPLETED|Overall Study||0
10412236|NCT00771537|11556275|FG007|NOT COMPLETED|Overall Study||0
10412237|NCT00771537|11556276|FG008|NOT COMPLETED|Overall Study||0
10412238|NCT00771537|11556277|FG009|NOT COMPLETED|Overall Study||0
10412239|NCT00771537|11556278|FG010|NOT COMPLETED|Overall Study||0
10412240|NCT00771537|11556279|FG011|NOT COMPLETED|Overall Study||0
10412241|NCT00771537|11556280|FG012|NOT COMPLETED|Overall Study||0
10412242|NCT00771537|11556281|FG013|NOT COMPLETED|Overall Study||0
10412243|NCT00771537|11556282|FG014|NOT COMPLETED|Overall Study||0
10412244|NCT00771537|11556283|FG015|NOT COMPLETED|Overall Study||0
10412245|NCT00771615|11556318|FG000|STARTED|Overall Study||49
10412246|NCT00771615|11556319|FG001|STARTED|Overall Study||72
10412247|NCT00771615|11556320|FG002|STARTED|Overall Study||41
10412248|NCT00771615|11556321|FG003|STARTED|Overall Study||60
10412249|NCT00771615|11556322|FG004|STARTED|Overall Study||40
10412250|NCT00771615|11556323|FG005|STARTED|Overall Study||61
10412251|NCT00771615|11556324|FG006|STARTED|Overall Study||46
10412252|NCT00771615|11556325|FG007|STARTED|Overall Study||59
10412253|NCT00771615|11556326|FG008|STARTED|Overall Study||41
10412254|NCT00771615|11556318|FG000|COMPLETED|Overall Study|Up to Day 364|48
10412255|NCT00771615|11556319|FG001|COMPLETED|Overall Study|Up to Day 364|70
10412256|NCT00771615|11556320|FG002|COMPLETED|Overall Study|Up to Day 364|40
10412257|NCT00771615|11556321|FG003|COMPLETED|Overall Study|Up to Day 364|59
10412258|NCT00771615|11556322|FG004|COMPLETED|Overall Study|Up to Day 364|40
10412259|NCT00771615|11556323|FG005|COMPLETED|Overall Study|Up to Day 364|60
10412260|NCT00771615|11556324|FG006|COMPLETED|Overall Study|Up to Day 364|45
10412261|NCT00771615|11556325|FG007|COMPLETED|Overall Study|Up to Day 364|58
10412262|NCT00771615|11556326|FG008|COMPLETED|Overall Study|Up to Day 364|41
10412263|NCT00771615|11556318|FG000|NOT COMPLETED|Overall Study||1
10412264|NCT00771615|11556319|FG001|NOT COMPLETED|Overall Study||2
10412265|NCT00771615|11556320|FG002|NOT COMPLETED|Overall Study||1
10412266|NCT00771615|11556321|FG003|NOT COMPLETED|Overall Study||1
10412267|NCT00771615|11556322|FG004|NOT COMPLETED|Overall Study||0
10412268|NCT00771615|11556323|FG005|NOT COMPLETED|Overall Study||1
10412269|NCT00771615|11556324|FG006|NOT COMPLETED|Overall Study||1
10412270|NCT00771615|11556325|FG007|NOT COMPLETED|Overall Study||1
10412271|NCT00771615|11556326|FG008|NOT COMPLETED|Overall Study||0
10844228|NCT00462943|12010111|FG000|NOT COMPLETED|Overall Study||45
10844229|NCT00462943|12010112|FG001|NOT COMPLETED|Overall Study||30
10844230|NCT00462943|12010113|FG002|NOT COMPLETED|Overall Study||23
10844231|NCT00248287|12010123|FG000|STARTED|Overall Study||75
10844232|NCT00248287|12010124|FG001|STARTED|Overall Study||79
10844233|NCT00248287|12010123|FG000|COMPLETED|Overall Study||51
10844234|NCT00248287|12010124|FG001|COMPLETED|Overall Study||60
10844235|NCT00248287|12010123|FG000|NOT COMPLETED|Overall Study||24
10844236|NCT00248287|12010124|FG001|NOT COMPLETED|Overall Study||19
10844237|NCT00182728|12010130|FG000|STARTED|Overall Study||71
10844238|NCT00182728|12010130|FG000|COMPLETED|Overall Study||71
10844239|NCT00182728|12010130|FG000|NOT COMPLETED|Overall Study||0
10844240|NCT00105560|12010134|FG000|STARTED|Overall Study||59
10844241|NCT00105560|12010134|FG000|COMPLETED|Overall Study||58
10844242|NCT00105560|12010134|FG000|NOT COMPLETED|Overall Study||1
10844243|NCT00038727|12010150|FG000|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|916
10844244|NCT00038727|12010151|FG001|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|927
10844245|NCT00038727|12010152|FG002|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|936
10844246|NCT00038727|12010150|FG000|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|910
10844247|NCT00038727|12010151|FG001|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|924
10844248|NCT00038727|12010152|FG002|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|932
10844249|NCT00038727|12010150|FG000|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|915
10844250|NCT00038727|12010151|FG001|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|926
10844251|NCT00038727|12010152|FG002|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|935
10844252|NCT00038727|12010150|FG000|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|751
10844253|NCT00038727|12010151|FG001|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|772
10844254|NCT00038727|12010152|FG002|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|780
10844255|NCT00038727|12010150|FG000|DPPOS Phase 3 Enrolled|Overall Study||916
10844256|NCT00038727|12010151|FG001|DPPOS Phase 3 Enrolled|Overall Study||927
10844257|NCT00038727|12010152|FG002|DPPOS Phase 3 Enrolled|Overall Study||936
10844258|NCT00038727|12010150|FG000|COMPLETED|Overall Study||916
10844259|NCT00038727|12010151|FG001|COMPLETED|Overall Study||927
10844260|NCT00038727|12010152|FG002|COMPLETED|Overall Study||936
10844261|NCT00038727|12010150|FG000|NOT COMPLETED|Overall Study||0
10844262|NCT00038727|12010151|FG001|NOT COMPLETED|Overall Study||0
10844263|NCT00038727|12010152|FG002|NOT COMPLETED|Overall Study||0
10412272|NCT00771667|11556359|FG000|STARTED|Induction Phase||132
10412273|NCT00771667|11556360|FG001|STARTED|Induction Phase||131
10412274|NCT00771667|11556361|FG002|STARTED|Induction Phase||132
10412275|NCT00771667|11556362|FG003|STARTED|Induction Phase||131
10412276|NCT00771667|11556363|FG004|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
10412277|NCT00771667|11556364|FG005|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
10412278|NCT00771667|11556365|FG006|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
10412279|NCT00771667|11556366|FG007|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
10412280|NCT00771667|11556367|FG008|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
10412281|NCT00771667|11556368|FG009|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
10412282|NCT00771667|11556359|FG000|COMPLETED|Induction Phase||113
10412283|NCT00771667|11556360|FG001|COMPLETED|Induction Phase||121
10412284|NCT00771667|11556361|FG002|COMPLETED|Induction Phase||120
10412285|NCT00771667|11556362|FG003|COMPLETED|Induction Phase||123
10412286|NCT00771667|11556363|FG004|COMPLETED|Induction Phase||0
10412287|NCT00771667|11556364|FG005|COMPLETED|Induction Phase||0
10412288|NCT00771667|11556365|FG006|COMPLETED|Induction Phase||0
10412289|NCT00771667|11556366|FG007|COMPLETED|Induction Phase||0
10412290|NCT00771667|11556367|FG008|COMPLETED|Induction Phase||0
10412291|NCT00771667|11556368|FG009|COMPLETED|Induction Phase||0
10412292|NCT00771667|11556359|FG000|NOT COMPLETED|Induction Phase||19
10412293|NCT00771667|11556360|FG001|NOT COMPLETED|Induction Phase||10
10844264|NCT04569786|12010168|FG000|STARTED|Overall Study||39
10844265|NCT04569786|12010169|FG001|STARTED|Overall Study||39
10844266|NCT04569786|12010170|FG002|STARTED|Overall Study||42
10844267|NCT04569786|12010171|FG003|STARTED|Overall Study||56
10844268|NCT04569786|12010172|FG004|STARTED|Overall Study||56
10844269|NCT04569786|12010168|FG000|COMPLETED|Overall Study||38
10844270|NCT04569786|12010169|FG001|COMPLETED|Overall Study||39
10844271|NCT04569786|12010170|FG002|COMPLETED|Overall Study||38
10844272|NCT04569786|12010171|FG003|COMPLETED|Overall Study||49
10844273|NCT04569786|12010172|FG004|COMPLETED|Overall Study||55
10844274|NCT04569786|12010168|FG000|NOT COMPLETED|Overall Study||1
10844275|NCT04569786|12010169|FG001|NOT COMPLETED|Overall Study||0
10844276|NCT04569786|12010170|FG002|NOT COMPLETED|Overall Study||4
10844277|NCT04569786|12010171|FG003|NOT COMPLETED|Overall Study||7
10844278|NCT04569786|12010172|FG004|NOT COMPLETED|Overall Study||1
10412294|NCT00771667|11556361|FG002|NOT COMPLETED|Induction Phase||12
10412295|NCT00771667|11556362|FG003|NOT COMPLETED|Induction Phase||8
10412296|NCT00771667|11556363|FG004|NOT COMPLETED|Induction Phase||0
10412297|NCT00771667|11556364|FG005|NOT COMPLETED|Induction Phase||0
10412298|NCT00771667|11556365|FG006|NOT COMPLETED|Induction Phase||0
10412299|NCT00771667|11556366|FG007|NOT COMPLETED|Induction Phase||0
10412300|NCT00771667|11556367|FG008|NOT COMPLETED|Induction Phase||0
10412301|NCT00771667|11556368|FG009|NOT COMPLETED|Induction Phase||0
10412302|NCT00771667|11556359|FG000|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
10412303|NCT00771667|11556360|FG001|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
10412304|NCT00771667|11556361|FG002|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
10412305|NCT00771667|11556362|FG003|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
10412306|NCT00771667|11556363|FG004|STARTED|Maintenance Phase||28
10412307|NCT00771667|11556364|FG005|STARTED|Maintenance Phase||85
10412308|NCT00771667|11556365|FG006|STARTED|Maintenance Phase||73
10412309|NCT00771667|11556366|FG007|STARTED|Maintenance Phase||72
10412310|NCT00771667|11556367|FG008|STARTED|Maintenance Phase||110
10412311|NCT00771667|11556368|FG009|STARTED|Maintenance Phase||109
10412312|NCT00771667|11556359|FG000|COMPLETED|Maintenance Phase||0
10412313|NCT00771667|11556360|FG001|COMPLETED|Maintenance Phase||0
10412314|NCT00771667|11556361|FG002|COMPLETED|Maintenance Phase||0
10412315|NCT00771667|11556362|FG003|COMPLETED|Maintenance Phase||0
10412316|NCT00771667|11556363|FG004|COMPLETED|Maintenance Phase||26
10412317|NCT00771667|11556364|FG005|COMPLETED|Maintenance Phase||78
10412318|NCT00771667|11556365|FG006|COMPLETED|Maintenance Phase||63
10412319|NCT00771667|11556366|FG007|COMPLETED|Maintenance Phase||67
10412320|NCT00771667|11556367|FG008|COMPLETED|Maintenance Phase||88
10412321|NCT00771667|11556368|FG009|COMPLETED|Maintenance Phase||92
10412322|NCT00771667|11556359|FG000|NOT COMPLETED|Maintenance Phase||0
10412323|NCT00771667|11556360|FG001|NOT COMPLETED|Maintenance Phase||0
10412324|NCT00771667|11556361|FG002|NOT COMPLETED|Maintenance Phase||0
10412325|NCT00771667|11556362|FG003|NOT COMPLETED|Maintenance Phase||0
10412326|NCT00771667|11556363|FG004|NOT COMPLETED|Maintenance Phase||2
10412327|NCT00771667|11556364|FG005|NOT COMPLETED|Maintenance Phase||7
10412328|NCT00771667|11556365|FG006|NOT COMPLETED|Maintenance Phase||10
10412329|NCT00771667|11556366|FG007|NOT COMPLETED|Maintenance Phase||5
10412330|NCT00771667|11556367|FG008|NOT COMPLETED|Maintenance Phase||22
10412331|NCT00771667|11556368|FG009|NOT COMPLETED|Maintenance Phase||17
10412332|NCT00771745|11556388|FG000|STARTED|Overall Study||6
10412333|NCT00771745|11556389|FG001|STARTED|Overall Study||5
10412334|NCT00771745|11556388|FG000|COMPLETED|Overall Study||6
10412335|NCT00771745|11556389|FG001|COMPLETED|Overall Study||5
10412336|NCT00771745|11556388|FG000|NOT COMPLETED|Overall Study||0
10412337|NCT00771745|11556389|FG001|NOT COMPLETED|Overall Study||0
10412338|NCT00771758|11556398|FG000|STARTED|Overall Study||44
10412339|NCT00771758|11556399|FG001|STARTED|Overall Study||43
10412340|NCT00771758|11556400|FG002|STARTED|Overall Study||21
10412341|NCT00771758|11556398|FG000|COMPLETED|Overall Study||36
10412342|NCT00771758|11556399|FG001|COMPLETED|Overall Study||31
10412343|NCT00771758|11556400|FG002|COMPLETED|Overall Study||19
10412344|NCT00771758|11556398|FG000|NOT COMPLETED|Overall Study||8
10412345|NCT00771758|11556399|FG001|NOT COMPLETED|Overall Study||12
10412346|NCT00771758|11556400|FG002|NOT COMPLETED|Overall Study||2
10412347|NCT00771810|11556428|FG000|STARTED|Overall Study||10
10412348|NCT00771810|11556429|FG001|STARTED|Overall Study||11
10412349|NCT00771810|11556430|FG002|STARTED|Overall Study||13
10412350|NCT00771810|11556428|FG000|COMPLETED|Overall Study||5
10412351|NCT00771810|11556429|FG001|COMPLETED|Overall Study||6
10412352|NCT00771810|11556430|FG002|COMPLETED|Overall Study||6
10412353|NCT00771810|11556428|FG000|NOT COMPLETED|Overall Study||5
10412354|NCT00771810|11556429|FG001|NOT COMPLETED|Overall Study||5
10412355|NCT00771810|11556430|FG002|NOT COMPLETED|Overall Study||7
10412356|NCT00771849|11556441|FG000|STARTED|Overall Study||52
10412357|NCT00771849|11556442|FG001|STARTED|Overall Study|One subject was not vaccinated|51
10412358|NCT00771849|11556441|FG000|COMPLETED|Overall Study||50
10412359|NCT00771849|11556442|FG001|COMPLETED|Overall Study||47
10412360|NCT00771849|11556441|FG000|NOT COMPLETED|Overall Study||2
10412361|NCT00771849|11556442|FG001|NOT COMPLETED|Overall Study||4
10844279|NCT04409041|12010184|FG000|STARTED|Overall Study||43
10844280|NCT04409041|12010184|FG000|COMPLETED|Overall Study||26
10844281|NCT04409041|12010184|FG000|NOT COMPLETED|Overall Study||17
10844282|NCT04129944|12010193|FG000|STARTED|Overall Study||46
10844283|NCT04129944|12010194|FG001|STARTED|Overall Study||45
10844284|NCT04129944|12010195|FG002|STARTED|Overall Study||46
10844285|NCT04129944|12010196|FG003|STARTED|Overall Study||46
10844286|NCT04129944|12010193|FG000|COMPLETED|Overall Study||44
10844287|NCT04129944|12010194|FG001|COMPLETED|Overall Study||45
10844288|NCT04129944|12010195|FG002|COMPLETED|Overall Study||45
10844289|NCT04129944|12010196|FG003|COMPLETED|Overall Study||43
10844290|NCT04129944|12010193|FG000|NOT COMPLETED|Overall Study||2
10844291|NCT04129944|12010194|FG001|NOT COMPLETED|Overall Study||0
10844292|NCT04129944|12010195|FG002|NOT COMPLETED|Overall Study||1
10844293|NCT04129944|12010196|FG003|NOT COMPLETED|Overall Study||3
10844294|NCT03861728|12010208|FG000|STARTED|Overall Study||6
10844295|NCT03861728|12010209|FG001|STARTED|Overall Study||5
10844296|NCT03861728|12010208|FG000|COMPLETED|Overall Study||6
10844297|NCT03861728|12010209|FG001|COMPLETED|Overall Study||5
10844298|NCT03861728|12010208|FG000|NOT COMPLETED|Overall Study||0
10844299|NCT03861728|12010209|FG001|NOT COMPLETED|Overall Study||0
10844300|NCT03857542|12010217|FG000|STARTED|Overall Study||215
10844301|NCT03857542|12010218|FG001|STARTED|Overall Study||212
10844302|NCT03857542|12010217|FG000|COMPLETED|Overall Study||209
10844303|NCT03857542|12010218|FG001|COMPLETED|Overall Study||207
10844304|NCT03857542|12010217|FG000|NOT COMPLETED|Overall Study||6
10844305|NCT03857542|12010218|FG001|NOT COMPLETED|Overall Study||5
10292488|NCT02852967|11425307|FG004|Completed Period 2: Open-label|Overall Study||14
10292489|NCT02852967|11425303|FG000|COMPLETED|Overall Study||9
10292490|NCT02852967|11425304|FG001|COMPLETED|Overall Study||6
10292491|NCT02852967|11425305|FG002|COMPLETED|Overall Study||9
10292492|NCT02852967|11425306|FG003|COMPLETED|Overall Study||4
10292493|NCT02852967|11425307|FG004|COMPLETED|Overall Study||2
10292494|NCT02852967|11425303|FG000|NOT COMPLETED|Overall Study||14
10292495|NCT02852967|11425304|FG001|NOT COMPLETED|Overall Study||16
10292496|NCT02852967|11425305|FG002|NOT COMPLETED|Overall Study||12
10292497|NCT02852967|11425306|FG003|NOT COMPLETED|Overall Study||22
10292498|NCT02852967|11425307|FG004|NOT COMPLETED|Overall Study||16
10292499|NCT02810418|11425334|FG000|STARTED|Arm A Dose Escalation||6
10844315|NCT03688802|12010242|FG000|STARTED|Overall Study||12
10844316|NCT03688802|12010243|FG001|STARTED|Overall Study||6
10844317|NCT03688802|12010242|FG000|COMPLETED|Overall Study||11
10844318|NCT03688802|12010243|FG001|COMPLETED|Overall Study||6
10844319|NCT03688802|12010242|FG000|NOT COMPLETED|Overall Study||1
10844320|NCT03688802|12010243|FG001|NOT COMPLETED|Overall Study||0
10844321|NCT03656744|12010252|FG000|STARTED|Overall Study||34
10844322|NCT03656744|12010253|FG001|STARTED|Overall Study||34
10844323|NCT03656744|12010254|FG002|STARTED|Overall Study||33
10844324|NCT03656744|12010252|FG000|COMPLETED|Overall Study||29
10844325|NCT03656744|12010253|FG001|COMPLETED|Overall Study||27
10844326|NCT03656744|12010254|FG002|COMPLETED|Overall Study||32
10844327|NCT03656744|12010252|FG000|NOT COMPLETED|Overall Study||5
10844328|NCT03656744|12010253|FG001|NOT COMPLETED|Overall Study||7
10844329|NCT03656744|12010254|FG002|NOT COMPLETED|Overall Study||1
10844330|NCT03510598|12010262|FG000|STARTED|Overall Study||16
10844331|NCT03510598|12010262|FG000|COMPLETED|Overall Study||15
10844332|NCT03510598|12010262|FG000|NOT COMPLETED|Overall Study||1
10844333|NCT03487796|12010270|FG000|STARTED|Overall Study||41
10844334|NCT03487796|12010271|FG001|STARTED|Overall Study||31
10844335|NCT03487796|12010270|FG000|2 Month Follow-up|Overall Study||24
10844336|NCT03487796|12010271|FG001|2 Month Follow-up|Overall Study||26
10844337|NCT03487796|12010270|FG000|COMPLETED|Overall Study||23
10844338|NCT03487796|12010271|FG001|COMPLETED|Overall Study||25
10844339|NCT03487796|12010270|FG000|NOT COMPLETED|Overall Study||18
10844340|NCT03487796|12010271|FG001|NOT COMPLETED|Overall Study||6
10844341|NCT03446612|12010285|FG000|STARTED|Overall Study||2
10844342|NCT03446612|12010286|FG001|STARTED|Overall Study||3
10844343|NCT03446612|12010285|FG000|COMPLETED|Overall Study||2
10844344|NCT03446612|12010286|FG001|COMPLETED|Overall Study||2
10844345|NCT03446612|12010285|FG000|NOT COMPLETED|Overall Study||0
10844346|NCT03446612|12010286|FG001|NOT COMPLETED|Overall Study||1
10844347|NCT03436433|12010297|FG000|STARTED|Overall Study||1
10844348|NCT03436433|12010298|FG001|STARTED|Overall Study||2
10844349|NCT03436433|12010299|FG002|STARTED|Overall Study||1
10844350|NCT03436433|12010297|FG000|COMPLETED|Overall Study||1
10844351|NCT03436433|12010298|FG001|COMPLETED|Overall Study||2
10844352|NCT03436433|12010299|FG002|COMPLETED|Overall Study||1
10844353|NCT03436433|12010297|FG000|NOT COMPLETED|Overall Study||0
10844354|NCT03436433|12010298|FG001|NOT COMPLETED|Overall Study||0
10844355|NCT03436433|12010299|FG002|NOT COMPLETED|Overall Study||0
10844356|NCT03370120|12010307|FG000|STARTED|Overall Study||406
10844357|NCT03370120|12010307|FG000|COMPLETED|Overall Study||0
10844358|NCT03370120|12010307|FG000|NOT COMPLETED|Overall Study||406
10844359|NCT03367429|12010316|FG000|STARTED|Overall Study||0
10844360|NCT03367429|12010317|FG001|STARTED|Overall Study||1
10844361|NCT03367429|12010318|FG002|STARTED|Overall Study||2
10844362|NCT03367429|12010316|FG000|COMPLETED|Overall Study||0
10844363|NCT03367429|12010317|FG001|COMPLETED|Overall Study||1
10844364|NCT03367429|12010318|FG002|COMPLETED|Overall Study||2
10844365|NCT03367429|12010316|FG000|NOT COMPLETED|Overall Study||0
10844366|NCT03367429|12010317|FG001|NOT COMPLETED|Overall Study||0
10844367|NCT03367429|12010318|FG002|NOT COMPLETED|Overall Study||0
10844368|NCT03143829|12010330|FG000|STARTED|Overall Study||38
10844369|NCT03143829|12010331|FG001|STARTED|Overall Study||42
10844370|NCT03143829|12010330|FG000|COMPLETED|Overall Study||33
10844371|NCT03143829|12010331|FG001|COMPLETED|Overall Study||32
10844372|NCT03143829|12010330|FG000|NOT COMPLETED|Overall Study||5
10844373|NCT03143829|12010331|FG001|NOT COMPLETED|Overall Study||10
10844374|NCT03099863|12010339|FG000|STARTED|Overall Study||121
10844375|NCT03099863|12010340|FG001|STARTED|Overall Study||121
10844376|NCT03099863|12010339|FG000|COMPLETED|Overall Study||111
10844377|NCT03099863|12010340|FG001|COMPLETED|Overall Study||105
10844378|NCT03099863|12010339|FG000|NOT COMPLETED|Overall Study||10
10844379|NCT03099863|12010340|FG001|NOT COMPLETED|Overall Study||16
10844380|NCT02963610|12010346|FG000|STARTED|Overall Study||3
10844381|NCT02963610|12010346|FG000|COMPLETED|Overall Study||0
10844382|NCT02963610|12010346|FG000|NOT COMPLETED|Overall Study||3
10844383|NCT02766335|12010353|FG000|STARTED|Initial Registration||68
10844384|NCT02766335|12010354|FG001|STARTED|Initial Registration||30
10844385|NCT02766335|12010355|FG002|STARTED|Initial Registration||0
10844386|NCT02766335|12010353|FG000|Eligible Participants Enrolled Before Docetaxel Arm Closed|Initial Registration||32
10844387|NCT02766335|12010354|FG001|Eligible Participants Enrolled Before Docetaxel Arm Closed|Initial Registration||30
10844388|NCT02766335|12010355|FG002|Eligible Participants Enrolled Before Docetaxel Arm Closed|Initial Registration||0
10844389|NCT02766335|12010353|FG000|COMPLETED|Initial Registration||10
10844390|NCT02766335|12010354|FG001|COMPLETED|Initial Registration||0
10844391|NCT02766335|12010355|FG002|COMPLETED|Initial Registration||0
10844392|NCT02766335|12010353|FG000|NOT COMPLETED|Initial Registration||58
10844393|NCT02766335|12010354|FG001|NOT COMPLETED|Initial Registration||30
10844394|NCT02766335|12010355|FG002|NOT COMPLETED|Initial Registration||0
10844395|NCT02766335|12010353|FG000|STARTED|Re-registration of Arm I to MEDI4738||0
10844396|NCT02766335|12010354|FG001|STARTED|Re-registration of Arm I to MEDI4738||0
10844397|NCT02766335|12010355|FG002|STARTED|Re-registration of Arm I to MEDI4738||4
10844398|NCT02766335|12010353|FG000|COMPLETED|Re-registration of Arm I to MEDI4738||0
10844399|NCT02766335|12010354|FG001|COMPLETED|Re-registration of Arm I to MEDI4738||0
10844400|NCT02766335|12010355|FG002|COMPLETED|Re-registration of Arm I to MEDI4738||2
10844401|NCT02766335|12010353|FG000|NOT COMPLETED|Re-registration of Arm I to MEDI4738||0
10844402|NCT02766335|12010354|FG001|NOT COMPLETED|Re-registration of Arm I to MEDI4738||0
10844403|NCT02766335|12010355|FG002|NOT COMPLETED|Re-registration of Arm I to MEDI4738||2
10844404|NCT02606136|12010361|FG000|STARTED|Overall Study||21
10844405|NCT02606136|12010361|FG000|Received at Least 1 Dose of Study Drug|Overall Study||21
10844406|NCT02606136|12010361|FG000|COMPLETED|Overall Study||15
10844407|NCT02606136|12010361|FG000|NOT COMPLETED|Overall Study||6
10412362|NCT00771875|11556451|FG000|STARTED|Overall Study||10
10412363|NCT00771875|11556452|FG001|STARTED|Overall Study||10
10412364|NCT00771875|11556453|FG002|STARTED|Overall Study||10
10412365|NCT00771875|11556451|FG000|COMPLETED|Overall Study||10
10412366|NCT00771875|11556452|FG001|COMPLETED|Overall Study||9
10412367|NCT00771875|11556453|FG002|COMPLETED|Overall Study||10
10412368|NCT00771875|11556451|FG000|NOT COMPLETED|Overall Study||0
10754628|NCT03054337|11918338|FG004|NOT COMPLETED|Dose Adjustment and Maintenance Period||0
10754629|NCT03054337|11918339|FG005|NOT COMPLETED|Dose Adjustment and Maintenance Period||1
10754630|NCT03054350|11918372|FG000|STARTED|Primary Efficacy Period (6 Weeks)||15
10754631|NCT03054350|11918373|FG001|STARTED|Primary Efficacy Period (6 Weeks)||15
10754632|NCT03054350|11918374|FG002|STARTED|Primary Efficacy Period (6 Weeks)||15
10754633|NCT03054350|11918375|FG003|STARTED|Primary Efficacy Period (6 Weeks)||5
10754634|NCT03054350|11918376|FG004|STARTED|Primary Efficacy Period (6 Weeks)||5
10754635|NCT03054350|11918377|FG005|STARTED|Primary Efficacy Period (6 Weeks)||5
10754636|NCT03054350|11918372|FG000|COMPLETED|Primary Efficacy Period (6 Weeks)||11
10754637|NCT03054350|11918373|FG001|COMPLETED|Primary Efficacy Period (6 Weeks)||13
10754638|NCT03054350|11918374|FG002|COMPLETED|Primary Efficacy Period (6 Weeks)||13
10754639|NCT03054350|11918375|FG003|COMPLETED|Primary Efficacy Period (6 Weeks)||3
10754640|NCT03054350|11918376|FG004|COMPLETED|Primary Efficacy Period (6 Weeks)||1
10754641|NCT03054350|11918377|FG005|COMPLETED|Primary Efficacy Period (6 Weeks)||2
10754642|NCT03054350|11918372|FG000|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||4
10754643|NCT03054350|11918373|FG001|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||2
10754644|NCT03054350|11918374|FG002|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||2
10754645|NCT03054350|11918375|FG003|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||2
10754646|NCT03054350|11918376|FG004|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||4
10754647|NCT03054350|11918377|FG005|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||3
10754648|NCT03054350|11918372|FG000|STARTED|Dose Adjustment and Maintenance Period||11
10754649|NCT03054350|11918373|FG001|STARTED|Dose Adjustment and Maintenance Period||13
10754650|NCT03054350|11918374|FG002|STARTED|Dose Adjustment and Maintenance Period||13
10754651|NCT03054350|11918375|FG003|STARTED|Dose Adjustment and Maintenance Period||3
10754652|NCT03054350|11918376|FG004|STARTED|Dose Adjustment and Maintenance Period||1
10754653|NCT03054350|11918377|FG005|STARTED|Dose Adjustment and Maintenance Period||2
10754654|NCT03054350|11918372|FG000|COMPLETED|Dose Adjustment and Maintenance Period||10
10754655|NCT03054350|11918373|FG001|COMPLETED|Dose Adjustment and Maintenance Period||13
10754656|NCT03054350|11918374|FG002|COMPLETED|Dose Adjustment and Maintenance Period||12
10754657|NCT03054350|11918375|FG003|COMPLETED|Dose Adjustment and Maintenance Period||2
10754658|NCT03054350|11918376|FG004|COMPLETED|Dose Adjustment and Maintenance Period||1
10754659|NCT03054350|11918377|FG005|COMPLETED|Dose Adjustment and Maintenance Period||2
10412369|NCT00771875|11556452|FG001|NOT COMPLETED|Overall Study||1
10412370|NCT00771875|11556453|FG002|NOT COMPLETED|Overall Study||0
10844408|NCT02228382|12010370|FG000|STARTED|Overall Study||46
10844409|NCT02228382|12010371|FG001|STARTED|Overall Study||61
10844410|NCT02228382|12010372|FG002|STARTED|Overall Study||49
10844411|NCT02228382|12010373|FG003|STARTED|Overall Study||4
10844412|NCT02228382|12010374|FG004|STARTED|Overall Study||3
10844413|NCT02228382|12010370|FG000|COMPLETED|Overall Study||36
10844414|NCT02228382|12010371|FG001|COMPLETED|Overall Study||43
10844415|NCT02228382|12010372|FG002|COMPLETED|Overall Study||28
10844416|NCT02228382|12010373|FG003|COMPLETED|Overall Study||2
10844417|NCT02228382|12010374|FG004|COMPLETED|Overall Study||1
10844418|NCT02228382|12010370|FG000|NOT COMPLETED|Overall Study||10
10844419|NCT02228382|12010371|FG001|NOT COMPLETED|Overall Study||18
10844420|NCT02228382|12010372|FG002|NOT COMPLETED|Overall Study||21
10844421|NCT02228382|12010373|FG003|NOT COMPLETED|Overall Study||2
10844422|NCT02228382|12010374|FG004|NOT COMPLETED|Overall Study||2
10844423|NCT02090998|12010393|FG000|STARTED|Overall Study||2
10844424|NCT02090998|12010394|FG001|STARTED|Overall Study||8
10844425|NCT02090998|12010393|FG000|COMPLETED|Overall Study||2
10844426|NCT02090998|12010394|FG001|COMPLETED|Overall Study||8
10844427|NCT02090998|12010393|FG000|NOT COMPLETED|Overall Study||0
10844428|NCT02090998|12010394|FG001|NOT COMPLETED|Overall Study||0
10844429|NCT02051309|12010402|FG000|STARTED|Overall Study||58
10844430|NCT02051309|12010403|FG001|STARTED|Overall Study||63
10844431|NCT02051309|12010402|FG000|COMPLETED|Overall Study||26
10844432|NCT02051309|12010403|FG001|COMPLETED|Overall Study||35
10844433|NCT02051309|12010402|FG000|NOT COMPLETED|Overall Study||32
10844434|NCT02051309|12010403|FG001|NOT COMPLETED|Overall Study||28
10844435|NCT02001623|12010424|FG000|STARTED|Overall Study||3
10844436|NCT02001623|12010425|FG001|STARTED|Overall Study||3
10844437|NCT02001623|12010426|FG002|STARTED|Overall Study||3
10844438|NCT02001623|12010427|FG003|STARTED|Overall Study||3
10844439|NCT02001623|12010428|FG004|STARTED|Overall Study||3
10844440|NCT02001623|12010429|FG005|STARTED|Overall Study||3
10844441|NCT02001623|12010430|FG006|STARTED|Overall Study||3
10844442|NCT02001623|12010431|FG007|STARTED|Overall Study||6
10844443|NCT02001623|12010432|FG008|STARTED|Overall Study||15
10844444|NCT02001623|12010433|FG009|STARTED|Overall Study||55
10844445|NCT02001623|12010434|FG010|STARTED|Overall Study||14
10844446|NCT02001623|12010435|FG011|STARTED|Overall Study||15
10844447|NCT02001623|12010436|FG012|STARTED|Overall Study||15
10844448|NCT02001623|12010437|FG013|STARTED|Overall Study||36
10844449|NCT02001623|12010438|FG014|STARTED|Overall Study||18
10844450|NCT02001623|12010424|FG000|Completed 4 Cycles of Treatment|Overall Study||0
10844451|NCT02001623|12010425|FG001|Completed 4 Cycles of Treatment|Overall Study||1
10844452|NCT02001623|12010426|FG002|Completed 4 Cycles of Treatment|Overall Study||1
10844453|NCT02001623|12010427|FG003|Completed 4 Cycles of Treatment|Overall Study||2
10844454|NCT02001623|12010428|FG004|Completed 4 Cycles of Treatment|Overall Study||0
10844455|NCT02001623|12010429|FG005|Completed 4 Cycles of Treatment|Overall Study||2
10844456|NCT02001623|12010430|FG006|Completed 4 Cycles of Treatment|Overall Study||2
10844457|NCT02001623|12010431|FG007|Completed 4 Cycles of Treatment|Overall Study||1
10844458|NCT02001623|12010432|FG008|Completed 4 Cycles of Treatment|Overall Study||5
10844459|NCT02001623|12010433|FG009|Completed 4 Cycles of Treatment|Overall Study||31
10844460|NCT02001623|12010434|FG010|Completed 4 Cycles of Treatment|Overall Study||6
10844461|NCT02001623|12010435|FG011|Completed 4 Cycles of Treatment|Overall Study||4
10844462|NCT02001623|12010436|FG012|Completed 4 Cycles of Treatment|Overall Study||6
10844463|NCT02001623|12010437|FG013|Completed 4 Cycles of Treatment|Overall Study||22
10844464|NCT02001623|12010438|FG014|Completed 4 Cycles of Treatment|Overall Study||7
10844465|NCT02001623|12010424|FG000|Completed 12 Cycles of Treatment|Overall Study||0
10844466|NCT02001623|12010425|FG001|Completed 12 Cycles of Treatment|Overall Study||1
10844467|NCT02001623|12010426|FG002|Completed 12 Cycles of Treatment|Overall Study||0
10844468|NCT02001623|12010427|FG003|Completed 12 Cycles of Treatment|Overall Study||1
10844469|NCT02001623|12010428|FG004|Completed 12 Cycles of Treatment|Overall Study||0
10844470|NCT02001623|12010429|FG005|Completed 12 Cycles of Treatment|Overall Study||0
10844471|NCT02001623|12010430|FG006|Completed 12 Cycles of Treatment|Overall Study||0
10844472|NCT02001623|12010431|FG007|Completed 12 Cycles of Treatment|Overall Study||0
10844473|NCT02001623|12010432|FG008|Completed 12 Cycles of Treatment|Overall Study||0
10844474|NCT02001623|12010433|FG009|Completed 12 Cycles of Treatment|Overall Study||3
10844475|NCT02001623|12010434|FG010|Completed 12 Cycles of Treatment|Overall Study||0
10844476|NCT02001623|12010435|FG011|Completed 12 Cycles of Treatment|Overall Study||0
10844477|NCT02001623|12010436|FG012|Completed 12 Cycles of Treatment|Overall Study||1
10844478|NCT02001623|12010437|FG013|Completed 12 Cycles of Treatment|Overall Study||1
10844479|NCT02001623|12010438|FG014|Completed 12 Cycles of Treatment|Overall Study||0
10844480|NCT02001623|12010424|FG000|COMPLETED|Overall Study||0
10844481|NCT02001623|12010425|FG001|COMPLETED|Overall Study||0
10844482|NCT02001623|12010426|FG002|COMPLETED|Overall Study||0
10844483|NCT02001623|12010427|FG003|COMPLETED|Overall Study||1
10844484|NCT02001623|12010428|FG004|COMPLETED|Overall Study||0
10844485|NCT02001623|12010429|FG005|COMPLETED|Overall Study||0
10844486|NCT02001623|12010430|FG006|COMPLETED|Overall Study||0
10844487|NCT02001623|12010431|FG007|COMPLETED|Overall Study||0
10844488|NCT02001623|12010432|FG008|COMPLETED|Overall Study||0
10844489|NCT02001623|12010433|FG009|COMPLETED|Overall Study||2
10844490|NCT02001623|12010434|FG010|COMPLETED|Overall Study||0
10844491|NCT02001623|12010435|FG011|COMPLETED|Overall Study||0
10844492|NCT02001623|12010436|FG012|COMPLETED|Overall Study||1
10844493|NCT02001623|12010437|FG013|COMPLETED|Overall Study||1
10844494|NCT02001623|12010438|FG014|COMPLETED|Overall Study||0
10844495|NCT02001623|12010424|FG000|NOT COMPLETED|Overall Study||3
10844496|NCT02001623|12010425|FG001|NOT COMPLETED|Overall Study||3
10844497|NCT02001623|12010426|FG002|NOT COMPLETED|Overall Study||3
10844498|NCT02001623|12010427|FG003|NOT COMPLETED|Overall Study||2
10844499|NCT02001623|12010428|FG004|NOT COMPLETED|Overall Study||3
10844500|NCT02001623|12010429|FG005|NOT COMPLETED|Overall Study||3
10844501|NCT02001623|12010430|FG006|NOT COMPLETED|Overall Study||3
10844502|NCT02001623|12010431|FG007|NOT COMPLETED|Overall Study||6
10844503|NCT02001623|12010432|FG008|NOT COMPLETED|Overall Study||15
10844504|NCT02001623|12010433|FG009|NOT COMPLETED|Overall Study||53
10844505|NCT02001623|12010434|FG010|NOT COMPLETED|Overall Study||14
10844506|NCT02001623|12010435|FG011|NOT COMPLETED|Overall Study||15
10844507|NCT02001623|12010436|FG012|NOT COMPLETED|Overall Study||14
10844508|NCT02001623|12010437|FG013|NOT COMPLETED|Overall Study||35
10844509|NCT02001623|12010438|FG014|NOT COMPLETED|Overall Study||18
10844510|NCT01900002|12010487|FG000|STARTED|Overall Study||40
10844511|NCT01900002|12010487|FG000|COMPLETED|Overall Study||34
10844512|NCT01900002|12010487|FG000|NOT COMPLETED|Overall Study||6
10844513|NCT01595061|12010491|FG000|STARTED|Overall Study||57
10844514|NCT01595061|12010491|FG000|COMPLETED|Overall Study||53
10844515|NCT01595061|12010491|FG000|NOT COMPLETED|Overall Study||4
10844516|NCT04502212|12010495|FG000|STARTED|Overall Study||16
10844517|NCT04502212|12010495|FG000|COMPLETED|Overall Study||14
10844518|NCT04502212|12010495|FG000|NOT COMPLETED|Overall Study||2
10844519|NCT04442230|12010502|FG000|STARTED|Overall Study||23
10844520|NCT04442230|12010503|FG001|STARTED|Overall Study||25
10844521|NCT04442230|12010502|FG000|COMPLETED|Overall Study||23
10844522|NCT04442230|12010503|FG001|COMPLETED|Overall Study||24
10844523|NCT04442230|12010502|FG000|NOT COMPLETED|Overall Study||0
10844524|NCT04442230|12010503|FG001|NOT COMPLETED|Overall Study||1
10844525|NCT04794803|12010511|FG000|STARTED|Overall Study||37
10844526|NCT04794803|12010512|FG001|STARTED|Overall Study||19
10844527|NCT04794803|12010511|FG000|FAS Population|Overall Study||36
10844528|NCT04794803|12010512|FG001|FAS Population|Overall Study||19
10844529|NCT04794803|12010511|FG000|Safety Set|Overall Study||36
10844530|NCT04794803|12010512|FG001|Safety Set|Overall Study||19
10844531|NCT04794803|12010511|FG000|Per Protocol Set|Overall Study||17
10844532|NCT04794803|12010512|FG001|Per Protocol Set|Overall Study||11
10844533|NCT04794803|12010511|FG000|COMPLETED|Overall Study||27
10844534|NCT04794803|12010512|FG001|COMPLETED|Overall Study||11
10844535|NCT04794803|12010511|FG000|NOT COMPLETED|Overall Study||10
10844536|NCT04794803|12010512|FG001|NOT COMPLETED|Overall Study||8
10844537|NCT04706403|12010523|FG000|STARTED|Overall Study||172
10844538|NCT04706403|12010524|FG001|STARTED|Overall Study||121
10844539|NCT04706403|12010525|FG002|STARTED|Overall Study||165
10844540|NCT04706403|12010526|FG003|STARTED|Overall Study||146
10844541|NCT04706403|12010527|FG004|STARTED|Overall Study||152
10844542|NCT04706403|12010523|FG000|COMPLETED|Overall Study||172
10844543|NCT04706403|12010524|FG001|COMPLETED|Overall Study||121
10844544|NCT04706403|12010525|FG002|COMPLETED|Overall Study||164
10844545|NCT04706403|12010526|FG003|COMPLETED|Overall Study||145
10844546|NCT04706403|12010527|FG004|COMPLETED|Overall Study||150
10844547|NCT04706403|12010523|FG000|NOT COMPLETED|Overall Study||0
10844548|NCT04706403|12010524|FG001|NOT COMPLETED|Overall Study||0
10844549|NCT04706403|12010525|FG002|NOT COMPLETED|Overall Study||1
10844550|NCT04706403|12010526|FG003|NOT COMPLETED|Overall Study||1
10844551|NCT04706403|12010527|FG004|NOT COMPLETED|Overall Study||2
10844552|NCT04440449|12010541|FG000|STARTED|Overall Study||20
10844553|NCT04440449|12010542|FG001|STARTED|Overall Study||0
10844554|NCT04440449|12010541|FG000|COMPLETED|Overall Study||18
10844555|NCT04440449|12010542|FG001|COMPLETED|Overall Study||0
10844556|NCT04440449|12010541|FG000|NOT COMPLETED|Overall Study||2
10844557|NCT04440449|12010542|FG001|NOT COMPLETED|Overall Study||0
10844558|NCT04369469|12010551|FG000|STARTED|Overall Study||135
10844559|NCT04369469|12010552|FG001|STARTED|Overall Study||67
10844560|NCT04369469|12010551|FG000|Intent to Treat (ITT) Population|Overall Study||135
10844561|NCT04369469|12010552|FG001|Intent to Treat (ITT) Population|Overall Study||66
10844562|NCT04369469|12010551|FG000|Pharmacokinetic (PK)|Overall Study||127
10844563|NCT04369469|12010552|FG001|Pharmacokinetic (PK)|Overall Study||52
10844564|NCT04369469|12010551|FG000|Safety Population|Overall Study||127
10844565|NCT04369469|12010552|FG001|Safety Population|Overall Study||67
10844566|NCT04369469|12010551|FG000|COMPLETED|Overall Study||125
10844567|NCT04369469|12010552|FG001|COMPLETED|Overall Study||58
10844568|NCT04369469|12010551|FG000|NOT COMPLETED|Overall Study||10
10844569|NCT04369469|12010552|FG001|NOT COMPLETED|Overall Study||9
10844570|NCT04036799|12010558|FG000|STARTED|Overall Study||572
10844571|NCT04036799|12010558|FG000|COMPLETED|Overall Study||572
10844572|NCT04036799|12010558|FG000|NOT COMPLETED|Overall Study||0
10292500|NCT02810418|11425335|FG001|STARTED|Arm A Dose Escalation||8
10292501|NCT02810418|11425336|FG002|STARTED|Arm A Dose Escalation||0
10292502|NCT02810418|11425337|FG003|STARTED|Arm A Dose Escalation||0
10292503|NCT02810418|11425338|FG004|STARTED|Arm A Dose Escalation||0
10292504|NCT02810418|11425339|FG005|STARTED|Arm A Dose Escalation||0
10292505|NCT02810418|11425340|FG006|STARTED|Arm A Dose Escalation||0
10292506|NCT02810418|11425334|FG000|COMPLETED|Arm A Dose Escalation||4
10292507|NCT02810418|11425335|FG001|COMPLETED|Arm A Dose Escalation||7
10292508|NCT02810418|11425336|FG002|COMPLETED|Arm A Dose Escalation||0
10292509|NCT02810418|11425337|FG003|COMPLETED|Arm A Dose Escalation||0
10292510|NCT02810418|11425338|FG004|COMPLETED|Arm A Dose Escalation||0
10292511|NCT02810418|11425339|FG005|COMPLETED|Arm A Dose Escalation||0
10292512|NCT02810418|11425340|FG006|COMPLETED|Arm A Dose Escalation||0
10292513|NCT02810418|11425334|FG000|NOT COMPLETED|Arm A Dose Escalation||2
10292514|NCT02810418|11425335|FG001|NOT COMPLETED|Arm A Dose Escalation||1
10292515|NCT02810418|11425336|FG002|NOT COMPLETED|Arm A Dose Escalation||0
10292516|NCT02810418|11425337|FG003|NOT COMPLETED|Arm A Dose Escalation||0
10844609|NCT03772574|12010582|FG000|STARTED|Overall Study||42
10844610|NCT03772574|12010583|FG001|STARTED|Overall Study||25
10844611|NCT03772574|12010584|FG002|STARTED|Overall Study||24
10844612|NCT03772574|12010582|FG000|COMPLETED|Overall Study||40
10844613|NCT03772574|12010583|FG001|COMPLETED|Overall Study||20
10844614|NCT03772574|12010584|FG002|COMPLETED|Overall Study||20
10844615|NCT03772574|12010582|FG000|NOT COMPLETED|Overall Study||2
10844616|NCT03772574|12010583|FG001|NOT COMPLETED|Overall Study||5
10844617|NCT03772574|12010584|FG002|NOT COMPLETED|Overall Study||4
10844618|NCT03594955|12010592|FG000|STARTED|Overall Study||7
10844619|NCT03594955|12010592|FG000|COMPLETED|Overall Study||0
10844620|NCT03594955|12010592|FG000|NOT COMPLETED|Overall Study||7
10844621|NCT03548220|12010600|FG000|STARTED|Overall Study||40
10844622|NCT03548220|12010601|FG001|STARTED|Overall Study||2
10844623|NCT03548220|12010602|FG002|STARTED|Overall Study||3
10844624|NCT03548220|12010603|FG003|STARTED|Overall Study||35
10844625|NCT03548220|12010600|FG000|COMPLETED|Overall Study||39
10844626|NCT03548220|12010601|FG001|COMPLETED|Overall Study||2
10844627|NCT03548220|12010602|FG002|COMPLETED|Overall Study||3
10844628|NCT03548220|12010603|FG003|COMPLETED|Overall Study||35
10844629|NCT03548220|12010600|FG000|NOT COMPLETED|Overall Study||1
10844630|NCT03548220|12010601|FG001|NOT COMPLETED|Overall Study||0
10844631|NCT03548220|12010602|FG002|NOT COMPLETED|Overall Study||0
10844632|NCT03548220|12010603|FG003|NOT COMPLETED|Overall Study||0
10844633|NCT03453684|12010623|FG000|STARTED|Overall Study||60
10844634|NCT03453684|12010623|FG000|COMPLETED|Overall Study||60
10844635|NCT03453684|12010623|FG000|NOT COMPLETED|Overall Study||0
10844636|NCT03434041|12010629|FG000|STARTED|Double Blind Treatment Phase (4 Weeks)||126
10844637|NCT03434041|12010630|FG001|STARTED|Double Blind Treatment Phase (4 Weeks)||126
10844638|NCT03434041|12010629|FG000|Full Analysis Set|Double Blind Treatment Phase (4 Weeks)||124
10844639|NCT03434041|12010630|FG001|Full Analysis Set|Double Blind Treatment Phase (4 Weeks)||126
10844640|NCT03434041|12010629|FG000|COMPLETED|Double Blind Treatment Phase (4 Weeks)||108
10844641|NCT03434041|12010630|FG001|COMPLETED|Double Blind Treatment Phase (4 Weeks)||106
10844642|NCT03434041|12010629|FG000|NOT COMPLETED|Double Blind Treatment Phase (4 Weeks)||18
10844643|NCT03434041|12010630|FG001|NOT COMPLETED|Double Blind Treatment Phase (4 Weeks)||20
10844644|NCT03434041|12010629|FG000|STARTED|Follow-up Phase (Up to 8 Weeks)||106
10844645|NCT03434041|12010630|FG001|STARTED|Follow-up Phase (Up to 8 Weeks)||103
10844646|NCT03434041|12010629|FG000|COMPLETED|Follow-up Phase (Up to 8 Weeks)||99
10844647|NCT03434041|12010630|FG001|COMPLETED|Follow-up Phase (Up to 8 Weeks)||100
10844648|NCT03434041|12010629|FG000|NOT COMPLETED|Follow-up Phase (Up to 8 Weeks)||7
10844649|NCT03434041|12010630|FG001|NOT COMPLETED|Follow-up Phase (Up to 8 Weeks)||3
10844650|NCT03420222|12010640|FG000|STARTED|Overall Study||8
10844651|NCT03420222|12010641|FG001|STARTED|Overall Study||2
10844652|NCT03420222|12010640|FG000|COMPLETED|Overall Study||3
10844653|NCT03420222|12010641|FG001|COMPLETED|Overall Study||1
10844654|NCT03420222|12010640|FG000|NOT COMPLETED|Overall Study||5
10844655|NCT03420222|12010641|FG001|NOT COMPLETED|Overall Study||1
10844656|NCT03409796|12010649|FG000|STARTED|Overall Study||9
10844657|NCT03409796|12010650|FG001|STARTED|Overall Study||7
10844658|NCT03409796|12010649|FG000|COMPLETED|Overall Study||7
10844659|NCT03409796|12010650|FG001|COMPLETED|Overall Study||6
10844660|NCT03409796|12010649|FG000|NOT COMPLETED|Overall Study||2
10844661|NCT03409796|12010650|FG001|NOT COMPLETED|Overall Study||1
10844662|NCT03215706|12010658|FG000|STARTED|Randomization||361
10844663|NCT03215706|12010659|FG001|STARTED|Randomization||358
10844664|NCT03215706|12010658|FG000|COMPLETED|Randomization||358
10844665|NCT03215706|12010659|FG001|COMPLETED|Randomization||349
10844666|NCT03215706|12010658|FG000|NOT COMPLETED|Randomization||3
10844667|NCT03215706|12010659|FG001|NOT COMPLETED|Randomization||9
10844668|NCT03215706|12010658|FG000|STARTED|Treatment Period||358
10844669|NCT03215706|12010659|FG001|STARTED|Treatment Period||349
10844670|NCT03215706|12010658|FG000|COMPLETED|Treatment Period||16
10844671|NCT03215706|12010659|FG001|COMPLETED|Treatment Period||103
10844672|NCT03215706|12010658|FG000|NOT COMPLETED|Treatment Period||342
10844673|NCT03215706|12010659|FG001|NOT COMPLETED|Treatment Period||246
10844674|NCT03189563|12010668|FG000|STARTED|Overall Study||20
10844675|NCT03189563|12010669|FG001|STARTED|Overall Study||21
10844676|NCT03189563|12010670|FG002|STARTED|Overall Study||20
10844677|NCT03189563|12010668|FG000|ITT Population|Overall Study||20
10844678|NCT03189563|12010669|FG001|ITT Population|Overall Study||21
10844679|NCT03189563|12010670|FG002|ITT Population|Overall Study||19
10844680|NCT03189563|12010668|FG000|Safety Population|Overall Study||20
10844681|NCT03189563|12010669|FG001|Safety Population|Overall Study||21
10844682|NCT03189563|12010670|FG002|Safety Population|Overall Study||19
10844683|NCT03189563|12010668|FG000|COMPLETED|Overall Study||19
10844684|NCT03189563|12010669|FG001|COMPLETED|Overall Study||20
10844685|NCT03189563|12010670|FG002|COMPLETED|Overall Study||18
10844686|NCT03189563|12010668|FG000|NOT COMPLETED|Overall Study||1
10844687|NCT03189563|12010669|FG001|NOT COMPLETED|Overall Study||1
10844688|NCT03189563|12010670|FG002|NOT COMPLETED|Overall Study||2
10412371|NCT00771901|11556464|FG000|STARTED|Overall Study||10
10412372|NCT00771901|11556465|FG001|STARTED|Overall Study||10
10412373|NCT00771901|11556466|FG002|STARTED|Overall Study||10
10412374|NCT00771901|11556464|FG000|COMPLETED|Overall Study||10
10412375|NCT00771901|11556465|FG001|COMPLETED|Overall Study||10
10412376|NCT00771901|11556466|FG002|COMPLETED|Overall Study||6
10412377|NCT00771901|11556464|FG000|NOT COMPLETED|Overall Study||0
10412378|NCT00771901|11556465|FG001|NOT COMPLETED|Overall Study||0
10412379|NCT00771901|11556466|FG002|NOT COMPLETED|Overall Study||4
10412380|NCT00771914|11556478|FG000|STARTED|Overall Study||7
10412381|NCT00771914|11556479|FG001|STARTED|Overall Study||6
10412382|NCT00771914|11556480|FG002|STARTED|Overall Study||6
10412383|NCT00771914|11556481|FG003|STARTED|Overall Study||8
10412384|NCT00771914|11556478|FG000|COMPLETED|Overall Study||7
10412385|NCT00771914|11556479|FG001|COMPLETED|Overall Study||6
10412386|NCT00771914|11556480|FG002|COMPLETED|Overall Study||6
10412387|NCT00771914|11556481|FG003|COMPLETED|Overall Study||6
10412388|NCT00771914|11556478|FG000|NOT COMPLETED|Overall Study||0
10412389|NCT00771914|11556479|FG001|NOT COMPLETED|Overall Study||0
10412390|NCT00771914|11556480|FG002|NOT COMPLETED|Overall Study||0
10412391|NCT00771914|11556481|FG003|NOT COMPLETED|Overall Study||2
10412392|NCT00771927|11556493|FG000|STARTED|Overall Study|Participant Flow and Baseline Characteristics refer to the Safety Set population.|511
10412393|NCT00771927|11556494|FG001|STARTED|Overall Study|Participant Flow and Baseline Characteristics refer to the Safety Set population.|493
10412394|NCT00771927|11556493|FG000|COMPLETED|Overall Study||256
10412395|NCT00771927|11556494|FG001|COMPLETED|Overall Study||256
10412396|NCT00771927|11556493|FG000|NOT COMPLETED|Overall Study||255
10412397|NCT00771927|11556494|FG001|NOT COMPLETED|Overall Study||237
10412398|NCT00771953|11556502|FG000|STARTED|Overall Study||36
10412399|NCT00771953|11556503|FG001|STARTED|Overall Study||36
10412400|NCT00771953|11556502|FG000|COMPLETED|Overall Study||26
10412401|NCT00771953|11556503|FG001|COMPLETED|Overall Study||26
10412402|NCT00771953|11556502|FG000|NOT COMPLETED|Overall Study||10
10412403|NCT00771953|11556503|FG001|NOT COMPLETED|Overall Study||10
10412404|NCT00772005|11556515|FG000|STARTED|Overall Study||71
10412405|NCT00772005|11556516|FG001|STARTED|Overall Study|One patient withdrew before taking any study drug.|70
10412406|NCT00772005|11556517|FG002|STARTED|Overall Study|One patient withdrew before taking any study drug.|72
10412407|NCT00772005|11556518|FG003|STARTED|Overall Study|Two patients withdrew before taking any study drug.|72
10412408|NCT00772005|11556515|FG000|COMPLETED|Overall Study||46
10412409|NCT00772005|11556516|FG001|COMPLETED|Overall Study||40
10844701|NCT03093350|12010700|FG000|STARTED|Overall Study||12
10844702|NCT03093350|12010700|FG000|Started Treatment|Overall Study||10
10844703|NCT03093350|12010700|FG000|COMPLETED|Overall Study||10
10844704|NCT03093350|12010700|FG000|NOT COMPLETED|Overall Study||2
10844710|NCT02999854|12010713|FG000|STARTED|Active Study Phase (up to 18 Months)||32
10844711|NCT02999854|12010714|FG001|STARTED|Active Study Phase (up to 18 Months)||31
10844712|NCT02999854|12010713|FG000|COMPLETED|Active Study Phase (up to 18 Months)||8
10844713|NCT02999854|12010714|FG001|COMPLETED|Active Study Phase (up to 18 Months)||22
10844714|NCT02999854|12010713|FG000|NOT COMPLETED|Active Study Phase (up to 18 Months)||24
10844715|NCT02999854|12010714|FG001|NOT COMPLETED|Active Study Phase (up to 18 Months)||9
10844716|NCT02999854|12010713|FG000|STARTED|Long Term Safety FU (up to 24 Months)||8
10844717|NCT02999854|12010714|FG001|STARTED|Long Term Safety FU (up to 24 Months)||22
10844718|NCT02999854|12010713|FG000|COMPLETED|Long Term Safety FU (up to 24 Months)||5
10844719|NCT02999854|12010714|FG001|COMPLETED|Long Term Safety FU (up to 24 Months)||19
10844720|NCT02999854|12010713|FG000|NOT COMPLETED|Long Term Safety FU (up to 24 Months)||3
10844721|NCT02999854|12010714|FG001|NOT COMPLETED|Long Term Safety FU (up to 24 Months)||3
10844722|NCT02960763|12010725|FG000|STARTED|Step 1||211
10844723|NCT02960763|12010726|FG001|STARTED|Step 1||206
10844724|NCT02960763|12010727|FG002|STARTED|Step 1||202
10844725|NCT02960763|12010728|FG003|STARTED|Step 1||0
10844726|NCT02960763|12010729|FG004|STARTED|Step 1||0
10844727|NCT02960763|12010725|FG000|COMPLETED|Step 1||192
10844728|NCT02960763|12010726|FG001|COMPLETED|Step 1||188
10844729|NCT02960763|12010727|FG002|COMPLETED|Step 1||174
10844730|NCT02960763|12010728|FG003|COMPLETED|Step 1||0
10844731|NCT02960763|12010729|FG004|COMPLETED|Step 1||0
10844732|NCT02960763|12010725|FG000|NOT COMPLETED|Step 1||19
10844733|NCT02960763|12010726|FG001|NOT COMPLETED|Step 1||18
10844734|NCT02960763|12010727|FG002|NOT COMPLETED|Step 1||28
10844735|NCT02960763|12010728|FG003|NOT COMPLETED|Step 1||0
10844736|NCT02960763|12010729|FG004|NOT COMPLETED|Step 1||0
10844737|NCT02960763|12010725|FG000|STARTED|Step 2||0
10844738|NCT02960763|12010726|FG001|STARTED|Step 2||0
10844739|NCT02960763|12010727|FG002|STARTED|Step 2||0
10844740|NCT02960763|12010728|FG003|STARTED|Step 2||127
10844741|NCT02960763|12010729|FG004|STARTED|Step 2||121
10844742|NCT02960763|12010725|FG000|People Who Participated in Step 1 and Continued to Participate in Step 2|Step 2||43
10844743|NCT02960763|12010726|FG001|People Who Participated in Step 1 and Continued to Participate in Step 2|Step 2||44
10844744|NCT02960763|12010727|FG002|People Who Participated in Step 1 and Continued to Participate in Step 2|Step 2||38
10844745|NCT02960763|12010728|FG003|People Who Participated in Step 1 and Continued to Participate in Step 2|Step 2||0
10844746|NCT02960763|12010729|FG004|People Who Participated in Step 1 and Continued to Participate in Step 2|Step 2||0
10844747|NCT02960763|12010725|FG000|People Who Began Step 2 Without Having Participated in Step 1|Step 2||0
10844748|NCT02960763|12010726|FG001|People Who Began Step 2 Without Having Participated in Step 1|Step 2||0
10844749|NCT02960763|12010727|FG002|People Who Began Step 2 Without Having Participated in Step 1|Step 2||0
10844750|NCT02960763|12010728|FG003|People Who Began Step 2 Without Having Participated in Step 1|Step 2||63
10844751|NCT02960763|12010729|FG004|People Who Began Step 2 Without Having Participated in Step 1|Step 2||60
10844752|NCT02960763|12010725|FG000|COMPLETED|Step 2||0
10844753|NCT02960763|12010726|FG001|COMPLETED|Step 2||0
10844754|NCT02960763|12010727|FG002|COMPLETED|Step 2||0
10844755|NCT02960763|12010728|FG003|COMPLETED|Step 2||116
10844756|NCT02960763|12010729|FG004|COMPLETED|Step 2||116
10844757|NCT02960763|12010725|FG000|NOT COMPLETED|Step 2||0
10844758|NCT02960763|12010726|FG001|NOT COMPLETED|Step 2||0
10844759|NCT02960763|12010727|FG002|NOT COMPLETED|Step 2||0
10844760|NCT02960763|12010728|FG003|NOT COMPLETED|Step 2||11
10844761|NCT02960763|12010729|FG004|NOT COMPLETED|Step 2||5
10844762|NCT02839343|12010743|FG000|STARTED|Overall Study||70
10844763|NCT02839343|12010744|FG001|STARTED|Overall Study||56
10844764|NCT02839343|12010743|FG000|COMPLETED|Overall Study||65
10844765|NCT02839343|12010744|FG001|COMPLETED|Overall Study||55
10844766|NCT02839343|12010743|FG000|NOT COMPLETED|Overall Study||5
10844767|NCT02839343|12010744|FG001|NOT COMPLETED|Overall Study||1
10844768|NCT02819479|12010750|FG000|STARTED|Overall Study||10
10844769|NCT02819479|12010750|FG000|COMPLETED|Overall Study|2 subjects experienced recurrence of radiation necrosis requiring intervention at approx. month 11.|8
10844770|NCT02819479|12010750|FG000|NOT COMPLETED|Overall Study||2
10844771|NCT02601313|12010758|FG000|STARTED|Overall Study||14
10844772|NCT02601313|12010759|FG001|STARTED|Overall Study||74
10844773|NCT02601313|12010760|FG002|STARTED|Overall Study||17
10844774|NCT02601313|12010758|FG000|COMPLETED|Overall Study||8
10844775|NCT02601313|12010759|FG001|COMPLETED|Overall Study||0
10844776|NCT02601313|12010760|FG002|COMPLETED|Overall Study||0
10844777|NCT02601313|12010758|FG000|NOT COMPLETED|Overall Study||6
10844778|NCT02601313|12010759|FG001|NOT COMPLETED|Overall Study||74
10844779|NCT02601313|12010760|FG002|NOT COMPLETED|Overall Study||17
10844800|NCT02484430|12010784|FG000|STARTED|Overall Study||16
10844801|NCT02484430|12010784|FG000|COMPLETED|Overall Study||16
10844802|NCT02484430|12010784|FG000|NOT COMPLETED|Overall Study||0
10844803|NCT02438722|12010790|FG000|STARTED|Overall Study||83
10844804|NCT02438722|12010791|FG001|STARTED|Overall Study||85
10844805|NCT02438722|12010790|FG000|Participants Evaluable for Adverse Events|Overall Study||78
10844806|NCT02438722|12010791|FG001|Participants Evaluable for Adverse Events|Overall Study||85
10844807|NCT02438722|12010790|FG000|COMPLETED|Overall Study||0
10844808|NCT02438722|12010791|FG001|COMPLETED|Overall Study||0
10844809|NCT02438722|12010790|FG000|NOT COMPLETED|Overall Study||83
10844810|NCT02438722|12010791|FG001|NOT COMPLETED|Overall Study||85
10412410|NCT00772005|11556517|FG002|COMPLETED|Overall Study||44
10412411|NCT00772005|11556518|FG003|COMPLETED|Overall Study||46
10412412|NCT00772005|11556515|FG000|NOT COMPLETED|Overall Study||25
10412413|NCT00772005|11556516|FG001|NOT COMPLETED|Overall Study||30
10412414|NCT00772005|11556517|FG002|NOT COMPLETED|Overall Study||28
10412415|NCT00772005|11556518|FG003|NOT COMPLETED|Overall Study||26
10412416|NCT00772031|11556530|FG000|STARTED|Overall Study||96
10412417|NCT00772031|11556531|FG001|STARTED|Overall Study||95
10412418|NCT00772031|11556530|FG000|COMPLETED|Overall Study||64
10412419|NCT00772031|11556531|FG001|COMPLETED|Overall Study||52
10412420|NCT00772031|11556530|FG000|NOT COMPLETED|Overall Study||32
10412421|NCT00772031|11556531|FG001|NOT COMPLETED|Overall Study||43
10412422|NCT00772070|11556545|FG000|STARTED|Overall Study||102
10412423|NCT00772070|11556546|FG001|STARTED|Overall Study||71
10412424|NCT00772070|11556545|FG000|COMPLETED|Overall Study|Two participants had vaccination errors, they were removed from analysis.|100
10412425|NCT00772070|11556546|FG001|COMPLETED|Overall Study||61
10412426|NCT00772070|11556545|FG000|NOT COMPLETED|Overall Study||2
10412427|NCT00772070|11556546|FG001|NOT COMPLETED|Overall Study||10
10412428|NCT00772109|11556556|FG000|STARTED|Overall Study||956
10412429|NCT00772109|11556557|FG001|STARTED|Overall Study||953
10412430|NCT00772109|11556558|FG002|STARTED|Overall Study||955
10412431|NCT00772109|11556559|FG003|STARTED|Overall Study||1428
10412432|NCT00772109|11556556|FG000|COMPLETED|Overall Study||935
10412433|NCT00772109|11556557|FG001|COMPLETED|Overall Study||934
10412434|NCT00772109|11556558|FG002|COMPLETED|Overall Study||936
10412435|NCT00772109|11556559|FG003|COMPLETED|Overall Study||1397
10412436|NCT00772109|11556556|FG000|NOT COMPLETED|Overall Study||21
10412437|NCT00772109|11556557|FG001|NOT COMPLETED|Overall Study||19
10412438|NCT00772109|11556558|FG002|NOT COMPLETED|Overall Study||19
10412439|NCT00772109|11556559|FG003|NOT COMPLETED|Overall Study||31
10412440|NCT00772148|11556571|FG000|STARTED|Pharmacokinetic Phase (14 Days)||29
10412441|NCT00772148|11556572|FG001|STARTED|Pharmacokinetic Phase (14 Days)||29
10412442|NCT00772148|11556571|FG000|COMPLETED|Pharmacokinetic Phase (14 Days)||21
10412443|NCT00772148|11556572|FG001|COMPLETED|Pharmacokinetic Phase (14 Days)||23
10412444|NCT00772148|11556571|FG000|NOT COMPLETED|Pharmacokinetic Phase (14 Days)||8
10412445|NCT00772148|11556572|FG001|NOT COMPLETED|Pharmacokinetic Phase (14 Days)||6
10412446|NCT00772148|11556571|FG000|STARTED|Maintenance Phase (Week 52)||21
10412447|NCT00772148|11556572|FG001|STARTED|Maintenance Phase (Week 52)||23
10412448|NCT00772148|11556571|FG000|COMPLETED|Maintenance Phase (Week 52)||17
10412449|NCT00772148|11556572|FG001|COMPLETED|Maintenance Phase (Week 52)||18
10412450|NCT00772148|11556571|FG000|NOT COMPLETED|Maintenance Phase (Week 52)||4
10412451|NCT00772148|11556572|FG001|NOT COMPLETED|Maintenance Phase (Week 52)||5
10412452|NCT00772304|11556578|FG000|STARTED|Overall Study||102
10412453|NCT00772304|11556578|FG000|COMPLETED|Overall Study||102
10412454|NCT00772304|11556578|FG000|NOT COMPLETED|Overall Study||0
10412455|NCT00772330|11556582|FG000|STARTED|Overall Study||23
10412456|NCT00772330|11556582|FG000|COMPLETED|Overall Study||20
10412457|NCT00772330|11556582|FG000|NOT COMPLETED|Overall Study||3
10412458|NCT00772369|11556589|FG000|STARTED|Overall Study||3214
10412459|NCT00772369|11556589|FG000|COMPLETED|Overall Study||3213
10412460|NCT00772369|11556589|FG000|NOT COMPLETED|Overall Study||1
10844835|NCT02114814|12010816|FG000|STARTED|Overall Study||103
10844836|NCT02114814|12010817|FG001|STARTED|Overall Study||83
10844837|NCT02114814|12010816|FG000|COMPLETED|Overall Study||88
10844838|NCT02114814|12010817|FG001|COMPLETED|Overall Study||74
10844839|NCT02114814|12010816|FG000|NOT COMPLETED|Overall Study||15
10844840|NCT02114814|12010817|FG001|NOT COMPLETED|Overall Study||9
10844841|NCT02067819|12010829|FG000|STARTED|Overall Study||11
10844842|NCT02067819|12010830|FG001|STARTED|Overall Study||10
10844843|NCT02067819|12010829|FG000|COMPLETED|Overall Study||6
10844844|NCT02067819|12010830|FG001|COMPLETED|Overall Study||7
10844845|NCT02067819|12010829|FG000|NOT COMPLETED|Overall Study||5
10844846|NCT02067819|12010830|FG001|NOT COMPLETED|Overall Study||3
10844847|NCT02004691|12010838|FG000|STARTED|PAP: Up to 52 Weeks||18
10844848|NCT02004691|12010839|FG001|STARTED|PAP: Up to 52 Weeks||18
10844849|NCT02004691|12010838|FG000|COMPLETED|PAP: Up to 52 Weeks||17
10844850|NCT02004691|12010839|FG001|COMPLETED|PAP: Up to 52 Weeks||18
10844851|NCT02004691|12010838|FG000|NOT COMPLETED|PAP: Up to 52 Weeks||1
10844852|NCT02004691|12010839|FG001|NOT COMPLETED|PAP: Up to 52 Weeks||0
10844853|NCT02004691|12010838|FG000|STARTED|ETP: Ongoing From Week 52||17
10844854|NCT02004691|12010839|FG001|STARTED|ETP: Ongoing From Week 52||18
10844855|NCT02004691|12010838|FG000|COMPLETED|ETP: Ongoing From Week 52||0
10844856|NCT02004691|12010839|FG001|COMPLETED|ETP: Ongoing From Week 52||0
10844857|NCT02004691|12010838|FG000|NOT COMPLETED|ETP: Ongoing From Week 52||17
10844858|NCT02004691|12010839|FG001|NOT COMPLETED|ETP: Ongoing From Week 52||18
10844877|NCT01668719|12010871|FG000|STARTED|Phase I||6
10844878|NCT01668719|12010872|FG001|STARTED|Phase I||0
10844879|NCT01668719|12010873|FG002|STARTED|Phase I||0
10844880|NCT01668719|12010871|FG000|COMPLETED|Phase I||0
10844881|NCT01668719|12010872|FG001|COMPLETED|Phase I||0
10844882|NCT01668719|12010873|FG002|COMPLETED|Phase I||0
10844883|NCT01668719|12010871|FG000|NOT COMPLETED|Phase I||6
10844884|NCT01668719|12010872|FG001|NOT COMPLETED|Phase I||0
10844885|NCT01668719|12010873|FG002|NOT COMPLETED|Phase I||0
10844886|NCT01668719|12010871|FG000|STARTED|Phase II||0
10844887|NCT01668719|12010872|FG001|STARTED|Phase II||52
10844888|NCT01668719|12010873|FG002|STARTED|Phase II||48
10844889|NCT01668719|12010871|FG000|COMPLETED|Phase II||0
10844890|NCT01668719|12010872|FG001|COMPLETED|Phase II||0
10844891|NCT01668719|12010873|FG002|COMPLETED|Phase II||0
10844892|NCT01668719|12010871|FG000|NOT COMPLETED|Phase II||0
10844893|NCT01668719|12010872|FG001|NOT COMPLETED|Phase II||52
10844894|NCT01668719|12010873|FG002|NOT COMPLETED|Phase II||48
10412461|NCT00772382|11556593|FG000|STARTED|Overall Study||116
10412462|NCT00772382|11556593|FG000|COMPLETED|Overall Study||61
10412463|NCT00772382|11556593|FG000|NOT COMPLETED|Overall Study||55
10412464|NCT00772447|11556599|FG000|STARTED|Overall Study||131
10412465|NCT00772447|11556600|FG001|STARTED|Overall Study||134
10412466|NCT00772447|11556599|FG000|COMPLETED|Overall Study||111
10412467|NCT00772447|11556600|FG001|COMPLETED|Overall Study||110
10412468|NCT00772447|11556599|FG000|NOT COMPLETED|Overall Study||20
10412469|NCT00772447|11556600|FG001|NOT COMPLETED|Overall Study||24
10412470|NCT00772538|11556609|FG000|STARTED|Overall Study||222
10412471|NCT00772538|11556610|FG001|STARTED|Overall Study||237
10412472|NCT00772538|11556609|FG000|COMPLETED|Overall Study||202
10412473|NCT00772538|11556610|FG001|COMPLETED|Overall Study||211
10412474|NCT00772538|11556609|FG000|NOT COMPLETED|Overall Study||20
10412475|NCT00772538|11556610|FG001|NOT COMPLETED|Overall Study||26
10412476|NCT00772577|11556618|FG000|STARTED|Overall Study||193
10412477|NCT00772577|11556619|FG001|STARTED|Overall Study||193
10412478|NCT00772577|11556618|FG000|COMPLETED|Overall Study||170
10412479|NCT00772577|11556619|FG001|COMPLETED|Overall Study||170
10412480|NCT00772577|11556618|FG000|NOT COMPLETED|Overall Study||23
10412481|NCT00772577|11556619|FG001|NOT COMPLETED|Overall Study||23
10545119|NCT01494532|11698374|FG005|COMPLETED|Overall Study||25
10545120|NCT01494532|11698369|FG000|NOT COMPLETED|Overall Study||10
10545121|NCT01494532|11698370|FG001|NOT COMPLETED|Overall Study||4
10545122|NCT01494532|11698371|FG002|NOT COMPLETED|Overall Study||17
10545123|NCT01494532|11698372|FG003|NOT COMPLETED|Overall Study||15
10545124|NCT01494532|11698373|FG004|NOT COMPLETED|Overall Study||12
10545125|NCT01494532|11698374|FG005|NOT COMPLETED|Overall Study||0
10545126|NCT01494545|11698389|FG000|STARTED|Overall Study||102
10545127|NCT01494545|11698389|FG000|COMPLETED|Overall Study||92
10545128|NCT01494545|11698389|FG000|NOT COMPLETED|Overall Study||10
10545129|NCT01494584|11698396|FG000|STARTED|Overall Study||5
10545130|NCT01494584|11698396|FG000|COMPLETED|Overall Study||4
10545131|NCT01494584|11698396|FG000|NOT COMPLETED|Overall Study||1
10545132|NCT01494610|11698419|FG000|STARTED|Period 1||31
10545133|NCT01494610|11698420|FG001|STARTED|Period 1||29
10545134|NCT01494610|11698419|FG000|COMPLETED|Period 1||30
10545135|NCT01494610|11698420|FG001|COMPLETED|Period 1||28
10545136|NCT01494610|11698419|FG000|NOT COMPLETED|Period 1||1
10545137|NCT01494610|11698420|FG001|NOT COMPLETED|Period 1||1
10545138|NCT01494610|11698419|FG000|STARTED|Period 2||30
10545139|NCT01494610|11698420|FG001|STARTED|Period 2||28
10545140|NCT01494610|11698419|FG000|COMPLETED|Period 2||30
10545141|NCT01494610|11698420|FG001|COMPLETED|Period 2||28
10545142|NCT01494610|11698419|FG000|NOT COMPLETED|Period 2||0
10545143|NCT01494610|11698420|FG001|NOT COMPLETED|Period 2||0
10545144|NCT01494610|11698419|FG000|STARTED|Period 3||30
10545145|NCT01494610|11698420|FG001|STARTED|Period 3||28
10545146|NCT01494610|11698419|FG000|COMPLETED|Period 3||28
10545147|NCT01494610|11698420|FG001|COMPLETED|Period 3||28
10545148|NCT01494610|11698419|FG000|NOT COMPLETED|Period 3||2
10545149|NCT01494610|11698420|FG001|NOT COMPLETED|Period 3||0
10545150|NCT01494610|11698419|FG000|STARTED|Period 4||28
10545151|NCT01494610|11698420|FG001|STARTED|Period 4||28
10545152|NCT01494610|11698419|FG000|COMPLETED|Period 4||27
10545153|NCT01494610|11698420|FG001|COMPLETED|Period 4||28
10545154|NCT01494610|11698419|FG000|NOT COMPLETED|Period 4||1
10545155|NCT01494610|11698420|FG001|NOT COMPLETED|Period 4||0
10545156|NCT01494649|11698434|FG000|STARTED|Overall Study||59
10545157|NCT01494649|11698435|FG001|STARTED|Overall Study||59
10545158|NCT01494649|11698434|FG000|COMPLETED|Overall Study||59
10545159|NCT01494649|11698435|FG001|COMPLETED|Overall Study||58
10545160|NCT01494649|11698434|FG000|NOT COMPLETED|Overall Study||0
10545161|NCT01494649|11698435|FG001|NOT COMPLETED|Overall Study||1
10545162|NCT01494753|11698445|FG000|STARTED|Day0-Day42||15
10545163|NCT01494753|11698446|FG001|STARTED|Day0-Day42||15
10545164|NCT01494753|11698445|FG000|COMPLETED|Day0-Day42||15
10545165|NCT01494753|11698446|FG001|COMPLETED|Day0-Day42||15
10545166|NCT01494753|11698445|FG000|NOT COMPLETED|Day0-Day42||0
10545167|NCT01494753|11698446|FG001|NOT COMPLETED|Day0-Day42||0
10545168|NCT01494753|11698445|FG000|STARTED|Day42-Day84||15
10545169|NCT01494753|11698446|FG001|STARTED|Day42-Day84||15
10545170|NCT01494753|11698445|FG000|COMPLETED|Day42-Day84||15
10545171|NCT01494753|11698446|FG001|COMPLETED|Day42-Day84||15
10545172|NCT01494753|11698445|FG000|NOT COMPLETED|Day42-Day84||0
10661236|NCT02257970|11823120|FG000|NOT COMPLETED|Part 1||0
10661237|NCT02257970|11823121|FG001|NOT COMPLETED|Part 1||0
10412482|NCT00772590|11556629|FG000|STARTED|Overall Study||19
10412483|NCT00772590|11556630|FG001|STARTED|Overall Study||19
10412484|NCT00772590|11556631|FG002|STARTED|Overall Study||18
10545173|NCT01494753|11698446|FG001|NOT COMPLETED|Day42-Day84||0
10545174|NCT01494818|11698454|FG000|STARTED|Overall Study||39
10545175|NCT01494818|11698455|FG001|STARTED|Overall Study||39
10545176|NCT01494818|11698454|FG000|COMPLETED|Overall Study||37
10545177|NCT01494818|11698455|FG001|COMPLETED|Overall Study||37
10545178|NCT01494818|11698454|FG000|NOT COMPLETED|Overall Study||2
10844930|NCT01515748|12010914|FG000|STARTED|Overall Study||264
10844931|NCT01515748|12010915|FG001|STARTED|Overall Study||266
10844932|NCT01515748|12010914|FG000|Treated|Overall Study||195
10844933|NCT01515748|12010915|FG001|Treated|Overall Study||241
10844934|NCT01515748|12010914|FG000|COMPLETED|Overall Study||144
10844935|NCT01515748|12010915|FG001|COMPLETED|Overall Study||131
10844936|NCT01515748|12010914|FG000|NOT COMPLETED|Overall Study||120
10844937|NCT01515748|12010915|FG001|NOT COMPLETED|Overall Study||135
10844938|NCT01261247|12010922|FG000|STARTED|Overall Study||41
10844939|NCT01261247|12010922|FG000|COMPLETED|Overall Study||39
10844940|NCT01261247|12010922|FG000|NOT COMPLETED|Overall Study||2
10844941|NCT01169259|12010930|FG000|STARTED|Overall Study||6463
10844942|NCT01169259|12010931|FG001|STARTED|Overall Study||6464
10844943|NCT01169259|12010932|FG002|STARTED|Overall Study||6470
10844944|NCT01169259|12010933|FG003|STARTED|Overall Study||6474
10844945|NCT01169259|12010930|FG000|COMPLETED|Overall Study||6463
10844946|NCT01169259|12010931|FG001|COMPLETED|Overall Study||6464
10844947|NCT01169259|12010932|FG002|COMPLETED|Overall Study||6470
10844948|NCT01169259|12010933|FG003|COMPLETED|Overall Study||6474
10844949|NCT01169259|12010930|FG000|NOT COMPLETED|Overall Study||0
10844950|NCT01169259|12010931|FG001|NOT COMPLETED|Overall Study||0
10844951|NCT01169259|12010932|FG002|NOT COMPLETED|Overall Study||0
10844952|NCT01169259|12010933|FG003|NOT COMPLETED|Overall Study||0
10412485|NCT00772590|11556632|FG003|STARTED|Overall Study||17
10412486|NCT00772590|11556629|FG000|COMPLETED|Overall Study||19
10412487|NCT00772590|11556630|FG001|COMPLETED|Overall Study||19
10412488|NCT00772590|11556631|FG002|COMPLETED|Overall Study||18
10412489|NCT00772590|11556632|FG003|COMPLETED|Overall Study||17
10412490|NCT00772590|11556629|FG000|NOT COMPLETED|Overall Study||0
10412491|NCT00772590|11556630|FG001|NOT COMPLETED|Overall Study||0
10412492|NCT00772590|11556631|FG002|NOT COMPLETED|Overall Study||0
10412493|NCT00772590|11556632|FG003|NOT COMPLETED|Overall Study||0
10412494|NCT00772603|11556645|FG000|STARTED|Overall Study||123
10412495|NCT00772603|11556646|FG001|STARTED|Overall Study||122
10412496|NCT00772603|11556647|FG002|STARTED|Overall Study||121
10412497|NCT00772603|11556645|FG000|COMPLETED|Overall Study||71
10412498|NCT00772603|11556646|FG001|COMPLETED|Overall Study||82
10412499|NCT00772603|11556647|FG002|COMPLETED|Overall Study||95
10412500|NCT00772603|11556645|FG000|NOT COMPLETED|Overall Study||52
10412501|NCT00772603|11556646|FG001|NOT COMPLETED|Overall Study||40
10412502|NCT00772603|11556647|FG002|NOT COMPLETED|Overall Study||26
10412503|NCT00772629|11556660|FG000|STARTED|Overall Study||17
10412504|NCT00772629|11556661|FG001|STARTED|Overall Study||1
10412505|NCT00772629|11556660|FG000|COMPLETED|Overall Study||16
10412506|NCT00772629|11556661|FG001|COMPLETED|Overall Study||1
10412507|NCT00772629|11556660|FG000|NOT COMPLETED|Overall Study||1
10412508|NCT00772629|11556661|FG001|NOT COMPLETED|Overall Study||0
10412509|NCT00772668|11556667|FG000|STARTED|Overall Study||3
10412510|NCT00772668|11556667|FG000|COMPLETED|Overall Study||0
10412511|NCT00772668|11556667|FG000|NOT COMPLETED|Overall Study||3
10412512|NCT00772707|11556672|FG000|STARTED|Overall Study||114
10412513|NCT00772707|11556672|FG000|COMPLETED|Overall Study||111
10412514|NCT00772707|11556672|FG000|NOT COMPLETED|Overall Study||3
10412515|NCT00772772|11556676|FG000|STARTED|Overall Study||12
10412516|NCT00772772|11556676|FG000|COMPLETED|Overall Study||12
10412517|NCT00772772|11556676|FG000|NOT COMPLETED|Overall Study||0
10412518|NCT00772889|11556684|FG000|STARTED|Overall Study||375
10412519|NCT00772889|11556685|FG001|STARTED|Overall Study||393
10412520|NCT00772889|11556686|FG002|STARTED|Overall Study||203
10412521|NCT00772889|11556684|FG000|Completed at Day 21|Overall Study||374
10412522|NCT00772889|11556685|FG001|Completed at Day 21|Overall Study||390
10412523|NCT00772889|11556686|FG002|Completed at Day 21|Overall Study||203
10412524|NCT00772889|11556684|FG000|COMPLETED|Overall Study||353
10412525|NCT00772889|11556685|FG001|COMPLETED|Overall Study||375
10412526|NCT00772889|11556686|FG002|COMPLETED|Overall Study||187
10412527|NCT00772889|11556684|FG000|NOT COMPLETED|Overall Study||22
10412528|NCT00772889|11556685|FG001|NOT COMPLETED|Overall Study||18
10412529|NCT00772889|11556686|FG002|NOT COMPLETED|Overall Study||16
10412530|NCT00772915|11556694|FG000|STARTED|Overall Study||38
10412531|NCT00772915|11556694|FG000|COMPLETED|Overall Study||23
10844953|NCT00790933|12010954|FG000|STARTED|Overall Study||675
10844954|NCT00790933|12010955|FG001|STARTED|Overall Study||726
10412532|NCT00772915|11556694|FG000|NOT COMPLETED|Overall Study||15
10412533|NCT00772928|11556700|FG000|STARTED|Overall Study||587
10412534|NCT00772928|11556701|FG001|STARTED|Overall Study||579
10412535|NCT00772928|11556700|FG000|COMPLETED|Overall Study||543
10412536|NCT00772928|11556701|FG001|COMPLETED|Overall Study||538
10844955|NCT00790933|12010956|FG002|STARTED|Overall Study||384
10844956|NCT00790933|12010957|FG003|STARTED|Overall Study||37
10844957|NCT00790933|12010958|FG004|STARTED|Overall Study||421
10844958|NCT00790933|12010954|FG000|COMPLETED|Overall Study||237
10844959|NCT00790933|12010955|FG001|COMPLETED|Overall Study||246
10844960|NCT00790933|12010956|FG002|COMPLETED|Overall Study||115
10844961|NCT00790933|12010957|FG003|COMPLETED|Overall Study||23
10844962|NCT00790933|12010958|FG004|COMPLETED|Overall Study||145
10844963|NCT00790933|12010954|FG000|NOT COMPLETED|Overall Study||438
10844964|NCT00790933|12010955|FG001|NOT COMPLETED|Overall Study||480
10844965|NCT00790933|12010956|FG002|NOT COMPLETED|Overall Study||269
10844966|NCT00790933|12010957|FG003|NOT COMPLETED|Overall Study||14
10844967|NCT00790933|12010958|FG004|NOT COMPLETED|Overall Study||276
10844968|NCT00624234|12010980|FG000|STARTED|Overall Study||8
10844969|NCT00624234|12010981|FG001|STARTED|Overall Study||9
10844970|NCT00624234|12010982|FG002|STARTED|Overall Study||26
10844971|NCT00624234|12010983|FG003|STARTED|Overall Study||14
10844972|NCT00624234|12010984|FG004|STARTED|Overall Study||18
10844973|NCT00624234|12010985|FG005|STARTED|Overall Study||14
10844974|NCT00624234|12010980|FG000|COMPLETED|Overall Study||8
10844975|NCT00624234|12010981|FG001|COMPLETED|Overall Study||9
10844976|NCT00624234|12010982|FG002|COMPLETED|Overall Study||26
10844977|NCT00624234|12010983|FG003|COMPLETED|Overall Study||14
10844978|NCT00624234|12010984|FG004|COMPLETED|Overall Study||18
10844979|NCT00624234|12010985|FG005|COMPLETED|Overall Study||14
10844980|NCT00624234|12010980|FG000|NOT COMPLETED|Overall Study||0
10844981|NCT00624234|12010981|FG001|NOT COMPLETED|Overall Study||0
10844982|NCT00624234|12010982|FG002|NOT COMPLETED|Overall Study||0
10844983|NCT00624234|12010983|FG003|NOT COMPLETED|Overall Study||0
10844984|NCT00624234|12010984|FG004|NOT COMPLETED|Overall Study||0
10844985|NCT00624234|12010985|FG005|NOT COMPLETED|Overall Study||0
10844986|NCT00127673|12011003|FG000|STARTED|Overall Study||48
10844987|NCT00127673|12011004|FG001|STARTED|Overall Study||61
10844988|NCT00127673|12011005|FG002|STARTED|Overall Study||55
10844989|NCT00127673|12011006|FG003|STARTED|Overall Study||36
10844990|NCT00127673|12011003|FG000|COMPLETED|Overall Study||23
10844991|NCT00127673|12011004|FG001|COMPLETED|Overall Study||44
10844992|NCT00127673|12011005|FG002|COMPLETED|Overall Study||35
10844993|NCT00127673|12011006|FG003|COMPLETED|Overall Study||25
10844994|NCT00127673|12011003|FG000|NOT COMPLETED|Overall Study||25
10412537|NCT00772928|11556700|FG000|NOT COMPLETED|Overall Study||44
10412538|NCT00772928|11556701|FG001|NOT COMPLETED|Overall Study||41
10412539|NCT00772941|11556707|FG000|STARTED|Overall Study||3939
10412540|NCT00772941|11556707|FG000|COMPLETED|Overall Study||3257
10412541|NCT00772941|11556707|FG000|NOT COMPLETED|Overall Study||682
10412542|NCT00772954|11556737|FG000|STARTED|Overall Study||12
10412543|NCT00772954|11556738|FG001|STARTED|Overall Study||12
10412544|NCT00772954|11556739|FG002|STARTED|Overall Study||12
10412545|NCT00772954|11556737|FG000|COMPLETED|Overall Study||12
10412546|NCT00772954|11556738|FG001|COMPLETED|Overall Study||12
10412547|NCT00772954|11556739|FG002|COMPLETED|Overall Study||11
10412548|NCT00772954|11556737|FG000|NOT COMPLETED|Overall Study||0
10412549|NCT00772954|11556738|FG001|NOT COMPLETED|Overall Study||0
10412550|NCT00772954|11556739|FG002|NOT COMPLETED|Overall Study||1
10412551|NCT00772967|11556747|FG000|STARTED|Crossover Treatment 1||3
10412552|NCT00772967|11556748|FG001|STARTED|Crossover Treatment 1||5
10412553|NCT00772967|11556749|FG002|STARTED|Crossover Treatment 1||3
10412554|NCT00772967|11556750|FG003|STARTED|Crossover Treatment 1||4
10412555|NCT00772967|11556751|FG004|STARTED|Crossover Treatment 1||4
10412556|NCT00772967|11556752|FG005|STARTED|Crossover Treatment 1||3
10412557|NCT00772967|11556747|FG000|COMPLETED|Crossover Treatment 1||3
10412558|NCT00772967|11556748|FG001|COMPLETED|Crossover Treatment 1||5
10412559|NCT00772967|11556749|FG002|COMPLETED|Crossover Treatment 1||3
10412560|NCT00772967|11556750|FG003|COMPLETED|Crossover Treatment 1|The withdrawal is not included in any outcomes; but is part of the Adverse Event group for placebo|3
10412561|NCT00772967|11556751|FG004|COMPLETED|Crossover Treatment 1||4
10412562|NCT00772967|11556752|FG005|COMPLETED|Crossover Treatment 1||3
10412563|NCT00772967|11556747|FG000|NOT COMPLETED|Crossover Treatment 1||0
10412564|NCT00772967|11556748|FG001|NOT COMPLETED|Crossover Treatment 1||0
10412565|NCT00772967|11556749|FG002|NOT COMPLETED|Crossover Treatment 1||0
10412566|NCT00772967|11556750|FG003|NOT COMPLETED|Crossover Treatment 1||1
10412567|NCT00772967|11556751|FG004|NOT COMPLETED|Crossover Treatment 1||0
10412568|NCT00772967|11556752|FG005|NOT COMPLETED|Crossover Treatment 1||0
10412569|NCT00772967|11556747|FG000|STARTED|Break 1 (4-7 Days)||3
10412570|NCT00772967|11556748|FG001|STARTED|Break 1 (4-7 Days)||5
10412571|NCT00772967|11556749|FG002|STARTED|Break 1 (4-7 Days)||3
10412572|NCT00772967|11556750|FG003|STARTED|Break 1 (4-7 Days)||3
10412573|NCT00772967|11556751|FG004|STARTED|Break 1 (4-7 Days)||4
10844995|NCT00127673|12011004|FG001|NOT COMPLETED|Overall Study||17
10844996|NCT00127673|12011005|FG002|NOT COMPLETED|Overall Study||20
10844997|NCT00127673|12011006|FG003|NOT COMPLETED|Overall Study||11
10412574|NCT00772967|11556752|FG005|STARTED|Break 1 (4-7 Days)||3
10412575|NCT00772967|11556747|FG000|COMPLETED|Break 1 (4-7 Days)||3
10844998|NCT04388527|12011020|FG000|STARTED|Overall Study||32
10844999|NCT04388527|12011020|FG000|COMPLETED|Overall Study||15
10845000|NCT04388527|12011020|FG000|NOT COMPLETED|Overall Study||17
10845001|NCT04369833|12011024|FG000|STARTED|Overall Study||130
10845002|NCT04369833|12011024|FG000|COMPLETED|Overall Study||129
10845003|NCT04369833|12011024|FG000|NOT COMPLETED|Overall Study||1
10845004|NCT04280081|12011028|FG000|STARTED|Overall Study||77
10845005|NCT04280081|12011028|FG000|Enrolled: All NSCLC|Overall Study||47
10845006|NCT04280081|12011028|FG000|Enrolled: All TC|Overall Study||1
10845007|NCT04280081|12011028|FG000|Enrolled: All MTC|Overall Study||29
10845008|NCT04280081|12011028|FG000|PAS: RET Fusion Positive NSCLC|Overall Study||26
10845009|NCT04280081|12011028|FG000|PAS: RET Fusion Positive TC|Overall Study||1
10845010|NCT04280081|12011028|FG000|PAS: Advance RET-mutant MTC|Overall Study||26
10845011|NCT04280081|12011028|FG000|COMPLETED|Overall Study||65
10845012|NCT04280081|12011028|FG000|NOT COMPLETED|Overall Study||12
10845013|NCT04238429|12011043|FG000|STARTED|Overall Study||43
10845014|NCT04238429|12011044|FG001|STARTED|Overall Study||43
10845015|NCT04238429|12011043|FG000|COMPLETED|Overall Study||40
10845016|NCT04238429|12011044|FG001|COMPLETED|Overall Study||41
10845017|NCT04238429|12011043|FG000|NOT COMPLETED|Overall Study||3
10845018|NCT04238429|12011044|FG001|NOT COMPLETED|Overall Study||2
10845019|NCT04126083|12011050|FG000|STARTED|Overall Study||6
10845020|NCT04126083|12011050|FG000|COMPLETED|Overall Study||5
10845021|NCT04126083|12011050|FG000|NOT COMPLETED|Overall Study||1
10845028|NCT03744637|12011073|FG000|STARTED|Overall Study||2
10845029|NCT03744637|12011074|FG001|STARTED|Overall Study||2
10845030|NCT03744637|12011075|FG002|STARTED|Overall Study||2
10845031|NCT03744637|12011076|FG003|STARTED|Overall Study||1
10845032|NCT03744637|12011077|FG004|STARTED|Overall Study||1
10845033|NCT03744637|12011078|FG005|STARTED|Overall Study||1
10845034|NCT03744637|12011079|FG006|STARTED|Overall Study||8
10845035|NCT03744637|12011080|FG007|STARTED|Overall Study||4
10845036|NCT03744637|12011081|FG008|STARTED|Overall Study||3
10845037|NCT03744637|12011082|FG009|STARTED|Overall Study||1
10845038|NCT03744637|12011073|FG000|COMPLETED|Overall Study||2
10845039|NCT03744637|12011074|FG001|COMPLETED|Overall Study||2
10845040|NCT03744637|12011075|FG002|COMPLETED|Overall Study||2
10845041|NCT03744637|12011076|FG003|COMPLETED|Overall Study||1
10845042|NCT03744637|12011077|FG004|COMPLETED|Overall Study|Participant did not receive MK-5475 240 ug in Part 2 as planned.|1
10845043|NCT03744637|12011078|FG005|COMPLETED|Overall Study|Participant received 165 ug in Part 2 Periods 2 and 3, instead of planned 360 ug.|1
10845044|NCT03744637|12011079|FG006|COMPLETED|Overall Study||8
10845045|NCT03744637|12011080|FG007|COMPLETED|Overall Study|Participants received 120 ug in Part 2 Periods 2 and 3, instead of planned 360 ug.|4
10845046|NCT03744637|12011081|FG008|COMPLETED|Overall Study||3
10845047|NCT03744637|12011082|FG009|COMPLETED|Overall Study|Participant did not receive 120 ug in Part 2 Period 3 as planned.|1
10845048|NCT03744637|12011073|FG000|NOT COMPLETED|Overall Study||0
10845049|NCT03744637|12011074|FG001|NOT COMPLETED|Overall Study||0
10845050|NCT03744637|12011075|FG002|NOT COMPLETED|Overall Study||0
10845051|NCT03744637|12011076|FG003|NOT COMPLETED|Overall Study||0
10845052|NCT03744637|12011077|FG004|NOT COMPLETED|Overall Study||0
10845053|NCT03744637|12011078|FG005|NOT COMPLETED|Overall Study||0
10845054|NCT03744637|12011079|FG006|NOT COMPLETED|Overall Study||0
10845055|NCT03744637|12011080|FG007|NOT COMPLETED|Overall Study||0
10845056|NCT03744637|12011081|FG008|NOT COMPLETED|Overall Study||0
10845057|NCT03744637|12011082|FG009|NOT COMPLETED|Overall Study||0
10545179|NCT01494818|11698455|FG001|NOT COMPLETED|Overall Study||2
10545180|NCT01494922|11698461|FG000|STARTED|Overall Study||14
10545181|NCT01494922|11698461|FG000|COMPLETED|Overall Study||13
10845058|NCT03576144|12011149|FG000|STARTED|Overall Study||10
10845059|NCT03576144|12011150|FG001|STARTED|Overall Study||8
10845060|NCT03576144|12011151|FG002|STARTED|Overall Study||8
10845061|NCT03576144|12011152|FG003|STARTED|Overall Study||8
10845062|NCT03576144|12011153|FG004|STARTED|Overall Study||8
10845063|NCT03576144|12011154|FG005|STARTED|Overall Study||8
10845064|NCT03576144|12011149|FG000|COMPLETED|Overall Study||10
10845065|NCT03576144|12011150|FG001|COMPLETED|Overall Study||8
10845066|NCT03576144|12011151|FG002|COMPLETED|Overall Study||8
10845067|NCT03576144|12011152|FG003|COMPLETED|Overall Study||8
10845068|NCT03576144|12011153|FG004|COMPLETED|Overall Study||8
10845069|NCT03576144|12011154|FG005|COMPLETED|Overall Study||8
10845070|NCT03576144|12011149|FG000|NOT COMPLETED|Overall Study||0
10845071|NCT03576144|12011150|FG001|NOT COMPLETED|Overall Study||0
10845072|NCT03576144|12011151|FG002|NOT COMPLETED|Overall Study||0
10845073|NCT03576144|12011152|FG003|NOT COMPLETED|Overall Study||0
10845074|NCT03576144|12011153|FG004|NOT COMPLETED|Overall Study||0
10845075|NCT03576144|12011154|FG005|NOT COMPLETED|Overall Study||0
10845076|NCT03444038|12011173|FG000|STARTED|Overall Study||85
10845077|NCT03444038|12011173|FG000|COMPLETED|Overall Study||56
10845078|NCT03444038|12011173|FG000|NOT COMPLETED|Overall Study||29
10845079|NCT03432897|12011177|FG000|STARTED|Overall Study||1
10845080|NCT03432897|12011177|FG000|COMPLETED|Overall Study||1
10845081|NCT03432897|12011177|FG000|NOT COMPLETED|Overall Study||0
10845082|NCT03265665|12011183|FG000|STARTED|24-week Data Collection||25
10845083|NCT03265665|12011184|FG001|STARTED|24-week Data Collection||28
10845084|NCT03265665|12011183|FG000|COMPLETED|24-week Data Collection||19
10845085|NCT03265665|12011184|FG001|COMPLETED|24-week Data Collection||21
10845086|NCT03265665|12011183|FG000|NOT COMPLETED|24-week Data Collection||6
10845087|NCT03265665|12011184|FG001|NOT COMPLETED|24-week Data Collection||7
10845088|NCT03265665|12011183|FG000|STARTED|36-week Data Collection|Used the number of participants that did not withdraw from the study. If a participant did not complete the 24 week week data collection, they were still allowed to complete the 36-week data collection. Thus the number we started with for this period was the total number of participants in each group that did not withdraw from the study.|23
10845089|NCT03265665|12011184|FG001|STARTED|36-week Data Collection|Used the number of participants that did not withdraw from the study. If a participant did not complete the 24 week week data collection, they were still allowed to complete the 36-week data collection. Thus the number we started with for this period was the total number of participants in each group that did not withdraw from the study.|26
10845090|NCT03265665|12011183|FG000|COMPLETED|36-week Data Collection||17
10845091|NCT03265665|12011184|FG001|COMPLETED|36-week Data Collection||18
10845092|NCT03265665|12011183|FG000|NOT COMPLETED|36-week Data Collection||6
10845093|NCT03265665|12011184|FG001|NOT COMPLETED|36-week Data Collection||8
10845094|NCT03196180|12011192|FG000|STARTED|Overall Study||13
10845095|NCT03196180|12011192|FG000|COMPLETED|Overall Study||11
10845096|NCT03196180|12011192|FG000|NOT COMPLETED|Overall Study||2
10845097|NCT02725593|12011198|FG000|STARTED|Blinded Treatment Period||39
10845098|NCT02725593|12011199|FG001|STARTED|Blinded Treatment Period||33
10845099|NCT02725593|12011198|FG000|Received Treatment|Blinded Treatment Period||39
10845100|NCT02725593|12011199|FG001|Received Treatment|Blinded Treatment Period||33
10845101|NCT02725593|12011198|FG000|COMPLETED|Blinded Treatment Period||34
10845102|NCT02725593|12011199|FG001|COMPLETED|Blinded Treatment Period||27
10845103|NCT02725593|12011198|FG000|NOT COMPLETED|Blinded Treatment Period||5
10845104|NCT02725593|12011199|FG001|NOT COMPLETED|Blinded Treatment Period||6
10845105|NCT02725593|12011198|FG000|STARTED|Long Term Extension|1 participant who completed Period 1 did not enter the long-term extension period.|33
10845106|NCT02725593|12011199|FG001|STARTED|Long Term Extension||27
10845107|NCT02725593|12011198|FG000|COMPLETED|Long Term Extension||32
10845108|NCT02725593|12011199|FG001|COMPLETED|Long Term Extension||24
10845109|NCT02725593|12011198|FG000|NOT COMPLETED|Long Term Extension||1
10845110|NCT02725593|12011199|FG001|NOT COMPLETED|Long Term Extension||3
10845111|NCT02716675|12011208|FG000|STARTED|Overall Study||903
10845112|NCT02716675|12011209|FG001|STARTED|Overall Study||899
10845113|NCT02716675|12011210|FG002|STARTED|Overall Study||897
10845114|NCT02716675|12011208|FG000|Modified Intent-to-treat Population|Overall Study||898
10845115|NCT02716675|12011209|FG001|Modified Intent-to-treat Population|Overall Study||895
10845116|NCT02716675|12011210|FG002|Modified Intent-to-treat Population|Overall Study||894
10845117|NCT02716675|12011208|FG000|COMPLETED|Overall Study||703
10845118|NCT02716675|12011209|FG001|COMPLETED|Overall Study||702
10845119|NCT02716675|12011210|FG002|COMPLETED|Overall Study||686
10845120|NCT02716675|12011208|FG000|NOT COMPLETED|Overall Study||200
10845121|NCT02716675|12011209|FG001|NOT COMPLETED|Overall Study||197
10845122|NCT02716675|12011210|FG002|NOT COMPLETED|Overall Study||211
10845123|NCT02636946|12011225|FG000|STARTED|Cycle 1 (Day 1 to Week 15)||72
10845124|NCT02636946|12011226|FG001|STARTED|Cycle 1 (Day 1 to Week 15)||72
10845125|NCT02636946|12011225|FG000|Received Treatment in Either Eye|Cycle 1 (Day 1 to Week 15)||72
10845126|NCT02636946|12011226|FG001|Received Treatment in Either Eye|Cycle 1 (Day 1 to Week 15)||70
10845127|NCT02636946|12011225|FG000|COMPLETED|Cycle 1 (Day 1 to Week 15)||71
10845128|NCT02636946|12011226|FG001|COMPLETED|Cycle 1 (Day 1 to Week 15)||67
10845129|NCT02636946|12011225|FG000|NOT COMPLETED|Cycle 1 (Day 1 to Week 15)||1
10845130|NCT02636946|12011226|FG001|NOT COMPLETED|Cycle 1 (Day 1 to Week 15)||5
10845131|NCT02636946|12011225|FG000|STARTED|Cycle 2 (Week 16 to Week 31)||65
10845132|NCT02636946|12011226|FG001|STARTED|Cycle 2 (Week 16 to Week 31)||62
10845133|NCT02636946|12011225|FG000|COMPLETED|Cycle 2 (Week 16 to Week 31)||63
10845134|NCT02636946|12011226|FG001|COMPLETED|Cycle 2 (Week 16 to Week 31)||61
10845135|NCT02636946|12011225|FG000|NOT COMPLETED|Cycle 2 (Week 16 to Week 31)||2
10845136|NCT02636946|12011226|FG001|NOT COMPLETED|Cycle 2 (Week 16 to Week 31)||1
10845137|NCT02636946|12011225|FG000|STARTED|Cycle 3 (Week 32 to Week 52)||17
10845138|NCT02636946|12011226|FG001|STARTED|Cycle 3 (Week 32 to Week 52)||16
10845139|NCT02636946|12011225|FG000|COMPLETED|Cycle 3 (Week 32 to Week 52)||17
10845140|NCT02636946|12011226|FG001|COMPLETED|Cycle 3 (Week 32 to Week 52)||16
10845141|NCT02636946|12011225|FG000|NOT COMPLETED|Cycle 3 (Week 32 to Week 52)||0
10845142|NCT02636946|12011226|FG001|NOT COMPLETED|Cycle 3 (Week 32 to Week 52)||0
10845143|NCT02631941|12011242|FG000|STARTED|Overall Study||9
10845144|NCT02631941|12011243|FG001|STARTED|Overall Study||10
10845145|NCT02631941|12011244|FG002|STARTED|Overall Study||9
10845146|NCT02631941|12011245|FG003|STARTED|Overall Study||9
10845147|NCT02631941|12011246|FG004|STARTED|Overall Study||9
10845148|NCT02631941|12011247|FG005|STARTED|Overall Study||8
10845149|NCT02631941|12011248|FG006|STARTED|Overall Study||9
10845150|NCT02631941|12011249|FG007|STARTED|Overall Study||9
10845151|NCT02631941|12011250|FG008|STARTED|Overall Study||10
10845152|NCT02631941|12011251|FG009|STARTED|Overall Study||9
10845153|NCT02631941|12011242|FG000|A|Overall Study||9
10845154|NCT02631941|12011243|FG001|A|Overall Study||8
10845155|NCT02631941|12011244|FG002|A|Overall Study||9
10845156|NCT02631941|12011245|FG003|A|Overall Study||9
10845157|NCT02631941|12011246|FG004|A|Overall Study||9
10845158|NCT02631941|12011247|FG005|A|Overall Study||8
10845159|NCT02631941|12011248|FG006|A|Overall Study||9
10845160|NCT02631941|12011249|FG007|A|Overall Study||9
10845161|NCT02631941|12011250|FG008|A|Overall Study||9
10845162|NCT02631941|12011251|FG009|A|Overall Study||9
10845163|NCT02631941|12011242|FG000|B1|Overall Study||9
10845164|NCT02631941|12011243|FG001|B1|Overall Study||10
10845165|NCT02631941|12011244|FG002|B1|Overall Study||9
10845166|NCT02631941|12011245|FG003|B1|Overall Study||9
10845167|NCT02631941|12011246|FG004|B1|Overall Study||8
10845168|NCT02631941|12011247|FG005|B1|Overall Study||8
10845169|NCT02631941|12011248|FG006|B1|Overall Study||9
10845170|NCT02631941|12011249|FG007|B1|Overall Study||9
10845171|NCT02631941|12011250|FG008|B1|Overall Study||10
10845172|NCT02631941|12011251|FG009|B1|Overall Study||9
10845173|NCT02631941|12011242|FG000|B2|Overall Study||9
10845174|NCT02631941|12011243|FG001|B2|Overall Study||8
10845175|NCT02631941|12011244|FG002|B2|Overall Study||9
10845176|NCT02631941|12011245|FG003|B2|Overall Study||9
10845177|NCT02631941|12011246|FG004|B2|Overall Study||9
10845178|NCT02631941|12011247|FG005|B2|Overall Study||8
10845179|NCT02631941|12011248|FG006|B2|Overall Study||9
10845180|NCT02631941|12011249|FG007|B2|Overall Study||9
10845181|NCT02631941|12011250|FG008|B2|Overall Study||9
10845182|NCT02631941|12011251|FG009|B2|Overall Study||9
10845183|NCT02631941|12011242|FG000|C|Overall Study||9
10845184|NCT02631941|12011243|FG001|C|Overall Study||8
10845185|NCT02631941|12011244|FG002|C|Overall Study||9
10845186|NCT02631941|12011245|FG003|C|Overall Study||9
10845187|NCT02631941|12011246|FG004|C|Overall Study||8
10845188|NCT02631941|12011247|FG005|C|Overall Study||8
10845189|NCT02631941|12011248|FG006|C|Overall Study||9
10845190|NCT02631941|12011249|FG007|C|Overall Study||8
10845191|NCT02631941|12011250|FG008|C|Overall Study||9
10845192|NCT02631941|12011251|FG009|C|Overall Study||9
10845193|NCT02631941|12011242|FG000|D|Overall Study||9
10845194|NCT02631941|12011243|FG001|D|Overall Study||8
10845195|NCT02631941|12011244|FG002|D|Overall Study||9
10845196|NCT02631941|12011245|FG003|D|Overall Study||9
10845197|NCT02631941|12011246|FG004|D|Overall Study||8
10845198|NCT02631941|12011247|FG005|D|Overall Study||8
10845199|NCT02631941|12011248|FG006|D|Overall Study||9
10845200|NCT02631941|12011249|FG007|D|Overall Study||9
10845201|NCT02631941|12011250|FG008|D|Overall Study||9
10845202|NCT02631941|12011251|FG009|D|Overall Study||9
10845203|NCT02631941|12011242|FG000|COMPLETED|Overall Study||9
10845204|NCT02631941|12011243|FG001|COMPLETED|Overall Study||8
10845205|NCT02631941|12011244|FG002|COMPLETED|Overall Study||9
10845206|NCT02631941|12011245|FG003|COMPLETED|Overall Study||9
10845207|NCT02631941|12011246|FG004|COMPLETED|Overall Study||8
10845208|NCT02631941|12011247|FG005|COMPLETED|Overall Study||8
10845209|NCT02631941|12011248|FG006|COMPLETED|Overall Study||9
10845210|NCT02631941|12011249|FG007|COMPLETED|Overall Study||8
10845211|NCT02631941|12011250|FG008|COMPLETED|Overall Study||9
10845212|NCT02631941|12011251|FG009|COMPLETED|Overall Study||9
10845213|NCT02631941|12011242|FG000|NOT COMPLETED|Overall Study||0
10845214|NCT02631941|12011243|FG001|NOT COMPLETED|Overall Study||2
10845215|NCT02631941|12011244|FG002|NOT COMPLETED|Overall Study||0
10845216|NCT02631941|12011245|FG003|NOT COMPLETED|Overall Study||0
10845217|NCT02631941|12011246|FG004|NOT COMPLETED|Overall Study||1
10845218|NCT02631941|12011247|FG005|NOT COMPLETED|Overall Study||0
10845219|NCT02631941|12011248|FG006|NOT COMPLETED|Overall Study||0
10845220|NCT02631941|12011249|FG007|NOT COMPLETED|Overall Study||1
10845221|NCT02631941|12011250|FG008|NOT COMPLETED|Overall Study||1
10845222|NCT02631941|12011251|FG009|NOT COMPLETED|Overall Study||0
10845223|NCT02568215|12011264|FG000|STARTED|Overall Study||637
10845224|NCT02568215|12011265|FG001|STARTED|Overall Study||642
10845225|NCT02568215|12011266|FG002|STARTED|Overall Study||645
10845226|NCT02568215|12011264|FG000|Modified Intent-to-treat Population|Overall Study||637
10845227|NCT02568215|12011265|FG001|Modified Intent-to-treat Population|Overall Study||642
10845228|NCT02568215|12011266|FG002|Modified Intent-to-treat Population|Overall Study||645
10845229|NCT02568215|12011264|FG000|COMPLETED|Overall Study||558
10845230|NCT02568215|12011265|FG001|COMPLETED|Overall Study||562
10845231|NCT02568215|12011266|FG002|COMPLETED|Overall Study||555
10845232|NCT02568215|12011264|FG000|NOT COMPLETED|Overall Study||79
10412576|NCT00772967|11556748|FG001|COMPLETED|Break 1 (4-7 Days)||4
10845233|NCT02568215|12011265|FG001|NOT COMPLETED|Overall Study||80
10845234|NCT02568215|12011266|FG002|NOT COMPLETED|Overall Study||90
10412577|NCT00772967|11556749|FG002|COMPLETED|Break 1 (4-7 Days)||3
10845235|NCT02562378|12011282|FG000|STARTED|Overall Study||3
10845236|NCT02562378|12011283|FG001|STARTED|Overall Study||3
10845237|NCT02562378|12011284|FG002|STARTED|Overall Study||9
10845238|NCT02562378|12011282|FG000|COMPLETED|Overall Study||3
10845239|NCT02562378|12011283|FG001|COMPLETED|Overall Study||3
10845240|NCT02562378|12011284|FG002|COMPLETED|Overall Study||9
10845241|NCT02562378|12011282|FG000|NOT COMPLETED|Overall Study||0
10845242|NCT02562378|12011283|FG001|NOT COMPLETED|Overall Study||0
10845243|NCT02562378|12011284|FG002|NOT COMPLETED|Overall Study||0
10845244|NCT02528643|12011294|FG000|STARTED|DB (Median Duration up to 14.65 Months)||55
10845245|NCT02528643|12011295|FG001|STARTED|DB (Median Duration up to 14.65 Months)||110
10845246|NCT02528643|12011294|FG000|Treated|DB (Median Duration up to 14.65 Months)||55
10845247|NCT02528643|12011295|FG001|Treated|DB (Median Duration up to 14.65 Months)||107
10845248|NCT02528643|12011294|FG000|COMPLETED|DB (Median Duration up to 14.65 Months)||0
10845249|NCT02528643|12011295|FG001|COMPLETED|DB (Median Duration up to 14.65 Months)||0
10845250|NCT02528643|12011294|FG000|NOT COMPLETED|DB (Median Duration up to 14.65 Months)||55
10845251|NCT02528643|12011295|FG001|NOT COMPLETED|DB (Median Duration up to 14.65 Months)||110
10845252|NCT02528643|12011294|FG000|STARTED|OL (Median Duration up to 27.56 Months)||0
10845253|NCT02528643|12011295|FG001|STARTED|OL (Median Duration up to 27.56 Months)||1
10845254|NCT02528643|12011294|FG000|COMPLETED|OL (Median Duration up to 27.56 Months)||0
10845255|NCT02528643|12011295|FG001|COMPLETED|OL (Median Duration up to 27.56 Months)||0
10845256|NCT02528643|12011294|FG000|NOT COMPLETED|OL (Median Duration up to 27.56 Months)||0
10845257|NCT02528643|12011295|FG001|NOT COMPLETED|OL (Median Duration up to 27.56 Months)||1
10845258|NCT02416011|12011306|FG000|STARTED|Overall Study||575
10845259|NCT02416011|12011307|FG001|STARTED|Overall Study||1154
10845260|NCT02416011|12011308|FG002|STARTED|Overall Study||1167
10845261|NCT02416011|12011306|FG000|COMPLETED|Overall Study||561
10845262|NCT02416011|12011307|FG001|COMPLETED|Overall Study||1101
10845263|NCT02416011|12011308|FG002|COMPLETED|Overall Study||1114
10845264|NCT02416011|12011306|FG000|NOT COMPLETED|Overall Study||14
10845265|NCT02416011|12011307|FG001|NOT COMPLETED|Overall Study||53
10845266|NCT02416011|12011308|FG002|NOT COMPLETED|Overall Study||53
10845267|NCT02237508|12011339|FG000|STARTED|Overall Study||9
10845268|NCT02237508|12011340|FG001|STARTED|Overall Study||9
10845269|NCT02237508|12011341|FG002|STARTED|Overall Study||9
10845270|NCT02237508|12011342|FG003|STARTED|Overall Study||9
10845271|NCT02237508|12011343|FG004|STARTED|Overall Study||9
10845272|NCT02237508|12011344|FG005|STARTED|Overall Study||9
10845273|NCT02237508|12011345|FG006|STARTED|Overall Study||9
10845274|NCT02237508|12011346|FG007|STARTED|Overall Study||9
10845275|NCT02237508|12011347|FG008|STARTED|Overall Study||9
10845276|NCT02237508|12011348|FG009|STARTED|Overall Study||9
10845277|NCT02237508|12011339|FG000|A|Overall Study||9
10845278|NCT02237508|12011340|FG001|A|Overall Study||6
10845279|NCT02237508|12011341|FG002|A|Overall Study||8
10845280|NCT02237508|12011342|FG003|A|Overall Study||8
10845281|NCT02237508|12011343|FG004|A|Overall Study||9
10845282|NCT02237508|12011344|FG005|A|Overall Study||8
10845283|NCT02237508|12011345|FG006|A|Overall Study||8
10845284|NCT02237508|12011346|FG007|A|Overall Study||9
10845285|NCT02237508|12011347|FG008|A|Overall Study||9
10845286|NCT02237508|12011348|FG009|A|Overall Study||9
10845287|NCT02237508|12011339|FG000|B1|Overall Study||9
10845288|NCT02237508|12011340|FG001|B1|Overall Study||9
10845289|NCT02237508|12011341|FG002|B1|Overall Study||9
10845290|NCT02237508|12011342|FG003|B1|Overall Study||8
10845291|NCT02237508|12011343|FG004|B1|Overall Study||9
10845292|NCT02237508|12011344|FG005|B1|Overall Study||9
10845293|NCT02237508|12011345|FG006|B1|Overall Study||9
10845294|NCT02237508|12011346|FG007|B1|Overall Study||9
10845295|NCT02237508|12011347|FG008|B1|Overall Study||9
10845296|NCT02237508|12011348|FG009|B1|Overall Study||9
10845297|NCT02237508|12011339|FG000|B2|Overall Study||9
10845298|NCT02237508|12011340|FG001|B2|Overall Study||6
10845299|NCT02237508|12011341|FG002|B2|Overall Study||9
10845300|NCT02237508|12011342|FG003|B2|Overall Study||9
10845301|NCT02237508|12011343|FG004|B2|Overall Study||9
10845302|NCT02237508|12011344|FG005|B2|Overall Study||9
10845303|NCT02237508|12011345|FG006|B2|Overall Study||9
10845304|NCT02237508|12011346|FG007|B2|Overall Study||9
10845305|NCT02237508|12011347|FG008|B2|Overall Study||8
10845306|NCT02237508|12011348|FG009|B2|Overall Study||9
10845307|NCT02237508|12011339|FG000|C|Overall Study||9
10845308|NCT02237508|12011340|FG001|C|Overall Study||8
10845309|NCT02237508|12011341|FG002|C|Overall Study||9
10845310|NCT02237508|12011342|FG003|C|Overall Study||8
10845311|NCT02237508|12011343|FG004|C|Overall Study||9
10845312|NCT02237508|12011344|FG005|C|Overall Study||9
10845313|NCT02237508|12011345|FG006|C|Overall Study||9
10845314|NCT02237508|12011346|FG007|C|Overall Study||9
10845315|NCT02237508|12011347|FG008|C|Overall Study||9
10845316|NCT02237508|12011348|FG009|C|Overall Study||9
10845317|NCT02237508|12011339|FG000|D|Overall Study||9
10845318|NCT02237508|12011340|FG001|D|Overall Study||6
10845319|NCT02237508|12011341|FG002|D|Overall Study||9
10845320|NCT02237508|12011342|FG003|D|Overall Study||9
10845321|NCT02237508|12011343|FG004|D|Overall Study||9
10845322|NCT02237508|12011344|FG005|D|Overall Study||9
10845323|NCT02237508|12011345|FG006|D|Overall Study||9
10845324|NCT02237508|12011346|FG007|D|Overall Study||9
10845325|NCT02237508|12011347|FG008|D|Overall Study||8
10845326|NCT02237508|12011348|FG009|D|Overall Study||9
10845327|NCT02237508|12011339|FG000|COMPLETED|Overall Study||9
10845328|NCT02237508|12011340|FG001|COMPLETED|Overall Study||6
10845329|NCT02237508|12011341|FG002|COMPLETED|Overall Study||8
10845330|NCT02237508|12011342|FG003|COMPLETED|Overall Study||8
10845331|NCT02237508|12011343|FG004|COMPLETED|Overall Study||9
10845332|NCT02237508|12011344|FG005|COMPLETED|Overall Study||8
10845333|NCT02237508|12011345|FG006|COMPLETED|Overall Study||8
10845334|NCT02237508|12011346|FG007|COMPLETED|Overall Study||9
10412578|NCT00772967|11556750|FG003|COMPLETED|Break 1 (4-7 Days)||3
10412579|NCT00772967|11556751|FG004|COMPLETED|Break 1 (4-7 Days)||4
10412580|NCT00772967|11556752|FG005|COMPLETED|Break 1 (4-7 Days)||3
10412581|NCT00772967|11556747|FG000|NOT COMPLETED|Break 1 (4-7 Days)||0
10412582|NCT00772967|11556748|FG001|NOT COMPLETED|Break 1 (4-7 Days)||1
10412583|NCT00772967|11556749|FG002|NOT COMPLETED|Break 1 (4-7 Days)||0
10412584|NCT00772967|11556750|FG003|NOT COMPLETED|Break 1 (4-7 Days)||0
10412585|NCT00772967|11556751|FG004|NOT COMPLETED|Break 1 (4-7 Days)||0
10412586|NCT00772967|11556752|FG005|NOT COMPLETED|Break 1 (4-7 Days)||0
10412587|NCT00772967|11556747|FG000|STARTED|Crossover Treatment 2||3
10412588|NCT00772967|11556748|FG001|STARTED|Crossover Treatment 2||4
10412589|NCT00772967|11556749|FG002|STARTED|Crossover Treatment 2||3
10412590|NCT00772967|11556750|FG003|STARTED|Crossover Treatment 2||3
10412591|NCT00772967|11556751|FG004|STARTED|Crossover Treatment 2||4
10412592|NCT00772967|11556752|FG005|STARTED|Crossover Treatment 2||3
10412593|NCT00772967|11556747|FG000|COMPLETED|Crossover Treatment 2||3
10412594|NCT00772967|11556748|FG001|COMPLETED|Crossover Treatment 2||4
10412595|NCT00772967|11556749|FG002|COMPLETED|Crossover Treatment 2||3
10412596|NCT00772967|11556750|FG003|COMPLETED|Crossover Treatment 2||3
10412597|NCT00772967|11556751|FG004|COMPLETED|Crossover Treatment 2||4
10412598|NCT00772967|11556752|FG005|COMPLETED|Crossover Treatment 2||3
10412599|NCT00772967|11556747|FG000|NOT COMPLETED|Crossover Treatment 2||0
10412600|NCT00772967|11556748|FG001|NOT COMPLETED|Crossover Treatment 2||0
10412601|NCT00772967|11556749|FG002|NOT COMPLETED|Crossover Treatment 2||0
10412602|NCT00772967|11556750|FG003|NOT COMPLETED|Crossover Treatment 2||0
10412603|NCT00772967|11556751|FG004|NOT COMPLETED|Crossover Treatment 2||0
10412604|NCT00772967|11556752|FG005|NOT COMPLETED|Crossover Treatment 2||0
10412605|NCT00772967|11556747|FG000|STARTED|Break 2 (4-7 Days)||3
10412606|NCT00772967|11556748|FG001|STARTED|Break 2 (4-7 Days)||4
10412607|NCT00772967|11556749|FG002|STARTED|Break 2 (4-7 Days)||3
10412608|NCT00772967|11556750|FG003|STARTED|Break 2 (4-7 Days)||3
10412609|NCT00772967|11556751|FG004|STARTED|Break 2 (4-7 Days)||4
10412610|NCT00772967|11556752|FG005|STARTED|Break 2 (4-7 Days)||3
10412611|NCT00772967|11556747|FG000|COMPLETED|Break 2 (4-7 Days)||3
10412612|NCT00772967|11556748|FG001|COMPLETED|Break 2 (4-7 Days)||4
10412613|NCT00772967|11556749|FG002|COMPLETED|Break 2 (4-7 Days)||3
10412614|NCT00772967|11556750|FG003|COMPLETED|Break 2 (4-7 Days)||3
10412615|NCT00772967|11556751|FG004|COMPLETED|Break 2 (4-7 Days)||4
10412616|NCT00772967|11556752|FG005|COMPLETED|Break 2 (4-7 Days)||3
10412617|NCT00772967|11556747|FG000|NOT COMPLETED|Break 2 (4-7 Days)||0
10412618|NCT00772967|11556748|FG001|NOT COMPLETED|Break 2 (4-7 Days)||0
10412619|NCT00772967|11556749|FG002|NOT COMPLETED|Break 2 (4-7 Days)||0
10412620|NCT00772967|11556750|FG003|NOT COMPLETED|Break 2 (4-7 Days)||0
10412621|NCT00772967|11556751|FG004|NOT COMPLETED|Break 2 (4-7 Days)||0
10412622|NCT00772967|11556752|FG005|NOT COMPLETED|Break 2 (4-7 Days)||0
10412623|NCT00772967|11556747|FG000|STARTED|Crossover Treatment 3||3
10412624|NCT00772967|11556748|FG001|STARTED|Crossover Treatment 3||4
10412625|NCT00772967|11556749|FG002|STARTED|Crossover Treatment 3||3
10412626|NCT00772967|11556750|FG003|STARTED|Crossover Treatment 3||3
10412627|NCT00772967|11556751|FG004|STARTED|Crossover Treatment 3||4
10412628|NCT00772967|11556752|FG005|STARTED|Crossover Treatment 3||3
10412629|NCT00772967|11556747|FG000|COMPLETED|Crossover Treatment 3||3
10412630|NCT00772967|11556748|FG001|COMPLETED|Crossover Treatment 3||4
10412631|NCT00772967|11556749|FG002|COMPLETED|Crossover Treatment 3||3
10754660|NCT03054350|11918372|FG000|NOT COMPLETED|Dose Adjustment and Maintenance Period||1
10754661|NCT03054350|11918373|FG001|NOT COMPLETED|Dose Adjustment and Maintenance Period||0
10754662|NCT03054350|11918374|FG002|NOT COMPLETED|Dose Adjustment and Maintenance Period||1
10754663|NCT03054350|11918375|FG003|NOT COMPLETED|Dose Adjustment and Maintenance Period||1
10754664|NCT03054350|11918376|FG004|NOT COMPLETED|Dose Adjustment and Maintenance Period||0
10754665|NCT03054350|11918377|FG005|NOT COMPLETED|Dose Adjustment and Maintenance Period||0
10754666|NCT03054428|11918411|FG000|STARTED|Overall Study||85
10754667|NCT03054428|11918412|FG001|STARTED|Overall Study||84
10754668|NCT03054428|11918413|FG002|STARTED|Overall Study||82
10754669|NCT03054428|11918411|FG000|Completed Wk 16 End of Treatment (EOT)|Overall Study||80
10754670|NCT03054428|11918412|FG001|Completed Wk 16 End of Treatment (EOT)|Overall Study||81
10754671|NCT03054428|11918413|FG002|Completed Wk 16 End of Treatment (EOT)|Overall Study||79
10754672|NCT03054428|11918411|FG000|Completed Week 28 (End of Study)|Overall Study||2
10754673|NCT03054428|11918412|FG001|Completed Week 28 (End of Study)|Overall Study||4
10754674|NCT03054428|11918413|FG002|Completed Week 28 (End of Study)|Overall Study||3
10754675|NCT03054428|11918411|FG000|COMPLETED|Overall Study||2
10412632|NCT00772967|11556750|FG003|COMPLETED|Crossover Treatment 3||3
10412633|NCT00772967|11556751|FG004|COMPLETED|Crossover Treatment 3||3
10412634|NCT00772967|11556752|FG005|COMPLETED|Crossover Treatment 3||3
10412635|NCT00772967|11556747|FG000|NOT COMPLETED|Crossover Treatment 3||0
10845335|NCT02237508|12011347|FG008|COMPLETED|Overall Study||8
10845336|NCT02237508|12011348|FG009|COMPLETED|Overall Study||9
10412636|NCT00772967|11556748|FG001|NOT COMPLETED|Crossover Treatment 3||0
10412637|NCT00772967|11556749|FG002|NOT COMPLETED|Crossover Treatment 3||0
10412638|NCT00772967|11556750|FG003|NOT COMPLETED|Crossover Treatment 3||0
10412639|NCT00772967|11556751|FG004|NOT COMPLETED|Crossover Treatment 3||1
10412640|NCT00772967|11556752|FG005|NOT COMPLETED|Crossover Treatment 3||0
10845337|NCT02237508|12011339|FG000|NOT COMPLETED|Overall Study||0
10845338|NCT02237508|12011340|FG001|NOT COMPLETED|Overall Study||3
10845339|NCT02237508|12011341|FG002|NOT COMPLETED|Overall Study||1
10845340|NCT02237508|12011342|FG003|NOT COMPLETED|Overall Study||1
10845341|NCT02237508|12011343|FG004|NOT COMPLETED|Overall Study||0
10845342|NCT02237508|12011344|FG005|NOT COMPLETED|Overall Study||1
10845343|NCT02237508|12011345|FG006|NOT COMPLETED|Overall Study||1
10845344|NCT02237508|12011346|FG007|NOT COMPLETED|Overall Study||0
10845345|NCT02237508|12011347|FG008|NOT COMPLETED|Overall Study||1
10845346|NCT02237508|12011348|FG009|NOT COMPLETED|Overall Study||0
10845347|NCT01706705|12011366|FG000|STARTED|Overall Study||57
10845348|NCT01706705|12011366|FG000|COMPLETED|Overall Study||37
10845349|NCT01706705|12011366|FG000|NOT COMPLETED|Overall Study||20
10845350|NCT01609842|12011375|FG000|STARTED|Pre-Intervention Control||0
10845351|NCT01609842|12011376|FG001|STARTED|Pre-Intervention Control|Intervention sites patients prior to enrollment period who did not receive the intervention|6081
10845352|NCT01609842|12011375|FG000|COMPLETED|Pre-Intervention Control||0
10845353|NCT01609842|12011376|FG001|COMPLETED|Pre-Intervention Control||6081
10845354|NCT01609842|12011375|FG000|NOT COMPLETED|Pre-Intervention Control||0
10845355|NCT01609842|12011376|FG001|NOT COMPLETED|Pre-Intervention Control||0
10845356|NCT01609842|12011375|FG000|STARTED|Post-Intervention Control||0
10845357|NCT01609842|12011376|FG001|STARTED|Post-Intervention Control|Intervention sites patients after enrollment period ended who did not receive the intervention.|2917
10845358|NCT01609842|12011375|FG000|COMPLETED|Post-Intervention Control||0
10845359|NCT01609842|12011376|FG001|COMPLETED|Post-Intervention Control||2917
10845360|NCT01609842|12011375|FG000|NOT COMPLETED|Post-Intervention Control||0
10845361|NCT01609842|12011376|FG001|NOT COMPLETED|Post-Intervention Control||0
10845362|NCT01609842|12011375|FG000|STARTED|Concurrent Intervention Control||708
10845363|NCT01609842|12011376|FG001|STARTED|Concurrent Intervention Control|Nonintervention sites patients during the period prior and post enrollment at the intervention sites|4869
10845364|NCT01609842|12011375|FG000|COMPLETED|Concurrent Intervention Control||706
10845365|NCT01609842|12011376|FG001|COMPLETED|Concurrent Intervention Control||4869
10845366|NCT01609842|12011375|FG000|NOT COMPLETED|Concurrent Intervention Control||2
10845367|NCT01609842|12011376|FG001|NOT COMPLETED|Concurrent Intervention Control||0
10845368|NCT01341600|12011389|FG000|STARTED|Clopidogrel 75 mg||6
10845369|NCT01341600|12011390|FG001|STARTED|Clopidogrel 75 mg||6
10845370|NCT01341600|12011391|FG002|STARTED|Clopidogrel 75 mg||6
10845371|NCT01341600|12011389|FG000|COMPLETED|Clopidogrel 75 mg||6
10845372|NCT01341600|12011390|FG001|COMPLETED|Clopidogrel 75 mg||6
10845373|NCT01341600|12011391|FG002|COMPLETED|Clopidogrel 75 mg||6
10845374|NCT01341600|12011389|FG000|NOT COMPLETED|Clopidogrel 75 mg||0
10845375|NCT01341600|12011390|FG001|NOT COMPLETED|Clopidogrel 75 mg||0
10845376|NCT01341600|12011391|FG002|NOT COMPLETED|Clopidogrel 75 mg||0
10845377|NCT01341600|12011389|FG000|STARTED|Clopidogrel 150 mg||6
10845378|NCT01341600|12011390|FG001|STARTED|Clopidogrel 150 mg||6
10845379|NCT01341600|12011391|FG002|STARTED|Clopidogrel 150 mg||6
10845380|NCT01341600|12011389|FG000|COMPLETED|Clopidogrel 150 mg||6
10845381|NCT01341600|12011390|FG001|COMPLETED|Clopidogrel 150 mg||6
10845382|NCT01341600|12011391|FG002|COMPLETED|Clopidogrel 150 mg||6
10845383|NCT01341600|12011389|FG000|NOT COMPLETED|Clopidogrel 150 mg||0
10845384|NCT01341600|12011390|FG001|NOT COMPLETED|Clopidogrel 150 mg||0
10845385|NCT01341600|12011391|FG002|NOT COMPLETED|Clopidogrel 150 mg||0
10845386|NCT01341600|12011389|FG000|STARTED|Clopidogrel 225 mg||6
10845387|NCT01341600|12011390|FG001|STARTED|Clopidogrel 225 mg||6
10845388|NCT01341600|12011391|FG002|STARTED|Clopidogrel 225 mg||6
10845389|NCT01341600|12011389|FG000|COMPLETED|Clopidogrel 225 mg||6
10845390|NCT01341600|12011390|FG001|COMPLETED|Clopidogrel 225 mg||6
10845391|NCT01341600|12011391|FG002|COMPLETED|Clopidogrel 225 mg||6
10845392|NCT01341600|12011389|FG000|NOT COMPLETED|Clopidogrel 225 mg||0
10845393|NCT01341600|12011390|FG001|NOT COMPLETED|Clopidogrel 225 mg||0
10845394|NCT01341600|12011391|FG002|NOT COMPLETED|Clopidogrel 225 mg||0
10845395|NCT01341600|12011389|FG000|STARTED|Clopidogrel Plus Omeprazole||5
10845396|NCT01341600|12011390|FG001|STARTED|Clopidogrel Plus Omeprazole||5
10845397|NCT01341600|12011391|FG002|STARTED|Clopidogrel Plus Omeprazole||4
10845398|NCT01341600|12011389|FG000|COMPLETED|Clopidogrel Plus Omeprazole||5
10845399|NCT01341600|12011390|FG001|COMPLETED|Clopidogrel Plus Omeprazole||5
10845400|NCT01341600|12011391|FG002|COMPLETED|Clopidogrel Plus Omeprazole||4
10845401|NCT01341600|12011389|FG000|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
10845402|NCT01341600|12011390|FG001|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
10845403|NCT01341600|12011391|FG002|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
10845404|NCT01044901|12011401|FG000|STARTED|Overall Study||38
10845405|NCT01044901|12011402|FG001|STARTED|Overall Study||13
10845406|NCT01044901|12011401|FG000|COMPLETED|Overall Study||38
10845407|NCT01044901|12011402|FG001|COMPLETED|Overall Study||13
10845408|NCT01044901|12011401|FG000|NOT COMPLETED|Overall Study||0
10845409|NCT01044901|12011402|FG001|NOT COMPLETED|Overall Study||0
10845410|NCT00003479|12011408|FG000|STARTED|Overall Study||9
10845411|NCT00003479|12011408|FG000|COMPLETED|Overall Study||6
10845412|NCT00003479|12011408|FG000|NOT COMPLETED|Overall Study||3
10845413|NCT04160195|12011414|FG000|STARTED|Overall Study||2
10845414|NCT04160195|12011415|FG001|STARTED|Overall Study||0
10845415|NCT04160195|12011414|FG000|COMPLETED|Overall Study||1
10845416|NCT04160195|12011415|FG001|COMPLETED|Overall Study||0
10845417|NCT04160195|12011414|FG000|NOT COMPLETED|Overall Study||1
10845418|NCT04160195|12011415|FG001|NOT COMPLETED|Overall Study||0
10845445|NCT04152447|12011438|FG000|STARTED|Overall Study||16
10845446|NCT04152447|12011439|FG001|STARTED|Overall Study||19
10845447|NCT04152447|12011438|FG000|COMPLETED|Overall Study||13
10845448|NCT04152447|12011439|FG001|COMPLETED|Overall Study||14
10845449|NCT04152447|12011438|FG000|NOT COMPLETED|Overall Study||3
10845450|NCT04152447|12011439|FG001|NOT COMPLETED|Overall Study||5
10845469|NCT04006847|12011456|FG000|STARTED|Overall Study||1
10845470|NCT04006847|12011456|FG000|COMPLETED|Overall Study||0
10845471|NCT04006847|12011456|FG000|NOT COMPLETED|Overall Study||1
10845472|NCT03922711|12011463|FG000|STARTED|Overall Study||7
10845473|NCT03922711|12011464|FG001|STARTED|Overall Study||8
10845474|NCT03922711|12011465|FG002|STARTED|Overall Study||8
10845475|NCT03922711|12011463|FG000|Treatment Group Based on Maximal Possible Highest Dose Received (Used for Analysis)|Overall Study||12
10845476|NCT03922711|12011464|FG001|Treatment Group Based on Maximal Possible Highest Dose Received (Used for Analysis)|Overall Study||3
10845477|NCT03922711|12011465|FG002|Treatment Group Based on Maximal Possible Highest Dose Received (Used for Analysis)|Overall Study||8
10845478|NCT03922711|12011463|FG000|COMPLETED|Overall Study||3
10845479|NCT03922711|12011464|FG001|COMPLETED|Overall Study||3
10845480|NCT03922711|12011465|FG002|COMPLETED|Overall Study||4
10845481|NCT03922711|12011463|FG000|NOT COMPLETED|Overall Study||4
10845482|NCT03922711|12011464|FG001|NOT COMPLETED|Overall Study||5
10845483|NCT03922711|12011465|FG002|NOT COMPLETED|Overall Study||4
10845484|NCT04460183|12011474|FG000|STARTED|Overall Study||14
10845485|NCT04460183|12011475|FG001|STARTED|Overall Study||5
10845486|NCT04460183|12011474|FG000|COMPLETED|Overall Study||10
10845487|NCT04460183|12011475|FG001|COMPLETED|Overall Study||4
10845488|NCT04460183|12011474|FG000|NOT COMPLETED|Overall Study||4
10845489|NCT04460183|12011475|FG001|NOT COMPLETED|Overall Study||1
10845498|NCT03831360|12011494|FG000|STARTED|Overall Study||15
10845499|NCT03831360|12011495|FG001|STARTED|Overall Study||15
10845500|NCT03831360|12011494|FG000|COMPLETED|Overall Study||12
10845501|NCT03831360|12011495|FG001|COMPLETED|Overall Study||14
10845502|NCT03831360|12011494|FG000|NOT COMPLETED|Overall Study||3
10845503|NCT03831360|12011495|FG001|NOT COMPLETED|Overall Study||1
10845504|NCT03829332|12011503|FG000|STARTED|Overall Study||309
10845505|NCT03829332|12011504|FG001|STARTED|Overall Study||314
10845506|NCT03829332|12011503|FG000|Treated|Overall Study||309
10845507|NCT03829332|12011504|FG001|Treated|Overall Study||312
10845508|NCT03829332|12011503|FG000|COMPLETED|Overall Study||0
10845509|NCT03829332|12011504|FG001|COMPLETED|Overall Study||0
10845510|NCT03829332|12011503|FG000|NOT COMPLETED|Overall Study||309
10845511|NCT03829332|12011504|FG001|NOT COMPLETED|Overall Study||314
10845419|NCT04159701|12011425|FG000|STARTED|Period 1: Treatment Period||39
10845420|NCT04159701|12011426|FG001|STARTED|Period 1: Treatment Period||13
10845421|NCT04159701|12011425|FG000|Received at Least One Dose of Study Drug|Period 1: Treatment Period||39
10845422|NCT04159701|12011426|FG001|Received at Least One Dose of Study Drug|Period 1: Treatment Period||13
10845423|NCT04159701|12011425|FG000|COMPLETED|Period 1: Treatment Period||31
10845424|NCT04159701|12011426|FG001|COMPLETED|Period 1: Treatment Period||12
10845425|NCT04159701|12011425|FG000|NOT COMPLETED|Period 1: Treatment Period||8
10845426|NCT04159701|12011426|FG001|NOT COMPLETED|Period 1: Treatment Period||1
10845427|NCT04159701|12011425|FG000|STARTED|Washout Period||31
10845428|NCT04159701|12011426|FG001|STARTED|Washout Period||12
10845429|NCT04159701|12011425|FG000|COMPLETED|Washout Period||18
10845430|NCT04159701|12011426|FG001|COMPLETED|Washout Period||8
10845431|NCT04159701|12011425|FG000|NOT COMPLETED|Washout Period||13
10845432|NCT04159701|12011426|FG001|NOT COMPLETED|Washout Period||4
10845433|NCT04159701|12011425|FG000|STARTED|Period 2: Treatment Period (Crossover)||18
10845434|NCT04159701|12011426|FG001|STARTED|Period 2: Treatment Period (Crossover)||8
10845435|NCT04159701|12011425|FG000|COMPLETED|Period 2: Treatment Period (Crossover)||18
10845436|NCT04159701|12011426|FG001|COMPLETED|Period 2: Treatment Period (Crossover)||5
10845437|NCT04159701|12011425|FG000|NOT COMPLETED|Period 2: Treatment Period (Crossover)||0
10845438|NCT04159701|12011426|FG001|NOT COMPLETED|Period 2: Treatment Period (Crossover)||3
10845439|NCT04159701|12011425|FG000|STARTED|Post-treatment Follow-up|All participants who received study drug could move to post-treatment follow-up.|29
10845440|NCT04159701|12011426|FG001|STARTED|Post-treatment Follow-up|All participants who received study drug could move to post-treatment follow-up.|9
10845441|NCT04159701|12011425|FG000|COMPLETED|Post-treatment Follow-up||19
10845442|NCT04159701|12011426|FG001|COMPLETED|Post-treatment Follow-up||6
10845443|NCT04159701|12011425|FG000|NOT COMPLETED|Post-treatment Follow-up||10
10845444|NCT04159701|12011426|FG001|NOT COMPLETED|Post-treatment Follow-up||3
10845451|NCT04150107|12011447|FG000|STARTED|Period 1- Placebo run-in (All Patients)||14
10845452|NCT04150107|12011448|FG001|STARTED|Period 1- Placebo run-in (All Patients)||16
10845453|NCT04150107|12011447|FG000|COMPLETED|Period 1- Placebo run-in (All Patients)||14
10845454|NCT04150107|12011448|FG001|COMPLETED|Period 1- Placebo run-in (All Patients)||16
10845455|NCT04150107|12011447|FG000|NOT COMPLETED|Period 1- Placebo run-in (All Patients)||0
10845456|NCT04150107|12011448|FG001|NOT COMPLETED|Period 1- Placebo run-in (All Patients)||0
10845457|NCT04150107|12011447|FG000|STARTED|Period 2- Either Treatment A or B||14
10845458|NCT04150107|12011448|FG001|STARTED|Period 2- Either Treatment A or B||16
10845459|NCT04150107|12011447|FG000|COMPLETED|Period 2- Either Treatment A or B||14
10845460|NCT04150107|12011448|FG001|COMPLETED|Period 2- Either Treatment A or B||16
10845461|NCT04150107|12011447|FG000|NOT COMPLETED|Period 2- Either Treatment A or B||0
10845462|NCT04150107|12011448|FG001|NOT COMPLETED|Period 2- Either Treatment A or B||0
10845463|NCT04150107|12011447|FG000|STARTED|Period 3 Crossover-Treatment B or A||14
10845464|NCT04150107|12011448|FG001|STARTED|Period 3 Crossover-Treatment B or A||16
10845465|NCT04150107|12011447|FG000|COMPLETED|Period 3 Crossover-Treatment B or A||12
10845466|NCT04150107|12011448|FG001|COMPLETED|Period 3 Crossover-Treatment B or A||15
10845467|NCT04150107|12011447|FG000|NOT COMPLETED|Period 3 Crossover-Treatment B or A||2
10845468|NCT04150107|12011448|FG001|NOT COMPLETED|Period 3 Crossover-Treatment B or A||1
10412641|NCT00773097|11556760|FG000|STARTED|Overall Study||46
10412642|NCT00773097|11556760|FG000|COMPLETED|Overall Study||39
10412643|NCT00773097|11556760|FG000|NOT COMPLETED|Overall Study||7
10412644|NCT00773136|11556764|FG000|STARTED|Overall Study||21
10412645|NCT00773136|11556764|FG000|COMPLETED|Overall Study||19
10412646|NCT00773136|11556764|FG000|NOT COMPLETED|Overall Study||2
10412647|NCT00773175|11556771|FG000|STARTED|Overall Study||73
10412648|NCT00773175|11556772|FG001|STARTED|Overall Study||75
10412649|NCT00773175|11556771|FG000|Initial Fluids Via Randomized Route|Overall Study||73
10412650|NCT00773175|11556772|FG001|Initial Fluids Via Randomized Route|Overall Study||59
10412651|NCT00773175|11556771|FG000|Initial Fluids Via Subcutaneous Rescue|Overall Study||0
10412652|NCT00773175|11556772|FG001|Initial Fluids Via Subcutaneous Rescue|Overall Study||15
10412653|NCT00773175|11556771|FG000|No Fluids Received|Overall Study||0
10412654|NCT00773175|11556772|FG001|No Fluids Received|Overall Study||1
10412655|NCT00773175|11556771|FG000|COMPLETED|Overall Study||71
10412656|NCT00773175|11556772|FG001|COMPLETED|Overall Study||73
10412657|NCT00773175|11556771|FG000|NOT COMPLETED|Overall Study||2
10412658|NCT00773175|11556772|FG001|NOT COMPLETED|Overall Study||2
10412659|NCT00773253|11556785|FG000|STARTED|First Intervention (Week 0-24)||5
10412660|NCT00773253|11556786|FG001|STARTED|First Intervention (Week 0-24)||5
10412661|NCT00773253|11556785|FG000|COMPLETED|First Intervention (Week 0-24)||5
10412662|NCT00773253|11556786|FG001|COMPLETED|First Intervention (Week 0-24)||4
10412663|NCT00773253|11556785|FG000|NOT COMPLETED|First Intervention (Week 0-24)||0
10412664|NCT00773253|11556786|FG001|NOT COMPLETED|First Intervention (Week 0-24)||1
10412665|NCT00773253|11556785|FG000|STARTED|Second Intervention (Week 24-48)||5
10412666|NCT00773253|11556786|FG001|STARTED|Second Intervention (Week 24-48)||4
10412667|NCT00773253|11556785|FG000|COMPLETED|Second Intervention (Week 24-48)||5
10412668|NCT00773253|11556786|FG001|COMPLETED|Second Intervention (Week 24-48)||4
10412669|NCT00773253|11556785|FG000|NOT COMPLETED|Second Intervention (Week 24-48)||0
10412670|NCT00773253|11556786|FG001|NOT COMPLETED|Second Intervention (Week 24-48)||0
10412671|NCT00773279|11556794|FG000|STARTED|Period 1||121
10412672|NCT00773279|11556795|FG001|STARTED|Period 1||121
10412673|NCT00773279|11556794|FG000|COMPLETED|Period 1||114
10412674|NCT00773279|11556795|FG001|COMPLETED|Period 1||117
10412675|NCT00773279|11556794|FG000|NOT COMPLETED|Period 1||7
10412676|NCT00773279|11556795|FG001|NOT COMPLETED|Period 1||4
10412677|NCT00773279|11556794|FG000|STARTED|Period 2||114
10412678|NCT00773279|11556795|FG001|STARTED|Period 2||117
10412679|NCT00773279|11556794|FG000|COMPLETED|Period 2||111
10412680|NCT00773279|11556795|FG001|COMPLETED|Period 2||111
10412681|NCT00773279|11556794|FG000|NOT COMPLETED|Period 2||3
10412682|NCT00773279|11556795|FG001|NOT COMPLETED|Period 2||6
10412683|NCT00773292|11556802|FG000|STARTED|Pre-treatment 4 Weeks||7
10412684|NCT00773292|11556802|FG000|COMPLETED|Pre-treatment 4 Weeks||7
10412685|NCT00773292|11556802|FG000|NOT COMPLETED|Pre-treatment 4 Weeks||0
10412686|NCT00773292|11556802|FG000|STARTED|Treatment 48 Weeks||7
10412687|NCT00773292|11556802|FG000|COMPLETED|Treatment 48 Weeks|Two patients discontinued the treatment but remained on the study|5
10412688|NCT00773292|11556802|FG000|NOT COMPLETED|Treatment 48 Weeks||2
10412689|NCT00773292|11556802|FG000|STARTED|Post Treatment 24 Weeks||7
10412690|NCT00773292|11556802|FG000|COMPLETED|Post Treatment 24 Weeks||7
10412691|NCT00773292|11556802|FG000|NOT COMPLETED|Post Treatment 24 Weeks||0
10412692|NCT00773370|11556808|FG000|STARTED|Overall Study||43
10412693|NCT00773370|11556809|FG001|STARTED|Overall Study||33
10412694|NCT00773370|11556808|FG000|COMPLETED|Overall Study||25
10412695|NCT00773370|11556809|FG001|COMPLETED|Overall Study||23
10412696|NCT00773370|11556808|FG000|NOT COMPLETED|Overall Study||18
10412697|NCT00773370|11556809|FG001|NOT COMPLETED|Overall Study||10
10412698|NCT00773383|11556815|FG000|STARTED|Overall Study||35
10412699|NCT00773383|11556815|FG000|Received Study Drug|Overall Study||34
10412700|NCT00773383|11556815|FG000|COMPLETED|Overall Study|this includes at the time of clinical cut-off (2/23/2010) there were 4 patients ongoing|4
10412701|NCT00773383|11556815|FG000|NOT COMPLETED|Overall Study||31
10412702|NCT00773422|11556826|FG000|STARTED|Overall Study||11
10412703|NCT00773422|11556827|FG001|STARTED|Overall Study||9
10412704|NCT00773422|11556828|FG002|STARTED|Overall Study||10
10412705|NCT00773422|11556826|FG000|COMPLETED|Overall Study||11
10412706|NCT00773422|11556827|FG001|COMPLETED|Overall Study||9
10412707|NCT00773422|11556828|FG002|COMPLETED|Overall Study||10
10412708|NCT00773422|11556826|FG000|NOT COMPLETED|Overall Study||0
10412709|NCT00773422|11556827|FG001|NOT COMPLETED|Overall Study||0
10412710|NCT00773422|11556828|FG002|NOT COMPLETED|Overall Study||0
10429214|NCT00862849|11575286|FG000|STARTED|Washout 4 (3 to 14 Days)||3
10429215|NCT00862849|11575287|FG001|STARTED|Washout 4 (3 to 14 Days)||3
10429216|NCT00862849|11575288|FG002|STARTED|Washout 4 (3 to 14 Days)||3
10429217|NCT00862849|11575289|FG003|STARTED|Washout 4 (3 to 14 Days)||4
10429218|NCT00862849|11575290|FG004|STARTED|Washout 4 (3 to 14 Days)||4
10429219|NCT00862849|11575291|FG005|STARTED|Washout 4 (3 to 14 Days)||3
10429220|NCT00862849|11575286|FG000|COMPLETED|Washout 4 (3 to 14 Days)||3
10429221|NCT00862849|11575287|FG001|COMPLETED|Washout 4 (3 to 14 Days)||3
10429222|NCT00862849|11575288|FG002|COMPLETED|Washout 4 (3 to 14 Days)||3
10429223|NCT00862849|11575289|FG003|COMPLETED|Washout 4 (3 to 14 Days)||4
10429224|NCT00862849|11575290|FG004|COMPLETED|Washout 4 (3 to 14 Days)||4
10429225|NCT00862849|11575291|FG005|COMPLETED|Washout 4 (3 to 14 Days)||3
10429226|NCT00862849|11575286|FG000|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
10429227|NCT00862849|11575287|FG001|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
10545182|NCT01494922|11698461|FG000|NOT COMPLETED|Overall Study||1
10545183|NCT01494987|11698467|FG000|STARTED|Overall Study||216
10545184|NCT01494987|11698468|FG001|STARTED|Overall Study||215
10545185|NCT01494987|11698467|FG000|COMPLETED|Overall Study||188
10545186|NCT01494987|11698468|FG001|COMPLETED|Overall Study||187
10545187|NCT01494987|11698467|FG000|NOT COMPLETED|Overall Study||28
10545188|NCT01494987|11698468|FG001|NOT COMPLETED|Overall Study||28
10545189|NCT01495000|11698476|FG000|STARTED|Overall Study||124
10545190|NCT01495000|11698477|FG001|STARTED|Overall Study||126
10545191|NCT01495000|11698476|FG000|COMPLETED|Overall Study||111
10545192|NCT01495000|11698477|FG001|COMPLETED|Overall Study||114
10545193|NCT01495000|11698476|FG000|NOT COMPLETED|Overall Study||13
10545194|NCT01495000|11698477|FG001|NOT COMPLETED|Overall Study||12
10545195|NCT01495221|11698483|FG000|STARTED|Overall Study|First Patient enrolled December 2011.|9
10545196|NCT01495221|11698483|FG000|COMPLETED|Overall Study|Last patient enrolled May 2012.|9
10545197|NCT01495221|11698483|FG000|NOT COMPLETED|Overall Study||0
10545198|NCT01495286|11698487|FG000|STARTED|Overall Study||30
10545199|NCT01495286|11698487|FG000|COMPLETED|Overall Study||30
10545200|NCT01495286|11698487|FG000|NOT COMPLETED|Overall Study||0
10545201|NCT01495481|11698491|FG000|STARTED|Adenosine|Patients first received adenosine and then dexmedetomidine.|22
10545202|NCT01495481|11698491|FG000|COMPLETED|Adenosine||22
10545203|NCT01495481|11698491|FG000|NOT COMPLETED|Adenosine||0
10545204|NCT01495481|11698491|FG000|STARTED|Washout||22
10545205|NCT01495481|11698491|FG000|COMPLETED|Washout||22
10545206|NCT01495481|11698491|FG000|NOT COMPLETED|Washout||0
10545207|NCT01495481|11698491|FG000|STARTED|Dexmedetomidine||22
10545208|NCT01495481|11698491|FG000|COMPLETED|Dexmedetomidine||22
10545209|NCT01495481|11698491|FG000|NOT COMPLETED|Dexmedetomidine||0
10429228|NCT00862849|11575288|FG002|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
10429229|NCT00862849|11575289|FG003|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
10545210|NCT01495572|11698501|FG000|STARTED|Overall Study||0
10845638|NCT03543046|12011562|FG000|STARTED|Overall Study||14
10845639|NCT03543046|12011563|FG001|STARTED|Overall Study||13
10845640|NCT03543046|12011562|FG000|COMPLETED|Overall Study||11
10845641|NCT03543046|12011563|FG001|COMPLETED|Overall Study||11
10845642|NCT03543046|12011562|FG000|NOT COMPLETED|Overall Study||3
10845643|NCT03543046|12011563|FG001|NOT COMPLETED|Overall Study||2
10845644|NCT03530800|12011571|FG000|STARTED|Overall Study||25
10845645|NCT03530800|12011572|FG001|STARTED|Overall Study||25
10845646|NCT03530800|12011571|FG000|COMPLETED|Overall Study||14
10845647|NCT03530800|12011572|FG001|COMPLETED|Overall Study||16
10845648|NCT03530800|12011571|FG000|NOT COMPLETED|Overall Study||11
10845649|NCT03530800|12011572|FG001|NOT COMPLETED|Overall Study||9
10412711|NCT00773461|11556838|FG000|STARTED|Overall Study||70
10412712|NCT00773461|11556839|FG001|STARTED|Overall Study||139
10412713|NCT00773461|11556838|FG000|COMPLETED|Overall Study||65
10412714|NCT00773461|11556839|FG001|COMPLETED|Overall Study||135
10412715|NCT00773461|11556838|FG000|NOT COMPLETED|Overall Study||5
10412716|NCT00773461|11556839|FG001|NOT COMPLETED|Overall Study||4
10845650|NCT03270462|12011578|FG000|STARTED|Overall Study||20
10845651|NCT03270462|12011578|FG000|COMPLETED|Overall Study||20
10845652|NCT03270462|12011578|FG000|NOT COMPLETED|Overall Study||0
10845662|NCT03090412|12011597|FG000|STARTED|Overall Study||1
10845663|NCT03090412|12011598|FG001|STARTED|Overall Study||1
10845664|NCT03090412|12011597|FG000|COMPLETED|Overall Study||1
10845665|NCT03090412|12011598|FG001|COMPLETED|Overall Study||1
10845666|NCT03090412|12011597|FG000|NOT COMPLETED|Overall Study||0
10845667|NCT03090412|12011598|FG001|NOT COMPLETED|Overall Study||0
10845668|NCT03065517|12011606|FG000|STARTED|Overall Study||110
10845669|NCT03065517|12011607|FG001|STARTED|Overall Study||106
10845670|NCT03065517|12011606|FG000|COMPLETED|Overall Study||84
10845671|NCT03065517|12011607|FG001|COMPLETED|Overall Study||90
10845672|NCT03065517|12011606|FG000|NOT COMPLETED|Overall Study||26
10845673|NCT03065517|12011607|FG001|NOT COMPLETED|Overall Study||16
10845674|NCT03063203|12011613|FG000|STARTED|Overall Study||17
10845675|NCT03063203|12011613|FG000|COMPLETED|Overall Study||3
10845676|NCT03063203|12011613|FG000|NOT COMPLETED|Overall Study||14
10412717|NCT00773474|11556846|FG000|STARTED|Overall Study||29
10412718|NCT00773474|11556846|FG000|COMPLETED|Overall Study||29
10412719|NCT00773474|11556846|FG000|NOT COMPLETED|Overall Study||0
10412720|NCT00773513|11556852|FG000|STARTED|Overall Study||1413
10412721|NCT00773513|11556853|FG001|STARTED|Overall Study||1412
10412722|NCT00773513|11556852|FG000|Received Study Treatment|Overall Study||1409
10412723|NCT00773513|11556853|FG001|Received Study Treatment|Overall Study||1409
10412724|NCT00773513|11556852|FG000|COMPLETED|Overall Study||312
10412725|NCT00773513|11556853|FG001|COMPLETED|Overall Study||303
10412726|NCT00773513|11556852|FG000|NOT COMPLETED|Overall Study||1101
10412727|NCT00773513|11556853|FG001|NOT COMPLETED|Overall Study||1109
10412728|NCT00773604|11556859|FG000|STARTED|Overall Study||9
10412729|NCT00773604|11556859|FG000|COMPLETED|Overall Study||9
10412730|NCT00773604|11556859|FG000|NOT COMPLETED|Overall Study||0
10412731|NCT00773734|11556867|FG000|STARTED|Core: Placebo Controlled Phase Week 0-16||88
10412732|NCT00773734|11556868|FG001|STARTED|Core: Placebo Controlled Phase Week 0-16||89
10412733|NCT00773734|11556869|FG002|STARTED|Core: Placebo Controlled Phase Week 0-16||87
10412734|NCT00773734|11556870|FG003|STARTED|Core: Placebo Controlled Phase Week 0-16||88
10412735|NCT00773734|11556871|FG004|STARTED|Core: Placebo Controlled Phase Week 0-16||0
10412736|NCT00773734|11556872|FG005|STARTED|Core: Placebo Controlled Phase Week 0-16||0
10412737|NCT00773734|11556867|FG000|COMPLETED|Core: Placebo Controlled Phase Week 0-16|2 participants completed placebo controlled phase but elected not to continue|72
10412738|NCT00773734|11556868|FG001|COMPLETED|Core: Placebo Controlled Phase Week 0-16|2 participants completed placebo controlled phase but elected not to continue|79
10412739|NCT00773734|11556869|FG002|COMPLETED|Core: Placebo Controlled Phase Week 0-16||66
10412740|NCT00773734|11556870|FG003|COMPLETED|Core: Placebo Controlled Phase Week 0-16|3 participants completed placebo controlled phase but elected not to continue|70
10845683|NCT02722941|12011635|FG000|STARTED|Overall Study||15
10845684|NCT02722941|12011636|FG001|STARTED|Overall Study||15
10845685|NCT02722941|12011635|FG000|COMPLETED|Overall Study||15
10845686|NCT02722941|12011636|FG001|COMPLETED|Overall Study||15
10845687|NCT02722941|12011635|FG000|NOT COMPLETED|Overall Study||0
10845688|NCT02722941|12011636|FG001|NOT COMPLETED|Overall Study||0
10845689|NCT02655692|12011645|FG000|STARTED|Overall Study||55
10845690|NCT02655692|12011646|FG001|STARTED|Overall Study||55
10845691|NCT02655692|12011647|FG002|STARTED|Overall Study||53
10845692|NCT02655692|12011645|FG000|COMPLETED|Overall Study||36
10412741|NCT00773734|11556871|FG004|COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
10412742|NCT00773734|11556872|FG005|COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
10845693|NCT02655692|12011646|FG001|COMPLETED|Overall Study||41
10845694|NCT02655692|12011647|FG002|COMPLETED|Overall Study||40
10845695|NCT02655692|12011645|FG000|NOT COMPLETED|Overall Study||19
10845696|NCT02655692|12011646|FG001|NOT COMPLETED|Overall Study||14
10845697|NCT02655692|12011647|FG002|NOT COMPLETED|Overall Study||13
10845698|NCT02623205|12011657|FG000|STARTED|Overall Study||42
10845699|NCT02623205|12011658|FG001|STARTED|Overall Study||43
10845700|NCT02623205|12011657|FG000|COMPLETED|Overall Study||38
10845701|NCT02623205|12011658|FG001|COMPLETED|Overall Study||40
10845702|NCT02623205|12011657|FG000|NOT COMPLETED|Overall Study||4
10845703|NCT02623205|12011658|FG001|NOT COMPLETED|Overall Study||3
10845704|NCT02348203|12011666|FG000|STARTED|Overall Study||31
10292517|NCT02810418|11425338|FG004|NOT COMPLETED|Arm A Dose Escalation||0
10292518|NCT02810418|11425339|FG005|NOT COMPLETED|Arm A Dose Escalation||0
10292519|NCT02810418|11425340|FG006|NOT COMPLETED|Arm A Dose Escalation||0
10292520|NCT02810418|11425334|FG000|STARTED|Dose Expansion||0
10292521|NCT02810418|11425335|FG001|STARTED|Dose Expansion||8
10292522|NCT02810418|11425336|FG002|STARTED|Dose Expansion||6
10292523|NCT02810418|11425337|FG003|STARTED|Dose Expansion||0
10292524|NCT02810418|11425338|FG004|STARTED|Dose Expansion||0
10292525|NCT02810418|11425339|FG005|STARTED|Dose Expansion||0
10292526|NCT02810418|11425340|FG006|STARTED|Dose Expansion||0
10292527|NCT02810418|11425334|FG000|COMPLETED|Dose Expansion||0
10292528|NCT02810418|11425335|FG001|COMPLETED|Dose Expansion||7
10292529|NCT02810418|11425336|FG002|COMPLETED|Dose Expansion||3
10292530|NCT02810418|11425337|FG003|COMPLETED|Dose Expansion||0
10292531|NCT02810418|11425338|FG004|COMPLETED|Dose Expansion||0
10292532|NCT02810418|11425339|FG005|COMPLETED|Dose Expansion||0
10292533|NCT02810418|11425340|FG006|COMPLETED|Dose Expansion||0
10292534|NCT02810418|11425334|FG000|NOT COMPLETED|Dose Expansion||0
10292535|NCT02810418|11425335|FG001|NOT COMPLETED|Dose Expansion||1
10292536|NCT02810418|11425336|FG002|NOT COMPLETED|Dose Expansion||3
10292537|NCT02810418|11425337|FG003|NOT COMPLETED|Dose Expansion||0
10292538|NCT02810418|11425338|FG004|NOT COMPLETED|Dose Expansion||0
10292539|NCT02810418|11425339|FG005|NOT COMPLETED|Dose Expansion||0
10292540|NCT02810418|11425340|FG006|NOT COMPLETED|Dose Expansion||0
10292541|NCT02810418|11425334|FG000|STARTED|Arm B Dose Escalation||0
10292542|NCT02810418|11425335|FG001|STARTED|Arm B Dose Escalation||0
10292543|NCT02810418|11425336|FG002|STARTED|Arm B Dose Escalation||0
10292544|NCT02810418|11425337|FG003|STARTED|Arm B Dose Escalation||6
10292545|NCT02810418|11425338|FG004|STARTED|Arm B Dose Escalation||3
10292546|NCT02810418|11425339|FG005|STARTED|Arm B Dose Escalation||6
10292547|NCT02810418|11425340|FG006|STARTED|Arm B Dose Escalation||0
10292548|NCT02810418|11425334|FG000|COMPLETED|Arm B Dose Escalation||0
10292549|NCT02810418|11425335|FG001|COMPLETED|Arm B Dose Escalation||0
10292550|NCT02810418|11425336|FG002|COMPLETED|Arm B Dose Escalation||0
10292551|NCT02810418|11425337|FG003|COMPLETED|Arm B Dose Escalation||6
10292552|NCT02810418|11425338|FG004|COMPLETED|Arm B Dose Escalation||2
10292553|NCT02810418|11425339|FG005|COMPLETED|Arm B Dose Escalation||4
10292554|NCT02810418|11425340|FG006|COMPLETED|Arm B Dose Escalation||0
10292555|NCT02810418|11425334|FG000|NOT COMPLETED|Arm B Dose Escalation||0
10292556|NCT02810418|11425335|FG001|NOT COMPLETED|Arm B Dose Escalation||0
10292557|NCT02810418|11425336|FG002|NOT COMPLETED|Arm B Dose Escalation||0
10292558|NCT02810418|11425337|FG003|NOT COMPLETED|Arm B Dose Escalation||0
10292559|NCT02810418|11425338|FG004|NOT COMPLETED|Arm B Dose Escalation||1
10292560|NCT02810418|11425339|FG005|NOT COMPLETED|Arm B Dose Escalation||2
10292561|NCT02810418|11425340|FG006|NOT COMPLETED|Arm B Dose Escalation||0
10292562|NCT02810418|11425334|FG000|STARTED|Arm B Combination Therapy||0
10292563|NCT02810418|11425335|FG001|STARTED|Arm B Combination Therapy||0
10292564|NCT02810418|11425336|FG002|STARTED|Arm B Combination Therapy||0
10292565|NCT02810418|11425337|FG003|STARTED|Arm B Combination Therapy||0
10292566|NCT02810418|11425338|FG004|STARTED|Arm B Combination Therapy||0
10292567|NCT02810418|11425339|FG005|STARTED|Arm B Combination Therapy||0
10292568|NCT02810418|11425340|FG006|STARTED|Arm B Combination Therapy||5
10292569|NCT02810418|11425334|FG000|COMPLETED|Arm B Combination Therapy||0
10292570|NCT02810418|11425335|FG001|COMPLETED|Arm B Combination Therapy||0
10292571|NCT02810418|11425336|FG002|COMPLETED|Arm B Combination Therapy||0
10292572|NCT02810418|11425337|FG003|COMPLETED|Arm B Combination Therapy||0
10292573|NCT02810418|11425338|FG004|COMPLETED|Arm B Combination Therapy||0
10292574|NCT02810418|11425339|FG005|COMPLETED|Arm B Combination Therapy||0
10292575|NCT02810418|11425340|FG006|COMPLETED|Arm B Combination Therapy||5
10292576|NCT02810418|11425334|FG000|NOT COMPLETED|Arm B Combination Therapy||0
10292577|NCT02810418|11425335|FG001|NOT COMPLETED|Arm B Combination Therapy||0
10292578|NCT02810418|11425336|FG002|NOT COMPLETED|Arm B Combination Therapy||0
10292579|NCT02810418|11425337|FG003|NOT COMPLETED|Arm B Combination Therapy||0
10292580|NCT02810418|11425338|FG004|NOT COMPLETED|Arm B Combination Therapy||0
10292581|NCT02810418|11425339|FG005|NOT COMPLETED|Arm B Combination Therapy||0
10292582|NCT02810418|11425340|FG006|NOT COMPLETED|Arm B Combination Therapy||0
10292583|NCT02785991|11425403|FG000|STARTED|Overall Study||1742
10292584|NCT02785991|11425403|FG000|COMPLETED|Overall Study||1741
10292585|NCT02785991|11425403|FG000|NOT COMPLETED|Overall Study||1
10292586|NCT02781584|11425421|FG000|STARTED|Pre-treatment Phase||0
10292587|NCT02781584|11425422|FG001|STARTED|Pre-treatment Phase||0
10292588|NCT02781584|11425423|FG002|STARTED|Pre-treatment Phase||0
10292589|NCT02781584|11425424|FG003|STARTED|Pre-treatment Phase||0
10292590|NCT02781584|11425425|FG004|STARTED|Pre-treatment Phase||0
10292591|NCT02781584|11425426|FG005|STARTED|Pre-treatment Phase||0
10292592|NCT02781584|11425427|FG006|STARTED|Pre-treatment Phase||0
10292593|NCT02781584|11425428|FG007|STARTED|Pre-treatment Phase||0
10292594|NCT02781584|11425429|FG008|STARTED|Pre-treatment Phase||0
10292595|NCT02781584|11425430|FG009|STARTED|Pre-treatment Phase||15
10292596|NCT02781584|11425431|FG010|STARTED|Pre-treatment Phase||16
10292597|NCT02781584|11425432|FG011|STARTED|Pre-treatment Phase||33
10292598|NCT02781584|11425433|FG012|STARTED|Pre-treatment Phase||33
10292599|NCT02781584|11425421|FG000|COMPLETED|Pre-treatment Phase||0
10292600|NCT02781584|11425422|FG001|COMPLETED|Pre-treatment Phase||0
10292601|NCT02781584|11425423|FG002|COMPLETED|Pre-treatment Phase||0
10292602|NCT02781584|11425424|FG003|COMPLETED|Pre-treatment Phase||0
10845705|NCT02348203|12011667|FG001|STARTED|Overall Study||32
10845706|NCT02348203|12011666|FG000|COMPLETED|Overall Study||21
10845707|NCT02348203|12011667|FG001|COMPLETED|Overall Study||22
10845708|NCT02348203|12011666|FG000|NOT COMPLETED|Overall Study||10
10845709|NCT02348203|12011667|FG001|NOT COMPLETED|Overall Study||10
10292603|NCT02781584|11425425|FG004|COMPLETED|Pre-treatment Phase||0
10292604|NCT02781584|11425426|FG005|COMPLETED|Pre-treatment Phase||0
10292605|NCT02781584|11425427|FG006|COMPLETED|Pre-treatment Phase||0
10292606|NCT02781584|11425428|FG007|COMPLETED|Pre-treatment Phase||0
10292607|NCT02781584|11425429|FG008|COMPLETED|Pre-treatment Phase||0
10292608|NCT02781584|11425430|FG009|COMPLETED|Pre-treatment Phase||15
10292609|NCT02781584|11425431|FG010|COMPLETED|Pre-treatment Phase||16
10292610|NCT02781584|11425432|FG011|COMPLETED|Pre-treatment Phase||30
10292611|NCT02781584|11425433|FG012|COMPLETED|Pre-treatment Phase||32
10292612|NCT02781584|11425421|FG000|NOT COMPLETED|Pre-treatment Phase||0
10292613|NCT02781584|11425422|FG001|NOT COMPLETED|Pre-treatment Phase||0
10292614|NCT02781584|11425423|FG002|NOT COMPLETED|Pre-treatment Phase||0
10292615|NCT02781584|11425424|FG003|NOT COMPLETED|Pre-treatment Phase||0
10292616|NCT02781584|11425425|FG004|NOT COMPLETED|Pre-treatment Phase||0
10292617|NCT02781584|11425426|FG005|NOT COMPLETED|Pre-treatment Phase||0
10292618|NCT02781584|11425427|FG006|NOT COMPLETED|Pre-treatment Phase||0
10292619|NCT02781584|11425428|FG007|NOT COMPLETED|Pre-treatment Phase||0
10292620|NCT02781584|11425429|FG008|NOT COMPLETED|Pre-treatment Phase||0
10292621|NCT02781584|11425430|FG009|NOT COMPLETED|Pre-treatment Phase||0
10292622|NCT02781584|11425431|FG010|NOT COMPLETED|Pre-treatment Phase||0
10292623|NCT02781584|11425432|FG011|NOT COMPLETED|Pre-treatment Phase||3
10292624|NCT02781584|11425433|FG012|NOT COMPLETED|Pre-treatment Phase||1
10292625|NCT02781584|11425421|FG000|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|10
10292626|NCT02781584|11425422|FG001|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|10
10292627|NCT02781584|11425423|FG002|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|10
10292628|NCT02781584|11425424|FG003|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|20
10292629|NCT02781584|11425425|FG004|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|20
10292630|NCT02781584|11425426|FG005|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|20
10292631|NCT02781584|11425427|FG006|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|10
10292632|NCT02781584|11425428|FG007|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|10
10292633|NCT02781584|11425429|FG008|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|13
10292634|NCT02781584|11425430|FG009|STARTED|Treatment Phase||15
10292635|NCT02781584|11425431|FG010|STARTED|Treatment Phase||16
10292636|NCT02781584|11425432|FG011|STARTED|Treatment Phase||30
10292637|NCT02781584|11425433|FG012|STARTED|Treatment Phase||32
10292638|NCT02781584|11425421|FG000|COMPLETED|Treatment Phase||10
10292639|NCT02781584|11425422|FG001|COMPLETED|Treatment Phase||10
10292640|NCT02781584|11425423|FG002|COMPLETED|Treatment Phase||10
10292641|NCT02781584|11425424|FG003|COMPLETED|Treatment Phase||20
10292642|NCT02781584|11425425|FG004|COMPLETED|Treatment Phase||20
10292643|NCT02781584|11425426|FG005|COMPLETED|Treatment Phase||19
10292644|NCT02781584|11425427|FG006|COMPLETED|Treatment Phase||10
10292645|NCT02781584|11425428|FG007|COMPLETED|Treatment Phase||9
10292646|NCT02781584|11425429|FG008|COMPLETED|Treatment Phase||13
10292647|NCT02781584|11425430|FG009|COMPLETED|Treatment Phase||15
10292648|NCT02781584|11425431|FG010|COMPLETED|Treatment Phase||15
10292649|NCT02781584|11425432|FG011|COMPLETED|Treatment Phase||28
10292650|NCT02781584|11425433|FG012|COMPLETED|Treatment Phase||32
10292651|NCT02781584|11425421|FG000|NOT COMPLETED|Treatment Phase||0
10292652|NCT02781584|11425422|FG001|NOT COMPLETED|Treatment Phase||0
10292653|NCT02781584|11425423|FG002|NOT COMPLETED|Treatment Phase||0
10292654|NCT02781584|11425424|FG003|NOT COMPLETED|Treatment Phase||0
10292655|NCT02781584|11425425|FG004|NOT COMPLETED|Treatment Phase||0
10292656|NCT02781584|11425426|FG005|NOT COMPLETED|Treatment Phase||1
10292657|NCT02781584|11425427|FG006|NOT COMPLETED|Treatment Phase||0
10292658|NCT02781584|11425428|FG007|NOT COMPLETED|Treatment Phase||1
10292659|NCT02781584|11425429|FG008|NOT COMPLETED|Treatment Phase||0
10292660|NCT02781584|11425430|FG009|NOT COMPLETED|Treatment Phase||0
10292661|NCT02781584|11425431|FG010|NOT COMPLETED|Treatment Phase||1
10292662|NCT02781584|11425432|FG011|NOT COMPLETED|Treatment Phase||2
10292663|NCT02781584|11425433|FG012|NOT COMPLETED|Treatment Phase||0
10845742|NCT01560637|12011698|FG000|STARTED|Overall Study|471 subjects from the parent study (TDE-PH-310) consented to participate in TDE-PH-311. However, one subject withdrew consent prior to receiving oral treprostinil in TDE-PH-311. This subject was not included in the data summary.|470
10845743|NCT01560637|12011698|FG000|COMPLETED|Overall Study||272
10845744|NCT01560637|12011698|FG000|NOT COMPLETED|Overall Study||198
10845745|NCT00999804|12011704|FG000|STARTED|Overall Study||85
10845746|NCT00999804|12011705|FG001|STARTED|Overall Study||43
10845747|NCT00999804|12011704|FG000|COMPLETED|Overall Study||64
10845748|NCT00999804|12011705|FG001|COMPLETED|Overall Study||38
10845749|NCT00999804|12011704|FG000|NOT COMPLETED|Overall Study||21
10845750|NCT00999804|12011705|FG001|NOT COMPLETED|Overall Study||5
10845751|NCT00458003|12011713|FG000|STARTED|Overall Study||55
10845752|NCT00458003|12011714|FG001|STARTED|Overall Study||55
10845753|NCT00458003|12011713|FG000|COMPLETED|Overall Study||54
10845754|NCT00458003|12011714|FG001|COMPLETED|Overall Study||54
10845755|NCT00458003|12011713|FG000|NOT COMPLETED|Overall Study||1
10845756|NCT00458003|12011714|FG001|NOT COMPLETED|Overall Study||1
10412743|NCT00773734|11556867|FG000|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||16
10412744|NCT00773734|11556868|FG001|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||10
10412745|NCT00773734|11556869|FG002|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||21
10412746|NCT00773734|11556870|FG003|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||18
10412747|NCT00773734|11556871|FG004|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
10412748|NCT00773734|11556872|FG005|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
10412749|NCT00773734|11556867|FG000|STARTED|Core: Active Treatment Phase Week 16-24|Placebo participants were re-randomized at Week 16 to receive apremilast 20mg or 30mg PO BID.|0
10412750|NCT00773734|11556868|FG001|STARTED|Core: Active Treatment Phase Week 16-24|2 participants elected not to continue from previous period|77
10412751|NCT00773734|11556869|FG002|STARTED|Core: Active Treatment Phase Week 16-24||66
10412752|NCT00773734|11556870|FG003|STARTED|Core: Active Treatment Phase Week 16-24|3 participants elected not to continue from previous period|67
10412753|NCT00773734|11556871|FG004|STARTED|Core: Active Treatment Phase Week 16-24||34
10412754|NCT00773734|11556872|FG005|STARTED|Core: Active Treatment Phase Week 16-24||36
10412755|NCT00773734|11556867|FG000|COMPLETED|Core: Active Treatment Phase Week 16-24||0
10412756|NCT00773734|11556868|FG001|COMPLETED|Core: Active Treatment Phase Week 16-24||65
10412757|NCT00773734|11556869|FG002|COMPLETED|Core: Active Treatment Phase Week 16-24||59
10412758|NCT00773734|11556870|FG003|COMPLETED|Core: Active Treatment Phase Week 16-24||65
10412759|NCT00773734|11556871|FG004|COMPLETED|Core: Active Treatment Phase Week 16-24||33
10412760|NCT00773734|11556872|FG005|COMPLETED|Core: Active Treatment Phase Week 16-24||31
10412761|NCT00773734|11556867|FG000|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||0
10412762|NCT00773734|11556868|FG001|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||12
10412763|NCT00773734|11556869|FG002|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||7
10429230|NCT00862849|11575290|FG004|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
10845757|NCT03882788|12011724|FG000|STARTED|Overall Study||44
10845758|NCT03882788|12011725|FG001|STARTED|Overall Study||45
10845759|NCT03882788|12011724|FG000|COMPLETED|Overall Study||44
10845760|NCT03882788|12011725|FG001|COMPLETED|Overall Study||45
10845761|NCT03882788|12011724|FG000|NOT COMPLETED|Overall Study||0
10845762|NCT03882788|12011725|FG001|NOT COMPLETED|Overall Study||0
10845763|NCT03834974|12011733|FG000|STARTED|Overall Study||34
10845764|NCT03834974|12011734|FG001|STARTED|Overall Study||32
10845765|NCT03834974|12011733|FG000|COMPLETED|Overall Study||34
10845766|NCT03834974|12011734|FG001|COMPLETED|Overall Study||32
10845767|NCT03834974|12011733|FG000|NOT COMPLETED|Overall Study||0
10845768|NCT03834974|12011734|FG001|NOT COMPLETED|Overall Study||0
10845769|NCT03821675|12011743|FG000|STARTED|Overall Study||19
10845770|NCT03821675|12011744|FG001|STARTED|Overall Study||19
10845771|NCT03821675|12011743|FG000|COMPLETED|Overall Study||16
10845772|NCT03821675|12011744|FG001|COMPLETED|Overall Study||17
10845773|NCT03821675|12011743|FG000|NOT COMPLETED|Overall Study||3
10845774|NCT03821675|12011744|FG001|NOT COMPLETED|Overall Study||2
10845775|NCT03794544|12011756|FG000|STARTED|Overall Study||27
10845776|NCT03794544|12011757|FG001|STARTED|Overall Study||21
10845777|NCT03794544|12011758|FG002|STARTED|Overall Study||20
10845778|NCT03794544|12011759|FG003|STARTED|Overall Study||16
10845779|NCT03794544|12011756|FG000|Treated|Overall Study||26
10845780|NCT03794544|12011757|FG001|Treated|Overall Study||21
10845781|NCT03794544|12011758|FG002|Treated|Overall Study||20
10845782|NCT03794544|12011759|FG003|Treated|Overall Study||16
10845783|NCT03794544|12011756|FG000|COMPLETED|Overall Study||26
10845784|NCT03794544|12011757|FG001|COMPLETED|Overall Study||18
10845785|NCT03794544|12011758|FG002|COMPLETED|Overall Study||19
10845786|NCT03794544|12011759|FG003|COMPLETED|Overall Study||15
10845787|NCT03794544|12011756|FG000|NOT COMPLETED|Overall Study||1
10845788|NCT03794544|12011757|FG001|NOT COMPLETED|Overall Study||3
10845789|NCT03794544|12011758|FG002|NOT COMPLETED|Overall Study||1
10845790|NCT03794544|12011759|FG003|NOT COMPLETED|Overall Study||1
10845791|NCT03732807|12011776|FG000|STARTED|Treatment Period (up to Week 24)||132
10845792|NCT03732807|12011777|FG001|STARTED|Treatment Period (up to Week 24)||130
10845793|NCT03732807|12011778|FG002|STARTED|Treatment Period (up to Week 24)||130
10845794|NCT03732807|12011779|FG003|STARTED|Treatment Period (up to Week 24)||132
10845795|NCT03732807|12011780|FG004|STARTED|Treatment Period (up to Week 24)||63
10845796|NCT03732807|12011781|FG005|STARTED|Treatment Period (up to Week 24)||65
10845797|NCT03732807|12011782|FG006|STARTED|Treatment Period (up to Week 24)||66
10845798|NCT03732807|12011776|FG000|COMPLETED|Treatment Period (up to Week 24)||122
10845799|NCT03732807|12011777|FG001|COMPLETED|Treatment Period (up to Week 24)||124
10845800|NCT03732807|12011778|FG002|COMPLETED|Treatment Period (up to Week 24)||121
10845801|NCT03732807|12011779|FG003|COMPLETED|Treatment Period (up to Week 24)||117
10845802|NCT03732807|12011780|FG004|COMPLETED|Treatment Period (up to Week 24)||58
10845803|NCT03732807|12011781|FG005|COMPLETED|Treatment Period (up to Week 24)||63
10412764|NCT00773734|11556870|FG003|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||2
10412765|NCT00773734|11556871|FG004|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||1
10412766|NCT00773734|11556872|FG005|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||5
10412767|NCT00773734|11556867|FG000|STARTED|Extension: Active Treatment Week 24-52||0
10412768|NCT00773734|11556868|FG001|STARTED|Extension: Active Treatment Week 24-52||47
10412769|NCT00773734|11556869|FG002|STARTED|Extension: Active Treatment Week 24-52||50
10412770|NCT00773734|11556870|FG003|STARTED|Extension: Active Treatment Week 24-52||58
10412771|NCT00773734|11556871|FG004|STARTED|Extension: Active Treatment Week 24-52||27
10412772|NCT00773734|11556872|FG005|STARTED|Extension: Active Treatment Week 24-52||27
10412773|NCT00773734|11556867|FG000|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||0
10412774|NCT00773734|11556868|FG001|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||5
10412775|NCT00773734|11556869|FG002|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||10
10412776|NCT00773734|11556870|FG003|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||10
10412777|NCT00773734|11556871|FG004|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||4
10412778|NCT00773734|11556872|FG005|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||4
10412779|NCT00773734|11556867|FG000|COMPLETED|Extension: Active Treatment Week 24-52||0
10412780|NCT00773734|11556868|FG001|COMPLETED|Extension: Active Treatment Week 24-52|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|34
10412781|NCT00773734|11556869|FG002|COMPLETED|Extension: Active Treatment Week 24-52||33
10412782|NCT00773734|11556870|FG003|COMPLETED|Extension: Active Treatment Week 24-52||48
10412783|NCT00773734|11556871|FG004|COMPLETED|Extension: Active Treatment Week 24-52||22
10412784|NCT00773734|11556872|FG005|COMPLETED|Extension: Active Treatment Week 24-52||19
10412785|NCT00773734|11556867|FG000|NOT COMPLETED|Extension: Active Treatment Week 24-52||0
10412786|NCT00773734|11556868|FG001|NOT COMPLETED|Extension: Active Treatment Week 24-52||13
10412787|NCT00773734|11556869|FG002|NOT COMPLETED|Extension: Active Treatment Week 24-52||17
10412788|NCT00773734|11556870|FG003|NOT COMPLETED|Extension: Active Treatment Week 24-52||10
10412789|NCT00773734|11556871|FG004|NOT COMPLETED|Extension: Active Treatment Week 24-52||5
10412790|NCT00773734|11556872|FG005|NOT COMPLETED|Extension: Active Treatment Week 24-52||8
10845804|NCT03732807|12011782|FG006|COMPLETED|Treatment Period (up to Week 24)||61
10845805|NCT03732807|12011776|FG000|NOT COMPLETED|Treatment Period (up to Week 24)||10
10845806|NCT03732807|12011777|FG001|NOT COMPLETED|Treatment Period (up to Week 24)||6
10845807|NCT03732807|12011778|FG002|NOT COMPLETED|Treatment Period (up to Week 24)||9
10845808|NCT03732807|12011779|FG003|NOT COMPLETED|Treatment Period (up to Week 24)||15
10845809|NCT03732807|12011780|FG004|NOT COMPLETED|Treatment Period (up to Week 24)||5
10845810|NCT03732807|12011781|FG005|NOT COMPLETED|Treatment Period (up to Week 24)||2
10845811|NCT03732807|12011782|FG006|NOT COMPLETED|Treatment Period (up to Week 24)||5
10845812|NCT03732807|12011776|FG000|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|113
10845813|NCT03732807|12011777|FG001|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|111
10845814|NCT03732807|12011778|FG002|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|108
10845815|NCT03732807|12011779|FG003|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|106
10845816|NCT03732807|12011780|FG004|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|49
10845817|NCT03732807|12011781|FG005|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|59
10845818|NCT03732807|12011782|FG006|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|57
10845819|NCT03732807|12011776|FG000|COMPLETED|Treatment Extension (Week 25 up to 48)||107
10845820|NCT03732807|12011777|FG001|COMPLETED|Treatment Extension (Week 25 up to 48)||100
10845821|NCT03732807|12011778|FG002|COMPLETED|Treatment Extension (Week 25 up to 48)||103
10845822|NCT03732807|12011779|FG003|COMPLETED|Treatment Extension (Week 25 up to 48)||97
10845823|NCT03732807|12011780|FG004|COMPLETED|Treatment Extension (Week 25 up to 48)||44
10845824|NCT03732807|12011781|FG005|COMPLETED|Treatment Extension (Week 25 up to 48)||56
10845825|NCT03732807|12011782|FG006|COMPLETED|Treatment Extension (Week 25 up to 48)||53
10845826|NCT03732807|12011776|FG000|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||6
10845827|NCT03732807|12011777|FG001|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||11
10845828|NCT03732807|12011778|FG002|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||5
10845829|NCT03732807|12011779|FG003|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||9
10845830|NCT03732807|12011780|FG004|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||5
10845831|NCT03732807|12011781|FG005|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||3
10845832|NCT03732807|12011782|FG006|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||4
10545211|NCT01495572|11698502|FG001|STARTED|Overall Study||5
10545212|NCT01495572|11698501|FG000|COMPLETED|Overall Study||0
10545213|NCT01495572|11698502|FG001|COMPLETED|Overall Study||5
10545214|NCT01495572|11698501|FG000|NOT COMPLETED|Overall Study||0
10545215|NCT01495572|11698502|FG001|NOT COMPLETED|Overall Study||0
10545216|NCT01495585|11698512|FG000|STARTED|Overall Study||4
10545217|NCT01495585|11698513|FG001|STARTED|Overall Study||6
10545218|NCT01495585|11698514|FG002|STARTED|Overall Study||4
10545219|NCT01495585|11698512|FG000|Open Label Lonafarnib 200 mg|Overall Study||2
10545220|NCT01495585|11698513|FG001|Open Label Lonafarnib 200 mg|Overall Study||0
10845833|NCT03731364|12011804|FG000|STARTED|Overall Study||9
10845834|NCT03731364|12011805|FG001|STARTED|Overall Study||9
10845835|NCT03731364|12011806|FG002|STARTED|Overall Study||13
10845836|NCT03731364|12011807|FG003|STARTED|Overall Study||13
10845837|NCT03731364|12011808|FG004|STARTED|Overall Study||11
10845838|NCT03731364|12011804|FG000|COMPLETED|Overall Study||9
10845839|NCT03731364|12011805|FG001|COMPLETED|Overall Study||9
10845840|NCT03731364|12011806|FG002|COMPLETED|Overall Study||12
10845841|NCT03731364|12011807|FG003|COMPLETED|Overall Study||11
10845842|NCT03731364|12011808|FG004|COMPLETED|Overall Study||10
10845843|NCT03731364|12011804|FG000|NOT COMPLETED|Overall Study||0
10845844|NCT03731364|12011805|FG001|NOT COMPLETED|Overall Study||0
10845845|NCT03731364|12011806|FG002|NOT COMPLETED|Overall Study||1
10845846|NCT03731364|12011807|FG003|NOT COMPLETED|Overall Study||2
10845847|NCT03731364|12011808|FG004|NOT COMPLETED|Overall Study||1
10292664|NCT02730130|11425461|FG000|STARTED|Overall Study||17
10292665|NCT02730130|11425461|FG000|COMPLETED|Overall Study||17
10292666|NCT02730130|11425461|FG000|NOT COMPLETED|Overall Study||0
10845848|NCT03728153|12011820|FG000|STARTED|Overall Study||34
10845849|NCT03728153|12011820|FG000|COMPLETED|Overall Study||32
10845850|NCT03728153|12011820|FG000|NOT COMPLETED|Overall Study||2
10845857|NCT03720899|12011835|FG000|STARTED|Overall Study||21
10845858|NCT03720899|12011836|FG001|STARTED|Overall Study||24
10845859|NCT03720899|12011835|FG000|COMPLETED|Overall Study||13
10845860|NCT03720899|12011836|FG001|COMPLETED|Overall Study||13
10845861|NCT03720899|12011835|FG000|NOT COMPLETED|Overall Study||8
10845862|NCT03720899|12011836|FG001|NOT COMPLETED|Overall Study||11
10845863|NCT03716869|12011844|FG000|STARTED|Overall Study||6436
10845864|NCT03716869|12011845|FG001|STARTED|Overall Study||6473
10845865|NCT03716869|12011844|FG000|COMPLETED|Overall Study||6436
10845866|NCT03716869|12011845|FG001|COMPLETED|Overall Study||6473
10845867|NCT03716869|12011844|FG000|NOT COMPLETED|Overall Study||0
10845868|NCT03716869|12011845|FG001|NOT COMPLETED|Overall Study||0
10845875|NCT04598152|12011860|FG000|STARTED|Overall Study||3
10845876|NCT04598152|12011861|FG001|STARTED|Overall Study||1
10845877|NCT04598152|12011860|FG000|COMPLETED|Overall Study||3
10845878|NCT04598152|12011861|FG001|COMPLETED|Overall Study||0
10845879|NCT04598152|12011860|FG000|NOT COMPLETED|Overall Study||0
10412791|NCT00773734|11556867|FG000|STARTED|LTE Period: Week 52 to 6 Years||0
10412792|NCT00773734|11556868|FG001|STARTED|LTE Period: Week 52 to 6 Years||0
10412793|NCT00773734|11556869|FG002|STARTED|LTE Period: Week 52 to 6 Years|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|16
10412794|NCT00773734|11556870|FG003|STARTED|LTE Period: Week 52 to 6 Years|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|17
10412795|NCT00773734|11556871|FG004|STARTED|LTE Period: Week 52 to 6 Years||0
10412796|NCT00773734|11556872|FG005|STARTED|LTE Period: Week 52 to 6 Years||0
10412797|NCT00773734|11556867|FG000|COMPLETED|LTE Period: Week 52 to 6 Years||0
10412798|NCT00773734|11556868|FG001|COMPLETED|LTE Period: Week 52 to 6 Years||0
10412799|NCT00773734|11556869|FG002|COMPLETED|LTE Period: Week 52 to 6 Years|Completed = Completed Long Term Extension study|4
10412800|NCT00773734|11556870|FG003|COMPLETED|LTE Period: Week 52 to 6 Years|Completed = Completed Long Term Extension study|5
10412801|NCT00773734|11556871|FG004|COMPLETED|LTE Period: Week 52 to 6 Years||0
10412802|NCT00773734|11556872|FG005|COMPLETED|LTE Period: Week 52 to 6 Years||0
10412803|NCT00773734|11556867|FG000|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
10412804|NCT00773734|11556868|FG001|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
10412805|NCT00773734|11556869|FG002|NOT COMPLETED|LTE Period: Week 52 to 6 Years||12
10412806|NCT00773734|11556870|FG003|NOT COMPLETED|LTE Period: Week 52 to 6 Years||12
10412807|NCT00773734|11556871|FG004|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
10412808|NCT00773734|11556872|FG005|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
10412809|NCT00773747|11556931|FG000|STARTED|Overall Study||317
10412810|NCT00773747|11556932|FG001|STARTED|Overall Study||320
10412811|NCT00773747|11556931|FG000|Treated|Overall Study||315
10412812|NCT00773747|11556932|FG001|Treated|Overall Study||320
10412813|NCT00773747|11556931|FG000|COMPLETED|Overall Study||20
10412814|NCT00773747|11556932|FG001|COMPLETED|Overall Study||24
10412815|NCT00773747|11556931|FG000|NOT COMPLETED|Overall Study||297
10412816|NCT00773747|11556932|FG001|NOT COMPLETED|Overall Study||296
10412817|NCT00773786|11556938|FG000|STARTED|First Intervention (1 Week)||10
10412818|NCT00773786|11556939|FG001|STARTED|First Intervention (1 Week)||10
10412819|NCT00773786|11556938|FG000|COMPLETED|First Intervention (1 Week)||10
10412820|NCT00773786|11556939|FG001|COMPLETED|First Intervention (1 Week)||10
10412821|NCT00773786|11556938|FG000|NOT COMPLETED|First Intervention (1 Week)||0
10412822|NCT00773786|11556939|FG001|NOT COMPLETED|First Intervention (1 Week)||0
10412823|NCT00773786|11556938|FG000|STARTED|Washout (1 Week)||10
10412824|NCT00773786|11556939|FG001|STARTED|Washout (1 Week)||10
10412825|NCT00773786|11556938|FG000|COMPLETED|Washout (1 Week)||10
10412826|NCT00773786|11556939|FG001|COMPLETED|Washout (1 Week)||10
10412827|NCT00773786|11556938|FG000|NOT COMPLETED|Washout (1 Week)||0
10412828|NCT00773786|11556939|FG001|NOT COMPLETED|Washout (1 Week)||0
10412829|NCT00773786|11556938|FG000|STARTED|Second Intervention (1 Week)||10
10412830|NCT00773786|11556939|FG001|STARTED|Second Intervention (1 Week)||10
10412831|NCT00773786|11556938|FG000|COMPLETED|Second Intervention (1 Week)||10
10412832|NCT00773786|11556939|FG001|COMPLETED|Second Intervention (1 Week)||10
10412833|NCT00773786|11556938|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
10412834|NCT00773786|11556939|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
10412835|NCT00773838|11556946|FG000|STARTED|Overall Study||143
10412836|NCT00773838|11556946|FG000|COMPLETED|Overall Study||0
10412837|NCT00773838|11556946|FG000|NOT COMPLETED|Overall Study||143
10412838|NCT00773955|11556950|FG000|STARTED|Overall Study||15
10412839|NCT00773955|11556950|FG000|COMPLETED|Overall Study||15
10412840|NCT00773955|11556950|FG000|NOT COMPLETED|Overall Study||0
10412841|NCT00773968|11556954|FG000|STARTED|Overall Study||140
10412842|NCT00773968|11556954|FG000|Treated|Overall Study||111
10412843|NCT00773968|11556954|FG000|COMPLETED|Overall Study||95
10412844|NCT00773968|11556954|FG000|NOT COMPLETED|Overall Study||45
10412845|NCT00774046|11556958|FG000|STARTED|Screening||116
10412846|NCT00774046|11556958|FG000|COMPLETED|Screening||60
10412847|NCT00774046|11556958|FG000|NOT COMPLETED|Screening||56
10412848|NCT00774046|11556958|FG000|STARTED|Enrollment||60
10412849|NCT00774046|11556958|FG000|COMPLETED|Enrollment||32
10412850|NCT00774046|11556958|FG000|NOT COMPLETED|Enrollment||28
10845880|NCT04598152|12011861|FG001|NOT COMPLETED|Overall Study||1
10845881|NCT04353271|12011869|FG000|STARTED|Overall Study||1
10845882|NCT04353271|12011870|FG001|STARTED|Overall Study||2
10845883|NCT04353271|12011869|FG000|COMPLETED|Overall Study||1
10845884|NCT04353271|12011870|FG001|COMPLETED|Overall Study||1
10845851|NCT03724422|12011826|FG000|STARTED|Overall Study||1
10845852|NCT03724422|12011827|FG001|STARTED|Overall Study||2
10845853|NCT03724422|12011826|FG000|COMPLETED|Overall Study||1
10845854|NCT03724422|12011827|FG001|COMPLETED|Overall Study|Patients had interval healing then lost follow up|0
10845855|NCT03724422|12011826|FG000|NOT COMPLETED|Overall Study||0
10845856|NCT03724422|12011827|FG001|NOT COMPLETED|Overall Study||2
10845869|NCT03713957|12011853|FG000|STARTED|Overall Study||53
10845870|NCT03713957|12011854|FG001|STARTED|Overall Study||26
10845871|NCT03713957|12011853|FG000|COMPLETED|Overall Study||35
10845872|NCT03713957|12011854|FG001|COMPLETED|Overall Study||16
10845873|NCT03713957|12011853|FG000|NOT COMPLETED|Overall Study||18
10845874|NCT03713957|12011854|FG001|NOT COMPLETED|Overall Study||10
10845885|NCT04353271|12011869|FG000|NOT COMPLETED|Overall Study||0
10845886|NCT04353271|12011870|FG001|NOT COMPLETED|Overall Study||1
10845887|NCT05166824|12011880|FG000|STARTED|Overall Study||1
10845888|NCT05166824|12011881|FG001|STARTED|Overall Study||10
10845889|NCT05166824|12011882|FG002|STARTED|Overall Study||68
10845890|NCT05166824|12011883|FG003|STARTED|Overall Study||10
10845891|NCT05166824|12011880|FG000|COMPLETED|Overall Study||1
10845892|NCT05166824|12011881|FG001|COMPLETED|Overall Study||10
10845893|NCT05166824|12011882|FG002|COMPLETED|Overall Study||59
10845894|NCT05166824|12011883|FG003|COMPLETED|Overall Study||10
10845895|NCT05166824|12011880|FG000|NOT COMPLETED|Overall Study||0
10845896|NCT05166824|12011881|FG001|NOT COMPLETED|Overall Study||0
10845897|NCT05166824|12011882|FG002|NOT COMPLETED|Overall Study||9
10845898|NCT05166824|12011883|FG003|NOT COMPLETED|Overall Study||0
10845899|NCT04570670|12011895|FG000|STARTED|Overall Study||25
10845900|NCT04570670|12011896|FG001|STARTED|Overall Study||25
10845901|NCT04570670|12011895|FG000|COMPLETED|Overall Study||24
10845902|NCT04570670|12011896|FG001|COMPLETED|Overall Study||25
10845903|NCT04570670|12011895|FG000|NOT COMPLETED|Overall Study||1
10845904|NCT04570670|12011896|FG001|NOT COMPLETED|Overall Study||0
10845905|NCT04552704|12011905|FG000|STARTED|Overall Study||3
10845906|NCT04552704|12011905|FG000|COMPLETED|Overall Study||3
10845907|NCT04552704|12011905|FG000|NOT COMPLETED|Overall Study||0
10845908|NCT04546581|12011912|FG000|STARTED|Overall Study||301
10845909|NCT04546581|12011913|FG001|STARTED|Overall Study||292
10845910|NCT04546581|12011912|FG000|COMPLETED|Overall Study||288
10845911|NCT04546581|12011913|FG001|COMPLETED|Overall Study||279
10845912|NCT04546581|12011912|FG000|NOT COMPLETED|Overall Study||13
10845913|NCT04546581|12011913|FG001|NOT COMPLETED|Overall Study||13
10845914|NCT04236245|12011919|FG000|STARTED|Overall Study||25
10845915|NCT04236245|12011919|FG000|COMPLETED|Overall Study||25
10845916|NCT04236245|12011919|FG000|NOT COMPLETED|Overall Study||0
10845917|NCT04021290|12011925|FG000|STARTED|Overall Study||246
10845918|NCT04021290|12011926|FG001|STARTED|Overall Study||247
10845919|NCT04021290|12011925|FG000|COMPLETED|Overall Study||143
10845920|NCT04021290|12011926|FG001|COMPLETED|Overall Study||229
10845921|NCT04021290|12011925|FG000|NOT COMPLETED|Overall Study||103
10845922|NCT04021290|12011926|FG001|NOT COMPLETED|Overall Study||18
10845923|NCT03915626|12011932|FG000|STARTED|Overall Study||7
10845924|NCT03915626|12011932|FG000|COMPLETED|Overall Study||6
10845925|NCT03915626|12011932|FG000|NOT COMPLETED|Overall Study||1
10845926|NCT03698279|12011948|FG000|STARTED|Overall Study||124
10845927|NCT03698279|12011949|FG001|STARTED|Overall Study||122
10845928|NCT03698279|12011950|FG002|STARTED|Overall Study||159
10845929|NCT03698279|12011951|FG003|STARTED|Overall Study||234
10845930|NCT03698279|12011952|FG004|STARTED|Overall Study||13
10845931|NCT03698279|12011953|FG005|STARTED|Overall Study||13
10845932|NCT03698279|12011948|FG000|Safety Analysis Set Population (SafAS)|Overall Study||122
10845933|NCT03698279|12011949|FG001|Safety Analysis Set Population (SafAS)|Overall Study||121
10845934|NCT03698279|12011950|FG002|Safety Analysis Set Population (SafAS)|Overall Study||158
10845935|NCT03698279|12011951|FG003|Safety Analysis Set Population (SafAS)|Overall Study||234
10845936|NCT03698279|12011952|FG004|Safety Analysis Set Population (SafAS)|Overall Study||13
10845937|NCT03698279|12011953|FG005|Safety Analysis Set Population (SafAS)|Overall Study||13
10845938|NCT03698279|12011948|FG000|COMPLETED|Overall Study||119
10845939|NCT03698279|12011949|FG001|COMPLETED|Overall Study||120
10845940|NCT03698279|12011950|FG002|COMPLETED|Overall Study||152
10845941|NCT03698279|12011951|FG003|COMPLETED|Overall Study||228
10845942|NCT03698279|12011952|FG004|COMPLETED|Overall Study||13
10845943|NCT03698279|12011953|FG005|COMPLETED|Overall Study||13
10845944|NCT03698279|12011948|FG000|NOT COMPLETED|Overall Study||5
10845945|NCT03698279|12011949|FG001|NOT COMPLETED|Overall Study||2
10845946|NCT03698279|12011950|FG002|NOT COMPLETED|Overall Study||7
10845947|NCT03698279|12011951|FG003|NOT COMPLETED|Overall Study||6
10845948|NCT03698279|12011952|FG004|NOT COMPLETED|Overall Study||0
10845949|NCT03698279|12011953|FG005|NOT COMPLETED|Overall Study||0
10845950|NCT03559010|12011972|FG000|STARTED|Overall Study|The number of participants to start a period is not equal to the number who completed previous period|189
10845951|NCT03559010|12011972|FG000|Purchaser Population|Overall Study||113
10845952|NCT03559010|12011972|FG000|Use Phase Norgestrel 0.075 mg|Overall Study||109
10845953|NCT03559010|12011972|FG000|COMPLETED|Overall Study||189
10845954|NCT03559010|12011972|FG000|NOT COMPLETED|Overall Study||0
10845955|NCT03478930|12011983|FG000|STARTED|Overall Study||126
10845956|NCT03478930|12011984|FG001|STARTED|Overall Study||123
10845957|NCT03478930|12011983|FG000|COMPLETED|Overall Study||117
10845958|NCT03478930|12011984|FG001|COMPLETED|Overall Study||114
10845959|NCT03478930|12011983|FG000|NOT COMPLETED|Overall Study||9
10845960|NCT03478930|12011984|FG001|NOT COMPLETED|Overall Study||9
10845961|NCT03434353|12011995|FG000|STARTED|Overall Study||30
10845962|NCT03434353|12011996|FG001|STARTED|Overall Study||12
10845963|NCT03434353|12011997|FG002|STARTED|Overall Study||30
10845964|NCT03434353|12011998|FG003|STARTED|Overall Study||21
10845965|NCT03434353|12011999|FG004|STARTED|Overall Study||30
10845966|NCT03434353|12011995|FG000|COMPLETED|Overall Study||16
10845967|NCT03434353|12011996|FG001|COMPLETED|Overall Study||9
10845968|NCT03434353|12011997|FG002|COMPLETED|Overall Study||16
10845969|NCT03434353|12011998|FG003|COMPLETED|Overall Study||18
10845970|NCT03434353|12011999|FG004|COMPLETED|Overall Study||12
10845971|NCT03434353|12011995|FG000|NOT COMPLETED|Overall Study||14
10845972|NCT03434353|12011996|FG001|NOT COMPLETED|Overall Study||3
10845973|NCT03434353|12011997|FG002|NOT COMPLETED|Overall Study||14
10845974|NCT03434353|12011998|FG003|NOT COMPLETED|Overall Study||3
10845975|NCT03434353|12011999|FG004|NOT COMPLETED|Overall Study||18
10845976|NCT03415022|12012013|FG000|STARTED|Overall Study||21
10845977|NCT03415022|12012014|FG001|STARTED|Overall Study||20
10845978|NCT03415022|12012013|FG000|COMPLETED|Overall Study||16
10845979|NCT03415022|12012014|FG001|COMPLETED|Overall Study||15
10412851|NCT00774046|11556958|FG000|STARTED|Induction Therapy||32
10412852|NCT00774046|11556958|FG000|COMPLETED|Induction Therapy||32
10412853|NCT00774046|11556958|FG000|NOT COMPLETED|Induction Therapy||0
10412854|NCT00774046|11556958|FG000|STARTED|Stem Cell Mobilization|For mobilization, the patient must have had a CR and not been a candidate for allogeneic transplant|10
10412855|NCT00774046|11556958|FG000|COMPLETED|Stem Cell Mobilization||7
10412856|NCT00774046|11556958|FG000|NOT COMPLETED|Stem Cell Mobilization||3
10412857|NCT00774046|11556958|FG000|STARTED|Autologous Transplant|2 patients died in remission and 1 relapsed without having received transplant|4
10412858|NCT00774046|11556958|FG000|COMPLETED|Autologous Transplant||4
10412859|NCT00774046|11556958|FG000|NOT COMPLETED|Autologous Transplant||0
10412860|NCT00774163|11556964|FG000|STARTED|Overall Study||30
10412861|NCT00774163|11556965|FG001|STARTED|Overall Study||15
10412862|NCT00774163|11556964|FG000|COMPLETED|Overall Study||30
10412863|NCT00774163|11556965|FG001|COMPLETED|Overall Study||15
10412864|NCT00774163|11556964|FG000|NOT COMPLETED|Overall Study||0
10412865|NCT00774163|11556965|FG001|NOT COMPLETED|Overall Study||0
10412866|NCT00774202|11556973|FG000|STARTED|Overall Study||9
10412867|NCT00774202|11556974|FG001|STARTED|Overall Study||8
10412868|NCT00774202|11556973|FG000|COMPLETED|Overall Study||9
10412869|NCT00774202|11556974|FG001|COMPLETED|Overall Study||8
10412870|NCT00774202|11556973|FG000|NOT COMPLETED|Overall Study||0
10412871|NCT00774202|11556974|FG001|NOT COMPLETED|Overall Study||0
10412872|NCT00774267|11556988|FG000|STARTED|Overall Study||132
10412873|NCT00774267|11556989|FG001|STARTED|Overall Study||111
10412874|NCT00774267|11556990|FG002|STARTED|Overall Study||129
10412875|NCT00774267|11556991|FG003|STARTED|Overall Study||135
10412876|NCT00774267|11556988|FG000|COMPLETED|Overall Study||132
10412877|NCT00774267|11556989|FG001|COMPLETED|Overall Study||111
10412878|NCT00774267|11556990|FG002|COMPLETED|Overall Study||129
10412879|NCT00774267|11556991|FG003|COMPLETED|Overall Study||135
10412880|NCT00774267|11556988|FG000|NOT COMPLETED|Overall Study||0
10412881|NCT00774267|11556989|FG001|NOT COMPLETED|Overall Study||0
10412882|NCT00774267|11556990|FG002|NOT COMPLETED|Overall Study||0
10412883|NCT00774267|11556991|FG003|NOT COMPLETED|Overall Study||0
10412884|NCT00774397|11557008|FG000|STARTED|Overall Study||71
10412885|NCT00774397|11557009|FG001|STARTED|Overall Study||69
10412886|NCT00774397|11557010|FG002|STARTED|Overall Study||143
10412887|NCT00774397|11557011|FG003|STARTED|Overall Study||146
10412888|NCT00774397|11557012|FG004|STARTED|Overall Study||143
10412889|NCT00774397|11557013|FG005|STARTED|Overall Study||76
10412890|NCT00774397|11557014|FG006|STARTED|Overall Study||71
10412891|NCT00774397|11557008|FG000|COMPLETED|Overall Study||57
10412892|NCT00774397|11557009|FG001|COMPLETED|Overall Study||56
10412893|NCT00774397|11557010|FG002|COMPLETED|Overall Study||113
10412894|NCT00774397|11557011|FG003|COMPLETED|Overall Study||129
10412895|NCT00774397|11557012|FG004|COMPLETED|Overall Study||97
10412896|NCT00774397|11557013|FG005|COMPLETED|Overall Study||54
10412897|NCT00774397|11557014|FG006|COMPLETED|Overall Study||41
10412898|NCT00774397|11557008|FG000|NOT COMPLETED|Overall Study||14
10412899|NCT00774397|11557009|FG001|NOT COMPLETED|Overall Study||13
10412900|NCT00774397|11557010|FG002|NOT COMPLETED|Overall Study||30
10412901|NCT00774397|11557011|FG003|NOT COMPLETED|Overall Study||17
10412902|NCT00774397|11557012|FG004|NOT COMPLETED|Overall Study||46
10412903|NCT00774397|11557013|FG005|NOT COMPLETED|Overall Study||22
10412904|NCT00774397|11557014|FG006|NOT COMPLETED|Overall Study||30
10412905|NCT00774566|11557039|FG000|STARTED|Overall Study||159
10412906|NCT00774566|11557040|FG001|STARTED|Overall Study||156
10412907|NCT00774566|11557039|FG000|6 Month Follow up|Overall Study||154
10412908|NCT00774566|11557040|FG001|6 Month Follow up|Overall Study||150
10412909|NCT00774566|11557039|FG000|12 Month Follow up|Overall Study||141
10412910|NCT00774566|11557040|FG001|12 Month Follow up|Overall Study||141
10412911|NCT00774566|11557039|FG000|COMPLETED|Overall Study||141
10412912|NCT00774566|11557040|FG001|COMPLETED|Overall Study||141
10412913|NCT00774566|11557039|FG000|NOT COMPLETED|Overall Study||18
10412914|NCT00774566|11557040|FG001|NOT COMPLETED|Overall Study||15
10412915|NCT00774579|11557048|FG000|STARTED|Overall Study||9
10412916|NCT00774579|11557049|FG001|STARTED|Overall Study||9
10412917|NCT00774579|11557048|FG000|COMPLETED|Overall Study||9
10412918|NCT00774579|11557049|FG001|COMPLETED|Overall Study||9
10412919|NCT00774579|11557048|FG000|NOT COMPLETED|Overall Study||0
10412920|NCT00774579|11557049|FG001|NOT COMPLETED|Overall Study||0
10545221|NCT01495585|11698514|FG002|Open Label Lonafarnib 200 mg|Overall Study||0
10545222|NCT01495585|11698512|FG000|COMPLETED|Overall Study||4
10545223|NCT01495585|11698513|FG001|COMPLETED|Overall Study||6
10545224|NCT01495585|11698514|FG002|COMPLETED|Overall Study||4
10545225|NCT01495585|11698512|FG000|NOT COMPLETED|Overall Study||0
10545226|NCT01495585|11698513|FG001|NOT COMPLETED|Overall Study||0
10545227|NCT01495585|11698514|FG002|NOT COMPLETED|Overall Study||0
10545228|NCT01495689|11698524|FG000|STARTED|Overall Study||26
10545229|NCT01495689|11698525|FG001|STARTED|Overall Study||23
10545230|NCT01495689|11698524|FG000|COMPLETED|Overall Study||16
10845980|NCT03415022|12012013|FG000|NOT COMPLETED|Overall Study||5
10412921|NCT00774748|11557055|FG000|STARTED|Overall Study||21
10412922|NCT00774748|11557055|FG000|COMPLETED|Overall Study||18
10412923|NCT00774748|11557055|FG000|NOT COMPLETED|Overall Study||3
10412924|NCT00774787|11557063|FG000|STARTED|Overall Study||27
10412925|NCT00774787|11557063|FG000|COMPLETED|Overall Study||26
10845981|NCT03415022|12012014|FG001|NOT COMPLETED|Overall Study||5
10845982|NCT03283670|12012020|FG000|STARTED|Placebo Gas||24
10845983|NCT03283670|12012020|FG000|COMPLETED|Placebo Gas||22
10845984|NCT03283670|12012020|FG000|NOT COMPLETED|Placebo Gas||2
10845985|NCT03283670|12012020|FG000|STARTED|25% Nitrous Oxide||24
10845986|NCT03283670|12012020|FG000|COMPLETED|25% Nitrous Oxide||20
10845987|NCT03283670|12012020|FG000|NOT COMPLETED|25% Nitrous Oxide||4
10845988|NCT03283670|12012020|FG000|STARTED|50% Nitrous Oxide||24
10845989|NCT03283670|12012020|FG000|COMPLETED|50% Nitrous Oxide||23
10845990|NCT03283670|12012020|FG000|NOT COMPLETED|50% Nitrous Oxide||1
10845991|NCT03233217|12012033|FG000|STARTED|Overall Study||5
10845992|NCT03233217|12012034|FG001|STARTED|Overall Study||5
10845993|NCT03233217|12012035|FG002|STARTED|Overall Study||55
10845994|NCT03233217|12012036|FG003|STARTED|Overall Study||55
10845995|NCT03233217|12012037|FG004|STARTED|Overall Study||55
10845996|NCT03233217|12012033|FG000|Safety Analysis Set (SafAS)|Overall Study||5
10845997|NCT03233217|12012034|FG001|Safety Analysis Set (SafAS)|Overall Study||5
10845998|NCT03233217|12012035|FG002|Safety Analysis Set (SafAS)|Overall Study||55
10845999|NCT03233217|12012036|FG003|Safety Analysis Set (SafAS)|Overall Study||55
10846000|NCT03233217|12012037|FG004|Safety Analysis Set (SafAS)|Overall Study||55
10846001|NCT03233217|12012033|FG000|Per-protocol Analysis Set (PPAS)|Overall Study||5
10846002|NCT03233217|12012034|FG001|Per-protocol Analysis Set (PPAS)|Overall Study||5
10846003|NCT03233217|12012035|FG002|Per-protocol Analysis Set (PPAS)|Overall Study||55
10846004|NCT03233217|12012036|FG003|Per-protocol Analysis Set (PPAS)|Overall Study||55
10846005|NCT03233217|12012037|FG004|Per-protocol Analysis Set (PPAS)|Overall Study||54
10846006|NCT03233217|12012033|FG000|COMPLETED|Overall Study||5
10846007|NCT03233217|12012034|FG001|COMPLETED|Overall Study||5
10846008|NCT03233217|12012035|FG002|COMPLETED|Overall Study||55
10846009|NCT03233217|12012036|FG003|COMPLETED|Overall Study||55
10846010|NCT03233217|12012037|FG004|COMPLETED|Overall Study||55
10846011|NCT03233217|12012033|FG000|NOT COMPLETED|Overall Study||0
10846012|NCT03233217|12012034|FG001|NOT COMPLETED|Overall Study||0
10846013|NCT03233217|12012035|FG002|NOT COMPLETED|Overall Study||0
10846014|NCT03233217|12012036|FG003|NOT COMPLETED|Overall Study||0
10846015|NCT03233217|12012037|FG004|NOT COMPLETED|Overall Study||0
10846016|NCT03219567|12012051|FG000|STARTED|Overall Study||18
10846017|NCT03219567|12012052|FG001|STARTED|Overall Study||64
10846018|NCT03219567|12012051|FG000|COMPLETED|Overall Study||18
10846019|NCT03219567|12012052|FG001|COMPLETED|Overall Study||63
10846020|NCT03219567|12012051|FG000|NOT COMPLETED|Overall Study||0
10846021|NCT03219567|12012052|FG001|NOT COMPLETED|Overall Study||1
10846022|NCT03205358|12012061|FG000|STARTED|Overall Study||94
10846023|NCT03205358|12012062|FG001|STARTED|Overall Study||94
10846024|NCT03205358|12012061|FG000|COMPLETED|Overall Study||94
10846025|NCT03205358|12012062|FG001|COMPLETED|Overall Study||94
10846026|NCT03205358|12012061|FG000|NOT COMPLETED|Overall Study||0
10846027|NCT03205358|12012062|FG001|NOT COMPLETED|Overall Study||0
10846028|NCT03153111|12012070|FG000|STARTED|Overall Study||71
10846029|NCT03153111|12012071|FG001|STARTED|Overall Study||71
10846030|NCT03153111|12012070|FG000|COMPLETED|Overall Study||60
10846031|NCT03153111|12012071|FG001|COMPLETED|Overall Study||62
10846032|NCT03153111|12012070|FG000|NOT COMPLETED|Overall Study||11
10846033|NCT03153111|12012071|FG001|NOT COMPLETED|Overall Study||9
10846034|NCT03073733|12012080|FG000|STARTED|Overall Study||29
10846035|NCT03073733|12012081|FG001|STARTED|Overall Study||27
10846036|NCT03073733|12012082|FG002|STARTED|Overall Study||27
10846037|NCT03073733|12012080|FG000|COMPLETED|Overall Study||28
10846038|NCT03073733|12012081|FG001|COMPLETED|Overall Study||26
10846039|NCT03073733|12012082|FG002|COMPLETED|Overall Study||26
10846040|NCT03073733|12012080|FG000|NOT COMPLETED|Overall Study||1
10846041|NCT03073733|12012081|FG001|NOT COMPLETED|Overall Study||1
10846042|NCT03073733|12012082|FG002|NOT COMPLETED|Overall Study||1
10846047|NCT02749968|12012098|FG000|STARTED|Overall Study||50
10846048|NCT02749968|12012099|FG001|STARTED|Overall Study||50
10846049|NCT02749968|12012098|FG000|Interim Analysis|Overall Study||25
10846050|NCT02749968|12012099|FG001|Interim Analysis|Overall Study||25
10846051|NCT02749968|12012098|FG000|COMPLETED|Overall Study||50
10846052|NCT02749968|12012099|FG001|COMPLETED|Overall Study||50
10846053|NCT02749968|12012098|FG000|NOT COMPLETED|Overall Study||0
10846054|NCT02749968|12012099|FG001|NOT COMPLETED|Overall Study||0
10846055|NCT02738255|12012107|FG000|STARTED|Overall Study||11
10846056|NCT02738255|12012108|FG001|STARTED|Overall Study||15
10846057|NCT02738255|12012107|FG000|COMPLETED|Overall Study||11
10846058|NCT02738255|12012108|FG001|COMPLETED|Overall Study||14
10846059|NCT02738255|12012107|FG000|NOT COMPLETED|Overall Study||0
10846060|NCT02738255|12012108|FG001|NOT COMPLETED|Overall Study||1
10846061|NCT02702414|12012120|FG000|STARTED|Overall Study||105
10846062|NCT02702414|12012121|FG001|STARTED|Overall Study||51
10846063|NCT02702414|12012120|FG000|Treated|Overall Study||104
10846064|NCT02702414|12012121|FG001|Treated|Overall Study||51
10846065|NCT02702414|12012120|FG000|COMPLETED|Overall Study||0
10846066|NCT02702414|12012121|FG001|COMPLETED|Overall Study||0
10846067|NCT02702414|12012120|FG000|NOT COMPLETED|Overall Study||105
10846068|NCT02702414|12012121|FG001|NOT COMPLETED|Overall Study||51
10846069|NCT02605616|12012131|FG000|STARTED|Overall Study||46
10846070|NCT02605616|12012132|FG001|STARTED|Overall Study||47
10846071|NCT02605616|12012131|FG000|COMPLETED|Overall Study||42
10846072|NCT02605616|12012132|FG001|COMPLETED|Overall Study||43
10846073|NCT02605616|12012131|FG000|NOT COMPLETED|Overall Study||4
10846074|NCT02605616|12012132|FG001|NOT COMPLETED|Overall Study||4
10846075|NCT02573233|12012140|FG000|STARTED|Overall Study||22
10846076|NCT02573233|12012141|FG001|STARTED|Overall Study||20
10846077|NCT02573233|12012140|FG000|COMPLETED|Overall Study||22
10846078|NCT02573233|12012141|FG001|COMPLETED|Overall Study||20
10846079|NCT02573233|12012140|FG000|NOT COMPLETED|Overall Study||0
10846080|NCT02573233|12012141|FG001|NOT COMPLETED|Overall Study||0
10846081|NCT02425904|12012150|FG000|STARTED|Overall Study||20
10846082|NCT02425904|12012151|FG001|STARTED|Overall Study||5
10846083|NCT02425904|12012150|FG000|Efficacy Analysis|Overall Study||20
10846084|NCT02425904|12012151|FG001|Efficacy Analysis|Overall Study|1 patient was incorrectly assigned to LCH-related disorders cohort but it is actually LCH patients, so excluded from efficacy analysis.|4
10846085|NCT02425904|12012150|FG000|COMPLETED|Overall Study||17
10846086|NCT02425904|12012151|FG001|COMPLETED|Overall Study||2
10846087|NCT02425904|12012150|FG000|NOT COMPLETED|Overall Study||3
10846088|NCT02425904|12012151|FG001|NOT COMPLETED|Overall Study||3
10846089|NCT02420795|12012161|FG000|STARTED|Overall Study||4
10846090|NCT02420795|12012162|FG001|STARTED|Overall Study||2
10846091|NCT02420795|12012163|FG002|STARTED|Overall Study||5
10846092|NCT02420795|12012161|FG000|COMPLETED|Overall Study||0
10846093|NCT02420795|12012162|FG001|COMPLETED|Overall Study||0
10846094|NCT02420795|12012163|FG002|COMPLETED|Overall Study||0
10846095|NCT02420795|12012161|FG000|NOT COMPLETED|Overall Study||4
10846096|NCT02420795|12012162|FG001|NOT COMPLETED|Overall Study||2
10846097|NCT02420795|12012163|FG002|NOT COMPLETED|Overall Study||5
10846098|NCT02240485|12012175|FG000|STARTED|3 Months Post-admission||44
10846099|NCT02240485|12012176|FG001|STARTED|3 Months Post-admission||36
10846100|NCT02240485|12012175|FG000|COMPLETED|3 Months Post-admission|Couple modality: 1 couple refused and one gambler refused but his partner continued|41
10846101|NCT02240485|12012176|FG001|COMPLETED|3 Months Post-admission||30
10846102|NCT02240485|12012175|FG000|NOT COMPLETED|3 Months Post-admission||3
10846103|NCT02240485|12012176|FG001|NOT COMPLETED|3 Months Post-admission||6
10846104|NCT02240485|12012175|FG000|STARTED|9 Months Post-admission||41
10846105|NCT02240485|12012176|FG001|STARTED|9 Months Post-admission||30
10846106|NCT02240485|12012175|FG000|COMPLETED|9 Months Post-admission||38
10846107|NCT02240485|12012176|FG001|COMPLETED|9 Months Post-admission|26 couples completed + 1 individual (partner lost)|26
10846108|NCT02240485|12012175|FG000|NOT COMPLETED|9 Months Post-admission||3
10846109|NCT02240485|12012176|FG001|NOT COMPLETED|9 Months Post-admission||4
10846110|NCT02240485|12012175|FG000|STARTED|18 Months Post-admission||38
10846111|NCT02240485|12012176|FG001|STARTED|18 Months Post-admission||26
10846112|NCT02240485|12012175|FG000|COMPLETED|18 Months Post-admission||35
10846113|NCT02240485|12012176|FG001|COMPLETED|18 Months Post-admission||21
10846114|NCT02240485|12012175|FG000|NOT COMPLETED|18 Months Post-admission||3
10846115|NCT02240485|12012176|FG001|NOT COMPLETED|18 Months Post-admission||5
10846116|NCT02227147|12012188|FG000|STARTED|Controlled Treatment Period||24
10846117|NCT02227147|12012189|FG001|STARTED|Controlled Treatment Period||24
10846118|NCT02227147|12012188|FG000|COMPLETED|Controlled Treatment Period||18
10846119|NCT02227147|12012189|FG001|COMPLETED|Controlled Treatment Period||21
10846120|NCT02227147|12012188|FG000|NOT COMPLETED|Controlled Treatment Period||6
10846121|NCT02227147|12012189|FG001|NOT COMPLETED|Controlled Treatment Period||3
10846122|NCT02227147|12012188|FG000|STARTED|Follow-up Period||18
10846123|NCT02227147|12012189|FG001|STARTED|Follow-up Period||21
10846124|NCT02227147|12012188|FG000|COMPLETED|Follow-up Period||15
10846125|NCT02227147|12012189|FG001|COMPLETED|Follow-up Period||16
10846126|NCT02227147|12012188|FG000|NOT COMPLETED|Follow-up Period||3
10846127|NCT02227147|12012189|FG001|NOT COMPLETED|Follow-up Period||5
10846128|NCT02199691|12012203|FG000|STARTED|Overall Study||505
10846129|NCT02199691|12012204|FG001|STARTED|Overall Study||507
10846130|NCT02199691|12012205|FG002|STARTED|Overall Study||403
10846131|NCT02199691|12012206|FG003|STARTED|Overall Study||300
10846132|NCT02199691|12012203|FG000|Safety Analysis Set (SafAS)|Overall Study||503
10846133|NCT02199691|12012204|FG001|Safety Analysis Set (SafAS)|Overall Study||501
10846134|NCT02199691|12012205|FG002|Safety Analysis Set (SafAS)|Overall Study||392
10846135|NCT02199691|12012206|FG003|Safety Analysis Set (SafAS)|Overall Study||296
10846136|NCT02199691|12012203|FG000|COMPLETED|Overall Study||495
10846137|NCT02199691|12012204|FG001|COMPLETED|Overall Study||500
10846138|NCT02199691|12012205|FG002|COMPLETED|Overall Study||376
10846139|NCT02199691|12012206|FG003|COMPLETED|Overall Study||270
10846140|NCT02199691|12012203|FG000|NOT COMPLETED|Overall Study||10
10846141|NCT02199691|12012204|FG001|NOT COMPLETED|Overall Study||7
10846142|NCT02199691|12012205|FG002|NOT COMPLETED|Overall Study||27
10846143|NCT02199691|12012206|FG003|NOT COMPLETED|Overall Study||30
10846144|NCT02143726|12012220|FG000|STARTED|Overall Study||18
10846145|NCT02143726|12012221|FG001|STARTED|Overall Study||17
10846146|NCT02143726|12012220|FG000|Received Everolimus After Disease Progression|Overall Study||11
10846147|NCT02143726|12012221|FG001|Received Everolimus After Disease Progression|Overall Study||0
10846148|NCT02143726|12012220|FG000|COMPLETED|Overall Study||16
10846149|NCT02143726|12012221|FG001|COMPLETED|Overall Study||17
10846150|NCT02143726|12012220|FG000|NOT COMPLETED|Overall Study||2
10846151|NCT02143726|12012221|FG001|NOT COMPLETED|Overall Study||0
10846152|NCT02046512|12012229|FG000|STARTED|Overall Study||45
10846153|NCT02046512|12012230|FG001|STARTED|Overall Study||44
10846154|NCT02046512|12012229|FG000|COMPLETED|Overall Study||44
10846155|NCT02046512|12012230|FG001|COMPLETED|Overall Study||44
10846156|NCT02046512|12012229|FG000|NOT COMPLETED|Overall Study||1
10846157|NCT02046512|12012230|FG001|NOT COMPLETED|Overall Study||0
10412926|NCT00774787|11557063|FG000|NOT COMPLETED|Overall Study||1
10412927|NCT00774800|11557067|FG000|STARTED|Intervention 1||22
10412928|NCT00774800|11557067|FG000|Received at Least One Dose of Study Drug|Intervention 1||22
10412929|NCT00774800|11557067|FG000|COMPLETED|Intervention 1||22
10412930|NCT00774800|11557067|FG000|NOT COMPLETED|Intervention 1||0
10412931|NCT00774800|11557067|FG000|STARTED|Washout (3 to 10 Days)||22
10412932|NCT00774800|11557067|FG000|COMPLETED|Washout (3 to 10 Days)||22
10412933|NCT00774800|11557067|FG000|NOT COMPLETED|Washout (3 to 10 Days)||0
10412934|NCT00774800|11557067|FG000|STARTED|Intervention 2||22
10412935|NCT00774800|11557067|FG000|Received at Least One Dose of Study Drug|Intervention 2||22
10412936|NCT00774800|11557067|FG000|COMPLETED|Intervention 2||22
10412937|NCT00774800|11557067|FG000|NOT COMPLETED|Intervention 2||0
10412938|NCT00774800|11557067|FG000|STARTED|Washout (3 to 10 Days)||22
10412939|NCT00774800|11557067|FG000|COMPLETED|Washout (3 to 10 Days)||22
10412940|NCT00774800|11557067|FG000|NOT COMPLETED|Washout (3 to 10 Days)||0
10412941|NCT00774800|11557067|FG000|STARTED|Intervention 3||22
10412942|NCT00774800|11557067|FG000|Received at Least One Dose of Study Drug|Intervention 3||22
10412943|NCT00774800|11557067|FG000|COMPLETED|Intervention 3||22
10412944|NCT00774800|11557067|FG000|NOT COMPLETED|Intervention 3||0
10412945|NCT00774800|11557067|FG000|STARTED|Washout (3 to 10 Days)||22
10412946|NCT00774800|11557067|FG000|COMPLETED|Washout (3 to 10 Days)||22
10412947|NCT00774800|11557067|FG000|NOT COMPLETED|Washout (3 to 10 Days)||0
10545231|NCT01495689|11698525|FG001|COMPLETED|Overall Study||16
10545232|NCT01495689|11698524|FG000|NOT COMPLETED|Overall Study||10
10545233|NCT01495689|11698525|FG001|NOT COMPLETED|Overall Study||7
10545234|NCT01495702|11698533|FG000|STARTED|Randomized Phase||292
10545235|NCT01495702|11698534|FG001|STARTED|Randomized Phase||147
10545236|NCT01495702|11698533|FG000|COMPLETED|Randomized Phase||266
10545237|NCT01495702|11698534|FG001|COMPLETED|Randomized Phase||119
10545238|NCT01495702|11698533|FG000|NOT COMPLETED|Randomized Phase||26
10545239|NCT01495702|11698534|FG001|NOT COMPLETED|Randomized Phase||28
10545240|NCT01495702|11698533|FG000|STARTED|Extension Phase||26
10545241|NCT01495702|11698534|FG001|STARTED|Extension Phase||2
10545242|NCT01495702|11698533|FG000|COMPLETED|Extension Phase||26
10545243|NCT01495702|11698534|FG001|COMPLETED|Extension Phase||2
10545244|NCT01495702|11698533|FG000|NOT COMPLETED|Extension Phase||0
10846158|NCT01842035|12012236|FG000|STARTED|Overall Study||90
10846159|NCT01842035|12012236|FG000|COMPLETED|Overall Study||90
10846160|NCT01842035|12012236|FG000|NOT COMPLETED|Overall Study||0
10846161|NCT01751984|12012243|FG000|STARTED|Overall Study||37
10846162|NCT01751984|12012244|FG001|STARTED|Overall Study||19
10846163|NCT01751984|12012243|FG000|COMPLETED|Overall Study||31
10846164|NCT01751984|12012244|FG001|COMPLETED|Overall Study||15
10846165|NCT01751984|12012243|FG000|NOT COMPLETED|Overall Study||6
10846166|NCT01751984|12012244|FG001|NOT COMPLETED|Overall Study||4
10846167|NCT01732627|12012252|FG000|STARTED|Overall Study||201
10846168|NCT01732627|12012253|FG001|STARTED|Overall Study||100
10846169|NCT01732627|12012252|FG000|Safety Analysis Set (SafAS)|Overall Study||199
10846170|NCT01732627|12012253|FG001|Safety Analysis Set (SafAS)|Overall Study||100
10846171|NCT01732627|12012252|FG000|COMPLETED|Overall Study||200
10846172|NCT01732627|12012253|FG001|COMPLETED|Overall Study||100
10846173|NCT01732627|12012252|FG000|NOT COMPLETED|Overall Study||1
10846174|NCT01732627|12012253|FG001|NOT COMPLETED|Overall Study||0
10846175|NCT01702571|12012261|FG000|STARTED|Overall Study||2003
10846176|NCT01702571|12012262|FG001|STARTED|Overall Study||182
10846177|NCT01702571|12012261|FG000|COMPLETED|Overall Study|For one participant, the site incorrectly answered the question 'Did the participant complete follow-up as per protocol?' It was answered No, however the participant was in survival follow-up and the site should have answered Yes. This participant is wrongly counted in the 'discontinued from study' number.|494
10846178|NCT01702571|12012262|FG001|COMPLETED|Overall Study||65
10846179|NCT01702571|12012261|FG000|NOT COMPLETED|Overall Study||1509
10846180|NCT01702571|12012262|FG001|NOT COMPLETED|Overall Study||117
10846181|NCT01578239|12012270|FG000|STARTED|Treatment Period||117
10846182|NCT01578239|12012271|FG001|STARTED|Treatment Period||114
10846183|NCT01578239|12012270|FG000|Full Analysis Set (FAS)|Treatment Period||117
10846184|NCT01578239|12012271|FG001|Full Analysis Set (FAS)|Treatment Period||114
10846185|NCT01578239|12012270|FG000|Safety Analysis Set (SAF)|Treatment Period||111
10846186|NCT01578239|12012271|FG001|Safety Analysis Set (SAF)|Treatment Period||112
10846187|NCT01578239|12012270|FG000|FAS-Entered Long-term Follow-up|Treatment Period||101
10661242|NCT02257970|11823122|FG002|STARTED|Part 2||0
10846188|NCT01578239|12012271|FG001|FAS-Entered Long-term Follow-up|Treatment Period||99
10846189|NCT01578239|12012270|FG000|COMPLETED|Treatment Period||50
10846190|NCT01578239|12012271|FG001|COMPLETED|Treatment Period||13
10846191|NCT01578239|12012270|FG000|NOT COMPLETED|Treatment Period||67
10846192|NCT01578239|12012271|FG001|NOT COMPLETED|Treatment Period||101
10846193|NCT01578239|12012270|FG000|STARTED|Long-term Follow-Up Period|FAS-Entered long-term follow-up|101
10846194|NCT01578239|12012271|FG001|STARTED|Long-term Follow-Up Period|FAS-Entered long-term follow-up|99
10846195|NCT01578239|12012270|FG000|COMPLETED|Long-term Follow-Up Period||24
10846196|NCT01578239|12012271|FG001|COMPLETED|Long-term Follow-Up Period||19
10846197|NCT01578239|12012270|FG000|NOT COMPLETED|Long-term Follow-Up Period||77
10846198|NCT01578239|12012271|FG001|NOT COMPLETED|Long-term Follow-Up Period||80
10846199|NCT01458340|12012280|FG000|STARTED|Overall Study||97
10846200|NCT01458340|12012281|FG001|STARTED|Overall Study||99
10846201|NCT01458340|12012282|FG002|STARTED|Overall Study||99
10846202|NCT01458340|12012280|FG000|Received Study Treatment|Overall Study||97
10846203|NCT01458340|12012281|FG001|Received Study Treatment|Overall Study||98
10846204|NCT01458340|12012282|FG002|Received Study Treatment|Overall Study||98
10846205|NCT01458340|12012280|FG000|COMPLETED|Overall Study||70
10846206|NCT01458340|12012281|FG001|COMPLETED|Overall Study||78
10846207|NCT01458340|12012282|FG002|COMPLETED|Overall Study||76
10846208|NCT01458340|12012280|FG000|NOT COMPLETED|Overall Study||27
10846209|NCT01458340|12012281|FG001|NOT COMPLETED|Overall Study||21
10846210|NCT01458340|12012282|FG002|NOT COMPLETED|Overall Study||23
10846211|NCT01411267|12012300|FG000|STARTED|Overall Study||0
10846212|NCT01411267|12012301|FG001|STARTED|Overall Study||3
10846213|NCT01411267|12012302|FG002|STARTED|Overall Study||2
10846214|NCT01411267|12012303|FG003|STARTED|Overall Study||5
10846215|NCT01411267|12012304|FG004|STARTED|Overall Study||2
10846216|NCT01411267|12012305|FG005|STARTED|Overall Study||12
10846217|NCT01411267|12012306|FG006|STARTED|Overall Study||0
10846218|NCT01411267|12012307|FG007|STARTED|Overall Study||0
10846219|NCT01411267|12012308|FG008|STARTED|Overall Study||0
10846220|NCT01411267|12012309|FG009|STARTED|Overall Study||0
10846221|NCT01411267|12012300|FG000|COMPLETED|Overall Study||0
10846222|NCT01411267|12012301|FG001|COMPLETED|Overall Study||3
10846223|NCT01411267|12012302|FG002|COMPLETED|Overall Study||2
10846224|NCT01411267|12012303|FG003|COMPLETED|Overall Study||4
10846225|NCT01411267|12012304|FG004|COMPLETED|Overall Study||0
10846226|NCT01411267|12012305|FG005|COMPLETED|Overall Study||10
10846227|NCT01411267|12012306|FG006|COMPLETED|Overall Study||0
10846228|NCT01411267|12012307|FG007|COMPLETED|Overall Study||0
10846229|NCT01411267|12012308|FG008|COMPLETED|Overall Study||0
10846230|NCT01411267|12012309|FG009|COMPLETED|Overall Study||0
10846231|NCT01411267|12012300|FG000|NOT COMPLETED|Overall Study||0
10846232|NCT01411267|12012301|FG001|NOT COMPLETED|Overall Study||0
10846233|NCT01411267|12012302|FG002|NOT COMPLETED|Overall Study||0
10846234|NCT01411267|12012303|FG003|NOT COMPLETED|Overall Study||1
10846235|NCT01411267|12012304|FG004|NOT COMPLETED|Overall Study||2
10846236|NCT01411267|12012305|FG005|NOT COMPLETED|Overall Study||2
10846237|NCT01411267|12012306|FG006|NOT COMPLETED|Overall Study||0
10846238|NCT01411267|12012307|FG007|NOT COMPLETED|Overall Study||0
10846239|NCT01411267|12012308|FG008|NOT COMPLETED|Overall Study||0
10846240|NCT01411267|12012309|FG009|NOT COMPLETED|Overall Study||0
10846241|NCT01336634|12012330|FG000|STARTED|Overall Study||84
10846242|NCT01336634|12012331|FG001|STARTED|Overall Study||57
10846243|NCT01336634|12012332|FG002|STARTED|Overall Study|includes 34 subjects from Cohort C and 2 subjects enrolled as protocol deviations from Cohort B.|36
10846244|NCT01336634|12012330|FG000|2nd Line Plus All Treated|Overall Study||78
10846245|NCT01336634|12012331|FG001|2nd Line Plus All Treated|Overall Study||57
10846246|NCT01336634|12012332|FG002|2nd Line Plus All Treated|Overall Study||0
10846247|NCT01336634|12012330|FG000|1st Line All Treated|Overall Study||6
10846248|NCT01336634|12012331|FG001|1st Line All Treated|Overall Study||2
10846249|NCT01336634|12012332|FG002|1st Line All Treated|Overall Study||34
10846250|NCT01336634|12012330|FG000|Crossover|Overall Study||20
10846251|NCT01336634|12012331|FG001|Crossover|Overall Study||0
10846252|NCT01336634|12012332|FG002|Crossover|Overall Study||0
10846253|NCT01336634|12012330|FG000|COMPLETED|Overall Study||70
10846254|NCT01336634|12012331|FG001|COMPLETED|Overall Study||49
10846255|NCT01336634|12012332|FG002|COMPLETED|Overall Study||27
10846256|NCT01336634|12012330|FG000|NOT COMPLETED|Overall Study||14
10846257|NCT01336634|12012331|FG001|NOT COMPLETED|Overall Study||8
10846258|NCT01336634|12012332|FG002|NOT COMPLETED|Overall Study||9
10846259|NCT01155375|12012345|FG000|STARTED|Overall Study||8
10846260|NCT01155375|12012346|FG001|STARTED|Overall Study||6
10846261|NCT01155375|12012345|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
10846262|NCT01155375|12012346|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
10846263|NCT01155375|12012345|FG000|COMPLETED|Overall Study||7
10846264|NCT01155375|12012346|FG001|COMPLETED|Overall Study||6
10846265|NCT01155375|12012345|FG000|NOT COMPLETED|Overall Study||1
10846266|NCT01155375|12012346|FG001|NOT COMPLETED|Overall Study||0
10846267|NCT00785798|12012353|FG000|STARTED|Overall Study||17
10846268|NCT00785798|12012353|FG000|COMPLETED|Overall Study||16
10846269|NCT00785798|12012353|FG000|NOT COMPLETED|Overall Study||1
10846270|NCT00628095|12012359|FG000|STARTED|Overall Study||53
10846271|NCT00628095|12012360|FG001|STARTED|Overall Study||47
10846272|NCT00628095|12012359|FG000|COMPLETED|Overall Study||46
10661238|NCT02257970|11823122|FG002|NOT COMPLETED|Part 1||0
10661239|NCT02257970|11823123|FG003|NOT COMPLETED|Part 1||0
10661240|NCT02257970|11823120|FG000|STARTED|Part 2||0
10661241|NCT02257970|11823121|FG001|STARTED|Part 2||23
10661243|NCT02257970|11823123|FG003|STARTED|Part 2||0
10661244|NCT02257970|11823120|FG000|COMPLETED|Part 2||0
10661245|NCT02257970|11823121|FG001|COMPLETED|Part 2||16
10661246|NCT02257970|11823122|FG002|COMPLETED|Part 2||0
10661247|NCT02257970|11823123|FG003|COMPLETED|Part 2||0
10661248|NCT02257970|11823120|FG000|NOT COMPLETED|Part 2||0
10661249|NCT02257970|11823121|FG001|NOT COMPLETED|Part 2||7
10292676|NCT02707055|11425482|FG000|STARTED|Phase 1||18
10292677|NCT02707055|11425483|FG001|STARTED|Phase 1||19
10292678|NCT02707055|11425482|FG000|COMPLETED|Phase 1||17
10292679|NCT02707055|11425483|FG001|COMPLETED|Phase 1||16
10292680|NCT02707055|11425482|FG000|NOT COMPLETED|Phase 1||1
10292681|NCT02707055|11425483|FG001|NOT COMPLETED|Phase 1||3
10292682|NCT02707055|11425482|FG000|STARTED|Washout Period||17
10292683|NCT02707055|11425483|FG001|STARTED|Washout Period||16
10292684|NCT02707055|11425482|FG000|COMPLETED|Washout Period||17
10292685|NCT02707055|11425483|FG001|COMPLETED|Washout Period||16
10292686|NCT02707055|11425482|FG000|NOT COMPLETED|Washout Period||0
10292687|NCT02707055|11425483|FG001|NOT COMPLETED|Washout Period||0
10292688|NCT02707055|11425482|FG000|STARTED|Phase 2||17
10292689|NCT02707055|11425483|FG001|STARTED|Phase 2||16
10292690|NCT02707055|11425482|FG000|COMPLETED|Phase 2||16
10292691|NCT02707055|11425483|FG001|COMPLETED|Phase 2||14
10292692|NCT02707055|11425482|FG000|NOT COMPLETED|Phase 2||1
10292693|NCT02707055|11425483|FG001|NOT COMPLETED|Phase 2||2
10292694|NCT02696759|11425489|FG000|STARTED|Overall Study||15
10292695|NCT02696759|11425489|FG000|COMPLETED|Overall Study||15
10292696|NCT02696759|11425489|FG000|NOT COMPLETED|Overall Study||0
10292697|NCT02656290|11425493|FG000|STARTED|Overall Study||26
10292698|NCT02656290|11425493|FG000|1 Year|Overall Study|One subject missed the 1 year follow-up visit.|25
10292699|NCT02656290|11425493|FG000|2 Year|Overall Study||17
10292700|NCT02656290|11425493|FG000|3 Year|Overall Study||6
10292701|NCT02656290|11425493|FG000|COMPLETED|Overall Study||0
10292702|NCT02656290|11425493|FG000|NOT COMPLETED|Overall Study||26
10292703|NCT02652130|11425497|FG000|STARTED|Overall Study||32
10292704|NCT02652130|11425497|FG000|COMPLETED|Overall Study||31
10412948|NCT00774800|11557067|FG000|STARTED|Intervention 4||22
10292705|NCT02652130|11425497|FG000|NOT COMPLETED|Overall Study||1
10292706|NCT02616393|11425504|FG000|STARTED|Overall Study||13
10292707|NCT02616393|11425505|FG001|STARTED|Overall Study||20
10292708|NCT02616393|11425506|FG002|STARTED|Overall Study||3
10661250|NCT02257970|11823122|FG002|NOT COMPLETED|Part 2||0
10661251|NCT02257970|11823123|FG003|NOT COMPLETED|Part 2||0
10661252|NCT02257970|11823120|FG000|STARTED|Part 3||0
10661253|NCT02257970|11823121|FG001|STARTED|Part 3||0
10846273|NCT00628095|12012360|FG001|COMPLETED|Overall Study||40
10846274|NCT00628095|12012359|FG000|NOT COMPLETED|Overall Study||7
10846275|NCT00628095|12012360|FG001|NOT COMPLETED|Overall Study||7
10846276|NCT04246021|12012368|FG000|STARTED|Overall Study||84
10846277|NCT04246021|12012368|FG000|COMPLETED|Overall Study||84
10846278|NCT04246021|12012368|FG000|NOT COMPLETED|Overall Study||0
10846279|NCT04098497|12012382|FG000|STARTED|Overall Study||30
10846280|NCT04098497|12012382|FG000|Initial Interview|Overall Study||30
10846281|NCT04098497|12012382|FG000|Set Up Study App|Overall Study||29
10846282|NCT04098497|12012382|FG000|Logged Symptoms Into Study App at Least Once|Overall Study||26
10846283|NCT04098497|12012382|FG000|Linked Fitbit to Study Database|Overall Study||27
10846284|NCT04098497|12012382|FG000|Used Fitbit|Overall Study||24
10846285|NCT04098497|12012382|FG000|Exit Interview|Overall Study||29
10846286|NCT04098497|12012382|FG000|COMPLETED|Overall Study||30
10846287|NCT04098497|12012382|FG000|NOT COMPLETED|Overall Study||0
10412949|NCT00774800|11557067|FG000|Received at Least One Dose of Study Drug|Intervention 4||21
10412950|NCT00774800|11557067|FG000|COMPLETED|Intervention 4||21
10412951|NCT00774800|11557067|FG000|NOT COMPLETED|Intervention 4||1
10412952|NCT00774852|11557079|FG000|STARTED|Overall Study||69
10412953|NCT00774852|11557080|FG001|STARTED|Overall Study||68
10412954|NCT00774852|11557079|FG000|COMPLETED|Overall Study||24
10412955|NCT00774852|11557080|FG001|COMPLETED|Overall Study||27
10412956|NCT00774852|11557079|FG000|NOT COMPLETED|Overall Study||45
10545245|NCT01495702|11698534|FG001|NOT COMPLETED|Extension Phase||0
10545246|NCT01495793|11698541|FG000|STARTED|Overall Study||24
10545247|NCT01495793|11698541|FG000|COMPLETED|Overall Study||22
10545248|NCT01495793|11698541|FG000|NOT COMPLETED|Overall Study||2
10545249|NCT01495819|11698545|FG000|STARTED|Overall Study||34
10545250|NCT01495819|11698545|FG000|Nicotine 0.0125|Overall Study||31
10545251|NCT01495819|11698545|FG000|Nicotine 0.025|Overall Study||32
10545252|NCT01495819|11698545|FG000|Nicotine 0.05|Overall Study||33
10545253|NCT01495819|11698545|FG000|Nicotine 0.1|Overall Study||31
10545254|NCT01495819|11698545|FG000|NIcotine 0.2|Overall Study||33
10545255|NCT01495819|11698545|FG000|COMPLETED|Overall Study||30
10545256|NCT01495819|11698545|FG000|NOT COMPLETED|Overall Study||4
10545257|NCT01495858|11698557|FG000|STARTED|Overall Study||107
10545258|NCT01495858|11698558|FG001|STARTED|Overall Study||106
10545259|NCT01495858|11698559|FG002|STARTED|Overall Study||54
10545260|NCT01495858|11698557|FG000|COMPLETED|Overall Study||107
10545261|NCT01495858|11698558|FG001|COMPLETED|Overall Study||106
10545262|NCT01495858|11698559|FG002|COMPLETED|Overall Study||54
10545263|NCT01495858|11698557|FG000|NOT COMPLETED|Overall Study||0
10545264|NCT01495858|11698558|FG001|NOT COMPLETED|Overall Study||0
10545265|NCT01495858|11698559|FG002|NOT COMPLETED|Overall Study||0
10545266|NCT01495923|11698569|FG000|STARTED|Overall Study||73
10846288|NCT03945825|12012392|FG000|STARTED|Overall Study||41
10846289|NCT03945825|12012393|FG001|STARTED|Overall Study||37
10846290|NCT03945825|12012394|FG002|STARTED|Overall Study||40
10846291|NCT03945825|12012395|FG003|STARTED|Overall Study||41
10846292|NCT03945825|12012396|FG004|STARTED|Overall Study||39
10846293|NCT03945825|12012397|FG005|STARTED|Overall Study||43
10846294|NCT03945825|12012392|FG000|COMPLETED|Overall Study||39
10846295|NCT03945825|12012393|FG001|COMPLETED|Overall Study||32
10846296|NCT03945825|12012394|FG002|COMPLETED|Overall Study||39
10846297|NCT03945825|12012395|FG003|COMPLETED|Overall Study||39
10846298|NCT03945825|12012396|FG004|COMPLETED|Overall Study||36
10846299|NCT03945825|12012397|FG005|COMPLETED|Overall Study||40
10846300|NCT03945825|12012392|FG000|NOT COMPLETED|Overall Study||2
10846301|NCT03945825|12012393|FG001|NOT COMPLETED|Overall Study||5
10846302|NCT03945825|12012394|FG002|NOT COMPLETED|Overall Study||1
10846303|NCT03945825|12012395|FG003|NOT COMPLETED|Overall Study||2
10846304|NCT03945825|12012396|FG004|NOT COMPLETED|Overall Study||3
10846305|NCT03945825|12012397|FG005|NOT COMPLETED|Overall Study||3
10846306|NCT03937141|12012420|FG000|STARTED|Overall Study||16
10846307|NCT03937141|12012420|FG000|COMPLETED|Overall Study||16
10846308|NCT03937141|12012420|FG000|NOT COMPLETED|Overall Study||0
10846309|NCT03678402|12012424|FG000|STARTED|Overall Study||521
10846310|NCT03678402|12012424|FG000|COMPLETED|Overall Study||521
10846311|NCT03678402|12012424|FG000|NOT COMPLETED|Overall Study||0
10846312|NCT03641937|12012428|FG000|STARTED|Overall Study||10
10846313|NCT03641937|12012428|FG000|COMPLETED|Overall Study||10
10846314|NCT03641937|12012428|FG000|NOT COMPLETED|Overall Study||0
10846315|NCT03572244|12012434|FG000|STARTED|Overall Study||6
10846316|NCT03572244|12012435|FG001|STARTED|Overall Study||6
10846317|NCT03572244|12012434|FG000|COMPLETED|Overall Study||6
10846318|NCT03572244|12012435|FG001|COMPLETED|Overall Study||6
10846319|NCT03572244|12012434|FG000|NOT COMPLETED|Overall Study||0
10846320|NCT03572244|12012435|FG001|NOT COMPLETED|Overall Study||0
10846321|NCT03562767|12012444|FG000|STARTED|Overall Study||10
10846322|NCT03562767|12012445|FG001|STARTED|Overall Study||10
10846323|NCT03562767|12012446|FG002|STARTED|Overall Study||0
10846324|NCT03562767|12012444|FG000|COMPLETED|Overall Study||7
10846325|NCT03562767|12012445|FG001|COMPLETED|Overall Study||7
10846326|NCT03562767|12012446|FG002|COMPLETED|Overall Study||0
10846327|NCT03562767|12012444|FG000|NOT COMPLETED|Overall Study||3
10846328|NCT03562767|12012445|FG001|NOT COMPLETED|Overall Study||3
10846329|NCT03562767|12012446|FG002|NOT COMPLETED|Overall Study||0
10846330|NCT03559699|12012458|FG000|STARTED|Overall Study||27
10846331|NCT03559699|12012458|FG000|COMPLETED|Overall Study||20
10846332|NCT03559699|12012458|FG000|NOT COMPLETED|Overall Study||7
10846333|NCT03333057|12012465|FG000|STARTED|Overall Study||111
10846334|NCT03333057|12012466|FG001|STARTED|Overall Study||114
10846335|NCT03333057|12012467|FG002|STARTED|Overall Study||111
10846336|NCT03333057|12012465|FG000|COMPLETED|Overall Study||105
10846337|NCT03333057|12012466|FG001|COMPLETED|Overall Study||110
10846338|NCT03333057|12012467|FG002|COMPLETED|Overall Study||108
10846339|NCT03333057|12012465|FG000|NOT COMPLETED|Overall Study||6
10846340|NCT03333057|12012466|FG001|NOT COMPLETED|Overall Study||4
10846341|NCT03333057|12012467|FG002|NOT COMPLETED|Overall Study||3
10846342|NCT03305016|12012475|FG000|STARTED|Overall Study||146
10846343|NCT03305016|12012475|FG000|COMPLETED|Overall Study||144
10846344|NCT03305016|12012475|FG000|NOT COMPLETED|Overall Study||2
10846345|NCT03300336|12012481|FG000|STARTED|Overall Study||7267
10846346|NCT03300336|12012482|FG001|STARTED|Overall Study||6859
10846347|NCT03300336|12012481|FG000|COMPLETED|Overall Study||7267
10846348|NCT03300336|12012482|FG001|COMPLETED|Overall Study||6859
10846349|NCT03300336|12012481|FG000|NOT COMPLETED|Overall Study||0
10846350|NCT03300336|12012482|FG001|NOT COMPLETED|Overall Study||0
10846351|NCT03291067|12012492|FG000|STARTED|Overall Study||94
10846352|NCT03291067|12012493|FG001|STARTED|Overall Study||92
10846353|NCT03291067|12012494|FG002|STARTED|Overall Study||94
10846354|NCT03291067|12012495|FG003|STARTED|Overall Study||94
10846355|NCT03291067|12012492|FG000|Treated|Overall Study||95
10846356|NCT03291067|12012493|FG001|Treated|Overall Study||90
10846357|NCT03291067|12012494|FG002|Treated|Overall Study||93
10846358|NCT03291067|12012495|FG003|Treated|Overall Study||90
10292709|NCT02616393|11425504|FG000|COMPLETED|Overall Study||0
10846359|NCT03291067|12012492|FG000|COMPLETED|Overall Study||84
10846360|NCT03291067|12012493|FG001|COMPLETED|Overall Study||78
10846361|NCT03291067|12012494|FG002|COMPLETED|Overall Study||61
10846362|NCT03291067|12012495|FG003|COMPLETED|Overall Study||77
10846363|NCT03291067|12012492|FG000|NOT COMPLETED|Overall Study||10
10846364|NCT03291067|12012493|FG001|NOT COMPLETED|Overall Study||14
10846365|NCT03291067|12012494|FG002|NOT COMPLETED|Overall Study||33
10292710|NCT02616393|11425505|FG001|COMPLETED|Overall Study||0
10292711|NCT02616393|11425506|FG002|COMPLETED|Overall Study||0
10846366|NCT03291067|12012495|FG003|NOT COMPLETED|Overall Study||17
10846367|NCT03271047|12012509|FG000|STARTED|Phase 1b: Dose Finding Period||10
10846368|NCT03271047|12012510|FG001|STARTED|Phase 1b: Dose Finding Period||11
10846369|NCT03271047|12012511|FG002|STARTED|Phase 1b: Dose Finding Period||0
10846370|NCT03271047|12012512|FG003|STARTED|Phase 1b: Dose Finding Period||0
10846371|NCT03271047|12012509|FG000|COMPLETED|Phase 1b: Dose Finding Period||0
10846372|NCT03271047|12012510|FG001|COMPLETED|Phase 1b: Dose Finding Period||0
10846373|NCT03271047|12012511|FG002|COMPLETED|Phase 1b: Dose Finding Period||0
10846374|NCT03271047|12012512|FG003|COMPLETED|Phase 1b: Dose Finding Period||0
10846375|NCT03271047|12012509|FG000|NOT COMPLETED|Phase 1b: Dose Finding Period||10
10846376|NCT03271047|12012510|FG001|NOT COMPLETED|Phase 1b: Dose Finding Period||11
10846377|NCT03271047|12012511|FG002|NOT COMPLETED|Phase 1b: Dose Finding Period||0
10846378|NCT03271047|12012512|FG003|NOT COMPLETED|Phase 1b: Dose Finding Period||0
10846379|NCT03271047|12012509|FG000|STARTED|Randomized Phase 2 Period||0
10846380|NCT03271047|12012510|FG001|STARTED|Randomized Phase 2 Period||0
10846381|NCT03271047|12012511|FG002|STARTED|Randomized Phase 2 Period|Participants randomized to Phase 2 of the study.|27
10846382|NCT03271047|12012512|FG003|STARTED|Randomized Phase 2 Period|Participants randomized to Phase 2 of the study.|27
10846383|NCT03271047|12012509|FG000|COMPLETED|Randomized Phase 2 Period||0
10846384|NCT03271047|12012510|FG001|COMPLETED|Randomized Phase 2 Period||0
10846385|NCT03271047|12012511|FG002|COMPLETED|Randomized Phase 2 Period||0
10846386|NCT03271047|12012512|FG003|COMPLETED|Randomized Phase 2 Period||0
10846387|NCT03271047|12012509|FG000|NOT COMPLETED|Randomized Phase 2 Period||0
10846388|NCT03271047|12012510|FG001|NOT COMPLETED|Randomized Phase 2 Period||0
10846389|NCT03271047|12012511|FG002|NOT COMPLETED|Randomized Phase 2 Period||27
10846390|NCT03271047|12012512|FG003|NOT COMPLETED|Randomized Phase 2 Period||27
10846391|NCT03257436|12012524|FG000|STARTED|Overall Study||584
10846392|NCT03257436|12012524|FG000|COMPLETED|Overall Study||489
10846393|NCT03257436|12012524|FG000|NOT COMPLETED|Overall Study||95
10846394|NCT03171480|12012530|FG000|STARTED|Overall Study||89
10846395|NCT03171480|12012531|FG001|STARTED|Overall Study||87
10846396|NCT03171480|12012530|FG000|COMPLETED|Overall Study||89
10846397|NCT03171480|12012531|FG001|COMPLETED|Overall Study||87
10846398|NCT03171480|12012530|FG000|NOT COMPLETED|Overall Study||0
10846399|NCT03171480|12012531|FG001|NOT COMPLETED|Overall Study||0
10846400|NCT03158285|12012541|FG000|STARTED|Placebo-controlled Period: Week 0 - 24||246
10846401|NCT03158285|12012542|FG001|STARTED|Placebo-controlled Period: Week 0 - 24||248
10846402|NCT03158285|12012543|FG002|STARTED|Placebo-controlled Period: Week 0 - 24||245
10846403|NCT03158285|12012541|FG000|Pooled Population: Enthesitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (255) = 77 (CNTO1959PSA3001[NCT03162796]) + 178 (CNTO1959PSA3002)|255
10846404|NCT03158285|12012542|FG001|Pooled Population: Enthesitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (230)= 72 (CNTO1959PSA3001) + 158 (CNTO1959PSA3002)|230
10846405|NCT03158285|12012543|FG002|Pooled Population: Enthesitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (243)= 73 (CNTO1959PSA3001) + 170 (CNTO1959PSA3002)|243
10846406|NCT03158285|12012541|FG000|Pooled Population: Dactylitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (154) = 55 (CNTO1959PSA3001) + 99 (CNTO1959PSA3002)|154
10846407|NCT03158285|12012542|FG001|Pooled Population: Dactylitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (160) = 49 (CNTO1959PSA3001) + 111 (CNTO1959PSA3002)|160
10846408|NCT03158285|12012543|FG002|Pooled Population: Dactylitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (159) = 38 (CNTO1959PSA3001) + 121 (CNTO1959PSA3002)|159
10846409|NCT03158285|12012541|FG000|COMPLETED|Placebo-controlled Period: Week 0 - 24||240
10846410|NCT03158285|12012542|FG001|COMPLETED|Placebo-controlled Period: Week 0 - 24||240
10846411|NCT03158285|12012543|FG002|COMPLETED|Placebo-controlled Period: Week 0 - 24||236
10846412|NCT03158285|12012541|FG000|NOT COMPLETED|Placebo-controlled Period: Week 0 - 24||6
10846413|NCT03158285|12012542|FG001|NOT COMPLETED|Placebo-controlled Period: Week 0 - 24||8
10846414|NCT03158285|12012543|FG002|NOT COMPLETED|Placebo-controlled Period: Week 0 - 24||9
10846415|NCT03158285|12012541|FG000|STARTED|Active Treatment Period: Week 24 - 52|2 participants did not enter the active treatment.|238
10846416|NCT03158285|12012542|FG001|STARTED|Active Treatment Period: Week 24 - 52||240
10846417|NCT03158285|12012543|FG002|STARTED|Active Treatment Period: Week 24 - 52|2 participants did not enter the active treatment.|234
10846418|NCT03158285|12012541|FG000|COMPLETED|Active Treatment Period: Week 24 - 52||228
10846419|NCT03158285|12012542|FG001|COMPLETED|Active Treatment Period: Week 24 - 52||234
10846420|NCT03158285|12012543|FG002|COMPLETED|Active Treatment Period: Week 24 - 52||227
10846421|NCT03158285|12012541|FG000|NOT COMPLETED|Active Treatment Period: Week 24 - 52||10
10846422|NCT03158285|12012542|FG001|NOT COMPLETED|Active Treatment Period: Week 24 - 52||6
10846423|NCT03158285|12012543|FG002|NOT COMPLETED|Active Treatment Period: Week 24 - 52||7
10846424|NCT03158285|12012541|FG000|STARTED|Active Treatment Period: Week 52-100||228
10846425|NCT03158285|12012542|FG001|STARTED|Active Treatment Period: Week 52-100|2 participants did not enter the active treatment.|232
10846426|NCT03158285|12012543|FG002|STARTED|Active Treatment Period: Week 52-100||227
10846427|NCT03158285|12012541|FG000|COMPLETED|Active Treatment Period: Week 52-100||210
10846428|NCT03158285|12012542|FG001|COMPLETED|Active Treatment Period: Week 52-100||223
10846429|NCT03158285|12012543|FG002|COMPLETED|Active Treatment Period: Week 52-100||219
10412957|NCT00774852|11557080|FG001|NOT COMPLETED|Overall Study||41
10412958|NCT00774930|11557098|FG000|STARTED|DB Phase|One subject was randomised to receive lanreotide Autogel, but erroneously received placebo.|59
10412959|NCT00774930|11557099|FG001|STARTED|DB Phase|One subject was randomised to receive lanreotide Autogel, but erroneously received placebo.|56
10412960|NCT00774930|11557098|FG000|COMPLETED|DB Phase|Received 4 DB study injections AND continued to IOL phase OR|45
10412961|NCT00774930|11557099|FG001|COMPLETED|DB Phase|had diary data at least up to day 21 after 4th dose, regardless of missing diary data before day 21.|34
10412962|NCT00774930|11557098|FG000|NOT COMPLETED|DB Phase||14
10412963|NCT00774930|11557099|FG001|NOT COMPLETED|DB Phase||22
10412964|NCT00774930|11557098|FG000|STARTED|IOL Phase||56
10412965|NCT00774930|11557099|FG001|STARTED|IOL Phase|Includes 1 subject listed as completing and withdrawing from the DB phase due to brain radiation|46
10412966|NCT00774930|11557098|FG000|COMPLETED|IOL Phase||43
10412967|NCT00774930|11557099|FG001|COMPLETED|IOL Phase||37
10412968|NCT00774930|11557098|FG000|NOT COMPLETED|IOL Phase||13
10412969|NCT00774930|11557099|FG001|NOT COMPLETED|IOL Phase||9
10412970|NCT00774930|11557098|FG000|STARTED|LTOLE Phase|24 subjects from IOL did not enter LTOLE (11 completed IOL, 13 did not complete IOL).|32
10846430|NCT03158285|12012541|FG000|NOT COMPLETED|Active Treatment Period: Week 52-100||18
10846431|NCT03158285|12012542|FG001|NOT COMPLETED|Active Treatment Period: Week 52-100||9
10846432|NCT03158285|12012543|FG002|NOT COMPLETED|Active Treatment Period: Week 52-100||8
10846433|NCT04723173|12012556|FG000|STARTED|Measure of Detection Threshold (in dB)||10
10846434|NCT04723173|12012556|FG000|Feature for Soft Sounds On|Measure of Detection Threshold (in dB)||10
10846435|NCT04723173|12012556|FG000|Feature for Soft Sounds Off|Measure of Detection Threshold (in dB)||10
10846436|NCT04723173|12012556|FG000|COMPLETED|Measure of Detection Threshold (in dB)||10
10846437|NCT04723173|12012556|FG000|NOT COMPLETED|Measure of Detection Threshold (in dB)||0
10846438|NCT04723173|12012556|FG000|STARTED|Subjective Listening Effort Scaling|The test in this test period is independent (also temporally) from the previous test period. That is the reason, why the number of participants, who started this test period is lesser than the number of participants, who completed the previous period.|9
10846439|NCT04723173|12012556|FG000|DNC on|Subjective Listening Effort Scaling||9
10846440|NCT04723173|12012556|FG000|DNC Off|Subjective Listening Effort Scaling||9
10846441|NCT04723173|12012556|FG000|COMPLETED|Subjective Listening Effort Scaling||8
10846442|NCT04723173|12012556|FG000|NOT COMPLETED|Subjective Listening Effort Scaling||1
10846443|NCT04723173|12012556|FG000|STARTED|Subjective Ratings of Sound Samples|The test in this test period is independent (also temporal) from the previous test period. That is the reason, why the number of participants, who started this test period is greater than the number of participants, who completed the previous period.|9
10846444|NCT04723173|12012556|FG000|DNC on|Subjective Ratings of Sound Samples||9
10846445|NCT04723173|12012556|FG000|DNC Off|Subjective Ratings of Sound Samples||9
10846446|NCT04723173|12012556|FG000|COMPLETED|Subjective Ratings of Sound Samples|"All participants completed this study period, but just the results of 8 participants could be used.~This was because technical issues limited the reliability of the measures made for one participant.~N.B. this test was independent from the other tests in the study. Therefore the results are not influenced by other test periods. The number of people included in the analysis described here relates only to this test."|9
10846447|NCT04723173|12012556|FG000|NOT COMPLETED|Subjective Ratings of Sound Samples||0
10846448|NCT04552470|12012572|FG000|STARTED|Overall Study||9
10846449|NCT04552470|12012573|FG001|STARTED|Overall Study||10
10846450|NCT04552470|12012574|FG002|STARTED|Overall Study||9
10846451|NCT04552470|12012575|FG003|STARTED|Overall Study||9
10846452|NCT04552470|12012572|FG000|COMPLETED|Overall Study||9
10846453|NCT04552470|12012573|FG001|COMPLETED|Overall Study||10
10846454|NCT04552470|12012574|FG002|COMPLETED|Overall Study||9
10846455|NCT04552470|12012575|FG003|COMPLETED|Overall Study||9
10846456|NCT04552470|12012572|FG000|NOT COMPLETED|Overall Study||0
10846457|NCT04552470|12012573|FG001|NOT COMPLETED|Overall Study||0
10846458|NCT04552470|12012574|FG002|NOT COMPLETED|Overall Study||0
10846459|NCT04552470|12012575|FG003|NOT COMPLETED|Overall Study||0
10846460|NCT04251884|12012590|FG000|STARTED|Overall Study||23
10846461|NCT04251884|12012591|FG001|STARTED|Overall Study||26
10846462|NCT04251884|12012590|FG000|COMPLETED|Overall Study||23
10846463|NCT04251884|12012591|FG001|COMPLETED|Overall Study||26
10846464|NCT04251884|12012590|FG000|NOT COMPLETED|Overall Study||0
10846465|NCT04251884|12012591|FG001|NOT COMPLETED|Overall Study||0
10846466|NCT03683823|12012600|FG000|STARTED|Post-treatment Assessment||11
10846467|NCT03683823|12012601|FG001|STARTED|Post-treatment Assessment||10
10846468|NCT03683823|12012600|FG000|COMPLETED|Post-treatment Assessment||10
10846469|NCT03683823|12012601|FG001|COMPLETED|Post-treatment Assessment||8
10846470|NCT03683823|12012600|FG000|NOT COMPLETED|Post-treatment Assessment||1
10846471|NCT03683823|12012601|FG001|NOT COMPLETED|Post-treatment Assessment||2
10846472|NCT03683823|12012600|FG000|STARTED|1-week Follow-up||10
10846473|NCT03683823|12012601|FG001|STARTED|1-week Follow-up||8
10846474|NCT03683823|12012600|FG000|COMPLETED|1-week Follow-up||9
10846475|NCT03683823|12012601|FG001|COMPLETED|1-week Follow-up||7
10846476|NCT03683823|12012600|FG000|NOT COMPLETED|1-week Follow-up||1
10846477|NCT03683823|12012601|FG001|NOT COMPLETED|1-week Follow-up||1
10846478|NCT03546439|12012610|FG000|STARTED|Overall Study||203
10846479|NCT03546439|12012611|FG001|STARTED|Overall Study||156
10846480|NCT03546439|12012612|FG002|STARTED|Overall Study||75
10846481|NCT03546439|12012610|FG000|COMPLETED|Overall Study||203
10846482|NCT03546439|12012611|FG001|COMPLETED|Overall Study||156
10846483|NCT03546439|12012612|FG002|COMPLETED|Overall Study||75
10846484|NCT03546439|12012610|FG000|NOT COMPLETED|Overall Study||0
10846485|NCT03546439|12012611|FG001|NOT COMPLETED|Overall Study||0
10846486|NCT03546439|12012612|FG002|NOT COMPLETED|Overall Study||0
10846487|NCT03515551|12012627|FG000|STARTED|Overall Study||4
10846488|NCT03515551|12012628|FG001|STARTED|Overall Study||3
10846489|NCT03515551|12012629|FG002|STARTED|Overall Study||5
10846490|NCT03515551|12012630|FG003|STARTED|Overall Study||3
10846491|NCT03515551|12012631|FG004|STARTED|Overall Study|1 participant from the 10 mcg cohort was sequentially enrolled in the 30-100 mcg cohort and is counted as starting in both columns; reason for study discontinuation recorded as part of 30-100 mcg cohort.|5
10846492|NCT03515551|12012632|FG005|STARTED|Overall Study||4
10846493|NCT03515551|12012633|FG006|STARTED|Overall Study||5
10846494|NCT03515551|12012627|FG000|COMPLETED|Overall Study||0
10846495|NCT03515551|12012628|FG001|COMPLETED|Overall Study||0
10846496|NCT03515551|12012629|FG002|COMPLETED|Overall Study||0
10846497|NCT03515551|12012630|FG003|COMPLETED|Overall Study||0
10846498|NCT03515551|12012631|FG004|COMPLETED|Overall Study||0
10846499|NCT03515551|12012632|FG005|COMPLETED|Overall Study||0
10846500|NCT03515551|12012633|FG006|COMPLETED|Overall Study||0
10846501|NCT03515551|12012627|FG000|NOT COMPLETED|Overall Study||4
10846502|NCT03515551|12012628|FG001|NOT COMPLETED|Overall Study||3
10846503|NCT03515551|12012629|FG002|NOT COMPLETED|Overall Study||5
10846504|NCT03515551|12012630|FG003|NOT COMPLETED|Overall Study||3
10846505|NCT03515551|12012631|FG004|NOT COMPLETED|Overall Study||5
10429231|NCT00862849|11575291|FG005|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
10846506|NCT03515551|12012632|FG005|NOT COMPLETED|Overall Study||4
10846507|NCT03515551|12012633|FG006|NOT COMPLETED|Overall Study||5
10846508|NCT03385265|12012658|FG000|STARTED|Overall Study||20
10846509|NCT03385265|12012659|FG001|STARTED|Overall Study||11
10846510|NCT03385265|12012660|FG002|STARTED|Overall Study||20
10846511|NCT03385265|12012661|FG003|STARTED|Overall Study||11
10846512|NCT03385265|12012658|FG000|COMPLETED|Overall Study|this is Time 3 or 33 weeks post-baseline|15
10846513|NCT03385265|12012659|FG001|COMPLETED|Overall Study|this is Time 3 or 33 weeks post-baseline|9
10846514|NCT03385265|12012660|FG002|COMPLETED|Overall Study|this is Time 3 or 33 weeks post-baseline|15
10846515|NCT03385265|12012661|FG003|COMPLETED|Overall Study|this is Time 3 or 33 weeks post-baseline|9
10846516|NCT03385265|12012658|FG000|NOT COMPLETED|Overall Study||5
10846517|NCT03385265|12012659|FG001|NOT COMPLETED|Overall Study||2
10846518|NCT03385265|12012660|FG002|NOT COMPLETED|Overall Study||5
10846519|NCT03385265|12012661|FG003|NOT COMPLETED|Overall Study||2
10846520|NCT03316807|12012675|FG000|STARTED|Overall Study||91
10846521|NCT03316807|12012676|FG001|STARTED|Overall Study||91
10846522|NCT03316807|12012675|FG000|COMPLETED|Overall Study||60
10846523|NCT03316807|12012676|FG001|COMPLETED|Overall Study||65
10846524|NCT03316807|12012675|FG000|NOT COMPLETED|Overall Study||31
10846525|NCT03316807|12012676|FG001|NOT COMPLETED|Overall Study||26
10846526|NCT03138538|12012688|FG000|STARTED|Overall Study||3
10846527|NCT03138538|12012689|FG001|STARTED|Overall Study||3
10846528|NCT03138538|12012690|FG002|STARTED|Overall Study||3
10846529|NCT03138538|12012691|FG003|STARTED|Overall Study||8
10846530|NCT03138538|12012692|FG004|STARTED|Overall Study||7
10846531|NCT03138538|12012693|FG005|STARTED|Overall Study||3
10846532|NCT03138538|12012688|FG000|COMPLETED|Overall Study||3
10846533|NCT03138538|12012689|FG001|COMPLETED|Overall Study||3
10846534|NCT03138538|12012690|FG002|COMPLETED|Overall Study||3
10846535|NCT03138538|12012691|FG003|COMPLETED|Overall Study||8
10846536|NCT03138538|12012692|FG004|COMPLETED|Overall Study||7
10846537|NCT03138538|12012693|FG005|COMPLETED|Overall Study||3
10846538|NCT03138538|12012688|FG000|NOT COMPLETED|Overall Study||0
10846539|NCT03138538|12012689|FG001|NOT COMPLETED|Overall Study||0
10846540|NCT03138538|12012690|FG002|NOT COMPLETED|Overall Study||0
10846541|NCT03138538|12012691|FG003|NOT COMPLETED|Overall Study||0
10846542|NCT03138538|12012692|FG004|NOT COMPLETED|Overall Study||0
10846543|NCT03138538|12012693|FG005|NOT COMPLETED|Overall Study||0
10846544|NCT02919306|12012714|FG000|STARTED|Overall Study||18
10846545|NCT02919306|12012715|FG001|STARTED|Overall Study||9
10846546|NCT02919306|12012714|FG000|COMPLETED|Overall Study||16
10846547|NCT02919306|12012715|FG001|COMPLETED|Overall Study||9
10846548|NCT02919306|12012714|FG000|NOT COMPLETED|Overall Study||2
10846549|NCT02919306|12012715|FG001|NOT COMPLETED|Overall Study||0
10846550|NCT02763189|12012723|FG000|STARTED|Overall Study||4
10412971|NCT00774930|11557099|FG001|STARTED|LTOLE Phase|20 subjects from IOL did not enter LTOLE (12 completed IOL, 8 did not complete IOL).|25
10412972|NCT00774930|11557098|FG000|COMPLETED|LTOLE Phase||17
10412973|NCT00774930|11557099|FG001|COMPLETED|LTOLE Phase||8
10412974|NCT00774930|11557098|FG000|NOT COMPLETED|LTOLE Phase||15
10412975|NCT00774930|11557099|FG001|NOT COMPLETED|LTOLE Phase||17
10412976|NCT00774995|11557111|FG000|STARTED|Overall Study||9
10412977|NCT00774995|11557112|FG001|STARTED|Overall Study||16
10412978|NCT00774995|11557113|FG002|STARTED|Overall Study||8
10412979|NCT00774995|11557114|FG003|STARTED|Overall Study||16
10412980|NCT00774995|11557111|FG000|COMPLETED|Overall Study||9
10412981|NCT00774995|11557112|FG001|COMPLETED|Overall Study||16
10412982|NCT00774995|11557113|FG002|COMPLETED|Overall Study||7
10412983|NCT00774995|11557114|FG003|COMPLETED|Overall Study||16
10412984|NCT00774995|11557111|FG000|NOT COMPLETED|Overall Study||0
10412985|NCT00774995|11557112|FG001|NOT COMPLETED|Overall Study||0
10412986|NCT00774995|11557113|FG002|NOT COMPLETED|Overall Study||1
10412987|NCT00774995|11557114|FG003|NOT COMPLETED|Overall Study||0
10412988|NCT00775021|11557124|FG000|STARTED|First Intervention||63
10412989|NCT00775021|11557125|FG001|STARTED|First Intervention||60
10412990|NCT00775021|11557124|FG000|COMPLETED|First Intervention||62
10412991|NCT00775021|11557125|FG001|COMPLETED|First Intervention||60
10412992|NCT00775021|11557124|FG000|NOT COMPLETED|First Intervention||1
10412993|NCT00775021|11557125|FG001|NOT COMPLETED|First Intervention||0
10412994|NCT00775021|11557124|FG000|STARTED|Second Intervention||62
10412995|NCT00775021|11557125|FG001|STARTED|Second Intervention||60
10412996|NCT00775021|11557124|FG000|COMPLETED|Second Intervention||62
10412997|NCT00775021|11557125|FG001|COMPLETED|Second Intervention||59
10412998|NCT00775021|11557124|FG000|NOT COMPLETED|Second Intervention||0
10412999|NCT00775021|11557125|FG001|NOT COMPLETED|Second Intervention||1
10413000|NCT00775138|11557135|FG000|STARTED|Overall Study||24
10413001|NCT00775138|11557136|FG001|STARTED|Overall Study||10
10413002|NCT00775138|11557137|FG002|STARTED|Overall Study||20
10413003|NCT00775138|11557138|FG003|STARTED|Overall Study||10
10413004|NCT00775138|11557135|FG000|COMPLETED|Overall Study||24
10413005|NCT00775138|11557136|FG001|COMPLETED|Overall Study||10
10413006|NCT00775138|11557137|FG002|COMPLETED|Overall Study||17
10413007|NCT00775138|11557138|FG003|COMPLETED|Overall Study||8
10413008|NCT00775138|11557135|FG000|NOT COMPLETED|Overall Study||0
10413009|NCT00775138|11557136|FG001|NOT COMPLETED|Overall Study||0
10413010|NCT00775138|11557137|FG002|NOT COMPLETED|Overall Study||3
10413011|NCT00775138|11557138|FG003|NOT COMPLETED|Overall Study||2
10846551|NCT02763189|12012724|FG001|STARTED|Overall Study||4
10846552|NCT02763189|12012723|FG000|COMPLETED|Overall Study||4
10846553|NCT02763189|12012724|FG001|COMPLETED|Overall Study||2
10846554|NCT02763189|12012723|FG000|NOT COMPLETED|Overall Study||0
10846555|NCT02763189|12012724|FG001|NOT COMPLETED|Overall Study||2
10846556|NCT02700945|12012732|FG000|STARTED|Overall Study||242
10413012|NCT00775203|11557152|FG000|STARTED|Overall Study||206
10413013|NCT00775203|11557153|FG001|STARTED|Overall Study||206
10413014|NCT00775203|11557152|FG000|Received Study Medication|Overall Study||202
10413015|NCT00775203|11557153|FG001|Received Study Medication|Overall Study||204
10413016|NCT00775203|11557152|FG000|COMPLETED|Overall Study||144
10413017|NCT00775203|11557153|FG001|COMPLETED|Overall Study||163
10413018|NCT00775203|11557152|FG000|NOT COMPLETED|Overall Study||62
10413019|NCT00775203|11557153|FG001|NOT COMPLETED|Overall Study||43
10413020|NCT00775229|11557161|FG000|STARTED|Overall Study||25
10413021|NCT00775229|11557162|FG001|STARTED|Overall Study||26
10413022|NCT00775229|11557161|FG000|COMPLETED|Overall Study||20
10846557|NCT02700945|12012733|FG001|STARTED|Overall Study||250
10846558|NCT02700945|12012732|FG000|COMPLETED|Overall Study||210
10846559|NCT02700945|12012733|FG001|COMPLETED|Overall Study||207
10846560|NCT02700945|12012732|FG000|NOT COMPLETED|Overall Study||32
10846561|NCT02700945|12012733|FG001|NOT COMPLETED|Overall Study||43
10846562|NCT02659514|12012741|FG000|STARTED|Overall Study||33
10846563|NCT02659514|12012742|FG001|STARTED|Overall Study||34
10545267|NCT01495923|11698570|FG001|STARTED|Overall Study||72
10545268|NCT01495923|11698569|FG000|COMPLETED|Overall Study||73
10545269|NCT01495923|11698570|FG001|COMPLETED|Overall Study||72
10545270|NCT01495923|11698569|FG000|NOT COMPLETED|Overall Study||0
10545271|NCT01495923|11698570|FG001|NOT COMPLETED|Overall Study||0
10846564|NCT02659514|12012741|FG000|Safety Population|Overall Study||33
10846565|NCT02659514|12012742|FG001|Safety Population|Overall Study||34
10846566|NCT02659514|12012741|FG000|Evaluable Population|Overall Study||30
10846567|NCT02659514|12012742|FG001|Evaluable Population|Overall Study||27
10846568|NCT02659514|12012741|FG000|COMPLETED|Overall Study||1
10846569|NCT02659514|12012742|FG001|COMPLETED|Overall Study||0
10846570|NCT02659514|12012741|FG000|NOT COMPLETED|Overall Study||32
10846571|NCT02659514|12012742|FG001|NOT COMPLETED|Overall Study||34
10413023|NCT00775229|11557162|FG001|COMPLETED|Overall Study||24
10413024|NCT00775229|11557161|FG000|NOT COMPLETED|Overall Study||5
10413025|NCT00775229|11557162|FG001|NOT COMPLETED|Overall Study||2
10413026|NCT00775268|11557170|FG000|STARTED|Baseline||9
10413027|NCT00775268|11557171|FG001|STARTED|Baseline||22
10413028|NCT00775268|11557170|FG000|COMPLETED|Baseline||8
10413029|NCT00775268|11557171|FG001|COMPLETED|Baseline||21
10413030|NCT00775268|11557170|FG000|NOT COMPLETED|Baseline||1
10413031|NCT00775268|11557171|FG001|NOT COMPLETED|Baseline||1
10413032|NCT00775268|11557170|FG000|STARTED|After 2 Cycles||8
10413033|NCT00775268|11557171|FG001|STARTED|After 2 Cycles|These 21 patients were not scanned after 2-cycles in this Arm. They were only scanned at baseline.|0
10413034|NCT00775268|11557170|FG000|COMPLETED|After 2 Cycles||7
10413035|NCT00775268|11557171|FG001|COMPLETED|After 2 Cycles||0
10413036|NCT00775268|11557170|FG000|NOT COMPLETED|After 2 Cycles||1
10413037|NCT00775268|11557171|FG001|NOT COMPLETED|After 2 Cycles||0
10413038|NCT00775268|11557170|FG000|STARTED|After Completion||7
10413039|NCT00775268|11557171|FG001|STARTED|After Completion||0
10413040|NCT00775268|11557170|FG000|COMPLETED|After Completion||6
10413041|NCT00775268|11557171|FG001|COMPLETED|After Completion||0
10413042|NCT00775268|11557170|FG000|NOT COMPLETED|After Completion||1
10413043|NCT00775268|11557171|FG001|NOT COMPLETED|After Completion||0
10413044|NCT00775346|11557188|FG000|STARTED|Overall Study||92
10413045|NCT00775346|11557188|FG000|COMPLETED|Overall Study||92
10413046|NCT00775346|11557188|FG000|NOT COMPLETED|Overall Study||0
10413047|NCT00775411|11557192|FG000|STARTED|Overall Study||44
10413048|NCT00775411|11557192|FG000|COMPLETED|Overall Study||43
10413049|NCT00775411|11557192|FG000|NOT COMPLETED|Overall Study||1
10545272|NCT01495975|11698580|FG000|STARTED|Overall Study||15
10846626|NCT01673867|12012790|FG000|STARTED|Randomization||292
10846627|NCT01673867|12012791|FG001|STARTED|Randomization||290
10846628|NCT01673867|12012790|FG000|COMPLETED|Randomization||287
10846629|NCT01673867|12012791|FG001|COMPLETED|Randomization||268
10846630|NCT01673867|12012790|FG000|NOT COMPLETED|Randomization||5
10846631|NCT01673867|12012791|FG001|NOT COMPLETED|Randomization||22
10846632|NCT01673867|12012790|FG000|STARTED|Treatment||287
10846633|NCT01673867|12012791|FG001|STARTED|Treatment||268
10846634|NCT01673867|12012790|FG000|COMPLETED|Treatment||43
10846635|NCT01673867|12012791|FG001|COMPLETED|Treatment||0
10846636|NCT01673867|12012790|FG000|NOT COMPLETED|Treatment||244
10846637|NCT01673867|12012791|FG001|NOT COMPLETED|Treatment||268
10846638|NCT01182727|12012797|FG000|STARTED|Overall Study||10
10846639|NCT01182727|12012797|FG000|COMPLETED|Overall Study||10
10846640|NCT01182727|12012797|FG000|NOT COMPLETED|Overall Study||0
10846641|NCT00335777|12012801|FG000|STARTED|Enrolled and Dispensed Study Medication|64 subjects enrolled. 35 treated 2 headaches, but 22/35 at appropriate times, as per protocol.|64
10846642|NCT00335777|12012801|FG000|COMPLETED|Enrolled and Dispensed Study Medication||35
10846643|NCT00335777|12012801|FG000|NOT COMPLETED|Enrolled and Dispensed Study Medication||29
10846644|NCT00335777|12012801|FG000|STARTED|Treated 2 Headaches Per Protocol||35
10846645|NCT00335777|12012801|FG000|COMPLETED|Treated 2 Headaches Per Protocol||22
10846646|NCT00335777|12012801|FG000|NOT COMPLETED|Treated 2 Headaches Per Protocol||13
10846647|NCT00159588|12012809|FG000|STARTED|5 Month Follow-up||19
10846648|NCT00159588|12012810|FG001|STARTED|5 Month Follow-up||22
10846649|NCT00159588|12012811|FG002|STARTED|5 Month Follow-up||20
10846650|NCT00159588|12012809|FG000|COMPLETED|5 Month Follow-up||17
10846651|NCT00159588|12012810|FG001|COMPLETED|5 Month Follow-up||18
10846652|NCT00159588|12012811|FG002|COMPLETED|5 Month Follow-up||18
10846653|NCT00159588|12012809|FG000|NOT COMPLETED|5 Month Follow-up||2
10846654|NCT00159588|12012810|FG001|NOT COMPLETED|5 Month Follow-up||4
10846655|NCT00159588|12012811|FG002|NOT COMPLETED|5 Month Follow-up||2
10846656|NCT00159588|12012809|FG000|STARTED|1-year Follow-up for Group 1 and 2||17
10846657|NCT00159588|12012810|FG001|STARTED|1-year Follow-up for Group 1 and 2||18
10846658|NCT00159588|12012811|FG002|STARTED|1-year Follow-up for Group 1 and 2||18
10846659|NCT00159588|12012809|FG000|COMPLETED|1-year Follow-up for Group 1 and 2||16
10846660|NCT00159588|12012810|FG001|COMPLETED|1-year Follow-up for Group 1 and 2||14
10846661|NCT00159588|12012811|FG002|COMPLETED|1-year Follow-up for Group 1 and 2||18
10846662|NCT00159588|12012809|FG000|NOT COMPLETED|1-year Follow-up for Group 1 and 2||1
10846663|NCT00159588|12012810|FG001|NOT COMPLETED|1-year Follow-up for Group 1 and 2||4
10846664|NCT00159588|12012811|FG002|NOT COMPLETED|1-year Follow-up for Group 1 and 2||0
10846665|NCT03051217|12012825|FG000|STARTED|Initial Period (Week 0 to Week 16)||26
10846666|NCT03051217|12012826|FG001|STARTED|Initial Period (Week 0 to Week 16)||48
10846667|NCT03051217|12012827|FG002|STARTED|Initial Period (Week 0 to Week 16)||53
10846668|NCT03051217|12012828|FG003|STARTED|Initial Period (Week 0 to Week 16)||0
10846669|NCT03051217|12012829|FG004|STARTED|Initial Period (Week 0 to Week 16)||0
10846670|NCT03051217|12012830|FG005|STARTED|Initial Period (Week 0 to Week 16)||0
10846671|NCT03051217|12012831|FG006|STARTED|Initial Period (Week 0 to Week 16)||0
10846672|NCT03051217|12012825|FG000|COMPLETED|Initial Period (Week 0 to Week 16)||23
10846673|NCT03051217|12012826|FG001|COMPLETED|Initial Period (Week 0 to Week 16)||46
10846674|NCT03051217|12012827|FG002|COMPLETED|Initial Period (Week 0 to Week 16)||51
10846675|NCT03051217|12012828|FG003|COMPLETED|Initial Period (Week 0 to Week 16)||0
10661254|NCT02257970|11823122|FG002|STARTED|Part 3||23
10661255|NCT02257970|11823123|FG003|STARTED|Part 3||21
10661256|NCT02257970|11823120|FG000|COMPLETED|Part 3||0
10661257|NCT02257970|11823121|FG001|COMPLETED|Part 3||0
10661258|NCT02257970|11823122|FG002|COMPLETED|Part 3||16
10661259|NCT02257970|11823123|FG003|COMPLETED|Part 3||14
10661260|NCT02257970|11823120|FG000|NOT COMPLETED|Part 3||0
10661261|NCT02257970|11823121|FG001|NOT COMPLETED|Part 3||0
10661262|NCT02257970|11823122|FG002|NOT COMPLETED|Part 3||7
10661263|NCT02257970|11823123|FG003|NOT COMPLETED|Part 3||7
10661264|NCT02258074|11823146|FG000|STARTED|Overall Study||53
10661265|NCT02258074|11823147|FG001|STARTED|Overall Study||50
10846676|NCT03051217|12012829|FG004|COMPLETED|Initial Period (Week 0 to Week 16)||0
10846677|NCT03051217|12012830|FG005|COMPLETED|Initial Period (Week 0 to Week 16)||0
10661266|NCT02258074|11823148|FG002|STARTED|Overall Study||51
10661267|NCT02258074|11823149|FG003|STARTED|Overall Study||51
10661268|NCT02258074|11823146|FG000|COMPLETED|Overall Study||52
10661269|NCT02258074|11823147|FG001|COMPLETED|Overall Study||50
10661270|NCT02258074|11823148|FG002|COMPLETED|Overall Study||51
10846678|NCT03051217|12012831|FG006|COMPLETED|Initial Period (Week 0 to Week 16)||0
10846679|NCT03051217|12012825|FG000|NOT COMPLETED|Initial Period (Week 0 to Week 16)||3
10846680|NCT03051217|12012826|FG001|NOT COMPLETED|Initial Period (Week 0 to Week 16)||2
10846681|NCT03051217|12012827|FG002|NOT COMPLETED|Initial Period (Week 0 to Week 16)||2
10846682|NCT03051217|12012828|FG003|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10846683|NCT03051217|12012829|FG004|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10846684|NCT03051217|12012830|FG005|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10846685|NCT03051217|12012831|FG006|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10846686|NCT03051217|12012825|FG000|STARTED|Maintenance Period (Week 16 to Week 52)||0
10846687|NCT03051217|12012826|FG001|STARTED|Maintenance Period (Week 16 to Week 52)||0
10846688|NCT03051217|12012827|FG002|STARTED|Maintenance Period (Week 16 to Week 52)||0
10846689|NCT03051217|12012828|FG003|STARTED|Maintenance Period (Week 16 to Week 52)||23
10846690|NCT03051217|12012829|FG004|STARTED|Maintenance Period (Week 16 to Week 52)||51
10846691|NCT03051217|12012830|FG005|STARTED|Maintenance Period (Week 16 to Week 52)||26
10846692|NCT03051217|12012831|FG006|STARTED|Maintenance Period (Week 16 to Week 52)||20
10846693|NCT03051217|12012825|FG000|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||0
10846694|NCT03051217|12012826|FG001|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||0
10846695|NCT03051217|12012827|FG002|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||0
10846696|NCT03051217|12012828|FG003|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||21
10846697|NCT03051217|12012829|FG004|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||3
10846698|NCT03051217|12012830|FG005|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||7
10846699|NCT03051217|12012831|FG006|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||3
10846700|NCT03051217|12012825|FG000|COMPLETED|Maintenance Period (Week 16 to Week 52)||0
10846701|NCT03051217|12012826|FG001|COMPLETED|Maintenance Period (Week 16 to Week 52)||0
10846702|NCT03051217|12012827|FG002|COMPLETED|Maintenance Period (Week 16 to Week 52)||0
10846703|NCT03051217|12012828|FG003|COMPLETED|Maintenance Period (Week 16 to Week 52)||20
10846704|NCT03051217|12012829|FG004|COMPLETED|Maintenance Period (Week 16 to Week 52)||48
10846705|NCT03051217|12012830|FG005|COMPLETED|Maintenance Period (Week 16 to Week 52)||24
10846706|NCT03051217|12012831|FG006|COMPLETED|Maintenance Period (Week 16 to Week 52)||19
10846707|NCT03051217|12012825|FG000|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||0
10846708|NCT03051217|12012826|FG001|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||0
10846709|NCT03051217|12012827|FG002|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||0
10846710|NCT03051217|12012828|FG003|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||3
10846711|NCT03051217|12012829|FG004|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||3
10846712|NCT03051217|12012830|FG005|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||2
10846713|NCT03051217|12012831|FG006|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||1
10413050|NCT00775437|11557196|FG000|STARTED|Overall Study||32
10413051|NCT00775437|11557196|FG000|COMPLETED|Overall Study||26
10413052|NCT00775437|11557196|FG000|NOT COMPLETED|Overall Study||6
10413053|NCT00775450|11557205|FG000|STARTED|Overall Study||295
10413054|NCT00775450|11557206|FG001|STARTED|Overall Study||98
10413055|NCT00775450|11557207|FG002|STARTED|Overall Study||105
10413056|NCT00775450|11557208|FG003|STARTED|Overall Study||108
10413057|NCT00775450|11557209|FG004|STARTED|Overall Study||201
10413058|NCT00775450|11557205|FG000|COMPLETED|Overall Study||292
10413059|NCT00775450|11557206|FG001|COMPLETED|Overall Study||98
10413060|NCT00775450|11557207|FG002|COMPLETED|Overall Study||105
10413061|NCT00775450|11557208|FG003|COMPLETED|Overall Study||108
10413062|NCT00775450|11557209|FG004|COMPLETED|Overall Study||199
10413063|NCT00775450|11557205|FG000|NOT COMPLETED|Overall Study||3
10413064|NCT00775450|11557206|FG001|NOT COMPLETED|Overall Study||0
10413065|NCT00775450|11557207|FG002|NOT COMPLETED|Overall Study||0
10413066|NCT00775450|11557208|FG003|NOT COMPLETED|Overall Study||0
10413067|NCT00775450|11557209|FG004|NOT COMPLETED|Overall Study||2
10413068|NCT00775463|11557223|FG000|STARTED|Overall Study||76
10413069|NCT00775463|11557224|FG001|STARTED|Overall Study||72
10413070|NCT00775463|11557223|FG000|COMPLETED|Overall Study||65
10413071|NCT00775463|11557224|FG001|COMPLETED|Overall Study||59
10545273|NCT01495975|11698581|FG001|STARTED|Overall Study||14
10545274|NCT01495975|11698580|FG000|COMPLETED|Overall Study||14
10545275|NCT01495975|11698581|FG001|COMPLETED|Overall Study||14
10545276|NCT01495975|11698580|FG000|NOT COMPLETED|Overall Study||1
10545277|NCT01495975|11698581|FG001|NOT COMPLETED|Overall Study||0
10545278|NCT01496066|11698589|FG000|STARTED|Overall Study||403
10846720|NCT02958319|12012860|FG000|STARTED|Overall Study||145
10846721|NCT02958319|12012861|FG001|STARTED|Overall Study||133
10846722|NCT02958319|12012860|FG000|COMPLETED|Overall Study||145
10846723|NCT02958319|12012861|FG001|COMPLETED|Overall Study||133
10846724|NCT02958319|12012860|FG000|NOT COMPLETED|Overall Study||0
10846725|NCT02958319|12012861|FG001|NOT COMPLETED|Overall Study||0
10846726|NCT02929069|12012870|FG000|STARTED|Overall Study||100
10545279|NCT01496066|11698590|FG001|STARTED|Overall Study||197
10545280|NCT01496066|11698589|FG000|COMPLETED|Overall Study||391
10413072|NCT00775463|11557223|FG000|NOT COMPLETED|Overall Study||11
10413073|NCT00775463|11557224|FG001|NOT COMPLETED|Overall Study||13
10545281|NCT01496066|11698590|FG001|COMPLETED|Overall Study||188
10846727|NCT02929069|12012871|FG001|STARTED|Overall Study||102
10846728|NCT02929069|12012872|FG002|STARTED|Overall Study||52
10846729|NCT02929069|12012870|FG000|Completed 4 Month Follow Up|Overall Study||83
10846730|NCT02929069|12012871|FG001|Completed 4 Month Follow Up|Overall Study||76
10846731|NCT02929069|12012872|FG002|Completed 4 Month Follow Up|Overall Study||43
10846732|NCT02929069|12012870|FG000|Completed 8 Month Follow Up|Overall Study||82
10846733|NCT02929069|12012871|FG001|Completed 8 Month Follow Up|Overall Study||77
10846734|NCT02929069|12012872|FG002|Completed 8 Month Follow Up|Overall Study||36
10846735|NCT02929069|12012870|FG000|Assessed STI 12 Month|Overall Study||74
10846736|NCT02929069|12012871|FG001|Assessed STI 12 Month|Overall Study||75
10846737|NCT02929069|12012872|FG002|Assessed STI 12 Month|Overall Study||38
10846738|NCT02929069|12012870|FG000|Assessed HIV 12 Month|Overall Study||76
10846739|NCT02929069|12012871|FG001|Assessed HIV 12 Month|Overall Study||76
10846740|NCT02929069|12012872|FG002|Assessed HIV 12 Month|Overall Study||39
10846741|NCT02929069|12012870|FG000|Complete 12 Month Follow Up|Overall Study||81
10846742|NCT02929069|12012871|FG001|Complete 12 Month Follow Up|Overall Study||81
10846743|NCT02929069|12012872|FG002|Complete 12 Month Follow Up|Overall Study||42
10846744|NCT02929069|12012870|FG000|COMPLETED|Overall Study||81
10846745|NCT02929069|12012871|FG001|COMPLETED|Overall Study||81
10846746|NCT02929069|12012872|FG002|COMPLETED|Overall Study||42
10846747|NCT02929069|12012870|FG000|NOT COMPLETED|Overall Study||19
10846748|NCT02929069|12012871|FG001|NOT COMPLETED|Overall Study||21
10846749|NCT02929069|12012872|FG002|NOT COMPLETED|Overall Study||10
10846750|NCT02889809|12012884|FG000|STARTED|Overall Study||239
10846751|NCT02889809|12012885|FG001|STARTED|Overall Study||238
10846752|NCT02889809|12012884|FG000|COMPLETED|Overall Study||196
10846753|NCT02889809|12012885|FG001|COMPLETED|Overall Study||205
10846754|NCT02889809|12012884|FG000|NOT COMPLETED|Overall Study||43
10846755|NCT02889809|12012885|FG001|NOT COMPLETED|Overall Study||33
10846756|NCT02849587|12012894|FG000|STARTED|Overall Study||65
10846757|NCT02849587|12012895|FG001|STARTED|Overall Study||70
10846758|NCT02849587|12012896|FG002|STARTED|Overall Study||64
10846759|NCT02849587|12012894|FG000|COMPLETED|Overall Study||63
10846760|NCT02849587|12012895|FG001|COMPLETED|Overall Study||66
10846761|NCT02849587|12012896|FG002|COMPLETED|Overall Study||62
10846762|NCT02849587|12012894|FG000|NOT COMPLETED|Overall Study||2
10846763|NCT02849587|12012895|FG001|NOT COMPLETED|Overall Study||4
10846764|NCT02849587|12012896|FG002|NOT COMPLETED|Overall Study||2
10846768|NCT02814708|12012919|FG000|STARTED|Overall Study||20
10846769|NCT02814708|12012920|FG001|STARTED|Overall Study||20
10846770|NCT02814708|12012921|FG002|STARTED|Overall Study||20
10846771|NCT02814708|12012922|FG003|STARTED|Overall Study||20
10846772|NCT02814708|12012923|FG004|STARTED|Overall Study||20
10846773|NCT02814708|12012924|FG005|STARTED|Overall Study||20
10846774|NCT02814708|12012925|FG006|STARTED|Overall Study||20
10846775|NCT02814708|12012919|FG000|COMPLETED|Overall Study||18
10846776|NCT02814708|12012920|FG001|COMPLETED|Overall Study||17
10846777|NCT02814708|12012921|FG002|COMPLETED|Overall Study||19
10846778|NCT02814708|12012922|FG003|COMPLETED|Overall Study||20
10846779|NCT02814708|12012923|FG004|COMPLETED|Overall Study||17
10846780|NCT02814708|12012924|FG005|COMPLETED|Overall Study||16
10846781|NCT02814708|12012925|FG006|COMPLETED|Overall Study||19
10846782|NCT02814708|12012919|FG000|NOT COMPLETED|Overall Study||2
10846783|NCT02814708|12012920|FG001|NOT COMPLETED|Overall Study||3
10846784|NCT02814708|12012921|FG002|NOT COMPLETED|Overall Study||1
10846785|NCT02814708|12012922|FG003|NOT COMPLETED|Overall Study||0
10846786|NCT02814708|12012923|FG004|NOT COMPLETED|Overall Study||3
10846787|NCT02814708|12012924|FG005|NOT COMPLETED|Overall Study||4
10846788|NCT02814708|12012925|FG006|NOT COMPLETED|Overall Study||1
10846789|NCT02781727|12012943|FG000|STARTED|Pre-dosing Period|106 subjects were randomized to the lonapegsomatropin arm, but 1 subject withdrew consent before receiving the first dose of study drug.|106
10846790|NCT02781727|12012944|FG001|STARTED|Pre-dosing Period||56
10846791|NCT02781727|12012943|FG000|COMPLETED|Pre-dosing Period||105
10846792|NCT02781727|12012944|FG001|COMPLETED|Pre-dosing Period||56
10846793|NCT02781727|12012943|FG000|NOT COMPLETED|Pre-dosing Period||1
10846794|NCT02781727|12012944|FG001|NOT COMPLETED|Pre-dosing Period||0
10846795|NCT02781727|12012943|FG000|STARTED|Treatment Period||105
10846796|NCT02781727|12012944|FG001|STARTED|Treatment Period||56
10846797|NCT02781727|12012943|FG000|COMPLETED|Treatment Period||104
10846798|NCT02781727|12012944|FG001|COMPLETED|Treatment Period||55
10846799|NCT02781727|12012943|FG000|NOT COMPLETED|Treatment Period||1
10846800|NCT02781727|12012944|FG001|NOT COMPLETED|Treatment Period||1
10846801|NCT02778204|12012954|FG000|STARTED|Overall Study||8
10846802|NCT02778204|12012955|FG001|STARTED|Overall Study||7
10846803|NCT02778204|12012956|FG002|STARTED|Overall Study||16
10846804|NCT02778204|12012957|FG003|STARTED|Overall Study||16
10846805|NCT02778204|12012954|FG000|COMPLETED|Overall Study||6
10846806|NCT02778204|12012955|FG001|COMPLETED|Overall Study||7
10846807|NCT02778204|12012956|FG002|COMPLETED|Overall Study||12
10846808|NCT02778204|12012957|FG003|COMPLETED|Overall Study||12
10846809|NCT02778204|12012954|FG000|NOT COMPLETED|Overall Study||2
10846810|NCT02778204|12012955|FG001|NOT COMPLETED|Overall Study||0
10846811|NCT02778204|12012956|FG002|NOT COMPLETED|Overall Study||4
10846812|NCT02778204|12012957|FG003|NOT COMPLETED|Overall Study||4
10846813|NCT02743364|12012971|FG000|STARTED|Overall Study||6
10846814|NCT02743364|12012972|FG001|STARTED|Overall Study||2
10846815|NCT02743364|12012971|FG000|COMPLETED|Overall Study||6
10846816|NCT02743364|12012972|FG001|COMPLETED|Overall Study||2
10846817|NCT02743364|12012971|FG000|NOT COMPLETED|Overall Study||0
10846818|NCT02743364|12012972|FG001|NOT COMPLETED|Overall Study||0
10846819|NCT02496611|12012980|FG000|STARTED|Overall Study||33
10846820|NCT02496611|12012981|FG001|STARTED|Overall Study||33
10846821|NCT02496611|12012980|FG000|COMPLETED|Overall Study||26
10846822|NCT02496611|12012981|FG001|COMPLETED|Overall Study||30
10846823|NCT02496611|12012980|FG000|NOT COMPLETED|Overall Study||7
10846824|NCT02496611|12012981|FG001|NOT COMPLETED|Overall Study||3
10846825|NCT02245308|12012990|FG000|STARTED|Overall Study||63
10846826|NCT02245308|12012991|FG001|STARTED|Overall Study||64
10846827|NCT02245308|12012990|FG000|COMPLETED|Overall Study|Using intent-to-treat analyses, i.e., missing=smoking|63
10846828|NCT02245308|12012991|FG001|COMPLETED|Overall Study|Using intent-to-treat analyses, i.e., missing=smoking|64
10846829|NCT02245308|12012990|FG000|NOT COMPLETED|Overall Study||0
10846830|NCT02245308|12012991|FG001|NOT COMPLETED|Overall Study||0
10846831|NCT02177695|12012999|FG000|STARTED|ITT Analysis||120
10846832|NCT02177695|12013000|FG001|STARTED|ITT Analysis||117
10846833|NCT02177695|12012999|FG000|COMPLETED|ITT Analysis||115
10846834|NCT02177695|12013000|FG001|COMPLETED|ITT Analysis||112
10846835|NCT02177695|12012999|FG000|NOT COMPLETED|ITT Analysis||5
10846836|NCT02177695|12013000|FG001|NOT COMPLETED|ITT Analysis||5
10846837|NCT02177695|12012999|FG000|STARTED|Primary COXEN Analysis||115
10846838|NCT02177695|12013000|FG001|STARTED|Primary COXEN Analysis||112
10846839|NCT02177695|12012999|FG000|Participants Excluded From Primary COXEN Analysis|Primary COXEN Analysis||33
10846840|NCT02177695|12013000|FG001|Participants Excluded From Primary COXEN Analysis|Primary COXEN Analysis||27
10846841|NCT02177695|12012999|FG000|COMPLETED|Primary COXEN Analysis||82
10846842|NCT02177695|12013000|FG001|COMPLETED|Primary COXEN Analysis||85
10846843|NCT02177695|12012999|FG000|NOT COMPLETED|Primary COXEN Analysis||33
10846844|NCT02177695|12013000|FG001|NOT COMPLETED|Primary COXEN Analysis||27
10846845|NCT02145403|12013012|FG000|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||3
10846846|NCT02145403|12013013|FG001|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
10846847|NCT02145403|12013014|FG002|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
10846848|NCT02145403|12013015|FG003|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
10846849|NCT02145403|12013012|FG000|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||3
10846850|NCT02145403|12013013|FG001|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
10846851|NCT02145403|12013014|FG002|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
10846852|NCT02145403|12013015|FG003|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
10846853|NCT02145403|12013012|FG000|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
10846854|NCT02145403|12013013|FG001|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
10846855|NCT02145403|12013014|FG002|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
10846856|NCT02145403|12013015|FG003|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
10846857|NCT02145403|12013012|FG000|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
10846858|NCT02145403|12013013|FG001|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||3
10846859|NCT02145403|12013014|FG002|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
10846860|NCT02145403|12013015|FG003|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
10846861|NCT02145403|12013012|FG000|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
10846862|NCT02145403|12013013|FG001|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||3
10846863|NCT02145403|12013014|FG002|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
10846864|NCT02145403|12013015|FG003|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
10846865|NCT02145403|12013012|FG000|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
10846866|NCT02145403|12013013|FG001|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
10846867|NCT02145403|12013014|FG002|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
10846868|NCT02145403|12013015|FG003|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
10846869|NCT02145403|12013012|FG000|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
10846870|NCT02145403|12013013|FG001|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
10846871|NCT02145403|12013014|FG002|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||4
10846872|NCT02145403|12013015|FG003|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
10846873|NCT02145403|12013012|FG000|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
10846874|NCT02145403|12013013|FG001|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
10846875|NCT02145403|12013014|FG002|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||3
10846876|NCT02145403|12013015|FG003|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
10846877|NCT02145403|12013012|FG000|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
10846878|NCT02145403|12013013|FG001|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
10846879|NCT02145403|12013014|FG002|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||1
10846880|NCT02145403|12013015|FG003|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
10846881|NCT02145403|12013012|FG000|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
10846882|NCT02145403|12013013|FG001|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
10846883|NCT02145403|12013014|FG002|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
10846884|NCT02145403|12013015|FG003|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||4
10846885|NCT02145403|12013012|FG000|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
10846886|NCT02145403|12013013|FG001|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
10846887|NCT02145403|12013014|FG002|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
10846888|NCT02145403|12013015|FG003|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||2
10846889|NCT02145403|12013012|FG000|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
10846890|NCT02145403|12013013|FG001|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
10846891|NCT02145403|12013014|FG002|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
10846892|NCT02145403|12013015|FG003|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||2
10846893|NCT02145403|12013012|FG000|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
10846894|NCT02145403|12013013|FG001|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
10846895|NCT02145403|12013014|FG002|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||37
10846896|NCT02145403|12013015|FG003|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
10846897|NCT02145403|12013012|FG000|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
10846898|NCT02145403|12013013|FG001|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
10846899|NCT02145403|12013014|FG002|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||36
10846900|NCT02145403|12013015|FG003|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
10846901|NCT02145403|12013012|FG000|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
10846902|NCT02145403|12013013|FG001|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
10846903|NCT02145403|12013014|FG002|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||1
10846904|NCT02145403|12013015|FG003|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
10846905|NCT02105636|12013030|FG000|STARTED|Overall Study||236
10846906|NCT02105636|12013031|FG001|STARTED|Overall Study||111
10846907|NCT02105636|12013030|FG000|COMPLETED|Overall Study|Completed=Still on Treatment|41
10846908|NCT02105636|12013031|FG001|COMPLETED|Overall Study|Completed=Still on Treatment|3
10846909|NCT02105636|12013030|FG000|NOT COMPLETED|Overall Study||195
10846910|NCT02105636|12013031|FG001|NOT COMPLETED|Overall Study||108
10846911|NCT02038946|12013038|FG000|STARTED|Overall Study||92
10846912|NCT02038946|12013038|FG000|COMPLETED|Overall Study||80
10846913|NCT02038946|12013038|FG000|NOT COMPLETED|Overall Study||12
10846914|NCT01988571|12013044|FG000|STARTED|Overall Study||139
10846915|NCT01988571|12013045|FG001|STARTED|Overall Study||140
10846916|NCT01988571|12013044|FG000|Completed Baseline|Overall Study||136
10846917|NCT01988571|12013045|FG001|Completed Baseline|Overall Study||139
10846918|NCT01988571|12013044|FG000|Completed 6 Month Visit|Overall Study||122
10846919|NCT01988571|12013045|FG001|Completed 6 Month Visit|Overall Study||126
10846920|NCT01988571|12013044|FG000|COMPLETED|Overall Study||100
10846921|NCT01988571|12013045|FG001|COMPLETED|Overall Study||105
10846922|NCT01988571|12013044|FG000|NOT COMPLETED|Overall Study||39
10846923|NCT01988571|12013045|FG001|NOT COMPLETED|Overall Study||35
10846924|NCT01332266|12013056|FG000|STARTED|Phase 1b||4
10846925|NCT01332266|12013057|FG001|STARTED|Phase 1b||5
10846926|NCT01332266|12013058|FG002|STARTED|Phase 1b||3
10846927|NCT01332266|12013059|FG003|STARTED|Phase 1b||0
10846928|NCT01332266|12013060|FG004|STARTED|Phase 1b||0
10846929|NCT01332266|12013056|FG000|COMPLETED|Phase 1b||0
10846930|NCT01332266|12013057|FG001|COMPLETED|Phase 1b||0
10846931|NCT01332266|12013058|FG002|COMPLETED|Phase 1b||0
10846932|NCT01332266|12013059|FG003|COMPLETED|Phase 1b||0
10846933|NCT01332266|12013060|FG004|COMPLETED|Phase 1b||0
10846934|NCT01332266|12013056|FG000|NOT COMPLETED|Phase 1b||4
10846935|NCT01332266|12013057|FG001|NOT COMPLETED|Phase 1b||5
10846936|NCT01332266|12013058|FG002|NOT COMPLETED|Phase 1b||3
10846937|NCT01332266|12013059|FG003|NOT COMPLETED|Phase 1b||0
10846938|NCT01332266|12013060|FG004|NOT COMPLETED|Phase 1b||0
10846939|NCT01332266|12013056|FG000|STARTED|Phase 2||0
10846940|NCT01332266|12013057|FG001|STARTED|Phase 2||0
10846941|NCT01332266|12013058|FG002|STARTED|Phase 2||0
10846942|NCT01332266|12013059|FG003|STARTED|Phase 2||42
10846943|NCT01332266|12013060|FG004|STARTED|Phase 2||41
10846944|NCT01332266|12013056|FG000|COMPLETED|Phase 2||0
10846945|NCT01332266|12013057|FG001|COMPLETED|Phase 2||0
10846946|NCT01332266|12013058|FG002|COMPLETED|Phase 2||0
10846947|NCT01332266|12013059|FG003|COMPLETED|Phase 2||0
10846948|NCT01332266|12013060|FG004|COMPLETED|Phase 2||0
10846949|NCT01332266|12013056|FG000|NOT COMPLETED|Phase 2||0
10846950|NCT01332266|12013057|FG001|NOT COMPLETED|Phase 2||0
10846951|NCT01332266|12013058|FG002|NOT COMPLETED|Phase 2||0
10846952|NCT01332266|12013059|FG003|NOT COMPLETED|Phase 2||42
10846953|NCT01332266|12013060|FG004|NOT COMPLETED|Phase 2||41
10846954|NCT01150890|12013077|FG000|STARTED|Overall Study||32
10846955|NCT01150890|12013078|FG001|STARTED|Overall Study||32
10846956|NCT01150890|12013079|FG002|STARTED|Overall Study||33
10846957|NCT01150890|12013080|FG003|STARTED|Overall Study||33
10846958|NCT01150890|12013077|FG000|Received Study Drug|Overall Study||32
10846959|NCT01150890|12013078|FG001|Received Study Drug|Overall Study||31
10846960|NCT01150890|12013079|FG002|Received Study Drug|Overall Study||32
10846961|NCT01150890|12013080|FG003|Received Study Drug|Overall Study||33
10846962|NCT01150890|12013077|FG000|COMPLETED|Overall Study||28
10846963|NCT01150890|12013078|FG001|COMPLETED|Overall Study||19
10846964|NCT01150890|12013079|FG002|COMPLETED|Overall Study||21
10846965|NCT01150890|12013080|FG003|COMPLETED|Overall Study||16
10846966|NCT01150890|12013077|FG000|NOT COMPLETED|Overall Study||4
10846967|NCT01150890|12013078|FG001|NOT COMPLETED|Overall Study||13
10846968|NCT01150890|12013079|FG002|NOT COMPLETED|Overall Study||12
10846969|NCT01150890|12013080|FG003|NOT COMPLETED|Overall Study||17
10846970|NCT01140867|12013093|FG000|STARTED|Overall Study||121
10846971|NCT01140867|12013093|FG000|COMPLETED|Overall Study||88
10846972|NCT01140867|12013093|FG000|NOT COMPLETED|Overall Study||33
10846973|NCT01137773|12013099|FG000|STARTED|Overall Study||33
10846974|NCT01137773|12013100|FG001|STARTED|Overall Study||23
10846975|NCT01137773|12013099|FG000|COMPLETED|Overall Study||24
10846976|NCT01137773|12013100|FG001|COMPLETED|Overall Study||20
10846977|NCT01137773|12013099|FG000|NOT COMPLETED|Overall Study||9
10846978|NCT01137773|12013100|FG001|NOT COMPLETED|Overall Study||3
10846979|NCT01127256|12013110|FG000|STARTED|Overall Study||96
10846980|NCT01127256|12013111|FG001|STARTED|Overall Study||104
10846981|NCT01127256|12013110|FG000|COMPLETED|Overall Study||57
10846982|NCT01127256|12013111|FG001|COMPLETED|Overall Study||65
10846983|NCT01127256|12013110|FG000|NOT COMPLETED|Overall Study||39
10846984|NCT01127256|12013111|FG001|NOT COMPLETED|Overall Study||39
10846985|NCT01004861|12013130|FG000|STARTED|Overall Study||3
10846986|NCT01004861|12013131|FG001|STARTED|Overall Study||6
10846987|NCT01004861|12013132|FG002|STARTED|Overall Study||6
10846988|NCT01004861|12013133|FG003|STARTED|Overall Study||6
10846989|NCT01004861|12013134|FG004|STARTED|Overall Study||7
10846990|NCT01004861|12013135|FG005|STARTED|Overall Study||6
10846991|NCT01004861|12013136|FG006|STARTED|Overall Study||7
10846992|NCT01004861|12013137|FG007|STARTED|Overall Study||4
10846993|NCT01004861|12013138|FG008|STARTED|Overall Study||39
10846994|NCT01004861|12013139|FG009|STARTED|Overall Study||11
10413074|NCT00775528|11557237|FG000|STARTED|Overall Study|Started means number of patients who consented|19
10413075|NCT00775528|11557237|FG000|COMPLETED|Overall Study||18
10846995|NCT01004861|12013140|FG010|STARTED|Overall Study||9
10846996|NCT01004861|12013141|FG011|STARTED|Overall Study||8
10846997|NCT01004861|12013142|FG012|STARTED|Overall Study||20
10846998|NCT01004861|12013130|FG000|COMPLETED|Overall Study||0
10846999|NCT01004861|12013131|FG001|COMPLETED|Overall Study||0
10847000|NCT01004861|12013132|FG002|COMPLETED|Overall Study||0
10847001|NCT01004861|12013133|FG003|COMPLETED|Overall Study||0
10847002|NCT01004861|12013134|FG004|COMPLETED|Overall Study||0
10847003|NCT01004861|12013135|FG005|COMPLETED|Overall Study||0
10847004|NCT01004861|12013136|FG006|COMPLETED|Overall Study||0
10847005|NCT01004861|12013137|FG007|COMPLETED|Overall Study||0
10847006|NCT01004861|12013138|FG008|COMPLETED|Overall Study||0
10847007|NCT01004861|12013139|FG009|COMPLETED|Overall Study||0
10847008|NCT01004861|12013140|FG010|COMPLETED|Overall Study||0
10847009|NCT01004861|12013141|FG011|COMPLETED|Overall Study||0
10847010|NCT01004861|12013142|FG012|COMPLETED|Overall Study||0
10847011|NCT01004861|12013130|FG000|NOT COMPLETED|Overall Study||3
10847012|NCT01004861|12013131|FG001|NOT COMPLETED|Overall Study||6
10847013|NCT01004861|12013132|FG002|NOT COMPLETED|Overall Study||6
10847014|NCT01004861|12013133|FG003|NOT COMPLETED|Overall Study||6
10847015|NCT01004861|12013134|FG004|NOT COMPLETED|Overall Study||7
10847016|NCT01004861|12013135|FG005|NOT COMPLETED|Overall Study||6
10847017|NCT01004861|12013136|FG006|NOT COMPLETED|Overall Study||7
10847018|NCT01004861|12013137|FG007|NOT COMPLETED|Overall Study||4
10847019|NCT01004861|12013138|FG008|NOT COMPLETED|Overall Study||39
10847020|NCT01004861|12013139|FG009|NOT COMPLETED|Overall Study||11
10847021|NCT01004861|12013140|FG010|NOT COMPLETED|Overall Study||9
10847022|NCT01004861|12013141|FG011|NOT COMPLETED|Overall Study||8
10847023|NCT01004861|12013142|FG012|NOT COMPLETED|Overall Study||20
10847024|NCT00912223|12013174|FG000|STARTED|Overall Study||65
10847025|NCT00912223|12013174|FG000|COMPLETED|Overall Study||62
10847026|NCT00912223|12013174|FG000|NOT COMPLETED|Overall Study||3
10847027|NCT00381381|12013178|FG000|STARTED|Overall Study||199
10847028|NCT00381381|12013178|FG000|COMPLETED|Overall Study||135
10847029|NCT00381381|12013178|FG000|NOT COMPLETED|Overall Study||64
10847030|NCT00038675|12013182|FG000|STARTED|Overall Study||125
10847031|NCT00038675|12013182|FG000|COMPLETED|Overall Study||125
10847032|NCT00038675|12013182|FG000|NOT COMPLETED|Overall Study||0
10292712|NCT02616393|11425504|FG000|NOT COMPLETED|Overall Study||13
10292713|NCT02616393|11425505|FG001|NOT COMPLETED|Overall Study||20
10292714|NCT02616393|11425506|FG002|NOT COMPLETED|Overall Study||3
10292715|NCT02602288|11425532|FG000|STARTED|End of Treatment/3 Month Follow-up||199
10292716|NCT02602288|11425533|FG001|STARTED|End of Treatment/3 Month Follow-up||197
10292717|NCT02602288|11425532|FG000|COMPLETED|End of Treatment/3 Month Follow-up||174
10292718|NCT02602288|11425533|FG001|COMPLETED|End of Treatment/3 Month Follow-up||179
10292719|NCT02602288|11425532|FG000|NOT COMPLETED|End of Treatment/3 Month Follow-up||25
10292720|NCT02602288|11425533|FG001|NOT COMPLETED|End of Treatment/3 Month Follow-up||18
10292721|NCT02602288|11425532|FG000|STARTED|12 Month Follow-up||174
10292722|NCT02602288|11425533|FG001|STARTED|12 Month Follow-up||179
10292723|NCT02602288|11425532|FG000|COMPLETED|12 Month Follow-up||172
10292724|NCT02602288|11425533|FG001|COMPLETED|12 Month Follow-up||175
10292725|NCT02602288|11425532|FG000|NOT COMPLETED|12 Month Follow-up||2
10292726|NCT02602288|11425533|FG001|NOT COMPLETED|12 Month Follow-up||4
10292727|NCT02577523|11425541|FG000|STARTED|Overall Study||19
10292728|NCT02577523|11425542|FG001|STARTED|Overall Study||19
10292729|NCT02577523|11425541|FG000|COMPLETED|Overall Study||16
10292730|NCT02577523|11425542|FG001|COMPLETED|Overall Study||17
10292731|NCT02577523|11425541|FG000|NOT COMPLETED|Overall Study||3
10292732|NCT02577523|11425542|FG001|NOT COMPLETED|Overall Study||2
10292745|NCT02461225|11425562|FG000|STARTED|Overall Study||19
10292746|NCT02461225|11425563|FG001|STARTED|Overall Study||11
10292747|NCT02461225|11425562|FG000|COMPLETED|Overall Study||19
10292748|NCT02461225|11425563|FG001|COMPLETED|Overall Study||11
10292749|NCT02461225|11425562|FG000|NOT COMPLETED|Overall Study||0
10292750|NCT02461225|11425563|FG001|NOT COMPLETED|Overall Study||0
10292751|NCT02427958|11425569|FG000|STARTED|Overall Study||307
10292752|NCT02427958|11425569|FG000|COMPLETED|Overall Study||283
10292753|NCT02427958|11425569|FG000|NOT COMPLETED|Overall Study||24
10292754|NCT02425826|11425575|FG000|STARTED|Placebo-controlled Phase (Week 0 - 16)||148
10292755|NCT02425826|11425576|FG001|STARTED|Placebo-controlled Phase (Week 0 - 16)||73
10292756|NCT02425826|11425577|FG002|STARTED|Placebo-controlled Phase (Week 0 - 16)||0
10292757|NCT02425826|11425575|FG000|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)|ITT = includes participants who received at least one dose of study drug.|147
10292758|NCT02425826|11425576|FG001|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)|ITT = includes participants who received at least one dose of study drug.|73
10847033|NCT04389333|12013188|FG000|STARTED|Overall Study|From March 26th to April 26th, 2020, 20 patients were enrolled and underwent non-contract MCE in Changhai hpospital and the first medical center of PLA general hospital.|20
10847034|NCT04389333|12013189|FG001|STARTED|Overall Study|From March 26th to April 26th, 2020, 20 patients were enrolled and accept MCE in Changhai hpospital and the first medical center of PLA general hospital.|20
10847035|NCT04389333|12013188|FG000|COMPLETED|Overall Study||20
10847036|NCT04389333|12013189|FG001|COMPLETED|Overall Study||20
10847037|NCT04389333|12013188|FG000|NOT COMPLETED|Overall Study||0
10413076|NCT00775528|11557237|FG000|NOT COMPLETED|Overall Study||1
10413077|NCT00775593|11557241|FG000|STARTED|Overall Study||60
10413078|NCT00775593|11557241|FG000|COMPLETED|Overall Study||53
10413079|NCT00775593|11557241|FG000|NOT COMPLETED|Overall Study||7
10413080|NCT00775606|11557247|FG000|STARTED|Overall Study||8
10413081|NCT00775606|11557248|FG001|STARTED|Overall Study||5
10413082|NCT00775606|11557247|FG000|COMPLETED|Overall Study||5
10413083|NCT00775606|11557248|FG001|COMPLETED|Overall Study||5
10413084|NCT00775606|11557247|FG000|NOT COMPLETED|Overall Study||3
10413085|NCT00775606|11557248|FG001|NOT COMPLETED|Overall Study||0
10413086|NCT00775645|11557258|FG000|STARTED|Overall Study||208
10413087|NCT00775645|11557259|FG001|STARTED|Overall Study||201
10413088|NCT00775645|11557258|FG000|COMPLETED|Overall Study||191
10413089|NCT00775645|11557259|FG001|COMPLETED|Overall Study||181
10413090|NCT00775645|11557258|FG000|NOT COMPLETED|Overall Study||17
10413091|NCT00775645|11557259|FG001|NOT COMPLETED|Overall Study||20
10413092|NCT00775658|11557265|FG000|STARTED|First Intervention||10
10413093|NCT00775658|11557266|FG001|STARTED|First Intervention||11
10413094|NCT00775658|11557265|FG000|COMPLETED|First Intervention||10
10413095|NCT00775658|11557266|FG001|COMPLETED|First Intervention||11
10413096|NCT00775658|11557265|FG000|NOT COMPLETED|First Intervention||0
10413097|NCT00775658|11557266|FG001|NOT COMPLETED|First Intervention||0
10413098|NCT00775658|11557265|FG000|STARTED|Second Intervention||10
10413099|NCT00775658|11557266|FG001|STARTED|Second Intervention||11
10413100|NCT00775658|11557265|FG000|COMPLETED|Second Intervention||10
10413101|NCT00775658|11557266|FG001|COMPLETED|Second Intervention||11
10413102|NCT00775658|11557265|FG000|NOT COMPLETED|Second Intervention||0
10413103|NCT00775658|11557266|FG001|NOT COMPLETED|Second Intervention||0
10413104|NCT00775671|11557274|FG000|STARTED|Overall Study||23
10413105|NCT00775671|11557275|FG001|STARTED|Overall Study||23
10413106|NCT00775671|11557274|FG000|COMPLETED|Overall Study||23
10413107|NCT00775671|11557275|FG001|COMPLETED|Overall Study||23
10413108|NCT00775671|11557274|FG000|NOT COMPLETED|Overall Study||0
10413109|NCT00775671|11557275|FG001|NOT COMPLETED|Overall Study||0
10847038|NCT04389333|12013189|FG001|NOT COMPLETED|Overall Study||0
10847039|NCT03712124|12013198|FG000|STARTED|Overall Study||10
10847040|NCT03712124|12013199|FG001|STARTED|Overall Study||11
10847041|NCT03712124|12013198|FG000|Received at Least 1 Dose of Study Drug|Overall Study||10
10847042|NCT03712124|12013199|FG001|Received at Least 1 Dose of Study Drug|Overall Study||11
10847043|NCT03712124|12013198|FG000|COMPLETED|Overall Study||9
10847044|NCT03712124|12013199|FG001|COMPLETED|Overall Study||11
10847045|NCT03712124|12013198|FG000|NOT COMPLETED|Overall Study||1
10847046|NCT03712124|12013199|FG001|NOT COMPLETED|Overall Study||0
10847047|NCT03689582|12013205|FG000|STARTED|Overall Study||11
10847048|NCT03689582|12013205|FG000|COMPLETED|Overall Study||11
10847049|NCT03689582|12013205|FG000|NOT COMPLETED|Overall Study||0
10847050|NCT03535740|12013211|FG000|STARTED|Overall Study||103
10847051|NCT03535740|12013211|FG000|Participants Who Received Escalated Dose of Brigatinib 240 mg|Overall Study||13
10847052|NCT03535740|12013211|FG000|COMPLETED|Overall Study||0
10847053|NCT03535740|12013211|FG000|NOT COMPLETED|Overall Study||103
10847054|NCT02986789|12013218|FG000|STARTED|Overall Study||43
10847055|NCT02986789|12013219|FG001|STARTED|Overall Study||0
10847056|NCT02986789|12013218|FG000|COMPLETED|Overall Study||43
10847057|NCT02986789|12013219|FG001|COMPLETED|Overall Study||0
10847058|NCT02986789|12013218|FG000|NOT COMPLETED|Overall Study||0
10847059|NCT02986789|12013219|FG001|NOT COMPLETED|Overall Study||0
10847060|NCT02974907|12013227|FG000|STARTED|Overall Study||299
10847061|NCT02974907|12013228|FG001|STARTED|Overall Study||302
10847062|NCT02974907|12013227|FG000|COMPLETED|Overall Study||286
10847063|NCT02974907|12013228|FG001|COMPLETED|Overall Study||292
10847064|NCT02974907|12013227|FG000|NOT COMPLETED|Overall Study||13
10847065|NCT02974907|12013228|FG001|NOT COMPLETED|Overall Study||10
10847066|NCT02918500|12013236|FG000|STARTED|Overall Study||2
10847067|NCT02918500|12013237|FG001|STARTED|Overall Study||2
10847068|NCT02918500|12013236|FG000|COMPLETED|Overall Study||2
10847069|NCT02918500|12013237|FG001|COMPLETED|Overall Study||2
10847070|NCT02918500|12013236|FG000|NOT COMPLETED|Overall Study||0
10847071|NCT02918500|12013237|FG001|NOT COMPLETED|Overall Study||0
10847072|NCT02896257|12013248|FG000|STARTED|Providers||88
10847073|NCT02896257|12013249|FG001|STARTED|Providers||93
10847074|NCT02896257|12013248|FG000|PCPs Assigned to 1 Primary Care Team|Providers||68
10847075|NCT02896257|12013249|FG001|PCPs Assigned to 1 Primary Care Team|Providers||79
10847076|NCT02896257|12013248|FG000|PCPs Assigned to Two Primary Care Teams|Providers||18
10847077|NCT02896257|12013249|FG001|PCPs Assigned to Two Primary Care Teams|Providers||12
10847078|NCT02896257|12013248|FG000|PCPs Assigned to 3 Primary Care Teams|Providers||1
10847079|NCT02896257|12013249|FG001|PCPs Assigned to 3 Primary Care Teams|Providers||2
10847080|NCT02896257|12013248|FG000|PCPs Assigned to Four Primary Care Teams|Providers||1
10847081|NCT02896257|12013249|FG001|PCPs Assigned to Four Primary Care Teams|Providers||0
10847082|NCT02896257|12013248|FG000|COMPLETED|Providers||67
10847083|NCT02896257|12013249|FG001|COMPLETED|Providers||65
10847084|NCT02896257|12013248|FG000|NOT COMPLETED|Providers||21
10847085|NCT02896257|12013249|FG001|NOT COMPLETED|Providers||28
10847086|NCT02896257|12013248|FG000|STARTED|Patients|Eligible patient participants assigned to a usual care PCP=344|344
10847087|NCT02896257|12013249|FG001|STARTED|Patients|Eligible patient participants assigned to an intervention PCP=342|342
10847088|NCT02896257|12013248|FG000|COMPLETED|Patients|Patients with an eligible primary care appointment with a usual care PCP who were assigned an index date=281|281
10847089|NCT02896257|12013249|FG001|COMPLETED|Patients|Patients with an eligible primary care appointment with an intervention PCP who were assigned an index date=269|269
10847090|NCT02896257|12013248|FG000|NOT COMPLETED|Patients||63
10847091|NCT02896257|12013249|FG001|NOT COMPLETED|Patients||73
10847092|NCT02774265|12013258|FG000|STARTED|Overall Study||164
10847093|NCT02774265|12013259|FG001|STARTED|Overall Study||165
10847094|NCT02774265|12013258|FG000|COMPLETED|Overall Study||151
10847095|NCT02774265|12013259|FG001|COMPLETED|Overall Study||159
10847096|NCT02774265|12013258|FG000|NOT COMPLETED|Overall Study||13
10847097|NCT02774265|12013259|FG001|NOT COMPLETED|Overall Study||6
10847098|NCT02736617|12013265|FG000|STARTED|Treatment||10
10847099|NCT02736617|12013265|FG000|COMPLETED|Treatment||7
10847100|NCT02736617|12013265|FG000|NOT COMPLETED|Treatment||3
10847101|NCT02736617|12013265|FG000|STARTED|Maintenance||7
10847102|NCT02736617|12013265|FG000|COMPLETED|Maintenance||2
10847103|NCT02736617|12013265|FG000|NOT COMPLETED|Maintenance||5
10847104|NCT02652468|12013270|FG000|STARTED|Overall Study||11
10847105|NCT02652468|12013270|FG000|COMPLETED|Overall Study||11
10847106|NCT02652468|12013270|FG000|NOT COMPLETED|Overall Study||0
10847107|NCT02579265|12013276|FG000|STARTED|Overall Study||83
10847108|NCT02579265|12013277|FG001|STARTED|Overall Study||78
10847109|NCT02579265|12013276|FG000|COMPLETED|Overall Study||33
10847110|NCT02579265|12013277|FG001|COMPLETED|Overall Study||33
10847111|NCT02579265|12013276|FG000|NOT COMPLETED|Overall Study||50
10847112|NCT02579265|12013277|FG001|NOT COMPLETED|Overall Study||45
10847113|NCT02013167|12013285|FG000|STARTED|Overall Study||134
10847114|NCT02013167|12013286|FG001|STARTED|Overall Study||271
10847115|NCT02013167|12013285|FG000|Received Treatment|Overall Study||109
10847116|NCT02013167|12013286|FG001|Received Treatment|Overall Study||267
10847117|NCT02013167|12013285|FG000|COMPLETED|Overall Study|Indicates participants continuing study at time of data cut-off|33
10847118|NCT02013167|12013286|FG001|COMPLETED|Overall Study|Indicates participants continuing study at time of data cut-off; 22 were receiving treatment|93
10847119|NCT02013167|12013285|FG000|NOT COMPLETED|Overall Study||101
10847120|NCT02013167|12013286|FG001|NOT COMPLETED|Overall Study||178
10847121|NCT02004522|12013295|FG000|STARTED|Overall Study||160
10847122|NCT02004522|12013296|FG001|STARTED|Overall Study||159
10847123|NCT02004522|12013295|FG000|Number of Subjects Treated|Overall Study||158
10847124|NCT02004522|12013296|FG001|Number of Subjects Treated|Overall Study||155
10847125|NCT02004522|12013295|FG000|COMPLETED|Overall Study|Completed defined here as still on treatment.|34
10847126|NCT02004522|12013296|FG001|COMPLETED|Overall Study|Completed defined here as still on treatment.|0
10847127|NCT02004522|12013295|FG000|NOT COMPLETED|Overall Study||126
10847128|NCT02004522|12013296|FG001|NOT COMPLETED|Overall Study||159
10847132|NCT01981850|12013313|FG000|STARTED|Main Phase Stage 1||8
10847133|NCT01981850|12013314|FG001|STARTED|Main Phase Stage 1||7
10847134|NCT01981850|12013315|FG002|STARTED|Main Phase Stage 1||6
10847135|NCT01981850|12013316|FG003|STARTED|Main Phase Stage 1||6
10847136|NCT01981850|12013317|FG004|STARTED|Main Phase Stage 1||0
10847137|NCT01981850|12013318|FG005|STARTED|Main Phase Stage 1||0
10847138|NCT01981850|12013319|FG006|STARTED|Main Phase Stage 1||0
10847139|NCT01981850|12013320|FG007|STARTED|Main Phase Stage 1||0
10847140|NCT01981850|12013321|FG008|STARTED|Main Phase Stage 1||0
10847141|NCT01981850|12013322|FG009|STARTED|Main Phase Stage 1||0
10847142|NCT01981850|12013313|FG000|COMPLETED|Main Phase Stage 1||5
10847143|NCT01981850|12013314|FG001|COMPLETED|Main Phase Stage 1||5
10847144|NCT01981850|12013315|FG002|COMPLETED|Main Phase Stage 1||4
10847145|NCT01981850|12013316|FG003|COMPLETED|Main Phase Stage 1||6
10847146|NCT01981850|12013317|FG004|COMPLETED|Main Phase Stage 1||0
10847147|NCT01981850|12013318|FG005|COMPLETED|Main Phase Stage 1||0
10847148|NCT01981850|12013319|FG006|COMPLETED|Main Phase Stage 1||0
10847149|NCT01981850|12013320|FG007|COMPLETED|Main Phase Stage 1||0
10847150|NCT01981850|12013321|FG008|COMPLETED|Main Phase Stage 1||0
10545282|NCT01496066|11698589|FG000|NOT COMPLETED|Overall Study||12
10847151|NCT01981850|12013322|FG009|COMPLETED|Main Phase Stage 1||0
10847152|NCT01981850|12013313|FG000|NOT COMPLETED|Main Phase Stage 1||3
10847153|NCT01981850|12013314|FG001|NOT COMPLETED|Main Phase Stage 1||2
10847154|NCT01981850|12013315|FG002|NOT COMPLETED|Main Phase Stage 1||2
10847155|NCT01981850|12013316|FG003|NOT COMPLETED|Main Phase Stage 1||0
10847156|NCT01981850|12013317|FG004|NOT COMPLETED|Main Phase Stage 1||0
10847157|NCT01981850|12013318|FG005|NOT COMPLETED|Main Phase Stage 1||0
10847158|NCT01981850|12013319|FG006|NOT COMPLETED|Main Phase Stage 1||0
10847159|NCT01981850|12013320|FG007|NOT COMPLETED|Main Phase Stage 1||0
10847160|NCT01981850|12013321|FG008|NOT COMPLETED|Main Phase Stage 1||0
10847161|NCT01981850|12013322|FG009|NOT COMPLETED|Main Phase Stage 1||0
10847162|NCT01981850|12013313|FG000|STARTED|Main Phase Stage 2||0
10847163|NCT01981850|12013314|FG001|STARTED|Main Phase Stage 2||0
10847164|NCT01981850|12013315|FG002|STARTED|Main Phase Stage 2||0
10847165|NCT01981850|12013316|FG003|STARTED|Main Phase Stage 2||0
10847166|NCT01981850|12013317|FG004|STARTED|Main Phase Stage 2||33
10847167|NCT01981850|12013318|FG005|STARTED|Main Phase Stage 2||32
10847168|NCT01981850|12013319|FG006|STARTED|Main Phase Stage 2||32
10847169|NCT01981850|12013320|FG007|STARTED|Main Phase Stage 2||0
10847170|NCT01981850|12013321|FG008|STARTED|Main Phase Stage 2||0
10847171|NCT01981850|12013322|FG009|STARTED|Main Phase Stage 2||0
10847172|NCT01981850|12013313|FG000|COMPLETED|Main Phase Stage 2||0
10847173|NCT01981850|12013314|FG001|COMPLETED|Main Phase Stage 2||0
10847174|NCT01981850|12013315|FG002|COMPLETED|Main Phase Stage 2||0
10847175|NCT01981850|12013316|FG003|COMPLETED|Main Phase Stage 2||0
10847176|NCT01981850|12013317|FG004|COMPLETED|Main Phase Stage 2||20
10847177|NCT01981850|12013318|FG005|COMPLETED|Main Phase Stage 2||16
10847178|NCT01981850|12013319|FG006|COMPLETED|Main Phase Stage 2||15
10754676|NCT03054428|11918412|FG001|COMPLETED|Overall Study||4
10754677|NCT03054428|11918413|FG002|COMPLETED|Overall Study||3
10754678|NCT03054428|11918411|FG000|NOT COMPLETED|Overall Study||83
10754679|NCT03054428|11918412|FG001|NOT COMPLETED|Overall Study||80
10754680|NCT03054428|11918413|FG002|NOT COMPLETED|Overall Study||79
10754681|NCT03054506|11918424|FG000|STARTED|Overall Study||20
10754682|NCT03054506|11918425|FG001|STARTED|Overall Study||11
10754683|NCT03054506|11918426|FG002|STARTED|Overall Study||9
10754684|NCT03054506|11918424|FG000|COMPLETED|Overall Study||19
10754685|NCT03054506|11918425|FG001|COMPLETED|Overall Study||11
10754686|NCT03054506|11918426|FG002|COMPLETED|Overall Study||9
10754687|NCT03054506|11918424|FG000|NOT COMPLETED|Overall Study||1
10754688|NCT03054506|11918425|FG001|NOT COMPLETED|Overall Study||0
10754689|NCT03054506|11918426|FG002|NOT COMPLETED|Overall Study||0
10754690|NCT03054649|11918434|FG000|STARTED|Overall Study||27
10754691|NCT03054649|11918435|FG001|STARTED|Overall Study||27
10847179|NCT01981850|12013320|FG007|COMPLETED|Main Phase Stage 2||0
10847180|NCT01981850|12013321|FG008|COMPLETED|Main Phase Stage 2||0
10847181|NCT01981850|12013322|FG009|COMPLETED|Main Phase Stage 2||0
10847182|NCT01981850|12013313|FG000|NOT COMPLETED|Main Phase Stage 2||0
10847183|NCT01981850|12013314|FG001|NOT COMPLETED|Main Phase Stage 2||0
10847184|NCT01981850|12013315|FG002|NOT COMPLETED|Main Phase Stage 2||0
10847185|NCT01981850|12013316|FG003|NOT COMPLETED|Main Phase Stage 2||0
10847186|NCT01981850|12013317|FG004|NOT COMPLETED|Main Phase Stage 2||13
10847187|NCT01981850|12013318|FG005|NOT COMPLETED|Main Phase Stage 2||16
10847188|NCT01981850|12013319|FG006|NOT COMPLETED|Main Phase Stage 2||17
10847189|NCT01981850|12013320|FG007|NOT COMPLETED|Main Phase Stage 2||0
10847190|NCT01981850|12013321|FG008|NOT COMPLETED|Main Phase Stage 2||0
10847191|NCT01981850|12013322|FG009|NOT COMPLETED|Main Phase Stage 2||0
10847192|NCT01981850|12013313|FG000|STARTED|Open Label Extension (OLE)||0
10847193|NCT01981850|12013314|FG001|STARTED|Open Label Extension (OLE)||0
10847194|NCT01981850|12013315|FG002|STARTED|Open Label Extension (OLE)||0
10847195|NCT01981850|12013316|FG003|STARTED|Open Label Extension (OLE)||0
10847196|NCT01981850|12013317|FG004|STARTED|Open Label Extension (OLE)||0
10847197|NCT01981850|12013318|FG005|STARTED|Open Label Extension (OLE)||0
10847198|NCT01981850|12013319|FG006|STARTED|Open Label Extension (OLE)||0
10847199|NCT01981850|12013320|FG007|STARTED|Open Label Extension (OLE)||13
10847200|NCT01981850|12013321|FG008|STARTED|Open Label Extension (OLE)||5
10847201|NCT01981850|12013322|FG009|STARTED|Open Label Extension (OLE)||48
10847202|NCT01981850|12013313|FG000|COMPLETED|Open Label Extension (OLE)||0
10847203|NCT01981850|12013314|FG001|COMPLETED|Open Label Extension (OLE)||0
10847204|NCT01981850|12013315|FG002|COMPLETED|Open Label Extension (OLE)||0
10847205|NCT01981850|12013316|FG003|COMPLETED|Open Label Extension (OLE)||0
10847206|NCT01981850|12013317|FG004|COMPLETED|Open Label Extension (OLE)||0
10847207|NCT01981850|12013318|FG005|COMPLETED|Open Label Extension (OLE)||0
10847208|NCT01981850|12013319|FG006|COMPLETED|Open Label Extension (OLE)||0
10847209|NCT01981850|12013320|FG007|COMPLETED|Open Label Extension (OLE)||1
10847210|NCT01981850|12013321|FG008|COMPLETED|Open Label Extension (OLE)||0
10847211|NCT01981850|12013322|FG009|COMPLETED|Open Label Extension (OLE)||0
10847212|NCT01981850|12013313|FG000|NOT COMPLETED|Open Label Extension (OLE)||0
10847213|NCT01981850|12013314|FG001|NOT COMPLETED|Open Label Extension (OLE)||0
10847214|NCT01981850|12013315|FG002|NOT COMPLETED|Open Label Extension (OLE)||0
10847215|NCT01981850|12013316|FG003|NOT COMPLETED|Open Label Extension (OLE)||0
10847216|NCT01981850|12013317|FG004|NOT COMPLETED|Open Label Extension (OLE)||0
10847217|NCT01981850|12013318|FG005|NOT COMPLETED|Open Label Extension (OLE)||0
10847218|NCT01981850|12013319|FG006|NOT COMPLETED|Open Label Extension (OLE)||0
10847219|NCT01981850|12013320|FG007|NOT COMPLETED|Open Label Extension (OLE)||12
10847220|NCT01981850|12013321|FG008|NOT COMPLETED|Open Label Extension (OLE)||5
10847221|NCT01981850|12013322|FG009|NOT COMPLETED|Open Label Extension (OLE)||48
10413110|NCT00775931|11557283|FG000|STARTED|Overall Study||6
10413111|NCT00775931|11557284|FG001|STARTED|Overall Study||1
10413112|NCT00775931|11557283|FG000|COMPLETED|Overall Study||6
10847222|NCT01804816|12013354|FG000|STARTED|No Acupuncture (Initial 5 Weeks)||14
10847223|NCT01804816|12013354|FG000|COMPLETED|No Acupuncture (Initial 5 Weeks)||11
10847224|NCT01804816|12013354|FG000|NOT COMPLETED|No Acupuncture (Initial 5 Weeks)||3
10413113|NCT00775931|11557284|FG001|COMPLETED|Overall Study||1
10413114|NCT00775931|11557283|FG000|NOT COMPLETED|Overall Study||0
10847225|NCT01804816|12013354|FG000|STARTED|Acupuncture (Second 5 Weeks)||11
10847226|NCT01804816|12013354|FG000|COMPLETED|Acupuncture (Second 5 Weeks)||10
10754692|NCT03054649|11918434|FG000|COMPLETED|Overall Study||27
10754693|NCT03054649|11918435|FG001|COMPLETED|Overall Study||27
10754694|NCT03054649|11918434|FG000|NOT COMPLETED|Overall Study||0
10847227|NCT01804816|12013354|FG000|NOT COMPLETED|Acupuncture (Second 5 Weeks)||1
10847228|NCT01572207|12013363|FG000|STARTED|Overall Study||14
10847229|NCT01572207|12013364|FG001|STARTED|Overall Study||16
10847230|NCT01572207|12013363|FG000|COMPLETED|Overall Study||12
10847231|NCT01572207|12013364|FG001|COMPLETED|Overall Study||13
10847232|NCT01572207|12013363|FG000|NOT COMPLETED|Overall Study||2
10847233|NCT01572207|12013364|FG001|NOT COMPLETED|Overall Study||3
10847234|NCT01550315|12013372|FG000|STARTED|Overall Study||7
10413115|NCT00775931|11557284|FG001|NOT COMPLETED|Overall Study||0
10413116|NCT00775944|11557294|FG000|STARTED|Overall Study||648
10413117|NCT00775944|11557295|FG001|STARTED|Overall Study||647
10413118|NCT00775944|11557296|FG002|STARTED|Overall Study||648
10413119|NCT00775944|11557297|FG003|STARTED|Overall Study||648
10413120|NCT00775944|11557294|FG000|COMPLETED|Overall Study|15 participants withdrew consent|633
10413121|NCT00775944|11557295|FG001|COMPLETED|Overall Study|9 participants withdrew consent|638
10413122|NCT00775944|11557296|FG002|COMPLETED|Overall Study|16 participants withdrew consent|632
10413123|NCT00775944|11557297|FG003|COMPLETED|Overall Study|16 participants withdrew consent|632
10413124|NCT00775944|11557294|FG000|NOT COMPLETED|Overall Study||15
10413125|NCT00775944|11557295|FG001|NOT COMPLETED|Overall Study||9
10413126|NCT00775944|11557296|FG002|NOT COMPLETED|Overall Study||16
10413127|NCT00775944|11557297|FG003|NOT COMPLETED|Overall Study||16
10413128|NCT00775983|11557309|FG000|STARTED|Overall Study||36
10413129|NCT00775983|11557310|FG001|STARTED|Overall Study||36
10413130|NCT00775983|11557309|FG000|COMPLETED|Overall Study||35
10413131|NCT00775983|11557310|FG001|COMPLETED|Overall Study||34
10413132|NCT00775983|11557309|FG000|NOT COMPLETED|Overall Study||1
10413133|NCT00775983|11557310|FG001|NOT COMPLETED|Overall Study||2
10413134|NCT00776009|11557322|FG000|STARTED|Period 1: First Intervention||26
10413135|NCT00776009|11557323|FG001|STARTED|Period 1: First Intervention||28
10413136|NCT00776009|11557324|FG002|STARTED|Period 1: First Intervention||29
10413137|NCT00776009|11557325|FG003|STARTED|Period 1: First Intervention||27
10413138|NCT00776009|11557326|FG004|STARTED|Period 1: First Intervention||28
10413139|NCT00776009|11557327|FG005|STARTED|Period 1: First Intervention||27
10413140|NCT00776009|11557322|FG000|COMPLETED|Period 1: First Intervention||26
10413141|NCT00776009|11557323|FG001|COMPLETED|Period 1: First Intervention||27
10413142|NCT00776009|11557324|FG002|COMPLETED|Period 1: First Intervention||28
10413143|NCT00776009|11557325|FG003|COMPLETED|Period 1: First Intervention||27
10413144|NCT00776009|11557326|FG004|COMPLETED|Period 1: First Intervention||26
10413145|NCT00776009|11557327|FG005|COMPLETED|Period 1: First Intervention||27
10413146|NCT00776009|11557322|FG000|NOT COMPLETED|Period 1: First Intervention||0
10413147|NCT00776009|11557323|FG001|NOT COMPLETED|Period 1: First Intervention||1
10413148|NCT00776009|11557324|FG002|NOT COMPLETED|Period 1: First Intervention||1
10413149|NCT00776009|11557325|FG003|NOT COMPLETED|Period 1: First Intervention||0
10413150|NCT00776009|11557326|FG004|NOT COMPLETED|Period 1: First Intervention||2
10413151|NCT00776009|11557327|FG005|NOT COMPLETED|Period 1: First Intervention||0
10413152|NCT00776009|11557322|FG000|STARTED|Period 2: Second Intervention||26
10413153|NCT00776009|11557323|FG001|STARTED|Period 2: Second Intervention||27
10413154|NCT00776009|11557324|FG002|STARTED|Period 2: Second Intervention||28
10413155|NCT00776009|11557325|FG003|STARTED|Period 2: Second Intervention||27
10413156|NCT00776009|11557326|FG004|STARTED|Period 2: Second Intervention||26
10413157|NCT00776009|11557327|FG005|STARTED|Period 2: Second Intervention||27
10413158|NCT00776009|11557322|FG000|COMPLETED|Period 2: Second Intervention||25
10413159|NCT00776009|11557323|FG001|COMPLETED|Period 2: Second Intervention||27
10413160|NCT00776009|11557324|FG002|COMPLETED|Period 2: Second Intervention||27
10413161|NCT00776009|11557325|FG003|COMPLETED|Period 2: Second Intervention||27
10413162|NCT00776009|11557326|FG004|COMPLETED|Period 2: Second Intervention||26
10413163|NCT00776009|11557327|FG005|COMPLETED|Period 2: Second Intervention||26
10413164|NCT00776009|11557322|FG000|NOT COMPLETED|Period 2: Second Intervention||1
10413165|NCT00776009|11557323|FG001|NOT COMPLETED|Period 2: Second Intervention||0
10413166|NCT00776009|11557324|FG002|NOT COMPLETED|Period 2: Second Intervention||1
10413167|NCT00776009|11557325|FG003|NOT COMPLETED|Period 2: Second Intervention||0
10413168|NCT00776009|11557326|FG004|NOT COMPLETED|Period 2: Second Intervention||0
10413169|NCT00776009|11557327|FG005|NOT COMPLETED|Period 2: Second Intervention||1
10413170|NCT00776009|11557322|FG000|STARTED|Period 3: Third Intervention||25
10413171|NCT00776009|11557323|FG001|STARTED|Period 3: Third Intervention||27
10413172|NCT00776009|11557324|FG002|STARTED|Period 3: Third Intervention||27
10413173|NCT00776009|11557325|FG003|STARTED|Period 3: Third Intervention||27
10413174|NCT00776009|11557326|FG004|STARTED|Period 3: Third Intervention||26
10413175|NCT00776009|11557327|FG005|STARTED|Period 3: Third Intervention||26
10413176|NCT00776009|11557322|FG000|COMPLETED|Period 3: Third Intervention||24
10413177|NCT00776009|11557323|FG001|COMPLETED|Period 3: Third Intervention||27
10413178|NCT00776009|11557324|FG002|COMPLETED|Period 3: Third Intervention||27
10413179|NCT00776009|11557325|FG003|COMPLETED|Period 3: Third Intervention||27
10413180|NCT00776009|11557326|FG004|COMPLETED|Period 3: Third Intervention||26
10413181|NCT00776009|11557327|FG005|COMPLETED|Period 3: Third Intervention||26
10413182|NCT00776009|11557322|FG000|NOT COMPLETED|Period 3: Third Intervention||1
10413183|NCT00776009|11557323|FG001|NOT COMPLETED|Period 3: Third Intervention||0
10413184|NCT00776009|11557324|FG002|NOT COMPLETED|Period 3: Third Intervention||0
10413185|NCT00776009|11557325|FG003|NOT COMPLETED|Period 3: Third Intervention||0
10429232|NCT00862849|11575286|FG000|STARTED|Intervention 5||3
10847235|NCT01550315|12013373|FG001|STARTED|Overall Study||7
10847236|NCT01550315|12013374|FG002|STARTED|Overall Study||6
10847237|NCT01550315|12013375|FG003|STARTED|Overall Study||7
10847238|NCT01550315|12013372|FG000|COMPLETED|Overall Study||7
10847239|NCT01550315|12013373|FG001|COMPLETED|Overall Study||7
10847240|NCT01550315|12013374|FG002|COMPLETED|Overall Study||6
10847241|NCT01550315|12013375|FG003|COMPLETED|Overall Study||7
10847242|NCT01550315|12013372|FG000|NOT COMPLETED|Overall Study||0
10847243|NCT01550315|12013373|FG001|NOT COMPLETED|Overall Study||0
10847244|NCT01550315|12013374|FG002|NOT COMPLETED|Overall Study||0
10847245|NCT01550315|12013375|FG003|NOT COMPLETED|Overall Study||0
10847246|NCT01519960|12013388|FG000|STARTED|Overall Study||101
10847247|NCT01519960|12013389|FG001|STARTED|Overall Study||50
10847248|NCT01519960|12013390|FG002|STARTED|Overall Study||10
10847249|NCT01519960|12013388|FG000|Completed Week 48|Overall Study||99
10847250|NCT01519960|12013389|FG001|Completed Week 48|Overall Study||47
10847251|NCT01519960|12013390|FG002|Completed Week 48|Overall Study||10
10847252|NCT01519960|12013388|FG000|Completed Follow-Up (FU) Week 12|Overall Study||101
10847253|NCT01519960|12013389|FG001|Completed Follow-Up (FU) Week 12|Overall Study||26
10847254|NCT01519960|12013390|FG002|Completed Follow-Up (FU) Week 12|Overall Study||10
10847255|NCT01519960|12013388|FG000|Completed FU Week 24|Overall Study||101
10847256|NCT01519960|12013389|FG001|Completed FU Week 24|Overall Study||15
10847257|NCT01519960|12013390|FG002|Completed FU Week 24|Overall Study||10
10847258|NCT01519960|12013388|FG000|COMPLETED|Overall Study||0
10847259|NCT01519960|12013389|FG001|COMPLETED|Overall Study||0
10847260|NCT01519960|12013390|FG002|COMPLETED|Overall Study||0
10847261|NCT01519960|12013388|FG000|NOT COMPLETED|Overall Study||101
10847262|NCT01519960|12013389|FG001|NOT COMPLETED|Overall Study||50
10847263|NCT01519960|12013390|FG002|NOT COMPLETED|Overall Study||10
10847264|NCT00688376|12013403|FG000|STARTED|Double-Blind Phase||40
10847265|NCT00688376|12013404|FG001|STARTED|Double-Blind Phase||32
10847266|NCT00688376|12013403|FG000|Safety Population|Double-Blind Phase||40
10847267|NCT00688376|12013404|FG001|Safety Population|Double-Blind Phase||31
10847268|NCT00688376|12013403|FG000|COMPLETED|Double-Blind Phase||34
10847269|NCT00688376|12013404|FG001|COMPLETED|Double-Blind Phase||25
10847270|NCT00688376|12013403|FG000|NOT COMPLETED|Double-Blind Phase||6
10847271|NCT00688376|12013404|FG001|NOT COMPLETED|Double-Blind Phase||7
10847272|NCT00688376|12013403|FG000|STARTED|Blinded Extension Phase||34
10847273|NCT00688376|12013404|FG001|STARTED|Blinded Extension Phase||25
10847274|NCT00688376|12013403|FG000|COMPLETED|Blinded Extension Phase||29
10847275|NCT00688376|12013404|FG001|COMPLETED|Blinded Extension Phase||20
10847276|NCT00688376|12013403|FG000|NOT COMPLETED|Blinded Extension Phase||5
10847277|NCT00688376|12013404|FG001|NOT COMPLETED|Blinded Extension Phase||5
10847278|NCT00604201|12013412|FG000|STARTED|Overall Study||31
10847279|NCT00604201|12013412|FG000|COMPLETED|Overall Study||21
10847280|NCT00604201|12013412|FG000|NOT COMPLETED|Overall Study||10
10847281|NCT00492349|12013418|FG000|STARTED|Overall Study||35
10847282|NCT00492349|12013419|FG001|STARTED|Overall Study||34
10847283|NCT00492349|12013418|FG000|Week 2|Overall Study||32
10847284|NCT00492349|12013419|FG001|Week 2|Overall Study||33
10847285|NCT00492349|12013418|FG000|Week 8|Overall Study||32
10847286|NCT00492349|12013419|FG001|Week 8|Overall Study||27
10847287|NCT00492349|12013418|FG000|COMPLETED|Overall Study||32
10847288|NCT00492349|12013419|FG001|COMPLETED|Overall Study||27
10847289|NCT00492349|12013418|FG000|NOT COMPLETED|Overall Study||3
10847290|NCT00492349|12013419|FG001|NOT COMPLETED|Overall Study||7
10847291|NCT00121108|12013431|FG000|STARTED|Overall Study||710
10847292|NCT00121108|12013432|FG001|STARTED|Overall Study||1417
10847293|NCT00121108|12013431|FG000|COMPLETED|Overall Study||589
10847294|NCT00121108|12013432|FG001|COMPLETED|Overall Study||1192
10847295|NCT00121108|12013431|FG000|NOT COMPLETED|Overall Study||121
10847296|NCT00121108|12013432|FG001|NOT COMPLETED|Overall Study||225
10847297|NCT00003102|12013442|FG000|STARTED|Overall Study||3
10847298|NCT00003102|12013443|FG001|STARTED|Overall Study||9
10847299|NCT00003102|12013444|FG002|STARTED|Overall Study||3
10847300|NCT00003102|12013442|FG000|COMPLETED|Overall Study||2
10847301|NCT00003102|12013443|FG001|COMPLETED|Overall Study||6
10847302|NCT00003102|12013444|FG002|COMPLETED|Overall Study||1
10847303|NCT00003102|12013442|FG000|NOT COMPLETED|Overall Study||1
10847304|NCT00003102|12013443|FG001|NOT COMPLETED|Overall Study||3
10847305|NCT00003102|12013444|FG002|NOT COMPLETED|Overall Study||2
10292759|NCT02425826|11425577|FG002|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)||0
10292760|NCT02425826|11425575|FG000|COMPLETED|Placebo-controlled Phase (Week 0 - 16)|Completed = participants who completed Week 16|121
10292761|NCT02425826|11425576|FG001|COMPLETED|Placebo-controlled Phase (Week 0 - 16)|Completed = participants who completed Week 16|64
10292762|NCT02425826|11425577|FG002|COMPLETED|Placebo-controlled Phase (Week 0 - 16)||0
10292763|NCT02425826|11425575|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||27
10292764|NCT02425826|11425576|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||9
10292765|NCT02425826|11425577|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||0
10292766|NCT02425826|11425575|FG000|STARTED|Apremilast Extension Phase (Weeks 16-52)||121
10292767|NCT02425826|11425576|FG001|STARTED|Apremilast Extension Phase (Weeks 16-52)||0
10292768|NCT02425826|11425577|FG002|STARTED|Apremilast Extension Phase (Weeks 16-52)||64
10847306|NCT04633837|12013454|FG000|STARTED|Overall Study||5
10847307|NCT04633837|12013455|FG001|STARTED|Overall Study||0
10847308|NCT04633837|12013454|FG000|COMPLETED|Overall Study||0
10847309|NCT04633837|12013455|FG001|COMPLETED|Overall Study||0
10847310|NCT04633837|12013454|FG000|NOT COMPLETED|Overall Study||5
10847311|NCT04633837|12013455|FG001|NOT COMPLETED|Overall Study||0
10847312|NCT04057937|12013463|FG000|STARTED|Placebo-controlled Phase||44
10847313|NCT04057937|12013464|FG001|STARTED|Placebo-controlled Phase||46
10847314|NCT04057937|12013463|FG000|COMPLETED|Placebo-controlled Phase||41
10847315|NCT04057937|12013464|FG001|COMPLETED|Placebo-controlled Phase||46
10847316|NCT04057937|12013463|FG000|NOT COMPLETED|Placebo-controlled Phase||3
10847317|NCT04057937|12013464|FG001|NOT COMPLETED|Placebo-controlled Phase||0
10847318|NCT04057937|12013463|FG000|STARTED|Active-treatment Phase||41
10847319|NCT04057937|12013464|FG001|STARTED|Active-treatment Phase||46
10847320|NCT04057937|12013463|FG000|COMPLETED|Active-treatment Phase||40
10847321|NCT04057937|12013464|FG001|COMPLETED|Active-treatment Phase||44
10847322|NCT04057937|12013463|FG000|NOT COMPLETED|Active-treatment Phase||1
10847323|NCT04057937|12013464|FG001|NOT COMPLETED|Active-treatment Phase||2
10847324|NCT03566732|12013471|FG000|STARTED|Overall Study|1683 eligible cases identified and screened, 914 participants enrolled.|914
10847325|NCT03566732|12013471|FG000|COMPLETED|Overall Study|914 completed questionnaires|914
10847326|NCT03566732|12013471|FG000|NOT COMPLETED|Overall Study||0
10847327|NCT03032510|12013477|FG000|STARTED|Overall Study||603
10847328|NCT03032510|12013478|FG001|STARTED|Overall Study||602
10847329|NCT03032510|12013477|FG000|COMPLETED|Overall Study||576
10847330|NCT03032510|12013478|FG001|COMPLETED|Overall Study||584
10847331|NCT03032510|12013477|FG000|NOT COMPLETED|Overall Study||27
10847332|NCT03032510|12013478|FG001|NOT COMPLETED|Overall Study||18
10847333|NCT03029000|12013488|FG000|STARTED|Overall Study||1
10847334|NCT03029000|12013488|FG000|COMPLETED|Overall Study||1
10847335|NCT03029000|12013488|FG000|NOT COMPLETED|Overall Study||0
10847336|NCT03022292|12013492|FG000|STARTED|Overall Study||26
10847337|NCT03022292|12013492|FG000|COMPLETED|Overall Study||24
10847338|NCT03022292|12013492|FG000|NOT COMPLETED|Overall Study||2
10847339|NCT02968602|12013498|FG000|STARTED|Overall Study||16
10847340|NCT02968602|12013499|FG001|STARTED|Overall Study||16
10847341|NCT02968602|12013498|FG000|COMPLETED|Overall Study||16
10847342|NCT02968602|12013499|FG001|COMPLETED|Overall Study||16
10847343|NCT02968602|12013498|FG000|NOT COMPLETED|Overall Study||0
10847344|NCT02968602|12013499|FG001|NOT COMPLETED|Overall Study||0
10847345|NCT02946047|12013509|FG000|STARTED|Overall Study||4
10847346|NCT02946047|12013510|FG001|STARTED|Overall Study||3
10847347|NCT02946047|12013511|FG002|STARTED|Overall Study||3
10847348|NCT02946047|12013512|FG003|STARTED|Overall Study||7
10847349|NCT02946047|12013509|FG000|COMPLETED|Overall Study||3
10847350|NCT02946047|12013510|FG001|COMPLETED|Overall Study||3
10847351|NCT02946047|12013511|FG002|COMPLETED|Overall Study||3
10847352|NCT02946047|12013512|FG003|COMPLETED|Overall Study||7
10847353|NCT02946047|12013509|FG000|NOT COMPLETED|Overall Study||1
10847354|NCT02946047|12013510|FG001|NOT COMPLETED|Overall Study||0
10847355|NCT02946047|12013511|FG002|NOT COMPLETED|Overall Study||0
10847356|NCT02946047|12013512|FG003|NOT COMPLETED|Overall Study||0
10847357|NCT02830165|12013522|FG000|STARTED|Overall Study||11
10847358|NCT02830165|12013522|FG000|COMPLETED|Overall Study||11
10847359|NCT02830165|12013522|FG000|NOT COMPLETED|Overall Study||0
10847360|NCT02784704|12013530|FG000|STARTED|Overall Study||250
10847361|NCT02784704|12013531|FG001|STARTED|Overall Study||250
10847362|NCT02784704|12013530|FG000|Treated|Overall Study||250
10847363|NCT02784704|12013531|FG001|Treated|Overall Study||249
10847364|NCT02784704|12013530|FG000|COMPLETED|Overall Study||237
10847365|NCT02784704|12013531|FG001|COMPLETED|Overall Study||241
10847366|NCT02784704|12013530|FG000|NOT COMPLETED|Overall Study||13
10847367|NCT02784704|12013531|FG001|NOT COMPLETED|Overall Study||9
10847368|NCT04831515|12013539|FG000|STARTED|First Intervention||24
10847369|NCT04831515|12013540|FG001|STARTED|First Intervention||24
10847370|NCT04831515|12013539|FG000|COMPLETED|First Intervention||24
10847371|NCT04831515|12013540|FG001|COMPLETED|First Intervention||23
10847372|NCT04831515|12013539|FG000|NOT COMPLETED|First Intervention||0
10847373|NCT04831515|12013540|FG001|NOT COMPLETED|First Intervention||1
10847374|NCT04831515|12013539|FG000|STARTED|Second Intervention||24
10847375|NCT04831515|12013540|FG001|STARTED|Second Intervention||23
10847376|NCT04831515|12013539|FG000|COMPLETED|Second Intervention||24
10847377|NCT04831515|12013540|FG001|COMPLETED|Second Intervention||23
10847378|NCT04831515|12013539|FG000|NOT COMPLETED|Second Intervention||0
10847379|NCT04831515|12013540|FG001|NOT COMPLETED|Second Intervention||0
10847380|NCT04634409|12013573|FG000|STARTED|Overall Study||155
10847381|NCT04634409|12013574|FG001|STARTED|Overall Study||83
10847382|NCT04634409|12013575|FG002|STARTED|Overall Study||158
10847383|NCT04634409|12013576|FG003|STARTED|Overall Study||103
10847384|NCT04634409|12013577|FG004|STARTED|Overall Study||105
10847385|NCT04634409|12013578|FG005|STARTED|Overall Study||101
10847386|NCT04634409|12013579|FG006|STARTED|Overall Study|During the study period, 20 participants from the BAM 175-mg + ETE 350-mg arm potentially received 700 mg bamlanivimab + 700 mg etesevimab instead. These 20 participants, who were randomized at 8 different sites were identified through pharmacokinetics analyses.|20
10847387|NCT04634409|12013580|FG007|STARTED|Overall Study||101
10847388|NCT04634409|12013581|FG008|STARTED|Overall Study||101
10847389|NCT04634409|12013582|FG009|STARTED|Overall Study||125
10847390|NCT04634409|12013583|FG010|STARTED|Overall Study||127
10847391|NCT04634409|12013584|FG011|STARTED|Overall Study||128
10847392|NCT04634409|12013585|FG012|STARTED|Overall Study||100
10847393|NCT04634409|12013586|FG013|STARTED|Overall Study||50
10847394|NCT04634409|12013587|FG014|STARTED|Overall Study||176
10847395|NCT04634409|12013588|FG015|STARTED|Overall Study||30
10847396|NCT04634409|12013589|FG016|STARTED|Overall Study||6
10847397|NCT04634409|12013590|FG017|STARTED|Overall Study||30
10847398|NCT04634409|12013591|FG018|STARTED|Overall Study||10
10847399|NCT04634409|12013592|FG019|STARTED|Overall Study||6
10847400|NCT04634409|12013593|FG020|STARTED|Overall Study||6
10847401|NCT04634409|12013594|FG021|STARTED|Overall Study||6
10847402|NCT04634409|12013595|FG022|STARTED|Overall Study||6
10847403|NCT04634409|12013596|FG023|STARTED|Overall Study||6
10847404|NCT04634409|12013597|FG024|STARTED|Overall Study||4
10847405|NCT04634409|12013598|FG025|STARTED|Overall Study||6
10847406|NCT04634409|12013599|FG026|STARTED|Overall Study||6
10847407|NCT04634409|12013573|FG000|Received at Least One Dose of Study Drug|Overall Study||155
10847408|NCT04634409|12013574|FG001|Received at Least One Dose of Study Drug|Overall Study||83
10847409|NCT04634409|12013575|FG002|Received at Least One Dose of Study Drug|Overall Study||158
10847410|NCT04634409|12013576|FG003|Received at Least One Dose of Study Drug|Overall Study||103
10847411|NCT04634409|12013577|FG004|Received at Least One Dose of Study Drug|Overall Study||105
10847412|NCT04634409|12013578|FG005|Received at Least One Dose of Study Drug|Overall Study||101
10847413|NCT04634409|12013579|FG006|Received at Least One Dose of Study Drug|Overall Study||20
10847414|NCT04634409|12013580|FG007|Received at Least One Dose of Study Drug|Overall Study||101
10847415|NCT04634409|12013581|FG008|Received at Least One Dose of Study Drug|Overall Study||101
10847416|NCT04634409|12013582|FG009|Received at Least One Dose of Study Drug|Overall Study||125
10847417|NCT04634409|12013583|FG010|Received at Least One Dose of Study Drug|Overall Study||127
10847418|NCT04634409|12013584|FG011|Received at Least One Dose of Study Drug|Overall Study||128
10847419|NCT04634409|12013585|FG012|Received at Least One Dose of Study Drug|Overall Study||100
10847420|NCT04634409|12013586|FG013|Received at Least One Dose of Study Drug|Overall Study||50
10847421|NCT04634409|12013587|FG014|Received at Least One Dose of Study Drug|Overall Study||176
10847422|NCT04634409|12013588|FG015|Received at Least One Dose of Study Drug|Overall Study||30
10847423|NCT04634409|12013589|FG016|Received at Least One Dose of Study Drug|Overall Study||6
10847424|NCT04634409|12013590|FG017|Received at Least One Dose of Study Drug|Overall Study||30
10847425|NCT04634409|12013591|FG018|Received at Least One Dose of Study Drug|Overall Study||10
10847426|NCT04634409|12013592|FG019|Received at Least One Dose of Study Drug|Overall Study||6
10847427|NCT04634409|12013593|FG020|Received at Least One Dose of Study Drug|Overall Study||6
10847428|NCT04634409|12013594|FG021|Received at Least One Dose of Study Drug|Overall Study||6
10847429|NCT04634409|12013595|FG022|Received at Least One Dose of Study Drug|Overall Study||6
10754695|NCT03054649|11918435|FG001|NOT COMPLETED|Overall Study||0
10754696|NCT03054740|11918466|FG000|STARTED|Overall Study||15
10754697|NCT03054740|11918467|FG001|STARTED|Overall Study||15
10754698|NCT03054740|11918466|FG000|COMPLETED|Overall Study||15
10754699|NCT03054740|11918467|FG001|COMPLETED|Overall Study||15
10754700|NCT03054740|11918466|FG000|NOT COMPLETED|Overall Study||0
10754701|NCT03054740|11918467|FG001|NOT COMPLETED|Overall Study||0
10754702|NCT03054805|11918476|FG000|STARTED|Overall Study||58
10754703|NCT03054805|11918477|FG001|STARTED|Overall Study||51
10847430|NCT04634409|12013596|FG023|Received at Least One Dose of Study Drug|Overall Study||6
10847431|NCT04634409|12013597|FG024|Received at Least One Dose of Study Drug|Overall Study||4
10847432|NCT04634409|12013598|FG025|Received at Least One Dose of Study Drug|Overall Study||6
10847433|NCT04634409|12013599|FG026|Received at Least One Dose of Study Drug|Overall Study||6
10847434|NCT04634409|12013573|FG000|COMPLETED|Overall Study||148
10847435|NCT04634409|12013574|FG001|COMPLETED|Overall Study||81
10847436|NCT04634409|12013575|FG002|COMPLETED|Overall Study||150
10847437|NCT04634409|12013576|FG003|COMPLETED|Overall Study||96
10847438|NCT04634409|12013577|FG004|COMPLETED|Overall Study||102
10847439|NCT04634409|12013578|FG005|COMPLETED|Overall Study||99
10847440|NCT04634409|12013579|FG006|COMPLETED|Overall Study||19
10847441|NCT04634409|12013580|FG007|COMPLETED|Overall Study||90
10847442|NCT04634409|12013581|FG008|COMPLETED|Overall Study||91
10847443|NCT04634409|12013582|FG009|COMPLETED|Overall Study||112
10847444|NCT04634409|12013583|FG010|COMPLETED|Overall Study||114
10847445|NCT04634409|12013584|FG011|COMPLETED|Overall Study||109
10413186|NCT00776009|11557326|FG004|NOT COMPLETED|Period 3: Third Intervention||0
10413187|NCT00776009|11557327|FG005|NOT COMPLETED|Period 3: Third Intervention||0
10413188|NCT00776230|11557338|FG000|STARTED|Overall Study||99
10413189|NCT00776230|11557339|FG001|STARTED|Overall Study||103
10413190|NCT00776230|11557340|FG002|STARTED|Overall Study||102
10413191|NCT00776230|11557338|FG000|Enrolled and Vaccinated at Day 0|Overall Study||98
10413192|NCT00776230|11557339|FG001|Enrolled and Vaccinated at Day 0|Overall Study||103
10413193|NCT00776230|11557340|FG002|Enrolled and Vaccinated at Day 0|Overall Study||102
10413194|NCT00776230|11557338|FG000|COMPLETED|Overall Study||96
10413195|NCT00776230|11557339|FG001|COMPLETED|Overall Study||100
10413196|NCT00776230|11557340|FG002|COMPLETED|Overall Study||97
10413197|NCT00776230|11557338|FG000|NOT COMPLETED|Overall Study||3
10413198|NCT00776230|11557339|FG001|NOT COMPLETED|Overall Study||3
10754704|NCT03054805|11918478|FG002|STARTED|Overall Study||44
10413199|NCT00776230|11557340|FG002|NOT COMPLETED|Overall Study||5
10413200|NCT00776295|11557348|FG000|STARTED|Overall Study||2
10413201|NCT00776295|11557348|FG000|COMPLETED|Overall Study||2
10413202|NCT00776295|11557348|FG000|NOT COMPLETED|Overall Study||0
10754705|NCT03054805|11918476|FG000|COMPLETED|Overall Study||42
10754706|NCT03054805|11918477|FG001|COMPLETED|Overall Study||41
10754707|NCT03054805|11918478|FG002|COMPLETED|Overall Study||42
10754708|NCT03054805|11918476|FG000|NOT COMPLETED|Overall Study||16
10754709|NCT03054805|11918477|FG001|NOT COMPLETED|Overall Study||10
10847446|NCT04634409|12013585|FG012|COMPLETED|Overall Study||92
10847447|NCT04634409|12013586|FG013|COMPLETED|Overall Study||46
10847448|NCT04634409|12013587|FG014|COMPLETED|Overall Study||164
10847449|NCT04634409|12013588|FG015|COMPLETED|Overall Study||30
10847450|NCT04634409|12013589|FG016|COMPLETED|Overall Study||6
10847451|NCT04634409|12013590|FG017|COMPLETED|Overall Study||29
10847452|NCT04634409|12013591|FG018|COMPLETED|Overall Study||10
10847453|NCT04634409|12013592|FG019|COMPLETED|Overall Study||6
10847454|NCT04634409|12013593|FG020|COMPLETED|Overall Study||6
10847455|NCT04634409|12013594|FG021|COMPLETED|Overall Study||6
10847456|NCT04634409|12013595|FG022|COMPLETED|Overall Study||6
10847457|NCT04634409|12013596|FG023|COMPLETED|Overall Study||5
10847458|NCT04634409|12013597|FG024|COMPLETED|Overall Study||4
10847459|NCT04634409|12013598|FG025|COMPLETED|Overall Study||6
10847460|NCT04634409|12013599|FG026|COMPLETED|Overall Study||6
10847461|NCT04634409|12013573|FG000|NOT COMPLETED|Overall Study||7
10847462|NCT04634409|12013574|FG001|NOT COMPLETED|Overall Study||2
10847463|NCT04634409|12013575|FG002|NOT COMPLETED|Overall Study||8
10847464|NCT04634409|12013576|FG003|NOT COMPLETED|Overall Study||7
10847465|NCT04634409|12013577|FG004|NOT COMPLETED|Overall Study||3
10847466|NCT04634409|12013578|FG005|NOT COMPLETED|Overall Study||2
10847467|NCT04634409|12013579|FG006|NOT COMPLETED|Overall Study||1
10847468|NCT04634409|12013580|FG007|NOT COMPLETED|Overall Study||11
10847469|NCT04634409|12013581|FG008|NOT COMPLETED|Overall Study||10
10847470|NCT04634409|12013582|FG009|NOT COMPLETED|Overall Study||13
10847471|NCT04634409|12013583|FG010|NOT COMPLETED|Overall Study||13
10847472|NCT04634409|12013584|FG011|NOT COMPLETED|Overall Study||19
10847473|NCT04634409|12013585|FG012|NOT COMPLETED|Overall Study||8
10847474|NCT04634409|12013586|FG013|NOT COMPLETED|Overall Study||4
10847475|NCT04634409|12013587|FG014|NOT COMPLETED|Overall Study||12
10847476|NCT04634409|12013588|FG015|NOT COMPLETED|Overall Study||0
10847477|NCT04634409|12013589|FG016|NOT COMPLETED|Overall Study||0
10847478|NCT04634409|12013590|FG017|NOT COMPLETED|Overall Study||1
10847479|NCT04634409|12013591|FG018|NOT COMPLETED|Overall Study||0
10847480|NCT04634409|12013592|FG019|NOT COMPLETED|Overall Study||0
10847481|NCT04634409|12013593|FG020|NOT COMPLETED|Overall Study||0
10847482|NCT04634409|12013594|FG021|NOT COMPLETED|Overall Study||0
10847483|NCT04634409|12013595|FG022|NOT COMPLETED|Overall Study||0
10847484|NCT04634409|12013596|FG023|NOT COMPLETED|Overall Study||1
10847485|NCT04634409|12013597|FG024|NOT COMPLETED|Overall Study||0
10847486|NCT04634409|12013598|FG025|NOT COMPLETED|Overall Study||0
10847487|NCT04634409|12013599|FG026|NOT COMPLETED|Overall Study||0
10847488|NCT04286412|12013677|FG000|STARTED|Overall Study||25
10847489|NCT04286412|12013677|FG000|COMPLETED|Overall Study||25
10847490|NCT04286412|12013677|FG000|NOT COMPLETED|Overall Study||0
10847491|NCT04278846|12013683|FG000|STARTED|Overall Study|No longer patients to study|25
10847492|NCT04278846|12013684|FG001|STARTED|Overall Study||25
10847493|NCT04278846|12013683|FG000|COMPLETED|Overall Study||25
10847494|NCT04278846|12013684|FG001|COMPLETED|Overall Study||25
10847495|NCT04278846|12013683|FG000|NOT COMPLETED|Overall Study||0
10847496|NCT04278846|12013684|FG001|NOT COMPLETED|Overall Study||0
10545283|NCT01496066|11698590|FG001|NOT COMPLETED|Overall Study||9
10545284|NCT01496131|11698605|FG000|STARTED|Overall Study||14
10545285|NCT01496131|11698606|FG001|STARTED|Overall Study||14
10545286|NCT01496131|11698605|FG000|COMPLETED|Overall Study||14
10545287|NCT01496131|11698606|FG001|COMPLETED|Overall Study||14
10545288|NCT01496131|11698605|FG000|NOT COMPLETED|Overall Study||0
10545289|NCT01496131|11698606|FG001|NOT COMPLETED|Overall Study||0
10545290|NCT01496157|11698612|FG000|STARTED|Overall Study||13
10545291|NCT01496157|11698612|FG000|COMPLETED|Overall Study||13
10545292|NCT01496157|11698612|FG000|NOT COMPLETED|Overall Study||0
10545293|NCT01496183|11698618|FG000|STARTED|Overall Study||9
10545294|NCT01496183|11698619|FG001|STARTED|Overall Study||15
10545295|NCT01496183|11698618|FG000|COMPLETED|Overall Study||6
10545296|NCT01496183|11698619|FG001|COMPLETED|Overall Study||13
10545297|NCT01496183|11698618|FG000|NOT COMPLETED|Overall Study||3
10545298|NCT01496183|11698619|FG001|NOT COMPLETED|Overall Study||2
10545299|NCT01496248|11698626|FG000|STARTED|Overall Study||35
10545300|NCT01496248|11698626|FG000|COMPLETED|Overall Study||25
10545301|NCT01496248|11698626|FG000|NOT COMPLETED|Overall Study||10
10545302|NCT01496274|11698632|FG000|STARTED|Overall Study||40
10545303|NCT01496274|11698633|FG001|STARTED|Overall Study||23
10545304|NCT01496274|11698632|FG000|COMPLETED|Overall Study||37
10545305|NCT01496274|11698633|FG001|COMPLETED|Overall Study||18
10545306|NCT01496274|11698632|FG000|NOT COMPLETED|Overall Study||3
10545307|NCT01496274|11698633|FG001|NOT COMPLETED|Overall Study||5
10545308|NCT01496287|11698654|FG000|STARTED|Overall Study||70
10545309|NCT01496287|11698654|FG000|COMPLETED|Overall Study||64
10545310|NCT01496287|11698654|FG000|NOT COMPLETED|Overall Study||6
10545311|NCT01496313|11698661|FG000|STARTED|Overall Study||40
10545312|NCT01496313|11698662|FG001|STARTED|Overall Study||41
10754710|NCT03054805|11918478|FG002|NOT COMPLETED|Overall Study||2
10754711|NCT03054844|11918488|FG000|STARTED|Overall Study||28
10754712|NCT03054844|11918489|FG001|STARTED|Overall Study||27
10754713|NCT03054844|11918488|FG000|COMPLETED|Overall Study||25
10754714|NCT03054844|11918489|FG001|COMPLETED|Overall Study||26
10754715|NCT03054844|11918488|FG000|NOT COMPLETED|Overall Study||3
10754716|NCT03054844|11918489|FG001|NOT COMPLETED|Overall Study||1
10754717|NCT03054857|11918497|FG000|STARTED|Overall Study||50
10754718|NCT03054857|11918498|FG001|STARTED|Overall Study||50
10754719|NCT03054857|11918497|FG000|COMPLETED|Overall Study||49
10754720|NCT03054857|11918498|FG001|COMPLETED|Overall Study||50
10754721|NCT03054857|11918497|FG000|NOT COMPLETED|Overall Study||1
10754722|NCT03054857|11918498|FG001|NOT COMPLETED|Overall Study||0
10754723|NCT03054870|11918508|FG000|STARTED|Day of Ventilation Imaging|16 of 226 enrolled subjects were withdrawn from the study prior to receiving Technegas and were not included in further study assessments.|210
10754724|NCT03054870|11918508|FG000|COMPLETED|Day of Ventilation Imaging||205
10754725|NCT03054870|11918508|FG000|NOT COMPLETED|Day of Ventilation Imaging||5
10754726|NCT03054870|11918508|FG000|STARTED|24-hour Follow-up|24-hour follow-up was omitted from Protocol Amendment 1, so 92 subjects enrolled under Amendment 1 not included.|118
10754727|NCT03054870|11918508|FG000|COMPLETED|24-hour Follow-up||118
10754728|NCT03054870|11918508|FG000|NOT COMPLETED|24-hour Follow-up||0
10754729|NCT03054870|11918508|FG000|STARTED|Blinded Read of Images|At time of study termination, 200 subjects had completed the blinded read assessments. The decision to terminate was based on the positive results of an unplanned interim analysis of these blind read data by a third party statistician.|200
10754730|NCT03054870|11918508|FG000|COMPLETED|Blinded Read of Images||200
10754731|NCT03054870|11918508|FG000|NOT COMPLETED|Blinded Read of Images||0
10754732|NCT03054922|11918526|FG000|STARTED|Overall Study||20
10754733|NCT03054922|11918527|FG001|STARTED|Overall Study||19
10754734|NCT03054922|11918528|FG002|STARTED|Overall Study||20
10754735|NCT03054922|11918526|FG000|COMPLETED|Overall Study||20
10754736|NCT03054922|11918527|FG001|COMPLETED|Overall Study||19
10754737|NCT03054922|11918528|FG002|COMPLETED|Overall Study||20
10754738|NCT03054922|11918526|FG000|NOT COMPLETED|Overall Study||0
10754739|NCT03054922|11918527|FG001|NOT COMPLETED|Overall Study||0
10754740|NCT03054922|11918528|FG002|NOT COMPLETED|Overall Study||0
10754741|NCT03055000|11918539|FG000|STARTED|Overall Study||16
10754742|NCT03055000|11918540|FG001|STARTED|Overall Study||17
10754743|NCT03055000|11918541|FG002|STARTED|Overall Study||16
10754744|NCT03055000|11918539|FG000|COMPLETED|Overall Study||16
10754745|NCT03055000|11918540|FG001|COMPLETED|Overall Study||17
10754746|NCT03055000|11918541|FG002|COMPLETED|Overall Study||16
10545313|NCT01496313|11698661|FG000|COMPLETED|Overall Study||35
10545314|NCT01496313|11698662|FG001|COMPLETED|Overall Study||26
10545315|NCT01496313|11698661|FG000|NOT COMPLETED|Overall Study||5
10545316|NCT01496313|11698662|FG001|NOT COMPLETED|Overall Study||15
10545317|NCT01496352|11698670|FG000|STARTED|Overall Study||24
10545318|NCT01496352|11698671|FG001|STARTED|Overall Study||6
10545319|NCT01496352|11698670|FG000|COMPLETED|Overall Study||24
10661271|NCT02258074|11823149|FG003|COMPLETED|Overall Study||51
10661272|NCT02258074|11823146|FG000|NOT COMPLETED|Overall Study||1
10661273|NCT02258074|11823147|FG001|NOT COMPLETED|Overall Study||0
10661274|NCT02258074|11823148|FG002|NOT COMPLETED|Overall Study||0
10661275|NCT02258074|11823149|FG003|NOT COMPLETED|Overall Study||0
10661276|NCT02258139|11823159|FG000|STARTED|Overall Study||38
10661277|NCT02258139|11823159|FG000|COMPLETED|Overall Study||30
10661278|NCT02258139|11823159|FG000|NOT COMPLETED|Overall Study||8
10661279|NCT02258152|11823167|FG000|STARTED|Overall Study||44
10661280|NCT02258152|11823168|FG001|STARTED|Overall Study||38
10661281|NCT02258152|11823167|FG000|COMPLETED|Overall Study||38
10661282|NCT02258152|11823168|FG001|COMPLETED|Overall Study||34
10661283|NCT02258152|11823167|FG000|NOT COMPLETED|Overall Study||6
10661284|NCT02258152|11823168|FG001|NOT COMPLETED|Overall Study||4
10545320|NCT01496352|11698671|FG001|COMPLETED|Overall Study||6
10545321|NCT01496352|11698670|FG000|NOT COMPLETED|Overall Study||0
10545322|NCT01496352|11698671|FG001|NOT COMPLETED|Overall Study||0
10545323|NCT01496365|11698693|FG000|STARTED|Overall Study||112
10545324|NCT01496365|11698694|FG001|STARTED|Overall Study||56
10545325|NCT01496365|11698695|FG002|STARTED|Overall Study||57
10545326|NCT01496365|11698696|FG003|STARTED|Overall Study||57
10545327|NCT01496365|11698697|FG004|STARTED|Overall Study||57
10545328|NCT01496365|11698698|FG005|STARTED|Overall Study||56
10545329|NCT01496365|11698699|FG006|STARTED|Overall Study||57
10545330|NCT01496365|11698693|FG000|COMPLETED|Overall Study||97
10545331|NCT01496365|11698694|FG001|COMPLETED|Overall Study||41
10545332|NCT01496365|11698695|FG002|COMPLETED|Overall Study||51
10545333|NCT01496365|11698696|FG003|COMPLETED|Overall Study||53
10545334|NCT01496365|11698697|FG004|COMPLETED|Overall Study||44
10545335|NCT01496365|11698698|FG005|COMPLETED|Overall Study||46
10545336|NCT01496365|11698699|FG006|COMPLETED|Overall Study||51
10545337|NCT01496365|11698693|FG000|NOT COMPLETED|Overall Study||15
10545338|NCT01496365|11698694|FG001|NOT COMPLETED|Overall Study||15
10545339|NCT01496365|11698695|FG002|NOT COMPLETED|Overall Study||6
10545340|NCT01496365|11698696|FG003|NOT COMPLETED|Overall Study||4
10545341|NCT01496365|11698697|FG004|NOT COMPLETED|Overall Study||13
10545342|NCT01496365|11698698|FG005|NOT COMPLETED|Overall Study||10
10545343|NCT01496365|11698699|FG006|NOT COMPLETED|Overall Study||6
10545344|NCT01496430|11698718|FG000|STARTED|Overall Study||35
10545345|NCT01496430|11698719|FG001|STARTED|Overall Study||35
10545346|NCT01496430|11698720|FG002|STARTED|Overall Study||35
10545347|NCT01496430|11698718|FG000|COMPLETED|Overall Study||29
10545348|NCT01496430|11698719|FG001|COMPLETED|Overall Study||30
10545349|NCT01496430|11698720|FG002|COMPLETED|Overall Study||25
10545350|NCT01496430|11698718|FG000|NOT COMPLETED|Overall Study||6
10545351|NCT01496430|11698719|FG001|NOT COMPLETED|Overall Study||5
10545352|NCT01496430|11698720|FG002|NOT COMPLETED|Overall Study||10
10545353|NCT01496456|11698728|FG000|STARTED|Overall Study||17
10545354|NCT01496456|11698728|FG000|Baseline|Overall Study|Baseline group started with 16 patients.|16
10545355|NCT01496456|11698728|FG000|1-yr Recall|Overall Study||12
10545356|NCT01496456|11698728|FG000|2-yr Recall|Overall Study||10
10545357|NCT01496456|11698728|FG000|3-yr Final Recall|Overall Study||9
10545358|NCT01496456|11698728|FG000|COMPLETED|Overall Study||9
10545359|NCT01496456|11698728|FG000|NOT COMPLETED|Overall Study||8
10545360|NCT01496469|11698737|FG000|STARTED|Overall Study||60
10545361|NCT01496469|11698738|FG001|STARTED|Overall Study||61
10545362|NCT01496469|11698737|FG000|COMPLETED|Overall Study||50
10545363|NCT01496469|11698738|FG001|COMPLETED|Overall Study||53
10545364|NCT01496469|11698737|FG000|NOT COMPLETED|Overall Study||10
10545365|NCT01496469|11698738|FG001|NOT COMPLETED|Overall Study||8
10545366|NCT01496612|11698744|FG000|STARTED|1st Intervention||3
10545367|NCT01496612|11698745|FG001|STARTED|1st Intervention||4
10545368|NCT01496612|11698744|FG000|COMPLETED|1st Intervention||1
10545369|NCT01496612|11698745|FG001|COMPLETED|1st Intervention||4
10545370|NCT01496612|11698744|FG000|NOT COMPLETED|1st Intervention||2
10545371|NCT01496612|11698745|FG001|NOT COMPLETED|1st Intervention||0
10545372|NCT01496612|11698744|FG000|STARTED|2nd Intervention||1
10545373|NCT01496612|11698745|FG001|STARTED|2nd Intervention||4
10545374|NCT01496612|11698744|FG000|COMPLETED|2nd Intervention||1
10545375|NCT01496612|11698745|FG001|COMPLETED|2nd Intervention||4
10545376|NCT01496612|11698744|FG000|NOT COMPLETED|2nd Intervention||0
10545377|NCT01496612|11698745|FG001|NOT COMPLETED|2nd Intervention||0
10545378|NCT01496807|11698753|FG000|STARTED|Overall Study||31
10545379|NCT01496807|11698753|FG000|COMPLETED|Overall Study||1
10545380|NCT01496807|11698753|FG000|NOT COMPLETED|Overall Study||30
10545381|NCT01496846|11698763|FG000|STARTED|IANB Articaine (All Participants)||28
10545382|NCT01496846|11698764|FG001|STARTED|IANB Articaine (All Participants)||24
10545383|NCT01496846|11698765|FG002|STARTED|IANB Articaine (All Participants)||36
10545384|NCT01496846|11698766|FG003|STARTED|IANB Articaine (All Participants)||40
10545385|NCT01496846|11698767|FG004|STARTED|IANB Articaine (All Participants)||35
10545386|NCT01496846|11698768|FG005|STARTED|IANB Articaine (All Participants)||38
10545387|NCT01496846|11698763|FG000|COMPLETED|IANB Articaine (All Participants)||27
10545388|NCT01496846|11698764|FG001|COMPLETED|IANB Articaine (All Participants)||23
10545389|NCT01496846|11698765|FG002|COMPLETED|IANB Articaine (All Participants)||36
10545390|NCT01496846|11698766|FG003|COMPLETED|IANB Articaine (All Participants)||40
10545391|NCT01496846|11698767|FG004|COMPLETED|IANB Articaine (All Participants)||35
10545392|NCT01496846|11698768|FG005|COMPLETED|IANB Articaine (All Participants)||38
10545393|NCT01496846|11698763|FG000|NOT COMPLETED|IANB Articaine (All Participants)||1
10545394|NCT01496846|11698764|FG001|NOT COMPLETED|IANB Articaine (All Participants)||1
10545395|NCT01496846|11698765|FG002|NOT COMPLETED|IANB Articaine (All Participants)||0
10545396|NCT01496846|11698766|FG003|NOT COMPLETED|IANB Articaine (All Participants)||0
10545397|NCT01496846|11698767|FG004|NOT COMPLETED|IANB Articaine (All Participants)||0
10545398|NCT01496846|11698768|FG005|NOT COMPLETED|IANB Articaine (All Participants)||0
10545399|NCT01496846|11698763|FG000|STARTED|Supplemental Buccal Infiltration|No participants with successful IANB initially were brought forward to supplemental anesthetic|0
10545400|NCT01496846|11698764|FG001|STARTED|Supplemental Buccal Infiltration|No participants with successful IANB initially were brought forward to supplemental anesthetic|0
10545401|NCT01496846|11698765|FG002|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|36
10545402|NCT01496846|11698766|FG003|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|40
10545403|NCT01496846|11698767|FG004|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|35
10545404|NCT01496846|11698768|FG005|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|38
10661285|NCT02258217|11823174|FG000|STARTED|Overall Study||30
10661286|NCT02258217|11823174|FG000|COMPLETED|Overall Study||30
10847497|NCT03638947|12013695|FG000|STARTED|Overall Study||130
10847498|NCT03638947|12013696|FG001|STARTED|Overall Study||106
10847499|NCT03638947|12013695|FG000|COMPLETED|Overall Study||130
10847500|NCT03638947|12013696|FG001|COMPLETED|Overall Study||106
10847501|NCT03638947|12013695|FG000|NOT COMPLETED|Overall Study||0
10847502|NCT03638947|12013696|FG001|NOT COMPLETED|Overall Study||0
10847503|NCT03502681|12013704|FG000|STARTED|Overall Study||3
10847504|NCT03502681|12013705|FG001|STARTED|Overall Study||3
10847505|NCT03502681|12013704|FG000|COMPLETED|Overall Study||0
10847506|NCT03502681|12013705|FG001|COMPLETED|Overall Study||1
10847507|NCT03502681|12013704|FG000|NOT COMPLETED|Overall Study||3
10847508|NCT03502681|12013705|FG001|NOT COMPLETED|Overall Study||2
10847509|NCT03405662|12013712|FG000|STARTED|Overall Study||7
10847510|NCT03405662|12013713|FG001|STARTED|Overall Study||7
10847511|NCT03405662|12013712|FG000|COMPLETED|Overall Study||6
10847512|NCT03405662|12013713|FG001|COMPLETED|Overall Study||4
10847513|NCT03405662|12013712|FG000|NOT COMPLETED|Overall Study||1
10847514|NCT03405662|12013713|FG001|NOT COMPLETED|Overall Study||3
10847515|NCT03367715|12013719|FG000|STARTED|Overall Study||10
10847516|NCT03367715|12013719|FG000|COMPLETED|Overall Study||10
10847517|NCT03367715|12013719|FG000|NOT COMPLETED|Overall Study||0
10847518|NCT03334435|12013728|FG000|STARTED|Overall Study||91
10847519|NCT03334435|12013729|FG001|STARTED|Overall Study||45
10847520|NCT03334435|12013730|FG002|STARTED|Overall Study||519
10847521|NCT03334435|12013731|FG003|STARTED|Overall Study||743
10847522|NCT03334435|12013732|FG004|STARTED|Overall Study||247
10847523|NCT03334435|12013728|FG000|RPR|Overall Study||91
10847524|NCT03334435|12013729|FG001|RPR|Overall Study||45
10847525|NCT03334435|12013730|FG002|RPR|Overall Study||108
10847526|NCT03334435|12013731|FG003|RPR|Overall Study||134
10847527|NCT03334435|12013732|FG004|RPR|Overall Study||0
10847528|NCT03334435|12013728|FG000|NR|Overall Study||0
10847529|NCT03334435|12013729|FG001|NR|Overall Study||0
10847530|NCT03334435|12013730|FG002|NR|Overall Study||411
10847531|NCT03334435|12013731|FG003|NR|Overall Study||609
10847532|NCT03334435|12013732|FG004|NR|Overall Study||0
10847533|NCT03334435|12013728|FG000|COMPLETED|Overall Study||2
10847534|NCT03334435|12013729|FG001|COMPLETED|Overall Study||2
10847535|NCT03334435|12013730|FG002|COMPLETED|Overall Study||12
10847536|NCT03334435|12013731|FG003|COMPLETED|Overall Study||15
10847537|NCT03334435|12013732|FG004|COMPLETED|Overall Study||5
10847538|NCT03334435|12013728|FG000|NOT COMPLETED|Overall Study||89
10847539|NCT03334435|12013729|FG001|NOT COMPLETED|Overall Study||43
10847540|NCT03334435|12013730|FG002|NOT COMPLETED|Overall Study||507
10847541|NCT03334435|12013731|FG003|NOT COMPLETED|Overall Study||728
10847542|NCT03334435|12013732|FG004|NOT COMPLETED|Overall Study||242
10847543|NCT03284424|12013764|FG000|STARTED|Overall Study||105
10847544|NCT03284424|12013765|FG001|STARTED|Overall Study||54
10847545|NCT03284424|12013764|FG000|COMPLETED|Overall Study||0
10847546|NCT03284424|12013765|FG001|COMPLETED|Overall Study||0
10847547|NCT03284424|12013764|FG000|NOT COMPLETED|Overall Study||105
10847548|NCT03284424|12013765|FG001|NOT COMPLETED|Overall Study||54
10847565|NCT02963766|12013795|FG000|STARTED|Double-Blind Period||51
10847566|NCT02963766|12013796|FG001|STARTED|Double-Blind Period||51
10847567|NCT02963766|12013797|FG002|STARTED|Double-Blind Period||52
10847568|NCT02963766|12013795|FG000|Received at Least 1 Dose of Study Drug|Double-Blind Period||51
10847569|NCT02963766|12013796|FG001|Received at Least 1 Dose of Study Drug|Double-Blind Period||51
10847570|NCT02963766|12013797|FG002|Received at Least 1 Dose of Study Drug|Double-Blind Period||52
10847571|NCT02963766|12013795|FG000|COMPLETED|Double-Blind Period||47
10847572|NCT02963766|12013796|FG001|COMPLETED|Double-Blind Period||49
10847573|NCT02963766|12013797|FG002|COMPLETED|Double-Blind Period||50
10847574|NCT02963766|12013795|FG000|NOT COMPLETED|Double-Blind Period||4
10847575|NCT02963766|12013796|FG001|NOT COMPLETED|Double-Blind Period||2
10847576|NCT02963766|12013797|FG002|NOT COMPLETED|Double-Blind Period||2
10847577|NCT02963766|12013795|FG000|STARTED|Open Label Extension (OLE)||47
10847578|NCT02963766|12013796|FG001|STARTED|Open Label Extension (OLE)||49
10847579|NCT02963766|12013797|FG002|STARTED|Open Label Extension (OLE)||50
10847580|NCT02963766|12013795|FG000|COMPLETED|Open Label Extension (OLE)||45
10847581|NCT02963766|12013796|FG001|COMPLETED|Open Label Extension (OLE)||46
10847582|NCT02963766|12013797|FG002|COMPLETED|Open Label Extension (OLE)||48
10847583|NCT02963766|12013795|FG000|NOT COMPLETED|Open Label Extension (OLE)||2
10545405|NCT01496846|11698763|FG000|COMPLETED|Supplemental Buccal Infiltration||0
10847584|NCT02963766|12013796|FG001|NOT COMPLETED|Open Label Extension (OLE)||3
10847585|NCT02963766|12013797|FG002|NOT COMPLETED|Open Label Extension (OLE)||2
10847586|NCT02795182|12013819|FG000|STARTED|Overall Study||15
10847587|NCT02795182|12013820|FG001|STARTED|Overall Study||10
10847588|NCT02795182|12013821|FG002|STARTED|Overall Study||7
10847589|NCT02795182|12013822|FG003|STARTED|Overall Study||43
10847590|NCT02795182|12013819|FG000|COMPLETED|Overall Study||0
10847591|NCT02795182|12013820|FG001|COMPLETED|Overall Study||0
10847592|NCT02795182|12013821|FG002|COMPLETED|Overall Study||0
10847593|NCT02795182|12013822|FG003|COMPLETED|Overall Study||0
10847594|NCT02795182|12013819|FG000|NOT COMPLETED|Overall Study||15
10847595|NCT02795182|12013820|FG001|NOT COMPLETED|Overall Study||10
10847596|NCT02795182|12013821|FG002|NOT COMPLETED|Overall Study||7
10847597|NCT02795182|12013822|FG003|NOT COMPLETED|Overall Study||43
10847598|NCT02711878|12013841|FG000|STARTED|Overall Study||76
10847599|NCT02711878|12013842|FG001|STARTED|Overall Study||39
10847600|NCT02711878|12013841|FG000|Completed Visit T1 (13-15 Weeks Post Baseline)|Overall Study||69
10847601|NCT02711878|12013842|FG001|Completed Visit T1 (13-15 Weeks Post Baseline)|Overall Study||33
10847602|NCT02711878|12013841|FG000|Completed Visit T2 (28-30 Weeks Post Baseline)|Overall Study||68
10847603|NCT02711878|12013842|FG001|Completed Visit T2 (28-30 Weeks Post Baseline)|Overall Study||33
10847604|NCT02711878|12013841|FG000|Completed Visit T3 (56-58 Weeks Post Baseline)|Overall Study||72
10847605|NCT02711878|12013842|FG001|Completed Visit T3 (56-58 Weeks Post Baseline)|Overall Study||31
10847606|NCT02711878|12013841|FG000|COMPLETED|Overall Study||68
10847607|NCT02711878|12013842|FG001|COMPLETED|Overall Study||33
10847608|NCT02711878|12013841|FG000|NOT COMPLETED|Overall Study||8
10847609|NCT02711878|12013842|FG001|NOT COMPLETED|Overall Study||6
10847610|NCT02674464|12013857|FG000|STARTED|Overall Study|There were 15 practices in this arm. Each practice makes a cluster|927
10847611|NCT02674464|12013858|FG001|STARTED|Overall Study|There were 15 practices in the arm. Each practice makes a cluster|893
10847612|NCT02674464|12013857|FG000|6 Month Follow-up|Overall Study|10 deceased; 17 withdrew; 95 missed|771
10847613|NCT02674464|12013858|FG001|6 Month Follow-up|Overall Study|2 deceased; 8 withdrew; 111 missed|806
10847614|NCT02674464|12013857|FG000|COMPLETED|Overall Study||790
10847615|NCT02674464|12013858|FG001|COMPLETED|Overall Study||733
10847616|NCT02674464|12013857|FG000|NOT COMPLETED|Overall Study||137
10847617|NCT02674464|12013858|FG001|NOT COMPLETED|Overall Study||160
10847618|NCT02318784|12013864|FG000|STARTED|Overall Study||62
10413203|NCT00776594|11557354|FG000|STARTED|Overall Study||66
10413204|NCT00776594|11557355|FG001|STARTED|Overall Study||36
10413205|NCT00776594|11557354|FG000|COMPLETED|Overall Study||62
10413206|NCT00776594|11557355|FG001|COMPLETED|Overall Study||34
10413207|NCT00776594|11557354|FG000|NOT COMPLETED|Overall Study||4
10413208|NCT00776594|11557355|FG001|NOT COMPLETED|Overall Study||2
10413209|NCT00776659|11557363|FG000|STARTED|Overall Study||39
10413210|NCT00776659|11557363|FG000|COMPLETED|Overall Study||13
10413211|NCT00776659|11557363|FG000|NOT COMPLETED|Overall Study||26
10413212|NCT00776789|11557369|FG000|STARTED|Overall Study||20
10413213|NCT00776789|11557370|FG001|STARTED|Overall Study||21
10413214|NCT00776789|11557369|FG000|COMPLETED|Overall Study||17
10413215|NCT00776789|11557370|FG001|COMPLETED|Overall Study||18
10413216|NCT00776789|11557369|FG000|NOT COMPLETED|Overall Study||3
10413217|NCT00776789|11557370|FG001|NOT COMPLETED|Overall Study||3
10413218|NCT00776919|11557382|FG000|STARTED|Overall Study||327
10413219|NCT00776919|11557383|FG001|STARTED|Overall Study||328
10413220|NCT00776919|11557384|FG002|STARTED|Overall Study||328
10413221|NCT00776919|11557385|FG003|STARTED|Overall Study||332
10413222|NCT00776919|11557382|FG000|COMPLETED|Overall Study||300
10413223|NCT00776919|11557383|FG001|COMPLETED|Overall Study||295
10413224|NCT00776919|11557384|FG002|COMPLETED|Overall Study||296
10413225|NCT00776919|11557385|FG003|COMPLETED|Overall Study||293
10413226|NCT00776919|11557382|FG000|NOT COMPLETED|Overall Study||27
10413227|NCT00776919|11557383|FG001|NOT COMPLETED|Overall Study||33
10413228|NCT00776919|11557384|FG002|NOT COMPLETED|Overall Study||32
10413229|NCT00776919|11557385|FG003|NOT COMPLETED|Overall Study||39
10545406|NCT01496846|11698764|FG001|COMPLETED|Supplemental Buccal Infiltration||0
10545407|NCT01496846|11698765|FG002|COMPLETED|Supplemental Buccal Infiltration||36
10545408|NCT01496846|11698766|FG003|COMPLETED|Supplemental Buccal Infiltration||40
10545409|NCT01496846|11698767|FG004|COMPLETED|Supplemental Buccal Infiltration||35
10545410|NCT01496846|11698768|FG005|COMPLETED|Supplemental Buccal Infiltration||38
10545411|NCT01496846|11698763|FG000|NOT COMPLETED|Supplemental Buccal Infiltration||0
10847619|NCT02318784|12013864|FG000|COMPLETED|Overall Study||0
10847620|NCT02318784|12013864|FG000|NOT COMPLETED|Overall Study||62
10847621|NCT02317991|12013868|FG000|STARTED|Overall Study||65
10847622|NCT02317991|12013868|FG000|COMPLETED|Overall Study||0
10545412|NCT01496846|11698764|FG001|NOT COMPLETED|Supplemental Buccal Infiltration||0
10545413|NCT01496846|11698765|FG002|NOT COMPLETED|Supplemental Buccal Infiltration||0
10545414|NCT01496846|11698766|FG003|NOT COMPLETED|Supplemental Buccal Infiltration||0
10545415|NCT01496846|11698767|FG004|NOT COMPLETED|Supplemental Buccal Infiltration||0
10847623|NCT02317991|12013868|FG000|NOT COMPLETED|Overall Study||65
10413230|NCT00776984|11557397|FG000|STARTED|Overall Study||234
10413231|NCT00776984|11557398|FG001|STARTED|Overall Study||219
10545416|NCT01496846|11698768|FG005|NOT COMPLETED|Supplemental Buccal Infiltration||0
10413232|NCT00776984|11557397|FG000|COMPLETED|Overall Study||203
10413233|NCT00776984|11557398|FG001|COMPLETED|Overall Study||198
10413234|NCT00776984|11557397|FG000|NOT COMPLETED|Overall Study||31
10847638|NCT02263014|12013895|FG000|STARTED|Overall Study||44
10847639|NCT02263014|12013896|FG001|STARTED|Overall Study||208
10847640|NCT02263014|12013895|FG000|COMPLETED|Overall Study||44
10847641|NCT02263014|12013896|FG001|COMPLETED|Overall Study||208
10847642|NCT02263014|12013895|FG000|NOT COMPLETED|Overall Study||0
10847643|NCT02263014|12013896|FG001|NOT COMPLETED|Overall Study||0
10847644|NCT02260193|12013907|FG000|STARTED|Overall Study||30
10847645|NCT02260193|12013908|FG001|STARTED|Overall Study||33
10847646|NCT02260193|12013909|FG002|STARTED|Overall Study||31
10847647|NCT02260193|12013907|FG000|COMPLETED|Overall Study||24
10847648|NCT02260193|12013908|FG001|COMPLETED|Overall Study||24
10847649|NCT02260193|12013909|FG002|COMPLETED|Overall Study||21
10847650|NCT02260193|12013907|FG000|NOT COMPLETED|Overall Study||6
10413235|NCT00776984|11557398|FG001|NOT COMPLETED|Overall Study||21
10413236|NCT00776997|11557404|FG000|STARTED|Overall Study||100
10413237|NCT00776997|11557404|FG000|COMPLETED|Overall Study|98 subjects evaluated at 12-months. Endpoint analysis based on all subjects treated (n=100)|98
10413238|NCT00776997|11557404|FG000|NOT COMPLETED|Overall Study||2
10413239|NCT00777023|11557411|FG000|STARTED|Overall Study|192 patients were randomized, but only 186 received study treatment.|186
10413240|NCT00777023|11557412|FG001|STARTED|Overall Study|190 patients were randomized, and 190 received study treatment.|190
10413241|NCT00777023|11557413|FG002|STARTED|Overall Study|183 patients were randomized, and 183 received study treatment.|183
10413242|NCT00777023|11557411|FG000|COMPLETED|Overall Study||151
10413243|NCT00777023|11557412|FG001|COMPLETED|Overall Study||149
10413244|NCT00777023|11557413|FG002|COMPLETED|Overall Study||146
10413245|NCT00777023|11557411|FG000|NOT COMPLETED|Overall Study||35
10413246|NCT00777023|11557412|FG001|NOT COMPLETED|Overall Study||41
10413247|NCT00777023|11557413|FG002|NOT COMPLETED|Overall Study||37
10413248|NCT00777049|11557423|FG000|STARTED|Overall Study||33
10413249|NCT00777049|11557424|FG001|STARTED|Overall Study||21
10413250|NCT00777049|11557423|FG000|COMPLETED|Overall Study||32
10413251|NCT00777049|11557424|FG001|COMPLETED|Overall Study||20
10413252|NCT00777049|11557423|FG000|NOT COMPLETED|Overall Study||1
10413253|NCT00777049|11557424|FG001|NOT COMPLETED|Overall Study||1
10413254|NCT00777062|11557432|FG000|STARTED|Overall Study||39
10413255|NCT00777062|11557433|FG001|STARTED|Overall Study||41
10413256|NCT00777062|11557432|FG000|COMPLETED|Overall Study||36
10413257|NCT00777062|11557433|FG001|COMPLETED|Overall Study||36
10413258|NCT00777062|11557432|FG000|NOT COMPLETED|Overall Study||3
10413259|NCT00777062|11557433|FG001|NOT COMPLETED|Overall Study||5
10413260|NCT00777088|11557439|FG000|STARTED|Overall Study||108
10413261|NCT00777088|11557439|FG000|COMPLETED|Overall Study||107
10413262|NCT00777088|11557439|FG000|NOT COMPLETED|Overall Study||1
10413263|NCT00777101|11557446|FG000|STARTED|Overall Study||117
10413264|NCT00777101|11557447|FG001|STARTED|Overall Study||116
10413265|NCT00777101|11557446|FG000|Treated|Overall Study||116
10413266|NCT00777101|11557447|FG001|Treated|Overall Study||115
10413267|NCT00777101|11557446|FG000|COMPLETED|Overall Study||55
10413268|NCT00777101|11557447|FG001|COMPLETED|Overall Study||65
10413269|NCT00777101|11557446|FG000|NOT COMPLETED|Overall Study||62
10413270|NCT00777101|11557447|FG001|NOT COMPLETED|Overall Study||51
10413271|NCT00777153|11557457|FG000|STARTED|Overall Study||131
10413272|NCT00777153|11557458|FG001|STARTED|Overall Study||129
10413273|NCT00777153|11557459|FG002|STARTED|Overall Study||65
10413274|NCT00777153|11557457|FG000|COMPLETED|Overall Study||41
10413275|NCT00777153|11557458|FG001|COMPLETED|Overall Study||46
10413276|NCT00777153|11557459|FG002|COMPLETED|Overall Study||28
10413277|NCT00777153|11557457|FG000|NOT COMPLETED|Overall Study||90
10413278|NCT00777153|11557458|FG001|NOT COMPLETED|Overall Study||83
10413279|NCT00777153|11557459|FG002|NOT COMPLETED|Overall Study||37
10413280|NCT00777179|11557473|FG000|STARTED|Overall Study|Number of participants for intent-to-treat (ITT) set population|75
10413281|NCT00777179|11557474|FG001|STARTED|Overall Study|Number of participants for intent-to-treat (ITT) set population|42
10413282|NCT00777179|11557473|FG000|COMPLETED|Overall Study|All participants' data within ITT set were included for final result.|75
10413283|NCT00777179|11557474|FG001|COMPLETED|Overall Study|All participants' data within ITT set were included for final result.|42
10413284|NCT00777179|11557473|FG000|NOT COMPLETED|Overall Study||0
10413285|NCT00777179|11557474|FG001|NOT COMPLETED|Overall Study||0
10413286|NCT00777205|11557482|FG000|STARTED|Overall Study||243
10413287|NCT00777205|11557483|FG001|STARTED|Overall Study||200
10413288|NCT00777205|11557482|FG000|Intervention Interruption|Overall Study||0
10429233|NCT00862849|11575287|FG001|STARTED|Intervention 5||3
10545417|NCT01496885|11698779|FG000|STARTED|Overall Study||120
10847651|NCT02260193|12013908|FG001|NOT COMPLETED|Overall Study||9
10847652|NCT02260193|12013909|FG002|NOT COMPLETED|Overall Study||10
10847719|NCT02006251|12013994|FG000|STARTED|Overall Study||12
10847720|NCT02006251|12013995|FG001|STARTED|Overall Study||12
10847721|NCT02006251|12013994|FG000|COMPLETED|Overall Study||10
10847722|NCT02006251|12013995|FG001|COMPLETED|Overall Study||11
10847723|NCT02006251|12013994|FG000|NOT COMPLETED|Overall Study||2
10847724|NCT02006251|12013995|FG001|NOT COMPLETED|Overall Study||1
10847731|NCT01832402|12014012|FG000|STARTED|Overall Study||19
10847732|NCT01832402|12014013|FG001|STARTED|Overall Study||16
10847733|NCT01832402|12014012|FG000|Received Allocated Medication|Overall Study||12
10847734|NCT01832402|12014013|FG001|Received Allocated Medication|Overall Study||12
10847735|NCT01832402|12014012|FG000|Completed Study With Correct Dose|Overall Study||10
10847736|NCT01832402|12014013|FG001|Completed Study With Correct Dose|Overall Study||9
10847737|NCT01832402|12014012|FG000|Completed Study With Incorrect Dose|Overall Study||2
10847738|NCT01832402|12014013|FG001|Completed Study With Incorrect Dose|Overall Study||3
10847739|NCT01832402|12014012|FG000|COMPLETED|Overall Study||12
10847740|NCT01832402|12014013|FG001|COMPLETED|Overall Study||12
10847741|NCT01832402|12014012|FG000|NOT COMPLETED|Overall Study||7
10847742|NCT01832402|12014013|FG001|NOT COMPLETED|Overall Study||4
10847743|NCT01468922|12014032|FG000|STARTED|Overall Study||3
10847744|NCT01468922|12014033|FG001|STARTED|Overall Study||3
10847745|NCT01468922|12014034|FG002|STARTED|Overall Study||2
10847746|NCT01468922|12014035|FG003|STARTED|Overall Study||1
10847747|NCT01468922|12014036|FG004|STARTED|Overall Study||4
10847748|NCT01468922|12014037|FG005|STARTED|Overall Study||1
10847749|NCT01468922|12014038|FG006|STARTED|Overall Study||1
10847750|NCT01468922|12014039|FG007|STARTED|Overall Study||16
10847751|NCT01468922|12014040|FG008|STARTED|Overall Study||1
10847752|NCT01468922|12014032|FG000|COMPLETED|Overall Study||1
10847753|NCT01468922|12014033|FG001|COMPLETED|Overall Study||3
10847754|NCT01468922|12014034|FG002|COMPLETED|Overall Study||2
10413289|NCT00777205|11557483|FG001|Intervention Interruption|Overall Study|56 participants excluded from main analyses due to 2 mos interruption in study intervention|56
10413290|NCT00777205|11557482|FG000|COMPLETED|Overall Study||212
10413291|NCT00777205|11557483|FG001|COMPLETED|Overall Study||129
10413292|NCT00777205|11557482|FG000|NOT COMPLETED|Overall Study||31
10413293|NCT00777205|11557483|FG001|NOT COMPLETED|Overall Study||71
10413294|NCT00777257|11557494|FG000|STARTED|Overall Study||444
10413295|NCT00777257|11557495|FG001|STARTED|Overall Study||450
10413296|NCT00777257|11557496|FG002|STARTED|Overall Study||451
10413297|NCT00777257|11557494|FG000|COMPLETED|Overall Study||433
10413298|NCT00777257|11557495|FG001|COMPLETED|Overall Study||438
10413299|NCT00777257|11557496|FG002|COMPLETED|Overall Study||442
10413300|NCT00777257|11557494|FG000|NOT COMPLETED|Overall Study||11
10413301|NCT00777257|11557495|FG001|NOT COMPLETED|Overall Study||12
10413302|NCT00777257|11557496|FG002|NOT COMPLETED|Overall Study||9
10413303|NCT00777296|11557508|FG000|STARTED|Overall Study||21
10413304|NCT00777296|11557509|FG001|STARTED|Overall Study||11
10413305|NCT00777296|11557510|FG002|STARTED|Overall Study||23
10413306|NCT00777296|11557511|FG003|STARTED|Overall Study||11
10413307|NCT00777296|11557508|FG000|COMPLETED|Overall Study||20
10413308|NCT00777296|11557509|FG001|COMPLETED|Overall Study||10
10413309|NCT00777296|11557510|FG002|COMPLETED|Overall Study||21
10413310|NCT00777296|11557511|FG003|COMPLETED|Overall Study||10
10413311|NCT00777296|11557508|FG000|NOT COMPLETED|Overall Study||1
10413312|NCT00777296|11557509|FG001|NOT COMPLETED|Overall Study||1
10413313|NCT00777296|11557510|FG002|NOT COMPLETED|Overall Study||2
10413314|NCT00777296|11557511|FG003|NOT COMPLETED|Overall Study||1
10413315|NCT00777335|11557535|FG000|STARTED|Overall Study||2
10413316|NCT00777335|11557536|FG001|STARTED|Overall Study||2
10413317|NCT00777335|11557535|FG000|COMPLETED|Overall Study||2
10413318|NCT00777335|11557536|FG001|COMPLETED|Overall Study||2
10413319|NCT00777335|11557535|FG000|NOT COMPLETED|Overall Study||0
10413320|NCT00777335|11557536|FG001|NOT COMPLETED|Overall Study||0
10413321|NCT00777556|11557542|FG000|STARTED|Overall Study|Enrolled; signed informed consent|343
10413322|NCT00777556|11557542|FG000|Dispensed Product|Overall Study||307
10429234|NCT00862849|11575288|FG002|STARTED|Intervention 5||3
10847755|NCT01468922|12014035|FG003|COMPLETED|Overall Study||1
10847756|NCT01468922|12014036|FG004|COMPLETED|Overall Study||2
10847757|NCT01468922|12014037|FG005|COMPLETED|Overall Study||1
10847758|NCT01468922|12014038|FG006|COMPLETED|Overall Study||1
10847759|NCT01468922|12014039|FG007|COMPLETED|Overall Study||12
10847760|NCT01468922|12014040|FG008|COMPLETED|Overall Study||0
10847761|NCT01468922|12014032|FG000|NOT COMPLETED|Overall Study||2
10847762|NCT01468922|12014033|FG001|NOT COMPLETED|Overall Study||0
10847763|NCT01468922|12014034|FG002|NOT COMPLETED|Overall Study||0
10847764|NCT01468922|12014035|FG003|NOT COMPLETED|Overall Study||0
10847765|NCT01468922|12014036|FG004|NOT COMPLETED|Overall Study||2
10847766|NCT01468922|12014037|FG005|NOT COMPLETED|Overall Study||0
10847767|NCT01468922|12014038|FG006|NOT COMPLETED|Overall Study||0
10847768|NCT01468922|12014039|FG007|NOT COMPLETED|Overall Study||4
10847769|NCT01468922|12014040|FG008|NOT COMPLETED|Overall Study||1
10847770|NCT01381094|12014063|FG000|STARTED|Overall Study||18
10847771|NCT01381094|12014064|FG001|STARTED|Overall Study||18
10847772|NCT01381094|12014065|FG002|STARTED|Overall Study||17
10847773|NCT01381094|12014066|FG003|STARTED|Overall Study||19
10847774|NCT01381094|12014067|FG004|STARTED|Overall Study||19
10847775|NCT01381094|12014063|FG000|COMPLETED|Overall Study||16
10847776|NCT01381094|12014064|FG001|COMPLETED|Overall Study||15
10847777|NCT01381094|12014065|FG002|COMPLETED|Overall Study||17
10847778|NCT01381094|12014066|FG003|COMPLETED|Overall Study||18
10847779|NCT01381094|12014067|FG004|COMPLETED|Overall Study||18
10847780|NCT01381094|12014063|FG000|NOT COMPLETED|Overall Study||2
10847781|NCT01381094|12014064|FG001|NOT COMPLETED|Overall Study||3
10847782|NCT01381094|12014065|FG002|NOT COMPLETED|Overall Study||0
10847783|NCT01381094|12014066|FG003|NOT COMPLETED|Overall Study||1
10847784|NCT01381094|12014067|FG004|NOT COMPLETED|Overall Study||1
10847788|NCT01235936|12014083|FG000|STARTED|Overall Study||10
10847789|NCT01235936|12014083|FG000|COMPLETED|Overall Study||10
10847790|NCT01235936|12014083|FG000|NOT COMPLETED|Overall Study||0
10847791|NCT01081951|12014089|FG000|STARTED|Overall Study||81
10847792|NCT01081951|12014090|FG001|STARTED|Overall Study||81
10847793|NCT01081951|12014089|FG000|Received Study Treatment|Overall Study||81
10847794|NCT01081951|12014090|FG001|Received Study Treatment|Overall Study||75
10847795|NCT01081951|12014089|FG000|Entered Maintenance Phase|Overall Study||66
10847796|NCT01081951|12014090|FG001|Entered Maintenance Phase|Overall Study||55
10847797|NCT01081951|12014089|FG000|Ongoing Study Treatment at Data Cut-off|Overall Study||11
10413323|NCT00777556|11557542|FG000|Safety Population|Overall Study|Participants who used the product; two were given product in error (inappropriately self-selected)|299
10413324|NCT00777556|11557542|FG000|Used Product|Overall Study||297
10413325|NCT00777556|11557542|FG000|COMPLETED|Overall Study|Completed all 3 follow-up visits|277
10413326|NCT00777556|11557542|FG000|NOT COMPLETED|Overall Study||66
10413327|NCT00777608|11557548|FG000|STARTED|Overall Study||53
10413328|NCT00777608|11557549|FG001|STARTED|Overall Study||53
10413329|NCT00777608|11557548|FG000|COMPLETED|Overall Study||49
10413330|NCT00777608|11557549|FG001|COMPLETED|Overall Study||47
10413331|NCT00777608|11557548|FG000|NOT COMPLETED|Overall Study||4
10413332|NCT00777608|11557549|FG001|NOT COMPLETED|Overall Study||6
10413333|NCT00777634|11557557|FG000|STARTED|Overall Study||134
10413334|NCT00777634|11557558|FG001|STARTED|Overall Study||134
10413335|NCT00777634|11557557|FG000|COMPLETED|Overall Study||129
10413336|NCT00777634|11557558|FG001|COMPLETED|Overall Study||133
10413337|NCT00777634|11557557|FG000|NOT COMPLETED|Overall Study||5
10413338|NCT00777634|11557558|FG001|NOT COMPLETED|Overall Study||1
10413339|NCT00777764|11557566|FG000|STARTED|Overall Study||30
10413340|NCT00777764|11557567|FG001|STARTED|Overall Study||30
10413341|NCT00777764|11557566|FG000|COMPLETED|Overall Study||30
10413342|NCT00777764|11557567|FG001|COMPLETED|Overall Study||29
10413343|NCT00777764|11557566|FG000|NOT COMPLETED|Overall Study||0
10413344|NCT00777764|11557567|FG001|NOT COMPLETED|Overall Study||1
10413345|NCT00777790|11557578|FG000|STARTED|Overall Study||76
10413346|NCT00777790|11557579|FG001|STARTED|Overall Study||77
10413347|NCT00777790|11557580|FG002|STARTED|Overall Study||88
10413348|NCT00777790|11557578|FG000|COMPLETED|Overall Study||76
10413349|NCT00777790|11557579|FG001|COMPLETED|Overall Study||77
10413350|NCT00777790|11557580|FG002|COMPLETED|Overall Study||88
10413351|NCT00777790|11557578|FG000|NOT COMPLETED|Overall Study||0
10413352|NCT00777790|11557579|FG001|NOT COMPLETED|Overall Study||0
10413353|NCT00777790|11557580|FG002|NOT COMPLETED|Overall Study||0
10413354|NCT00777803|11557590|FG000|STARTED|Overall Study||284
10413355|NCT00777803|11557591|FG001|STARTED|Overall Study||97
10413356|NCT00777803|11557590|FG000|COMPLETED|Overall Study||269
10413357|NCT00777803|11557591|FG001|COMPLETED|Overall Study||90
10413358|NCT00777803|11557590|FG000|NOT COMPLETED|Overall Study||15
10847798|NCT01081951|12014090|FG001|Ongoing Study Treatment at Data Cut-off|Overall Study||0
10847899|NCT03135249|12014184|FG000|STARTED|Overall Study|Nine patient entered the study|9
10847799|NCT01081951|12014089|FG000|COMPLETED|Overall Study|Completed is ongoing study at DCO (Data cut-off),either on-treatment or in survival follow-up|25
10413359|NCT00777803|11557591|FG001|NOT COMPLETED|Overall Study||7
10413360|NCT00777829|11557597|FG000|STARTED|Overall Study||15
10413361|NCT00777829|11557598|FG001|STARTED|Overall Study||15
10413362|NCT00777829|11557597|FG000|Study Orientation|Overall Study||15
10413363|NCT00777829|11557598|FG001|Study Orientation|Overall Study||13
10413364|NCT00777829|11557597|FG000|COMPLETED|Overall Study||15
10413365|NCT00777829|11557598|FG001|COMPLETED|Overall Study||13
10413366|NCT00777829|11557597|FG000|NOT COMPLETED|Overall Study||0
10413367|NCT00777829|11557598|FG001|NOT COMPLETED|Overall Study||2
10413368|NCT00777855|11557606|FG000|STARTED|First Intervention||5
10413369|NCT00777855|11557607|FG001|STARTED|First Intervention||5
10413370|NCT00777855|11557606|FG000|COMPLETED|First Intervention||5
10413371|NCT00777855|11557607|FG001|COMPLETED|First Intervention||5
10413372|NCT00777855|11557606|FG000|NOT COMPLETED|First Intervention||0
10847800|NCT01081951|12014090|FG001|COMPLETED|Overall Study|Completed is ongoing study at DCO (Data cut-off), either on-treatment or in survival follow-up|26
10847801|NCT01081951|12014089|FG000|NOT COMPLETED|Overall Study||56
10847802|NCT01081951|12014090|FG001|NOT COMPLETED|Overall Study||55
10847803|NCT00852696|12014096|FG000|STARTED|Overall Study||0
10847804|NCT00852696|12014097|FG001|STARTED|Overall Study||0
10847805|NCT00852696|12014096|FG000|COMPLETED|Overall Study||0
10847806|NCT00852696|12014097|FG001|COMPLETED|Overall Study||0
10847807|NCT00852696|12014096|FG000|NOT COMPLETED|Overall Study||0
10847808|NCT00852696|12014097|FG001|NOT COMPLETED|Overall Study||0
10847839|NCT00788671|12014119|FG000|STARTED|Overall Study||57
10847840|NCT00788671|12014119|FG000|COMPLETED|Overall Study||47
10847841|NCT00788671|12014119|FG000|NOT COMPLETED|Overall Study||10
10847842|NCT00367003|12014123|FG000|STARTED|Overall Study||37
10847843|NCT00367003|12014123|FG000|COMPLETED|Overall Study||28
10847844|NCT00367003|12014123|FG000|NOT COMPLETED|Overall Study||9
10847845|NCT04253834|12014129|FG000|STARTED|Overall Study||10
10847846|NCT04253834|12014130|FG001|STARTED|Overall Study||10
10847847|NCT04253834|12014129|FG000|COMPLETED|Overall Study||10
10847848|NCT04253834|12014130|FG001|COMPLETED|Overall Study||10
10847849|NCT04253834|12014129|FG000|NOT COMPLETED|Overall Study||0
10847850|NCT04253834|12014130|FG001|NOT COMPLETED|Overall Study||0
10847851|NCT03881059|12014139|FG000|STARTED|Treatment Period - Part A||66
10847852|NCT03881059|12014140|FG001|STARTED|Treatment Period - Part A||70
10847853|NCT03881059|12014141|FG002|STARTED|Treatment Period - Part A||67
10847854|NCT03881059|12014139|FG000|COMPLETED|Treatment Period - Part A||58
10847855|NCT03881059|12014140|FG001|COMPLETED|Treatment Period - Part A||63
10847856|NCT03881059|12014141|FG002|COMPLETED|Treatment Period - Part A||59
10847857|NCT03881059|12014139|FG000|NOT COMPLETED|Treatment Period - Part A||8
10847858|NCT03881059|12014140|FG001|NOT COMPLETED|Treatment Period - Part A||7
10847859|NCT03881059|12014141|FG002|NOT COMPLETED|Treatment Period - Part A||8
10847860|NCT03881059|12014139|FG000|STARTED|Treatment Period - Part B||55
10847861|NCT03881059|12014140|FG001|STARTED|Treatment Period - Part B||60
10847862|NCT03881059|12014141|FG002|STARTED|Treatment Period - Part B||58
10847863|NCT03881059|12014139|FG000|Participants Maintaining Same Treatment as in Part A|Treatment Period - Part B||0
10847864|NCT03881059|12014140|FG001|Participants Maintaining Same Treatment as in Part A|Treatment Period - Part B||13
10847865|NCT03881059|12014141|FG002|Participants Maintaining Same Treatment as in Part A|Treatment Period - Part B||16
10847866|NCT03881059|12014139|FG000|Participants Treated With Ustekinumab in Part B|Treatment Period - Part B||55
10847867|NCT03881059|12014140|FG001|Participants Treated With Ustekinumab in Part B|Treatment Period - Part B||47
10847868|NCT03881059|12014141|FG002|Participants Treated With Ustekinumab in Part B|Treatment Period - Part B||42
10847869|NCT03881059|12014139|FG000|COMPLETED|Treatment Period - Part B||47
10847870|NCT03881059|12014140|FG001|COMPLETED|Treatment Period - Part B||54
10847871|NCT03881059|12014141|FG002|COMPLETED|Treatment Period - Part B||47
10847872|NCT03881059|12014139|FG000|NOT COMPLETED|Treatment Period - Part B||8
10847873|NCT03881059|12014140|FG001|NOT COMPLETED|Treatment Period - Part B||6
10847874|NCT03881059|12014141|FG002|NOT COMPLETED|Treatment Period - Part B||11
10847875|NCT03878277|12014154|FG000|STARTED|Overall Study||10
10847876|NCT03878277|12014154|FG000|COMPLETED|Overall Study||10
10847877|NCT03878277|12014154|FG000|NOT COMPLETED|Overall Study||0
10847878|NCT03450629|12014160|FG000|STARTED|Overall Study||341
10847879|NCT03450629|12014161|FG001|STARTED|Overall Study||341
10847880|NCT03450629|12014160|FG000|COMPLETED|Overall Study||293
10847881|NCT03450629|12014161|FG001|COMPLETED|Overall Study||307
10847882|NCT03450629|12014160|FG000|NOT COMPLETED|Overall Study||48
10847883|NCT03450629|12014161|FG001|NOT COMPLETED|Overall Study||34
10847884|NCT03367403|12014170|FG000|STARTED|Overall Study||131
10847885|NCT03367403|12014171|FG001|STARTED|Overall Study||126
10847886|NCT03367403|12014172|FG002|STARTED|Overall Study||15
10847887|NCT03367403|12014170|FG000|Received at Least One Dose of Study Drug|Overall Study||131
10847888|NCT03367403|12014171|FG001|Received at Least One Dose of Study Drug|Overall Study||125
10847889|NCT03367403|12014172|FG002|Received at Least One Dose of Study Drug|Overall Study||15
10847890|NCT03367403|12014170|FG000|COMPLETED|Overall Study||94
10847891|NCT03367403|12014171|FG001|COMPLETED|Overall Study||93
10847892|NCT03367403|12014172|FG002|COMPLETED|Overall Study||12
10847893|NCT03367403|12014170|FG000|NOT COMPLETED|Overall Study||37
10847894|NCT03367403|12014171|FG001|NOT COMPLETED|Overall Study||33
10847895|NCT03367403|12014172|FG002|NOT COMPLETED|Overall Study||3
10847896|NCT03286426|12014180|FG000|STARTED|Overall Study||3
10847897|NCT03286426|12014180|FG000|COMPLETED|Overall Study||0
10847898|NCT03286426|12014180|FG000|NOT COMPLETED|Overall Study||3
10847900|NCT03135249|12014184|FG000|COMPLETED|Overall Study|Eight patient completed the study.|7
10847901|NCT03135249|12014184|FG000|NOT COMPLETED|Overall Study||2
10847902|NCT02818582|12014190|FG000|STARTED|Overall Study||20
10847903|NCT02818582|12014191|FG001|STARTED|Overall Study||18
10847904|NCT02818582|12014190|FG000|COMPLETED|Overall Study||20
10847905|NCT02818582|12014191|FG001|COMPLETED|Overall Study||18
10847906|NCT02818582|12014190|FG000|NOT COMPLETED|Overall Study||0
10847907|NCT02818582|12014191|FG001|NOT COMPLETED|Overall Study||0
10847908|NCT02809677|12014197|FG000|STARTED|Overall Study||205
10847909|NCT02809677|12014197|FG000|COMPLETED|Overall Study||197
10847910|NCT02809677|12014197|FG000|NOT COMPLETED|Overall Study||8
10847911|NCT02728258|12014202|FG000|STARTED|Overall Study||11
10847912|NCT02728258|12014202|FG000|COMPLETED|Overall Study||11
10847913|NCT02728258|12014202|FG000|NOT COMPLETED|Overall Study||0
10847914|NCT02554253|12014208|FG000|STARTED|Overall Study||26
10847915|NCT02554253|12014209|FG001|STARTED|Overall Study||26
10847916|NCT02554253|12014208|FG000|COMPLETED|Overall Study||25
10847917|NCT02554253|12014209|FG001|COMPLETED|Overall Study||24
10847918|NCT02554253|12014208|FG000|NOT COMPLETED|Overall Study||1
10847919|NCT02554253|12014209|FG001|NOT COMPLETED|Overall Study||2
10847920|NCT01524536|12014216|FG000|STARTED|Overall Study||23
10847921|NCT01524536|12014216|FG000|COMPLETED|Overall Study||23
10847922|NCT01524536|12014216|FG000|NOT COMPLETED|Overall Study||0
10847923|NCT01307046|12014228|FG000|STARTED|Overall Study||166
10847924|NCT01307046|12014229|FG001|STARTED|Overall Study||170
10847925|NCT01307046|12014228|FG000|COMPLETED|Overall Study||154
10847926|NCT01307046|12014229|FG001|COMPLETED|Overall Study||159
10847927|NCT01307046|12014228|FG000|NOT COMPLETED|Overall Study||12
10847928|NCT01307046|12014229|FG001|NOT COMPLETED|Overall Study||11
10847929|NCT01307033|12014237|FG000|STARTED|8-week Double-blind Period||144
10847930|NCT01307033|12014238|FG001|STARTED|8-week Double-blind Period||134
10847931|NCT01307033|12014239|FG002|STARTED|8-week Double-blind Period||0
10847932|NCT01307033|12014240|FG003|STARTED|8-week Double-blind Period||0
10847933|NCT01307033|12014237|FG000|COMPLETED|8-week Double-blind Period||131
10847934|NCT01307033|12014238|FG001|COMPLETED|8-week Double-blind Period||127
10847935|NCT01307033|12014239|FG002|COMPLETED|8-week Double-blind Period||0
10847936|NCT01307033|12014240|FG003|COMPLETED|8-week Double-blind Period||0
10847937|NCT01307033|12014237|FG000|NOT COMPLETED|8-week Double-blind Period||13
10847938|NCT01307033|12014238|FG001|NOT COMPLETED|8-week Double-blind Period||7
10847939|NCT01307033|12014239|FG002|NOT COMPLETED|8-week Double-blind Period||0
10847940|NCT01307033|12014240|FG003|NOT COMPLETED|8-week Double-blind Period||0
10847941|NCT01307033|12014237|FG000|STARTED|44-week Open-label Extension||0
10847942|NCT01307033|12014238|FG001|STARTED|44-week Open-label Extension||0
10847943|NCT01307033|12014239|FG002|STARTED|44-week Open-label Extension||131
10847944|NCT01307033|12014240|FG003|STARTED|44-week Open-label Extension||127
10847945|NCT01307033|12014237|FG000|COMPLETED|44-week Open-label Extension||0
10847946|NCT01307033|12014238|FG001|COMPLETED|44-week Open-label Extension||0
10847947|NCT01307033|12014239|FG002|COMPLETED|44-week Open-label Extension||120
10847948|NCT01307033|12014240|FG003|COMPLETED|44-week Open-label Extension||115
10847949|NCT01307033|12014237|FG000|NOT COMPLETED|44-week Open-label Extension||0
10847950|NCT01307033|12014238|FG001|NOT COMPLETED|44-week Open-label Extension||0
10847951|NCT01307033|12014239|FG002|NOT COMPLETED|44-week Open-label Extension||11
10847952|NCT01307033|12014240|FG003|NOT COMPLETED|44-week Open-label Extension||12
10847953|NCT00739674|12014254|FG000|STARTED|Overall Study||535
10847954|NCT00739674|12014255|FG001|STARTED|Overall Study||457
10847955|NCT00739674|12014254|FG000|Screening Failures|Overall Study||19
10847956|NCT00739674|12014255|FG001|Screening Failures|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|17
10847957|NCT00739674|12014254|FG000|Site 212 Removal|Overall Study|lack of source documentation & frequent discrepancies between source notes and case report entries.|19
10847958|NCT00739674|12014255|FG001|Site 212 Removal|Overall Study|lack of source documentation & frequent discrepancies between source notes and case report entries.|13
10847959|NCT00739674|12014254|FG000|No Follow-up Data|Overall Study||33
10847960|NCT00739674|12014255|FG001|No Follow-up Data|Overall Study||18
10847961|NCT00739674|12014254|FG000|Dietician Consultation >30 Days|Overall Study|Patients with dietician consultations >30 days after visit 1 were not included in the data analysis.|1
10847962|NCT00739674|12014255|FG001|Dietician Consultation >30 Days|Overall Study|Patients with dietician consultations >30 days after visit 1 were not included in the data analysis.|9
10847963|NCT00739674|12014254|FG000|Intent-to-treat (ITT) Population|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|463
10847964|NCT00739674|12014255|FG001|Intent-to-treat (ITT) Population|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|400
10847965|NCT00739674|12014254|FG000|COMPLETED|Overall Study||354
10847966|NCT00739674|12014255|FG001|COMPLETED|Overall Study||335
10847967|NCT00739674|12014254|FG000|NOT COMPLETED|Overall Study||181
10847968|NCT00739674|12014255|FG001|NOT COMPLETED|Overall Study||122
10847969|NCT00546754|12014263|FG000|STARTED|Overall Study|Number of patients enrolled and randomized|425
10847970|NCT00546754|12014264|FG001|STARTED|Overall Study|Number of patients enrolled and randomized|383
10847971|NCT00546754|12014263|FG000|Treated|Overall Study|Patients that received at least one dose of study medication and had 1 follow-up visit|416
10847972|NCT00546754|12014264|FG001|Treated|Overall Study|Patients that received at least one dose of study medication and had 1 follow-up visit|373
10847973|NCT00546754|12014263|FG000|Week 6|Overall Study||396
10847974|NCT00546754|12014264|FG001|Week 6|Overall Study||347
10847975|NCT00546754|12014263|FG000|Week 12|Overall Study||375
10413373|NCT00777855|11557607|FG001|NOT COMPLETED|First Intervention||0
10413374|NCT00777855|11557606|FG000|STARTED|Washout Period (>= 14 Days)||5
10413375|NCT00777855|11557607|FG001|STARTED|Washout Period (>= 14 Days)||5
10413376|NCT00777855|11557606|FG000|COMPLETED|Washout Period (>= 14 Days)||5
10413377|NCT00777855|11557607|FG001|COMPLETED|Washout Period (>= 14 Days)||5
10413378|NCT00777855|11557606|FG000|NOT COMPLETED|Washout Period (>= 14 Days)||0
10413379|NCT00777855|11557607|FG001|NOT COMPLETED|Washout Period (>= 14 Days)||0
10413380|NCT00777855|11557606|FG000|STARTED|Second Intervention||5
10413381|NCT00777855|11557607|FG001|STARTED|Second Intervention||5
10413382|NCT00777855|11557606|FG000|COMPLETED|Second Intervention||5
10413383|NCT00777855|11557607|FG001|COMPLETED|Second Intervention||5
10413384|NCT00777855|11557606|FG000|NOT COMPLETED|Second Intervention||0
10413385|NCT00777855|11557607|FG001|NOT COMPLETED|Second Intervention||0
10413386|NCT00777920|11557612|FG000|STARTED|Overall Study||140
10413387|NCT00777920|11557612|FG000|COMPLETED|Overall Study||90
10413388|NCT00777920|11557612|FG000|NOT COMPLETED|Overall Study||50
10413389|NCT00777946|11557619|FG000|STARTED|Overall Study|1 patient in the Aliskiren 300 mg/Amlodipine 10 mg group was randomized in error.|283
10413390|NCT00777946|11557620|FG001|STARTED|Overall Study|1 patient in the Aliskiren 300 mg/Amlodipine 5 mg group was randomized in error.|277
10413391|NCT00777946|11557621|FG002|STARTED|Overall Study||260
10413392|NCT00777946|11557619|FG000|Safety & Full Analysis Sets|Overall Study||282
10413393|NCT00777946|11557620|FG001|Safety & Full Analysis Sets|Overall Study||276
10413394|NCT00777946|11557621|FG002|Safety & Full Analysis Sets|Overall Study||260
10413395|NCT00777946|11557619|FG000|COMPLETED|Overall Study||262
10413396|NCT00777946|11557620|FG001|COMPLETED|Overall Study||271
10413397|NCT00777946|11557621|FG002|COMPLETED|Overall Study||244
10413398|NCT00777946|11557619|FG000|NOT COMPLETED|Overall Study||21
10413399|NCT00777946|11557620|FG001|NOT COMPLETED|Overall Study||6
10413400|NCT00777946|11557621|FG002|NOT COMPLETED|Overall Study||16
10413401|NCT00778102|11557631|FG000|STARTED|Overall Study||39
10413402|NCT00778102|11557632|FG001|STARTED|Overall Study||41
10413403|NCT00778102|11557631|FG000|COMPLETED|Overall Study||18
10413404|NCT00778102|11557632|FG001|COMPLETED|Overall Study||19
10413405|NCT00778102|11557631|FG000|NOT COMPLETED|Overall Study||21
10413406|NCT00778102|11557632|FG001|NOT COMPLETED|Overall Study||22
10847976|NCT00546754|12014264|FG001|Week 12|Overall Study||334
10847977|NCT00546754|12014263|FG000|COMPLETED|Overall Study||375
10847978|NCT00546754|12014264|FG001|COMPLETED|Overall Study||334
10847979|NCT00546754|12014263|FG000|NOT COMPLETED|Overall Study||50
10847980|NCT00546754|12014264|FG001|NOT COMPLETED|Overall Study||49
10847981|NCT00479713|12014272|FG000|STARTED|Overall Study||314
10847982|NCT00479713|12014273|FG001|STARTED|Overall Study||304
10847983|NCT00479713|12014272|FG000|COMPLETED|Overall Study||301
10847984|NCT00479713|12014273|FG001|COMPLETED|Overall Study||295
10847985|NCT00479713|12014272|FG000|NOT COMPLETED|Overall Study||13
10847986|NCT00479713|12014273|FG001|NOT COMPLETED|Overall Study||9
10847987|NCT00406783|12014281|FG000|STARTED|Overall Study||276
10847988|NCT00406783|12014282|FG001|STARTED|Overall Study||271
10847989|NCT00406783|12014281|FG000|COMPLETED|Overall Study||262
10847990|NCT00406783|12014282|FG001|COMPLETED|Overall Study||256
10847991|NCT00406783|12014281|FG000|NOT COMPLETED|Overall Study||14
10847992|NCT00406783|12014282|FG001|NOT COMPLETED|Overall Study||15
10847993|NCT00405964|12014290|FG000|STARTED|Overall Study||360
10847994|NCT00405964|12014291|FG001|STARTED|Overall Study||356
10847995|NCT00405964|12014290|FG000|COMPLETED|Overall Study||301
10847996|NCT00405964|12014291|FG001|COMPLETED|Overall Study||261
10847997|NCT00405964|12014290|FG000|NOT COMPLETED|Overall Study||59
10847998|NCT00405964|12014291|FG001|NOT COMPLETED|Overall Study||95
10847999|NCT00383721|12014302|FG000|STARTED|26-Week Double-Blind Treatment Period||225
10848000|NCT00383721|12014303|FG001|STARTED|26-Week Double-Blind Treatment Period||239
10848001|NCT00383721|12014304|FG002|STARTED|26-Week Double-Blind Treatment Period||253
10848002|NCT00383721|12014305|FG003|STARTED|26-Week Double-Blind Treatment Period||243
10848003|NCT00383721|12014306|FG004|STARTED|26-Week Double-Blind Treatment Period||236
10848004|NCT00383721|12014302|FG000|COMPLETED|26-Week Double-Blind Treatment Period|"1 participant listed as ongoing since the participant status could not be formally confirmed."|190
10848005|NCT00383721|12014303|FG001|COMPLETED|26-Week Double-Blind Treatment Period||202
10848006|NCT00383721|12014304|FG002|COMPLETED|26-Week Double-Blind Treatment Period||202
10848007|NCT00383721|12014305|FG003|COMPLETED|26-Week Double-Blind Treatment Period||193
10848008|NCT00383721|12014306|FG004|COMPLETED|26-Week Double-Blind Treatment Period||169
10848009|NCT00383721|12014302|FG000|NOT COMPLETED|26-Week Double-Blind Treatment Period||35
10848010|NCT00383721|12014303|FG001|NOT COMPLETED|26-Week Double-Blind Treatment Period||37
10848011|NCT00383721|12014304|FG002|NOT COMPLETED|26-Week Double-Blind Treatment Period||51
10848012|NCT00383721|12014305|FG003|NOT COMPLETED|26-Week Double-Blind Treatment Period||50
10848013|NCT00383721|12014306|FG004|NOT COMPLETED|26-Week Double-Blind Treatment Period||67
10848014|NCT00383721|12014302|FG000|STARTED|26-Week Treatment Safety Extension||145
10848015|NCT00383721|12014303|FG001|STARTED|26-Week Treatment Safety Extension||153
10848016|NCT00383721|12014304|FG002|STARTED|26-Week Treatment Safety Extension||149
10848017|NCT00383721|12014305|FG003|STARTED|26-Week Treatment Safety Extension||148
10848018|NCT00383721|12014306|FG004|STARTED|26-Week Treatment Safety Extension||8
10848019|NCT00383721|12014302|FG000|COMPLETED|26-Week Treatment Safety Extension||126
10848020|NCT00383721|12014303|FG001|COMPLETED|26-Week Treatment Safety Extension||136
10848021|NCT00383721|12014304|FG002|COMPLETED|26-Week Treatment Safety Extension||126
10848022|NCT00383721|12014305|FG003|COMPLETED|26-Week Treatment Safety Extension||131
10848023|NCT00383721|12014306|FG004|COMPLETED|26-Week Treatment Safety Extension||8
10848024|NCT00383721|12014302|FG000|NOT COMPLETED|26-Week Treatment Safety Extension||19
10848025|NCT00383721|12014303|FG001|NOT COMPLETED|26-Week Treatment Safety Extension||17
10848026|NCT00383721|12014304|FG002|NOT COMPLETED|26-Week Treatment Safety Extension||23
10848027|NCT00383721|12014305|FG003|NOT COMPLETED|26-Week Treatment Safety Extension||17
10848028|NCT00383721|12014306|FG004|NOT COMPLETED|26-Week Treatment Safety Extension||0
10848029|NCT00383552|12014322|FG000|STARTED|Overall Study||182
10848030|NCT00383552|12014323|FG001|STARTED|Overall Study||188
10848031|NCT00383552|12014324|FG002|STARTED|Overall Study||188
10848032|NCT00383552|12014325|FG003|STARTED|Overall Study||188
10848033|NCT00383552|12014322|FG000|COMPLETED|Overall Study||146
10848034|NCT00383552|12014323|FG001|COMPLETED|Overall Study||147
10292769|NCT02425826|11425575|FG000|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||121
10292770|NCT02425826|11425576|FG001|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||0
10292771|NCT02425826|11425577|FG002|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||64
10292772|NCT02425826|11425575|FG000|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||86
10292773|NCT02425826|11425576|FG001|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||0
10848035|NCT00383552|12014324|FG002|COMPLETED|Overall Study||127
10848036|NCT00383552|12014325|FG003|COMPLETED|Overall Study||116
10848037|NCT00383552|12014322|FG000|NOT COMPLETED|Overall Study||36
10848038|NCT00383552|12014323|FG001|NOT COMPLETED|Overall Study||41
10848039|NCT00383552|12014324|FG002|NOT COMPLETED|Overall Study||61
10848040|NCT00383552|12014325|FG003|NOT COMPLETED|Overall Study||72
10848041|NCT00383435|12014345|FG000|STARTED|26-Week Double-Blind Treatment Period||217
10848042|NCT00383435|12014346|FG001|STARTED|26-Week Double-Blind Treatment Period||207
10848043|NCT00383435|12014347|FG002|STARTED|26-Week Double-Blind Treatment Period||210
10848044|NCT00383435|12014348|FG003|STARTED|26-Week Double-Blind Treatment Period||209
10848045|NCT00383435|12014349|FG004|STARTED|26-Week Double-Blind Treatment Period||212
10848046|NCT00383435|12014345|FG000|COMPLETED|26-Week Double-Blind Treatment Period||176
10848047|NCT00383435|12014346|FG001|COMPLETED|26-Week Double-Blind Treatment Period||169
10848048|NCT00383435|12014347|FG002|COMPLETED|26-Week Double-Blind Treatment Period||164
10848049|NCT00383435|12014348|FG003|COMPLETED|26-Week Double-Blind Treatment Period||172
10848050|NCT00383435|12014349|FG004|COMPLETED|26-Week Double-Blind Treatment Period||159
10848051|NCT00383435|12014345|FG000|NOT COMPLETED|26-Week Double-Blind Treatment Period||41
10848052|NCT00383435|12014346|FG001|NOT COMPLETED|26-Week Double-Blind Treatment Period||38
10848053|NCT00383435|12014347|FG002|NOT COMPLETED|26-Week Double-Blind Treatment Period||46
10848054|NCT00383435|12014348|FG003|NOT COMPLETED|26-Week Double-Blind Treatment Period||37
10848055|NCT00383435|12014349|FG004|NOT COMPLETED|26-Week Double-Blind Treatment Period||53
10848056|NCT00383435|12014345|FG000|STARTED|26-Week Treatment Safety Extension||131
10848057|NCT00383435|12014346|FG001|STARTED|26-Week Treatment Safety Extension||130
10848058|NCT00383435|12014347|FG002|STARTED|26-Week Treatment Safety Extension||124
10848059|NCT00383435|12014348|FG003|STARTED|26-Week Treatment Safety Extension||131
10848060|NCT00383435|12014349|FG004|STARTED|26-Week Treatment Safety Extension||13
10848061|NCT00383435|12014345|FG000|COMPLETED|26-Week Treatment Safety Extension||117
10848062|NCT00383435|12014346|FG001|COMPLETED|26-Week Treatment Safety Extension||121
10848063|NCT00383435|12014347|FG002|COMPLETED|26-Week Treatment Safety Extension||108
10848064|NCT00383435|12014348|FG003|COMPLETED|26-Week Treatment Safety Extension||116
10848065|NCT00383435|12014349|FG004|COMPLETED|26-Week Treatment Safety Extension||10
10848066|NCT00383435|12014345|FG000|NOT COMPLETED|26-Week Treatment Safety Extension||14
10848067|NCT00383435|12014346|FG001|NOT COMPLETED|26-Week Treatment Safety Extension||9
10848068|NCT00383435|12014347|FG002|NOT COMPLETED|26-Week Treatment Safety Extension||16
10848069|NCT00383435|12014348|FG003|NOT COMPLETED|26-Week Treatment Safety Extension||15
10848070|NCT00383435|12014349|FG004|NOT COMPLETED|26-Week Treatment Safety Extension||3
10848071|NCT00381485|12014364|FG000|STARTED|Open-Label Run-In Period||834
10848072|NCT00381485|12014365|FG001|STARTED|Open-Label Run-In Period||0
10848073|NCT00381485|12014366|FG002|STARTED|Open-Label Run-In Period||0
10848074|NCT00381485|12014367|FG003|STARTED|Open-Label Run-In Period||0
10848075|NCT00381485|12014364|FG000|COMPLETED|Open-Label Run-In Period||728
10848076|NCT00381485|12014365|FG001|COMPLETED|Open-Label Run-In Period||0
10848077|NCT00381485|12014366|FG002|COMPLETED|Open-Label Run-In Period||0
10848078|NCT00381485|12014367|FG003|COMPLETED|Open-Label Run-In Period||0
10848079|NCT00381485|12014364|FG000|NOT COMPLETED|Open-Label Run-In Period||106
10848080|NCT00381485|12014365|FG001|NOT COMPLETED|Open-Label Run-In Period||0
10848081|NCT00381485|12014366|FG002|NOT COMPLETED|Open-Label Run-In Period||0
10848082|NCT00381485|12014367|FG003|NOT COMPLETED|Open-Label Run-In Period||0
10848083|NCT00381485|12014364|FG000|STARTED|Double-Blind Treatment Period||0
10848084|NCT00381485|12014365|FG001|STARTED|Double-Blind Treatment Period||255
10848085|NCT00381485|12014366|FG002|STARTED|Double-Blind Treatment Period||233
10848086|NCT00381485|12014367|FG003|STARTED|Double-Blind Treatment Period||240
10848087|NCT00381485|12014364|FG000|COMPLETED|Double-Blind Treatment Period||0
10848088|NCT00381485|12014365|FG001|COMPLETED|Double-Blind Treatment Period||228
10848089|NCT00381485|12014366|FG002|COMPLETED|Double-Blind Treatment Period||208
10848090|NCT00381485|12014367|FG003|COMPLETED|Double-Blind Treatment Period||207
10848091|NCT00381485|12014364|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
10848092|NCT00381485|12014365|FG001|NOT COMPLETED|Double-Blind Treatment Period||27
10848093|NCT00381485|12014366|FG002|NOT COMPLETED|Double-Blind Treatment Period||25
10848094|NCT00381485|12014367|FG003|NOT COMPLETED|Double-Blind Treatment Period||33
10848095|NCT00379288|12014380|FG000|STARTED|Overall Study||141
10848096|NCT00379288|12014381|FG001|STARTED|Overall Study||130
10848097|NCT00379288|12014382|FG002|STARTED|Overall Study||68
10848098|NCT00379288|12014383|FG003|STARTED|Overall Study||65
10848099|NCT00379288|12014380|FG000|COMPLETED|Overall Study||122
10848100|NCT00379288|12014381|FG001|COMPLETED|Overall Study||108
10848101|NCT00379288|12014382|FG002|COMPLETED|Overall Study||58
10848102|NCT00379288|12014383|FG003|COMPLETED|Overall Study||57
10848103|NCT00379288|12014380|FG000|NOT COMPLETED|Overall Study||19
10848104|NCT00379288|12014381|FG001|NOT COMPLETED|Overall Study||22
10848105|NCT00379288|12014382|FG002|NOT COMPLETED|Overall Study||10
10848106|NCT00379288|12014383|FG003|NOT COMPLETED|Overall Study||8
10848107|NCT00378378|12014396|FG000|STARTED|Overall Study||51
10848108|NCT00378378|12014397|FG001|STARTED|Overall Study||50
10848109|NCT00378378|12014398|FG002|STARTED|Overall Study||26
10848110|NCT00378378|12014396|FG000|COMPLETED|Overall Study||51
10848111|NCT00378378|12014397|FG001|COMPLETED|Overall Study||49
10848112|NCT00378378|12014398|FG002|COMPLETED|Overall Study||24
10848113|NCT00378378|12014396|FG000|NOT COMPLETED|Overall Study||0
10848114|NCT00378378|12014397|FG001|NOT COMPLETED|Overall Study||1
10848115|NCT00378378|12014398|FG002|NOT COMPLETED|Overall Study||2
10848116|NCT00089895|12014408|FG000|STARTED|Overall Study|Number of Subjects Randomized with Intent to Treat|4722
10848117|NCT00089895|12014409|FG001|STARTED|Overall Study|Number of Subjects Randomized with Intent to Treat|4684
10848118|NCT00089895|12014408|FG000|COMPLETED|Overall Study|Number of Subjects treated|4687
10848119|NCT00089895|12014409|FG001|COMPLETED|Overall Study|Number of Subjects treated|4642
10848120|NCT00089895|12014408|FG000|NOT COMPLETED|Overall Study||35
10848121|NCT00089895|12014409|FG001|NOT COMPLETED|Overall Study||42
10413407|NCT00778167|11557641|FG000|STARTED|Overall Study||6
10848122|NCT02577354|12014417|FG000|STARTED|Overall Study||102
10848123|NCT02577354|12014418|FG001|STARTED|Overall Study||102
10848124|NCT02577354|12014417|FG000|120 Day Primary Endpoint|Overall Study||100
10848125|NCT02577354|12014418|FG001|120 Day Primary Endpoint|Overall Study||101
10848126|NCT02577354|12014417|FG000|COMPLETED|Overall Study||87
10848127|NCT02577354|12014418|FG001|COMPLETED|Overall Study||89
10848128|NCT02577354|12014417|FG000|NOT COMPLETED|Overall Study||15
10848129|NCT02577354|12014418|FG001|NOT COMPLETED|Overall Study||13
10848130|NCT02471807|12014434|FG000|STARTED|Overall Study||34
10848131|NCT02471807|12014434|FG000|COMPLETED|Overall Study||11
10848132|NCT02471807|12014434|FG000|NOT COMPLETED|Overall Study||23
10848136|NCT02118610|12014444|FG000|STARTED|Overall Study||30
10848137|NCT02118610|12014445|FG001|STARTED|Overall Study||33
10848138|NCT02118610|12014444|FG000|COMPLETED|Overall Study||29
10848139|NCT02118610|12014445|FG001|COMPLETED|Overall Study||32
10848140|NCT02118610|12014444|FG000|NOT COMPLETED|Overall Study||1
10848141|NCT02118610|12014445|FG001|NOT COMPLETED|Overall Study||1
10848142|NCT01909570|12014453|FG000|STARTED|Overall Study||84
10848143|NCT01909570|12014454|FG001|STARTED|Overall Study||91
10848144|NCT01909570|12014453|FG000|COMPLETED|Overall Study||57
10848145|NCT01909570|12014454|FG001|COMPLETED|Overall Study||64
10848146|NCT01909570|12014453|FG000|NOT COMPLETED|Overall Study||27
10848147|NCT01909570|12014454|FG001|NOT COMPLETED|Overall Study||27
10848148|NCT01453946|12014460|FG000|STARTED|Overall Study||50
10848149|NCT01453946|12014460|FG000|COMPLETED|Overall Study||41
10848150|NCT01453946|12014460|FG000|NOT COMPLETED|Overall Study||9
10848151|NCT01444092|12014464|FG000|STARTED|Overall Study||108
10848152|NCT01444092|12014464|FG000|INFORMED CONSENT OBTAINED|Overall Study||108
10848153|NCT01444092|12014464|FG000|COMPLETED|Overall Study||91
10848154|NCT01444092|12014464|FG000|NOT COMPLETED|Overall Study||17
10848155|NCT01265784|12014471|FG000|STARTED|Overall Study||56
10848156|NCT01265784|12014472|FG001|STARTED|Overall Study||57
10848157|NCT01265784|12014473|FG002|STARTED|Overall Study||30
10848158|NCT01265784|12014471|FG000|Received at Least 1 Dose of Study Drug|Overall Study|1 participant randomized to TP-434 1.5 mg/kg took ertapenem. Results are included in ertapenem arm.|54
10848159|NCT01265784|12014472|FG001|Received at Least 1 Dose of Study Drug|Overall Study||56
10848160|NCT01265784|12014473|FG002|Received at Least 1 Dose of Study Drug|Overall Study||29
10848161|NCT01265784|12014471|FG000|COMPLETED|Overall Study||44
10848162|NCT01265784|12014472|FG001|COMPLETED|Overall Study||49
10848163|NCT01265784|12014473|FG002|COMPLETED|Overall Study||26
10848164|NCT01265784|12014471|FG000|NOT COMPLETED|Overall Study||12
10848165|NCT01265784|12014472|FG001|NOT COMPLETED|Overall Study||8
10848166|NCT01265784|12014473|FG002|NOT COMPLETED|Overall Study||4
10848167|NCT00577577|12014483|FG000|STARTED|Overall Study||34
10848168|NCT00577577|12014484|FG001|STARTED|Overall Study||35
10848169|NCT00577577|12014483|FG000|Received Treatment|Overall Study||34
10848170|NCT00577577|12014484|FG001|Received Treatment|Overall Study||35
10848171|NCT00577577|12014483|FG000|COMPLETED|Overall Study||29
10848172|NCT00577577|12014484|FG001|COMPLETED|Overall Study||30
10848173|NCT00577577|12014483|FG000|NOT COMPLETED|Overall Study||5
10848174|NCT00577577|12014484|FG001|NOT COMPLETED|Overall Study||5
10848175|NCT00392327|12014498|FG000|STARTED|Overall Study||87
10848176|NCT00392327|12014499|FG001|STARTED|Overall Study||93
10848177|NCT00392327|12014500|FG002|STARTED|Overall Study||56
10848178|NCT00392327|12014501|FG003|STARTED|Overall Study||58
10848179|NCT00392327|12014502|FG004|STARTED|Overall Study||23
10848180|NCT00392327|12014503|FG005|STARTED|Overall Study||19
10848181|NCT00392327|12014504|FG006|STARTED|Overall Study||21
10848182|NCT00392327|12014505|FG007|STARTED|Overall Study||22
10848183|NCT00392327|12014498|FG000|COMPLETED|Overall Study||72
10848184|NCT00392327|12014499|FG001|COMPLETED|Overall Study||74
10848185|NCT00392327|12014500|FG002|COMPLETED|Overall Study||36
10848186|NCT00392327|12014501|FG003|COMPLETED|Overall Study||42
10848187|NCT00392327|12014502|FG004|COMPLETED|Overall Study||20
10848188|NCT00392327|12014503|FG005|COMPLETED|Overall Study||14
10848189|NCT00392327|12014504|FG006|COMPLETED|Overall Study||12
10848190|NCT00392327|12014505|FG007|COMPLETED|Overall Study||11
10848191|NCT00392327|12014498|FG000|NOT COMPLETED|Overall Study||15
10848192|NCT00392327|12014499|FG001|NOT COMPLETED|Overall Study||19
10848193|NCT00392327|12014500|FG002|NOT COMPLETED|Overall Study||20
10848194|NCT00392327|12014501|FG003|NOT COMPLETED|Overall Study||16
10848195|NCT00392327|12014502|FG004|NOT COMPLETED|Overall Study||3
10848196|NCT00392327|12014503|FG005|NOT COMPLETED|Overall Study||5
10848197|NCT00392327|12014504|FG006|NOT COMPLETED|Overall Study||9
10848198|NCT00392327|12014505|FG007|NOT COMPLETED|Overall Study||11
10848199|NCT00085202|12014525|FG000|STARTED|Overall Study||269
10848200|NCT00085202|12014526|FG001|STARTED|Overall Study||144
10848201|NCT00085202|12014525|FG000|COMPLETED|Overall Study||251
10848202|NCT00085202|12014526|FG001|COMPLETED|Overall Study||120
10848203|NCT00085202|12014525|FG000|NOT COMPLETED|Overall Study||18
10848204|NCT00085202|12014526|FG001|NOT COMPLETED|Overall Study||24
10848205|NCT05007639|12014545|FG000|STARTED|Overall Study||274
10848206|NCT05007639|12014545|FG000|COMPLETED|Overall Study||274
10848207|NCT05007639|12014545|FG000|NOT COMPLETED|Overall Study||0
10848208|NCT04739735|12014551|FG000|STARTED|Overall Study||25
10848209|NCT04739735|12014552|FG001|STARTED|Overall Study||25
10848210|NCT04739735|12014551|FG000|COMPLETED|Overall Study||25
10848211|NCT04739735|12014552|FG001|COMPLETED|Overall Study||25
10848212|NCT04739735|12014551|FG000|NOT COMPLETED|Overall Study||0
10848213|NCT04739735|12014552|FG001|NOT COMPLETED|Overall Study||0
10848214|NCT04552535|12014560|FG000|STARTED|Overall Study||99
10848215|NCT04552535|12014561|FG001|STARTED|Overall Study||101
10848216|NCT04552535|12014560|FG000|COMPLETED|Overall Study||99
10848217|NCT04552535|12014561|FG001|COMPLETED|Overall Study||101
10848218|NCT04552535|12014560|FG000|NOT COMPLETED|Overall Study||0
10848219|NCT04552535|12014561|FG001|NOT COMPLETED|Overall Study||0
10848220|NCT04502472|12014572|FG000|STARTED|Overall Study||61
10848221|NCT04502472|12014573|FG001|STARTED|Overall Study||48
10848222|NCT04502472|12014572|FG000|COMPLETED|Overall Study||58
10848223|NCT04502472|12014573|FG001|COMPLETED|Overall Study||45
10848224|NCT04502472|12014572|FG000|NOT COMPLETED|Overall Study||3
10848225|NCT04502472|12014573|FG001|NOT COMPLETED|Overall Study||3
10848226|NCT04495166|12014582|FG000|STARTED|Overall Study||37
10848227|NCT04495166|12014583|FG001|STARTED|Overall Study||44
10848228|NCT04495166|12014582|FG000|COMPLETED|Overall Study||30
10848229|NCT04495166|12014583|FG001|COMPLETED|Overall Study||41
10848230|NCT04495166|12014582|FG000|NOT COMPLETED|Overall Study||7
10848231|NCT04495166|12014583|FG001|NOT COMPLETED|Overall Study||3
10848316|NCT04172467|12014698|FG000|STARTED|Overall Study||1086
10545418|NCT01496885|11698779|FG000|COMPLETED|Overall Study||97
10545419|NCT01496885|11698779|FG000|NOT COMPLETED|Overall Study||23
10545420|NCT01497067|11698783|FG000|STARTED|Overall Study||657
10545421|NCT01497067|11698783|FG000|COMPLETED|Overall Study||575
10545422|NCT01497067|11698783|FG000|NOT COMPLETED|Overall Study||82
10545423|NCT01497197|11698790|FG000|STARTED|Overall Study||89
10545424|NCT01497197|11698791|FG001|STARTED|Overall Study||85
10545425|NCT01497197|11698790|FG000|COMPLETED|Overall Study||72
10545426|NCT01497197|11698791|FG001|COMPLETED|Overall Study||70
10545427|NCT01497197|11698790|FG000|NOT COMPLETED|Overall Study||17
10545428|NCT01497197|11698791|FG001|NOT COMPLETED|Overall Study||15
10545429|NCT01497262|11698797|FG000|STARTED|Overall Study||162
10545430|NCT01497262|11698797|FG000|COMPLETED|Overall Study||151
10545431|NCT01497262|11698797|FG000|NOT COMPLETED|Overall Study||11
10545432|NCT01497275|11698801|FG000|STARTED|Overall Study||5
10545433|NCT01497275|11698801|FG000|COMPLETED|Overall Study||3
10545434|NCT01497275|11698801|FG000|NOT COMPLETED|Overall Study||2
10545435|NCT01497366|11698807|FG000|STARTED|Overall Study||263
10545436|NCT01497366|11698808|FG001|STARTED|Overall Study||264
10545437|NCT01497366|11698807|FG000|Randomized But Not Treated|Overall Study||7
10545438|NCT01497366|11698808|FG001|Randomized But Not Treated|Overall Study||21
10545439|NCT01497366|11698807|FG000|COMPLETED|Overall Study||224
10545440|NCT01497366|11698808|FG001|COMPLETED|Overall Study||176
10545441|NCT01497366|11698807|FG000|NOT COMPLETED|Overall Study||39
10545442|NCT01497366|11698808|FG001|NOT COMPLETED|Overall Study||88
10545443|NCT01497496|11698815|FG000|STARTED|Overall Study||29
10545444|NCT01497496|11698815|FG000|COMPLETED|Overall Study||29
10545445|NCT01497496|11698815|FG000|NOT COMPLETED|Overall Study||0
10545446|NCT01497613|11698821|FG000|STARTED|Overall Study||150
10545447|NCT01497613|11698822|FG001|STARTED|Overall Study||150
10545448|NCT01497613|11698821|FG000|COMPLETED|Overall Study||113
10545449|NCT01497613|11698822|FG001|COMPLETED|Overall Study||131
10545450|NCT01497613|11698821|FG000|NOT COMPLETED|Overall Study||37
10545451|NCT01497613|11698822|FG001|NOT COMPLETED|Overall Study||19
10545452|NCT01497665|11698828|FG000|STARTED|Overall Study||16
10545453|NCT01497665|11698828|FG000|Completed Effifcacy Assessment|Overall Study|Number of patients who completed efficacy assessment with CNS lesions per Overall RECIST 1.1.|10
10545454|NCT01497665|11698828|FG000|COMPLETED|Overall Study||16
10545455|NCT01497665|11698828|FG000|NOT COMPLETED|Overall Study||0
10545456|NCT01497756|11698832|FG000|STARTED|Overall Study||10
10545457|NCT01497756|11698832|FG000|COMPLETED|Overall Study||10
10545458|NCT01497756|11698832|FG000|NOT COMPLETED|Overall Study||0
10545459|NCT01497808|11698840|FG000|STARTED|Overall Study||6
10545460|NCT01497808|11698841|FG001|STARTED|Overall Study||4
10545461|NCT01497808|11698842|FG002|STARTED|Overall Study||6
10545462|NCT01497808|11698843|FG003|STARTED|Overall Study||6
10545463|NCT01497808|11698840|FG000|COMPLETED|Overall Study||6
10545464|NCT01497808|11698841|FG001|COMPLETED|Overall Study||4
10545465|NCT01497808|11698842|FG002|COMPLETED|Overall Study||6
10848317|NCT04172467|12014698|FG000|COMPLETED|Overall Study||1086
10848318|NCT04172467|12014698|FG000|NOT COMPLETED|Overall Study||0
10545466|NCT01497808|11698843|FG003|COMPLETED|Overall Study||6
10545467|NCT01497808|11698840|FG000|NOT COMPLETED|Overall Study||0
10545468|NCT01497808|11698841|FG001|NOT COMPLETED|Overall Study||0
10545469|NCT01497808|11698842|FG002|NOT COMPLETED|Overall Study||0
10545470|NCT01497808|11698843|FG003|NOT COMPLETED|Overall Study||0
10545471|NCT01497860|11698853|FG000|STARTED|Overall Study||12
10545472|NCT01497860|11698853|FG000|COMPLETED|Overall Study||12
10545473|NCT01497860|11698853|FG000|NOT COMPLETED|Overall Study||0
10848322|NCT03963011|12014711|FG000|STARTED|Overall Study||8
10848323|NCT03963011|12014712|FG001|STARTED|Overall Study||6
10848324|NCT03963011|12014711|FG000|COMPLETED|Overall Study||8
10848232|NCT04461483|12014595|FG000|STARTED|Part 1 (Day 1)||6
10848233|NCT04461483|12014596|FG001|STARTED|Part 1 (Day 1)||6
10848234|NCT04461483|12014597|FG002|STARTED|Part 1 (Day 1)||6
10848235|NCT04461483|12014598|FG003|STARTED|Part 1 (Day 1)||6
10848236|NCT04461483|12014599|FG004|STARTED|Part 1 (Day 1)||0
10848237|NCT04461483|12014600|FG005|STARTED|Part 1 (Day 1)||0
10848238|NCT04461483|12014595|FG000|COMPLETED|Part 1 (Day 1)||6
10848239|NCT04461483|12014596|FG001|COMPLETED|Part 1 (Day 1)||6
10848240|NCT04461483|12014597|FG002|COMPLETED|Part 1 (Day 1)||6
10848241|NCT04461483|12014598|FG003|COMPLETED|Part 1 (Day 1)||6
10848242|NCT04461483|12014599|FG004|COMPLETED|Part 1 (Day 1)||0
10848243|NCT04461483|12014600|FG005|COMPLETED|Part 1 (Day 1)||0
10848244|NCT04461483|12014595|FG000|NOT COMPLETED|Part 1 (Day 1)||0
10848245|NCT04461483|12014596|FG001|NOT COMPLETED|Part 1 (Day 1)||0
10848246|NCT04461483|12014597|FG002|NOT COMPLETED|Part 1 (Day 1)||0
10848247|NCT04461483|12014598|FG003|NOT COMPLETED|Part 1 (Day 1)||0
10848248|NCT04461483|12014599|FG004|NOT COMPLETED|Part 1 (Day 1)||0
10848249|NCT04461483|12014600|FG005|NOT COMPLETED|Part 1 (Day 1)||0
10848250|NCT04461483|12014595|FG000|STARTED|Part 2 (Day 1 to 21)||0
10848251|NCT04461483|12014596|FG001|STARTED|Part 2 (Day 1 to 21)||0
10848252|NCT04461483|12014597|FG002|STARTED|Part 2 (Day 1 to 21)||0
10848253|NCT04461483|12014598|FG003|STARTED|Part 2 (Day 1 to 21)||0
10848254|NCT04461483|12014599|FG004|STARTED|Part 2 (Day 1 to 21)||3
10848255|NCT04461483|12014600|FG005|STARTED|Part 2 (Day 1 to 21)||6
10848256|NCT04461483|12014595|FG000|COMPLETED|Part 2 (Day 1 to 21)||0
10848257|NCT04461483|12014596|FG001|COMPLETED|Part 2 (Day 1 to 21)||0
10848258|NCT04461483|12014597|FG002|COMPLETED|Part 2 (Day 1 to 21)||0
10848259|NCT04461483|12014598|FG003|COMPLETED|Part 2 (Day 1 to 21)||0
10848260|NCT04461483|12014599|FG004|COMPLETED|Part 2 (Day 1 to 21)||3
10848261|NCT04461483|12014600|FG005|COMPLETED|Part 2 (Day 1 to 21)||6
10848262|NCT04461483|12014595|FG000|NOT COMPLETED|Part 2 (Day 1 to 21)||0
10848263|NCT04461483|12014596|FG001|NOT COMPLETED|Part 2 (Day 1 to 21)||0
10848264|NCT04461483|12014597|FG002|NOT COMPLETED|Part 2 (Day 1 to 21)||0
10848265|NCT04461483|12014598|FG003|NOT COMPLETED|Part 2 (Day 1 to 21)||0
10848266|NCT04461483|12014599|FG004|NOT COMPLETED|Part 2 (Day 1 to 21)||0
10848267|NCT04461483|12014600|FG005|NOT COMPLETED|Part 2 (Day 1 to 21)||0
10848268|NCT04386616|12014627|FG000|STARTED|Overall Study||134
10848269|NCT04386616|12014628|FG001|STARTED|Overall Study||130
10848270|NCT04386616|12014629|FG002|STARTED|Overall Study||132
10848271|NCT04386616|12014627|FG000|Received at Least One Dose of Study Drug|Overall Study|In this arm, 68 and 66 participants received MSTT1041A-matched placebo and UTTR1147A-matched placebo, respectively.|134
10848272|NCT04386616|12014628|FG001|Received at Least One Dose of Study Drug|Overall Study||130
10848273|NCT04386616|12014629|FG002|Received at Least One Dose of Study Drug|Overall Study||132
10848274|NCT04386616|12014627|FG000|Completed Both Doses of Study Drug at Day 15|Overall Study||31
10848275|NCT04386616|12014628|FG001|Completed Both Doses of Study Drug at Day 15|Overall Study||27
10848276|NCT04386616|12014629|FG002|Completed Both Doses of Study Drug at Day 15|Overall Study||25
10848277|NCT04386616|12014627|FG000|COMPLETED|Overall Study||104
10848278|NCT04386616|12014628|FG001|COMPLETED|Overall Study||95
10848279|NCT04386616|12014629|FG002|COMPLETED|Overall Study||104
10848280|NCT04386616|12014627|FG000|NOT COMPLETED|Overall Study||30
10848281|NCT04386616|12014628|FG001|NOT COMPLETED|Overall Study||35
10848282|NCT04386616|12014629|FG002|NOT COMPLETED|Overall Study||28
10848283|NCT04377711|12014648|FG000|STARTED|Overall Study||197
10848284|NCT04377711|12014649|FG001|STARTED|Overall Study||203
10848285|NCT04377711|12014648|FG000|COMPLETED|Overall Study||178
10848286|NCT04377711|12014649|FG001|COMPLETED|Overall Study||181
10848287|NCT04377711|12014648|FG000|NOT COMPLETED|Overall Study||19
10848288|NCT04377711|12014649|FG001|NOT COMPLETED|Overall Study||22
10848289|NCT04347408|12014655|FG000|STARTED|Overall Study||992
10848290|NCT04347408|12014655|FG000|COMPLETED|Overall Study||992
10848291|NCT04347408|12014655|FG000|NOT COMPLETED|Overall Study||0
10848292|NCT04296942|12014662|FG000|STARTED|Overall Study||1
10848293|NCT04296942|12014663|FG001|STARTED|Overall Study||0
10848294|NCT04296942|12014664|FG002|STARTED|Overall Study||0
10848295|NCT04296942|12014662|FG000|COMPLETED|Overall Study||0
10848296|NCT04296942|12014663|FG001|COMPLETED|Overall Study||0
10848297|NCT04296942|12014664|FG002|COMPLETED|Overall Study||0
10848298|NCT04296942|12014662|FG000|NOT COMPLETED|Overall Study||1
10848299|NCT04296942|12014663|FG001|NOT COMPLETED|Overall Study||0
10848300|NCT04296942|12014664|FG002|NOT COMPLETED|Overall Study||0
10848301|NCT04278872|12014676|FG000|STARTED|Overall Study||7
10848302|NCT04278872|12014677|FG001|STARTED|Overall Study||6
10848303|NCT04278872|12014676|FG000|COMPLETED|Overall Study||4
10848304|NCT04278872|12014677|FG001|COMPLETED|Overall Study||5
10848305|NCT04278872|12014676|FG000|NOT COMPLETED|Overall Study||3
10848306|NCT04278872|12014677|FG001|NOT COMPLETED|Overall Study||1
10848307|NCT04213807|12014686|FG000|STARTED|Overall Study||5
10848308|NCT04213807|12014687|FG001|STARTED|Overall Study||6
10848309|NCT04213807|12014688|FG002|STARTED|Overall Study||7
10848310|NCT04213807|12014686|FG000|COMPLETED|Overall Study||5
10848311|NCT04213807|12014687|FG001|COMPLETED|Overall Study||6
10848312|NCT04213807|12014688|FG002|COMPLETED|Overall Study||6
10848313|NCT04213807|12014686|FG000|NOT COMPLETED|Overall Study||0
10848314|NCT04213807|12014687|FG001|NOT COMPLETED|Overall Study||0
10848315|NCT04213807|12014688|FG002|NOT COMPLETED|Overall Study||1
10848325|NCT03963011|12014712|FG001|COMPLETED|Overall Study||6
10848326|NCT03963011|12014711|FG000|NOT COMPLETED|Overall Study||0
10848327|NCT03963011|12014712|FG001|NOT COMPLETED|Overall Study||0
10848328|NCT03894501|12014720|FG000|STARTED|Overall Study||15
10848329|NCT03894501|12014721|FG001|STARTED|Overall Study||15
10848330|NCT03894501|12014720|FG000|COMPLETED|Overall Study||15
10848331|NCT03894501|12014721|FG001|COMPLETED|Overall Study||15
10848332|NCT03894501|12014720|FG000|NOT COMPLETED|Overall Study||0
10848333|NCT03894501|12014721|FG001|NOT COMPLETED|Overall Study||0
10848337|NCT03735420|12014748|FG000|STARTED|Overall Study||16
10848338|NCT03735420|12014749|FG001|STARTED|Overall Study||14
10848339|NCT03735420|12014748|FG000|COMPLETED|Overall Study||16
10848340|NCT03735420|12014749|FG001|COMPLETED|Overall Study||14
10848341|NCT03735420|12014748|FG000|NOT COMPLETED|Overall Study||0
10848342|NCT03735420|12014749|FG001|NOT COMPLETED|Overall Study||0
10848343|NCT03721328|12014757|FG000|STARTED|Overall Study||15
10848344|NCT03721328|12014757|FG000|COMPLETED|Overall Study||15
10848345|NCT03721328|12014757|FG000|NOT COMPLETED|Overall Study||0
10848346|NCT03721107|12014765|FG000|STARTED|Overall Study||80
10848347|NCT03721107|12014766|FG001|STARTED|Overall Study||84
10848348|NCT03721107|12014767|FG002|STARTED|Overall Study||98
10848349|NCT03721107|12014768|FG003|STARTED|Overall Study||104
10848350|NCT03721107|12014765|FG000|Treated|Overall Study||80
10848351|NCT03721107|12014766|FG001|Treated|Overall Study||84
10848352|NCT03721107|12014767|FG002|Treated|Overall Study||97
10848353|NCT03721107|12014768|FG003|Treated|Overall Study||104
10848354|NCT03721107|12014765|FG000|COMPLETED|Overall Study||75
10848355|NCT03721107|12014766|FG001|COMPLETED|Overall Study||81
10848356|NCT03721107|12014767|FG002|COMPLETED|Overall Study||83
10848357|NCT03721107|12014768|FG003|COMPLETED|Overall Study||92
10848358|NCT03721107|12014765|FG000|NOT COMPLETED|Overall Study||5
10848359|NCT03721107|12014766|FG001|NOT COMPLETED|Overall Study||3
10848360|NCT03721107|12014767|FG002|NOT COMPLETED|Overall Study||15
10848361|NCT03721107|12014768|FG003|NOT COMPLETED|Overall Study||12
10848362|NCT03691727|12014780|FG000|STARTED|Overall Study||18
10848363|NCT03691727|12014781|FG001|STARTED|Overall Study||12
10848364|NCT03691727|12014780|FG000|COMPLETED|Overall Study||16
10848365|NCT03691727|12014781|FG001|COMPLETED|Overall Study||11
10848366|NCT03691727|12014780|FG000|NOT COMPLETED|Overall Study||2
10848367|NCT03691727|12014781|FG001|NOT COMPLETED|Overall Study||1
10848368|NCT03689920|12014789|FG000|STARTED|Overall Study||47
10848369|NCT03689920|12014790|FG001|STARTED|Overall Study||52
10848370|NCT03689920|12014789|FG000|COMPLETED|Overall Study||41
10848371|NCT03689920|12014790|FG001|COMPLETED|Overall Study||48
10848372|NCT03689920|12014789|FG000|NOT COMPLETED|Overall Study||6
10848373|NCT03689920|12014790|FG001|NOT COMPLETED|Overall Study||4
10848374|NCT03672227|12014798|FG000|STARTED|Overall Study||112
10848375|NCT03672227|12014799|FG001|STARTED|Overall Study||52
10848376|NCT03672227|12014798|FG000|Teachers Started|Overall Study||8
10848377|NCT03672227|12014799|FG001|Teachers Started|Overall Study||6
10848378|NCT03672227|12014798|FG000|Children Started|Overall Study||52
10848379|NCT03672227|12014799|FG001|Children Started|Overall Study||23
10848380|NCT03672227|12014798|FG000|Parents Started|Overall Study||52
10848381|NCT03672227|12014799|FG001|Parents Started|Overall Study||23
10848382|NCT03672227|12014798|FG000|COMPLETED|Overall Study||105
10848383|NCT03672227|12014799|FG001|COMPLETED|Overall Study||52
10848384|NCT03672227|12014798|FG000|NOT COMPLETED|Overall Study||7
10848385|NCT03672227|12014799|FG001|NOT COMPLETED|Overall Study||0
10848386|NCT03644849|12014808|FG000|STARTED|Overall Study||24
10848387|NCT03644849|12014809|FG001|STARTED|Overall Study||24
10848388|NCT03644849|12014808|FG000|COMPLETED|Overall Study||23
10848389|NCT03644849|12014809|FG001|COMPLETED|Overall Study||21
10848390|NCT03644849|12014808|FG000|NOT COMPLETED|Overall Study||1
10848391|NCT03644849|12014809|FG001|NOT COMPLETED|Overall Study||3
10848392|NCT03604159|12014817|FG000|STARTED|Overall Study||26
10848393|NCT03604159|12014818|FG001|STARTED|Overall Study||26
10848394|NCT03604159|12014817|FG000|COMPLETED|Overall Study||20
10848395|NCT03604159|12014818|FG001|COMPLETED|Overall Study||19
10848396|NCT03604159|12014817|FG000|NOT COMPLETED|Overall Study||6
10848397|NCT03604159|12014818|FG001|NOT COMPLETED|Overall Study||7
10848398|NCT03602885|12014826|FG000|STARTED|Overall Study||5
10848399|NCT03602885|12014827|FG001|STARTED|Overall Study||5
10848400|NCT03602885|12014826|FG000|COMPLETED|Overall Study||2
10848401|NCT03602885|12014827|FG001|COMPLETED|Overall Study||5
10848402|NCT03602885|12014826|FG000|NOT COMPLETED|Overall Study||3
10848403|NCT03602885|12014827|FG001|NOT COMPLETED|Overall Study||0
10848404|NCT03539601|12014837|FG000|STARTED|Overall Study||60
10848405|NCT03539601|12014838|FG001|STARTED|Overall Study||59
10848406|NCT03539601|12014839|FG002|STARTED|Overall Study||71
10848407|NCT03539601|12014840|FG003|STARTED|Overall Study||47
10848408|NCT03539601|12014837|FG000|Treated|Overall Study||59
10848409|NCT03539601|12014838|FG001|Treated|Overall Study||58
10848410|NCT03539601|12014839|FG002|Treated|Overall Study||71
10848411|NCT03539601|12014840|FG003|Treated|Overall Study||47
10848412|NCT03539601|12014837|FG000|COMPLETED|Overall Study||54
10848413|NCT03539601|12014838|FG001|COMPLETED|Overall Study||52
10848414|NCT03539601|12014839|FG002|COMPLETED|Overall Study||65
10848415|NCT03539601|12014840|FG003|COMPLETED|Overall Study||46
10848416|NCT03539601|12014837|FG000|NOT COMPLETED|Overall Study||6
10848417|NCT03539601|12014838|FG001|NOT COMPLETED|Overall Study||7
10848418|NCT03539601|12014839|FG002|NOT COMPLETED|Overall Study||6
10848419|NCT03539601|12014840|FG003|NOT COMPLETED|Overall Study||1
10848420|NCT03539458|12014858|FG000|STARTED|Overall Study||11
10848421|NCT03539458|12014858|FG000|COMPLETED|Overall Study||10
10848422|NCT03539458|12014858|FG000|NOT COMPLETED|Overall Study||1
10848423|NCT03532451|12014864|FG000|STARTED|Overall Study||13
10848424|NCT03532451|12014865|FG001|STARTED|Overall Study||30
10848425|NCT03532451|12014864|FG000|COMPLETED|Overall Study||12
10848426|NCT03532451|12014865|FG001|COMPLETED|Overall Study||29
10848427|NCT03532451|12014864|FG000|NOT COMPLETED|Overall Study||1
10848428|NCT03532451|12014865|FG001|NOT COMPLETED|Overall Study||1
10848437|NCT03494647|12014882|FG000|STARTED|Overall Study||21
10848438|NCT03494647|12014883|FG001|STARTED|Overall Study||22
10848439|NCT03494647|12014882|FG000|COMPLETED|Overall Study||16
10848440|NCT03494647|12014883|FG001|COMPLETED|Overall Study||16
10848441|NCT03494647|12014882|FG000|NOT COMPLETED|Overall Study||5
10848442|NCT03494647|12014883|FG001|NOT COMPLETED|Overall Study||6
10848443|NCT03439657|12014891|FG000|STARTED|Overall Study||449
10848444|NCT03439657|12014892|FG001|STARTED|Overall Study||463
10848445|NCT03439657|12014891|FG000|COMPLETED|Overall Study||442
10848446|NCT03439657|12014892|FG001|COMPLETED|Overall Study||459
10848447|NCT03439657|12014891|FG000|NOT COMPLETED|Overall Study||7
10848448|NCT03439657|12014892|FG001|NOT COMPLETED|Overall Study||4
10848449|NCT03377790|12014902|FG000|STARTED|Overall Study||160
10848450|NCT03377790|12014903|FG001|STARTED|Overall Study||106
10848451|NCT03377790|12014902|FG000|COMPLETED|Overall Study||150
10848452|NCT03377790|12014903|FG001|COMPLETED|Overall Study||100
10848453|NCT03377790|12014902|FG000|NOT COMPLETED|Overall Study||10
10848454|NCT03377790|12014903|FG001|NOT COMPLETED|Overall Study||6
10848455|NCT03353675|12014909|FG000|STARTED|Overall Study||44
10848456|NCT03353675|12014909|FG000|COMPLETED|Overall Study||40
10848457|NCT03353675|12014909|FG000|NOT COMPLETED|Overall Study||4
10848458|NCT03294109|12014915|FG000|STARTED|Overall Study||46
10848459|NCT03294109|12014916|FG001|STARTED|Overall Study||57
10848460|NCT03294109|12014915|FG000|Underwent Surgery|Overall Study||40
10848461|NCT03294109|12014916|FG001|Underwent Surgery|Overall Study||52
10848462|NCT03294109|12014915|FG000|COMPLETED|Overall Study||40
10848463|NCT03294109|12014916|FG001|COMPLETED|Overall Study||52
10848464|NCT03294109|12014915|FG000|NOT COMPLETED|Overall Study||6
10848465|NCT03294109|12014916|FG001|NOT COMPLETED|Overall Study||5
10848466|NCT03268005|12014925|FG000|STARTED|Overall Study||546
10848467|NCT03268005|12014926|FG001|STARTED|Overall Study||545
10848468|NCT03268005|12014925|FG000|Full Analysis Set|Overall Study||546
10848469|NCT03268005|12014926|FG001|Full Analysis Set|Overall Study||545
10848470|NCT03268005|12014925|FG000|Safety Analysis Set|Overall Study||544
10848471|NCT03268005|12014926|FG001|Safety Analysis Set|Overall Study||544
10848472|NCT03268005|12014925|FG000|COMPLETED|Overall Study||531
10848473|NCT03268005|12014926|FG001|COMPLETED|Overall Study||531
10848474|NCT03268005|12014925|FG000|NOT COMPLETED|Overall Study||15
10848475|NCT03268005|12014926|FG001|NOT COMPLETED|Overall Study||14
10848476|NCT03225170|12014935|FG000|STARTED|Overall Study||23
10848477|NCT03225170|12014936|FG001|STARTED|Overall Study||22
10848478|NCT03225170|12014937|FG002|STARTED|Overall Study||2
10848479|NCT03225170|12014935|FG000|COMPLETED|Overall Study||19
10848480|NCT03225170|12014936|FG001|COMPLETED|Overall Study||17
10848481|NCT03225170|12014937|FG002|COMPLETED|Overall Study||2
10848482|NCT03225170|12014935|FG000|NOT COMPLETED|Overall Study||4
10848483|NCT03225170|12014936|FG001|NOT COMPLETED|Overall Study||5
10848484|NCT03225170|12014937|FG002|NOT COMPLETED|Overall Study||0
10848485|NCT03220854|12014946|FG000|STARTED|Overall Study||4
10848486|NCT03220854|12014947|FG001|STARTED|Overall Study||0
10848487|NCT03220854|12014948|FG002|STARTED|Overall Study||1
10848488|NCT03220854|12014946|FG000|COMPLETED|Overall Study||4
10848489|NCT03220854|12014947|FG001|COMPLETED|Overall Study||0
10848490|NCT03220854|12014948|FG002|COMPLETED|Overall Study||1
10848491|NCT03220854|12014946|FG000|NOT COMPLETED|Overall Study||0
10848492|NCT03220854|12014947|FG001|NOT COMPLETED|Overall Study||0
10848493|NCT03220854|12014948|FG002|NOT COMPLETED|Overall Study||0
10848494|NCT03219034|12014961|FG000|STARTED|Overall Study||31
10848495|NCT03219034|12014962|FG001|STARTED|Overall Study||31
10848496|NCT03219034|12014961|FG000|COMPLETED|Overall Study||20
10848497|NCT03219034|12014962|FG001|COMPLETED|Overall Study||16
10848498|NCT03219034|12014961|FG000|NOT COMPLETED|Overall Study||11
10848499|NCT03219034|12014962|FG001|NOT COMPLETED|Overall Study||15
10848500|NCT03168438|12014972|FG000|STARTED|Overall Study||3
10848501|NCT03168438|12014973|FG001|STARTED|Overall Study||3
10848502|NCT03168438|12014972|FG000|COMPLETED|Overall Study||3
10848503|NCT03168438|12014973|FG001|COMPLETED|Overall Study||2
10848504|NCT03168438|12014972|FG000|NOT COMPLETED|Overall Study||0
10848505|NCT03168438|12014973|FG001|NOT COMPLETED|Overall Study||1
10848506|NCT03110380|12014982|FG000|STARTED|Double-Blind Treatment Phase||284
10848507|NCT03110380|12014983|FG001|STARTED|Double-Blind Treatment Phase||283
10848508|NCT03110380|12014984|FG002|STARTED|Double-Blind Treatment Phase||0
10848509|NCT03110380|12014985|FG003|STARTED|Double-Blind Treatment Phase||0
10848510|NCT03110380|12014982|FG000|Safety Analysis Set|Double-Blind Treatment Phase||284
10848511|NCT03110380|12014983|FG001|Safety Analysis Set|Double-Blind Treatment Phase||281
10848512|NCT03110380|12014984|FG002|Safety Analysis Set|Double-Blind Treatment Phase||0
10848513|NCT03110380|12014985|FG003|Safety Analysis Set|Double-Blind Treatment Phase||0
10848514|NCT03110380|12014982|FG000|COMPLETED|Double-Blind Treatment Phase||263
10848515|NCT03110380|12014983|FG001|COMPLETED|Double-Blind Treatment Phase||253
10848516|NCT03110380|12014984|FG002|COMPLETED|Double-Blind Treatment Phase||0
10848517|NCT03110380|12014985|FG003|COMPLETED|Double-Blind Treatment Phase||0
10848518|NCT03110380|12014982|FG000|NOT COMPLETED|Double-Blind Treatment Phase||21
10848519|NCT03110380|12014983|FG001|NOT COMPLETED|Double-Blind Treatment Phase||30
10848520|NCT03110380|12014984|FG002|NOT COMPLETED|Double-Blind Treatment Phase||0
10848521|NCT03110380|12014985|FG003|NOT COMPLETED|Double-Blind Treatment Phase||0
10848522|NCT03110380|12014982|FG000|STARTED|Open-label B/F/TAF Extension Phase|Following the end of Double-Blind treatment phase, participants in a country where B/F/TAF FDC was not available were given the option to receive open-label B/F/TAF.|0
10848523|NCT03110380|12014983|FG001|STARTED|Open-label B/F/TAF Extension Phase|Following the end of Double-Blind treatment phase, participants in a country where B/F/TAF FDC was not available were given the option to receive open-label B/F/TAF.|0
10848524|NCT03110380|12014984|FG002|STARTED|Open-label B/F/TAF Extension Phase|138 participants completed the Double-Blind treatment phase, but did not continue in the Open-label B/F/TAF extension phase.|125
10848525|NCT03110380|12014985|FG003|STARTED|Open-label B/F/TAF Extension Phase|137 participants completed the Double-Blind treatment phase, but did not continue in the Open-label B/F/TAF extension phase.|116
10848526|NCT03110380|12014982|FG000|COMPLETED|Open-label B/F/TAF Extension Phase||0
10848527|NCT03110380|12014983|FG001|COMPLETED|Open-label B/F/TAF Extension Phase||0
10848528|NCT03110380|12014984|FG002|COMPLETED|Open-label B/F/TAF Extension Phase||121
10848529|NCT03110380|12014985|FG003|COMPLETED|Open-label B/F/TAF Extension Phase||113
10848530|NCT03110380|12014982|FG000|NOT COMPLETED|Open-label B/F/TAF Extension Phase||0
10848531|NCT03110380|12014983|FG001|NOT COMPLETED|Open-label B/F/TAF Extension Phase||0
10848532|NCT03110380|12014984|FG002|NOT COMPLETED|Open-label B/F/TAF Extension Phase||4
10848533|NCT03110380|12014985|FG003|NOT COMPLETED|Open-label B/F/TAF Extension Phase||3
10848534|NCT03109262|12014993|FG000|STARTED|Overall Study||42
10848535|NCT03109262|12014993|FG000|COMPLETED|Overall Study||42
10848536|NCT03109262|12014993|FG000|NOT COMPLETED|Overall Study||0
10848537|NCT03078478|12015001|FG000|STARTED|Titration Period (16 Weeks)||805
10848538|NCT03078478|12015002|FG001|STARTED|Titration Period (16 Weeks)||804
10848539|NCT03078478|12015001|FG000|Full Analysis Set|Titration Period (16 Weeks)||805
10848540|NCT03078478|12015002|FG001|Full Analysis Set|Titration Period (16 Weeks)||804
10848541|NCT03078478|12015001|FG000|Safety Analysis Set|Titration Period (16 Weeks)||802
10848542|NCT03078478|12015002|FG001|Safety Analysis Set|Titration Period (16 Weeks)||798
10848543|NCT03078478|12015001|FG000|COMPLETED|Titration Period (16 Weeks)||805
10848544|NCT03078478|12015002|FG001|COMPLETED|Titration Period (16 Weeks)||804
10848545|NCT03078478|12015001|FG000|NOT COMPLETED|Titration Period (16 Weeks)||0
10848546|NCT03078478|12015002|FG001|NOT COMPLETED|Titration Period (16 Weeks)||0
10848547|NCT03078478|12015001|FG000|STARTED|Maintenance Period 1 (36 Weeks)||805
10848548|NCT03078478|12015002|FG001|STARTED|Maintenance Period 1 (36 Weeks)||804
10848549|NCT03078478|12015001|FG000|COMPLETED|Maintenance Period 1 (36 Weeks)||758
10848550|NCT03078478|12015002|FG001|COMPLETED|Maintenance Period 1 (36 Weeks)||761
10848551|NCT03078478|12015001|FG000|NOT COMPLETED|Maintenance Period 1 (36 Weeks)||47
10413408|NCT00778167|11557642|FG001|STARTED|Overall Study||8
10413409|NCT00778167|11557643|FG002|STARTED|Overall Study||4
10413410|NCT00778167|11557641|FG000|COMPLETED|Overall Study||6
10413411|NCT00778167|11557642|FG001|COMPLETED|Overall Study||8
10413412|NCT00778167|11557643|FG002|COMPLETED|Overall Study||4
10413413|NCT00778167|11557641|FG000|NOT COMPLETED|Overall Study||0
10413414|NCT00778167|11557642|FG001|NOT COMPLETED|Overall Study||0
10413415|NCT00778167|11557643|FG002|NOT COMPLETED|Overall Study||0
10413416|NCT00778258|11557660|FG000|STARTED|Overall Study||16
10413417|NCT00778258|11557661|FG001|STARTED|Overall Study||5
10413418|NCT00778258|11557662|FG002|STARTED|Overall Study||20
10413419|NCT00778258|11557663|FG003|STARTED|Overall Study||15
10413420|NCT00778258|11557664|FG004|STARTED|Overall Study||6
10413421|NCT00778258|11557665|FG005|STARTED|Overall Study||23
10413422|NCT00778258|11557666|FG006|STARTED|Overall Study||34
10413423|NCT00778258|11557667|FG007|STARTED|Overall Study||41
10413424|NCT00778258|11557668|FG008|STARTED|Overall Study||10
10413425|NCT00778258|11557660|FG000|COMPLETED|Overall Study||9
10413426|NCT00778258|11557661|FG001|COMPLETED|Overall Study||3
10413427|NCT00778258|11557662|FG002|COMPLETED|Overall Study||10
10413428|NCT00778258|11557663|FG003|COMPLETED|Overall Study||12
10413429|NCT00778258|11557664|FG004|COMPLETED|Overall Study||6
10413430|NCT00778258|11557665|FG005|COMPLETED|Overall Study||13
10413431|NCT00778258|11557666|FG006|COMPLETED|Overall Study||19
10413432|NCT00778258|11557667|FG007|COMPLETED|Overall Study||26
10413433|NCT00778258|11557668|FG008|COMPLETED|Overall Study||6
10413434|NCT00778258|11557660|FG000|NOT COMPLETED|Overall Study||7
10413435|NCT00778258|11557661|FG001|NOT COMPLETED|Overall Study||2
10413436|NCT00778258|11557662|FG002|NOT COMPLETED|Overall Study||10
10413437|NCT00778258|11557663|FG003|NOT COMPLETED|Overall Study||3
10413438|NCT00778258|11557664|FG004|NOT COMPLETED|Overall Study||0
10413439|NCT00778258|11557665|FG005|NOT COMPLETED|Overall Study||10
10413440|NCT00778258|11557666|FG006|NOT COMPLETED|Overall Study||15
10413441|NCT00778258|11557667|FG007|NOT COMPLETED|Overall Study||15
10413442|NCT00778258|11557668|FG008|NOT COMPLETED|Overall Study||4
10413443|NCT00778310|11557696|FG000|STARTED|Overall Study||17
10413444|NCT00778310|11557697|FG001|STARTED|Overall Study||26
10413445|NCT00778310|11557696|FG000|Usable Data|Overall Study||14
10413446|NCT00778310|11557697|FG001|Usable Data|Overall Study||21
10413447|NCT00778310|11557696|FG000|COMPLETED|Overall Study||17
10413448|NCT00778310|11557697|FG001|COMPLETED|Overall Study||26
10413449|NCT00778310|11557696|FG000|NOT COMPLETED|Overall Study||0
10413450|NCT00778310|11557697|FG001|NOT COMPLETED|Overall Study||0
10413451|NCT00778336|11557709|FG000|STARTED|Index Procedure-Discharge||198
10413452|NCT00778336|11557710|FG001|STARTED|Index Procedure-Discharge||170
10413453|NCT00778336|11557711|FG002|STARTED|Index Procedure-Discharge||72
10413454|NCT00778336|11557712|FG003|STARTED|Index Procedure-Discharge||12
10413455|NCT00778336|11557709|FG000|COMPLETED|Index Procedure-Discharge||192
10413456|NCT00778336|11557710|FG001|COMPLETED|Index Procedure-Discharge||167
10413457|NCT00778336|11557711|FG002|COMPLETED|Index Procedure-Discharge||70
10413458|NCT00778336|11557712|FG003|COMPLETED|Index Procedure-Discharge||12
10413459|NCT00778336|11557709|FG000|NOT COMPLETED|Index Procedure-Discharge||6
10413460|NCT00778336|11557710|FG001|NOT COMPLETED|Index Procedure-Discharge||3
10413461|NCT00778336|11557711|FG002|NOT COMPLETED|Index Procedure-Discharge||2
10413462|NCT00778336|11557712|FG003|NOT COMPLETED|Index Procedure-Discharge||0
10413463|NCT00778336|11557709|FG000|STARTED|3 Month Follow Up||192
10413464|NCT00778336|11557710|FG001|STARTED|3 Month Follow Up||167
10413465|NCT00778336|11557711|FG002|STARTED|3 Month Follow Up||70
10413466|NCT00778336|11557712|FG003|STARTED|3 Month Follow Up||12
10413467|NCT00778336|11557709|FG000|COMPLETED|3 Month Follow Up||169
10413468|NCT00778336|11557710|FG001|COMPLETED|3 Month Follow Up||144
10413469|NCT00778336|11557711|FG002|COMPLETED|3 Month Follow Up||65
10413470|NCT00778336|11557712|FG003|COMPLETED|3 Month Follow Up||12
10413471|NCT00778336|11557709|FG000|NOT COMPLETED|3 Month Follow Up||23
10413472|NCT00778336|11557710|FG001|NOT COMPLETED|3 Month Follow Up||23
10413473|NCT00778336|11557711|FG002|NOT COMPLETED|3 Month Follow Up||5
10413474|NCT00778336|11557712|FG003|NOT COMPLETED|3 Month Follow Up||0
10413475|NCT00778375|11557722|FG000|STARTED|Overall Study||122
10413476|NCT00778375|11557722|FG000|COMPLETED|Overall Study||119
10413477|NCT00778375|11557722|FG000|NOT COMPLETED|Overall Study||3
10413478|NCT00778622|11557731|FG000|STARTED|Overall Study||125
10413479|NCT00778622|11557732|FG001|STARTED|Overall Study||122
10413480|NCT00778622|11557733|FG002|STARTED|Overall Study||124
10413481|NCT00778622|11557731|FG000|COMPLETED|Overall Study||109
10413482|NCT00778622|11557732|FG001|COMPLETED|Overall Study||107
10848552|NCT03078478|12015002|FG001|NOT COMPLETED|Maintenance Period 1 (36 Weeks)||43
10848553|NCT03078478|12015001|FG000|STARTED|Maintencance Period 2 (36 Weeks)||758
10848554|NCT03078478|12015002|FG001|STARTED|Maintencance Period 2 (36 Weeks)||761
10848555|NCT03078478|12015001|FG000|COMPLETED|Maintencance Period 2 (36 Weeks)||733
10848556|NCT03078478|12015002|FG001|COMPLETED|Maintencance Period 2 (36 Weeks)||734
10848557|NCT03078478|12015001|FG000|NOT COMPLETED|Maintencance Period 2 (36 Weeks)||25
10848558|NCT03078478|12015002|FG001|NOT COMPLETED|Maintencance Period 2 (36 Weeks)||27
10848559|NCT03040661|12015010|FG000|STARTED|Overall Study||35
10848560|NCT03040661|12015011|FG001|STARTED|Overall Study||35
10848561|NCT03040661|12015010|FG000|COMPLETED|Overall Study||35
10848562|NCT03040661|12015011|FG001|COMPLETED|Overall Study||35
10848563|NCT03040661|12015010|FG000|NOT COMPLETED|Overall Study||0
10848564|NCT03040661|12015011|FG001|NOT COMPLETED|Overall Study||0
10848565|NCT02993263|12015017|FG000|STARTED|Overall Study||323
10848566|NCT02993263|12015017|FG000|COMPLETED|Overall Study||0
10848567|NCT02993263|12015017|FG000|NOT COMPLETED|Overall Study||323
10848568|NCT02985684|12015021|FG000|STARTED|6-Month Clinical Success Evaluation||125
10848569|NCT02985684|12015021|FG000|COMPLETED|6-Month Clinical Success Evaluation||120
10848570|NCT02985684|12015021|FG000|NOT COMPLETED|6-Month Clinical Success Evaluation||5
10848571|NCT02985684|12015021|FG000|STARTED|6-Month Closure Success Evaluation||120
10848572|NCT02985684|12015021|FG000|COMPLETED|6-Month Closure Success Evaluation||112
10848573|NCT02985684|12015021|FG000|NOT COMPLETED|6-Month Closure Success Evaluation||8
10848574|NCT02964897|12015027|FG000|STARTED|Overall Study||43
10848575|NCT02964897|12015028|FG001|STARTED|Overall Study||36
10848576|NCT02964897|12015027|FG000|COMPLETED|Overall Study||43
10848577|NCT02964897|12015028|FG001|COMPLETED|Overall Study||36
10848578|NCT02964897|12015027|FG000|NOT COMPLETED|Overall Study||0
10848579|NCT02964897|12015028|FG001|NOT COMPLETED|Overall Study||0
10848580|NCT02873195|12015036|FG000|STARTED|Overall Study||87
10848581|NCT02873195|12015037|FG001|STARTED|Overall Study||46
10848582|NCT02873195|12015036|FG000|Never Began Treatment (Cancel)|Overall Study||1
10848583|NCT02873195|12015037|FG001|Never Began Treatment (Cancel)|Overall Study||0
10848584|NCT02873195|12015036|FG000|COMPLETED|Overall Study||82
10848585|NCT02873195|12015037|FG001|COMPLETED|Overall Study||46
10848586|NCT02873195|12015036|FG000|NOT COMPLETED|Overall Study||5
10848587|NCT02873195|12015037|FG001|NOT COMPLETED|Overall Study||0
10848588|NCT02809131|12015045|FG000|STARTED|Overall Study||505
10848589|NCT02809131|12015046|FG001|STARTED|Overall Study||505
10848590|NCT02809131|12015045|FG000|COMPLETED|Overall Study||445
10848591|NCT02809131|12015046|FG001|COMPLETED|Overall Study||445
10848592|NCT02809131|12015045|FG000|NOT COMPLETED|Overall Study||60
10848593|NCT02809131|12015046|FG001|NOT COMPLETED|Overall Study||60
10848594|NCT02785952|12015054|FG000|STARTED|Overall Study||125
10848595|NCT02785952|12015055|FG001|STARTED|Overall Study||127
10848596|NCT02785952|12015054|FG000|COMPLETED|Overall Study||0
10848597|NCT02785952|12015055|FG001|COMPLETED|Overall Study||0
10848598|NCT02785952|12015054|FG000|NOT COMPLETED|Overall Study||125
10848599|NCT02785952|12015055|FG001|NOT COMPLETED|Overall Study||127
10848603|NCT02748616|12015067|FG000|STARTED|Overall Study||9
10848604|NCT02748616|12015067|FG000|COMPLETED|Overall Study||2
10848605|NCT02748616|12015067|FG000|NOT COMPLETED|Overall Study||7
10848606|NCT02719522|12015071|FG000|STARTED|Overall Study|In 1 consented subject, device deployment was not attempted due to significant arterial stenosis.|204
10848607|NCT02719522|12015071|FG000|COMPLETED|Overall Study||193
10848608|NCT02719522|12015071|FG000|NOT COMPLETED|Overall Study||11
10848618|NCT02585232|12015092|FG000|STARTED|Overall Study||40
10848619|NCT02585232|12015093|FG001|STARTED|Overall Study||42
10848620|NCT02585232|12015092|FG000|COMPLETED|Overall Study||28
10848621|NCT02585232|12015093|FG001|COMPLETED|Overall Study||26
10848622|NCT02585232|12015092|FG000|NOT COMPLETED|Overall Study||12
10848623|NCT02585232|12015093|FG001|NOT COMPLETED|Overall Study||16
10413483|NCT00778622|11557733|FG002|COMPLETED|Overall Study||109
10413484|NCT00778622|11557731|FG000|NOT COMPLETED|Overall Study||16
10413485|NCT00778622|11557732|FG001|NOT COMPLETED|Overall Study||15
10413486|NCT00778622|11557733|FG002|NOT COMPLETED|Overall Study||15
10413487|NCT00778648|11557747|FG000|STARTED|Overall Study||272
10413488|NCT00778648|11557748|FG001|STARTED|Overall Study||271
10413489|NCT00778648|11557747|FG000|COMPLETED|Overall Study||263
10413490|NCT00778648|11557748|FG001|COMPLETED|Overall Study||266
10413491|NCT00778648|11557747|FG000|NOT COMPLETED|Overall Study||9
10413492|NCT00778648|11557748|FG001|NOT COMPLETED|Overall Study||5
10413493|NCT00778817|11557754|FG000|STARTED|Overall Study||20
10413494|NCT00778817|11557754|FG000|COMPLETED|Overall Study||16
10413495|NCT00778817|11557754|FG000|NOT COMPLETED|Overall Study||4
10413496|NCT00778830|11557760|FG000|STARTED|Overall Study||101
10413497|NCT00778830|11557761|FG001|STARTED|Overall Study||188
10413498|NCT00778830|11557760|FG000|COMPLETED|Overall Study||101
10413499|NCT00778830|11557761|FG001|COMPLETED|Overall Study||187
10413500|NCT00778830|11557760|FG000|NOT COMPLETED|Overall Study||0
10413501|NCT00778830|11557761|FG001|NOT COMPLETED|Overall Study||1
10413502|NCT00778869|11557767|FG000|STARTED|Overall Study||10
10413503|NCT00778869|11557767|FG000|COMPLETED|Overall Study||10
10413504|NCT00778869|11557767|FG000|NOT COMPLETED|Overall Study||0
10413505|NCT00778895|11557774|FG000|STARTED|Active Phase||164
10413506|NCT00778895|11557775|FG001|STARTED|Active Phase||167
10413507|NCT00778895|11557776|FG002|STARTED|Active Phase||43
10413508|NCT00778895|11557774|FG000|COMPLETED|Active Phase||157
10413509|NCT00778895|11557775|FG001|COMPLETED|Active Phase||161
10413510|NCT00778895|11557776|FG002|COMPLETED|Active Phase||43
10413511|NCT00778895|11557774|FG000|NOT COMPLETED|Active Phase||7
10413512|NCT00778895|11557775|FG001|NOT COMPLETED|Active Phase||6
10413513|NCT00778895|11557776|FG002|NOT COMPLETED|Active Phase||0
10413514|NCT00778895|11557774|FG000|STARTED|ESFU Phase||164
10413515|NCT00778895|11557775|FG001|STARTED|ESFU Phase||167
10413516|NCT00778895|11557776|FG002|STARTED|ESFU Phase||43
10413517|NCT00778895|11557774|FG000|COMPLETED|ESFU Phase||153
10413518|NCT00778895|11557775|FG001|COMPLETED|ESFU Phase||155
10413519|NCT00778895|11557776|FG002|COMPLETED|ESFU Phase||41
10413520|NCT00778895|11557774|FG000|NOT COMPLETED|ESFU Phase||11
10413521|NCT00778895|11557775|FG001|NOT COMPLETED|ESFU Phase||12
10413522|NCT00778895|11557776|FG002|NOT COMPLETED|ESFU Phase||2
10413523|NCT00778921|11557788|FG000|STARTED|Overall Study||279
10413524|NCT00778921|11557789|FG001|STARTED|Overall Study||285
10413525|NCT00778921|11557790|FG002|STARTED|Overall Study||283
10413526|NCT00778921|11557788|FG000|COMPLETED|Overall Study||261
10413527|NCT00778921|11557789|FG001|COMPLETED|Overall Study||266
10413528|NCT00778921|11557790|FG002|COMPLETED|Overall Study||255
10413529|NCT00778921|11557788|FG000|NOT COMPLETED|Overall Study||18
10413530|NCT00778921|11557789|FG001|NOT COMPLETED|Overall Study||19
10848639|NCT02556606|12015125|FG000|STARTED|Overall Study||4
10848640|NCT02556606|12015126|FG001|STARTED|Overall Study||5
10848641|NCT02556606|12015127|FG002|STARTED|Overall Study||11
10413531|NCT00778921|11557790|FG002|NOT COMPLETED|Overall Study||28
10413532|NCT00779025|11557798|FG000|STARTED|Overall Study||82
10413533|NCT00779025|11557798|FG000|COMPLETED|Overall Study||81
10413534|NCT00779025|11557798|FG000|NOT COMPLETED|Overall Study||1
10413535|NCT00779103|11557803|FG000|STARTED|Overall Study|Initial Phase (First Implant) - 36 Completed|36
10413536|NCT00779103|11557803|FG000|Second & Third Implant|Overall Study|Initial Extension Phase/Extended Access Phase (Second and Third Implant) - 22 Completed|31
10429235|NCT00862849|11575289|FG003|STARTED|Intervention 5||4
10848642|NCT02556606|12015128|FG003|STARTED|Overall Study||13
10848643|NCT02556606|12015125|FG000|COMPLETED|Overall Study||4
10848644|NCT02556606|12015126|FG001|COMPLETED|Overall Study||5
10848645|NCT02556606|12015127|FG002|COMPLETED|Overall Study||11
10848646|NCT02556606|12015128|FG003|COMPLETED|Overall Study||13
10848647|NCT02556606|12015125|FG000|NOT COMPLETED|Overall Study||0
10848648|NCT02556606|12015126|FG001|NOT COMPLETED|Overall Study||0
10848649|NCT02556606|12015127|FG002|NOT COMPLETED|Overall Study||0
10848650|NCT02556606|12015128|FG003|NOT COMPLETED|Overall Study||0
10848651|NCT02545283|12015144|FG000|STARTED|Overall Study||149
10848652|NCT02545283|12015145|FG001|STARTED|Overall Study||298
10848653|NCT02545283|12015144|FG000|Received Treatment|Overall Study||149
10848654|NCT02545283|12015145|FG001|Received Treatment|Overall Study||292
10848655|NCT02545283|12015144|FG000|Safety Follow Up|Overall Study|I participant was not treated and 1 participant entered from the Idasanutlin arm|149
10848656|NCT02545283|12015145|FG001|Safety Follow Up|Overall Study|5 participants were not treated, 1 participant did not receive Idasanutlin and was moved to the Placebo arm|292
10848657|NCT02545283|12015144|FG000|COMPLETED|Overall Study||0
10848658|NCT02545283|12015145|FG001|COMPLETED|Overall Study||0
10848659|NCT02545283|12015144|FG000|NOT COMPLETED|Overall Study||149
10848660|NCT02545283|12015145|FG001|NOT COMPLETED|Overall Study||298
10848661|NCT02524171|12015155|FG000|STARTED|6-month Follow-up||172
10848662|NCT02524171|12015156|FG001|STARTED|6-month Follow-up||169
10848663|NCT02524171|12015155|FG000|COMPLETED|6-month Follow-up||119
10848664|NCT02524171|12015156|FG001|COMPLETED|6-month Follow-up||124
10848665|NCT02524171|12015155|FG000|NOT COMPLETED|6-month Follow-up||53
10413537|NCT00779103|11557803|FG000|Fourth Implant|Overall Study|Second Extension Phase (4th Implant with Yearly Implantations till no longer required): 11 Completed|13
10413538|NCT00779103|11557803|FG000|No Treatment|Overall Study|Optional Long Term Follow-up Phase (No Treatment)|9
10413539|NCT00779103|11557803|FG000|COMPLETED|Overall Study|Initial Phase (First Implant)|36
10413540|NCT00779103|11557803|FG000|NOT COMPLETED|Overall Study||0
10413541|NCT00779142|11557811|FG000|STARTED|Overall Study|5 patients signed consent and were screened.|5
10413542|NCT00779142|11557811|FG000|COMPLETED|Overall Study|Only 2 patients were actually enrolled.|2
10413543|NCT00779142|11557811|FG000|NOT COMPLETED|Overall Study||3
10413544|NCT00779155|11557818|FG000|STARTED|Overall Study||6
10413545|NCT00779155|11557819|FG001|STARTED|Overall Study||6
10413546|NCT00779155|11557818|FG000|COMPLETED|Overall Study||6
10413547|NCT00779155|11557819|FG001|COMPLETED|Overall Study||6
10413548|NCT00779155|11557818|FG000|NOT COMPLETED|Overall Study||0
10413549|NCT00779155|11557819|FG001|NOT COMPLETED|Overall Study||0
10413550|NCT00779246|11557827|FG000|STARTED|Overall Study||750
10413551|NCT00779246|11557828|FG001|STARTED|Overall Study||768
10413552|NCT00779246|11557827|FG000|COMPLETED|Overall Study||717
10413553|NCT00779246|11557828|FG001|COMPLETED|Overall Study||715
10413554|NCT00779246|11557827|FG000|NOT COMPLETED|Overall Study||33
10413555|NCT00779246|11557828|FG001|NOT COMPLETED|Overall Study||53
10413556|NCT00779259|11557834|FG000|STARTED|Theophylline Alone||24
10413557|NCT00779259|11557834|FG000|COMPLETED|Theophylline Alone||24
10413558|NCT00779259|11557834|FG000|NOT COMPLETED|Theophylline Alone||0
10413559|NCT00779259|11557834|FG000|STARTED|4 Day Washout Period||24
10413560|NCT00779259|11557834|FG000|COMPLETED|4 Day Washout Period||24
10413561|NCT00779259|11557834|FG000|NOT COMPLETED|4 Day Washout Period||0
10413562|NCT00779259|11557834|FG000|STARTED|Quinine Alone||24
10413563|NCT00779259|11557834|FG000|COMPLETED|Quinine Alone||22
10413564|NCT00779259|11557834|FG000|NOT COMPLETED|Quinine Alone||2
10413565|NCT00779259|11557834|FG000|STARTED|Theophylline With Quinine||22
10413566|NCT00779259|11557834|FG000|COMPLETED|Theophylline With Quinine||22
10413567|NCT00779259|11557834|FG000|NOT COMPLETED|Theophylline With Quinine||0
10413568|NCT00779285|11557852|FG000|STARTED|Overall Study||1
10413569|NCT00779285|11557852|FG000|COMPLETED|Overall Study||1
10413570|NCT00779285|11557852|FG000|NOT COMPLETED|Overall Study||0
10413571|NCT00779311|11557861|FG000|STARTED|Overall Study|2 of 6 patients were not evaluable for DLT assessment and were replaced for a total of 8 enrolled.|8
10413572|NCT00779311|11557862|FG001|STARTED|Overall Study||0
10413573|NCT00779311|11557863|FG002|STARTED|Overall Study||0
10413574|NCT00779311|11557864|FG003|STARTED|Overall Study||0
10413575|NCT00779311|11557865|FG004|STARTED|Overall Study||0
10413576|NCT00779311|11557861|FG000|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||6
10413577|NCT00779311|11557862|FG001|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
10413578|NCT00779311|11557863|FG002|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
10413579|NCT00779311|11557864|FG003|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
10848666|NCT02524171|12015156|FG001|NOT COMPLETED|6-month Follow-up||45
10848667|NCT02524171|12015155|FG000|STARTED|12-month Follow-up Interview||172
10848668|NCT02524171|12015156|FG001|STARTED|12-month Follow-up Interview||169
10848669|NCT02524171|12015155|FG000|COMPLETED|12-month Follow-up Interview||127
10848670|NCT02524171|12015156|FG001|COMPLETED|12-month Follow-up Interview||128
10848671|NCT02524171|12015155|FG000|NOT COMPLETED|12-month Follow-up Interview||45
10848672|NCT02524171|12015156|FG001|NOT COMPLETED|12-month Follow-up Interview||41
10848673|NCT02489422|12015164|FG000|STARTED|Overall Study||23
10848674|NCT02489422|12015165|FG001|STARTED|Overall Study||21
10848675|NCT02489422|12015164|FG000|COMPLETED|Overall Study||23
10413580|NCT00779311|11557865|FG004|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
10413581|NCT00779311|11557861|FG000|COMPLETED|Overall Study||8
10413582|NCT00779311|11557862|FG001|COMPLETED|Overall Study||0
10413583|NCT00779311|11557863|FG002|COMPLETED|Overall Study||0
10413584|NCT00779311|11557864|FG003|COMPLETED|Overall Study||0
10848676|NCT02489422|12015165|FG001|COMPLETED|Overall Study||21
10848677|NCT02489422|12015164|FG000|NOT COMPLETED|Overall Study||0
10848678|NCT02489422|12015165|FG001|NOT COMPLETED|Overall Study||0
10848679|NCT02487251|12015176|FG000|STARTED|Overall Study||434
10848680|NCT02487251|12015177|FG001|STARTED|Overall Study||65
10848681|NCT02487251|12015178|FG002|STARTED|Overall Study||152
10848682|NCT02487251|12015179|FG003|STARTED|Overall Study||159
10848683|NCT02487251|12015176|FG000|COMPLETED|Overall Study||366
10848684|NCT02487251|12015177|FG001|COMPLETED|Overall Study||55
10848685|NCT02487251|12015178|FG002|COMPLETED|Overall Study||125
10848686|NCT02487251|12015179|FG003|COMPLETED|Overall Study||134
10848687|NCT02487251|12015176|FG000|NOT COMPLETED|Overall Study||68
10848688|NCT02487251|12015177|FG001|NOT COMPLETED|Overall Study||10
10848689|NCT02487251|12015178|FG002|NOT COMPLETED|Overall Study||27
10848690|NCT02487251|12015179|FG003|NOT COMPLETED|Overall Study||25
10848703|NCT02306122|12015211|FG000|STARTED|Initial Physician Randomization||0
10848704|NCT02306122|12015212|FG001|STARTED|Initial Physician Randomization||0
10848705|NCT02306122|12015213|FG002|STARTED|Initial Physician Randomization||0
10848706|NCT02306122|12015214|FG003|STARTED|Initial Physician Randomization||0
10848707|NCT02306122|12015215|FG004|STARTED|Initial Physician Randomization||0
10848708|NCT02306122|12015216|FG005|STARTED|Initial Physician Randomization||0
10848709|NCT02306122|12015217|FG006|STARTED|Initial Physician Randomization||0
10848710|NCT02306122|12015218|FG007|STARTED|Initial Physician Randomization||0
10848711|NCT02306122|12015219|FG008|STARTED|Initial Physician Randomization||29
10848712|NCT02306122|12015220|FG009|STARTED|Initial Physician Randomization||31
10848713|NCT02306122|12015221|FG010|STARTED|Initial Physician Randomization||31
10848714|NCT02306122|12015211|FG000|COMPLETED|Initial Physician Randomization||0
10848715|NCT02306122|12015212|FG001|COMPLETED|Initial Physician Randomization||0
10848716|NCT02306122|12015213|FG002|COMPLETED|Initial Physician Randomization||0
10848717|NCT02306122|12015214|FG003|COMPLETED|Initial Physician Randomization||0
10848718|NCT02306122|12015215|FG004|COMPLETED|Initial Physician Randomization||0
10848719|NCT02306122|12015216|FG005|COMPLETED|Initial Physician Randomization||0
10848720|NCT02306122|12015217|FG006|COMPLETED|Initial Physician Randomization||0
10848721|NCT02306122|12015218|FG007|COMPLETED|Initial Physician Randomization||0
10848722|NCT02306122|12015219|FG008|COMPLETED|Initial Physician Randomization||28
10848723|NCT02306122|12015220|FG009|COMPLETED|Initial Physician Randomization||31
10848724|NCT02306122|12015221|FG010|COMPLETED|Initial Physician Randomization||31
10848725|NCT02306122|12015211|FG000|NOT COMPLETED|Initial Physician Randomization||0
10848726|NCT02306122|12015212|FG001|NOT COMPLETED|Initial Physician Randomization||0
10848727|NCT02306122|12015213|FG002|NOT COMPLETED|Initial Physician Randomization||0
10848728|NCT02306122|12015214|FG003|NOT COMPLETED|Initial Physician Randomization||0
10848729|NCT02306122|12015215|FG004|NOT COMPLETED|Initial Physician Randomization||0
10848730|NCT02306122|12015216|FG005|NOT COMPLETED|Initial Physician Randomization||0
10848731|NCT02306122|12015217|FG006|NOT COMPLETED|Initial Physician Randomization||0
10848732|NCT02306122|12015218|FG007|NOT COMPLETED|Initial Physician Randomization||0
10848733|NCT02306122|12015219|FG008|NOT COMPLETED|Initial Physician Randomization||1
10848734|NCT02306122|12015220|FG009|NOT COMPLETED|Initial Physician Randomization||0
10848735|NCT02306122|12015221|FG010|NOT COMPLETED|Initial Physician Randomization||0
10848736|NCT02306122|12015211|FG000|STARTED|Post Nonadherence Subgroup Randomization||244
10848737|NCT02306122|12015212|FG001|STARTED|Post Nonadherence Subgroup Randomization||123
10848738|NCT02306122|12015213|FG002|STARTED|Post Nonadherence Subgroup Randomization||121
10848739|NCT02306122|12015214|FG003|STARTED|Post Nonadherence Subgroup Randomization||274
10848740|NCT02306122|12015215|FG004|STARTED|Post Nonadherence Subgroup Randomization||134
10848741|NCT02306122|12015216|FG005|STARTED|Post Nonadherence Subgroup Randomization||137
10848742|NCT02306122|12015217|FG006|STARTED|Post Nonadherence Subgroup Randomization||220
10848743|NCT02306122|12015218|FG007|STARTED|Post Nonadherence Subgroup Randomization||221
10848744|NCT02306122|12015219|FG008|STARTED|Post Nonadherence Subgroup Randomization||28
10848745|NCT02306122|12015220|FG009|STARTED|Post Nonadherence Subgroup Randomization||31
10848746|NCT02306122|12015221|FG010|STARTED|Post Nonadherence Subgroup Randomization||31
10848747|NCT02306122|12015211|FG000|COMPLETED|Post Nonadherence Subgroup Randomization||244
10848748|NCT02306122|12015212|FG001|COMPLETED|Post Nonadherence Subgroup Randomization||123
10848749|NCT02306122|12015213|FG002|COMPLETED|Post Nonadherence Subgroup Randomization||121
10848750|NCT02306122|12015214|FG003|COMPLETED|Post Nonadherence Subgroup Randomization||274
10848751|NCT02306122|12015215|FG004|COMPLETED|Post Nonadherence Subgroup Randomization||134
10848752|NCT02306122|12015216|FG005|COMPLETED|Post Nonadherence Subgroup Randomization||137
10848753|NCT02306122|12015217|FG006|COMPLETED|Post Nonadherence Subgroup Randomization||220
10848754|NCT02306122|12015218|FG007|COMPLETED|Post Nonadherence Subgroup Randomization||221
10848755|NCT02306122|12015219|FG008|COMPLETED|Post Nonadherence Subgroup Randomization||28
10848756|NCT02306122|12015220|FG009|COMPLETED|Post Nonadherence Subgroup Randomization||31
10848757|NCT02306122|12015221|FG010|COMPLETED|Post Nonadherence Subgroup Randomization||31
10848758|NCT02306122|12015211|FG000|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
10848759|NCT02306122|12015212|FG001|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
10848760|NCT02306122|12015213|FG002|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
10848761|NCT02306122|12015214|FG003|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
10848762|NCT02306122|12015215|FG004|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
10848763|NCT02306122|12015216|FG005|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
10848764|NCT02306122|12015217|FG006|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
10848765|NCT02306122|12015218|FG007|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
10848766|NCT02306122|12015219|FG008|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
10848767|NCT02306122|12015220|FG009|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
10848768|NCT02306122|12015221|FG010|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
10848769|NCT02304991|12015241|FG000|STARTED|Overall Study||25
10848770|NCT02304991|12015242|FG001|STARTED|Overall Study||25
10848771|NCT02304991|12015241|FG000|COMPLETED|Overall Study||18
10848772|NCT02304991|12015242|FG001|COMPLETED|Overall Study||15
10848773|NCT02304991|12015241|FG000|NOT COMPLETED|Overall Study||7
10848774|NCT02304991|12015242|FG001|NOT COMPLETED|Overall Study||10
10848775|NCT02223520|12015250|FG000|STARTED|Overall Study||147
10848776|NCT02223520|12015251|FG001|STARTED|Overall Study||160
10848777|NCT02223520|12015250|FG000|COMPLETED|Overall Study|101 neonates of these parents were enrolled. 12 were lost to follow-up.|147
10848778|NCT02223520|12015251|FG001|COMPLETED|Overall Study|107 neonates of these parents were enrolled. 6 were lost to follow-up.|160
10848779|NCT02223520|12015250|FG000|NOT COMPLETED|Overall Study||0
10848780|NCT02223520|12015251|FG001|NOT COMPLETED|Overall Study||0
10848781|NCT02147184|12015259|FG000|STARTED|Overall Study||127
10848782|NCT02147184|12015260|FG001|STARTED|Overall Study||137
10848783|NCT02147184|12015259|FG000|COMPLETED|Overall Study||78
10848784|NCT02147184|12015260|FG001|COMPLETED|Overall Study||110
10848785|NCT02147184|12015259|FG000|NOT COMPLETED|Overall Study||49
10848786|NCT02147184|12015260|FG001|NOT COMPLETED|Overall Study||27
10848787|NCT02122198|12015268|FG000|STARTED|Overall Study||5
10848788|NCT02122198|12015269|FG001|STARTED|Overall Study||12
10848789|NCT02122198|12015268|FG000|COMPLETED|Overall Study||3
10848790|NCT02122198|12015269|FG001|COMPLETED|Overall Study||10
10848791|NCT02122198|12015268|FG000|NOT COMPLETED|Overall Study||2
10848792|NCT02122198|12015269|FG001|NOT COMPLETED|Overall Study||2
10848793|NCT02055053|12015278|FG000|STARTED|Overall Study||35
10848794|NCT02055053|12015279|FG001|STARTED|Overall Study||35
10848795|NCT02055053|12015278|FG000|COMPLETED|Overall Study||35
10848796|NCT02055053|12015279|FG001|COMPLETED|Overall Study||35
10848797|NCT02055053|12015278|FG000|NOT COMPLETED|Overall Study||0
10848798|NCT02055053|12015279|FG001|NOT COMPLETED|Overall Study||0
10848799|NCT02000219|12015285|FG000|STARTED|14-Week Study Period||12
10413585|NCT00779311|11557865|FG004|COMPLETED|Overall Study||0
10413586|NCT00779311|11557861|FG000|NOT COMPLETED|Overall Study||0
10413587|NCT00779311|11557862|FG001|NOT COMPLETED|Overall Study||0
10413588|NCT00779311|11557863|FG002|NOT COMPLETED|Overall Study||0
10413589|NCT00779311|11557864|FG003|NOT COMPLETED|Overall Study||0
10413590|NCT00779311|11557865|FG004|NOT COMPLETED|Overall Study||0
10848800|NCT02000219|12015285|FG000|COMPLETED|14-Week Study Period||9
10848801|NCT02000219|12015285|FG000|NOT COMPLETED|14-Week Study Period||3
10848802|NCT02000219|12015285|FG000|STARTED|Continuation Period||8
10848803|NCT02000219|12015285|FG000|COMPLETED|Continuation Period||3
10848804|NCT02000219|12015285|FG000|NOT COMPLETED|Continuation Period||5
10848805|NCT01978938|12015291|FG000|STARTED|Overall Study||455
10848806|NCT01978938|12015292|FG001|STARTED|Overall Study||453
10848807|NCT01978938|12015291|FG000|Received at Least 1 Dose of Study Drug|Overall Study||454
10413599|NCT00779402|11557888|FG000|STARTED|Treatment Phase 1||117
10413600|NCT00779402|11557889|FG001|STARTED|Treatment Phase 1||59
10413601|NCT00779402|11557888|FG000|Received ≥1 Leukapherisis (Safety Set)|Treatment Phase 1||116
10413602|NCT00779402|11557889|FG001|Received ≥1 Leukapherisis (Safety Set)|Treatment Phase 1||59
10413603|NCT00779402|11557888|FG000|Received ≥1 Study Product (Exposure Set)|Treatment Phase 1||113
10413604|NCT00779402|11557889|FG001|Received ≥1 Study Product (Exposure Set)|Treatment Phase 1||59
10413605|NCT00779402|11557888|FG000|Received Booster Infusion|Treatment Phase 1||50
10413606|NCT00779402|11557889|FG001|Received Booster Infusion|Treatment Phase 1||30
10413607|NCT00779402|11557888|FG000|COMPLETED|Treatment Phase 1||84
10413608|NCT00779402|11557889|FG001|COMPLETED|Treatment Phase 1||44
10413609|NCT00779402|11557888|FG000|NOT COMPLETED|Treatment Phase 1||33
10413610|NCT00779402|11557889|FG001|NOT COMPLETED|Treatment Phase 1||15
10413611|NCT00779402|11557888|FG000|STARTED|Surveillance Phase||84
10413612|NCT00779402|11557889|FG001|STARTED|Surveillance Phase||44
10413613|NCT00779402|11557888|FG000|COMPLETED|Surveillance Phase||41
10413614|NCT00779402|11557889|FG001|COMPLETED|Surveillance Phase||13
10848808|NCT01978938|12015292|FG001|Received at Least 1 Dose of Study Drug|Overall Study||451
10848809|NCT01978938|12015291|FG000|COMPLETED|Overall Study||432
10848810|NCT01978938|12015292|FG001|COMPLETED|Overall Study||439
10848811|NCT01978938|12015291|FG000|NOT COMPLETED|Overall Study||23
10848812|NCT01978938|12015292|FG001|NOT COMPLETED|Overall Study||14
10413615|NCT00779402|11557888|FG000|NOT COMPLETED|Surveillance Phase||43
10413616|NCT00779402|11557889|FG001|NOT COMPLETED|Surveillance Phase||31
10413617|NCT00779402|11557888|FG000|STARTED|Long-term Follow-up||41
10413618|NCT00779402|11557889|FG001|STARTED|Long-term Follow-up||13
10413619|NCT00779402|11557888|FG000|COMPLETED|Long-term Follow-up||20
10848813|NCT01854385|12015298|FG000|STARTED|Pre-Treatment||40
10848814|NCT01854385|12015298|FG000|COMPLETED|Pre-Treatment||17
10848815|NCT01854385|12015298|FG000|NOT COMPLETED|Pre-Treatment||23
10848816|NCT01854385|12015298|FG000|STARTED|Treatment||17
10848817|NCT01854385|12015298|FG000|COMPLETED|Treatment||16
10848818|NCT01854385|12015298|FG000|NOT COMPLETED|Treatment||1
10848819|NCT01844856|12015304|FG000|STARTED|Overall Study||270
10848820|NCT01844856|12015305|FG001|STARTED|Overall Study||271
10848821|NCT01844856|12015304|FG000|Received at Least 1 Dose of Study Drug|Overall Study||270
10848822|NCT01844856|12015305|FG001|Received at Least 1 Dose of Study Drug|Overall Study||268
10848823|NCT01844856|12015304|FG000|COMPLETED|Overall Study||246
10848824|NCT01844856|12015305|FG001|COMPLETED|Overall Study||255
10848825|NCT01844856|12015304|FG000|NOT COMPLETED|Overall Study||24
10848826|NCT01844856|12015305|FG001|NOT COMPLETED|Overall Study||16
10848827|NCT01788306|12015313|FG000|STARTED|Overall Study||125
10848828|NCT01788306|12015314|FG001|STARTED|Overall Study||131
10848829|NCT01788306|12015313|FG000|COMPLETED|Overall Study||115
10848830|NCT01788306|12015314|FG001|COMPLETED|Overall Study||126
10848831|NCT01788306|12015313|FG000|NOT COMPLETED|Overall Study||10
10848832|NCT01788306|12015314|FG001|NOT COMPLETED|Overall Study||5
10848833|NCT01744041|12015328|FG000|STARTED|Overall Study||21
10848834|NCT01744041|12015329|FG001|STARTED|Overall Study||21
10848835|NCT01744041|12015328|FG000|COMPLETED|Overall Study||15
10848836|NCT01744041|12015329|FG001|COMPLETED|Overall Study||13
10848837|NCT01744041|12015328|FG000|NOT COMPLETED|Overall Study||6
10848838|NCT01744041|12015329|FG001|NOT COMPLETED|Overall Study||8
10848839|NCT01733147|12015337|FG000|STARTED|Overall Study||30
10848840|NCT01733147|12015338|FG001|STARTED|Overall Study||30
10848841|NCT01733147|12015337|FG000|COMPLETED|Overall Study||30
10848842|NCT01733147|12015338|FG001|COMPLETED|Overall Study||30
10848843|NCT01733147|12015337|FG000|NOT COMPLETED|Overall Study||0
10848844|NCT01733147|12015338|FG001|NOT COMPLETED|Overall Study||0
10848845|NCT01712789|12015344|FG000|STARTED|Overall Study||682
10848846|NCT01712789|12015344|FG000|Received Study Treatment|Overall Study||676
10848847|NCT01712789|12015344|FG000|COMPLETED|Overall Study||0
10848848|NCT01712789|12015344|FG000|NOT COMPLETED|Overall Study||682
10848861|NCT01543633|12015362|FG000|STARTED|Overall Study||36
10848862|NCT01543633|12015362|FG000|COMPLETED|Overall Study||17
10848863|NCT01543633|12015362|FG000|NOT COMPLETED|Overall Study||19
10848864|NCT01542736|12015366|FG000|STARTED|Overall Study||8
10848865|NCT01542736|12015366|FG000|COMPLETED|Overall Study||7
10848866|NCT01542736|12015366|FG000|NOT COMPLETED|Overall Study||1
10848867|NCT01535807|12015372|FG000|STARTED|Overall Study||22
10848868|NCT01535807|12015373|FG001|STARTED|Overall Study||22
10848869|NCT01535807|12015372|FG000|COMPLETED|Overall Study||20
10848870|NCT01535807|12015373|FG001|COMPLETED|Overall Study||20
10848871|NCT01535807|12015372|FG000|NOT COMPLETED|Overall Study||2
10848872|NCT01535807|12015373|FG001|NOT COMPLETED|Overall Study||2
10848873|NCT01147666|12015394|FG000|STARTED|Dosing Period 1: 6-Week Treatment||12
10848874|NCT01147666|12015395|FG001|STARTED|Dosing Period 1: 6-Week Treatment||12
10848875|NCT01147666|12015396|FG002|STARTED|Dosing Period 1: 6-Week Treatment||12
10848876|NCT01147666|12015397|FG003|STARTED|Dosing Period 1: 6-Week Treatment||12
10848877|NCT01147666|12015398|FG004|STARTED|Dosing Period 1: 6-Week Treatment||12
10848878|NCT01147666|12015399|FG005|STARTED|Dosing Period 1: 6-Week Treatment||12
10848879|NCT01147666|12015400|FG006|STARTED|Dosing Period 1: 6-Week Treatment||12
10848880|NCT01147666|12015401|FG007|STARTED|Dosing Period 1: 6-Week Treatment||12
10848881|NCT01147666|12015402|FG008|STARTED|Dosing Period 1: 6-Week Treatment||2
10848882|NCT01147666|12015403|FG009|STARTED|Dosing Period 1: 6-Week Treatment||10
10848883|NCT01147666|12015404|FG010|STARTED|Dosing Period 1: 6-Week Treatment||36
10848884|NCT01147666|12015405|FG011|STARTED|Dosing Period 1: 6-Week Treatment||4
10848885|NCT01147666|12015406|FG012|STARTED|Dosing Period 1: 6-Week Treatment||5
10848886|NCT01147666|12015407|FG013|STARTED|Dosing Period 1: 6-Week Treatment||4
10848887|NCT01147666|12015408|FG014|STARTED|Dosing Period 1: 6-Week Treatment||4
10848888|NCT01147666|12015394|FG000|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12
10848889|NCT01147666|12015395|FG001|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12
10848890|NCT01147666|12015396|FG002|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12
10848891|NCT01147666|12015397|FG003|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12
10848892|NCT01147666|12015398|FG004|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12
10848893|NCT01147666|12015399|FG005|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12
10848894|NCT01147666|12015400|FG006|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12
10848895|NCT01147666|12015401|FG007|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12
10848896|NCT01147666|12015402|FG008|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||2
10848897|NCT01147666|12015403|FG009|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||10
10848898|NCT01147666|12015404|FG010|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||36
10848899|NCT01147666|12015405|FG011|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||4
10848900|NCT01147666|12015406|FG012|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||5
10848901|NCT01147666|12015407|FG013|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||4
10848902|NCT01147666|12015408|FG014|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||4
10848903|NCT01147666|12015394|FG000|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||9
10848904|NCT01147666|12015395|FG001|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||10
10848905|NCT01147666|12015396|FG002|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||9
10848906|NCT01147666|12015397|FG003|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||11
10848907|NCT01147666|12015398|FG004|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||11
10848908|NCT01147666|12015399|FG005|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||11
10848909|NCT01147666|12015400|FG006|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||11
10848910|NCT01147666|12015401|FG007|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||10
10848911|NCT01147666|12015402|FG008|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||2
10848912|NCT01147666|12015403|FG009|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||10
10848913|NCT01147666|12015404|FG010|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||31
10848914|NCT01147666|12015405|FG011|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||1
10848915|NCT01147666|12015406|FG012|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||3
10848916|NCT01147666|12015407|FG013|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||4
10848917|NCT01147666|12015408|FG014|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||3
10848918|NCT01147666|12015394|FG000|COMPLETED|Dosing Period 1: 6-Week Treatment||10
10848919|NCT01147666|12015395|FG001|COMPLETED|Dosing Period 1: 6-Week Treatment||10
10848920|NCT01147666|12015396|FG002|COMPLETED|Dosing Period 1: 6-Week Treatment||11
10848921|NCT01147666|12015397|FG003|COMPLETED|Dosing Period 1: 6-Week Treatment||10
10848922|NCT01147666|12015398|FG004|COMPLETED|Dosing Period 1: 6-Week Treatment||7
10848923|NCT01147666|12015399|FG005|COMPLETED|Dosing Period 1: 6-Week Treatment||9
10848924|NCT01147666|12015400|FG006|COMPLETED|Dosing Period 1: 6-Week Treatment||9
10848925|NCT01147666|12015401|FG007|COMPLETED|Dosing Period 1: 6-Week Treatment||9
10848926|NCT01147666|12015402|FG008|COMPLETED|Dosing Period 1: 6-Week Treatment||2
10848927|NCT01147666|12015403|FG009|COMPLETED|Dosing Period 1: 6-Week Treatment||8
10848928|NCT01147666|12015404|FG010|COMPLETED|Dosing Period 1: 6-Week Treatment||33
10848929|NCT01147666|12015405|FG011|COMPLETED|Dosing Period 1: 6-Week Treatment||2
10848930|NCT01147666|12015406|FG012|COMPLETED|Dosing Period 1: 6-Week Treatment||1
10848931|NCT01147666|12015407|FG013|COMPLETED|Dosing Period 1: 6-Week Treatment||3
10848932|NCT01147666|12015408|FG014|COMPLETED|Dosing Period 1: 6-Week Treatment||0
10848933|NCT01147666|12015394|FG000|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||2
10848934|NCT01147666|12015395|FG001|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||2
10848935|NCT01147666|12015396|FG002|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||1
10848936|NCT01147666|12015397|FG003|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||2
10848937|NCT01147666|12015398|FG004|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||5
10848938|NCT01147666|12015399|FG005|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||3
10848939|NCT01147666|12015400|FG006|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||3
10848940|NCT01147666|12015401|FG007|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||3
10848941|NCT01147666|12015402|FG008|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||0
10848942|NCT01147666|12015403|FG009|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||2
10848943|NCT01147666|12015404|FG010|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||3
10848944|NCT01147666|12015405|FG011|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||2
10848945|NCT01147666|12015406|FG012|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||4
10848946|NCT01147666|12015407|FG013|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||1
10848947|NCT01147666|12015408|FG014|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||4
10848948|NCT01147666|12015394|FG000|STARTED|Dosing Period 2: 19-Week Treatment||0
10848949|NCT01147666|12015395|FG001|STARTED|Dosing Period 2: 19-Week Treatment||0
10848950|NCT01147666|12015396|FG002|STARTED|Dosing Period 2: 19-Week Treatment||0
10848951|NCT01147666|12015397|FG003|STARTED|Dosing Period 2: 19-Week Treatment||7
10848952|NCT01147666|12015398|FG004|STARTED|Dosing Period 2: 19-Week Treatment||12
10848953|NCT01147666|12015399|FG005|STARTED|Dosing Period 2: 19-Week Treatment||12
10848954|NCT01147666|12015400|FG006|STARTED|Dosing Period 2: 19-Week Treatment||12
10848955|NCT01147666|12015401|FG007|STARTED|Dosing Period 2: 19-Week Treatment||12
10848956|NCT01147666|12015402|FG008|STARTED|Dosing Period 2: 19-Week Treatment||2
10848957|NCT01147666|12015403|FG009|STARTED|Dosing Period 2: 19-Week Treatment||10
10848958|NCT01147666|12015404|FG010|STARTED|Dosing Period 2: 19-Week Treatment||23
10848959|NCT01147666|12015405|FG011|STARTED|Dosing Period 2: 19-Week Treatment||0
10848960|NCT01147666|12015406|FG012|STARTED|Dosing Period 2: 19-Week Treatment||5
10848961|NCT01147666|12015407|FG013|STARTED|Dosing Period 2: 19-Week Treatment||3
10848962|NCT01147666|12015408|FG014|STARTED|Dosing Period 2: 19-Week Treatment||3
10848963|NCT01147666|12015394|FG000|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||0
10848964|NCT01147666|12015395|FG001|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||0
10848965|NCT01147666|12015396|FG002|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||0
10848966|NCT01147666|12015397|FG003|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||7
10848967|NCT01147666|12015398|FG004|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||12
10848968|NCT01147666|12015399|FG005|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||12
10848969|NCT01147666|12015400|FG006|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||12
10848970|NCT01147666|12015401|FG007|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||12
10848971|NCT01147666|12015402|FG008|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||2
10848972|NCT01147666|12015403|FG009|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||10
10848973|NCT01147666|12015404|FG010|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||23
10848974|NCT01147666|12015405|FG011|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||0
10848975|NCT01147666|12015406|FG012|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||5
10848976|NCT01147666|12015407|FG013|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||3
10848977|NCT01147666|12015408|FG014|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||3
10848978|NCT01147666|12015394|FG000|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||0
10848979|NCT01147666|12015395|FG001|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||0
10848980|NCT01147666|12015396|FG002|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||0
10848981|NCT01147666|12015397|FG003|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||6
10848982|NCT01147666|12015398|FG004|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||11
10848983|NCT01147666|12015399|FG005|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||11
10848984|NCT01147666|12015400|FG006|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||11
10848985|NCT01147666|12015401|FG007|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||10
10848986|NCT01147666|12015402|FG008|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||2
10848987|NCT01147666|12015403|FG009|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||10
10848988|NCT01147666|12015404|FG010|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||22
10848989|NCT01147666|12015405|FG011|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||0
10848990|NCT01147666|12015406|FG012|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||3
10848991|NCT01147666|12015407|FG013|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||3
10848992|NCT01147666|12015408|FG014|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||2
10848993|NCT01147666|12015394|FG000|COMPLETED|Dosing Period 2: 19-Week Treatment||0
10848994|NCT01147666|12015395|FG001|COMPLETED|Dosing Period 2: 19-Week Treatment||0
10848995|NCT01147666|12015396|FG002|COMPLETED|Dosing Period 2: 19-Week Treatment||0
10848996|NCT01147666|12015397|FG003|COMPLETED|Dosing Period 2: 19-Week Treatment||5
10848997|NCT01147666|12015398|FG004|COMPLETED|Dosing Period 2: 19-Week Treatment||7
10848998|NCT01147666|12015399|FG005|COMPLETED|Dosing Period 2: 19-Week Treatment||9
10848999|NCT01147666|12015400|FG006|COMPLETED|Dosing Period 2: 19-Week Treatment||9
10849000|NCT01147666|12015401|FG007|COMPLETED|Dosing Period 2: 19-Week Treatment||9
10849001|NCT01147666|12015402|FG008|COMPLETED|Dosing Period 2: 19-Week Treatment||2
10849002|NCT01147666|12015403|FG009|COMPLETED|Dosing Period 2: 19-Week Treatment||8
10849003|NCT01147666|12015404|FG010|COMPLETED|Dosing Period 2: 19-Week Treatment||21
10849004|NCT01147666|12015405|FG011|COMPLETED|Dosing Period 2: 19-Week Treatment||0
10849005|NCT01147666|12015406|FG012|COMPLETED|Dosing Period 2: 19-Week Treatment||1
10849006|NCT01147666|12015407|FG013|COMPLETED|Dosing Period 2: 19-Week Treatment||2
10849007|NCT01147666|12015408|FG014|COMPLETED|Dosing Period 2: 19-Week Treatment||0
10849008|NCT01147666|12015394|FG000|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||0
10849009|NCT01147666|12015395|FG001|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||0
10849010|NCT01147666|12015396|FG002|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||0
10849011|NCT01147666|12015397|FG003|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||2
10849012|NCT01147666|12015398|FG004|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||5
10849013|NCT01147666|12015399|FG005|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||3
10849014|NCT01147666|12015400|FG006|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||3
10849015|NCT01147666|12015401|FG007|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||3
10849016|NCT01147666|12015402|FG008|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||0
10849017|NCT01147666|12015403|FG009|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||2
10849018|NCT01147666|12015404|FG010|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||2
10849019|NCT01147666|12015405|FG011|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||0
10849020|NCT01147666|12015406|FG012|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||4
10849021|NCT01147666|12015407|FG013|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||1
10849022|NCT01147666|12015408|FG014|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||3
10849023|NCT00982111|12015472|FG000|STARTED|Overall Study||315
10849024|NCT00982111|12015473|FG001|STARTED|Overall Study||318
10849025|NCT00982111|12015472|FG000|Received at Least 1 Dose of Study Drug|Overall Study||304
10849026|NCT00982111|12015473|FG001|Received at Least 1 Dose of Study Drug|Overall Study||312
10849027|NCT00982111|12015472|FG000|Death Due to Any Cause|Overall Study||236
10849028|NCT00982111|12015473|FG001|Death Due to Any Cause|Overall Study||246
10849029|NCT00982111|12015472|FG000|COMPLETED|Overall Study||236
10849030|NCT00982111|12015473|FG001|COMPLETED|Overall Study||246
10849031|NCT00982111|12015472|FG000|NOT COMPLETED|Overall Study||79
10849032|NCT00982111|12015473|FG001|NOT COMPLETED|Overall Study||72
10849033|NCT00193219|12015480|FG000|STARTED|Overall Study||36
10849034|NCT00193219|12015480|FG000|COMPLETED|Overall Study||6
10849035|NCT00193219|12015480|FG000|NOT COMPLETED|Overall Study||30
10849036|NCT00116142|12015487|FG000|STARTED|Overall Study||175
10849037|NCT00116142|12015488|FG001|STARTED|Overall Study||175
10849038|NCT00116142|12015487|FG000|Treated|Overall Study||174
10849039|NCT00116142|12015488|FG001|Treated|Overall Study||171
10849040|NCT00116142|12015487|FG000|COMPLETED|Overall Study||156
10849041|NCT00116142|12015488|FG001|COMPLETED|Overall Study||155
10849042|NCT00116142|12015487|FG000|NOT COMPLETED|Overall Study||19
10849043|NCT00116142|12015488|FG001|NOT COMPLETED|Overall Study||20
10849044|NCT00070018|12015497|FG000|STARTED|Overall Study||46
10849045|NCT00070018|12015497|FG000|Eligible|Overall Study||46
10849046|NCT00070018|12015497|FG000|Eligible and Began Protocol Therapy|Overall Study||46
10849047|NCT00070018|12015497|FG000|COMPLETED|Overall Study||42
10849048|NCT00070018|12015497|FG000|NOT COMPLETED|Overall Study||4
10292774|NCT02425826|11425577|FG002|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||50
10292775|NCT02425826|11425575|FG000|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||35
10292776|NCT02425826|11425576|FG001|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||0
10292777|NCT02425826|11425577|FG002|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||14
10292778|NCT02425826|11425575|FG000|STARTED|Post-Treatment Observational Follow-Up||81
10292779|NCT02425826|11425576|FG001|STARTED|Post-Treatment Observational Follow-Up||0
10292780|NCT02425826|11425577|FG002|STARTED|Post-Treatment Observational Follow-Up||49
10292781|NCT02425826|11425575|FG000|COMPLETED|Post-Treatment Observational Follow-Up||80
10292782|NCT02425826|11425576|FG001|COMPLETED|Post-Treatment Observational Follow-Up||0
10292783|NCT02425826|11425577|FG002|COMPLETED|Post-Treatment Observational Follow-Up||49
10292784|NCT02425826|11425575|FG000|NOT COMPLETED|Post-Treatment Observational Follow-Up||1
10292785|NCT02425826|11425576|FG001|NOT COMPLETED|Post-Treatment Observational Follow-Up||0
10292786|NCT02425826|11425577|FG002|NOT COMPLETED|Post-Treatment Observational Follow-Up||0
10292787|NCT02384239|11425589|FG000|STARTED|Overall Study||36
10292788|NCT02384239|11425590|FG001|STARTED|Overall Study||34
10292789|NCT02384239|11425589|FG000|COMPLETED|Overall Study||36
10292790|NCT02384239|11425590|FG001|COMPLETED|Overall Study||34
10292791|NCT02384239|11425589|FG000|NOT COMPLETED|Overall Study||0
10292792|NCT02384239|11425590|FG001|NOT COMPLETED|Overall Study||0
10292793|NCT02356705|11425600|FG000|STARTED|Overall Study||14
10292794|NCT02356705|11425601|FG001|STARTED|Overall Study||14
10292795|NCT02356705|11425602|FG002|STARTED|Overall Study||14
10292796|NCT02356705|11425600|FG000|COMPLETED|Overall Study||14
10292797|NCT02356705|11425601|FG001|COMPLETED|Overall Study||14
10292798|NCT02356705|11425602|FG002|COMPLETED|Overall Study||14
10292799|NCT02356705|11425600|FG000|NOT COMPLETED|Overall Study||0
10292800|NCT02356705|11425601|FG001|NOT COMPLETED|Overall Study||0
10292801|NCT02356705|11425602|FG002|NOT COMPLETED|Overall Study||0
10314475|NCT00162981|11448107|FG001|COMPLETED|Overall Study||30
10314476|NCT00162981|11448106|FG000|NOT COMPLETED|Overall Study||4
10314477|NCT00162981|11448107|FG001|NOT COMPLETED|Overall Study||6
10314478|NCT00163020|11448115|FG000|STARTED|Overall Study|Twins = 160 Triplets = 56|216
10314479|NCT00163020|11448116|FG001|STARTED|Overall Study|Twins = 80 Triplets = 25|105
10314480|NCT00163020|11448115|FG000|COMPLETED|Overall Study|Twins = 160 Triplets = 56|216
10314481|NCT00163020|11448116|FG001|COMPLETED|Overall Study|Twins = 78 Triplets = 25|103
10314482|NCT00163020|11448115|FG000|NOT COMPLETED|Overall Study||0
10314483|NCT00163020|11448116|FG001|NOT COMPLETED|Overall Study||2
10314484|NCT00163189|11448124|FG000|STARTED|Overall Study||98
10314485|NCT00163189|11448124|FG000|COMPLETED|Overall Study||35
10314486|NCT00163189|11448124|FG000|NOT COMPLETED|Overall Study||63
10315645|NCT00181610|11449587|FG000|NOT COMPLETED|Overall Study||0
10315646|NCT00181610|11449588|FG001|NOT COMPLETED|Overall Study||1
10315647|NCT00181610|11449589|FG002|NOT COMPLETED|Overall Study||0
10315648|NCT00181623|11449598|FG000|STARTED|Overall Study||6
10315649|NCT00181623|11449598|FG000|COMPLETED|Overall Study||5
10315650|NCT00181623|11449598|FG000|NOT COMPLETED|Overall Study||1
10315651|NCT00181714|11449603|FG000|STARTED|Signed Consent/Enrolled||203
10292802|NCT02353247|11425615|FG000|STARTED|Overall Study||30
10292803|NCT02353247|11425616|FG001|STARTED|Overall Study||23
10292804|NCT02353247|11425617|FG002|STARTED|Overall Study||35
10292805|NCT02353247|11425615|FG000|COMPLETED|Overall Study||21
10292806|NCT02353247|11425616|FG001|COMPLETED|Overall Study||18
10292807|NCT02353247|11425617|FG002|COMPLETED|Overall Study||0
10292808|NCT02353247|11425615|FG000|NOT COMPLETED|Overall Study||9
10292809|NCT02353247|11425616|FG001|NOT COMPLETED|Overall Study||5
10292810|NCT02353247|11425617|FG002|NOT COMPLETED|Overall Study||35
10292811|NCT02316002|11425631|FG000|STARTED|Overall Study||51
10292812|NCT02316002|11425631|FG000|COMPLETED|Overall Study||45
10292813|NCT02316002|11425631|FG000|NOT COMPLETED|Overall Study||6
10292814|NCT02021071|11425637|FG000|STARTED|Overall Study||12
10292815|NCT02021071|11425638|FG001|STARTED|Overall Study||12
10292816|NCT02021071|11425637|FG000|COMPLETED|Overall Study||12
10413620|NCT00779402|11557889|FG001|COMPLETED|Long-term Follow-up||7
10849049|NCT04631796|12015501|FG000|STARTED|Overall Study||35
10849050|NCT04631796|12015501|FG000|COMPLETED|Overall Study||35
10849051|NCT04631796|12015501|FG000|NOT COMPLETED|Overall Study||0
10849052|NCT04447287|12015510|FG000|STARTED|Period 1: Run-in Period||23
10849053|NCT04447287|12015511|FG001|STARTED|Period 1: Run-in Period||0
10849054|NCT04447287|12015512|FG002|STARTED|Period 1: Run-in Period||0
10849055|NCT04447287|12015510|FG000|COMPLETED|Period 1: Run-in Period||19
10849056|NCT04447287|12015511|FG001|COMPLETED|Period 1: Run-in Period||0
10849057|NCT04447287|12015512|FG002|COMPLETED|Period 1: Run-in Period||0
10849058|NCT04447287|12015510|FG000|NOT COMPLETED|Period 1: Run-in Period||4
10849059|NCT04447287|12015511|FG001|NOT COMPLETED|Period 1: Run-in Period||0
10849060|NCT04447287|12015512|FG002|NOT COMPLETED|Period 1: Run-in Period||0
10849061|NCT04447287|12015510|FG000|STARTED|Period 2: Investigational Period||1
10849062|NCT04447287|12015511|FG001|STARTED|Period 2: Investigational Period||12
10849063|NCT04447287|12015512|FG002|STARTED|Period 2: Investigational Period||6
10849064|NCT04447287|12015510|FG000|COMPLETED|Period 2: Investigational Period||0
10849065|NCT04447287|12015511|FG001|COMPLETED|Period 2: Investigational Period||12
10849066|NCT04447287|12015512|FG002|COMPLETED|Period 2: Investigational Period||6
10849067|NCT04447287|12015510|FG000|NOT COMPLETED|Period 2: Investigational Period||1
10849068|NCT04447287|12015511|FG001|NOT COMPLETED|Period 2: Investigational Period||0
10849069|NCT04447287|12015512|FG002|NOT COMPLETED|Period 2: Investigational Period||0
10849070|NCT04447287|12015510|FG000|STARTED|Period 3: Down-Titration Period||0
10849071|NCT04447287|12015511|FG001|STARTED|Period 3: Down-Titration Period||12
10849072|NCT04447287|12015512|FG002|STARTED|Period 3: Down-Titration Period||6
10849073|NCT04447287|12015510|FG000|COMPLETED|Period 3: Down-Titration Period||0
10849074|NCT04447287|12015511|FG001|COMPLETED|Period 3: Down-Titration Period||12
10849075|NCT04447287|12015512|FG002|COMPLETED|Period 3: Down-Titration Period||6
10849076|NCT04447287|12015510|FG000|NOT COMPLETED|Period 3: Down-Titration Period||0
10849077|NCT04447287|12015511|FG001|NOT COMPLETED|Period 3: Down-Titration Period||0
10849078|NCT04447287|12015512|FG002|NOT COMPLETED|Period 3: Down-Titration Period||0
10849079|NCT04203537|12015535|FG000|STARTED|Overall Study||6
10849080|NCT04203537|12015536|FG001|STARTED|Overall Study||6
10849081|NCT04203537|12015537|FG002|STARTED|Overall Study||6
10849082|NCT04203537|12015538|FG003|STARTED|Overall Study||6
10849083|NCT04203537|12015539|FG004|STARTED|Overall Study||54
10849084|NCT04203537|12015540|FG005|STARTED|Overall Study||55
10849085|NCT04203537|12015541|FG006|STARTED|Overall Study||60
10849086|NCT04203537|12015535|FG000|COMPLETED|Overall Study||6
10849087|NCT04203537|12015536|FG001|COMPLETED|Overall Study||6
10849088|NCT04203537|12015537|FG002|COMPLETED|Overall Study||6
10849089|NCT04203537|12015538|FG003|COMPLETED|Overall Study||6
10849090|NCT04203537|12015539|FG004|COMPLETED|Overall Study||54
10849091|NCT04203537|12015540|FG005|COMPLETED|Overall Study||55
10849092|NCT04203537|12015541|FG006|COMPLETED|Overall Study||60
10849093|NCT04203537|12015535|FG000|NOT COMPLETED|Overall Study||0
10849094|NCT04203537|12015536|FG001|NOT COMPLETED|Overall Study||0
10849095|NCT04203537|12015537|FG002|NOT COMPLETED|Overall Study||0
10849096|NCT04203537|12015538|FG003|NOT COMPLETED|Overall Study||0
10849097|NCT04203537|12015539|FG004|NOT COMPLETED|Overall Study||0
10849098|NCT04203537|12015540|FG005|NOT COMPLETED|Overall Study||0
10849099|NCT04203537|12015541|FG006|NOT COMPLETED|Overall Study||0
10849100|NCT04125745|12015551|FG000|STARTED|Overall Study||1
10849101|NCT04125745|12015551|FG000|COMPLETED|Overall Study||1
10849102|NCT04125745|12015551|FG000|NOT COMPLETED|Overall Study||0
10849103|NCT04074928|12015557|FG000|STARTED|Overall Study||1605
10849104|NCT04074928|12015558|FG001|STARTED|Overall Study||809
10849105|NCT04074928|12015557|FG000|Received Study Vaccine|Overall Study||1597
10849106|NCT04074928|12015558|FG001|Received Study Vaccine|Overall Study||805
10849107|NCT04074928|12015557|FG000|COMPLETED|Overall Study||1370
10849108|NCT04074928|12015558|FG001|COMPLETED|Overall Study||710
10849109|NCT04074928|12015557|FG000|NOT COMPLETED|Overall Study||235
10849110|NCT04074928|12015558|FG001|NOT COMPLETED|Overall Study||99
10849111|NCT04039503|12015568|FG000|STARTED|Overall Study||116
10849112|NCT04039503|12015569|FG001|STARTED|Overall Study||119
10849113|NCT04039503|12015570|FG002|STARTED|Overall Study||120
10849114|NCT04039503|12015571|FG003|STARTED|Overall Study||120
10849115|NCT04039503|12015568|FG000|Received at Least One Dose of Study Drug|Overall Study||116
10849116|NCT04039503|12015569|FG001|Received at Least One Dose of Study Drug|Overall Study||119
10849117|NCT04039503|12015570|FG002|Received at Least One Dose of Study Drug|Overall Study||120
10292817|NCT02021071|11425638|FG001|COMPLETED|Overall Study||12
10292818|NCT02021071|11425637|FG000|NOT COMPLETED|Overall Study||0
10292819|NCT02021071|11425638|FG001|NOT COMPLETED|Overall Study||0
10849118|NCT04039503|12015571|FG003|Received at Least One Dose of Study Drug|Overall Study||120
10849119|NCT04039503|12015568|FG000|COMPLETED|Overall Study||109
10849120|NCT04039503|12015569|FG001|COMPLETED|Overall Study||115
10849121|NCT04039503|12015570|FG002|COMPLETED|Overall Study||110
10849122|NCT04039503|12015571|FG003|COMPLETED|Overall Study||117
10849123|NCT04039503|12015568|FG000|NOT COMPLETED|Overall Study||7
10849124|NCT04039503|12015569|FG001|NOT COMPLETED|Overall Study||4
10849125|NCT04039503|12015570|FG002|NOT COMPLETED|Overall Study||10
10849126|NCT04039503|12015571|FG003|NOT COMPLETED|Overall Study||3
10413621|NCT00779402|11557888|FG000|NOT COMPLETED|Long-term Follow-up||21
10849127|NCT03695172|12015589|FG000|STARTED|Overall Study||5
10849128|NCT03695172|12015590|FG001|STARTED|Overall Study||4
10849129|NCT03695172|12015591|FG002|STARTED|Overall Study||3
10849130|NCT03695172|12015589|FG000|COMPLETED|Overall Study||4
10849131|NCT03695172|12015590|FG001|COMPLETED|Overall Study||3
10849132|NCT03695172|12015591|FG002|COMPLETED|Overall Study||3
10849133|NCT03695172|12015589|FG000|NOT COMPLETED|Overall Study||1
10849134|NCT03695172|12015590|FG001|NOT COMPLETED|Overall Study||1
10849135|NCT03695172|12015591|FG002|NOT COMPLETED|Overall Study||0
10849136|NCT03433040|12015602|FG000|STARTED|Overall Study||19
10849137|NCT03433040|12015603|FG001|STARTED|Overall Study||16
10849138|NCT03433040|12015604|FG002|STARTED|Overall Study||9
10849139|NCT03433040|12015602|FG000|COMPLETED|Overall Study||17
10849140|NCT03433040|12015603|FG001|COMPLETED|Overall Study||8
10849141|NCT03433040|12015604|FG002|COMPLETED|Overall Study||5
10849142|NCT03433040|12015602|FG000|NOT COMPLETED|Overall Study||2
10849143|NCT03433040|12015603|FG001|NOT COMPLETED|Overall Study||8
10849144|NCT03433040|12015604|FG002|NOT COMPLETED|Overall Study||4
10849154|NCT03357952|12015645|FG000|STARTED|Overall Study||9
10849155|NCT03357952|12015646|FG001|STARTED|Overall Study||1
10849156|NCT03357952|12015645|FG000|COMPLETED|Overall Study||0
10849157|NCT03357952|12015646|FG001|COMPLETED|Overall Study||0
10849158|NCT03357952|12015645|FG000|NOT COMPLETED|Overall Study||9
10849159|NCT03357952|12015646|FG001|NOT COMPLETED|Overall Study||1
10849160|NCT03237234|12015654|FG000|STARTED|Overall Study||14
10849161|NCT03237234|12015655|FG001|STARTED|Overall Study||11
10849162|NCT03237234|12015654|FG000|COMPLETED|Overall Study||14
10849163|NCT03237234|12015655|FG001|COMPLETED|Overall Study||11
10849164|NCT03237234|12015654|FG000|NOT COMPLETED|Overall Study||0
10849165|NCT03237234|12015655|FG001|NOT COMPLETED|Overall Study||0
10849166|NCT03170869|12015661|FG000|STARTED|Overall Study||11
10849167|NCT03170869|12015661|FG000|COMPLETED|Overall Study||3
10849168|NCT03170869|12015661|FG000|NOT COMPLETED|Overall Study||8
10849169|NCT03066622|12015668|FG000|STARTED|Overall Study||61
10849170|NCT03066622|12015669|FG001|STARTED|Overall Study||61
10849171|NCT03066622|12015668|FG000|COMPLETED|Overall Study||35
10849172|NCT03066622|12015669|FG001|COMPLETED|Overall Study||35
10849173|NCT03066622|12015668|FG000|NOT COMPLETED|Overall Study||26
10849174|NCT03066622|12015669|FG001|NOT COMPLETED|Overall Study||26
10849175|NCT03052920|12015675|FG000|STARTED|Overall Study||40
10849176|NCT03052920|12015675|FG000|COMPLETED|Overall Study||39
10849177|NCT03052920|12015675|FG000|NOT COMPLETED|Overall Study||1
10849178|NCT03029104|12015682|FG000|STARTED|Overall Study||745
10849179|NCT03029104|12015683|FG001|STARTED|Overall Study||735
10849180|NCT03029104|12015684|FG002|STARTED|Overall Study||748
10849181|NCT03029104|12015682|FG000|COMPLETED|Overall Study||612
10849182|NCT03029104|12015683|FG001|COMPLETED|Overall Study||597
10849183|NCT03029104|12015684|FG002|COMPLETED|Overall Study||623
10849184|NCT03029104|12015682|FG000|NOT COMPLETED|Overall Study||133
10849185|NCT03029104|12015683|FG001|NOT COMPLETED|Overall Study||138
10849186|NCT03029104|12015684|FG002|NOT COMPLETED|Overall Study||125
10849193|NCT02722434|12015703|FG000|STARTED|Overall Study||25
10849194|NCT02722434|12015704|FG001|STARTED|Overall Study||25
10849195|NCT02722434|12015703|FG000|Started Treatment|Overall Study||24
10849196|NCT02722434|12015704|FG001|Started Treatment|Overall Study||25
10849197|NCT02722434|12015703|FG000|COMPLETED|Overall Study||24
10849198|NCT02722434|12015704|FG001|COMPLETED|Overall Study||22
10754747|NCT03055000|11918539|FG000|NOT COMPLETED|Overall Study||0
10754748|NCT03055000|11918540|FG001|NOT COMPLETED|Overall Study||0
10754749|NCT03055000|11918541|FG002|NOT COMPLETED|Overall Study||0
10754750|NCT03055156|11918551|FG000|STARTED|Overall Study||281
10754751|NCT03055156|11918552|FG001|STARTED|Overall Study||273
10754752|NCT03055156|11918551|FG000|COMPLETED|Overall Study||281
10754753|NCT03055156|11918552|FG001|COMPLETED|Overall Study||273
10754754|NCT03055156|11918551|FG000|NOT COMPLETED|Overall Study||0
10754755|NCT03055156|11918552|FG001|NOT COMPLETED|Overall Study||0
10754756|NCT03055195|11918560|FG000|STARTED|Overall Study||16
10754757|NCT03055195|11918561|FG001|STARTED|Overall Study||18
10849199|NCT02722434|12015703|FG000|NOT COMPLETED|Overall Study||1
10849200|NCT02722434|12015704|FG001|NOT COMPLETED|Overall Study||3
10849201|NCT02721979|12015710|FG000|STARTED|Overall Study||23
10754758|NCT03055195|11918560|FG000|COMPLETED|Overall Study||4
10849202|NCT02721979|12015710|FG000|COMPLETED|Overall Study||22
10849203|NCT02721979|12015710|FG000|NOT COMPLETED|Overall Study||1
10849207|NCT02369536|12015720|FG000|STARTED|Overall Study||62
10849208|NCT02369536|12015721|FG001|STARTED|Overall Study||64
10849209|NCT02369536|12015720|FG000|COMPLETED|Overall Study||55
10849210|NCT02369536|12015721|FG001|COMPLETED|Overall Study||58
10849211|NCT02369536|12015720|FG000|NOT COMPLETED|Overall Study||7
10849212|NCT02369536|12015721|FG001|NOT COMPLETED|Overall Study||6
10849213|NCT02358681|12015731|FG000|STARTED|Overall Study||29
10849214|NCT02358681|12015732|FG001|STARTED|Overall Study||30
10849215|NCT02358681|12015731|FG000|COMPLETED|Overall Study||27
10849216|NCT02358681|12015732|FG001|COMPLETED|Overall Study||29
10849217|NCT02358681|12015731|FG000|NOT COMPLETED|Overall Study||2
10849218|NCT02358681|12015732|FG001|NOT COMPLETED|Overall Study||1
10849219|NCT02101788|12015740|FG000|STARTED|Overall Study||130
10849220|NCT02101788|12015741|FG001|STARTED|Overall Study||130
10849221|NCT02101788|12015740|FG000|Crossover From Arm A to Arm B|Overall Study||88
10849222|NCT02101788|12015741|FG001|Crossover From Arm A to Arm B|Overall Study||0
10849223|NCT02101788|12015740|FG000|COMPLETED|Overall Study||120
10849224|NCT02101788|12015741|FG001|COMPLETED|Overall Study||116
10849225|NCT02101788|12015740|FG000|NOT COMPLETED|Overall Study||10
10849226|NCT02101788|12015741|FG001|NOT COMPLETED|Overall Study||14
10849233|NCT01248247|12015767|FG000|STARTED|Overall Study||22
10849234|NCT01248247|12015768|FG001|STARTED|Overall Study||42
10849235|NCT01248247|12015769|FG002|STARTED|Overall Study||75
10413622|NCT00779402|11557889|FG001|NOT COMPLETED|Long-term Follow-up||6
10413623|NCT00779467|11557899|FG000|STARTED|Overall Study||53
10413624|NCT00779467|11557900|FG001|STARTED|Overall Study||45
10413625|NCT00779467|11557901|FG002|STARTED|Overall Study||48
10413626|NCT00779467|11557902|FG003|STARTED|Overall Study||54
10413627|NCT00779467|11557899|FG000|COMPLETED|Overall Study||38
10413628|NCT00779467|11557900|FG001|COMPLETED|Overall Study||40
10413629|NCT00779467|11557901|FG002|COMPLETED|Overall Study||38
10413630|NCT00779467|11557902|FG003|COMPLETED|Overall Study||35
10413631|NCT00779467|11557899|FG000|NOT COMPLETED|Overall Study||15
10413632|NCT00779467|11557900|FG001|NOT COMPLETED|Overall Study||5
10413633|NCT00779467|11557901|FG002|NOT COMPLETED|Overall Study||10
10413634|NCT00779467|11557902|FG003|NOT COMPLETED|Overall Study||19
10413635|NCT00779506|11557912|FG000|STARTED|Overall Study||96
10413636|NCT00779506|11557912|FG000|Enrolled|Overall Study||96
10413637|NCT00779506|11557912|FG000|Screen Failed|Overall Study||2
10413638|NCT00779506|11557912|FG000|Assigned|Overall Study||94
10413639|NCT00779506|11557912|FG000|MITT|Overall Study||89
10413640|NCT00779506|11557912|FG000|Treatment Complete|Overall Study||67
10413641|NCT00779506|11557912|FG000|Withdrawal Treatment|Overall Study||27
10413642|NCT00779506|11557912|FG000|COMPLETED|Overall Study||67
10413643|NCT00779506|11557912|FG000|NOT COMPLETED|Overall Study||29
10413644|NCT00779558|11557918|FG000|STARTED|Overall Study||57
10413645|NCT00779558|11557919|FG001|STARTED|Overall Study||44
10413646|NCT00779558|11557918|FG000|COMPLETED|Overall Study||53
10413647|NCT00779558|11557919|FG001|COMPLETED|Overall Study||37
10413648|NCT00779558|11557918|FG000|NOT COMPLETED|Overall Study||4
10413649|NCT00779558|11557919|FG001|NOT COMPLETED|Overall Study||7
10413650|NCT00779584|11557934|FG000|STARTED|Overall Study||3
10413651|NCT00779584|11557935|FG001|STARTED|Overall Study||3
10413652|NCT00779584|11557936|FG002|STARTED|Overall Study||7
10413653|NCT00779584|11557937|FG003|STARTED|Overall Study||6
10413654|NCT00779584|11557938|FG004|STARTED|Overall Study||7
10413655|NCT00779584|11557939|FG005|STARTED|Overall Study||6
10413656|NCT00779584|11557940|FG006|STARTED|Overall Study||8
10413657|NCT00779584|11557941|FG007|STARTED|Overall Study||3
10413658|NCT00779584|11557942|FG008|STARTED|Overall Study||2
10413659|NCT00779584|11557934|FG000|Treated|Overall Study||3
10413660|NCT00779584|11557935|FG001|Treated|Overall Study||3
10413661|NCT00779584|11557936|FG002|Treated|Overall Study||7
10413662|NCT00779584|11557937|FG003|Treated|Overall Study||6
10413663|NCT00779584|11557938|FG004|Treated|Overall Study||7
10413664|NCT00779584|11557939|FG005|Treated|Overall Study||4
10413665|NCT00779584|11557940|FG006|Treated|Overall Study||8
10413666|NCT00779584|11557941|FG007|Treated|Overall Study||3
10849236|NCT01248247|12015770|FG003|STARTED|Overall Study||61
10849237|NCT01248247|12015767|FG000|COMPLETED|Overall Study||0
10849238|NCT01248247|12015768|FG001|COMPLETED|Overall Study||0
10849239|NCT01248247|12015769|FG002|COMPLETED|Overall Study||0
10292832|NCT01927068|11425665|FG000|STARTED|Overall Study||370
10292833|NCT01927068|11425666|FG001|STARTED|Overall Study||129
10849240|NCT01248247|12015770|FG003|COMPLETED|Overall Study||0
10849241|NCT01248247|12015767|FG000|NOT COMPLETED|Overall Study||22
10849242|NCT01248247|12015768|FG001|NOT COMPLETED|Overall Study||42
10849243|NCT01248247|12015769|FG002|NOT COMPLETED|Overall Study||75
10292834|NCT01927068|11425665|FG000|COMPLETED|Overall Study||262
10292835|NCT01927068|11425666|FG001|COMPLETED|Overall Study||121
10292836|NCT01927068|11425665|FG000|NOT COMPLETED|Overall Study||108
10849244|NCT01248247|12015770|FG003|NOT COMPLETED|Overall Study||61
10849245|NCT01164228|12015782|FG000|STARTED|Overall Study||47
10849246|NCT01164228|12015783|FG001|STARTED|Overall Study||40
10849247|NCT01164228|12015782|FG000|Receipt of Protocol Therapy|Overall Study||46
10849248|NCT01164228|12015783|FG001|Receipt of Protocol Therapy|Overall Study||37
10849249|NCT01164228|12015782|FG000|Treated and Eligible Patients|Overall Study||45
10849250|NCT01164228|12015783|FG001|Treated and Eligible Patients|Overall Study||37
10849251|NCT01164228|12015782|FG000|COMPLETED|Overall Study||3
10849252|NCT01164228|12015783|FG001|COMPLETED|Overall Study||2
10849253|NCT01164228|12015782|FG000|NOT COMPLETED|Overall Study||44
10849254|NCT01164228|12015783|FG001|NOT COMPLETED|Overall Study||38
10849255|NCT01012167|12015792|FG000|STARTED|Overall Study||17
10849256|NCT01012167|12015793|FG001|STARTED|Overall Study||20
10849257|NCT01012167|12015794|FG002|STARTED|Overall Study||21
10849258|NCT01012167|12015792|FG000|Withdrawn Prior to Study Drug Exposure|Overall Study||1
10849259|NCT01012167|12015793|FG001|Withdrawn Prior to Study Drug Exposure|Overall Study||0
10849260|NCT01012167|12015794|FG002|Withdrawn Prior to Study Drug Exposure|Overall Study||1
10849261|NCT01012167|12015792|FG000|Exposed to Study Drug|Overall Study||16
10849262|NCT01012167|12015793|FG001|Exposed to Study Drug|Overall Study||20
10849263|NCT01012167|12015794|FG002|Exposed to Study Drug|Overall Study||20
10849264|NCT01012167|12015792|FG000|COMPLETED|Overall Study||15
10849265|NCT01012167|12015793|FG001|COMPLETED|Overall Study||18
10849266|NCT01012167|12015794|FG002|COMPLETED|Overall Study||17
10849267|NCT01012167|12015792|FG000|NOT COMPLETED|Overall Study||2
10849268|NCT01012167|12015793|FG001|NOT COMPLETED|Overall Study||2
10849269|NCT01012167|12015794|FG002|NOT COMPLETED|Overall Study||4
10849270|NCT00924326|12015818|FG000|STARTED|Dose Administration||8
10849271|NCT00924326|12015819|FG001|STARTED|Dose Administration||2
10849272|NCT00924326|12015820|FG002|STARTED|Dose Administration||5
10849273|NCT00924326|12015821|FG003|STARTED|Dose Administration||6
10849274|NCT00924326|12015822|FG004|STARTED|Dose Administration||7
10849275|NCT00924326|12015823|FG005|STARTED|Dose Administration||10
10849276|NCT00924326|12015824|FG006|STARTED|Dose Administration||1
10849277|NCT00924326|12015825|FG007|STARTED|Dose Administration||2
10849278|NCT00924326|12015826|FG008|STARTED|Dose Administration||2
10849279|NCT00924326|12015818|FG000|COMPLETED|Dose Administration||8
10849280|NCT00924326|12015819|FG001|COMPLETED|Dose Administration||2
10849281|NCT00924326|12015820|FG002|COMPLETED|Dose Administration||5
10849282|NCT00924326|12015821|FG003|COMPLETED|Dose Administration||6
10849283|NCT00924326|12015822|FG004|COMPLETED|Dose Administration||7
10849284|NCT00924326|12015823|FG005|COMPLETED|Dose Administration||10
10849285|NCT00924326|12015824|FG006|COMPLETED|Dose Administration||1
10849286|NCT00924326|12015825|FG007|COMPLETED|Dose Administration||2
10849287|NCT00924326|12015826|FG008|COMPLETED|Dose Administration||2
10849288|NCT00924326|12015818|FG000|NOT COMPLETED|Dose Administration||0
10849289|NCT00924326|12015819|FG001|NOT COMPLETED|Dose Administration||0
10849290|NCT00924326|12015820|FG002|NOT COMPLETED|Dose Administration||0
10849291|NCT00924326|12015821|FG003|NOT COMPLETED|Dose Administration||0
10849292|NCT00924326|12015822|FG004|NOT COMPLETED|Dose Administration||0
10849293|NCT00924326|12015823|FG005|NOT COMPLETED|Dose Administration||0
10849294|NCT00924326|12015824|FG006|NOT COMPLETED|Dose Administration||0
10849295|NCT00924326|12015825|FG007|NOT COMPLETED|Dose Administration||0
10849296|NCT00924326|12015826|FG008|NOT COMPLETED|Dose Administration||0
10849297|NCT00924326|12015818|FG000|STARTED|1x10^9-1x10^10 + High Dose Retreat||3
10849298|NCT00924326|12015819|FG001|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
10849299|NCT00924326|12015820|FG002|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
10849300|NCT00924326|12015821|FG003|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
10849301|NCT00924326|12015822|FG004|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
10849302|NCT00924326|12015823|FG005|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
10849303|NCT00924326|12015824|FG006|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
10849304|NCT00924326|12015825|FG007|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
10849305|NCT00924326|12015826|FG008|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
10849306|NCT00924326|12015818|FG000|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||3
10849307|NCT00924326|12015819|FG001|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
10849308|NCT00924326|12015820|FG002|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
10849309|NCT00924326|12015821|FG003|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
10849310|NCT00924326|12015822|FG004|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
10849311|NCT00924326|12015823|FG005|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
10849312|NCT00924326|12015824|FG006|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
10849313|NCT00924326|12015825|FG007|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
10849314|NCT00924326|12015826|FG008|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
10849315|NCT00924326|12015818|FG000|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
10849316|NCT00924326|12015819|FG001|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
10849317|NCT00924326|12015820|FG002|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
10849318|NCT00924326|12015821|FG003|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
10849319|NCT00924326|12015822|FG004|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
10849320|NCT00924326|12015823|FG005|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
10849321|NCT00924326|12015824|FG006|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
10849322|NCT00924326|12015825|FG007|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
10849323|NCT00924326|12015826|FG008|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
10849324|NCT00591318|12015850|FG000|STARTED|Overall Study||5
10849325|NCT00591318|12015851|FG001|STARTED|Overall Study||5
10849326|NCT00591318|12015850|FG000|COMPLETED|Overall Study|For our protocol, participants in both treatment arms were considered completers if they completed at least 6 weeks. At the 6 week point, if response on PANS was not sufficient (15% or greater), they were considered unlikely to respond and therefore were not given the option of the 2 additional weeks of ceftriaxone or placebo. For the analysis, we used the last observed rating between baseline to week 8 for each participant, regardless of whether the participant completed the study treatments.|1
10849327|NCT00591318|12015851|FG001|COMPLETED|Overall Study|For our protocol, participants in both treatment arms were considered completers if they completed at least 6 weeks. At the 6 week point, if response on PANS was not sufficient (15% or greater), they were considered unlikely to respond and therefore were not given the option of the 2 additional weeks of ceftriaxone or placebo. For the analysis, we used the last observed rating between baseline to week 8 for each participant regardless of whether the participant completed the study treatments..|5
10849328|NCT00591318|12015850|FG000|NOT COMPLETED|Overall Study||4
10849329|NCT00591318|12015851|FG001|NOT COMPLETED|Overall Study||0
10849330|NCT00321100|12015863|FG000|STARTED|Overall Study||12
10849331|NCT00321100|12015864|FG001|STARTED|Overall Study||11
10849332|NCT00321100|12015863|FG000|COMPLETED|Overall Study||12
10849333|NCT00321100|12015864|FG001|COMPLETED|Overall Study||11
10849334|NCT00321100|12015863|FG000|NOT COMPLETED|Overall Study||0
10849335|NCT00321100|12015864|FG001|NOT COMPLETED|Overall Study||0
10849336|NCT04534517|12015872|FG000|STARTED|Overall Study||114
10849337|NCT04534517|12015872|FG000|COMPLETED|Overall Study||110
10849338|NCT04534517|12015872|FG000|NOT COMPLETED|Overall Study||4
10849339|NCT04494646|12015878|FG000|STARTED|Overall Study||21
10849340|NCT04494646|12015879|FG001|STARTED|Overall Study||19
10849341|NCT04494646|12015878|FG000|COMPLETED|Overall Study||21
10849342|NCT04494646|12015879|FG001|COMPLETED|Overall Study||17
10849343|NCT04494646|12015878|FG000|NOT COMPLETED|Overall Study||0
10849344|NCT04494646|12015879|FG001|NOT COMPLETED|Overall Study||2
10413667|NCT00779584|11557942|FG008|Treated|Overall Study||2
10413668|NCT00779584|11557934|FG000|COMPLETED|Overall Study||0
10413669|NCT00779584|11557935|FG001|COMPLETED|Overall Study||0
10413670|NCT00779584|11557936|FG002|COMPLETED|Overall Study||0
10413671|NCT00779584|11557937|FG003|COMPLETED|Overall Study||0
10413672|NCT00779584|11557938|FG004|COMPLETED|Overall Study||0
10413673|NCT00779584|11557939|FG005|COMPLETED|Overall Study||0
10413674|NCT00779584|11557940|FG006|COMPLETED|Overall Study||0
10413675|NCT00779584|11557941|FG007|COMPLETED|Overall Study||0
10413676|NCT00779584|11557942|FG008|COMPLETED|Overall Study||0
10413677|NCT00779584|11557934|FG000|NOT COMPLETED|Overall Study||3
10413678|NCT00779584|11557935|FG001|NOT COMPLETED|Overall Study||3
10413679|NCT00779584|11557936|FG002|NOT COMPLETED|Overall Study||7
10413680|NCT00779584|11557937|FG003|NOT COMPLETED|Overall Study||6
10413681|NCT00779584|11557938|FG004|NOT COMPLETED|Overall Study||7
10413682|NCT00779584|11557939|FG005|NOT COMPLETED|Overall Study||6
10413683|NCT00779584|11557940|FG006|NOT COMPLETED|Overall Study||8
10413684|NCT00779584|11557941|FG007|NOT COMPLETED|Overall Study||3
10413685|NCT00779584|11557942|FG008|NOT COMPLETED|Overall Study||2
10413686|NCT00779675|11557962|FG000|STARTED|Treatment Period|One of the 660 participants did not receive study treatment.|660
10413687|NCT00779675|11557962|FG000|COMPLETED|Treatment Period||328
10413688|NCT00779675|11557962|FG000|NOT COMPLETED|Treatment Period||332
10413689|NCT00779675|11557962|FG000|STARTED|Extended Treatment Period|Clinical responders during the treatment period could enter the extended treatment period.|193
10413690|NCT00779675|11557962|FG000|COMPLETED|Extended Treatment Period||147
10413691|NCT00779675|11557962|FG000|NOT COMPLETED|Extended Treatment Period||46
10429236|NCT00862849|11575290|FG004|STARTED|Intervention 5||4
10429237|NCT00862849|11575291|FG005|STARTED|Intervention 5||3
10429238|NCT00862849|11575286|FG000|COMPLETED|Intervention 5||3
10429239|NCT00862849|11575287|FG001|COMPLETED|Intervention 5||3
10429240|NCT00862849|11575288|FG002|COMPLETED|Intervention 5||3
10429241|NCT00862849|11575289|FG003|COMPLETED|Intervention 5||4
10429242|NCT00862849|11575290|FG004|COMPLETED|Intervention 5||4
10429243|NCT00862849|11575291|FG005|COMPLETED|Intervention 5||3
10429244|NCT00862849|11575286|FG000|NOT COMPLETED|Intervention 5||0
10429245|NCT00862849|11575287|FG001|NOT COMPLETED|Intervention 5||0
10429246|NCT00862849|11575288|FG002|NOT COMPLETED|Intervention 5||0
10429247|NCT00862849|11575289|FG003|NOT COMPLETED|Intervention 5||0
10429248|NCT00862849|11575290|FG004|NOT COMPLETED|Intervention 5||0
10429249|NCT00862849|11575291|FG005|NOT COMPLETED|Intervention 5||0
10429250|NCT00862849|11575286|FG000|STARTED|Washout 5 (3 to 14 Days)||3
10429251|NCT00862849|11575287|FG001|STARTED|Washout 5 (3 to 14 Days)||3
10429252|NCT00862849|11575288|FG002|STARTED|Washout 5 (3 to 14 Days)||3
10429253|NCT00862849|11575289|FG003|STARTED|Washout 5 (3 to 14 Days)||4
10429254|NCT00862849|11575290|FG004|STARTED|Washout 5 (3 to 14 Days)||4
10429255|NCT00862849|11575291|FG005|STARTED|Washout 5 (3 to 14 Days)||3
10429256|NCT00862849|11575286|FG000|COMPLETED|Washout 5 (3 to 14 Days)||3
10429257|NCT00862849|11575287|FG001|COMPLETED|Washout 5 (3 to 14 Days)||3
10429258|NCT00862849|11575288|FG002|COMPLETED|Washout 5 (3 to 14 Days)||3
10429259|NCT00862849|11575289|FG003|COMPLETED|Washout 5 (3 to 14 Days)||4
10429260|NCT00862849|11575290|FG004|COMPLETED|Washout 5 (3 to 14 Days)||4
10429261|NCT00862849|11575291|FG005|COMPLETED|Washout 5 (3 to 14 Days)||3
10429262|NCT00862849|11575286|FG000|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
10429263|NCT00862849|11575287|FG001|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
10429264|NCT00862849|11575288|FG002|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
10429265|NCT00862849|11575289|FG003|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
10429266|NCT00862849|11575290|FG004|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
10849345|NCT04258020|12015887|FG000|STARTED|Overall Study||4
10849346|NCT04258020|12015888|FG001|STARTED|Overall Study||0
10849347|NCT04258020|12015887|FG000|COMPLETED|Overall Study||3
10849348|NCT04258020|12015888|FG001|COMPLETED|Overall Study||0
10849349|NCT04258020|12015887|FG000|NOT COMPLETED|Overall Study||1
10849350|NCT04258020|12015888|FG001|NOT COMPLETED|Overall Study||0
10849351|NCT04234464|12015896|FG000|STARTED|Period 1 (First Treatment Intervention)||29
10849352|NCT04234464|12015897|FG001|STARTED|Period 1 (First Treatment Intervention)||31
10849353|NCT04234464|12015896|FG000|COMPLETED|Period 1 (First Treatment Intervention)||29
10849354|NCT04234464|12015897|FG001|COMPLETED|Period 1 (First Treatment Intervention)||31
10849355|NCT04234464|12015896|FG000|NOT COMPLETED|Period 1 (First Treatment Intervention)||0
10849356|NCT04234464|12015897|FG001|NOT COMPLETED|Period 1 (First Treatment Intervention)||0
10849357|NCT04234464|12015896|FG000|STARTED|Period 2 (Second Treatment Intervention)||29
10849358|NCT04234464|12015897|FG001|STARTED|Period 2 (Second Treatment Intervention)||31
10849359|NCT04234464|12015896|FG000|COMPLETED|Period 2 (Second Treatment Intervention)||28
10849360|NCT04234464|12015897|FG001|COMPLETED|Period 2 (Second Treatment Intervention)||31
10849361|NCT04234464|12015896|FG000|NOT COMPLETED|Period 2 (Second Treatment Intervention)||1
10849362|NCT04234464|12015897|FG001|NOT COMPLETED|Period 2 (Second Treatment Intervention)||0
10849363|NCT03852316|12015903|FG000|STARTED|Overall Study||1585
10849364|NCT03852316|12015903|FG000|COMPLETED|Overall Study||1581
10849365|NCT03852316|12015903|FG000|NOT COMPLETED|Overall Study||4
10849366|NCT03789318|12015912|FG000|STARTED|Overall Study||9
10849367|NCT03789318|12015913|FG001|STARTED|Overall Study||9
10849368|NCT03789318|12015914|FG002|STARTED|Overall Study||12
10849369|NCT03789318|12015915|FG003|STARTED|Overall Study||12
10849370|NCT03789318|12015916|FG004|STARTED|Overall Study||12
10849371|NCT03789318|12015912|FG000|COMPLETED|Overall Study||9
10849372|NCT03789318|12015913|FG001|COMPLETED|Overall Study||9
10849373|NCT03789318|12015914|FG002|COMPLETED|Overall Study||9
10849374|NCT03789318|12015915|FG003|COMPLETED|Overall Study||11
10849375|NCT03789318|12015916|FG004|COMPLETED|Overall Study||12
10849376|NCT03789318|12015912|FG000|NOT COMPLETED|Overall Study||0
10849377|NCT03789318|12015913|FG001|NOT COMPLETED|Overall Study||0
10849378|NCT03789318|12015914|FG002|NOT COMPLETED|Overall Study||3
10849379|NCT03789318|12015915|FG003|NOT COMPLETED|Overall Study||1
10413692|NCT00779701|11557970|FG000|STARTED|Overall Study||27
10413693|NCT00779701|11557970|FG000|COMPLETED|Overall Study||27
10413694|NCT00779701|11557970|FG000|NOT COMPLETED|Overall Study||0
10413695|NCT00779766|11557976|FG000|STARTED|Month 24||3026
10413696|NCT00779766|11557977|FG001|STARTED|Month 24||3025
10413697|NCT00779766|11557976|FG000|COMPLETED|Month 24||2694
10413698|NCT00779766|11557977|FG001|COMPLETED|Month 24||2693
10413699|NCT00779766|11557976|FG000|NOT COMPLETED|Month 24||332
10413700|NCT00779766|11557977|FG001|NOT COMPLETED|Month 24||332
10413701|NCT00779766|11557976|FG000|STARTED|Month 48||2703
10413702|NCT00779766|11557977|FG001|STARTED|Month 48||2727
10413703|NCT00779766|11557976|FG000|COMPLETED|Month 48||2529
10413704|NCT00779766|11557977|FG001|COMPLETED|Month 48||2559
10413705|NCT00779766|11557976|FG000|NOT COMPLETED|Month 48||174
10413706|NCT00779766|11557977|FG001|NOT COMPLETED|Month 48||168
10413707|NCT00779766|11557976|FG000|STARTED|Month 72||2319
10413708|NCT00779766|11557977|FG001|STARTED|Month 72||2347
10413709|NCT00779766|11557976|FG000|COMPLETED|Month 72||2134
10413710|NCT00779766|11557977|FG001|COMPLETED|Month 72||2158
10413711|NCT00779766|11557976|FG000|NOT COMPLETED|Month 72||185
10413712|NCT00779766|11557977|FG001|NOT COMPLETED|Month 72||189
10413713|NCT00779779|11557984|FG000|STARTED|Overall Study||522
10413714|NCT00779779|11557984|FG000|COMPLETED|Overall Study||498
10413715|NCT00779779|11557984|FG000|NOT COMPLETED|Overall Study||24
10413716|NCT00779857|11557988|FG000|STARTED|Overall Study|70 patients treated|70
10413717|NCT00779857|11557988|FG000|30 Day Post Procedure|Overall Study|2 missed Visit|68
10413718|NCT00779857|11557988|FG000|3 Month Post Procedure|Overall Study|3 month follow-up, 65 of the subjects were available for evaluation.|65
10413719|NCT00779857|11557988|FG000|COMPLETED|Overall Study|12 Month Post procedure, 64 subjects available for evaluation|64
10413720|NCT00779857|11557988|FG000|NOT COMPLETED|Overall Study||6
10413721|NCT00779870|11557995|FG000|STARTED|Overall Study||5
10413722|NCT00779870|11557996|FG001|STARTED|Overall Study||6
10413723|NCT00779870|11557997|FG002|STARTED|Overall Study||7
10413724|NCT00779870|11557995|FG000|COMPLETED|Overall Study||5
10413725|NCT00779870|11557996|FG001|COMPLETED|Overall Study||6
10413726|NCT00779870|11557997|FG002|COMPLETED|Overall Study||7
10413727|NCT00779870|11557995|FG000|NOT COMPLETED|Overall Study||0
10413728|NCT00779870|11557996|FG001|NOT COMPLETED|Overall Study||0
10849380|NCT03789318|12015916|FG004|NOT COMPLETED|Overall Study||0
10413729|NCT00779870|11557997|FG002|NOT COMPLETED|Overall Study||0
10413730|NCT00779909|11558009|FG000|STARTED|Overall Study||10
10413731|NCT00779909|11558010|FG001|STARTED|Overall Study||9
10413732|NCT00779909|11558011|FG002|STARTED|Overall Study||8
10413733|NCT00779909|11558012|FG003|STARTED|Overall Study||8
10413734|NCT00779909|11558009|FG000|COMPLETED|Overall Study||9
10413735|NCT00779909|11558010|FG001|COMPLETED|Overall Study||8
10413736|NCT00779909|11558011|FG002|COMPLETED|Overall Study||8
10413737|NCT00779909|11558012|FG003|COMPLETED|Overall Study||7
10413738|NCT00779909|11558009|FG000|NOT COMPLETED|Overall Study||1
10413739|NCT00779909|11558010|FG001|NOT COMPLETED|Overall Study||1
10413740|NCT00779909|11558011|FG002|NOT COMPLETED|Overall Study||0
10849389|NCT03613662|12015937|FG000|STARTED|Overall Study||19
10849390|NCT03613662|12015937|FG000|COMPLETED|Overall Study||19
10849391|NCT03613662|12015937|FG000|NOT COMPLETED|Overall Study||0
10849392|NCT03232736|12015943|FG000|STARTED|Overall Study||9
10849393|NCT03232736|12015944|FG001|STARTED|Overall Study||13
10849394|NCT03232736|12015943|FG000|COMPLETED|Overall Study||9
10849395|NCT03232736|12015944|FG001|COMPLETED|Overall Study||13
10849396|NCT03232736|12015943|FG000|NOT COMPLETED|Overall Study||0
10849397|NCT03232736|12015944|FG001|NOT COMPLETED|Overall Study||0
10849398|NCT03208530|12015954|FG000|STARTED|Overall Study||75
10849399|NCT03208530|12015954|FG000|COMPLETED|Overall Study||48
10849400|NCT03208530|12015954|FG000|NOT COMPLETED|Overall Study||27
10849409|NCT03103321|12015971|FG000|STARTED|Overall Study||25
10849410|NCT03103321|12015972|FG001|STARTED|Overall Study||39
10849411|NCT03103321|12015973|FG002|STARTED|Overall Study||44
10849412|NCT03103321|12015974|FG003|STARTED|Overall Study||50
10849413|NCT03103321|12015971|FG000|COMPLETED|Overall Study||24
10849414|NCT03103321|12015972|FG001|COMPLETED|Overall Study||38
10849415|NCT03103321|12015973|FG002|COMPLETED|Overall Study||43
10849416|NCT03103321|12015974|FG003|COMPLETED|Overall Study||50
10849417|NCT03103321|12015971|FG000|NOT COMPLETED|Overall Study||1
10849418|NCT03103321|12015972|FG001|NOT COMPLETED|Overall Study||1
10849419|NCT03103321|12015973|FG002|NOT COMPLETED|Overall Study||1
10849420|NCT03103321|12015974|FG003|NOT COMPLETED|Overall Study||0
10849421|NCT03079869|12015986|FG000|STARTED|Overall Study||28
10849422|NCT03079869|12015987|FG001|STARTED|Overall Study||27
10849423|NCT03079869|12015986|FG000|COMPLETED|Overall Study||15
10849424|NCT03079869|12015987|FG001|COMPLETED|Overall Study||16
10849425|NCT03079869|12015986|FG000|NOT COMPLETED|Overall Study||13
10849426|NCT03079869|12015987|FG001|NOT COMPLETED|Overall Study||11
10849427|NCT03033875|12015996|FG000|STARTED|Overall Study||96
10849428|NCT03033875|12015997|FG001|STARTED|Overall Study||111
10849429|NCT03033875|12015998|FG002|STARTED|Overall Study||54
10849430|NCT03033875|12015996|FG000|Completed Month 3 Assessment|Overall Study||71
10849431|NCT03033875|12015997|FG001|Completed Month 3 Assessment|Overall Study||83
10849432|NCT03033875|12015998|FG002|Completed Month 3 Assessment|Overall Study||43
10849433|NCT03033875|12015996|FG000|Completed Month 6 Assessment|Overall Study||73
10849434|NCT03033875|12015997|FG001|Completed Month 6 Assessment|Overall Study||81
10849435|NCT03033875|12015998|FG002|Completed Month 6 Assessment|Overall Study||46
10849436|NCT03033875|12015996|FG000|COMPLETED|Overall Study||77
10849437|NCT03033875|12015997|FG001|COMPLETED|Overall Study||87
10849438|NCT03033875|12015998|FG002|COMPLETED|Overall Study||42
10849439|NCT03033875|12015996|FG000|NOT COMPLETED|Overall Study||19
10849440|NCT03033875|12015997|FG001|NOT COMPLETED|Overall Study||24
10849441|NCT03033875|12015998|FG002|NOT COMPLETED|Overall Study||12
10849442|NCT02935595|12016006|FG000|STARTED|Overall Study||5
10849443|NCT02935595|12016006|FG000|COMPLETED|Overall Study||4
10849444|NCT02935595|12016006|FG000|NOT COMPLETED|Overall Study||1
10849445|NCT02887248|12016010|FG000|STARTED|Overall Study||3
10849446|NCT02887248|12016010|FG000|COMPLETED|Overall Study||0
10849447|NCT02887248|12016010|FG000|NOT COMPLETED|Overall Study||3
10849448|NCT02849990|12016014|FG000|STARTED|Overall Study||22
10849449|NCT02849990|12016014|FG000|COMPLETED|Overall Study||20
10849450|NCT02849990|12016014|FG000|NOT COMPLETED|Overall Study||2
10849451|NCT02673151|12016018|FG000|STARTED|Overall Study||61
10849452|NCT02673151|12016018|FG000|COMPLETED|Overall Study||61
10849453|NCT02673151|12016018|FG000|NOT COMPLETED|Overall Study||0
10849454|NCT02523274|12016030|FG000|STARTED|Overall Study||20
10849455|NCT02523274|12016031|FG001|STARTED|Overall Study||20
10849456|NCT02523274|12016032|FG002|STARTED|Overall Study||20
10849457|NCT02523274|12016030|FG000|COMPLETED|Overall Study||19
10849458|NCT02523274|12016031|FG001|COMPLETED|Overall Study||18
10849459|NCT02523274|12016032|FG002|COMPLETED|Overall Study||18
10849460|NCT02523274|12016030|FG000|NOT COMPLETED|Overall Study||1
10849461|NCT02523274|12016031|FG001|NOT COMPLETED|Overall Study||2
10849462|NCT02523274|12016032|FG002|NOT COMPLETED|Overall Study||2
10849463|NCT02467270|12016047|FG000|STARTED|Overall Study||94
10849464|NCT02467270|12016048|FG001|STARTED|Overall Study||95
10849465|NCT02467270|12016049|FG002|STARTED|Overall Study||94
10849466|NCT02467270|12016047|FG000|Treated (Safety Population)|Overall Study||94
10849467|NCT02467270|12016048|FG001|Treated (Safety Population)|Overall Study||94
10849468|NCT02467270|12016049|FG002|Treated (Safety Population)|Overall Study||94
10849469|NCT02467270|12016047|FG000|COMPLETED|Overall Study||0
10849470|NCT02467270|12016048|FG001|COMPLETED|Overall Study||0
10849471|NCT02467270|12016049|FG002|COMPLETED|Overall Study||0
10849472|NCT02467270|12016047|FG000|NOT COMPLETED|Overall Study||94
10849473|NCT02467270|12016048|FG001|NOT COMPLETED|Overall Study||95
10849474|NCT02467270|12016049|FG002|NOT COMPLETED|Overall Study||94
10849475|NCT02452554|12016063|FG000|STARTED|Overall Study||17
10849476|NCT02452554|12016064|FG001|STARTED|Overall Study||17
10849477|NCT02452554|12016065|FG002|STARTED|Overall Study||12
10849478|NCT02452554|12016066|FG003|STARTED|Overall Study||1
10849479|NCT02452554|12016067|FG004|STARTED|Overall Study||5
10849480|NCT02452554|12016068|FG005|STARTED|Overall Study||10
10849481|NCT02452554|12016063|FG000|COMPLETED|Overall Study||0
10849482|NCT02452554|12016064|FG001|COMPLETED|Overall Study||0
10849483|NCT02452554|12016065|FG002|COMPLETED|Overall Study||1
10849484|NCT02452554|12016066|FG003|COMPLETED|Overall Study||0
10849485|NCT02452554|12016067|FG004|COMPLETED|Overall Study||0
10849486|NCT02452554|12016068|FG005|COMPLETED|Overall Study||1
10849487|NCT02452554|12016063|FG000|NOT COMPLETED|Overall Study||17
10849488|NCT02452554|12016064|FG001|NOT COMPLETED|Overall Study||17
10849489|NCT02452554|12016065|FG002|NOT COMPLETED|Overall Study||11
10849490|NCT02452554|12016066|FG003|NOT COMPLETED|Overall Study||1
10849491|NCT02452554|12016067|FG004|NOT COMPLETED|Overall Study||5
10849492|NCT02452554|12016068|FG005|NOT COMPLETED|Overall Study||9
10849493|NCT02318277|12016091|FG000|STARTED|Overall Study||6
10849494|NCT02318277|12016092|FG001|STARTED|Overall Study||3
10849495|NCT02318277|12016093|FG002|STARTED|Overall Study||4
10849496|NCT02318277|12016094|FG003|STARTED|Overall Study||4
10849497|NCT02318277|12016095|FG004|STARTED|Overall Study||8
10849498|NCT02318277|12016096|FG005|STARTED|Overall Study||9
10849499|NCT02318277|12016097|FG006|STARTED|Overall Study||49
10849500|NCT02318277|12016098|FG007|STARTED|Overall Study||93
10849501|NCT02318277|12016091|FG000|COMPLETED|Overall Study||0
10849502|NCT02318277|12016092|FG001|COMPLETED|Overall Study||0
10849503|NCT02318277|12016093|FG002|COMPLETED|Overall Study||0
10849504|NCT02318277|12016094|FG003|COMPLETED|Overall Study||0
10849505|NCT02318277|12016095|FG004|COMPLETED|Overall Study||0
10849506|NCT02318277|12016096|FG005|COMPLETED|Overall Study||0
10849507|NCT02318277|12016097|FG006|COMPLETED|Overall Study||0
10849508|NCT02318277|12016098|FG007|COMPLETED|Overall Study||0
10849509|NCT02318277|12016091|FG000|NOT COMPLETED|Overall Study||6
10849510|NCT02318277|12016092|FG001|NOT COMPLETED|Overall Study||3
10849511|NCT02318277|12016093|FG002|NOT COMPLETED|Overall Study||4
10849512|NCT02318277|12016094|FG003|NOT COMPLETED|Overall Study||4
10849513|NCT02318277|12016095|FG004|NOT COMPLETED|Overall Study||8
10849514|NCT02318277|12016096|FG005|NOT COMPLETED|Overall Study||9
10849515|NCT02318277|12016097|FG006|NOT COMPLETED|Overall Study||49
10849516|NCT02318277|12016098|FG007|NOT COMPLETED|Overall Study||93
10849517|NCT02296801|12016134|FG000|STARTED|Overall Study||103
10849518|NCT02296801|12016135|FG001|STARTED|Overall Study||68
10849519|NCT02296801|12016136|FG002|STARTED|Overall Study||69
10849520|NCT02296801|12016137|FG003|STARTED|Overall Study||67
10849521|NCT02296801|12016134|FG000|COMPLETED|Overall Study||83
10849522|NCT02296801|12016135|FG001|COMPLETED|Overall Study||53
10849523|NCT02296801|12016136|FG002|COMPLETED|Overall Study||50
10849524|NCT02296801|12016137|FG003|COMPLETED|Overall Study||58
10849525|NCT02296801|12016134|FG000|NOT COMPLETED|Overall Study||20
10849526|NCT02296801|12016135|FG001|NOT COMPLETED|Overall Study||15
10849527|NCT02296801|12016136|FG002|NOT COMPLETED|Overall Study||19
10849528|NCT02296801|12016137|FG003|NOT COMPLETED|Overall Study||9
10849529|NCT02143063|12016154|FG000|STARTED|Overall Study||61
10849530|NCT02143063|12016155|FG001|STARTED|Overall Study||105
10849531|NCT02143063|12016156|FG002|STARTED|Overall Study||108
10849532|NCT02143063|12016154|FG000|COMPLETED|Overall Study||45
10849533|NCT02143063|12016155|FG001|COMPLETED|Overall Study||75
10849534|NCT02143063|12016156|FG002|COMPLETED|Overall Study||78
10849535|NCT02143063|12016154|FG000|NOT COMPLETED|Overall Study||16
10849536|NCT02143063|12016155|FG001|NOT COMPLETED|Overall Study||30
10849537|NCT02143063|12016156|FG002|NOT COMPLETED|Overall Study||30
10849538|NCT02017964|12016164|FG000|STARTED|Overall Study||26
10849539|NCT02017964|12016164|FG000|COMPLETED|Overall Study||25
10849540|NCT02017964|12016164|FG000|NOT COMPLETED|Overall Study||1
10849541|NCT01968785|12016170|FG000|STARTED|Overall Study||2
10849542|NCT01968785|12016171|FG001|STARTED|Overall Study||0
10849543|NCT01968785|12016170|FG000|COMPLETED|Overall Study||1
10849544|NCT01968785|12016171|FG001|COMPLETED|Overall Study||0
10849545|NCT01968785|12016170|FG000|NOT COMPLETED|Overall Study||1
10849546|NCT01968785|12016171|FG001|NOT COMPLETED|Overall Study||0
10849547|NCT01956110|12016179|FG000|STARTED|Overall Study||665
10849548|NCT01956110|12016180|FG001|STARTED|Overall Study||661
10849549|NCT01956110|12016179|FG000|COMPLETED|Overall Study||630
10849550|NCT01956110|12016180|FG001|COMPLETED|Overall Study||639
10849551|NCT01956110|12016179|FG000|NOT COMPLETED|Overall Study||35
10849552|NCT01956110|12016180|FG001|NOT COMPLETED|Overall Study||22
10849553|NCT01648023|12016189|FG000|STARTED|Overall Study||25
10849554|NCT01648023|12016190|FG001|STARTED|Overall Study||24
10849555|NCT01648023|12016189|FG000|COMPLETED|Overall Study||24
10849556|NCT01648023|12016190|FG001|COMPLETED|Overall Study||22
10849557|NCT01648023|12016189|FG000|NOT COMPLETED|Overall Study||1
10849558|NCT01648023|12016190|FG001|NOT COMPLETED|Overall Study||2
10849559|NCT01335581|12016198|FG000|STARTED|Overall Study||9
10849560|NCT01335581|12016199|FG001|STARTED|Overall Study||9
10849561|NCT01335581|12016198|FG000|COMPLETED|Overall Study||5
10849562|NCT01335581|12016199|FG001|COMPLETED|Overall Study||3
10849563|NCT01335581|12016198|FG000|NOT COMPLETED|Overall Study||4
10849564|NCT01335581|12016199|FG001|NOT COMPLETED|Overall Study||6
10849565|NCT01209923|12016205|FG000|STARTED|Overall Study||362
10849566|NCT01209923|12016205|FG000|COMPLETED|Overall Study||362
10849567|NCT01209923|12016205|FG000|NOT COMPLETED|Overall Study||0
10849568|NCT01083433|12016213|FG000|STARTED|Overall Study||22
10849569|NCT01083433|12016214|FG001|STARTED|Overall Study||23
10849570|NCT01083433|12016215|FG002|STARTED|Overall Study||23
10849571|NCT01083433|12016213|FG000|COMPLETED|Overall Study||20
10849572|NCT01083433|12016214|FG001|COMPLETED|Overall Study||17
10849573|NCT01083433|12016215|FG002|COMPLETED|Overall Study||18
10849574|NCT01083433|12016213|FG000|NOT COMPLETED|Overall Study||2
10849575|NCT01083433|12016214|FG001|NOT COMPLETED|Overall Study||6
10849576|NCT01083433|12016215|FG002|NOT COMPLETED|Overall Study||5
10849577|NCT00787176|12016231|FG000|STARTED|Overall Study||69
10849578|NCT00787176|12016232|FG001|STARTED|Overall Study||62
10849579|NCT00787176|12016233|FG002|STARTED|Overall Study||60
10849580|NCT00787176|12016234|FG003|STARTED|Overall Study||60
10849581|NCT00787176|12016231|FG000|COMPLETED|Overall Study||62
10849582|NCT00787176|12016232|FG001|COMPLETED|Overall Study||59
10849583|NCT00787176|12016233|FG002|COMPLETED|Overall Study||54
10849584|NCT00787176|12016234|FG003|COMPLETED|Overall Study||55
10849585|NCT00787176|12016231|FG000|NOT COMPLETED|Overall Study||7
10849586|NCT00787176|12016232|FG001|NOT COMPLETED|Overall Study||3
10849587|NCT00787176|12016233|FG002|NOT COMPLETED|Overall Study||6
10849588|NCT00787176|12016234|FG003|NOT COMPLETED|Overall Study||5
10849589|NCT00352534|12016247|FG000|STARTED|Initial Staging||211
10849590|NCT00352534|12016248|FG001|STARTED|Initial Staging||597
10849591|NCT00352534|12016249|FG002|STARTED|Initial Staging||0
10849592|NCT00352534|12016250|FG003|STARTED|Initial Staging||0
10413741|NCT00779909|11558012|FG003|NOT COMPLETED|Overall Study||1
10413742|NCT00780026|11558031|FG000|STARTED|Overall Study||50
10413743|NCT00780026|11558032|FG001|STARTED|Overall Study||50
10413744|NCT00780026|11558031|FG000|COMPLETED|Overall Study||50
10413745|NCT00780026|11558032|FG001|COMPLETED|Overall Study||50
10413746|NCT00780026|11558031|FG000|NOT COMPLETED|Overall Study||0
10413747|NCT00780026|11558032|FG001|NOT COMPLETED|Overall Study||0
10413748|NCT00780143|11558038|FG000|STARTED|Overall Study||3
10413749|NCT00780143|11558038|FG000|COMPLETED|Overall Study||0
10413750|NCT00780143|11558038|FG000|NOT COMPLETED|Overall Study||3
10413751|NCT00780208|11558042|FG000|STARTED|Overall Study||14
10413752|NCT00780208|11558042|FG000|COMPLETED|Overall Study||8
10413753|NCT00780208|11558042|FG000|NOT COMPLETED|Overall Study||6
10413754|NCT00780234|11558048|FG000|STARTED|Overall Study||47
10413755|NCT00780234|11558049|FG001|STARTED|Overall Study||45
10413756|NCT00780234|11558048|FG000|COMPLETED|Overall Study||39
10413757|NCT00780234|11558049|FG001|COMPLETED|Overall Study||37
10413758|NCT00780234|11558048|FG000|NOT COMPLETED|Overall Study||8
10413759|NCT00780234|11558049|FG001|NOT COMPLETED|Overall Study||8
10413760|NCT00780273|11558055|FG000|STARTED|Overall Study||19
10413761|NCT00780273|11558055|FG000|COMPLETED|Overall Study||17
10413762|NCT00780273|11558055|FG000|NOT COMPLETED|Overall Study||2
10413763|NCT00780338|11558062|FG000|STARTED|Baseline to Mid (1 Year)||174
10413764|NCT00780338|11558063|FG001|STARTED|Baseline to Mid (1 Year)||202
10413765|NCT00780338|11558062|FG000|COMPLETED|Baseline to Mid (1 Year)||169
10413766|NCT00780338|11558063|FG001|COMPLETED|Baseline to Mid (1 Year)||164
10413767|NCT00780338|11558062|FG000|NOT COMPLETED|Baseline to Mid (1 Year)||5
10413768|NCT00780338|11558063|FG001|NOT COMPLETED|Baseline to Mid (1 Year)||38
10413769|NCT00780338|11558062|FG000|STARTED|Mid to Post (1 Year; 2 Years in Total)||169
10413770|NCT00780338|11558063|FG001|STARTED|Mid to Post (1 Year; 2 Years in Total)||164
10413771|NCT00780338|11558062|FG000|COMPLETED|Mid to Post (1 Year; 2 Years in Total)||156
10413772|NCT00780338|11558063|FG001|COMPLETED|Mid to Post (1 Year; 2 Years in Total)||159
10413773|NCT00780338|11558062|FG000|NOT COMPLETED|Mid to Post (1 Year; 2 Years in Total)||13
10413774|NCT00780338|11558063|FG001|NOT COMPLETED|Mid to Post (1 Year; 2 Years in Total)||5
10413775|NCT00780416|11558075|FG000|STARTED|Overall Study||126
10413776|NCT00780416|11558076|FG001|STARTED|Overall Study||63
10413777|NCT00780416|11558075|FG000|COMPLETED|Overall Study||114
10754759|NCT03055195|11918561|FG001|COMPLETED|Overall Study||4
10754760|NCT03055195|11918560|FG000|NOT COMPLETED|Overall Study||12
10754761|NCT03055195|11918561|FG001|NOT COMPLETED|Overall Study||14
10754762|NCT03055221|11918567|FG000|STARTED|Overall Study||16
10754763|NCT03055221|11918567|FG000|COMPLETED|Overall Study||0
10754764|NCT03055221|11918567|FG000|NOT COMPLETED|Overall Study||16
10754765|NCT03055260|11918573|FG000|STARTED|Overall Study||8
10754766|NCT03055260|11918574|FG001|STARTED|Overall Study||0
10754767|NCT03055260|11918573|FG000|COMPLETED|Overall Study||7
10754768|NCT03055260|11918574|FG001|COMPLETED|Overall Study||0
10754769|NCT03055260|11918573|FG000|NOT COMPLETED|Overall Study||1
10754770|NCT03055260|11918574|FG001|NOT COMPLETED|Overall Study||0
10754771|NCT03055338|11918583|FG000|STARTED|Overall Study||90
10754772|NCT03055338|11918584|FG001|STARTED|Overall Study||45
10754773|NCT03055338|11918585|FG002|STARTED|Overall Study||89
10754774|NCT03055338|11918583|FG000|COMPLETED|Overall Study||72
10754775|NCT03055338|11918584|FG001|COMPLETED|Overall Study||34
10754776|NCT03055338|11918585|FG002|COMPLETED|Overall Study||77
10754777|NCT03055338|11918583|FG000|NOT COMPLETED|Overall Study||18
10754778|NCT03055338|11918584|FG001|NOT COMPLETED|Overall Study||11
10754779|NCT03055338|11918585|FG002|NOT COMPLETED|Overall Study||12
10754780|NCT03055494|11918595|FG000|STARTED|Overall Study||54
10754781|NCT03055494|11918596|FG001|STARTED|Overall Study||28
10754782|NCT03055494|11918595|FG000|COMPLETED|Overall Study||44
10754783|NCT03055494|11918596|FG001|COMPLETED|Overall Study||27
10754784|NCT03055494|11918595|FG000|NOT COMPLETED|Overall Study||10
10754785|NCT03055494|11918596|FG001|NOT COMPLETED|Overall Study||1
10413778|NCT00780416|11558076|FG001|COMPLETED|Overall Study||54
10413779|NCT00780416|11558075|FG000|NOT COMPLETED|Overall Study||12
10413780|NCT00780416|11558076|FG001|NOT COMPLETED|Overall Study||9
10754786|NCT03055624|11918603|FG000|STARTED|Overall Study||9
10849593|NCT00352534|12016251|FG004|STARTED|Initial Staging||0
10754787|NCT03055624|11918603|FG000|COMPLETED|Overall Study||0
10754788|NCT03055624|11918603|FG000|NOT COMPLETED|Overall Study||9
10754789|NCT03055650|11918607|FG000|STARTED|Overall Study||30
10849594|NCT00352534|12016252|FG005|STARTED|Initial Staging||0
10849595|NCT00352534|12016253|FG006|STARTED|Initial Staging||0
10849596|NCT00352534|12016247|FG000|COMPLETED|Initial Staging||203
10849597|NCT00352534|12016248|FG001|COMPLETED|Initial Staging||588
10849598|NCT00352534|12016249|FG002|COMPLETED|Initial Staging||0
10849599|NCT00352534|12016250|FG003|COMPLETED|Initial Staging||0
10849600|NCT00352534|12016251|FG004|COMPLETED|Initial Staging||0
10292837|NCT01927068|11425666|FG001|NOT COMPLETED|Overall Study||8
10292838|NCT01883817|11425675|FG000|STARTED|Overall Study||14
10292839|NCT01883817|11425676|FG001|STARTED|Overall Study||16
10292840|NCT01883817|11425675|FG000|COMPLETED|Overall Study||10
10292841|NCT01883817|11425676|FG001|COMPLETED|Overall Study||9
10292842|NCT01883817|11425675|FG000|NOT COMPLETED|Overall Study||4
10292843|NCT01883817|11425676|FG001|NOT COMPLETED|Overall Study||7
10292844|NCT01813435|11425684|FG000|STARTED|Overall Study|12 participants withdrew consent or objected to use further use of data|7980
10292845|NCT01813435|11425685|FG001|STARTED|Overall Study|11 participants withdrew consent or objected to use further use of data|7988
10292846|NCT01813435|11425684|FG000|COMPLETED|Overall Study||5810
10292847|NCT01813435|11425685|FG001|COMPLETED|Overall Study||6981
10292848|NCT01813435|11425684|FG000|NOT COMPLETED|Overall Study||2170
10292849|NCT01813435|11425685|FG001|NOT COMPLETED|Overall Study||1007
10292850|NCT01700439|11425691|FG000|STARTED|Overall Study||889
10292851|NCT01700439|11425691|FG000|Study Valve Group|Overall Study|Received the Edwards INTUITY surgical aortic heart valve.|839
10292852|NCT01700439|11425691|FG000|Discharge|Overall Study||831
10292853|NCT01700439|11425691|FG000|3 Month|Overall Study||778
10292854|NCT01700439|11425691|FG000|1 Year|Overall Study||573
10292855|NCT01700439|11425691|FG000|2 Year|Overall Study||215
10292856|NCT01700439|11425691|FG000|COMPLETED|Overall Study||0
10292857|NCT01700439|11425691|FG000|NOT COMPLETED|Overall Study||889
10292858|NCT01690299|11425699|FG000|STARTED|Placebo-controlled Phase (Weeks 0-16)||84
10292859|NCT01690299|11425700|FG001|STARTED|Placebo-controlled Phase (Weeks 0-16)||83
10292860|NCT01690299|11425701|FG002|STARTED|Placebo-controlled Phase (Weeks 0-16)||83
10292861|NCT01690299|11425702|FG003|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
10292862|NCT01690299|11425703|FG004|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
10292863|NCT01690299|11425704|FG005|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
10292864|NCT01690299|11425699|FG000|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|84
10292865|NCT01690299|11425700|FG001|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|83
10292866|NCT01690299|11425701|FG002|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|83
10292867|NCT01690299|11425702|FG003|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
10292868|NCT01690299|11425703|FG004|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
10292869|NCT01690299|11425704|FG005|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
10292870|NCT01690299|11425699|FG000|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||75
10849651|NCT04118348|12016293|FG001|STARTED|Overall Study||3312
10292871|NCT01690299|11425700|FG001|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||77
10292872|NCT01690299|11425701|FG002|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||81
10292873|NCT01690299|11425702|FG003|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
10292874|NCT01690299|11425703|FG004|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
10292875|NCT01690299|11425704|FG005|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
10292876|NCT01690299|11425699|FG000|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||9
10292877|NCT01690299|11425700|FG001|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||6
10292878|NCT01690299|11425701|FG002|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||2
10292879|NCT01690299|11425702|FG003|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
10292880|NCT01690299|11425703|FG004|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
10292881|NCT01690299|11425704|FG005|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
10292882|NCT01690299|11425699|FG000|STARTED|Apremilast Extension Phase (Weeks16-104)||0
10292883|NCT01690299|11425700|FG001|STARTED|Apremilast Extension Phase (Weeks16-104)||0
10292884|NCT01690299|11425701|FG002|STARTED|Apremilast Extension Phase (Weeks16-104)||0
10292885|NCT01690299|11425702|FG003|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|73
10292886|NCT01690299|11425703|FG004|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|74
10292887|NCT01690299|11425704|FG005|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|80
10292888|NCT01690299|11425699|FG000|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
10292889|NCT01690299|11425700|FG001|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
10292890|NCT01690299|11425701|FG002|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
10292891|NCT01690299|11425702|FG003|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|73
10292892|NCT01690299|11425703|FG004|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|74
10292893|NCT01690299|11425704|FG005|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|79
10292894|NCT01690299|11425699|FG000|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
10849601|NCT00352534|12016252|FG005|COMPLETED|Initial Staging||0
10849602|NCT00352534|12016253|FG006|COMPLETED|Initial Staging||0
10849603|NCT00352534|12016247|FG000|NOT COMPLETED|Initial Staging||8
10849604|NCT00352534|12016248|FG001|NOT COMPLETED|Initial Staging||9
10849605|NCT00352534|12016249|FG002|NOT COMPLETED|Initial Staging||0
10849606|NCT00352534|12016250|FG003|NOT COMPLETED|Initial Staging||0
10849607|NCT00352534|12016251|FG004|NOT COMPLETED|Initial Staging||0
10849608|NCT00352534|12016252|FG005|NOT COMPLETED|Initial Staging||0
10849609|NCT00352534|12016253|FG006|NOT COMPLETED|Initial Staging||0
10849610|NCT00352534|12016247|FG000|STARTED|Final Risk Group Assignment||0
10849611|NCT00352534|12016248|FG001|STARTED|Final Risk Group Assignment||0
10849612|NCT00352534|12016249|FG002|STARTED|Final Risk Group Assignment||119
10849613|NCT00352534|12016250|FG003|STARTED|Final Risk Group Assignment||52
10849614|NCT00352534|12016251|FG004|STARTED|Final Risk Group Assignment||32
10849615|NCT00352534|12016252|FG005|STARTED|Final Risk Group Assignment||548
10849616|NCT00352534|12016253|FG006|STARTED|Final Risk Group Assignment||40
10849617|NCT00352534|12016247|FG000|COMPLETED|Final Risk Group Assignment||0
10849618|NCT00352534|12016248|FG001|COMPLETED|Final Risk Group Assignment||0
10849619|NCT00352534|12016249|FG002|COMPLETED|Final Risk Group Assignment||116
10849620|NCT00352534|12016250|FG003|COMPLETED|Final Risk Group Assignment||49
10849621|NCT00352534|12016251|FG004|COMPLETED|Final Risk Group Assignment||31
10849622|NCT00352534|12016252|FG005|COMPLETED|Final Risk Group Assignment||503
10849623|NCT00352534|12016253|FG006|COMPLETED|Final Risk Group Assignment||1
10849624|NCT00352534|12016247|FG000|NOT COMPLETED|Final Risk Group Assignment||0
10849625|NCT00352534|12016248|FG001|NOT COMPLETED|Final Risk Group Assignment||0
10849626|NCT00352534|12016249|FG002|NOT COMPLETED|Final Risk Group Assignment||3
10849627|NCT00352534|12016250|FG003|NOT COMPLETED|Final Risk Group Assignment||3
10849628|NCT00352534|12016251|FG004|NOT COMPLETED|Final Risk Group Assignment||1
10849629|NCT00352534|12016252|FG005|NOT COMPLETED|Final Risk Group Assignment||45
10849630|NCT00352534|12016253|FG006|NOT COMPLETED|Final Risk Group Assignment||39
10849631|NCT00033293|12016265|FG000|STARTED|Overall Study||26
10849632|NCT00033293|12016266|FG001|STARTED|Overall Study||27
10849633|NCT00033293|12016265|FG000|COMPLETED|Overall Study||16
10849634|NCT00033293|12016266|FG001|COMPLETED|Overall Study||9
10849635|NCT00033293|12016265|FG000|NOT COMPLETED|Overall Study||10
10849636|NCT00033293|12016266|FG001|NOT COMPLETED|Overall Study||18
10849637|NCT04497415|12016276|FG000|STARTED|Overall Study||229
10849638|NCT04497415|12016277|FG001|STARTED|Overall Study||121
10849639|NCT04497415|12016276|FG000|Post-intervention Assessment (Day 1)|Overall Study||229
10849640|NCT04497415|12016277|FG001|Post-intervention Assessment (Day 1)|Overall Study||121
10849641|NCT04497415|12016276|FG000|First Follow-up Assessment (Day 14)|Overall Study||195
10849642|NCT04497415|12016277|FG001|First Follow-up Assessment (Day 14)|Overall Study||102
10849643|NCT04497415|12016276|FG000|COMPLETED|Overall Study||186
10849644|NCT04497415|12016277|FG001|COMPLETED|Overall Study||94
10849645|NCT04497415|12016276|FG000|NOT COMPLETED|Overall Study||43
10413781|NCT00780442|11558084|FG000|STARTED|Overall Study||12
10849646|NCT04497415|12016277|FG001|NOT COMPLETED|Overall Study||27
10849647|NCT04231396|12016283|FG000|STARTED|Overall Study||27
10849648|NCT04231396|12016283|FG000|COMPLETED|Overall Study||27
10849649|NCT04231396|12016283|FG000|NOT COMPLETED|Overall Study||0
10849650|NCT04118348|12016292|FG000|STARTED|Overall Study||3445
10849652|NCT04118348|12016294|FG002|STARTED|Overall Study||3461
10849653|NCT04118348|12016295|FG003|STARTED|Overall Study||3262
10849654|NCT04118348|12016292|FG000|COMPLETED|Overall Study||3445
10849655|NCT04118348|12016293|FG001|COMPLETED|Overall Study||3312
10849656|NCT04118348|12016294|FG002|COMPLETED|Overall Study||3461
10849657|NCT04118348|12016295|FG003|COMPLETED|Overall Study||3262
10849658|NCT04118348|12016292|FG000|NOT COMPLETED|Overall Study||0
10849659|NCT04118348|12016293|FG001|NOT COMPLETED|Overall Study||0
10849660|NCT04118348|12016294|FG002|NOT COMPLETED|Overall Study||0
10849661|NCT04118348|12016295|FG003|NOT COMPLETED|Overall Study||0
10849662|NCT04975321|12016308|FG000|STARTED|Overall Study||25
10849663|NCT04975321|12016309|FG001|STARTED|Overall Study||26
10849664|NCT04975321|12016310|FG002|STARTED|Overall Study||25
10849665|NCT04975321|12016308|FG000|COMPLETED|Overall Study||15
10849666|NCT04975321|12016309|FG001|COMPLETED|Overall Study||15
10849667|NCT04975321|12016310|FG002|COMPLETED|Overall Study||17
10849668|NCT04975321|12016308|FG000|NOT COMPLETED|Overall Study||10
10849669|NCT04975321|12016309|FG001|NOT COMPLETED|Overall Study||11
10849670|NCT04975321|12016310|FG002|NOT COMPLETED|Overall Study||8
10849671|NCT04594759|12016318|FG000|STARTED|Overall Study||22
10849672|NCT04594759|12016318|FG000|COMPLETED|Overall Study||19
10849673|NCT04594759|12016318|FG000|NOT COMPLETED|Overall Study||3
10849674|NCT04463069|12016324|FG000|STARTED|Overall Study||41
10849675|NCT04463069|12016325|FG001|STARTED|Overall Study||45
10849676|NCT04463069|12016324|FG000|COMPLETED|Overall Study||39
10849677|NCT04463069|12016325|FG001|COMPLETED|Overall Study||22
10849678|NCT04463069|12016324|FG000|NOT COMPLETED|Overall Study||2
10849679|NCT04463069|12016325|FG001|NOT COMPLETED|Overall Study||23
10849680|NCT04250337|12016333|FG000|STARTED|Overall Study||75
10849681|NCT04250337|12016334|FG001|STARTED|Overall Study||153
10849682|NCT04250337|12016333|FG000|Received at Least One Dose of Study Drug|Overall Study||75
10849683|NCT04250337|12016334|FG001|Received at Least One Dose of Study Drug|Overall Study||153
10849684|NCT04250337|12016333|FG000|COMPLETED|Overall Study||67
10849685|NCT04250337|12016334|FG001|COMPLETED|Overall Study||142
10849686|NCT04250337|12016333|FG000|NOT COMPLETED|Overall Study||8
10849687|NCT04250337|12016334|FG001|NOT COMPLETED|Overall Study||11
10849688|NCT04126733|12016341|FG000|STARTED|Treatment Period||70
10849689|NCT04126733|12016341|FG000|COMPLETED|Treatment Period||0
10849690|NCT04126733|12016341|FG000|NOT COMPLETED|Treatment Period||70
10849691|NCT04126733|12016341|FG000|STARTED|Active Follow-up Period|Participants had the option to decline participation in active follow-up.|34
10849692|NCT04126733|12016341|FG000|COMPLETED|Active Follow-up Period||14
10849693|NCT04126733|12016341|FG000|NOT COMPLETED|Active Follow-up Period||20
10849694|NCT04126733|12016341|FG000|STARTED|Long-term Follow-up Period|All participants who accepted long-term follow-up.|6
10849695|NCT04126733|12016341|FG000|COMPLETED|Long-term Follow-up Period||0
10849696|NCT04126733|12016341|FG000|NOT COMPLETED|Long-term Follow-up Period||6
10849697|NCT03909178|12016347|FG000|STARTED|Overall Study||46
10849698|NCT03909178|12016348|FG001|STARTED|Overall Study||44
10849699|NCT03909178|12016347|FG000|COMPLETED|Overall Study||42
10849700|NCT03909178|12016348|FG001|COMPLETED|Overall Study||39
10849701|NCT03909178|12016347|FG000|NOT COMPLETED|Overall Study||4
10849702|NCT03909178|12016348|FG001|NOT COMPLETED|Overall Study||5
10849715|NCT03631472|12016365|FG000|STARTED|Overall Study||21
10849716|NCT03631472|12016365|FG000|COMPLETED|Overall Study||21
10849717|NCT03631472|12016365|FG000|NOT COMPLETED|Overall Study||0
10849718|NCT03575572|12016371|FG000|STARTED|Overall Study||9
10849719|NCT03575572|12016371|FG000|COMPLETED|Overall Study||5
10849720|NCT03575572|12016371|FG000|NOT COMPLETED|Overall Study||4
10849721|NCT03521687|12016384|FG000|STARTED|Overall Study||20
10849722|NCT03521687|12016384|FG000|COMPLETED|Overall Study||15
10413782|NCT00780442|11558085|FG001|STARTED|Overall Study||15
10849723|NCT03521687|12016384|FG000|NOT COMPLETED|Overall Study||5
10849755|NCT03256045|12016410|FG000|STARTED|Overall Study||9
10849756|NCT03256045|12016410|FG000|COMPLETED|Overall Study||9
10849757|NCT03256045|12016410|FG000|NOT COMPLETED|Overall Study||0
10849758|NCT03216499|12016414|FG000|STARTED|Overall Study||24
10849759|NCT03216499|12016414|FG000|COMPLETED|Overall Study||24
10849760|NCT03216499|12016414|FG000|NOT COMPLETED|Overall Study||0
10849761|NCT03046836|12016420|FG000|STARTED|Overall Study||100
10849762|NCT03046836|12016421|FG001|STARTED|Overall Study||100
10849763|NCT03046836|12016420|FG000|COMPLETED|Overall Study||100
10849764|NCT03046836|12016421|FG001|COMPLETED|Overall Study||100
10849765|NCT03046836|12016420|FG000|NOT COMPLETED|Overall Study||0
10849766|NCT03046836|12016421|FG001|NOT COMPLETED|Overall Study||0
10849767|NCT02966301|12016428|FG000|STARTED|Overall Study||21
10849768|NCT02966301|12016428|FG000|Full Analysis Set (FAS)|Overall Study|All patients who entered the study, completed their first cycle of ATO (11 infusions) and for whom the response at Week 6 after diagnosis of chronic GvHD has been evaluated.|20
10849769|NCT02966301|12016428|FG000|Safety Analysis (SA)|Overall Study|All patients included in the study for whom received at least one ATO infusion. One patient received 2 infusions and then exited the study due to SAE (reversible liver toxicity).|21
10849770|NCT02966301|12016428|FG000|COMPLETED|Overall Study||18
10849771|NCT02966301|12016428|FG000|NOT COMPLETED|Overall Study||3
10545474|NCT01497899|11698861|FG000|STARTED|Double-Blind Phase||113
10545475|NCT01497899|11698862|FG001|STARTED|Double-Blind Phase||58
10545476|NCT01497899|11698863|FG002|STARTED|Double-Blind Phase||0
10545477|NCT01497899|11698864|FG003|STARTED|Double-Blind Phase||0
10545478|NCT01497899|11698861|FG000|COMPLETED|Double-Blind Phase||107
10545479|NCT01497899|11698862|FG001|COMPLETED|Double-Blind Phase||53
10849772|NCT02893514|12016434|FG000|STARTED|Overall Study||42
10849773|NCT02893514|12016435|FG001|STARTED|Overall Study||37
10849774|NCT02893514|12016434|FG000|COMPLETED|Overall Study||42
10849775|NCT02893514|12016435|FG001|COMPLETED|Overall Study||37
10849776|NCT02893514|12016434|FG000|NOT COMPLETED|Overall Study||0
10849777|NCT02893514|12016435|FG001|NOT COMPLETED|Overall Study||0
10849778|NCT02832167|12016441|FG000|STARTED|Treatment Period 1||239
10849779|NCT02832167|12016441|FG000|COMPLETED|Treatment Period 1||110
10849780|NCT02832167|12016441|FG000|NOT COMPLETED|Treatment Period 1||129
10849781|NCT02832167|12016441|FG000|STARTED|Transition From Period 1 to Period 2||110
10849782|NCT02832167|12016441|FG000|COMPLETED|Transition From Period 1 to Period 2||103
10849783|NCT02832167|12016441|FG000|NOT COMPLETED|Transition From Period 1 to Period 2||7
10849784|NCT02832167|12016441|FG000|STARTED|Treatment Period 2||103
10849785|NCT02832167|12016441|FG000|COMPLETED|Treatment Period 2||19
10849786|NCT02832167|12016441|FG000|NOT COMPLETED|Treatment Period 2||84
10849787|NCT02699554|12016445|FG000|STARTED|Overall Study||55
10849788|NCT02699554|12016445|FG000|COMPLETED|Overall Study||46
10849789|NCT02699554|12016445|FG000|NOT COMPLETED|Overall Study||9
10849790|NCT02659020|12016456|FG000|STARTED|Overall Study||21
10849791|NCT02659020|12016457|FG001|STARTED|Overall Study||18
10849792|NCT02659020|12016458|FG002|STARTED|Overall Study||15
10849793|NCT02659020|12016459|FG003|STARTED|Overall Study||81
10849794|NCT02659020|12016460|FG004|STARTED|Overall Study||46
10849795|NCT02659020|12016461|FG005|STARTED|Overall Study||86
10849796|NCT02659020|12016462|FG006|STARTED|Overall Study||43
10849797|NCT02659020|12016456|FG000|Received at Least 1 Dose of Study Drug|Overall Study||21
10849798|NCT02659020|12016457|FG001|Received at Least 1 Dose of Study Drug|Overall Study||18
10849799|NCT02659020|12016458|FG002|Received at Least 1 Dose of Study Drug|Overall Study||15
10849800|NCT02659020|12016459|FG003|Received at Least 1 Dose of Study Drug|Overall Study||81
10849801|NCT02659020|12016460|FG004|Received at Least 1 Dose of Study Drug|Overall Study||45
10849802|NCT02659020|12016461|FG005|Received at Least 1 Dose of Study Drug|Overall Study||86
10849803|NCT02659020|12016462|FG006|Received at Least 1 Dose of Study Drug|Overall Study||43
10849804|NCT02659020|12016456|FG000|COMPLETED|Overall Study||18
10849805|NCT02659020|12016457|FG001|COMPLETED|Overall Study||15
10849806|NCT02659020|12016458|FG002|COMPLETED|Overall Study||14
10849807|NCT02659020|12016459|FG003|COMPLETED|Overall Study||65
10849808|NCT02659020|12016460|FG004|COMPLETED|Overall Study||40
10849809|NCT02659020|12016461|FG005|COMPLETED|Overall Study||75
10849810|NCT02659020|12016462|FG006|COMPLETED|Overall Study||35
10849811|NCT02659020|12016456|FG000|NOT COMPLETED|Overall Study||3
10849812|NCT02659020|12016457|FG001|NOT COMPLETED|Overall Study||3
10849813|NCT02659020|12016458|FG002|NOT COMPLETED|Overall Study||1
10849814|NCT02659020|12016459|FG003|NOT COMPLETED|Overall Study||16
10849815|NCT02659020|12016460|FG004|NOT COMPLETED|Overall Study||6
10849816|NCT02659020|12016461|FG005|NOT COMPLETED|Overall Study||11
10849817|NCT02659020|12016462|FG006|NOT COMPLETED|Overall Study||8
10849818|NCT02626949|12016487|FG000|STARTED|Randomization, Pre-Enrollment||56
10849819|NCT02626949|12016488|FG001|STARTED|Randomization, Pre-Enrollment||58
10849820|NCT02626949|12016487|FG000|COMPLETED|Randomization, Pre-Enrollment||40
10849821|NCT02626949|12016488|FG001|COMPLETED|Randomization, Pre-Enrollment||44
10849822|NCT02626949|12016487|FG000|NOT COMPLETED|Randomization, Pre-Enrollment||16
10849823|NCT02626949|12016488|FG001|NOT COMPLETED|Randomization, Pre-Enrollment||14
10849824|NCT02626949|12016487|FG000|STARTED|Enrolled||40
10849825|NCT02626949|12016488|FG001|STARTED|Enrolled||44
10849826|NCT02626949|12016487|FG000|COMPLETED|Enrolled||30
10849827|NCT02626949|12016488|FG001|COMPLETED|Enrolled||36
10849828|NCT02626949|12016487|FG000|NOT COMPLETED|Enrolled||10
10849829|NCT02626949|12016488|FG001|NOT COMPLETED|Enrolled||8
10849830|NCT02625766|12016496|FG000|STARTED|Overall Study||47
10849831|NCT02625766|12016497|FG001|STARTED|Overall Study||48
10849832|NCT02625766|12016496|FG000|COMPLETED|Overall Study||47
10849833|NCT02625766|12016497|FG001|COMPLETED|Overall Study||48
10849834|NCT02625766|12016496|FG000|NOT COMPLETED|Overall Study||0
10849835|NCT02625766|12016497|FG001|NOT COMPLETED|Overall Study||0
10849836|NCT02565914|12016503|FG000|STARTED|Overall Study||1044
10849837|NCT02565914|12016503|FG000|Safety Set|Overall Study||1042
10849838|NCT02565914|12016503|FG000|COMPLETED|Overall Study||951
10849839|NCT02565914|12016503|FG000|NOT COMPLETED|Overall Study||93
10849840|NCT02385045|12016515|FG000|STARTED|Overall Study||157
10849841|NCT02385045|12016515|FG000|COMPLETED|Overall Study|4 patients could not complete endoscopy as planned|153
10849842|NCT02385045|12016515|FG000|NOT COMPLETED|Overall Study||4
10849843|NCT02373241|12016521|FG000|STARTED|Overall Study||0
10849844|NCT02373241|12016522|FG001|STARTED|Overall Study||1
10849845|NCT02373241|12016521|FG000|COMPLETED|Overall Study||0
10314487|NCT00163215|11448128|FG000|STARTED|Overall Study||46
10849846|NCT02373241|12016522|FG001|COMPLETED|Overall Study||1
10849847|NCT02373241|12016521|FG000|NOT COMPLETED|Overall Study||0
10849848|NCT02373241|12016522|FG001|NOT COMPLETED|Overall Study||0
10849849|NCT01845649|12016530|FG000|STARTED|Overall Study||273
10849850|NCT01845649|12016531|FG001|STARTED|Overall Study||277
10849851|NCT01845649|12016530|FG000|Safety Population|Overall Study||271
10849852|NCT01845649|12016531|FG001|Safety Population|Overall Study||277
10849853|NCT01845649|12016530|FG000|Modified Intent-to-treat (mITT) Population|Overall Study||233
10849854|NCT01845649|12016531|FG001|Modified Intent-to-treat (mITT) Population|Overall Study||239
10849855|NCT01845649|12016530|FG000|COMPLETED|Overall Study||242
10849856|NCT01845649|12016531|FG001|COMPLETED|Overall Study||255
10849857|NCT01845649|12016530|FG000|NOT COMPLETED|Overall Study||31
10849858|NCT01845649|12016531|FG001|NOT COMPLETED|Overall Study||22
10849865|NCT01816139|12016548|FG000|STARTED|Overall Study||289
10849866|NCT01816139|12016549|FG001|STARTED|Overall Study||287
10849867|NCT01816139|12016548|FG000|Safety Population|Overall Study||287
10849868|NCT01816139|12016549|FG001|Safety Population|Overall Study||286
10849869|NCT01816139|12016548|FG000|Modified Intent-to-treat (mITT) Population|Overall Study||240
10849870|NCT01816139|12016549|FG001|Modified Intent-to-treat (mITT) Population|Overall Study||248
10849871|NCT01816139|12016548|FG000|COMPLETED|Overall Study||261
10849872|NCT01816139|12016549|FG001|COMPLETED|Overall Study||265
10849873|NCT01816139|12016548|FG000|NOT COMPLETED|Overall Study||28
10849874|NCT01816139|12016549|FG001|NOT COMPLETED|Overall Study||22
10849875|NCT01455597|12016555|FG000|STARTED|Overall Study||101
10849876|NCT01455597|12016556|FG001|STARTED|Overall Study||56
10849877|NCT01455597|12016557|FG002|STARTED|Overall Study||100
10849878|NCT01455597|12016558|FG003|STARTED|Overall Study||52
10849879|NCT01455597|12016555|FG000|All-Participants-Treated Population|Overall Study||101
10849880|NCT01455597|12016556|FG001|All-Participants-Treated Population|Overall Study||56
10849881|NCT01455597|12016557|FG002|All-Participants-Treated Population|Overall Study||99
10849882|NCT01455597|12016558|FG003|All-Participants-Treated Population|Overall Study||52
10849883|NCT01455597|12016555|FG000|COMPLETED|Overall Study||84
10849884|NCT01455597|12016556|FG001|COMPLETED|Overall Study||48
10849885|NCT01455597|12016557|FG002|COMPLETED|Overall Study||80
10849886|NCT01455597|12016558|FG003|COMPLETED|Overall Study||42
10849887|NCT01455597|12016555|FG000|NOT COMPLETED|Overall Study||17
10849888|NCT01455597|12016556|FG001|NOT COMPLETED|Overall Study||8
10849889|NCT01455597|12016557|FG002|NOT COMPLETED|Overall Study||20
10849890|NCT01455597|12016558|FG003|NOT COMPLETED|Overall Study||10
10849891|NCT01400776|12016574|FG000|STARTED|Overall Study||238
10849892|NCT01400776|12016575|FG001|STARTED|Overall Study||124
10849893|NCT01400776|12016576|FG002|STARTED|Overall Study||237
10849894|NCT01400776|12016577|FG003|STARTED|Overall Study||123
10849895|NCT01400776|12016574|FG000|COMPLETED|Overall Study||217
10849896|NCT01400776|12016575|FG001|COMPLETED|Overall Study||119
10849897|NCT01400776|12016576|FG002|COMPLETED|Overall Study||209
10849898|NCT01400776|12016577|FG003|COMPLETED|Overall Study||114
10849899|NCT01400776|12016574|FG000|NOT COMPLETED|Overall Study||21
10849900|NCT01400776|12016575|FG001|NOT COMPLETED|Overall Study||5
10849901|NCT01400776|12016576|FG002|NOT COMPLETED|Overall Study||28
10849902|NCT01400776|12016577|FG003|NOT COMPLETED|Overall Study||9
10849903|NCT00511134|12016589|FG000|STARTED|Overall Study||1
10849904|NCT00511134|12016590|FG001|STARTED|Overall Study||3
10849905|NCT00511134|12016589|FG000|COMPLETED|Overall Study||1
10849906|NCT00511134|12016590|FG001|COMPLETED|Overall Study||1
10849907|NCT00511134|12016589|FG000|NOT COMPLETED|Overall Study||0
10849908|NCT00511134|12016590|FG001|NOT COMPLETED|Overall Study||2
10849909|NCT00349466|12016598|FG000|STARTED|Overall Study||42
10849910|NCT00349466|12016599|FG001|STARTED|Overall Study||38
10849911|NCT00349466|12016598|FG000|COMPLETED|Overall Study||33
10849912|NCT00349466|12016599|FG001|COMPLETED|Overall Study||35
10849913|NCT00349466|12016598|FG000|NOT COMPLETED|Overall Study||9
10849914|NCT00349466|12016599|FG001|NOT COMPLETED|Overall Study||3
10849933|NCT03816202|12016636|FG000|STARTED|Overall Study||100
10849934|NCT03816202|12016636|FG000|COMPLETED|Overall Study||100
10849935|NCT03816202|12016636|FG000|NOT COMPLETED|Overall Study||0
10849936|NCT03725293|12016642|FG000|STARTED|Overall Study||106
10849937|NCT03725293|12016643|FG001|STARTED|Overall Study||106
10849938|NCT03725293|12016642|FG000|COMPLETED|Overall Study||94
10849939|NCT03725293|12016643|FG001|COMPLETED|Overall Study||97
10849940|NCT03725293|12016642|FG000|NOT COMPLETED|Overall Study||12
10849941|NCT03725293|12016643|FG001|NOT COMPLETED|Overall Study||9
10849942|NCT03702231|12016652|FG000|STARTED|Overall Study||59
10849943|NCT03702231|12016653|FG001|STARTED|Overall Study||29
10849944|NCT03702231|12016654|FG002|STARTED|Overall Study||28
10849945|NCT03702231|12016652|FG000|COMPLETED|Overall Study||55
10849946|NCT03702231|12016653|FG001|COMPLETED|Overall Study||25
10849947|NCT03702231|12016654|FG002|COMPLETED|Overall Study||26
10849948|NCT03702231|12016652|FG000|NOT COMPLETED|Overall Study||4
10849949|NCT03702231|12016653|FG001|NOT COMPLETED|Overall Study||4
10849950|NCT03702231|12016654|FG002|NOT COMPLETED|Overall Study||2
10849951|NCT03690284|12016664|FG000|STARTED|Overall Study||25
10849952|NCT03690284|12016665|FG001|STARTED|Overall Study||25
10849953|NCT03690284|12016664|FG000|COMPLETED|Overall Study||25
10849954|NCT03690284|12016665|FG001|COMPLETED|Overall Study||25
10849955|NCT03690284|12016664|FG000|NOT COMPLETED|Overall Study||0
10849956|NCT03690284|12016665|FG001|NOT COMPLETED|Overall Study||0
10849957|NCT03670277|12016673|FG000|STARTED|Overall Study||20
10849958|NCT03670277|12016674|FG001|STARTED|Overall Study||8
10849959|NCT03670277|12016673|FG000|COMPLETED|Overall Study||20
10849960|NCT03670277|12016674|FG001|COMPLETED|Overall Study||8
10849961|NCT03670277|12016673|FG000|NOT COMPLETED|Overall Study||0
10849962|NCT03670277|12016674|FG001|NOT COMPLETED|Overall Study||0
10849963|NCT03556358|12016685|FG000|STARTED|Overall Study||404
10849964|NCT03556358|12016686|FG001|STARTED|Overall Study||405
10849965|NCT03556358|12016685|FG000|Subjects Treated|Overall Study||401
10849966|NCT03556358|12016686|FG001|Subjects Treated|Overall Study||405
10849967|NCT03556358|12016685|FG000|Subjects Receiving TX05 or Herceptin|Overall Study||394
10849968|NCT03556358|12016686|FG001|Subjects Receiving TX05 or Herceptin|Overall Study||400
10849969|NCT03556358|12016685|FG000|COMPLETED|Overall Study||393
10849970|NCT03556358|12016686|FG001|COMPLETED|Overall Study||393
10849971|NCT03556358|12016685|FG000|NOT COMPLETED|Overall Study||11
10849972|NCT03556358|12016686|FG001|NOT COMPLETED|Overall Study||12
10849973|NCT03290781|12016699|FG000|STARTED|Overall Study||73
10849974|NCT03290781|12016700|FG001|STARTED|Overall Study||71
10849975|NCT03290781|12016701|FG002|STARTED|Overall Study||86
10849976|NCT03290781|12016702|FG003|STARTED|Overall Study||82
10849977|NCT03290781|12016703|FG004|STARTED|Overall Study||11
10849978|NCT03290781|12016704|FG005|STARTED|Overall Study||22
10849979|NCT03290781|12016705|FG006|STARTED|Overall Study||21
10849980|NCT03290781|12016699|FG000|COMPLETED|Overall Study||24
10849981|NCT03290781|12016700|FG001|COMPLETED|Overall Study||53
10849982|NCT03290781|12016701|FG002|COMPLETED|Overall Study||30
10849983|NCT03290781|12016702|FG003|COMPLETED|Overall Study||59
10849984|NCT03290781|12016703|FG004|COMPLETED|Overall Study||6
10849985|NCT03290781|12016704|FG005|COMPLETED|Overall Study||19
10849986|NCT03290781|12016705|FG006|COMPLETED|Overall Study||17
10849987|NCT03290781|12016699|FG000|NOT COMPLETED|Overall Study||49
10849988|NCT03290781|12016700|FG001|NOT COMPLETED|Overall Study||18
10849989|NCT03290781|12016701|FG002|NOT COMPLETED|Overall Study||56
10849990|NCT03290781|12016702|FG003|NOT COMPLETED|Overall Study||23
10849991|NCT03290781|12016703|FG004|NOT COMPLETED|Overall Study||5
10849992|NCT03290781|12016704|FG005|NOT COMPLETED|Overall Study||3
10849993|NCT03290781|12016705|FG006|NOT COMPLETED|Overall Study||4
10849994|NCT03263195|12016732|FG000|STARTED|Overall Study||174
10849995|NCT03263195|12016733|FG001|STARTED|Overall Study||0
10849996|NCT03263195|12016734|FG002|STARTED|Overall Study||0
10849997|NCT03263195|12016735|FG003|STARTED|Overall Study||26
10849998|NCT03263195|12016736|FG004|STARTED|Overall Study||170
10849999|NCT03263195|12016737|FG005|STARTED|Overall Study||0
10850000|NCT03263195|12016738|FG006|STARTED|Overall Study||0
10850001|NCT03263195|12016739|FG007|STARTED|Overall Study||25
10850002|NCT03263195|12016732|FG000|COMPLETED|Overall Study||168
10850003|NCT03263195|12016733|FG001|COMPLETED|Overall Study||0
10850004|NCT03263195|12016734|FG002|COMPLETED|Overall Study||0
10850005|NCT03263195|12016735|FG003|COMPLETED|Overall Study||23
10850006|NCT03263195|12016736|FG004|COMPLETED|Overall Study||155
10850007|NCT03263195|12016737|FG005|COMPLETED|Overall Study||0
10850008|NCT03263195|12016738|FG006|COMPLETED|Overall Study||0
10850009|NCT03263195|12016739|FG007|COMPLETED|Overall Study||19
10850010|NCT03263195|12016732|FG000|NOT COMPLETED|Overall Study||6
10850011|NCT03263195|12016733|FG001|NOT COMPLETED|Overall Study||0
10850012|NCT03263195|12016734|FG002|NOT COMPLETED|Overall Study||0
10850013|NCT03263195|12016735|FG003|NOT COMPLETED|Overall Study||3
10850014|NCT03263195|12016736|FG004|NOT COMPLETED|Overall Study||15
10850015|NCT03263195|12016737|FG005|NOT COMPLETED|Overall Study||0
10850016|NCT03263195|12016738|FG006|NOT COMPLETED|Overall Study||0
10850017|NCT03263195|12016739|FG007|NOT COMPLETED|Overall Study||6
10850018|NCT03228680|12016764|FG000|STARTED|Overall Study||170
10850019|NCT03228680|12016765|FG001|STARTED|Overall Study||178
10850020|NCT03228680|12016764|FG000|COMPLETED|Overall Study||147
10850021|NCT03228680|12016765|FG001|COMPLETED|Overall Study||143
10850022|NCT03228680|12016764|FG000|NOT COMPLETED|Overall Study||23
10850023|NCT03228680|12016765|FG001|NOT COMPLETED|Overall Study||35
10850024|NCT03196167|12016774|FG000|STARTED|Overall Study||45
10850025|NCT03196167|12016775|FG001|STARTED|Overall Study||45
10850026|NCT03196167|12016774|FG000|COMPLETED|Overall Study||40
10850027|NCT03196167|12016775|FG001|COMPLETED|Overall Study||43
10850028|NCT03196167|12016774|FG000|NOT COMPLETED|Overall Study||5
10850029|NCT03196167|12016775|FG001|NOT COMPLETED|Overall Study||2
10850030|NCT03077204|12016785|FG000|STARTED|Overall Study||20
10850031|NCT03077204|12016785|FG000|COMPLETED|Overall Study||20
10850032|NCT03077204|12016785|FG000|NOT COMPLETED|Overall Study||0
10850033|NCT03029611|12016790|FG000|STARTED|Overall Study|We had 11 patients sign consent with 2 patients deciding not to continue to receive treatment.|9
10850034|NCT03029611|12016790|FG000|COMPLETED|Overall Study|Please note that we did not fully enroll this study due to lack of funding. The complete date here relates to the last treatment administration.|9
10850035|NCT03029611|12016790|FG000|NOT COMPLETED|Overall Study||0
10850036|NCT02891798|12016796|FG000|STARTED|Overall Study||62
10850037|NCT02891798|12016797|FG001|STARTED|Overall Study||16
10850038|NCT02891798|12016796|FG000|COMPLETED|Overall Study||62
10850039|NCT02891798|12016797|FG001|COMPLETED|Overall Study||16
10850040|NCT02891798|12016796|FG000|NOT COMPLETED|Overall Study||0
10850041|NCT02891798|12016797|FG001|NOT COMPLETED|Overall Study||0
10850042|NCT02679781|12016805|FG000|STARTED|Overall Study||37
10850043|NCT02679781|12016806|FG001|STARTED|Overall Study||33
10850044|NCT02679781|12016805|FG000|COMPLETED|Overall Study||30
10850045|NCT02679781|12016806|FG001|COMPLETED|Overall Study||30
10850046|NCT02679781|12016805|FG000|NOT COMPLETED|Overall Study||7
10850047|NCT02679781|12016806|FG001|NOT COMPLETED|Overall Study||3
10850048|NCT02624869|12016815|FG000|STARTED|Overall Study||49
10850049|NCT02624869|12016816|FG001|STARTED|Overall Study||101
10850050|NCT02624869|12016817|FG002|STARTED|Overall Study||13
10850051|NCT02624869|12016815|FG000|Received Study Drug|Overall Study||49
10850052|NCT02624869|12016816|FG001|Received Study Drug|Overall Study||101
10850053|NCT02624869|12016817|FG002|Received Study Drug|Overall Study||12
10850054|NCT02624869|12016815|FG000|COMPLETED|Overall Study||48
10850055|NCT02624869|12016816|FG001|COMPLETED|Overall Study||98
10850056|NCT02624869|12016817|FG002|COMPLETED|Overall Study||11
10413783|NCT00780442|11558084|FG000|COMPLETED|Overall Study||12
10413784|NCT00780442|11558085|FG001|COMPLETED|Overall Study||15
10413785|NCT00780442|11558084|FG000|NOT COMPLETED|Overall Study||0
10413786|NCT00780442|11558085|FG001|NOT COMPLETED|Overall Study||0
10413787|NCT00780494|11558091|FG000|STARTED|Overall Study||35
10413788|NCT00780494|11558091|FG000|COMPLETED|Overall Study||35
10413789|NCT00780494|11558091|FG000|NOT COMPLETED|Overall Study||0
10413790|NCT00780559|11558097|FG000|STARTED|Overall Study||32
10413791|NCT00780559|11558098|FG001|STARTED|Overall Study||40
10413792|NCT00780559|11558097|FG000|COMPLETED|Overall Study||29
10413793|NCT00780559|11558098|FG001|COMPLETED|Overall Study||33
10413794|NCT00780559|11558097|FG000|NOT COMPLETED|Overall Study||3
10413795|NCT00780559|11558098|FG001|NOT COMPLETED|Overall Study||7
10413796|NCT00780572|11558108|FG000|STARTED|Overall Study||297
10413797|NCT00780572|11558109|FG001|STARTED|Overall Study||298
10413798|NCT00780572|11558108|FG000|COMPLETED|Overall Study||297
10413799|NCT00780572|11558109|FG001|COMPLETED|Overall Study||298
10413800|NCT00780572|11558108|FG000|NOT COMPLETED|Overall Study||0
10413801|NCT00780572|11558109|FG001|NOT COMPLETED|Overall Study||0
10413802|NCT00780676|11558120|FG000|STARTED|Overall Study||9
10413803|NCT00780676|11558121|FG001|STARTED|Overall Study||8
10413804|NCT00780676|11558122|FG002|STARTED|Overall Study||13
10413805|NCT00780676|11558123|FG003|STARTED|Overall Study||0
10413806|NCT00780676|11558124|FG004|STARTED|Overall Study||0
10413807|NCT00780676|11558120|FG000|COMPLETED|Overall Study||9
10413808|NCT00780676|11558121|FG001|COMPLETED|Overall Study||8
10413809|NCT00780676|11558122|FG002|COMPLETED|Overall Study||13
10413810|NCT00780676|11558123|FG003|COMPLETED|Overall Study||0
10413811|NCT00780676|11558124|FG004|COMPLETED|Overall Study||0
10413812|NCT00780676|11558120|FG000|NOT COMPLETED|Overall Study||0
10413813|NCT00780676|11558121|FG001|NOT COMPLETED|Overall Study||0
10413814|NCT00780676|11558122|FG002|NOT COMPLETED|Overall Study||0
10413815|NCT00780676|11558123|FG003|NOT COMPLETED|Overall Study||0
10850057|NCT02624869|12016815|FG000|NOT COMPLETED|Overall Study||1
10850058|NCT02624869|12016816|FG001|NOT COMPLETED|Overall Study||3
10850059|NCT02624869|12016817|FG002|NOT COMPLETED|Overall Study||2
10850060|NCT02614690|12016829|FG000|STARTED|Overall Study||20
10850061|NCT02614690|12016830|FG001|STARTED|Overall Study||20
10413816|NCT00780676|11558124|FG004|NOT COMPLETED|Overall Study||0
10413817|NCT00780715|11558134|FG000|STARTED|Overall Study||6
10413818|NCT00780715|11558135|FG001|STARTED|Overall Study||6
10413819|NCT00780715|11558136|FG002|STARTED|Overall Study||6
10413820|NCT00780715|11558137|FG003|STARTED|Overall Study||11
10413821|NCT00780715|11558134|FG000|COMPLETED|Overall Study||6
10413822|NCT00780715|11558135|FG001|COMPLETED|Overall Study||6
10413823|NCT00780715|11558136|FG002|COMPLETED|Overall Study||6
10413824|NCT00780715|11558137|FG003|COMPLETED|Overall Study||11
10413825|NCT00780715|11558134|FG000|NOT COMPLETED|Overall Study||0
10413826|NCT00780715|11558135|FG001|NOT COMPLETED|Overall Study||0
10413827|NCT00780715|11558136|FG002|NOT COMPLETED|Overall Study||0
10413828|NCT00780715|11558137|FG003|NOT COMPLETED|Overall Study||0
10413829|NCT00780741|11558149|FG000|STARTED|Overall Study|randomized|82
10850062|NCT02614690|12016831|FG002|STARTED|Overall Study||20
10850063|NCT02614690|12016829|FG000|COMPLETED|Overall Study||20
10850064|NCT02614690|12016830|FG001|COMPLETED|Overall Study||20
10850065|NCT02614690|12016831|FG002|COMPLETED|Overall Study||20
10850066|NCT02614690|12016829|FG000|NOT COMPLETED|Overall Study||0
10850067|NCT02614690|12016830|FG001|NOT COMPLETED|Overall Study||0
10850068|NCT02614690|12016831|FG002|NOT COMPLETED|Overall Study||0
10850069|NCT02516969|12016841|FG000|STARTED|Overall Study||3
10850070|NCT02516969|12016842|FG001|STARTED|Overall Study||4
10850071|NCT02516969|12016841|FG000|COMPLETED|Overall Study||3
10850072|NCT02516969|12016842|FG001|COMPLETED|Overall Study||4
10850073|NCT02516969|12016841|FG000|NOT COMPLETED|Overall Study||0
10850074|NCT02516969|12016842|FG001|NOT COMPLETED|Overall Study||0
10850075|NCT02507960|12016850|FG000|STARTED|Overall Study||17
10850076|NCT02507960|12016850|FG000|COMPLETED|Overall Study||17
10850077|NCT02507960|12016850|FG000|NOT COMPLETED|Overall Study||0
10850078|NCT02435433|12016856|FG000|STARTED|Overall Study||197
10850079|NCT02435433|12016857|FG001|STARTED|Overall Study||95
10850080|NCT02435433|12016858|FG002|STARTED|Overall Study||0
10850081|NCT02435433|12016859|FG003|STARTED|Overall Study||0
10850082|NCT02435433|12016860|FG004|STARTED|Overall Study||0
10850083|NCT02435433|12016856|FG000|Participants Who Received Study Drug|Overall Study||197
10850084|NCT02435433|12016857|FG001|Participants Who Received Study Drug|Overall Study||95
10850085|NCT02435433|12016858|FG002|Participants Who Received Study Drug|Overall Study||0
10850086|NCT02435433|12016859|FG003|Participants Who Received Study Drug|Overall Study||0
10850087|NCT02435433|12016860|FG004|Participants Who Received Study Drug|Overall Study||0
10850088|NCT02435433|12016856|FG000|COMPLETED|Overall Study||182
10850089|NCT02435433|12016857|FG001|COMPLETED|Overall Study||90
10850090|NCT02435433|12016858|FG002|COMPLETED|Overall Study||0
10850091|NCT02435433|12016859|FG003|COMPLETED|Overall Study||0
10850092|NCT02435433|12016860|FG004|COMPLETED|Overall Study||0
10850093|NCT02435433|12016856|FG000|NOT COMPLETED|Overall Study||15
10850094|NCT02435433|12016857|FG001|NOT COMPLETED|Overall Study||5
10850095|NCT02435433|12016858|FG002|NOT COMPLETED|Overall Study||0
10850096|NCT02435433|12016859|FG003|NOT COMPLETED|Overall Study||0
10850097|NCT02435433|12016860|FG004|NOT COMPLETED|Overall Study||0
10850108|NCT02417142|12016881|FG000|STARTED|Overall Study||35
10850109|NCT02417142|12016882|FG001|STARTED|Overall Study||35
10850110|NCT02417142|12016881|FG000|COMPLETED|Overall Study||19
10850111|NCT02417142|12016882|FG001|COMPLETED|Overall Study||22
10850112|NCT02417142|12016881|FG000|NOT COMPLETED|Overall Study||16
10850113|NCT02417142|12016882|FG001|NOT COMPLETED|Overall Study||13
10850114|NCT02368886|12016892|FG000|STARTED|Overall Study||29
10850115|NCT02368886|12016893|FG001|STARTED|Overall Study||27
10850116|NCT02368886|12016894|FG002|STARTED|Overall Study||34
10850117|NCT02368886|12016895|FG003|STARTED|Overall Study||33
10850118|NCT02368886|12016892|FG000|COMPLETED|Overall Study||28
10850119|NCT02368886|12016893|FG001|COMPLETED|Overall Study||26
10850120|NCT02368886|12016894|FG002|COMPLETED|Overall Study||33
10850121|NCT02368886|12016895|FG003|COMPLETED|Overall Study||29
10850122|NCT02368886|12016892|FG000|NOT COMPLETED|Overall Study||1
10850123|NCT02368886|12016893|FG001|NOT COMPLETED|Overall Study||1
10850124|NCT02368886|12016894|FG002|NOT COMPLETED|Overall Study||1
10850125|NCT02368886|12016895|FG003|NOT COMPLETED|Overall Study||4
10850126|NCT02354703|12016907|FG000|STARTED|Overall Study||12
10850127|NCT02354703|12016908|FG001|STARTED|Overall Study||34
10850128|NCT02354703|12016909|FG002|STARTED|Overall Study||39
10850129|NCT02354703|12016910|FG003|STARTED|Overall Study||10
10850130|NCT02354703|12016907|FG000|COMPLETED|Overall Study||9
10850131|NCT02354703|12016908|FG001|COMPLETED|Overall Study||26
10850132|NCT02354703|12016909|FG002|COMPLETED|Overall Study||28
10850133|NCT02354703|12016910|FG003|COMPLETED|Overall Study||7
10850134|NCT02354703|12016907|FG000|NOT COMPLETED|Overall Study||3
10850135|NCT02354703|12016908|FG001|NOT COMPLETED|Overall Study||8
10850136|NCT02354703|12016909|FG002|NOT COMPLETED|Overall Study||11
10850137|NCT02354703|12016910|FG003|NOT COMPLETED|Overall Study||3
10850138|NCT01981551|12016922|FG000|STARTED|Overall Study||17
10850139|NCT01981551|12016922|FG000|COMPLETED|Overall Study||8
10850140|NCT01981551|12016922|FG000|NOT COMPLETED|Overall Study||9
10850141|NCT00740181|12016926|FG000|STARTED|Overall Study||9
10850142|NCT00740181|12016926|FG000|COMPLETED|Overall Study||9
10850143|NCT00740181|12016926|FG000|NOT COMPLETED|Overall Study||0
10850144|NCT00468130|12016932|FG000|STARTED|Overall Study||7
10850145|NCT00468130|12016933|FG001|STARTED|Overall Study||6
10850146|NCT00468130|12016932|FG000|COMPLETED|Overall Study||5
10850147|NCT00468130|12016933|FG001|COMPLETED|Overall Study||4
10850148|NCT00468130|12016932|FG000|NOT COMPLETED|Overall Study||2
10850149|NCT00468130|12016933|FG001|NOT COMPLETED|Overall Study||2
10850150|NCT00384111|12016941|FG000|STARTED|Overall Study||26
10850151|NCT00384111|12016941|FG000|COMPLETED|Overall Study||0
10850152|NCT00384111|12016941|FG000|NOT COMPLETED|Overall Study||26
10850153|NCT04854642|12016945|FG000|STARTED|Overall Study||18
10850154|NCT04854642|12016946|FG001|STARTED|Overall Study||18
10850155|NCT04854642|12016945|FG000|Safety Set|Overall Study||18
10850156|NCT04854642|12016946|FG001|Safety Set|Overall Study||18
10850157|NCT04854642|12016945|FG000|PK Set 1|Overall Study||18
10850158|NCT04854642|12016946|FG001|PK Set 1|Overall Study||18
10850159|NCT04854642|12016945|FG000|PK Set 2|Overall Study||18
10850160|NCT04854642|12016946|FG001|PK Set 2|Overall Study||18
10850161|NCT04854642|12016945|FG000|COMPLETED|Overall Study||17
10850162|NCT04854642|12016946|FG001|COMPLETED|Overall Study||15
10850163|NCT04854642|12016945|FG000|NOT COMPLETED|Overall Study||1
10850164|NCT04854642|12016946|FG001|NOT COMPLETED|Overall Study||3
10850165|NCT04583592|12016956|FG000|STARTED|Overall Study||194
10850166|NCT04583592|12016957|FG001|STARTED|Overall Study||101
10850167|NCT04583592|12016956|FG000|COMPLETED|Overall Study||194
10850168|NCT04583592|12016957|FG001|COMPLETED|Overall Study||100
10850169|NCT04583592|12016956|FG000|NOT COMPLETED|Overall Study||0
10850170|NCT04583592|12016957|FG001|NOT COMPLETED|Overall Study||1
10850171|NCT04572399|12016963|FG000|STARTED|Overall Study||5
10850172|NCT04572399|12016963|FG000|COMPLETED|Overall Study||5
10850173|NCT04572399|12016963|FG000|NOT COMPLETED|Overall Study||0
10850230|NCT04097301|12017040|FG000|STARTED|Overall Study|Enrolled patients. Overall, 8 patients were enrolled in the study and underwent the screening phase to evaluate the compliance to the clinical inclusion / exclusion criteria as well as the CD44v6 expression by tumor cells.|8
10850231|NCT04097301|12017040|FG000|Treated Patients|Overall Study|Of the 8 enrolled patients, 2 were treated with MLM-CAR44.1 T-cell at the first dose level.|2
10850232|NCT04097301|12017040|FG000|COMPLETED|Overall Study||1
10850233|NCT04097301|12017040|FG000|NOT COMPLETED|Overall Study||7
10850234|NCT04054375|12017046|FG000|STARTED|Overall Study||20
10850235|NCT04054375|12017046|FG000|COMPLETED|Overall Study|Due to COVID-19, some participants were not able to come to our site to complete all outcome measurements. Our study team worked with individuals to make them feel safe and collect as much data as we possibly could. This is the reason why some outcome metrics have less than 20 data points. All 20 patients completed the study and took the medication for all 24 weeks.|20
10850236|NCT04054375|12017046|FG000|NOT COMPLETED|Overall Study||0
10850237|NCT03953079|12017053|FG000|STARTED|Core Study||21
10850238|NCT03953079|12017054|FG001|STARTED|Core Study||22
10850239|NCT03953079|12017055|FG002|STARTED|Core Study||13
10850240|NCT03953079|12017053|FG000|COMPLETED|Core Study||20
10850241|NCT03953079|12017054|FG001|COMPLETED|Core Study||18
10850242|NCT03953079|12017055|FG002|COMPLETED|Core Study||12
10850243|NCT03953079|12017053|FG000|NOT COMPLETED|Core Study||1
10850244|NCT03953079|12017054|FG001|NOT COMPLETED|Core Study||4
10850245|NCT03953079|12017055|FG002|NOT COMPLETED|Core Study||1
10850246|NCT03953079|12017053|FG000|STARTED|Extension Study||12
10850247|NCT03953079|12017054|FG001|STARTED|Extension Study||10
10850248|NCT03953079|12017055|FG002|STARTED|Extension Study||6
10850249|NCT03953079|12017053|FG000|COMPLETED|Extension Study||6
10850250|NCT03953079|12017054|FG001|COMPLETED|Extension Study||4
10850251|NCT03953079|12017055|FG002|COMPLETED|Extension Study||1
10850252|NCT03953079|12017053|FG000|NOT COMPLETED|Extension Study||6
10850253|NCT03953079|12017054|FG001|NOT COMPLETED|Extension Study||6
10850254|NCT03953079|12017055|FG002|NOT COMPLETED|Extension Study||5
10850255|NCT03922750|12017067|FG000|STARTED|Overall Study||50
10850256|NCT03922750|12017068|FG001|STARTED|Overall Study||54
10850257|NCT03922750|12017069|FG002|STARTED|Overall Study||50
10850258|NCT03922750|12017067|FG000|Full Analysis Set (FAS)|Overall Study||50
10850259|NCT03922750|12017068|FG001|Full Analysis Set (FAS)|Overall Study||54
10850260|NCT03922750|12017069|FG002|Full Analysis Set (FAS)|Overall Study||50
10850261|NCT03922750|12017067|FG000|Safety Analysis Set (SAS)|Overall Study||50
10850262|NCT03922750|12017068|FG001|Safety Analysis Set (SAS)|Overall Study||54
10850263|NCT03922750|12017069|FG002|Safety Analysis Set (SAS)|Overall Study||50
10850264|NCT03922750|12017067|FG000|COMPLETED|Overall Study||50
10850265|NCT03922750|12017068|FG001|COMPLETED|Overall Study||53
10850266|NCT03922750|12017069|FG002|COMPLETED|Overall Study||49
10850267|NCT03922750|12017067|FG000|NOT COMPLETED|Overall Study||0
10850268|NCT03922750|12017068|FG001|NOT COMPLETED|Overall Study||1
10850269|NCT03922750|12017069|FG002|NOT COMPLETED|Overall Study||1
10850270|NCT03910673|12017082|FG000|STARTED|Overall Study||7
10850271|NCT03910673|12017083|FG001|STARTED|Overall Study||6
10850272|NCT03910673|12017084|FG002|STARTED|Overall Study||7
10850273|NCT03910673|12017085|FG003|STARTED|Overall Study||13
10850274|NCT03910673|12017086|FG004|STARTED|Overall Study||6
10850275|NCT03910673|12017082|FG000|Enrolled and Randomized|Overall Study||6
10850174|NCT04388787|12016967|FG000|STARTED|Blinded Period||16
10850175|NCT04388787|12016967|FG000|Completed First Assessment - Approximately 15 Minutes (Specific Treatment Unknown)|Blinded Period||15
10850176|NCT04388787|12016967|FG000|Completed Second Assessment - Approximately 15 Minutes (Specific Treatment Unknown)|Blinded Period||15
10850177|NCT04388787|12016967|FG000|COMPLETED|Blinded Period||15
10850178|NCT04388787|12016967|FG000|NOT COMPLETED|Blinded Period||1
10850179|NCT04388787|12016967|FG000|STARTED|Unblinded Period||15
10850180|NCT04388787|12016967|FG000|COMPLETED|Unblinded Period||6
10850181|NCT04388787|12016967|FG000|NOT COMPLETED|Unblinded Period||9
10850182|NCT04380090|12016977|FG000|STARTED|Overall Study||76
10850183|NCT04380090|12016978|FG001|STARTED|Overall Study||78
10850184|NCT04380090|12016977|FG000|COMPLETED|Overall Study||60
10850185|NCT04380090|12016978|FG001|COMPLETED|Overall Study||58
10850186|NCT04380090|12016977|FG000|NOT COMPLETED|Overall Study||16
10850187|NCT04380090|12016978|FG001|NOT COMPLETED|Overall Study||20
10850188|NCT04377620|12016991|FG000|STARTED|Overall Study||77
10850189|NCT04377620|12016992|FG001|STARTED|Overall Study||87
10850190|NCT04377620|12016993|FG002|STARTED|Overall Study||47
10850191|NCT04377620|12016991|FG000|COMPLETED|Overall Study||35
10850192|NCT04377620|12016992|FG001|COMPLETED|Overall Study||37
10850193|NCT04377620|12016993|FG002|COMPLETED|Overall Study||11
10850194|NCT04377620|12016991|FG000|NOT COMPLETED|Overall Study||42
10850195|NCT04377620|12016992|FG001|NOT COMPLETED|Overall Study||50
10850196|NCT04377620|12016993|FG002|NOT COMPLETED|Overall Study||36
10850197|NCT04355169|12017006|FG000|STARTED|Overall Study||0
10850198|NCT04355169|12017007|FG001|STARTED|Overall Study||0
10850199|NCT04355169|12017008|FG002|STARTED|Overall Study||0
10850200|NCT04355169|12017009|FG003|STARTED|Overall Study||0
10850201|NCT04355169|12017006|FG000|COMPLETED|Overall Study||0
10850202|NCT04355169|12017007|FG001|COMPLETED|Overall Study||0
10850203|NCT04355169|12017008|FG002|COMPLETED|Overall Study||0
10850204|NCT04355169|12017009|FG003|COMPLETED|Overall Study||0
10850205|NCT04355169|12017006|FG000|NOT COMPLETED|Overall Study||0
10850206|NCT04355169|12017007|FG001|NOT COMPLETED|Overall Study||0
10850207|NCT04355169|12017008|FG002|NOT COMPLETED|Overall Study||0
10850208|NCT04355169|12017009|FG003|NOT COMPLETED|Overall Study||0
10850209|NCT04338971|12017019|FG000|STARTED|Overall Study||24
10850210|NCT04338971|12017019|FG000|COMPLETED|Overall Study||17
10850211|NCT04338971|12017019|FG000|NOT COMPLETED|Overall Study||7
10850212|NCT04310566|12017024|FG000|STARTED|Period 1||31
10850213|NCT04310566|12017025|FG001|STARTED|Period 1||34
10850214|NCT04310566|12017024|FG000|COMPLETED|Period 1||15
10850215|NCT04310566|12017025|FG001|COMPLETED|Period 1||14
10850216|NCT04310566|12017024|FG000|NOT COMPLETED|Period 1||16
10850217|NCT04310566|12017025|FG001|NOT COMPLETED|Period 1||20
10850218|NCT04310566|12017024|FG000|STARTED|Period 2||15
10850219|NCT04310566|12017025|FG001|STARTED|Period 2||14
10850220|NCT04310566|12017024|FG000|COMPLETED|Period 2||8
10850221|NCT04310566|12017025|FG001|COMPLETED|Period 2||9
10850222|NCT04310566|12017024|FG000|NOT COMPLETED|Period 2||7
10850223|NCT04310566|12017025|FG001|NOT COMPLETED|Period 2||5
10850224|NCT04206020|12017033|FG000|STARTED|Overall Study||306
10850225|NCT04206020|12017034|FG001|STARTED|Overall Study||304
10850226|NCT04206020|12017033|FG000|COMPLETED|Overall Study||298
10850227|NCT04206020|12017034|FG001|COMPLETED|Overall Study||297
10850228|NCT04206020|12017033|FG000|NOT COMPLETED|Overall Study||8
10850229|NCT04206020|12017034|FG001|NOT COMPLETED|Overall Study||7
10850276|NCT03910673|12017083|FG001|Enrolled and Randomized|Overall Study||6
10850277|NCT03910673|12017084|FG002|Enrolled and Randomized|Overall Study||6
10850278|NCT03910673|12017085|FG003|Enrolled and Randomized|Overall Study||6
10850279|NCT03910673|12017086|FG004|Enrolled and Randomized|Overall Study||6
10850280|NCT03910673|12017082|FG000|Enrolled as Replacement|Overall Study||1
10850281|NCT03910673|12017083|FG001|Enrolled as Replacement|Overall Study||0
10850282|NCT03910673|12017084|FG002|Enrolled as Replacement|Overall Study||1
10850283|NCT03910673|12017085|FG003|Enrolled as Replacement|Overall Study||7
10850284|NCT03910673|12017086|FG004|Enrolled as Replacement|Overall Study||0
10850285|NCT03910673|12017082|FG000|Began Infusion of Dose 1|Overall Study||7
10850286|NCT03910673|12017083|FG001|Began Infusion of Dose 1|Overall Study||6
10850287|NCT03910673|12017084|FG002|Began Infusion of Dose 1|Overall Study||7
10850288|NCT03910673|12017085|FG003|Began Infusion of Dose 1|Overall Study||13
10850289|NCT03910673|12017086|FG004|Began Infusion of Dose 1|Overall Study||6
10850290|NCT03910673|12017082|FG000|Completed Dose 1|Overall Study||7
10850291|NCT03910673|12017083|FG001|Completed Dose 1|Overall Study||6
10850292|NCT03910673|12017084|FG002|Completed Dose 1|Overall Study||7
10850293|NCT03910673|12017085|FG003|Completed Dose 1|Overall Study||13
10850294|NCT03910673|12017086|FG004|Completed Dose 1|Overall Study||6
10850295|NCT03910673|12017082|FG000|Completed Dose 2|Overall Study||7
10850296|NCT03910673|12017083|FG001|Completed Dose 2|Overall Study||6
10850297|NCT03910673|12017084|FG002|Completed Dose 2|Overall Study||7
10850298|NCT03910673|12017085|FG003|Completed Dose 2|Overall Study||13
10850299|NCT03910673|12017086|FG004|Completed Dose 2|Overall Study||6
10850300|NCT03910673|12017082|FG000|Completed Dose 3|Overall Study||6
10850301|NCT03910673|12017083|FG001|Completed Dose 3|Overall Study||6
10850302|NCT03910673|12017084|FG002|Completed Dose 3|Overall Study||7
10850303|NCT03910673|12017085|FG003|Completed Dose 3|Overall Study||12
10850304|NCT03910673|12017086|FG004|Completed Dose 3|Overall Study||6
10850305|NCT03910673|12017082|FG000|Completed All Scheduled Treatment|Overall Study||6
10850306|NCT03910673|12017083|FG001|Completed All Scheduled Treatment|Overall Study||6
10850307|NCT03910673|12017084|FG002|Completed All Scheduled Treatment|Overall Study||7
10850308|NCT03910673|12017085|FG003|Completed All Scheduled Treatment|Overall Study||12
10850309|NCT03910673|12017086|FG004|Completed All Scheduled Treatment|Overall Study||6
10850310|NCT03910673|12017082|FG000|Completed All PK Blood Draws|Overall Study||6
10850311|NCT03910673|12017083|FG001|Completed All PK Blood Draws|Overall Study||6
10850312|NCT03910673|12017084|FG002|Completed All PK Blood Draws|Overall Study||6
10850313|NCT03910673|12017085|FG003|Completed All PK Blood Draws|Overall Study||6
10850314|NCT03910673|12017086|FG004|Completed All PK Blood Draws|Overall Study||6
10850315|NCT03910673|12017082|FG000|Completed Bronchoscopy With BAL|Overall Study||6
10850316|NCT03910673|12017083|FG001|Completed Bronchoscopy With BAL|Overall Study||6
10850317|NCT03910673|12017084|FG002|Completed Bronchoscopy With BAL|Overall Study||6
10850318|NCT03910673|12017085|FG003|Completed Bronchoscopy With BAL|Overall Study||6
10850319|NCT03910673|12017086|FG004|Completed Bronchoscopy With BAL|Overall Study||6
10850320|NCT03910673|12017082|FG000|Completed All Plasma Urea Samples|Overall Study||6
10850321|NCT03910673|12017083|FG001|Completed All Plasma Urea Samples|Overall Study||6
10850322|NCT03910673|12017084|FG002|Completed All Plasma Urea Samples|Overall Study||6
10850323|NCT03910673|12017085|FG003|Completed All Plasma Urea Samples|Overall Study||6
10850324|NCT03910673|12017086|FG004|Completed All Plasma Urea Samples|Overall Study||6
10850325|NCT03910673|12017082|FG000|At Least One PK Blood Draw Concurrent With BAL Timepoint|Overall Study||6
10850326|NCT03910673|12017083|FG001|At Least One PK Blood Draw Concurrent With BAL Timepoint|Overall Study||6
10850327|NCT03910673|12017084|FG002|At Least One PK Blood Draw Concurrent With BAL Timepoint|Overall Study||6
10850328|NCT03910673|12017085|FG003|At Least One PK Blood Draw Concurrent With BAL Timepoint|Overall Study||6
10850329|NCT03910673|12017086|FG004|At Least One PK Blood Draw Concurrent With BAL Timepoint|Overall Study||6
10413830|NCT00780741|11558150|FG001|STARTED|Overall Study|randomized|81
10413831|NCT00780741|11558149|FG000|6-Month Visit|Overall Study|6 months (±2 weeks) timed from randomization|73
10413832|NCT00780741|11558150|FG001|6-Month Visit|Overall Study|6 months (±2 weeks) timed from randomization|67
10413833|NCT00780741|11558149|FG000|COMPLETED|Overall Study|18 months of age (±4 weeks)|75
10413834|NCT00780741|11558150|FG001|COMPLETED|Overall Study|18 months of age (±4 weeks)|71
10413835|NCT00780741|11558149|FG000|NOT COMPLETED|Overall Study||7
10413836|NCT00780741|11558150|FG001|NOT COMPLETED|Overall Study||10
10413837|NCT00780910|11558157|FG000|STARTED|Overall Study||109
10413838|NCT00780910|11558157|FG000|COMPLETED|Overall Study||107
10413839|NCT00780910|11558157|FG000|NOT COMPLETED|Overall Study||2
10413840|NCT00780962|11558163|FG000|STARTED|Overall Study||200
10413841|NCT00780962|11558164|FG001|STARTED|Overall Study||199
10413842|NCT00780962|11558163|FG000|Second Blood Draw (Outcome Measurement)|Overall Study||185
10413843|NCT00780962|11558164|FG001|Second Blood Draw (Outcome Measurement)|Overall Study||172
10413844|NCT00780962|11558163|FG000|COMPLETED|Overall Study||185
10413845|NCT00780962|11558164|FG001|COMPLETED|Overall Study||172
10413846|NCT00780962|11558163|FG000|NOT COMPLETED|Overall Study||15
10413847|NCT00780962|11558164|FG001|NOT COMPLETED|Overall Study||27
10413848|NCT00780975|11558170|FG000|STARTED|Overall Study||8
10413849|NCT00780975|11558170|FG000|COMPLETED|Overall Study||0
10413850|NCT00780975|11558170|FG000|NOT COMPLETED|Overall Study||8
10413851|NCT00781079|11558176|FG000|STARTED|Overall Study||149
10413852|NCT00781079|11558177|FG001|STARTED|Overall Study||133
10413853|NCT00781079|11558176|FG000|COMPLETED|Overall Study||122
10413854|NCT00781079|11558177|FG001|COMPLETED|Overall Study||116
10413855|NCT00781079|11558176|FG000|NOT COMPLETED|Overall Study||27
10413856|NCT00781079|11558177|FG001|NOT COMPLETED|Overall Study||17
10413857|NCT00781274|11558183|FG000|STARTED|Overall Study||32
10413858|NCT00781274|11558183|FG000|COMPLETED|Overall Study||30
10413859|NCT00781274|11558183|FG000|NOT COMPLETED|Overall Study||2
10413860|NCT00781326|11558187|FG000|STARTED|Phase I|Nine subjects consented; 3 did not meet eligibility criteria. 6 started antidepressant treatment.|6
10413861|NCT00781326|11558187|FG000|COMPLETED|Phase I||2
10413862|NCT00781326|11558187|FG000|NOT COMPLETED|Phase I||4
10413863|NCT00781326|11558187|FG000|STARTED|Phase 2|Study terminated prior to enrollment into Phase II|0
10413864|NCT00781326|11558187|FG000|COMPLETED|Phase 2||0
10413865|NCT00781326|11558187|FG000|NOT COMPLETED|Phase 2||0
10413866|NCT00781365|11558193|FG000|STARTED|Overall Study||228
10413867|NCT00781365|11558194|FG001|STARTED|Overall Study||222
10413868|NCT00781365|11558193|FG000|COMPLETED|Overall Study|completed both 6 and 12 month follow up|194
10413869|NCT00781365|11558194|FG001|COMPLETED|Overall Study|completed both 6 and 12 month follow up|186
10413870|NCT00781365|11558193|FG000|NOT COMPLETED|Overall Study||34
10413871|NCT00781365|11558194|FG001|NOT COMPLETED|Overall Study||36
10413872|NCT00781391|11558203|FG000|STARTED|Overall Study||7036
10413873|NCT00781391|11558204|FG001|STARTED|Overall Study||7035
10413874|NCT00781391|11558205|FG002|STARTED|Overall Study||7034
10850330|NCT03910673|12017082|FG000|COMPLETED|Overall Study||7
10850331|NCT03910673|12017083|FG001|COMPLETED|Overall Study||6
10850332|NCT03910673|12017084|FG002|COMPLETED|Overall Study||7
10413875|NCT00781391|11558203|FG000|Safety Analysis Set (Received Drug)|Overall Study||7012
10413876|NCT00781391|11558204|FG001|Safety Analysis Set (Received Drug)|Overall Study||7012
10413877|NCT00781391|11558205|FG002|Safety Analysis Set (Received Drug)|Overall Study||7002
10413878|NCT00781391|11558203|FG000|mITT Analysis Set (Received Drug)|Overall Study||7012
10413879|NCT00781391|11558204|FG001|mITT Analysis Set (Received Drug)|Overall Study||7012
10413880|NCT00781391|11558205|FG002|mITT Analysis Set (Received Drug)|Overall Study||7002
10413881|NCT00781391|11558203|FG000|Per Protocol Analysis Set|Overall Study||6993
10413882|NCT00781391|11558204|FG001|Per Protocol Analysis Set|Overall Study||6995
10413883|NCT00781391|11558205|FG002|Per Protocol Analysis Set|Overall Study||6982
10413884|NCT00781391|11558203|FG000|COMPLETED|Overall Study||6157
10850333|NCT03910673|12017085|FG003|COMPLETED|Overall Study||11
10850334|NCT03910673|12017086|FG004|COMPLETED|Overall Study||6
10850335|NCT03910673|12017082|FG000|NOT COMPLETED|Overall Study||0
10850336|NCT03910673|12017083|FG001|NOT COMPLETED|Overall Study||0
10850337|NCT03910673|12017084|FG002|NOT COMPLETED|Overall Study||0
10850338|NCT03910673|12017085|FG003|NOT COMPLETED|Overall Study||2
10850339|NCT03910673|12017086|FG004|NOT COMPLETED|Overall Study||0
10850340|NCT03885999|12017090|FG000|STARTED|Overall Study||12
10850341|NCT03885999|12017090|FG000|COMPLETED|Overall Study||11
10850342|NCT03885999|12017090|FG000|NOT COMPLETED|Overall Study||1
10850343|NCT03882970|12017098|FG000|STARTED|Overall Study||359
10850344|NCT03882970|12017099|FG001|STARTED|Overall Study||361
10850345|NCT03882970|12017100|FG002|STARTED|Overall Study||359
10850346|NCT03882970|12017101|FG003|STARTED|Overall Study||365
10850347|NCT03882970|12017098|FG000|Received at Least One Dose of Study Drug|Overall Study||358
10850348|NCT03882970|12017099|FG001|Received at Least One Dose of Study Drug|Overall Study||360
10850349|NCT03882970|12017100|FG002|Received at Least One Dose of Study Drug|Overall Study||359
10850350|NCT03882970|12017101|FG003|Received at Least One Dose of Study Drug|Overall Study||360
10850351|NCT03882970|12017098|FG000|COMPLETED|Overall Study||333
10850352|NCT03882970|12017099|FG001|COMPLETED|Overall Study||321
10850353|NCT03882970|12017100|FG002|COMPLETED|Overall Study||340
10850354|NCT03882970|12017101|FG003|COMPLETED|Overall Study||331
10850355|NCT03882970|12017098|FG000|NOT COMPLETED|Overall Study||26
10850356|NCT03882970|12017099|FG001|NOT COMPLETED|Overall Study||40
10850357|NCT03882970|12017100|FG002|NOT COMPLETED|Overall Study||19
10850358|NCT03882970|12017101|FG003|NOT COMPLETED|Overall Study||34
10850359|NCT03879525|12017117|FG000|STARTED|Overall Study||15
10850360|NCT03879525|12017118|FG001|STARTED|Overall Study||15
10850361|NCT03879525|12017117|FG000|COMPLETED|Overall Study||15
10850362|NCT03879525|12017118|FG001|COMPLETED|Overall Study||15
10850363|NCT03879525|12017117|FG000|NOT COMPLETED|Overall Study||0
10850364|NCT03879525|12017118|FG001|NOT COMPLETED|Overall Study||0
10850365|NCT03867734|12017125|FG000|STARTED|Overall Study||32
10850366|NCT03867734|12017125|FG000|COMPLETED|Overall Study||30
10850367|NCT03867734|12017125|FG000|NOT COMPLETED|Overall Study||2
10850368|NCT03781778|12017135|FG000|STARTED|Overall Study||4
10850369|NCT03781778|12017136|FG001|STARTED|Overall Study||6
10850370|NCT03781778|12017135|FG000|Started Intervention|Overall Study||3
10850371|NCT03781778|12017136|FG001|Started Intervention|Overall Study||4
10850372|NCT03781778|12017135|FG000|COMPLETED|Overall Study||2
10850373|NCT03781778|12017136|FG001|COMPLETED|Overall Study||4
10850374|NCT03781778|12017135|FG000|NOT COMPLETED|Overall Study||2
10850375|NCT03781778|12017136|FG001|NOT COMPLETED|Overall Study||2
10850376|NCT03764735|12017145|FG000|STARTED|Overall Study||151
10850377|NCT03764735|12017146|FG001|STARTED|Overall Study||150
10850378|NCT03764735|12017147|FG002|STARTED|Overall Study||151
10850379|NCT03764735|12017145|FG000|COMPLETED|Overall Study||147
10850380|NCT03764735|12017146|FG001|COMPLETED|Overall Study||144
10850381|NCT03764735|12017147|FG002|COMPLETED|Overall Study||147
10850382|NCT03764735|12017145|FG000|NOT COMPLETED|Overall Study||4
10850383|NCT03764735|12017146|FG001|NOT COMPLETED|Overall Study||6
10413885|NCT00781391|11558204|FG001|COMPLETED|Overall Study||6228
10413886|NCT00781391|11558205|FG002|COMPLETED|Overall Study||6250
10413887|NCT00781391|11558203|FG000|NOT COMPLETED|Overall Study||879
10413888|NCT00781391|11558204|FG001|NOT COMPLETED|Overall Study||807
10413889|NCT00781391|11558205|FG002|NOT COMPLETED|Overall Study||784
10413890|NCT00781456|11558215|FG000|STARTED|Overall Study||58
10413891|NCT00781456|11558216|FG001|STARTED|Overall Study||51
10413892|NCT00781456|11558215|FG000|Received Study Drug|Overall Study||57
10413893|NCT00781456|11558216|FG001|Received Study Drug|Overall Study||49
10413894|NCT00781456|11558215|FG000|COMPLETED|Overall Study||37
10413895|NCT00781456|11558216|FG001|COMPLETED|Overall Study||35
10413896|NCT00781456|11558215|FG000|NOT COMPLETED|Overall Study||21
10413897|NCT00781456|11558216|FG001|NOT COMPLETED|Overall Study||16
10413898|NCT00781508|11558224|FG000|STARTED|Overall Study|"First Intervention (1 day), Washout (48 hours), Second Intervention (1 day)"|5
10413899|NCT00781508|11558225|FG001|STARTED|Overall Study|"First Intervention (1 day), Washout (48 hours), Second Intervention (1 day)"|5
10413900|NCT00781508|11558224|FG000|COMPLETED|Overall Study||5
10413901|NCT00781508|11558225|FG001|COMPLETED|Overall Study||5
10413902|NCT00781508|11558224|FG000|NOT COMPLETED|Overall Study||0
10413903|NCT00781508|11558225|FG001|NOT COMPLETED|Overall Study||0
10413904|NCT00781599|11558235|FG000|STARTED|Overall Study||36
10413905|NCT00781599|11558236|FG001|STARTED|Overall Study||36
10413906|NCT00781599|11558235|FG000|COMPLETED|Overall Study||29
10413907|NCT00781599|11558236|FG001|COMPLETED|Overall Study||32
10413908|NCT00781599|11558235|FG000|NOT COMPLETED|Overall Study||7
10413909|NCT00781599|11558236|FG001|NOT COMPLETED|Overall Study||4
10413910|NCT00781768|11558244|FG000|STARTED|Overall Study||89
10413911|NCT00781768|11558245|FG001|STARTED|Overall Study||92
10413912|NCT00781768|11558244|FG000|COMPLETED|Overall Study||89
10413913|NCT00781768|11558245|FG001|COMPLETED|Overall Study||90
10413914|NCT00781768|11558244|FG000|NOT COMPLETED|Overall Study||0
10413915|NCT00781768|11558245|FG001|NOT COMPLETED|Overall Study||2
10413916|NCT00781859|11558253|FG000|STARTED|Overall Study||219
10413917|NCT00781859|11558254|FG001|STARTED|Overall Study||107
10850384|NCT03764735|12017147|FG002|NOT COMPLETED|Overall Study||4
10850385|NCT03730480|12017155|FG000|STARTED|Overall Study||372
10850386|NCT03730480|12017155|FG000|COMPLETED|Overall Study||371
10850387|NCT03730480|12017155|FG000|NOT COMPLETED|Overall Study||1
10850388|NCT03713073|12017160|FG000|STARTED|Overall Study||19
10850389|NCT03713073|12017160|FG000|Allogenic Amnion Chorion Membrane|Overall Study||19
10292895|NCT01690299|11425700|FG001|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
10292896|NCT01690299|11425701|FG002|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
10292897|NCT01690299|11425702|FG003|COMPLETED|Apremilast Extension Phase (Weeks16-104)||47
10292898|NCT01690299|11425703|FG004|COMPLETED|Apremilast Extension Phase (Weeks16-104)||41
10292899|NCT01690299|11425704|FG005|COMPLETED|Apremilast Extension Phase (Weeks16-104)||50
10292900|NCT01690299|11425699|FG000|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
10292901|NCT01690299|11425700|FG001|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
10292902|NCT01690299|11425701|FG002|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
10292903|NCT01690299|11425702|FG003|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||26
10292904|NCT01690299|11425703|FG004|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||33
10292905|NCT01690299|11425704|FG005|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||30
10292906|NCT01525329|11425727|FG000|STARTED|Overall Study||4
10292907|NCT01525329|11425728|FG001|STARTED|Overall Study||14
10292908|NCT01525329|11425727|FG000|COMPLETED|Overall Study||4
10292909|NCT01525329|11425728|FG001|COMPLETED|Overall Study||14
10292910|NCT01525329|11425727|FG000|NOT COMPLETED|Overall Study||0
10292911|NCT01525329|11425728|FG001|NOT COMPLETED|Overall Study||0
10292912|NCT01482286|11425742|FG000|STARTED|Overall Study||7
10292913|NCT01482286|11425743|FG001|STARTED|Overall Study||7
10292914|NCT01482286|11425744|FG002|STARTED|Overall Study||8
10292915|NCT01482286|11425745|FG003|STARTED|Overall Study||10
10292916|NCT01482286|11425742|FG000|COMPLETED|Overall Study||4
10292917|NCT01482286|11425743|FG001|COMPLETED|Overall Study||4
10413918|NCT00781859|11558253|FG000|COMPLETED|Overall Study||200
10413919|NCT00781859|11558254|FG001|COMPLETED|Overall Study||98
10413920|NCT00781859|11558253|FG000|NOT COMPLETED|Overall Study||19
10413921|NCT00781859|11558254|FG001|NOT COMPLETED|Overall Study||9
10413922|NCT00781885|11558260|FG000|STARTED|Overall Study||19
10413923|NCT00781885|11558260|FG000|Received at Least 1 Dose of Study Drug|Overall Study||19
10413924|NCT00781885|11558260|FG000|COMPLETED|Overall Study||18
10413925|NCT00781885|11558260|FG000|NOT COMPLETED|Overall Study||1
10413926|NCT00781898|11558266|FG000|STARTED|Overall Study||153
10413927|NCT00781898|11558267|FG001|STARTED|Overall Study||155
10413928|NCT00781898|11558266|FG000|COMPLETED|Overall Study||119
10413929|NCT00781898|11558267|FG001|COMPLETED|Overall Study||126
10413930|NCT00781898|11558266|FG000|NOT COMPLETED|Overall Study||34
10413931|NCT00781898|11558267|FG001|NOT COMPLETED|Overall Study||29
10413932|NCT00781911|11558275|FG000|STARTED|Overall Study||31
10413933|NCT00781911|11558276|FG001|STARTED|Overall Study||12
10413934|NCT00781911|11558275|FG000|Received at Least 1 Dose of Study Drug|Overall Study||31
10413935|NCT00781911|11558276|FG001|Received at Least 1 Dose of Study Drug|Overall Study||12
10413936|NCT00781911|11558275|FG000|COMPLETED|Overall Study||25
10413937|NCT00781911|11558276|FG001|COMPLETED|Overall Study||4
10413938|NCT00781911|11558275|FG000|NOT COMPLETED|Overall Study||6
10413939|NCT00781911|11558276|FG001|NOT COMPLETED|Overall Study||8
10413940|NCT00781937|11558286|FG000|STARTED|Main Trial Period Through Week 56||212
10413941|NCT00781937|11558287|FG001|STARTED|Main Trial Period Through Week 56||210
10413942|NCT00781937|11558286|FG000|COMPLETED|Main Trial Period Through Week 56||159
10413943|NCT00781937|11558287|FG001|COMPLETED|Main Trial Period Through Week 56||146
10413944|NCT00781937|11558286|FG000|NOT COMPLETED|Main Trial Period Through Week 56||53
10413945|NCT00781937|11558287|FG001|NOT COMPLETED|Main Trial Period Through Week 56||64
10413946|NCT00781937|11558286|FG000|STARTED|Follow up Period (Week 56-68)||159
10413947|NCT00781937|11558287|FG001|STARTED|Follow up Period (Week 56-68)||146
10413948|NCT00781937|11558286|FG000|COMPLETED|Follow up Period (Week 56-68)||153
10413949|NCT00781937|11558287|FG001|COMPLETED|Follow up Period (Week 56-68)||141
10413950|NCT00781937|11558286|FG000|NOT COMPLETED|Follow up Period (Week 56-68)||6
10413951|NCT00781937|11558287|FG001|NOT COMPLETED|Follow up Period (Week 56-68)||5
10413952|NCT00781950|11558295|FG000|STARTED|Overall Study||52
10413953|NCT00781950|11558296|FG001|STARTED|Overall Study||58
10413954|NCT00781950|11558295|FG000|COMPLETED|Overall Study||41
10413955|NCT00781950|11558296|FG001|COMPLETED|Overall Study||45
10413956|NCT00781950|11558295|FG000|NOT COMPLETED|Overall Study||11
10413957|NCT00781950|11558296|FG001|NOT COMPLETED|Overall Study||13
10413958|NCT00781963|11558305|FG000|STARTED|Overall Study||106
10413959|NCT00781963|11558306|FG001|STARTED|Overall Study||53
10413960|NCT00781963|11558305|FG000|COMPLETED|Overall Study||89
10413961|NCT00781963|11558306|FG001|COMPLETED|Overall Study||51
10413962|NCT00781963|11558305|FG000|NOT COMPLETED|Overall Study||17
10413963|NCT00781963|11558306|FG001|NOT COMPLETED|Overall Study||2
10413964|NCT00782067|11558312|FG000|STARTED|Overall Study||116
10413965|NCT00782067|11558312|FG000|Safety Set (SS)|Overall Study||116
10413966|NCT00782067|11558312|FG000|Primary Efficacy Population (PEP)|Overall Study||89
10413967|NCT00782067|11558312|FG000|COMPLETED|Overall Study||0
10413968|NCT00782067|11558312|FG000|NOT COMPLETED|Overall Study||116
10413969|NCT00782171|11558318|FG000|STARTED|Overall Study||146
10413970|NCT00782171|11558319|FG001|STARTED|Overall Study||134
10413971|NCT00782171|11558318|FG000|20-23 Weeks|Overall Study||135
10413972|NCT00782171|11558319|FG001|20-23 Weeks|Overall Study||124
10850390|NCT03713073|12017160|FG000|Collagen Dressing|Overall Study||19
10850391|NCT03713073|12017160|FG000|COMPLETED|Overall Study||19
10850392|NCT03713073|12017160|FG000|NOT COMPLETED|Overall Study||0
10850393|NCT03713034|12017168|FG000|STARTED|Overall Study||150
10850394|NCT03713034|12017169|FG001|STARTED|Overall Study||146
10850395|NCT03713034|12017168|FG000|COMPLETED|Overall Study||145
10850396|NCT03713034|12017169|FG001|COMPLETED|Overall Study||142
10850397|NCT03713034|12017168|FG000|NOT COMPLETED|Overall Study||5
10850398|NCT03713034|12017169|FG001|NOT COMPLETED|Overall Study||4
10850399|NCT03654404|12017177|FG000|STARTED|Overall Study||20
10850400|NCT03654404|12017177|FG000|COMPLETED|Overall Study||12
10850401|NCT03654404|12017177|FG000|NOT COMPLETED|Overall Study||8
10850402|NCT03567057|12017184|FG000|STARTED|Overall Study||159
10850403|NCT03567057|12017185|FG001|STARTED|Overall Study||151
10850404|NCT03567057|12017186|FG002|STARTED|Overall Study||114
10850405|NCT03567057|12017184|FG000|COMPLETED|Overall Study||64
10850406|NCT03567057|12017185|FG001|COMPLETED|Overall Study||64
10850407|NCT03567057|12017186|FG002|COMPLETED|Overall Study||68
10850408|NCT03567057|12017184|FG000|NOT COMPLETED|Overall Study||95
10850409|NCT03567057|12017185|FG001|NOT COMPLETED|Overall Study||87
10850410|NCT03567057|12017186|FG002|NOT COMPLETED|Overall Study||46
10850411|NCT03548987|12017196|FG000|STARTED|Run-in Period (Week 0 to Week 20)||902
10850412|NCT03548987|12017197|FG001|STARTED|Run-in Period (Week 0 to Week 20)||0
10850413|NCT03548987|12017196|FG000|Safety Analysis Set (SAS)|Run-in Period (Week 0 to Week 20)||902
10850414|NCT03548987|12017197|FG001|Safety Analysis Set (SAS)|Run-in Period (Week 0 to Week 20)||0
10850415|NCT03548987|12017196|FG000|COMPLETED|Run-in Period (Week 0 to Week 20)||803
10850416|NCT03548987|12017197|FG001|COMPLETED|Run-in Period (Week 0 to Week 20)||0
10850417|NCT03548987|12017196|FG000|NOT COMPLETED|Run-in Period (Week 0 to Week 20)||99
10850418|NCT03548987|12017197|FG001|NOT COMPLETED|Run-in Period (Week 0 to Week 20)||0
10850419|NCT03548987|12017196|FG000|STARTED|Maintenance Period (Week 20 to Week 68)||535
10850420|NCT03548987|12017197|FG001|STARTED|Maintenance Period (Week 20 to Week 68)||268
10850421|NCT03548987|12017196|FG000|Full Analysis Set (FAS)|Maintenance Period (Week 20 to Week 68)||535
10850422|NCT03548987|12017197|FG001|Full Analysis Set (FAS)|Maintenance Period (Week 20 to Week 68)||268
10850423|NCT03548987|12017196|FG000|COMPLETED|Maintenance Period (Week 20 to Week 68)||504
10850424|NCT03548987|12017197|FG001|COMPLETED|Maintenance Period (Week 20 to Week 68)||237
10850425|NCT03548987|12017196|FG000|NOT COMPLETED|Maintenance Period (Week 20 to Week 68)||31
10850426|NCT03548987|12017197|FG001|NOT COMPLETED|Maintenance Period (Week 20 to Week 68)||31
10850427|NCT03548064|12017212|FG000|STARTED|Overall Study||12
10850428|NCT03548064|12017213|FG001|STARTED|Overall Study||12
10850429|NCT03548064|12017214|FG002|STARTED|Overall Study||6
10850430|NCT03548064|12017215|FG003|STARTED|Overall Study||12
10850431|NCT03548064|12017216|FG004|STARTED|Overall Study||12
10850432|NCT03548064|12017217|FG005|STARTED|Overall Study||6
10850433|NCT03548064|12017218|FG006|STARTED|Overall Study||12
10850434|NCT03548064|12017219|FG007|STARTED|Overall Study||3
10850435|NCT03548064|12017212|FG000|COMPLETED|Overall Study||12
10850436|NCT03548064|12017213|FG001|COMPLETED|Overall Study||12
10850437|NCT03548064|12017214|FG002|COMPLETED|Overall Study||6
10850438|NCT03548064|12017215|FG003|COMPLETED|Overall Study||11
10850439|NCT03548064|12017216|FG004|COMPLETED|Overall Study||0
10850440|NCT03548064|12017217|FG005|COMPLETED|Overall Study||3
10850441|NCT03548064|12017218|FG006|COMPLETED|Overall Study||12
10850442|NCT03548064|12017219|FG007|COMPLETED|Overall Study||3
10850443|NCT03548064|12017212|FG000|NOT COMPLETED|Overall Study||0
10850444|NCT03548064|12017213|FG001|NOT COMPLETED|Overall Study||0
10850445|NCT03548064|12017214|FG002|NOT COMPLETED|Overall Study||0
10850446|NCT03548064|12017215|FG003|NOT COMPLETED|Overall Study||1
10850447|NCT03548064|12017216|FG004|NOT COMPLETED|Overall Study||12
10850448|NCT03548064|12017217|FG005|NOT COMPLETED|Overall Study||3
10850449|NCT03548064|12017218|FG006|NOT COMPLETED|Overall Study||0
10850450|NCT03548064|12017219|FG007|NOT COMPLETED|Overall Study||0
10850451|NCT03446456|12017245|FG000|STARTED|Overall Study||20
10850452|NCT03446456|12017246|FG001|STARTED|Overall Study||20
10850453|NCT03446456|12017245|FG000|COMPLETED|Overall Study||16
10850454|NCT03446456|12017246|FG001|COMPLETED|Overall Study||16
10850455|NCT03446456|12017245|FG000|NOT COMPLETED|Overall Study||4
10850456|NCT03446456|12017246|FG001|NOT COMPLETED|Overall Study||4
10850457|NCT03382834|12017254|FG000|STARTED|Overall Study||21
10850458|NCT03382834|12017255|FG001|STARTED|Overall Study||10
10850459|NCT03382834|12017254|FG000|COMPLETED|Overall Study||20
10850460|NCT03382834|12017255|FG001|COMPLETED|Overall Study||9
10850461|NCT03382834|12017254|FG000|NOT COMPLETED|Overall Study||1
10850462|NCT03382834|12017255|FG001|NOT COMPLETED|Overall Study||1
10850463|NCT03371823|12017263|FG000|STARTED|Overall Study||8
10850464|NCT03371823|12017264|FG001|STARTED|Overall Study|We had trouble enrolling naive to therapy women with high blood pressure|0
10850465|NCT03371823|12017263|FG000|COMPLETED|Overall Study||7
10850466|NCT03371823|12017264|FG001|COMPLETED|Overall Study||0
10850467|NCT03371823|12017263|FG000|NOT COMPLETED|Overall Study||1
10850468|NCT03371823|12017264|FG001|NOT COMPLETED|Overall Study||0
10850469|NCT03353350|12017274|FG000|STARTED|30-week Core Treatment Period||102
10850470|NCT03353350|12017275|FG001|STARTED|30-week Core Treatment Period||100
10850471|NCT03353350|12017276|FG002|STARTED|30-week Core Treatment Period||101
10850472|NCT03353350|12017277|FG003|STARTED|30-week Core Treatment Period||103
10850473|NCT03353350|12017274|FG000|COMPLETED|30-week Core Treatment Period||80
10850474|NCT03353350|12017275|FG001|COMPLETED|30-week Core Treatment Period||81
10850475|NCT03353350|12017276|FG002|COMPLETED|30-week Core Treatment Period||77
10850476|NCT03353350|12017277|FG003|COMPLETED|30-week Core Treatment Period||81
10850477|NCT03353350|12017274|FG000|NOT COMPLETED|30-week Core Treatment Period||22
10850478|NCT03353350|12017275|FG001|NOT COMPLETED|30-week Core Treatment Period||19
10850479|NCT03353350|12017276|FG002|NOT COMPLETED|30-week Core Treatment Period||24
10850480|NCT03353350|12017277|FG003|NOT COMPLETED|30-week Core Treatment Period||22
10850481|NCT03353350|12017274|FG000|STARTED|26-week Treatment Extension Period||80
10850482|NCT03353350|12017275|FG001|STARTED|26-week Treatment Extension Period||81
10850483|NCT03353350|12017276|FG002|STARTED|26-week Treatment Extension Period||77
10850484|NCT03353350|12017277|FG003|STARTED|26-week Treatment Extension Period||81
10850485|NCT03353350|12017274|FG000|COMPLETED|26-week Treatment Extension Period||75
10850486|NCT03353350|12017275|FG001|COMPLETED|26-week Treatment Extension Period||78
10850487|NCT03353350|12017276|FG002|COMPLETED|26-week Treatment Extension Period||73
10850488|NCT03353350|12017277|FG003|COMPLETED|26-week Treatment Extension Period||67
10850489|NCT03353350|12017274|FG000|NOT COMPLETED|26-week Treatment Extension Period||5
10850490|NCT03353350|12017275|FG001|NOT COMPLETED|26-week Treatment Extension Period||3
10850491|NCT03353350|12017276|FG002|NOT COMPLETED|26-week Treatment Extension Period||4
10850492|NCT03353350|12017277|FG003|NOT COMPLETED|26-week Treatment Extension Period||14
10850493|NCT03350503|12017287|FG000|STARTED|Overall Study||121
10850494|NCT03350503|12017287|FG000|COMPLETED|Overall Study||116
10850495|NCT03350503|12017287|FG000|NOT COMPLETED|Overall Study||5
10850499|NCT03287687|12017297|FG000|STARTED|Overall Study||88
10850500|NCT03287687|12017298|FG001|STARTED|Overall Study||90
10850501|NCT03287687|12017297|FG000|Procedures|Overall Study||88
10850502|NCT03287687|12017298|FG001|Procedures|Overall Study||90
10850503|NCT03287687|12017297|FG000|COMPLETED|Overall Study||88
10850504|NCT03287687|12017298|FG001|COMPLETED|Overall Study||90
10850505|NCT03287687|12017297|FG000|NOT COMPLETED|Overall Study||0
10850506|NCT03287687|12017298|FG001|NOT COMPLETED|Overall Study||0
10850507|NCT03282565|12017307|FG000|STARTED|Overall Study||10
10850508|NCT03282565|12017308|FG001|STARTED|Overall Study||10
10850509|NCT03282565|12017309|FG002|STARTED|Overall Study||10
10850510|NCT03282565|12017307|FG000|COMPLETED|Overall Study||10
10850511|NCT03282565|12017308|FG001|COMPLETED|Overall Study||8
10850512|NCT03282565|12017309|FG002|COMPLETED|Overall Study||8
10850513|NCT03282565|12017307|FG000|NOT COMPLETED|Overall Study||0
10850514|NCT03282565|12017308|FG001|NOT COMPLETED|Overall Study||2
10850515|NCT03282565|12017309|FG002|NOT COMPLETED|Overall Study||2
10850516|NCT03276936|12017319|FG000|STARTED|Overall Study||332
10850517|NCT03276936|12017320|FG001|STARTED|Overall Study||172
10850518|NCT03276936|12017319|FG000|COMPLETED|Overall Study||276
10850519|NCT03276936|12017320|FG001|COMPLETED|Overall Study||134
10850520|NCT03276936|12017319|FG000|NOT COMPLETED|Overall Study||56
10850521|NCT03276936|12017320|FG001|NOT COMPLETED|Overall Study||38
10850522|NCT03271021|12017328|FG000|STARTED|Overall Study||738
10850523|NCT03271021|12017329|FG001|STARTED|Overall Study||750
10850524|NCT03271021|12017328|FG000|COMPLETED|Overall Study||649
10850525|NCT03271021|12017329|FG001|COMPLETED|Overall Study||644
10850526|NCT03271021|12017328|FG000|NOT COMPLETED|Overall Study||89
10850527|NCT03271021|12017329|FG001|NOT COMPLETED|Overall Study||106
10850528|NCT03255083|12017339|FG000|STARTED|Overall Study||6
10850529|NCT03255083|12017340|FG001|STARTED|Overall Study||3
10850530|NCT03255083|12017341|FG002|STARTED|Overall Study||3
10850531|NCT03255083|12017342|FG003|STARTED|Overall Study||1
10850532|NCT03255083|12017339|FG000|COMPLETED|Overall Study||0
10850533|NCT03255083|12017340|FG001|COMPLETED|Overall Study||0
10850534|NCT03255083|12017341|FG002|COMPLETED|Overall Study||0
10850535|NCT03255083|12017342|FG003|COMPLETED|Overall Study||0
10850536|NCT03255083|12017339|FG000|NOT COMPLETED|Overall Study||6
10850537|NCT03255083|12017340|FG001|NOT COMPLETED|Overall Study||3
10850538|NCT03255083|12017341|FG002|NOT COMPLETED|Overall Study||3
10850539|NCT03255083|12017342|FG003|NOT COMPLETED|Overall Study||1
10850540|NCT03227471|12017367|FG000|STARTED|Overall Study||9
10850541|NCT03227471|12017368|FG001|STARTED|Overall Study||30
10850542|NCT03227471|12017369|FG002|STARTED|Overall Study||8
10850543|NCT03227471|12017370|FG003|STARTED|Overall Study||7
10850544|NCT03227471|12017371|FG004|STARTED|Overall Study||25
10850545|NCT03227471|12017372|FG005|STARTED|Overall Study||6
10850546|NCT03227471|12017373|FG006|STARTED|Overall Study||17
10850547|NCT03227471|12017374|FG007|STARTED|Overall Study||12
10850548|NCT03227471|12017375|FG008|STARTED|Overall Study||10
10850549|NCT03227471|12017376|FG009|STARTED|Overall Study||22
10850550|NCT03227471|12017377|FG010|STARTED|Overall Study||21
10850551|NCT03227471|12017378|FG011|STARTED|Overall Study||7
10850552|NCT03227471|12017379|FG012|STARTED|Overall Study||21
10850553|NCT03227471|12017380|FG013|STARTED|Overall Study||8
10850554|NCT03227471|12017381|FG014|STARTED|Overall Study||22
10850555|NCT03227471|12017367|FG000|Safety Set|Overall Study||9
10850556|NCT03227471|12017368|FG001|Safety Set|Overall Study||30
10850557|NCT03227471|12017369|FG002|Safety Set|Overall Study||8
10850558|NCT03227471|12017370|FG003|Safety Set|Overall Study||7
10850559|NCT03227471|12017371|FG004|Safety Set|Overall Study||25
10850560|NCT03227471|12017372|FG005|Safety Set|Overall Study||6
10850561|NCT03227471|12017373|FG006|Safety Set|Overall Study||17
10850562|NCT03227471|12017374|FG007|Safety Set|Overall Study||12
10850563|NCT03227471|12017375|FG008|Safety Set|Overall Study||10
10850564|NCT03227471|12017376|FG009|Safety Set|Overall Study||22
10850565|NCT03227471|12017377|FG010|Safety Set|Overall Study||21
10850566|NCT03227471|12017378|FG011|Safety Set|Overall Study||7
10850567|NCT03227471|12017379|FG012|Safety Set|Overall Study||21
10850568|NCT03227471|12017380|FG013|Safety Set|Overall Study||8
10850569|NCT03227471|12017381|FG014|Safety Set|Overall Study||21
10850570|NCT03227471|12017367|FG000|COMPLETED|Overall Study||9
10850571|NCT03227471|12017368|FG001|COMPLETED|Overall Study||30
10850572|NCT03227471|12017369|FG002|COMPLETED|Overall Study||8
10850573|NCT03227471|12017370|FG003|COMPLETED|Overall Study||7
10850574|NCT03227471|12017371|FG004|COMPLETED|Overall Study||24
10850575|NCT03227471|12017372|FG005|COMPLETED|Overall Study||6
10850576|NCT03227471|12017373|FG006|COMPLETED|Overall Study||17
10850577|NCT03227471|12017374|FG007|COMPLETED|Overall Study||12
10850578|NCT03227471|12017375|FG008|COMPLETED|Overall Study||10
10850579|NCT03227471|12017376|FG009|COMPLETED|Overall Study||22
10850580|NCT03227471|12017377|FG010|COMPLETED|Overall Study||21
10850581|NCT03227471|12017378|FG011|COMPLETED|Overall Study||7
10850582|NCT03227471|12017379|FG012|COMPLETED|Overall Study||20
10850583|NCT03227471|12017380|FG013|COMPLETED|Overall Study||8
10850584|NCT03227471|12017381|FG014|COMPLETED|Overall Study||21
10850585|NCT03227471|12017367|FG000|NOT COMPLETED|Overall Study||0
10850586|NCT03227471|12017368|FG001|NOT COMPLETED|Overall Study||0
10850587|NCT03227471|12017369|FG002|NOT COMPLETED|Overall Study||0
10850588|NCT03227471|12017370|FG003|NOT COMPLETED|Overall Study||0
10850589|NCT03227471|12017371|FG004|NOT COMPLETED|Overall Study||1
10850590|NCT03227471|12017372|FG005|NOT COMPLETED|Overall Study||0
10850591|NCT03227471|12017373|FG006|NOT COMPLETED|Overall Study||0
10850592|NCT03227471|12017374|FG007|NOT COMPLETED|Overall Study||0
10850593|NCT03227471|12017375|FG008|NOT COMPLETED|Overall Study||0
10850594|NCT03227471|12017376|FG009|NOT COMPLETED|Overall Study||0
10850595|NCT03227471|12017377|FG010|NOT COMPLETED|Overall Study||0
10850596|NCT03227471|12017378|FG011|NOT COMPLETED|Overall Study||0
10850597|NCT03227471|12017379|FG012|NOT COMPLETED|Overall Study||1
10850598|NCT03227471|12017380|FG013|NOT COMPLETED|Overall Study||0
10850599|NCT03227471|12017381|FG014|NOT COMPLETED|Overall Study||1
10850612|NCT03194321|12017453|FG000|STARTED|Overall Study||20
10850613|NCT03194321|12017453|FG000|COMPLETED|Overall Study||17
10850614|NCT03194321|12017453|FG000|NOT COMPLETED|Overall Study||3
10850615|NCT03085095|12017459|FG000|STARTED|Overall Study||624
10850616|NCT03085095|12017460|FG001|STARTED|Overall Study||310
10850617|NCT03085095|12017459|FG000|Received at Least 1 Dose of Study Drug|Overall Study||622
10850618|NCT03085095|12017460|FG001|Received at Least 1 Dose of Study Drug|Overall Study||308
10850619|NCT03085095|12017459|FG000|COMPLETED|Overall Study||563
10850620|NCT03085095|12017460|FG001|COMPLETED|Overall Study||276
10850621|NCT03085095|12017459|FG000|NOT COMPLETED|Overall Study||61
10850622|NCT03085095|12017460|FG001|NOT COMPLETED|Overall Study||34
10850623|NCT03048422|12017472|FG000|STARTED|Overall Study||217
10850624|NCT03048422|12017473|FG001|STARTED|Overall Study||215
10850625|NCT03048422|12017474|FG002|STARTED|Overall Study||211
10850626|NCT03048422|12017472|FG000|COMPLETED|Overall Study||200
10850627|NCT03048422|12017473|FG001|COMPLETED|Overall Study||205
10850628|NCT03048422|12017474|FG002|COMPLETED|Overall Study||202
10850629|NCT03048422|12017472|FG000|NOT COMPLETED|Overall Study||17
10850630|NCT03048422|12017473|FG001|NOT COMPLETED|Overall Study||10
10850631|NCT03048422|12017474|FG002|NOT COMPLETED|Overall Study||9
10850632|NCT03032068|12017492|FG000|STARTED|Overall Study||10
10850633|NCT03032068|12017492|FG000|Preoperative Visit|Overall Study||10
10850634|NCT03032068|12017492|FG000|Postoperative Home Care Visit 1|Overall Study||10
10850635|NCT03032068|12017492|FG000|Postoperative Home Care Visit 2|Overall Study||10
10850636|NCT03032068|12017492|FG000|Postoperative Home Care Visit 3|Overall Study||10
10850637|NCT03032068|12017492|FG000|4 Weeks Postoperative Visit|Overall Study||9
10850638|NCT03032068|12017492|FG000|8 Weeks Postoperative Visit|Overall Study||9
10850639|NCT03032068|12017492|FG000|12 Weeks Postoperative Visit|Overall Study||9
10850640|NCT03032068|12017492|FG000|COMPLETED|Overall Study||9
10850641|NCT03032068|12017492|FG000|NOT COMPLETED|Overall Study||1
10850651|NCT02835690|12017512|FG000|STARTED|Overall Study||14
10850652|NCT02835690|12017513|FG001|STARTED|Overall Study||15
10850653|NCT02835690|12017514|FG002|STARTED|Overall Study||15
10850654|NCT02835690|12017512|FG000|Treated|Overall Study||14
10850655|NCT02835690|12017513|FG001|Treated|Overall Study||13
10850656|NCT02835690|12017514|FG002|Treated|Overall Study||15
10850657|NCT02835690|12017512|FG000|COMPLETED|Overall Study||0
10850658|NCT02835690|12017513|FG001|COMPLETED|Overall Study||0
10850659|NCT02835690|12017514|FG002|COMPLETED|Overall Study||0
10850660|NCT02835690|12017512|FG000|NOT COMPLETED|Overall Study||14
10850661|NCT02835690|12017513|FG001|NOT COMPLETED|Overall Study||15
10850662|NCT02835690|12017514|FG002|NOT COMPLETED|Overall Study||15
10850663|NCT02828982|12017522|FG000|STARTED|First Intervention (3 Weeks)||5
10850664|NCT02828982|12017523|FG001|STARTED|First Intervention (3 Weeks)||7
10850665|NCT02828982|12017522|FG000|Received Intervention|First Intervention (3 Weeks)||5
10850666|NCT02828982|12017523|FG001|Received Intervention|First Intervention (3 Weeks)||7
10850667|NCT02828982|12017522|FG000|COMPLETED|First Intervention (3 Weeks)||4
10850668|NCT02828982|12017523|FG001|COMPLETED|First Intervention (3 Weeks)||6
10850669|NCT02828982|12017522|FG000|NOT COMPLETED|First Intervention (3 Weeks)||1
10850670|NCT02828982|12017523|FG001|NOT COMPLETED|First Intervention (3 Weeks)||1
10850671|NCT02828982|12017522|FG000|STARTED|Second Intervention (3 Weeks)||4
10850672|NCT02828982|12017523|FG001|STARTED|Second Intervention (3 Weeks)||6
10850673|NCT02828982|12017522|FG000|Received Intervention|Second Intervention (3 Weeks)||4
10850674|NCT02828982|12017523|FG001|Received Intervention|Second Intervention (3 Weeks)||6
10850675|NCT02828982|12017522|FG000|COMPLETED|Second Intervention (3 Weeks)||4
10850676|NCT02828982|12017523|FG001|COMPLETED|Second Intervention (3 Weeks)||6
10850677|NCT02828982|12017522|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
10850678|NCT02828982|12017523|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
10850679|NCT02823457|12017531|FG000|STARTED|Overall Study||20
10850680|NCT02823457|12017531|FG000|COMPLETED|Overall Study||15
10850681|NCT02823457|12017531|FG000|NOT COMPLETED|Overall Study||5
10850682|NCT02815280|12017537|FG000|STARTED|Double-Blind Phase||333
10850683|NCT02815280|12017538|FG001|STARTED|Double-Blind Phase||162
10850684|NCT02815280|12017537|FG000|COMPLETED|Double-Blind Phase||297
10850685|NCT02815280|12017538|FG001|COMPLETED|Double-Blind Phase||137
10850686|NCT02815280|12017537|FG000|NOT COMPLETED|Double-Blind Phase||36
10850687|NCT02815280|12017538|FG001|NOT COMPLETED|Double-Blind Phase||25
10850688|NCT02815280|12017537|FG000|STARTED|Open-Label Phase||256
10850689|NCT02815280|12017538|FG001|STARTED|Open-Label Phase||117
10850690|NCT02815280|12017537|FG000|COMPLETED|Open-Label Phase||169
10850691|NCT02815280|12017538|FG001|COMPLETED|Open-Label Phase||73
10850692|NCT02815280|12017537|FG000|NOT COMPLETED|Open-Label Phase||87
10850693|NCT02815280|12017538|FG001|NOT COMPLETED|Open-Label Phase||44
10850694|NCT02815267|12017550|FG000|STARTED|Double-Blind Phase||307
10850695|NCT02815267|12017551|FG001|STARTED|Double-Blind Phase||159
10850696|NCT02815267|12017550|FG000|COMPLETED|Double-Blind Phase||274
10850697|NCT02815267|12017551|FG001|COMPLETED|Double-Blind Phase||128
10850698|NCT02815267|12017550|FG000|NOT COMPLETED|Double-Blind Phase||33
10850699|NCT02815267|12017551|FG001|NOT COMPLETED|Double-Blind Phase||31
10850700|NCT02815267|12017550|FG000|STARTED|Open-Label Phase||193
10850701|NCT02815267|12017551|FG001|STARTED|Open-Label Phase||91
10850702|NCT02815267|12017550|FG000|COMPLETED|Open-Label Phase||122
10850703|NCT02815267|12017551|FG001|COMPLETED|Open-Label Phase||50
10850704|NCT02815267|12017550|FG000|NOT COMPLETED|Open-Label Phase||71
10850705|NCT02815267|12017551|FG001|NOT COMPLETED|Open-Label Phase||41
10850706|NCT02802228|12017563|FG000|STARTED|Overall Study||20
10850707|NCT02802228|12017564|FG001|STARTED|Overall Study||10
10850708|NCT02802228|12017563|FG000|COMPLETED|Overall Study||15
10850709|NCT02802228|12017564|FG001|COMPLETED|Overall Study||10
10850710|NCT02802228|12017563|FG000|NOT COMPLETED|Overall Study||5
10850711|NCT02802228|12017564|FG001|NOT COMPLETED|Overall Study||0
10850727|NCT02674516|12017595|FG000|STARTED|Overall Study||17
10850728|NCT02674516|12017596|FG001|STARTED|Overall Study||15
10850729|NCT02674516|12017595|FG000|COMPLETED|Overall Study||13
10850730|NCT02674516|12017596|FG001|COMPLETED|Overall Study||11
10850731|NCT02674516|12017595|FG000|NOT COMPLETED|Overall Study||4
10850732|NCT02674516|12017596|FG001|NOT COMPLETED|Overall Study||4
10850733|NCT02607046|12017604|FG000|STARTED|Overall Study||22
10850734|NCT02607046|12017605|FG001|STARTED|Overall Study||13
10850735|NCT02607046|12017604|FG000|COMPLETED|Overall Study||14
10850736|NCT02607046|12017605|FG001|COMPLETED|Overall Study||10
10850737|NCT02607046|12017604|FG000|NOT COMPLETED|Overall Study||8
10850738|NCT02607046|12017605|FG001|NOT COMPLETED|Overall Study||3
10850739|NCT02505425|12017615|FG000|STARTED|Overall Study||208
10850740|NCT02505425|12017616|FG001|STARTED|Overall Study||207
10850741|NCT02505425|12017617|FG002|STARTED|Overall Study||82
10850742|NCT02505425|12017618|FG003|STARTED|Overall Study||76
10850743|NCT02505425|12017615|FG000|COMPLETED|Overall Study||120
10850744|NCT02505425|12017616|FG001|COMPLETED|Overall Study||125
10850745|NCT02505425|12017617|FG002|COMPLETED|Overall Study||32
10850746|NCT02505425|12017618|FG003|COMPLETED|Overall Study||50
10850747|NCT02505425|12017615|FG000|NOT COMPLETED|Overall Study||88
10850748|NCT02505425|12017616|FG001|NOT COMPLETED|Overall Study||82
10850749|NCT02505425|12017617|FG002|NOT COMPLETED|Overall Study||50
10850750|NCT02505425|12017618|FG003|NOT COMPLETED|Overall Study||26
10850751|NCT02487979|12017628|FG000|STARTED|Overall Study||22
10850752|NCT02487979|12017628|FG000|COMPLETED|Overall Study||1
10850753|NCT02487979|12017628|FG000|NOT COMPLETED|Overall Study||21
10850754|NCT02463448|12017632|FG000|STARTED|Enrollment Through 6 Months||23
10850755|NCT02463448|12017632|FG000|COMPLETED|Enrollment Through 6 Months||20
10850756|NCT02463448|12017632|FG000|NOT COMPLETED|Enrollment Through 6 Months||3
10850757|NCT02463448|12017632|FG000|STARTED|6 Months Through 12 Months||20
10850758|NCT02463448|12017632|FG000|COMPLETED|6 Months Through 12 Months||18
10850759|NCT02463448|12017632|FG000|NOT COMPLETED|6 Months Through 12 Months||2
10850760|NCT02463448|12017632|FG000|STARTED|12 Months Through End of Study||18
10850761|NCT02463448|12017632|FG000|COMPLETED|12 Months Through End of Study||17
10850762|NCT02463448|12017632|FG000|NOT COMPLETED|12 Months Through End of Study||1
10850763|NCT02288897|12017638|FG000|STARTED|Overall Study||12
10850764|NCT02288897|12017639|FG001|STARTED|Overall Study||8
10850765|NCT02288897|12017638|FG000|COMPLETED|Overall Study||12
10850766|NCT02288897|12017639|FG001|COMPLETED|Overall Study||8
10850767|NCT02288897|12017638|FG000|NOT COMPLETED|Overall Study||0
10850768|NCT02288897|12017639|FG001|NOT COMPLETED|Overall Study||0
10850769|NCT02276547|12017645|FG000|STARTED|Overall Study||27
10850770|NCT02276547|12017645|FG000|COMPLETED|Overall Study||23
10850771|NCT02276547|12017645|FG000|NOT COMPLETED|Overall Study||4
10850772|NCT02263885|12017649|FG000|STARTED|Overall Study||20
10850773|NCT02263885|12017649|FG000|COMPLETED|Overall Study||10
10850774|NCT02263885|12017649|FG000|NOT COMPLETED|Overall Study||10
10850778|NCT01995175|12017658|FG000|STARTED|Overall Study||2401
10850779|NCT01995175|12017658|FG000|COMPLETED|Overall Study||2148
10850780|NCT01995175|12017658|FG000|NOT COMPLETED|Overall Study||253
10850781|NCT01883804|12017662|FG000|STARTED|Overall Study||25
10850782|NCT01883804|12017662|FG000|COMPLETED|Overall Study||20
10850783|NCT01883804|12017662|FG000|NOT COMPLETED|Overall Study||5
10850784|NCT01804296|12017666|FG000|STARTED|Overall Study||4
10850785|NCT01804296|12017666|FG000|COMPLETED|Overall Study||4
10850786|NCT01804296|12017666|FG000|NOT COMPLETED|Overall Study||0
10850787|NCT01804270|12017672|FG000|STARTED|Overall Study||2
10850788|NCT01804270|12017673|FG001|STARTED|Overall Study||4
10850789|NCT01804270|12017672|FG000|COMPLETED|Overall Study||1
10850790|NCT01804270|12017673|FG001|COMPLETED|Overall Study||3
10850791|NCT01804270|12017672|FG000|NOT COMPLETED|Overall Study||1
10850792|NCT01804270|12017673|FG001|NOT COMPLETED|Overall Study||1
10850793|NCT01338636|12017679|FG000|STARTED|Overall Study||30
10850794|NCT01338636|12017679|FG000|COMPLETED|Overall Study||22
10850795|NCT01338636|12017679|FG000|NOT COMPLETED|Overall Study||8
10850796|NCT01208974|12017683|FG000|STARTED|NAC-Sparing Mastectomy||21
10850797|NCT01208974|12017684|FG001|STARTED|NAC-Sparing Mastectomy||0
10850798|NCT01208974|12017685|FG002|STARTED|NAC-Sparing Mastectomy||0
10850799|NCT01208974|12017686|FG003|STARTED|NAC-Sparing Mastectomy||0
10850800|NCT01208974|12017683|FG000|COMPLETED|NAC-Sparing Mastectomy||21
10850801|NCT01208974|12017684|FG001|COMPLETED|NAC-Sparing Mastectomy||0
10850802|NCT01208974|12017685|FG002|COMPLETED|NAC-Sparing Mastectomy||0
10850803|NCT01208974|12017686|FG003|COMPLETED|NAC-Sparing Mastectomy||0
10850804|NCT01208974|12017683|FG000|NOT COMPLETED|NAC-Sparing Mastectomy||0
10850805|NCT01208974|12017684|FG001|NOT COMPLETED|NAC-Sparing Mastectomy||0
10850806|NCT01208974|12017685|FG002|NOT COMPLETED|NAC-Sparing Mastectomy||0
10850807|NCT01208974|12017686|FG003|NOT COMPLETED|NAC-Sparing Mastectomy||0
10850808|NCT01208974|12017683|FG000|STARTED|Post-Mastectomy Period (Weeks 1 to 4)||21
10850809|NCT01208974|12017684|FG001|STARTED|Post-Mastectomy Period (Weeks 1 to 4)||0
10850810|NCT01208974|12017685|FG002|STARTED|Post-Mastectomy Period (Weeks 1 to 4)||0
10850811|NCT01208974|12017686|FG003|STARTED|Post-Mastectomy Period (Weeks 1 to 4)||0
10850812|NCT01208974|12017683|FG000|COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||18
10850813|NCT01208974|12017684|FG001|COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||0
10850814|NCT01208974|12017685|FG002|COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||0
10850815|NCT01208974|12017686|FG003|COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||0
10850816|NCT01208974|12017683|FG000|NOT COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||3
10850817|NCT01208974|12017684|FG001|NOT COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||0
10850818|NCT01208974|12017685|FG002|NOT COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||0
10850819|NCT01208974|12017686|FG003|NOT COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||0
10850820|NCT01208974|12017683|FG000|STARTED|Prophylactic NAC RT (Weeks 5 to 8)||0
10850821|NCT01208974|12017684|FG001|STARTED|Prophylactic NAC RT (Weeks 5 to 8)||6
10850822|NCT01208974|12017685|FG002|STARTED|Prophylactic NAC RT (Weeks 5 to 8)||6
10850823|NCT01208974|12017686|FG003|STARTED|Prophylactic NAC RT (Weeks 5 to 8)||6
10850824|NCT01208974|12017683|FG000|Cohort 1: Starting Dose|Prophylactic NAC RT (Weeks 5 to 8)||0
10850825|NCT01208974|12017684|FG001|Cohort 1: Starting Dose|Prophylactic NAC RT (Weeks 5 to 8)||6
10850826|NCT01208974|12017685|FG002|Cohort 1: Starting Dose|Prophylactic NAC RT (Weeks 5 to 8)||0
10850827|NCT01208974|12017686|FG003|Cohort 1: Starting Dose|Prophylactic NAC RT (Weeks 5 to 8)||0
10850828|NCT01208974|12017683|FG000|Cohort 2: 1st Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||0
10850829|NCT01208974|12017684|FG001|Cohort 2: 1st Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||0
10850830|NCT01208974|12017685|FG002|Cohort 2: 1st Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||6
10850831|NCT01208974|12017686|FG003|Cohort 2: 1st Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||0
10850832|NCT01208974|12017683|FG000|Cohort 3: 2nd Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||0
10850833|NCT01208974|12017684|FG001|Cohort 3: 2nd Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||0
10850834|NCT01208974|12017685|FG002|Cohort 3: 2nd Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||0
10850835|NCT01208974|12017686|FG003|Cohort 3: 2nd Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||6
10850836|NCT01208974|12017683|FG000|COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||0
10850837|NCT01208974|12017684|FG001|COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||6
10292924|NCT01452152|11425758|FG000|STARTED|Overall Study||5
10850838|NCT01208974|12017685|FG002|COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||6
10850839|NCT01208974|12017686|FG003|COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||6
10850840|NCT01208974|12017683|FG000|NOT COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||0
10850841|NCT01208974|12017684|FG001|NOT COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||0
10850842|NCT01208974|12017685|FG002|NOT COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||0
10850843|NCT01208974|12017686|FG003|NOT COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||0
10850844|NCT00938912|12017693|FG000|STARTED|Overall Study||365
10413973|NCT00782171|11558318|FG000|1 Year|Overall Study||131
10413974|NCT00782171|11558319|FG001|1 Year|Overall Study||120
10413975|NCT00782171|11558318|FG000|Surgery (Baseline)|Overall Study||138
10413976|NCT00782171|11558319|FG001|Surgery (Baseline)|Overall Study||128
10413977|NCT00782171|11558318|FG000|COMPLETED|Overall Study||124
10413978|NCT00782171|11558319|FG001|COMPLETED|Overall Study||115
10413979|NCT00782171|11558318|FG000|NOT COMPLETED|Overall Study||22
10413980|NCT00782171|11558319|FG001|NOT COMPLETED|Overall Study||19
10413981|NCT00782210|11558328|FG000|STARTED|Overall Study||209
10413982|NCT00782210|11558329|FG001|STARTED|Overall Study||208
10413983|NCT00782210|11558330|FG002|STARTED|Overall Study||207
10413984|NCT00782210|11558328|FG000|COMPLETED|Overall Study||159
10413985|NCT00782210|11558329|FG001|COMPLETED|Overall Study||173
10413986|NCT00782210|11558330|FG002|COMPLETED|Overall Study||172
10413987|NCT00782210|11558328|FG000|NOT COMPLETED|Overall Study||50
10413988|NCT00782210|11558329|FG001|NOT COMPLETED|Overall Study||35
10413989|NCT00782210|11558330|FG002|NOT COMPLETED|Overall Study||35
10413990|NCT00782275|11558347|FG000|STARTED|Overall Study||41
10413991|NCT00782275|11558347|FG000|Treated|Overall Study||40
10413992|NCT00782275|11558347|FG000|Prior VEGFR Response Evaluable|Overall Study|One patient was unevaluable and therefore excluded from related subgroup analyses.|39
10413993|NCT00782275|11558347|FG000|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
10413994|NCT00782275|11558347|FG000|NOT COMPLETED|Overall Study||41
10413995|NCT00782340|11558354|FG000|STARTED|Open Label Titration||263
10413996|NCT00782340|11558355|FG001|STARTED|Open Label Titration||0
10413997|NCT00782340|11558356|FG002|STARTED|Open Label Titration||0
10413998|NCT00782340|11558354|FG000|COMPLETED|Open Label Titration||162
10850845|NCT00938912|12017693|FG000|COMPLETED|Overall Study||254
10850846|NCT00938912|12017693|FG000|NOT COMPLETED|Overall Study||111
10850847|NCT00925652|12017704|FG000|STARTED|Overall Study||13
10850848|NCT00925652|12017705|FG001|STARTED|Overall Study||13
10850849|NCT00925652|12017706|FG002|STARTED|Overall Study||11
10850850|NCT00925652|12017707|FG003|STARTED|Overall Study||13
10850851|NCT00925652|12017704|FG000|Withdraw|Overall Study||6
10850852|NCT00925652|12017705|FG001|Withdraw|Overall Study||5
10850853|NCT00925652|12017706|FG002|Withdraw|Overall Study||3
10850854|NCT00925652|12017707|FG003|Withdraw|Overall Study||1
10850855|NCT00925652|12017704|FG000|Off Treatment Because of Other Complicating Disease|Overall Study||0
10850856|NCT00925652|12017705|FG001|Off Treatment Because of Other Complicating Disease|Overall Study||0
10850857|NCT00925652|12017706|FG002|Off Treatment Because of Other Complicating Disease|Overall Study||2
10850858|NCT00925652|12017707|FG003|Off Treatment Because of Other Complicating Disease|Overall Study||3
10850859|NCT00925652|12017704|FG000|Off Treatment Because of Disease Recurrence|Overall Study||1
10850860|NCT00925652|12017705|FG001|Off Treatment Because of Disease Recurrence|Overall Study||3
10850861|NCT00925652|12017706|FG002|Off Treatment Because of Disease Recurrence|Overall Study||0
10850862|NCT00925652|12017707|FG003|Off Treatment Because of Disease Recurrence|Overall Study||0
10850863|NCT00925652|12017704|FG000|Lost of Follow-up|Overall Study||0
10850864|NCT00925652|12017705|FG001|Lost of Follow-up|Overall Study||1
10850865|NCT00925652|12017706|FG002|Lost of Follow-up|Overall Study||0
10850866|NCT00925652|12017707|FG003|Lost of Follow-up|Overall Study||0
10850867|NCT00925652|12017704|FG000|Death|Overall Study||0
10850868|NCT00925652|12017705|FG001|Death|Overall Study||0
10850869|NCT00925652|12017706|FG002|Death|Overall Study||0
10850870|NCT00925652|12017707|FG003|Death|Overall Study||3
10850871|NCT00925652|12017704|FG000|COMPLETED|Overall Study||6
10850872|NCT00925652|12017705|FG001|COMPLETED|Overall Study||4
10850873|NCT00925652|12017706|FG002|COMPLETED|Overall Study||6
10850874|NCT00925652|12017707|FG003|COMPLETED|Overall Study||6
10850875|NCT00925652|12017704|FG000|NOT COMPLETED|Overall Study||7
10850876|NCT00925652|12017705|FG001|NOT COMPLETED|Overall Study||9
10850877|NCT00925652|12017706|FG002|NOT COMPLETED|Overall Study||5
10850878|NCT00925652|12017707|FG003|NOT COMPLETED|Overall Study||7
10850891|NCT00579826|12017744|FG000|STARTED|Overall Study||29
10850892|NCT00579826|12017745|FG001|STARTED|Overall Study||26
10850893|NCT00579826|12017744|FG000|6 Months|Overall Study|RPFNA for assessment for primary endpoint.|28
10850894|NCT00579826|12017745|FG001|6 Months|Overall Study|RPFNA for assessment for primary endpoint.|25
10850895|NCT00579826|12017744|FG000|COMPLETED|Overall Study|Optional open label letrozole months 6-12; followed by RPFNA,|24
10292925|NCT01452152|11425759|FG001|STARTED|Overall Study||0
10850896|NCT00579826|12017745|FG001|COMPLETED|Overall Study|Optional open label letrozole months 6-12; followed by RPFNA,|23
10850897|NCT00579826|12017744|FG000|NOT COMPLETED|Overall Study||5
10850898|NCT00579826|12017745|FG001|NOT COMPLETED|Overall Study||3
10850899|NCT00322218|12017753|FG000|STARTED|Overall Study||34
10850900|NCT00322218|12017754|FG001|STARTED|Overall Study||34
10850901|NCT00322218|12017753|FG000|Per-Protocol Set|Overall Study||33
10850902|NCT00322218|12017754|FG001|Per-Protocol Set|Overall Study||32
10850903|NCT00322218|12017753|FG000|COMPLETED|Overall Study||31
10850904|NCT00322218|12017754|FG001|COMPLETED|Overall Study||28
10850905|NCT00322218|12017753|FG000|NOT COMPLETED|Overall Study||3
10850906|NCT00322218|12017754|FG001|NOT COMPLETED|Overall Study||6
10850907|NCT00186888|12017763|FG000|STARTED|Overall Study||23
10850908|NCT00186888|12017764|FG001|STARTED|Overall Study||27
10850909|NCT00186888|12017765|FG002|STARTED|Overall Study||55
10850910|NCT00186888|12017763|FG000|Window Therapy|Overall Study||0
10850911|NCT00186888|12017764|FG001|Window Therapy|Overall Study||27
10850912|NCT00186888|12017765|FG002|Window Therapy|Overall Study||0
10850913|NCT00186888|12017763|FG000|COMPLETED|Overall Study||19
10850914|NCT00186888|12017764|FG001|COMPLETED|Overall Study||24
10850915|NCT00186888|12017765|FG002|COMPLETED|Overall Study||55
10850916|NCT00186888|12017763|FG000|NOT COMPLETED|Overall Study||4
10850917|NCT00186888|12017764|FG001|NOT COMPLETED|Overall Study||3
10850918|NCT00186888|12017765|FG002|NOT COMPLETED|Overall Study||0
10850919|NCT04579549|12017800|FG000|STARTED|Overall Study||464
10850920|NCT04579549|12017800|FG000|Number of Individuals Trained In COVID-19 Assay|Overall Study||11
10850921|NCT04579549|12017800|FG000|COMPLETED|Overall Study||464
10850922|NCT04579549|12017800|FG000|NOT COMPLETED|Overall Study||0
10850923|NCT04622709|12017804|FG000|STARTED|Period 1 (First 6 Weeks)||39
10850924|NCT04622709|12017804|FG000|COMPLETED|Period 1 (First 6 Weeks)||36
10850925|NCT04622709|12017804|FG000|NOT COMPLETED|Period 1 (First 6 Weeks)||3
10850926|NCT04622709|12017804|FG000|STARTED|Period 2 (Subsequent 12 Weeks)||36
10850927|NCT04622709|12017804|FG000|COMPLETED|Period 2 (Subsequent 12 Weeks)||32
10850928|NCT04622709|12017804|FG000|NOT COMPLETED|Period 2 (Subsequent 12 Weeks)||4
10850929|NCT04066491|12017811|FG000|STARTED|Overall Study||12
10850930|NCT04066491|12017812|FG001|STARTED|Overall Study||149
10850931|NCT04066491|12017813|FG002|STARTED|Overall Study||148
10850932|NCT04066491|12017811|FG000|Treated|Overall Study||12
10850933|NCT04066491|12017812|FG001|Treated|Overall Study||149
10850934|NCT04066491|12017813|FG002|Treated|Overall Study||146
10850935|NCT04066491|12017811|FG000|COMPLETED|Overall Study||8
10850936|NCT04066491|12017812|FG001|COMPLETED|Overall Study||38
10850937|NCT04066491|12017813|FG002|COMPLETED|Overall Study||39
10850938|NCT04066491|12017811|FG000|NOT COMPLETED|Overall Study||4
10850939|NCT04066491|12017812|FG001|NOT COMPLETED|Overall Study||111
10850940|NCT04066491|12017813|FG002|NOT COMPLETED|Overall Study||109
10850941|NCT03259425|12017822|FG000|STARTED|Overall Study||7
10850942|NCT03259425|12017822|FG000|Surgery|Overall Study||6
10850943|NCT03259425|12017822|FG000|COMPLETED|Overall Study||6
10850944|NCT03259425|12017822|FG000|NOT COMPLETED|Overall Study||1
10850945|NCT03129100|12017831|FG000|STARTED|Lead-In Period (Period 1)||350
10850946|NCT03129100|12017832|FG001|STARTED|Lead-In Period (Period 1)||423
10850947|NCT03129100|12017833|FG002|STARTED|Lead-In Period (Period 1)||0
10850948|NCT03129100|12017834|FG003|STARTED|Lead-In Period (Period 1)||0
10850949|NCT03129100|12017835|FG004|STARTED|Lead-In Period (Period 1)||0
10850950|NCT03129100|12017836|FG005|STARTED|Lead-In Period (Period 1)||0
10850951|NCT03129100|12017837|FG006|STARTED|Lead-In Period (Period 1)||0
10850952|NCT03129100|12017838|FG007|STARTED|Lead-In Period (Period 1)||0
10850953|NCT03129100|12017839|FG008|STARTED|Lead-In Period (Period 1)||0
10850954|NCT03129100|12017840|FG009|STARTED|Lead-In Period (Period 1)||0
10850955|NCT03129100|12017841|FG010|STARTED|Lead-In Period (Period 1)||0
10413999|NCT00782340|11558355|FG001|COMPLETED|Open Label Titration||0
10414000|NCT00782340|11558356|FG002|COMPLETED|Open Label Titration||0
10414001|NCT00782340|11558354|FG000|NOT COMPLETED|Open Label Titration||101
10414002|NCT00782340|11558355|FG001|NOT COMPLETED|Open Label Titration||0
10414003|NCT00782340|11558356|FG002|NOT COMPLETED|Open Label Titration||0
10850956|NCT03129100|12017842|FG011|STARTED|Lead-In Period (Period 1)||0
10850957|NCT03129100|12017843|FG012|STARTED|Lead-In Period (Period 1)||0
10850958|NCT03129100|12017844|FG013|STARTED|Lead-In Period (Period 1)||0
10850959|NCT03129100|12017845|FG014|STARTED|Lead-In Period (Period 1)||0
10850960|NCT03129100|12017846|FG015|STARTED|Lead-In Period (Period 1)||0
10850961|NCT03129100|12017847|FG016|STARTED|Lead-In Period (Period 1)||0
10850962|NCT03129100|12017848|FG017|STARTED|Lead-In Period (Period 1)||0
10850963|NCT03129100|12017849|FG018|STARTED|Lead-In Period (Period 1)||0
10850964|NCT03129100|12017850|FG019|STARTED|Lead-In Period (Period 1)||0
10850965|NCT03129100|12017851|FG020|STARTED|Lead-In Period (Period 1)||0
10850966|NCT03129100|12017852|FG021|STARTED|Lead-In Period (Period 1)||0
10850967|NCT03129100|12017853|FG022|STARTED|Lead-In Period (Period 1)||0
10850968|NCT03129100|12017854|FG023|STARTED|Lead-In Period (Period 1)||0
10850969|NCT03129100|12017855|FG024|STARTED|Lead-In Period (Period 1)||0
10850970|NCT03129100|12017856|FG025|STARTED|Lead-In Period (Period 1)||0
10850971|NCT03129100|12017831|FG000|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||348
10850972|NCT03129100|12017832|FG001|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||423
10292918|NCT01482286|11425744|FG002|COMPLETED|Overall Study||4
10292919|NCT01482286|11425745|FG003|COMPLETED|Overall Study||5
10292920|NCT01482286|11425742|FG000|NOT COMPLETED|Overall Study||3
10292921|NCT01482286|11425743|FG001|NOT COMPLETED|Overall Study||3
10292922|NCT01482286|11425744|FG002|NOT COMPLETED|Overall Study||4
10292923|NCT01482286|11425745|FG003|NOT COMPLETED|Overall Study||5
10292926|NCT01452152|11425760|FG002|STARTED|Overall Study||4
10292927|NCT01452152|11425758|FG000|COMPLETED|Overall Study||0
10292928|NCT01452152|11425759|FG001|COMPLETED|Overall Study||0
10292929|NCT01452152|11425760|FG002|COMPLETED|Overall Study||0
10292930|NCT01452152|11425758|FG000|NOT COMPLETED|Overall Study||5
10292931|NCT01452152|11425759|FG001|NOT COMPLETED|Overall Study||0
10292932|NCT01452152|11425760|FG002|NOT COMPLETED|Overall Study||4
10292933|NCT01313351|11425768|FG000|STARTED|Overall Study||206
10292934|NCT01313351|11425768|FG000|COMPLETED|Overall Study||206
10292935|NCT01313351|11425768|FG000|NOT COMPLETED|Overall Study||0
10292936|NCT01232283|11425775|FG000|STARTED|Placebo Controlled Phase (Weeks 0-16)||275
10292937|NCT01232283|11425776|FG001|STARTED|Placebo Controlled Phase (Weeks 0-16)||138
10292938|NCT01232283|11425777|FG002|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
10292939|NCT01232283|11425778|FG003|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
10292940|NCT01232283|11425779|FG004|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
10292941|NCT01232283|11425780|FG005|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
10292942|NCT01232283|11425781|FG006|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
10850973|NCT03129100|12017833|FG002|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
10850974|NCT03129100|12017834|FG003|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
10850975|NCT03129100|12017835|FG004|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
10850976|NCT03129100|12017836|FG005|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
10850977|NCT03129100|12017837|FG006|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
10850978|NCT03129100|12017838|FG007|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
10850979|NCT03129100|12017839|FG008|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
10850980|NCT03129100|12017840|FG009|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
10850981|NCT03129100|12017841|FG010|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
10850982|NCT03129100|12017842|FG011|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
10850983|NCT03129100|12017843|FG012|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
10850984|NCT03129100|12017844|FG013|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
10850985|NCT03129100|12017845|FG014|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
10850986|NCT03129100|12017846|FG015|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
10850987|NCT03129100|12017847|FG016|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
10850988|NCT03129100|12017848|FG017|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
10850989|NCT03129100|12017849|FG018|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
10850990|NCT03129100|12017850|FG019|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
10850991|NCT03129100|12017851|FG020|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
10850992|NCT03129100|12017852|FG021|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
10850993|NCT03129100|12017853|FG022|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
10850994|NCT03129100|12017854|FG023|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
10850995|NCT03129100|12017855|FG024|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
10850996|NCT03129100|12017856|FG025|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
10850997|NCT03129100|12017831|FG000|COMPLETED|Lead-In Period (Period 1)||335
10850998|NCT03129100|12017832|FG001|COMPLETED|Lead-In Period (Period 1)||406
10850999|NCT03129100|12017833|FG002|COMPLETED|Lead-In Period (Period 1)||0
10851000|NCT03129100|12017834|FG003|COMPLETED|Lead-In Period (Period 1)||0
10851001|NCT03129100|12017835|FG004|COMPLETED|Lead-In Period (Period 1)||0
10851002|NCT03129100|12017836|FG005|COMPLETED|Lead-In Period (Period 1)||0
10851003|NCT03129100|12017837|FG006|COMPLETED|Lead-In Period (Period 1)||0
10851004|NCT03129100|12017838|FG007|COMPLETED|Lead-In Period (Period 1)||0
10851005|NCT03129100|12017839|FG008|COMPLETED|Lead-In Period (Period 1)||0
10851006|NCT03129100|12017840|FG009|COMPLETED|Lead-In Period (Period 1)||0
10851007|NCT03129100|12017841|FG010|COMPLETED|Lead-In Period (Period 1)||0
10851008|NCT03129100|12017842|FG011|COMPLETED|Lead-In Period (Period 1)||0
10851009|NCT03129100|12017843|FG012|COMPLETED|Lead-In Period (Period 1)||0
10851010|NCT03129100|12017844|FG013|COMPLETED|Lead-In Period (Period 1)||0
10851011|NCT03129100|12017845|FG014|COMPLETED|Lead-In Period (Period 1)||0
10851012|NCT03129100|12017846|FG015|COMPLETED|Lead-In Period (Period 1)||0
10851013|NCT03129100|12017847|FG016|COMPLETED|Lead-In Period (Period 1)||0
10851014|NCT03129100|12017848|FG017|COMPLETED|Lead-In Period (Period 1)||0
10851015|NCT03129100|12017849|FG018|COMPLETED|Lead-In Period (Period 1)||0
10851016|NCT03129100|12017850|FG019|COMPLETED|Lead-In Period (Period 1)||0
10851017|NCT03129100|12017851|FG020|COMPLETED|Lead-In Period (Period 1)||0
10851018|NCT03129100|12017852|FG021|COMPLETED|Lead-In Period (Period 1)||0
10851019|NCT03129100|12017853|FG022|COMPLETED|Lead-In Period (Period 1)||0
10851020|NCT03129100|12017854|FG023|COMPLETED|Lead-In Period (Period 1)||0
10851021|NCT03129100|12017855|FG024|COMPLETED|Lead-In Period (Period 1)||0
10851022|NCT03129100|12017856|FG025|COMPLETED|Lead-In Period (Period 1)||0
10851023|NCT03129100|12017831|FG000|NOT COMPLETED|Lead-In Period (Period 1)||15
10851024|NCT03129100|12017832|FG001|NOT COMPLETED|Lead-In Period (Period 1)||17
10851025|NCT03129100|12017833|FG002|NOT COMPLETED|Lead-In Period (Period 1)||0
10851026|NCT03129100|12017834|FG003|NOT COMPLETED|Lead-In Period (Period 1)||0
10851027|NCT03129100|12017835|FG004|NOT COMPLETED|Lead-In Period (Period 1)||0
10851028|NCT03129100|12017836|FG005|NOT COMPLETED|Lead-In Period (Period 1)||0
10851029|NCT03129100|12017837|FG006|NOT COMPLETED|Lead-In Period (Period 1)||0
10851030|NCT03129100|12017838|FG007|NOT COMPLETED|Lead-In Period (Period 1)||0
10851031|NCT03129100|12017839|FG008|NOT COMPLETED|Lead-In Period (Period 1)||0
10414004|NCT00782340|11558354|FG000|STARTED|Randomized Double Blind||0
10414005|NCT00782340|11558355|FG001|STARTED|Randomized Double Blind||82
10414006|NCT00782340|11558356|FG002|STARTED|Randomized Double Blind||80
10414007|NCT00782340|11558354|FG000|COMPLETED|Randomized Double Blind||0
10414008|NCT00782340|11558355|FG001|COMPLETED|Randomized Double Blind||82
10414009|NCT00782340|11558356|FG002|COMPLETED|Randomized Double Blind||80
10414010|NCT00782340|11558354|FG000|NOT COMPLETED|Randomized Double Blind||0
10414011|NCT00782340|11558355|FG001|NOT COMPLETED|Randomized Double Blind||0
10414012|NCT00782340|11558356|FG002|NOT COMPLETED|Randomized Double Blind||0
10414013|NCT00782379|11558363|FG000|STARTED|Overall Study||20
10414014|NCT00782379|11558363|FG000|COMPLETED|Overall Study||20
10414015|NCT00782379|11558363|FG000|NOT COMPLETED|Overall Study||0
10414016|NCT00782418|11558367|FG000|STARTED|Period 1 Procedure/Treatment Groups||3
10414017|NCT00782418|11558368|FG001|STARTED|Period 1 Procedure/Treatment Groups||4
10414018|NCT00782418|11558369|FG002|STARTED|Period 1 Procedure/Treatment Groups||4
10414019|NCT00782418|11558370|FG003|STARTED|Period 1 Procedure/Treatment Groups||2
10851032|NCT03129100|12017840|FG009|NOT COMPLETED|Lead-In Period (Period 1)||0
10851033|NCT03129100|12017841|FG010|NOT COMPLETED|Lead-In Period (Period 1)||0
10851034|NCT03129100|12017842|FG011|NOT COMPLETED|Lead-In Period (Period 1)||0
10851035|NCT03129100|12017843|FG012|NOT COMPLETED|Lead-In Period (Period 1)||0
10851036|NCT03129100|12017844|FG013|NOT COMPLETED|Lead-In Period (Period 1)||0
10851037|NCT03129100|12017845|FG014|NOT COMPLETED|Lead-In Period (Period 1)||0
10851038|NCT03129100|12017846|FG015|NOT COMPLETED|Lead-In Period (Period 1)||0
10851039|NCT03129100|12017847|FG016|NOT COMPLETED|Lead-In Period (Period 1)||0
10851040|NCT03129100|12017848|FG017|NOT COMPLETED|Lead-In Period (Period 1)||0
10851041|NCT03129100|12017849|FG018|NOT COMPLETED|Lead-In Period (Period 1)||0
10851042|NCT03129100|12017850|FG019|NOT COMPLETED|Lead-In Period (Period 1)||0
10851043|NCT03129100|12017851|FG020|NOT COMPLETED|Lead-In Period (Period 1)||0
10851044|NCT03129100|12017852|FG021|NOT COMPLETED|Lead-In Period (Period 1)||0
10851045|NCT03129100|12017853|FG022|NOT COMPLETED|Lead-In Period (Period 1)||0
10851046|NCT03129100|12017854|FG023|NOT COMPLETED|Lead-In Period (Period 1)||0
10851047|NCT03129100|12017855|FG024|NOT COMPLETED|Lead-In Period (Period 1)||0
10851048|NCT03129100|12017856|FG025|NOT COMPLETED|Lead-In Period (Period 1)||0
10851049|NCT03129100|12017831|FG000|STARTED|Period2 Extension Period (Group A and B)|Only Extension Period participants were included.|0
10851050|NCT03129100|12017832|FG001|STARTED|Period2 Extension Period (Group A and B)|Only Extension Period participants were included.|0
10851051|NCT03129100|12017833|FG002|STARTED|Period2 Extension Period (Group A and B)|Participants who entered extension period (Group A).|255
10851052|NCT03129100|12017834|FG003|STARTED|Period2 Extension Period (Group A and B)|Participants who entered extension period (Group A).|318
10851053|NCT03129100|12017835|FG004|STARTED|Period2 Extension Period (Group A and B)|Participants who entered extension period (Group B).|48
10851054|NCT03129100|12017836|FG005|STARTED|Period2 Extension Period (Group A and B)|Participants who entered extension period (Group B).|54
10851055|NCT03129100|12017837|FG006|STARTED|Period2 Extension Period (Group A and B)|Participants who entered extension period (Group B).|53
10851056|NCT03129100|12017838|FG007|STARTED|Period2 Extension Period (Group A and B)||0
10851057|NCT03129100|12017839|FG008|STARTED|Period2 Extension Period (Group A and B)||0
10851058|NCT03129100|12017840|FG009|STARTED|Period2 Extension Period (Group A and B)||0
10851059|NCT03129100|12017841|FG010|STARTED|Period2 Extension Period (Group A and B)||0
10851060|NCT03129100|12017842|FG011|STARTED|Period2 Extension Period (Group A and B)||0
10851061|NCT03129100|12017843|FG012|STARTED|Period2 Extension Period (Group A and B)||0
10851062|NCT03129100|12017844|FG013|STARTED|Period2 Extension Period (Group A and B)||0
10851063|NCT03129100|12017845|FG014|STARTED|Period2 Extension Period (Group A and B)||0
10851064|NCT03129100|12017846|FG015|STARTED|Period2 Extension Period (Group A and B)||0
10851065|NCT03129100|12017847|FG016|STARTED|Period2 Extension Period (Group A and B)||0
10851066|NCT03129100|12017848|FG017|STARTED|Period2 Extension Period (Group A and B)||0
10851067|NCT03129100|12017849|FG018|STARTED|Period2 Extension Period (Group A and B)||0
10851068|NCT03129100|12017850|FG019|STARTED|Period2 Extension Period (Group A and B)||0
10851069|NCT03129100|12017851|FG020|STARTED|Period2 Extension Period (Group A and B)||0
10851070|NCT03129100|12017852|FG021|STARTED|Period2 Extension Period (Group A and B)||0
10851071|NCT03129100|12017853|FG022|STARTED|Period2 Extension Period (Group A and B)||0
10851072|NCT03129100|12017854|FG023|STARTED|Period2 Extension Period (Group A and B)||0
10851073|NCT03129100|12017855|FG024|STARTED|Period2 Extension Period (Group A and B)||0
10851074|NCT03129100|12017856|FG025|STARTED|Period2 Extension Period (Group A and B)||0
10851075|NCT03129100|12017831|FG000|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
10851076|NCT03129100|12017832|FG001|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
10851077|NCT03129100|12017833|FG002|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||255
10851078|NCT03129100|12017834|FG003|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||318
10851079|NCT03129100|12017835|FG004|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||47
10851080|NCT03129100|12017836|FG005|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||54
10851081|NCT03129100|12017837|FG006|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||53
10851082|NCT03129100|12017838|FG007|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
10851083|NCT03129100|12017839|FG008|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
10851084|NCT03129100|12017840|FG009|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
10851372|NCT03129100|12017842|FG011|NOT COMPLETED|Period 3 (Flare)||0
10851085|NCT03129100|12017841|FG010|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
10851086|NCT03129100|12017842|FG011|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
10851087|NCT03129100|12017843|FG012|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
10851088|NCT03129100|12017844|FG013|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
10851089|NCT03129100|12017845|FG014|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
10851090|NCT03129100|12017846|FG015|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
10851091|NCT03129100|12017847|FG016|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
10851092|NCT03129100|12017848|FG017|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
10851093|NCT03129100|12017849|FG018|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
10851094|NCT03129100|12017850|FG019|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
10851095|NCT03129100|12017851|FG020|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
10851096|NCT03129100|12017852|FG021|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
10851097|NCT03129100|12017853|FG022|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
10851098|NCT03129100|12017854|FG023|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
10851099|NCT03129100|12017855|FG024|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
10851100|NCT03129100|12017856|FG025|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
10851101|NCT03129100|12017831|FG000|COMPLETED|Period2 Extension Period (Group A and B)||0
10851102|NCT03129100|12017832|FG001|COMPLETED|Period2 Extension Period (Group A and B)||0
10851103|NCT03129100|12017833|FG002|COMPLETED|Period2 Extension Period (Group A and B)||234
10851104|NCT03129100|12017834|FG003|COMPLETED|Period2 Extension Period (Group A and B)||312
10851105|NCT03129100|12017835|FG004|COMPLETED|Period2 Extension Period (Group A and B)||42
10851106|NCT03129100|12017836|FG005|COMPLETED|Period2 Extension Period (Group A and B)||45
10851107|NCT03129100|12017837|FG006|COMPLETED|Period2 Extension Period (Group A and B)||32
10851108|NCT03129100|12017838|FG007|COMPLETED|Period2 Extension Period (Group A and B)||0
10851109|NCT03129100|12017839|FG008|COMPLETED|Period2 Extension Period (Group A and B)||0
10851110|NCT03129100|12017840|FG009|COMPLETED|Period2 Extension Period (Group A and B)||0
10851111|NCT03129100|12017841|FG010|COMPLETED|Period2 Extension Period (Group A and B)||0
10851112|NCT03129100|12017842|FG011|COMPLETED|Period2 Extension Period (Group A and B)||0
10851113|NCT03129100|12017843|FG012|COMPLETED|Period2 Extension Period (Group A and B)||0
10851114|NCT03129100|12017844|FG013|COMPLETED|Period2 Extension Period (Group A and B)||0
10414020|NCT00782418|11558371|FG004|STARTED|Period 1 Procedure/Treatment Groups||5
10414021|NCT00782418|11558372|FG005|STARTED|Period 1 Procedure/Treatment Groups||5
10414022|NCT00782418|11558373|FG006|STARTED|Period 1 Procedure/Treatment Groups||4
10414023|NCT00782418|11558367|FG000|COMPLETED|Period 1 Procedure/Treatment Groups||1
10414024|NCT00782418|11558368|FG001|COMPLETED|Period 1 Procedure/Treatment Groups||4
10414025|NCT00782418|11558369|FG002|COMPLETED|Period 1 Procedure/Treatment Groups||4
10414026|NCT00782418|11558370|FG003|COMPLETED|Period 1 Procedure/Treatment Groups||2
10414027|NCT00782418|11558371|FG004|COMPLETED|Period 1 Procedure/Treatment Groups||4
10414028|NCT00782418|11558372|FG005|COMPLETED|Period 1 Procedure/Treatment Groups||4
10851115|NCT03129100|12017845|FG014|COMPLETED|Period2 Extension Period (Group A and B)||0
10851116|NCT03129100|12017846|FG015|COMPLETED|Period2 Extension Period (Group A and B)||0
10851117|NCT03129100|12017847|FG016|COMPLETED|Period2 Extension Period (Group A and B)||0
10851118|NCT03129100|12017848|FG017|COMPLETED|Period2 Extension Period (Group A and B)||0
10851119|NCT03129100|12017849|FG018|COMPLETED|Period2 Extension Period (Group A and B)||0
10851120|NCT03129100|12017850|FG019|COMPLETED|Period2 Extension Period (Group A and B)||0
10851121|NCT03129100|12017851|FG020|COMPLETED|Period2 Extension Period (Group A and B)||0
10851122|NCT03129100|12017852|FG021|COMPLETED|Period2 Extension Period (Group A and B)||0
10851123|NCT03129100|12017853|FG022|COMPLETED|Period2 Extension Period (Group A and B)||0
10851124|NCT03129100|12017854|FG023|COMPLETED|Period2 Extension Period (Group A and B)||0
10851125|NCT03129100|12017855|FG024|COMPLETED|Period2 Extension Period (Group A and B)||0
10851126|NCT03129100|12017856|FG025|COMPLETED|Period2 Extension Period (Group A and B)||0
10851127|NCT03129100|12017831|FG000|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
10851128|NCT03129100|12017832|FG001|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
10851129|NCT03129100|12017833|FG002|NOT COMPLETED|Period2 Extension Period (Group A and B)||21
10851130|NCT03129100|12017834|FG003|NOT COMPLETED|Period2 Extension Period (Group A and B)||6
10851131|NCT03129100|12017835|FG004|NOT COMPLETED|Period2 Extension Period (Group A and B)||6
10851132|NCT03129100|12017836|FG005|NOT COMPLETED|Period2 Extension Period (Group A and B)||9
10851133|NCT03129100|12017837|FG006|NOT COMPLETED|Period2 Extension Period (Group A and B)||21
10851134|NCT03129100|12017838|FG007|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
10851135|NCT03129100|12017839|FG008|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
10851136|NCT03129100|12017840|FG009|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
10851137|NCT03129100|12017841|FG010|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
10851138|NCT03129100|12017842|FG011|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
10851139|NCT03129100|12017843|FG012|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
10851140|NCT03129100|12017844|FG013|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
10851141|NCT03129100|12017845|FG014|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
10851142|NCT03129100|12017846|FG015|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
10851143|NCT03129100|12017847|FG016|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
10851144|NCT03129100|12017848|FG017|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
10851145|NCT03129100|12017849|FG018|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
10851146|NCT03129100|12017850|FG019|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
10851147|NCT03129100|12017851|FG020|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
10851148|NCT03129100|12017852|FG021|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
10851149|NCT03129100|12017853|FG022|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
10851150|NCT03129100|12017854|FG023|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
10851151|NCT03129100|12017855|FG024|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
10851152|NCT03129100|12017856|FG025|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
10851153|NCT03129100|12017831|FG000|STARTED|Period 2 (Retreatment Extension Period)||0
10851154|NCT03129100|12017832|FG001|STARTED|Period 2 (Retreatment Extension Period)||0
10414029|NCT00782418|11558373|FG006|COMPLETED|Period 1 Procedure/Treatment Groups||4
10851155|NCT03129100|12017833|FG002|STARTED|Period 2 (Retreatment Extension Period)||0
10851156|NCT03129100|12017834|FG003|STARTED|Period 2 (Retreatment Extension Period)||0
10851157|NCT03129100|12017835|FG004|STARTED|Period 2 (Retreatment Extension Period)||0
10851158|NCT03129100|12017836|FG005|STARTED|Period 2 (Retreatment Extension Period)||0
10851159|NCT03129100|12017837|FG006|STARTED|Period 2 (Retreatment Extension Period)||0
10851160|NCT03129100|12017838|FG007|STARTED|Period 2 (Retreatment Extension Period)|Participants who experienced flare in Group B Extension period.|6
10851161|NCT03129100|12017839|FG008|STARTED|Period 2 (Retreatment Extension Period)|Participants who experienced flare in Group B Extension period.|5
10851162|NCT03129100|12017840|FG009|STARTED|Period 2 (Retreatment Extension Period)|Participants who experienced flare in Group B Extension period.|9
10851163|NCT03129100|12017841|FG010|STARTED|Period 2 (Retreatment Extension Period)|Participants who experienced flare in Group B Extension period.|10
10851164|NCT03129100|12017842|FG011|STARTED|Period 2 (Retreatment Extension Period)||0
10851165|NCT03129100|12017843|FG012|STARTED|Period 2 (Retreatment Extension Period)||0
10851166|NCT03129100|12017844|FG013|STARTED|Period 2 (Retreatment Extension Period)||0
10851167|NCT03129100|12017845|FG014|STARTED|Period 2 (Retreatment Extension Period)||0
10851168|NCT03129100|12017846|FG015|STARTED|Period 2 (Retreatment Extension Period)||0
10851169|NCT03129100|12017847|FG016|STARTED|Period 2 (Retreatment Extension Period)||0
10851170|NCT03129100|12017848|FG017|STARTED|Period 2 (Retreatment Extension Period)||0
10851171|NCT03129100|12017849|FG018|STARTED|Period 2 (Retreatment Extension Period)||0
10851172|NCT03129100|12017850|FG019|STARTED|Period 2 (Retreatment Extension Period)||0
10851173|NCT03129100|12017851|FG020|STARTED|Period 2 (Retreatment Extension Period)||0
10851174|NCT03129100|12017852|FG021|STARTED|Period 2 (Retreatment Extension Period)||0
10851175|NCT03129100|12017853|FG022|STARTED|Period 2 (Retreatment Extension Period)||0
10851176|NCT03129100|12017854|FG023|STARTED|Period 2 (Retreatment Extension Period)||0
10851177|NCT03129100|12017855|FG024|STARTED|Period 2 (Retreatment Extension Period)||0
10851178|NCT03129100|12017856|FG025|STARTED|Period 2 (Retreatment Extension Period)||0
10851179|NCT03129100|12017831|FG000|COMPLETED|Period 2 (Retreatment Extension Period)||0
10851180|NCT03129100|12017832|FG001|COMPLETED|Period 2 (Retreatment Extension Period)||0
10851181|NCT03129100|12017833|FG002|COMPLETED|Period 2 (Retreatment Extension Period)||0
10851182|NCT03129100|12017834|FG003|COMPLETED|Period 2 (Retreatment Extension Period)||0
10414030|NCT00782418|11558367|FG000|NOT COMPLETED|Period 1 Procedure/Treatment Groups||2
10414031|NCT00782418|11558368|FG001|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
10414032|NCT00782418|11558369|FG002|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
10414033|NCT00782418|11558370|FG003|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
10414034|NCT00782418|11558371|FG004|NOT COMPLETED|Period 1 Procedure/Treatment Groups||1
10414035|NCT00782418|11558372|FG005|NOT COMPLETED|Period 1 Procedure/Treatment Groups||1
10414036|NCT00782418|11558373|FG006|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
10414037|NCT00782418|11558367|FG000|STARTED|Period 2 Procedure/Treatment Groups||3
10414038|NCT00782418|11558368|FG001|STARTED|Period 2 Procedure/Treatment Groups||4
10414039|NCT00782418|11558369|FG002|STARTED|Period 2 Procedure/Treatment Groups||4
10414040|NCT00782418|11558370|FG003|STARTED|Period 2 Procedure/Treatment Groups||1
10414041|NCT00782418|11558371|FG004|STARTED|Period 2 Procedure/Treatment Groups||3
10414042|NCT00782418|11558372|FG005|STARTED|Period 2 Procedure/Treatment Groups||4
10414043|NCT00782418|11558373|FG006|STARTED|Period 2 Procedure/Treatment Groups||4
10414044|NCT00782418|11558367|FG000|COMPLETED|Period 2 Procedure/Treatment Groups||3
10414045|NCT00782418|11558368|FG001|COMPLETED|Period 2 Procedure/Treatment Groups||4
10414046|NCT00782418|11558369|FG002|COMPLETED|Period 2 Procedure/Treatment Groups||4
10414047|NCT00782418|11558370|FG003|COMPLETED|Period 2 Procedure/Treatment Groups||1
10414048|NCT00782418|11558371|FG004|COMPLETED|Period 2 Procedure/Treatment Groups||3
10414049|NCT00782418|11558372|FG005|COMPLETED|Period 2 Procedure/Treatment Groups||4
10414050|NCT00782418|11558373|FG006|COMPLETED|Period 2 Procedure/Treatment Groups||4
10414051|NCT00782418|11558367|FG000|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
10414052|NCT00782418|11558368|FG001|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
10414053|NCT00782418|11558369|FG002|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
10414054|NCT00782418|11558370|FG003|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
10851183|NCT03129100|12017835|FG004|COMPLETED|Period 2 (Retreatment Extension Period)||0
10292943|NCT01232283|11425782|FG007|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
10292944|NCT01232283|11425783|FG008|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
10292945|NCT01232283|11425784|FG009|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
10851184|NCT03129100|12017836|FG005|COMPLETED|Period 2 (Retreatment Extension Period)||0
10851185|NCT03129100|12017837|FG006|COMPLETED|Period 2 (Retreatment Extension Period)||0
10851186|NCT03129100|12017838|FG007|COMPLETED|Period 2 (Retreatment Extension Period)||6
10851187|NCT03129100|12017839|FG008|COMPLETED|Period 2 (Retreatment Extension Period)||5
10851188|NCT03129100|12017840|FG009|COMPLETED|Period 2 (Retreatment Extension Period)||8
10851189|NCT03129100|12017841|FG010|COMPLETED|Period 2 (Retreatment Extension Period)||10
10851190|NCT03129100|12017842|FG011|COMPLETED|Period 2 (Retreatment Extension Period)||0
10851191|NCT03129100|12017843|FG012|COMPLETED|Period 2 (Retreatment Extension Period)||0
10851192|NCT03129100|12017844|FG013|COMPLETED|Period 2 (Retreatment Extension Period)||0
10851193|NCT03129100|12017845|FG014|COMPLETED|Period 2 (Retreatment Extension Period)||0
10851194|NCT03129100|12017846|FG015|COMPLETED|Period 2 (Retreatment Extension Period)||0
10851195|NCT03129100|12017847|FG016|COMPLETED|Period 2 (Retreatment Extension Period)||0
10851196|NCT03129100|12017848|FG017|COMPLETED|Period 2 (Retreatment Extension Period)||0
10851197|NCT03129100|12017849|FG018|COMPLETED|Period 2 (Retreatment Extension Period)||0
10851198|NCT03129100|12017850|FG019|COMPLETED|Period 2 (Retreatment Extension Period)||0
10851199|NCT03129100|12017851|FG020|COMPLETED|Period 2 (Retreatment Extension Period)||0
10851200|NCT03129100|12017852|FG021|COMPLETED|Period 2 (Retreatment Extension Period)||0
10851201|NCT03129100|12017853|FG022|COMPLETED|Period 2 (Retreatment Extension Period)||0
10851202|NCT03129100|12017854|FG023|COMPLETED|Period 2 (Retreatment Extension Period)||0
10851203|NCT03129100|12017855|FG024|COMPLETED|Period 2 (Retreatment Extension Period)||0
10851204|NCT03129100|12017856|FG025|COMPLETED|Period 2 (Retreatment Extension Period)||0
10851205|NCT03129100|12017831|FG000|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
10851206|NCT03129100|12017832|FG001|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
10851207|NCT03129100|12017833|FG002|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
10851208|NCT03129100|12017834|FG003|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
10851209|NCT03129100|12017835|FG004|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
10414055|NCT00782418|11558371|FG004|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
10414056|NCT00782418|11558372|FG005|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
10414057|NCT00782418|11558373|FG006|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
10414058|NCT00782496|11558389|FG000|STARTED|Overall Study||106
10414059|NCT00782496|11558390|FG001|STARTED|Overall Study||105
10414060|NCT00782496|11558389|FG000|COMPLETED|Overall Study||92
10414061|NCT00782496|11558390|FG001|COMPLETED|Overall Study||90
10414062|NCT00782496|11558389|FG000|NOT COMPLETED|Overall Study||14
10414063|NCT00782496|11558390|FG001|NOT COMPLETED|Overall Study||15
10414064|NCT00782509|11558400|FG000|STARTED|Overall Study||216
10414065|NCT00782509|11558401|FG001|STARTED|Overall Study||209
10414066|NCT00782509|11558402|FG002|STARTED|Overall Study||217
10414067|NCT00782509|11558400|FG000|COMPLETED|Overall Study||175
10851210|NCT03129100|12017836|FG005|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
10851211|NCT03129100|12017837|FG006|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
10851212|NCT03129100|12017838|FG007|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
10851213|NCT03129100|12017839|FG008|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
10851214|NCT03129100|12017840|FG009|NOT COMPLETED|Period 2 (Retreatment Extension Period)||1
10851215|NCT03129100|12017841|FG010|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
10292946|NCT01232283|11425775|FG000|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)|1 protocol violation occurred|272
10292947|NCT01232283|11425776|FG001|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)|1 protocol violation occurred|136
10292948|NCT01232283|11425777|FG002|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
10292949|NCT01232283|11425778|FG003|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
10292950|NCT01232283|11425779|FG004|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
10292951|NCT01232283|11425780|FG005|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
10292952|NCT01232283|11425781|FG006|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
10292953|NCT01232283|11425782|FG007|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
10292954|NCT01232283|11425783|FG008|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
10292955|NCT01232283|11425784|FG009|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
10292956|NCT01232283|11425775|FG000|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||239
10292957|NCT01232283|11425776|FG001|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||112
10292958|NCT01232283|11425777|FG002|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
10292959|NCT01232283|11425778|FG003|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
10292960|NCT01232283|11425779|FG004|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
10292961|NCT01232283|11425780|FG005|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
10292962|NCT01232283|11425781|FG006|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
10292963|NCT01232283|11425782|FG007|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
10292964|NCT01232283|11425783|FG008|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
10292965|NCT01232283|11425784|FG009|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
10414068|NCT00782509|11558401|FG001|COMPLETED|Overall Study||185
10851216|NCT03129100|12017842|FG011|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
10851217|NCT03129100|12017843|FG012|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
10851218|NCT03129100|12017844|FG013|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
10851219|NCT03129100|12017845|FG014|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
10851220|NCT03129100|12017846|FG015|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
10851221|NCT03129100|12017847|FG016|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
10851222|NCT03129100|12017848|FG017|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
10851223|NCT03129100|12017849|FG018|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
10851224|NCT03129100|12017850|FG019|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
10851225|NCT03129100|12017851|FG020|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
10851373|NCT03129100|12017843|FG012|NOT COMPLETED|Period 3 (Flare)||0
10851226|NCT03129100|12017852|FG021|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
10851227|NCT03129100|12017853|FG022|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
10851228|NCT03129100|12017854|FG023|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
10851229|NCT03129100|12017855|FG024|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
10851230|NCT03129100|12017856|FG025|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
10851231|NCT03129100|12017831|FG000|STARTED|Period3-Long-Term Extension Period A & B||0
10851232|NCT03129100|12017832|FG001|STARTED|Period3-Long-Term Extension Period A & B||0
10851233|NCT03129100|12017833|FG002|STARTED|Period3-Long-Term Extension Period A & B||0
10851234|NCT03129100|12017834|FG003|STARTED|Period3-Long-Term Extension Period A & B||0
10851235|NCT03129100|12017835|FG004|STARTED|Period3-Long-Term Extension Period A & B||0
10851236|NCT03129100|12017836|FG005|STARTED|Period3-Long-Term Extension Period A & B||0
10851237|NCT03129100|12017837|FG006|STARTED|Period3-Long-Term Extension Period A & B||0
10851238|NCT03129100|12017838|FG007|STARTED|Period3-Long-Term Extension Period A & B|This period is to report Long-Term Extension Period participants|0
10851239|NCT03129100|12017839|FG008|STARTED|Period3-Long-Term Extension Period A & B|This period is to report Long-Term Extension Period participants|0
10851240|NCT03129100|12017840|FG009|STARTED|Period3-Long-Term Extension Period A & B|This period is to report Long-Term Extension Period participants|0
10851241|NCT03129100|12017841|FG010|STARTED|Period3-Long-Term Extension Period A & B|This period is to report Long-Term Extension Period participants|0
10851242|NCT03129100|12017842|FG011|STARTED|Period3-Long-Term Extension Period A & B|This period is to report Long-Term Extension Period participants|306
10851243|NCT03129100|12017843|FG012|STARTED|Period3-Long-Term Extension Period A & B|This period is to report Long-Term Extension Period participants|177
10851244|NCT03129100|12017844|FG013|STARTED|Period3-Long-Term Extension Period A & B|This period is to report Long-Term Extension Period participants|45
10851245|NCT03129100|12017845|FG014|STARTED|Period3-Long-Term Extension Period A & B|This period is to report Long-Term Extension Period participants|42
10851246|NCT03129100|12017846|FG015|STARTED|Period3-Long-Term Extension Period A & B|This period is to report Long-Term Extension Period participants|30
10851247|NCT03129100|12017847|FG016|STARTED|Period3-Long-Term Extension Period A & B||0
10851248|NCT03129100|12017848|FG017|STARTED|Period3-Long-Term Extension Period A & B||0
10851249|NCT03129100|12017849|FG018|STARTED|Period3-Long-Term Extension Period A & B||0
10851250|NCT03129100|12017850|FG019|STARTED|Period3-Long-Term Extension Period A & B||0
10851251|NCT03129100|12017851|FG020|STARTED|Period3-Long-Term Extension Period A & B||0
10851252|NCT03129100|12017852|FG021|STARTED|Period3-Long-Term Extension Period A & B||0
10851253|NCT03129100|12017853|FG022|STARTED|Period3-Long-Term Extension Period A & B||0
10851254|NCT03129100|12017854|FG023|STARTED|Period3-Long-Term Extension Period A & B||0
10851255|NCT03129100|12017855|FG024|STARTED|Period3-Long-Term Extension Period A & B||0
10851256|NCT03129100|12017856|FG025|STARTED|Period3-Long-Term Extension Period A & B||0
10851257|NCT03129100|12017831|FG000|COMPLETED|Period3-Long-Term Extension Period A & B||0
10851258|NCT03129100|12017832|FG001|COMPLETED|Period3-Long-Term Extension Period A & B||0
10851259|NCT03129100|12017833|FG002|COMPLETED|Period3-Long-Term Extension Period A & B||0
10851260|NCT03129100|12017834|FG003|COMPLETED|Period3-Long-Term Extension Period A & B||0
10851261|NCT03129100|12017835|FG004|COMPLETED|Period3-Long-Term Extension Period A & B||0
10851262|NCT03129100|12017836|FG005|COMPLETED|Period3-Long-Term Extension Period A & B||0
10851263|NCT03129100|12017837|FG006|COMPLETED|Period3-Long-Term Extension Period A & B||0
10851264|NCT03129100|12017838|FG007|COMPLETED|Period3-Long-Term Extension Period A & B||0
10851265|NCT03129100|12017839|FG008|COMPLETED|Period3-Long-Term Extension Period A & B||0
10851266|NCT03129100|12017840|FG009|COMPLETED|Period3-Long-Term Extension Period A & B||0
10851267|NCT03129100|12017841|FG010|COMPLETED|Period3-Long-Term Extension Period A & B||0
10851268|NCT03129100|12017842|FG011|COMPLETED|Period3-Long-Term Extension Period A & B||287
10851269|NCT03129100|12017843|FG012|COMPLETED|Period3-Long-Term Extension Period A & B||146
10851270|NCT03129100|12017844|FG013|COMPLETED|Period3-Long-Term Extension Period A & B||40
10851271|NCT03129100|12017845|FG014|COMPLETED|Period3-Long-Term Extension Period A & B||37
10851272|NCT03129100|12017846|FG015|COMPLETED|Period3-Long-Term Extension Period A & B||21
10851273|NCT03129100|12017847|FG016|COMPLETED|Period3-Long-Term Extension Period A & B||0
10851274|NCT03129100|12017848|FG017|COMPLETED|Period3-Long-Term Extension Period A & B||0
10851275|NCT03129100|12017849|FG018|COMPLETED|Period3-Long-Term Extension Period A & B||0
10851276|NCT03129100|12017850|FG019|COMPLETED|Period3-Long-Term Extension Period A & B||0
10851277|NCT03129100|12017851|FG020|COMPLETED|Period3-Long-Term Extension Period A & B||0
10851278|NCT03129100|12017852|FG021|COMPLETED|Period3-Long-Term Extension Period A & B||0
10851279|NCT03129100|12017853|FG022|COMPLETED|Period3-Long-Term Extension Period A & B||0
10851280|NCT03129100|12017854|FG023|COMPLETED|Period3-Long-Term Extension Period A & B||0
10851281|NCT03129100|12017855|FG024|COMPLETED|Period3-Long-Term Extension Period A & B||0
10851282|NCT03129100|12017856|FG025|COMPLETED|Period3-Long-Term Extension Period A & B||0
10851283|NCT03129100|12017831|FG000|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
10851284|NCT03129100|12017832|FG001|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
10851285|NCT03129100|12017833|FG002|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
10851286|NCT03129100|12017834|FG003|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
10851287|NCT03129100|12017835|FG004|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
10851288|NCT03129100|12017836|FG005|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
10851289|NCT03129100|12017837|FG006|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
10851290|NCT03129100|12017838|FG007|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
10851291|NCT03129100|12017839|FG008|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
10851292|NCT03129100|12017840|FG009|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
10851293|NCT03129100|12017841|FG010|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
10851294|NCT03129100|12017842|FG011|NOT COMPLETED|Period3-Long-Term Extension Period A & B||19
10851295|NCT03129100|12017843|FG012|NOT COMPLETED|Period3-Long-Term Extension Period A & B||31
10851296|NCT03129100|12017844|FG013|NOT COMPLETED|Period3-Long-Term Extension Period A & B||5
10851297|NCT03129100|12017845|FG014|NOT COMPLETED|Period3-Long-Term Extension Period A & B||5
10851298|NCT03129100|12017846|FG015|NOT COMPLETED|Period3-Long-Term Extension Period A & B||9
10851299|NCT03129100|12017847|FG016|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
10851300|NCT03129100|12017848|FG017|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
10851301|NCT03129100|12017849|FG018|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
10851302|NCT03129100|12017850|FG019|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
10851303|NCT03129100|12017851|FG020|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
10851304|NCT03129100|12017852|FG021|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
10851305|NCT03129100|12017853|FG022|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
10851306|NCT03129100|12017854|FG023|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
10851307|NCT03129100|12017855|FG024|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
10851308|NCT03129100|12017856|FG025|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
10851309|NCT03129100|12017831|FG000|STARTED|Period 3 (Flare)||0
10851310|NCT03129100|12017832|FG001|STARTED|Period 3 (Flare)||0
10851311|NCT03129100|12017833|FG002|STARTED|Period 3 (Flare)||0
10851312|NCT03129100|12017834|FG003|STARTED|Period 3 (Flare)||0
10851313|NCT03129100|12017835|FG004|STARTED|Period 3 (Flare)||0
10851314|NCT03129100|12017836|FG005|STARTED|Period 3 (Flare)||0
10851315|NCT03129100|12017837|FG006|STARTED|Period 3 (Flare)||0
10851316|NCT03129100|12017838|FG007|STARTED|Period 3 (Flare)||0
10851317|NCT03129100|12017839|FG008|STARTED|Period 3 (Flare)||0
10851318|NCT03129100|12017840|FG009|STARTED|Period 3 (Flare)||0
10851319|NCT03129100|12017841|FG010|STARTED|Period 3 (Flare)||0
10851320|NCT03129100|12017842|FG011|STARTED|Period 3 (Flare)|This period is to report participants who experienced a flare in Period 3.|0
10851321|NCT03129100|12017843|FG012|STARTED|Period 3 (Flare)|This period is to report participants who experienced a flare in Period 3.|0
10851322|NCT03129100|12017844|FG013|STARTED|Period 3 (Flare)|This period is to report participants who experienced a flare in Period 3.|0
10851323|NCT03129100|12017845|FG014|STARTED|Period 3 (Flare)|This period is to report participants who experienced a flare in Period 3.|0
10851324|NCT03129100|12017846|FG015|STARTED|Period 3 (Flare)|This period is to report participants who experienced a flare in Period 3.|0
10851325|NCT03129100|12017847|FG016|STARTED|Period 3 (Flare)|This period is to report participants who experienced a flare in Period 3.|6
10851326|NCT03129100|12017848|FG017|STARTED|Period 3 (Flare)|This period is to report participants who experienced a flare in Period 3.|4
10851327|NCT03129100|12017849|FG018|STARTED|Period 3 (Flare)|This period is to report participants who experienced a flare in Period 3.|11
10851328|NCT03129100|12017850|FG019|STARTED|Period 3 (Flare)|This period is to report participants who experienced a flare in Period 3.|15
10851329|NCT03129100|12017851|FG020|STARTED|Period 3 (Flare)||0
10851330|NCT03129100|12017852|FG021|STARTED|Period 3 (Flare)||0
10851331|NCT03129100|12017853|FG022|STARTED|Period 3 (Flare)||0
10851332|NCT03129100|12017854|FG023|STARTED|Period 3 (Flare)||0
10851333|NCT03129100|12017855|FG024|STARTED|Period 3 (Flare)||0
10851334|NCT03129100|12017856|FG025|STARTED|Period 3 (Flare)||0
10851335|NCT03129100|12017831|FG000|COMPLETED|Period 3 (Flare)||0
10851336|NCT03129100|12017832|FG001|COMPLETED|Period 3 (Flare)||0
10851337|NCT03129100|12017833|FG002|COMPLETED|Period 3 (Flare)||0
10851338|NCT03129100|12017834|FG003|COMPLETED|Period 3 (Flare)||0
10851339|NCT03129100|12017835|FG004|COMPLETED|Period 3 (Flare)||0
10851340|NCT03129100|12017836|FG005|COMPLETED|Period 3 (Flare)||0
10851341|NCT03129100|12017837|FG006|COMPLETED|Period 3 (Flare)||0
10851342|NCT03129100|12017838|FG007|COMPLETED|Period 3 (Flare)||0
10851343|NCT03129100|12017839|FG008|COMPLETED|Period 3 (Flare)||0
10851344|NCT03129100|12017840|FG009|COMPLETED|Period 3 (Flare)||0
10851345|NCT03129100|12017841|FG010|COMPLETED|Period 3 (Flare)||0
10851346|NCT03129100|12017842|FG011|COMPLETED|Period 3 (Flare)||0
10851347|NCT03129100|12017843|FG012|COMPLETED|Period 3 (Flare)||0
10851348|NCT03129100|12017844|FG013|COMPLETED|Period 3 (Flare)||0
10851349|NCT03129100|12017845|FG014|COMPLETED|Period 3 (Flare)||0
10851350|NCT03129100|12017846|FG015|COMPLETED|Period 3 (Flare)||0
10851351|NCT03129100|12017847|FG016|COMPLETED|Period 3 (Flare)||6
10851352|NCT03129100|12017848|FG017|COMPLETED|Period 3 (Flare)||2
10851353|NCT03129100|12017849|FG018|COMPLETED|Period 3 (Flare)||11
10851354|NCT03129100|12017850|FG019|COMPLETED|Period 3 (Flare)||12
10851355|NCT03129100|12017851|FG020|COMPLETED|Period 3 (Flare)||0
10851356|NCT03129100|12017852|FG021|COMPLETED|Period 3 (Flare)||0
10851357|NCT03129100|12017853|FG022|COMPLETED|Period 3 (Flare)||0
10851358|NCT03129100|12017854|FG023|COMPLETED|Period 3 (Flare)||0
10851359|NCT03129100|12017855|FG024|COMPLETED|Period 3 (Flare)||0
10851360|NCT03129100|12017856|FG025|COMPLETED|Period 3 (Flare)||0
10851361|NCT03129100|12017831|FG000|NOT COMPLETED|Period 3 (Flare)||0
10851362|NCT03129100|12017832|FG001|NOT COMPLETED|Period 3 (Flare)||0
10851363|NCT03129100|12017833|FG002|NOT COMPLETED|Period 3 (Flare)||0
10851364|NCT03129100|12017834|FG003|NOT COMPLETED|Period 3 (Flare)||0
10851365|NCT03129100|12017835|FG004|NOT COMPLETED|Period 3 (Flare)||0
10851366|NCT03129100|12017836|FG005|NOT COMPLETED|Period 3 (Flare)||0
10851367|NCT03129100|12017837|FG006|NOT COMPLETED|Period 3 (Flare)||0
10851368|NCT03129100|12017838|FG007|NOT COMPLETED|Period 3 (Flare)||0
10851369|NCT03129100|12017839|FG008|NOT COMPLETED|Period 3 (Flare)||0
10851370|NCT03129100|12017840|FG009|NOT COMPLETED|Period 3 (Flare)||0
10851371|NCT03129100|12017841|FG010|NOT COMPLETED|Period 3 (Flare)||0
10851374|NCT03129100|12017844|FG013|NOT COMPLETED|Period 3 (Flare)||0
10414069|NCT00782509|11558402|FG002|COMPLETED|Overall Study||181
10414070|NCT00782509|11558400|FG000|NOT COMPLETED|Overall Study||41
10414071|NCT00782509|11558401|FG001|NOT COMPLETED|Overall Study||24
10414072|NCT00782509|11558402|FG002|NOT COMPLETED|Overall Study||36
10414073|NCT00782626|11558417|FG000|STARTED|Overall Study||23
10414074|NCT00782626|11558417|FG000|COMPLETED|Overall Study||16
10414075|NCT00782626|11558417|FG000|NOT COMPLETED|Overall Study||7
10414076|NCT00782639|11558423|FG000|STARTED|Overall Study||12
10414077|NCT00782639|11558424|FG001|STARTED|Overall Study||11
10414078|NCT00782639|11558423|FG000|COMPLETED|Overall Study|This study was terminated due to low enrollment.|12
10414079|NCT00782639|11558424|FG001|COMPLETED|Overall Study|This study was terminated due to low enrollment.|11
10414080|NCT00782639|11558423|FG000|NOT COMPLETED|Overall Study||0
10414081|NCT00782639|11558424|FG001|NOT COMPLETED|Overall Study||0
10414082|NCT00782717|11558434|FG000|STARTED|Overall Study||133
10414083|NCT00782717|11558435|FG001|STARTED|Overall Study||130
10414084|NCT00782717|11558434|FG000|COMPLETED|Overall Study||118
10414085|NCT00782717|11558435|FG001|COMPLETED|Overall Study||102
10414086|NCT00782717|11558434|FG000|NOT COMPLETED|Overall Study||15
10414087|NCT00782717|11558435|FG001|NOT COMPLETED|Overall Study||28
10414088|NCT00782756|11558441|FG000|STARTED|Overall Study||40
10414089|NCT00782756|11558441|FG000|COMPLETED|Overall Study||40
10414090|NCT00782756|11558441|FG000|NOT COMPLETED|Overall Study||0
10414091|NCT00782795|11558447|FG000|STARTED|Overall Study||17
10414092|NCT00782795|11558448|FG001|STARTED|Overall Study||8
10414093|NCT00782795|11558447|FG000|6 Weeks (1st Apptment)|Overall Study||16
10414094|NCT00782795|11558448|FG001|6 Weeks (1st Apptment)|Overall Study||7
10414095|NCT00782795|11558447|FG000|24 Week Appointment|Overall Study||16
10414096|NCT00782795|11558448|FG001|24 Week Appointment|Overall Study||7
10414097|NCT00782795|11558447|FG000|COMPLETED|Overall Study||16
10414098|NCT00782795|11558448|FG001|COMPLETED|Overall Study||6
10414099|NCT00782795|11558447|FG000|NOT COMPLETED|Overall Study||1
10414100|NCT00782795|11558448|FG001|NOT COMPLETED|Overall Study||2
10414101|NCT00782821|11558458|FG000|STARTED|Overall Study||10
10414102|NCT00782821|11558459|FG001|STARTED|Overall Study||10
10414103|NCT00782821|11558460|FG002|STARTED|Overall Study||10
10414104|NCT00782821|11558461|FG003|STARTED|Overall Study||10
10414105|NCT00782821|11558458|FG000|COMPLETED|Overall Study||10
10414106|NCT00782821|11558459|FG001|COMPLETED|Overall Study||10
10414107|NCT00782821|11558460|FG002|COMPLETED|Overall Study||9
10414108|NCT00782821|11558461|FG003|COMPLETED|Overall Study||8
10414109|NCT00782821|11558458|FG000|NOT COMPLETED|Overall Study||0
10414110|NCT00782821|11558459|FG001|NOT COMPLETED|Overall Study||0
10414111|NCT00782821|11558460|FG002|NOT COMPLETED|Overall Study||1
10414112|NCT00782821|11558461|FG003|NOT COMPLETED|Overall Study||2
10414113|NCT00782834|11558478|FG000|STARTED|Screened Patients||15
10414114|NCT00782834|11558478|FG000|COMPLETED|Screened Patients|1 pt ineligible d/t arrhythmia|14
10414115|NCT00782834|11558478|FG000|NOT COMPLETED|Screened Patients||1
10414116|NCT00782834|11558478|FG000|STARTED|Treatment Phase||14
10414117|NCT00782834|11558478|FG000|COMPLETED|Treatment Phase||13
10414118|NCT00782834|11558478|FG000|NOT COMPLETED|Treatment Phase||1
10414119|NCT00783094|11558485|FG000|STARTED|Randomized Double-Blind Treatment Period||142
10414120|NCT00783094|11558486|FG001|STARTED|Randomized Double-Blind Treatment Period||140
10414121|NCT00783094|11558487|FG002|STARTED|Randomized Double-Blind Treatment Period||140
10414122|NCT00783094|11558485|FG000|COMPLETED|Randomized Double-Blind Treatment Period||135
10414123|NCT00783094|11558486|FG001|COMPLETED|Randomized Double-Blind Treatment Period||128
10414124|NCT00783094|11558487|FG002|COMPLETED|Randomized Double-Blind Treatment Period||131
10851375|NCT03129100|12017845|FG014|NOT COMPLETED|Period 3 (Flare)||0
10414125|NCT00783094|11558485|FG000|NOT COMPLETED|Randomized Double-Blind Treatment Period||7
10414126|NCT00783094|11558486|FG001|NOT COMPLETED|Randomized Double-Blind Treatment Period||12
10414127|NCT00783094|11558487|FG002|NOT COMPLETED|Randomized Double-Blind Treatment Period||9
10414128|NCT00783094|11558485|FG000|STARTED|Open-Label Extension Period||135
10414129|NCT00783094|11558486|FG001|STARTED|Open-Label Extension Period||128
10414130|NCT00783094|11558487|FG002|STARTED|Open-Label Extension Period||131
10414131|NCT00783094|11558485|FG000|COMPLETED|Open-Label Extension Period||113
10414132|NCT00783094|11558486|FG001|COMPLETED|Open-Label Extension Period||109
10414133|NCT00783094|11558487|FG002|COMPLETED|Open-Label Extension Period||101
10414134|NCT00783094|11558485|FG000|NOT COMPLETED|Open-Label Extension Period||22
10414135|NCT00783094|11558486|FG001|NOT COMPLETED|Open-Label Extension Period||19
10851376|NCT03129100|12017846|FG015|NOT COMPLETED|Period 3 (Flare)||0
10851377|NCT03129100|12017847|FG016|NOT COMPLETED|Period 3 (Flare)||0
10851378|NCT03129100|12017848|FG017|NOT COMPLETED|Period 3 (Flare)||2
10851379|NCT03129100|12017849|FG018|NOT COMPLETED|Period 3 (Flare)||0
10851380|NCT03129100|12017850|FG019|NOT COMPLETED|Period 3 (Flare)||3
10851381|NCT03129100|12017851|FG020|NOT COMPLETED|Period 3 (Flare)||0
10851382|NCT03129100|12017852|FG021|NOT COMPLETED|Period 3 (Flare)||0
10851383|NCT03129100|12017853|FG022|NOT COMPLETED|Period 3 (Flare)||0
10851384|NCT03129100|12017854|FG023|NOT COMPLETED|Period 3 (Flare)||0
10851385|NCT03129100|12017855|FG024|NOT COMPLETED|Period 3 (Flare)||0
10851386|NCT03129100|12017856|FG025|NOT COMPLETED|Period 3 (Flare)||0
10851387|NCT03129100|12017831|FG000|STARTED|Period 3 (Dose Escalation)||0
10851388|NCT03129100|12017832|FG001|STARTED|Period 3 (Dose Escalation)||0
10851389|NCT03129100|12017833|FG002|STARTED|Period 3 (Dose Escalation)||0
10851390|NCT03129100|12017834|FG003|STARTED|Period 3 (Dose Escalation)||0
10851391|NCT03129100|12017835|FG004|STARTED|Period 3 (Dose Escalation)||0
10851392|NCT03129100|12017836|FG005|STARTED|Period 3 (Dose Escalation)||0
10851393|NCT03129100|12017837|FG006|STARTED|Period 3 (Dose Escalation)||0
10851394|NCT03129100|12017838|FG007|STARTED|Period 3 (Dose Escalation)||0
10851395|NCT03129100|12017839|FG008|STARTED|Period 3 (Dose Escalation)||0
10851396|NCT03129100|12017840|FG009|STARTED|Period 3 (Dose Escalation)||0
10851397|NCT03129100|12017841|FG010|STARTED|Period 3 (Dose Escalation)||0
10851398|NCT03129100|12017842|FG011|STARTED|Period 3 (Dose Escalation)||0
10851399|NCT03129100|12017843|FG012|STARTED|Period 3 (Dose Escalation)||0
10851400|NCT03129100|12017844|FG013|STARTED|Period 3 (Dose Escalation)||0
10851401|NCT03129100|12017845|FG014|STARTED|Period 3 (Dose Escalation)||0
10851402|NCT03129100|12017846|FG015|STARTED|Period 3 (Dose Escalation)||0
10851403|NCT03129100|12017847|FG016|STARTED|Period 3 (Dose Escalation)|Participants who are eligible for dose escalations.|0
10851404|NCT03129100|12017848|FG017|STARTED|Period 3 (Dose Escalation)|Participants who are eligible for dose escalations.|0
10851405|NCT03129100|12017849|FG018|STARTED|Period 3 (Dose Escalation)|Participants who are eligible for dose escalations.|0
10851406|NCT03129100|12017850|FG019|STARTED|Period 3 (Dose Escalation)|Participants who are eligible for dose escalations.|0
10851407|NCT03129100|12017851|FG020|STARTED|Period 3 (Dose Escalation)|Participants who are eligible for dose escalations.|77
10851408|NCT03129100|12017852|FG021|STARTED|Period 3 (Dose Escalation)|Participants who are eligible for dose escalations.|5
10851409|NCT03129100|12017853|FG022|STARTED|Period 3 (Dose Escalation)|Participants who are eligible for dose escalations.|4
10851410|NCT03129100|12017854|FG023|STARTED|Period 3 (Dose Escalation)||0
10851411|NCT03129100|12017855|FG024|STARTED|Period 3 (Dose Escalation)||0
10851412|NCT03129100|12017856|FG025|STARTED|Period 3 (Dose Escalation)||0
10851413|NCT03129100|12017831|FG000|COMPLETED|Period 3 (Dose Escalation)||0
10851414|NCT03129100|12017832|FG001|COMPLETED|Period 3 (Dose Escalation)||0
10851415|NCT03129100|12017833|FG002|COMPLETED|Period 3 (Dose Escalation)||0
10851416|NCT03129100|12017834|FG003|COMPLETED|Period 3 (Dose Escalation)||0
10851417|NCT03129100|12017835|FG004|COMPLETED|Period 3 (Dose Escalation)||0
10851418|NCT03129100|12017836|FG005|COMPLETED|Period 3 (Dose Escalation)||0
10851419|NCT03129100|12017837|FG006|COMPLETED|Period 3 (Dose Escalation)||0
10851420|NCT03129100|12017838|FG007|COMPLETED|Period 3 (Dose Escalation)||0
10851421|NCT03129100|12017839|FG008|COMPLETED|Period 3 (Dose Escalation)||0
10851422|NCT03129100|12017840|FG009|COMPLETED|Period 3 (Dose Escalation)||0
10851423|NCT03129100|12017841|FG010|COMPLETED|Period 3 (Dose Escalation)||0
10851424|NCT03129100|12017842|FG011|COMPLETED|Period 3 (Dose Escalation)||0
10851425|NCT03129100|12017843|FG012|COMPLETED|Period 3 (Dose Escalation)||0
10851426|NCT03129100|12017844|FG013|COMPLETED|Period 3 (Dose Escalation)||0
10851427|NCT03129100|12017845|FG014|COMPLETED|Period 3 (Dose Escalation)||0
10851428|NCT03129100|12017846|FG015|COMPLETED|Period 3 (Dose Escalation)||0
10851429|NCT03129100|12017847|FG016|COMPLETED|Period 3 (Dose Escalation)||0
10851430|NCT03129100|12017848|FG017|COMPLETED|Period 3 (Dose Escalation)||0
10851431|NCT03129100|12017849|FG018|COMPLETED|Period 3 (Dose Escalation)||0
10851432|NCT03129100|12017850|FG019|COMPLETED|Period 3 (Dose Escalation)||0
10851433|NCT03129100|12017851|FG020|COMPLETED|Period 3 (Dose Escalation)||73
10851434|NCT03129100|12017852|FG021|COMPLETED|Period 3 (Dose Escalation)||5
10851435|NCT03129100|12017853|FG022|COMPLETED|Period 3 (Dose Escalation)||4
10851436|NCT03129100|12017854|FG023|COMPLETED|Period 3 (Dose Escalation)||0
10851437|NCT03129100|12017855|FG024|COMPLETED|Period 3 (Dose Escalation)||0
10851438|NCT03129100|12017856|FG025|COMPLETED|Period 3 (Dose Escalation)||0
10851439|NCT03129100|12017831|FG000|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851440|NCT03129100|12017832|FG001|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851441|NCT03129100|12017833|FG002|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851442|NCT03129100|12017834|FG003|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851443|NCT03129100|12017835|FG004|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851444|NCT03129100|12017836|FG005|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851445|NCT03129100|12017837|FG006|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851446|NCT03129100|12017838|FG007|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851447|NCT03129100|12017839|FG008|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851448|NCT03129100|12017840|FG009|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851449|NCT03129100|12017841|FG010|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851450|NCT03129100|12017842|FG011|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851451|NCT03129100|12017843|FG012|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851452|NCT03129100|12017844|FG013|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851453|NCT03129100|12017845|FG014|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851454|NCT03129100|12017846|FG015|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851455|NCT03129100|12017847|FG016|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851456|NCT03129100|12017848|FG017|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851457|NCT03129100|12017849|FG018|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851458|NCT03129100|12017850|FG019|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851459|NCT03129100|12017851|FG020|NOT COMPLETED|Period 3 (Dose Escalation)||4
10851460|NCT03129100|12017852|FG021|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851461|NCT03129100|12017853|FG022|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851462|NCT03129100|12017854|FG023|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851463|NCT03129100|12017855|FG024|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851464|NCT03129100|12017856|FG025|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851465|NCT03129100|12017831|FG000|STARTED|Period 4 (Post Treatment Follow-up)||0
10851466|NCT03129100|12017832|FG001|STARTED|Period 4 (Post Treatment Follow-up)||0
10851467|NCT03129100|12017833|FG002|STARTED|Period 4 (Post Treatment Follow-up)||0
10851468|NCT03129100|12017834|FG003|STARTED|Period 4 (Post Treatment Follow-up)||0
10851469|NCT03129100|12017835|FG004|STARTED|Period 4 (Post Treatment Follow-up)||0
10851470|NCT03129100|12017836|FG005|STARTED|Period 4 (Post Treatment Follow-up)||0
10851471|NCT03129100|12017837|FG006|STARTED|Period 4 (Post Treatment Follow-up)||0
10851472|NCT03129100|12017838|FG007|STARTED|Period 4 (Post Treatment Follow-up)||0
10851473|NCT03129100|12017839|FG008|STARTED|Period 4 (Post Treatment Follow-up)||0
10851474|NCT03129100|12017840|FG009|STARTED|Period 4 (Post Treatment Follow-up)||0
10851475|NCT03129100|12017841|FG010|STARTED|Period 4 (Post Treatment Follow-up)||0
10851476|NCT03129100|12017842|FG011|STARTED|Period 4 (Post Treatment Follow-up)||0
10851477|NCT03129100|12017843|FG012|STARTED|Period 4 (Post Treatment Follow-up)||0
10851478|NCT03129100|12017844|FG013|STARTED|Period 4 (Post Treatment Follow-up)||0
10851479|NCT03129100|12017845|FG014|STARTED|Period 4 (Post Treatment Follow-up)||0
10851480|NCT03129100|12017846|FG015|STARTED|Period 4 (Post Treatment Follow-up)||0
10851481|NCT03129100|12017847|FG016|STARTED|Period 4 (Post Treatment Follow-up)||0
10851482|NCT03129100|12017848|FG017|STARTED|Period 4 (Post Treatment Follow-up)||0
10851483|NCT03129100|12017849|FG018|STARTED|Period 4 (Post Treatment Follow-up)||0
10851484|NCT03129100|12017850|FG019|STARTED|Period 4 (Post Treatment Follow-up)||0
10851485|NCT03129100|12017851|FG020|STARTED|Period 4 (Post Treatment Follow-up)|This period is to report Follow-Up period participants.|0
10851486|NCT03129100|12017852|FG021|STARTED|Period 4 (Post Treatment Follow-up)|This period is to report Follow-Up period participants.|0
10851487|NCT03129100|12017853|FG022|STARTED|Period 4 (Post Treatment Follow-up)|This period is to report Follow-Up period participants.|0
10851488|NCT03129100|12017854|FG023|STARTED|Period 4 (Post Treatment Follow-up)|This period is to report Follow-Up period participants.|25
10851489|NCT03129100|12017855|FG024|STARTED|Period 4 (Post Treatment Follow-up)|This period is to report Follow-Up period participants.|223
10851490|NCT03129100|12017856|FG025|STARTED|Period 4 (Post Treatment Follow-up)|This period is to report Follow-Up period participants.|453
10851491|NCT03129100|12017831|FG000|COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851492|NCT03129100|12017832|FG001|COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851493|NCT03129100|12017833|FG002|COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851494|NCT03129100|12017834|FG003|COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851495|NCT03129100|12017835|FG004|COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851496|NCT03129100|12017836|FG005|COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851497|NCT03129100|12017837|FG006|COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851498|NCT03129100|12017838|FG007|COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851499|NCT03129100|12017839|FG008|COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851500|NCT03129100|12017840|FG009|COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851501|NCT03129100|12017841|FG010|COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851502|NCT03129100|12017842|FG011|COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851503|NCT03129100|12017843|FG012|COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851504|NCT03129100|12017844|FG013|COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851505|NCT03129100|12017845|FG014|COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851506|NCT03129100|12017846|FG015|COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851507|NCT03129100|12017847|FG016|COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851508|NCT03129100|12017848|FG017|COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851509|NCT03129100|12017849|FG018|COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851510|NCT03129100|12017850|FG019|COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851511|NCT03129100|12017851|FG020|COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851512|NCT03129100|12017852|FG021|COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851513|NCT03129100|12017853|FG022|COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851514|NCT03129100|12017854|FG023|COMPLETED|Period 4 (Post Treatment Follow-up)||22
10851515|NCT03129100|12017855|FG024|COMPLETED|Period 4 (Post Treatment Follow-up)||198
10851516|NCT03129100|12017856|FG025|COMPLETED|Period 4 (Post Treatment Follow-up)||411
10851517|NCT03129100|12017831|FG000|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851518|NCT03129100|12017832|FG001|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851519|NCT03129100|12017833|FG002|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851520|NCT03129100|12017834|FG003|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851521|NCT03129100|12017835|FG004|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851522|NCT03129100|12017836|FG005|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851523|NCT03129100|12017837|FG006|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851524|NCT03129100|12017838|FG007|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851525|NCT03129100|12017839|FG008|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851526|NCT03129100|12017840|FG009|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851527|NCT03129100|12017841|FG010|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851528|NCT03129100|12017842|FG011|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851529|NCT03129100|12017843|FG012|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851530|NCT03129100|12017844|FG013|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851531|NCT03129100|12017845|FG014|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851532|NCT03129100|12017846|FG015|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851533|NCT03129100|12017847|FG016|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851534|NCT03129100|12017848|FG017|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851535|NCT03129100|12017849|FG018|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851536|NCT03129100|12017850|FG019|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851537|NCT03129100|12017851|FG020|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851538|NCT03129100|12017852|FG021|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
10292966|NCT01232283|11425775|FG000|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||36
10292967|NCT01232283|11425776|FG001|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||26
10292968|NCT01232283|11425777|FG002|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
10292969|NCT01232283|11425778|FG003|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
10292970|NCT01232283|11425779|FG004|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
10292971|NCT01232283|11425780|FG005|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
10292972|NCT01232283|11425781|FG006|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
10292973|NCT01232283|11425782|FG007|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
10292974|NCT01232283|11425783|FG008|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
10292975|NCT01232283|11425784|FG009|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
10292976|NCT01232283|11425775|FG000|STARTED|Maintenance Phase (Weeks16-32)||0
10292977|NCT01232283|11425776|FG001|STARTED|Maintenance Phase (Weeks16-32)||0
10292978|NCT01232283|11425777|FG002|STARTED|Maintenance Phase (Weeks16-32)|5 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|234
10292979|NCT01232283|11425778|FG003|STARTED|Maintenance Phase (Weeks16-32)|4 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|108
10292980|NCT01232283|11425779|FG004|STARTED|Maintenance Phase (Weeks16-32)||0
10292981|NCT01232283|11425780|FG005|STARTED|Maintenance Phase (Weeks16-32)||0
10292982|NCT01232283|11425781|FG006|STARTED|Maintenance Phase (Weeks16-32)||0
10292983|NCT01232283|11425782|FG007|STARTED|Maintenance Phase (Weeks16-32)||0
10292984|NCT01232283|11425783|FG008|STARTED|Maintenance Phase (Weeks16-32)||0
10292985|NCT01232283|11425784|FG009|STARTED|Maintenance Phase (Weeks16-32)||0
10292986|NCT01232283|11425775|FG000|COMPLETED|Maintenance Phase (Weeks16-32)||0
10292987|NCT01232283|11425776|FG001|COMPLETED|Maintenance Phase (Weeks16-32)||0
10292988|NCT01232283|11425777|FG002|COMPLETED|Maintenance Phase (Weeks16-32)||194
10292989|NCT01232283|11425778|FG003|COMPLETED|Maintenance Phase (Weeks16-32)||100
10292990|NCT01232283|11425779|FG004|COMPLETED|Maintenance Phase (Weeks16-32)||0
10292991|NCT01232283|11425780|FG005|COMPLETED|Maintenance Phase (Weeks16-32)||0
10292992|NCT01232283|11425781|FG006|COMPLETED|Maintenance Phase (Weeks16-32)||0
10292993|NCT01232283|11425782|FG007|COMPLETED|Maintenance Phase (Weeks16-32)||0
10292994|NCT01232283|11425783|FG008|COMPLETED|Maintenance Phase (Weeks16-32)||0
10292995|NCT01232283|11425784|FG009|COMPLETED|Maintenance Phase (Weeks16-32)||0
10292996|NCT01232283|11425775|FG000|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
10292997|NCT01232283|11425776|FG001|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
10292998|NCT01232283|11425777|FG002|NOT COMPLETED|Maintenance Phase (Weeks16-32)||40
10292999|NCT01232283|11425778|FG003|NOT COMPLETED|Maintenance Phase (Weeks16-32)||8
10293000|NCT01232283|11425779|FG004|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
10293001|NCT01232283|11425780|FG005|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
10293002|NCT01232283|11425781|FG006|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
10293003|NCT01232283|11425782|FG007|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
10293004|NCT01232283|11425783|FG008|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
10293005|NCT01232283|11425784|FG009|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
10293006|NCT01232283|11425775|FG000|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
10293007|NCT01232283|11425776|FG001|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
10293008|NCT01232283|11425777|FG002|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
10293009|NCT01232283|11425778|FG003|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
10293010|NCT01232283|11425779|FG004|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|4 participants discontinued after Week 32 but prior to entry into the Randomized Withdrawal Phase|62
10293011|NCT01232283|11425780|FG005|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|13 participants discontinued after Week 32 but prior to entry into the Randomized Withdrawal Phase|61
10293012|NCT01232283|11425781|FG006|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||58
10293013|NCT01232283|11425782|FG007|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||96
10293014|NCT01232283|11425783|FG008|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
10293015|NCT01232283|11425784|FG009|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
10293016|NCT01232283|11425775|FG000|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
10293017|NCT01232283|11425776|FG001|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
10293018|NCT01232283|11425777|FG002|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
10293019|NCT01232283|11425778|FG003|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
10293020|NCT01232283|11425779|FG004|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
10293021|NCT01232283|11425780|FG005|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
10851539|NCT03129100|12017853|FG022|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851540|NCT03129100|12017854|FG023|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||3
10851541|NCT03129100|12017855|FG024|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||25
10851542|NCT03129100|12017856|FG025|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||42
10851543|NCT02831257|12017893|FG000|STARTED|Overall Study||18
10851544|NCT02831257|12017893|FG000|COMPLETED|Overall Study||6
10851545|NCT02831257|12017893|FG000|NOT COMPLETED|Overall Study||12
10851574|NCT02406027|12017931|FG000|STARTED|Double-blind Treatment Phase (Period 1)||35
10851575|NCT02406027|12017932|FG001|STARTED|Double-blind Treatment Phase (Period 1)||29
10851576|NCT02406027|12017933|FG002|STARTED|Double-blind Treatment Phase (Period 1)||26
10851577|NCT02406027|12017934|FG003|STARTED|Double-blind Treatment Phase (Period 1)||0
10851578|NCT02406027|12017935|FG004|STARTED|Double-blind Treatment Phase (Period 1)||0
10851579|NCT02406027|12017936|FG005|STARTED|Double-blind Treatment Phase (Period 1)||0
10851580|NCT02406027|12017937|FG006|STARTED|Double-blind Treatment Phase (Period 1)||0
10851581|NCT02406027|12017931|FG000|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||6
10851582|NCT02406027|12017932|FG001|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||8
10851583|NCT02406027|12017933|FG002|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||6
10851584|NCT02406027|12017934|FG003|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
10851585|NCT02406027|12017935|FG004|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
10851586|NCT02406027|12017936|FG005|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
10851587|NCT02406027|12017937|FG006|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
10851588|NCT02406027|12017931|FG000|Prodromal|Double-blind Treatment Phase (Period 1)||29
10851589|NCT02406027|12017932|FG001|Prodromal|Double-blind Treatment Phase (Period 1)||21
10851590|NCT02406027|12017933|FG002|Prodromal|Double-blind Treatment Phase (Period 1)||20
10851591|NCT02406027|12017934|FG003|Prodromal|Double-blind Treatment Phase (Period 1)||0
10851592|NCT02406027|12017935|FG004|Prodromal|Double-blind Treatment Phase (Period 1)||0
10851593|NCT02406027|12017936|FG005|Prodromal|Double-blind Treatment Phase (Period 1)||0
10851594|NCT02406027|12017937|FG006|Prodromal|Double-blind Treatment Phase (Period 1)||0
10851595|NCT02406027|12017931|FG000|COMPLETED|Double-blind Treatment Phase (Period 1)||29
10851596|NCT02406027|12017932|FG001|COMPLETED|Double-blind Treatment Phase (Period 1)||26
10851597|NCT02406027|12017933|FG002|COMPLETED|Double-blind Treatment Phase (Period 1)||22
10851598|NCT02406027|12017934|FG003|COMPLETED|Double-blind Treatment Phase (Period 1)||0
10851599|NCT02406027|12017935|FG004|COMPLETED|Double-blind Treatment Phase (Period 1)||0
10851600|NCT02406027|12017936|FG005|COMPLETED|Double-blind Treatment Phase (Period 1)||0
10851601|NCT02406027|12017937|FG006|COMPLETED|Double-blind Treatment Phase (Period 1)||0
10851602|NCT02406027|12017931|FG000|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||6
10851603|NCT02406027|12017932|FG001|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||3
10851604|NCT02406027|12017933|FG002|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||4
10851605|NCT02406027|12017934|FG003|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
10851606|NCT02406027|12017935|FG004|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
10851607|NCT02406027|12017936|FG005|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
10851608|NCT02406027|12017937|FG006|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
10851609|NCT02406027|12017931|FG000|STARTED|Open-label Phase (Period 2)||0
10851610|NCT02406027|12017932|FG001|STARTED|Open-label Phase (Period 2)||0
10851611|NCT02406027|12017933|FG002|STARTED|Open-label Phase (Period 2)||0
10851612|NCT02406027|12017934|FG003|STARTED|Open-label Phase (Period 2)||15
10851613|NCT02406027|12017935|FG004|STARTED|Open-label Phase (Period 2)||14
10851614|NCT02406027|12017936|FG005|STARTED|Open-label Phase (Period 2)||26
10851615|NCT02406027|12017937|FG006|STARTED|Open-label Phase (Period 2)||22
10851616|NCT02406027|12017931|FG000|COMPLETED|Open-label Phase (Period 2)||0
10851617|NCT02406027|12017932|FG001|COMPLETED|Open-label Phase (Period 2)||0
10851618|NCT02406027|12017933|FG002|COMPLETED|Open-label Phase (Period 2)||0
10851619|NCT02406027|12017934|FG003|COMPLETED|Open-label Phase (Period 2)||0
10851620|NCT02406027|12017935|FG004|COMPLETED|Open-label Phase (Period 2)||0
10851621|NCT02406027|12017936|FG005|COMPLETED|Open-label Phase (Period 2)||0
10851622|NCT02406027|12017937|FG006|COMPLETED|Open-label Phase (Period 2)||0
10851623|NCT02406027|12017931|FG000|NOT COMPLETED|Open-label Phase (Period 2)||0
10851624|NCT02406027|12017932|FG001|NOT COMPLETED|Open-label Phase (Period 2)||0
10851625|NCT02406027|12017933|FG002|NOT COMPLETED|Open-label Phase (Period 2)||0
10851626|NCT02406027|12017934|FG003|NOT COMPLETED|Open-label Phase (Period 2)||15
10851627|NCT02406027|12017935|FG004|NOT COMPLETED|Open-label Phase (Period 2)||14
10851628|NCT02406027|12017936|FG005|NOT COMPLETED|Open-label Phase (Period 2)||26
10851629|NCT02406027|12017937|FG006|NOT COMPLETED|Open-label Phase (Period 2)||22
10851630|NCT02374814|12017959|FG000|STARTED|Overall Study||12
10851631|NCT02374814|12017960|FG001|STARTED|Overall Study||12
10851632|NCT02374814|12017961|FG002|STARTED|Overall Study||12
10851633|NCT02374814|12017962|FG003|STARTED|Overall Study||11
10851634|NCT02374814|12017963|FG004|STARTED|Overall Study||6
10851635|NCT02374814|12017964|FG005|STARTED|Overall Study||6
10293022|NCT01232283|11425781|FG006|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||28
10293023|NCT01232283|11425782|FG007|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||17
10293024|NCT01232283|11425783|FG008|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
10293025|NCT01232283|11425784|FG009|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
10293026|NCT01232283|11425775|FG000|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
10293027|NCT01232283|11425776|FG001|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
10293028|NCT01232283|11425777|FG002|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
10545480|NCT01497899|11698863|FG002|COMPLETED|Double-Blind Phase||0
10545481|NCT01497899|11698864|FG003|COMPLETED|Double-Blind Phase||0
10545482|NCT01497899|11698861|FG000|NOT COMPLETED|Double-Blind Phase||6
10545483|NCT01497899|11698862|FG001|NOT COMPLETED|Double-Blind Phase||5
10545484|NCT01497899|11698863|FG002|NOT COMPLETED|Double-Blind Phase||0
10293029|NCT01232283|11425778|FG003|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
10293030|NCT01232283|11425779|FG004|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||50
10293031|NCT01232283|11425780|FG005|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||56
10293032|NCT01232283|11425781|FG006|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||41
10293033|NCT01232283|11425782|FG007|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||84
10293034|NCT01232283|11425783|FG008|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
10293035|NCT01232283|11425784|FG009|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
10293036|NCT01232283|11425775|FG000|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
10293037|NCT01232283|11425776|FG001|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
10293038|NCT01232283|11425777|FG002|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
10293039|NCT01232283|11425778|FG003|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
10293040|NCT01232283|11425779|FG004|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||12
10293041|NCT01232283|11425780|FG005|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||5
10293042|NCT01232283|11425781|FG006|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||17
10293043|NCT01232283|11425782|FG007|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||12
10293044|NCT01232283|11425783|FG008|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
10293045|NCT01232283|11425784|FG009|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
10293046|NCT01232283|11425775|FG000|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
10293047|NCT01232283|11425776|FG001|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
10293048|NCT01232283|11425777|FG002|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
10293049|NCT01232283|11425778|FG003|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
10293050|NCT01232283|11425779|FG004|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
10293051|NCT01232283|11425780|FG005|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
10293052|NCT01232283|11425781|FG006|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
10293053|NCT01232283|11425782|FG007|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
10293054|NCT01232283|11425783|FG008|STARTED|Long-Term Extension Phase (Weeks 52-260)||137
10293055|NCT01232283|11425784|FG009|STARTED|Long-Term Extension Phase (Weeks 52-260)||80
10293056|NCT01232283|11425775|FG000|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
10293057|NCT01232283|11425776|FG001|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
10293058|NCT01232283|11425777|FG002|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
10293059|NCT01232283|11425778|FG003|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
10293060|NCT01232283|11425779|FG004|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
10293061|NCT01232283|11425780|FG005|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
10293062|NCT01232283|11425781|FG006|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
10293063|NCT01232283|11425782|FG007|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
10293064|NCT01232283|11425783|FG008|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||29
10293065|NCT01232283|11425784|FG009|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||19
10293066|NCT01232283|11425775|FG000|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
10293067|NCT01232283|11425776|FG001|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
10293068|NCT01232283|11425777|FG002|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
10851636|NCT02374814|12017959|FG000|COMPLETED|Overall Study||11
10851637|NCT02374814|12017960|FG001|COMPLETED|Overall Study||11
10851638|NCT02374814|12017961|FG002|COMPLETED|Overall Study||11
10851639|NCT02374814|12017962|FG003|COMPLETED|Overall Study||9
10851640|NCT02374814|12017963|FG004|COMPLETED|Overall Study||6
10851641|NCT02374814|12017964|FG005|COMPLETED|Overall Study||6
10851642|NCT02374814|12017959|FG000|NOT COMPLETED|Overall Study||1
10851643|NCT02374814|12017960|FG001|NOT COMPLETED|Overall Study||1
10851644|NCT02374814|12017961|FG002|NOT COMPLETED|Overall Study||1
10851645|NCT02374814|12017962|FG003|NOT COMPLETED|Overall Study||2
10851646|NCT02374814|12017963|FG004|NOT COMPLETED|Overall Study||0
10851647|NCT02374814|12017964|FG005|NOT COMPLETED|Overall Study||0
10851648|NCT02142738|12017988|FG000|STARTED|Overall Study||154
10851649|NCT02142738|12017989|FG001|STARTED|Overall Study||151
10851650|NCT02142738|12017988|FG000|Treated|Overall Study||154
10851651|NCT02142738|12017989|FG001|Treated|Overall Study||150
10851652|NCT02142738|12017988|FG000|Chemotherapy Switch to Pembrolizumab|Overall Study||0
10851653|NCT02142738|12017989|FG001|Chemotherapy Switch to Pembrolizumab|Overall Study||83
10851654|NCT02142738|12017988|FG000|Second Course Pembrolizumab|Overall Study||12
10851655|NCT02142738|12017989|FG001|Second Course Pembrolizumab|Overall Study||1
10851656|NCT02142738|12017988|FG000|COMPLETED|Overall Study||0
10851657|NCT02142738|12017989|FG001|COMPLETED|Overall Study||0
10851658|NCT02142738|12017988|FG000|NOT COMPLETED|Overall Study||154
10851659|NCT02142738|12017989|FG001|NOT COMPLETED|Overall Study||151
10851666|NCT02005172|12018007|FG000|STARTED|Overall Study||33
10851667|NCT02005172|12018007|FG000|ITT|Overall Study||38
10851668|NCT02005172|12018007|FG000|COMPLETED|Overall Study||33
10851669|NCT02005172|12018007|FG000|NOT COMPLETED|Overall Study||0
10851670|NCT01931709|12018012|FG000|STARTED|Overall Study||35
10851671|NCT01931709|12018012|FG000|COMPLETED|Overall Study||35
10851672|NCT01931709|12018012|FG000|NOT COMPLETED|Overall Study||0
10851673|NCT01667133|12018030|FG000|STARTED|Phase 1: Dose-escalation||1
10851674|NCT01667133|12018031|FG001|STARTED|Phase 1: Dose-escalation||1
10851675|NCT01667133|12018032|FG002|STARTED|Phase 1: Dose-escalation||4
10851676|NCT01667133|12018033|FG003|STARTED|Phase 1: Dose-escalation||3
10851677|NCT01667133|12018034|FG004|STARTED|Phase 1: Dose-escalation||1
10851678|NCT01667133|12018035|FG005|STARTED|Phase 1: Dose-escalation||1
10851679|NCT01667133|12018036|FG006|STARTED|Phase 1: Dose-escalation||1
10851680|NCT01667133|12018037|FG007|STARTED|Phase 1: Dose-escalation||0
10851681|NCT01667133|12018038|FG008|STARTED|Phase 1: Dose-escalation||0
10851682|NCT01667133|12018039|FG009|STARTED|Phase 1: Dose-escalation||0
10851683|NCT01667133|12018040|FG010|STARTED|Phase 1: Dose-escalation||0
10851684|NCT01667133|12018041|FG011|STARTED|Phase 1: Dose-escalation||0
10851685|NCT01667133|12018030|FG000|COMPLETED|Phase 1: Dose-escalation||1
10851686|NCT01667133|12018031|FG001|COMPLETED|Phase 1: Dose-escalation||0
10851687|NCT01667133|12018032|FG002|COMPLETED|Phase 1: Dose-escalation||0
10851688|NCT01667133|12018033|FG003|COMPLETED|Phase 1: Dose-escalation||2
10851689|NCT01667133|12018034|FG004|COMPLETED|Phase 1: Dose-escalation||0
10851690|NCT01667133|12018035|FG005|COMPLETED|Phase 1: Dose-escalation||0
10851691|NCT01667133|12018036|FG006|COMPLETED|Phase 1: Dose-escalation||0
10851692|NCT01667133|12018037|FG007|COMPLETED|Phase 1: Dose-escalation||0
10851693|NCT01667133|12018038|FG008|COMPLETED|Phase 1: Dose-escalation||0
10851694|NCT01667133|12018039|FG009|COMPLETED|Phase 1: Dose-escalation||0
10851695|NCT01667133|12018040|FG010|COMPLETED|Phase 1: Dose-escalation||0
10851696|NCT01667133|12018041|FG011|COMPLETED|Phase 1: Dose-escalation||0
10851697|NCT01667133|12018030|FG000|NOT COMPLETED|Phase 1: Dose-escalation||0
10851698|NCT01667133|12018031|FG001|NOT COMPLETED|Phase 1: Dose-escalation||1
10851699|NCT01667133|12018032|FG002|NOT COMPLETED|Phase 1: Dose-escalation||4
10851700|NCT01667133|12018033|FG003|NOT COMPLETED|Phase 1: Dose-escalation||1
10851701|NCT01667133|12018034|FG004|NOT COMPLETED|Phase 1: Dose-escalation||1
10851702|NCT01667133|12018035|FG005|NOT COMPLETED|Phase 1: Dose-escalation||1
10851703|NCT01667133|12018036|FG006|NOT COMPLETED|Phase 1: Dose-escalation||1
10851704|NCT01667133|12018037|FG007|NOT COMPLETED|Phase 1: Dose-escalation||0
10851705|NCT01667133|12018038|FG008|NOT COMPLETED|Phase 1: Dose-escalation||0
10851706|NCT01667133|12018039|FG009|NOT COMPLETED|Phase 1: Dose-escalation||0
10851707|NCT01667133|12018040|FG010|NOT COMPLETED|Phase 1: Dose-escalation||0
10851708|NCT01667133|12018041|FG011|NOT COMPLETED|Phase 1: Dose-escalation||0
10851709|NCT01667133|12018030|FG000|STARTED|Phase 2: Dose-expansion||0
10851710|NCT01667133|12018031|FG001|STARTED|Phase 2: Dose-expansion||0
10851711|NCT01667133|12018032|FG002|STARTED|Phase 2: Dose-expansion||0
10851712|NCT01667133|12018033|FG003|STARTED|Phase 2: Dose-expansion||0
10851713|NCT01667133|12018034|FG004|STARTED|Phase 2: Dose-expansion||0
10851714|NCT01667133|12018035|FG005|STARTED|Phase 2: Dose-expansion||0
10851715|NCT01667133|12018036|FG006|STARTED|Phase 2: Dose-expansion||0
10851716|NCT01667133|12018037|FG007|STARTED|Phase 2: Dose-expansion||2
10851717|NCT01667133|12018038|FG008|STARTED|Phase 2: Dose-expansion||1
10851718|NCT01667133|12018039|FG009|STARTED|Phase 2: Dose-expansion||11
10851719|NCT01667133|12018040|FG010|STARTED|Phase 2: Dose-expansion||3
10851720|NCT01667133|12018041|FG011|STARTED|Phase 2: Dose-expansion||6
10851721|NCT01667133|12018030|FG000|COMPLETED|Phase 2: Dose-expansion||0
10851722|NCT01667133|12018031|FG001|COMPLETED|Phase 2: Dose-expansion||0
10851723|NCT01667133|12018032|FG002|COMPLETED|Phase 2: Dose-expansion||0
10851724|NCT01667133|12018033|FG003|COMPLETED|Phase 2: Dose-expansion||0
10851725|NCT01667133|12018034|FG004|COMPLETED|Phase 2: Dose-expansion||0
10851726|NCT01667133|12018035|FG005|COMPLETED|Phase 2: Dose-expansion||0
10851727|NCT01667133|12018036|FG006|COMPLETED|Phase 2: Dose-expansion||0
10851728|NCT01667133|12018037|FG007|COMPLETED|Phase 2: Dose-expansion||0
10851729|NCT01667133|12018038|FG008|COMPLETED|Phase 2: Dose-expansion||0
10851730|NCT01667133|12018039|FG009|COMPLETED|Phase 2: Dose-expansion||5
10851731|NCT01667133|12018040|FG010|COMPLETED|Phase 2: Dose-expansion||0
10851732|NCT01667133|12018041|FG011|COMPLETED|Phase 2: Dose-expansion||0
10851733|NCT01667133|12018030|FG000|NOT COMPLETED|Phase 2: Dose-expansion||0
10851734|NCT01667133|12018031|FG001|NOT COMPLETED|Phase 2: Dose-expansion||0
10851735|NCT01667133|12018032|FG002|NOT COMPLETED|Phase 2: Dose-expansion||0
10851736|NCT01667133|12018033|FG003|NOT COMPLETED|Phase 2: Dose-expansion||0
10851737|NCT01667133|12018034|FG004|NOT COMPLETED|Phase 2: Dose-expansion||0
10851738|NCT01667133|12018035|FG005|NOT COMPLETED|Phase 2: Dose-expansion||0
10851739|NCT01667133|12018036|FG006|NOT COMPLETED|Phase 2: Dose-expansion||0
10851740|NCT01667133|12018037|FG007|NOT COMPLETED|Phase 2: Dose-expansion||2
10851741|NCT01667133|12018038|FG008|NOT COMPLETED|Phase 2: Dose-expansion||1
10851742|NCT01667133|12018039|FG009|NOT COMPLETED|Phase 2: Dose-expansion||6
10851743|NCT01667133|12018040|FG010|NOT COMPLETED|Phase 2: Dose-expansion||3
10851744|NCT01667133|12018041|FG011|NOT COMPLETED|Phase 2: Dose-expansion||6
10851745|NCT01585103|12018102|FG000|STARTED|Overall Study||86
10851746|NCT01585103|12018102|FG000|COMPLETED|Overall Study||80
10851747|NCT01585103|12018102|FG000|NOT COMPLETED|Overall Study||6
10851748|NCT01427725|12018106|FG000|STARTED|Overall Study||579
10851749|NCT01427725|12018106|FG000|Collected CRFs|Overall Study|Not collected Case Report Forms (CRFs) of 17 patients.|562
10851750|NCT01427725|12018106|FG000|Safety Analysis Set|Overall Study|Analysis of safety data. 9 patients dropped out, could not confirm existence of Adverse Events.|553
10851751|NCT01427725|12018106|FG000|COMPLETED|Overall Study|Among the patients in the safety analysis set, 175 patients discontinued the survey.|378
10851752|NCT01427725|12018106|FG000|NOT COMPLETED|Overall Study||201
10851753|NCT00921115|12018111|FG000|STARTED|Overall Study||42
10851754|NCT00921115|12018111|FG000|COMPLETED|Overall Study||42
10851755|NCT00921115|12018111|FG000|NOT COMPLETED|Overall Study||0
10414136|NCT00783094|11558487|FG002|NOT COMPLETED|Open-Label Extension Period||30
10414137|NCT00783198|11558501|FG000|STARTED|Overall Study||190
10414138|NCT00783198|11558502|FG001|STARTED|Overall Study||187
10414139|NCT00783198|11558503|FG002|STARTED|Overall Study||188
10414140|NCT00783198|11558501|FG000|COMPLETED|Overall Study||133
10414141|NCT00783198|11558502|FG001|COMPLETED|Overall Study||144
10414142|NCT00783198|11558503|FG002|COMPLETED|Overall Study||146
10414143|NCT00783198|11558501|FG000|NOT COMPLETED|Overall Study||57
10414144|NCT00783198|11558502|FG001|NOT COMPLETED|Overall Study||43
10414145|NCT00783198|11558503|FG002|NOT COMPLETED|Overall Study||42
10414146|NCT00783289|11558515|FG000|STARTED|Overall Study||6
10414147|NCT00783289|11558516|FG001|STARTED|Overall Study||7
10414148|NCT00783289|11558517|FG002|STARTED|Overall Study||6
10414149|NCT00783289|11558518|FG003|STARTED|Overall Study||6
10414150|NCT00783289|11558515|FG000|COMPLETED|Overall Study||6
10414151|NCT00783289|11558516|FG001|COMPLETED|Overall Study||6
10851756|NCT04608344|12018117|FG000|STARTED|Period 1 (AB: 3 Days, BA: 11 Days)||14
10851757|NCT04608344|12018118|FG001|STARTED|Period 1 (AB: 3 Days, BA: 11 Days)||13
10851758|NCT04608344|12018117|FG000|COMPLETED|Period 1 (AB: 3 Days, BA: 11 Days)||13
10851759|NCT04608344|12018118|FG001|COMPLETED|Period 1 (AB: 3 Days, BA: 11 Days)||12
10851760|NCT04608344|12018117|FG000|NOT COMPLETED|Period 1 (AB: 3 Days, BA: 11 Days)||1
10851761|NCT04608344|12018118|FG001|NOT COMPLETED|Period 1 (AB: 3 Days, BA: 11 Days)||1
10851762|NCT04608344|12018117|FG000|STARTED|Period 2 (AB: 11 Days, BA: 3 Days)||13
10851763|NCT04608344|12018118|FG001|STARTED|Period 2 (AB: 11 Days, BA: 3 Days)||12
10851764|NCT04608344|12018117|FG000|COMPLETED|Period 2 (AB: 11 Days, BA: 3 Days)||13
10851765|NCT04608344|12018118|FG001|COMPLETED|Period 2 (AB: 11 Days, BA: 3 Days)||12
10851766|NCT04608344|12018117|FG000|NOT COMPLETED|Period 2 (AB: 11 Days, BA: 3 Days)||0
10851767|NCT04608344|12018118|FG001|NOT COMPLETED|Period 2 (AB: 11 Days, BA: 3 Days)||0
10851768|NCT04569253|12018132|FG000|STARTED|Overall Study||65
10851769|NCT04569253|12018132|FG000|Control Flanks|Overall Study||65
10851770|NCT04569253|12018132|FG000|Treatment Flanks|Overall Study||65
10851771|NCT04569253|12018132|FG000|COMPLETED|Overall Study||57
10851772|NCT04569253|12018132|FG000|NOT COMPLETED|Overall Study||8
10851773|NCT04350372|12018137|FG000|STARTED|Overall Study||16
10851774|NCT04350372|12018137|FG000|COMPLETED|Overall Study||15
10851775|NCT04350372|12018137|FG000|NOT COMPLETED|Overall Study||1
10851776|NCT04343989|12018144|FG000|STARTED|Overall Study||78
10851777|NCT04343989|12018145|FG001|STARTED|Overall Study||26
10851778|NCT04343989|12018146|FG002|STARTED|Overall Study||74
10851779|NCT04343989|12018144|FG000|COMPLETED|Overall Study||78
10851780|NCT04343989|12018145|FG001|COMPLETED|Overall Study||26
10851781|NCT04343989|12018146|FG002|COMPLETED|Overall Study||74
10851782|NCT04343989|12018144|FG000|NOT COMPLETED|Overall Study||0
10851783|NCT04343989|12018145|FG001|NOT COMPLETED|Overall Study||0
10851784|NCT04343989|12018146|FG002|NOT COMPLETED|Overall Study||0
10545485|NCT01497899|11698864|FG003|NOT COMPLETED|Double-Blind Phase||0
10545486|NCT01497899|11698861|FG000|STARTED|Open-Label Extension Phase|2 participants completed the Double-Blind Phase, but did not continue in the Open-Label Extension.|105
10851797|NCT04249310|12018179|FG000|STARTED|Overall Study||1436
10851798|NCT04249310|12018180|FG001|STARTED|Overall Study||5352
10851799|NCT04249310|12018179|FG000|PS-matched Cohort|Overall Study||1412
10851800|NCT04249310|12018180|FG001|PS-matched Cohort|Overall Study||1412
10851801|NCT04249310|12018179|FG000|hdPS-matched Cohort|Overall Study||1302
10851802|NCT04249310|12018180|FG001|hdPS-matched Cohort|Overall Study||1302
10851803|NCT04249310|12018179|FG000|COMPLETED|Overall Study||1436
10851804|NCT04249310|12018180|FG001|COMPLETED|Overall Study||5352
10851805|NCT04249310|12018179|FG000|NOT COMPLETED|Overall Study||0
10851806|NCT04249310|12018180|FG001|NOT COMPLETED|Overall Study||0
10851807|NCT04234984|12018188|FG000|STARTED|Follow-up at 6 Weeks||61
10851808|NCT04234984|12018188|FG000|COMPLETED|Follow-up at 6 Weeks||59
10851809|NCT04234984|12018188|FG000|NOT COMPLETED|Follow-up at 6 Weeks||2
10851810|NCT04234984|12018188|FG000|STARTED|Follow-up at the Second Time Point||19
10851811|NCT04234984|12018188|FG000|COMPLETED|Follow-up at the Second Time Point||17
10851812|NCT04234984|12018188|FG000|NOT COMPLETED|Follow-up at the Second Time Point||2
10851813|NCT04227197|12018196|FG000|STARTED|Randomization||117
10851814|NCT04227197|12018197|FG001|STARTED|Randomization||113
10851815|NCT04227197|12018196|FG000|COMPLETED|Randomization||115
10851816|NCT04227197|12018197|FG001|COMPLETED|Randomization||113
10851817|NCT04227197|12018196|FG000|NOT COMPLETED|Randomization||2
10851818|NCT04227197|12018197|FG001|NOT COMPLETED|Randomization||0
10851819|NCT04227197|12018196|FG000|STARTED|Primary Care Provider (PCP) Visit||115
10851820|NCT04227197|12018197|FG001|STARTED|Primary Care Provider (PCP) Visit||113
10851821|NCT04227197|12018196|FG000|COMPLETED|Primary Care Provider (PCP) Visit||113
10851822|NCT04227197|12018197|FG001|COMPLETED|Primary Care Provider (PCP) Visit||113
10851823|NCT04227197|12018196|FG000|NOT COMPLETED|Primary Care Provider (PCP) Visit||2
10851824|NCT04227197|12018197|FG001|NOT COMPLETED|Primary Care Provider (PCP) Visit||0
10851825|NCT04227197|12018196|FG000|STARTED|2-week Follow-up Survey for Caregivers||113
10851826|NCT04227197|12018197|FG001|STARTED|2-week Follow-up Survey for Caregivers||113
10851827|NCT04227197|12018196|FG000|COMPLETED|2-week Follow-up Survey for Caregivers||101
10851828|NCT04227197|12018197|FG001|COMPLETED|2-week Follow-up Survey for Caregivers||108
10851829|NCT04227197|12018196|FG000|NOT COMPLETED|2-week Follow-up Survey for Caregivers||12
10851830|NCT04227197|12018197|FG001|NOT COMPLETED|2-week Follow-up Survey for Caregivers||5
10851831|NCT04227197|12018196|FG000|STARTED|2-week Follow-up Survey for PCP's||114
10851832|NCT04227197|12018197|FG001|STARTED|2-week Follow-up Survey for PCP's||113
10851833|NCT04227197|12018196|FG000|COMPLETED|2-week Follow-up Survey for PCP's||94
10851834|NCT04227197|12018197|FG001|COMPLETED|2-week Follow-up Survey for PCP's||88
10851835|NCT04227197|12018196|FG000|NOT COMPLETED|2-week Follow-up Survey for PCP's||20
10851836|NCT04227197|12018197|FG001|NOT COMPLETED|2-week Follow-up Survey for PCP's||25
10851837|NCT04227197|12018196|FG000|STARTED|7-month Follow-up Survey for Caregivers||114
10851838|NCT04227197|12018197|FG001|STARTED|7-month Follow-up Survey for Caregivers||113
10851839|NCT04227197|12018196|FG000|COMPLETED|7-month Follow-up Survey for Caregivers||103
10851840|NCT04227197|12018197|FG001|COMPLETED|7-month Follow-up Survey for Caregivers||110
10851841|NCT04227197|12018196|FG000|NOT COMPLETED|7-month Follow-up Survey for Caregivers||11
10851842|NCT04227197|12018197|FG001|NOT COMPLETED|7-month Follow-up Survey for Caregivers||3
10851843|NCT04105725|12018208|FG000|STARTED|Primary Intervention||37
10851844|NCT04105725|12018209|FG001|STARTED|Primary Intervention||29
10851845|NCT04105725|12018208|FG000|COMPLETED|Primary Intervention||37
10851846|NCT04105725|12018209|FG001|COMPLETED|Primary Intervention||26
10851847|NCT04105725|12018208|FG000|NOT COMPLETED|Primary Intervention||0
10851848|NCT04105725|12018209|FG001|NOT COMPLETED|Primary Intervention||3
10851849|NCT04105725|12018208|FG000|STARTED|Mini-Session Week 1|Number based on number completed both sessions of the BMI+Substance-Free Activity Session.|37
10851850|NCT04105725|12018209|FG001|STARTED|Mini-Session Week 1|Number based on number completed both sessions of the Alcohol + Nutrition Education Session.|26
10851851|NCT04105725|12018208|FG000|COMPLETED|Mini-Session Week 1|Number of participants who completed both sessions of the BMI+Substance-Free Activity Session and Mini-Session Week 1|36
10851852|NCT04105725|12018209|FG001|COMPLETED|Mini-Session Week 1|Number of participants who completed both sessions of the Alcohol + Nutrition Education and Mini-Session Week 1|25
10851853|NCT04105725|12018208|FG000|NOT COMPLETED|Mini-Session Week 1||1
10851854|NCT04105725|12018209|FG001|NOT COMPLETED|Mini-Session Week 1||1
10851855|NCT04105725|12018208|FG000|STARTED|Mini-Session Week 2|Number based on number completed both sessions of the BMI+Substance-Free Activity Session.|37
10851856|NCT04105725|12018209|FG001|STARTED|Mini-Session Week 2|Number based on number completed both sessions of the Alcohol + Nutrition Education Session.|26
10851857|NCT04105725|12018208|FG000|COMPLETED|Mini-Session Week 2|Number of participants who completed both sessions of the BMI+Substance-Free Activity Session and Mini-Session Week 2|34
10851858|NCT04105725|12018209|FG001|COMPLETED|Mini-Session Week 2|Number of participants who completed both sessions of the Alcohol + Nutrition Education and Mini-Session Week 2|22
10851859|NCT04105725|12018208|FG000|NOT COMPLETED|Mini-Session Week 2||3
10851860|NCT04105725|12018209|FG001|NOT COMPLETED|Mini-Session Week 2||4
10851861|NCT04105725|12018208|FG000|STARTED|Mini-Session Week 3|Number based on number completed both sessions of the BMI+Substance-Free Activity Session.|37
10414152|NCT00783289|11558517|FG002|COMPLETED|Overall Study||6
10414153|NCT00783289|11558518|FG003|COMPLETED|Overall Study||6
10414154|NCT00783289|11558515|FG000|NOT COMPLETED|Overall Study||0
10414155|NCT00783289|11558516|FG001|NOT COMPLETED|Overall Study||1
10414156|NCT00783289|11558517|FG002|NOT COMPLETED|Overall Study||0
10414157|NCT00783289|11558518|FG003|NOT COMPLETED|Overall Study||0
10414158|NCT00783302|11558531|FG000|STARTED|Overall Study||885
10414159|NCT00783302|11558531|FG000|COMPLETED|Overall Study||850
10414160|NCT00783302|11558531|FG000|NOT COMPLETED|Overall Study||35
10414161|NCT00783432|11558551|FG000|STARTED|Overall Study|This includes 2 subjects that received a randomization number but did not receive study drug|430
10414162|NCT00783432|11558552|FG001|STARTED|Overall Study|This includes 2 subjects that received a randomization number but did not receive study drug|432
10414163|NCT00783432|11558551|FG000|COMPLETED|Overall Study||345
10414164|NCT00783432|11558552|FG001|COMPLETED|Overall Study||354
10414165|NCT00783432|11558551|FG000|NOT COMPLETED|Overall Study||85
10414166|NCT00783432|11558552|FG001|NOT COMPLETED|Overall Study||78
10414167|NCT00783614|11558562|FG000|STARTED|Overall Study||6
10414168|NCT00783614|11558563|FG001|STARTED|Overall Study||6
10414169|NCT00783614|11558564|FG002|STARTED|Overall Study||5
10414170|NCT00783614|11558565|FG003|STARTED|Overall Study||5
10414171|NCT00783614|11558562|FG000|COMPLETED|Overall Study||6
10414172|NCT00783614|11558563|FG001|COMPLETED|Overall Study||6
10414173|NCT00783614|11558564|FG002|COMPLETED|Overall Study||5
10414174|NCT00783614|11558565|FG003|COMPLETED|Overall Study||5
10414175|NCT00783614|11558562|FG000|NOT COMPLETED|Overall Study||0
10414176|NCT00783614|11558563|FG001|NOT COMPLETED|Overall Study||0
10414177|NCT00783614|11558564|FG002|NOT COMPLETED|Overall Study||0
10754790|NCT03055650|11918607|FG000|COMPLETED|Overall Study||30
10754791|NCT03055650|11918607|FG000|NOT COMPLETED|Overall Study||0
10754792|NCT03055806|11918615|FG000|STARTED|Overall Study||48
10754793|NCT03055806|11918616|FG001|STARTED|Overall Study||48
10754794|NCT03055806|11918617|FG002|STARTED|Overall Study||71
10754795|NCT03055806|11918618|FG003|STARTED|Overall Study||72
10754796|NCT03055806|11918615|FG000|COMPLETED|Overall Study||42
10754797|NCT03055806|11918616|FG001|COMPLETED|Overall Study||41
10754798|NCT03055806|11918617|FG002|COMPLETED|Overall Study||58
10754799|NCT03055806|11918618|FG003|COMPLETED|Overall Study||57
10754800|NCT03055806|11918615|FG000|NOT COMPLETED|Overall Study||6
10754801|NCT03055806|11918616|FG001|NOT COMPLETED|Overall Study||7
10754802|NCT03055806|11918617|FG002|NOT COMPLETED|Overall Study||13
10754803|NCT03055806|11918618|FG003|NOT COMPLETED|Overall Study||15
10754804|NCT03055832|11918630|FG000|STARTED|Baseline||71
10754805|NCT03055832|11918631|FG001|STARTED|Baseline||71
10754806|NCT03055832|11918630|FG000|COMPLETED|Baseline||71
10754807|NCT03055832|11918631|FG001|COMPLETED|Baseline||71
10754808|NCT03055832|11918630|FG000|NOT COMPLETED|Baseline||0
10754809|NCT03055832|11918631|FG001|NOT COMPLETED|Baseline||0
10754810|NCT03055832|11918630|FG000|STARTED|Immediately Post-Procedure (Hour 1)||71
10754811|NCT03055832|11918631|FG001|STARTED|Immediately Post-Procedure (Hour 1)||71
10754812|NCT03055832|11918630|FG000|COMPLETED|Immediately Post-Procedure (Hour 1)||71
10754813|NCT03055832|11918631|FG001|COMPLETED|Immediately Post-Procedure (Hour 1)||71
10851862|NCT04105725|12018209|FG001|STARTED|Mini-Session Week 3|Number based on number completed both sessions of the Alcohol + Nutrition Education Session.|26
10851863|NCT04105725|12018208|FG000|COMPLETED|Mini-Session Week 3|Number of participants who completed both sessions of the BMI+Substance-Free Activity Session and Mini-Session Week 3|34
10851864|NCT04105725|12018209|FG001|COMPLETED|Mini-Session Week 3|Number of participants who completed both sessions of the Alcohol + Nutrition Education and Mini-Session Week 3|22
10851865|NCT04105725|12018208|FG000|NOT COMPLETED|Mini-Session Week 3||3
10851866|NCT04105725|12018209|FG001|NOT COMPLETED|Mini-Session Week 3||4
10851867|NCT04105725|12018208|FG000|STARTED|Mini-Session Week 4|Number based on number completed both sessions of the BMI+Substance-Free Activity Session.|37
10851868|NCT04105725|12018209|FG001|STARTED|Mini-Session Week 4|Number based on number completed both sessions of the Alcohol + Nutrition Education Session.|26
10851869|NCT04105725|12018208|FG000|COMPLETED|Mini-Session Week 4|Number of participants who completed both sessions of the BMI+Substance-Free Activity Session and Mini-Session Week 4|35
10851870|NCT04105725|12018209|FG001|COMPLETED|Mini-Session Week 4|Number of participants who completed both sessions of the Alcohol + Nutrition Education and Mini-Session Week 4|21
10851871|NCT04105725|12018208|FG000|NOT COMPLETED|Mini-Session Week 4||2
10851872|NCT04105725|12018209|FG001|NOT COMPLETED|Mini-Session Week 4||5
10851873|NCT04105725|12018208|FG000|STARTED|Post-Intervention Survey|Number based on number completed both sessions of the BMI+Substance-Free Activity Session.|37
10851874|NCT04105725|12018209|FG001|STARTED|Post-Intervention Survey|Number based on number completed both sessions of the Alcohol + Nutrition Education Session.|26
10851875|NCT04105725|12018208|FG000|COMPLETED|Post-Intervention Survey|Number of participants who completed both sessions of the BMI+Substance-Free Activity Session and the Post-Intervention Survey|33
10851876|NCT04105725|12018209|FG001|COMPLETED|Post-Intervention Survey|Number of participants who completed both sessions of the Alcohol + Nutrition Education and the Post-Intervention Survey|18
10851877|NCT04105725|12018208|FG000|NOT COMPLETED|Post-Intervention Survey||4
10851878|NCT04105725|12018209|FG001|NOT COMPLETED|Post-Intervention Survey||8
10851879|NCT04105725|12018208|FG000|STARTED|3-Month Follow-up Survey|Number based on number completed both sessions of the BMI+Substance-Free Activity Session.|37
10851880|NCT04105725|12018209|FG001|STARTED|3-Month Follow-up Survey|Number based on number completed both sessions of the Alcohol + Nutrition Education Session.|26
10851881|NCT04105725|12018208|FG000|COMPLETED|3-Month Follow-up Survey|Number of participants who completed both sessions of the BMI+Substance-Free Activity Session and the 3-Month Follow-up Survey|33
10851882|NCT04105725|12018209|FG001|COMPLETED|3-Month Follow-up Survey|Number of participants who completed both sessions of the Alcohol + Nutrition Education and the 3-Month Follow-up Survey|22
10851883|NCT04105725|12018208|FG000|NOT COMPLETED|3-Month Follow-up Survey||4
10851884|NCT04105725|12018209|FG001|NOT COMPLETED|3-Month Follow-up Survey||4
10851885|NCT04066023|12018218|FG000|STARTED|Overall Study||12
10851886|NCT04066023|12018219|FG001|STARTED|Overall Study||17
10851887|NCT04066023|12018220|FG002|STARTED|Overall Study||13
10851888|NCT04066023|12018218|FG000|COMPLETED|Overall Study||9
10851889|NCT04066023|12018219|FG001|COMPLETED|Overall Study||9
10851890|NCT04066023|12018220|FG002|COMPLETED|Overall Study||7
10851891|NCT04066023|12018218|FG000|NOT COMPLETED|Overall Study||3
10851892|NCT04066023|12018219|FG001|NOT COMPLETED|Overall Study||8
10851893|NCT04066023|12018220|FG002|NOT COMPLETED|Overall Study||6
10851894|NCT04011475|12018231|FG000|STARTED|Overall Study||239
10851895|NCT04011475|12018232|FG001|STARTED|Overall Study||937
10851896|NCT04011475|12018233|FG002|STARTED|Overall Study||441
10851897|NCT04011475|12018231|FG000|Propensity Score Matched Cohort|Overall Study||114
10851898|NCT04011475|12018232|FG001|Propensity Score Matched Cohort|Overall Study||114
10851899|NCT04011475|12018233|FG002|Propensity Score Matched Cohort|Overall Study||114
10851900|NCT04011475|12018231|FG000|COMPLETED|Overall Study||239
10851901|NCT04011475|12018232|FG001|COMPLETED|Overall Study||937
10851902|NCT04011475|12018233|FG002|COMPLETED|Overall Study||441
10851903|NCT04011475|12018231|FG000|NOT COMPLETED|Overall Study||0
10851904|NCT04011475|12018232|FG001|NOT COMPLETED|Overall Study||0
10851905|NCT04011475|12018233|FG002|NOT COMPLETED|Overall Study||0
10851906|NCT03882957|12018241|FG000|STARTED|Overall Study||92
10851907|NCT03882957|12018241|FG000|Participant Flow 1|Overall Study|participant flow sequence: video --> media multitask --> sustained attention|17
10851908|NCT03882957|12018241|FG000|Participant Flow 2|Overall Study|participant flow sequence: video --> sustained attention -- media multitask|16
10851909|NCT03882957|12018241|FG000|Participant Flow 3|Overall Study|participant flow sequence: media multitask --> video --> sustained attention|13
10852000|NCT03104413|12018362|FG003|STARTED|Induction Period 1||0
10851910|NCT03882957|12018241|FG000|Participant Flow 4|Overall Study|participant flow sequence: sustained attention --> video -- media multitask|15
10851911|NCT03882957|12018241|FG000|Participant Flow 5|Overall Study|participant flow sequence: sustained attention --> media multitask --> video|16
10851912|NCT03882957|12018241|FG000|Participant Flow 6|Overall Study|participant flow 6: media multitask --> sustained attention --> video|14
10851913|NCT03882957|12018241|FG000|COMPLETED|Overall Study||91
10851914|NCT03882957|12018241|FG000|NOT COMPLETED|Overall Study||1
10851915|NCT03711500|12018254|FG000|STARTED|Overall Study||12
10851916|NCT03711500|12018255|FG001|STARTED|Overall Study||12
10851917|NCT03711500|12018256|FG002|STARTED|Overall Study||12
10851918|NCT03711500|12018257|FG003|STARTED|Overall Study||9
10851919|NCT03711500|12018254|FG000|COMPLETED|Overall Study||12
10851920|NCT03711500|12018255|FG001|COMPLETED|Overall Study|One subject completed 2 of three treatment sessions, with LOCF carried forward for analysis|11
10851921|NCT03711500|12018256|FG002|COMPLETED|Overall Study||12
10851922|NCT03711500|12018257|FG003|COMPLETED|Overall Study||9
10851923|NCT03711500|12018254|FG000|NOT COMPLETED|Overall Study||0
10851924|NCT03711500|12018255|FG001|NOT COMPLETED|Overall Study||1
10851925|NCT03711500|12018256|FG002|NOT COMPLETED|Overall Study||0
10851926|NCT03711500|12018257|FG003|NOT COMPLETED|Overall Study||0
10851927|NCT03639558|12018269|FG000|STARTED|Overall Study||52
10851928|NCT03639558|12018270|FG001|STARTED|Overall Study||48
10851929|NCT03639558|12018269|FG000|COMPLETED|Overall Study||51
10851930|NCT03639558|12018270|FG001|COMPLETED|Overall Study||43
10851931|NCT03639558|12018269|FG000|NOT COMPLETED|Overall Study||1
10851932|NCT03639558|12018270|FG001|NOT COMPLETED|Overall Study||5
10851933|NCT03630770|12018278|FG000|STARTED|Overall Study||4
10851934|NCT03630770|12018279|FG001|STARTED|Overall Study||8
10851935|NCT03630770|12018278|FG000|COMPLETED|Overall Study||4
10851936|NCT03630770|12018279|FG001|COMPLETED|Overall Study||8
10851937|NCT03630770|12018278|FG000|NOT COMPLETED|Overall Study||0
10851938|NCT03630770|12018279|FG001|NOT COMPLETED|Overall Study||0
10851939|NCT03387852|12018289|FG000|STARTED|Overall Study||74
10851940|NCT03387852|12018290|FG001|STARTED|Overall Study||73
10851941|NCT03387852|12018291|FG002|STARTED|Overall Study||74
10851942|NCT03387852|12018292|FG003|STARTED|Overall Study||75
10851943|NCT03387852|12018289|FG000|Treated|Overall Study||74
10851944|NCT03387852|12018290|FG001|Treated|Overall Study||73
10851945|NCT03387852|12018291|FG002|Treated|Overall Study||74
10851946|NCT03387852|12018292|FG003|Treated|Overall Study||74
10851947|NCT03387852|12018289|FG000|COMPLETED|Overall Study||41
10851948|NCT03387852|12018290|FG001|COMPLETED|Overall Study||55
10851949|NCT03387852|12018291|FG002|COMPLETED|Overall Study||47
10851950|NCT03387852|12018292|FG003|COMPLETED|Overall Study||56
10851951|NCT03387852|12018289|FG000|NOT COMPLETED|Overall Study||33
10851952|NCT03387852|12018290|FG001|NOT COMPLETED|Overall Study||18
10851953|NCT03387852|12018291|FG002|NOT COMPLETED|Overall Study||27
10851954|NCT03387852|12018292|FG003|NOT COMPLETED|Overall Study||19
10851955|NCT03382574|12018303|FG000|STARTED|Overall Study||0
10851956|NCT03382574|12018303|FG000|COMPLETED|Overall Study||0
10851957|NCT03382574|12018303|FG000|NOT COMPLETED|Overall Study||0
10851958|NCT03364673|12018309|FG000|STARTED|Overall Study||29
10851959|NCT03364673|12018309|FG000|COMPLETED|Overall Study||24
10851960|NCT03364673|12018309|FG000|NOT COMPLETED|Overall Study||5
10851961|NCT03343704|12018315|FG000|STARTED|Overall Study||13
10851962|NCT03343704|12018316|FG001|STARTED|Overall Study||6
10851963|NCT03343704|12018315|FG000|COMPLETED|Overall Study||12
10851964|NCT03343704|12018316|FG001|COMPLETED|Overall Study||4
10851965|NCT03343704|12018315|FG000|NOT COMPLETED|Overall Study||1
10851966|NCT03343704|12018316|FG001|NOT COMPLETED|Overall Study||2
10851967|NCT03265145|12018326|FG000|STARTED|Overall Study||356
10851968|NCT03265145|12018327|FG001|STARTED|Overall Study||358
10851969|NCT03265145|12018326|FG000|COMPLETED|Overall Study||285
10851970|NCT03265145|12018327|FG001|COMPLETED|Overall Study||302
10851971|NCT03265145|12018326|FG000|NOT COMPLETED|Overall Study||71
10851972|NCT03265145|12018327|FG001|NOT COMPLETED|Overall Study||56
10851973|NCT03219164|12018336|FG000|STARTED|Overall Study||74
10851974|NCT03219164|12018337|FG001|STARTED|Overall Study||75
10851975|NCT03219164|12018336|FG000|COMPLETED|Overall Study||49
10851976|NCT03219164|12018337|FG001|COMPLETED|Overall Study||57
10851977|NCT03219164|12018336|FG000|NOT COMPLETED|Overall Study||25
10851978|NCT03219164|12018337|FG001|NOT COMPLETED|Overall Study||18
10851979|NCT03143153|12018346|FG000|STARTED|Pre-Treatment||325
10851980|NCT03143153|12018347|FG001|STARTED|Pre-Treatment||321
10851981|NCT03143153|12018348|FG002|STARTED|Pre-Treatment||324
10851982|NCT03143153|12018346|FG000|COMPLETED|Pre-Treatment||322
10851983|NCT03143153|12018347|FG001|COMPLETED|Pre-Treatment||310
10851984|NCT03143153|12018348|FG002|COMPLETED|Pre-Treatment||304
10851985|NCT03143153|12018346|FG000|NOT COMPLETED|Pre-Treatment||3
10851986|NCT03143153|12018347|FG001|NOT COMPLETED|Pre-Treatment||11
10851987|NCT03143153|12018348|FG002|NOT COMPLETED|Pre-Treatment||20
10851988|NCT03143153|12018346|FG000|STARTED|Treatment||322
10851989|NCT03143153|12018347|FG001|STARTED|Treatment||310
10851990|NCT03143153|12018348|FG002|STARTED|Treatment||304
10851991|NCT03143153|12018346|FG000|COMPLETED|Treatment||21
10851992|NCT03143153|12018347|FG001|COMPLETED|Treatment||25
10851993|NCT03143153|12018348|FG002|COMPLETED|Treatment||4
10851994|NCT03143153|12018346|FG000|NOT COMPLETED|Treatment||301
10851995|NCT03143153|12018347|FG001|NOT COMPLETED|Treatment||285
10851996|NCT03143153|12018348|FG002|NOT COMPLETED|Treatment||300
10851997|NCT03104413|12018359|FG000|STARTED|Induction Period 1||207
10851998|NCT03104413|12018360|FG001|STARTED|Induction Period 1||206
10851999|NCT03104413|12018361|FG002|STARTED|Induction Period 1||205
10852001|NCT03104413|12018363|FG004|STARTED|Induction Period 1||0
10852002|NCT03104413|12018364|FG005|STARTED|Induction Period 1||0
10852003|NCT03104413|12018365|FG006|STARTED|Induction Period 1||0
10852004|NCT03104413|12018359|FG000|COMPLETED|Induction Period 1||186
10852005|NCT03104413|12018360|FG001|COMPLETED|Induction Period 1||202
10852006|NCT03104413|12018361|FG002|COMPLETED|Induction Period 1||199
10852007|NCT03104413|12018362|FG003|COMPLETED|Induction Period 1||0
10852008|NCT03104413|12018363|FG004|COMPLETED|Induction Period 1||0
10852009|NCT03104413|12018364|FG005|COMPLETED|Induction Period 1||0
10852010|NCT03104413|12018365|FG006|COMPLETED|Induction Period 1||0
10852011|NCT03104413|12018359|FG000|NOT COMPLETED|Induction Period 1||21
10852012|NCT03104413|12018360|FG001|NOT COMPLETED|Induction Period 1||4
10852013|NCT03104413|12018361|FG002|NOT COMPLETED|Induction Period 1||6
10852014|NCT03104413|12018362|FG003|NOT COMPLETED|Induction Period 1||0
10852015|NCT03104413|12018363|FG004|NOT COMPLETED|Induction Period 1||0
10852016|NCT03104413|12018364|FG005|NOT COMPLETED|Induction Period 1||0
10852017|NCT03104413|12018365|FG006|NOT COMPLETED|Induction Period 1||0
10852018|NCT03104413|12018359|FG000|STARTED|Induction Period 2||0
10852019|NCT03104413|12018360|FG001|STARTED|Induction Period 2||0
10852020|NCT03104413|12018361|FG002|STARTED|Induction Period 2||0
10852021|NCT03104413|12018362|FG003|STARTED|Induction Period 2||41
10852022|NCT03104413|12018363|FG004|STARTED|Induction Period 2||42
10852023|NCT03104413|12018364|FG005|STARTED|Induction Period 2||42
10852024|NCT03104413|12018365|FG006|STARTED|Induction Period 2||86
10852025|NCT03104413|12018359|FG000|COMPLETED|Induction Period 2||0
10852026|NCT03104413|12018360|FG001|COMPLETED|Induction Period 2||0
10852027|NCT03104413|12018361|FG002|COMPLETED|Induction Period 2||0
10852028|NCT03104413|12018362|FG003|COMPLETED|Induction Period 2||39
10852029|NCT03104413|12018363|FG004|COMPLETED|Induction Period 2||39
10852030|NCT03104413|12018364|FG005|COMPLETED|Induction Period 2||38
10852031|NCT03104413|12018365|FG006|COMPLETED|Induction Period 2||76
10852032|NCT03104413|12018359|FG000|NOT COMPLETED|Induction Period 2||0
10852033|NCT03104413|12018360|FG001|NOT COMPLETED|Induction Period 2||0
10852034|NCT03104413|12018361|FG002|NOT COMPLETED|Induction Period 2||0
10852035|NCT03104413|12018362|FG003|NOT COMPLETED|Induction Period 2||2
10852036|NCT03104413|12018363|FG004|NOT COMPLETED|Induction Period 2||3
10852037|NCT03104413|12018364|FG005|NOT COMPLETED|Induction Period 2||4
10852038|NCT03104413|12018365|FG006|NOT COMPLETED|Induction Period 2||10
10852039|NCT02930590|12018379|FG000|STARTED|First Intervention (2 Hours)||3
10852040|NCT02930590|12018380|FG001|STARTED|First Intervention (2 Hours)||3
10852041|NCT02930590|12018381|FG002|STARTED|First Intervention (2 Hours)||3
10852042|NCT02930590|12018382|FG003|STARTED|First Intervention (2 Hours)||2
10852043|NCT02930590|12018383|FG004|STARTED|First Intervention (2 Hours)||2
10852044|NCT02930590|12018384|FG005|STARTED|First Intervention (2 Hours)||2
10852045|NCT02930590|12018379|FG000|COMPLETED|First Intervention (2 Hours)||3
10852046|NCT02930590|12018380|FG001|COMPLETED|First Intervention (2 Hours)||3
10852047|NCT02930590|12018381|FG002|COMPLETED|First Intervention (2 Hours)||3
10852048|NCT02930590|12018382|FG003|COMPLETED|First Intervention (2 Hours)||2
10852049|NCT02930590|12018383|FG004|COMPLETED|First Intervention (2 Hours)||2
10852050|NCT02930590|12018384|FG005|COMPLETED|First Intervention (2 Hours)||2
10852051|NCT02930590|12018379|FG000|NOT COMPLETED|First Intervention (2 Hours)||0
10852052|NCT02930590|12018380|FG001|NOT COMPLETED|First Intervention (2 Hours)||0
10852053|NCT02930590|12018381|FG002|NOT COMPLETED|First Intervention (2 Hours)||0
10852054|NCT02930590|12018382|FG003|NOT COMPLETED|First Intervention (2 Hours)||0
10852055|NCT02930590|12018383|FG004|NOT COMPLETED|First Intervention (2 Hours)||0
10852056|NCT02930590|12018384|FG005|NOT COMPLETED|First Intervention (2 Hours)||0
10852057|NCT02930590|12018379|FG000|STARTED|Second Intervention (2 Hours)||3
10852058|NCT02930590|12018380|FG001|STARTED|Second Intervention (2 Hours)||3
10852059|NCT02930590|12018381|FG002|STARTED|Second Intervention (2 Hours)||3
10852060|NCT02930590|12018382|FG003|STARTED|Second Intervention (2 Hours)||2
10852061|NCT02930590|12018383|FG004|STARTED|Second Intervention (2 Hours)||2
10852062|NCT02930590|12018384|FG005|STARTED|Second Intervention (2 Hours)||2
10852063|NCT02930590|12018379|FG000|COMPLETED|Second Intervention (2 Hours)||3
10852064|NCT02930590|12018380|FG001|COMPLETED|Second Intervention (2 Hours)||3
10852065|NCT02930590|12018381|FG002|COMPLETED|Second Intervention (2 Hours)||3
10852066|NCT02930590|12018382|FG003|COMPLETED|Second Intervention (2 Hours)||2
10852067|NCT02930590|12018383|FG004|COMPLETED|Second Intervention (2 Hours)||2
10852068|NCT02930590|12018384|FG005|COMPLETED|Second Intervention (2 Hours)||2
10852069|NCT02930590|12018379|FG000|NOT COMPLETED|Second Intervention (2 Hours)||0
10852070|NCT02930590|12018380|FG001|NOT COMPLETED|Second Intervention (2 Hours)||0
10852071|NCT02930590|12018381|FG002|NOT COMPLETED|Second Intervention (2 Hours)||0
10852072|NCT02930590|12018382|FG003|NOT COMPLETED|Second Intervention (2 Hours)||0
10852073|NCT02930590|12018383|FG004|NOT COMPLETED|Second Intervention (2 Hours)||0
10852074|NCT02930590|12018384|FG005|NOT COMPLETED|Second Intervention (2 Hours)||0
10852075|NCT02930590|12018379|FG000|STARTED|Third Intervention (2 Hours)||3
10852076|NCT02930590|12018380|FG001|STARTED|Third Intervention (2 Hours)||3
10852077|NCT02930590|12018381|FG002|STARTED|Third Intervention (2 Hours)||3
10852078|NCT02930590|12018382|FG003|STARTED|Third Intervention (2 Hours)||2
10852079|NCT02930590|12018383|FG004|STARTED|Third Intervention (2 Hours)||2
10852080|NCT02930590|12018384|FG005|STARTED|Third Intervention (2 Hours)||2
10852081|NCT02930590|12018379|FG000|COMPLETED|Third Intervention (2 Hours)||3
10852082|NCT02930590|12018380|FG001|COMPLETED|Third Intervention (2 Hours)||3
10852083|NCT02930590|12018381|FG002|COMPLETED|Third Intervention (2 Hours)||3
10852084|NCT02930590|12018382|FG003|COMPLETED|Third Intervention (2 Hours)||2
10852085|NCT02930590|12018383|FG004|COMPLETED|Third Intervention (2 Hours)||2
10852086|NCT02930590|12018384|FG005|COMPLETED|Third Intervention (2 Hours)||2
10852087|NCT02930590|12018379|FG000|NOT COMPLETED|Third Intervention (2 Hours)||0
10852088|NCT02930590|12018380|FG001|NOT COMPLETED|Third Intervention (2 Hours)||0
10852089|NCT02930590|12018381|FG002|NOT COMPLETED|Third Intervention (2 Hours)||0
10852090|NCT02930590|12018382|FG003|NOT COMPLETED|Third Intervention (2 Hours)||0
10852091|NCT02930590|12018383|FG004|NOT COMPLETED|Third Intervention (2 Hours)||0
10852092|NCT02930590|12018384|FG005|NOT COMPLETED|Third Intervention (2 Hours)||0
10852093|NCT02921789|12018396|FG000|STARTED|Overall Study||34
10852094|NCT02921789|12018397|FG001|STARTED|Overall Study||29
10852095|NCT02921789|12018396|FG000|Randomized and Took Study Drug|Overall Study||34
10852096|NCT02921789|12018397|FG001|Randomized and Took Study Drug|Overall Study||29
10852097|NCT02921789|12018396|FG000|COMPLETED|Overall Study||26
10852098|NCT02921789|12018397|FG001|COMPLETED|Overall Study||25
10852099|NCT02921789|12018396|FG000|NOT COMPLETED|Overall Study||8
10852100|NCT02921789|12018397|FG001|NOT COMPLETED|Overall Study||4
10852101|NCT02898077|12018405|FG000|STARTED|Overall Study||294
10852102|NCT02898077|12018406|FG001|STARTED|Overall Study||146
10852103|NCT02898077|12018405|FG000|Received at Least 1 Dose of Study Drug|Overall Study||293
10852104|NCT02898077|12018406|FG001|Received at Least 1 Dose of Study Drug|Overall Study||145
10852105|NCT02898077|12018405|FG000|COMPLETED|Overall Study||246
10852106|NCT02898077|12018406|FG001|COMPLETED|Overall Study||123
10852107|NCT02898077|12018405|FG000|NOT COMPLETED|Overall Study||48
10852108|NCT02898077|12018406|FG001|NOT COMPLETED|Overall Study||23
10852109|NCT02702271|12018414|FG000|STARTED|Overall Study||400
10852110|NCT02702271|12018415|FG001|STARTED|Overall Study||58
10852111|NCT02702271|12018414|FG000|COMPLETED|Overall Study||337
10852112|NCT02702271|12018415|FG001|COMPLETED|Overall Study||49
10852113|NCT02702271|12018414|FG000|NOT COMPLETED|Overall Study||63
10852114|NCT02702271|12018415|FG001|NOT COMPLETED|Overall Study||9
10852115|NCT02658136|12018421|FG000|STARTED|Overall Study|Approved to start in year 2016. Goal was to reach 15 participants (1 day study).|15
10852116|NCT02658136|12018421|FG000|COMPLETED|Overall Study|Date of end of study: June 2017, N=15|15
10852117|NCT02658136|12018421|FG000|NOT COMPLETED|Overall Study||0
10852118|NCT02558634|12018426|FG000|STARTED|Blinded: First Intervention (3 Months)||4
10852119|NCT02558634|12018427|FG001|STARTED|Blinded: First Intervention (3 Months)||2
10852120|NCT02558634|12018426|FG000|COMPLETED|Blinded: First Intervention (3 Months)||4
10852121|NCT02558634|12018427|FG001|COMPLETED|Blinded: First Intervention (3 Months)||2
10852122|NCT02558634|12018426|FG000|NOT COMPLETED|Blinded: First Intervention (3 Months)||0
10852123|NCT02558634|12018427|FG001|NOT COMPLETED|Blinded: First Intervention (3 Months)||0
10852124|NCT02558634|12018426|FG000|STARTED|Blinded: Second Intervention (3 Months)||4
10852125|NCT02558634|12018427|FG001|STARTED|Blinded: Second Intervention (3 Months)||2
10852126|NCT02558634|12018426|FG000|COMPLETED|Blinded: Second Intervention (3 Months)|Assessed after 2 weeks - 1 participant requested to have their DBS 'on'|3
10852127|NCT02558634|12018427|FG001|COMPLETED|Blinded: Second Intervention (3 Months)||2
10852128|NCT02558634|12018426|FG000|NOT COMPLETED|Blinded: Second Intervention (3 Months)||1
10852129|NCT02558634|12018427|FG001|NOT COMPLETED|Blinded: Second Intervention (3 Months)||0
10852130|NCT02558634|12018426|FG000|STARTED|Unblinded: DBS on (6 Months)||4
10852131|NCT02558634|12018427|FG001|STARTED|Unblinded: DBS on (6 Months)||2
10852132|NCT02558634|12018426|FG000|COMPLETED|Unblinded: DBS on (6 Months)||4
10852133|NCT02558634|12018427|FG001|COMPLETED|Unblinded: DBS on (6 Months)||2
10852134|NCT02558634|12018426|FG000|NOT COMPLETED|Unblinded: DBS on (6 Months)||0
10852135|NCT02558634|12018427|FG001|NOT COMPLETED|Unblinded: DBS on (6 Months)||0
10852136|NCT02471339|12018439|FG000|STARTED|Overall Study||32
10852137|NCT02471339|12018440|FG001|STARTED|Overall Study||34
10852138|NCT02471339|12018439|FG000|COMPLETED|Overall Study||30
10852139|NCT02471339|12018440|FG001|COMPLETED|Overall Study||34
10852140|NCT02471339|12018439|FG000|NOT COMPLETED|Overall Study||2
10852141|NCT02471339|12018440|FG001|NOT COMPLETED|Overall Study||0
10852142|NCT02470585|12018449|FG000|STARTED|Overall Study||375
10852143|NCT02470585|12018450|FG001|STARTED|Overall Study||383
10852144|NCT02470585|12018451|FG002|STARTED|Overall Study||382
10852145|NCT02470585|12018449|FG000|Received Study Drug|Overall Study||371
10852146|NCT02470585|12018450|FG001|Received Study Drug|Overall Study||376
10852147|NCT02470585|12018451|FG002|Received Study Drug|Overall Study||377
10852148|NCT02470585|12018449|FG000|COMPLETED|Overall Study||268
10852149|NCT02470585|12018450|FG001|COMPLETED|Overall Study||266
10852150|NCT02470585|12018451|FG002|COMPLETED|Overall Study||257
10852151|NCT02470585|12018449|FG000|NOT COMPLETED|Overall Study||107
10414178|NCT00783614|11558565|FG003|NOT COMPLETED|Overall Study||0
10414179|NCT00783692|11558578|FG000|STARTED|Induction Phase||148
10414180|NCT00783692|11558579|FG001|STARTED|Induction Phase||220
10414181|NCT00783692|11558580|FG002|STARTED|Induction Phase||748
10414182|NCT00783692|11558581|FG003|STARTED|Induction Phase||0
10414183|NCT00783692|11558582|FG004|STARTED|Induction Phase||0
10414184|NCT00783692|11558583|FG005|STARTED|Induction Phase||0
10414185|NCT00783692|11558584|FG006|STARTED|Induction Phase||0
10414186|NCT00783692|11558578|FG000|Treated|Induction Phase||148
10414187|NCT00783692|11558579|FG001|Treated|Induction Phase||220
10414188|NCT00783692|11558580|FG002|Treated|Induction Phase||747
10414189|NCT00783692|11558581|FG003|Treated|Induction Phase||0
10414190|NCT00783692|11558582|FG004|Treated|Induction Phase||0
10414191|NCT00783692|11558583|FG005|Treated|Induction Phase||0
10414192|NCT00783692|11558584|FG006|Treated|Induction Phase||0
10414193|NCT00783692|11558578|FG000|COMPLETED|Induction Phase||137
10414194|NCT00783692|11558579|FG001|COMPLETED|Induction Phase||199
10414195|NCT00783692|11558580|FG002|COMPLETED|Induction Phase||674
10414196|NCT00783692|11558581|FG003|COMPLETED|Induction Phase||0
10414197|NCT00783692|11558582|FG004|COMPLETED|Induction Phase||0
10414198|NCT00783692|11558583|FG005|COMPLETED|Induction Phase||0
10414199|NCT00783692|11558584|FG006|COMPLETED|Induction Phase||0
10414200|NCT00783692|11558578|FG000|NOT COMPLETED|Induction Phase||11
10414201|NCT00783692|11558579|FG001|NOT COMPLETED|Induction Phase||21
10414202|NCT00783692|11558580|FG002|NOT COMPLETED|Induction Phase||74
10414203|NCT00783692|11558581|FG003|NOT COMPLETED|Induction Phase||0
10414204|NCT00783692|11558582|FG004|NOT COMPLETED|Induction Phase||0
10414205|NCT00783692|11558583|FG005|NOT COMPLETED|Induction Phase||0
10414206|NCT00783692|11558584|FG006|NOT COMPLETED|Induction Phase||0
10414207|NCT00783692|11558578|FG000|STARTED|Maintenance Phase||137
10414208|NCT00783692|11558579|FG001|STARTED|Maintenance Phase||0
10414209|NCT00783692|11558580|FG002|STARTED|Maintenance Phase||0
10414210|NCT00783692|11558581|FG003|STARTED|Maintenance Phase||153
10414211|NCT00783692|11558582|FG004|STARTED|Maintenance Phase||154
10414212|NCT00783692|11558583|FG005|STARTED|Maintenance Phase||154
10414213|NCT00783692|11558584|FG006|STARTED|Maintenance Phase||412
10852152|NCT02470585|12018450|FG001|NOT COMPLETED|Overall Study||117
10852153|NCT02470585|12018451|FG002|NOT COMPLETED|Overall Study||125
10852154|NCT02426749|12018461|FG000|STARTED|Overall Study||12
10852155|NCT02426749|12018462|FG001|STARTED|Overall Study||10
10852156|NCT02426749|12018461|FG000|COMPLETED|Overall Study||9
10414214|NCT00783692|11558578|FG000|COMPLETED|Maintenance Phase||42
10414215|NCT00783692|11558579|FG001|COMPLETED|Maintenance Phase||0
10414216|NCT00783692|11558580|FG002|COMPLETED|Maintenance Phase||0
10414217|NCT00783692|11558581|FG003|COMPLETED|Maintenance Phase||64
10414218|NCT00783692|11558582|FG004|COMPLETED|Maintenance Phase||73
10414219|NCT00783692|11558583|FG005|COMPLETED|Maintenance Phase||82
10414220|NCT00783692|11558584|FG006|COMPLETED|Maintenance Phase||163
10852157|NCT02426749|12018462|FG001|COMPLETED|Overall Study||9
10852158|NCT02426749|12018461|FG000|NOT COMPLETED|Overall Study||3
10852159|NCT02426749|12018462|FG001|NOT COMPLETED|Overall Study||1
10852160|NCT02318264|12018472|FG000|STARTED|Overall Study||8
10852161|NCT02318264|12018473|FG001|STARTED|Overall Study||7
10852162|NCT02318264|12018472|FG000|COMPLETED|Overall Study||8
10852163|NCT02318264|12018473|FG001|COMPLETED|Overall Study||7
10852164|NCT02318264|12018472|FG000|NOT COMPLETED|Overall Study||0
10852165|NCT02318264|12018473|FG001|NOT COMPLETED|Overall Study||0
10852166|NCT02163694|12018482|FG000|STARTED|Overall Study||172
10852167|NCT02163694|12018483|FG001|STARTED|Overall Study||337
10852168|NCT02163694|12018482|FG000|COMPLETED|Overall Study||18
10852169|NCT02163694|12018483|FG001|COMPLETED|Overall Study||70
10852170|NCT02163694|12018482|FG000|NOT COMPLETED|Overall Study||154
10852171|NCT02163694|12018483|FG001|NOT COMPLETED|Overall Study||267
10293069|NCT01232283|11425778|FG003|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
10293070|NCT01232283|11425779|FG004|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
10293071|NCT01232283|11425780|FG005|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
10293072|NCT01232283|11425781|FG006|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
10293073|NCT01232283|11425782|FG007|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
10852172|NCT01966471|12018491|FG000|STARTED|Overall Study||918
10852173|NCT01966471|12018492|FG001|STARTED|Overall Study||928
10852174|NCT01966471|12018491|FG000|COMPLETED|Overall Study||0
10414221|NCT00783692|11558578|FG000|NOT COMPLETED|Maintenance Phase||95
10414222|NCT00783692|11558579|FG001|NOT COMPLETED|Maintenance Phase||0
10414223|NCT00783692|11558580|FG002|NOT COMPLETED|Maintenance Phase||0
10414224|NCT00783692|11558581|FG003|NOT COMPLETED|Maintenance Phase||89
10414225|NCT00783692|11558582|FG004|NOT COMPLETED|Maintenance Phase||81
10414226|NCT00783692|11558583|FG005|NOT COMPLETED|Maintenance Phase||72
10414227|NCT00783692|11558584|FG006|NOT COMPLETED|Maintenance Phase||249
10414228|NCT00783705|11558599|FG000|STARTED|Overall Study||44
10414229|NCT00783705|11558600|FG001|STARTED|Overall Study||41
10414230|NCT00783705|11558599|FG000|COMPLETED|Overall Study||38
10414231|NCT00783705|11558600|FG001|COMPLETED|Overall Study||36
10414232|NCT00783705|11558599|FG000|NOT COMPLETED|Overall Study||6
10414233|NCT00783705|11558600|FG001|NOT COMPLETED|Overall Study||5
10414234|NCT00783718|11558609|FG000|STARTED|Induction Phase||149
10414235|NCT00783718|11558610|FG001|STARTED|Induction Phase||225
10414236|NCT00783718|11558611|FG002|STARTED|Induction Phase||521
10414237|NCT00783718|11558612|FG003|STARTED|Induction Phase||0
10414238|NCT00783718|11558613|FG004|STARTED|Induction Phase||0
10414239|NCT00783718|11558614|FG005|STARTED|Induction Phase||0
10414240|NCT00783718|11558615|FG006|STARTED|Induction Phase||0
10414241|NCT00783718|11558609|FG000|COMPLETED|Induction Phase||135
10414242|NCT00783718|11558610|FG001|COMPLETED|Induction Phase||218
10414243|NCT00783718|11558611|FG002|COMPLETED|Induction Phase||485
10414244|NCT00783718|11558612|FG003|COMPLETED|Induction Phase||0
10414245|NCT00783718|11558613|FG004|COMPLETED|Induction Phase||0
10414246|NCT00783718|11558614|FG005|COMPLETED|Induction Phase||0
10414247|NCT00783718|11558615|FG006|COMPLETED|Induction Phase||0
10414248|NCT00783718|11558609|FG000|NOT COMPLETED|Induction Phase||14
10414249|NCT00783718|11558610|FG001|NOT COMPLETED|Induction Phase||7
10414250|NCT00783718|11558611|FG002|NOT COMPLETED|Induction Phase||36
10414251|NCT00783718|11558612|FG003|NOT COMPLETED|Induction Phase||0
10414252|NCT00783718|11558613|FG004|NOT COMPLETED|Induction Phase||0
10414253|NCT00783718|11558614|FG005|NOT COMPLETED|Induction Phase||0
10414254|NCT00783718|11558615|FG006|NOT COMPLETED|Induction Phase||0
10414255|NCT00783718|11558609|FG000|STARTED|Maintenance Phase||135
10414256|NCT00783718|11558610|FG001|STARTED|Maintenance Phase||0
10414257|NCT00783718|11558611|FG002|STARTED|Maintenance Phase||0
10414258|NCT00783718|11558612|FG003|STARTED|Maintenance Phase||126
10414259|NCT00783718|11558613|FG004|STARTED|Maintenance Phase||122
10414260|NCT00783718|11558614|FG005|STARTED|Maintenance Phase||125
10414261|NCT00783718|11558615|FG006|STARTED|Maintenance Phase||330
10414262|NCT00783718|11558609|FG000|COMPLETED|Maintenance Phase||30
10414263|NCT00783718|11558610|FG001|COMPLETED|Maintenance Phase||0
10414264|NCT00783718|11558611|FG002|COMPLETED|Maintenance Phase||0
10414265|NCT00783718|11558612|FG003|COMPLETED|Maintenance Phase||48
10414266|NCT00783718|11558613|FG004|COMPLETED|Maintenance Phase||77
10414267|NCT00783718|11558614|FG005|COMPLETED|Maintenance Phase||84
10414268|NCT00783718|11558615|FG006|COMPLETED|Maintenance Phase||135
10414269|NCT00783718|11558609|FG000|NOT COMPLETED|Maintenance Phase||105
10414270|NCT00783718|11558610|FG001|NOT COMPLETED|Maintenance Phase||0
10414271|NCT00783718|11558611|FG002|NOT COMPLETED|Maintenance Phase||0
10414272|NCT00783718|11558612|FG003|NOT COMPLETED|Maintenance Phase||78
10414273|NCT00783718|11558613|FG004|NOT COMPLETED|Maintenance Phase||45
10414274|NCT00783718|11558614|FG005|NOT COMPLETED|Maintenance Phase||41
10414275|NCT00783718|11558615|FG006|NOT COMPLETED|Maintenance Phase||195
10414276|NCT00783796|11558625|FG000|STARTED|Overall Study||150
10414277|NCT00783796|11558625|FG000|COMPLETED|Overall Study||144
10414278|NCT00783796|11558625|FG000|NOT COMPLETED|Overall Study||6
10414279|NCT00783835|11558631|FG000|STARTED|Overall Study||60
10414280|NCT00783835|11558631|FG000|COMPLETED|Overall Study||50
10414281|NCT00783835|11558631|FG000|NOT COMPLETED|Overall Study||10
10414282|NCT00783952|11558635|FG000|STARTED|Overall Study||8
10414283|NCT00783952|11558635|FG000|COMPLETED|Overall Study||8
10414284|NCT00783952|11558635|FG000|NOT COMPLETED|Overall Study||0
10414285|NCT00783965|11558642|FG000|STARTED|First Intervention (12 Months)||5
10414286|NCT00783965|11558643|FG001|STARTED|First Intervention (12 Months)||29
10414287|NCT00783965|11558642|FG000|COMPLETED|First Intervention (12 Months)||2
10414288|NCT00783965|11558643|FG001|COMPLETED|First Intervention (12 Months)||25
10414289|NCT00783965|11558642|FG000|NOT COMPLETED|First Intervention (12 Months)||3
10414290|NCT00783965|11558643|FG001|NOT COMPLETED|First Intervention (12 Months)||4
10414291|NCT00783965|11558642|FG000|STARTED|Second Intervention (24 Months)||2
10414292|NCT00783965|11558643|FG001|STARTED|Second Intervention (24 Months)||25
10414293|NCT00783965|11558642|FG000|COMPLETED|Second Intervention (24 Months)||2
10414294|NCT00783965|11558643|FG001|COMPLETED|Second Intervention (24 Months)||16
10414295|NCT00783965|11558642|FG000|NOT COMPLETED|Second Intervention (24 Months)||0
10414296|NCT00783965|11558643|FG001|NOT COMPLETED|Second Intervention (24 Months)||9
10414297|NCT00784030|11558651|FG000|STARTED|Overall Study||13
10414298|NCT00784030|11558652|FG001|STARTED|Overall Study||10
10414299|NCT00784030|11558651|FG000|COMPLETED|Overall Study||13
10414300|NCT00784030|11558652|FG001|COMPLETED|Overall Study||10
10414301|NCT00784030|11558651|FG000|NOT COMPLETED|Overall Study||0
10414302|NCT00784030|11558652|FG001|NOT COMPLETED|Overall Study||0
10414303|NCT00784095|11558661|FG000|STARTED|Overall Study||12
10545487|NCT01497899|11698862|FG001|STARTED|Open-Label Extension Phase||53
10852175|NCT01966471|12018492|FG001|COMPLETED|Overall Study|There is a difference in the death count displayed here and in the All-Cause Mortality section under Adverse Events. The difference relates to a participant that died and who was randomized to the AC-KP arm, but never received trastuzumab emtansine. Consequently they were assigned to the AC-THP for safety analyses. This death counts in the AC-KP arm when summary is based on the ITT population, but counts in the AC-THP arm when the summary on the safety population.|0
10852176|NCT01966471|12018491|FG000|NOT COMPLETED|Overall Study||918
10852177|NCT01966471|12018492|FG001|NOT COMPLETED|Overall Study||928
10852178|NCT01871220|12018500|FG000|STARTED|Overall Study||29
10852179|NCT01871220|12018501|FG001|STARTED|Overall Study||32
10852180|NCT01871220|12018500|FG000|COMPLETED|Overall Study||25
10852181|NCT01871220|12018501|FG001|COMPLETED|Overall Study||29
10852182|NCT01871220|12018500|FG000|NOT COMPLETED|Overall Study||4
10852183|NCT01871220|12018501|FG001|NOT COMPLETED|Overall Study||3
10852184|NCT01825187|12018509|FG000|STARTED|Overall Study||25
10852185|NCT01825187|12018510|FG001|STARTED|Overall Study||25
10852186|NCT01825187|12018511|FG002|STARTED|Overall Study||25
10852187|NCT01825187|12018509|FG000|COMPLETED|Overall Study||24
10852188|NCT01825187|12018510|FG001|COMPLETED|Overall Study||24
10852189|NCT01825187|12018511|FG002|COMPLETED|Overall Study||24
10852190|NCT01825187|12018509|FG000|NOT COMPLETED|Overall Study||1
10852191|NCT01825187|12018510|FG001|NOT COMPLETED|Overall Study||1
10852192|NCT01825187|12018511|FG002|NOT COMPLETED|Overall Study||1
10852193|NCT01465334|12018522|FG000|STARTED|Overall Study||15
10852194|NCT01465334|12018523|FG001|STARTED|Overall Study||15
10852195|NCT01465334|12018522|FG000|Complete Part A Induction|Overall Study||12
10852196|NCT01465334|12018523|FG001|Complete Part A Induction|Overall Study||15
10852197|NCT01465334|12018522|FG000|Complete Part B Induction|Overall Study||7
10852198|NCT01465334|12018523|FG001|Complete Part B Induction|Overall Study||15
10852199|NCT01465334|12018522|FG000|Eligible for Allogeneic Transplant|Overall Study||9
10852200|NCT01465334|12018523|FG001|Eligible for Allogeneic Transplant|Overall Study||9
10852201|NCT01465334|12018522|FG000|COMPLETED|Overall Study||13
10852202|NCT01465334|12018523|FG001|COMPLETED|Overall Study||9
10852203|NCT01465334|12018522|FG000|NOT COMPLETED|Overall Study||2
10852204|NCT01465334|12018523|FG001|NOT COMPLETED|Overall Study||6
10852205|NCT01307423|12018532|FG000|STARTED|Placebo-controlled Phase (Week 0 - 24)||176
10852206|NCT01307423|12018533|FG001|STARTED|Placebo-controlled Phase (Week 0 - 24)||175
10852207|NCT01307423|12018534|FG002|STARTED|Placebo-controlled Phase (Week 0 - 24)||177
10852208|NCT01307423|12018535|FG003|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
10852209|NCT01307423|12018536|FG004|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
10852210|NCT01307423|12018537|FG005|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
10852211|NCT01307423|12018538|FG006|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
10852212|NCT01307423|12018539|FG007|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
10852213|NCT01307423|12018540|FG008|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
10852214|NCT01307423|12018532|FG000|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||176
10852215|NCT01307423|12018533|FG001|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||175
10852216|NCT01307423|12018534|FG002|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||175
10852217|NCT01307423|12018535|FG003|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
10852218|NCT01307423|12018536|FG004|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
10852219|NCT01307423|12018537|FG005|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
10852220|NCT01307423|12018538|FG006|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
10852221|NCT01307423|12018539|FG007|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
10852222|NCT01307423|12018540|FG008|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
10852223|NCT01307423|12018532|FG000|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||166
10852224|NCT01307423|12018533|FG001|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||168
10852225|NCT01307423|12018534|FG002|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||166
10852226|NCT01307423|12018535|FG003|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
10852227|NCT01307423|12018536|FG004|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
10852228|NCT01307423|12018537|FG005|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
10852229|NCT01307423|12018538|FG006|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
10852230|NCT01307423|12018539|FG007|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
10852231|NCT01307423|12018540|FG008|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
10852232|NCT01307423|12018532|FG000|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|One participant who escaped early did not complete Week 24|103
10852233|NCT01307423|12018533|FG001|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||73
10852234|NCT01307423|12018534|FG002|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||79
10852235|NCT01307423|12018535|FG003|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
10852236|NCT01307423|12018536|FG004|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
10852237|NCT01307423|12018537|FG005|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
10852238|NCT01307423|12018538|FG006|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
10852239|NCT01307423|12018539|FG007|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
10852240|NCT01307423|12018540|FG008|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
10852241|NCT01307423|12018532|FG000|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|Two participants did not escape early and finished Week 24 did not enter the active treatment phase|156
10852242|NCT01307423|12018533|FG001|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||160
10852243|NCT01307423|12018534|FG002|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||155
10852244|NCT01307423|12018535|FG003|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
10852245|NCT01307423|12018536|FG004|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
10852246|NCT01307423|12018537|FG005|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
10852247|NCT01307423|12018538|FG006|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
10852248|NCT01307423|12018539|FG007|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
10852249|NCT01307423|12018540|FG008|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
10852250|NCT01307423|12018532|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20
10852251|NCT01307423|12018533|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||15
10852252|NCT01307423|12018534|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
10852253|NCT01307423|12018535|FG003|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
10852254|NCT01307423|12018536|FG004|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
10852255|NCT01307423|12018537|FG005|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
10852256|NCT01307423|12018538|FG006|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
10852257|NCT01307423|12018539|FG007|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
10852258|NCT01307423|12018540|FG008|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
10852259|NCT01307423|12018532|FG000|STARTED|Active Treatment Phase (Week 25-52)||0
10852260|NCT01307423|12018533|FG001|STARTED|Active Treatment Phase (Week 25-52)|Nine participants who completed Week 24 did not enter active treatment phase|151
10852261|NCT01307423|12018534|FG002|STARTED|Active Treatment Phase (Week 25-52)|Five participants who completed Week 24 did not enter active treatment phase|150
10852262|NCT01307423|12018535|FG003|STARTED|Active Treatment Phase (Week 25-52)|Four participants who escaped early and completed Week 24 did not enter the active treatment phase.|46
10852263|NCT01307423|12018536|FG004|STARTED|Active Treatment Phase (Week 25-52)||26
10852264|NCT01307423|12018537|FG005|STARTED|Active Treatment Phase (Week 25-52)|Six participants who escaped early and completed Week 24 did not enter the active treatment phase|46
10852265|NCT01307423|12018538|FG006|STARTED|Active Treatment Phase (Week 25-52)||26
10852266|NCT01307423|12018539|FG007|STARTED|Active Treatment Phase (Week 25-52)||0
10852267|NCT01307423|12018540|FG008|STARTED|Active Treatment Phase (Week 25-52)||0
10852268|NCT01307423|12018532|FG000|COMPLETED|Active Treatment Phase (Week 25-52)||0
10852269|NCT01307423|12018533|FG001|COMPLETED|Active Treatment Phase (Week 25-52)||132
10852270|NCT01307423|12018534|FG002|COMPLETED|Active Treatment Phase (Week 25-52)||141
10852271|NCT01307423|12018535|FG003|COMPLETED|Active Treatment Phase (Week 25-52)||38
10852272|NCT01307423|12018536|FG004|COMPLETED|Active Treatment Phase (Week 25-52)||23
10852273|NCT01307423|12018537|FG005|COMPLETED|Active Treatment Phase (Week 25-52)||43
10852274|NCT01307423|12018538|FG006|COMPLETED|Active Treatment Phase (Week 25-52)||25
10852275|NCT01307423|12018539|FG007|COMPLETED|Active Treatment Phase (Week 25-52)||0
10852276|NCT01307423|12018540|FG008|COMPLETED|Active Treatment Phase (Week 25-52)||0
10852277|NCT01307423|12018532|FG000|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
10852278|NCT01307423|12018533|FG001|NOT COMPLETED|Active Treatment Phase (Week 25-52)||19
10852279|NCT01307423|12018534|FG002|NOT COMPLETED|Active Treatment Phase (Week 25-52)||9
10852280|NCT01307423|12018535|FG003|NOT COMPLETED|Active Treatment Phase (Week 25-52)||8
10852281|NCT01307423|12018536|FG004|NOT COMPLETED|Active Treatment Phase (Week 25-52)||3
10852282|NCT01307423|12018537|FG005|NOT COMPLETED|Active Treatment Phase (Week 25-52)||3
10852283|NCT01307423|12018538|FG006|NOT COMPLETED|Active Treatment Phase (Week 25-52)||1
10852284|NCT01307423|12018539|FG007|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
10852285|NCT01307423|12018540|FG008|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
10852286|NCT01307423|12018532|FG000|STARTED|Long-term Safety Phase (Year 2)||0
10852287|NCT01307423|12018533|FG001|STARTED|Long-term Safety Phase (Year 2)|10 participants who completed Week 52 did not enter the long-term safety phase|122
10852288|NCT01307423|12018534|FG002|STARTED|Long-term Safety Phase (Year 2)|7 participants who completed Week 52 did not enter the long-term safety phase|134
10852289|NCT01307423|12018535|FG003|STARTED|Long-term Safety Phase (Year 2)||0
10852290|NCT01307423|12018536|FG004|STARTED|Long-term Safety Phase (Year 2)||0
10852291|NCT01307423|12018537|FG005|STARTED|Long-term Safety Phase (Year 2)||0
10852292|NCT01307423|12018538|FG006|STARTED|Long-term Safety Phase (Year 2)||0
10852293|NCT01307423|12018539|FG007|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 20 mg EE and XO are combined;15 patients finished Wk 52;no entry into LTSP|57
10852294|NCT01307423|12018540|FG008|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 30 mg EE and XO are combined;5 patients finished Wk 52;no entry into LTSP|67
10852295|NCT01307423|12018532|FG000|COMPLETED|Long-term Safety Phase (Year 2)||0
10852296|NCT01307423|12018533|FG001|COMPLETED|Long-term Safety Phase (Year 2)||99
10852297|NCT01307423|12018534|FG002|COMPLETED|Long-term Safety Phase (Year 2)||109
10852298|NCT01307423|12018535|FG003|COMPLETED|Long-term Safety Phase (Year 2)||0
10852299|NCT01307423|12018536|FG004|COMPLETED|Long-term Safety Phase (Year 2)||0
10852300|NCT01307423|12018537|FG005|COMPLETED|Long-term Safety Phase (Year 2)||0
10852301|NCT01307423|12018538|FG006|COMPLETED|Long-term Safety Phase (Year 2)||0
10852302|NCT01307423|12018539|FG007|COMPLETED|Long-term Safety Phase (Year 2)||48
10852303|NCT01307423|12018540|FG008|COMPLETED|Long-term Safety Phase (Year 2)||60
10852304|NCT01307423|12018532|FG000|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
10852305|NCT01307423|12018533|FG001|NOT COMPLETED|Long-term Safety Phase (Year 2)||23
10852306|NCT01307423|12018534|FG002|NOT COMPLETED|Long-term Safety Phase (Year 2)||25
10852307|NCT01307423|12018535|FG003|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
10852308|NCT01307423|12018536|FG004|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
10852309|NCT01307423|12018537|FG005|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
10852310|NCT01307423|12018538|FG006|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
10852311|NCT01307423|12018539|FG007|NOT COMPLETED|Long-term Safety Phase (Year 2)||9
10852312|NCT01307423|12018540|FG008|NOT COMPLETED|Long-term Safety Phase (Year 2)||7
10852313|NCT01307423|12018532|FG000|STARTED|Long-term Safety Phase (Year 3)||0
10852314|NCT01307423|12018533|FG001|STARTED|Long-term Safety Phase (Year 3)||99
10852315|NCT01307423|12018534|FG002|STARTED|Long-term Safety Phase (Year 3)||109
10852316|NCT01307423|12018535|FG003|STARTED|Long-term Safety Phase (Year 3)||0
10852317|NCT01307423|12018536|FG004|STARTED|Long-term Safety Phase (Year 3)||0
10852318|NCT01307423|12018537|FG005|STARTED|Long-term Safety Phase (Year 3)||0
10852319|NCT01307423|12018538|FG006|STARTED|Long-term Safety Phase (Year 3)||0
10852320|NCT01307423|12018539|FG007|STARTED|Long-term Safety Phase (Year 3)||48
10852321|NCT01307423|12018540|FG008|STARTED|Long-term Safety Phase (Year 3)||60
10852322|NCT01307423|12018532|FG000|COMPLETED|Long-term Safety Phase (Year 3)||0
10852323|NCT01307423|12018533|FG001|COMPLETED|Long-term Safety Phase (Year 3)||90
10852324|NCT01307423|12018534|FG002|COMPLETED|Long-term Safety Phase (Year 3)||91
10852325|NCT01307423|12018535|FG003|COMPLETED|Long-term Safety Phase (Year 3)||0
10852326|NCT01307423|12018536|FG004|COMPLETED|Long-term Safety Phase (Year 3)||0
10414304|NCT00784095|11558662|FG001|STARTED|Overall Study||12
10414305|NCT00784095|11558663|FG002|STARTED|Overall Study||12
10414306|NCT00784095|11558661|FG000|COMPLETED|Overall Study||12
10414307|NCT00784095|11558662|FG001|COMPLETED|Overall Study||11
10414308|NCT00784095|11558663|FG002|COMPLETED|Overall Study||11
10414309|NCT00784095|11558661|FG000|NOT COMPLETED|Overall Study||0
10414310|NCT00784095|11558662|FG001|NOT COMPLETED|Overall Study||1
10414311|NCT00784095|11558663|FG002|NOT COMPLETED|Overall Study||1
10414312|NCT00784134|11558676|FG000|STARTED|Overall Study||249
10414313|NCT00784134|11558677|FG001|STARTED|Overall Study||251
10414314|NCT00784134|11558676|FG000|COMPLETED|Overall Study||246
10414315|NCT00784134|11558677|FG001|COMPLETED|Overall Study||245
10414316|NCT00784134|11558676|FG000|NOT COMPLETED|Overall Study||3
10414317|NCT00784134|11558677|FG001|NOT COMPLETED|Overall Study||6
10414318|NCT00784147|11558685|FG000|STARTED|Overall Study||59
10414319|NCT00784147|11558686|FG001|STARTED|Overall Study||54
10414320|NCT00784147|11558685|FG000|COMPLETED|Overall Study||51
10414321|NCT00784147|11558686|FG001|COMPLETED|Overall Study||45
10545488|NCT01497899|11698863|FG002|STARTED|Open-Label Extension Phase|Participants enrolled from other Gilead-sponsored Study GS-US-299-0102.|70
10545489|NCT01497899|11698864|FG003|STARTED|Open-Label Extension Phase|Participants enrolled from other Gilead-sponsored Study GS-US-299-0102.|38
10545490|NCT01497899|11698861|FG000|COMPLETED|Open-Label Extension Phase||86
10545491|NCT01497899|11698862|FG001|COMPLETED|Open-Label Extension Phase||46
10545492|NCT01497899|11698863|FG002|COMPLETED|Open-Label Extension Phase||61
10545493|NCT01497899|11698864|FG003|COMPLETED|Open-Label Extension Phase||33
10545494|NCT01497899|11698861|FG000|NOT COMPLETED|Open-Label Extension Phase||19
10545495|NCT01497899|11698862|FG001|NOT COMPLETED|Open-Label Extension Phase||7
10545496|NCT01497899|11698863|FG002|NOT COMPLETED|Open-Label Extension Phase||9
10545497|NCT01497899|11698864|FG003|NOT COMPLETED|Open-Label Extension Phase||5
10545498|NCT01497938|11698873|FG000|STARTED|Overall Study||121
10545499|NCT01497938|11698874|FG001|STARTED|Overall Study||126
10545500|NCT01497938|11698873|FG000|COMPLETED|Overall Study||116
10545501|NCT01497938|11698874|FG001|COMPLETED|Overall Study||124
10545502|NCT01497938|11698873|FG000|NOT COMPLETED|Overall Study||5
10545503|NCT01497938|11698874|FG001|NOT COMPLETED|Overall Study||2
10545504|NCT01498068|11698882|FG000|STARTED|Overall Study||16
10545505|NCT01498068|11698883|FG001|STARTED|Overall Study||20
10545506|NCT01498068|11698882|FG000|COMPLETED|Overall Study||15
10545507|NCT01498068|11698883|FG001|COMPLETED|Overall Study||19
10545508|NCT01498068|11698882|FG000|NOT COMPLETED|Overall Study||1
10545509|NCT01498068|11698883|FG001|NOT COMPLETED|Overall Study||1
10545510|NCT01498120|11698889|FG000|STARTED|Overall Study||14
10545511|NCT01498120|11698889|FG000|COMPLETED|Overall Study||1
10545512|NCT01498120|11698889|FG000|NOT COMPLETED|Overall Study||13
10545513|NCT01498185|11698898|FG000|STARTED|Overall Study||13
10545514|NCT01498185|11698899|FG001|STARTED|Overall Study||13
10545515|NCT01498185|11698900|FG002|STARTED|Overall Study||15
10545516|NCT01498185|11698901|FG003|STARTED|Overall Study||14
10545517|NCT01498185|11698902|FG004|STARTED|Overall Study||15
10545518|NCT01498185|11698898|FG000|COMPLETED|Overall Study||12
10545519|NCT01498185|11698899|FG001|COMPLETED|Overall Study||12
10545520|NCT01498185|11698900|FG002|COMPLETED|Overall Study||15
10545521|NCT01498185|11698901|FG003|COMPLETED|Overall Study||11
10545522|NCT01498185|11698902|FG004|COMPLETED|Overall Study||12
10545523|NCT01498185|11698898|FG000|NOT COMPLETED|Overall Study||1
10545524|NCT01498185|11698899|FG001|NOT COMPLETED|Overall Study||1
10545525|NCT01498185|11698900|FG002|NOT COMPLETED|Overall Study||0
10545526|NCT01498185|11698901|FG003|NOT COMPLETED|Overall Study||3
10545527|NCT01498185|11698902|FG004|NOT COMPLETED|Overall Study||3
10545528|NCT01498289|11698920|FG000|STARTED|Overall Study||98
10545529|NCT01498289|11698921|FG001|STARTED|Overall Study||104
10545530|NCT01498289|11698920|FG000|Participants Assessed for AEs|Overall Study||91
10545531|NCT01498289|11698921|FG001|Participants Assessed for AEs|Overall Study||98
10545532|NCT01498289|11698920|FG000|COMPLETED|Overall Study||0
10545533|NCT01498289|11698921|FG001|COMPLETED|Overall Study||0
10545534|NCT01498289|11698920|FG000|NOT COMPLETED|Overall Study||98
10545535|NCT01498289|11698921|FG001|NOT COMPLETED|Overall Study||104
10545536|NCT01498419|11698935|FG000|STARTED|Overall Study||60
10545537|NCT01498419|11698936|FG001|STARTED|Overall Study||62
10414322|NCT00784147|11558685|FG000|NOT COMPLETED|Overall Study||8
10414323|NCT00784147|11558686|FG001|NOT COMPLETED|Overall Study||9
10414324|NCT00784225|11558696|FG000|STARTED|Overall Study||3375
10414325|NCT00784225|11558697|FG001|STARTED|Overall Study||3357
10414326|NCT00784225|11558698|FG002|STARTED|Overall Study||3369
10414327|NCT00784225|11558699|FG003|STARTED|Overall Study||3374
10545538|NCT01498419|11698937|FG002|STARTED|Overall Study||59
10545539|NCT01498419|11698938|FG003|STARTED|Overall Study||26
10852327|NCT01307423|12018537|FG005|COMPLETED|Long-term Safety Phase (Year 3)||0
10852328|NCT01307423|12018538|FG006|COMPLETED|Long-term Safety Phase (Year 3)||0
10852329|NCT01307423|12018539|FG007|COMPLETED|Long-term Safety Phase (Year 3)||40
10852330|NCT01307423|12018540|FG008|COMPLETED|Long-term Safety Phase (Year 3)||49
10852331|NCT01307423|12018532|FG000|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
10852332|NCT01307423|12018533|FG001|NOT COMPLETED|Long-term Safety Phase (Year 3)||9
10852333|NCT01307423|12018534|FG002|NOT COMPLETED|Long-term Safety Phase (Year 3)||18
10852334|NCT01307423|12018535|FG003|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
10852335|NCT01307423|12018536|FG004|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
10852336|NCT01307423|12018537|FG005|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
10852337|NCT01307423|12018538|FG006|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
10852338|NCT01307423|12018539|FG007|NOT COMPLETED|Long-term Safety Phase (Year 3)||8
10852339|NCT01307423|12018540|FG008|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
10852340|NCT01307423|12018532|FG000|STARTED|Long-term Safety Phase (Year 4)||0
10852341|NCT01307423|12018533|FG001|STARTED|Long-term Safety Phase (Year 4)|1 participant who completed Year 3 did not continue treatment in Year 4|89
10852342|NCT01307423|12018534|FG002|STARTED|Long-term Safety Phase (Year 4)||91
10852343|NCT01307423|12018535|FG003|STARTED|Long-term Safety Phase (Year 4)||0
10852344|NCT01307423|12018536|FG004|STARTED|Long-term Safety Phase (Year 4)||0
10852345|NCT01307423|12018537|FG005|STARTED|Long-term Safety Phase (Year 4)||0
10852346|NCT01307423|12018538|FG006|STARTED|Long-term Safety Phase (Year 4)||0
10852347|NCT01307423|12018539|FG007|STARTED|Long-term Safety Phase (Year 4)||40
10852348|NCT01307423|12018540|FG008|STARTED|Long-term Safety Phase (Year 4)||49
10852349|NCT01307423|12018532|FG000|COMPLETED|Long-term Safety Phase (Year 4)||0
10852350|NCT01307423|12018533|FG001|COMPLETED|Long-term Safety Phase (Year 4)||81
10852351|NCT01307423|12018534|FG002|COMPLETED|Long-term Safety Phase (Year 4)||86
10852352|NCT01307423|12018535|FG003|COMPLETED|Long-term Safety Phase (Year 4)||0
10852353|NCT01307423|12018536|FG004|COMPLETED|Long-term Safety Phase (Year 4)||0
10852354|NCT01307423|12018537|FG005|COMPLETED|Long-term Safety Phase (Year 4)||0
10852355|NCT01307423|12018538|FG006|COMPLETED|Long-term Safety Phase (Year 4)||0
10852356|NCT01307423|12018539|FG007|COMPLETED|Long-term Safety Phase (Year 4)||38
10852357|NCT01307423|12018540|FG008|COMPLETED|Long-term Safety Phase (Year 4)||44
10852358|NCT01307423|12018532|FG000|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
10852359|NCT01307423|12018533|FG001|NOT COMPLETED|Long-term Safety Phase (Year 4)||8
10852360|NCT01307423|12018534|FG002|NOT COMPLETED|Long-term Safety Phase (Year 4)||5
10852361|NCT01307423|12018535|FG003|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
10852362|NCT01307423|12018536|FG004|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
10852363|NCT01307423|12018537|FG005|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
10852364|NCT01307423|12018538|FG006|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
10852365|NCT01307423|12018539|FG007|NOT COMPLETED|Long-term Safety Phase (Year 4)||2
10852366|NCT01307423|12018540|FG008|NOT COMPLETED|Long-term Safety Phase (Year 4)||5
10852367|NCT01307423|12018532|FG000|STARTED|Long-term Safety Phase (Year 5)||0
10852368|NCT01307423|12018533|FG001|STARTED|Long-term Safety Phase (Year 5)||81
10852369|NCT01307423|12018534|FG002|STARTED|Long-term Safety Phase (Year 5)||86
10852370|NCT01307423|12018535|FG003|STARTED|Long-term Safety Phase (Year 5)||0
10852371|NCT01307423|12018536|FG004|STARTED|Long-term Safety Phase (Year 5)||0
10852372|NCT01307423|12018537|FG005|STARTED|Long-term Safety Phase (Year 5)||0
10852373|NCT01307423|12018538|FG006|STARTED|Long-term Safety Phase (Year 5)||0
10852374|NCT01307423|12018539|FG007|STARTED|Long-term Safety Phase (Year 5)||38
10852375|NCT01307423|12018540|FG008|STARTED|Long-term Safety Phase (Year 5)||44
10852376|NCT01307423|12018532|FG000|COMPLETED|Long-term Safety Phase (Year 5)||0
10852377|NCT01307423|12018533|FG001|COMPLETED|Long-term Safety Phase (Year 5)||71
10852378|NCT01307423|12018534|FG002|COMPLETED|Long-term Safety Phase (Year 5)||80
10852379|NCT01307423|12018535|FG003|COMPLETED|Long-term Safety Phase (Year 5)||0
10852380|NCT01307423|12018536|FG004|COMPLETED|Long-term Safety Phase (Year 5)||0
10852381|NCT01307423|12018537|FG005|COMPLETED|Long-term Safety Phase (Year 5)||0
10852382|NCT01307423|12018538|FG006|COMPLETED|Long-term Safety Phase (Year 5)||0
10852383|NCT01307423|12018539|FG007|COMPLETED|Long-term Safety Phase (Year 5)||37
10852384|NCT01307423|12018540|FG008|COMPLETED|Long-term Safety Phase (Year 5)||41
10852385|NCT01307423|12018532|FG000|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
10852386|NCT01307423|12018533|FG001|NOT COMPLETED|Long-term Safety Phase (Year 5)||10
10852387|NCT01307423|12018534|FG002|NOT COMPLETED|Long-term Safety Phase (Year 5)||6
10852388|NCT01307423|12018535|FG003|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
10852389|NCT01307423|12018536|FG004|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
10852390|NCT01307423|12018537|FG005|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
10852391|NCT01307423|12018538|FG006|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
10293074|NCT01232283|11425783|FG008|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||108
10293075|NCT01232283|11425784|FG009|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||61
10293076|NCT01231516|11425808|FG000|STARTED|Double-blind Phase (Up to Week [Wk] 48)||360
10293077|NCT01231516|11425809|FG001|STARTED|Double-blind Phase (Up to Week [Wk] 48)||364
10293078|NCT01231516|11425808|FG000|ITT-E Population|Double-blind Phase (Up to Week [Wk] 48)||357
10293079|NCT01231516|11425809|FG001|ITT-E Population|Double-blind Phase (Up to Week [Wk] 48)||362
10293080|NCT01231516|11425808|FG000|Modified (m)ITT-E Population|Double-blind Phase (Up to Week [Wk] 48)||354
10293081|NCT01231516|11425809|FG001|Modified (m)ITT-E Population|Double-blind Phase (Up to Week [Wk] 48)||361
10293082|NCT01231516|11425808|FG000|COMPLETED|Double-blind Phase (Up to Week [Wk] 48)||299
10293083|NCT01231516|11425809|FG001|COMPLETED|Double-blind Phase (Up to Week [Wk] 48)||283
10293084|NCT01231516|11425808|FG000|NOT COMPLETED|Double-blind Phase (Up to Week [Wk] 48)||61
10852392|NCT01307423|12018539|FG007|NOT COMPLETED|Long-term Safety Phase (Year 5)||1
10852393|NCT01307423|12018540|FG008|NOT COMPLETED|Long-term Safety Phase (Year 5)||3
10852394|NCT01030575|12018576|FG000|STARTED|Overall Study||29
10852395|NCT01030575|12018577|FG001|STARTED|Overall Study||30
10852396|NCT01030575|12018578|FG002|STARTED|Overall Study||28
10852397|NCT01030575|12018579|FG003|STARTED|Overall Study||35
10852398|NCT01030575|12018576|FG000|COMPLETED|Overall Study|1 infant randomized to the placebo arm incorrectly received the low dose. The infant was included in the low dose arm for the pharmacokinetics analyses and as randomized to the placebo arm for all other analyzes.|29
10852399|NCT01030575|12018577|FG001|COMPLETED|Overall Study||30
10852400|NCT01030575|12018578|FG002|COMPLETED|Overall Study||28
10852401|NCT01030575|12018579|FG003|COMPLETED|Overall Study|1 infant randomized to the placebo arm incorrectly received the low dose. The infant was included in the low dose arm for the pharmacokinetics analyses and as randomized to the placebo arm for all other analyzes.|35
10852402|NCT01030575|12018576|FG000|NOT COMPLETED|Overall Study||0
10852403|NCT01030575|12018577|FG001|NOT COMPLETED|Overall Study||0
10852404|NCT01030575|12018578|FG002|NOT COMPLETED|Overall Study||0
10852405|NCT01030575|12018579|FG003|NOT COMPLETED|Overall Study||0
10852406|NCT00911183|12018592|FG000|STARTED|Overall Study||47
10852407|NCT00911183|12018593|FG001|STARTED|Overall Study||20
10852408|NCT00911183|12018592|FG000|COMPLETED|Overall Study||47
10852409|NCT00911183|12018593|FG001|COMPLETED|Overall Study||20
10852410|NCT00911183|12018592|FG000|NOT COMPLETED|Overall Study||0
10852411|NCT00911183|12018593|FG001|NOT COMPLETED|Overall Study||0
10852412|NCT00655876|12018601|FG000|STARTED|Overall Study||168
10852413|NCT00655876|12018602|FG001|STARTED|Overall Study||176
10852414|NCT00655876|12018601|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|159
10852415|NCT00655876|12018602|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|169
10852416|NCT00655876|12018601|FG000|NOT COMPLETED|Overall Study||9
10852417|NCT00655876|12018602|FG001|NOT COMPLETED|Overall Study||7
10852418|NCT00602576|12018612|FG000|STARTED|Overall Study||38
10852419|NCT00602576|12018613|FG001|STARTED|Overall Study||40
10852420|NCT00602576|12018614|FG002|STARTED|Overall Study||38
10852421|NCT00602576|12018615|FG003|STARTED|Overall Study||53
10852422|NCT00602576|12018612|FG000|COMPLETED|Overall Study||38
10852423|NCT00602576|12018613|FG001|COMPLETED|Overall Study||40
10852424|NCT00602576|12018614|FG002|COMPLETED|Overall Study||38
10852425|NCT00602576|12018615|FG003|COMPLETED|Overall Study||53
10852426|NCT00602576|12018612|FG000|NOT COMPLETED|Overall Study||0
10852427|NCT00602576|12018613|FG001|NOT COMPLETED|Overall Study||0
10852428|NCT00602576|12018614|FG002|NOT COMPLETED|Overall Study||0
10852429|NCT00602576|12018615|FG003|NOT COMPLETED|Overall Study||0
10852430|NCT00265941|12018627|FG000|STARTED|Overall Study||470
10852431|NCT00265941|12018628|FG001|STARTED|Overall Study||470
10852432|NCT00265941|12018627|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|447
10852433|NCT00265941|12018628|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|444
10852434|NCT00265941|12018627|FG000|NOT COMPLETED|Overall Study||23
10852435|NCT00265941|12018628|FG001|NOT COMPLETED|Overall Study||26
10852436|NCT00114140|12018642|FG000|STARTED|Overall Study||136
10852437|NCT00114140|12018642|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|129
10852438|NCT00114140|12018642|FG000|NOT COMPLETED|Overall Study||7
10852439|NCT00047008|12018655|FG000|STARTED|Overall Study||372
10852440|NCT00047008|12018656|FG001|STARTED|Overall Study||371
10852441|NCT00047008|12018655|FG000|COMPLETED|Overall Study||361
10852442|NCT00047008|12018656|FG001|COMPLETED|Overall Study||360
10852443|NCT00047008|12018655|FG000|NOT COMPLETED|Overall Study||11
10852444|NCT00047008|12018656|FG001|NOT COMPLETED|Overall Study||11
10852445|NCT04701138|12018662|FG000|STARTED|Overall Study||24
10852446|NCT04701138|12018662|FG000|COMPLETED|Overall Study||23
10852447|NCT04701138|12018662|FG000|NOT COMPLETED|Overall Study||1
10852448|NCT04392583|12018666|FG000|STARTED|Overall Study||40
10852449|NCT04392583|12018666|FG000|COMPLETED|Overall Study||39
10852450|NCT04392583|12018666|FG000|NOT COMPLETED|Overall Study||1
10852451|NCT04332640|12018670|FG000|STARTED|Overall Study||79
10852452|NCT04332640|12018670|FG000|COMPLETED|Overall Study||79
10852453|NCT04332640|12018670|FG000|NOT COMPLETED|Overall Study||0
10852454|NCT04326439|12018676|FG000|STARTED|Overall Study||5
10852455|NCT04326439|12018677|FG001|STARTED|Overall Study||3
10852456|NCT04326439|12018676|FG000|COMPLETED|Overall Study||3
10852457|NCT04326439|12018677|FG001|COMPLETED|Overall Study||0
10852458|NCT04326439|12018676|FG000|NOT COMPLETED|Overall Study||2
10852459|NCT04326439|12018677|FG001|NOT COMPLETED|Overall Study||3
10852460|NCT04188730|12018689|FG000|STARTED|Overall Study||4
10852461|NCT04188730|12018690|FG001|STARTED|Overall Study||4
10852462|NCT04188730|12018691|FG002|STARTED|Overall Study||4
10852463|NCT04188730|12018692|FG003|STARTED|Overall Study||4
10852464|NCT04188730|12018689|FG000|Period 1|Overall Study||4
10852465|NCT04188730|12018690|FG001|Period 1|Overall Study||4
10852466|NCT04188730|12018691|FG002|Period 1|Overall Study||4
10852467|NCT04188730|12018692|FG003|Period 1|Overall Study||4
10852468|NCT04188730|12018689|FG000|Period 2|Overall Study||3
10852469|NCT04188730|12018690|FG001|Period 2|Overall Study||4
10852470|NCT04188730|12018691|FG002|Period 2|Overall Study||4
10852471|NCT04188730|12018692|FG003|Period 2|Overall Study||4
10852472|NCT04188730|12018689|FG000|Period 3|Overall Study||3
10414328|NCT00784225|11558696|FG000|COMPLETED|Overall Study||3375
10414329|NCT00784225|11558697|FG001|COMPLETED|Overall Study||3357
10414330|NCT00784225|11558698|FG002|COMPLETED|Overall Study||3369
10414331|NCT00784225|11558699|FG003|COMPLETED|Overall Study||3374
10414332|NCT00784225|11558696|FG000|NOT COMPLETED|Overall Study||0
10414333|NCT00784225|11558697|FG001|NOT COMPLETED|Overall Study||0
10414334|NCT00784225|11558698|FG002|NOT COMPLETED|Overall Study||0
10414335|NCT00784225|11558699|FG003|NOT COMPLETED|Overall Study||0
10414336|NCT00784238|11558713|FG000|STARTED|Overall Study||289
10545540|NCT01498419|11698935|FG000|COMPLETED|Overall Study||42
10545541|NCT01498419|11698936|FG001|COMPLETED|Overall Study||39
10545542|NCT01498419|11698937|FG002|COMPLETED|Overall Study||41
10545543|NCT01498419|11698938|FG003|COMPLETED|Overall Study||7
10545544|NCT01498419|11698935|FG000|NOT COMPLETED|Overall Study||18
10545545|NCT01498419|11698936|FG001|NOT COMPLETED|Overall Study||23
10545546|NCT01498419|11698937|FG002|NOT COMPLETED|Overall Study||18
10545547|NCT01498419|11698938|FG003|NOT COMPLETED|Overall Study||19
10545548|NCT01498445|11698954|FG000|STARTED|Overall Study||4
10545549|NCT01498445|11698955|FG001|STARTED|Overall Study||3
10545550|NCT01498445|11698956|FG002|STARTED|Overall Study||8
10545551|NCT01498445|11698957|FG003|STARTED|Overall Study||8
10545552|NCT01498445|11698958|FG004|STARTED|Overall Study||4
10545553|NCT01498445|11698959|FG005|STARTED|Overall Study||5
10545554|NCT01498445|11698954|FG000|COMPLETED|Overall Study||4
10545555|NCT01498445|11698955|FG001|COMPLETED|Overall Study||3
10545556|NCT01498445|11698956|FG002|COMPLETED|Overall Study||7
10545557|NCT01498445|11698957|FG003|COMPLETED|Overall Study||6
10545558|NCT01498445|11698958|FG004|COMPLETED|Overall Study||3
10545559|NCT01498445|11698959|FG005|COMPLETED|Overall Study||4
10545560|NCT01498445|11698954|FG000|NOT COMPLETED|Overall Study||0
10545561|NCT01498445|11698955|FG001|NOT COMPLETED|Overall Study||0
10545562|NCT01498445|11698956|FG002|NOT COMPLETED|Overall Study||1
10545563|NCT01498445|11698957|FG003|NOT COMPLETED|Overall Study||2
10545564|NCT01498445|11698958|FG004|NOT COMPLETED|Overall Study||1
10545565|NCT01498445|11698959|FG005|NOT COMPLETED|Overall Study||1
10545566|NCT01498549|11698973|FG000|STARTED|Overall Study||39
10545567|NCT01498549|11698973|FG000|Atomoxetine 40 mg|Overall Study||39
10545568|NCT01498549|11698973|FG000|Atomoxetine 80 mg|Overall Study||37
10545569|NCT01498549|11698973|FG000|Sugar Pill 0 mg|Overall Study||36
10545570|NCT01498549|11698973|FG000|COMPLETED|Overall Study||35
10545571|NCT01498549|11698973|FG000|NOT COMPLETED|Overall Study||4
10545572|NCT01498575|11698984|FG000|STARTED|Overall Sample||610
10545573|NCT01498575|11698985|FG001|STARTED|Overall Sample||414
10545574|NCT01498575|11698984|FG000|COMPLETED|Overall Sample||550
10852473|NCT04188730|12018690|FG001|Period 3|Overall Study||4
10852474|NCT04188730|12018691|FG002|Period 3|Overall Study||4
10852475|NCT04188730|12018692|FG003|Period 3|Overall Study||4
10852476|NCT04188730|12018689|FG000|COMPLETED|Overall Study||3
10852477|NCT04188730|12018690|FG001|COMPLETED|Overall Study||4
10852478|NCT04188730|12018691|FG002|COMPLETED|Overall Study||4
10852479|NCT04188730|12018692|FG003|COMPLETED|Overall Study||4
10852480|NCT04188730|12018689|FG000|NOT COMPLETED|Overall Study||1
10852481|NCT04188730|12018690|FG001|NOT COMPLETED|Overall Study||0
10545575|NCT01498575|11698985|FG001|COMPLETED|Overall Sample||400
10545576|NCT01498575|11698984|FG000|NOT COMPLETED|Overall Sample||60
10545577|NCT01498575|11698985|FG001|NOT COMPLETED|Overall Sample||14
10545578|NCT01498575|11698984|FG000|STARTED|On the Road Driving Assessment (ODA)||128
10545579|NCT01498575|11698985|FG001|STARTED|On the Road Driving Assessment (ODA)||89
10545580|NCT01498575|11698984|FG000|COMPLETED|On the Road Driving Assessment (ODA)||86
10852482|NCT04188730|12018691|FG002|NOT COMPLETED|Overall Study||0
10852483|NCT04188730|12018692|FG003|NOT COMPLETED|Overall Study||0
10414337|NCT00784238|11558713|FG000|COMPLETED|Overall Study||170
10852484|NCT04003142|12018706|FG000|STARTED|Double-blind Period (12 Weeks)||168
10852485|NCT04003142|12018707|FG001|STARTED|Double-blind Period (12 Weeks)||166
10852486|NCT04003142|12018708|FG002|STARTED|Double-blind Period (12 Weeks)||167
10852487|NCT04003142|12018709|FG003|STARTED|Double-blind Period (12 Weeks)||0
10852488|NCT04003142|12018710|FG004|STARTED|Double-blind Period (12 Weeks)||0
10852489|NCT04003142|12018706|FG000|Treated|Double-blind Period (12 Weeks)||167
10852490|NCT04003142|12018707|FG001|Treated|Double-blind Period (12 Weeks)||166
10414338|NCT00784238|11558713|FG000|NOT COMPLETED|Overall Study||119
10414339|NCT00784277|11558724|FG000|STARTED|IR Treatment||148
10414340|NCT00784277|11558725|FG001|STARTED|IR Treatment||151
10414341|NCT00784277|11558726|FG002|STARTED|IR Treatment||154
10414342|NCT00784277|11558727|FG003|STARTED|IR Treatment||143
10414343|NCT00784277|11558728|FG004|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
10414344|NCT00784277|11558729|FG005|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
10414345|NCT00784277|11558730|FG006|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
10414346|NCT00784277|11558724|FG000|COMPLETED|IR Treatment||132
10414347|NCT00784277|11558725|FG001|COMPLETED|IR Treatment||134
10414348|NCT00784277|11558726|FG002|COMPLETED|IR Treatment||126
10414349|NCT00784277|11558727|FG003|COMPLETED|IR Treatment||100
10414350|NCT00784277|11558728|FG004|COMPLETED|IR Treatment||0
10414351|NCT00784277|11558729|FG005|COMPLETED|IR Treatment||0
10414352|NCT00784277|11558730|FG006|COMPLETED|IR Treatment||0
10414353|NCT00784277|11558724|FG000|NOT COMPLETED|IR Treatment||16
10414354|NCT00784277|11558725|FG001|NOT COMPLETED|IR Treatment||17
10414355|NCT00784277|11558726|FG002|NOT COMPLETED|IR Treatment||28
10414356|NCT00784277|11558727|FG003|NOT COMPLETED|IR Treatment||43
10414357|NCT00784277|11558728|FG004|NOT COMPLETED|IR Treatment||0
10414358|NCT00784277|11558729|FG005|NOT COMPLETED|IR Treatment||0
10414359|NCT00784277|11558730|FG006|NOT COMPLETED|IR Treatment||0
10414360|NCT00784277|11558724|FG000|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
10414361|NCT00784277|11558725|FG001|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
10414362|NCT00784277|11558726|FG002|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
10414363|NCT00784277|11558727|FG003|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
10414364|NCT00784277|11558728|FG004|STARTED|ER Treatment|10 participants who had completed IR treatment have not taken any ER treatment.|122
10414365|NCT00784277|11558729|FG005|STARTED|ER Treatment|10 participants who had completed IR treatment have not taken any ER treatment.|250
10414366|NCT00784277|11558730|FG006|STARTED|ER Treatment|9 participants who had completed IR treatment have not taken any ER treatment.|91
10414367|NCT00784277|11558724|FG000|COMPLETED|ER Treatment||0
10414368|NCT00784277|11558725|FG001|COMPLETED|ER Treatment||0
10414369|NCT00784277|11558726|FG002|COMPLETED|ER Treatment||0
10414370|NCT00784277|11558727|FG003|COMPLETED|ER Treatment||0
10414371|NCT00784277|11558728|FG004|COMPLETED|ER Treatment||113
10414372|NCT00784277|11558729|FG005|COMPLETED|ER Treatment||226
10414373|NCT00784277|11558730|FG006|COMPLETED|ER Treatment||76
10414374|NCT00784277|11558724|FG000|NOT COMPLETED|ER Treatment||0
10414375|NCT00784277|11558725|FG001|NOT COMPLETED|ER Treatment||0
10414376|NCT00784277|11558726|FG002|NOT COMPLETED|ER Treatment||0
10414377|NCT00784277|11558727|FG003|NOT COMPLETED|ER Treatment||0
10414378|NCT00784277|11558728|FG004|NOT COMPLETED|ER Treatment||9
10414379|NCT00784277|11558729|FG005|NOT COMPLETED|ER Treatment||24
10414380|NCT00784277|11558730|FG006|NOT COMPLETED|ER Treatment||15
10414381|NCT00784303|11558745|FG000|STARTED|Overall Study||58
10414382|NCT00784303|11558746|FG001|STARTED|Overall Study||59
10414383|NCT00784303|11558745|FG000|COMPLETED|Overall Study||58
10414384|NCT00784303|11558746|FG001|COMPLETED|Overall Study||59
10414385|NCT00784303|11558745|FG000|NOT COMPLETED|Overall Study||0
10414386|NCT00784303|11558746|FG001|NOT COMPLETED|Overall Study||0
10414387|NCT00784368|11558756|FG000|STARTED|Overall Study||16
10414388|NCT00784368|11558757|FG001|STARTED|Overall Study||16
10414389|NCT00784368|11558758|FG002|STARTED|Overall Study||23
10414390|NCT00784368|11558756|FG000|COMPLETED|Overall Study||8
10414391|NCT00784368|11558757|FG001|COMPLETED|Overall Study||5
10414392|NCT00784368|11558758|FG002|COMPLETED|Overall Study||12
10414393|NCT00784368|11558756|FG000|NOT COMPLETED|Overall Study||8
10414394|NCT00784368|11558757|FG001|NOT COMPLETED|Overall Study||11
10414395|NCT00784368|11558758|FG002|NOT COMPLETED|Overall Study||11
10414396|NCT00784459|11558771|FG000|STARTED|Overall Study||11
10414397|NCT00784459|11558772|FG001|STARTED|Overall Study||13
10414398|NCT00784459|11558771|FG000|COMPLETED|Overall Study||11
10414399|NCT00784459|11558772|FG001|COMPLETED|Overall Study||11
10414400|NCT00784459|11558771|FG000|NOT COMPLETED|Overall Study||0
10414401|NCT00784459|11558772|FG001|NOT COMPLETED|Overall Study||2
10414402|NCT00784524|11558778|FG000|STARTED|Overall Study||14
10414403|NCT00784524|11558778|FG000|COMPLETED|Overall Study||14
10414404|NCT00784524|11558778|FG000|NOT COMPLETED|Overall Study||0
10414405|NCT00784550|11558784|FG000|STARTED|Overall Study||173
10414406|NCT00784550|11558785|FG001|STARTED|Overall Study||169
10414407|NCT00784550|11558784|FG000|COMPLETED|Overall Study||137
10414408|NCT00784550|11558785|FG001|COMPLETED|Overall Study||127
10414409|NCT00784550|11558784|FG000|NOT COMPLETED|Overall Study||36
10414410|NCT00784550|11558785|FG001|NOT COMPLETED|Overall Study||42
10414411|NCT00784563|11558794|FG000|STARTED|Years 1 & 2||21
10414412|NCT00784563|11558795|FG001|STARTED|Years 1 & 2||22
10414413|NCT00784563|11558796|FG002|STARTED|Years 1 & 2||0
10852491|NCT04003142|12018708|FG002|Treated|Double-blind Period (12 Weeks)||167
10852492|NCT04003142|12018709|FG003|Treated|Double-blind Period (12 Weeks)||0
10852493|NCT04003142|12018710|FG004|Treated|Double-blind Period (12 Weeks)||0
10852494|NCT04003142|12018706|FG000|COMPLETED|Double-blind Period (12 Weeks)||151
10852495|NCT04003142|12018707|FG001|COMPLETED|Double-blind Period (12 Weeks)||152
10852496|NCT04003142|12018708|FG002|COMPLETED|Double-blind Period (12 Weeks)||155
10852497|NCT04003142|12018709|FG003|COMPLETED|Double-blind Period (12 Weeks)||0
10852498|NCT04003142|12018710|FG004|COMPLETED|Double-blind Period (12 Weeks)||0
10852499|NCT04003142|12018706|FG000|NOT COMPLETED|Double-blind Period (12 Weeks)||17
10852500|NCT04003142|12018707|FG001|NOT COMPLETED|Double-blind Period (12 Weeks)||14
10852501|NCT04003142|12018708|FG002|NOT COMPLETED|Double-blind Period (12 Weeks)||12
10852502|NCT04003142|12018709|FG003|NOT COMPLETED|Double-blind Period (12 Weeks)||0
10852503|NCT04003142|12018710|FG004|NOT COMPLETED|Double-blind Period (12 Weeks)||0
10852504|NCT04003142|12018706|FG000|STARTED|Extension Period (40 Weeks)|Participants who received placebo in double-blind period were moved to fezolinetant 30/45 mg arms in extension treatment period|0
10852505|NCT04003142|12018707|FG001|STARTED|Extension Period (40 Weeks)||152
10852506|NCT04003142|12018708|FG002|STARTED|Extension Period (40 Weeks)|One participant who completed double-blind period discontinued the study before entering the extension treatment period.|154
10852507|NCT04003142|12018709|FG003|STARTED|Extension Period (40 Weeks)|Participants who received placebo in double-blind period were randomized to fezolinetant 30 mg arms|76
10852508|NCT04003142|12018710|FG004|STARTED|Extension Period (40 Weeks)|Participants who received placebo in double-blind period were randomized to fezolinetant 45 mg arms|75
10852509|NCT04003142|12018706|FG000|COMPLETED|Extension Period (40 Weeks)||0
10852510|NCT04003142|12018707|FG001|COMPLETED|Extension Period (40 Weeks)||125
10852511|NCT04003142|12018708|FG002|COMPLETED|Extension Period (40 Weeks)||132
10852512|NCT04003142|12018709|FG003|COMPLETED|Extension Period (40 Weeks)||63
10852513|NCT04003142|12018710|FG004|COMPLETED|Extension Period (40 Weeks)||63
10852514|NCT04003142|12018706|FG000|NOT COMPLETED|Extension Period (40 Weeks)||0
10852515|NCT04003142|12018707|FG001|NOT COMPLETED|Extension Period (40 Weeks)||27
10852516|NCT04003142|12018708|FG002|NOT COMPLETED|Extension Period (40 Weeks)||22
10852517|NCT04003142|12018709|FG003|NOT COMPLETED|Extension Period (40 Weeks)||13
10852518|NCT04003142|12018710|FG004|NOT COMPLETED|Extension Period (40 Weeks)||12
10852519|NCT03909607|12018731|FG000|STARTED|Overall Study||40
10852520|NCT03909607|12018732|FG001|STARTED|Overall Study||40
10852521|NCT03909607|12018733|FG002|STARTED|Overall Study||40
10852522|NCT03909607|12018731|FG000|COMPLETED|Overall Study||35
10852523|NCT03909607|12018732|FG001|COMPLETED|Overall Study||36
10852524|NCT03909607|12018733|FG002|COMPLETED|Overall Study||38
10852525|NCT03909607|12018731|FG000|NOT COMPLETED|Overall Study||5
10852526|NCT03909607|12018732|FG001|NOT COMPLETED|Overall Study||4
10852527|NCT03909607|12018733|FG002|NOT COMPLETED|Overall Study||2
10545581|NCT01498575|11698985|FG001|COMPLETED|On the Road Driving Assessment (ODA)||65
10852528|NCT03430531|12018741|FG000|STARTED|Overall Study||6
10852529|NCT03430531|12018741|FG000|COMPLETED|Overall Study||6
10852530|NCT03430531|12018741|FG000|NOT COMPLETED|Overall Study||0
10852531|NCT03402841|12018745|FG000|STARTED|Overall Study||279
10852532|NCT03402841|12018745|FG000|COMPLETED|Overall Study||187
10852533|NCT03402841|12018745|FG000|NOT COMPLETED|Overall Study||92
10852534|NCT03383666|12018749|FG000|STARTED|Overall Study||21
10852535|NCT03383666|12018749|FG000|Implanted With Pulse Rider|Overall Study||18
10852536|NCT03383666|12018749|FG000|Attempted But Unsuccessful Implantation|Overall Study||3
10852537|NCT03383666|12018749|FG000|COMPLETED|Overall Study||17
10852538|NCT03383666|12018749|FG000|NOT COMPLETED|Overall Study||4
10852545|NCT03219333|12018771|FG000|STARTED|Overall Study||128
10852546|NCT03219333|12018772|FG001|STARTED|Overall Study||91
10852547|NCT03219333|12018771|FG000|Treated|Overall Study||125
10852548|NCT03219333|12018772|FG001|Treated|Overall Study||89
10852549|NCT03219333|12018771|FG000|COMPLETED|Overall Study|Cohort 1 Completed includes 4 participants on treatment and 19 participants in follow-up.|23
10852550|NCT03219333|12018772|FG001|COMPLETED|Overall Study|Cohort 2 Completed includes 16 participants on treatment and 26 participants in follow-up.|42
10852551|NCT03219333|12018771|FG000|NOT COMPLETED|Overall Study||105
10852552|NCT03219333|12018772|FG001|NOT COMPLETED|Overall Study||49
10414414|NCT00784563|11558794|FG000|COMPLETED|Years 1 & 2||18
10414415|NCT00784563|11558795|FG001|COMPLETED|Years 1 & 2||17
10414416|NCT00784563|11558796|FG002|COMPLETED|Years 1 & 2||0
10414417|NCT00784563|11558794|FG000|NOT COMPLETED|Years 1 & 2||3
10414418|NCT00784563|11558795|FG001|NOT COMPLETED|Years 1 & 2||5
10414419|NCT00784563|11558796|FG002|NOT COMPLETED|Years 1 & 2||0
10414420|NCT00784563|11558794|FG000|STARTED|Year 3||0
10414421|NCT00784563|11558795|FG001|STARTED|Year 3||0
10414422|NCT00784563|11558796|FG002|STARTED|Year 3||17
10414423|NCT00784563|11558794|FG000|COMPLETED|Year 3||0
10414424|NCT00784563|11558795|FG001|COMPLETED|Year 3||0
10414425|NCT00784563|11558796|FG002|COMPLETED|Year 3||14
10414426|NCT00784563|11558794|FG000|NOT COMPLETED|Year 3||0
10414427|NCT00784563|11558795|FG001|NOT COMPLETED|Year 3||0
10414428|NCT00784563|11558796|FG002|NOT COMPLETED|Year 3||3
10414429|NCT00784641|11558805|FG000|STARTED|Overall Study||189
10414430|NCT00784641|11558806|FG001|STARTED|Overall Study||189
10414431|NCT00784641|11558807|FG002|STARTED|Overall Study||189
10414432|NCT00784641|11558805|FG000|COMPLETED|Overall Study||183
10414433|NCT00784641|11558806|FG001|COMPLETED|Overall Study||186
10414434|NCT00784641|11558807|FG002|COMPLETED|Overall Study||187
10414435|NCT00784641|11558805|FG000|NOT COMPLETED|Overall Study||6
10414436|NCT00784641|11558806|FG001|NOT COMPLETED|Overall Study||3
10414437|NCT00784641|11558807|FG002|NOT COMPLETED|Overall Study||2
10414438|NCT00784654|11558815|FG000|STARTED|Open-Label Period (Non-Randomized)||276
10414439|NCT00784654|11558816|FG001|STARTED|Open-Label Period (Non-Randomized)||0
10414440|NCT00784654|11558817|FG002|STARTED|Open-Label Period (Non-Randomized)||0
10414441|NCT00784654|11558815|FG000|COMPLETED|Open-Label Period (Non-Randomized)||165
10414442|NCT00784654|11558816|FG001|COMPLETED|Open-Label Period (Non-Randomized)||0
10414443|NCT00784654|11558817|FG002|COMPLETED|Open-Label Period (Non-Randomized)||0
10414444|NCT00784654|11558815|FG000|NOT COMPLETED|Open-Label Period (Non-Randomized)||111
10414445|NCT00784654|11558816|FG001|NOT COMPLETED|Open-Label Period (Non-Randomized)||0
10414446|NCT00784654|11558817|FG002|NOT COMPLETED|Open-Label Period (Non-Randomized)||0
10414447|NCT00784654|11558815|FG000|STARTED|Randomized Withdrawal Period||0
10414448|NCT00784654|11558816|FG001|STARTED|Randomized Withdrawal Period||78
10414449|NCT00784654|11558817|FG002|STARTED|Randomized Withdrawal Period||79
10414450|NCT00784654|11558815|FG000|COMPLETED|Randomized Withdrawal Period||0
10414451|NCT00784654|11558816|FG001|COMPLETED|Randomized Withdrawal Period||60
10414452|NCT00784654|11558817|FG002|COMPLETED|Randomized Withdrawal Period||16
10414453|NCT00784654|11558815|FG000|NOT COMPLETED|Randomized Withdrawal Period||0
10414454|NCT00784654|11558816|FG001|NOT COMPLETED|Randomized Withdrawal Period||18
10414455|NCT00784654|11558817|FG002|NOT COMPLETED|Randomized Withdrawal Period||63
10414456|NCT00784693|11558830|FG000|STARTED|Overall Study||23
10414457|NCT00784693|11558831|FG001|STARTED|Overall Study||25
10414458|NCT00784693|11558830|FG000|Treated|Overall Study||22
10414459|NCT00784693|11558831|FG001|Treated|Overall Study||25
10414460|NCT00784693|11558830|FG000|COMPLETED|Overall Study||20
10414461|NCT00784693|11558831|FG001|COMPLETED|Overall Study||19
10414462|NCT00784693|11558830|FG000|NOT COMPLETED|Overall Study||3
10414463|NCT00784693|11558831|FG001|NOT COMPLETED|Overall Study||6
10414464|NCT00784719|11558844|FG000|STARTED|Overall Study||47
10414465|NCT00784719|11558845|FG001|STARTED|Overall Study||46
10414466|NCT00784719|11558846|FG002|STARTED|Overall Study||47
10414467|NCT00784719|11558847|FG003|STARTED|Overall Study||48
10414468|NCT00784719|11558848|FG004|STARTED|Overall Study||48
10414469|NCT00784719|11558849|FG005|STARTED|Overall Study||44
10414470|NCT00784719|11558850|FG006|STARTED|Overall Study||47
10414471|NCT00784719|11558844|FG000|COMPLETED|Overall Study||44
10414472|NCT00784719|11558845|FG001|COMPLETED|Overall Study||43
10414473|NCT00784719|11558846|FG002|COMPLETED|Overall Study||46
10414474|NCT00784719|11558847|FG003|COMPLETED|Overall Study||48
10414475|NCT00784719|11558848|FG004|COMPLETED|Overall Study||42
10414476|NCT00784719|11558849|FG005|COMPLETED|Overall Study||41
10414477|NCT00784719|11558850|FG006|COMPLETED|Overall Study||42
10414478|NCT00784719|11558844|FG000|NOT COMPLETED|Overall Study||3
10414479|NCT00784719|11558845|FG001|NOT COMPLETED|Overall Study||3
10414480|NCT00784719|11558846|FG002|NOT COMPLETED|Overall Study||1
10414481|NCT00784719|11558847|FG003|NOT COMPLETED|Overall Study||0
10414482|NCT00784719|11558848|FG004|NOT COMPLETED|Overall Study||6
10414483|NCT00784719|11558849|FG005|NOT COMPLETED|Overall Study||3
10414484|NCT00784719|11558850|FG006|NOT COMPLETED|Overall Study||5
10414485|NCT00784758|11558868|FG000|STARTED|Overall Study||42
10852637|NCT02881957|12018833|FG000|STARTED|Overall Study||136
10852638|NCT02881957|12018834|FG001|STARTED|Overall Study||138
10852639|NCT02881957|12018833|FG000|COMPLETED|Overall Study||133
10852640|NCT02881957|12018834|FG001|COMPLETED|Overall Study||134
10852641|NCT02881957|12018833|FG000|NOT COMPLETED|Overall Study||3
10852642|NCT02881957|12018834|FG001|NOT COMPLETED|Overall Study||4
10852643|NCT02880189|12018840|FG000|STARTED|Overall Study||21
10852644|NCT02880189|12018840|FG000|COMPLETED|Overall Study||21
10852645|NCT02880189|12018840|FG000|NOT COMPLETED|Overall Study||0
10852646|NCT02761694|12018856|FG000|STARTED|Overall Study||4
10852647|NCT02761694|12018857|FG001|STARTED|Overall Study||4
10852648|NCT02761694|12018858|FG002|STARTED|Overall Study||1
10852649|NCT02761694|12018859|FG003|STARTED|Overall Study||3
10852650|NCT02761694|12018860|FG004|STARTED|Overall Study||3
10852651|NCT02761694|12018861|FG005|STARTED|Overall Study||3
10852652|NCT02761694|12018862|FG006|STARTED|Overall Study||33
10852653|NCT02761694|12018863|FG007|STARTED|Overall Study||8
10852654|NCT02761694|12018864|FG008|STARTED|Overall Study||5
10852655|NCT02761694|12018865|FG009|STARTED|Overall Study||5
10852656|NCT02761694|12018866|FG010|STARTED|Overall Study||3
10852657|NCT02761694|12018867|FG011|STARTED|Overall Study||6
10852658|NCT02761694|12018856|FG000|Treated|Overall Study||4
10852659|NCT02761694|12018857|FG001|Treated|Overall Study||4
10852660|NCT02761694|12018858|FG002|Treated|Overall Study||1
10852661|NCT02761694|12018859|FG003|Treated|Overall Study||3
10852662|NCT02761694|12018860|FG004|Treated|Overall Study||3
10852663|NCT02761694|12018861|FG005|Treated|Overall Study||3
10852664|NCT02761694|12018862|FG006|Treated|Overall Study||32
10852665|NCT02761694|12018863|FG007|Treated|Overall Study||8
10852666|NCT02761694|12018864|FG008|Treated|Overall Study||5
10852667|NCT02761694|12018865|FG009|Treated|Overall Study||5
10852668|NCT02761694|12018866|FG010|Treated|Overall Study||3
10852669|NCT02761694|12018867|FG011|Treated|Overall Study||6
10852670|NCT02761694|12018856|FG000|COMPLETED|Overall Study||0
10852671|NCT02761694|12018857|FG001|COMPLETED|Overall Study||0
10852672|NCT02761694|12018858|FG002|COMPLETED|Overall Study||0
10852673|NCT02761694|12018859|FG003|COMPLETED|Overall Study||0
10852674|NCT02761694|12018860|FG004|COMPLETED|Overall Study||0
10852675|NCT02761694|12018861|FG005|COMPLETED|Overall Study||0
10852676|NCT02761694|12018862|FG006|COMPLETED|Overall Study||0
10852677|NCT02761694|12018863|FG007|COMPLETED|Overall Study||0
10852678|NCT02761694|12018864|FG008|COMPLETED|Overall Study||0
10852679|NCT02761694|12018865|FG009|COMPLETED|Overall Study||0
10852680|NCT02761694|12018866|FG010|COMPLETED|Overall Study||0
10852681|NCT02761694|12018867|FG011|COMPLETED|Overall Study||0
10852682|NCT02761694|12018856|FG000|NOT COMPLETED|Overall Study||4
10852683|NCT02761694|12018857|FG001|NOT COMPLETED|Overall Study||4
10852684|NCT02761694|12018858|FG002|NOT COMPLETED|Overall Study||1
10852685|NCT02761694|12018859|FG003|NOT COMPLETED|Overall Study||3
10852686|NCT02761694|12018860|FG004|NOT COMPLETED|Overall Study||3
10852687|NCT02761694|12018861|FG005|NOT COMPLETED|Overall Study||3
10852688|NCT02761694|12018862|FG006|NOT COMPLETED|Overall Study||33
10852689|NCT02761694|12018863|FG007|NOT COMPLETED|Overall Study||8
10852690|NCT02761694|12018864|FG008|NOT COMPLETED|Overall Study||5
10852691|NCT02761694|12018865|FG009|NOT COMPLETED|Overall Study||5
10852692|NCT02761694|12018866|FG010|NOT COMPLETED|Overall Study||3
10852693|NCT02761694|12018867|FG011|NOT COMPLETED|Overall Study||6
10852694|NCT02611960|12018896|FG000|STARTED|Overall Study||117
10852695|NCT02611960|12018897|FG001|STARTED|Overall Study||116
10852696|NCT02611960|12018896|FG000|Treated|Overall Study||116
10852697|NCT02611960|12018897|FG001|Treated|Overall Study||112
10852698|NCT02611960|12018896|FG000|COMPLETED|Overall Study||0
10852699|NCT02611960|12018897|FG001|COMPLETED|Overall Study||0
10852700|NCT02611960|12018896|FG000|NOT COMPLETED|Overall Study||117
10852701|NCT02611960|12018897|FG001|NOT COMPLETED|Overall Study||116
10852702|NCT02574455|12018906|FG000|STARTED|Overall Study||267
10852703|NCT02574455|12018907|FG001|STARTED|Overall Study||262
10852704|NCT02574455|12018906|FG000|Enrolled and Treated|Overall Study||258
10852705|NCT02574455|12018907|FG001|Enrolled and Treated|Overall Study||224
10852706|NCT02574455|12018906|FG000|COMPLETED|Overall Study||0
10852707|NCT02574455|12018907|FG001|COMPLETED|Overall Study||0
10852708|NCT02574455|12018906|FG000|NOT COMPLETED|Overall Study||267
10852709|NCT02574455|12018907|FG001|NOT COMPLETED|Overall Study||262
10852710|NCT02493660|12018915|FG000|STARTED|Overall Study|ITT|93
10852711|NCT02493660|12018916|FG001|STARTED|Overall Study|ITT|91
10852712|NCT02493660|12018915|FG000|COMPLETED|Overall Study||83
10852713|NCT02493660|12018916|FG001|COMPLETED|Overall Study|Investigator requested subject be discontinued prior to any post-procedure efficacy assessments.|79
10852714|NCT02493660|12018915|FG000|NOT COMPLETED|Overall Study||10
10852715|NCT02493660|12018916|FG001|NOT COMPLETED|Overall Study||12
10852716|NCT02232087|12018924|FG000|STARTED|Overall Study||9
10852717|NCT02232087|12018925|FG001|STARTED|Overall Study||10
10852718|NCT02232087|12018926|FG002|STARTED|Overall Study||8
10852719|NCT02232087|12018927|FG003|STARTED|Overall Study||8
10852720|NCT02232087|12018928|FG004|STARTED|Overall Study||8
10852721|NCT02232087|12018929|FG005|STARTED|Overall Study||9
10852722|NCT02232087|12018924|FG000|COMPLETED|Overall Study||7
10852723|NCT02232087|12018925|FG001|COMPLETED|Overall Study||8
10852724|NCT02232087|12018926|FG002|COMPLETED|Overall Study||8
10852725|NCT02232087|12018927|FG003|COMPLETED|Overall Study||7
10852726|NCT02232087|12018928|FG004|COMPLETED|Overall Study||7
10852727|NCT02232087|12018929|FG005|COMPLETED|Overall Study||6
10852728|NCT02232087|12018924|FG000|NOT COMPLETED|Overall Study||2
10852729|NCT02232087|12018925|FG001|NOT COMPLETED|Overall Study||2
10852730|NCT02232087|12018926|FG002|NOT COMPLETED|Overall Study||0
10852731|NCT02232087|12018927|FG003|NOT COMPLETED|Overall Study||1
10852732|NCT02232087|12018928|FG004|NOT COMPLETED|Overall Study||1
10852733|NCT02232087|12018929|FG005|NOT COMPLETED|Overall Study||3
10852734|NCT02065154|12018948|FG000|STARTED|Overall Study||39
10852735|NCT02065154|12018948|FG000|COMPLETED|Overall Study||39
10852736|NCT02065154|12018948|FG000|NOT COMPLETED|Overall Study||0
10852737|NCT01952847|12018956|FG000|STARTED|Overall Study||27
10852738|NCT01952847|12018957|FG001|STARTED|Overall Study||26
10852739|NCT01952847|12018958|FG002|STARTED|Overall Study||7
10852740|NCT01952847|12018959|FG003|STARTED|Overall Study||7
10852741|NCT01952847|12018956|FG000|COMPLETED|Overall Study||25
10293085|NCT01231516|11425809|FG001|NOT COMPLETED|Double-blind Phase (Up to Week [Wk] 48)||81
10293086|NCT01231516|11425808|FG000|STARTED|Open-label Phase:From Wk 48 up to Wk 480|4 participants completed the Double-blind Phase but did not enter the Open-label Phase.|295
10293087|NCT01231516|11425809|FG001|STARTED|Open-label Phase:From Wk 48 up to Wk 480|157 participants completed the Double-blind Phase but did not enter the Open-label Phase.|126
10293088|NCT01231516|11425808|FG000|COMPLETED|Open-label Phase:From Wk 48 up to Wk 480||227
10293089|NCT01231516|11425809|FG001|COMPLETED|Open-label Phase:From Wk 48 up to Wk 480||109
10293090|NCT01231516|11425808|FG000|NOT COMPLETED|Open-label Phase:From Wk 48 up to Wk 480||68
10293091|NCT01231516|11425809|FG001|NOT COMPLETED|Open-label Phase:From Wk 48 up to Wk 480||17
10293098|NCT01194219|11425828|FG000|STARTED|Placebo-Controlled Phase Weeks 0-16||562
10293099|NCT01194219|11425829|FG001|STARTED|Placebo-Controlled Phase Weeks 0-16||282
10293100|NCT01194219|11425830|FG002|STARTED|Placebo-Controlled Phase Weeks 0-16||0
10852742|NCT01952847|12018957|FG001|COMPLETED|Overall Study||24
10852743|NCT01952847|12018958|FG002|COMPLETED|Overall Study||7
10852744|NCT01952847|12018959|FG003|COMPLETED|Overall Study||6
10852745|NCT01952847|12018956|FG000|NOT COMPLETED|Overall Study||2
10852746|NCT01952847|12018957|FG001|NOT COMPLETED|Overall Study||2
10852747|NCT01952847|12018958|FG002|NOT COMPLETED|Overall Study||0
10852748|NCT01952847|12018959|FG003|NOT COMPLETED|Overall Study||1
10852749|NCT01889238|12018971|FG000|STARTED|Overall Study||118
10852750|NCT01889238|12018971|FG000|COMPLETED|Overall Study|DP, AE, death, treatment withdrawal were considered completed (defined in protocol).|109
10852751|NCT01889238|12018971|FG000|NOT COMPLETED|Overall Study||9
10852758|NCT01672892|12018986|FG000|STARTED|Overall Study||137
10852759|NCT01672892|12018987|FG001|STARTED|Overall Study||152
10852760|NCT01672892|12018986|FG000|Eligible Population|Overall Study||130
10852761|NCT01672892|12018987|FG001|Eligible Population|Overall Study||149
10852762|NCT01672892|12018986|FG000|Adverse Event Population|Overall Study||125
10852763|NCT01672892|12018987|FG001|Adverse Event Population|Overall Study||144
10852764|NCT01672892|12018986|FG000|COMPLETED|Overall Study||130
10852765|NCT01672892|12018987|FG001|COMPLETED|Overall Study||149
10852766|NCT01672892|12018986|FG000|NOT COMPLETED|Overall Study||7
10852767|NCT01672892|12018987|FG001|NOT COMPLETED|Overall Study||3
10852768|NCT01560585|12018996|FG000|STARTED|Overall Study||3
10852769|NCT01560585|12018996|FG000|Screened|Overall Study|3 subjects screend and started treatment in open label|3
10852770|NCT01560585|12018996|FG000|COMPLETED|Overall Study|Study stopped due to adverse events One subject had transient loss of consciousness - possibly related to treatment One subject declined rapidly and found to have glioblastoma- not rrelated to treatment|0
10852771|NCT01560585|12018996|FG000|NOT COMPLETED|Overall Study||3
10852772|NCT00979212|12019003|FG000|STARTED|Overall Study||24
10852773|NCT00979212|12019004|FG001|STARTED|Overall Study||47
10852774|NCT00979212|12019003|FG000|COMPLETED|Overall Study|Subjects with data available for primary analysis are considered to have completed the study.|22
10852775|NCT00979212|12019004|FG001|COMPLETED|Overall Study|Subjects with data available for primary analysis are considered to have completed the study.|39
10852776|NCT00979212|12019003|FG000|NOT COMPLETED|Overall Study||2
10852777|NCT00979212|12019004|FG001|NOT COMPLETED|Overall Study||8
10852778|NCT00777491|12019012|FG000|STARTED|Overall Study||35
10852779|NCT00777491|12019013|FG001|STARTED|Overall Study||35
10852780|NCT00777491|12019012|FG000|Eligible|Overall Study||33
10852781|NCT00777491|12019013|FG001|Eligible|Overall Study||33
10852782|NCT00777491|12019012|FG000|Has 3-year Efficacy Data|Overall Study||27
10852783|NCT00777491|12019013|FG001|Has 3-year Efficacy Data|Overall Study||25
10852784|NCT00777491|12019012|FG000|Started Induction Therapy|Overall Study||33
10852785|NCT00777491|12019013|FG001|Started Induction Therapy|Overall Study||33
10852786|NCT00777491|12019012|FG000|Started Consolidation Therapy|Overall Study||29
10852787|NCT00777491|12019013|FG001|Started Consolidation Therapy|Overall Study||25
10852788|NCT00777491|12019012|FG000|Started Adjuvant Therapy|Overall Study||32
10852789|NCT00777491|12019013|FG001|Started Adjuvant Therapy|Overall Study||31
10852790|NCT00777491|12019012|FG000|Has Adverse Event Data (Treatment)|Overall Study||33
10852791|NCT00777491|12019013|FG001|Has Adverse Event Data (Treatment)|Overall Study||33
10852792|NCT00777491|12019012|FG000|Has Adverse Event Data (Late)|Overall Study||32
10852793|NCT00777491|12019013|FG001|Has Adverse Event Data (Late)|Overall Study||31
10852794|NCT00777491|12019012|FG000|Has 3 Year AUASI Data|Overall Study||6
10852795|NCT00777491|12019013|FG001|Has 3 Year AUASI Data|Overall Study||6
10852796|NCT00777491|12019012|FG000|COMPLETED|Overall Study||33
10852797|NCT00777491|12019013|FG001|COMPLETED|Overall Study||33
10852798|NCT00777491|12019012|FG000|NOT COMPLETED|Overall Study||2
10852799|NCT00777491|12019013|FG001|NOT COMPLETED|Overall Study||2
10852800|NCT00759655|12019019|FG000|STARTED|Overall Study||1
10852801|NCT00759655|12019019|FG000|COMPLETED|Overall Study||0
10852802|NCT00759655|12019019|FG000|NOT COMPLETED|Overall Study||1
10852803|NCT00145795|12019025|FG000|STARTED|Overall Study||10
10852804|NCT00145795|12019026|FG001|STARTED|Overall Study||10
10852805|NCT00145795|12019025|FG000|COMPLETED|Overall Study|1 patient discontinued early due to grade II gastrointestinal symptoms.|9
10852806|NCT00145795|12019026|FG001|COMPLETED|Overall Study||10
10852807|NCT00145795|12019025|FG000|NOT COMPLETED|Overall Study||1
10852808|NCT00145795|12019026|FG001|NOT COMPLETED|Overall Study||0
10852809|NCT00005044|12019034|FG000|STARTED|Overall Study||790
10852810|NCT00005044|12019035|FG001|STARTED|Overall Study||789
10852811|NCT00005044|12019034|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|752
10852812|NCT00005044|12019035|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|737
10852813|NCT00005044|12019034|FG000|NOT COMPLETED|Overall Study||38
10852814|NCT00005044|12019035|FG001|NOT COMPLETED|Overall Study||52
10852815|NCT00002874|12019043|FG000|STARTED|Overall Study||421
10852816|NCT00002874|12019044|FG001|STARTED|Overall Study||419
10852817|NCT00002874|12019043|FG000|COMPLETED|Overall Study||376
10852818|NCT00002874|12019044|FG001|COMPLETED|Overall Study||384
10852819|NCT00002874|12019043|FG000|NOT COMPLETED|Overall Study||45
10852820|NCT00002874|12019044|FG001|NOT COMPLETED|Overall Study||35
10852821|NCT04391894|12019055|FG000|STARTED|Overall Study||111
10852822|NCT04391894|12019056|FG001|STARTED|Overall Study||112
10852823|NCT04391894|12019057|FG002|STARTED|Overall Study||112
10852824|NCT04391894|12019058|FG003|STARTED|Overall Study||109
10852825|NCT04391894|12019059|FG004|STARTED|Overall Study||114
10852826|NCT04391894|12019055|FG000|COMPLETED|Overall Study||107
10852827|NCT04391894|12019056|FG001|COMPLETED|Overall Study||111
10852828|NCT04391894|12019057|FG002|COMPLETED|Overall Study||108
10852829|NCT04391894|12019058|FG003|COMPLETED|Overall Study||107
10852830|NCT04391894|12019059|FG004|COMPLETED|Overall Study||111
10852831|NCT04391894|12019055|FG000|NOT COMPLETED|Overall Study||4
10852832|NCT04391894|12019056|FG001|NOT COMPLETED|Overall Study||1
10852833|NCT04391894|12019057|FG002|NOT COMPLETED|Overall Study||4
10852834|NCT04391894|12019058|FG003|NOT COMPLETED|Overall Study||2
10852835|NCT04391894|12019059|FG004|NOT COMPLETED|Overall Study||3
10852842|NCT03501966|12019084|FG000|STARTED|Overall Study||2
10852843|NCT03501966|12019085|FG001|STARTED|Overall Study||2
10852844|NCT03501966|12019086|FG002|STARTED|Overall Study||3
10852845|NCT03501966|12019084|FG000|COMPLETED|Overall Study||0
10852846|NCT03501966|12019085|FG001|COMPLETED|Overall Study||0
10852847|NCT03501966|12019086|FG002|COMPLETED|Overall Study||0
10852848|NCT03501966|12019084|FG000|NOT COMPLETED|Overall Study||2
10852849|NCT03501966|12019085|FG001|NOT COMPLETED|Overall Study||2
10852850|NCT03501966|12019086|FG002|NOT COMPLETED|Overall Study||3
10852851|NCT03489291|12019094|FG000|STARTED|Overall Study||3
10852852|NCT03489291|12019094|FG000|COMPLETED|Overall Study||3
10852853|NCT03489291|12019094|FG000|NOT COMPLETED|Overall Study||0
10852854|NCT03428100|12019102|FG000|STARTED|Overall Study||93
10852855|NCT03428100|12019103|FG001|STARTED|Overall Study||93
10852856|NCT03428100|12019104|FG002|STARTED|Overall Study||185
10852857|NCT03428100|12019105|FG003|STARTED|Overall Study||92
10852858|NCT03428100|12019102|FG000|Received at Least One Dose of Study Drug|Overall Study||93
10852859|NCT03428100|12019103|FG001|Received at Least One Dose of Study Drug|Overall Study||93
10852860|NCT03428100|12019104|FG002|Received at Least One Dose of Study Drug|Overall Study||184
10852861|NCT03428100|12019105|FG003|Received at Least One Dose of Study Drug|Overall Study||92
10852862|NCT03428100|12019102|FG000|COMPLETED|Overall Study||72
10852863|NCT03428100|12019103|FG001|COMPLETED|Overall Study||80
10852864|NCT03428100|12019104|FG002|COMPLETED|Overall Study||173
10852865|NCT03428100|12019105|FG003|COMPLETED|Overall Study||85
10852866|NCT03428100|12019102|FG000|NOT COMPLETED|Overall Study||21
10852867|NCT03428100|12019103|FG001|NOT COMPLETED|Overall Study||13
10852868|NCT03428100|12019104|FG002|NOT COMPLETED|Overall Study||12
10852869|NCT03428100|12019105|FG003|NOT COMPLETED|Overall Study||7
10852870|NCT03341936|12019125|FG000|STARTED|Overall Study||29
10852871|NCT03341936|12019125|FG000|Treated|Overall Study||28
10852872|NCT03341936|12019125|FG000|COMPLETED|Overall Study||18
10852873|NCT03341936|12019125|FG000|NOT COMPLETED|Overall Study||11
10852874|NCT03174353|12019129|FG000|STARTED|Overall Study||114
10852875|NCT03174353|12019129|FG000|COMPLETED|Overall Study||98
10852876|NCT03174353|12019129|FG000|NOT COMPLETED|Overall Study||16
10852877|NCT03144687|12019135|FG000|STARTED|Overall Study||13
10852878|NCT03144687|12019136|FG001|STARTED|Overall Study||10
10852879|NCT03144687|12019135|FG000|COMPLETED|Overall Study||10
10852880|NCT03144687|12019136|FG001|COMPLETED|Overall Study||3
10852881|NCT03144687|12019135|FG000|NOT COMPLETED|Overall Study||3
10852882|NCT03144687|12019136|FG001|NOT COMPLETED|Overall Study||7
10852886|NCT02880371|12019158|FG000|STARTED|Phase 1b||6
10852887|NCT02880371|12019159|FG001|STARTED|Phase 1b||7
10852888|NCT02880371|12019160|FG002|STARTED|Phase 1b||7
10852889|NCT02880371|12019161|FG003|STARTED|Phase 1b||1
10852890|NCT02880371|12019162|FG004|STARTED|Phase 1b||0
10852891|NCT02880371|12019163|FG005|STARTED|Phase 1b||0
10852892|NCT02880371|12019164|FG006|STARTED|Phase 1b||0
10852893|NCT02880371|12019165|FG007|STARTED|Phase 1b||0
10852894|NCT02880371|12019158|FG000|Treated|Phase 1b||6
10852895|NCT02880371|12019159|FG001|Treated|Phase 1b||6
10852896|NCT02880371|12019160|FG002|Treated|Phase 1b||7
10852897|NCT02880371|12019161|FG003|Treated|Phase 1b||1
10852898|NCT02880371|12019162|FG004|Treated|Phase 1b||0
10852899|NCT02880371|12019163|FG005|Treated|Phase 1b||0
10852900|NCT02880371|12019164|FG006|Treated|Phase 1b||0
10852901|NCT02880371|12019165|FG007|Treated|Phase 1b||0
10852902|NCT02880371|12019158|FG000|COMPLETED|Phase 1b||0
10852903|NCT02880371|12019159|FG001|COMPLETED|Phase 1b||0
10852904|NCT02880371|12019160|FG002|COMPLETED|Phase 1b||1
10852905|NCT02880371|12019161|FG003|COMPLETED|Phase 1b||0
10852906|NCT02880371|12019162|FG004|COMPLETED|Phase 1b||0
10852907|NCT02880371|12019163|FG005|COMPLETED|Phase 1b||0
10852908|NCT02880371|12019164|FG006|COMPLETED|Phase 1b||0
10852909|NCT02880371|12019165|FG007|COMPLETED|Phase 1b||0
10852910|NCT02880371|12019158|FG000|NOT COMPLETED|Phase 1b||6
10852911|NCT02880371|12019159|FG001|NOT COMPLETED|Phase 1b||7
10852912|NCT02880371|12019160|FG002|NOT COMPLETED|Phase 1b||6
10852913|NCT02880371|12019161|FG003|NOT COMPLETED|Phase 1b||1
10852914|NCT02880371|12019162|FG004|NOT COMPLETED|Phase 1b||0
10852915|NCT02880371|12019163|FG005|NOT COMPLETED|Phase 1b||0
10852916|NCT02880371|12019164|FG006|NOT COMPLETED|Phase 1b||0
10852917|NCT02880371|12019165|FG007|NOT COMPLETED|Phase 1b||0
10852918|NCT02880371|12019158|FG000|STARTED|Phase 2|Participants of Phase 1b were different from Phase 2.|0
10852919|NCT02880371|12019159|FG001|STARTED|Phase 2|Participants of Phase 1b were different from Phase 2.|0
10852920|NCT02880371|12019160|FG002|STARTED|Phase 2|Participants of Phase 1b were different from Phase 2.|0
10852921|NCT02880371|12019161|FG003|STARTED|Phase 2|Participants of Phase 1b were different from Phase 2.|0
10852922|NCT02880371|12019162|FG004|STARTED|Phase 2|Participants enrolled for Phase 2 were different from participants enrolled for Phase 1b.|2
10853012|NCT02395120|12019257|FG004|Completed-Caregivers|Overall Study||164
10852923|NCT02880371|12019163|FG005|STARTED|Phase 2|Participants enrolled for Phase 2 were different from participants enrolled for Phase 1b.|20
10852924|NCT02880371|12019164|FG006|STARTED|Phase 2|Participants enrolled for Phase 2 were different from participants enrolled for Phase 1b.|28
10852925|NCT02880371|12019165|FG007|STARTED|Phase 2|Participants enrolled for Phase 2 were different from participants enrolled for Phase 1b.|11
10852926|NCT02880371|12019158|FG000|Treated|Phase 2||0
10852927|NCT02880371|12019159|FG001|Treated|Phase 2||0
10852928|NCT02880371|12019160|FG002|Treated|Phase 2||0
10852929|NCT02880371|12019161|FG003|Treated|Phase 2||0
10852930|NCT02880371|12019162|FG004|Treated|Phase 2||2
10852931|NCT02880371|12019163|FG005|Treated|Phase 2||19
10852932|NCT02880371|12019164|FG006|Treated|Phase 2||27
10852933|NCT02880371|12019165|FG007|Treated|Phase 2||11
10852934|NCT02880371|12019158|FG000|COMPLETED|Phase 2||0
10852935|NCT02880371|12019159|FG001|COMPLETED|Phase 2||0
10852936|NCT02880371|12019160|FG002|COMPLETED|Phase 2||0
10852937|NCT02880371|12019161|FG003|COMPLETED|Phase 2||0
10852938|NCT02880371|12019162|FG004|COMPLETED|Phase 2||0
10852939|NCT02880371|12019163|FG005|COMPLETED|Phase 2||0
10852940|NCT02880371|12019164|FG006|COMPLETED|Phase 2||0
10852941|NCT02880371|12019165|FG007|COMPLETED|Phase 2||0
10852942|NCT02880371|12019158|FG000|NOT COMPLETED|Phase 2||0
10852943|NCT02880371|12019159|FG001|NOT COMPLETED|Phase 2||0
10852944|NCT02880371|12019160|FG002|NOT COMPLETED|Phase 2||0
10852945|NCT02880371|12019161|FG003|NOT COMPLETED|Phase 2||0
10852946|NCT02880371|12019162|FG004|NOT COMPLETED|Phase 2||2
10852947|NCT02880371|12019163|FG005|NOT COMPLETED|Phase 2||20
10852948|NCT02880371|12019164|FG006|NOT COMPLETED|Phase 2||28
10852949|NCT02880371|12019165|FG007|NOT COMPLETED|Phase 2||11
10852956|NCT02434354|12019194|FG000|STARTED|Overall Study|Consented|33
10852957|NCT02434354|12019194|FG000|Post Consent Screening|Overall Study||30
10852958|NCT02434354|12019194|FG000|COMPLETED|Overall Study||30
10852959|NCT02434354|12019194|FG000|NOT COMPLETED|Overall Study||3
10852960|NCT02419417|12019209|FG000|STARTED|Overall Study||5
10852961|NCT02419417|12019210|FG001|STARTED|Overall Study||4
10852962|NCT02419417|12019211|FG002|STARTED|Overall Study||13
10852963|NCT02419417|12019212|FG003|STARTED|Overall Study||10
10852964|NCT02419417|12019213|FG004|STARTED|Overall Study||13
10852965|NCT02419417|12019214|FG005|STARTED|Overall Study||4
10852966|NCT02419417|12019215|FG006|STARTED|Overall Study||4
10852967|NCT02419417|12019216|FG007|STARTED|Overall Study||6
10852968|NCT02419417|12019217|FG008|STARTED|Overall Study||13
10852969|NCT02419417|12019218|FG009|STARTED|Overall Study||10
10852970|NCT02419417|12019219|FG010|STARTED|Overall Study||1
10852971|NCT02419417|12019209|FG000|COMPLETED|Overall Study||0
10852972|NCT02419417|12019210|FG001|COMPLETED|Overall Study||0
10852973|NCT02419417|12019211|FG002|COMPLETED|Overall Study||0
10852974|NCT02419417|12019212|FG003|COMPLETED|Overall Study||0
10852975|NCT02419417|12019213|FG004|COMPLETED|Overall Study||0
10852976|NCT02419417|12019214|FG005|COMPLETED|Overall Study||0
10852977|NCT02419417|12019215|FG006|COMPLETED|Overall Study||0
10852978|NCT02419417|12019216|FG007|COMPLETED|Overall Study||0
10852979|NCT02419417|12019217|FG008|COMPLETED|Overall Study||0
10852980|NCT02419417|12019218|FG009|COMPLETED|Overall Study||0
10852981|NCT02419417|12019219|FG010|COMPLETED|Overall Study||0
10852982|NCT02419417|12019209|FG000|NOT COMPLETED|Overall Study||5
10852983|NCT02419417|12019210|FG001|NOT COMPLETED|Overall Study||4
10852984|NCT02419417|12019211|FG002|NOT COMPLETED|Overall Study||13
10852985|NCT02419417|12019212|FG003|NOT COMPLETED|Overall Study||10
10852986|NCT02419417|12019213|FG004|NOT COMPLETED|Overall Study||13
10852987|NCT02419417|12019214|FG005|NOT COMPLETED|Overall Study||4
10852988|NCT02419417|12019215|FG006|NOT COMPLETED|Overall Study||4
10852989|NCT02419417|12019216|FG007|NOT COMPLETED|Overall Study||6
10852990|NCT02419417|12019217|FG008|NOT COMPLETED|Overall Study||13
10852991|NCT02419417|12019218|FG009|NOT COMPLETED|Overall Study||10
10852992|NCT02419417|12019219|FG010|NOT COMPLETED|Overall Study||1
10852993|NCT02395120|12019253|FG000|STARTED|Overall Study|Caregivers and Children|400
10852994|NCT02395120|12019254|FG001|STARTED|Overall Study|Caregivers and Children|398
10852995|NCT02395120|12019255|FG002|STARTED|Overall Study|Caregivers and Children|43
10852996|NCT02395120|12019256|FG003|STARTED|Overall Study|Caregivers and Children|63
10852997|NCT02395120|12019257|FG004|STARTED|Overall Study|Caregivers and Children|401
10852998|NCT02395120|12019253|FG000|Started-Caregivers|Overall Study||188
10852999|NCT02395120|12019254|FG001|Started-Caregivers|Overall Study||188
10853000|NCT02395120|12019255|FG002|Started-Caregivers|Overall Study||20
10853001|NCT02395120|12019256|FG003|Started-Caregivers|Overall Study||28
10853002|NCT02395120|12019257|FG004|Started-Caregivers|Overall Study||187
10853003|NCT02395120|12019253|FG000|Started-Children|Overall Study||212
10853004|NCT02395120|12019254|FG001|Started-Children|Overall Study||210
10853005|NCT02395120|12019255|FG002|Started-Children|Overall Study||23
10853006|NCT02395120|12019256|FG003|Started-Children|Overall Study||35
10853007|NCT02395120|12019257|FG004|Started-Children|Overall Study||214
10853008|NCT02395120|12019253|FG000|Completed-Caregivers|Overall Study||161
10853009|NCT02395120|12019254|FG001|Completed-Caregivers|Overall Study||159
10853010|NCT02395120|12019255|FG002|Completed-Caregivers|Overall Study||17
10853011|NCT02395120|12019256|FG003|Completed-Caregivers|Overall Study||25
10853013|NCT02395120|12019253|FG000|Completed-Children|Overall Study||182
10853014|NCT02395120|12019254|FG001|Completed-Children|Overall Study||177
10853015|NCT02395120|12019255|FG002|Completed-Children|Overall Study||20
10853016|NCT02395120|12019256|FG003|Completed-Children|Overall Study||32
10853017|NCT02395120|12019257|FG004|Completed-Children|Overall Study||186
10853018|NCT02395120|12019253|FG000|COMPLETED|Overall Study|Caregivers and Children|343
10853019|NCT02395120|12019254|FG001|COMPLETED|Overall Study|Caregivers and Children|336
10314488|NCT00163215|11448128|FG000|COMPLETED|Overall Study||31
10853020|NCT02395120|12019255|FG002|COMPLETED|Overall Study|Caregivers and Children|37
10853021|NCT02395120|12019256|FG003|COMPLETED|Overall Study|Caregivers and Children|57
10853022|NCT02395120|12019257|FG004|COMPLETED|Overall Study|Caregivers and Children|350
10853023|NCT02395120|12019253|FG000|NOT COMPLETED|Overall Study||57
10853024|NCT02395120|12019254|FG001|NOT COMPLETED|Overall Study||62
10853025|NCT02395120|12019255|FG002|NOT COMPLETED|Overall Study||6
10853026|NCT02395120|12019256|FG003|NOT COMPLETED|Overall Study||6
10853027|NCT02395120|12019257|FG004|NOT COMPLETED|Overall Study||51
10853028|NCT02342275|12019271|FG000|STARTED|Overall Study||190
10853029|NCT02342275|12019272|FG001|STARTED|Overall Study||187
10853030|NCT02342275|12019271|FG000|COMPLETED|Overall Study||184
10853031|NCT02342275|12019272|FG001|COMPLETED|Overall Study||182
10853032|NCT02342275|12019271|FG000|NOT COMPLETED|Overall Study||6
10853033|NCT02342275|12019272|FG001|NOT COMPLETED|Overall Study||5
10293101|NCT01194219|11425831|FG003|STARTED|Placebo-Controlled Phase Weeks 0-16||0
10293102|NCT01194219|11425832|FG004|STARTED|Placebo-Controlled Phase Weeks 0-16||0
10293103|NCT01194219|11425833|FG005|STARTED|Placebo-Controlled Phase Weeks 0-16||0
10293104|NCT01194219|11425834|FG006|STARTED|Placebo-Controlled Phase Weeks 0-16||0
10293105|NCT01194219|11425835|FG007|STARTED|Placebo-Controlled Phase Weeks 0-16||0
10293106|NCT01194219|11425836|FG008|STARTED|Placebo-Controlled Phase Weeks 0-16||0
10293107|NCT01194219|11425837|FG009|STARTED|Placebo-Controlled Phase Weeks 0-16||0
10293108|NCT01194219|11425828|FG000|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||560
10293109|NCT01194219|11425829|FG001|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||282
10293110|NCT01194219|11425830|FG002|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
10293111|NCT01194219|11425831|FG003|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
10293112|NCT01194219|11425832|FG004|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
10293113|NCT01194219|11425833|FG005|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
10293114|NCT01194219|11425834|FG006|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
10293115|NCT01194219|11425835|FG007|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
10293116|NCT01194219|11425836|FG008|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
10293117|NCT01194219|11425837|FG009|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
10293118|NCT01194219|11425828|FG000|COMPLETED|Placebo-Controlled Phase Weeks 0-16||503
10293119|NCT01194219|11425829|FG001|COMPLETED|Placebo-Controlled Phase Weeks 0-16||249
10293120|NCT01194219|11425830|FG002|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
10293121|NCT01194219|11425831|FG003|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
10293122|NCT01194219|11425832|FG004|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
10293123|NCT01194219|11425833|FG005|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
10293124|NCT01194219|11425834|FG006|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
10293125|NCT01194219|11425835|FG007|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
10293126|NCT01194219|11425836|FG008|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
10293127|NCT01194219|11425837|FG009|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
10293128|NCT01194219|11425828|FG000|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||59
10293129|NCT01194219|11425829|FG001|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||33
10293130|NCT01194219|11425830|FG002|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
10293131|NCT01194219|11425831|FG003|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
10293132|NCT01194219|11425832|FG004|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
10293133|NCT01194219|11425833|FG005|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
10414486|NCT00784758|11558869|FG001|STARTED|Overall Study||39
10414487|NCT00784758|11558868|FG000|Began Treatment|Overall Study||41
10414488|NCT00784758|11558869|FG001|Began Treatment|Overall Study||39
10414489|NCT00784758|11558868|FG000|Completed Treatment|Overall Study||40
10414490|NCT00784758|11558869|FG001|Completed Treatment|Overall Study||39
10414491|NCT00784758|11558868|FG000|COMPLETED|Overall Study||38
10414492|NCT00784758|11558869|FG001|COMPLETED|Overall Study||39
10414493|NCT00784758|11558868|FG000|NOT COMPLETED|Overall Study||4
10414494|NCT00784758|11558869|FG001|NOT COMPLETED|Overall Study||0
10414495|NCT00784784|11558879|FG000|STARTED|Overall Study||22
10414496|NCT00784784|11558880|FG001|STARTED|Overall Study||42
10414497|NCT00784784|11558879|FG000|COMPLETED|Overall Study||20
10414498|NCT00784784|11558880|FG001|COMPLETED|Overall Study||40
10414499|NCT00784784|11558879|FG000|NOT COMPLETED|Overall Study||2
10414500|NCT00784784|11558880|FG001|NOT COMPLETED|Overall Study||2
10414501|NCT00784810|11558888|FG000|STARTED|Overall Study||124
10414502|NCT00784810|11558889|FG001|STARTED|Overall Study||123
10414503|NCT00784810|11558888|FG000|COMPLETED|Overall Study||61
10414504|NCT00784810|11558889|FG001|COMPLETED|Overall Study||74
10414505|NCT00784810|11558888|FG000|NOT COMPLETED|Overall Study||63
10414506|NCT00784810|11558889|FG001|NOT COMPLETED|Overall Study||49
10414507|NCT00784836|11558895|FG000|STARTED|Overall Study||3
10414508|NCT00784836|11558895|FG000|COMPLETED|Overall Study|The study was terminated early by the Sponsor for business reason not related to safety.|0
10414509|NCT00784836|11558895|FG000|NOT COMPLETED|Overall Study||3
10414510|NCT00784849|11558899|FG000|STARTED|Overall Study||62
10414511|NCT00784849|11558899|FG000|COMPLETED|Overall Study||62
10414512|NCT00784849|11558899|FG000|NOT COMPLETED|Overall Study||0
10414513|NCT00784875|11558907|FG000|STARTED|Period A - Baseline||0
10414514|NCT00784875|11558908|FG001|STARTED|Period A - Baseline||0
10414515|NCT00784875|11558909|FG002|STARTED|Period A - Baseline||0
10545582|NCT01498575|11698984|FG000|NOT COMPLETED|On the Road Driving Assessment (ODA)||42
10545583|NCT01498575|11698985|FG001|NOT COMPLETED|On the Road Driving Assessment (ODA)||24
10545584|NCT01498588|11698991|FG000|STARTED|Overall Study||7
10545585|NCT01498588|11698991|FG000|COMPLETED|Overall Study||7
10853040|NCT02051608|12019292|FG000|STARTED|Part 1: Double Blind Treatment||195
10853041|NCT02051608|12019293|FG001|STARTED|Part 1: Double Blind Treatment||192
10853042|NCT02051608|12019294|FG002|STARTED|Part 1: Double Blind Treatment||0
10853043|NCT02051608|12019295|FG003|STARTED|Part 1: Double Blind Treatment||0
10853044|NCT02051608|12019292|FG000|COMPLETED|Part 1: Double Blind Treatment||134
10853045|NCT02051608|12019293|FG001|COMPLETED|Part 1: Double Blind Treatment||136
10853046|NCT02051608|12019294|FG002|COMPLETED|Part 1: Double Blind Treatment||0
10853047|NCT02051608|12019295|FG003|COMPLETED|Part 1: Double Blind Treatment||0
10853048|NCT02051608|12019292|FG000|NOT COMPLETED|Part 1: Double Blind Treatment||61
10853049|NCT02051608|12019293|FG001|NOT COMPLETED|Part 1: Double Blind Treatment||56
10853050|NCT02051608|12019294|FG002|NOT COMPLETED|Part 1: Double Blind Treatment||0
10853051|NCT02051608|12019295|FG003|NOT COMPLETED|Part 1: Double Blind Treatment||0
10853052|NCT02051608|12019292|FG000|STARTED|Part 2: Open-label Extension||0
10853053|NCT02051608|12019293|FG001|STARTED|Part 2: Open-label Extension||0
10853054|NCT02051608|12019294|FG002|STARTED|Part 2: Open-label Extension||119
10853055|NCT02051608|12019295|FG003|STARTED|Part 2: Open-label Extension||111
10853056|NCT02051608|12019292|FG000|COMPLETED|Part 2: Open-label Extension||0
10853057|NCT02051608|12019293|FG001|COMPLETED|Part 2: Open-label Extension||0
10853058|NCT02051608|12019294|FG002|COMPLETED|Part 2: Open-label Extension||49
10853059|NCT02051608|12019295|FG003|COMPLETED|Part 2: Open-label Extension||50
10853060|NCT02051608|12019292|FG000|NOT COMPLETED|Part 2: Open-label Extension||0
10853061|NCT02051608|12019293|FG001|NOT COMPLETED|Part 2: Open-label Extension||0
10853062|NCT02051608|12019294|FG002|NOT COMPLETED|Part 2: Open-label Extension||70
10853063|NCT02051608|12019295|FG003|NOT COMPLETED|Part 2: Open-label Extension||61
10853083|NCT01700673|12019331|FG000|STARTED|Overall Study||1
10853084|NCT01700673|12019332|FG001|STARTED|Overall Study||23
10853085|NCT01700673|12019333|FG002|STARTED|Overall Study||1
10853086|NCT01700673|12019331|FG000|COMPLETED|Overall Study||1
10853087|NCT01700673|12019332|FG001|COMPLETED|Overall Study||17
10853088|NCT01700673|12019333|FG002|COMPLETED|Overall Study||1
10853089|NCT01700673|12019331|FG000|NOT COMPLETED|Overall Study||0
10853090|NCT01700673|12019332|FG001|NOT COMPLETED|Overall Study||6
10853091|NCT01700673|12019333|FG002|NOT COMPLETED|Overall Study||0
10853092|NCT01531374|12019345|FG000|STARTED|Overall Study||1285
10853093|NCT01531374|12019346|FG001|STARTED|Overall Study||373
10853094|NCT01531374|12019347|FG002|STARTED|Overall Study||1119
10853095|NCT01531374|12019345|FG000|COMPLETED|Overall Study||921
10853096|NCT01531374|12019346|FG001|COMPLETED|Overall Study||231
10853097|NCT01531374|12019347|FG002|COMPLETED|Overall Study||836
10853098|NCT01531374|12019345|FG000|NOT COMPLETED|Overall Study||364
10853099|NCT01531374|12019346|FG001|NOT COMPLETED|Overall Study||142
10853100|NCT01531374|12019347|FG002|NOT COMPLETED|Overall Study||283
10853101|NCT01240902|12019361|FG000|STARTED|Overall Study||500
10853102|NCT01240902|12019362|FG001|STARTED|Overall Study||156
10853103|NCT01240902|12019363|FG002|STARTED|Overall Study||395
10853104|NCT01240902|12019364|FG003|STARTED|Overall Study||402
10853105|NCT01240902|12019361|FG000|COMPLETED|Overall Study||289
10853106|NCT01240902|12019362|FG001|COMPLETED|Overall Study||77
10853107|NCT01240902|12019363|FG002|COMPLETED|Overall Study||295
10853108|NCT01240902|12019364|FG003|COMPLETED|Overall Study||237
10853109|NCT01240902|12019361|FG000|NOT COMPLETED|Overall Study||211
10853110|NCT01240902|12019362|FG001|NOT COMPLETED|Overall Study||79
10853111|NCT01240902|12019363|FG002|NOT COMPLETED|Overall Study||100
10853112|NCT01240902|12019364|FG003|NOT COMPLETED|Overall Study||165
10853113|NCT00726596|12019376|FG000|STARTED|Overall Study||36
10853114|NCT00726596|12019377|FG001|STARTED|Overall Study||28
10853115|NCT00726596|12019376|FG000|COMPLETED|Overall Study||31
10853116|NCT00726596|12019377|FG001|COMPLETED|Overall Study||24
10853117|NCT00726596|12019376|FG000|NOT COMPLETED|Overall Study||5
10853118|NCT00726596|12019377|FG001|NOT COMPLETED|Overall Study||4
10853119|NCT00489827|12019385|FG000|STARTED|Overall Study||430
10853120|NCT00489827|12019386|FG001|STARTED|Overall Study||435
10853121|NCT00489827|12019385|FG000|COMPLETED|Overall Study||428
10853122|NCT00489827|12019386|FG001|COMPLETED|Overall Study||433
10853123|NCT00489827|12019385|FG000|NOT COMPLETED|Overall Study||2
10853124|NCT00489827|12019386|FG001|NOT COMPLETED|Overall Study||2
10853128|NCT04460690|12019398|FG000|STARTED|Overall Study||93
10853129|NCT04460690|12019398|FG000|Community Participants|Overall Study||83
10853130|NCT04460690|12019398|FG000|Investigator Participants|Overall Study||10
10853131|NCT04460690|12019398|FG000|COMPLETED|Overall Study||93
10853132|NCT04460690|12019398|FG000|NOT COMPLETED|Overall Study||0
10853133|NCT04374019|12019409|FG000|STARTED|Overall Study||1
10853134|NCT04374019|12019410|FG001|STARTED|Overall Study||1
10853135|NCT04374019|12019411|FG002|STARTED|Overall Study||6
10853136|NCT04374019|12019412|FG003|STARTED|Overall Study||5
10853137|NCT04374019|12019409|FG000|COMPLETED|Overall Study||1
10853138|NCT04374019|12019410|FG001|COMPLETED|Overall Study||1
10853139|NCT04374019|12019411|FG002|COMPLETED|Overall Study||5
10853140|NCT04374019|12019412|FG003|COMPLETED|Overall Study||5
10853141|NCT04374019|12019409|FG000|NOT COMPLETED|Overall Study||0
10853142|NCT04374019|12019410|FG001|NOT COMPLETED|Overall Study||0
10853143|NCT04374019|12019411|FG002|NOT COMPLETED|Overall Study||1
10853144|NCT04374019|12019412|FG003|NOT COMPLETED|Overall Study||0
10853145|NCT04357730|12019426|FG000|STARTED|Phase 1||17
10853146|NCT04357730|12019427|FG001|STARTED|Phase 1||19
10853147|NCT04357730|12019428|FG002|STARTED|Phase 1||0
10853148|NCT04357730|12019426|FG000|COMPLETED|Phase 1||17
10853149|NCT04357730|12019427|FG001|COMPLETED|Phase 1||19
10853150|NCT04357730|12019428|FG002|COMPLETED|Phase 1||0
10853151|NCT04357730|12019426|FG000|NOT COMPLETED|Phase 1||0
10853152|NCT04357730|12019427|FG001|NOT COMPLETED|Phase 1||0
10853153|NCT04357730|12019428|FG002|NOT COMPLETED|Phase 1||0
10853154|NCT04357730|12019426|FG000|STARTED|Phase 2||8
10853155|NCT04357730|12019427|FG001|STARTED|Phase 2||0
10853156|NCT04357730|12019428|FG002|STARTED|Phase 2||6
10853157|NCT04357730|12019426|FG000|COMPLETED|Phase 2||8
10853158|NCT04357730|12019427|FG001|COMPLETED|Phase 2||0
10853159|NCT04357730|12019428|FG002|COMPLETED|Phase 2||6
10853160|NCT04357730|12019426|FG000|NOT COMPLETED|Phase 2||0
10853161|NCT04357730|12019427|FG001|NOT COMPLETED|Phase 2||0
10853162|NCT04357730|12019428|FG002|NOT COMPLETED|Phase 2||0
10853163|NCT04311463|12019442|FG000|STARTED|Period 1 (Up to Day 3)||19
10853164|NCT04311463|12019443|FG001|STARTED|Period 1 (Up to Day 3)||19
10853165|NCT04311463|12019442|FG000|COMPLETED|Period 1 (Up to Day 3)||18
10853166|NCT04311463|12019443|FG001|COMPLETED|Period 1 (Up to Day 3)||19
10853167|NCT04311463|12019442|FG000|NOT COMPLETED|Period 1 (Up to Day 3)||1
10853168|NCT04311463|12019443|FG001|NOT COMPLETED|Period 1 (Up to Day 3)||0
10293134|NCT01194219|11425834|FG006|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
10293135|NCT01194219|11425835|FG007|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
10293136|NCT01194219|11425836|FG008|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
10293137|NCT01194219|11425837|FG009|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
10293138|NCT01194219|11425828|FG000|STARTED|Maintenance Phase Weeks16-32||0
10293139|NCT01194219|11425829|FG001|STARTED|Maintenance Phase Weeks16-32||0
10293140|NCT01194219|11425830|FG002|STARTED|Maintenance Phase Weeks16-32|9 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|494
10293141|NCT01194219|11425831|FG003|STARTED|Maintenance Phase Weeks16-32|4 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|245
10414516|NCT00784875|11558910|FG003|STARTED|Period A - Baseline||643
10414517|NCT00784875|11558907|FG000|COMPLETED|Period A - Baseline||0
10414518|NCT00784875|11558908|FG001|COMPLETED|Period A - Baseline||0
10414519|NCT00784875|11558909|FG002|COMPLETED|Period A - Baseline||0
10414520|NCT00784875|11558910|FG003|COMPLETED|Period A - Baseline||461
10414521|NCT00784875|11558907|FG000|NOT COMPLETED|Period A - Baseline||0
10414522|NCT00784875|11558908|FG001|NOT COMPLETED|Period A - Baseline||0
10414523|NCT00784875|11558909|FG002|NOT COMPLETED|Period A - Baseline||0
10414524|NCT00784875|11558910|FG003|NOT COMPLETED|Period A - Baseline||182
10414525|NCT00784875|11558907|FG000|STARTED|Period B - Efficacy Endpoint||114
10414526|NCT00784875|11558908|FG001|STARTED|Period B - Efficacy Endpoint||113
10414527|NCT00784875|11558909|FG002|STARTED|Period B - Efficacy Endpoint||117
10414528|NCT00784875|11558910|FG003|STARTED|Period B - Efficacy Endpoint||117
10414529|NCT00784875|11558907|FG000|Cohort 2|Period B - Efficacy Endpoint||102
10414530|NCT00784875|11558908|FG001|Cohort 2|Period B - Efficacy Endpoint||102
10754814|NCT03055832|11918630|FG000|NOT COMPLETED|Immediately Post-Procedure (Hour 1)||0
10754815|NCT03055832|11918631|FG001|NOT COMPLETED|Immediately Post-Procedure (Hour 1)||0
10754816|NCT03055832|11918630|FG000|STARTED|Day 1||71
10754817|NCT03055832|11918631|FG001|STARTED|Day 1||71
10754818|NCT03055832|11918630|FG000|COMPLETED|Day 1||71
10754819|NCT03055832|11918631|FG001|COMPLETED|Day 1||71
10754820|NCT03055832|11918630|FG000|NOT COMPLETED|Day 1||0
10754821|NCT03055832|11918631|FG001|NOT COMPLETED|Day 1||0
10754822|NCT03055832|11918630|FG000|STARTED|Week 2||71
10754823|NCT03055832|11918631|FG001|STARTED|Week 2||71
10754824|NCT03055832|11918630|FG000|COMPLETED|Week 2||70
10754825|NCT03055832|11918631|FG001|COMPLETED|Week 2||71
10853169|NCT04311463|12019442|FG000|STARTED|Washout Period (Up to Day 7)||18
10853170|NCT04311463|12019443|FG001|STARTED|Washout Period (Up to Day 7)||19
10853171|NCT04311463|12019442|FG000|COMPLETED|Washout Period (Up to Day 7)||17
10853172|NCT04311463|12019443|FG001|COMPLETED|Washout Period (Up to Day 7)||18
10853173|NCT04311463|12019442|FG000|NOT COMPLETED|Washout Period (Up to Day 7)||1
10853174|NCT04311463|12019443|FG001|NOT COMPLETED|Washout Period (Up to Day 7)||1
10853175|NCT04311463|12019442|FG000|STARTED|Period 2 (Up to Day 3)||17
10853176|NCT04311463|12019443|FG001|STARTED|Period 2 (Up to Day 3)||18
10293142|NCT01194219|11425832|FG004|STARTED|Maintenance Phase Weeks16-32||0
10293143|NCT01194219|11425833|FG005|STARTED|Maintenance Phase Weeks16-32||0
10293144|NCT01194219|11425834|FG006|STARTED|Maintenance Phase Weeks16-32||0
10293145|NCT01194219|11425835|FG007|STARTED|Maintenance Phase Weeks16-32||0
10293146|NCT01194219|11425836|FG008|STARTED|Maintenance Phase Weeks16-32||0
10293147|NCT01194219|11425837|FG009|STARTED|Maintenance Phase Weeks16-32||0
10293148|NCT01194219|11425828|FG000|Received Apremilast|Maintenance Phase Weeks16-32||0
10293149|NCT01194219|11425829|FG001|Received Apremilast|Maintenance Phase Weeks16-32||0
10853177|NCT04311463|12019442|FG000|COMPLETED|Period 2 (Up to Day 3)||15
10853178|NCT04311463|12019443|FG001|COMPLETED|Period 2 (Up to Day 3)||17
10853179|NCT04311463|12019442|FG000|NOT COMPLETED|Period 2 (Up to Day 3)||2
10853180|NCT04311463|12019443|FG001|NOT COMPLETED|Period 2 (Up to Day 3)||1
10853181|NCT04175509|12019452|FG000|STARTED|Overall Study||19
10853182|NCT04175509|12019453|FG001|STARTED|Overall Study||21
10853183|NCT04175509|12019452|FG000|COMPLETED|Overall Study||17
10853184|NCT04175509|12019453|FG001|COMPLETED|Overall Study||19
10853185|NCT04175509|12019452|FG000|NOT COMPLETED|Overall Study||2
10853186|NCT04175509|12019453|FG001|NOT COMPLETED|Overall Study||2
10853187|NCT03930186|12019459|FG000|STARTED|Weeks 0 to 16||152
10853188|NCT03930186|12019459|FG000|Received Study Drug|Weeks 0 to 16||152
10853189|NCT03930186|12019459|FG000|COMPLETED|Weeks 0 to 16||140
10853190|NCT03930186|12019459|FG000|NOT COMPLETED|Weeks 0 to 16||12
10853191|NCT03930186|12019459|FG000|STARTED|Weeks 16 to 32||140
10853192|NCT03930186|12019459|FG000|COMPLETED|Weeks 16 to 32||136
10853193|NCT03930186|12019459|FG000|NOT COMPLETED|Weeks 16 to 32||4
10853194|NCT03740100|12019463|FG000|STARTED|Overall Study|Note: Ten patients were consented, but two died before starting therapy.|8
10853195|NCT03740100|12019463|FG000|Confirmed Partial Response|Overall Study|"Using a Simon's optimal two-stage design, we planned to enroll up to 10 evaluable patients in the first stage.~Two of eight treated patients were not evaluable for response based on toxicity.~We did not reach this milestone."|1
10853196|NCT03740100|12019463|FG000|COMPLETED|Overall Study||6
10853197|NCT03740100|12019463|FG000|NOT COMPLETED|Overall Study||2
10853198|NCT03597295|12019467|FG000|STARTED|Overall Study||94
10853199|NCT03597295|12019467|FG000|COMPLETED|Overall Study||0
10853200|NCT03597295|12019467|FG000|NOT COMPLETED|Overall Study||94
10414531|NCT00784875|11558909|FG002|Cohort 2|Period B - Efficacy Endpoint||102
10414532|NCT00784875|11558910|FG003|Cohort 2|Period B - Efficacy Endpoint||101
10414533|NCT00784875|11558907|FG000|COMPLETED|Period B - Efficacy Endpoint||100
10414534|NCT00784875|11558908|FG001|COMPLETED|Period B - Efficacy Endpoint||101
10414535|NCT00784875|11558909|FG002|COMPLETED|Period B - Efficacy Endpoint||96
10414536|NCT00784875|11558910|FG003|COMPLETED|Period B - Efficacy Endpoint||98
10414537|NCT00784875|11558907|FG000|NOT COMPLETED|Period B - Efficacy Endpoint||14
10414538|NCT00784875|11558908|FG001|NOT COMPLETED|Period B - Efficacy Endpoint||12
10414539|NCT00784875|11558909|FG002|NOT COMPLETED|Period B - Efficacy Endpoint||21
10414540|NCT00784875|11558910|FG003|NOT COMPLETED|Period B - Efficacy Endpoint||19
10414541|NCT00784875|11558907|FG000|STARTED|Period C||103
10414542|NCT00784875|11558908|FG001|STARTED|Period C||97
10414543|NCT00784875|11558909|FG002|STARTED|Period C||97
10414544|NCT00784875|11558910|FG003|STARTED|Period C||98
10414545|NCT00784875|11558907|FG000|COMPLETED|Period C||96
10414546|NCT00784875|11558908|FG001|COMPLETED|Period C||91
10414547|NCT00784875|11558909|FG002|COMPLETED|Period C||84
10414548|NCT00784875|11558910|FG003|COMPLETED|Period C||91
10414549|NCT00784875|11558907|FG000|NOT COMPLETED|Period C||7
10414550|NCT00784875|11558908|FG001|NOT COMPLETED|Period C||6
10414551|NCT00784875|11558909|FG002|NOT COMPLETED|Period C||13
10414552|NCT00784875|11558910|FG003|NOT COMPLETED|Period C||7
10414553|NCT00784875|11558907|FG000|STARTED|Period D||91
10414554|NCT00784875|11558908|FG001|STARTED|Period D||89
10414555|NCT00784875|11558909|FG002|STARTED|Period D||94
10853201|NCT03053362|12019474|FG000|STARTED|Overall Study||100
10853202|NCT03053362|12019475|FG001|STARTED|Overall Study||58
10853203|NCT03053362|12019474|FG000|COMPLETED|Overall Study||83
10853204|NCT03053362|12019475|FG001|COMPLETED|Overall Study||50
10853205|NCT03053362|12019474|FG000|NOT COMPLETED|Overall Study||17
10853206|NCT03053362|12019475|FG001|NOT COMPLETED|Overall Study||8
10853207|NCT05059366|12019484|FG000|STARTED|Overall Study||8
10853208|NCT05059366|12019485|FG001|STARTED|Overall Study||8
10853209|NCT05059366|12019486|FG002|STARTED|Overall Study||8
10853210|NCT05059366|12019487|FG003|STARTED|Overall Study||8
10853211|NCT05059366|12019484|FG000|COMPLETED|Overall Study||8
10853212|NCT05059366|12019485|FG001|COMPLETED|Overall Study||8
10853213|NCT05059366|12019486|FG002|COMPLETED|Overall Study||8
10853214|NCT05059366|12019487|FG003|COMPLETED|Overall Study||8
10853215|NCT05059366|12019484|FG000|NOT COMPLETED|Overall Study||0
10853216|NCT05059366|12019485|FG001|NOT COMPLETED|Overall Study||0
10853217|NCT05059366|12019486|FG002|NOT COMPLETED|Overall Study||0
10853218|NCT05059366|12019487|FG003|NOT COMPLETED|Overall Study||0
10853219|NCT04808609|12019495|FG000|STARTED|Overall Study||20
10853220|NCT04808609|12019496|FG001|STARTED|Overall Study||20
10853221|NCT04808609|12019495|FG000|COMPLETED|Overall Study||20
10853222|NCT04808609|12019496|FG001|COMPLETED|Overall Study||17
10853223|NCT04808609|12019495|FG000|NOT COMPLETED|Overall Study||0
10853224|NCT04808609|12019496|FG001|NOT COMPLETED|Overall Study||3
10853225|NCT04577781|12019504|FG000|STARTED|Overall Study||16
10853226|NCT04577781|12019505|FG001|STARTED|Overall Study||12
10853227|NCT04577781|12019504|FG000|COMPLETED|Overall Study||13
10853228|NCT04577781|12019505|FG001|COMPLETED|Overall Study||10
10853229|NCT04577781|12019504|FG000|NOT COMPLETED|Overall Study||3
10853230|NCT04577781|12019505|FG001|NOT COMPLETED|Overall Study||2
10853231|NCT04524598|12019516|FG000|STARTED|Phase I - Feasibility||35
10414556|NCT00784875|11558910|FG003|STARTED|Period D||88
10414557|NCT00784875|11558907|FG000|COMPLETED|Period D||86
10414558|NCT00784875|11558908|FG001|COMPLETED|Period D||85
10414559|NCT00784875|11558909|FG002|COMPLETED|Period D||88
10414560|NCT00784875|11558910|FG003|COMPLETED|Period D||87
10414561|NCT00784875|11558907|FG000|NOT COMPLETED|Period D||5
10414562|NCT00784875|11558908|FG001|NOT COMPLETED|Period D||4
10414563|NCT00784875|11558909|FG002|NOT COMPLETED|Period D||6
10414564|NCT00784875|11558910|FG003|NOT COMPLETED|Period D||1
10414565|NCT00784927|11558933|FG000|STARTED|Overall Study||36
10414566|NCT00784927|11558933|FG000|COMPLETED|Overall Study||33
10414567|NCT00784927|11558933|FG000|NOT COMPLETED|Overall Study||3
10414568|NCT00784979|11558938|FG000|STARTED|Overall Study||26
10414569|NCT00784979|11558938|FG000|COMPLETED|Overall Study||20
10414570|NCT00784979|11558938|FG000|NOT COMPLETED|Overall Study||6
10414571|NCT00785044|11558942|FG000|STARTED|Overall Study|Eligible to participate in MBG313|964
10414572|NCT00785044|11558942|FG000|Enrolled Participants|Overall Study|Out of 964 from MBG311 and MBG312 HF participants, 471 enrolled into the extension MBG313 study.|471
10414573|NCT00785044|11558942|FG000|COMPLETED|Overall Study|Data for 471 participants (MBG313) combined with data from MBG311 and MBG312 for efficacy analysis|468
10414574|NCT00785044|11558942|FG000|NOT COMPLETED|Overall Study||496
10414575|NCT00785213|11558947|FG000|STARTED|Rosiglitazone Alone||23
10414576|NCT00785213|11558947|FG000|COMPLETED|Rosiglitazone Alone||23
10414577|NCT00785213|11558947|FG000|NOT COMPLETED|Rosiglitazone Alone||0
10414578|NCT00785213|11558947|FG000|STARTED|2 Day Washout Period||23
10414579|NCT00785213|11558947|FG000|COMPLETED|2 Day Washout Period||23
10414580|NCT00785213|11558947|FG000|NOT COMPLETED|2 Day Washout Period||0
10414581|NCT00785213|11558947|FG000|STARTED|Quinine Sulfate Alone||23
10414582|NCT00785213|11558947|FG000|COMPLETED|Quinine Sulfate Alone||19
10414583|NCT00785213|11558947|FG000|NOT COMPLETED|Quinine Sulfate Alone||4
10414584|NCT00785213|11558947|FG000|STARTED|Rosiglitazone With Quinine Sulfate||19
10414585|NCT00785213|11558947|FG000|COMPLETED|Rosiglitazone With Quinine Sulfate||18
10414586|NCT00785213|11558947|FG000|NOT COMPLETED|Rosiglitazone With Quinine Sulfate||1
10414587|NCT00785486|11558954|FG000|STARTED|Midazolam Alone||24
10414588|NCT00785486|11558954|FG000|COMPLETED|Midazolam Alone|one participant withdrew for personal reasons after first midazolam dose|23
10414589|NCT00785486|11558954|FG000|NOT COMPLETED|Midazolam Alone||1
10754826|NCT03055832|11918630|FG000|NOT COMPLETED|Week 2||1
10754827|NCT03055832|11918631|FG001|NOT COMPLETED|Week 2||0
10754828|NCT03055832|11918630|FG000|STARTED|Week 4||70
10754829|NCT03055832|11918631|FG001|STARTED|Week 4||71
10754830|NCT03055832|11918630|FG000|COMPLETED|Week 4||70
10754831|NCT03055832|11918631|FG001|COMPLETED|Week 4||71
10754832|NCT03055832|11918630|FG000|NOT COMPLETED|Week 4||0
10754833|NCT03055832|11918631|FG001|NOT COMPLETED|Week 4||0
10754834|NCT03055897|11918651|FG000|STARTED|Overall Study||15
10754835|NCT03055897|11918651|FG000|COMPLETED|Overall Study||15
10754836|NCT03055897|11918651|FG000|NOT COMPLETED|Overall Study||0
10754837|NCT03055936|11918659|FG000|STARTED|Overall Study||14
10754838|NCT03055936|11918660|FG001|STARTED|Overall Study||14
10754839|NCT03055936|11918661|FG002|STARTED|Overall Study||14
10754840|NCT03055936|11918662|FG003|STARTED|Overall Study||14
10754841|NCT03055936|11918659|FG000|COMPLETED|Overall Study||12
10754842|NCT03055936|11918660|FG001|COMPLETED|Overall Study||13
10754843|NCT03055936|11918661|FG002|COMPLETED|Overall Study||12
10754844|NCT03055936|11918662|FG003|COMPLETED|Overall Study||13
10754845|NCT03055936|11918659|FG000|NOT COMPLETED|Overall Study||2
10754846|NCT03055936|11918660|FG001|NOT COMPLETED|Overall Study||1
10853232|NCT04524598|12019517|FG001|STARTED|Phase I - Feasibility||25
10853233|NCT04524598|12019518|FG002|STARTED|Phase I - Feasibility||0
10853234|NCT04524598|12019519|FG003|STARTED|Phase I - Feasibility||0
10853235|NCT04524598|12019520|FG004|STARTED|Phase I - Feasibility||0
10853236|NCT04524598|12019516|FG000|COMPLETED|Phase I - Feasibility||31
10853237|NCT04524598|12019517|FG001|COMPLETED|Phase I - Feasibility||20
10853238|NCT04524598|12019518|FG002|COMPLETED|Phase I - Feasibility||0
10853239|NCT04524598|12019519|FG003|COMPLETED|Phase I - Feasibility||0
10853240|NCT04524598|12019520|FG004|COMPLETED|Phase I - Feasibility||0
10853241|NCT04524598|12019516|FG000|NOT COMPLETED|Phase I - Feasibility||4
10853242|NCT04524598|12019517|FG001|NOT COMPLETED|Phase I - Feasibility||5
10853243|NCT04524598|12019518|FG002|NOT COMPLETED|Phase I - Feasibility||0
10853244|NCT04524598|12019519|FG003|NOT COMPLETED|Phase I - Feasibility||0
10853245|NCT04524598|12019520|FG004|NOT COMPLETED|Phase I - Feasibility||0
10853246|NCT04524598|12019516|FG000|STARTED|Phase II - Outcomes||0
10853247|NCT04524598|12019517|FG001|STARTED|Phase II - Outcomes||0
10853248|NCT04524598|12019518|FG002|STARTED|Phase II - Outcomes||80
10853249|NCT04524598|12019519|FG003|STARTED|Phase II - Outcomes||80
10853250|NCT04524598|12019520|FG004|STARTED|Phase II - Outcomes||0
10853251|NCT04524598|12019516|FG000|Met PHQ-8 Threshold (Baseline >/= 10)|Phase II - Outcomes||0
10853252|NCT04524598|12019517|FG001|Met PHQ-8 Threshold (Baseline >/= 10)|Phase II - Outcomes||0
10853253|NCT04524598|12019518|FG002|Met PHQ-8 Threshold (Baseline >/= 10)|Phase II - Outcomes||63
10853254|NCT04524598|12019519|FG003|Met PHQ-8 Threshold (Baseline >/= 10)|Phase II - Outcomes||58
10853255|NCT04524598|12019520|FG004|Met PHQ-8 Threshold (Baseline >/= 10)|Phase II - Outcomes||0
10853256|NCT04524598|12019516|FG000|COMPLETED|Phase II - Outcomes||0
10853257|NCT04524598|12019517|FG001|COMPLETED|Phase II - Outcomes||0
10853258|NCT04524598|12019518|FG002|COMPLETED|Phase II - Outcomes||54
10853259|NCT04524598|12019519|FG003|COMPLETED|Phase II - Outcomes||67
10853260|NCT04524598|12019520|FG004|COMPLETED|Phase II - Outcomes||0
10853261|NCT04524598|12019516|FG000|NOT COMPLETED|Phase II - Outcomes||0
10853262|NCT04524598|12019517|FG001|NOT COMPLETED|Phase II - Outcomes||0
10853263|NCT04524598|12019518|FG002|NOT COMPLETED|Phase II - Outcomes||26
10853264|NCT04524598|12019519|FG003|NOT COMPLETED|Phase II - Outcomes||13
10853265|NCT04524598|12019520|FG004|NOT COMPLETED|Phase II - Outcomes||0
10853266|NCT04524598|12019516|FG000|STARTED|Phase II - Control Extension||0
10853267|NCT04524598|12019517|FG001|STARTED|Phase II - Control Extension||0
10853268|NCT04524598|12019518|FG002|STARTED|Phase II - Control Extension||0
10853269|NCT04524598|12019519|FG003|STARTED|Phase II - Control Extension||0
10853270|NCT04524598|12019520|FG004|STARTED|Phase II - Control Extension||66
10853271|NCT04524598|12019516|FG000|COMPLETED|Phase II - Control Extension||0
10853272|NCT04524598|12019517|FG001|COMPLETED|Phase II - Control Extension||0
10853273|NCT04524598|12019518|FG002|COMPLETED|Phase II - Control Extension||0
10853274|NCT04524598|12019519|FG003|COMPLETED|Phase II - Control Extension||0
10853275|NCT04524598|12019520|FG004|COMPLETED|Phase II - Control Extension||54
10853276|NCT04524598|12019516|FG000|NOT COMPLETED|Phase II - Control Extension||0
10853277|NCT04524598|12019517|FG001|NOT COMPLETED|Phase II - Control Extension||0
10853278|NCT04524598|12019518|FG002|NOT COMPLETED|Phase II - Control Extension||0
10853279|NCT04524598|12019519|FG003|NOT COMPLETED|Phase II - Control Extension||0
10853280|NCT04524598|12019520|FG004|NOT COMPLETED|Phase II - Control Extension||12
10853281|NCT04518462|12019537|FG000|STARTED|Overall Study||40
10853282|NCT04518462|12019538|FG001|STARTED|Overall Study||41
10853283|NCT04518462|12019539|FG002|STARTED|Overall Study||40
10853284|NCT04518462|12019537|FG000|COMPLETED|Overall Study||39
10853285|NCT04518462|12019538|FG001|COMPLETED|Overall Study||40
10853286|NCT04518462|12019539|FG002|COMPLETED|Overall Study||39
10853287|NCT04518462|12019537|FG000|NOT COMPLETED|Overall Study||1
10853288|NCT04518462|12019538|FG001|NOT COMPLETED|Overall Study||1
10853289|NCT04518462|12019539|FG002|NOT COMPLETED|Overall Study||1
10853290|NCT04432298|12019549|FG000|STARTED|Overall Study||11
10853291|NCT04432298|12019550|FG001|STARTED|Overall Study||11
10853292|NCT04432298|12019549|FG000|Intent-to-Treat (ITT) Population|Overall Study||11
10853293|NCT04432298|12019550|FG001|Intent-to-Treat (ITT) Population|Overall Study||11
10853294|NCT04432298|12019549|FG000|Safety Population|Overall Study||9
10853295|NCT04432298|12019550|FG001|Safety Population|Overall Study||11
10853296|NCT04432298|12019549|FG000|COMPLETED|Overall Study||5
10853297|NCT04432298|12019550|FG001|COMPLETED|Overall Study||8
10853298|NCT04432298|12019549|FG000|NOT COMPLETED|Overall Study||6
10853299|NCT04432298|12019550|FG001|NOT COMPLETED|Overall Study||3
10853300|NCT04428034|12019556|FG000|STARTED|Enrollment to Intervention Completion||45
10853301|NCT04428034|12019556|FG000|Attended at Least 2 Intervention Sessions in One Cohort|Enrollment to Intervention Completion|"Forty-five (45) participants enrolled and completed the baseline survey. Of those who completed they baseline survey, six participants of those who completed the baseline survey did not attend at least 2 sessions. Three participants started the intervention in one cohort, but completed in another (off-protocol). One participant was found to be a fraudulent case, identified through none-varying (straight line) responses to survey questions."|35
10853302|NCT04428034|12019556|FG000|COMPLETED|Enrollment to Intervention Completion||35
10853303|NCT04428034|12019556|FG000|NOT COMPLETED|Enrollment to Intervention Completion||10
10853304|NCT04428034|12019556|FG000|STARTED|4-Week Follow Up Survey||35
10853305|NCT04428034|12019556|FG000|COMPLETED|4-Week Follow Up Survey||29
10853306|NCT04428034|12019556|FG000|NOT COMPLETED|4-Week Follow Up Survey||6
10853307|NCT04428034|12019556|FG000|STARTED|8-Week Follow Up Survey||29
10853308|NCT04428034|12019556|FG000|COMPLETED|8-Week Follow Up Survey|Of those 27 who completed the 8-week follow up survey, one participant skipped the 4-week follow up survey but completed the 8-week survey.|27
10853309|NCT04428034|12019556|FG000|NOT COMPLETED|8-Week Follow Up Survey||2
10853310|NCT03895632|12019560|FG000|STARTED|Overall Study||25
10853311|NCT03895632|12019560|FG000|COMPLETED|Overall Study||25
10853312|NCT03895632|12019560|FG000|NOT COMPLETED|Overall Study||0
10853313|NCT03888885|12019566|FG000|STARTED|Overall Study||208
10853314|NCT03888885|12019567|FG001|STARTED|Overall Study||202
10853315|NCT03888885|12019566|FG000|Post-intervention|Overall Study||191
10853316|NCT03888885|12019567|FG001|Post-intervention|Overall Study||190
10853317|NCT03888885|12019566|FG000|COMPLETED|Overall Study||188
10853318|NCT03888885|12019567|FG001|COMPLETED|Overall Study||184
10853319|NCT03888885|12019566|FG000|NOT COMPLETED|Overall Study||20
10853320|NCT03888885|12019567|FG001|NOT COMPLETED|Overall Study||18
10853321|NCT03853694|12019576|FG000|STARTED|Overall Study||56
10853322|NCT03853694|12019577|FG001|STARTED|Overall Study||56
10853323|NCT03853694|12019578|FG002|STARTED|Overall Study||55
10853324|NCT03853694|12019576|FG000|COMPLETED|Overall Study||53
10853325|NCT03853694|12019577|FG001|COMPLETED|Overall Study||47
10853326|NCT03853694|12019578|FG002|COMPLETED|Overall Study||51
10853327|NCT03853694|12019576|FG000|NOT COMPLETED|Overall Study||3
10853328|NCT03853694|12019577|FG001|NOT COMPLETED|Overall Study||9
10853329|NCT03853694|12019578|FG002|NOT COMPLETED|Overall Study||4
10853330|NCT03785340|12019588|FG000|STARTED|Overall Study||126
10853331|NCT03785340|12019589|FG001|STARTED|Overall Study||126
10414606|NCT00785538|11558990|FG001|STARTED|PK Period||1
10853332|NCT03785340|12019588|FG000|Received at Least 1 Study Treatment|Overall Study||126
10853333|NCT03785340|12019589|FG001|Received at Least 1 Study Treatment|Overall Study||126
10853334|NCT03785340|12019588|FG000|COMPLETED|Overall Study||123
10853335|NCT03785340|12019589|FG001|COMPLETED|Overall Study||126
10853336|NCT03785340|12019588|FG000|NOT COMPLETED|Overall Study||3
10853337|NCT03785340|12019589|FG001|NOT COMPLETED|Overall Study||0
10853338|NCT03760224|12019597|FG000|STARTED|Overall Study||469
10853339|NCT03760224|12019598|FG001|STARTED|Overall Study||459
10853340|NCT03760224|12019597|FG000|COMPLETED|Overall Study||469
10853341|NCT03760224|12019598|FG001|COMPLETED|Overall Study||459
10853342|NCT03760224|12019597|FG000|NOT COMPLETED|Overall Study||0
10853343|NCT03760224|12019598|FG001|NOT COMPLETED|Overall Study||0
10853344|NCT03657264|12019608|FG000|STARTED|Overall Study||12
10853345|NCT03657264|12019609|FG001|STARTED|Overall Study||12
10853346|NCT03657264|12019610|FG002|STARTED|Overall Study||12
10853347|NCT03657264|12019611|FG003|STARTED|Overall Study||12
10853348|NCT03657264|12019608|FG000|COMPLETED|Overall Study||12
10853349|NCT03657264|12019609|FG001|COMPLETED|Overall Study||12
10853350|NCT03657264|12019610|FG002|COMPLETED|Overall Study||12
10853351|NCT03657264|12019611|FG003|COMPLETED|Overall Study||12
10853352|NCT03657264|12019608|FG000|NOT COMPLETED|Overall Study||0
10853353|NCT03657264|12019609|FG001|NOT COMPLETED|Overall Study||0
10853354|NCT03657264|12019610|FG002|NOT COMPLETED|Overall Study||0
10853355|NCT03657264|12019611|FG003|NOT COMPLETED|Overall Study||0
10853356|NCT03427528|12019624|FG000|STARTED|Overall Study||30
10853357|NCT03427528|12019625|FG001|STARTED|Overall Study||30
10853358|NCT03427528|12019624|FG000|COMPLETED|Overall Study||17
10853359|NCT03427528|12019625|FG001|COMPLETED|Overall Study||23
10853360|NCT03427528|12019624|FG000|NOT COMPLETED|Overall Study||13
10853361|NCT03427528|12019625|FG001|NOT COMPLETED|Overall Study||7
10853362|NCT03373435|12019633|FG000|STARTED|Treatment Period 1 (14 Days)||8
10853363|NCT03373435|12019634|FG001|STARTED|Treatment Period 1 (14 Days)||10
10853364|NCT03373435|12019633|FG000|COMPLETED|Treatment Period 1 (14 Days)||8
10853365|NCT03373435|12019634|FG001|COMPLETED|Treatment Period 1 (14 Days)||10
10853366|NCT03373435|12019633|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||0
10853367|NCT03373435|12019634|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||0
10853368|NCT03373435|12019633|FG000|STARTED|Treatment Period 2 (14 Days)||8
10853369|NCT03373435|12019634|FG001|STARTED|Treatment Period 2 (14 Days)||10
10853370|NCT03373435|12019633|FG000|COMPLETED|Treatment Period 2 (14 Days)||8
10853371|NCT03373435|12019634|FG001|COMPLETED|Treatment Period 2 (14 Days)||10
10853372|NCT03373435|12019633|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||0
10853373|NCT03373435|12019634|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||0
10853374|NCT03373435|12019633|FG000|STARTED|Treatment Period 3 (14 Days)||8
10853375|NCT03373435|12019634|FG001|STARTED|Treatment Period 3 (14 Days)||10
10853376|NCT03373435|12019633|FG000|COMPLETED|Treatment Period 3 (14 Days)||8
10853377|NCT03373435|12019634|FG001|COMPLETED|Treatment Period 3 (14 Days)||10
10853378|NCT03373435|12019633|FG000|NOT COMPLETED|Treatment Period 3 (14 Days)||0
10853379|NCT03373435|12019634|FG001|NOT COMPLETED|Treatment Period 3 (14 Days)||0
10853386|NCT03248297|12019654|FG000|STARTED|Overall Study||253
10853387|NCT03248297|12019655|FG001|STARTED|Overall Study||253
10853388|NCT03248297|12019656|FG002|STARTED|Overall Study||250
10853389|NCT03248297|12019654|FG000|COMPLETED|Overall Study||253
10853390|NCT03248297|12019655|FG001|COMPLETED|Overall Study||253
10853391|NCT03248297|12019656|FG002|COMPLETED|Overall Study||250
10853392|NCT03248297|12019654|FG000|NOT COMPLETED|Overall Study||0
10853393|NCT03248297|12019655|FG001|NOT COMPLETED|Overall Study||0
10853394|NCT03248297|12019656|FG002|NOT COMPLETED|Overall Study||0
10853395|NCT03197064|12019664|FG000|STARTED|Overall Study||11
10853396|NCT03197064|12019664|FG000|COMPLETED|Overall Study||11
10853397|NCT03197064|12019664|FG000|NOT COMPLETED|Overall Study||0
10853398|NCT03173560|12019670|FG000|STARTED|Overall Study||172
10853399|NCT03173560|12019671|FG001|STARTED|Overall Study||171
10853400|NCT03173560|12019670|FG000|Treated Participants|Overall Study||172
10853401|NCT03173560|12019671|FG001|Treated Participants|Overall Study||169
10853402|NCT03173560|12019670|FG000|Safety Set|Overall Study||173
10853403|NCT03173560|12019671|FG001|Safety Set|Overall Study||168
10853404|NCT03173560|12019670|FG000|COMPLETED|Overall Study||67
10853405|NCT03173560|12019671|FG001|COMPLETED|Overall Study||54
10853406|NCT03173560|12019670|FG000|NOT COMPLETED|Overall Study||105
10853407|NCT03173560|12019671|FG001|NOT COMPLETED|Overall Study||117
10853408|NCT03113422|12019677|FG000|STARTED|Overall Study||56
10853409|NCT03113422|12019677|FG000|COMPLETED|Overall Study||56
10853410|NCT03113422|12019677|FG000|NOT COMPLETED|Overall Study||0
10853417|NCT02865850|12019693|FG000|STARTED|Overall Study||181
10293150|NCT01194219|11425830|FG002|Received Apremilast|Maintenance Phase Weeks16-32|1 participant elected not to participate at the time the first dose was dispensed.|493
10414607|NCT00785538|11558991|FG002|STARTED|PK Period||1
10414608|NCT00785538|11558992|FG003|STARTED|PK Period||0
10293151|NCT01194219|11425831|FG003|Received Apremilast|Maintenance Phase Weeks16-32|1 participant elected not to participate at the time the first dose was dispensed.|244
10414590|NCT00785486|11558954|FG000|STARTED|3 Day Washout||23
10414591|NCT00785486|11558954|FG000|COMPLETED|3 Day Washout||23
10414592|NCT00785486|11558954|FG000|NOT COMPLETED|3 Day Washout||0
10414593|NCT00785486|11558954|FG000|STARTED|Qualaquin Alone at Steady State||23
10414594|NCT00785486|11558954|FG000|COMPLETED|Qualaquin Alone at Steady State||23
10414595|NCT00785486|11558954|FG000|NOT COMPLETED|Qualaquin Alone at Steady State||0
10414596|NCT00785486|11558954|FG000|STARTED|Midazolam With Qualaquin at Steady State||23
10414597|NCT00785486|11558954|FG000|COMPLETED|Midazolam With Qualaquin at Steady State||23
10414598|NCT00785486|11558954|FG000|NOT COMPLETED|Midazolam With Qualaquin at Steady State||0
10414599|NCT00785512|11558977|FG000|STARTED|Overall Study||102
10414600|NCT00785512|11558978|FG001|STARTED|Overall Study||105
10414601|NCT00785512|11558977|FG000|COMPLETED|Overall Study||99
10414602|NCT00785512|11558978|FG001|COMPLETED|Overall Study||101
10414603|NCT00785512|11558977|FG000|NOT COMPLETED|Overall Study||3
10853418|NCT02865850|12019694|FG001|STARTED|Overall Study||188
10853419|NCT02865850|12019693|FG000|COMPLETED|Overall Study||160
10853420|NCT02865850|12019694|FG001|COMPLETED|Overall Study||165
10853421|NCT02865850|12019693|FG000|NOT COMPLETED|Overall Study||21
10853422|NCT02865850|12019694|FG001|NOT COMPLETED|Overall Study||23
10853423|NCT02763579|12019702|FG000|STARTED|Overall Study||201
10853424|NCT02763579|12019703|FG001|STARTED|Overall Study||202
10853425|NCT02763579|12019702|FG000|COMPLETED|Overall Study||0
10853426|NCT02763579|12019703|FG001|COMPLETED|Overall Study||0
10853427|NCT02763579|12019702|FG000|NOT COMPLETED|Overall Study||201
10853428|NCT02763579|12019703|FG001|NOT COMPLETED|Overall Study||202
10853429|NCT02746471|12019709|FG000|STARTED|Overall Study||1604
10853430|NCT02746471|12019709|FG000|COMPLETED|Overall Study||442
10853431|NCT02746471|12019709|FG000|NOT COMPLETED|Overall Study||1162
10853444|NCT02706873|12019727|FG000|STARTED|Overall Study||315
10853445|NCT02706873|12019728|FG001|STARTED|Overall Study||55
10853446|NCT02706873|12019729|FG002|STARTED|Overall Study||317
10853447|NCT02706873|12019730|FG003|STARTED|Overall Study||315
10853448|NCT02706873|12019727|FG000|Received Study Drug|Overall Study||314
10853449|NCT02706873|12019728|FG001|Received Study Drug|Overall Study||55
10853450|NCT02706873|12019729|FG002|Received Study Drug|Overall Study||317
10853451|NCT02706873|12019730|FG003|Received Study Drug|Overall Study||314
10853452|NCT02706873|12019727|FG000|Global Analysis Population|Overall Study|Includes 28 participants in the Japan sub-study|314
10853453|NCT02706873|12019728|FG001|Global Analysis Population|Overall Study||0
10853454|NCT02706873|12019729|FG002|Global Analysis Population|Overall Study|Includes 27 participants in the Japan sub-study|317
10853455|NCT02706873|12019730|FG003|Global Analysis Population|Overall Study|Includes 28 participants in the Japan sub-study|314
10853456|NCT02706873|12019727|FG000|Japan Sub-study|Overall Study||28
10853457|NCT02706873|12019728|FG001|Japan Sub-study|Overall Study||55
10853458|NCT02706873|12019729|FG002|Japan Sub-study|Overall Study||27
10853459|NCT02706873|12019730|FG003|Japan Sub-study|Overall Study||28
10853460|NCT02706873|12019727|FG000|COMPLETED|Overall Study||268
10853461|NCT02706873|12019728|FG001|COMPLETED|Overall Study||51
10853462|NCT02706873|12019729|FG002|COMPLETED|Overall Study||290
10853463|NCT02706873|12019730|FG003|COMPLETED|Overall Study||282
10293152|NCT01194219|11425832|FG004|Received Apremilast|Maintenance Phase Weeks16-32||0
10293153|NCT01194219|11425833|FG005|Received Apremilast|Maintenance Phase Weeks16-32||0
10293154|NCT01194219|11425834|FG006|Received Apremilast|Maintenance Phase Weeks16-32||0
10293155|NCT01194219|11425835|FG007|Received Apremilast|Maintenance Phase Weeks16-32||0
10293156|NCT01194219|11425836|FG008|Received Apremilast|Maintenance Phase Weeks16-32||0
10853464|NCT02706873|12019727|FG000|NOT COMPLETED|Overall Study||47
10853465|NCT02706873|12019728|FG001|NOT COMPLETED|Overall Study||4
10853466|NCT02706873|12019729|FG002|NOT COMPLETED|Overall Study||27
10853467|NCT02706873|12019730|FG003|NOT COMPLETED|Overall Study||33
10853468|NCT02591953|12019744|FG000|STARTED|Overall Study||12
10853469|NCT02591953|12019745|FG001|STARTED|Overall Study||10
10853470|NCT02591953|12019744|FG000|COMPLETED|Overall Study||6
10853471|NCT02591953|12019745|FG001|COMPLETED|Overall Study||4
10853472|NCT02591953|12019744|FG000|NOT COMPLETED|Overall Study||6
10853473|NCT02591953|12019745|FG001|NOT COMPLETED|Overall Study||6
10853474|NCT02509494|12019759|FG000|STARTED|Overall Study||43
10853475|NCT02509494|12019760|FG001|STARTED|Overall Study||298
10853476|NCT02509494|12019761|FG002|STARTED|Overall Study||102
10853477|NCT02509494|12019762|FG003|STARTED|Overall Study||143
10853478|NCT02509494|12019763|FG004|STARTED|Overall Study||48
10853479|NCT02509494|12019764|FG005|STARTED|Overall Study||144
10853480|NCT02509494|12019765|FG006|STARTED|Overall Study||48
10853481|NCT02509494|12019766|FG007|STARTED|Overall Study||144
10853482|NCT02509494|12019767|FG008|STARTED|Overall Study||48
10414604|NCT00785512|11558978|FG001|NOT COMPLETED|Overall Study||4
10414605|NCT00785538|11558989|FG000|STARTED|PK Period||7
10414609|NCT00785538|11558989|FG000|COMPLETED|PK Period||7
10414610|NCT00785538|11558990|FG001|COMPLETED|PK Period||1
10414611|NCT00785538|11558991|FG002|COMPLETED|PK Period||1
10414612|NCT00785538|11558992|FG003|COMPLETED|PK Period||0
10414613|NCT00785538|11558989|FG000|NOT COMPLETED|PK Period||0
10414614|NCT00785538|11558990|FG001|NOT COMPLETED|PK Period||0
10414615|NCT00785538|11558991|FG002|NOT COMPLETED|PK Period||0
10414616|NCT00785538|11558992|FG003|NOT COMPLETED|PK Period||0
10414617|NCT00785538|11558989|FG000|STARTED|Treatment Period||7
10414618|NCT00785538|11558990|FG001|STARTED|Treatment Period||9
10414619|NCT00785538|11558991|FG002|STARTED|Treatment Period||6
10853483|NCT02509494|12019759|FG000|COMPLETED|Overall Study||28
10853484|NCT02509494|12019760|FG001|COMPLETED|Overall Study||217
10853485|NCT02509494|12019761|FG002|COMPLETED|Overall Study||64
10853486|NCT02509494|12019762|FG003|COMPLETED|Overall Study||132
10853487|NCT02509494|12019763|FG004|COMPLETED|Overall Study||43
10853488|NCT02509494|12019764|FG005|COMPLETED|Overall Study||133
10853489|NCT02509494|12019765|FG006|COMPLETED|Overall Study||45
10853490|NCT02509494|12019766|FG007|COMPLETED|Overall Study||137
10853491|NCT02509494|12019767|FG008|COMPLETED|Overall Study||46
10853492|NCT02509494|12019759|FG000|NOT COMPLETED|Overall Study||15
10853493|NCT02509494|12019760|FG001|NOT COMPLETED|Overall Study||81
10853494|NCT02509494|12019761|FG002|NOT COMPLETED|Overall Study||38
10853495|NCT02509494|12019762|FG003|NOT COMPLETED|Overall Study||11
10853496|NCT02509494|12019763|FG004|NOT COMPLETED|Overall Study||5
10853497|NCT02509494|12019764|FG005|NOT COMPLETED|Overall Study||11
10853498|NCT02509494|12019765|FG006|NOT COMPLETED|Overall Study||3
10853499|NCT02509494|12019766|FG007|NOT COMPLETED|Overall Study||7
10853500|NCT02509494|12019767|FG008|NOT COMPLETED|Overall Study||2
10853501|NCT02420990|12019803|FG000|STARTED|Baseline||53
10853502|NCT02420990|12019804|FG001|STARTED|Baseline||92
10853503|NCT02420990|12019803|FG000|COMPLETED|Baseline||53
10853504|NCT02420990|12019804|FG001|COMPLETED|Baseline||92
10853505|NCT02420990|12019803|FG000|NOT COMPLETED|Baseline||0
10853506|NCT02420990|12019804|FG001|NOT COMPLETED|Baseline||0
10853507|NCT02420990|12019803|FG000|STARTED|3-Month Follow-up||53
10853508|NCT02420990|12019804|FG001|STARTED|3-Month Follow-up||92
10853509|NCT02420990|12019803|FG000|COMPLETED|3-Month Follow-up||53
10853510|NCT02420990|12019804|FG001|COMPLETED|3-Month Follow-up||92
10853511|NCT02420990|12019803|FG000|NOT COMPLETED|3-Month Follow-up||0
10853512|NCT02420990|12019804|FG001|NOT COMPLETED|3-Month Follow-up||0
10853513|NCT02420990|12019803|FG000|STARTED|6-Month Follow-up||53
10853514|NCT02420990|12019804|FG001|STARTED|6-Month Follow-up||92
10853515|NCT02420990|12019803|FG000|COMPLETED|6-Month Follow-up||53
10853516|NCT02420990|12019804|FG001|COMPLETED|6-Month Follow-up||92
10853517|NCT02420990|12019803|FG000|NOT COMPLETED|6-Month Follow-up||0
10853518|NCT02420990|12019804|FG001|NOT COMPLETED|6-Month Follow-up||0
10853519|NCT02420990|12019803|FG000|STARTED|12-Month Follow-up||53
10853520|NCT02420990|12019804|FG001|STARTED|12-Month Follow-up||92
10853521|NCT02420990|12019803|FG000|COMPLETED|12-Month Follow-up||53
10853522|NCT02420990|12019804|FG001|COMPLETED|12-Month Follow-up||92
10853523|NCT02420990|12019803|FG000|NOT COMPLETED|12-Month Follow-up||0
10853524|NCT02420990|12019804|FG001|NOT COMPLETED|12-Month Follow-up||0
10853525|NCT02151981|12019812|FG000|STARTED|Overall Study||279
10414620|NCT00785538|11558992|FG003|STARTED|Treatment Period||2
10414621|NCT00785538|11558989|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||7
10414622|NCT00785538|11558990|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||9
10414623|NCT00785538|11558991|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||6
10853526|NCT02151981|12019813|FG001|STARTED|Overall Study||140
10853527|NCT02151981|12019812|FG000|Received Randomised Treatment Only|Overall Study||279
10853528|NCT02151981|12019813|FG001|Received Randomised Treatment Only|Overall Study||136
10853529|NCT02151981|12019812|FG000|Did Not Receive Treatment|Overall Study||0
10853530|NCT02151981|12019813|FG001|Did Not Receive Treatment|Overall Study||4
10853531|NCT02151981|12019812|FG000|Crossed Over Osimertinib|Overall Study||0
10853532|NCT02151981|12019813|FG001|Crossed Over Osimertinib|Overall Study|Patients randomised to chemotherapy were allowed to crossover to Osimertinib after progression|99
10853533|NCT02151981|12019812|FG000|COMPLETED|Overall Study||0
10853534|NCT02151981|12019813|FG001|COMPLETED|Overall Study||0
10853535|NCT02151981|12019812|FG000|NOT COMPLETED|Overall Study||279
10853536|NCT02151981|12019813|FG001|NOT COMPLETED|Overall Study||140
10853537|NCT02087423|12019822|FG000|STARTED|Overall Study|Treated|111
10853538|NCT02087423|12019823|FG001|STARTED|Overall Study|Treated|265
10853539|NCT02087423|12019824|FG002|STARTED|Overall Study|Treated|68
10853540|NCT02087423|12019822|FG000|Completed 12 Months of Treatment|Overall Study||18
10853541|NCT02087423|12019823|FG001|Completed 12 Months of Treatment|Overall Study||60
10853542|NCT02087423|12019824|FG002|Completed 12 Months of Treatment|Overall Study||26
10853543|NCT02087423|12019822|FG000|COMPLETED|Overall Study||0
10853544|NCT02087423|12019823|FG001|COMPLETED|Overall Study||0
10853545|NCT02087423|12019824|FG002|COMPLETED|Overall Study||0
10853546|NCT02087423|12019822|FG000|NOT COMPLETED|Overall Study||111
10853547|NCT02087423|12019823|FG001|NOT COMPLETED|Overall Study||265
10853548|NCT02087423|12019824|FG002|NOT COMPLETED|Overall Study||68
10853557|NCT01874353|12019845|FG000|STARTED|Overall Study||196
10853558|NCT01874353|12019846|FG001|STARTED|Overall Study||99
10853559|NCT01874353|12019847|FG002|STARTED|Overall Study||22
10853560|NCT01874353|12019848|FG003|STARTED|Overall Study||10
10853561|NCT01874353|12019845|FG000|COMPLETED|Overall Study||69
10853562|NCT01874353|12019846|FG001|COMPLETED|Overall Study||26
10853563|NCT01874353|12019847|FG002|COMPLETED|Overall Study||7
10853564|NCT01874353|12019848|FG003|COMPLETED|Overall Study||3
10853565|NCT01874353|12019845|FG000|NOT COMPLETED|Overall Study||127
10853566|NCT01874353|12019846|FG001|NOT COMPLETED|Overall Study||73
10853567|NCT01874353|12019847|FG002|NOT COMPLETED|Overall Study||15
10853568|NCT01874353|12019848|FG003|NOT COMPLETED|Overall Study||7
10853569|NCT01773395|12019862|FG000|STARTED|Overall Study||64
10853570|NCT01773395|12019863|FG001|STARTED|Overall Study||59
10853571|NCT01773395|12019862|FG000|COMPLETED|Overall Study||30
10853572|NCT01773395|12019863|FG001|COMPLETED|Overall Study||27
10853573|NCT01773395|12019862|FG000|NOT COMPLETED|Overall Study||34
10853574|NCT01773395|12019863|FG001|NOT COMPLETED|Overall Study||32
10414624|NCT00785538|11558992|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||2
10414625|NCT00785538|11558989|FG000|COMPLETED|Treatment Period||6
10414626|NCT00785538|11558990|FG001|COMPLETED|Treatment Period||7
10414627|NCT00785538|11558991|FG002|COMPLETED|Treatment Period||4
10414628|NCT00785538|11558992|FG003|COMPLETED|Treatment Period||1
10414629|NCT00785538|11558989|FG000|NOT COMPLETED|Treatment Period||1
10414630|NCT00785538|11558990|FG001|NOT COMPLETED|Treatment Period||2
10414631|NCT00785538|11558991|FG002|NOT COMPLETED|Treatment Period||2
10414632|NCT00785538|11558992|FG003|NOT COMPLETED|Treatment Period||1
10414633|NCT00785577|11559008|FG000|STARTED|Study Period 2: Therapy Phase||89
10853619|NCT00614432|12019923|FG000|STARTED|Overall Study||4
10853620|NCT00614432|12019924|FG001|STARTED|Overall Study||6
10853621|NCT00614432|12019923|FG000|COMPLETED|Overall Study||4
10853622|NCT00614432|12019924|FG001|COMPLETED|Overall Study||6
10853623|NCT00614432|12019923|FG000|NOT COMPLETED|Overall Study||0
10853624|NCT00614432|12019924|FG001|NOT COMPLETED|Overall Study||0
10853625|NCT02849626|12019932|FG000|STARTED|Core Phase (up to 23 Weeks)||149
10853626|NCT02849626|12019933|FG001|STARTED|Core Phase (up to 23 Weeks)||31
10853627|NCT02849626|12019932|FG000|COMPLETED|Core Phase (up to 23 Weeks)||122
10853628|NCT02849626|12019933|FG001|COMPLETED|Core Phase (up to 23 Weeks)||24
10853629|NCT02849626|12019932|FG000|NOT COMPLETED|Core Phase (up to 23 Weeks)||27
10853630|NCT02849626|12019933|FG001|NOT COMPLETED|Core Phase (up to 23 Weeks)||7
10853631|NCT02849626|12019932|FG000|STARTED|Extension Phase A (up to 29 Weeks)||116
10853632|NCT02849626|12019933|FG001|STARTED|Extension Phase A (up to 29 Weeks)||20
10853633|NCT02849626|12019932|FG000|COMPLETED|Extension Phase A (up to 29 Weeks)||105
10853634|NCT02849626|12019933|FG001|COMPLETED|Extension Phase A (up to 29 Weeks)||17
10853635|NCT02849626|12019932|FG000|NOT COMPLETED|Extension Phase A (up to 29 Weeks)||11
10853636|NCT02849626|12019933|FG001|NOT COMPLETED|Extension Phase A (up to 29 Weeks)||3
10853637|NCT02654132|12019951|FG000|STARTED|Overall Study||60
10853638|NCT02654132|12019952|FG001|STARTED|Overall Study||57
10853639|NCT02654132|12019951|FG000|COMPLETED|Overall Study||24
10853640|NCT02654132|12019952|FG001|COMPLETED|Overall Study||11
10853641|NCT02654132|12019951|FG000|NOT COMPLETED|Overall Study||36
10853642|NCT02654132|12019952|FG001|NOT COMPLETED|Overall Study||46
10853649|NCT02600923|12019968|FG000|STARTED|Overall Study||131
10853650|NCT02600923|12019968|FG000|Treated|Overall Study||130
10853651|NCT02600923|12019968|FG000|COMPLETED|Overall Study||0
10853652|NCT02600923|12019968|FG000|NOT COMPLETED|Overall Study||131
10853653|NCT02597790|12019974|FG000|STARTED|Overall Study||45
10853654|NCT02597790|12019975|FG001|STARTED|Overall Study||41
10853655|NCT02597790|12019974|FG000|COMPLETED|Overall Study||36
10853656|NCT02597790|12019975|FG001|COMPLETED|Overall Study||29
10853657|NCT02597790|12019974|FG000|NOT COMPLETED|Overall Study||9
10853658|NCT02597790|12019975|FG001|NOT COMPLETED|Overall Study||12
10853659|NCT02484664|12019986|FG000|STARTED|Overall Study||12
10853660|NCT02484664|12019986|FG000|COMPLETED|Overall Study||9
10853661|NCT02484664|12019986|FG000|NOT COMPLETED|Overall Study||3
10853662|NCT02412735|12019993|FG000|STARTED|Overall Study||143
10853663|NCT02412735|12019994|FG001|STARTED|Overall Study||129
10853664|NCT02412735|12019995|FG002|STARTED|Overall Study||132
10853665|NCT02412735|12019993|FG000|Received Treatment|Overall Study||140
10853666|NCT02412735|12019994|FG001|Received Treatment|Overall Study||128
10853667|NCT02412735|12019995|FG002|Received Treatment|Overall Study||130
10853668|NCT02412735|12019993|FG000|COMPLETED|Overall Study||97
10853669|NCT02412735|12019994|FG001|COMPLETED|Overall Study||85
10853670|NCT02412735|12019995|FG002|COMPLETED|Overall Study||86
10853671|NCT02412735|12019993|FG000|NOT COMPLETED|Overall Study||46
10853672|NCT02412735|12019994|FG001|NOT COMPLETED|Overall Study||44
10853673|NCT02412735|12019995|FG002|NOT COMPLETED|Overall Study||46
10853674|NCT02371889|12020005|FG000|STARTED|Overall Study||85
10853675|NCT02371889|12020006|FG001|STARTED|Overall Study||85
10853676|NCT02371889|12020005|FG000|COMPLETED|Overall Study||66
10853677|NCT02371889|12020006|FG001|COMPLETED|Overall Study||71
10853678|NCT02371889|12020005|FG000|NOT COMPLETED|Overall Study||19
10853679|NCT02371889|12020006|FG001|NOT COMPLETED|Overall Study||14
10853680|NCT02121158|12020018|FG000|STARTED|Overall Study||85
10853681|NCT02121158|12020019|FG001|STARTED|Overall Study||82
10853682|NCT02121158|12020018|FG000|COMPLETED|Overall Study||85
10853683|NCT02121158|12020019|FG001|COMPLETED|Overall Study||82
10853684|NCT02121158|12020018|FG000|NOT COMPLETED|Overall Study||0
10853685|NCT02121158|12020019|FG001|NOT COMPLETED|Overall Study||0
10853686|NCT02100722|12020027|FG000|STARTED|Overall Study||757
10853687|NCT02100722|12020028|FG001|STARTED|Overall Study||743
10853688|NCT02100722|12020027|FG000|Underwent Alternate Procedure|Overall Study||11
10853689|NCT02100722|12020028|FG001|Underwent Alternate Procedure|Overall Study||37
10853690|NCT02100722|12020027|FG000|COMPLETED|Overall Study||0
10853691|NCT02100722|12020028|FG001|COMPLETED|Overall Study||0
10853692|NCT02100722|12020027|FG000|NOT COMPLETED|Overall Study||757
10853693|NCT02100722|12020028|FG001|NOT COMPLETED|Overall Study||743
10853694|NCT02046096|12020037|FG000|STARTED|Overall Study||149
10853695|NCT02046096|12020038|FG001|STARTED|Overall Study||324
10853696|NCT02046096|12020037|FG000|COMPLETED|Overall Study||105
10853697|NCT02046096|12020038|FG001|COMPLETED|Overall Study||223
10853698|NCT02046096|12020037|FG000|NOT COMPLETED|Overall Study||44
10853699|NCT02046096|12020038|FG001|NOT COMPLETED|Overall Study||101
10853700|NCT01945775|12020048|FG000|STARTED|Overall Study||287
10853701|NCT01945775|12020049|FG001|STARTED|Overall Study||144
10853702|NCT01945775|12020048|FG000|Treated|Overall Study||286
10853703|NCT01945775|12020049|FG001|Treated|Overall Study||126
10853704|NCT01945775|12020048|FG000|COMPLETED|Overall Study||0
10853705|NCT01945775|12020049|FG001|COMPLETED|Overall Study||0
10853706|NCT01945775|12020048|FG000|NOT COMPLETED|Overall Study||287
10853707|NCT01945775|12020049|FG001|NOT COMPLETED|Overall Study||144
10853708|NCT01781637|12020057|FG000|STARTED|Overall Study||28
10853709|NCT01781637|12020058|FG001|STARTED|Overall Study||8
10853710|NCT01781637|12020057|FG000|COMPLETED|Overall Study||24
10853711|NCT01781637|12020058|FG001|COMPLETED|Overall Study||2
10853712|NCT01781637|12020057|FG000|NOT COMPLETED|Overall Study||4
10853713|NCT01781637|12020058|FG001|NOT COMPLETED|Overall Study||6
10853714|NCT01670539|12020064|FG000|STARTED|Overall Study||26
10853715|NCT01670539|12020065|FG001|STARTED|Overall Study||21
10853716|NCT01670539|12020064|FG000|COMPLETED|Overall Study||20
10853717|NCT01670539|12020065|FG001|COMPLETED|Overall Study||16
10853718|NCT01670539|12020064|FG000|NOT COMPLETED|Overall Study||6
10853719|NCT01670539|12020065|FG001|NOT COMPLETED|Overall Study||5
10853720|NCT00407602|12020072|FG000|STARTED|Overall Study||30
10853721|NCT00407602|12020072|FG000|COMPLETED|Overall Study||23
10853722|NCT00407602|12020072|FG000|NOT COMPLETED|Overall Study||7
10853723|NCT05143541|12020079|FG000|STARTED|Overall Study||80
10853724|NCT05143541|12020079|FG000|COMPLETED|Overall Study||80
10853725|NCT05143541|12020079|FG000|NOT COMPLETED|Overall Study||0
10853726|NCT04685213|12020085|FG000|STARTED|Overall Study||9
10853727|NCT04685213|12020086|FG001|STARTED|Overall Study||10
10853728|NCT04685213|12020085|FG000|COMPLETED|Overall Study||8
10853729|NCT04685213|12020086|FG001|COMPLETED|Overall Study||7
10853730|NCT04685213|12020085|FG000|NOT COMPLETED|Overall Study||1
10853731|NCT04685213|12020086|FG001|NOT COMPLETED|Overall Study||3
10853732|NCT04567186|12020092|FG000|STARTED|Period 1||38
10853733|NCT04567186|12020093|FG001|STARTED|Period 1||40
10853734|NCT04567186|12020092|FG000|COMPLETED|Period 1||37
10853735|NCT04567186|12020093|FG001|COMPLETED|Period 1||37
10853736|NCT04567186|12020092|FG000|NOT COMPLETED|Period 1||1
10853737|NCT04567186|12020093|FG001|NOT COMPLETED|Period 1||3
10853738|NCT04567186|12020092|FG000|STARTED|Period 2||37
10853739|NCT04567186|12020093|FG001|STARTED|Period 2||37
10293157|NCT01194219|11425837|FG009|Received Apremilast|Maintenance Phase Weeks16-32||0
10293158|NCT01194219|11425828|FG000|COMPLETED|Maintenance Phase Weeks16-32||0
10293159|NCT01194219|11425829|FG001|COMPLETED|Maintenance Phase Weeks16-32||0
10293160|NCT01194219|11425830|FG002|COMPLETED|Maintenance Phase Weeks16-32||424
10293161|NCT01194219|11425831|FG003|COMPLETED|Maintenance Phase Weeks16-32||215
10293162|NCT01194219|11425832|FG004|COMPLETED|Maintenance Phase Weeks16-32||0
10293163|NCT01194219|11425833|FG005|COMPLETED|Maintenance Phase Weeks16-32||0
10293164|NCT01194219|11425834|FG006|COMPLETED|Maintenance Phase Weeks16-32||0
10293165|NCT01194219|11425835|FG007|COMPLETED|Maintenance Phase Weeks16-32||0
10293166|NCT01194219|11425836|FG008|COMPLETED|Maintenance Phase Weeks16-32||0
10293167|NCT01194219|11425837|FG009|COMPLETED|Maintenance Phase Weeks16-32||0
10293168|NCT01194219|11425828|FG000|NOT COMPLETED|Maintenance Phase Weeks16-32||0
10293169|NCT01194219|11425829|FG001|NOT COMPLETED|Maintenance Phase Weeks16-32||0
10293170|NCT01194219|11425830|FG002|NOT COMPLETED|Maintenance Phase Weeks16-32||70
10293171|NCT01194219|11425831|FG003|NOT COMPLETED|Maintenance Phase Weeks16-32||30
10293172|NCT01194219|11425832|FG004|NOT COMPLETED|Maintenance Phase Weeks16-32||0
10293173|NCT01194219|11425833|FG005|NOT COMPLETED|Maintenance Phase Weeks16-32||0
10293174|NCT01194219|11425834|FG006|NOT COMPLETED|Maintenance Phase Weeks16-32||0
10293175|NCT01194219|11425835|FG007|NOT COMPLETED|Maintenance Phase Weeks16-32||0
10293176|NCT01194219|11425836|FG008|NOT COMPLETED|Maintenance Phase Weeks16-32||0
10293177|NCT01194219|11425837|FG009|NOT COMPLETED|Maintenance Phase Weeks16-32||0
10293178|NCT01194219|11425828|FG000|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
10293179|NCT01194219|11425829|FG001|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
10293180|NCT01194219|11425830|FG002|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
10293181|NCT01194219|11425831|FG003|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
10293182|NCT01194219|11425832|FG004|STARTED|Randomized Withdrawal Phase-Weeks 32-52|7 participants discontinued after week 32 but prior to entry into the Randomized withdrawal Phase|77
10314489|NCT00163215|11448128|FG000|NOT COMPLETED|Overall Study||15
10314490|NCT00163293|11448135|FG000|STARTED|Overall Study||79
10314491|NCT00163293|11448136|FG001|STARTED|Overall Study||76
10314492|NCT00163293|11448137|FG002|STARTED|Overall Study||85
10314493|NCT00163293|11448135|FG000|COMPLETED|Overall Study||66
10314494|NCT00163293|11448136|FG001|COMPLETED|Overall Study||69
10314495|NCT00163293|11448137|FG002|COMPLETED|Overall Study||66
10314496|NCT00163293|11448135|FG000|NOT COMPLETED|Overall Study||13
10314497|NCT00163293|11448136|FG001|NOT COMPLETED|Overall Study||7
10414634|NCT00785577|11559009|FG001|STARTED|Study Period 2: Therapy Phase||45
10414635|NCT00785577|11559010|FG002|STARTED|Study Period 2: Therapy Phase||43
10414636|NCT00785577|11559011|FG003|STARTED|Study Period 2: Therapy Phase||49
10414637|NCT00785577|11559012|FG004|STARTED|Study Period 2: Therapy Phase||47
10414638|NCT00785577|11559008|FG000|COMPLETED|Study Period 2: Therapy Phase||78
10414639|NCT00785577|11559009|FG001|COMPLETED|Study Period 2: Therapy Phase||36
10414640|NCT00785577|11559010|FG002|COMPLETED|Study Period 2: Therapy Phase||25
10414641|NCT00785577|11559011|FG003|COMPLETED|Study Period 2: Therapy Phase||36
10414642|NCT00785577|11559012|FG004|COMPLETED|Study Period 2: Therapy Phase||27
10414643|NCT00785577|11559008|FG000|NOT COMPLETED|Study Period 2: Therapy Phase||11
10414644|NCT00785577|11559009|FG001|NOT COMPLETED|Study Period 2: Therapy Phase||9
10414645|NCT00785577|11559010|FG002|NOT COMPLETED|Study Period 2: Therapy Phase||18
10414646|NCT00785577|11559011|FG003|NOT COMPLETED|Study Period 2: Therapy Phase||13
10414647|NCT00785577|11559012|FG004|NOT COMPLETED|Study Period 2: Therapy Phase||20
10414648|NCT00785577|11559008|FG000|STARTED|Study Period 3: 1-Week Washout Phase||78
10414649|NCT00785577|11559009|FG001|STARTED|Study Period 3: 1-Week Washout Phase||36
10414650|NCT00785577|11559010|FG002|STARTED|Study Period 3: 1-Week Washout Phase||25
10414651|NCT00785577|11559011|FG003|STARTED|Study Period 3: 1-Week Washout Phase||36
10414652|NCT00785577|11559012|FG004|STARTED|Study Period 3: 1-Week Washout Phase||27
10414653|NCT00785577|11559008|FG000|COMPLETED|Study Period 3: 1-Week Washout Phase||78
10414654|NCT00785577|11559009|FG001|COMPLETED|Study Period 3: 1-Week Washout Phase||36
10414655|NCT00785577|11559010|FG002|COMPLETED|Study Period 3: 1-Week Washout Phase||25
10853740|NCT04567186|12020092|FG000|COMPLETED|Period 2||37
10853741|NCT04567186|12020093|FG001|COMPLETED|Period 2||34
10853742|NCT04567186|12020092|FG000|NOT COMPLETED|Period 2||0
10853743|NCT04567186|12020093|FG001|NOT COMPLETED|Period 2||3
10853744|NCT04567186|12020092|FG000|STARTED|Period 3||37
10853745|NCT04567186|12020093|FG001|STARTED|Period 3||34
10853746|NCT04567186|12020092|FG000|COMPLETED|Period 3||36
10314498|NCT00163293|11448137|FG002|NOT COMPLETED|Overall Study||19
10314499|NCT00163657|11448148|FG000|STARTED|Overall Study||80
10853747|NCT04567186|12020093|FG001|COMPLETED|Period 3||34
10853748|NCT04567186|12020092|FG000|NOT COMPLETED|Period 3||1
10853749|NCT04567186|12020093|FG001|NOT COMPLETED|Period 3||0
10853750|NCT04065074|12020099|FG000|STARTED|Overall Study||16
10853751|NCT04065074|12020099|FG000|COMPLETED|Overall Study||14
10853752|NCT04065074|12020099|FG000|NOT COMPLETED|Overall Study||2
10853753|NCT03980730|12020105|FG000|STARTED|Overall Study||21
10853754|NCT03980730|12020106|FG001|STARTED|Overall Study||22
10853755|NCT03980730|12020105|FG000|COMPLETED|Overall Study||19
10853756|NCT03980730|12020106|FG001|COMPLETED|Overall Study||18
10853757|NCT03980730|12020105|FG000|NOT COMPLETED|Overall Study||2
10853758|NCT03980730|12020106|FG001|NOT COMPLETED|Overall Study||4
10853759|NCT03793010|12020114|FG000|STARTED|Overall Study||35
10853760|NCT03793010|12020115|FG001|STARTED|Overall Study||35
10853761|NCT03793010|12020114|FG000|Randomized But Not Dosed|Overall Study||2
10853762|NCT03793010|12020115|FG001|Randomized But Not Dosed|Overall Study||0
10853763|NCT03793010|12020114|FG000|COMPLETED|Overall Study||7
10853764|NCT03793010|12020115|FG001|COMPLETED|Overall Study||8
10853765|NCT03793010|12020114|FG000|NOT COMPLETED|Overall Study||28
10853766|NCT03793010|12020115|FG001|NOT COMPLETED|Overall Study||27
10853767|NCT03644017|12020121|FG000|STARTED|Overall Study||46
10853768|NCT03644017|12020121|FG000|COMPLETED|Overall Study||39
10853769|NCT03644017|12020121|FG000|NOT COMPLETED|Overall Study||7
10853770|NCT03592186|12020127|FG000|STARTED|Overall Study||60
10853771|NCT03592186|12020128|FG001|STARTED|Overall Study||62
10853772|NCT03592186|12020127|FG000|6-week Follow-up|Overall Study||49
10853773|NCT03592186|12020128|FG001|6-week Follow-up|Overall Study||56
10853774|NCT03592186|12020127|FG000|12-week Follow-up|Overall Study||47
10853775|NCT03592186|12020128|FG001|12-week Follow-up|Overall Study||51
10853776|NCT03592186|12020127|FG000|COMPLETED|Overall Study||43
10853777|NCT03592186|12020128|FG001|COMPLETED|Overall Study||51
10853778|NCT03592186|12020127|FG000|NOT COMPLETED|Overall Study||17
10853779|NCT03592186|12020128|FG001|NOT COMPLETED|Overall Study||11
10853780|NCT03529942|12020134|FG000|STARTED|Overall Study||129
10853781|NCT03529942|12020134|FG000|Reached Week 6 With Paired MRI|Overall Study||108
10853782|NCT03529942|12020134|FG000|COMPLETED|Overall Study||106
10853783|NCT03529942|12020134|FG000|NOT COMPLETED|Overall Study||23
10853784|NCT03349775|12020143|FG000|STARTED|Overall Study||10
10853785|NCT03349775|12020144|FG001|STARTED|Overall Study||11
10853786|NCT03349775|12020143|FG000|COMPLETED|Overall Study||8
10853787|NCT03349775|12020144|FG001|COMPLETED|Overall Study||7
10853788|NCT03349775|12020143|FG000|NOT COMPLETED|Overall Study||2
10853789|NCT03349775|12020144|FG001|NOT COMPLETED|Overall Study||4
10853790|NCT03292471|12020152|FG000|STARTED|Overall Study||8
10853791|NCT03292471|12020153|FG001|STARTED|Overall Study||8
10853792|NCT03292471|12020152|FG000|COMPLETED|Overall Study||8
10853793|NCT03292471|12020153|FG001|COMPLETED|Overall Study||8
10853794|NCT03292471|12020152|FG000|NOT COMPLETED|Overall Study||0
10853795|NCT03292471|12020153|FG001|NOT COMPLETED|Overall Study||0
10853796|NCT03256344|12020161|FG000|STARTED|Overall Study||11
10853797|NCT03256344|12020162|FG001|STARTED|Overall Study||25
10853798|NCT03256344|12020161|FG000|Received Talimogene Laherparepvec|Overall Study||8
10853799|NCT03256344|12020162|FG001|Received Talimogene Laherparepvec|Overall Study||23
10853800|NCT03256344|12020161|FG000|Received Atezolizumab|Overall Study||10
10853801|NCT03256344|12020162|FG001|Received Atezolizumab|Overall Study||24
10853802|NCT03256344|12020161|FG000|COMPLETED|Overall Study||0
10853803|NCT03256344|12020162|FG001|COMPLETED|Overall Study||0
10853804|NCT03256344|12020161|FG000|NOT COMPLETED|Overall Study||11
10853805|NCT03256344|12020162|FG001|NOT COMPLETED|Overall Study||25
10853806|NCT03207815|12020170|FG000|STARTED|Overall Study||38
10853807|NCT03207815|12020171|FG001|STARTED|Overall Study||36
10853808|NCT03207815|12020170|FG000|COMPLETED|Overall Study||30
10853809|NCT03207815|12020171|FG001|COMPLETED|Overall Study||29
10853810|NCT03207815|12020170|FG000|NOT COMPLETED|Overall Study||8
10853811|NCT03207815|12020171|FG001|NOT COMPLETED|Overall Study||7
10853812|NCT03077737|12020179|FG000|STARTED|Week 6 (10 Weeks After Enrollment)||97
10853813|NCT03077737|12020180|FG001|STARTED|Week 6 (10 Weeks After Enrollment)||93
10853814|NCT03077737|12020179|FG000|COMPLETED|Week 6 (10 Weeks After Enrollment)||89
10853815|NCT03077737|12020180|FG001|COMPLETED|Week 6 (10 Weeks After Enrollment)||79
10414656|NCT00785577|11559011|FG003|COMPLETED|Study Period 3: 1-Week Washout Phase||35
10414657|NCT00785577|11559012|FG004|COMPLETED|Study Period 3: 1-Week Washout Phase||26
10414658|NCT00785577|11559008|FG000|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
10414659|NCT00785577|11559009|FG001|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
10414660|NCT00785577|11559010|FG002|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
10414661|NCT00785577|11559011|FG003|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
10414662|NCT00785577|11559012|FG004|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
10414663|NCT00785629|11559038|FG000|STARTED|Overall Study||30
10414664|NCT00785629|11559039|FG001|STARTED|Overall Study||30
10414665|NCT00785629|11559040|FG002|STARTED|Overall Study||28
10414666|NCT00785629|11559041|FG003|STARTED|Overall Study||57
10414667|NCT00785629|11559038|FG000|COMPLETED|Overall Study|8 not completed|22
10414668|NCT00785629|11559039|FG001|COMPLETED|Overall Study|5 not completed|25
10414669|NCT00785629|11559040|FG002|COMPLETED|Overall Study|10 not completed|18
10414670|NCT00785629|11559041|FG003|COMPLETED|Overall Study|16 not completed|41
10414671|NCT00785629|11559038|FG000|NOT COMPLETED|Overall Study||8
10414672|NCT00785629|11559039|FG001|NOT COMPLETED|Overall Study||5
10853816|NCT03077737|12020179|FG000|NOT COMPLETED|Week 6 (10 Weeks After Enrollment)||8
10853817|NCT03077737|12020180|FG001|NOT COMPLETED|Week 6 (10 Weeks After Enrollment)||14
10853818|NCT03077737|12020179|FG000|STARTED|Week 14 (18 Weeks After Enrollment)||97
10853819|NCT03077737|12020180|FG001|STARTED|Week 14 (18 Weeks After Enrollment)||93
10853820|NCT03077737|12020179|FG000|COMPLETED|Week 14 (18 Weeks After Enrollment)||83
10853821|NCT03077737|12020180|FG001|COMPLETED|Week 14 (18 Weeks After Enrollment)||76
10853822|NCT03077737|12020179|FG000|NOT COMPLETED|Week 14 (18 Weeks After Enrollment)||14
10853823|NCT03077737|12020180|FG001|NOT COMPLETED|Week 14 (18 Weeks After Enrollment)||17
10853824|NCT03077737|12020179|FG000|STARTED|Week 28 (32 Weeks After Enrollment)||49
10853825|NCT03077737|12020180|FG001|STARTED|Week 28 (32 Weeks After Enrollment)||47
10853826|NCT03077737|12020179|FG000|COMPLETED|Week 28 (32 Weeks After Enrollment)||39
10853827|NCT03077737|12020180|FG001|COMPLETED|Week 28 (32 Weeks After Enrollment)||40
10853828|NCT03077737|12020179|FG000|NOT COMPLETED|Week 28 (32 Weeks After Enrollment)||10
10853829|NCT03077737|12020180|FG001|NOT COMPLETED|Week 28 (32 Weeks After Enrollment)||7
10853830|NCT02991937|12020188|FG000|STARTED|Overall Study||20
10853831|NCT02991937|12020189|FG001|STARTED|Overall Study||19
10853832|NCT02991937|12020188|FG000|COMPLETED|Overall Study||20
10853833|NCT02991937|12020189|FG001|COMPLETED|Overall Study||19
10853834|NCT02991937|12020188|FG000|NOT COMPLETED|Overall Study||0
10853835|NCT02991937|12020189|FG001|NOT COMPLETED|Overall Study||0
10853836|NCT02968563|12020197|FG000|STARTED|Overall Study||5
10853837|NCT02968563|12020198|FG001|STARTED|Overall Study||30
10853838|NCT02968563|12020197|FG000|COMPLETED|Overall Study||4
10414673|NCT00785629|11559040|FG002|NOT COMPLETED|Overall Study||10
10414674|NCT00785629|11559041|FG003|NOT COMPLETED|Overall Study||16
10429267|NCT00862849|11575291|FG005|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
10429268|NCT00862849|11575286|FG000|STARTED|Intervention 6||3
10429269|NCT00862849|11575287|FG001|STARTED|Intervention 6||3
10429270|NCT00862849|11575288|FG002|STARTED|Intervention 6||3
10429271|NCT00862849|11575289|FG003|STARTED|Intervention 6||4
10429272|NCT00862849|11575290|FG004|STARTED|Intervention 6||4
10429273|NCT00862849|11575291|FG005|STARTED|Intervention 6||3
10429274|NCT00862849|11575286|FG000|COMPLETED|Intervention 6||3
10429275|NCT00862849|11575287|FG001|COMPLETED|Intervention 6||3
10429276|NCT00862849|11575288|FG002|COMPLETED|Intervention 6||3
10429277|NCT00862849|11575289|FG003|COMPLETED|Intervention 6||4
10429278|NCT00862849|11575290|FG004|COMPLETED|Intervention 6||4
10429279|NCT00862849|11575291|FG005|COMPLETED|Intervention 6||3
10429280|NCT00862849|11575286|FG000|NOT COMPLETED|Intervention 6||0
10429281|NCT00862849|11575287|FG001|NOT COMPLETED|Intervention 6||0
10429282|NCT00862849|11575288|FG002|NOT COMPLETED|Intervention 6||0
10429283|NCT00862849|11575289|FG003|NOT COMPLETED|Intervention 6||0
10429284|NCT00862849|11575290|FG004|NOT COMPLETED|Intervention 6||0
10429285|NCT00862849|11575291|FG005|NOT COMPLETED|Intervention 6||0
10429286|NCT00862940|11575301|FG000|STARTED|Overall Study||133
10429287|NCT00862940|11575302|FG001|STARTED|Overall Study||144
10429288|NCT00862940|11575301|FG000|COMPLETED|Overall Study||103
10429289|NCT00862940|11575302|FG001|COMPLETED|Overall Study||114
10429290|NCT00862940|11575301|FG000|NOT COMPLETED|Overall Study||30
10429291|NCT00862940|11575302|FG001|NOT COMPLETED|Overall Study||30
10429292|NCT00862979|11575310|FG000|STARTED|Overall Study||84
10429293|NCT00862979|11575311|FG001|STARTED|Overall Study||78
10429294|NCT00862979|11575310|FG000|Full Analysis Set (FAS)|Overall Study||74
10429295|NCT00862979|11575311|FG001|Full Analysis Set (FAS)|Overall Study||71
10429296|NCT00862979|11575310|FG000|COMPLETED|Overall Study||76
10429297|NCT00862979|11575311|FG001|COMPLETED|Overall Study||71
10429298|NCT00862979|11575310|FG000|NOT COMPLETED|Overall Study||8
10429299|NCT00862979|11575311|FG001|NOT COMPLETED|Overall Study||7
10429300|NCT00862992|11575320|FG000|STARTED|Overall Study||12
10429301|NCT00862992|11575321|FG001|STARTED|Overall Study||10
10429302|NCT00862992|11575322|FG002|STARTED|Overall Study||12
10429303|NCT00862992|11575320|FG000|COMPLETED|Overall Study||9
10429304|NCT00862992|11575321|FG001|COMPLETED|Overall Study||9
10429305|NCT00862992|11575322|FG002|COMPLETED|Overall Study||9
10429306|NCT00862992|11575320|FG000|NOT COMPLETED|Overall Study||3
10429307|NCT00862992|11575321|FG001|NOT COMPLETED|Overall Study||1
10429308|NCT00862992|11575322|FG002|NOT COMPLETED|Overall Study||3
10429309|NCT00863057|11575334|FG000|STARTED|Milestones Period 1 (Weeks 0-5)||4
10429310|NCT00863057|11575335|FG001|STARTED|Milestones Period 1 (Weeks 0-5)||4
10429311|NCT00863057|11575336|FG002|STARTED|Milestones Period 1 (Weeks 0-5)||3
10429312|NCT00863057|11575337|FG003|STARTED|Milestones Period 1 (Weeks 0-5)||4
10429313|NCT00863057|11575334|FG000|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
10429314|NCT00863057|11575335|FG001|COMPLETED|Milestones Period 1 (Weeks 0-5)||2
10429315|NCT00863057|11575336|FG002|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
10429316|NCT00863057|11575337|FG003|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
10429317|NCT00863057|11575334|FG000|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||1
10429318|NCT00863057|11575335|FG001|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||2
10429319|NCT00863057|11575336|FG002|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||0
10429320|NCT00863057|11575337|FG003|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||1
10429321|NCT00863057|11575334|FG000|STARTED|Period 2 (Weeks 6-10)||3
10429322|NCT00863057|11575335|FG001|STARTED|Period 2 (Weeks 6-10)||2
10429323|NCT00863057|11575336|FG002|STARTED|Period 2 (Weeks 6-10)||3
10429324|NCT00863057|11575337|FG003|STARTED|Period 2 (Weeks 6-10)||3
10429325|NCT00863057|11575334|FG000|COMPLETED|Period 2 (Weeks 6-10)||3
10429326|NCT00863057|11575335|FG001|COMPLETED|Period 2 (Weeks 6-10)||1
10429327|NCT00863057|11575336|FG002|COMPLETED|Period 2 (Weeks 6-10)||2
10429328|NCT00863057|11575337|FG003|COMPLETED|Period 2 (Weeks 6-10)||2
10429329|NCT00863057|11575334|FG000|NOT COMPLETED|Period 2 (Weeks 6-10)||0
10429330|NCT00863057|11575335|FG001|NOT COMPLETED|Period 2 (Weeks 6-10)||1
10429331|NCT00863057|11575336|FG002|NOT COMPLETED|Period 2 (Weeks 6-10)||1
10429332|NCT00863057|11575337|FG003|NOT COMPLETED|Period 2 (Weeks 6-10)||1
10429333|NCT00863057|11575334|FG000|STARTED|Period 3 (Weeks 11-15)||3
10429334|NCT00863057|11575335|FG001|STARTED|Period 3 (Weeks 11-15)||1
10429335|NCT00863057|11575336|FG002|STARTED|Period 3 (Weeks 11-15)||2
10429336|NCT00863057|11575337|FG003|STARTED|Period 3 (Weeks 11-15)||2
10429337|NCT00863057|11575334|FG000|COMPLETED|Period 3 (Weeks 11-15)||3
10853839|NCT02968563|12020198|FG001|COMPLETED|Overall Study||22
10853840|NCT02968563|12020197|FG000|NOT COMPLETED|Overall Study||1
10853841|NCT02968563|12020198|FG001|NOT COMPLETED|Overall Study||8
10853842|NCT02915783|12020204|FG000|STARTED|Overall Study||31
10853843|NCT02915783|12020204|FG000|COMPLETED|Overall Study||17
10853844|NCT02915783|12020204|FG000|NOT COMPLETED|Overall Study||14
10853845|NCT02913482|12020211|FG000|STARTED|Overall Study||4
10853846|NCT02913482|12020212|FG001|STARTED|Overall Study||17
10853847|NCT02913482|12020213|FG002|STARTED|Overall Study||41
10853848|NCT02913482|12020211|FG000|COMPLETED|Overall Study|Participants remaining in the study at CCOD of 12 Nov 2020|3
10853849|NCT02913482|12020212|FG001|COMPLETED|Overall Study|Participants remaining in the study at CCOD of 12 Nov 2020|14
10853850|NCT02913482|12020213|FG002|COMPLETED|Overall Study|Participants remaining in the study at CCOD of 12 Nov 2020|38
10853851|NCT02913482|12020211|FG000|NOT COMPLETED|Overall Study||1
10853852|NCT02913482|12020212|FG001|NOT COMPLETED|Overall Study||3
10853853|NCT02913482|12020213|FG002|NOT COMPLETED|Overall Study||3
10853854|NCT02787044|12020225|FG000|STARTED|Overall Study||2630
10853855|NCT02787044|12020226|FG001|STARTED|Overall Study||2630
10853856|NCT02787044|12020225|FG000|COMPLETED|Overall Study||2615
10853857|NCT02787044|12020226|FG001|COMPLETED|Overall Study||2611
10853858|NCT02787044|12020225|FG000|NOT COMPLETED|Overall Study||15
10853859|NCT02787044|12020226|FG001|NOT COMPLETED|Overall Study||19
10853860|NCT02698163|12020238|FG000|STARTED|Overall Study||1
10853861|NCT02698163|12020239|FG001|STARTED|Overall Study||3
10853862|NCT02698163|12020238|FG000|COMPLETED|Overall Study||1
10853863|NCT02698163|12020239|FG001|COMPLETED|Overall Study||2
10853864|NCT02698163|12020238|FG000|NOT COMPLETED|Overall Study||0
10414675|NCT00785707|11559049|FG000|STARTED|Overall Study||31
10414676|NCT00785707|11559049|FG000|COMPLETED|Overall Study||24
10414677|NCT00785707|11559049|FG000|NOT COMPLETED|Overall Study||7
10414678|NCT00785772|11559053|FG000|STARTED|Overall Study||1
10414679|NCT00785772|11559053|FG000|COMPLETED|Overall Study||1
10414680|NCT00785772|11559053|FG000|NOT COMPLETED|Overall Study||0
10414681|NCT00785785|11559059|FG000|STARTED|Core Phase up to 36 Months||324
10414682|NCT00785785|11559060|FG001|STARTED|Core Phase up to 36 Months||320
10414683|NCT00785785|11559059|FG000|COMPLETED|Core Phase up to 36 Months||0
10414684|NCT00785785|11559060|FG001|COMPLETED|Core Phase up to 36 Months||0
10414685|NCT00785785|11559059|FG000|NOT COMPLETED|Core Phase up to 36 Months||324
10414686|NCT00785785|11559060|FG001|NOT COMPLETED|Core Phase up to 36 Months||320
10414687|NCT00785785|11559059|FG000|STARTED|Optional Extension Phase|crossover extension phase was optional|39
10414688|NCT00785785|11559060|FG001|STARTED|Optional Extension Phase|crossover extension phase was optional|125
10414689|NCT00785785|11559059|FG000|COMPLETED|Optional Extension Phase||0
10414690|NCT00785785|11559060|FG001|COMPLETED|Optional Extension Phase||0
10414691|NCT00785785|11559059|FG000|NOT COMPLETED|Optional Extension Phase||39
10414692|NCT00785785|11559060|FG001|NOT COMPLETED|Optional Extension Phase||125
10414693|NCT00785928|11559075|FG000|STARTED|Treatment Phase||36
10414694|NCT00785928|11559076|FG001|STARTED|Treatment Phase||30
10414695|NCT00785928|11559077|FG002|STARTED|Treatment Phase||20
10414696|NCT00785928|11559078|FG003|STARTED|Treatment Phase||15
10414697|NCT00785928|11559079|FG004|STARTED|Treatment Phase||18
10414698|NCT00785928|11559080|FG005|STARTED|Treatment Phase||13
10414699|NCT00785928|11559081|FG006|STARTED|Treatment Phase||26
10414700|NCT00785928|11559075|FG000|COMPLETED|Treatment Phase||33
10414701|NCT00785928|11559076|FG001|COMPLETED|Treatment Phase||25
10414702|NCT00785928|11559077|FG002|COMPLETED|Treatment Phase||17
10414703|NCT00785928|11559078|FG003|COMPLETED|Treatment Phase||15
10414704|NCT00785928|11559079|FG004|COMPLETED|Treatment Phase||16
10414705|NCT00785928|11559080|FG005|COMPLETED|Treatment Phase||13
10414706|NCT00785928|11559081|FG006|COMPLETED|Treatment Phase||23
10414707|NCT00785928|11559075|FG000|NOT COMPLETED|Treatment Phase||3
10414708|NCT00785928|11559076|FG001|NOT COMPLETED|Treatment Phase||5
10414709|NCT00785928|11559077|FG002|NOT COMPLETED|Treatment Phase||3
10414710|NCT00785928|11559078|FG003|NOT COMPLETED|Treatment Phase||0
10414711|NCT00785928|11559079|FG004|NOT COMPLETED|Treatment Phase||2
10414712|NCT00785928|11559080|FG005|NOT COMPLETED|Treatment Phase||0
10414713|NCT00785928|11559081|FG006|NOT COMPLETED|Treatment Phase||3
10414714|NCT00785928|11559075|FG000|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|8
10414715|NCT00785928|11559076|FG001|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|8
10414716|NCT00785928|11559077|FG002|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|6
10414717|NCT00785928|11559078|FG003|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|4
10414718|NCT00785928|11559079|FG004|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|6
10414719|NCT00785928|11559080|FG005|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|0
10414720|NCT00785928|11559081|FG006|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|14
10414721|NCT00785928|11559075|FG000|COMPLETED|Follow-up Phases (Weeks 24-72)||7
10414722|NCT00785928|11559076|FG001|COMPLETED|Follow-up Phases (Weeks 24-72)||5
10414723|NCT00785928|11559077|FG002|COMPLETED|Follow-up Phases (Weeks 24-72)||4
10414724|NCT00785928|11559078|FG003|COMPLETED|Follow-up Phases (Weeks 24-72)||4
10853865|NCT02698163|12020239|FG001|NOT COMPLETED|Overall Study||1
10853866|NCT02586675|12020245|FG000|STARTED|Overall Study||7
10853867|NCT02586675|12020245|FG000|COMPLETED|Overall Study||7
10853868|NCT02586675|12020245|FG000|NOT COMPLETED|Overall Study||0
10853875|NCT01816165|12020266|FG000|STARTED|Overall Study||5
10853876|NCT01816165|12020267|FG001|STARTED|Overall Study||4
10853877|NCT01816165|12020268|FG002|STARTED|Overall Study||5
10853878|NCT01816165|12020269|FG003|STARTED|Overall Study||4
10853879|NCT01816165|12020266|FG000|Completed Intervention 1|Overall Study||4
10853880|NCT01816165|12020267|FG001|Completed Intervention 1|Overall Study||4
10853881|NCT01816165|12020268|FG002|Completed Intervention 1|Overall Study||5
10853882|NCT01816165|12020269|FG003|Completed Intervention 1|Overall Study||4
10853883|NCT01816165|12020266|FG000|Completed ~2 Week Washout|Overall Study||4
10853884|NCT01816165|12020267|FG001|Completed ~2 Week Washout|Overall Study||4
10853885|NCT01816165|12020268|FG002|Completed ~2 Week Washout|Overall Study||5
10853886|NCT01816165|12020269|FG003|Completed ~2 Week Washout|Overall Study||4
10853887|NCT01816165|12020266|FG000|Started Second Intervention|Overall Study||4
10853888|NCT01816165|12020267|FG001|Started Second Intervention|Overall Study||4
10853889|NCT01816165|12020268|FG002|Started Second Intervention|Overall Study||5
10853890|NCT01816165|12020269|FG003|Started Second Intervention|Overall Study||4
10853891|NCT01816165|12020266|FG000|COMPLETED|Overall Study||4
10853892|NCT01816165|12020267|FG001|COMPLETED|Overall Study||4
10853893|NCT01816165|12020268|FG002|COMPLETED|Overall Study||5
10853894|NCT01816165|12020269|FG003|COMPLETED|Overall Study||4
10853895|NCT01816165|12020266|FG000|NOT COMPLETED|Overall Study||1
10853896|NCT01816165|12020267|FG001|NOT COMPLETED|Overall Study||0
10853897|NCT01816165|12020268|FG002|NOT COMPLETED|Overall Study||0
10853898|NCT01816165|12020269|FG003|NOT COMPLETED|Overall Study||0
10853899|NCT01813929|12020291|FG000|STARTED|Overall Study||5
10853900|NCT01813929|12020292|FG001|STARTED|Overall Study||12
10853901|NCT01813929|12020291|FG000|Completed Intervention 1|Overall Study||5
10853902|NCT01813929|12020292|FG001|Completed Intervention 1|Overall Study||12
10853903|NCT01813929|12020291|FG000|Completed Washout (2weeks up to 2 Months)|Overall Study||5
10853904|NCT01813929|12020292|FG001|Completed Washout (2weeks up to 2 Months)|Overall Study||11
10853905|NCT01813929|12020291|FG000|Started Intervention 2|Overall Study||5
10853906|NCT01813929|12020292|FG001|Started Intervention 2|Overall Study||11
10853907|NCT01813929|12020291|FG000|COMPLETED|Overall Study||5
10853908|NCT01813929|12020292|FG001|COMPLETED|Overall Study||11
10853909|NCT01813929|12020291|FG000|NOT COMPLETED|Overall Study||0
10853910|NCT01813929|12020292|FG001|NOT COMPLETED|Overall Study||1
10853911|NCT01502085|12020298|FG000|STARTED|Overall Study||25
10853912|NCT01502085|12020298|FG000|COMPLETED|Overall Study||25
10853913|NCT01502085|12020298|FG000|NOT COMPLETED|Overall Study||0
10853914|NCT01178814|12020302|FG000|STARTED|Overall Study||57
10853915|NCT01178814|12020302|FG000|COMPLETED|Overall Study||57
10853916|NCT01178814|12020302|FG000|NOT COMPLETED|Overall Study||0
10853917|NCT01125176|12020306|FG000|STARTED|Treatment Phase||14
10853918|NCT01125176|12020306|FG000|COMPLETED|Treatment Phase||13
10853919|NCT01125176|12020306|FG000|NOT COMPLETED|Treatment Phase||1
10853920|NCT01125176|12020306|FG000|STARTED|Post-treatment Follow-up Phase||13
10853921|NCT01125176|12020306|FG000|COMPLETED|Post-treatment Follow-up Phase||2
10853922|NCT01125176|12020306|FG000|NOT COMPLETED|Post-treatment Follow-up Phase||11
10853923|NCT00882050|12020313|FG000|STARTED|Overall Study||32
10853924|NCT00882050|12020314|FG001|STARTED|Overall Study||33
10853925|NCT00882050|12020315|FG002|STARTED|Overall Study||39
10853926|NCT00882050|12020313|FG000|COMPLETED|Overall Study||31
10853927|NCT00882050|12020314|FG001|COMPLETED|Overall Study||33
10853928|NCT00882050|12020315|FG002|COMPLETED|Overall Study||39
10853929|NCT00882050|12020313|FG000|NOT COMPLETED|Overall Study||1
10853930|NCT00882050|12020314|FG001|NOT COMPLETED|Overall Study||0
10853931|NCT00882050|12020315|FG002|NOT COMPLETED|Overall Study||0
10853932|NCT00070564|12020329|FG000|STARTED|Overall Study||678
10853933|NCT00070564|12020330|FG001|STARTED|Overall Study||693
10853934|NCT00070564|12020331|FG002|STARTED|Overall Study||697
10853935|NCT00070564|12020332|FG003|STARTED|Overall Study||648
10853936|NCT00070564|12020333|FG004|STARTED|Overall Study||282
10853937|NCT00070564|12020334|FG005|STARTED|Overall Study||296
10853938|NCT00070564|12020329|FG000|COMPLETED|Overall Study||478
10853939|NCT00070564|12020330|FG001|COMPLETED|Overall Study||490
10314500|NCT00163657|11448149|FG001|STARTED|Overall Study||79
10853940|NCT00070564|12020331|FG002|COMPLETED|Overall Study||526
10853941|NCT00070564|12020332|FG003|COMPLETED|Overall Study||481
10853942|NCT00070564|12020333|FG004|COMPLETED|Overall Study||203
10853943|NCT00070564|12020334|FG005|COMPLETED|Overall Study||244
10853944|NCT00070564|12020329|FG000|NOT COMPLETED|Overall Study||200
10853945|NCT00070564|12020330|FG001|NOT COMPLETED|Overall Study||203
10853946|NCT00070564|12020331|FG002|NOT COMPLETED|Overall Study||171
10853947|NCT00070564|12020332|FG003|NOT COMPLETED|Overall Study||167
10853948|NCT00070564|12020333|FG004|NOT COMPLETED|Overall Study||79
10853949|NCT00070564|12020334|FG005|NOT COMPLETED|Overall Study||52
10853950|NCT05167370|12020354|FG000|STARTED|Overall Study||2
10853951|NCT05167370|12020354|FG000|COMPLETED|Overall Study||2
10853952|NCT05167370|12020354|FG000|NOT COMPLETED|Overall Study||0
10853953|NCT04500821|12020358|FG000|STARTED|Overall Study||44
10853954|NCT04500821|12020358|FG000|COMPLETED|Overall Study||44
10853955|NCT04500821|12020358|FG000|NOT COMPLETED|Overall Study||0
10853956|NCT04425720|12020365|FG000|STARTED|Overall Study||150
10853957|NCT04425720|12020366|FG001|STARTED|Overall Study||150
10853958|NCT04425720|12020365|FG000|COMPLETED|Overall Study||150
10853959|NCT04425720|12020366|FG001|COMPLETED|Overall Study||130
10853960|NCT04425720|12020365|FG000|NOT COMPLETED|Overall Study||0
10853961|NCT04425720|12020366|FG001|NOT COMPLETED|Overall Study||20
10853962|NCT04409509|12020375|FG000|STARTED|Overall Study||61
10853963|NCT04409509|12020376|FG001|STARTED|Overall Study||63
10853964|NCT04409509|12020375|FG000|COMPLETED|Overall Study||48
10853965|NCT04409509|12020376|FG001|COMPLETED|Overall Study||43
10853966|NCT04409509|12020375|FG000|NOT COMPLETED|Overall Study||13
10853967|NCT04409509|12020376|FG001|NOT COMPLETED|Overall Study||20
10853968|NCT04380519|12020386|FG000|STARTED|Overall Study||124
10853969|NCT04380519|12020387|FG001|STARTED|Overall Study||124
10853970|NCT04380519|12020388|FG002|STARTED|Overall Study||124
10853971|NCT04380519|12020386|FG000|Intent-to-Treat (ITT)|Overall Study||124
10853972|NCT04380519|12020387|FG001|Intent-to-Treat (ITT)|Overall Study||124
10853973|NCT04380519|12020388|FG002|Intent-to-Treat (ITT)|Overall Study||124
10853974|NCT04380519|12020386|FG000|Modified Intent-to-Treat (mITT)|Overall Study||115
10853975|NCT04380519|12020387|FG001|Modified Intent-to-Treat (mITT)|Overall Study||119
10853976|NCT04380519|12020388|FG002|Modified Intent-to-Treat (mITT)|Overall Study||118
10853977|NCT04380519|12020386|FG000|Safety Population|Overall Study||123
10853978|NCT04380519|12020387|FG001|Safety Population|Overall Study||124
10853979|NCT04380519|12020388|FG002|Safety Population|Overall Study||124
10853980|NCT04380519|12020386|FG000|COMPLETED|Overall Study||106
10853981|NCT04380519|12020387|FG001|COMPLETED|Overall Study||113
10853982|NCT04380519|12020388|FG002|COMPLETED|Overall Study||117
10853983|NCT04380519|12020386|FG000|NOT COMPLETED|Overall Study||18
10853984|NCT04380519|12020387|FG001|NOT COMPLETED|Overall Study||11
10853985|NCT04380519|12020388|FG002|NOT COMPLETED|Overall Study||7
10853986|NCT04362813|12020398|FG000|STARTED|Overall Study||227
10853987|NCT04362813|12020399|FG001|STARTED|Overall Study||227
10853988|NCT04362813|12020398|FG000|Safety Set|Overall Study||225
10853989|NCT04362813|12020399|FG001|Safety Set|Overall Study||223
10853990|NCT04362813|12020398|FG000|Completed Day 29|Overall Study||211
10853991|NCT04362813|12020399|FG001|Completed Day 29|Overall Study||206
10853992|NCT04362813|12020398|FG000|COMPLETED|Overall Study||209
10853993|NCT04362813|12020399|FG001|COMPLETED|Overall Study||202
10853994|NCT04362813|12020398|FG000|NOT COMPLETED|Overall Study||18
10853995|NCT04362813|12020399|FG001|NOT COMPLETED|Overall Study||25
10414725|NCT00785928|11559079|FG004|COMPLETED|Follow-up Phases (Weeks 24-72)||4
10414726|NCT00785928|11559080|FG005|COMPLETED|Follow-up Phases (Weeks 24-72)||0
10414727|NCT00785928|11559081|FG006|COMPLETED|Follow-up Phases (Weeks 24-72)||9
10414728|NCT00785928|11559075|FG000|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||1
10414729|NCT00785928|11559076|FG001|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||3
10414730|NCT00785928|11559077|FG002|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||2
10414731|NCT00785928|11559078|FG003|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||0
10414732|NCT00785928|11559079|FG004|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||2
10414733|NCT00785928|11559080|FG005|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||0
10414734|NCT00785928|11559081|FG006|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||5
10414735|NCT00785980|11559119|FG000|STARTED|Quinine Sulfate Alone||24
10853996|NCT04231409|12020407|FG000|STARTED|Overall Study||5
10853997|NCT04231409|12020408|FG001|STARTED|Overall Study||4
10853998|NCT04231409|12020407|FG000|COMPLETED|Overall Study||0
10853999|NCT04231409|12020408|FG001|COMPLETED|Overall Study||0
10854000|NCT04231409|12020407|FG000|NOT COMPLETED|Overall Study||5
10854001|NCT04231409|12020408|FG001|NOT COMPLETED|Overall Study||4
10854002|NCT04136548|12020414|FG000|STARTED|Enrolled & Randomized||19
10854003|NCT04136548|12020415|FG001|STARTED|Enrolled & Randomized||19
10854004|NCT04136548|12020414|FG000|COMPLETED|Enrolled & Randomized||13
10854005|NCT04136548|12020415|FG001|COMPLETED|Enrolled & Randomized||15
10854006|NCT04136548|12020414|FG000|NOT COMPLETED|Enrolled & Randomized||6
10854007|NCT04136548|12020415|FG001|NOT COMPLETED|Enrolled & Randomized||4
10854008|NCT04136548|12020414|FG000|STARTED|First Visit||13
10854009|NCT04136548|12020415|FG001|STARTED|First Visit||15
10854010|NCT04136548|12020414|FG000|COMPLETED|First Visit||13
10854011|NCT04136548|12020415|FG001|COMPLETED|First Visit||15
10854012|NCT04136548|12020414|FG000|NOT COMPLETED|First Visit||0
10854013|NCT04136548|12020415|FG001|NOT COMPLETED|First Visit||0
10854014|NCT04136548|12020414|FG000|STARTED|Washout (at Least 48 Hours)||13
10854015|NCT04136548|12020415|FG001|STARTED|Washout (at Least 48 Hours)||15
10854016|NCT04136548|12020414|FG000|COMPLETED|Washout (at Least 48 Hours)||13
10854017|NCT04136548|12020415|FG001|COMPLETED|Washout (at Least 48 Hours)||15
10854018|NCT04136548|12020414|FG000|NOT COMPLETED|Washout (at Least 48 Hours)||0
10854019|NCT04136548|12020415|FG001|NOT COMPLETED|Washout (at Least 48 Hours)||0
10854020|NCT04136548|12020414|FG000|STARTED|Second Visit||13
10854021|NCT04136548|12020415|FG001|STARTED|Second Visit||15
10854022|NCT04136548|12020414|FG000|COMPLETED|Second Visit||13
10854023|NCT04136548|12020415|FG001|COMPLETED|Second Visit||15
10854024|NCT04136548|12020414|FG000|NOT COMPLETED|Second Visit||0
10854025|NCT04136548|12020415|FG001|NOT COMPLETED|Second Visit||0
10854026|NCT04126057|12020423|FG000|STARTED|Overall Study||50
10854027|NCT04126057|12020424|FG001|STARTED|Overall Study||50
10854028|NCT04126057|12020423|FG000|COMPLETED|Overall Study||47
10854029|NCT04126057|12020424|FG001|COMPLETED|Overall Study||46
10854030|NCT04126057|12020423|FG000|NOT COMPLETED|Overall Study||3
10854031|NCT04126057|12020424|FG001|NOT COMPLETED|Overall Study||4
10854032|NCT04087395|12020430|FG000|STARTED|Overall Study||30
10854033|NCT04087395|12020430|FG000|COMPLETED|Overall Study||30
10854034|NCT04087395|12020430|FG000|NOT COMPLETED|Overall Study||0
10854035|NCT04072432|12020441|FG000|STARTED|Overall Study||6
10854036|NCT04072432|12020442|FG001|STARTED|Overall Study||6
10854037|NCT04072432|12020443|FG002|STARTED|Overall Study||6
10854038|NCT04072432|12020441|FG000|COMPLETED|Overall Study||6
10854039|NCT04072432|12020442|FG001|COMPLETED|Overall Study||6
10854040|NCT04072432|12020443|FG002|COMPLETED|Overall Study||6
10854041|NCT04072432|12020441|FG000|NOT COMPLETED|Overall Study||0
10854042|NCT04072432|12020442|FG001|NOT COMPLETED|Overall Study||0
10854043|NCT04072432|12020443|FG002|NOT COMPLETED|Overall Study||0
10854044|NCT04069585|12020451|FG000|STARTED|Overall Study||30
10854045|NCT04069585|12020451|FG000|COMPLETED|Overall Study||30
10854046|NCT04069585|12020451|FG000|NOT COMPLETED|Overall Study||0
10854047|NCT03922321|12020457|FG000|STARTED|Overall Study||7
10854048|NCT03922321|12020457|FG000|COMPLETED|Overall Study||5
10854049|NCT03922321|12020457|FG000|NOT COMPLETED|Overall Study||2
10854050|NCT03911713|12020466|FG000|STARTED|Overall Study||12
10854051|NCT03911713|12020467|FG001|STARTED|Overall Study||6
10854052|NCT03911713|12020468|FG002|STARTED|Overall Study||11
10854053|NCT03911713|12020469|FG003|STARTED|Overall Study||24
10854054|NCT03911713|12020470|FG004|STARTED|Overall Study||24
10854055|NCT03911713|12020466|FG000|Full Analysis Set|Overall Study||11
10854056|NCT03911713|12020467|FG001|Full Analysis Set|Overall Study||6
10854057|NCT03911713|12020468|FG002|Full Analysis Set|Overall Study||11
10854058|NCT03911713|12020469|FG003|Full Analysis Set|Overall Study||23
10854059|NCT03911713|12020470|FG004|Full Analysis Set|Overall Study||24
10854060|NCT03911713|12020466|FG000|COMPLETED|Overall Study||11
10854061|NCT03911713|12020467|FG001|COMPLETED|Overall Study||4
10854062|NCT03911713|12020468|FG002|COMPLETED|Overall Study||11
10854063|NCT03911713|12020469|FG003|COMPLETED|Overall Study||22
10854064|NCT03911713|12020470|FG004|COMPLETED|Overall Study||24
10854065|NCT03911713|12020466|FG000|NOT COMPLETED|Overall Study||1
10854066|NCT03911713|12020467|FG001|NOT COMPLETED|Overall Study||2
10854067|NCT03911713|12020468|FG002|NOT COMPLETED|Overall Study||0
10854068|NCT03911713|12020469|FG003|NOT COMPLETED|Overall Study||2
10854069|NCT03911713|12020470|FG004|NOT COMPLETED|Overall Study||0
10854070|NCT03879642|12020486|FG000|STARTED|Overall Study||22
10854071|NCT03879642|12020487|FG001|STARTED|Overall Study||21
10854072|NCT03879642|12020486|FG000|COMPLETED|Overall Study||19
10854073|NCT03879642|12020487|FG001|COMPLETED|Overall Study||18
10854074|NCT03879642|12020486|FG000|NOT COMPLETED|Overall Study||3
10854075|NCT03879642|12020487|FG001|NOT COMPLETED|Overall Study||3
10854076|NCT03852459|12020495|FG000|STARTED|Overall Study||126
10854077|NCT03852459|12020496|FG001|STARTED|Overall Study||125
10854078|NCT03852459|12020495|FG000|COMPLETED|Overall Study||123
10854079|NCT03852459|12020496|FG001|COMPLETED|Overall Study||122
10854080|NCT03852459|12020495|FG000|NOT COMPLETED|Overall Study||3
10854081|NCT03852459|12020496|FG001|NOT COMPLETED|Overall Study||3
10854082|NCT03740919|12020505|FG000|STARTED|Lead-in Period||751
10854083|NCT03740919|12020506|FG001|STARTED|Lead-in Period||0
10854084|NCT03740919|12020507|FG002|STARTED|Lead-in Period||0
10854085|NCT03740919|12020508|FG003|STARTED|Lead-in Period||0
10854086|NCT03740919|12020505|FG000|Received at Least One Dose of Study Drug|Lead-in Period||751
10854087|NCT03740919|12020506|FG001|Received at Least One Dose of Study Drug|Lead-in Period||0
10854088|NCT03740919|12020507|FG002|Received at Least One Dose of Study Drug|Lead-in Period||0
10854089|NCT03740919|12020508|FG003|Received at Least One Dose of Study Drug|Lead-in Period||0
10854090|NCT03740919|12020505|FG000|COMPLETED|Lead-in Period||716
10854091|NCT03740919|12020506|FG001|COMPLETED|Lead-in Period||0
10854092|NCT03740919|12020507|FG002|COMPLETED|Lead-in Period||0
10854093|NCT03740919|12020508|FG003|COMPLETED|Lead-in Period||0
10854094|NCT03740919|12020505|FG000|NOT COMPLETED|Lead-in Period||35
10854095|NCT03740919|12020506|FG001|NOT COMPLETED|Lead-in Period||0
10854096|NCT03740919|12020507|FG002|NOT COMPLETED|Lead-in Period||0
10854097|NCT03740919|12020508|FG003|NOT COMPLETED|Lead-in Period||0
10854098|NCT03740919|12020505|FG000|STARTED|Treatment Period||0
10854099|NCT03740919|12020506|FG001|STARTED|Treatment Period|Participants were randomized from Lead-in Period to Insulin Lispro (Humalog).|298
10854100|NCT03740919|12020507|FG002|STARTED|Treatment Period|Participants were randomized from Lead-in Period to LY900014.|280
10854101|NCT03740919|12020508|FG003|STARTED|Treatment Period|Participants were randomized from Lead-in Period to open-label LY900014.|138
10854102|NCT03740919|12020505|FG000|Received at Least One Dose of Study Drug|Treatment Period||0
10854103|NCT03740919|12020506|FG001|Received at Least One Dose of Study Drug|Treatment Period||298
10854104|NCT03740919|12020507|FG002|Received at Least One Dose of Study Drug|Treatment Period||280
10854105|NCT03740919|12020508|FG003|Received at Least One Dose of Study Drug|Treatment Period||138
10854106|NCT03740919|12020505|FG000|COMPLETED|Treatment Period||0
10854107|NCT03740919|12020506|FG001|COMPLETED|Treatment Period||288
10854108|NCT03740919|12020507|FG002|COMPLETED|Treatment Period||266
10854109|NCT03740919|12020508|FG003|COMPLETED|Treatment Period||135
10854110|NCT03740919|12020505|FG000|NOT COMPLETED|Treatment Period||0
10854111|NCT03740919|12020506|FG001|NOT COMPLETED|Treatment Period||10
10854112|NCT03740919|12020507|FG002|NOT COMPLETED|Treatment Period||14
10854113|NCT03740919|12020508|FG003|NOT COMPLETED|Treatment Period||3
10854114|NCT03700970|12020521|FG000|STARTED|Overall Study||30
10854115|NCT03700970|12020522|FG001|STARTED|Overall Study||30
10854116|NCT03700970|12020521|FG000|COMPLETED|Overall Study||21
10854117|NCT03700970|12020522|FG001|COMPLETED|Overall Study||19
10854118|NCT03700970|12020521|FG000|NOT COMPLETED|Overall Study||9
10854119|NCT03700970|12020522|FG001|NOT COMPLETED|Overall Study||11
10854120|NCT03652454|12020532|FG000|STARTED|Overall Study||14
10854121|NCT03652454|12020533|FG001|STARTED|Overall Study||14
10854122|NCT03652454|12020532|FG000|COMPLETED|Overall Study||14
10854123|NCT03652454|12020533|FG001|COMPLETED|Overall Study||14
10854124|NCT03652454|12020532|FG000|NOT COMPLETED|Overall Study||0
10854125|NCT03652454|12020533|FG001|NOT COMPLETED|Overall Study||0
10854126|NCT03647488|12020542|FG000|STARTED|Overall Study||18
10854127|NCT03647488|12020543|FG001|STARTED|Overall Study|Randomized part was not opened|0
10854128|NCT03647488|12020544|FG002|STARTED|Overall Study|Randomized part was not opened|0
10854129|NCT03647488|12020542|FG000|COMPLETED|Overall Study||0
10854130|NCT03647488|12020543|FG001|COMPLETED|Overall Study||0
10854131|NCT03647488|12020544|FG002|COMPLETED|Overall Study||0
10854132|NCT03647488|12020542|FG000|NOT COMPLETED|Overall Study||18
10854133|NCT03647488|12020543|FG001|NOT COMPLETED|Overall Study||0
10854134|NCT03647488|12020544|FG002|NOT COMPLETED|Overall Study||0
10854135|NCT03614923|12020553|FG000|STARTED|Overall Study||35
10854136|NCT03614923|12020554|FG001|STARTED|Overall Study||35
10854137|NCT03614923|12020555|FG002|STARTED|Overall Study||35
10854138|NCT03614923|12020553|FG000|COMPLETED|Overall Study||30
10854139|NCT03614923|12020554|FG001|COMPLETED|Overall Study||30
10414736|NCT00785980|11559119|FG000|COMPLETED|Quinine Sulfate Alone||24
10414737|NCT00785980|11559119|FG000|NOT COMPLETED|Quinine Sulfate Alone||0
10414738|NCT00785980|11559119|FG000|STARTED|7 Day Washout Period||24
10414739|NCT00785980|11559119|FG000|COMPLETED|7 Day Washout Period||21
10414740|NCT00785980|11559119|FG000|NOT COMPLETED|7 Day Washout Period||3
10414741|NCT00785980|11559119|FG000|STARTED|Ciprofloxacin Alone||21
10414742|NCT00785980|11559119|FG000|COMPLETED|Ciprofloxacin Alone||21
10414743|NCT00785980|11559119|FG000|NOT COMPLETED|Ciprofloxacin Alone||0
10414744|NCT00785980|11559119|FG000|STARTED|Quinine Sulfate With Ciprofloxacin||21
10414745|NCT00785980|11559119|FG000|COMPLETED|Quinine Sulfate With Ciprofloxacin||21
10414746|NCT00785980|11559119|FG000|NOT COMPLETED|Quinine Sulfate With Ciprofloxacin||0
10414747|NCT00786019|11559128|FG000|STARTED|Overall Study||20
10414748|NCT00786019|11559129|FG001|STARTED|Overall Study||27
10414749|NCT00786019|11559128|FG000|COMPLETED|Overall Study||15
10414750|NCT00786019|11559129|FG001|COMPLETED|Overall Study||17
10414751|NCT00786019|11559128|FG000|NOT COMPLETED|Overall Study||5
10414752|NCT00786019|11559129|FG001|NOT COMPLETED|Overall Study||10
10414753|NCT00786032|11559137|FG000|STARTED|Overall Study||27
10414754|NCT00786032|11559137|FG000|Independent Users|Overall Study|All data analyses were based on the 14 independent users.|14
10414755|NCT00786032|11559137|FG000|COMPLETED|Overall Study||3
10414756|NCT00786032|11559137|FG000|NOT COMPLETED|Overall Study||24
10414757|NCT00786188|11559145|FG000|STARTED|Overall Study||50
10414758|NCT00786188|11559146|FG001|STARTED|Overall Study||52
10414759|NCT00786188|11559145|FG000|COMPLETED|Overall Study||45
10414760|NCT00786188|11559146|FG001|COMPLETED|Overall Study||51
10414761|NCT00786188|11559145|FG000|NOT COMPLETED|Overall Study||5
10854140|NCT03614923|12020555|FG002|COMPLETED|Overall Study||30
10854141|NCT03614923|12020553|FG000|NOT COMPLETED|Overall Study||5
10854142|NCT03614923|12020554|FG001|NOT COMPLETED|Overall Study||5
10854143|NCT03614923|12020555|FG002|NOT COMPLETED|Overall Study||5
10854144|NCT03502187|12020566|FG000|STARTED|Overall Study||43
10854145|NCT03502187|12020567|FG001|STARTED|Overall Study||43
10854146|NCT03502187|12020568|FG002|STARTED|Overall Study||42
10854147|NCT03502187|12020566|FG000|COMPLETED|Overall Study||34
10854148|NCT03502187|12020567|FG001|COMPLETED|Overall Study||36
10854149|NCT03502187|12020568|FG002|COMPLETED|Overall Study||34
10854150|NCT03502187|12020566|FG000|NOT COMPLETED|Overall Study||9
10854151|NCT03502187|12020567|FG001|NOT COMPLETED|Overall Study||7
10854152|NCT03502187|12020568|FG002|NOT COMPLETED|Overall Study||8
10854153|NCT03447262|12020576|FG000|STARTED|Overall Study||481
10854154|NCT03447262|12020576|FG000|COMPLETED|Overall Study||2
10854155|NCT03447262|12020576|FG000|NOT COMPLETED|Overall Study||479
10854156|NCT03432819|12020585|FG000|STARTED|Overall Study||38
10854157|NCT03432819|12020586|FG001|STARTED|Overall Study||38
10854158|NCT03432819|12020585|FG000|COMPLETED|Overall Study||31
10854159|NCT03432819|12020586|FG001|COMPLETED|Overall Study||33
10854160|NCT03432819|12020585|FG000|NOT COMPLETED|Overall Study||7
10854161|NCT03432819|12020586|FG001|NOT COMPLETED|Overall Study||5
10854162|NCT03323749|12020594|FG000|STARTED|Double-blind Period||109
10854163|NCT03323749|12020595|FG001|STARTED|Double-blind Period||109
10854164|NCT03323749|12020594|FG000|COMPLETED|Double-blind Period||102
10854165|NCT03323749|12020595|FG001|COMPLETED|Double-blind Period||103
10854166|NCT03323749|12020594|FG000|NOT COMPLETED|Double-blind Period||7
10854167|NCT03323749|12020595|FG001|NOT COMPLETED|Double-blind Period||6
10854168|NCT03323749|12020594|FG000|STARTED|Open-Label Period||93
10854169|NCT03323749|12020595|FG001|STARTED|Open-Label Period||103
10854170|NCT03323749|12020594|FG000|COMPLETED|Open-Label Period||0
10854171|NCT03323749|12020595|FG001|COMPLETED|Open-Label Period||0
10854172|NCT03323749|12020594|FG000|NOT COMPLETED|Open-Label Period||93
10854173|NCT03323749|12020595|FG001|NOT COMPLETED|Open-Label Period||103
10854174|NCT03322566|12020608|FG000|STARTED|Overall Study||91
10854175|NCT03322566|12020609|FG001|STARTED|Overall Study||87
10854176|NCT03322566|12020610|FG002|STARTED|Overall Study||55
10854177|NCT03322566|12020608|FG000|COMPLETED|Overall Study||46
10854178|NCT03322566|12020609|FG001|COMPLETED|Overall Study||42
10854179|NCT03322566|12020610|FG002|COMPLETED|Overall Study||22
10854180|NCT03322566|12020608|FG000|NOT COMPLETED|Overall Study||45
10854181|NCT03322566|12020609|FG001|NOT COMPLETED|Overall Study||45
10854182|NCT03322566|12020610|FG002|NOT COMPLETED|Overall Study||33
10854183|NCT03322540|12020620|FG000|STARTED|Overall Study||77
10854184|NCT03322540|12020621|FG001|STARTED|Overall Study||77
10854185|NCT03322540|12020620|FG000|Number of Subjects Received Treatment (Actual Treatment) (ASaT)|Overall Study||75
10854186|NCT03322540|12020621|FG001|Number of Subjects Received Treatment (Actual Treatment) (ASaT)|Overall Study||77
10854187|NCT03322540|12020620|FG000|COMPLETED|Overall Study||46
10854188|NCT03322540|12020621|FG001|COMPLETED|Overall Study||40
10854189|NCT03322540|12020620|FG000|NOT COMPLETED|Overall Study||31
10854190|NCT03322540|12020621|FG001|NOT COMPLETED|Overall Study||37
10854191|NCT03240601|12020631|FG000|STARTED|Overall Study||9
10854192|NCT03240601|12020632|FG001|STARTED|Overall Study||9
10854193|NCT03240601|12020631|FG000|COMPLETED|Overall Study||8
10854194|NCT03240601|12020632|FG001|COMPLETED|Overall Study||8
10854195|NCT03240601|12020631|FG000|NOT COMPLETED|Overall Study||1
10854196|NCT03240601|12020632|FG001|NOT COMPLETED|Overall Study||1
10854197|NCT03189719|12020640|FG000|STARTED|Overall Study||373
10854198|NCT03189719|12020641|FG001|STARTED|Overall Study||376
10854199|NCT03189719|12020640|FG000|Treated|Overall Study||370
10854200|NCT03189719|12020641|FG001|Treated|Overall Study||370
10854201|NCT03189719|12020640|FG000|COMPLETED|Overall Study||0
10854202|NCT03189719|12020641|FG001|COMPLETED|Overall Study||0
10854203|NCT03189719|12020640|FG000|NOT COMPLETED|Overall Study||373
10854204|NCT03189719|12020641|FG001|NOT COMPLETED|Overall Study||376
10854205|NCT03155997|12020649|FG000|STARTED|Overall Study||2808
10854206|NCT03155997|12020650|FG001|STARTED|Overall Study||2829
10854207|NCT03155997|12020649|FG000|Received at Least One Dose of Study Drug|Overall Study||2791
10854208|NCT03155997|12020650|FG001|Received at Least One Dose of Study Drug|Overall Study||2800
10854209|NCT03155997|12020649|FG000|COMPLETED|Overall Study||650
10854210|NCT03155997|12020650|FG001|COMPLETED|Overall Study||607
10854211|NCT03155997|12020649|FG000|NOT COMPLETED|Overall Study||2158
10854212|NCT03155997|12020650|FG001|NOT COMPLETED|Overall Study||2222
10854213|NCT03104400|12020660|FG000|STARTED|Overall Study||211
10854214|NCT03104400|12020661|FG001|STARTED|Overall Study||212
10854215|NCT03104400|12020662|FG002|STARTED|Overall Study||429
10854216|NCT03104400|12020663|FG003|STARTED|Overall Study||430
10854217|NCT03104400|12020664|FG004|STARTED|Overall Study||423
10854218|NCT03104400|12020660|FG000|Received Study Drug|Overall Study||211
10854219|NCT03104400|12020661|FG001|Received Study Drug|Overall Study||212
10854220|NCT03104400|12020662|FG002|Received Study Drug|Overall Study||429
10854221|NCT03104400|12020663|FG003|Received Study Drug|Overall Study||429
10854222|NCT03104400|12020664|FG004|Received Study Drug|Overall Study||423
10854223|NCT03104400|12020660|FG000|Completed Week 24|Overall Study||190
10854224|NCT03104400|12020661|FG001|Completed Week 24|Overall Study||193
10854225|NCT03104400|12020662|FG002|Completed Week 24|Overall Study||404
10854226|NCT03104400|12020663|FG003|Completed Week 24|Overall Study||408
10854227|NCT03104400|12020664|FG004|Completed Week 24|Overall Study||394
10854228|NCT03104400|12020660|FG000|COMPLETED|Overall Study||177
10854229|NCT03104400|12020661|FG001|COMPLETED|Overall Study||178
10854230|NCT03104400|12020662|FG002|COMPLETED|Overall Study||370
10293183|NCT01194219|11425833|FG005|STARTED|Randomized Withdrawal Phase-Weeks 32-52|25 participants discontinued after week 32 but prior to entry into the Randomized withdrawal Phase|77
10293184|NCT01194219|11425834|FG006|STARTED|Randomized Withdrawal Phase-Weeks 32-52||245
10293185|NCT01194219|11425835|FG007|STARTED|Randomized Withdrawal Phase-Weeks 32-52||208
10293186|NCT01194219|11425836|FG008|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
10293187|NCT01194219|11425837|FG009|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
10293188|NCT01194219|11425828|FG000|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
10293189|NCT01194219|11425829|FG001|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
10293190|NCT01194219|11425830|FG002|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
10293191|NCT01194219|11425831|FG003|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
10293192|NCT01194219|11425832|FG004|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
10293193|NCT01194219|11425833|FG005|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
10293194|NCT01194219|11425834|FG006|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||126
10293195|NCT01194219|11425835|FG007|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||91
10293196|NCT01194219|11425836|FG008|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
10293197|NCT01194219|11425837|FG009|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
10293198|NCT01194219|11425828|FG000|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
10293199|NCT01194219|11425829|FG001|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
10293200|NCT01194219|11425830|FG002|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
10293201|NCT01194219|11425831|FG003|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
10293202|NCT01194219|11425832|FG004|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|1 participant discontinued after Week 52 but prior to entry into the long term extension study|73
10293203|NCT01194219|11425833|FG005|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|5 participants discontinued after Week 52 but prior to entry into the long term extension study|73
10293204|NCT01194219|11425834|FG006|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|18 participants discontinued after Week 52 but prior to entry into the long term extension study|184
10293205|NCT01194219|11425835|FG007|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|10 participants discontinued after Week 52 but prior to entry into the long term extension study|163
10293206|NCT01194219|11425836|FG008|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
10293207|NCT01194219|11425837|FG009|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
10293208|NCT01194219|11425828|FG000|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
10293209|NCT01194219|11425829|FG001|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
10293210|NCT01194219|11425830|FG002|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
10293211|NCT01194219|11425831|FG003|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
10293212|NCT01194219|11425832|FG004|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||4
10293213|NCT01194219|11425833|FG005|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||4
10314501|NCT00163657|11448150|FG002|STARTED|Overall Study||153
10854231|NCT03104400|12020663|FG003|COMPLETED|Overall Study||379
10854232|NCT03104400|12020664|FG004|COMPLETED|Overall Study||366
10854233|NCT03104400|12020660|FG000|NOT COMPLETED|Overall Study||34
10854234|NCT03104400|12020661|FG001|NOT COMPLETED|Overall Study||34
10854235|NCT03104400|12020662|FG002|NOT COMPLETED|Overall Study||59
10854236|NCT03104400|12020663|FG003|NOT COMPLETED|Overall Study||51
10854237|NCT03104400|12020664|FG004|NOT COMPLETED|Overall Study||57
10854238|NCT03104374|12020681|FG000|STARTED|Overall Study||106
10854239|NCT03104374|12020682|FG001|STARTED|Overall Study||106
10854240|NCT03104374|12020683|FG002|STARTED|Overall Study||211
10854241|NCT03104374|12020684|FG003|STARTED|Overall Study||219
10854242|NCT03104374|12020681|FG000|Received Study Drug|Overall Study||106
10854243|NCT03104374|12020682|FG001|Received Study Drug|Overall Study||106
10854244|NCT03104374|12020683|FG002|Received Study Drug|Overall Study||211
10854245|NCT03104374|12020684|FG003|Received Study Drug|Overall Study||218
10854246|NCT03104374|12020681|FG000|Completed Week 24|Overall Study||81
10854247|NCT03104374|12020682|FG001|Completed Week 24|Overall Study||92
10854248|NCT03104374|12020683|FG002|Completed Week 24|Overall Study||192
10854249|NCT03104374|12020684|FG003|Completed Week 24|Overall Study||195
10854250|NCT03104374|12020681|FG000|COMPLETED|Overall Study||69
10854251|NCT03104374|12020682|FG001|COMPLETED|Overall Study||77
10854252|NCT03104374|12020683|FG002|COMPLETED|Overall Study||167
10854253|NCT03104374|12020684|FG003|COMPLETED|Overall Study||166
10854254|NCT03104374|12020681|FG000|NOT COMPLETED|Overall Study||37
10854255|NCT03104374|12020682|FG001|NOT COMPLETED|Overall Study||29
10854256|NCT03104374|12020683|FG002|NOT COMPLETED|Overall Study||44
10854257|NCT03104374|12020684|FG003|NOT COMPLETED|Overall Study||53
10854258|NCT03072043|12020697|FG000|STARTED|Overall Study||3
10854259|NCT03072043|12020698|FG001|STARTED|Overall Study||3
10854260|NCT03072043|12020699|FG002|STARTED|Overall Study||49
10854261|NCT03072043|12020697|FG000|COMPLETED|Overall Study||3
10854262|NCT03072043|12020698|FG001|COMPLETED|Overall Study||3
10854263|NCT03072043|12020699|FG002|COMPLETED|Overall Study||40
10854264|NCT03072043|12020697|FG000|NOT COMPLETED|Overall Study||0
10854265|NCT03072043|12020698|FG001|NOT COMPLETED|Overall Study||0
10854266|NCT03072043|12020699|FG002|NOT COMPLETED|Overall Study||9
10854270|NCT02946853|12020717|FG000|STARTED|Overall Study||13
10854271|NCT02946853|12020718|FG001|STARTED|Overall Study||13
10854272|NCT02946853|12020717|FG000|COMPLETED|Overall Study||12
10854273|NCT02946853|12020718|FG001|COMPLETED|Overall Study||13
10854274|NCT02946853|12020717|FG000|NOT COMPLETED|Overall Study||1
10854275|NCT02946853|12020718|FG001|NOT COMPLETED|Overall Study||0
10854276|NCT02905032|12020727|FG000|STARTED|Overall Study||467
10854277|NCT02905032|12020728|FG001|STARTED|Overall Study||475
10854278|NCT02905032|12020729|FG002|STARTED|Overall Study||244
10854279|NCT02905032|12020727|FG000|COMPLETED|Overall Study||459
10854280|NCT02905032|12020728|FG001|COMPLETED|Overall Study||463
10854281|NCT02905032|12020729|FG002|COMPLETED|Overall Study||244
10854282|NCT02905032|12020727|FG000|NOT COMPLETED|Overall Study||8
10854283|NCT02905032|12020728|FG001|NOT COMPLETED|Overall Study||12
10854284|NCT02905032|12020729|FG002|NOT COMPLETED|Overall Study||0
10854285|NCT02837029|12020739|FG000|STARTED|Screening||15
10854286|NCT02837029|12020740|FG001|STARTED|Screening||12
10854287|NCT02837029|12020741|FG002|STARTED|Screening||0
10854288|NCT02837029|12020739|FG000|COMPLETED|Screening||8
10854289|NCT02837029|12020740|FG001|COMPLETED|Screening||9
10854290|NCT02837029|12020741|FG002|COMPLETED|Screening||0
10854291|NCT02837029|12020739|FG000|NOT COMPLETED|Screening||7
10854292|NCT02837029|12020740|FG001|NOT COMPLETED|Screening||3
10293214|NCT01194219|11425834|FG006|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||61
10293215|NCT01194219|11425835|FG007|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||45
10293216|NCT01194219|11425836|FG008|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
10293217|NCT01194219|11425837|FG009|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
10293218|NCT01194219|11425828|FG000|STARTED|Long-Term Extension Weeks 52 to 260||0
10293219|NCT01194219|11425829|FG001|STARTED|Long-Term Extension Weeks 52 to 260||0
10293220|NCT01194219|11425830|FG002|STARTED|Long-Term Extension Weeks 52 to 260||0
10293221|NCT01194219|11425831|FG003|STARTED|Long-Term Extension Weeks 52 to 260||0
10293222|NCT01194219|11425832|FG004|STARTED|Long-Term Extension Weeks 52 to 260||0
10293223|NCT01194219|11425833|FG005|STARTED|Long-Term Extension Weeks 52 to 260||0
10293224|NCT01194219|11425834|FG006|STARTED|Long-Term Extension Weeks 52 to 260||0
10293225|NCT01194219|11425835|FG007|STARTED|Long-Term Extension Weeks 52 to 260||0
10293226|NCT01194219|11425836|FG008|STARTED|Long-Term Extension Weeks 52 to 260||306
10293227|NCT01194219|11425837|FG009|STARTED|Long-Term Extension Weeks 52 to 260||153
10293228|NCT01194219|11425828|FG000|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
10293229|NCT01194219|11425829|FG001|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
10293230|NCT01194219|11425830|FG002|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
10293231|NCT01194219|11425831|FG003|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
10293232|NCT01194219|11425832|FG004|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
10314502|NCT00163657|11448148|FG000|COMPLETED|Overall Study||60
10414762|NCT00786188|11559146|FG001|NOT COMPLETED|Overall Study||1
10854293|NCT02837029|12020741|FG002|NOT COMPLETED|Screening||0
10854294|NCT02837029|12020739|FG000|STARTED|Induction Treatment With Y90||8
10854295|NCT02837029|12020740|FG001|STARTED|Induction Treatment With Y90||9
10854296|NCT02837029|12020741|FG002|STARTED|Induction Treatment With Y90||0
10854297|NCT02837029|12020739|FG000|COMPLETED|Induction Treatment With Y90||8
10854298|NCT02837029|12020740|FG001|COMPLETED|Induction Treatment With Y90||9
10854299|NCT02837029|12020741|FG002|COMPLETED|Induction Treatment With Y90||0
10854300|NCT02837029|12020739|FG000|NOT COMPLETED|Induction Treatment With Y90||0
10854301|NCT02837029|12020740|FG001|NOT COMPLETED|Induction Treatment With Y90||0
10854302|NCT02837029|12020741|FG002|NOT COMPLETED|Induction Treatment With Y90||0
10854303|NCT02837029|12020739|FG000|STARTED|Cycle 1 (DLT Monitoring Period)||8
10854304|NCT02837029|12020740|FG001|STARTED|Cycle 1 (DLT Monitoring Period)||9
10854305|NCT02837029|12020741|FG002|STARTED|Cycle 1 (DLT Monitoring Period)||0
10854306|NCT02837029|12020739|FG000|Received Nivolumab Dose|Cycle 1 (DLT Monitoring Period)||6
10854307|NCT02837029|12020740|FG001|Received Nivolumab Dose|Cycle 1 (DLT Monitoring Period)||7
10854308|NCT02837029|12020741|FG002|Received Nivolumab Dose|Cycle 1 (DLT Monitoring Period)||0
10854309|NCT02837029|12020739|FG000|COMPLETED|Cycle 1 (DLT Monitoring Period)||6
10854310|NCT02837029|12020740|FG001|COMPLETED|Cycle 1 (DLT Monitoring Period)||6
10854311|NCT02837029|12020741|FG002|COMPLETED|Cycle 1 (DLT Monitoring Period)||0
10854312|NCT02837029|12020739|FG000|NOT COMPLETED|Cycle 1 (DLT Monitoring Period)||2
10854313|NCT02837029|12020740|FG001|NOT COMPLETED|Cycle 1 (DLT Monitoring Period)||3
10854314|NCT02837029|12020741|FG002|NOT COMPLETED|Cycle 1 (DLT Monitoring Period)||0
10854315|NCT02837029|12020739|FG000|STARTED|Cycle 2 and Beyond||6
10854316|NCT02837029|12020740|FG001|STARTED|Cycle 2 and Beyond||6
10854317|NCT02837029|12020741|FG002|STARTED|Cycle 2 and Beyond||0
10854318|NCT02837029|12020739|FG000|COMPLETED|Cycle 2 and Beyond||5
10854319|NCT02837029|12020740|FG001|COMPLETED|Cycle 2 and Beyond||6
10854320|NCT02837029|12020741|FG002|COMPLETED|Cycle 2 and Beyond||0
10854321|NCT02837029|12020739|FG000|NOT COMPLETED|Cycle 2 and Beyond||1
10854322|NCT02837029|12020740|FG001|NOT COMPLETED|Cycle 2 and Beyond||0
10854323|NCT02837029|12020741|FG002|NOT COMPLETED|Cycle 2 and Beyond||0
10854324|NCT02837029|12020739|FG000|STARTED|2 Year Follow-up|All patients who receive at least one dose of nivolumab go into follow-up.|6
10854325|NCT02837029|12020740|FG001|STARTED|2 Year Follow-up|All patients who receive at least one dose of nivolumab go into follow-up.|7
10854326|NCT02837029|12020741|FG002|STARTED|2 Year Follow-up||0
10854327|NCT02837029|12020739|FG000|COMPLETED|2 Year Follow-up||0
10854328|NCT02837029|12020740|FG001|COMPLETED|2 Year Follow-up||0
10414763|NCT00786409|11559154|FG000|STARTED|Overall Study||27
10414764|NCT00786409|11559154|FG000|COMPLETED|Overall Study||20
10414765|NCT00786409|11559154|FG000|NOT COMPLETED|Overall Study||7
10414766|NCT00786422|11559158|FG000|STARTED|Rivaroxaban Treatment||25
10414767|NCT00786422|11559158|FG000|COMPLETED|Rivaroxaban Treatment||14
10414768|NCT00786422|11559158|FG000|NOT COMPLETED|Rivaroxaban Treatment||11
10414769|NCT00786422|11559158|FG000|STARTED|Follow-up Period|Participants entered follow-up period. No reason documents for those not entering this period|20
10414770|NCT00786422|11559158|FG000|COMPLETED|Follow-up Period||17
10414771|NCT00786422|11559158|FG000|NOT COMPLETED|Follow-up Period||3
10414772|NCT00786474|11559166|FG000|STARTED|Overall Study||950
10414773|NCT00786474|11559167|FG001|STARTED|Overall Study||934
10414774|NCT00786474|11559166|FG000|COMPLETED|Overall Study||913
10414775|NCT00786474|11559167|FG001|COMPLETED|Overall Study||891
10414776|NCT00786474|11559166|FG000|NOT COMPLETED|Overall Study||37
10414777|NCT00786474|11559167|FG001|NOT COMPLETED|Overall Study||43
10414778|NCT00786487|11559177|FG000|STARTED|Overall Study||10
10414779|NCT00786487|11559178|FG001|STARTED|Overall Study||7
10414780|NCT00786487|11559179|FG002|STARTED|Overall Study||9
10414781|NCT00786487|11559180|FG003|STARTED|Overall Study||7
10414782|NCT00786487|11559177|FG000|COMPLETED|Overall Study||10
10414783|NCT00786487|11559178|FG001|COMPLETED|Overall Study||7
10414784|NCT00786487|11559179|FG002|COMPLETED|Overall Study||9
10414785|NCT00786487|11559180|FG003|COMPLETED|Overall Study||7
10414786|NCT00786487|11559177|FG000|NOT COMPLETED|Overall Study||0
10414787|NCT00786487|11559178|FG001|NOT COMPLETED|Overall Study||0
10414788|NCT00786487|11559179|FG002|NOT COMPLETED|Overall Study||0
10414789|NCT00786487|11559180|FG003|NOT COMPLETED|Overall Study||0
10414790|NCT00786565|11559190|FG000|STARTED|Enrollment Prior to Surgery||75
10414791|NCT00786565|11559190|FG000|COMPLETED|Enrollment Prior to Surgery|69 participants - Akreos Advanced Optic Lens in one eye and Akreos Adapt Lens in the fellow eye.|69
10414792|NCT00786565|11559190|FG000|NOT COMPLETED|Enrollment Prior to Surgery||6
10414793|NCT00786565|11559190|FG000|STARTED|Post Surgery||69
10414794|NCT00786565|11559190|FG000|COMPLETED|Post Surgery|67 Participants (134 eyes) completed the study.|67
10414795|NCT00786565|11559190|FG000|NOT COMPLETED|Post Surgery||2
10414796|NCT00786643|11559198|FG000|STARTED|Overall Study||20
10414797|NCT00786643|11559199|FG001|STARTED|Overall Study||28
10414798|NCT00786643|11559198|FG000|COMPLETED|Overall Study||20
10414799|NCT00786643|11559199|FG001|COMPLETED|Overall Study||28
10414800|NCT00786643|11559198|FG000|NOT COMPLETED|Overall Study||0
10414801|NCT00786643|11559199|FG001|NOT COMPLETED|Overall Study||0
10414802|NCT00786799|11559207|FG000|STARTED|Overall Study||14
10414803|NCT00786799|11559208|FG001|STARTED|Overall Study||13
10414804|NCT00786799|11559207|FG000|COMPLETED|Overall Study||13
10414805|NCT00786799|11559208|FG001|COMPLETED|Overall Study||12
10414806|NCT00786799|11559207|FG000|NOT COMPLETED|Overall Study||1
10414807|NCT00786799|11559208|FG001|NOT COMPLETED|Overall Study||1
10414808|NCT00786825|11559221|FG000|STARTED|Overall Study||5
10414809|NCT00786825|11559222|FG001|STARTED|Overall Study||5
10414810|NCT00786825|11559221|FG000|COMPLETED|Overall Study||5
10414811|NCT00786825|11559222|FG001|COMPLETED|Overall Study||5
10414812|NCT00786825|11559221|FG000|NOT COMPLETED|Overall Study||0
10414813|NCT00786825|11559222|FG001|NOT COMPLETED|Overall Study||0
10414814|NCT00786838|11559228|FG000|STARTED|Overall Study||75
10414815|NCT00786838|11559228|FG000|COMPLETED|Overall Study||26
10414816|NCT00786838|11559228|FG000|NOT COMPLETED|Overall Study||49
10414817|NCT00786864|11559239|FG000|STARTED|Overall Study||39
10414818|NCT00786864|11559240|FG001|STARTED|Overall Study||33
10414819|NCT00786864|11559239|FG000|COMPLETED|Overall Study|1 child excluded at the 3 month follow-up, as he sustained a serious back injury|38
10414820|NCT00786864|11559240|FG001|COMPLETED|Overall Study|1 child lost to study immediately post-intervention as she left the school|32
10414821|NCT00786864|11559239|FG000|NOT COMPLETED|Overall Study||1
10414822|NCT00786864|11559240|FG001|NOT COMPLETED|Overall Study||1
10414823|NCT00786916|11559249|FG000|STARTED|Overall Study||39
10854329|NCT02837029|12020741|FG002|COMPLETED|2 Year Follow-up||0
10854330|NCT02837029|12020739|FG000|NOT COMPLETED|2 Year Follow-up||6
10854331|NCT02837029|12020740|FG001|NOT COMPLETED|2 Year Follow-up||7
10854332|NCT02837029|12020741|FG002|NOT COMPLETED|2 Year Follow-up||0
10854333|NCT02740127|12020752|FG000|STARTED|Overall Study||24
10854334|NCT02740127|12020753|FG001|STARTED|Overall Study||28
10854335|NCT02740127|12020752|FG000|COMPLETED|Overall Study||24
10854336|NCT02740127|12020753|FG001|COMPLETED|Overall Study||28
10854337|NCT02740127|12020752|FG000|NOT COMPLETED|Overall Study||0
10854338|NCT02740127|12020753|FG001|NOT COMPLETED|Overall Study||0
10854339|NCT02737553|12020761|FG000|STARTED|Overall Study||49
10854340|NCT02737553|12020762|FG001|STARTED|Overall Study||48
10854341|NCT02737553|12020761|FG000|COMPLETED|Overall Study||49
10854342|NCT02737553|12020762|FG001|COMPLETED|Overall Study||48
10854343|NCT02737553|12020761|FG000|NOT COMPLETED|Overall Study||0
10854344|NCT02737553|12020762|FG001|NOT COMPLETED|Overall Study||0
10854345|NCT02737475|12020796|FG000|STARTED|Overall Study||4
10854346|NCT02737475|12020797|FG001|STARTED|Overall Study||4
10854347|NCT02737475|12020798|FG002|STARTED|Overall Study||4
10854348|NCT02737475|12020799|FG003|STARTED|Overall Study||4
10854349|NCT02737475|12020800|FG004|STARTED|Overall Study||4
10854350|NCT02737475|12020801|FG005|STARTED|Overall Study||7
10854351|NCT02737475|12020802|FG006|STARTED|Overall Study||8
10854352|NCT02737475|12020803|FG007|STARTED|Overall Study||12
10854353|NCT02737475|12020804|FG008|STARTED|Overall Study||8
10854354|NCT02737475|12020805|FG009|STARTED|Overall Study||8
10854355|NCT02737475|12020806|FG010|STARTED|Overall Study||4
10854356|NCT02737475|12020807|FG011|STARTED|Overall Study||10
10854357|NCT02737475|12020808|FG012|STARTED|Overall Study||7
10854358|NCT02737475|12020809|FG013|STARTED|Overall Study||8
10854359|NCT02737475|12020810|FG014|STARTED|Overall Study||6
10854360|NCT02737475|12020811|FG015|STARTED|Overall Study||18
10854361|NCT02737475|12020812|FG016|STARTED|Overall Study||12
10854362|NCT02737475|12020813|FG017|STARTED|Overall Study||6
10854363|NCT02737475|12020814|FG018|STARTED|Overall Study||7
10854364|NCT02737475|12020815|FG019|STARTED|Overall Study||1
10854365|NCT02737475|12020816|FG020|STARTED|Overall Study||6
10854366|NCT02737475|12020817|FG021|STARTED|Overall Study||9
10854367|NCT02737475|12020818|FG022|STARTED|Overall Study||2
10854368|NCT02737475|12020819|FG023|STARTED|Overall Study||2
10854369|NCT02737475|12020820|FG024|STARTED|Overall Study||2
10854370|NCT02737475|12020821|FG025|STARTED|Overall Study||2
10854371|NCT02737475|12020822|FG026|STARTED|Overall Study||1
10854372|NCT02737475|12020796|FG000|COMPLETED|Overall Study||3
10854373|NCT02737475|12020797|FG001|COMPLETED|Overall Study||4
10854374|NCT02737475|12020798|FG002|COMPLETED|Overall Study||4
10854375|NCT02737475|12020799|FG003|COMPLETED|Overall Study||3
10854376|NCT02737475|12020800|FG004|COMPLETED|Overall Study||3
10854377|NCT02737475|12020801|FG005|COMPLETED|Overall Study||4
10854378|NCT02737475|12020802|FG006|COMPLETED|Overall Study||8
10854379|NCT02737475|12020803|FG007|COMPLETED|Overall Study||10
10854380|NCT02737475|12020804|FG008|COMPLETED|Overall Study||7
10293233|NCT01194219|11425833|FG005|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
10293234|NCT01194219|11425834|FG006|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
10293235|NCT01194219|11425835|FG007|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
10293236|NCT01194219|11425836|FG008|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||304
10293237|NCT01194219|11425837|FG009|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||153
10293238|NCT01194219|11425828|FG000|COMPLETED|Long-Term Extension Weeks 52 to 260||0
10293239|NCT01194219|11425829|FG001|COMPLETED|Long-Term Extension Weeks 52 to 260||0
10293240|NCT01194219|11425830|FG002|COMPLETED|Long-Term Extension Weeks 52 to 260||0
10293241|NCT01194219|11425831|FG003|COMPLETED|Long-Term Extension Weeks 52 to 260||0
10293242|NCT01194219|11425832|FG004|COMPLETED|Long-Term Extension Weeks 52 to 260||0
10293243|NCT01194219|11425833|FG005|COMPLETED|Long-Term Extension Weeks 52 to 260||0
10293244|NCT01194219|11425834|FG006|COMPLETED|Long-Term Extension Weeks 52 to 260||0
10293245|NCT01194219|11425835|FG007|COMPLETED|Long-Term Extension Weeks 52 to 260||0
10293246|NCT01194219|11425836|FG008|COMPLETED|Long-Term Extension Weeks 52 to 260||86
10293247|NCT01194219|11425837|FG009|COMPLETED|Long-Term Extension Weeks 52 to 260||41
10293248|NCT01194219|11425828|FG000|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
10293249|NCT01194219|11425829|FG001|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
10293250|NCT01194219|11425830|FG002|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
10293251|NCT01194219|11425831|FG003|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
10293252|NCT01194219|11425832|FG004|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
10293253|NCT01194219|11425833|FG005|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
10293254|NCT01194219|11425834|FG006|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
10293255|NCT01194219|11425835|FG007|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
10293256|NCT01194219|11425836|FG008|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||220
10293257|NCT01194219|11425837|FG009|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||112
10293258|NCT01193842|11425865|FG000|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||3
10293259|NCT01193842|11425866|FG001|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
10854381|NCT02737475|12020805|FG009|COMPLETED|Overall Study||8
10854382|NCT02737475|12020806|FG010|COMPLETED|Overall Study||3
10854383|NCT02737475|12020807|FG011|COMPLETED|Overall Study||6
10854384|NCT02737475|12020808|FG012|COMPLETED|Overall Study||5
10854385|NCT02737475|12020809|FG013|COMPLETED|Overall Study||6
10854386|NCT02737475|12020810|FG014|COMPLETED|Overall Study||5
10854387|NCT02737475|12020811|FG015|COMPLETED|Overall Study||15
10854388|NCT02737475|12020812|FG016|COMPLETED|Overall Study||10
10854389|NCT02737475|12020813|FG017|COMPLETED|Overall Study||2
10854390|NCT02737475|12020814|FG018|COMPLETED|Overall Study||5
10854391|NCT02737475|12020815|FG019|COMPLETED|Overall Study||1
10854392|NCT02737475|12020816|FG020|COMPLETED|Overall Study||4
10854393|NCT02737475|12020817|FG021|COMPLETED|Overall Study||8
10854394|NCT02737475|12020818|FG022|COMPLETED|Overall Study||2
10854395|NCT02737475|12020819|FG023|COMPLETED|Overall Study||1
10854396|NCT02737475|12020820|FG024|COMPLETED|Overall Study||1
10854397|NCT02737475|12020821|FG025|COMPLETED|Overall Study||1
10854398|NCT02737475|12020822|FG026|COMPLETED|Overall Study||0
10854399|NCT02737475|12020796|FG000|NOT COMPLETED|Overall Study||1
10854400|NCT02737475|12020797|FG001|NOT COMPLETED|Overall Study||0
10854401|NCT02737475|12020798|FG002|NOT COMPLETED|Overall Study||0
10854402|NCT02737475|12020799|FG003|NOT COMPLETED|Overall Study||1
10854403|NCT02737475|12020800|FG004|NOT COMPLETED|Overall Study||1
10854404|NCT02737475|12020801|FG005|NOT COMPLETED|Overall Study||3
10854405|NCT02737475|12020802|FG006|NOT COMPLETED|Overall Study||0
10854406|NCT02737475|12020803|FG007|NOT COMPLETED|Overall Study||2
10854407|NCT02737475|12020804|FG008|NOT COMPLETED|Overall Study||1
10854408|NCT02737475|12020805|FG009|NOT COMPLETED|Overall Study||0
10854409|NCT02737475|12020806|FG010|NOT COMPLETED|Overall Study||1
10854410|NCT02737475|12020807|FG011|NOT COMPLETED|Overall Study||4
10854411|NCT02737475|12020808|FG012|NOT COMPLETED|Overall Study||2
10854412|NCT02737475|12020809|FG013|NOT COMPLETED|Overall Study||2
10854413|NCT02737475|12020810|FG014|NOT COMPLETED|Overall Study||1
10854414|NCT02737475|12020811|FG015|NOT COMPLETED|Overall Study||3
10854415|NCT02737475|12020812|FG016|NOT COMPLETED|Overall Study||2
10854416|NCT02737475|12020813|FG017|NOT COMPLETED|Overall Study||4
10854417|NCT02737475|12020814|FG018|NOT COMPLETED|Overall Study||2
10854418|NCT02737475|12020815|FG019|NOT COMPLETED|Overall Study||0
10854419|NCT02737475|12020816|FG020|NOT COMPLETED|Overall Study||2
10854420|NCT02737475|12020817|FG021|NOT COMPLETED|Overall Study||1
10854421|NCT02737475|12020818|FG022|NOT COMPLETED|Overall Study||0
10854422|NCT02737475|12020819|FG023|NOT COMPLETED|Overall Study||1
10854423|NCT02737475|12020820|FG024|NOT COMPLETED|Overall Study||1
10854424|NCT02737475|12020821|FG025|NOT COMPLETED|Overall Study||1
10854425|NCT02737475|12020822|FG026|NOT COMPLETED|Overall Study||1
10854426|NCT02703714|12020910|FG000|STARTED|Overall Study||42
10854427|NCT02703714|12020910|FG000|COMPLETED|Overall Study||42
10854428|NCT02703714|12020910|FG000|NOT COMPLETED|Overall Study||0
10854429|NCT02642965|12020914|FG000|STARTED|Overall Study||38
10854430|NCT02642965|12020914|FG000|COMPLETED|Overall Study||25
10854431|NCT02642965|12020914|FG000|NOT COMPLETED|Overall Study||13
10854432|NCT02604433|12020920|FG000|STARTED|Overall Study||224
10854433|NCT02604433|12020921|FG001|STARTED|Overall Study||112
10854434|NCT02604433|12020920|FG000|Participants Treated|Overall Study||223
10854435|NCT02604433|12020921|FG001|Participants Treated|Overall Study||109
10854436|NCT02604433|12020920|FG000|Completed 24 Weeks of Treatment|Overall Study||211
10854437|NCT02604433|12020921|FG001|Completed 24 Weeks of Treatment|Overall Study||102
10854438|NCT02604433|12020920|FG000|Completed 48 Weeks of Treatment|Overall Study||202
10854439|NCT02604433|12020921|FG001|Completed 48 Weeks of Treatment|Overall Study||96
10854440|NCT02604433|12020920|FG000|Completed 96 Weeks of Treatment|Overall Study||155
10854441|NCT02604433|12020921|FG001|Completed 96 Weeks of Treatment|Overall Study||3
10854442|NCT02604433|12020920|FG000|Completed 144 Weeks of Treatment|Overall Study||125
10854443|NCT02604433|12020921|FG001|Completed 144 Weeks of Treatment|Overall Study||0
10854444|NCT02604433|12020920|FG000|Completed 192 Weeks of Treatment|Overall Study||6
10854445|NCT02604433|12020921|FG001|Completed 192 Weeks of Treatment|Overall Study||0
10854446|NCT02604433|12020920|FG000|COMPLETED|Overall Study||6
10854447|NCT02604433|12020921|FG001|COMPLETED|Overall Study||6
10414824|NCT00786916|11559250|FG001|STARTED|Overall Study||36
10414825|NCT00786916|11559251|FG002|STARTED|Overall Study||34
10414826|NCT00786916|11559249|FG000|COMPLETED|Overall Study||39
10414827|NCT00786916|11559250|FG001|COMPLETED|Overall Study||36
10414828|NCT00786916|11559251|FG002|COMPLETED|Overall Study||34
10414829|NCT00786916|11559249|FG000|NOT COMPLETED|Overall Study||0
10414830|NCT00786916|11559250|FG001|NOT COMPLETED|Overall Study||0
10414831|NCT00786916|11559251|FG002|NOT COMPLETED|Overall Study||0
10414832|NCT00786994|11559263|FG000|STARTED|Overall Study||57
10414833|NCT00786994|11559264|FG001|STARTED|Overall Study||54
10414834|NCT00786994|11559265|FG002|STARTED|Overall Study||26
10414835|NCT00786994|11559266|FG003|STARTED|Overall Study||28
10414836|NCT00786994|11559263|FG000|ITT|Overall Study||53
10854448|NCT02604433|12020920|FG000|NOT COMPLETED|Overall Study||218
10854449|NCT02604433|12020921|FG001|NOT COMPLETED|Overall Study||106
10854450|NCT02519738|12020930|FG000|STARTED|Overall Study||20
10854451|NCT02519738|12020931|FG001|STARTED|Overall Study||17
10293260|NCT01193842|11425867|FG002|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
10293261|NCT01193842|11425868|FG003|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
10293262|NCT01193842|11425869|FG004|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
10293263|NCT01193842|11425865|FG000|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||3
10293264|NCT01193842|11425866|FG001|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
10293265|NCT01193842|11425867|FG002|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
10293266|NCT01193842|11425868|FG003|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
10293267|NCT01193842|11425869|FG004|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
10293268|NCT01193842|11425865|FG000|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
10293269|NCT01193842|11425866|FG001|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
10854452|NCT02519738|12020932|FG002|STARTED|Overall Study||15
10854453|NCT02519738|12020930|FG000|COMPLETED|Overall Study||6
10854454|NCT02519738|12020931|FG001|COMPLETED|Overall Study||4
10854455|NCT02519738|12020932|FG002|COMPLETED|Overall Study||3
10854456|NCT02519738|12020930|FG000|NOT COMPLETED|Overall Study||14
10854457|NCT02519738|12020931|FG001|NOT COMPLETED|Overall Study||13
10854458|NCT02519738|12020932|FG002|NOT COMPLETED|Overall Study||12
10854459|NCT02502071|12020940|FG000|STARTED|Overall Study||45
10854460|NCT02502071|12020940|FG000|COMPLETED|Overall Study||45
10854461|NCT02502071|12020940|FG000|NOT COMPLETED|Overall Study||0
10854462|NCT02420821|12020946|FG000|STARTED|Overall Study||461
10854463|NCT02420821|12020947|FG001|STARTED|Overall Study||454
10854464|NCT02420821|12020946|FG000|COMPLETED|Overall Study||293
10854465|NCT02420821|12020947|FG001|COMPLETED|Overall Study||317
10854466|NCT02420821|12020946|FG000|NOT COMPLETED|Overall Study||168
10854467|NCT02420821|12020947|FG001|NOT COMPLETED|Overall Study||137
10854476|NCT02410343|12020965|FG000|STARTED|Core Period (24 Weeks)||6
10854477|NCT02410343|12020966|FG001|STARTED|Core Period (24 Weeks)||8
10854478|NCT02410343|12020965|FG000|COMPLETED|Core Period (24 Weeks)||1
10854479|NCT02410343|12020966|FG001|COMPLETED|Core Period (24 Weeks)||1
10854480|NCT02410343|12020965|FG000|NOT COMPLETED|Core Period (24 Weeks)||5
10854481|NCT02410343|12020966|FG001|NOT COMPLETED|Core Period (24 Weeks)||7
10854482|NCT02410343|12020965|FG000|STARTED|Extension Period (12 Months)||1
10854483|NCT02410343|12020966|FG001|STARTED|Extension Period (12 Months)||1
10854484|NCT02410343|12020965|FG000|COMPLETED|Extension Period (12 Months)||0
10854485|NCT02410343|12020966|FG001|COMPLETED|Extension Period (12 Months)||0
10854486|NCT02410343|12020965|FG000|NOT COMPLETED|Extension Period (12 Months)||1
10854487|NCT02410343|12020966|FG001|NOT COMPLETED|Extension Period (12 Months)||1
10854488|NCT02343224|12020973|FG000|STARTED|Overall Study||9
10854489|NCT02343224|12020973|FG000|COMPLETED|Overall Study||0
10854490|NCT02343224|12020973|FG000|NOT COMPLETED|Overall Study||9
10754847|NCT03055936|11918661|FG002|NOT COMPLETED|Overall Study||2
10754848|NCT03055936|11918662|FG003|NOT COMPLETED|Overall Study||1
10754849|NCT03055988|11918696|FG000|STARTED|Period 1||38
10754850|NCT03055988|11918697|FG001|STARTED|Period 1||38
10754851|NCT03055988|11918696|FG000|COMPLETED|Period 1||37
10754852|NCT03055988|11918697|FG001|COMPLETED|Period 1||33
10754853|NCT03055988|11918696|FG000|NOT COMPLETED|Period 1||1
10754854|NCT03055988|11918697|FG001|NOT COMPLETED|Period 1||5
10754855|NCT03055988|11918696|FG000|STARTED|Period 2||37
10754856|NCT03055988|11918697|FG001|STARTED|Period 2||33
10754857|NCT03055988|11918696|FG000|COMPLETED|Period 2||36
10754858|NCT03055988|11918697|FG001|COMPLETED|Period 2||31
10754859|NCT03055988|11918696|FG000|NOT COMPLETED|Period 2||1
10754860|NCT03055988|11918697|FG001|NOT COMPLETED|Period 2||2
10854491|NCT02339740|12020979|FG000|STARTED|Overall Study||101
10854492|NCT02339740|12020980|FG001|STARTED|Overall Study||57
10854493|NCT02339740|12020979|FG000|COMPLETED|Overall Study||92
10854494|NCT02339740|12020980|FG001|COMPLETED|Overall Study||53
10854495|NCT02339740|12020979|FG000|NOT COMPLETED|Overall Study||9
10854496|NCT02339740|12020980|FG001|NOT COMPLETED|Overall Study||4
10854497|NCT02291445|12020988|FG000|STARTED|Overall Study||4
10854498|NCT02291445|12020989|FG001|STARTED|Overall Study||4
10854499|NCT02291445|12020988|FG000|COMPLETED|Overall Study||4
10854500|NCT02291445|12020989|FG001|COMPLETED|Overall Study||4
10854501|NCT02291445|12020988|FG000|NOT COMPLETED|Overall Study||0
10854502|NCT02291445|12020989|FG001|NOT COMPLETED|Overall Study||0
10854503|NCT02248688|12020997|FG000|STARTED|Overall Study||5
10854504|NCT02248688|12020997|FG000|COMPLETED|Overall Study||5
10854505|NCT02248688|12020997|FG000|NOT COMPLETED|Overall Study||0
10854506|NCT02045303|12021003|FG000|STARTED|Overall Study||6
10854507|NCT02045303|12021004|FG001|STARTED|Overall Study||3
10854508|NCT02045303|12021005|FG002|STARTED|Overall Study||2
10854509|NCT02045303|12021003|FG000|COMPLETED|Overall Study||4
10854510|NCT02045303|12021004|FG001|COMPLETED|Overall Study||0
10854511|NCT02045303|12021005|FG002|COMPLETED|Overall Study||2
10854512|NCT02045303|12021003|FG000|NOT COMPLETED|Overall Study||2
10854513|NCT02045303|12021004|FG001|NOT COMPLETED|Overall Study||3
10854514|NCT02045303|12021005|FG002|NOT COMPLETED|Overall Study||0
10854515|NCT02025556|12021017|FG000|STARTED|Overall Study||104
10854516|NCT02025556|12021018|FG001|STARTED|Overall Study||96
10854517|NCT02025556|12021019|FG002|STARTED|Overall Study||97
10854518|NCT02025556|12021017|FG000|Safety Analysis Set|Overall Study||104
10854519|NCT02025556|12021018|FG001|Safety Analysis Set|Overall Study||96
10854520|NCT02025556|12021019|FG002|Safety Analysis Set|Overall Study||96
10854521|NCT02025556|12021017|FG000|Intent-to-treat (ITT) Set|Overall Study||104
10854522|NCT02025556|12021018|FG001|Intent-to-treat (ITT) Set|Overall Study||95
10854523|NCT02025556|12021019|FG002|Intent-to-treat (ITT) Set|Overall Study||96
10854524|NCT02025556|12021017|FG000|COMPLETED|Overall Study||98
10854525|NCT02025556|12021018|FG001|COMPLETED|Overall Study||83
10854526|NCT02025556|12021019|FG002|COMPLETED|Overall Study||88
10854527|NCT02025556|12021017|FG000|NOT COMPLETED|Overall Study||6
10854528|NCT02025556|12021018|FG001|NOT COMPLETED|Overall Study||13
10854529|NCT02025556|12021019|FG002|NOT COMPLETED|Overall Study||9
10854530|NCT01986933|12021032|FG000|STARTED|Placebo-controlled (Part A)||53
10854531|NCT01986933|12021033|FG001|STARTED|Placebo-controlled (Part A)||53
10854532|NCT01986933|12021034|FG002|STARTED|Placebo-controlled (Part A)||54
10854533|NCT01986933|12021035|FG003|STARTED|Placebo-controlled (Part A)||52
10854534|NCT01986933|12021036|FG004|STARTED|Placebo-controlled (Part A)||52
10854535|NCT01986933|12021032|FG000|COMPLETED|Placebo-controlled (Part A)||44
10854536|NCT01986933|12021033|FG001|COMPLETED|Placebo-controlled (Part A)||44
10854537|NCT01986933|12021034|FG002|COMPLETED|Placebo-controlled (Part A)||45
10854538|NCT01986933|12021035|FG003|COMPLETED|Placebo-controlled (Part A)||45
10854539|NCT01986933|12021036|FG004|COMPLETED|Placebo-controlled (Part A)||38
10854540|NCT01986933|12021032|FG000|NOT COMPLETED|Placebo-controlled (Part A)||9
10854541|NCT01986933|12021033|FG001|NOT COMPLETED|Placebo-controlled (Part A)||9
10854542|NCT01986933|12021034|FG002|NOT COMPLETED|Placebo-controlled (Part A)||9
10854543|NCT01986933|12021035|FG003|NOT COMPLETED|Placebo-controlled (Part A)||7
10854544|NCT01986933|12021036|FG004|NOT COMPLETED|Placebo-controlled (Part A)||14
10854545|NCT01986933|12021032|FG000|STARTED|Active-to-active (Part B)||0
10854546|NCT01986933|12021033|FG001|STARTED|Active-to-active (Part B)||41
10854547|NCT01986933|12021034|FG002|STARTED|Active-to-active (Part B)||38
10854548|NCT01986933|12021035|FG003|STARTED|Active-to-active (Part B)||39
10854549|NCT01986933|12021036|FG004|STARTED|Active-to-active (Part B)||35
10854550|NCT01986933|12021032|FG000|COMPLETED|Active-to-active (Part B)||0
10854551|NCT01986933|12021033|FG001|COMPLETED|Active-to-active (Part B)||31
10854552|NCT01986933|12021034|FG002|COMPLETED|Active-to-active (Part B)||28
10854553|NCT01986933|12021035|FG003|COMPLETED|Active-to-active (Part B)||30
10854554|NCT01986933|12021036|FG004|COMPLETED|Active-to-active (Part B)||19
10854555|NCT01986933|12021032|FG000|NOT COMPLETED|Active-to-active (Part B)||0
10854556|NCT01986933|12021033|FG001|NOT COMPLETED|Active-to-active (Part B)||10
10854557|NCT01986933|12021034|FG002|NOT COMPLETED|Active-to-active (Part B)||10
10854558|NCT01986933|12021035|FG003|NOT COMPLETED|Active-to-active (Part B)||9
10854559|NCT01986933|12021036|FG004|NOT COMPLETED|Active-to-active (Part B)||16
10854560|NCT01986933|12021032|FG000|STARTED|Placebo-to-active (Part B)||0
10854561|NCT01986933|12021033|FG001|STARTED|Placebo-to-active (Part B)|Patients in the initial placebo group were re-randomized into Nemoliozumab groups (0.1, 0.5 or 2.0 mg/kg Q4W) in Part B.|13
10854562|NCT01986933|12021034|FG002|STARTED|Placebo-to-active (Part B)|Patients in the initial placebo group were re-randomized into Nemoliozumab groups (0.1, 0.5 or 2.0 mg/kg Q4W) in Part B.|12
10854563|NCT01986933|12021035|FG003|STARTED|Placebo-to-active (Part B)|Patients in the initial placebo group were re-randomized into Nemoliozumab groups (0.1, 0.5 or 2.0 mg/kg Q4W) in Part B.|13
10854564|NCT01986933|12021036|FG004|STARTED|Placebo-to-active (Part B)|Patients in the initial placebo group were not re-randomized into Nemoliozumab (2.0 mg/kg) Q8W group in Part B.|0
10854565|NCT01986933|12021032|FG000|COMPLETED|Placebo-to-active (Part B)||0
10854566|NCT01986933|12021033|FG001|COMPLETED|Placebo-to-active (Part B)||8
10854567|NCT01986933|12021034|FG002|COMPLETED|Placebo-to-active (Part B)||7
10854568|NCT01986933|12021035|FG003|COMPLETED|Placebo-to-active (Part B)||8
10854569|NCT01986933|12021036|FG004|COMPLETED|Placebo-to-active (Part B)||0
10854570|NCT01986933|12021032|FG000|NOT COMPLETED|Placebo-to-active (Part B)||0
10854571|NCT01986933|12021033|FG001|NOT COMPLETED|Placebo-to-active (Part B)||5
10854572|NCT01986933|12021034|FG002|NOT COMPLETED|Placebo-to-active (Part B)||5
10854573|NCT01986933|12021035|FG003|NOT COMPLETED|Placebo-to-active (Part B)||5
10854574|NCT01986933|12021036|FG004|NOT COMPLETED|Placebo-to-active (Part B)||0
10854575|NCT01986075|12021058|FG000|STARTED|Initial CBT + CM (Pre-randomization)||0
10854576|NCT01986075|12021059|FG001|STARTED|Initial CBT + CM (Pre-randomization)||0
10854577|NCT01986075|12021060|FG002|STARTED|Initial CBT + CM (Pre-randomization)||145
10854578|NCT01986075|12021058|FG000|COMPLETED|Initial CBT + CM (Pre-randomization)||0
10854579|NCT01986075|12021059|FG001|COMPLETED|Initial CBT + CM (Pre-randomization)||0
10854580|NCT01986075|12021060|FG002|COMPLETED|Initial CBT + CM (Pre-randomization)||86
10854581|NCT01986075|12021058|FG000|NOT COMPLETED|Initial CBT + CM (Pre-randomization)||0
10854582|NCT01986075|12021059|FG001|NOT COMPLETED|Initial CBT + CM (Pre-randomization)||0
10854583|NCT01986075|12021060|FG002|NOT COMPLETED|Initial CBT + CM (Pre-randomization)||59
10854584|NCT01986075|12021058|FG000|STARTED|Randomized Intervention||45
10854585|NCT01986075|12021059|FG001|STARTED|Randomized Intervention||41
10854586|NCT01986075|12021060|FG002|STARTED|Randomized Intervention||0
10854587|NCT01986075|12021058|FG000|COMPLETED|Randomized Intervention||30
10854588|NCT01986075|12021059|FG001|COMPLETED|Randomized Intervention||27
10854589|NCT01986075|12021060|FG002|COMPLETED|Randomized Intervention||0
10854590|NCT01986075|12021058|FG000|NOT COMPLETED|Randomized Intervention||15
10854591|NCT01986075|12021059|FG001|NOT COMPLETED|Randomized Intervention||14
10854592|NCT01986075|12021060|FG002|NOT COMPLETED|Randomized Intervention||0
10854593|NCT01841333|12021067|FG000|STARTED|Overall Study||31
10854594|NCT01841333|12021067|FG000|COMPLETED|Overall Study||31
10854595|NCT01841333|12021067|FG000|NOT COMPLETED|Overall Study||0
10854596|NCT01802788|12021073|FG000|STARTED|Overall Study||941
10854597|NCT01802788|12021074|FG001|STARTED|Overall Study||59
10854598|NCT01802788|12021073|FG000|COMPLETED|Overall Study||755
10854599|NCT01802788|12021074|FG001|COMPLETED|Overall Study||59
10854600|NCT01802788|12021073|FG000|NOT COMPLETED|Overall Study||186
10854601|NCT01802788|12021074|FG001|NOT COMPLETED|Overall Study||0
10854602|NCT01563107|12021082|FG000|STARTED|Overall Study|12 Healthy Controls were randomized to receive LS diet followed by HS diet|12
10854603|NCT01563107|12021083|FG001|STARTED|Overall Study|5 Healthy Controls were randomized to receive HS diet followed by LS diet|5
10854604|NCT01563107|12021084|FG002|STARTED|Overall Study|10 POTS patients were randomized to receive LS diet followed by HS diet|10
10854605|NCT01563107|12021085|FG003|STARTED|Overall Study|11 POTS patients were randomized to receive HS diet followed by LS diet|11
10854606|NCT01563107|12021082|FG000|Phase 1 Baseline Labs|Overall Study||12
10854607|NCT01563107|12021083|FG001|Phase 1 Baseline Labs|Overall Study|1 healthy control was unable to find time to schedule study|4
10854608|NCT01563107|12021084|FG002|Phase 1 Baseline Labs|Overall Study|2 patients with POTS did not discontinue medication that was prohibited by protocol.|8
10854609|NCT01563107|12021085|FG003|Phase 1 Baseline Labs|Overall Study|1 patient with POTS did not discontinue medication that was prohibited by protocol, 1 patient was unable to find time to schedule the study, 1 was noted to be too old to participate, and 1 became pregnant between enrollment and the start of phase 1.|7
10854610|NCT01563107|12021082|FG000|Phase 1-150 mEq Sodium/Day|Overall Study||12
10854611|NCT01563107|12021083|FG001|Phase 1-150 mEq Sodium/Day|Overall Study||4
10854612|NCT01563107|12021084|FG002|Phase 1-150 mEq Sodium/Day|Overall Study||8
10854613|NCT01563107|12021085|FG003|Phase 1-150 mEq Sodium/Day|Overall Study||7
10854614|NCT01563107|12021082|FG000|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||12
10854615|NCT01563107|12021083|FG001|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||4
10854616|NCT01563107|12021084|FG002|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||8
10854617|NCT01563107|12021085|FG003|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||7
10854618|NCT01563107|12021082|FG000|Phase 1-finish|Overall Study|1 healthy control withdrew with migraines during phase 1 (low Na+).|11
10854619|NCT01563107|12021083|FG001|Phase 1-finish|Overall Study|2 healthy controls withdrew during phase 1 (high Na+): 1 unable to tolerate study diet and another with difficulty cooperating with investigators.|2
10854620|NCT01563107|12021084|FG002|Phase 1-finish|Overall Study||8
10854621|NCT01563107|12021085|FG003|Phase 1-finish|Overall Study|1 patient with POTS withdrew during phase 1 due to a family illness.|6
10854622|NCT01563107|12021082|FG000|Phase 2-150 mEq Sodium/Day|Overall Study||11
10854623|NCT01563107|12021083|FG001|Phase 2-150 mEq Sodium/Day|Overall Study||2
10414837|NCT00786994|11559264|FG001|ITT|Overall Study||51
10414838|NCT00786994|11559265|FG002|ITT|Overall Study||25
10414839|NCT00786994|11559266|FG003|ITT|Overall Study||28
10414840|NCT00786994|11559263|FG000|COMPLETED|Overall Study||47
10414841|NCT00786994|11559264|FG001|COMPLETED|Overall Study||39
10414842|NCT00786994|11559265|FG002|COMPLETED|Overall Study||24
10414843|NCT00786994|11559266|FG003|COMPLETED|Overall Study||22
10414844|NCT00786994|11559263|FG000|NOT COMPLETED|Overall Study||10
10414845|NCT00786994|11559264|FG001|NOT COMPLETED|Overall Study||15
10414846|NCT00786994|11559265|FG002|NOT COMPLETED|Overall Study||2
10414847|NCT00786994|11559266|FG003|NOT COMPLETED|Overall Study||6
10414848|NCT00787020|11559277|FG000|STARTED|Overall Study||24
10414849|NCT00787020|11559278|FG001|STARTED|Overall Study||13
10414850|NCT00787020|11559277|FG000|COMPLETED|Overall Study||24
10414851|NCT00787020|11559278|FG001|COMPLETED|Overall Study||13
10414852|NCT00787020|11559277|FG000|NOT COMPLETED|Overall Study||0
10414853|NCT00787020|11559278|FG001|NOT COMPLETED|Overall Study||0
10414854|NCT00787137|11559287|FG000|STARTED|Overall Study||6
10414855|NCT00787137|11559288|FG001|STARTED|Overall Study||6
10414856|NCT00787137|11559289|FG002|STARTED|Overall Study||5
10414857|NCT00787137|11559287|FG000|COMPLETED|Overall Study||6
10414858|NCT00787137|11559288|FG001|COMPLETED|Overall Study||6
10414859|NCT00787137|11559289|FG002|COMPLETED|Overall Study||4
10854624|NCT01563107|12021084|FG002|Phase 2-150 mEq Sodium/Day|Overall Study||8
10854625|NCT01563107|12021085|FG003|Phase 2-150 mEq Sodium/Day|Overall Study||6
10854626|NCT01563107|12021082|FG000|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||11
10854627|NCT01563107|12021083|FG001|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||2
10854628|NCT01563107|12021084|FG002|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||8
10854629|NCT01563107|12021085|FG003|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||6
10854630|NCT01563107|12021082|FG000|Phase 2-finish|Overall Study||11
10854631|NCT01563107|12021083|FG001|Phase 2-finish|Overall Study||2
10854632|NCT01563107|12021084|FG002|Phase 2-finish|Overall Study||8
10854633|NCT01563107|12021085|FG003|Phase 2-finish|Overall Study||6
10854634|NCT01563107|12021082|FG000|COMPLETED|Overall Study||11
10854635|NCT01563107|12021083|FG001|COMPLETED|Overall Study||2
10854636|NCT01563107|12021084|FG002|COMPLETED|Overall Study||8
10854637|NCT01563107|12021085|FG003|COMPLETED|Overall Study||6
10854638|NCT01563107|12021082|FG000|NOT COMPLETED|Overall Study||1
10854639|NCT01563107|12021083|FG001|NOT COMPLETED|Overall Study||3
10854640|NCT01563107|12021084|FG002|NOT COMPLETED|Overall Study||2
10854641|NCT01563107|12021085|FG003|NOT COMPLETED|Overall Study||5
10854642|NCT01320072|12021147|FG000|STARTED|Overall Study||16
10854643|NCT01320072|12021148|FG001|STARTED|Overall Study||13
10854644|NCT01320072|12021147|FG000|COMPLETED|Overall Study||16
10854645|NCT01320072|12021148|FG001|COMPLETED|Overall Study||13
10854646|NCT01320072|12021147|FG000|NOT COMPLETED|Overall Study||0
10854647|NCT01320072|12021148|FG001|NOT COMPLETED|Overall Study||0
10854654|NCT01042522|12021166|FG000|STARTED|Overall Study||31
10854655|NCT01042522|12021167|FG001|STARTED|Overall Study||32
10854656|NCT01042522|12021166|FG000|COMPLETED|Overall Study|Completed 6 cycles of protocol regimen|23
10854760|NCT04034355|12021268|FG000|COMPLETED|Overall Study||117
10854657|NCT01042522|12021167|FG001|COMPLETED|Overall Study|Completed 4 cycles of protocol regimen|26
10854658|NCT01042522|12021166|FG000|NOT COMPLETED|Overall Study||8
10854659|NCT01042522|12021167|FG001|NOT COMPLETED|Overall Study||6
10854660|NCT00944528|12021176|FG000|STARTED|Overall Study||9
10854661|NCT00944528|12021177|FG001|STARTED|Overall Study||10
10854662|NCT00944528|12021178|FG002|STARTED|Overall Study||16
10854663|NCT00944528|12021176|FG000|COMPLETED|Overall Study||8
10854664|NCT00944528|12021177|FG001|COMPLETED|Overall Study||8
10854665|NCT00944528|12021178|FG002|COMPLETED|Overall Study||16
10854666|NCT00944528|12021176|FG000|NOT COMPLETED|Overall Study||1
10854667|NCT00944528|12021177|FG001|NOT COMPLETED|Overall Study||2
10854668|NCT00944528|12021178|FG002|NOT COMPLETED|Overall Study||0
10854669|NCT00941915|12021187|FG000|STARTED|Overall Study||60
10854670|NCT00941915|12021187|FG000|COMPLETED|Overall Study||60
10854671|NCT00941915|12021187|FG000|NOT COMPLETED|Overall Study||0
10854672|NCT00826462|12021194|FG000|STARTED|Overall Study||59
10854673|NCT00826462|12021195|FG001|STARTED|Overall Study||58
10854674|NCT00826462|12021196|FG002|STARTED|Overall Study||60
10854675|NCT00826462|12021194|FG000|COMPLETED|Overall Study||52
10854676|NCT00826462|12021195|FG001|COMPLETED|Overall Study||53
10854677|NCT00826462|12021196|FG002|COMPLETED|Overall Study||52
10854678|NCT00826462|12021194|FG000|NOT COMPLETED|Overall Study||7
10854679|NCT00826462|12021195|FG001|NOT COMPLETED|Overall Study||5
10854680|NCT00826462|12021196|FG002|NOT COMPLETED|Overall Study||8
10854681|NCT00710970|12021206|FG000|STARTED|Overall Study||28
10854682|NCT00710970|12021206|FG000|COMPLETED|Overall Study||25
10854683|NCT00710970|12021206|FG000|NOT COMPLETED|Overall Study||3
10854684|NCT00685919|12021214|FG000|STARTED|Overall Study|8 healthy controls were randomized to receive placebo followed by carbidopa. 1 received only 50 mg doses of carbidopa and her data were excluded.|8
10854685|NCT00685919|12021215|FG001|STARTED|Overall Study|9 healthy controls were randomized to receive carbidopa followed by placebo.|9
10854686|NCT00685919|12021216|FG002|STARTED|Overall Study|8 patients with POTS were randomized to receive placebo followed by carbidopa. 1 of these received only 50 mg doses of carbidopa and her data are excluded.|8
10854687|NCT00685919|12021217|FG003|STARTED|Overall Study|3 patients with POTS were randomized to receive carbidopa followed by placebo.|3
10854688|NCT00685919|12021214|FG000|Baseline A|Overall Study|After achieving sodium balance on 200 mEq/day sodium diet, subjects collected baseline 24hr urine. They fasted from 7pm until the next morning. In the morning, while still supine, heart rate and blood pressure were recorded and blood was drawn. Participants then stood for 10 min. Heart rate and blood pressure were measured at intervals and an upright blood sample was collected. Urine was collected to end the 24hr collection.|8
10854689|NCT00685919|12021215|FG001|Baseline A|Overall Study|After achieving sodium balance on 200 mEq/day sodium diet, subjects collected baseline 24hr urine. They fasted from 7pm until the next morning. In the morning, while still supine, heart rate and blood pressure were recorded and blood was drawn. Participants then stood for 10 min. Heart rate and blood pressure were measured at intervals and an upright blood sample was collected. Urine was collected to end the 24hr collection. 1 patient withdrew after orthostatic symptoms during baseline.|9
10854690|NCT00685919|12021216|FG002|Baseline A|Overall Study|After achieving sodium balance on 200 mEq/day sodium diet, subjects collected baseline 24hr urine. They fasted from 7pm until the next morning. In the morning, while still supine, heart rate and blood pressure were recorded and blood was drawn. Participants then stood for 10 min. Heart rate and blood pressure were measured at intervals and an upright blood sample was collected. Urine was collected to end the 24hr collection. 1 patient withdrew after orthostatic symptoms during baseline.|8
10854691|NCT00685919|12021217|FG003|Baseline A|Overall Study|After achieving sodium balance on 200 mEq/day sodium diet, subjects collected baseline 24hr urine. They fasted from 7pm until the next morning. In the morning, while still supine, heart rate and blood pressure were recorded and blood was drawn. Participants then stood for 10 min. Heart rate and blood pressure were measured at intervals and an upright blood sample was collected. Urine was collected to end the 24hr collection.|3
10854692|NCT00685919|12021214|FG000|Treatment A|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, placebo was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|7
10854693|NCT00685919|12021215|FG001|Treatment A|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, carbidopa 200 mg was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|9
10854694|NCT00685919|12021216|FG002|Treatment A|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, placebo was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|8
10854695|NCT00685919|12021217|FG003|Treatment A|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, carbidopa 200 mg was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|3
10854696|NCT00685919|12021214|FG000|24 hr Post-treatment A|Overall Study|Urine was collected for 24 hr after the last dose of Treatment A.|7
10854697|NCT00685919|12021215|FG001|24 hr Post-treatment A|Overall Study|Urine was collected for 24 hr after the last dose of Treatment A.|9
10854698|NCT00685919|12021216|FG002|24 hr Post-treatment A|Overall Study|Urine was collected for 24 hr after the last dose of Treatment A.|7
10854699|NCT00685919|12021217|FG003|24 hr Post-treatment A|Overall Study|Urine was collected for 24 hr after the last dose of Treatment A.|3
10854700|NCT00685919|12021214|FG000|Baseline B|Overall Study|After at least a 1-day washout period, patients underwent baseline procedures as described previously.|7
10854701|NCT00685919|12021215|FG001|Baseline B|Overall Study|After at least a 1-day washout period, patients underwent baseline procedures as described previously.|9
10854761|NCT04034355|12021269|FG001|COMPLETED|Overall Study||115
10854702|NCT00685919|12021216|FG002|Baseline B|Overall Study|After at least a 1-day washout period, patients underwent baseline procedures as described previously.|7
10854703|NCT00685919|12021217|FG003|Baseline B|Overall Study|After at least a 1-day washout period, patients underwent baseline procedures as described previously.|3
10854704|NCT00685919|12021214|FG000|Treatment B|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, carbidopa 200 mg was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|7
10854705|NCT00685919|12021215|FG001|Treatment B|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, placebo was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|9
10854706|NCT00685919|12021216|FG002|Treatment B|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, carbidopa 200 mg was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|7
10854707|NCT00685919|12021217|FG003|Treatment B|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, placebo was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|3
10854708|NCT00685919|12021214|FG000|24 hr Post Treatment B|Overall Study|Urine was collected for 24 hr after last dose of Treatment B.|7
10854709|NCT00685919|12021215|FG001|24 hr Post Treatment B|Overall Study|Urine was collected for 24 hr after last dose of Treatment B.|9
10854710|NCT00685919|12021216|FG002|24 hr Post Treatment B|Overall Study|Urine was collected for 24 hr after last dose of Treatment B.|7
10854711|NCT00685919|12021217|FG003|24 hr Post Treatment B|Overall Study|Urine was collected for 24 hr after last dose of Treatment B.|3
10854712|NCT00685919|12021214|FG000|COMPLETED|Overall Study||7
10854713|NCT00685919|12021215|FG001|COMPLETED|Overall Study||9
10854714|NCT00685919|12021216|FG002|COMPLETED|Overall Study||7
10854715|NCT00685919|12021217|FG003|COMPLETED|Overall Study||3
10854716|NCT00685919|12021214|FG000|NOT COMPLETED|Overall Study||1
10854717|NCT00685919|12021215|FG001|NOT COMPLETED|Overall Study||0
10854718|NCT00685919|12021216|FG002|NOT COMPLETED|Overall Study||1
10854719|NCT00685919|12021217|FG003|NOT COMPLETED|Overall Study||0
10854720|NCT00344487|12021227|FG000|STARTED|Overall Study||3
10854721|NCT00344487|12021227|FG000|COMPLETED|Overall Study|One subject was withdrawn at month 9 because he was considered an immunologic failure on study.|2
10854722|NCT00344487|12021227|FG000|NOT COMPLETED|Overall Study||1
10854723|NCT00281658|12021235|FG000|STARTED|Double-blind, Randomized Phase||222
10854724|NCT00281658|12021236|FG001|STARTED|Double-blind, Randomized Phase|Of these participants, 149 entered the open-label extension phase.|222
10854725|NCT00281658|12021237|FG002|STARTED|Double-blind, Randomized Phase||0
10854726|NCT00281658|12021235|FG000|COMPLETED|Double-blind, Randomized Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|85
10854727|NCT00281658|12021236|FG001|COMPLETED|Double-blind, Randomized Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|168
10854728|NCT00281658|12021237|FG002|COMPLETED|Double-blind, Randomized Phase||0
10854729|NCT00281658|12021235|FG000|NOT COMPLETED|Double-blind, Randomized Phase||137
10854730|NCT00281658|12021236|FG001|NOT COMPLETED|Double-blind, Randomized Phase||54
10854731|NCT00281658|12021237|FG002|NOT COMPLETED|Double-blind, Randomized Phase||0
10854732|NCT00281658|12021235|FG000|STARTED|Open-label Monotherapy Extension Phase||0
10854733|NCT00281658|12021236|FG001|STARTED|Open-label Monotherapy Extension Phase||0
10854734|NCT00281658|12021237|FG002|STARTED|Open-label Monotherapy Extension Phase||149
10854735|NCT00281658|12021235|FG000|COMPLETED|Open-label Monotherapy Extension Phase||0
10854736|NCT00281658|12021236|FG001|COMPLETED|Open-label Monotherapy Extension Phase||0
10854737|NCT00281658|12021237|FG002|COMPLETED|Open-label Monotherapy Extension Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|48
10854738|NCT00281658|12021235|FG000|NOT COMPLETED|Open-label Monotherapy Extension Phase||0
10854739|NCT00281658|12021236|FG001|NOT COMPLETED|Open-label Monotherapy Extension Phase||0
10854740|NCT00281658|12021237|FG002|NOT COMPLETED|Open-label Monotherapy Extension Phase||101
10414860|NCT00787137|11559287|FG000|NOT COMPLETED|Overall Study||0
10414861|NCT00787137|11559288|FG001|NOT COMPLETED|Overall Study||0
10293270|NCT01193842|11425867|FG002|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
10414862|NCT00787137|11559289|FG002|NOT COMPLETED|Overall Study||1
10854741|NCT04368910|12021246|FG000|STARTED|Overall Study||15
10854742|NCT04368910|12021247|FG001|STARTED|Overall Study||15
10854743|NCT04368910|12021246|FG000|COMPLETED|Overall Study||15
10854744|NCT04368910|12021247|FG001|COMPLETED|Overall Study||15
10854745|NCT04368910|12021246|FG000|NOT COMPLETED|Overall Study||0
10854746|NCT04368910|12021247|FG001|NOT COMPLETED|Overall Study||0
10854747|NCT04365985|12021256|FG000|STARTED|Overall Study||9
10854748|NCT04365985|12021257|FG001|STARTED|Overall Study||9
10854749|NCT04365985|12021258|FG002|STARTED|Overall Study||52
10854750|NCT04365985|12021256|FG000|COMPLETED|Overall Study||9
10854751|NCT04365985|12021257|FG001|COMPLETED|Overall Study||9
10854752|NCT04365985|12021258|FG002|COMPLETED|Overall Study||52
10854753|NCT04365985|12021256|FG000|NOT COMPLETED|Overall Study||0
10854754|NCT04365985|12021257|FG001|NOT COMPLETED|Overall Study||0
10854755|NCT04365985|12021258|FG002|NOT COMPLETED|Overall Study||0
10314503|NCT00163657|11448149|FG001|COMPLETED|Overall Study||56
10854756|NCT04034355|12021268|FG000|STARTED|Overall Study||151
10854757|NCT04034355|12021269|FG001|STARTED|Overall Study||150
10854758|NCT04034355|12021268|FG000|Treated|Overall Study||147
10854759|NCT04034355|12021269|FG001|Treated|Overall Study||150
10854762|NCT04034355|12021268|FG000|NOT COMPLETED|Overall Study||34
10854763|NCT04034355|12021269|FG001|NOT COMPLETED|Overall Study||35
10854764|NCT03781726|12021275|FG000|STARTED|Overall Study||30
10854765|NCT03781726|12021275|FG000|COMPLETED|Overall Study||28
10854766|NCT03781726|12021275|FG000|NOT COMPLETED|Overall Study||2
10854767|NCT03721276|12021281|FG000|STARTED|Overall Study||30
10854768|NCT03721276|12021282|FG001|STARTED|Overall Study||30
10854769|NCT03721276|12021281|FG000|Three-month Pre-intervention|Overall Study|Participants in this arm started therapy immediately after randomization, and therefore, did not have a three-month waiting period prior to receiving the intervention.|0
10854770|NCT03721276|12021282|FG001|Three-month Pre-intervention|Overall Study||30
10854771|NCT03721276|12021281|FG000|Immediate Pre-intervention|Overall Study||30
10854772|NCT03721276|12021282|FG001|Immediate Pre-intervention|Overall Study||29
10854773|NCT03721276|12021281|FG000|Post-intervention|Overall Study||25
10854774|NCT03721276|12021282|FG001|Post-intervention|Overall Study||26
10854775|NCT03721276|12021281|FG000|Three-month Follow-up (Post Intervention)|Overall Study||25
10854776|NCT03721276|12021282|FG001|Three-month Follow-up (Post Intervention)|Overall Study|Participants in this arm started therapy three months after randomization (waitlist) and therefore, were not assessed at the three-month follow-up time point due to completion of the study|0
10854777|NCT03721276|12021281|FG000|COMPLETED|Overall Study||25
10854778|NCT03721276|12021282|FG001|COMPLETED|Overall Study||26
10854779|NCT03721276|12021281|FG000|NOT COMPLETED|Overall Study||5
10854780|NCT03721276|12021282|FG001|NOT COMPLETED|Overall Study||4
10854781|NCT03700658|12021288|FG000|STARTED|Overall Study||27
10854782|NCT03700658|12021288|FG000|Received at Least 1 Dose of Study Drug|Overall Study||27
10854783|NCT03700658|12021288|FG000|COMPLETED|Overall Study||27
10854784|NCT03700658|12021288|FG000|NOT COMPLETED|Overall Study||0
10854785|NCT03637491|12021305|FG000|STARTED|Overall Study||10
10854786|NCT03637491|12021306|FG001|STARTED|Overall Study||12
10854787|NCT03637491|12021307|FG002|STARTED|Overall Study||7
10854788|NCT03637491|12021308|FG003|STARTED|Overall Study||6
10854789|NCT03637491|12021305|FG000|Received Treatment|Overall Study||10
10854790|NCT03637491|12021306|FG001|Received Treatment|Overall Study||12
10854791|NCT03637491|12021307|FG002|Received Treatment|Overall Study||7
10854792|NCT03637491|12021308|FG003|Received Treatment|Overall Study||6
10854793|NCT03637491|12021305|FG000|COMPLETED|Overall Study||0
10854794|NCT03637491|12021306|FG001|COMPLETED|Overall Study||0
10854795|NCT03637491|12021307|FG002|COMPLETED|Overall Study||0
10854796|NCT03637491|12021308|FG003|COMPLETED|Overall Study||0
10854797|NCT03637491|12021305|FG000|NOT COMPLETED|Overall Study||10
10854798|NCT03637491|12021306|FG001|NOT COMPLETED|Overall Study||12
10854799|NCT03637491|12021307|FG002|NOT COMPLETED|Overall Study||7
10854800|NCT03637491|12021308|FG003|NOT COMPLETED|Overall Study||6
10854801|NCT03610334|12021332|FG000|STARTED|Period 1: 2.5mg (1 Day)||6
10854802|NCT03610334|12021333|FG001|STARTED|Period 1: 2.5mg (1 Day)||2
10854803|NCT03610334|12021334|FG002|STARTED|Period 1: 2.5mg (1 Day)||0
10854804|NCT03610334|12021335|FG003|STARTED|Period 1: 2.5mg (1 Day)||0
10854805|NCT03610334|12021336|FG004|STARTED|Period 1: 2.5mg (1 Day)||0
10854806|NCT03610334|12021337|FG005|STARTED|Period 1: 2.5mg (1 Day)||0
10854807|NCT03610334|12021338|FG006|STARTED|Period 1: 2.5mg (1 Day)||0
10854808|NCT03610334|12021339|FG007|STARTED|Period 1: 2.5mg (1 Day)||0
10854809|NCT03610334|12021340|FG008|STARTED|Period 1: 2.5mg (1 Day)||0
10854810|NCT03610334|12021341|FG009|STARTED|Period 1: 2.5mg (1 Day)||0
10854811|NCT03610334|12021342|FG010|STARTED|Period 1: 2.5mg (1 Day)||0
10854812|NCT03610334|12021343|FG011|STARTED|Period 1: 2.5mg (1 Day)||0
10854813|NCT03610334|12021344|FG012|STARTED|Period 1: 2.5mg (1 Day)||0
10854814|NCT03610334|12021345|FG013|STARTED|Period 1: 2.5mg (1 Day)||0
10854815|NCT03610334|12021346|FG014|STARTED|Period 1: 2.5mg (1 Day)||0
10854816|NCT03610334|12021347|FG015|STARTED|Period 1: 2.5mg (1 Day)||0
10854817|NCT03610334|12021348|FG016|STARTED|Period 1: 2.5mg (1 Day)||0
10854818|NCT03610334|12021349|FG017|STARTED|Period 1: 2.5mg (1 Day)||0
10854819|NCT03610334|12021332|FG000|COMPLETED|Period 1: 2.5mg (1 Day)||6
10854820|NCT03610334|12021333|FG001|COMPLETED|Period 1: 2.5mg (1 Day)||2
10854821|NCT03610334|12021334|FG002|COMPLETED|Period 1: 2.5mg (1 Day)||0
10854822|NCT03610334|12021335|FG003|COMPLETED|Period 1: 2.5mg (1 Day)||0
10854823|NCT03610334|12021336|FG004|COMPLETED|Period 1: 2.5mg (1 Day)||0
10854824|NCT03610334|12021337|FG005|COMPLETED|Period 1: 2.5mg (1 Day)||0
10854825|NCT03610334|12021338|FG006|COMPLETED|Period 1: 2.5mg (1 Day)||0
10854826|NCT03610334|12021339|FG007|COMPLETED|Period 1: 2.5mg (1 Day)||0
10854827|NCT03610334|12021340|FG008|COMPLETED|Period 1: 2.5mg (1 Day)||0
10854828|NCT03610334|12021341|FG009|COMPLETED|Period 1: 2.5mg (1 Day)||0
10854829|NCT03610334|12021342|FG010|COMPLETED|Period 1: 2.5mg (1 Day)||0
10854830|NCT03610334|12021343|FG011|COMPLETED|Period 1: 2.5mg (1 Day)||0
10854831|NCT03610334|12021344|FG012|COMPLETED|Period 1: 2.5mg (1 Day)||0
10854832|NCT03610334|12021345|FG013|COMPLETED|Period 1: 2.5mg (1 Day)||0
10854833|NCT03610334|12021346|FG014|COMPLETED|Period 1: 2.5mg (1 Day)||0
10854834|NCT03610334|12021347|FG015|COMPLETED|Period 1: 2.5mg (1 Day)||0
10854835|NCT03610334|12021348|FG016|COMPLETED|Period 1: 2.5mg (1 Day)||0
10854836|NCT03610334|12021349|FG017|COMPLETED|Period 1: 2.5mg (1 Day)||0
10854837|NCT03610334|12021332|FG000|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
10854838|NCT03610334|12021333|FG001|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
10854839|NCT03610334|12021334|FG002|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
10545586|NCT01498588|11698991|FG000|NOT COMPLETED|Overall Study||0
10754877|NCT03056144|11918712|FG000|STARTED|Overall Study||1
10754878|NCT03056144|11918712|FG000|COMPLETED|Overall Study||1
10754879|NCT03056144|11918712|FG000|NOT COMPLETED|Overall Study||0
10754880|NCT03056300|11918716|FG000|STARTED|Overall Study||50
10754881|NCT03056300|11918716|FG000|COMPLETED|Overall Study||47
10754882|NCT03056300|11918716|FG000|NOT COMPLETED|Overall Study||3
10754883|NCT03056352|11918720|FG000|STARTED|Overall Study||21
10754884|NCT03056352|11918720|FG000|COMPLETED|Overall Study||20
10754885|NCT03056352|11918720|FG000|NOT COMPLETED|Overall Study||1
10754886|NCT03056456|11918724|FG000|STARTED|Period 1||6
10754887|NCT03056456|11918725|FG001|STARTED|Period 1||6
10754888|NCT03056456|11918726|FG002|STARTED|Period 1||6
10754889|NCT03056456|11918727|FG003|STARTED|Period 1||6
10754890|NCT03056456|11918724|FG000|Received One Dose of Study Drug|Period 1||6
10754891|NCT03056456|11918725|FG001|Received One Dose of Study Drug|Period 1||6
10754892|NCT03056456|11918726|FG002|Received One Dose of Study Drug|Period 1||6
10754893|NCT03056456|11918727|FG003|Received One Dose of Study Drug|Period 1||6
10754894|NCT03056456|11918724|FG000|COMPLETED|Period 1||6
10754895|NCT03056456|11918725|FG001|COMPLETED|Period 1||6
10754896|NCT03056456|11918726|FG002|COMPLETED|Period 1||6
10754897|NCT03056456|11918727|FG003|COMPLETED|Period 1||6
10754898|NCT03056456|11918724|FG000|NOT COMPLETED|Period 1||0
10754899|NCT03056456|11918725|FG001|NOT COMPLETED|Period 1||0
10754900|NCT03056456|11918726|FG002|NOT COMPLETED|Period 1||0
10754901|NCT03056456|11918727|FG003|NOT COMPLETED|Period 1||0
10754902|NCT03056456|11918724|FG000|STARTED|Period 2||6
10754903|NCT03056456|11918725|FG001|STARTED|Period 2||6
10754904|NCT03056456|11918726|FG002|STARTED|Period 2||6
10754905|NCT03056456|11918727|FG003|STARTED|Period 2||6
10754906|NCT03056456|11918724|FG000|COMPLETED|Period 2||6
10754907|NCT03056456|11918725|FG001|COMPLETED|Period 2||6
10754908|NCT03056456|11918726|FG002|COMPLETED|Period 2||6
10754909|NCT03056456|11918727|FG003|COMPLETED|Period 2||6
10754910|NCT03056456|11918724|FG000|NOT COMPLETED|Period 2||0
10754911|NCT03056456|11918725|FG001|NOT COMPLETED|Period 2||0
10754912|NCT03056456|11918726|FG002|NOT COMPLETED|Period 2||0
10754913|NCT03056456|11918727|FG003|NOT COMPLETED|Period 2||0
10754914|NCT03056456|11918724|FG000|STARTED|Period 3||6
10754915|NCT03056456|11918725|FG001|STARTED|Period 3||6
10754916|NCT03056456|11918726|FG002|STARTED|Period 3||6
10754917|NCT03056456|11918727|FG003|STARTED|Period 3||6
10754918|NCT03056456|11918724|FG000|COMPLETED|Period 3||6
10754919|NCT03056456|11918725|FG001|COMPLETED|Period 3||6
10754920|NCT03056456|11918726|FG002|COMPLETED|Period 3||6
10754921|NCT03056456|11918727|FG003|COMPLETED|Period 3||6
10754922|NCT03056456|11918724|FG000|NOT COMPLETED|Period 3||0
10754923|NCT03056456|11918725|FG001|NOT COMPLETED|Period 3||0
10754924|NCT03056456|11918726|FG002|NOT COMPLETED|Period 3||0
10754925|NCT03056456|11918727|FG003|NOT COMPLETED|Period 3||0
10754926|NCT03056456|11918724|FG000|STARTED|Period 4||6
10754927|NCT03056456|11918725|FG001|STARTED|Period 4||6
10754928|NCT03056456|11918726|FG002|STARTED|Period 4||6
10754929|NCT03056456|11918727|FG003|STARTED|Period 4|Participant deviated from 1 week maximum between consecutive periods and did not start Period 4.|5
10754930|NCT03056456|11918724|FG000|COMPLETED|Period 4||6
10754931|NCT03056456|11918725|FG001|COMPLETED|Period 4||6
10754932|NCT03056456|11918726|FG002|COMPLETED|Period 4||6
10754933|NCT03056456|11918727|FG003|COMPLETED|Period 4||5
10754934|NCT03056456|11918724|FG000|NOT COMPLETED|Period 4||0
10754935|NCT03056456|11918725|FG001|NOT COMPLETED|Period 4||0
10754936|NCT03056456|11918726|FG002|NOT COMPLETED|Period 4||0
10754937|NCT03056456|11918727|FG003|NOT COMPLETED|Period 4||0
10754938|NCT03056573|11918742|FG000|STARTED|Overall Study||45
10754939|NCT03056573|11918743|FG001|STARTED|Overall Study||19
10754940|NCT03056573|11918742|FG000|COMPLETED|Overall Study||40
10754941|NCT03056573|11918743|FG001|COMPLETED|Overall Study||14
10754942|NCT03056573|11918742|FG000|NOT COMPLETED|Overall Study||5
10754943|NCT03056573|11918743|FG001|NOT COMPLETED|Overall Study||5
10754944|NCT03056690|11918751|FG000|STARTED|Overall Study||95
10545587|NCT01498601|11698997|FG000|STARTED|Overall Study||51
10754945|NCT03056690|11918752|FG001|STARTED|Overall Study||91
10754946|NCT03056690|11918751|FG000|Treated|Overall Study||94
10754947|NCT03056690|11918752|FG001|Treated|Overall Study||90
10754948|NCT03056690|11918751|FG000|COMPLETED|Overall Study||81
10754949|NCT03056690|11918752|FG001|COMPLETED|Overall Study||75
10754950|NCT03056690|11918751|FG000|NOT COMPLETED|Overall Study||14
10545588|NCT01498601|11698998|FG001|STARTED|Overall Study||32
10754951|NCT03056690|11918752|FG001|NOT COMPLETED|Overall Study||16
10754952|NCT03057132|11918758|FG000|STARTED|Overall Study||1
10854840|NCT03610334|12021335|FG003|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
10854841|NCT03610334|12021336|FG004|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
10854842|NCT03610334|12021337|FG005|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
10854843|NCT03610334|12021338|FG006|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
10854844|NCT03610334|12021339|FG007|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
10854845|NCT03610334|12021340|FG008|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
10854846|NCT03610334|12021341|FG009|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
10854847|NCT03610334|12021342|FG010|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
10854848|NCT03610334|12021343|FG011|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
10854849|NCT03610334|12021344|FG012|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
10854850|NCT03610334|12021345|FG013|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
10854851|NCT03610334|12021346|FG014|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
10854852|NCT03610334|12021347|FG015|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
10854853|NCT03610334|12021348|FG016|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
10854854|NCT03610334|12021349|FG017|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
10854855|NCT03610334|12021332|FG000|STARTED|Period 2: 5.0mg (1 Day)||6
10854856|NCT03610334|12021333|FG001|STARTED|Period 2: 5.0mg (1 Day)||2
10854857|NCT03610334|12021334|FG002|STARTED|Period 2: 5.0mg (1 Day)||6
10854858|NCT03610334|12021335|FG003|STARTED|Period 2: 5.0mg (1 Day)||2
10854859|NCT03610334|12021336|FG004|STARTED|Period 2: 5.0mg (1 Day)||0
10854860|NCT03610334|12021337|FG005|STARTED|Period 2: 5.0mg (1 Day)||0
10854861|NCT03610334|12021338|FG006|STARTED|Period 2: 5.0mg (1 Day)||0
10854862|NCT03610334|12021339|FG007|STARTED|Period 2: 5.0mg (1 Day)||0
10854863|NCT03610334|12021340|FG008|STARTED|Period 2: 5.0mg (1 Day)||0
10854864|NCT03610334|12021341|FG009|STARTED|Period 2: 5.0mg (1 Day)||0
10854865|NCT03610334|12021342|FG010|STARTED|Period 2: 5.0mg (1 Day)||0
10854866|NCT03610334|12021343|FG011|STARTED|Period 2: 5.0mg (1 Day)||0
10854867|NCT03610334|12021344|FG012|STARTED|Period 2: 5.0mg (1 Day)||0
10854868|NCT03610334|12021345|FG013|STARTED|Period 2: 5.0mg (1 Day)||0
10854869|NCT03610334|12021346|FG014|STARTED|Period 2: 5.0mg (1 Day)||0
10854870|NCT03610334|12021347|FG015|STARTED|Period 2: 5.0mg (1 Day)||0
10854871|NCT03610334|12021348|FG016|STARTED|Period 2: 5.0mg (1 Day)||0
10854872|NCT03610334|12021349|FG017|STARTED|Period 2: 5.0mg (1 Day)||0
10854873|NCT03610334|12021332|FG000|COMPLETED|Period 2: 5.0mg (1 Day)||6
10854874|NCT03610334|12021333|FG001|COMPLETED|Period 2: 5.0mg (1 Day)||2
10854875|NCT03610334|12021334|FG002|COMPLETED|Period 2: 5.0mg (1 Day)||6
10854876|NCT03610334|12021335|FG003|COMPLETED|Period 2: 5.0mg (1 Day)||2
10854877|NCT03610334|12021336|FG004|COMPLETED|Period 2: 5.0mg (1 Day)||0
10854878|NCT03610334|12021337|FG005|COMPLETED|Period 2: 5.0mg (1 Day)||0
10854879|NCT03610334|12021338|FG006|COMPLETED|Period 2: 5.0mg (1 Day)||0
10854880|NCT03610334|12021339|FG007|COMPLETED|Period 2: 5.0mg (1 Day)||0
10854881|NCT03610334|12021340|FG008|COMPLETED|Period 2: 5.0mg (1 Day)||0
10854882|NCT03610334|12021341|FG009|COMPLETED|Period 2: 5.0mg (1 Day)||0
10854883|NCT03610334|12021342|FG010|COMPLETED|Period 2: 5.0mg (1 Day)||0
10854884|NCT03610334|12021343|FG011|COMPLETED|Period 2: 5.0mg (1 Day)||0
10854885|NCT03610334|12021344|FG012|COMPLETED|Period 2: 5.0mg (1 Day)||0
10854886|NCT03610334|12021345|FG013|COMPLETED|Period 2: 5.0mg (1 Day)||0
10854887|NCT03610334|12021346|FG014|COMPLETED|Period 2: 5.0mg (1 Day)||0
10854888|NCT03610334|12021347|FG015|COMPLETED|Period 2: 5.0mg (1 Day)||0
10854889|NCT03610334|12021348|FG016|COMPLETED|Period 2: 5.0mg (1 Day)||0
10854890|NCT03610334|12021349|FG017|COMPLETED|Period 2: 5.0mg (1 Day)||0
10854891|NCT03610334|12021332|FG000|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
10854892|NCT03610334|12021333|FG001|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
10854893|NCT03610334|12021334|FG002|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
10854894|NCT03610334|12021335|FG003|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
10854895|NCT03610334|12021336|FG004|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
10854896|NCT03610334|12021337|FG005|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
10854897|NCT03610334|12021338|FG006|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
10854898|NCT03610334|12021339|FG007|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
10854899|NCT03610334|12021340|FG008|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
10854900|NCT03610334|12021341|FG009|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
10854901|NCT03610334|12021342|FG010|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
10854902|NCT03610334|12021343|FG011|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
10854903|NCT03610334|12021344|FG012|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
10854904|NCT03610334|12021345|FG013|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
10854905|NCT03610334|12021346|FG014|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
10854906|NCT03610334|12021347|FG015|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
10854907|NCT03610334|12021348|FG016|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
10854908|NCT03610334|12021349|FG017|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
10854909|NCT03610334|12021332|FG000|STARTED|Period 3: 10.0mg (1 Day)||6
10854910|NCT03610334|12021333|FG001|STARTED|Period 3: 10.0mg (1 Day)||2
10854911|NCT03610334|12021334|FG002|STARTED|Period 3: 10.0mg (1 Day)||6
10854912|NCT03610334|12021335|FG003|STARTED|Period 3: 10.0mg (1 Day)||2
10854913|NCT03610334|12021336|FG004|STARTED|Period 3: 10.0mg (1 Day)||6
10854914|NCT03610334|12021337|FG005|STARTED|Period 3: 10.0mg (1 Day)||2
10854915|NCT03610334|12021338|FG006|STARTED|Period 3: 10.0mg (1 Day)||0
10854916|NCT03610334|12021339|FG007|STARTED|Period 3: 10.0mg (1 Day)||0
10854917|NCT03610334|12021340|FG008|STARTED|Period 3: 10.0mg (1 Day)||0
10854918|NCT03610334|12021341|FG009|STARTED|Period 3: 10.0mg (1 Day)||0
10854919|NCT03610334|12021342|FG010|STARTED|Period 3: 10.0mg (1 Day)||0
10854920|NCT03610334|12021343|FG011|STARTED|Period 3: 10.0mg (1 Day)||0
10854921|NCT03610334|12021344|FG012|STARTED|Period 3: 10.0mg (1 Day)||0
10854922|NCT03610334|12021345|FG013|STARTED|Period 3: 10.0mg (1 Day)||0
10854923|NCT03610334|12021346|FG014|STARTED|Period 3: 10.0mg (1 Day)||0
10854924|NCT03610334|12021347|FG015|STARTED|Period 3: 10.0mg (1 Day)||0
10854925|NCT03610334|12021348|FG016|STARTED|Period 3: 10.0mg (1 Day)||0
10854926|NCT03610334|12021349|FG017|STARTED|Period 3: 10.0mg (1 Day)||0
10854927|NCT03610334|12021332|FG000|COMPLETED|Period 3: 10.0mg (1 Day)||6
10854928|NCT03610334|12021333|FG001|COMPLETED|Period 3: 10.0mg (1 Day)||2
10854929|NCT03610334|12021334|FG002|COMPLETED|Period 3: 10.0mg (1 Day)||6
10854930|NCT03610334|12021335|FG003|COMPLETED|Period 3: 10.0mg (1 Day)||2
10854931|NCT03610334|12021336|FG004|COMPLETED|Period 3: 10.0mg (1 Day)||6
10854932|NCT03610334|12021337|FG005|COMPLETED|Period 3: 10.0mg (1 Day)||2
10854933|NCT03610334|12021338|FG006|COMPLETED|Period 3: 10.0mg (1 Day)||0
10854934|NCT03610334|12021339|FG007|COMPLETED|Period 3: 10.0mg (1 Day)||0
10854935|NCT03610334|12021340|FG008|COMPLETED|Period 3: 10.0mg (1 Day)||0
10854936|NCT03610334|12021341|FG009|COMPLETED|Period 3: 10.0mg (1 Day)||0
10854937|NCT03610334|12021342|FG010|COMPLETED|Period 3: 10.0mg (1 Day)||0
10854938|NCT03610334|12021343|FG011|COMPLETED|Period 3: 10.0mg (1 Day)||0
10854939|NCT03610334|12021344|FG012|COMPLETED|Period 3: 10.0mg (1 Day)||0
10854940|NCT03610334|12021345|FG013|COMPLETED|Period 3: 10.0mg (1 Day)||0
10854941|NCT03610334|12021346|FG014|COMPLETED|Period 3: 10.0mg (1 Day)||0
10854942|NCT03610334|12021347|FG015|COMPLETED|Period 3: 10.0mg (1 Day)||0
10854943|NCT03610334|12021348|FG016|COMPLETED|Period 3: 10.0mg (1 Day)||0
10854944|NCT03610334|12021349|FG017|COMPLETED|Period 3: 10.0mg (1 Day)||0
10854945|NCT03610334|12021332|FG000|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
10854946|NCT03610334|12021333|FG001|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
10854947|NCT03610334|12021334|FG002|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
10854948|NCT03610334|12021335|FG003|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
10854949|NCT03610334|12021336|FG004|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
10854950|NCT03610334|12021337|FG005|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
10854951|NCT03610334|12021338|FG006|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
10854952|NCT03610334|12021339|FG007|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
10854953|NCT03610334|12021340|FG008|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
10854954|NCT03610334|12021341|FG009|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
10854955|NCT03610334|12021342|FG010|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
10854956|NCT03610334|12021343|FG011|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
10854957|NCT03610334|12021344|FG012|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
10854958|NCT03610334|12021345|FG013|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
10854959|NCT03610334|12021346|FG014|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
10854960|NCT03610334|12021347|FG015|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
10854961|NCT03610334|12021348|FG016|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
10854962|NCT03610334|12021349|FG017|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
10854963|NCT03610334|12021332|FG000|STARTED|Period 4: 20.0mg (1 Day)||6
10854964|NCT03610334|12021333|FG001|STARTED|Period 4: 20.0mg (1 Day)||2
10854965|NCT03610334|12021334|FG002|STARTED|Period 4: 20.0mg (1 Day)||6
10854966|NCT03610334|12021335|FG003|STARTED|Period 4: 20.0mg (1 Day)||2
10854967|NCT03610334|12021336|FG004|STARTED|Period 4: 20.0mg (1 Day)||6
10854968|NCT03610334|12021337|FG005|STARTED|Period 4: 20.0mg (1 Day)||2
10854969|NCT03610334|12021338|FG006|STARTED|Period 4: 20.0mg (1 Day)||6
10854970|NCT03610334|12021339|FG007|STARTED|Period 4: 20.0mg (1 Day)||2
10854971|NCT03610334|12021340|FG008|STARTED|Period 4: 20.0mg (1 Day)||0
10854972|NCT03610334|12021341|FG009|STARTED|Period 4: 20.0mg (1 Day)||0
10854973|NCT03610334|12021342|FG010|STARTED|Period 4: 20.0mg (1 Day)||0
10854974|NCT03610334|12021343|FG011|STARTED|Period 4: 20.0mg (1 Day)||0
10854975|NCT03610334|12021344|FG012|STARTED|Period 4: 20.0mg (1 Day)||0
10854976|NCT03610334|12021345|FG013|STARTED|Period 4: 20.0mg (1 Day)||0
10293271|NCT01193842|11425868|FG003|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
10293272|NCT01193842|11425869|FG004|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
10293273|NCT01193842|11425865|FG000|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
10293274|NCT01193842|11425866|FG001|STARTED|Phase I: VR-DA-EPOCH, DL 2||7
10293275|NCT01193842|11425867|FG002|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
10293276|NCT01193842|11425868|FG003|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
10293277|NCT01193842|11425869|FG004|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
10293278|NCT01193842|11425865|FG000|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
10293279|NCT01193842|11425866|FG001|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||6
10293280|NCT01193842|11425867|FG002|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
10293281|NCT01193842|11425868|FG003|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
10293282|NCT01193842|11425869|FG004|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
10293283|NCT01193842|11425865|FG000|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
10293284|NCT01193842|11425866|FG001|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||1
10293285|NCT01193842|11425867|FG002|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
10293286|NCT01193842|11425868|FG003|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
10293287|NCT01193842|11425869|FG004|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
10293288|NCT01193842|11425865|FG000|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||4
10293289|NCT01193842|11425866|FG001|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
10293290|NCT01193842|11425867|FG002|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
10293291|NCT01193842|11425868|FG003|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
10293292|NCT01193842|11425869|FG004|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
10293293|NCT01193842|11425865|FG000|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||3
10293294|NCT01193842|11425866|FG001|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
10293295|NCT01193842|11425867|FG002|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
10293296|NCT01193842|11425868|FG003|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
10293297|NCT01193842|11425869|FG004|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
10854977|NCT03610334|12021346|FG014|STARTED|Period 4: 20.0mg (1 Day)||0
10854978|NCT03610334|12021347|FG015|STARTED|Period 4: 20.0mg (1 Day)||0
10854979|NCT03610334|12021348|FG016|STARTED|Period 4: 20.0mg (1 Day)||0
10854980|NCT03610334|12021349|FG017|STARTED|Period 4: 20.0mg (1 Day)||0
10854981|NCT03610334|12021332|FG000|COMPLETED|Period 4: 20.0mg (1 Day)||6
10854982|NCT03610334|12021333|FG001|COMPLETED|Period 4: 20.0mg (1 Day)||2
10854983|NCT03610334|12021334|FG002|COMPLETED|Period 4: 20.0mg (1 Day)||6
10854984|NCT03610334|12021335|FG003|COMPLETED|Period 4: 20.0mg (1 Day)||2
10854985|NCT03610334|12021336|FG004|COMPLETED|Period 4: 20.0mg (1 Day)||6
10854986|NCT03610334|12021337|FG005|COMPLETED|Period 4: 20.0mg (1 Day)||2
10854987|NCT03610334|12021338|FG006|COMPLETED|Period 4: 20.0mg (1 Day)||6
10854988|NCT03610334|12021339|FG007|COMPLETED|Period 4: 20.0mg (1 Day)||2
10854989|NCT03610334|12021340|FG008|COMPLETED|Period 4: 20.0mg (1 Day)||0
10854990|NCT03610334|12021341|FG009|COMPLETED|Period 4: 20.0mg (1 Day)||0
10854991|NCT03610334|12021342|FG010|COMPLETED|Period 4: 20.0mg (1 Day)||0
10854992|NCT03610334|12021343|FG011|COMPLETED|Period 4: 20.0mg (1 Day)||0
10854993|NCT03610334|12021344|FG012|COMPLETED|Period 4: 20.0mg (1 Day)||0
10854994|NCT03610334|12021345|FG013|COMPLETED|Period 4: 20.0mg (1 Day)||0
10854995|NCT03610334|12021346|FG014|COMPLETED|Period 4: 20.0mg (1 Day)||0
10854996|NCT03610334|12021347|FG015|COMPLETED|Period 4: 20.0mg (1 Day)||0
10854997|NCT03610334|12021348|FG016|COMPLETED|Period 4: 20.0mg (1 Day)||0
10854998|NCT03610334|12021349|FG017|COMPLETED|Period 4: 20.0mg (1 Day)||0
10854999|NCT03610334|12021332|FG000|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
10293298|NCT01193842|11425865|FG000|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||1
10293299|NCT01193842|11425866|FG001|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
10293300|NCT01193842|11425867|FG002|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
10293301|NCT01193842|11425868|FG003|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
10293302|NCT01193842|11425869|FG004|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
10293303|NCT01193842|11425865|FG000|STARTED|Phase I: VR-CHOP, DL 1||0
10293304|NCT01193842|11425866|FG001|STARTED|Phase I: VR-CHOP, DL 1||0
10293305|NCT01193842|11425867|FG002|STARTED|Phase I: VR-CHOP, DL 1||2
10293306|NCT01193842|11425868|FG003|STARTED|Phase I: VR-CHOP, DL 1||0
10293307|NCT01193842|11425869|FG004|STARTED|Phase I: VR-CHOP, DL 1||0
10293308|NCT01193842|11425865|FG000|COMPLETED|Phase I: VR-CHOP, DL 1||0
10293309|NCT01193842|11425866|FG001|COMPLETED|Phase I: VR-CHOP, DL 1||0
10293310|NCT01193842|11425867|FG002|COMPLETED|Phase I: VR-CHOP, DL 1||1
10293311|NCT01193842|11425868|FG003|COMPLETED|Phase I: VR-CHOP, DL 1||0
10293312|NCT01193842|11425869|FG004|COMPLETED|Phase I: VR-CHOP, DL 1||0
10293313|NCT01193842|11425865|FG000|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
10414863|NCT00787150|11559300|FG000|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|75
10414864|NCT00787150|11559301|FG001|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|72
10414865|NCT00787150|11559302|FG002|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|71
10414866|NCT00787150|11559300|FG000|COMPLETED|Overall Study||66
10414867|NCT00787150|11559301|FG001|COMPLETED|Overall Study||65
10414868|NCT00787150|11559302|FG002|COMPLETED|Overall Study||66
10293314|NCT01193842|11425866|FG001|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
10293315|NCT01193842|11425867|FG002|NOT COMPLETED|Phase I: VR-CHOP, DL 1||1
10293316|NCT01193842|11425868|FG003|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
10293317|NCT01193842|11425869|FG004|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
10293318|NCT01193842|11425865|FG000|STARTED|Phase II: Randomized Groups||0
10293319|NCT01193842|11425866|FG001|STARTED|Phase II: Randomized Groups||0
10293320|NCT01193842|11425867|FG002|STARTED|Phase II: Randomized Groups||0
10293321|NCT01193842|11425868|FG003|STARTED|Phase II: Randomized Groups||45
10293322|NCT01193842|11425869|FG004|STARTED|Phase II: Randomized Groups||46
10293323|NCT01193842|11425865|FG000|COMPLETED|Phase II: Randomized Groups||0
10414869|NCT00787150|11559300|FG000|NOT COMPLETED|Overall Study||9
10414870|NCT00787150|11559301|FG001|NOT COMPLETED|Overall Study||7
10414871|NCT00787150|11559302|FG002|NOT COMPLETED|Overall Study||5
10414872|NCT00787189|11559314|FG000|STARTED|Overall Study||32
10414873|NCT00787189|11559315|FG001|STARTED|Overall Study||32
10414874|NCT00787189|11559314|FG000|COMPLETED|Overall Study|To study end point.|30
10414875|NCT00787189|11559315|FG001|COMPLETED|Overall Study|To study end point.|30
10414876|NCT00787189|11559314|FG000|NOT COMPLETED|Overall Study||2
10414877|NCT00787189|11559315|FG001|NOT COMPLETED|Overall Study||2
10414878|NCT00787202|11559326|FG000|STARTED|Overall Study||49
10414879|NCT00787202|11559327|FG001|STARTED|Overall Study||31
10414880|NCT00787202|11559328|FG002|STARTED|Overall Study||33
10414881|NCT00787202|11559329|FG003|STARTED|Overall Study||33
10414882|NCT00787202|11559330|FG004|STARTED|Overall Study||49
10414883|NCT00787202|11559326|FG000|Treated|Overall Study||48
10414884|NCT00787202|11559327|FG001|Treated|Overall Study||31
10414885|NCT00787202|11559328|FG002|Treated|Overall Study||33
10293324|NCT01193842|11425866|FG001|COMPLETED|Phase II: Randomized Groups||0
10293325|NCT01193842|11425867|FG002|COMPLETED|Phase II: Randomized Groups||0
10293326|NCT01193842|11425868|FG003|COMPLETED|Phase II: Randomized Groups||33
10293327|NCT01193842|11425869|FG004|COMPLETED|Phase II: Randomized Groups||36
10293328|NCT01193842|11425865|FG000|NOT COMPLETED|Phase II: Randomized Groups||0
10293329|NCT01193842|11425866|FG001|NOT COMPLETED|Phase II: Randomized Groups||0
10293330|NCT01193842|11425867|FG002|NOT COMPLETED|Phase II: Randomized Groups||0
10293331|NCT01193842|11425868|FG003|NOT COMPLETED|Phase II: Randomized Groups||12
10293332|NCT01193842|11425869|FG004|NOT COMPLETED|Phase II: Randomized Groups||10
10293333|NCT00855803|11425886|FG000|STARTED|Overall Study||35
10293334|NCT00855803|11425886|FG000|COMPLETED|Overall Study||21
10855000|NCT03610334|12021333|FG001|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
10855001|NCT03610334|12021334|FG002|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
10855002|NCT03610334|12021335|FG003|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
10855003|NCT03610334|12021336|FG004|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
10855004|NCT03610334|12021337|FG005|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
10855005|NCT03610334|12021338|FG006|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
10855006|NCT03610334|12021339|FG007|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
10855007|NCT03610334|12021340|FG008|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
10855008|NCT03610334|12021341|FG009|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
10855009|NCT03610334|12021342|FG010|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
10855010|NCT03610334|12021343|FG011|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
10855011|NCT03610334|12021344|FG012|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
10855012|NCT03610334|12021345|FG013|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
10855013|NCT03610334|12021346|FG014|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
10855014|NCT03610334|12021347|FG015|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
10855015|NCT03610334|12021348|FG016|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
10855016|NCT03610334|12021349|FG017|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
10855017|NCT03610334|12021332|FG000|STARTED|Period 5: 40.0mg (1 Day)||6
10855018|NCT03610334|12021333|FG001|STARTED|Period 5: 40.0mg (1 Day)||2
10855019|NCT03610334|12021334|FG002|STARTED|Period 5: 40.0mg (1 Day)||6
10855020|NCT03610334|12021335|FG003|STARTED|Period 5: 40.0mg (1 Day)||2
10855021|NCT03610334|12021336|FG004|STARTED|Period 5: 40.0mg (1 Day)||6
10855022|NCT03610334|12021337|FG005|STARTED|Period 5: 40.0mg (1 Day)||2
10855023|NCT03610334|12021338|FG006|STARTED|Period 5: 40.0mg (1 Day)||6
10855024|NCT03610334|12021339|FG007|STARTED|Period 5: 40.0mg (1 Day)||2
10855025|NCT03610334|12021340|FG008|STARTED|Period 5: 40.0mg (1 Day)||6
10855026|NCT03610334|12021341|FG009|STARTED|Period 5: 40.0mg (1 Day)||2
10855027|NCT03610334|12021342|FG010|STARTED|Period 5: 40.0mg (1 Day)||0
10855028|NCT03610334|12021343|FG011|STARTED|Period 5: 40.0mg (1 Day)||0
10855029|NCT03610334|12021344|FG012|STARTED|Period 5: 40.0mg (1 Day)||0
10855030|NCT03610334|12021345|FG013|STARTED|Period 5: 40.0mg (1 Day)||0
10855031|NCT03610334|12021346|FG014|STARTED|Period 5: 40.0mg (1 Day)||0
10855032|NCT03610334|12021347|FG015|STARTED|Period 5: 40.0mg (1 Day)||0
10855033|NCT03610334|12021348|FG016|STARTED|Period 5: 40.0mg (1 Day)||0
10855034|NCT03610334|12021349|FG017|STARTED|Period 5: 40.0mg (1 Day)||0
10855035|NCT03610334|12021332|FG000|COMPLETED|Period 5: 40.0mg (1 Day)||6
10855036|NCT03610334|12021333|FG001|COMPLETED|Period 5: 40.0mg (1 Day)||2
10855037|NCT03610334|12021334|FG002|COMPLETED|Period 5: 40.0mg (1 Day)||6
10855038|NCT03610334|12021335|FG003|COMPLETED|Period 5: 40.0mg (1 Day)||2
10855039|NCT03610334|12021336|FG004|COMPLETED|Period 5: 40.0mg (1 Day)||6
10855040|NCT03610334|12021337|FG005|COMPLETED|Period 5: 40.0mg (1 Day)||2
10855041|NCT03610334|12021338|FG006|COMPLETED|Period 5: 40.0mg (1 Day)||6
10855042|NCT03610334|12021339|FG007|COMPLETED|Period 5: 40.0mg (1 Day)||2
10855043|NCT03610334|12021340|FG008|COMPLETED|Period 5: 40.0mg (1 Day)||6
10855044|NCT03610334|12021341|FG009|COMPLETED|Period 5: 40.0mg (1 Day)||2
10855045|NCT03610334|12021342|FG010|COMPLETED|Period 5: 40.0mg (1 Day)||0
10855046|NCT03610334|12021343|FG011|COMPLETED|Period 5: 40.0mg (1 Day)||0
10855047|NCT03610334|12021344|FG012|COMPLETED|Period 5: 40.0mg (1 Day)||0
10855048|NCT03610334|12021345|FG013|COMPLETED|Period 5: 40.0mg (1 Day)||0
10855049|NCT03610334|12021346|FG014|COMPLETED|Period 5: 40.0mg (1 Day)||0
10855050|NCT03610334|12021347|FG015|COMPLETED|Period 5: 40.0mg (1 Day)||0
10855051|NCT03610334|12021348|FG016|COMPLETED|Period 5: 40.0mg (1 Day)||0
10855052|NCT03610334|12021349|FG017|COMPLETED|Period 5: 40.0mg (1 Day)||0
10855053|NCT03610334|12021332|FG000|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
10855054|NCT03610334|12021333|FG001|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
10855055|NCT03610334|12021334|FG002|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
10855056|NCT03610334|12021335|FG003|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
10855057|NCT03610334|12021336|FG004|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
10855058|NCT03610334|12021337|FG005|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
10855059|NCT03610334|12021338|FG006|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
10855060|NCT03610334|12021339|FG007|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
10855061|NCT03610334|12021340|FG008|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
10855062|NCT03610334|12021341|FG009|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
10855063|NCT03610334|12021342|FG010|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
10855064|NCT03610334|12021343|FG011|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
10855065|NCT03610334|12021344|FG012|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
10855066|NCT03610334|12021345|FG013|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
10855067|NCT03610334|12021346|FG014|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
10855068|NCT03610334|12021347|FG015|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
10855069|NCT03610334|12021348|FG016|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
10855070|NCT03610334|12021349|FG017|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
10855071|NCT03610334|12021332|FG000|STARTED|Period 6: 60.0mg (1 Day)||6
10855072|NCT03610334|12021333|FG001|STARTED|Period 6: 60.0mg (1 Day)||2
10855073|NCT03610334|12021334|FG002|STARTED|Period 6: 60.0mg (1 Day)||6
10855074|NCT03610334|12021335|FG003|STARTED|Period 6: 60.0mg (1 Day)||2
10855075|NCT03610334|12021336|FG004|STARTED|Period 6: 60.0mg (1 Day)||6
10855076|NCT03610334|12021337|FG005|STARTED|Period 6: 60.0mg (1 Day)||2
10855077|NCT03610334|12021338|FG006|STARTED|Period 6: 60.0mg (1 Day)||6
10855078|NCT03610334|12021339|FG007|STARTED|Period 6: 60.0mg (1 Day)||2
10855079|NCT03610334|12021340|FG008|STARTED|Period 6: 60.0mg (1 Day)||6
10855080|NCT03610334|12021341|FG009|STARTED|Period 6: 60.0mg (1 Day)||2
10855081|NCT03610334|12021342|FG010|STARTED|Period 6: 60.0mg (1 Day)||6
10855082|NCT03610334|12021343|FG011|STARTED|Period 6: 60.0mg (1 Day)||2
10855083|NCT03610334|12021344|FG012|STARTED|Period 6: 60.0mg (1 Day)||0
10855084|NCT03610334|12021345|FG013|STARTED|Period 6: 60.0mg (1 Day)||0
10855085|NCT03610334|12021346|FG014|STARTED|Period 6: 60.0mg (1 Day)||0
10855086|NCT03610334|12021347|FG015|STARTED|Period 6: 60.0mg (1 Day)||0
10855087|NCT03610334|12021348|FG016|STARTED|Period 6: 60.0mg (1 Day)||0
10855088|NCT03610334|12021349|FG017|STARTED|Period 6: 60.0mg (1 Day)||0
10855089|NCT03610334|12021332|FG000|COMPLETED|Period 6: 60.0mg (1 Day)||6
10855090|NCT03610334|12021333|FG001|COMPLETED|Period 6: 60.0mg (1 Day)||2
10855091|NCT03610334|12021334|FG002|COMPLETED|Period 6: 60.0mg (1 Day)||6
10855092|NCT03610334|12021335|FG003|COMPLETED|Period 6: 60.0mg (1 Day)||2
10855093|NCT03610334|12021336|FG004|COMPLETED|Period 6: 60.0mg (1 Day)||6
10855094|NCT03610334|12021337|FG005|COMPLETED|Period 6: 60.0mg (1 Day)||2
10855095|NCT03610334|12021338|FG006|COMPLETED|Period 6: 60.0mg (1 Day)||6
10855096|NCT03610334|12021339|FG007|COMPLETED|Period 6: 60.0mg (1 Day)||2
10855097|NCT03610334|12021340|FG008|COMPLETED|Period 6: 60.0mg (1 Day)||6
10855098|NCT03610334|12021341|FG009|COMPLETED|Period 6: 60.0mg (1 Day)||2
10855099|NCT03610334|12021342|FG010|COMPLETED|Period 6: 60.0mg (1 Day)||6
10855100|NCT03610334|12021343|FG011|COMPLETED|Period 6: 60.0mg (1 Day)||2
10414886|NCT00787202|11559329|FG003|Treated|Overall Study||33
10414887|NCT00787202|11559330|FG004|Treated|Overall Study||49
10414888|NCT00787202|11559326|FG000|COMPLETED|Overall Study||35
10414889|NCT00787202|11559327|FG001|COMPLETED|Overall Study||20
10414890|NCT00787202|11559328|FG002|COMPLETED|Overall Study||26
10414891|NCT00787202|11559329|FG003|COMPLETED|Overall Study||31
10414892|NCT00787202|11559330|FG004|COMPLETED|Overall Study||45
10414893|NCT00787202|11559326|FG000|NOT COMPLETED|Overall Study||14
10414894|NCT00787202|11559327|FG001|NOT COMPLETED|Overall Study||11
10414895|NCT00787202|11559328|FG002|NOT COMPLETED|Overall Study||7
10855101|NCT03610334|12021344|FG012|COMPLETED|Period 6: 60.0mg (1 Day)||0
10855102|NCT03610334|12021345|FG013|COMPLETED|Period 6: 60.0mg (1 Day)||0
10855103|NCT03610334|12021346|FG014|COMPLETED|Period 6: 60.0mg (1 Day)||0
10855104|NCT03610334|12021347|FG015|COMPLETED|Period 6: 60.0mg (1 Day)||0
10855105|NCT03610334|12021348|FG016|COMPLETED|Period 6: 60.0mg (1 Day)||0
10855106|NCT03610334|12021349|FG017|COMPLETED|Period 6: 60.0mg (1 Day)||0
10855107|NCT03610334|12021332|FG000|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
10855108|NCT03610334|12021333|FG001|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
10855109|NCT03610334|12021334|FG002|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
10414896|NCT00787202|11559329|FG003|NOT COMPLETED|Overall Study||2
10414897|NCT00787202|11559330|FG004|NOT COMPLETED|Overall Study||4
10414898|NCT00787241|11559349|FG000|STARTED|Overall Study||261
10414899|NCT00787241|11559350|FG001|STARTED|Overall Study||143
10414900|NCT00787241|11559351|FG002|STARTED|Overall Study||41
10414901|NCT00787241|11559349|FG000|COMPLETED|Overall Study||261
10414902|NCT00787241|11559350|FG001|COMPLETED|Overall Study||143
10414903|NCT00787241|11559351|FG002|COMPLETED|Overall Study||41
10414904|NCT00787241|11559349|FG000|NOT COMPLETED|Overall Study||0
10414905|NCT00787241|11559350|FG001|NOT COMPLETED|Overall Study||0
10414906|NCT00787241|11559351|FG002|NOT COMPLETED|Overall Study||0
10414907|NCT00787254|11559361|FG000|STARTED|Overall Study||185
10414908|NCT00787254|11559362|FG001|STARTED|Overall Study||181
10414909|NCT00787254|11559361|FG000|COMPLETED|Overall Study||109
10414910|NCT00787254|11559362|FG001|COMPLETED|Overall Study||99
10414911|NCT00787254|11559361|FG000|NOT COMPLETED|Overall Study||76
10414912|NCT00787254|11559362|FG001|NOT COMPLETED|Overall Study||82
10414913|NCT00787267|11559368|FG000|STARTED|Overall Study|Signed a consent form|37
10414914|NCT00787267|11559368|FG000|COMPLETED|Overall Study|Received at least one dose of study drug|25
10414915|NCT00787267|11559368|FG000|NOT COMPLETED|Overall Study||12
10855110|NCT03610334|12021335|FG003|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
10855111|NCT03610334|12021336|FG004|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
10855112|NCT03610334|12021337|FG005|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
10855113|NCT03610334|12021338|FG006|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
10855114|NCT03610334|12021339|FG007|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
10855115|NCT03610334|12021340|FG008|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
10855116|NCT03610334|12021341|FG009|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
10855117|NCT03610334|12021342|FG010|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
10855118|NCT03610334|12021343|FG011|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
10855119|NCT03610334|12021344|FG012|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
10855120|NCT03610334|12021345|FG013|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
10855121|NCT03610334|12021346|FG014|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
10855122|NCT03610334|12021347|FG015|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
10855123|NCT03610334|12021348|FG016|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
10855124|NCT03610334|12021349|FG017|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
10855125|NCT03610334|12021332|FG000|STARTED|Period 7: 15.0mg (Day 1 to 14)||6
10855126|NCT03610334|12021333|FG001|STARTED|Period 7: 15.0mg (Day 1 to 14)||2
10855127|NCT03610334|12021334|FG002|STARTED|Period 7: 15.0mg (Day 1 to 14)||6
10855128|NCT03610334|12021335|FG003|STARTED|Period 7: 15.0mg (Day 1 to 14)||2
10855129|NCT03610334|12021336|FG004|STARTED|Period 7: 15.0mg (Day 1 to 14)||6
10855130|NCT03610334|12021337|FG005|STARTED|Period 7: 15.0mg (Day 1 to 14)||2
10855131|NCT03610334|12021338|FG006|STARTED|Period 7: 15.0mg (Day 1 to 14)||6
10855132|NCT03610334|12021339|FG007|STARTED|Period 7: 15.0mg (Day 1 to 14)||2
10855133|NCT03610334|12021340|FG008|STARTED|Period 7: 15.0mg (Day 1 to 14)||6
10855134|NCT03610334|12021341|FG009|STARTED|Period 7: 15.0mg (Day 1 to 14)||2
10855135|NCT03610334|12021342|FG010|STARTED|Period 7: 15.0mg (Day 1 to 14)||6
10855136|NCT03610334|12021343|FG011|STARTED|Period 7: 15.0mg (Day 1 to 14)||2
10855137|NCT03610334|12021344|FG012|STARTED|Period 7: 15.0mg (Day 1 to 14)||6
10855138|NCT03610334|12021345|FG013|STARTED|Period 7: 15.0mg (Day 1 to 14)||2
10855139|NCT03610334|12021346|FG014|STARTED|Period 7: 15.0mg (Day 1 to 14)||0
10855140|NCT03610334|12021347|FG015|STARTED|Period 7: 15.0mg (Day 1 to 14)||0
10855141|NCT03610334|12021348|FG016|STARTED|Period 7: 15.0mg (Day 1 to 14)||0
10414916|NCT00787319|11559372|FG000|STARTED|Overall Study||108
10414917|NCT00787319|11559372|FG000|COMPLETED|Overall Study||45
10414918|NCT00787319|11559372|FG000|NOT COMPLETED|Overall Study||63
10414919|NCT00787332|11559378|FG000|STARTED|Overall Study||8
10414920|NCT00787332|11559379|FG001|STARTED|Overall Study||8
10414921|NCT00787332|11559378|FG000|COMPLETED|Overall Study||8
10414922|NCT00787332|11559379|FG001|COMPLETED|Overall Study||8
10414923|NCT00787332|11559378|FG000|NOT COMPLETED|Overall Study||0
10414924|NCT00787332|11559379|FG001|NOT COMPLETED|Overall Study||0
10414925|NCT00787527|11559385|FG000|STARTED|Overall Study||14
10414926|NCT00787527|11559385|FG000|COMPLETED|Overall Study||11
10414927|NCT00787527|11559385|FG000|NOT COMPLETED|Overall Study||3
10414928|NCT00787566|11559396|FG000|STARTED|Overall Study||21
10414929|NCT00787566|11559397|FG001|STARTED|Overall Study||25
10414930|NCT00787566|11559398|FG002|STARTED|Overall Study||22
10414931|NCT00787566|11559396|FG000|COMPLETED|Overall Study||21
10414932|NCT00787566|11559397|FG001|COMPLETED|Overall Study|1 patient withdrew from the study due to an AE related to chemotherapy agent administration.|24
10414933|NCT00787566|11559398|FG002|COMPLETED|Overall Study||22
10414934|NCT00787566|11559396|FG000|NOT COMPLETED|Overall Study||0
10414935|NCT00787566|11559397|FG001|NOT COMPLETED|Overall Study||1
10414936|NCT00787566|11559398|FG002|NOT COMPLETED|Overall Study||0
10414937|NCT00787605|11559408|FG000|STARTED|Overall Study||428
10414938|NCT00787605|11559409|FG001|STARTED|Overall Study||432
10414939|NCT00787605|11559408|FG000|COMPLETED|Overall Study||382
10414940|NCT00787605|11559409|FG001|COMPLETED|Overall Study||376
10414941|NCT00787605|11559408|FG000|NOT COMPLETED|Overall Study||46
10414942|NCT00787605|11559409|FG001|NOT COMPLETED|Overall Study||56
10414943|NCT00787644|11559417|FG000|STARTED|Overall Study||12
10414944|NCT00787644|11559418|FG001|STARTED|Overall Study||11
10414945|NCT00787644|11559417|FG000|COMPLETED|Overall Study||10
10414946|NCT00787644|11559418|FG001|COMPLETED|Overall Study||9
10414947|NCT00787644|11559417|FG000|NOT COMPLETED|Overall Study||2
10855142|NCT03610334|12021349|FG017|STARTED|Period 7: 15.0mg (Day 1 to 14)||0
10855143|NCT03610334|12021332|FG000|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6
10855144|NCT03610334|12021333|FG001|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2
10855145|NCT03610334|12021334|FG002|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6
10855146|NCT03610334|12021335|FG003|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2
10855147|NCT03610334|12021336|FG004|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6
10855148|NCT03610334|12021337|FG005|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2
10855149|NCT03610334|12021338|FG006|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6
10855150|NCT03610334|12021339|FG007|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2
10855151|NCT03610334|12021340|FG008|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6
10855152|NCT03610334|12021341|FG009|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2
10855153|NCT03610334|12021342|FG010|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6
10855154|NCT03610334|12021343|FG011|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2
10855155|NCT03610334|12021344|FG012|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6
10855156|NCT03610334|12021345|FG013|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2
10855157|NCT03610334|12021346|FG014|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
10855158|NCT03610334|12021347|FG015|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
10855159|NCT03610334|12021348|FG016|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
10855160|NCT03610334|12021349|FG017|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
10855161|NCT03610334|12021332|FG000|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
10855162|NCT03610334|12021333|FG001|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
10855163|NCT03610334|12021334|FG002|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
10855164|NCT03610334|12021335|FG003|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
10855165|NCT03610334|12021336|FG004|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
10855166|NCT03610334|12021337|FG005|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
10855167|NCT03610334|12021338|FG006|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
10855168|NCT03610334|12021339|FG007|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
10855169|NCT03610334|12021340|FG008|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
10855170|NCT03610334|12021341|FG009|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
10855171|NCT03610334|12021342|FG010|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
10855172|NCT03610334|12021343|FG011|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
10855173|NCT03610334|12021344|FG012|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
10855174|NCT03610334|12021345|FG013|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
10855175|NCT03610334|12021346|FG014|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
10855176|NCT03610334|12021347|FG015|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
10855177|NCT03610334|12021348|FG016|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
10855178|NCT03610334|12021349|FG017|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
10855179|NCT03610334|12021332|FG000|STARTED|Period 8: 30.0mg (Day 1 to 14)||6
10855180|NCT03610334|12021333|FG001|STARTED|Period 8: 30.0mg (Day 1 to 14)||2
10855181|NCT03610334|12021334|FG002|STARTED|Period 8: 30.0mg (Day 1 to 14)||6
10855182|NCT03610334|12021335|FG003|STARTED|Period 8: 30.0mg (Day 1 to 14)||2
10855183|NCT03610334|12021336|FG004|STARTED|Period 8: 30.0mg (Day 1 to 14)||6
10855184|NCT03610334|12021337|FG005|STARTED|Period 8: 30.0mg (Day 1 to 14)||2
10855185|NCT03610334|12021338|FG006|STARTED|Period 8: 30.0mg (Day 1 to 14)||6
10855186|NCT03610334|12021339|FG007|STARTED|Period 8: 30.0mg (Day 1 to 14)||2
10855187|NCT03610334|12021340|FG008|STARTED|Period 8: 30.0mg (Day 1 to 14)||6
10855188|NCT03610334|12021341|FG009|STARTED|Period 8: 30.0mg (Day 1 to 14)||2
10855189|NCT03610334|12021342|FG010|STARTED|Period 8: 30.0mg (Day 1 to 14)||6
10855190|NCT03610334|12021343|FG011|STARTED|Period 8: 30.0mg (Day 1 to 14)||2
10855191|NCT03610334|12021344|FG012|STARTED|Period 8: 30.0mg (Day 1 to 14)||6
10855192|NCT03610334|12021345|FG013|STARTED|Period 8: 30.0mg (Day 1 to 14)||2
10855193|NCT03610334|12021346|FG014|STARTED|Period 8: 30.0mg (Day 1 to 14)||6
10855194|NCT03610334|12021347|FG015|STARTED|Period 8: 30.0mg (Day 1 to 14)||2
10855195|NCT03610334|12021348|FG016|STARTED|Period 8: 30.0mg (Day 1 to 14)||0
10855196|NCT03610334|12021349|FG017|STARTED|Period 8: 30.0mg (Day 1 to 14)||0
10855197|NCT03610334|12021332|FG000|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6
10855198|NCT03610334|12021333|FG001|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2
10855199|NCT03610334|12021334|FG002|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6
10855200|NCT03610334|12021335|FG003|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2
10855201|NCT03610334|12021336|FG004|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6
10855202|NCT03610334|12021337|FG005|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2
10855203|NCT03610334|12021338|FG006|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6
10855204|NCT03610334|12021339|FG007|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2
10855205|NCT03610334|12021340|FG008|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6
10855206|NCT03610334|12021341|FG009|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2
10855207|NCT03610334|12021342|FG010|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6
10855208|NCT03610334|12021343|FG011|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2
10855209|NCT03610334|12021344|FG012|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6
10855210|NCT03610334|12021345|FG013|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2
10855211|NCT03610334|12021346|FG014|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6
10855212|NCT03610334|12021347|FG015|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2
10855213|NCT03610334|12021348|FG016|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
10855214|NCT03610334|12021349|FG017|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
10855215|NCT03610334|12021332|FG000|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
10855216|NCT03610334|12021333|FG001|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
10855217|NCT03610334|12021334|FG002|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
10855218|NCT03610334|12021335|FG003|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
10855219|NCT03610334|12021336|FG004|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
10855220|NCT03610334|12021337|FG005|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
10855221|NCT03610334|12021338|FG006|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
10855222|NCT03610334|12021339|FG007|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
10855223|NCT03610334|12021340|FG008|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
10855224|NCT03610334|12021341|FG009|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
10855225|NCT03610334|12021342|FG010|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
10855226|NCT03610334|12021343|FG011|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
10855227|NCT03610334|12021344|FG012|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
10855228|NCT03610334|12021345|FG013|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
10855229|NCT03610334|12021346|FG014|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
10855230|NCT03610334|12021347|FG015|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
10855231|NCT03610334|12021348|FG016|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
10855232|NCT03610334|12021349|FG017|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
10855233|NCT03610334|12021332|FG000|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
10855234|NCT03610334|12021333|FG001|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
10855235|NCT03610334|12021334|FG002|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
10855236|NCT03610334|12021335|FG003|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
10293335|NCT00855803|11425886|FG000|NOT COMPLETED|Overall Study||14
10293336|NCT00790803|11425890|FG000|STARTED|Overall Study||5
10293337|NCT00790803|11425890|FG000|COMPLETED|Overall Study||5
10293338|NCT00790803|11425890|FG000|NOT COMPLETED|Overall Study||0
10293339|NCT00740116|11425896|FG000|STARTED|Overall Study||50
10293340|NCT00740116|11425897|FG001|STARTED|Overall Study||50
10293341|NCT00740116|11425896|FG000|COMPLETED|Overall Study||48
10293342|NCT00740116|11425897|FG001|COMPLETED|Overall Study||45
10293343|NCT00740116|11425896|FG000|NOT COMPLETED|Overall Study||2
10293344|NCT00740116|11425897|FG001|NOT COMPLETED|Overall Study||5
10293345|NCT00565617|11425905|FG000|STARTED|Overall Study||6
10293346|NCT00565617|11425905|FG000|COMPLETED|Overall Study||5
10293347|NCT00565617|11425905|FG000|NOT COMPLETED|Overall Study||1
10414948|NCT00787644|11559418|FG001|NOT COMPLETED|Overall Study||2
10414949|NCT00787722|11559424|FG000|STARTED|Overall Study||13
10414950|NCT00787722|11559424|FG000|COMPLETED|Overall Study||12
10414951|NCT00787722|11559424|FG000|NOT COMPLETED|Overall Study||1
10414952|NCT00787761|11559429|FG000|STARTED|Overall Study||24
10414953|NCT00787761|11559429|FG000|COMPLETED|Overall Study||24
10414954|NCT00787761|11559429|FG000|NOT COMPLETED|Overall Study||0
10414955|NCT00787787|11559435|FG000|STARTED|Overall Study||7
10414956|NCT00787787|11559435|FG000|COMPLETED|Overall Study||0
10414957|NCT00787787|11559435|FG000|NOT COMPLETED|Overall Study||7
10414958|NCT00787800|11559441|FG000|STARTED|Overall Study||50
10414959|NCT00787800|11559442|FG001|STARTED|Overall Study||50
10414960|NCT00787800|11559441|FG000|COMPLETED|Overall Study||47
10754953|NCT03057132|11918758|FG000|COMPLETED|Overall Study||1
10754954|NCT03057132|11918758|FG000|NOT COMPLETED|Overall Study||0
10754955|NCT03057366|11918763|FG000|STARTED|Part A||8
10754956|NCT03057366|11918764|FG001|STARTED|Part A||0
10754957|NCT03057366|11918765|FG002|STARTED|Part A||0
10754958|NCT03057366|11918763|FG000|COMPLETED|Part A||8
10754959|NCT03057366|11918764|FG001|COMPLETED|Part A||0
10754960|NCT03057366|11918765|FG002|COMPLETED|Part A||0
10754961|NCT03057366|11918763|FG000|NOT COMPLETED|Part A||0
10754962|NCT03057366|11918764|FG001|NOT COMPLETED|Part A||0
10754963|NCT03057366|11918765|FG002|NOT COMPLETED|Part A||0
10754964|NCT03057366|11918763|FG000|STARTED|Part B||0
10754965|NCT03057366|11918764|FG001|STARTED|Part B|Participants completed Part A, met eligibility criteria, and provided consent for Part B.|5
10754966|NCT03057366|11918765|FG002|STARTED|Part B|Participants completed Part A, met eligibility criteria, and provided consent for Part B.|2
10754967|NCT03057366|11918763|FG000|COMPLETED|Part B||0
10754968|NCT03057366|11918764|FG001|COMPLETED|Part B||5
10754969|NCT03057366|11918765|FG002|COMPLETED|Part B||2
10754970|NCT03057366|11918763|FG000|NOT COMPLETED|Part B||0
10754971|NCT03057366|11918764|FG001|NOT COMPLETED|Part B||0
10754972|NCT03057366|11918765|FG002|NOT COMPLETED|Part B||0
10754973|NCT03057496|11918775|FG000|STARTED|Overall Study||49
10754974|NCT03057496|11918775|FG000|Started Home-use Trial|Overall Study||36
10754975|NCT03057496|11918775|FG000|COMPLETED|Overall Study||31
10754976|NCT03057496|11918775|FG000|NOT COMPLETED|Overall Study||18
10754977|NCT03057704|11918783|FG000|STARTED|Overall Study||25
10754978|NCT03057704|11918784|FG001|STARTED|Overall Study||25
10754979|NCT03057704|11918783|FG000|COMPLETED|Overall Study||25
10754980|NCT03057704|11918784|FG001|COMPLETED|Overall Study||25
10754981|NCT03057704|11918783|FG000|NOT COMPLETED|Overall Study||0
10754982|NCT03057704|11918784|FG001|NOT COMPLETED|Overall Study||0
10754983|NCT03057977|11918792|FG000|STARTED|Discontinuation From Treatment||1867
10754984|NCT03057977|11918793|FG001|STARTED|Discontinuation From Treatment||1863
10754985|NCT03057977|11918792|FG000|Treated|Discontinuation From Treatment||1863
10754986|NCT03057977|11918793|FG001|Treated|Discontinuation From Treatment||1863
10754987|NCT03057977|11918792|FG000|COMPLETED|Discontinuation From Treatment||1352
10754988|NCT03057977|11918793|FG001|COMPLETED|Discontinuation From Treatment||1381
10754989|NCT03057977|11918792|FG000|NOT COMPLETED|Discontinuation From Treatment||515
10754990|NCT03057977|11918793|FG001|NOT COMPLETED|Discontinuation From Treatment||482
10754991|NCT03057977|11918792|FG000|STARTED|Discontinuation From Trial||1867
10754992|NCT03057977|11918793|FG001|STARTED|Discontinuation From Trial||1863
10754993|NCT03057977|11918792|FG000|Treated|Discontinuation From Trial||1863
10754994|NCT03057977|11918793|FG001|Treated|Discontinuation From Trial||1863
10754995|NCT03057977|11918792|FG000|COMPLETED|Discontinuation From Trial||1847
10754996|NCT03057977|11918793|FG001|COMPLETED|Discontinuation From Trial||1841
10855237|NCT03610334|12021336|FG004|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
10855238|NCT03610334|12021337|FG005|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
10855239|NCT03610334|12021338|FG006|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
10855240|NCT03610334|12021339|FG007|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
10855241|NCT03610334|12021340|FG008|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
10855242|NCT03610334|12021341|FG009|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
10855243|NCT03610334|12021342|FG010|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
10855244|NCT03610334|12021343|FG011|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
10855245|NCT03610334|12021344|FG012|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
10855246|NCT03610334|12021345|FG013|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
10855247|NCT03610334|12021346|FG014|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
10855248|NCT03610334|12021347|FG015|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
10855249|NCT03610334|12021348|FG016|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
10855250|NCT03610334|12021349|FG017|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
10855251|NCT03610334|12021332|FG000|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
10855252|NCT03610334|12021333|FG001|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
10855253|NCT03610334|12021334|FG002|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
10855254|NCT03610334|12021335|FG003|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
10855255|NCT03610334|12021336|FG004|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
10855256|NCT03610334|12021337|FG005|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
10855257|NCT03610334|12021338|FG006|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
10855258|NCT03610334|12021339|FG007|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
10855259|NCT03610334|12021340|FG008|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
10855260|NCT03610334|12021341|FG009|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
10855261|NCT03610334|12021342|FG010|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
10855262|NCT03610334|12021343|FG011|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
10855263|NCT03610334|12021344|FG012|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
10855264|NCT03610334|12021345|FG013|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
10855265|NCT03610334|12021346|FG014|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
10855266|NCT03610334|12021347|FG015|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
10855267|NCT03610334|12021348|FG016|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
10855268|NCT03610334|12021349|FG017|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
10855269|NCT03610334|12021332|FG000|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
10855270|NCT03610334|12021333|FG001|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
10855271|NCT03610334|12021334|FG002|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
10855272|NCT03610334|12021335|FG003|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
10855273|NCT03610334|12021336|FG004|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
10855274|NCT03610334|12021337|FG005|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
10855275|NCT03610334|12021338|FG006|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
10855276|NCT03610334|12021339|FG007|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
10855277|NCT03610334|12021340|FG008|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
10855278|NCT03610334|12021341|FG009|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
10855279|NCT03610334|12021342|FG010|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
10855280|NCT03610334|12021343|FG011|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
10855281|NCT03610334|12021344|FG012|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
10855282|NCT03610334|12021345|FG013|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
10855283|NCT03610334|12021346|FG014|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
10855284|NCT03610334|12021347|FG015|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
10855285|NCT03610334|12021348|FG016|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
10855286|NCT03610334|12021349|FG017|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
10855287|NCT03334539|12021399|FG000|STARTED|Overall Study||50
10855288|NCT03334539|12021400|FG001|STARTED|Overall Study||50
10855289|NCT03334539|12021401|FG002|STARTED|Overall Study||50
10855290|NCT03334539|12021399|FG000|COMPLETED|Overall Study||46
10855291|NCT03334539|12021400|FG001|COMPLETED|Overall Study||43
10855292|NCT03334539|12021401|FG002|COMPLETED|Overall Study||49
10855293|NCT03334539|12021399|FG000|NOT COMPLETED|Overall Study||4
10855294|NCT03334539|12021400|FG001|NOT COMPLETED|Overall Study||7
10855295|NCT03334539|12021401|FG002|NOT COMPLETED|Overall Study||1
10855296|NCT03311854|12021414|FG000|STARTED|Overall Study||14
10855297|NCT03311854|12021414|FG000|COMPLETED|Overall Study||14
10855298|NCT03311854|12021414|FG000|NOT COMPLETED|Overall Study||0
10855299|NCT03269344|12021423|FG000|STARTED|Overall Study||33
10855300|NCT03269344|12021424|FG001|STARTED|Overall Study||32
10855301|NCT03269344|12021423|FG000|COMPLETED|Overall Study||29
10855302|NCT03269344|12021424|FG001|COMPLETED|Overall Study||29
10855303|NCT03269344|12021423|FG000|NOT COMPLETED|Overall Study||4
10414961|NCT00787800|11559442|FG001|COMPLETED|Overall Study||43
10414962|NCT00787800|11559441|FG000|NOT COMPLETED|Overall Study||3
10414963|NCT00787800|11559442|FG001|NOT COMPLETED|Overall Study||7
10414964|NCT00787839|11559449|FG000|STARTED|Overall Study||1939
10414965|NCT00787839|11559449|FG000|Consented|Overall Study|consented|1939
10414966|NCT00787839|11559449|FG000|Completed GCT Screening|Overall Study||1876
10293358|NCT00427193|11425920|FG000|STARTED|Overall Study||143
10855304|NCT03269344|12021424|FG001|NOT COMPLETED|Overall Study||3
10855305|NCT03079284|12021430|FG000|STARTED|Overall Study||10
10855306|NCT03079284|12021430|FG000|COMPLETED|Overall Study||10
10855307|NCT03079284|12021430|FG000|NOT COMPLETED|Overall Study||0
10855308|NCT03076775|12021438|FG000|STARTED|Overall Study||44
10855309|NCT03076775|12021439|FG001|STARTED|Overall Study||42
10855310|NCT03076775|12021438|FG000|Neonates Born During Study|Overall Study||43
10855311|NCT03076775|12021439|FG001|Neonates Born During Study|Overall Study||42
10855312|NCT03076775|12021438|FG000|Umbilical Cord Blood Collected|Overall Study||33
10855313|NCT03076775|12021439|FG001|Umbilical Cord Blood Collected|Overall Study||38
10855314|NCT03076775|12021438|FG000|COMPLETED|Overall Study||43
10855315|NCT03076775|12021439|FG001|COMPLETED|Overall Study||42
10855316|NCT03076775|12021438|FG000|NOT COMPLETED|Overall Study||1
10855317|NCT03076775|12021439|FG001|NOT COMPLETED|Overall Study||0
10414967|NCT00787839|11559449|FG000|Complete GCT, OGTT, A1c, Demographics|Overall Study||1535
10414968|NCT00787839|11559449|FG000|COMPLETED|Overall Study||1535
10414969|NCT00787839|11559449|FG000|NOT COMPLETED|Overall Study||404
10414970|NCT00787852|11559472|FG000|STARTED|Overall Study||6
10414971|NCT00787852|11559473|FG001|STARTED|Overall Study|The study was terminated prior to enrolled to group 2|5
10414972|NCT00787852|11559472|FG000|COMPLETED|Overall Study|1 patient withdrew consent prior to starting|5
10414973|NCT00787852|11559473|FG001|COMPLETED|Overall Study||5
10414974|NCT00787852|11559472|FG000|NOT COMPLETED|Overall Study||1
10414975|NCT00787852|11559473|FG001|NOT COMPLETED|Overall Study||0
10414976|NCT00787891|11559481|FG000|STARTED|Short-term Double-blind Phase (Part 1)||65
10414977|NCT00787891|11559482|FG001|STARTED|Short-term Double-blind Phase (Part 1)||62
10414978|NCT00787891|11559481|FG000|COMPLETED|Short-term Double-blind Phase (Part 1)||55
10414979|NCT00787891|11559482|FG001|COMPLETED|Short-term Double-blind Phase (Part 1)||53
10414980|NCT00787891|11559481|FG000|NOT COMPLETED|Short-term Double-blind Phase (Part 1)||10
10414981|NCT00787891|11559482|FG001|NOT COMPLETED|Short-term Double-blind Phase (Part 1)||9
10414982|NCT00787891|11559481|FG000|STARTED|Maintenance Double-blind Phase (Part 2)||33
10414983|NCT00787891|11559482|FG001|STARTED|Maintenance Double-blind Phase (Part 2)||31
10414984|NCT00787891|11559481|FG000|COMPLETED|Maintenance Double-blind Phase (Part 2)||26
10414985|NCT00787891|11559482|FG001|COMPLETED|Maintenance Double-blind Phase (Part 2)||24
10414986|NCT00787891|11559481|FG000|NOT COMPLETED|Maintenance Double-blind Phase (Part 2)||7
10414987|NCT00787891|11559482|FG001|NOT COMPLETED|Maintenance Double-blind Phase (Part 2)||7
10414988|NCT00787904|11559492|FG000|STARTED|Overall Study||6
10414989|NCT00787904|11559493|FG001|STARTED|Overall Study||13
10414990|NCT00787904|11559492|FG000|COMPLETED|Overall Study||6
10414991|NCT00787904|11559493|FG001|COMPLETED|Overall Study||13
10414992|NCT00787904|11559492|FG000|NOT COMPLETED|Overall Study||0
10414993|NCT00787904|11559493|FG001|NOT COMPLETED|Overall Study||0
10414994|NCT00787930|11559499|FG000|STARTED|Acute Treatment -- 3 Weeks||19
10414995|NCT00787930|11559499|FG000|COMPLETED|Acute Treatment -- 3 Weeks||19
10414996|NCT00787930|11559499|FG000|NOT COMPLETED|Acute Treatment -- 3 Weeks||0
10754997|NCT03057977|11918792|FG000|NOT COMPLETED|Discontinuation From Trial||20
10754998|NCT03057977|11918793|FG001|NOT COMPLETED|Discontinuation From Trial||22
10754999|NCT03058679|11918801|FG000|STARTED|Baseline to Week 6|3 randomized to SCD withdrew before starting diet;2 randomized pts w/ baseline sCDAI<150 excluded.|99
10755000|NCT03058679|11918802|FG001|STARTED|Baseline to Week 6|Due to an error 1 participant was randomized with a baseline sCDAI<150. This pt was excluded.|92
10755001|NCT03058679|11918801|FG000|COMPLETED|Baseline to Week 6||81
10755002|NCT03058679|11918802|FG001|COMPLETED|Baseline to Week 6||77
10755003|NCT03058679|11918801|FG000|NOT COMPLETED|Baseline to Week 6||18
10755004|NCT03058679|11918802|FG001|NOT COMPLETED|Baseline to Week 6||15
10755005|NCT03058679|11918801|FG000|STARTED|Week 6 to Week 12||81
10755006|NCT03058679|11918802|FG001|STARTED|Week 6 to Week 12||77
10755007|NCT03058679|11918801|FG000|COMPLETED|Week 6 to Week 12||61
10755008|NCT03058679|11918802|FG001|COMPLETED|Week 6 to Week 12||60
10755009|NCT03058679|11918801|FG000|NOT COMPLETED|Week 6 to Week 12||20
10755010|NCT03058679|11918802|FG001|NOT COMPLETED|Week 6 to Week 12||17
10755011|NCT03058692|11918810|FG000|STARTED|Overall Study||61
10755012|NCT03058692|11918811|FG001|STARTED|Overall Study||59
10755013|NCT03058692|11918810|FG000|COMPLETED|Overall Study||58
10755014|NCT03058692|11918811|FG001|COMPLETED|Overall Study||57
10755015|NCT03058692|11918810|FG000|NOT COMPLETED|Overall Study||3
10755016|NCT03058692|11918811|FG001|NOT COMPLETED|Overall Study||2
10755017|NCT03058991|11918821|FG000|STARTED|Overall Study||39
10755018|NCT03058991|11918822|FG001|STARTED|Overall Study||32
10755019|NCT03058991|11918823|FG002|STARTED|Overall Study||37
10755020|NCT03058991|11918821|FG000|1-Week Follow Up|Overall Study||23
10755021|NCT03058991|11918822|FG001|1-Week Follow Up|Overall Study||27
10755022|NCT03058991|11918823|FG002|1-Week Follow Up|Overall Study||28
10755023|NCT03058991|11918821|FG000|COMPLETED|Overall Study||21
10755024|NCT03058991|11918822|FG001|COMPLETED|Overall Study||20
10755025|NCT03058991|11918823|FG002|COMPLETED|Overall Study||25
10755026|NCT03058991|11918821|FG000|NOT COMPLETED|Overall Study||18
10755027|NCT03058991|11918822|FG001|NOT COMPLETED|Overall Study||12
10755028|NCT03058991|11918823|FG002|NOT COMPLETED|Overall Study||12
10755029|NCT03059810|11918831|FG000|STARTED|Overall Study||63
10755030|NCT03059810|11918831|FG000|COMPLETED|Overall Study||63
10755031|NCT03059810|11918831|FG000|NOT COMPLETED|Overall Study||0
10755032|NCT03059901|11918837|FG000|STARTED|Overall Study||30
10755033|NCT03059901|11918838|FG001|STARTED|Overall Study||30
10414997|NCT00787930|11559499|FG000|STARTED|Continuation Treatment -- up to 12 Month||19
10414998|NCT00787930|11559499|FG000|COMPLETED|Continuation Treatment -- up to 12 Month||16
10414999|NCT00787930|11559499|FG000|NOT COMPLETED|Continuation Treatment -- up to 12 Month||3
10415000|NCT00787943|11559509|FG000|STARTED|Overall Study||10
10415001|NCT00787943|11559509|FG000|COMPLETED|Overall Study||10
10415002|NCT00787943|11559509|FG000|NOT COMPLETED|Overall Study||0
10415003|NCT00788008|11559519|FG000|STARTED|Overall Study||98
10415004|NCT00788008|11559520|FG001|STARTED|Overall Study||101
10415005|NCT00788008|11559519|FG000|COMPLETED|Overall Study||98
10415006|NCT00788008|11559520|FG001|COMPLETED|Overall Study||101
10755034|NCT03059901|11918837|FG000|COMPLETED|Overall Study||26
10755035|NCT03059901|11918838|FG001|COMPLETED|Overall Study||28
10755036|NCT03059901|11918837|FG000|NOT COMPLETED|Overall Study||4
10755037|NCT03059901|11918838|FG001|NOT COMPLETED|Overall Study||2
10755038|NCT03060447|11918846|FG000|STARTED|Overall Study||17
10855318|NCT02933944|12021449|FG000|STARTED|Overall Study||6
10855319|NCT02933944|12021449|FG000|COMPLETED|Overall Study||6
10855320|NCT02933944|12021449|FG000|NOT COMPLETED|Overall Study||0
10855321|NCT02921997|12021458|FG000|STARTED|Overall Study||10
10855322|NCT02921997|12021459|FG001|STARTED|Overall Study||10
10855323|NCT02921997|12021460|FG002|STARTED|Overall Study||10
10855324|NCT02921997|12021458|FG000|COMPLETED|Overall Study||10
10855325|NCT02921997|12021459|FG001|COMPLETED|Overall Study||10
10855326|NCT02921997|12021460|FG002|COMPLETED|Overall Study||10
10855327|NCT02921997|12021458|FG000|NOT COMPLETED|Overall Study||0
10855328|NCT02921997|12021459|FG001|NOT COMPLETED|Overall Study||0
10855329|NCT02921997|12021460|FG002|NOT COMPLETED|Overall Study||0
10855330|NCT02833935|12021472|FG000|STARTED|Overall Study||12
10855331|NCT02833935|12021473|FG001|STARTED|Overall Study||12
10855332|NCT02833935|12021472|FG000|COMPLETED|Overall Study||10
10855333|NCT02833935|12021473|FG001|COMPLETED|Overall Study||12
10855334|NCT02833935|12021472|FG000|NOT COMPLETED|Overall Study||2
10855335|NCT02833935|12021473|FG001|NOT COMPLETED|Overall Study||0
10855336|NCT02660827|12021479|FG000|STARTED|From Study to End of Continued Access||151
10855337|NCT02660827|12021479|FG000|COMPLETED|From Study to End of Continued Access||120
10855338|NCT02660827|12021479|FG000|NOT COMPLETED|From Study to End of Continued Access||31
10855339|NCT02660827|12021479|FG000|STARTED|Period 1: Study Period||151
10855340|NCT02660827|12021479|FG000|COMPLETED|Period 1: Study Period||150
10855341|NCT02660827|12021479|FG000|NOT COMPLETED|Period 1: Study Period||1
10855342|NCT02660827|12021479|FG000|STARTED|Period 2: Continued Access Period||145
10855343|NCT02660827|12021479|FG000|COMPLETED|Period 2: Continued Access Period||120
10855344|NCT02660827|12021479|FG000|NOT COMPLETED|Period 2: Continued Access Period||25
10855345|NCT02627963|12021488|FG000|STARTED|Overall Study||175
10855346|NCT02627963|12021489|FG001|STARTED|Overall Study||175
10855347|NCT02627963|12021488|FG000|COMPLETED|Overall Study||139
10855348|NCT02627963|12021489|FG001|COMPLETED|Overall Study||161
10855349|NCT02627963|12021488|FG000|NOT COMPLETED|Overall Study||36
10855350|NCT02627963|12021489|FG001|NOT COMPLETED|Overall Study||14
10855351|NCT02425644|12021497|FG000|STARTED|Overall Study||567
10855352|NCT02425644|12021498|FG001|STARTED|Overall Study||566
10855353|NCT02425644|12021497|FG000|Treated|Overall Study||565
10855354|NCT02425644|12021498|FG001|Treated|Overall Study||566
10855355|NCT02425644|12021497|FG000|COMPLETED|Overall Study||490
10855356|NCT02425644|12021498|FG001|COMPLETED|Overall Study||495
10855357|NCT02425644|12021497|FG000|NOT COMPLETED|Overall Study||77
10855358|NCT02425644|12021498|FG001|NOT COMPLETED|Overall Study||71
10855359|NCT02395614|12021504|FG000|STARTED|Overall Study||88
10855360|NCT02395614|12021504|FG000|Chlorhexidine Irrigation|Overall Study||88
10855361|NCT02395614|12021504|FG000|Triple Antibiotic Irrigation|Overall Study||88
10855362|NCT02395614|12021504|FG000|COMPLETED|Overall Study||88
10855363|NCT02395614|12021504|FG000|NOT COMPLETED|Overall Study||0
10855364|NCT02270957|12021511|FG000|STARTED|Overall Study||31
10855365|NCT02270957|12021512|FG001|STARTED|Overall Study||35
10855366|NCT02270957|12021511|FG000|COMPLETED|Overall Study||27
10855367|NCT02270957|12021512|FG001|COMPLETED|Overall Study||31
10855368|NCT02270957|12021511|FG000|NOT COMPLETED|Overall Study||4
10855369|NCT02270957|12021512|FG001|NOT COMPLETED|Overall Study||4
10855370|NCT02054104|12021521|FG000|STARTED|Overall Study||10
10855371|NCT02054104|12021522|FG001|STARTED|Overall Study||11
10855372|NCT02054104|12021521|FG000|COMPLETED|Overall Study||2
10855373|NCT02054104|12021522|FG001|COMPLETED|Overall Study||2
10855374|NCT02054104|12021521|FG000|NOT COMPLETED|Overall Study||8
10855375|NCT02054104|12021522|FG001|NOT COMPLETED|Overall Study||9
10855376|NCT01899144|12021528|FG000|STARTED|Treatment Period 1||61
10855377|NCT01899144|12021528|FG000|COMPLETED|Treatment Period 1||61
10855378|NCT01899144|12021528|FG000|NOT COMPLETED|Treatment Period 1||0
10855379|NCT01899144|12021528|FG000|STARTED|Treatment Period 2||61
10855380|NCT01899144|12021528|FG000|COMPLETED|Treatment Period 2|Last treatment taken by the patient who discontinued was placebo.|60
10855381|NCT01899144|12021528|FG000|NOT COMPLETED|Treatment Period 2||1
10855382|NCT01899144|12021528|FG000|STARTED|Treatment Period 3||60
10855465|NCT00603954|12021613|FG001|COMPLETED|Overall Study||45
10855466|NCT00603954|12021612|FG000|NOT COMPLETED|Overall Study||1
10855383|NCT01899144|12021528|FG000|COMPLETED|Treatment Period 3|Last treatment taken by patients who discontinued were ABS Spiromax 180 mcg and ABS Spiromax 90 mcg.|58
10855384|NCT01899144|12021528|FG000|NOT COMPLETED|Treatment Period 3||2
10855385|NCT01899144|12021528|FG000|STARTED|Treatment Period 4||58
10855386|NCT01899144|12021528|FG000|COMPLETED|Treatment Period 4||58
10855387|NCT01899144|12021528|FG000|NOT COMPLETED|Treatment Period 4||0
10855388|NCT01899144|12021528|FG000|STARTED|Treatment Period 5||58
10855389|NCT01899144|12021528|FG000|COMPLETED|Treatment Period 5|Last treatment taken by the patient who discontinued was ABS Spiromax 180 mcg.|57
10855390|NCT01899144|12021528|FG000|NOT COMPLETED|Treatment Period 5||1
10855391|NCT01757665|12021542|FG000|STARTED|Overall Study||694
10855392|NCT01757665|12021543|FG001|STARTED|Overall Study||83
10855393|NCT01757665|12021542|FG000|Implanted With Device|Overall Study||689
10855394|NCT01757665|12021543|FG001|Implanted With Device|Overall Study||82
10855395|NCT01757665|12021542|FG000|COMPLETED|Overall Study||0
10855396|NCT01757665|12021543|FG001|COMPLETED|Overall Study||0
10855397|NCT01757665|12021542|FG000|NOT COMPLETED|Overall Study||694
10855398|NCT01757665|12021543|FG001|NOT COMPLETED|Overall Study||83
10855399|NCT01482195|12021564|FG000|STARTED|Overall Study||6
10855400|NCT01482195|12021564|FG000|One Year Results|Overall Study||6
10855401|NCT01482195|12021564|FG000|COMPLETED|Overall Study||6
10855402|NCT01482195|12021564|FG000|NOT COMPLETED|Overall Study||0
10855403|NCT01468831|12021571|FG000|STARTED|Overall Study||4
10855404|NCT01468831|12021572|FG001|STARTED|Overall Study||5
10855405|NCT01468831|12021571|FG000|Month 12 (Primary Outcome)|Overall Study||4
10855406|NCT01468831|12021572|FG001|Month 12 (Primary Outcome)|Overall Study||4
10855407|NCT01468831|12021571|FG000|COMPLETED|Overall Study||4
10855408|NCT01468831|12021572|FG001|COMPLETED|Overall Study||4
10855409|NCT01468831|12021571|FG000|NOT COMPLETED|Overall Study||0
10855410|NCT01468831|12021572|FG001|NOT COMPLETED|Overall Study||1
10855411|NCT01383109|12021578|FG000|STARTED|Overall Study||6
10855412|NCT01383109|12021578|FG000|COMPLETED|Overall Study||6
10855413|NCT01383109|12021578|FG000|NOT COMPLETED|Overall Study||0
10855462|NCT00603954|12021612|FG000|STARTED|Overall Study|5 patients in Screening failure between inclusion and transplantation|50
10855463|NCT00603954|12021613|FG001|STARTED|Overall Study|5 patients in Screening failure between inclusion and transplantation|47
10855464|NCT00603954|12021612|FG000|COMPLETED|Overall Study||49
10855467|NCT00603954|12021613|FG001|NOT COMPLETED|Overall Study||2
10855468|NCT05087524|12021620|FG000|STARTED|Overall Study||65
10855469|NCT05087524|12021620|FG000|COMPLETED|Overall Study||65
10855470|NCT05087524|12021620|FG000|NOT COMPLETED|Overall Study||0
10855471|NCT04532294|12021627|FG000|STARTED|Overall Study||4
10855472|NCT04532294|12021628|FG001|STARTED|Overall Study||6
10855473|NCT04532294|12021629|FG002|STARTED|Overall Study||8
10855474|NCT04532294|12021627|FG000|COMPLETED|Overall Study||4
10855475|NCT04532294|12021628|FG001|COMPLETED|Overall Study||6
10855476|NCT04532294|12021629|FG002|COMPLETED|Overall Study||5
10855477|NCT04532294|12021627|FG000|NOT COMPLETED|Overall Study||0
10855478|NCT04532294|12021628|FG001|NOT COMPLETED|Overall Study||0
10855479|NCT04532294|12021629|FG002|NOT COMPLETED|Overall Study||3
10855480|NCT04250077|12021642|FG000|STARTED|Overall Study||15
10855481|NCT04250077|12021643|FG001|STARTED|Overall Study||15
10855482|NCT04250077|12021644|FG002|STARTED|Overall Study||15
10855483|NCT04250077|12021642|FG000|COMPLETED|Overall Study||13
10855484|NCT04250077|12021643|FG001|COMPLETED|Overall Study||11
10855485|NCT04250077|12021644|FG002|COMPLETED|Overall Study||15
10855486|NCT04250077|12021642|FG000|NOT COMPLETED|Overall Study||2
10855487|NCT04250077|12021643|FG001|NOT COMPLETED|Overall Study||4
10855488|NCT04250077|12021644|FG002|NOT COMPLETED|Overall Study||0
10855510|NCT03583931|12021688|FG000|STARTED|Overall Study||5
10855511|NCT03583931|12021689|FG001|STARTED|Overall Study||5
10855512|NCT03583931|12021688|FG000|COMPLETED|Overall Study||5
10855513|NCT03583931|12021689|FG001|COMPLETED|Overall Study||5
10855514|NCT03583931|12021688|FG000|NOT COMPLETED|Overall Study||0
10855515|NCT03583931|12021689|FG001|NOT COMPLETED|Overall Study||0
10855516|NCT03505710|12021698|FG000|STARTED|Overall Study||49
10855517|NCT03505710|12021699|FG001|STARTED|Overall Study||41
10855518|NCT03505710|12021700|FG002|STARTED|Overall Study||91
10855519|NCT03505710|12021698|FG000|COMPLETED|Overall Study||2
10855520|NCT03505710|12021699|FG001|COMPLETED|Overall Study||14
10855521|NCT03505710|12021700|FG002|COMPLETED|Overall Study||15
10855522|NCT03505710|12021698|FG000|NOT COMPLETED|Overall Study||47
10855523|NCT03505710|12021699|FG001|NOT COMPLETED|Overall Study||27
10855524|NCT03505710|12021700|FG002|NOT COMPLETED|Overall Study||76
10855525|NCT03296553|12021710|FG000|STARTED|Overall Study||20
10855526|NCT03296553|12021711|FG001|STARTED|Overall Study||20
10855527|NCT03296553|12021710|FG000|COMPLETED|Overall Study||18
10855528|NCT03296553|12021711|FG001|COMPLETED|Overall Study||19
10855529|NCT03296553|12021710|FG000|NOT COMPLETED|Overall Study||2
10855530|NCT03296553|12021711|FG001|NOT COMPLETED|Overall Study||1
10855531|NCT03049449|12021725|FG000|STARTED|Overall Study||0
10855532|NCT03049449|12021726|FG001|STARTED|Overall Study||3
10855533|NCT03049449|12021727|FG002|STARTED|Overall Study|One participant was enrolled and removed from study with no treatment and was later re-enrolled and treated.|4
10855534|NCT03049449|12021728|FG003|STARTED|Overall Study|One participant was enrolled and removed from study with no treatment and was later re-enrolled and treated.|8
10855535|NCT03049449|12021729|FG004|STARTED|Overall Study||5
10855536|NCT03049449|12021730|FG005|STARTED|Overall Study||0
10855537|NCT03049449|12021731|FG006|STARTED|Overall Study||3
10855538|NCT03049449|12021732|FG007|STARTED|Overall Study||1
10855539|NCT03049449|12021733|FG008|STARTED|Overall Study||1
10855540|NCT03049449|12021734|FG009|STARTED|Overall Study||1
10855541|NCT03049449|12021725|FG000|COMPLETED|Overall Study||0
10855542|NCT03049449|12021726|FG001|COMPLETED|Overall Study||3
10855543|NCT03049449|12021727|FG002|COMPLETED|Overall Study||3
10855544|NCT03049449|12021728|FG003|COMPLETED|Overall Study||7
10855545|NCT03049449|12021729|FG004|COMPLETED|Overall Study||5
10855546|NCT03049449|12021730|FG005|COMPLETED|Overall Study||0
10855547|NCT03049449|12021731|FG006|COMPLETED|Overall Study||3
10855548|NCT03049449|12021732|FG007|COMPLETED|Overall Study||0
10855549|NCT03049449|12021733|FG008|COMPLETED|Overall Study||0
10855550|NCT03049449|12021734|FG009|COMPLETED|Overall Study||0
10855551|NCT03049449|12021725|FG000|NOT COMPLETED|Overall Study||0
10855552|NCT03049449|12021726|FG001|NOT COMPLETED|Overall Study||0
10855553|NCT03049449|12021727|FG002|NOT COMPLETED|Overall Study||1
10855554|NCT03049449|12021728|FG003|NOT COMPLETED|Overall Study||1
10855555|NCT03049449|12021729|FG004|NOT COMPLETED|Overall Study||0
10855556|NCT03049449|12021730|FG005|NOT COMPLETED|Overall Study||0
10855557|NCT03049449|12021731|FG006|NOT COMPLETED|Overall Study||0
10855558|NCT03049449|12021732|FG007|NOT COMPLETED|Overall Study||1
10755039|NCT03060447|11918847|FG001|STARTED|Overall Study||8
10755040|NCT03060447|11918846|FG000|COMPLETED|Overall Study||15
10755041|NCT03060447|11918847|FG001|COMPLETED|Overall Study||8
10755042|NCT03060447|11918846|FG000|NOT COMPLETED|Overall Study||2
10755043|NCT03060447|11918847|FG001|NOT COMPLETED|Overall Study||0
10755044|NCT03060486|11918859|FG000|STARTED|Overall Study||15
10755045|NCT03060486|11918859|FG000|COMPLETED|Overall Study||15
10755046|NCT03060486|11918859|FG000|NOT COMPLETED|Overall Study||0
10755047|NCT03060512|11918865|FG000|STARTED|Overall Study||137
10755048|NCT03060512|11918866|FG001|STARTED|Overall Study||139
10755049|NCT03060512|11918865|FG000|Treated With Movantik|Overall Study||136
10755050|NCT03060512|11918866|FG001|Treated With Movantik|Overall Study||135
10755051|NCT03060512|11918865|FG000|Treated With PEG 3350|Overall Study||130
10755052|NCT03060512|11918866|FG001|Treated With PEG 3350|Overall Study||138
10855559|NCT03049449|12021733|FG008|NOT COMPLETED|Overall Study||1
10855560|NCT03049449|12021734|FG009|NOT COMPLETED|Overall Study||1
10855561|NCT03000569|12021754|FG000|STARTED|Overall Study||15
10855562|NCT03000569|12021755|FG001|STARTED|Overall Study||14
10755053|NCT03060512|11918865|FG000|COMPLETED|Overall Study||130
10755054|NCT03060512|11918866|FG001|COMPLETED|Overall Study||130
10855489|NCT04068142|12021656|FG000|STARTED|Overall Study||17
10855490|NCT04068142|12021657|FG001|STARTED|Overall Study||20
10855491|NCT04068142|12021656|FG000|COMPLETED|Overall Study||15
10855492|NCT04068142|12021657|FG001|COMPLETED|Overall Study||16
10855493|NCT04068142|12021656|FG000|NOT COMPLETED|Overall Study||2
10855494|NCT04068142|12021657|FG001|NOT COMPLETED|Overall Study||4
10855495|NCT03961009|12021663|FG000|STARTED|Overall Study||47
10855496|NCT03961009|12021663|FG000|COMPLETED|Overall Study||47
10855497|NCT03961009|12021663|FG000|NOT COMPLETED|Overall Study||0
10855498|NCT03875495|12021667|FG000|STARTED|Overall Study||3
10855499|NCT03875495|12021667|FG000|COMPLETED|Overall Study||0
10855500|NCT03875495|12021667|FG000|NOT COMPLETED|Overall Study||3
10855501|NCT03702439|12021671|FG000|STARTED|Overall Study||408
10855502|NCT03702439|12021671|FG000|COMPLETED|Overall Study||408
10855503|NCT03702439|12021671|FG000|NOT COMPLETED|Overall Study||0
10855504|NCT03687190|12021679|FG000|STARTED|Overall Study||12
10855505|NCT03687190|12021680|FG001|STARTED|Overall Study||9
10855506|NCT03687190|12021679|FG000|COMPLETED|Overall Study||12
10855507|NCT03687190|12021680|FG001|COMPLETED|Overall Study||9
10855508|NCT03687190|12021679|FG000|NOT COMPLETED|Overall Study||0
10855509|NCT03687190|12021680|FG001|NOT COMPLETED|Overall Study||0
10855563|NCT03000569|12021754|FG000|COMPLETED|Overall Study||14
10855564|NCT03000569|12021755|FG001|COMPLETED|Overall Study||14
10855565|NCT03000569|12021754|FG000|NOT COMPLETED|Overall Study||1
10855566|NCT03000569|12021755|FG001|NOT COMPLETED|Overall Study||0
10855567|NCT03000530|12021772|FG000|STARTED|Overall Study||13
10855568|NCT03000530|12021773|FG001|STARTED|Overall Study||44
10855569|NCT03000530|12021774|FG002|STARTED|Overall Study||45
10855570|NCT03000530|12021772|FG000|COMPLETED|Overall Study||13
10855571|NCT03000530|12021773|FG001|COMPLETED|Overall Study||39
10855572|NCT03000530|12021774|FG002|COMPLETED|Overall Study||41
10855573|NCT03000530|12021772|FG000|NOT COMPLETED|Overall Study||0
10855574|NCT03000530|12021773|FG001|NOT COMPLETED|Overall Study||5
10855575|NCT03000530|12021774|FG002|NOT COMPLETED|Overall Study||4
10855576|NCT02978781|12021788|FG000|STARTED|Part A||2
10855577|NCT02978781|12021789|FG001|STARTED|Part A||14
10855578|NCT02978781|12021790|FG002|STARTED|Part A||0
10855579|NCT02978781|12021791|FG003|STARTED|Part A||0
10855580|NCT02978781|12021792|FG004|STARTED|Part A||0
10855581|NCT02978781|12021788|FG000|COMPLETED|Part A||1
10855582|NCT02978781|12021789|FG001|COMPLETED|Part A||12
10855583|NCT02978781|12021790|FG002|COMPLETED|Part A||0
10855584|NCT02978781|12021791|FG003|COMPLETED|Part A||0
10855585|NCT02978781|12021792|FG004|COMPLETED|Part A||0
10855586|NCT02978781|12021788|FG000|NOT COMPLETED|Part A||1
10855587|NCT02978781|12021789|FG001|NOT COMPLETED|Part A||2
10855588|NCT02978781|12021790|FG002|NOT COMPLETED|Part A||0
10855589|NCT02978781|12021791|FG003|NOT COMPLETED|Part A||0
10855590|NCT02978781|12021792|FG004|NOT COMPLETED|Part A||0
10855591|NCT02978781|12021788|FG000|STARTED|Part B||0
10855592|NCT02978781|12021789|FG001|STARTED|Part B||0
10855593|NCT02978781|12021790|FG002|STARTED|Part B|Include participants who tolerated a dose ≥10 mg in Part A and achieved response on Day 8.|4
10855594|NCT02978781|12021791|FG003|STARTED|Part B|Include participants who tolerated a dose ≥10 mg in Part A and achieved response on Day 8.|4
10855595|NCT02978781|12021792|FG004|STARTED|Part B||0
10855596|NCT02978781|12021788|FG000|COMPLETED|Part B||0
10855597|NCT02978781|12021789|FG001|COMPLETED|Part B||0
10855598|NCT02978781|12021790|FG002|COMPLETED|Part B||4
10855599|NCT02978781|12021791|FG003|COMPLETED|Part B||3
10855600|NCT02978781|12021792|FG004|COMPLETED|Part B||0
10855601|NCT02978781|12021788|FG000|NOT COMPLETED|Part B||0
10855602|NCT02978781|12021789|FG001|NOT COMPLETED|Part B||0
10855603|NCT02978781|12021790|FG002|NOT COMPLETED|Part B||0
10855604|NCT02978781|12021791|FG003|NOT COMPLETED|Part B||1
10415007|NCT00788008|11559519|FG000|NOT COMPLETED|Overall Study||0
10415008|NCT00788008|11559520|FG001|NOT COMPLETED|Overall Study||0
10415009|NCT00788073|11559528|FG000|STARTED|STX209 Then Placebo||30
10415010|NCT00788073|11559529|FG001|STARTED|STX209 Then Placebo||33
10415011|NCT00788073|11559528|FG000|COMPLETED|STX209 Then Placebo||29
10415012|NCT00788073|11559529|FG001|COMPLETED|STX209 Then Placebo||30
10855605|NCT02978781|12021792|FG004|NOT COMPLETED|Part B||0
10855606|NCT02978781|12021788|FG000|STARTED|Part C||0
10855607|NCT02978781|12021789|FG001|STARTED|Part C||0
10855608|NCT02978781|12021790|FG002|STARTED|Part C||0
10855609|NCT02978781|12021791|FG003|STARTED|Part C||0
10855610|NCT02978781|12021792|FG004|STARTED|Part C||18
10855611|NCT02978781|12021788|FG000|COMPLETED|Part C||0
10855612|NCT02978781|12021789|FG001|COMPLETED|Part C||0
10855613|NCT02978781|12021790|FG002|COMPLETED|Part C||0
10855614|NCT02978781|12021791|FG003|COMPLETED|Part C||0
10855615|NCT02978781|12021792|FG004|COMPLETED|Part C||14
10855616|NCT02978781|12021788|FG000|NOT COMPLETED|Part C||0
10855617|NCT02978781|12021789|FG001|NOT COMPLETED|Part C||0
10855618|NCT02978781|12021790|FG002|NOT COMPLETED|Part C||0
10855619|NCT02978781|12021791|FG003|NOT COMPLETED|Part C||0
10415013|NCT00788073|11559528|FG000|NOT COMPLETED|STX209 Then Placebo||1
10415014|NCT00788073|11559529|FG001|NOT COMPLETED|STX209 Then Placebo||3
10415015|NCT00788073|11559528|FG000|STARTED|Placebo Then STX209||29
10855620|NCT02978781|12021792|FG004|NOT COMPLETED|Part C||4
10855621|NCT02964507|12021826|FG000|STARTED|Overall Study||33
10855622|NCT02964507|12021827|FG001|STARTED|Overall Study||12
10855623|NCT02964507|12021828|FG002|STARTED|Overall Study||42
10855624|NCT02964507|12021829|FG003|STARTED|Overall Study||7
10415016|NCT00788073|11559529|FG001|STARTED|Placebo Then STX209||30
10855625|NCT02964507|12021830|FG004|STARTED|Overall Study||18
10855626|NCT02964507|12021831|FG005|STARTED|Overall Study||11
10415017|NCT00788073|11559528|FG000|COMPLETED|Placebo Then STX209||27
10415018|NCT00788073|11559529|FG001|COMPLETED|Placebo Then STX209||29
10415019|NCT00788073|11559528|FG000|NOT COMPLETED|Placebo Then STX209||2
10415020|NCT00788073|11559529|FG001|NOT COMPLETED|Placebo Then STX209||1
10415021|NCT00788255|11559535|FG000|STARTED|Overall Study||25
10415022|NCT00788255|11559535|FG000|Oxytocin Infusion 1: 22.5 μU/mL|Overall Study||25
10415023|NCT00788255|11559535|FG000|Oxytocin Infusion 2: 30.1μU/mL|Overall Study||25
10415024|NCT00788255|11559535|FG000|Oxytocin Infusion 3: 32.9μU/mL|Overall Study||25
10415025|NCT00788255|11559535|FG000|Oxytocin: 0 μU/mL|Overall Study||25
10415026|NCT00788255|11559535|FG000|COMPLETED|Overall Study||25
10415027|NCT00788255|11559535|FG000|NOT COMPLETED|Overall Study||0
10415028|NCT00788372|11559542|FG000|STARTED|Period 1 (up to 4 Weeks)||142
10415029|NCT00788372|11559542|FG000|COMPLETED|Period 1 (up to 4 Weeks)||111
10415030|NCT00788372|11559542|FG000|NOT COMPLETED|Period 1 (up to 4 Weeks)||31
10415031|NCT00788372|11559542|FG000|STARTED|Period 2 (Week 4 to Week 52)||111
10415032|NCT00788372|11559542|FG000|COMPLETED|Period 2 (Week 4 to Week 52)||79
10415033|NCT00788372|11559542|FG000|NOT COMPLETED|Period 2 (Week 4 to Week 52)||32
10415034|NCT00788593|11559546|FG000|STARTED|Placebo Run-in Phase||82
10415035|NCT00788593|11559547|FG001|STARTED|Placebo Run-in Phase||0
10415036|NCT00788593|11559548|FG002|STARTED|Placebo Run-in Phase||0
10415037|NCT00788593|11559546|FG000|COMPLETED|Placebo Run-in Phase||76
10855627|NCT02964507|12021832|FG006|STARTED|Overall Study||0
10855628|NCT02964507|12021833|FG007|STARTED|Overall Study||0
10855629|NCT02964507|12021826|FG000|COMPLETED|Overall Study||7
10855630|NCT02964507|12021827|FG001|COMPLETED|Overall Study||1
10855631|NCT02964507|12021828|FG002|COMPLETED|Overall Study||17
10855632|NCT02964507|12021829|FG003|COMPLETED|Overall Study||1
10855633|NCT02964507|12021830|FG004|COMPLETED|Overall Study||2
10855634|NCT02964507|12021831|FG005|COMPLETED|Overall Study||3
10855635|NCT02964507|12021832|FG006|COMPLETED|Overall Study||0
10855636|NCT02964507|12021833|FG007|COMPLETED|Overall Study||0
10855637|NCT02964507|12021826|FG000|NOT COMPLETED|Overall Study||26
10855638|NCT02964507|12021827|FG001|NOT COMPLETED|Overall Study||11
10855639|NCT02964507|12021828|FG002|NOT COMPLETED|Overall Study||25
10855640|NCT02964507|12021829|FG003|NOT COMPLETED|Overall Study||6
10855641|NCT02964507|12021830|FG004|NOT COMPLETED|Overall Study||16
10855642|NCT02964507|12021831|FG005|NOT COMPLETED|Overall Study||8
10855643|NCT02964507|12021832|FG006|NOT COMPLETED|Overall Study||0
10855644|NCT02964507|12021833|FG007|NOT COMPLETED|Overall Study||0
10855645|NCT02942277|12021863|FG000|STARTED|Year 1||5
10855646|NCT02942277|12021864|FG001|STARTED|Year 1||10
10855647|NCT02942277|12021865|FG002|STARTED|Year 1||5
10855648|NCT02942277|12021866|FG003|STARTED|Year 1||10
10855649|NCT02942277|12021867|FG004|STARTED|Year 1||56
10855650|NCT02942277|12021868|FG005|STARTED|Year 1||61
10855651|NCT02942277|12021869|FG006|STARTED|Year 1||5
10855652|NCT02942277|12021870|FG007|STARTED|Year 1||10
10855653|NCT02942277|12021871|FG008|STARTED|Year 1||10
10855654|NCT02942277|12021872|FG009|STARTED|Year 1||10
10855655|NCT02942277|12021873|FG010|STARTED|Year 1||119
10855656|NCT02942277|12021863|FG000|COMPLETED|Year 1||5
10855657|NCT02942277|12021864|FG001|COMPLETED|Year 1||8
10855658|NCT02942277|12021865|FG002|COMPLETED|Year 1||5
10855659|NCT02942277|12021866|FG003|COMPLETED|Year 1||9
10855660|NCT02942277|12021867|FG004|COMPLETED|Year 1||49
10855661|NCT02942277|12021868|FG005|COMPLETED|Year 1||51
10855662|NCT02942277|12021869|FG006|COMPLETED|Year 1||5
10855663|NCT02942277|12021870|FG007|COMPLETED|Year 1||9
10855664|NCT02942277|12021871|FG008|COMPLETED|Year 1||10
10855665|NCT02942277|12021872|FG009|COMPLETED|Year 1||10
10855666|NCT02942277|12021873|FG010|COMPLETED|Year 1||104
10855667|NCT02942277|12021863|FG000|NOT COMPLETED|Year 1||0
10855668|NCT02942277|12021864|FG001|NOT COMPLETED|Year 1||2
10855669|NCT02942277|12021865|FG002|NOT COMPLETED|Year 1||0
10855670|NCT02942277|12021866|FG003|NOT COMPLETED|Year 1||1
10855671|NCT02942277|12021867|FG004|NOT COMPLETED|Year 1||7
10855672|NCT02942277|12021868|FG005|NOT COMPLETED|Year 1||10
10855673|NCT02942277|12021869|FG006|NOT COMPLETED|Year 1||0
10855674|NCT02942277|12021870|FG007|NOT COMPLETED|Year 1||1
10855675|NCT02942277|12021871|FG008|NOT COMPLETED|Year 1||0
10855676|NCT02942277|12021872|FG009|NOT COMPLETED|Year 1||0
10855677|NCT02942277|12021873|FG010|NOT COMPLETED|Year 1||15
10855678|NCT02942277|12021863|FG000|STARTED|Year 2||5
10855679|NCT02942277|12021864|FG001|STARTED|Year 2||8
10855680|NCT02942277|12021865|FG002|STARTED|Year 2||5
10855681|NCT02942277|12021866|FG003|STARTED|Year 2||9
10855682|NCT02942277|12021867|FG004|STARTED|Year 2||49
10855683|NCT02942277|12021868|FG005|STARTED|Year 2||51
10855684|NCT02942277|12021869|FG006|STARTED|Year 2||5
10855685|NCT02942277|12021870|FG007|STARTED|Year 2||9
10855686|NCT02942277|12021871|FG008|STARTED|Year 2||10
10855687|NCT02942277|12021872|FG009|STARTED|Year 2||10
10855688|NCT02942277|12021873|FG010|STARTED|Year 2||104
10855689|NCT02942277|12021863|FG000|COMPLETED|Year 2||5
10855690|NCT02942277|12021864|FG001|COMPLETED|Year 2||7
10855691|NCT02942277|12021865|FG002|COMPLETED|Year 2||4
10855692|NCT02942277|12021866|FG003|COMPLETED|Year 2||8
10855693|NCT02942277|12021867|FG004|COMPLETED|Year 2||36
10855694|NCT02942277|12021868|FG005|COMPLETED|Year 2||40
10855695|NCT02942277|12021869|FG006|COMPLETED|Year 2||4
10855696|NCT02942277|12021870|FG007|COMPLETED|Year 2||8
10855697|NCT02942277|12021871|FG008|COMPLETED|Year 2||10
10855698|NCT02942277|12021872|FG009|COMPLETED|Year 2||9
10855699|NCT02942277|12021873|FG010|COMPLETED|Year 2||79
10855700|NCT02942277|12021863|FG000|NOT COMPLETED|Year 2||0
10855701|NCT02942277|12021864|FG001|NOT COMPLETED|Year 2||1
10855702|NCT02942277|12021865|FG002|NOT COMPLETED|Year 2||1
10855703|NCT02942277|12021866|FG003|NOT COMPLETED|Year 2||1
10855704|NCT02942277|12021867|FG004|NOT COMPLETED|Year 2||13
10855705|NCT02942277|12021868|FG005|NOT COMPLETED|Year 2||11
10855706|NCT02942277|12021869|FG006|NOT COMPLETED|Year 2||1
10855707|NCT02942277|12021870|FG007|NOT COMPLETED|Year 2||1
10855708|NCT02942277|12021871|FG008|NOT COMPLETED|Year 2||0
10855709|NCT02942277|12021872|FG009|NOT COMPLETED|Year 2||1
10855710|NCT02942277|12021873|FG010|NOT COMPLETED|Year 2||25
10855711|NCT02942017|12021902|FG000|STARTED|Overall Study||54
10855712|NCT02942017|12021903|FG001|STARTED|Overall Study||54
10855713|NCT02942017|12021902|FG000|Treated|Overall Study||53
10855714|NCT02942017|12021903|FG001|Treated|Overall Study||51
10855715|NCT02942017|12021902|FG000|COMPLETED|Overall Study||52
10855716|NCT02942017|12021903|FG001|COMPLETED|Overall Study||48
10855717|NCT02942017|12021902|FG000|NOT COMPLETED|Overall Study||2
10855718|NCT02942017|12021903|FG001|NOT COMPLETED|Overall Study||6
10855719|NCT02942004|12021912|FG000|STARTED|Overall Study||46
10855720|NCT02942004|12021913|FG001|STARTED|Overall Study||47
10855721|NCT02942004|12021914|FG002|STARTED|Overall Study||45
10855722|NCT02942004|12021912|FG000|Participants Who Received Study Drug|Overall Study||43
10855723|NCT02942004|12021913|FG001|Participants Who Received Study Drug|Overall Study||38
10855724|NCT02942004|12021914|FG002|Participants Who Received Study Drug|Overall Study||41
10855725|NCT02942004|12021912|FG000|COMPLETED|Overall Study||42
10855726|NCT02942004|12021913|FG001|COMPLETED|Overall Study||35
10855727|NCT02942004|12021914|FG002|COMPLETED|Overall Study||36
10855728|NCT02942004|12021912|FG000|NOT COMPLETED|Overall Study||4
10855729|NCT02942004|12021913|FG001|NOT COMPLETED|Overall Study||12
10855730|NCT02942004|12021914|FG002|NOT COMPLETED|Overall Study||9
10855731|NCT02861014|12021922|FG000|STARTED|Primary Analysis||680
10855732|NCT02861014|12021922|FG000|COMPLETED|Primary Analysis||641
10855733|NCT02861014|12021922|FG000|NOT COMPLETED|Primary Analysis||39
10855734|NCT02861014|12021922|FG000|STARTED|Safety Follow-up||64
10855735|NCT02861014|12021922|FG000|COMPLETED|Safety Follow-up||14
10855736|NCT02861014|12021922|FG000|NOT COMPLETED|Safety Follow-up||50
10293359|NCT00427193|11425921|FG001|STARTED|Overall Study||75
10293360|NCT00427193|11425920|FG000|COMPLETED|Overall Study||117
10293361|NCT00427193|11425921|FG001|COMPLETED|Overall Study||71
10293362|NCT00427193|11425920|FG000|NOT COMPLETED|Overall Study||26
10293363|NCT00427193|11425921|FG001|NOT COMPLETED|Overall Study||4
10293364|NCT00148733|11425931|FG000|STARTED|Overall Study||1314
10293365|NCT00148733|11425932|FG001|STARTED|Overall Study||1314
10293366|NCT00148733|11425931|FG000|COMPLETED|Overall Study||1300
10293367|NCT00148733|11425932|FG001|COMPLETED|Overall Study||1299
10293368|NCT00148733|11425931|FG000|NOT COMPLETED|Overall Study||14
10293369|NCT00148733|11425932|FG001|NOT COMPLETED|Overall Study||15
10293370|NCT00142584|11425940|FG000|STARTED|Overall Study||252
10293371|NCT00142584|11425941|FG001|STARTED|Overall Study||84
10293372|NCT00142584|11425940|FG000|COMPLETED|Overall Study||108
10293373|NCT00142584|11425941|FG001|COMPLETED|Overall Study||28
10293374|NCT00142584|11425940|FG000|NOT COMPLETED|Overall Study||144
10293375|NCT00142584|11425941|FG001|NOT COMPLETED|Overall Study||56
10314504|NCT00163657|11448150|FG002|COMPLETED|Overall Study||116
10314505|NCT00163657|11448148|FG000|NOT COMPLETED|Overall Study||20
10314506|NCT00163657|11448149|FG001|NOT COMPLETED|Overall Study||23
10314507|NCT00163657|11448150|FG002|NOT COMPLETED|Overall Study||37
10314508|NCT00165646|11448161|FG000|STARTED|Overall Study||93
10314509|NCT00165646|11448162|FG001|STARTED|Overall Study||93
10314510|NCT00165646|11448163|FG002|STARTED|Overall Study||102
10314511|NCT00165646|11448161|FG000|COMPLETED|Overall Study||88
10314512|NCT00165646|11448162|FG001|COMPLETED|Overall Study||88
10314513|NCT00165646|11448163|FG002|COMPLETED|Overall Study||98
10314514|NCT00165646|11448161|FG000|NOT COMPLETED|Overall Study||5
10415038|NCT00788593|11559547|FG001|COMPLETED|Placebo Run-in Phase||0
10855747|NCT02767531|12021937|FG000|STARTED|Period 1|Orlistat therapy|1
10855748|NCT02767531|12021938|FG001|STARTED|Period 1|Off Orlistat|1
10855749|NCT02767531|12021937|FG000|COMPLETED|Period 1||1
10855750|NCT02767531|12021938|FG001|COMPLETED|Period 1||1
10855751|NCT02767531|12021937|FG000|NOT COMPLETED|Period 1||0
10855752|NCT02767531|12021938|FG001|NOT COMPLETED|Period 1||0
10855753|NCT02767531|12021937|FG000|STARTED|Period 2|Off Orlistat|1
10855754|NCT02767531|12021938|FG001|STARTED|Period 2|Orlistat Therapy|1
10855755|NCT02767531|12021937|FG000|COMPLETED|Period 2||1
10855756|NCT02767531|12021938|FG001|COMPLETED|Period 2||1
10855757|NCT02767531|12021937|FG000|NOT COMPLETED|Period 2||0
10855758|NCT02767531|12021938|FG001|NOT COMPLETED|Period 2||0
10314515|NCT00165646|11448162|FG001|NOT COMPLETED|Overall Study||5
10314516|NCT00165646|11448163|FG002|NOT COMPLETED|Overall Study||4
10314517|NCT00165672|11448173|FG000|STARTED|Overall Study||13
10855759|NCT02767531|12021937|FG000|STARTED|Period 3|Orlistat Therapy|1
10314518|NCT00165672|11448174|FG001|STARTED|Overall Study||13
10314519|NCT00165672|11448173|FG000|COMPLETED|Overall Study||13
10314520|NCT00165672|11448174|FG001|COMPLETED|Overall Study||12
10855760|NCT02767531|12021938|FG001|STARTED|Period 3|Off Orlistat|1
10855761|NCT02767531|12021937|FG000|COMPLETED|Period 3||1
10855762|NCT02767531|12021938|FG001|COMPLETED|Period 3||1
10855763|NCT02767531|12021937|FG000|NOT COMPLETED|Period 3||0
10855764|NCT02767531|12021938|FG001|NOT COMPLETED|Period 3||0
10855765|NCT02767531|12021937|FG000|STARTED|Period 4|Off Orlistat|1
10855766|NCT02767531|12021938|FG001|STARTED|Period 4|Orlistat Therapy|1
10855767|NCT02767531|12021937|FG000|COMPLETED|Period 4||1
10855768|NCT02767531|12021938|FG001|COMPLETED|Period 4||1
10855769|NCT02767531|12021937|FG000|NOT COMPLETED|Period 4||0
10855770|NCT02767531|12021938|FG001|NOT COMPLETED|Period 4||0
10855771|NCT02726880|12021946|FG000|STARTED|Overall Study||17
10855772|NCT02726880|12021947|FG001|STARTED|Overall Study||19
10855773|NCT02726880|12021946|FG000|COMPLETED|Overall Study||14
10855774|NCT02726880|12021947|FG001|COMPLETED|Overall Study||16
10855775|NCT02726880|12021946|FG000|NOT COMPLETED|Overall Study||3
10855776|NCT02726880|12021947|FG001|NOT COMPLETED|Overall Study||3
10415039|NCT00788593|11559548|FG002|COMPLETED|Placebo Run-in Phase||0
10415040|NCT00788593|11559546|FG000|NOT COMPLETED|Placebo Run-in Phase||6
10415041|NCT00788593|11559547|FG001|NOT COMPLETED|Placebo Run-in Phase||0
10415042|NCT00788593|11559548|FG002|NOT COMPLETED|Placebo Run-in Phase||0
10415043|NCT00788593|11559546|FG000|STARTED|First Intervention Period||0
10415044|NCT00788593|11559547|FG001|STARTED|First Intervention Period||39
10415045|NCT00788593|11559548|FG002|STARTED|First Intervention Period||37
10415046|NCT00788593|11559546|FG000|COMPLETED|First Intervention Period||0
10415047|NCT00788593|11559547|FG001|COMPLETED|First Intervention Period||38
10415048|NCT00788593|11559548|FG002|COMPLETED|First Intervention Period||37
10415049|NCT00788593|11559546|FG000|NOT COMPLETED|First Intervention Period||0
10415050|NCT00788593|11559547|FG001|NOT COMPLETED|First Intervention Period||1
10415051|NCT00788593|11559548|FG002|NOT COMPLETED|First Intervention Period||0
10855777|NCT02614547|12021956|FG000|STARTED|Overall Study||11
10855778|NCT02614547|12021957|FG001|STARTED|Overall Study||10
10855779|NCT02614547|12021956|FG000|COMPLETED|Overall Study||11
10855780|NCT02614547|12021957|FG001|COMPLETED|Overall Study||10
10855781|NCT02614547|12021956|FG000|NOT COMPLETED|Overall Study||0
10855782|NCT02614547|12021957|FG001|NOT COMPLETED|Overall Study||0
10855783|NCT02592551|12021969|FG000|STARTED|Overall Study||9
10855784|NCT02592551|12021970|FG001|STARTED|Overall Study||11
10855785|NCT02592551|12021971|FG002|STARTED|Overall Study||4
10855786|NCT02592551|12021969|FG000|COMPLETED|Overall Study|One participant completed all study procedures and got the tumor sample for analysis. However, the sample was too small to analyze in the lab and so that it was not evaluable for primary and secondary analysis.|8
10855787|NCT02592551|12021970|FG001|COMPLETED|Overall Study||8
10855788|NCT02592551|12021971|FG002|COMPLETED|Overall Study||4
10855789|NCT02592551|12021969|FG000|NOT COMPLETED|Overall Study||1
10855790|NCT02592551|12021970|FG001|NOT COMPLETED|Overall Study||3
10855791|NCT02592551|12021971|FG002|NOT COMPLETED|Overall Study||0
10855792|NCT02583048|12021983|FG000|STARTED|Overall Study||28
10855793|NCT02583048|12021984|FG001|STARTED|Overall Study||28
10855794|NCT02583048|12021985|FG002|STARTED|Overall Study||28
10855795|NCT02583048|12021983|FG000|COMPLETED|Overall Study||28
10855796|NCT02583048|12021984|FG001|COMPLETED|Overall Study||27
10855797|NCT02583048|12021985|FG002|COMPLETED|Overall Study||27
10855798|NCT02583048|12021983|FG000|NOT COMPLETED|Overall Study||0
10855799|NCT02583048|12021984|FG001|NOT COMPLETED|Overall Study||1
10855800|NCT02583048|12021985|FG002|NOT COMPLETED|Overall Study||1
10855813|NCT02539160|12022007|FG000|STARTED|Phase 1 Pre-crossover||24
10855814|NCT02539160|12022008|FG001|STARTED|Phase 1 Pre-crossover||24
10855815|NCT02539160|12022009|FG002|STARTED|Phase 1 Pre-crossover||22
10855816|NCT02539160|12022010|FG003|STARTED|Phase 1 Pre-crossover||22
10855817|NCT02539160|12022007|FG000|COMPLETED|Phase 1 Pre-crossover||19
10855818|NCT02539160|12022008|FG001|COMPLETED|Phase 1 Pre-crossover||20
10855819|NCT02539160|12022009|FG002|COMPLETED|Phase 1 Pre-crossover||19
10855820|NCT02539160|12022010|FG003|COMPLETED|Phase 1 Pre-crossover||19
10855821|NCT02539160|12022007|FG000|NOT COMPLETED|Phase 1 Pre-crossover||5
10855822|NCT02539160|12022008|FG001|NOT COMPLETED|Phase 1 Pre-crossover||4
10855823|NCT02539160|12022009|FG002|NOT COMPLETED|Phase 1 Pre-crossover||3
10855824|NCT02539160|12022010|FG003|NOT COMPLETED|Phase 1 Pre-crossover||3
10855825|NCT02539160|12022007|FG000|STARTED|Phase 2 Post-crossover||19
10855826|NCT02539160|12022008|FG001|STARTED|Phase 2 Post-crossover||20
10855827|NCT02539160|12022009|FG002|STARTED|Phase 2 Post-crossover||19
10855828|NCT02539160|12022010|FG003|STARTED|Phase 2 Post-crossover||19
10855829|NCT02539160|12022007|FG000|COMPLETED|Phase 2 Post-crossover||19
10855830|NCT02539160|12022008|FG001|COMPLETED|Phase 2 Post-crossover||20
10855831|NCT02539160|12022009|FG002|COMPLETED|Phase 2 Post-crossover||19
10855832|NCT02539160|12022010|FG003|COMPLETED|Phase 2 Post-crossover||19
10855833|NCT02539160|12022007|FG000|NOT COMPLETED|Phase 2 Post-crossover||0
10855834|NCT02539160|12022008|FG001|NOT COMPLETED|Phase 2 Post-crossover||0
10855835|NCT02539160|12022009|FG002|NOT COMPLETED|Phase 2 Post-crossover||0
10855836|NCT02539160|12022010|FG003|NOT COMPLETED|Phase 2 Post-crossover||0
10855837|NCT02507973|12022020|FG000|STARTED|Overall Study||8
10855838|NCT02507973|12022020|FG000|COMPLETED|Overall Study||7
10855839|NCT02507973|12022020|FG000|NOT COMPLETED|Overall Study||1
10855840|NCT02477618|12022028|FG000|STARTED|Overall Study||65
10855841|NCT02477618|12022029|FG001|STARTED|Overall Study||67
10855842|NCT02477618|12022028|FG000|Intent-to-Treat Analysis Set|Overall Study||66
10855843|NCT02477618|12022029|FG001|Intent-to-Treat Analysis Set|Overall Study||66
10855844|NCT02477618|12022028|FG000|COMPLETED|Overall Study||50
10855845|NCT02477618|12022029|FG001|COMPLETED|Overall Study||53
10855846|NCT02477618|12022028|FG000|NOT COMPLETED|Overall Study||15
10855847|NCT02477618|12022029|FG001|NOT COMPLETED|Overall Study||14
10855848|NCT02424851|12022037|FG000|STARTED|Overall Study||16
10855849|NCT02424851|12022038|FG001|STARTED|Overall Study||15
10855850|NCT02424851|12022037|FG000|COMPLETED|Overall Study||14
10855851|NCT02424851|12022038|FG001|COMPLETED|Overall Study||12
10855852|NCT02424851|12022037|FG000|NOT COMPLETED|Overall Study||2
10855853|NCT02424851|12022038|FG001|NOT COMPLETED|Overall Study||3
10855854|NCT02285504|12022044|FG000|STARTED|Overall Study||4
10855855|NCT02285504|12022044|FG000|COMPLETED|Overall Study||4
10855856|NCT02285504|12022044|FG000|NOT COMPLETED|Overall Study||0
10855857|NCT02227394|12022048|FG000|STARTED|Overall Study||10
10855858|NCT02227394|12022049|FG001|STARTED|Overall Study||10
10855859|NCT02227394|12022048|FG000|COMPLETED|Overall Study||10
10855860|NCT02227394|12022049|FG001|COMPLETED|Overall Study||10
10855861|NCT02227394|12022048|FG000|NOT COMPLETED|Overall Study||0
10855862|NCT02227394|12022049|FG001|NOT COMPLETED|Overall Study||0
10855863|NCT02073968|12022055|FG000|STARTED|Overall Study||35
10855864|NCT02073968|12022055|FG000|COMPLETED|Overall Study||35
10855865|NCT02073968|12022055|FG000|NOT COMPLETED|Overall Study||0
10855866|NCT02003924|12022061|FG000|STARTED|Double-blind Phase||933
10855867|NCT02003924|12022062|FG001|STARTED|Double-blind Phase||468
10855868|NCT02003924|12022063|FG002|STARTED|Double-blind Phase||0
10855869|NCT02003924|12022061|FG000|Treated|Double-blind Phase||930
10855870|NCT02003924|12022062|FG001|Treated|Double-blind Phase||465
10855871|NCT02003924|12022063|FG002|Treated|Double-blind Phase||0
10855872|NCT02003924|12022061|FG000|COMPLETED|Double-blind Phase||478
10855873|NCT02003924|12022062|FG001|COMPLETED|Double-blind Phase||87
10855874|NCT02003924|12022063|FG002|COMPLETED|Double-blind Phase||0
10855875|NCT02003924|12022061|FG000|NOT COMPLETED|Double-blind Phase||455
10855876|NCT02003924|12022062|FG001|NOT COMPLETED|Double-blind Phase||381
10855877|NCT02003924|12022063|FG002|NOT COMPLETED|Double-blind Phase||0
10855878|NCT02003924|12022061|FG000|STARTED|Open-label Phase||478
10855879|NCT02003924|12022062|FG001|STARTED|Open-label Phase|Participants were offered to switch from double blind placebo to open label Enzalutamide.|0
10855880|NCT02003924|12022063|FG002|STARTED|Open-label Phase|Participants previously treated with placebo, switched to receive open label Enzalutamide.|87
10855881|NCT02003924|12022061|FG000|Treated|Open-label Phase||478
10855882|NCT02003924|12022062|FG001|Treated|Open-label Phase||0
10855883|NCT02003924|12022063|FG002|Treated|Open-label Phase||87
10855884|NCT02003924|12022061|FG000|COMPLETED|Open-label Phase||378
10855885|NCT02003924|12022062|FG001|COMPLETED|Open-label Phase||0
10855886|NCT02003924|12022063|FG002|COMPLETED|Open-label Phase||70
10855887|NCT02003924|12022061|FG000|NOT COMPLETED|Open-label Phase||100
10855888|NCT02003924|12022062|FG001|NOT COMPLETED|Open-label Phase||0
10855889|NCT02003924|12022063|FG002|NOT COMPLETED|Open-label Phase||17
10855890|NCT02003924|12022061|FG000|STARTED|Long-term Follow-up Phase|Participants followed up after discontinuing study drug in either double blind or open label phase.|933
10855891|NCT02003924|12022062|FG001|STARTED|Long-term Follow-up Phase|Participants were followed up after study drug discontinuation in double blind phase.|381
10855892|NCT02003924|12022063|FG002|STARTED|Long-term Follow-up Phase|Participants were followed up after study drug discontinuation in open label phase.|87
10855893|NCT02003924|12022061|FG000|COMPLETED|Long-term Follow-up Phase||566
10855894|NCT02003924|12022062|FG001|COMPLETED|Long-term Follow-up Phase||144
10855895|NCT02003924|12022063|FG002|COMPLETED|Long-term Follow-up Phase||80
10855896|NCT02003924|12022061|FG000|NOT COMPLETED|Long-term Follow-up Phase||367
10855897|NCT02003924|12022062|FG001|NOT COMPLETED|Long-term Follow-up Phase||237
10855898|NCT02003924|12022063|FG002|NOT COMPLETED|Long-term Follow-up Phase||7
10855899|NCT01971970|12022072|FG000|STARTED|Baseline Until Week 6||24
10855900|NCT01971970|12022073|FG001|STARTED|Baseline Until Week 6||21
10855901|NCT01971970|12022072|FG000|Receiving Standard Therapy|Baseline Until Week 6||23
10855902|NCT01971970|12022073|FG001|Receiving Standard Therapy|Baseline Until Week 6||21
10855903|NCT01971970|12022072|FG000|Therapy Escalation|Baseline Until Week 6||1
10855904|NCT01971970|12022073|FG001|Therapy Escalation|Baseline Until Week 6||0
10855905|NCT01971970|12022072|FG000|COMPLETED|Baseline Until Week 6||23
10855906|NCT01971970|12022073|FG001|COMPLETED|Baseline Until Week 6||21
10855907|NCT01971970|12022072|FG000|NOT COMPLETED|Baseline Until Week 6||1
10855908|NCT01971970|12022073|FG001|NOT COMPLETED|Baseline Until Week 6||0
10855909|NCT01971970|12022072|FG000|STARTED|Week 6 Until Week 8||23
10855910|NCT01971970|12022073|FG001|STARTED|Week 6 Until Week 8||21
10855911|NCT01971970|12022072|FG000|Receiving Standard Therapy|Week 6 Until Week 8||23
10855912|NCT01971970|12022073|FG001|Receiving Standard Therapy|Week 6 Until Week 8||20
10855913|NCT01971970|12022072|FG000|COMPLETED|Week 6 Until Week 8||23
10855914|NCT01971970|12022073|FG001|COMPLETED|Week 6 Until Week 8||20
10855915|NCT01971970|12022072|FG000|NOT COMPLETED|Week 6 Until Week 8||0
10855916|NCT01971970|12022073|FG001|NOT COMPLETED|Week 6 Until Week 8||1
10855917|NCT01971970|12022072|FG000|STARTED|Week 8 Until Week 14||23
10855918|NCT01971970|12022073|FG001|STARTED|Week 8 Until Week 14||20
10855919|NCT01971970|12022072|FG000|Receiving Standard Therapy|Week 8 Until Week 14||16
10855920|NCT01971970|12022073|FG001|Receiving Standard Therapy|Week 8 Until Week 14||19
10855921|NCT01971970|12022072|FG000|Therapy Escalation|Week 8 Until Week 14||7
10855922|NCT01971970|12022073|FG001|Therapy Escalation|Week 8 Until Week 14||1
10855923|NCT01971970|12022072|FG000|COMPLETED|Week 8 Until Week 14||23
10855924|NCT01971970|12022073|FG001|COMPLETED|Week 8 Until Week 14||20
10855925|NCT01971970|12022072|FG000|NOT COMPLETED|Week 8 Until Week 14||0
10855926|NCT01971970|12022073|FG001|NOT COMPLETED|Week 8 Until Week 14||0
10855927|NCT01971970|12022072|FG000|STARTED|Week 14 Until Week 22||23
10855928|NCT01971970|12022073|FG001|STARTED|Week 14 Until Week 22||20
10855929|NCT01971970|12022072|FG000|Receiving Standard Therapy|Week 14 Until Week 22||12
10855930|NCT01971970|12022073|FG001|Receiving Standard Therapy|Week 14 Until Week 22||16
10855931|NCT01971970|12022072|FG000|Therapy Escalation|Week 14 Until Week 22||3
10855932|NCT01971970|12022073|FG001|Therapy Escalation|Week 14 Until Week 22||2
10855933|NCT01971970|12022072|FG000|COMPLETED|Week 14 Until Week 22||23
10855934|NCT01971970|12022073|FG001|COMPLETED|Week 14 Until Week 22||19
10855935|NCT01971970|12022072|FG000|NOT COMPLETED|Week 14 Until Week 22||0
10855936|NCT01971970|12022073|FG001|NOT COMPLETED|Week 14 Until Week 22||1
10855937|NCT01971970|12022072|FG000|STARTED|Week 22 Until Week 52||23
10855938|NCT01971970|12022073|FG001|STARTED|Week 22 Until Week 52||19
10855939|NCT01971970|12022072|FG000|Receiving Standard Therapy|Week 22 Until Week 52||5
10855940|NCT01971970|12022073|FG001|Receiving Standard Therapy|Week 22 Until Week 52||9
10855941|NCT01971970|12022072|FG000|Therapy Escalation|Week 22 Until Week 52||6
10855942|NCT01971970|12022073|FG001|Therapy Escalation|Week 22 Until Week 52||6
10855943|NCT01971970|12022072|FG000|COMPLETED|Week 22 Until Week 52||15
10855944|NCT01971970|12022073|FG001|COMPLETED|Week 22 Until Week 52||15
10855945|NCT01971970|12022072|FG000|NOT COMPLETED|Week 22 Until Week 52||8
10855946|NCT01971970|12022073|FG001|NOT COMPLETED|Week 22 Until Week 52||4
10855947|NCT01971970|12022072|FG000|STARTED|Week 52 Until Week 78||15
10855948|NCT01971970|12022073|FG001|STARTED|Week 52 Until Week 78||15
10855949|NCT01971970|12022072|FG000|COMPLETED|Week 52 Until Week 78||14
10855950|NCT01971970|12022073|FG001|COMPLETED|Week 52 Until Week 78||12
10855951|NCT01971970|12022072|FG000|NOT COMPLETED|Week 52 Until Week 78||1
10855952|NCT01971970|12022073|FG001|NOT COMPLETED|Week 52 Until Week 78||3
10855953|NCT01969409|12022086|FG000|STARTED|Overall Study||28
10855954|NCT01969409|12022087|FG001|STARTED|Overall Study||30
10855955|NCT01969409|12022086|FG000|COMPLETED|Overall Study||25
10855956|NCT01969409|12022087|FG001|COMPLETED|Overall Study||26
10855957|NCT01969409|12022086|FG000|NOT COMPLETED|Overall Study||3
10855958|NCT01969409|12022087|FG001|NOT COMPLETED|Overall Study||4
10855959|NCT01459497|12022095|FG000|STARTED|Overall Study||52
10855960|NCT01459497|12022096|FG001|STARTED|Overall Study||51
10855961|NCT01459497|12022095|FG000|COMPLETED|Overall Study||50
10855962|NCT01459497|12022096|FG001|COMPLETED|Overall Study||46
10855963|NCT01459497|12022095|FG000|NOT COMPLETED|Overall Study||2
10855964|NCT01459497|12022096|FG001|NOT COMPLETED|Overall Study||5
10855965|NCT01307787|12022104|FG000|STARTED|Overall Study||19
10855966|NCT01307787|12022105|FG001|STARTED|Overall Study||15
10855967|NCT01307787|12022104|FG000|T1= After 9 Weeks Post Intervention|Overall Study||18
10855968|NCT01307787|12022105|FG001|T1= After 9 Weeks Post Intervention|Overall Study||15
10855969|NCT01307787|12022104|FG000|T2= After 22 Weeks at Follow-up|Overall Study||17
10855970|NCT01307787|12022105|FG001|T2= After 22 Weeks at Follow-up|Overall Study||15
10855971|NCT01307787|12022104|FG000|COMPLETED|Overall Study||17
10855972|NCT01307787|12022105|FG001|COMPLETED|Overall Study||15
10855973|NCT01307787|12022104|FG000|NOT COMPLETED|Overall Study||2
10855974|NCT01307787|12022105|FG001|NOT COMPLETED|Overall Study||0
10855975|NCT01250912|12022116|FG000|STARTED|Overall Study||20
10855976|NCT01250912|12022116|FG000|COMPLETED|Overall Study||19
10855977|NCT01250912|12022116|FG000|NOT COMPLETED|Overall Study||1
10855978|NCT01218555|12022123|FG000|STARTED|Overall Study||3
10855979|NCT01218555|12022124|FG001|STARTED|Overall Study||3
10855980|NCT01218555|12022125|FG002|STARTED|Overall Study||5
10855981|NCT01218555|12022126|FG003|STARTED|Overall Study||3
10855982|NCT01218555|12022127|FG004|STARTED|Overall Study||8
10855983|NCT01218555|12022128|FG005|STARTED|Overall Study||22
10855984|NCT01218555|12022123|FG000|COMPLETED|Overall Study||3
10855985|NCT01218555|12022124|FG001|COMPLETED|Overall Study||3
10855986|NCT01218555|12022125|FG002|COMPLETED|Overall Study||5
10855987|NCT01218555|12022126|FG003|COMPLETED|Overall Study||3
10855988|NCT01218555|12022127|FG004|COMPLETED|Overall Study||8
10855989|NCT01218555|12022128|FG005|COMPLETED|Overall Study||22
10855990|NCT01218555|12022123|FG000|NOT COMPLETED|Overall Study||0
10855991|NCT01218555|12022124|FG001|NOT COMPLETED|Overall Study||0
10855992|NCT01218555|12022125|FG002|NOT COMPLETED|Overall Study||0
10855993|NCT01218555|12022126|FG003|NOT COMPLETED|Overall Study||0
10855994|NCT01218555|12022127|FG004|NOT COMPLETED|Overall Study||0
10415052|NCT00788593|11559546|FG000|STARTED|Second Intervention Period||0
10415053|NCT00788593|11559547|FG001|STARTED|Second Intervention Period||38
10415054|NCT00788593|11559548|FG002|STARTED|Second Intervention Period||37
10415055|NCT00788593|11559546|FG000|COMPLETED|Second Intervention Period||0
10415056|NCT00788593|11559547|FG001|COMPLETED|Second Intervention Period||37
10415057|NCT00788593|11559548|FG002|COMPLETED|Second Intervention Period||36
10415058|NCT00788593|11559546|FG000|NOT COMPLETED|Second Intervention Period||0
10415059|NCT00788593|11559547|FG001|NOT COMPLETED|Second Intervention Period||1
10415060|NCT00788593|11559548|FG002|NOT COMPLETED|Second Intervention Period||1
10415061|NCT00788697|11559558|FG000|STARTED|Overall Study||349
10415062|NCT00788697|11559558|FG000|COMPLETED|Overall Study||240
10415063|NCT00788697|11559558|FG000|NOT COMPLETED|Overall Study||109
10415064|NCT00788775|11559572|FG000|STARTED|Overall Study||11
10415065|NCT00788775|11559573|FG001|STARTED|Overall Study||9
10415066|NCT00788775|11559572|FG000|Treated|Overall Study||11
10415067|NCT00788775|11559573|FG001|Treated|Overall Study||8
10415068|NCT00788775|11559572|FG000|COMPLETED|Overall Study||1
10415069|NCT00788775|11559573|FG001|COMPLETED|Overall Study||1
10415070|NCT00788775|11559572|FG000|NOT COMPLETED|Overall Study||10
10415071|NCT00788775|11559573|FG001|NOT COMPLETED|Overall Study||8
10415072|NCT00788827|11559579|FG000|STARTED|Overall Study||7
10415073|NCT00788827|11559579|FG000|COMPLETED|Overall Study||5
10415074|NCT00788827|11559579|FG000|NOT COMPLETED|Overall Study||2
10415075|NCT00788892|11559587|FG000|STARTED|Overall Study||85
10755055|NCT03060512|11918865|FG000|NOT COMPLETED|Overall Study||7
10755056|NCT03060512|11918866|FG001|NOT COMPLETED|Overall Study||9
10755057|NCT03060551|11918877|FG000|STARTED|Overall Study||20
10755058|NCT03060551|11918877|FG000|COMPLETED|Overall Study||18
10755059|NCT03060551|11918877|FG000|NOT COMPLETED|Overall Study||2
10755060|NCT03060759|11918883|FG000|STARTED|Overall Study||20
10755061|NCT03060759|11918884|FG001|STARTED|Overall Study||15
10755062|NCT03060759|11918883|FG000|COMPLETED|Overall Study||15
10755063|NCT03060759|11918884|FG001|COMPLETED|Overall Study||12
10755064|NCT03060759|11918883|FG000|NOT COMPLETED|Overall Study||5
10755065|NCT03060759|11918884|FG001|NOT COMPLETED|Overall Study||3
10755066|NCT03061097|11918892|FG000|STARTED|Overall Study||4
10755067|NCT03061097|11918893|FG001|STARTED|Overall Study||3
10755068|NCT03061097|11918892|FG000|COMPLETED|Overall Study||4
10755069|NCT03061097|11918893|FG001|COMPLETED|Overall Study||0
10755070|NCT03061097|11918892|FG000|NOT COMPLETED|Overall Study||0
10755071|NCT03061097|11918893|FG001|NOT COMPLETED|Overall Study||3
10755072|NCT03061175|11918901|FG000|STARTED|Baseline||47
10755073|NCT03061175|11918902|FG001|STARTED|Baseline||47
10755074|NCT03061175|11918901|FG000|COMPLETED|Baseline||46
10755075|NCT03061175|11918902|FG001|COMPLETED|Baseline||47
10755076|NCT03061175|11918901|FG000|NOT COMPLETED|Baseline||1
10755077|NCT03061175|11918902|FG001|NOT COMPLETED|Baseline||0
10755078|NCT03061175|11918901|FG000|STARTED|Followup 1 at 2-4 Weeks Post-surgery|1 Participant dropped out of the study before the follow-up survey was to be sent|45
10755079|NCT03061175|11918902|FG001|STARTED|Followup 1 at 2-4 Weeks Post-surgery||47
10755080|NCT03061175|11918901|FG000|COMPLETED|Followup 1 at 2-4 Weeks Post-surgery|39 participants completed the follow-up survey out of the 45 who were sent the survey|39
10755081|NCT03061175|11918902|FG001|COMPLETED|Followup 1 at 2-4 Weeks Post-surgery|44 participants completed the follow-up survey out of the 47 who were sent the survey|44
10755082|NCT03061175|11918901|FG000|NOT COMPLETED|Followup 1 at 2-4 Weeks Post-surgery||6
10755083|NCT03061175|11918902|FG001|NOT COMPLETED|Followup 1 at 2-4 Weeks Post-surgery||3
10755084|NCT03061175|11918901|FG000|STARTED|Followup 2 at 6 Months|Participants who skipped the first follow-up survey were still sent the second FU survey|45
10755085|NCT03061175|11918902|FG001|STARTED|Followup 2 at 6 Months|1 participant withdrew from the study in between the 1st and 2nd follow-up survey so only 46 sent|46
10755086|NCT03061175|11918901|FG000|COMPLETED|Followup 2 at 6 Months|41 participants completed the 2nd follow-up survey out of the 45 who were sent the survey|41
10755087|NCT03061175|11918902|FG001|COMPLETED|Followup 2 at 6 Months|39 participants completed the follow-up survey out of the 46 who were sent the survey|39
10755088|NCT03061175|11918901|FG000|NOT COMPLETED|Followup 2 at 6 Months||4
10755089|NCT03061175|11918902|FG001|NOT COMPLETED|Followup 2 at 6 Months||7
10778761|NCT03358407|11940527|FG008|COMPLETED|Part B: Overall Period (11 Weeks)||0
10855995|NCT01218555|12022128|FG005|NOT COMPLETED|Overall Study||0
10855996|NCT01141712|12022132|FG000|STARTED|Overall Study||43
10855997|NCT01141712|12022132|FG000|COMPLETED|Overall Study||40
10855998|NCT01141712|12022132|FG000|NOT COMPLETED|Overall Study||3
10855999|NCT01111305|12022138|FG000|STARTED|Overall Study||4
10856000|NCT01111305|12022139|FG001|STARTED|Overall Study||4
10856001|NCT01111305|12022138|FG000|COMPLETED|Overall Study||4
10415076|NCT00788892|11559588|FG001|STARTED|Overall Study||41
10415077|NCT00788892|11559587|FG000|COMPLETED|Overall Study||36
10415078|NCT00788892|11559588|FG001|COMPLETED|Overall Study||18
10415079|NCT00788892|11559587|FG000|NOT COMPLETED|Overall Study||49
10415080|NCT00788892|11559588|FG001|NOT COMPLETED|Overall Study||23
10415081|NCT00788957|11559598|FG000|STARTED|Part 1||11
10856002|NCT01111305|12022139|FG001|COMPLETED|Overall Study||4
10415082|NCT00788957|11559599|FG001|STARTED|Part 1||0
10415083|NCT00788957|11559600|FG002|STARTED|Part 1||0
10415084|NCT00788957|11559601|FG003|STARTED|Part 1||0
10415085|NCT00788957|11559602|FG004|STARTED|Part 1||0
10415086|NCT00788957|11559603|FG005|STARTED|Part 1||0
10415087|NCT00788957|11559598|FG000|COMPLETED|Part 1|Completed the safety follow-up visit|2
10415088|NCT00788957|11559599|FG001|COMPLETED|Part 1||0
10856003|NCT01111305|12022138|FG000|NOT COMPLETED|Overall Study||0
10856004|NCT01111305|12022139|FG001|NOT COMPLETED|Overall Study||0
10856005|NCT00659646|12022149|FG000|STARTED|Overall Study||38
10856006|NCT00659646|12022150|FG001|STARTED|Overall Study||18
10856007|NCT00659646|12022149|FG000|COMPLETED|Overall Study||23
10856008|NCT00659646|12022150|FG001|COMPLETED|Overall Study||10
10856009|NCT00659646|12022149|FG000|NOT COMPLETED|Overall Study||15
10856010|NCT00659646|12022150|FG001|NOT COMPLETED|Overall Study||8
10856011|NCT00477412|12022162|FG000|STARTED|Overall Study||4
10856012|NCT00477412|12022163|FG001|STARTED|Overall Study||3
10856013|NCT00477412|12022164|FG002|STARTED|Overall Study||5
10856014|NCT00477412|12022165|FG003|STARTED|Overall Study||95
10856015|NCT00477412|12022162|FG000|COMPLETED|Overall Study||3
10856016|NCT00477412|12022163|FG001|COMPLETED|Overall Study||3
10856017|NCT00477412|12022164|FG002|COMPLETED|Overall Study||4
10856018|NCT00477412|12022165|FG003|COMPLETED|Overall Study||87
10856019|NCT00477412|12022162|FG000|NOT COMPLETED|Overall Study||1
10856020|NCT00477412|12022163|FG001|NOT COMPLETED|Overall Study||0
10856021|NCT00477412|12022164|FG002|NOT COMPLETED|Overall Study||1
10856022|NCT00477412|12022165|FG003|NOT COMPLETED|Overall Study||8
10856023|NCT00369317|12022173|FG000|STARTED|Overall Study||205
10856024|NCT00369317|12022173|FG000|COMPLETED|Overall Study||185
10856025|NCT00369317|12022173|FG000|NOT COMPLETED|Overall Study||20
10856026|NCT00261807|12022178|FG000|STARTED|Overall Study||25
10856027|NCT00261807|12022178|FG000|COMPLETED|Overall Study||18
10856028|NCT00261807|12022178|FG000|NOT COMPLETED|Overall Study||7
10415089|NCT00788957|11559600|FG002|COMPLETED|Part 1||0
10415090|NCT00788957|11559601|FG003|COMPLETED|Part 1||0
10415091|NCT00788957|11559602|FG004|COMPLETED|Part 1||0
10415092|NCT00788957|11559603|FG005|COMPLETED|Part 1||0
10415093|NCT00788957|11559598|FG000|NOT COMPLETED|Part 1||9
10415094|NCT00788957|11559599|FG001|NOT COMPLETED|Part 1||0
10415095|NCT00788957|11559600|FG002|NOT COMPLETED|Part 1||0
10415096|NCT00788957|11559601|FG003|NOT COMPLETED|Part 1||0
10415097|NCT00788957|11559602|FG004|NOT COMPLETED|Part 1||0
10415098|NCT00788957|11559603|FG005|NOT COMPLETED|Part 1||0
10415099|NCT00788957|11559598|FG000|STARTED|Part 2||0
10415100|NCT00788957|11559599|FG001|STARTED|Part 2||48
10415101|NCT00788957|11559600|FG002|STARTED|Part 2||48
10415102|NCT00788957|11559601|FG003|STARTED|Part 2||46
10415103|NCT00788957|11559602|FG004|STARTED|Part 2||0
10415104|NCT00788957|11559603|FG005|STARTED|Part 2||0
10415105|NCT00788957|11559598|FG000|COMPLETED|Part 2||0
10415106|NCT00788957|11559599|FG001|COMPLETED|Part 2|Completed the safety follow-up visit at the end of the study|6
10415107|NCT00788957|11559600|FG002|COMPLETED|Part 2|Completed the safety follow-up visit|4
10415108|NCT00788957|11559601|FG003|COMPLETED|Part 2|Completed the safety follow-up visit|5
10415109|NCT00788957|11559602|FG004|COMPLETED|Part 2||0
10415110|NCT00788957|11559603|FG005|COMPLETED|Part 2||0
10415111|NCT00788957|11559598|FG000|NOT COMPLETED|Part 2||0
10415112|NCT00788957|11559599|FG001|NOT COMPLETED|Part 2||42
10415113|NCT00788957|11559600|FG002|NOT COMPLETED|Part 2||44
10415114|NCT00788957|11559601|FG003|NOT COMPLETED|Part 2||41
10415115|NCT00788957|11559602|FG004|NOT COMPLETED|Part 2||0
10415116|NCT00788957|11559603|FG005|NOT COMPLETED|Part 2||0
10415117|NCT00788957|11559598|FG000|STARTED|Part 3||0
10415118|NCT00788957|11559599|FG001|STARTED|Part 3||0
10415119|NCT00788957|11559600|FG002|STARTED|Part 3||0
10415120|NCT00788957|11559601|FG003|STARTED|Part 3||0
10415121|NCT00788957|11559602|FG004|STARTED|Part 3||13
10415122|NCT00788957|11559603|FG005|STARTED|Part 3||12
10415123|NCT00788957|11559598|FG000|COMPLETED|Part 3||0
10415124|NCT00788957|11559599|FG001|COMPLETED|Part 3||0
10415125|NCT00788957|11559600|FG002|COMPLETED|Part 3||0
10415126|NCT00788957|11559601|FG003|COMPLETED|Part 3||0
10415127|NCT00788957|11559602|FG004|COMPLETED|Part 3|Completed the safety follow-up visit|4
10415128|NCT00788957|11559603|FG005|COMPLETED|Part 3|Completed the safety follow-up visit|1
10415129|NCT00788957|11559598|FG000|NOT COMPLETED|Part 3||0
10415130|NCT00788957|11559599|FG001|NOT COMPLETED|Part 3||0
10415131|NCT00788957|11559600|FG002|NOT COMPLETED|Part 3||0
10415132|NCT00788957|11559601|FG003|NOT COMPLETED|Part 3||0
10415133|NCT00788957|11559602|FG004|NOT COMPLETED|Part 3||9
10415134|NCT00788957|11559603|FG005|NOT COMPLETED|Part 3||11
10415135|NCT00789035|11559625|FG000|STARTED|Overall Study||82
10415136|NCT00789035|11559626|FG001|STARTED|Overall Study||81
10856029|NCT04964193|12022183|FG000|STARTED|1st Intervention||12
10856030|NCT04964193|12022184|FG001|STARTED|1st Intervention||12
10856031|NCT04964193|12022183|FG000|COMPLETED|1st Intervention||12
10856032|NCT04964193|12022184|FG001|COMPLETED|1st Intervention||12
10856033|NCT04964193|12022183|FG000|NOT COMPLETED|1st Intervention||0
10856034|NCT04964193|12022184|FG001|NOT COMPLETED|1st Intervention||0
10856035|NCT04964193|12022183|FG000|STARTED|Washout = Three Weeks||12
10856036|NCT04964193|12022184|FG001|STARTED|Washout = Three Weeks||12
10856037|NCT04964193|12022183|FG000|COMPLETED|Washout = Three Weeks||12
10856038|NCT04964193|12022184|FG001|COMPLETED|Washout = Three Weeks||12
10856039|NCT04964193|12022183|FG000|NOT COMPLETED|Washout = Three Weeks||0
10856040|NCT04964193|12022184|FG001|NOT COMPLETED|Washout = Three Weeks||0
10856041|NCT04964193|12022183|FG000|STARTED|2nd Intervention||12
10856042|NCT04964193|12022184|FG001|STARTED|2nd Intervention||12
10856043|NCT04964193|12022183|FG000|COMPLETED|2nd Intervention||12
10856044|NCT04964193|12022184|FG001|COMPLETED|2nd Intervention||12
10856045|NCT04964193|12022183|FG000|NOT COMPLETED|2nd Intervention||0
10856046|NCT04964193|12022184|FG001|NOT COMPLETED|2nd Intervention||0
10293376|NCT04753710|11425951|FG000|STARTED|Overall||67
10415137|NCT00789035|11559627|FG002|STARTED|Overall Study||81
10415138|NCT00789035|11559628|FG003|STARTED|Overall Study||82
10415139|NCT00789035|11559629|FG004|STARTED|Overall Study||80
10415140|NCT00789035|11559625|FG000|COMPLETED|Overall Study||76
10415141|NCT00789035|11559626|FG001|COMPLETED|Overall Study||74
10415142|NCT00789035|11559627|FG002|COMPLETED|Overall Study||80
10415143|NCT00789035|11559628|FG003|COMPLETED|Overall Study||81
10415144|NCT00789035|11559629|FG004|COMPLETED|Overall Study||74
10415145|NCT00789035|11559625|FG000|NOT COMPLETED|Overall Study||6
10415146|NCT00789035|11559626|FG001|NOT COMPLETED|Overall Study||7
10415147|NCT00789035|11559627|FG002|NOT COMPLETED|Overall Study||1
10415148|NCT00789035|11559628|FG003|NOT COMPLETED|Overall Study||1
10415149|NCT00789035|11559629|FG004|NOT COMPLETED|Overall Study||6
10415150|NCT00789074|11559646|FG000|STARTED|Overall Study||53
10415151|NCT00789074|11559647|FG001|STARTED|Overall Study||48
10415152|NCT00789074|11559646|FG000|COMPLETED|Overall Study||42
10415153|NCT00789074|11559647|FG001|COMPLETED|Overall Study||35
10415154|NCT00789074|11559646|FG000|NOT COMPLETED|Overall Study||11
10415155|NCT00789074|11559647|FG001|NOT COMPLETED|Overall Study||13
10415156|NCT00789113|11559656|FG000|STARTED|Overall Study||12
10415157|NCT00789113|11559656|FG000|COMPLETED|Overall Study||12
10415158|NCT00789113|11559656|FG000|NOT COMPLETED|Overall Study||0
10415159|NCT00789191|11559663|FG000|STARTED|Overall Study||111
10415160|NCT00789191|11559664|FG001|STARTED|Overall Study||111
10415161|NCT00789191|11559663|FG000|Exposed|Overall Study|2 withdrew informed consent. 1 randomised by mistake. 1 non-compliance|107
10415162|NCT00789191|11559664|FG001|Exposed|Overall Study|1 non-compliance|110
10415163|NCT00789191|11559663|FG000|COMPLETED|Overall Study||97
10415164|NCT00789191|11559664|FG001|COMPLETED|Overall Study||92
10415165|NCT00789191|11559663|FG000|NOT COMPLETED|Overall Study||14
10415166|NCT00789191|11559664|FG001|NOT COMPLETED|Overall Study||19
10415167|NCT00789256|11559672|FG000|STARTED|Overall Study||14
10415168|NCT00789256|11559673|FG001|STARTED|Overall Study||12
10415169|NCT00789256|11559672|FG000|COMPLETED|Overall Study|Strata 1 had 5 responders and continued accrual, but the study was closed due to low accrual.|14
10415170|NCT00789256|11559673|FG001|COMPLETED|Overall Study||12
10415171|NCT00789256|11559672|FG000|NOT COMPLETED|Overall Study||0
10415172|NCT00789256|11559673|FG001|NOT COMPLETED|Overall Study||0
10415173|NCT00789321|11559684|FG000|STARTED|Overall Study||24
10415174|NCT00789321|11559685|FG001|STARTED|Overall Study||23
10415175|NCT00789321|11559684|FG000|COMPLETED|Overall Study||24
10415176|NCT00789321|11559685|FG001|COMPLETED|Overall Study||22
10415177|NCT00789321|11559684|FG000|NOT COMPLETED|Overall Study||0
10415178|NCT00789321|11559685|FG001|NOT COMPLETED|Overall Study||1
10415179|NCT00789360|11559693|FG000|STARTED|Overall Study||15
10415180|NCT00789360|11559694|FG001|STARTED|Overall Study||15
10415181|NCT00789360|11559693|FG000|COMPLETED|Overall Study||12
10415182|NCT00789360|11559694|FG001|COMPLETED|Overall Study||14
10415183|NCT00789360|11559693|FG000|NOT COMPLETED|Overall Study||3
10415184|NCT00789360|11559694|FG001|NOT COMPLETED|Overall Study||1
10415185|NCT00789373|11559701|FG000|STARTED|Induction||939
10415186|NCT00789373|11559702|FG001|STARTED|Induction||0
10415187|NCT00789373|11559703|FG002|STARTED|Induction||0
10415188|NCT00789373|11559701|FG000|COMPLETED|Induction|1 patient received maintenance therapy post-induction but was never randomized.|540
10415189|NCT00789373|11559702|FG001|COMPLETED|Induction||0
10415190|NCT00789373|11559703|FG002|COMPLETED|Induction||0
10415191|NCT00789373|11559701|FG000|NOT COMPLETED|Induction||399
10415192|NCT00789373|11559702|FG001|NOT COMPLETED|Induction||0
10415193|NCT00789373|11559703|FG002|NOT COMPLETED|Induction||0
10415194|NCT00789373|11559701|FG000|STARTED|Maintenance||0
10415195|NCT00789373|11559702|FG001|STARTED|Maintenance||359
10856091|NCT03284853|12022250|FG000|STARTED|Overall Study||218
10856092|NCT03284853|12022251|FG001|STARTED|Overall Study||212
10856093|NCT03284853|12022250|FG000|Intent-to-Treat Population|Overall Study||218
10293377|NCT04753710|11425952|FG001|STARTED|Overall||29
10415196|NCT00789373|11559703|FG002|STARTED|Maintenance||180
10415197|NCT00789373|11559701|FG000|COMPLETED|Maintenance||0
10415198|NCT00789373|11559702|FG001|COMPLETED|Maintenance||0
10415199|NCT00789373|11559703|FG002|COMPLETED|Maintenance||0
10415200|NCT00789373|11559701|FG000|NOT COMPLETED|Maintenance||0
10856047|NCT04826731|12022192|FG000|STARTED|Overall Study||10
10856048|NCT04826731|12022193|FG001|STARTED|Overall Study||4
10856049|NCT04826731|12022192|FG000|COMPLETED|Overall Study|All patients were initially accepted as the study group per study design, with those unable to utilize respiratory exerciser (n=4) were later removed to standard care group.|10
10856050|NCT04826731|12022193|FG001|COMPLETED|Overall Study|Patients who could not use the respiratory exerciser (n=2) or refused to do so (n=2) were accepted as the control group.|4
10856051|NCT04826731|12022192|FG000|NOT COMPLETED|Overall Study||0
10856052|NCT04826731|12022193|FG001|NOT COMPLETED|Overall Study||0
10856053|NCT04620798|12022201|FG000|STARTED|Overall Study||536
10856054|NCT04620798|12022202|FG001|STARTED|Overall Study||540
10856055|NCT04620798|12022201|FG000|Completed Behavioral Survey|Overall Study||477
10856056|NCT04620798|12022202|FG001|Completed Behavioral Survey|Overall Study||508
10856057|NCT04620798|12022201|FG000|COMPLETED|Overall Study||410
10856058|NCT04620798|12022202|FG001|COMPLETED|Overall Study||402
10856059|NCT04620798|12022201|FG000|NOT COMPLETED|Overall Study||126
10856060|NCT04620798|12022202|FG001|NOT COMPLETED|Overall Study||138
10856061|NCT04507321|12022208|FG000|STARTED|Treatment Period 1 (8 Days)||5
10856062|NCT04507321|12022208|FG000|COMPLETED|Treatment Period 1 (8 Days)||5
10856063|NCT04507321|12022208|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10856064|NCT04507321|12022208|FG000|STARTED|Treatment Period 2 (8 Days)||5
10856065|NCT04507321|12022208|FG000|COMPLETED|Treatment Period 2 (8 Days)||5
10856066|NCT04507321|12022208|FG000|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10856067|NCT04256629|12022227|FG000|STARTED|Overall Study||4
10856068|NCT04256629|12022228|FG001|STARTED|Overall Study||4
10856069|NCT04256629|12022229|FG002|STARTED|Overall Study||4
10856070|NCT04256629|12022230|FG003|STARTED|Overall Study||4
10856071|NCT04256629|12022231|FG004|STARTED|Overall Study||4
10856072|NCT04256629|12022232|FG005|STARTED|Overall Study||4
10856073|NCT04256629|12022227|FG000|COMPLETED|Overall Study||4
10856074|NCT04256629|12022228|FG001|COMPLETED|Overall Study||3
10856075|NCT04256629|12022229|FG002|COMPLETED|Overall Study||4
10856076|NCT04256629|12022230|FG003|COMPLETED|Overall Study||4
10856077|NCT04256629|12022231|FG004|COMPLETED|Overall Study||4
10856078|NCT04256629|12022232|FG005|COMPLETED|Overall Study||3
10856079|NCT04256629|12022227|FG000|NOT COMPLETED|Overall Study||0
10856080|NCT04256629|12022228|FG001|NOT COMPLETED|Overall Study||1
10856081|NCT04256629|12022229|FG002|NOT COMPLETED|Overall Study||0
10856082|NCT04256629|12022230|FG003|NOT COMPLETED|Overall Study||0
10856083|NCT04256629|12022231|FG004|NOT COMPLETED|Overall Study||0
10856084|NCT04256629|12022232|FG005|NOT COMPLETED|Overall Study||1
10856085|NCT04174521|12022240|FG000|STARTED|Overall Study|A unit is defined as a mother-child pair; each unit was comprised of two participants: the mother and the child.|20670
10856086|NCT04174521|12022240|FG000|COMPLETED|Overall Study|This was a retrospective observational study so there really was no drop-out.|20670
10856087|NCT04174521|12022240|FG000|NOT COMPLETED|Overall Study||0
10856094|NCT03284853|12022251|FG001|Intent-to-Treat Population|Overall Study||212
10856095|NCT03284853|12022250|FG000|Per-Protocol Population|Overall Study||169
10856096|NCT03284853|12022251|FG001|Per-Protocol Population|Overall Study||170
10856097|NCT03284853|12022250|FG000|Safety Population|Overall Study||218
10856098|NCT03284853|12022251|FG001|Safety Population|Overall Study||212
10856099|NCT03284853|12022250|FG000|COMPLETED|Overall Study||163
10856100|NCT03284853|12022251|FG001|COMPLETED|Overall Study||199
10856101|NCT03284853|12022250|FG000|NOT COMPLETED|Overall Study||55
10856102|NCT03284853|12022251|FG001|NOT COMPLETED|Overall Study||13
10856103|NCT03032250|12022259|FG000|STARTED|Overall Study||17
10856104|NCT03032250|12022260|FG001|STARTED|Overall Study||18
10856105|NCT03032250|12022259|FG000|COMPLETED|Overall Study||17
10856106|NCT03032250|12022260|FG001|COMPLETED|Overall Study||18
10856107|NCT03032250|12022259|FG000|NOT COMPLETED|Overall Study||0
10856108|NCT03032250|12022260|FG001|NOT COMPLETED|Overall Study||0
10856109|NCT02942966|12022268|FG000|STARTED|Overall Study|Intent to Treat (ITT) population.|233
10856110|NCT02942966|12022268|FG000|COMPLETED|Overall Study|Completed 6-month follow-up|205
10856111|NCT02942966|12022268|FG000|NOT COMPLETED|Overall Study||28
10856112|NCT02774889|12022274|FG000|STARTED|Overall Study||23
10856113|NCT02774889|12022275|FG001|STARTED|Overall Study||22
10856114|NCT02774889|12022274|FG000|COMPLETED|Overall Study||21
10856115|NCT02774889|12022275|FG001|COMPLETED|Overall Study||21
10856116|NCT02774889|12022274|FG000|NOT COMPLETED|Overall Study||2
10856117|NCT02774889|12022275|FG001|NOT COMPLETED|Overall Study||1
10856118|NCT02721069|12022283|FG000|STARTED|Overall Study||175
10856119|NCT02721069|12022283|FG000|COMPLETED|Overall Study||117
10856120|NCT02721069|12022283|FG000|NOT COMPLETED|Overall Study||58
10856121|NCT02297438|12022295|FG000|STARTED|Overall Study||169
10856122|NCT02297438|12022296|FG001|STARTED|Overall Study||171
10856123|NCT02297438|12022295|FG000|Received Treatment|Overall Study||168
10856124|NCT02297438|12022296|FG001|Received Treatment|Overall Study||171
10856125|NCT02297438|12022295|FG000|COMPLETED|Overall Study||0
10856126|NCT02297438|12022296|FG001|COMPLETED|Overall Study||0
10856127|NCT02297438|12022295|FG000|NOT COMPLETED|Overall Study||169
10856128|NCT02297438|12022296|FG001|NOT COMPLETED|Overall Study||171
10856129|NCT02297412|12022304|FG000|STARTED|Overall Study||23
10856130|NCT02297412|12022305|FG001|STARTED|Overall Study||24
10856131|NCT02297412|12022304|FG000|COMPLETED|Overall Study||22
10856132|NCT02297412|12022305|FG001|COMPLETED|Overall Study||23
10856133|NCT02297412|12022304|FG000|NOT COMPLETED|Overall Study||1
10856134|NCT02297412|12022305|FG001|NOT COMPLETED|Overall Study||1
10856135|NCT02292758|12022313|FG000|STARTED|Overall Study||19
10856136|NCT02292758|12022314|FG001|STARTED|Overall Study||17
10856137|NCT02292758|12022313|FG000|COMPLETED|Overall Study||19
10856138|NCT02292758|12022314|FG001|COMPLETED|Overall Study||17
10856139|NCT02292758|12022313|FG000|NOT COMPLETED|Overall Study||0
10856140|NCT02292758|12022314|FG001|NOT COMPLETED|Overall Study||0
10856141|NCT02250326|12022323|FG000|STARTED|Treatment Period||81
10856142|NCT02250326|12022324|FG001|STARTED|Treatment Period||79
10856143|NCT02250326|12022325|FG002|STARTED|Treatment Period||80
10856144|NCT02250326|12022323|FG000|Treated Population|Treatment Period||79
10856145|NCT02250326|12022324|FG001|Treated Population|Treatment Period||78
10856146|NCT02250326|12022325|FG002|Treated Population|Treatment Period||79
10856147|NCT02250326|12022323|FG000|COMPLETED|Treatment Period|Data Cut-off Date = 30 August 2017|0
10856148|NCT02250326|12022324|FG001|COMPLETED|Treatment Period|Data Cut-off Date = 23 December 2017|15
10856149|NCT02250326|12022325|FG002|COMPLETED|Treatment Period|Data Cut-off Date = 30 August 2017|3
10856150|NCT02250326|12022323|FG000|NOT COMPLETED|Treatment Period||81
10856151|NCT02250326|12022324|FG001|NOT COMPLETED|Treatment Period||64
10856152|NCT02250326|12022325|FG002|NOT COMPLETED|Treatment Period||77
10856153|NCT02250326|12022323|FG000|STARTED|Follow-Up Period||67
10293378|NCT04753710|11425951|FG000|COMPLETED|Overall||67
10293379|NCT04753710|11425952|FG001|COMPLETED|Overall||29
10293380|NCT04753710|11425951|FG000|NOT COMPLETED|Overall||0
10293381|NCT04753710|11425952|FG001|NOT COMPLETED|Overall||0
10293382|NCT04753710|11425951|FG000|STARTED|First Phase||27
10293383|NCT04753710|11425952|FG001|STARTED|First Phase||9
10293384|NCT04753710|11425951|FG000|COMPLETED|First Phase||27
10293385|NCT04753710|11425952|FG001|COMPLETED|First Phase||9
10293386|NCT04753710|11425951|FG000|NOT COMPLETED|First Phase||0
10293387|NCT04753710|11425952|FG001|NOT COMPLETED|First Phase||0
10293388|NCT04753710|11425951|FG000|STARTED|Second Phase||40
10293389|NCT04753710|11425952|FG001|STARTED|Second Phase||20
10293390|NCT04753710|11425951|FG000|COMPLETED|Second Phase||40
10293391|NCT04753710|11425952|FG001|COMPLETED|Second Phase||20
10293392|NCT04753710|11425951|FG000|NOT COMPLETED|Second Phase||0
10293393|NCT04753710|11425952|FG001|NOT COMPLETED|Second Phase||0
10293394|NCT04570605|11425960|FG000|STARTED|Overall Study||15
10293395|NCT04570605|11425961|FG001|STARTED|Overall Study||15
10293396|NCT04570605|11425960|FG000|COMPLETED|Overall Study||11
10293397|NCT04570605|11425961|FG001|COMPLETED|Overall Study||13
10415201|NCT00789373|11559702|FG001|NOT COMPLETED|Maintenance||359
10415202|NCT00789373|11559703|FG002|NOT COMPLETED|Maintenance||180
10415203|NCT00789438|11559717|FG000|STARTED|Overall Study||21
10415204|NCT00789438|11559718|FG001|STARTED|Overall Study||20
10415205|NCT00789438|11559719|FG002|STARTED|Overall Study||28
10415206|NCT00789438|11559717|FG000|COMPLETED|Overall Study||21
10415207|NCT00789438|11559718|FG001|COMPLETED|Overall Study||20
10415208|NCT00789438|11559719|FG002|COMPLETED|Overall Study||28
10415209|NCT00789438|11559717|FG000|NOT COMPLETED|Overall Study||0
10415210|NCT00789438|11559718|FG001|NOT COMPLETED|Overall Study||0
10415211|NCT00789438|11559719|FG002|NOT COMPLETED|Overall Study||0
10415212|NCT00789477|11559732|FG000|STARTED|Overall Study|randomized|44
10415213|NCT00789477|11559733|FG001|STARTED|Overall Study|randomized|44
10415214|NCT00789477|11559734|FG002|STARTED|Overall Study|randomized|44
10415215|NCT00789477|11559735|FG003|STARTED|Overall Study|randomized|44
10415216|NCT00789477|11559736|FG004|STARTED|Overall Study|randomized|45
10415217|NCT00789477|11559732|FG000|Participants Received Treatment|Overall Study|safety analysis set (SAF)|44
10415218|NCT00789477|11559733|FG001|Participants Received Treatment|Overall Study|SAF|44
10415219|NCT00789477|11559734|FG002|Participants Received Treatment|Overall Study|SAF|44
10415220|NCT00789477|11559735|FG003|Participants Received Treatment|Overall Study|SAF|42
10415221|NCT00789477|11559736|FG004|Participants Received Treatment|Overall Study|SAF|45
10415222|NCT00789477|11559732|FG000|COMPLETED|Overall Study||33
10415223|NCT00789477|11559733|FG001|COMPLETED|Overall Study||38
10293398|NCT04570605|11425960|FG000|NOT COMPLETED|Overall Study||4
10293399|NCT04570605|11425961|FG001|NOT COMPLETED|Overall Study||2
10293400|NCT04551898|11425971|FG000|STARTED|Overall Study||47
10293401|NCT04551898|11425972|FG001|STARTED|Overall Study||45
10293402|NCT04551898|11425973|FG002|STARTED|Overall Study||43
10293403|NCT04551898|11425974|FG003|STARTED|Overall Study||46
10293404|NCT04551898|11425971|FG000|COMPLETED|Overall Study||39
10293405|NCT04551898|11425972|FG001|COMPLETED|Overall Study||42
10293406|NCT04551898|11425973|FG002|COMPLETED|Overall Study||35
10293407|NCT04551898|11425974|FG003|COMPLETED|Overall Study||41
10293408|NCT04551898|11425971|FG000|NOT COMPLETED|Overall Study||8
10293409|NCT04551898|11425972|FG001|NOT COMPLETED|Overall Study||3
10293410|NCT04551898|11425973|FG002|NOT COMPLETED|Overall Study||8
10293411|NCT04551898|11425974|FG003|NOT COMPLETED|Overall Study||5
10314521|NCT00165672|11448173|FG000|NOT COMPLETED|Overall Study||0
10314522|NCT00165672|11448174|FG001|NOT COMPLETED|Overall Study||1
10314523|NCT00165698|11448182|FG000|STARTED|Overall Study||120
10314524|NCT00165698|11448183|FG001|STARTED|Overall Study||120
10415224|NCT00789477|11559734|FG002|COMPLETED|Overall Study||33
10415225|NCT00789477|11559735|FG003|COMPLETED|Overall Study||34
10415226|NCT00789477|11559736|FG004|COMPLETED|Overall Study||38
10415227|NCT00789477|11559732|FG000|NOT COMPLETED|Overall Study||11
10314525|NCT00165698|11448182|FG000|COMPLETED|Overall Study||112
10314526|NCT00165698|11448183|FG001|COMPLETED|Overall Study||105
10314527|NCT00165698|11448182|FG000|NOT COMPLETED|Overall Study||8
10415228|NCT00789477|11559733|FG001|NOT COMPLETED|Overall Study||6
10314528|NCT00165698|11448183|FG001|NOT COMPLETED|Overall Study||15
10415229|NCT00789477|11559734|FG002|NOT COMPLETED|Overall Study||11
10856154|NCT02250326|12022324|FG001|STARTED|Follow-Up Period||43
10856155|NCT02250326|12022325|FG002|STARTED|Follow-Up Period||64
10856156|NCT02250326|12022323|FG000|COMPLETED|Follow-Up Period||18
10856157|NCT02250326|12022324|FG001|COMPLETED|Follow-Up Period||13
10856158|NCT02250326|12022325|FG002|COMPLETED|Follow-Up Period||26
10856159|NCT02250326|12022323|FG000|NOT COMPLETED|Follow-Up Period||49
10856160|NCT02250326|12022324|FG001|NOT COMPLETED|Follow-Up Period||30
10856161|NCT02250326|12022325|FG002|NOT COMPLETED|Follow-Up Period||38
10856162|NCT01856270|12022336|FG000|STARTED|Overall Study||24
10856163|NCT01856270|12022337|FG001|STARTED|Overall Study||26
10856164|NCT01856270|12022336|FG000|COMPLETED|Overall Study||13
10856165|NCT01856270|12022337|FG001|COMPLETED|Overall Study||14
10856166|NCT01856270|12022336|FG000|NOT COMPLETED|Overall Study||11
10856167|NCT01856270|12022337|FG001|NOT COMPLETED|Overall Study||12
10856168|NCT01503515|12022347|FG000|STARTED|Overall Study||145
10856169|NCT01503515|12022348|FG001|STARTED|Overall Study||147
10856170|NCT01503515|12022347|FG000|COMPLETED|Overall Study||124
10856171|NCT01503515|12022348|FG001|COMPLETED|Overall Study||112
10856172|NCT01503515|12022347|FG000|NOT COMPLETED|Overall Study||21
10856173|NCT01503515|12022348|FG001|NOT COMPLETED|Overall Study||35
10856174|NCT01491893|12022354|FG000|STARTED|Overall Study||1
10856175|NCT01491893|12022355|FG001|STARTED|Overall Study||1
10856176|NCT01491893|12022356|FG002|STARTED|Overall Study||1
10856177|NCT01491893|12022357|FG003|STARTED|Overall Study||1
10856178|NCT01491893|12022358|FG004|STARTED|Overall Study||4
10856179|NCT01491893|12022359|FG005|STARTED|Overall Study||1
10856180|NCT01491893|12022360|FG006|STARTED|Overall Study||6
10856181|NCT01491893|12022361|FG007|STARTED|Overall Study||24
10856182|NCT01491893|12022362|FG008|STARTED|Overall Study||15
10856183|NCT01491893|12022363|FG009|STARTED|Overall Study||7
10856184|NCT01491893|12022354|FG000|COMPLETED|Overall Study||1
10856185|NCT01491893|12022355|FG001|COMPLETED|Overall Study||1
10856186|NCT01491893|12022356|FG002|COMPLETED|Overall Study||1
10856187|NCT01491893|12022357|FG003|COMPLETED|Overall Study||1
10856188|NCT01491893|12022358|FG004|COMPLETED|Overall Study||4
10856189|NCT01491893|12022359|FG005|COMPLETED|Overall Study||1
10856190|NCT01491893|12022360|FG006|COMPLETED|Overall Study||6
10856191|NCT01491893|12022361|FG007|COMPLETED|Overall Study||24
10856192|NCT01491893|12022362|FG008|COMPLETED|Overall Study||15
10856193|NCT01491893|12022363|FG009|COMPLETED|Overall Study||7
10856194|NCT01491893|12022354|FG000|NOT COMPLETED|Overall Study||0
10856195|NCT01491893|12022355|FG001|NOT COMPLETED|Overall Study||0
10856196|NCT01491893|12022356|FG002|NOT COMPLETED|Overall Study||0
10856197|NCT01491893|12022357|FG003|NOT COMPLETED|Overall Study||0
10856198|NCT01491893|12022358|FG004|NOT COMPLETED|Overall Study||0
10856199|NCT01491893|12022359|FG005|NOT COMPLETED|Overall Study||0
10856200|NCT01491893|12022360|FG006|NOT COMPLETED|Overall Study||0
10856201|NCT01491893|12022361|FG007|NOT COMPLETED|Overall Study||0
10856202|NCT01491893|12022362|FG008|NOT COMPLETED|Overall Study||0
10856203|NCT01491893|12022363|FG009|NOT COMPLETED|Overall Study||0
10856204|NCT00245960|12022381|FG000|STARTED|Period 1 (Double Blind): 1-12 Weeks||379
10856205|NCT00245960|12022382|FG001|STARTED|Period 1 (Double Blind): 1-12 Weeks||373
10856206|NCT00245960|12022381|FG000|COMPLETED|Period 1 (Double Blind): 1-12 Weeks||364
10856207|NCT00245960|12022382|FG001|COMPLETED|Period 1 (Double Blind): 1-12 Weeks||362
10856208|NCT00245960|12022381|FG000|NOT COMPLETED|Period 1 (Double Blind): 1-12 Weeks||15
10856209|NCT00245960|12022382|FG001|NOT COMPLETED|Period 1 (Double Blind): 1-12 Weeks||11
10856210|NCT00245960|12022381|FG000|STARTED|Period 2 (Open Label): 13-24 Weeks||364
10856211|NCT00245960|12022382|FG001|STARTED|Period 2 (Open Label): 13-24 Weeks||362
10856212|NCT00245960|12022381|FG000|COMPLETED|Period 2 (Open Label): 13-24 Weeks||350
10856213|NCT00245960|12022382|FG001|COMPLETED|Period 2 (Open Label): 13-24 Weeks||344
10856214|NCT00245960|12022381|FG000|NOT COMPLETED|Period 2 (Open Label): 13-24 Weeks||14
10856215|NCT00245960|12022382|FG001|NOT COMPLETED|Period 2 (Open Label): 13-24 Weeks||18
10856216|NCT04565353|12022408|FG000|STARTED|Overall Study||3742
10856217|NCT04565353|12022409|FG001|STARTED|Overall Study||3737
10856218|NCT04565353|12022410|FG002|STARTED|Overall Study||3709
10856219|NCT04565353|12022411|FG003|STARTED|Overall Study||3735
10856220|NCT04565353|12022412|FG004|STARTED|Overall Study||3758
10856221|NCT04565353|12022413|FG005|STARTED|Overall Study||3769
10856222|NCT04565353|12022414|FG006|STARTED|Overall Study||3719
10856223|NCT04565353|12022415|FG007|STARTED|Overall Study||3732
10856224|NCT04565353|12022416|FG008|STARTED|Overall Study||3728
10856225|NCT04565353|12022417|FG009|STARTED|Overall Study||3777
10856226|NCT04565353|12022418|FG010|STARTED|Overall Study||3672
10856227|NCT04565353|12022419|FG011|STARTED|Overall Study||3751
10856228|NCT04565353|12022420|FG012|STARTED|Overall Study||3737
10856229|NCT04565353|12022421|FG013|STARTED|Overall Study||3714
10856230|NCT04565353|12022422|FG014|STARTED|Overall Study||3773
10856231|NCT04565353|12022423|FG015|STARTED|Overall Study||3739
10856232|NCT04565353|12022424|FG016|STARTED|Overall Study||3776
10856233|NCT04565353|12022425|FG017|STARTED|Overall Study||3744
10856234|NCT04565353|12022426|FG018|STARTED|Overall Study||3741
10856235|NCT04565353|12022427|FG019|STARTED|Overall Study||3758
10856236|NCT04565353|12022408|FG000|COMPLETED|Overall Study||3742
10856237|NCT04565353|12022409|FG001|COMPLETED|Overall Study||3688
10856238|NCT04565353|12022410|FG002|COMPLETED|Overall Study||3670
10856239|NCT04565353|12022411|FG003|COMPLETED|Overall Study||3693
10856240|NCT04565353|12022412|FG004|COMPLETED|Overall Study||3717
10856241|NCT04565353|12022413|FG005|COMPLETED|Overall Study||3716
10856242|NCT04565353|12022414|FG006|COMPLETED|Overall Study||3665
10856243|NCT04565353|12022415|FG007|COMPLETED|Overall Study||3693
10856244|NCT04565353|12022416|FG008|COMPLETED|Overall Study||3662
10856245|NCT04565353|12022417|FG009|COMPLETED|Overall Study||3734
10856246|NCT04565353|12022418|FG010|COMPLETED|Overall Study||3623
10856247|NCT04565353|12022419|FG011|COMPLETED|Overall Study||3710
10856248|NCT04565353|12022420|FG012|COMPLETED|Overall Study||3685
10856249|NCT04565353|12022421|FG013|COMPLETED|Overall Study||3664
10856250|NCT04565353|12022422|FG014|COMPLETED|Overall Study||3736
10856251|NCT04565353|12022423|FG015|COMPLETED|Overall Study||3690
10856252|NCT04565353|12022424|FG016|COMPLETED|Overall Study||3734
10856253|NCT04565353|12022425|FG017|COMPLETED|Overall Study||3696
10856254|NCT04565353|12022426|FG018|COMPLETED|Overall Study||3698
10856255|NCT04565353|12022427|FG019|COMPLETED|Overall Study||3712
10856256|NCT04565353|12022408|FG000|NOT COMPLETED|Overall Study||0
10856257|NCT04565353|12022409|FG001|NOT COMPLETED|Overall Study||49
10856258|NCT04565353|12022410|FG002|NOT COMPLETED|Overall Study||39
10856259|NCT04565353|12022411|FG003|NOT COMPLETED|Overall Study||42
10856260|NCT04565353|12022412|FG004|NOT COMPLETED|Overall Study||41
10856261|NCT04565353|12022413|FG005|NOT COMPLETED|Overall Study||53
10856262|NCT04565353|12022414|FG006|NOT COMPLETED|Overall Study||54
10856263|NCT04565353|12022415|FG007|NOT COMPLETED|Overall Study||39
10856264|NCT04565353|12022416|FG008|NOT COMPLETED|Overall Study||66
10856265|NCT04565353|12022417|FG009|NOT COMPLETED|Overall Study||43
10856266|NCT04565353|12022418|FG010|NOT COMPLETED|Overall Study||49
10856267|NCT04565353|12022419|FG011|NOT COMPLETED|Overall Study||41
10856268|NCT04565353|12022420|FG012|NOT COMPLETED|Overall Study||52
10856269|NCT04565353|12022421|FG013|NOT COMPLETED|Overall Study||50
10856270|NCT04565353|12022422|FG014|NOT COMPLETED|Overall Study||37
10856271|NCT04565353|12022423|FG015|NOT COMPLETED|Overall Study||49
10856272|NCT04565353|12022424|FG016|NOT COMPLETED|Overall Study||42
10856273|NCT04565353|12022425|FG017|NOT COMPLETED|Overall Study||48
10856274|NCT04565353|12022426|FG018|NOT COMPLETED|Overall Study||43
10856275|NCT04565353|12022427|FG019|NOT COMPLETED|Overall Study||46
10856276|NCT04015336|12022469|FG000|STARTED|Overall Study||1
10856277|NCT04015336|12022469|FG000|COMPLETED|Overall Study||0
10856278|NCT04015336|12022469|FG000|NOT COMPLETED|Overall Study||1
10856279|NCT03972813|12022491|FG000|STARTED|Overall Study||85
10856280|NCT03972813|12022492|FG001|STARTED|Overall Study||49
10856281|NCT03972813|12022493|FG002|STARTED|Overall Study||58
10856282|NCT03972813|12022494|FG003|STARTED|Overall Study||55
10856283|NCT03972813|12022495|FG004|STARTED|Overall Study||52
10856284|NCT03972813|12022496|FG005|STARTED|Overall Study||51
10856285|NCT03972813|12022497|FG006|STARTED|Overall Study||53
10856286|NCT03972813|12022498|FG007|STARTED|Overall Study||55
10856287|NCT03972813|12022499|FG008|STARTED|Overall Study||58
10856288|NCT03972813|12022500|FG009|STARTED|Overall Study||60
10856289|NCT03972813|12022501|FG010|STARTED|Overall Study||62
10856290|NCT03972813|12022502|FG011|STARTED|Overall Study||55
10856291|NCT03972813|12022503|FG012|STARTED|Overall Study||58
10856292|NCT03972813|12022504|FG013|STARTED|Overall Study||55
10856293|NCT03972813|12022505|FG014|STARTED|Overall Study||58
10856294|NCT03972813|12022506|FG015|STARTED|Overall Study||56
10856295|NCT03972813|12022507|FG016|STARTED|Overall Study||51
10856296|NCT03972813|12022508|FG017|STARTED|Overall Study||50
10856297|NCT03972813|12022491|FG000|COMPLETED|Overall Study||79
10856298|NCT03972813|12022492|FG001|COMPLETED|Overall Study||45
10856299|NCT03972813|12022493|FG002|COMPLETED|Overall Study||52
10856300|NCT03972813|12022494|FG003|COMPLETED|Overall Study||51
10856301|NCT03972813|12022495|FG004|COMPLETED|Overall Study||48
10856302|NCT03972813|12022496|FG005|COMPLETED|Overall Study||49
10856303|NCT03972813|12022497|FG006|COMPLETED|Overall Study||49
10856304|NCT03972813|12022498|FG007|COMPLETED|Overall Study||52
10856305|NCT03972813|12022499|FG008|COMPLETED|Overall Study||53
10856306|NCT03972813|12022500|FG009|COMPLETED|Overall Study||58
10856307|NCT03972813|12022501|FG010|COMPLETED|Overall Study||57
10856308|NCT03972813|12022502|FG011|COMPLETED|Overall Study||51
10856309|NCT03972813|12022503|FG012|COMPLETED|Overall Study||55
10856310|NCT03972813|12022504|FG013|COMPLETED|Overall Study||52
10856311|NCT03972813|12022505|FG014|COMPLETED|Overall Study||56
10856312|NCT03972813|12022506|FG015|COMPLETED|Overall Study||50
10856313|NCT03972813|12022507|FG016|COMPLETED|Overall Study||48
10856314|NCT03972813|12022508|FG017|COMPLETED|Overall Study||48
10856315|NCT03972813|12022491|FG000|NOT COMPLETED|Overall Study||6
10856316|NCT03972813|12022492|FG001|NOT COMPLETED|Overall Study||4
10856317|NCT03972813|12022493|FG002|NOT COMPLETED|Overall Study||6
10856318|NCT03972813|12022494|FG003|NOT COMPLETED|Overall Study||4
10856319|NCT03972813|12022495|FG004|NOT COMPLETED|Overall Study||4
10856320|NCT03972813|12022496|FG005|NOT COMPLETED|Overall Study||2
10856321|NCT03972813|12022497|FG006|NOT COMPLETED|Overall Study||4
10856322|NCT03972813|12022498|FG007|NOT COMPLETED|Overall Study||3
10856323|NCT03972813|12022499|FG008|NOT COMPLETED|Overall Study||5
10856324|NCT03972813|12022500|FG009|NOT COMPLETED|Overall Study||2
10856325|NCT03972813|12022501|FG010|NOT COMPLETED|Overall Study||5
10856326|NCT03972813|12022502|FG011|NOT COMPLETED|Overall Study||4
10856327|NCT03972813|12022503|FG012|NOT COMPLETED|Overall Study||3
10856328|NCT03972813|12022504|FG013|NOT COMPLETED|Overall Study||3
10856329|NCT03972813|12022505|FG014|NOT COMPLETED|Overall Study||2
10856330|NCT03972813|12022506|FG015|NOT COMPLETED|Overall Study||6
10856331|NCT03972813|12022507|FG016|NOT COMPLETED|Overall Study||3
10856332|NCT03972813|12022508|FG017|NOT COMPLETED|Overall Study||2
10856339|NCT03913091|12022560|FG000|STARTED|Overall Study||92
10856340|NCT03913091|12022561|FG001|STARTED|Overall Study||92
10856341|NCT03913091|12022560|FG000|COMPLETED|Overall Study||72
10856342|NCT03913091|12022561|FG001|COMPLETED|Overall Study||78
10856343|NCT03913091|12022560|FG000|NOT COMPLETED|Overall Study||20
10856344|NCT03913091|12022561|FG001|NOT COMPLETED|Overall Study||14
10856345|NCT03802565|12022572|FG000|STARTED|Overall Study||82
10856346|NCT03802565|12022573|FG001|STARTED|Overall Study||87
10856347|NCT03802565|12022574|FG002|STARTED|Overall Study||83
10856348|NCT03802565|12022575|FG003|STARTED|Overall Study||85
10856349|NCT03802565|12022576|FG004|STARTED|Overall Study||78
10856350|NCT03802565|12022572|FG000|COMPLETED|Overall Study||77
10856351|NCT03802565|12022573|FG001|COMPLETED|Overall Study||83
10856352|NCT03802565|12022574|FG002|COMPLETED|Overall Study||74
10856353|NCT03802565|12022575|FG003|COMPLETED|Overall Study||77
10856354|NCT03802565|12022576|FG004|COMPLETED|Overall Study||72
10856355|NCT03802565|12022572|FG000|NOT COMPLETED|Overall Study||5
10856356|NCT03802565|12022573|FG001|NOT COMPLETED|Overall Study||4
10856357|NCT03802565|12022574|FG002|NOT COMPLETED|Overall Study||9
10856358|NCT03802565|12022575|FG003|NOT COMPLETED|Overall Study||8
10856359|NCT03802565|12022576|FG004|NOT COMPLETED|Overall Study||6
10856360|NCT03769194|12022592|FG000|STARTED|Overall Study||29
10856361|NCT03769194|12022593|FG001|STARTED|Overall Study||214
10856362|NCT03769194|12022594|FG002|STARTED|Overall Study||205
10856363|NCT03769194|12022595|FG003|STARTED|Overall Study||124
10856364|NCT03769194|12022592|FG000|COMPLETED|Overall Study||25
10856365|NCT03769194|12022593|FG001|COMPLETED|Overall Study||196
10856366|NCT03769194|12022594|FG002|COMPLETED|Overall Study||197
10856367|NCT03769194|12022595|FG003|COMPLETED|Overall Study||115
10856368|NCT03769194|12022592|FG000|NOT COMPLETED|Overall Study||4
10755090|NCT03061188|11918912|FG000|STARTED|Completed 1st Cycle||0
10755091|NCT03061188|11918913|FG001|STARTED|Completed 1st Cycle||3
10755092|NCT03061188|11918914|FG002|STARTED|Completed 1st Cycle||6
10755093|NCT03061188|11918915|FG003|STARTED|Completed 1st Cycle||6
10755094|NCT03061188|11918912|FG000|COMPLETED|Completed 1st Cycle||0
10755095|NCT03061188|11918913|FG001|COMPLETED|Completed 1st Cycle||3
10755096|NCT03061188|11918914|FG002|COMPLETED|Completed 1st Cycle||6
10755097|NCT03061188|11918915|FG003|COMPLETED|Completed 1st Cycle||6
10755098|NCT03061188|11918912|FG000|NOT COMPLETED|Completed 1st Cycle||0
10755099|NCT03061188|11918913|FG001|NOT COMPLETED|Completed 1st Cycle||0
10856369|NCT03769194|12022593|FG001|NOT COMPLETED|Overall Study||18
10856370|NCT03769194|12022594|FG002|NOT COMPLETED|Overall Study||8
10856371|NCT03769194|12022595|FG003|NOT COMPLETED|Overall Study||9
10856372|NCT03738332|12022605|FG000|STARTED|Overall Study||12
10755100|NCT03061188|11918914|FG002|NOT COMPLETED|Completed 1st Cycle||0
10856373|NCT03738332|12022605|FG000|COMPLETED|Overall Study||11
10856374|NCT03738332|12022605|FG000|NOT COMPLETED|Overall Study||1
10856375|NCT03451786|12022610|FG000|STARTED|Overall Study||369
10856376|NCT03451786|12022610|FG000|COMPLETED|Overall Study||310
10856377|NCT03451786|12022610|FG000|NOT COMPLETED|Overall Study||59
10856378|NCT03416179|12022618|FG000|STARTED|Overall Study||201
10856379|NCT03416179|12022619|FG001|STARTED|Overall Study||203
10856380|NCT03416179|12022620|FG002|STARTED|Overall Study||163
10856381|NCT03416179|12022621|FG003|STARTED|Overall Study||162
10856382|NCT03416179|12022618|FG000|COMPLETED|Overall Study||0
10856383|NCT03416179|12022619|FG001|COMPLETED|Overall Study||0
10856384|NCT03416179|12022620|FG002|COMPLETED|Overall Study||0
10856385|NCT03416179|12022621|FG003|COMPLETED|Overall Study||0
10856386|NCT03416179|12022618|FG000|NOT COMPLETED|Overall Study||201
10856387|NCT03416179|12022619|FG001|NOT COMPLETED|Overall Study||203
10856388|NCT03416179|12022620|FG002|NOT COMPLETED|Overall Study||163
10856389|NCT03416179|12022621|FG003|NOT COMPLETED|Overall Study||162
10856390|NCT03353922|12022631|FG000|STARTED|Overall Study||6
10856391|NCT03353922|12022632|FG001|STARTED|Overall Study||6
10856392|NCT03353922|12022633|FG002|STARTED|Overall Study||6
10856393|NCT03353922|12022634|FG003|STARTED|Overall Study||6
10856394|NCT03353922|12022635|FG004|STARTED|Overall Study||5
10856395|NCT03353922|12022636|FG005|STARTED|Overall Study||6
10856396|NCT03353922|12022631|FG000|COMPLETED|Overall Study||5
10856397|NCT03353922|12022632|FG001|COMPLETED|Overall Study||5
10856398|NCT03353922|12022633|FG002|COMPLETED|Overall Study||5
10856399|NCT03353922|12022634|FG003|COMPLETED|Overall Study||5
10856400|NCT03353922|12022635|FG004|COMPLETED|Overall Study||5
10856401|NCT03353922|12022636|FG005|COMPLETED|Overall Study||6
10856402|NCT03353922|12022631|FG000|NOT COMPLETED|Overall Study||1
10856403|NCT03353922|12022632|FG001|NOT COMPLETED|Overall Study||1
10856404|NCT03353922|12022633|FG002|NOT COMPLETED|Overall Study||1
10856405|NCT03353922|12022634|FG003|NOT COMPLETED|Overall Study||1
10856406|NCT03353922|12022635|FG004|NOT COMPLETED|Overall Study||0
10856407|NCT03353922|12022636|FG005|NOT COMPLETED|Overall Study||0
10856408|NCT03322384|12022647|FG000|STARTED|Overall Study||20
10856409|NCT03322384|12022647|FG000|COMPLETED|Overall Study||14
10856410|NCT03322384|12022647|FG000|NOT COMPLETED|Overall Study||6
10856411|NCT03243071|12022653|FG000|STARTED|Overall Study||59
10856412|NCT03243071|12022654|FG001|STARTED|Overall Study||53
10856413|NCT03243071|12022653|FG000|COMPLETED|Overall Study||59
10856414|NCT03243071|12022654|FG001|COMPLETED|Overall Study||53
10856415|NCT03243071|12022653|FG000|NOT COMPLETED|Overall Study||0
10856416|NCT03243071|12022654|FG001|NOT COMPLETED|Overall Study||0
10856417|NCT03173456|12022671|FG000|STARTED|Baseline||120
10856418|NCT03173456|12022672|FG001|STARTED|Baseline||120
10856419|NCT03173456|12022673|FG002|STARTED|Baseline||120
10856420|NCT03173456|12022674|FG003|STARTED|Baseline||120
10856421|NCT03173456|12022675|FG004|STARTED|Baseline||120
10856422|NCT03173456|12022671|FG000|COMPLETED|Baseline||120
10856423|NCT03173456|12022672|FG001|COMPLETED|Baseline||119
10856424|NCT03173456|12022673|FG002|COMPLETED|Baseline||120
10856425|NCT03173456|12022674|FG003|COMPLETED|Baseline||120
10856426|NCT03173456|12022675|FG004|COMPLETED|Baseline||118
10856427|NCT03173456|12022671|FG000|NOT COMPLETED|Baseline||0
10856428|NCT03173456|12022672|FG001|NOT COMPLETED|Baseline||1
10856429|NCT03173456|12022673|FG002|NOT COMPLETED|Baseline||0
10856430|NCT03173456|12022674|FG003|NOT COMPLETED|Baseline||0
10856431|NCT03173456|12022675|FG004|NOT COMPLETED|Baseline||2
10856432|NCT03173456|12022671|FG000|STARTED|2 Hour Follow-up||120
10856433|NCT03173456|12022672|FG001|STARTED|2 Hour Follow-up||119
10856434|NCT03173456|12022673|FG002|STARTED|2 Hour Follow-up||120
10856435|NCT03173456|12022674|FG003|STARTED|2 Hour Follow-up||120
10856436|NCT03173456|12022675|FG004|STARTED|2 Hour Follow-up||118
10856437|NCT03173456|12022671|FG000|COMPLETED|2 Hour Follow-up||120
10856438|NCT03173456|12022672|FG001|COMPLETED|2 Hour Follow-up||118
10856439|NCT03173456|12022673|FG002|COMPLETED|2 Hour Follow-up||119
10856440|NCT03173456|12022674|FG003|COMPLETED|2 Hour Follow-up||119
10856441|NCT03173456|12022675|FG004|COMPLETED|2 Hour Follow-up||116
10856442|NCT03173456|12022671|FG000|NOT COMPLETED|2 Hour Follow-up||0
10856443|NCT03173456|12022672|FG001|NOT COMPLETED|2 Hour Follow-up||1
10856444|NCT03173456|12022673|FG002|NOT COMPLETED|2 Hour Follow-up||1
10856445|NCT03173456|12022674|FG003|NOT COMPLETED|2 Hour Follow-up||1
10856446|NCT03173456|12022675|FG004|NOT COMPLETED|2 Hour Follow-up||2
10856447|NCT03101566|12022689|FG000|STARTED|Overall Study||37
10856448|NCT03101566|12022690|FG001|STARTED|Overall Study||38
10856449|NCT03101566|12022689|FG000|Received at Least One Dose of Protocol Therapy|Overall Study||35
10856450|NCT03101566|12022690|FG001|Received at Least One Dose of Protocol Therapy|Overall Study||33
10856451|NCT03101566|12022689|FG000|Assessed for Primary and Secondary Progression-free Survival|Overall Study||32
10856452|NCT03101566|12022690|FG001|Assessed for Primary and Secondary Progression-free Survival|Overall Study||33
10856453|NCT03101566|12022689|FG000|COMPLETED|Overall Study||31
10856454|NCT03101566|12022690|FG001|COMPLETED|Overall Study||31
10856455|NCT03101566|12022689|FG000|NOT COMPLETED|Overall Study||6
10856456|NCT03101566|12022690|FG001|NOT COMPLETED|Overall Study||7
10545589|NCT01498601|11698997|FG000|COMPLETED|Overall Study||51
10545590|NCT01498601|11698998|FG001|COMPLETED|Overall Study||32
10545591|NCT01498601|11698997|FG000|NOT COMPLETED|Overall Study||0
10545592|NCT01498601|11698998|FG001|NOT COMPLETED|Overall Study||0
10856500|NCT02820753|12022752|FG000|STARTED|Baseline||256
10856501|NCT02820753|12022753|FG001|STARTED|Baseline||421
10856502|NCT02820753|12022752|FG000|COMPLETED|Baseline||256
10856503|NCT02820753|12022753|FG001|COMPLETED|Baseline||421
10856504|NCT02820753|12022752|FG000|NOT COMPLETED|Baseline||0
10545593|NCT01498640|11699004|FG000|STARTED|Overall Study||52
10415230|NCT00789477|11559735|FG003|NOT COMPLETED|Overall Study||10
10415231|NCT00789477|11559736|FG004|NOT COMPLETED|Overall Study||7
10415232|NCT00789529|11559752|FG000|STARTED|Overall Study||16
10545594|NCT01498640|11699004|FG000|COMPLETED|Overall Study||47
10545595|NCT01498640|11699004|FG000|NOT COMPLETED|Overall Study||5
10545596|NCT01498653|11699014|FG000|STARTED|Overall Study||155
10545597|NCT01498653|11699015|FG001|STARTED|Overall Study||154
10545598|NCT01498653|11699014|FG000|COMPLETED|Overall Study||136
10545599|NCT01498653|11699015|FG001|COMPLETED|Overall Study||119
10545600|NCT01498653|11699014|FG000|NOT COMPLETED|Overall Study||19
10545601|NCT01498653|11699015|FG001|NOT COMPLETED|Overall Study||35
10545602|NCT01498679|11699023|FG000|STARTED|Overall Study||154
10545603|NCT01498679|11699024|FG001|STARTED|Overall Study||153
10545604|NCT01498679|11699023|FG000|COMPLETED|Overall Study||65
10545605|NCT01498679|11699024|FG001|COMPLETED|Overall Study||131
10545606|NCT01498679|11699023|FG000|NOT COMPLETED|Overall Study||89
10545607|NCT01498679|11699024|FG001|NOT COMPLETED|Overall Study||22
10545608|NCT01498692|11699030|FG000|STARTED|Overall Study||94
10545609|NCT01498692|11699030|FG000|COMPLETED|Overall Study||86
10545610|NCT01498692|11699030|FG000|NOT COMPLETED|Overall Study||8
10545611|NCT01498744|11699036|FG000|STARTED|Overall Study||22
10545612|NCT01498744|11699037|FG001|STARTED|Overall Study||31
10545613|NCT01498744|11699036|FG000|COMPLETED|Overall Study||22
10545614|NCT01498744|11699037|FG001|COMPLETED|Overall Study||31
10545615|NCT01498744|11699036|FG000|NOT COMPLETED|Overall Study||0
10545616|NCT01498744|11699037|FG001|NOT COMPLETED|Overall Study||0
10545617|NCT01498822|11699045|FG000|STARTED|Overall Study||175
10545618|NCT01498822|11699046|FG001|STARTED|Overall Study||178
10661287|NCT02258217|11823174|FG000|NOT COMPLETED|Overall Study||0
10661288|NCT02258256|11823178|FG000|STARTED|Overall Study||11
10661289|NCT02258256|11823178|FG000|COMPLETED|Overall Study||11
10661290|NCT02258256|11823178|FG000|NOT COMPLETED|Overall Study||0
10661291|NCT02258334|11823186|FG000|STARTED|Overall Study||50
10661292|NCT02258334|11823187|FG001|STARTED|Overall Study||54
10661293|NCT02258334|11823188|FG002|STARTED|Overall Study||52
10661294|NCT02258334|11823189|FG003|STARTED|Overall Study||52
10661295|NCT02258334|11823186|FG000|COMPLETED|Overall Study||49
10661296|NCT02258334|11823187|FG001|COMPLETED|Overall Study||54
10661297|NCT02258334|11823188|FG002|COMPLETED|Overall Study||52
10661298|NCT02258334|11823189|FG003|COMPLETED|Overall Study||52
10661299|NCT02258334|11823186|FG000|NOT COMPLETED|Overall Study||1
10661300|NCT02258334|11823187|FG001|NOT COMPLETED|Overall Study||0
10661301|NCT02258334|11823188|FG002|NOT COMPLETED|Overall Study||0
10661302|NCT02258334|11823189|FG003|NOT COMPLETED|Overall Study||0
10661303|NCT02258373|11823203|FG000|STARTED|Overall Study||149
10661304|NCT02258373|11823204|FG001|STARTED|Overall Study||77
10661305|NCT02258373|11823203|FG000|COMPLETED|Overall Study||142
10755101|NCT03061188|11918915|FG003|NOT COMPLETED|Completed 1st Cycle||0
10755102|NCT03061188|11918912|FG000|STARTED|Went on to Cycle 2 and Beyond||0
10755103|NCT03061188|11918913|FG001|STARTED|Went on to Cycle 2 and Beyond||3
10755104|NCT03061188|11918914|FG002|STARTED|Went on to Cycle 2 and Beyond||6
10755105|NCT03061188|11918915|FG003|STARTED|Went on to Cycle 2 and Beyond||6
10755106|NCT03061188|11918912|FG000|Received Dose of Study Drugs|Went on to Cycle 2 and Beyond||0
10755107|NCT03061188|11918913|FG001|Received Dose of Study Drugs|Went on to Cycle 2 and Beyond||3
10755108|NCT03061188|11918914|FG002|Received Dose of Study Drugs|Went on to Cycle 2 and Beyond||5
10755109|NCT03061188|11918915|FG003|Received Dose of Study Drugs|Went on to Cycle 2 and Beyond||5
10755110|NCT03061188|11918912|FG000|COMPLETED|Went on to Cycle 2 and Beyond||0
10755111|NCT03061188|11918913|FG001|COMPLETED|Went on to Cycle 2 and Beyond||3
10755112|NCT03061188|11918914|FG002|COMPLETED|Went on to Cycle 2 and Beyond||5
10755113|NCT03061188|11918915|FG003|COMPLETED|Went on to Cycle 2 and Beyond||5
10755114|NCT03061188|11918912|FG000|NOT COMPLETED|Went on to Cycle 2 and Beyond||0
10755115|NCT03061188|11918913|FG001|NOT COMPLETED|Went on to Cycle 2 and Beyond||0
10755116|NCT03061188|11918914|FG002|NOT COMPLETED|Went on to Cycle 2 and Beyond||1
10755117|NCT03061188|11918915|FG003|NOT COMPLETED|Went on to Cycle 2 and Beyond||1
10755118|NCT03061188|11918912|FG000|STARTED|On Follow-up for 3 Years||0
10755119|NCT03061188|11918913|FG001|STARTED|On Follow-up for 3 Years||3
10755120|NCT03061188|11918914|FG002|STARTED|On Follow-up for 3 Years|Patients who received at least one dose of study drug go into follow-up.|6
10755121|NCT03061188|11918915|FG003|STARTED|On Follow-up for 3 Years|Patients who receive at least one dose of study drug go into follow-up.|6
10755122|NCT03061188|11918912|FG000|COMPLETED|On Follow-up for 3 Years||0
10755123|NCT03061188|11918913|FG001|COMPLETED|On Follow-up for 3 Years||0
10755124|NCT03061188|11918914|FG002|COMPLETED|On Follow-up for 3 Years||1
10755125|NCT03061188|11918915|FG003|COMPLETED|On Follow-up for 3 Years||1
10755126|NCT03061188|11918912|FG000|NOT COMPLETED|On Follow-up for 3 Years||0
10755127|NCT03061188|11918913|FG001|NOT COMPLETED|On Follow-up for 3 Years||3
10755128|NCT03061188|11918914|FG002|NOT COMPLETED|On Follow-up for 3 Years||5
10755129|NCT03061188|11918915|FG003|NOT COMPLETED|On Follow-up for 3 Years||5
10755130|NCT03061214|11918933|FG000|STARTED|Overall Study||288
10755131|NCT03061214|11918934|FG001|STARTED|Overall Study||290
10755132|NCT03061214|11918935|FG002|STARTED|Overall Study||290
10545619|NCT01498822|11699045|FG000|COMPLETED|Overall Study||121
10545620|NCT01498822|11699046|FG001|COMPLETED|Overall Study||122
10755133|NCT03061214|11918933|FG000|Exposed|Overall Study||287
10755134|NCT03061214|11918934|FG001|Exposed|Overall Study||290
10661306|NCT02258373|11823204|FG001|COMPLETED|Overall Study||75
10661307|NCT02258373|11823203|FG000|NOT COMPLETED|Overall Study||7
10661308|NCT02258373|11823204|FG001|NOT COMPLETED|Overall Study||2
10856505|NCT02820753|12022753|FG001|NOT COMPLETED|Baseline||0
10856506|NCT02820753|12022752|FG000|STARTED|2 Month||256
10856507|NCT02820753|12022753|FG001|STARTED|2 Month||421
10856508|NCT02820753|12022752|FG000|COMPLETED|2 Month||178
10856509|NCT02820753|12022753|FG001|COMPLETED|2 Month||379
10856510|NCT02820753|12022752|FG000|NOT COMPLETED|2 Month||78
10856511|NCT02820753|12022753|FG001|NOT COMPLETED|2 Month||42
10856512|NCT02820753|12022752|FG000|STARTED|6 Month||253
10856513|NCT02820753|12022753|FG001|STARTED|6 Month||418
10856514|NCT02820753|12022752|FG000|COMPLETED|6 Month||150
10856515|NCT02820753|12022753|FG001|COMPLETED|6 Month||307
10856516|NCT02820753|12022752|FG000|NOT COMPLETED|6 Month||103
10856517|NCT02820753|12022753|FG001|NOT COMPLETED|6 Month||111
10856518|NCT02733042|12022778|FG000|STARTED|Treatment Period||3
10856519|NCT02733042|12022779|FG001|STARTED|Treatment Period||3
10856520|NCT02733042|12022780|FG002|STARTED|Treatment Period||8
10415233|NCT00789529|11559753|FG001|STARTED|Overall Study||16
10415234|NCT00789529|11559752|FG000|COMPLETED|Overall Study||15
10415235|NCT00789529|11559753|FG001|COMPLETED|Overall Study||15
10415236|NCT00789529|11559752|FG000|NOT COMPLETED|Overall Study||1
10415237|NCT00789529|11559753|FG001|NOT COMPLETED|Overall Study||1
10415238|NCT00789555|11559762|FG000|STARTED|Overall Study||421
10415239|NCT00789555|11559763|FG001|STARTED|Overall Study||417
10415240|NCT00789555|11559764|FG002|STARTED|Overall Study||422
10545621|NCT01498822|11699045|FG000|NOT COMPLETED|Overall Study||54
10545622|NCT01498822|11699046|FG001|NOT COMPLETED|Overall Study||56
10545623|NCT01498887|11699056|FG000|STARTED|Overall Study||200
10545624|NCT01498887|11699057|FG001|STARTED|Overall Study||147
10545625|NCT01498887|11699056|FG000|Safety Set|Overall Study||200
10545626|NCT01498887|11699057|FG001|Safety Set|Overall Study||147
10545627|NCT01498887|11699056|FG000|Intent-to-treat|Overall Study||185
10545628|NCT01498887|11699057|FG001|Intent-to-treat|Overall Study||135
10545629|NCT01498887|11699056|FG000|COMPLETED|Overall Study||184
10545630|NCT01498887|11699057|FG001|COMPLETED|Overall Study||136
10545631|NCT01498887|11699056|FG000|NOT COMPLETED|Overall Study||16
10545632|NCT01498887|11699057|FG001|NOT COMPLETED|Overall Study||11
10545633|NCT01498952|11699066|FG000|STARTED|Overall Study||3
10545634|NCT01498952|11699067|FG001|STARTED|Overall Study||3
10545635|NCT01498952|11699068|FG002|STARTED|Overall Study||0
10545636|NCT01498952|11699069|FG003|STARTED|Overall Study||0
10545637|NCT01498952|11699070|FG004|STARTED|Overall Study||0
10545638|NCT01498952|11699066|FG000|COMPLETED|Overall Study||1
10545639|NCT01498952|11699067|FG001|COMPLETED|Overall Study||1
10545640|NCT01498952|11699068|FG002|COMPLETED|Overall Study||0
10545641|NCT01498952|11699069|FG003|COMPLETED|Overall Study||0
10545642|NCT01498952|11699070|FG004|COMPLETED|Overall Study||0
10545643|NCT01498952|11699066|FG000|NOT COMPLETED|Overall Study||2
10545644|NCT01498952|11699067|FG001|NOT COMPLETED|Overall Study||2
10545645|NCT01498952|11699068|FG002|NOT COMPLETED|Overall Study||0
10545646|NCT01498952|11699069|FG003|NOT COMPLETED|Overall Study||0
10545647|NCT01498952|11699070|FG004|NOT COMPLETED|Overall Study||0
10545648|NCT01498978|11699083|FG000|STARTED|Overall Study||10
10545649|NCT01498978|11699083|FG000|COMPLETED|Overall Study||8
10545650|NCT01498978|11699083|FG000|NOT COMPLETED|Overall Study||2
10545651|NCT01499043|11699089|FG000|STARTED|Overall Study||6
10545652|NCT01499043|11699089|FG000|COMPLETED|Overall Study||0
10545653|NCT01499043|11699089|FG000|NOT COMPLETED|Overall Study||6
10545654|NCT01499134|11699100|FG000|STARTED|Overall Study||9
10545655|NCT01499134|11699101|FG001|STARTED|Overall Study||8
10545656|NCT01499134|11699100|FG000|COMPLETED|Overall Study||9
10545657|NCT01499134|11699101|FG001|COMPLETED|Overall Study||7
10545658|NCT01499134|11699100|FG000|NOT COMPLETED|Overall Study||0
10545659|NCT01499134|11699101|FG001|NOT COMPLETED|Overall Study||1
10545660|NCT01499147|11699109|FG000|STARTED|Overall Study||33
10856521|NCT02733042|12022781|FG003|STARTED|Treatment Period||3
10856522|NCT02733042|12022782|FG004|STARTED|Treatment Period||4
10856523|NCT02733042|12022783|FG005|STARTED|Treatment Period||3
10545661|NCT01499147|11699110|FG001|STARTED|Overall Study||17
10545662|NCT01499147|11699109|FG000|COMPLETED|Overall Study||18
10545663|NCT01499147|11699110|FG001|COMPLETED|Overall Study||12
10545664|NCT01499147|11699109|FG000|NOT COMPLETED|Overall Study||15
10545665|NCT01499147|11699110|FG001|NOT COMPLETED|Overall Study||5
10545666|NCT01499173|11699120|FG000|STARTED|Overall Study||101
10545667|NCT01499173|11699120|FG000|COMPLETED|Overall Study||64
10545668|NCT01499173|11699120|FG000|NOT COMPLETED|Overall Study||37
10856524|NCT02733042|12022784|FG006|STARTED|Treatment Period||1
10856525|NCT02733042|12022785|FG007|STARTED|Treatment Period||4
10415241|NCT00789555|11559762|FG000|COMPLETED|Overall Study||262
10545669|NCT01499199|11699125|FG000|STARTED|Overall Study||13
10545670|NCT01499199|11699125|FG000|COMPLETED|Overall Study||11
10545671|NCT01499199|11699125|FG000|NOT COMPLETED|Overall Study||2
10545672|NCT01499277|11699131|FG000|STARTED|Overall Study||506
10545673|NCT01499277|11699132|FG001|STARTED|Overall Study||255
10545674|NCT01499277|11699131|FG000|COMPLETED|Overall Study||459
10545675|NCT01499277|11699132|FG001|COMPLETED|Overall Study||223
10856526|NCT02733042|12022786|FG008|STARTED|Treatment Period||5
10856527|NCT02733042|12022787|FG009|STARTED|Treatment Period||10
10856528|NCT02733042|12022788|FG010|STARTED|Treatment Period||10
10856529|NCT02733042|12022789|FG011|STARTED|Treatment Period||10
10856530|NCT02733042|12022790|FG012|STARTED|Treatment Period||10
10856531|NCT02733042|12022791|FG013|STARTED|Treatment Period||5
10856532|NCT02733042|12022792|FG014|STARTED|Treatment Period||5
10856533|NCT02733042|12022793|FG015|STARTED|Treatment Period||10
10856534|NCT02733042|12022794|FG016|STARTED|Treatment Period||2
10856535|NCT02733042|12022795|FG017|STARTED|Treatment Period||5
10856536|NCT02733042|12022796|FG018|STARTED|Treatment Period||5
10856537|NCT02733042|12022778|FG000|COMPLETED|Treatment Period||0
10856538|NCT02733042|12022779|FG001|COMPLETED|Treatment Period||1
10856539|NCT02733042|12022780|FG002|COMPLETED|Treatment Period||1
10856540|NCT02733042|12022781|FG003|COMPLETED|Treatment Period||0
10856541|NCT02733042|12022782|FG004|COMPLETED|Treatment Period||0
10856542|NCT02733042|12022783|FG005|COMPLETED|Treatment Period||0
10856543|NCT02733042|12022784|FG006|COMPLETED|Treatment Period||0
10856544|NCT02733042|12022785|FG007|COMPLETED|Treatment Period||1
10856545|NCT02733042|12022786|FG008|COMPLETED|Treatment Period||0
10856546|NCT02733042|12022787|FG009|COMPLETED|Treatment Period||0
10856547|NCT02733042|12022788|FG010|COMPLETED|Treatment Period||0
10856548|NCT02733042|12022789|FG011|COMPLETED|Treatment Period||4
10856549|NCT02733042|12022790|FG012|COMPLETED|Treatment Period||1
10856550|NCT02733042|12022791|FG013|COMPLETED|Treatment Period||1
10856551|NCT02733042|12022792|FG014|COMPLETED|Treatment Period||0
10856552|NCT02733042|12022793|FG015|COMPLETED|Treatment Period||0
10856553|NCT02733042|12022794|FG016|COMPLETED|Treatment Period||0
10856554|NCT02733042|12022795|FG017|COMPLETED|Treatment Period||0
10856555|NCT02733042|12022796|FG018|COMPLETED|Treatment Period||0
10856556|NCT02733042|12022778|FG000|NOT COMPLETED|Treatment Period||3
10856557|NCT02733042|12022779|FG001|NOT COMPLETED|Treatment Period||2
10856558|NCT02733042|12022780|FG002|NOT COMPLETED|Treatment Period||7
10856559|NCT02733042|12022781|FG003|NOT COMPLETED|Treatment Period||3
10856560|NCT02733042|12022782|FG004|NOT COMPLETED|Treatment Period||4
10856561|NCT02733042|12022783|FG005|NOT COMPLETED|Treatment Period||3
10856562|NCT02733042|12022784|FG006|NOT COMPLETED|Treatment Period||1
10856563|NCT02733042|12022785|FG007|NOT COMPLETED|Treatment Period||3
10856564|NCT02733042|12022786|FG008|NOT COMPLETED|Treatment Period||5
10856565|NCT02733042|12022787|FG009|NOT COMPLETED|Treatment Period||10
10856566|NCT02733042|12022788|FG010|NOT COMPLETED|Treatment Period||10
10856567|NCT02733042|12022789|FG011|NOT COMPLETED|Treatment Period||6
10856568|NCT02733042|12022790|FG012|NOT COMPLETED|Treatment Period||9
10856569|NCT02733042|12022791|FG013|NOT COMPLETED|Treatment Period||4
10856570|NCT02733042|12022792|FG014|NOT COMPLETED|Treatment Period||5
10856571|NCT02733042|12022793|FG015|NOT COMPLETED|Treatment Period||10
10856572|NCT02733042|12022794|FG016|NOT COMPLETED|Treatment Period||2
10856573|NCT02733042|12022795|FG017|NOT COMPLETED|Treatment Period||5
10856574|NCT02733042|12022796|FG018|NOT COMPLETED|Treatment Period||5
10856575|NCT02733042|12022778|FG000|STARTED|Follow-up Period||3
10856576|NCT02733042|12022779|FG001|STARTED|Follow-up Period||3
10856577|NCT02733042|12022780|FG002|STARTED|Follow-up Period||6
10856578|NCT02733042|12022781|FG003|STARTED|Follow-up Period||3
10856579|NCT02733042|12022782|FG004|STARTED|Follow-up Period||1
10856580|NCT02733042|12022783|FG005|STARTED|Follow-up Period||2
10856581|NCT02733042|12022784|FG006|STARTED|Follow-up Period||0
10856582|NCT02733042|12022785|FG007|STARTED|Follow-up Period||4
10856583|NCT02733042|12022786|FG008|STARTED|Follow-up Period||4
10856584|NCT02733042|12022787|FG009|STARTED|Follow-up Period||2
10856585|NCT02733042|12022788|FG010|STARTED|Follow-up Period||5
10856586|NCT02733042|12022789|FG011|STARTED|Follow-up Period||9
10856587|NCT02733042|12022790|FG012|STARTED|Follow-up Period||9
10856588|NCT02733042|12022791|FG013|STARTED|Follow-up Period||4
10856589|NCT02733042|12022792|FG014|STARTED|Follow-up Period||1
10856590|NCT02733042|12022793|FG015|STARTED|Follow-up Period||5
10856591|NCT02733042|12022794|FG016|STARTED|Follow-up Period||0
10856592|NCT02733042|12022795|FG017|STARTED|Follow-up Period||3
10856593|NCT02733042|12022796|FG018|STARTED|Follow-up Period||2
10856594|NCT02733042|12022778|FG000|COMPLETED|Follow-up Period||0
10856595|NCT02733042|12022779|FG001|COMPLETED|Follow-up Period||0
10856596|NCT02733042|12022780|FG002|COMPLETED|Follow-up Period||0
10856597|NCT02733042|12022781|FG003|COMPLETED|Follow-up Period||0
10856598|NCT02733042|12022782|FG004|COMPLETED|Follow-up Period||0
10856599|NCT02733042|12022783|FG005|COMPLETED|Follow-up Period||0
10856600|NCT02733042|12022784|FG006|COMPLETED|Follow-up Period||0
10856601|NCT02733042|12022785|FG007|COMPLETED|Follow-up Period||0
10856602|NCT02733042|12022786|FG008|COMPLETED|Follow-up Period||0
10856603|NCT02733042|12022787|FG009|COMPLETED|Follow-up Period||0
10856604|NCT02733042|12022788|FG010|COMPLETED|Follow-up Period||0
10856605|NCT02733042|12022789|FG011|COMPLETED|Follow-up Period||0
10856606|NCT02733042|12022790|FG012|COMPLETED|Follow-up Period||0
10856607|NCT02733042|12022791|FG013|COMPLETED|Follow-up Period||0
10856608|NCT02733042|12022792|FG014|COMPLETED|Follow-up Period||0
10856609|NCT02733042|12022793|FG015|COMPLETED|Follow-up Period||0
10856610|NCT02733042|12022794|FG016|COMPLETED|Follow-up Period||0
10856611|NCT02733042|12022795|FG017|COMPLETED|Follow-up Period||1
10856612|NCT02733042|12022796|FG018|COMPLETED|Follow-up Period||0
10856613|NCT02733042|12022778|FG000|NOT COMPLETED|Follow-up Period||3
10856614|NCT02733042|12022779|FG001|NOT COMPLETED|Follow-up Period||3
10856615|NCT02733042|12022780|FG002|NOT COMPLETED|Follow-up Period||6
10856616|NCT02733042|12022781|FG003|NOT COMPLETED|Follow-up Period||3
10856617|NCT02733042|12022782|FG004|NOT COMPLETED|Follow-up Period||1
10856618|NCT02733042|12022783|FG005|NOT COMPLETED|Follow-up Period||2
10856619|NCT02733042|12022784|FG006|NOT COMPLETED|Follow-up Period||0
10856620|NCT02733042|12022785|FG007|NOT COMPLETED|Follow-up Period||4
10856621|NCT02733042|12022786|FG008|NOT COMPLETED|Follow-up Period||4
10856622|NCT02733042|12022787|FG009|NOT COMPLETED|Follow-up Period||2
10856623|NCT02733042|12022788|FG010|NOT COMPLETED|Follow-up Period||5
10856624|NCT02733042|12022789|FG011|NOT COMPLETED|Follow-up Period||9
10856625|NCT02733042|12022790|FG012|NOT COMPLETED|Follow-up Period||9
10856626|NCT02733042|12022791|FG013|NOT COMPLETED|Follow-up Period||4
10856627|NCT02733042|12022792|FG014|NOT COMPLETED|Follow-up Period||1
10856628|NCT02733042|12022793|FG015|NOT COMPLETED|Follow-up Period||5
10856629|NCT02733042|12022794|FG016|NOT COMPLETED|Follow-up Period||0
10856630|NCT02733042|12022795|FG017|NOT COMPLETED|Follow-up Period||2
10856631|NCT02733042|12022796|FG018|NOT COMPLETED|Follow-up Period||2
10856632|NCT02668874|12022846|FG000|STARTED|Overall Study||104
10856633|NCT02668874|12022847|FG001|STARTED|Overall Study||104
10856634|NCT02668874|12022846|FG000|6 Months After Placement|Overall Study||59
10856635|NCT02668874|12022847|FG001|6 Months After Placement|Overall Study||59
10856636|NCT02668874|12022846|FG000|COMPLETED|Overall Study||47
10856637|NCT02668874|12022847|FG001|COMPLETED|Overall Study||47
10856638|NCT02668874|12022846|FG000|NOT COMPLETED|Overall Study||57
10856639|NCT02668874|12022847|FG001|NOT COMPLETED|Overall Study||57
10856640|NCT02609737|12022853|FG000|STARTED|Overall Study||20
10856641|NCT02609737|12022853|FG000|COMPLETED|Overall Study||20
10856642|NCT02609737|12022853|FG000|NOT COMPLETED|Overall Study||0
10856643|NCT02574286|12022857|FG000|STARTED|Overall Study||21
10856644|NCT02574286|12022857|FG000|COMPLETED|Overall Study||16
10856645|NCT02574286|12022857|FG000|NOT COMPLETED|Overall Study||5
10856646|NCT02471144|12022865|FG000|STARTED|Induction Period (Up to Week 12)||40
10856647|NCT02471144|12022866|FG001|STARTED|Induction Period (Up to Week 12)||40
10856648|NCT02471144|12022867|FG002|STARTED|Induction Period (Up to Week 12)||41
10856649|NCT02471144|12022868|FG003|STARTED|Induction Period (Up to Week 12)||41
10856650|NCT02471144|12022869|FG004|STARTED|Induction Period (Up to Week 12)||0
10856651|NCT02471144|12022870|FG005|STARTED|Induction Period (Up to Week 12)||0
10856652|NCT02471144|12022871|FG006|STARTED|Induction Period (Up to Week 12)||0
10856653|NCT02471144|12022872|FG007|STARTED|Induction Period (Up to Week 12)||0
10856654|NCT02471144|12022873|FG008|STARTED|Induction Period (Up to Week 12)||0
10856655|NCT02471144|12022874|FG009|STARTED|Induction Period (Up to Week 12)||0
10856656|NCT02471144|12022875|FG010|STARTED|Induction Period (Up to Week 12)||0
10856657|NCT02471144|12022865|FG000|COMPLETED|Induction Period (Up to Week 12)||39
10856658|NCT02471144|12022866|FG001|COMPLETED|Induction Period (Up to Week 12)||38
10856659|NCT02471144|12022867|FG002|COMPLETED|Induction Period (Up to Week 12)||39
10856660|NCT02471144|12022868|FG003|COMPLETED|Induction Period (Up to Week 12)||40
10856661|NCT02471144|12022869|FG004|COMPLETED|Induction Period (Up to Week 12)||0
10856662|NCT02471144|12022870|FG005|COMPLETED|Induction Period (Up to Week 12)||0
10856663|NCT02471144|12022871|FG006|COMPLETED|Induction Period (Up to Week 12)||0
10856664|NCT02471144|12022872|FG007|COMPLETED|Induction Period (Up to Week 12)||0
10856665|NCT02471144|12022873|FG008|COMPLETED|Induction Period (Up to Week 12)||0
10856666|NCT02471144|12022874|FG009|COMPLETED|Induction Period (Up to Week 12)||0
10856667|NCT02471144|12022875|FG010|COMPLETED|Induction Period (Up to Week 12)||0
10856668|NCT02471144|12022865|FG000|NOT COMPLETED|Induction Period (Up to Week 12)||1
10856669|NCT02471144|12022866|FG001|NOT COMPLETED|Induction Period (Up to Week 12)||2
10856670|NCT02471144|12022867|FG002|NOT COMPLETED|Induction Period (Up to Week 12)||2
10856671|NCT02471144|12022868|FG003|NOT COMPLETED|Induction Period (Up to Week 12)||1
10856672|NCT02471144|12022869|FG004|NOT COMPLETED|Induction Period (Up to Week 12)||0
10856673|NCT02471144|12022870|FG005|NOT COMPLETED|Induction Period (Up to Week 12)||0
10856674|NCT02471144|12022871|FG006|NOT COMPLETED|Induction Period (Up to Week 12)||0
10856675|NCT02471144|12022872|FG007|NOT COMPLETED|Induction Period (Up to Week 12)||0
10856676|NCT02471144|12022873|FG008|NOT COMPLETED|Induction Period (Up to Week 12)||0
10856677|NCT02471144|12022874|FG009|NOT COMPLETED|Induction Period (Up to Week 12)||0
10856678|NCT02471144|12022875|FG010|NOT COMPLETED|Induction Period (Up to Week 12)||0
10856679|NCT02471144|12022865|FG000|STARTED|Maintenance Period (Week 12 to Week 52)||0
10856680|NCT02471144|12022866|FG001|STARTED|Maintenance Period (Week 12 to Week 52)||0
10856681|NCT02471144|12022867|FG002|STARTED|Maintenance Period (Week 12 to Week 52)||0
10856682|NCT02471144|12022868|FG003|STARTED|Maintenance Period (Week 12 to Week 52)||0
10856683|NCT02471144|12022869|FG004|STARTED|Maintenance Period (Week 12 to Week 52)||39
10856684|NCT02471144|12022870|FG005|STARTED|Maintenance Period (Week 12 to Week 52)||38
10856685|NCT02471144|12022871|FG006|STARTED|Maintenance Period (Week 12 to Week 52)||16
10856686|NCT02471144|12022872|FG007|STARTED|Maintenance Period (Week 12 to Week 52)||18
10856687|NCT02471144|12022873|FG008|STARTED|Maintenance Period (Week 12 to Week 52)||40
10856688|NCT02471144|12022874|FG009|STARTED|Maintenance Period (Week 12 to Week 52)||0
10856689|NCT02471144|12022875|FG010|STARTED|Maintenance Period (Week 12 to Week 52)||0
10856690|NCT02471144|12022865|FG000|COMPLETED|Maintenance Period (Week 12 to Week 52)||0
10856691|NCT02471144|12022866|FG001|COMPLETED|Maintenance Period (Week 12 to Week 52)||0
10856692|NCT02471144|12022867|FG002|COMPLETED|Maintenance Period (Week 12 to Week 52)||0
10856693|NCT02471144|12022868|FG003|COMPLETED|Maintenance Period (Week 12 to Week 52)||0
10856694|NCT02471144|12022869|FG004|COMPLETED|Maintenance Period (Week 12 to Week 52)||38
10856695|NCT02471144|12022870|FG005|COMPLETED|Maintenance Period (Week 12 to Week 52)||37
10856696|NCT02471144|12022871|FG006|COMPLETED|Maintenance Period (Week 12 to Week 52)||15
10856697|NCT02471144|12022872|FG007|COMPLETED|Maintenance Period (Week 12 to Week 52)||16
10856698|NCT02471144|12022873|FG008|COMPLETED|Maintenance Period (Week 12 to Week 52)||34
10856699|NCT02471144|12022874|FG009|COMPLETED|Maintenance Period (Week 12 to Week 52)||0
10856700|NCT02471144|12022875|FG010|COMPLETED|Maintenance Period (Week 12 to Week 52)||0
10856701|NCT02471144|12022865|FG000|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0
10856702|NCT02471144|12022866|FG001|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0
10856703|NCT02471144|12022867|FG002|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0
10856704|NCT02471144|12022868|FG003|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0
10856705|NCT02471144|12022869|FG004|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||1
10856706|NCT02471144|12022870|FG005|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||1
10856707|NCT02471144|12022871|FG006|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||1
10856708|NCT02471144|12022872|FG007|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||2
10856709|NCT02471144|12022873|FG008|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||6
10856710|NCT02471144|12022874|FG009|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0
10856711|NCT02471144|12022875|FG010|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0
10856712|NCT02471144|12022865|FG000|STARTED|Extension Period (Week 52 to Week 236)||0
10856713|NCT02471144|12022866|FG001|STARTED|Extension Period (Week 52 to Week 236)||0
10856714|NCT02471144|12022867|FG002|STARTED|Extension Period (Week 52 to Week 236)||0
10856715|NCT02471144|12022868|FG003|STARTED|Extension Period (Week 52 to Week 236)||0
10856716|NCT02471144|12022869|FG004|STARTED|Extension Period (Week 52 to Week 236)||0
10856717|NCT02471144|12022870|FG005|STARTED|Extension Period (Week 52 to Week 236)||0
10856718|NCT02471144|12022871|FG006|STARTED|Extension Period (Week 52 to Week 236)||0
10856719|NCT02471144|12022872|FG007|STARTED|Extension Period (Week 52 to Week 236)||0
10856720|NCT02471144|12022873|FG008|STARTED|Extension Period (Week 52 to Week 236)||0
10856721|NCT02471144|12022874|FG009|STARTED|Extension Period (Week 52 to Week 236)||53
10415242|NCT00789555|11559763|FG001|COMPLETED|Overall Study||278
10415243|NCT00789555|11559764|FG002|COMPLETED|Overall Study||263
10415244|NCT00789555|11559762|FG000|NOT COMPLETED|Overall Study||159
10415245|NCT00789555|11559763|FG001|NOT COMPLETED|Overall Study||139
10415246|NCT00789555|11559764|FG002|NOT COMPLETED|Overall Study||159
10415247|NCT00789581|11559774|FG000|STARTED|AC Therapy||306
10415248|NCT00789581|11559775|FG001|STARTED|AC Therapy||308
10415249|NCT00789581|11559774|FG000|COMPLETED|AC Therapy||295
10415250|NCT00789581|11559775|FG001|COMPLETED|AC Therapy||291
10415251|NCT00789581|11559774|FG000|NOT COMPLETED|AC Therapy||11
10415252|NCT00789581|11559775|FG001|NOT COMPLETED|AC Therapy||17
10415253|NCT00789581|11559774|FG000|STARTED|Adjuvant Therapy||295
10415254|NCT00789581|11559775|FG001|STARTED|Adjuvant Therapy||291
10415255|NCT00789581|11559774|FG000|COMPLETED|Adjuvant Therapy||255
10415256|NCT00789581|11559775|FG001|COMPLETED|Adjuvant Therapy||234
10415257|NCT00789581|11559774|FG000|NOT COMPLETED|Adjuvant Therapy||40
10415258|NCT00789581|11559775|FG001|NOT COMPLETED|Adjuvant Therapy||57
10415259|NCT00789672|11559784|FG000|STARTED|Overall Study||16
10415260|NCT00789672|11559785|FG001|STARTED|Overall Study||17
10415261|NCT00789672|11559784|FG000|COMPLETED|Overall Study||16
10415262|NCT00789672|11559785|FG001|COMPLETED|Overall Study||17
10415263|NCT00789672|11559784|FG000|NOT COMPLETED|Overall Study||0
10415264|NCT00789672|11559785|FG001|NOT COMPLETED|Overall Study||0
10415265|NCT00789685|11559791|FG000|STARTED|Overall Study||37
10415266|NCT00789685|11559791|FG000|COMPLETED|Overall Study|Completed the study to Day 28|25
10415267|NCT00789685|11559791|FG000|NOT COMPLETED|Overall Study||12
10415268|NCT00789698|11559799|FG000|STARTED|Overall Study||72
10415269|NCT00789698|11559800|FG001|STARTED|Overall Study||79
10415270|NCT00789698|11559801|FG002|STARTED|Overall Study||56
10415271|NCT00789698|11559802|FG003|STARTED|Overall Study||85
10415272|NCT00789698|11559799|FG000|COMPLETED|Overall Study||32
10545676|NCT01499277|11699131|FG000|NOT COMPLETED|Overall Study||47
10545677|NCT01499277|11699132|FG001|NOT COMPLETED|Overall Study||32
10545678|NCT01499290|11699140|FG000|STARTED|Overall Study|Patients dosed in pooled protocols D4280C00001/D4280C00005 (NCT01499290/NCT01500239) agreed with FDA|529
10545679|NCT01499290|11699141|FG001|STARTED|Overall Study|Patients dosed in pooled protocols D4280C00001/D4280C00005 (NCT01499290/NCT01500239) agreed with FDA|529
10545680|NCT01499290|11699140|FG000|COMPLETED|Overall Study|(Numbers indicate patients who completed treatment)|474
10545681|NCT01499290|11699141|FG001|COMPLETED|Overall Study|(Numbers indicate patients who completed treatment)|494
10545682|NCT01499290|11699140|FG000|NOT COMPLETED|Overall Study||55
10545683|NCT01499290|11699141|FG001|NOT COMPLETED|Overall Study||35
10545684|NCT01499303|11699168|FG000|STARTED|Overall Study||21
10545685|NCT01499303|11699169|FG001|STARTED|Overall Study||47
10545686|NCT01499303|11699168|FG000|COMPLETED|Overall Study||18
10545687|NCT01499303|11699169|FG001|COMPLETED|Overall Study||40
10545688|NCT01499303|11699168|FG000|NOT COMPLETED|Overall Study||3
10545689|NCT01499303|11699169|FG001|NOT COMPLETED|Overall Study||7
10545690|NCT01499355|11699175|FG000|STARTED|Run-In Period||276
10545691|NCT01499355|11699176|FG001|STARTED|Run-In Period||0
10545692|NCT01499355|11699177|FG002|STARTED|Run-In Period||0
10545693|NCT01499355|11699178|FG003|STARTED|Run-In Period||0
10545694|NCT01499355|11699175|FG000|COMPLETED|Run-In Period||245
10545695|NCT01499355|11699176|FG001|COMPLETED|Run-In Period||0
10545696|NCT01499355|11699177|FG002|COMPLETED|Run-In Period||0
10545697|NCT01499355|11699178|FG003|COMPLETED|Run-In Period||0
10545698|NCT01499355|11699175|FG000|NOT COMPLETED|Run-In Period||31
10545699|NCT01499355|11699176|FG001|NOT COMPLETED|Run-In Period||0
10545700|NCT01499355|11699177|FG002|NOT COMPLETED|Run-In Period||0
10545701|NCT01499355|11699178|FG003|NOT COMPLETED|Run-In Period||0
10545702|NCT01499355|11699175|FG000|STARTED|Double-Blind Period||0
10545703|NCT01499355|11699176|FG001|STARTED|Double-Blind Period||63
10545704|NCT01499355|11699177|FG002|STARTED|Double-Blind Period||63
10545705|NCT01499355|11699178|FG003|STARTED|Double-Blind Period||62
10415273|NCT00789698|11559800|FG001|COMPLETED|Overall Study||46
10415274|NCT00789698|11559801|FG002|COMPLETED|Overall Study||29
10415275|NCT00789698|11559802|FG003|COMPLETED|Overall Study||33
10856722|NCT02471144|12022875|FG010|STARTED|Extension Period (Week 52 to Week 236)||53
10856723|NCT02471144|12022865|FG000|COMPLETED|Extension Period (Week 52 to Week 236)||0
10856724|NCT02471144|12022866|FG001|COMPLETED|Extension Period (Week 52 to Week 236)||0
10856725|NCT02471144|12022867|FG002|COMPLETED|Extension Period (Week 52 to Week 236)||0
10856726|NCT02471144|12022868|FG003|COMPLETED|Extension Period (Week 52 to Week 236)||0
10856727|NCT02471144|12022869|FG004|COMPLETED|Extension Period (Week 52 to Week 236)||0
10856728|NCT02471144|12022870|FG005|COMPLETED|Extension Period (Week 52 to Week 236)||0
10856729|NCT02471144|12022871|FG006|COMPLETED|Extension Period (Week 52 to Week 236)||0
10856730|NCT02471144|12022872|FG007|COMPLETED|Extension Period (Week 52 to Week 236)||0
10856731|NCT02471144|12022873|FG008|COMPLETED|Extension Period (Week 52 to Week 236)||0
10856732|NCT02471144|12022874|FG009|COMPLETED|Extension Period (Week 52 to Week 236)||46
10856733|NCT02471144|12022875|FG010|COMPLETED|Extension Period (Week 52 to Week 236)||49
10415276|NCT00789698|11559799|FG000|NOT COMPLETED|Overall Study||40
10415277|NCT00789698|11559800|FG001|NOT COMPLETED|Overall Study||33
10415278|NCT00789698|11559801|FG002|NOT COMPLETED|Overall Study||27
10415279|NCT00789698|11559802|FG003|NOT COMPLETED|Overall Study||52
10415280|NCT00789724|11559813|FG000|STARTED|Overall Study||5
10415281|NCT00789724|11559814|FG001|STARTED|Overall Study||5
10415282|NCT00789724|11559813|FG000|COMPLETED|Overall Study||5
10415283|NCT00789724|11559814|FG001|COMPLETED|Overall Study||5
10415284|NCT00789724|11559813|FG000|NOT COMPLETED|Overall Study||0
10415285|NCT00789724|11559814|FG001|NOT COMPLETED|Overall Study||0
10415286|NCT00789737|11559822|FG000|STARTED|Overall Study||176
10415287|NCT00789737|11559823|FG001|STARTED|Overall Study||181
10415288|NCT00789737|11559822|FG000|COMPLETED|Overall Study||128
10415289|NCT00789737|11559823|FG001|COMPLETED|Overall Study||126
10415290|NCT00789737|11559822|FG000|NOT COMPLETED|Overall Study||48
10415291|NCT00789737|11559823|FG001|NOT COMPLETED|Overall Study||55
10415292|NCT00789750|11559831|FG000|STARTED|Overall Study||280
10415293|NCT00789750|11559832|FG001|STARTED|Overall Study||282
10415294|NCT00789750|11559831|FG000|Dropped During run-in Period|Overall Study||6
10415295|NCT00789750|11559832|FG001|Dropped During run-in Period|Overall Study||5
10415296|NCT00789750|11559831|FG000|Safety Set|Overall Study||274
10415297|NCT00789750|11559832|FG001|Safety Set|Overall Study||277
10415298|NCT00789750|11559831|FG000|Intent to Treat Set|Overall Study||271
10415299|NCT00789750|11559832|FG001|Intent to Treat Set|Overall Study||276
10415300|NCT00789750|11559831|FG000|COMPLETED|Overall Study||221
10415301|NCT00789750|11559832|FG001|COMPLETED|Overall Study||222
10415302|NCT00789750|11559831|FG000|NOT COMPLETED|Overall Study||59
10415303|NCT00789750|11559832|FG001|NOT COMPLETED|Overall Study||60
10415304|NCT00789776|11559840|FG000|STARTED|Overall Study||5
10415305|NCT00789776|11559841|FG001|STARTED|Overall Study||36
10415306|NCT00789776|11559840|FG000|COMPLETED|Overall Study||5
10415307|NCT00789776|11559841|FG001|COMPLETED|Overall Study||35
10415308|NCT00789776|11559840|FG000|NOT COMPLETED|Overall Study||0
10415309|NCT00789776|11559841|FG001|NOT COMPLETED|Overall Study||1
10415310|NCT00789802|11559850|FG000|STARTED|Overall Study||44
10415311|NCT00789802|11559851|FG001|STARTED|Overall Study||42
10415312|NCT00789802|11559852|FG002|STARTED|Overall Study||43
10415313|NCT00789802|11559850|FG000|COMPLETED|Overall Study||34
10415314|NCT00789802|11559851|FG001|COMPLETED|Overall Study||35
10415315|NCT00789802|11559852|FG002|COMPLETED|Overall Study||37
10415316|NCT00789802|11559850|FG000|NOT COMPLETED|Overall Study||10
10415317|NCT00789802|11559851|FG001|NOT COMPLETED|Overall Study||7
10415318|NCT00789802|11559852|FG002|NOT COMPLETED|Overall Study||6
10415319|NCT00789815|11559865|FG000|STARTED|Overall Study||250
10415320|NCT00789815|11559866|FG001|STARTED|Overall Study||250
10415321|NCT00789815|11559865|FG000|COMPLETED|Overall Study||243
10415322|NCT00789815|11559866|FG001|COMPLETED|Overall Study||249
10415323|NCT00789815|11559865|FG000|NOT COMPLETED|Overall Study||7
10415324|NCT00789815|11559866|FG001|NOT COMPLETED|Overall Study||1
10415325|NCT00789828|11559874|FG000|STARTED|Core Period (48 Weeks)||78
10415326|NCT00789828|11559875|FG001|STARTED|Core Period (48 Weeks)||39
10415327|NCT00789828|11559874|FG000|COMPLETED|Core Period (48 Weeks)||78
10755135|NCT03061214|11918935|FG002|Exposed|Overall Study||290
10755136|NCT03061214|11918933|FG000|Full Analysis Set (FAS)|Overall Study||288
10755137|NCT03061214|11918934|FG001|Full Analysis Set (FAS)|Overall Study||290
10755138|NCT03061214|11918935|FG002|Full Analysis Set (FAS)|Overall Study||290
10755139|NCT03061214|11918933|FG000|Safety Analysis Set (SAS)|Overall Study||287
10755140|NCT03061214|11918934|FG001|Safety Analysis Set (SAS)|Overall Study||290
10755141|NCT03061214|11918935|FG002|Safety Analysis Set (SAS)|Overall Study||290
10755142|NCT03061214|11918933|FG000|COMPLETED|Overall Study||263
10755143|NCT03061214|11918934|FG001|COMPLETED|Overall Study||262
10755144|NCT03061214|11918935|FG002|COMPLETED|Overall Study||280
10755145|NCT03061214|11918933|FG000|NOT COMPLETED|Overall Study||25
10415328|NCT00789828|11559875|FG001|COMPLETED|Core Period (48 Weeks)||33
10415329|NCT00789828|11559874|FG000|NOT COMPLETED|Core Period (48 Weeks)||0
10755146|NCT03061214|11918934|FG001|NOT COMPLETED|Overall Study||28
10755147|NCT03061214|11918935|FG002|NOT COMPLETED|Overall Study||10
10755148|NCT03061331|11918945|FG000|STARTED|Treatment Period 1 (8 Weeks)||10
10755149|NCT03061331|11918946|FG001|STARTED|Treatment Period 1 (8 Weeks)||10
10415330|NCT00789828|11559875|FG001|NOT COMPLETED|Core Period (48 Weeks)||6
10415331|NCT00789828|11559874|FG000|STARTED|Open-label Extension Period (4 Years)|Of 117 participants only 111 completed the core period and continued in the extension period|111
10415332|NCT00789828|11559875|FG001|STARTED|Open-label Extension Period (4 Years)|No participant received placebo.|0
10755150|NCT03061331|11918945|FG000|COMPLETED|Treatment Period 1 (8 Weeks)||10
10856734|NCT02471144|12022865|FG000|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
10856735|NCT02471144|12022866|FG001|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
10856736|NCT02471144|12022867|FG002|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
10856737|NCT02471144|12022868|FG003|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
10856738|NCT02471144|12022869|FG004|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
10856739|NCT02471144|12022870|FG005|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
10856740|NCT02471144|12022871|FG006|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
10856741|NCT02471144|12022872|FG007|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
10856742|NCT02471144|12022873|FG008|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
10856743|NCT02471144|12022874|FG009|NOT COMPLETED|Extension Period (Week 52 to Week 236)||7
10856744|NCT02471144|12022875|FG010|NOT COMPLETED|Extension Period (Week 52 to Week 236)||4
10856745|NCT02440464|12022893|FG000|STARTED|Overall Study||21
10856746|NCT02440464|12022894|FG001|STARTED|Overall Study||22
10856747|NCT02440464|12022893|FG000|COMPLETED|Overall Study||18
10856748|NCT02440464|12022894|FG001|COMPLETED|Overall Study||20
10856749|NCT02440464|12022893|FG000|NOT COMPLETED|Overall Study||3
10856750|NCT02440464|12022894|FG001|NOT COMPLETED|Overall Study||2
10856751|NCT02384421|12022901|FG000|STARTED|Overall Study||22
10856752|NCT02384421|12022901|FG000|COMPLETED|Overall Study||22
10856753|NCT02384421|12022901|FG000|NOT COMPLETED|Overall Study||0
10856754|NCT02366728|12022911|FG000|STARTED|Overall Study||27
10856755|NCT02366728|12022912|FG001|STARTED|Overall Study||28
10856756|NCT02366728|12022913|FG002|STARTED|Overall Study||9
10856757|NCT02366728|12022911|FG000|Received at Least One ppp65 Vaccine|Overall Study||25
10856758|NCT02366728|12022912|FG001|Received at Least One ppp65 Vaccine|Overall Study||27
10856759|NCT02366728|12022913|FG002|Received at Least One ppp65 Vaccine|Overall Study||8
10856760|NCT02366728|12022911|FG000|COMPLETED|Overall Study||23
10856761|NCT02366728|12022912|FG001|COMPLETED|Overall Study||27
10856762|NCT02366728|12022913|FG002|COMPLETED|Overall Study||8
10856763|NCT02366728|12022911|FG000|NOT COMPLETED|Overall Study||4
10856764|NCT02366728|12022912|FG001|NOT COMPLETED|Overall Study||1
10856765|NCT02366728|12022913|FG002|NOT COMPLETED|Overall Study||1
10856766|NCT02236572|12022921|FG000|STARTED|Overall Study||17
10856767|NCT02236572|12022921|FG000|COMPLETED|Overall Study||14
10856768|NCT02236572|12022921|FG000|NOT COMPLETED|Overall Study||3
10856769|NCT02083354|12022925|FG000|STARTED|Overall Study||77
10856770|NCT02083354|12022925|FG000|COMPLETED|Overall Study||13
10856771|NCT02083354|12022925|FG000|NOT COMPLETED|Overall Study||64
10856772|NCT01775813|12022933|FG000|STARTED|Overall Study||47
10856773|NCT01775813|12022934|FG001|STARTED|Overall Study||13
10856774|NCT01775813|12022935|FG002|STARTED|Overall Study||24
10856775|NCT01775813|12022936|FG003|STARTED|Overall Study||20
10856776|NCT01775813|12022933|FG000|Study Visit 2 (Tanner 4)|Overall Study||36
10856777|NCT01775813|12022934|FG001|Study Visit 2 (Tanner 4)|Overall Study||4
10856778|NCT01775813|12022935|FG002|Study Visit 2 (Tanner 4)|Overall Study||11
10856779|NCT01775813|12022936|FG003|Study Visit 2 (Tanner 4)|Overall Study||11
10856780|NCT01775813|12022933|FG000|Study Visit 3 (Tanner 5)|Overall Study||34
10856781|NCT01775813|12022934|FG001|Study Visit 3 (Tanner 5)|Overall Study||8
10856782|NCT01775813|12022935|FG002|Study Visit 3 (Tanner 5)|Overall Study||12
10856783|NCT01775813|12022936|FG003|Study Visit 3 (Tanner 5)|Overall Study||11
10856784|NCT01775813|12022933|FG000|Study Visit 4 (Post-Puberty)|Overall Study||10
10856785|NCT01775813|12022934|FG001|Study Visit 4 (Post-Puberty)|Overall Study||0
10856786|NCT01775813|12022935|FG002|Study Visit 4 (Post-Puberty)|Overall Study||13
10856787|NCT01775813|12022936|FG003|Study Visit 4 (Post-Puberty)|Overall Study||11
10856788|NCT01775813|12022933|FG000|COMPLETED|Overall Study||34
10856789|NCT01775813|12022934|FG001|COMPLETED|Overall Study||8
10856790|NCT01775813|12022935|FG002|COMPLETED|Overall Study||12
10856791|NCT01775813|12022936|FG003|COMPLETED|Overall Study||11
10415333|NCT00789828|11559874|FG000|COMPLETED|Open-label Extension Period (4 Years)||82
10415334|NCT00789828|11559875|FG001|COMPLETED|Open-label Extension Period (4 Years)||0
10415335|NCT00789828|11559874|FG000|NOT COMPLETED|Open-label Extension Period (4 Years)||29
10415336|NCT00789828|11559875|FG001|NOT COMPLETED|Open-label Extension Period (4 Years)||0
10415337|NCT00789854|11559887|FG000|STARTED|Overall Study||228
10415338|NCT00789854|11559888|FG001|STARTED|Overall Study||231
10415339|NCT00789854|11559889|FG002|STARTED|Overall Study||229
10415340|NCT00789854|11559887|FG000|COMPLETED|Overall Study||179
10415341|NCT00789854|11559888|FG001|COMPLETED|Overall Study||196
10415342|NCT00789854|11559889|FG002|COMPLETED|Overall Study||182
10415343|NCT00789854|11559887|FG000|NOT COMPLETED|Overall Study||49
10545706|NCT01499355|11699175|FG000|COMPLETED|Double-Blind Period||0
10856792|NCT01775813|12022933|FG000|NOT COMPLETED|Overall Study||13
10856793|NCT01775813|12022934|FG001|NOT COMPLETED|Overall Study||5
10856794|NCT01775813|12022935|FG002|NOT COMPLETED|Overall Study||12
10856795|NCT01775813|12022936|FG003|NOT COMPLETED|Overall Study||9
10856796|NCT01694069|12022953|FG000|STARTED|Overall Study||6
10856797|NCT01694069|12022953|FG000|COMPLETED|Overall Study||6
10856798|NCT01694069|12022953|FG000|NOT COMPLETED|Overall Study||0
10856799|NCT01446016|12022959|FG000|STARTED|Overall Study||38
10856800|NCT01446016|12022959|FG000|COMPLETED|Overall Study||31
10856801|NCT01446016|12022959|FG000|NOT COMPLETED|Overall Study||7
10856802|NCT01445327|12022966|FG000|STARTED|Overall Study||3
10856803|NCT01445327|12022967|FG001|STARTED|Overall Study||1
10415344|NCT00789854|11559888|FG001|NOT COMPLETED|Overall Study||35
10415345|NCT00789854|11559889|FG002|NOT COMPLETED|Overall Study||47
10415346|NCT00789867|11559900|FG000|STARTED|Overall Study||17
10415347|NCT00789867|11559901|FG001|STARTED|Overall Study||10
10856804|NCT01445327|12022968|FG002|STARTED|Overall Study||5
10856805|NCT01445327|12022966|FG000|COMPLETED|Overall Study||3
10856806|NCT01445327|12022967|FG001|COMPLETED|Overall Study||1
10856807|NCT01445327|12022968|FG002|COMPLETED|Overall Study||5
10856808|NCT01445327|12022966|FG000|NOT COMPLETED|Overall Study||0
10856809|NCT01445327|12022967|FG001|NOT COMPLETED|Overall Study||0
10856810|NCT01445327|12022968|FG002|NOT COMPLETED|Overall Study||0
10856811|NCT01411332|12022978|FG000|STARTED|Overall Study||10
10856812|NCT01411332|12022979|FG001|STARTED|Overall Study||9
10856813|NCT01411332|12022978|FG000|COMPLETED|Overall Study||8
10856814|NCT01411332|12022979|FG001|COMPLETED|Overall Study||7
10856815|NCT01411332|12022978|FG000|NOT COMPLETED|Overall Study||2
10856816|NCT01411332|12022979|FG001|NOT COMPLETED|Overall Study||2
10856817|NCT01399918|12022985|FG000|STARTED|Overall Study||57
10856818|NCT01399918|12022985|FG000|COMPLETED|Overall Study||55
10856819|NCT01399918|12022985|FG000|NOT COMPLETED|Overall Study||2
10856820|NCT01377753|12022989|FG000|STARTED|Overall Study||15
10856821|NCT01377753|12022989|FG000|COMPLETED|Overall Study||15
10856822|NCT01377753|12022989|FG000|NOT COMPLETED|Overall Study||0
10856823|NCT01147653|12022995|FG000|STARTED|Year 1||32
10856824|NCT01147653|12022996|FG001|STARTED|Year 1||31
10856825|NCT01147653|12022995|FG000|COMPLETED|Year 1||32
10856826|NCT01147653|12022996|FG001|COMPLETED|Year 1||31
10856827|NCT01147653|12022995|FG000|NOT COMPLETED|Year 1||0
10856828|NCT01147653|12022996|FG001|NOT COMPLETED|Year 1||0
10856829|NCT01147653|12022995|FG000|STARTED|Year 2||32
10856830|NCT01147653|12022996|FG001|STARTED|Year 2||31
10415348|NCT00789867|11559902|FG002|STARTED|Overall Study||8
10415349|NCT00789867|11559900|FG000|COMPLETED|Overall Study||17
10415350|NCT00789867|11559901|FG001|COMPLETED|Overall Study||10
10415351|NCT00789867|11559902|FG002|COMPLETED|Overall Study||8
10415352|NCT00789867|11559900|FG000|NOT COMPLETED|Overall Study||0
10415353|NCT00789867|11559901|FG001|NOT COMPLETED|Overall Study||0
10415354|NCT00789867|11559902|FG002|NOT COMPLETED|Overall Study||0
10415355|NCT00789880|11559917|FG000|STARTED|Overall Study||16
10415356|NCT00789880|11559918|FG001|STARTED|Overall Study||16
10415357|NCT00789880|11559919|FG002|STARTED|Overall Study||8
10415358|NCT00789880|11559920|FG003|STARTED|Overall Study||16
10415359|NCT00789880|11559921|FG004|STARTED|Overall Study||18
10415360|NCT00789880|11559922|FG005|STARTED|Overall Study||8
10415361|NCT00789880|11559917|FG000|COMPLETED|Overall Study||15
10415362|NCT00789880|11559918|FG001|COMPLETED|Overall Study||15
10415363|NCT00789880|11559919|FG002|COMPLETED|Overall Study||8
10415364|NCT00789880|11559920|FG003|COMPLETED|Overall Study||15
10415365|NCT00789880|11559921|FG004|COMPLETED|Overall Study||15
10415366|NCT00789880|11559922|FG005|COMPLETED|Overall Study||8
10415367|NCT00789880|11559917|FG000|NOT COMPLETED|Overall Study||1
10415368|NCT00789880|11559918|FG001|NOT COMPLETED|Overall Study||1
10415369|NCT00789880|11559919|FG002|NOT COMPLETED|Overall Study||0
10415370|NCT00789880|11559920|FG003|NOT COMPLETED|Overall Study||1
10415371|NCT00789880|11559921|FG004|NOT COMPLETED|Overall Study||3
10415372|NCT00789880|11559922|FG005|NOT COMPLETED|Overall Study||0
10415373|NCT00789958|11559936|FG000|STARTED|Overall Study||105
10415374|NCT00789958|11559936|FG000|Eligible and Analyzable|Overall Study||79
10415375|NCT00789958|11559936|FG000|COMPLETED|Overall Study||68
10415376|NCT00789958|11559936|FG000|NOT COMPLETED|Overall Study||37
10415377|NCT00789997|11559944|FG000|STARTED|Overall Study||41
10415378|NCT00789997|11559945|FG001|STARTED|Overall Study||40
10415379|NCT00789997|11559944|FG000|COMPLETED|Overall Study||40
10415380|NCT00789997|11559945|FG001|COMPLETED|Overall Study||38
10415381|NCT00789997|11559944|FG000|NOT COMPLETED|Overall Study||1
10415382|NCT00789997|11559945|FG001|NOT COMPLETED|Overall Study||2
10415383|NCT00790023|11559954|FG000|STARTED|Overall Study||237
10415384|NCT00790023|11559955|FG001|STARTED|Overall Study||235
10415385|NCT00790023|11559956|FG002|STARTED|Overall Study||235
10415386|NCT00790023|11559954|FG000|COMPLETED|Overall Study||226
10415387|NCT00790023|11559955|FG001|COMPLETED|Overall Study||225
10415388|NCT00790023|11559956|FG002|COMPLETED|Overall Study||214
10415389|NCT00790023|11559954|FG000|NOT COMPLETED|Overall Study||11
10415390|NCT00790023|11559955|FG001|NOT COMPLETED|Overall Study||10
10415391|NCT00790023|11559956|FG002|NOT COMPLETED|Overall Study||21
10415392|NCT00790036|11559967|FG000|STARTED|Overall Study||372
10415393|NCT00790036|11559968|FG001|STARTED|Overall Study||370
10415394|NCT00790036|11559967|FG000|Untreated Participants|Overall Study|not treated due to administrative problems, protocol deviation, and subject withdrawal of consent.|4
10415395|NCT00790036|11559968|FG001|Untreated Participants|Overall Study|not treated due to administrative problems and subject withdrawal of consent.|6
10415396|NCT00790036|11559967|FG000|COMPLETED|Overall Study|completed = treatment duration completed as per protocol|177
10415397|NCT00790036|11559968|FG001|COMPLETED|Overall Study|completed = treatment duration completed as per protocol|249
10415398|NCT00790036|11559967|FG000|NOT COMPLETED|Overall Study||195
10415399|NCT00790036|11559968|FG001|NOT COMPLETED|Overall Study||121
10415400|NCT00790062|11559978|FG000|STARTED|Overall Study||659
10415401|NCT00790062|11559979|FG001|STARTED|Overall Study||481
10856831|NCT01147653|12022995|FG000|COMPLETED|Year 2||30
10856832|NCT01147653|12022996|FG001|COMPLETED|Year 2||28
10415402|NCT00790062|11559980|FG002|STARTED|Overall Study||658
10415403|NCT00790062|11559978|FG000|COMPLETED|Overall Study||659
10415404|NCT00790062|11559979|FG001|COMPLETED|Overall Study||481
10415405|NCT00790062|11559980|FG002|COMPLETED|Overall Study||658
10415406|NCT00790062|11559978|FG000|NOT COMPLETED|Overall Study||0
10856833|NCT01147653|12022995|FG000|NOT COMPLETED|Year 2||2
10856834|NCT01147653|12022996|FG001|NOT COMPLETED|Year 2||3
10856835|NCT01078454|12023016|FG000|STARTED|Overall Study||6
10856836|NCT01078454|12023017|FG001|STARTED|Overall Study||5
10856837|NCT01078454|12023016|FG000|COMPLETED|Overall Study||5
10856838|NCT01078454|12023017|FG001|COMPLETED|Overall Study||3
10856839|NCT01078454|12023016|FG000|NOT COMPLETED|Overall Study||1
10856840|NCT01078454|12023017|FG001|NOT COMPLETED|Overall Study||2
10856841|NCT00687596|12023025|FG000|STARTED|Overall Study||26
10856842|NCT00687596|12023026|FG001|STARTED|Overall Study||26
10856843|NCT00687596|12023025|FG000|COMPLETED|Overall Study||0
10856844|NCT00687596|12023026|FG001|COMPLETED|Overall Study||0
10856845|NCT00687596|12023025|FG000|NOT COMPLETED|Overall Study||26
10856846|NCT00687596|12023026|FG001|NOT COMPLETED|Overall Study||26
10856847|NCT00458536|12023032|FG000|STARTED|Overall Study||38
10856848|NCT00458536|12023032|FG000|COMPLETED|Overall Study||19
10856849|NCT00458536|12023032|FG000|NOT COMPLETED|Overall Study||19
10856850|NCT00112840|12023039|FG000|STARTED|Overall Study||8
10856851|NCT00112840|12023040|FG001|STARTED|Overall Study||6
10856852|NCT00112840|12023041|FG002|STARTED|Overall Study||46
10856853|NCT00112840|12023039|FG000|COMPLETED|Overall Study||6
10856854|NCT00112840|12023040|FG001|COMPLETED|Overall Study||6
10856855|NCT00112840|12023041|FG002|COMPLETED|Overall Study||40
10856856|NCT00112840|12023039|FG000|NOT COMPLETED|Overall Study||2
10856857|NCT00112840|12023040|FG001|NOT COMPLETED|Overall Study||0
10856858|NCT00112840|12023041|FG002|NOT COMPLETED|Overall Study||6
10293412|NCT04402866|11425996|FG000|STARTED|Overall Study||6
10856859|NCT04957732|12023056|FG000|STARTED|Overall Study||19
10856860|NCT04957732|12023057|FG001|STARTED|Overall Study||16
10856861|NCT04957732|12023056|FG000|COMPLETED|Overall Study||18
10856862|NCT04957732|12023057|FG001|COMPLETED|Overall Study||12
10856863|NCT04957732|12023056|FG000|NOT COMPLETED|Overall Study||1
10856864|NCT04957732|12023057|FG001|NOT COMPLETED|Overall Study||4
10856865|NCT04207749|12023070|FG000|STARTED|Overall Study||78
10856866|NCT04207749|12023071|FG001|STARTED|Overall Study||156
10856867|NCT04207749|12023070|FG000|COMPLETED|Overall Study||74
10856868|NCT04207749|12023071|FG001|COMPLETED|Overall Study||149
10856869|NCT04207749|12023070|FG000|NOT COMPLETED|Overall Study||4
10856870|NCT04207749|12023071|FG001|NOT COMPLETED|Overall Study||7
10856871|NCT04167345|12023085|FG000|STARTED|Overall Study||10
10856872|NCT04167345|12023086|FG001|STARTED|Overall Study||4
10856873|NCT04167345|12023087|FG002|STARTED|Overall Study||3
10856874|NCT04167345|12023088|FG003|STARTED|Overall Study||13
10856875|NCT04167345|12023089|FG004|STARTED|Overall Study||18
10856876|NCT04167345|12023085|FG000|COMPLETED|Overall Study||9
10856877|NCT04167345|12023086|FG001|COMPLETED|Overall Study||3
10856878|NCT04167345|12023087|FG002|COMPLETED|Overall Study||3
10856879|NCT04167345|12023088|FG003|COMPLETED|Overall Study||13
10856880|NCT04167345|12023089|FG004|COMPLETED|Overall Study||18
10856881|NCT04167345|12023085|FG000|NOT COMPLETED|Overall Study||1
10856882|NCT04167345|12023086|FG001|NOT COMPLETED|Overall Study||1
10856883|NCT04167345|12023087|FG002|NOT COMPLETED|Overall Study||0
10856884|NCT04167345|12023088|FG003|NOT COMPLETED|Overall Study||0
10856885|NCT04167345|12023089|FG004|NOT COMPLETED|Overall Study||0
10856886|NCT04042077|12023107|FG000|STARTED|Overall Study||134
10856887|NCT04042077|12023108|FG001|STARTED|Overall Study||132
10856888|NCT04042077|12023107|FG000|Vancomycin IV|Overall Study||0
10856889|NCT04042077|12023108|FG001|Vancomycin IV|Overall Study||2
10856890|NCT04042077|12023107|FG000|Linezolid IV, With the Option to Switch to Linezolid Oral|Overall Study||0
10856891|NCT04042077|12023108|FG001|Linezolid IV, With the Option to Switch to Linezolid Oral|Overall Study||8
10856892|NCT04042077|12023107|FG000|Piperacillin/Tazobactam IV|Overall Study||0
10856893|NCT04042077|12023108|FG001|Piperacillin/Tazobactam IV|Overall Study||68
10856894|NCT04042077|12023107|FG000|Tigecycline IV|Overall Study||0
10856895|NCT04042077|12023108|FG001|Tigecycline IV|Overall Study||54
10856896|NCT04042077|12023107|FG000|COMPLETED|Overall Study||127
10856897|NCT04042077|12023108|FG001|COMPLETED|Overall Study||127
10856898|NCT04042077|12023107|FG000|NOT COMPLETED|Overall Study||7
10856899|NCT04042077|12023108|FG001|NOT COMPLETED|Overall Study||5
10856900|NCT04001803|12023120|FG000|STARTED|Overall Study||115
10856901|NCT04001803|12023120|FG000|COMPLETED|Overall Study||1
10856902|NCT04001803|12023120|FG000|NOT COMPLETED|Overall Study||114
10856903|NCT03936699|12023127|FG000|STARTED|Overall Study||83
10856904|NCT03936699|12023128|FG001|STARTED|Overall Study||78
10856905|NCT03936699|12023127|FG000|COMPLETED|Overall Study||61
10856906|NCT03936699|12023128|FG001|COMPLETED|Overall Study||55
10856907|NCT03936699|12023127|FG000|NOT COMPLETED|Overall Study||22
10856908|NCT03936699|12023128|FG001|NOT COMPLETED|Overall Study||23
10856909|NCT03925324|12023136|FG000|STARTED|Overall Study||2
10856910|NCT03925324|12023137|FG001|STARTED|Overall Study||2
10856911|NCT03925324|12023136|FG000|COMPLETED|Overall Study||1
10856912|NCT03925324|12023137|FG001|COMPLETED|Overall Study||1
10856913|NCT03925324|12023136|FG000|NOT COMPLETED|Overall Study||1
10856914|NCT03925324|12023137|FG001|NOT COMPLETED|Overall Study||1
10856925|NCT03814382|12023152|FG000|STARTED|Overall Study||10
10856926|NCT03814382|12023152|FG000|COMPLETED|Overall Study||10
10856927|NCT03814382|12023152|FG000|NOT COMPLETED|Overall Study||0
10856928|NCT03740009|12023156|FG000|STARTED|Overall Study||20
10856929|NCT03740009|12023156|FG000|Consented|Overall Study||20
10856930|NCT03740009|12023156|FG000|Received Intervention|Overall Study||10
10856931|NCT03740009|12023156|FG000|COMPLETED|Overall Study||10
10856932|NCT03740009|12023156|FG000|NOT COMPLETED|Overall Study||10
10856933|NCT03738397|12023162|FG000|STARTED|Overall Study||344
10856934|NCT03738397|12023163|FG001|STARTED|Overall Study||348
10856935|NCT03738397|12023162|FG000|COMPLETED|Overall Study||320
10856936|NCT03738397|12023163|FG001|COMPLETED|Overall Study||318
10856937|NCT03738397|12023162|FG000|NOT COMPLETED|Overall Study||24
10856938|NCT03738397|12023163|FG001|NOT COMPLETED|Overall Study||30
10856939|NCT03666624|12023171|FG000|STARTED|Overall Study||15
10856940|NCT03666624|12023172|FG001|STARTED|Overall Study||15
10856941|NCT03666624|12023171|FG000|COMPLETED|Overall Study||14
10856942|NCT03666624|12023172|FG001|COMPLETED|Overall Study||15
10856943|NCT03666624|12023171|FG000|NOT COMPLETED|Overall Study||1
10856944|NCT03666624|12023172|FG001|NOT COMPLETED|Overall Study||0
10856945|NCT03649217|12023178|FG000|STARTED|Overall Study||23
10856946|NCT03649217|12023178|FG000|COMPLETED|Overall Study||21
10856947|NCT03649217|12023178|FG000|NOT COMPLETED|Overall Study||2
10856948|NCT03569293|12023188|FG000|STARTED|Overall Study||241
10856949|NCT03569293|12023189|FG001|STARTED|Overall Study||239
10856950|NCT03569293|12023190|FG002|STARTED|Overall Study||243
10856951|NCT03569293|12023191|FG003|STARTED|Overall Study||61
10856952|NCT03569293|12023192|FG004|STARTED|Overall Study||64
10856953|NCT03569293|12023193|FG005|STARTED|Overall Study||64
10856954|NCT03569293|12023188|FG000|Received Study Drug|Overall Study||241
10856955|NCT03569293|12023189|FG001|Received Study Drug|Overall Study||239
10856956|NCT03569293|12023190|FG002|Received Study Drug|Overall Study||243
10856957|NCT03569293|12023191|FG003|Received Study Drug|Overall Study||61
10856958|NCT03569293|12023192|FG004|Received Study Drug|Overall Study||64
10856959|NCT03569293|12023193|FG005|Received Study Drug|Overall Study||64
10856960|NCT03569293|12023188|FG000|COMPLETED|Overall Study||204
10856961|NCT03569293|12023189|FG001|COMPLETED|Overall Study||230
10856962|NCT03569293|12023190|FG002|COMPLETED|Overall Study||229
10856963|NCT03569293|12023191|FG003|COMPLETED|Overall Study||57
10856964|NCT03569293|12023192|FG004|COMPLETED|Overall Study||64
10856965|NCT03569293|12023193|FG005|COMPLETED|Overall Study||64
10856966|NCT03569293|12023188|FG000|NOT COMPLETED|Overall Study||37
10856967|NCT03569293|12023189|FG001|NOT COMPLETED|Overall Study||9
10856968|NCT03569293|12023190|FG002|NOT COMPLETED|Overall Study||14
10856969|NCT03569293|12023191|FG003|NOT COMPLETED|Overall Study||4
10856970|NCT03569293|12023192|FG004|NOT COMPLETED|Overall Study||0
10856971|NCT03569293|12023193|FG005|NOT COMPLETED|Overall Study||0
10856972|NCT03564353|12023211|FG000|STARTED|Overall Study||10
10856973|NCT03564353|12023212|FG001|STARTED|Overall Study||10
10856974|NCT03564353|12023213|FG002|STARTED|Overall Study||10
10856975|NCT03564353|12023214|FG003|STARTED|Overall Study||10
10856976|NCT03564353|12023211|FG000|COMPLETED|Overall Study||10
10856977|NCT03564353|12023212|FG001|COMPLETED|Overall Study||10
10856978|NCT03564353|12023213|FG002|COMPLETED|Overall Study||10
10856979|NCT03564353|12023214|FG003|COMPLETED|Overall Study||10
10856980|NCT03564353|12023211|FG000|NOT COMPLETED|Overall Study||0
10856981|NCT03564353|12023212|FG001|NOT COMPLETED|Overall Study||0
10856982|NCT03564353|12023213|FG002|NOT COMPLETED|Overall Study||0
10856983|NCT03564353|12023214|FG003|NOT COMPLETED|Overall Study||0
10856984|NCT03541499|12023228|FG000|STARTED|Overall Study||15
10856985|NCT03541499|12023229|FG001|STARTED|Overall Study||15
10856986|NCT03541499|12023230|FG002|STARTED|Overall Study||5
10856987|NCT03541499|12023231|FG003|STARTED|Overall Study||15
10856988|NCT03541499|12023228|FG000|COMPLETED|Overall Study||15
10856989|NCT03541499|12023229|FG001|COMPLETED|Overall Study||15
10856990|NCT03541499|12023230|FG002|COMPLETED|Overall Study||5
10856991|NCT03541499|12023231|FG003|COMPLETED|Overall Study||15
10856992|NCT03541499|12023228|FG000|NOT COMPLETED|Overall Study||0
10856993|NCT03541499|12023229|FG001|NOT COMPLETED|Overall Study||0
10856994|NCT03541499|12023230|FG002|NOT COMPLETED|Overall Study||0
10856995|NCT03541499|12023231|FG003|NOT COMPLETED|Overall Study||0
10293413|NCT04402866|11425997|FG001|STARTED|Overall Study||6
10293414|NCT04402866|11425998|FG002|STARTED|Overall Study||7
10293415|NCT04402866|11425999|FG003|STARTED|Overall Study||6
10293416|NCT04402866|11426000|FG004|STARTED|Overall Study||104
10293417|NCT04402866|11426001|FG005|STARTED|Overall Study||106
10293418|NCT04402866|11425996|FG000|Randomized and Treated With Study Drug|Overall Study||6
10293419|NCT04402866|11425997|FG001|Randomized and Treated With Study Drug|Overall Study||6
10293420|NCT04402866|11425998|FG002|Randomized and Treated With Study Drug|Overall Study||7
10293421|NCT04402866|11425999|FG003|Randomized and Treated With Study Drug|Overall Study||6
10293422|NCT04402866|11426000|FG004|Randomized and Treated With Study Drug|Overall Study||102
10293423|NCT04402866|11426001|FG005|Randomized and Treated With Study Drug|Overall Study||103
10293424|NCT04402866|11425996|FG000|COMPLETED|Overall Study||4
10856996|NCT03473977|12023243|FG000|STARTED|Overall Study||13
10856997|NCT03473977|12023244|FG001|STARTED|Overall Study||13
10856998|NCT03473977|12023243|FG000|COMPLETED|Overall Study||13
10856999|NCT03473977|12023244|FG001|COMPLETED|Overall Study||13
10857000|NCT03473977|12023243|FG000|NOT COMPLETED|Overall Study||0
10857001|NCT03473977|12023244|FG001|NOT COMPLETED|Overall Study||0
10857002|NCT03373110|12023253|FG000|STARTED|Overall Study||133
10857003|NCT03373110|12023254|FG001|STARTED|Overall Study||137
10857004|NCT03373110|12023255|FG002|STARTED|Overall Study||70
10857005|NCT03373110|12023253|FG000|Provided Fitbit Data|Overall Study||123
10857006|NCT03373110|12023254|FG001|Provided Fitbit Data|Overall Study||130
10857007|NCT03373110|12023255|FG002|Provided Fitbit Data|Overall Study||63
10857008|NCT03373110|12023253|FG000|COMPLETED|Overall Study||55
10857009|NCT03373110|12023254|FG001|COMPLETED|Overall Study||58
10857010|NCT03373110|12023255|FG002|COMPLETED|Overall Study||26
10857011|NCT03373110|12023253|FG000|NOT COMPLETED|Overall Study||78
10857012|NCT03373110|12023254|FG001|NOT COMPLETED|Overall Study||79
10857013|NCT03373110|12023255|FG002|NOT COMPLETED|Overall Study||44
10857014|NCT03365102|12023266|FG000|STARTED|Overall Study||22
10857015|NCT03365102|12023267|FG001|STARTED|Overall Study||22
10857016|NCT03365102|12023268|FG002|STARTED|Overall Study||20
10857017|NCT03365102|12023266|FG000|COMPLETED|Overall Study||18
10857018|NCT03365102|12023267|FG001|COMPLETED|Overall Study||21
10857019|NCT03365102|12023268|FG002|COMPLETED|Overall Study||19
10857020|NCT03365102|12023266|FG000|NOT COMPLETED|Overall Study||4
10857021|NCT03365102|12023267|FG001|NOT COMPLETED|Overall Study||1
10857022|NCT03365102|12023268|FG002|NOT COMPLETED|Overall Study||1
10857023|NCT03318003|12023278|FG000|STARTED|Overall Study||21
10857024|NCT03318003|12023279|FG001|STARTED|Overall Study||22
10857025|NCT03318003|12023278|FG000|COMPLETED|Overall Study|completed means the presence of 3rd trimester ultrasound and delivery information.|20
10857026|NCT03318003|12023279|FG001|COMPLETED|Overall Study||20
10857027|NCT03318003|12023278|FG000|NOT COMPLETED|Overall Study||1
10857028|NCT03318003|12023279|FG001|NOT COMPLETED|Overall Study||2
10857029|NCT03309072|12023287|FG000|STARTED|Overall Study||15
10857030|NCT03309072|12023288|FG001|STARTED|Overall Study||15
10857031|NCT03309072|12023287|FG000|COMPLETED|Overall Study||15
10857032|NCT03309072|12023288|FG001|COMPLETED|Overall Study||15
10857033|NCT03309072|12023287|FG000|NOT COMPLETED|Overall Study||0
10857034|NCT03309072|12023288|FG001|NOT COMPLETED|Overall Study||0
10857035|NCT03138590|12023296|FG000|STARTED|Overall Study||10
10857036|NCT03138590|12023297|FG001|STARTED|Overall Study||10
10857037|NCT03138590|12023296|FG000|COMPLETED|Overall Study||10
10857038|NCT03138590|12023297|FG001|COMPLETED|Overall Study||10
10857039|NCT03138590|12023296|FG000|NOT COMPLETED|Overall Study||0
10857040|NCT03138590|12023297|FG001|NOT COMPLETED|Overall Study||0
10857041|NCT03132753|12023305|FG000|STARTED|Baseline - 6 Month Follow-Up||46
10857042|NCT03132753|12023306|FG001|STARTED|Baseline - 6 Month Follow-Up||54
10857043|NCT03132753|12023305|FG000|COMPLETED|Baseline - 6 Month Follow-Up||19
10857044|NCT03132753|12023306|FG001|COMPLETED|Baseline - 6 Month Follow-Up||22
10857045|NCT03132753|12023305|FG000|NOT COMPLETED|Baseline - 6 Month Follow-Up||27
10857046|NCT03132753|12023306|FG001|NOT COMPLETED|Baseline - 6 Month Follow-Up||32
10857047|NCT03132753|12023305|FG000|STARTED|6 Month Follow-Up - 12 Month Follow-Up||19
10857048|NCT03132753|12023306|FG001|STARTED|6 Month Follow-Up - 12 Month Follow-Up||22
10857049|NCT03132753|12023305|FG000|COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||13
10857050|NCT03132753|12023306|FG001|COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||20
10857051|NCT03132753|12023305|FG000|NOT COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||6
10857052|NCT03132753|12023306|FG001|NOT COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||2
10857059|NCT03067077|12023321|FG000|STARTED|Overall Study||44
10857060|NCT03067077|12023322|FG001|STARTED|Overall Study||44
10857061|NCT03067077|12023321|FG000|Received Surgery|Overall Study||40
10857062|NCT03067077|12023322|FG001|Received Surgery|Overall Study||39
10857063|NCT03067077|12023321|FG000|COMPLETED|Overall Study||37
10857064|NCT03067077|12023322|FG001|COMPLETED|Overall Study||37
10857065|NCT03067077|12023321|FG000|NOT COMPLETED|Overall Study||7
10857066|NCT03067077|12023322|FG001|NOT COMPLETED|Overall Study||7
10857067|NCT03059446|12023328|FG000|STARTED|Overall Study||167
10857068|NCT03059446|12023328|FG000|COMPLETED|Overall Study||0
10857069|NCT03059446|12023328|FG000|NOT COMPLETED|Overall Study||167
10857070|NCT03019575|12023332|FG000|STARTED|Overall Study||17
10857071|NCT03019575|12023332|FG000|COMPLETED|Overall Study||17
10857072|NCT03019575|12023332|FG000|NOT COMPLETED|Overall Study||0
10857073|NCT03011034|12023338|FG000|STARTED|Overall Study||1
10857074|NCT03011034|12023339|FG001|STARTED|Overall Study||33
10857075|NCT03011034|12023338|FG000|COMPLETED|Overall Study||0
10857076|NCT03011034|12023339|FG001|COMPLETED|Overall Study||33
10857077|NCT03011034|12023338|FG000|NOT COMPLETED|Overall Study||1
10857078|NCT03011034|12023339|FG001|NOT COMPLETED|Overall Study||0
10857079|NCT02980666|12023347|FG000|STARTED|Overall Study||8
10857080|NCT02980666|12023348|FG001|STARTED|Overall Study||2
10857081|NCT02980666|12023347|FG000|COMPLETED|Overall Study||8
10857082|NCT02980666|12023348|FG001|COMPLETED|Overall Study||2
10857083|NCT02980666|12023347|FG000|NOT COMPLETED|Overall Study||0
10857084|NCT02980666|12023348|FG001|NOT COMPLETED|Overall Study||0
10857085|NCT02962102|12023357|FG000|STARTED|Overall Study||51
10857086|NCT02962102|12023358|FG001|STARTED|Overall Study||50
10857087|NCT02962102|12023359|FG002|STARTED|Overall Study||49
10857088|NCT02962102|12023357|FG000|COMPLETED|Overall Study||51
10857089|NCT02962102|12023358|FG001|COMPLETED|Overall Study||50
10857090|NCT02962102|12023359|FG002|COMPLETED|Overall Study||49
10857091|NCT02962102|12023357|FG000|NOT COMPLETED|Overall Study||0
10857092|NCT02962102|12023358|FG001|NOT COMPLETED|Overall Study||0
10857093|NCT02962102|12023359|FG002|NOT COMPLETED|Overall Study||0
10857102|NCT02749045|12023376|FG000|STARTED|Overall Study||27
10857103|NCT02749045|12023376|FG000|COMPLETED|Overall Study||27
10857104|NCT02749045|12023376|FG000|NOT COMPLETED|Overall Study||0
10857105|NCT02659605|12023382|FG000|STARTED|Overall Study||40
10857106|NCT02659605|12023383|FG001|STARTED|Overall Study||34
10857107|NCT02659605|12023382|FG000|COMPLETED|Overall Study||31
10857108|NCT02659605|12023383|FG001|COMPLETED|Overall Study||30
10857109|NCT02659605|12023382|FG000|NOT COMPLETED|Overall Study||9
10857110|NCT02659605|12023383|FG001|NOT COMPLETED|Overall Study||4
10755151|NCT03061331|11918946|FG001|COMPLETED|Treatment Period 1 (8 Weeks)||10
10755152|NCT03061331|11918945|FG000|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0
10755153|NCT03061331|11918946|FG001|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0
10755154|NCT03061331|11918945|FG000|STARTED|Washout Period (8 Weeks)||10
10755155|NCT03061331|11918946|FG001|STARTED|Washout Period (8 Weeks)||10
10755156|NCT03061331|11918945|FG000|COMPLETED|Washout Period (8 Weeks)||8
10755157|NCT03061331|11918946|FG001|COMPLETED|Washout Period (8 Weeks)||9
10755158|NCT03061331|11918945|FG000|NOT COMPLETED|Washout Period (8 Weeks)||2
10755159|NCT03061331|11918946|FG001|NOT COMPLETED|Washout Period (8 Weeks)||1
10755160|NCT03061331|11918945|FG000|STARTED|Treatment Period 2 (8 Weeks)||8
10755161|NCT03061331|11918946|FG001|STARTED|Treatment Period 2 (8 Weeks)||9
10755162|NCT03061331|11918945|FG000|COMPLETED|Treatment Period 2 (8 Weeks)||8
10755163|NCT03061331|11918946|FG001|COMPLETED|Treatment Period 2 (8 Weeks)||9
10857111|NCT02601014|12023391|FG000|STARTED|Overall Study||15
10857112|NCT02601014|12023392|FG001|STARTED|Overall Study||15
10857113|NCT02601014|12023391|FG000|COMPLETED|Overall Study||5
10857114|NCT02601014|12023392|FG001|COMPLETED|Overall Study||3
10857115|NCT02601014|12023391|FG000|NOT COMPLETED|Overall Study||10
10857116|NCT02601014|12023392|FG001|NOT COMPLETED|Overall Study||12
10415407|NCT00790062|11559979|FG001|NOT COMPLETED|Overall Study||0
10415408|NCT00790062|11559980|FG002|NOT COMPLETED|Overall Study||0
10415409|NCT00790088|11559997|FG000|STARTED|Overall Study||274
10415410|NCT00790088|11559997|FG000|Eligible for Data Analysis|Overall Study|Number of participants minus 11 protocol violation|263
10415411|NCT00790088|11559997|FG000|COMPLETED|Overall Study||235
10415412|NCT00790088|11559997|FG000|NOT COMPLETED|Overall Study||39
10415413|NCT00790192|11560007|FG000|STARTED|Overall Study||125
10415414|NCT00790192|11560008|FG001|STARTED|Overall Study||121
10415415|NCT00790192|11560009|FG002|STARTED|Overall Study||120
10415416|NCT00790192|11560010|FG003|STARTED|Overall Study||122
10415417|NCT00790192|11560007|FG000|COMPLETED|Overall Study||89
10415418|NCT00790192|11560008|FG001|COMPLETED|Overall Study||93
10415419|NCT00790192|11560009|FG002|COMPLETED|Overall Study||97
10415420|NCT00790192|11560010|FG003|COMPLETED|Overall Study||74
10415421|NCT00790192|11560007|FG000|NOT COMPLETED|Overall Study||36
10415422|NCT00790192|11560008|FG001|NOT COMPLETED|Overall Study||28
10415423|NCT00790192|11560009|FG002|NOT COMPLETED|Overall Study||23
10415424|NCT00790192|11560010|FG003|NOT COMPLETED|Overall Study||48
10415425|NCT00790205|11560022|FG000|STARTED|Overall Study||7332
10415426|NCT00790205|11560023|FG001|STARTED|Overall Study||7339
10415427|NCT00790205|11560022|FG000|Treated|Overall Study||7266
10415428|NCT00790205|11560023|FG001|Treated|Overall Study||7274
10415429|NCT00790205|11560022|FG000|COMPLETED|Overall Study||6972
10415430|NCT00790205|11560023|FG001|COMPLETED|Overall Study||6905
10415431|NCT00790205|11560022|FG000|NOT COMPLETED|Overall Study||360
10415432|NCT00790205|11560023|FG001|NOT COMPLETED|Overall Study||434
10415433|NCT00790270|11560032|FG000|STARTED|Overall Study||21
10415434|NCT00790270|11560033|FG001|STARTED|Overall Study||20
10415435|NCT00790270|11560034|FG002|STARTED|Overall Study||20
10415436|NCT00790270|11560032|FG000|COMPLETED|Overall Study||21
10415437|NCT00790270|11560033|FG001|COMPLETED|Overall Study||20
10415438|NCT00790270|11560034|FG002|COMPLETED|Overall Study||20
10415439|NCT00790270|11560032|FG000|NOT COMPLETED|Overall Study||0
10415440|NCT00790270|11560033|FG001|NOT COMPLETED|Overall Study||0
10415441|NCT00790270|11560034|FG002|NOT COMPLETED|Overall Study||0
10415442|NCT00790296|11560044|FG000|STARTED|Overall Study||5
10415443|NCT00790296|11560045|FG001|STARTED|Overall Study||6
10415444|NCT00790296|11560044|FG000|COMPLETED|Overall Study||4
10415445|NCT00790296|11560045|FG001|COMPLETED|Overall Study||4
10415446|NCT00790296|11560044|FG000|NOT COMPLETED|Overall Study||1
10415447|NCT00790296|11560045|FG001|NOT COMPLETED|Overall Study||2
10415448|NCT00790335|11560053|FG000|STARTED|Overall Study||337
10415449|NCT00790335|11560054|FG001|STARTED|Overall Study||355
10415450|NCT00790335|11560053|FG000|COMPLETED|Overall Study||257
10415451|NCT00790335|11560054|FG001|COMPLETED|Overall Study||243
10415452|NCT00790335|11560053|FG000|NOT COMPLETED|Overall Study||80
10415453|NCT00790335|11560054|FG001|NOT COMPLETED|Overall Study||112
10415454|NCT00790400|11560062|FG000|STARTED|Double-blind Period (Core Phase)||79
10415455|NCT00790400|11560063|FG001|STARTED|Double-blind Period (Core Phase)||39
10415456|NCT00790400|11560062|FG000|COMPLETED|Double-blind Period (Core Phase)|Completed = Completed the Core phase & moved to Extension phase|72
10415457|NCT00790400|11560063|FG001|COMPLETED|Double-blind Period (Core Phase)|Completed = 1st received Placebo in the Core phase, switched to Everolimus in Extension phase|26
10415458|NCT00790400|11560062|FG000|NOT COMPLETED|Double-blind Period (Core Phase)||7
10415459|NCT00790400|11560063|FG001|NOT COMPLETED|Double-blind Period (Core Phase)||13
10415460|NCT00790400|11560062|FG000|STARTED|Everolimus Period (Core or Extension)|112 pts had Everolimus during core and/or extension (6 from placebo did not switch to Eve. in ext.)|112
10415461|NCT00790400|11560063|FG001|STARTED|Everolimus Period (Core or Extension)|"Placebo randomized patients who switched to Everolimus are reported in Everolimus arm."|0
10415462|NCT00790400|11560062|FG000|COMPLETED|Everolimus Period (Core or Extension)|Treatment duration completed as per protocol|83
10415463|NCT00790400|11560063|FG001|COMPLETED|Everolimus Period (Core or Extension)||0
10415464|NCT00790400|11560062|FG000|NOT COMPLETED|Everolimus Period (Core or Extension)||29
10415465|NCT00790400|11560063|FG001|NOT COMPLETED|Everolimus Period (Core or Extension)||0
10415466|NCT00790556|11560072|FG000|STARTED|Treatment Period 1||8
10415467|NCT00790556|11560073|FG001|STARTED|Treatment Period 1||6
10415468|NCT00790556|11560072|FG000|COMPLETED|Treatment Period 1||6
10415469|NCT00790556|11560073|FG001|COMPLETED|Treatment Period 1||6
10415470|NCT00790556|11560072|FG000|NOT COMPLETED|Treatment Period 1||2
10415471|NCT00790556|11560073|FG001|NOT COMPLETED|Treatment Period 1||0
10415472|NCT00790556|11560072|FG000|STARTED|Washout After Period 1||6
10857135|NCT02538666|12023410|FG000|STARTED|Overall Study||275
10857136|NCT02538666|12023411|FG001|STARTED|Overall Study||280
10857137|NCT02538666|12023412|FG002|STARTED|Overall Study||279
10857138|NCT02538666|12023410|FG000|COMPLETED|Overall Study||273
10857139|NCT02538666|12023411|FG001|COMPLETED|Overall Study||279
10857140|NCT02538666|12023412|FG002|COMPLETED|Overall Study||278
10857141|NCT02538666|12023410|FG000|NOT COMPLETED|Overall Study||2
10857142|NCT02538666|12023411|FG001|NOT COMPLETED|Overall Study||1
10857143|NCT02538666|12023412|FG002|NOT COMPLETED|Overall Study||1
10857144|NCT02527200|12023425|FG000|STARTED|Overall Study||20
10857145|NCT02527200|12023426|FG001|STARTED|Overall Study||12
10857146|NCT02527200|12023427|FG002|STARTED|Overall Study||17
10857147|NCT02527200|12023428|FG003|STARTED|Overall Study||7
10857148|NCT02527200|12023425|FG000|Safety Analysis Set (SAS)|Overall Study||20
10857149|NCT02527200|12023426|FG001|Safety Analysis Set (SAS)|Overall Study||12
10857150|NCT02527200|12023427|FG002|Safety Analysis Set (SAS)|Overall Study||17
10857151|NCT02527200|12023428|FG003|Safety Analysis Set (SAS)|Overall Study||7
10857152|NCT02527200|12023425|FG000|Full Analysis Set (FAS)|Overall Study||19
10857153|NCT02527200|12023426|FG001|Full Analysis Set (FAS)|Overall Study||12
10857154|NCT02527200|12023427|FG002|Full Analysis Set (FAS)|Overall Study||17
10857155|NCT02527200|12023428|FG003|Full Analysis Set (FAS)|Overall Study||7
10857156|NCT02527200|12023425|FG000|COMPLETED|Overall Study||17
10857157|NCT02527200|12023426|FG001|COMPLETED|Overall Study||9
10857158|NCT02527200|12023427|FG002|COMPLETED|Overall Study||15
10857159|NCT02527200|12023428|FG003|COMPLETED|Overall Study||7
10857160|NCT02527200|12023425|FG000|NOT COMPLETED|Overall Study||3
10857161|NCT02527200|12023426|FG001|NOT COMPLETED|Overall Study||3
10857162|NCT02527200|12023427|FG002|NOT COMPLETED|Overall Study||2
10857163|NCT02527200|12023428|FG003|NOT COMPLETED|Overall Study||0
10857164|NCT02511106|12023444|FG000|STARTED|Overall Study||339
10857165|NCT02511106|12023445|FG001|STARTED|Overall Study||343
10857166|NCT02511106|12023444|FG000|Received Treatment|Overall Study||337
10857167|NCT02511106|12023445|FG001|Received Treatment|Overall Study||343
10857168|NCT02511106|12023444|FG000|COMPLETED|Overall Study||8
10857169|NCT02511106|12023445|FG001|COMPLETED|Overall Study||20
10857170|NCT02511106|12023444|FG000|NOT COMPLETED|Overall Study||331
10857171|NCT02511106|12023445|FG001|NOT COMPLETED|Overall Study||323
10857172|NCT02477358|12023455|FG000|STARTED|Overall Study||18
10857173|NCT02477358|12023456|FG001|STARTED|Overall Study||18
10857174|NCT02477358|12023455|FG000|COMPLETED|Overall Study||18
10857175|NCT02477358|12023456|FG001|COMPLETED|Overall Study||18
10857176|NCT02477358|12023455|FG000|NOT COMPLETED|Overall Study||0
10857177|NCT02477358|12023456|FG001|NOT COMPLETED|Overall Study||0
10857178|NCT02432209|12023466|FG000|STARTED|Overall Study||188
10857179|NCT02432209|12023467|FG001|STARTED|Overall Study||191
10857180|NCT02432209|12023466|FG000|COMPLETED|Overall Study||157
10857181|NCT02432209|12023467|FG001|COMPLETED|Overall Study||151
10857182|NCT02432209|12023466|FG000|NOT COMPLETED|Overall Study||31
10857183|NCT02432209|12023467|FG001|NOT COMPLETED|Overall Study||40
10857184|NCT02392637|12023475|FG000|STARTED|Overall Study||32
10857185|NCT02392637|12023476|FG001|STARTED|Overall Study||28
10857186|NCT02392637|12023475|FG000|COMPLETED|Overall Study||32
10857187|NCT02392637|12023476|FG001|COMPLETED|Overall Study||28
10857188|NCT02392637|12023475|FG000|NOT COMPLETED|Overall Study||0
10857189|NCT02392637|12023476|FG001|NOT COMPLETED|Overall Study||0
10857190|NCT02224573|12023487|FG000|STARTED|Treatment Phase||315
10857191|NCT02224573|12023488|FG001|STARTED|Treatment Phase||366
10857192|NCT02224573|12023487|FG000|COMPLETED|Treatment Phase||170
10857193|NCT02224573|12023488|FG001|COMPLETED|Treatment Phase||243
10857194|NCT02224573|12023487|FG000|NOT COMPLETED|Treatment Phase||145
10857195|NCT02224573|12023488|FG001|NOT COMPLETED|Treatment Phase||123
10857196|NCT02224573|12023487|FG000|STARTED|Taper Phase|The number of participants to start the Taper Phase is not equal to the number who completed the Treatment Phase because not all participants tapered IMP.|79
10857197|NCT02224573|12023488|FG001|STARTED|Taper Phase|The number of participants to start the Taper Phase is not equal to the number who completed the Treatment Phase because not all participants tapered IMP.|71
10857198|NCT02224573|12023487|FG000|COMPLETED|Taper Phase||76
10857199|NCT02224573|12023488|FG001|COMPLETED|Taper Phase||67
10857200|NCT02224573|12023487|FG000|NOT COMPLETED|Taper Phase||3
10857201|NCT02224573|12023488|FG001|NOT COMPLETED|Taper Phase||4
10857202|NCT01991067|12023497|FG000|STARTED|Overall Study||19
10857203|NCT01991067|12023498|FG001|STARTED|Overall Study||15
10857204|NCT01991067|12023497|FG000|COMPLETED|Overall Study||13
10857205|NCT01991067|12023498|FG001|COMPLETED|Overall Study||10
10857206|NCT01991067|12023497|FG000|NOT COMPLETED|Overall Study||6
10857207|NCT01991067|12023498|FG001|NOT COMPLETED|Overall Study||5
10857208|NCT01928732|12023506|FG000|STARTED|Overall Study||455
10857209|NCT01928732|12023507|FG001|STARTED|Overall Study||461
10857210|NCT01928732|12023506|FG000|COMPLETED|Overall Study||326
10857211|NCT01928732|12023507|FG001|COMPLETED|Overall Study||334
10857212|NCT01928732|12023506|FG000|NOT COMPLETED|Overall Study||129
10857213|NCT01928732|12023507|FG001|NOT COMPLETED|Overall Study||127
10857214|NCT01925573|12023513|FG000|STARTED|Overall Study||7
10857215|NCT01925573|12023513|FG000|COMPLETED|Overall Study||0
10857216|NCT01925573|12023513|FG000|NOT COMPLETED|Overall Study||7
10857217|NCT01774721|12023519|FG000|STARTED|Overall Study||227
10857218|NCT01774721|12023520|FG001|STARTED|Overall Study||225
10857219|NCT01774721|12023519|FG000|Treated|Overall Study||227
10857220|NCT01774721|12023520|FG001|Treated|Overall Study||224
10857221|NCT01774721|12023519|FG000|COMPLETED|Overall Study||0
10857222|NCT01774721|12023520|FG001|COMPLETED|Overall Study||0
10857223|NCT01774721|12023519|FG000|NOT COMPLETED|Overall Study||227
10857224|NCT01774721|12023520|FG001|NOT COMPLETED|Overall Study||225
10857225|NCT01747447|12023530|FG000|STARTED|Overall Study||388
10857226|NCT01747447|12023531|FG001|STARTED|Overall Study||383
10857227|NCT01747447|12023530|FG000|COMPLETED|Overall Study||347
10857228|NCT01747447|12023531|FG001|COMPLETED|Overall Study||340
10857229|NCT01747447|12023530|FG000|NOT COMPLETED|Overall Study||41
10857230|NCT01747447|12023531|FG001|NOT COMPLETED|Overall Study||43
10857231|NCT01709331|12023537|FG000|STARTED|Overall Study||18
10857232|NCT01709331|12023537|FG000|COMPLETED|Overall Study||17
10857233|NCT01709331|12023537|FG000|NOT COMPLETED|Overall Study||1
10857234|NCT01656434|12023543|FG000|STARTED|Overall Study||2553
10857235|NCT01656434|12023544|FG001|STARTED|Overall Study||620
10857236|NCT01656434|12023543|FG000|Treated|Overall Study|One treated participant had incomplete data and was not included in the Safety Analyses.|2466
10857237|NCT01656434|12023544|FG001|Treated|Overall Study||604
10857238|NCT01656434|12023543|FG000|COMPLETED|Overall Study||152
10857239|NCT01656434|12023544|FG001|COMPLETED|Overall Study||40
10857240|NCT01656434|12023543|FG000|NOT COMPLETED|Overall Study||2401
10857241|NCT01656434|12023544|FG001|NOT COMPLETED|Overall Study||580
10857242|NCT01518517|12023553|FG000|STARTED|Overall Study||29
10857243|NCT01518517|12023554|FG001|STARTED|Overall Study||30
10857244|NCT01518517|12023555|FG002|STARTED|Overall Study||26
10857245|NCT01518517|12023553|FG000|COMPLETED|Overall Study||1
10857246|NCT01518517|12023554|FG001|COMPLETED|Overall Study||3
10857247|NCT01518517|12023555|FG002|COMPLETED|Overall Study||0
10857248|NCT01518517|12023553|FG000|NOT COMPLETED|Overall Study||28
10857249|NCT01518517|12023554|FG001|NOT COMPLETED|Overall Study||27
10857250|NCT01518517|12023555|FG002|NOT COMPLETED|Overall Study||26
10857251|NCT01496118|12023573|FG000|STARTED|Overall Study||4
10857252|NCT01496118|12023574|FG001|STARTED|Overall Study||3
10857253|NCT01496118|12023575|FG002|STARTED|Overall Study||3
10857254|NCT01496118|12023576|FG003|STARTED|Overall Study||3
10857255|NCT01496118|12023577|FG004|STARTED|Overall Study||3
10857256|NCT01496118|12023578|FG005|STARTED|Overall Study||3
10857257|NCT01496118|12023579|FG006|STARTED|Overall Study||31
10857258|NCT01496118|12023580|FG007|STARTED|Overall Study||30
10857259|NCT01496118|12023573|FG000|COMPLETED|Overall Study||0
10857260|NCT01496118|12023574|FG001|COMPLETED|Overall Study||0
10857261|NCT01496118|12023575|FG002|COMPLETED|Overall Study||0
10857262|NCT01496118|12023576|FG003|COMPLETED|Overall Study||0
10857263|NCT01496118|12023577|FG004|COMPLETED|Overall Study||0
10857264|NCT01496118|12023578|FG005|COMPLETED|Overall Study||0
10857265|NCT01496118|12023579|FG006|COMPLETED|Overall Study||0
10857266|NCT01496118|12023580|FG007|COMPLETED|Overall Study||0
10857267|NCT01496118|12023573|FG000|NOT COMPLETED|Overall Study||4
10857268|NCT01496118|12023574|FG001|NOT COMPLETED|Overall Study||3
10857269|NCT01496118|12023575|FG002|NOT COMPLETED|Overall Study||3
10857270|NCT01496118|12023576|FG003|NOT COMPLETED|Overall Study||3
10857271|NCT01496118|12023577|FG004|NOT COMPLETED|Overall Study||3
10857272|NCT01496118|12023578|FG005|NOT COMPLETED|Overall Study||3
10857273|NCT01496118|12023579|FG006|NOT COMPLETED|Overall Study||31
10857274|NCT01496118|12023580|FG007|NOT COMPLETED|Overall Study||30
10857275|NCT01350934|12023600|FG000|STARTED|Base Study||111
10857276|NCT01350934|12023601|FG001|STARTED|Base Study||108
10857277|NCT01350934|12023600|FG000|COMPLETED|Base Study||100
10857278|NCT01350934|12023601|FG001|COMPLETED|Base Study||105
10857279|NCT01350934|12023600|FG000|NOT COMPLETED|Base Study||11
10857280|NCT01350934|12023601|FG001|NOT COMPLETED|Base Study||3
10857281|NCT01350934|12023600|FG000|STARTED|Extension Study||100
10857282|NCT01350934|12023601|FG001|STARTED|Extension Study||105
10857283|NCT01350934|12023600|FG000|COMPLETED|Extension Study||95
10857284|NCT01350934|12023601|FG001|COMPLETED|Extension Study||101
10857285|NCT01350934|12023600|FG000|NOT COMPLETED|Extension Study||5
10857286|NCT01350934|12023601|FG001|NOT COMPLETED|Extension Study||4
10857287|NCT01286207|12023610|FG000|STARTED|Overall Study||751
10857288|NCT01286207|12023611|FG001|STARTED|Overall Study||857
10857289|NCT01286207|12023612|FG002|STARTED|Overall Study||351
10857290|NCT01286207|12023610|FG000|COMPLETED|Overall Study||453
10857291|NCT01286207|12023611|FG001|COMPLETED|Overall Study||609
10857292|NCT01286207|12023612|FG002|COMPLETED|Overall Study||261
10857293|NCT01286207|12023610|FG000|NOT COMPLETED|Overall Study||298
10857294|NCT01286207|12023611|FG001|NOT COMPLETED|Overall Study||248
10857295|NCT01286207|12023612|FG002|NOT COMPLETED|Overall Study||90
10857299|NCT01227187|12023628|FG000|STARTED|Overall Study||1
10857300|NCT01227187|12023629|FG001|STARTED|Overall Study||3
10857301|NCT01227187|12023630|FG002|STARTED|Overall Study||3
10857302|NCT01227187|12023631|FG003|STARTED|Overall Study||5
10857303|NCT01227187|12023628|FG000|COMPLETED|Overall Study||1
10857304|NCT01227187|12023629|FG001|COMPLETED|Overall Study||3
10857305|NCT01227187|12023630|FG002|COMPLETED|Overall Study||3
10857306|NCT01227187|12023631|FG003|COMPLETED|Overall Study||4
10857307|NCT01227187|12023628|FG000|NOT COMPLETED|Overall Study||0
10857308|NCT01227187|12023629|FG001|NOT COMPLETED|Overall Study||0
10857309|NCT01227187|12023630|FG002|NOT COMPLETED|Overall Study||0
10857310|NCT01227187|12023631|FG003|NOT COMPLETED|Overall Study||1
10857311|NCT01146418|12023643|FG000|STARTED|Base Study P06029 (NCT01144416)||694
10857312|NCT01146418|12023644|FG001|STARTED|Base Study P06029 (NCT01144416)||696
10857313|NCT01146418|12023645|FG002|STARTED|Base Study P06029 (NCT01144416)||0
10857314|NCT01146418|12023646|FG003|STARTED|Base Study P06029 (NCT01144416)||0
10857315|NCT01146418|12023643|FG000|COMPLETED|Base Study P06029 (NCT01144416)|Participants who underwent ET in base study|632
10857316|NCT01146418|12023644|FG001|COMPLETED|Base Study P06029 (NCT01144416)|Participants who underwent ET in base study|647
10857317|NCT01146418|12023645|FG002|COMPLETED|Base Study P06029 (NCT01144416)||0
10857318|NCT01146418|12023646|FG003|COMPLETED|Base Study P06029 (NCT01144416)||0
10857319|NCT01146418|12023643|FG000|NOT COMPLETED|Base Study P06029 (NCT01144416)||62
10857320|NCT01146418|12023644|FG001|NOT COMPLETED|Base Study P06029 (NCT01144416)||49
10857321|NCT01146418|12023645|FG002|NOT COMPLETED|Base Study P06029 (NCT01144416)||0
10857322|NCT01146418|12023646|FG003|NOT COMPLETED|Base Study P06029 (NCT01144416)||0
10857323|NCT01146418|12023643|FG000|STARTED|Women/Expectant Mother Follow Up|Participants from Base Study P06029 with at least one embryo thawed for use in FTET cycle.|157
10857324|NCT01146418|12023644|FG001|STARTED|Women/Expectant Mother Follow Up|Participants from base study P06029 with at least one embryo thawed for use in FTET cycle.|150
10857325|NCT01146418|12023645|FG002|STARTED|Women/Expectant Mother Follow Up||0
10857326|NCT01146418|12023646|FG003|STARTED|Women/Expectant Mother Follow Up||0
10857327|NCT01146418|12023643|FG000|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||151
10857328|NCT01146418|12023644|FG001|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||147
10857329|NCT01146418|12023645|FG002|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||0
10857330|NCT01146418|12023646|FG003|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||0
10857331|NCT01146418|12023643|FG000|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up|Ongoing pregnancy defined as intra-uterine pregnancy with fetal heart beat on USS 10 weeks after ET|52
10857332|NCT01146418|12023644|FG001|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up|Ongoing pregnancy defined as intra-uterine pregnancy with fetal heart beat on USS 10 weeks after ET|50
10857333|NCT01146418|12023645|FG002|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up||0
10857334|NCT01146418|12023646|FG003|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up||0
10857335|NCT01146418|12023643|FG000|COMPLETED|Women/Expectant Mother Follow Up|Participants with ET transfer who completed follow-up study|113
10857336|NCT01146418|12023644|FG001|COMPLETED|Women/Expectant Mother Follow Up|Participants with ET transfer who completed follow-up study|110
10857337|NCT01146418|12023645|FG002|COMPLETED|Women/Expectant Mother Follow Up||0
10857338|NCT01146418|12023646|FG003|COMPLETED|Women/Expectant Mother Follow Up||0
10857339|NCT01146418|12023643|FG000|NOT COMPLETED|Women/Expectant Mother Follow Up||44
10857340|NCT01146418|12023644|FG001|NOT COMPLETED|Women/Expectant Mother Follow Up||40
10857341|NCT01146418|12023645|FG002|NOT COMPLETED|Women/Expectant Mother Follow Up||0
10857342|NCT01146418|12023646|FG003|NOT COMPLETED|Women/Expectant Mother Follow Up||0
10857343|NCT01146418|12023643|FG000|STARTED|Live-Born Infant Follow Up||0
10857344|NCT01146418|12023644|FG001|STARTED|Live-Born Infant Follow Up||0
10857345|NCT01146418|12023645|FG002|STARTED|Live-Born Infant Follow Up||61
10857346|NCT01146418|12023646|FG003|STARTED|Live-Born Infant Follow Up||56
10857347|NCT01146418|12023643|FG000|COMPLETED|Live-Born Infant Follow Up||0
10857348|NCT01146418|12023644|FG001|COMPLETED|Live-Born Infant Follow Up||0
10857349|NCT01146418|12023645|FG002|COMPLETED|Live-Born Infant Follow Up|Infants who completed follow up|55
10857350|NCT01146418|12023646|FG003|COMPLETED|Live-Born Infant Follow Up|Infants who completed follow up|51
10857351|NCT01146418|12023643|FG000|NOT COMPLETED|Live-Born Infant Follow Up||0
10857352|NCT01146418|12023644|FG001|NOT COMPLETED|Live-Born Infant Follow Up||0
10857353|NCT01146418|12023645|FG002|NOT COMPLETED|Live-Born Infant Follow Up||6
10857354|NCT01146418|12023646|FG003|NOT COMPLETED|Live-Born Infant Follow Up||5
10857355|NCT01144416|12023658|FG000|STARTED|Intervention Period||694
10857356|NCT01144416|12023659|FG001|STARTED|Intervention Period||696
10857357|NCT01144416|12023658|FG000|COMPLETED|Intervention Period||632
10857358|NCT01144416|12023659|FG001|COMPLETED|Intervention Period||647
10857359|NCT01144416|12023658|FG000|NOT COMPLETED|Intervention Period||62
10857360|NCT01144416|12023659|FG001|NOT COMPLETED|Intervention Period||49
10857361|NCT01144416|12023658|FG000|STARTED|Pregnancy Follow-up Period|Participants received 150 ug SCH 900962 in Intervention Period and became pregnant.|154
10857362|NCT01144416|12023659|FG001|STARTED|Pregnancy Follow-up Period|Participants received daily injections of 300 IU recFSH in Intervention Period and became pregnant.|167
10857363|NCT01144416|12023658|FG000|COMPLETED|Pregnancy Follow-up Period||146
10857364|NCT01144416|12023659|FG001|COMPLETED|Pregnancy Follow-up Period||157
10857365|NCT01144416|12023658|FG000|NOT COMPLETED|Pregnancy Follow-up Period||8
10857366|NCT01144416|12023659|FG001|NOT COMPLETED|Pregnancy Follow-up Period||10
10857367|NCT01140048|12023669|FG000|STARTED|Overall Study||343
10857368|NCT01140048|12023669|FG000|COMPLETED|Overall Study||298
10857369|NCT01140048|12023669|FG000|NOT COMPLETED|Overall Study||45
10857370|NCT01077817|12023673|FG000|STARTED|Overall Study|STARTED and COMPLETED is the number of participants meeting incl./excl. criteria in the GPRD.|684815
10857371|NCT01077817|12023673|FG000|COMPLETED|Overall Study||684815
10857372|NCT01077817|12023673|FG000|NOT COMPLETED|Overall Study||0
10857373|NCT01065779|12023684|FG000|STARTED|Overall Study||880
10857374|NCT01065779|12023684|FG000|COMPLETED|Overall Study||798
10857375|NCT01065779|12023684|FG000|NOT COMPLETED|Overall Study||82
10415473|NCT00790556|11560073|FG001|STARTED|Washout After Period 1||6
10415474|NCT00790556|11560072|FG000|COMPLETED|Washout After Period 1||6
10415475|NCT00790556|11560073|FG001|COMPLETED|Washout After Period 1||6
10415476|NCT00790556|11560072|FG000|NOT COMPLETED|Washout After Period 1||0
10415477|NCT00790556|11560073|FG001|NOT COMPLETED|Washout After Period 1||0
10293425|NCT04402866|11425997|FG001|COMPLETED|Overall Study||5
10293426|NCT04402866|11425998|FG002|COMPLETED|Overall Study||6
10293427|NCT04402866|11425999|FG003|COMPLETED|Overall Study||6
10293428|NCT04402866|11426000|FG004|COMPLETED|Overall Study||89
10293429|NCT04402866|11426001|FG005|COMPLETED|Overall Study||92
10293430|NCT04402866|11425996|FG000|NOT COMPLETED|Overall Study||2
10293431|NCT04402866|11425997|FG001|NOT COMPLETED|Overall Study||1
10293432|NCT04402866|11425998|FG002|NOT COMPLETED|Overall Study||1
10857376|NCT00974571|12023691|FG000|STARTED|Overall Study||630
10857377|NCT00974571|12023692|FG001|STARTED|Overall Study||122
10857378|NCT00974571|12023693|FG002|STARTED|Overall Study||613
10857379|NCT00974571|12023691|FG000|COMPLETED|Overall Study||562
10857380|NCT00974571|12023692|FG001|COMPLETED|Overall Study||106
10415478|NCT00790556|11560072|FG000|STARTED|Treatment Period 2||6
10415479|NCT00790556|11560073|FG001|STARTED|Treatment Period 2||6
10415480|NCT00790556|11560072|FG000|COMPLETED|Treatment Period 2||6
10415481|NCT00790556|11560073|FG001|COMPLETED|Treatment Period 2||6
10415482|NCT00790556|11560072|FG000|NOT COMPLETED|Treatment Period 2||0
10415483|NCT00790556|11560073|FG001|NOT COMPLETED|Treatment Period 2||0
10415484|NCT00790569|11560082|FG000|STARTED|End of Treatment (6 Month Interview)||137
10415485|NCT00790569|11560083|FG001|STARTED|End of Treatment (6 Month Interview)||45
10415486|NCT00790569|11560084|FG002|STARTED|End of Treatment (6 Month Interview)||133
10415487|NCT00790569|11560082|FG000|COMPLETED|End of Treatment (6 Month Interview)||115
10415488|NCT00790569|11560083|FG001|COMPLETED|End of Treatment (6 Month Interview)||35
10415489|NCT00790569|11560084|FG002|COMPLETED|End of Treatment (6 Month Interview)||107
10415490|NCT00790569|11560082|FG000|NOT COMPLETED|End of Treatment (6 Month Interview)||22
10415491|NCT00790569|11560083|FG001|NOT COMPLETED|End of Treatment (6 Month Interview)||10
10415492|NCT00790569|11560084|FG002|NOT COMPLETED|End of Treatment (6 Month Interview)||26
10415493|NCT00790569|11560082|FG000|STARTED|End of Study (12 Month Interview)||137
10415494|NCT00790569|11560083|FG001|STARTED|End of Study (12 Month Interview)||45
10415495|NCT00790569|11560084|FG002|STARTED|End of Study (12 Month Interview)||133
10415496|NCT00790569|11560082|FG000|COMPLETED|End of Study (12 Month Interview)||71
10415497|NCT00790569|11560083|FG001|COMPLETED|End of Study (12 Month Interview)||26
10415498|NCT00790569|11560084|FG002|COMPLETED|End of Study (12 Month Interview)||83
10415499|NCT00790569|11560082|FG000|NOT COMPLETED|End of Study (12 Month Interview)||66
10415500|NCT00790569|11560083|FG001|NOT COMPLETED|End of Study (12 Month Interview)||19
10415501|NCT00790569|11560084|FG002|NOT COMPLETED|End of Study (12 Month Interview)||50
10415502|NCT00790582|11560094|FG000|STARTED|Overall Study||109
10415503|NCT00790582|11560095|FG001|STARTED|Overall Study||249
10415504|NCT00790582|11560094|FG000|COMPLETED|Overall Study||78
10415505|NCT00790582|11560095|FG001|COMPLETED|Overall Study||162
10415506|NCT00790582|11560094|FG000|NOT COMPLETED|Overall Study||31
10415507|NCT00790582|11560095|FG001|NOT COMPLETED|Overall Study||87
10415508|NCT00790647|11560103|FG000|STARTED|Overall Study||10
10415509|NCT00790647|11560103|FG000|COMPLETED|Overall Study||9
10415510|NCT00790647|11560103|FG000|NOT COMPLETED|Overall Study||1
10415511|NCT00790673|11560113|FG000|STARTED|Overall Study||6
10415512|NCT00790673|11560114|FG001|STARTED|Overall Study||6
10415513|NCT00790673|11560115|FG002|STARTED|Overall Study||12
10415514|NCT00790673|11560116|FG003|STARTED|Overall Study||8
10415515|NCT00790673|11560113|FG000|COMPLETED|Overall Study||6
10415516|NCT00790673|11560114|FG001|COMPLETED|Overall Study||6
10415517|NCT00790673|11560115|FG002|COMPLETED|Overall Study||12
10415518|NCT00790673|11560116|FG003|COMPLETED|Overall Study||8
10415519|NCT00790673|11560113|FG000|NOT COMPLETED|Overall Study||0
10415520|NCT00790673|11560114|FG001|NOT COMPLETED|Overall Study||0
10415521|NCT00790673|11560115|FG002|NOT COMPLETED|Overall Study||0
10415522|NCT00790673|11560116|FG003|NOT COMPLETED|Overall Study||0
10415523|NCT00790699|11560128|FG000|STARTED|Overall Study||17
10415524|NCT00790699|11560129|FG001|STARTED|Overall Study||14
10415525|NCT00790699|11560128|FG000|COMPLETED|Overall Study||16
10415526|NCT00790699|11560129|FG001|COMPLETED|Overall Study||14
10415527|NCT00790699|11560128|FG000|NOT COMPLETED|Overall Study||1
10415528|NCT00790699|11560129|FG001|NOT COMPLETED|Overall Study||0
10415529|NCT00790738|11560139|FG000|STARTED|Overall Study||5
10415530|NCT00790738|11560140|FG001|STARTED|Overall Study||6
10415531|NCT00790738|11560139|FG000|COMPLETED|Overall Study||3
10415532|NCT00790738|11560140|FG001|COMPLETED|Overall Study||3
10415533|NCT00790738|11560139|FG000|NOT COMPLETED|Overall Study||2
10415534|NCT00790738|11560140|FG001|NOT COMPLETED|Overall Study||3
10415535|NCT00790751|11560150|FG000|STARTED|Overall Study||162
10415536|NCT00790751|11560151|FG001|STARTED|Overall Study||161
10415537|NCT00790751|11560152|FG002|STARTED|Overall Study||161
10415538|NCT00790751|11560153|FG003|STARTED|Overall Study||162
10415539|NCT00790751|11560150|FG000|COMPLETED|Overall Study||137
10415540|NCT00790751|11560151|FG001|COMPLETED|Overall Study||131
10415541|NCT00790751|11560152|FG002|COMPLETED|Overall Study||141
10415542|NCT00790751|11560153|FG003|COMPLETED|Overall Study||141
10415543|NCT00790751|11560150|FG000|NOT COMPLETED|Overall Study||25
10415544|NCT00790751|11560151|FG001|NOT COMPLETED|Overall Study||30
10415545|NCT00790751|11560152|FG002|NOT COMPLETED|Overall Study||20
10415546|NCT00790751|11560153|FG003|NOT COMPLETED|Overall Study||21
10429338|NCT00863057|11575335|FG001|COMPLETED|Period 3 (Weeks 11-15)||1
10429339|NCT00863057|11575336|FG002|COMPLETED|Period 3 (Weeks 11-15)||2
10429340|NCT00863057|11575337|FG003|COMPLETED|Period 3 (Weeks 11-15)||2
10429341|NCT00863057|11575334|FG000|NOT COMPLETED|Period 3 (Weeks 11-15)||0
10429342|NCT00863057|11575335|FG001|NOT COMPLETED|Period 3 (Weeks 11-15)||0
10429343|NCT00863057|11575336|FG002|NOT COMPLETED|Period 3 (Weeks 11-15)||0
10429344|NCT00863057|11575337|FG003|NOT COMPLETED|Period 3 (Weeks 11-15)||0
10429345|NCT00863057|11575334|FG000|STARTED|Period 4 (Weeks 16-20)||3
10429346|NCT00863057|11575335|FG001|STARTED|Period 4 (Weeks 16-20)||1
10429347|NCT00863057|11575336|FG002|STARTED|Period 4 (Weeks 16-20)||2
10429348|NCT00863057|11575337|FG003|STARTED|Period 4 (Weeks 16-20)||2
10429349|NCT00863057|11575334|FG000|COMPLETED|Period 4 (Weeks 16-20)||3
10429350|NCT00863057|11575335|FG001|COMPLETED|Period 4 (Weeks 16-20)||1
10857381|NCT00974571|12023693|FG002|COMPLETED|Overall Study||530
10857382|NCT00974571|12023691|FG000|NOT COMPLETED|Overall Study||68
10857383|NCT00974571|12023692|FG001|NOT COMPLETED|Overall Study||16
10857384|NCT00974571|12023693|FG002|NOT COMPLETED|Overall Study||83
10857385|NCT00972738|12023704|FG000|STARTED|Overall Study||522
10857386|NCT00972738|12023705|FG001|STARTED|Overall Study||171
10857387|NCT00972738|12023706|FG002|STARTED|Overall Study||521
10857388|NCT00972738|12023704|FG000|COMPLETED|Overall Study||501
10857389|NCT00972738|12023705|FG001|COMPLETED|Overall Study||165
10857390|NCT00972738|12023706|FG002|COMPLETED|Overall Study||492
10857391|NCT00972738|12023704|FG000|NOT COMPLETED|Overall Study||21
10857392|NCT00972738|12023705|FG001|NOT COMPLETED|Overall Study||6
10857393|NCT00972738|12023706|FG002|NOT COMPLETED|Overall Study||29
10857394|NCT00968201|12023716|FG000|STARTED|Base Study - (Period II)|Includes patients who completed Period I (2-week placebo run-in) and were randomized to placebo.|228
10857395|NCT00968201|12023717|FG001|STARTED|Base Study - (Period II)||0
10857396|NCT00968201|12023718|FG002|STARTED|Base Study - (Period II)|Includes patients who completed Period I (2-week placebo run-in) and were randomized to montelukast.|461
10857397|NCT00968201|12023716|FG000|COMPLETED|Base Study - (Period II)|Patients completing Period II were eligible to enter the optional Period III|202
10857398|NCT00968201|12023717|FG001|COMPLETED|Base Study - (Period II)||0
10857399|NCT00968201|12023718|FG002|COMPLETED|Base Study - (Period II)|Patients completing Period II were eligible to enter the optional Period III|416
10857400|NCT00968201|12023716|FG000|NOT COMPLETED|Base Study - (Period II)||26
10857401|NCT00968201|12023717|FG001|NOT COMPLETED|Base Study - (Period II)||0
10857402|NCT00968201|12023718|FG002|NOT COMPLETED|Base Study - (Period II)||45
10857403|NCT00968201|12023716|FG000|STARTED|Extension Study - (Period III)||0
10857404|NCT00968201|12023717|FG001|STARTED|Extension Study - (Period III)|Eligible Patients who completed Period II and entered the optional Extension Study (Period III)|157
10857405|NCT00968201|12023718|FG002|STARTED|Extension Study - (Period III)|Eligible Patients who completed Period II and entered the optional Extension Study (Period III)|364
10857406|NCT00968201|12023716|FG000|COMPLETED|Extension Study - (Period III)||0
10857407|NCT00968201|12023717|FG001|COMPLETED|Extension Study - (Period III)||33
10857408|NCT00968201|12023718|FG002|COMPLETED|Extension Study - (Period III)||84
10857409|NCT00968201|12023716|FG000|NOT COMPLETED|Extension Study - (Period III)||0
10857410|NCT00968201|12023717|FG001|NOT COMPLETED|Extension Study - (Period III)||124
10857411|NCT00968201|12023718|FG002|NOT COMPLETED|Extension Study - (Period III)||280
10857412|NCT00968149|12023729|FG000|STARTED|Overall Study||280
10857413|NCT00968149|12023730|FG001|STARTED|Overall Study||133
10857414|NCT00968149|12023729|FG000|COMPLETED|Overall Study||269
10857415|NCT00968149|12023730|FG001|COMPLETED|Overall Study||127
10857416|NCT00968149|12023729|FG000|NOT COMPLETED|Overall Study||11
10857417|NCT00968149|12023730|FG001|NOT COMPLETED|Overall Study||6
10857418|NCT00963469|12023739|FG000|STARTED|Overall Study||451
10857419|NCT00963469|12023740|FG001|STARTED|Overall Study||448
10857420|NCT00963469|12023741|FG002|STARTED|Overall Study||180
10857421|NCT00963469|12023739|FG000|COMPLETED|Overall Study||410
10857422|NCT00963469|12023740|FG001|COMPLETED|Overall Study||420
10857423|NCT00963469|12023741|FG002|COMPLETED|Overall Study||170
10857424|NCT00963469|12023739|FG000|NOT COMPLETED|Overall Study||41
10857425|NCT00963469|12023740|FG001|NOT COMPLETED|Overall Study||28
10857426|NCT00963469|12023741|FG002|NOT COMPLETED|Overall Study||10
10857427|NCT00960141|12023752|FG000|STARTED|Overall Study||333
10857428|NCT00960141|12023753|FG001|STARTED|Overall Study||326
10857429|NCT00960141|12023754|FG002|STARTED|Overall Study||170
10857430|NCT00960141|12023752|FG000|COMPLETED|Overall Study||323
10857431|NCT00960141|12023753|FG001|COMPLETED|Overall Study||309
10857432|NCT00960141|12023754|FG002|COMPLETED|Overall Study||163
10857433|NCT00960141|12023752|FG000|NOT COMPLETED|Overall Study||10
10857434|NCT00960141|12023753|FG001|NOT COMPLETED|Overall Study||17
10857435|NCT00960141|12023754|FG002|NOT COMPLETED|Overall Study||7
10857436|NCT00943683|12023764|FG000|STARTED|Overall Study||81
10857437|NCT00943683|12023765|FG001|STARTED|Overall Study||175
10857438|NCT00943683|12023764|FG000|COMPLETED|Overall Study||74
10857439|NCT00943683|12023765|FG001|COMPLETED|Overall Study||169
10857440|NCT00943683|12023764|FG000|NOT COMPLETED|Overall Study||7
10857441|NCT00943683|12023765|FG001|NOT COMPLETED|Overall Study||6
10857442|NCT00943397|12023773|FG000|STARTED|Overall Study||32
10857443|NCT00943397|12023774|FG001|STARTED|Overall Study||158
10857444|NCT00943397|12023773|FG000|COMPLETED|Overall Study|Site terminated - Merck administrative decision (11); Discontinued for other (1)|17
10857445|NCT00943397|12023774|FG001|COMPLETED|Overall Study|Site terminated - Merck administrative decision (52); Patient moved (1); Discontinued for other (3)|86
10857446|NCT00943397|12023773|FG000|NOT COMPLETED|Overall Study||15
10857447|NCT00943397|12023774|FG001|NOT COMPLETED|Overall Study||72
10857448|NCT00911547|12023784|FG000|STARTED|Overall Study|Efficacy in last 10 wks to minimize confounding effect of beclo in 1st 4 wks & allow beclo washout.|48
10857449|NCT00911547|12023785|FG001|STARTED|Overall Study|Efficacy in last 10 wks to minimize confounding effect of beclo in 1st 4 wks & allow beclo washout.|201
10857450|NCT00911547|12023786|FG002|STARTED|Overall Study|Efficacy analyses were over the 16 weeks of treatment.|200
10857451|NCT00911547|12023787|FG003|STARTED|Overall Study|Efficacy analyses were over the 16 weeks of treatment.|193
10857452|NCT00911547|12023784|FG000|COMPLETED|Overall Study||37
10857453|NCT00911547|12023785|FG001|COMPLETED|Overall Study||159
10857454|NCT00911547|12023786|FG002|COMPLETED|Overall Study||178
10857455|NCT00911547|12023787|FG003|COMPLETED|Overall Study||177
10857456|NCT00911547|12023784|FG000|NOT COMPLETED|Overall Study||11
10857457|NCT00911547|12023785|FG001|NOT COMPLETED|Overall Study||42
10857458|NCT00911547|12023786|FG002|NOT COMPLETED|Overall Study||22
10857459|NCT00911547|12023787|FG003|NOT COMPLETED|Overall Study||16
10857460|NCT00899379|12023802|FG000|STARTED|Overall Study|Patients who were allocated study drug|95
10857461|NCT00899379|12023803|FG001|STARTED|Overall Study|Patients who were allocated study drug|95
10857462|NCT00899379|12023804|FG002|STARTED|Overall Study|Patients who were allocated study drug|95
10857463|NCT00899379|12023805|FG003|STARTED|Overall Study|Patients who were allocated study drug|94
10857464|NCT00899379|12023806|FG004|STARTED|Overall Study|Patients who were allocated study drug|94
10857465|NCT00899379|12023802|FG000|Patients Treated|Overall Study|Patients who took study drug|83
10857466|NCT00899379|12023803|FG001|Patients Treated|Overall Study|Patients who took study drug|82
10857467|NCT00899379|12023804|FG002|Patients Treated|Overall Study|Patients who took study drug|84
10857468|NCT00899379|12023805|FG003|Patients Treated|Overall Study|Patients who took study drug|77
10857469|NCT00899379|12023806|FG004|Patients Treated|Overall Study|Patients who took study drug|81
10857470|NCT00899379|12023802|FG000|Patients Not Treated|Overall Study|Patients who did not take study drug|12
10857471|NCT00899379|12023803|FG001|Patients Not Treated|Overall Study|Patients who did not take study drug|13
10857472|NCT00899379|12023804|FG002|Patients Not Treated|Overall Study|Patients who did not take study drug|11
10857473|NCT00899379|12023805|FG003|Patients Not Treated|Overall Study|Patients who did not take study drug|17
10857474|NCT00899379|12023806|FG004|Patients Not Treated|Overall Study|Patients who did not take study drug|13
10857475|NCT00899379|12023802|FG000|COMPLETED|Overall Study|Patients who took study drug and completed the study|61
10857476|NCT00899379|12023803|FG001|COMPLETED|Overall Study|Patients who took study drug and completed the study|66
10857477|NCT00899379|12023804|FG002|COMPLETED|Overall Study|Patients who took study drug and completed the study|66
10857478|NCT00899379|12023805|FG003|COMPLETED|Overall Study|Patients who took study drug and completed the study|57
10857479|NCT00899379|12023806|FG004|COMPLETED|Overall Study|Patients who took study drug and completed the study|63
10857480|NCT00899379|12023802|FG000|NOT COMPLETED|Overall Study||34
10857481|NCT00899379|12023803|FG001|NOT COMPLETED|Overall Study||29
10857482|NCT00899379|12023804|FG002|NOT COMPLETED|Overall Study||29
10857483|NCT00899379|12023805|FG003|NOT COMPLETED|Overall Study||37
10857484|NCT00899379|12023806|FG004|NOT COMPLETED|Overall Study||31
10857485|NCT00898677|12023816|FG000|STARTED|Overall Study||180
10857486|NCT00898677|12023817|FG001|STARTED|Overall Study||455
10857487|NCT00898677|12023818|FG002|STARTED|Overall Study||455
10857488|NCT00898677|12023819|FG003|STARTED|Overall Study||178
10857489|NCT00898677|12023816|FG000|Patients Treated|Overall Study|Patients Not Treated: 16|164
10857490|NCT00898677|12023817|FG001|Patients Treated|Overall Study|Patients Not Treated: 68|387
10857491|NCT00898677|12023818|FG002|Patients Treated|Overall Study|Patients Not Treated: 67|388
10857492|NCT00898677|12023819|FG003|Patients Treated|Overall Study|Patients Not Treated: 18|160
10857493|NCT00898677|12023816|FG000|COMPLETED|Overall Study||163
10857494|NCT00898677|12023817|FG001|COMPLETED|Overall Study||386
10857495|NCT00898677|12023818|FG002|COMPLETED|Overall Study||383
10857496|NCT00898677|12023819|FG003|COMPLETED|Overall Study||159
10857497|NCT00898677|12023816|FG000|NOT COMPLETED|Overall Study||17
10857498|NCT00898677|12023817|FG001|NOT COMPLETED|Overall Study||69
10857499|NCT00898677|12023818|FG002|NOT COMPLETED|Overall Study||72
10857500|NCT00898677|12023819|FG003|NOT COMPLETED|Overall Study||19
10857501|NCT00897949|12023832|FG000|STARTED|Overall Study|Patients who were allocated study drug|554
10857502|NCT00897949|12023833|FG001|STARTED|Overall Study|Patients who were allocated study drug|549
10857503|NCT00897949|12023834|FG002|STARTED|Overall Study|Patients who were allocated study drug|370
10857504|NCT00897949|12023832|FG000|Patients Treated|Overall Study|Patients who took study drug|458
10857505|NCT00897949|12023833|FG001|Patients Treated|Overall Study|Patients who took study drug|456
10857506|NCT00897949|12023834|FG002|Patients Treated|Overall Study|Patients who took study drug|304
10857507|NCT00897949|12023832|FG000|COMPLETED|Overall Study|Patients who took study drug and completed the study|450
10857508|NCT00897949|12023833|FG001|COMPLETED|Overall Study|Patients who took study drug and completed the study|446
10857509|NCT00897949|12023834|FG002|COMPLETED|Overall Study|Patients who took study drug and completed the study|301
10857510|NCT00897949|12023832|FG000|NOT COMPLETED|Overall Study||104
10857511|NCT00897949|12023833|FG001|NOT COMPLETED|Overall Study||103
10415547|NCT00790790|11560166|FG000|STARTED|Study Period 2: Therapy Phase||49
10415548|NCT00790790|11560167|FG001|STARTED|Study Period 2: Therapy Phase||50
10415549|NCT00790790|11560168|FG002|STARTED|Study Period 2: Therapy Phase||48
10415550|NCT00790790|11560166|FG000|COMPLETED|Study Period 2: Therapy Phase||37
10415551|NCT00790790|11560167|FG001|COMPLETED|Study Period 2: Therapy Phase||32
10415552|NCT00790790|11560168|FG002|COMPLETED|Study Period 2: Therapy Phase||27
10415553|NCT00790790|11560166|FG000|NOT COMPLETED|Study Period 2: Therapy Phase||12
10415554|NCT00790790|11560167|FG001|NOT COMPLETED|Study Period 2: Therapy Phase||18
10415555|NCT00790790|11560168|FG002|NOT COMPLETED|Study Period 2: Therapy Phase||21
10415556|NCT00790790|11560166|FG000|STARTED|Study Period 3: 1-Week Washout Phase||37
10415557|NCT00790790|11560167|FG001|STARTED|Study Period 3: 1-Week Washout Phase||32
10415558|NCT00790790|11560168|FG002|STARTED|Study Period 3: 1-Week Washout Phase||27
10415559|NCT00790790|11560166|FG000|COMPLETED|Study Period 3: 1-Week Washout Phase||37
10415560|NCT00790790|11560167|FG001|COMPLETED|Study Period 3: 1-Week Washout Phase||31
10415561|NCT00790790|11560168|FG002|COMPLETED|Study Period 3: 1-Week Washout Phase||26
10415562|NCT00790790|11560166|FG000|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
10415563|NCT00790790|11560167|FG001|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
10415564|NCT00790790|11560168|FG002|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
10415565|NCT00790842|11560184|FG000|STARTED|Dose Level 1||6
10415566|NCT00790842|11560185|FG001|STARTED|Dose Level 1||0
10857512|NCT00897949|12023834|FG002|NOT COMPLETED|Overall Study||69
10857513|NCT00897104|12023851|FG000|STARTED|Overall Study|Participants who were allocated study drug|418
10857514|NCT00897104|12023852|FG001|STARTED|Overall Study|Participants who were allocated study drug|428
10857515|NCT00897104|12023853|FG002|STARTED|Overall Study|Participants who were allocated study drug|87
10857516|NCT00897104|12023851|FG000|Participants Treated|Overall Study|Participants who took study drug|355
10857517|NCT00897104|12023852|FG001|Participants Treated|Overall Study|Participants who took study drug|357
10857518|NCT00897104|12023853|FG002|Participants Treated|Overall Study|Participants who took study drug|80
10857519|NCT00897104|12023851|FG000|Participants Not Treated|Overall Study|Participants who did not take study drug|63
10857520|NCT00897104|12023852|FG001|Participants Not Treated|Overall Study|Participants who did not take study drug|71
10857521|NCT00897104|12023853|FG002|Participants Not Treated|Overall Study|Participants who did not take study drug|7
10857522|NCT00897104|12023851|FG000|COMPLETED|Overall Study|Participants who took study drug and completed the study|354
10857523|NCT00897104|12023852|FG001|COMPLETED|Overall Study|Participants who took study drug and completed the study|357
10857524|NCT00897104|12023853|FG002|COMPLETED|Overall Study|Participants who took study drug and completed the study|79
10857525|NCT00897104|12023851|FG000|NOT COMPLETED|Overall Study||64
10857526|NCT00897104|12023852|FG001|NOT COMPLETED|Overall Study||71
10857527|NCT00897104|12023853|FG002|NOT COMPLETED|Overall Study||8
10857528|NCT00803790|12023863|FG000|STARTED|Period 1||125
10857529|NCT00803790|12023864|FG001|STARTED|Period 1||126
10857530|NCT00803790|12023865|FG002|STARTED|Period 1||32
10857531|NCT00803790|12023866|FG003|STARTED|Period 1||35
10857532|NCT00803790|12023863|FG000|COMPLETED|Period 1||116
10857533|NCT00803790|12023864|FG001|COMPLETED|Period 1||114
10857534|NCT00803790|12023865|FG002|COMPLETED|Period 1||31
10857535|NCT00803790|12023866|FG003|COMPLETED|Period 1||31
10857536|NCT00803790|12023863|FG000|NOT COMPLETED|Period 1||9
10857537|NCT00803790|12023864|FG001|NOT COMPLETED|Period 1||12
10857538|NCT00803790|12023865|FG002|NOT COMPLETED|Period 1||1
10857539|NCT00803790|12023866|FG003|NOT COMPLETED|Period 1||4
10857540|NCT00803790|12023863|FG000|STARTED|Period 2||116
10857541|NCT00803790|12023864|FG001|STARTED|Period 2||114
10857542|NCT00803790|12023865|FG002|STARTED|Period 2||31
10857543|NCT00803790|12023866|FG003|STARTED|Period 2||31
10857544|NCT00803790|12023863|FG000|COMPLETED|Period 2||114
10857545|NCT00803790|12023864|FG001|COMPLETED|Period 2||114
10857546|NCT00803790|12023865|FG002|COMPLETED|Period 2||30
10857547|NCT00803790|12023866|FG003|COMPLETED|Period 2||30
10857548|NCT00803790|12023863|FG000|NOT COMPLETED|Period 2||2
10857549|NCT00803790|12023864|FG001|NOT COMPLETED|Period 2||0
10857550|NCT00803790|12023865|FG002|NOT COMPLETED|Period 2||1
10857551|NCT00803790|12023866|FG003|NOT COMPLETED|Period 2||1
10857552|NCT00725491|12023879|FG000|STARTED|Overall Study|Intent-to-Treat Group|113
10857553|NCT00725491|12023880|FG001|STARTED|Overall Study|Intent-to-Treat Group|120
10857554|NCT00725491|12023879|FG000|COMPLETED|Overall Study||104
10857555|NCT00725491|12023880|FG001|COMPLETED|Overall Study||102
10857556|NCT00725491|12023879|FG000|NOT COMPLETED|Overall Study||9
10857557|NCT00725491|12023880|FG001|NOT COMPLETED|Overall Study||18
10857558|NCT00703014|12023888|FG000|STARTED|Mothers Base Trial P05787 (NCT00696800)|Randomized in Base Trial P05787 (NCT00696800)|757
10857559|NCT00703014|12023889|FG001|STARTED|Mothers Base Trial P05787 (NCT00696800)|Randomized in Base Trial P05787 (NCT00696800)|752
10857560|NCT00703014|12023890|FG002|STARTED|Mothers Base Trial P05787 (NCT00696800)||0
10857561|NCT00703014|12023891|FG003|STARTED|Mothers Base Trial P05787 (NCT00696800)||0
10857562|NCT00703014|12023888|FG000|Treated|Mothers Base Trial P05787 (NCT00696800)|Intent-To-Treat (ITT) group in Base Trial P05787 (NCT00696800)|756
10857563|NCT00703014|12023889|FG001|Treated|Mothers Base Trial P05787 (NCT00696800)|ITT group in Base Trial P05787 (NCT006968000)|750
10857564|NCT00703014|12023890|FG002|Treated|Mothers Base Trial P05787 (NCT00696800)||0
10415567|NCT00790842|11560186|FG002|STARTED|Dose Level 1||0
10415568|NCT00790842|11560187|FG003|STARTED|Dose Level 1||3
10415569|NCT00790842|11560188|FG004|STARTED|Dose Level 1||0
10415570|NCT00790842|11560189|FG005|STARTED|Dose Level 1||0
10415571|NCT00790842|11560190|FG006|STARTED|Dose Level 1||0
10415572|NCT00790842|11560191|FG007|STARTED|Dose Level 1||3
10415573|NCT00790842|11560192|FG008|STARTED|Dose Level 1||0
10415574|NCT00790842|11560193|FG009|STARTED|Dose Level 1||0
10415575|NCT00790842|11560194|FG010|STARTED|Dose Level 1||0
10415576|NCT00790842|11560184|FG000|Began Treatment|Dose Level 1||6
10415577|NCT00790842|11560185|FG001|Began Treatment|Dose Level 1||0
10415578|NCT00790842|11560186|FG002|Began Treatment|Dose Level 1||0
10415579|NCT00790842|11560187|FG003|Began Treatment|Dose Level 1||3
10415580|NCT00790842|11560188|FG004|Began Treatment|Dose Level 1||0
10415581|NCT00790842|11560189|FG005|Began Treatment|Dose Level 1||0
10415582|NCT00790842|11560190|FG006|Began Treatment|Dose Level 1||0
10415583|NCT00790842|11560191|FG007|Began Treatment|Dose Level 1||3
10415584|NCT00790842|11560192|FG008|Began Treatment|Dose Level 1||0
10415585|NCT00790842|11560193|FG009|Began Treatment|Dose Level 1||0
10415586|NCT00790842|11560194|FG010|Began Treatment|Dose Level 1||0
10415587|NCT00790842|11560184|FG000|COMPLETED|Dose Level 1||3
10857565|NCT00703014|12023891|FG003|Treated|Mothers Base Trial P05787 (NCT00696800)||0
10857566|NCT00703014|12023888|FG000|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)|Embryo transfer (ET) in Base Trial P05787 (NCT006968000)|672
10857567|NCT00703014|12023889|FG001|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)|Embryo transfer (ET) in Base Trial P05787 (NCT006968000)|704
10415588|NCT00790842|11560185|FG001|COMPLETED|Dose Level 1||0
10415589|NCT00790842|11560186|FG002|COMPLETED|Dose Level 1||0
10415590|NCT00790842|11560187|FG003|COMPLETED|Dose Level 1||1
10415591|NCT00790842|11560188|FG004|COMPLETED|Dose Level 1||0
10857568|NCT00703014|12023890|FG002|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)||0
10857569|NCT00703014|12023891|FG003|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)||0
10857570|NCT00703014|12023888|FG000|COMPLETED|Mothers Base Trial P05787 (NCT00696800)|ITT group in P05712, ongoing pregnancy at 10 weeks after ET in Base Trial P05787 (NCT006968000)|295
10857571|NCT00703014|12023889|FG001|COMPLETED|Mothers Base Trial P05787 (NCT00696800)|ITT group in P05712, ongoing pregnancy at 10 weeks after ET in Base Trial P05787 (NCT006968000)|286
10857572|NCT00703014|12023890|FG002|COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
10857573|NCT00703014|12023891|FG003|COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
10857574|NCT00703014|12023888|FG000|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||462
10857575|NCT00703014|12023889|FG001|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||466
10857576|NCT00703014|12023890|FG002|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
10857577|NCT00703014|12023891|FG003|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
10857578|NCT00703014|12023888|FG000|STARTED|Mothers Follow Up Trial P05712|Eligible participants who completed Base Trial P05787 and then enrolled in Follow Up Trial P05712|274
10857579|NCT00703014|12023889|FG001|STARTED|Mothers Follow Up Trial P05712|Eligible participants who completed Base Trial P05787 and then enrolled in Follow Up Trial P05712|267
10857580|NCT00703014|12023890|FG002|STARTED|Mothers Follow Up Trial P05712||0
10857581|NCT00703014|12023891|FG003|STARTED|Mothers Follow Up Trial P05712||0
10857582|NCT00703014|12023888|FG000|COMPLETED|Mothers Follow Up Trial P05712|Completed Follow Up in Trial P05712|241
10857583|NCT00703014|12023889|FG001|COMPLETED|Mothers Follow Up Trial P05712|Completed Follow Up in Trial P05712|235
10857584|NCT00703014|12023890|FG002|COMPLETED|Mothers Follow Up Trial P05712||0
10857585|NCT00703014|12023891|FG003|COMPLETED|Mothers Follow Up Trial P05712||0
10857586|NCT00703014|12023888|FG000|NOT COMPLETED|Mothers Follow Up Trial P05712||33
10857587|NCT00703014|12023889|FG001|NOT COMPLETED|Mothers Follow Up Trial P05712||32
10857588|NCT00703014|12023890|FG002|NOT COMPLETED|Mothers Follow Up Trial P05712||0
10857589|NCT00703014|12023891|FG003|NOT COMPLETED|Mothers Follow Up Trial P05712||0
10857590|NCT00703014|12023888|FG000|STARTED|Fetuses/Infants Follow Up Trial P05712||0
10857591|NCT00703014|12023889|FG001|STARTED|Fetuses/Infants Follow Up Trial P05712||0
10857592|NCT00703014|12023890|FG002|STARTED|Fetuses/Infants Follow Up Trial P05712|Fetuses in Follow Up Trial P05712|352
10857593|NCT00703014|12023891|FG003|STARTED|Fetuses/Infants Follow Up Trial P05712|Fetuses in Follow Up Trial P05712|326
10857594|NCT00703014|12023888|FG000|Live Born Infants|Fetuses/Infants Follow Up Trial P05712||0
10857595|NCT00703014|12023889|FG001|Live Born Infants|Fetuses/Infants Follow Up Trial P05712||0
10857596|NCT00703014|12023890|FG002|Live Born Infants|Fetuses/Infants Follow Up Trial P05712|Live born infants in Follow Up Trail P05712|344
10857597|NCT00703014|12023891|FG003|Live Born Infants|Fetuses/Infants Follow Up Trial P05712|Live born infants in Follow Up Trail P05712|315
10857598|NCT00703014|12023888|FG000|COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
10857599|NCT00703014|12023889|FG001|COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
10857600|NCT00703014|12023890|FG002|COMPLETED|Fetuses/Infants Follow Up Trial P05712|Infants in P05712 with Follow Up Completed|305
10857601|NCT00703014|12023891|FG003|COMPLETED|Fetuses/Infants Follow Up Trial P05712|Infants in P05712 with Follow Up Completed|284
10857602|NCT00703014|12023888|FG000|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
10857603|NCT00703014|12023889|FG001|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
10857604|NCT00703014|12023890|FG002|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||47
10857605|NCT00703014|12023891|FG003|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||42
10857606|NCT00702845|12023903|FG000|STARTED|Overall Study||268
10857607|NCT00702845|12023904|FG001|STARTED|Overall Study|Includes one treated participant who was not randomized|129
10857608|NCT00702845|12023903|FG000|Randomized|Overall Study||268
10857609|NCT00702845|12023904|FG001|Randomized|Overall Study||128
10857610|NCT00702845|12023903|FG000|COMPLETED|Overall Study||246
10857611|NCT00702845|12023904|FG001|COMPLETED|Overall Study||121
10857612|NCT00702845|12023903|FG000|NOT COMPLETED|Overall Study||22
10857613|NCT00702845|12023904|FG001|NOT COMPLETED|Overall Study||8
10857614|NCT00702624|12023912|FG000|STARTED|Base Study P05690 (NCT00702845)||268
10857615|NCT00702624|12023913|FG001|STARTED|Base Study P05690 (NCT00702845)||128
10857616|NCT00702624|12023914|FG002|STARTED|Base Study P05690 (NCT00702845)||0
10857617|NCT00702624|12023915|FG003|STARTED|Base Study P05690 (NCT00702845)||0
10857618|NCT00702624|12023912|FG000|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|246
10857619|NCT00702624|12023913|FG001|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|121
10857620|NCT00702624|12023914|FG002|COMPLETED|Base Study P05690 (NCT00702845)||0
10857621|NCT00702624|12023915|FG003|COMPLETED|Base Study P05690 (NCT00702845)||0
10857622|NCT00702624|12023912|FG000|NOT COMPLETED|Base Study P05690 (NCT00702845)||22
10857623|NCT00702624|12023913|FG001|NOT COMPLETED|Base Study P05690 (NCT00702845)||7
10857624|NCT00702624|12023914|FG002|NOT COMPLETED|Base Study P05690 (NCT00702845)||0
10857625|NCT00702624|12023915|FG003|NOT COMPLETED|Base Study P05690 (NCT00702845)||0
10857626|NCT00702624|12023912|FG000|STARTED|Expectant Mother Follow-up||68
10857627|NCT00702624|12023913|FG001|STARTED|Expectant Mother Follow-up||45
10857628|NCT00702624|12023914|FG002|STARTED|Expectant Mother Follow-up||0
10857629|NCT00702624|12023915|FG003|STARTED|Expectant Mother Follow-up||0
10857630|NCT00702624|12023912|FG000|COMPLETED|Expectant Mother Follow-up|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|61
10857631|NCT00702624|12023913|FG001|COMPLETED|Expectant Mother Follow-up|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|45
10857632|NCT00702624|12023914|FG002|COMPLETED|Expectant Mother Follow-up||0
10857633|NCT00702624|12023915|FG003|COMPLETED|Expectant Mother Follow-up||0
10415592|NCT00790842|11560189|FG005|COMPLETED|Dose Level 1||0
10415593|NCT00790842|11560190|FG006|COMPLETED|Dose Level 1||0
10415594|NCT00790842|11560191|FG007|COMPLETED|Dose Level 1||1
10415595|NCT00790842|11560192|FG008|COMPLETED|Dose Level 1||0
10415596|NCT00790842|11560193|FG009|COMPLETED|Dose Level 1||0
10415597|NCT00790842|11560194|FG010|COMPLETED|Dose Level 1||0
10415598|NCT00790842|11560184|FG000|NOT COMPLETED|Dose Level 1||3
10415599|NCT00790842|11560185|FG001|NOT COMPLETED|Dose Level 1||0
10415600|NCT00790842|11560186|FG002|NOT COMPLETED|Dose Level 1||0
10415601|NCT00790842|11560187|FG003|NOT COMPLETED|Dose Level 1||2
10415602|NCT00790842|11560188|FG004|NOT COMPLETED|Dose Level 1||0
10415603|NCT00790842|11560189|FG005|NOT COMPLETED|Dose Level 1||0
10415604|NCT00790842|11560190|FG006|NOT COMPLETED|Dose Level 1||0
10415605|NCT00790842|11560191|FG007|NOT COMPLETED|Dose Level 1||2
10415606|NCT00790842|11560192|FG008|NOT COMPLETED|Dose Level 1||0
10415607|NCT00790842|11560193|FG009|NOT COMPLETED|Dose Level 1||0
10415608|NCT00790842|11560194|FG010|NOT COMPLETED|Dose Level 1||0
10415609|NCT00790842|11560184|FG000|STARTED|Dose Level 2||0
10415610|NCT00790842|11560185|FG001|STARTED|Dose Level 2||3
10415611|NCT00790842|11560186|FG002|STARTED|Dose Level 2||0
10415612|NCT00790842|11560187|FG003|STARTED|Dose Level 2||0
10415613|NCT00790842|11560188|FG004|STARTED|Dose Level 2||3
10415614|NCT00790842|11560189|FG005|STARTED|Dose Level 2||0
10415615|NCT00790842|11560190|FG006|STARTED|Dose Level 2||0
10415616|NCT00790842|11560191|FG007|STARTED|Dose Level 2||0
10415617|NCT00790842|11560192|FG008|STARTED|Dose Level 2||3
10415618|NCT00790842|11560193|FG009|STARTED|Dose Level 2||0
10415619|NCT00790842|11560194|FG010|STARTED|Dose Level 2||0
10415620|NCT00790842|11560184|FG000|Began Treatment|Dose Level 2||0
10415621|NCT00790842|11560185|FG001|Began Treatment|Dose Level 2||3
10415622|NCT00790842|11560186|FG002|Began Treatment|Dose Level 2||0
10415623|NCT00790842|11560187|FG003|Began Treatment|Dose Level 2||0
10415624|NCT00790842|11560188|FG004|Began Treatment|Dose Level 2||3
10415625|NCT00790842|11560189|FG005|Began Treatment|Dose Level 2||0
10415626|NCT00790842|11560190|FG006|Began Treatment|Dose Level 2||0
10415627|NCT00790842|11560191|FG007|Began Treatment|Dose Level 2||0
10415628|NCT00790842|11560192|FG008|Began Treatment|Dose Level 2||3
10415629|NCT00790842|11560193|FG009|Began Treatment|Dose Level 2||0
10415630|NCT00790842|11560194|FG010|Began Treatment|Dose Level 2||0
10415631|NCT00790842|11560184|FG000|COMPLETED|Dose Level 2||0
10415632|NCT00790842|11560185|FG001|COMPLETED|Dose Level 2||0
10415633|NCT00790842|11560186|FG002|COMPLETED|Dose Level 2||0
10415634|NCT00790842|11560187|FG003|COMPLETED|Dose Level 2||0
10415635|NCT00790842|11560188|FG004|COMPLETED|Dose Level 2||2
10415636|NCT00790842|11560189|FG005|COMPLETED|Dose Level 2||0
10415637|NCT00790842|11560190|FG006|COMPLETED|Dose Level 2||0
10415638|NCT00790842|11560191|FG007|COMPLETED|Dose Level 2||0
10415639|NCT00790842|11560192|FG008|COMPLETED|Dose Level 2||1
10415640|NCT00790842|11560193|FG009|COMPLETED|Dose Level 2||0
10415641|NCT00790842|11560194|FG010|COMPLETED|Dose Level 2||0
10415642|NCT00790842|11560184|FG000|NOT COMPLETED|Dose Level 2||0
10415643|NCT00790842|11560185|FG001|NOT COMPLETED|Dose Level 2||3
10415644|NCT00790842|11560186|FG002|NOT COMPLETED|Dose Level 2||0
10415645|NCT00790842|11560187|FG003|NOT COMPLETED|Dose Level 2||0
10415646|NCT00790842|11560188|FG004|NOT COMPLETED|Dose Level 2||1
10415647|NCT00790842|11560189|FG005|NOT COMPLETED|Dose Level 2||0
10415648|NCT00790842|11560190|FG006|NOT COMPLETED|Dose Level 2||0
10415649|NCT00790842|11560191|FG007|NOT COMPLETED|Dose Level 2||0
10415650|NCT00790842|11560192|FG008|NOT COMPLETED|Dose Level 2||2
10415651|NCT00790842|11560193|FG009|NOT COMPLETED|Dose Level 2||0
10415652|NCT00790842|11560194|FG010|NOT COMPLETED|Dose Level 2||0
10415653|NCT00790842|11560184|FG000|STARTED|Dose Level 3||0
10415654|NCT00790842|11560185|FG001|STARTED|Dose Level 3||0
10415655|NCT00790842|11560186|FG002|STARTED|Dose Level 3||7
10415656|NCT00790842|11560187|FG003|STARTED|Dose Level 3||0
10415657|NCT00790842|11560188|FG004|STARTED|Dose Level 3||0
10415658|NCT00790842|11560189|FG005|STARTED|Dose Level 3||3
10415659|NCT00790842|11560190|FG006|STARTED|Dose Level 3||0
10415660|NCT00790842|11560191|FG007|STARTED|Dose Level 3||0
10415661|NCT00790842|11560192|FG008|STARTED|Dose Level 3||0
10415662|NCT00790842|11560193|FG009|STARTED|Dose Level 3||3
10415663|NCT00790842|11560194|FG010|STARTED|Dose Level 3||0
10755164|NCT03061331|11918945|FG000|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
10755165|NCT03061331|11918946|FG001|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
10755166|NCT03061513|11918954|FG000|STARTED|Overall Study||6
10755167|NCT03061513|11918955|FG001|STARTED|Overall Study||5
10755168|NCT03061513|11918954|FG000|COMPLETED|Overall Study||6
10755169|NCT03061513|11918955|FG001|COMPLETED|Overall Study||4
10755170|NCT03061513|11918954|FG000|NOT COMPLETED|Overall Study||0
10415664|NCT00790842|11560184|FG000|Began Treatment|Dose Level 3||0
10415665|NCT00790842|11560185|FG001|Began Treatment|Dose Level 3||0
10415666|NCT00790842|11560186|FG002|Began Treatment|Dose Level 3||6
10415667|NCT00790842|11560187|FG003|Began Treatment|Dose Level 3||0
10755171|NCT03061513|11918955|FG001|NOT COMPLETED|Overall Study||1
10755172|NCT03061812|11918963|FG000|STARTED|Overall Study||148
10415668|NCT00790842|11560188|FG004|Began Treatment|Dose Level 3||0
10415669|NCT00790842|11560189|FG005|Began Treatment|Dose Level 3||3
10415670|NCT00790842|11560190|FG006|Began Treatment|Dose Level 3||0
10415671|NCT00790842|11560191|FG007|Began Treatment|Dose Level 3||0
10415672|NCT00790842|11560192|FG008|Began Treatment|Dose Level 3||0
10755173|NCT03061812|11918964|FG001|STARTED|Overall Study||296
10755174|NCT03061812|11918963|FG000|COMPLETED|Overall Study||148
10857634|NCT00702624|12023912|FG000|NOT COMPLETED|Expectant Mother Follow-up||7
10857635|NCT00702624|12023913|FG001|NOT COMPLETED|Expectant Mother Follow-up||0
10857636|NCT00702624|12023914|FG002|NOT COMPLETED|Expectant Mother Follow-up||0
10857637|NCT00702624|12023915|FG003|NOT COMPLETED|Expectant Mother Follow-up||0
10545707|NCT01499355|11699176|FG001|COMPLETED|Double-Blind Period||40
10545708|NCT01499355|11699177|FG002|COMPLETED|Double-Blind Period||38
10545709|NCT01499355|11699178|FG003|COMPLETED|Double-Blind Period||39
10857638|NCT00702624|12023912|FG000|STARTED|Fetuses/Infant Follow-up||0
10857639|NCT00702624|12023913|FG001|STARTED|Fetuses/Infant Follow-up||0
10857640|NCT00702624|12023914|FG002|STARTED|Fetuses/Infant Follow-up||88
10857641|NCT00702624|12023915|FG003|STARTED|Fetuses/Infant Follow-up||55
10857642|NCT00702624|12023912|FG000|Live Born Infants|Fetuses/Infant Follow-up||0
10857643|NCT00702624|12023913|FG001|Live Born Infants|Fetuses/Infant Follow-up||0
10857644|NCT00702624|12023914|FG002|Live Born Infants|Fetuses/Infant Follow-up|Infants born to eligible mothers were followed for safety and efficacy|80
10857645|NCT00702624|12023915|FG003|Live Born Infants|Fetuses/Infant Follow-up|Infants born to eligible mothers were followed for safety and efficacy.|55
10857646|NCT00702624|12023912|FG000|COMPLETED|Fetuses/Infant Follow-up||0
10857647|NCT00702624|12023913|FG001|COMPLETED|Fetuses/Infant Follow-up||0
10857648|NCT00702624|12023914|FG002|COMPLETED|Fetuses/Infant Follow-up|To complete the study, infants must have completed a follow-up visit at 4-12 weeks postpartum.|78
10857649|NCT00702624|12023915|FG003|COMPLETED|Fetuses/Infant Follow-up|To complete the study, infants must have completed a follow-up visit at 4-12 weeks postpartum.|55
10857650|NCT00702624|12023912|FG000|NOT COMPLETED|Fetuses/Infant Follow-up||0
10857651|NCT00702624|12023913|FG001|NOT COMPLETED|Fetuses/Infant Follow-up||0
10857652|NCT00702624|12023914|FG002|NOT COMPLETED|Fetuses/Infant Follow-up||10
10857653|NCT00702624|12023915|FG003|NOT COMPLETED|Fetuses/Infant Follow-up||0
10857654|NCT00702546|12023930|FG000|STARTED|Base Study P05690 (NCT00702845)||268
10857655|NCT00702546|12023931|FG001|STARTED|Base Study P05690 (NCT00702845)||128
10857656|NCT00702546|12023930|FG000|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|246
10857657|NCT00702546|12023931|FG001|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|121
10857658|NCT00702546|12023930|FG000|NOT COMPLETED|Base Study P05690 (NCT00702845)||22
10857659|NCT00702546|12023931|FG001|NOT COMPLETED|Base Study P05690 (NCT00702845)||7
10857660|NCT00702546|12023930|FG000|STARTED|Follow Up Study P05711 (NCT00702546)|Participants from base study P05690 with at least one embryo thawed for use in FTET cycle.|77
10857661|NCT00702546|12023931|FG001|STARTED|Follow Up Study P05711 (NCT00702546)|Participants from base study P05690 with at least one embryo thawed for use in FTET cycle.|25
10857662|NCT00702546|12023930|FG000|COMPLETED|Follow Up Study P05711 (NCT00702546)|Participants with embryo transfer in any FTET cycle|72
10857663|NCT00702546|12023931|FG001|COMPLETED|Follow Up Study P05711 (NCT00702546)|Participants with embryo transfer in any FTET cycle|24
10857664|NCT00702546|12023930|FG000|NOT COMPLETED|Follow Up Study P05711 (NCT00702546)||5
10857665|NCT00702546|12023931|FG001|NOT COMPLETED|Follow Up Study P05711 (NCT00702546)||1
10857666|NCT00702520|12023939|FG000|STARTED|Base Study P05788 - Assigned Treatment||25
10857667|NCT00702520|12023940|FG001|STARTED|Base Study P05788 - Assigned Treatment||25
10857668|NCT00702520|12023941|FG002|STARTED|Base Study P05788 - Assigned Treatment||0
10857669|NCT00702520|12023942|FG003|STARTED|Base Study P05788 - Assigned Treatment||0
10857670|NCT00702520|12023939|FG000|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||25
10857671|NCT00702520|12023940|FG001|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||24
10857672|NCT00702520|12023941|FG002|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||0
10857673|NCT00702520|12023942|FG003|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||0
10857674|NCT00702520|12023939|FG000|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||25
10857675|NCT00702520|12023940|FG001|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||24
10857676|NCT00702520|12023941|FG002|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||0
10857677|NCT00702520|12023942|FG003|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||0
10857678|NCT00702520|12023939|FG000|COMPLETED|Base Study P05788 - Assigned Treatment||25
10857679|NCT00702520|12023940|FG001|COMPLETED|Base Study P05788 - Assigned Treatment||24
10857680|NCT00702520|12023941|FG002|COMPLETED|Base Study P05788 - Assigned Treatment||0
10857681|NCT00702520|12023942|FG003|COMPLETED|Base Study P05788 - Assigned Treatment||0
10857682|NCT00702520|12023939|FG000|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
10857683|NCT00702520|12023940|FG001|NOT COMPLETED|Base Study P05788 - Assigned Treatment||1
10857684|NCT00702520|12023941|FG002|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
10857685|NCT00702520|12023942|FG003|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
10857686|NCT00702520|12023939|FG000|STARTED|Base Study P05788 - Embryo Transfer||25
10857687|NCT00702520|12023940|FG001|STARTED|Base Study P05788 - Embryo Transfer||24
10857688|NCT00702520|12023941|FG002|STARTED|Base Study P05788 - Embryo Transfer||0
10857689|NCT00702520|12023942|FG003|STARTED|Base Study P05788 - Embryo Transfer||0
10857690|NCT00702520|12023939|FG000|Embryo Transfer|Base Study P05788 - Embryo Transfer||22
10857691|NCT00702520|12023940|FG001|Embryo Transfer|Base Study P05788 - Embryo Transfer||18
10857692|NCT00702520|12023941|FG002|Embryo Transfer|Base Study P05788 - Embryo Transfer||0
10857693|NCT00702520|12023942|FG003|Embryo Transfer|Base Study P05788 - Embryo Transfer||0
10857694|NCT00702520|12023939|FG000|COMPLETED|Base Study P05788 - Embryo Transfer||22
10857695|NCT00702520|12023940|FG001|COMPLETED|Base Study P05788 - Embryo Transfer||18
10545710|NCT01499355|11699175|FG000|NOT COMPLETED|Double-Blind Period||0
10857696|NCT00702520|12023941|FG002|COMPLETED|Base Study P05788 - Embryo Transfer||0
10857697|NCT00702520|12023942|FG003|COMPLETED|Base Study P05788 - Embryo Transfer||0
10857698|NCT00702520|12023939|FG000|NOT COMPLETED|Base Study P05788 - Embryo Transfer||3
10857699|NCT00702520|12023940|FG001|NOT COMPLETED|Base Study P05788 - Embryo Transfer||6
10857700|NCT00702520|12023941|FG002|NOT COMPLETED|Base Study P05788 - Embryo Transfer||0
10857701|NCT00702520|12023942|FG003|NOT COMPLETED|Base Study P05788 - Embryo Transfer||0
10857702|NCT00702520|12023939|FG000|STARTED|Base Study P05788 - Follow-Up||22
10857703|NCT00702520|12023940|FG001|STARTED|Base Study P05788 - Follow-Up||18
10857704|NCT00702520|12023941|FG002|STARTED|Base Study P05788 - Follow-Up||0
10857705|NCT00702520|12023942|FG003|STARTED|Base Study P05788 - Follow-Up||0
10857706|NCT00702520|12023939|FG000|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||7
10857707|NCT00702520|12023940|FG001|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||8
10857708|NCT00702520|12023941|FG002|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||0
10857709|NCT00702520|12023942|FG003|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||0
10857710|NCT00702520|12023939|FG000|COMPLETED|Base Study P05788 - Follow-Up||7
10293433|NCT04402866|11425999|FG003|NOT COMPLETED|Overall Study||0
10293434|NCT04402866|11426000|FG004|NOT COMPLETED|Overall Study||15
10293435|NCT04402866|11426001|FG005|NOT COMPLETED|Overall Study||14
10293436|NCT04327388|11426014|FG000|STARTED|Overall Study||161
10293437|NCT04327388|11426015|FG001|STARTED|Overall Study||173
10293438|NCT04327388|11426016|FG002|STARTED|Overall Study||86
10293439|NCT04327388|11426014|FG000|Treated|Overall Study||159
10293440|NCT04327388|11426015|FG001|Treated|Overall Study||173
10293441|NCT04327388|11426016|FG002|Treated|Overall Study||84
10293442|NCT04327388|11426014|FG000|Participants Who Received Second Dose|Overall Study||13
10293443|NCT04327388|11426015|FG001|Participants Who Received Second Dose|Overall Study||11
10293444|NCT04327388|11426016|FG002|Participants Who Received Second Dose|Overall Study||5
10293445|NCT04327388|11426014|FG000|COMPLETED|Overall Study||141
10293446|NCT04327388|11426015|FG001|COMPLETED|Overall Study||153
10293447|NCT04327388|11426016|FG002|COMPLETED|Overall Study||75
10293448|NCT04327388|11426014|FG000|NOT COMPLETED|Overall Study||20
10293449|NCT04327388|11426015|FG001|NOT COMPLETED|Overall Study||20
10293450|NCT04327388|11426016|FG002|NOT COMPLETED|Overall Study||11
10314529|NCT00165776|11448193|FG000|STARTED|Overall Study||35
10314530|NCT00165776|11448194|FG001|STARTED|Overall Study||34
10314531|NCT00165776|11448195|FG002|STARTED|Overall Study||33
10314532|NCT00165776|11448196|FG003|STARTED|Overall Study||31
10314533|NCT00165776|11448193|FG000|COMPLETED|Overall Study||31
10314534|NCT00165776|11448194|FG001|COMPLETED|Overall Study||33
10314535|NCT00165776|11448195|FG002|COMPLETED|Overall Study||31
10314536|NCT00165776|11448196|FG003|COMPLETED|Overall Study||29
10314537|NCT00165776|11448193|FG000|NOT COMPLETED|Overall Study||4
10314538|NCT00165776|11448194|FG001|NOT COMPLETED|Overall Study||1
10314539|NCT00165776|11448195|FG002|NOT COMPLETED|Overall Study||2
10314540|NCT00165776|11448196|FG003|NOT COMPLETED|Overall Study||2
10314541|NCT00165789|11448210|FG000|STARTED|Overall Study||8
10314542|NCT00165789|11448211|FG001|STARTED|Overall Study||20
10314543|NCT00165789|11448212|FG002|STARTED|Overall Study||12
10314544|NCT00165789|11448213|FG003|STARTED|Overall Study||35
10314545|NCT00165789|11448210|FG000|COMPLETED|Overall Study||8
10314546|NCT00165789|11448211|FG001|COMPLETED|Overall Study||16
10314547|NCT00165789|11448212|FG002|COMPLETED|Overall Study||11
10314548|NCT00165789|11448213|FG003|COMPLETED|Overall Study||21
10314549|NCT00165789|11448210|FG000|NOT COMPLETED|Overall Study||0
10314550|NCT00165789|11448211|FG001|NOT COMPLETED|Overall Study||4
10314551|NCT00165789|11448212|FG002|NOT COMPLETED|Overall Study||1
10314552|NCT00165789|11448213|FG003|NOT COMPLETED|Overall Study||14
10314553|NCT00165841|11448225|FG000|STARTED|Overall Study||103
10314554|NCT00165841|11448226|FG001|STARTED|Overall Study||97
10314555|NCT00165841|11448225|FG000|COMPLETED|Overall Study||73
10314556|NCT00165841|11448226|FG001|COMPLETED|Overall Study||35
10314557|NCT00165841|11448225|FG000|NOT COMPLETED|Overall Study||30
10314558|NCT00165841|11448226|FG001|NOT COMPLETED|Overall Study||62
10314559|NCT00165958|11448234|FG000|STARTED|Overall Study||19
10314560|NCT00165958|11448235|FG001|STARTED|Overall Study||21
10314561|NCT00165958|11448234|FG000|COMPLETED|Overall Study||18
10314562|NCT00165958|11448235|FG001|COMPLETED|Overall Study||19
10314563|NCT00165958|11448234|FG000|NOT COMPLETED|Overall Study||1
10314564|NCT00165958|11448235|FG001|NOT COMPLETED|Overall Study||2
10314565|NCT00165984|11448241|FG000|STARTED|Overall Study||165
10314566|NCT00165984|11448241|FG000|COMPLETED|Overall Study||150
10314567|NCT00165984|11448241|FG000|NOT COMPLETED|Overall Study||15
10857711|NCT00702520|12023940|FG001|COMPLETED|Base Study P05788 - Follow-Up||8
10314568|NCT00166036|11448250|FG000|STARTED|Overall Study||17
10314569|NCT00166036|11448251|FG001|STARTED|Overall Study||19
10314570|NCT00166036|11448250|FG000|COMPLETED|Overall Study||17
10314571|NCT00166036|11448251|FG001|COMPLETED|Overall Study||19
10314572|NCT00166036|11448250|FG000|NOT COMPLETED|Overall Study||0
10314573|NCT00166036|11448251|FG001|NOT COMPLETED|Overall Study||0
10314574|NCT00166114|11448260|FG000|STARTED|Overall Study||21
10314575|NCT00166114|11448261|FG001|STARTED|Overall Study||19
10314576|NCT00166114|11448260|FG000|COMPLETED|Overall Study||7
10314577|NCT00166114|11448261|FG001|COMPLETED|Overall Study||13
10314578|NCT00166114|11448260|FG000|NOT COMPLETED|Overall Study||14
10314579|NCT00166114|11448261|FG001|NOT COMPLETED|Overall Study||6
10314580|NCT00166166|11448269|FG000|STARTED|Overall Study||103
10314581|NCT00166166|11448270|FG001|STARTED|Overall Study||71
10314582|NCT00166166|11448269|FG000|COMPLETED|Overall Study||103
10857712|NCT00702520|12023941|FG002|COMPLETED|Base Study P05788 - Follow-Up||0
10857713|NCT00702520|12023942|FG003|COMPLETED|Base Study P05788 - Follow-Up||0
10857714|NCT00702520|12023939|FG000|NOT COMPLETED|Base Study P05788 - Follow-Up||15
10857715|NCT00702520|12023940|FG001|NOT COMPLETED|Base Study P05788 - Follow-Up||10
10857716|NCT00702520|12023941|FG002|NOT COMPLETED|Base Study P05788 - Follow-Up||0
10857717|NCT00702520|12023942|FG003|NOT COMPLETED|Base Study P05788 - Follow-Up||0
10857718|NCT00702520|12023939|FG000|STARTED|Follow-up Study P05783||7
10857719|NCT00702520|12023940|FG001|STARTED|Follow-up Study P05783||8
10857720|NCT00702520|12023941|FG002|STARTED|Follow-up Study P05783|This is the number of infants born from mothers administered Corifollitropin alpha 100 ug.|8
10857721|NCT00702520|12023942|FG003|STARTED|Follow-up Study P05783|This is the number of infants born from mothers administered Corifollitropin alpha 150 ug.|11
10857722|NCT00702520|12023939|FG000|COMPLETED|Follow-up Study P05783||7
10857723|NCT00702520|12023940|FG001|COMPLETED|Follow-up Study P05783||8
10857724|NCT00702520|12023941|FG002|COMPLETED|Follow-up Study P05783||8
10857725|NCT00702520|12023942|FG003|COMPLETED|Follow-up Study P05783||11
10857726|NCT00702520|12023939|FG000|NOT COMPLETED|Follow-up Study P05783||0
10857727|NCT00702520|12023940|FG001|NOT COMPLETED|Follow-up Study P05783||0
10293451|NCT03860259|11426026|FG000|STARTED|Overall Study||25
10293452|NCT03860259|11426027|FG001|STARTED|Overall Study||25
10293453|NCT03860259|11426026|FG000|COMPLETED|Overall Study||19
10293454|NCT03860259|11426027|FG001|COMPLETED|Overall Study||20
10293455|NCT03860259|11426026|FG000|NOT COMPLETED|Overall Study||6
10293456|NCT03860259|11426027|FG001|NOT COMPLETED|Overall Study||5
10293457|NCT03767634|11426036|FG000|STARTED|Overall Study||62145
10293458|NCT03767634|11426037|FG001|STARTED|Overall Study|8,146 neonates were included in the matched propensity score analysis|19080
10293459|NCT03767634|11426038|FG002|STARTED|Overall Study|8,146 neonates were included in the matched propensity score analysis|16282
10293460|NCT03767634|11426036|FG000|COMPLETED|Overall Study||62145
10293461|NCT03767634|11426037|FG001|COMPLETED|Overall Study|8,146 neonates were included in the matched propensity score analysis|19080
10293462|NCT03767634|11426038|FG002|COMPLETED|Overall Study|8,146 neonates were included in the matched propensity score analysis|16282
10293463|NCT03767634|11426036|FG000|NOT COMPLETED|Overall Study||0
10293464|NCT03767634|11426037|FG001|NOT COMPLETED|Overall Study||0
10293465|NCT03767634|11426038|FG002|NOT COMPLETED|Overall Study||0
10293472|NCT03388138|11426061|FG000|STARTED|Overall Study||94
10293473|NCT03388138|11426062|FG001|STARTED|Overall Study||47
10293474|NCT03388138|11426061|FG000|COMPLETED|Overall Study||93
10293475|NCT03388138|11426062|FG001|COMPLETED|Overall Study||47
10293476|NCT03388138|11426061|FG000|NOT COMPLETED|Overall Study||1
10293477|NCT03388138|11426062|FG001|NOT COMPLETED|Overall Study||0
10293478|NCT03067610|11426068|FG000|STARTED|Overall Study||72
10293479|NCT03067610|11426068|FG000|COMPLETED|Overall Study||72
10293480|NCT03067610|11426068|FG000|NOT COMPLETED|Overall Study||0
10293481|NCT03027609|11426078|FG000|STARTED|Overall Study|Safety and ITT population|79
10293482|NCT03027609|11426079|FG001|STARTED|Overall Study|Safety and ITT population|79
10293483|NCT03027609|11426078|FG000|COMPLETED|Overall Study|Safety and ITT population|49
10293484|NCT03027609|11426079|FG001|COMPLETED|Overall Study|Safety and ITT population|62
10293485|NCT03027609|11426078|FG000|NOT COMPLETED|Overall Study||30
10293486|NCT03027609|11426079|FG001|NOT COMPLETED|Overall Study||17
10293487|NCT02993107|11426095|FG000|STARTED|Overall Study||113
10293488|NCT02993107|11426096|FG001|STARTED|Overall Study||120
10293489|NCT02993107|11426097|FG002|STARTED|Overall Study||50
10293490|NCT02993107|11426098|FG003|STARTED|Overall Study||35
10293491|NCT02993107|11426099|FG004|STARTED|Overall Study||34
10293492|NCT02993107|11426100|FG005|STARTED|Overall Study||36
10293493|NCT02993107|11426095|FG000|Adverse Event|Overall Study||12
10293494|NCT02993107|11426096|FG001|Adverse Event|Overall Study||4
10293495|NCT02993107|11426097|FG002|Adverse Event|Overall Study||1
10415673|NCT00790842|11560193|FG009|Began Treatment|Dose Level 3||3
10415674|NCT00790842|11560194|FG010|Began Treatment|Dose Level 3||0
10415675|NCT00790842|11560184|FG000|COMPLETED|Dose Level 3||0
10293496|NCT02993107|11426098|FG003|Adverse Event|Overall Study||1
10293497|NCT02993107|11426099|FG004|Adverse Event|Overall Study||3
10293498|NCT02993107|11426100|FG005|Adverse Event|Overall Study||5
10293499|NCT02993107|11426095|FG000|Physician Decision|Overall Study||1
10293500|NCT02993107|11426096|FG001|Physician Decision|Overall Study||0
10293501|NCT02993107|11426097|FG002|Physician Decision|Overall Study||1
10293502|NCT02993107|11426098|FG003|Physician Decision|Overall Study||0
10293503|NCT02993107|11426099|FG004|Physician Decision|Overall Study||0
10293504|NCT02993107|11426100|FG005|Physician Decision|Overall Study||0
10293505|NCT02993107|11426095|FG000|Withdrawal by Subject|Overall Study||32
10293506|NCT02993107|11426096|FG001|Withdrawal by Subject|Overall Study||7
10293507|NCT02993107|11426097|FG002|Withdrawal by Subject|Overall Study||7
10293508|NCT02993107|11426098|FG003|Withdrawal by Subject|Overall Study||3
10293509|NCT02993107|11426099|FG004|Withdrawal by Subject|Overall Study||6
10293510|NCT02993107|11426100|FG005|Withdrawal by Subject|Overall Study||2
10415676|NCT00790842|11560185|FG001|COMPLETED|Dose Level 3||0
10415677|NCT00790842|11560186|FG002|COMPLETED|Dose Level 3||2
10415678|NCT00790842|11560187|FG003|COMPLETED|Dose Level 3||0
10415679|NCT00790842|11560188|FG004|COMPLETED|Dose Level 3||0
10857728|NCT00702520|12023941|FG002|NOT COMPLETED|Follow-up Study P05783||0
10857729|NCT00702520|12023942|FG003|NOT COMPLETED|Follow-up Study P05783||0
10857730|NCT00702338|12023952|FG000|STARTED|Base Study (NCT00697255)||5
10857731|NCT00702338|12023953|FG001|STARTED|Base Study (NCT00697255)||3
10857732|NCT00702338|12023954|FG002|STARTED|Base Study (NCT00697255)||0
10857733|NCT00702338|12023952|FG000|COMPLETED|Base Study (NCT00697255)|To complete the study, participants must have received hCG bolus injection.|2
10857734|NCT00702338|12023953|FG001|COMPLETED|Base Study (NCT00697255)|To complete the study, participants must have received hCG bolus injection.|1
10857735|NCT00702338|12023954|FG002|COMPLETED|Base Study (NCT00697255)||0
10857736|NCT00702338|12023952|FG000|NOT COMPLETED|Base Study (NCT00697255)||3
10857737|NCT00702338|12023953|FG001|NOT COMPLETED|Base Study (NCT00697255)||2
10857738|NCT00702338|12023954|FG002|NOT COMPLETED|Base Study (NCT00697255)||0
10857739|NCT00702338|12023952|FG000|STARTED|Follow-up Study: Expectant Mothers FU|To enroll in follow-up study, confirmed pregnancy at ≥10 wks after hCG bolus injection was required|0
10857804|NCT00696878|12023988|FG000|COMPLETED|Overall Study||178
10857805|NCT00696878|12023988|FG000|NOT COMPLETED|Overall Study||504
10857740|NCT00702338|12023953|FG001|STARTED|Follow-up Study: Expectant Mothers FU|To enroll in follow-up study, confirmed pregnancy at ≥10 wks after hCG bolus injection was required|1
10857741|NCT00702338|12023954|FG002|STARTED|Follow-up Study: Expectant Mothers FU||0
10857742|NCT00702338|12023952|FG000|COMPLETED|Follow-up Study: Expectant Mothers FU||0
10857743|NCT00702338|12023953|FG001|COMPLETED|Follow-up Study: Expectant Mothers FU|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|0
10857744|NCT00702338|12023954|FG002|COMPLETED|Follow-up Study: Expectant Mothers FU||0
10857745|NCT00702338|12023952|FG000|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||0
10857746|NCT00702338|12023953|FG001|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||1
10857747|NCT00702338|12023954|FG002|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||0
10857748|NCT00702338|12023952|FG000|STARTED|Follow-up Study: Infant FU||0
10857749|NCT00702338|12023953|FG001|STARTED|Follow-up Study: Infant FU||0
10857750|NCT00702338|12023954|FG002|STARTED|Follow-up Study: Infant FU|Participants died on day of delivery, did not complete follow-up visit at 4-12 weeks postpartum.|2
10857751|NCT00702338|12023952|FG000|COMPLETED|Follow-up Study: Infant FU||0
10857752|NCT00702338|12023953|FG001|COMPLETED|Follow-up Study: Infant FU||0
10857753|NCT00702338|12023954|FG002|COMPLETED|Follow-up Study: Infant FU||0
10857754|NCT00702338|12023952|FG000|NOT COMPLETED|Follow-up Study: Infant FU||0
10857755|NCT00702338|12023953|FG001|NOT COMPLETED|Follow-up Study: Infant FU||0
10857756|NCT00702338|12023954|FG002|NOT COMPLETED|Follow-up Study: Infant FU||2
10857757|NCT00702273|12023964|FG000|STARTED|Base Study P05787 (NCT00696800)|Participants randomized to the base study P05787 (NCT00696800)|757
10857758|NCT00702273|12023965|FG001|STARTED|Base Study P05787 (NCT00696800)|Participants randomized to the base study P05787 (NCT00696800)|752
10857759|NCT00702273|12023964|FG000|Treated|Base Study P05787 (NCT00696800)|Participants from the Intent to Treat group (ITT) from the base study P05787 (NCT00696800)|756
10857760|NCT00702273|12023965|FG001|Treated|Base Study P05787 (NCT00696800)|Participants from the Intent to Treat group (ITT) from the base study P05787 (NCT00696800)|750
10857761|NCT00702273|12023964|FG000|COMPLETED|Base Study P05787 (NCT00696800)|To complete study, participants from the base study P05787 (NCT00696800) had embryos transferred|672
10857762|NCT00702273|12023965|FG001|COMPLETED|Base Study P05787 (NCT00696800)|To complete study, participants from the base study P05787 (NCT00696800) had embryos transferred|704
10857763|NCT00702273|12023964|FG000|NOT COMPLETED|Base Study P05787 (NCT00696800)||85
10857764|NCT00702273|12023965|FG001|NOT COMPLETED|Base Study P05787 (NCT00696800)||48
10857765|NCT00702273|12023964|FG000|STARTED|Follow Up Study P05716 (NCT00702273)|Participants from base study,who had at least one embryo thawed for a FTET cycle.|168
10857766|NCT00702273|12023965|FG001|STARTED|Follow Up Study P05716 (NCT00702273)|Participants from base study, who had at least one embryo thawed for a FTET cycle|176
10857767|NCT00702273|12023964|FG000|COMPLETED|Follow Up Study P05716 (NCT00702273)|Participants with embryo transfer in any FTET cycle|148
10857768|NCT00702273|12023965|FG001|COMPLETED|Follow Up Study P05716 (NCT00702273)|Participants with embryo transfer in any FTET cycle|147
10857769|NCT00702273|12023964|FG000|NOT COMPLETED|Follow Up Study P05716 (NCT00702273)||20
10857770|NCT00702273|12023965|FG001|NOT COMPLETED|Follow Up Study P05716 (NCT00702273)||29
10857771|NCT00702234|12023971|FG000|STARTED|Base Study (NCT00696878)||682
10857772|NCT00702234|12023972|FG001|STARTED|Base Study (NCT00696878)||0
10857773|NCT00702234|12023971|FG000|COMPLETED|Base Study (NCT00696878)||178
10857774|NCT00702234|12023972|FG001|COMPLETED|Base Study (NCT00696878)||0
10857775|NCT00702234|12023971|FG000|NOT COMPLETED|Base Study (NCT00696878)||504
10857776|NCT00702234|12023972|FG001|NOT COMPLETED|Base Study (NCT00696878)||0
10857777|NCT00702234|12023971|FG000|STARTED|Follow-up Study: Expectant Mothers|"A participant could enter follow-up study without meeting definition for Completion of base study"|268
10857778|NCT00702234|12023972|FG001|STARTED|Follow-up Study: Expectant Mothers||0
10857779|NCT00702234|12023971|FG000|COMPLETED|Follow-up Study: Expectant Mothers||246
10857780|NCT00702234|12023972|FG001|COMPLETED|Follow-up Study: Expectant Mothers||0
10857781|NCT00702234|12023971|FG000|NOT COMPLETED|Follow-up Study: Expectant Mothers||22
10857782|NCT00702234|12023972|FG001|NOT COMPLETED|Follow-up Study: Expectant Mothers||0
10857783|NCT00702234|12023971|FG000|STARTED|Follow-up Study: Fetuses/Infants||0
10857784|NCT00702234|12023972|FG001|STARTED|Follow-up Study: Fetuses/Infants|Fetuses present 10 weeks after fresh ET and/or at enrollment of expectant mother in follow-up study|315
10857785|NCT00702234|12023971|FG000|Live Born Infants|Follow-up Study: Fetuses/Infants||0
10857786|NCT00702234|12023972|FG001|Live Born Infants|Follow-up Study: Fetuses/Infants|Of the 11 that were not live born infants, outcome is known for 8 (fetus was lost) and unknown for 3|304
10857787|NCT00702234|12023971|FG000|COMPLETED|Follow-up Study: Fetuses/Infants||0
10857788|NCT00702234|12023972|FG001|COMPLETED|Follow-up Study: Fetuses/Infants|All 288 who completed were live born infants|288
10857789|NCT00702234|12023971|FG000|NOT COMPLETED|Follow-up Study: Fetuses/Infants||0
10857790|NCT00702234|12023972|FG001|NOT COMPLETED|Follow-up Study: Fetuses/Infants||27
10857791|NCT00697255|12023981|FG000|STARTED|Stage 1a||5
10857792|NCT00697255|12023982|FG001|STARTED|Stage 1a||0
10857793|NCT00697255|12023981|FG000|COMPLETED|Stage 1a|Participants who completed 1a received hCG bolus injection and did not proceed further in the trial|2
10857794|NCT00697255|12023982|FG001|COMPLETED|Stage 1a||0
10857795|NCT00697255|12023981|FG000|NOT COMPLETED|Stage 1a||3
10857796|NCT00697255|12023982|FG001|NOT COMPLETED|Stage 1a||0
10857797|NCT00697255|12023981|FG000|STARTED|Stage 1b||0
10857798|NCT00697255|12023982|FG001|STARTED|Stage 1b|After enrollment in Stage 1a completed, a new cohort of participants enrolled in Stage 1b.|3
10857799|NCT00697255|12023981|FG000|COMPLETED|Stage 1b||0
10857800|NCT00697255|12023982|FG001|COMPLETED|Stage 1b|Participants who completed 1b received hCG bolus injection and did not proceed further in the trial|1
10857801|NCT00697255|12023981|FG000|NOT COMPLETED|Stage 1b||0
10857802|NCT00697255|12023982|FG001|NOT COMPLETED|Stage 1b||2
10857803|NCT00696878|12023988|FG000|STARTED|Overall Study||682
10857806|NCT00696800|12023994|FG000|STARTED|Overall Study||757
10857807|NCT00696800|12023995|FG001|STARTED|Overall Study||752
10857808|NCT00696800|12023994|FG000|Treated (ITT)|Overall Study|The ITT group|756
10857809|NCT00696800|12023995|FG001|Treated (ITT)|Overall Study|The ITT group|750
10857810|NCT00696800|12023994|FG000|COMPLETED|Overall Study|Participants who had embryos transferred|672
10857811|NCT00696800|12023995|FG001|COMPLETED|Overall Study|Participants who had embryos transferred|704
10857812|NCT00696800|12023994|FG000|NOT COMPLETED|Overall Study||85
10857813|NCT00696800|12023995|FG001|NOT COMPLETED|Overall Study||48
10857814|NCT00616967|12024003|FG000|STARTED|Overall Study||6
10857815|NCT00616967|12024004|FG001|STARTED|Overall Study||31
10857816|NCT00616967|12024005|FG002|STARTED|Overall Study||31
10857817|NCT00616967|12024003|FG000|COMPLETED|Overall Study||6
10293511|NCT02993107|11426095|FG000|Lost to Follow-up|Overall Study||0
10293512|NCT02993107|11426096|FG001|Lost to Follow-up|Overall Study||1
10293513|NCT02993107|11426097|FG002|Lost to Follow-up|Overall Study||0
10293514|NCT02993107|11426098|FG003|Lost to Follow-up|Overall Study||0
10293515|NCT02993107|11426099|FG004|Lost to Follow-up|Overall Study||0
10293516|NCT02993107|11426100|FG005|Lost to Follow-up|Overall Study||1
10293517|NCT02993107|11426095|FG000|Sponsor Decision|Overall Study||4
10293518|NCT02993107|11426096|FG001|Sponsor Decision|Overall Study||0
10293519|NCT02993107|11426097|FG002|Sponsor Decision|Overall Study||1
10293520|NCT02993107|11426098|FG003|Sponsor Decision|Overall Study||1
10293521|NCT02993107|11426099|FG004|Sponsor Decision|Overall Study||0
10293522|NCT02993107|11426100|FG005|Sponsor Decision|Overall Study||4
10293523|NCT02993107|11426095|FG000|Protocol Deviation|Overall Study||0
10293524|NCT02993107|11426096|FG001|Protocol Deviation|Overall Study||0
10293525|NCT02993107|11426097|FG002|Protocol Deviation|Overall Study||0
10293526|NCT02993107|11426098|FG003|Protocol Deviation|Overall Study||0
10293527|NCT02993107|11426099|FG004|Protocol Deviation|Overall Study||1
10293528|NCT02993107|11426100|FG005|Protocol Deviation|Overall Study||0
10293529|NCT02993107|11426095|FG000|Other Reasons|Overall Study||2
10293530|NCT02993107|11426096|FG001|Other Reasons|Overall Study||1
10293531|NCT02993107|11426097|FG002|Other Reasons|Overall Study||1
10293532|NCT02993107|11426098|FG003|Other Reasons|Overall Study||1
10293533|NCT02993107|11426099|FG004|Other Reasons|Overall Study||2
10293534|NCT02993107|11426100|FG005|Other Reasons|Overall Study||3
10293535|NCT02993107|11426095|FG000|COMPLETED|Overall Study||62
10293536|NCT02993107|11426096|FG001|COMPLETED|Overall Study||107
10293537|NCT02993107|11426097|FG002|COMPLETED|Overall Study||39
10293538|NCT02993107|11426098|FG003|COMPLETED|Overall Study||29
10293539|NCT02993107|11426099|FG004|COMPLETED|Overall Study||22
10293540|NCT02993107|11426100|FG005|COMPLETED|Overall Study||21
10293541|NCT02993107|11426095|FG000|NOT COMPLETED|Overall Study||51
10293542|NCT02993107|11426096|FG001|NOT COMPLETED|Overall Study||13
10293543|NCT02993107|11426097|FG002|NOT COMPLETED|Overall Study||11
10293544|NCT02993107|11426098|FG003|NOT COMPLETED|Overall Study||6
10293545|NCT02993107|11426099|FG004|NOT COMPLETED|Overall Study||12
10293546|NCT02993107|11426100|FG005|NOT COMPLETED|Overall Study||15
10293547|NCT02981082|11426128|FG000|STARTED|Overall Study||4
10293548|NCT02981082|11426129|FG001|STARTED|Overall Study||2
10293549|NCT02981082|11426128|FG000|COMPLETED|Overall Study||1
10293550|NCT02981082|11426129|FG001|COMPLETED|Overall Study||1
10293551|NCT02981082|11426128|FG000|NOT COMPLETED|Overall Study||3
10293552|NCT02981082|11426129|FG001|NOT COMPLETED|Overall Study||1
10293553|NCT02924129|11426137|FG000|STARTED|Overall Study||67
10293554|NCT02924129|11426138|FG001|STARTED|Overall Study||67
10293555|NCT02924129|11426137|FG000|COMPLETED|Overall Study||62
10293556|NCT02924129|11426138|FG001|COMPLETED|Overall Study||63
10293557|NCT02924129|11426137|FG000|NOT COMPLETED|Overall Study||5
10293558|NCT02924129|11426138|FG001|NOT COMPLETED|Overall Study||4
10293559|NCT02741700|11426146|FG000|STARTED|Overall Study||152
10293560|NCT02741700|11426147|FG001|STARTED|Overall Study||154
10293561|NCT02741700|11426146|FG000|COMPLETED|Overall Study||126
10293562|NCT02741700|11426147|FG001|COMPLETED|Overall Study||135
10293563|NCT02741700|11426146|FG000|NOT COMPLETED|Overall Study||26
10293564|NCT02741700|11426147|FG001|NOT COMPLETED|Overall Study||19
10293565|NCT02635776|11426155|FG000|STARTED|Overall Study||416
10293566|NCT02635776|11426156|FG001|STARTED|Overall Study||139
10293567|NCT02635776|11426155|FG000|COMPLETED|Overall Study||314
10293568|NCT02635776|11426156|FG001|COMPLETED|Overall Study||128
10293569|NCT02635776|11426155|FG000|NOT COMPLETED|Overall Study||102
10857818|NCT00616967|12024004|FG001|COMPLETED|Overall Study||31
10857819|NCT00616967|12024005|FG002|COMPLETED|Overall Study||30
10857820|NCT00616967|12024003|FG000|NOT COMPLETED|Overall Study||0
10857821|NCT00616967|12024004|FG001|NOT COMPLETED|Overall Study||0
10857822|NCT00616967|12024005|FG002|NOT COMPLETED|Overall Study||1
10857823|NCT00461032|12024025|FG000|STARTED|Overall Study||582
10857824|NCT00461032|12024026|FG001|STARTED|Overall Study||580
10857825|NCT00461032|12024025|FG000|COMPLETED|Overall Study||545
10857826|NCT00461032|12024026|FG001|COMPLETED|Overall Study||536
10857827|NCT00461032|12024025|FG000|NOT COMPLETED|Overall Study||37
10857828|NCT00461032|12024026|FG001|NOT COMPLETED|Overall Study||44
10857829|NCT00442338|12024035|FG000|STARTED|Overall Study||30
10857830|NCT00442338|12024036|FG001|STARTED|Overall Study||30
10857831|NCT00442338|12024037|FG002|STARTED|Overall Study||31
10857832|NCT00442338|12024035|FG000|COMPLETED|Overall Study||30
10415680|NCT00790842|11560189|FG005|COMPLETED|Dose Level 3||2
10415681|NCT00790842|11560190|FG006|COMPLETED|Dose Level 3||0
10415682|NCT00790842|11560191|FG007|COMPLETED|Dose Level 3||0
10415683|NCT00790842|11560192|FG008|COMPLETED|Dose Level 3||0
10415684|NCT00790842|11560193|FG009|COMPLETED|Dose Level 3||1
10415685|NCT00790842|11560194|FG010|COMPLETED|Dose Level 3||0
10415686|NCT00790842|11560184|FG000|NOT COMPLETED|Dose Level 3||0
10415687|NCT00790842|11560185|FG001|NOT COMPLETED|Dose Level 3||0
10415688|NCT00790842|11560186|FG002|NOT COMPLETED|Dose Level 3||5
10415689|NCT00790842|11560187|FG003|NOT COMPLETED|Dose Level 3||0
10415690|NCT00790842|11560188|FG004|NOT COMPLETED|Dose Level 3||0
10415691|NCT00790842|11560189|FG005|NOT COMPLETED|Dose Level 3||1
10415692|NCT00790842|11560190|FG006|NOT COMPLETED|Dose Level 3||0
10415693|NCT00790842|11560191|FG007|NOT COMPLETED|Dose Level 3||0
10415694|NCT00790842|11560192|FG008|NOT COMPLETED|Dose Level 3||0
10415695|NCT00790842|11560193|FG009|NOT COMPLETED|Dose Level 3||2
10415696|NCT00790842|11560194|FG010|NOT COMPLETED|Dose Level 3||0
10415697|NCT00790842|11560184|FG000|STARTED|Dose Level 4||0
10415698|NCT00790842|11560185|FG001|STARTED|Dose Level 4||0
10415699|NCT00790842|11560186|FG002|STARTED|Dose Level 4||0
10415700|NCT00790842|11560187|FG003|STARTED|Dose Level 4||0
10415701|NCT00790842|11560188|FG004|STARTED|Dose Level 4||0
10415702|NCT00790842|11560189|FG005|STARTED|Dose Level 4||0
10415703|NCT00790842|11560190|FG006|STARTED|Dose Level 4||8
10415704|NCT00790842|11560191|FG007|STARTED|Dose Level 4||0
10415705|NCT00790842|11560192|FG008|STARTED|Dose Level 4||0
10415706|NCT00790842|11560193|FG009|STARTED|Dose Level 4||0
10415707|NCT00790842|11560194|FG010|STARTED|Dose Level 4||5
10415708|NCT00790842|11560184|FG000|Began Treatment|Dose Level 4||0
10415709|NCT00790842|11560185|FG001|Began Treatment|Dose Level 4||0
10415710|NCT00790842|11560186|FG002|Began Treatment|Dose Level 4||0
10415711|NCT00790842|11560187|FG003|Began Treatment|Dose Level 4||0
10415712|NCT00790842|11560188|FG004|Began Treatment|Dose Level 4||0
10415713|NCT00790842|11560189|FG005|Began Treatment|Dose Level 4||0
10415714|NCT00790842|11560190|FG006|Began Treatment|Dose Level 4||8
10415715|NCT00790842|11560191|FG007|Began Treatment|Dose Level 4||0
10415716|NCT00790842|11560192|FG008|Began Treatment|Dose Level 4||0
10415717|NCT00790842|11560193|FG009|Began Treatment|Dose Level 4||0
10415718|NCT00790842|11560194|FG010|Began Treatment|Dose Level 4||5
10415719|NCT00790842|11560184|FG000|COMPLETED|Dose Level 4||0
10415720|NCT00790842|11560185|FG001|COMPLETED|Dose Level 4||0
10415721|NCT00790842|11560186|FG002|COMPLETED|Dose Level 4||0
10415722|NCT00790842|11560187|FG003|COMPLETED|Dose Level 4||0
10415723|NCT00790842|11560188|FG004|COMPLETED|Dose Level 4||0
10415724|NCT00790842|11560189|FG005|COMPLETED|Dose Level 4||0
10415725|NCT00790842|11560190|FG006|COMPLETED|Dose Level 4||6
10415726|NCT00790842|11560191|FG007|COMPLETED|Dose Level 4||0
10415727|NCT00790842|11560192|FG008|COMPLETED|Dose Level 4||0
10415728|NCT00790842|11560193|FG009|COMPLETED|Dose Level 4||0
10415729|NCT00790842|11560194|FG010|COMPLETED|Dose Level 4||3
10415730|NCT00790842|11560184|FG000|NOT COMPLETED|Dose Level 4||0
10415731|NCT00790842|11560185|FG001|NOT COMPLETED|Dose Level 4||0
10415732|NCT00790842|11560186|FG002|NOT COMPLETED|Dose Level 4||0
10415733|NCT00790842|11560187|FG003|NOT COMPLETED|Dose Level 4||0
10415734|NCT00790842|11560188|FG004|NOT COMPLETED|Dose Level 4||0
10415735|NCT00790842|11560189|FG005|NOT COMPLETED|Dose Level 4||0
10415736|NCT00790842|11560190|FG006|NOT COMPLETED|Dose Level 4||2
10415737|NCT00790842|11560191|FG007|NOT COMPLETED|Dose Level 4||0
10415738|NCT00790842|11560192|FG008|NOT COMPLETED|Dose Level 4||0
10857833|NCT00442338|12024036|FG001|COMPLETED|Overall Study||30
10857834|NCT00442338|12024037|FG002|COMPLETED|Overall Study||31
10415739|NCT00790842|11560193|FG009|NOT COMPLETED|Dose Level 4||0
10415740|NCT00790842|11560194|FG010|NOT COMPLETED|Dose Level 4||2
10415741|NCT00790842|11560184|FG000|STARTED|Expansion Cohort||0
10415742|NCT00790842|11560185|FG001|STARTED|Expansion Cohort||0
10415743|NCT00790842|11560186|FG002|STARTED|Expansion Cohort||14
10415744|NCT00790842|11560187|FG003|STARTED|Expansion Cohort||0
10415745|NCT00790842|11560188|FG004|STARTED|Expansion Cohort||0
10415746|NCT00790842|11560189|FG005|STARTED|Expansion Cohort||0
10415747|NCT00790842|11560190|FG006|STARTED|Expansion Cohort||2
10415748|NCT00790842|11560191|FG007|STARTED|Expansion Cohort||0
10415749|NCT00790842|11560192|FG008|STARTED|Expansion Cohort||0
10857835|NCT00442338|12024035|FG000|NOT COMPLETED|Overall Study||0
10857836|NCT00442338|12024036|FG001|NOT COMPLETED|Overall Study||0
10857837|NCT00442338|12024037|FG002|NOT COMPLETED|Overall Study||0
10857838|NCT00289874|12024047|FG000|STARTED|Overall Study||203
10857839|NCT00289874|12024048|FG001|STARTED|Overall Study||218
10857840|NCT00289874|12024047|FG000|COMPLETED|Overall Study||197
10857841|NCT00289874|12024048|FG001|COMPLETED|Overall Study||210
10857842|NCT00289874|12024047|FG000|NOT COMPLETED|Overall Study||6
10857843|NCT00289874|12024048|FG001|NOT COMPLETED|Overall Study||8
10857844|NCT00250458|12024056|FG000|STARTED|Overall Study||232
10857845|NCT00250458|12024057|FG001|STARTED|Overall Study||114
10857846|NCT00250458|12024056|FG000|COMPLETED|Overall Study||200
10857847|NCT00250458|12024057|FG001|COMPLETED|Overall Study||97
10857848|NCT00250458|12024056|FG000|NOT COMPLETED|Overall Study||32
10857849|NCT00250458|12024057|FG001|NOT COMPLETED|Overall Study||17
10857850|NCT00245570|12024063|FG000|STARTED|Treatment Period II||7
10857851|NCT00245570|12024064|FG001|STARTED|Treatment Period II||8
10857852|NCT00245570|12024065|FG002|STARTED|Treatment Period II||8
10857853|NCT00245570|12024066|FG003|STARTED|Treatment Period II||8
10857854|NCT00245570|12024067|FG004|STARTED|Treatment Period II||8
10857855|NCT00245570|12024068|FG005|STARTED|Treatment Period II||8
10857856|NCT00245570|12024063|FG000|COMPLETED|Treatment Period II||7
10857857|NCT00245570|12024064|FG001|COMPLETED|Treatment Period II||8
10857858|NCT00245570|12024065|FG002|COMPLETED|Treatment Period II||8
10857859|NCT00245570|12024066|FG003|COMPLETED|Treatment Period II||8
10857860|NCT00245570|12024067|FG004|COMPLETED|Treatment Period II||8
10857861|NCT00245570|12024068|FG005|COMPLETED|Treatment Period II||8
10857862|NCT00245570|12024063|FG000|NOT COMPLETED|Treatment Period II||0
10857863|NCT00245570|12024064|FG001|NOT COMPLETED|Treatment Period II||0
10857864|NCT00245570|12024065|FG002|NOT COMPLETED|Treatment Period II||0
10857865|NCT00245570|12024066|FG003|NOT COMPLETED|Treatment Period II||0
10857866|NCT00245570|12024067|FG004|NOT COMPLETED|Treatment Period II||0
10857867|NCT00245570|12024068|FG005|NOT COMPLETED|Treatment Period II||0
10857868|NCT00245570|12024063|FG000|STARTED|Washout Between Periods II and III||7
10857869|NCT00245570|12024064|FG001|STARTED|Washout Between Periods II and III||8
10857870|NCT00245570|12024065|FG002|STARTED|Washout Between Periods II and III||8
10857871|NCT00245570|12024066|FG003|STARTED|Washout Between Periods II and III||8
10857872|NCT00245570|12024067|FG004|STARTED|Washout Between Periods II and III||8
10857873|NCT00245570|12024068|FG005|STARTED|Washout Between Periods II and III||8
10857874|NCT00245570|12024063|FG000|COMPLETED|Washout Between Periods II and III||7
10857875|NCT00245570|12024064|FG001|COMPLETED|Washout Between Periods II and III||8
10857876|NCT00245570|12024065|FG002|COMPLETED|Washout Between Periods II and III||8
10857877|NCT00245570|12024066|FG003|COMPLETED|Washout Between Periods II and III||8
10857878|NCT00245570|12024067|FG004|COMPLETED|Washout Between Periods II and III||8
10857879|NCT00245570|12024068|FG005|COMPLETED|Washout Between Periods II and III||8
10857880|NCT00245570|12024063|FG000|NOT COMPLETED|Washout Between Periods II and III||0
10857881|NCT00245570|12024064|FG001|NOT COMPLETED|Washout Between Periods II and III||0
10857882|NCT00245570|12024065|FG002|NOT COMPLETED|Washout Between Periods II and III||0
10857883|NCT00245570|12024066|FG003|NOT COMPLETED|Washout Between Periods II and III||0
10857884|NCT00245570|12024067|FG004|NOT COMPLETED|Washout Between Periods II and III||0
10857885|NCT00245570|12024068|FG005|NOT COMPLETED|Washout Between Periods II and III||0
10857886|NCT00245570|12024063|FG000|STARTED|Treatment Period III||7
10857887|NCT00245570|12024064|FG001|STARTED|Treatment Period III||8
10857888|NCT00245570|12024065|FG002|STARTED|Treatment Period III||8
10857889|NCT00245570|12024066|FG003|STARTED|Treatment Period III||8
10857890|NCT00245570|12024067|FG004|STARTED|Treatment Period III||8
10857891|NCT00245570|12024068|FG005|STARTED|Treatment Period III||8
10857892|NCT00245570|12024063|FG000|COMPLETED|Treatment Period III||7
10415750|NCT00790842|11560193|FG009|STARTED|Expansion Cohort||0
10415751|NCT00790842|11560194|FG010|STARTED|Expansion Cohort||0
10415752|NCT00790842|11560184|FG000|Began Treatment|Expansion Cohort||0
10415753|NCT00790842|11560185|FG001|Began Treatment|Expansion Cohort||0
10415754|NCT00790842|11560186|FG002|Began Treatment|Expansion Cohort||14
10415755|NCT00790842|11560187|FG003|Began Treatment|Expansion Cohort||0
10415756|NCT00790842|11560188|FG004|Began Treatment|Expansion Cohort||0
10415757|NCT00790842|11560189|FG005|Began Treatment|Expansion Cohort||0
10415758|NCT00790842|11560190|FG006|Began Treatment|Expansion Cohort||2
10415759|NCT00790842|11560191|FG007|Began Treatment|Expansion Cohort||0
10415760|NCT00790842|11560192|FG008|Began Treatment|Expansion Cohort||0
10415761|NCT00790842|11560193|FG009|Began Treatment|Expansion Cohort||0
10415762|NCT00790842|11560194|FG010|Began Treatment|Expansion Cohort||0
10415763|NCT00790842|11560184|FG000|COMPLETED|Expansion Cohort||0
10415764|NCT00790842|11560185|FG001|COMPLETED|Expansion Cohort||0
10415765|NCT00790842|11560186|FG002|COMPLETED|Expansion Cohort||7
10415766|NCT00790842|11560187|FG003|COMPLETED|Expansion Cohort||0
10415767|NCT00790842|11560188|FG004|COMPLETED|Expansion Cohort||0
10415768|NCT00790842|11560189|FG005|COMPLETED|Expansion Cohort||0
10415769|NCT00790842|11560190|FG006|COMPLETED|Expansion Cohort||1
10415770|NCT00790842|11560191|FG007|COMPLETED|Expansion Cohort||0
10857893|NCT00245570|12024064|FG001|COMPLETED|Treatment Period III||8
10857894|NCT00245570|12024065|FG002|COMPLETED|Treatment Period III||8
10415771|NCT00790842|11560192|FG008|COMPLETED|Expansion Cohort||0
10415772|NCT00790842|11560193|FG009|COMPLETED|Expansion Cohort||0
10415773|NCT00790842|11560194|FG010|COMPLETED|Expansion Cohort||0
10415774|NCT00790842|11560184|FG000|NOT COMPLETED|Expansion Cohort||0
10415775|NCT00790842|11560185|FG001|NOT COMPLETED|Expansion Cohort||0
10415776|NCT00790842|11560186|FG002|NOT COMPLETED|Expansion Cohort||7
10415777|NCT00790842|11560187|FG003|NOT COMPLETED|Expansion Cohort||0
10857895|NCT00245570|12024066|FG003|COMPLETED|Treatment Period III||8
10857896|NCT00245570|12024067|FG004|COMPLETED|Treatment Period III||8
10857897|NCT00245570|12024068|FG005|COMPLETED|Treatment Period III||8
10857898|NCT00245570|12024063|FG000|NOT COMPLETED|Treatment Period III||0
10857899|NCT00245570|12024064|FG001|NOT COMPLETED|Treatment Period III||0
10857900|NCT00245570|12024065|FG002|NOT COMPLETED|Treatment Period III||0
10857901|NCT00245570|12024066|FG003|NOT COMPLETED|Treatment Period III||0
10857902|NCT00245570|12024067|FG004|NOT COMPLETED|Treatment Period III||0
10857903|NCT00245570|12024068|FG005|NOT COMPLETED|Treatment Period III||0
10857904|NCT00245570|12024063|FG000|STARTED|Washout Between Periods III and IV||7
10857905|NCT00245570|12024064|FG001|STARTED|Washout Between Periods III and IV|1 pt in the montelukast/placebo/salmeterol group discontinued during washout period 2 after placebo|8
10857906|NCT00245570|12024065|FG002|STARTED|Washout Between Periods III and IV||8
10857907|NCT00245570|12024066|FG003|STARTED|Washout Between Periods III and IV||8
10857908|NCT00245570|12024067|FG004|STARTED|Washout Between Periods III and IV||8
10857909|NCT00245570|12024068|FG005|STARTED|Washout Between Periods III and IV||8
10857910|NCT00245570|12024063|FG000|COMPLETED|Washout Between Periods III and IV||7
10857911|NCT00245570|12024064|FG001|COMPLETED|Washout Between Periods III and IV||7
10857912|NCT00245570|12024065|FG002|COMPLETED|Washout Between Periods III and IV||8
10857913|NCT00245570|12024066|FG003|COMPLETED|Washout Between Periods III and IV||8
10857914|NCT00245570|12024067|FG004|COMPLETED|Washout Between Periods III and IV||8
10857915|NCT00245570|12024068|FG005|COMPLETED|Washout Between Periods III and IV||8
10857916|NCT00245570|12024063|FG000|NOT COMPLETED|Washout Between Periods III and IV||0
10857917|NCT00245570|12024064|FG001|NOT COMPLETED|Washout Between Periods III and IV||1
10857918|NCT00245570|12024065|FG002|NOT COMPLETED|Washout Between Periods III and IV||0
10857919|NCT00245570|12024066|FG003|NOT COMPLETED|Washout Between Periods III and IV||0
10857920|NCT00245570|12024067|FG004|NOT COMPLETED|Washout Between Periods III and IV||0
10857921|NCT00245570|12024068|FG005|NOT COMPLETED|Washout Between Periods III and IV||0
10857922|NCT00245570|12024063|FG000|STARTED|Treatment Period IV||7
10857923|NCT00245570|12024064|FG001|STARTED|Treatment Period IV||7
10857924|NCT00245570|12024065|FG002|STARTED|Treatment Period IV||8
10857925|NCT00245570|12024066|FG003|STARTED|Treatment Period IV||8
10857926|NCT00245570|12024067|FG004|STARTED|Treatment Period IV||8
10857927|NCT00245570|12024068|FG005|STARTED|Treatment Period IV||8
10857928|NCT00245570|12024063|FG000|COMPLETED|Treatment Period IV||7
10857929|NCT00245570|12024064|FG001|COMPLETED|Treatment Period IV||7
10857930|NCT00245570|12024065|FG002|COMPLETED|Treatment Period IV||8
10857931|NCT00245570|12024066|FG003|COMPLETED|Treatment Period IV||8
10857932|NCT00245570|12024067|FG004|COMPLETED|Treatment Period IV||8
10857933|NCT00245570|12024068|FG005|COMPLETED|Treatment Period IV||8
10857934|NCT00245570|12024063|FG000|NOT COMPLETED|Treatment Period IV||0
10857935|NCT00245570|12024064|FG001|NOT COMPLETED|Treatment Period IV||0
10857936|NCT00245570|12024065|FG002|NOT COMPLETED|Treatment Period IV||0
10857937|NCT00245570|12024066|FG003|NOT COMPLETED|Treatment Period IV||0
10857938|NCT00245570|12024067|FG004|NOT COMPLETED|Treatment Period IV||0
10857939|NCT00245570|12024068|FG005|NOT COMPLETED|Treatment Period IV||0
10857940|NCT00229970|12024082|FG000|STARTED|Overall Study||78
10857941|NCT00229970|12024083|FG001|STARTED|Overall Study||72
10857942|NCT00229970|12024084|FG002|STARTED|Overall Study||75
10857943|NCT00229970|12024082|FG000|COMPLETED|Overall Study||78
10857944|NCT00229970|12024083|FG001|COMPLETED|Overall Study||72
10857945|NCT00229970|12024084|FG002|COMPLETED|Overall Study||75
10857946|NCT00229970|12024082|FG000|NOT COMPLETED|Overall Study||0
10857947|NCT00229970|12024083|FG001|NOT COMPLETED|Overall Study||0
10857948|NCT00229970|12024084|FG002|NOT COMPLETED|Overall Study||0
10857949|NCT00092131|12024092|FG000|STARTED|Treatment Period I|1 patient discontinued due to influenza which started in washout (11 days after Period I medication)|25
10857950|NCT00092131|12024093|FG001|STARTED|Treatment Period I||26
10857951|NCT00092131|12024092|FG000|COMPLETED|Treatment Period I||24
10857952|NCT00092131|12024093|FG001|COMPLETED|Treatment Period I||26
10857953|NCT00092131|12024092|FG000|NOT COMPLETED|Treatment Period I||1
10857954|NCT00092131|12024093|FG001|NOT COMPLETED|Treatment Period I||0
10857955|NCT00092131|12024092|FG000|STARTED|Treatment Period II||24
10857956|NCT00092131|12024093|FG001|STARTED|Treatment Period II|1 patient discontinued after taking Period II study medication, due to asthma exacerbation|26
10857957|NCT00092131|12024092|FG000|COMPLETED|Treatment Period II||24
10857958|NCT00092131|12024093|FG001|COMPLETED|Treatment Period II||25
10857959|NCT00092131|12024092|FG000|NOT COMPLETED|Treatment Period II||0
10857960|NCT00092131|12024093|FG001|NOT COMPLETED|Treatment Period II||1
10857961|NCT00092118|12024101|FG000|STARTED|Overall Study|1 patient discontinued after randomization due to a adverse experience that began pre-randomization.|990
10857962|NCT00092118|12024102|FG001|STARTED|Overall Study|2 patients discontinued after randomization due to adverse experience that began pre-randomization.|1002
10857963|NCT00092118|12024101|FG000|COMPLETED|Overall Study||906
10857964|NCT00092118|12024102|FG001|COMPLETED|Overall Study||913
10857965|NCT00092118|12024101|FG000|NOT COMPLETED|Overall Study||84
10857966|NCT00092118|12024102|FG001|NOT COMPLETED|Overall Study||89
10857967|NCT00090142|12024108|FG000|STARTED|Treatment Period I|1 patient was lost to follow-up after randomization and did not receive any study drug.|31
10857968|NCT00090142|12024109|FG001|STARTED|Treatment Period I||31
10857969|NCT00090142|12024108|FG000|COMPLETED|Treatment Period I||26
10857970|NCT00090142|12024109|FG001|COMPLETED|Treatment Period I||28
10857971|NCT00090142|12024108|FG000|NOT COMPLETED|Treatment Period I||5
10857972|NCT00090142|12024109|FG001|NOT COMPLETED|Treatment Period I||3
10857973|NCT00090142|12024108|FG000|STARTED|Treatment Period II||26
10857974|NCT00090142|12024109|FG001|STARTED|Treatment Period II||28
10857975|NCT00090142|12024108|FG000|COMPLETED|Treatment Period II||25
10857976|NCT00090142|12024109|FG001|COMPLETED|Treatment Period II||28
10857977|NCT00090142|12024108|FG000|NOT COMPLETED|Treatment Period II||1
10857978|NCT00090142|12024109|FG001|NOT COMPLETED|Treatment Period II||0
10857979|NCT00043108|12024115|FG000|STARTED|Overall Study||19
10857980|NCT00043108|12024115|FG000|COMPLETED|Overall Study||19
10857981|NCT00043108|12024115|FG000|NOT COMPLETED|Overall Study||0
10857982|NCT04771013|12024121|FG000|STARTED|Overall Study||22
10857983|NCT04771013|12024122|FG001|STARTED|Overall Study||22
10857984|NCT04771013|12024121|FG000|COMPLETED|Overall Study||20
10857985|NCT04771013|12024122|FG001|COMPLETED|Overall Study||16
10857986|NCT04771013|12024121|FG000|NOT COMPLETED|Overall Study||2
10857987|NCT04771013|12024122|FG001|NOT COMPLETED|Overall Study||6
10857988|NCT04497987|12024130|FG000|STARTED|Overall Study||592
10857989|NCT04497987|12024131|FG001|STARTED|Overall Study||588
10857990|NCT04497987|12024130|FG000|Received at Least One Dose of Study Drug|Overall Study||587
10857991|NCT04497987|12024131|FG001|Received at Least One Dose of Study Drug|Overall Study||588
10857992|NCT04497987|12024130|FG000|Prevention Population|Overall Study||485
10857993|NCT04497987|12024131|FG001|Prevention Population|Overall Study||487
10857994|NCT04497987|12024130|FG000|Treatment Population|Overall Study||68
10857995|NCT04497987|12024131|FG001|Treatment Population|Overall Study||66
10857996|NCT04497987|12024130|FG000|Serology Positive|Overall Study||36
10857997|NCT04497987|12024131|FG001|Serology Positive|Overall Study||35
10857998|NCT04497987|12024130|FG000|COMPLETED|Overall Study||493
10857999|NCT04497987|12024131|FG001|COMPLETED|Overall Study||521
10858000|NCT04497987|12024130|FG000|NOT COMPLETED|Overall Study||99
10858001|NCT04497987|12024131|FG001|NOT COMPLETED|Overall Study||67
10858079|NCT03180307|12024228|FG000|Safety Analysis Set|Overall Study||134
10858080|NCT03180307|12024229|FG001|Safety Analysis Set|Overall Study||16
10858081|NCT03180307|12024228|FG000|Full Analysis Set/ Intent to Image Set|Overall Study||134
10858082|NCT03180307|12024229|FG001|Full Analysis Set/ Intent to Image Set|Overall Study||0
10858083|NCT03180307|12024228|FG000|Per Protocol Analysis Set|Overall Study||106
10858084|NCT03180307|12024229|FG001|Per Protocol Analysis Set|Overall Study||0
10858085|NCT03180307|12024228|FG000|Pharmacokinetic Analysis Set|Overall Study||122
10858086|NCT03180307|12024229|FG001|Pharmacokinetic Analysis Set|Overall Study||6
10858087|NCT03180307|12024228|FG000|COMPLETED|Overall Study||128
10858088|NCT03180307|12024229|FG001|COMPLETED|Overall Study||6
10858089|NCT03180307|12024228|FG000|NOT COMPLETED|Overall Study||6
10858090|NCT03180307|12024229|FG001|NOT COMPLETED|Overall Study||0
10858091|NCT03151083|12024236|FG000|STARTED|Overall Study||27
10858092|NCT03151083|12024237|FG001|STARTED|Overall Study||20
10858093|NCT03151083|12024238|FG002|STARTED|Overall Study||30
10858094|NCT03151083|12024236|FG000|COMPLETED|Overall Study||25
10858095|NCT03151083|12024237|FG001|COMPLETED|Overall Study||19
10858096|NCT03151083|12024238|FG002|COMPLETED|Overall Study||26
10858097|NCT03151083|12024236|FG000|NOT COMPLETED|Overall Study||2
10858098|NCT03151083|12024237|FG001|NOT COMPLETED|Overall Study||1
10858099|NCT03151083|12024238|FG002|NOT COMPLETED|Overall Study||4
10858100|NCT02668822|12024248|FG000|STARTED|Overall Study||9
10858101|NCT02668822|12024249|FG001|STARTED|Overall Study||9
10858102|NCT02668822|12024248|FG000|COMPLETED|Overall Study||0
10858103|NCT02668822|12024249|FG001|COMPLETED|Overall Study||0
10858104|NCT02668822|12024248|FG000|NOT COMPLETED|Overall Study||9
10858105|NCT02668822|12024249|FG001|NOT COMPLETED|Overall Study||9
10858106|NCT02668783|12024257|FG000|STARTED|Overall Study||13
10858107|NCT02668783|12024258|FG001|STARTED|Overall Study||12
10858108|NCT02668783|12024257|FG000|Treated|Overall Study||13
10858109|NCT02668783|12024258|FG001|Treated|Overall Study||11
10858110|NCT02668783|12024257|FG000|COMPLETED|Overall Study||0
10858111|NCT02668783|12024258|FG001|COMPLETED|Overall Study||0
10858112|NCT02668783|12024257|FG000|NOT COMPLETED|Overall Study||13
10858113|NCT02668783|12024258|FG001|NOT COMPLETED|Overall Study||12
10858114|NCT02616146|12024266|FG000|STARTED|Overall Study||1512
10415778|NCT00790842|11560188|FG004|NOT COMPLETED|Expansion Cohort||0
10415779|NCT00790842|11560189|FG005|NOT COMPLETED|Expansion Cohort||0
10415780|NCT00790842|11560190|FG006|NOT COMPLETED|Expansion Cohort||1
10415781|NCT00790842|11560191|FG007|NOT COMPLETED|Expansion Cohort||0
10415782|NCT00790842|11560192|FG008|NOT COMPLETED|Expansion Cohort||0
10415783|NCT00790842|11560193|FG009|NOT COMPLETED|Expansion Cohort||0
10415784|NCT00790842|11560194|FG010|NOT COMPLETED|Expansion Cohort||0
10415785|NCT00790855|11560242|FG000|STARTED|Overall Study||25
10415786|NCT00790855|11560242|FG000|COMPLETED|Overall Study||25
10415787|NCT00790855|11560242|FG000|NOT COMPLETED|Overall Study||0
10415788|NCT00790868|11560249|FG000|STARTED|Overall Study||88
10415789|NCT00790868|11560250|FG001|STARTED|Overall Study||92
10415790|NCT00790868|11560249|FG000|COMPLETED|Overall Study||82
10415791|NCT00790868|11560250|FG001|COMPLETED|Overall Study||75
10415792|NCT00790868|11560249|FG000|NOT COMPLETED|Overall Study||6
10415793|NCT00790868|11560250|FG001|NOT COMPLETED|Overall Study||17
10415794|NCT00790907|11560261|FG000|STARTED|Overall Study||1209
10415795|NCT00790907|11560262|FG001|STARTED|Overall Study||1024
10415796|NCT00790907|11560263|FG002|STARTED|Overall Study||1002
10415797|NCT00790907|11560261|FG000|COMPLETED|Overall Study||754
10415798|NCT00790907|11560262|FG001|COMPLETED|Overall Study||684
10415799|NCT00790907|11560263|FG002|COMPLETED|Overall Study||663
10415800|NCT00790907|11560261|FG000|NOT COMPLETED|Overall Study||455
10415801|NCT00790907|11560262|FG001|NOT COMPLETED|Overall Study||340
10415802|NCT00790907|11560263|FG002|NOT COMPLETED|Overall Study||339
10415803|NCT00791037|11560270|FG000|STARTED|Overall Study||23
10858115|NCT02616146|12024267|FG001|STARTED|Overall Study||504
10858116|NCT02616146|12024266|FG000|COMPLETED|Overall Study|Due to termination of study, ENG-E2 reporting group received only up to 10 cycles of treatment.|0
10858117|NCT02616146|12024267|FG001|COMPLETED|Overall Study|Due to termination of study, LNG-EE reporting group received only up to 9 cycles of treatment.|0
10858118|NCT02616146|12024266|FG000|NOT COMPLETED|Overall Study||1512
10858119|NCT02616146|12024267|FG001|NOT COMPLETED|Overall Study||504
10858002|NCT04198584|12024140|FG000|STARTED|Overall Study||24
10858003|NCT04198584|12024141|FG001|STARTED|Overall Study||8
10858004|NCT04198584|12024140|FG000|Randomized to Wave 1|Overall Study||5
10858005|NCT04198584|12024141|FG001|Randomized to Wave 1|Overall Study||2
10858006|NCT04198584|12024140|FG000|Randomized to Wave 2|Overall Study||7
10858007|NCT04198584|12024141|FG001|Randomized to Wave 2|Overall Study||2
10858008|NCT04198584|12024140|FG000|Randomized to Wave 3|Overall Study||6
10858009|NCT04198584|12024141|FG001|Randomized to Wave 3|Overall Study||2
10858010|NCT04198584|12024140|FG000|Randomized to Wave 4|Overall Study||6
10858011|NCT04198584|12024141|FG001|Randomized to Wave 4|Overall Study||2
10858012|NCT04198584|12024140|FG000|Total Randomized|Overall Study||24
10858013|NCT04198584|12024141|FG001|Total Randomized|Overall Study||8
10858014|NCT04198584|12024140|FG000|Actually Received Treatment|Overall Study||21
10858015|NCT04198584|12024141|FG001|Actually Received Treatment|Overall Study||8
10858016|NCT04198584|12024140|FG000|COMPLETED|Overall Study||19
10858017|NCT04198584|12024141|FG001|COMPLETED|Overall Study||8
10858018|NCT04198584|12024140|FG000|NOT COMPLETED|Overall Study||5
10858019|NCT04198584|12024141|FG001|NOT COMPLETED|Overall Study||0
10858020|NCT04013932|12024154|FG000|STARTED|Overall Study||33
10858021|NCT04013932|12024155|FG001|STARTED|Overall Study||33
10858022|NCT04013932|12024154|FG000|COMPLETED|Overall Study||33
10858023|NCT04013932|12024155|FG001|COMPLETED|Overall Study||28
10858024|NCT04013932|12024154|FG000|NOT COMPLETED|Overall Study||0
10858025|NCT04013932|12024155|FG001|NOT COMPLETED|Overall Study||5
10858026|NCT03840616|12024165|FG000|STARTED|2-Week Induction Phase||147
10858027|NCT03840616|12024166|FG001|STARTED|2-Week Induction Phase||72
10858028|NCT03840616|12024165|FG000|COMPLETED|2-Week Induction Phase||123
10858029|NCT03840616|12024166|FG001|COMPLETED|2-Week Induction Phase||62
10858030|NCT03840616|12024165|FG000|NOT COMPLETED|2-Week Induction Phase||24
10858031|NCT03840616|12024166|FG001|NOT COMPLETED|2-Week Induction Phase||10
10858032|NCT03840616|12024165|FG000|STARTED|48-Week Maintenance Phase||123
10858033|NCT03840616|12024166|FG001|STARTED|48-Week Maintenance Phase||62
10858034|NCT03840616|12024165|FG000|COMPLETED|48-Week Maintenance Phase||112
10858035|NCT03840616|12024166|FG001|COMPLETED|48-Week Maintenance Phase||55
10858036|NCT03840616|12024165|FG000|NOT COMPLETED|48-Week Maintenance Phase||11
10858037|NCT03840616|12024166|FG001|NOT COMPLETED|48-Week Maintenance Phase||7
10858038|NCT03623373|12024174|FG000|STARTED|Overall Study||13
10858039|NCT03623373|12024174|FG000|COMPLETED|Overall Study||13
10858040|NCT03623373|12024174|FG000|NOT COMPLETED|Overall Study||0
10858041|NCT03581279|12024180|FG000|STARTED|Overall Study||18
10858042|NCT03581279|12024181|FG001|STARTED|Overall Study||0
10858043|NCT03581279|12024180|FG000|COMPLETED|Overall Study||16
10858044|NCT03581279|12024181|FG001|COMPLETED|Overall Study||0
10858045|NCT03581279|12024180|FG000|NOT COMPLETED|Overall Study||2
10858046|NCT03581279|12024181|FG001|NOT COMPLETED|Overall Study||0
10858047|NCT03512210|12024187|FG000|STARTED|Step 1: MINMON Intervention||400
10858048|NCT03512210|12024187|FG000|COMPLETED|Step 1: MINMON Intervention||396
10858049|NCT03512210|12024187|FG000|NOT COMPLETED|Step 1: MINMON Intervention||4
10858050|NCT03512210|12024187|FG000|STARTED|Step 2:Post-MINMON||396
10858051|NCT03512210|12024187|FG000|COMPLETED|Step 2:Post-MINMON||362
10858052|NCT03512210|12024187|FG000|NOT COMPLETED|Step 2:Post-MINMON||34
10858053|NCT03506412|12024193|FG000|STARTED|Overall Study||18
10858054|NCT03506412|12024194|FG001|STARTED|Overall Study||19
10858055|NCT03506412|12024193|FG000|COMPLETED|Overall Study||18
10858056|NCT03506412|12024194|FG001|COMPLETED|Overall Study||19
10858057|NCT03506412|12024193|FG000|NOT COMPLETED|Overall Study||0
10858058|NCT03506412|12024194|FG001|NOT COMPLETED|Overall Study||0
10858059|NCT03420768|12024203|FG000|STARTED|Overall Study||18
10858060|NCT03420768|12024204|FG001|STARTED|Overall Study||28
10415804|NCT00791037|11560270|FG000|Primary Outcome|Overall Study||19
10415805|NCT00791037|11560270|FG000|Skeletal or Bone-only Disease by FDG-PET|Overall Study||1
10858061|NCT03420768|12024205|FG002|STARTED|Overall Study||15
10858062|NCT03420768|12024203|FG000|COMPLETED|Overall Study||18
10858063|NCT03420768|12024204|FG001|COMPLETED|Overall Study||28
10858064|NCT03420768|12024205|FG002|COMPLETED|Overall Study||15
10858065|NCT03420768|12024203|FG000|NOT COMPLETED|Overall Study||0
10858066|NCT03420768|12024204|FG001|NOT COMPLETED|Overall Study||0
10858067|NCT03420768|12024205|FG002|NOT COMPLETED|Overall Study||0
10858068|NCT03395288|12024216|FG000|STARTED|Overall Study||28
10858069|NCT03395288|12024217|FG001|STARTED|Overall Study||29
10858070|NCT03395288|12024218|FG002|STARTED|Overall Study||4
10858071|NCT03395288|12024216|FG000|COMPLETED|Overall Study||19
10858072|NCT03395288|12024217|FG001|COMPLETED|Overall Study||25
10293570|NCT02635776|11426156|FG001|NOT COMPLETED|Overall Study||11
10293571|NCT02609724|11426167|FG000|STARTED|Overall Study||65
10293572|NCT02609724|11426168|FG001|STARTED|Overall Study||64
10293573|NCT02609724|11426169|FG002|STARTED|Overall Study||65
10293574|NCT02609724|11426167|FG000|Post Intensive Treatment Phase (= Primary Endpoint)|Overall Study||63
10293575|NCT02609724|11426168|FG001|Post Intensive Treatment Phase (= Primary Endpoint)|Overall Study||63
10293576|NCT02609724|11426169|FG002|Post Intensive Treatment Phase (= Primary Endpoint)|Overall Study||64
10293577|NCT02609724|11426167|FG000|COMPLETED|Overall Study|post follow-up phase|60
10858073|NCT03395288|12024218|FG002|COMPLETED|Overall Study||3
10858074|NCT03395288|12024216|FG000|NOT COMPLETED|Overall Study||9
10858075|NCT03395288|12024217|FG001|NOT COMPLETED|Overall Study||4
10858076|NCT03395288|12024218|FG002|NOT COMPLETED|Overall Study||1
10858077|NCT03180307|12024228|FG000|STARTED|Overall Study||134
10858078|NCT03180307|12024229|FG001|STARTED|Overall Study||6
10858126|NCT02524288|12024286|FG000|STARTED|Overall Study||1941
10858127|NCT02524288|12024286|FG000|Treated|Overall Study||1936
10858128|NCT02524288|12024286|FG000|COMPLETED|Overall Study||0
10858129|NCT02524288|12024286|FG000|NOT COMPLETED|Overall Study||1941
10415806|NCT00791037|11560270|FG000|COMPLETED|Overall Study||23
10415807|NCT00791037|11560270|FG000|NOT COMPLETED|Overall Study||0
10415808|NCT00791089|11560278|FG000|STARTED|Overall Study||6
10415809|NCT00791089|11560279|FG001|STARTED|Overall Study||6
10415810|NCT00791089|11560278|FG000|Began Actually Taking Fish Oil or Placeb|Overall Study||6
10415811|NCT00791089|11560279|FG001|Began Actually Taking Fish Oil or Placeb|Overall Study||5
10415812|NCT00791089|11560278|FG000|Six-month Data Collected|Overall Study||6
10415813|NCT00791089|11560279|FG001|Six-month Data Collected|Overall Study||5
10415814|NCT00791089|11560278|FG000|COMPLETED|Overall Study||0
10415815|NCT00791089|11560279|FG001|COMPLETED|Overall Study||0
10415816|NCT00791089|11560278|FG000|NOT COMPLETED|Overall Study||6
10415817|NCT00791089|11560279|FG001|NOT COMPLETED|Overall Study||6
10415818|NCT00791102|11560285|FG000|STARTED|Period 1||10
10415819|NCT00791102|11560286|FG001|STARTED|Period 1||10
10415820|NCT00791102|11560285|FG000|COMPLETED|Period 1||10
10415821|NCT00791102|11560286|FG001|COMPLETED|Period 1||10
10415822|NCT00791102|11560285|FG000|NOT COMPLETED|Period 1||0
10415823|NCT00791102|11560286|FG001|NOT COMPLETED|Period 1||0
10415824|NCT00791102|11560285|FG000|STARTED|Washout Period of 2 Weeks||10
10415825|NCT00791102|11560286|FG001|STARTED|Washout Period of 2 Weeks||10
10415826|NCT00791102|11560285|FG000|COMPLETED|Washout Period of 2 Weeks||10
10415827|NCT00791102|11560286|FG001|COMPLETED|Washout Period of 2 Weeks||10
10415828|NCT00791102|11560285|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
10415829|NCT00791102|11560286|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
10415830|NCT00791102|11560285|FG000|STARTED|Period 2||10
10415831|NCT00791102|11560286|FG001|STARTED|Period 2||10
10415832|NCT00791102|11560285|FG000|COMPLETED|Period 2||10
10415833|NCT00791102|11560286|FG001|COMPLETED|Period 2||10
10415834|NCT00791102|11560285|FG000|NOT COMPLETED|Period 2||0
10415835|NCT00791102|11560286|FG001|NOT COMPLETED|Period 2||0
10415836|NCT00791128|11560292|FG000|STARTED|Overall Study||22
10415837|NCT00791128|11560292|FG000|COMPLETED|Overall Study||13
10415838|NCT00791128|11560292|FG000|NOT COMPLETED|Overall Study||9
10415839|NCT00791219|11560299|FG000|STARTED|Overall Study||24
10415840|NCT00791219|11560300|FG001|STARTED|Overall Study||76
10415841|NCT00791219|11560301|FG002|STARTED|Overall Study||75
10415842|NCT00791219|11560299|FG000|COMPLETED|Overall Study||19
10415843|NCT00791219|11560300|FG001|COMPLETED|Overall Study||60
10415844|NCT00791219|11560301|FG002|COMPLETED|Overall Study||61
10415845|NCT00791219|11560299|FG000|NOT COMPLETED|Overall Study||5
10415846|NCT00791219|11560300|FG001|NOT COMPLETED|Overall Study||16
10415847|NCT00791219|11560301|FG002|NOT COMPLETED|Overall Study||14
10415848|NCT00791258|11560309|FG000|STARTED|Overall Study||999
10415849|NCT00791258|11560309|FG000|COMPLETED|Overall Study||736
10415850|NCT00791258|11560309|FG000|NOT COMPLETED|Overall Study||263
10415851|NCT00791323|11560315|FG000|STARTED|Overall Study||6
10415852|NCT00791323|11560316|FG001|STARTED|Overall Study||3
10415853|NCT00791323|11560315|FG000|COMPLETED|Overall Study||6
10415854|NCT00791323|11560316|FG001|COMPLETED|Overall Study||3
10415855|NCT00791323|11560315|FG000|NOT COMPLETED|Overall Study||0
10415856|NCT00791323|11560316|FG001|NOT COMPLETED|Overall Study||0
10415857|NCT00791388|11560327|FG000|STARTED|Period 1 - 50 mg Dose Group||3
10415858|NCT00791388|11560328|FG001|STARTED|Period 1 - 50 mg Dose Group||8
10415859|NCT00791388|11560329|FG002|STARTED|Period 1 - 50 mg Dose Group||0
10415860|NCT00791388|11560330|FG003|STARTED|Period 1 - 50 mg Dose Group||0
10415861|NCT00791388|11560331|FG004|STARTED|Period 1 - 50 mg Dose Group||0
10415862|NCT00791388|11560327|FG000|COMPLETED|Period 1 - 50 mg Dose Group||3
10415863|NCT00791388|11560328|FG001|COMPLETED|Period 1 - 50 mg Dose Group||7
10415864|NCT00791388|11560329|FG002|COMPLETED|Period 1 - 50 mg Dose Group||0
10415865|NCT00791388|11560330|FG003|COMPLETED|Period 1 - 50 mg Dose Group||0
10415866|NCT00791388|11560331|FG004|COMPLETED|Period 1 - 50 mg Dose Group||0
10415867|NCT00791388|11560327|FG000|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
10415868|NCT00791388|11560328|FG001|NOT COMPLETED|Period 1 - 50 mg Dose Group||1
10415869|NCT00791388|11560329|FG002|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
10415870|NCT00791388|11560330|FG003|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
10415871|NCT00791388|11560331|FG004|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
10415872|NCT00791388|11560327|FG000|STARTED|Period 2 - 100 mg Dose Group||3
10858130|NCT02489942|12024290|FG000|STARTED|Overall Study||8145
10858131|NCT02489942|12024290|FG000|Case Report Form (CRF) Collected|Overall Study||8059
10858132|NCT02489942|12024290|FG000|Treated|Overall Study||8057
10858133|NCT02489942|12024290|FG000|COMPLETED|Overall Study||4729
10858134|NCT02489942|12024290|FG000|NOT COMPLETED|Overall Study||3416
10858135|NCT02409342|12024296|FG000|STARTED|Overall Study||287
10858136|NCT02409342|12024297|FG001|STARTED|Overall Study||285
10858137|NCT02409342|12024296|FG000|COMPLETED|Overall Study||0
10858138|NCT02409342|12024297|FG001|COMPLETED|Overall Study||0
10858139|NCT02409342|12024296|FG000|NOT COMPLETED|Overall Study||287
10858140|NCT02409342|12024297|FG001|NOT COMPLETED|Overall Study||285
10858141|NCT02293655|12024307|FG000|STARTED|Overall Study||92
10858142|NCT02293655|12024308|FG001|STARTED|Overall Study||17
10858143|NCT02293655|12024307|FG000|COMPLETED|Overall Study||85
10858144|NCT02293655|12024308|FG001|COMPLETED|Overall Study||15
10858145|NCT02293655|12024307|FG000|NOT COMPLETED|Overall Study||7
10858146|NCT02293655|12024308|FG001|NOT COMPLETED|Overall Study||2
10858147|NCT02275546|12024314|FG000|STARTED|Treatment Period 1||81
10858148|NCT02275546|12024315|FG001|STARTED|Treatment Period 1||83
10858149|NCT02275546|12024314|FG000|COMPLETED|Treatment Period 1||81
10858150|NCT02275546|12024315|FG001|COMPLETED|Treatment Period 1||83
10858151|NCT02275546|12024314|FG000|NOT COMPLETED|Treatment Period 1||0
10858152|NCT02275546|12024315|FG001|NOT COMPLETED|Treatment Period 1||0
10858153|NCT02275546|12024314|FG000|STARTED|Treatment Period 2||81
10858154|NCT02275546|12024315|FG001|STARTED|Treatment Period 2||83
10858155|NCT02275546|12024314|FG000|COMPLETED|Treatment Period 2||79
10858156|NCT02275546|12024315|FG001|COMPLETED|Treatment Period 2||81
10858157|NCT02275546|12024314|FG000|NOT COMPLETED|Treatment Period 2||2
10858158|NCT02275546|12024315|FG001|NOT COMPLETED|Treatment Period 2||2
10858159|NCT02077166|12024328|FG000|STARTED|Overall Study||12
10858160|NCT02077166|12024329|FG001|STARTED|Overall Study||7
10858161|NCT02077166|12024330|FG002|STARTED|Overall Study||9
10858162|NCT02077166|12024331|FG003|STARTED|Overall Study||9
10858163|NCT02077166|12024332|FG004|STARTED|Overall Study||8
10858164|NCT02077166|12024333|FG005|STARTED|Overall Study||55
10858165|NCT02077166|12024334|FG006|STARTED|Overall Study||34
10858166|NCT02077166|12024328|FG000|COMPLETED|Overall Study||0
10858167|NCT02077166|12024329|FG001|COMPLETED|Overall Study||0
10858168|NCT02077166|12024330|FG002|COMPLETED|Overall Study||0
10858169|NCT02077166|12024331|FG003|COMPLETED|Overall Study||0
10858170|NCT02077166|12024332|FG004|COMPLETED|Overall Study||0
10858171|NCT02077166|12024333|FG005|COMPLETED|Overall Study||0
10858172|NCT02077166|12024334|FG006|COMPLETED|Overall Study||0
10858173|NCT02077166|12024328|FG000|NOT COMPLETED|Overall Study||12
10858174|NCT02077166|12024329|FG001|NOT COMPLETED|Overall Study||7
10858175|NCT02077166|12024330|FG002|NOT COMPLETED|Overall Study||9
10858176|NCT02077166|12024331|FG003|NOT COMPLETED|Overall Study||9
10858177|NCT02077166|12024332|FG004|NOT COMPLETED|Overall Study||8
10858178|NCT02077166|12024333|FG005|NOT COMPLETED|Overall Study||55
10858179|NCT02077166|12024334|FG006|NOT COMPLETED|Overall Study||34
10858180|NCT01891344|12024359|FG000|STARTED|Overall Study||40
10858181|NCT01891344|12024360|FG001|STARTED|Overall Study||82
10858182|NCT01891344|12024361|FG002|STARTED|Overall Study||70
10858183|NCT01891344|12024362|FG003|STARTED|Overall Study||12
10858184|NCT01891344|12024363|FG004|STARTED|Overall Study||84
10858185|NCT01891344|12024364|FG005|STARTED|Overall Study||73
10858186|NCT01891344|12024365|FG006|STARTED|Overall Study||107
10858187|NCT01891344|12024366|FG007|STARTED|Overall Study||23
10858188|NCT01891344|12024359|FG000|COMPLETED|Overall Study||34
10858189|NCT01891344|12024360|FG001|COMPLETED|Overall Study||80
10858190|NCT01891344|12024361|FG002|COMPLETED|Overall Study||70
10858191|NCT01891344|12024362|FG003|COMPLETED|Overall Study||11
10858192|NCT01891344|12024363|FG004|COMPLETED|Overall Study||80
10858193|NCT01891344|12024364|FG005|COMPLETED|Overall Study||72
10858194|NCT01891344|12024365|FG006|COMPLETED|Overall Study||107
10858195|NCT01891344|12024366|FG007|COMPLETED|Overall Study||23
10858196|NCT01891344|12024359|FG000|NOT COMPLETED|Overall Study||6
10858197|NCT01891344|12024360|FG001|NOT COMPLETED|Overall Study||2
10858198|NCT01891344|12024361|FG002|NOT COMPLETED|Overall Study||0
10858199|NCT01891344|12024362|FG003|NOT COMPLETED|Overall Study||1
10858200|NCT01891344|12024363|FG004|NOT COMPLETED|Overall Study||4
10858201|NCT01891344|12024364|FG005|NOT COMPLETED|Overall Study||1
10858202|NCT01891344|12024365|FG006|NOT COMPLETED|Overall Study||0
10858203|NCT01891344|12024366|FG007|NOT COMPLETED|Overall Study||0
10858204|NCT01847274|12024388|FG000|STARTED|Overall Study||138
10858205|NCT01847274|12024389|FG001|STARTED|Overall Study||65
10858206|NCT01847274|12024390|FG002|STARTED|Overall Study||234
10858207|NCT01847274|12024391|FG003|STARTED|Overall Study||116
10858208|NCT01847274|12024388|FG000|COMPLETED|Overall Study||47
10858209|NCT01847274|12024389|FG001|COMPLETED|Overall Study||4
10858210|NCT01847274|12024390|FG002|COMPLETED|Overall Study||46
10858211|NCT01847274|12024391|FG003|COMPLETED|Overall Study||12
10858212|NCT01847274|12024388|FG000|NOT COMPLETED|Overall Study||91
10858213|NCT01847274|12024389|FG001|NOT COMPLETED|Overall Study||61
10858214|NCT01847274|12024390|FG002|NOT COMPLETED|Overall Study||188
10858215|NCT01847274|12024391|FG003|NOT COMPLETED|Overall Study||104
10858216|NCT01670656|12024406|FG000|STARTED|Overall Study||86
10858217|NCT01670656|12024407|FG001|STARTED|Overall Study||91
10858218|NCT01670656|12024408|FG002|STARTED|Overall Study||87
10858219|NCT01670656|12024409|FG003|STARTED|Overall Study||85
10858220|NCT01670656|12024410|FG004|STARTED|Overall Study||90
10858221|NCT01670656|12024406|FG000|Treated|Overall Study||86
10858222|NCT01670656|12024407|FG001|Treated|Overall Study||91
10858223|NCT01670656|12024408|FG002|Treated|Overall Study||86
10858224|NCT01670656|12024409|FG003|Treated|Overall Study||85
10858225|NCT01670656|12024410|FG004|Treated|Overall Study||90
10858226|NCT01670656|12024406|FG000|COMPLETED|Overall Study||83
10858227|NCT01670656|12024407|FG001|COMPLETED|Overall Study||84
10858228|NCT01670656|12024408|FG002|COMPLETED|Overall Study||79
10858229|NCT01670656|12024409|FG003|COMPLETED|Overall Study||79
10858230|NCT01670656|12024410|FG004|COMPLETED|Overall Study||79
10858231|NCT01670656|12024406|FG000|NOT COMPLETED|Overall Study||3
10858232|NCT01670656|12024407|FG001|NOT COMPLETED|Overall Study||7
10858233|NCT01670656|12024408|FG002|NOT COMPLETED|Overall Study||8
10858234|NCT01670656|12024409|FG003|NOT COMPLETED|Overall Study||6
10858235|NCT01670656|12024410|FG004|NOT COMPLETED|Overall Study||11
10858236|NCT01501955|12024424|FG000|STARTED|Overall Study||11
10858237|NCT01501955|12024425|FG001|STARTED|Overall Study||9
10858238|NCT01501955|12024424|FG000|Surgery|Overall Study||11
10858239|NCT01501955|12024425|FG001|Surgery|Overall Study||9
10858240|NCT01501955|12024424|FG000|6 Weeks Postop|Overall Study|1 patient withdrew on own request|10
10858241|NCT01501955|12024425|FG001|6 Weeks Postop|Overall Study||9
10858242|NCT01501955|12024424|FG000|1 Year Postop|Overall Study|1 patient terminated due to stem revision|9
10858243|NCT01501955|12024425|FG001|1 Year Postop|Overall Study|2 patients terminated due to stem revision|7
10858244|NCT01501955|12024424|FG000|2 Years Postop|Overall Study||9
10858245|NCT01501955|12024425|FG001|2 Years Postop|Overall Study|1 patient terminated due to stem revision|6
10858246|NCT01501955|12024424|FG000|COMPLETED|Overall Study||9
10858247|NCT01501955|12024425|FG001|COMPLETED|Overall Study||6
10858248|NCT01501955|12024424|FG000|NOT COMPLETED|Overall Study||2
10858249|NCT01501955|12024425|FG001|NOT COMPLETED|Overall Study||3
10858262|NCT01277211|12024442|FG000|STARTED|Overall Study||738
10858263|NCT01277211|12024443|FG001|STARTED|Overall Study||245
10858264|NCT01277211|12024442|FG000|Treated|Overall Study||714
10858265|NCT01277211|12024443|FG001|Treated|Overall Study||232
10858266|NCT01277211|12024442|FG000|COMPLETED|Overall Study||588
10858267|NCT01277211|12024443|FG001|COMPLETED|Overall Study||182
10858268|NCT01277211|12024442|FG000|NOT COMPLETED|Overall Study||150
10858269|NCT01277211|12024443|FG001|NOT COMPLETED|Overall Study||63
10858270|NCT01267812|12024449|FG000|STARTED|Overall Study||23
10858271|NCT01267812|12024449|FG000|COMPLETED|Overall Study||23
10858272|NCT01267812|12024449|FG000|NOT COMPLETED|Overall Study||0
10858273|NCT01244828|12024453|FG000|STARTED|Overall Study|Received study drug|157
10858274|NCT01244828|12024453|FG000|COMPLETED|Overall Study||79
10858275|NCT01244828|12024453|FG000|NOT COMPLETED|Overall Study||78
10293578|NCT02609724|11426168|FG001|COMPLETED|Overall Study|post follow-up phase|61
10858279|NCT01181778|12024461|FG000|STARTED|Overall Study||1919
10858280|NCT01181778|12024461|FG000|COMPLETED|Overall Study||1871
10858281|NCT01181778|12024461|FG000|NOT COMPLETED|Overall Study||48
10858282|NCT01047540|12024472|FG000|STARTED|Overall Study||34
10858283|NCT01047540|12024473|FG001|STARTED|Overall Study||32
10858284|NCT01047540|12024474|FG002|STARTED|Overall Study||29
10858285|NCT01047540|12024475|FG003|STARTED|Overall Study||31
10858286|NCT01047540|12024476|FG004|STARTED|Overall Study||30
10858287|NCT01047540|12024472|FG000|COMPLETED|Overall Study||29
10858288|NCT01047540|12024473|FG001|COMPLETED|Overall Study||32
10858289|NCT01047540|12024474|FG002|COMPLETED|Overall Study||26
10858290|NCT01047540|12024475|FG003|COMPLETED|Overall Study||31
10858291|NCT01047540|12024476|FG004|COMPLETED|Overall Study||29
10858292|NCT01047540|12024472|FG000|NOT COMPLETED|Overall Study||5
10858293|NCT01047540|12024473|FG001|NOT COMPLETED|Overall Study||0
10858294|NCT01047540|12024474|FG002|NOT COMPLETED|Overall Study||3
10858295|NCT01047540|12024475|FG003|NOT COMPLETED|Overall Study||0
10858296|NCT01047540|12024476|FG004|NOT COMPLETED|Overall Study||1
10858297|NCT01044056|12024491|FG000|STARTED|Overall Study||8
10858298|NCT01044056|12024492|FG001|STARTED|Overall Study||8
10858299|NCT01044056|12024493|FG002|STARTED|Overall Study||8
10858300|NCT01044056|12024491|FG000|COMPLETED|Overall Study||8
10858301|NCT01044056|12024492|FG001|COMPLETED|Overall Study||8
10858302|NCT01044056|12024493|FG002|COMPLETED|Overall Study||8
10858303|NCT01044056|12024491|FG000|NOT COMPLETED|Overall Study||0
10858304|NCT01044056|12024492|FG001|NOT COMPLETED|Overall Study||0
10858305|NCT01044056|12024493|FG002|NOT COMPLETED|Overall Study||0
10858306|NCT00944216|12024501|FG000|STARTED|Overall Study||1
10858307|NCT00944216|12024501|FG000|COMPLETED|Overall Study||1
10858308|NCT00944216|12024501|FG000|NOT COMPLETED|Overall Study||0
10858309|NCT00886691|12024508|FG000|STARTED|Overall Study||75
10858310|NCT00886691|12024509|FG001|STARTED|Overall Study||75
10858311|NCT00886691|12024508|FG000|COMPLETED|Overall Study||75
10858312|NCT00886691|12024509|FG001|COMPLETED|Overall Study||75
10858313|NCT00886691|12024508|FG000|NOT COMPLETED|Overall Study||0
10858314|NCT00886691|12024509|FG001|NOT COMPLETED|Overall Study||0
10858315|NCT00778999|12024521|FG000|STARTED|Overall Study||223
10858316|NCT00778999|12024522|FG001|STARTED|Overall Study||219
10858317|NCT00778999|12024521|FG000|COMPLETED|Overall Study||195
10858318|NCT00778999|12024522|FG001|COMPLETED|Overall Study||185
10858319|NCT00778999|12024521|FG000|NOT COMPLETED|Overall Study||28
10858320|NCT00778999|12024522|FG001|NOT COMPLETED|Overall Study||34
10858321|NCT00620464|12024530|FG000|STARTED|Overall Study||52
10858322|NCT00620464|12024531|FG001|STARTED|Overall Study||56
10858323|NCT00620464|12024530|FG000|COMPLETED|Overall Study||32
10858324|NCT00620464|12024531|FG001|COMPLETED|Overall Study||32
10858325|NCT00620464|12024530|FG000|NOT COMPLETED|Overall Study||20
10858326|NCT00620464|12024531|FG001|NOT COMPLETED|Overall Study||24
10858327|NCT00620035|12024537|FG000|STARTED|Overall Study||301
10858328|NCT00620035|12024537|FG000|COMPLETED|Overall Study||156
10858329|NCT00620035|12024537|FG000|NOT COMPLETED|Overall Study||145
10858330|NCT00210249|12024541|FG000|STARTED|Overall Study||364
10858331|NCT00210249|12024541|FG000|COMPLETED|Overall Study||348
10858332|NCT00210249|12024541|FG000|NOT COMPLETED|Overall Study||16
10858333|NCT03704142|12024549|FG000|STARTED|Overall Study||10
10858334|NCT03704142|12024550|FG001|STARTED|Overall Study||10
10858335|NCT03704142|12024551|FG002|STARTED|Overall Study||10
10858336|NCT03704142|12024552|FG003|STARTED|Overall Study||10
10858337|NCT03704142|12024549|FG000|COMPLETED|Overall Study||10
10858338|NCT03704142|12024550|FG001|COMPLETED|Overall Study||10
10858339|NCT03704142|12024551|FG002|COMPLETED|Overall Study||10
10858340|NCT03704142|12024552|FG003|COMPLETED|Overall Study||10
10858341|NCT03704142|12024549|FG000|NOT COMPLETED|Overall Study||0
10858342|NCT03704142|12024550|FG001|NOT COMPLETED|Overall Study||0
10858343|NCT03704142|12024551|FG002|NOT COMPLETED|Overall Study||0
10858344|NCT03704142|12024552|FG003|NOT COMPLETED|Overall Study||0
10858351|NCT03626168|12024573|FG000|STARTED|First Intervention (4 Weeks)||9
10858352|NCT03626168|12024574|FG001|STARTED|First Intervention (4 Weeks)||12
10858353|NCT03626168|12024573|FG000|COMPLETED|First Intervention (4 Weeks)||8
10858354|NCT03626168|12024574|FG001|COMPLETED|First Intervention (4 Weeks)||11
10858443|NCT03653026|12024666|FG000|STARTED|Part 2: Open-label Extension||0
10858355|NCT03626168|12024573|FG000|NOT COMPLETED|First Intervention (4 Weeks)||1
10858356|NCT03626168|12024574|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1
10858357|NCT03626168|12024573|FG000|STARTED|Washout (2 Weeks)||8
10858358|NCT03626168|12024574|FG001|STARTED|Washout (2 Weeks)||11
10858359|NCT03626168|12024573|FG000|COMPLETED|Washout (2 Weeks)||8
10858360|NCT03626168|12024574|FG001|COMPLETED|Washout (2 Weeks)||11
10858361|NCT03626168|12024573|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10858362|NCT03626168|12024574|FG001|NOT COMPLETED|Washout (2 Weeks)||0
10858363|NCT03626168|12024573|FG000|STARTED|Second Intervention (4 Weeks)||8
10858364|NCT03626168|12024574|FG001|STARTED|Second Intervention (4 Weeks)||11
10858365|NCT03626168|12024573|FG000|COMPLETED|Second Intervention (4 Weeks)||8
10858366|NCT03626168|12024574|FG001|COMPLETED|Second Intervention (4 Weeks)||9
10858367|NCT03626168|12024573|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
10858368|NCT03626168|12024574|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||2
10858369|NCT03597035|12024580|FG000|STARTED|Overall Study||8
10858370|NCT03597035|12024580|FG000|COMPLETED|Overall Study||4
10858371|NCT03597035|12024580|FG000|NOT COMPLETED|Overall Study||4
10858381|NCT04823221|12024598|FG000|STARTED|Overall Study||22
10858382|NCT04823221|12024598|FG000|COMPLETED|Overall Study||22
10858383|NCT04823221|12024598|FG000|NOT COMPLETED|Overall Study||0
10858384|NCT04579393|12024604|FG000|STARTED|Overall Study||30
10858385|NCT04579393|12024605|FG001|STARTED|Overall Study||29
10858386|NCT04579393|12024604|FG000|COMPLETED|Overall Study||27
10858387|NCT04579393|12024605|FG001|COMPLETED|Overall Study||24
10858388|NCT04579393|12024604|FG000|NOT COMPLETED|Overall Study||3
10858389|NCT04579393|12024605|FG001|NOT COMPLETED|Overall Study||5
10858409|NCT03796637|12024639|FG000|STARTED|Overall Study||6
10858410|NCT03796637|12024639|FG000|COMPLETED|Overall Study||6
10858411|NCT03796637|12024639|FG000|NOT COMPLETED|Overall Study||0
10858412|NCT03679884|12024648|FG000|STARTED|Overall Study||142
10858413|NCT03679884|12024649|FG001|STARTED|Overall Study||268
10858414|NCT03679884|12024650|FG002|STARTED|Overall Study||137
10858415|NCT03679884|12024651|FG003|STARTED|Overall Study||128
10858416|NCT03679884|12024652|FG004|STARTED|Overall Study||126
10858417|NCT03679884|12024648|FG000|COMPLETED|Overall Study||99
10858418|NCT03679884|12024649|FG001|COMPLETED|Overall Study||190
10858419|NCT03679884|12024650|FG002|COMPLETED|Overall Study||93
10858420|NCT03679884|12024651|FG003|COMPLETED|Overall Study||78
10858421|NCT03679884|12024652|FG004|COMPLETED|Overall Study||90
10858422|NCT03679884|12024648|FG000|NOT COMPLETED|Overall Study||43
10858423|NCT03679884|12024649|FG001|NOT COMPLETED|Overall Study||78
10858424|NCT03679884|12024650|FG002|NOT COMPLETED|Overall Study||44
10858425|NCT03679884|12024651|FG003|NOT COMPLETED|Overall Study||50
10858426|NCT03679884|12024652|FG004|NOT COMPLETED|Overall Study||36
10858427|NCT03653026|12024666|FG000|STARTED|Part 1: Placebo-controlled Period||345
10858428|NCT03653026|12024667|FG001|STARTED|Part 1: Placebo-controlled Period||177
10858429|NCT03653026|12024668|FG002|STARTED|Part 1: Placebo-controlled Period||0
10858430|NCT03653026|12024669|FG003|STARTED|Part 1: Placebo-controlled Period||0
10858431|NCT03653026|12024666|FG000|Received Treatment|Part 1: Placebo-controlled Period||344
10858432|NCT03653026|12024667|FG001|Received Treatment|Part 1: Placebo-controlled Period||177
10858433|NCT03653026|12024668|FG002|Received Treatment|Part 1: Placebo-controlled Period||0
10858434|NCT03653026|12024669|FG003|Received Treatment|Part 1: Placebo-controlled Period||0
10858435|NCT03653026|12024666|FG000|COMPLETED|Part 1: Placebo-controlled Period||334
10858436|NCT03653026|12024667|FG001|COMPLETED|Part 1: Placebo-controlled Period||164
10858437|NCT03653026|12024668|FG002|COMPLETED|Part 1: Placebo-controlled Period||0
10858438|NCT03653026|12024669|FG003|COMPLETED|Part 1: Placebo-controlled Period||0
10858439|NCT03653026|12024666|FG000|NOT COMPLETED|Part 1: Placebo-controlled Period||11
10858390|NCT04426656|12024614|FG000|STARTED|Overall Study||24
10858391|NCT04426656|12024615|FG001|STARTED|Overall Study||46
10858392|NCT04426656|12024614|FG000|COMPLETED|Overall Study||21
10858393|NCT04426656|12024615|FG001|COMPLETED|Overall Study||43
10858394|NCT04426656|12024614|FG000|NOT COMPLETED|Overall Study||3
10858395|NCT04426656|12024615|FG001|NOT COMPLETED|Overall Study||3
10858396|NCT04325906|12024623|FG000|STARTED|Overall Study||112
10858397|NCT04325906|12024624|FG001|STARTED|Overall Study||112
10858398|NCT04325906|12024623|FG000|COMPLETED|Overall Study||110
10858399|NCT04325906|12024624|FG001|COMPLETED|Overall Study||112
10858400|NCT04325906|12024623|FG000|NOT COMPLETED|Overall Study||2
10858401|NCT04325906|12024624|FG001|NOT COMPLETED|Overall Study||0
10858402|NCT04319445|12024630|FG000|STARTED|Overall Study||144
10858403|NCT04319445|12024630|FG000|COMPLETED|Overall Study||144
10858404|NCT04319445|12024630|FG000|NOT COMPLETED|Overall Study||0
10858405|NCT04203667|12024634|FG000|STARTED|Overall Study||66
10858406|NCT04203667|12024634|FG000|Per Protocol Population|Overall Study||45
10858407|NCT04203667|12024634|FG000|COMPLETED|Overall Study||62
10858408|NCT04203667|12024634|FG000|NOT COMPLETED|Overall Study||4
10858440|NCT03653026|12024667|FG001|NOT COMPLETED|Part 1: Placebo-controlled Period||13
10858441|NCT03653026|12024668|FG002|NOT COMPLETED|Part 1: Placebo-controlled Period||0
10858442|NCT03653026|12024669|FG003|NOT COMPLETED|Part 1: Placebo-controlled Period||0
10858444|NCT03653026|12024667|FG001|STARTED|Part 2: Open-label Extension||0
10858445|NCT03653026|12024668|FG002|STARTED|Part 2: Open-label Extension||68
10858446|NCT03653026|12024669|FG003|STARTED|Part 2: Open-label Extension||116
10858447|NCT03653026|12024666|FG000|COMPLETED|Part 2: Open-label Extension||0
10858448|NCT03653026|12024667|FG001|COMPLETED|Part 2: Open-label Extension||0
10858449|NCT03653026|12024668|FG002|COMPLETED|Part 2: Open-label Extension||65
10858450|NCT03653026|12024669|FG003|COMPLETED|Part 2: Open-label Extension||111
10858451|NCT03653026|12024666|FG000|NOT COMPLETED|Part 2: Open-label Extension||0
10858452|NCT03653026|12024667|FG001|NOT COMPLETED|Part 2: Open-label Extension||0
10858453|NCT03653026|12024668|FG002|NOT COMPLETED|Part 2: Open-label Extension||3
10858454|NCT03653026|12024669|FG003|NOT COMPLETED|Part 2: Open-label Extension||5
10858455|NCT03648827|12024677|FG000|STARTED|Overall Study||20
10858456|NCT03648827|12024677|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20
10858457|NCT03648827|12024677|FG000|COMPLETED|Overall Study||20
10858458|NCT03648827|12024677|FG000|NOT COMPLETED|Overall Study||0
10858459|NCT03553498|12024683|FG000|STARTED|Overall Study||81
10858460|NCT03553498|12024684|FG001|STARTED|Overall Study||81
10858461|NCT03553498|12024683|FG000|COMPLETED|Overall Study||80
10858462|NCT03553498|12024684|FG001|COMPLETED|Overall Study||79
10858463|NCT03553498|12024683|FG000|NOT COMPLETED|Overall Study||1
10858464|NCT03553498|12024684|FG001|NOT COMPLETED|Overall Study||2
10858465|NCT03530293|12024692|FG000|STARTED|Pre-randomization||81
10858466|NCT03530293|12024693|FG001|STARTED|Pre-randomization||0
10858467|NCT03530293|12024694|FG002|STARTED|Pre-randomization||0
10858468|NCT03530293|12024692|FG000|Safety Analysis Set|Pre-randomization||80
10858469|NCT03530293|12024693|FG001|Safety Analysis Set|Pre-randomization||0
10858470|NCT03530293|12024694|FG002|Safety Analysis Set|Pre-randomization||0
10858471|NCT03530293|12024692|FG000|COMPLETED|Pre-randomization||57
10858472|NCT03530293|12024693|FG001|COMPLETED|Pre-randomization||0
10858473|NCT03530293|12024694|FG002|COMPLETED|Pre-randomization||0
10858474|NCT03530293|12024692|FG000|NOT COMPLETED|Pre-randomization||24
10858475|NCT03530293|12024693|FG001|NOT COMPLETED|Pre-randomization||0
10858476|NCT03530293|12024694|FG002|NOT COMPLETED|Pre-randomization||0
10858477|NCT03530293|12024692|FG000|STARTED|Randomized Withdrawal Period / Follow-up||0
10858478|NCT03530293|12024693|FG001|STARTED|Randomized Withdrawal Period / Follow-up||26
10858479|NCT03530293|12024694|FG002|STARTED|Randomized Withdrawal Period / Follow-up||26
10858480|NCT03530293|12024692|FG000|COMPLETED|Randomized Withdrawal Period / Follow-up||0
10858481|NCT03530293|12024693|FG001|COMPLETED|Randomized Withdrawal Period / Follow-up||9
10858482|NCT03530293|12024694|FG002|COMPLETED|Randomized Withdrawal Period / Follow-up||9
10858483|NCT03530293|12024692|FG000|NOT COMPLETED|Randomized Withdrawal Period / Follow-up||0
10858484|NCT03530293|12024693|FG001|NOT COMPLETED|Randomized Withdrawal Period / Follow-up||17
10858485|NCT03530293|12024694|FG002|NOT COMPLETED|Randomized Withdrawal Period / Follow-up||17
10858486|NCT03505749|12024703|FG000|STARTED|Overall Study||38
10858487|NCT03505749|12024704|FG001|STARTED|Overall Study||45
10858488|NCT03505749|12024703|FG000|COMPLETED|Overall Study||22
10858489|NCT03505749|12024704|FG001|COMPLETED|Overall Study||28
10858490|NCT03505749|12024703|FG000|NOT COMPLETED|Overall Study||16
10858491|NCT03505749|12024704|FG001|NOT COMPLETED|Overall Study||17
10858497|NCT03311269|12024719|FG000|STARTED|Overall Study||10
10858498|NCT03311269|12024720|FG001|STARTED|Overall Study||9
10858499|NCT03311269|12024719|FG000|COMPLETED|Overall Study||10
10858500|NCT03311269|12024720|FG001|COMPLETED|Overall Study||9
10858501|NCT03311269|12024719|FG000|NOT COMPLETED|Overall Study||0
10858502|NCT03311269|12024720|FG001|NOT COMPLETED|Overall Study||0
10858503|NCT03249376|12024728|FG000|STARTED|Overall Study|191 patients were randomized but only 188 patients received study drug. The number completed and discontinued is based on the 188 patients that received study drug.|188
10858504|NCT03249376|12024729|FG001|STARTED|Overall Study|190 patients were randomized but only 189 patients received study drug. The number completed and discontinued is based on the 189 patients that received study drug.|189
10858505|NCT03249376|12024728|FG000|COMPLETED|Overall Study||167
10858506|NCT03249376|12024729|FG001|COMPLETED|Overall Study||166
10858507|NCT03249376|12024728|FG000|NOT COMPLETED|Overall Study||21
10858508|NCT03249376|12024729|FG001|NOT COMPLETED|Overall Study||23
10858509|NCT03137381|12024739|FG000|STARTED|Overall Study||44
10858510|NCT03137381|12024740|FG001|STARTED|Overall Study||30
10858511|NCT03137381|12024741|FG002|STARTED|Overall Study||38
10858512|NCT03137381|12024742|FG003|STARTED|Overall Study||37
10858513|NCT03137381|12024739|FG000|Safety Population|Overall Study||44
10858514|NCT03137381|12024740|FG001|Safety Population|Overall Study||29
10858515|NCT03137381|12024741|FG002|Safety Population|Overall Study||38
10858516|NCT03137381|12024742|FG003|Safety Population|Overall Study||36
10858517|NCT03137381|12024739|FG000|COMPLETED|Overall Study||35
10858518|NCT03137381|12024740|FG001|COMPLETED|Overall Study||23
10858519|NCT03137381|12024741|FG002|COMPLETED|Overall Study||30
10858520|NCT03137381|12024742|FG003|COMPLETED|Overall Study||36
10858521|NCT03137381|12024739|FG000|NOT COMPLETED|Overall Study||9
10858522|NCT03137381|12024740|FG001|NOT COMPLETED|Overall Study||7
10858523|NCT03137381|12024741|FG002|NOT COMPLETED|Overall Study||8
10858524|NCT03137381|12024742|FG003|NOT COMPLETED|Overall Study||1
10858525|NCT03118570|12024757|FG000|STARTED|Overall Study||31
10858526|NCT03118570|12024758|FG001|STARTED|Overall Study||29
10858527|NCT03118570|12024759|FG002|STARTED|Overall Study||30
10858528|NCT03118570|12024760|FG003|STARTED|Overall Study||2
10858529|NCT03118570|12024761|FG004|STARTED|Overall Study||20
10858530|NCT03118570|12024757|FG000|Reassigned From Placebo to 20 mg/kg Open-Label Setrusumab|Overall Study||0
10858531|NCT03118570|12024758|FG001|Reassigned From Placebo to 20 mg/kg Open-Label Setrusumab|Overall Study||0
10858532|NCT03118570|12024759|FG002|Reassigned From Placebo to 20 mg/kg Open-Label Setrusumab|Overall Study||0
10858533|NCT03118570|12024760|FG003|Reassigned From Placebo to 20 mg/kg Open-Label Setrusumab|Overall Study||0
10858534|NCT03118570|12024761|FG004|Reassigned From Placebo to 20 mg/kg Open-Label Setrusumab|Overall Study||19
10858535|NCT03118570|12024757|FG000|COMPLETED|Overall Study||26
10858536|NCT03118570|12024758|FG001|COMPLETED|Overall Study||22
10858537|NCT03118570|12024759|FG002|COMPLETED|Overall Study||25
10858538|NCT03118570|12024760|FG003|COMPLETED|Overall Study||2
10858539|NCT03118570|12024761|FG004|COMPLETED|Overall Study||15
10858540|NCT03118570|12024757|FG000|NOT COMPLETED|Overall Study||5
10858541|NCT03118570|12024758|FG001|NOT COMPLETED|Overall Study||7
10858542|NCT03118570|12024759|FG002|NOT COMPLETED|Overall Study||5
10858543|NCT03118570|12024760|FG003|NOT COMPLETED|Overall Study||0
10858544|NCT03118570|12024761|FG004|NOT COMPLETED|Overall Study||5
10858545|NCT03094416|12024774|FG000|STARTED|Run-in||66
10858546|NCT03094416|12024774|FG000|COMPLETED|Run-in||47
10858547|NCT03094416|12024774|FG000|NOT COMPLETED|Run-in||19
10858548|NCT03094416|12024774|FG000|STARTED|Treatment Period||47
10858549|NCT03094416|12024774|FG000|COMPLETED|Treatment Period||45
10858550|NCT03094416|12024774|FG000|NOT COMPLETED|Treatment Period||2
10858551|NCT02933671|12024781|FG000|STARTED|Overall Study||5
10858552|NCT02933671|12024782|FG001|STARTED|Overall Study||5
10858553|NCT02933671|12024781|FG000|COMPLETED|Overall Study||5
10858554|NCT02933671|12024782|FG001|COMPLETED|Overall Study||5
10858555|NCT02933671|12024781|FG000|NOT COMPLETED|Overall Study||0
10858556|NCT02933671|12024782|FG001|NOT COMPLETED|Overall Study||0
10858557|NCT02734667|12024790|FG000|STARTED|Overall Study||84
10858558|NCT02734667|12024791|FG001|STARTED|Overall Study||36
10858559|NCT02734667|12024790|FG000|Youth|Overall Study||42
10858560|NCT02734667|12024791|FG001|Youth|Overall Study||18
10858561|NCT02734667|12024790|FG000|Parent|Overall Study||42
10858562|NCT02734667|12024791|FG001|Parent|Overall Study||18
10858563|NCT02734667|12024790|FG000|COMPLETED|Overall Study||82
10858564|NCT02734667|12024791|FG001|COMPLETED|Overall Study||30
10858565|NCT02734667|12024790|FG000|NOT COMPLETED|Overall Study||2
10858566|NCT02734667|12024791|FG001|NOT COMPLETED|Overall Study||6
10858567|NCT02709317|12024799|FG000|STARTED|Overall Study||50
10858568|NCT02709317|12024800|FG001|STARTED|Overall Study||58
10858569|NCT02709317|12024799|FG000|COMPLETED|Overall Study||18
10858570|NCT02709317|12024800|FG001|COMPLETED|Overall Study||31
10858571|NCT02709317|12024799|FG000|NOT COMPLETED|Overall Study||32
10858572|NCT02709317|12024800|FG001|NOT COMPLETED|Overall Study||27
10858573|NCT02607930|12024808|FG000|STARTED|Double-Blinded Treatment Phase||316
10858574|NCT02607930|12024809|FG001|STARTED|Double-Blinded Treatment Phase||315
10858575|NCT02607930|12024810|FG002|STARTED|Double-Blinded Treatment Phase||0
10858576|NCT02607930|12024811|FG003|STARTED|Double-Blinded Treatment Phase||0
10858577|NCT02607930|12024808|FG000|COMPLETED|Double-Blinded Treatment Phase||262
10858578|NCT02607930|12024809|FG001|COMPLETED|Double-Blinded Treatment Phase||262
10858579|NCT02607930|12024810|FG002|COMPLETED|Double-Blinded Treatment Phase||0
10858580|NCT02607930|12024811|FG003|COMPLETED|Double-Blinded Treatment Phase||0
10858581|NCT02607930|12024808|FG000|NOT COMPLETED|Double-Blinded Treatment Phase||54
10858582|NCT02607930|12024809|FG001|NOT COMPLETED|Double-Blinded Treatment Phase||53
10858583|NCT02607930|12024810|FG002|NOT COMPLETED|Double-Blinded Treatment Phase||0
10858584|NCT02607930|12024811|FG003|NOT COMPLETED|Double-Blinded Treatment Phase||0
10858585|NCT02607930|12024808|FG000|STARTED|Open-Label B/F/TAF Extension Phase|At the End of Blinded Treatment Visit, participants were given the option to receive B/F/TAF FDC in an OL extension phase for up to 96 weeks.|0
10858586|NCT02607930|12024809|FG001|STARTED|Open-Label B/F/TAF Extension Phase|At the End of Blinded Treatment Visit, participants were given the option to receive B/F/TAF FDC in an OL extension phase for up to 96 weeks.|0
10858587|NCT02607930|12024810|FG002|STARTED|Open-Label B/F/TAF Extension Phase|10 participants from B/F/TAF arm did not enter the Open-Label Extension Phase.|252
10858588|NCT02607930|12024811|FG003|STARTED|Open-Label B/F/TAF Extension Phase|8 participants from the ABC/DTG/3TC arm did not enter the Open-Label Extension Phase.|254
10858589|NCT02607930|12024808|FG000|COMPLETED|Open-Label B/F/TAF Extension Phase||0
10858590|NCT02607930|12024809|FG001|COMPLETED|Open-Label B/F/TAF Extension Phase||0
10858591|NCT02607930|12024810|FG002|COMPLETED|Open-Label B/F/TAF Extension Phase||218
10858592|NCT02607930|12024811|FG003|COMPLETED|Open-Label B/F/TAF Extension Phase||221
10858593|NCT02607930|12024808|FG000|NOT COMPLETED|Open-Label B/F/TAF Extension Phase||0
10858594|NCT02607930|12024809|FG001|NOT COMPLETED|Open-Label B/F/TAF Extension Phase||0
10858595|NCT02607930|12024810|FG002|NOT COMPLETED|Open-Label B/F/TAF Extension Phase||34
10858596|NCT02607930|12024811|FG003|NOT COMPLETED|Open-Label B/F/TAF Extension Phase||33
10858625|NCT02476201|12024852|FG000|STARTED|Overall Study||105
10858626|NCT02476201|12024852|FG000|Implant Attempts|Overall Study||103
10858627|NCT02476201|12024852|FG000|Sucessful Implants|Overall Study||102
10858628|NCT02476201|12024852|FG000|6 Months Visit|Overall Study||82
10858629|NCT02476201|12024852|FG000|COMPLETED|Overall Study||79
10858630|NCT02476201|12024852|FG000|NOT COMPLETED|Overall Study||26
10858631|NCT01399658|12024857|FG000|STARTED|Overall Study||93
10858632|NCT01399658|12024857|FG000|COMPLETED|Overall Study||87
10858633|NCT01399658|12024857|FG000|NOT COMPLETED|Overall Study||6
10858634|NCT01397968|12024863|FG000|STARTED|Double-blind Period of Study YKP3089C013||113
10858635|NCT01397968|12024864|FG001|STARTED|Double-blind Period of Study YKP3089C013||109
10858636|NCT01397968|12024863|FG000|COMPLETED|Double-blind Period of Study YKP3089C013||102
10858637|NCT01397968|12024864|FG001|COMPLETED|Double-blind Period of Study YKP3089C013||99
10858638|NCT01397968|12024863|FG000|NOT COMPLETED|Double-blind Period of Study YKP3089C013||11
10858639|NCT01397968|12024864|FG001|NOT COMPLETED|Double-blind Period of Study YKP3089C013||10
10858640|NCT01397968|12024863|FG000|STARTED|Open-label Extension Study YKP3089C013|Not all subjects from double-blind rolled over to open-label.|76
10858641|NCT01397968|12024864|FG001|STARTED|Open-label Extension Study YKP3089C013|Not all subjects from double-blind rolled over to open-label.|73
10858642|NCT01397968|12024863|FG000|COMPLETED|Open-label Extension Study YKP3089C013||40
10858643|NCT01397968|12024864|FG001|COMPLETED|Open-label Extension Study YKP3089C013||37
10858644|NCT01397968|12024863|FG000|NOT COMPLETED|Open-label Extension Study YKP3089C013||36
10858645|NCT01397968|12024864|FG001|NOT COMPLETED|Open-label Extension Study YKP3089C013||36
10858646|NCT01365195|12024875|FG000|STARTED|Overall Study||6
10858647|NCT01365195|12024876|FG001|STARTED|Overall Study||8
10858648|NCT01365195|12024877|FG002|STARTED|Overall Study||7
10858649|NCT01365195|12024875|FG000|COMPLETED|Overall Study||6
10858650|NCT01365195|12024876|FG001|COMPLETED|Overall Study||8
10858651|NCT01365195|12024877|FG002|COMPLETED|Overall Study||7
10858652|NCT01365195|12024875|FG000|NOT COMPLETED|Overall Study||0
10858653|NCT01365195|12024876|FG001|NOT COMPLETED|Overall Study||0
10858654|NCT01365195|12024877|FG002|NOT COMPLETED|Overall Study||0
10858655|NCT00966953|12024889|FG000|STARTED|1st Intervention||6
10858656|NCT00966953|12024890|FG001|STARTED|1st Intervention||6
10858657|NCT00966953|12024891|FG002|STARTED|1st Intervention||6
10858658|NCT00966953|12024892|FG003|STARTED|1st Intervention||7
10858659|NCT00966953|12024889|FG000|COMPLETED|1st Intervention||6
10858660|NCT00966953|12024890|FG001|COMPLETED|1st Intervention||6
10858661|NCT00966953|12024891|FG002|COMPLETED|1st Intervention||6
10858662|NCT00966953|12024892|FG003|COMPLETED|1st Intervention||7
10858663|NCT00966953|12024889|FG000|NOT COMPLETED|1st Intervention||0
10858664|NCT00966953|12024890|FG001|NOT COMPLETED|1st Intervention||0
10858665|NCT00966953|12024891|FG002|NOT COMPLETED|1st Intervention||0
10858666|NCT00966953|12024892|FG003|NOT COMPLETED|1st Intervention||0
10858667|NCT00966953|12024889|FG000|STARTED|1 Week Washout After 1st Intervention||6
10858668|NCT00966953|12024890|FG001|STARTED|1 Week Washout After 1st Intervention||6
10858669|NCT00966953|12024891|FG002|STARTED|1 Week Washout After 1st Intervention||6
10858670|NCT00966953|12024892|FG003|STARTED|1 Week Washout After 1st Intervention||7
10858671|NCT00966953|12024889|FG000|COMPLETED|1 Week Washout After 1st Intervention||6
10858672|NCT00966953|12024890|FG001|COMPLETED|1 Week Washout After 1st Intervention||6
10858673|NCT00966953|12024891|FG002|COMPLETED|1 Week Washout After 1st Intervention||6
10858674|NCT00966953|12024892|FG003|COMPLETED|1 Week Washout After 1st Intervention||7
10858675|NCT00966953|12024889|FG000|NOT COMPLETED|1 Week Washout After 1st Intervention||0
10858676|NCT00966953|12024890|FG001|NOT COMPLETED|1 Week Washout After 1st Intervention||0
10858677|NCT00966953|12024891|FG002|NOT COMPLETED|1 Week Washout After 1st Intervention||0
10858678|NCT00966953|12024892|FG003|NOT COMPLETED|1 Week Washout After 1st Intervention||0
10858679|NCT00966953|12024889|FG000|STARTED|2nd Intervention||6
10858680|NCT00966953|12024890|FG001|STARTED|2nd Intervention||6
10858681|NCT00966953|12024891|FG002|STARTED|2nd Intervention||6
10858682|NCT00966953|12024892|FG003|STARTED|2nd Intervention||7
10858683|NCT00966953|12024889|FG000|COMPLETED|2nd Intervention||6
10858684|NCT00966953|12024890|FG001|COMPLETED|2nd Intervention||6
10858685|NCT00966953|12024891|FG002|COMPLETED|2nd Intervention||6
10858686|NCT00966953|12024892|FG003|COMPLETED|2nd Intervention||7
10858687|NCT00966953|12024889|FG000|NOT COMPLETED|2nd Intervention||0
10858688|NCT00966953|12024890|FG001|NOT COMPLETED|2nd Intervention||0
10858689|NCT00966953|12024891|FG002|NOT COMPLETED|2nd Intervention||0
10858690|NCT00966953|12024892|FG003|NOT COMPLETED|2nd Intervention||0
10858691|NCT00966953|12024889|FG000|STARTED|1 Week Washout After 2nd Intervention||6
10858692|NCT00966953|12024890|FG001|STARTED|1 Week Washout After 2nd Intervention||6
10858693|NCT00966953|12024891|FG002|STARTED|1 Week Washout After 2nd Intervention||6
10858694|NCT00966953|12024892|FG003|STARTED|1 Week Washout After 2nd Intervention||7
10858695|NCT00966953|12024889|FG000|COMPLETED|1 Week Washout After 2nd Intervention||6
10858696|NCT00966953|12024890|FG001|COMPLETED|1 Week Washout After 2nd Intervention||6
10858697|NCT00966953|12024891|FG002|COMPLETED|1 Week Washout After 2nd Intervention||6
10858698|NCT00966953|12024892|FG003|COMPLETED|1 Week Washout After 2nd Intervention||7
10858699|NCT00966953|12024889|FG000|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
10858700|NCT00966953|12024890|FG001|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
10858701|NCT00966953|12024891|FG002|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
10858702|NCT00966953|12024892|FG003|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
10858703|NCT00966953|12024889|FG000|STARTED|3rd Intervention Order||6
10858704|NCT00966953|12024890|FG001|STARTED|3rd Intervention Order||6
10858705|NCT00966953|12024891|FG002|STARTED|3rd Intervention Order||6
10858706|NCT00966953|12024892|FG003|STARTED|3rd Intervention Order||7
10858707|NCT00966953|12024889|FG000|COMPLETED|3rd Intervention Order||6
10858708|NCT00966953|12024890|FG001|COMPLETED|3rd Intervention Order||6
10858709|NCT00966953|12024891|FG002|COMPLETED|3rd Intervention Order||6
10858710|NCT00966953|12024892|FG003|COMPLETED|3rd Intervention Order||7
10858711|NCT00966953|12024889|FG000|NOT COMPLETED|3rd Intervention Order||0
10858712|NCT00966953|12024890|FG001|NOT COMPLETED|3rd Intervention Order||0
10858713|NCT00966953|12024891|FG002|NOT COMPLETED|3rd Intervention Order||0
10858714|NCT00966953|12024892|FG003|NOT COMPLETED|3rd Intervention Order||0
10858715|NCT00966953|12024889|FG000|STARTED|1 Week Washout After 3rd Intervention||6
10858716|NCT00966953|12024890|FG001|STARTED|1 Week Washout After 3rd Intervention||6
10858717|NCT00966953|12024891|FG002|STARTED|1 Week Washout After 3rd Intervention||6
10858718|NCT00966953|12024892|FG003|STARTED|1 Week Washout After 3rd Intervention||7
10858719|NCT00966953|12024889|FG000|COMPLETED|1 Week Washout After 3rd Intervention||6
10858720|NCT00966953|12024890|FG001|COMPLETED|1 Week Washout After 3rd Intervention||6
10858721|NCT00966953|12024891|FG002|COMPLETED|1 Week Washout After 3rd Intervention||6
10858722|NCT00966953|12024892|FG003|COMPLETED|1 Week Washout After 3rd Intervention||7
10858723|NCT00966953|12024889|FG000|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
10858724|NCT00966953|12024890|FG001|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
10858725|NCT00966953|12024891|FG002|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
10858726|NCT00966953|12024892|FG003|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
10858727|NCT00966953|12024889|FG000|STARTED|4th Intervention Order||6
10858728|NCT00966953|12024890|FG001|STARTED|4th Intervention Order||6
10858729|NCT00966953|12024891|FG002|STARTED|4th Intervention Order||6
10858730|NCT00966953|12024892|FG003|STARTED|4th Intervention Order||7
10858731|NCT00966953|12024889|FG000|COMPLETED|4th Intervention Order||6
10415873|NCT00791388|11560328|FG001|STARTED|Period 2 - 100 mg Dose Group||0
10415874|NCT00791388|11560329|FG002|STARTED|Period 2 - 100 mg Dose Group||8
10415875|NCT00791388|11560330|FG003|STARTED|Period 2 - 100 mg Dose Group||0
10415876|NCT00791388|11560331|FG004|STARTED|Period 2 - 100 mg Dose Group||0
10415877|NCT00791388|11560327|FG000|COMPLETED|Period 2 - 100 mg Dose Group||2
10415878|NCT00791388|11560328|FG001|COMPLETED|Period 2 - 100 mg Dose Group||0
10415879|NCT00791388|11560329|FG002|COMPLETED|Period 2 - 100 mg Dose Group||8
10415880|NCT00791388|11560330|FG003|COMPLETED|Period 2 - 100 mg Dose Group||0
10415881|NCT00791388|11560331|FG004|COMPLETED|Period 2 - 100 mg Dose Group||0
10415882|NCT00791388|11560327|FG000|NOT COMPLETED|Period 2 - 100 mg Dose Group||1
10415883|NCT00791388|11560328|FG001|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
10415884|NCT00791388|11560329|FG002|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
10415885|NCT00791388|11560330|FG003|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
10415886|NCT00791388|11560331|FG004|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
10415887|NCT00791388|11560327|FG000|STARTED|Period 3 - 200 mg Dose Group||3
10415888|NCT00791388|11560328|FG001|STARTED|Period 3 - 200 mg Dose Group||0
10415889|NCT00791388|11560329|FG002|STARTED|Period 3 - 200 mg Dose Group||0
10415890|NCT00791388|11560330|FG003|STARTED|Period 3 - 200 mg Dose Group||8
10415891|NCT00791388|11560331|FG004|STARTED|Period 3 - 200 mg Dose Group||0
10415892|NCT00791388|11560327|FG000|COMPLETED|Period 3 - 200 mg Dose Group||3
10415893|NCT00791388|11560328|FG001|COMPLETED|Period 3 - 200 mg Dose Group||0
10415894|NCT00791388|11560329|FG002|COMPLETED|Period 3 - 200 mg Dose Group||0
10415895|NCT00791388|11560330|FG003|COMPLETED|Period 3 - 200 mg Dose Group||8
10415896|NCT00791388|11560331|FG004|COMPLETED|Period 3 - 200 mg Dose Group||0
10415897|NCT00791388|11560327|FG000|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
10415898|NCT00791388|11560328|FG001|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
10415899|NCT00791388|11560329|FG002|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
10415900|NCT00791388|11560330|FG003|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
10415901|NCT00791388|11560331|FG004|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
10415902|NCT00791388|11560327|FG000|STARTED|Period 4 - 400 mg Dose Group||4
10415903|NCT00791388|11560328|FG001|STARTED|Period 4 - 400 mg Dose Group||0
10415904|NCT00791388|11560329|FG002|STARTED|Period 4 - 400 mg Dose Group||0
10415905|NCT00791388|11560330|FG003|STARTED|Period 4 - 400 mg Dose Group||0
10415906|NCT00791388|11560331|FG004|STARTED|Period 4 - 400 mg Dose Group||8
10415907|NCT00791388|11560327|FG000|COMPLETED|Period 4 - 400 mg Dose Group||4
10415908|NCT00791388|11560328|FG001|COMPLETED|Period 4 - 400 mg Dose Group||0
10415909|NCT00791388|11560329|FG002|COMPLETED|Period 4 - 400 mg Dose Group||0
10415910|NCT00791388|11560330|FG003|COMPLETED|Period 4 - 400 mg Dose Group||0
10858732|NCT00966953|12024890|FG001|COMPLETED|4th Intervention Order||6
10858733|NCT00966953|12024891|FG002|COMPLETED|4th Intervention Order||6
10858734|NCT00966953|12024892|FG003|COMPLETED|4th Intervention Order||7
10858735|NCT00966953|12024889|FG000|NOT COMPLETED|4th Intervention Order||0
10858736|NCT00966953|12024890|FG001|NOT COMPLETED|4th Intervention Order||0
10858737|NCT00966953|12024891|FG002|NOT COMPLETED|4th Intervention Order||0
10858738|NCT00966953|12024892|FG003|NOT COMPLETED|4th Intervention Order||0
10858739|NCT00961805|12024900|FG000|STARTED|Overall Study||40
10858740|NCT00961805|12024901|FG001|STARTED|Overall Study||40
10858741|NCT00961805|12024900|FG000|COMPLETED|Overall Study||40
10858742|NCT00961805|12024901|FG001|COMPLETED|Overall Study||40
10858743|NCT00961805|12024900|FG000|NOT COMPLETED|Overall Study||0
10858744|NCT00961805|12024901|FG001|NOT COMPLETED|Overall Study||0
10858745|NCT00950937|12024907|FG000|STARTED|Overall Study||14
10858746|NCT00950937|12024908|FG001|STARTED|Overall Study||14
10858747|NCT00950937|12024907|FG000|COMPLETED|Overall Study||14
10858748|NCT00950937|12024908|FG001|COMPLETED|Overall Study||14
10858749|NCT00950937|12024907|FG000|NOT COMPLETED|Overall Study||0
10858750|NCT00950937|12024908|FG001|NOT COMPLETED|Overall Study||0
10858751|NCT00948753|12024915|FG000|STARTED|Phase 1||7
10858752|NCT00948753|12024916|FG001|STARTED|Phase 1||6
10858753|NCT00948753|12024917|FG002|STARTED|Phase 1||0
10858754|NCT00948753|12024915|FG000|COMPLETED|Phase 1||7
10858755|NCT00948753|12024916|FG001|COMPLETED|Phase 1||6
10858756|NCT00948753|12024917|FG002|COMPLETED|Phase 1||0
10858757|NCT00948753|12024915|FG000|NOT COMPLETED|Phase 1||0
10858758|NCT00948753|12024916|FG001|NOT COMPLETED|Phase 1||0
10858759|NCT00948753|12024917|FG002|NOT COMPLETED|Phase 1||0
10858760|NCT00948753|12024915|FG000|STARTED|Phase 2||0
10858761|NCT00948753|12024916|FG001|STARTED|Phase 2||0
10858762|NCT00948753|12024917|FG002|STARTED|Phase 2||25
10858763|NCT00948753|12024915|FG000|COMPLETED|Phase 2||0
10858764|NCT00948753|12024916|FG001|COMPLETED|Phase 2||0
10858765|NCT00948753|12024917|FG002|COMPLETED|Phase 2||25
10858766|NCT00948753|12024915|FG000|NOT COMPLETED|Phase 2||0
10858767|NCT00948753|12024916|FG001|NOT COMPLETED|Phase 2||0
10858768|NCT00948753|12024917|FG002|NOT COMPLETED|Phase 2||0
10858769|NCT00947518|12024929|FG000|STARTED|Overall Study||20
10858770|NCT00947518|12024930|FG001|STARTED|Overall Study||20
10858771|NCT00947518|12024931|FG002|STARTED|Overall Study||20
10858772|NCT00947518|12024929|FG000|COMPLETED|Overall Study||20
10858773|NCT00947518|12024930|FG001|COMPLETED|Overall Study||20
10858774|NCT00947518|12024931|FG002|COMPLETED|Overall Study||20
10858775|NCT00947518|12024929|FG000|NOT COMPLETED|Overall Study||0
10858776|NCT00947518|12024930|FG001|NOT COMPLETED|Overall Study||0
10858777|NCT00947518|12024931|FG002|NOT COMPLETED|Overall Study||0
10415911|NCT00791388|11560331|FG004|COMPLETED|Period 4 - 400 mg Dose Group||4
10415912|NCT00791388|11560327|FG000|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
10415913|NCT00791388|11560328|FG001|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
10415914|NCT00791388|11560329|FG002|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
10415915|NCT00791388|11560330|FG003|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
10415916|NCT00791388|11560331|FG004|NOT COMPLETED|Period 4 - 400 mg Dose Group||4
10415917|NCT00791479|11560349|FG000|STARTED|Overall Study||35
10415918|NCT00791479|11560350|FG001|STARTED|Overall Study||34
10415919|NCT00791479|11560351|FG002|STARTED|Overall Study||34
10415920|NCT00791479|11560352|FG003|STARTED|Overall Study||29
10415921|NCT00791479|11560353|FG004|STARTED|Overall Study|3mg LY2189265 discont. Replaced with 1.5mg dose based on dose finding Study H9X-MC-GBCF; NCT00734474|3
10415922|NCT00791479|11560354|FG005|STARTED|Overall Study||32
10415923|NCT00791479|11560349|FG000|Received at Least One Dose of Study Drug|Overall Study||35
10415924|NCT00791479|11560350|FG001|Received at Least One Dose of Study Drug|Overall Study||34
10415925|NCT00791479|11560351|FG002|Received at Least One Dose of Study Drug|Overall Study||34
10415926|NCT00791479|11560352|FG003|Received at Least One Dose of Study Drug|Overall Study||29
10415927|NCT00791479|11560353|FG004|Received at Least One Dose of Study Drug|Overall Study||3
10415928|NCT00791479|11560354|FG005|Received at Least One Dose of Study Drug|Overall Study||32
10415929|NCT00791479|11560349|FG000|COMPLETED|Overall Study||33
10415930|NCT00791479|11560350|FG001|COMPLETED|Overall Study||31
10415931|NCT00791479|11560351|FG002|COMPLETED|Overall Study||34
10415932|NCT00791479|11560352|FG003|COMPLETED|Overall Study||25
10415933|NCT00791479|11560353|FG004|COMPLETED|Overall Study||0
10415934|NCT00791479|11560354|FG005|COMPLETED|Overall Study||29
10293579|NCT02609724|11426169|FG002|COMPLETED|Overall Study|post follow-up phase|61
10858778|NCT00934921|12024938|FG000|STARTED|First Intervention||12
10858779|NCT00934921|12024939|FG001|STARTED|First Intervention||12
10858780|NCT00934921|12024938|FG000|COMPLETED|First Intervention||12
10858781|NCT00934921|12024939|FG001|COMPLETED|First Intervention||12
10858782|NCT00934921|12024938|FG000|NOT COMPLETED|First Intervention||0
10858783|NCT00934921|12024939|FG001|NOT COMPLETED|First Intervention||0
10858784|NCT00934921|12024938|FG000|STARTED|Second Intervention||12
10858785|NCT00934921|12024939|FG001|STARTED|Second Intervention||12
10858786|NCT00934921|12024938|FG000|COMPLETED|Second Intervention||12
10858787|NCT00934921|12024939|FG001|COMPLETED|Second Intervention||12
10858788|NCT00934921|12024938|FG000|NOT COMPLETED|Second Intervention||0
10858789|NCT00934921|12024939|FG001|NOT COMPLETED|Second Intervention||0
10858790|NCT00934180|12024945|FG000|STARTED|First Intervention||12
10858791|NCT00934180|12024946|FG001|STARTED|First Intervention||12
10858792|NCT00934180|12024945|FG000|COMPLETED|First Intervention||12
10858793|NCT00934180|12024946|FG001|COMPLETED|First Intervention||12
10858794|NCT00934180|12024945|FG000|NOT COMPLETED|First Intervention||0
10858795|NCT00934180|12024946|FG001|NOT COMPLETED|First Intervention||0
10858796|NCT00934180|12024945|FG000|STARTED|Second Intervention||12
10858797|NCT00934180|12024946|FG001|STARTED|Second Intervention||12
10858798|NCT00934180|12024945|FG000|COMPLETED|Second Intervention||12
10858799|NCT00934180|12024946|FG001|COMPLETED|Second Intervention||12
10858800|NCT00934180|12024945|FG000|NOT COMPLETED|Second Intervention||0
10858801|NCT00934180|12024946|FG001|NOT COMPLETED|Second Intervention||0
10858802|NCT00924833|12024953|FG000|STARTED|Overall Study||9
10858803|NCT00924833|12024954|FG001|STARTED|Overall Study||9
10858804|NCT00924833|12024955|FG002|STARTED|Overall Study||9
10858805|NCT00924833|12024953|FG000|COMPLETED|Overall Study|7 subjects analyzed (2 were excluded for poor cardiopulmonary exercise stress test quality).|9
10858806|NCT00924833|12024954|FG001|COMPLETED|Overall Study|1 subject was excluded from the analysis for incomplete data.|9
10858807|NCT00924833|12024955|FG002|COMPLETED|Overall Study|1 subject was excluded from the analysis for medical problems unrelated to the study.|9
10858808|NCT00924833|12024953|FG000|NOT COMPLETED|Overall Study||0
10858809|NCT00924833|12024954|FG001|NOT COMPLETED|Overall Study||0
10858810|NCT00924833|12024955|FG002|NOT COMPLETED|Overall Study||0
10858811|NCT00919893|12024962|FG000|STARTED|Overall Study||70
10858812|NCT00919893|12024963|FG001|STARTED|Overall Study||69
10858813|NCT00919893|12024962|FG000|COMPLETED|Overall Study||51
10858814|NCT00919893|12024963|FG001|COMPLETED|Overall Study||60
10858815|NCT00919893|12024962|FG000|NOT COMPLETED|Overall Study||19
10858816|NCT00919893|12024963|FG001|NOT COMPLETED|Overall Study||9
10858817|NCT00912158|12024970|FG000|STARTED|Overall Study||44
10858818|NCT00912158|12024971|FG001|STARTED|Overall Study||44
10858819|NCT00912158|12024972|FG002|STARTED|Overall Study||41
10858820|NCT00912158|12024970|FG000|COMPLETED|Overall Study||44
10858821|NCT00912158|12024971|FG001|COMPLETED|Overall Study||44
10858822|NCT00912158|12024972|FG002|COMPLETED|Overall Study||41
10858823|NCT00912158|12024970|FG000|NOT COMPLETED|Overall Study||0
10858824|NCT00912158|12024971|FG001|NOT COMPLETED|Overall Study||0
10858825|NCT00912158|12024972|FG002|NOT COMPLETED|Overall Study||0
10858826|NCT00911443|12024982|FG000|STARTED|Overall Study||97
10858827|NCT00911443|12024983|FG001|STARTED|Overall Study||97
10858828|NCT00911443|12024984|FG002|STARTED|Overall Study||98
10858829|NCT00911443|12024985|FG003|STARTED|Overall Study||99
10858830|NCT00911443|12024986|FG004|STARTED|Overall Study||97
10858831|NCT00911443|12024982|FG000|COMPLETED|Overall Study||97
10858832|NCT00911443|12024983|FG001|COMPLETED|Overall Study||97
10858833|NCT00911443|12024984|FG002|COMPLETED|Overall Study||98
10858834|NCT00911443|12024985|FG003|COMPLETED|Overall Study||99
10858835|NCT00911443|12024986|FG004|COMPLETED|Overall Study||97
10858836|NCT00911443|12024982|FG000|NOT COMPLETED|Overall Study||0
10858837|NCT00911443|12024983|FG001|NOT COMPLETED|Overall Study||0
10858838|NCT00911443|12024984|FG002|NOT COMPLETED|Overall Study||0
10858839|NCT00911443|12024985|FG003|NOT COMPLETED|Overall Study||0
10858840|NCT00911443|12024986|FG004|NOT COMPLETED|Overall Study||0
10858841|NCT00911274|12024995|FG000|STARTED|Period 1||27
10858842|NCT00911274|12024996|FG001|STARTED|Period 1||26
10858843|NCT00911274|12024995|FG000|COMPLETED|Period 1||27
10858844|NCT00911274|12024996|FG001|COMPLETED|Period 1||26
10858845|NCT00911274|12024995|FG000|NOT COMPLETED|Period 1||0
10858846|NCT00911274|12024996|FG001|NOT COMPLETED|Period 1||0
10858847|NCT00911274|12024995|FG000|STARTED|Period 2||27
10858848|NCT00911274|12024996|FG001|STARTED|Period 2||26
10858849|NCT00911274|12024995|FG000|COMPLETED|Period 2||27
10858850|NCT00911274|12024996|FG001|COMPLETED|Period 2||26
10858851|NCT00911274|12024995|FG000|NOT COMPLETED|Period 2||0
10858852|NCT00911274|12024996|FG001|NOT COMPLETED|Period 2||0
10858853|NCT00909753|12025002|FG000|STARTED|Period: First Intervention||46
10858854|NCT00909753|12025003|FG001|STARTED|Period: First Intervention||46
10858855|NCT00909753|12025002|FG000|COMPLETED|Period: First Intervention||46
10858856|NCT00909753|12025003|FG001|COMPLETED|Period: First Intervention||46
10858857|NCT00909753|12025002|FG000|NOT COMPLETED|Period: First Intervention||0
10858858|NCT00909753|12025003|FG001|NOT COMPLETED|Period: First Intervention||0
10858859|NCT00909753|12025002|FG000|STARTED|Period: Washout of 28 Days||46
10858860|NCT00909753|12025003|FG001|STARTED|Period: Washout of 28 Days||46
10858861|NCT00909753|12025002|FG000|COMPLETED|Period: Washout of 28 Days||44
10858862|NCT00909753|12025003|FG001|COMPLETED|Period: Washout of 28 Days||43
10858863|NCT00909753|12025002|FG000|NOT COMPLETED|Period: Washout of 28 Days||2
10858864|NCT00909753|12025003|FG001|NOT COMPLETED|Period: Washout of 28 Days||3
10858865|NCT00909753|12025002|FG000|STARTED|Period: Second Intervention||44
10858866|NCT00909753|12025003|FG001|STARTED|Period: Second Intervention||43
10858867|NCT00909753|12025002|FG000|COMPLETED|Period: Second Intervention||43
10858868|NCT00909753|12025003|FG001|COMPLETED|Period: Second Intervention||43
10858869|NCT00909753|12025002|FG000|NOT COMPLETED|Period: Second Intervention||1
10858870|NCT00909753|12025003|FG001|NOT COMPLETED|Period: Second Intervention||0
10858871|NCT00909649|12025009|FG000|STARTED|Overall Study||25
10858872|NCT00909649|12025010|FG001|STARTED|Overall Study||25
10858873|NCT00909649|12025009|FG000|COMPLETED|Overall Study||25
10858874|NCT00909649|12025010|FG001|COMPLETED|Overall Study||25
10858875|NCT00909649|12025009|FG000|NOT COMPLETED|Overall Study||0
10858876|NCT00909649|12025010|FG001|NOT COMPLETED|Overall Study||0
10858877|NCT00909610|12025016|FG000|STARTED|Period: First Intervention||40
10858878|NCT00909610|12025017|FG001|STARTED|Period: First Intervention||40
10858879|NCT00909610|12025016|FG000|COMPLETED|Period: First Intervention||40
10858880|NCT00909610|12025017|FG001|COMPLETED|Period: First Intervention||39
10858881|NCT00909610|12025016|FG000|NOT COMPLETED|Period: First Intervention||0
10858882|NCT00909610|12025017|FG001|NOT COMPLETED|Period: First Intervention||1
10858883|NCT00909610|12025016|FG000|STARTED|Period: Washout of 28 Days||40
10858884|NCT00909610|12025017|FG001|STARTED|Period: Washout of 28 Days||39
10858885|NCT00909610|12025016|FG000|COMPLETED|Period: Washout of 28 Days||37
10858886|NCT00909610|12025017|FG001|COMPLETED|Period: Washout of 28 Days||33
10858887|NCT00909610|12025016|FG000|NOT COMPLETED|Period: Washout of 28 Days||3
10858888|NCT00909610|12025017|FG001|NOT COMPLETED|Period: Washout of 28 Days||6
10858889|NCT00909610|12025016|FG000|STARTED|Period: Second Intervention||37
10858890|NCT00909610|12025017|FG001|STARTED|Period: Second Intervention||33
10858891|NCT00909610|12025016|FG000|COMPLETED|Period: Second Intervention||36
10858892|NCT00909610|12025017|FG001|COMPLETED|Period: Second Intervention||33
10858893|NCT00909610|12025016|FG000|NOT COMPLETED|Period: Second Intervention||1
10858894|NCT00909610|12025017|FG001|NOT COMPLETED|Period: Second Intervention||0
10858895|NCT00908648|12025024|FG000|STARTED|Overall Study||108
10858896|NCT00908648|12025025|FG001|STARTED|Overall Study||103
10858897|NCT00908648|12025024|FG000|COMPLETED|Overall Study||108
10858898|NCT00908648|12025025|FG001|COMPLETED|Overall Study||103
10858899|NCT00908648|12025024|FG000|NOT COMPLETED|Overall Study||0
10858900|NCT00908648|12025025|FG001|NOT COMPLETED|Overall Study||0
10858901|NCT00908128|12025031|FG000|STARTED|Period 1||20
10858902|NCT00908128|12025032|FG001|STARTED|Period 1||20
10858903|NCT00908128|12025031|FG000|COMPLETED|Period 1||20
10858904|NCT00908128|12025032|FG001|COMPLETED|Period 1||20
10858905|NCT00908128|12025031|FG000|NOT COMPLETED|Period 1||0
10858906|NCT00908128|12025032|FG001|NOT COMPLETED|Period 1||0
10858907|NCT00908128|12025031|FG000|STARTED|Period 2||20
10858908|NCT00908128|12025032|FG001|STARTED|Period 2||20
10858909|NCT00908128|12025031|FG000|COMPLETED|Period 2||20
10858910|NCT00908128|12025032|FG001|COMPLETED|Period 2||20
10858911|NCT00908128|12025031|FG000|NOT COMPLETED|Period 2||0
10858912|NCT00908128|12025032|FG001|NOT COMPLETED|Period 2||0
10858913|NCT00908128|12025031|FG000|STARTED|Period 3||20
10858914|NCT00908128|12025032|FG001|STARTED|Period 3||20
10858915|NCT00908128|12025031|FG000|COMPLETED|Period 3||20
10858916|NCT00908128|12025032|FG001|COMPLETED|Period 3||20
10858917|NCT00908128|12025031|FG000|NOT COMPLETED|Period 3||0
10858918|NCT00908128|12025032|FG001|NOT COMPLETED|Period 3||0
10858919|NCT00908128|12025031|FG000|STARTED|Period 4||20
10858920|NCT00908128|12025032|FG001|STARTED|Period 4|One subject withdrew prior to Period 4 dosing due to adverse events|19
10858921|NCT00908128|12025031|FG000|COMPLETED|Period 4||20
10858922|NCT00908128|12025032|FG001|COMPLETED|Period 4||19
10858923|NCT00908128|12025031|FG000|NOT COMPLETED|Period 4||0
10858924|NCT00908128|12025032|FG001|NOT COMPLETED|Period 4||0
10858925|NCT00907907|12025038|FG000|STARTED|Period 1||20
10858926|NCT00907907|12025039|FG001|STARTED|Period 1||20
10858927|NCT00907907|12025038|FG000|COMPLETED|Period 1||20
10858928|NCT00907907|12025039|FG001|COMPLETED|Period 1||20
10858929|NCT00907907|12025038|FG000|NOT COMPLETED|Period 1||0
10858930|NCT00907907|12025039|FG001|NOT COMPLETED|Period 1||0
10858931|NCT00907907|12025038|FG000|STARTED|Period 2||20
10858932|NCT00907907|12025039|FG001|STARTED|Period 2||20
10858933|NCT00907907|12025038|FG000|COMPLETED|Period 2||20
10858934|NCT00907907|12025039|FG001|COMPLETED|Period 2||20
10858935|NCT00907907|12025038|FG000|NOT COMPLETED|Period 2||0
10858936|NCT00907907|12025039|FG001|NOT COMPLETED|Period 2||0
10858937|NCT00907907|12025038|FG000|STARTED|Period 3||20
10858938|NCT00907907|12025039|FG001|STARTED|Period 3||20
10858939|NCT00907907|12025038|FG000|COMPLETED|Period 3||20
10858940|NCT00907907|12025039|FG001|COMPLETED|Period 3||20
10858941|NCT00907907|12025038|FG000|NOT COMPLETED|Period 3||0
10858942|NCT00907907|12025039|FG001|NOT COMPLETED|Period 3||0
10858943|NCT00907907|12025038|FG000|STARTED|Period 4|one subject withdrew prior to Period 4 dosing|19
10858944|NCT00907907|12025039|FG001|STARTED|Period 4|two subjects were withdrawn prior to Period 4 dosing|18
10858945|NCT00907907|12025038|FG000|COMPLETED|Period 4||19
10858946|NCT00907907|12025039|FG001|COMPLETED|Period 4||18
10858947|NCT00907907|12025038|FG000|NOT COMPLETED|Period 4||0
10858948|NCT00907907|12025039|FG001|NOT COMPLETED|Period 4||0
10858949|NCT00905606|12025045|FG000|STARTED|Period 1||15
10858950|NCT00905606|12025046|FG001|STARTED|Period 1||15
10858951|NCT00905606|12025045|FG000|COMPLETED|Period 1||15
10858952|NCT00905606|12025046|FG001|COMPLETED|Period 1||14
10858953|NCT00905606|12025045|FG000|NOT COMPLETED|Period 1||0
10858954|NCT00905606|12025046|FG001|NOT COMPLETED|Period 1||1
10858955|NCT00905606|12025045|FG000|STARTED|Washout||15
10858956|NCT00905606|12025046|FG001|STARTED|Washout||14
10858957|NCT00905606|12025045|FG000|COMPLETED|Washout||14
10858958|NCT00905606|12025046|FG001|COMPLETED|Washout||14
10858959|NCT00905606|12025045|FG000|NOT COMPLETED|Washout||1
10858960|NCT00905606|12025046|FG001|NOT COMPLETED|Washout||0
10858961|NCT00905606|12025045|FG000|STARTED|Period 2||14
10858962|NCT00905606|12025046|FG001|STARTED|Period 2||14
10858963|NCT00905606|12025045|FG000|COMPLETED|Period 2||14
10858964|NCT00905606|12025046|FG001|COMPLETED|Period 2||14
10858965|NCT00905606|12025045|FG000|NOT COMPLETED|Period 2||0
10858966|NCT00905606|12025046|FG001|NOT COMPLETED|Period 2||0
10858967|NCT00905567|12025052|FG000|STARTED|Period 1||12
10858968|NCT00905567|12025053|FG001|STARTED|Period 1||12
10858969|NCT00905567|12025052|FG000|COMPLETED|Period 1||12
10858970|NCT00905567|12025053|FG001|COMPLETED|Period 1||12
10858971|NCT00905567|12025052|FG000|NOT COMPLETED|Period 1||0
10858972|NCT00905567|12025053|FG001|NOT COMPLETED|Period 1||0
10858973|NCT00905567|12025052|FG000|STARTED|Washout||12
10858974|NCT00905567|12025053|FG001|STARTED|Washout||12
10858975|NCT00905567|12025052|FG000|COMPLETED|Washout||12
10858976|NCT00905567|12025053|FG001|COMPLETED|Washout||11
10858977|NCT00905567|12025052|FG000|NOT COMPLETED|Washout||0
10858978|NCT00905567|12025053|FG001|NOT COMPLETED|Washout||1
10858979|NCT00905567|12025052|FG000|STARTED|Period 2||12
10858980|NCT00905567|12025053|FG001|STARTED|Period 2||11
10858981|NCT00905567|12025052|FG000|COMPLETED|Period 2||12
10858982|NCT00905567|12025053|FG001|COMPLETED|Period 2||11
10858983|NCT00905567|12025052|FG000|NOT COMPLETED|Period 2||0
10858984|NCT00905567|12025053|FG001|NOT COMPLETED|Period 2||0
10858985|NCT00905346|12025059|FG000|STARTED|Period 1||12
10858986|NCT00905346|12025060|FG001|STARTED|Period 1||12
10858987|NCT00905346|12025059|FG000|COMPLETED|Period 1||11
10858988|NCT00905346|12025060|FG001|COMPLETED|Period 1||12
10858989|NCT00905346|12025059|FG000|NOT COMPLETED|Period 1||1
10858990|NCT00905346|12025060|FG001|NOT COMPLETED|Period 1||0
10858991|NCT00905346|12025059|FG000|STARTED|Period 2|one subject withdrew prior to Pd. 2 dosing|10
10858992|NCT00905346|12025060|FG001|STARTED|Period 2|one subject withdrew prior to Pd. 2 dosing|11
10858993|NCT00905346|12025059|FG000|COMPLETED|Period 2||10
10858994|NCT00905346|12025060|FG001|COMPLETED|Period 2||11
10858995|NCT00905346|12025059|FG000|NOT COMPLETED|Period 2||0
10858996|NCT00905346|12025060|FG001|NOT COMPLETED|Period 2||0
10858997|NCT00905164|12025066|FG000|STARTED|Period 1||12
10858998|NCT00905164|12025067|FG001|STARTED|Period 1||12
10858999|NCT00905164|12025066|FG000|COMPLETED|Period 1||12
10859000|NCT00905164|12025067|FG001|COMPLETED|Period 1||11
10859001|NCT00905164|12025066|FG000|NOT COMPLETED|Period 1||0
10859002|NCT00905164|12025067|FG001|NOT COMPLETED|Period 1||1
10859003|NCT00905164|12025066|FG000|STARTED|Period 2||12
10859004|NCT00905164|12025067|FG001|STARTED|Period 2||11
10859005|NCT00905164|12025066|FG000|COMPLETED|Period 2||12
10859006|NCT00905164|12025067|FG001|COMPLETED|Period 2||11
10859007|NCT00905164|12025066|FG000|NOT COMPLETED|Period 2||0
10859008|NCT00905164|12025067|FG001|NOT COMPLETED|Period 2||0
10859009|NCT00904943|12025073|FG000|STARTED|Period 1||9
10415935|NCT00791479|11560349|FG000|NOT COMPLETED|Overall Study||2
10415936|NCT00791479|11560350|FG001|NOT COMPLETED|Overall Study||3
10415937|NCT00791479|11560351|FG002|NOT COMPLETED|Overall Study||0
10415938|NCT00791479|11560352|FG003|NOT COMPLETED|Overall Study||4
10415939|NCT00791479|11560353|FG004|NOT COMPLETED|Overall Study||3
10415940|NCT00791479|11560354|FG005|NOT COMPLETED|Overall Study||3
10415941|NCT00791492|11560377|FG000|STARTED|Overall Study||45
10415942|NCT00791492|11560378|FG001|STARTED|Overall Study||41
10415943|NCT00791492|11560377|FG000|TREATED|Overall Study||44
10415944|NCT00791492|11560378|FG001|TREATED|Overall Study||41
10415945|NCT00791492|11560377|FG000|COMPLETED|Overall Study||39
10415946|NCT00791492|11560378|FG001|COMPLETED|Overall Study||38
10415947|NCT00791492|11560377|FG000|NOT COMPLETED|Overall Study||6
10415948|NCT00791492|11560378|FG001|NOT COMPLETED|Overall Study||3
10415949|NCT00791518|11560384|FG000|STARTED|Overall Study||1084
10415950|NCT00791518|11560384|FG000|COMPLETED|Overall Study||991
10415951|NCT00791518|11560384|FG000|NOT COMPLETED|Overall Study||93
10415952|NCT00791557|11560403|FG000|STARTED|Overall Study||2
10415953|NCT00791557|11560403|FG000|COMPLETED|Overall Study||1
10415954|NCT00791557|11560403|FG000|NOT COMPLETED|Overall Study||1
10415955|NCT00791648|11560409|FG000|STARTED|Overall Study||308
10415956|NCT00791648|11560410|FG001|STARTED|Overall Study||309
10415957|NCT00791648|11560409|FG000|COMPLETED|Overall Study||308
10415958|NCT00791648|11560410|FG001|COMPLETED|Overall Study||307
10415959|NCT00791648|11560409|FG000|NOT COMPLETED|Overall Study||0
10415960|NCT00791648|11560410|FG001|NOT COMPLETED|Overall Study||2
10859010|NCT00904943|12025074|FG001|STARTED|Period 1||9
10859011|NCT00904943|12025073|FG000|COMPLETED|Period 1||9
10859012|NCT00904943|12025074|FG001|COMPLETED|Period 1||9
10859013|NCT00904943|12025073|FG000|NOT COMPLETED|Period 1||0
10859014|NCT00904943|12025074|FG001|NOT COMPLETED|Period 1||0
10859015|NCT00904943|12025073|FG000|STARTED|Period 2||9
10859016|NCT00904943|12025074|FG001|STARTED|Period 2|one subject was withdrawn prior to Pd. 2 dosing|8
10859017|NCT00904943|12025073|FG000|COMPLETED|Period 2||9
10859018|NCT00904943|12025074|FG001|COMPLETED|Period 2||8
10859019|NCT00904943|12025073|FG000|NOT COMPLETED|Period 2||0
10859020|NCT00904943|12025074|FG001|NOT COMPLETED|Period 2||0
10859021|NCT00890591|12025078|FG000|STARTED|Overall Study||144
10859022|NCT00890591|12025078|FG000|COMPLETED|Overall Study||124
10859023|NCT00890591|12025078|FG000|NOT COMPLETED|Overall Study||20
10415961|NCT00791661|11560419|FG000|STARTED|Period 1||8
10859024|NCT00890409|12025086|FG000|STARTED|Overall Study||116
10859025|NCT00890409|12025087|FG001|STARTED|Overall Study||140
10859026|NCT00890409|12025086|FG000|COMPLETED|Overall Study||96
10859027|NCT00890409|12025087|FG001|COMPLETED|Overall Study||119
10859028|NCT00890409|12025086|FG000|NOT COMPLETED|Overall Study||20
10859029|NCT00890409|12025087|FG001|NOT COMPLETED|Overall Study||21
10415962|NCT00791661|11560420|FG001|STARTED|Period 1||8
10415963|NCT00791661|11560421|FG002|STARTED|Period 1||8
10415964|NCT00791661|11560419|FG000|Received MK-1006|Period 1||6
10415965|NCT00791661|11560420|FG001|Received MK-1006|Period 1||6
10415966|NCT00791661|11560421|FG002|Received MK-1006|Period 1||6
10415967|NCT00791661|11560419|FG000|Received Matching Placebo to MK-1006|Period 1||2
10415968|NCT00791661|11560420|FG001|Received Matching Placebo to MK-1006|Period 1||2
10415969|NCT00791661|11560421|FG002|Received Matching Placebo to MK-1006|Period 1||2
10415970|NCT00791661|11560419|FG000|COMPLETED|Period 1||8
10415971|NCT00791661|11560420|FG001|COMPLETED|Period 1||8
10415972|NCT00791661|11560421|FG002|COMPLETED|Period 1||8
10415973|NCT00791661|11560419|FG000|NOT COMPLETED|Period 1||0
10415974|NCT00791661|11560420|FG001|NOT COMPLETED|Period 1||0
10415975|NCT00791661|11560421|FG002|NOT COMPLETED|Period 1||0
10415976|NCT00791661|11560419|FG000|STARTED|7 Day Wash-out||8
10415977|NCT00791661|11560420|FG001|STARTED|7 Day Wash-out||8
10415978|NCT00791661|11560421|FG002|STARTED|7 Day Wash-out||8
10415979|NCT00791661|11560419|FG000|COMPLETED|7 Day Wash-out||8
10415980|NCT00791661|11560420|FG001|COMPLETED|7 Day Wash-out||8
10415981|NCT00791661|11560421|FG002|COMPLETED|7 Day Wash-out||6
10415982|NCT00791661|11560419|FG000|NOT COMPLETED|7 Day Wash-out||0
10415983|NCT00791661|11560420|FG001|NOT COMPLETED|7 Day Wash-out||0
10415984|NCT00791661|11560421|FG002|NOT COMPLETED|7 Day Wash-out||2
10415985|NCT00791661|11560419|FG000|STARTED|Period 2||8
10415986|NCT00791661|11560420|FG001|STARTED|Period 2||8
10415987|NCT00791661|11560421|FG002|STARTED|Period 2||6
10415988|NCT00791661|11560419|FG000|Received MK-1006|Period 2||6
10415989|NCT00791661|11560420|FG001|Received MK-1006|Period 2||6
10415990|NCT00791661|11560421|FG002|Received MK-1006|Period 2||4
10415991|NCT00791661|11560419|FG000|Received Matching Placebo to MK-1006|Period 2||2
10415992|NCT00791661|11560420|FG001|Received Matching Placebo to MK-1006|Period 2||2
10415993|NCT00791661|11560421|FG002|Received Matching Placebo to MK-1006|Period 2||2
10415994|NCT00791661|11560419|FG000|COMPLETED|Period 2||8
10415995|NCT00791661|11560420|FG001|COMPLETED|Period 2||8
10415996|NCT00791661|11560421|FG002|COMPLETED|Period 2||6
10415997|NCT00791661|11560419|FG000|NOT COMPLETED|Period 2||0
10415998|NCT00791661|11560420|FG001|NOT COMPLETED|Period 2||0
10415999|NCT00791661|11560421|FG002|NOT COMPLETED|Period 2||0
10416000|NCT00791661|11560419|FG000|STARTED|7 Day Wash-out||8
10416001|NCT00791661|11560420|FG001|STARTED|7 Day Wash-out||8
10416002|NCT00791661|11560421|FG002|STARTED|7 Day Wash-out||6
10416003|NCT00791661|11560419|FG000|COMPLETED|7 Day Wash-out||8
10416004|NCT00791661|11560420|FG001|COMPLETED|7 Day Wash-out||8
10416005|NCT00791661|11560421|FG002|COMPLETED|7 Day Wash-out||6
10416006|NCT00791661|11560419|FG000|NOT COMPLETED|7 Day Wash-out||0
10416007|NCT00791661|11560420|FG001|NOT COMPLETED|7 Day Wash-out||0
10416008|NCT00791661|11560421|FG002|NOT COMPLETED|7 Day Wash-out||0
10416009|NCT00791661|11560419|FG000|STARTED|Period 3||8
10416010|NCT00791661|11560420|FG001|STARTED|Period 3||8
10416011|NCT00791661|11560421|FG002|STARTED|Period 3||6
10545711|NCT01499355|11699176|FG001|NOT COMPLETED|Double-Blind Period||23
10545712|NCT01499355|11699177|FG002|NOT COMPLETED|Double-Blind Period||25
10545713|NCT01499355|11699178|FG003|NOT COMPLETED|Double-Blind Period||23
10545714|NCT01499368|11699191|FG000|STARTED|Overall Study||165
10545715|NCT01499368|11699192|FG001|STARTED|Overall Study||163
10545716|NCT01499368|11699193|FG002|STARTED|Overall Study||167
10545717|NCT01499368|11699191|FG000|COMPLETED|Overall Study||138
10545718|NCT01499368|11699192|FG001|COMPLETED|Overall Study||145
10416012|NCT00791661|11560419|FG000|Received MK-1006|Period 3||6
10416013|NCT00791661|11560420|FG001|Received MK-1006|Period 3||6
10416014|NCT00791661|11560421|FG002|Received MK-1006|Period 3||5
10416015|NCT00791661|11560419|FG000|Received Matching Placebo to MK-1006|Period 3||2
10545719|NCT01499368|11699193|FG002|COMPLETED|Overall Study||146
10859030|NCT00888355|12025095|FG000|STARTED|Overall Study||108
10859031|NCT00888355|12025096|FG001|STARTED|Overall Study||108
10859032|NCT00888355|12025097|FG002|STARTED|Overall Study||106
10859033|NCT00888355|12025098|FG003|STARTED|Overall Study||106
10859034|NCT00888355|12025095|FG000|COMPLETED|Overall Study||86
10859035|NCT00888355|12025096|FG001|COMPLETED|Overall Study||99
10859036|NCT00888355|12025097|FG002|COMPLETED|Overall Study||94
10859037|NCT00888355|12025098|FG003|COMPLETED|Overall Study||96
10859038|NCT00888355|12025095|FG000|NOT COMPLETED|Overall Study||22
10859039|NCT00888355|12025096|FG001|NOT COMPLETED|Overall Study||9
10859040|NCT00888355|12025097|FG002|NOT COMPLETED|Overall Study||12
10859041|NCT00888355|12025098|FG003|NOT COMPLETED|Overall Study||10
10859042|NCT00887250|12025107|FG000|STARTED|Overall Study||116
10859043|NCT00887250|12025108|FG001|STARTED|Overall Study||127
10859044|NCT00887250|12025109|FG002|STARTED|Overall Study||123
10859045|NCT00887250|12025107|FG000|COMPLETED|Overall Study||98
10859046|NCT00887250|12025108|FG001|COMPLETED|Overall Study||115
10859047|NCT00887250|12025109|FG002|COMPLETED|Overall Study||110
10859048|NCT00887250|12025107|FG000|NOT COMPLETED|Overall Study||18
10859049|NCT00887250|12025108|FG001|NOT COMPLETED|Overall Study||12
10859050|NCT00887250|12025109|FG002|NOT COMPLETED|Overall Study||13
10859051|NCT00886600|12025118|FG000|STARTED|Double-blind Monotherapy||32
10859052|NCT00886600|12025119|FG001|STARTED|Double-blind Monotherapy||29
10859053|NCT00886600|12025120|FG002|STARTED|Double-blind Monotherapy||30
10859054|NCT00886600|12025121|FG003|STARTED|Double-blind Monotherapy||31
10859055|NCT00886600|12025118|FG000|COMPLETED|Double-blind Monotherapy||30
10859056|NCT00886600|12025119|FG001|COMPLETED|Double-blind Monotherapy|1 pt discontinued after Wk 4 due to AE starting in placebo baseline and continuing into double-blind|28
10859057|NCT00886600|12025120|FG002|COMPLETED|Double-blind Monotherapy||29
10859058|NCT00886600|12025121|FG003|COMPLETED|Double-blind Monotherapy||29
10859059|NCT00886600|12025118|FG000|NOT COMPLETED|Double-blind Monotherapy||2
10859060|NCT00886600|12025119|FG001|NOT COMPLETED|Double-blind Monotherapy||1
10859061|NCT00886600|12025120|FG002|NOT COMPLETED|Double-blind Monotherapy||1
10416016|NCT00791661|11560420|FG001|Received Matching Placebo to MK-1006|Period 3||2
10416017|NCT00791661|11560421|FG002|Received Matching Placebo to MK-1006|Period 3||1
10416018|NCT00791661|11560419|FG000|COMPLETED|Period 3||8
10416019|NCT00791661|11560420|FG001|COMPLETED|Period 3||8
10416020|NCT00791661|11560421|FG002|COMPLETED|Period 3||6
10416021|NCT00791661|11560419|FG000|NOT COMPLETED|Period 3||0
10416022|NCT00791661|11560420|FG001|NOT COMPLETED|Period 3||0
10416023|NCT00791661|11560421|FG002|NOT COMPLETED|Period 3||0
10416024|NCT00791700|11560449|FG000|STARTED|Overall Study||16
10416025|NCT00791700|11560450|FG001|STARTED|Overall Study||31
10416026|NCT00791700|11560451|FG002|STARTED|Overall Study||13
10416027|NCT00791700|11560452|FG003|STARTED|Overall Study||43
10416028|NCT00791700|11560449|FG000|COMPLETED|Overall Study||10
10416029|NCT00791700|11560450|FG001|COMPLETED|Overall Study||20
10416030|NCT00791700|11560451|FG002|COMPLETED|Overall Study||7
10416031|NCT00791700|11560452|FG003|COMPLETED|Overall Study||13
10416032|NCT00791700|11560449|FG000|NOT COMPLETED|Overall Study||6
10416033|NCT00791700|11560450|FG001|NOT COMPLETED|Overall Study||11
10416034|NCT00791700|11560451|FG002|NOT COMPLETED|Overall Study||6
10416035|NCT00791700|11560452|FG003|NOT COMPLETED|Overall Study||30
10416036|NCT00791765|11560475|FG000|STARTED|Weeks 1 to 12||62
10416037|NCT00791765|11560476|FG001|STARTED|Weeks 1 to 12||62
10416038|NCT00791765|11560475|FG000|Treated|Weeks 1 to 12||62
10416039|NCT00791765|11560476|FG001|Treated|Weeks 1 to 12||59
10416040|NCT00791765|11560475|FG000|COMPLETED|Weeks 1 to 12||54
10416041|NCT00791765|11560476|FG001|COMPLETED|Weeks 1 to 12||58
10416042|NCT00791765|11560475|FG000|NOT COMPLETED|Weeks 1 to 12||8
10416043|NCT00791765|11560476|FG001|NOT COMPLETED|Weeks 1 to 12||4
10416044|NCT00791765|11560475|FG000|STARTED|Weeks 13 to 24||54
10416045|NCT00791765|11560476|FG001|STARTED|Weeks 13 to 24|1 participant discontinued due to an adverse event after completing 12 weeks.|57
10416046|NCT00791765|11560475|FG000|COMPLETED|Weeks 13 to 24||49
10416047|NCT00791765|11560476|FG001|COMPLETED|Weeks 13 to 24||49
10416048|NCT00791765|11560475|FG000|NOT COMPLETED|Weeks 13 to 24||5
10416049|NCT00791765|11560476|FG001|NOT COMPLETED|Weeks 13 to 24||8
10416050|NCT00791778|11560484|FG000|STARTED|Double-blind Treatment||123
10416051|NCT00791778|11560485|FG001|STARTED|Double-blind Treatment||123
10416052|NCT00791778|11560484|FG000|COMPLETED|Double-blind Treatment|includes: 42 subjects with progression, 4 subjects transferred to a continuation study|46
10416053|NCT00791778|11560485|FG001|COMPLETED|Double-blind Treatment|includes: 75 subjects with progression|75
10416054|NCT00791778|11560484|FG000|NOT COMPLETED|Double-blind Treatment||77
10416055|NCT00791778|11560485|FG001|NOT COMPLETED|Double-blind Treatment||48
10416056|NCT00791778|11560484|FG000|STARTED|Follow-up||100
10416057|NCT00791778|11560485|FG001|STARTED|Follow-up||91
10416058|NCT00791778|11560484|FG000|COMPLETED|Follow-up|Includes 79 participants with study follow-up terminated by sponsor and 16 deaths|95
10416059|NCT00791778|11560485|FG001|COMPLETED|Follow-up|Includes 78 participants with study follow-up terminated by sponsor and 12 deaths|90
10416060|NCT00791778|11560484|FG000|NOT COMPLETED|Follow-up||5
10416061|NCT00791778|11560485|FG001|NOT COMPLETED|Follow-up||1
10416062|NCT00791817|11560493|FG000|STARTED|1: Single Dose Followed by Week Washout||5
10416063|NCT00791817|11560494|FG001|STARTED|1: Single Dose Followed by Week Washout||5
10416064|NCT00791817|11560493|FG000|COMPLETED|1: Single Dose Followed by Week Washout||5
10416065|NCT00791817|11560494|FG001|COMPLETED|1: Single Dose Followed by Week Washout||5
10859062|NCT00886600|12025121|FG003|NOT COMPLETED|Double-blind Monotherapy||2
10859063|NCT00886600|12025118|FG000|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 2-(Sitting Diastolic Blood Pressure (SiDBP) <85)|28
10859064|NCT00886600|12025119|FG001|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 4-(SiDBP <85); 3-(SiDBP ≥85)|21
10859065|NCT00886600|12025120|FG002|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 7-(SiDBP <85); 1-(SiDBP ≥85)|21
10859066|NCT00886600|12025121|FG003|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 5-(SiDBP <85); 1-(SiDBP ≥85)|23
10859067|NCT00886600|12025118|FG000|COMPLETED|Combination Therapy Period||28
10859068|NCT00886600|12025119|FG001|COMPLETED|Combination Therapy Period||21
10859069|NCT00886600|12025120|FG002|COMPLETED|Combination Therapy Period||19
10859070|NCT00886600|12025121|FG003|COMPLETED|Combination Therapy Period||23
10859071|NCT00886600|12025118|FG000|NOT COMPLETED|Combination Therapy Period||0
10859072|NCT00886600|12025119|FG001|NOT COMPLETED|Combination Therapy Period||0
10859073|NCT00886600|12025120|FG002|NOT COMPLETED|Combination Therapy Period||2
10859074|NCT00886600|12025121|FG003|NOT COMPLETED|Combination Therapy Period||0
10859075|NCT00882440|12025134|FG000|STARTED|Overall Study||78
10859076|NCT00882440|12025135|FG001|STARTED|Overall Study||80
10859077|NCT00882440|12025136|FG002|STARTED|Overall Study||82
10859078|NCT00882440|12025137|FG003|STARTED|Overall Study||79
10859079|NCT00882440|12025138|FG004|STARTED|Overall Study||90
10859080|NCT00882440|12025139|FG005|STARTED|Overall Study||84
10859081|NCT00882440|12025140|FG006|STARTED|Overall Study||83
10859082|NCT00882440|12025134|FG000|COMPLETED|Overall Study||67
10859083|NCT00882440|12025135|FG001|COMPLETED|Overall Study||72
10859084|NCT00882440|12025136|FG002|COMPLETED|Overall Study||75
10859085|NCT00882440|12025137|FG003|COMPLETED|Overall Study||76
10859086|NCT00882440|12025138|FG004|COMPLETED|Overall Study||80
10859087|NCT00882440|12025139|FG005|COMPLETED|Overall Study||77
10859088|NCT00882440|12025140|FG006|COMPLETED|Overall Study||79
10859089|NCT00882440|12025134|FG000|NOT COMPLETED|Overall Study||11
10859090|NCT00882440|12025135|FG001|NOT COMPLETED|Overall Study||8
10859091|NCT00882440|12025136|FG002|NOT COMPLETED|Overall Study||7
10859092|NCT00882440|12025137|FG003|NOT COMPLETED|Overall Study||3
10859093|NCT00882440|12025138|FG004|NOT COMPLETED|Overall Study||10
10859094|NCT00882440|12025139|FG005|NOT COMPLETED|Overall Study||7
10859095|NCT00882440|12025140|FG006|NOT COMPLETED|Overall Study||4
10859096|NCT00872430|12025151|FG000|STARTED|First Intervention||10
10859097|NCT00872430|12025152|FG001|STARTED|First Intervention||10
10859098|NCT00872430|12025151|FG000|COMPLETED|First Intervention||10
10859099|NCT00872430|12025152|FG001|COMPLETED|First Intervention||10
10859100|NCT00872430|12025151|FG000|NOT COMPLETED|First Intervention||0
10859101|NCT00872430|12025152|FG001|NOT COMPLETED|First Intervention||0
10859102|NCT00872430|12025151|FG000|STARTED|Washout Period||10
10859103|NCT00872430|12025152|FG001|STARTED|Washout Period||10
10859104|NCT00872430|12025151|FG000|COMPLETED|Washout Period||10
10859105|NCT00872430|12025152|FG001|COMPLETED|Washout Period||10
10859106|NCT00872430|12025151|FG000|NOT COMPLETED|Washout Period||0
10859107|NCT00872430|12025152|FG001|NOT COMPLETED|Washout Period||0
10859108|NCT00872430|12025151|FG000|STARTED|Second Intervention||10
10859109|NCT00872430|12025152|FG001|STARTED|Second Intervention||10
10859110|NCT00872430|12025151|FG000|COMPLETED|Second Intervention||10
10859111|NCT00872430|12025152|FG001|COMPLETED|Second Intervention||10
10859112|NCT00872430|12025151|FG000|NOT COMPLETED|Second Intervention||0
10859113|NCT00872430|12025152|FG001|NOT COMPLETED|Second Intervention||0
10859114|NCT00870688|12025156|FG000|STARTED|Overall Study||82
10859115|NCT00870688|12025156|FG000|COMPLETED|Overall Study||78
10859116|NCT00870688|12025156|FG000|NOT COMPLETED|Overall Study||4
10859117|NCT00869128|12025159|FG000|STARTED|Overall Study||18
10859118|NCT00869128|12025160|FG001|STARTED|Overall Study||18
10859119|NCT00869128|12025159|FG000|COMPLETED|Overall Study||12
10859120|NCT00869128|12025160|FG001|COMPLETED|Overall Study||12
10859121|NCT00869128|12025159|FG000|NOT COMPLETED|Overall Study||6
10859122|NCT00869128|12025160|FG001|NOT COMPLETED|Overall Study||6
10859135|NCT00859521|12025191|FG000|STARTED|First Intervention||15
10859136|NCT00859521|12025192|FG001|STARTED|First Intervention||15
10859137|NCT00859521|12025191|FG000|COMPLETED|First Intervention||15
10859138|NCT00859521|12025192|FG001|COMPLETED|First Intervention||15
10859139|NCT00859521|12025191|FG000|NOT COMPLETED|First Intervention||0
10416066|NCT00791817|11560493|FG000|NOT COMPLETED|1: Single Dose Followed by Week Washout||0
10859140|NCT00859521|12025192|FG001|NOT COMPLETED|First Intervention||0
10859141|NCT00859521|12025191|FG000|STARTED|Washout||15
10859142|NCT00859521|12025192|FG001|STARTED|Washout||15
10859143|NCT00859521|12025191|FG000|COMPLETED|Washout||15
10859144|NCT00859521|12025192|FG001|COMPLETED|Washout||14
10859145|NCT00859521|12025191|FG000|NOT COMPLETED|Washout||0
10859146|NCT00859521|12025192|FG001|NOT COMPLETED|Washout||1
10859147|NCT00859521|12025191|FG000|STARTED|Second Intervention||15
10859148|NCT00859521|12025192|FG001|STARTED|Second Intervention||14
10859149|NCT00859521|12025191|FG000|COMPLETED|Second Intervention||15
10859150|NCT00859521|12025192|FG001|COMPLETED|Second Intervention||14
10859151|NCT00859521|12025191|FG000|NOT COMPLETED|Second Intervention||0
10859152|NCT00859521|12025192|FG001|NOT COMPLETED|Second Intervention||0
10859153|NCT00859430|12025198|FG000|STARTED|First Intervention||11
10416067|NCT00791817|11560494|FG001|NOT COMPLETED|1: Single Dose Followed by Week Washout||0
10755175|NCT03061812|11918964|FG001|COMPLETED|Overall Study||296
10755176|NCT03061812|11918963|FG000|NOT COMPLETED|Overall Study||0
10755177|NCT03061812|11918964|FG001|NOT COMPLETED|Overall Study||0
10755178|NCT03062228|11918970|FG000|STARTED|Overall Study||162
10755179|NCT03062228|11918970|FG000|COMPLETED|Overall Study||162
10755180|NCT03062228|11918970|FG000|NOT COMPLETED|Overall Study||0
10755181|NCT03062267|11918976|FG000|STARTED|Overall Study||12
10755182|NCT03062267|11918977|FG001|STARTED|Overall Study||37
10755183|NCT03062267|11918976|FG000|COMPLETED|Overall Study||10
10755184|NCT03062267|11918977|FG001|COMPLETED|Overall Study||32
10755185|NCT03062267|11918976|FG000|NOT COMPLETED|Overall Study||2
10755186|NCT03062267|11918977|FG001|NOT COMPLETED|Overall Study||5
10755187|NCT03062488|11918986|FG000|STARTED|Overall Study||51
10755188|NCT03062488|11918987|FG001|STARTED|Overall Study||51
10755189|NCT03062488|11918988|FG002|STARTED|Overall Study||41
10293580|NCT02609724|11426167|FG000|NOT COMPLETED|Overall Study||5
10293581|NCT02609724|11426168|FG001|NOT COMPLETED|Overall Study||3
10293582|NCT02609724|11426169|FG002|NOT COMPLETED|Overall Study||4
10314583|NCT00166166|11448270|FG001|COMPLETED|Overall Study||71
10314584|NCT00166166|11448269|FG000|NOT COMPLETED|Overall Study||0
10755190|NCT03062488|11918986|FG000|COMPLETED|Overall Study||51
10859154|NCT00859430|12025199|FG001|STARTED|First Intervention||11
10859155|NCT00859430|12025198|FG000|COMPLETED|First Intervention||11
10859156|NCT00859430|12025199|FG001|COMPLETED|First Intervention||10
10859157|NCT00859430|12025198|FG000|NOT COMPLETED|First Intervention||0
10859158|NCT00859430|12025199|FG001|NOT COMPLETED|First Intervention||1
10859159|NCT00859430|12025198|FG000|STARTED|Second Intervention||11
10859160|NCT00859430|12025199|FG001|STARTED|Second Intervention||10
10859161|NCT00859430|12025198|FG000|COMPLETED|Second Intervention||11
10859162|NCT00859430|12025199|FG001|COMPLETED|Second Intervention||10
10859163|NCT00859430|12025198|FG000|NOT COMPLETED|Second Intervention||0
10859164|NCT00859430|12025199|FG001|NOT COMPLETED|Second Intervention||0
10859165|NCT00858702|12025205|FG000|STARTED|Overall Study||53
10859166|NCT00858702|12025206|FG001|STARTED|Overall Study||52
10859167|NCT00858702|12025205|FG000|COMPLETED|Overall Study||48
10859168|NCT00858702|12025206|FG001|COMPLETED|Overall Study||50
10859169|NCT00858702|12025205|FG000|NOT COMPLETED|Overall Study||5
10859170|NCT00858702|12025206|FG001|NOT COMPLETED|Overall Study||2
10859171|NCT00857285|12025214|FG000|STARTED|Overall Study||65
10859172|NCT00857285|12025215|FG001|STARTED|Overall Study||65
10859173|NCT00857285|12025214|FG000|COMPLETED|Overall Study||53
10859174|NCT00857285|12025215|FG001|COMPLETED|Overall Study||59
10859175|NCT00857285|12025214|FG000|NOT COMPLETED|Overall Study||12
10859176|NCT00857285|12025215|FG001|NOT COMPLETED|Overall Study||6
10859177|NCT00856934|12025222|FG000|STARTED|Overall Study||15
10859178|NCT00856934|12025223|FG001|STARTED|Overall Study||15
10859179|NCT00856934|12025224|FG002|STARTED|Overall Study||15
10859180|NCT00856934|12025222|FG000|COMPLETED|Overall Study||15
10859181|NCT00856934|12025223|FG001|COMPLETED|Overall Study||15
10859182|NCT00856934|12025224|FG002|COMPLETED|Overall Study||15
10859183|NCT00856934|12025222|FG000|NOT COMPLETED|Overall Study||0
10859184|NCT00856934|12025223|FG001|NOT COMPLETED|Overall Study||0
10859185|NCT00856934|12025224|FG002|NOT COMPLETED|Overall Study||0
10859186|NCT00850174|12025231|FG000|STARTED|First Intervention||30
10859187|NCT00850174|12025232|FG001|STARTED|First Intervention||30
10859188|NCT00850174|12025231|FG000|COMPLETED|First Intervention||30
10859189|NCT00850174|12025232|FG001|COMPLETED|First Intervention||30
10859190|NCT00850174|12025231|FG000|NOT COMPLETED|First Intervention||0
10859191|NCT00850174|12025232|FG001|NOT COMPLETED|First Intervention||0
10859192|NCT00850174|12025231|FG000|STARTED|Washout: One Week||30
10859193|NCT00850174|12025232|FG001|STARTED|Washout: One Week||30
10859194|NCT00850174|12025231|FG000|COMPLETED|Washout: One Week||30
10859195|NCT00850174|12025232|FG001|COMPLETED|Washout: One Week||28
10859196|NCT00850174|12025231|FG000|NOT COMPLETED|Washout: One Week||0
10859197|NCT00850174|12025232|FG001|NOT COMPLETED|Washout: One Week||2
10859198|NCT00850174|12025231|FG000|STARTED|Second Intervention||30
10859199|NCT00850174|12025232|FG001|STARTED|Second Intervention||28
10859200|NCT00850174|12025231|FG000|COMPLETED|Second Intervention||29
10859201|NCT00850174|12025232|FG001|COMPLETED|Second Intervention||28
10859202|NCT00850174|12025231|FG000|NOT COMPLETED|Second Intervention||1
10859203|NCT00850174|12025232|FG001|NOT COMPLETED|Second Intervention||0
10859204|NCT00849862|12025238|FG000|STARTED|First Intervention||11
10859205|NCT00849862|12025239|FG001|STARTED|First Intervention||11
10859206|NCT00849862|12025238|FG000|COMPLETED|First Intervention||11
10859207|NCT00849862|12025239|FG001|COMPLETED|First Intervention||11
10859208|NCT00849862|12025238|FG000|NOT COMPLETED|First Intervention||0
10859209|NCT00849862|12025239|FG001|NOT COMPLETED|First Intervention||0
10859210|NCT00849862|12025238|FG000|STARTED|Washout: 7 Days||11
10859211|NCT00849862|12025239|FG001|STARTED|Washout: 7 Days||11
10859212|NCT00849862|12025238|FG000|COMPLETED|Washout: 7 Days||11
10859213|NCT00849862|12025239|FG001|COMPLETED|Washout: 7 Days||11
10859214|NCT00849862|12025238|FG000|NOT COMPLETED|Washout: 7 Days||0
10859215|NCT00849862|12025239|FG001|NOT COMPLETED|Washout: 7 Days||0
10859216|NCT00849862|12025238|FG000|STARTED|Second Intervention||11
10859217|NCT00849862|12025239|FG001|STARTED|Second Intervention||11
10859218|NCT00849862|12025238|FG000|COMPLETED|Second Intervention||11
10859219|NCT00849862|12025239|FG001|COMPLETED|Second Intervention||11
10859220|NCT00849862|12025238|FG000|NOT COMPLETED|Second Intervention||0
10859221|NCT00849862|12025239|FG001|NOT COMPLETED|Second Intervention||0
10859222|NCT00849797|12025245|FG000|STARTED|First Intervention||60
10859223|NCT00849797|12025246|FG001|STARTED|First Intervention||60
10859224|NCT00849797|12025245|FG000|COMPLETED|First Intervention||59
10859225|NCT00849797|12025246|FG001|COMPLETED|First Intervention||59
10859226|NCT00849797|12025245|FG000|NOT COMPLETED|First Intervention||1
10859227|NCT00849797|12025246|FG001|NOT COMPLETED|First Intervention||1
10859228|NCT00849797|12025245|FG000|STARTED|Washout: One Week||59
10859229|NCT00849797|12025246|FG001|STARTED|Washout: One Week||59
10859230|NCT00849797|12025245|FG000|COMPLETED|Washout: One Week||59
10859231|NCT00849797|12025246|FG001|COMPLETED|Washout: One Week||57
10859232|NCT00849797|12025245|FG000|NOT COMPLETED|Washout: One Week||0
10859233|NCT00849797|12025246|FG001|NOT COMPLETED|Washout: One Week||2
10859234|NCT00849797|12025245|FG000|STARTED|Second Intervention||59
10859235|NCT00849797|12025246|FG001|STARTED|Second Intervention||57
10859236|NCT00849797|12025245|FG000|COMPLETED|Second Intervention||59
10859237|NCT00849797|12025246|FG001|COMPLETED|Second Intervention||57
10859238|NCT00849797|12025245|FG000|NOT COMPLETED|Second Intervention||0
10859239|NCT00849797|12025246|FG001|NOT COMPLETED|Second Intervention||0
10859240|NCT00849485|12025253|FG000|STARTED|First Intervention||11
10859241|NCT00849485|12025254|FG001|STARTED|First Intervention||11
10859242|NCT00849485|12025253|FG000|COMPLETED|First Intervention||11
10859243|NCT00849485|12025254|FG001|COMPLETED|First Intervention||11
10859244|NCT00849485|12025253|FG000|NOT COMPLETED|First Intervention||0
10859245|NCT00849485|12025254|FG001|NOT COMPLETED|First Intervention||0
10859246|NCT00849485|12025253|FG000|STARTED|Washout: 7 Days||11
10859247|NCT00849485|12025254|FG001|STARTED|Washout: 7 Days||11
10859248|NCT00849485|12025253|FG000|COMPLETED|Washout: 7 Days||11
10859249|NCT00849485|12025254|FG001|COMPLETED|Washout: 7 Days||11
10859250|NCT00849485|12025253|FG000|NOT COMPLETED|Washout: 7 Days||0
10859251|NCT00849485|12025254|FG001|NOT COMPLETED|Washout: 7 Days||0
10859252|NCT00849485|12025253|FG000|STARTED|Second Intervention||11
10859253|NCT00849485|12025254|FG001|STARTED|Second Intervention||11
10859254|NCT00849485|12025253|FG000|COMPLETED|Second Intervention||11
10859255|NCT00849485|12025254|FG001|COMPLETED|Second Intervention||11
10859256|NCT00849485|12025253|FG000|NOT COMPLETED|Second Intervention||0
10859257|NCT00849485|12025254|FG001|NOT COMPLETED|Second Intervention||0
10859258|NCT00847405|12025260|FG000|STARTED|First Intervention||14
10859259|NCT00847405|12025261|FG001|STARTED|First Intervention||14
10859260|NCT00847405|12025260|FG000|COMPLETED|First Intervention||14
10859261|NCT00847405|12025261|FG001|COMPLETED|First Intervention||13
10859262|NCT00847405|12025260|FG000|NOT COMPLETED|First Intervention||0
10859263|NCT00847405|12025261|FG001|NOT COMPLETED|First Intervention||1
10859264|NCT00847405|12025260|FG000|STARTED|Washout of 7 Days||14
10859265|NCT00847405|12025261|FG001|STARTED|Washout of 7 Days||13
10859266|NCT00847405|12025260|FG000|COMPLETED|Washout of 7 Days||13
10859267|NCT00847405|12025261|FG001|COMPLETED|Washout of 7 Days||13
10859268|NCT00847405|12025260|FG000|NOT COMPLETED|Washout of 7 Days||1
10859269|NCT00847405|12025261|FG001|NOT COMPLETED|Washout of 7 Days||0
10859270|NCT00847405|12025260|FG000|STARTED|Second Intervention||13
10859271|NCT00847405|12025261|FG001|STARTED|Second Intervention||13
10859272|NCT00847405|12025260|FG000|COMPLETED|Second Intervention||13
10859273|NCT00847405|12025261|FG001|COMPLETED|Second Intervention||13
10859274|NCT00847405|12025260|FG000|NOT COMPLETED|Second Intervention||0
10859275|NCT00847405|12025261|FG001|NOT COMPLETED|Second Intervention||0
10859276|NCT00846885|12025267|FG000|STARTED|First Intervention||14
10859277|NCT00846885|12025268|FG001|STARTED|First Intervention||14
10859278|NCT00846885|12025267|FG000|COMPLETED|First Intervention||14
10859279|NCT00846885|12025268|FG001|COMPLETED|First Intervention||14
10859280|NCT00846885|12025267|FG000|NOT COMPLETED|First Intervention||0
10859281|NCT00846885|12025268|FG001|NOT COMPLETED|First Intervention||0
10859282|NCT00846885|12025267|FG000|STARTED|Washout of 7 Days||14
10859283|NCT00846885|12025268|FG001|STARTED|Washout of 7 Days||14
10859284|NCT00846885|12025267|FG000|COMPLETED|Washout of 7 Days||14
10859285|NCT00846885|12025268|FG001|COMPLETED|Washout of 7 Days||14
10859286|NCT00846885|12025267|FG000|NOT COMPLETED|Washout of 7 Days||0
10859287|NCT00846885|12025268|FG001|NOT COMPLETED|Washout of 7 Days||0
10859288|NCT00846885|12025267|FG000|STARTED|Second Intervention||14
10859289|NCT00846885|12025268|FG001|STARTED|Second Intervention||14
10859290|NCT00846885|12025267|FG000|COMPLETED|Second Intervention||14
10859291|NCT00846885|12025268|FG001|COMPLETED|Second Intervention||14
10859292|NCT00846885|12025267|FG000|NOT COMPLETED|Second Intervention||0
10859293|NCT00846885|12025268|FG001|NOT COMPLETED|Second Intervention||0
10859294|NCT00841815|12025274|FG000|STARTED|Period 1||14
10859295|NCT00841815|12025275|FG001|STARTED|Period 1||14
10859296|NCT00841815|12025274|FG000|COMPLETED|Period 1||14
10859297|NCT00841815|12025275|FG001|COMPLETED|Period 1||14
10859298|NCT00841815|12025274|FG000|NOT COMPLETED|Period 1||0
10859299|NCT00841815|12025275|FG001|NOT COMPLETED|Period 1||0
10859300|NCT00841815|12025274|FG000|STARTED|Washout||14
10859301|NCT00841815|12025275|FG001|STARTED|Washout||14
10859302|NCT00841815|12025274|FG000|COMPLETED|Washout||14
10859303|NCT00841815|12025275|FG001|COMPLETED|Washout||13
10859304|NCT00841815|12025274|FG000|NOT COMPLETED|Washout||0
10859305|NCT00841815|12025275|FG001|NOT COMPLETED|Washout||1
10859306|NCT00841815|12025274|FG000|STARTED|Period 2||14
10859307|NCT00841815|12025275|FG001|STARTED|Period 2||13
10859308|NCT00841815|12025274|FG000|COMPLETED|Period 2||14
10859309|NCT00841815|12025275|FG001|COMPLETED|Period 2||13
10859310|NCT00841815|12025274|FG000|NOT COMPLETED|Period 2||0
10859311|NCT00841815|12025275|FG001|NOT COMPLETED|Period 2||0
10859312|NCT00841698|12025282|FG000|STARTED|First Intervention||25
10859313|NCT00841698|12025283|FG001|STARTED|First Intervention||25
10859314|NCT00841698|12025282|FG000|COMPLETED|First Intervention||24
10859315|NCT00841698|12025283|FG001|COMPLETED|First Intervention||25
10859316|NCT00841698|12025282|FG000|NOT COMPLETED|First Intervention||1
10859317|NCT00841698|12025283|FG001|NOT COMPLETED|First Intervention||0
10859318|NCT00841698|12025282|FG000|STARTED|Washout: 2 Weeks||24
10859319|NCT00841698|12025283|FG001|STARTED|Washout: 2 Weeks||25
10859320|NCT00841698|12025282|FG000|COMPLETED|Washout: 2 Weeks||24
10859321|NCT00841698|12025283|FG001|COMPLETED|Washout: 2 Weeks||25
10859322|NCT00841698|12025282|FG000|NOT COMPLETED|Washout: 2 Weeks||0
10859323|NCT00841698|12025283|FG001|NOT COMPLETED|Washout: 2 Weeks||0
10859324|NCT00841698|12025282|FG000|STARTED|Second Intervention||24
10859325|NCT00841698|12025283|FG001|STARTED|Second Intervention||25
10859326|NCT00841698|12025282|FG000|COMPLETED|Second Intervention||24
10859327|NCT00841698|12025283|FG001|COMPLETED|Second Intervention||25
10859328|NCT00841698|12025282|FG000|NOT COMPLETED|Second Intervention||0
10859329|NCT00841698|12025283|FG001|NOT COMPLETED|Second Intervention||0
10859330|NCT00841659|12025289|FG000|STARTED|First Intervention||12
10859331|NCT00841659|12025290|FG001|STARTED|First Intervention||12
10859332|NCT00841659|12025289|FG000|COMPLETED|First Intervention||12
10859333|NCT00841659|12025290|FG001|COMPLETED|First Intervention||12
10859334|NCT00841659|12025289|FG000|NOT COMPLETED|First Intervention||0
10859335|NCT00841659|12025290|FG001|NOT COMPLETED|First Intervention||0
10859336|NCT00841659|12025289|FG000|STARTED|Washout: 2 Weeks||12
10859337|NCT00841659|12025290|FG001|STARTED|Washout: 2 Weeks||12
10859338|NCT00841659|12025289|FG000|COMPLETED|Washout: 2 Weeks||11
10293583|NCT02359994|11426179|FG000|STARTED|Overall Population Study||161
10293584|NCT02359994|11426180|FG001|STARTED|Overall Population Study||163
10293585|NCT02359994|11426179|FG000|Treated|Overall Population Study||160
10859339|NCT00841659|12025290|FG001|COMPLETED|Washout: 2 Weeks||12
10859340|NCT00841659|12025289|FG000|NOT COMPLETED|Washout: 2 Weeks||1
10859341|NCT00841659|12025290|FG001|NOT COMPLETED|Washout: 2 Weeks||0
10859342|NCT00841659|12025289|FG000|STARTED|Second Intervention||11
10859343|NCT00841659|12025290|FG001|STARTED|Second Intervention||12
10859344|NCT00841659|12025289|FG000|COMPLETED|Second Intervention||11
10859345|NCT00841659|12025290|FG001|COMPLETED|Second Intervention||12
10859346|NCT00841659|12025289|FG000|NOT COMPLETED|Second Intervention||0
10859347|NCT00841659|12025290|FG001|NOT COMPLETED|Second Intervention||0
10859348|NCT00841542|12025296|FG000|STARTED|Period 1||14
10859349|NCT00841542|12025297|FG001|STARTED|Period 1||14
10859350|NCT00841542|12025296|FG000|COMPLETED|Period 1||13
10859351|NCT00841542|12025297|FG001|COMPLETED|Period 1||14
10859352|NCT00841542|12025296|FG000|NOT COMPLETED|Period 1||1
10859353|NCT00841542|12025297|FG001|NOT COMPLETED|Period 1||0
10859354|NCT00841542|12025296|FG000|STARTED|Period 2||13
10859355|NCT00841542|12025297|FG001|STARTED|Period 2||14
10859356|NCT00841542|12025296|FG000|COMPLETED|Period 2||13
10859357|NCT00841542|12025297|FG001|COMPLETED|Period 2||14
10859358|NCT00841542|12025296|FG000|NOT COMPLETED|Period 2||0
10859359|NCT00841542|12025297|FG001|NOT COMPLETED|Period 2||0
10859360|NCT00840879|12025303|FG000|STARTED|First Intervention||14
10859361|NCT00840879|12025304|FG001|STARTED|First Intervention||14
10859362|NCT00840879|12025303|FG000|COMPLETED|First Intervention||14
10859363|NCT00840879|12025304|FG001|COMPLETED|First Intervention||14
10859364|NCT00840879|12025303|FG000|NOT COMPLETED|First Intervention||0
10859365|NCT00840879|12025304|FG001|NOT COMPLETED|First Intervention||0
10859366|NCT00840879|12025303|FG000|STARTED|Washout: 14 Days||14
10859367|NCT00840879|12025304|FG001|STARTED|Washout: 14 Days||14
10859368|NCT00840879|12025303|FG000|COMPLETED|Washout: 14 Days||14
10859369|NCT00840879|12025304|FG001|COMPLETED|Washout: 14 Days||14
10859370|NCT00840879|12025303|FG000|NOT COMPLETED|Washout: 14 Days||0
10859371|NCT00840879|12025304|FG001|NOT COMPLETED|Washout: 14 Days||0
10859372|NCT00840879|12025303|FG000|STARTED|Second Intervention||14
10859373|NCT00840879|12025304|FG001|STARTED|Second Intervention||14
10859374|NCT00840879|12025303|FG000|COMPLETED|Second Intervention||13
10859375|NCT00840879|12025304|FG001|COMPLETED|Second Intervention||14
10859376|NCT00840879|12025303|FG000|NOT COMPLETED|Second Intervention||1
10859377|NCT00840879|12025304|FG001|NOT COMPLETED|Second Intervention||0
10859378|NCT00840866|12025310|FG000|STARTED|First Intervention||20
10859379|NCT00840866|12025311|FG001|STARTED|First Intervention||19
10859380|NCT00840866|12025310|FG000|COMPLETED|First Intervention||20
10859381|NCT00840866|12025311|FG001|COMPLETED|First Intervention||19
10859382|NCT00840866|12025310|FG000|NOT COMPLETED|First Intervention||0
10859383|NCT00840866|12025311|FG001|NOT COMPLETED|First Intervention||0
10859384|NCT00840866|12025310|FG000|STARTED|Washout of 7 Days||20
10859385|NCT00840866|12025311|FG001|STARTED|Washout of 7 Days||19
10859386|NCT00840866|12025310|FG000|COMPLETED|Washout of 7 Days||20
10859387|NCT00840866|12025311|FG001|COMPLETED|Washout of 7 Days||19
10859388|NCT00840866|12025310|FG000|NOT COMPLETED|Washout of 7 Days||0
10859389|NCT00840866|12025311|FG001|NOT COMPLETED|Washout of 7 Days||0
10859390|NCT00840866|12025310|FG000|STARTED|Second Intervention||20
10859391|NCT00840866|12025311|FG001|STARTED|Second Intervention||19
10859392|NCT00840866|12025310|FG000|COMPLETED|Second Intervention||20
10859393|NCT00840866|12025311|FG001|COMPLETED|Second Intervention||19
10293586|NCT02359994|11426180|FG001|Treated|Overall Population Study||162
10293587|NCT02359994|11426179|FG000|COMPLETED|Overall Population Study||156
10293588|NCT02359994|11426180|FG001|COMPLETED|Overall Population Study||155
10293589|NCT02359994|11426179|FG000|NOT COMPLETED|Overall Population Study||5
10293590|NCT02359994|11426180|FG001|NOT COMPLETED|Overall Population Study||8
10293591|NCT02359994|11426179|FG000|STARTED|Extended Oncology 24-Month Survival|Oncology subjects in the PerClot group who completed either the 6 week or 3 month visit in the Overall Population Study.|85
10293592|NCT02359994|11426180|FG001|STARTED|Extended Oncology 24-Month Survival|Oncology subjects in the Arista group who completed either the 6 week or 3 month visit in the Overall Population Study.|93
10293593|NCT02359994|11426179|FG000|COMPLETED|Extended Oncology 24-Month Survival||65
10293594|NCT02359994|11426180|FG001|COMPLETED|Extended Oncology 24-Month Survival||72
10293595|NCT02359994|11426179|FG000|NOT COMPLETED|Extended Oncology 24-Month Survival||20
10293596|NCT02359994|11426180|FG001|NOT COMPLETED|Extended Oncology 24-Month Survival||21
10293597|NCT02336230|11426186|FG000|STARTED|Overall Study||55
10293598|NCT02336230|11426186|FG000|Full Analysis Set (FAS)|Overall Study||55
10293599|NCT02336230|11426186|FG000|Safety Analysis Population|Overall Study||54
10293600|NCT02336230|11426186|FG000|COMPLETED|Overall Study||42
10293601|NCT02336230|11426186|FG000|NOT COMPLETED|Overall Study||13
10293602|NCT01557751|11426190|FG000|STARTED|Overall Study||156
10293603|NCT01557751|11426190|FG000|COMPLETED|Overall Study||153
10293604|NCT01557751|11426190|FG000|NOT COMPLETED|Overall Study||3
10293605|NCT01363401|11426196|FG000|STARTED|Overall Study|"Including 8 subjects of Phase 1 safety assessment. (Called Modified ITT in this clinical trials)"|41
10293606|NCT01363401|11426197|FG001|STARTED|Overall Study||31
10293607|NCT01363401|11426196|FG000|COMPLETED|Overall Study||39
10293608|NCT01363401|11426197|FG001|COMPLETED|Overall Study||27
10293609|NCT01363401|11426196|FG000|NOT COMPLETED|Overall Study||2
10293610|NCT01363401|11426197|FG001|NOT COMPLETED|Overall Study||4
10859394|NCT00840866|12025310|FG000|NOT COMPLETED|Second Intervention||0
10859395|NCT00840866|12025311|FG001|NOT COMPLETED|Second Intervention||0
10859396|NCT00840840|12025317|FG000|STARTED|Period 1||24
10859397|NCT00840840|12025318|FG001|STARTED|Period 1||24
10859398|NCT00840840|12025317|FG000|COMPLETED|Period 1||24
10859399|NCT00840840|12025318|FG001|COMPLETED|Period 1||24
10859400|NCT00840840|12025317|FG000|NOT COMPLETED|Period 1||0
10859401|NCT00840840|12025318|FG001|NOT COMPLETED|Period 1||0
10859402|NCT00840840|12025317|FG000|STARTED|Period 2|One subject was withdrawn due to AE after Period 1|23
10859403|NCT00840840|12025318|FG001|STARTED|Period 2||24
10859404|NCT00840840|12025317|FG000|COMPLETED|Period 2||23
10859405|NCT00840840|12025318|FG001|COMPLETED|Period 2||24
10859406|NCT00840840|12025317|FG000|NOT COMPLETED|Period 2||0
10859407|NCT00840840|12025318|FG001|NOT COMPLETED|Period 2||0
10859408|NCT00840632|12025324|FG000|STARTED|First Intervention||20
10859409|NCT00840632|12025325|FG001|STARTED|First Intervention||20
10859410|NCT00840632|12025324|FG000|COMPLETED|First Intervention||20
10859411|NCT00840632|12025325|FG001|COMPLETED|First Intervention||19
10859412|NCT00840632|12025324|FG000|NOT COMPLETED|First Intervention||0
10859413|NCT00840632|12025325|FG001|NOT COMPLETED|First Intervention||1
10859414|NCT00840632|12025324|FG000|STARTED|Washout||20
10859415|NCT00840632|12025325|FG001|STARTED|Washout||19
10859416|NCT00840632|12025324|FG000|COMPLETED|Washout||19
10859417|NCT00840632|12025325|FG001|COMPLETED|Washout||18
10859418|NCT00840632|12025324|FG000|NOT COMPLETED|Washout||1
10859419|NCT00840632|12025325|FG001|NOT COMPLETED|Washout||1
10859420|NCT00840632|12025324|FG000|STARTED|Second Intervention||19
10859421|NCT00840632|12025325|FG001|STARTED|Second Intervention||18
10859422|NCT00840632|12025324|FG000|COMPLETED|Second Intervention||19
10859423|NCT00840632|12025325|FG001|COMPLETED|Second Intervention||18
10859424|NCT00840632|12025324|FG000|NOT COMPLETED|Second Intervention||0
10859425|NCT00840632|12025325|FG001|NOT COMPLETED|Second Intervention||0
10859426|NCT00840476|12025331|FG000|STARTED|First Intervention||14
10859427|NCT00840476|12025332|FG001|STARTED|First Intervention||14
10416068|NCT00791817|11560493|FG000|STARTED|2: Single Dose||5
10416069|NCT00791817|11560494|FG001|STARTED|2: Single Dose||5
10416070|NCT00791817|11560493|FG000|COMPLETED|2: Single Dose||5
10416071|NCT00791817|11560494|FG001|COMPLETED|2: Single Dose||5
10416072|NCT00791817|11560493|FG000|NOT COMPLETED|2: Single Dose||0
10416073|NCT00791817|11560494|FG001|NOT COMPLETED|2: Single Dose||0
10859428|NCT00840476|12025331|FG000|COMPLETED|First Intervention||14
10859429|NCT00840476|12025332|FG001|COMPLETED|First Intervention||14
10859430|NCT00840476|12025331|FG000|NOT COMPLETED|First Intervention||0
10859431|NCT00840476|12025332|FG001|NOT COMPLETED|First Intervention||0
10859432|NCT00840476|12025331|FG000|STARTED|Washout: 14 Days||14
10859433|NCT00840476|12025332|FG001|STARTED|Washout: 14 Days||14
10859434|NCT00840476|12025331|FG000|COMPLETED|Washout: 14 Days||14
10859435|NCT00840476|12025332|FG001|COMPLETED|Washout: 14 Days||14
10859436|NCT00840476|12025331|FG000|NOT COMPLETED|Washout: 14 Days||0
10859437|NCT00840476|12025332|FG001|NOT COMPLETED|Washout: 14 Days||0
10859438|NCT00840476|12025331|FG000|STARTED|Second Intervention||14
10859439|NCT00840476|12025332|FG001|STARTED|Second Intervention||14
10859440|NCT00840476|12025331|FG000|COMPLETED|Second Intervention||14
10859441|NCT00840476|12025332|FG001|COMPLETED|Second Intervention||14
10859442|NCT00840476|12025331|FG000|NOT COMPLETED|Second Intervention||0
10859443|NCT00840476|12025332|FG001|NOT COMPLETED|Second Intervention||0
10859444|NCT00840411|12025338|FG000|STARTED|First Intervention||33
10859445|NCT00840411|12025339|FG001|STARTED|First Intervention||33
10859446|NCT00840411|12025338|FG000|COMPLETED|First Intervention||32
10859447|NCT00840411|12025339|FG001|COMPLETED|First Intervention||33
10859448|NCT00840411|12025338|FG000|NOT COMPLETED|First Intervention||1
10859449|NCT00840411|12025339|FG001|NOT COMPLETED|First Intervention||0
10859450|NCT00840411|12025338|FG000|STARTED|Washout||32
10859451|NCT00840411|12025339|FG001|STARTED|Washout||33
10859452|NCT00840411|12025338|FG000|COMPLETED|Washout||31
10859453|NCT00840411|12025339|FG001|COMPLETED|Washout||33
10859454|NCT00840411|12025338|FG000|NOT COMPLETED|Washout||1
10859455|NCT00840411|12025339|FG001|NOT COMPLETED|Washout||0
10859456|NCT00840411|12025338|FG000|STARTED|Second Intervention||31
10859457|NCT00840411|12025339|FG001|STARTED|Second Intervention||33
10859458|NCT00840411|12025338|FG000|COMPLETED|Second Intervention||31
10859459|NCT00840411|12025339|FG001|COMPLETED|Second Intervention||33
10859460|NCT00840411|12025338|FG000|NOT COMPLETED|Second Intervention||0
10859461|NCT00840411|12025339|FG001|NOT COMPLETED|Second Intervention||0
10859462|NCT00840281|12025345|FG000|STARTED|First Intervention||19
10859463|NCT00840281|12025346|FG001|STARTED|First Intervention||19
10859464|NCT00840281|12025345|FG000|COMPLETED|First Intervention||19
10859465|NCT00840281|12025346|FG001|COMPLETED|First Intervention||19
10859466|NCT00840281|12025345|FG000|NOT COMPLETED|First Intervention||0
10859467|NCT00840281|12025346|FG001|NOT COMPLETED|First Intervention||0
10859468|NCT00840281|12025345|FG000|STARTED|Washout of 7 Days||19
10859469|NCT00840281|12025346|FG001|STARTED|Washout of 7 Days||19
10859470|NCT00840281|12025345|FG000|COMPLETED|Washout of 7 Days||19
10859471|NCT00840281|12025346|FG001|COMPLETED|Washout of 7 Days||19
10859472|NCT00840281|12025345|FG000|NOT COMPLETED|Washout of 7 Days||0
10859473|NCT00840281|12025346|FG001|NOT COMPLETED|Washout of 7 Days||0
10859474|NCT00840281|12025345|FG000|STARTED|Second Intervention||19
10859475|NCT00840281|12025346|FG001|STARTED|Second Intervention||19
10859476|NCT00840281|12025345|FG000|COMPLETED|Second Intervention||19
10859477|NCT00840281|12025346|FG001|COMPLETED|Second Intervention||19
10859478|NCT00840281|12025345|FG000|NOT COMPLETED|Second Intervention||0
10859479|NCT00840281|12025346|FG001|NOT COMPLETED|Second Intervention||0
10859480|NCT00840216|12025352|FG000|STARTED|First Intervention||11
10859481|NCT00840216|12025353|FG001|STARTED|First Intervention||11
10859482|NCT00840216|12025352|FG000|COMPLETED|First Intervention||11
10859483|NCT00840216|12025353|FG001|COMPLETED|First Intervention||11
10859484|NCT00840216|12025352|FG000|NOT COMPLETED|First Intervention||0
10859485|NCT00840216|12025353|FG001|NOT COMPLETED|First Intervention||0
10859486|NCT00840216|12025352|FG000|STARTED|Washout: 7 Days||11
10859487|NCT00840216|12025353|FG001|STARTED|Washout: 7 Days||11
10859488|NCT00840216|12025352|FG000|COMPLETED|Washout: 7 Days||10
10859489|NCT00840216|12025353|FG001|COMPLETED|Washout: 7 Days||11
10859490|NCT00840216|12025352|FG000|NOT COMPLETED|Washout: 7 Days||1
10859491|NCT00840216|12025353|FG001|NOT COMPLETED|Washout: 7 Days||0
10859492|NCT00840216|12025352|FG000|STARTED|Second Intervention||10
10859493|NCT00840216|12025353|FG001|STARTED|Second Intervention||11
10859494|NCT00840216|12025352|FG000|COMPLETED|Second Intervention||10
10859495|NCT00840216|12025353|FG001|COMPLETED|Second Intervention||11
10859496|NCT00840216|12025352|FG000|NOT COMPLETED|Second Intervention||0
10859497|NCT00840216|12025353|FG001|NOT COMPLETED|Second Intervention||0
10859498|NCT00840203|12025359|FG000|STARTED|First Intervention||37
10859499|NCT00840203|12025360|FG001|STARTED|First Intervention||35
10859500|NCT00840203|12025359|FG000|COMPLETED|First Intervention||36
10859501|NCT00840203|12025360|FG001|COMPLETED|First Intervention||34
10859502|NCT00840203|12025359|FG000|NOT COMPLETED|First Intervention||1
10859503|NCT00840203|12025360|FG001|NOT COMPLETED|First Intervention||1
10859504|NCT00840203|12025359|FG000|STARTED|Washout||36
10859505|NCT00840203|12025360|FG001|STARTED|Washout||34
10859506|NCT00840203|12025359|FG000|COMPLETED|Washout||35
10859507|NCT00840203|12025360|FG001|COMPLETED|Washout||34
10859508|NCT00840203|12025359|FG000|NOT COMPLETED|Washout||1
10859509|NCT00840203|12025360|FG001|NOT COMPLETED|Washout||0
10859510|NCT00840203|12025359|FG000|STARTED|Second Intervention||35
10859511|NCT00840203|12025360|FG001|STARTED|Second Intervention||34
10859512|NCT00840203|12025359|FG000|COMPLETED|Second Intervention||35
10859513|NCT00840203|12025360|FG001|COMPLETED|Second Intervention||34
10859514|NCT00840203|12025359|FG000|NOT COMPLETED|Second Intervention||0
10859515|NCT00840203|12025360|FG001|NOT COMPLETED|Second Intervention||0
10859516|NCT00840099|12025366|FG000|STARTED|Period 1||24
10859517|NCT00840099|12025367|FG001|STARTED|Period 1||24
10859518|NCT00840099|12025366|FG000|COMPLETED|Period 1||24
10859519|NCT00840099|12025367|FG001|COMPLETED|Period 1||24
10859520|NCT00840099|12025366|FG000|NOT COMPLETED|Period 1||0
10859521|NCT00840099|12025367|FG001|NOT COMPLETED|Period 1||0
10859522|NCT00840099|12025366|FG000|STARTED|Period 2|3 subjects were dismissed from study prior to period 2 dosing|21
10859523|NCT00840099|12025367|FG001|STARTED|Period 2||24
10859524|NCT00840099|12025366|FG000|COMPLETED|Period 2||21
10859525|NCT00840099|12025367|FG001|COMPLETED|Period 2||24
10859526|NCT00840099|12025366|FG000|NOT COMPLETED|Period 2||0
10859527|NCT00840099|12025367|FG001|NOT COMPLETED|Period 2||0
10859528|NCT00840073|12025373|FG000|STARTED|First Intervention||25
10859529|NCT00840073|12025374|FG001|STARTED|First Intervention||25
10859530|NCT00840073|12025373|FG000|COMPLETED|First Intervention||25
10859531|NCT00840073|12025374|FG001|COMPLETED|First Intervention||25
10859532|NCT00840073|12025373|FG000|NOT COMPLETED|First Intervention||0
10859533|NCT00840073|12025374|FG001|NOT COMPLETED|First Intervention||0
10859534|NCT00840073|12025373|FG000|STARTED|Second Intervention||25
10859535|NCT00840073|12025374|FG001|STARTED|Second Intervention||25
10859536|NCT00840073|12025373|FG000|COMPLETED|Second Intervention||24
10859537|NCT00840073|12025374|FG001|COMPLETED|Second Intervention||24
10859538|NCT00840073|12025373|FG000|NOT COMPLETED|Second Intervention||1
10859539|NCT00840073|12025374|FG001|NOT COMPLETED|Second Intervention||1
10416074|NCT00791908|11560500|FG000|STARTED|Overall Study||15
10416075|NCT00791908|11560500|FG000|COMPLETED|Overall Study||15
10416076|NCT00791908|11560500|FG000|NOT COMPLETED|Overall Study||0
10416077|NCT00791921|11560510|FG000|STARTED|Overall Study||116
10416078|NCT00791921|11560511|FG001|STARTED|Overall Study||114
10416079|NCT00791921|11560510|FG000|COMPLETED|Overall Study||82
10416080|NCT00791921|11560511|FG001|COMPLETED|Overall Study||18
10416081|NCT00791921|11560510|FG000|NOT COMPLETED|Overall Study||34
10416082|NCT00791921|11560511|FG001|NOT COMPLETED|Overall Study||96
10416083|NCT00791934|11560517|FG000|STARTED|Overall Study||63
10416084|NCT00791934|11560517|FG000|COMPLETED|Overall Study|Follow-up extended to 1 yr. 13 subjects chose not to participate in the extension.|48
10416085|NCT00791934|11560517|FG000|NOT COMPLETED|Overall Study||15
10416086|NCT00791973|11560523|FG000|STARTED|First Intervention (1 Week)||8
10416087|NCT00791973|11560524|FG001|STARTED|First Intervention (1 Week)||7
10416088|NCT00791973|11560523|FG000|COMPLETED|First Intervention (1 Week)||8
10416089|NCT00791973|11560524|FG001|COMPLETED|First Intervention (1 Week)||7
10416090|NCT00791973|11560523|FG000|NOT COMPLETED|First Intervention (1 Week)||0
10859540|NCT00839930|12025380|FG000|STARTED|First Intervention||15
10859541|NCT00839930|12025381|FG001|STARTED|First Intervention||15
10859542|NCT00839930|12025380|FG000|COMPLETED|First Intervention||15
10859543|NCT00839930|12025381|FG001|COMPLETED|First Intervention||15
10859544|NCT00839930|12025380|FG000|NOT COMPLETED|First Intervention||0
10859545|NCT00839930|12025381|FG001|NOT COMPLETED|First Intervention||0
10859546|NCT00839930|12025380|FG000|STARTED|Washout: 7 Days||15
10859547|NCT00839930|12025381|FG001|STARTED|Washout: 7 Days||15
10859548|NCT00839930|12025380|FG000|COMPLETED|Washout: 7 Days||15
10859549|NCT00839930|12025381|FG001|COMPLETED|Washout: 7 Days||15
10859550|NCT00839930|12025380|FG000|NOT COMPLETED|Washout: 7 Days||0
10859551|NCT00839930|12025381|FG001|NOT COMPLETED|Washout: 7 Days||0
10859552|NCT00839930|12025380|FG000|STARTED|Second Intervention||15
10416091|NCT00791973|11560524|FG001|NOT COMPLETED|First Intervention (1 Week)||0
10416092|NCT00791973|11560523|FG000|STARTED|Washout (1 Week)||8
10416093|NCT00791973|11560524|FG001|STARTED|Washout (1 Week)||7
10416094|NCT00791973|11560523|FG000|COMPLETED|Washout (1 Week)||8
10416095|NCT00791973|11560524|FG001|COMPLETED|Washout (1 Week)||7
10416096|NCT00791973|11560523|FG000|NOT COMPLETED|Washout (1 Week)||0
10416097|NCT00791973|11560524|FG001|NOT COMPLETED|Washout (1 Week)||0
10416098|NCT00791973|11560523|FG000|STARTED|Second Intervention (1 Week)||8
10416099|NCT00791973|11560524|FG001|STARTED|Second Intervention (1 Week)||7
10416100|NCT00791973|11560523|FG000|COMPLETED|Second Intervention (1 Week)||8
10416101|NCT00791973|11560524|FG001|COMPLETED|Second Intervention (1 Week)||7
10416102|NCT00791973|11560523|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
10416103|NCT00791973|11560524|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
10416104|NCT00791999|11560534|FG000|STARTED|Overall Study||72
10416105|NCT00791999|11560535|FG001|STARTED|Overall Study||82
10416106|NCT00791999|11560536|FG002|STARTED|Overall Study||85
10416107|NCT00791999|11560537|FG003|STARTED|Overall Study||77
10416108|NCT00791999|11560534|FG000|COMPLETED|Overall Study||51
10416109|NCT00791999|11560535|FG001|COMPLETED|Overall Study||66
10416110|NCT00791999|11560536|FG002|COMPLETED|Overall Study||65
10416111|NCT00791999|11560537|FG003|COMPLETED|Overall Study||25
10416112|NCT00791999|11560534|FG000|NOT COMPLETED|Overall Study||21
10416113|NCT00791999|11560535|FG001|NOT COMPLETED|Overall Study||16
10416114|NCT00791999|11560536|FG002|NOT COMPLETED|Overall Study||20
10416115|NCT00791999|11560537|FG003|NOT COMPLETED|Overall Study||52
10416116|NCT00792077|11560547|FG000|STARTED|Overall Study||6
10416117|NCT00792077|11560547|FG000|Day 15+/- 3 Days|Overall Study||6
10416118|NCT00792077|11560547|FG000|Day 29+/-3 Days|Overall Study||6
10416119|NCT00792077|11560547|FG000|Day 43+/-3 Days|Overall Study||6
10416120|NCT00792077|11560547|FG000|Day 57+/-3 Days|Overall Study||6
10416121|NCT00792077|11560547|FG000|COMPLETED|Overall Study||6
10416122|NCT00792077|11560547|FG000|NOT COMPLETED|Overall Study||0
10416123|NCT00792103|11560551|FG000|STARTED|Overall Study|15 subjects were enrolled but did not treat for a total of 183 subjects in the safety population|198
10416124|NCT00792103|11560551|FG000|COMPLETED|Overall Study||65
10416125|NCT00792103|11560551|FG000|NOT COMPLETED|Overall Study||133
10416126|NCT00792142|11560555|FG000|STARTED|Overall Study||45
10416127|NCT00792142|11560555|FG000|COMPLETED|Overall Study||45
10416128|NCT00792142|11560555|FG000|NOT COMPLETED|Overall Study||0
10416129|NCT00792298|11560559|FG000|STARTED|Treatment Period 1||31
10416130|NCT00792298|11560560|FG001|STARTED|Treatment Period 1||32
10416131|NCT00792298|11560561|FG002|STARTED|Treatment Period 1||33
10755191|NCT03062488|11918987|FG001|COMPLETED|Overall Study||51
10755192|NCT03062488|11918988|FG002|COMPLETED|Overall Study||41
10755193|NCT03062488|11918986|FG000|NOT COMPLETED|Overall Study||0
10755194|NCT03062488|11918987|FG001|NOT COMPLETED|Overall Study||0
10755195|NCT03062488|11918988|FG002|NOT COMPLETED|Overall Study||0
10755196|NCT03062605|11918998|FG000|STARTED|Overall Study||25
10755197|NCT03062605|11918999|FG001|STARTED|Overall Study||23
10755198|NCT03062605|11918998|FG000|COMPLETED|Overall Study||14
10755199|NCT03062605|11918999|FG001|COMPLETED|Overall Study||13
10755200|NCT03062605|11918998|FG000|NOT COMPLETED|Overall Study||11
10755201|NCT03062605|11918999|FG001|NOT COMPLETED|Overall Study||10
10755202|NCT03062891|11919007|FG000|STARTED|Overall Study||99
10755203|NCT03062891|11919008|FG001|STARTED|Overall Study||100
10755204|NCT03062891|11919007|FG000|Mid-intervention|Overall Study||68
10755205|NCT03062891|11919008|FG001|Mid-intervention|Overall Study||74
10755206|NCT03062891|11919007|FG000|End of Intervention|Overall Study||67
10755207|NCT03062891|11919008|FG001|End of Intervention|Overall Study||78
10755208|NCT03062891|11919007|FG000|Followup|Overall Study||47
10755209|NCT03062891|11919008|FG001|Followup|Overall Study||62
10755210|NCT03062891|11919007|FG000|COMPLETED|Overall Study||47
10755211|NCT03062891|11919008|FG001|COMPLETED|Overall Study||62
10755212|NCT03062891|11919007|FG000|NOT COMPLETED|Overall Study||52
10755213|NCT03062891|11919008|FG001|NOT COMPLETED|Overall Study||38
10755214|NCT03062917|11919020|FG000|STARTED|Overall Study||32
10755215|NCT03062917|11919021|FG001|STARTED|Overall Study||51
10755216|NCT03062917|11919022|FG002|STARTED|Overall Study||49
10755217|NCT03062917|11919023|FG003|STARTED|Overall Study||20
10755218|NCT03062917|11919024|FG004|STARTED|Overall Study||0
10755219|NCT03062917|11919020|FG000|COMPLETED|Overall Study||32
10755220|NCT03062917|11919021|FG001|COMPLETED|Overall Study||51
10755221|NCT03062917|11919022|FG002|COMPLETED|Overall Study||49
10755222|NCT03062917|11919023|FG003|COMPLETED|Overall Study||20
10755223|NCT03062917|11919024|FG004|COMPLETED|Overall Study||0
10416132|NCT00792298|11560562|FG003|STARTED|Treatment Period 1||32
10416133|NCT00792298|11560563|FG004|STARTED|Treatment Period 1||32
10416134|NCT00792298|11560564|FG005|STARTED|Treatment Period 1||32
10416135|NCT00792298|11560565|FG006|STARTED|Treatment Period 1||31
10416136|NCT00792298|11560566|FG007|STARTED|Treatment Period 1||31
10416137|NCT00792298|11560559|FG000|COMPLETED|Treatment Period 1||30
10416138|NCT00792298|11560560|FG001|COMPLETED|Treatment Period 1||31
10755224|NCT03062917|11919020|FG000|NOT COMPLETED|Overall Study||0
10755225|NCT03062917|11919021|FG001|NOT COMPLETED|Overall Study||0
10755226|NCT03062917|11919022|FG002|NOT COMPLETED|Overall Study||0
10755227|NCT03062917|11919023|FG003|NOT COMPLETED|Overall Study||0
10755228|NCT03062917|11919024|FG004|NOT COMPLETED|Overall Study||0
10755229|NCT03063086|11919035|FG000|STARTED|Overall Study||19
10755230|NCT03063086|11919036|FG001|STARTED|Overall Study||20
10755231|NCT03063086|11919037|FG002|STARTED|Overall Study||18
10859553|NCT00839930|12025381|FG001|STARTED|Second Intervention||15
10859554|NCT00839930|12025380|FG000|COMPLETED|Second Intervention||15
10859555|NCT00839930|12025381|FG001|COMPLETED|Second Intervention||15
10859556|NCT00839930|12025380|FG000|NOT COMPLETED|Second Intervention||0
10859557|NCT00839930|12025381|FG001|NOT COMPLETED|Second Intervention||0
10859558|NCT00838630|12025387|FG000|STARTED|First Intervention||18
10859559|NCT00838630|12025388|FG001|STARTED|First Intervention||18
10859560|NCT00838630|12025387|FG000|COMPLETED|First Intervention||17
10859561|NCT00838630|12025388|FG001|COMPLETED|First Intervention||18
10859562|NCT00838630|12025387|FG000|NOT COMPLETED|First Intervention||1
10859563|NCT00838630|12025388|FG001|NOT COMPLETED|First Intervention||0
10859564|NCT00838630|12025387|FG000|STARTED|Washout: 7 Days||17
10859565|NCT00838630|12025388|FG001|STARTED|Washout: 7 Days||18
10859566|NCT00838630|12025387|FG000|COMPLETED|Washout: 7 Days||16
10859567|NCT00838630|12025388|FG001|COMPLETED|Washout: 7 Days||18
10859568|NCT00838630|12025387|FG000|NOT COMPLETED|Washout: 7 Days||1
10859569|NCT00838630|12025388|FG001|NOT COMPLETED|Washout: 7 Days||0
10859570|NCT00838630|12025387|FG000|STARTED|Second Intervention||16
10859571|NCT00838630|12025388|FG001|STARTED|Second Intervention||18
10859572|NCT00838630|12025387|FG000|COMPLETED|Second Intervention||16
10859573|NCT00838630|12025388|FG001|COMPLETED|Second Intervention||18
10859574|NCT00838630|12025387|FG000|NOT COMPLETED|Second Intervention||0
10859575|NCT00838630|12025388|FG001|NOT COMPLETED|Second Intervention||0
10859576|NCT00838279|12025394|FG000|STARTED|First Intervention||16
10859577|NCT00838279|12025395|FG001|STARTED|First Intervention||16
10859578|NCT00838279|12025394|FG000|COMPLETED|First Intervention||16
10859579|NCT00838279|12025395|FG001|COMPLETED|First Intervention||16
10859580|NCT00838279|12025394|FG000|NOT COMPLETED|First Intervention||0
10859581|NCT00838279|12025395|FG001|NOT COMPLETED|First Intervention||0
10859582|NCT00838279|12025394|FG000|STARTED|Washout||16
10859583|NCT00838279|12025395|FG001|STARTED|Washout||16
10859584|NCT00838279|12025394|FG000|COMPLETED|Washout||15
10859585|NCT00838279|12025395|FG001|COMPLETED|Washout||15
10859586|NCT00838279|12025394|FG000|NOT COMPLETED|Washout||1
10859587|NCT00838279|12025395|FG001|NOT COMPLETED|Washout||1
10859588|NCT00838279|12025394|FG000|STARTED|Second Intervention||15
10859589|NCT00838279|12025395|FG001|STARTED|Second Intervention||15
10859590|NCT00838279|12025394|FG000|COMPLETED|Second Intervention||15
10859591|NCT00838279|12025395|FG001|COMPLETED|Second Intervention||15
10859592|NCT00838279|12025394|FG000|NOT COMPLETED|Second Intervention||0
10859593|NCT00838279|12025395|FG001|NOT COMPLETED|Second Intervention||0
10859594|NCT00838136|12025401|FG000|STARTED|First Intervention||16
10859595|NCT00838136|12025402|FG001|STARTED|First Intervention||16
10859596|NCT00838136|12025401|FG000|COMPLETED|First Intervention||16
10859597|NCT00838136|12025402|FG001|COMPLETED|First Intervention||16
10859598|NCT00838136|12025401|FG000|NOT COMPLETED|First Intervention||0
10859599|NCT00838136|12025402|FG001|NOT COMPLETED|First Intervention||0
10859600|NCT00838136|12025401|FG000|STARTED|Second Intervention||16
10859601|NCT00838136|12025402|FG001|STARTED|Second Intervention||16
10859602|NCT00838136|12025401|FG000|COMPLETED|Second Intervention||16
10859603|NCT00838136|12025402|FG001|COMPLETED|Second Intervention||15
10859604|NCT00838136|12025401|FG000|NOT COMPLETED|Second Intervention||0
10859605|NCT00838136|12025402|FG001|NOT COMPLETED|Second Intervention||1
10859606|NCT00836901|12025408|FG000|STARTED|First Intervention||24
10859607|NCT00836901|12025409|FG001|STARTED|First Intervention||28
10859608|NCT00836901|12025408|FG000|COMPLETED|First Intervention||23
10859609|NCT00836901|12025409|FG001|COMPLETED|First Intervention||28
10859610|NCT00836901|12025408|FG000|NOT COMPLETED|First Intervention||1
10859611|NCT00836901|12025409|FG001|NOT COMPLETED|First Intervention||0
10859612|NCT00836901|12025408|FG000|STARTED|Second Intervention||23
10859613|NCT00836901|12025409|FG001|STARTED|Second Intervention||28
10859614|NCT00836901|12025408|FG000|COMPLETED|Second Intervention||23
10859615|NCT00836901|12025409|FG001|COMPLETED|Second Intervention||28
10859616|NCT00836901|12025408|FG000|NOT COMPLETED|Second Intervention||0
10859617|NCT00836901|12025409|FG001|NOT COMPLETED|Second Intervention||0
10859618|NCT00836706|12025415|FG000|STARTED|First Intervention||11
10859619|NCT00836706|12025416|FG001|STARTED|First Intervention||12
10859620|NCT00836706|12025415|FG000|COMPLETED|First Intervention||11
10859621|NCT00836706|12025416|FG001|COMPLETED|First Intervention||12
10859622|NCT00836706|12025415|FG000|NOT COMPLETED|First Intervention||0
10859623|NCT00836706|12025416|FG001|NOT COMPLETED|First Intervention||0
10859624|NCT00836706|12025415|FG000|STARTED|Washout: 7 Days||11
10859625|NCT00836706|12025416|FG001|STARTED|Washout: 7 Days||12
10859626|NCT00836706|12025415|FG000|COMPLETED|Washout: 7 Days||11
10859627|NCT00836706|12025416|FG001|COMPLETED|Washout: 7 Days||11
10859628|NCT00836706|12025415|FG000|NOT COMPLETED|Washout: 7 Days||0
10859629|NCT00836706|12025416|FG001|NOT COMPLETED|Washout: 7 Days||1
10859630|NCT00836706|12025415|FG000|STARTED|Second Intervention||11
10859631|NCT00836706|12025416|FG001|STARTED|Second Intervention||11
10859632|NCT00836706|12025415|FG000|COMPLETED|Second Intervention||11
10859633|NCT00836706|12025416|FG001|COMPLETED|Second Intervention||11
10859634|NCT00836706|12025415|FG000|NOT COMPLETED|Second Intervention||0
10859635|NCT00836706|12025416|FG001|NOT COMPLETED|Second Intervention||0
10859636|NCT00836472|12025422|FG000|STARTED|First Intervention||30
10859637|NCT00836472|12025423|FG001|STARTED|First Intervention||30
10859638|NCT00836472|12025422|FG000|COMPLETED|First Intervention||30
10859639|NCT00836472|12025423|FG001|COMPLETED|First Intervention||30
10859640|NCT00836472|12025422|FG000|NOT COMPLETED|First Intervention||0
10859641|NCT00836472|12025423|FG001|NOT COMPLETED|First Intervention||0
10859642|NCT00836472|12025422|FG000|STARTED|Washout||30
10859643|NCT00836472|12025423|FG001|STARTED|Washout||30
10859644|NCT00836472|12025422|FG000|COMPLETED|Washout||28
10859645|NCT00836472|12025423|FG001|COMPLETED|Washout||27
10859646|NCT00836472|12025422|FG000|NOT COMPLETED|Washout||2
10859647|NCT00836472|12025423|FG001|NOT COMPLETED|Washout||3
10859648|NCT00836472|12025422|FG000|STARTED|Second Intervention||28
10859649|NCT00836472|12025423|FG001|STARTED|Second Intervention||27
10859650|NCT00836472|12025422|FG000|COMPLETED|Second Intervention||28
10859651|NCT00836472|12025423|FG001|COMPLETED|Second Intervention||27
10859652|NCT00836472|12025422|FG000|NOT COMPLETED|Second Intervention||0
10859653|NCT00836472|12025423|FG001|NOT COMPLETED|Second Intervention||0
10859654|NCT00836056|12025429|FG000|STARTED|First Intervention||12
10859655|NCT00836056|12025430|FG001|STARTED|First Intervention||12
10859656|NCT00836056|12025429|FG000|COMPLETED|First Intervention||11
10859657|NCT00836056|12025430|FG001|COMPLETED|First Intervention||12
10859658|NCT00836056|12025429|FG000|NOT COMPLETED|First Intervention||1
10859659|NCT00836056|12025430|FG001|NOT COMPLETED|First Intervention||0
10859660|NCT00836056|12025429|FG000|STARTED|Washout: 7 Days||11
10859661|NCT00836056|12025430|FG001|STARTED|Washout: 7 Days||12
10859662|NCT00836056|12025429|FG000|COMPLETED|Washout: 7 Days||11
10859663|NCT00836056|12025430|FG001|COMPLETED|Washout: 7 Days||12
10859664|NCT00836056|12025429|FG000|NOT COMPLETED|Washout: 7 Days||0
10859665|NCT00836056|12025430|FG001|NOT COMPLETED|Washout: 7 Days||0
10859666|NCT00836056|12025429|FG000|STARTED|Second Intervention||11
10859667|NCT00836056|12025430|FG001|STARTED|Second Intervention||12
10859668|NCT00836056|12025429|FG000|COMPLETED|Second Intervention||11
10859669|NCT00836056|12025430|FG001|COMPLETED|Second Intervention||12
10859670|NCT00836056|12025429|FG000|NOT COMPLETED|Second Intervention||0
10859671|NCT00836056|12025430|FG001|NOT COMPLETED|Second Intervention||0
10859672|NCT00836004|12025436|FG000|STARTED|First Intervention||12
10859673|NCT00836004|12025437|FG001|STARTED|First Intervention||12
10859674|NCT00836004|12025436|FG000|COMPLETED|First Intervention||12
10859675|NCT00836004|12025437|FG001|COMPLETED|First Intervention||12
10859676|NCT00836004|12025436|FG000|NOT COMPLETED|First Intervention||0
10859677|NCT00836004|12025437|FG001|NOT COMPLETED|First Intervention||0
10859678|NCT00836004|12025436|FG000|STARTED|Washout: 7 Days||12
10859679|NCT00836004|12025437|FG001|STARTED|Washout: 7 Days||12
10859680|NCT00836004|12025436|FG000|COMPLETED|Washout: 7 Days||12
10859681|NCT00836004|12025437|FG001|COMPLETED|Washout: 7 Days||12
10859682|NCT00836004|12025436|FG000|NOT COMPLETED|Washout: 7 Days||0
10859683|NCT00836004|12025437|FG001|NOT COMPLETED|Washout: 7 Days||0
10859684|NCT00836004|12025436|FG000|STARTED|Second Intervention||12
10416139|NCT00792298|11560561|FG002|COMPLETED|Treatment Period 1||31
10416140|NCT00792298|11560562|FG003|COMPLETED|Treatment Period 1||28
10416141|NCT00792298|11560563|FG004|COMPLETED|Treatment Period 1||32
10416142|NCT00792298|11560564|FG005|COMPLETED|Treatment Period 1||29
10416143|NCT00792298|11560565|FG006|COMPLETED|Treatment Period 1||27
10416144|NCT00792298|11560566|FG007|COMPLETED|Treatment Period 1||30
10416145|NCT00792298|11560559|FG000|NOT COMPLETED|Treatment Period 1||1
10416146|NCT00792298|11560560|FG001|NOT COMPLETED|Treatment Period 1||1
10416147|NCT00792298|11560561|FG002|NOT COMPLETED|Treatment Period 1||2
10416148|NCT00792298|11560562|FG003|NOT COMPLETED|Treatment Period 1||4
10416149|NCT00792298|11560563|FG004|NOT COMPLETED|Treatment Period 1||0
10416150|NCT00792298|11560564|FG005|NOT COMPLETED|Treatment Period 1||3
10416151|NCT00792298|11560565|FG006|NOT COMPLETED|Treatment Period 1||4
10416152|NCT00792298|11560566|FG007|NOT COMPLETED|Treatment Period 1||1
10416153|NCT00792298|11560559|FG000|STARTED|Washout||30
10416154|NCT00792298|11560560|FG001|STARTED|Washout||31
10416155|NCT00792298|11560561|FG002|STARTED|Washout|1 participant discontinued therapy during Period 1 but entered the Washout as allowed per protocol|32
10416156|NCT00792298|11560562|FG003|STARTED|Washout||28
10416157|NCT00792298|11560563|FG004|STARTED|Washout||32
10416158|NCT00792298|11560564|FG005|STARTED|Washout||29
10416159|NCT00792298|11560565|FG006|STARTED|Washout|2 participants discontinued therapy during Period 1 but entered the Washout as allowed per protocol|29
10416160|NCT00792298|11560566|FG007|STARTED|Washout||30
10416161|NCT00792298|11560559|FG000|COMPLETED|Washout||30
10416162|NCT00792298|11560560|FG001|COMPLETED|Washout||31
10416163|NCT00792298|11560561|FG002|COMPLETED|Washout||31
10416164|NCT00792298|11560562|FG003|COMPLETED|Washout||28
10416165|NCT00792298|11560563|FG004|COMPLETED|Washout||32
10416166|NCT00792298|11560564|FG005|COMPLETED|Washout||27
10416167|NCT00792298|11560565|FG006|COMPLETED|Washout||29
10416168|NCT00792298|11560566|FG007|COMPLETED|Washout||30
10416169|NCT00792298|11560559|FG000|NOT COMPLETED|Washout||0
10416170|NCT00792298|11560560|FG001|NOT COMPLETED|Washout||0
10416171|NCT00792298|11560561|FG002|NOT COMPLETED|Washout||1
10416172|NCT00792298|11560562|FG003|NOT COMPLETED|Washout||0
10416173|NCT00792298|11560563|FG004|NOT COMPLETED|Washout||0
10416174|NCT00792298|11560564|FG005|NOT COMPLETED|Washout||2
10416175|NCT00792298|11560565|FG006|NOT COMPLETED|Washout||0
10416176|NCT00792298|11560566|FG007|NOT COMPLETED|Washout||0
10416177|NCT00792298|11560559|FG000|STARTED|Treatment Period 2||30
10416178|NCT00792298|11560560|FG001|STARTED|Treatment Period 2||31
10416179|NCT00792298|11560561|FG002|STARTED|Treatment Period 2||31
10416180|NCT00792298|11560562|FG003|STARTED|Treatment Period 2||28
10416181|NCT00792298|11560563|FG004|STARTED|Treatment Period 2||32
10859685|NCT00836004|12025437|FG001|STARTED|Second Intervention||12
10859686|NCT00836004|12025436|FG000|COMPLETED|Second Intervention||12
10859687|NCT00836004|12025437|FG001|COMPLETED|Second Intervention||12
10859688|NCT00836004|12025436|FG000|NOT COMPLETED|Second Intervention||0
10416182|NCT00792298|11560564|FG005|STARTED|Treatment Period 2||27
10416183|NCT00792298|11560565|FG006|STARTED|Treatment Period 2||29
10859689|NCT00836004|12025437|FG001|NOT COMPLETED|Second Intervention||0
10859690|NCT00835991|12025443|FG000|STARTED|First Intervention||30
10859691|NCT00835991|12025444|FG001|STARTED|First Intervention||30
10859692|NCT00835991|12025443|FG000|COMPLETED|First Intervention||30
10859693|NCT00835991|12025444|FG001|COMPLETED|First Intervention||29
10859694|NCT00835991|12025443|FG000|NOT COMPLETED|First Intervention||0
10859695|NCT00835991|12025444|FG001|NOT COMPLETED|First Intervention||1
10859696|NCT00835991|12025443|FG000|STARTED|Washout||30
10859697|NCT00835991|12025444|FG001|STARTED|Washout||29
10859698|NCT00835991|12025443|FG000|COMPLETED|Washout||27
10859699|NCT00835991|12025444|FG001|COMPLETED|Washout||26
10859700|NCT00835991|12025443|FG000|NOT COMPLETED|Washout||3
10859701|NCT00835991|12025444|FG001|NOT COMPLETED|Washout||3
10859702|NCT00835991|12025443|FG000|STARTED|Second Intervention||27
10859703|NCT00835991|12025444|FG001|STARTED|Second Intervention||26
10859704|NCT00835991|12025443|FG000|COMPLETED|Second Intervention||27
10859705|NCT00835991|12025444|FG001|COMPLETED|Second Intervention||26
10859706|NCT00835991|12025443|FG000|NOT COMPLETED|Second Intervention||0
10859707|NCT00835991|12025444|FG001|NOT COMPLETED|Second Intervention||0
10859708|NCT00835796|12025450|FG000|STARTED|First Intervention||10
10859709|NCT00835796|12025451|FG001|STARTED|First Intervention||10
10859710|NCT00835796|12025450|FG000|COMPLETED|First Intervention||10
10859711|NCT00835796|12025451|FG001|COMPLETED|First Intervention||9
10859712|NCT00835796|12025450|FG000|NOT COMPLETED|First Intervention||0
10859713|NCT00835796|12025451|FG001|NOT COMPLETED|First Intervention||1
10859714|NCT00835796|12025450|FG000|STARTED|Washout||10
10859715|NCT00835796|12025451|FG001|STARTED|Washout||9
10859716|NCT00835796|12025450|FG000|COMPLETED|Washout||10
10859717|NCT00835796|12025451|FG001|COMPLETED|Washout||9
10859718|NCT00835796|12025450|FG000|NOT COMPLETED|Washout||0
10859719|NCT00835796|12025451|FG001|NOT COMPLETED|Washout||0
10859720|NCT00835796|12025450|FG000|STARTED|Second Intervention||10
10859721|NCT00835796|12025451|FG001|STARTED|Second Intervention||9
10859722|NCT00835796|12025450|FG000|COMPLETED|Second Intervention||10
10859723|NCT00835796|12025451|FG001|COMPLETED|Second Intervention||9
10859724|NCT00835796|12025450|FG000|NOT COMPLETED|Second Intervention||0
10859725|NCT00835796|12025451|FG001|NOT COMPLETED|Second Intervention||0
10859726|NCT00835705|12025457|FG000|STARTED|First Intervention||24
10859727|NCT00835705|12025458|FG001|STARTED|First Intervention||28
10859728|NCT00835705|12025457|FG000|COMPLETED|First Intervention||23
10859729|NCT00835705|12025458|FG001|COMPLETED|First Intervention||28
10859730|NCT00835705|12025457|FG000|NOT COMPLETED|First Intervention||1
10859731|NCT00835705|12025458|FG001|NOT COMPLETED|First Intervention||0
10416184|NCT00792298|11560566|FG007|STARTED|Treatment Period 2||30
10416185|NCT00792298|11560559|FG000|COMPLETED|Treatment Period 2||29
10416186|NCT00792298|11560560|FG001|COMPLETED|Treatment Period 2||30
10416187|NCT00792298|11560561|FG002|COMPLETED|Treatment Period 2||30
10416188|NCT00792298|11560562|FG003|COMPLETED|Treatment Period 2||26
10416189|NCT00792298|11560563|FG004|COMPLETED|Treatment Period 2||30
10416190|NCT00792298|11560564|FG005|COMPLETED|Treatment Period 2||27
10416191|NCT00792298|11560565|FG006|COMPLETED|Treatment Period 2||28
10416192|NCT00792298|11560566|FG007|COMPLETED|Treatment Period 2||28
10416193|NCT00792298|11560559|FG000|NOT COMPLETED|Treatment Period 2||1
10545720|NCT01499368|11699191|FG000|NOT COMPLETED|Overall Study||27
10859732|NCT00835705|12025457|FG000|STARTED|Second Intervention||23
10859733|NCT00835705|12025458|FG001|STARTED|Second Intervention||28
10859734|NCT00835705|12025457|FG000|COMPLETED|Second Intervention||22
10859735|NCT00835705|12025458|FG001|COMPLETED|Second Intervention||28
10859736|NCT00835705|12025457|FG000|NOT COMPLETED|Second Intervention||1
10859737|NCT00835705|12025458|FG001|NOT COMPLETED|Second Intervention||0
10859738|NCT00835692|12025464|FG000|STARTED|First Intervention||28
10859739|NCT00835692|12025465|FG001|STARTED|First Intervention||28
10859740|NCT00835692|12025464|FG000|COMPLETED|First Intervention||27
10859741|NCT00835692|12025465|FG001|COMPLETED|First Intervention||28
10859742|NCT00835692|12025464|FG000|NOT COMPLETED|First Intervention||1
10859743|NCT00835692|12025465|FG001|NOT COMPLETED|First Intervention||0
10859744|NCT00835692|12025464|FG000|STARTED|Washout||27
10859745|NCT00835692|12025465|FG001|STARTED|Washout||28
10859746|NCT00835692|12025464|FG000|COMPLETED|Washout||27
10859747|NCT00835692|12025465|FG001|COMPLETED|Washout||28
10859748|NCT00835692|12025464|FG000|NOT COMPLETED|Washout||0
10859749|NCT00835692|12025465|FG001|NOT COMPLETED|Washout||0
10859750|NCT00835692|12025464|FG000|STARTED|Second Intervention||27
10859751|NCT00835692|12025465|FG001|STARTED|Second Intervention||28
10859752|NCT00835692|12025464|FG000|COMPLETED|Second Intervention||27
10859753|NCT00835692|12025465|FG001|COMPLETED|Second Intervention||28
10859754|NCT00835692|12025464|FG000|NOT COMPLETED|Second Intervention||0
10859755|NCT00835692|12025465|FG001|NOT COMPLETED|Second Intervention||0
10293614|NCT03825393|11426209|FG000|STARTED|Overall Study||100
10293615|NCT03825393|11426210|FG001|STARTED|Overall Study||100
10293616|NCT03825393|11426209|FG000|COMPLETED|Overall Study||100
10293617|NCT03825393|11426210|FG001|COMPLETED|Overall Study||100
10293618|NCT03825393|11426209|FG000|NOT COMPLETED|Overall Study||0
10293619|NCT03825393|11426210|FG001|NOT COMPLETED|Overall Study||0
10314585|NCT00166166|11448270|FG001|NOT COMPLETED|Overall Study||0
10859756|NCT00835666|12025471|FG000|STARTED|First Intervention||16
10859757|NCT00835666|12025472|FG001|STARTED|First Intervention||16
10859758|NCT00835666|12025471|FG000|COMPLETED|First Intervention||16
10859759|NCT00835666|12025472|FG001|COMPLETED|First Intervention||16
10859760|NCT00835666|12025471|FG000|NOT COMPLETED|First Intervention||0
10859761|NCT00835666|12025472|FG001|NOT COMPLETED|First Intervention||0
10859762|NCT00835666|12025471|FG000|STARTED|Washout||16
10859763|NCT00835666|12025472|FG001|STARTED|Washout||16
10859764|NCT00835666|12025471|FG000|COMPLETED|Washout||14
10859765|NCT00835666|12025472|FG001|COMPLETED|Washout||16
10859766|NCT00835666|12025471|FG000|NOT COMPLETED|Washout||2
10859767|NCT00835666|12025472|FG001|NOT COMPLETED|Washout||0
10859768|NCT00835666|12025471|FG000|STARTED|Second Intervention||14
10859769|NCT00835666|12025472|FG001|STARTED|Second Intervention||16
10859770|NCT00835666|12025471|FG000|COMPLETED|Second Intervention||14
10859771|NCT00835666|12025472|FG001|COMPLETED|Second Intervention||16
10859772|NCT00835666|12025471|FG000|NOT COMPLETED|Second Intervention||0
10859773|NCT00835666|12025472|FG001|NOT COMPLETED|Second Intervention||0
10859774|NCT00835640|12025478|FG000|STARTED|First Intervention||12
10859775|NCT00835640|12025479|FG001|STARTED|First Intervention||12
10859776|NCT00835640|12025478|FG000|COMPLETED|First Intervention||12
10859777|NCT00835640|12025479|FG001|COMPLETED|First Intervention||12
10859778|NCT00835640|12025478|FG000|NOT COMPLETED|First Intervention||0
10859779|NCT00835640|12025479|FG001|NOT COMPLETED|First Intervention||0
10859780|NCT00835640|12025478|FG000|STARTED|Washout of 7 Days||12
10859781|NCT00835640|12025479|FG001|STARTED|Washout of 7 Days||12
10859782|NCT00835640|12025478|FG000|COMPLETED|Washout of 7 Days||12
10859783|NCT00835640|12025479|FG001|COMPLETED|Washout of 7 Days||12
10859784|NCT00835640|12025478|FG000|NOT COMPLETED|Washout of 7 Days||0
10859785|NCT00835640|12025479|FG001|NOT COMPLETED|Washout of 7 Days||0
10859786|NCT00835640|12025478|FG000|STARTED|Second Intervention||12
10859787|NCT00835640|12025479|FG001|STARTED|Second Intervention||12
10859788|NCT00835640|12025478|FG000|COMPLETED|Second Intervention||11
10859789|NCT00835640|12025479|FG001|COMPLETED|Second Intervention||12
10859790|NCT00835640|12025478|FG000|NOT COMPLETED|Second Intervention||1
10859791|NCT00835640|12025479|FG001|NOT COMPLETED|Second Intervention||0
10859792|NCT00835614|12025485|FG000|STARTED|First Intervention||13
10859793|NCT00835614|12025486|FG001|STARTED|First Intervention||13
10859794|NCT00835614|12025485|FG000|COMPLETED|First Intervention||13
10859795|NCT00835614|12025486|FG001|COMPLETED|First Intervention||13
10859796|NCT00835614|12025485|FG000|NOT COMPLETED|First Intervention||0
10859797|NCT00835614|12025486|FG001|NOT COMPLETED|First Intervention||0
10859798|NCT00835614|12025485|FG000|STARTED|Washout of 7 Days||13
10859799|NCT00835614|12025486|FG001|STARTED|Washout of 7 Days||13
10859800|NCT00835614|12025485|FG000|COMPLETED|Washout of 7 Days||13
10859801|NCT00835614|12025486|FG001|COMPLETED|Washout of 7 Days||13
10859802|NCT00835614|12025485|FG000|NOT COMPLETED|Washout of 7 Days||0
10859803|NCT00835614|12025486|FG001|NOT COMPLETED|Washout of 7 Days||0
10859804|NCT00835614|12025485|FG000|STARTED|Second Intervention||13
10859805|NCT00835614|12025486|FG001|STARTED|Second Intervention||13
10859806|NCT00835614|12025485|FG000|COMPLETED|Second Intervention||13
10859807|NCT00835614|12025486|FG001|COMPLETED|Second Intervention||13
10859808|NCT00835614|12025485|FG000|NOT COMPLETED|Second Intervention||0
10859809|NCT00835614|12025486|FG001|NOT COMPLETED|Second Intervention||0
10859810|NCT00835588|12025492|FG000|STARTED|First Intervention||50
10859811|NCT00835588|12025493|FG001|STARTED|First Intervention||50
10859812|NCT00835588|12025492|FG000|COMPLETED|First Intervention||50
10859813|NCT00835588|12025493|FG001|COMPLETED|First Intervention||50
10859814|NCT00835588|12025492|FG000|NOT COMPLETED|First Intervention||0
10859815|NCT00835588|12025493|FG001|NOT COMPLETED|First Intervention||0
10859816|NCT00835588|12025492|FG000|STARTED|Washout: 5 Days||50
10859817|NCT00835588|12025493|FG001|STARTED|Washout: 5 Days||50
10859818|NCT00835588|12025492|FG000|COMPLETED|Washout: 5 Days||50
10859819|NCT00835588|12025493|FG001|COMPLETED|Washout: 5 Days||50
10859820|NCT00835588|12025492|FG000|NOT COMPLETED|Washout: 5 Days||0
10859821|NCT00835588|12025493|FG001|NOT COMPLETED|Washout: 5 Days||0
10859822|NCT00835588|12025492|FG000|STARTED|Second Intervention||50
10859823|NCT00835588|12025493|FG001|STARTED|Second Intervention||50
10859824|NCT00835588|12025492|FG000|COMPLETED|Second Intervention||50
10859825|NCT00835588|12025493|FG001|COMPLETED|Second Intervention||50
10859826|NCT00835588|12025492|FG000|NOT COMPLETED|Second Intervention||0
10859827|NCT00835588|12025493|FG001|NOT COMPLETED|Second Intervention||0
10859828|NCT00835575|12025499|FG000|STARTED|First Intervention||16
10859829|NCT00835575|12025500|FG001|STARTED|First Intervention||16
10859830|NCT00835575|12025499|FG000|COMPLETED|First Intervention||16
10859831|NCT00835575|12025500|FG001|COMPLETED|First Intervention||16
10859832|NCT00835575|12025499|FG000|NOT COMPLETED|First Intervention||0
10859833|NCT00835575|12025500|FG001|NOT COMPLETED|First Intervention||0
10859834|NCT00835575|12025499|FG000|STARTED|Washout of 14 Days||16
10859835|NCT00835575|12025500|FG001|STARTED|Washout of 14 Days||16
10859836|NCT00835575|12025499|FG000|COMPLETED|Washout of 14 Days||15
10859837|NCT00835575|12025500|FG001|COMPLETED|Washout of 14 Days||16
10859838|NCT00835575|12025499|FG000|NOT COMPLETED|Washout of 14 Days||1
10859839|NCT00835575|12025500|FG001|NOT COMPLETED|Washout of 14 Days||0
10859840|NCT00835575|12025499|FG000|STARTED|Second Intervention||15
10859841|NCT00835575|12025500|FG001|STARTED|Second Intervention||16
10293620|NCT03813719|11426218|FG000|STARTED|Overall Study||250
10293621|NCT03813719|11426218|FG000|COMPLETED|Overall Study||250
10859842|NCT00835575|12025499|FG000|COMPLETED|Second Intervention||15
10859843|NCT00835575|12025500|FG001|COMPLETED|Second Intervention||16
10859844|NCT00835575|12025499|FG000|NOT COMPLETED|Second Intervention||0
10859845|NCT00835575|12025500|FG001|NOT COMPLETED|Second Intervention||0
10859846|NCT00835549|12025506|FG000|STARTED|First Intervention||16
10859847|NCT00835549|12025507|FG001|STARTED|First Intervention||16
10859848|NCT00835549|12025506|FG000|COMPLETED|First Intervention||16
10859849|NCT00835549|12025507|FG001|COMPLETED|First Intervention||16
10859850|NCT00835549|12025506|FG000|NOT COMPLETED|First Intervention||0
10859851|NCT00835549|12025507|FG001|NOT COMPLETED|First Intervention||0
10859852|NCT00835549|12025506|FG000|STARTED|Washout of 7 Days||16
10859853|NCT00835549|12025507|FG001|STARTED|Washout of 7 Days||16
10859854|NCT00835549|12025506|FG000|COMPLETED|Washout of 7 Days||14
10859855|NCT00835549|12025507|FG001|COMPLETED|Washout of 7 Days||16
10859856|NCT00835549|12025506|FG000|NOT COMPLETED|Washout of 7 Days||2
10859857|NCT00835549|12025507|FG001|NOT COMPLETED|Washout of 7 Days||0
10859858|NCT00835549|12025506|FG000|STARTED|Second Intervention||14
10859859|NCT00835549|12025507|FG001|STARTED|Second Intervention||16
10859860|NCT00835549|12025506|FG000|COMPLETED|Second Intervention||14
10859861|NCT00835549|12025507|FG001|COMPLETED|Second Intervention||16
10859862|NCT00835549|12025506|FG000|NOT COMPLETED|Second Intervention||0
10859863|NCT00835549|12025507|FG001|NOT COMPLETED|Second Intervention||0
10859864|NCT00835536|12025513|FG000|STARTED|First Intervention||13
10859865|NCT00835536|12025514|FG001|STARTED|First Intervention||14
10859866|NCT00835536|12025513|FG000|COMPLETED|First Intervention||13
10859867|NCT00835536|12025514|FG001|COMPLETED|First Intervention||14
10859868|NCT00835536|12025513|FG000|NOT COMPLETED|First Intervention||0
10859869|NCT00835536|12025514|FG001|NOT COMPLETED|First Intervention||0
10859870|NCT00835536|12025513|FG000|STARTED|Washout of 5 Weeks||13
10859871|NCT00835536|12025514|FG001|STARTED|Washout of 5 Weeks||14
10859872|NCT00835536|12025513|FG000|COMPLETED|Washout of 5 Weeks||12
10859873|NCT00835536|12025514|FG001|COMPLETED|Washout of 5 Weeks||14
10859874|NCT00835536|12025513|FG000|NOT COMPLETED|Washout of 5 Weeks||1
10859875|NCT00835536|12025514|FG001|NOT COMPLETED|Washout of 5 Weeks||0
10859876|NCT00835536|12025513|FG000|STARTED|Second Intervention||12
10859877|NCT00835536|12025514|FG001|STARTED|Second Intervention||14
10859878|NCT00835536|12025513|FG000|COMPLETED|Second Intervention||12
10859879|NCT00835536|12025514|FG001|COMPLETED|Second Intervention||14
10859880|NCT00835536|12025513|FG000|NOT COMPLETED|Second Intervention||0
10859881|NCT00835536|12025514|FG001|NOT COMPLETED|Second Intervention||0
10859882|NCT00835497|12025520|FG000|STARTED|First Intervention||20
10859883|NCT00835497|12025521|FG001|STARTED|First Intervention||20
10859884|NCT00835497|12025520|FG000|COMPLETED|First Intervention||20
10859885|NCT00835497|12025521|FG001|COMPLETED|First Intervention||20
10859886|NCT00835497|12025520|FG000|NOT COMPLETED|First Intervention||0
10859887|NCT00835497|12025521|FG001|NOT COMPLETED|First Intervention||0
10859888|NCT00835497|12025520|FG000|STARTED|Washout: 7 Days||20
10859889|NCT00835497|12025521|FG001|STARTED|Washout: 7 Days||20
10859890|NCT00835497|12025520|FG000|COMPLETED|Washout: 7 Days||20
10859891|NCT00835497|12025521|FG001|COMPLETED|Washout: 7 Days||20
10859892|NCT00835497|12025520|FG000|NOT COMPLETED|Washout: 7 Days||0
10859893|NCT00835497|12025521|FG001|NOT COMPLETED|Washout: 7 Days||0
10859894|NCT00835497|12025520|FG000|STARTED|Second Intervention||20
10859895|NCT00835497|12025521|FG001|STARTED|Second Intervention||20
10859896|NCT00835497|12025520|FG000|COMPLETED|Second Intervention||20
10859897|NCT00835497|12025521|FG001|COMPLETED|Second Intervention||20
10859898|NCT00835497|12025520|FG000|NOT COMPLETED|Second Intervention||0
10859899|NCT00835497|12025521|FG001|NOT COMPLETED|Second Intervention||0
10859900|NCT00835484|12025527|FG000|STARTED|First Intervention||16
10859901|NCT00835484|12025528|FG001|STARTED|First Intervention||16
10859902|NCT00835484|12025527|FG000|COMPLETED|First Intervention||16
10859903|NCT00835484|12025528|FG001|COMPLETED|First Intervention||16
10859904|NCT00835484|12025527|FG000|NOT COMPLETED|First Intervention||0
10859905|NCT00835484|12025528|FG001|NOT COMPLETED|First Intervention||0
10859906|NCT00835484|12025527|FG000|STARTED|Washout of 7 Days||16
10859907|NCT00835484|12025528|FG001|STARTED|Washout of 7 Days||16
10859908|NCT00835484|12025527|FG000|COMPLETED|Washout of 7 Days||16
10859909|NCT00835484|12025528|FG001|COMPLETED|Washout of 7 Days||16
10859910|NCT00835484|12025527|FG000|NOT COMPLETED|Washout of 7 Days||0
10859911|NCT00835484|12025528|FG001|NOT COMPLETED|Washout of 7 Days||0
10859912|NCT00835484|12025527|FG000|STARTED|Second Intervention||16
10859913|NCT00835484|12025528|FG001|STARTED|Second Intervention||16
10859914|NCT00835484|12025527|FG000|COMPLETED|Second Intervention||16
10859915|NCT00835484|12025528|FG001|COMPLETED|Second Intervention||16
10859916|NCT00835484|12025527|FG000|NOT COMPLETED|Second Intervention||0
10859917|NCT00835484|12025528|FG001|NOT COMPLETED|Second Intervention||0
10859918|NCT00835406|12025534|FG000|STARTED|Period: First Intervention||70
10859919|NCT00835406|12025535|FG001|STARTED|Period: First Intervention||70
10859920|NCT00835406|12025534|FG000|COMPLETED|Period: First Intervention||68
10859921|NCT00835406|12025535|FG001|COMPLETED|Period: First Intervention||69
10859922|NCT00835406|12025534|FG000|NOT COMPLETED|Period: First Intervention||2
10859923|NCT00835406|12025535|FG001|NOT COMPLETED|Period: First Intervention||1
10859924|NCT00835406|12025534|FG000|STARTED|Period: Washout of 7 Days||68
10859925|NCT00835406|12025535|FG001|STARTED|Period: Washout of 7 Days||69
10859926|NCT00835406|12025534|FG000|COMPLETED|Period: Washout of 7 Days||68
10859927|NCT00835406|12025535|FG001|COMPLETED|Period: Washout of 7 Days||67
10859928|NCT00835406|12025534|FG000|NOT COMPLETED|Period: Washout of 7 Days||0
10859929|NCT00835406|12025535|FG001|NOT COMPLETED|Period: Washout of 7 Days||2
10859930|NCT00835406|12025534|FG000|STARTED|Period: Second Intervention||68
10859931|NCT00835406|12025535|FG001|STARTED|Period: Second Intervention||67
10859932|NCT00835406|12025534|FG000|COMPLETED|Period: Second Intervention||68
10859933|NCT00835406|12025535|FG001|COMPLETED|Period: Second Intervention||67
10859934|NCT00835406|12025534|FG000|NOT COMPLETED|Period: Second Intervention||0
10859935|NCT00835406|12025535|FG001|NOT COMPLETED|Period: Second Intervention||0
10859936|NCT00835367|12025541|FG000|STARTED|First Intervention||34
10859937|NCT00835367|12025542|FG001|STARTED|First Intervention||34
10859938|NCT00835367|12025541|FG000|COMPLETED|First Intervention||34
10859939|NCT00835367|12025542|FG001|COMPLETED|First Intervention||34
10859940|NCT00835367|12025541|FG000|NOT COMPLETED|First Intervention||0
10859941|NCT00835367|12025542|FG001|NOT COMPLETED|First Intervention||0
10859942|NCT00835367|12025541|FG000|STARTED|Washout||34
10859943|NCT00835367|12025542|FG001|STARTED|Washout||34
10859944|NCT00835367|12025541|FG000|COMPLETED|Washout||31
10859945|NCT00835367|12025542|FG001|COMPLETED|Washout||34
10859946|NCT00835367|12025541|FG000|NOT COMPLETED|Washout||3
10859947|NCT00835367|12025542|FG001|NOT COMPLETED|Washout||0
10859948|NCT00835367|12025541|FG000|STARTED|Second Intervention||31
10859949|NCT00835367|12025542|FG001|STARTED|Second Intervention||34
10859950|NCT00835367|12025541|FG000|COMPLETED|Second Intervention||30
10859951|NCT00835367|12025542|FG001|COMPLETED|Second Intervention||33
10859952|NCT00835367|12025541|FG000|NOT COMPLETED|Second Intervention||1
10859953|NCT00835367|12025542|FG001|NOT COMPLETED|Second Intervention||1
10859954|NCT00835354|12025548|FG000|STARTED|First Intervention||13
10859955|NCT00835354|12025549|FG001|STARTED|First Intervention||13
10859956|NCT00835354|12025548|FG000|COMPLETED|First Intervention||13
10859957|NCT00835354|12025549|FG001|COMPLETED|First Intervention||12
10859958|NCT00835354|12025548|FG000|NOT COMPLETED|First Intervention||0
10859959|NCT00835354|12025549|FG001|NOT COMPLETED|First Intervention||1
10859960|NCT00835354|12025548|FG000|STARTED|Washout of 7 Days||13
10859961|NCT00835354|12025549|FG001|STARTED|Washout of 7 Days||12
10859962|NCT00835354|12025548|FG000|COMPLETED|Washout of 7 Days||13
10859963|NCT00835354|12025549|FG001|COMPLETED|Washout of 7 Days||12
10859964|NCT00835354|12025548|FG000|NOT COMPLETED|Washout of 7 Days||0
10859965|NCT00835354|12025549|FG001|NOT COMPLETED|Washout of 7 Days||0
10859966|NCT00835354|12025548|FG000|STARTED|Second Intervention||13
10859967|NCT00835354|12025549|FG001|STARTED|Second Intervention||12
10859968|NCT00835354|12025548|FG000|COMPLETED|Second Intervention||13
10859969|NCT00835354|12025549|FG001|COMPLETED|Second Intervention||12
10859970|NCT00835354|12025548|FG000|NOT COMPLETED|Second Intervention||0
10859971|NCT00835354|12025549|FG001|NOT COMPLETED|Second Intervention||0
10859972|NCT00835276|12025555|FG000|STARTED|First Intervention||24
10859973|NCT00835276|12025556|FG001|STARTED|First Intervention||24
10859974|NCT00835276|12025555|FG000|COMPLETED|First Intervention||24
10859975|NCT00835276|12025556|FG001|COMPLETED|First Intervention||24
10859976|NCT00835276|12025555|FG000|NOT COMPLETED|First Intervention||0
10859977|NCT00835276|12025556|FG001|NOT COMPLETED|First Intervention||0
10859978|NCT00835276|12025555|FG000|STARTED|Washout of 7 Days||24
10859979|NCT00835276|12025556|FG001|STARTED|Washout of 7 Days||24
10859980|NCT00835276|12025555|FG000|COMPLETED|Washout of 7 Days||24
10859981|NCT00835276|12025556|FG001|COMPLETED|Washout of 7 Days||24
10859982|NCT00835276|12025555|FG000|NOT COMPLETED|Washout of 7 Days||0
10859983|NCT00835276|12025556|FG001|NOT COMPLETED|Washout of 7 Days||0
10859984|NCT00835276|12025555|FG000|STARTED|Second Intervention||24
10859985|NCT00835276|12025556|FG001|STARTED|Second Intervention||24
10859986|NCT00835276|12025555|FG000|COMPLETED|Second Intervention||24
10859987|NCT00835276|12025556|FG001|COMPLETED|Second Intervention||24
10859988|NCT00835276|12025555|FG000|NOT COMPLETED|Second Intervention||0
10859989|NCT00835276|12025556|FG001|NOT COMPLETED|Second Intervention||0
10859990|NCT00835263|12025562|FG000|STARTED|First Intervention||16
10859991|NCT00835263|12025563|FG001|STARTED|First Intervention||16
10859992|NCT00835263|12025562|FG000|COMPLETED|First Intervention||16
10859993|NCT00835263|12025563|FG001|COMPLETED|First Intervention||16
10859994|NCT00835263|12025562|FG000|NOT COMPLETED|First Intervention||0
10859995|NCT00835263|12025563|FG001|NOT COMPLETED|First Intervention||0
10859996|NCT00835263|12025562|FG000|STARTED|Second Intervention||16
10859997|NCT00835263|12025563|FG001|STARTED|Second Intervention||16
10859998|NCT00835263|12025562|FG000|COMPLETED|Second Intervention||15
10859999|NCT00835263|12025563|FG001|COMPLETED|Second Intervention||16
10860000|NCT00835263|12025562|FG000|NOT COMPLETED|Second Intervention||1
10860001|NCT00835263|12025563|FG001|NOT COMPLETED|Second Intervention||0
10860002|NCT00835211|12025569|FG000|STARTED|First Intervention||24
10860003|NCT00835211|12025570|FG001|STARTED|First Intervention||24
10860004|NCT00835211|12025569|FG000|COMPLETED|First Intervention||24
10860005|NCT00835211|12025570|FG001|COMPLETED|First Intervention||23
10860006|NCT00835211|12025569|FG000|NOT COMPLETED|First Intervention||0
10860007|NCT00835211|12025570|FG001|NOT COMPLETED|First Intervention||1
10860008|NCT00835211|12025569|FG000|STARTED|Washout: 7 Days||24
10860009|NCT00835211|12025570|FG001|STARTED|Washout: 7 Days||23
10860010|NCT00835211|12025569|FG000|COMPLETED|Washout: 7 Days||21
10860011|NCT00835211|12025570|FG001|COMPLETED|Washout: 7 Days||22
10860012|NCT00835211|12025569|FG000|NOT COMPLETED|Washout: 7 Days||3
10860013|NCT00835211|12025570|FG001|NOT COMPLETED|Washout: 7 Days||1
10860014|NCT00835211|12025569|FG000|STARTED|Second Intervention||21
10860015|NCT00835211|12025570|FG001|STARTED|Second Intervention||22
10860016|NCT00835211|12025569|FG000|COMPLETED|Second Intervention||21
10860017|NCT00835211|12025570|FG001|COMPLETED|Second Intervention||22
10860018|NCT00835211|12025569|FG000|NOT COMPLETED|Second Intervention||0
10860019|NCT00835211|12025570|FG001|NOT COMPLETED|Second Intervention||0
10860020|NCT00835172|12025576|FG000|STARTED|First Intervention||16
10860021|NCT00835172|12025577|FG001|STARTED|First Intervention||16
10860022|NCT00835172|12025576|FG000|COMPLETED|First Intervention||16
10860023|NCT00835172|12025577|FG001|COMPLETED|First Intervention||16
10860024|NCT00835172|12025576|FG000|NOT COMPLETED|First Intervention||0
10860025|NCT00835172|12025577|FG001|NOT COMPLETED|First Intervention||0
10860026|NCT00835172|12025576|FG000|STARTED|Washout||16
10860027|NCT00835172|12025577|FG001|STARTED|Washout||16
10860028|NCT00835172|12025576|FG000|COMPLETED|Washout||16
10860029|NCT00835172|12025577|FG001|COMPLETED|Washout||15
10860030|NCT00835172|12025576|FG000|NOT COMPLETED|Washout||0
10860031|NCT00835172|12025577|FG001|NOT COMPLETED|Washout||1
10860032|NCT00835172|12025576|FG000|STARTED|Second Intervention||16
10860033|NCT00835172|12025577|FG001|STARTED|Second Intervention||15
10860034|NCT00835172|12025576|FG000|COMPLETED|Second Intervention||16
10860035|NCT00835172|12025577|FG001|COMPLETED|Second Intervention||15
10860036|NCT00835172|12025576|FG000|NOT COMPLETED|Second Intervention||0
10860037|NCT00835172|12025577|FG001|NOT COMPLETED|Second Intervention||0
10860038|NCT00835146|12025583|FG000|STARTED|First Intervention||14
10860039|NCT00835146|12025584|FG001|STARTED|First Intervention||14
10860040|NCT00835146|12025583|FG000|COMPLETED|First Intervention||14
10860041|NCT00835146|12025584|FG001|COMPLETED|First Intervention||14
10860042|NCT00835146|12025583|FG000|NOT COMPLETED|First Intervention||0
10860043|NCT00835146|12025584|FG001|NOT COMPLETED|First Intervention||0
10860044|NCT00835146|12025583|FG000|STARTED|Washout of 5 Weeks||14
10860045|NCT00835146|12025584|FG001|STARTED|Washout of 5 Weeks||14
10860046|NCT00835146|12025583|FG000|COMPLETED|Washout of 5 Weeks||14
10860047|NCT00835146|12025584|FG001|COMPLETED|Washout of 5 Weeks||14
10860048|NCT00835146|12025583|FG000|NOT COMPLETED|Washout of 5 Weeks||0
10860049|NCT00835146|12025584|FG001|NOT COMPLETED|Washout of 5 Weeks||0
10860050|NCT00835146|12025583|FG000|STARTED|Second Intervention||14
10860051|NCT00835146|12025584|FG001|STARTED|Second Intervention||14
10860052|NCT00835146|12025583|FG000|COMPLETED|Second Intervention||14
10860053|NCT00835146|12025584|FG001|COMPLETED|Second Intervention||14
10860054|NCT00835146|12025583|FG000|NOT COMPLETED|Second Intervention||0
10860055|NCT00835146|12025584|FG001|NOT COMPLETED|Second Intervention||0
10860056|NCT00835081|12025590|FG000|STARTED|First Intervention||13
10860057|NCT00835081|12025591|FG001|STARTED|First Intervention||13
10860058|NCT00835081|12025590|FG000|COMPLETED|First Intervention||13
10860059|NCT00835081|12025591|FG001|COMPLETED|First Intervention||13
10860060|NCT00835081|12025590|FG000|NOT COMPLETED|First Intervention||0
10860061|NCT00835081|12025591|FG001|NOT COMPLETED|First Intervention||0
10860062|NCT00835081|12025590|FG000|STARTED|Washout of 7 Days||13
10860063|NCT00835081|12025591|FG001|STARTED|Washout of 7 Days||13
10860064|NCT00835081|12025590|FG000|COMPLETED|Washout of 7 Days||12
10860065|NCT00835081|12025591|FG001|COMPLETED|Washout of 7 Days||13
10860066|NCT00835081|12025590|FG000|NOT COMPLETED|Washout of 7 Days||1
10860067|NCT00835081|12025591|FG001|NOT COMPLETED|Washout of 7 Days||0
10860068|NCT00835081|12025590|FG000|STARTED|Second Intervention||12
10860069|NCT00835081|12025591|FG001|STARTED|Second Intervention||13
10860070|NCT00835081|12025590|FG000|COMPLETED|Second Intervention||12
10860071|NCT00835081|12025591|FG001|COMPLETED|Second Intervention||13
10860072|NCT00835081|12025590|FG000|NOT COMPLETED|Second Intervention||0
10860073|NCT00835081|12025591|FG001|NOT COMPLETED|Second Intervention||0
10860074|NCT00835042|12025597|FG000|STARTED|First Intervention||30
10860075|NCT00835042|12025598|FG001|STARTED|First Intervention||28
10860076|NCT00835042|12025597|FG000|COMPLETED|First Intervention||26
10860077|NCT00835042|12025598|FG001|COMPLETED|First Intervention||26
10860078|NCT00835042|12025597|FG000|NOT COMPLETED|First Intervention||4
10860079|NCT00835042|12025598|FG001|NOT COMPLETED|First Intervention||2
10860080|NCT00835042|12025597|FG000|STARTED|Washout of 21 Days||26
10860081|NCT00835042|12025598|FG001|STARTED|Washout of 21 Days||26
10860082|NCT00835042|12025597|FG000|COMPLETED|Washout of 21 Days||26
10860083|NCT00835042|12025598|FG001|COMPLETED|Washout of 21 Days||24
10860084|NCT00835042|12025597|FG000|NOT COMPLETED|Washout of 21 Days||0
10860085|NCT00835042|12025598|FG001|NOT COMPLETED|Washout of 21 Days||2
10860086|NCT00835042|12025597|FG000|STARTED|Second Intervention||26
10860087|NCT00835042|12025598|FG001|STARTED|Second Intervention||24
10860088|NCT00835042|12025597|FG000|COMPLETED|Second Intervention||26
10860089|NCT00835042|12025598|FG001|COMPLETED|Second Intervention||24
10860090|NCT00835042|12025597|FG000|NOT COMPLETED|Second Intervention||0
10860091|NCT00835042|12025598|FG001|NOT COMPLETED|Second Intervention||0
10860092|NCT00834990|12025604|FG000|STARTED|First Intervention||12
10860093|NCT00834990|12025605|FG001|STARTED|First Intervention||11
10860094|NCT00834990|12025604|FG000|COMPLETED|First Intervention||12
10860095|NCT00834990|12025605|FG001|COMPLETED|First Intervention||11
10860096|NCT00834990|12025604|FG000|NOT COMPLETED|First Intervention||0
10860097|NCT00834990|12025605|FG001|NOT COMPLETED|First Intervention||0
10860098|NCT00834990|12025604|FG000|STARTED|Washout of 7 Days||12
10860099|NCT00834990|12025605|FG001|STARTED|Washout of 7 Days||11
10860100|NCT00834990|12025604|FG000|COMPLETED|Washout of 7 Days||12
10860101|NCT00834990|12025605|FG001|COMPLETED|Washout of 7 Days||11
10860102|NCT00834990|12025604|FG000|NOT COMPLETED|Washout of 7 Days||0
10860103|NCT00834990|12025605|FG001|NOT COMPLETED|Washout of 7 Days||0
10860104|NCT00834990|12025604|FG000|STARTED|Second Intervention||12
10860105|NCT00834990|12025605|FG001|STARTED|Second Intervention||11
10860106|NCT00834990|12025604|FG000|COMPLETED|Second Intervention||12
10860107|NCT00834990|12025605|FG001|COMPLETED|Second Intervention||11
10860108|NCT00834990|12025604|FG000|NOT COMPLETED|Second Intervention||0
10860109|NCT00834990|12025605|FG001|NOT COMPLETED|Second Intervention||0
10860110|NCT00834977|12025611|FG000|STARTED|First Intervention||24
10860111|NCT00834977|12025612|FG001|STARTED|First Intervention||24
10860112|NCT00834977|12025611|FG000|COMPLETED|First Intervention||24
10860113|NCT00834977|12025612|FG001|COMPLETED|First Intervention||24
10860114|NCT00834977|12025611|FG000|NOT COMPLETED|First Intervention||0
10860115|NCT00834977|12025612|FG001|NOT COMPLETED|First Intervention||0
10860116|NCT00834977|12025611|FG000|STARTED|Second Intervention||24
10860117|NCT00834977|12025612|FG001|STARTED|Second Intervention||24
10860118|NCT00834977|12025611|FG000|COMPLETED|Second Intervention||24
10860119|NCT00834977|12025612|FG001|COMPLETED|Second Intervention||24
10860120|NCT00834977|12025611|FG000|NOT COMPLETED|Second Intervention||0
10860121|NCT00834977|12025612|FG001|NOT COMPLETED|Second Intervention||0
10860122|NCT00834964|12025618|FG000|STARTED|First Intervention||15
10860123|NCT00834964|12025619|FG001|STARTED|First Intervention||15
10860124|NCT00834964|12025618|FG000|COMPLETED|First Intervention||15
10860125|NCT00834964|12025619|FG001|COMPLETED|First Intervention||15
10860126|NCT00834964|12025618|FG000|NOT COMPLETED|First Intervention||0
10860127|NCT00834964|12025619|FG001|NOT COMPLETED|First Intervention||0
10860128|NCT00834964|12025618|FG000|STARTED|Washout: 7 Days||15
10860129|NCT00834964|12025619|FG001|STARTED|Washout: 7 Days||15
10860130|NCT00834964|12025618|FG000|COMPLETED|Washout: 7 Days||15
10860131|NCT00834964|12025619|FG001|COMPLETED|Washout: 7 Days||15
10860132|NCT00834964|12025618|FG000|NOT COMPLETED|Washout: 7 Days||0
10860133|NCT00834964|12025619|FG001|NOT COMPLETED|Washout: 7 Days||0
10860134|NCT00834964|12025618|FG000|STARTED|Second Intervention||15
10860135|NCT00834964|12025619|FG001|STARTED|Second Intervention||15
10860136|NCT00834964|12025618|FG000|COMPLETED|Second Intervention||15
10860137|NCT00834964|12025619|FG001|COMPLETED|Second Intervention||15
10860138|NCT00834964|12025618|FG000|NOT COMPLETED|Second Intervention||0
10860139|NCT00834964|12025619|FG001|NOT COMPLETED|Second Intervention||0
10860140|NCT00834873|12025625|FG000|STARTED|First Intervention||12
10860141|NCT00834873|12025626|FG001|STARTED|First Intervention||12
10860142|NCT00834873|12025625|FG000|COMPLETED|First Intervention||12
10860143|NCT00834873|12025626|FG001|COMPLETED|First Intervention||11
10860144|NCT00834873|12025625|FG000|NOT COMPLETED|First Intervention||0
10860145|NCT00834873|12025626|FG001|NOT COMPLETED|First Intervention||1
10860146|NCT00834873|12025625|FG000|STARTED|Washout: 7 Days||12
10860147|NCT00834873|12025626|FG001|STARTED|Washout: 7 Days||11
10860148|NCT00834873|12025625|FG000|COMPLETED|Washout: 7 Days||12
10860149|NCT00834873|12025626|FG001|COMPLETED|Washout: 7 Days||11
10860150|NCT00834873|12025625|FG000|NOT COMPLETED|Washout: 7 Days||0
10860151|NCT00834873|12025626|FG001|NOT COMPLETED|Washout: 7 Days||0
10860152|NCT00834873|12025625|FG000|STARTED|Second Intervention||12
10860153|NCT00834873|12025626|FG001|STARTED|Second Intervention||11
10860154|NCT00834873|12025625|FG000|COMPLETED|Second Intervention||12
10860155|NCT00834873|12025626|FG001|COMPLETED|Second Intervention||11
10860156|NCT00834873|12025625|FG000|NOT COMPLETED|Second Intervention||0
10860157|NCT00834873|12025626|FG001|NOT COMPLETED|Second Intervention||0
10860158|NCT00834795|12025632|FG000|STARTED|First Intervention||18
10860159|NCT00834795|12025633|FG001|STARTED|First Intervention||18
10860160|NCT00834795|12025632|FG000|COMPLETED|First Intervention||18
10860161|NCT00834795|12025633|FG001|COMPLETED|First Intervention||18
10860162|NCT00834795|12025632|FG000|NOT COMPLETED|First Intervention||0
10860163|NCT00834795|12025633|FG001|NOT COMPLETED|First Intervention||0
10860164|NCT00834795|12025632|FG000|STARTED|Washout: 7 Days||18
10860165|NCT00834795|12025633|FG001|STARTED|Washout: 7 Days||18
10860166|NCT00834795|12025632|FG000|COMPLETED|Washout: 7 Days||18
10860167|NCT00834795|12025633|FG001|COMPLETED|Washout: 7 Days||17
10860168|NCT00834795|12025632|FG000|NOT COMPLETED|Washout: 7 Days||0
10860169|NCT00834795|12025633|FG001|NOT COMPLETED|Washout: 7 Days||1
10860170|NCT00834795|12025632|FG000|STARTED|Second Intervention||18
10860171|NCT00834795|12025633|FG001|STARTED|Second Intervention||17
10860172|NCT00834795|12025632|FG000|COMPLETED|Second Intervention||17
10860173|NCT00834795|12025633|FG001|COMPLETED|Second Intervention||17
10860174|NCT00834795|12025632|FG000|NOT COMPLETED|Second Intervention||1
10860175|NCT00834795|12025633|FG001|NOT COMPLETED|Second Intervention||0
10860176|NCT00834756|12025639|FG000|STARTED|First Intervention||18
10860177|NCT00834756|12025640|FG001|STARTED|First Intervention||18
10860178|NCT00834756|12025639|FG000|COMPLETED|First Intervention||17
10860179|NCT00834756|12025640|FG001|COMPLETED|First Intervention||18
10860180|NCT00834756|12025639|FG000|NOT COMPLETED|First Intervention||1
10860181|NCT00834756|12025640|FG001|NOT COMPLETED|First Intervention||0
10860182|NCT00834756|12025639|FG000|STARTED|Washout: 21 Days||17
10860183|NCT00834756|12025640|FG001|STARTED|Washout: 21 Days||18
10860184|NCT00834756|12025639|FG000|COMPLETED|Washout: 21 Days||16
10860185|NCT00834756|12025640|FG001|COMPLETED|Washout: 21 Days||18
10860186|NCT00834756|12025639|FG000|NOT COMPLETED|Washout: 21 Days||1
10860187|NCT00834756|12025640|FG001|NOT COMPLETED|Washout: 21 Days||0
10860188|NCT00834756|12025639|FG000|STARTED|Second Intervention||16
10860189|NCT00834756|12025640|FG001|STARTED|Second Intervention||18
10860190|NCT00834756|12025639|FG000|COMPLETED|Second Intervention||16
10860191|NCT00834756|12025640|FG001|COMPLETED|Second Intervention||18
10860192|NCT00834756|12025639|FG000|NOT COMPLETED|Second Intervention||0
10860193|NCT00834756|12025640|FG001|NOT COMPLETED|Second Intervention||0
10860194|NCT00834743|12025646|FG000|STARTED|First Intervention||16
10860195|NCT00834743|12025647|FG001|STARTED|First Intervention||16
10860196|NCT00834743|12025646|FG000|COMPLETED|First Intervention||16
10860197|NCT00834743|12025647|FG001|COMPLETED|First Intervention||16
10860198|NCT00834743|12025646|FG000|NOT COMPLETED|First Intervention||0
10860199|NCT00834743|12025647|FG001|NOT COMPLETED|First Intervention||0
10860200|NCT00834743|12025646|FG000|STARTED|Washout of 7 Days||16
10860201|NCT00834743|12025647|FG001|STARTED|Washout of 7 Days||16
10860202|NCT00834743|12025646|FG000|COMPLETED|Washout of 7 Days||16
10860203|NCT00834743|12025647|FG001|COMPLETED|Washout of 7 Days||16
10860204|NCT00834743|12025646|FG000|NOT COMPLETED|Washout of 7 Days||0
10860205|NCT00834743|12025647|FG001|NOT COMPLETED|Washout of 7 Days||0
10860206|NCT00834743|12025646|FG000|STARTED|Second Intervention||16
10860207|NCT00834743|12025647|FG001|STARTED|Second Intervention||16
10860208|NCT00834743|12025646|FG000|COMPLETED|Second Intervention||15
10860209|NCT00834743|12025647|FG001|COMPLETED|Second Intervention||16
10860210|NCT00834743|12025646|FG000|NOT COMPLETED|Second Intervention||1
10860211|NCT00834743|12025647|FG001|NOT COMPLETED|Second Intervention||0
10860212|NCT00834717|12025653|FG000|STARTED|First Intervention||20
10860213|NCT00834717|12025654|FG001|STARTED|First Intervention||20
10416194|NCT00792298|11560560|FG001|NOT COMPLETED|Treatment Period 2||1
10416195|NCT00792298|11560561|FG002|NOT COMPLETED|Treatment Period 2||1
10860214|NCT00834717|12025653|FG000|COMPLETED|First Intervention||19
10860215|NCT00834717|12025654|FG001|COMPLETED|First Intervention||19
10860216|NCT00834717|12025653|FG000|NOT COMPLETED|First Intervention||1
10860217|NCT00834717|12025654|FG001|NOT COMPLETED|First Intervention||1
10860218|NCT00834717|12025653|FG000|STARTED|Second Intervention||19
10860219|NCT00834717|12025654|FG001|STARTED|Second Intervention||19
10860220|NCT00834717|12025653|FG000|COMPLETED|Second Intervention||19
10860221|NCT00834717|12025654|FG001|COMPLETED|Second Intervention||19
10860222|NCT00834717|12025653|FG000|NOT COMPLETED|Second Intervention||0
10860223|NCT00834717|12025654|FG001|NOT COMPLETED|Second Intervention||0
10860224|NCT00834639|12025660|FG000|STARTED|First Intervention||12
10860225|NCT00834639|12025661|FG001|STARTED|First Intervention||12
10860226|NCT00834639|12025660|FG000|COMPLETED|First Intervention||12
10860227|NCT00834639|12025661|FG001|COMPLETED|First Intervention||12
10860228|NCT00834639|12025660|FG000|NOT COMPLETED|First Intervention||0
10860229|NCT00834639|12025661|FG001|NOT COMPLETED|First Intervention||0
10860230|NCT00834639|12025660|FG000|STARTED|Washout of 7 Days||12
10860231|NCT00834639|12025661|FG001|STARTED|Washout of 7 Days||12
10860232|NCT00834639|12025660|FG000|COMPLETED|Washout of 7 Days||12
10860233|NCT00834639|12025661|FG001|COMPLETED|Washout of 7 Days||12
10860234|NCT00834639|12025660|FG000|NOT COMPLETED|Washout of 7 Days||0
10860235|NCT00834639|12025661|FG001|NOT COMPLETED|Washout of 7 Days||0
10860236|NCT00834639|12025660|FG000|STARTED|Second Intervention||12
10860237|NCT00834639|12025661|FG001|STARTED|Second Intervention||12
10860238|NCT00834639|12025660|FG000|COMPLETED|Second Intervention||12
10860239|NCT00834639|12025661|FG001|COMPLETED|Second Intervention||10
10860240|NCT00834639|12025660|FG000|NOT COMPLETED|Second Intervention||0
10860241|NCT00834639|12025661|FG001|NOT COMPLETED|Second Intervention||2
10860242|NCT00834613|12025667|FG000|STARTED|First Intervention||16
10860243|NCT00834613|12025668|FG001|STARTED|First Intervention||16
10860244|NCT00834613|12025667|FG000|COMPLETED|First Intervention||15
10860245|NCT00834613|12025668|FG001|COMPLETED|First Intervention||16
10860246|NCT00834613|12025667|FG000|NOT COMPLETED|First Intervention||1
10860247|NCT00834613|12025668|FG001|NOT COMPLETED|First Intervention||0
10860248|NCT00834613|12025667|FG000|STARTED|Washout of 7 Days||15
10860249|NCT00834613|12025668|FG001|STARTED|Washout of 7 Days||16
10860250|NCT00834613|12025667|FG000|COMPLETED|Washout of 7 Days||15
10860251|NCT00834613|12025668|FG001|COMPLETED|Washout of 7 Days||16
10860252|NCT00834613|12025667|FG000|NOT COMPLETED|Washout of 7 Days||0
10860253|NCT00834613|12025668|FG001|NOT COMPLETED|Washout of 7 Days||0
10860254|NCT00834613|12025667|FG000|STARTED|Second Intervention||15
10860255|NCT00834613|12025668|FG001|STARTED|Second Intervention||16
10860256|NCT00834613|12025667|FG000|COMPLETED|Second Intervention||15
10860257|NCT00834613|12025668|FG001|COMPLETED|Second Intervention||16
10860258|NCT00834613|12025667|FG000|NOT COMPLETED|Second Intervention||0
10860259|NCT00834613|12025668|FG001|NOT COMPLETED|Second Intervention||0
10860260|NCT00834587|12025674|FG000|STARTED|First Intervention||20
10860261|NCT00834587|12025675|FG001|STARTED|First Intervention||20
10860262|NCT00834587|12025674|FG000|COMPLETED|First Intervention||20
10860263|NCT00834587|12025675|FG001|COMPLETED|First Intervention||20
10860264|NCT00834587|12025674|FG000|NOT COMPLETED|First Intervention||0
10860265|NCT00834587|12025675|FG001|NOT COMPLETED|First Intervention||0
10860266|NCT00834587|12025674|FG000|STARTED|Washout: 7 Days||20
10860267|NCT00834587|12025675|FG001|STARTED|Washout: 7 Days||20
10860268|NCT00834587|12025674|FG000|COMPLETED|Washout: 7 Days||19
10860269|NCT00834587|12025675|FG001|COMPLETED|Washout: 7 Days||20
10860270|NCT00834587|12025674|FG000|NOT COMPLETED|Washout: 7 Days||1
10860271|NCT00834587|12025675|FG001|NOT COMPLETED|Washout: 7 Days||0
10860272|NCT00834587|12025674|FG000|STARTED|Second Intervention||19
10860273|NCT00834587|12025675|FG001|STARTED|Second Intervention||20
10860274|NCT00834587|12025674|FG000|COMPLETED|Second Intervention||19
10293622|NCT03813719|11426218|FG000|NOT COMPLETED|Overall Study||0
10314586|NCT00166205|11448289|FG000|STARTED|Overall Study||276
10314587|NCT00166205|11448289|FG000|Intervention - SAGB Surgery|Overall Study||276
10314588|NCT00166205|11448289|FG000|COMPLETED|Overall Study||228
10314589|NCT00166205|11448289|FG000|NOT COMPLETED|Overall Study||48
10314590|NCT00166296|11448295|FG000|STARTED|Overall Study|Randomized patients|67
10314591|NCT00166296|11448296|FG001|STARTED|Overall Study|Randomized patients|66
10314592|NCT00166296|11448295|FG000|ANALYZED|Overall Study|Patients who did receive at least the first dose of study medications, included in the analysis|66
10314593|NCT00166296|11448296|FG001|ANALYZED|Overall Study|Patients who did receive at least the first dose of study medications, included in the analysis|63
10416196|NCT00792298|11560562|FG003|NOT COMPLETED|Treatment Period 2||2
10860275|NCT00834587|12025675|FG001|COMPLETED|Second Intervention||20
10860276|NCT00834587|12025674|FG000|NOT COMPLETED|Second Intervention||0
10860277|NCT00834587|12025675|FG001|NOT COMPLETED|Second Intervention||0
10860278|NCT00834574|12025681|FG000|STARTED|First Intervention||16
10860279|NCT00834574|12025682|FG001|STARTED|First Intervention||16
10860280|NCT00834574|12025681|FG000|COMPLETED|First Intervention||16
10860281|NCT00834574|12025682|FG001|COMPLETED|First Intervention||16
10860282|NCT00834574|12025681|FG000|NOT COMPLETED|First Intervention||0
10860283|NCT00834574|12025682|FG001|NOT COMPLETED|First Intervention||0
10860284|NCT00834574|12025681|FG000|STARTED|Washout of 7 Days||16
10860285|NCT00834574|12025682|FG001|STARTED|Washout of 7 Days||16
10860286|NCT00834574|12025681|FG000|COMPLETED|Washout of 7 Days||16
10860287|NCT00834574|12025682|FG001|COMPLETED|Washout of 7 Days||16
10860288|NCT00834574|12025681|FG000|NOT COMPLETED|Washout of 7 Days||0
10860289|NCT00834574|12025682|FG001|NOT COMPLETED|Washout of 7 Days||0
10860290|NCT00834574|12025681|FG000|STARTED|Second Intervention||16
10860291|NCT00834574|12025682|FG001|STARTED|Second Intervention||16
10860292|NCT00834574|12025681|FG000|COMPLETED|Second Intervention||16
10860293|NCT00834574|12025682|FG001|COMPLETED|Second Intervention||16
10860294|NCT00834574|12025681|FG000|NOT COMPLETED|Second Intervention||0
10860295|NCT00834574|12025682|FG001|NOT COMPLETED|Second Intervention||0
10860296|NCT00834561|12025688|FG000|STARTED|First Intervention||16
10860297|NCT00834561|12025689|FG001|STARTED|First Intervention||16
10860298|NCT00834561|12025688|FG000|COMPLETED|First Intervention||16
10860299|NCT00834561|12025689|FG001|COMPLETED|First Intervention||16
10860300|NCT00834561|12025688|FG000|NOT COMPLETED|First Intervention||0
10860301|NCT00834561|12025689|FG001|NOT COMPLETED|First Intervention||0
10860302|NCT00834561|12025688|FG000|STARTED|Second Intervention||16
10860303|NCT00834561|12025689|FG001|STARTED|Second Intervention||16
10860304|NCT00834561|12025688|FG000|COMPLETED|Second Intervention||16
10860305|NCT00834561|12025689|FG001|COMPLETED|Second Intervention||16
10860306|NCT00834561|12025688|FG000|NOT COMPLETED|Second Intervention||0
10860307|NCT00834561|12025689|FG001|NOT COMPLETED|Second Intervention||0
10860308|NCT00834535|12025695|FG000|STARTED|First Intervention||16
10860309|NCT00834535|12025696|FG001|STARTED|First Intervention||16
10860310|NCT00834535|12025695|FG000|COMPLETED|First Intervention||16
10860311|NCT00834535|12025696|FG001|COMPLETED|First Intervention||16
10860312|NCT00834535|12025695|FG000|NOT COMPLETED|First Intervention||0
10860313|NCT00834535|12025696|FG001|NOT COMPLETED|First Intervention||0
10860314|NCT00834535|12025695|FG000|STARTED|Washout of 7 Days||16
10860315|NCT00834535|12025696|FG001|STARTED|Washout of 7 Days||16
10860316|NCT00834535|12025695|FG000|COMPLETED|Washout of 7 Days||16
10860317|NCT00834535|12025696|FG001|COMPLETED|Washout of 7 Days||16
10860318|NCT00834535|12025695|FG000|NOT COMPLETED|Washout of 7 Days||0
10860319|NCT00834535|12025696|FG001|NOT COMPLETED|Washout of 7 Days||0
10860320|NCT00834535|12025695|FG000|STARTED|Second Intervention||16
10860321|NCT00834535|12025696|FG001|STARTED|Second Intervention||16
10293623|NCT03798756|11426224|FG000|STARTED|Overall Study||9274
10293624|NCT03798756|11426224|FG000|COMPLETED|Overall Study||9274
10293625|NCT03798756|11426224|FG000|NOT COMPLETED|Overall Study||0
10293626|NCT03790917|11426229|FG000|STARTED|Overall Study||201
10293627|NCT03790917|11426229|FG000|COMPLETED|Overall Study||200
10293628|NCT03790917|11426229|FG000|NOT COMPLETED|Overall Study||1
10293629|NCT03790306|11426234|FG000|STARTED|Overall Study||207
10293630|NCT03790306|11426234|FG000|COMPLETED|Overall Study||207
10293631|NCT03790306|11426234|FG000|NOT COMPLETED|Overall Study||0
10314594|NCT00166296|11448295|FG000|COMPLETED|Overall Study|Patients who completed both trial medication and interferon+ribavirin treatment for 12 weeks|60
10314595|NCT00166296|11448296|FG001|COMPLETED|Overall Study|Patients who completed both trial medication and interferon+ribavirin treatment for 12 weeks|57
10314596|NCT00166296|11448295|FG000|NOT COMPLETED|Overall Study||7
10314597|NCT00166296|11448296|FG001|NOT COMPLETED|Overall Study||9
10314598|NCT00166361|11448304|FG000|STARTED|Overall Study||14
10755232|NCT03063086|11919038|FG003|STARTED|Overall Study||20
10755233|NCT03063086|11919039|FG004|STARTED|Overall Study||20
10755234|NCT03063086|11919040|FG005|STARTED|Overall Study||19
10755235|NCT03063086|11919035|FG000|COMPLETED|Overall Study||16
10755236|NCT03063086|11919036|FG001|COMPLETED|Overall Study||19
10755237|NCT03063086|11919037|FG002|COMPLETED|Overall Study||17
10755238|NCT03063086|11919038|FG003|COMPLETED|Overall Study||17
10755239|NCT03063086|11919039|FG004|COMPLETED|Overall Study||20
10755240|NCT03063086|11919040|FG005|COMPLETED|Overall Study||18
10755241|NCT03063086|11919035|FG000|NOT COMPLETED|Overall Study||3
10755242|NCT03063086|11919036|FG001|NOT COMPLETED|Overall Study||1
10755243|NCT03063086|11919037|FG002|NOT COMPLETED|Overall Study||1
10755244|NCT03063086|11919038|FG003|NOT COMPLETED|Overall Study||3
10755245|NCT03063086|11919039|FG004|NOT COMPLETED|Overall Study||0
10755246|NCT03063086|11919040|FG005|NOT COMPLETED|Overall Study||1
10755247|NCT03063125|11919049|FG000|STARTED|Overall Study||25
10755248|NCT03063125|11919049|FG000|COMPLETED|Overall Study||23
10755249|NCT03063125|11919049|FG000|NOT COMPLETED|Overall Study||2
10755250|NCT03063255|11919055|FG000|STARTED|Overall Study||30
10755251|NCT03063255|11919056|FG001|STARTED|Overall Study||30
10755252|NCT03063255|11919055|FG000|COMPLETED|Overall Study||29
10755253|NCT03063255|11919056|FG001|COMPLETED|Overall Study||30
10755254|NCT03063255|11919055|FG000|NOT COMPLETED|Overall Study||1
10860322|NCT00834535|12025695|FG000|COMPLETED|Second Intervention||16
10860323|NCT00834535|12025696|FG001|COMPLETED|Second Intervention||16
10860324|NCT00834535|12025695|FG000|NOT COMPLETED|Second Intervention||0
10860325|NCT00834535|12025696|FG001|NOT COMPLETED|Second Intervention||0
10416197|NCT00792298|11560563|FG004|NOT COMPLETED|Treatment Period 2||2
10416198|NCT00792298|11560564|FG005|NOT COMPLETED|Treatment Period 2||0
10416199|NCT00792298|11560565|FG006|NOT COMPLETED|Treatment Period 2||1
10416200|NCT00792298|11560566|FG007|NOT COMPLETED|Treatment Period 2||2
10416201|NCT00792428|11560585|FG000|STARTED|Overall Study||10
10416202|NCT00792428|11560586|FG001|STARTED|Overall Study||10
10416203|NCT00792428|11560585|FG000|COMPLETED|Overall Study||10
10416204|NCT00792428|11560586|FG001|COMPLETED|Overall Study||10
10416205|NCT00792428|11560585|FG000|NOT COMPLETED|Overall Study||0
10860326|NCT00834522|12025702|FG000|STARTED|First Intervention||40
10860327|NCT00834522|12025703|FG001|STARTED|First Intervention||40
10860328|NCT00834522|12025702|FG000|COMPLETED|First Intervention||40
10860329|NCT00834522|12025703|FG001|COMPLETED|First Intervention||40
10860330|NCT00834522|12025702|FG000|NOT COMPLETED|First Intervention||0
10860331|NCT00834522|12025703|FG001|NOT COMPLETED|First Intervention||0
10860332|NCT00834522|12025702|FG000|STARTED|Washout||40
10860333|NCT00834522|12025703|FG001|STARTED|Washout||40
10860334|NCT00834522|12025702|FG000|COMPLETED|Washout||37
10860335|NCT00834522|12025703|FG001|COMPLETED|Washout||39
10860336|NCT00834522|12025702|FG000|NOT COMPLETED|Washout||3
10860337|NCT00834522|12025703|FG001|NOT COMPLETED|Washout||1
10860338|NCT00834522|12025702|FG000|STARTED|Second Intervention||37
10860339|NCT00834522|12025703|FG001|STARTED|Second Intervention||39
10860340|NCT00834522|12025702|FG000|COMPLETED|Second Intervention||37
10860341|NCT00834522|12025703|FG001|COMPLETED|Second Intervention||39
10860342|NCT00834522|12025702|FG000|NOT COMPLETED|Second Intervention||0
10860343|NCT00834522|12025703|FG001|NOT COMPLETED|Second Intervention||0
10860344|NCT00834444|12025709|FG000|STARTED|First Intervention||18
10860345|NCT00834444|12025710|FG001|STARTED|First Intervention||18
10860346|NCT00834444|12025709|FG000|COMPLETED|First Intervention||17
10860347|NCT00834444|12025710|FG001|COMPLETED|First Intervention||17
10860348|NCT00834444|12025709|FG000|NOT COMPLETED|First Intervention||1
10860349|NCT00834444|12025710|FG001|NOT COMPLETED|First Intervention||1
10860350|NCT00834444|12025709|FG000|STARTED|Washout of 7 Days||17
10860351|NCT00834444|12025710|FG001|STARTED|Washout of 7 Days||17
10860352|NCT00834444|12025709|FG000|COMPLETED|Washout of 7 Days||17
10860353|NCT00834444|12025710|FG001|COMPLETED|Washout of 7 Days||16
10416206|NCT00792428|11560586|FG001|NOT COMPLETED|Overall Study||0
10416207|NCT00792467|11560592|FG000|STARTED|Overall Study||24
10416208|NCT00792467|11560592|FG000|COMPLETED|Overall Study||2
10416209|NCT00792467|11560592|FG000|NOT COMPLETED|Overall Study||22
10416210|NCT00792571|11560597|FG000|STARTED|Overall Study||18
10416211|NCT00792571|11560597|FG000|COMPLETED|Overall Study||8
10416212|NCT00792571|11560597|FG000|NOT COMPLETED|Overall Study||10
10416213|NCT00792610|11560601|FG000|STARTED|Overall Study||127
10416214|NCT00792610|11560601|FG000|Youths|Overall Study||127
10416215|NCT00792610|11560601|FG000|COMPLETED|Overall Study||127
10416216|NCT00792610|11560601|FG000|NOT COMPLETED|Overall Study||0
10416217|NCT00792623|11560605|FG000|STARTED|Overall Study||29
10416218|NCT00792623|11560605|FG000|COMPLETED|Overall Study||22
10416219|NCT00792623|11560605|FG000|NOT COMPLETED|Overall Study||7
10416220|NCT00792636|11560613|FG000|STARTED|Overall Study||135
10416221|NCT00792636|11560614|FG001|STARTED|Overall Study||136
10545721|NCT01499368|11699192|FG001|NOT COMPLETED|Overall Study||18
10545722|NCT01499368|11699193|FG002|NOT COMPLETED|Overall Study||21
10545723|NCT01499498|11699201|FG000|STARTED|Overall Study||13
10545724|NCT01499498|11699201|FG000|COMPLETED|Overall Study||13
10545725|NCT01499498|11699201|FG000|NOT COMPLETED|Overall Study||0
10545726|NCT01499511|11699210|FG000|STARTED|Overall Study||885
10545727|NCT01499511|11699211|FG001|STARTED|Overall Study||833
10545728|NCT01499511|11699210|FG000|COMPLETED|Overall Study||884
10545729|NCT01499511|11699211|FG001|COMPLETED|Overall Study||833
10545730|NCT01499511|11699210|FG000|NOT COMPLETED|Overall Study||1
10545731|NCT01499511|11699211|FG001|NOT COMPLETED|Overall Study||0
10860354|NCT00834444|12025709|FG000|NOT COMPLETED|Washout of 7 Days||0
10860355|NCT00834444|12025710|FG001|NOT COMPLETED|Washout of 7 Days||1
10860356|NCT00834444|12025709|FG000|STARTED|Second Intervention||17
10860357|NCT00834444|12025710|FG001|STARTED|Second Intervention||16
10860358|NCT00834444|12025709|FG000|COMPLETED|Second Intervention||16
10860359|NCT00834444|12025710|FG001|COMPLETED|Second Intervention||16
10860360|NCT00834444|12025709|FG000|NOT COMPLETED|Second Intervention||1
10860361|NCT00834444|12025710|FG001|NOT COMPLETED|Second Intervention||0
10860362|NCT00834431|12025716|FG000|STARTED|First Intervention||18
10860363|NCT00834431|12025717|FG001|STARTED|First Intervention||18
10860364|NCT00834431|12025716|FG000|COMPLETED|First Intervention||18
10545732|NCT01499576|11699218|FG000|STARTED|Overall Study||126
10545733|NCT01499576|11699218|FG000|COMPLETED|Overall Study||105
10545734|NCT01499576|11699218|FG000|NOT COMPLETED|Overall Study||21
10545735|NCT01499654|11699223|FG000|STARTED|Overall Study||64
10545736|NCT01499654|11699223|FG000|COMPLETED|Overall Study||64
10545737|NCT01499654|11699223|FG000|NOT COMPLETED|Overall Study||0
10860365|NCT00834431|12025717|FG001|COMPLETED|First Intervention||17
10416222|NCT00792636|11560615|FG002|STARTED|Overall Study||136
10416223|NCT00792636|11560613|FG000|COMPLETED|Overall Study||67
10416224|NCT00792636|11560614|FG001|COMPLETED|Overall Study||55
10545738|NCT01499667|11699236|FG000|STARTED|Overall Study|"Started indicates randomized as well as safety population."|50
10545739|NCT01499667|11699237|FG001|STARTED|Overall Study||42
10860366|NCT00834431|12025716|FG000|NOT COMPLETED|First Intervention||0
10860367|NCT00834431|12025717|FG001|NOT COMPLETED|First Intervention||1
10860368|NCT00834431|12025716|FG000|STARTED|Washout of 7 Days||18
10860369|NCT00834431|12025717|FG001|STARTED|Washout of 7 Days||17
10860370|NCT00834431|12025716|FG000|COMPLETED|Washout of 7 Days||18
10860371|NCT00834431|12025717|FG001|COMPLETED|Washout of 7 Days||16
10860372|NCT00834431|12025716|FG000|NOT COMPLETED|Washout of 7 Days||0
10860373|NCT00834431|12025717|FG001|NOT COMPLETED|Washout of 7 Days||1
10860374|NCT00834431|12025716|FG000|STARTED|Second Intervention||18
10860375|NCT00834431|12025717|FG001|STARTED|Second Intervention||16
10860376|NCT00834431|12025716|FG000|COMPLETED|Second Intervention||18
10860377|NCT00834431|12025717|FG001|COMPLETED|Second Intervention||16
10860378|NCT00834431|12025716|FG000|NOT COMPLETED|Second Intervention||0
10860379|NCT00834431|12025717|FG001|NOT COMPLETED|Second Intervention||0
10860380|NCT00834418|12025723|FG000|STARTED|Overall Study||42
10860381|NCT00834418|12025724|FG001|STARTED|Overall Study||42
10860382|NCT00834418|12025723|FG000|COMPLETED|Overall Study||42
10860383|NCT00834418|12025724|FG001|COMPLETED|Overall Study||40
10860384|NCT00834418|12025723|FG000|NOT COMPLETED|Overall Study||0
10860385|NCT00834418|12025724|FG001|NOT COMPLETED|Overall Study||2
10860386|NCT00834405|12025730|FG000|STARTED|Overall Study||20
10860387|NCT00834405|12025731|FG001|STARTED|Overall Study||17
10860388|NCT00834405|12025730|FG000|COMPLETED|Overall Study||20
10860389|NCT00834405|12025731|FG001|COMPLETED|Overall Study||17
10860390|NCT00834405|12025730|FG000|NOT COMPLETED|Overall Study||0
10860391|NCT00834405|12025731|FG001|NOT COMPLETED|Overall Study||0
10860392|NCT00834340|12025737|FG000|STARTED|First Intervention||16
10860393|NCT00834340|12025738|FG001|STARTED|First Intervention||16
10860394|NCT00834340|12025737|FG000|COMPLETED|First Intervention||16
10860395|NCT00834340|12025738|FG001|COMPLETED|First Intervention||16
10860396|NCT00834340|12025737|FG000|NOT COMPLETED|First Intervention||0
10860397|NCT00834340|12025738|FG001|NOT COMPLETED|First Intervention||0
10860398|NCT00834340|12025737|FG000|STARTED|Washout||16
10860399|NCT00834340|12025738|FG001|STARTED|Washout||16
10860400|NCT00834340|12025737|FG000|COMPLETED|Washout||14
10860401|NCT00834340|12025738|FG001|COMPLETED|Washout||16
10860402|NCT00834340|12025737|FG000|NOT COMPLETED|Washout||2
10860403|NCT00834340|12025738|FG001|NOT COMPLETED|Washout||0
10860404|NCT00834340|12025737|FG000|STARTED|Second Intervention||14
10860405|NCT00834340|12025738|FG001|STARTED|Second Intervention||16
10860406|NCT00834340|12025737|FG000|COMPLETED|Second Intervention||14
10860407|NCT00834340|12025738|FG001|COMPLETED|Second Intervention||16
10860408|NCT00834340|12025737|FG000|NOT COMPLETED|Second Intervention||0
10860409|NCT00834340|12025738|FG001|NOT COMPLETED|Second Intervention||0
10860410|NCT00834275|12025744|FG000|STARTED|First Intervention||13
10860411|NCT00834275|12025745|FG001|STARTED|First Intervention||13
10860412|NCT00834275|12025744|FG000|COMPLETED|First Intervention||13
10860413|NCT00834275|12025745|FG001|COMPLETED|First Intervention||13
10860414|NCT00834275|12025744|FG000|NOT COMPLETED|First Intervention||0
10860415|NCT00834275|12025745|FG001|NOT COMPLETED|First Intervention||0
10860416|NCT00834275|12025744|FG000|STARTED|Washout of 7 Days||13
10860417|NCT00834275|12025745|FG001|STARTED|Washout of 7 Days||13
10860418|NCT00834275|12025744|FG000|COMPLETED|Washout of 7 Days||13
10860419|NCT00834275|12025745|FG001|COMPLETED|Washout of 7 Days||13
10860420|NCT00834275|12025744|FG000|NOT COMPLETED|Washout of 7 Days||0
10860421|NCT00834275|12025745|FG001|NOT COMPLETED|Washout of 7 Days||0
10860422|NCT00834275|12025744|FG000|STARTED|Second Intervention||13
10860423|NCT00834275|12025745|FG001|STARTED|Second Intervention||13
10860424|NCT00834275|12025744|FG000|COMPLETED|Second Intervention||13
10860425|NCT00834275|12025745|FG001|COMPLETED|Second Intervention||13
10860426|NCT00834275|12025744|FG000|NOT COMPLETED|Second Intervention||0
10860427|NCT00834275|12025745|FG001|NOT COMPLETED|Second Intervention||0
10860428|NCT00834249|12025751|FG000|STARTED|First Intervention||9
10860429|NCT00834249|12025752|FG001|STARTED|First Intervention||9
10860430|NCT00834249|12025751|FG000|COMPLETED|First Intervention||9
10860431|NCT00834249|12025752|FG001|COMPLETED|First Intervention||9
10860432|NCT00834249|12025751|FG000|NOT COMPLETED|First Intervention||0
10860433|NCT00834249|12025752|FG001|NOT COMPLETED|First Intervention||0
10860434|NCT00834249|12025751|FG000|STARTED|Washout: 7 Days||9
10860435|NCT00834249|12025752|FG001|STARTED|Washout: 7 Days||9
10860436|NCT00834249|12025751|FG000|COMPLETED|Washout: 7 Days||8
10860437|NCT00834249|12025752|FG001|COMPLETED|Washout: 7 Days||8
10860438|NCT00834249|12025751|FG000|NOT COMPLETED|Washout: 7 Days||1
10860439|NCT00834249|12025752|FG001|NOT COMPLETED|Washout: 7 Days||1
10860440|NCT00834249|12025751|FG000|STARTED|Second Intervention||8
10860441|NCT00834249|12025752|FG001|STARTED|Second Intervention||8
10860442|NCT00834249|12025751|FG000|COMPLETED|Second Intervention||7
10860443|NCT00834249|12025752|FG001|COMPLETED|Second Intervention||8
10860444|NCT00834249|12025751|FG000|NOT COMPLETED|Second Intervention||1
10860445|NCT00834249|12025752|FG001|NOT COMPLETED|Second Intervention||0
10860446|NCT00834197|12025758|FG000|STARTED|First Intervention||16
10860447|NCT00834197|12025759|FG001|STARTED|First Intervention||16
10860448|NCT00834197|12025758|FG000|COMPLETED|First Intervention||16
10860449|NCT00834197|12025759|FG001|COMPLETED|First Intervention||16
10860450|NCT00834197|12025758|FG000|NOT COMPLETED|First Intervention||0
10860451|NCT00834197|12025759|FG001|NOT COMPLETED|First Intervention||0
10860452|NCT00834197|12025758|FG000|STARTED|Washout of 14 Days||16
10860453|NCT00834197|12025759|FG001|STARTED|Washout of 14 Days||16
10860454|NCT00834197|12025758|FG000|COMPLETED|Washout of 14 Days||16
10860455|NCT00834197|12025759|FG001|COMPLETED|Washout of 14 Days||16
10860456|NCT00834197|12025758|FG000|NOT COMPLETED|Washout of 14 Days||0
10860457|NCT00834197|12025759|FG001|NOT COMPLETED|Washout of 14 Days||0
10860458|NCT00834197|12025758|FG000|STARTED|Second Intervention||16
10860459|NCT00834197|12025759|FG001|STARTED|Second Intervention||16
10860460|NCT00834197|12025758|FG000|COMPLETED|Second Intervention||16
10860461|NCT00834197|12025759|FG001|COMPLETED|Second Intervention||16
10860462|NCT00834197|12025758|FG000|NOT COMPLETED|Second Intervention||0
10860463|NCT00834197|12025759|FG001|NOT COMPLETED|Second Intervention||0
10860464|NCT00834132|12025765|FG000|STARTED|First Intervention||12
10860465|NCT00834132|12025766|FG001|STARTED|First Intervention||12
10860466|NCT00834132|12025765|FG000|COMPLETED|First Intervention||12
10860467|NCT00834132|12025766|FG001|COMPLETED|First Intervention||12
10860468|NCT00834132|12025765|FG000|NOT COMPLETED|First Intervention||0
10860469|NCT00834132|12025766|FG001|NOT COMPLETED|First Intervention||0
10860470|NCT00834132|12025765|FG000|STARTED|Washout: 21 Days||12
10860471|NCT00834132|12025766|FG001|STARTED|Washout: 21 Days||12
10860472|NCT00834132|12025765|FG000|COMPLETED|Washout: 21 Days||12
10860473|NCT00834132|12025766|FG001|COMPLETED|Washout: 21 Days||12
10860474|NCT00834132|12025765|FG000|NOT COMPLETED|Washout: 21 Days||0
10860475|NCT00834132|12025766|FG001|NOT COMPLETED|Washout: 21 Days||0
10860476|NCT00834132|12025765|FG000|STARTED|Second Intervention||12
10860477|NCT00834132|12025766|FG001|STARTED|Second Intervention||12
10860478|NCT00834132|12025765|FG000|COMPLETED|Second Intervention||12
10860479|NCT00834132|12025766|FG001|COMPLETED|Second Intervention||12
10860480|NCT00834132|12025765|FG000|NOT COMPLETED|Second Intervention||0
10860481|NCT00834132|12025766|FG001|NOT COMPLETED|Second Intervention||0
10860482|NCT00834067|12025772|FG000|STARTED|First Intervention||30
10860483|NCT00834067|12025773|FG001|STARTED|First Intervention||30
10860484|NCT00834067|12025772|FG000|COMPLETED|First Intervention||30
10860485|NCT00834067|12025773|FG001|COMPLETED|First Intervention||30
10860486|NCT00834067|12025772|FG000|NOT COMPLETED|First Intervention||0
10860487|NCT00834067|12025773|FG001|NOT COMPLETED|First Intervention||0
10860488|NCT00834067|12025772|FG000|STARTED|Washout of 21 Days||30
10860489|NCT00834067|12025773|FG001|STARTED|Washout of 21 Days||30
10860490|NCT00834067|12025772|FG000|COMPLETED|Washout of 21 Days||30
10860491|NCT00834067|12025773|FG001|COMPLETED|Washout of 21 Days||29
10860492|NCT00834067|12025772|FG000|NOT COMPLETED|Washout of 21 Days||0
10860493|NCT00834067|12025773|FG001|NOT COMPLETED|Washout of 21 Days||1
10860494|NCT00834067|12025772|FG000|STARTED|Second Intervention||30
10860495|NCT00834067|12025773|FG001|STARTED|Second Intervention||29
10860496|NCT00834067|12025772|FG000|COMPLETED|Second Intervention||30
10860497|NCT00834067|12025773|FG001|COMPLETED|Second Intervention||29
10860498|NCT00834067|12025772|FG000|NOT COMPLETED|Second Intervention||0
10860499|NCT00834067|12025773|FG001|NOT COMPLETED|Second Intervention||0
10860500|NCT00833937|12025779|FG000|STARTED|First Intervention||12
10860501|NCT00833937|12025780|FG001|STARTED|First Intervention||12
10860502|NCT00833937|12025779|FG000|COMPLETED|First Intervention||12
10860503|NCT00833937|12025780|FG001|COMPLETED|First Intervention||12
10860504|NCT00833937|12025779|FG000|NOT COMPLETED|First Intervention||0
10860505|NCT00833937|12025780|FG001|NOT COMPLETED|First Intervention||0
10860506|NCT00833937|12025779|FG000|STARTED|Washout||12
10860507|NCT00833937|12025780|FG001|STARTED|Washout||12
10860508|NCT00833937|12025779|FG000|COMPLETED|Washout||11
10860509|NCT00833937|12025780|FG001|COMPLETED|Washout||12
10860510|NCT00833937|12025779|FG000|NOT COMPLETED|Washout||1
10860511|NCT00833937|12025780|FG001|NOT COMPLETED|Washout||0
10860512|NCT00833937|12025779|FG000|STARTED|Second Intervention||11
10860513|NCT00833937|12025780|FG001|STARTED|Second Intervention||12
10860514|NCT00833937|12025779|FG000|COMPLETED|Second Intervention||11
10860515|NCT00833937|12025780|FG001|COMPLETED|Second Intervention||12
10860516|NCT00833937|12025779|FG000|NOT COMPLETED|Second Intervention||0
10860517|NCT00833937|12025780|FG001|NOT COMPLETED|Second Intervention||0
10860518|NCT00833664|12025786|FG000|STARTED|First Intervention||11
10860519|NCT00833664|12025787|FG001|STARTED|First Intervention||11
10860520|NCT00833664|12025786|FG000|COMPLETED|First Intervention||11
10860521|NCT00833664|12025787|FG001|COMPLETED|First Intervention||11
10860522|NCT00833664|12025786|FG000|NOT COMPLETED|First Intervention||0
10860523|NCT00833664|12025787|FG001|NOT COMPLETED|First Intervention||0
10860524|NCT00833664|12025786|FG000|STARTED|Washout: 14 Days||11
10860525|NCT00833664|12025787|FG001|STARTED|Washout: 14 Days||11
10860526|NCT00833664|12025786|FG000|COMPLETED|Washout: 14 Days||10
10860527|NCT00833664|12025787|FG001|COMPLETED|Washout: 14 Days||11
10860528|NCT00833664|12025786|FG000|NOT COMPLETED|Washout: 14 Days||1
10860529|NCT00833664|12025787|FG001|NOT COMPLETED|Washout: 14 Days||0
10860530|NCT00833664|12025786|FG000|STARTED|Second Intervention||10
10860531|NCT00833664|12025787|FG001|STARTED|Second Intervention||11
10860532|NCT00833664|12025786|FG000|COMPLETED|Second Intervention||10
10860533|NCT00833664|12025787|FG001|COMPLETED|Second Intervention||11
10860534|NCT00833664|12025786|FG000|NOT COMPLETED|Second Intervention||0
10860535|NCT00833664|12025787|FG001|NOT COMPLETED|Second Intervention||0
10860536|NCT00833586|12025793|FG000|STARTED|First Intervention||14
10860537|NCT00833586|12025794|FG001|STARTED|First Intervention||14
10860538|NCT00833586|12025793|FG000|COMPLETED|First Intervention||14
10860539|NCT00833586|12025794|FG001|COMPLETED|First Intervention||14
10860540|NCT00833586|12025793|FG000|NOT COMPLETED|First Intervention||0
10860541|NCT00833586|12025794|FG001|NOT COMPLETED|First Intervention||0
10860542|NCT00833586|12025793|FG000|STARTED|Washout: 14 Days||14
10860543|NCT00833586|12025794|FG001|STARTED|Washout: 14 Days||14
10860544|NCT00833586|12025793|FG000|COMPLETED|Washout: 14 Days||14
10860545|NCT00833586|12025794|FG001|COMPLETED|Washout: 14 Days||14
10860546|NCT00833586|12025793|FG000|NOT COMPLETED|Washout: 14 Days||0
10860547|NCT00833586|12025794|FG001|NOT COMPLETED|Washout: 14 Days||0
10860548|NCT00833586|12025793|FG000|STARTED|Second Intervention||14
10755255|NCT03063255|11919056|FG001|NOT COMPLETED|Overall Study||0
10860549|NCT00833586|12025794|FG001|STARTED|Second Intervention||14
10860550|NCT00833586|12025793|FG000|COMPLETED|Second Intervention||14
10860551|NCT00833586|12025794|FG001|COMPLETED|Second Intervention||14
10860552|NCT00833586|12025793|FG000|NOT COMPLETED|Second Intervention||0
10860553|NCT00833586|12025794|FG001|NOT COMPLETED|Second Intervention||0
10860554|NCT00833521|12025800|FG000|STARTED|First Intervention||19
10860555|NCT00833521|12025801|FG001|STARTED|First Intervention||19
10860556|NCT00833521|12025800|FG000|COMPLETED|First Intervention||19
10860557|NCT00833521|12025801|FG001|COMPLETED|First Intervention||19
10860558|NCT00833521|12025800|FG000|NOT COMPLETED|First Intervention||0
10860559|NCT00833521|12025801|FG001|NOT COMPLETED|First Intervention||0
10860560|NCT00833521|12025800|FG000|STARTED|Second Intervention||19
10860561|NCT00833521|12025801|FG001|STARTED|Second Intervention||19
10860562|NCT00833521|12025800|FG000|COMPLETED|Second Intervention||19
10860563|NCT00833521|12025801|FG001|COMPLETED|Second Intervention||19
10860564|NCT00833521|12025800|FG000|NOT COMPLETED|Second Intervention||0
10860565|NCT00833521|12025801|FG001|NOT COMPLETED|Second Intervention||0
10860566|NCT00830336|12025807|FG000|STARTED|First Intervention||40
10860567|NCT00830336|12025808|FG001|STARTED|First Intervention||40
10860568|NCT00830336|12025807|FG000|COMPLETED|First Intervention||40
10860569|NCT00830336|12025808|FG001|COMPLETED|First Intervention||40
10860570|NCT00830336|12025807|FG000|NOT COMPLETED|First Intervention||0
10860571|NCT00830336|12025808|FG001|NOT COMPLETED|First Intervention||0
10860572|NCT00830336|12025807|FG000|STARTED|Washout: 21 Days||40
10860573|NCT00830336|12025808|FG001|STARTED|Washout: 21 Days||40
10860574|NCT00830336|12025807|FG000|COMPLETED|Washout: 21 Days||39
10860575|NCT00830336|12025808|FG001|COMPLETED|Washout: 21 Days||40
10860576|NCT00830336|12025807|FG000|NOT COMPLETED|Washout: 21 Days||1
10860577|NCT00830336|12025808|FG001|NOT COMPLETED|Washout: 21 Days||0
10860578|NCT00830336|12025807|FG000|STARTED|Second Intervention||39
10860579|NCT00830336|12025808|FG001|STARTED|Second Intervention||40
10860580|NCT00830336|12025807|FG000|COMPLETED|Second Intervention||39
10860581|NCT00830336|12025808|FG001|COMPLETED|Second Intervention||40
10860582|NCT00830336|12025807|FG000|NOT COMPLETED|Second Intervention||0
10860583|NCT00830336|12025808|FG001|NOT COMPLETED|Second Intervention||0
10860584|NCT00830258|12025814|FG000|STARTED|First Intervention||30
10860585|NCT00830258|12025815|FG001|STARTED|First Intervention||30
10860586|NCT00830258|12025814|FG000|COMPLETED|First Intervention||29
10860587|NCT00830258|12025815|FG001|COMPLETED|First Intervention||30
10860588|NCT00830258|12025814|FG000|NOT COMPLETED|First Intervention||1
10860589|NCT00830258|12025815|FG001|NOT COMPLETED|First Intervention||0
10860590|NCT00830258|12025814|FG000|STARTED|Washout: 7 Days||29
10860591|NCT00830258|12025815|FG001|STARTED|Washout: 7 Days||30
10860592|NCT00830258|12025814|FG000|COMPLETED|Washout: 7 Days||28
10860593|NCT00830258|12025815|FG001|COMPLETED|Washout: 7 Days||30
10860594|NCT00830258|12025814|FG000|NOT COMPLETED|Washout: 7 Days||1
10860595|NCT00830258|12025815|FG001|NOT COMPLETED|Washout: 7 Days||0
10860596|NCT00830258|12025814|FG000|STARTED|Second Intervention||28
10860597|NCT00830258|12025815|FG001|STARTED|Second Intervention||30
10860598|NCT00830258|12025814|FG000|COMPLETED|Second Intervention||28
10860599|NCT00830258|12025815|FG001|COMPLETED|Second Intervention||30
10860600|NCT00830258|12025814|FG000|NOT COMPLETED|Second Intervention||0
10860601|NCT00830258|12025815|FG001|NOT COMPLETED|Second Intervention||0
10755256|NCT03063294|11919064|FG000|STARTED|Overall Study|2463 equals the sum of 1241 cross-sectional survey respondents at baseline and 1222 at follow-up.|2463
10755257|NCT03063294|11919065|FG001|STARTED|Overall Study|2502 equals the sum of 1243 cross-sectional survey respondents at baseline and 1259 at follow-up.|2502
10755258|NCT03063294|11919064|FG000|COMPLETED|Overall Study|2463 equals the sum of 1241 cross-sectional survey respondents at baseline and 1222 at follow-up.|2463
10755259|NCT03063294|11919065|FG001|COMPLETED|Overall Study|2502 equals the sum of 1243 cross-sectional survey respondents at baseline and 1259 at follow-up.|2502
10755260|NCT03063294|11919064|FG000|NOT COMPLETED|Overall Study||0
10755261|NCT03063294|11919065|FG001|NOT COMPLETED|Overall Study||0
10755262|NCT03063385|11919073|FG000|STARTED|Overall Study||330
10755263|NCT03063385|11919074|FG001|STARTED|Overall Study||330
10755264|NCT03063385|11919073|FG000|3-month Follow-up|Overall Study||257
10755265|NCT03063385|11919074|FG001|3-month Follow-up|Overall Study||259
10755266|NCT03063385|11919073|FG000|6-month Follow-up|Overall Study||265
10755267|NCT03063385|11919074|FG001|6-month Follow-up|Overall Study||259
10755268|NCT03063385|11919073|FG000|12-month Follow-up|Overall Study||243
10755269|NCT03063385|11919074|FG001|12-month Follow-up|Overall Study||254
10860602|NCT00830219|12025821|FG000|STARTED|First Intervention||23
10860603|NCT00830219|12025822|FG001|STARTED|First Intervention||23
10860604|NCT00830219|12025821|FG000|COMPLETED|First Intervention||23
10860605|NCT00830219|12025822|FG001|COMPLETED|First Intervention||23
10860606|NCT00830219|12025821|FG000|NOT COMPLETED|First Intervention||0
10860607|NCT00830219|12025822|FG001|NOT COMPLETED|First Intervention||0
10860608|NCT00830219|12025821|FG000|STARTED|Washout of 7 Days||23
10860609|NCT00830219|12025822|FG001|STARTED|Washout of 7 Days||23
10860610|NCT00830219|12025821|FG000|COMPLETED|Washout of 7 Days||22
10860611|NCT00830219|12025822|FG001|COMPLETED|Washout of 7 Days||22
10860612|NCT00830219|12025821|FG000|NOT COMPLETED|Washout of 7 Days||1
10860613|NCT00830219|12025822|FG001|NOT COMPLETED|Washout of 7 Days||1
10860614|NCT00830219|12025821|FG000|STARTED|Second Intervention||22
10860615|NCT00830219|12025822|FG001|STARTED|Second Intervention||22
10860616|NCT00830219|12025821|FG000|COMPLETED|Second Intervention||22
10755270|NCT03063385|11919073|FG000|COMPLETED|Overall Study||243
10755271|NCT03063385|11919074|FG001|COMPLETED|Overall Study||254
10860617|NCT00830219|12025822|FG001|COMPLETED|Second Intervention||22
10860618|NCT00830219|12025821|FG000|NOT COMPLETED|Second Intervention||0
10860619|NCT00830219|12025822|FG001|NOT COMPLETED|Second Intervention||0
10860620|NCT00830206|12025828|FG000|STARTED|First Intervention||40
10860621|NCT00830206|12025829|FG001|STARTED|First Intervention||40
10860622|NCT00830206|12025828|FG000|COMPLETED|First Intervention||40
10860623|NCT00830206|12025829|FG001|COMPLETED|First Intervention||40
10860624|NCT00830206|12025828|FG000|NOT COMPLETED|First Intervention||0
10860625|NCT00830206|12025829|FG001|NOT COMPLETED|First Intervention||0
10860626|NCT00830206|12025828|FG000|STARTED|Washout: 21 Days||40
10416225|NCT00792636|11560615|FG002|COMPLETED|Overall Study||55
10416226|NCT00792636|11560613|FG000|NOT COMPLETED|Overall Study||68
10416227|NCT00792636|11560614|FG001|NOT COMPLETED|Overall Study||81
10416228|NCT00792636|11560615|FG002|NOT COMPLETED|Overall Study||81
10416229|NCT00792688|11560628|FG000|STARTED|Overall Study||9
10416230|NCT00792688|11560629|FG001|STARTED|Overall Study||8
10416231|NCT00792688|11560630|FG002|STARTED|Overall Study||9
10416232|NCT00792688|11560628|FG000|COMPLETED|Overall Study||9
10416233|NCT00792688|11560629|FG001|COMPLETED|Overall Study||8
10416234|NCT00792688|11560630|FG002|COMPLETED|Overall Study||9
10416235|NCT00792688|11560628|FG000|NOT COMPLETED|Overall Study||0
10416236|NCT00792688|11560629|FG001|NOT COMPLETED|Overall Study||0
10416237|NCT00792688|11560630|FG002|NOT COMPLETED|Overall Study||0
10416238|NCT00792701|11560640|FG000|STARTED|Overall Study||19
10416239|NCT00792701|11560641|FG001|STARTED|Overall Study||66
10416240|NCT00792701|11560640|FG000|Eligible|Overall Study||18
10416241|NCT00792701|11560641|FG001|Eligible|Overall Study||63
10416242|NCT00792701|11560640|FG000|Eligible and Analyzable|Overall Study||17
10416243|NCT00792701|11560641|FG001|Eligible and Analyzable|Overall Study||44
10416244|NCT00792701|11560640|FG000|COMPLETED|Overall Study||0
10416245|NCT00792701|11560641|FG001|COMPLETED|Overall Study||22
10416246|NCT00792701|11560640|FG000|NOT COMPLETED|Overall Study||19
10416247|NCT00792701|11560641|FG001|NOT COMPLETED|Overall Study||44
10416248|NCT00792805|11560652|FG000|STARTED|Overall Study||188
10416249|NCT00792805|11560653|FG001|STARTED|Overall Study||188
10416250|NCT00792805|11560654|FG002|STARTED|Overall Study||187
10416251|NCT00792805|11560652|FG000|Exposed to Study Medication or Placebo|Overall Study|One patient in this group did not receive any study treatment.|187
10416252|NCT00792805|11560653|FG001|Exposed to Study Medication or Placebo|Overall Study||188
10293645|NCT05017493|11426245|FG000|NOT COMPLETED|Overall Study||122
10416253|NCT00792805|11560654|FG002|Exposed to Study Medication or Placebo|Overall Study|One patient in this group did not receive any study treatment.|186
10416254|NCT00792805|11560652|FG000|COMPLETED|Overall Study||166
10416255|NCT00792805|11560653|FG001|COMPLETED|Overall Study||162
10416256|NCT00792805|11560654|FG002|COMPLETED|Overall Study||154
10416257|NCT00792805|11560652|FG000|NOT COMPLETED|Overall Study||22
10416258|NCT00792805|11560653|FG001|NOT COMPLETED|Overall Study||26
10416259|NCT00792805|11560654|FG002|NOT COMPLETED|Overall Study||33
10416260|NCT00792909|11560665|FG000|STARTED|Overall Study||51
10416261|NCT00792909|11560666|FG001|STARTED|Overall Study||59
10416262|NCT00792909|11560667|FG002|STARTED|Overall Study||62
10416263|NCT00792909|11560665|FG000|COMPLETED|Overall Study||51
10416264|NCT00792909|11560666|FG001|COMPLETED|Overall Study||58
10416265|NCT00792909|11560667|FG002|COMPLETED|Overall Study||62
10416266|NCT00792909|11560665|FG000|NOT COMPLETED|Overall Study||0
10416267|NCT00792909|11560666|FG001|NOT COMPLETED|Overall Study||1
10416268|NCT00792909|11560667|FG002|NOT COMPLETED|Overall Study||0
10416269|NCT00792922|11560682|FG000|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|
10416270|NCT00792922|11560683|FG001|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|
10416271|NCT00792922|11560684|FG002|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|
10416272|NCT00792922|11560685|FG003|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|
10416273|NCT00792922|11560682|FG000|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|
10416274|NCT00792922|11560683|FG001|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|
10416275|NCT00792922|11560684|FG002|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|
10416276|NCT00792922|11560685|FG003|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|
10545740|NCT01499667|11699238|FG002|STARTED|Overall Study||50
10860627|NCT00830206|12025829|FG001|STARTED|Washout: 21 Days||40
10860628|NCT00830206|12025828|FG000|COMPLETED|Washout: 21 Days||39
10860629|NCT00830206|12025829|FG001|COMPLETED|Washout: 21 Days||39
10860630|NCT00830206|12025828|FG000|NOT COMPLETED|Washout: 21 Days||1
10860631|NCT00830206|12025829|FG001|NOT COMPLETED|Washout: 21 Days||1
10860632|NCT00830206|12025828|FG000|STARTED|Second Intervention||39
10416277|NCT00792922|11560682|FG000|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|
10416278|NCT00792922|11560683|FG001|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|
10416279|NCT00792922|11560684|FG002|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|
10416280|NCT00792922|11560685|FG003|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|
10416281|NCT00792922|11560682|FG000|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|
10416282|NCT00792922|11560683|FG001|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|
10416283|NCT00792922|11560684|FG002|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|
10416284|NCT00792922|11560685|FG003|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|
10860633|NCT00830206|12025829|FG001|STARTED|Second Intervention||39
10860634|NCT00830206|12025828|FG000|COMPLETED|Second Intervention||39
10860635|NCT00830206|12025829|FG001|COMPLETED|Second Intervention||39
10860636|NCT00830206|12025828|FG000|NOT COMPLETED|Second Intervention||0
10860637|NCT00830206|12025829|FG001|NOT COMPLETED|Second Intervention||0
10860638|NCT00830024|12025835|FG000|STARTED|First Intervention||18
10860639|NCT00830024|12025836|FG001|STARTED|First Intervention||18
10860640|NCT00830024|12025835|FG000|COMPLETED|First Intervention||18
10860641|NCT00830024|12025836|FG001|COMPLETED|First Intervention||18
10860642|NCT00830024|12025835|FG000|NOT COMPLETED|First Intervention||0
10860643|NCT00830024|12025836|FG001|NOT COMPLETED|First Intervention||0
10860644|NCT00830024|12025835|FG000|STARTED|Washout: 7 Days||18
10860645|NCT00830024|12025836|FG001|STARTED|Washout: 7 Days||18
10860646|NCT00830024|12025835|FG000|COMPLETED|Washout: 7 Days||17
10860647|NCT00830024|12025836|FG001|COMPLETED|Washout: 7 Days||18
10860648|NCT00830024|12025835|FG000|NOT COMPLETED|Washout: 7 Days||1
10860649|NCT00830024|12025836|FG001|NOT COMPLETED|Washout: 7 Days||0
10860650|NCT00830024|12025835|FG000|STARTED|Second Intervention||17
10860651|NCT00830024|12025836|FG001|STARTED|Second Intervention||18
10860652|NCT00830024|12025835|FG000|COMPLETED|Second Intervention||17
10860653|NCT00830024|12025836|FG001|COMPLETED|Second Intervention||18
10860654|NCT00830024|12025835|FG000|NOT COMPLETED|Second Intervention||0
10860655|NCT00830024|12025836|FG001|NOT COMPLETED|Second Intervention||0
10860656|NCT00829998|12025842|FG000|STARTED|First Intervention||21
10860657|NCT00829998|12025843|FG001|STARTED|First Intervention||20
10860658|NCT00829998|12025842|FG000|COMPLETED|First Intervention||21
10293632|NCT03727373|11426239|FG000|STARTED|Overall Study||8
10293633|NCT03727373|11426239|FG000|COMPLETED|Overall Study||8
10293634|NCT03727373|11426239|FG000|NOT COMPLETED|Overall Study||0
10293635|NCT05017493|11426245|FG000|STARTED|Overall Study||483
10293636|NCT05017493|11426246|FG001|STARTED|Overall Study||178
10293637|NCT05017493|11426245|FG000|Treatment & Care|Overall Study||483
10293638|NCT05017493|11426246|FG001|Treatment & Care|Overall Study||178
10293639|NCT05017493|11426245|FG000|Follow up|Overall Study||483
10293640|NCT05017493|11426246|FG001|Follow up|Overall Study||178
10293641|NCT05017493|11426245|FG000|Mortality Check|Overall Study||483
10293642|NCT05017493|11426246|FG001|Mortality Check|Overall Study||178
10293643|NCT05017493|11426245|FG000|COMPLETED|Overall Study||361
10293644|NCT05017493|11426246|FG001|COMPLETED|Overall Study||178
10293646|NCT05017493|11426246|FG001|NOT COMPLETED|Overall Study||0
10293647|NCT04870138|11426255|FG000|STARTED|Overall Study||5
10293648|NCT04870138|11426256|FG001|STARTED|Overall Study||5
10293649|NCT04870138|11426257|FG002|STARTED|Overall Study||6
10293650|NCT04870138|11426255|FG000|COMPLETED|Overall Study||5
10293651|NCT04870138|11426256|FG001|COMPLETED|Overall Study||5
10293652|NCT04870138|11426257|FG002|COMPLETED|Overall Study||6
10293653|NCT04870138|11426255|FG000|NOT COMPLETED|Overall Study||0
10293654|NCT04870138|11426256|FG001|NOT COMPLETED|Overall Study||0
10293655|NCT04870138|11426257|FG002|NOT COMPLETED|Overall Study||0
10293656|NCT04374149|11426270|FG000|STARTED|Overall Study||10
10293657|NCT04374149|11426271|FG001|STARTED|Overall Study||10
10416285|NCT00792922|11560682|FG000|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|
10416286|NCT00792922|11560683|FG001|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|
10416287|NCT00792922|11560684|FG002|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|
10416288|NCT00792922|11560685|FG003|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|
10416289|NCT00792922|11560682|FG000|NOT COMPLETED|At Baseline||
10416290|NCT00792922|11560683|FG001|NOT COMPLETED|At Baseline||
10416291|NCT00792922|11560684|FG002|NOT COMPLETED|At Baseline||
10416292|NCT00792922|11560685|FG003|NOT COMPLETED|At Baseline||
10416293|NCT00792922|11560682|FG000|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|
10416294|NCT00792922|11560683|FG001|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|
10416295|NCT00792922|11560684|FG002|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|
10416296|NCT00792922|11560685|FG003|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|
10416297|NCT00792922|11560682|FG000|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|
10416298|NCT00792922|11560683|FG001|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|
10416299|NCT00792922|11560684|FG002|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|
10416300|NCT00792922|11560685|FG003|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|
10416301|NCT00792922|11560682|FG000|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|
10429351|NCT00863057|11575336|FG002|COMPLETED|Period 4 (Weeks 16-20)||2
10860659|NCT00829998|12025843|FG001|COMPLETED|First Intervention||20
10860660|NCT00829998|12025842|FG000|NOT COMPLETED|First Intervention||0
10860661|NCT00829998|12025843|FG001|NOT COMPLETED|First Intervention||0
10860662|NCT00829998|12025842|FG000|STARTED|Washout||21
10860663|NCT00829998|12025843|FG001|STARTED|Washout||20
10293658|NCT04374149|11426270|FG000|COMPLETED|Overall Study||10
10860664|NCT00829998|12025842|FG000|COMPLETED|Washout||21
10860665|NCT00829998|12025843|FG001|COMPLETED|Washout||19
10860666|NCT00829998|12025842|FG000|NOT COMPLETED|Washout||0
10860667|NCT00829998|12025843|FG001|NOT COMPLETED|Washout||1
10860668|NCT00829998|12025842|FG000|STARTED|Second Intervention||21
10860669|NCT00829998|12025843|FG001|STARTED|Second Intervention||19
10860670|NCT00829998|12025842|FG000|COMPLETED|Second Intervention||21
10860671|NCT00829998|12025843|FG001|COMPLETED|Second Intervention||19
10860672|NCT00829998|12025842|FG000|NOT COMPLETED|Second Intervention||0
10860673|NCT00829998|12025843|FG001|NOT COMPLETED|Second Intervention||0
10860674|NCT00829868|12025849|FG000|STARTED|First Intervention||21
10860675|NCT00829868|12025850|FG001|STARTED|First Intervention||21
10860676|NCT00829868|12025849|FG000|COMPLETED|First Intervention||21
10860677|NCT00829868|12025850|FG001|COMPLETED|First Intervention||21
10860678|NCT00829868|12025849|FG000|NOT COMPLETED|First Intervention||0
10293659|NCT04374149|11426271|FG001|COMPLETED|Overall Study||10
10416302|NCT00792922|11560683|FG001|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|
10416303|NCT00792922|11560684|FG002|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|
10416304|NCT00792922|11560685|FG003|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|
10416305|NCT00792922|11560682|FG000|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|
10416306|NCT00792922|11560683|FG001|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|
10416307|NCT00792922|11560684|FG002|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|
10416308|NCT00792922|11560685|FG003|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|
10416309|NCT00792922|11560682|FG000|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|
10416310|NCT00792922|11560683|FG001|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|
10416311|NCT00792922|11560684|FG002|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|
10416312|NCT00792922|11560685|FG003|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|
10416313|NCT00792922|11560682|FG000|NOT COMPLETED|At 3 Years||
10416314|NCT00792922|11560683|FG001|NOT COMPLETED|At 3 Years||
10416315|NCT00792922|11560684|FG002|NOT COMPLETED|At 3 Years||
10416316|NCT00792922|11560685|FG003|NOT COMPLETED|At 3 Years||
10416317|NCT00792935|11560699|FG000|STARTED|Overall Study||72
10416318|NCT00792935|11560700|FG001|STARTED|Overall Study||71
10416319|NCT00792935|11560699|FG000|COMPLETED|Overall Study||68
10416320|NCT00792935|11560700|FG001|COMPLETED|Overall Study||68
10416321|NCT00792935|11560699|FG000|NOT COMPLETED|Overall Study||4
10416322|NCT00792935|11560700|FG001|NOT COMPLETED|Overall Study||3
10416323|NCT00793104|11560706|FG000|STARTED|Overall Study||10
10416324|NCT00793104|11560706|FG000|COMPLETED|Overall Study||9
10416325|NCT00793104|11560706|FG000|NOT COMPLETED|Overall Study||1
10416326|NCT00793182|11560712|FG000|STARTED|Overall Study||2
10416327|NCT00793182|11560713|FG001|STARTED|Overall Study||4
10416328|NCT00793182|11560712|FG000|COMPLETED|Overall Study||2
10416329|NCT00793182|11560713|FG001|COMPLETED|Overall Study||3
10416330|NCT00793182|11560712|FG000|NOT COMPLETED|Overall Study||0
10416331|NCT00793182|11560713|FG001|NOT COMPLETED|Overall Study||1
10416332|NCT00793325|11560719|FG000|STARTED|Overall Study||909
10416333|NCT00793325|11560719|FG000|COMPLETED|Overall Study||890
10416334|NCT00793325|11560719|FG000|NOT COMPLETED|Overall Study||19
10416335|NCT00793403|11560742|FG000|STARTED|Overall Study||293
10416336|NCT00793403|11560742|FG000|COMPLETED|Overall Study||220
10416337|NCT00793403|11560742|FG000|NOT COMPLETED|Overall Study||73
10416338|NCT00793455|11560748|FG000|STARTED|Overall Study||314
10416339|NCT00793455|11560749|FG001|STARTED|Overall Study||314
10416340|NCT00793455|11560748|FG000|COMPLETED|Overall Study||314
10416341|NCT00793455|11560749|FG001|COMPLETED|Overall Study||314
10416342|NCT00793455|11560748|FG000|NOT COMPLETED|Overall Study||0
10416343|NCT00793455|11560749|FG001|NOT COMPLETED|Overall Study||0
10416344|NCT00793546|11560758|FG000|STARTED|Overall Study||14
10416345|NCT00793546|11560759|FG001|STARTED|Overall Study||28
10416346|NCT00793546|11560758|FG000|COMPLETED|Overall Study||0
10416347|NCT00793546|11560759|FG001|COMPLETED|Overall Study||0
10416348|NCT00793546|11560758|FG000|NOT COMPLETED|Overall Study||14
10416349|NCT00793546|11560759|FG001|NOT COMPLETED|Overall Study||28
10416350|NCT00793572|11560767|FG000|STARTED|Overall Study||32
10416351|NCT00793572|11560767|FG000|COMPLETED|Overall Study||32
10416352|NCT00793572|11560767|FG000|NOT COMPLETED|Overall Study||0
10416353|NCT00793585|11560773|FG000|STARTED|Overall Study||19
10416354|NCT00793585|11560774|FG001|STARTED|Overall Study||21
10860679|NCT00829868|12025850|FG001|NOT COMPLETED|First Intervention||0
10860680|NCT00829868|12025849|FG000|STARTED|Washout||21
10293660|NCT04374149|11426270|FG000|NOT COMPLETED|Overall Study||0
10293661|NCT04374149|11426271|FG001|NOT COMPLETED|Overall Study||0
10293662|NCT04348500|11426279|FG000|STARTED|Overall Study||8
10293663|NCT04348500|11426280|FG001|STARTED|Overall Study||9
10293664|NCT04348500|11426279|FG000|Treated|Overall Study||8
10293665|NCT04348500|11426280|FG001|Treated|Overall Study||8
10293666|NCT04348500|11426279|FG000|COMPLETED|Overall Study||6
10293667|NCT04348500|11426280|FG001|COMPLETED|Overall Study||6
10293668|NCT04348500|11426279|FG000|NOT COMPLETED|Overall Study||2
10416355|NCT00793585|11560773|FG000|COMPLETED|Overall Study||17
10416356|NCT00793585|11560774|FG001|COMPLETED|Overall Study||18
10416357|NCT00793585|11560773|FG000|NOT COMPLETED|Overall Study||2
10860681|NCT00829868|12025850|FG001|STARTED|Washout||21
10416358|NCT00793585|11560774|FG001|NOT COMPLETED|Overall Study||3
10416359|NCT00793598|11560785|FG000|STARTED|Overall Study||1
10755272|NCT03063385|11919073|FG000|NOT COMPLETED|Overall Study||87
10755273|NCT03063385|11919074|FG001|NOT COMPLETED|Overall Study||76
10755274|NCT03063437|11919082|FG000|STARTED|Overall Study||4
10755275|NCT03063437|11919083|FG001|STARTED|Overall Study||5
10755276|NCT03063437|11919082|FG000|COMPLETED|Overall Study||4
10755277|NCT03063437|11919083|FG001|COMPLETED|Overall Study||5
10755278|NCT03063437|11919082|FG000|NOT COMPLETED|Overall Study||0
10755279|NCT03063437|11919083|FG001|NOT COMPLETED|Overall Study||0
10755280|NCT03063476|11919089|FG000|STARTED|Overall Study||2
10755281|NCT03063476|11919089|FG000|COMPLETED|Overall Study||2
10755282|NCT03063476|11919089|FG000|NOT COMPLETED|Overall Study||0
10755283|NCT03064152|11919095|FG000|STARTED|Overall Study||26
10755284|NCT03064152|11919096|FG001|STARTED|Overall Study||23
10755285|NCT03064152|11919095|FG000|COMPLETED|Overall Study||26
10755286|NCT03064152|11919096|FG001|COMPLETED|Overall Study||23
10755287|NCT03064152|11919095|FG000|NOT COMPLETED|Overall Study||0
10755288|NCT03064152|11919096|FG001|NOT COMPLETED|Overall Study||0
10755289|NCT03064438|11919104|FG000|STARTED|Overall Study||27
10755290|NCT03064438|11919105|FG001|STARTED|Overall Study||13
10755291|NCT03064438|11919104|FG000|COMPLETED|Overall Study||26
10755292|NCT03064438|11919105|FG001|COMPLETED|Overall Study||12
10755293|NCT03064438|11919104|FG000|NOT COMPLETED|Overall Study||1
10755294|NCT03064438|11919105|FG001|NOT COMPLETED|Overall Study||1
10755295|NCT03064451|11919111|FG000|STARTED|Overall Study||60
10755296|NCT03064451|11919111|FG000|Safety Population|Overall Study||52
10755297|NCT03064451|11919111|FG000|COMPLETED|Overall Study||46
10755298|NCT03064451|11919111|FG000|NOT COMPLETED|Overall Study||14
10755299|NCT03064841|11919115|FG000|STARTED|Overall Study||1537
10755300|NCT03064841|11919115|FG000|COMPLETED|Overall Study||1520
10755301|NCT03064841|11919115|FG000|NOT COMPLETED|Overall Study||17
10755302|NCT03065023|11919123|FG000|STARTED|Overall Study||3
10755303|NCT03065023|11919124|FG001|STARTED|Overall Study||3
10755304|NCT03065023|11919125|FG002|STARTED|Overall Study||3
10755305|NCT03065023|11919126|FG003|STARTED|Overall Study||6
10755306|NCT03065023|11919127|FG004|STARTED|Overall Study|Group B not started for business reasons.|0
10755307|NCT03065023|11919123|FG000|COMPLETED|Overall Study||1
10755308|NCT03065023|11919124|FG001|COMPLETED|Overall Study||1
10755309|NCT03065023|11919125|FG002|COMPLETED|Overall Study||2
10755310|NCT03065023|11919126|FG003|COMPLETED|Overall Study||3
10755311|NCT03065023|11919127|FG004|COMPLETED|Overall Study||0
10755312|NCT03065023|11919123|FG000|NOT COMPLETED|Overall Study||2
10755313|NCT03065023|11919124|FG001|NOT COMPLETED|Overall Study||2
10755314|NCT03065023|11919125|FG002|NOT COMPLETED|Overall Study||1
10755315|NCT03065023|11919126|FG003|NOT COMPLETED|Overall Study||3
10755316|NCT03065023|11919127|FG004|NOT COMPLETED|Overall Study||0
10755317|NCT03065075|11919139|FG000|STARTED|Overall Study||76
10755318|NCT03065075|11919140|FG001|STARTED|Overall Study||76
10755319|NCT03065075|11919139|FG000|Intent-to-treat Analysis|Overall Study||72
10755320|NCT03065075|11919140|FG001|Intent-to-treat Analysis|Overall Study||74
10755321|NCT03065075|11919139|FG000|As-treated Analysis|Overall Study||69
10755322|NCT03065075|11919140|FG001|As-treated Analysis|Overall Study||77
10755323|NCT03065075|11919139|FG000|COMPLETED|Overall Study||76
10755324|NCT03065075|11919140|FG001|COMPLETED|Overall Study||76
10755325|NCT03065075|11919139|FG000|NOT COMPLETED|Overall Study||0
10755326|NCT03065075|11919140|FG001|NOT COMPLETED|Overall Study||0
10755327|NCT03065179|11919146|FG000|STARTED|Overall Study||25
10755328|NCT03065179|11919146|FG000|COMPLETED|Overall Study||25
10755329|NCT03065179|11919146|FG000|NOT COMPLETED|Overall Study||0
10755330|NCT03065205|11919150|FG000|STARTED|Overall Study||65
10755331|NCT03065205|11919150|FG000|COMPLETED|Overall Study||53
10755332|NCT03065205|11919150|FG000|NOT COMPLETED|Overall Study||12
10755333|NCT03065283|11919157|FG000|STARTED|Overall Study||50
10755334|NCT03065283|11919158|FG001|STARTED|Overall Study||25
10755335|NCT03065283|11919157|FG000|COMPLETED|Overall Study||50
10755336|NCT03065283|11919158|FG001|COMPLETED|Overall Study||25
10755337|NCT03065283|11919157|FG000|NOT COMPLETED|Overall Study||0
10755338|NCT03065283|11919158|FG001|NOT COMPLETED|Overall Study||0
10755339|NCT03065400|11919164|FG000|STARTED|Overall Study||10
10755340|NCT03065400|11919164|FG000|COMPLETED|Overall Study||0
10755341|NCT03065400|11919164|FG000|NOT COMPLETED|Overall Study||10
10755342|NCT03065530|11919172|FG000|STARTED|Overall Study||30
10755343|NCT03065530|11919173|FG001|STARTED|Overall Study||30
10755344|NCT03065530|11919174|FG002|STARTED|Overall Study||30
10755345|NCT03065530|11919175|FG003|STARTED|Overall Study||30
10755346|NCT03065530|11919172|FG000|COMPLETED|Overall Study||28
10755347|NCT03065530|11919173|FG001|COMPLETED|Overall Study||29
10755348|NCT03065530|11919174|FG002|COMPLETED|Overall Study||29
10755349|NCT03065530|11919175|FG003|COMPLETED|Overall Study||28
10755350|NCT03065530|11919172|FG000|NOT COMPLETED|Overall Study||2
10416360|NCT00793598|11560786|FG001|STARTED|Overall Study||1
10755351|NCT03065530|11919173|FG001|NOT COMPLETED|Overall Study||1
10755352|NCT03065530|11919174|FG002|NOT COMPLETED|Overall Study||1
10755353|NCT03065530|11919175|FG003|NOT COMPLETED|Overall Study||2
10755354|NCT03065647|11919195|FG000|STARTED|Overall Study||3
10755355|NCT03065647|11919196|FG001|STARTED|Overall Study||12
10755356|NCT03065647|11919195|FG000|COMPLETED|Overall Study||3
10755357|NCT03065647|11919196|FG001|COMPLETED|Overall Study||12
10755358|NCT03065647|11919195|FG000|NOT COMPLETED|Overall Study||0
10860682|NCT00829868|12025849|FG000|COMPLETED|Washout||20
10860683|NCT00829868|12025850|FG001|COMPLETED|Washout||21
10860684|NCT00829868|12025849|FG000|NOT COMPLETED|Washout||1
10860685|NCT00829868|12025850|FG001|NOT COMPLETED|Washout||0
10860686|NCT00829868|12025849|FG000|STARTED|Second Intervention||20
10860687|NCT00829868|12025850|FG001|STARTED|Second Intervention||21
10860688|NCT00829868|12025849|FG000|COMPLETED|Second Intervention||20
10860689|NCT00829868|12025850|FG001|COMPLETED|Second Intervention||21
10860690|NCT00829868|12025849|FG000|NOT COMPLETED|Second Intervention||0
10860691|NCT00829868|12025850|FG001|NOT COMPLETED|Second Intervention||0
10860692|NCT00829790|12025856|FG000|STARTED|First Intervention||15
10860693|NCT00829790|12025857|FG001|STARTED|First Intervention||15
10860694|NCT00829790|12025856|FG000|COMPLETED|First Intervention||15
10860695|NCT00829790|12025857|FG001|COMPLETED|First Intervention||15
10860696|NCT00829790|12025856|FG000|NOT COMPLETED|First Intervention||0
10860697|NCT00829790|12025857|FG001|NOT COMPLETED|First Intervention||0
10860698|NCT00829790|12025856|FG000|STARTED|Washout of 14 Days||15
10860699|NCT00829790|12025857|FG001|STARTED|Washout of 14 Days||15
10860700|NCT00829790|12025856|FG000|COMPLETED|Washout of 14 Days||15
10860701|NCT00829790|12025857|FG001|COMPLETED|Washout of 14 Days||14
10860702|NCT00829790|12025856|FG000|NOT COMPLETED|Washout of 14 Days||0
10860703|NCT00829790|12025857|FG001|NOT COMPLETED|Washout of 14 Days||1
10860704|NCT00829790|12025856|FG000|STARTED|Second Intervention||15
10860705|NCT00829790|12025857|FG001|STARTED|Second Intervention||14
10860706|NCT00829790|12025856|FG000|COMPLETED|Second Intervention||15
10860707|NCT00829790|12025857|FG001|COMPLETED|Second Intervention||14
10860708|NCT00829790|12025856|FG000|NOT COMPLETED|Second Intervention||0
10860709|NCT00829790|12025857|FG001|NOT COMPLETED|Second Intervention||0
10860710|NCT00829764|12025863|FG000|STARTED|First Intervention||15
10860711|NCT00829764|12025864|FG001|STARTED|First Intervention||15
10860712|NCT00829764|12025863|FG000|COMPLETED|First Intervention||13
10860713|NCT00829764|12025864|FG001|COMPLETED|First Intervention||14
10860714|NCT00829764|12025863|FG000|NOT COMPLETED|First Intervention||2
10860715|NCT00829764|12025864|FG001|NOT COMPLETED|First Intervention||1
10860716|NCT00829764|12025863|FG000|STARTED|Washout of 14 Days||13
10860717|NCT00829764|12025864|FG001|STARTED|Washout of 14 Days||14
10860718|NCT00829764|12025863|FG000|COMPLETED|Washout of 14 Days||13
10860719|NCT00829764|12025864|FG001|COMPLETED|Washout of 14 Days||14
10860720|NCT00829764|12025863|FG000|NOT COMPLETED|Washout of 14 Days||0
10860721|NCT00829764|12025864|FG001|NOT COMPLETED|Washout of 14 Days||0
10860722|NCT00829764|12025863|FG000|STARTED|Second Intervention||13
10860723|NCT00829764|12025864|FG001|STARTED|Second Intervention||14
10860724|NCT00829764|12025863|FG000|COMPLETED|Second Intervention||13
10860725|NCT00829764|12025864|FG001|COMPLETED|Second Intervention||14
10860726|NCT00829764|12025863|FG000|NOT COMPLETED|Second Intervention||0
10860727|NCT00829764|12025864|FG001|NOT COMPLETED|Second Intervention||0
10860728|NCT00829712|12025870|FG000|STARTED|First Intervention||12
10860729|NCT00829712|12025871|FG001|STARTED|First Intervention||12
10860730|NCT00829712|12025870|FG000|COMPLETED|First Intervention||12
10860731|NCT00829712|12025871|FG001|COMPLETED|First Intervention||12
10860732|NCT00829712|12025870|FG000|NOT COMPLETED|First Intervention||0
10860733|NCT00829712|12025871|FG001|NOT COMPLETED|First Intervention||0
10860734|NCT00829712|12025870|FG000|STARTED|Washout of 7 Days||12
10860735|NCT00829712|12025871|FG001|STARTED|Washout of 7 Days||12
10860736|NCT00829712|12025870|FG000|COMPLETED|Washout of 7 Days||12
10860737|NCT00829712|12025871|FG001|COMPLETED|Washout of 7 Days||11
10860738|NCT00829712|12025870|FG000|NOT COMPLETED|Washout of 7 Days||0
10860739|NCT00829712|12025871|FG001|NOT COMPLETED|Washout of 7 Days||1
10860740|NCT00829712|12025870|FG000|STARTED|Second Intervention||12
10860741|NCT00829712|12025871|FG001|STARTED|Second Intervention||11
10860742|NCT00829712|12025870|FG000|COMPLETED|Second Intervention||12
10860743|NCT00829712|12025871|FG001|COMPLETED|Second Intervention||11
10860744|NCT00829712|12025870|FG000|NOT COMPLETED|Second Intervention||0
10860745|NCT00829712|12025871|FG001|NOT COMPLETED|Second Intervention||0
10860746|NCT00829686|12025877|FG000|STARTED|Overall Study||13
10860747|NCT00829686|12025878|FG001|STARTED|Overall Study||18
10860748|NCT00829686|12025877|FG000|COMPLETED|Overall Study||13
10860749|NCT00829686|12025878|FG001|COMPLETED|Overall Study||18
10860750|NCT00829686|12025877|FG000|NOT COMPLETED|Overall Study||0
10860751|NCT00829686|12025878|FG001|NOT COMPLETED|Overall Study||0
10860752|NCT00829673|12025884|FG000|STARTED|First Intervention||12
10860753|NCT00829673|12025885|FG001|STARTED|First Intervention||12
10860754|NCT00829673|12025884|FG000|COMPLETED|First Intervention||12
10860755|NCT00829673|12025885|FG001|COMPLETED|First Intervention||12
10860756|NCT00829673|12025884|FG000|NOT COMPLETED|First Intervention||0
10860757|NCT00829673|12025885|FG001|NOT COMPLETED|First Intervention||0
10860758|NCT00829673|12025884|FG000|STARTED|Washout of 7 Days||12
10860759|NCT00829673|12025885|FG001|STARTED|Washout of 7 Days||12
10860760|NCT00829673|12025884|FG000|COMPLETED|Washout of 7 Days||11
10860761|NCT00829673|12025885|FG001|COMPLETED|Washout of 7 Days||12
10860762|NCT00829673|12025884|FG000|NOT COMPLETED|Washout of 7 Days||1
10860763|NCT00829673|12025885|FG001|NOT COMPLETED|Washout of 7 Days||0
10860764|NCT00829673|12025884|FG000|STARTED|Second Intervention||11
10860765|NCT00829673|12025885|FG001|STARTED|Second Intervention||12
10860766|NCT00829673|12025884|FG000|COMPLETED|Second Intervention||11
10860767|NCT00829673|12025885|FG001|COMPLETED|Second Intervention||12
10860768|NCT00829673|12025884|FG000|NOT COMPLETED|Second Intervention||0
10860769|NCT00829673|12025885|FG001|NOT COMPLETED|Second Intervention||0
10860770|NCT00829530|12025891|FG000|STARTED|First Intervention||20
10860771|NCT00829530|12025892|FG001|STARTED|First Intervention||20
10860772|NCT00829530|12025891|FG000|COMPLETED|First Intervention||20
10860773|NCT00829530|12025892|FG001|COMPLETED|First Intervention||18
10860774|NCT00829530|12025891|FG000|NOT COMPLETED|First Intervention||0
10860775|NCT00829530|12025892|FG001|NOT COMPLETED|First Intervention||2
10860776|NCT00829530|12025891|FG000|STARTED|Washout of 42 Days||20
10860777|NCT00829530|12025892|FG001|STARTED|Washout of 42 Days||18
10860778|NCT00829530|12025891|FG000|COMPLETED|Washout of 42 Days||20
10860779|NCT00829530|12025892|FG001|COMPLETED|Washout of 42 Days||18
10860780|NCT00829530|12025891|FG000|NOT COMPLETED|Washout of 42 Days||0
10860781|NCT00829530|12025892|FG001|NOT COMPLETED|Washout of 42 Days||0
10860782|NCT00829530|12025891|FG000|STARTED|Second Intervention||20
10860783|NCT00829530|12025892|FG001|STARTED|Second Intervention||18
10860784|NCT00829530|12025891|FG000|COMPLETED|Second Intervention||19
10860785|NCT00829530|12025892|FG001|COMPLETED|Second Intervention||18
10860786|NCT00829530|12025891|FG000|NOT COMPLETED|Second Intervention||1
10860787|NCT00829530|12025892|FG001|NOT COMPLETED|Second Intervention||0
10860788|NCT00829504|12025898|FG000|STARTED|First Intervention||22
10860789|NCT00829504|12025899|FG001|STARTED|First Intervention||22
10860790|NCT00829504|12025898|FG000|COMPLETED|First Intervention||21
10860791|NCT00829504|12025899|FG001|COMPLETED|First Intervention||22
10860792|NCT00829504|12025898|FG000|NOT COMPLETED|First Intervention||1
10860793|NCT00829504|12025899|FG001|NOT COMPLETED|First Intervention||0
10860794|NCT00829504|12025898|FG000|STARTED|Washout of 7 Days||21
10860795|NCT00829504|12025899|FG001|STARTED|Washout of 7 Days||22
10860796|NCT00829504|12025898|FG000|COMPLETED|Washout of 7 Days||20
10860797|NCT00829504|12025899|FG001|COMPLETED|Washout of 7 Days||22
10860798|NCT00829504|12025898|FG000|NOT COMPLETED|Washout of 7 Days||1
10860799|NCT00829504|12025899|FG001|NOT COMPLETED|Washout of 7 Days||0
10860800|NCT00829504|12025898|FG000|STARTED|Second Intervention||20
10860801|NCT00829504|12025899|FG001|STARTED|Second Intervention||22
10860802|NCT00829504|12025898|FG000|COMPLETED|Second Intervention||19
10860803|NCT00829504|12025899|FG001|COMPLETED|Second Intervention||22
10860804|NCT00829504|12025898|FG000|NOT COMPLETED|Second Intervention||1
10860805|NCT00829504|12025899|FG001|NOT COMPLETED|Second Intervention||0
10860806|NCT00829452|12025905|FG000|STARTED|First Intervention||20
10860807|NCT00829452|12025906|FG001|STARTED|First Intervention||20
10860808|NCT00829452|12025905|FG000|COMPLETED|First Intervention||20
10860809|NCT00829452|12025906|FG001|COMPLETED|First Intervention||19
10860810|NCT00829452|12025905|FG000|NOT COMPLETED|First Intervention||0
10860811|NCT00829452|12025906|FG001|NOT COMPLETED|First Intervention||1
10860812|NCT00829452|12025905|FG000|STARTED|Washout of 42 Days||20
10860813|NCT00829452|12025906|FG001|STARTED|Washout of 42 Days||19
10860814|NCT00829452|12025905|FG000|COMPLETED|Washout of 42 Days||20
10860815|NCT00829452|12025906|FG001|COMPLETED|Washout of 42 Days||18
10860816|NCT00829452|12025905|FG000|NOT COMPLETED|Washout of 42 Days||0
10860817|NCT00829452|12025906|FG001|NOT COMPLETED|Washout of 42 Days||1
10860818|NCT00829452|12025905|FG000|STARTED|Second Intervention||20
10860819|NCT00829452|12025906|FG001|STARTED|Second Intervention||18
10860820|NCT00829452|12025905|FG000|COMPLETED|Second Intervention||20
10860821|NCT00829452|12025906|FG001|COMPLETED|Second Intervention||17
10860822|NCT00829452|12025905|FG000|NOT COMPLETED|Second Intervention||0
10860823|NCT00829452|12025906|FG001|NOT COMPLETED|Second Intervention||1
10860824|NCT00829426|12025912|FG000|STARTED|First Intervention||16
10860825|NCT00829426|12025913|FG001|STARTED|First Intervention||16
10860826|NCT00829426|12025912|FG000|COMPLETED|First Intervention||16
10860827|NCT00829426|12025913|FG001|COMPLETED|First Intervention||16
10860828|NCT00829426|12025912|FG000|NOT COMPLETED|First Intervention||0
10860829|NCT00829426|12025913|FG001|NOT COMPLETED|First Intervention||0
10860830|NCT00829426|12025912|FG000|STARTED|Washout: 7 Days||16
10860831|NCT00829426|12025913|FG001|STARTED|Washout: 7 Days||16
10860832|NCT00829426|12025912|FG000|COMPLETED|Washout: 7 Days||15
10860833|NCT00829426|12025913|FG001|COMPLETED|Washout: 7 Days||16
10860834|NCT00829426|12025912|FG000|NOT COMPLETED|Washout: 7 Days||1
10860835|NCT00829426|12025913|FG001|NOT COMPLETED|Washout: 7 Days||0
10860836|NCT00829426|12025912|FG000|STARTED|Second Intervention||15
10860837|NCT00829426|12025913|FG001|STARTED|Second Intervention||16
10860838|NCT00829426|12025912|FG000|COMPLETED|Second Intervention||15
10860839|NCT00829426|12025913|FG001|COMPLETED|Second Intervention||16
10860840|NCT00829426|12025912|FG000|NOT COMPLETED|Second Intervention||0
10860841|NCT00829426|12025913|FG001|NOT COMPLETED|Second Intervention||0
10860842|NCT00829309|12025919|FG000|STARTED|First Intervention||8
10860843|NCT00829309|12025920|FG001|STARTED|First Intervention||8
10860844|NCT00829309|12025919|FG000|COMPLETED|First Intervention||8
10860845|NCT00829309|12025920|FG001|COMPLETED|First Intervention||8
10860846|NCT00829309|12025919|FG000|NOT COMPLETED|First Intervention||0
10860847|NCT00829309|12025920|FG001|NOT COMPLETED|First Intervention||0
10860848|NCT00829309|12025919|FG000|STARTED|Washout: 7 Days||8
10860849|NCT00829309|12025920|FG001|STARTED|Washout: 7 Days||8
10860850|NCT00829309|12025919|FG000|COMPLETED|Washout: 7 Days||7
10860851|NCT00829309|12025920|FG001|COMPLETED|Washout: 7 Days||8
10860852|NCT00829309|12025919|FG000|NOT COMPLETED|Washout: 7 Days||1
10860853|NCT00829309|12025920|FG001|NOT COMPLETED|Washout: 7 Days||0
10860854|NCT00829309|12025919|FG000|STARTED|Second Intervention||7
10860855|NCT00829309|12025920|FG001|STARTED|Second Intervention||8
10860856|NCT00829309|12025919|FG000|COMPLETED|Second Intervention||7
10860857|NCT00829309|12025920|FG001|COMPLETED|Second Intervention||8
10860858|NCT00829309|12025919|FG000|NOT COMPLETED|Second Intervention||0
10860859|NCT00829309|12025920|FG001|NOT COMPLETED|Second Intervention||0
10860860|NCT00828321|12025926|FG000|STARTED|First Intervention||20
10860861|NCT00828321|12025927|FG001|STARTED|First Intervention||20
10860862|NCT00828321|12025926|FG000|COMPLETED|First Intervention||20
10860863|NCT00828321|12025927|FG001|COMPLETED|First Intervention||20
10860864|NCT00828321|12025926|FG000|NOT COMPLETED|First Intervention||0
10860865|NCT00828321|12025927|FG001|NOT COMPLETED|First Intervention||0
10860866|NCT00828321|12025926|FG000|STARTED|Washout of 42 Days||20
10860867|NCT00828321|12025927|FG001|STARTED|Washout of 42 Days||20
10860868|NCT00828321|12025926|FG000|COMPLETED|Washout of 42 Days||18
10860869|NCT00828321|12025927|FG001|COMPLETED|Washout of 42 Days||20
10860870|NCT00828321|12025926|FG000|NOT COMPLETED|Washout of 42 Days||2
10860871|NCT00828321|12025927|FG001|NOT COMPLETED|Washout of 42 Days||0
10860872|NCT00828321|12025926|FG000|STARTED|Second Intervention||18
10860873|NCT00828321|12025927|FG001|STARTED|Second Intervention||20
10860874|NCT00828321|12025926|FG000|COMPLETED|Second Intervention||18
10860875|NCT00828321|12025927|FG001|COMPLETED|Second Intervention||19
10860876|NCT00828321|12025926|FG000|NOT COMPLETED|Second Intervention||0
10860877|NCT00828321|12025927|FG001|NOT COMPLETED|Second Intervention||1
10293669|NCT04348500|11426280|FG001|NOT COMPLETED|Overall Study||3
10293670|NCT04347941|11426288|FG000|STARTED|Overall Study||12
10293671|NCT04347941|11426289|FG001|STARTED|Overall Study||12
10293672|NCT04347941|11426288|FG000|COMPLETED|Overall Study||12
10293673|NCT04347941|11426289|FG001|COMPLETED|Overall Study||12
10293674|NCT04347941|11426288|FG000|NOT COMPLETED|Overall Study||0
10293675|NCT04347941|11426289|FG001|NOT COMPLETED|Overall Study||0
10293676|NCT04308694|11426298|FG000|STARTED|Overall Study||20
10293677|NCT04308694|11426298|FG000|COMPLETED|Overall Study||16
10293678|NCT04308694|11426298|FG000|NOT COMPLETED|Overall Study||4
10293679|NCT03999411|11426305|FG000|STARTED|Overall Study||13
10293680|NCT03999411|11426306|FG001|STARTED|Overall Study||13
10293681|NCT03999411|11426307|FG002|STARTED|Overall Study||13
10293682|NCT03999411|11426305|FG000|COMPLETED|Overall Study||12
10293683|NCT03999411|11426306|FG001|COMPLETED|Overall Study||11
10293684|NCT03999411|11426307|FG002|COMPLETED|Overall Study||13
10293685|NCT03999411|11426305|FG000|NOT COMPLETED|Overall Study||1
10293686|NCT03999411|11426306|FG001|NOT COMPLETED|Overall Study||2
10860878|NCT00806403|12025933|FG000|STARTED|Overall Study||104
10860879|NCT00806403|12025934|FG001|STARTED|Overall Study||101
10860880|NCT00806403|12025933|FG000|COMPLETED|Overall Study||100
10860881|NCT00806403|12025934|FG001|COMPLETED|Overall Study||98
10860882|NCT00806403|12025933|FG000|NOT COMPLETED|Overall Study||4
10860883|NCT00806403|12025934|FG001|NOT COMPLETED|Overall Study||3
10860884|NCT00803517|12025940|FG000|STARTED|Overall Study||12
10860885|NCT00803517|12025941|FG001|STARTED|Overall Study||12
10860886|NCT00803517|12025940|FG000|COMPLETED|Overall Study||12
10860887|NCT00803517|12025941|FG001|COMPLETED|Overall Study||12
10860888|NCT00803517|12025940|FG000|NOT COMPLETED|Overall Study||0
10860889|NCT00803517|12025941|FG001|NOT COMPLETED|Overall Study||0
10860890|NCT00803413|12025949|FG000|STARTED|Overall Period||28
10860891|NCT00803413|12025950|FG001|STARTED|Overall Period||32
10860892|NCT00803413|12025951|FG002|STARTED|Overall Period||29
10860893|NCT00803413|12025952|FG003|STARTED|Overall Period||30
10860894|NCT00803413|12025949|FG000|COMPLETED|Overall Period||28
10860895|NCT00803413|12025950|FG001|COMPLETED|Overall Period||32
10860896|NCT00803413|12025951|FG002|COMPLETED|Overall Period||29
10860897|NCT00803413|12025952|FG003|COMPLETED|Overall Period||30
10860898|NCT00803413|12025949|FG000|NOT COMPLETED|Overall Period||0
10860899|NCT00803413|12025950|FG001|NOT COMPLETED|Overall Period||0
10860900|NCT00803413|12025951|FG002|NOT COMPLETED|Overall Period||0
10860901|NCT00803413|12025952|FG003|NOT COMPLETED|Overall Period||0
10860902|NCT00803114|12025960|FG000|STARTED|Overall Study||113
10860903|NCT00803114|12025961|FG001|STARTED|Overall Study||115
10860904|NCT00803114|12025960|FG000|COMPLETED|Overall Study||113
10860905|NCT00803114|12025961|FG001|COMPLETED|Overall Study||115
10860906|NCT00803114|12025960|FG000|NOT COMPLETED|Overall Study||0
10860907|NCT00803114|12025961|FG001|NOT COMPLETED|Overall Study||0
10860908|NCT00799292|12025967|FG000|STARTED|Overall Study||29
10860909|NCT00799292|12025968|FG001|STARTED|Overall Study||29
10860910|NCT00799292|12025967|FG000|COMPLETED|Overall Study||29
10860911|NCT00799292|12025968|FG001|COMPLETED|Overall Study||29
10860912|NCT00799292|12025967|FG000|NOT COMPLETED|Overall Study||0
10860913|NCT00799292|12025968|FG001|NOT COMPLETED|Overall Study||0
10860914|NCT00796523|12025974|FG000|STARTED|Overall Study||27
10860915|NCT00796523|12025975|FG001|STARTED|Overall Study||24
10860916|NCT00796523|12025974|FG000|COMPLETED|Overall Study||18
10860917|NCT00796523|12025975|FG001|COMPLETED|Overall Study||17
10860918|NCT00796523|12025974|FG000|NOT COMPLETED|Overall Study||9
10860919|NCT00796523|12025975|FG001|NOT COMPLETED|Overall Study||7
10860920|NCT00794924|12025981|FG000|STARTED|Overall Study|14 patients refused to start the study|174
10860921|NCT00794924|12025982|FG001|STARTED|Overall Study|14 patients refused to start the study|171
10860922|NCT00794924|12025981|FG000|COMPLETED|Overall Study||114
10860923|NCT00794924|12025982|FG001|COMPLETED|Overall Study||101
10860924|NCT00794924|12025981|FG000|NOT COMPLETED|Overall Study||60
10860925|NCT00794924|12025982|FG001|NOT COMPLETED|Overall Study||70
10860926|NCT00794677|12025988|FG000|STARTED|First Intervention||13
10860927|NCT00794677|12025989|FG001|STARTED|First Intervention||13
10860928|NCT00794677|12025988|FG000|COMPLETED|First Intervention||11
10860929|NCT00794677|12025989|FG001|COMPLETED|First Intervention||13
10860930|NCT00794677|12025988|FG000|NOT COMPLETED|First Intervention||2
10860931|NCT00794677|12025989|FG001|NOT COMPLETED|First Intervention||0
10860932|NCT00794677|12025988|FG000|STARTED|Second Intervention||11
10860933|NCT00794677|12025989|FG001|STARTED|Second Intervention||13
10860934|NCT00794677|12025988|FG000|COMPLETED|Second Intervention||11
10860935|NCT00794677|12025989|FG001|COMPLETED|Second Intervention||13
10860936|NCT00794677|12025988|FG000|NOT COMPLETED|Second Intervention||0
10860937|NCT00794677|12025989|FG001|NOT COMPLETED|Second Intervention||0
10860938|NCT00792116|12025995|FG000|STARTED|Overall Study||53
10860939|NCT00792116|12025996|FG001|STARTED|Overall Study||55
10860940|NCT00792116|12025995|FG000|COMPLETED|Overall Study||52
10860941|NCT00792116|12025996|FG001|COMPLETED|Overall Study||54
10860942|NCT00792116|12025995|FG000|NOT COMPLETED|Overall Study||1
10860943|NCT00792116|12025996|FG001|NOT COMPLETED|Overall Study||1
10293687|NCT03999411|11426307|FG002|NOT COMPLETED|Overall Study||0
10293688|NCT03803605|11426316|FG000|STARTED|Overall Study||15
10860944|NCT00758563|12026002|FG000|STARTED|Overall Study||7
10860945|NCT00758563|12026003|FG001|STARTED|Overall Study||8
10860946|NCT00758563|12026002|FG000|COMPLETED|Overall Study||7
10860947|NCT00758563|12026003|FG001|COMPLETED|Overall Study||8
10860948|NCT00758563|12026002|FG000|NOT COMPLETED|Overall Study||0
10860949|NCT00758563|12026003|FG001|NOT COMPLETED|Overall Study||0
10860950|NCT00758290|12026009|FG000|STARTED|Overall Study||11
10860951|NCT00758290|12026010|FG001|STARTED|Overall Study||12
10860952|NCT00758290|12026009|FG000|COMPLETED|Overall Study||11
10860953|NCT00758290|12026010|FG001|COMPLETED|Overall Study||12
10860954|NCT00758290|12026009|FG000|NOT COMPLETED|Overall Study||0
10860955|NCT00758290|12026010|FG001|NOT COMPLETED|Overall Study||0
10860956|NCT00756574|12026016|FG000|STARTED|Overall Study||225
10860957|NCT00756574|12026017|FG001|STARTED|Overall Study||221
10860958|NCT00756574|12026016|FG000|COMPLETED|Overall Study||212
10416361|NCT00793598|11560787|FG002|STARTED|Overall Study||1
10416362|NCT00793598|11560788|FG003|STARTED|Overall Study||2
10416363|NCT00793598|11560789|FG004|STARTED|Overall Study||8
10416364|NCT00793598|11560790|FG005|STARTED|Overall Study||8
10416365|NCT00793598|11560791|FG006|STARTED|Overall Study||4
10416366|NCT00793598|11560792|FG007|STARTED|Overall Study||4
10416367|NCT00793598|11560785|FG000|COMPLETED|Overall Study||1
10416368|NCT00793598|11560786|FG001|COMPLETED|Overall Study||0
10416369|NCT00793598|11560787|FG002|COMPLETED|Overall Study||1
10416370|NCT00793598|11560788|FG003|COMPLETED|Overall Study||2
10416371|NCT00793598|11560789|FG004|COMPLETED|Overall Study||8
10416372|NCT00793598|11560790|FG005|COMPLETED|Overall Study||7
10416373|NCT00793598|11560791|FG006|COMPLETED|Overall Study||4
10416374|NCT00793598|11560792|FG007|COMPLETED|Overall Study||3
10416375|NCT00793598|11560785|FG000|NOT COMPLETED|Overall Study||0
10416376|NCT00793598|11560786|FG001|NOT COMPLETED|Overall Study||1
10416377|NCT00793598|11560787|FG002|NOT COMPLETED|Overall Study||0
10416378|NCT00793598|11560788|FG003|NOT COMPLETED|Overall Study||0
10416379|NCT00793598|11560789|FG004|NOT COMPLETED|Overall Study||0
10416380|NCT00793598|11560790|FG005|NOT COMPLETED|Overall Study||1
10416381|NCT00793598|11560791|FG006|NOT COMPLETED|Overall Study||0
10416382|NCT00793598|11560792|FG007|NOT COMPLETED|Overall Study||1
10416383|NCT00793611|11560816|FG000|STARTED|Overall Study||10
10416384|NCT00793611|11560817|FG001|STARTED|Overall Study||10
10416385|NCT00793611|11560816|FG000|COMPLETED|Overall Study||10
10416386|NCT00793611|11560817|FG001|COMPLETED|Overall Study||10
10416387|NCT00793611|11560816|FG000|NOT COMPLETED|Overall Study||0
10416388|NCT00793611|11560817|FG001|NOT COMPLETED|Overall Study||0
10416389|NCT00793624|11560827|FG000|STARTED|Overall Study||225
10416390|NCT00793624|11560828|FG001|STARTED|Overall Study||227
10416391|NCT00793624|11560829|FG002|STARTED|Overall Study||225
10416392|NCT00793624|11560830|FG003|STARTED|Overall Study||227
10416393|NCT00793624|11560827|FG000|COMPLETED|Overall Study||168
10416394|NCT00793624|11560828|FG001|COMPLETED|Overall Study||191
10416395|NCT00793624|11560829|FG002|COMPLETED|Overall Study||186
10416396|NCT00793624|11560830|FG003|COMPLETED|Overall Study||184
10416397|NCT00793624|11560827|FG000|NOT COMPLETED|Overall Study||57
10416398|NCT00793624|11560828|FG001|NOT COMPLETED|Overall Study||36
10416399|NCT00793624|11560829|FG002|NOT COMPLETED|Overall Study||39
10416400|NCT00793624|11560830|FG003|NOT COMPLETED|Overall Study||43
10416401|NCT00793650|11560850|FG000|STARTED|Overall Study||19
10416402|NCT00793650|11560851|FG001|STARTED|Overall Study||20
10416403|NCT00793650|11560850|FG000|COMPLETED|Overall Study||19
10416404|NCT00793650|11560851|FG001|COMPLETED|Overall Study||20
10416405|NCT00793650|11560850|FG000|NOT COMPLETED|Overall Study||0
10416406|NCT00793650|11560851|FG001|NOT COMPLETED|Overall Study||0
10416407|NCT00793780|11560861|FG000|STARTED|Overall Study||12
10416408|NCT00793780|11560862|FG001|STARTED|Overall Study||12
10416409|NCT00793780|11560861|FG000|Randomization|Overall Study||12
10416410|NCT00793780|11560862|FG001|Randomization|Overall Study||12
10416411|NCT00793780|11560861|FG000|Collected Baseline Data|Overall Study||11
10416412|NCT00793780|11560862|FG001|Collected Baseline Data|Overall Study||12
10416413|NCT00793780|11560861|FG000|COMPLETED|Overall Study||10
10416414|NCT00793780|11560862|FG001|COMPLETED|Overall Study||11
10416415|NCT00793780|11560861|FG000|NOT COMPLETED|Overall Study||2
10416416|NCT00793780|11560862|FG001|NOT COMPLETED|Overall Study||1
10860959|NCT00756574|12026017|FG001|COMPLETED|Overall Study||210
10860960|NCT00756574|12026016|FG000|NOT COMPLETED|Overall Study||13
10860961|NCT00756574|12026017|FG001|NOT COMPLETED|Overall Study||11
10860962|NCT00740727|12026021|FG000|STARTED|Overall Study||18
10860963|NCT00740727|12026021|FG000|COMPLETED|Overall Study||18
10860964|NCT00740727|12026021|FG000|NOT COMPLETED|Overall Study||0
10860965|NCT00740480|12026024|FG000|STARTED|Overall Study||25
10860966|NCT00740480|12026024|FG000|COMPLETED|Overall Study||23
10860967|NCT00740480|12026024|FG000|NOT COMPLETED|Overall Study||2
10416417|NCT00793793|11560880|FG000|STARTED|Overall Study||8
10416418|NCT00793793|11560881|FG001|STARTED|Overall Study||6
10416419|NCT00793793|11560882|FG002|STARTED|Overall Study||7
10416420|NCT00793793|11560883|FG003|STARTED|Overall Study||7
10416421|NCT00793793|11560884|FG004|STARTED|Overall Study||6
10416422|NCT00793793|11560885|FG005|STARTED|Overall Study||6
10416423|NCT00793793|11560886|FG006|STARTED|Overall Study||7
10416424|NCT00793793|11560887|FG007|STARTED|Overall Study||6
10416425|NCT00793793|11560888|FG008|STARTED|Overall Study||15
10416426|NCT00793793|11560889|FG009|STARTED|Overall Study||15
10416427|NCT00793793|11560890|FG010|STARTED|Overall Study||6
10416428|NCT00793793|11560891|FG011|STARTED|Overall Study||7
10860968|NCT00724698|12026027|FG000|STARTED|Overall Study||3011
10860969|NCT00724698|12026027|FG000|COMPLETED|Overall Study||2921
10860970|NCT00724698|12026027|FG000|NOT COMPLETED|Overall Study||90
10860971|NCT00711555|12026030|FG000|STARTED|Overall Study||22
10860972|NCT00711555|12026030|FG000|COMPLETED|Overall Study||19
10860973|NCT00711555|12026030|FG000|NOT COMPLETED|Overall Study||3
10860974|NCT00676494|12026033|FG000|STARTED|Overall Study||172
10860975|NCT00676494|12026033|FG000|COMPLETED|Overall Study||158
10860976|NCT00676494|12026033|FG000|NOT COMPLETED|Overall Study||14
10416429|NCT00793793|11560880|FG000|COMPLETED|Overall Study||8
10416430|NCT00793793|11560881|FG001|COMPLETED|Overall Study||5
10416431|NCT00793793|11560882|FG002|COMPLETED|Overall Study||5
10416432|NCT00793793|11560883|FG003|COMPLETED|Overall Study||4
10416433|NCT00793793|11560884|FG004|COMPLETED|Overall Study||4
10416434|NCT00793793|11560885|FG005|COMPLETED|Overall Study||4
10416435|NCT00793793|11560886|FG006|COMPLETED|Overall Study||3
10416436|NCT00793793|11560887|FG007|COMPLETED|Overall Study||6
10416437|NCT00793793|11560888|FG008|COMPLETED|Overall Study||6
10416438|NCT00793793|11560889|FG009|COMPLETED|Overall Study||6
10860977|NCT00662389|12026036|FG000|STARTED|Overall Study||4
10860978|NCT00662389|12026036|FG000|COMPLETED|Overall Study||4
10860979|NCT00662389|12026036|FG000|NOT COMPLETED|Overall Study||0
10860980|NCT00659061|12026041|FG000|STARTED|Overall Study||308
10860981|NCT00659061|12026042|FG001|STARTED|Overall Study||302
10860982|NCT00659061|12026041|FG000|COMPLETED|Overall Study|Those with either complete or partial biochemical and anthropometric data|287
10860983|NCT00659061|12026042|FG001|COMPLETED|Overall Study|Those with either complete or partial biochemical and anthropometric data|287
10860984|NCT00659061|12026041|FG000|NOT COMPLETED|Overall Study||21
10860985|NCT00659061|12026042|FG001|NOT COMPLETED|Overall Study||15
10860986|NCT00654992|12026048|FG000|STARTED|Overall Study||36
10860987|NCT00654992|12026049|FG001|STARTED|Overall Study||35
10860988|NCT00654992|12026048|FG000|COMPLETED|Overall Study||36
10860989|NCT00654992|12026049|FG001|COMPLETED|Overall Study||35
10860990|NCT00654992|12026048|FG000|NOT COMPLETED|Overall Study||0
10860991|NCT00654992|12026049|FG001|NOT COMPLETED|Overall Study||0
10860992|NCT00581477|12026053|FG000|STARTED|Overall Study|8 patients were enrolled|8
10860993|NCT00581477|12026053|FG000|Dose Selection Trial With Droxidopa|Overall Study|2 patients had been treated with droxidopa prior to enrollment and their data is not included. Since droxidopa restores the norepinephrine that is absent in untreated patients with DBH deficiency, we present only the results for naive patients.|6
10293689|NCT03803605|11426316|FG000|Step 1: Participants With an RCI Measurement > 0.30 Per Million Cells|Overall Study||8
10293690|NCT03803605|11426316|FG000|Steps 2-4: Participants Receiving Study Intervention|Overall Study||8
10293691|NCT03803605|11426316|FG000|COMPLETED|Overall Study||8
10293692|NCT03803605|11426316|FG000|NOT COMPLETED|Overall Study||7
10293693|NCT03799198|11426323|FG000|STARTED|Overall Study||100
10293694|NCT03799198|11426324|FG001|STARTED|Overall Study||100
10293695|NCT03799198|11426323|FG000|Full Analysis Set (FAS)|Overall Study||100
10293696|NCT03799198|11426324|FG001|Full Analysis Set (FAS)|Overall Study||100
10293697|NCT03799198|11426323|FG000|COMPLETED|Overall Study||96
10293698|NCT03799198|11426324|FG001|COMPLETED|Overall Study||91
10293699|NCT03799198|11426323|FG000|NOT COMPLETED|Overall Study||4
10293700|NCT03799198|11426324|FG001|NOT COMPLETED|Overall Study||9
10293701|NCT03770728|11426334|FG000|STARTED|Overall Study||79
10293702|NCT03770728|11426335|FG001|STARTED|Overall Study||78
10293703|NCT03770728|11426336|FG002|STARTED|Overall Study||77
10293704|NCT03770728|11426337|FG003|STARTED|Overall Study||78
10293705|NCT03770728|11426334|FG000|Safety Population|Overall Study||79
10293706|NCT03770728|11426335|FG001|Safety Population|Overall Study||78
10293707|NCT03770728|11426336|FG002|Safety Population|Overall Study|For safety analysis, participants were included in the treatment group that they were exposed for longer duration. 3 participants randomized to Efpeglenatide 6 mg received 4 mg dose for longer duration; and considered in Efpeglenatide 4 mg group for safety analysis.|80
10293708|NCT03770728|11426337|FG003|Safety Population|Overall Study||75
10293709|NCT03770728|11426334|FG000|COMPLETED|Overall Study||41
10293710|NCT03770728|11426335|FG001|COMPLETED|Overall Study||47
10293711|NCT03770728|11426336|FG002|COMPLETED|Overall Study||45
10293712|NCT03770728|11426337|FG003|COMPLETED|Overall Study||43
10293713|NCT03770728|11426334|FG000|NOT COMPLETED|Overall Study||38
10293714|NCT03770728|11426335|FG001|NOT COMPLETED|Overall Study||31
10293715|NCT03770728|11426336|FG002|NOT COMPLETED|Overall Study||32
10293716|NCT03770728|11426337|FG003|NOT COMPLETED|Overall Study||35
10293717|NCT03760146|11426355|FG000|STARTED|Overall Study||1514
10293718|NCT03760146|11426356|FG001|STARTED|Overall Study||1495
10293719|NCT03760146|11426357|FG002|STARTED|Overall Study||334
10293720|NCT03760146|11426358|FG003|STARTED|Overall Study||111
10293721|NCT03760146|11426359|FG004|STARTED|Overall Study||336
10293722|NCT03760146|11426360|FG005|STARTED|Overall Study||112
10293723|NCT03760146|11426355|FG000|Evaluable 13-Matched Immunogenicity Population|Overall Study||1435
10293724|NCT03760146|11426356|FG001|Evaluable 13-Matched Immunogenicity Population|Overall Study||1420
10293725|NCT03760146|11426357|FG002|Evaluable 13-Matched Immunogenicity Population|Overall Study||0
10293726|NCT03760146|11426358|FG003|Evaluable 13-Matched Immunogenicity Population|Overall Study||0
10293727|NCT03760146|11426359|FG004|Evaluable 13-Matched Immunogenicity Population|Overall Study||0
10293728|NCT03760146|11426360|FG005|Evaluable 13-Matched Immunogenicity Population|Overall Study||0
10293729|NCT03760146|11426355|FG000|Evaluable 7-Additional Immunogenicity Population|Overall Study||1433
10293730|NCT03760146|11426356|FG001|Evaluable 7-Additional Immunogenicity Population|Overall Study||1383
10416439|NCT00793793|11560890|FG010|COMPLETED|Overall Study||3
10416440|NCT00793793|11560891|FG011|COMPLETED|Overall Study||1
10416441|NCT00793793|11560880|FG000|NOT COMPLETED|Overall Study||0
10416442|NCT00793793|11560881|FG001|NOT COMPLETED|Overall Study||1
10416443|NCT00793793|11560882|FG002|NOT COMPLETED|Overall Study||2
10416444|NCT00793793|11560883|FG003|NOT COMPLETED|Overall Study||3
10416445|NCT00793793|11560884|FG004|NOT COMPLETED|Overall Study||2
10416446|NCT00793793|11560885|FG005|NOT COMPLETED|Overall Study||2
10416447|NCT00793793|11560886|FG006|NOT COMPLETED|Overall Study||4
10416448|NCT00793793|11560887|FG007|NOT COMPLETED|Overall Study||0
10416449|NCT00793793|11560888|FG008|NOT COMPLETED|Overall Study||9
10416450|NCT00793793|11560889|FG009|NOT COMPLETED|Overall Study||9
10416451|NCT00793793|11560890|FG010|NOT COMPLETED|Overall Study||3
10416452|NCT00793793|11560891|FG011|NOT COMPLETED|Overall Study||6
10416453|NCT00793819|11560939|FG000|STARTED|Overall Study||111
10416454|NCT00793819|11560940|FG001|STARTED|Overall Study||98
10416455|NCT00793819|11560939|FG000|COMPLETED|Overall Study||97
10416456|NCT00793819|11560940|FG001|COMPLETED|Overall Study||89
10416457|NCT00793819|11560939|FG000|NOT COMPLETED|Overall Study||14
10860994|NCT00581477|12026053|FG000|Droxidopa 25 mg|Overall Study|Because dosing was individualized for the participants, only 5 of the 6 patients were administered 25 mg of Droxidopa.|6
10860995|NCT00581477|12026053|FG000|Droxidopa 50 mg|Overall Study|Because dosing was individualized for the participants, only 5 of the 6 patients were administered 50 mg of Droxidopa.|6
10860996|NCT00581477|12026053|FG000|Droxidopa 100 mg|Overall Study|Because dosing was individualized for the participants, only 4 of the 6 patients were administered 100 mg of Droxidopa.|6
10860997|NCT00581477|12026053|FG000|Droxidopa 200 mg|Overall Study|Because dosing was individualized for the participants, only 5 of the 6 patients were administered 200 mg of Droxidopa.|6
10860998|NCT00581477|12026053|FG000|Droxidopa 250 mg|Overall Study|Because dosing was individualized for the participants, only 2 of the 6 patients were administered 250 mg of Droxidopa.|6
10860999|NCT00581477|12026053|FG000|Droxidopa 300 mg|Overall Study|Because dosing was individualized for the participants, only 1 of the 6 patients was administered 300 mg of Droxidopa.|6
10861000|NCT00581477|12026053|FG000|COMPLETED|Overall Study||6
10861001|NCT00581477|12026053|FG000|NOT COMPLETED|Overall Study||2
10416458|NCT00793819|11560940|FG001|NOT COMPLETED|Overall Study||9
10416459|NCT00793871|11560946|FG000|STARTED|Overall Study||60
10416460|NCT00793871|11560946|FG000|Received Treatment|Overall Study||59
10416461|NCT00793871|11560946|FG000|COMPLETED|Overall Study||0
10416462|NCT00793871|11560946|FG000|NOT COMPLETED|Overall Study||60
10416463|NCT00793910|11560952|FG000|STARTED|Overall Study||53
10416464|NCT00793910|11560953|FG001|STARTED|Overall Study||53
10416465|NCT00793910|11560952|FG000|COMPLETED|Overall Study||48
10416466|NCT00793910|11560953|FG001|COMPLETED|Overall Study||46
10416467|NCT00793910|11560952|FG000|NOT COMPLETED|Overall Study||5
10416468|NCT00793910|11560953|FG001|NOT COMPLETED|Overall Study||7
10416469|NCT00794040|11560961|FG000|STARTED|Overall Study||25
10416470|NCT00794040|11560962|FG001|STARTED|Overall Study||28
10416471|NCT00794040|11560961|FG000|COMPLETED|Overall Study||22
10416472|NCT00794040|11560962|FG001|COMPLETED|Overall Study||23
10416473|NCT00794040|11560961|FG000|NOT COMPLETED|Overall Study||3
10416474|NCT00794040|11560962|FG001|NOT COMPLETED|Overall Study||5
10416475|NCT00794118|11560968|FG000|STARTED|Overall Study||299
10416476|NCT00794118|11560968|FG000|COMPLETED|Overall Study||272
10416477|NCT00794118|11560968|FG000|NOT COMPLETED|Overall Study||27
10416478|NCT00794144|11560974|FG000|STARTED|Overall Study||66
10416479|NCT00794144|11560975|FG001|STARTED|Overall Study||66
10416480|NCT00794144|11560974|FG000|COMPLETED|Overall Study||63
10416481|NCT00794144|11560975|FG001|COMPLETED|Overall Study||63
10416482|NCT00794144|11560974|FG000|NOT COMPLETED|Overall Study||3
10416483|NCT00794144|11560975|FG001|NOT COMPLETED|Overall Study||3
10416484|NCT00794157|11560984|FG000|STARTED|Overall Study||114
10416485|NCT00794157|11560985|FG001|STARTED|Overall Study||116
10416486|NCT00794157|11560986|FG002|STARTED|Overall Study||117
10416487|NCT00794157|11560984|FG000|COMPLETED|Overall Study||104
10416488|NCT00794157|11560985|FG001|COMPLETED|Overall Study||106
10416489|NCT00794157|11560986|FG002|COMPLETED|Overall Study||98
10416490|NCT00794157|11560984|FG000|NOT COMPLETED|Overall Study||10
10416491|NCT00794157|11560985|FG001|NOT COMPLETED|Overall Study||10
10416492|NCT00794157|11560986|FG002|NOT COMPLETED|Overall Study||19
10416493|NCT00794170|11560996|FG000|STARTED|Overall Study||157
10416494|NCT00794170|11560997|FG001|STARTED|Overall Study||155
10416495|NCT00794170|11560996|FG000|COMPLETED|Overall Study||150
10416496|NCT00794170|11560997|FG001|COMPLETED|Overall Study||152
10416497|NCT00794170|11560996|FG000|NOT COMPLETED|Overall Study||7
10416498|NCT00794170|11560997|FG001|NOT COMPLETED|Overall Study||3
10416499|NCT00794196|11561005|FG000|STARTED|Overall Study||92
10416500|NCT00794196|11561006|FG001|STARTED|Overall Study||87
10416501|NCT00794196|11561005|FG000|COMPLETED|Overall Study||87
10416502|NCT00794196|11561006|FG001|COMPLETED|Overall Study||64
10416503|NCT00794196|11561005|FG000|NOT COMPLETED|Overall Study||5
10861002|NCT00554294|12026069|FG000|STARTED|Overall Study||1469
10861003|NCT00554294|12026070|FG001|STARTED|Overall Study||1721
10861004|NCT00554294|12026069|FG000|COMPLETED|Overall Study||1309
10861005|NCT00554294|12026070|FG001|COMPLETED|Overall Study||1641
10861006|NCT00554294|12026069|FG000|NOT COMPLETED|Overall Study||160
10861007|NCT00554294|12026070|FG001|NOT COMPLETED|Overall Study||80
10861008|NCT00554190|12026074|FG000|STARTED|Overall Study|29 subjects treated.|29
10861009|NCT00554190|12026074|FG000|COMPLETED|Overall Study|10 subjects did not complete the Termination Study Forms|19
10861010|NCT00554190|12026074|FG000|NOT COMPLETED|Overall Study||10
10861011|NCT00546273|12026083|FG000|STARTED|I||4
10861012|NCT00546273|12026084|FG001|STARTED|I||0
10861013|NCT00546273|12026085|FG002|STARTED|I||0
10861014|NCT00546273|12026086|FG003|STARTED|I||0
10861015|NCT00546273|12026087|FG004|STARTED|I||2
10861016|NCT00546273|12026083|FG000|COMPLETED|I||4
10861017|NCT00546273|12026084|FG001|COMPLETED|I||0
10861018|NCT00546273|12026085|FG002|COMPLETED|I||0
10861019|NCT00546273|12026086|FG003|COMPLETED|I||0
10861020|NCT00546273|12026087|FG004|COMPLETED|I||2
10861021|NCT00546273|12026083|FG000|NOT COMPLETED|I||0
10861022|NCT00546273|12026084|FG001|NOT COMPLETED|I||0
10861023|NCT00546273|12026085|FG002|NOT COMPLETED|I||0
10861024|NCT00546273|12026086|FG003|NOT COMPLETED|I||0
10861025|NCT00546273|12026087|FG004|NOT COMPLETED|I||0
10861026|NCT00546273|12026083|FG000|STARTED|II||0
10861027|NCT00546273|12026084|FG001|STARTED|II||4
10861028|NCT00546273|12026085|FG002|STARTED|II||0
10861029|NCT00546273|12026086|FG003|STARTED|II||0
10861030|NCT00546273|12026087|FG004|STARTED|II||2
10861031|NCT00546273|12026083|FG000|COMPLETED|II||0
10861032|NCT00546273|12026084|FG001|COMPLETED|II||4
10861033|NCT00546273|12026085|FG002|COMPLETED|II||0
10861034|NCT00546273|12026086|FG003|COMPLETED|II||0
10861035|NCT00546273|12026087|FG004|COMPLETED|II||2
10861036|NCT00546273|12026083|FG000|NOT COMPLETED|II||0
10861037|NCT00546273|12026084|FG001|NOT COMPLETED|II||0
10861038|NCT00546273|12026085|FG002|NOT COMPLETED|II||0
10861039|NCT00546273|12026086|FG003|NOT COMPLETED|II||0
10861040|NCT00546273|12026087|FG004|NOT COMPLETED|II||0
10861041|NCT00546273|12026083|FG000|STARTED|III||0
10861042|NCT00546273|12026084|FG001|STARTED|III||0
10861043|NCT00546273|12026085|FG002|STARTED|III||4
10861044|NCT00546273|12026086|FG003|STARTED|III||0
10861045|NCT00546273|12026087|FG004|STARTED|III||2
10861046|NCT00546273|12026083|FG000|COMPLETED|III||0
10861047|NCT00546273|12026084|FG001|COMPLETED|III||0
10861048|NCT00546273|12026085|FG002|COMPLETED|III||4
10861049|NCT00546273|12026086|FG003|COMPLETED|III||0
10861050|NCT00546273|12026087|FG004|COMPLETED|III||2
10861051|NCT00546273|12026083|FG000|NOT COMPLETED|III||0
10861052|NCT00546273|12026084|FG001|NOT COMPLETED|III||0
10861053|NCT00546273|12026085|FG002|NOT COMPLETED|III||0
10861054|NCT00546273|12026086|FG003|NOT COMPLETED|III||0
10861055|NCT00546273|12026087|FG004|NOT COMPLETED|III||0
10861056|NCT00546273|12026083|FG000|STARTED|IV||0
10861057|NCT00546273|12026084|FG001|STARTED|IV||0
10861058|NCT00546273|12026085|FG002|STARTED|IV||0
10861059|NCT00546273|12026086|FG003|STARTED|IV||4
10861060|NCT00546273|12026087|FG004|STARTED|IV||2
10861061|NCT00546273|12026083|FG000|COMPLETED|IV||0
10861062|NCT00546273|12026084|FG001|COMPLETED|IV||0
10293731|NCT03760146|11426357|FG002|Evaluable 7-Additional Immunogenicity Population|Overall Study||0
10293732|NCT03760146|11426358|FG003|Evaluable 7-Additional Immunogenicity Population|Overall Study||0
10293733|NCT03760146|11426359|FG004|Evaluable 7-Additional Immunogenicity Population|Overall Study||0
10293734|NCT03760146|11426360|FG005|Evaluable 7-Additional Immunogenicity Population|Overall Study||0
10293735|NCT03760146|11426355|FG000|Vaccination 1|Overall Study||1507
10293736|NCT03760146|11426356|FG001|Vaccination 1|Overall Study||1490
10293737|NCT03760146|11426357|FG002|Vaccination 1|Overall Study||334
10293738|NCT03760146|11426358|FG003|Vaccination 1|Overall Study||111
10293739|NCT03760146|11426359|FG004|Vaccination 1|Overall Study||335
10293740|NCT03760146|11426360|FG005|Vaccination 1|Overall Study||112
10293741|NCT03760146|11426355|FG000|Vaccination 2|Overall Study||1461
10293742|NCT03760146|11426356|FG001|Vaccination 2|Overall Study||1446
10293743|NCT03760146|11426357|FG002|Vaccination 2|Overall Study||0
10293744|NCT03760146|11426358|FG003|Vaccination 2|Overall Study||0
10293745|NCT03760146|11426359|FG004|Vaccination 2|Overall Study||0
10293746|NCT03760146|11426360|FG005|Vaccination 2|Overall Study||0
10293747|NCT03760146|11426355|FG000|Safety Population|Overall Study||1507
10293748|NCT03760146|11426356|FG001|Safety Population|Overall Study||1490
10293749|NCT03760146|11426357|FG002|Safety Population|Overall Study||334
10293750|NCT03760146|11426358|FG003|Safety Population|Overall Study||111
10293751|NCT03760146|11426359|FG004|Safety Population|Overall Study||335
10293752|NCT03760146|11426360|FG005|Safety Population|Overall Study||112
10293753|NCT03760146|11426355|FG000|Evaluable-20 Immunogenicity Population|Overall Study|Only for 60-64 years of age.|946
10293754|NCT03760146|11426356|FG001|Evaluable-20 Immunogenicity Population|Overall Study||0
10293755|NCT03760146|11426357|FG002|Evaluable-20 Immunogenicity Population|Overall Study||321
10861063|NCT00546273|12026085|FG002|COMPLETED|IV||0
10861064|NCT00546273|12026086|FG003|COMPLETED|IV||4
10861065|NCT00546273|12026087|FG004|COMPLETED|IV||2
10861066|NCT00546273|12026083|FG000|NOT COMPLETED|IV||0
10861067|NCT00546273|12026084|FG001|NOT COMPLETED|IV||0
10861068|NCT00546273|12026085|FG002|NOT COMPLETED|IV||0
10861069|NCT00546273|12026086|FG003|NOT COMPLETED|IV||0
10861070|NCT00546273|12026087|FG004|NOT COMPLETED|IV||0
10861071|NCT00529152|12026094|FG000|STARTED|Overall Study||100
10861072|NCT00529152|12026094|FG000|COMPLETED|Overall Study||95
10861073|NCT00529152|12026094|FG000|NOT COMPLETED|Overall Study||5
10861074|NCT00526227|12026097|FG000|STARTED|Overall Study||81
10861075|NCT00526227|12026097|FG000|COMPLETED|Overall Study||79
10861076|NCT00526227|12026097|FG000|NOT COMPLETED|Overall Study||2
10861077|NCT00513617|12026105|FG000|STARTED|Overall Study||36
10861078|NCT00513617|12026106|FG001|STARTED|Overall Study||35
10861079|NCT00513617|12026107|FG002|STARTED|Overall Study||38
10861080|NCT00513617|12026105|FG000|COMPLETED|Overall Study||25
10861081|NCT00513617|12026106|FG001|COMPLETED|Overall Study||25
10861082|NCT00513617|12026107|FG002|COMPLETED|Overall Study||30
10861083|NCT00513617|12026105|FG000|NOT COMPLETED|Overall Study||11
10861084|NCT00513617|12026106|FG001|NOT COMPLETED|Overall Study||10
10861085|NCT00513617|12026107|FG002|NOT COMPLETED|Overall Study||8
10861086|NCT00495222|12026112|FG000|STARTED|Overall Study||9
10861087|NCT00495222|12026112|FG000|COMPLETED|Overall Study||9
10861088|NCT00495222|12026112|FG000|NOT COMPLETED|Overall Study||0
10861089|NCT00495131|12026117|FG000|STARTED|Overall Study||154
10861090|NCT00495131|12026118|FG001|STARTED|Overall Study||154
10861091|NCT00495131|12026117|FG000|COMPLETED|Overall Study||147
10861092|NCT00495131|12026118|FG001|COMPLETED|Overall Study||148
10861093|NCT00495131|12026117|FG000|NOT COMPLETED|Overall Study||7
10861094|NCT00495131|12026118|FG001|NOT COMPLETED|Overall Study||6
10861095|NCT00491738|12026124|FG000|STARTED|Overall Study||7
10861096|NCT00491738|12026125|FG001|STARTED|Overall Study||9
10861097|NCT00491738|12026124|FG000|COMPLETED|Overall Study||7
10861098|NCT00491738|12026125|FG001|COMPLETED|Overall Study||9
10861099|NCT00491738|12026124|FG000|NOT COMPLETED|Overall Study||0
10861100|NCT00491738|12026125|FG001|NOT COMPLETED|Overall Study||0
10861101|NCT00484419|12026132|FG000|STARTED|Overall Study||57
10861102|NCT00484419|12026133|FG001|STARTED|Overall Study||56
10861103|NCT00484419|12026134|FG002|STARTED|Overall Study||56
10861104|NCT00484419|12026132|FG000|COMPLETED|Overall Study||45
10861105|NCT00484419|12026133|FG001|COMPLETED|Overall Study||51
10861106|NCT00484419|12026134|FG002|COMPLETED|Overall Study||45
10861107|NCT00484419|12026132|FG000|NOT COMPLETED|Overall Study||12
10861108|NCT00484419|12026133|FG001|NOT COMPLETED|Overall Study||5
10861109|NCT00484419|12026134|FG002|NOT COMPLETED|Overall Study||11
10861110|NCT00479258|12026141|FG000|STARTED|Overall Study||0
10861111|NCT00479258|12026142|FG001|STARTED|Overall Study||0
10861112|NCT00479258|12026141|FG000|COMPLETED|Overall Study||0
10861113|NCT00479258|12026142|FG001|COMPLETED|Overall Study||0
10861114|NCT00479258|12026141|FG000|NOT COMPLETED|Overall Study||0
10861115|NCT00479258|12026142|FG001|NOT COMPLETED|Overall Study||0
10861116|NCT00474188|12026146|FG000|STARTED|Overall Study||26
10861117|NCT00474188|12026146|FG000|COMPLETED|Overall Study|Disease progression=15, adverse event=4, death=1|20
10861118|NCT00474188|12026146|FG000|NOT COMPLETED|Overall Study||6
10861119|NCT00440531|12026152|FG000|STARTED|Overall Study||185
10861120|NCT00440531|12026153|FG001|STARTED|Overall Study||183
10861121|NCT00440531|12026154|FG002|STARTED|Overall Study||172
10861122|NCT00440531|12026152|FG000|Vaccination 1|Overall Study||183
10861123|NCT00440531|12026153|FG001|Vaccination 1|Overall Study||183
10861124|NCT00440531|12026154|FG002|Vaccination 1|Overall Study||172
10861125|NCT00440531|12026152|FG000|Vaccination 2|Overall Study||181
10861126|NCT00440531|12026153|FG001|Vaccination 2|Overall Study||182
10861127|NCT00440531|12026154|FG002|Vaccination 2|Overall Study||171
10861128|NCT00440531|12026152|FG000|Vaccination 3|Overall Study||176
10861129|NCT00440531|12026153|FG001|Vaccination 3|Overall Study||178
10861130|NCT00440531|12026154|FG002|Vaccination 3|Overall Study||166
10861131|NCT00440531|12026152|FG000|COMPLETED|Overall Study||175
10861132|NCT00440531|12026153|FG001|COMPLETED|Overall Study||178
10861133|NCT00440531|12026154|FG002|COMPLETED|Overall Study||165
10861134|NCT00440531|12026152|FG000|NOT COMPLETED|Overall Study||10
10861135|NCT00440531|12026153|FG001|NOT COMPLETED|Overall Study||5
10861136|NCT00440531|12026154|FG002|NOT COMPLETED|Overall Study||7
10861137|NCT00439738|12026162|FG000|STARTED|Overall Study||206
10861138|NCT00439738|12026163|FG001|STARTED|Overall Study||206
10861139|NCT00439738|12026162|FG000|COMPLETED|Overall Study||170
10861140|NCT00439738|12026163|FG001|COMPLETED|Overall Study||178
10861141|NCT00439738|12026162|FG000|NOT COMPLETED|Overall Study||36
10861142|NCT00439738|12026163|FG001|NOT COMPLETED|Overall Study||28
10861143|NCT00434226|12026169|FG000|STARTED|Overall Study||30
10861144|NCT00434226|12026170|FG001|STARTED|Overall Study||26
10861145|NCT00434226|12026169|FG000|COMPLETED|Overall Study||0
10861146|NCT00434226|12026170|FG001|COMPLETED|Overall Study||0
10861147|NCT00434226|12026169|FG000|NOT COMPLETED|Overall Study||30
10861148|NCT00434226|12026170|FG001|NOT COMPLETED|Overall Study||26
10861149|NCT00430950|12026176|FG000|STARTED|Overall Study||502
10861150|NCT00430950|12026177|FG001|STARTED|Overall Study||508
10861151|NCT00430950|12026176|FG000|COMPLETED|Overall Study||489
10861152|NCT00430950|12026177|FG001|COMPLETED|Overall Study||495
10861153|NCT00430950|12026176|FG000|NOT COMPLETED|Overall Study||13
10861154|NCT00430950|12026177|FG001|NOT COMPLETED|Overall Study||13
10861155|NCT00430508|12026185|FG000|STARTED|Overall Study||140
10861156|NCT00430508|12026186|FG001|STARTED|Overall Study||278
10861157|NCT00430508|12026187|FG002|STARTED|Overall Study||279
10861158|NCT00430508|12026188|FG003|STARTED|Overall Study||274
10861159|NCT00430508|12026185|FG000|COMPLETED|Overall Study||137
10861160|NCT00430508|12026186|FG001|COMPLETED|Overall Study||272
10861161|NCT00430508|12026187|FG002|COMPLETED|Overall Study||266
10861162|NCT00430508|12026188|FG003|COMPLETED|Overall Study||269
10861163|NCT00430508|12026185|FG000|NOT COMPLETED|Overall Study||3
10861164|NCT00430508|12026186|FG001|NOT COMPLETED|Overall Study||6
10861165|NCT00430508|12026187|FG002|NOT COMPLETED|Overall Study||13
10861166|NCT00430508|12026188|FG003|NOT COMPLETED|Overall Study||5
10861167|NCT00430092|12026197|FG000|STARTED|Overall Study||54
10861168|NCT00430092|12026198|FG001|STARTED|Overall Study||52
10861169|NCT00430092|12026199|FG002|STARTED|Overall Study||113
10861170|NCT00430092|12026197|FG000|COMPLETED|Overall Study||48
10861171|NCT00430092|12026198|FG001|COMPLETED|Overall Study||48
10861172|NCT00430092|12026199|FG002|COMPLETED|Overall Study||56
10861173|NCT00430092|12026197|FG000|NOT COMPLETED|Overall Study||6
10861174|NCT00430092|12026198|FG001|NOT COMPLETED|Overall Study||4
10861175|NCT00430092|12026199|FG002|NOT COMPLETED|Overall Study||57
10861176|NCT00429923|12026207|FG000|STARTED|Overall Study||57
10861177|NCT00429923|12026208|FG001|STARTED|Overall Study||55
10861178|NCT00429923|12026209|FG002|STARTED|Overall Study||107
10861179|NCT00429923|12026207|FG000|COMPLETED|Overall Study||52
10861180|NCT00429923|12026208|FG001|COMPLETED|Overall Study||51
10861181|NCT00429923|12026209|FG002|COMPLETED|Overall Study||68
10861182|NCT00429923|12026207|FG000|NOT COMPLETED|Overall Study||5
10861183|NCT00429923|12026208|FG001|NOT COMPLETED|Overall Study||4
10861184|NCT00429923|12026209|FG002|NOT COMPLETED|Overall Study||39
10861185|NCT00425100|12026214|FG000|STARTED|Overall Study||516
10861186|NCT00425100|12026214|FG000|COMPLETED|Overall Study||463
10861187|NCT00425100|12026214|FG000|NOT COMPLETED|Overall Study||53
10861188|NCT00415623|12026221|FG000|STARTED|Overall Study||154
10861189|NCT00415623|12026222|FG001|STARTED|Overall Study||151
10861190|NCT00415623|12026221|FG000|COMPLETED|Overall Study||149
10861191|NCT00415623|12026222|FG001|COMPLETED|Overall Study||146
10861192|NCT00415623|12026221|FG000|NOT COMPLETED|Overall Study||5
10861193|NCT00415623|12026222|FG001|NOT COMPLETED|Overall Study||5
10861194|NCT00412932|12026229|FG000|STARTED|Olmesartan (Olm) 20 mg||178
10861195|NCT00412932|12026229|FG000|COMPLETED|Olmesartan (Olm) 20 mg||171
10861196|NCT00412932|12026229|FG000|NOT COMPLETED|Olmesartan (Olm) 20 mg||7
10861197|NCT00412932|12026229|FG000|STARTED|Olmesartan 40 mg|171 -1 met blood pressure goal (stayed on olmesartan 20) -1 who erroneously skipped this step = 169.|169
10861198|NCT00412932|12026229|FG000|COMPLETED|Olmesartan 40 mg||161
10861199|NCT00412932|12026229|FG000|NOT COMPLETED|Olmesartan 40 mg||8
10861200|NCT00412932|12026229|FG000|STARTED|Olm+Hydrochlorothiazide 12.5 mg|161 -2 met blood pressure goal (stayed on olmesartan 40) = 159|159
10861201|NCT00412932|12026229|FG000|COMPLETED|Olm+Hydrochlorothiazide 12.5 mg||153
10861202|NCT00412932|12026229|FG000|NOT COMPLETED|Olm+Hydrochlorothiazide 12.5 mg||6
10861203|NCT00412932|12026229|FG000|STARTED|Olm+ Hydrochlorothiazide 25 mg|153 -28 met their blood pressure goal (stayed on olmesartan 40/hydrochlorothiazide 12.5) = 125|125
10861204|NCT00412932|12026229|FG000|COMPLETED|Olm+ Hydrochlorothiazide 25 mg||123
10861205|NCT00412932|12026229|FG000|NOT COMPLETED|Olm+ Hydrochlorothiazide 25 mg||2
10416504|NCT00794196|11561006|FG001|NOT COMPLETED|Overall Study||23
10416505|NCT00794313|11561012|FG000|STARTED|Overall Study||1
10416506|NCT00794313|11561013|FG001|STARTED|Overall Study||1
10416507|NCT00794313|11561014|FG002|STARTED|Overall Study||1
10416508|NCT00794313|11561012|FG000|COMPLETED|Overall Study||1
10416509|NCT00794313|11561013|FG001|COMPLETED|Overall Study||1
10416510|NCT00794313|11561014|FG002|COMPLETED|Overall Study||1
10416511|NCT00794313|11561012|FG000|NOT COMPLETED|Overall Study||0
10416512|NCT00794313|11561013|FG001|NOT COMPLETED|Overall Study||0
10416513|NCT00794313|11561014|FG002|NOT COMPLETED|Overall Study||0
10416514|NCT00794339|11561025|FG000|STARTED|Overall Study||73
10416515|NCT00794339|11561025|FG000|Eligible|Overall Study||69
10416516|NCT00794339|11561025|FG000|Evaluable|Overall Study||59
10416517|NCT00794339|11561025|FG000|COMPLETED|Overall Study||59
10416518|NCT00794339|11561025|FG000|NOT COMPLETED|Overall Study||14
10416519|NCT00794365|11561046|FG000|STARTED|Overall Study||330
10416520|NCT00794365|11561046|FG000|COMPLETED|Overall Study||251
10416521|NCT00794365|11561046|FG000|NOT COMPLETED|Overall Study||79
10548298|NCT01518699|11702090|FG005|COMPLETED|Period 3||9
10416522|NCT00794417|11561054|FG000|STARTED|Phase 1: Baseline (Day 1) up to Day 751||4
10416523|NCT00794417|11561055|FG001|STARTED|Phase 1: Baseline (Day 1) up to Day 751||7
10416524|NCT00794417|11561056|FG002|STARTED|Phase 1: Baseline (Day 1) up to Day 751||7
10861206|NCT00397254|12026232|FG000|STARTED|Overall Study||79
10861207|NCT00397254|12026233|FG001|STARTED|Overall Study||76
10861208|NCT00397254|12026232|FG000|COMPLETED|Overall Study||77
10861209|NCT00397254|12026233|FG001|COMPLETED|Overall Study||74
10861210|NCT00397254|12026232|FG000|NOT COMPLETED|Overall Study||2
10861211|NCT00397254|12026233|FG001|NOT COMPLETED|Overall Study||2
10861212|NCT00393068|12026237|FG000|STARTED|Overall Study||62
10861213|NCT00393068|12026237|FG000|COMPLETED|Overall Study||44
10861214|NCT00393068|12026237|FG000|NOT COMPLETED|Overall Study||18
10861215|NCT00385515|12026243|FG000|STARTED|Overall Study||57
10861216|NCT00385515|12026244|FG001|STARTED|Overall Study||24
10861217|NCT00385515|12026243|FG000|COMPLETED|Overall Study||53
10861218|NCT00385515|12026244|FG001|COMPLETED|Overall Study||21
10861219|NCT00385515|12026243|FG000|NOT COMPLETED|Overall Study||4
10861220|NCT00385515|12026244|FG001|NOT COMPLETED|Overall Study||3
10861221|NCT00362401|12026251|FG000|STARTED|Overall Study||15
10861222|NCT00362401|12026252|FG001|STARTED|Overall Study||29
10861223|NCT00362401|12026253|FG002|STARTED|Overall Study||40
10861224|NCT00362401|12026251|FG000|COMPLETED|Overall Study||15
10861225|NCT00362401|12026252|FG001|COMPLETED|Overall Study||29
10861226|NCT00362401|12026253|FG002|COMPLETED|Overall Study||40
10861227|NCT00362401|12026251|FG000|NOT COMPLETED|Overall Study||0
10861228|NCT00362401|12026252|FG001|NOT COMPLETED|Overall Study||0
10861229|NCT00362401|12026253|FG002|NOT COMPLETED|Overall Study||0
10861230|NCT00338104|12026261|FG000|STARTED|Overall Study||25
10861231|NCT00338104|12026262|FG001|STARTED|Overall Study||25
10861232|NCT00338104|12026263|FG002|STARTED|Overall Study||25
10861233|NCT00338104|12026261|FG000|COMPLETED|Overall Study||23
10861234|NCT00338104|12026262|FG001|COMPLETED|Overall Study||24
10861235|NCT00338104|12026263|FG002|COMPLETED|Overall Study||22
10861236|NCT00338104|12026261|FG000|NOT COMPLETED|Overall Study||2
10861237|NCT00338104|12026262|FG001|NOT COMPLETED|Overall Study||1
10861238|NCT00338104|12026263|FG002|NOT COMPLETED|Overall Study||3
10861239|NCT00336973|12026268|FG000|STARTED|Overall Study||66
10861240|NCT00336973|12026268|FG000|COMPLETED|Overall Study||33
10861241|NCT00336973|12026268|FG000|NOT COMPLETED|Overall Study||33
10861242|NCT00326183|12026273|FG000|STARTED|Overall Study||1453
10861243|NCT00326183|12026274|FG001|STARTED|Overall Study||347
10861244|NCT00326183|12026273|FG000|Vaccination 1 + Safety Follow-up|Overall Study||1453
10861245|NCT00326183|12026274|FG001|Vaccination 1 + Safety Follow-up|Overall Study||347
10861246|NCT00326183|12026273|FG000|Postvaccination 1 Post-safety Follow-up|Overall Study||1393
10861247|NCT00326183|12026274|FG001|Postvaccination 1 Post-safety Follow-up|Overall Study||325
10861248|NCT00326183|12026273|FG000|Vaccination 2 + Safety Follow-up|Overall Study||1301
10861249|NCT00326183|12026274|FG001|Vaccination 2 + Safety Follow-up|Overall Study||292
10861250|NCT00326183|12026273|FG000|Postvaccination 2 Post-safety Follow-up|Overall Study||1265
10861251|NCT00326183|12026274|FG001|Postvaccination 2 Post-safety Follow-up|Overall Study||271
10861252|NCT00326183|12026273|FG000|COMPLETED|Overall Study||1253
10861253|NCT00326183|12026274|FG001|COMPLETED|Overall Study||264
10861254|NCT00326183|12026273|FG000|NOT COMPLETED|Overall Study||200
10861255|NCT00326183|12026274|FG001|NOT COMPLETED|Overall Study||83
10861256|NCT00323037|12026280|FG000|STARTED|Overall Study|Number randomized|165
10861257|NCT00323037|12026281|FG001|STARTED|Overall Study|Number randomized|153
10861258|NCT00323037|12026280|FG000|COMPLETED|Overall Study||132
10861259|NCT00323037|12026281|FG001|COMPLETED|Overall Study||126
10861260|NCT00323037|12026280|FG000|NOT COMPLETED|Overall Study||33
10861261|NCT00323037|12026281|FG001|NOT COMPLETED|Overall Study||27
10861262|NCT00318656|12026287|FG000|STARTED|Overall Study||12
10861263|NCT00318656|12026288|FG001|STARTED|Overall Study||11
10861264|NCT00318656|12026287|FG000|COMPLETED|Overall Study||12
10861265|NCT00318656|12026288|FG001|COMPLETED|Overall Study|1 patient received by error avandamet treatment and 1 patient did not receive any treatment.|9
10861266|NCT00318656|12026287|FG000|NOT COMPLETED|Overall Study||0
10416525|NCT00794417|11561057|FG003|STARTED|Phase 1: Baseline (Day 1) up to Day 751||0
10416526|NCT00794417|11561054|FG000|COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||1
10416527|NCT00794417|11561055|FG001|COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||4
10416528|NCT00794417|11561056|FG002|COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||4
10416529|NCT00794417|11561057|FG003|COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||0
10861267|NCT00318656|12026288|FG001|NOT COMPLETED|Overall Study||2
10861268|NCT00301262|12026294|FG000|STARTED|Double Blind Phase (DB)||94
10861269|NCT00301262|12026295|FG001|STARTED|Double Blind Phase (DB)||82
10293756|NCT03760146|11426358|FG003|Evaluable-20 Immunogenicity Population|Overall Study||0
10293757|NCT03760146|11426359|FG004|Evaluable-20 Immunogenicity Population|Overall Study||317
10293758|NCT03760146|11426360|FG005|Evaluable-20 Immunogenicity Population|Overall Study||0
10293759|NCT03760146|11426355|FG000|COMPLETED|Overall Study||1418
10293760|NCT03760146|11426356|FG001|COMPLETED|Overall Study||1417
10293761|NCT03760146|11426357|FG002|COMPLETED|Overall Study||323
10293762|NCT03760146|11426358|FG003|COMPLETED|Overall Study||109
10293763|NCT03760146|11426359|FG004|COMPLETED|Overall Study||319
10293764|NCT03760146|11426360|FG005|COMPLETED|Overall Study||104
10293765|NCT03760146|11426355|FG000|NOT COMPLETED|Overall Study||96
10293766|NCT03760146|11426356|FG001|NOT COMPLETED|Overall Study||78
10861270|NCT00301262|12026294|FG000|COMPLETED|Double Blind Phase (DB)||84
10861271|NCT00301262|12026295|FG001|COMPLETED|Double Blind Phase (DB)||69
10861272|NCT00301262|12026294|FG000|NOT COMPLETED|Double Blind Phase (DB)||10
10861273|NCT00301262|12026295|FG001|NOT COMPLETED|Double Blind Phase (DB)||13
10861274|NCT00301262|12026294|FG000|STARTED|Open Label Phase (OL)||83
10861275|NCT00301262|12026295|FG001|STARTED|Open Label Phase (OL)||69
10861276|NCT00301262|12026294|FG000|COMPLETED|Open Label Phase (OL)||79
10861277|NCT00301262|12026295|FG001|COMPLETED|Open Label Phase (OL)||67
10861278|NCT00301262|12026294|FG000|NOT COMPLETED|Open Label Phase (OL)||4
10861279|NCT00301262|12026295|FG001|NOT COMPLETED|Open Label Phase (OL)||2
10861280|NCT00283868|12026322|FG000|STARTED|Overall Study||111
10861281|NCT00283868|12026323|FG001|STARTED|Overall Study||111
10861282|NCT00283868|12026322|FG000|COMPLETED|Overall Study||104
10861283|NCT00283868|12026323|FG001|COMPLETED|Overall Study||103
10861284|NCT00283868|12026322|FG000|NOT COMPLETED|Overall Study||7
10861285|NCT00283868|12026323|FG001|NOT COMPLETED|Overall Study||8
10861286|NCT00282867|12026330|FG000|STARTED|Overall Study||24
10861287|NCT00282867|12026331|FG001|STARTED|Overall Study||25
10861288|NCT00282867|12026332|FG002|STARTED|Overall Study||25
10861289|NCT00282867|12026330|FG000|COMPLETED|Overall Study||23
10861290|NCT00282867|12026331|FG001|COMPLETED|Overall Study||24
10861291|NCT00282867|12026332|FG002|COMPLETED|Overall Study||25
10861292|NCT00282867|12026330|FG000|NOT COMPLETED|Overall Study||1
10861293|NCT00282867|12026331|FG001|NOT COMPLETED|Overall Study||1
10861294|NCT00282867|12026332|FG002|NOT COMPLETED|Overall Study||0
10861295|NCT00275340|12026339|FG000|STARTED|Overall Study||52
10861296|NCT00275340|12026340|FG001|STARTED|Overall Study||49
10861297|NCT00275340|12026339|FG000|COMPLETED|Overall Study||50
10861298|NCT00275340|12026340|FG001|COMPLETED|Overall Study||45
10861299|NCT00275340|12026339|FG000|NOT COMPLETED|Overall Study||2
10861300|NCT00275340|12026340|FG001|NOT COMPLETED|Overall Study||4
10861301|NCT00271544|12026344|FG000|STARTED|Overall Study|Total number of subjects enrolled.|190
10861302|NCT00271544|12026344|FG000|Implant Attempted|Overall Study|Total number of subjects completed baseline and underwent system implant attempt.|186
10861303|NCT00271544|12026344|FG000|Model 4196 Lead Attempted|Overall Study|Total number of subjects attempted Model 4196 lead.|177
10861304|NCT00271544|12026344|FG000|COMPLETED|Overall Study|Total number subjects successfully implanted 4196 lead.|170
10861305|NCT00271544|12026344|FG000|NOT COMPLETED|Overall Study||20
10293767|NCT03760146|11426357|FG002|NOT COMPLETED|Overall Study||11
10293768|NCT03760146|11426358|FG003|NOT COMPLETED|Overall Study||2
10293769|NCT03760146|11426359|FG004|NOT COMPLETED|Overall Study||17
10861306|NCT00240500|12026366|FG000|STARTED|Overall Study||17
10861307|NCT00240500|12026367|FG001|STARTED|Overall Study||20
10861308|NCT00240500|12026368|FG002|STARTED|Overall Study||17
10861309|NCT00240500|12026369|FG003|STARTED|Overall Study||23
10861310|NCT00240500|12026370|FG004|STARTED|Overall Study||29
10861311|NCT00240500|12026371|FG005|STARTED|Overall Study||3
10861312|NCT00240500|12026366|FG000|COMPLETED|Overall Study||16
10861313|NCT00240500|12026367|FG001|COMPLETED|Overall Study||17
10861314|NCT00240500|12026368|FG002|COMPLETED|Overall Study||14
10861315|NCT00240500|12026369|FG003|COMPLETED|Overall Study||19
10861316|NCT00240500|12026370|FG004|COMPLETED|Overall Study||26
10861317|NCT00240500|12026371|FG005|COMPLETED|Overall Study||2
10861318|NCT00240500|12026366|FG000|NOT COMPLETED|Overall Study||1
10861319|NCT00240500|12026367|FG001|NOT COMPLETED|Overall Study||3
10861320|NCT00240500|12026368|FG002|NOT COMPLETED|Overall Study||3
10861321|NCT00240500|12026369|FG003|NOT COMPLETED|Overall Study||4
10861322|NCT00240500|12026370|FG004|NOT COMPLETED|Overall Study||3
10861323|NCT00240500|12026371|FG005|NOT COMPLETED|Overall Study||1
10861324|NCT00235326|12026381|FG000|STARTED|Overall Study||1575
10861325|NCT00235326|12026382|FG001|STARTED|Overall Study||2986
10861326|NCT00235326|12026381|FG000|COMPLETED|Overall Study||829
10861327|NCT00235326|12026382|FG001|COMPLETED|Overall Study||1586
10416530|NCT00794417|11561054|FG000|NOT COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||3
10416531|NCT00794417|11561055|FG001|NOT COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||3
10416532|NCT00794417|11561056|FG002|NOT COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||3
10416533|NCT00794417|11561057|FG003|NOT COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||0
10416534|NCT00794417|11561054|FG000|STARTED|Phase 2: Baseline (Day 421) to Day 972|Participants enrolled in phase 1 were not eligible for enrollment in phase 2.|0
10416535|NCT00794417|11561055|FG001|STARTED|Phase 2: Baseline (Day 421) to Day 972|Participants enrolled in phase 1 were not eligible for enrollment in phase 2.|0
10416536|NCT00794417|11561056|FG002|STARTED|Phase 2: Baseline (Day 421) to Day 972|Participants enrolled in phase 1 were not eligible for enrollment in phase 2.|0
10416537|NCT00794417|11561057|FG003|STARTED|Phase 2: Baseline (Day 421) to Day 972||42
10416538|NCT00794417|11561054|FG000|COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
10416539|NCT00794417|11561055|FG001|COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
10416540|NCT00794417|11561056|FG002|COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
10416541|NCT00794417|11561057|FG003|COMPLETED|Phase 2: Baseline (Day 421) to Day 972||7
10416542|NCT00794417|11561054|FG000|NOT COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
10416543|NCT00794417|11561055|FG001|NOT COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
10416544|NCT00794417|11561056|FG002|NOT COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
10416545|NCT00794417|11561057|FG003|NOT COMPLETED|Phase 2: Baseline (Day 421) to Day 972||35
10416546|NCT00794469|11561069|FG000|STARTED|Overall Study||21
10416547|NCT00794469|11561069|FG000|COMPLETED|Overall Study||21
10416548|NCT00794469|11561069|FG000|NOT COMPLETED|Overall Study||0
10416549|NCT00794508|11561073|FG000|STARTED|Overall Study||10
10416550|NCT00794508|11561073|FG000|COMPLETED|Overall Study||10
10416551|NCT00794508|11561073|FG000|NOT COMPLETED|Overall Study||0
10416552|NCT00794547|11561077|FG000|STARTED|Overall Study||18
10416553|NCT00794547|11561078|FG001|STARTED|Overall Study||16
10416554|NCT00794547|11561077|FG000|COMPLETED|Overall Study||18
10416555|NCT00794547|11561078|FG001|COMPLETED|Overall Study||16
10416556|NCT00794547|11561077|FG000|NOT COMPLETED|Overall Study||0
10416557|NCT00794547|11561078|FG001|NOT COMPLETED|Overall Study||0
10416558|NCT00794560|11561086|FG000|STARTED|Overall Study||36
10416559|NCT00794560|11561087|FG001|STARTED|Overall Study||36
10416560|NCT00794560|11561088|FG002|STARTED|Overall Study||44
10416561|NCT00794560|11561089|FG003|STARTED|Overall Study||38
10416562|NCT00794560|11561086|FG000|COMPLETED|Overall Study||33
10416563|NCT00794560|11561087|FG001|COMPLETED|Overall Study||32
10416564|NCT00794560|11561088|FG002|COMPLETED|Overall Study||40
10416565|NCT00794560|11561089|FG003|COMPLETED|Overall Study||34
10416566|NCT00794560|11561086|FG000|NOT COMPLETED|Overall Study||3
10416567|NCT00794560|11561087|FG001|NOT COMPLETED|Overall Study||4
10416568|NCT00794560|11561088|FG002|NOT COMPLETED|Overall Study||4
10416569|NCT00794560|11561089|FG003|NOT COMPLETED|Overall Study||4
10416570|NCT00794573|11561101|FG000|STARTED|Overall Study||151
10416571|NCT00794573|11561102|FG001|STARTED|Overall Study||151
10416572|NCT00794573|11561101|FG000|COMPLETED|Overall Study||113
10416573|NCT00794573|11561102|FG001|COMPLETED|Overall Study||106
10416574|NCT00794573|11561101|FG000|NOT COMPLETED|Overall Study||38
10416575|NCT00794573|11561102|FG001|NOT COMPLETED|Overall Study||45
10416576|NCT00794664|11561110|FG000|STARTED|Treatment Period||19
10416577|NCT00794664|11561111|FG001|STARTED|Treatment Period||39
10416578|NCT00794664|11561110|FG000|COMPLETED|Treatment Period|3 participants enrolled in open-label extension study NCT00694109|18
10416579|NCT00794664|11561111|FG001|COMPLETED|Treatment Period|6 participants enrolled in open-label extension study NCT00694109|27
10416580|NCT00794664|11561110|FG000|NOT COMPLETED|Treatment Period||1
10416581|NCT00794664|11561111|FG001|NOT COMPLETED|Treatment Period||12
10416582|NCT00794664|11561110|FG000|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|16
10429352|NCT00863057|11575337|FG003|COMPLETED|Period 4 (Weeks 16-20)||2
10861328|NCT00235326|12026381|FG000|NOT COMPLETED|Overall Study||746
10861329|NCT00235326|12026382|FG001|NOT COMPLETED|Overall Study||1400
10861330|NCT00232141|12026388|FG000|STARTED|Overall Study||151
10861331|NCT00232141|12026389|FG001|STARTED|Overall Study||151
10861332|NCT00232141|12026388|FG000|COMPLETED|Overall Study||120
10861333|NCT00232141|12026389|FG001|COMPLETED|Overall Study||125
10861334|NCT00232141|12026388|FG000|NOT COMPLETED|Overall Study||31
10861335|NCT00232141|12026389|FG001|NOT COMPLETED|Overall Study||26
10861336|NCT00231153|12026395|FG000|STARTED|Overall Study|Subjects randomized to omiganan 1% gel who received at least one dose of study treatment.|907
10861337|NCT00231153|12026396|FG001|STARTED|Overall Study|Subjects randomized to povidone-iodine who received at least one dose of study treatment.|908
10861338|NCT00231153|12026395|FG000|COMPLETED|Overall Study||690
10861339|NCT00231153|12026396|FG001|COMPLETED|Overall Study||720
10861340|NCT00231153|12026395|FG000|NOT COMPLETED|Overall Study||217
10861341|NCT00231153|12026396|FG001|NOT COMPLETED|Overall Study||188
10861342|NCT00224003|12026400|FG000|STARTED|Overall Study|First patient in: April 2, 2003|23
10861343|NCT00224003|12026400|FG000|COMPLETED|Overall Study|Last patient out: March 31, 2004|16
10861344|NCT00224003|12026400|FG000|NOT COMPLETED|Overall Study||7
10861345|NCT00162942|12026405|FG000|STARTED|Overall Study||157
10861346|NCT00162942|12026406|FG001|STARTED|Overall Study||78
10861347|NCT00162942|12026405|FG000|Week 12|Overall Study||127
10861348|NCT00162942|12026406|FG001|Week 12|Overall Study||61
10861349|NCT00162942|12026405|FG000|COMPLETED|Overall Study||51
10861350|NCT00162942|12026406|FG001|COMPLETED|Overall Study||26
10861351|NCT00162942|12026405|FG000|NOT COMPLETED|Overall Study||106
10861352|NCT00162942|12026406|FG001|NOT COMPLETED|Overall Study||52
10861353|NCT00147290|12026412|FG000|STARTED|Overall Study||266
10861354|NCT00147290|12026413|FG001|STARTED|Overall Study||260
10861355|NCT00147290|12026412|FG000|COMPLETED|Overall Study||266
10861356|NCT00147290|12026413|FG001|COMPLETED|Overall Study||260
10861357|NCT00147290|12026412|FG000|NOT COMPLETED|Overall Study||0
10861358|NCT00147290|12026413|FG001|NOT COMPLETED|Overall Study||0
10861359|NCT00147277|12026419|FG000|STARTED|Overall Study||475
10861360|NCT00147277|12026420|FG001|STARTED|Overall Study||450
10861361|NCT00147277|12026419|FG000|COMPLETED|Overall Study||475
10861362|NCT00147277|12026420|FG001|COMPLETED|Overall Study||450
10861363|NCT00147277|12026419|FG000|NOT COMPLETED|Overall Study||0
10861364|NCT00147277|12026420|FG001|NOT COMPLETED|Overall Study||0
10861365|NCT00126776|12026426|FG000|STARTED|Overall Study||372
10861366|NCT00126776|12026427|FG001|STARTED|Overall Study||371
10861367|NCT00126776|12026426|FG000|COMPLETED|Overall Study||372
10861368|NCT00126776|12026427|FG001|COMPLETED|Overall Study||371
10861369|NCT00126776|12026426|FG000|NOT COMPLETED|Overall Study||0
10861370|NCT00126776|12026427|FG001|NOT COMPLETED|Overall Study||0
10861371|NCT00120042|12026434|FG000|STARTED|Overall Study||85
10861372|NCT00120042|12026435|FG001|STARTED|Overall Study||83
10861373|NCT00120042|12026436|FG002|STARTED|Overall Study||83
10861374|NCT00120042|12026434|FG000|COMPLETED|Overall Study||85
10861375|NCT00120042|12026435|FG001|COMPLETED|Overall Study||83
10861376|NCT00120042|12026436|FG002|COMPLETED|Overall Study||83
10861377|NCT00120042|12026434|FG000|NOT COMPLETED|Overall Study||0
10861378|NCT00120042|12026435|FG001|NOT COMPLETED|Overall Study||0
10861379|NCT00120042|12026436|FG002|NOT COMPLETED|Overall Study||0
10416583|NCT00794664|11561111|FG001|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|33
10416584|NCT00794664|11561110|FG000|COMPLETED|Follow-up Period||15
10416585|NCT00794664|11561111|FG001|COMPLETED|Follow-up Period||28
10416586|NCT00794664|11561110|FG000|NOT COMPLETED|Follow-up Period||1
10416587|NCT00794664|11561111|FG001|NOT COMPLETED|Follow-up Period||5
10416588|NCT00794820|11561117|FG000|STARTED|Overall Study||66
10416589|NCT00794820|11561117|FG000|COMPLETED|Overall Study||50
10416590|NCT00794820|11561117|FG000|NOT COMPLETED|Overall Study||16
10416591|NCT00794950|11561121|FG000|STARTED|BCG Induction||43
10416592|NCT00794950|11561121|FG000|COMPLETED|BCG Induction||36
10416593|NCT00794950|11561121|FG000|NOT COMPLETED|BCG Induction||7
10416594|NCT00794950|11561121|FG000|STARTED|Beginning Sunitinib Treatment||36
10416595|NCT00794950|11561121|FG000|COMPLETED|Beginning Sunitinib Treatment||24
10416596|NCT00794950|11561121|FG000|NOT COMPLETED|Beginning Sunitinib Treatment||12
10861380|NCT00106626|12026445|FG000|STARTED|Overall Study||13
10861381|NCT00106626|12026446|FG001|STARTED|Overall Study||9
10861382|NCT00106626|12026447|FG002|STARTED|Overall Study||14
10861383|NCT00106626|12026448|FG003|STARTED|Overall Study||16
10861384|NCT00106626|12026445|FG000|COMPLETED|Overall Study||3
10861385|NCT00106626|12026446|FG001|COMPLETED|Overall Study||3
10861386|NCT00106626|12026447|FG002|COMPLETED|Overall Study||2
10861387|NCT00106626|12026448|FG003|COMPLETED|Overall Study||3
10861388|NCT00106626|12026445|FG000|NOT COMPLETED|Overall Study||10
10861389|NCT00106626|12026446|FG001|NOT COMPLETED|Overall Study||6
10861390|NCT00106626|12026447|FG002|NOT COMPLETED|Overall Study||12
10861391|NCT00106626|12026448|FG003|NOT COMPLETED|Overall Study||13
10861392|NCT00089141|12026465|FG000|STARTED|Overall Study||74
10861393|NCT00089141|12026466|FG001|STARTED|Overall Study||77
10861394|NCT00089141|12026465|FG000|COMPLETED|Overall Study||56
10861395|NCT00089141|12026466|FG001|COMPLETED|Overall Study||53
10861396|NCT00089141|12026465|FG000|NOT COMPLETED|Overall Study||18
10861397|NCT00089141|12026466|FG001|NOT COMPLETED|Overall Study||24
10861398|NCT00083759|12026472|FG000|STARTED|Overall Study|150 subjects enrolled, 137 (Modified Intention-to-Treat [MITT] Population) for efficacy analyses|150
10861399|NCT00083759|12026473|FG001|STARTED|Overall Study|149 subjects enrolled, 136 (Modified Intention-to-Treat [MITT] Population) for efficacy analyses|149
10861400|NCT00083759|12026472|FG000|COMPLETED|Overall Study||66
10861401|NCT00083759|12026473|FG001|COMPLETED|Overall Study||66
10861402|NCT00083759|12026472|FG000|NOT COMPLETED|Overall Study||84
10861403|NCT00083759|12026473|FG001|NOT COMPLETED|Overall Study||83
10861404|NCT03513068|12026479|FG000|STARTED|Overall Study||54
10861405|NCT03513068|12026480|FG001|STARTED|Overall Study||54
10861406|NCT03513068|12026479|FG000|COMPLETED|Overall Study||49
10861407|NCT03513068|12026480|FG001|COMPLETED|Overall Study||48
10861408|NCT03513068|12026479|FG000|NOT COMPLETED|Overall Study||5
10861409|NCT03513068|12026480|FG001|NOT COMPLETED|Overall Study||6
10861410|NCT03507127|12026488|FG000|STARTED|Overall Study||3
10861411|NCT03507127|12026489|FG001|STARTED|Overall Study||2
10861412|NCT03507127|12026488|FG000|COMPLETED|Overall Study||1
10861413|NCT03507127|12026489|FG001|COMPLETED|Overall Study||1
10861414|NCT03507127|12026488|FG000|NOT COMPLETED|Overall Study||2
10861415|NCT03507127|12026489|FG001|NOT COMPLETED|Overall Study||1
10861416|NCT03502811|12026495|FG000|STARTED|Overall Study||1041
10861417|NCT03502811|12026495|FG000|COMPLETED|Overall Study||722
10861418|NCT03502811|12026495|FG000|NOT COMPLETED|Overall Study||319
10861419|NCT04789382|12026503|FG000|STARTED|First Wear Period (2 Hours)||9
10861420|NCT04789382|12026504|FG001|STARTED|First Wear Period (2 Hours)||9
10861421|NCT04789382|12026505|FG002|STARTED|First Wear Period (2 Hours)||9
10861422|NCT04789382|12026506|FG003|STARTED|First Wear Period (2 Hours)||9
10861423|NCT04789382|12026503|FG000|COMPLETED|First Wear Period (2 Hours)||9
10861424|NCT04789382|12026504|FG001|COMPLETED|First Wear Period (2 Hours)||9
10861425|NCT04789382|12026505|FG002|COMPLETED|First Wear Period (2 Hours)||9
10861426|NCT04789382|12026506|FG003|COMPLETED|First Wear Period (2 Hours)||9
10861427|NCT04789382|12026503|FG000|NOT COMPLETED|First Wear Period (2 Hours)||0
10861428|NCT04789382|12026504|FG001|NOT COMPLETED|First Wear Period (2 Hours)||0
10861429|NCT04789382|12026505|FG002|NOT COMPLETED|First Wear Period (2 Hours)||0
10861430|NCT04789382|12026506|FG003|NOT COMPLETED|First Wear Period (2 Hours)||0
10861431|NCT04789382|12026503|FG000|STARTED|Washout (Day of & Day Prior to Visit 3)||9
10861432|NCT04789382|12026504|FG001|STARTED|Washout (Day of & Day Prior to Visit 3)||9
10861433|NCT04789382|12026505|FG002|STARTED|Washout (Day of & Day Prior to Visit 3)||9
10861434|NCT04789382|12026506|FG003|STARTED|Washout (Day of & Day Prior to Visit 3)||9
10861435|NCT04789382|12026503|FG000|COMPLETED|Washout (Day of & Day Prior to Visit 3)||9
10861436|NCT04789382|12026504|FG001|COMPLETED|Washout (Day of & Day Prior to Visit 3)||9
10861437|NCT04789382|12026505|FG002|COMPLETED|Washout (Day of & Day Prior to Visit 3)||9
10861438|NCT04789382|12026506|FG003|COMPLETED|Washout (Day of & Day Prior to Visit 3)||9
10861439|NCT04789382|12026503|FG000|NOT COMPLETED|Washout (Day of & Day Prior to Visit 3)||0
10861440|NCT04789382|12026504|FG001|NOT COMPLETED|Washout (Day of & Day Prior to Visit 3)||0
10861441|NCT04789382|12026505|FG002|NOT COMPLETED|Washout (Day of & Day Prior to Visit 3)||0
10861442|NCT04789382|12026506|FG003|NOT COMPLETED|Washout (Day of & Day Prior to Visit 3)||0
10861443|NCT04789382|12026503|FG000|STARTED|Second Wear Period (2 Hours)||9
10861444|NCT04789382|12026504|FG001|STARTED|Second Wear Period (2 Hours)||9
10861445|NCT04789382|12026505|FG002|STARTED|Second Wear Period (2 Hours)||9
10861446|NCT04789382|12026506|FG003|STARTED|Second Wear Period (2 Hours)||9
10861447|NCT04789382|12026503|FG000|COMPLETED|Second Wear Period (2 Hours)||9
10861448|NCT04789382|12026504|FG001|COMPLETED|Second Wear Period (2 Hours)||9
10416597|NCT00794963|11561128|FG000|STARTED|Overall Study||4
10416598|NCT00794963|11561129|FG001|STARTED|Overall Study||4
10861449|NCT04789382|12026505|FG002|COMPLETED|Second Wear Period (2 Hours)||9
10861450|NCT04789382|12026506|FG003|COMPLETED|Second Wear Period (2 Hours)||9
10861451|NCT04789382|12026503|FG000|NOT COMPLETED|Second Wear Period (2 Hours)||0
10861452|NCT04789382|12026504|FG001|NOT COMPLETED|Second Wear Period (2 Hours)||0
10861453|NCT04789382|12026505|FG002|NOT COMPLETED|Second Wear Period (2 Hours)||0
10861454|NCT04789382|12026506|FG003|NOT COMPLETED|Second Wear Period (2 Hours)||0
10416599|NCT00794963|11561128|FG000|COMPLETED|Overall Study||3
10416600|NCT00794963|11561129|FG001|COMPLETED|Overall Study||0
10416601|NCT00794963|11561128|FG000|NOT COMPLETED|Overall Study||1
10861465|NCT03530995|12026529|FG000|STARTED|Part 1 Period 1; Part 2 Period 1||35
10861466|NCT03530995|12026530|FG001|STARTED|Part 1 Period 1; Part 2 Period 1||38
10861467|NCT03530995|12026529|FG000|COMPLETED|Part 1 Period 1; Part 2 Period 1||35
10861468|NCT03530995|12026530|FG001|COMPLETED|Part 1 Period 1; Part 2 Period 1||38
10861469|NCT03530995|12026529|FG000|NOT COMPLETED|Part 1 Period 1; Part 2 Period 1||0
10861470|NCT03530995|12026530|FG001|NOT COMPLETED|Part 1 Period 1; Part 2 Period 1||0
10861471|NCT03530995|12026529|FG000|STARTED|Part 1 Period 2; Part 2 Period 2||35
10861472|NCT03530995|12026530|FG001|STARTED|Part 1 Period 2; Part 2 Period 2||38
10861473|NCT03530995|12026529|FG000|COMPLETED|Part 1 Period 2; Part 2 Period 2||35
10861474|NCT03530995|12026530|FG001|COMPLETED|Part 1 Period 2; Part 2 Period 2||38
10861475|NCT03530995|12026529|FG000|NOT COMPLETED|Part 1 Period 2; Part 2 Period 2||0
10861476|NCT03530995|12026530|FG001|NOT COMPLETED|Part 1 Period 2; Part 2 Period 2||0
10861477|NCT03530995|12026529|FG000|STARTED|Part 1 Period 3||35
10861478|NCT03530995|12026530|FG001|STARTED|Part 1 Period 3|Period 3 is not applicable to part 2 of the study.|0
10861479|NCT03530995|12026529|FG000|COMPLETED|Part 1 Period 3||32
10861480|NCT03530995|12026530|FG001|COMPLETED|Part 1 Period 3|Period 3 is not applicable to part 2 of the study.|0
10861481|NCT03530995|12026529|FG000|NOT COMPLETED|Part 1 Period 3||3
10861482|NCT03530995|12026530|FG001|NOT COMPLETED|Part 1 Period 3||0
10861483|NCT03530995|12026529|FG000|STARTED|Part 1 Period 4||32
10861484|NCT03530995|12026530|FG001|STARTED|Part 1 Period 4|Period 4 is not applicable to part 2 of the study.|0
10861485|NCT03530995|12026529|FG000|COMPLETED|Part 1 Period 4||30
10861486|NCT03530995|12026530|FG001|COMPLETED|Part 1 Period 4|Period 4 is not applicable to part 2 of the study.|0
10861487|NCT03530995|12026529|FG000|NOT COMPLETED|Part 1 Period 4||2
10861488|NCT03530995|12026530|FG001|NOT COMPLETED|Part 1 Period 4||0
10861489|NCT03373006|12026552|FG000|STARTED|Overall Study||20
10861490|NCT03373006|12026552|FG000|COMPLETED|Overall Study||20
10861491|NCT03373006|12026552|FG000|NOT COMPLETED|Overall Study||0
10861492|NCT03368937|12026556|FG000|STARTED|Overall Study||5
10861493|NCT03368937|12026556|FG000|COMPLETED|Overall Study||5
10861494|NCT03368937|12026556|FG000|NOT COMPLETED|Overall Study||0
10861495|NCT03204812|12026560|FG000|STARTED|Overall Study||26
10861496|NCT03204812|12026560|FG000|COMPLETED|Overall Study||23
10861497|NCT03204812|12026560|FG000|NOT COMPLETED|Overall Study||3
10861501|NCT03072459|12026571|FG000|STARTED|Overall Study||128
10861502|NCT03072459|12026571|FG000|COMPLETED|Overall Study||126
10861503|NCT03072459|12026571|FG000|NOT COMPLETED|Overall Study||2
10861504|NCT03029234|12026575|FG000|STARTED|Overall Study||126
10861505|NCT03029234|12026575|FG000|Received Carfilzomib|Overall Study||123
10416602|NCT00794963|11561129|FG001|NOT COMPLETED|Overall Study||4
10416603|NCT00795002|11561137|FG000|STARTED|Overall Study||37
10416604|NCT00795002|11561138|FG001|STARTED|Overall Study||37
10416605|NCT00795002|11561137|FG000|COMPLETED|Overall Study||37
10416606|NCT00795002|11561138|FG001|COMPLETED|Overall Study||37
10416607|NCT00795002|11561137|FG000|NOT COMPLETED|Overall Study||0
10416608|NCT00795002|11561138|FG001|NOT COMPLETED|Overall Study||0
10416609|NCT00795132|11561144|FG000|STARTED|Overall Study||47
10416610|NCT00795132|11561144|FG000|COMPLETED|Overall Study||44
10416611|NCT00795132|11561144|FG000|NOT COMPLETED|Overall Study||3
10416612|NCT00795145|11561158|FG000|STARTED|Cohort 1||3
10416613|NCT00795145|11561159|FG001|STARTED|Cohort 1||3
10416614|NCT00795145|11561160|FG002|STARTED|Cohort 1||3
10416615|NCT00795145|11561161|FG003|STARTED|Cohort 1||0
10416616|NCT00795145|11561162|FG004|STARTED|Cohort 1||0
10416617|NCT00795145|11561163|FG005|STARTED|Cohort 1||0
10416618|NCT00795145|11561164|FG006|STARTED|Cohort 1||0
10416619|NCT00795145|11561158|FG000|COMPLETED|Cohort 1||3
10416620|NCT00795145|11561159|FG001|COMPLETED|Cohort 1||3
10861506|NCT03029234|12026575|FG000|COMPLETED|Overall Study||27
10861507|NCT03029234|12026575|FG000|NOT COMPLETED|Overall Study||99
10861508|NCT03019406|12026583|FG000|STARTED|PAP: up to 25 Weeks||6
10861509|NCT03019406|12026584|FG001|STARTED|PAP: up to 25 Weeks||5
10861510|NCT03019406|12026585|FG002|STARTED|PAP: up to 25 Weeks||5
10861511|NCT03019406|12026586|FG003|STARTED|PAP: up to 25 Weeks||6
10861512|NCT03019406|12026583|FG000|Treated|PAP: up to 25 Weeks||6
10861513|NCT03019406|12026584|FG001|Treated|PAP: up to 25 Weeks||5
10861514|NCT03019406|12026585|FG002|Treated|PAP: up to 25 Weeks||5
10861515|NCT03019406|12026586|FG003|Treated|PAP: up to 25 Weeks||6
10861516|NCT03019406|12026583|FG000|COMPLETED|PAP: up to 25 Weeks||6
10861517|NCT03019406|12026584|FG001|COMPLETED|PAP: up to 25 Weeks||5
10861518|NCT03019406|12026585|FG002|COMPLETED|PAP: up to 25 Weeks||5
10416621|NCT00795145|11561160|FG002|COMPLETED|Cohort 1||3
10416622|NCT00795145|11561161|FG003|COMPLETED|Cohort 1||0
10416623|NCT00795145|11561162|FG004|COMPLETED|Cohort 1||0
10416624|NCT00795145|11561163|FG005|COMPLETED|Cohort 1||0
10416625|NCT00795145|11561164|FG006|COMPLETED|Cohort 1||0
10861519|NCT03019406|12026586|FG003|COMPLETED|PAP: up to 25 Weeks||6
10861520|NCT03019406|12026583|FG000|NOT COMPLETED|PAP: up to 25 Weeks||0
10861521|NCT03019406|12026584|FG001|NOT COMPLETED|PAP: up to 25 Weeks||0
10861522|NCT03019406|12026585|FG002|NOT COMPLETED|PAP: up to 25 Weeks||0
10861523|NCT03019406|12026586|FG003|NOT COMPLETED|PAP: up to 25 Weeks||0
10861524|NCT03019406|12026583|FG000|STARTED|ETP: Ongoing From Week 26||6
10861525|NCT03019406|12026584|FG001|STARTED|ETP: Ongoing From Week 26||5
10861526|NCT03019406|12026585|FG002|STARTED|ETP: Ongoing From Week 26||5
10861527|NCT03019406|12026586|FG003|STARTED|ETP: Ongoing From Week 26|Participants who completed PAP and accepted to receive avalglucosidase alfa treatment in ETP.|3
10861528|NCT03019406|12026583|FG000|COMPLETED|ETP: Ongoing From Week 26||0
10861529|NCT03019406|12026584|FG001|COMPLETED|ETP: Ongoing From Week 26||0
10861530|NCT03019406|12026585|FG002|COMPLETED|ETP: Ongoing From Week 26||0
10861531|NCT03019406|12026586|FG003|COMPLETED|ETP: Ongoing From Week 26||0
10861532|NCT03019406|12026583|FG000|NOT COMPLETED|ETP: Ongoing From Week 26||6
10861533|NCT03019406|12026584|FG001|NOT COMPLETED|ETP: Ongoing From Week 26||5
10861534|NCT03019406|12026585|FG002|NOT COMPLETED|ETP: Ongoing From Week 26||5
10861535|NCT03019406|12026586|FG003|NOT COMPLETED|ETP: Ongoing From Week 26||3
10861536|NCT02874144|12026601|FG000|STARTED|Overall Study||22
10861537|NCT02874144|12026602|FG001|STARTED|Overall Study||21
10861538|NCT02874144|12026601|FG000|COMPLETED|Overall Study||19
10861539|NCT02874144|12026602|FG001|COMPLETED|Overall Study||16
10861540|NCT02874144|12026601|FG000|NOT COMPLETED|Overall Study||3
10861541|NCT02874144|12026602|FG001|NOT COMPLETED|Overall Study||5
10861542|NCT02611830|12026612|FG000|STARTED|OL Induction Phase||383
10861543|NCT02611830|12026613|FG001|STARTED|OL Induction Phase||0
10861544|NCT02611830|12026614|FG002|STARTED|OL Induction Phase||0
10861545|NCT02611830|12026615|FG003|STARTED|OL Induction Phase||0
10861546|NCT02611830|12026612|FG000|COMPLETED|OL Induction Phase||353
10861547|NCT02611830|12026613|FG001|COMPLETED|OL Induction Phase||0
10861548|NCT02611830|12026614|FG002|COMPLETED|OL Induction Phase||0
10861549|NCT02611830|12026615|FG003|COMPLETED|OL Induction Phase||0
10861550|NCT02611830|12026612|FG000|NOT COMPLETED|OL Induction Phase||30
10861551|NCT02611830|12026613|FG001|NOT COMPLETED|OL Induction Phase||0
10861552|NCT02611830|12026614|FG002|NOT COMPLETED|OL Induction Phase||0
10861553|NCT02611830|12026615|FG003|NOT COMPLETED|OL Induction Phase||0
10861554|NCT02611830|12026612|FG000|STARTED|Maintenance Phase||0
10861555|NCT02611830|12026613|FG001|STARTED|Maintenance Phase||56
10861556|NCT02611830|12026614|FG002|STARTED|Maintenance Phase||106
10861557|NCT02611830|12026615|FG003|STARTED|Maintenance Phase||54
10861558|NCT02611830|12026612|FG000|COMPLETED|Maintenance Phase||0
10861559|NCT02611830|12026613|FG001|COMPLETED|Maintenance Phase||20
10861560|NCT02611830|12026614|FG002|COMPLETED|Maintenance Phase||75
10861561|NCT02611830|12026615|FG003|COMPLETED|Maintenance Phase||39
10861562|NCT02611830|12026612|FG000|NOT COMPLETED|Maintenance Phase||0
10861563|NCT02611830|12026613|FG001|NOT COMPLETED|Maintenance Phase||36
10861564|NCT02611830|12026614|FG002|NOT COMPLETED|Maintenance Phase||31
10861565|NCT02611830|12026615|FG003|NOT COMPLETED|Maintenance Phase||15
10861566|NCT02611817|12026627|FG000|STARTED|Open-label Induction Phase||644
10861567|NCT02611817|12026628|FG001|STARTED|Open-label Induction Phase||0
10861568|NCT02611817|12026629|FG002|STARTED|Open-label Induction Phase||0
10861569|NCT02611817|12026627|FG000|COMPLETED|Open-label Induction Phase||594
10861570|NCT02611817|12026628|FG001|COMPLETED|Open-label Induction Phase||0
10861571|NCT02611817|12026629|FG002|COMPLETED|Open-label Induction Phase||0
10861572|NCT02611817|12026627|FG000|NOT COMPLETED|Open-label Induction Phase||50
10861573|NCT02611817|12026628|FG001|NOT COMPLETED|Open-label Induction Phase||0
10861574|NCT02611817|12026629|FG002|NOT COMPLETED|Open-label Induction Phase||0
10861575|NCT02611817|12026627|FG000|STARTED|Double-blind Maintenance Phase||0
10861576|NCT02611817|12026628|FG001|STARTED|Double-blind Maintenance Phase||135
10861577|NCT02611817|12026629|FG002|STARTED|Double-blind Maintenance Phase||275
10861578|NCT02611817|12026627|FG000|COMPLETED|Double-blind Maintenance Phase||0
10861579|NCT02611817|12026628|FG001|COMPLETED|Double-blind Maintenance Phase||73
10861580|NCT02611817|12026629|FG002|COMPLETED|Double-blind Maintenance Phase||168
10861581|NCT02611817|12026627|FG000|NOT COMPLETED|Double-blind Maintenance Phase||0
10861582|NCT02611817|12026628|FG001|NOT COMPLETED|Double-blind Maintenance Phase||62
10861583|NCT02611817|12026629|FG002|NOT COMPLETED|Double-blind Maintenance Phase||107
10861584|NCT02557139|12026639|FG000|STARTED|Overall Study||8
10861585|NCT02557139|12026640|FG001|STARTED|Overall Study||8
10861586|NCT02557139|12026641|FG002|STARTED|Overall Study||7
10861587|NCT02557139|12026639|FG000|COMPLETED|Overall Study||6
10861588|NCT02557139|12026640|FG001|COMPLETED|Overall Study||8
10861589|NCT02557139|12026641|FG002|COMPLETED|Overall Study||5
10861590|NCT02557139|12026639|FG000|NOT COMPLETED|Overall Study||2
10861591|NCT02557139|12026640|FG001|NOT COMPLETED|Overall Study||0
10861592|NCT02557139|12026641|FG002|NOT COMPLETED|Overall Study||2
10861593|NCT02211131|12026660|FG000|STARTED|Overall Study||74
10861594|NCT02211131|12026661|FG001|STARTED|Overall Study||76
10861595|NCT02211131|12026660|FG000|COMPLETED|Overall Study||0
10861596|NCT02211131|12026661|FG001|COMPLETED|Overall Study||0
10861597|NCT02211131|12026660|FG000|NOT COMPLETED|Overall Study||74
10861598|NCT02211131|12026661|FG001|NOT COMPLETED|Overall Study||76
10861599|NCT02186847|12026676|FG000|STARTED|Overall Study||84
10861600|NCT02186847|12026677|FG001|STARTED|Overall Study||86
10861601|NCT02186847|12026676|FG000|Eligible Population|Overall Study||81
10861602|NCT02186847|12026677|FG001|Eligible Population|Overall Study||86
10861603|NCT02186847|12026676|FG000|Eligible and Started Protocol Treatment|Overall Study||76
10861604|NCT02186847|12026677|FG001|Eligible and Started Protocol Treatment|Overall Study||82
10861605|NCT02186847|12026676|FG000|COMPLETED|Overall Study||81
10861606|NCT02186847|12026677|FG001|COMPLETED|Overall Study||86
10861607|NCT02186847|12026676|FG000|NOT COMPLETED|Overall Study||3
10861608|NCT02186847|12026677|FG001|NOT COMPLETED|Overall Study||0
10861609|NCT02101034|12026688|FG000|STARTED|Overall Study||3
10861610|NCT02101034|12026689|FG001|STARTED|Overall Study||6
10861611|NCT02101034|12026690|FG002|STARTED|Overall Study||31
10861612|NCT02101034|12026691|FG003|STARTED|Overall Study||32
10861613|NCT02101034|12026692|FG004|STARTED|Overall Study||24
10861614|NCT02101034|12026688|FG000|COMPLETED|Overall Study||3
10861615|NCT02101034|12026689|FG001|COMPLETED|Overall Study||6
10861616|NCT02101034|12026690|FG002|COMPLETED|Overall Study||30
10861617|NCT02101034|12026691|FG003|COMPLETED|Overall Study||32
10861618|NCT02101034|12026692|FG004|COMPLETED|Overall Study||24
10861619|NCT02101034|12026688|FG000|NOT COMPLETED|Overall Study||0
10861620|NCT02101034|12026689|FG001|NOT COMPLETED|Overall Study||0
10861621|NCT02101034|12026690|FG002|NOT COMPLETED|Overall Study||1
10861622|NCT02101034|12026691|FG003|NOT COMPLETED|Overall Study||0
10861623|NCT02101034|12026692|FG004|NOT COMPLETED|Overall Study||0
10861632|NCT01865617|12026732|FG000|STARTED|Overall Study||39
10861633|NCT01865617|12026733|FG001|STARTED|Overall Study||5
10861634|NCT01865617|12026734|FG002|STARTED|Overall Study||2
10861635|NCT01865617|12026735|FG003|STARTED|Overall Study||1
10861636|NCT01865617|12026736|FG004|STARTED|Overall Study||18
10861637|NCT01865617|12026737|FG005|STARTED|Overall Study||5
10861638|NCT01865617|12026738|FG006|STARTED|Overall Study||22
10861639|NCT01865617|12026739|FG007|STARTED|Overall Study||1
10861640|NCT01865617|12026740|FG008|STARTED|Overall Study||20
10861641|NCT01865617|12026741|FG009|STARTED|Overall Study||5
10861642|NCT01865617|12026742|FG010|STARTED|Overall Study||49
10861643|NCT01865617|12026743|FG011|STARTED|Overall Study||10
10861644|NCT01865617|12026744|FG012|STARTED|Overall Study||20
10861645|NCT01865617|12026732|FG000|COMPLETED|Overall Study||9
10861646|NCT01865617|12026733|FG001|COMPLETED|Overall Study||2
10861647|NCT01865617|12026734|FG002|COMPLETED|Overall Study||1
10861648|NCT01865617|12026735|FG003|COMPLETED|Overall Study||0
10861649|NCT01865617|12026736|FG004|COMPLETED|Overall Study||11
10861650|NCT01865617|12026737|FG005|COMPLETED|Overall Study||4
10861651|NCT01865617|12026738|FG006|COMPLETED|Overall Study||10
10861652|NCT01865617|12026739|FG007|COMPLETED|Overall Study||0
10861653|NCT01865617|12026740|FG008|COMPLETED|Overall Study||9
10861654|NCT01865617|12026741|FG009|COMPLETED|Overall Study||2
10861655|NCT01865617|12026742|FG010|COMPLETED|Overall Study||17
10861656|NCT01865617|12026743|FG011|COMPLETED|Overall Study||4
10861657|NCT01865617|12026744|FG012|COMPLETED|Overall Study||7
10861658|NCT01865617|12026732|FG000|NOT COMPLETED|Overall Study||30
10861659|NCT01865617|12026733|FG001|NOT COMPLETED|Overall Study||3
10861660|NCT01865617|12026734|FG002|NOT COMPLETED|Overall Study||1
10861661|NCT01865617|12026735|FG003|NOT COMPLETED|Overall Study||1
10861662|NCT01865617|12026736|FG004|NOT COMPLETED|Overall Study||7
10861663|NCT01865617|12026737|FG005|NOT COMPLETED|Overall Study||1
10861664|NCT01865617|12026738|FG006|NOT COMPLETED|Overall Study||12
10861665|NCT01865617|12026739|FG007|NOT COMPLETED|Overall Study||1
10861666|NCT01865617|12026740|FG008|NOT COMPLETED|Overall Study||11
10861667|NCT01865617|12026741|FG009|NOT COMPLETED|Overall Study||3
10861668|NCT01865617|12026742|FG010|NOT COMPLETED|Overall Study||32
10861669|NCT01865617|12026743|FG011|NOT COMPLETED|Overall Study||6
10861670|NCT01865617|12026744|FG012|NOT COMPLETED|Overall Study||13
10861671|NCT01828112|12026777|FG000|STARTED|Overall Study||115
10861672|NCT01828112|12026778|FG001|STARTED|Overall Study||116
10416626|NCT00795145|11561158|FG000|NOT COMPLETED|Cohort 1||0
10416627|NCT00795145|11561159|FG001|NOT COMPLETED|Cohort 1||0
10416628|NCT00795145|11561160|FG002|NOT COMPLETED|Cohort 1||0
10416629|NCT00795145|11561161|FG003|NOT COMPLETED|Cohort 1||0
10416630|NCT00795145|11561162|FG004|NOT COMPLETED|Cohort 1||0
10416631|NCT00795145|11561163|FG005|NOT COMPLETED|Cohort 1||0
10416632|NCT00795145|11561164|FG006|NOT COMPLETED|Cohort 1||0
10416633|NCT00795145|11561158|FG000|STARTED|Cohort 2||0
10416634|NCT00795145|11561159|FG001|STARTED|Cohort 2||0
10416635|NCT00795145|11561160|FG002|STARTED|Cohort 2||0
10416636|NCT00795145|11561161|FG003|STARTED|Cohort 2||10
10416637|NCT00795145|11561162|FG004|STARTED|Cohort 2||10
10416638|NCT00795145|11561163|FG005|STARTED|Cohort 2||10
10416639|NCT00795145|11561164|FG006|STARTED|Cohort 2||10
10416640|NCT00795145|11561158|FG000|COMPLETED|Cohort 2||0
10416641|NCT00795145|11561159|FG001|COMPLETED|Cohort 2||0
10416642|NCT00795145|11561160|FG002|COMPLETED|Cohort 2||0
10416643|NCT00795145|11561161|FG003|COMPLETED|Cohort 2||10
10416644|NCT00795145|11561162|FG004|COMPLETED|Cohort 2||10
10416645|NCT00795145|11561163|FG005|COMPLETED|Cohort 2||10
10416646|NCT00795145|11561164|FG006|COMPLETED|Cohort 2||10
10416647|NCT00795145|11561158|FG000|NOT COMPLETED|Cohort 2||0
10416648|NCT00795145|11561159|FG001|NOT COMPLETED|Cohort 2||0
10416649|NCT00795145|11561160|FG002|NOT COMPLETED|Cohort 2||0
10861673|NCT01828112|12026777|FG000|Entered Extension Treatment Phase|Overall Study||0
10861674|NCT01828112|12026778|FG001|Entered Extension Treatment Phase|Overall Study||74
10861675|NCT01828112|12026777|FG000|Entered Post-treatment Follow-up Phase|Overall Study||7
10861676|NCT01828112|12026778|FG001|Entered Post-treatment Follow-up Phase|Overall Study||5
10416650|NCT00795145|11561161|FG003|NOT COMPLETED|Cohort 2||0
10416651|NCT00795145|11561162|FG004|NOT COMPLETED|Cohort 2||0
10416652|NCT00795145|11561163|FG005|NOT COMPLETED|Cohort 2||0
10416653|NCT00795145|11561164|FG006|NOT COMPLETED|Cohort 2||0
10416654|NCT00795184|11561191|FG000|STARTED|Overall Study||65
10416655|NCT00795184|11561192|FG001|STARTED|Overall Study||57
10416656|NCT00795184|11561191|FG000|COMPLETED|Overall Study|57 patients analysable, completed all 3 imaging procedures|57
10416657|NCT00795184|11561192|FG001|COMPLETED|Overall Study|44 patients analysable, completed all 3 imaging procedures|44
10416658|NCT00795184|11561191|FG000|NOT COMPLETED|Overall Study||8
10416659|NCT00795184|11561192|FG001|NOT COMPLETED|Overall Study||13
10416660|NCT00795210|11561204|FG000|STARTED|Overall Study||8
10416661|NCT00795210|11561205|FG001|STARTED|Overall Study||12
10416662|NCT00795210|11561206|FG002|STARTED|Overall Study||5
10861677|NCT01828112|12026777|FG000|Entered Survival Follow-up Phase|Overall Study||61
10861678|NCT01828112|12026778|FG001|Entered Survival Follow-up Phase|Overall Study||19
10861679|NCT01828112|12026777|FG000|Discontinued From Study|Overall Study||14
10861680|NCT01828112|12026778|FG001|Discontinued From Study|Overall Study||10
10861681|NCT01828112|12026777|FG000|Untreated Patients|Overall Study||0
10861682|NCT01828112|12026778|FG001|Untreated Patients|Overall Study|untreated = did not receive study drug|3
10861683|NCT01828112|12026777|FG000|Untreated|Overall Study||0
10861684|NCT01828112|12026778|FG001|Untreated|Overall Study||3
10861685|NCT01828112|12026777|FG000|Treated|Overall Study||115
10861686|NCT01828112|12026778|FG001|Treated|Overall Study||113
10861687|NCT01828112|12026777|FG000|COMPLETED|Overall Study|Completed = Ongoing at time of data cut-off of 26-Jan-2016|33
10861688|NCT01828112|12026778|FG001|COMPLETED|Overall Study|Completed = Ongoing at time of data cut-off of 26-Jan-2016|8
10861689|NCT01828112|12026777|FG000|NOT COMPLETED|Overall Study||82
10861690|NCT01828112|12026778|FG001|NOT COMPLETED|Overall Study||108
10861691|NCT01733888|12026788|FG000|STARTED|Overall Study||20
10861692|NCT01733888|12026789|FG001|STARTED|Overall Study||20
10861693|NCT01733888|12026790|FG002|STARTED|Overall Study||20
10861694|NCT01733888|12026791|FG003|STARTED|Overall Study||20
10416663|NCT00795210|11561204|FG000|COMPLETED|Overall Study||8
10416664|NCT00795210|11561205|FG001|COMPLETED|Overall Study||11
10416665|NCT00795210|11561206|FG002|COMPLETED|Overall Study||3
10416666|NCT00795210|11561204|FG000|NOT COMPLETED|Overall Study||0
10416667|NCT00795210|11561205|FG001|NOT COMPLETED|Overall Study||1
10416668|NCT00795210|11561206|FG002|NOT COMPLETED|Overall Study||2
10861695|NCT01733888|12026788|FG000|COMPLETED|Overall Study||20
10861696|NCT01733888|12026789|FG001|COMPLETED|Overall Study||20
10861697|NCT01733888|12026790|FG002|COMPLETED|Overall Study||20
10861698|NCT01733888|12026791|FG003|COMPLETED|Overall Study||20
10861699|NCT01733888|12026788|FG000|NOT COMPLETED|Overall Study||0
10861700|NCT01733888|12026789|FG001|NOT COMPLETED|Overall Study||0
10861701|NCT01733888|12026790|FG002|NOT COMPLETED|Overall Study||0
10861702|NCT01733888|12026791|FG003|NOT COMPLETED|Overall Study||0
10861703|NCT01709981|12026803|FG000|STARTED|Overall Study||141
10861704|NCT01709981|12026804|FG001|STARTED|Overall Study||139
10861705|NCT01709981|12026803|FG000|COMPLETED|Overall Study||141
10861706|NCT01709981|12026804|FG001|COMPLETED|Overall Study||139
10861707|NCT01709981|12026803|FG000|NOT COMPLETED|Overall Study||0
10861708|NCT01709981|12026804|FG001|NOT COMPLETED|Overall Study||0
10861709|NCT01670500|12026812|FG000|STARTED|Overall Study||58
10861710|NCT01670500|12026813|FG001|STARTED|Overall Study||60
10293770|NCT03760146|11426360|FG005|NOT COMPLETED|Overall Study||8
10293771|NCT03760081|11426380|FG000|STARTED|Overall Study||6
10293772|NCT03760081|11426381|FG001|STARTED|Overall Study||13
10293773|NCT03760081|11426380|FG000|COMPLETED|Overall Study||0
10293774|NCT03760081|11426381|FG001|COMPLETED|Overall Study||1
10293775|NCT03760081|11426380|FG000|NOT COMPLETED|Overall Study||6
10293776|NCT03760081|11426381|FG001|NOT COMPLETED|Overall Study||12
10416669|NCT00795275|11561216|FG000|STARTED|Overall Study||11
10416670|NCT00795275|11561217|FG001|STARTED|Overall Study||15
10861711|NCT01670500|12026812|FG000|COMPLETED|Overall Study|1 patient withdrew after 3 cycles; 5 patients received additional non-protocol chemo before surgery|57
10293810|NCT03713684|11426415|FG000|STARTED|Overall Study||92
10293811|NCT03713684|11426416|FG001|STARTED|Overall Study||92
10293812|NCT03713684|11426417|FG002|STARTED|Overall Study||93
10293813|NCT03713684|11426418|FG003|STARTED|Overall Study||93
10293814|NCT03713684|11426415|FG000|Safety Population|Overall Study||92
10293815|NCT03713684|11426416|FG001|Safety Population|Overall Study||92
10293816|NCT03713684|11426417|FG002|Safety Population|Overall Study|For safety analysis participants were included in the treatment arm that they were exposed for longer duration. 3 participants randomized to Efpeglenatide 6 mg arm received 4 mg dose for longer duration; and considered in Efpeglenatide 4 mg arm for safety analysis.|96
10293817|NCT03713684|11426418|FG003|Safety Population|Overall Study||90
10293818|NCT03713684|11426415|FG000|Completed 30-Week Core Treatment Period|Overall Study||50
10293819|NCT03713684|11426416|FG001|Completed 30-Week Core Treatment Period|Overall Study||52
10293820|NCT03713684|11426417|FG002|Completed 30-Week Core Treatment Period|Overall Study||51
10293821|NCT03713684|11426418|FG003|Completed 30-Week Core Treatment Period|Overall Study||49
10293822|NCT03713684|11426415|FG000|COMPLETED|Overall Study||6
10293823|NCT03713684|11426416|FG001|COMPLETED|Overall Study||5
10293824|NCT03713684|11426417|FG002|COMPLETED|Overall Study||5
10293825|NCT03713684|11426418|FG003|COMPLETED|Overall Study||6
10293826|NCT03713684|11426415|FG000|NOT COMPLETED|Overall Study||86
10293827|NCT03713684|11426416|FG001|NOT COMPLETED|Overall Study||87
10293828|NCT03713684|11426417|FG002|NOT COMPLETED|Overall Study||88
10293829|NCT03713684|11426418|FG003|NOT COMPLETED|Overall Study||87
10293830|NCT03644550|11426428|FG000|STARTED|Overall Study||18
10293831|NCT03644550|11426428|FG000|COMPLETED|Overall Study||0
10293832|NCT03644550|11426428|FG000|NOT COMPLETED|Overall Study||18
10314599|NCT00166361|11448305|FG001|STARTED|Overall Study||10
10314600|NCT00166361|11448304|FG000|COMPLETED|Overall Study||14
10314601|NCT00166361|11448305|FG001|COMPLETED|Overall Study||10
10314602|NCT00166361|11448304|FG000|NOT COMPLETED|Overall Study||0
10314603|NCT00166361|11448305|FG001|NOT COMPLETED|Overall Study||0
10314604|NCT00166439|11448311|FG000|STARTED|Overall Study||50
10314605|NCT00166439|11448311|FG000|COMPLETED|Overall Study||45
10314606|NCT00166439|11448311|FG000|NOT COMPLETED|Overall Study||5
10314607|NCT00166517|11448317|FG000|STARTED|Overall Study||115
10314608|NCT00166517|11448318|FG001|STARTED|Overall Study||63
10314609|NCT00166517|11448317|FG000|Vaccinated at Visit 1|Overall Study||115
10314610|NCT00166517|11448318|FG001|Vaccinated at Visit 1|Overall Study||63
10314611|NCT00166517|11448317|FG000|Vaccinated at Visit 2|Overall Study||112
10314612|NCT00166517|11448318|FG001|Vaccinated at Visit 2|Overall Study||61
10314613|NCT00166517|11448317|FG000|Vaccinated at Visit 3|Overall Study||110
10416671|NCT00795275|11561216|FG000|COMPLETED|Overall Study||10
10416672|NCT00795275|11561217|FG001|COMPLETED|Overall Study||13
10416673|NCT00795275|11561216|FG000|NOT COMPLETED|Overall Study||1
10416674|NCT00795275|11561217|FG001|NOT COMPLETED|Overall Study||2
10416675|NCT00795288|11561227|FG000|STARTED|Overall Study||21
10416676|NCT00795288|11561228|FG001|STARTED|Overall Study||21
10416677|NCT00795288|11561227|FG000|COMPLETED|Overall Study||21
10416678|NCT00795288|11561228|FG001|COMPLETED|Overall Study||21
10416679|NCT00795288|11561227|FG000|NOT COMPLETED|Overall Study||0
10416680|NCT00795288|11561228|FG001|NOT COMPLETED|Overall Study||0
10416681|NCT00795340|11561238|FG000|STARTED|Overall Study||153
10416682|NCT00795340|11561239|FG001|STARTED|Overall Study||153
10416683|NCT00795340|11561238|FG000|COMPLETED|Overall Study||146
10416684|NCT00795340|11561239|FG001|COMPLETED|Overall Study||153
10416685|NCT00795340|11561238|FG000|NOT COMPLETED|Overall Study||7
10416686|NCT00795340|11561239|FG001|NOT COMPLETED|Overall Study||0
10416687|NCT00795366|11561247|FG000|STARTED|Overall Study||42
10416688|NCT00795366|11561248|FG001|STARTED|Overall Study||54
10416689|NCT00795366|11561247|FG000|COMPLETED|Overall Study||42
10416690|NCT00795366|11561248|FG001|COMPLETED|Overall Study||54
10416691|NCT00795366|11561247|FG000|NOT COMPLETED|Overall Study||0
10416692|NCT00795366|11561248|FG001|NOT COMPLETED|Overall Study||0
10416693|NCT00795509|11561254|FG000|STARTED|Overall Study||374
10416694|NCT00795509|11561254|FG000|COMPLETED|Overall Study||343
10416695|NCT00795509|11561254|FG000|NOT COMPLETED|Overall Study||31
10416696|NCT00795535|11561258|FG000|STARTED|Overall Study||95
10416697|NCT00795535|11561258|FG000|COMPLETED|Overall Study||75
10416698|NCT00795535|11561258|FG000|NOT COMPLETED|Overall Study||20
10416699|NCT00795600|11561264|FG000|STARTED|Overall Study||25
10416700|NCT00795600|11561265|FG001|STARTED|Overall Study||35
10416701|NCT00795600|11561264|FG000|Exposed to Drug|Overall Study|1 patient did not take study medication because the patient withdrew consent|24
10416702|NCT00795600|11561265|FG001|Exposed to Drug|Overall Study||35
10416703|NCT00795600|11561264|FG000|COMPLETED|Overall Study||21
10416704|NCT00795600|11561265|FG001|COMPLETED|Overall Study||31
10314614|NCT00166517|11448318|FG001|Vaccinated at Visit 3|Overall Study||61
10314615|NCT00166517|11448317|FG000|COMPLETED|Overall Study||110
10416705|NCT00795600|11561264|FG000|NOT COMPLETED|Overall Study||4
10416706|NCT00795600|11561265|FG001|NOT COMPLETED|Overall Study||4
10416707|NCT00795639|11561273|FG000|STARTED|Overall Study||91
10416708|NCT00795639|11561274|FG001|STARTED|Overall Study||92
10416709|NCT00795639|11561273|FG000|Randomized and Not Treated|Overall Study||0
10416710|NCT00795639|11561274|FG001|Randomized and Not Treated|Overall Study||1
10416711|NCT00795639|11561273|FG000|COMPLETED|Overall Study||70
10416712|NCT00795639|11561274|FG001|COMPLETED|Overall Study||66
10416713|NCT00795639|11561273|FG000|NOT COMPLETED|Overall Study||21
10861712|NCT01670500|12026813|FG001|COMPLETED|Overall Study|4 pts received <4 cycles of assigned chemo; 2 pts received add'l non-protocol chemo before surgery|60
10861713|NCT01670500|12026812|FG000|NOT COMPLETED|Overall Study||1
10861714|NCT01670500|12026813|FG001|NOT COMPLETED|Overall Study||0
10861729|NCT01453101|12026829|FG000|STARTED|Overall Study||54
10861730|NCT01453101|12026829|FG000|COMPLETED|Overall Study||54
10861731|NCT01453101|12026829|FG000|NOT COMPLETED|Overall Study||0
10861732|NCT04604184|12026835|FG000|STARTED|Overall Study||67
10861733|NCT04604184|12026836|FG001|STARTED|Overall Study||66
10861734|NCT04604184|12026835|FG000|Treated|Overall Study||65
10861735|NCT04604184|12026836|FG001|Treated|Overall Study||64
10861736|NCT04604184|12026835|FG000|COMPLETED|Overall Study||47
10861737|NCT04604184|12026836|FG001|COMPLETED|Overall Study||47
10861738|NCT04604184|12026835|FG000|NOT COMPLETED|Overall Study||20
10861739|NCT04604184|12026836|FG001|NOT COMPLETED|Overall Study||19
10861757|NCT03688555|12026865|FG000|STARTED|Run-in Period||10
10861758|NCT03688555|12026866|FG001|STARTED|Run-in Period||0
10861759|NCT03688555|12026867|FG002|STARTED|Run-in Period||0
10861760|NCT03688555|12026865|FG000|COMPLETED|Run-in Period||10
10861761|NCT03688555|12026866|FG001|COMPLETED|Run-in Period||0
10861762|NCT03688555|12026867|FG002|COMPLETED|Run-in Period||0
10861763|NCT03688555|12026865|FG000|NOT COMPLETED|Run-in Period||0
10861764|NCT03688555|12026866|FG001|NOT COMPLETED|Run-in Period||0
10861765|NCT03688555|12026867|FG002|NOT COMPLETED|Run-in Period||0
10861766|NCT03688555|12026865|FG000|STARTED|Treatment Period|All 10 participants that completed the run-in period were eligible to be randomized to ACT-774312 or placebo.|0
10861767|NCT03688555|12026866|FG001|STARTED|Treatment Period||7
10861768|NCT03688555|12026867|FG002|STARTED|Treatment Period||3
10861769|NCT03688555|12026865|FG000|COMPLETED|Treatment Period||0
10861770|NCT03688555|12026866|FG001|COMPLETED|Treatment Period||7
10861771|NCT03688555|12026867|FG002|COMPLETED|Treatment Period||2
10861772|NCT03688555|12026865|FG000|NOT COMPLETED|Treatment Period||0
10861773|NCT03688555|12026866|FG001|NOT COMPLETED|Treatment Period||0
10861774|NCT03688555|12026867|FG002|NOT COMPLETED|Treatment Period||1
10861775|NCT03593213|12026877|FG000|STARTED|Open-label Treatment Period (18 Weeks)|Out of 162 participants who completed Open-label Treatment Period, 159 participants were randomized to Double-blind treatment Period.|587
10861776|NCT03593213|12026878|FG001|STARTED|Open-label Treatment Period (18 Weeks)||0
10861777|NCT03593213|12026879|FG002|STARTED|Open-label Treatment Period (18 Weeks)||0
10861778|NCT03593213|12026880|FG003|STARTED|Open-label Treatment Period (18 Weeks)||0
10861779|NCT03593213|12026877|FG000|COMPLETED|Open-label Treatment Period (18 Weeks)||162
10861780|NCT03593213|12026878|FG001|COMPLETED|Open-label Treatment Period (18 Weeks)||0
10861781|NCT03593213|12026879|FG002|COMPLETED|Open-label Treatment Period (18 Weeks)||0
10861782|NCT03593213|12026880|FG003|COMPLETED|Open-label Treatment Period (18 Weeks)||0
10861783|NCT03593213|12026877|FG000|NOT COMPLETED|Open-label Treatment Period (18 Weeks)||425
10861784|NCT03593213|12026878|FG001|NOT COMPLETED|Open-label Treatment Period (18 Weeks)||0
10861785|NCT03593213|12026879|FG002|NOT COMPLETED|Open-label Treatment Period (18 Weeks)||0
10861786|NCT03593213|12026880|FG003|NOT COMPLETED|Open-label Treatment Period (18 Weeks)||0
10861787|NCT03593213|12026877|FG000|STARTED|Double-blind Treatment Period (26 Weeks)||0
10861788|NCT03593213|12026878|FG001|STARTED|Double-blind Treatment Period (26 Weeks)||54
10861789|NCT03593213|12026879|FG002|STARTED|Double-blind Treatment Period (26 Weeks)||49
10861790|NCT03593213|12026880|FG003|STARTED|Double-blind Treatment Period (26 Weeks)||56
10861791|NCT03593213|12026877|FG000|Safety Population|Double-blind Treatment Period (26 Weeks)||0
10861792|NCT03593213|12026878|FG001|Safety Population|Double-blind Treatment Period (26 Weeks)||53
10861793|NCT03593213|12026879|FG002|Safety Population|Double-blind Treatment Period (26 Weeks)||49
10861794|NCT03593213|12026880|FG003|Safety Population|Double-blind Treatment Period (26 Weeks)||54
10861795|NCT03593213|12026877|FG000|COMPLETED|Double-blind Treatment Period (26 Weeks)||0
10861796|NCT03593213|12026878|FG001|COMPLETED|Double-blind Treatment Period (26 Weeks)||14
10861797|NCT03593213|12026879|FG002|COMPLETED|Double-blind Treatment Period (26 Weeks)||16
10861798|NCT03593213|12026880|FG003|COMPLETED|Double-blind Treatment Period (26 Weeks)||21
10416714|NCT00795639|11561274|FG001|NOT COMPLETED|Overall Study||26
10416715|NCT00795704|11561282|FG000|STARTED|Overall Study||12
10416716|NCT00795704|11561283|FG001|STARTED|Overall Study||12
10861799|NCT03593213|12026877|FG000|NOT COMPLETED|Double-blind Treatment Period (26 Weeks)||0
10416717|NCT00795704|11561282|FG000|COMPLETED|Overall Study||8
10416718|NCT00795704|11561283|FG001|COMPLETED|Overall Study||9
10416719|NCT00795704|11561282|FG000|NOT COMPLETED|Overall Study||4
10416720|NCT00795704|11561283|FG001|NOT COMPLETED|Overall Study||3
10861800|NCT03593213|12026878|FG001|NOT COMPLETED|Double-blind Treatment Period (26 Weeks)||40
10861801|NCT03593213|12026879|FG002|NOT COMPLETED|Double-blind Treatment Period (26 Weeks)||33
10861802|NCT03593213|12026880|FG003|NOT COMPLETED|Double-blind Treatment Period (26 Weeks)||35
10861803|NCT03349723|12026901|FG000|STARTED|Overall Study||6
10861804|NCT03349723|12026902|FG001|STARTED|Overall Study||6
10861805|NCT03349723|12026903|FG002|STARTED|Overall Study||6
10861806|NCT03349723|12026904|FG003|STARTED|Overall Study||6
10861807|NCT03349723|12026905|FG004|STARTED|Overall Study||6
10861808|NCT03349723|12026906|FG005|STARTED|Overall Study||6
10861809|NCT03349723|12026907|FG006|STARTED|Overall Study||6
10861810|NCT03349723|12026908|FG007|STARTED|Overall Study||14
10861811|NCT03349723|12026901|FG000|COMPLETED|Overall Study||6
10861812|NCT03349723|12026902|FG001|COMPLETED|Overall Study||6
10861813|NCT03349723|12026903|FG002|COMPLETED|Overall Study||6
10861814|NCT03349723|12026904|FG003|COMPLETED|Overall Study||6
10861815|NCT03349723|12026905|FG004|COMPLETED|Overall Study||6
10861816|NCT03349723|12026906|FG005|COMPLETED|Overall Study||6
10861817|NCT03349723|12026907|FG006|COMPLETED|Overall Study||6
10861818|NCT03349723|12026908|FG007|COMPLETED|Overall Study||14
10861819|NCT03349723|12026901|FG000|NOT COMPLETED|Overall Study||0
10861820|NCT03349723|12026902|FG001|NOT COMPLETED|Overall Study||0
10861821|NCT03349723|12026903|FG002|NOT COMPLETED|Overall Study||0
10416721|NCT00795717|11561291|FG000|STARTED|Phase I Followed by Wash Out x 4 Weeks|Randomized to treatment first|20
10861740|NCT04368429|12026844|FG000|STARTED|Overall Study||180
10861741|NCT04368429|12026845|FG001|STARTED|Overall Study||180
10861742|NCT04368429|12026844|FG000|Safety Analysis Set|Overall Study||179
10861743|NCT04368429|12026845|FG001|Safety Analysis Set|Overall Study||180
10861744|NCT04368429|12026844|FG000|COMPLETED|Overall Study||179
10861745|NCT04368429|12026845|FG001|COMPLETED|Overall Study||180
10861746|NCT04368429|12026844|FG000|NOT COMPLETED|Overall Study||1
10861747|NCT04368429|12026845|FG001|NOT COMPLETED|Overall Study||0
10861748|NCT04266158|12026851|FG000|STARTED|Overall Study||0
10861749|NCT04266158|12026851|FG000|COMPLETED|Overall Study||0
10861750|NCT04266158|12026851|FG000|NOT COMPLETED|Overall Study||0
10861751|NCT04155840|12026855|FG000|STARTED|Overall Study||1
10861752|NCT04155840|12026855|FG000|COMPLETED|Overall Study||1
10861753|NCT04155840|12026855|FG000|NOT COMPLETED|Overall Study||0
10861754|NCT03865316|12026859|FG000|STARTED|Overall Study||108
10861755|NCT03865316|12026859|FG000|COMPLETED|Overall Study||100
10861756|NCT03865316|12026859|FG000|NOT COMPLETED|Overall Study||8
10861822|NCT03349723|12026904|FG003|NOT COMPLETED|Overall Study||0
10861823|NCT03349723|12026905|FG004|NOT COMPLETED|Overall Study||0
10861824|NCT03349723|12026906|FG005|NOT COMPLETED|Overall Study||0
10861825|NCT03349723|12026907|FG006|NOT COMPLETED|Overall Study||0
10861826|NCT03349723|12026908|FG007|NOT COMPLETED|Overall Study||0
10861827|NCT03248531|12026929|FG000|STARTED|Overall Study||22
10861828|NCT03248531|12026930|FG001|STARTED|Overall Study||22
10861829|NCT03248531|12026931|FG002|STARTED|Overall Study||46
10861830|NCT03248531|12026929|FG000|Completed Week 12|Overall Study||19
10861831|NCT03248531|12026930|FG001|Completed Week 12|Overall Study||18
10861832|NCT03248531|12026931|FG002|Completed Week 12|Overall Study||42
10861833|NCT03248531|12026929|FG000|COMPLETED|Overall Study||18
10861834|NCT03248531|12026930|FG001|COMPLETED|Overall Study||17
10861835|NCT03248531|12026931|FG002|COMPLETED|Overall Study||38
10861836|NCT03248531|12026929|FG000|NOT COMPLETED|Overall Study||4
10861837|NCT03248531|12026930|FG001|NOT COMPLETED|Overall Study||5
10861838|NCT03248531|12026931|FG002|NOT COMPLETED|Overall Study||8
10861839|NCT03205605|12026946|FG000|STARTED|Overall Study||13
10861840|NCT03205605|12026946|FG000|COMPLETED|Overall Study||12
10861841|NCT03205605|12026946|FG000|NOT COMPLETED|Overall Study||1
10861842|NCT02556736|12026956|FG000|STARTED|Overall Study||14
10861843|NCT02556736|12026956|FG000|COMPLETED|Overall Study||14
10861844|NCT02556736|12026956|FG000|NOT COMPLETED|Overall Study||0
10861845|NCT02484456|12026962|FG000|STARTED|First Treatment Period: Week 1||10
10861846|NCT02484456|12026963|FG001|STARTED|First Treatment Period: Week 1||9
10861847|NCT02484456|12026962|FG000|COMPLETED|First Treatment Period: Week 1||10
10861848|NCT02484456|12026963|FG001|COMPLETED|First Treatment Period: Week 1||9
10861849|NCT02484456|12026962|FG000|NOT COMPLETED|First Treatment Period: Week 1||0
10861850|NCT02484456|12026963|FG001|NOT COMPLETED|First Treatment Period: Week 1||0
10861851|NCT02484456|12026962|FG000|STARTED|First Treatment Period: Week 2||10
10861852|NCT02484456|12026963|FG001|STARTED|First Treatment Period: Week 2||9
10861853|NCT02484456|12026962|FG000|COMPLETED|First Treatment Period: Week 2||10
10861854|NCT02484456|12026963|FG001|COMPLETED|First Treatment Period: Week 2||9
10861855|NCT02484456|12026962|FG000|NOT COMPLETED|First Treatment Period: Week 2||0
10861856|NCT02484456|12026963|FG001|NOT COMPLETED|First Treatment Period: Week 2||0
10861857|NCT02484456|12026962|FG000|STARTED|Washout Period||10
10861858|NCT02484456|12026963|FG001|STARTED|Washout Period||9
10861859|NCT02484456|12026962|FG000|COMPLETED|Washout Period||10
10861860|NCT02484456|12026963|FG001|COMPLETED|Washout Period||8
10861861|NCT02484456|12026962|FG000|NOT COMPLETED|Washout Period||0
10861862|NCT02484456|12026963|FG001|NOT COMPLETED|Washout Period||1
10861863|NCT02484456|12026962|FG000|STARTED|Second Treatment Period: Week 1||10
10861864|NCT02484456|12026963|FG001|STARTED|Second Treatment Period: Week 1||8
10861865|NCT02484456|12026962|FG000|COMPLETED|Second Treatment Period: Week 1||9
10861866|NCT02484456|12026963|FG001|COMPLETED|Second Treatment Period: Week 1||7
10861867|NCT02484456|12026962|FG000|NOT COMPLETED|Second Treatment Period: Week 1||1
10861868|NCT02484456|12026963|FG001|NOT COMPLETED|Second Treatment Period: Week 1||1
10861869|NCT02484456|12026962|FG000|STARTED|Second Treatment Period: Week 2||9
10861870|NCT02484456|12026963|FG001|STARTED|Second Treatment Period: Week 2||7
10861871|NCT02484456|12026962|FG000|COMPLETED|Second Treatment Period: Week 2||9
10861872|NCT02484456|12026963|FG001|COMPLETED|Second Treatment Period: Week 2||6
10861873|NCT02484456|12026962|FG000|NOT COMPLETED|Second Treatment Period: Week 2||0
10861874|NCT02484456|12026963|FG001|NOT COMPLETED|Second Treatment Period: Week 2||1
10293833|NCT03557970|11426435|FG000|STARTED|Overall Study||1
10861875|NCT02481830|12026972|FG000|STARTED|Overall Study||284
10861876|NCT02481830|12026973|FG001|STARTED|Overall Study||285
10861877|NCT02481830|12026972|FG000|COMPLETED|Overall Study||282
10861878|NCT02481830|12026973|FG001|COMPLETED|Overall Study||265
10861879|NCT02481830|12026972|FG000|NOT COMPLETED|Overall Study||2
10861880|NCT02481830|12026973|FG001|NOT COMPLETED|Overall Study||20
10861881|NCT02234323|12026979|FG000|STARTED|All Enrolled||108
10861882|NCT02234323|12026979|FG000|COMPLETED|All Enrolled|These participants received at least one dose of study drug.|103
10861883|NCT02234323|12026979|FG000|NOT COMPLETED|All Enrolled||5
10861884|NCT02234323|12026979|FG000|STARTED|All Treated||103
10861885|NCT02234323|12026979|FG000|Episodic Treatment Regimen|All Treated|Participants were treated in more than one regimen and counted in all categories wherever applicable|81
10861886|NCT02234323|12026979|FG000|Prophylactic Treatment Regimen|All Treated|69 participants among the 81 who started in episodic regimen, switched to the prophylactic regimen.|89
10861887|NCT02234323|12026979|FG000|Immune Tolerance Induction (ITI)|All Treated|1/81 on episodic and 14/89 on prophylactic regimen had inhibitors and were switched directly to ITI.|15
10861888|NCT02234323|12026979|FG000|COMPLETED|All Treated||85
10861889|NCT02234323|12026979|FG000|NOT COMPLETED|All Treated||18
10861890|NCT02220855|12026985|FG000|STARTED|Overall Study||14
10861891|NCT02220855|12026985|FG000|COMPLETED|Overall Study||0
10861892|NCT02220855|12026985|FG000|NOT COMPLETED|Overall Study||14
10861893|NCT01791595|12026996|FG000|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||3
10861894|NCT01791595|12026997|FG001|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
10861895|NCT01791595|12026998|FG002|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
10861896|NCT01791595|12026999|FG003|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
10861897|NCT01791595|12027000|FG004|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
10861898|NCT01791595|12027001|FG005|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
10861899|NCT01791595|12027002|FG006|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
10861900|NCT01791595|12026996|FG000|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
10861901|NCT01791595|12026997|FG001|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
10861902|NCT01791595|12026998|FG002|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
10861903|NCT01791595|12026999|FG003|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
10861904|NCT01791595|12027000|FG004|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
10861905|NCT01791595|12027001|FG005|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
10861906|NCT01791595|12027002|FG006|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
10861907|NCT01791595|12026996|FG000|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||3
10861908|NCT01791595|12026997|FG001|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
10861909|NCT01791595|12026998|FG002|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
10861910|NCT01791595|12026999|FG003|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
10861911|NCT01791595|12027000|FG004|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
10861912|NCT01791595|12027001|FG005|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
10861913|NCT01791595|12027002|FG006|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
10861914|NCT01791595|12026996|FG000|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
10861915|NCT01791595|12026997|FG001|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||5
10861916|NCT01791595|12026998|FG002|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
10861917|NCT01791595|12026999|FG003|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
10293834|NCT03557970|11426436|FG001|STARTED|Overall Study||2
10293835|NCT03557970|11426435|FG000|COMPLETED|Overall Study||0
10293836|NCT03557970|11426436|FG001|COMPLETED|Overall Study||0
10293837|NCT03557970|11426435|FG000|NOT COMPLETED|Overall Study||1
10293838|NCT03557970|11426436|FG001|NOT COMPLETED|Overall Study||2
10293839|NCT03369197|11426444|FG000|STARTED|Overall Study||53
10293840|NCT03369197|11426445|FG001|STARTED|Overall Study||57
10293841|NCT03369197|11426444|FG000|COMPLETED|Overall Study||53
10293842|NCT03369197|11426445|FG001|COMPLETED|Overall Study||57
10293843|NCT03369197|11426444|FG000|NOT COMPLETED|Overall Study||0
10293844|NCT03369197|11426445|FG001|NOT COMPLETED|Overall Study||0
10293854|NCT02964039|11426466|FG000|STARTED|Overall Study||18
10293855|NCT02964039|11426467|FG001|STARTED|Overall Study||18
10293856|NCT02964039|11426468|FG002|STARTED|Overall Study||18
10293857|NCT02964039|11426466|FG000|Received Allocated Intervention|Overall Study||15
10293858|NCT02964039|11426467|FG001|Received Allocated Intervention|Overall Study||17
10293859|NCT02964039|11426468|FG002|Received Allocated Intervention|Overall Study||14
10293860|NCT02964039|11426466|FG000|COMPLETED|Overall Study||14
10293861|NCT02964039|11426467|FG001|COMPLETED|Overall Study||17
10293862|NCT02964039|11426468|FG002|COMPLETED|Overall Study||13
10293863|NCT02964039|11426466|FG000|NOT COMPLETED|Overall Study||4
10293864|NCT02964039|11426467|FG001|NOT COMPLETED|Overall Study||1
10293865|NCT02964039|11426468|FG002|NOT COMPLETED|Overall Study||5
10293866|NCT02930889|11426476|FG000|STARTED|Overall Study||21
10293867|NCT02930889|11426476|FG000|COMPLETED|Overall Study||5
10293868|NCT02930889|11426476|FG000|NOT COMPLETED|Overall Study||16
10416722|NCT00795717|11561292|FG001|STARTED|Phase I Followed by Wash Out x 4 Weeks|Randomized to placebo first|21
10293869|NCT02919618|11426480|FG000|STARTED|Overall Study||19
10293870|NCT02919618|11426480|FG000|Primary Safety Endpoint (</=90 Days)|Overall Study||19
10293871|NCT02919618|11426480|FG000|Primary Efficacy Endpoint (6 Months)|Overall Study||18
10293872|NCT02919618|11426480|FG000|COMPLETED|Overall Study||18
10293873|NCT02919618|11426480|FG000|NOT COMPLETED|Overall Study||1
10293874|NCT02844946|11426497|FG000|STARTED|Overall Study||27
10293875|NCT02844946|11426498|FG001|STARTED|Overall Study||12
10293876|NCT02844946|11426497|FG000|COMPLETED|Overall Study||20
10861918|NCT01791595|12027000|FG004|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
10861919|NCT01791595|12027001|FG005|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
10861920|NCT01791595|12027002|FG006|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
10861921|NCT01791595|12026996|FG000|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
10861922|NCT01791595|12026997|FG001|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
10861923|NCT01791595|12026998|FG002|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
10861924|NCT01791595|12026999|FG003|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
10861925|NCT01791595|12027000|FG004|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
10861926|NCT01791595|12027001|FG005|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
10861927|NCT01791595|12027002|FG006|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
10861928|NCT01791595|12026996|FG000|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
10861929|NCT01791595|12026997|FG001|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||5
10861930|NCT01791595|12026998|FG002|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
10861931|NCT01791595|12026999|FG003|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
10861932|NCT01791595|12027000|FG004|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
10861933|NCT01791595|12027001|FG005|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
10861934|NCT01791595|12027002|FG006|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
10861935|NCT01791595|12026996|FG000|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
10861936|NCT01791595|12026997|FG001|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
10861937|NCT01791595|12026998|FG002|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||8
10861938|NCT01791595|12026999|FG003|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
10861939|NCT01791595|12027000|FG004|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
10861940|NCT01791595|12027001|FG005|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
10861941|NCT01791595|12027002|FG006|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
10861942|NCT01791595|12026996|FG000|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
10861943|NCT01791595|12026997|FG001|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
10861944|NCT01791595|12026998|FG002|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
10861945|NCT01791595|12026999|FG003|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
10861946|NCT01791595|12027000|FG004|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
10861947|NCT01791595|12027001|FG005|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
10861948|NCT01791595|12027002|FG006|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
10861949|NCT01791595|12026996|FG000|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
10861950|NCT01791595|12026997|FG001|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
10861951|NCT01791595|12026998|FG002|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||8
10861952|NCT01791595|12026999|FG003|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
10861953|NCT01791595|12027000|FG004|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
10861954|NCT01791595|12027001|FG005|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
10861955|NCT01791595|12027002|FG006|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
10861956|NCT01791595|12026996|FG000|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
10861957|NCT01791595|12026997|FG001|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
10861958|NCT01791595|12026998|FG002|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
10861959|NCT01791595|12026999|FG003|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||5
10861960|NCT01791595|12027000|FG004|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
10861961|NCT01791595|12027001|FG005|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
10861962|NCT01791595|12027002|FG006|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
10861963|NCT01791595|12026996|FG000|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
10861964|NCT01791595|12026997|FG001|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
10861965|NCT01791595|12026998|FG002|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
10861966|NCT01791595|12026999|FG003|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||1
10861967|NCT01791595|12027000|FG004|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
10861968|NCT01791595|12027001|FG005|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
10861969|NCT01791595|12027002|FG006|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
10861970|NCT01791595|12026996|FG000|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
10861971|NCT01791595|12026997|FG001|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
10861972|NCT01791595|12026998|FG002|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
10861973|NCT01791595|12026999|FG003|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||4
10861974|NCT01791595|12027000|FG004|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
10861975|NCT01791595|12027001|FG005|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
10861976|NCT01791595|12027002|FG006|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
10861977|NCT01791595|12026996|FG000|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
10861978|NCT01791595|12026997|FG001|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
10861979|NCT01791595|12026998|FG002|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
10861980|NCT01791595|12026999|FG003|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
10861981|NCT01791595|12027000|FG004|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||11
10861982|NCT01791595|12027001|FG005|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
10861983|NCT01791595|12027002|FG006|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
10861984|NCT01791595|12026996|FG000|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
10861985|NCT01791595|12026997|FG001|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
10861986|NCT01791595|12026998|FG002|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
10293877|NCT02844946|11426498|FG001|COMPLETED|Overall Study||12
10293878|NCT02844946|11426497|FG000|NOT COMPLETED|Overall Study||7
10293879|NCT02844946|11426498|FG001|NOT COMPLETED|Overall Study||0
10293880|NCT02675114|11426506|FG000|STARTED|Overall Study||497
10293881|NCT02675114|11426507|FG001|STARTED|Overall Study||503
10293882|NCT02675114|11426506|FG000|As Treated|Overall Study||454
10293883|NCT02675114|11426507|FG001|As Treated|Overall Study||496
10861987|NCT01791595|12026999|FG003|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
10861988|NCT01791595|12027000|FG004|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
10861989|NCT01791595|12027001|FG005|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
10861990|NCT01791595|12027002|FG006|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
10861991|NCT01791595|12026996|FG000|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
10861992|NCT01791595|12026997|FG001|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
10861993|NCT01791595|12026998|FG002|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
10861994|NCT01791595|12026999|FG003|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
10861995|NCT01791595|12027000|FG004|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||11
10861996|NCT01791595|12027001|FG005|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
10861997|NCT01791595|12027002|FG006|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
10861998|NCT01791595|12026996|FG000|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
10861999|NCT01791595|12026997|FG001|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
10862000|NCT01791595|12026998|FG002|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
10862001|NCT01791595|12026999|FG003|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
10862002|NCT01791595|12027000|FG004|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
10862003|NCT01791595|12027001|FG005|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||8
10862004|NCT01791595|12027002|FG006|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
10862005|NCT01791595|12026996|FG000|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
10862006|NCT01791595|12026997|FG001|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
10862007|NCT01791595|12026998|FG002|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
10862008|NCT01791595|12026999|FG003|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
10862009|NCT01791595|12027000|FG004|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
10862010|NCT01791595|12027001|FG005|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
10862011|NCT01791595|12027002|FG006|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
10862012|NCT01791595|12026996|FG000|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
10862013|NCT01791595|12026997|FG001|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
10862014|NCT01791595|12026998|FG002|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
10862015|NCT01791595|12026999|FG003|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
10862016|NCT01791595|12027000|FG004|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
10862017|NCT01791595|12027001|FG005|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||8
10862018|NCT01791595|12027002|FG006|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
10862019|NCT01791595|12026996|FG000|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||0
10862020|NCT01791595|12026997|FG001|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||0
10416723|NCT00795717|11561291|FG000|COMPLETED|Phase I Followed by Wash Out x 4 Weeks||18
10416724|NCT00795717|11561292|FG001|COMPLETED|Phase I Followed by Wash Out x 4 Weeks||19
10416725|NCT00795717|11561291|FG000|NOT COMPLETED|Phase I Followed by Wash Out x 4 Weeks||2
10416726|NCT00795717|11561292|FG001|NOT COMPLETED|Phase I Followed by Wash Out x 4 Weeks||2
10416727|NCT00795717|11561291|FG000|STARTED|Phase II||18
10416728|NCT00795717|11561292|FG001|STARTED|Phase II||19
10416729|NCT00795717|11561291|FG000|COMPLETED|Phase II||18
10416730|NCT00795717|11561292|FG001|COMPLETED|Phase II||18
10416731|NCT00795717|11561291|FG000|NOT COMPLETED|Phase II||0
10416732|NCT00795717|11561292|FG001|NOT COMPLETED|Phase II||1
10416733|NCT00795769|11561299|FG000|STARTED|Overall Study||49
10416734|NCT00795769|11561299|FG000|COMPLETED|Overall Study||49
10416735|NCT00795769|11561299|FG000|NOT COMPLETED|Overall Study||0
10416736|NCT00795821|11561305|FG000|STARTED|Acute Treatment Phase||250
10416737|NCT00795821|11561306|FG001|STARTED|Acute Treatment Phase||245
10416738|NCT00795821|11561305|FG000|COMPLETED|Acute Treatment Phase|4 LY-treated participants in the Acute Phase chose not to enter the Long-term Extension Phase.|194
10862021|NCT01791595|12026998|FG002|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||0
10862022|NCT01791595|12026999|FG003|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||0
10862023|NCT01791595|12027000|FG004|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||0
10862024|NCT01791595|12027001|FG005|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||0
10862025|NCT01791595|12027002|FG006|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||11
10862026|NCT01791595|12026996|FG000|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
10862027|NCT01791595|12026997|FG001|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
10862028|NCT01791595|12026998|FG002|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
10862029|NCT01791595|12026999|FG003|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
10862030|NCT01791595|12027000|FG004|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
10862031|NCT01791595|12027001|FG005|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
10862032|NCT01791595|12027002|FG006|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||1
10416739|NCT00795821|11561306|FG001|COMPLETED|Acute Treatment Phase|7 placebo-treated participants in the Acute Phase chose not to enter the Long-term Extension Phase.|214
10416740|NCT00795821|11561305|FG000|NOT COMPLETED|Acute Treatment Phase||56
10416741|NCT00795821|11561306|FG001|NOT COMPLETED|Acute Treatment Phase||31
10416742|NCT00795821|11561305|FG000|STARTED|Long-term Extension Phase||190
10416743|NCT00795821|11561306|FG001|STARTED|Long-term Extension Phase|All placebo-treated participants received LY2216684 in the Long-term Extension Phase.|207
10416744|NCT00795821|11561305|FG000|COMPLETED|Long-term Extension Phase||100
10416745|NCT00795821|11561306|FG001|COMPLETED|Long-term Extension Phase||115
10862033|NCT01791595|12026996|FG000|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
10862034|NCT01791595|12026997|FG001|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
10862035|NCT01791595|12026998|FG002|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
10862036|NCT01791595|12026999|FG003|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
10416746|NCT00795821|11561305|FG000|NOT COMPLETED|Long-term Extension Phase||90
10416747|NCT00795821|11561306|FG001|NOT COMPLETED|Long-term Extension Phase||92
10862037|NCT01791595|12027000|FG004|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
10862038|NCT01791595|12027001|FG005|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
10862039|NCT01791595|12027002|FG006|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||10
10862040|NCT01192776|12027026|FG000|STARTED|Overall Study||95
10862041|NCT01192776|12027027|FG001|STARTED|Overall Study||90
10862042|NCT01192776|12027028|FG002|STARTED|Overall Study||96
10862043|NCT01192776|12027029|FG003|STARTED|Overall Study||83
10862044|NCT01192776|12027026|FG000|Died Prior to Discharge|Overall Study||7
10862045|NCT01192776|12027027|FG001|Died Prior to Discharge|Overall Study||13
10862046|NCT01192776|12027028|FG002|Died Prior to Discharge|Overall Study||15
10862047|NCT01192776|12027029|FG003|Died Prior to Discharge|Overall Study||14
10862048|NCT01192776|12027026|FG000|Died After Discharge|Overall Study||1
10862049|NCT01192776|12027027|FG001|Died After Discharge|Overall Study||2
10862050|NCT01192776|12027028|FG002|Died After Discharge|Overall Study||3
10862051|NCT01192776|12027029|FG003|Died After Discharge|Overall Study||1
10862052|NCT01192776|12027026|FG000|COMPLETED|Overall Study||84
10862053|NCT01192776|12027027|FG001|COMPLETED|Overall Study||69
10862054|NCT01192776|12027028|FG002|COMPLETED|Overall Study||75
10862055|NCT01192776|12027029|FG003|COMPLETED|Overall Study||63
10862056|NCT01192776|12027026|FG000|NOT COMPLETED|Overall Study||11
10862057|NCT01192776|12027027|FG001|NOT COMPLETED|Overall Study||21
10862058|NCT01192776|12027028|FG002|NOT COMPLETED|Overall Study||21
10862059|NCT01192776|12027029|FG003|NOT COMPLETED|Overall Study||20
10416748|NCT00795821|11561305|FG000|STARTED|Taper Phase|N=240 participants entered Taper Phases: N=4 from Acute Phase; N=236 from Extension Phase.|240
10416749|NCT00795821|11561306|FG001|STARTED|Taper Phase|N=6 participants entered only Acute Taper Phase.|6
10416750|NCT00795821|11561305|FG000|COMPLETED|Taper Phase|N=231 participants completed Taper Phases: N=3 from Acute Phase; N=228 from Extension Phase.|231
10416751|NCT00795821|11561306|FG001|COMPLETED|Taper Phase|N=6 participants completed only Acute Taper Phase; N=0 participants entered Extension Taper Phase.|6
10416752|NCT00795821|11561305|FG000|NOT COMPLETED|Taper Phase||9
10416753|NCT00795821|11561306|FG001|NOT COMPLETED|Taper Phase||0
10416754|NCT00795886|11561322|FG000|STARTED|Overall Study||63
10416755|NCT00795886|11561322|FG000|COMPLETED|Overall Study||53
10416756|NCT00795886|11561322|FG000|NOT COMPLETED|Overall Study||10
10416757|NCT00795951|11561327|FG000|STARTED|Overall Study||102
10416758|NCT00795951|11561327|FG000|COMPLETED|Overall Study||100
10416759|NCT00795951|11561327|FG000|NOT COMPLETED|Overall Study||2
10416760|NCT00796003|11561334|FG000|STARTED|Overall Study|Number of participants enrolled|3
10416761|NCT00796003|11561335|FG001|STARTED|Overall Study|Number of participants enrolled. Includes 6 participants from Phase I (20 mg/m2) group|36
10416762|NCT00796003|11561334|FG000|Treated|Overall Study|Number of participants treated|3
10416763|NCT00796003|11561335|FG001|Treated|Overall Study|Number of participants treated|34
10416764|NCT00796003|11561334|FG000|COMPLETED|Overall Study||0
10416765|NCT00796003|11561335|FG001|COMPLETED|Overall Study|Includes 2 participants from Phase I (20 mg/m2) group|7
10416766|NCT00796003|11561334|FG000|NOT COMPLETED|Overall Study||3
10416767|NCT00796003|11561335|FG001|NOT COMPLETED|Overall Study||29
10429353|NCT00863057|11575334|FG000|NOT COMPLETED|Period 4 (Weeks 16-20)||0
10429354|NCT00863057|11575335|FG001|NOT COMPLETED|Period 4 (Weeks 16-20)||0
10429355|NCT00863057|11575336|FG002|NOT COMPLETED|Period 4 (Weeks 16-20)||0
10429356|NCT00863057|11575337|FG003|NOT COMPLETED|Period 4 (Weeks 16-20)||0
10429357|NCT00863109|11575353|FG000|STARTED|Treatment Period||130
10429358|NCT00863109|11575353|FG000|COMPLETED|Treatment Period||53
10429359|NCT00863109|11575353|FG000|NOT COMPLETED|Treatment Period||77
10429360|NCT00863109|11575353|FG000|STARTED|Follow-up Period|Follow-up performed on 53 who completed Treatment Period plus 6 who discontinued treatment|59
10429361|NCT00863109|11575353|FG000|COMPLETED|Follow-up Period||48
10429362|NCT00863109|11575353|FG000|NOT COMPLETED|Follow-up Period||11
10429363|NCT00863122|11575361|FG000|STARTED|Overall Study||19
10429364|NCT00863122|11575362|FG001|STARTED|Overall Study||7
10429365|NCT00863122|11575361|FG000|COMPLETED|Overall Study||19
10429366|NCT00863122|11575362|FG001|COMPLETED|Overall Study||7
10429367|NCT00863122|11575361|FG000|NOT COMPLETED|Overall Study||0
10429368|NCT00863122|11575362|FG001|NOT COMPLETED|Overall Study||0
10429369|NCT00863265|11575372|FG000|STARTED|Overall Study||4
10429370|NCT00863265|11575373|FG001|STARTED|Overall Study||3
10429371|NCT00863265|11575374|FG002|STARTED|Overall Study||4
10429372|NCT00863265|11575375|FG003|STARTED|Overall Study||4
10429373|NCT00863265|11575376|FG004|STARTED|Overall Study||4
10429374|NCT00863265|11575377|FG005|STARTED|Overall Study||3
10429375|NCT00863265|11575372|FG000|COMPLETED|Overall Study||4
10429376|NCT00863265|11575373|FG001|COMPLETED|Overall Study||3
10429377|NCT00863265|11575374|FG002|COMPLETED|Overall Study||4
10429378|NCT00863265|11575375|FG003|COMPLETED|Overall Study||4
10429379|NCT00863265|11575376|FG004|COMPLETED|Overall Study||3
10862070|NCT03397264|12027055|FG000|STARTED|Overall Study||3
10862071|NCT03397264|12027056|FG001|STARTED|Overall Study||3
10862072|NCT03397264|12027057|FG002|STARTED|Overall Study||3
10862073|NCT03397264|12027058|FG003|STARTED|Overall Study||96
10862074|NCT03397264|12027059|FG004|STARTED|Overall Study||48
10862075|NCT03397264|12027055|FG000|COMPLETED|Overall Study||3
10862076|NCT03397264|12027056|FG001|COMPLETED|Overall Study||3
10862077|NCT03397264|12027057|FG002|COMPLETED|Overall Study||3
10862078|NCT03397264|12027058|FG003|COMPLETED|Overall Study||89
10862079|NCT03397264|12027059|FG004|COMPLETED|Overall Study||47
10862080|NCT03397264|12027055|FG000|NOT COMPLETED|Overall Study||0
10862081|NCT03397264|12027056|FG001|NOT COMPLETED|Overall Study||0
10862082|NCT03397264|12027057|FG002|NOT COMPLETED|Overall Study||0
10862083|NCT03397264|12027058|FG003|NOT COMPLETED|Overall Study||7
10862084|NCT03397264|12027059|FG004|NOT COMPLETED|Overall Study||1
10862085|NCT03392883|12027075|FG000|STARTED|Overall Study||1264
10862086|NCT03392883|12027076|FG001|STARTED|Overall Study||45
10862087|NCT03392883|12027077|FG002|STARTED|Overall Study||39
10862088|NCT03392883|12027075|FG000|COMPLETED|Overall Study||928
10862089|NCT03392883|12027076|FG001|COMPLETED|Overall Study||32
10862090|NCT03392883|12027077|FG002|COMPLETED|Overall Study||30
10862091|NCT03392883|12027075|FG000|NOT COMPLETED|Overall Study||336
10862092|NCT03392883|12027076|FG001|NOT COMPLETED|Overall Study||13
10862093|NCT03392883|12027077|FG002|NOT COMPLETED|Overall Study||9
10862094|NCT03376789|12027085|FG000|STARTED|Overall Study||108
10862095|NCT03376789|12027086|FG001|STARTED|Overall Study||111
10862096|NCT03376789|12027085|FG000|COMPLETED|Overall Study||103
10862097|NCT03376789|12027086|FG001|COMPLETED|Overall Study||102
10862098|NCT03376789|12027085|FG000|NOT COMPLETED|Overall Study||5
10862099|NCT03376789|12027086|FG001|NOT COMPLETED|Overall Study||9
10862100|NCT03342742|12027094|FG000|STARTED|Overall Study||15
10862101|NCT03342742|12027095|FG001|STARTED|Overall Study||13
10862102|NCT03342742|12027094|FG000|COMPLETED|Overall Study||13
10862103|NCT03342742|12027095|FG001|COMPLETED|Overall Study||11
10862104|NCT03342742|12027094|FG000|NOT COMPLETED|Overall Study||2
10862105|NCT03342742|12027095|FG001|NOT COMPLETED|Overall Study||2
10862112|NCT03307967|12027114|FG000|STARTED|Overall Study||40
10862113|NCT03307967|12027114|FG000|COMPLETED|Overall Study||36
10862114|NCT03307967|12027114|FG000|NOT COMPLETED|Overall Study||4
10862127|NCT03272711|12027139|FG000|STARTED|Overall Study||51
10862128|NCT03272711|12027140|FG001|STARTED|Overall Study||49
10862129|NCT03272711|12027139|FG000|COMPLETED|Overall Study||44
10862130|NCT03272711|12027140|FG001|COMPLETED|Overall Study||41
10862131|NCT03272711|12027139|FG000|NOT COMPLETED|Overall Study||7
10862132|NCT03272711|12027140|FG001|NOT COMPLETED|Overall Study||8
10862133|NCT03271983|12027146|FG000|STARTED|Overall Study|The plan was to do n=12 volunteers; however, funding was terminated due to pandemic so only 7 volunteers were completed.|7
10862134|NCT03271983|12027146|FG000|COMPLETED|Overall Study||7
10862135|NCT03271983|12027146|FG000|NOT COMPLETED|Overall Study||0
10862136|NCT03246789|12027156|FG000|STARTED|Overall Study||24
10862137|NCT03246789|12027157|FG001|STARTED|Overall Study||15
10862138|NCT03246789|12027156|FG000|COMPLETED|Overall Study||24
10862139|NCT03246789|12027157|FG001|COMPLETED|Overall Study||15
10862140|NCT03246789|12027156|FG000|NOT COMPLETED|Overall Study||0
10862141|NCT03246789|12027157|FG001|NOT COMPLETED|Overall Study||0
10862142|NCT03241225|12027165|FG000|STARTED|Overall Study||24
10862143|NCT03241225|12027166|FG001|STARTED|Overall Study||16
10862144|NCT03241225|12027165|FG000|COMPLETED|Overall Study||17
10862145|NCT03241225|12027166|FG001|COMPLETED|Overall Study||14
10862146|NCT03241225|12027165|FG000|NOT COMPLETED|Overall Study||7
10862147|NCT03241225|12027166|FG001|NOT COMPLETED|Overall Study||2
10862148|NCT03225846|12027179|FG000|STARTED|Overall Study||22
10862149|NCT03225846|12027180|FG001|STARTED|Overall Study||9
10862150|NCT03225846|12027181|FG002|STARTED|Overall Study||12
10862151|NCT03225846|12027182|FG003|STARTED|Overall Study||15
10862152|NCT03225846|12027183|FG004|STARTED|Overall Study||8
10862153|NCT03225846|12027184|FG005|STARTED|Overall Study||9
10862154|NCT03225846|12027185|FG006|STARTED|Overall Study||13
10293884|NCT02675114|11426506|FG000|Valve Implant|Overall Study||453
10862155|NCT03225846|12027179|FG000|Single Dose Period Only|Overall Study||6
10862156|NCT03225846|12027180|FG001|Single Dose Period Only|Overall Study||3
10862157|NCT03225846|12027181|FG002|Single Dose Period Only|Overall Study||4
10862158|NCT03225846|12027182|FG003|Single Dose Period Only|Overall Study||7
10862159|NCT03225846|12027183|FG004|Single Dose Period Only|Overall Study||8
10862160|NCT03225846|12027184|FG005|Single Dose Period Only|Overall Study||0
10862161|NCT03225846|12027185|FG006|Single Dose Period Only|Overall Study||4
10862162|NCT03225846|12027179|FG000|Multiple Dose Period Only|Overall Study||3
10862118|NCT03288129|12027124|FG000|STARTED|Overall Study||54
10862119|NCT03288129|12027124|FG000|COMPLETED|Overall Study||32
10862120|NCT03288129|12027124|FG000|NOT COMPLETED|Overall Study||22
10862163|NCT03225846|12027180|FG001|Multiple Dose Period Only|Overall Study||0
10862164|NCT03225846|12027181|FG002|Multiple Dose Period Only|Overall Study||3
10862165|NCT03225846|12027182|FG003|Multiple Dose Period Only|Overall Study||6
10862166|NCT03225846|12027183|FG004|Multiple Dose Period Only|Overall Study||0
10862167|NCT03225846|12027184|FG005|Multiple Dose Period Only|Overall Study||0
10862168|NCT03225846|12027185|FG006|Multiple Dose Period Only|Overall Study||4
10862169|NCT03225846|12027179|FG000|Single Dose and Multiple Dose|Overall Study||13
10862170|NCT03225846|12027180|FG001|Single Dose and Multiple Dose|Overall Study||6
10862171|NCT03225846|12027181|FG002|Single Dose and Multiple Dose|Overall Study||5
10862172|NCT03225846|12027182|FG003|Single Dose and Multiple Dose|Overall Study||2
10862173|NCT03225846|12027183|FG004|Single Dose and Multiple Dose|Overall Study||0
10862174|NCT03225846|12027184|FG005|Single Dose and Multiple Dose|Overall Study||9
10862175|NCT03225846|12027185|FG006|Single Dose and Multiple Dose|Overall Study||5
10862176|NCT03225846|12027179|FG000|COMPLETED|Overall Study||22
10862177|NCT03225846|12027180|FG001|COMPLETED|Overall Study||7
10862178|NCT03225846|12027181|FG002|COMPLETED|Overall Study||11
10862179|NCT03225846|12027182|FG003|COMPLETED|Overall Study||15
10862180|NCT03225846|12027183|FG004|COMPLETED|Overall Study||8
10862181|NCT03225846|12027184|FG005|COMPLETED|Overall Study||9
10862182|NCT03225846|12027185|FG006|COMPLETED|Overall Study||6
10862183|NCT03225846|12027179|FG000|NOT COMPLETED|Overall Study||0
10862184|NCT03225846|12027180|FG001|NOT COMPLETED|Overall Study||2
10862185|NCT03225846|12027181|FG002|NOT COMPLETED|Overall Study||1
10862186|NCT03225846|12027182|FG003|NOT COMPLETED|Overall Study||0
10862187|NCT03225846|12027183|FG004|NOT COMPLETED|Overall Study||0
10862188|NCT03225846|12027184|FG005|NOT COMPLETED|Overall Study||0
10862189|NCT03225846|12027185|FG006|NOT COMPLETED|Overall Study||7
10293885|NCT02675114|11426507|FG001|Valve Implant|Overall Study||495
10293886|NCT02675114|11426506|FG000|COMPLETED|Overall Study||424
10862190|NCT03221270|12027212|FG000|STARTED|Overall Study||8
10862191|NCT03221270|12027213|FG001|STARTED|Overall Study||6
10862192|NCT03221270|12027214|FG002|STARTED|Overall Study||5
10862193|NCT03221270|12027215|FG003|STARTED|Overall Study||6
10862194|NCT03221270|12027212|FG000|Completed 5-Day Treatment|Overall Study||8
10862195|NCT03221270|12027213|FG001|Completed 5-Day Treatment|Overall Study||6
10862196|NCT03221270|12027214|FG002|Completed 5-Day Treatment|Overall Study||5
10862197|NCT03221270|12027215|FG003|Completed 5-Day Treatment|Overall Study||6
10862198|NCT03221270|12027212|FG000|Completed 8-Week Maintenance|Overall Study||4
10862199|NCT03221270|12027213|FG001|Completed 8-Week Maintenance|Overall Study||6
10862200|NCT03221270|12027214|FG002|Completed 8-Week Maintenance|Overall Study||5
10862201|NCT03221270|12027215|FG003|Completed 8-Week Maintenance|Overall Study||5
10862202|NCT03221270|12027212|FG000|COMPLETED|Overall Study||4
10862203|NCT03221270|12027213|FG001|COMPLETED|Overall Study||6
10862204|NCT03221270|12027214|FG002|COMPLETED|Overall Study||5
10862205|NCT03221270|12027215|FG003|COMPLETED|Overall Study||5
10862206|NCT03221270|12027212|FG000|NOT COMPLETED|Overall Study||4
10862207|NCT03221270|12027213|FG001|NOT COMPLETED|Overall Study||0
10862208|NCT03221270|12027214|FG002|NOT COMPLETED|Overall Study||0
10862209|NCT03221270|12027215|FG003|NOT COMPLETED|Overall Study||1
10862210|NCT03191903|12027228|FG000|STARTED|Overall Study||251
10862211|NCT03191903|12027229|FG001|STARTED|Overall Study||251
10862212|NCT03191903|12027230|FG002|STARTED|Overall Study||74
10862213|NCT03191903|12027228|FG000|Intent to Treat Population|Overall Study||251
10862214|NCT03191903|12027229|FG001|Intent to Treat Population|Overall Study||251
10862215|NCT03191903|12027230|FG002|Intent to Treat Population|Overall Study||74
10862216|NCT03191903|12027228|FG000|COMPLETED|Overall Study||244
10862217|NCT03191903|12027229|FG001|COMPLETED|Overall Study||246
10862218|NCT03191903|12027230|FG002|COMPLETED|Overall Study||70
10862219|NCT03191903|12027228|FG000|NOT COMPLETED|Overall Study||7
10862220|NCT03191903|12027229|FG001|NOT COMPLETED|Overall Study||5
10862221|NCT03191903|12027230|FG002|NOT COMPLETED|Overall Study||4
10862222|NCT03186794|12027243|FG000|STARTED|Overall Study||20
10862223|NCT03186794|12027243|FG000|COMPLETED|Overall Study||16
10862224|NCT03186794|12027243|FG000|NOT COMPLETED|Overall Study||4
10862225|NCT04289051|12027248|FG000|STARTED|Overall Study||13
10862226|NCT04289051|12027249|FG001|STARTED|Overall Study||13
10862227|NCT04289051|12027250|FG002|STARTED|Overall Study||13
10862228|NCT04289051|12027248|FG000|First Intervention (2 Weeks)|Overall Study||13
10862229|NCT04289051|12027249|FG001|First Intervention (2 Weeks)|Overall Study||13
10862230|NCT04289051|12027250|FG002|First Intervention (2 Weeks)|Overall Study||11
10862231|NCT04289051|12027248|FG000|Washout (1 Week)|Overall Study||13
10862232|NCT04289051|12027249|FG001|Washout (1 Week)|Overall Study||13
10862233|NCT04289051|12027250|FG002|Washout (1 Week)|Overall Study||11
10862234|NCT04289051|12027248|FG000|Second Intervention (2 Weeks)|Overall Study||13
10862235|NCT04289051|12027249|FG001|Second Intervention (2 Weeks)|Overall Study||13
10862236|NCT04289051|12027250|FG002|Second Intervention (2 Weeks)|Overall Study||11
10862237|NCT04289051|12027248|FG000|Washout (1 Week)|Overall Study||13
10862238|NCT04289051|12027249|FG001|Washout (1 Week)|Overall Study||13
10862239|NCT04289051|12027250|FG002|Washout (1 Week)|Overall Study||11
10862240|NCT04289051|12027248|FG000|Third Intervention (2 Weeks)|Overall Study||13
10862241|NCT04289051|12027249|FG001|Third Intervention (2 Weeks)|Overall Study||13
10862242|NCT04289051|12027250|FG002|Third Intervention (2 Weeks)|Overall Study||11
10862243|NCT04289051|12027248|FG000|COMPLETED|Overall Study||13
10862244|NCT04289051|12027249|FG001|COMPLETED|Overall Study||13
10862245|NCT04289051|12027250|FG002|COMPLETED|Overall Study||11
10862246|NCT04289051|12027248|FG000|NOT COMPLETED|Overall Study||0
10416768|NCT00796120|11561346|FG000|STARTED|Overall Study||61
10416769|NCT00796120|11561347|FG001|STARTED|Overall Study||60
10416770|NCT00796120|11561346|FG000|Treated|Overall Study||61
10416771|NCT00796120|11561347|FG001|Treated|Overall Study||57
10416772|NCT00796120|11561346|FG000|COMPLETED|Overall Study||0
10416773|NCT00796120|11561347|FG001|COMPLETED|Overall Study||0
10416774|NCT00796120|11561346|FG000|NOT COMPLETED|Overall Study||61
10416775|NCT00796120|11561347|FG001|NOT COMPLETED|Overall Study||60
10416776|NCT00796224|11561355|FG000|STARTED|Overall Study||19
10416777|NCT00796224|11561356|FG001|STARTED|Overall Study||19
10416778|NCT00796224|11561355|FG000|COMPLETED|Overall Study||18
10416779|NCT00796224|11561356|FG001|COMPLETED|Overall Study||18
10416780|NCT00796224|11561355|FG000|NOT COMPLETED|Overall Study||1
10416781|NCT00796224|11561356|FG001|NOT COMPLETED|Overall Study||1
10416782|NCT00796302|11561366|FG000|STARTED|Overall Study||84
10416783|NCT00796302|11561367|FG001|STARTED|Overall Study||84
10416784|NCT00796302|11561366|FG000|COMPLETED|Overall Study||71
10416785|NCT00796302|11561367|FG001|COMPLETED|Overall Study||66
10416786|NCT00796302|11561366|FG000|NOT COMPLETED|Overall Study||13
10416787|NCT00796302|11561367|FG001|NOT COMPLETED|Overall Study||18
10548299|NCT01518699|11702085|FG000|NOT COMPLETED|Period 3||0
10416788|NCT00796315|11561374|FG000|STARTED|Overall Study||9
10416789|NCT00796315|11561375|FG001|STARTED|Overall Study||17
10416790|NCT00796315|11561376|FG002|STARTED|Overall Study||15
10416791|NCT00796315|11561374|FG000|COMPLETED|Overall Study||9
10416792|NCT00796315|11561375|FG001|COMPLETED|Overall Study||16
10416793|NCT00796315|11561376|FG002|COMPLETED|Overall Study||15
10416794|NCT00796315|11561374|FG000|NOT COMPLETED|Overall Study||0
10862247|NCT04289051|12027249|FG001|NOT COMPLETED|Overall Study||0
10862248|NCT04289051|12027250|FG002|NOT COMPLETED|Overall Study||2
10862249|NCT04210180|12027258|FG000|STARTED|Overall Study||25
10862250|NCT04210180|12027258|FG000|COMPLETED|Overall Study||23
10862251|NCT04210180|12027258|FG000|NOT COMPLETED|Overall Study||2
10862252|NCT04097223|12027262|FG000|STARTED|Overall Study||17464
10862253|NCT04097223|12027262|FG000|COMPLETED|Overall Study||17464
10862254|NCT04097223|12027262|FG000|NOT COMPLETED|Overall Study||0
10862255|NCT03675308|12027301|FG000|STARTED|Overall Study||481
10862256|NCT03675308|12027302|FG001|STARTED|Overall Study||483
10862257|NCT03675308|12027301|FG000|COMPLETED|Overall Study||467
10862258|NCT03675308|12027302|FG001|COMPLETED|Overall Study||473
10862259|NCT03675308|12027301|FG000|NOT COMPLETED|Overall Study||14
10862260|NCT03675308|12027302|FG001|NOT COMPLETED|Overall Study||10
10862261|NCT03573817|12027310|FG000|STARTED|Overall Study||63
10862262|NCT03573817|12027311|FG001|STARTED|Overall Study||59
10862263|NCT03573817|12027310|FG000|Randomized and Treated With Study Drug|Overall Study||63
10862264|NCT03573817|12027311|FG001|Randomized and Treated With Study Drug|Overall Study||59
10862265|NCT03573817|12027310|FG000|COMPLETED|Overall Study||62
10862266|NCT03573817|12027311|FG001|COMPLETED|Overall Study||55
10862267|NCT03573817|12027310|FG000|NOT COMPLETED|Overall Study||1
10862268|NCT03573817|12027311|FG001|NOT COMPLETED|Overall Study||4
10862290|NCT03095456|12027349|FG000|STARTED|Overall Study||103
10862291|NCT03095456|12027350|FG001|STARTED|Overall Study||104
10416795|NCT00796315|11561375|FG001|NOT COMPLETED|Overall Study||1
10416796|NCT00796315|11561376|FG002|NOT COMPLETED|Overall Study||0
10416797|NCT00796328|11561387|FG000|STARTED|Overall Study||46
10416798|NCT00796328|11561387|FG000|COMPLETED|Overall Study||40
10416799|NCT00796328|11561387|FG000|NOT COMPLETED|Overall Study||6
10862292|NCT03095456|12027349|FG000|COMPLETED|Overall Study||99
10862293|NCT03095456|12027350|FG001|COMPLETED|Overall Study||96
10862294|NCT03095456|12027349|FG000|NOT COMPLETED|Overall Study||4
10862295|NCT03095456|12027350|FG001|NOT COMPLETED|Overall Study||8
10416800|NCT00796367|11561394|FG000|STARTED|Overall Study||227
10429380|NCT00863265|11575377|FG005|COMPLETED|Overall Study||3
10862296|NCT03064113|12027360|FG000|STARTED|Intervention 1 (2 Days)||8
10862297|NCT03064113|12027361|FG001|STARTED|Intervention 1 (2 Days)||8
10862298|NCT03064113|12027362|FG002|STARTED|Intervention 1 (2 Days)||8
10862299|NCT03064113|12027363|FG003|STARTED|Intervention 1 (2 Days)||8
10862300|NCT03064113|12027360|FG000|COMPLETED|Intervention 1 (2 Days)||8
10862301|NCT03064113|12027361|FG001|COMPLETED|Intervention 1 (2 Days)||8
10862302|NCT03064113|12027362|FG002|COMPLETED|Intervention 1 (2 Days)||8
10862303|NCT03064113|12027363|FG003|COMPLETED|Intervention 1 (2 Days)||8
10862304|NCT03064113|12027360|FG000|NOT COMPLETED|Intervention 1 (2 Days)||0
10862305|NCT03064113|12027361|FG001|NOT COMPLETED|Intervention 1 (2 Days)||0
10862306|NCT03064113|12027362|FG002|NOT COMPLETED|Intervention 1 (2 Days)||0
10862307|NCT03064113|12027363|FG003|NOT COMPLETED|Intervention 1 (2 Days)||0
10862308|NCT03064113|12027360|FG000|STARTED|Washout (7 Days)||8
10862309|NCT03064113|12027361|FG001|STARTED|Washout (7 Days)||8
10862310|NCT03064113|12027362|FG002|STARTED|Washout (7 Days)||8
10862311|NCT03064113|12027363|FG003|STARTED|Washout (7 Days)||8
10862312|NCT03064113|12027360|FG000|COMPLETED|Washout (7 Days)||8
10862313|NCT03064113|12027361|FG001|COMPLETED|Washout (7 Days)||8
10862314|NCT03064113|12027362|FG002|COMPLETED|Washout (7 Days)||8
10862315|NCT03064113|12027363|FG003|COMPLETED|Washout (7 Days)||8
10862316|NCT03064113|12027360|FG000|NOT COMPLETED|Washout (7 Days)||0
10862317|NCT03064113|12027361|FG001|NOT COMPLETED|Washout (7 Days)||0
10862318|NCT03064113|12027362|FG002|NOT COMPLETED|Washout (7 Days)||0
10862319|NCT03064113|12027363|FG003|NOT COMPLETED|Washout (7 Days)||0
10862320|NCT03064113|12027360|FG000|STARTED|Intervention 2 (2 Days)||8
10862321|NCT03064113|12027361|FG001|STARTED|Intervention 2 (2 Days)||8
10862322|NCT03064113|12027362|FG002|STARTED|Intervention 2 (2 Days)||8
10862323|NCT03064113|12027363|FG003|STARTED|Intervention 2 (2 Days)||8
10862324|NCT03064113|12027360|FG000|COMPLETED|Intervention 2 (2 Days)||8
10862325|NCT03064113|12027361|FG001|COMPLETED|Intervention 2 (2 Days)||8
10862326|NCT03064113|12027362|FG002|COMPLETED|Intervention 2 (2 Days)||8
10862327|NCT03064113|12027363|FG003|COMPLETED|Intervention 2 (2 Days)||8
10862328|NCT03064113|12027360|FG000|NOT COMPLETED|Intervention 2 (2 Days)||0
10862329|NCT03064113|12027361|FG001|NOT COMPLETED|Intervention 2 (2 Days)||0
10862330|NCT03064113|12027362|FG002|NOT COMPLETED|Intervention 2 (2 Days)||0
10862331|NCT03064113|12027363|FG003|NOT COMPLETED|Intervention 2 (2 Days)||0
10862332|NCT03064113|12027360|FG000|STARTED|Washout (7 Days)||8
10862333|NCT03064113|12027361|FG001|STARTED|Washout (7 Days)||8
10862334|NCT03064113|12027362|FG002|STARTED|Washout (7 Days)||8
10545741|NCT01499667|11699236|FG000|Full Analysis Set (FAS)|Overall Study|One randomized patient did not receive natalizumub at screening, which was a requirement for FAS.|49
10545742|NCT01499667|11699237|FG001|Full Analysis Set (FAS)|Overall Study||42
10545743|NCT01499667|11699238|FG002|Full Analysis Set (FAS)|Overall Study||50
10545744|NCT01499667|11699236|FG000|Modified Full Analysis Set|Overall Study|mFAS included all FAS patients who completed 8 wks of fingolimod treatment with MRI scan|41
10545745|NCT01499667|11699237|FG001|Modified Full Analysis Set|Overall Study||29
10545746|NCT01499667|11699238|FG002|Modified Full Analysis Set|Overall Study||39
10545747|NCT01499667|11699236|FG000|COMPLETED|Overall Study||41
10545748|NCT01499667|11699237|FG001|COMPLETED|Overall Study||31
10545749|NCT01499667|11699238|FG002|COMPLETED|Overall Study||40
10545750|NCT01499667|11699236|FG000|NOT COMPLETED|Overall Study||9
10545751|NCT01499667|11699237|FG001|NOT COMPLETED|Overall Study||11
10545752|NCT01499667|11699238|FG002|NOT COMPLETED|Overall Study||10
10545753|NCT01499810|11699246|FG000|STARTED|Overall Study||53
10545754|NCT01499810|11699246|FG000|COMPLETED|Overall Study||41
10862335|NCT03064113|12027363|FG003|STARTED|Washout (7 Days)||8
10862336|NCT03064113|12027360|FG000|COMPLETED|Washout (7 Days)||8
10862337|NCT03064113|12027361|FG001|COMPLETED|Washout (7 Days)||8
10862338|NCT03064113|12027362|FG002|COMPLETED|Washout (7 Days)||8
10862339|NCT03064113|12027363|FG003|COMPLETED|Washout (7 Days)||8
10862340|NCT03064113|12027360|FG000|NOT COMPLETED|Washout (7 Days)||0
10293887|NCT02675114|11426507|FG001|COMPLETED|Overall Study||490
10293888|NCT02675114|11426506|FG000|NOT COMPLETED|Overall Study||73
10293889|NCT02675114|11426507|FG001|NOT COMPLETED|Overall Study||13
10293890|NCT02564796|11426515|FG000|STARTED|Overall Study||2
10293891|NCT02564796|11426516|FG001|STARTED|Overall Study||2
10293892|NCT02564796|11426515|FG000|COMPLETED|Overall Study||0
10293893|NCT02564796|11426516|FG001|COMPLETED|Overall Study||0
10293894|NCT02564796|11426515|FG000|NOT COMPLETED|Overall Study||2
10293895|NCT02564796|11426516|FG001|NOT COMPLETED|Overall Study||2
10293896|NCT02562716|11426524|FG000|STARTED|Overall Study||55
10293897|NCT02562716|11426525|FG001|STARTED|Overall Study||47
10293898|NCT02562716|11426524|FG000|Participants Assessed for AEs|Overall Study||53
10293899|NCT02562716|11426525|FG001|Participants Assessed for AEs|Overall Study||45
10293900|NCT02562716|11426524|FG000|COMPLETED|Overall Study||27
10545755|NCT01499810|11699246|FG000|NOT COMPLETED|Overall Study||12
10545756|NCT01499849|11699253|FG000|STARTED|Overall Study|Number of randomized patients|266
10545757|NCT01499849|11699254|FG001|STARTED|Overall Study||266
10862341|NCT03064113|12027361|FG001|NOT COMPLETED|Washout (7 Days)||0
10862342|NCT03064113|12027362|FG002|NOT COMPLETED|Washout (7 Days)||0
10545758|NCT01499849|11699253|FG000|COMPLETED|Overall Study|Number of patients who completed 6 cycles|42
10862343|NCT03064113|12027363|FG003|NOT COMPLETED|Washout (7 Days)||0
10862344|NCT03064113|12027360|FG000|STARTED|Intervention 3 (2 Days)||8
10862345|NCT03064113|12027361|FG001|STARTED|Intervention 3 (2 Days)||8
10862346|NCT03064113|12027362|FG002|STARTED|Intervention 3 (2 Days)||8
10862347|NCT03064113|12027363|FG003|STARTED|Intervention 3 (2 Days)||8
10862348|NCT03064113|12027360|FG000|COMPLETED|Intervention 3 (2 Days)||8
10862349|NCT03064113|12027361|FG001|COMPLETED|Intervention 3 (2 Days)||8
10862350|NCT03064113|12027362|FG002|COMPLETED|Intervention 3 (2 Days)||8
10862351|NCT03064113|12027363|FG003|COMPLETED|Intervention 3 (2 Days)||8
10862352|NCT03064113|12027360|FG000|NOT COMPLETED|Intervention 3 (2 Days)||0
10862353|NCT03064113|12027361|FG001|NOT COMPLETED|Intervention 3 (2 Days)||0
10862354|NCT03064113|12027362|FG002|NOT COMPLETED|Intervention 3 (2 Days)||0
10862355|NCT03064113|12027363|FG003|NOT COMPLETED|Intervention 3 (2 Days)||0
10862356|NCT03064113|12027360|FG000|STARTED|Washout (7 Days)||8
10862357|NCT03064113|12027361|FG001|STARTED|Washout (7 Days)||8
10862358|NCT03064113|12027362|FG002|STARTED|Washout (7 Days)||8
10862359|NCT03064113|12027363|FG003|STARTED|Washout (7 Days)||8
10862360|NCT03064113|12027360|FG000|COMPLETED|Washout (7 Days)||8
10862361|NCT03064113|12027361|FG001|COMPLETED|Washout (7 Days)||8
10545759|NCT01499849|11699254|FG001|COMPLETED|Overall Study||40
10545760|NCT01499849|11699253|FG000|NOT COMPLETED|Overall Study||224
10545761|NCT01499849|11699254|FG001|NOT COMPLETED|Overall Study||226
10545762|NCT01499862|11699260|FG000|STARTED|Overall Study||3
10545763|NCT01499862|11699260|FG000|COMPLETED|Overall Study||3
10545764|NCT01499862|11699260|FG000|NOT COMPLETED|Overall Study||0
10545765|NCT01499940|11699278|FG000|STARTED|Overall Study||9
10545766|NCT01499940|11699278|FG000|COMPLETED|Overall Study||0
10545767|NCT01499940|11699278|FG000|NOT COMPLETED|Overall Study||9
10545768|NCT01500031|11699282|FG000|STARTED|Overall Study||92
10545769|NCT01500031|11699282|FG000|COMPLETED|Overall Study||87
10545770|NCT01500031|11699282|FG000|NOT COMPLETED|Overall Study||5
10862362|NCT03064113|12027362|FG002|COMPLETED|Washout (7 Days)||8
10862363|NCT03064113|12027363|FG003|COMPLETED|Washout (7 Days)||8
10862364|NCT03064113|12027360|FG000|NOT COMPLETED|Washout (7 Days)||0
10862365|NCT03064113|12027361|FG001|NOT COMPLETED|Washout (7 Days)||0
10862366|NCT03064113|12027362|FG002|NOT COMPLETED|Washout (7 Days)||0
10862367|NCT03064113|12027363|FG003|NOT COMPLETED|Washout (7 Days)||0
10862368|NCT03064113|12027360|FG000|STARTED|Intervention 4 (2 Days)||8
10862369|NCT03064113|12027361|FG001|STARTED|Intervention 4 (2 Days)||8
10862370|NCT03064113|12027362|FG002|STARTED|Intervention 4 (2 Days)||8
10862371|NCT03064113|12027363|FG003|STARTED|Intervention 4 (2 Days)||8
10862372|NCT03064113|12027360|FG000|COMPLETED|Intervention 4 (2 Days)||8
10862373|NCT03064113|12027361|FG001|COMPLETED|Intervention 4 (2 Days)||8
10862374|NCT03064113|12027362|FG002|COMPLETED|Intervention 4 (2 Days)||8
10862375|NCT03064113|12027363|FG003|COMPLETED|Intervention 4 (2 Days)||8
10862376|NCT03064113|12027360|FG000|NOT COMPLETED|Intervention 4 (2 Days)||0
10862377|NCT03064113|12027361|FG001|NOT COMPLETED|Intervention 4 (2 Days)||0
10862378|NCT03064113|12027362|FG002|NOT COMPLETED|Intervention 4 (2 Days)||0
10862379|NCT03064113|12027363|FG003|NOT COMPLETED|Intervention 4 (2 Days)||0
10862380|NCT03064113|12027360|FG000|STARTED|Washout (7 Days)||8
10862381|NCT03064113|12027361|FG001|STARTED|Washout (7 Days)||8
10862382|NCT03064113|12027362|FG002|STARTED|Washout (7 Days)||8
10862383|NCT03064113|12027363|FG003|STARTED|Washout (7 Days)||8
10862384|NCT03064113|12027360|FG000|COMPLETED|Washout (7 Days)||8
10862385|NCT03064113|12027361|FG001|COMPLETED|Washout (7 Days)||8
10862386|NCT03064113|12027362|FG002|COMPLETED|Washout (7 Days)||8
10862387|NCT03064113|12027363|FG003|COMPLETED|Washout (7 Days)||8
10862388|NCT03064113|12027360|FG000|NOT COMPLETED|Washout (7 Days)||0
10862389|NCT03064113|12027361|FG001|NOT COMPLETED|Washout (7 Days)||0
10862390|NCT03064113|12027362|FG002|NOT COMPLETED|Washout (7 Days)||0
10862391|NCT03064113|12027363|FG003|NOT COMPLETED|Washout (7 Days)||0
10862392|NCT02938013|12027376|FG000|STARTED|Overall Study||5
10862393|NCT02938013|12027377|FG001|STARTED|Overall Study||5
10862394|NCT02938013|12027378|FG002|STARTED|Overall Study||5
10862395|NCT02938013|12027376|FG000|COMPLETED|Overall Study||5
10862396|NCT02938013|12027377|FG001|COMPLETED|Overall Study||5
10862397|NCT02938013|12027378|FG002|COMPLETED|Overall Study||5
10862398|NCT02938013|12027376|FG000|NOT COMPLETED|Overall Study||0
10862399|NCT02938013|12027377|FG001|NOT COMPLETED|Overall Study||0
10862400|NCT02938013|12027378|FG002|NOT COMPLETED|Overall Study||0
10862401|NCT02919683|12027388|FG000|STARTED|Pre-Surgery Intervention||15
10862402|NCT02919683|12027389|FG001|STARTED|Pre-Surgery Intervention||15
10862403|NCT02919683|12027388|FG000|COMPLETED|Pre-Surgery Intervention||15
10862404|NCT02919683|12027389|FG001|COMPLETED|Pre-Surgery Intervention||15
10862405|NCT02919683|12027388|FG000|NOT COMPLETED|Pre-Surgery Intervention||0
10862406|NCT02919683|12027389|FG001|NOT COMPLETED|Pre-Surgery Intervention||0
10862407|NCT02919683|12027388|FG000|STARTED|Post-Surgery Follow-Up||15
10862408|NCT02919683|12027389|FG001|STARTED|Post-Surgery Follow-Up||15
10862409|NCT02919683|12027388|FG000|COMPLETED|Post-Surgery Follow-Up||12
10862410|NCT02919683|12027389|FG001|COMPLETED|Post-Surgery Follow-Up||13
10862411|NCT02919683|12027388|FG000|NOT COMPLETED|Post-Surgery Follow-Up||3
10545771|NCT01500057|11699288|FG000|STARTED|Overall Study||31
10545772|NCT01500057|11699289|FG001|STARTED|Overall Study||35
10545773|NCT01500057|11699288|FG000|COMPLETED|Overall Study||25
10545774|NCT01500057|11699289|FG001|COMPLETED|Overall Study||31
10862412|NCT02919683|12027389|FG001|NOT COMPLETED|Post-Surgery Follow-Up||2
10862416|NCT02790138|12027402|FG000|STARTED|Overall Study||51
10862417|NCT02790138|12027403|FG001|STARTED|Overall Study||51
10862418|NCT02790138|12027402|FG000|COMPLETED|Overall Study||30
10862419|NCT02790138|12027403|FG001|COMPLETED|Overall Study||32
10862420|NCT02790138|12027402|FG000|NOT COMPLETED|Overall Study||21
10862421|NCT02790138|12027403|FG001|NOT COMPLETED|Overall Study||19
10862422|NCT02642315|12027410|FG000|STARTED|Overall Study||10
10862423|NCT02642315|12027410|FG000|COMPLETED|Overall Study||8
10862424|NCT02642315|12027410|FG000|NOT COMPLETED|Overall Study||2
10862425|NCT02518139|12027417|FG000|STARTED|Overall Study||364
10862426|NCT02518139|12027418|FG001|STARTED|Overall Study||335
10862427|NCT02518139|12027419|FG002|STARTED|Overall Study||356
10862428|NCT02518139|12027417|FG000|COMPLETED|Overall Study||219
10862429|NCT02518139|12027418|FG001|COMPLETED|Overall Study||191
10862430|NCT02518139|12027419|FG002|COMPLETED|Overall Study||262
10862431|NCT02518139|12027417|FG000|NOT COMPLETED|Overall Study||145
10862432|NCT02518139|12027418|FG001|NOT COMPLETED|Overall Study||144
10862433|NCT02518139|12027419|FG002|NOT COMPLETED|Overall Study||94
10862434|NCT02514239|12027437|FG000|STARTED|Overall Study||5
10862435|NCT02514239|12027438|FG001|STARTED|Overall Study||4
10862436|NCT02514239|12027439|FG002|STARTED|Overall Study||3
10862437|NCT02514239|12027440|FG003|STARTED|Overall Study||3
10862438|NCT02514239|12027441|FG004|STARTED|Overall Study||3
10862439|NCT02514239|12027442|FG005|STARTED|Overall Study||5
10862440|NCT02514239|12027443|FG006|STARTED|Overall Study||4
10862441|NCT02514239|12027444|FG007|STARTED|Overall Study||3
10862442|NCT02514239|12027445|FG008|STARTED|Overall Study||10
10862443|NCT02514239|12027446|FG009|STARTED|Overall Study||3
10862444|NCT02514239|12027437|FG000|Treated|Overall Study||5
10862445|NCT02514239|12027438|FG001|Treated|Overall Study||3
10862446|NCT02514239|12027439|FG002|Treated|Overall Study||3
10862447|NCT02514239|12027440|FG003|Treated|Overall Study||3
10862448|NCT02514239|12027441|FG004|Treated|Overall Study||3
10862449|NCT02514239|12027442|FG005|Treated|Overall Study||5
10862450|NCT02514239|12027443|FG006|Treated|Overall Study||4
10862451|NCT02514239|12027444|FG007|Treated|Overall Study||3
10862452|NCT02514239|12027445|FG008|Treated|Overall Study||10
10862453|NCT02514239|12027446|FG009|Treated|Overall Study||3
10862454|NCT02514239|12027437|FG000|COMPLETED|Overall Study||0
10862455|NCT02514239|12027438|FG001|COMPLETED|Overall Study||0
10862456|NCT02514239|12027439|FG002|COMPLETED|Overall Study||1
10862457|NCT02514239|12027440|FG003|COMPLETED|Overall Study||0
10862458|NCT02514239|12027441|FG004|COMPLETED|Overall Study||0
10862459|NCT02514239|12027442|FG005|COMPLETED|Overall Study||1
10862460|NCT02514239|12027443|FG006|COMPLETED|Overall Study||0
10862461|NCT02514239|12027444|FG007|COMPLETED|Overall Study||0
10862462|NCT02514239|12027445|FG008|COMPLETED|Overall Study||2
10862463|NCT02514239|12027446|FG009|COMPLETED|Overall Study||0
10862464|NCT02514239|12027437|FG000|NOT COMPLETED|Overall Study||5
10862465|NCT02514239|12027438|FG001|NOT COMPLETED|Overall Study||4
10862466|NCT02514239|12027439|FG002|NOT COMPLETED|Overall Study||2
10862467|NCT02514239|12027440|FG003|NOT COMPLETED|Overall Study||3
10862468|NCT02514239|12027441|FG004|NOT COMPLETED|Overall Study||3
10862469|NCT02514239|12027442|FG005|NOT COMPLETED|Overall Study||4
10862470|NCT02514239|12027443|FG006|NOT COMPLETED|Overall Study||4
10862471|NCT02514239|12027444|FG007|NOT COMPLETED|Overall Study||3
10862472|NCT02514239|12027445|FG008|NOT COMPLETED|Overall Study||8
10862473|NCT02514239|12027446|FG009|NOT COMPLETED|Overall Study||3
10862474|NCT02512510|12027489|FG000|STARTED|Overall Study||205
10862475|NCT02512510|12027490|FG001|STARTED|Overall Study||197
10862476|NCT02512510|12027491|FG002|STARTED|Overall Study||209
10862477|NCT02512510|12027489|FG000|COMPLETED|Overall Study||163
10862478|NCT02512510|12027490|FG001|COMPLETED|Overall Study||162
10862479|NCT02512510|12027491|FG002|COMPLETED|Overall Study||157
10862480|NCT02512510|12027489|FG000|NOT COMPLETED|Overall Study||42
10862481|NCT02512510|12027490|FG001|NOT COMPLETED|Overall Study||35
10862482|NCT02512510|12027491|FG002|NOT COMPLETED|Overall Study||52
10862483|NCT02459080|12027502|FG000|STARTED|Overall Study||212
10862484|NCT02459080|12027503|FG001|STARTED|Overall Study||198
10862485|NCT02459080|12027504|FG002|STARTED|Overall Study||209
10862486|NCT02459080|12027502|FG000|COMPLETED|Overall Study||168
10862487|NCT02459080|12027503|FG001|COMPLETED|Overall Study||158
10862488|NCT02459080|12027504|FG002|COMPLETED|Overall Study||151
10862489|NCT02459080|12027502|FG000|NOT COMPLETED|Overall Study||44
10862490|NCT02459080|12027503|FG001|NOT COMPLETED|Overall Study||40
10862491|NCT02459080|12027504|FG002|NOT COMPLETED|Overall Study||58
10862492|NCT02245672|12027515|FG000|STARTED|Overall Study||512
10862493|NCT02245672|12027516|FG001|STARTED|Overall Study||513
10862494|NCT02245672|12027517|FG002|STARTED|Overall Study||103
10862495|NCT02245672|12027515|FG000|COMPLETED|Overall Study||499
10862496|NCT02245672|12027516|FG001|COMPLETED|Overall Study||500
10862497|NCT02245672|12027517|FG002|COMPLETED|Overall Study||98
10862498|NCT02245672|12027515|FG000|NOT COMPLETED|Overall Study||13
10862499|NCT02245672|12027516|FG001|NOT COMPLETED|Overall Study||13
10862500|NCT02245672|12027517|FG002|NOT COMPLETED|Overall Study||5
10862501|NCT02109172|12027525|FG000|STARTED|Overall Study||11
10862502|NCT02109172|12027526|FG001|STARTED|Overall Study||11
10862503|NCT02109172|12027527|FG002|STARTED|Overall Study||10
10862504|NCT02109172|12027528|FG003|STARTED|Overall Study||11
10862505|NCT02109172|12027529|FG004|STARTED|Overall Study||10
10862506|NCT02109172|12027530|FG005|STARTED|Overall Study||11
10862507|NCT02109172|12027525|FG000|COMPLETED|Overall Study||10
10862508|NCT02109172|12027526|FG001|COMPLETED|Overall Study||11
10862509|NCT02109172|12027527|FG002|COMPLETED|Overall Study||9
10862510|NCT02109172|12027528|FG003|COMPLETED|Overall Study||10
10862511|NCT02109172|12027529|FG004|COMPLETED|Overall Study||9
10862512|NCT02109172|12027530|FG005|COMPLETED|Overall Study||10
10862513|NCT02109172|12027525|FG000|NOT COMPLETED|Overall Study||1
10862514|NCT02109172|12027526|FG001|NOT COMPLETED|Overall Study||0
10862515|NCT02109172|12027527|FG002|NOT COMPLETED|Overall Study||1
10862516|NCT02109172|12027528|FG003|NOT COMPLETED|Overall Study||1
10862517|NCT02109172|12027529|FG004|NOT COMPLETED|Overall Study||1
10862518|NCT02109172|12027530|FG005|NOT COMPLETED|Overall Study||1
10862519|NCT02040792|12027543|FG000|STARTED|Overall Study||70
10862520|NCT02040792|12027544|FG001|STARTED|Overall Study||68
10862521|NCT02040792|12027545|FG002|STARTED|Overall Study||71
10862522|NCT02040792|12027546|FG003|STARTED|Overall Study||71
10862523|NCT02040792|12027547|FG004|STARTED|Overall Study||74
10862524|NCT02040792|12027543|FG000|COMPLETED|Overall Study||64
10862525|NCT02040792|12027544|FG001|COMPLETED|Overall Study||65
10862526|NCT02040792|12027545|FG002|COMPLETED|Overall Study||68
10862527|NCT02040792|12027546|FG003|COMPLETED|Overall Study||64
10862528|NCT02040792|12027547|FG004|COMPLETED|Overall Study||67
10862529|NCT02040792|12027543|FG000|NOT COMPLETED|Overall Study||6
10862530|NCT02040792|12027544|FG001|NOT COMPLETED|Overall Study||3
10862531|NCT02040792|12027545|FG002|NOT COMPLETED|Overall Study||3
10862532|NCT02040792|12027546|FG003|NOT COMPLETED|Overall Study||7
10862533|NCT02040792|12027547|FG004|NOT COMPLETED|Overall Study||7
10862534|NCT01979003|12027559|FG000|STARTED|Overall Study||100
10862535|NCT01979003|12027559|FG000|COMPLETED|Overall Study||72
10862536|NCT01979003|12027559|FG000|NOT COMPLETED|Overall Study||28
10862537|NCT01704404|12027563|FG000|STARTED|Overall Study||11
10862538|NCT01704404|12027564|FG001|STARTED|Overall Study||10
10862539|NCT01704404|12027565|FG002|STARTED|Overall Study||10
10862540|NCT01704404|12027566|FG003|STARTED|Overall Study||11
10862541|NCT01704404|12027567|FG004|STARTED|Overall Study||11
10862542|NCT01704404|12027568|FG005|STARTED|Overall Study||9
10862543|NCT01704404|12027563|FG000|COMPLETED|Overall Study||10
10862544|NCT01704404|12027564|FG001|COMPLETED|Overall Study||9
10862545|NCT01704404|12027565|FG002|COMPLETED|Overall Study||9
10862546|NCT01704404|12027566|FG003|COMPLETED|Overall Study||8
10862547|NCT01704404|12027567|FG004|COMPLETED|Overall Study||10
10862548|NCT01704404|12027568|FG005|COMPLETED|Overall Study||9
10862549|NCT01704404|12027563|FG000|NOT COMPLETED|Overall Study||1
10862550|NCT01704404|12027564|FG001|NOT COMPLETED|Overall Study||1
10862551|NCT01704404|12027565|FG002|NOT COMPLETED|Overall Study||1
10862552|NCT01704404|12027566|FG003|NOT COMPLETED|Overall Study||3
10862553|NCT01704404|12027567|FG004|NOT COMPLETED|Overall Study||1
10862554|NCT01704404|12027568|FG005|NOT COMPLETED|Overall Study||0
10862555|NCT01307813|12027584|FG000|STARTED|Overall Study||4
10862556|NCT01307813|12027584|FG000|COMPLETED|Overall Study||4
10862557|NCT01307813|12027584|FG000|NOT COMPLETED|Overall Study||0
10862558|NCT00799396|12027588|FG000|STARTED|Clopidogrel Treatment||682
10862559|NCT00799396|12027588|FG000|COMPLETED|Clopidogrel Treatment||669
10862560|NCT00799396|12027588|FG000|NOT COMPLETED|Clopidogrel Treatment||13
10862561|NCT00799396|12027588|FG000|STARTED|Clopidogrel Plus Aspirin||669
10862562|NCT00799396|12027588|FG000|COMPLETED|Clopidogrel Plus Aspirin||663
10862563|NCT00799396|12027588|FG000|NOT COMPLETED|Clopidogrel Plus Aspirin||6
10862564|NCT00069238|12027592|FG000|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||25
10862565|NCT00069238|12027593|FG001|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
10862566|NCT00069238|12027594|FG002|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
10862567|NCT00069238|12027592|FG000|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||16
10862568|NCT00069238|12027593|FG001|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
10862569|NCT00069238|12027594|FG002|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
10862570|NCT00069238|12027592|FG000|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||9
10862571|NCT00069238|12027593|FG001|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
10862572|NCT00069238|12027594|FG002|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
10862573|NCT00069238|12027592|FG000|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
10862574|NCT00069238|12027593|FG001|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||3
10862575|NCT00069238|12027594|FG002|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
10862576|NCT00069238|12027592|FG000|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
10862577|NCT00069238|12027593|FG001|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||1
10862578|NCT00069238|12027594|FG002|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
10862579|NCT00069238|12027592|FG000|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
10862580|NCT00069238|12027593|FG001|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||2
10862581|NCT00069238|12027594|FG002|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
10862582|NCT00069238|12027592|FG000|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
10862583|NCT00069238|12027593|FG001|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
10862584|NCT00069238|12027594|FG002|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||3
10862585|NCT00069238|12027592|FG000|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
10862586|NCT00069238|12027593|FG001|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
10862587|NCT00069238|12027594|FG002|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||1
10862588|NCT00069238|12027592|FG000|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
10862589|NCT00069238|12027593|FG001|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
10862590|NCT00069238|12027594|FG002|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||2
10862591|NCT03138499|12027601|FG000|STARTED|Overall Study||12
10862592|NCT03138499|12027602|FG001|STARTED|Overall Study||11
10862593|NCT03138499|12027601|FG000|COMPLETED|Overall Study||3
10862594|NCT03138499|12027602|FG001|COMPLETED|Overall Study||1
10862595|NCT03138499|12027601|FG000|NOT COMPLETED|Overall Study||9
10862596|NCT03138499|12027602|FG001|NOT COMPLETED|Overall Study||10
10862597|NCT04763044|12027613|FG000|STARTED|Period 1||3
10862598|NCT04763044|12027614|FG001|STARTED|Period 1||4
10862599|NCT04763044|12027615|FG002|STARTED|Period 1||4
10862600|NCT04763044|12027616|FG003|STARTED|Period 1||4
10862601|NCT04763044|12027613|FG000|COMPLETED|Period 1||3
10862602|NCT04763044|12027614|FG001|COMPLETED|Period 1||4
10862603|NCT04763044|12027615|FG002|COMPLETED|Period 1||4
10862604|NCT04763044|12027616|FG003|COMPLETED|Period 1||3
10862605|NCT04763044|12027613|FG000|NOT COMPLETED|Period 1||0
10862606|NCT04763044|12027614|FG001|NOT COMPLETED|Period 1||0
10862607|NCT04763044|12027615|FG002|NOT COMPLETED|Period 1||0
10862608|NCT04763044|12027616|FG003|NOT COMPLETED|Period 1||1
10862609|NCT04763044|12027613|FG000|STARTED|Period 2||3
10862610|NCT04763044|12027614|FG001|STARTED|Period 2||4
10862611|NCT04763044|12027615|FG002|STARTED|Period 2||4
10862612|NCT04763044|12027616|FG003|STARTED|Period 2||3
10862613|NCT04763044|12027613|FG000|COMPLETED|Period 2||3
10862614|NCT04763044|12027614|FG001|COMPLETED|Period 2||4
10862615|NCT04763044|12027615|FG002|COMPLETED|Period 2||4
10862616|NCT04763044|12027616|FG003|COMPLETED|Period 2||3
10862617|NCT04763044|12027613|FG000|NOT COMPLETED|Period 2||0
10862618|NCT04763044|12027614|FG001|NOT COMPLETED|Period 2||0
10862619|NCT04763044|12027615|FG002|NOT COMPLETED|Period 2||0
10862620|NCT04763044|12027616|FG003|NOT COMPLETED|Period 2||0
10862621|NCT04763044|12027613|FG000|STARTED|Period 3||3
10862622|NCT04763044|12027614|FG001|STARTED|Period 3||4
10862623|NCT04763044|12027615|FG002|STARTED|Period 3||4
10862624|NCT04763044|12027616|FG003|STARTED|Period 3||3
10862625|NCT04763044|12027613|FG000|COMPLETED|Period 3||3
10862626|NCT04763044|12027614|FG001|COMPLETED|Period 3||4
10862627|NCT04763044|12027615|FG002|COMPLETED|Period 3||4
10862628|NCT04763044|12027616|FG003|COMPLETED|Period 3||3
10862629|NCT04763044|12027613|FG000|NOT COMPLETED|Period 3||0
10862630|NCT04763044|12027614|FG001|NOT COMPLETED|Period 3||0
10862631|NCT04763044|12027615|FG002|NOT COMPLETED|Period 3||0
10862632|NCT04763044|12027616|FG003|NOT COMPLETED|Period 3||0
10862633|NCT04763044|12027613|FG000|STARTED|Period 4||3
10862634|NCT04763044|12027614|FG001|STARTED|Period 4||3
10862635|NCT04763044|12027615|FG002|STARTED|Period 4||4
10862636|NCT04763044|12027616|FG003|STARTED|Period 4||3
10293901|NCT02562716|11426525|FG001|COMPLETED|Overall Study||19
10293902|NCT02562716|11426524|FG000|NOT COMPLETED|Overall Study||28
10293903|NCT02562716|11426525|FG001|NOT COMPLETED|Overall Study||28
10293904|NCT01803854|11426533|FG000|STARTED|Overall Study||1275
10293905|NCT01803854|11426533|FG000|COMPLETED|Overall Study||1275
10293906|NCT01803854|11426533|FG000|NOT COMPLETED|Overall Study||0
10293907|NCT01472081|11426544|FG000|STARTED|Overall Study||7
10416801|NCT00796367|11561395|FG001|STARTED|Overall Study|one participant signed ICF but withdrew from study prior to first dosing in OB-305|154
10416802|NCT00796367|11561396|FG002|STARTED|Overall Study||295
10416803|NCT00796367|11561394|FG000|COMPLETED|Overall Study||197
10416804|NCT00796367|11561395|FG001|COMPLETED|Overall Study||129
10416805|NCT00796367|11561396|FG002|COMPLETED|Overall Study||248
10416806|NCT00796367|11561394|FG000|NOT COMPLETED|Overall Study||30
10416807|NCT00796367|11561395|FG001|NOT COMPLETED|Overall Study||25
10416808|NCT00796367|11561396|FG002|NOT COMPLETED|Overall Study||47
10416809|NCT00796419|11561406|FG000|STARTED|Overall Study||13
10416810|NCT00796419|11561407|FG001|STARTED|Overall Study||14
10416811|NCT00796419|11561406|FG000|COMPLETED|Overall Study||13
10416812|NCT00796419|11561407|FG001|COMPLETED|Overall Study||13
10416813|NCT00796419|11561406|FG000|NOT COMPLETED|Overall Study||0
10416814|NCT00796419|11561407|FG001|NOT COMPLETED|Overall Study||1
10416815|NCT00796445|11561415|FG000|STARTED|Overall Study||895
10416816|NCT00796445|11561416|FG001|STARTED|Overall Study||450
10416817|NCT00796445|11561415|FG000|COMPLETED|Overall Study||310
10862637|NCT04763044|12027613|FG000|COMPLETED|Period 4||3
10862638|NCT04763044|12027614|FG001|COMPLETED|Period 4||3
10862639|NCT04763044|12027615|FG002|COMPLETED|Period 4||4
10862640|NCT04763044|12027616|FG003|COMPLETED|Period 4||3
10862641|NCT04763044|12027613|FG000|NOT COMPLETED|Period 4||0
10862642|NCT04763044|12027614|FG001|NOT COMPLETED|Period 4||0
10416818|NCT00796445|11561416|FG001|COMPLETED|Overall Study||158
10416819|NCT00796445|11561415|FG000|NOT COMPLETED|Overall Study||585
10416820|NCT00796445|11561416|FG001|NOT COMPLETED|Overall Study||292
10416821|NCT00796549|11561430|FG000|STARTED|Overall Study|Excluding duplicate records for 5 patients who were screened twice|218
10416822|NCT00796549|11561430|FG000|Entered|Overall Study|entered and treated|69
10862643|NCT04763044|12027615|FG002|NOT COMPLETED|Period 4||0
10862644|NCT04763044|12027616|FG003|NOT COMPLETED|Period 4||0
10862645|NCT04763044|12027613|FG000|STARTED|Period 5||3
10862646|NCT04763044|12027614|FG001|STARTED|Period 5||3
10862647|NCT04763044|12027615|FG002|STARTED|Period 5||4
10862648|NCT04763044|12027616|FG003|STARTED|Period 5||3
10862649|NCT04763044|12027613|FG000|COMPLETED|Period 5||2
10862650|NCT04763044|12027614|FG001|COMPLETED|Period 5||3
10862651|NCT04763044|12027615|FG002|COMPLETED|Period 5||4
10862652|NCT04763044|12027616|FG003|COMPLETED|Period 5||3
10862653|NCT04763044|12027613|FG000|NOT COMPLETED|Period 5||1
10862654|NCT04763044|12027614|FG001|NOT COMPLETED|Period 5||0
10862655|NCT04763044|12027615|FG002|NOT COMPLETED|Period 5||0
10862656|NCT04763044|12027616|FG003|NOT COMPLETED|Period 5||0
10862663|NCT04466384|12027637|FG000|STARTED|First Phase||14
10862664|NCT04466384|12027638|FG001|STARTED|First Phase||10
10862665|NCT04466384|12027637|FG000|COMPLETED|First Phase||12
10862666|NCT04466384|12027638|FG001|COMPLETED|First Phase||10
10862667|NCT04466384|12027637|FG000|NOT COMPLETED|First Phase||2
10862668|NCT04466384|12027638|FG001|NOT COMPLETED|First Phase||0
10862669|NCT04466384|12027637|FG000|STARTED|Cross Over Phase||14
10862670|NCT04466384|12027638|FG001|STARTED|Cross Over Phase||10
10862671|NCT04466384|12027637|FG000|COMPLETED|Cross Over Phase||13
10862672|NCT04466384|12027638|FG001|COMPLETED|Cross Over Phase||9
10862673|NCT04466384|12027637|FG000|NOT COMPLETED|Cross Over Phase||1
10862674|NCT04466384|12027638|FG001|NOT COMPLETED|Cross Over Phase||1
10862693|NCT04428645|12027662|FG000|STARTED|Run in Visit Training (2 Hours)||25
10862694|NCT04428645|12027662|FG000|COMPLETED|Run in Visit Training (2 Hours)||25
10862695|NCT04428645|12027662|FG000|NOT COMPLETED|Run in Visit Training (2 Hours)||0
10862696|NCT04428645|12027662|FG000|STARTED|First at Home Period (~2 Weeks)||25
10862697|NCT04428645|12027662|FG000|COMPLETED|First at Home Period (~2 Weeks)||25
10862698|NCT04428645|12027662|FG000|NOT COMPLETED|First at Home Period (~2 Weeks)||0
10862699|NCT04428645|12027662|FG000|STARTED|DailyDose Training Visit (2 Hours)||25
10862700|NCT04428645|12027662|FG000|COMPLETED|DailyDose Training Visit (2 Hours)||25
10862701|NCT04428645|12027662|FG000|NOT COMPLETED|DailyDose Training Visit (2 Hours)||0
10862702|NCT04428645|12027662|FG000|STARTED|Second at Home Period (8 Weeks)||25
10862703|NCT04428645|12027662|FG000|COMPLETED|Second at Home Period (8 Weeks)||24
10862704|NCT04428645|12027662|FG000|NOT COMPLETED|Second at Home Period (8 Weeks)||1
10862705|NCT04428645|12027662|FG000|STARTED|Study Close-out Visit (30 Minutes)||24
10862706|NCT04428645|12027662|FG000|COMPLETED|Study Close-out Visit (30 Minutes)||24
10862707|NCT04428645|12027662|FG000|NOT COMPLETED|Study Close-out Visit (30 Minutes)||0
10862708|NCT04371471|12027666|FG000|STARTED|Overall Study||91
10862709|NCT04371471|12027666|FG000|COMPLETED|Overall Study||81
10862710|NCT04371471|12027666|FG000|NOT COMPLETED|Overall Study||10
10862711|NCT04157751|12027674|FG000|STARTED|Overall Study||265
10862712|NCT04157751|12027675|FG001|STARTED|Overall Study||265
10862713|NCT04157751|12027674|FG000|Treated|Overall Study||264
10862714|NCT04157751|12027675|FG001|Treated|Overall Study||260
10862715|NCT04157751|12027674|FG000|COMPLETED|Overall Study||202
10862716|NCT04157751|12027675|FG001|COMPLETED|Overall Study||208
10862717|NCT04157751|12027674|FG000|NOT COMPLETED|Overall Study||63
10862718|NCT04157751|12027675|FG001|NOT COMPLETED|Overall Study||57
10862719|NCT04151628|12027683|FG000|STARTED|Overall Study||8
10862720|NCT04151628|12027684|FG001|STARTED|Overall Study||64
10862721|NCT04151628|12027683|FG000|COMPLETED|Overall Study||8
10862722|NCT04151628|12027684|FG001|COMPLETED|Overall Study||64
10862723|NCT04151628|12027683|FG000|NOT COMPLETED|Overall Study||0
10862724|NCT04151628|12027684|FG001|NOT COMPLETED|Overall Study||0
10862725|NCT04086121|12027691|FG000|STARTED|Overall Study||14
10862726|NCT04086121|12027691|FG000|COMPLETED|Overall Study||0
10862727|NCT04086121|12027691|FG000|NOT COMPLETED|Overall Study||14
10862728|NCT04046328|12027696|FG000|STARTED|First Intervention (14 Days)||6
10862729|NCT04046328|12027697|FG001|STARTED|First Intervention (14 Days)||7
10862730|NCT04046328|12027696|FG000|COMPLETED|First Intervention (14 Days)||6
10862731|NCT04046328|12027697|FG001|COMPLETED|First Intervention (14 Days)||7
10862732|NCT04046328|12027696|FG000|NOT COMPLETED|First Intervention (14 Days)||0
10862733|NCT04046328|12027697|FG001|NOT COMPLETED|First Intervention (14 Days)||0
10862734|NCT04046328|12027696|FG000|STARTED|Washout (14 Days)||6
10862735|NCT04046328|12027697|FG001|STARTED|Washout (14 Days)||7
10862736|NCT04046328|12027696|FG000|COMPLETED|Washout (14 Days)||6
10862737|NCT04046328|12027697|FG001|COMPLETED|Washout (14 Days)||7
10862738|NCT04046328|12027696|FG000|NOT COMPLETED|Washout (14 Days)||0
10545775|NCT01500057|11699288|FG000|NOT COMPLETED|Overall Study||6
10862739|NCT04046328|12027697|FG001|NOT COMPLETED|Washout (14 Days)||0
10862740|NCT04046328|12027696|FG000|STARTED|Second Intervention (14 Days)||6
10862741|NCT04046328|12027697|FG001|STARTED|Second Intervention (14 Days)||7
10862742|NCT04046328|12027696|FG000|COMPLETED|Second Intervention (14 Days)||6
10862743|NCT04046328|12027697|FG001|COMPLETED|Second Intervention (14 Days)||7
10862744|NCT04046328|12027696|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
10862745|NCT04046328|12027697|FG001|NOT COMPLETED|Second Intervention (14 Days)||0
10862746|NCT03988205|12027703|FG000|STARTED|Overall Study||3
10862747|NCT03988205|12027703|FG000|COMPLETED|Overall Study||3
10862748|NCT03988205|12027703|FG000|NOT COMPLETED|Overall Study||0
10862749|NCT03965962|12027711|FG000|STARTED|Overall Study||320
10862750|NCT03965962|12027712|FG001|STARTED|Overall Study||107
10862751|NCT03965962|12027713|FG002|STARTED|Overall Study||107
10862752|NCT03965962|12027714|FG003|STARTED|Overall Study||106
10862753|NCT03965962|12027711|FG000|Vaccination 1 (Day 0)|Overall Study||318
10862754|NCT03965962|12027712|FG001|Vaccination 1 (Day 0)|Overall Study||107
10862755|NCT03965962|12027713|FG002|Vaccination 1 (Day 0)|Overall Study||107
10862756|NCT03965962|12027714|FG003|Vaccination 1 (Day 0)|Overall Study||106
10862757|NCT03965962|12027711|FG000|Vaccination 2 (Day 3)|Overall Study||317
10862758|NCT03965962|12027712|FG001|Vaccination 2 (Day 3)|Overall Study||104
10862759|NCT03965962|12027713|FG002|Vaccination 2 (Day 3)|Overall Study||107
10416823|NCT00796549|11561430|FG000|COMPLETED|Overall Study||0
10416824|NCT00796549|11561430|FG000|NOT COMPLETED|Overall Study||218
10416825|NCT00796562|11561436|FG000|STARTED|Overall Study||96
10416826|NCT00796562|11561436|FG000|COMPLETED|Overall Study||47
10416827|NCT00796562|11561436|FG000|NOT COMPLETED|Overall Study||49
10416828|NCT00796614|11561444|FG000|STARTED|Overall Study||41
10416829|NCT00796614|11561445|FG001|STARTED|Overall Study||40
10416830|NCT00796614|11561446|FG002|STARTED|Overall Study||39
10416831|NCT00796614|11561447|FG003|STARTED|Overall Study||41
10416832|NCT00796614|11561444|FG000|Not Treated|Overall Study||0
10416833|NCT00796614|11561445|FG001|Not Treated|Overall Study||0
10416834|NCT00796614|11561446|FG002|Not Treated|Overall Study||1
10416835|NCT00796614|11561447|FG003|Not Treated|Overall Study||0
10416836|NCT00796614|11561444|FG000|COMPLETED|Overall Study||36
10416837|NCT00796614|11561445|FG001|COMPLETED|Overall Study||36
10416838|NCT00796614|11561446|FG002|COMPLETED|Overall Study||36
10416839|NCT00796614|11561447|FG003|COMPLETED|Overall Study||40
10416840|NCT00796614|11561444|FG000|NOT COMPLETED|Overall Study||5
10416841|NCT00796614|11561445|FG001|NOT COMPLETED|Overall Study||4
10416842|NCT00796614|11561446|FG002|NOT COMPLETED|Overall Study||3
10416843|NCT00796614|11561447|FG003|NOT COMPLETED|Overall Study||1
10416844|NCT00796627|11561459|FG000|STARTED|Overall Study||10
10416845|NCT00796627|11561460|FG001|STARTED|Overall Study||31
10416846|NCT00796627|11561459|FG000|COMPLETED|Overall Study||10
10416847|NCT00796627|11561460|FG001|COMPLETED|Overall Study||31
10416848|NCT00796627|11561459|FG000|NOT COMPLETED|Overall Study||0
10416849|NCT00796627|11561460|FG001|NOT COMPLETED|Overall Study||0
10416850|NCT00796653|11561470|FG000|STARTED|Overall Study||235
10416851|NCT00796653|11561471|FG001|STARTED|Overall Study||232
10416852|NCT00796653|11561472|FG002|STARTED|Overall Study||234
10416853|NCT00796653|11561473|FG003|STARTED|Overall Study||233
10416854|NCT00796653|11561470|FG000|COMPLETED|Overall Study||184
10416855|NCT00796653|11561471|FG001|COMPLETED|Overall Study||195
10416856|NCT00796653|11561472|FG002|COMPLETED|Overall Study||198
10416857|NCT00796653|11561473|FG003|COMPLETED|Overall Study||193
10416858|NCT00796653|11561470|FG000|NOT COMPLETED|Overall Study||51
10416859|NCT00796653|11561471|FG001|NOT COMPLETED|Overall Study||37
10416860|NCT00796653|11561472|FG002|NOT COMPLETED|Overall Study||36
10416861|NCT00796653|11561473|FG003|NOT COMPLETED|Overall Study||40
10416862|NCT00796666|11561493|FG000|STARTED|Overall Study||67
10416863|NCT00796666|11561494|FG001|STARTED|Overall Study||64
10416864|NCT00796666|11561493|FG000|Treated|Overall Study||66
10416865|NCT00796666|11561494|FG001|Treated|Overall Study||64
10416866|NCT00796666|11561493|FG000|Randomized and Not Treated|Overall Study||1
10416867|NCT00796666|11561494|FG001|Randomized and Not Treated|Overall Study||0
10416868|NCT00796666|11561493|FG000|COMPLETED|Overall Study||0
10416869|NCT00796666|11561494|FG001|COMPLETED|Overall Study||0
10416870|NCT00796666|11561493|FG000|NOT COMPLETED|Overall Study||67
10862760|NCT03965962|12027714|FG003|Vaccination 2 (Day 3)|Overall Study||106
10862761|NCT03965962|12027711|FG000|Vaccination 3 (Day 7)|Overall Study||311
10416871|NCT00796666|11561494|FG001|NOT COMPLETED|Overall Study||64
10416872|NCT00796705|11561504|FG000|STARTED|Overall Study||3
10416873|NCT00796705|11561505|FG001|STARTED|Overall Study||4
10416874|NCT00796705|11561506|FG002|STARTED|Overall Study||4
10416875|NCT00796705|11561507|FG003|STARTED|Overall Study||2
10416876|NCT00796705|11561504|FG000|COMPLETED|Overall Study||3
10416877|NCT00796705|11561505|FG001|COMPLETED|Overall Study||4
10416878|NCT00796705|11561506|FG002|COMPLETED|Overall Study||4
10416879|NCT00796705|11561507|FG003|COMPLETED|Overall Study||2
10416880|NCT00796705|11561504|FG000|NOT COMPLETED|Overall Study||0
10416881|NCT00796705|11561505|FG001|NOT COMPLETED|Overall Study||0
10416882|NCT00796705|11561506|FG002|NOT COMPLETED|Overall Study||0
10416883|NCT00796705|11561507|FG003|NOT COMPLETED|Overall Study||0
10416884|NCT00796718|11561519|FG000|STARTED|Overall Study||62
10416885|NCT00796718|11561519|FG000|COMPLETED|Overall Study||53
10416886|NCT00796718|11561519|FG000|NOT COMPLETED|Overall Study||9
10416887|NCT00796744|11561526|FG000|STARTED|Overall Study||24
10416888|NCT00796744|11561527|FG001|STARTED|Overall Study||26
10416889|NCT00796744|11561528|FG002|STARTED|Overall Study||28
10416890|NCT00796744|11561526|FG000|COMPLETED|Overall Study||24
10416891|NCT00796744|11561527|FG001|COMPLETED|Overall Study||26
10416892|NCT00796744|11561528|FG002|COMPLETED|Overall Study||27
10416893|NCT00796744|11561526|FG000|NOT COMPLETED|Overall Study||0
10862762|NCT03965962|12027712|FG001|Vaccination 3 (Day 7)|Overall Study||103
10862763|NCT03965962|12027713|FG002|Vaccination 3 (Day 7)|Overall Study||105
10862764|NCT03965962|12027714|FG003|Vaccination 3 (Day 7)|Overall Study||105
10862765|NCT03965962|12027711|FG000|Vaccination 4 (Day 14)|Overall Study||301
10862766|NCT03965962|12027712|FG001|Vaccination 4 (Day 14)|Overall Study||101
10862767|NCT03965962|12027713|FG002|Vaccination 4 (Day 14)|Overall Study||101
10862768|NCT03965962|12027714|FG003|Vaccination 4 (Day 14)|Overall Study||103
10862769|NCT03965962|12027711|FG000|Vaccination 5 (Day 28)|Overall Study||294
10862770|NCT03965962|12027712|FG001|Vaccination 5 (Day 28)|Overall Study||98
10862771|NCT03965962|12027713|FG002|Vaccination 5 (Day 28)|Overall Study||97
10862772|NCT03965962|12027714|FG003|Vaccination 5 (Day 28)|Overall Study||98
10862773|NCT03965962|12027711|FG000|Safety Analysis Set (SafAS)|Overall Study|2 participants randomized to Group 4: VRVg-2 received vaccination in Group 1: VRVg-2+HRIG and were considered in Group 1 for safety analysis purpose.|320
10862774|NCT03965962|12027712|FG001|Safety Analysis Set (SafAS)|Overall Study||107
10862775|NCT03965962|12027713|FG002|Safety Analysis Set (SafAS)|Overall Study||107
10862776|NCT03965962|12027714|FG003|Safety Analysis Set (SafAS)|Overall Study|2 participants randomized to Group 4: VRVg-2 received vaccination in Group 1: VRVg-2+HRIG and were considered in Group 1 for safety analysis purpose.|104
10862777|NCT03965962|12027711|FG000|COMPLETED|Overall Study||295
10862778|NCT03965962|12027712|FG001|COMPLETED|Overall Study||102
10862779|NCT03965962|12027713|FG002|COMPLETED|Overall Study||97
10862780|NCT03965962|12027714|FG003|COMPLETED|Overall Study||100
10862781|NCT03965962|12027711|FG000|NOT COMPLETED|Overall Study||25
10862782|NCT03965962|12027712|FG001|NOT COMPLETED|Overall Study||5
10862783|NCT03965962|12027713|FG002|NOT COMPLETED|Overall Study||10
10862784|NCT03965962|12027714|FG003|NOT COMPLETED|Overall Study||6
10416894|NCT00796744|11561527|FG001|NOT COMPLETED|Overall Study||0
10416895|NCT00796744|11561528|FG002|NOT COMPLETED|Overall Study||1
10416896|NCT00796757|11561538|FG000|STARTED|Overall Study||146
10416897|NCT00796757|11561538|FG000|COMPLETED|Overall Study||60
10862807|NCT03112590|12027755|FG000|STARTED|Overall Study||3
10862808|NCT03112590|12027756|FG001|STARTED|Overall Study||6
10862809|NCT03112590|12027757|FG002|STARTED|Overall Study||42
10862810|NCT03112590|12027755|FG000|COMPLETED|Overall Study||3
10862811|NCT03112590|12027756|FG001|COMPLETED|Overall Study||5
10862812|NCT03112590|12027757|FG002|COMPLETED|Overall Study||42
10862813|NCT03112590|12027755|FG000|NOT COMPLETED|Overall Study||0
10862814|NCT03112590|12027756|FG001|NOT COMPLETED|Overall Study||1
10862815|NCT03112590|12027757|FG002|NOT COMPLETED|Overall Study||0
10862816|NCT03086343|12027767|FG000|STARTED|Overall Study||309
10862817|NCT03086343|12027768|FG001|STARTED|Overall Study||303
10862818|NCT03086343|12027767|FG000|COMPLETED|Overall Study||277
10862819|NCT03086343|12027768|FG001|COMPLETED|Overall Study||278
10862820|NCT03086343|12027767|FG000|NOT COMPLETED|Overall Study||32
10862821|NCT03086343|12027768|FG001|NOT COMPLETED|Overall Study||25
10862834|NCT02657434|12027785|FG000|STARTED|Overall Study||286
10862835|NCT02657434|12027786|FG001|STARTED|Overall Study||292
10862836|NCT02657434|12027785|FG000|COMPLETED|Overall Study||0
10862837|NCT02657434|12027786|FG001|COMPLETED|Overall Study||0
10862838|NCT02657434|12027785|FG000|NOT COMPLETED|Overall Study||286
10862839|NCT02657434|12027786|FG001|NOT COMPLETED|Overall Study||292
10416898|NCT00796757|11561538|FG000|NOT COMPLETED|Overall Study||86
10416899|NCT00796822|11561544|FG000|STARTED|Overall Study||13
10862840|NCT02583269|12027798|FG000|STARTED|Overall Study||3
10862841|NCT02583269|12027799|FG001|STARTED|Overall Study||7
10862842|NCT02583269|12027800|FG002|STARTED|Overall Study||3
10862843|NCT02583269|12027801|FG003|STARTED|Overall Study||5
10416900|NCT00796822|11561545|FG001|STARTED|Overall Study||13
10416901|NCT00796822|11561544|FG000|COMPLETED|Overall Study||10
10416902|NCT00796822|11561545|FG001|COMPLETED|Overall Study||13
10416903|NCT00796822|11561544|FG000|NOT COMPLETED|Overall Study||3
10416904|NCT00796822|11561545|FG001|NOT COMPLETED|Overall Study||0
10416905|NCT00796926|11561553|FG000|STARTED|Overall Study||15
10416906|NCT00796926|11561554|FG001|STARTED|Overall Study||15
10416907|NCT00796926|11561553|FG000|COMPLETED|Overall Study||14
10416908|NCT00796926|11561554|FG001|COMPLETED|Overall Study||15
10416909|NCT00796926|11561553|FG000|NOT COMPLETED|Overall Study||1
10416910|NCT00796926|11561554|FG001|NOT COMPLETED|Overall Study||0
10416911|NCT00796978|11561560|FG000|STARTED|Overall Study||56
10416912|NCT00796978|11561560|FG000|COMPLETED|Overall Study||44
10416913|NCT00796978|11561560|FG000|NOT COMPLETED|Overall Study||12
10416914|NCT00796991|11561567|FG000|STARTED|Overall Study||20
10416915|NCT00796991|11561568|FG001|STARTED|Overall Study||19
10416916|NCT00796991|11561569|FG002|STARTED|Overall Study||20
10416917|NCT00796991|11561567|FG000|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|5
10416918|NCT00796991|11561568|FG001|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|7
10416919|NCT00796991|11561569|FG002|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|6
10416920|NCT00796991|11561567|FG000|NOT COMPLETED|Overall Study||15
10416921|NCT00796991|11561568|FG001|NOT COMPLETED|Overall Study||12
10416922|NCT00796991|11561569|FG002|NOT COMPLETED|Overall Study||14
10416923|NCT00797108|11561580|FG000|STARTED|Overall Study||12
10416924|NCT00797108|11561581|FG001|STARTED|Overall Study||11
10416925|NCT00797108|11561582|FG002|STARTED|Overall Study||12
10416926|NCT00797108|11561580|FG000|Treated|Overall Study||10
10416927|NCT00797108|11561581|FG001|Treated|Overall Study||11
10416928|NCT00797108|11561582|FG002|Treated|Overall Study||12
10416929|NCT00797108|11561580|FG000|COMPLETED|Overall Study||8
10416930|NCT00797108|11561581|FG001|COMPLETED|Overall Study||9
10416931|NCT00797108|11561582|FG002|COMPLETED|Overall Study||6
10416932|NCT00797108|11561580|FG000|NOT COMPLETED|Overall Study||4
10416933|NCT00797108|11561581|FG001|NOT COMPLETED|Overall Study||2
10416934|NCT00797108|11561582|FG002|NOT COMPLETED|Overall Study||6
10416935|NCT00797212|11561590|FG000|STARTED|Overall Study||50
10416936|NCT00797212|11561590|FG000|COMPLETED|Overall Study||50
10416937|NCT00797212|11561590|FG000|NOT COMPLETED|Overall Study||0
10416938|NCT00797225|11561598|FG000|STARTED|Weeks 1 to 12||43
10416939|NCT00797225|11561599|FG001|STARTED|Weeks 1 to 12||43
10416940|NCT00797225|11561600|FG002|STARTED|Weeks 1 to 12||44
10416941|NCT00797225|11561601|FG003|STARTED|Weeks 1 to 12||44
10545776|NCT01500057|11699289|FG001|NOT COMPLETED|Overall Study||4
10545777|NCT01500083|11699297|FG000|STARTED|Overall Study||16
10545778|NCT01500083|11699298|FG001|STARTED|Overall Study||74
10545779|NCT01500083|11699297|FG000|COMPLETED|Overall Study||4
10545780|NCT01500083|11699298|FG001|COMPLETED|Overall Study||31
10545781|NCT01500083|11699297|FG000|NOT COMPLETED|Overall Study||12
10545782|NCT01500083|11699298|FG001|NOT COMPLETED|Overall Study||43
10545783|NCT01500096|11699308|FG000|STARTED|Overall Study||32
10545784|NCT01500096|11699309|FG001|STARTED|Overall Study||17
10545785|NCT01500096|11699310|FG002|STARTED|Overall Study||31
10545786|NCT01500096|11699311|FG003|STARTED|Overall Study||16
10545787|NCT01500096|11699308|FG000|COMPLETED|Overall Study||31
10545788|NCT01500096|11699309|FG001|COMPLETED|Overall Study||17
10545789|NCT01500096|11699310|FG002|COMPLETED|Overall Study||31
10545790|NCT01500096|11699311|FG003|COMPLETED|Overall Study||14
10545791|NCT01500096|11699308|FG000|NOT COMPLETED|Overall Study||1
10545792|NCT01500096|11699309|FG001|NOT COMPLETED|Overall Study||0
10545793|NCT01500096|11699310|FG002|NOT COMPLETED|Overall Study||0
10545794|NCT01500096|11699311|FG003|NOT COMPLETED|Overall Study||2
10545795|NCT01500135|11699323|FG000|STARTED|Overall Study||100
10545796|NCT01500135|11699324|FG001|STARTED|Overall Study||50
10545797|NCT01500135|11699323|FG000|COMPLETED|Overall Study||83
10545798|NCT01500135|11699324|FG001|COMPLETED|Overall Study||39
10545799|NCT01500135|11699323|FG000|NOT COMPLETED|Overall Study||17
10545800|NCT01500135|11699324|FG001|NOT COMPLETED|Overall Study||11
10545801|NCT01500187|11699332|FG000|STARTED|Overall Study||23
10545802|NCT01500187|11699333|FG001|STARTED|Overall Study||15
10545803|NCT01500187|11699332|FG000|COMPLETED|Overall Study||17
10545804|NCT01500187|11699333|FG001|COMPLETED|Overall Study||15
10545805|NCT01500187|11699332|FG000|NOT COMPLETED|Overall Study||6
10545806|NCT01500187|11699333|FG001|NOT COMPLETED|Overall Study||0
10545807|NCT01500200|11699342|FG000|STARTED|Stage 1||98
10545808|NCT01500200|11699343|FG001|STARTED|Stage 1||24
10862844|NCT02583269|12027802|FG004|STARTED|Overall Study||6
10416942|NCT00797225|11561602|FG004|STARTED|Weeks 1 to 12||0
10416943|NCT00797225|11561603|FG005|STARTED|Weeks 1 to 12||0
10416944|NCT00797225|11561604|FG006|STARTED|Weeks 1 to 12||0
10416945|NCT00797225|11561605|FG007|STARTED|Weeks 1 to 12||0
10416946|NCT00797225|11561598|FG000|Received Study Drug|Weeks 1 to 12||43
10416947|NCT00797225|11561599|FG001|Received Study Drug|Weeks 1 to 12||43
10416948|NCT00797225|11561600|FG002|Received Study Drug|Weeks 1 to 12||44
10416949|NCT00797225|11561601|FG003|Received Study Drug|Weeks 1 to 12||44
10416950|NCT00797225|11561602|FG004|Received Study Drug|Weeks 1 to 12||0
10545809|NCT01500200|11699344|FG002|STARTED|Stage 1||19
10545810|NCT01500200|11699345|FG003|STARTED|Stage 1||0
10545811|NCT01500200|11699346|FG004|STARTED|Stage 1||0
10545812|NCT01500200|11699347|FG005|STARTED|Stage 1||0
10862845|NCT02583269|12027798|FG000|COMPLETED|Overall Study||2
10862846|NCT02583269|12027799|FG001|COMPLETED|Overall Study||7
10862847|NCT02583269|12027800|FG002|COMPLETED|Overall Study||3
10862848|NCT02583269|12027801|FG003|COMPLETED|Overall Study||5
10862849|NCT02583269|12027802|FG004|COMPLETED|Overall Study||6
10862850|NCT02583269|12027798|FG000|NOT COMPLETED|Overall Study||1
10862851|NCT02583269|12027799|FG001|NOT COMPLETED|Overall Study||0
10862852|NCT02583269|12027800|FG002|NOT COMPLETED|Overall Study||0
10862853|NCT02583269|12027801|FG003|NOT COMPLETED|Overall Study||0
10862854|NCT02583269|12027802|FG004|NOT COMPLETED|Overall Study||0
10862861|NCT02576847|12027823|FG000|STARTED|Overall Study||307
10862862|NCT02576847|12027823|FG000|COMPLETED|Overall Study||170
10862863|NCT02576847|12027823|FG000|NOT COMPLETED|Overall Study||137
10862864|NCT02568566|12027827|FG000|STARTED|Overall Study||201
10862865|NCT02568566|12027827|FG000|COMPLETED|Overall Study||187
10862866|NCT02568566|12027827|FG000|NOT COMPLETED|Overall Study||14
10862876|NCT02428192|12027846|FG000|STARTED|Overall Study||12
10862877|NCT02428192|12027847|FG001|STARTED|Overall Study||8
10862878|NCT02428192|12027846|FG000|COMPLETED|Overall Study||0
10862879|NCT02428192|12027847|FG001|COMPLETED|Overall Study||7
10862880|NCT02428192|12027846|FG000|NOT COMPLETED|Overall Study||12
10862881|NCT02428192|12027847|FG001|NOT COMPLETED|Overall Study||1
10862882|NCT02425891|12027856|FG000|STARTED|Overall Study||451
10862883|NCT02425891|12027857|FG001|STARTED|Overall Study||451
10293908|NCT01472081|11426545|FG001|STARTED|Overall Study||26
10293909|NCT01472081|11426546|FG002|STARTED|Overall Study||20
10416951|NCT00797225|11561603|FG005|Received Study Drug|Weeks 1 to 12||0
10416952|NCT00797225|11561604|FG006|Received Study Drug|Weeks 1 to 12||0
10416953|NCT00797225|11561605|FG007|Received Study Drug|Weeks 1 to 12||0
10416954|NCT00797225|11561598|FG000|COMPLETED|Weeks 1 to 12||41
10416955|NCT00797225|11561599|FG001|COMPLETED|Weeks 1 to 12||42
10416956|NCT00797225|11561600|FG002|COMPLETED|Weeks 1 to 12||43
10416957|NCT00797225|11561601|FG003|COMPLETED|Weeks 1 to 12||44
10416958|NCT00797225|11561602|FG004|COMPLETED|Weeks 1 to 12||0
10416959|NCT00797225|11561603|FG005|COMPLETED|Weeks 1 to 12||0
10416960|NCT00797225|11561604|FG006|COMPLETED|Weeks 1 to 12||0
10416961|NCT00797225|11561605|FG007|COMPLETED|Weeks 1 to 12||0
10416962|NCT00797225|11561598|FG000|NOT COMPLETED|Weeks 1 to 12||2
10416963|NCT00797225|11561599|FG001|NOT COMPLETED|Weeks 1 to 12||1
10416964|NCT00797225|11561600|FG002|NOT COMPLETED|Weeks 1 to 12||1
10416965|NCT00797225|11561601|FG003|NOT COMPLETED|Weeks 1 to 12||0
10416966|NCT00797225|11561602|FG004|NOT COMPLETED|Weeks 1 to 12||0
10416967|NCT00797225|11561603|FG005|NOT COMPLETED|Weeks 1 to 12||0
10416968|NCT00797225|11561604|FG006|NOT COMPLETED|Weeks 1 to 12||0
10416969|NCT00797225|11561605|FG007|NOT COMPLETED|Weeks 1 to 12||0
10416970|NCT00797225|11561598|FG000|STARTED|Weeks 13 to 24||0
10416971|NCT00797225|11561599|FG001|STARTED|Weeks 13 to 24||42
10416972|NCT00797225|11561600|FG002|STARTED|Weeks 13 to 24||43
10416973|NCT00797225|11561601|FG003|STARTED|Weeks 13 to 24||0
10416974|NCT00797225|11561602|FG004|STARTED|Weeks 13 to 24||20
10416975|NCT00797225|11561603|FG005|STARTED|Weeks 13 to 24||21
10416976|NCT00797225|11561604|FG006|STARTED|Weeks 13 to 24||22
10545813|NCT01500200|11699342|FG000|COMPLETED|Stage 1||90
10545814|NCT01500200|11699343|FG001|COMPLETED|Stage 1||18
10545815|NCT01500200|11699344|FG002|COMPLETED|Stage 1||13
10545816|NCT01500200|11699345|FG003|COMPLETED|Stage 1||0
10862884|NCT02425891|12027856|FG000|COMPLETED|Overall Study||0
10293910|NCT01472081|11426547|FG003|STARTED|Overall Study||47
10293911|NCT01472081|11426548|FG004|STARTED|Overall Study||47
10293912|NCT01472081|11426549|FG005|STARTED|Overall Study||6
10293913|NCT01472081|11426544|FG000|COMPLETED|Overall Study||0
10293914|NCT01472081|11426545|FG001|COMPLETED|Overall Study||0
10293915|NCT01472081|11426546|FG002|COMPLETED|Overall Study||0
10293916|NCT01472081|11426547|FG003|COMPLETED|Overall Study||1
10293917|NCT01472081|11426548|FG004|COMPLETED|Overall Study||0
10293918|NCT01472081|11426549|FG005|COMPLETED|Overall Study||0
10293919|NCT01472081|11426544|FG000|NOT COMPLETED|Overall Study||7
10293920|NCT01472081|11426545|FG001|NOT COMPLETED|Overall Study||26
10416977|NCT00797225|11561605|FG007|STARTED|Weeks 13 to 24||22
10545817|NCT01500200|11699346|FG004|COMPLETED|Stage 1||0
10545818|NCT01500200|11699347|FG005|COMPLETED|Stage 1||0
10545819|NCT01500200|11699342|FG000|NOT COMPLETED|Stage 1||8
10293921|NCT01472081|11426546|FG002|NOT COMPLETED|Overall Study||20
10416978|NCT00797225|11561598|FG000|COMPLETED|Weeks 13 to 24||0
10416979|NCT00797225|11561599|FG001|COMPLETED|Weeks 13 to 24||38
10416980|NCT00797225|11561600|FG002|COMPLETED|Weeks 13 to 24||41
10416981|NCT00797225|11561601|FG003|COMPLETED|Weeks 13 to 24||0
10416982|NCT00797225|11561602|FG004|COMPLETED|Weeks 13 to 24||19
10416983|NCT00797225|11561603|FG005|COMPLETED|Weeks 13 to 24||21
10545820|NCT01500200|11699343|FG001|NOT COMPLETED|Stage 1||6
10862885|NCT02425891|12027857|FG001|COMPLETED|Overall Study||0
10862886|NCT02425891|12027856|FG000|NOT COMPLETED|Overall Study||451
10862887|NCT02425891|12027857|FG001|NOT COMPLETED|Overall Study||451
10862896|NCT02359838|12027876|FG000|STARTED|Overall Study||100
10862897|NCT02359838|12027877|FG001|STARTED|Overall Study||60
10862898|NCT02359838|12027876|FG000|COMPLETED|Overall Study||100
10862899|NCT02359838|12027877|FG001|COMPLETED|Overall Study||48
10862900|NCT02359838|12027876|FG000|NOT COMPLETED|Overall Study||0
10862901|NCT02359838|12027877|FG001|NOT COMPLETED|Overall Study||12
10862902|NCT02352948|12027889|FG000|STARTED|Overall Study||62
10862903|NCT02352948|12027890|FG001|STARTED|Overall Study||64
10862904|NCT02352948|12027891|FG002|STARTED|Overall Study||174
10862905|NCT02352948|12027892|FG003|STARTED|Overall Study||118
10862906|NCT02352948|12027893|FG004|STARTED|Overall Study||117
10862907|NCT02352948|12027894|FG005|STARTED|Overall Study||60
10862908|NCT02352948|12027889|FG000|Received Treatment|Overall Study||62
10862909|NCT02352948|12027890|FG001|Received Treatment|Overall Study||63
10862910|NCT02352948|12027891|FG002|Received Treatment|Overall Study||173
10862911|NCT02352948|12027892|FG003|Received Treatment|Overall Study||110
10293922|NCT01472081|11426547|FG003|NOT COMPLETED|Overall Study||46
10293923|NCT01472081|11426548|FG004|NOT COMPLETED|Overall Study||47
10293924|NCT01472081|11426549|FG005|NOT COMPLETED|Overall Study||6
10293925|NCT01309672|11426562|FG000|STARTED|Overall Study||41
10293926|NCT01309672|11426562|FG000|Received Protocol Treatment|Overall Study||40
10293927|NCT01309672|11426562|FG000|COMPLETED|Overall Study||4
10293928|NCT01309672|11426562|FG000|NOT COMPLETED|Overall Study||37
10293929|NCT01131169|11426569|FG000|STARTED|Overall Study||47
10293930|NCT01131169|11426570|FG001|STARTED|Overall Study||19
10293931|NCT01131169|11426569|FG000|COMPLETED|Overall Study||47
10293932|NCT01131169|11426570|FG001|COMPLETED|Overall Study||19
10293933|NCT01131169|11426569|FG000|NOT COMPLETED|Overall Study||0
10293934|NCT01131169|11426570|FG001|NOT COMPLETED|Overall Study||0
10293935|NCT00774345|11426579|FG000|STARTED|Pre-treatment||160
10293936|NCT00774345|11426580|FG001|STARTED|Pre-treatment||157
10293937|NCT00774345|11426579|FG000|COMPLETED|Pre-treatment||158
10293938|NCT00774345|11426580|FG001|COMPLETED|Pre-treatment||157
10293939|NCT00774345|11426579|FG000|NOT COMPLETED|Pre-treatment||2
10293940|NCT00774345|11426580|FG001|NOT COMPLETED|Pre-treatment||0
10293941|NCT00774345|11426579|FG000|STARTED|Treatment||158
10293942|NCT00774345|11426580|FG001|STARTED|Treatment||157
10293943|NCT00774345|11426579|FG000|Participants Escalated to 5mg|Treatment||129
10293944|NCT00774345|11426580|FG001|Participants Escalated to 5mg|Treatment||149
10293945|NCT00774345|11426579|FG000|Participants Escalated to 10mg|Treatment||68
10293946|NCT00774345|11426580|FG001|Participants Escalated to 10mg|Treatment||88
10293947|NCT00774345|11426579|FG000|COMPLETED|Treatment||0
10293948|NCT00774345|11426580|FG001|COMPLETED|Treatment||0
10293949|NCT00774345|11426579|FG000|NOT COMPLETED|Treatment||158
10293950|NCT00774345|11426580|FG001|NOT COMPLETED|Treatment||157
10314616|NCT00166517|11448318|FG001|COMPLETED|Overall Study||61
10314617|NCT00166517|11448317|FG000|NOT COMPLETED|Overall Study||5
10314618|NCT00166517|11448318|FG001|NOT COMPLETED|Overall Study||2
10314619|NCT00166712|11448326|FG000|STARTED|Overall Study|Consented:Randomized-Group 1. Given MMF prior to surgery, Alemtuzumab & TAC (Prograf) day of surgery|24
10314620|NCT00166712|11448327|FG001|STARTED|Overall Study|Consented: Randomized-Group 2. Given Sirolimus & MMF prior to surgery, Alemtuzumab day of surgery.|16
10314621|NCT00166712|11448326|FG000|Phase 1|Overall Study|Evaluated for rejection at 6months post-transplant|22
10314622|NCT00166712|11448327|FG001|Phase 1|Overall Study|Evaluated at 6 month post-transplant to potentially be weaned off Sirolimus.|12
10314623|NCT00166712|11448326|FG000|Phase 2a|Overall Study|Subjects who remained on Prograf at 6mo post-transplant.|19
10314624|NCT00166712|11448327|FG001|Phase 2a|Overall Study|Subject who remained on Sirolimus at 6 months post-transplant.|12
10314625|NCT00166712|11448326|FG000|Phase 2b|Overall Study|Subjects converted to Sirolimus post-transplant.|3
10314626|NCT00166712|11448327|FG001|Phase 2b|Overall Study|Subjects weaned off Sirolimus|0
10314627|NCT00166712|11448326|FG000|Phase 3|Overall Study|Subjects from Phase 2b who were weaned off Sirolimus @ 12 months post-transplant.|0
10314628|NCT00166712|11448327|FG001|Phase 3|Overall Study|# weaned off Sirolimus at 12 months post-transplant.|0
10314629|NCT00166712|11448326|FG000|COMPLETED|Overall Study|Completed study participation.|22
10314630|NCT00166712|11448327|FG001|COMPLETED|Overall Study|Completed study participation.|11
10314631|NCT00166712|11448326|FG000|NOT COMPLETED|Overall Study||2
10314632|NCT00166712|11448327|FG001|NOT COMPLETED|Overall Study||5
10314633|NCT00167102|11448339|FG000|STARTED|Overall Study||23
10314634|NCT00167102|11448340|FG001|STARTED|Overall Study||22
10314635|NCT00167102|11448339|FG000|COMPLETED|Overall Study||23
10314636|NCT00167102|11448340|FG001|COMPLETED|Overall Study||22
10314637|NCT00167102|11448339|FG000|NOT COMPLETED|Overall Study||0
10416984|NCT00797225|11561604|FG006|COMPLETED|Weeks 13 to 24||20
10416985|NCT00797225|11561605|FG007|COMPLETED|Weeks 13 to 24||22
10416986|NCT00797225|11561598|FG000|NOT COMPLETED|Weeks 13 to 24||0
10416987|NCT00797225|11561599|FG001|NOT COMPLETED|Weeks 13 to 24||4
10416988|NCT00797225|11561600|FG002|NOT COMPLETED|Weeks 13 to 24||2
10862912|NCT02352948|12027893|FG004|Received Treatment|Overall Study||117
10862913|NCT02352948|12027894|FG005|Received Treatment|Overall Study||60
10862914|NCT02352948|12027889|FG000|Completed Study Treatment|Overall Study||15
10862915|NCT02352948|12027890|FG001|Completed Study Treatment|Overall Study||0
10862916|NCT02352948|12027891|FG002|Completed Study Treatment|Overall Study||36
10862917|NCT02352948|12027892|FG003|Completed Study Treatment|Overall Study||0
10862918|NCT02352948|12027893|FG004|Completed Study Treatment|Overall Study||23
10862919|NCT02352948|12027894|FG005|Completed Study Treatment|Overall Study||4
10862920|NCT02352948|12027889|FG000|COMPLETED|Overall Study||13
10862921|NCT02352948|12027890|FG001|COMPLETED|Overall Study||5
10862922|NCT02352948|12027891|FG002|COMPLETED|Overall Study||45
10862923|NCT02352948|12027892|FG003|COMPLETED|Overall Study||19
10862924|NCT02352948|12027893|FG004|COMPLETED|Overall Study||29
10862925|NCT02352948|12027894|FG005|COMPLETED|Overall Study||11
10862926|NCT02352948|12027889|FG000|NOT COMPLETED|Overall Study||49
10862927|NCT02352948|12027890|FG001|NOT COMPLETED|Overall Study||59
10862928|NCT02352948|12027891|FG002|NOT COMPLETED|Overall Study||129
10862929|NCT02352948|12027892|FG003|NOT COMPLETED|Overall Study||99
10862930|NCT02352948|12027893|FG004|NOT COMPLETED|Overall Study||88
10862931|NCT02352948|12027894|FG005|NOT COMPLETED|Overall Study||49
10862932|NCT02349893|12027914|FG000|STARTED|Overall Study||56
10862933|NCT02349893|12027914|FG000|COMPLETED|Overall Study||43
10862934|NCT02349893|12027914|FG000|NOT COMPLETED|Overall Study||13
10862935|NCT02315703|12027926|FG000|STARTED|Overall Study||50
10862936|NCT02315703|12027927|FG001|STARTED|Overall Study||49
10862937|NCT02315703|12027928|FG002|STARTED|Overall Study||49
10862938|NCT02315703|12027929|FG003|STARTED|Overall Study||48
10862939|NCT02315703|12027930|FG004|STARTED|Overall Study||49
10862940|NCT02315703|12027931|FG005|STARTED|Overall Study||49
10862941|NCT02315703|12027932|FG006|STARTED|Overall Study||50
10862942|NCT02315703|12027933|FG007|STARTED|Overall Study||49
10862943|NCT02315703|12027926|FG000|COMPLETED|Overall Study||44
10862944|NCT02315703|12027927|FG001|COMPLETED|Overall Study||39
10862945|NCT02315703|12027928|FG002|COMPLETED|Overall Study||44
10862946|NCT02315703|12027929|FG003|COMPLETED|Overall Study||39
10862947|NCT02315703|12027930|FG004|COMPLETED|Overall Study||41
10862948|NCT02315703|12027931|FG005|COMPLETED|Overall Study||43
10862949|NCT02315703|12027932|FG006|COMPLETED|Overall Study||37
10862950|NCT02315703|12027933|FG007|COMPLETED|Overall Study||42
10862951|NCT02315703|12027926|FG000|NOT COMPLETED|Overall Study||6
10862952|NCT02315703|12027927|FG001|NOT COMPLETED|Overall Study||10
10862953|NCT02315703|12027928|FG002|NOT COMPLETED|Overall Study||5
10862954|NCT02315703|12027929|FG003|NOT COMPLETED|Overall Study||9
10862955|NCT02315703|12027930|FG004|NOT COMPLETED|Overall Study||8
10862956|NCT02315703|12027931|FG005|NOT COMPLETED|Overall Study||6
10862957|NCT02315703|12027932|FG006|NOT COMPLETED|Overall Study||13
10862958|NCT02315703|12027933|FG007|NOT COMPLETED|Overall Study||7
10862971|NCT02214160|12027971|FG000|STARTED|Overall Study||24
10862972|NCT02214160|12027972|FG001|STARTED|Overall Study||37
10862973|NCT02214160|12027973|FG002|STARTED|Overall Study||33
10862974|NCT02214160|12027971|FG000|COMPLETED|Overall Study||20
10862975|NCT02214160|12027972|FG001|COMPLETED|Overall Study||29
10862976|NCT02214160|12027973|FG002|COMPLETED|Overall Study||23
10862977|NCT02214160|12027971|FG000|NOT COMPLETED|Overall Study||4
10862978|NCT02214160|12027972|FG001|NOT COMPLETED|Overall Study||8
10293951|NCT00457951|11426589|FG000|STARTED|Overall Study||13
10293952|NCT00457951|11426590|FG001|STARTED|Overall Study||66
10293953|NCT00457951|11426591|FG002|STARTED|Overall Study||72
10293954|NCT00457951|11426589|FG000|COMPLETED|Overall Study||13
10293955|NCT00457951|11426590|FG001|COMPLETED|Overall Study||50
10293956|NCT00457951|11426591|FG002|COMPLETED|Overall Study||60
10293957|NCT00457951|11426589|FG000|NOT COMPLETED|Overall Study||0
10293958|NCT00457951|11426590|FG001|NOT COMPLETED|Overall Study||16
10293959|NCT00457951|11426591|FG002|NOT COMPLETED|Overall Study||12
10293960|NCT00345943|11426600|FG000|STARTED|Overall Study||38
10293961|NCT00345943|11426601|FG001|STARTED|Overall Study||33
10293962|NCT00345943|11426600|FG000|COMPLETED|Overall Study||33
10293963|NCT00345943|11426601|FG001|COMPLETED|Overall Study||28
10293964|NCT00345943|11426600|FG000|NOT COMPLETED|Overall Study||5
10293965|NCT00345943|11426601|FG001|NOT COMPLETED|Overall Study||5
10293966|NCT00258427|11426611|FG000|STARTED|Overall Study||3
10293967|NCT00258427|11426612|FG001|STARTED|Overall Study||8
10293968|NCT00258427|11426613|FG002|STARTED|Overall Study||2
10293969|NCT00258427|11426614|FG003|STARTED|Overall Study||1
10293970|NCT00258427|11426611|FG000|COMPLETED|Overall Study||3
10293971|NCT00258427|11426612|FG001|COMPLETED|Overall Study||8
10862979|NCT02214160|12027973|FG002|NOT COMPLETED|Overall Study||10
10862980|NCT02167945|12027985|FG000|STARTED|Overall Study||615
10862981|NCT02167945|12027985|FG000|COMPLETED|Overall Study||366
10862982|NCT02167945|12027985|FG000|NOT COMPLETED|Overall Study||249
10862983|NCT02128763|12027999|FG000|STARTED|Overall Study||349
10862984|NCT02128763|12028000|FG001|STARTED|Overall Study||186
10862985|NCT02128763|12027999|FG000|COMPLETED|Overall Study||329
10862986|NCT02128763|12028000|FG001|COMPLETED|Overall Study||170
10862987|NCT02128763|12027999|FG000|NOT COMPLETED|Overall Study||20
10862988|NCT02128763|12028000|FG001|NOT COMPLETED|Overall Study||16
10862989|NCT02074436|12028011|FG000|STARTED|Overall Study||15
10862990|NCT02074436|12028012|FG001|STARTED|Overall Study||14
10862991|NCT02074436|12028011|FG000|COMPLETED|Overall Study||15
10862992|NCT02074436|12028012|FG001|COMPLETED|Overall Study||14
10862993|NCT02074436|12028011|FG000|NOT COMPLETED|Overall Study||0
10862994|NCT02074436|12028012|FG001|NOT COMPLETED|Overall Study||0
10862995|NCT01991977|12028018|FG000|STARTED|Overall Study||91
10862996|NCT01991977|12028018|FG000|Received PET Tracer|Overall Study||84
10862997|NCT01991977|12028018|FG000|Received IMRT Treatment|Overall Study||79
10862998|NCT01991977|12028018|FG000|Evaluable for the Primary Outcome|Overall Study||39
10862999|NCT01991977|12028018|FG000|COMPLETED|Overall Study||79
10863000|NCT01991977|12028018|FG000|NOT COMPLETED|Overall Study||12
10863007|NCT01903733|12028037|FG000|STARTED|Overall Study||250
10863008|NCT01903733|12028038|FG001|STARTED|Overall Study||284
10863009|NCT01903733|12028039|FG002|STARTED|Overall Study||119
10863010|NCT01903733|12028040|FG003|STARTED|Overall Study||167
10863011|NCT01903733|12028037|FG000|Full Analysis Set|Overall Study||250
10863012|NCT01903733|12028038|FG001|Full Analysis Set|Overall Study||284
10863013|NCT01903733|12028039|FG002|Full Analysis Set|Overall Study||119
10863014|NCT01903733|12028040|FG003|Full Analysis Set|Overall Study||167
10863015|NCT01903733|12028037|FG000|Safety Analysis Set|Overall Study||248
10863016|NCT01903733|12028038|FG001|Safety Analysis Set|Overall Study||284
10863017|NCT01903733|12028039|FG002|Safety Analysis Set|Overall Study||119
10863018|NCT01903733|12028040|FG003|Safety Analysis Set|Overall Study||167
10863019|NCT01903733|12028037|FG000|Enrolled in B1871040|Overall Study||124
10863020|NCT01903733|12028038|FG001|Enrolled in B1871040|Overall Study||90
10863021|NCT01903733|12028039|FG002|Enrolled in B1871040|Overall Study||28
10863022|NCT01903733|12028040|FG003|Enrolled in B1871040|Overall Study||18
10863023|NCT01903733|12028037|FG000|Treated in B1871040|Overall Study||98
10863024|NCT01903733|12028038|FG001|Treated in B1871040|Overall Study||69
10863025|NCT01903733|12028039|FG002|Treated in B1871040|Overall Study||13
10863026|NCT01903733|12028040|FG003|Treated in B1871040|Overall Study||8
10863027|NCT01903733|12028037|FG000|COMPLETED|Overall Study||144
10863028|NCT01903733|12028038|FG001|COMPLETED|Overall Study||158
10863029|NCT01903733|12028039|FG002|COMPLETED|Overall Study||58
10863030|NCT01903733|12028040|FG003|COMPLETED|Overall Study||48
10863031|NCT01903733|12028037|FG000|NOT COMPLETED|Overall Study||106
10863032|NCT01903733|12028038|FG001|NOT COMPLETED|Overall Study||126
10863033|NCT01903733|12028039|FG002|NOT COMPLETED|Overall Study||61
10863034|NCT01903733|12028040|FG003|NOT COMPLETED|Overall Study||119
10863043|NCT01575548|12028071|FG000|STARTED|Overall Study||66
10863044|NCT01575548|12028072|FG001|STARTED|Overall Study||63
10863045|NCT01575548|12028071|FG000|Received Protocol Therapy|Overall Study||63
10863046|NCT01575548|12028072|FG001|Received Protocol Therapy|Overall Study||61
10863047|NCT01575548|12028071|FG000|COMPLETED|Overall Study||26
10863048|NCT01575548|12028072|FG001|COMPLETED|Overall Study||30
10863049|NCT01575548|12028071|FG000|NOT COMPLETED|Overall Study||40
10863050|NCT01575548|12028072|FG001|NOT COMPLETED|Overall Study||33
10416989|NCT00797225|11561601|FG003|NOT COMPLETED|Weeks 13 to 24||0
10416990|NCT00797225|11561602|FG004|NOT COMPLETED|Weeks 13 to 24||1
10416991|NCT00797225|11561603|FG005|NOT COMPLETED|Weeks 13 to 24||0
10416992|NCT00797225|11561604|FG006|NOT COMPLETED|Weeks 13 to 24||2
10416993|NCT00797225|11561605|FG007|NOT COMPLETED|Weeks 13 to 24||0
10416994|NCT00797277|11561623|FG000|STARTED|Overall Study||37
10416995|NCT00797277|11561624|FG001|STARTED|Overall Study||30
10416996|NCT00797277|11561623|FG000|COMPLETED|Overall Study||37
10416997|NCT00797277|11561624|FG001|COMPLETED|Overall Study||30
10416998|NCT00797277|11561623|FG000|NOT COMPLETED|Overall Study||0
10416999|NCT00797277|11561624|FG001|NOT COMPLETED|Overall Study||0
10417000|NCT00797316|11561633|FG000|STARTED|Overall Study||267
10417001|NCT00797316|11561634|FG001|STARTED|Overall Study||265
10417002|NCT00797316|11561633|FG000|COMPLETED|Overall Study||244
10417003|NCT00797316|11561634|FG001|COMPLETED|Overall Study||233
10417004|NCT00797316|11561633|FG000|NOT COMPLETED|Overall Study||23
10417005|NCT00797316|11561634|FG001|NOT COMPLETED|Overall Study||32
10417006|NCT00797459|11561640|FG000|STARTED|Overall Study||60
10417007|NCT00797459|11561640|FG000|COMPLETED|Overall Study||60
10417008|NCT00797459|11561640|FG000|NOT COMPLETED|Overall Study||0
10417009|NCT00797511|11561648|FG000|STARTED|Overall Study||132
10755359|NCT03065647|11919196|FG001|NOT COMPLETED|Overall Study||0
10755360|NCT03066102|11919202|FG000|STARTED|Overall Study||30
10755361|NCT03066102|11919202|FG000|COMPLETED|Overall Study||30
10755362|NCT03066102|11919202|FG000|NOT COMPLETED|Overall Study||0
10755363|NCT03066193|11919206|FG000|STARTED|Overall Study||17
10755364|NCT03066193|11919206|FG000|COMPLETED|Overall Study||16
10755365|NCT03066193|11919206|FG000|NOT COMPLETED|Overall Study||1
10755366|NCT03066609|11919213|FG000|STARTED|INDUCTION||136
10755367|NCT03066609|11919214|FG001|STARTED|INDUCTION||272
10755368|NCT03066609|11919215|FG002|STARTED|INDUCTION||135
10755369|NCT03066609|11919216|FG003|STARTED|INDUCTION||0
10755370|NCT03066609|11919213|FG000|COMPLETED|INDUCTION||134
10755371|NCT03066609|11919214|FG001|COMPLETED|INDUCTION||270
10755372|NCT03066609|11919215|FG002|COMPLETED|INDUCTION||133
10755373|NCT03066609|11919216|FG003|COMPLETED|INDUCTION||0
10755374|NCT03066609|11919213|FG000|NOT COMPLETED|INDUCTION||2
10755375|NCT03066609|11919214|FG001|NOT COMPLETED|INDUCTION||2
10755376|NCT03066609|11919215|FG002|NOT COMPLETED|INDUCTION||2
10755377|NCT03066609|11919216|FG003|NOT COMPLETED|INDUCTION||0
10755378|NCT03066609|11919213|FG000|STARTED|MAINTENANCE||134
10755379|NCT03066609|11919214|FG001|STARTED|MAINTENANCE||270
10755380|NCT03066609|11919215|FG002|STARTED|MAINTENANCE||4
10755381|NCT03066609|11919216|FG003|STARTED|MAINTENANCE||129
10755382|NCT03066609|11919213|FG000|COMPLETED|MAINTENANCE||127
10755383|NCT03066609|11919214|FG001|COMPLETED|MAINTENANCE||266
10755384|NCT03066609|11919215|FG002|COMPLETED|MAINTENANCE||2
10755385|NCT03066609|11919216|FG003|COMPLETED|MAINTENANCE||126
10755386|NCT03066609|11919213|FG000|NOT COMPLETED|MAINTENANCE||7
10755387|NCT03066609|11919214|FG001|NOT COMPLETED|MAINTENANCE||4
10755388|NCT03066609|11919215|FG002|NOT COMPLETED|MAINTENANCE||2
10755389|NCT03066609|11919216|FG003|NOT COMPLETED|MAINTENANCE||3
10755390|NCT03066609|11919213|FG000|STARTED|OVERALL STUDY||136
10755391|NCT03066609|11919214|FG001|STARTED|OVERALL STUDY||272
10755392|NCT03066609|11919215|FG002|STARTED|OVERALL STUDY||6
10755393|NCT03066609|11919216|FG003|STARTED|OVERALL STUDY||129
10755394|NCT03066609|11919213|FG000|COMPLETED|OVERALL STUDY||126
10755395|NCT03066609|11919214|FG001|COMPLETED|OVERALL STUDY||264
10755396|NCT03066609|11919215|FG002|COMPLETED|OVERALL STUDY||2
10755397|NCT03066609|11919216|FG003|COMPLETED|OVERALL STUDY||124
10755398|NCT03066609|11919213|FG000|NOT COMPLETED|OVERALL STUDY||10
10755399|NCT03066609|11919214|FG001|NOT COMPLETED|OVERALL STUDY||8
10755400|NCT03066609|11919215|FG002|NOT COMPLETED|OVERALL STUDY||4
10755401|NCT03066609|11919216|FG003|NOT COMPLETED|OVERALL STUDY||5
10755402|NCT03066778|11919229|FG000|STARTED|Overall Study||228
10755403|NCT03066778|11919230|FG001|STARTED|Overall Study||225
10755404|NCT03066778|11919229|FG000|Treated|Overall Study|1 participant randomized to the pembrolizumab+etoposide arm was treated with placebo+etoposide.|223
10755405|NCT03066778|11919230|FG001|Treated|Overall Study|1 participant randomized to the pembrolizumab+etoposide arm was treated with placebo+etoposide.|223
10755406|NCT03066778|11919229|FG000|COMPLETED|Overall Study||0
10755407|NCT03066778|11919230|FG001|COMPLETED|Overall Study||0
10755408|NCT03066778|11919229|FG000|NOT COMPLETED|Overall Study||228
10755409|NCT03066778|11919230|FG001|NOT COMPLETED|Overall Study||225
10755410|NCT03066804|11919238|FG000|STARTED|Overall Study||1286
10755411|NCT03066804|11919239|FG001|STARTED|Overall Study||1286
10755412|NCT03066804|11919238|FG000|COMPLETED|Overall Study||1235
10755413|NCT03066804|11919239|FG001|COMPLETED|Overall Study||1236
10755414|NCT03066804|11919238|FG000|NOT COMPLETED|Overall Study||51
10755415|NCT03066804|11919239|FG001|NOT COMPLETED|Overall Study||50
10755416|NCT03066830|11919248|FG000|STARTED|Overall Study||254
10755417|NCT03066830|11919249|FG001|STARTED|Overall Study||253
10755418|NCT03066830|11919248|FG000|COMPLETED|Overall Study||221
10755419|NCT03066830|11919249|FG001|COMPLETED|Overall Study||231
10755420|NCT03066830|11919248|FG000|NOT COMPLETED|Overall Study||33
10755421|NCT03066830|11919249|FG001|NOT COMPLETED|Overall Study||22
10417010|NCT00797511|11561648|FG000|COMPLETED|Overall Study||131
10417011|NCT00797511|11561648|FG000|NOT COMPLETED|Overall Study||1
10755422|NCT03066947|11919256|FG000|STARTED|Overall Study||24
10417012|NCT00797563|11561653|FG000|STARTED|Overall Study|number of subjects|102
10417013|NCT00797563|11561653|FG000|COMPLETED|Overall Study||101
10417014|NCT00797563|11561653|FG000|NOT COMPLETED|Overall Study||1
10293972|NCT00258427|11426613|FG002|COMPLETED|Overall Study||2
10293973|NCT00258427|11426614|FG003|COMPLETED|Overall Study||1
10293974|NCT00258427|11426611|FG000|NOT COMPLETED|Overall Study||0
10293975|NCT00258427|11426612|FG001|NOT COMPLETED|Overall Study||0
10293976|NCT00258427|11426613|FG002|NOT COMPLETED|Overall Study||0
10293977|NCT00258427|11426614|FG003|NOT COMPLETED|Overall Study||0
10293978|NCT03722810|11426626|FG000|STARTED|Overall Study||157
10293979|NCT03722810|11426627|FG001|STARTED|Overall Study||160
10293980|NCT03722810|11426626|FG000|COMPLETED|Overall Study||150
10293981|NCT03722810|11426627|FG001|COMPLETED|Overall Study||156
10293982|NCT03722810|11426626|FG000|NOT COMPLETED|Overall Study||7
10293983|NCT03722810|11426627|FG001|NOT COMPLETED|Overall Study||4
10293984|NCT00000125|11426642|FG000|STARTED|Overall Study||819
10293985|NCT00000125|11426643|FG001|STARTED|Overall Study||817
10293986|NCT00000125|11426642|FG000|Completed OHTS Phase I, June 2002|Overall Study||706
10293987|NCT00000125|11426643|FG001|Completed OHTS Phase I, June 2002|Overall Study||702
10293988|NCT00000125|11426642|FG000|COMPLETED|Overall Study|Completed OHTS Phase 2, through March 2009|580
10293989|NCT00000125|11426643|FG001|COMPLETED|Overall Study|Completed OHTS Phase 2, through March 2009|579
10293990|NCT00000125|11426642|FG000|NOT COMPLETED|Overall Study||239
10293991|NCT00000125|11426643|FG001|NOT COMPLETED|Overall Study||238
10293992|NCT00000134|11426652|FG000|STARTED|Overall Study||89
10293993|NCT00000134|11426653|FG001|STARTED|Overall Study||94
10293994|NCT00000134|11426654|FG002|STARTED|Overall Study||96
10293995|NCT00000134|11426652|FG000|COMPLETED|Overall Study||89
10293996|NCT00000134|11426653|FG001|COMPLETED|Overall Study||94
10293997|NCT00000134|11426654|FG002|COMPLETED|Overall Study||96
10293998|NCT00000134|11426652|FG000|NOT COMPLETED|Overall Study||0
10293999|NCT00000134|11426653|FG001|NOT COMPLETED|Overall Study||0
10294000|NCT00000134|11426654|FG002|NOT COMPLETED|Overall Study||0
10294001|NCT00000135|11426664|FG000|STARTED|Overall Study||104
10294002|NCT00000135|11426665|FG001|STARTED|Overall Study||105
10294003|NCT00000135|11426664|FG000|COMPLETED|Overall Study||77
10294004|NCT00000135|11426665|FG001|COMPLETED|Overall Study||91
10294005|NCT00000135|11426664|FG000|NOT COMPLETED|Overall Study||27
10294006|NCT00000135|11426665|FG001|NOT COMPLETED|Overall Study||14
10294007|NCT00000136|11426673|FG000|STARTED|Overall Study||107
10294008|NCT00000136|11426674|FG001|STARTED|Overall Study||127
10294009|NCT00000136|11426673|FG000|COMPLETED|Overall Study||107
10294010|NCT00000136|11426674|FG001|COMPLETED|Overall Study||127
10294011|NCT00000136|11426673|FG000|NOT COMPLETED|Overall Study||0
10294012|NCT00000136|11426674|FG001|NOT COMPLETED|Overall Study||0
10294013|NCT00000142|11426683|FG000|STARTED|Overall Study||26
10294014|NCT00000142|11426684|FG001|STARTED|Overall Study||26
10294015|NCT00000142|11426685|FG002|STARTED|Overall Study||12
10294016|NCT00000142|11426683|FG000|COMPLETED|Overall Study||26
10294017|NCT00000142|11426684|FG001|COMPLETED|Overall Study||26
10294018|NCT00000142|11426685|FG002|COMPLETED|Overall Study||12
10294019|NCT00000142|11426683|FG000|NOT COMPLETED|Overall Study||0
10294020|NCT00000142|11426684|FG001|NOT COMPLETED|Overall Study||0
10863249|NCT01321073|12028120|FG000|STARTED|Overall Study||64
10863250|NCT01321073|12028120|FG000|COMPLETED|Overall Study||57
10863251|NCT01321073|12028120|FG000|NOT COMPLETED|Overall Study||7
10863288|NCT01236547|12028172|FG000|STARTED|Overall Study||11
10863289|NCT01236547|12028173|FG001|STARTED|Overall Study||11
10863290|NCT01236547|12028174|FG002|STARTED|Overall Study||12
10863291|NCT01236547|12028175|FG003|STARTED|Overall Study||42
10863292|NCT01236547|12028176|FG004|STARTED|Overall Study||47
10863293|NCT01236547|12028172|FG000|Eligible|Overall Study||11
10863294|NCT01236547|12028173|FG001|Eligible|Overall Study||10
10863295|NCT01236547|12028174|FG002|Eligible|Overall Study||11
10863296|NCT01236547|12028175|FG003|Eligible|Overall Study||36
10863297|NCT01236547|12028176|FG004|Eligible|Overall Study||35
10863298|NCT01236547|12028172|FG000|Eligible and Started Study Treatment|Overall Study||11
10863299|NCT01236547|12028173|FG001|Eligible and Started Study Treatment|Overall Study||10
10863300|NCT01236547|12028174|FG002|Eligible and Started Study Treatment|Overall Study||11
10863301|NCT01236547|12028175|FG003|Eligible and Started Study Treatment|Overall Study||36
10863302|NCT01236547|12028176|FG004|Eligible and Started Study Treatment|Overall Study||34
10863303|NCT01236547|12028172|FG000|Eligible and Response Assessed|Overall Study||0
10863304|NCT01236547|12028173|FG001|Eligible and Response Assessed|Overall Study||0
10863305|NCT01236547|12028174|FG002|Eligible and Response Assessed|Overall Study||0
10863306|NCT01236547|12028175|FG003|Eligible and Response Assessed|Overall Study||23
10863307|NCT01236547|12028176|FG004|Eligible and Response Assessed|Overall Study||27
10863308|NCT01236547|12028172|FG000|COMPLETED|Overall Study||11
10863309|NCT01236547|12028173|FG001|COMPLETED|Overall Study||10
10863310|NCT01236547|12028174|FG002|COMPLETED|Overall Study||11
10863311|NCT01236547|12028175|FG003|COMPLETED|Overall Study||36
10863312|NCT01236547|12028176|FG004|COMPLETED|Overall Study||35
10863313|NCT01236547|12028172|FG000|NOT COMPLETED|Overall Study||0
10863314|NCT01236547|12028173|FG001|NOT COMPLETED|Overall Study||1
10863315|NCT01236547|12028174|FG002|NOT COMPLETED|Overall Study||1
10863316|NCT01236547|12028175|FG003|NOT COMPLETED|Overall Study||6
10863317|NCT01236547|12028176|FG004|NOT COMPLETED|Overall Study||12
10863336|NCT01038778|12028219|FG000|STARTED|Overall Study||3
10863337|NCT01038778|12028220|FG001|STARTED|Overall Study||8
10863338|NCT01038778|12028221|FG002|STARTED|Overall Study||36
10863339|NCT01038778|12028219|FG000|COMPLETED|Overall Study||3
10863340|NCT01038778|12028220|FG001|COMPLETED|Overall Study||6
10863341|NCT01038778|12028221|FG002|COMPLETED|Overall Study||33
10863342|NCT01038778|12028219|FG000|NOT COMPLETED|Overall Study||0
10863343|NCT01038778|12028220|FG001|NOT COMPLETED|Overall Study||2
10863344|NCT01038778|12028221|FG002|NOT COMPLETED|Overall Study||3
10294021|NCT00000142|11426685|FG002|NOT COMPLETED|Overall Study||0
10294022|NCT00000143|11426695|FG000|STARTED|Overall Study||31
10294023|NCT00000143|11426696|FG001|STARTED|Overall Study||30
10417015|NCT00797667|11561660|FG000|STARTED|Overall Study||265
10417016|NCT00797667|11561661|FG001|STARTED|Overall Study||264
10417017|NCT00797667|11561662|FG002|STARTED|Overall Study||131
10417018|NCT00797667|11561660|FG000|Treated|Overall Study||263
10417019|NCT00797667|11561661|FG001|Treated|Overall Study||263
10417020|NCT00797667|11561662|FG002|Treated|Overall Study||130
10863383|NCT00919763|12028290|FG000|STARTED|Overall Study||53
10863384|NCT00919763|12028291|FG001|STARTED|Overall Study||49
10863385|NCT00919763|12028290|FG000|COMPLETED|Overall Study||41
10863386|NCT00919763|12028291|FG001|COMPLETED|Overall Study||45
10294024|NCT00000143|11426695|FG000|COMPLETED|Overall Study||31
10294025|NCT00000143|11426696|FG001|COMPLETED|Overall Study||30
10294026|NCT00000143|11426695|FG000|NOT COMPLETED|Overall Study||0
10294027|NCT00000143|11426696|FG001|NOT COMPLETED|Overall Study||0
10294028|NCT00000371|11426704|FG000|STARTED|Overall Study||27
10294029|NCT00000371|11426705|FG001|STARTED|Overall Study||28
10294030|NCT00000371|11426704|FG000|COMPLETED|Overall Study||14
10294031|NCT00000371|11426705|FG001|COMPLETED|Overall Study||12
10294032|NCT00000371|11426704|FG000|NOT COMPLETED|Overall Study||13
10294033|NCT00000371|11426705|FG001|NOT COMPLETED|Overall Study||16
10294034|NCT00000378|11426713|FG000|STARTED|Overall Study||58
10294035|NCT00000378|11426714|FG001|STARTED|Overall Study||52
10294036|NCT00000378|11426713|FG000|COMPLETED|Overall Study||42
10294037|NCT00000378|11426714|FG001|COMPLETED|Overall Study||38
10294038|NCT00000378|11426713|FG000|NOT COMPLETED|Overall Study||16
10294039|NCT00000378|11426714|FG001|NOT COMPLETED|Overall Study||14
10294040|NCT00000392|11426722|FG000|STARTED|Overall Study||106
10294041|NCT00000392|11426723|FG001|STARTED|Overall Study||109
10294042|NCT00000392|11426722|FG000|COMPLETED|Overall Study|provided complete NP outcome data constituted the sample for the primary efficacy analyses|66
10294043|NCT00000392|11426723|FG001|COMPLETED|Overall Study|provided complete NP outcome data constituted the sample for the primary efficacy analyses|77
10294044|NCT00000392|11426722|FG000|NOT COMPLETED|Overall Study||40
10294045|NCT00000392|11426723|FG001|NOT COMPLETED|Overall Study||32
10294046|NCT00000479|11426733|FG000|STARTED|Overall Study||9968
10294047|NCT00000479|11426734|FG001|STARTED|Overall Study||9971
10294048|NCT00000479|11426735|FG002|STARTED|Overall Study||9966
10294049|NCT00000479|11426736|FG003|STARTED|Overall Study||9971
10294050|NCT00000479|11426733|FG000|COMPLETED|Overall Study||9968
10294051|NCT00000479|11426734|FG001|COMPLETED|Overall Study||9971
10294052|NCT00000479|11426735|FG002|COMPLETED|Overall Study||9966
10294053|NCT00000479|11426736|FG003|COMPLETED|Overall Study||9971
10294054|NCT00000479|11426733|FG000|NOT COMPLETED|Overall Study||0
10294055|NCT00000479|11426734|FG001|NOT COMPLETED|Overall Study||0
10294056|NCT00000479|11426735|FG002|NOT COMPLETED|Overall Study||0
10294057|NCT00000479|11426736|FG003|NOT COMPLETED|Overall Study||0
10294058|NCT00000575|11426749|FG000|STARTED|Overall Study||311
10294059|NCT00000575|11426750|FG001|STARTED|Overall Study||312
10294060|NCT00000575|11426751|FG002|STARTED|Overall Study||418
10294061|NCT00000575|11426749|FG000|COMPLETED|Overall Study||311
10294062|NCT00000575|11426750|FG001|COMPLETED|Overall Study||312
10294063|NCT00000575|11426751|FG002|COMPLETED|Overall Study||418
10294064|NCT00000575|11426749|FG000|NOT COMPLETED|Overall Study||0
10294065|NCT00000575|11426750|FG001|NOT COMPLETED|Overall Study||0
10863387|NCT00919763|12028290|FG000|NOT COMPLETED|Overall Study||12
10863388|NCT00919763|12028291|FG001|NOT COMPLETED|Overall Study||4
10294066|NCT00000575|11426751|FG002|NOT COMPLETED|Overall Study||0
10294067|NCT00000620|11426761|FG000|STARTED|Overall Study||1178
10294068|NCT00000620|11426762|FG001|STARTED|Overall Study||1193
10294069|NCT00000620|11426763|FG002|STARTED|Overall Study||1374
10294070|NCT00000620|11426764|FG003|STARTED|Overall Study||1383
10755423|NCT03066947|11919256|FG000|COMPLETED|Overall Study||14
10417021|NCT00797667|11561660|FG000|COMPLETED|Overall Study||5
10755424|NCT03066947|11919256|FG000|NOT COMPLETED|Overall Study||10
10755425|NCT03066999|11919263|FG000|STARTED|Overall Study||2
10755426|NCT03066999|11919264|FG001|STARTED|Overall Study||3
10755427|NCT03066999|11919263|FG000|COMPLETED|Overall Study||2
10755428|NCT03066999|11919264|FG001|COMPLETED|Overall Study||1
10755429|NCT03066999|11919263|FG000|NOT COMPLETED|Overall Study||0
10755430|NCT03066999|11919264|FG001|NOT COMPLETED|Overall Study||2
10755431|NCT03067311|11919273|FG000|STARTED|Overall Study||19
10755432|NCT03067311|11919274|FG001|STARTED|Overall Study||19
10863476|NCT00390325|12028385|FG000|STARTED|Overall Study||5
10863477|NCT00390325|12028386|FG001|STARTED|Overall Study||16
10863478|NCT00390325|12028385|FG000|COMPLETED|Overall Study||5
10863479|NCT00390325|12028386|FG001|COMPLETED|Overall Study||16
10863480|NCT00390325|12028385|FG000|NOT COMPLETED|Overall Study||0
10863481|NCT00390325|12028386|FG001|NOT COMPLETED|Overall Study||0
10417022|NCT00797667|11561661|FG001|COMPLETED|Overall Study||5
10417023|NCT00797667|11561662|FG002|COMPLETED|Overall Study||4
10417024|NCT00797667|11561660|FG000|NOT COMPLETED|Overall Study||260
10417025|NCT00797667|11561661|FG001|NOT COMPLETED|Overall Study||259
10417026|NCT00797667|11561662|FG002|NOT COMPLETED|Overall Study||127
10417027|NCT00797732|11561672|FG000|STARTED|Overall Study||21
10417028|NCT00797732|11561673|FG001|STARTED|Overall Study||21
10417029|NCT00797732|11561674|FG002|STARTED|Overall Study||154
10417030|NCT00797732|11561672|FG000|Evaluable at Baseline|Overall Study||18
10417031|NCT00797732|11561673|FG001|Evaluable at Baseline|Overall Study||18
10417032|NCT00797732|11561674|FG002|Evaluable at Baseline|Overall Study||0
10417033|NCT00797732|11561672|FG000|Evaluable at 20 Weeks|Overall Study||17
10417034|NCT00797732|11561673|FG001|Evaluable at 20 Weeks|Overall Study||18
10417035|NCT00797732|11561674|FG002|Evaluable at 20 Weeks|Overall Study||0
10417036|NCT00797732|11561672|FG000|Evaluable at 12 Months|Overall Study||17
10417037|NCT00797732|11561673|FG001|Evaluable at 12 Months|Overall Study||18
10417038|NCT00797732|11561674|FG002|Evaluable at 12 Months|Overall Study||0
10417039|NCT00797732|11561672|FG000|COMPLETED|Overall Study||16
10417040|NCT00797732|11561673|FG001|COMPLETED|Overall Study||18
10417041|NCT00797732|11561674|FG002|COMPLETED|Overall Study||0
10417042|NCT00797732|11561672|FG000|NOT COMPLETED|Overall Study||5
10417043|NCT00797732|11561673|FG001|NOT COMPLETED|Overall Study||3
10417044|NCT00797732|11561674|FG002|NOT COMPLETED|Overall Study||154
10417045|NCT00797797|11561682|FG000|STARTED|Overall Study|Two patients took no background stable dose of pregabalin after randomization and are not included.|178
10417046|NCT00797797|11561683|FG001|STARTED|Overall Study||184
10417047|NCT00797797|11561682|FG000|COMPLETED|Overall Study||123
10417048|NCT00797797|11561683|FG001|COMPLETED|Overall Study||141
10417049|NCT00797797|11561682|FG000|NOT COMPLETED|Overall Study||55
10417050|NCT00797797|11561683|FG001|NOT COMPLETED|Overall Study||43
10417051|NCT00797823|11561692|FG000|STARTED|Pilot Studies|Not involved in pilot studies|0
10417052|NCT00797823|11561693|FG001|STARTED|Pilot Studies|Not involved in pilot studies|0
10417053|NCT00797823|11561694|FG002|STARTED|Pilot Studies||6
10417054|NCT00797823|11561692|FG000|COMPLETED|Pilot Studies||0
10417055|NCT00797823|11561693|FG001|COMPLETED|Pilot Studies||0
10417056|NCT00797823|11561694|FG002|COMPLETED|Pilot Studies||6
10417057|NCT00797823|11561692|FG000|NOT COMPLETED|Pilot Studies||0
10417058|NCT00797823|11561693|FG001|NOT COMPLETED|Pilot Studies||0
10417059|NCT00797823|11561694|FG002|NOT COMPLETED|Pilot Studies||0
10417060|NCT00797823|11561692|FG000|STARTED|First Period (Initial Randomization)||4
10417061|NCT00797823|11561693|FG001|STARTED|First Period (Initial Randomization)||4
10417062|NCT00797823|11561694|FG002|STARTED|First Period (Initial Randomization)|Pilot studies only performed during initial period.|0
10417063|NCT00797823|11561692|FG000|COMPLETED|First Period (Initial Randomization)||3
10417064|NCT00797823|11561693|FG001|COMPLETED|First Period (Initial Randomization)||4
10417065|NCT00797823|11561694|FG002|COMPLETED|First Period (Initial Randomization)||0
10417066|NCT00797823|11561692|FG000|NOT COMPLETED|First Period (Initial Randomization)||1
10417067|NCT00797823|11561693|FG001|NOT COMPLETED|First Period (Initial Randomization)||0
10417068|NCT00797823|11561694|FG002|NOT COMPLETED|First Period (Initial Randomization)||0
10417069|NCT00797823|11561692|FG000|STARTED|Second Period (Crossover)||3
10417070|NCT00797823|11561693|FG001|STARTED|Second Period (Crossover)||4
10417071|NCT00797823|11561694|FG002|STARTED|Second Period (Crossover)||0
10417072|NCT00797823|11561692|FG000|COMPLETED|Second Period (Crossover)||3
10417073|NCT00797823|11561693|FG001|COMPLETED|Second Period (Crossover)||4
10417074|NCT00797823|11561694|FG002|COMPLETED|Second Period (Crossover)||0
10417075|NCT00797823|11561692|FG000|NOT COMPLETED|Second Period (Crossover)||0
10417076|NCT00797823|11561693|FG001|NOT COMPLETED|Second Period (Crossover)||0
10863496|NCT00306917|12028418|FG000|STARTED|Overall Study|400 subjects were to be followed for 5 years; due to slow enrollment study closed early with 245.|121
10863497|NCT00306917|12028419|FG001|STARTED|Overall Study|400 subjects were to be followed for 5 years; due to slow enrollment study closed early with 245.|124
10863498|NCT00306917|12028418|FG000|Postoperative to 6 Month Follow up|Overall Study||93
10863499|NCT00306917|12028419|FG001|Postoperative to 6 Month Follow up|Overall Study||100
10863500|NCT00306917|12028418|FG000|12 Month Follow|Overall Study||86
10863501|NCT00306917|12028419|FG001|12 Month Follow|Overall Study||94
10863502|NCT00306917|12028418|FG000|24 Month Follow up|Overall Study||60
10863503|NCT00306917|12028419|FG001|24 Month Follow up|Overall Study||71
10863504|NCT00306917|12028418|FG000|36 Month Follow up|Overall Study||56
10863505|NCT00306917|12028419|FG001|36 Month Follow up|Overall Study||42
10863506|NCT00306917|12028418|FG000|48 Month Follow up|Overall Study||29
10863507|NCT00306917|12028419|FG001|48 Month Follow up|Overall Study||22
10863508|NCT00306917|12028418|FG000|60 Month Follow up|Overall Study||13
10863509|NCT00306917|12028419|FG001|60 Month Follow up|Overall Study||15
10863510|NCT00306917|12028418|FG000|COMPLETED|Overall Study||13
10863511|NCT00306917|12028419|FG001|COMPLETED|Overall Study||15
10863512|NCT00306917|12028418|FG000|NOT COMPLETED|Overall Study||108
10863513|NCT00306917|12028419|FG001|NOT COMPLETED|Overall Study||109
10863514|NCT00238420|12028427|FG000|STARTED|Overall Study||22
10863515|NCT00238420|12028428|FG001|STARTED|Overall Study||48
10863516|NCT00238420|12028427|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|21
10863517|NCT00238420|12028428|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|47
10863518|NCT00238420|12028427|FG000|NOT COMPLETED|Overall Study||1
10863519|NCT00238420|12028428|FG001|NOT COMPLETED|Overall Study||1
10417077|NCT00797823|11561694|FG002|NOT COMPLETED|Second Period (Crossover)||0
10417078|NCT00797862|11561704|FG000|STARTED|Overall Study|3 participants were mis-randomized and discontinued. Only 617 participants received study drug.|620
10417079|NCT00797862|11561705|FG001|STARTED|Overall Study|3 participants were mis-randomized and discontinued. Only 315 participants received study drug.|318
10417080|NCT00797862|11561706|FG002|STARTED|Overall Study|1 participant was mis-randomized and discontinued. Only 315 participants received study drug.|316
10417081|NCT00797862|11561704|FG000|Entered Double-Blind Treatment (FAS)|Overall Study||617
10417082|NCT00797862|11561705|FG001|Entered Double-Blind Treatment (FAS)|Overall Study||315
10417083|NCT00797862|11561706|FG002|Entered Double-Blind Treatment (FAS)|Overall Study||315
10417084|NCT00797862|11561704|FG000|COMPLETED|Overall Study||496
10417085|NCT00797862|11561705|FG001|COMPLETED|Overall Study||250
10417086|NCT00797862|11561706|FG002|COMPLETED|Overall Study||230
10417087|NCT00797862|11561704|FG000|NOT COMPLETED|Overall Study||124
10417088|NCT00797862|11561705|FG001|NOT COMPLETED|Overall Study||68
10417089|NCT00797862|11561706|FG002|NOT COMPLETED|Overall Study||86
10417090|NCT00797966|11561718|FG000|STARTED|Phase A||0
10863532|NCT03107208|12028460|FG000|STARTED|Overall Study||30
10863533|NCT03107208|12028461|FG001|STARTED|Overall Study||27
10863534|NCT03107208|12028460|FG000|Received Intervention|Overall Study||26
10863535|NCT03107208|12028461|FG001|Received Intervention|Overall Study||24
10863536|NCT03107208|12028460|FG000|COMPLETED|Overall Study||26
10863537|NCT03107208|12028461|FG001|COMPLETED|Overall Study||24
10863538|NCT03107208|12028460|FG000|NOT COMPLETED|Overall Study||4
10863539|NCT03107208|12028461|FG001|NOT COMPLETED|Overall Study||3
10863540|NCT04509739|12028467|FG000|STARTED|Overall Study||16
10863541|NCT04509739|12028467|FG000|COMPLETED|Overall Study||15
10863542|NCT04509739|12028467|FG000|NOT COMPLETED|Overall Study||1
10863543|NCT04391959|12028473|FG000|STARTED|Overall Study||16
10863544|NCT04391959|12028474|FG001|STARTED|Overall Study|One subject should have been excluded based upon Schirmer test = 0 mm at baseline < 5mm. Subject was removed from the study.|15
10863545|NCT04391959|12028473|FG000|COMPLETED|Overall Study||15
10863546|NCT04391959|12028474|FG001|COMPLETED|Overall Study||10
10863547|NCT04391959|12028473|FG000|NOT COMPLETED|Overall Study||1
10863548|NCT04391959|12028474|FG001|NOT COMPLETED|Overall Study||5
10863549|NCT04368364|12028483|FG000|STARTED|Overall Study||1
10863550|NCT04368364|12028484|FG001|STARTED|Overall Study||1
10863551|NCT04368364|12028485|FG002|STARTED|Overall Study||1
10863552|NCT04368364|12028483|FG000|COMPLETED|Overall Study||1
10863553|NCT04368364|12028484|FG001|COMPLETED|Overall Study||1
10863554|NCT04368364|12028485|FG002|COMPLETED|Overall Study||1
10863555|NCT04368364|12028483|FG000|NOT COMPLETED|Overall Study||0
10863556|NCT04368364|12028484|FG001|NOT COMPLETED|Overall Study||0
10863557|NCT04368364|12028485|FG002|NOT COMPLETED|Overall Study||0
10863558|NCT04244084|12028495|FG000|STARTED|Overall Study||118
10863559|NCT04244084|12028496|FG001|STARTED|Overall Study||122
10863560|NCT04244084|12028495|FG000|COMPLETED|Overall Study||118
10863561|NCT04244084|12028496|FG001|COMPLETED|Overall Study||122
10863562|NCT04244084|12028495|FG000|NOT COMPLETED|Overall Study||0
10863563|NCT04244084|12028496|FG001|NOT COMPLETED|Overall Study||0
10863564|NCT04189588|12028504|FG000|STARTED|Overall Study||17
10863565|NCT04189588|12028505|FG001|STARTED|Overall Study||17
10863566|NCT04189588|12028504|FG000|Completed Treatment|Overall Study||17
10863567|NCT04189588|12028505|FG001|Completed Treatment|Overall Study||17
10863568|NCT04189588|12028504|FG000|COMPLETED|Overall Study||17
10863569|NCT04189588|12028505|FG001|COMPLETED|Overall Study||15
10863570|NCT04189588|12028504|FG000|NOT COMPLETED|Overall Study||0
10863571|NCT04189588|12028505|FG001|NOT COMPLETED|Overall Study||2
10863572|NCT04150562|12028511|FG000|STARTED|Overall Study||2
10863573|NCT04150562|12028512|FG001|STARTED|Overall Study||0
10863574|NCT04150562|12028511|FG000|COMPLETED|Overall Study||2
10863575|NCT04150562|12028512|FG001|COMPLETED|Overall Study||0
10863576|NCT04150562|12028511|FG000|NOT COMPLETED|Overall Study||0
10863577|NCT04150562|12028512|FG001|NOT COMPLETED|Overall Study||0
10863578|NCT04115748|12028520|FG000|STARTED|Main Study (Up to 16 Weeks)||19
10863579|NCT04115748|12028521|FG001|STARTED|Main Study (Up to 16 Weeks)||19
10863580|NCT04115748|12028522|FG002|STARTED|Main Study (Up to 16 Weeks)||9
10863581|NCT04115748|12028523|FG003|STARTED|Main Study (Up to 16 Weeks)||20
10863582|NCT04115748|12028524|FG004|STARTED|Main Study (Up to 16 Weeks)||0
10863583|NCT04115748|12028525|FG005|STARTED|Main Study (Up to 16 Weeks)||0
10863584|NCT04115748|12028526|FG006|STARTED|Main Study (Up to 16 Weeks)||0
10863585|NCT04115748|12028527|FG007|STARTED|Main Study (Up to 16 Weeks)||0
10863586|NCT04115748|12028528|FG008|STARTED|Main Study (Up to 16 Weeks)||0
10863587|NCT04115748|12028529|FG009|STARTED|Main Study (Up to 16 Weeks)||0
10863588|NCT04115748|12028520|FG000|COMPLETED|Main Study (Up to 16 Weeks)||4
10294071|NCT00000620|11426765|FG004|STARTED|Overall Study||1184
10294072|NCT00000620|11426766|FG005|STARTED|Overall Study||1178
10294073|NCT00000620|11426767|FG006|STARTED|Overall Study||1391
10294074|NCT00000620|11426768|FG007|STARTED|Overall Study||1370
10294075|NCT00000620|11426761|FG000|COMPLETED|Overall Study||1016
10294076|NCT00000620|11426762|FG001|COMPLETED|Overall Study||1057
10294077|NCT00000620|11426763|FG002|COMPLETED|Overall Study||1204
10294078|NCT00000620|11426764|FG003|COMPLETED|Overall Study||1205
10294079|NCT00000620|11426765|FG004|COMPLETED|Overall Study||1049
10294080|NCT00000620|11426766|FG005|COMPLETED|Overall Study||1026
10294081|NCT00000620|11426767|FG006|COMPLETED|Overall Study||1242
10294082|NCT00000620|11426768|FG007|COMPLETED|Overall Study||1224
10294083|NCT00000620|11426761|FG000|NOT COMPLETED|Overall Study||162
10294084|NCT00000620|11426762|FG001|NOT COMPLETED|Overall Study||136
10294085|NCT00000620|11426763|FG002|NOT COMPLETED|Overall Study||170
10294086|NCT00000620|11426764|FG003|NOT COMPLETED|Overall Study||178
10294087|NCT00000620|11426765|FG004|NOT COMPLETED|Overall Study||135
10294088|NCT00000620|11426766|FG005|NOT COMPLETED|Overall Study||152
10294089|NCT00000620|11426767|FG006|NOT COMPLETED|Overall Study||149
10294090|NCT00000620|11426768|FG007|NOT COMPLETED|Overall Study||146
10294091|NCT00001151|11426780|FG000|STARTED|Overall Study||6
10294092|NCT00001151|11426780|FG000|COMPLETED|Overall Study||1
10863589|NCT04115748|12028521|FG001|COMPLETED|Main Study (Up to 16 Weeks)||3
10863590|NCT04115748|12028522|FG002|COMPLETED|Main Study (Up to 16 Weeks)||2
10863591|NCT04115748|12028523|FG003|COMPLETED|Main Study (Up to 16 Weeks)||4
10863592|NCT04115748|12028524|FG004|COMPLETED|Main Study (Up to 16 Weeks)||0
10294093|NCT00001151|11426780|FG000|NOT COMPLETED|Overall Study||5
10294094|NCT00001213|11426784|FG000|STARTED|Overall Study||328
10294095|NCT00001213|11426784|FG000|COMPLETED|Overall Study||310
10294096|NCT00001213|11426784|FG000|NOT COMPLETED|Overall Study||18
10294097|NCT00001262|11426791|FG000|STARTED|Overall Study||35
10294098|NCT00001262|11426792|FG001|STARTED|Overall Study||22
10863593|NCT04115748|12028525|FG005|COMPLETED|Main Study (Up to 16 Weeks)||0
10863594|NCT04115748|12028526|FG006|COMPLETED|Main Study (Up to 16 Weeks)||0
10863595|NCT04115748|12028527|FG007|COMPLETED|Main Study (Up to 16 Weeks)||0
10863596|NCT04115748|12028528|FG008|COMPLETED|Main Study (Up to 16 Weeks)||0
10863597|NCT04115748|12028529|FG009|COMPLETED|Main Study (Up to 16 Weeks)||0
10863598|NCT04115748|12028520|FG000|NOT COMPLETED|Main Study (Up to 16 Weeks)||15
10863599|NCT04115748|12028521|FG001|NOT COMPLETED|Main Study (Up to 16 Weeks)||16
10863600|NCT04115748|12028522|FG002|NOT COMPLETED|Main Study (Up to 16 Weeks)||7
10863601|NCT04115748|12028523|FG003|NOT COMPLETED|Main Study (Up to 16 Weeks)||16
10863602|NCT04115748|12028524|FG004|NOT COMPLETED|Main Study (Up to 16 Weeks)||0
10863603|NCT04115748|12028525|FG005|NOT COMPLETED|Main Study (Up to 16 Weeks)||0
10863604|NCT04115748|12028526|FG006|NOT COMPLETED|Main Study (Up to 16 Weeks)||0
10863605|NCT04115748|12028527|FG007|NOT COMPLETED|Main Study (Up to 16 Weeks)||0
10863606|NCT04115748|12028528|FG008|NOT COMPLETED|Main Study (Up to 16 Weeks)||0
10863607|NCT04115748|12028529|FG009|NOT COMPLETED|Main Study (Up to 16 Weeks)||0
10863608|NCT04115748|12028520|FG000|STARTED|LTE (After 16 Weeks to Week 50)|Participants who completed main study received filgotinib 200 mg.|0
10863609|NCT04115748|12028521|FG001|STARTED|LTE (After 16 Weeks to Week 50)|Participants who completed main study received filgotinib 100 mg.|0
10863610|NCT04115748|12028522|FG002|STARTED|LTE (After 16 Weeks to Week 50)|Participants who completed main study were randomized in LTE phase to receive filgotinib 200 mg or 100 mg.|0
10863611|NCT04115748|12028523|FG003|STARTED|LTE (After 16 Weeks to Week 50)|Participants who completed main study were randomized in LTE phase to receive filgotinib 200 mg or 100 mg.|0
10863612|NCT04115748|12028524|FG004|STARTED|LTE (After 16 Weeks to Week 50)|Participants who completed main study received filgotinib 200 mg.|4
10863613|NCT04115748|12028525|FG005|STARTED|LTE (After 16 Weeks to Week 50)|Participants who completed main study received filgotinib 100 mg.|3
10863614|NCT04115748|12028526|FG006|STARTED|LTE (After 16 Weeks to Week 50)|1 participant who received adalimumab injection and completed main study were randomised in LTE phase to receive filgotinib 200 mg.|1
10863615|NCT04115748|12028527|FG007|STARTED|LTE (After 16 Weeks to Week 50)|1 participant who received adalimumab injection and completed main study were randomised in LTE phase to receive filgotinib 100 mg.|1
10863616|NCT04115748|12028528|FG008|STARTED|LTE (After 16 Weeks to Week 50)|2 participants who received placebo and completed main study were randomised in LTE phase to receive filgotinib 200 mg.|2
10863617|NCT04115748|12028529|FG009|STARTED|LTE (After 16 Weeks to Week 50)|2 participants who received placebo and completed main study were randomised in LTE phase to receive filgotinib 100 mg.|2
10863618|NCT04115748|12028520|FG000|COMPLETED|LTE (After 16 Weeks to Week 50)||0
10863619|NCT04115748|12028521|FG001|COMPLETED|LTE (After 16 Weeks to Week 50)||0
10863620|NCT04115748|12028522|FG002|COMPLETED|LTE (After 16 Weeks to Week 50)||0
10863621|NCT04115748|12028523|FG003|COMPLETED|LTE (After 16 Weeks to Week 50)||0
10863622|NCT04115748|12028524|FG004|COMPLETED|LTE (After 16 Weeks to Week 50)||0
10863623|NCT04115748|12028525|FG005|COMPLETED|LTE (After 16 Weeks to Week 50)||0
10863624|NCT04115748|12028526|FG006|COMPLETED|LTE (After 16 Weeks to Week 50)||0
10863625|NCT04115748|12028527|FG007|COMPLETED|LTE (After 16 Weeks to Week 50)||0
10863626|NCT04115748|12028528|FG008|COMPLETED|LTE (After 16 Weeks to Week 50)||0
10863627|NCT04115748|12028529|FG009|COMPLETED|LTE (After 16 Weeks to Week 50)||0
10863628|NCT04115748|12028520|FG000|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||0
10863629|NCT04115748|12028521|FG001|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||0
10863630|NCT04115748|12028522|FG002|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||0
10863631|NCT04115748|12028523|FG003|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||0
10863632|NCT04115748|12028524|FG004|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||4
10863633|NCT04115748|12028525|FG005|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||3
10863634|NCT04115748|12028526|FG006|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||1
10863635|NCT04115748|12028527|FG007|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||1
10863636|NCT04115748|12028528|FG008|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||2
10863637|NCT04115748|12028529|FG009|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||2
10863638|NCT04044664|12028554|FG000|STARTED|Stage 1||103
10863639|NCT04044664|12028555|FG001|STARTED|Stage 1||26
10863640|NCT04044664|12028556|FG002|STARTED|Stage 1||23
10863641|NCT04044664|12028554|FG000|COMPLETED|Stage 1||86
10863642|NCT04044664|12028555|FG001|COMPLETED|Stage 1||19
10863643|NCT04044664|12028556|FG002|COMPLETED|Stage 1||20
10863644|NCT04044664|12028554|FG000|NOT COMPLETED|Stage 1||17
10863645|NCT04044664|12028555|FG001|NOT COMPLETED|Stage 1||7
10863646|NCT04044664|12028556|FG002|NOT COMPLETED|Stage 1||3
10863647|NCT04044664|12028554|FG000|STARTED|Stage 2||76
10863648|NCT04044664|12028555|FG001|STARTED|Stage 2||26
10863649|NCT04044664|12028556|FG002|STARTED|Stage 2||22
10863650|NCT04044664|12028554|FG000|From Placebo, Responder|Stage 2||20
10863651|NCT04044664|12028555|FG001|From Placebo, Responder|Stage 2||13
10863652|NCT04044664|12028556|FG002|From Placebo, Responder|Stage 2||11
10863653|NCT04044664|12028554|FG000|From Placebo, Non-Responder|Stage 2||18
10863654|NCT04044664|12028555|FG001|From Placebo, Non-Responder|Stage 2||13
10863655|NCT04044664|12028556|FG002|From Placebo, Non-Responder|Stage 2||11
10863656|NCT04044664|12028554|FG000|From NYX-783 (10 mg or 50 mg)|Stage 2||38
10863657|NCT04044664|12028555|FG001|From NYX-783 (10 mg or 50 mg)|Stage 2||0
10863658|NCT04044664|12028556|FG002|From NYX-783 (10 mg or 50 mg)|Stage 2||0
10863659|NCT04044664|12028554|FG000|COMPLETED|Stage 2||67
10863660|NCT04044664|12028555|FG001|COMPLETED|Stage 2||24
10863661|NCT04044664|12028556|FG002|COMPLETED|Stage 2||21
10863662|NCT04044664|12028554|FG000|NOT COMPLETED|Stage 2||9
10863663|NCT04044664|12028555|FG001|NOT COMPLETED|Stage 2||2
10863664|NCT04044664|12028556|FG002|NOT COMPLETED|Stage 2||1
10863665|NCT04009850|12028566|FG000|STARTED|Overall Study||3
10863666|NCT04009850|12028567|FG001|STARTED|Overall Study||0
10863667|NCT04009850|12028566|FG000|COMPLETED|Overall Study||3
10863668|NCT04009850|12028567|FG001|COMPLETED|Overall Study||0
10863669|NCT04009850|12028566|FG000|NOT COMPLETED|Overall Study||0
10863670|NCT04009850|12028567|FG001|NOT COMPLETED|Overall Study||0
10863671|NCT03994731|12028575|FG000|STARTED|Run-in Period (From Week -4 to Day 1)||100
10863672|NCT03994731|12028576|FG001|STARTED|Run-in Period (From Week -4 to Day 1)||52
10863673|NCT03994731|12028575|FG000|Took at Least 1 Dose of MTX or Placebo|Run-in Period (From Week -4 to Day 1)||98
10863674|NCT03994731|12028576|FG001|Took at Least 1 Dose of MTX or Placebo|Run-in Period (From Week -4 to Day 1)||51
10294099|NCT00001262|11426793|FG002|STARTED|Overall Study||3
10417091|NCT00797966|11561719|FG001|STARTED|Phase A||0
10417092|NCT00797966|11561720|FG002|STARTED|Phase A||0
10417093|NCT00797966|11561721|FG003|STARTED|Phase A||0
10417094|NCT00797966|11561722|FG004|STARTED|Phase A|850 participants entered Phase A; 849 participants were treated.|849
10417095|NCT00797966|11561723|FG005|STARTED|Phase A||0
10417096|NCT00797966|11561718|FG000|COMPLETED|Phase A||0
10417097|NCT00797966|11561719|FG001|COMPLETED|Phase A||0
10417098|NCT00797966|11561720|FG002|COMPLETED|Phase A||0
10417099|NCT00797966|11561721|FG003|COMPLETED|Phase A||0
10417100|NCT00797966|11561722|FG004|COMPLETED|Phase A||664
10417101|NCT00797966|11561723|FG005|COMPLETED|Phase A||0
10417102|NCT00797966|11561718|FG000|NOT COMPLETED|Phase A||0
10417103|NCT00797966|11561719|FG001|NOT COMPLETED|Phase A||0
10417104|NCT00797966|11561720|FG002|NOT COMPLETED|Phase A||0
10417105|NCT00797966|11561721|FG003|NOT COMPLETED|Phase A||0
10417106|NCT00797966|11561722|FG004|NOT COMPLETED|Phase A||185
10417107|NCT00797966|11561723|FG005|NOT COMPLETED|Phase A||0
10863675|NCT03994731|12028575|FG000|COMPLETED|Run-in Period (From Week -4 to Day 1)||96
10863676|NCT03994731|12028576|FG001|COMPLETED|Run-in Period (From Week -4 to Day 1)||49
10863677|NCT03994731|12028575|FG000|NOT COMPLETED|Run-in Period (From Week -4 to Day 1)||4
10294100|NCT00001262|11426791|FG000|COMPLETED|Overall Study||25
10294101|NCT00001262|11426792|FG001|COMPLETED|Overall Study||8
10294102|NCT00001262|11426793|FG002|COMPLETED|Overall Study||3
10294103|NCT00001262|11426791|FG000|NOT COMPLETED|Overall Study||10
10294104|NCT00001262|11426792|FG001|NOT COMPLETED|Overall Study||14
10294105|NCT00001262|11426793|FG002|NOT COMPLETED|Overall Study||0
10294106|NCT00001304|11426803|FG000|STARTED|Overall Study||13
10294107|NCT00001304|11426804|FG001|STARTED|Overall Study||14
10294108|NCT00001304|11426803|FG000|COMPLETED|Overall Study||13
10294109|NCT00001304|11426804|FG001|COMPLETED|Overall Study||14
10294110|NCT00001304|11426803|FG000|NOT COMPLETED|Overall Study||0
10294111|NCT00001304|11426804|FG001|NOT COMPLETED|Overall Study||0
10294112|NCT00001305|11426810|FG000|STARTED|Overall Study||42
10294113|NCT00001305|11426810|FG000|COMPLETED|Overall Study||42
10294114|NCT00001305|11426810|FG000|NOT COMPLETED|Overall Study||0
10294115|NCT00001566|11426814|FG000|STARTED|Overall Study||42
10294116|NCT00001566|11426814|FG000|Completed Immunotherapy|Overall Study||23
10417108|NCT00797966|11561718|FG000|STARTED|Phase B|Randomized participants.|62
10417109|NCT00797966|11561719|FG001|STARTED|Phase B|Randomized participants.|120
10417110|NCT00797966|11561720|FG002|STARTED|Phase B|Randomized participants.|121
10417111|NCT00797966|11561721|FG003|STARTED|Phase B|Randomized participants.|126
10417112|NCT00797966|11561722|FG004|STARTED|Phase B||0
10417113|NCT00797966|11561723|FG005|STARTED|Phase B||0
10417114|NCT00797966|11561718|FG000|COMPLETED|Phase B||51
10863678|NCT03994731|12028576|FG001|NOT COMPLETED|Run-in Period (From Week -4 to Day 1)||3
10863679|NCT03994731|12028575|FG000|STARTED|Pegloticase + IMM Period||96
10863680|NCT03994731|12028576|FG001|STARTED|Pegloticase + IMM Period||49
10863681|NCT03994731|12028575|FG000|Discontinued Study Treatment Early|Pegloticase + IMM Period||38
10417115|NCT00797966|11561719|FG001|COMPLETED|Phase B||102
10417116|NCT00797966|11561720|FG002|COMPLETED|Phase B||100
10417117|NCT00797966|11561721|FG003|COMPLETED|Phase B||110
10417118|NCT00797966|11561722|FG004|COMPLETED|Phase B||0
10863682|NCT03994731|12028576|FG001|Discontinued Study Treatment Early|Pegloticase + IMM Period||33
10863683|NCT03994731|12028575|FG000|COMPLETED|Pegloticase + IMM Period||76
10863684|NCT03994731|12028576|FG001|COMPLETED|Pegloticase + IMM Period||34
10863685|NCT03994731|12028575|FG000|NOT COMPLETED|Pegloticase + IMM Period||20
10863686|NCT03994731|12028576|FG001|NOT COMPLETED|Pegloticase + IMM Period||15
10863687|NCT03963895|12028588|FG000|STARTED|Pre-dose Period (Study Days -7, -5, -2)||12
10863688|NCT03963895|12028589|FG001|STARTED|Pre-dose Period (Study Days -7, -5, -2)||12
10863689|NCT03963895|12028590|FG002|STARTED|Pre-dose Period (Study Days -7, -5, -2)||12
10417119|NCT00797966|11561723|FG005|COMPLETED|Phase B||0
10417120|NCT00797966|11561718|FG000|NOT COMPLETED|Phase B||11
10417121|NCT00797966|11561719|FG001|NOT COMPLETED|Phase B||18
10417122|NCT00797966|11561720|FG002|NOT COMPLETED|Phase B||21
10417123|NCT00797966|11561721|FG003|NOT COMPLETED|Phase B||16
10417124|NCT00797966|11561722|FG004|NOT COMPLETED|Phase B||0
10417125|NCT00797966|11561723|FG005|NOT COMPLETED|Phase B||0
10417126|NCT00797966|11561718|FG000|STARTED|Phase A+||0
10417127|NCT00797966|11561719|FG001|STARTED|Phase A+||0
10417128|NCT00797966|11561720|FG002|STARTED|Phase A+||0
10417129|NCT00797966|11561721|FG003|STARTED|Phase A+||0
10417130|NCT00797966|11561722|FG004|STARTED|Phase A+||0
10417131|NCT00797966|11561723|FG005|STARTED|Phase A+||235
10417132|NCT00797966|11561718|FG000|COMPLETED|Phase A+||0
10417133|NCT00797966|11561719|FG001|COMPLETED|Phase A+||0
10417134|NCT00797966|11561720|FG002|COMPLETED|Phase A+||0
10417135|NCT00797966|11561721|FG003|COMPLETED|Phase A+||0
10417136|NCT00797966|11561722|FG004|COMPLETED|Phase A+||0
10417137|NCT00797966|11561723|FG005|COMPLETED|Phase A+||207
10417138|NCT00797966|11561718|FG000|NOT COMPLETED|Phase A+||0
10417139|NCT00797966|11561719|FG001|NOT COMPLETED|Phase A+||0
10417140|NCT00797966|11561720|FG002|NOT COMPLETED|Phase A+||0
10417141|NCT00797966|11561721|FG003|NOT COMPLETED|Phase A+||0
10417142|NCT00797966|11561722|FG004|NOT COMPLETED|Phase A+||0
10417143|NCT00797966|11561723|FG005|NOT COMPLETED|Phase A+||28
10417144|NCT00798018|11561739|FG000|STARTED|Overall Study||25
10417145|NCT00798018|11561740|FG001|STARTED|Overall Study||25
10417146|NCT00798018|11561741|FG002|STARTED|Overall Study||25
10417147|NCT00798018|11561742|FG003|STARTED|Overall Study||25
10417148|NCT00798018|11561739|FG000|COMPLETED|Overall Study||25
10417149|NCT00798018|11561740|FG001|COMPLETED|Overall Study||25
10417150|NCT00798018|11561741|FG002|COMPLETED|Overall Study||25
10417151|NCT00798018|11561742|FG003|COMPLETED|Overall Study||25
10417152|NCT00798018|11561739|FG000|NOT COMPLETED|Overall Study||0
10417153|NCT00798018|11561740|FG001|NOT COMPLETED|Overall Study||0
10417154|NCT00798018|11561741|FG002|NOT COMPLETED|Overall Study||0
10417155|NCT00798018|11561742|FG003|NOT COMPLETED|Overall Study||0
10417156|NCT00798096|11561752|FG000|STARTED|Overall Study|Treatment with 200 mg bid, oral Fostamatanib until disease progression, toxicity or withdrawal|18
10417157|NCT00798096|11561752|FG000|COMPLETED|Overall Study|Completion of Study is defined as a minimum of 8 weeks of treatment or early disease progression|16
10417158|NCT00798096|11561752|FG000|NOT COMPLETED|Overall Study||2
10417159|NCT00798135|11561756|FG000|STARTED|Overall Study||13
10417160|NCT00798135|11561756|FG000|COMPLETED|Overall Study||0
10417161|NCT00798135|11561756|FG000|NOT COMPLETED|Overall Study||13
10417162|NCT00798161|11561767|FG000|STARTED|Overall Study||72
10417163|NCT00798161|11561768|FG001|STARTED|Overall Study||144
10417164|NCT00798161|11561769|FG002|STARTED|Overall Study||147
10417165|NCT00798161|11561770|FG003|STARTED|Overall Study||142
10417166|NCT00798161|11561771|FG004|STARTED|Overall Study||143
10417167|NCT00798161|11561772|FG005|STARTED|Overall Study||143
10417168|NCT00798161|11561773|FG006|STARTED|Overall Study||66
10417169|NCT00798161|11561767|FG000|COMPLETED|Overall Study||54
10417170|NCT00798161|11561768|FG001|COMPLETED|Overall Study||127
10417171|NCT00798161|11561769|FG002|COMPLETED|Overall Study||126
10417172|NCT00798161|11561770|FG003|COMPLETED|Overall Study||121
10417173|NCT00798161|11561771|FG004|COMPLETED|Overall Study||127
10417174|NCT00798161|11561772|FG005|COMPLETED|Overall Study||132
10417175|NCT00798161|11561773|FG006|COMPLETED|Overall Study||56
10417176|NCT00798161|11561767|FG000|NOT COMPLETED|Overall Study||18
10417177|NCT00798161|11561768|FG001|NOT COMPLETED|Overall Study||17
10417178|NCT00798161|11561769|FG002|NOT COMPLETED|Overall Study||21
10755433|NCT03067311|11919273|FG000|COMPLETED|Overall Study||17
10755434|NCT03067311|11919274|FG001|COMPLETED|Overall Study||17
10755435|NCT03067311|11919273|FG000|NOT COMPLETED|Overall Study||2
10755436|NCT03067311|11919274|FG001|NOT COMPLETED|Overall Study||2
10755437|NCT03067441|11919282|FG000|STARTED|Overall Study||492
10755438|NCT03067441|11919283|FG001|STARTED|Overall Study||970
10755439|NCT03067441|11919282|FG000|COMPLETED|Overall Study||459
10755440|NCT03067441|11919283|FG001|COMPLETED|Overall Study||913
10755441|NCT03067441|11919282|FG000|NOT COMPLETED|Overall Study||33
10755442|NCT03067441|11919283|FG001|NOT COMPLETED|Overall Study||57
10755443|NCT03067506|11919292|FG000|STARTED|Overall Study||30
10755444|NCT03067506|11919292|FG000|COMPLETED|Overall Study||30
10755445|NCT03067506|11919292|FG000|NOT COMPLETED|Overall Study||0
10755446|NCT03067948|11919296|FG000|STARTED|Overall Study||32
10863690|NCT03963895|12028588|FG000|COMPLETED|Pre-dose Period (Study Days -7, -5, -2)||12
10863691|NCT03963895|12028589|FG001|COMPLETED|Pre-dose Period (Study Days -7, -5, -2)||12
10755447|NCT03067948|11919296|FG000|COMPLETED|Overall Study||32
10417179|NCT00798161|11561770|FG003|NOT COMPLETED|Overall Study||21
10417180|NCT00798161|11561771|FG004|NOT COMPLETED|Overall Study||16
10417181|NCT00798161|11561772|FG005|NOT COMPLETED|Overall Study||11
10755448|NCT03067948|11919296|FG000|NOT COMPLETED|Overall Study||0
10755449|NCT03067987|11919302|FG000|STARTED|Overall Study||50
10863692|NCT03963895|12028590|FG002|COMPLETED|Pre-dose Period (Study Days -7, -5, -2)||12
10863693|NCT03963895|12028588|FG000|NOT COMPLETED|Pre-dose Period (Study Days -7, -5, -2)||0
10863694|NCT03963895|12028589|FG001|NOT COMPLETED|Pre-dose Period (Study Days -7, -5, -2)||0
10863695|NCT03963895|12028590|FG002|NOT COMPLETED|Pre-dose Period (Study Days -7, -5, -2)||0
10863696|NCT03963895|12028588|FG000|STARTED|Dosing Period (Study Day 1)||12
10863697|NCT03963895|12028589|FG001|STARTED|Dosing Period (Study Day 1)||12
10863698|NCT03963895|12028590|FG002|STARTED|Dosing Period (Study Day 1)||12
10863699|NCT03963895|12028588|FG000|COMPLETED|Dosing Period (Study Day 1)||12
10863700|NCT03963895|12028589|FG001|COMPLETED|Dosing Period (Study Day 1)||12
10863701|NCT03963895|12028590|FG002|COMPLETED|Dosing Period (Study Day 1)||12
10863702|NCT03963895|12028588|FG000|NOT COMPLETED|Dosing Period (Study Day 1)||0
10863703|NCT03963895|12028589|FG001|NOT COMPLETED|Dosing Period (Study Day 1)||0
10863704|NCT03963895|12028590|FG002|NOT COMPLETED|Dosing Period (Study Day 1)||0
10863705|NCT03963895|12028588|FG000|STARTED|Recovery Period (Study Day 3)||12
10863706|NCT03963895|12028589|FG001|STARTED|Recovery Period (Study Day 3)||12
10863707|NCT03963895|12028590|FG002|STARTED|Recovery Period (Study Day 3)||12
10863708|NCT03963895|12028588|FG000|COMPLETED|Recovery Period (Study Day 3)||12
10863709|NCT03963895|12028589|FG001|COMPLETED|Recovery Period (Study Day 3)||12
10863710|NCT03963895|12028590|FG002|COMPLETED|Recovery Period (Study Day 3)||12
10863711|NCT03963895|12028588|FG000|NOT COMPLETED|Recovery Period (Study Day 3)||0
10863712|NCT03963895|12028589|FG001|NOT COMPLETED|Recovery Period (Study Day 3)||0
10863713|NCT03963895|12028590|FG002|NOT COMPLETED|Recovery Period (Study Day 3)||0
10863714|NCT03963895|12028588|FG000|STARTED|Follow-up Period (Study Day 14)||12
10863715|NCT03963895|12028589|FG001|STARTED|Follow-up Period (Study Day 14)||12
10863716|NCT03963895|12028590|FG002|STARTED|Follow-up Period (Study Day 14)||12
10863717|NCT03963895|12028588|FG000|COMPLETED|Follow-up Period (Study Day 14)||12
10863718|NCT03963895|12028589|FG001|COMPLETED|Follow-up Period (Study Day 14)||11
10863719|NCT03963895|12028590|FG002|COMPLETED|Follow-up Period (Study Day 14)||12
10863720|NCT03963895|12028588|FG000|NOT COMPLETED|Follow-up Period (Study Day 14)||0
10863721|NCT03963895|12028589|FG001|NOT COMPLETED|Follow-up Period (Study Day 14)||1
10863722|NCT03963895|12028590|FG002|NOT COMPLETED|Follow-up Period (Study Day 14)||0
10863723|NCT03924622|12028604|FG000|STARTED|Overall Study||12
10863724|NCT03924622|12028605|FG001|STARTED|Overall Study||12
10863725|NCT03924622|12028606|FG002|STARTED|Overall Study||12
10863726|NCT03924622|12028607|FG003|STARTED|Overall Study||12
10863727|NCT03924622|12028608|FG004|STARTED|Overall Study||12
10863728|NCT03924622|12028609|FG005|STARTED|Overall Study||12
10863729|NCT03924622|12028604|FG000|COMPLETED|Overall Study||10
10863730|NCT03924622|12028605|FG001|COMPLETED|Overall Study||9
10863731|NCT03924622|12028606|FG002|COMPLETED|Overall Study||9
10863732|NCT03924622|12028607|FG003|COMPLETED|Overall Study||8
10863733|NCT03924622|12028608|FG004|COMPLETED|Overall Study||9
10863734|NCT03924622|12028609|FG005|COMPLETED|Overall Study||9
10863735|NCT03924622|12028604|FG000|NOT COMPLETED|Overall Study||2
10863736|NCT03924622|12028605|FG001|NOT COMPLETED|Overall Study||3
10863737|NCT03924622|12028606|FG002|NOT COMPLETED|Overall Study||3
10863738|NCT03924622|12028607|FG003|NOT COMPLETED|Overall Study||4
10863739|NCT03924622|12028608|FG004|NOT COMPLETED|Overall Study||3
10863740|NCT03924622|12028609|FG005|NOT COMPLETED|Overall Study||3
10863741|NCT03905811|12028625|FG000|STARTED|Overall Study||8
10863742|NCT03905811|12028626|FG001|STARTED|Overall Study||5
10863743|NCT03905811|12028625|FG000|COMPLETED|Overall Study||6
10863744|NCT03905811|12028626|FG001|COMPLETED|Overall Study||5
10863745|NCT03905811|12028625|FG000|NOT COMPLETED|Overall Study||2
10863746|NCT03905811|12028626|FG001|NOT COMPLETED|Overall Study||0
10863747|NCT03867396|12028632|FG000|STARTED|Intervention 1||8
10863748|NCT03867396|12028633|FG001|STARTED|Intervention 1||8
10863749|NCT03867396|12028634|FG002|STARTED|Intervention 1||7
10863750|NCT03867396|12028635|FG003|STARTED|Intervention 1||5
10863751|NCT03867396|12028636|FG004|STARTED|Intervention 1||7
10863752|NCT03867396|12028637|FG005|STARTED|Intervention 1||5
10863753|NCT03867396|12028632|FG000|Data Collection|Intervention 1||8
10863754|NCT03867396|12028633|FG001|Data Collection|Intervention 1||5
10863755|NCT03867396|12028634|FG002|Data Collection|Intervention 1||7
10863756|NCT03867396|12028635|FG003|Data Collection|Intervention 1||5
10863757|NCT03867396|12028636|FG004|Data Collection|Intervention 1||0
10863758|NCT03867396|12028637|FG005|Data Collection|Intervention 1||0
10863759|NCT03867396|12028632|FG000|COMPLETED|Intervention 1||8
10863760|NCT03867396|12028633|FG001|COMPLETED|Intervention 1||5
10863761|NCT03867396|12028634|FG002|COMPLETED|Intervention 1||7
10863762|NCT03867396|12028635|FG003|COMPLETED|Intervention 1||5
10863763|NCT03867396|12028636|FG004|COMPLETED|Intervention 1||0
10863764|NCT03867396|12028637|FG005|COMPLETED|Intervention 1||0
10863765|NCT03867396|12028632|FG000|NOT COMPLETED|Intervention 1||0
10863766|NCT03867396|12028633|FG001|NOT COMPLETED|Intervention 1||3
10863767|NCT03867396|12028634|FG002|NOT COMPLETED|Intervention 1||0
10863768|NCT03867396|12028635|FG003|NOT COMPLETED|Intervention 1||0
10863769|NCT03867396|12028636|FG004|NOT COMPLETED|Intervention 1||7
10863770|NCT03867396|12028637|FG005|NOT COMPLETED|Intervention 1||5
10863771|NCT03867396|12028632|FG000|STARTED|Intervention 2||8
10294117|NCT00001566|11426814|FG000|COMPLETED|Overall Study||23
10294118|NCT00001566|11426814|FG000|NOT COMPLETED|Overall Study||19
10294119|NCT00001575|11426818|FG000|STARTED|Overall Study||87
10294120|NCT00001575|11426818|FG000|Treated|Overall Study||65
10294121|NCT00001575|11426818|FG000|COMPLETED|Overall Study||42
10294122|NCT00001575|11426818|FG000|NOT COMPLETED|Overall Study||45
10294123|NCT00001586|11426824|FG000|STARTED|Overall Study||49
10863772|NCT03867396|12028633|FG001|STARTED|Intervention 2||5
10863773|NCT03867396|12028634|FG002|STARTED|Intervention 2||7
10863774|NCT03867396|12028635|FG003|STARTED|Intervention 2||5
10863775|NCT03867396|12028636|FG004|STARTED|Intervention 2||0
10863776|NCT03867396|12028637|FG005|STARTED|Intervention 2||0
10863777|NCT03867396|12028632|FG000|COMPLETED|Intervention 2||8
10863778|NCT03867396|12028633|FG001|COMPLETED|Intervention 2||5
10863779|NCT03867396|12028634|FG002|COMPLETED|Intervention 2||7
10863780|NCT03867396|12028635|FG003|COMPLETED|Intervention 2||5
10863781|NCT03867396|12028636|FG004|COMPLETED|Intervention 2||0
10863782|NCT03867396|12028637|FG005|COMPLETED|Intervention 2||0
10863783|NCT03867396|12028632|FG000|NOT COMPLETED|Intervention 2||0
10863784|NCT03867396|12028633|FG001|NOT COMPLETED|Intervention 2||0
10863785|NCT03867396|12028634|FG002|NOT COMPLETED|Intervention 2||0
10863786|NCT03867396|12028635|FG003|NOT COMPLETED|Intervention 2||0
10863787|NCT03867396|12028636|FG004|NOT COMPLETED|Intervention 2||0
10863788|NCT03867396|12028637|FG005|NOT COMPLETED|Intervention 2||0
10863789|NCT03867396|12028632|FG000|STARTED|Intervention 3||8
10863790|NCT03867396|12028633|FG001|STARTED|Intervention 3||5
10863791|NCT03867396|12028634|FG002|STARTED|Intervention 3||7
10863792|NCT03867396|12028635|FG003|STARTED|Intervention 3||5
10863793|NCT03867396|12028636|FG004|STARTED|Intervention 3||0
10863794|NCT03867396|12028637|FG005|STARTED|Intervention 3||0
10863795|NCT03867396|12028632|FG000|COMPLETED|Intervention 3||8
10863796|NCT03867396|12028633|FG001|COMPLETED|Intervention 3||5
10863797|NCT03867396|12028634|FG002|COMPLETED|Intervention 3||7
10863798|NCT03867396|12028635|FG003|COMPLETED|Intervention 3||5
10863799|NCT03867396|12028636|FG004|COMPLETED|Intervention 3||0
10863800|NCT03867396|12028637|FG005|COMPLETED|Intervention 3||0
10863801|NCT03867396|12028632|FG000|NOT COMPLETED|Intervention 3||0
10863802|NCT03867396|12028633|FG001|NOT COMPLETED|Intervention 3||0
10863803|NCT03867396|12028634|FG002|NOT COMPLETED|Intervention 3||0
10863804|NCT03867396|12028635|FG003|NOT COMPLETED|Intervention 3||0
10863805|NCT03867396|12028636|FG004|NOT COMPLETED|Intervention 3||0
10863806|NCT03867396|12028637|FG005|NOT COMPLETED|Intervention 3||0
10863813|NCT03802513|12028657|FG000|STARTED|Overall Study||10
10863814|NCT03802513|12028657|FG000|COMPLETED|Overall Study||9
10863815|NCT03802513|12028657|FG000|NOT COMPLETED|Overall Study||1
10863828|NCT03576716|12028682|FG000|STARTED|Overall Study||10
10863829|NCT03576716|12028683|FG001|STARTED|Overall Study||9
10863830|NCT03576716|12028682|FG000|COMPLETED|Overall Study||10
10863831|NCT03576716|12028683|FG001|COMPLETED|Overall Study||8
10863832|NCT03576716|12028682|FG000|NOT COMPLETED|Overall Study||0
10863833|NCT03576716|12028683|FG001|NOT COMPLETED|Overall Study||1
10863837|NCT03367819|12028695|FG000|STARTED|Overall Study||24
10863838|NCT03367819|12028696|FG001|STARTED|Overall Study||20
10863839|NCT03367819|12028695|FG000|COMPLETED|Overall Study||0
10863840|NCT03367819|12028696|FG001|COMPLETED|Overall Study||1
10863841|NCT03367819|12028695|FG000|NOT COMPLETED|Overall Study||24
10863842|NCT03367819|12028696|FG001|NOT COMPLETED|Overall Study||19
10863843|NCT03182868|12028712|FG000|STARTED|Overall Study||12
10863844|NCT03182868|12028713|FG001|STARTED|Overall Study||20
10294124|NCT00001586|11426825|FG001|STARTED|Overall Study||56
10294125|NCT00001586|11426824|FG000|COMPLETED|Overall Study||49
10294126|NCT00001586|11426825|FG001|COMPLETED|Overall Study||56
10294127|NCT00001586|11426824|FG000|NOT COMPLETED|Overall Study||0
10294128|NCT00001586|11426825|FG001|NOT COMPLETED|Overall Study||0
10294129|NCT00001596|11426833|FG000|STARTED|Overall Study||23
10294130|NCT00001596|11426834|FG001|STARTED|Overall Study||12
10294131|NCT00001596|11426833|FG000|COMPLETED|Overall Study||6
10294132|NCT00001596|11426834|FG001|COMPLETED|Overall Study||2
10294133|NCT00001596|11426833|FG000|NOT COMPLETED|Overall Study||17
10294134|NCT00001596|11426834|FG001|NOT COMPLETED|Overall Study||10
10294135|NCT00001656|11426842|FG000|STARTED|Overall Study||13
10294136|NCT00001656|11426843|FG001|STARTED|Overall Study||12
10294137|NCT00001656|11426842|FG000|COMPLETED|Overall Study||12
10417182|NCT00798161|11561773|FG006|NOT COMPLETED|Overall Study||10
10417183|NCT00798174|11561789|FG000|STARTED|Overall Study||16
10417184|NCT00798174|11561790|FG001|STARTED|Overall Study||16
10417185|NCT00798174|11561789|FG000|COMPLETED|Overall Study||12
10417186|NCT00798174|11561790|FG001|COMPLETED|Overall Study||13
10417187|NCT00798174|11561789|FG000|NOT COMPLETED|Overall Study||4
10417188|NCT00798174|11561790|FG001|NOT COMPLETED|Overall Study||3
10417189|NCT00798304|11561797|FG000|STARTED|Overall Study||14
10417190|NCT00798304|11561798|FG001|STARTED|Overall Study||22
10417191|NCT00798304|11561799|FG002|STARTED|Overall Study||10
10417192|NCT00798304|11561797|FG000|COMPLETED|Overall Study||0
10417193|NCT00798304|11561798|FG001|COMPLETED|Overall Study||0
10417194|NCT00798304|11561799|FG002|COMPLETED|Overall Study||0
10417195|NCT00798304|11561797|FG000|NOT COMPLETED|Overall Study||14
10417196|NCT00798304|11561798|FG001|NOT COMPLETED|Overall Study||22
10417197|NCT00798304|11561799|FG002|NOT COMPLETED|Overall Study||10
10417198|NCT00798317|11561809|FG000|STARTED|Overall Study||245
10417199|NCT00798317|11561810|FG001|STARTED|Overall Study||81
10294138|NCT00001656|11426843|FG001|COMPLETED|Overall Study||12
10294139|NCT00001656|11426842|FG000|NOT COMPLETED|Overall Study||1
10294140|NCT00001656|11426843|FG001|NOT COMPLETED|Overall Study||0
10294141|NCT00001703|11426849|FG000|STARTED|Overall Study||6
10294142|NCT00001703|11426849|FG000|Peptide Stock Completed|Overall Study|off therapy reason for 3 patients|3
10294143|NCT00001703|11426849|FG000|COMPLETED|Overall Study||1
10294144|NCT00001703|11426849|FG000|NOT COMPLETED|Overall Study||5
10294145|NCT00001723|11426855|FG000|STARTED|Overall Study||100
10294146|NCT00001723|11426856|FG001|STARTED|Overall Study||100
10294147|NCT00001723|11426855|FG000|COMPLETED|Overall Study||87
10294148|NCT00001723|11426856|FG001|COMPLETED|Overall Study||84
10294149|NCT00001723|11426855|FG000|NOT COMPLETED|Overall Study||13
10294150|NCT00001723|11426856|FG001|NOT COMPLETED|Overall Study||16
10294151|NCT00001832|11426880|FG000|STARTED|Apheresis Period||170
10294152|NCT00001832|11426881|FG001|STARTED|Apheresis Period||0
10294153|NCT00001832|11426882|FG002|STARTED|Apheresis Period||0
10294154|NCT00001832|11426883|FG003|STARTED|Apheresis Period||0
10294155|NCT00001832|11426884|FG004|STARTED|Apheresis Period||0
10417200|NCT00798317|11561809|FG000|COMPLETED|Overall Study||235
10417201|NCT00798317|11561810|FG001|COMPLETED|Overall Study||74
10417202|NCT00798317|11561809|FG000|NOT COMPLETED|Overall Study||10
10417203|NCT00798317|11561810|FG001|NOT COMPLETED|Overall Study||7
10863845|NCT03182868|12028714|FG002|STARTED|Overall Study||21
10863846|NCT03182868|12028715|FG003|STARTED|Overall Study||1
10863847|NCT03182868|12028716|FG004|STARTED|Overall Study||24
10863848|NCT03182868|12028712|FG000|COMPLETED|Overall Study||9
10863849|NCT03182868|12028713|FG001|COMPLETED|Overall Study||20
10863850|NCT03182868|12028714|FG002|COMPLETED|Overall Study||17
10863851|NCT03182868|12028715|FG003|COMPLETED|Overall Study||0
10863852|NCT03182868|12028716|FG004|COMPLETED|Overall Study||16
10863853|NCT03182868|12028712|FG000|NOT COMPLETED|Overall Study||3
10863854|NCT03182868|12028713|FG001|NOT COMPLETED|Overall Study||0
10863855|NCT03182868|12028714|FG002|NOT COMPLETED|Overall Study||4
10863856|NCT03182868|12028715|FG003|NOT COMPLETED|Overall Study||1
10863857|NCT03182868|12028716|FG004|NOT COMPLETED|Overall Study||8
10863864|NCT03077620|12028741|FG000|STARTED|Overall Study||14
10863865|NCT03077620|12028742|FG001|STARTED|Overall Study||14
10863866|NCT03077620|12028743|FG002|STARTED|Overall Study||14
10863867|NCT03077620|12028744|FG003|STARTED|Overall Study||6
10863868|NCT03077620|12028741|FG000|COMPLETED|Overall Study||13
10863869|NCT03077620|12028742|FG001|COMPLETED|Overall Study||13
10863870|NCT03077620|12028743|FG002|COMPLETED|Overall Study||12
10863871|NCT03077620|12028744|FG003|COMPLETED|Overall Study||6
10863872|NCT03077620|12028741|FG000|NOT COMPLETED|Overall Study||1
10863873|NCT03077620|12028742|FG001|NOT COMPLETED|Overall Study||1
10863874|NCT03077620|12028743|FG002|NOT COMPLETED|Overall Study||2
10863875|NCT03077620|12028744|FG003|NOT COMPLETED|Overall Study||0
10863876|NCT03027414|12028757|FG000|STARTED|Overall Study||28
10863877|NCT03027414|12028758|FG001|STARTED|Overall Study||0
10863878|NCT03027414|12028759|FG002|STARTED|Overall Study||26
10863879|NCT03027414|12028757|FG000|COMPLETED|Overall Study||19
10863880|NCT03027414|12028758|FG001|COMPLETED|Overall Study||0
10863881|NCT03027414|12028759|FG002|COMPLETED|Overall Study||20
10863882|NCT03027414|12028757|FG000|NOT COMPLETED|Overall Study||9
10863883|NCT03027414|12028758|FG001|NOT COMPLETED|Overall Study||0
10863884|NCT03027414|12028759|FG002|NOT COMPLETED|Overall Study||6
10863885|NCT02951052|12028769|FG000|STARTED|Overall Study||308
10863886|NCT02951052|12028770|FG001|STARTED|Overall Study||308
10863887|NCT02951052|12028769|FG000|COMPLETED|Overall Study||281
10863888|NCT02951052|12028770|FG001|COMPLETED|Overall Study||290
10863889|NCT02951052|12028769|FG000|NOT COMPLETED|Overall Study||27
10863890|NCT02951052|12028770|FG001|NOT COMPLETED|Overall Study||18
10755450|NCT03067987|11919303|FG001|STARTED|Overall Study||53
10755451|NCT03067987|11919302|FG000|COMPLETED|Overall Study||40
10755452|NCT03067987|11919303|FG001|COMPLETED|Overall Study||40
10755453|NCT03067987|11919302|FG000|NOT COMPLETED|Overall Study||10
10755454|NCT03067987|11919303|FG001|NOT COMPLETED|Overall Study||13
10755455|NCT03068091|11919309|FG000|STARTED|Overall Study||25
10755456|NCT03068091|11919309|FG000|COMPLETED|Overall Study||24
10755457|NCT03068091|11919309|FG000|NOT COMPLETED|Overall Study||1
10755458|NCT03068312|11919316|FG000|STARTED|Overall Study||19
10755459|NCT03068312|11919317|FG001|STARTED|Overall Study||19
10755460|NCT03068312|11919316|FG000|COMPLETED|Overall Study||19
10755461|NCT03068312|11919317|FG001|COMPLETED|Overall Study||19
10755462|NCT03068312|11919316|FG000|NOT COMPLETED|Overall Study||0
10755463|NCT03068312|11919317|FG001|NOT COMPLETED|Overall Study||0
10755464|NCT03068455|11919325|FG000|STARTED|Pre-treatment Period||920
10755465|NCT03068455|11919326|FG001|STARTED|Pre-treatment Period||924
10755466|NCT03068455|11919325|FG000|COMPLETED|Pre-treatment Period||916
10755467|NCT03068455|11919326|FG001|COMPLETED|Pre-treatment Period||917
10755468|NCT03068455|11919325|FG000|NOT COMPLETED|Pre-treatment Period||4
10755469|NCT03068455|11919326|FG001|NOT COMPLETED|Pre-treatment Period||7
10755470|NCT03068455|11919325|FG000|STARTED|Treatment Period||916
10755471|NCT03068455|11919326|FG001|STARTED|Treatment Period||917
10755472|NCT03068455|11919325|FG000|COMPLETED|Treatment Period||364
10755473|NCT03068455|11919326|FG001|COMPLETED|Treatment Period||561
10755474|NCT03068455|11919325|FG000|NOT COMPLETED|Treatment Period||552
10755475|NCT03068455|11919326|FG001|NOT COMPLETED|Treatment Period||356
10755476|NCT03068468|11919334|FG000|STARTED|Placebo-Controlled Period||166
10755477|NCT03068468|11919335|FG001|STARTED|Placebo-Controlled Period||324
10755478|NCT03068468|11919336|FG002|STARTED|Placebo-Controlled Period||0
10755479|NCT03068468|11919337|FG003|STARTED|Placebo-Controlled Period||0
10755480|NCT03068468|11919334|FG000|Treated|Placebo-Controlled Period||165
10755481|NCT03068468|11919335|FG001|Treated|Placebo-Controlled Period||321
10755482|NCT03068468|11919336|FG002|Treated|Placebo-Controlled Period||0
10755483|NCT03068468|11919337|FG003|Treated|Placebo-Controlled Period||0
10755484|NCT03068468|11919334|FG000|COMPLETED|Placebo-Controlled Period||144
10755485|NCT03068468|11919335|FG001|COMPLETED|Placebo-Controlled Period||279
10755486|NCT03068468|11919336|FG002|COMPLETED|Placebo-Controlled Period||0
10755487|NCT03068468|11919337|FG003|COMPLETED|Placebo-Controlled Period||0
10755488|NCT03068468|11919334|FG000|NOT COMPLETED|Placebo-Controlled Period||22
10755489|NCT03068468|11919335|FG001|NOT COMPLETED|Placebo-Controlled Period||45
10755490|NCT03068468|11919336|FG002|NOT COMPLETED|Placebo-Controlled Period||0
10755491|NCT03068468|11919337|FG003|NOT COMPLETED|Placebo-Controlled Period||0
10755492|NCT03068468|11919334|FG000|STARTED|Open-Label Extension Period||0
10755493|NCT03068468|11919335|FG001|STARTED|Open-Label Extension Period||0
10755494|NCT03068468|11919336|FG002|STARTED|Open-Label Extension Period|4 participants did not enter OLE period.|140
10755495|NCT03068468|11919337|FG003|STARTED|Open-Label Extension Period|3 participants did not enter OLE period.|276
10755496|NCT03068468|11919334|FG000|COMPLETED|Open-Label Extension Period||0
10755497|NCT03068468|11919335|FG001|COMPLETED|Open-Label Extension Period||0
10755498|NCT03068468|11919336|FG002|COMPLETED|Open-Label Extension Period||0
10755499|NCT03068468|11919337|FG003|COMPLETED|Open-Label Extension Period||0
10755500|NCT03068468|11919334|FG000|NOT COMPLETED|Open-Label Extension Period||0
10755501|NCT03068468|11919335|FG001|NOT COMPLETED|Open-Label Extension Period||0
10755502|NCT03068468|11919336|FG002|NOT COMPLETED|Open-Label Extension Period||140
10755503|NCT03068468|11919337|FG003|NOT COMPLETED|Open-Label Extension Period||276
10755504|NCT03068611|11919347|FG000|STARTED|Overall Study||61
10755505|NCT03068611|11919348|FG001|STARTED|Overall Study||58
10755506|NCT03068611|11919347|FG000|COMPLETED|Overall Study|This is the number of participants followed through 6 months from enrollment.|30
10755507|NCT03068611|11919348|FG001|COMPLETED|Overall Study|This is the number of participants followed through 6 months from enrollment.|33
10755508|NCT03068611|11919347|FG000|NOT COMPLETED|Overall Study||31
10755509|NCT03068611|11919348|FG001|NOT COMPLETED|Overall Study||25
10755510|NCT03068754|11919356|FG000|STARTED|Randomized Treatment Period (RTP)||95
10755511|NCT03068754|11919357|FG001|STARTED|Randomized Treatment Period (RTP)||48
10755512|NCT03068754|11919358|FG002|STARTED|Randomized Treatment Period (RTP)|OLE Arms were not included during the RTP|0
10755513|NCT03068754|11919359|FG003|STARTED|Randomized Treatment Period (RTP)||0
10755514|NCT03068754|11919356|FG000|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||95
10755515|NCT03068754|11919357|FG001|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||48
10755516|NCT03068754|11919358|FG002|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||0
10755517|NCT03068754|11919359|FG003|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||0
10755518|NCT03068754|11919356|FG000|Safety Population|Randomized Treatment Period (RTP)||95
10755519|NCT03068754|11919357|FG001|Safety Population|Randomized Treatment Period (RTP)||47
10755520|NCT03068754|11919358|FG002|Safety Population|Randomized Treatment Period (RTP)||0
10755521|NCT03068754|11919359|FG003|Safety Population|Randomized Treatment Period (RTP)||0
10755522|NCT03068754|11919356|FG000|Modified ITT (mITT)|Randomized Treatment Period (RTP)||93
10755523|NCT03068754|11919357|FG001|Modified ITT (mITT)|Randomized Treatment Period (RTP)||46
10755524|NCT03068754|11919358|FG002|Modified ITT (mITT)|Randomized Treatment Period (RTP)||0
10755525|NCT03068754|11919359|FG003|Modified ITT (mITT)|Randomized Treatment Period (RTP)||0
10863891|NCT02724410|12028782|FG000|STARTED|Overall Study||44
10863892|NCT02724410|12028783|FG001|STARTED|Overall Study||38
10863893|NCT02724410|12028782|FG000|COMPLETED|Overall Study||44
10863894|NCT02724410|12028783|FG001|COMPLETED|Overall Study||38
10863895|NCT02724410|12028782|FG000|NOT COMPLETED|Overall Study||0
10863896|NCT02724410|12028783|FG001|NOT COMPLETED|Overall Study||0
10863897|NCT02598583|12028791|FG000|STARTED|Primary Evaluation Period||6
10863898|NCT02598583|12028792|FG001|STARTED|Primary Evaluation Period||7
10863899|NCT02598583|12028791|FG000|COMPLETED|Primary Evaluation Period||6
10863900|NCT02598583|12028792|FG001|COMPLETED|Primary Evaluation Period||7
10863901|NCT02598583|12028791|FG000|NOT COMPLETED|Primary Evaluation Period||0
10863902|NCT02598583|12028792|FG001|NOT COMPLETED|Primary Evaluation Period||0
10863903|NCT02598583|12028791|FG000|STARTED|Extension Period||6
10863904|NCT02598583|12028792|FG001|STARTED|Extension Period||7
10863905|NCT02598583|12028791|FG000|COMPLETED|Extension Period||5
10863906|NCT02598583|12028792|FG001|COMPLETED|Extension Period||7
10863907|NCT02598583|12028791|FG000|NOT COMPLETED|Extension Period||1
10863908|NCT02598583|12028792|FG001|NOT COMPLETED|Extension Period||0
10863909|NCT02550093|12028798|FG000|STARTED|Intervention 1||10
10863910|NCT02550093|12028799|FG001|STARTED|Intervention 1||10
10863911|NCT02550093|12028798|FG000|COMPLETED|Intervention 1||10
10863912|NCT02550093|12028799|FG001|COMPLETED|Intervention 1||10
10863913|NCT02550093|12028798|FG000|NOT COMPLETED|Intervention 1||0
10863914|NCT02550093|12028799|FG001|NOT COMPLETED|Intervention 1||0
10863915|NCT02550093|12028798|FG000|STARTED|Wash-out Period||10
10863916|NCT02550093|12028799|FG001|STARTED|Wash-out Period||10
10863917|NCT02550093|12028798|FG000|COMPLETED|Wash-out Period||10
10863918|NCT02550093|12028799|FG001|COMPLETED|Wash-out Period||10
10863919|NCT02550093|12028798|FG000|NOT COMPLETED|Wash-out Period||0
10863920|NCT02550093|12028799|FG001|NOT COMPLETED|Wash-out Period||0
10863921|NCT02550093|12028798|FG000|STARTED|Intervention 2||10
10863922|NCT02550093|12028799|FG001|STARTED|Intervention 2||10
10863923|NCT02550093|12028798|FG000|COMPLETED|Intervention 2||10
10863924|NCT02550093|12028799|FG001|COMPLETED|Intervention 2||10
10863925|NCT02550093|12028798|FG000|NOT COMPLETED|Intervention 2||0
10863926|NCT02550093|12028799|FG001|NOT COMPLETED|Intervention 2||0
10863927|NCT02536794|12028807|FG000|STARTED|Reached 1st Response Assessment||30
10863928|NCT02536794|12028807|FG000|Started Treatment|Reached 1st Response Assessment||30
10863929|NCT02536794|12028807|FG000|Attempted First Cycle|Reached 1st Response Assessment||30
10863930|NCT02536794|12028807|FG000|Attempted Second Cycle|Reached 1st Response Assessment||24
10863931|NCT02536794|12028807|FG000|Reached First Response|Reached 1st Response Assessment||24
10863932|NCT02536794|12028807|FG000|COMPLETED|Reached 1st Response Assessment||24
10863933|NCT02536794|12028807|FG000|NOT COMPLETED|Reached 1st Response Assessment||6
10863934|NCT02536794|12028807|FG000|STARTED|Continued Treatment After 1st Response||24
10863935|NCT02536794|12028807|FG000|Went on to Start Cycle 3|Continued Treatment After 1st Response||16
10863936|NCT02536794|12028807|FG000|COMPLETED|Continued Treatment After 1st Response||16
10863937|NCT02536794|12028807|FG000|NOT COMPLETED|Continued Treatment After 1st Response||8
10863938|NCT02536794|12028807|FG000|STARTED|Follow up for 3 Years or Death|one patient did not go into follow up as treatment was discontinued due to a protocol violation|29
10863939|NCT02536794|12028807|FG000|COMPLETED|Follow up for 3 Years or Death||29
10863940|NCT02536794|12028807|FG000|NOT COMPLETED|Follow up for 3 Years or Death||0
10863941|NCT02463773|12028811|FG000|STARTED|Overall Study||14
10863942|NCT02463773|12028811|FG000|COMPLETED|Overall Study||14
10863943|NCT02463773|12028811|FG000|NOT COMPLETED|Overall Study||0
10863944|NCT02356575|12028817|FG000|STARTED|Overall Study||80
10863945|NCT02356575|12028818|FG001|STARTED|Overall Study||80
10863946|NCT02356575|12028817|FG000|COMPLETED|Overall Study||80
10863947|NCT02356575|12028818|FG001|COMPLETED|Overall Study||80
10863948|NCT02356575|12028817|FG000|NOT COMPLETED|Overall Study||0
10863949|NCT02356575|12028818|FG001|NOT COMPLETED|Overall Study||0
10863950|NCT02285114|12028827|FG000|STARTED|Overall Study||29
10863951|NCT02285114|12028828|FG001|STARTED|Overall Study||9
10863952|NCT02285114|12028829|FG002|STARTED|Overall Study||3
10863953|NCT02285114|12028827|FG000|COMPLETED|Overall Study||7
10863954|NCT02285114|12028828|FG001|COMPLETED|Overall Study||2
10863955|NCT02285114|12028829|FG002|COMPLETED|Overall Study||0
10863956|NCT02285114|12028827|FG000|NOT COMPLETED|Overall Study||22
10863957|NCT02285114|12028828|FG001|NOT COMPLETED|Overall Study||7
10863958|NCT02285114|12028829|FG002|NOT COMPLETED|Overall Study||3
10863959|NCT02263508|12028846|FG000|STARTED|Overall Study||21
10863960|NCT02263508|12028847|FG001|STARTED|Overall Study||346
10863961|NCT02263508|12028848|FG002|STARTED|Overall Study||346
10863962|NCT02263508|12028846|FG000|Received Talimogene Laherparepvec/Placebo|Overall Study||21
10863963|NCT02263508|12028847|FG001|Received Talimogene Laherparepvec/Placebo|Overall Study||345
10863964|NCT02263508|12028848|FG002|Received Talimogene Laherparepvec/Placebo|Overall Study||343
10863965|NCT02263508|12028846|FG000|Received Pembrolizumab|Overall Study||21
10863966|NCT02263508|12028847|FG001|Received Pembrolizumab|Overall Study||345
10863967|NCT02263508|12028848|FG002|Received Pembrolizumab|Overall Study||343
10863968|NCT02263508|12028846|FG000|COMPLETED|Overall Study||0
10863969|NCT02263508|12028847|FG001|COMPLETED|Overall Study||0
10863970|NCT02263508|12028848|FG002|COMPLETED|Overall Study||0
10863971|NCT02263508|12028846|FG000|NOT COMPLETED|Overall Study||21
10863972|NCT02263508|12028847|FG001|NOT COMPLETED|Overall Study||346
10863973|NCT02263508|12028848|FG002|NOT COMPLETED|Overall Study||346
10863974|NCT02246530|12028861|FG000|STARTED|Overall Study||9
10863975|NCT02246530|12028862|FG001|STARTED|Overall Study||2
10863976|NCT02246530|12028861|FG000|COMPLETED|Overall Study||5
10863977|NCT02246530|12028862|FG001|COMPLETED|Overall Study||2
10863978|NCT02246530|12028861|FG000|NOT COMPLETED|Overall Study||4
10863979|NCT02246530|12028862|FG001|NOT COMPLETED|Overall Study||0
10863980|NCT02002819|12028870|FG000|STARTED|Overall Study||17
10863981|NCT02002819|12028871|FG001|STARTED|Overall Study||17
10863982|NCT02002819|12028870|FG000|COMPLETED|Overall Study|4 Discontinued intervention because of participant's decision|13
10863983|NCT02002819|12028871|FG001|COMPLETED|Overall Study|"1 Discontinued intervention because of participant's decision~1 Excluded per protocol because of biomarkers inconsistent with AD"|15
10863984|NCT02002819|12028870|FG000|NOT COMPLETED|Overall Study||4
10863985|NCT02002819|12028871|FG001|NOT COMPLETED|Overall Study||2
10863986|NCT01936857|12028895|FG000|STARTED|Overall Study||141
10863987|NCT01936857|12028896|FG001|STARTED|Overall Study||140
10863988|NCT01936857|12028895|FG000|COMPLETED|Overall Study||107
10863989|NCT01936857|12028896|FG001|COMPLETED|Overall Study||115
10863990|NCT01936857|12028895|FG000|NOT COMPLETED|Overall Study||34
10863991|NCT01936857|12028896|FG001|NOT COMPLETED|Overall Study||25
10863992|NCT01865539|12028904|FG000|STARTED|Overall Study||21
10863993|NCT01865539|12028905|FG001|STARTED|Overall Study||30
10863994|NCT01865539|12028904|FG000|COMPLETED|Overall Study||21
10863995|NCT01865539|12028905|FG001|COMPLETED|Overall Study||30
10863996|NCT01865539|12028904|FG000|NOT COMPLETED|Overall Study||0
10863997|NCT01865539|12028905|FG001|NOT COMPLETED|Overall Study||0
10863998|NCT01715285|12028913|FG000|STARTED|Treatment Period||597
10863999|NCT01715285|12028914|FG001|STARTED|Treatment Period||602
10864000|NCT01715285|12028915|FG002|STARTED|Treatment Period||0
10864001|NCT01715285|12028913|FG000|ITT Population|Treatment Period||597
10864002|NCT01715285|12028914|FG001|ITT Population|Treatment Period||602
10864003|NCT01715285|12028915|FG002|ITT Population|Treatment Period||0
10864004|NCT01715285|12028913|FG000|Safety Population|Treatment Period||597
10864005|NCT01715285|12028914|FG001|Safety Population|Treatment Period||602
10864006|NCT01715285|12028915|FG002|Safety Population|Treatment Period||0
10864007|NCT01715285|12028913|FG000|COMPLETED|Treatment Period||0
10864008|NCT01715285|12028914|FG001|COMPLETED|Treatment Period||0
10864009|NCT01715285|12028915|FG002|COMPLETED|Treatment Period||0
10864010|NCT01715285|12028913|FG000|NOT COMPLETED|Treatment Period||597
10864011|NCT01715285|12028914|FG001|NOT COMPLETED|Treatment Period||602
10864012|NCT01715285|12028915|FG002|NOT COMPLETED|Treatment Period||0
10864013|NCT01715285|12028913|FG000|STARTED|Open-label (OL) Extension Phase||157
10864014|NCT01715285|12028914|FG001|STARTED|Open-label (OL) Extension Phase||0
10864015|NCT01715285|12028915|FG002|STARTED|Open-label (OL) Extension Phase||72
10864016|NCT01715285|12028913|FG000|COMPLETED|Open-label (OL) Extension Phase||0
10864017|NCT01715285|12028914|FG001|COMPLETED|Open-label (OL) Extension Phase||0
10417204|NCT00798369|11561822|FG000|STARTED|Overall Study||28
10417205|NCT00798369|11561823|FG001|STARTED|Overall Study||29
10417206|NCT00798369|11561824|FG002|STARTED|Overall Study||29
10417207|NCT00798369|11561825|FG003|STARTED|Overall Study||29
10417208|NCT00798369|11561826|FG004|STARTED|Overall Study||28
10417209|NCT00798369|11561827|FG005|STARTED|Overall Study||57
10417210|NCT00798369|11561822|FG000|COMPLETED|Overall Study||27
10417211|NCT00798369|11561823|FG001|COMPLETED|Overall Study||28
10417212|NCT00798369|11561824|FG002|COMPLETED|Overall Study||27
10417213|NCT00798369|11561825|FG003|COMPLETED|Overall Study||28
10417214|NCT00798369|11561826|FG004|COMPLETED|Overall Study||27
10417215|NCT00798369|11561827|FG005|COMPLETED|Overall Study||54
10417216|NCT00798369|11561822|FG000|NOT COMPLETED|Overall Study||1
10417217|NCT00798369|11561823|FG001|NOT COMPLETED|Overall Study||1
10417218|NCT00798369|11561824|FG002|NOT COMPLETED|Overall Study||2
10417219|NCT00798369|11561825|FG003|NOT COMPLETED|Overall Study||1
10417220|NCT00798369|11561826|FG004|NOT COMPLETED|Overall Study||1
10417221|NCT00798369|11561827|FG005|NOT COMPLETED|Overall Study||3
10417222|NCT00798434|11561844|FG000|STARTED|Double-Blind||396
10417223|NCT00798434|11561845|FG001|STARTED|Double-Blind||398
10417224|NCT00798434|11561844|FG000|Received Treatment|Double-Blind||393
10417225|NCT00798434|11561845|FG001|Received Treatment|Double-Blind||392
10417226|NCT00798434|11561844|FG000|COMPLETED|Double-Blind||341
10417227|NCT00798434|11561845|FG001|COMPLETED|Double-Blind||314
10417228|NCT00798434|11561844|FG000|NOT COMPLETED|Double-Blind||55
10417229|NCT00798434|11561845|FG001|NOT COMPLETED|Double-Blind||84
10417230|NCT00798434|11561844|FG000|STARTED|Open-Label||341
10417231|NCT00798434|11561845|FG001|STARTED|Open-Label||314
10417232|NCT00798434|11561844|FG000|Received Treatment|Open-Label||341
10417233|NCT00798434|11561845|FG001|Received Treatment|Open-Label||313
10417234|NCT00798434|11561844|FG000|COMPLETED|Open-Label||299
10417235|NCT00798434|11561845|FG001|COMPLETED|Open-Label||282
10417236|NCT00798434|11561844|FG000|NOT COMPLETED|Open-Label||42
10417237|NCT00798434|11561845|FG001|NOT COMPLETED|Open-Label||32
10417238|NCT00798486|11561856|FG000|STARTED|Overall Study||110
10417239|NCT00798486|11561856|FG000|COMPLETED|Overall Study||110
10417240|NCT00798486|11561856|FG000|NOT COMPLETED|Overall Study||0
10417241|NCT00798577|11561862|FG000|STARTED|Overall Study||17
10417242|NCT00798577|11561863|FG001|STARTED|Overall Study||7
10417243|NCT00798577|11561862|FG000|COMPLETED|Overall Study||17
10417244|NCT00798577|11561863|FG001|COMPLETED|Overall Study||7
10417245|NCT00798577|11561862|FG000|NOT COMPLETED|Overall Study||0
10417246|NCT00798577|11561863|FG001|NOT COMPLETED|Overall Study||0
10864018|NCT01715285|12028915|FG002|COMPLETED|Open-label (OL) Extension Phase||0
10864019|NCT01715285|12028913|FG000|NOT COMPLETED|Open-label (OL) Extension Phase||157
10864020|NCT01715285|12028914|FG001|NOT COMPLETED|Open-label (OL) Extension Phase||0
10417247|NCT00798603|11561869|FG000|STARTED|Overall Study||62
10417248|NCT00798603|11561869|FG000|COMPLETED|Overall Study||27
10864021|NCT01715285|12028915|FG002|NOT COMPLETED|Open-label (OL) Extension Phase||72
10864046|NCT04585776|12028940|FG000|STARTED|Overall Study||31
10864047|NCT04585776|12028940|FG000|Received Atleast 1 Dose of Study Drug|Overall Study||31
10864048|NCT04585776|12028940|FG000|COMPLETED|Overall Study||31
10864049|NCT04585776|12028940|FG000|NOT COMPLETED|Overall Study||0
10864050|NCT04209725|12028944|FG000|STARTED|Overall Study||1
10864051|NCT04209725|12028944|FG000|COMPLETED|Overall Study||0
10864052|NCT04209725|12028944|FG000|NOT COMPLETED|Overall Study||1
10864053|NCT04185909|12028948|FG000|STARTED|Overall Study||55
10864054|NCT04185909|12028948|FG000|COMPLETED|Overall Study||54
10864055|NCT04185909|12028948|FG000|NOT COMPLETED|Overall Study||1
10864056|NCT04076943|12028952|FG000|STARTED|Overall Study||92
10864057|NCT04076943|12028952|FG000|Received at Least 1 Dose of Study Drug|Overall Study||92
10864058|NCT04076943|12028952|FG000|COMPLETED|Overall Study||58
10864059|NCT04076943|12028952|FG000|NOT COMPLETED|Overall Study||34
10864060|NCT03982043|12028958|FG000|STARTED|Overall Study||43
10864061|NCT03982043|12028959|FG001|STARTED|Overall Study||4
10864062|NCT03982043|12028958|FG000|COMPLETED|Overall Study||43
10864063|NCT03982043|12028959|FG001|COMPLETED|Overall Study||4
10864064|NCT03982043|12028958|FG000|NOT COMPLETED|Overall Study||0
10864065|NCT03982043|12028959|FG001|NOT COMPLETED|Overall Study||0
10864066|NCT03332498|12028969|FG000|STARTED|Overall Study||4
10864067|NCT03332498|12028970|FG001|STARTED|Overall Study||4
10864068|NCT03332498|12028971|FG002|STARTED|Overall Study||32
10864069|NCT03332498|12028969|FG000|COMPLETED|Overall Study||4
10864070|NCT03332498|12028970|FG001|COMPLETED|Overall Study||4
10864071|NCT03332498|12028971|FG002|COMPLETED|Overall Study||30
10864072|NCT03332498|12028969|FG000|NOT COMPLETED|Overall Study||0
10864073|NCT03332498|12028970|FG001|NOT COMPLETED|Overall Study||0
10864074|NCT03332498|12028971|FG002|NOT COMPLETED|Overall Study||2
10864081|NCT02900976|12028989|FG000|STARTED|Overall Study||2
10864082|NCT02900976|12028990|FG001|STARTED|Overall Study||16
10864083|NCT02900976|12028989|FG000|COMPLETED|Overall Study||2
10864084|NCT02900976|12028990|FG001|COMPLETED|Overall Study||7
10864085|NCT02900976|12028989|FG000|NOT COMPLETED|Overall Study||0
10864086|NCT02900976|12028990|FG001|NOT COMPLETED|Overall Study||9
10864087|NCT02807350|12028999|FG000|STARTED|Overall Study||196
10864088|NCT02807350|12029000|FG001|STARTED|Overall Study||190
10864089|NCT02807350|12028999|FG000|6 mo Follow Up Visit|Overall Study||188
10864090|NCT02807350|12029000|FG001|6 mo Follow Up Visit|Overall Study||171
10864091|NCT02807350|12028999|FG000|12 mo Follow Up Visit|Overall Study||189
10864092|NCT02807350|12029000|FG001|12 mo Follow Up Visit|Overall Study||169
10864093|NCT02807350|12028999|FG000|15 mo Follow Up Visit|Overall Study||180
10864094|NCT02807350|12029000|FG001|15 mo Follow Up Visit|Overall Study||153
10864095|NCT02807350|12028999|FG000|COMPLETED|Overall Study||176
10864096|NCT02807350|12029000|FG001|COMPLETED|Overall Study||155
10864097|NCT02807350|12028999|FG000|NOT COMPLETED|Overall Study||20
10864098|NCT02807350|12029000|FG001|NOT COMPLETED|Overall Study||35
10864099|NCT02720185|12029006|FG000|STARTED|Overall Study||5
10864100|NCT02720185|12029006|FG000|COMPLETED|Overall Study||4
10864101|NCT02720185|12029006|FG000|NOT COMPLETED|Overall Study||1
10864102|NCT02710669|12029013|FG000|STARTED|Overall Study||85
10864103|NCT02710669|12029014|FG001|STARTED|Overall Study||86
10864104|NCT02710669|12029015|FG002|STARTED|Overall Study||21
10864105|NCT02710669|12029013|FG000|COMPLETED|Overall Study||71
10864106|NCT02710669|12029014|FG001|COMPLETED|Overall Study||75
10864107|NCT02710669|12029015|FG002|COMPLETED|Overall Study||19
10864108|NCT02710669|12029013|FG000|NOT COMPLETED|Overall Study||14
10864109|NCT02710669|12029014|FG001|NOT COMPLETED|Overall Study||11
10864110|NCT02710669|12029015|FG002|NOT COMPLETED|Overall Study||2
10864111|NCT02684461|12029026|FG000|STARTED|Overall Study||7
10864112|NCT02684461|12029027|FG001|STARTED|Overall Study||7
10864113|NCT02684461|12029028|FG002|STARTED|Overall Study||6
10864114|NCT02684461|12029026|FG000|COMPLETED|Overall Study||5
10864115|NCT02684461|12029027|FG001|COMPLETED|Overall Study||5
10864116|NCT02684461|12029028|FG002|COMPLETED|Overall Study||6
10864117|NCT02684461|12029026|FG000|NOT COMPLETED|Overall Study||2
10864118|NCT02684461|12029027|FG001|NOT COMPLETED|Overall Study||2
10864119|NCT02684461|12029028|FG002|NOT COMPLETED|Overall Study||0
10294156|NCT00001832|11426885|FG005|STARTED|Apheresis Period||0
10294157|NCT00001832|11426886|FG006|STARTED|Apheresis Period||0
10864138|NCT02368132|12029070|FG000|STARTED|Overall Study||112
10864139|NCT02368132|12029071|FG001|STARTED|Overall Study||122
10864140|NCT02368132|12029072|FG002|STARTED|Overall Study||85
10864141|NCT02368132|12029070|FG000|COMPLETED|Overall Study||32
10864142|NCT02368132|12029071|FG001|COMPLETED|Overall Study||71
10864143|NCT02368132|12029072|FG002|COMPLETED|Overall Study||50
10864144|NCT02368132|12029070|FG000|NOT COMPLETED|Overall Study||80
10864145|NCT02368132|12029071|FG001|NOT COMPLETED|Overall Study||51
10864146|NCT02368132|12029072|FG002|NOT COMPLETED|Overall Study||35
10755526|NCT03068754|11919356|FG000|Completed Taper|Randomized Treatment Period (RTP)||58
10755527|NCT03068754|11919357|FG001|Completed Taper|Randomized Treatment Period (RTP)||28
10755528|NCT03068754|11919358|FG002|Completed Taper|Randomized Treatment Period (RTP)||0
10755529|NCT03068754|11919359|FG003|Completed Taper|Randomized Treatment Period (RTP)||0
10755530|NCT03068754|11919356|FG000|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||28
10755531|NCT03068754|11919357|FG001|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||9
10755532|NCT03068754|11919358|FG002|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||0
10755533|NCT03068754|11919359|FG003|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||0
10755534|NCT03068754|11919356|FG000|Completed RTP|Randomized Treatment Period (RTP)||27
10294158|NCT00001832|11426887|FG007|STARTED|Apheresis Period||0
10294159|NCT00001832|11426888|FG008|STARTED|Apheresis Period||0
10294160|NCT00001832|11426889|FG009|STARTED|Apheresis Period||0
10294161|NCT00001832|11426890|FG010|STARTED|Apheresis Period||0
10294162|NCT00001832|11426891|FG011|STARTED|Apheresis Period||0
10294163|NCT00001832|11426892|FG012|STARTED|Apheresis Period||0
10294164|NCT00001832|11426893|FG013|STARTED|Apheresis Period||0
10294165|NCT00001832|11426894|FG014|STARTED|Apheresis Period||0
10294166|NCT00001832|11426880|FG000|COMPLETED|Apheresis Period||110
10294167|NCT00001832|11426881|FG001|COMPLETED|Apheresis Period||0
10294168|NCT00001832|11426882|FG002|COMPLETED|Apheresis Period||0
10294169|NCT00001832|11426883|FG003|COMPLETED|Apheresis Period||0
10417249|NCT00798603|11561869|FG000|NOT COMPLETED|Overall Study||35
10417250|NCT00798655|11561873|FG000|STARTED|Overall Study||46
10864165|NCT01119807|12029112|FG000|STARTED|Overall Study||67
10864166|NCT01119807|12029113|FG001|STARTED|Overall Study||51
10864167|NCT01119807|12029114|FG002|STARTED|Overall Study||64
10864168|NCT01119807|12029112|FG000|COMPLETED|Overall Study||67
10864169|NCT01119807|12029113|FG001|COMPLETED|Overall Study||51
10864170|NCT01119807|12029114|FG002|COMPLETED|Overall Study||64
10864171|NCT01119807|12029112|FG000|NOT COMPLETED|Overall Study||0
10864172|NCT01119807|12029113|FG001|NOT COMPLETED|Overall Study||0
10864173|NCT01119807|12029114|FG002|NOT COMPLETED|Overall Study||0
10864174|NCT01295944|12029122|FG000|STARTED|Overall Study||35
10864175|NCT01295944|12029122|FG000|COMPLETED|Overall Study||17
10864176|NCT01295944|12029122|FG000|NOT COMPLETED|Overall Study||18
10864177|NCT01285557|12029128|FG000|STARTED|Overall Study||239
10864178|NCT01285557|12029129|FG001|STARTED|Overall Study||122
10864179|NCT01285557|12029128|FG000|Treated|Overall Study||238
10864180|NCT01285557|12029129|FG001|Treated|Overall Study||121
10864181|NCT01285557|12029128|FG000|As Treated (AT) Population|Overall Study||230
10864182|NCT01285557|12029129|FG001|As Treated (AT) Population|Overall Study||118
10864183|NCT01285557|12029128|FG000|COMPLETED|Overall Study||0
10864184|NCT01285557|12029129|FG001|COMPLETED|Overall Study||0
10864185|NCT01285557|12029128|FG000|NOT COMPLETED|Overall Study||239
10864186|NCT01285557|12029129|FG001|NOT COMPLETED|Overall Study||122
10864187|NCT01032603|12029137|FG000|STARTED|Overall Study||101
10864188|NCT01032603|12029138|FG001|STARTED|Overall Study||96
10864189|NCT01032603|12029137|FG000|COMPLETED|Overall Study||86
10864190|NCT01032603|12029138|FG001|COMPLETED|Overall Study||77
10864191|NCT01032603|12029137|FG000|NOT COMPLETED|Overall Study||15
10864192|NCT01032603|12029138|FG001|NOT COMPLETED|Overall Study||19
10864193|NCT00977691|12029147|FG000|STARTED|Overall Study||3
10864194|NCT00977691|12029148|FG001|STARTED|Overall Study||8
10864195|NCT00977691|12029149|FG002|STARTED|Overall Study||12
10864196|NCT00977691|12029147|FG000|COMPLETED|Overall Study||3
10864197|NCT00977691|12029148|FG001|COMPLETED|Overall Study||7
10864198|NCT00977691|12029149|FG002|COMPLETED|Overall Study||12
10864199|NCT00977691|12029147|FG000|NOT COMPLETED|Overall Study||0
10864200|NCT00977691|12029148|FG001|NOT COMPLETED|Overall Study||1
10864201|NCT00977691|12029149|FG002|NOT COMPLETED|Overall Study||0
10864202|NCT00964002|12029159|FG000|STARTED|Overall Study||61
10864203|NCT00964002|12029159|FG000|Assessable for Safety|Overall Study|59 patients were assessable for safety, they received treatment at least once.|59
10864204|NCT00964002|12029159|FG000|COMPLETED|Overall Study||53
10864205|NCT00964002|12029159|FG000|NOT COMPLETED|Overall Study||8
10864206|NCT00887783|12029165|FG000|STARTED|Overall Study||58
10864207|NCT00887783|12029166|FG001|STARTED|Overall Study||59
10864208|NCT00887783|12029165|FG000|COMPLETED|Overall Study||58
10864209|NCT00887783|12029166|FG001|COMPLETED|Overall Study||59
10864210|NCT00887783|12029165|FG000|NOT COMPLETED|Overall Study||0
10864211|NCT00887783|12029166|FG001|NOT COMPLETED|Overall Study||0
10864212|NCT00790218|12029172|FG000|STARTED|Overall Study||6
10864213|NCT00790218|12029173|FG001|STARTED|Overall Study||6
10864214|NCT00790218|12029174|FG002|STARTED|Overall Study||7
10864215|NCT00790218|12029172|FG000|COMPLETED|Overall Study||5
10864216|NCT00790218|12029173|FG001|COMPLETED|Overall Study||6
10864217|NCT00790218|12029174|FG002|COMPLETED|Overall Study||7
10864218|NCT00790218|12029172|FG000|NOT COMPLETED|Overall Study||1
10864219|NCT00790218|12029173|FG001|NOT COMPLETED|Overall Study||0
10864220|NCT00790218|12029174|FG002|NOT COMPLETED|Overall Study||0
10864221|NCT00583778|12029184|FG000|STARTED|Overall Study||74
10864222|NCT00583778|12029185|FG001|STARTED|Overall Study||67
10864223|NCT00583778|12029184|FG000|COMPLETED|Overall Study||74
10864224|NCT00583778|12029185|FG001|COMPLETED|Overall Study||67
10864225|NCT00583778|12029184|FG000|NOT COMPLETED|Overall Study||0
10864226|NCT00583778|12029185|FG001|NOT COMPLETED|Overall Study||0
10864227|NCT00432094|12029191|FG000|STARTED|Overall Study||14
10864228|NCT00432094|12029192|FG001|STARTED|Overall Study||9
10864229|NCT00432094|12029191|FG000|COMPLETED|Overall Study||14
10864230|NCT00432094|12029192|FG001|COMPLETED|Overall Study||9
10864231|NCT00432094|12029191|FG000|NOT COMPLETED|Overall Study||0
10864232|NCT00432094|12029192|FG001|NOT COMPLETED|Overall Study||0
10864233|NCT00416351|12029202|FG000|STARTED|Overall Study||1
10864234|NCT00416351|12029203|FG001|STARTED|Overall Study||3
10864235|NCT00416351|12029204|FG002|STARTED|Overall Study||4
10864236|NCT00416351|12029205|FG003|STARTED|Overall Study||17
10864237|NCT00416351|12029206|FG004|STARTED|Overall Study||4
10864238|NCT00416351|12029202|FG000|COMPLETED|Overall Study||1
10864239|NCT00416351|12029203|FG001|COMPLETED|Overall Study||3
10864240|NCT00416351|12029204|FG002|COMPLETED|Overall Study||4
10864241|NCT00416351|12029205|FG003|COMPLETED|Overall Study||17
10864242|NCT00416351|12029206|FG004|COMPLETED|Overall Study||4
10864243|NCT00416351|12029202|FG000|NOT COMPLETED|Overall Study||0
10864244|NCT00416351|12029203|FG001|NOT COMPLETED|Overall Study||0
10864245|NCT00416351|12029204|FG002|NOT COMPLETED|Overall Study||0
10864246|NCT00416351|12029205|FG003|NOT COMPLETED|Overall Study||0
10864247|NCT00416351|12029206|FG004|NOT COMPLETED|Overall Study||0
10864248|NCT00145600|12029227|FG000|STARTED|Overall Study||91
10864249|NCT00145600|12029228|FG001|STARTED|Overall Study||46
10864250|NCT00145600|12029229|FG002|STARTED|Overall Study||13
10864251|NCT00145600|12029230|FG003|STARTED|Overall Study||146
10864252|NCT00145600|12029227|FG000|COMPLETED|Overall Study||83
10864253|NCT00145600|12029228|FG001|COMPLETED|Overall Study||36
10864254|NCT00145600|12029229|FG002|COMPLETED|Overall Study||8
10864255|NCT00145600|12029230|FG003|COMPLETED|Overall Study||130
10864256|NCT00145600|12029227|FG000|NOT COMPLETED|Overall Study||8
10864257|NCT00145600|12029228|FG001|NOT COMPLETED|Overall Study||10
10864258|NCT00145600|12029229|FG002|NOT COMPLETED|Overall Study||5
10864259|NCT00145600|12029230|FG003|NOT COMPLETED|Overall Study||16
10864260|NCT00072358|12029254|FG000|STARTED|Overall Study||291
10864261|NCT00072358|12029254|FG000|COMPLETED|Overall Study||291
10864262|NCT00072358|12029254|FG000|NOT COMPLETED|Overall Study||0
10294170|NCT00001832|11426884|FG004|COMPLETED|Apheresis Period||0
10294171|NCT00001832|11426885|FG005|COMPLETED|Apheresis Period||0
10294172|NCT00001832|11426886|FG006|COMPLETED|Apheresis Period||0
10294173|NCT00001832|11426887|FG007|COMPLETED|Apheresis Period||0
10294174|NCT00001832|11426888|FG008|COMPLETED|Apheresis Period||0
10294175|NCT00001832|11426889|FG009|COMPLETED|Apheresis Period||0
10294176|NCT00001832|11426890|FG010|COMPLETED|Apheresis Period||0
10294177|NCT00001832|11426891|FG011|COMPLETED|Apheresis Period||0
10294178|NCT00001832|11426892|FG012|COMPLETED|Apheresis Period||0
10294179|NCT00001832|11426893|FG013|COMPLETED|Apheresis Period||0
10294180|NCT00001832|11426894|FG014|COMPLETED|Apheresis Period||0
10294181|NCT00001832|11426880|FG000|NOT COMPLETED|Apheresis Period||60
10294182|NCT00001832|11426881|FG001|NOT COMPLETED|Apheresis Period||0
10294183|NCT00001832|11426882|FG002|NOT COMPLETED|Apheresis Period||0
10294184|NCT00001832|11426883|FG003|NOT COMPLETED|Apheresis Period||0
10294185|NCT00001832|11426884|FG004|NOT COMPLETED|Apheresis Period||0
10294186|NCT00001832|11426885|FG005|NOT COMPLETED|Apheresis Period||0
10294187|NCT00001832|11426886|FG006|NOT COMPLETED|Apheresis Period||0
10294188|NCT00001832|11426887|FG007|NOT COMPLETED|Apheresis Period||0
10294189|NCT00001832|11426888|FG008|NOT COMPLETED|Apheresis Period||0
10294190|NCT00001832|11426889|FG009|NOT COMPLETED|Apheresis Period||0
10294191|NCT00001832|11426890|FG010|NOT COMPLETED|Apheresis Period||0
10294192|NCT00001832|11426891|FG011|NOT COMPLETED|Apheresis Period||0
10294193|NCT00001832|11426892|FG012|NOT COMPLETED|Apheresis Period||0
10294194|NCT00001832|11426893|FG013|NOT COMPLETED|Apheresis Period||0
10294195|NCT00001832|11426894|FG014|NOT COMPLETED|Apheresis Period||0
10294196|NCT00001832|11426880|FG000|STARTED|Treatment Period||0
10294197|NCT00001832|11426881|FG001|STARTED|Treatment Period||3
10294198|NCT00001832|11426882|FG002|STARTED|Treatment Period||3
10294199|NCT00001832|11426883|FG003|STARTED|Treatment Period||3
10294200|NCT00001832|11426884|FG004|STARTED|Treatment Period||6
10294201|NCT00001832|11426885|FG005|STARTED|Treatment Period||51
10294202|NCT00001832|11426886|FG006|STARTED|Treatment Period||4
10294203|NCT00001832|11426887|FG007|STARTED|Treatment Period||7
10294204|NCT00001832|11426888|FG008|STARTED|Treatment Period||8
10294205|NCT00001832|11426889|FG009|STARTED|Treatment Period||6
10294206|NCT00001832|11426890|FG010|STARTED|Treatment Period||1
10294207|NCT00001832|11426891|FG011|STARTED|Treatment Period||7
10294208|NCT00001832|11426892|FG012|STARTED|Treatment Period||6
10294209|NCT00001832|11426893|FG013|STARTED|Treatment Period||3
10294210|NCT00001832|11426894|FG014|STARTED|Treatment Period||2
10294211|NCT00001832|11426880|FG000|COMPLETED|Treatment Period||0
10294212|NCT00001832|11426881|FG001|COMPLETED|Treatment Period||3
10294213|NCT00001832|11426882|FG002|COMPLETED|Treatment Period||3
10294214|NCT00001832|11426883|FG003|COMPLETED|Treatment Period||3
10294215|NCT00001832|11426884|FG004|COMPLETED|Treatment Period||6
10294216|NCT00001832|11426885|FG005|COMPLETED|Treatment Period||50
10294217|NCT00001832|11426886|FG006|COMPLETED|Treatment Period||4
10294218|NCT00001832|11426887|FG007|COMPLETED|Treatment Period||6
10294219|NCT00001832|11426888|FG008|COMPLETED|Treatment Period||8
10294220|NCT00001832|11426889|FG009|COMPLETED|Treatment Period||6
10294221|NCT00001832|11426890|FG010|COMPLETED|Treatment Period||1
10294222|NCT00001832|11426891|FG011|COMPLETED|Treatment Period||7
10294223|NCT00001832|11426892|FG012|COMPLETED|Treatment Period||6
10294224|NCT00001832|11426893|FG013|COMPLETED|Treatment Period||3
10294225|NCT00001832|11426894|FG014|COMPLETED|Treatment Period||2
10294226|NCT00001832|11426880|FG000|NOT COMPLETED|Treatment Period||0
10294227|NCT00001832|11426881|FG001|NOT COMPLETED|Treatment Period||0
10294228|NCT00001832|11426882|FG002|NOT COMPLETED|Treatment Period||0
10294229|NCT00001832|11426883|FG003|NOT COMPLETED|Treatment Period||0
10294230|NCT00001832|11426884|FG004|NOT COMPLETED|Treatment Period||0
10294231|NCT00001832|11426885|FG005|NOT COMPLETED|Treatment Period||1
10864263|NCT03089281|12029260|FG000|STARTED|Overall Study||225
10864264|NCT03089281|12029261|FG001|STARTED|Overall Study||215
10864265|NCT03089281|12029260|FG000|COMPLETED|Overall Study||197
10864266|NCT03089281|12029261|FG001|COMPLETED|Overall Study||198
10864267|NCT03089281|12029260|FG000|NOT COMPLETED|Overall Study||28
10864268|NCT03089281|12029261|FG001|NOT COMPLETED|Overall Study||17
10864269|NCT03085563|12029269|FG000|STARTED|Overall Study||19
10864270|NCT03085563|12029270|FG001|STARTED|Overall Study||41
10864271|NCT03085563|12029269|FG000|COMPLETED|Overall Study||19
10864272|NCT03085563|12029270|FG001|COMPLETED|Overall Study||41
10864273|NCT03085563|12029269|FG000|NOT COMPLETED|Overall Study||0
10864274|NCT03085563|12029270|FG001|NOT COMPLETED|Overall Study||0
10864275|NCT03084367|12029276|FG000|STARTED|Overall Study||500
10864276|NCT03084367|12029276|FG000|Analyzable iFR Pullback Assessment Post Angiographically Successful PCI|Overall Study||467
10864277|NCT03084367|12029276|FG000|COMPLETED|Overall Study||463
10864278|NCT03084367|12029276|FG000|NOT COMPLETED|Overall Study||37
10864291|NCT03056443|12029304|FG000|STARTED|Overall Study||13
10864292|NCT03056443|12029304|FG000|COMPLETED|Overall Study||13
10864293|NCT03056443|12029304|FG000|NOT COMPLETED|Overall Study||0
10864294|NCT03020225|12029311|FG000|STARTED|Overall Study||12
10864295|NCT03020225|12029312|FG001|STARTED|Overall Study||11
10864296|NCT03020225|12029313|FG002|STARTED|Overall Study||13
10864297|NCT03020225|12029311|FG000|COMPLETED|Overall Study||12
10864298|NCT03020225|12029312|FG001|COMPLETED|Overall Study||11
10864299|NCT03020225|12029313|FG002|COMPLETED|Overall Study||13
10864300|NCT03020225|12029311|FG000|NOT COMPLETED|Overall Study||0
10864301|NCT03020225|12029312|FG001|NOT COMPLETED|Overall Study||0
10864302|NCT03020225|12029313|FG002|NOT COMPLETED|Overall Study||0
10864303|NCT03004586|12029345|FG000|STARTED|Overall Study||31
10864304|NCT03004586|12029346|FG001|STARTED|Overall Study||30
10864305|NCT03004586|12029345|FG000|COMPLETED|Overall Study||31
10864306|NCT03004586|12029346|FG001|COMPLETED|Overall Study||30
10864307|NCT03004586|12029345|FG000|NOT COMPLETED|Overall Study||0
10864308|NCT03004586|12029346|FG001|NOT COMPLETED|Overall Study||0
10864309|NCT05110014|12029356|FG000|STARTED|Overall Study||12239
10864310|NCT05110014|12029357|FG001|STARTED|Overall Study||10787
10864311|NCT05110014|12029356|FG000|COMPLETED|Overall Study||12239
10864312|NCT05110014|12029357|FG001|COMPLETED|Overall Study||10787
10864313|NCT05110014|12029356|FG000|NOT COMPLETED|Overall Study||0
10864314|NCT05110014|12029357|FG001|NOT COMPLETED|Overall Study||0
10864318|NCT04218279|12029371|FG000|STARTED|Overall Study||316
10864319|NCT04218279|12029372|FG001|STARTED|Overall Study||362
10864320|NCT04218279|12029371|FG000|COMPLETED|Overall Study||211
10864321|NCT04218279|12029372|FG001|COMPLETED|Overall Study||225
10864322|NCT04218279|12029371|FG000|NOT COMPLETED|Overall Study||105
10864323|NCT04218279|12029372|FG001|NOT COMPLETED|Overall Study||137
10864324|NCT04167670|12029381|FG000|STARTED|Overall Study||349
10864325|NCT04167670|12029382|FG001|STARTED|Overall Study||349
10864326|NCT04167670|12029383|FG002|STARTED|Overall Study||348
10864327|NCT04167670|12029381|FG000|Received Study Drugs|Overall Study||348
10864328|NCT04167670|12029382|FG001|Received Study Drugs|Overall Study||346
10864329|NCT04167670|12029383|FG002|Received Study Drugs|Overall Study||345
10864330|NCT04167670|12029381|FG000|COMPLETED|Overall Study||334
10864331|NCT04167670|12029382|FG001|COMPLETED|Overall Study||331
10864332|NCT04167670|12029383|FG002|COMPLETED|Overall Study||334
10864333|NCT04167670|12029381|FG000|NOT COMPLETED|Overall Study||15
10864334|NCT04167670|12029382|FG001|NOT COMPLETED|Overall Study||18
10864335|NCT04167670|12029383|FG002|NOT COMPLETED|Overall Study||14
10864336|NCT04076917|12029391|FG000|STARTED|Overall Study||84
10864337|NCT04076917|12029391|FG000|COMPLETED|Overall Study||15
10864338|NCT04076917|12029391|FG000|NOT COMPLETED|Overall Study||69
10864412|NCT03205371|12029480|FG004|Per-protocol Analysis Set (PPAS)|Overall Study||42
10864413|NCT03205371|12029481|FG005|Per-protocol Analysis Set (PPAS)|Overall Study||42
10864414|NCT03205371|12029482|FG006|Per-protocol Analysis Set (PPAS)|Overall Study||155
10864415|NCT03205371|12029483|FG007|Per-protocol Analysis Set (PPAS)|Overall Study||79
10864416|NCT03205371|12029484|FG008|Per-protocol Analysis Set (PPAS)|Overall Study||68
10864417|NCT03205371|12029485|FG009|Per-protocol Analysis Set (PPAS)|Overall Study||196
10864418|NCT03205371|12029486|FG010|Per-protocol Analysis Set (PPAS)|Overall Study||96
10864419|NCT03205371|12029487|FG011|Per-protocol Analysis Set (PPAS)|Overall Study||92
10864420|NCT03205371|12029476|FG000|COMPLETED|Overall Study||103
10864421|NCT03205371|12029477|FG001|COMPLETED|Overall Study||52
10864422|NCT03205371|12029478|FG002|COMPLETED|Overall Study||53
10864423|NCT03205371|12029479|FG003|COMPLETED|Overall Study||86
10864424|NCT03205371|12029480|FG004|COMPLETED|Overall Study||42
10864425|NCT03205371|12029481|FG005|COMPLETED|Overall Study||42
10864426|NCT03205371|12029482|FG006|COMPLETED|Overall Study||190
10864427|NCT03205371|12029483|FG007|COMPLETED|Overall Study||97
10864428|NCT03205371|12029484|FG008|COMPLETED|Overall Study||95
10864429|NCT03205371|12029485|FG009|COMPLETED|Overall Study||200
10864430|NCT03205371|12029486|FG010|COMPLETED|Overall Study||100
10864431|NCT03205371|12029487|FG011|COMPLETED|Overall Study||99
10864432|NCT03205371|12029476|FG000|NOT COMPLETED|Overall Study||4
10864433|NCT03205371|12029477|FG001|NOT COMPLETED|Overall Study||1
10864434|NCT03205371|12029478|FG002|NOT COMPLETED|Overall Study||0
10864435|NCT03205371|12029479|FG003|NOT COMPLETED|Overall Study||0
10864436|NCT03205371|12029480|FG004|NOT COMPLETED|Overall Study||0
10864437|NCT03205371|12029481|FG005|NOT COMPLETED|Overall Study||0
10864438|NCT03205371|12029482|FG006|NOT COMPLETED|Overall Study||10
10864439|NCT03205371|12029483|FG007|NOT COMPLETED|Overall Study||3
10864440|NCT03205371|12029484|FG008|NOT COMPLETED|Overall Study||5
10864279|NCT03082898|12029287|FG000|STARTED|Overall Study||27
10864280|NCT03082898|12029288|FG001|STARTED|Overall Study||12
10864281|NCT03082898|12029287|FG000|COMPLETED|Overall Study||24
10864282|NCT03082898|12029288|FG001|COMPLETED|Overall Study||11
10864283|NCT03082898|12029287|FG000|NOT COMPLETED|Overall Study||3
10864284|NCT03082898|12029288|FG001|NOT COMPLETED|Overall Study||1
10864285|NCT03082313|12029294|FG000|STARTED|Overall Study||12
10864286|NCT03082313|12029294|FG000|COMPLETED|Overall Study||12
10864287|NCT03082313|12029294|FG000|NOT COMPLETED|Overall Study||0
10864315|NCT04980040|12029365|FG000|STARTED|Overall Study||3623
10864316|NCT04980040|12029365|FG000|COMPLETED|Overall Study||3131
10864317|NCT04980040|12029365|FG000|NOT COMPLETED|Overall Study||492
10864339|NCT04000009|12029395|FG000|STARTED|Overall Study||235
10864340|NCT04000009|12029395|FG000|COMPLETED|Overall Study||70
10864341|NCT04000009|12029395|FG000|NOT COMPLETED|Overall Study||165
10864342|NCT03988335|12029401|FG000|STARTED|Overall Study||16
10864343|NCT03988335|12029402|FG001|STARTED|Overall Study||19
10864344|NCT03988335|12029401|FG000|COMPLETED|Overall Study||14
10864345|NCT03988335|12029402|FG001|COMPLETED|Overall Study||18
10864346|NCT03988335|12029401|FG000|NOT COMPLETED|Overall Study||2
10864347|NCT03988335|12029402|FG001|NOT COMPLETED|Overall Study||1
10864348|NCT03792737|12029411|FG000|STARTED|Overall Study||166
10864349|NCT03792737|12029412|FG001|STARTED|Overall Study||167
10864350|NCT03792737|12029413|FG002|STARTED|Overall Study||167
10864351|NCT03792737|12029411|FG000|Safety Analysis Set|Overall Study||162
10864352|NCT03792737|12029412|FG001|Safety Analysis Set|Overall Study|one subject didn't participate screen visit or randomize, but receive IP treatment by mistake.|161
10864353|NCT03792737|12029413|FG002|Safety Analysis Set|Overall Study||162
10864354|NCT03792737|12029411|FG000|Full Analysis Set|Overall Study||162
10864355|NCT03792737|12029412|FG001|Full Analysis Set|Overall Study||160
10864356|NCT03792737|12029413|FG002|Full Analysis Set|Overall Study||162
10864357|NCT03792737|12029411|FG000|COMPLETED|Overall Study||160
10864358|NCT03792737|12029412|FG001|COMPLETED|Overall Study||159
10864359|NCT03792737|12029413|FG002|COMPLETED|Overall Study||158
10864360|NCT03792737|12029411|FG000|NOT COMPLETED|Overall Study||6
10864361|NCT03792737|12029412|FG001|NOT COMPLETED|Overall Study||8
10864362|NCT03792737|12029413|FG002|NOT COMPLETED|Overall Study||9
10864378|NCT03584464|12029454|FG000|STARTED|Overall Study||205
10864379|NCT03584464|12029454|FG000|COMPLETED|Overall Study|Number of subjects that competed 1 year follow up or had a CEC event|204
10864380|NCT03584464|12029454|FG000|NOT COMPLETED|Overall Study||1
10864381|NCT03441477|12029458|FG000|STARTED|Overall Study||225
10864382|NCT03441477|12029458|FG000|COMPLETED|Overall Study||224
10864383|NCT03441477|12029458|FG000|NOT COMPLETED|Overall Study||1
10864384|NCT03205371|12029476|FG000|STARTED|Overall Study||107
10864385|NCT03205371|12029477|FG001|STARTED|Overall Study||53
10864386|NCT03205371|12029478|FG002|STARTED|Overall Study||53
10864387|NCT03205371|12029479|FG003|STARTED|Overall Study||86
10864388|NCT03205371|12029480|FG004|STARTED|Overall Study||42
10864389|NCT03205371|12029481|FG005|STARTED|Overall Study||42
10864390|NCT03205371|12029482|FG006|STARTED|Overall Study||200
10864391|NCT03205371|12029483|FG007|STARTED|Overall Study||100
10864392|NCT03205371|12029484|FG008|STARTED|Overall Study||100
10864393|NCT03205371|12029485|FG009|STARTED|Overall Study||200
10864394|NCT03205371|12029486|FG010|STARTED|Overall Study||100
10864395|NCT03205371|12029487|FG011|STARTED|Overall Study||100
10864396|NCT03205371|12029476|FG000|Safety Analysis Set (SafAS)|Overall Study||103
10864397|NCT03205371|12029477|FG001|Safety Analysis Set (SafAS)|Overall Study||52
10864398|NCT03205371|12029478|FG002|Safety Analysis Set (SafAS)|Overall Study||53
10864399|NCT03205371|12029479|FG003|Safety Analysis Set (SafAS)|Overall Study||86
10864400|NCT03205371|12029480|FG004|Safety Analysis Set (SafAS)|Overall Study||42
10864401|NCT03205371|12029481|FG005|Safety Analysis Set (SafAS)|Overall Study||42
10864402|NCT03205371|12029482|FG006|Safety Analysis Set (SafAS)|Overall Study||200
10864403|NCT03205371|12029483|FG007|Safety Analysis Set (SafAS)|Overall Study||100
10864404|NCT03205371|12029484|FG008|Safety Analysis Set (SafAS)|Overall Study||100
10864405|NCT03205371|12029485|FG009|Safety Analysis Set (SafAS)|Overall Study||200
10864406|NCT03205371|12029486|FG010|Safety Analysis Set (SafAS)|Overall Study||100
10864407|NCT03205371|12029487|FG011|Safety Analysis Set (SafAS)|Overall Study||99
10864408|NCT03205371|12029476|FG000|Per-protocol Analysis Set (PPAS)|Overall Study||92
10864409|NCT03205371|12029477|FG001|Per-protocol Analysis Set (PPAS)|Overall Study||45
10864410|NCT03205371|12029478|FG002|Per-protocol Analysis Set (PPAS)|Overall Study||50
10864411|NCT03205371|12029479|FG003|Per-protocol Analysis Set (PPAS)|Overall Study||85
10864288|NCT03081767|12029298|FG000|STARTED|Overall Study||199
10864289|NCT03081767|12029298|FG000|COMPLETED|Overall Study||199
10864290|NCT03081767|12029298|FG000|NOT COMPLETED|Overall Study||0
10864441|NCT03205371|12029485|FG009|NOT COMPLETED|Overall Study||0
10864442|NCT03205371|12029486|FG010|NOT COMPLETED|Overall Study||0
10864443|NCT03205371|12029487|FG011|NOT COMPLETED|Overall Study||1
10864444|NCT03165721|12029536|FG000|STARTED|Overall Study||7
10864445|NCT03165721|12029537|FG001|STARTED|Overall Study||1
10864446|NCT03165721|12029538|FG002|STARTED|Overall Study||1
10864447|NCT03165721|12029536|FG000|COMPLETED|Overall Study||3
10864448|NCT03165721|12029537|FG001|COMPLETED|Overall Study||1
10864449|NCT03165721|12029538|FG002|COMPLETED|Overall Study||1
10864450|NCT03165721|12029536|FG000|NOT COMPLETED|Overall Study||4
10864451|NCT03165721|12029537|FG001|NOT COMPLETED|Overall Study||0
10864452|NCT03165721|12029538|FG002|NOT COMPLETED|Overall Study||0
10294232|NCT00001832|11426886|FG006|NOT COMPLETED|Treatment Period||0
10294233|NCT00001832|11426887|FG007|NOT COMPLETED|Treatment Period||1
10294234|NCT00001832|11426888|FG008|NOT COMPLETED|Treatment Period||0
10294235|NCT00001832|11426889|FG009|NOT COMPLETED|Treatment Period||0
10294236|NCT00001832|11426890|FG010|NOT COMPLETED|Treatment Period||0
10294237|NCT00001832|11426891|FG011|NOT COMPLETED|Treatment Period||0
10294238|NCT00001832|11426892|FG012|NOT COMPLETED|Treatment Period||0
10294239|NCT00001832|11426893|FG013|NOT COMPLETED|Treatment Period||0
10294240|NCT00001832|11426894|FG014|NOT COMPLETED|Treatment Period||0
10294241|NCT00001849|11426924|FG000|STARTED|Overall Study||68
10294242|NCT00001849|11426924|FG000|COMPLETED|Overall Study|Patients completed when an ectopic ACTH-secreting tumor was identified|54
10294243|NCT00001849|11426924|FG000|NOT COMPLETED|Overall Study||14
10294244|NCT00001880|11426937|FG000|STARTED|Overall Study||42
10294245|NCT00001880|11426937|FG000|COMPLETED|Overall Study||28
10864513|NCT02955797|12029606|FG000|STARTED|Overall Study||306
10864514|NCT02955797|12029607|FG001|STARTED|Overall Study||306
10864515|NCT02955797|12029608|FG002|STARTED|Overall Study||203
10864516|NCT02955797|12029609|FG003|STARTED|Overall Study||103
10864517|NCT02955797|12029606|FG000|Safety Analysis Set (SafAS)|Overall Study||303
10864518|NCT02955797|12029607|FG001|Safety Analysis Set (SafAS)|Overall Study||306
10864519|NCT02955797|12029608|FG002|Safety Analysis Set (SafAS)|Overall Study||203
10864520|NCT02955797|12029609|FG003|Safety Analysis Set (SafAS)|Overall Study||102
10864521|NCT02955797|12029606|FG000|Per Protocol Analysis Set (PPAS)|Overall Study||293
10864522|NCT02955797|12029607|FG001|Per Protocol Analysis Set (PPAS)|Overall Study||296
10864523|NCT02955797|12029608|FG002|Per Protocol Analysis Set (PPAS)|Overall Study||198
10864524|NCT02955797|12029609|FG003|Per Protocol Analysis Set (PPAS)|Overall Study||99
10864525|NCT02955797|12029606|FG000|COMPLETED|Overall Study||303
10864526|NCT02955797|12029607|FG001|COMPLETED|Overall Study||303
10864527|NCT02955797|12029608|FG002|COMPLETED|Overall Study||203
10864528|NCT02955797|12029609|FG003|COMPLETED|Overall Study||101
10864529|NCT02955797|12029606|FG000|NOT COMPLETED|Overall Study||3
10864530|NCT02955797|12029607|FG001|NOT COMPLETED|Overall Study||3
10864531|NCT02955797|12029608|FG002|NOT COMPLETED|Overall Study||0
10864532|NCT02955797|12029609|FG003|NOT COMPLETED|Overall Study||2
10864533|NCT02859415|12029624|FG000|STARTED|Overall Study||1
10864534|NCT02859415|12029625|FG001|STARTED|Overall Study||2
10864535|NCT02859415|12029624|FG000|COMPLETED|Overall Study||0
10864536|NCT02859415|12029625|FG001|COMPLETED|Overall Study||1
10864537|NCT02859415|12029624|FG000|NOT COMPLETED|Overall Study||1
10864538|NCT02859415|12029625|FG001|NOT COMPLETED|Overall Study||1
10864539|NCT02842866|12029634|FG000|STARTED|Overall Study||451
10864540|NCT02842866|12029635|FG001|STARTED|Overall Study||455
10864541|NCT02842866|12029634|FG000|Vaccinated|Overall Study||448
10864542|NCT02842866|12029635|FG001|Vaccinated|Overall Study||453
10864543|NCT02842866|12029634|FG000|COMPLETED|Overall Study||444
10864544|NCT02842866|12029635|FG001|COMPLETED|Overall Study||452
10864545|NCT02842866|12029634|FG000|NOT COMPLETED|Overall Study||7
10864546|NCT02842866|12029635|FG001|NOT COMPLETED|Overall Study||3
10864547|NCT02842853|12029645|FG000|STARTED|Overall Study||902
10864548|NCT02842853|12029646|FG001|STARTED|Overall Study||895
10864549|NCT02842853|12029647|FG002|STARTED|Overall Study||906
10864550|NCT02842853|12029648|FG003|STARTED|Overall Study||641
10864551|NCT02842853|12029645|FG000|Vaccinated|Overall Study||895
10864552|NCT02842853|12029646|FG001|Vaccinated|Overall Study||886
10864553|NCT02842853|12029647|FG002|Vaccinated|Overall Study||900
10864554|NCT02842853|12029648|FG003|Vaccinated|Overall Study||636
10864555|NCT02842853|12029645|FG000|Safety Analysis Set (SafAS)|Overall Study||895
10864556|NCT02842853|12029646|FG001|Safety Analysis Set (SafAS)|Overall Study||883
10864557|NCT02842853|12029647|FG002|Safety Analysis Set (SafAS)|Overall Study||898
10864558|NCT02842853|12029648|FG003|Safety Analysis Set (SafAS)|Overall Study||635
10864559|NCT02842853|12029645|FG000|COMPLETED|Overall Study||879
10864560|NCT02842853|12029646|FG001|COMPLETED|Overall Study||861
10864561|NCT02842853|12029647|FG002|COMPLETED|Overall Study||885
10864562|NCT02842853|12029648|FG003|COMPLETED|Overall Study||617
10864563|NCT02842853|12029645|FG000|NOT COMPLETED|Overall Study||23
10864564|NCT02842853|12029646|FG001|NOT COMPLETED|Overall Study||34
10864565|NCT02842853|12029647|FG002|NOT COMPLETED|Overall Study||21
10864566|NCT02842853|12029648|FG003|NOT COMPLETED|Overall Study||24
10864567|NCT02752906|12029662|FG000|STARTED|Overall Study||403
10864568|NCT02752906|12029663|FG001|STARTED|Overall Study||407
10864569|NCT02752906|12029662|FG000|Vaccinated|Overall Study||402
10864570|NCT02752906|12029663|FG001|Vaccinated|Overall Study||407
10864571|NCT02752906|12029662|FG000|COMPLETED|Overall Study||396
10864572|NCT02752906|12029663|FG001|COMPLETED|Overall Study||402
10864573|NCT02752906|12029662|FG000|NOT COMPLETED|Overall Study||7
10864574|NCT02752906|12029663|FG001|NOT COMPLETED|Overall Study||5
10864575|NCT02693691|12029669|FG000|STARTED|Primary Endpoint Analysis (First 12M)||234
10864576|NCT02693691|12029669|FG000|COMPLETED|Primary Endpoint Analysis (First 12M)||184
10864577|NCT02693691|12029669|FG000|NOT COMPLETED|Primary Endpoint Analysis (First 12M)||50
10864578|NCT02693691|12029669|FG000|STARTED|Extended Follow-Up (Until Last pt 12M)||184
10864579|NCT02693691|12029669|FG000|COMPLETED|Extended Follow-Up (Until Last pt 12M)||160
10864580|NCT02693691|12029669|FG000|NOT COMPLETED|Extended Follow-Up (Until Last pt 12M)||24
10417251|NCT00798655|11561873|FG000|COMPLETED|Overall Study||44
10417252|NCT00798655|11561873|FG000|NOT COMPLETED|Overall Study||2
10417253|NCT00798694|11561879|FG000|STARTED|Overall Study||30
10417254|NCT00798694|11561880|FG001|STARTED|Overall Study||28
10417255|NCT00798694|11561879|FG000|COMPLETED|Overall Study||28
10755535|NCT03068754|11919357|FG001|Completed RTP|Randomized Treatment Period (RTP)||9
10755536|NCT03068754|11919358|FG002|Completed RTP|Randomized Treatment Period (RTP)||0
10755537|NCT03068754|11919359|FG003|Completed RTP|Randomized Treatment Period (RTP)||0
10755538|NCT03068754|11919356|FG000|Enrolled in OLE Period|Randomized Treatment Period (RTP)||25
10755539|NCT03068754|11919357|FG001|Enrolled in OLE Period|Randomized Treatment Period (RTP)||8
10755540|NCT03068754|11919358|FG002|Enrolled in OLE Period|Randomized Treatment Period (RTP)||0
10755541|NCT03068754|11919359|FG003|Enrolled in OLE Period|Randomized Treatment Period (RTP)||0
10755542|NCT03068754|11919356|FG000|COMPLETED|Randomized Treatment Period (RTP)||28
10417256|NCT00798694|11561880|FG001|COMPLETED|Overall Study||27
10864581|NCT04889625|12029673|FG000|STARTED|Period 1||40
10864582|NCT04889625|12029674|FG001|STARTED|Period 1||38
10864583|NCT04889625|12029673|FG000|COMPLETED|Period 1||37
10864584|NCT04889625|12029674|FG001|COMPLETED|Period 1||34
10864585|NCT04889625|12029673|FG000|NOT COMPLETED|Period 1||3
10864586|NCT04889625|12029674|FG001|NOT COMPLETED|Period 1||4
10864587|NCT04889625|12029673|FG000|STARTED|Period 2||37
10864588|NCT04889625|12029674|FG001|STARTED|Period 2||34
10864589|NCT04889625|12029673|FG000|COMPLETED|Period 2||35
10864590|NCT04889625|12029674|FG001|COMPLETED|Period 2||33
10864591|NCT04889625|12029673|FG000|NOT COMPLETED|Period 2||2
10864592|NCT04889625|12029674|FG001|NOT COMPLETED|Period 2||1
10864593|NCT04889625|12029673|FG000|STARTED|Period 3||35
10864594|NCT04889625|12029674|FG001|STARTED|Period 3||33
10864595|NCT04889625|12029673|FG000|COMPLETED|Period 3||35
10864596|NCT04889625|12029674|FG001|COMPLETED|Period 3||33
10864597|NCT04889625|12029673|FG000|NOT COMPLETED|Period 3||0
10864598|NCT04889625|12029674|FG001|NOT COMPLETED|Period 3||0
10864599|NCT04653766|12029685|FG000|STARTED|Overall Study||6
10864600|NCT04653766|12029686|FG001|STARTED|Overall Study||6
10864601|NCT04653766|12029687|FG002|STARTED|Overall Study||6
10864602|NCT04653766|12029688|FG003|STARTED|Overall Study||6
10864603|NCT04653766|12029689|FG004|STARTED|Overall Study||8
10864604|NCT04653766|12029685|FG000|COMPLETED|Overall Study||6
10864605|NCT04653766|12029686|FG001|COMPLETED|Overall Study||6
10864606|NCT04653766|12029687|FG002|COMPLETED|Overall Study||6
10864607|NCT04653766|12029688|FG003|COMPLETED|Overall Study||6
10864608|NCT04653766|12029689|FG004|COMPLETED|Overall Study||8
10864609|NCT04653766|12029685|FG000|NOT COMPLETED|Overall Study||0
10864610|NCT04653766|12029686|FG001|NOT COMPLETED|Overall Study||0
10864611|NCT04653766|12029687|FG002|NOT COMPLETED|Overall Study||0
10864612|NCT04653766|12029688|FG003|NOT COMPLETED|Overall Study||0
10864613|NCT04653766|12029689|FG004|NOT COMPLETED|Overall Study||0
10864614|NCT04602000|12029715|FG000|STARTED|Overall Study||105
10864615|NCT04602000|12029716|FG001|STARTED|Overall Study||111
10864616|NCT04602000|12029717|FG002|STARTED|Overall Study||111
10864617|NCT04602000|12029718|FG003|STARTED|Overall Study||656
10864618|NCT04602000|12029719|FG004|STARTED|Overall Study||659
10864619|NCT04602000|12029715|FG000|COMPLETED|Overall Study||97
10864620|NCT04602000|12029716|FG001|COMPLETED|Overall Study||103
10864621|NCT04602000|12029717|FG002|COMPLETED|Overall Study||105
10864622|NCT04602000|12029718|FG003|COMPLETED|Overall Study||618
10864623|NCT04602000|12029719|FG004|COMPLETED|Overall Study||608
10864624|NCT04602000|12029715|FG000|NOT COMPLETED|Overall Study||8
10864625|NCT04602000|12029716|FG001|NOT COMPLETED|Overall Study||8
10864626|NCT04602000|12029717|FG002|NOT COMPLETED|Overall Study||6
10864627|NCT04602000|12029718|FG003|NOT COMPLETED|Overall Study||38
10864628|NCT04602000|12029719|FG004|NOT COMPLETED|Overall Study||51
10864629|NCT04540887|12029733|FG000|STARTED|Overall Study||10
10864630|NCT04540887|12029733|FG000|COMPLETED|Overall Study||8
10864631|NCT04540887|12029733|FG000|NOT COMPLETED|Overall Study||2
10864632|NCT04428333|12029740|FG000|STARTED|Overall Study||57
10864633|NCT04428333|12029741|FG001|STARTED|Overall Study||59
10864634|NCT04428333|12029740|FG000|Modified Intent-to-Treat (mITT) Population|Overall Study||52
10864635|NCT04428333|12029741|FG001|Modified Intent-to-Treat (mITT) Population|Overall Study||55
10864636|NCT04428333|12029740|FG000|Safety Population|Overall Study||50
10864637|NCT04428333|12029741|FG001|Safety Population|Overall Study||65
10864638|NCT04428333|12029740|FG000|COMPLETED|Overall Study||3
10864639|NCT04428333|12029741|FG001|COMPLETED|Overall Study||1
10864640|NCT04428333|12029740|FG000|NOT COMPLETED|Overall Study||54
10864641|NCT04428333|12029741|FG001|NOT COMPLETED|Overall Study||58
10864642|NCT04167085|12029749|FG000|STARTED|Baseline||13
10864643|NCT04167085|12029750|FG001|STARTED|Baseline||13
10864644|NCT04167085|12029749|FG000|Day 1|Baseline||12
10864645|NCT04167085|12029750|FG001|Day 1|Baseline||12
10864646|NCT04167085|12029749|FG000|COMPLETED|Baseline||11
10864647|NCT04167085|12029750|FG001|COMPLETED|Baseline||12
10864648|NCT04167085|12029749|FG000|NOT COMPLETED|Baseline||2
10864649|NCT04167085|12029750|FG001|NOT COMPLETED|Baseline||1
10864650|NCT04167085|12029749|FG000|STARTED|First Intervention (2 Months)||11
10864651|NCT04167085|12029750|FG001|STARTED|First Intervention (2 Months)||12
10864652|NCT04167085|12029749|FG000|COMPLETED|First Intervention (2 Months)||11
10864653|NCT04167085|12029750|FG001|COMPLETED|First Intervention (2 Months)||12
10864654|NCT04167085|12029749|FG000|NOT COMPLETED|First Intervention (2 Months)||0
10864655|NCT04167085|12029750|FG001|NOT COMPLETED|First Intervention (2 Months)||0
10864656|NCT04167085|12029749|FG000|STARTED|Washout (1 Month)||11
10864657|NCT04167085|12029750|FG001|STARTED|Washout (1 Month)||12
10864658|NCT04167085|12029749|FG000|COMPLETED|Washout (1 Month)||10
10864659|NCT04167085|12029750|FG001|COMPLETED|Washout (1 Month)||12
10864660|NCT04167085|12029749|FG000|NOT COMPLETED|Washout (1 Month)||1
10864661|NCT04167085|12029750|FG001|NOT COMPLETED|Washout (1 Month)||0
10864662|NCT04167085|12029749|FG000|STARTED|Second Intervention (2 Months)||10
10864663|NCT04167085|12029750|FG001|STARTED|Second Intervention (2 Months)||12
10864664|NCT04167085|12029749|FG000|COMPLETED|Second Intervention (2 Months)||10
10864665|NCT04167085|12029750|FG001|COMPLETED|Second Intervention (2 Months)||12
10864666|NCT04167085|12029749|FG000|NOT COMPLETED|Second Intervention (2 Months)||0
10864667|NCT04167085|12029750|FG001|NOT COMPLETED|Second Intervention (2 Months)||0
10864668|NCT04167085|12029749|FG000|STARTED|Washout (1 Month)||10
10864669|NCT04167085|12029750|FG001|STARTED|Washout (1 Month)||12
10864670|NCT04167085|12029749|FG000|COMPLETED|Washout (1 Month)||10
10864671|NCT04167085|12029750|FG001|COMPLETED|Washout (1 Month)||12
10864672|NCT04167085|12029749|FG000|NOT COMPLETED|Washout (1 Month)||0
10864673|NCT04167085|12029750|FG001|NOT COMPLETED|Washout (1 Month)||0
10864674|NCT04146467|12029758|FG000|STARTED|Overall Study||17
10864675|NCT04146467|12029759|FG001|STARTED|Overall Study||65
10864676|NCT04146467|12029758|FG000|COMPLETED|Overall Study||17
10864677|NCT04146467|12029759|FG001|COMPLETED|Overall Study||62
10864678|NCT04146467|12029758|FG000|NOT COMPLETED|Overall Study||0
10864679|NCT04146467|12029759|FG001|NOT COMPLETED|Overall Study||3
10864680|NCT04019613|12029768|FG000|STARTED|Overall Study||4
10864681|NCT04019613|12029768|FG000|COMPLETED|Overall Study||4
10864682|NCT04019613|12029768|FG000|NOT COMPLETED|Overall Study||0
10864683|NCT03912337|12029774|FG000|STARTED|Overall Study||15
10864684|NCT03912337|12029775|FG001|STARTED|Overall Study||14
10864685|NCT03912337|12029774|FG000|COMPLETED|Overall Study||13
10864686|NCT03912337|12029775|FG001|COMPLETED|Overall Study||13
10864687|NCT03912337|12029774|FG000|NOT COMPLETED|Overall Study||2
10864688|NCT03912337|12029775|FG001|NOT COMPLETED|Overall Study||1
10864692|NCT03292588|12029789|FG000|STARTED|Overall Study||146
10864693|NCT03292588|12029790|FG001|STARTED|Overall Study||144
10864694|NCT03292588|12029789|FG000|COMPLETED|Overall Study||126
10864695|NCT03292588|12029790|FG001|COMPLETED|Overall Study||122
10864696|NCT03292588|12029789|FG000|NOT COMPLETED|Overall Study||20
10864697|NCT03292588|12029790|FG001|NOT COMPLETED|Overall Study||22
10864698|NCT03139318|12029798|FG000|STARTED|Overall Study||1
10864699|NCT03139318|12029798|FG000|COMPLETED|Overall Study||1
10864700|NCT03139318|12029798|FG000|NOT COMPLETED|Overall Study||0
10864701|NCT03131960|12029804|FG000|STARTED|Overall Study|1 participant missed the day one visit (V5) but remained in the study and returned for the day 90 assessment (V7).|53
10864702|NCT03131960|12029805|FG001|STARTED|Overall Study|1 discontinued treatment due to adverse event and inability to tolerate rehabilitation.|55
10864703|NCT03131960|12029804|FG000|COMPLETED|Overall Study||53
10864704|NCT03131960|12029805|FG001|COMPLETED|Overall Study||54
10864705|NCT03131960|12029804|FG000|NOT COMPLETED|Overall Study||0
10864706|NCT03131960|12029805|FG001|NOT COMPLETED|Overall Study||1
10864713|NCT03090737|12029820|FG000|STARTED|Overall Study||129
10864714|NCT03090737|12029820|FG000|COMPLETED|Overall Study||98
10864715|NCT03090737|12029820|FG000|NOT COMPLETED|Overall Study||31
10864716|NCT02906930|12029828|FG000|STARTED|Overall Study||175
10864717|NCT02906930|12029829|FG001|STARTED|Overall Study||175
10864718|NCT02906930|12029830|FG002|STARTED|Overall Study||175
10864719|NCT02906930|12029831|FG003|STARTED|Overall Study||178
10864720|NCT02906930|12029828|FG000|Full Analysis Set (FAS)|Overall Study||175
10864721|NCT02906930|12029829|FG001|Full Analysis Set (FAS)|Overall Study||175
10864722|NCT02906930|12029830|FG002|Full Analysis Set (FAS)|Overall Study||175
10864723|NCT02906930|12029831|FG003|Full Analysis Set (FAS)|Overall Study||178
10864724|NCT02906930|12029828|FG000|Safety Analysis Set (SAS)|Overall Study||175
10864725|NCT02906930|12029829|FG001|Safety Analysis Set (SAS)|Overall Study||175
10864726|NCT02906930|12029830|FG002|Safety Analysis Set (SAS)|Overall Study||175
10864727|NCT02906930|12029831|FG003|Safety Analysis Set (SAS)|Overall Study||178
10864728|NCT02906930|12029828|FG000|COMPLETED|Overall Study||169
10864729|NCT02906930|12029829|FG001|COMPLETED|Overall Study||161
10864730|NCT02906930|12029830|FG002|COMPLETED|Overall Study||163
10864731|NCT02906930|12029831|FG003|COMPLETED|Overall Study||170
10864732|NCT02906930|12029828|FG000|NOT COMPLETED|Overall Study||6
10864733|NCT02906930|12029829|FG001|NOT COMPLETED|Overall Study||14
10864734|NCT02906930|12029830|FG002|NOT COMPLETED|Overall Study||12
10864735|NCT02906930|12029831|FG003|NOT COMPLETED|Overall Study||8
10294246|NCT00001880|11426937|FG000|NOT COMPLETED|Overall Study||14
10294247|NCT00001941|11426941|FG000|STARTED|Overall Study||3
10294248|NCT00001941|11426942|FG001|STARTED|Overall Study||5
10294249|NCT00001941|11426943|FG002|STARTED|Overall Study||3
10294250|NCT00001941|11426944|FG003|STARTED|Overall Study||3
10294251|NCT00001941|11426945|FG004|STARTED|Overall Study||20
10294252|NCT00001941|11426941|FG000|COMPLETED|Overall Study||3
10294253|NCT00001941|11426942|FG001|COMPLETED|Overall Study||5
10294254|NCT00001941|11426943|FG002|COMPLETED|Overall Study||3
10294255|NCT00001941|11426944|FG003|COMPLETED|Overall Study||3
10294256|NCT00001941|11426945|FG004|COMPLETED|Overall Study||19
10294257|NCT00001941|11426941|FG000|NOT COMPLETED|Overall Study||0
10294258|NCT00001941|11426942|FG001|NOT COMPLETED|Overall Study||0
10294259|NCT00001941|11426943|FG002|NOT COMPLETED|Overall Study||0
10294260|NCT00001941|11426944|FG003|NOT COMPLETED|Overall Study||0
10294261|NCT00001941|11426945|FG004|NOT COMPLETED|Overall Study||1
10294262|NCT00001959|11426950|FG000|STARTED|Overall Study||21
10294263|NCT00001959|11426950|FG000|COMPLETED|Overall Study||18
10294264|NCT00001959|11426950|FG000|NOT COMPLETED|Overall Study||3
10294265|NCT00001962|11426954|FG000|STARTED|Overall Study||100
10294266|NCT00001962|11426954|FG000|COMPLETED|Overall Study||72
10417257|NCT00798694|11561879|FG000|NOT COMPLETED|Overall Study||2
10417258|NCT00798694|11561880|FG001|NOT COMPLETED|Overall Study||1
10417259|NCT00798707|11561895|FG000|STARTED|Overall Study||235
10417260|NCT00798707|11561896|FG001|STARTED|Overall Study||237
10417261|NCT00798707|11561897|FG002|STARTED|Overall Study||237
10417262|NCT00798707|11561895|FG000|Treated|Overall Study||231
10417263|NCT00798707|11561896|FG001|Treated|Overall Study||232
10417264|NCT00798707|11561897|FG002|Treated|Overall Study||236
10417265|NCT00798707|11561895|FG000|COMPLETED|Overall Study||209
10417266|NCT00798707|11561896|FG001|COMPLETED|Overall Study||204
10417267|NCT00798707|11561897|FG002|COMPLETED|Overall Study||215
10417268|NCT00798707|11561895|FG000|NOT COMPLETED|Overall Study||26
10417269|NCT00798707|11561896|FG001|NOT COMPLETED|Overall Study||33
10417270|NCT00798707|11561897|FG002|NOT COMPLETED|Overall Study||22
10294267|NCT00001962|11426954|FG000|NOT COMPLETED|Overall Study||28
10294268|NCT00001984|11426958|FG000|STARTED|Overall Study||5
10294269|NCT00001984|11426958|FG000|COMPLETED|Overall Study||5
10294270|NCT00001984|11426958|FG000|NOT COMPLETED|Overall Study||0
10294271|NCT00002525|11426964|FG000|STARTED|Overall Study|859 patients were enrolled to the study, but 4 patients were not randomized to any treatment arm|427
10417271|NCT00798720|11561905|FG000|STARTED|Overall Study||18
10417272|NCT00798720|11561905|FG000|COMPLETED|Overall Study||18
10417273|NCT00798720|11561905|FG000|NOT COMPLETED|Overall Study||0
10417274|NCT00798759|11561911|FG000|STARTED|Overall Study||117
10417275|NCT00798759|11561912|FG001|STARTED|Overall Study||119
10417276|NCT00798759|11561911|FG000|COMPLETED|Overall Study||109
10417277|NCT00798759|11561912|FG001|COMPLETED|Overall Study||106
10417278|NCT00798759|11561911|FG000|NOT COMPLETED|Overall Study||8
10417279|NCT00798759|11561912|FG001|NOT COMPLETED|Overall Study||13
10417280|NCT00798889|11561918|FG000|STARTED|Overall Study||314
10417281|NCT00798889|11561918|FG000|Treated|Overall Study||311
10417282|NCT00798889|11561918|FG000|COMPLETED|Overall Study||0
10417283|NCT00798889|11561918|FG000|NOT COMPLETED|Overall Study||314
10417284|NCT00798967|11561924|FG000|STARTED|Overall Study||43
10417285|NCT00798967|11561925|FG001|STARTED|Overall Study||43
10417286|NCT00798967|11561924|FG000|Discontinued During Dosing Period|Overall Study||4
10417287|NCT00798967|11561925|FG001|Discontinued During Dosing Period|Overall Study||4
10417288|NCT00798967|11561924|FG000|COMPLETED|Overall Study||39
10417289|NCT00798967|11561925|FG001|COMPLETED|Overall Study||39
10417290|NCT00798967|11561924|FG000|NOT COMPLETED|Overall Study||4
10417291|NCT00798967|11561925|FG001|NOT COMPLETED|Overall Study||4
10417292|NCT00799227|11561932|FG000|STARTED|Overall Study||56
10417293|NCT00799227|11561932|FG000|COMPLETED|Overall Study||53
10417294|NCT00799227|11561932|FG000|NOT COMPLETED|Overall Study||3
10417295|NCT00799383|11561938|FG000|STARTED|Overall Study||23
10417296|NCT00799383|11561939|FG001|STARTED|Overall Study||24
10417297|NCT00799383|11561938|FG000|COMPLETED|Overall Study||20
10417298|NCT00799383|11561939|FG001|COMPLETED|Overall Study||18
10417299|NCT00799383|11561938|FG000|NOT COMPLETED|Overall Study||3
10417300|NCT00799383|11561939|FG001|NOT COMPLETED|Overall Study||6
10417301|NCT00799409|11561948|FG000|STARTED|Overall Study||7
10417302|NCT00799409|11561949|FG001|STARTED|Overall Study||36
10417303|NCT00799409|11561950|FG002|STARTED|Overall Study||35
10417304|NCT00799409|11561948|FG000|COMPLETED|Overall Study||0
10417305|NCT00799409|11561949|FG001|COMPLETED|Overall Study||36
10417306|NCT00799409|11561950|FG002|COMPLETED|Overall Study||35
10417307|NCT00799409|11561948|FG000|NOT COMPLETED|Overall Study||7
10417308|NCT00799409|11561949|FG001|NOT COMPLETED|Overall Study||0
10417309|NCT00799409|11561950|FG002|NOT COMPLETED|Overall Study||0
10417310|NCT00799422|11561958|FG000|STARTED|First Week of Wear||4
10417311|NCT00799422|11561959|FG001|STARTED|First Week of Wear||4
10417312|NCT00799422|11561960|FG002|STARTED|First Week of Wear||4
10417313|NCT00799422|11561961|FG003|STARTED|First Week of Wear||5
10417314|NCT00799422|11561962|FG004|STARTED|First Week of Wear||4
10417315|NCT00799422|11561963|FG005|STARTED|First Week of Wear||5
10417316|NCT00799422|11561958|FG000|COMPLETED|First Week of Wear||4
10417317|NCT00799422|11561959|FG001|COMPLETED|First Week of Wear||4
10294272|NCT00002525|11426965|FG001|STARTED|Overall Study||428
10294273|NCT00002525|11426964|FG000|Treated|Overall Study||419
10294274|NCT00002525|11426965|FG001|Treated|Overall Study|"Patients on No perioperative 5-FU arm received no perioperative chemotherapy"|0
10294275|NCT00002525|11426964|FG000|Dukes' B3 or C Stage|Overall Study|"Primary population: pts with Duke's B3, C disease. 158 such pts on No perioperative 5-FU arm"|156
10294276|NCT00002525|11426965|FG001|Dukes' B3 or C Stage|Overall Study||158
10294277|NCT00002525|11426964|FG000|Dukes' B2 Stage|Overall Study||150
10294278|NCT00002525|11426965|FG001|Dukes' B2 Stage|Overall Study||139
10294279|NCT00002525|11426964|FG000|COMPLETED|Overall Study||241
10294280|NCT00002525|11426965|FG001|COMPLETED|Overall Study|"Patients on No perioperative 5-FU arm received no perioperative chemotherapy"|428
10294281|NCT00002525|11426964|FG000|NOT COMPLETED|Overall Study||186
10294282|NCT00002525|11426965|FG001|NOT COMPLETED|Overall Study||0
10294283|NCT00002558|11426975|FG000|STARTED|Overall Study||92
10294284|NCT00002558|11426976|FG001|STARTED|Overall Study||16
10294285|NCT00002558|11426975|FG000|COMPLETED|Overall Study||92
10294286|NCT00002558|11426976|FG001|COMPLETED|Overall Study||15
10294287|NCT00002558|11426975|FG000|NOT COMPLETED|Overall Study||0
10417318|NCT00799422|11561960|FG002|COMPLETED|First Week of Wear||3
10417319|NCT00799422|11561961|FG003|COMPLETED|First Week of Wear||4
10417320|NCT00799422|11561962|FG004|COMPLETED|First Week of Wear||4
10417321|NCT00799422|11561963|FG005|COMPLETED|First Week of Wear||5
10417322|NCT00799422|11561958|FG000|NOT COMPLETED|First Week of Wear||0
10417323|NCT00799422|11561959|FG001|NOT COMPLETED|First Week of Wear||0
10417324|NCT00799422|11561960|FG002|NOT COMPLETED|First Week of Wear||1
10417325|NCT00799422|11561961|FG003|NOT COMPLETED|First Week of Wear||1
10417326|NCT00799422|11561962|FG004|NOT COMPLETED|First Week of Wear||0
10417327|NCT00799422|11561963|FG005|NOT COMPLETED|First Week of Wear||0
10417328|NCT00799422|11561958|FG000|STARTED|Second Week of Wear||4
10417329|NCT00799422|11561959|FG001|STARTED|Second Week of Wear||4
10417330|NCT00799422|11561960|FG002|STARTED|Second Week of Wear||3
10417331|NCT00799422|11561961|FG003|STARTED|Second Week of Wear|One subject discontinued between First and Second 3 weeks (adverse event)|3
10417332|NCT00799422|11561962|FG004|STARTED|Second Week of Wear||4
10417333|NCT00799422|11561963|FG005|STARTED|Second Week of Wear|One subject discontinued between First and Second 3 weeks (adverse event)|4
10417334|NCT00799422|11561958|FG000|COMPLETED|Second Week of Wear||4
10417335|NCT00799422|11561959|FG001|COMPLETED|Second Week of Wear||4
10417336|NCT00799422|11561960|FG002|COMPLETED|Second Week of Wear||3
10417337|NCT00799422|11561961|FG003|COMPLETED|Second Week of Wear||3
10417338|NCT00799422|11561962|FG004|COMPLETED|Second Week of Wear||4
10417339|NCT00799422|11561963|FG005|COMPLETED|Second Week of Wear||4
10417340|NCT00799422|11561958|FG000|NOT COMPLETED|Second Week of Wear||0
10417341|NCT00799422|11561959|FG001|NOT COMPLETED|Second Week of Wear||0
10417342|NCT00799422|11561960|FG002|NOT COMPLETED|Second Week of Wear||0
10417343|NCT00799422|11561961|FG003|NOT COMPLETED|Second Week of Wear||0
10417344|NCT00799422|11561962|FG004|NOT COMPLETED|Second Week of Wear||0
10417345|NCT00799422|11561963|FG005|NOT COMPLETED|Second Week of Wear||0
10417346|NCT00799422|11561958|FG000|STARTED|Third Week of Wear||4
10417347|NCT00799422|11561959|FG001|STARTED|Third Week of Wear||4
10417348|NCT00799422|11561960|FG002|STARTED|Third Week of Wear||3
10417349|NCT00799422|11561961|FG003|STARTED|Third Week of Wear||3
10417350|NCT00799422|11561962|FG004|STARTED|Third Week of Wear||4
10417351|NCT00799422|11561963|FG005|STARTED|Third Week of Wear||4
10417352|NCT00799422|11561958|FG000|COMPLETED|Third Week of Wear||4
10417353|NCT00799422|11561959|FG001|COMPLETED|Third Week of Wear||4
10417354|NCT00799422|11561960|FG002|COMPLETED|Third Week of Wear||3
10417355|NCT00799422|11561961|FG003|COMPLETED|Third Week of Wear||3
10417356|NCT00799422|11561962|FG004|COMPLETED|Third Week of Wear||4
10417357|NCT00799422|11561963|FG005|COMPLETED|Third Week of Wear||4
10417358|NCT00799422|11561958|FG000|NOT COMPLETED|Third Week of Wear||0
10417359|NCT00799422|11561959|FG001|NOT COMPLETED|Third Week of Wear||0
10417360|NCT00799422|11561960|FG002|NOT COMPLETED|Third Week of Wear||0
10417361|NCT00799422|11561961|FG003|NOT COMPLETED|Third Week of Wear||0
10417362|NCT00799422|11561962|FG004|NOT COMPLETED|Third Week of Wear||0
10417363|NCT00799422|11561963|FG005|NOT COMPLETED|Third Week of Wear||0
10417364|NCT00799435|11561973|FG000|STARTED|Overall Study||1
10417365|NCT00799435|11561974|FG001|STARTED|Overall Study||1
10417366|NCT00799435|11561973|FG000|COMPLETED|Overall Study||1
10417367|NCT00799435|11561974|FG001|COMPLETED|Overall Study||1
10417368|NCT00799435|11561973|FG000|NOT COMPLETED|Overall Study||0
10417369|NCT00799435|11561974|FG001|NOT COMPLETED|Overall Study||0
10417370|NCT00799474|11561980|FG000|STARTED|Overall Study||609
10417371|NCT00799474|11561980|FG000|COMPLETED|Overall Study||609
10417372|NCT00799474|11561980|FG000|NOT COMPLETED|Overall Study||0
10417373|NCT00799487|11561987|FG000|STARTED|Dose Adjustment Period||21
10417374|NCT00799487|11561988|FG001|STARTED|Dose Adjustment Period||34
10417375|NCT00799487|11561989|FG002|STARTED|Dose Adjustment Period||34
10417376|NCT00799487|11561987|FG000|COMPLETED|Dose Adjustment Period||0
10417377|NCT00799487|11561988|FG001|COMPLETED|Dose Adjustment Period||34
10417378|NCT00799487|11561989|FG002|COMPLETED|Dose Adjustment Period||34
10417379|NCT00799487|11561987|FG000|NOT COMPLETED|Dose Adjustment Period||21
10417380|NCT00799487|11561988|FG001|NOT COMPLETED|Dose Adjustment Period||0
10417381|NCT00799487|11561989|FG002|NOT COMPLETED|Dose Adjustment Period||0
10417382|NCT00799487|11561987|FG000|STARTED|Double-Blind Assessment Period||0
10417383|NCT00799487|11561988|FG001|STARTED|Double-Blind Assessment Period||34
10294288|NCT00002558|11426976|FG001|NOT COMPLETED|Overall Study||1
10294289|NCT00002597|11426984|FG000|STARTED|Overall Study||1013
10294290|NCT00002597|11426985|FG001|STARTED|Overall Study||1015
10294291|NCT00002597|11426984|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|987
10294292|NCT00002597|11426985|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|992
10864944|NCT02863419|12029887|FG000|STARTED|Overall Study||285
10864945|NCT02863419|12029888|FG001|STARTED|Overall Study||284
10864946|NCT02863419|12029889|FG002|STARTED|Overall Study||142
10864947|NCT02863419|12029887|FG000|Full Analysis Set (FAS)|Overall Study||285
10864948|NCT02863419|12029888|FG001|Full Analysis Set (FAS)|Overall Study||284
10864949|NCT02863419|12029889|FG002|Full Analysis Set (FAS)|Overall Study||142
10864950|NCT02863419|12029887|FG000|Safety Analysis Set (SAS)|Overall Study||285
10864951|NCT02863419|12029888|FG001|Safety Analysis Set (SAS)|Overall Study||284
10864952|NCT02863419|12029889|FG002|Safety Analysis Set (SAS)|Overall Study||142
10864953|NCT02863419|12029887|FG000|COMPLETED|Overall Study||277
10864954|NCT02863419|12029888|FG001|COMPLETED|Overall Study||274
10864955|NCT02863419|12029889|FG002|COMPLETED|Overall Study||134
10864956|NCT02863419|12029887|FG000|NOT COMPLETED|Overall Study||8
10864957|NCT02863419|12029888|FG001|NOT COMPLETED|Overall Study||10
10864958|NCT02863419|12029889|FG002|NOT COMPLETED|Overall Study||8
10864959|NCT02863328|12029899|FG000|STARTED|Overall Study||411
10864960|NCT02863328|12029900|FG001|STARTED|Overall Study||410
10864961|NCT02863328|12029899|FG000|Full Analysis Set (FAS)|Overall Study||411
10864962|NCT02863328|12029900|FG001|Full Analysis Set (FAS)|Overall Study||410
10864963|NCT02863328|12029899|FG000|Safety Analysis Set (SAS)|Overall Study||410
10864964|NCT02863328|12029900|FG001|Safety Analysis Set (SAS)|Overall Study||409
10864965|NCT02863328|12029899|FG000|COMPLETED|Overall Study||400
10864966|NCT02863328|12029900|FG001|COMPLETED|Overall Study||387
10864967|NCT02863328|12029899|FG000|NOT COMPLETED|Overall Study||11
10864968|NCT02863328|12029900|FG001|NOT COMPLETED|Overall Study||23
10864969|NCT02849080|12029908|FG000|STARTED|Main Phase: 0 - 52 Weeks||253
10864970|NCT02849080|12029909|FG001|STARTED|Main Phase: 0 - 52 Weeks||251
10864971|NCT02849080|12029910|FG002|STARTED|Main Phase: 0 - 52 Weeks||0
10864972|NCT02849080|12029911|FG003|STARTED|Main Phase: 0 - 52 Weeks||0
10864973|NCT02849080|12029908|FG000|Exposed|Main Phase: 0 - 52 Weeks||253
10864974|NCT02849080|12029909|FG001|Exposed|Main Phase: 0 - 52 Weeks||250
10864975|NCT02849080|12029910|FG002|Exposed|Main Phase: 0 - 52 Weeks||0
10864976|NCT02849080|12029911|FG003|Exposed|Main Phase: 0 - 52 Weeks||0
10864977|NCT02849080|12029908|FG000|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||253
10864978|NCT02849080|12029909|FG001|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||251
10864979|NCT02849080|12029910|FG002|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||0
10864980|NCT02849080|12029911|FG003|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||0
10864981|NCT02849080|12029908|FG000|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||253
10864982|NCT02849080|12029909|FG001|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||250
10864983|NCT02849080|12029910|FG002|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||0
10864984|NCT02849080|12029911|FG003|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||0
10864985|NCT02849080|12029908|FG000|COMPLETED|Main Phase: 0 - 52 Weeks||241
10864986|NCT02849080|12029909|FG001|COMPLETED|Main Phase: 0 - 52 Weeks||244
10864987|NCT02849080|12029910|FG002|COMPLETED|Main Phase: 0 - 52 Weeks||0
10864988|NCT02849080|12029911|FG003|COMPLETED|Main Phase: 0 - 52 Weeks||0
10864989|NCT02849080|12029908|FG000|NOT COMPLETED|Main Phase: 0 - 52 Weeks||12
10864990|NCT02849080|12029909|FG001|NOT COMPLETED|Main Phase: 0 - 52 Weeks||7
10864991|NCT02849080|12029910|FG002|NOT COMPLETED|Main Phase: 0 - 52 Weeks||0
10864992|NCT02849080|12029911|FG003|NOT COMPLETED|Main Phase: 0 - 52 Weeks||0
10864993|NCT02849080|12029908|FG000|STARTED|Extension Phase: 53 - 104 Weeks|Participants who had provided consent to continue in the extension phase started in this period.|185
10864994|NCT02849080|12029909|FG001|STARTED|Extension Phase: 53 - 104 Weeks||0
10864995|NCT02849080|12029910|FG002|STARTED|Extension Phase: 53 - 104 Weeks|Participants who had provided consent to continue in the extension phase started in this period.|100
10864996|NCT02849080|12029911|FG003|STARTED|Extension Phase: 53 - 104 Weeks|Participants who had provided consent to continue in the extension phase started in this period.|98
10864997|NCT02849080|12029908|FG000|Exposed|Extension Phase: 53 - 104 Weeks||184
10864998|NCT02849080|12029909|FG001|Exposed|Extension Phase: 53 - 104 Weeks||0
10864999|NCT02849080|12029910|FG002|Exposed|Extension Phase: 53 - 104 Weeks||100
10865000|NCT02849080|12029911|FG003|Exposed|Extension Phase: 53 - 104 Weeks||97
10865001|NCT02849080|12029908|FG000|COMPLETED|Extension Phase: 53 - 104 Weeks||182
10865002|NCT02849080|12029909|FG001|COMPLETED|Extension Phase: 53 - 104 Weeks||0
10865003|NCT02849080|12029910|FG002|COMPLETED|Extension Phase: 53 - 104 Weeks||99
10865004|NCT02849080|12029911|FG003|COMPLETED|Extension Phase: 53 - 104 Weeks||98
10865005|NCT02849080|12029908|FG000|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||3
10865006|NCT02849080|12029909|FG001|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||0
10865007|NCT02849080|12029910|FG002|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||1
10865008|NCT02849080|12029911|FG003|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||0
10865009|NCT02764762|12029923|FG000|STARTED|Overall Study||55
10865010|NCT02764762|12029923|FG000|COMPLETED|Overall Study||46
10865011|NCT02764762|12029923|FG000|NOT COMPLETED|Overall Study||9
10865024|NCT02692716|12029942|FG000|STARTED|Overall Study||1591
10865025|NCT02692716|12029943|FG001|STARTED|Overall Study||1592
10865026|NCT02692716|12029942|FG000|Full Analysis Set (FAS)|Overall Study||1591
10865027|NCT02692716|12029943|FG001|Full Analysis Set (FAS)|Overall Study||1592
10865028|NCT02692716|12029942|FG000|Exposed|Overall Study||1591
10865029|NCT02692716|12029943|FG001|Exposed|Overall Study||1591
10865030|NCT02692716|12029942|FG000|COMPLETED|Overall Study||1586
10865031|NCT02692716|12029943|FG001|COMPLETED|Overall Study||1586
10865032|NCT02692716|12029942|FG000|NOT COMPLETED|Overall Study||5
10865033|NCT02692716|12029943|FG001|NOT COMPLETED|Overall Study||6
10865034|NCT02607865|12029953|FG000|STARTED|Overall Study||466
10865035|NCT02607865|12029954|FG001|STARTED|Overall Study||466
10865036|NCT02607865|12029955|FG002|STARTED|Overall Study||465
10865037|NCT02607865|12029956|FG003|STARTED|Overall Study||467
10865038|NCT02607865|12029953|FG000|Full Analysis Set (FAS)|Overall Study||466
10865039|NCT02607865|12029954|FG001|Full Analysis Set (FAS)|Overall Study||465
10865040|NCT02607865|12029955|FG002|Full Analysis Set (FAS)|Overall Study||465
10865041|NCT02607865|12029956|FG003|Full Analysis Set (FAS)|Overall Study||467
10865042|NCT02607865|12029953|FG000|Safety Analysis Set (SAS)|Overall Study||466
10865043|NCT02607865|12029954|FG001|Safety Analysis Set (SAS)|Overall Study||464
10865044|NCT02607865|12029955|FG002|Safety Analysis Set (SAS)|Overall Study||465
10865045|NCT02607865|12029956|FG003|Safety Analysis Set (SAS)|Overall Study||466
10865046|NCT02607865|12029953|FG000|COMPLETED|Overall Study||433
10865047|NCT02607865|12029954|FG001|COMPLETED|Overall Study||436
10294293|NCT00002597|11426984|FG000|NOT COMPLETED|Overall Study||26
10294294|NCT00002597|11426985|FG001|NOT COMPLETED|Overall Study||23
10294295|NCT00002601|11426991|FG000|STARTED|Overall Study||13
10294296|NCT00002601|11426991|FG000|COMPLETED|Overall Study||13
10294297|NCT00002601|11426991|FG000|NOT COMPLETED|Overall Study||0
10294298|NCT00002651|11426999|FG000|STARTED|Induction||3040
10294299|NCT00002651|11427000|FG001|STARTED|Induction||0
10294300|NCT00002651|11427001|FG002|STARTED|Induction||0
10294301|NCT00002651|11426999|FG000|Eligible|Induction||2950
10294302|NCT00002651|11427000|FG001|Eligible|Induction||0
10294303|NCT00002651|11427001|FG002|Eligible|Induction||0
10294304|NCT00002651|11426999|FG000|Eligible and Began Protocol Therapy|Induction||2950
10294305|NCT00002651|11427000|FG001|Eligible and Began Protocol Therapy|Induction||0
10294306|NCT00002651|11427001|FG002|Eligible and Began Protocol Therapy|Induction||0
10865048|NCT02607865|12029955|FG002|COMPLETED|Overall Study||438
10865049|NCT02607865|12029956|FG003|COMPLETED|Overall Study||451
10865050|NCT02607865|12029953|FG000|NOT COMPLETED|Overall Study||33
10865051|NCT02607865|12029954|FG001|NOT COMPLETED|Overall Study||30
10865052|NCT02607865|12029955|FG002|NOT COMPLETED|Overall Study||27
10865053|NCT02607865|12029956|FG003|NOT COMPLETED|Overall Study||16
10294307|NCT00002651|11426999|FG000|COMPLETED|Induction||1697
10294308|NCT00002651|11427000|FG001|COMPLETED|Induction||0
10294309|NCT00002651|11427001|FG002|COMPLETED|Induction||0
10865060|NCT02486367|12029977|FG000|STARTED|Overall Study||30
10865061|NCT02486367|12029978|FG001|STARTED|Overall Study||30
10865062|NCT02486367|12029977|FG000|COMPLETED|Overall Study||30
10865063|NCT02486367|12029978|FG001|COMPLETED|Overall Study||30
10865064|NCT02486367|12029977|FG000|NOT COMPLETED|Overall Study||0
10865065|NCT02486367|12029978|FG001|NOT COMPLETED|Overall Study||0
10865066|NCT02430480|12029984|FG000|STARTED|Overall Study||39
10865067|NCT02430480|12029984|FG000|COMPLETED|Overall Study||36
10865068|NCT02430480|12029984|FG000|NOT COMPLETED|Overall Study||3
10865069|NCT02416622|12029994|FG000|STARTED|Overall Study||6
10865070|NCT02416622|12029995|FG001|STARTED|Overall Study||8
10865071|NCT02416622|12029996|FG002|STARTED|Overall Study||13
10865072|NCT02416622|12029994|FG000|Completed Month 12|Overall Study||6
10865073|NCT02416622|12029995|FG001|Completed Month 12|Overall Study||8
10865074|NCT02416622|12029996|FG002|Completed Month 12|Overall Study||13
10865075|NCT02416622|12029994|FG000|Started Long-Term Follow-Up|Overall Study||6
10865076|NCT02416622|12029995|FG001|Started Long-Term Follow-Up|Overall Study||8
10865077|NCT02416622|12029996|FG002|Started Long-Term Follow-Up|Overall Study||13
10865078|NCT02416622|12029994|FG000|COMPLETED|Overall Study||0
10865079|NCT02416622|12029995|FG001|COMPLETED|Overall Study||0
10865080|NCT02416622|12029996|FG002|COMPLETED|Overall Study||0
10865081|NCT02416622|12029994|FG000|NOT COMPLETED|Overall Study||6
10865082|NCT02416622|12029995|FG001|NOT COMPLETED|Overall Study||8
10865083|NCT02416622|12029996|FG002|NOT COMPLETED|Overall Study||13
10865096|NCT02226276|12030013|FG000|STARTED|Overall Study||10
10865097|NCT02226276|12030013|FG000|COMPLETED|Overall Study||10
10865098|NCT02226276|12030013|FG000|NOT COMPLETED|Overall Study||0
10865099|NCT02213068|12030020|FG000|STARTED|Overall Study||9
10865100|NCT02213068|12030021|FG001|STARTED|Overall Study||8
10865101|NCT02213068|12030022|FG002|STARTED|Overall Study||10
10865102|NCT02213068|12030020|FG000|COMPLETED|Overall Study||9
10865103|NCT02213068|12030021|FG001|COMPLETED|Overall Study||8
10865104|NCT02213068|12030022|FG002|COMPLETED|Overall Study||10
10865105|NCT02213068|12030020|FG000|NOT COMPLETED|Overall Study||0
10865106|NCT02213068|12030021|FG001|NOT COMPLETED|Overall Study||0
10865107|NCT02213068|12030022|FG002|NOT COMPLETED|Overall Study||0
10865111|NCT01964430|12030036|FG000|STARTED|Overall Study||432
10865112|NCT01964430|12030037|FG001|STARTED|Overall Study||434
10865113|NCT01964430|12030036|FG000|Treated Population|Overall Study||429
10865114|NCT01964430|12030037|FG001|Treated Population|Overall Study||423
10865115|NCT01964430|12030036|FG000|COMPLETED|Overall Study||287
10865116|NCT01964430|12030037|FG001|COMPLETED|Overall Study||310
10865117|NCT01964430|12030036|FG000|NOT COMPLETED|Overall Study||145
10865118|NCT01964430|12030037|FG001|NOT COMPLETED|Overall Study||124
10865119|NCT01880957|12030045|FG000|STARTED|Overall Study||47
10865120|NCT01880957|12030046|FG001|STARTED|Overall Study||29
10865121|NCT01880957|12030045|FG000|COMPLETED|Overall Study||19
10865122|NCT01880957|12030046|FG001|COMPLETED|Overall Study||29
10865123|NCT01880957|12030045|FG000|NOT COMPLETED|Overall Study||28
10865124|NCT01880957|12030046|FG001|NOT COMPLETED|Overall Study||0
10865125|NCT01651403|12030063|FG000|STARTED|Double-Blind Period (Through Week 48/72)||60
10865126|NCT01651403|12030064|FG001|STARTED|Double-Blind Period (Through Week 48/72)||30
10865127|NCT01651403|12030063|FG000|COMPLETED|Double-Blind Period (Through Week 48/72)||56
10865128|NCT01651403|12030064|FG001|COMPLETED|Double-Blind Period (Through Week 48/72)||25
10865129|NCT01651403|12030063|FG000|NOT COMPLETED|Double-Blind Period (Through Week 48/72)||4
10865130|NCT01651403|12030064|FG001|NOT COMPLETED|Double-Blind Period (Through Week 48/72)||5
10865131|NCT01651403|12030063|FG000|STARTED|Open-Label Phase (Weeks 49/73-192)||56
10865132|NCT01651403|12030064|FG001|STARTED|Open-Label Phase (Weeks 49/73-192)||25
10865133|NCT01651403|12030063|FG000|COMPLETED|Open-Label Phase (Weeks 49/73-192)||35
10865134|NCT01651403|12030064|FG001|COMPLETED|Open-Label Phase (Weeks 49/73-192)||11
10865135|NCT01651403|12030063|FG000|NOT COMPLETED|Open-Label Phase (Weeks 49/73-192)||21
10865136|NCT01651403|12030064|FG001|NOT COMPLETED|Open-Label Phase (Weeks 49/73-192)||14
10865146|NCT01468896|12030093|FG000|STARTED|Overall Study||6
10865147|NCT01468896|12030094|FG001|STARTED|Overall Study||17
10865148|NCT01468896|12030093|FG000|COMPLETED|Overall Study||6
10865149|NCT01468896|12030094|FG001|COMPLETED|Overall Study||17
10865150|NCT01468896|12030093|FG000|NOT COMPLETED|Overall Study||0
10865151|NCT01468896|12030094|FG001|NOT COMPLETED|Overall Study||0
10865176|NCT01335399|12030142|FG000|STARTED|Pre-treatment Period||374
10865177|NCT01335399|12030143|FG001|STARTED|Pre-treatment Period||374
10865178|NCT01335399|12030142|FG000|COMPLETED|Pre-treatment Period||371
10865179|NCT01335399|12030143|FG001|COMPLETED|Pre-treatment Period||371
10865180|NCT01335399|12030142|FG000|NOT COMPLETED|Pre-treatment Period||3
10865181|NCT01335399|12030143|FG001|NOT COMPLETED|Pre-treatment Period||3
10865182|NCT01335399|12030142|FG000|STARTED|Treatment Period||371
10865183|NCT01335399|12030143|FG001|STARTED|Treatment Period||371
10865184|NCT01335399|12030142|FG000|COMPLETED|Treatment Period||38
10865185|NCT01335399|12030143|FG001|COMPLETED|Treatment Period||32
10865186|NCT01335399|12030142|FG000|NOT COMPLETED|Treatment Period||333
10865187|NCT01335399|12030143|FG001|NOT COMPLETED|Treatment Period||339
10865188|NCT01241786|12030149|FG000|STARTED|Overall Study||5
10865189|NCT01241786|12030149|FG000|COMPLETED|Overall Study||0
10865190|NCT01241786|12030149|FG000|NOT COMPLETED|Overall Study||5
10417384|NCT00799487|11561989|FG002|STARTED|Double-Blind Assessment Period||34
10417385|NCT00799487|11561987|FG000|COMPLETED|Double-Blind Assessment Period||0
10865254|NCT00606294|12030222|FG000|STARTED|Overall Study||197
10865255|NCT00606294|12030223|FG001|STARTED|Overall Study||19
10865256|NCT00606294|12030222|FG000|COMPLETED|Overall Study||161
10865257|NCT00606294|12030223|FG001|COMPLETED|Overall Study||19
10865258|NCT00606294|12030222|FG000|NOT COMPLETED|Overall Study||36
10865259|NCT00606294|12030223|FG001|NOT COMPLETED|Overall Study||0
10417386|NCT00799487|11561988|FG001|COMPLETED|Double-Blind Assessment Period||33
10417387|NCT00799487|11561989|FG002|COMPLETED|Double-Blind Assessment Period||32
10417388|NCT00799487|11561987|FG000|NOT COMPLETED|Double-Blind Assessment Period||0
10417389|NCT00799487|11561988|FG001|NOT COMPLETED|Double-Blind Assessment Period||1
10417390|NCT00799487|11561989|FG002|NOT COMPLETED|Double-Blind Assessment Period||2
10417391|NCT00799578|11562000|FG000|STARTED|Overall Study||13
10417392|NCT00799578|11562000|FG000|COMPLETED|Overall Study||11
10417393|NCT00799578|11562000|FG000|NOT COMPLETED|Overall Study||2
10417394|NCT00799591|11562004|FG000|STARTED|Overall Study||156
10417395|NCT00799591|11562004|FG000|COMPLETED|Overall Study||90
10417396|NCT00799591|11562004|FG000|NOT COMPLETED|Overall Study||66
10417397|NCT00799604|11562011|FG000|STARTED|Bolus 1 (Pre-anesthesia)||10
10417398|NCT00799604|11562012|FG001|STARTED|Bolus 1 (Pre-anesthesia)||10
10417399|NCT00799604|11562013|FG002|STARTED|Bolus 1 (Pre-anesthesia)||10
10417400|NCT00799604|11562011|FG000|COMPLETED|Bolus 1 (Pre-anesthesia)||10
10417401|NCT00799604|11562012|FG001|COMPLETED|Bolus 1 (Pre-anesthesia)||10
10417402|NCT00799604|11562013|FG002|COMPLETED|Bolus 1 (Pre-anesthesia)||10
10417403|NCT00799604|11562011|FG000|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
10417404|NCT00799604|11562012|FG001|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
10417405|NCT00799604|11562013|FG002|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
10417406|NCT00799604|11562011|FG000|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|6
10417407|NCT00799604|11562012|FG001|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|12
10417408|NCT00799604|11562013|FG002|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|3
10417409|NCT00799604|11562011|FG000|COMPLETED|Bolus 2 (With Anesthesia)||6
10417410|NCT00799604|11562012|FG001|COMPLETED|Bolus 2 (With Anesthesia)||12
10417411|NCT00799604|11562013|FG002|COMPLETED|Bolus 2 (With Anesthesia)||3
10417412|NCT00799604|11562011|FG000|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
10417413|NCT00799604|11562012|FG001|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
10417414|NCT00799604|11562013|FG002|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
10417415|NCT00799617|11562023|FG000|STARTED|Main Testosterone Trial||395
10417416|NCT00799617|11562024|FG001|STARTED|Main Testosterone Trial||395
10429381|NCT00863265|11575372|FG000|NOT COMPLETED|Overall Study||0
10865278|NCT00464178|12030247|FG000|STARTED|Overall Study||6
10865279|NCT00464178|12030247|FG000|COMPLETED|Overall Study||4
10865280|NCT00464178|12030247|FG000|NOT COMPLETED|Overall Study||2
10865281|NCT00265798|12030252|FG000|STARTED|Overall Study||38
10865282|NCT00265798|12030252|FG000|COMPLETED|Overall Study||38
10865283|NCT00265798|12030252|FG000|NOT COMPLETED|Overall Study||0
10294310|NCT00002651|11426999|FG000|NOT COMPLETED|Induction||1343
10294311|NCT00002651|11427000|FG001|NOT COMPLETED|Induction||0
10294312|NCT00002651|11427001|FG002|NOT COMPLETED|Induction||0
10294313|NCT00002651|11426999|FG000|STARTED|Consolidation and Randomization||0
10294314|NCT00002651|11427000|FG001|STARTED|Consolidation and Randomization|After induction,patients with stable or declining PSA (≤ 4.0 ng/mL) were eligible for randomization|867
10294315|NCT00002651|11427001|FG002|STARTED|Consolidation and Randomization|After induction,patients with stable or declining PSA (≤ 4.0 ng/mL) were eligible for randomization|882
10294316|NCT00002651|11426999|FG000|Eligible|Consolidation and Randomization||0
10294317|NCT00002651|11427000|FG001|Eligible|Consolidation and Randomization||765
10294318|NCT00002651|11427001|FG002|Eligible|Consolidation and Randomization||770
10294319|NCT00002651|11426999|FG000|Assessable for Toxicity|Consolidation and Randomization||0
10294320|NCT00002651|11427000|FG001|Assessable for Toxicity|Consolidation and Randomization||732
10294321|NCT00002651|11427001|FG002|Assessable for Toxicity|Consolidation and Randomization||702
10294322|NCT00002651|11426999|FG000|COMPLETED|Consolidation and Randomization||0
10294323|NCT00002651|11427000|FG001|COMPLETED|Consolidation and Randomization||29
10294324|NCT00002651|11427001|FG002|COMPLETED|Consolidation and Randomization||22
10294325|NCT00002651|11426999|FG000|NOT COMPLETED|Consolidation and Randomization||0
10294326|NCT00002651|11427000|FG001|NOT COMPLETED|Consolidation and Randomization||838
10294327|NCT00002651|11427001|FG002|NOT COMPLETED|Consolidation and Randomization||860
10294328|NCT00002766|11427011|FG000|STARTED|Overall Study||81
10294329|NCT00002766|11427012|FG001|STARTED|Overall Study||89
10294330|NCT00002766|11427011|FG000|COMPLETED|Overall Study||78
10294331|NCT00002766|11427012|FG001|COMPLETED|Overall Study||85
10294332|NCT00002766|11427011|FG000|NOT COMPLETED|Overall Study||3
10294333|NCT00002766|11427012|FG001|NOT COMPLETED|Overall Study||4
10294334|NCT00002842|11427018|FG000|STARTED|Overall Study||49
10294335|NCT00002842|11427018|FG000|COMPLETED|Overall Study||22
10294336|NCT00002842|11427018|FG000|NOT COMPLETED|Overall Study||27
10294337|NCT00002850|11427025|FG000|STARTED|Overall Study||69
10294338|NCT00002850|11427026|FG001|STARTED|Overall Study||76
10294339|NCT00002850|11427027|FG002|STARTED|Overall Study||67
10294340|NCT00002850|11427025|FG000|COMPLETED|Overall Study||64
10294341|NCT00002850|11427026|FG001|COMPLETED|Overall Study||74
10294342|NCT00002850|11427027|FG002|COMPLETED|Overall Study||63
10294343|NCT00002850|11427025|FG000|NOT COMPLETED|Overall Study||5
10294344|NCT00002850|11427026|FG001|NOT COMPLETED|Overall Study||2
10294345|NCT00002850|11427027|FG002|NOT COMPLETED|Overall Study||4
10314638|NCT00167102|11448340|FG001|NOT COMPLETED|Overall Study||0
10314639|NCT00167180|11448350|FG000|STARTED|Overall Study||0
10314640|NCT00167180|11448351|FG001|STARTED|Overall Study||57
10314641|NCT00167180|11448350|FG000|COMPLETED|Overall Study||0
10314642|NCT00167180|11448351|FG001|COMPLETED|Overall Study||57
10314643|NCT00167180|11448350|FG000|NOT COMPLETED|Overall Study||0
10314644|NCT00167180|11448351|FG001|NOT COMPLETED|Overall Study||0
10314645|NCT00167206|11448357|FG000|STARTED|Overall Study||16
10314646|NCT00167206|11448357|FG000|COMPLETED|Overall Study||16
10314647|NCT00167206|11448357|FG000|NOT COMPLETED|Overall Study||0
10314648|NCT00167245|11448363|FG000|STARTED|Overall Study||83
10314649|NCT00167245|11448364|FG001|STARTED|Overall Study||87
10417417|NCT00799617|11562023|FG000|COMPLETED|Main Testosterone Trial|Participants qualified for 1 of the 3 main trials (sexual function, physical function, vitality).|376
10417418|NCT00799617|11562024|FG001|COMPLETED|Main Testosterone Trial||374
10417419|NCT00799617|11562023|FG000|NOT COMPLETED|Main Testosterone Trial||19
10417420|NCT00799617|11562024|FG001|NOT COMPLETED|Main Testosterone Trial||21
10417421|NCT00799617|11562023|FG000|STARTED|Sexual Funtion Trial||234
10417422|NCT00799617|11562024|FG001|STARTED|Sexual Funtion Trial||236
10417423|NCT00799617|11562023|FG000|COMPLETED|Sexual Funtion Trial||218
10417424|NCT00799617|11562024|FG001|COMPLETED|Sexual Funtion Trial||215
10417425|NCT00799617|11562023|FG000|NOT COMPLETED|Sexual Funtion Trial||16
10417426|NCT00799617|11562024|FG001|NOT COMPLETED|Sexual Funtion Trial||21
10417427|NCT00799617|11562023|FG000|STARTED|Physical Function Trial||191
10417428|NCT00799617|11562024|FG001|STARTED|Physical Function Trial||196
10417429|NCT00799617|11562023|FG000|COMPLETED|Physical Function Trial||185
10417430|NCT00799617|11562024|FG001|COMPLETED|Physical Function Trial||185
10417431|NCT00799617|11562023|FG000|NOT COMPLETED|Physical Function Trial||6
10417432|NCT00799617|11562024|FG001|NOT COMPLETED|Physical Function Trial||11
10417433|NCT00799617|11562023|FG000|STARTED|Vitality Trial||236
10417434|NCT00799617|11562024|FG001|STARTED|Vitality Trial||238
10417435|NCT00799617|11562023|FG000|COMPLETED|Vitality Trial||229
10417436|NCT00799617|11562024|FG001|COMPLETED|Vitality Trial||216
10417437|NCT00799617|11562023|FG000|NOT COMPLETED|Vitality Trial||7
10417438|NCT00799617|11562024|FG001|NOT COMPLETED|Vitality Trial||22
10417439|NCT00799617|11562023|FG000|STARTED|Cardiovascular Trial||88
10417440|NCT00799617|11562024|FG001|STARTED|Cardiovascular Trial||82
10417441|NCT00799617|11562023|FG000|COMPLETED|Cardiovascular Trial||73
10314650|NCT00167245|11448363|FG000|COMPLETED|Overall Study||54
10314651|NCT00167245|11448364|FG001|COMPLETED|Overall Study||46
10865292|NCT04516746|12030267|FG000|STARTED|Overall Study||21635
10865293|NCT04516746|12030268|FG001|STARTED|Overall Study||10816
10865294|NCT04516746|12030267|FG000|Participants Who Received First Dose|Overall Study||21583
10865295|NCT04516746|12030268|FG001|Participants Who Received First Dose|Overall Study||10796
10865296|NCT04516746|12030267|FG000|Participants Who Received Second Dose|Overall Study||20769
10865297|NCT04516746|12030268|FG001|Participants Who Received Second Dose|Overall Study||9951
10865298|NCT04516746|12030267|FG000|COMPLETED|Overall Study||0
10865299|NCT04516746|12030268|FG001|COMPLETED|Overall Study||0
10865300|NCT04516746|12030267|FG000|NOT COMPLETED|Overall Study||21635
10865301|NCT04516746|12030268|FG001|NOT COMPLETED|Overall Study||10816
10865302|NCT04447417|12030276|FG000|STARTED|Overall Study||26
10865303|NCT04447417|12030277|FG001|STARTED|Overall Study||26
10865304|NCT04447417|12030276|FG000|COMPLETED|Overall Study||23
10865305|NCT04447417|12030277|FG001|COMPLETED|Overall Study||26
10865306|NCT04447417|12030276|FG000|NOT COMPLETED|Overall Study||3
10865307|NCT04447417|12030277|FG001|NOT COMPLETED|Overall Study||0
10865308|NCT04427917|12030285|FG000|STARTED|Overall Study||2
10865309|NCT04427917|12030286|FG001|STARTED|Overall Study||6
10865310|NCT04427917|12030285|FG000|COMPLETED|Overall Study||2
10865311|NCT04427917|12030286|FG001|COMPLETED|Overall Study||6
10865312|NCT04427917|12030285|FG000|NOT COMPLETED|Overall Study||0
10865313|NCT04427917|12030286|FG001|NOT COMPLETED|Overall Study||0
10865314|NCT04418765|12030296|FG000|STARTED|Overall Study||299
10865315|NCT04418765|12030297|FG001|STARTED|Overall Study||299
10865316|NCT04418765|12030298|FG002|STARTED|Overall Study||294
10865317|NCT04418765|12030296|FG000|Received at Least 1 Dose of Study Drug|Overall Study||298
10865318|NCT04418765|12030297|FG001|Received at Least 1 Dose of Study Drug|Overall Study||299
10865319|NCT04418765|12030298|FG002|Received at Least 1 Dose of Study Drug|Overall Study||294
10865320|NCT04418765|12030296|FG000|COMPLETED|Overall Study||293
10865321|NCT04418765|12030297|FG001|COMPLETED|Overall Study||288
10865322|NCT04418765|12030298|FG002|COMPLETED|Overall Study||284
10865323|NCT04418765|12030296|FG000|NOT COMPLETED|Overall Study||6
10865324|NCT04418765|12030297|FG001|NOT COMPLETED|Overall Study||11
10865325|NCT04418765|12030298|FG002|NOT COMPLETED|Overall Study||10
10865326|NCT04415073|12030308|FG000|STARTED|Overall Study||0
10865327|NCT04415073|12030309|FG001|STARTED|Overall Study||0
10865328|NCT04415073|12030308|FG000|COMPLETED|Overall Study||0
10865329|NCT04415073|12030309|FG001|COMPLETED|Overall Study||0
10865330|NCT04415073|12030308|FG000|NOT COMPLETED|Overall Study||0
10865331|NCT04415073|12030309|FG001|NOT COMPLETED|Overall Study||0
10865332|NCT04343976|12030317|FG000|STARTED|Overall Study||7
10865333|NCT04343976|12030318|FG001|STARTED|Overall Study||7
10865334|NCT04343976|12030317|FG000|COMPLETED|Overall Study||7
10865335|NCT04343976|12030318|FG001|COMPLETED|Overall Study||6
10865336|NCT04343976|12030317|FG000|NOT COMPLETED|Overall Study||0
10865337|NCT04343976|12030318|FG001|NOT COMPLETED|Overall Study||1
10865348|NCT04000581|12030335|FG000|STARTED|Overall Study||5
10865349|NCT04000581|12030336|FG001|STARTED|Overall Study||12
10865350|NCT04000581|12030335|FG000|COMPLETED|Overall Study||5
10865351|NCT04000581|12030336|FG001|COMPLETED|Overall Study||11
10865352|NCT04000581|12030335|FG000|NOT COMPLETED|Overall Study||0
10865353|NCT04000581|12030336|FG001|NOT COMPLETED|Overall Study||1
10865354|NCT03935880|12030344|FG000|STARTED|Overall Study||9
10865355|NCT03935880|12030345|FG001|STARTED|Overall Study||11
10865356|NCT03935880|12030344|FG000|Completed Surgery|Overall Study||9
10865357|NCT03935880|12030345|FG001|Completed Surgery|Overall Study||10
10865358|NCT03935880|12030344|FG000|COMPLETED|Overall Study||9
10865359|NCT03935880|12030345|FG001|COMPLETED|Overall Study||10
10865360|NCT03935880|12030344|FG000|NOT COMPLETED|Overall Study||0
10865361|NCT03935880|12030345|FG001|NOT COMPLETED|Overall Study||1
10865362|NCT03834350|12030351|FG000|STARTED|Overall Study||71
10865363|NCT03834350|12030351|FG000|COMPLETED|Overall Study||70
10865364|NCT03834350|12030351|FG000|NOT COMPLETED|Overall Study||1
10865365|NCT03782103|12030356|FG000|STARTED|Overall Study||156
10865366|NCT03782103|12030356|FG000|ZP|Overall Study||156
10865367|NCT03782103|12030356|FG000|CP|Overall Study||156
10865368|NCT03782103|12030356|FG000|Vehicle|Overall Study||156
10865369|NCT03782103|12030356|FG000|COMPLETED|Overall Study||156
10865370|NCT03782103|12030356|FG000|NOT COMPLETED|Overall Study||0
10865371|NCT03761056|12030368|FG000|STARTED|Overall Study||42
10865372|NCT03761056|12030368|FG000|COMPLETED|Overall Study||0
10865373|NCT03761056|12030368|FG000|NOT COMPLETED|Overall Study||42
10865377|NCT03710564|12030380|FG000|STARTED|Overall Study||356
10865378|NCT03710564|12030381|FG001|STARTED|Overall Study||179
10865379|NCT03710564|12030380|FG000|COMPLETED|Overall Study||172
10865380|NCT03710564|12030381|FG001|COMPLETED|Overall Study||86
10865381|NCT03710564|12030380|FG000|NOT COMPLETED|Overall Study||184
10865382|NCT03710564|12030381|FG001|NOT COMPLETED|Overall Study||93
10865383|NCT03693404|12030390|FG000|STARTED|Overall Study||109
10865384|NCT03693404|12030391|FG001|STARTED|Overall Study||81
10865385|NCT03693404|12030390|FG000|COMPLETED|Overall Study||108
10865386|NCT03693404|12030391|FG001|COMPLETED|Overall Study||75
10865387|NCT03693404|12030390|FG000|NOT COMPLETED|Overall Study||1
10865388|NCT03693404|12030391|FG001|NOT COMPLETED|Overall Study||6
10865389|NCT03660943|12030399|FG000|STARTED|Overall Study||145
10865390|NCT03660943|12030400|FG001|STARTED|Overall Study||187
10865391|NCT03660943|12030399|FG000|Treated|Overall Study||140
10865392|NCT03660943|12030400|FG001|Treated|Overall Study||184
10865393|NCT03660943|12030399|FG000|COMPLETED|Overall Study||109
10865394|NCT03660943|12030400|FG001|COMPLETED|Overall Study||134
10865395|NCT03660943|12030399|FG000|NOT COMPLETED|Overall Study||36
10865396|NCT03660943|12030400|FG001|NOT COMPLETED|Overall Study||53
10865397|NCT03658889|12030408|FG000|STARTED|Overall Study|Enrolled population|308
10865398|NCT03658889|12030409|FG001|STARTED|Overall Study||69
10865399|NCT03658889|12030408|FG000|COMPLETED|Overall Study|Analysis population|306
10865400|NCT03658889|12030409|FG001|COMPLETED|Overall Study||69
10865401|NCT03658889|12030408|FG000|NOT COMPLETED|Overall Study||2
10865402|NCT03658889|12030409|FG001|NOT COMPLETED|Overall Study||0
10865403|NCT03654885|12030416|FG000|STARTED|Overall Study|One eye, the worse eye, from each participant was selected as the study eye.|107
10865404|NCT03654885|12030417|FG001|STARTED|Overall Study|One eye, the worse eye, from each participant was selected as the study eye.|51
10865405|NCT03654885|12030416|FG000|Intent-to-Treat (ITT) Population|Overall Study||95
10865406|NCT03654885|12030417|FG001|Intent-to-Treat (ITT) Population|Overall Study||44
10865407|NCT03654885|12030416|FG000|Safety Population|Overall Study||95
10865408|NCT03654885|12030417|FG001|Safety Population|Overall Study||44
10865409|NCT03654885|12030416|FG000|COMPLETED|Overall Study||77
10865410|NCT03654885|12030417|FG001|COMPLETED|Overall Study||38
10865411|NCT03654885|12030416|FG000|NOT COMPLETED|Overall Study||30
10865412|NCT03654885|12030417|FG001|NOT COMPLETED|Overall Study||13
10865413|NCT03568461|12030423|FG000|STARTED|Overall Study||98
10865414|NCT03568461|12030423|FG000|Treated|Overall Study||97
10865415|NCT03568461|12030423|FG000|Discontinued Prior to Transfusion With Tisagenlecleucel|Overall Study||1
10865416|NCT03568461|12030423|FG000|COMPLETED|Overall Study||80
10865417|NCT03568461|12030423|FG000|NOT COMPLETED|Overall Study||18
10545821|NCT01500200|11699344|FG002|NOT COMPLETED|Stage 1||6
10545822|NCT01500200|11699345|FG003|NOT COMPLETED|Stage 1||0
10545823|NCT01500200|11699346|FG004|NOT COMPLETED|Stage 1||0
10545824|NCT01500200|11699347|FG005|NOT COMPLETED|Stage 1||0
10545825|NCT01500200|11699342|FG000|STARTED|Stage 2||0
10545826|NCT01500200|11699343|FG001|STARTED|Stage 2||0
10865424|NCT03500692|12030436|FG000|STARTED|Overall Study||500
10865425|NCT03500692|12030436|FG000|COMPLETED|Overall Study||391
10865426|NCT03500692|12030436|FG000|NOT COMPLETED|Overall Study||109
10865435|NCT03412747|12030452|FG000|STARTED|Initial Treatment Period: Wk0-Wk16||161
10865436|NCT03412747|12030453|FG001|STARTED|Initial Treatment Period: Wk0-Wk16||158
10865437|NCT03412747|12030454|FG002|STARTED|Initial Treatment Period: Wk0-Wk16||159
10865438|NCT03412747|12030452|FG000|COMPLETED|Initial Treatment Period: Wk0-Wk16||154
10865439|NCT03412747|12030453|FG001|COMPLETED|Initial Treatment Period: Wk0-Wk16||153
10865440|NCT03412747|12030454|FG002|COMPLETED|Initial Treatment Period: Wk0-Wk16||150
10865441|NCT03412747|12030452|FG000|NOT COMPLETED|Initial Treatment Period: Wk0-Wk16||7
10865442|NCT03412747|12030453|FG001|NOT COMPLETED|Initial Treatment Period: Wk0-Wk16||5
10865443|NCT03412747|12030454|FG002|NOT COMPLETED|Initial Treatment Period: Wk0-Wk16||9
10865444|NCT03412747|12030452|FG000|STARTED|Maintenance Treatment Period: Wk16-Wk24||154
10865445|NCT03412747|12030453|FG001|STARTED|Maintenance Treatment Period: Wk16-Wk24||153
10865446|NCT03412747|12030454|FG002|STARTED|Maintenance Treatment Period: Wk16-Wk24||150
10865447|NCT03412747|12030452|FG000|COMPLETED|Maintenance Treatment Period: Wk16-Wk24||149
10865448|NCT03412747|12030453|FG001|COMPLETED|Maintenance Treatment Period: Wk16-Wk24||152
10865449|NCT03412747|12030454|FG002|COMPLETED|Maintenance Treatment Period: Wk16-Wk24||149
10865450|NCT03412747|12030452|FG000|NOT COMPLETED|Maintenance Treatment Period: Wk16-Wk24||5
10865451|NCT03412747|12030453|FG001|NOT COMPLETED|Maintenance Treatment Period: Wk16-Wk24||1
10545827|NCT01500200|11699344|FG002|STARTED|Stage 2||0
10545828|NCT01500200|11699345|FG003|STARTED|Stage 2||20
10865452|NCT03412747|12030454|FG002|NOT COMPLETED|Maintenance Treatment Period: Wk16-Wk24||1
10865453|NCT03412747|12030452|FG000|STARTED|Maintenance Treatment Period: Wk24-Wk56||149
10865454|NCT03412747|12030453|FG001|STARTED|Maintenance Treatment Period: Wk24-Wk56||152
10865455|NCT03412747|12030454|FG002|STARTED|Maintenance Treatment Period: Wk24-Wk56||149
10865456|NCT03412747|12030452|FG000|COMPLETED|Maintenance Treatment Period: Wk24-Wk56||143
10865457|NCT03412747|12030453|FG001|COMPLETED|Maintenance Treatment Period: Wk24-Wk56||143
10865458|NCT03412747|12030454|FG002|COMPLETED|Maintenance Treatment Period: Wk24-Wk56||133
10865459|NCT03412747|12030452|FG000|NOT COMPLETED|Maintenance Treatment Period: Wk24-Wk56||6
10865460|NCT03412747|12030453|FG001|NOT COMPLETED|Maintenance Treatment Period: Wk24-Wk56||9
10865461|NCT03412747|12030454|FG002|NOT COMPLETED|Maintenance Treatment Period: Wk24-Wk56||16
10865462|NCT03326193|12030472|FG000|STARTED|Overall Study||105
10865463|NCT03326193|12030472|FG000|COMPLETED|Overall Study||52
10865464|NCT03326193|12030472|FG000|NOT COMPLETED|Overall Study||53
10865465|NCT03268382|12030480|FG000|STARTED|Overall Study||28
10865466|NCT03268382|12030481|FG001|STARTED|Overall Study||3
10865467|NCT03268382|12030482|FG002|STARTED|Overall Study||2
10865468|NCT03268382|12030483|FG003|STARTED|Overall Study||3
10865469|NCT03268382|12030480|FG000|COMPLETED|Overall Study||28
10865470|NCT03268382|12030481|FG001|COMPLETED|Overall Study||3
10865471|NCT03268382|12030482|FG002|COMPLETED|Overall Study||2
10865472|NCT03268382|12030483|FG003|COMPLETED|Overall Study||3
10865473|NCT03268382|12030480|FG000|NOT COMPLETED|Overall Study||0
10865474|NCT03268382|12030481|FG001|NOT COMPLETED|Overall Study||0
10865475|NCT03268382|12030482|FG002|NOT COMPLETED|Overall Study||0
10865476|NCT03268382|12030483|FG003|NOT COMPLETED|Overall Study||0
10865477|NCT03230292|12030493|FG000|STARTED|Overall Study||43
10865478|NCT03230292|12030493|FG000|COMPLETED|Overall Study||37
10865479|NCT03230292|12030493|FG000|NOT COMPLETED|Overall Study||6
10865480|NCT03227224|12030503|FG000|STARTED|Double-blind Treatment Period (6 Weeks)||138
10865481|NCT03227224|12030504|FG001|STARTED|Double-blind Treatment Period (6 Weeks)||33
10865482|NCT03227224|12030505|FG002|STARTED|Double-blind Treatment Period (6 Weeks)||63
10865483|NCT03227224|12030506|FG003|STARTED|Double-blind Treatment Period (6 Weeks)||53
10865484|NCT03227224|12030503|FG000|Treated|Double-blind Treatment Period (6 Weeks)||137
10865485|NCT03227224|12030504|FG001|Treated|Double-blind Treatment Period (6 Weeks)||33
10865486|NCT03227224|12030505|FG002|Treated|Double-blind Treatment Period (6 Weeks)||61
10865487|NCT03227224|12030506|FG003|Treated|Double-blind Treatment Period (6 Weeks)||52
10865488|NCT03227224|12030503|FG000|COMPLETED|Double-blind Treatment Period (6 Weeks)||123
10865489|NCT03227224|12030504|FG001|COMPLETED|Double-blind Treatment Period (6 Weeks)||27
10865490|NCT03227224|12030505|FG002|COMPLETED|Double-blind Treatment Period (6 Weeks)||55
10865491|NCT03227224|12030506|FG003|COMPLETED|Double-blind Treatment Period (6 Weeks)||46
10865492|NCT03227224|12030503|FG000|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||15
10865493|NCT03227224|12030504|FG001|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||6
10865494|NCT03227224|12030505|FG002|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||8
10865495|NCT03227224|12030506|FG003|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||7
10865496|NCT03227224|12030503|FG000|STARTED|Follow-up Phase (2 Weeks)|All participants that started the double-blind period were followed-up for follow-up phase.|138
10865497|NCT03227224|12030504|FG001|STARTED|Follow-up Phase (2 Weeks)|All participants that started the double-blind period were followed-up for follow-up phase.|33
10865498|NCT03227224|12030505|FG002|STARTED|Follow-up Phase (2 Weeks)|All participants that started the double-blind period were followed-up for follow-up phase.|63
10865499|NCT03227224|12030506|FG003|STARTED|Follow-up Phase (2 Weeks)|All participants that started the double-blind period were followed-up for follow-up phase.|53
10865500|NCT03227224|12030503|FG000|COMPLETED|Follow-up Phase (2 Weeks)||134
10865501|NCT03227224|12030504|FG001|COMPLETED|Follow-up Phase (2 Weeks)||29
10865502|NCT03227224|12030505|FG002|COMPLETED|Follow-up Phase (2 Weeks)||57
10865503|NCT03227224|12030506|FG003|COMPLETED|Follow-up Phase (2 Weeks)||50
10865504|NCT03227224|12030503|FG000|NOT COMPLETED|Follow-up Phase (2 Weeks)||4
10865505|NCT03227224|12030504|FG001|NOT COMPLETED|Follow-up Phase (2 Weeks)||4
10865506|NCT03227224|12030505|FG002|NOT COMPLETED|Follow-up Phase (2 Weeks)||6
10865507|NCT03227224|12030506|FG003|NOT COMPLETED|Follow-up Phase (2 Weeks)||3
10865508|NCT03202628|12030523|FG000|STARTED|Overall Study||8
10865509|NCT03202628|12030523|FG000|COMPLETED|Overall Study||8
10865510|NCT03202628|12030523|FG000|NOT COMPLETED|Overall Study||0
10865511|NCT03151746|12030529|FG000|STARTED|Overall Study||9
10865512|NCT03151746|12030530|FG001|STARTED|Overall Study||11
10865513|NCT03151746|12030529|FG000|COMPLETED|Overall Study||9
10865514|NCT03151746|12030530|FG001|COMPLETED|Overall Study||11
10865515|NCT03151746|12030529|FG000|NOT COMPLETED|Overall Study||0
10865516|NCT03151746|12030530|FG001|NOT COMPLETED|Overall Study||0
10865517|NCT03148496|12030540|FG000|STARTED|Overall Study||27
10865518|NCT03148496|12030541|FG001|STARTED|Overall Study||28
10865519|NCT03148496|12030542|FG002|STARTED|Overall Study||25
10865520|NCT03148496|12030543|FG003|STARTED|Overall Study||27
10865521|NCT03148496|12030540|FG000|COMPLETED|Overall Study||20
10865522|NCT03148496|12030541|FG001|COMPLETED|Overall Study||19
10865523|NCT03148496|12030542|FG002|COMPLETED|Overall Study||19
10865524|NCT03148496|12030543|FG003|COMPLETED|Overall Study||26
10865525|NCT03148496|12030540|FG000|NOT COMPLETED|Overall Study||7
10865526|NCT03148496|12030541|FG001|NOT COMPLETED|Overall Study||9
10865527|NCT03148496|12030542|FG002|NOT COMPLETED|Overall Study||6
10865528|NCT03148496|12030543|FG003|NOT COMPLETED|Overall Study||1
10865529|NCT03069352|12030559|FG000|STARTED|Overall Study||68
10865530|NCT03069352|12030560|FG001|STARTED|Overall Study||143
10865531|NCT03069352|12030559|FG000|Received Treatment|Overall Study||68
10865532|NCT03069352|12030560|FG001|Received Treatment|Overall Study||142
10865533|NCT03069352|12030559|FG000|COMPLETED|Overall Study||56
10865534|NCT03069352|12030560|FG001|COMPLETED|Overall Study||103
10865535|NCT03069352|12030559|FG000|NOT COMPLETED|Overall Study||12
10865536|NCT03069352|12030560|FG001|NOT COMPLETED|Overall Study||40
10865537|NCT03056040|12030568|FG000|STARTED|Primary Evaluation Period||97
10865538|NCT03056040|12030569|FG001|STARTED|Primary Evaluation Period||98
10865539|NCT03056040|12030568|FG000|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||97
10865540|NCT03056040|12030569|FG001|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||98
10865541|NCT03056040|12030568|FG000|COMPLETED|Primary Evaluation Period||96
10865542|NCT03056040|12030569|FG001|COMPLETED|Primary Evaluation Period||95
10865543|NCT03056040|12030568|FG000|NOT COMPLETED|Primary Evaluation Period||1
10865544|NCT03056040|12030569|FG001|NOT COMPLETED|Primary Evaluation Period||3
10865545|NCT03056040|12030568|FG000|STARTED|Extension Period||96
10865546|NCT03056040|12030569|FG001|STARTED|Extension Period||95
10865547|NCT03056040|12030568|FG000|Received at Least 1 Dose of Ravulizumab|Extension Period||96
10865548|NCT03056040|12030569|FG001|Received at Least 1 Dose of Ravulizumab|Extension Period||95
10865549|NCT03056040|12030568|FG000|COMPLETED|Extension Period||0
10865550|NCT03056040|12030569|FG001|COMPLETED|Extension Period||0
10865551|NCT03056040|12030568|FG000|NOT COMPLETED|Extension Period||96
10865552|NCT03056040|12030569|FG001|NOT COMPLETED|Extension Period||95
10865559|NCT03020589|12030590|FG000|STARTED|Overall Study||40
10865560|NCT03020589|12030591|FG001|STARTED|Overall Study||57
10865561|NCT03020589|12030590|FG000|COMPLETED|Overall Study||40
10865562|NCT03020589|12030591|FG001|COMPLETED|Overall Study||57
10865563|NCT03020589|12030590|FG000|NOT COMPLETED|Overall Study||0
10865564|NCT03020589|12030591|FG001|NOT COMPLETED|Overall Study||0
10865565|NCT03014635|12030599|FG000|STARTED|Overall Study||204
10865566|NCT03014635|12030600|FG001|STARTED|Overall Study||102
10865567|NCT03014635|12030599|FG000|COMPLETED|Overall Study||191
10865568|NCT03014635|12030600|FG001|COMPLETED|Overall Study||93
10865569|NCT03014635|12030599|FG000|NOT COMPLETED|Overall Study||13
10865570|NCT03014635|12030600|FG001|NOT COMPLETED|Overall Study||9
10865571|NCT03014622|12030608|FG000|STARTED|Overall Study||201
10865572|NCT03014622|12030609|FG001|STARTED|Overall Study||102
10865573|NCT03014622|12030608|FG000|COMPLETED|Overall Study||182
10865574|NCT03014622|12030609|FG001|COMPLETED|Overall Study||93
10865575|NCT03014622|12030608|FG000|NOT COMPLETED|Overall Study||19
10865576|NCT03014622|12030609|FG001|NOT COMPLETED|Overall Study||9
10865577|NCT03010527|12030619|FG000|STARTED|Overall Study||15
10865578|NCT03010527|12030620|FG001|STARTED|Overall Study||111
10865579|NCT03010527|12030621|FG002|STARTED|Overall Study||91
10865580|NCT03010527|12030619|FG000|COMPLETED|Overall Study||15
10865581|NCT03010527|12030620|FG001|COMPLETED|Overall Study||92
10865582|NCT03010527|12030621|FG002|COMPLETED|Overall Study||75
10865583|NCT03010527|12030619|FG000|NOT COMPLETED|Overall Study||0
10865584|NCT03010527|12030620|FG001|NOT COMPLETED|Overall Study||19
10865585|NCT03010527|12030621|FG002|NOT COMPLETED|Overall Study||16
10865586|NCT03007979|12030638|FG000|STARTED|Overall Study||55
10865587|NCT03007979|12030638|FG000|COMPLETED|Overall Study||54
10865588|NCT03007979|12030638|FG000|NOT COMPLETED|Overall Study||1
10865592|NCT02958865|12030653|FG000|STARTED|Induction Period (Day 1 to Week 8)||25
10865593|NCT02958865|12030654|FG001|STARTED|Induction Period (Day 1 to Week 8)||51
10865594|NCT02958865|12030655|FG002|STARTED|Induction Period (Day 1 to Week 8)||49
10865595|NCT02958865|12030656|FG003|STARTED|Induction Period (Day 1 to Week 8)||50
10865596|NCT02958865|12030657|FG004|STARTED|Induction Period (Day 1 to Week 8)||48
10865597|NCT02958865|12030658|FG005|STARTED|Induction Period (Day 1 to Week 8)||47
10865598|NCT02958865|12030659|FG006|STARTED|Induction Period (Day 1 to Week 8)||47
10865599|NCT02958865|12030660|FG007|STARTED|Induction Period (Day 1 to Week 8)||0
10865600|NCT02958865|12030661|FG008|STARTED|Induction Period (Day 1 to Week 8)||0
10865601|NCT02958865|12030662|FG009|STARTED|Induction Period (Day 1 to Week 8)||0
10865602|NCT02958865|12030663|FG010|STARTED|Induction Period (Day 1 to Week 8)||0
10865603|NCT02958865|12030664|FG011|STARTED|Induction Period (Day 1 to Week 8)||0
10294346|NCT03666988|11427041|FG000|STARTED|Part 1 (Up to 28 Months)||3
10294347|NCT03666988|11427042|FG001|STARTED|Part 1 (Up to 28 Months)||16
10294348|NCT03666988|11427043|FG002|STARTED|Part 1 (Up to 28 Months)||12
10294349|NCT03666988|11427044|FG003|STARTED|Part 1 (Up to 28 Months)||0
10294350|NCT03666988|11427045|FG004|STARTED|Part 1 (Up to 28 Months)||0
10294351|NCT03666988|11427046|FG005|STARTED|Part 1 (Up to 28 Months)||0
10294352|NCT03666988|11427041|FG000|COMPLETED|Part 1 (Up to 28 Months)||0
10294353|NCT03666988|11427042|FG001|COMPLETED|Part 1 (Up to 28 Months)||0
10294354|NCT03666988|11427043|FG002|COMPLETED|Part 1 (Up to 28 Months)||0
10294355|NCT03666988|11427044|FG003|COMPLETED|Part 1 (Up to 28 Months)||0
10294356|NCT03666988|11427045|FG004|COMPLETED|Part 1 (Up to 28 Months)||0
10294357|NCT03666988|11427046|FG005|COMPLETED|Part 1 (Up to 28 Months)||0
10294358|NCT03666988|11427041|FG000|NOT COMPLETED|Part 1 (Up to 28 Months)||3
10294359|NCT03666988|11427042|FG001|NOT COMPLETED|Part 1 (Up to 28 Months)||16
10865604|NCT02958865|12030665|FG012|STARTED|Induction Period (Day 1 to Week 8)||0
10865605|NCT02958865|12030666|FG013|STARTED|Induction Period (Day 1 to Week 8)||0
10865606|NCT02958865|12030667|FG014|STARTED|Induction Period (Day 1 to Week 8)||0
10865607|NCT02958865|12030668|FG015|STARTED|Induction Period (Day 1 to Week 8)||0
10865608|NCT02958865|12030653|FG000|COMPLETED|Induction Period (Day 1 to Week 8)||21
10865609|NCT02958865|12030654|FG001|COMPLETED|Induction Period (Day 1 to Week 8)||44
10865610|NCT02958865|12030655|FG002|COMPLETED|Induction Period (Day 1 to Week 8)||43
10417442|NCT00799617|11562024|FG001|COMPLETED|Cardiovascular Trial||65
10417443|NCT00799617|11562023|FG000|NOT COMPLETED|Cardiovascular Trial||15
10417444|NCT00799617|11562024|FG001|NOT COMPLETED|Cardiovascular Trial||17
10417445|NCT00799617|11562023|FG000|STARTED|Bone Trial||110
10417446|NCT00799617|11562024|FG001|STARTED|Bone Trial||101
10417447|NCT00799617|11562023|FG000|COMPLETED|Bone Trial||104
10417448|NCT00799617|11562024|FG001|COMPLETED|Bone Trial||85
10417449|NCT00799617|11562023|FG000|NOT COMPLETED|Bone Trial||6
10417450|NCT00799617|11562024|FG001|NOT COMPLETED|Bone Trial||16
10417451|NCT00799617|11562023|FG000|STARTED|Cognitive Function Trial||247
10417452|NCT00799617|11562024|FG001|STARTED|Cognitive Function Trial||246
10417453|NCT00799617|11562023|FG000|COMPLETED|Cognitive Function Trial||247
10417454|NCT00799617|11562024|FG001|COMPLETED|Cognitive Function Trial||245
10417455|NCT00799617|11562023|FG000|NOT COMPLETED|Cognitive Function Trial||0
10417456|NCT00799617|11562024|FG001|NOT COMPLETED|Cognitive Function Trial||1
10417457|NCT00799617|11562023|FG000|STARTED|Anemia Trial||27
10417458|NCT00799617|11562024|FG001|STARTED|Anemia Trial||35
10417459|NCT00799617|11562023|FG000|COMPLETED|Anemia Trial||24
10417460|NCT00799617|11562024|FG001|COMPLETED|Anemia Trial||32
10417461|NCT00799617|11562023|FG000|NOT COMPLETED|Anemia Trial||3
10417462|NCT00799617|11562024|FG001|NOT COMPLETED|Anemia Trial||3
10417463|NCT00799643|11562032|FG000|STARTED|Overall Study||140
10417464|NCT00799643|11562033|FG001|STARTED|Overall Study||146
10417465|NCT00799643|11562032|FG000|COMPLETED|Overall Study||115
10417466|NCT00799643|11562033|FG001|COMPLETED|Overall Study||119
10417467|NCT00799643|11562032|FG000|NOT COMPLETED|Overall Study||25
10417468|NCT00799643|11562033|FG001|NOT COMPLETED|Overall Study||27
10417469|NCT00799708|11562043|FG000|STARTED|Overall Study||10
10417470|NCT00799708|11562044|FG001|STARTED|Overall Study||6
10417471|NCT00799708|11562045|FG002|STARTED|Overall Study||11
10417472|NCT00799708|11562043|FG000|COMPLETED|Overall Study||9
10417473|NCT00799708|11562044|FG001|COMPLETED|Overall Study||6
10417474|NCT00799708|11562045|FG002|COMPLETED|Overall Study||11
10417475|NCT00799708|11562043|FG000|NOT COMPLETED|Overall Study||1
10417476|NCT00799708|11562044|FG001|NOT COMPLETED|Overall Study||0
10417477|NCT00799708|11562045|FG002|NOT COMPLETED|Overall Study||0
10417478|NCT00799812|11562055|FG000|STARTED|Overall Study||335
10417479|NCT00799812|11562055|FG000|CHG Swabstick (3 @ Once)|Overall Study||139
10417480|NCT00799812|11562055|FG000|CHG Swabstick Sequential|Overall Study||138
10417481|NCT00799812|11562055|FG000|Hibiclens|Overall Study||133
10417482|NCT00799812|11562055|FG000|Sterile Water Swab (3 @ Once)|Overall Study||132
10417483|NCT00799812|11562055|FG000|Sterile Water Swabstick (Sequential)|Overall Study||126
10417484|NCT00799812|11562055|FG000|COMPLETED|Overall Study||335
10417485|NCT00799812|11562055|FG000|NOT COMPLETED|Overall Study||0
10417486|NCT00799825|11562067|FG000|STARTED|Overall Study||344
10417487|NCT00799825|11562067|FG000|COMPLETED|Overall Study||296
10417488|NCT00799825|11562067|FG000|NOT COMPLETED|Overall Study||48
10417489|NCT00799903|11562073|FG000|STARTED|Overall Study||7904
10417490|NCT00799903|11562074|FG001|STARTED|Overall Study||7924
10417491|NCT00799903|11562073|FG000|COMPLETED|Overall Study||7631
10417492|NCT00799903|11562074|FG001|COMPLETED|Overall Study||7646
10417493|NCT00799903|11562073|FG000|NOT COMPLETED|Overall Study||273
10417494|NCT00799903|11562074|FG001|NOT COMPLETED|Overall Study||278
10417495|NCT00799981|11562080|FG000|STARTED|Overall Study||10
10417496|NCT00799981|11562081|FG001|STARTED|Overall Study||9
10417497|NCT00799981|11562082|FG002|STARTED|Overall Study||10
10417498|NCT00799981|11562083|FG003|STARTED|Overall Study||10
10417499|NCT00799981|11562084|FG004|STARTED|Overall Study||11
10417500|NCT00799981|11562085|FG005|STARTED|Overall Study||10
10417501|NCT00799981|11562080|FG000|COMPLETED|Overall Study||10
10417502|NCT00799981|11562081|FG001|COMPLETED|Overall Study||9
10417503|NCT00799981|11562082|FG002|COMPLETED|Overall Study||10
10417504|NCT00799981|11562083|FG003|COMPLETED|Overall Study||10
10417505|NCT00799981|11562084|FG004|COMPLETED|Overall Study||11
10417506|NCT00799981|11562085|FG005|COMPLETED|Overall Study||10
10417507|NCT00799981|11562080|FG000|NOT COMPLETED|Overall Study||0
10417508|NCT00799981|11562081|FG001|NOT COMPLETED|Overall Study||0
10417509|NCT00799981|11562082|FG002|NOT COMPLETED|Overall Study||0
10417510|NCT00799981|11562083|FG003|NOT COMPLETED|Overall Study||0
10417511|NCT00799981|11562084|FG004|NOT COMPLETED|Overall Study||0
10417512|NCT00799981|11562085|FG005|NOT COMPLETED|Overall Study||0
10417513|NCT00800176|11562100|FG000|STARTED|Overall Study||66
10865611|NCT02958865|12030656|FG003|COMPLETED|Induction Period (Day 1 to Week 8)||41
10865612|NCT02958865|12030657|FG004|COMPLETED|Induction Period (Day 1 to Week 8)||45
10417514|NCT00800176|11562101|FG001|STARTED|Overall Study||66
10417515|NCT00800176|11562102|FG002|STARTED|Overall Study||65
10417516|NCT00800176|11562103|FG003|STARTED|Overall Study||66
10417517|NCT00800176|11562104|FG004|STARTED|Overall Study||64
10417518|NCT00800176|11562105|FG005|STARTED|Overall Study||67
10417519|NCT00800176|11562100|FG000|COMPLETED|Overall Study||57
10417520|NCT00800176|11562101|FG001|COMPLETED|Overall Study||60
10417521|NCT00800176|11562102|FG002|COMPLETED|Overall Study||65
10417522|NCT00800176|11562103|FG003|COMPLETED|Overall Study||62
10865613|NCT02958865|12030658|FG005|COMPLETED|Induction Period (Day 1 to Week 8)||43
10865614|NCT02958865|12030659|FG006|COMPLETED|Induction Period (Day 1 to Week 8)||44
10865615|NCT02958865|12030660|FG007|COMPLETED|Induction Period (Day 1 to Week 8)||0
10865616|NCT02958865|12030661|FG008|COMPLETED|Induction Period (Day 1 to Week 8)||0
10865617|NCT02958865|12030662|FG009|COMPLETED|Induction Period (Day 1 to Week 8)||0
10865618|NCT02958865|12030663|FG010|COMPLETED|Induction Period (Day 1 to Week 8)||0
10865619|NCT02958865|12030664|FG011|COMPLETED|Induction Period (Day 1 to Week 8)||0
10865620|NCT02958865|12030665|FG012|COMPLETED|Induction Period (Day 1 to Week 8)||0
10865621|NCT02958865|12030666|FG013|COMPLETED|Induction Period (Day 1 to Week 8)||0
10865622|NCT02958865|12030667|FG014|COMPLETED|Induction Period (Day 1 to Week 8)||0
10865623|NCT02958865|12030668|FG015|COMPLETED|Induction Period (Day 1 to Week 8)||0
10865624|NCT02958865|12030653|FG000|NOT COMPLETED|Induction Period (Day 1 to Week 8)||4
10865625|NCT02958865|12030654|FG001|NOT COMPLETED|Induction Period (Day 1 to Week 8)||7
10865626|NCT02958865|12030655|FG002|NOT COMPLETED|Induction Period (Day 1 to Week 8)||6
10865627|NCT02958865|12030656|FG003|NOT COMPLETED|Induction Period (Day 1 to Week 8)||9
10865628|NCT02958865|12030657|FG004|NOT COMPLETED|Induction Period (Day 1 to Week 8)||3
10865629|NCT02958865|12030658|FG005|NOT COMPLETED|Induction Period (Day 1 to Week 8)||4
10865630|NCT02958865|12030659|FG006|NOT COMPLETED|Induction Period (Day 1 to Week 8)||3
10865631|NCT02958865|12030660|FG007|NOT COMPLETED|Induction Period (Day 1 to Week 8)||0
10865632|NCT02958865|12030661|FG008|NOT COMPLETED|Induction Period (Day 1 to Week 8)||0
10865633|NCT02958865|12030662|FG009|NOT COMPLETED|Induction Period (Day 1 to Week 8)||0
10865634|NCT02958865|12030663|FG010|NOT COMPLETED|Induction Period (Day 1 to Week 8)||0
10865635|NCT02958865|12030664|FG011|NOT COMPLETED|Induction Period (Day 1 to Week 8)||0
10865636|NCT02958865|12030665|FG012|NOT COMPLETED|Induction Period (Day 1 to Week 8)||0
10865637|NCT02958865|12030666|FG013|NOT COMPLETED|Induction Period (Day 1 to Week 8)||0
10865638|NCT02958865|12030667|FG014|NOT COMPLETED|Induction Period (Day 1 to Week 8)||0
10865639|NCT02958865|12030668|FG015|NOT COMPLETED|Induction Period (Day 1 to Week 8)||0
10865640|NCT02958865|12030653|FG000|STARTED|Chronic Period (Week 8 to Week 32)||0
10865641|NCT02958865|12030654|FG001|STARTED|Chronic Period (Week 8 to Week 32)||0
10865642|NCT02958865|12030655|FG002|STARTED|Chronic Period (Week 8 to Week 32)||0
10865643|NCT02958865|12030656|FG003|STARTED|Chronic Period (Week 8 to Week 32)||0
10865644|NCT02958865|12030657|FG004|STARTED|Chronic Period (Week 8 to Week 32)||0
10865645|NCT02958865|12030658|FG005|STARTED|Chronic Period (Week 8 to Week 32)||0
10865646|NCT02958865|12030659|FG006|STARTED|Chronic Period (Week 8 to Week 32)||0
10865647|NCT02958865|12030660|FG007|STARTED|Chronic Period (Week 8 to Week 32)||35
10865648|NCT02958865|12030661|FG008|STARTED|Chronic Period (Week 8 to Week 32)||36
10865649|NCT02958865|12030662|FG009|STARTED|Chronic Period (Week 8 to Week 32)||39
10865650|NCT02958865|12030663|FG010|STARTED|Chronic Period (Week 8 to Week 32)||10
10865651|NCT02958865|12030664|FG011|STARTED|Chronic Period (Week 8 to Week 32)||38
10865652|NCT02958865|12030665|FG012|STARTED|Chronic Period (Week 8 to Week 32)||37
10865653|NCT02958865|12030666|FG013|STARTED|Chronic Period (Week 8 to Week 32)||39
10865654|NCT02958865|12030667|FG014|STARTED|Chronic Period (Week 8 to Week 32)||9
10865655|NCT02958865|12030668|FG015|STARTED|Chronic Period (Week 8 to Week 32)||37
10865656|NCT02958865|12030653|FG000|COMPLETED|Chronic Period (Week 8 to Week 32)||0
10865657|NCT02958865|12030654|FG001|COMPLETED|Chronic Period (Week 8 to Week 32)||0
10865658|NCT02958865|12030655|FG002|COMPLETED|Chronic Period (Week 8 to Week 32)||0
10865659|NCT02958865|12030656|FG003|COMPLETED|Chronic Period (Week 8 to Week 32)||0
10865660|NCT02958865|12030657|FG004|COMPLETED|Chronic Period (Week 8 to Week 32)||0
10865661|NCT02958865|12030658|FG005|COMPLETED|Chronic Period (Week 8 to Week 32)||0
10865662|NCT02958865|12030659|FG006|COMPLETED|Chronic Period (Week 8 to Week 32)||0
10865663|NCT02958865|12030660|FG007|COMPLETED|Chronic Period (Week 8 to Week 32)||33
10865664|NCT02958865|12030661|FG008|COMPLETED|Chronic Period (Week 8 to Week 32)||33
10865665|NCT02958865|12030662|FG009|COMPLETED|Chronic Period (Week 8 to Week 32)||33
10865666|NCT02958865|12030663|FG010|COMPLETED|Chronic Period (Week 8 to Week 32)||10
10865667|NCT02958865|12030664|FG011|COMPLETED|Chronic Period (Week 8 to Week 32)||31
10865668|NCT02958865|12030665|FG012|COMPLETED|Chronic Period (Week 8 to Week 32)||26
10865669|NCT02958865|12030666|FG013|COMPLETED|Chronic Period (Week 8 to Week 32)||31
10865670|NCT02958865|12030667|FG014|COMPLETED|Chronic Period (Week 8 to Week 32)||5
10865671|NCT02958865|12030668|FG015|COMPLETED|Chronic Period (Week 8 to Week 32)||20
10865672|NCT02958865|12030653|FG000|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||0
10865673|NCT02958865|12030654|FG001|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||0
10865674|NCT02958865|12030655|FG002|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||0
10865675|NCT02958865|12030656|FG003|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||0
10865676|NCT02958865|12030657|FG004|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||0
10865677|NCT02958865|12030658|FG005|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||0
10865678|NCT02958865|12030659|FG006|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||0
10865679|NCT02958865|12030660|FG007|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||2
10865680|NCT02958865|12030661|FG008|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||3
10865681|NCT02958865|12030662|FG009|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||6
10865682|NCT02958865|12030663|FG010|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||0
10865683|NCT02958865|12030664|FG011|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||7
10865684|NCT02958865|12030665|FG012|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||11
10865685|NCT02958865|12030666|FG013|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||8
10865686|NCT02958865|12030667|FG014|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||4
10865687|NCT02958865|12030668|FG015|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||17
10865688|NCT02949700|12030715|FG000|STARTED|Phase I||9
10865689|NCT02949700|12030716|FG001|STARTED|Phase I||3
10865690|NCT02949700|12030717|FG002|STARTED|Phase I||0
10865691|NCT02949700|12030718|FG003|STARTED|Phase I||0
10865692|NCT02949700|12030715|FG000|COMPLETED|Phase I||7
10865693|NCT02949700|12030716|FG001|COMPLETED|Phase I||2
10865694|NCT02949700|12030717|FG002|COMPLETED|Phase I||0
10865695|NCT02949700|12030718|FG003|COMPLETED|Phase I||0
10865696|NCT02949700|12030715|FG000|NOT COMPLETED|Phase I||2
10865697|NCT02949700|12030716|FG001|NOT COMPLETED|Phase I||1
10865698|NCT02949700|12030717|FG002|NOT COMPLETED|Phase I||0
10865699|NCT02949700|12030718|FG003|NOT COMPLETED|Phase I||0
10865700|NCT02949700|12030715|FG000|STARTED|Phase II||0
10865701|NCT02949700|12030716|FG001|STARTED|Phase II||0
10865702|NCT02949700|12030717|FG002|STARTED|Phase II|"All patients underwent a 2 week lead-in period in order to decrease the gastrointestinal toxicity associated with metformin. During this lead-in period, all patients started metformin at the dose of 500mg PO BID and increased to their assigned dose levels at the end of the lead-in period.~One patient, however, did not complete the lead-in period and was taken off study due to protocol violation, hence the assignment of this patient to the lead-in dose, or DL-1."|1
10865703|NCT02949700|12030718|FG003|STARTED|Phase II||12
10865704|NCT02949700|12030715|FG000|COMPLETED|Phase II||0
10865705|NCT02949700|12030716|FG001|COMPLETED|Phase II||0
10865706|NCT02949700|12030717|FG002|COMPLETED|Phase II||0
10865707|NCT02949700|12030718|FG003|COMPLETED|Phase II||7
10865708|NCT02949700|12030715|FG000|NOT COMPLETED|Phase II||0
10865709|NCT02949700|12030716|FG001|NOT COMPLETED|Phase II||0
10865710|NCT02949700|12030717|FG002|NOT COMPLETED|Phase II||1
10865711|NCT02949700|12030718|FG003|NOT COMPLETED|Phase II||5
10865712|NCT02905006|12030733|FG000|STARTED|Overall Study||42
10865713|NCT02905006|12030734|FG001|STARTED|Overall Study||39
10865714|NCT02905006|12030735|FG002|STARTED|Overall Study||43
10865715|NCT02905006|12030736|FG003|STARTED|Overall Study||40
10865716|NCT02905006|12030737|FG004|STARTED|Overall Study||43
10865717|NCT02905006|12030738|FG005|STARTED|Overall Study||43
10865718|NCT02905006|12030733|FG000|Completed Treatment Period|Overall Study||37
10865719|NCT02905006|12030734|FG001|Completed Treatment Period|Overall Study||36
10865720|NCT02905006|12030735|FG002|Completed Treatment Period|Overall Study||38
10865721|NCT02905006|12030736|FG003|Completed Treatment Period|Overall Study||34
10865722|NCT02905006|12030737|FG004|Completed Treatment Period|Overall Study||40
10865723|NCT02905006|12030738|FG005|Completed Treatment Period|Overall Study||39
10865724|NCT02905006|12030733|FG000|Enrolled in Extension Study (PS0011)|Overall Study||38
10865725|NCT02905006|12030734|FG001|Enrolled in Extension Study (PS0011)|Overall Study||35
10865726|NCT02905006|12030735|FG002|Enrolled in Extension Study (PS0011)|Overall Study||39
10865727|NCT02905006|12030736|FG003|Enrolled in Extension Study (PS0011)|Overall Study||38
10865728|NCT02905006|12030737|FG004|Enrolled in Extension Study (PS0011)|Overall Study||42
10865729|NCT02905006|12030738|FG005|Enrolled in Extension Study (PS0011)|Overall Study||40
10865730|NCT02905006|12030733|FG000|Entered Safety Follow-up Period|Overall Study||4
10865731|NCT02905006|12030734|FG001|Entered Safety Follow-up Period|Overall Study||4
10865732|NCT02905006|12030735|FG002|Entered Safety Follow-up Period|Overall Study||4
10865733|NCT02905006|12030736|FG003|Entered Safety Follow-up Period|Overall Study||2
10865734|NCT02905006|12030737|FG004|Entered Safety Follow-up Period|Overall Study||1
10865735|NCT02905006|12030738|FG005|Entered Safety Follow-up Period|Overall Study||3
10865736|NCT02905006|12030733|FG000|COMPLETED|Overall Study||37
10865737|NCT02905006|12030734|FG001|COMPLETED|Overall Study||36
10865738|NCT02905006|12030735|FG002|COMPLETED|Overall Study||38
10865739|NCT02905006|12030736|FG003|COMPLETED|Overall Study||34
10865740|NCT02905006|12030737|FG004|COMPLETED|Overall Study||40
10865741|NCT02905006|12030738|FG005|COMPLETED|Overall Study||39
10865742|NCT02905006|12030733|FG000|NOT COMPLETED|Overall Study||5
10865743|NCT02905006|12030734|FG001|NOT COMPLETED|Overall Study||3
10865744|NCT02905006|12030735|FG002|NOT COMPLETED|Overall Study||5
10865745|NCT02905006|12030736|FG003|NOT COMPLETED|Overall Study||6
10865746|NCT02905006|12030737|FG004|NOT COMPLETED|Overall Study||3
10865747|NCT02905006|12030738|FG005|NOT COMPLETED|Overall Study||4
10865748|NCT02833844|12030778|FG000|STARTED|Double-Blind Period||157
10865749|NCT02833844|12030779|FG001|STARTED|Double-Blind Period||310
10417523|NCT00800176|11562104|FG004|COMPLETED|Overall Study||60
10417524|NCT00800176|11562105|FG005|COMPLETED|Overall Study||62
10417525|NCT00800176|11562100|FG000|NOT COMPLETED|Overall Study||9
10417526|NCT00800176|11562101|FG001|NOT COMPLETED|Overall Study||6
10417527|NCT00800176|11562102|FG002|NOT COMPLETED|Overall Study||0
10417528|NCT00800176|11562103|FG003|NOT COMPLETED|Overall Study||4
10417529|NCT00800176|11562104|FG004|NOT COMPLETED|Overall Study||4
10417530|NCT00800176|11562105|FG005|NOT COMPLETED|Overall Study||5
10417531|NCT00800202|11562121|FG000|STARTED|Overall Study||67
10417532|NCT00800202|11562122|FG001|STARTED|Overall Study||24
10417533|NCT00800202|11562121|FG000|COMPLETED|Overall Study||0
10417534|NCT00800202|11562122|FG001|COMPLETED|Overall Study||0
10417535|NCT00800202|11562121|FG000|NOT COMPLETED|Overall Study||67
10417536|NCT00800202|11562122|FG001|NOT COMPLETED|Overall Study||24
10417537|NCT00800254|11562130|FG000|STARTED|Overall Study||35
10417538|NCT00800254|11562131|FG001|STARTED|Overall Study||31
10417539|NCT00800254|11562130|FG000|3.5 Weeks Post-operatively|Overall Study||31
10417540|NCT00800254|11562131|FG001|3.5 Weeks Post-operatively|Overall Study||31
10417541|NCT00800254|11562130|FG000|COMPLETED|Overall Study||30
10417542|NCT00800254|11562131|FG001|COMPLETED|Overall Study||25
10417543|NCT00800254|11562130|FG000|NOT COMPLETED|Overall Study||5
10865750|NCT02833844|12030778|FG000|Randomized and Treated|Double-Blind Period||157
10865751|NCT02833844|12030779|FG001|Randomized and Treated|Double-Blind Period||307
10865752|NCT02833844|12030778|FG000|COMPLETED|Double-Blind Period|completed double-blind period|155
10865753|NCT02833844|12030779|FG001|COMPLETED|Double-Blind Period|completed double-blind period|303
10865754|NCT02833844|12030778|FG000|NOT COMPLETED|Double-Blind Period||2
10865755|NCT02833844|12030779|FG001|NOT COMPLETED|Double-Blind Period||7
10865756|NCT02833844|12030778|FG000|STARTED|Open-Label Period|3 participants did not continue to open-label period|152
10865757|NCT02833844|12030779|FG001|STARTED|Open-Label Period||303
10865758|NCT02833844|12030778|FG000|Received Open-Label Study Drug|Open-Label Period||152
10865759|NCT02833844|12030779|FG001|Received Open-Label Study Drug|Open-Label Period||299
10865760|NCT02833844|12030778|FG000|COMPLETED|Open-Label Period||150
10865761|NCT02833844|12030779|FG001|COMPLETED|Open-Label Period||301
10865762|NCT02833844|12030778|FG000|NOT COMPLETED|Open-Label Period||2
10865763|NCT02833844|12030779|FG001|NOT COMPLETED|Open-Label Period||2
10865764|NCT02778399|12030793|FG000|STARTED|Up to Week 12 Treatment Period||54
10865765|NCT02778399|12030794|FG001|STARTED|Up to Week 12 Treatment Period||49
10865766|NCT02778399|12030795|FG002|STARTED|Up to Week 12 Treatment Period||57
10865767|NCT02778399|12030796|FG003|STARTED|Up to Week 12 Treatment Period||58
10865768|NCT02778399|12030797|FG004|STARTED|Up to Week 12 Treatment Period||53
10865769|NCT02778399|12030798|FG005|STARTED|Up to Week 12 Treatment Period||57
10865770|NCT02778399|12030793|FG000|Included in SAFETY SET|Up to Week 12 Treatment Period||54
10865771|NCT02778399|12030794|FG001|Included in SAFETY SET|Up to Week 12 Treatment Period||49
10865772|NCT02778399|12030795|FG002|Included in SAFETY SET|Up to Week 12 Treatment Period||57
10865773|NCT02778399|12030796|FG003|Included in SAFETY SET|Up to Week 12 Treatment Period||58
10865774|NCT02778399|12030797|FG004|Included in SAFETY SET|Up to Week 12 Treatment Period||52
10865775|NCT02778399|12030798|FG005|Included in SAFETY SET|Up to Week 12 Treatment Period||57
10865776|NCT02778399|12030793|FG000|Included in FAS|Up to Week 12 Treatment Period||53
10865777|NCT02778399|12030794|FG001|Included in FAS|Up to Week 12 Treatment Period||49
10865778|NCT02778399|12030795|FG002|Included in FAS|Up to Week 12 Treatment Period||56
10865779|NCT02778399|12030796|FG003|Included in FAS|Up to Week 12 Treatment Period||58
10865780|NCT02778399|12030797|FG004|Included in FAS|Up to Week 12 Treatment Period||51
10865781|NCT02778399|12030798|FG005|Included in FAS|Up to Week 12 Treatment Period||56
10865782|NCT02778399|12030793|FG000|COMPLETED|Up to Week 12 Treatment Period||45
10865783|NCT02778399|12030794|FG001|COMPLETED|Up to Week 12 Treatment Period||45
10865784|NCT02778399|12030795|FG002|COMPLETED|Up to Week 12 Treatment Period||53
10865785|NCT02778399|12030796|FG003|COMPLETED|Up to Week 12 Treatment Period||51
10865786|NCT02778399|12030797|FG004|COMPLETED|Up to Week 12 Treatment Period||45
10865787|NCT02778399|12030798|FG005|COMPLETED|Up to Week 12 Treatment Period||49
10865788|NCT02778399|12030793|FG000|NOT COMPLETED|Up to Week 12 Treatment Period||9
10865789|NCT02778399|12030794|FG001|NOT COMPLETED|Up to Week 12 Treatment Period||4
10865790|NCT02778399|12030795|FG002|NOT COMPLETED|Up to Week 12 Treatment Period||4
10865791|NCT02778399|12030796|FG003|NOT COMPLETED|Up to Week 12 Treatment Period||7
10865792|NCT02778399|12030797|FG004|NOT COMPLETED|Up to Week 12 Treatment Period||8
10865793|NCT02778399|12030798|FG005|NOT COMPLETED|Up to Week 12 Treatment Period||8
10865794|NCT02778399|12030793|FG000|STARTED|Week 12 to Week 24 Treatment Period||45
10865795|NCT02778399|12030794|FG001|STARTED|Week 12 to Week 24 Treatment Period||45
10865796|NCT02778399|12030795|FG002|STARTED|Week 12 to Week 24 Treatment Period||53
10865797|NCT02778399|12030796|FG003|STARTED|Week 12 to Week 24 Treatment Period||51
10865798|NCT02778399|12030797|FG004|STARTED|Week 12 to Week 24 Treatment Period||45
10865799|NCT02778399|12030798|FG005|STARTED|Week 12 to Week 24 Treatment Period||49
10865800|NCT02778399|12030793|FG000|COMPLETED|Week 12 to Week 24 Treatment Period||37
10865801|NCT02778399|12030794|FG001|COMPLETED|Week 12 to Week 24 Treatment Period||41
10865802|NCT02778399|12030795|FG002|COMPLETED|Week 12 to Week 24 Treatment Period||48
10865803|NCT02778399|12030796|FG003|COMPLETED|Week 12 to Week 24 Treatment Period||46
10865804|NCT02778399|12030797|FG004|COMPLETED|Week 12 to Week 24 Treatment Period||39
10865805|NCT02778399|12030798|FG005|COMPLETED|Week 12 to Week 24 Treatment Period||42
10865806|NCT02778399|12030793|FG000|NOT COMPLETED|Week 12 to Week 24 Treatment Period||8
10865807|NCT02778399|12030794|FG001|NOT COMPLETED|Week 12 to Week 24 Treatment Period||4
10865808|NCT02778399|12030795|FG002|NOT COMPLETED|Week 12 to Week 24 Treatment Period||5
10865809|NCT02778399|12030796|FG003|NOT COMPLETED|Week 12 to Week 24 Treatment Period||5
10294360|NCT03666988|11427043|FG002|NOT COMPLETED|Part 1 (Up to 28 Months)||12
10865810|NCT02778399|12030797|FG004|NOT COMPLETED|Week 12 to Week 24 Treatment Period||6
10865811|NCT02778399|12030798|FG005|NOT COMPLETED|Week 12 to Week 24 Treatment Period||7
10865818|NCT02758717|12030826|FG000|STARTED|Overall Study||46
10865819|NCT02758717|12030826|FG000|COMPLETED|Overall Study||46
10865820|NCT02758717|12030826|FG000|NOT COMPLETED|Overall Study||0
10865821|NCT02701777|12030834|FG000|STARTED|Overall Study||17
10865822|NCT02701777|12030835|FG001|STARTED|Overall Study||16
10865823|NCT02701777|12030836|FG002|STARTED|Overall Study||16
10865824|NCT02701777|12030837|FG003|STARTED|Overall Study||13
10865825|NCT02701777|12030834|FG000|COMPLETED|Overall Study||13
10865826|NCT02701777|12030835|FG001|COMPLETED|Overall Study||13
10865827|NCT02701777|12030836|FG002|COMPLETED|Overall Study||12
10865828|NCT02701777|12030837|FG003|COMPLETED|Overall Study||11
10865829|NCT02701777|12030834|FG000|NOT COMPLETED|Overall Study||4
10865830|NCT02701777|12030835|FG001|NOT COMPLETED|Overall Study||3
10865831|NCT02701777|12030836|FG002|NOT COMPLETED|Overall Study||4
10865832|NCT02701777|12030837|FG003|NOT COMPLETED|Overall Study||2
10865833|NCT02633241|12030851|FG000|STARTED|Overall Study||30
10865834|NCT02633241|12030851|FG000|COMPLETED|Overall Study||27
10865835|NCT02633241|12030851|FG000|NOT COMPLETED|Overall Study||3
10865836|NCT02546674|12030857|FG000|STARTED|Overall Study||171
10865837|NCT02546674|12030857|FG000|COMPLETED|Overall Study||123
10865838|NCT02546674|12030857|FG000|NOT COMPLETED|Overall Study||48
10865839|NCT02520661|12030864|FG000|STARTED|Overall Study||992
10865840|NCT02520661|12030865|FG001|STARTED|Overall Study||987
10865841|NCT02520661|12030864|FG000|Removed Following Randomization|Overall Study||124
10865842|NCT02520661|12030865|FG001|Removed Following Randomization|Overall Study||99
10865843|NCT02520661|12030864|FG000|CTI Home Visit Scheduled|Overall Study||0
10865844|NCT02520661|12030865|FG001|CTI Home Visit Scheduled|Overall Study||863
10865845|NCT02520661|12030864|FG000|Participants in Dataset|Overall Study||893
10865846|NCT02520661|12030865|FG001|Participants in Dataset|Overall Study||863
10865847|NCT02520661|12030864|FG000|Participants Completing Home Visit|Overall Study||0
10865848|NCT02520661|12030865|FG001|Participants Completing Home Visit|Overall Study||726
10865849|NCT02520661|12030864|FG000|Participants With Primary Outcome Data (ITT)|Overall Study||886
10865850|NCT02520661|12030865|FG001|Participants With Primary Outcome Data (ITT)|Overall Study||860
10865851|NCT02520661|12030864|FG000|Participants With Primary Outcome Data (PP)|Overall Study||886
10865852|NCT02520661|12030865|FG001|Participants With Primary Outcome Data (PP)|Overall Study||725
10865853|NCT02520661|12030864|FG000|COMPLETED|Overall Study||886
10865854|NCT02520661|12030865|FG001|COMPLETED|Overall Study||860
10865855|NCT02520661|12030864|FG000|NOT COMPLETED|Overall Study||106
10865856|NCT02520661|12030865|FG001|NOT COMPLETED|Overall Study||127
10865857|NCT02511132|12030878|FG000|STARTED|Overall Study||5
10865858|NCT02511132|12030879|FG001|STARTED|Overall Study||8
10865859|NCT02511132|12030880|FG002|STARTED|Overall Study||9
10865860|NCT02511132|12030878|FG000|COMPLETED|Overall Study||5
10865861|NCT02511132|12030879|FG001|COMPLETED|Overall Study||7
10865862|NCT02511132|12030880|FG002|COMPLETED|Overall Study||9
10865863|NCT02511132|12030878|FG000|NOT COMPLETED|Overall Study||0
10865864|NCT02511132|12030879|FG001|NOT COMPLETED|Overall Study||1
10865865|NCT02511132|12030880|FG002|NOT COMPLETED|Overall Study||0
10865866|NCT02483585|12030891|FG000|STARTED|Double-blind Treatment Phase||291
10865867|NCT02483585|12030892|FG001|STARTED|Double-blind Treatment Phase||286
10865868|NCT02483585|12030891|FG000|Received Treatment|Double-blind Treatment Phase||289
10865869|NCT02483585|12030892|FG001|Received Treatment|Double-blind Treatment Phase||283
10865870|NCT02483585|12030891|FG000|COMPLETED|Double-blind Treatment Phase||275
10865871|NCT02483585|12030892|FG001|COMPLETED|Double-blind Treatment Phase||271
10865872|NCT02483585|12030891|FG000|NOT COMPLETED|Double-blind Treatment Phase||16
10865873|NCT02483585|12030892|FG001|NOT COMPLETED|Double-blind Treatment Phase||15
10865874|NCT02483585|12030891|FG000|STARTED|Open-label Treatment Phase|Five participants who completed the double-blind phase did not enter the open-label treatment phase|270
10865875|NCT02483585|12030892|FG001|STARTED|Open-label Treatment Phase|Three participants who completed the double-blind phase did not enter the open-label treatment phase|268
10865876|NCT02483585|12030891|FG000|COMPLETED|Open-label Treatment Phase||243
10865877|NCT02483585|12030892|FG001|COMPLETED|Open-label Treatment Phase||243
10865878|NCT02483585|12030891|FG000|NOT COMPLETED|Open-label Treatment Phase||27
10865879|NCT02483585|12030892|FG001|NOT COMPLETED|Open-label Treatment Phase||25
10545829|NCT01500200|11699346|FG004|STARTED|Stage 2||23
10545830|NCT01500200|11699347|FG005|STARTED|Stage 2||22
10294361|NCT03666988|11427044|FG003|NOT COMPLETED|Part 1 (Up to 28 Months)||0
10294362|NCT03666988|11427045|FG004|NOT COMPLETED|Part 1 (Up to 28 Months)||0
10294363|NCT03666988|11427046|FG005|NOT COMPLETED|Part 1 (Up to 28 Months)||0
10294364|NCT03666988|11427041|FG000|STARTED|Part 2 (Up to 48 Months)||0
10294365|NCT03666988|11427042|FG001|STARTED|Part 2 (Up to 48 Months)||0
10294366|NCT03666988|11427043|FG002|STARTED|Part 2 (Up to 48 Months)||0
10294367|NCT03666988|11427044|FG003|STARTED|Part 2 (Up to 48 Months)||0
10294368|NCT03666988|11427045|FG004|STARTED|Part 2 (Up to 48 Months)||0
10294369|NCT03666988|11427046|FG005|STARTED|Part 2 (Up to 48 Months)||0
10294370|NCT03666988|11427041|FG000|COMPLETED|Part 2 (Up to 48 Months)||0
10294371|NCT03666988|11427042|FG001|COMPLETED|Part 2 (Up to 48 Months)||0
10294372|NCT03666988|11427043|FG002|COMPLETED|Part 2 (Up to 48 Months)||0
10294373|NCT03666988|11427044|FG003|COMPLETED|Part 2 (Up to 48 Months)||0
10294374|NCT03666988|11427045|FG004|COMPLETED|Part 2 (Up to 48 Months)||0
10294375|NCT03666988|11427046|FG005|COMPLETED|Part 2 (Up to 48 Months)||0
10294376|NCT03666988|11427041|FG000|NOT COMPLETED|Part 2 (Up to 48 Months)||0
10294377|NCT03666988|11427042|FG001|NOT COMPLETED|Part 2 (Up to 48 Months)||0
10294378|NCT03666988|11427043|FG002|NOT COMPLETED|Part 2 (Up to 48 Months)||0
10294379|NCT03666988|11427044|FG003|NOT COMPLETED|Part 2 (Up to 48 Months)||0
10294380|NCT03666988|11427045|FG004|NOT COMPLETED|Part 2 (Up to 48 Months)||0
10294381|NCT03666988|11427046|FG005|NOT COMPLETED|Part 2 (Up to 48 Months)||0
10294382|NCT03552029|11427066|FG000|STARTED|Overall Study||4
10294383|NCT03552029|11427067|FG001|STARTED|Overall Study||6
10294384|NCT03552029|11427066|FG000|COMPLETED|Overall Study||0
10294385|NCT03552029|11427067|FG001|COMPLETED|Overall Study||0
10294386|NCT03552029|11427066|FG000|NOT COMPLETED|Overall Study||4
10294387|NCT03552029|11427067|FG001|NOT COMPLETED|Overall Study||6
10294388|NCT03549104|11427075|FG000|STARTED|Overall Study||26
10294389|NCT03549104|11427076|FG001|STARTED|Overall Study||25
10294390|NCT03549104|11427075|FG000|COMPLETED|Overall Study||18
10294391|NCT03549104|11427076|FG001|COMPLETED|Overall Study||21
10294392|NCT03549104|11427075|FG000|NOT COMPLETED|Overall Study||8
10294393|NCT03549104|11427076|FG001|NOT COMPLETED|Overall Study||4
10294400|NCT03332589|11427094|FG000|STARTED|Overall Study||4
10294401|NCT03332589|11427095|FG001|STARTED|Overall Study||0
10294402|NCT03332589|11427096|FG002|STARTED|Overall Study||0
10294403|NCT03332589|11427094|FG000|COMPLETED|Overall Study||0
10294404|NCT03332589|11427095|FG001|COMPLETED|Overall Study||0
10294405|NCT03332589|11427096|FG002|COMPLETED|Overall Study||0
10294406|NCT03332589|11427094|FG000|NOT COMPLETED|Overall Study||4
10294407|NCT03332589|11427095|FG001|NOT COMPLETED|Overall Study||0
10294408|NCT03332589|11427096|FG002|NOT COMPLETED|Overall Study||0
10314652|NCT00167245|11448363|FG000|NOT COMPLETED|Overall Study||29
10314653|NCT00167245|11448364|FG001|NOT COMPLETED|Overall Study||41
10314654|NCT00167310|11448375|FG000|STARTED|Overall Study||29
10314655|NCT00167310|11448376|FG001|STARTED|Overall Study||28
10314656|NCT00167310|11448375|FG000|COMPLETED|Overall Study||21
10314657|NCT00167310|11448376|FG001|COMPLETED|Overall Study||18
10314658|NCT00167310|11448375|FG000|NOT COMPLETED|Overall Study||8
10314659|NCT00167310|11448376|FG001|NOT COMPLETED|Overall Study||10
10314660|NCT00167388|11448386|FG000|STARTED|Overall Study||5
10314661|NCT00167388|11448387|FG001|STARTED|Overall Study||5
10314662|NCT00167388|11448388|FG002|STARTED|Overall Study||6
10545831|NCT01500200|11699342|FG000|COMPLETED|Stage 2||0
10314663|NCT00167388|11448389|FG003|STARTED|Overall Study||6
10314664|NCT00167388|11448386|FG000|Completed Doppler Study|Overall Study||5
10314665|NCT00167388|11448387|FG001|Completed Doppler Study|Overall Study||5
10314666|NCT00167388|11448388|FG002|Completed Doppler Study|Overall Study||6
10314667|NCT00167388|11448389|FG003|Completed Doppler Study|Overall Study||6
10314668|NCT00167388|11448386|FG000|COMPLETED|Overall Study||5
10314669|NCT00167388|11448387|FG001|COMPLETED|Overall Study||5
10314670|NCT00167388|11448388|FG002|COMPLETED|Overall Study||6
10545832|NCT01500200|11699343|FG001|COMPLETED|Stage 2||0
10865943|NCT02399215|12030923|FG000|STARTED|Overall Study||32
10865944|NCT02399215|12030923|FG000|COMPLETED|Overall Study||30
10865945|NCT02399215|12030923|FG000|NOT COMPLETED|Overall Study||2
10865952|NCT02202577|12030939|FG000|STARTED|Overall Study||461
10865953|NCT02202577|12030940|FG001|STARTED|Overall Study||471
10865954|NCT02202577|12030939|FG000|COMPLETED|Overall Study||448
10865955|NCT02202577|12030940|FG001|COMPLETED|Overall Study||452
10865956|NCT02202577|12030939|FG000|NOT COMPLETED|Overall Study||13
10865957|NCT02202577|12030940|FG001|NOT COMPLETED|Overall Study||19
10865958|NCT02130427|12030946|FG000|STARTED|Overall Study||74
10865959|NCT02130427|12030946|FG000|COMPLETED|Overall Study||44
10865960|NCT02130427|12030946|FG000|NOT COMPLETED|Overall Study||30
10865961|NCT02015832|12030950|FG000|STARTED|Overall Study||454
10865962|NCT02015832|12030950|FG000|COMPLETED|Overall Study||443
10865963|NCT02015832|12030950|FG000|NOT COMPLETED|Overall Study||11
10865964|NCT01959698|12030966|FG000|STARTED|Overall Study||3
10865965|NCT01959698|12030967|FG001|STARTED|Overall Study||3
10865966|NCT01959698|12030968|FG002|STARTED|Overall Study||3
10865967|NCT01959698|12030969|FG003|STARTED|Overall Study||3
10865968|NCT01959698|12030970|FG004|STARTED|Overall Study||3
10865969|NCT01959698|12030971|FG005|STARTED|Overall Study||6
10865970|NCT01959698|12030972|FG006|STARTED|Overall Study||8
10865971|NCT01959698|12030966|FG000|COMPLETED|Overall Study||2
10865972|NCT01959698|12030967|FG001|COMPLETED|Overall Study||3
10865973|NCT01959698|12030968|FG002|COMPLETED|Overall Study||2
10865974|NCT01959698|12030969|FG003|COMPLETED|Overall Study||1
10417544|NCT00800254|11562131|FG001|NOT COMPLETED|Overall Study||6
10417545|NCT00800345|11562137|FG000|STARTED|Overall Study||33
10417546|NCT00800345|11562137|FG000|COMPLETED|Overall Study||33
10417547|NCT00800345|11562137|FG000|NOT COMPLETED|Overall Study||0
10417548|NCT00800384|11562143|FG000|STARTED|Overall Study||1247
10417549|NCT00800384|11562144|FG001|STARTED|Overall Study||1253
10417550|NCT00800384|11562143|FG000|COMPLETED|Overall Study||1206
10417551|NCT00800384|11562144|FG001|COMPLETED|Overall Study||1210
10417552|NCT00800384|11562143|FG000|NOT COMPLETED|Overall Study||41
10417553|NCT00800384|11562144|FG001|NOT COMPLETED|Overall Study||43
10417554|NCT00800436|11562158|FG000|STARTED|Overall Study||6
10417555|NCT00800436|11562159|FG001|STARTED|Overall Study||6
10417556|NCT00800436|11562160|FG002|STARTED|Overall Study||6
10417557|NCT00800436|11562161|FG003|STARTED|Overall Study||6
10417558|NCT00800436|11562162|FG004|STARTED|Overall Study||6
10417559|NCT00800436|11562163|FG005|STARTED|Overall Study||20
10417560|NCT00800436|11562164|FG006|STARTED|Overall Study||20
10417561|NCT00800436|11562158|FG000|COMPLETED|Overall Study||6
10417562|NCT00800436|11562159|FG001|COMPLETED|Overall Study||6
10417563|NCT00800436|11562160|FG002|COMPLETED|Overall Study||5
10417564|NCT00800436|11562161|FG003|COMPLETED|Overall Study||5
10417565|NCT00800436|11562162|FG004|COMPLETED|Overall Study||6
10417566|NCT00800436|11562163|FG005|COMPLETED|Overall Study||20
10417567|NCT00800436|11562164|FG006|COMPLETED|Overall Study||20
10417568|NCT00800436|11562158|FG000|NOT COMPLETED|Overall Study||0
10417569|NCT00800436|11562159|FG001|NOT COMPLETED|Overall Study||0
10865975|NCT01959698|12030970|FG004|COMPLETED|Overall Study||3
10865976|NCT01959698|12030971|FG005|COMPLETED|Overall Study||3
10865977|NCT01959698|12030972|FG006|COMPLETED|Overall Study||4
10865978|NCT01959698|12030966|FG000|NOT COMPLETED|Overall Study||1
10865979|NCT01959698|12030967|FG001|NOT COMPLETED|Overall Study||0
10865980|NCT01959698|12030968|FG002|NOT COMPLETED|Overall Study||1
10865981|NCT01959698|12030969|FG003|NOT COMPLETED|Overall Study||2
10865982|NCT01959698|12030970|FG004|NOT COMPLETED|Overall Study||0
10865983|NCT01959698|12030971|FG005|NOT COMPLETED|Overall Study||3
10865984|NCT01959698|12030972|FG006|NOT COMPLETED|Overall Study||4
10865985|NCT01942837|12030989|FG000|STARTED|Overall Study||67
10865986|NCT01942837|12030989|FG000|COMPLETED|Overall Study||0
10865987|NCT01942837|12030989|FG000|NOT COMPLETED|Overall Study||67
10865988|NCT01906489|12030996|FG000|STARTED|Overall Study||138
10865989|NCT01906489|12030997|FG001|STARTED|Overall Study||72
10865990|NCT01906489|12030996|FG000|COMPLETED|Overall Study||112
10865991|NCT01906489|12030997|FG001|COMPLETED|Overall Study||63
10865992|NCT01906489|12030996|FG000|NOT COMPLETED|Overall Study||26
10865993|NCT01906489|12030997|FG001|NOT COMPLETED|Overall Study||9
10865994|NCT01855412|12031006|FG000|STARTED|Overall Study||501
10865995|NCT01855412|12031007|FG001|STARTED|Overall Study||603
10865996|NCT01855412|12031008|FG002|STARTED|Overall Study||100
10865997|NCT01855412|12031006|FG000|COMPLETED|Overall Study||289
10865998|NCT01855412|12031007|FG001|COMPLETED|Overall Study||260
10865999|NCT01855412|12031008|FG002|COMPLETED|Overall Study||24
10866000|NCT01855412|12031006|FG000|NOT COMPLETED|Overall Study||212
10866001|NCT01855412|12031007|FG001|NOT COMPLETED|Overall Study||343
10866002|NCT01855412|12031008|FG002|NOT COMPLETED|Overall Study||76
10866003|NCT01845805|12031024|FG000|STARTED|Overall Study||24
10866004|NCT01845805|12031025|FG001|STARTED|Overall Study||25
10866005|NCT01845805|12031024|FG000|COMPLETED|Overall Study||6
10866006|NCT01845805|12031025|FG001|COMPLETED|Overall Study||9
10866007|NCT01845805|12031024|FG000|NOT COMPLETED|Overall Study||18
10866008|NCT01845805|12031025|FG001|NOT COMPLETED|Overall Study||16
10866009|NCT01833754|12031034|FG000|STARTED|Overall Study||8
10866010|NCT01833754|12031035|FG001|STARTED|Overall Study||8
10866011|NCT01833754|12031036|FG002|STARTED|Overall Study||8
10866012|NCT01833754|12031034|FG000|COMPLETED|Overall Study||8
10866013|NCT01833754|12031035|FG001|COMPLETED|Overall Study||8
10866014|NCT01833754|12031036|FG002|COMPLETED|Overall Study||8
10866015|NCT01833754|12031034|FG000|NOT COMPLETED|Overall Study||0
10866016|NCT01833754|12031035|FG001|NOT COMPLETED|Overall Study||0
10866017|NCT01833754|12031036|FG002|NOT COMPLETED|Overall Study||0
10866018|NCT01808456|12031046|FG000|STARTED|Overall Study||30
10866019|NCT01808456|12031047|FG001|STARTED|Overall Study||32
10866020|NCT01808456|12031046|FG000|COMPLETED|Overall Study||26
10866021|NCT01808456|12031047|FG001|COMPLETED|Overall Study||30
10866022|NCT01808456|12031046|FG000|NOT COMPLETED|Overall Study||4
10866023|NCT01808456|12031047|FG001|NOT COMPLETED|Overall Study||2
10866024|NCT01764633|12031061|FG000|STARTED|Overall Study||13780
10866025|NCT01764633|12031062|FG001|STARTED|Overall Study||13784
10866026|NCT01764633|12031061|FG000|Received Treatment|Overall Study||13756
10866027|NCT01764633|12031062|FG001|Received Treatment|Overall Study||13769
10866028|NCT01764633|12031061|FG000|COMPLETED|Overall Study||13662
10866029|NCT01764633|12031062|FG001|COMPLETED|Overall Study||13691
10866030|NCT01764633|12031061|FG000|NOT COMPLETED|Overall Study||118
10866031|NCT01764633|12031062|FG001|NOT COMPLETED|Overall Study||93
10866032|NCT01744093|12031070|FG000|STARTED|Overall Study||18
10866033|NCT01744093|12031071|FG001|STARTED|Overall Study||9
10866034|NCT01744093|12031070|FG000|Treated|Overall Study||16
10866035|NCT01744093|12031071|FG001|Treated|Overall Study||8
10866036|NCT01744093|12031070|FG000|COMPLETED|Overall Study||12
10866037|NCT01744093|12031071|FG001|COMPLETED|Overall Study||8
10866038|NCT01744093|12031070|FG000|NOT COMPLETED|Overall Study||6
10866039|NCT01744093|12031071|FG001|NOT COMPLETED|Overall Study||1
10417570|NCT00800436|11562160|FG002|NOT COMPLETED|Overall Study||1
10417571|NCT00800436|11562161|FG003|NOT COMPLETED|Overall Study||1
10417572|NCT00800436|11562162|FG004|NOT COMPLETED|Overall Study||0
10417573|NCT00800436|11562163|FG005|NOT COMPLETED|Overall Study||0
10417574|NCT00800436|11562164|FG006|NOT COMPLETED|Overall Study||0
10417575|NCT00800540|11562180|FG000|STARTED|Period One: 6 Weeks||17
10417576|NCT00800540|11562181|FG001|STARTED|Period One: 6 Weeks||18
10417577|NCT00800540|11562180|FG000|COMPLETED|Period One: 6 Weeks||16
10417578|NCT00800540|11562181|FG001|COMPLETED|Period One: 6 Weeks||17
10417579|NCT00800540|11562180|FG000|NOT COMPLETED|Period One: 6 Weeks||1
10417580|NCT00800540|11562181|FG001|NOT COMPLETED|Period One: 6 Weeks||1
10417581|NCT00800540|11562180|FG000|STARTED|Washout: 4 Weeks||16
10417582|NCT00800540|11562181|FG001|STARTED|Washout: 4 Weeks||17
10417583|NCT00800540|11562180|FG000|COMPLETED|Washout: 4 Weeks||16
10417584|NCT00800540|11562181|FG001|COMPLETED|Washout: 4 Weeks||17
10417585|NCT00800540|11562180|FG000|NOT COMPLETED|Washout: 4 Weeks||0
10417586|NCT00800540|11562181|FG001|NOT COMPLETED|Washout: 4 Weeks||0
10417587|NCT00800540|11562180|FG000|STARTED|Period 2: 6 Weeks||16
10417588|NCT00800540|11562181|FG001|STARTED|Period 2: 6 Weeks||17
10417589|NCT00800540|11562180|FG000|COMPLETED|Period 2: 6 Weeks||16
10417590|NCT00800540|11562181|FG001|COMPLETED|Period 2: 6 Weeks||16
10417591|NCT00800540|11562180|FG000|NOT COMPLETED|Period 2: 6 Weeks||0
10417592|NCT00800540|11562181|FG001|NOT COMPLETED|Period 2: 6 Weeks||1
10417593|NCT00800683|11562189|FG000|STARTED|Overall Study|Number who started treatment|65
10417594|NCT00800683|11562190|FG001|STARTED|Overall Study|Number who started treatment|68
10417595|NCT00800683|11562189|FG000|COMPLETED|Overall Study|Number who completed treatment|48
10417596|NCT00800683|11562190|FG001|COMPLETED|Overall Study|Number who completed treatment|49
10417597|NCT00800683|11562189|FG000|NOT COMPLETED|Overall Study||17
10417598|NCT00800683|11562190|FG001|NOT COMPLETED|Overall Study||19
10417599|NCT00800735|11562196|FG000|STARTED|Overall Study||30
10417600|NCT00800735|11562196|FG000|COMPLETED|Overall Study||16
10417601|NCT00800735|11562196|FG000|NOT COMPLETED|Overall Study||14
10417602|NCT00800839|11562200|FG000|STARTED|Overall Study||56
10417603|NCT00800839|11562200|FG000|COMPLETED|Overall Study||49
10417604|NCT00800839|11562200|FG000|NOT COMPLETED|Overall Study||7
10417605|NCT00800865|11562206|FG000|STARTED|Overall Study||15
10417606|NCT00800865|11562207|FG001|STARTED|Overall Study||16
10417607|NCT00800865|11562206|FG000|COMPLETED|Overall Study||15
10417608|NCT00800865|11562207|FG001|COMPLETED|Overall Study||16
10417609|NCT00800865|11562206|FG000|NOT COMPLETED|Overall Study||0
10417610|NCT00800865|11562207|FG001|NOT COMPLETED|Overall Study||0
10417611|NCT00800982|11562215|FG000|STARTED|Overall Study||15
10417612|NCT00800982|11562216|FG001|STARTED|Overall Study||15
10417613|NCT00800982|11562215|FG000|COMPLETED|Overall Study||13
10417614|NCT00800982|11562216|FG001|COMPLETED|Overall Study||12
10417615|NCT00800982|11562215|FG000|NOT COMPLETED|Overall Study||2
10417616|NCT00800982|11562216|FG001|NOT COMPLETED|Overall Study||3
10417617|NCT00801099|11562222|FG000|STARTED|Overall Study||276
10417618|NCT00801099|11562222|FG000|COMPLETED|Overall Study||175
10417619|NCT00801099|11562222|FG000|NOT COMPLETED|Overall Study||101
10417620|NCT00801138|11562230|FG000|STARTED|Overall Study||54
10417621|NCT00801138|11562231|FG001|STARTED|Overall Study||56
10417622|NCT00801138|11562232|FG002|STARTED|Overall Study||54
10417623|NCT00801138|11562233|FG003|STARTED|Overall Study||54
10417624|NCT00801138|11562230|FG000|COMPLETED|Overall Study||54
10417625|NCT00801138|11562231|FG001|COMPLETED|Overall Study||56
10417626|NCT00801138|11562232|FG002|COMPLETED|Overall Study||54
10417627|NCT00801138|11562233|FG003|COMPLETED|Overall Study||54
10417628|NCT00801138|11562230|FG000|NOT COMPLETED|Overall Study||0
10417629|NCT00801138|11562231|FG001|NOT COMPLETED|Overall Study||0
10417630|NCT00801138|11562232|FG002|NOT COMPLETED|Overall Study||0
10417631|NCT00801138|11562233|FG003|NOT COMPLETED|Overall Study||0
10417632|NCT00801229|11562245|FG000|STARTED|Signed Consent||38
10417633|NCT00801229|11562246|FG001|STARTED|Signed Consent||37
10417634|NCT00801229|11562245|FG000|COMPLETED|Signed Consent||35
10417635|NCT00801229|11562246|FG001|COMPLETED|Signed Consent||34
10417636|NCT00801229|11562245|FG000|NOT COMPLETED|Signed Consent||3
10417637|NCT00801229|11562246|FG001|NOT COMPLETED|Signed Consent||3
10417638|NCT00801229|11562245|FG000|STARTED|Received Study Drug/Placebo||35
10417639|NCT00801229|11562246|FG001|STARTED|Received Study Drug/Placebo||34
10417640|NCT00801229|11562245|FG000|COMPLETED|Received Study Drug/Placebo||31
10417641|NCT00801229|11562246|FG001|COMPLETED|Received Study Drug/Placebo||30
10417642|NCT00801229|11562245|FG000|NOT COMPLETED|Received Study Drug/Placebo||4
10417643|NCT00801229|11562246|FG001|NOT COMPLETED|Received Study Drug/Placebo||4
10417644|NCT00801242|11562252|FG000|STARTED|Overall Study|Randomized participants.|220
10417645|NCT00801242|11562252|FG000|Safety Analysis Set|Overall Study|Randomized participants who received ≥1 dose of degarelix.|216
10417646|NCT00801242|11562252|FG000|Full Analysis Set (FAS), Cycle 1|Overall Study|Randomized participants who received ≥1 dose and had ≥1 efficacy assessment.|213
10417647|NCT00801242|11562252|FG000|FAS, Off-treatment Cycle 1|Overall Study|Completed 7 months induction period and were enrolled in the off-treatment period of cycle 1.|191
10417648|NCT00801242|11562252|FG000|Started Cycle 2|Overall Study||35
10417649|NCT00801242|11562252|FG000|Started Cycle 3|Overall Study||2
10417650|NCT00801242|11562252|FG000|COMPLETED|Overall Study|42, 10, and 0 participants withdrew during Cycles 1, 2, and 3 (i.e. 168 completed the trial).|168
10417651|NCT00801242|11562252|FG000|NOT COMPLETED|Overall Study||52
10417652|NCT00801398|11562262|FG000|STARTED|Overall Study||13
10417653|NCT00801398|11562263|FG001|STARTED|Overall Study||9
10417654|NCT00801398|11562264|FG002|STARTED|Overall Study||11
10417655|NCT00801398|11562265|FG003|STARTED|Overall Study||9
10417656|NCT00801398|11562266|FG004|STARTED|Overall Study||8
10417657|NCT00801398|11562267|FG005|STARTED|Overall Study||8
10417658|NCT00801398|11562262|FG000|COMPLETED|Overall Study||7
10417659|NCT00801398|11562263|FG001|COMPLETED|Overall Study||0
10417660|NCT00801398|11562264|FG002|COMPLETED|Overall Study||4
10417661|NCT00801398|11562265|FG003|COMPLETED|Overall Study||3
10417662|NCT00801398|11562266|FG004|COMPLETED|Overall Study||1
10417663|NCT00801398|11562267|FG005|COMPLETED|Overall Study||5
10866074|NCT01622868|12031135|FG000|STARTED|Overall Study||72
10866075|NCT01622868|12031136|FG001|STARTED|Overall Study||71
10866076|NCT01622868|12031135|FG000|Eligible|Overall Study||65
10866077|NCT01622868|12031136|FG001|Eligible|Overall Study||71
10866078|NCT01622868|12031135|FG000|Eligible, Started Study Treatment, Has Adverse Event Data|Overall Study||63
10866079|NCT01622868|12031136|FG001|Eligible, Started Study Treatment, Has Adverse Event Data|Overall Study||71
10866080|NCT01622868|12031135|FG000|COMPLETED|Overall Study||65
10866081|NCT01622868|12031136|FG001|COMPLETED|Overall Study||71
10866082|NCT01622868|12031135|FG000|NOT COMPLETED|Overall Study||7
10866083|NCT01622868|12031136|FG001|NOT COMPLETED|Overall Study||0
10866084|NCT01609790|12031145|FG000|STARTED|Overall Study||7
10866085|NCT01609790|12031146|FG001|STARTED|Overall Study||65
10866086|NCT01609790|12031147|FG002|STARTED|Overall Study||65
10866087|NCT01609790|12031145|FG000|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|6
10866088|NCT01609790|12031146|FG001|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|58
10866089|NCT01609790|12031147|FG002|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|57
10866090|NCT01609790|12031145|FG000|NOT COMPLETED|Overall Study||1
10866091|NCT01609790|12031146|FG001|NOT COMPLETED|Overall Study||7
10417664|NCT00801398|11562262|FG000|NOT COMPLETED|Overall Study||6
10417665|NCT00801398|11562263|FG001|NOT COMPLETED|Overall Study||9
10417666|NCT00801398|11562264|FG002|NOT COMPLETED|Overall Study||7
10417667|NCT00801398|11562265|FG003|NOT COMPLETED|Overall Study||6
10417668|NCT00801398|11562266|FG004|NOT COMPLETED|Overall Study||7
10417669|NCT00801398|11562267|FG005|NOT COMPLETED|Overall Study||3
10417670|NCT00801632|11562295|FG000|STARTED|Overall Study||5
10417671|NCT00801632|11562295|FG000|COMPLETED|Overall Study||4
10417672|NCT00801632|11562295|FG000|NOT COMPLETED|Overall Study||1
10417673|NCT00801684|11562299|FG000|STARTED|Overall Study||24
10417674|NCT00801684|11562299|FG000|COMPLETED|Overall Study||24
10417675|NCT00801684|11562299|FG000|NOT COMPLETED|Overall Study||0
10417676|NCT00801723|11562318|FG000|STARTED|Overall Study||61
10417677|NCT00801723|11562319|FG001|STARTED|Overall Study||62
10417678|NCT00801723|11562318|FG000|COMPLETED|Overall Study||25
10417679|NCT00801723|11562319|FG001|COMPLETED|Overall Study||27
10417680|NCT00801723|11562318|FG000|NOT COMPLETED|Overall Study||36
10417681|NCT00801723|11562319|FG001|NOT COMPLETED|Overall Study||35
10417682|NCT00801801|11562325|FG000|STARTED|Overall Study||5
10417683|NCT00801801|11562325|FG000|COMPLETED|Overall Study||5
10417684|NCT00801801|11562325|FG000|NOT COMPLETED|Overall Study||0
10417685|NCT00801827|11562330|FG000|STARTED|Overall Study|2 others consented but due to scheduling did not complete|5
10417686|NCT00801827|11562330|FG000|COMPLETED|Overall Study||5
10417687|NCT00801827|11562330|FG000|NOT COMPLETED|Overall Study||0
10417688|NCT00801892|11562336|FG000|STARTED|Main Study Period||12
10417689|NCT00801892|11562337|FG001|STARTED|Main Study Period||11
10417690|NCT00801892|11562336|FG000|COMPLETED|Main Study Period||12
10417691|NCT00801892|11562337|FG001|COMPLETED|Main Study Period||10
10417692|NCT00801892|11562336|FG000|NOT COMPLETED|Main Study Period||0
10417693|NCT00801892|11562337|FG001|NOT COMPLETED|Main Study Period||1
10417694|NCT00801892|11562336|FG000|STARTED|Sham Crossover Period||0
10417695|NCT00801892|11562337|FG001|STARTED|Sham Crossover Period||7
10417696|NCT00801892|11562336|FG000|COMPLETED|Sham Crossover Period||0
10417697|NCT00801892|11562337|FG001|COMPLETED|Sham Crossover Period||5
10417698|NCT00801892|11562336|FG000|NOT COMPLETED|Sham Crossover Period||0
10417699|NCT00801892|11562337|FG001|NOT COMPLETED|Sham Crossover Period||2
10417700|NCT00801983|11562347|FG000|STARTED|Period 1||44
10417701|NCT00801983|11562348|FG001|STARTED|Period 1||41
10417702|NCT00801983|11562347|FG000|COMPLETED|Period 1||40
10417703|NCT00801983|11562348|FG001|COMPLETED|Period 1||33
10417704|NCT00801983|11562347|FG000|NOT COMPLETED|Period 1||4
10417705|NCT00801983|11562348|FG001|NOT COMPLETED|Period 1||8
10417706|NCT00801983|11562347|FG000|STARTED|Period 2||40
10417707|NCT00801983|11562348|FG001|STARTED|Period 2||33
10417708|NCT00801983|11562347|FG000|COMPLETED|Period 2||38
10417709|NCT00801983|11562348|FG001|COMPLETED|Period 2||32
10417710|NCT00801983|11562347|FG000|NOT COMPLETED|Period 2||2
10417711|NCT00801983|11562348|FG001|NOT COMPLETED|Period 2||1
10417712|NCT00802074|11562360|FG000|STARTED|Overall Study||9
10417713|NCT00802074|11562361|FG001|STARTED|Overall Study||8
10417714|NCT00802074|11562362|FG002|STARTED|Overall Study||7
10417715|NCT00802074|11562363|FG003|STARTED|Overall Study||7
10417716|NCT00802074|11562364|FG004|STARTED|Overall Study||7
10417717|NCT00802074|11562365|FG005|STARTED|Overall Study||7
10417718|NCT00802074|11562360|FG000|COMPLETED|Overall Study||7
10866092|NCT01609790|12031147|FG002|NOT COMPLETED|Overall Study||8
10866099|NCT01539811|12031166|FG000|STARTED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
10866100|NCT01539811|12031167|FG001|STARTED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
10866101|NCT01539811|12031166|FG000|COMPLETED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
10866102|NCT01539811|12031167|FG001|COMPLETED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
10866103|NCT01539811|12031166|FG000|NOT COMPLETED|Overall Study||0
10866104|NCT01539811|12031167|FG001|NOT COMPLETED|Overall Study||0
10866105|NCT01516879|12031175|FG000|STARTED|Overall Study||303
10866106|NCT01516879|12031176|FG001|STARTED|Overall Study||602
10866107|NCT01516879|12031175|FG000|Received Treatment|Overall Study||302
10866108|NCT01516879|12031176|FG001|Received Treatment|Overall Study||599
10866109|NCT01516879|12031175|FG000|COMPLETED|Overall Study||287
10866110|NCT01516879|12031176|FG001|COMPLETED|Overall Study||568
10866111|NCT01516879|12031175|FG000|NOT COMPLETED|Overall Study||16
10866112|NCT01516879|12031176|FG001|NOT COMPLETED|Overall Study||34
10866131|NCT01261325|12031215|FG000|STARTED|Overall Study||263
10866132|NCT01261325|12031216|FG001|STARTED|Overall Study||254
10866133|NCT01261325|12031217|FG002|STARTED|Overall Study||251
10866134|NCT01261325|12031215|FG000|COMPLETED|Overall Study||246
10866135|NCT01261325|12031216|FG001|COMPLETED|Overall Study||225
10866136|NCT01261325|12031217|FG002|COMPLETED|Overall Study||225
10866137|NCT01261325|12031215|FG000|NOT COMPLETED|Overall Study||17
10866138|NCT01261325|12031216|FG001|NOT COMPLETED|Overall Study||29
10866139|NCT01261325|12031217|FG002|NOT COMPLETED|Overall Study||26
10866191|NCT00746590|12031277|FG000|STARTED|Overall Study||1
10866192|NCT00746590|12031277|FG000|COMPLETED|Overall Study||0
10866193|NCT00746590|12031277|FG000|NOT COMPLETED|Overall Study||1
10866194|NCT00659711|12031283|FG000|STARTED|Overall Study||12
10866195|NCT00659711|12031284|FG001|STARTED|Overall Study||10
10866196|NCT00659711|12031283|FG000|COMPLETED|Overall Study||12
10866197|NCT00659711|12031284|FG001|COMPLETED|Overall Study||10
10866198|NCT00659711|12031283|FG000|NOT COMPLETED|Overall Study||0
10417719|NCT00802074|11562361|FG001|COMPLETED|Overall Study||7
10417720|NCT00802074|11562362|FG002|COMPLETED|Overall Study||6
10417721|NCT00802074|11562363|FG003|COMPLETED|Overall Study||7
10417722|NCT00802074|11562364|FG004|COMPLETED|Overall Study||7
10417723|NCT00802074|11562365|FG005|COMPLETED|Overall Study||7
10417724|NCT00802074|11562360|FG000|NOT COMPLETED|Overall Study||2
10417725|NCT00802074|11562361|FG001|NOT COMPLETED|Overall Study||1
10417726|NCT00802074|11562362|FG002|NOT COMPLETED|Overall Study||1
10417727|NCT00802074|11562363|FG003|NOT COMPLETED|Overall Study||0
10417728|NCT00802074|11562364|FG004|NOT COMPLETED|Overall Study||0
10417729|NCT00802074|11562365|FG005|NOT COMPLETED|Overall Study||0
10417730|NCT00802100|11562385|FG000|STARTED|Overall Study||6
10417731|NCT00802100|11562386|FG001|STARTED|Overall Study||9
10417732|NCT00802100|11562387|FG002|STARTED|Overall Study||6
10417733|NCT00802100|11562385|FG000|COMPLETED|Overall Study||0
10417734|NCT00802100|11562386|FG001|COMPLETED|Overall Study||2
10417735|NCT00802100|11562387|FG002|COMPLETED|Overall Study||2
10417736|NCT00802100|11562385|FG000|NOT COMPLETED|Overall Study||6
10417737|NCT00802100|11562386|FG001|NOT COMPLETED|Overall Study||7
10417738|NCT00802100|11562387|FG002|NOT COMPLETED|Overall Study||4
10545833|NCT01500200|11699344|FG002|COMPLETED|Stage 2||0
10545834|NCT01500200|11699345|FG003|COMPLETED|Stage 2||20
10545835|NCT01500200|11699346|FG004|COMPLETED|Stage 2||18
10545836|NCT01500200|11699347|FG005|COMPLETED|Stage 2||18
10545837|NCT01500200|11699342|FG000|NOT COMPLETED|Stage 2||0
10545838|NCT01500200|11699343|FG001|NOT COMPLETED|Stage 2||0
10545839|NCT01500200|11699344|FG002|NOT COMPLETED|Stage 2||0
10545840|NCT01500200|11699345|FG003|NOT COMPLETED|Stage 2||0
10545841|NCT01500200|11699346|FG004|NOT COMPLETED|Stage 2||5
10545842|NCT01500200|11699347|FG005|NOT COMPLETED|Stage 2||4
10545843|NCT01500213|11699363|FG000|STARTED|Overall Study|Number of randomized patients|278
10545844|NCT01500213|11699364|FG001|STARTED|Overall Study||277
10545845|NCT01500213|11699363|FG000|COMPLETED|Overall Study|Number of patients who completed 6 cycles|61
10545846|NCT01500213|11699364|FG001|COMPLETED|Overall Study||53
10545847|NCT01500213|11699363|FG000|NOT COMPLETED|Overall Study||217
10545848|NCT01500213|11699364|FG001|NOT COMPLETED|Overall Study||224
10545849|NCT01500226|11699372|FG000|STARTED|Overall Study|Number of randomized patients|684
10545850|NCT01500226|11699373|FG001|STARTED|Overall Study||685
10545851|NCT01500226|11699372|FG000|COMPLETED|Overall Study|Number of patients who completed 6 cycles|185
10545852|NCT01500226|11699373|FG001|COMPLETED|Overall Study||191
10545853|NCT01500226|11699372|FG000|NOT COMPLETED|Overall Study||499
10545854|NCT01500226|11699373|FG001|NOT COMPLETED|Overall Study||494
10545855|NCT01500252|11699381|FG000|STARTED|Overall Study||21
10545856|NCT01500252|11699382|FG001|STARTED|Overall Study||17
10545857|NCT01500252|11699381|FG000|One Years|Overall Study||20
10755543|NCT03068754|11919357|FG001|COMPLETED|Randomized Treatment Period (RTP)||9
10755544|NCT03068754|11919358|FG002|COMPLETED|Randomized Treatment Period (RTP)||0
10755545|NCT03068754|11919359|FG003|COMPLETED|Randomized Treatment Period (RTP)||0
10755546|NCT03068754|11919356|FG000|NOT COMPLETED|Randomized Treatment Period (RTP)||67
10755547|NCT03068754|11919357|FG001|NOT COMPLETED|Randomized Treatment Period (RTP)||39
10755548|NCT03068754|11919358|FG002|NOT COMPLETED|Randomized Treatment Period (RTP)||0
10755549|NCT03068754|11919359|FG003|NOT COMPLETED|Randomized Treatment Period (RTP)||0
10755550|NCT03068754|11919356|FG000|STARTED|Open Label Extension Period (OLE)|RTP arms were not included during the OLE period|0
10755551|NCT03068754|11919357|FG001|STARTED|Open Label Extension Period (OLE)||0
10417739|NCT00802113|11562398|FG000|STARTED|Overall Study||6
10417740|NCT00802113|11562399|FG001|STARTED|Overall Study||17
10417741|NCT00802113|11562398|FG000|COMPLETED|Overall Study||6
10545858|NCT01500252|11699382|FG001|One Years|Overall Study||16
10545859|NCT01500252|11699381|FG000|Five Years|Overall Study||17
10545860|NCT01500252|11699382|FG001|Five Years|Overall Study||13
10545861|NCT01500252|11699381|FG000|Ten Years|Overall Study||12
10545862|NCT01500252|11699382|FG001|Ten Years|Overall Study||11
10545863|NCT01500252|11699381|FG000|COMPLETED|Overall Study|2 participants died within 5 years; 2 participants died between 5 & 10 years for a total of 4 deaths|12
10545864|NCT01500252|11699382|FG001|COMPLETED|Overall Study|2 participant deceased by 5 years; no further deaths between 5 & 10 years for a total of 2 deaths|11
10545865|NCT01500252|11699381|FG000|NOT COMPLETED|Overall Study||9
10545866|NCT01500252|11699382|FG001|NOT COMPLETED|Overall Study||6
10866199|NCT00659711|12031284|FG001|NOT COMPLETED|Overall Study||0
10866208|NCT00490035|12031303|FG000|STARTED|Overall Study||100
10866209|NCT00490035|12031304|FG001|STARTED|Overall Study||99
10866210|NCT00490035|12031305|FG002|STARTED|Overall Study||100
10866211|NCT00490035|12031306|FG003|STARTED|Overall Study||100
10866212|NCT00490035|12031303|FG000|COMPLETED|Overall Study||92
10866213|NCT00490035|12031304|FG001|COMPLETED|Overall Study||93
10866214|NCT00490035|12031305|FG002|COMPLETED|Overall Study||88
10866215|NCT00490035|12031306|FG003|COMPLETED|Overall Study||94
10294418|NCT02301156|11427119|FG000|STARTED|Overall Study||64
10294419|NCT02301156|11427120|FG001|STARTED|Overall Study||62
10294420|NCT02301156|11427119|FG000|Intent to Treat (ITT) Population|Overall Study||64
10294421|NCT02301156|11427120|FG001|Intent to Treat (ITT) Population|Overall Study||62
10294422|NCT02301156|11427119|FG000|Safety Population|Overall Study||59
10294423|NCT02301156|11427120|FG001|Safety Population|Overall Study||58
10294424|NCT02301156|11427119|FG000|COMPLETED|Overall Study||11
10294425|NCT02301156|11427120|FG001|COMPLETED|Overall Study||10
10294426|NCT02301156|11427119|FG000|NOT COMPLETED|Overall Study||53
10294427|NCT02301156|11427120|FG001|NOT COMPLETED|Overall Study||52
10866216|NCT00490035|12031303|FG000|NOT COMPLETED|Overall Study||8
10866217|NCT00490035|12031304|FG001|NOT COMPLETED|Overall Study||6
10866218|NCT00490035|12031305|FG002|NOT COMPLETED|Overall Study||12
10866219|NCT00490035|12031306|FG003|NOT COMPLETED|Overall Study||6
10866220|NCT00464269|12031320|FG000|STARTED|Overall Study||99
10866221|NCT00464269|12031321|FG001|STARTED|Overall Study||99
10866222|NCT00464269|12031322|FG002|STARTED|Overall Study||100
10866223|NCT00464269|12031323|FG003|STARTED|Overall Study||102
10294469|NCT01612351|11427182|FG000|STARTED|Chemotherapy||40
10294470|NCT01612351|11427182|FG000|COMPLETED|Chemotherapy||40
10294471|NCT01612351|11427182|FG000|NOT COMPLETED|Chemotherapy||0
10294472|NCT01612351|11427182|FG000|STARTED|Transoral Surgery|One patient completed chemotherapy then withdrew before surgery.|39
10294473|NCT01612351|11427182|FG000|COMPLETED|Transoral Surgery||39
10294474|NCT01612351|11427182|FG000|NOT COMPLETED|Transoral Surgery||0
10294475|NCT01612351|11427182|FG000|STARTED|Post-Operative Treatment||39
10294476|NCT01612351|11427182|FG000|COMPLETED|Post-Operative Treatment|One patient completed chemotherapy then withdrew before surgery.|39
10294477|NCT01612351|11427182|FG000|NOT COMPLETED|Post-Operative Treatment||0
10294478|NCT01590628|11427193|FG000|STARTED|Overall Study||13
10294479|NCT01590628|11427194|FG001|STARTED|Overall Study||3
10294480|NCT01590628|11427193|FG000|COMPLETED|Overall Study||11
10294481|NCT01590628|11427194|FG001|COMPLETED|Overall Study||3
10294482|NCT01590628|11427193|FG000|NOT COMPLETED|Overall Study||2
10294483|NCT01590628|11427194|FG001|NOT COMPLETED|Overall Study||0
10294484|NCT01533714|11427210|FG000|STARTED|Overall Study||10
10866224|NCT00464269|12031320|FG000|COMPLETED|Overall Study||93
10866225|NCT00464269|12031321|FG001|COMPLETED|Overall Study||82
10866226|NCT00464269|12031322|FG002|COMPLETED|Overall Study||93
10866227|NCT00464269|12031323|FG003|COMPLETED|Overall Study||93
10866228|NCT00464269|12031320|FG000|NOT COMPLETED|Overall Study||6
10866229|NCT00464269|12031321|FG001|NOT COMPLETED|Overall Study||17
10866230|NCT00464269|12031322|FG002|NOT COMPLETED|Overall Study||7
10866231|NCT00464269|12031323|FG003|NOT COMPLETED|Overall Study||9
10866232|NCT00334815|12031337|FG000|STARTED|Overall Study||16
10866233|NCT00334815|12031338|FG001|STARTED|Overall Study||13
10866234|NCT00334815|12031337|FG000|COMPLETED|Overall Study||9
10866235|NCT00334815|12031338|FG001|COMPLETED|Overall Study||3
10866236|NCT00334815|12031337|FG000|NOT COMPLETED|Overall Study||7
10866237|NCT00334815|12031338|FG001|NOT COMPLETED|Overall Study||10
10866238|NCT00042289|12031393|FG000|STARTED|Overall Study||26
10866239|NCT00042289|12031394|FG001|STARTED|Overall Study||30
10866240|NCT00042289|12031395|FG002|STARTED|Overall Study||27
10866241|NCT00042289|12031396|FG003|STARTED|Overall Study||33
10866242|NCT00042289|12031397|FG004|STARTED|Overall Study||29
10866243|NCT00042289|12031398|FG005|STARTED|Overall Study||31
10866244|NCT00042289|12031399|FG006|STARTED|Overall Study||28
10866245|NCT00042289|12031400|FG007|STARTED|Overall Study||12
10866246|NCT00042289|12031401|FG008|STARTED|Overall Study||27
10866247|NCT00042289|12031402|FG009|STARTED|Overall Study||24
10866248|NCT00042289|12031403|FG010|STARTED|Overall Study||2
10866249|NCT00042289|12031404|FG011|STARTED|Overall Study||27
10866250|NCT00042289|12031405|FG012|STARTED|Overall Study||13
10866251|NCT00042289|12031406|FG013|STARTED|Overall Study||2
10866252|NCT00042289|12031407|FG014|STARTED|Overall Study||6
10866253|NCT00042289|12031408|FG015|STARTED|Overall Study||29
10866254|NCT00042289|12031409|FG016|STARTED|Overall Study||28
10866255|NCT00042289|12031410|FG017|STARTED|Overall Study||12
10866256|NCT00042289|12031411|FG018|STARTED|Overall Study||26
10866257|NCT00042289|12031412|FG019|STARTED|Overall Study||17
10866258|NCT00042289|12031413|FG020|STARTED|Overall Study||1
10866259|NCT00042289|12031414|FG021|STARTED|Overall Study||30
10866260|NCT00042289|12031415|FG022|STARTED|Overall Study||29
10866261|NCT00042289|12031416|FG023|STARTED|Overall Study||22
10866262|NCT00042289|12031417|FG024|STARTED|Overall Study||18
10866263|NCT00042289|12031418|FG025|STARTED|Overall Study||21
10866264|NCT00042289|12031419|FG026|STARTED|Overall Study||28
10866265|NCT00042289|12031420|FG027|STARTED|Overall Study||25
10866266|NCT00042289|12031421|FG028|STARTED|Overall Study||29
10866267|NCT00042289|12031422|FG029|STARTED|Overall Study||25
10866268|NCT00042289|12031423|FG030|STARTED|Overall Study||1
10866269|NCT00042289|12031424|FG031|STARTED|Overall Study||35
10866270|NCT00042289|12031425|FG032|STARTED|Overall Study||43
10866271|NCT00042289|12031426|FG033|STARTED|Overall Study||16
10866272|NCT00042289|12031427|FG034|STARTED|Overall Study||12
10866273|NCT00042289|12031428|FG035|STARTED|Overall Study||32
10866274|NCT00042289|12031429|FG036|STARTED|Overall Study||36
10866275|NCT00042289|12031430|FG037|STARTED|Overall Study||38
10866276|NCT00042289|12031431|FG038|STARTED|Overall Study||35
10866277|NCT00042289|12031432|FG039|STARTED|Overall Study||18
10866278|NCT00042289|12031433|FG040|STARTED|Overall Study||26
10866279|NCT00042289|12031434|FG041|STARTED|Overall Study||25
10866280|NCT00042289|12031435|FG042|STARTED|Overall Study||32
10866281|NCT00042289|12031436|FG043|STARTED|Overall Study||25
10866282|NCT00042289|12031437|FG044|STARTED|Overall Study||27
10866283|NCT00042289|12031438|FG045|STARTED|Overall Study||27
10866284|NCT00042289|12031439|FG046|STARTED|Overall Study||28
10866285|NCT00042289|12031393|FG000|Infant Started|Overall Study||25
10866286|NCT00042289|12031394|FG001|Infant Started|Overall Study||30
10866287|NCT00042289|12031395|FG002|Infant Started|Overall Study||27
10866288|NCT00042289|12031396|FG003|Infant Started|Overall Study||32
10866289|NCT00042289|12031397|FG004|Infant Started|Overall Study||28
10866290|NCT00042289|12031398|FG005|Infant Started|Overall Study||31
10866291|NCT00042289|12031399|FG006|Infant Started|Overall Study||27
10866292|NCT00042289|12031400|FG007|Infant Started|Overall Study||12
10866293|NCT00042289|12031401|FG008|Infant Started|Overall Study||26
10866294|NCT00042289|12031402|FG009|Infant Started|Overall Study||23
10866295|NCT00042289|12031403|FG010|Infant Started|Overall Study||2
10866296|NCT00042289|12031404|FG011|Infant Started|Overall Study||27
10866297|NCT00042289|12031405|FG012|Infant Started|Overall Study||14
10866298|NCT00042289|12031406|FG013|Infant Started|Overall Study||0
10866299|NCT00042289|12031407|FG014|Infant Started|Overall Study||0
10866300|NCT00042289|12031408|FG015|Infant Started|Overall Study||0
10866301|NCT00042289|12031409|FG016|Infant Started|Overall Study||0
10866302|NCT00042289|12031410|FG017|Infant Started|Overall Study||0
10866303|NCT00042289|12031411|FG018|Infant Started|Overall Study||0
10866304|NCT00042289|12031412|FG019|Infant Started|Overall Study||0
10866305|NCT00042289|12031413|FG020|Infant Started|Overall Study||0
10866306|NCT00042289|12031414|FG021|Infant Started|Overall Study||9
10866307|NCT00042289|12031415|FG022|Infant Started|Overall Study||0
10866308|NCT00042289|12031416|FG023|Infant Started|Overall Study||22
10866309|NCT00042289|12031417|FG024|Infant Started|Overall Study||4
10866310|NCT00042289|12031418|FG025|Infant Started|Overall Study||5
10866311|NCT00042289|12031419|FG026|Infant Started|Overall Study||0
10866312|NCT00042289|12031420|FG027|Infant Started|Overall Study||21
10866313|NCT00042289|12031421|FG028|Infant Started|Overall Study||0
10866314|NCT00042289|12031422|FG029|Infant Started|Overall Study||21
10866315|NCT00042289|12031423|FG030|Infant Started|Overall Study||0
10866316|NCT00042289|12031424|FG031|Infant Started|Overall Study||0
10866317|NCT00042289|12031425|FG032|Infant Started|Overall Study||6
10866318|NCT00042289|12031426|FG033|Infant Started|Overall Study||6
10866319|NCT00042289|12031427|FG034|Infant Started|Overall Study||4
10866320|NCT00042289|12031428|FG035|Infant Started|Overall Study||0
10866321|NCT00042289|12031429|FG036|Infant Started|Overall Study||9
10866322|NCT00042289|12031430|FG037|Infant Started|Overall Study||38
10866323|NCT00042289|12031431|FG038|Infant Started|Overall Study||35
10866324|NCT00042289|12031432|FG039|Infant Started|Overall Study||0
10866325|NCT00042289|12031433|FG040|Infant Started|Overall Study||26
10866326|NCT00042289|12031434|FG041|Infant Started|Overall Study||25
10866327|NCT00042289|12031435|FG042|Infant Started|Overall Study||30
10866328|NCT00042289|12031436|FG043|Infant Started|Overall Study||0
10866329|NCT00042289|12031437|FG044|Infant Started|Overall Study||0
10866330|NCT00042289|12031438|FG045|Infant Started|Overall Study||0
10866331|NCT00042289|12031439|FG046|Infant Started|Overall Study||0
10866332|NCT00042289|12031393|FG000|Infant Completed|Overall Study||21
10866333|NCT00042289|12031394|FG001|Infant Completed|Overall Study||28
10294485|NCT01533714|11427211|FG001|STARTED|Overall Study||15
10294486|NCT01533714|11427212|FG002|STARTED|Overall Study||11
10294487|NCT01533714|11427213|FG003|STARTED|Overall Study||15
10294488|NCT01533714|11427214|FG004|STARTED|Overall Study||28
10294489|NCT01533714|11427215|FG005|STARTED|Overall Study||24
10294490|NCT01533714|11427210|FG000|COMPLETED|Overall Study||10
10294491|NCT01533714|11427211|FG001|COMPLETED|Overall Study||12
10294492|NCT01533714|11427212|FG002|COMPLETED|Overall Study||7
10417742|NCT00802113|11562399|FG001|COMPLETED|Overall Study||17
10417743|NCT00802113|11562398|FG000|NOT COMPLETED|Overall Study||0
10417744|NCT00802113|11562399|FG001|NOT COMPLETED|Overall Study||0
10417745|NCT00802178|11562405|FG000|STARTED|Overall Study||2448
10417746|NCT00802178|11562405|FG000|COMPLETED|Overall Study||2335
10417747|NCT00802178|11562405|FG000|NOT COMPLETED|Overall Study||113
10429382|NCT00863265|11575373|FG001|NOT COMPLETED|Overall Study||0
10429383|NCT00863265|11575374|FG002|NOT COMPLETED|Overall Study||0
10429384|NCT00863265|11575375|FG003|NOT COMPLETED|Overall Study||0
10429385|NCT00863265|11575376|FG004|NOT COMPLETED|Overall Study||1
10429386|NCT00863265|11575377|FG005|NOT COMPLETED|Overall Study||0
10429387|NCT00863304|11575395|FG000|STARTED|Overall Study||212
10429388|NCT00863304|11575396|FG001|STARTED|Overall Study||212
10429389|NCT00863304|11575397|FG002|STARTED|Overall Study||213
10429390|NCT00863304|11575398|FG003|STARTED|Overall Study||212
10429391|NCT00863304|11575395|FG000|Treated|Overall Study||209
10429392|NCT00863304|11575396|FG001|Treated|Overall Study||211
10429393|NCT00863304|11575397|FG002|Treated|Overall Study||209
10429394|NCT00863304|11575398|FG003|Treated|Overall Study||211
10429395|NCT00863304|11575395|FG000|COMPLETED|Overall Study||18
10429396|NCT00863304|11575396|FG001|COMPLETED|Overall Study||27
10429397|NCT00863304|11575397|FG002|COMPLETED|Overall Study||26
10429398|NCT00863304|11575398|FG003|COMPLETED|Overall Study||21
10429399|NCT00863304|11575395|FG000|NOT COMPLETED|Overall Study||194
10429400|NCT00863304|11575396|FG001|NOT COMPLETED|Overall Study||185
10429401|NCT00863304|11575397|FG002|NOT COMPLETED|Overall Study||187
10429402|NCT00863304|11575398|FG003|NOT COMPLETED|Overall Study||191
10429403|NCT00863317|11575412|FG000|STARTED|Overall Study||68
10429404|NCT00863317|11575413|FG001|STARTED|Overall Study||73
10429405|NCT00863317|11575412|FG000|COMPLETED|Overall Study||60
10429406|NCT00863317|11575413|FG001|COMPLETED|Overall Study||64
10429407|NCT00863317|11575412|FG000|NOT COMPLETED|Overall Study||8
10429408|NCT00863317|11575413|FG001|NOT COMPLETED|Overall Study||9
10429409|NCT00863343|11575421|FG000|STARTED|Overall Study||17
10429410|NCT00863343|11575422|FG001|STARTED|Overall Study||374
10429411|NCT00863343|11575421|FG000|COMPLETED|Overall Study||17
10429412|NCT00863343|11575422|FG001|COMPLETED|Overall Study||374
10429413|NCT00863343|11575421|FG000|NOT COMPLETED|Overall Study||0
10429414|NCT00863343|11575422|FG001|NOT COMPLETED|Overall Study||0
10429415|NCT00863356|11575430|FG000|STARTED|Overall Study||20
10294493|NCT01533714|11427213|FG003|COMPLETED|Overall Study||11
10294494|NCT01533714|11427214|FG004|COMPLETED|Overall Study||21
10294495|NCT01533714|11427215|FG005|COMPLETED|Overall Study||21
10429416|NCT00863356|11575430|FG000|COMPLETED|Overall Study||20
10429417|NCT00863356|11575430|FG000|NOT COMPLETED|Overall Study||0
10429418|NCT00863434|11575434|FG000|STARTED|Overall Study||2
10429419|NCT00863434|11575434|FG000|COMPLETED|Overall Study||2
10429420|NCT00863434|11575434|FG000|NOT COMPLETED|Overall Study||0
10429421|NCT00863551|11575438|FG000|STARTED|Overall Study||12
10429422|NCT00863551|11575438|FG000|COMPLETED|Overall Study||12
10429423|NCT00863551|11575438|FG000|NOT COMPLETED|Overall Study||0
10429424|NCT00863655|11575444|FG000|STARTED|Overall Study||485
10429425|NCT00863655|11575445|FG001|STARTED|Overall Study||239
10429426|NCT00863655|11575444|FG000|COMPLETED|Overall Study|Completed means discontinued the treatment period.|0
10429427|NCT00863655|11575445|FG001|COMPLETED|Overall Study|Completed means discontinued the treatment period.|0
10866334|NCT00042289|12031395|FG002|Infant Completed|Overall Study||27
10866335|NCT00042289|12031396|FG003|Infant Completed|Overall Study||29
10866336|NCT00042289|12031397|FG004|Infant Completed|Overall Study||26
10429428|NCT00863655|11575444|FG000|NOT COMPLETED|Overall Study||485
10429429|NCT00863655|11575445|FG001|NOT COMPLETED|Overall Study||239
10866337|NCT00042289|12031398|FG005|Infant Completed|Overall Study||25
10866338|NCT00042289|12031399|FG006|Infant Completed|Overall Study||26
10866339|NCT00042289|12031400|FG007|Infant Completed|Overall Study||10
10294496|NCT01533714|11427210|FG000|NOT COMPLETED|Overall Study||0
10294497|NCT01533714|11427211|FG001|NOT COMPLETED|Overall Study||3
10866340|NCT00042289|12031401|FG008|Infant Completed|Overall Study||25
10866341|NCT00042289|12031402|FG009|Infant Completed|Overall Study||20
10866342|NCT00042289|12031403|FG010|Infant Completed|Overall Study||2
10866343|NCT00042289|12031404|FG011|Infant Completed|Overall Study||24
10866344|NCT00042289|12031405|FG012|Infant Completed|Overall Study||11
10866345|NCT00042289|12031406|FG013|Infant Completed|Overall Study||0
10866346|NCT00042289|12031407|FG014|Infant Completed|Overall Study||0
10866347|NCT00042289|12031408|FG015|Infant Completed|Overall Study||0
10866348|NCT00042289|12031409|FG016|Infant Completed|Overall Study||0
10866349|NCT00042289|12031410|FG017|Infant Completed|Overall Study||0
10866350|NCT00042289|12031411|FG018|Infant Completed|Overall Study||0
10866351|NCT00042289|12031412|FG019|Infant Completed|Overall Study||0
10866352|NCT00042289|12031413|FG020|Infant Completed|Overall Study||0
10866353|NCT00042289|12031414|FG021|Infant Completed|Overall Study||9
10866354|NCT00042289|12031415|FG022|Infant Completed|Overall Study||0
10866355|NCT00042289|12031416|FG023|Infant Completed|Overall Study||20
10866356|NCT00042289|12031417|FG024|Infant Completed|Overall Study||3
10866357|NCT00042289|12031418|FG025|Infant Completed|Overall Study||5
10866358|NCT00042289|12031419|FG026|Infant Completed|Overall Study||0
10866359|NCT00042289|12031420|FG027|Infant Completed|Overall Study||20
10866360|NCT00042289|12031421|FG028|Infant Completed|Overall Study||0
10866361|NCT00042289|12031422|FG029|Infant Completed|Overall Study||21
10866362|NCT00042289|12031423|FG030|Infant Completed|Overall Study||0
10866363|NCT00042289|12031424|FG031|Infant Completed|Overall Study||0
10866364|NCT00042289|12031425|FG032|Infant Completed|Overall Study||6
10866365|NCT00042289|12031426|FG033|Infant Completed|Overall Study||4
10866366|NCT00042289|12031427|FG034|Infant Completed|Overall Study||4
10866367|NCT00042289|12031428|FG035|Infant Completed|Overall Study||0
10866368|NCT00042289|12031429|FG036|Infant Completed|Overall Study||8
10866369|NCT00042289|12031430|FG037|Infant Completed|Overall Study||35
10866370|NCT00042289|12031431|FG038|Infant Completed|Overall Study||34
10866371|NCT00042289|12031432|FG039|Infant Completed|Overall Study||0
10866372|NCT00042289|12031433|FG040|Infant Completed|Overall Study||26
10866373|NCT00042289|12031434|FG041|Infant Completed|Overall Study||21
10866374|NCT00042289|12031435|FG042|Infant Completed|Overall Study||27
10866375|NCT00042289|12031436|FG043|Infant Completed|Overall Study||0
10866376|NCT00042289|12031437|FG044|Infant Completed|Overall Study||0
10866377|NCT00042289|12031438|FG045|Infant Completed|Overall Study||0
10866378|NCT00042289|12031439|FG046|Infant Completed|Overall Study||0
10866379|NCT00042289|12031393|FG000|COMPLETED|Overall Study||19
10866380|NCT00042289|12031394|FG001|COMPLETED|Overall Study||29
10866381|NCT00042289|12031395|FG002|COMPLETED|Overall Study||27
10866382|NCT00042289|12031396|FG003|COMPLETED|Overall Study||25
10417748|NCT00802204|11562411|FG000|STARTED|Overall Study||9
10417749|NCT00802204|11562412|FG001|STARTED|Overall Study||19
10417750|NCT00802204|11562411|FG000|COMPLETED|Overall Study||8
10417751|NCT00802204|11562412|FG001|COMPLETED|Overall Study||18
10417752|NCT00802204|11562411|FG000|NOT COMPLETED|Overall Study||1
10417753|NCT00802204|11562412|FG001|NOT COMPLETED|Overall Study||1
10417754|NCT00802360|11562425|FG000|STARTED|Overall Study||42
10417755|NCT00802360|11562426|FG001|STARTED|Overall Study||42
10417756|NCT00802360|11562427|FG002|STARTED|Overall Study||42
10417757|NCT00802360|11562428|FG003|STARTED|Overall Study||39
10417758|NCT00802360|11562425|FG000|COMPLETED|Overall Study||18
10417759|NCT00802360|11562426|FG001|COMPLETED|Overall Study||16
10417760|NCT00802360|11562427|FG002|COMPLETED|Overall Study||17
10417761|NCT00802360|11562428|FG003|COMPLETED|Overall Study||17
10417762|NCT00802360|11562425|FG000|NOT COMPLETED|Overall Study||24
10417763|NCT00802360|11562426|FG001|NOT COMPLETED|Overall Study||26
10417764|NCT00802360|11562427|FG002|NOT COMPLETED|Overall Study||25
10417765|NCT00802360|11562428|FG003|NOT COMPLETED|Overall Study||22
10417766|NCT00802412|11562442|FG000|STARTED|Overall Study||65
10417767|NCT00802412|11562443|FG001|STARTED|Overall Study||67
10417768|NCT00802412|11562442|FG000|COMPLETED|Overall Study||63
10417769|NCT00802412|11562443|FG001|COMPLETED|Overall Study||66
10417770|NCT00802412|11562442|FG000|NOT COMPLETED|Overall Study||2
10417771|NCT00802412|11562443|FG001|NOT COMPLETED|Overall Study||1
10866383|NCT00042289|12031397|FG004|COMPLETED|Overall Study||26
10866384|NCT00042289|12031398|FG005|COMPLETED|Overall Study||25
10866385|NCT00042289|12031399|FG006|COMPLETED|Overall Study||22
10866386|NCT00042289|12031400|FG007|COMPLETED|Overall Study||10
10866387|NCT00042289|12031401|FG008|COMPLETED|Overall Study||26
10866388|NCT00042289|12031402|FG009|COMPLETED|Overall Study||23
10866389|NCT00042289|12031403|FG010|COMPLETED|Overall Study||2
10866390|NCT00042289|12031404|FG011|COMPLETED|Overall Study||27
10866391|NCT00042289|12031405|FG012|COMPLETED|Overall Study||11
10866392|NCT00042289|12031406|FG013|COMPLETED|Overall Study||2
10866393|NCT00042289|12031407|FG014|COMPLETED|Overall Study||6
10866394|NCT00042289|12031408|FG015|COMPLETED|Overall Study||28
10866395|NCT00042289|12031409|FG016|COMPLETED|Overall Study||27
10417772|NCT00802438|11562449|FG000|STARTED|Overall Study||38
10417773|NCT00802438|11562449|FG000|COMPLETED|Overall Study||10
10417774|NCT00802438|11562449|FG000|NOT COMPLETED|Overall Study||28
10417775|NCT00802464|11562457|FG000|STARTED|Month 0 - Month 8||38
10417776|NCT00802464|11562458|FG001|STARTED|Month 0 - Month 8||73
10417777|NCT00802464|11562459|FG002|STARTED|Month 0 - Month 8||149
10866396|NCT00042289|12031410|FG017|COMPLETED|Overall Study||12
10866397|NCT00042289|12031411|FG018|COMPLETED|Overall Study||18
10866398|NCT00042289|12031412|FG019|COMPLETED|Overall Study||13
10866399|NCT00042289|12031413|FG020|COMPLETED|Overall Study||1
10866400|NCT00042289|12031414|FG021|COMPLETED|Overall Study||26
10866401|NCT00042289|12031415|FG022|COMPLETED|Overall Study||27
10866402|NCT00042289|12031416|FG023|COMPLETED|Overall Study||17
10866403|NCT00042289|12031417|FG024|COMPLETED|Overall Study||17
10866404|NCT00042289|12031418|FG025|COMPLETED|Overall Study||20
10866405|NCT00042289|12031419|FG026|COMPLETED|Overall Study||20
10866406|NCT00042289|12031420|FG027|COMPLETED|Overall Study||22
10866407|NCT00042289|12031421|FG028|COMPLETED|Overall Study||21
10866408|NCT00042289|12031422|FG029|COMPLETED|Overall Study||25
10866409|NCT00042289|12031423|FG030|COMPLETED|Overall Study||0
10866410|NCT00042289|12031424|FG031|COMPLETED|Overall Study||26
10866411|NCT00042289|12031425|FG032|COMPLETED|Overall Study||38
10866412|NCT00042289|12031426|FG033|COMPLETED|Overall Study||10
10866413|NCT00042289|12031427|FG034|COMPLETED|Overall Study||10
10866414|NCT00042289|12031428|FG035|COMPLETED|Overall Study||27
10866415|NCT00042289|12031429|FG036|COMPLETED|Overall Study||32
10866416|NCT00042289|12031430|FG037|COMPLETED|Overall Study||36
10866417|NCT00042289|12031431|FG038|COMPLETED|Overall Study||33
10866418|NCT00042289|12031432|FG039|COMPLETED|Overall Study||13
10866419|NCT00042289|12031433|FG040|COMPLETED|Overall Study||26
10866420|NCT00042289|12031434|FG041|COMPLETED|Overall Study||22
10866421|NCT00042289|12031435|FG042|COMPLETED|Overall Study||25
10866422|NCT00042289|12031436|FG043|COMPLETED|Overall Study||22
10866423|NCT00042289|12031437|FG044|COMPLETED|Overall Study||27
10866424|NCT00042289|12031438|FG045|COMPLETED|Overall Study||26
10866425|NCT00042289|12031439|FG046|COMPLETED|Overall Study||27
10866426|NCT00042289|12031393|FG000|NOT COMPLETED|Overall Study||7
10866427|NCT00042289|12031394|FG001|NOT COMPLETED|Overall Study||1
10866428|NCT00042289|12031395|FG002|NOT COMPLETED|Overall Study||0
10866429|NCT00042289|12031396|FG003|NOT COMPLETED|Overall Study||8
10866430|NCT00042289|12031397|FG004|NOT COMPLETED|Overall Study||3
10866431|NCT00042289|12031398|FG005|NOT COMPLETED|Overall Study||6
10866432|NCT00042289|12031399|FG006|NOT COMPLETED|Overall Study||6
10866433|NCT00042289|12031400|FG007|NOT COMPLETED|Overall Study||2
10866434|NCT00042289|12031401|FG008|NOT COMPLETED|Overall Study||1
10866435|NCT00042289|12031402|FG009|NOT COMPLETED|Overall Study||1
10866436|NCT00042289|12031403|FG010|NOT COMPLETED|Overall Study||0
10866437|NCT00042289|12031404|FG011|NOT COMPLETED|Overall Study||0
10866438|NCT00042289|12031405|FG012|NOT COMPLETED|Overall Study||2
10866439|NCT00042289|12031406|FG013|NOT COMPLETED|Overall Study||0
10866440|NCT00042289|12031407|FG014|NOT COMPLETED|Overall Study||0
10866441|NCT00042289|12031408|FG015|NOT COMPLETED|Overall Study||1
10866442|NCT00042289|12031409|FG016|NOT COMPLETED|Overall Study||1
10866443|NCT00042289|12031410|FG017|NOT COMPLETED|Overall Study||0
10866444|NCT00042289|12031411|FG018|NOT COMPLETED|Overall Study||8
10866445|NCT00042289|12031412|FG019|NOT COMPLETED|Overall Study||4
10866446|NCT00042289|12031413|FG020|NOT COMPLETED|Overall Study||0
10866447|NCT00042289|12031414|FG021|NOT COMPLETED|Overall Study||4
10866448|NCT00042289|12031415|FG022|NOT COMPLETED|Overall Study||2
10866449|NCT00042289|12031416|FG023|NOT COMPLETED|Overall Study||5
10866450|NCT00042289|12031417|FG024|NOT COMPLETED|Overall Study||1
10866451|NCT00042289|12031418|FG025|NOT COMPLETED|Overall Study||1
10866452|NCT00042289|12031419|FG026|NOT COMPLETED|Overall Study||8
10866453|NCT00042289|12031420|FG027|NOT COMPLETED|Overall Study||3
10866454|NCT00042289|12031421|FG028|NOT COMPLETED|Overall Study||8
10866455|NCT00042289|12031422|FG029|NOT COMPLETED|Overall Study||0
10866456|NCT00042289|12031423|FG030|NOT COMPLETED|Overall Study||1
10866457|NCT00042289|12031424|FG031|NOT COMPLETED|Overall Study||9
10866458|NCT00042289|12031425|FG032|NOT COMPLETED|Overall Study||5
10866459|NCT00042289|12031426|FG033|NOT COMPLETED|Overall Study||6
10866460|NCT00042289|12031427|FG034|NOT COMPLETED|Overall Study||2
10866461|NCT00042289|12031428|FG035|NOT COMPLETED|Overall Study||5
10866462|NCT00042289|12031429|FG036|NOT COMPLETED|Overall Study||4
10866463|NCT00042289|12031430|FG037|NOT COMPLETED|Overall Study||2
10866464|NCT00042289|12031431|FG038|NOT COMPLETED|Overall Study||2
10866465|NCT00042289|12031432|FG039|NOT COMPLETED|Overall Study||5
10866466|NCT00042289|12031433|FG040|NOT COMPLETED|Overall Study||0
10866467|NCT00042289|12031434|FG041|NOT COMPLETED|Overall Study||3
10866468|NCT00042289|12031435|FG042|NOT COMPLETED|Overall Study||7
10866469|NCT00042289|12031436|FG043|NOT COMPLETED|Overall Study||3
10866470|NCT00042289|12031437|FG044|NOT COMPLETED|Overall Study||0
10866471|NCT00042289|12031438|FG045|NOT COMPLETED|Overall Study||1
10866472|NCT00042289|12031439|FG046|NOT COMPLETED|Overall Study||1
10866473|NCT02540330|12031609|FG000|STARTED|Overall Study||2
10866474|NCT02540330|12031610|FG001|STARTED|Overall Study||1
10866475|NCT02540330|12031609|FG000|COMPLETED|Overall Study||2
10866476|NCT02540330|12031610|FG001|COMPLETED|Overall Study||1
10866477|NCT02540330|12031609|FG000|NOT COMPLETED|Overall Study||0
10866478|NCT02540330|12031610|FG001|NOT COMPLETED|Overall Study||0
10866479|NCT02417701|12031616|FG000|STARTED|Overall Study||34
10866480|NCT02417701|12031616|FG000|COMPLETED|Overall Study||34
10866481|NCT02417701|12031616|FG000|NOT COMPLETED|Overall Study||0
10866482|NCT02384993|12031625|FG000|STARTED|Overall Study||12
10866483|NCT02384993|12031626|FG001|STARTED|Overall Study||12
10866484|NCT02384993|12031625|FG000|COMPLETED|Overall Study||12
10866485|NCT02384993|12031626|FG001|COMPLETED|Overall Study||11
10866486|NCT02384993|12031625|FG000|NOT COMPLETED|Overall Study||0
10866487|NCT02384993|12031626|FG001|NOT COMPLETED|Overall Study||1
10866488|NCT02304302|12031635|FG000|STARTED|Overall Study||79
10866489|NCT02304302|12031636|FG001|STARTED|Overall Study||81
10866490|NCT02304302|12031635|FG000|COMPLETED|Overall Study||76
10866491|NCT02304302|12031636|FG001|COMPLETED|Overall Study||73
10866492|NCT02304302|12031635|FG000|NOT COMPLETED|Overall Study||3
10866493|NCT02304302|12031636|FG001|NOT COMPLETED|Overall Study||8
10866494|NCT02269670|12031646|FG000|STARTED|Overall Study||3
10866495|NCT02269670|12031646|FG000|COMPLETED|Overall Study||0
10866496|NCT02269670|12031646|FG000|NOT COMPLETED|Overall Study||3
10866497|NCT02086175|12031650|FG000|STARTED|Overall Study||25
10866498|NCT02086175|12031650|FG000|COMPLETED|Overall Study||25
10866499|NCT02086175|12031650|FG000|NOT COMPLETED|Overall Study||0
10866500|NCT01860976|12031656|FG000|STARTED|Blinded Treatment||213
10866501|NCT01860976|12031657|FG001|STARTED|Blinded Treatment||211
10866502|NCT01860976|12031656|FG000|COMPLETED|Blinded Treatment||125
10866503|NCT01860976|12031657|FG001|COMPLETED|Blinded Treatment||98
10866504|NCT01860976|12031656|FG000|NOT COMPLETED|Blinded Treatment||88
10866505|NCT01860976|12031657|FG001|NOT COMPLETED|Blinded Treatment||113
10866506|NCT01860976|12031656|FG000|STARTED|Open-Label||197
10866507|NCT01860976|12031657|FG001|STARTED|Open-Label||185
10866508|NCT01860976|12031656|FG000|COMPLETED|Open-Label||169
10866509|NCT01860976|12031657|FG001|COMPLETED|Open-Label||166
10866510|NCT01860976|12031656|FG000|NOT COMPLETED|Open-Label||28
10866511|NCT01860976|12031657|FG001|NOT COMPLETED|Open-Label||19
10866512|NCT01860976|12031656|FG000|STARTED|Long Term Extension||106
10866513|NCT01860976|12031657|FG001|STARTED|Long Term Extension||0
10866514|NCT01860976|12031656|FG000|COMPLETED|Long Term Extension||81
10866515|NCT01860976|12031657|FG001|COMPLETED|Long Term Extension||0
10866516|NCT01860976|12031656|FG000|NOT COMPLETED|Long Term Extension||25
10866517|NCT01860976|12031657|FG001|NOT COMPLETED|Long Term Extension||0
10866518|NCT01761266|12031668|FG000|STARTED|Overall Study||478
10866519|NCT01761266|12031669|FG001|STARTED|Overall Study||476
10866520|NCT01761266|12031668|FG000|Treated|Overall Study||476
10866521|NCT01761266|12031669|FG001|Treated|Overall Study||475
10866522|NCT01761266|12031668|FG000|COMPLETED|Overall Study||0
10866523|NCT01761266|12031669|FG001|COMPLETED|Overall Study||0
10866524|NCT01761266|12031668|FG000|NOT COMPLETED|Overall Study||478
10866525|NCT01761266|12031669|FG001|NOT COMPLETED|Overall Study||476
10866526|NCT01550289|12031680|FG000|STARTED|Overall Study||128
10866527|NCT01550289|12031681|FG001|STARTED|Overall Study||61
10866528|NCT01550289|12031680|FG000|COMPLETED|Overall Study||115
10866529|NCT01550289|12031681|FG001|COMPLETED|Overall Study||57
10866530|NCT01550289|12031680|FG000|NOT COMPLETED|Overall Study||13
10866531|NCT01550289|12031681|FG001|NOT COMPLETED|Overall Study||4
10866532|NCT01346709|12031689|FG000|STARTED|Overall Study||5450
10866533|NCT01346709|12031689|FG000|COMPLETED|Overall Study||5099
10866534|NCT01346709|12031689|FG000|NOT COMPLETED|Overall Study||351
10866535|NCT01074190|12031696|FG000|STARTED|Overall Study||115
10866536|NCT01074190|12031697|FG001|STARTED|Overall Study||115
10866537|NCT01074190|12031698|FG002|STARTED|Overall Study||115
10866538|NCT01074190|12031696|FG000|COMPLETED|Overall Study||111
10866539|NCT01074190|12031697|FG001|COMPLETED|Overall Study||109
10866540|NCT01074190|12031698|FG002|COMPLETED|Overall Study||112
10866541|NCT01074190|12031696|FG000|NOT COMPLETED|Overall Study||4
10866542|NCT01074190|12031697|FG001|NOT COMPLETED|Overall Study||6
10866543|NCT01074190|12031698|FG002|NOT COMPLETED|Overall Study||3
10866544|NCT00875524|12031711|FG000|STARTED|Overall Study||120
10866545|NCT00875524|12031712|FG001|STARTED|Overall Study||60
10866546|NCT00875524|12031711|FG000|Received Vaccination 1|Overall Study||120
10866547|NCT00875524|12031712|FG001|Received Vaccination 1|Overall Study||60
10866548|NCT00875524|12031711|FG000|Received Vaccination 2|Overall Study||116
10866549|NCT00875524|12031712|FG001|Received Vaccination 2|Overall Study||58
10866550|NCT00875524|12031711|FG000|Received Vaccination 3|Overall Study||114
10866551|NCT00875524|12031712|FG001|Received Vaccination 3|Overall Study||58
10866552|NCT00875524|12031711|FG000|COMPLETED|Overall Study||112
10866553|NCT00875524|12031712|FG001|COMPLETED|Overall Study||54
10866554|NCT00875524|12031711|FG000|NOT COMPLETED|Overall Study||8
10866555|NCT00875524|12031712|FG001|NOT COMPLETED|Overall Study||6
10866556|NCT00842530|12031720|FG000|STARTED|Overall Study||2669
10866557|NCT00842530|12031721|FG001|STARTED|Overall Study||1333
10866558|NCT00842530|12031720|FG000|Received Vaccination 1|Overall Study||2666
10866559|NCT00842530|12031721|FG001|Received Vaccination 1|Overall Study||1331
10866560|NCT00842530|12031720|FG000|Received Vaccination 2|Overall Study||2584
10866561|NCT00842530|12031721|FG001|Received Vaccination 2|Overall Study||1300
10866562|NCT00842530|12031720|FG000|Received Vaccination 3|Overall Study||2557
10866563|NCT00842530|12031721|FG001|Received Vaccination 3|Overall Study||1282
10866564|NCT00842530|12031720|FG000|COMPLETED|Overall Study||2552
10866565|NCT00842530|12031721|FG001|COMPLETED|Overall Study||1276
10866566|NCT00842530|12031720|FG000|NOT COMPLETED|Overall Study||117
10866567|NCT00842530|12031721|FG001|NOT COMPLETED|Overall Study||57
10866568|NCT00788151|12031730|FG000|STARTED|Overall Study||200
10866569|NCT00788151|12031731|FG001|STARTED|Overall Study||100
10866570|NCT00788151|12031730|FG000|Received Vaccination 1|Overall Study||199
10866571|NCT00788151|12031731|FG001|Received Vaccination 1|Overall Study||99
10866572|NCT00788151|12031730|FG000|Received Vaccination 2|Overall Study||188
10866573|NCT00788151|12031731|FG001|Received Vaccination 2|Overall Study||92
10294498|NCT01533714|11427212|FG002|NOT COMPLETED|Overall Study||4
10294499|NCT01533714|11427213|FG003|NOT COMPLETED|Overall Study||4
10294500|NCT01533714|11427214|FG004|NOT COMPLETED|Overall Study||7
10294501|NCT01533714|11427215|FG005|NOT COMPLETED|Overall Study||3
10294502|NCT00002931|11427229|FG000|STARTED|Overall Study||48
10294503|NCT00002931|11427229|FG000|COMPLETED|Overall Study||46
10294504|NCT00002931|11427229|FG000|NOT COMPLETED|Overall Study||2
10294505|NCT00003138|11427235|FG000|STARTED|Step 1||61
10294506|NCT00003138|11427236|FG001|STARTED|Step 1||57
10294507|NCT00003138|11427235|FG000|Patients With Complete Data|Step 1||57
10294508|NCT00003138|11427236|FG001|Patients With Complete Data|Step 1||53
10294509|NCT00003138|11427235|FG000|Treated|Step 1||56
10294510|NCT00003138|11427236|FG001|Treated|Step 1||53
10294511|NCT00003138|11427235|FG000|Eligible and Treated|Step 1||52
10294512|NCT00003138|11427236|FG001|Eligible and Treated|Step 1||50
10294513|NCT00003138|11427235|FG000|Patients With QOL Data at 4 Months|Step 1||42
10294514|NCT00003138|11427236|FG001|Patients With QOL Data at 4 Months|Step 1||42
10294515|NCT00003138|11427235|FG000|Patients With Transfusion Data|Step 1||37
10294516|NCT00003138|11427236|FG001|Patients With Transfusion Data|Step 1||42
10294517|NCT00003138|11427235|FG000|COMPLETED|Step 1||0
10294518|NCT00003138|11427236|FG001|COMPLETED|Step 1||0
10294519|NCT00003138|11427235|FG000|NOT COMPLETED|Step 1||61
10294520|NCT00003138|11427236|FG001|NOT COMPLETED|Step 1||57
10294521|NCT00003138|11427235|FG000|STARTED|Step 2 (Cross Over)||26
10294522|NCT00003138|11427236|FG001|STARTED|Step 2 (Cross Over)|Only patients in the supportive care arm are eligible to cross over to the Erythropoietin arm.|0
10294523|NCT00003138|11427235|FG000|COMPLETED|Step 2 (Cross Over)||0
10294524|NCT00003138|11427236|FG001|COMPLETED|Step 2 (Cross Over)||0
10294525|NCT00003138|11427235|FG000|NOT COMPLETED|Step 2 (Cross Over)||26
10294526|NCT00003138|11427236|FG001|NOT COMPLETED|Step 2 (Cross Over)||0
10294527|NCT00003138|11427235|FG000|STARTED|Step 3 (EPO 150 Units/kg and G-CSF)||12
10294528|NCT00003138|11427236|FG001|STARTED|Step 3 (EPO 150 Units/kg and G-CSF)||20
10294529|NCT00003138|11427235|FG000|Treated|Step 3 (EPO 150 Units/kg and G-CSF)||12
10294530|NCT00003138|11427236|FG001|Treated|Step 3 (EPO 150 Units/kg and G-CSF)||19
10294531|NCT00003138|11427235|FG000|COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||0
10294532|NCT00003138|11427236|FG001|COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||0
10294533|NCT00003138|11427235|FG000|NOT COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||12
10294534|NCT00003138|11427236|FG001|NOT COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||20
10294535|NCT00003138|11427235|FG000|STARTED|Step 4 (EPO 300 Units/kg and G-CSF)||6
10294536|NCT00003138|11427236|FG001|STARTED|Step 4 (EPO 300 Units/kg and G-CSF)||7
10294537|NCT00003138|11427235|FG000|COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||0
10417778|NCT00802464|11562460|FG003|STARTED|Month 0 - Month 8||150
10417779|NCT00802464|11562457|FG000|COMPLETED|Month 0 - Month 8||38
10417780|NCT00802464|11562458|FG001|COMPLETED|Month 0 - Month 8||70
10417781|NCT00802464|11562459|FG002|COMPLETED|Month 0 - Month 8||142
10417782|NCT00802464|11562460|FG003|COMPLETED|Month 0 - Month 8||141
10417783|NCT00802464|11562457|FG000|NOT COMPLETED|Month 0 - Month 8||0
10417784|NCT00802464|11562458|FG001|NOT COMPLETED|Month 0 - Month 8||3
10417785|NCT00802464|11562459|FG002|NOT COMPLETED|Month 0 - Month 8||7
10417786|NCT00802464|11562460|FG003|NOT COMPLETED|Month 0 - Month 8||9
10294538|NCT00003138|11427236|FG001|COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||0
10294539|NCT00003138|11427235|FG000|NOT COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||6
10294540|NCT00003138|11427236|FG001|NOT COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||7
10294541|NCT00003199|11427245|FG000|STARTED|Overall Study||50
10294542|NCT00003199|11427245|FG000|COMPLETED|Overall Study||28
10294543|NCT00003199|11427245|FG000|NOT COMPLETED|Overall Study||22
10294544|NCT00003222|11427251|FG000|STARTED|Overall Study||13
10294545|NCT00003222|11427252|FG001|STARTED|Overall Study||28
10294546|NCT00003222|11427251|FG000|COMPLETED|Overall Study||13
10294547|NCT00003222|11427252|FG001|COMPLETED|Overall Study|Decline in performance status between enrollment and initiation of therapy.|27
10294548|NCT00003222|11427251|FG000|NOT COMPLETED|Overall Study||0
10294549|NCT00003222|11427252|FG001|NOT COMPLETED|Overall Study||1
10294550|NCT00003224|11427264|FG000|STARTED|Overall Study||4
10294551|NCT00003224|11427265|FG001|STARTED|Overall Study||5
10294552|NCT00003224|11427266|FG002|STARTED|Overall Study||4
10294553|NCT00003224|11427267|FG003|STARTED|Overall Study||2
10294554|NCT00003224|11427268|FG004|STARTED|Overall Study||4
10294555|NCT00003224|11427269|FG005|STARTED|Overall Study||3
10294556|NCT00003224|11427264|FG000|COMPLETED|Overall Study||4
10417787|NCT00802464|11562457|FG000|STARTED|Month 8 - Month 14||34
10417788|NCT00802464|11562458|FG001|STARTED|Month 8 - Month 14||65
10417789|NCT00802464|11562459|FG002|STARTED|Month 8 - Month 14||130
10417790|NCT00802464|11562460|FG003|STARTED|Month 8 - Month 14||126
10294557|NCT00003224|11427265|FG001|COMPLETED|Overall Study||5
10294558|NCT00003224|11427266|FG002|COMPLETED|Overall Study||4
10294559|NCT00003224|11427267|FG003|COMPLETED|Overall Study||2
10294560|NCT00003224|11427268|FG004|COMPLETED|Overall Study||4
10294561|NCT00003224|11427269|FG005|COMPLETED|Overall Study||3
10866574|NCT00788151|12031730|FG000|Received Vaccination 3|Overall Study||186
10866575|NCT00788151|12031731|FG001|Received Vaccination 3|Overall Study||90
10866576|NCT00788151|12031730|FG000|COMPLETED|Overall Study||186
10866577|NCT00788151|12031731|FG001|COMPLETED|Overall Study||90
10866578|NCT00788151|12031730|FG000|NOT COMPLETED|Overall Study||14
10866579|NCT00788151|12031731|FG001|NOT COMPLETED|Overall Study||10
10866580|NCT00539591|12031740|FG000|STARTED|Overall Study||23
10866581|NCT00539591|12031741|FG001|STARTED|Overall Study||2
10866582|NCT00539591|12031742|FG002|STARTED|Overall Study||4
10866583|NCT00539591|12031740|FG000|COMPLETED|Overall Study||18
10866584|NCT00539591|12031741|FG001|COMPLETED|Overall Study||0
10866585|NCT00539591|12031742|FG002|COMPLETED|Overall Study||1
10866586|NCT00539591|12031740|FG000|NOT COMPLETED|Overall Study||5
10866587|NCT00539591|12031741|FG001|NOT COMPLETED|Overall Study||2
10866588|NCT00539591|12031742|FG002|NOT COMPLETED|Overall Study||3
10294562|NCT00003224|11427264|FG000|NOT COMPLETED|Overall Study||0
10294563|NCT00003224|11427265|FG001|NOT COMPLETED|Overall Study||0
10294564|NCT00003224|11427266|FG002|NOT COMPLETED|Overall Study||0
10294565|NCT00003224|11427267|FG003|NOT COMPLETED|Overall Study||0
10294566|NCT00003224|11427268|FG004|NOT COMPLETED|Overall Study||0
10294567|NCT00003224|11427269|FG005|NOT COMPLETED|Overall Study||0
10294568|NCT00003270|11427281|FG000|STARTED|Overall Study||20
10294569|NCT00003270|11427281|FG000|COMPLETED|Overall Study||20
10294570|NCT00003270|11427281|FG000|NOT COMPLETED|Overall Study||0
10314671|NCT00167388|11448389|FG003|COMPLETED|Overall Study||6
10314672|NCT00167388|11448386|FG000|NOT COMPLETED|Overall Study||0
10314673|NCT00167388|11448387|FG001|NOT COMPLETED|Overall Study||0
10314674|NCT00167388|11448388|FG002|NOT COMPLETED|Overall Study||0
10314675|NCT00167388|11448389|FG003|NOT COMPLETED|Overall Study||0
10314676|NCT00167414|11448397|FG000|STARTED|Overall Study||49
10314677|NCT00167414|11448397|FG000|COMPLETED|Overall Study||39
10314678|NCT00167414|11448397|FG000|NOT COMPLETED|Overall Study||10
10314679|NCT00167544|11448403|FG000|STARTED|Overall Study||31
10314680|NCT00167544|11448404|FG001|STARTED|Overall Study||33
10314681|NCT00167544|11448403|FG000|COMPLETED|Overall Study||30
10314682|NCT00167544|11448404|FG001|COMPLETED|Overall Study||33
10314683|NCT00167544|11448403|FG000|NOT COMPLETED|Overall Study||1
10314684|NCT00167544|11448404|FG001|NOT COMPLETED|Overall Study||0
10314685|NCT00167661|11448410|FG000|STARTED|Overall Study||33
10314686|NCT00167661|11448410|FG000|COMPLETED|Overall Study||33
10314687|NCT00167661|11448410|FG000|NOT COMPLETED|Overall Study||0
10314688|NCT00167778|11448414|FG000|STARTED|Overall Study||11
10314689|NCT00167778|11448414|FG000|COMPLETED|Overall Study||10
10314690|NCT00167778|11448414|FG000|NOT COMPLETED|Overall Study||1
10314691|NCT00167934|11448421|FG000|STARTED|Overall Study||82
10314692|NCT00167934|11448422|FG001|STARTED|Overall Study||82
10314693|NCT00167934|11448421|FG000|COMPLETED|Overall Study||82
10314694|NCT00167934|11448422|FG001|COMPLETED|Overall Study||82
10314695|NCT00167934|11448421|FG000|NOT COMPLETED|Overall Study||0
10314696|NCT00167934|11448422|FG001|NOT COMPLETED|Overall Study||0
10314697|NCT00168038|11448428|FG000|STARTED|Overall Study||57
10314698|NCT00168038|11448428|FG000|COMPLETED|Overall Study||55
10314699|NCT00168038|11448428|FG000|NOT COMPLETED|Overall Study||2
10314700|NCT00168064|11448434|FG000|STARTED|Overall Study|128 participants received PG formulation|130
10314701|NCT00168064|11448435|FG001|STARTED|Overall Study|127 participants received AP formulation|130
10314702|NCT00168064|11448434|FG000|COMPLETED|Overall Study||81
10314703|NCT00168064|11448435|FG001|COMPLETED|Overall Study||86
10866589|NCT04794751|12031778|FG000|STARTED|Period 1||38
10866590|NCT04794751|12031779|FG001|STARTED|Period 1||37
10866591|NCT04794751|12031778|FG000|COMPLETED|Period 1||36
10866592|NCT04794751|12031779|FG001|COMPLETED|Period 1||32
10866593|NCT04794751|12031778|FG000|NOT COMPLETED|Period 1||2
10866594|NCT04794751|12031779|FG001|NOT COMPLETED|Period 1||5
10866595|NCT04794751|12031778|FG000|STARTED|Period 2||36
10866596|NCT04794751|12031779|FG001|STARTED|Period 2||32
10866597|NCT04794751|12031778|FG000|COMPLETED|Period 2||35
10866598|NCT04794751|12031779|FG001|COMPLETED|Period 2||29
10866599|NCT04794751|12031778|FG000|NOT COMPLETED|Period 2||1
10866600|NCT04794751|12031779|FG001|NOT COMPLETED|Period 2||3
10866601|NCT04794751|12031778|FG000|STARTED|Period 3||35
10866602|NCT04794751|12031779|FG001|STARTED|Period 3||29
10866603|NCT04794751|12031778|FG000|COMPLETED|Period 3||35
10866604|NCT04794751|12031779|FG001|COMPLETED|Period 3||29
10866605|NCT04794751|12031778|FG000|NOT COMPLETED|Period 3||0
10866606|NCT04794751|12031779|FG001|NOT COMPLETED|Period 3||0
10866607|NCT04584645|12031787|FG000|STARTED|Overall Study||24570
10866608|NCT04584645|12031788|FG001|STARTED|Overall Study||24568
10866609|NCT04584645|12031787|FG000|COMPLETED|Overall Study||5575
10866610|NCT04584645|12031788|FG001|COMPLETED|Overall Study||5662
10866611|NCT04584645|12031787|FG000|NOT COMPLETED|Overall Study||18995
10866612|NCT04584645|12031788|FG001|NOT COMPLETED|Overall Study||18906
10866613|NCT04538170|12031814|FG000|STARTED|Overall Study||158
10866614|NCT04538170|12031815|FG001|STARTED|Overall Study||265
10866615|NCT04538170|12031814|FG000|COMPLETED|Overall Study||54
10866616|NCT04538170|12031815|FG001|COMPLETED|Overall Study||55
10866617|NCT04538170|12031814|FG000|NOT COMPLETED|Overall Study||104
10866618|NCT04538170|12031815|FG001|NOT COMPLETED|Overall Study||210
10866619|NCT04461015|12031827|FG000|STARTED|Overall Study||5
10866620|NCT04461015|12031828|FG001|STARTED|Overall Study||7
10866621|NCT04461015|12031827|FG000|COMPLETED|Overall Study||5
10866622|NCT04461015|12031828|FG001|COMPLETED|Overall Study||5
10866623|NCT04461015|12031827|FG000|NOT COMPLETED|Overall Study||0
10417791|NCT00802464|11562457|FG000|COMPLETED|Month 8 - Month 14||33
10417792|NCT00802464|11562458|FG001|COMPLETED|Month 8 - Month 14||63
10417793|NCT00802464|11562459|FG002|COMPLETED|Month 8 - Month 14||129
10417794|NCT00802464|11562460|FG003|COMPLETED|Month 8 - Month 14||126
10417795|NCT00802464|11562457|FG000|NOT COMPLETED|Month 8 - Month 14||1
10417796|NCT00802464|11562458|FG001|NOT COMPLETED|Month 8 - Month 14||2
10417797|NCT00802464|11562459|FG002|NOT COMPLETED|Month 8 - Month 14||1
10417798|NCT00802464|11562460|FG003|NOT COMPLETED|Month 8 - Month 14||0
10417799|NCT00802503|11562474|FG000|STARTED|Overall Study||152
10417800|NCT00802503|11562475|FG001|STARTED|Overall Study||153
10417801|NCT00802503|11562474|FG000|COMPLETED|Overall Study||142
10417802|NCT00802503|11562475|FG001|COMPLETED|Overall Study||133
10417803|NCT00802503|11562474|FG000|NOT COMPLETED|Overall Study||10
10417804|NCT00802503|11562475|FG001|NOT COMPLETED|Overall Study||20
10417805|NCT00802529|11562487|FG000|STARTED|Overall Study||30
10417806|NCT00802529|11562488|FG001|STARTED|Overall Study||30
10417807|NCT00802529|11562487|FG000|COMPLETED|Overall Study|2 patients crossed-over to gentamicin after steroids failed to control vertigo (as per protocol).|30
10417808|NCT00802529|11562488|FG001|COMPLETED|Overall Study||29
10417809|NCT00802529|11562487|FG000|NOT COMPLETED|Overall Study||0
10417810|NCT00802529|11562488|FG001|NOT COMPLETED|Overall Study||1
10417811|NCT00802633|11562496|FG000|STARTED|Overall Study||40
10417812|NCT00802633|11562497|FG001|STARTED|Overall Study||40
10417813|NCT00802633|11562496|FG000|COMPLETED|Overall Study||40
10417814|NCT00802633|11562497|FG001|COMPLETED|Overall Study||40
10417815|NCT00802633|11562496|FG000|NOT COMPLETED|Overall Study||0
10417816|NCT00802633|11562497|FG001|NOT COMPLETED|Overall Study||0
10417817|NCT00802672|11562506|FG000|STARTED|Overall Study||224
10417818|NCT00802672|11562507|FG001|STARTED|Overall Study||226
10417819|NCT00802672|11562508|FG002|STARTED|Overall Study||111
10417820|NCT00802672|11562506|FG000|COMPLETED|Overall Study||156
10417821|NCT00802672|11562507|FG001|COMPLETED|Overall Study||174
10417822|NCT00802672|11562508|FG002|COMPLETED|Overall Study||77
10417823|NCT00802672|11562506|FG000|NOT COMPLETED|Overall Study||68
10417824|NCT00802672|11562507|FG001|NOT COMPLETED|Overall Study||52
10417825|NCT00802672|11562508|FG002|NOT COMPLETED|Overall Study||34
10417826|NCT00802685|11562518|FG000|STARTED|Overall Study||54
10417827|NCT00802685|11562519|FG001|STARTED|Overall Study||51
10866624|NCT04461015|12031828|FG001|NOT COMPLETED|Overall Study||2
10866625|NCT04380961|12031836|FG000|STARTED|Overall Study||140
10866626|NCT04380961|12031837|FG001|STARTED|Overall Study||72
10866627|NCT04380961|12031836|FG000|Treated|Overall Study||139
10866628|NCT04380961|12031837|FG001|Treated|Overall Study||70
10866629|NCT04380961|12031836|FG000|Participants Who Entered the Follow-up Phase|Overall Study||118
10866630|NCT04380961|12031837|FG001|Participants Who Entered the Follow-up Phase|Overall Study||57
10866631|NCT04380961|12031836|FG000|COMPLETED|Overall Study||96
10866632|NCT04380961|12031837|FG001|COMPLETED|Overall Study||43
10866633|NCT04380961|12031836|FG000|NOT COMPLETED|Overall Study||44
10866634|NCT04380961|12031837|FG001|NOT COMPLETED|Overall Study||29
10866635|NCT04341441|12031849|FG000|STARTED|Overall Study||197
10866636|NCT04341441|12031850|FG001|STARTED|Overall Study||201
10866637|NCT04341441|12031851|FG002|STARTED|Overall Study||200
10866638|NCT04341441|12031852|FG003|STARTED|Overall Study||26
10866639|NCT04341441|12031849|FG000|COMPLETED|Overall Study||188
10866640|NCT04341441|12031850|FG001|COMPLETED|Overall Study||199
10866641|NCT04341441|12031851|FG002|COMPLETED|Overall Study||191
10417828|NCT00802685|11562518|FG000|COMPLETED|Overall Study||54
10417829|NCT00802685|11562519|FG001|COMPLETED|Overall Study||51
10417830|NCT00802685|11562518|FG000|NOT COMPLETED|Overall Study||0
10866642|NCT04341441|12031852|FG003|COMPLETED|Overall Study||26
10866643|NCT04341441|12031849|FG000|NOT COMPLETED|Overall Study||9
10866644|NCT04341441|12031850|FG001|NOT COMPLETED|Overall Study||2
10866645|NCT04341441|12031851|FG002|NOT COMPLETED|Overall Study||9
10866646|NCT04341441|12031852|FG003|NOT COMPLETED|Overall Study||0
10866647|NCT04332419|12031862|FG000|STARTED|Overall Study||11
10866648|NCT04332419|12031862|FG000|COMPLETED|Overall Study||10
10866649|NCT04332419|12031862|FG000|NOT COMPLETED|Overall Study||1
10866650|NCT04239872|12031866|FG000|STARTED|Overall Study||11
10866651|NCT04239872|12031867|FG001|STARTED|Overall Study||9
10866652|NCT04239872|12031866|FG000|COMPLETED|Overall Study||11
10866653|NCT04239872|12031867|FG001|COMPLETED|Overall Study||8
10866654|NCT04239872|12031866|FG000|NOT COMPLETED|Overall Study||0
10866655|NCT04239872|12031867|FG001|NOT COMPLETED|Overall Study||1
10866656|NCT04141917|12031875|FG000|STARTED|Surveillance Year 1||63
10866657|NCT04141917|12031876|FG001|STARTED|Surveillance Year 1||76
10866658|NCT04141917|12031877|FG002|STARTED|Surveillance Year 1||81
10866659|NCT04141917|12031878|FG003|STARTED|Surveillance Year 1||324
10866660|NCT04141917|12031875|FG000|COMPLETED|Surveillance Year 1||63
10866661|NCT04141917|12031876|FG001|COMPLETED|Surveillance Year 1||76
10866662|NCT04141917|12031877|FG002|COMPLETED|Surveillance Year 1||81
10866663|NCT04141917|12031878|FG003|COMPLETED|Surveillance Year 1||324
10866664|NCT04141917|12031875|FG000|NOT COMPLETED|Surveillance Year 1||0
10866665|NCT04141917|12031876|FG001|NOT COMPLETED|Surveillance Year 1||0
10866666|NCT04141917|12031877|FG002|NOT COMPLETED|Surveillance Year 1||0
10866667|NCT04141917|12031878|FG003|NOT COMPLETED|Surveillance Year 1||0
10866668|NCT04141917|12031875|FG000|STARTED|Surveillance + Test and Treat Year 1||358
10866669|NCT04141917|12031876|FG001|STARTED|Surveillance + Test and Treat Year 1||153
10866670|NCT04141917|12031877|FG002|STARTED|Surveillance + Test and Treat Year 1||82
10866671|NCT04141917|12031878|FG003|STARTED|Surveillance + Test and Treat Year 1||83
10866672|NCT04141917|12031875|FG000|COMPLETED|Surveillance + Test and Treat Year 1||358
10866673|NCT04141917|12031876|FG001|COMPLETED|Surveillance + Test and Treat Year 1||153
10866674|NCT04141917|12031877|FG002|COMPLETED|Surveillance + Test and Treat Year 1||82
10866675|NCT04141917|12031878|FG003|COMPLETED|Surveillance + Test and Treat Year 1||83
10866676|NCT04141917|12031875|FG000|NOT COMPLETED|Surveillance + Test and Treat Year 1||0
10866677|NCT04141917|12031876|FG001|NOT COMPLETED|Surveillance + Test and Treat Year 1||0
10866678|NCT04141917|12031877|FG002|NOT COMPLETED|Surveillance + Test and Treat Year 1||0
10866679|NCT04141917|12031878|FG003|NOT COMPLETED|Surveillance + Test and Treat Year 1||0
10866680|NCT04141917|12031875|FG000|STARTED|Summer Surveillance||73
10866681|NCT04141917|12031876|FG001|STARTED|Summer Surveillance||39
10866682|NCT04141917|12031877|FG002|STARTED|Summer Surveillance||54
10866683|NCT04141917|12031878|FG003|STARTED|Summer Surveillance||20
10866684|NCT04141917|12031875|FG000|COMPLETED|Summer Surveillance||73
10866685|NCT04141917|12031876|FG001|COMPLETED|Summer Surveillance||39
10866686|NCT04141917|12031877|FG002|COMPLETED|Summer Surveillance||54
10866687|NCT04141917|12031878|FG003|COMPLETED|Summer Surveillance||20
10866688|NCT04141917|12031875|FG000|NOT COMPLETED|Summer Surveillance||0
10866689|NCT04141917|12031876|FG001|NOT COMPLETED|Summer Surveillance||0
10866690|NCT04141917|12031877|FG002|NOT COMPLETED|Summer Surveillance||0
10866691|NCT04141917|12031878|FG003|NOT COMPLETED|Summer Surveillance||0
10866692|NCT04141917|12031875|FG000|STARTED|Surveillance Year 2||3
10866693|NCT04141917|12031876|FG001|STARTED|Surveillance Year 2||3
10866694|NCT04141917|12031877|FG002|STARTED|Surveillance Year 2||10
10866695|NCT04141917|12031878|FG003|STARTED|Surveillance Year 2||7
10866696|NCT04141917|12031875|FG000|COMPLETED|Surveillance Year 2||3
10866697|NCT04141917|12031876|FG001|COMPLETED|Surveillance Year 2||3
10866698|NCT04141917|12031877|FG002|COMPLETED|Surveillance Year 2||10
10866699|NCT04141917|12031878|FG003|COMPLETED|Surveillance Year 2||7
10866700|NCT04141917|12031875|FG000|NOT COMPLETED|Surveillance Year 2||0
10866701|NCT04141917|12031876|FG001|NOT COMPLETED|Surveillance Year 2||0
10866702|NCT04141917|12031877|FG002|NOT COMPLETED|Surveillance Year 2||0
10866703|NCT04141917|12031878|FG003|NOT COMPLETED|Surveillance Year 2||0
10866704|NCT04141917|12031875|FG000|STARTED|Surveillance + Test and Treat Year 2||62
10866705|NCT04141917|12031876|FG001|STARTED|Surveillance + Test and Treat Year 2||13
10866706|NCT04141917|12031877|FG002|STARTED|Surveillance + Test and Treat Year 2||3
10866707|NCT04141917|12031878|FG003|STARTED|Surveillance + Test and Treat Year 2||3
10866708|NCT04141917|12031875|FG000|COMPLETED|Surveillance + Test and Treat Year 2||62
10866709|NCT04141917|12031876|FG001|COMPLETED|Surveillance + Test and Treat Year 2||13
10866710|NCT04141917|12031877|FG002|COMPLETED|Surveillance + Test and Treat Year 2||3
10866711|NCT04141917|12031878|FG003|COMPLETED|Surveillance + Test and Treat Year 2||3
10866712|NCT04141917|12031875|FG000|NOT COMPLETED|Surveillance + Test and Treat Year 2||0
10866713|NCT04141917|12031876|FG001|NOT COMPLETED|Surveillance + Test and Treat Year 2||0
10866714|NCT04141917|12031877|FG002|NOT COMPLETED|Surveillance + Test and Treat Year 2||0
10866715|NCT04141917|12031878|FG003|NOT COMPLETED|Surveillance + Test and Treat Year 2||0
10314704|NCT00168064|11448434|FG000|NOT COMPLETED|Overall Study||49
10866716|NCT04091581|12031886|FG000|STARTED|Overall Study||10
10866717|NCT04091581|12031887|FG001|STARTED|Overall Study||11
10866718|NCT04091581|12031886|FG000|COMPLETED|Overall Study||10
10866719|NCT04091581|12031887|FG001|COMPLETED|Overall Study||10
10866720|NCT04091581|12031886|FG000|NOT COMPLETED|Overall Study||0
10294571|NCT04848662|11427287|FG000|STARTED|Period 1 (First Treatment Intervention)||6
10294572|NCT04848662|11427288|FG001|STARTED|Period 1 (First Treatment Intervention)||6
10294573|NCT04848662|11427287|FG000|COMPLETED|Period 1 (First Treatment Intervention)||6
10294574|NCT04848662|11427288|FG001|COMPLETED|Period 1 (First Treatment Intervention)||6
10294575|NCT04848662|11427287|FG000|NOT COMPLETED|Period 1 (First Treatment Intervention)||0
10294576|NCT04848662|11427288|FG001|NOT COMPLETED|Period 1 (First Treatment Intervention)||0
10294577|NCT04848662|11427287|FG000|STARTED|Period 2 (Second Treatment Intervention)||6
10294578|NCT04848662|11427288|FG001|STARTED|Period 2 (Second Treatment Intervention)||6
10294579|NCT04848662|11427287|FG000|COMPLETED|Period 2 (Second Treatment Intervention)||5
10294580|NCT04848662|11427288|FG001|COMPLETED|Period 2 (Second Treatment Intervention)||6
10314705|NCT00168064|11448435|FG001|NOT COMPLETED|Overall Study||44
10417831|NCT00802685|11562519|FG001|NOT COMPLETED|Overall Study||0
10417832|NCT00802737|11562528|FG000|STARTED|Overall Study||17
10417833|NCT00802737|11562529|FG001|STARTED|Overall Study||11
10417834|NCT00802737|11562530|FG002|STARTED|Overall Study||1
10417835|NCT00802737|11562528|FG000|COMPLETED|Overall Study||0
10417836|NCT00802737|11562529|FG001|COMPLETED|Overall Study||0
10417837|NCT00802737|11562530|FG002|COMPLETED|Overall Study||0
10417838|NCT00802737|11562528|FG000|NOT COMPLETED|Overall Study||17
10417839|NCT00802737|11562529|FG001|NOT COMPLETED|Overall Study||11
10417840|NCT00802737|11562530|FG002|NOT COMPLETED|Overall Study||1
10417841|NCT00802841|11562541|FG000|STARTED|Overall Study||96
10417842|NCT00802841|11562542|FG001|STARTED|Overall Study||95
10417843|NCT00802841|11562541|FG000|Full Analysis Set|Overall Study||96
10417844|NCT00802841|11562542|FG001|Full Analysis Set|Overall Study||95
10417845|NCT00802841|11562541|FG000|Safety Set|Overall Study||96
10417846|NCT00802841|11562542|FG001|Safety Set|Overall Study||93
10417847|NCT00802841|11562541|FG000|Cross-over Set|Overall Study||13
10417848|NCT00802841|11562542|FG001|Cross-over Set|Overall Study||56
10417849|NCT00802841|11562541|FG000|COMPLETED|Overall Study||0
10417850|NCT00802841|11562542|FG001|COMPLETED|Overall Study||0
10417851|NCT00802841|11562541|FG000|NOT COMPLETED|Overall Study||96
10417852|NCT00802841|11562542|FG001|NOT COMPLETED|Overall Study||95
10417853|NCT00802854|11562550|FG000|STARTED|Overall Study||244
10417854|NCT00802854|11562550|FG000|COMPLETED|Overall Study||244
10417855|NCT00802854|11562550|FG000|NOT COMPLETED|Overall Study||0
10417856|NCT00802867|11562554|FG000|STARTED|Overall Study||989
10417857|NCT00802867|11562554|FG000|COMPLETED|Overall Study||976
10417858|NCT00802867|11562554|FG000|NOT COMPLETED|Overall Study||13
10417859|NCT00802880|11562558|FG000|STARTED|Overall Study||80
10417860|NCT00802880|11562558|FG000|COMPLETED|Overall Study||80
10417861|NCT00802880|11562558|FG000|NOT COMPLETED|Overall Study||0
10417862|NCT00802919|11562568|FG000|STARTED|Overall Study||45
10417863|NCT00802919|11562569|FG001|STARTED|Overall Study||46
10417864|NCT00802919|11562568|FG000|COMPLETED|Overall Study||42
10417865|NCT00802919|11562569|FG001|COMPLETED|Overall Study||45
10417866|NCT00802919|11562568|FG000|NOT COMPLETED|Overall Study||3
10417867|NCT00802919|11562569|FG001|NOT COMPLETED|Overall Study||1
10417868|NCT00802945|11562578|FG000|STARTED|Overall Study||35
10417869|NCT00802945|11562579|FG001|STARTED|Overall Study||35
10417870|NCT00802945|11562578|FG000|COMPLETED|Overall Study||0
10417871|NCT00802945|11562579|FG001|COMPLETED|Overall Study||0
10417872|NCT00802945|11562578|FG000|NOT COMPLETED|Overall Study||35
10417873|NCT00802945|11562579|FG001|NOT COMPLETED|Overall Study||35
10417874|NCT00802997|11562589|FG000|STARTED|Baseline to 3 Months||34
10417875|NCT00802997|11562590|FG001|STARTED|Baseline to 3 Months||17
10417876|NCT00802997|11562589|FG000|COMPLETED|Baseline to 3 Months||34
10417877|NCT00802997|11562590|FG001|COMPLETED|Baseline to 3 Months||17
10417878|NCT00802997|11562589|FG000|NOT COMPLETED|Baseline to 3 Months||0
10417879|NCT00802997|11562590|FG001|NOT COMPLETED|Baseline to 3 Months||0
10417880|NCT00802997|11562589|FG000|STARTED|3 Months to 6 Months||34
10417881|NCT00802997|11562590|FG001|STARTED|3 Months to 6 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
10417882|NCT00802997|11562589|FG000|COMPLETED|3 Months to 6 Months||27
10417883|NCT00802997|11562590|FG001|COMPLETED|3 Months to 6 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
10417884|NCT00802997|11562589|FG000|NOT COMPLETED|3 Months to 6 Months||7
10417885|NCT00802997|11562590|FG001|NOT COMPLETED|3 Months to 6 Months||0
10417886|NCT00802997|11562589|FG000|STARTED|6 Month to 9 Months||27
10417887|NCT00802997|11562590|FG001|STARTED|6 Month to 9 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
10417888|NCT00802997|11562589|FG000|COMPLETED|6 Month to 9 Months||25
10417889|NCT00802997|11562590|FG001|COMPLETED|6 Month to 9 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
10417890|NCT00802997|11562589|FG000|NOT COMPLETED|6 Month to 9 Months||2
10417891|NCT00802997|11562590|FG001|NOT COMPLETED|6 Month to 9 Months||0
10417892|NCT00803010|11562598|FG000|STARTED|Overall Study||37
10417893|NCT00803010|11562599|FG001|STARTED|Overall Study||37
10417894|NCT00803010|11562598|FG000|COMPLETED|Overall Study||37
10417895|NCT00803010|11562599|FG001|COMPLETED|Overall Study||37
10417896|NCT00803010|11562598|FG000|NOT COMPLETED|Overall Study||0
10417897|NCT00803010|11562599|FG001|NOT COMPLETED|Overall Study||0
10417898|NCT00803023|11562609|FG000|STARTED|Overall Study||32
10866721|NCT04091581|12031887|FG001|NOT COMPLETED|Overall Study||1
10866722|NCT03986671|12031896|FG000|STARTED|Overall Study||36
10866723|NCT03986671|12031897|FG001|STARTED|Overall Study||9
10866724|NCT03986671|12031898|FG002|STARTED|Overall Study||5
10866725|NCT03986671|12031896|FG000|Passed a Screening Visit With ENT|Overall Study||6
10866726|NCT03986671|12031897|FG001|Passed a Screening Visit With ENT|Overall Study||5
10866727|NCT03986671|12031898|FG002|Passed a Screening Visit With ENT|Overall Study||5
10866728|NCT03986671|12031896|FG000|COMPLETED|Overall Study||6
10866729|NCT03986671|12031897|FG001|COMPLETED|Overall Study||5
10866730|NCT03986671|12031898|FG002|COMPLETED|Overall Study||5
10866731|NCT03986671|12031896|FG000|NOT COMPLETED|Overall Study||30
10866732|NCT03986671|12031897|FG001|NOT COMPLETED|Overall Study||4
10417899|NCT00803023|11562610|FG001|STARTED|Overall Study||33
10417900|NCT00803023|11562611|FG002|STARTED|Overall Study||31
10417901|NCT00803023|11562612|FG003|STARTED|Overall Study||33
10417902|NCT00803023|11562609|FG000|COMPLETED|Overall Study||27
10417903|NCT00803023|11562610|FG001|COMPLETED|Overall Study||25
10417904|NCT00803023|11562611|FG002|COMPLETED|Overall Study||20
10417905|NCT00803023|11562612|FG003|COMPLETED|Overall Study||25
10417906|NCT00803023|11562609|FG000|NOT COMPLETED|Overall Study||5
10417907|NCT00803023|11562610|FG001|NOT COMPLETED|Overall Study||8
10417908|NCT00803023|11562611|FG002|NOT COMPLETED|Overall Study||11
10417909|NCT00803023|11562612|FG003|NOT COMPLETED|Overall Study||8
10417910|NCT00803049|11562626|FG000|STARTED|Overall Study|Randomized in extension study|129
10417911|NCT00803049|11562627|FG001|STARTED|Overall Study|Randomized in extension study|252
10417912|NCT00803049|11562628|FG002|STARTED|Overall Study|Randomized in extension study|108
10417913|NCT00803049|11562629|FG003|STARTED|Overall Study|Randomized in extension study|253
10417914|NCT00803049|11562626|FG000|Treated|Overall Study||129
10417915|NCT00803049|11562627|FG001|Treated|Overall Study||252
10417916|NCT00803049|11562628|FG002|Treated|Overall Study||108
10417917|NCT00803049|11562629|FG003|Treated|Overall Study||251
10417918|NCT00803049|11562626|FG000|Safety Population|Overall Study||129
10417919|NCT00803049|11562627|FG001|Safety Population|Overall Study|Included 1 participant from Placebo/Teriflunomide 14 mg and 1 from Teriflunomide14 mg/14 mg arm|254
10417920|NCT00803049|11562628|FG002|Safety Population|Overall Study|1 participant received Teriflunomide 7 mg and analysed in Teriflunomide 7 mg/7 mg arm|107
10417921|NCT00803049|11562629|FG003|Safety Population|Overall Study|1 participant received Teriflunomide 7 mg and analysed in Teriflunomide 7 mg/7 mg arm|250
10417922|NCT00803049|11562626|FG000|COMPLETED|Overall Study||68
10417923|NCT00803049|11562627|FG001|COMPLETED|Overall Study||134
10417924|NCT00803049|11562628|FG002|COMPLETED|Overall Study||64
10417925|NCT00803049|11562629|FG003|COMPLETED|Overall Study||151
10417926|NCT00803049|11562626|FG000|NOT COMPLETED|Overall Study||61
10417927|NCT00803049|11562627|FG001|NOT COMPLETED|Overall Study||118
10417928|NCT00803049|11562628|FG002|NOT COMPLETED|Overall Study||44
10417929|NCT00803049|11562629|FG003|NOT COMPLETED|Overall Study||102
10417930|NCT00803062|11562643|FG000|STARTED|Overall Study||114
10417931|NCT00803062|11562644|FG001|STARTED|Overall Study||115
10417932|NCT00803062|11562645|FG002|STARTED|Overall Study||111
10417933|NCT00803062|11562646|FG003|STARTED|Overall Study||112
10417934|NCT00803062|11562643|FG000|COMPLETED|Overall Study||114
10417935|NCT00803062|11562644|FG001|COMPLETED|Overall Study||115
10417936|NCT00803062|11562645|FG002|COMPLETED|Overall Study||111
10417937|NCT00803062|11562646|FG003|COMPLETED|Overall Study||112
10417938|NCT00803062|11562643|FG000|NOT COMPLETED|Overall Study||0
10417939|NCT00803062|11562644|FG001|NOT COMPLETED|Overall Study||0
10417940|NCT00803062|11562645|FG002|NOT COMPLETED|Overall Study||0
10417941|NCT00803062|11562646|FG003|NOT COMPLETED|Overall Study||0
10417942|NCT00803101|11562658|FG000|STARTED|Overall Study||88
10417943|NCT00803101|11562659|FG001|STARTED|Overall Study||88
10417944|NCT00803101|11562658|FG000|COMPLETED|Overall Study||70
10417945|NCT00803101|11562659|FG001|COMPLETED|Overall Study||66
10417946|NCT00803101|11562658|FG000|NOT COMPLETED|Overall Study||18
10417947|NCT00803101|11562659|FG001|NOT COMPLETED|Overall Study||22
10417948|NCT00803205|11562667|FG000|STARTED|Overall Study||120
10417949|NCT00803205|11562668|FG001|STARTED|Overall Study||118
10417950|NCT00803205|11562667|FG000|Completed Week 16|Overall Study||107
10417951|NCT00803205|11562668|FG001|Completed Week 16|Overall Study||113
10417952|NCT00803205|11562667|FG000|Completed Week 24|Overall Study||103
10417953|NCT00803205|11562668|FG001|Completed Week 24|Overall Study||110
10417954|NCT00803205|11562667|FG000|As-Treated Population*|Overall Study||120
10417955|NCT00803205|11562668|FG001|As-Treated Population*|Overall Study||118
10417956|NCT00803205|11562667|FG000|ITT Population|Overall Study||116
10417957|NCT00803205|11562668|FG001|ITT Population|Overall Study||116
10417958|NCT00803205|11562667|FG000|Per Protocol Population|Overall Study||100
10417959|NCT00803205|11562668|FG001|Per Protocol Population|Overall Study||103
10417960|NCT00803205|11562667|FG000|COMPLETED|Overall Study||100
10866733|NCT03986671|12031898|FG002|NOT COMPLETED|Overall Study||0
10294581|NCT04848662|11427287|FG000|NOT COMPLETED|Period 2 (Second Treatment Intervention)||1
10294582|NCT04848662|11427288|FG001|NOT COMPLETED|Period 2 (Second Treatment Intervention)||0
10294583|NCT04697693|11427294|FG000|STARTED|Overall Study||1
10294584|NCT04697693|11427294|FG000|COMPLETED|Overall Study||1
10294585|NCT04697693|11427294|FG000|NOT COMPLETED|Overall Study||0
10314706|NCT00168103|11448446|FG000|STARTED|Overall Study||40
10314707|NCT00168103|11448447|FG001|STARTED|Overall Study||43
10314708|NCT00168103|11448448|FG002|STARTED|Overall Study||42
10314709|NCT00168103|11448449|FG003|STARTED|Overall Study||1
10314710|NCT00168103|11448446|FG000|COMPLETED|Overall Study|1 randomized subject received open-label rescue medication before receiving randomized treatment.|38
10314711|NCT00168103|11448447|FG001|COMPLETED|Overall Study||38
10866734|NCT03850535|12031910|FG000|STARTED|Overall Study||4
10866735|NCT03850535|12031911|FG001|STARTED|Overall Study||9
10866736|NCT03850535|12031912|FG002|STARTED|Overall Study||6
10866737|NCT03850535|12031913|FG003|STARTED|Overall Study||4
10866738|NCT03850535|12031910|FG000|COMPLETED|Overall Study||0
10866739|NCT03850535|12031911|FG001|COMPLETED|Overall Study||0
10866740|NCT03850535|12031912|FG002|COMPLETED|Overall Study||0
10866741|NCT03850535|12031913|FG003|COMPLETED|Overall Study||0
10866742|NCT03850535|12031910|FG000|NOT COMPLETED|Overall Study||4
10866743|NCT03850535|12031911|FG001|NOT COMPLETED|Overall Study||9
10866744|NCT03850535|12031912|FG002|NOT COMPLETED|Overall Study||6
10866745|NCT03850535|12031913|FG003|NOT COMPLETED|Overall Study||4
10866746|NCT03839628|12031923|FG000|STARTED|Overall Study||9
10866747|NCT03839628|12031923|FG000|COMPLETED|Overall Study||8
10866748|NCT03839628|12031923|FG000|NOT COMPLETED|Overall Study||1
10866749|NCT03791398|12031930|FG000|STARTED|Overall Study||13
10866750|NCT03791398|12031931|FG001|STARTED|Overall Study||0
10866751|NCT03791398|12031932|FG002|STARTED|Overall Study||0
10866752|NCT03791398|12031930|FG000|COMPLETED|Overall Study||11
10866753|NCT03791398|12031931|FG001|COMPLETED|Overall Study||0
10866754|NCT03791398|12031932|FG002|COMPLETED|Overall Study||0
10866755|NCT03791398|12031930|FG000|NOT COMPLETED|Overall Study||2
10866756|NCT03791398|12031931|FG001|NOT COMPLETED|Overall Study||0
10866757|NCT03791398|12031932|FG002|NOT COMPLETED|Overall Study||0
10866773|NCT03726346|12031958|FG000|STARTED|Overall Study||39
10866774|NCT03726346|12031958|FG000|COMPLETED|Overall Study||39
10866775|NCT03726346|12031958|FG000|NOT COMPLETED|Overall Study||0
10866776|NCT03703882|12031964|FG000|STARTED|Overall Study||88
10866777|NCT03703882|12031965|FG001|STARTED|Overall Study||43
10866778|NCT03703882|12031964|FG000|COMPLETED|Overall Study||85
10866779|NCT03703882|12031965|FG001|COMPLETED|Overall Study||37
10866780|NCT03703882|12031964|FG000|NOT COMPLETED|Overall Study||3
10866781|NCT03703882|12031965|FG001|NOT COMPLETED|Overall Study||6
10866782|NCT03615040|12031973|FG000|STARTED|Overall Study||42
10866783|NCT03615040|12031974|FG001|STARTED|Overall Study||39
10866784|NCT03615040|12031973|FG000|COMPLETED|Overall Study||36
10866785|NCT03615040|12031974|FG001|COMPLETED|Overall Study||34
10866786|NCT03615040|12031973|FG000|NOT COMPLETED|Overall Study||6
10866787|NCT03615040|12031974|FG001|NOT COMPLETED|Overall Study||5
10866788|NCT03611075|12031989|FG000|STARTED|Overall Study||16
10866789|NCT03611075|12031990|FG001|STARTED|Overall Study||15
10866790|NCT03611075|12031991|FG002|STARTED|Overall Study||16
10866791|NCT03611075|12031992|FG003|STARTED|Overall Study||17
10866792|NCT03611075|12031993|FG004|STARTED|Overall Study||13
10866793|NCT03611075|12031994|FG005|STARTED|Overall Study||18
10866794|NCT03611075|12031995|FG006|STARTED|Overall Study||15
10866795|NCT03611075|12031996|FG007|STARTED|Overall Study||17
10866796|NCT03611075|12031997|FG008|STARTED|Overall Study||17
10866797|NCT03611075|12031989|FG000|COMPLETED|Overall Study||15
10866798|NCT03611075|12031990|FG001|COMPLETED|Overall Study||13
10866799|NCT03611075|12031991|FG002|COMPLETED|Overall Study||14
10866800|NCT03611075|12031992|FG003|COMPLETED|Overall Study||13
10866801|NCT03611075|12031993|FG004|COMPLETED|Overall Study||13
10866802|NCT03611075|12031994|FG005|COMPLETED|Overall Study||18
10866803|NCT03611075|12031995|FG006|COMPLETED|Overall Study||13
10866804|NCT03611075|12031996|FG007|COMPLETED|Overall Study||17
10866805|NCT03611075|12031997|FG008|COMPLETED|Overall Study||17
10866806|NCT03611075|12031989|FG000|NOT COMPLETED|Overall Study||1
10866807|NCT03611075|12031990|FG001|NOT COMPLETED|Overall Study||2
10866808|NCT03611075|12031991|FG002|NOT COMPLETED|Overall Study||2
10866809|NCT03611075|12031992|FG003|NOT COMPLETED|Overall Study||4
10866810|NCT03611075|12031993|FG004|NOT COMPLETED|Overall Study||0
10866811|NCT03611075|12031994|FG005|NOT COMPLETED|Overall Study||0
10866812|NCT03611075|12031995|FG006|NOT COMPLETED|Overall Study||2
10866813|NCT03611075|12031996|FG007|NOT COMPLETED|Overall Study||0
10866814|NCT03611075|12031997|FG008|NOT COMPLETED|Overall Study||0
10866815|NCT03595176|12032042|FG000|STARTED|Overall Study||47
10866816|NCT03595176|12032043|FG001|STARTED|Overall Study||384
10866817|NCT03595176|12032042|FG000|COMPLETED|Overall Study||47
10866818|NCT03595176|12032043|FG001|COMPLETED|Overall Study||381
10866819|NCT03595176|12032042|FG000|NOT COMPLETED|Overall Study||0
10866820|NCT03595176|12032043|FG001|NOT COMPLETED|Overall Study||3
10866821|NCT03541317|12032051|FG000|STARTED|Stage 1 of the Implementation||6
10866822|NCT03541317|12032052|FG001|STARTED|Stage 1 of the Implementation||37
10866823|NCT03541317|12032053|FG002|STARTED|Stage 1 of the Implementation||38
10866824|NCT03541317|12032054|FG003|STARTED|Stage 1 of the Implementation||9
10866825|NCT03541317|12032055|FG004|STARTED|Stage 1 of the Implementation||43
10866826|NCT03541317|12032056|FG005|STARTED|Stage 1 of the Implementation||36
10866827|NCT03541317|12032051|FG000|COMPLETED|Stage 1 of the Implementation||6
10866828|NCT03541317|12032052|FG001|COMPLETED|Stage 1 of the Implementation||37
10866829|NCT03541317|12032053|FG002|COMPLETED|Stage 1 of the Implementation||38
10866830|NCT03541317|12032054|FG003|COMPLETED|Stage 1 of the Implementation||9
10866831|NCT03541317|12032055|FG004|COMPLETED|Stage 1 of the Implementation||43
10866832|NCT03541317|12032056|FG005|COMPLETED|Stage 1 of the Implementation||36
10866833|NCT03541317|12032051|FG000|NOT COMPLETED|Stage 1 of the Implementation||0
10866834|NCT03541317|12032052|FG001|NOT COMPLETED|Stage 1 of the Implementation||0
10866835|NCT03541317|12032053|FG002|NOT COMPLETED|Stage 1 of the Implementation||0
10866836|NCT03541317|12032054|FG003|NOT COMPLETED|Stage 1 of the Implementation||0
10866837|NCT03541317|12032055|FG004|NOT COMPLETED|Stage 1 of the Implementation||0
10866838|NCT03541317|12032056|FG005|NOT COMPLETED|Stage 1 of the Implementation||0
10866839|NCT03541317|12032051|FG000|STARTED|Stage 2 of the Implementation||6
10866840|NCT03541317|12032052|FG001|STARTED|Stage 2 of the Implementation||37
10866841|NCT03541317|12032053|FG002|STARTED|Stage 2 of the Implementation||38
10866842|NCT03541317|12032054|FG003|STARTED|Stage 2 of the Implementation||9
10866843|NCT03541317|12032055|FG004|STARTED|Stage 2 of the Implementation||43
10866844|NCT03541317|12032056|FG005|STARTED|Stage 2 of the Implementation||36
10866845|NCT03541317|12032051|FG000|COMPLETED|Stage 2 of the Implementation||5
10866846|NCT03541317|12032052|FG001|COMPLETED|Stage 2 of the Implementation||37
10866847|NCT03541317|12032053|FG002|COMPLETED|Stage 2 of the Implementation||38
10866848|NCT03541317|12032054|FG003|COMPLETED|Stage 2 of the Implementation||9
10866849|NCT03541317|12032055|FG004|COMPLETED|Stage 2 of the Implementation||43
10866850|NCT03541317|12032056|FG005|COMPLETED|Stage 2 of the Implementation||36
10866851|NCT03541317|12032051|FG000|NOT COMPLETED|Stage 2 of the Implementation||1
10866852|NCT03541317|12032052|FG001|NOT COMPLETED|Stage 2 of the Implementation||0
10866853|NCT03541317|12032053|FG002|NOT COMPLETED|Stage 2 of the Implementation||0
10866854|NCT03541317|12032054|FG003|NOT COMPLETED|Stage 2 of the Implementation||0
10866855|NCT03541317|12032055|FG004|NOT COMPLETED|Stage 2 of the Implementation||0
10866856|NCT03541317|12032056|FG005|NOT COMPLETED|Stage 2 of the Implementation||0
10866857|NCT03523117|12032070|FG000|STARTED|Overall Study||40
10866858|NCT03523117|12032071|FG001|STARTED|Overall Study||39
10866859|NCT03523117|12032070|FG000|COMPLETED|Overall Study||39
10866860|NCT03523117|12032071|FG001|COMPLETED|Overall Study||37
10866861|NCT03523117|12032070|FG000|NOT COMPLETED|Overall Study||1
10866862|NCT03523117|12032071|FG001|NOT COMPLETED|Overall Study||2
10866863|NCT03400943|12032081|FG000|STARTED|Treatment Period 1||23
10866864|NCT03400943|12032082|FG001|STARTED|Treatment Period 1||23
10866865|NCT03400943|12032083|FG002|STARTED|Treatment Period 1||24
10866866|NCT03400943|12032084|FG003|STARTED|Treatment Period 1||23
10866867|NCT03400943|12032081|FG000|Treated|Treatment Period 1||18
10866868|NCT03400943|12032082|FG001|Treated|Treatment Period 1||21
10866869|NCT03400943|12032083|FG002|Treated|Treatment Period 1||20
10866870|NCT03400943|12032084|FG003|Treated|Treatment Period 1||20
10866871|NCT03400943|12032081|FG000|COMPLETED|Treatment Period 1||18
10866872|NCT03400943|12032082|FG001|COMPLETED|Treatment Period 1||21
10866873|NCT03400943|12032083|FG002|COMPLETED|Treatment Period 1||18
10866874|NCT03400943|12032084|FG003|COMPLETED|Treatment Period 1||18
10866875|NCT03400943|12032081|FG000|NOT COMPLETED|Treatment Period 1||5
10866876|NCT03400943|12032082|FG001|NOT COMPLETED|Treatment Period 1||2
10866877|NCT03400943|12032083|FG002|NOT COMPLETED|Treatment Period 1||6
10866878|NCT03400943|12032084|FG003|NOT COMPLETED|Treatment Period 1||5
10866879|NCT03400943|12032081|FG000|STARTED|Post-treatment Period 1||18
10866880|NCT03400943|12032082|FG001|STARTED|Post-treatment Period 1||0
10866881|NCT03400943|12032083|FG002|STARTED|Post-treatment Period 1||18
10866882|NCT03400943|12032084|FG003|STARTED|Post-treatment Period 1||18
10866883|NCT03400943|12032081|FG000|COMPLETED|Post-treatment Period 1||7
10866884|NCT03400943|12032082|FG001|COMPLETED|Post-treatment Period 1||0
10866885|NCT03400943|12032083|FG002|COMPLETED|Post-treatment Period 1||7
10866886|NCT03400943|12032084|FG003|COMPLETED|Post-treatment Period 1||5
10866887|NCT03400943|12032081|FG000|NOT COMPLETED|Post-treatment Period 1||11
10866888|NCT03400943|12032082|FG001|NOT COMPLETED|Post-treatment Period 1||0
10866889|NCT03400943|12032083|FG002|NOT COMPLETED|Post-treatment Period 1||11
10866890|NCT03400943|12032084|FG003|NOT COMPLETED|Post-treatment Period 1||13
10866891|NCT03400943|12032081|FG000|STARTED|Treatment Period 2||7
10866892|NCT03400943|12032082|FG001|STARTED|Treatment Period 2||21
10866893|NCT03400943|12032083|FG002|STARTED|Treatment Period 2||7
10866894|NCT03400943|12032084|FG003|STARTED|Treatment Period 2||5
10866895|NCT03400943|12032081|FG000|COMPLETED|Treatment Period 2||6
10866896|NCT03400943|12032082|FG001|COMPLETED|Treatment Period 2||13
10866897|NCT03400943|12032083|FG002|COMPLETED|Treatment Period 2||7
10866898|NCT03400943|12032084|FG003|COMPLETED|Treatment Period 2||5
10866899|NCT03400943|12032081|FG000|NOT COMPLETED|Treatment Period 2||1
10866900|NCT03400943|12032082|FG001|NOT COMPLETED|Treatment Period 2||8
10866901|NCT03400943|12032083|FG002|NOT COMPLETED|Treatment Period 2||0
10866902|NCT03400943|12032084|FG003|NOT COMPLETED|Treatment Period 2||0
10866903|NCT03400943|12032081|FG000|STARTED|Follow-up Period||7
10866904|NCT03400943|12032082|FG001|STARTED|Follow-up Period||15
10866905|NCT03400943|12032083|FG002|STARTED|Follow-up Period||7
10866906|NCT03400943|12032084|FG003|STARTED|Follow-up Period||5
10866907|NCT03400943|12032081|FG000|COMPLETED|Follow-up Period||6
10866908|NCT03400943|12032082|FG001|COMPLETED|Follow-up Period||15
10866909|NCT03400943|12032083|FG002|COMPLETED|Follow-up Period||7
10866910|NCT03400943|12032084|FG003|COMPLETED|Follow-up Period||5
10866911|NCT03400943|12032081|FG000|NOT COMPLETED|Follow-up Period||1
10866912|NCT03400943|12032082|FG001|NOT COMPLETED|Follow-up Period||0
10866913|NCT03400943|12032083|FG002|NOT COMPLETED|Follow-up Period||0
10866914|NCT03400943|12032084|FG003|NOT COMPLETED|Follow-up Period||0
10866915|NCT03396952|12032096|FG000|STARTED|Overall Study||27
10866916|NCT03396952|12032096|FG000|COMPLETED|Overall Study||27
10866917|NCT03396952|12032096|FG000|NOT COMPLETED|Overall Study||0
10866918|NCT03302234|12032102|FG000|STARTED|Overall Study||284
10866919|NCT03302234|12032103|FG001|STARTED|Overall Study||284
10866920|NCT03302234|12032102|FG000|COMPLETED|Overall Study||146
10866921|NCT03302234|12032103|FG001|COMPLETED|Overall Study||147
10866922|NCT03302234|12032102|FG000|NOT COMPLETED|Overall Study||138
10866923|NCT03302234|12032103|FG001|NOT COMPLETED|Overall Study||137
10866924|NCT03272763|12032110|FG000|STARTED|Overall Study||38
10866925|NCT03272763|12032110|FG000|COMPLETED|Overall Study||38
10866926|NCT03272763|12032110|FG000|NOT COMPLETED|Overall Study||0
10866927|NCT03232346|12032116|FG000|STARTED|Overall Study||6
10866928|NCT03232346|12032117|FG001|STARTED|Overall Study||5
10866929|NCT03232346|12032116|FG000|COMPLETED|Overall Study||2
10866930|NCT03232346|12032117|FG001|COMPLETED|Overall Study||3
10866931|NCT03232346|12032116|FG000|NOT COMPLETED|Overall Study||4
10866932|NCT03232346|12032117|FG001|NOT COMPLETED|Overall Study||2
10866933|NCT03208244|12032123|FG000|STARTED|Overall Study||33
10866934|NCT03208244|12032123|FG000|COMPLETED|Overall Study||32
10866935|NCT03208244|12032123|FG000|NOT COMPLETED|Overall Study||1
10866936|NCT03187379|12032129|FG000|STARTED|Overall Study||50
10866937|NCT03187379|12032130|FG001|STARTED|Overall Study||52
10866938|NCT03187379|12032129|FG000|COMPLETED|Overall Study||50
10866939|NCT03187379|12032130|FG001|COMPLETED|Overall Study||52
10866940|NCT03187379|12032129|FG000|NOT COMPLETED|Overall Study||0
10866941|NCT03187379|12032130|FG001|NOT COMPLETED|Overall Study||0
10866942|NCT03077360|12032139|FG000|STARTED|Overall Study||17
10866943|NCT03077360|12032140|FG001|STARTED|Overall Study||17
10866944|NCT03077360|12032141|FG002|STARTED|Overall Study||14
10866945|NCT03077360|12032139|FG000|COMPLETED|Overall Study||17
10866946|NCT03077360|12032140|FG001|COMPLETED|Overall Study||16
10866947|NCT03077360|12032141|FG002|COMPLETED|Overall Study||12
10866948|NCT03077360|12032139|FG000|NOT COMPLETED|Overall Study||0
10866949|NCT03077360|12032140|FG001|NOT COMPLETED|Overall Study||1
10866950|NCT03077360|12032141|FG002|NOT COMPLETED|Overall Study||2
10866951|NCT03050060|12032150|FG000|STARTED|Overall Study||20
10866952|NCT03050060|12032150|FG000|COMPLETED|Overall Study||5
10866953|NCT03050060|12032150|FG000|NOT COMPLETED|Overall Study||15
10866954|NCT02968381|12032156|FG000|STARTED|Overall Study||61
10866955|NCT02968381|12032157|FG001|STARTED|Overall Study||60
10866956|NCT02968381|12032156|FG000|COMPLETED|Overall Study||56
10866957|NCT02968381|12032157|FG001|COMPLETED|Overall Study||50
10866958|NCT02968381|12032156|FG000|NOT COMPLETED|Overall Study||5
10866959|NCT02968381|12032157|FG001|NOT COMPLETED|Overall Study||10
10866960|NCT02847637|12032167|FG000|STARTED|Overall Study||18
10866961|NCT02847637|12032168|FG001|STARTED|Overall Study||36
10866962|NCT02847637|12032169|FG002|STARTED|Overall Study||35
10866963|NCT02847637|12032170|FG003|STARTED|Overall Study||63
10866964|NCT02847637|12032167|FG000|Completed 24 Weeks on No Prophylaxis|Overall Study|One participant switched to emicizumab prior to completing 24 weeks No Prophylaxis (at 23.5 weeks).|16
10866965|NCT02847637|12032168|FG001|Completed 24 Weeks on No Prophylaxis|Overall Study||0
10866966|NCT02847637|12032169|FG002|Completed 24 Weeks on No Prophylaxis|Overall Study||0
10866967|NCT02847637|12032170|FG003|Completed 24 Weeks on No Prophylaxis|Overall Study||0
10866968|NCT02847637|12032167|FG000|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||16
10866969|NCT02847637|12032168|FG001|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||0
10866970|NCT02847637|12032169|FG002|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||0
10866971|NCT02847637|12032170|FG003|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||0
10417961|NCT00803205|11562668|FG001|COMPLETED|Overall Study||104
10417962|NCT00803205|11562667|FG000|NOT COMPLETED|Overall Study||20
10417963|NCT00803205|11562668|FG001|NOT COMPLETED|Overall Study||14
10417964|NCT00803244|11562676|FG000|STARTED|Overall Study||188
10417965|NCT00803244|11562677|FG001|STARTED|Overall Study||193
10417966|NCT00803244|11562676|FG000|COMPLETED|Overall Study||181
10417967|NCT00803244|11562677|FG001|COMPLETED|Overall Study||178
10417968|NCT00803244|11562676|FG000|NOT COMPLETED|Overall Study||7
10417969|NCT00803244|11562677|FG001|NOT COMPLETED|Overall Study||15
10417970|NCT00803270|11562685|FG000|STARTED|Overall Study||13
10417971|NCT00803270|11562686|FG001|STARTED|Overall Study||14
10417972|NCT00803270|11562685|FG000|COMPLETED|Overall Study||12
10417973|NCT00803270|11562686|FG001|COMPLETED|Overall Study||12
10417974|NCT00803270|11562685|FG000|NOT COMPLETED|Overall Study||1
10417975|NCT00803270|11562686|FG001|NOT COMPLETED|Overall Study||2
10417976|NCT00803361|11562694|FG000|STARTED|Overall Study||108
10417977|NCT00803361|11562695|FG001|STARTED|Overall Study||102
10417978|NCT00803361|11562694|FG000|COMPLETED|Overall Study||82
10417979|NCT00803361|11562695|FG001|COMPLETED|Overall Study||74
10417980|NCT00803361|11562694|FG000|NOT COMPLETED|Overall Study||26
10417981|NCT00803361|11562695|FG001|NOT COMPLETED|Overall Study||28
10417982|NCT00803400|11562703|FG000|STARTED|Overall Study||75
10417983|NCT00803400|11562704|FG001|STARTED|Overall Study||75
10417984|NCT00803400|11562703|FG000|COMPLETED|Overall Study||55
10417985|NCT00803400|11562704|FG001|COMPLETED|Overall Study||51
10417986|NCT00803400|11562703|FG000|NOT COMPLETED|Overall Study||20
10417987|NCT00803400|11562704|FG001|NOT COMPLETED|Overall Study||24
10417988|NCT00803452|11562713|FG000|STARTED|Overall Study||9
10417989|NCT00803452|11562714|FG001|STARTED|Overall Study||22
10417990|NCT00803452|11562713|FG000|COMPLETED|Overall Study||9
10417991|NCT00803452|11562714|FG001|COMPLETED|Overall Study||17
10417992|NCT00803452|11562713|FG000|NOT COMPLETED|Overall Study||0
10417993|NCT00803452|11562714|FG001|NOT COMPLETED|Overall Study||5
10417994|NCT00803543|11562722|FG000|STARTED|Overall Study||69
10417995|NCT00803543|11562723|FG001|STARTED|Overall Study||34
10417996|NCT00803543|11562722|FG000|COMPLETED|Overall Study||45
10417997|NCT00803543|11562723|FG001|COMPLETED|Overall Study||22
10417998|NCT00803543|11562722|FG000|NOT COMPLETED|Overall Study||24
10417999|NCT00803543|11562723|FG001|NOT COMPLETED|Overall Study||12
10418000|NCT00803569|11562729|FG000|STARTED|Overall Study||13
10418001|NCT00803569|11562729|FG000|COMPLETED|Overall Study||9
10418002|NCT00803569|11562729|FG000|NOT COMPLETED|Overall Study||4
10418003|NCT00803595|11562736|FG000|STARTED|Overall Study||337
10418004|NCT00803595|11562737|FG001|STARTED|Overall Study||327
10418005|NCT00803595|11562738|FG002|STARTED|Overall Study||338
10418006|NCT00803595|11562736|FG000|COMPLETED|Overall Study||322
10418007|NCT00803595|11562737|FG001|COMPLETED|Overall Study||319
10418008|NCT00803595|11562738|FG002|COMPLETED|Overall Study||322
10418009|NCT00803595|11562736|FG000|NOT COMPLETED|Overall Study||15
10418010|NCT00803595|11562737|FG001|NOT COMPLETED|Overall Study||8
10418011|NCT00803595|11562738|FG002|NOT COMPLETED|Overall Study||16
10418012|NCT00803634|11562748|FG000|STARTED|Overall Study|All patients dosed with clevidipine [Safety population]|51
10418013|NCT00803634|11562749|FG001|STARTED|Overall Study|All patients dosed with SOC antihypertensive therapy [Safety population]|53
10418014|NCT00803634|11562748|FG000|mITT (Dosed & Have Confirmed AHF)|Overall Study|All patients dosed with clevidipine and confirmed to have AHF [mITT population]|44
10418015|NCT00803634|11562749|FG001|mITT (Dosed & Have Confirmed AHF)|Overall Study|All patients dosed with SOC antihypertensive therapy and confirmed to have AHF [mITT population]|41
10418016|NCT00803634|11562748|FG000|COMPLETED|Overall Study|All patients dosed with clevidipine [Safety population]|45
10418017|NCT00803634|11562749|FG001|COMPLETED|Overall Study|All patients dosed with SOC antihypertensive therapy [Safety population]|48
10418018|NCT00803634|11562748|FG000|NOT COMPLETED|Overall Study||6
10418019|NCT00803634|11562749|FG001|NOT COMPLETED|Overall Study||5
10418020|NCT00803647|11562756|FG000|STARTED|Overall Study||20
10418021|NCT00803647|11562756|FG000|COMPLETED|Overall Study||20
10418022|NCT00803647|11562756|FG000|NOT COMPLETED|Overall Study||0
10418023|NCT00803686|11562764|FG000|STARTED|Part 1, Period 1||6
10418024|NCT00803686|11562765|FG001|STARTED|Part 1, Period 1||6
10418025|NCT00803686|11562766|FG002|STARTED|Part 1, Period 1||0
10418026|NCT00803686|11562767|FG003|STARTED|Part 1, Period 1||0
10418027|NCT00803686|11562764|FG000|COMPLETED|Part 1, Period 1||6
10545867|NCT01500278|11699391|FG000|STARTED|Week 0 - Week 12||457
10545868|NCT01500278|11699392|FG001|STARTED|Week 0 - Week 12||458
10418028|NCT00803686|11562765|FG001|COMPLETED|Part 1, Period 1||6
10866972|NCT02847637|12032167|FG000|Completed 24 Weeks Emicizumab Treatment|Overall Study|Participants started on 24 weeks No Prophylaxis first before switching to emicizumab.|1
10866973|NCT02847637|12032168|FG001|Completed 24 Weeks Emicizumab Treatment|Overall Study||35
10866974|NCT02847637|12032169|FG002|Completed 24 Weeks Emicizumab Treatment|Overall Study||34
10866975|NCT02847637|12032170|FG003|Completed 24 Weeks Emicizumab Treatment|Overall Study||58
10866976|NCT02847637|12032167|FG000|COMPLETED|Overall Study||1
10866977|NCT02847637|12032168|FG001|COMPLETED|Overall Study||1
10866978|NCT02847637|12032169|FG002|COMPLETED|Overall Study||0
10866979|NCT02847637|12032170|FG003|COMPLETED|Overall Study||0
10866980|NCT02847637|12032167|FG000|NOT COMPLETED|Overall Study||17
10866981|NCT02847637|12032168|FG001|NOT COMPLETED|Overall Study||35
10866982|NCT02847637|12032169|FG002|NOT COMPLETED|Overall Study||35
10866983|NCT02847637|12032170|FG003|NOT COMPLETED|Overall Study||63
10866984|NCT02837042|12032190|FG000|STARTED|Overall Study||6
10866985|NCT02837042|12032190|FG000|COMPLETED|Overall Study||6
10866986|NCT02837042|12032190|FG000|NOT COMPLETED|Overall Study||0
10866987|NCT02770391|12032194|FG000|STARTED|Overall Study||54
10866988|NCT02770391|12032194|FG000|COMPLETED|Overall Study||48
10866989|NCT02770391|12032194|FG000|NOT COMPLETED|Overall Study||6
10866990|NCT02650986|12032202|FG000|STARTED|Overall Study||3
10866991|NCT02650986|12032203|FG001|STARTED|Overall Study||3
10866992|NCT02650986|12032204|FG002|STARTED|Overall Study||3
10866993|NCT02650986|12032205|FG003|STARTED|Overall Study||6
10866994|NCT02650986|12032202|FG000|COMPLETED|Overall Study||3
10866995|NCT02650986|12032203|FG001|COMPLETED|Overall Study||3
10866996|NCT02650986|12032204|FG002|COMPLETED|Overall Study||3
10866997|NCT02650986|12032205|FG003|COMPLETED|Overall Study||6
10866998|NCT02650986|12032202|FG000|NOT COMPLETED|Overall Study||0
10866999|NCT02650986|12032203|FG001|NOT COMPLETED|Overall Study||0
10867000|NCT02650986|12032204|FG002|NOT COMPLETED|Overall Study||0
10867001|NCT02650986|12032205|FG003|NOT COMPLETED|Overall Study||0
10867002|NCT02648724|12032222|FG000|STARTED|Overall Study||3
10867003|NCT02648724|12032223|FG001|STARTED|Overall Study||3
10867004|NCT02648724|12032224|FG002|STARTED|Overall Study||3
10867005|NCT02648724|12032225|FG003|STARTED|Overall Study||3
10867006|NCT02648724|12032226|FG004|STARTED|Overall Study||25
10867007|NCT02648724|12032227|FG005|STARTED|Overall Study||8
10867008|NCT02648724|12032228|FG006|STARTED|Overall Study||12
10867009|NCT02648724|12032222|FG000|COMPLETED|Overall Study||0
10867010|NCT02648724|12032223|FG001|COMPLETED|Overall Study||0
10867011|NCT02648724|12032224|FG002|COMPLETED|Overall Study||0
10867012|NCT02648724|12032225|FG003|COMPLETED|Overall Study||0
10867013|NCT02648724|12032226|FG004|COMPLETED|Overall Study||0
10867014|NCT02648724|12032227|FG005|COMPLETED|Overall Study||0
10867015|NCT02648724|12032228|FG006|COMPLETED|Overall Study||0
10867016|NCT02648724|12032222|FG000|NOT COMPLETED|Overall Study||3
10867017|NCT02648724|12032223|FG001|NOT COMPLETED|Overall Study||3
10867018|NCT02648724|12032224|FG002|NOT COMPLETED|Overall Study||3
10867019|NCT02648724|12032225|FG003|NOT COMPLETED|Overall Study||3
10867020|NCT02648724|12032226|FG004|NOT COMPLETED|Overall Study||25
10867021|NCT02648724|12032227|FG005|NOT COMPLETED|Overall Study||8
10867022|NCT02648724|12032228|FG006|NOT COMPLETED|Overall Study||12
10867029|NCT02554474|12032271|FG000|STARTED|Overall Study||59
10867030|NCT02554474|12032272|FG001|STARTED|Overall Study||59
10867031|NCT02554474|12032271|FG000|COMPLETED|Overall Study|Indicates number of participants who completed assessment at the primary endpoint.|56
10867032|NCT02554474|12032272|FG001|COMPLETED|Overall Study|Indicates number of participants who completed assessment at the primary endpoint.|57
10867033|NCT02554474|12032271|FG000|NOT COMPLETED|Overall Study||3
10867034|NCT02554474|12032272|FG001|NOT COMPLETED|Overall Study||2
10867035|NCT02554318|12032280|FG000|STARTED|Overall Study||75
10867036|NCT02554318|12032281|FG001|STARTED|Overall Study||72
10867037|NCT02554318|12032280|FG000|COMPLETED|Overall Study||65
10867038|NCT02554318|12032281|FG001|COMPLETED|Overall Study||64
10867039|NCT02554318|12032280|FG000|NOT COMPLETED|Overall Study||10
10867040|NCT02554318|12032281|FG001|NOT COMPLETED|Overall Study||8
10867041|NCT02508532|12032294|FG000|STARTED|Part 1 - Dose Determining Period||6
10867042|NCT02508532|12032295|FG001|STARTED|Part 1 - Dose Determining Period||6
10867043|NCT02508532|12032296|FG002|STARTED|Part 1 - Dose Determining Period||6
10867044|NCT02508532|12032297|FG003|STARTED|Part 1 - Dose Determining Period||6
10867045|NCT02508532|12032298|FG004|STARTED|Part 1 - Dose Determining Period||6
10867046|NCT02508532|12032299|FG005|STARTED|Part 1 - Dose Determining Period||6
10867047|NCT02508532|12032300|FG006|STARTED|Part 1 - Dose Determining Period||7
10867048|NCT02508532|12032301|FG007|STARTED|Part 1 - Dose Determining Period||3
10867049|NCT02508532|12032302|FG008|STARTED|Part 1 - Dose Determining Period|This group includes patients enrolled in Part 1 and Part 2 at a starting dose of 300 or 400 mg QD. This group was not used to determine the MTD in Part 1|0
10867050|NCT02508532|12032294|FG000|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
10418029|NCT00803686|11562766|FG002|COMPLETED|Part 1, Period 1||0
10867051|NCT02508532|12032295|FG001|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
10867052|NCT02508532|12032296|FG002|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
10867053|NCT02508532|12032297|FG003|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
10867054|NCT02508532|12032298|FG004|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
10867055|NCT02508532|12032299|FG005|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||6
10867056|NCT02508532|12032300|FG006|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||7
10867057|NCT02508532|12032301|FG007|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
10867058|NCT02508532|12032302|FG008|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
10867059|NCT02508532|12032294|FG000|COMPLETED|Part 1 - Dose Determining Period||6
10867060|NCT02508532|12032295|FG001|COMPLETED|Part 1 - Dose Determining Period||6
10867061|NCT02508532|12032296|FG002|COMPLETED|Part 1 - Dose Determining Period||6
10867062|NCT02508532|12032297|FG003|COMPLETED|Part 1 - Dose Determining Period||6
10867063|NCT02508532|12032298|FG004|COMPLETED|Part 1 - Dose Determining Period||6
10867064|NCT02508532|12032299|FG005|COMPLETED|Part 1 - Dose Determining Period||6
10867065|NCT02508532|12032300|FG006|COMPLETED|Part 1 - Dose Determining Period||6
10867066|NCT02508532|12032301|FG007|COMPLETED|Part 1 - Dose Determining Period||2
10867067|NCT02508532|12032302|FG008|COMPLETED|Part 1 - Dose Determining Period||0
10867068|NCT02508532|12032294|FG000|NOT COMPLETED|Part 1 - Dose Determining Period||0
10867069|NCT02508532|12032295|FG001|NOT COMPLETED|Part 1 - Dose Determining Period||0
10867070|NCT02508532|12032296|FG002|NOT COMPLETED|Part 1 - Dose Determining Period||0
10867071|NCT02508532|12032297|FG003|NOT COMPLETED|Part 1 - Dose Determining Period||0
10867072|NCT02508532|12032298|FG004|NOT COMPLETED|Part 1 - Dose Determining Period||0
10867073|NCT02508532|12032299|FG005|NOT COMPLETED|Part 1 - Dose Determining Period||0
10867074|NCT02508532|12032300|FG006|NOT COMPLETED|Part 1 - Dose Determining Period||1
10867075|NCT02508532|12032301|FG007|NOT COMPLETED|Part 1 - Dose Determining Period||1
10867076|NCT02508532|12032302|FG008|NOT COMPLETED|Part 1 - Dose Determining Period||0
10867077|NCT02508532|12032294|FG000|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0
10867078|NCT02508532|12032295|FG001|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0
10867079|NCT02508532|12032296|FG002|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0
10867080|NCT02508532|12032297|FG003|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0
10867081|NCT02508532|12032298|FG004|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0
10867082|NCT02508532|12032299|FG005|STARTED|Part 2 - Treatment|"Part 1 Only:~6 Patients from this group are included in the 300 or 400 mg QD group."|0
10867083|NCT02508532|12032300|FG006|STARTED|Part 2 - Treatment|"Part 1 Only:~7 Patients from this group are included in the 300 or 400 mg QD group."|0
10867084|NCT02508532|12032301|FG007|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0
10867085|NCT02508532|12032302|FG008|STARTED|Part 2 - Treatment|Includes 13 patients enrolled in Part 1 at a starting dose of 300 mg (n = 6) or 400 mg (n = 7) QD.|217
10867086|NCT02508532|12032294|FG000|COMPLETED|Part 2 - Treatment||0
10867087|NCT02508532|12032295|FG001|COMPLETED|Part 2 - Treatment||0
10867088|NCT02508532|12032296|FG002|COMPLETED|Part 2 - Treatment||0
10867089|NCT02508532|12032297|FG003|COMPLETED|Part 2 - Treatment||0
10867090|NCT02508532|12032298|FG004|COMPLETED|Part 2 - Treatment||0
10867091|NCT02508532|12032299|FG005|COMPLETED|Part 2 - Treatment||0
10867092|NCT02508532|12032300|FG006|COMPLETED|Part 2 - Treatment||0
10867093|NCT02508532|12032301|FG007|COMPLETED|Part 2 - Treatment||0
10867094|NCT02508532|12032302|FG008|COMPLETED|Part 2 - Treatment||0
10867095|NCT02508532|12032294|FG000|NOT COMPLETED|Part 2 - Treatment||0
10867096|NCT02508532|12032295|FG001|NOT COMPLETED|Part 2 - Treatment||0
10867097|NCT02508532|12032296|FG002|NOT COMPLETED|Part 2 - Treatment||0
10867098|NCT02508532|12032297|FG003|NOT COMPLETED|Part 2 - Treatment||0
10867099|NCT02508532|12032298|FG004|NOT COMPLETED|Part 2 - Treatment||0
10867100|NCT02508532|12032299|FG005|NOT COMPLETED|Part 2 - Treatment||0
10418030|NCT00803686|11562767|FG003|COMPLETED|Part 1, Period 1||0
10418031|NCT00803686|11562764|FG000|NOT COMPLETED|Part 1, Period 1||0
10418032|NCT00803686|11562765|FG001|NOT COMPLETED|Part 1, Period 1||0
10418033|NCT00803686|11562766|FG002|NOT COMPLETED|Part 1, Period 1||0
10418034|NCT00803686|11562767|FG003|NOT COMPLETED|Part 1, Period 1||0
10418035|NCT00803686|11562764|FG000|STARTED|Part 1, Period 2||6
10418036|NCT00803686|11562765|FG001|STARTED|Part 1, Period 2||6
10418037|NCT00803686|11562766|FG002|STARTED|Part 1, Period 2|No subjects were to be treated until after Periods 1 and 2.|0
10418038|NCT00803686|11562767|FG003|STARTED|Part 1, Period 2|No subjects were to be treated until after Periods 1 and 2.|0
10418039|NCT00803686|11562764|FG000|COMPLETED|Part 1, Period 2||6
10418040|NCT00803686|11562765|FG001|COMPLETED|Part 1, Period 2||6
10418041|NCT00803686|11562766|FG002|COMPLETED|Part 1, Period 2|No subjects treated.|0
10418042|NCT00803686|11562767|FG003|COMPLETED|Part 1, Period 2|No subjects treated.|0
10545869|NCT01500278|11699391|FG000|COMPLETED|Week 0 - Week 12||426
10545870|NCT01500278|11699392|FG001|COMPLETED|Week 0 - Week 12||428
10545871|NCT01500278|11699391|FG000|NOT COMPLETED|Week 0 - Week 12||31
10545872|NCT01500278|11699392|FG001|NOT COMPLETED|Week 0 - Week 12||30
10545873|NCT01500278|11699391|FG000|STARTED|Week 13 - Week 104||426
10545874|NCT01500278|11699392|FG001|STARTED|Week 13 - Week 104||428
10545875|NCT01500278|11699391|FG000|COMPLETED|Week 13 - Week 104||287
10545876|NCT01500278|11699392|FG001|COMPLETED|Week 13 - Week 104||302
10545877|NCT01500278|11699391|FG000|NOT COMPLETED|Week 13 - Week 104||139
10545878|NCT01500278|11699392|FG001|NOT COMPLETED|Week 13 - Week 104||126
10867101|NCT02508532|12032300|FG006|NOT COMPLETED|Part 2 - Treatment||0
10867102|NCT02508532|12032301|FG007|NOT COMPLETED|Part 2 - Treatment||0
10867103|NCT02508532|12032302|FG008|NOT COMPLETED|Part 2 - Treatment||217
10867104|NCT02508532|12032294|FG000|STARTED|Part 1 and Part 2 End of Study||6
10867105|NCT02508532|12032295|FG001|STARTED|Part 1 and Part 2 End of Study||6
10418043|NCT00803686|11562764|FG000|NOT COMPLETED|Part 1, Period 2||0
10418044|NCT00803686|11562765|FG001|NOT COMPLETED|Part 1, Period 2||0
10418045|NCT00803686|11562766|FG002|NOT COMPLETED|Part 1, Period 2||0
10418046|NCT00803686|11562767|FG003|NOT COMPLETED|Part 1, Period 2||0
10418047|NCT00803686|11562764|FG000|STARTED|Part 2, Period 3|No subjects were treated in this period|0
10418048|NCT00803686|11562765|FG001|STARTED|Part 2, Period 3|No subjects were treated in this period.|0
10418049|NCT00803686|11562766|FG002|STARTED|Part 2, Period 3|Of the 6 eligible, 1 elected not to continue into Period 3.|5
10418050|NCT00803686|11562767|FG003|STARTED|Part 2, Period 3|Of the 6 eligible, 2 elected not to continue into Period 3.|4
10418051|NCT00803686|11562764|FG000|COMPLETED|Part 2, Period 3|No subjects were treated in this period|0
10418052|NCT00803686|11562765|FG001|COMPLETED|Part 2, Period 3|No subjects were treated in this period.|0
10418053|NCT00803686|11562766|FG002|COMPLETED|Part 2, Period 3|All who started this period completed|5
10418054|NCT00803686|11562767|FG003|COMPLETED|Part 2, Period 3|All who started this period completed|4
10418055|NCT00803686|11562764|FG000|NOT COMPLETED|Part 2, Period 3||0
10418056|NCT00803686|11562765|FG001|NOT COMPLETED|Part 2, Period 3||0
10418057|NCT00803686|11562766|FG002|NOT COMPLETED|Part 2, Period 3||0
10418058|NCT00803686|11562767|FG003|NOT COMPLETED|Part 2, Period 3||0
10418059|NCT00803712|11562781|FG000|STARTED|Overall Study|154 participants were randomized to the cinacalcet group|154
10418060|NCT00803712|11562782|FG001|STARTED|Overall Study|155 participants were randomized to the control group|155
10418061|NCT00803712|11562781|FG000|Full Analysis Set|Overall Study|153 participants randomized and had at least one PTH concentration available after study day 1.|153
10418062|NCT00803712|11562782|FG001|Full Analysis Set|Overall Study|151 participants randomized and had at least one PTH concentration available after study day 1.|151
10418063|NCT00803712|11562781|FG000|Safety Analysis Set|Overall Study|Rz'ed to cinacalcet and received at least 1 dose, or to control but received cinacalcet throughout|155
10418064|NCT00803712|11562782|FG001|Safety Analysis Set|Overall Study|Randomized to the control group|154
10418065|NCT00803712|11562781|FG000|COMPLETED|Overall Study|118 participants randomized to the cinacalcet group completed the study|118
10418066|NCT00803712|11562782|FG001|COMPLETED|Overall Study|128 participants randomized to the control group completed the study|128
10418067|NCT00803712|11562781|FG000|NOT COMPLETED|Overall Study||36
10418068|NCT00803712|11562782|FG001|NOT COMPLETED|Overall Study||27
10418069|NCT00803738|11562790|FG000|STARTED|Overall Study||286
10418070|NCT00803738|11562791|FG001|STARTED|Overall Study||286
10418071|NCT00803738|11562790|FG000|COMPLETED|Overall Study||192
10418072|NCT00803738|11562791|FG001|COMPLETED|Overall Study||176
10418073|NCT00803738|11562790|FG000|NOT COMPLETED|Overall Study||94
10418074|NCT00803738|11562791|FG001|NOT COMPLETED|Overall Study||110
10418075|NCT00803751|11562799|FG000|STARTED|Overall Study||26
10418076|NCT00803751|11562800|FG001|STARTED|Overall Study||23
10418077|NCT00803751|11562799|FG000|COMPLETED|Overall Study||26
10418078|NCT00803751|11562800|FG001|COMPLETED|Overall Study||23
10418079|NCT00803751|11562799|FG000|NOT COMPLETED|Overall Study||0
10418080|NCT00803751|11562800|FG001|NOT COMPLETED|Overall Study||0
10418081|NCT00803777|11562806|FG000|STARTED|Overall Study||147
10418082|NCT00803777|11562806|FG000|COMPLETED|Overall Study||147
10418083|NCT00803777|11562806|FG000|NOT COMPLETED|Overall Study||0
10418084|NCT00803959|11562812|FG000|STARTED|Overall Study||315
10418085|NCT00803959|11562813|FG001|STARTED|Overall Study||315
10418086|NCT00803959|11562812|FG000|ITT Analysis With Primary Outcome Data|Overall Study||266
10418087|NCT00803959|11562813|FG001|ITT Analysis With Primary Outcome Data|Overall Study||272
10418088|NCT00803959|11562812|FG000|COMPLETED|Overall Study|Because it is a non-inferiority trial, the PP analysis was the main analysis (n=259).|259
10418089|NCT00803959|11562813|FG001|COMPLETED|Overall Study|Because it is a non-inferiority trial, the PP analysis was the main analysis (n=264).|264
10418090|NCT00803959|11562812|FG000|NOT COMPLETED|Overall Study||56
10418091|NCT00803959|11562813|FG001|NOT COMPLETED|Overall Study||51
10418092|NCT00804141|11562819|FG000|STARTED|Overall Study||1040
10418093|NCT00804141|11562819|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1034
10418094|NCT00804141|11562819|FG000|COMPLETED|Overall Study||477
10418095|NCT00804141|11562819|FG000|NOT COMPLETED|Overall Study||563
10418096|NCT00804193|11562826|FG000|STARTED|Overall Study||220
10418097|NCT00804193|11562827|FG001|STARTED|Overall Study||224
10418098|NCT00804193|11562828|FG002|STARTED|Overall Study||109
10418099|NCT00804193|11562826|FG000|COMPLETED|Overall Study||181
10418100|NCT00804193|11562827|FG001|COMPLETED|Overall Study||180
10418101|NCT00804193|11562828|FG002|COMPLETED|Overall Study||77
10418102|NCT00804193|11562826|FG000|NOT COMPLETED|Overall Study||39
10418103|NCT00804193|11562827|FG001|NOT COMPLETED|Overall Study||44
10418104|NCT00804193|11562828|FG002|NOT COMPLETED|Overall Study||32
10418105|NCT00804570|11562838|FG000|STARTED|Overall Study||187
10418106|NCT00804570|11562839|FG001|STARTED|Overall Study||188
10418107|NCT00804570|11562838|FG000|COMPLETED|Overall Study||115
10418108|NCT00804570|11562839|FG001|COMPLETED|Overall Study||94
10418109|NCT00804570|11562838|FG000|NOT COMPLETED|Overall Study||72
10418110|NCT00804570|11562839|FG001|NOT COMPLETED|Overall Study||94
10418111|NCT00804596|11562846|FG000|STARTED|Overall Study||74
10418112|NCT00804596|11562846|FG000|COMPLETED|Overall Study||74
10418113|NCT00804596|11562846|FG000|NOT COMPLETED|Overall Study||0
10418114|NCT00804609|11562852|FG000|STARTED|Overall Study||15
10867106|NCT02508532|12032296|FG002|STARTED|Part 1 and Part 2 End of Study||6
10867107|NCT02508532|12032297|FG003|STARTED|Part 1 and Part 2 End of Study||6
10867108|NCT02508532|12032298|FG004|STARTED|Part 1 and Part 2 End of Study||6
10867109|NCT02508532|12032299|FG005|STARTED|Part 1 and Part 2 End of Study|These 6 patients are included in the 300 or 400 mg QD dose group|0
10867110|NCT02508532|12032300|FG006|STARTED|Part 1 and Part 2 End of Study|These 7 patients are included in the 300 or 400 mg QD dose group|0
10867111|NCT02508532|12032301|FG007|STARTED|Part 1 and Part 2 End of Study||3
10867112|NCT02508532|12032302|FG008|STARTED|Part 1 and Part 2 End of Study|Includes 13 patients enrolled in Part 1 at a starting dose of 300 mg (n = 6) or 400 mg (n = 7) QD.|217
10867113|NCT02508532|12032294|FG000|COMPLETED|Part 1 and Part 2 End of Study||0
10867114|NCT02508532|12032295|FG001|COMPLETED|Part 1 and Part 2 End of Study||0
10867115|NCT02508532|12032296|FG002|COMPLETED|Part 1 and Part 2 End of Study||0
10867116|NCT02508532|12032297|FG003|COMPLETED|Part 1 and Part 2 End of Study||0
10867117|NCT02508532|12032298|FG004|COMPLETED|Part 1 and Part 2 End of Study||0
10867118|NCT02508532|12032299|FG005|COMPLETED|Part 1 and Part 2 End of Study||0
10867119|NCT02508532|12032300|FG006|COMPLETED|Part 1 and Part 2 End of Study||0
10867120|NCT02508532|12032301|FG007|COMPLETED|Part 1 and Part 2 End of Study||0
10867121|NCT02508532|12032302|FG008|COMPLETED|Part 1 and Part 2 End of Study||0
10867122|NCT02508532|12032294|FG000|NOT COMPLETED|Part 1 and Part 2 End of Study||6
10867123|NCT02508532|12032295|FG001|NOT COMPLETED|Part 1 and Part 2 End of Study||6
10867124|NCT02508532|12032296|FG002|NOT COMPLETED|Part 1 and Part 2 End of Study||6
10867125|NCT02508532|12032297|FG003|NOT COMPLETED|Part 1 and Part 2 End of Study||6
10867126|NCT02508532|12032298|FG004|NOT COMPLETED|Part 1 and Part 2 End of Study||6
10867127|NCT02508532|12032299|FG005|NOT COMPLETED|Part 1 and Part 2 End of Study||0
10867128|NCT02508532|12032300|FG006|NOT COMPLETED|Part 1 and Part 2 End of Study||0
10867129|NCT02508532|12032301|FG007|NOT COMPLETED|Part 1 and Part 2 End of Study||3
10867130|NCT02508532|12032302|FG008|NOT COMPLETED|Part 1 and Part 2 End of Study||217
10867139|NCT02426684|12032339|FG000|STARTED|Overall Study||17
10867140|NCT02426684|12032339|FG000|COMPLETED|Overall Study||16
10867141|NCT02426684|12032339|FG000|NOT COMPLETED|Overall Study||1
10867160|NCT02337751|12032358|FG000|STARTED|Overall Study||95
10867161|NCT02337751|12032359|FG001|STARTED|Overall Study||103
10867162|NCT02337751|12032358|FG000|COMPLETED|Overall Study||84
10867163|NCT02337751|12032359|FG001|COMPLETED|Overall Study||87
10867164|NCT02337751|12032358|FG000|NOT COMPLETED|Overall Study||11
10867165|NCT02337751|12032359|FG001|NOT COMPLETED|Overall Study||16
10867166|NCT02337725|12032368|FG000|STARTED|Overall Study||126
10867167|NCT02337725|12032369|FG001|STARTED|Overall Study||118
10867168|NCT02337725|12032368|FG000|COMPLETED|Overall Study||100
10867169|NCT02337725|12032369|FG001|COMPLETED|Overall Study||110
10867170|NCT02337725|12032368|FG000|NOT COMPLETED|Overall Study||26
10867171|NCT02337725|12032369|FG001|NOT COMPLETED|Overall Study||8
10867172|NCT02332655|12032375|FG000|STARTED|Overall Study||5
10867173|NCT02332655|12032375|FG000|COMPLETED|Overall Study||4
10867174|NCT02332655|12032375|FG000|NOT COMPLETED|Overall Study||1
10867175|NCT02317705|12032379|FG000|STARTED|Overall Study||48
10867176|NCT02317705|12032379|FG000|Safety Population|Overall Study||44
10867177|NCT02317705|12032379|FG000|Modified Intent-to-Treat (mITT)|Overall Study||29
10867178|NCT02317705|12032379|FG000|COMPLETED|Overall Study||43
10867179|NCT02317705|12032379|FG000|NOT COMPLETED|Overall Study||5
10867180|NCT02272803|12032385|FG000|STARTED|Overall Study||40
10867181|NCT02272803|12032386|FG001|STARTED|Overall Study||42
10867182|NCT02272803|12032385|FG000|COMPLETED|Overall Study||0
10867183|NCT02272803|12032386|FG001|COMPLETED|Overall Study||0
10867184|NCT02272803|12032385|FG000|NOT COMPLETED|Overall Study||40
10867185|NCT02272803|12032386|FG001|NOT COMPLETED|Overall Study||42
10867186|NCT02240134|12032395|FG000|STARTED|Overall Study||176
10867187|NCT02240134|12032396|FG001|STARTED|Overall Study||176
10867188|NCT02240134|12032397|FG002|STARTED|Overall Study||171
10867189|NCT02240134|12032395|FG000|COMPLETED|Overall Study||126
10867190|NCT02240134|12032396|FG001|COMPLETED|Overall Study||123
10867191|NCT02240134|12032397|FG002|COMPLETED|Overall Study||118
10867192|NCT02240134|12032395|FG000|NOT COMPLETED|Overall Study||50
10867193|NCT02240134|12032396|FG001|NOT COMPLETED|Overall Study||53
10867194|NCT02240134|12032397|FG002|NOT COMPLETED|Overall Study||53
10867207|NCT02158585|12032414|FG000|STARTED|Overall Study||8
10867208|NCT02158585|12032415|FG001|STARTED|Overall Study||7
10867209|NCT02158585|12032414|FG000|COMPLETED|Overall Study||7
10867210|NCT02158585|12032415|FG001|COMPLETED|Overall Study||6
10867211|NCT02158585|12032414|FG000|NOT COMPLETED|Overall Study||1
10867212|NCT02158585|12032415|FG001|NOT COMPLETED|Overall Study||1
10867213|NCT02130687|12032425|FG000|STARTED|Washout||36
10867214|NCT02130687|12032426|FG001|STARTED|Washout||35
10867215|NCT02130687|12032427|FG002|STARTED|Washout||35
10867216|NCT02130687|12032425|FG000|COMPLETED|Washout||36
10867217|NCT02130687|12032426|FG001|COMPLETED|Washout||33
10867218|NCT02130687|12032427|FG002|COMPLETED|Washout||31
10867219|NCT02130687|12032425|FG000|NOT COMPLETED|Washout||0
10867220|NCT02130687|12032426|FG001|NOT COMPLETED|Washout||2
10867221|NCT02130687|12032427|FG002|NOT COMPLETED|Washout||4
10867222|NCT02130687|12032425|FG000|STARTED|Drug 1 Only||36
10867223|NCT02130687|12032426|FG001|STARTED|Drug 1 Only||33
10867224|NCT02130687|12032427|FG002|STARTED|Drug 1 Only||31
10867225|NCT02130687|12032425|FG000|COMPLETED|Drug 1 Only||33
10867226|NCT02130687|12032426|FG001|COMPLETED|Drug 1 Only||30
10867227|NCT02130687|12032427|FG002|COMPLETED|Drug 1 Only||30
10867228|NCT02130687|12032425|FG000|NOT COMPLETED|Drug 1 Only||3
10867229|NCT02130687|12032426|FG001|NOT COMPLETED|Drug 1 Only||3
10867230|NCT02130687|12032427|FG002|NOT COMPLETED|Drug 1 Only||1
10867231|NCT02130687|12032425|FG000|STARTED|Crossover Period 1||33
10867232|NCT02130687|12032426|FG001|STARTED|Crossover Period 1||30
10867233|NCT02130687|12032427|FG002|STARTED|Crossover Period 1||30
10867234|NCT02130687|12032425|FG000|COMPLETED|Crossover Period 1||33
10867235|NCT02130687|12032426|FG001|COMPLETED|Crossover Period 1||30
10867236|NCT02130687|12032427|FG002|COMPLETED|Crossover Period 1||30
10867237|NCT02130687|12032425|FG000|NOT COMPLETED|Crossover Period 1||0
10867238|NCT02130687|12032426|FG001|NOT COMPLETED|Crossover Period 1||0
10867239|NCT02130687|12032427|FG002|NOT COMPLETED|Crossover Period 1||0
10867240|NCT02130687|12032425|FG000|STARTED|Drug 1 Only Between Periods 1 and 2||33
10867241|NCT02130687|12032426|FG001|STARTED|Drug 1 Only Between Periods 1 and 2||30
10867242|NCT02130687|12032427|FG002|STARTED|Drug 1 Only Between Periods 1 and 2||30
10867243|NCT02130687|12032425|FG000|COMPLETED|Drug 1 Only Between Periods 1 and 2||33
10867244|NCT02130687|12032426|FG001|COMPLETED|Drug 1 Only Between Periods 1 and 2||26
10867245|NCT02130687|12032427|FG002|COMPLETED|Drug 1 Only Between Periods 1 and 2||29
10867246|NCT02130687|12032425|FG000|NOT COMPLETED|Drug 1 Only Between Periods 1 and 2||0
10867247|NCT02130687|12032426|FG001|NOT COMPLETED|Drug 1 Only Between Periods 1 and 2||4
10867248|NCT02130687|12032427|FG002|NOT COMPLETED|Drug 1 Only Between Periods 1 and 2||1
10867249|NCT02130687|12032425|FG000|STARTED|Crossover Period 2||33
10867250|NCT02130687|12032426|FG001|STARTED|Crossover Period 2||26
10867251|NCT02130687|12032427|FG002|STARTED|Crossover Period 2||29
10867252|NCT02130687|12032425|FG000|COMPLETED|Crossover Period 2||33
10867253|NCT02130687|12032426|FG001|COMPLETED|Crossover Period 2||26
10867254|NCT02130687|12032427|FG002|COMPLETED|Crossover Period 2||29
10867255|NCT02130687|12032425|FG000|NOT COMPLETED|Crossover Period 2||0
10867256|NCT02130687|12032426|FG001|NOT COMPLETED|Crossover Period 2||0
10867257|NCT02130687|12032427|FG002|NOT COMPLETED|Crossover Period 2||0
10867258|NCT02130687|12032425|FG000|STARTED|Drug 1 Only Between Periods 2 and 3||33
10867259|NCT02130687|12032426|FG001|STARTED|Drug 1 Only Between Periods 2 and 3||26
10867260|NCT02130687|12032427|FG002|STARTED|Drug 1 Only Between Periods 2 and 3||29
10867261|NCT02130687|12032425|FG000|COMPLETED|Drug 1 Only Between Periods 2 and 3||33
10867262|NCT02130687|12032426|FG001|COMPLETED|Drug 1 Only Between Periods 2 and 3||25
10867263|NCT02130687|12032427|FG002|COMPLETED|Drug 1 Only Between Periods 2 and 3||27
10867264|NCT02130687|12032425|FG000|NOT COMPLETED|Drug 1 Only Between Periods 2 and 3||0
10867265|NCT02130687|12032426|FG001|NOT COMPLETED|Drug 1 Only Between Periods 2 and 3||1
10867266|NCT02130687|12032427|FG002|NOT COMPLETED|Drug 1 Only Between Periods 2 and 3||2
10294586|NCT03969719|11427301|FG000|STARTED|Overall Study||54
10294587|NCT03969719|11427302|FG001|STARTED|Overall Study||55
10294588|NCT03969719|11427303|FG002|STARTED|Overall Study||55
10294589|NCT03969719|11427301|FG000|COMPLETED|Overall Study||50
10294590|NCT03969719|11427302|FG001|COMPLETED|Overall Study||46
10294591|NCT03969719|11427303|FG002|COMPLETED|Overall Study||50
10294592|NCT03969719|11427301|FG000|NOT COMPLETED|Overall Study||4
10294593|NCT03969719|11427302|FG001|NOT COMPLETED|Overall Study||9
10294594|NCT03969719|11427303|FG002|NOT COMPLETED|Overall Study||5
10294595|NCT03883477|11427313|FG000|STARTED|Overall Study||13
10294596|NCT03883477|11427314|FG001|STARTED|Overall Study||13
10418115|NCT00804609|11562853|FG001|STARTED|Overall Study||15
10418116|NCT00804609|11562852|FG000|COMPLETED|Overall Study||15
10418117|NCT00804609|11562853|FG001|COMPLETED|Overall Study||14
10418118|NCT00804609|11562852|FG000|NOT COMPLETED|Overall Study||0
10418119|NCT00804609|11562853|FG001|NOT COMPLETED|Overall Study||1
10418120|NCT00804648|11562859|FG000|STARTED|First Intervention||3
10418121|NCT00804648|11562860|FG001|STARTED|First Intervention||5
10418122|NCT00804648|11562861|FG002|STARTED|First Intervention||6
10418123|NCT00804648|11562862|FG003|STARTED|First Intervention||4
10418124|NCT00804648|11562863|FG004|STARTED|First Intervention||4
10418125|NCT00804648|11562864|FG005|STARTED|First Intervention||8
10418126|NCT00804648|11562859|FG000|COMPLETED|First Intervention||3
10418127|NCT00804648|11562860|FG001|COMPLETED|First Intervention||5
10418128|NCT00804648|11562861|FG002|COMPLETED|First Intervention||6
10418129|NCT00804648|11562862|FG003|COMPLETED|First Intervention||4
10418130|NCT00804648|11562863|FG004|COMPLETED|First Intervention||4
10418131|NCT00804648|11562864|FG005|COMPLETED|First Intervention||8
10418132|NCT00804648|11562859|FG000|NOT COMPLETED|First Intervention||0
10418133|NCT00804648|11562860|FG001|NOT COMPLETED|First Intervention||0
10418134|NCT00804648|11562861|FG002|NOT COMPLETED|First Intervention||0
10418135|NCT00804648|11562862|FG003|NOT COMPLETED|First Intervention||0
10418136|NCT00804648|11562863|FG004|NOT COMPLETED|First Intervention||0
10418137|NCT00804648|11562864|FG005|NOT COMPLETED|First Intervention||0
10418138|NCT00804648|11562859|FG000|STARTED|Second Intervention||3
10418139|NCT00804648|11562860|FG001|STARTED|Second Intervention||5
10294597|NCT03883477|11427313|FG000|COMPLETED|Overall Study||12
10294598|NCT03883477|11427314|FG001|COMPLETED|Overall Study||12
10294599|NCT03883477|11427313|FG000|NOT COMPLETED|Overall Study||1
10294600|NCT03883477|11427314|FG001|NOT COMPLETED|Overall Study||1
10294601|NCT03813108|11427326|FG000|STARTED|Overall Study||10
10294602|NCT03813108|11427327|FG001|STARTED|Overall Study||10
10294603|NCT03813108|11427328|FG002|STARTED|Overall Study||20
10294604|NCT03813108|11427329|FG003|STARTED|Overall Study||3
10294605|NCT03813108|11427330|FG004|STARTED|Overall Study||0
10294606|NCT03813108|11427331|FG005|STARTED|Overall Study||0
10294607|NCT03813108|11427326|FG000|COMPLETED|Overall Study||8
10294608|NCT03813108|11427327|FG001|COMPLETED|Overall Study||9
10418140|NCT00804648|11562861|FG002|STARTED|Second Intervention||6
10418141|NCT00804648|11562862|FG003|STARTED|Second Intervention||4
10867267|NCT02130687|12032425|FG000|STARTED|Crossover Period 3||33
10867268|NCT02130687|12032426|FG001|STARTED|Crossover Period 3||25
10867269|NCT02130687|12032427|FG002|STARTED|Crossover Period 3||27
10867270|NCT02130687|12032425|FG000|COMPLETED|Crossover Period 3||33
10867271|NCT02130687|12032426|FG001|COMPLETED|Crossover Period 3||25
10867272|NCT02130687|12032427|FG002|COMPLETED|Crossover Period 3||27
10867273|NCT02130687|12032425|FG000|NOT COMPLETED|Crossover Period 3||0
10867274|NCT02130687|12032426|FG001|NOT COMPLETED|Crossover Period 3||0
10867275|NCT02130687|12032427|FG002|NOT COMPLETED|Crossover Period 3||0
10294609|NCT03813108|11427328|FG002|COMPLETED|Overall Study||0
10294610|NCT03813108|11427329|FG003|COMPLETED|Overall Study||3
10294611|NCT03813108|11427330|FG004|COMPLETED|Overall Study||0
10294612|NCT03813108|11427331|FG005|COMPLETED|Overall Study||0
10294613|NCT03813108|11427326|FG000|NOT COMPLETED|Overall Study||2
10294614|NCT03813108|11427327|FG001|NOT COMPLETED|Overall Study||1
10294615|NCT03813108|11427328|FG002|NOT COMPLETED|Overall Study||20
10294616|NCT03813108|11427329|FG003|NOT COMPLETED|Overall Study||0
10418142|NCT00804648|11562863|FG004|STARTED|Second Intervention||4
10418143|NCT00804648|11562864|FG005|STARTED|Second Intervention||8
10418144|NCT00804648|11562859|FG000|COMPLETED|Second Intervention||3
10418145|NCT00804648|11562860|FG001|COMPLETED|Second Intervention||5
10418146|NCT00804648|11562861|FG002|COMPLETED|Second Intervention||6
10418147|NCT00804648|11562862|FG003|COMPLETED|Second Intervention||4
10418148|NCT00804648|11562863|FG004|COMPLETED|Second Intervention||4
10418149|NCT00804648|11562864|FG005|COMPLETED|Second Intervention||8
10418150|NCT00804648|11562859|FG000|NOT COMPLETED|Second Intervention||0
10755552|NCT03068754|11919358|FG002|STARTED|Open Label Extension Period (OLE)||25
10755553|NCT03068754|11919359|FG003|STARTED|Open Label Extension Period (OLE)||8
10755554|NCT03068754|11919356|FG000|Completed Taper|Open Label Extension Period (OLE)||0
10755555|NCT03068754|11919357|FG001|Completed Taper|Open Label Extension Period (OLE)||0
10755556|NCT03068754|11919358|FG002|Completed Taper|Open Label Extension Period (OLE)||19
10755557|NCT03068754|11919359|FG003|Completed Taper|Open Label Extension Period (OLE)||7
10755558|NCT03068754|11919356|FG000|Completed OLE Period|Open Label Extension Period (OLE)||0
10755559|NCT03068754|11919357|FG001|Completed OLE Period|Open Label Extension Period (OLE)||0
10755560|NCT03068754|11919358|FG002|Completed OLE Period|Open Label Extension Period (OLE)||3
10755561|NCT03068754|11919359|FG003|Completed OLE Period|Open Label Extension Period (OLE)||2
10755562|NCT03068754|11919356|FG000|Completed Treatment in OLE|Open Label Extension Period (OLE)||0
10755563|NCT03068754|11919357|FG001|Completed Treatment in OLE|Open Label Extension Period (OLE)||0
10755564|NCT03068754|11919358|FG002|Completed Treatment in OLE|Open Label Extension Period (OLE)||4
10755565|NCT03068754|11919359|FG003|Completed Treatment in OLE|Open Label Extension Period (OLE)||2
10755566|NCT03068754|11919356|FG000|COMPLETED|Open Label Extension Period (OLE)||0
10755567|NCT03068754|11919357|FG001|COMPLETED|Open Label Extension Period (OLE)||0
10755568|NCT03068754|11919358|FG002|COMPLETED|Open Label Extension Period (OLE)||4
10755569|NCT03068754|11919359|FG003|COMPLETED|Open Label Extension Period (OLE)||2
10755570|NCT03068754|11919356|FG000|NOT COMPLETED|Open Label Extension Period (OLE)||0
10294617|NCT03813108|11427330|FG004|NOT COMPLETED|Overall Study||0
10294618|NCT03813108|11427331|FG005|NOT COMPLETED|Overall Study||0
10294619|NCT03809611|11427343|FG000|STARTED|Overall Study||62
10418151|NCT00804648|11562860|FG001|NOT COMPLETED|Second Intervention||0
10418152|NCT00804648|11562861|FG002|NOT COMPLETED|Second Intervention||0
10418153|NCT00804648|11562862|FG003|NOT COMPLETED|Second Intervention||0
10418154|NCT00804648|11562863|FG004|NOT COMPLETED|Second Intervention||0
10867276|NCT01994382|12032470|FG000|STARTED|Overall Study||3
10867277|NCT01994382|12032471|FG001|STARTED|Overall Study||6
10867278|NCT01994382|12032472|FG002|STARTED|Overall Study||7
10867279|NCT01994382|12032473|FG003|STARTED|Overall Study||3
10867280|NCT01994382|12032474|FG004|STARTED|Overall Study||3
10867281|NCT01994382|12032475|FG005|STARTED|Overall Study||3
10867282|NCT01994382|12032476|FG006|STARTED|Overall Study||4
10867283|NCT01994382|12032477|FG007|STARTED|Overall Study||6
10867284|NCT01994382|12032478|FG008|STARTED|Overall Study||3
10867285|NCT01994382|12032479|FG009|STARTED|Overall Study||5
10867286|NCT01994382|12032480|FG010|STARTED|Overall Study||42
10867287|NCT01994382|12032481|FG011|STARTED|Overall Study||12
10867288|NCT01994382|12032482|FG012|STARTED|Overall Study||26
10867289|NCT01994382|12032483|FG013|STARTED|Overall Study||6
10867290|NCT01994382|12032484|FG014|STARTED|Overall Study||28
10867291|NCT01994382|12032485|FG015|STARTED|Overall Study||65
10867292|NCT01994382|12032486|FG016|STARTED|Overall Study||41
10867293|NCT01994382|12032470|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
10867294|NCT01994382|12032471|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
10867295|NCT01994382|12032472|FG002|Received at Least 1 Dose of Study Drug|Overall Study||7
10867296|NCT01994382|12032473|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
10867297|NCT01994382|12032474|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3
10867298|NCT01994382|12032475|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3
10867299|NCT01994382|12032476|FG006|Received at Least 1 Dose of Study Drug|Overall Study||4
10867300|NCT01994382|12032477|FG007|Received at Least 1 Dose of Study Drug|Overall Study||6
10867301|NCT01994382|12032478|FG008|Received at Least 1 Dose of Study Drug|Overall Study||3
10867302|NCT01994382|12032479|FG009|Received at Least 1 Dose of Study Drug|Overall Study||5
10867303|NCT01994382|12032480|FG010|Received at Least 1 Dose of Study Drug|Overall Study||42
10867304|NCT01994382|12032481|FG011|Received at Least 1 Dose of Study Drug|Overall Study||12
10867305|NCT01994382|12032482|FG012|Received at Least 1 Dose of Study Drug|Overall Study||26
10867306|NCT01994382|12032483|FG013|Received at Least 1 Dose of Study Drug|Overall Study||6
10867307|NCT01994382|12032484|FG014|Received at Least 1 Dose of Study Drug|Overall Study||28
10867308|NCT01994382|12032485|FG015|Received at Least 1 Dose of Study Drug|Overall Study||65
10867309|NCT01994382|12032486|FG016|Received at Least 1 Dose of Study Drug|Overall Study||41
10867310|NCT01994382|12032470|FG000|COMPLETED|Overall Study||0
10867311|NCT01994382|12032471|FG001|COMPLETED|Overall Study||0
10867312|NCT01994382|12032472|FG002|COMPLETED|Overall Study||0
10867313|NCT01994382|12032473|FG003|COMPLETED|Overall Study||0
10867314|NCT01994382|12032474|FG004|COMPLETED|Overall Study||0
10867315|NCT01994382|12032475|FG005|COMPLETED|Overall Study||0
10867316|NCT01994382|12032476|FG006|COMPLETED|Overall Study||0
10867317|NCT01994382|12032477|FG007|COMPLETED|Overall Study||0
10867318|NCT01994382|12032478|FG008|COMPLETED|Overall Study||0
10867319|NCT01994382|12032479|FG009|COMPLETED|Overall Study||0
10867320|NCT01994382|12032480|FG010|COMPLETED|Overall Study||0
10867321|NCT01994382|12032481|FG011|COMPLETED|Overall Study||0
10867322|NCT01994382|12032482|FG012|COMPLETED|Overall Study||0
10867323|NCT01994382|12032483|FG013|COMPLETED|Overall Study||0
10867324|NCT01994382|12032484|FG014|COMPLETED|Overall Study||0
10867325|NCT01994382|12032485|FG015|COMPLETED|Overall Study||0
10867326|NCT01994382|12032486|FG016|COMPLETED|Overall Study||0
10867327|NCT01994382|12032470|FG000|NOT COMPLETED|Overall Study||3
10867328|NCT01994382|12032471|FG001|NOT COMPLETED|Overall Study||6
10867329|NCT01994382|12032472|FG002|NOT COMPLETED|Overall Study||7
10867330|NCT01994382|12032473|FG003|NOT COMPLETED|Overall Study||3
10867331|NCT01994382|12032474|FG004|NOT COMPLETED|Overall Study||3
10867332|NCT01994382|12032475|FG005|NOT COMPLETED|Overall Study||3
10867333|NCT01994382|12032476|FG006|NOT COMPLETED|Overall Study||4
10867334|NCT01994382|12032477|FG007|NOT COMPLETED|Overall Study||6
10867335|NCT01994382|12032478|FG008|NOT COMPLETED|Overall Study||3
10867336|NCT01994382|12032479|FG009|NOT COMPLETED|Overall Study||5
10867337|NCT01994382|12032480|FG010|NOT COMPLETED|Overall Study||42
10867338|NCT01994382|12032481|FG011|NOT COMPLETED|Overall Study||12
10867339|NCT01994382|12032482|FG012|NOT COMPLETED|Overall Study||26
10867340|NCT01994382|12032483|FG013|NOT COMPLETED|Overall Study||6
10867341|NCT01994382|12032484|FG014|NOT COMPLETED|Overall Study||28
10867342|NCT01994382|12032485|FG015|NOT COMPLETED|Overall Study||65
10867343|NCT01994382|12032486|FG016|NOT COMPLETED|Overall Study||41
10867344|NCT01896531|12032531|FG000|STARTED|Overall Study||71
10867345|NCT01896531|12032532|FG001|STARTED|Overall Study||82
10867346|NCT01896531|12032531|FG000|Treated|Overall Study||70
10867347|NCT01896531|12032532|FG001|Treated|Overall Study||82
10867348|NCT01896531|12032531|FG000|COMPLETED|Overall Study||0
10867349|NCT01896531|12032532|FG001|COMPLETED|Overall Study||0
10867350|NCT01896531|12032531|FG000|NOT COMPLETED|Overall Study||71
10867351|NCT01896531|12032532|FG001|NOT COMPLETED|Overall Study||82
10867384|NCT01719744|12032561|FG000|STARTED|Overall Study||25
10867385|NCT01719744|12032561|FG000|COMPLETED|Overall Study||25
10867386|NCT01719744|12032561|FG000|NOT COMPLETED|Overall Study||0
10867387|NCT01684722|12032569|FG000|STARTED|Overall Study||333
10867388|NCT01684722|12032570|FG001|STARTED|Overall Study||289
10867389|NCT01684722|12032571|FG002|STARTED|Overall Study||320
10867390|NCT01684722|12032572|FG003|STARTED|Overall Study||370
10867391|NCT01684722|12032569|FG000|COMPLETED|Overall Study||236
10867392|NCT01684722|12032570|FG001|COMPLETED|Overall Study||212
10867393|NCT01684722|12032571|FG002|COMPLETED|Overall Study||226
10867394|NCT01684722|12032572|FG003|COMPLETED|Overall Study||260
10867395|NCT01684722|12032569|FG000|NOT COMPLETED|Overall Study||97
10294620|NCT03809611|11427344|FG001|STARTED|Overall Study||62
10294621|NCT03809611|11427343|FG000|COMPLETED|Overall Study||61
10294622|NCT03809611|11427344|FG001|COMPLETED|Overall Study||61
10294623|NCT03809611|11427343|FG000|NOT COMPLETED|Overall Study||1
10294624|NCT03809611|11427344|FG001|NOT COMPLETED|Overall Study||1
10294625|NCT03721705|11427353|FG000|STARTED|Overall Study||95
10294626|NCT03721705|11427354|FG001|STARTED|Overall Study||95
10294627|NCT03721705|11427353|FG000|COMPLETED|Overall Study||85
10294628|NCT03721705|11427354|FG001|COMPLETED|Overall Study||77
10294629|NCT03721705|11427353|FG000|NOT COMPLETED|Overall Study||10
10294630|NCT03721705|11427354|FG001|NOT COMPLETED|Overall Study||18
10314712|NCT00168103|11448448|FG002|COMPLETED|Overall Study||41
10314713|NCT00168103|11448449|FG003|COMPLETED|Overall Study||1
10314714|NCT00168103|11448446|FG000|NOT COMPLETED|Overall Study||2
10314715|NCT00168103|11448447|FG001|NOT COMPLETED|Overall Study||5
10314716|NCT00168103|11448448|FG002|NOT COMPLETED|Overall Study||1
10314717|NCT00168103|11448449|FG003|NOT COMPLETED|Overall Study||0
10314718|NCT00168298|11448460|FG000|STARTED|Double-Blind Period||226
10314719|NCT00168298|11448461|FG001|STARTED|Double-Blind Period||218
10314720|NCT00168298|11448462|FG002|STARTED|Double-Blind Period||224
10314721|NCT00168298|11448460|FG000|COMPLETED|Double-Blind Period||214
10314722|NCT00168298|11448461|FG001|COMPLETED|Double-Blind Period||206
10314723|NCT00168298|11448462|FG002|COMPLETED|Double-Blind Period||209
10314724|NCT00168298|11448460|FG000|NOT COMPLETED|Double-Blind Period||12
10314725|NCT00168298|11448461|FG001|NOT COMPLETED|Double-Blind Period||12
10314726|NCT00168298|11448462|FG002|NOT COMPLETED|Double-Blind Period||15
10314727|NCT00168298|11448460|FG000|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|179
10314728|NCT00168298|11448461|FG001|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|173
10314729|NCT00168298|11448462|FG002|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|168
10314730|NCT00168298|11448460|FG000|COMPLETED|Open-Label Period||172
10314731|NCT00168298|11448461|FG001|COMPLETED|Open-Label Period||168
10314732|NCT00168298|11448462|FG002|COMPLETED|Open-Label Period||160
10314733|NCT00168298|11448460|FG000|NOT COMPLETED|Open-Label Period||7
10314734|NCT00168298|11448461|FG001|NOT COMPLETED|Open-Label Period||5
10314735|NCT00168298|11448462|FG002|NOT COMPLETED|Open-Label Period||8
10314736|NCT00168311|11448472|FG000|STARTED|Overall Study||12
10314737|NCT00168311|11448473|FG001|STARTED|Overall Study||10
10314738|NCT00168311|11448472|FG000|COMPLETED|Overall Study||12
10314739|NCT00168311|11448473|FG001|COMPLETED|Overall Study||8
10314740|NCT00168311|11448472|FG000|NOT COMPLETED|Overall Study||0
10314741|NCT00168311|11448473|FG001|NOT COMPLETED|Overall Study||2
10314742|NCT00168324|11448482|FG000|STARTED|Double-Blind Period||201
10314743|NCT00168324|11448483|FG001|STARTED|Double-Blind Period||196
10314744|NCT00168324|11448484|FG002|STARTED|Double-Blind Period||202
10314745|NCT00168324|11448482|FG000|COMPLETED|Double-Blind Period||189
10314746|NCT00168324|11448483|FG001|COMPLETED|Double-Blind Period||189
10314747|NCT00168324|11448484|FG002|COMPLETED|Double-Blind Period||189
10314748|NCT00168324|11448482|FG000|NOT COMPLETED|Double-Blind Period||12
10314749|NCT00168324|11448483|FG001|NOT COMPLETED|Double-Blind Period||7
10314750|NCT00168324|11448484|FG002|NOT COMPLETED|Double-Blind Period||13
10314751|NCT00168324|11448482|FG000|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|164
10314752|NCT00168324|11448483|FG001|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|155
10314753|NCT00168324|11448484|FG002|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|158
10314754|NCT00168324|11448482|FG000|COMPLETED|Open-Label Period||160
10314755|NCT00168324|11448483|FG001|COMPLETED|Open-Label Period||147
10314756|NCT00168324|11448484|FG002|COMPLETED|Open-Label Period||152
10314757|NCT00168324|11448482|FG000|NOT COMPLETED|Open-Label Period||4
10314758|NCT00168324|11448483|FG001|NOT COMPLETED|Open-Label Period||8
10314759|NCT00168324|11448484|FG002|NOT COMPLETED|Open-Label Period||6
10314760|NCT00168337|11448495|FG000|STARTED|Overall Study||188
10314761|NCT00168337|11448496|FG001|STARTED|Overall Study||181
10314762|NCT00168337|11448497|FG002|STARTED|Overall Study||185
10314763|NCT00168337|11448495|FG000|COMPLETED|Overall Study||118
10314764|NCT00168337|11448496|FG001|COMPLETED|Overall Study||112
10314765|NCT00168337|11448497|FG002|COMPLETED|Overall Study||82
10314766|NCT00168337|11448495|FG000|NOT COMPLETED|Overall Study||70
10314767|NCT00168337|11448496|FG001|NOT COMPLETED|Overall Study||69
10314768|NCT00168337|11448497|FG002|NOT COMPLETED|Overall Study||103
10314769|NCT00168389|11448508|FG000|STARTED|Overall Study||163
10314770|NCT00168389|11448509|FG001|STARTED|Overall Study||166
10314771|NCT00168389|11448510|FG002|STARTED|Overall Study||165
10314772|NCT00168389|11448508|FG000|COMPLETED|Overall Study||107
10314773|NCT00168389|11448509|FG001|COMPLETED|Overall Study||118
10314774|NCT00168389|11448510|FG002|COMPLETED|Overall Study||70
10314775|NCT00168389|11448508|FG000|NOT COMPLETED|Overall Study||56
10314776|NCT00168389|11448509|FG001|NOT COMPLETED|Overall Study||48
10314777|NCT00168389|11448510|FG002|NOT COMPLETED|Overall Study||95
10314778|NCT00168428|11448520|FG000|STARTED|Double-Blind Phase (DB)||347
10314779|NCT00168428|11448521|FG001|STARTED|Double-Blind Phase (DB)||358
10314780|NCT00168428|11448520|FG000|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|311
10314781|NCT00168428|11448521|FG001|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|334
10314782|NCT00168428|11448520|FG000|NOT COMPLETED|Double-Blind Phase (DB)||36
10314783|NCT00168428|11448521|FG001|NOT COMPLETED|Double-Blind Phase (DB)||24
10315652|NCT00181714|11449603|FG000|COMPLETED|Signed Consent/Enrolled||154
10867352|NCT01864603|12032540|FG000|STARTED|Stage 1|Describes # of participants who were residents and aged 15+yrs at baseline|79818
10867353|NCT01864603|12032541|FG001|STARTED|Stage 1|Describes # of participants who were residents and aged 15+yrs at baseline|70577
10867354|NCT01864603|12032540|FG000|COMPLETED|Stage 1||71028
10867355|NCT01864603|12032541|FG001|COMPLETED|Stage 1||62912
10867356|NCT01864603|12032540|FG000|NOT COMPLETED|Stage 1||8790
10867357|NCT01864603|12032541|FG001|NOT COMPLETED|Stage 1||7665
10867358|NCT01864603|12032540|FG000|STARTED|Stage 2|Describes # of participants who were residents and aged 15+yrs at the start of Stage 2|91533
10867359|NCT01864603|12032541|FG001|STARTED|Stage 2|Describes # of participants who were residents and aged 15+yrs at the start of Stage 2|92558
10867360|NCT01864603|12032540|FG000|COMPLETED|Stage 2||5477
10867361|NCT01864603|12032541|FG001|COMPLETED|Stage 2||0
10867362|NCT01864603|12032540|FG000|NOT COMPLETED|Stage 2||86056
10867363|NCT01864603|12032541|FG001|NOT COMPLETED|Stage 2||92558
10867396|NCT01684722|12032570|FG001|NOT COMPLETED|Overall Study||77
10867397|NCT01684722|12032571|FG002|NOT COMPLETED|Overall Study||94
10867398|NCT01684722|12032572|FG003|NOT COMPLETED|Overall Study||110
10418155|NCT00804648|11562864|FG005|NOT COMPLETED|Second Intervention||0
10418156|NCT00804648|11562859|FG000|STARTED|Third Invervention||3
10418157|NCT00804648|11562860|FG001|STARTED|Third Invervention||5
10418158|NCT00804648|11562861|FG002|STARTED|Third Invervention||6
10418159|NCT00804648|11562862|FG003|STARTED|Third Invervention||4
10418160|NCT00804648|11562863|FG004|STARTED|Third Invervention||4
10418161|NCT00804648|11562864|FG005|STARTED|Third Invervention||8
10418162|NCT00804648|11562859|FG000|COMPLETED|Third Invervention||3
10418163|NCT00804648|11562860|FG001|COMPLETED|Third Invervention||5
10418164|NCT00804648|11562861|FG002|COMPLETED|Third Invervention||6
10418165|NCT00804648|11562862|FG003|COMPLETED|Third Invervention||4
10418166|NCT00804648|11562863|FG004|COMPLETED|Third Invervention||4
10418167|NCT00804648|11562864|FG005|COMPLETED|Third Invervention||8
10867399|NCT01516346|12032590|FG000|STARTED|Overall Study||13
10867400|NCT01516346|12032591|FG001|STARTED|Overall Study||15
10867401|NCT01516346|12032592|FG002|STARTED|Overall Study||16
10867402|NCT01516346|12032590|FG000|COMPLETED|Overall Study||7
10867403|NCT01516346|12032591|FG001|COMPLETED|Overall Study||9
10867404|NCT01516346|12032592|FG002|COMPLETED|Overall Study||11
10867405|NCT01516346|12032590|FG000|NOT COMPLETED|Overall Study||6
10867406|NCT01516346|12032591|FG001|NOT COMPLETED|Overall Study||6
10867407|NCT01516346|12032592|FG002|NOT COMPLETED|Overall Study||5
10867408|NCT01399372|12032602|FG000|STARTED|Overall Study||47
10867409|NCT01399372|12032603|FG001|STARTED|Overall Study||44
10867410|NCT01399372|12032602|FG000|Eligible|Overall Study||44
10867411|NCT01399372|12032603|FG001|Eligible|Overall Study||43
10867412|NCT01399372|12032602|FG000|Eligible and Started Protocol Treatment|Overall Study||43
10867413|NCT01399372|12032603|FG001|Eligible and Started Protocol Treatment|Overall Study||43
10867414|NCT01399372|12032602|FG000|COMPLETED|Overall Study||44
10867415|NCT01399372|12032603|FG001|COMPLETED|Overall Study||43
10867416|NCT01399372|12032602|FG000|NOT COMPLETED|Overall Study||3
10867417|NCT01399372|12032603|FG001|NOT COMPLETED|Overall Study||1
10867418|NCT01303796|12032611|FG000|STARTED|Lead In Phase||21
10867419|NCT01303796|12032612|FG001|STARTED|Lead In Phase|Intend-to-Treat study subject population|0
10867420|NCT01303796|12032613|FG002|STARTED|Lead In Phase|Intend-to-Treat study subject population|0
10867421|NCT01303796|12032611|FG000|COMPLETED|Lead In Phase||21
10867422|NCT01303796|12032612|FG001|COMPLETED|Lead In Phase||0
10867423|NCT01303796|12032613|FG002|COMPLETED|Lead In Phase||0
10867424|NCT01303796|12032611|FG000|NOT COMPLETED|Lead In Phase||0
10867425|NCT01303796|12032612|FG001|NOT COMPLETED|Lead In Phase||0
10867426|NCT01303796|12032613|FG002|NOT COMPLETED|Lead In Phase||0
10867427|NCT01303796|12032611|FG000|STARTED|Randomized Phase III||0
10867428|NCT01303796|12032612|FG001|STARTED|Randomized Phase III||241
10867429|NCT01303796|12032613|FG002|STARTED|Randomized Phase III||241
10867430|NCT01303796|12032611|FG000|COMPLETED|Randomized Phase III||0
10867431|NCT01303796|12032612|FG001|COMPLETED|Randomized Phase III||241
10867432|NCT01303796|12032613|FG002|COMPLETED|Randomized Phase III||241
10867433|NCT01303796|12032611|FG000|NOT COMPLETED|Randomized Phase III||0
10867434|NCT01303796|12032612|FG001|NOT COMPLETED|Randomized Phase III||0
10867435|NCT01303796|12032613|FG002|NOT COMPLETED|Randomized Phase III||0
10867436|NCT01235923|12032622|FG000|STARTED|Overall Study||10
10867437|NCT01235923|12032623|FG001|STARTED|Overall Study||10
10867438|NCT01235923|12032622|FG000|COMPLETED|Overall Study||10
10867439|NCT01235923|12032623|FG001|COMPLETED|Overall Study||10
10867440|NCT01235923|12032622|FG000|NOT COMPLETED|Overall Study||0
10867441|NCT01235923|12032623|FG001|NOT COMPLETED|Overall Study||0
10867448|NCT01082211|12032638|FG000|STARTED|Overall Study||65
10867449|NCT01082211|12032638|FG000|Has Baseline PT QOL Data|Overall Study||46
10867450|NCT01082211|12032638|FG000|Has Baseline MD QOL Data|Overall Study||44
10867451|NCT01082211|12032638|FG000|Has Baseline/12-month PT QOL Data|Overall Study||36
10867452|NCT01082211|12032638|FG000|Has Baseline/12-Month MD QOL Data|Overall Study||35
10867453|NCT01082211|12032638|FG000|Has Baseline/36-month PT QOL Data|Overall Study||32
10867454|NCT01082211|12032638|FG000|Has Baseline/36-Month MD QOL Data|Overall Study||27
10867455|NCT01082211|12032638|FG000|All Eligible Patients|Overall Study||58
10867456|NCT01082211|12032638|FG000|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|58
10867457|NCT01082211|12032638|FG000|NOT COMPLETED|Overall Study||7
10867458|NCT01080196|12032647|FG000|STARTED|Overall Study||68
10867459|NCT01080196|12032648|FG001|STARTED|Overall Study||66
10867460|NCT01080196|12032647|FG000|COMPLETED|Overall Study||68
10867461|NCT01080196|12032648|FG001|COMPLETED|Overall Study||66
10867462|NCT01080196|12032647|FG000|NOT COMPLETED|Overall Study||0
10867463|NCT01080196|12032648|FG001|NOT COMPLETED|Overall Study||0
10867464|NCT00976911|12032658|FG000|STARTED|Overall Study||182
10867465|NCT00976911|12032659|FG001|STARTED|Overall Study||179
10867466|NCT00976911|12032658|FG000|COMPLETED|Overall Study|At time of clinical cutoff for overall survival and safety (25 January 2013)|0
10867467|NCT00976911|12032659|FG001|COMPLETED|Overall Study|At time of clinical cutoff for overall survival and safety (25 January 2013)|0
10867468|NCT00976911|12032658|FG000|NOT COMPLETED|Overall Study||182
10867469|NCT00976911|12032659|FG001|NOT COMPLETED|Overall Study||179
10867470|NCT00712582|12032668|FG000|STARTED|Overall Study||60
10867471|NCT00712582|12032669|FG001|STARTED|Overall Study||32
10867472|NCT00712582|12032670|FG002|STARTED|Overall Study||4
10867473|NCT00712582|12032668|FG000|COMPLETED|Overall Study||60
10867474|NCT00712582|12032669|FG001|COMPLETED|Overall Study||32
10867475|NCT00712582|12032670|FG002|COMPLETED|Overall Study||4
10867476|NCT00712582|12032668|FG000|NOT COMPLETED|Overall Study||0
10867477|NCT00712582|12032669|FG001|NOT COMPLETED|Overall Study||0
10867478|NCT00712582|12032670|FG002|NOT COMPLETED|Overall Study||0
10867479|NCT00693238|12032680|FG000|STARTED|Overall Study||122
10867480|NCT00693238|12032681|FG001|STARTED|Overall Study||106
10867481|NCT00693238|12032680|FG000|COMPLETED|Overall Study||122
10867482|NCT00693238|12032681|FG001|COMPLETED|Overall Study||106
10867483|NCT00693238|12032680|FG000|NOT COMPLETED|Overall Study||0
10867484|NCT00693238|12032681|FG001|NOT COMPLETED|Overall Study||0
10294631|NCT03505021|11427362|FG000|STARTED|Overall Study||329
10418168|NCT00804648|11562859|FG000|NOT COMPLETED|Third Invervention||0
10418169|NCT00804648|11562860|FG001|NOT COMPLETED|Third Invervention||0
10418170|NCT00804648|11562861|FG002|NOT COMPLETED|Third Invervention||0
10418171|NCT00804648|11562862|FG003|NOT COMPLETED|Third Invervention||0
10418172|NCT00804648|11562863|FG004|NOT COMPLETED|Third Invervention||0
10418173|NCT00804648|11562864|FG005|NOT COMPLETED|Third Invervention||0
10418174|NCT00804687|11562872|FG000|STARTED|Period 1: Treatment Period||9
10418175|NCT00804687|11562873|FG001|STARTED|Period 1: Treatment Period||9
10418176|NCT00804687|11562874|FG002|STARTED|Period 1: Treatment Period||9
10418177|NCT00804687|11562875|FG003|STARTED|Period 1: Treatment Period||9
10418178|NCT00804687|11562876|FG004|STARTED|Period 1: Treatment Period||9
10418179|NCT00804687|11562877|FG005|STARTED|Period 1: Treatment Period||8
10418180|NCT00804687|11562872|FG000|COMPLETED|Period 1: Treatment Period||9
10418181|NCT00804687|11562873|FG001|COMPLETED|Period 1: Treatment Period||9
10418182|NCT00804687|11562874|FG002|COMPLETED|Period 1: Treatment Period||9
10418183|NCT00804687|11562875|FG003|COMPLETED|Period 1: Treatment Period||9
10418184|NCT00804687|11562876|FG004|COMPLETED|Period 1: Treatment Period||9
10418185|NCT00804687|11562877|FG005|COMPLETED|Period 1: Treatment Period||8
10418186|NCT00804687|11562872|FG000|NOT COMPLETED|Period 1: Treatment Period||0
10418187|NCT00804687|11562873|FG001|NOT COMPLETED|Period 1: Treatment Period||0
10418188|NCT00804687|11562874|FG002|NOT COMPLETED|Period 1: Treatment Period||0
10418189|NCT00804687|11562875|FG003|NOT COMPLETED|Period 1: Treatment Period||0
10418190|NCT00804687|11562876|FG004|NOT COMPLETED|Period 1: Treatment Period||0
10418191|NCT00804687|11562877|FG005|NOT COMPLETED|Period 1: Treatment Period||0
10418192|NCT00804687|11562872|FG000|STARTED|Period 2: Washout Period||9
10418193|NCT00804687|11562873|FG001|STARTED|Period 2: Washout Period||9
10418194|NCT00804687|11562874|FG002|STARTED|Period 2: Washout Period||9
10418195|NCT00804687|11562875|FG003|STARTED|Period 2: Washout Period||9
10418196|NCT00804687|11562876|FG004|STARTED|Period 2: Washout Period||9
10418197|NCT00804687|11562877|FG005|STARTED|Period 2: Washout Period||8
10418198|NCT00804687|11562872|FG000|COMPLETED|Period 2: Washout Period||9
10418199|NCT00804687|11562873|FG001|COMPLETED|Period 2: Washout Period||9
10418200|NCT00804687|11562874|FG002|COMPLETED|Period 2: Washout Period||9
10418201|NCT00804687|11562875|FG003|COMPLETED|Period 2: Washout Period||9
10418202|NCT00804687|11562876|FG004|COMPLETED|Period 2: Washout Period||9
10418203|NCT00804687|11562877|FG005|COMPLETED|Period 2: Washout Period||8
10418204|NCT00804687|11562872|FG000|NOT COMPLETED|Period 2: Washout Period||0
10418205|NCT00804687|11562873|FG001|NOT COMPLETED|Period 2: Washout Period||0
10418206|NCT00804687|11562874|FG002|NOT COMPLETED|Period 2: Washout Period||0
10418207|NCT00804687|11562875|FG003|NOT COMPLETED|Period 2: Washout Period||0
10418208|NCT00804687|11562876|FG004|NOT COMPLETED|Period 2: Washout Period||0
10418209|NCT00804687|11562877|FG005|NOT COMPLETED|Period 2: Washout Period||0
10418210|NCT00804687|11562872|FG000|STARTED|Period 3: Treatment Period||9
10418211|NCT00804687|11562873|FG001|STARTED|Period 3: Treatment Period||9
10418212|NCT00804687|11562874|FG002|STARTED|Period 3: Treatment Period||9
10418213|NCT00804687|11562875|FG003|STARTED|Period 3: Treatment Period||9
10418214|NCT00804687|11562876|FG004|STARTED|Period 3: Treatment Period||9
10418215|NCT00804687|11562877|FG005|STARTED|Period 3: Treatment Period||8
10418216|NCT00804687|11562872|FG000|COMPLETED|Period 3: Treatment Period||9
10418217|NCT00804687|11562873|FG001|COMPLETED|Period 3: Treatment Period||9
10418218|NCT00804687|11562874|FG002|COMPLETED|Period 3: Treatment Period||9
10418219|NCT00804687|11562875|FG003|COMPLETED|Period 3: Treatment Period||8
10418220|NCT00804687|11562876|FG004|COMPLETED|Period 3: Treatment Period||9
10418221|NCT00804687|11562877|FG005|COMPLETED|Period 3: Treatment Period||8
10418222|NCT00804687|11562872|FG000|NOT COMPLETED|Period 3: Treatment Period||0
10418223|NCT00804687|11562873|FG001|NOT COMPLETED|Period 3: Treatment Period||0
10418224|NCT00804687|11562874|FG002|NOT COMPLETED|Period 3: Treatment Period||0
10418225|NCT00804687|11562875|FG003|NOT COMPLETED|Period 3: Treatment Period||1
10418226|NCT00804687|11562876|FG004|NOT COMPLETED|Period 3: Treatment Period||0
10418227|NCT00804687|11562877|FG005|NOT COMPLETED|Period 3: Treatment Period||0
10418228|NCT00804687|11562872|FG000|STARTED|Period 4: Washout Period||9
10418229|NCT00804687|11562873|FG001|STARTED|Period 4: Washout Period||9
10418230|NCT00804687|11562874|FG002|STARTED|Period 4: Washout Period||9
10418231|NCT00804687|11562875|FG003|STARTED|Period 4: Washout Period||8
10418232|NCT00804687|11562876|FG004|STARTED|Period 4: Washout Period||9
10418233|NCT00804687|11562877|FG005|STARTED|Period 4: Washout Period||8
10418234|NCT00804687|11562872|FG000|COMPLETED|Period 4: Washout Period||9
10418235|NCT00804687|11562873|FG001|COMPLETED|Period 4: Washout Period||9
10294632|NCT03505021|11427363|FG001|STARTED|Overall Study||167
10294633|NCT03505021|11427362|FG000|COMPLETED|Overall Study||217
10294634|NCT03505021|11427363|FG001|COMPLETED|Overall Study||112
10294635|NCT03505021|11427362|FG000|NOT COMPLETED|Overall Study||112
10294636|NCT03505021|11427363|FG001|NOT COMPLETED|Overall Study||55
10294637|NCT03405714|11427373|FG000|STARTED|Overall Study||12
10294638|NCT03405714|11427374|FG001|STARTED|Overall Study||12
10294639|NCT03405714|11427375|FG002|STARTED|Overall Study||13
10294640|NCT03405714|11427376|FG003|STARTED|Overall Study||13
10294641|NCT03405714|11427373|FG000|COMPLETED|Overall Study||12
10294642|NCT03405714|11427374|FG001|COMPLETED|Overall Study||12
10294643|NCT03405714|11427375|FG002|COMPLETED|Overall Study||13
10294644|NCT03405714|11427376|FG003|COMPLETED|Overall Study||13
10294645|NCT03405714|11427373|FG000|NOT COMPLETED|Overall Study||0
10294646|NCT03405714|11427374|FG001|NOT COMPLETED|Overall Study||0
10867506|NCT00573131|12032718|FG000|STARTED|Overall Study||72
10867507|NCT00573131|12032719|FG001|STARTED|Overall Study||65
10867508|NCT00573131|12032718|FG000|COMPLETED|Overall Study||62
10867509|NCT00573131|12032719|FG001|COMPLETED|Overall Study||57
10867510|NCT00573131|12032718|FG000|NOT COMPLETED|Overall Study||10
10867511|NCT00573131|12032719|FG001|NOT COMPLETED|Overall Study||8
10294647|NCT03405714|11427375|FG002|NOT COMPLETED|Overall Study||0
10294648|NCT03405714|11427376|FG003|NOT COMPLETED|Overall Study||0
10294649|NCT03366194|11427392|FG000|STARTED|Overall Study||36
10294650|NCT03366194|11427392|FG000|COMPLETED|Overall Study||34
10294651|NCT03366194|11427392|FG000|NOT COMPLETED|Overall Study||2
10294652|NCT03272139|11427399|FG000|STARTED|Overall Study||63
10294653|NCT03272139|11427400|FG001|STARTED|Overall Study||63
10294654|NCT03272139|11427399|FG000|COMPLETED|Overall Study||63
10294655|NCT03272139|11427400|FG001|COMPLETED|Overall Study||63
10294656|NCT03272139|11427399|FG000|NOT COMPLETED|Overall Study||0
10294657|NCT03272139|11427400|FG001|NOT COMPLETED|Overall Study||0
10294658|NCT03203473|11427406|FG000|STARTED|Induction Phase||85
10294659|NCT03203473|11427407|FG001|STARTED|Induction Phase||0
10294660|NCT03203473|11427408|FG002|STARTED|Induction Phase||0
10294661|NCT03203473|11427406|FG000|COMPLETED|Induction Phase||69
10294662|NCT03203473|11427407|FG001|COMPLETED|Induction Phase||0
10294663|NCT03203473|11427408|FG002|COMPLETED|Induction Phase||0
10294664|NCT03203473|11427406|FG000|NOT COMPLETED|Induction Phase||16
10294665|NCT03203473|11427407|FG001|NOT COMPLETED|Induction Phase||0
10294666|NCT03203473|11427408|FG002|NOT COMPLETED|Induction Phase||0
10294667|NCT03203473|11427406|FG000|STARTED|Arm Allocation Phase||0
10294668|NCT03203473|11427407|FG001|STARTED|Arm Allocation Phase||12
10294669|NCT03203473|11427408|FG002|STARTED|Arm Allocation Phase||57
10294670|NCT03203473|11427406|FG000|COMPLETED|Arm Allocation Phase||0
10294671|NCT03203473|11427407|FG001|COMPLETED|Arm Allocation Phase||0
10294672|NCT03203473|11427408|FG002|COMPLETED|Arm Allocation Phase||0
10294673|NCT03203473|11427406|FG000|NOT COMPLETED|Arm Allocation Phase||0
10294674|NCT03203473|11427407|FG001|NOT COMPLETED|Arm Allocation Phase||12
10294675|NCT03203473|11427408|FG002|NOT COMPLETED|Arm Allocation Phase||57
10294676|NCT03180736|11427421|FG000|STARTED|Overall Study||151
10294677|NCT03180736|11427422|FG001|STARTED|Overall Study||153
10294678|NCT03180736|11427421|FG000|Treated|Overall Study||149
10294679|NCT03180736|11427422|FG001|Treated|Overall Study||150
10294680|NCT03180736|11427421|FG000|COMPLETED|Overall Study||60
10294681|NCT03180736|11427422|FG001|COMPLETED|Overall Study||33
10294682|NCT03180736|11427421|FG000|NOT COMPLETED|Overall Study||91
10294683|NCT03180736|11427422|FG001|NOT COMPLETED|Overall Study||120
10294684|NCT03051659|11427435|FG000|STARTED|Treatment Period||44
10294685|NCT03051659|11427436|FG001|STARTED|Treatment Period||46
10294686|NCT03051659|11427435|FG000|COMPLETED|Treatment Period||44
10294687|NCT03051659|11427436|FG001|COMPLETED|Treatment Period||44
10294688|NCT03051659|11427435|FG000|NOT COMPLETED|Treatment Period||0
10294689|NCT03051659|11427436|FG001|NOT COMPLETED|Treatment Period||2
10294690|NCT03051659|11427435|FG000|STARTED|Survival Follow-up||44
10294691|NCT03051659|11427436|FG001|STARTED|Survival Follow-up||44
10294692|NCT03051659|11427435|FG000|COMPLETED|Survival Follow-up||21
10294693|NCT03051659|11427436|FG001|COMPLETED|Survival Follow-up||22
10294694|NCT03051659|11427435|FG000|NOT COMPLETED|Survival Follow-up||23
10294695|NCT03051659|11427436|FG001|NOT COMPLETED|Survival Follow-up||22
10294696|NCT03048552|11427446|FG000|STARTED|Overall Study||4
10294697|NCT03048552|11427447|FG001|STARTED|Overall Study||18
10294698|NCT03048552|11427448|FG002|STARTED|Overall Study||4
10294699|NCT03048552|11427449|FG003|STARTED|Overall Study|Fewer caregivers were enrolled in Family CONNECT arm than youth as 2 caregivers had multiple children in the Family CONNECT arm: one caregiver had n=2 children and 1 caregiver had n=3 children.|15
10867512|NCT00533949|12032729|FG000|STARTED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|166
10867513|NCT00533949|12032730|FG001|STARTED|Overall Study||121
10867514|NCT00533949|12032731|FG002|STARTED|Overall Study||147
10867515|NCT00533949|12032732|FG003|STARTED|Overall Study||110
10867516|NCT00533949|12032729|FG000|COMPLETED|Overall Study||151
10867517|NCT00533949|12032730|FG001|COMPLETED|Overall Study||107
10867518|NCT00533949|12032731|FG002|COMPLETED|Overall Study||137
10867519|NCT00533949|12032732|FG003|COMPLETED|Overall Study||100
10867520|NCT00533949|12032729|FG000|NOT COMPLETED|Overall Study||15
10867521|NCT00533949|12032730|FG001|NOT COMPLETED|Overall Study||14
10867522|NCT00533949|12032731|FG002|NOT COMPLETED|Overall Study||10
10867523|NCT00533949|12032732|FG003|NOT COMPLETED|Overall Study||10
10867524|NCT00529763|12032753|FG000|STARTED|Overall Study||25
10867525|NCT00529763|12032754|FG001|STARTED|Overall Study|38 participants were enrolled; 37 were treated in this cohort|37
10867526|NCT00529763|12032755|FG002|STARTED|Overall Study||59
10867527|NCT00529763|12032753|FG000|COMPLETED|Overall Study|15 participants still on treatment; not completed = off treatment (n=10)|15
10867528|NCT00529763|12032754|FG001|COMPLETED|Overall Study|4 participants still on treatment; not completed = off treatment (n=33)|4
10867529|NCT00529763|12032755|FG002|COMPLETED|Overall Study|52 participants still on treatment; not completed = off treatment (n=7)|52
10867530|NCT00529763|12032753|FG000|NOT COMPLETED|Overall Study||10
10867531|NCT00529763|12032754|FG001|NOT COMPLETED|Overall Study||33
10867532|NCT00529763|12032755|FG002|NOT COMPLETED|Overall Study||7
10867533|NCT00479765|12032770|FG000|STARTED|Overall Study||4
10867534|NCT00479765|12032770|FG000|COMPLETED|Overall Study||0
10867535|NCT00479765|12032770|FG000|NOT COMPLETED|Overall Study||4
10867536|NCT00450411|12032774|FG000|STARTED|Overall Study||100
10867537|NCT00450411|12032774|FG000|Eligible and Started Protocol Treatment|Overall Study||92
10867538|NCT00450411|12032774|FG000|COMPLETED|Overall Study||92
10867539|NCT00450411|12032774|FG000|NOT COMPLETED|Overall Study||8
10867540|NCT00412880|12032778|FG000|STARTED|Overall Study||23
10867541|NCT00412880|12032778|FG000|COMPLETED|Overall Study||0
10867542|NCT00412880|12032778|FG000|NOT COMPLETED|Overall Study||23
10867543|NCT00376623|12032785|FG000|STARTED|Overall Study||49
10867544|NCT00376623|12032786|FG001|STARTED|Overall Study||26
10867545|NCT00376623|12032787|FG002|STARTED|Overall Study||21
10867546|NCT00376623|12032785|FG000|Treated With BI 2536|Overall Study||48
10867547|NCT00376623|12032786|FG001|Treated With BI 2536|Overall Study||26
10867548|NCT00376623|12032787|FG002|Treated With BI 2536|Overall Study||21
10867549|NCT00376623|12032785|FG000|COMPLETED|Overall Study||0
10867550|NCT00376623|12032786|FG001|COMPLETED|Overall Study||0
10867551|NCT00376623|12032787|FG002|COMPLETED|Overall Study||0
10867552|NCT00376623|12032785|FG000|NOT COMPLETED|Overall Study||49
10867553|NCT00376623|12032786|FG001|NOT COMPLETED|Overall Study||26
10867554|NCT00376623|12032787|FG002|NOT COMPLETED|Overall Study||21
10867555|NCT00288080|12032803|FG000|STARTED|Overall Study||307
10867556|NCT00288080|12032804|FG001|STARTED|Overall Study||305
10867557|NCT00288080|12032803|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|281
10867558|NCT00288080|12032804|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|282
10867559|NCT00288080|12032803|FG000|NOT COMPLETED|Overall Study||26
10867560|NCT00288080|12032804|FG001|NOT COMPLETED|Overall Study||23
10867561|NCT00194714|12032810|FG000|STARTED|Overall Study|Number of patients consented|22
10867562|NCT00194714|12032810|FG000|COMPLETED|Overall Study|Number of patients that received study treatment with the study vaccine|21
10867563|NCT00194714|12032810|FG000|NOT COMPLETED|Overall Study||1
10418236|NCT00804687|11562874|FG002|COMPLETED|Period 4: Washout Period||9
10418237|NCT00804687|11562875|FG003|COMPLETED|Period 4: Washout Period||8
10867570|NCT02878785|12032823|FG000|STARTED|Overall Study||3
10867571|NCT02878785|12032824|FG001|STARTED|Overall Study||0
10867572|NCT02878785|12032825|FG002|STARTED|Overall Study||0
10867573|NCT02878785|12032826|FG003|STARTED|Overall Study||0
10867574|NCT02878785|12032827|FG004|STARTED|Overall Study||0
10867575|NCT02878785|12032828|FG005|STARTED|Overall Study||0
10867576|NCT02878785|12032829|FG006|STARTED|Overall Study||0
10867577|NCT02878785|12032830|FG007|STARTED|Overall Study||0
10867578|NCT02878785|12032831|FG008|STARTED|Overall Study||3
10867579|NCT02878785|12032832|FG009|STARTED|Overall Study||7
10418238|NCT00804687|11562876|FG004|COMPLETED|Period 4: Washout Period||9
10418239|NCT00804687|11562877|FG005|COMPLETED|Period 4: Washout Period||8
10418240|NCT00804687|11562872|FG000|NOT COMPLETED|Period 4: Washout Period||0
10418241|NCT00804687|11562873|FG001|NOT COMPLETED|Period 4: Washout Period||0
10418242|NCT00804687|11562874|FG002|NOT COMPLETED|Period 4: Washout Period||0
10418243|NCT00804687|11562875|FG003|NOT COMPLETED|Period 4: Washout Period||0
10418244|NCT00804687|11562876|FG004|NOT COMPLETED|Period 4: Washout Period||0
10418245|NCT00804687|11562877|FG005|NOT COMPLETED|Period 4: Washout Period||0
10418246|NCT00804687|11562872|FG000|STARTED|Period 5: Treatment Period||9
10418247|NCT00804687|11562873|FG001|STARTED|Period 5: Treatment Period||9
10418248|NCT00804687|11562874|FG002|STARTED|Period 5: Treatment Period||9
10418249|NCT00804687|11562875|FG003|STARTED|Period 5: Treatment Period||8
10418250|NCT00804687|11562876|FG004|STARTED|Period 5: Treatment Period||9
10418251|NCT00804687|11562877|FG005|STARTED|Period 5: Treatment Period||8
10418252|NCT00804687|11562872|FG000|COMPLETED|Period 5: Treatment Period||8
10418253|NCT00804687|11562873|FG001|COMPLETED|Period 5: Treatment Period||9
10418254|NCT00804687|11562874|FG002|COMPLETED|Period 5: Treatment Period||8
10418255|NCT00804687|11562875|FG003|COMPLETED|Period 5: Treatment Period||8
10418256|NCT00804687|11562876|FG004|COMPLETED|Period 5: Treatment Period||8
10418257|NCT00804687|11562877|FG005|COMPLETED|Period 5: Treatment Period||8
10418258|NCT00804687|11562872|FG000|NOT COMPLETED|Period 5: Treatment Period||1
10418259|NCT00804687|11562873|FG001|NOT COMPLETED|Period 5: Treatment Period||0
10418260|NCT00804687|11562874|FG002|NOT COMPLETED|Period 5: Treatment Period||1
10418261|NCT00804687|11562875|FG003|NOT COMPLETED|Period 5: Treatment Period||0
10418262|NCT00804687|11562876|FG004|NOT COMPLETED|Period 5: Treatment Period||1
10418263|NCT00804687|11562877|FG005|NOT COMPLETED|Period 5: Treatment Period||0
10418264|NCT00804843|11562887|FG000|STARTED|Overall Study||50
10418265|NCT00804843|11562888|FG001|STARTED|Overall Study||50
10418266|NCT00804843|11562887|FG000|COMPLETED|Overall Study||40
10418267|NCT00804843|11562888|FG001|COMPLETED|Overall Study||43
10418268|NCT00804843|11562887|FG000|NOT COMPLETED|Overall Study||10
10418269|NCT00804843|11562888|FG001|NOT COMPLETED|Overall Study||7
10418270|NCT00804908|11562898|FG000|STARTED|Overall Study||115
10418271|NCT00804908|11562899|FG001|STARTED|Overall Study||116
10418272|NCT00804908|11562900|FG002|STARTED|Overall Study||115
10418273|NCT00804908|11562898|FG000|COMPLETED|Overall Study||0
10418274|NCT00804908|11562899|FG001|COMPLETED|Overall Study||0
10418275|NCT00804908|11562900|FG002|COMPLETED|Overall Study||1
10418276|NCT00804908|11562898|FG000|NOT COMPLETED|Overall Study||115
10418277|NCT00804908|11562899|FG001|NOT COMPLETED|Overall Study||116
10418278|NCT00804908|11562900|FG002|NOT COMPLETED|Overall Study||114
10418279|NCT00804973|11562911|FG000|STARTED|Overall Study||40
10418280|NCT00804973|11562912|FG001|STARTED|Overall Study||40
10418281|NCT00804973|11562913|FG002|STARTED|Overall Study||40
10418282|NCT00804973|11562911|FG000|Received at Least 1 Dose of Study Drug|Overall Study||40
10418283|NCT00804973|11562912|FG001|Received at Least 1 Dose of Study Drug|Overall Study||40
10418284|NCT00804973|11562913|FG002|Received at Least 1 Dose of Study Drug|Overall Study||40
10418285|NCT00804973|11562911|FG000|COMPLETED|Overall Study||40
10418286|NCT00804973|11562912|FG001|COMPLETED|Overall Study||40
10418287|NCT00804973|11562913|FG002|COMPLETED|Overall Study||40
10418288|NCT00804973|11562911|FG000|NOT COMPLETED|Overall Study||0
10418289|NCT00804973|11562912|FG001|NOT COMPLETED|Overall Study||0
10418290|NCT00804973|11562913|FG002|NOT COMPLETED|Overall Study||0
10418291|NCT00804986|11562927|FG000|STARTED|Overall Study||36
10418292|NCT00804986|11562928|FG001|STARTED|Overall Study||43
10418293|NCT00804986|11562929|FG002|STARTED|Overall Study||42
10418294|NCT00804986|11562930|FG003|STARTED|Overall Study||42
10418295|NCT00804986|11562931|FG004|STARTED|Overall Study||43
10418296|NCT00804986|11562932|FG005|STARTED|Overall Study||41
10418297|NCT00804986|11562927|FG000|COMPLETED|Overall Study||35
10418298|NCT00804986|11562928|FG001|COMPLETED|Overall Study||35
10418299|NCT00804986|11562929|FG002|COMPLETED|Overall Study||40
10418300|NCT00804986|11562930|FG003|COMPLETED|Overall Study||34
10418301|NCT00804986|11562931|FG004|COMPLETED|Overall Study||34
10418302|NCT00804986|11562932|FG005|COMPLETED|Overall Study||31
10418303|NCT00804986|11562927|FG000|NOT COMPLETED|Overall Study||1
10418304|NCT00804986|11562928|FG001|NOT COMPLETED|Overall Study||8
10418305|NCT00804986|11562929|FG002|NOT COMPLETED|Overall Study||2
10418306|NCT00804986|11562930|FG003|NOT COMPLETED|Overall Study||8
10418307|NCT00804986|11562931|FG004|NOT COMPLETED|Overall Study||9
10418308|NCT00804986|11562932|FG005|NOT COMPLETED|Overall Study||10
10418309|NCT00804999|11562950|FG000|STARTED|Overall Study||15
10418310|NCT00804999|11562951|FG001|STARTED|Overall Study||12
10418311|NCT00804999|11562952|FG002|STARTED|Overall Study||14
10867580|NCT02878785|12032833|FG010|STARTED|Overall Study||3
10418312|NCT00804999|11562953|FG003|STARTED|Overall Study||10
10418313|NCT00804999|11562950|FG000|COMPLETED|Overall Study||15
10418314|NCT00804999|11562951|FG001|COMPLETED|Overall Study||12
10867581|NCT02878785|12032834|FG011|STARTED|Overall Study||3
10867582|NCT02878785|12032835|FG012|STARTED|Overall Study||3
10867583|NCT02878785|12032836|FG013|STARTED|Overall Study||3
10867584|NCT02878785|12032823|FG000|COMPLETED|Overall Study||3
10867585|NCT02878785|12032824|FG001|COMPLETED|Overall Study||0
10867586|NCT02878785|12032825|FG002|COMPLETED|Overall Study||0
10867587|NCT02878785|12032826|FG003|COMPLETED|Overall Study||0
10867588|NCT02878785|12032827|FG004|COMPLETED|Overall Study||0
10867589|NCT02878785|12032828|FG005|COMPLETED|Overall Study||0
10867590|NCT02878785|12032829|FG006|COMPLETED|Overall Study||0
10867591|NCT02878785|12032830|FG007|COMPLETED|Overall Study||0
10867592|NCT02878785|12032831|FG008|COMPLETED|Overall Study||3
10867593|NCT02878785|12032832|FG009|COMPLETED|Overall Study||7
10867594|NCT02878785|12032833|FG010|COMPLETED|Overall Study||3
10867595|NCT02878785|12032834|FG011|COMPLETED|Overall Study||3
10867596|NCT02878785|12032835|FG012|COMPLETED|Overall Study||3
10867597|NCT02878785|12032836|FG013|COMPLETED|Overall Study||3
10867598|NCT02878785|12032823|FG000|NOT COMPLETED|Overall Study||0
10867599|NCT02878785|12032824|FG001|NOT COMPLETED|Overall Study||0
10867600|NCT02878785|12032825|FG002|NOT COMPLETED|Overall Study||0
10867601|NCT02878785|12032826|FG003|NOT COMPLETED|Overall Study||0
10867602|NCT02878785|12032827|FG004|NOT COMPLETED|Overall Study||0
10867603|NCT02878785|12032828|FG005|NOT COMPLETED|Overall Study||0
10867604|NCT02878785|12032829|FG006|NOT COMPLETED|Overall Study||0
10867605|NCT02878785|12032830|FG007|NOT COMPLETED|Overall Study||0
10867606|NCT02878785|12032831|FG008|NOT COMPLETED|Overall Study||0
10867607|NCT02878785|12032832|FG009|NOT COMPLETED|Overall Study||0
10867608|NCT02878785|12032833|FG010|NOT COMPLETED|Overall Study||0
10867609|NCT02878785|12032834|FG011|NOT COMPLETED|Overall Study||0
10867610|NCT02878785|12032835|FG012|NOT COMPLETED|Overall Study||0
10867611|NCT02878785|12032836|FG013|NOT COMPLETED|Overall Study||0
10867612|NCT04794270|12032853|FG000|STARTED|Period 1||35
10867613|NCT04794270|12032854|FG001|STARTED|Period 1||36
10867614|NCT04794270|12032853|FG000|COMPLETED|Period 1||33
10867615|NCT04794270|12032854|FG001|COMPLETED|Period 1||36
10867616|NCT04794270|12032853|FG000|NOT COMPLETED|Period 1||2
10867617|NCT04794270|12032854|FG001|NOT COMPLETED|Period 1||0
10867618|NCT04794270|12032853|FG000|STARTED|Period 2||33
10867619|NCT04794270|12032854|FG001|STARTED|Period 2||36
10867620|NCT04794270|12032853|FG000|COMPLETED|Period 2||32
10867621|NCT04794270|12032854|FG001|COMPLETED|Period 2||36
10294700|NCT03048552|11427446|FG000|COMPLETED|Overall Study||4
10294701|NCT03048552|11427447|FG001|COMPLETED|Overall Study||18
10294702|NCT03048552|11427448|FG002|COMPLETED|Overall Study||4
10294703|NCT03048552|11427449|FG003|COMPLETED|Overall Study||15
10294704|NCT03048552|11427446|FG000|NOT COMPLETED|Overall Study||0
10294705|NCT03048552|11427447|FG001|NOT COMPLETED|Overall Study||0
10294706|NCT03048552|11427448|FG002|NOT COMPLETED|Overall Study||0
10294707|NCT03048552|11427449|FG003|NOT COMPLETED|Overall Study||0
10867622|NCT04794270|12032853|FG000|NOT COMPLETED|Period 2||1
10867623|NCT04794270|12032854|FG001|NOT COMPLETED|Period 2||0
10867624|NCT04701814|12032862|FG000|STARTED|Overall Study||20
10294711|NCT02886884|11427467|FG000|STARTED|Treatment||3
10294712|NCT02886884|11427468|FG001|STARTED|Treatment||3
10294713|NCT02886884|11427469|FG002|STARTED|Treatment||5
10294714|NCT02886884|11427470|FG003|STARTED|Treatment||5
10294715|NCT02886884|11427467|FG000|COMPLETED|Treatment||3
10294716|NCT02886884|11427468|FG001|COMPLETED|Treatment||3
10294717|NCT02886884|11427469|FG002|COMPLETED|Treatment||5
10294718|NCT02886884|11427470|FG003|COMPLETED|Treatment||5
10294719|NCT02886884|11427467|FG000|NOT COMPLETED|Treatment||0
10294720|NCT02886884|11427468|FG001|NOT COMPLETED|Treatment||0
10294721|NCT02886884|11427469|FG002|NOT COMPLETED|Treatment||0
10294722|NCT02886884|11427470|FG003|NOT COMPLETED|Treatment||0
10294723|NCT02886884|11427467|FG000|STARTED|Follow-up||3
10294724|NCT02886884|11427468|FG001|STARTED|Follow-up||3
10294725|NCT02886884|11427469|FG002|STARTED|Follow-up||5
10294726|NCT02886884|11427470|FG003|STARTED|Follow-up||5
10294727|NCT02886884|11427467|FG000|COMPLETED|Follow-up||3
10294728|NCT02886884|11427468|FG001|COMPLETED|Follow-up||3
10294729|NCT02886884|11427469|FG002|COMPLETED|Follow-up||5
10294730|NCT02886884|11427470|FG003|COMPLETED|Follow-up||4
10294731|NCT02886884|11427467|FG000|NOT COMPLETED|Follow-up||0
10294732|NCT02886884|11427468|FG001|NOT COMPLETED|Follow-up||0
10294733|NCT02886884|11427469|FG002|NOT COMPLETED|Follow-up||0
10294734|NCT02886884|11427470|FG003|NOT COMPLETED|Follow-up||1
10294735|NCT02845453|11427482|FG000|STARTED|Overall Study||13
10294736|NCT02845453|11427483|FG001|STARTED|Overall Study||11
10294737|NCT02845453|11427482|FG000|Took One Dose of Study Medication|Overall Study||11
10294738|NCT02845453|11427483|FG001|Took One Dose of Study Medication|Overall Study||10
10294739|NCT02845453|11427482|FG000|Took One Week of Study Medication|Overall Study||10
10294740|NCT02845453|11427483|FG001|Took One Week of Study Medication|Overall Study||9
10294741|NCT02845453|11427482|FG000|COMPLETED|Overall Study||7
10294742|NCT02845453|11427483|FG001|COMPLETED|Overall Study||6
10294743|NCT02845453|11427482|FG000|NOT COMPLETED|Overall Study||6
10294744|NCT02845453|11427483|FG001|NOT COMPLETED|Overall Study||5
10294745|NCT02739542|11427491|FG000|STARTED|Overall Study||44
10294746|NCT02739542|11427492|FG001|STARTED|Overall Study||43
10294747|NCT02739542|11427491|FG000|COMPLETED|Overall Study||30
10294748|NCT02739542|11427492|FG001|COMPLETED|Overall Study||29
10418315|NCT00804999|11562952|FG002|COMPLETED|Overall Study||14
10418316|NCT00804999|11562953|FG003|COMPLETED|Overall Study||10
10418317|NCT00804999|11562950|FG000|NOT COMPLETED|Overall Study||0
10418318|NCT00804999|11562951|FG001|NOT COMPLETED|Overall Study||0
10418319|NCT00804999|11562952|FG002|NOT COMPLETED|Overall Study||0
10294749|NCT02739542|11427491|FG000|NOT COMPLETED|Overall Study||14
10294750|NCT02739542|11427492|FG001|NOT COMPLETED|Overall Study||14
10294751|NCT02717832|11427498|FG000|STARTED|Overall Study||20
10294752|NCT02717832|11427498|FG000|COMPLETED|Overall Study||17
10294753|NCT02717832|11427498|FG000|NOT COMPLETED|Overall Study||3
10294754|NCT02677324|11427503|FG000|STARTED|Overall Study||33
10294755|NCT02677324|11427503|FG000|COMPLETED|Overall Study||21
10294756|NCT02677324|11427503|FG000|NOT COMPLETED|Overall Study||12
10294757|NCT02563028|11427509|FG000|STARTED|Overall Study||20
10294758|NCT02563028|11427509|FG000|COMPLETED|Overall Study||18
10294759|NCT02563028|11427509|FG000|NOT COMPLETED|Overall Study||2
10545879|NCT01500317|11699403|FG000|STARTED|Overall Study||13
10545880|NCT01500317|11699404|FG001|STARTED|Overall Study||12
10867625|NCT04701814|12032863|FG001|STARTED|Overall Study||18
10867626|NCT04701814|12032862|FG000|COMPLETED|Overall Study||15
10867627|NCT04701814|12032863|FG001|COMPLETED|Overall Study||15
10867628|NCT04701814|12032862|FG000|NOT COMPLETED|Overall Study||5
10867629|NCT04701814|12032863|FG001|NOT COMPLETED|Overall Study||3
10867636|NCT04394286|12032883|FG000|STARTED|Overall Study||0
10867637|NCT04394286|12032884|FG001|STARTED|Overall Study||0
10867638|NCT04394286|12032885|FG002|STARTED|Overall Study||0
10867639|NCT04394286|12032883|FG000|COMPLETED|Overall Study||0
10867640|NCT04394286|12032884|FG001|COMPLETED|Overall Study||0
10867641|NCT04394286|12032885|FG002|COMPLETED|Overall Study||0
10867642|NCT04394286|12032883|FG000|NOT COMPLETED|Overall Study||0
10867643|NCT04394286|12032884|FG001|NOT COMPLETED|Overall Study||0
10867644|NCT04394286|12032885|FG002|NOT COMPLETED|Overall Study||0
10867645|NCT04327986|12032893|FG000|STARTED|Overall Study||3
10867646|NCT04327986|12032894|FG001|STARTED|Overall Study||0
10867647|NCT04327986|12032895|FG002|STARTED|Overall Study||0
10867648|NCT04327986|12032893|FG000|COMPLETED|Overall Study||0
10867649|NCT04327986|12032894|FG001|COMPLETED|Overall Study||0
10867650|NCT04327986|12032895|FG002|COMPLETED|Overall Study||0
10867651|NCT04327986|12032893|FG000|NOT COMPLETED|Overall Study||3
10867652|NCT04327986|12032894|FG001|NOT COMPLETED|Overall Study||0
10867653|NCT04327986|12032895|FG002|NOT COMPLETED|Overall Study||0
10867654|NCT04067843|12032901|FG000|STARTED|Overall Study||10
10867655|NCT04067843|12032902|FG001|STARTED|Overall Study||10
10867656|NCT04067843|12032901|FG000|COMPLETED|Overall Study||10
10867657|NCT04067843|12032902|FG001|COMPLETED|Overall Study||10
10867658|NCT04067843|12032901|FG000|NOT COMPLETED|Overall Study||0
10867659|NCT04067843|12032902|FG001|NOT COMPLETED|Overall Study||0
10867660|NCT04066738|12032910|FG000|STARTED|Overall Study||2
10867661|NCT04066738|12032910|FG000|COMPLETED|Overall Study||2
10867662|NCT04066738|12032910|FG000|NOT COMPLETED|Overall Study||0
10867663|NCT03933020|12032914|FG000|STARTED|Overall Study||0
10867664|NCT03933020|12032914|FG000|Received an Intervention|Overall Study||0
10867665|NCT03933020|12032914|FG000|COMPLETED|Overall Study||0
10867666|NCT03933020|12032914|FG000|NOT COMPLETED|Overall Study||0
10867667|NCT03793608|12032920|FG000|STARTED|Overall Study||1
10867668|NCT03793608|12032921|FG001|STARTED|Overall Study||24
10867669|NCT03793608|12032920|FG000|Treated|Overall Study||1
10867670|NCT03793608|12032921|FG001|Treated|Overall Study||24
10867671|NCT03793608|12032920|FG000|Safety Analysis Set (SAF)|Overall Study|1 participant randomized to placebo was not analyzed and thus excluded from analyses.|0
10867672|NCT03793608|12032921|FG001|Safety Analysis Set (SAF)|Overall Study||24
10867673|NCT03793608|12032920|FG000|COMPLETED|Overall Study||1
10867674|NCT03793608|12032921|FG001|COMPLETED|Overall Study||24
10867675|NCT03793608|12032920|FG000|NOT COMPLETED|Overall Study||0
10867676|NCT03793608|12032921|FG001|NOT COMPLETED|Overall Study||0
10867677|NCT03655054|12032926|FG000|STARTED|Overall Study||23
10867678|NCT03655054|12032926|FG000|COMPLETED|Overall Study||22
10867679|NCT03655054|12032926|FG000|NOT COMPLETED|Overall Study||1
10867680|NCT03601117|12032932|FG000|STARTED|Overall Study||20
10867681|NCT03601117|12032933|FG001|STARTED|Overall Study||2
10867682|NCT03601117|12032932|FG000|COMPLETED|Overall Study||17
10867683|NCT03601117|12032933|FG001|COMPLETED|Overall Study||1
10867684|NCT03601117|12032932|FG000|NOT COMPLETED|Overall Study||3
10867685|NCT03601117|12032933|FG001|NOT COMPLETED|Overall Study||1
10867686|NCT03542266|12032941|FG000|STARTED|Treatment Phase||21
10867687|NCT03542266|12032941|FG000|COMPLETED|Treatment Phase||18
10867688|NCT03542266|12032941|FG000|NOT COMPLETED|Treatment Phase||3
10867689|NCT03542266|12032941|FG000|STARTED|Post-treatment Follow-up Phase|Three subjects did not enter follow-up: 1 had PD at EOT, 2 withdrew consent|15
10867690|NCT03542266|12032941|FG000|COMPLETED|Post-treatment Follow-up Phase||0
10867691|NCT03542266|12032941|FG000|NOT COMPLETED|Post-treatment Follow-up Phase||15
10867692|NCT03529409|12032948|FG000|STARTED|Randomized||30
10867693|NCT03529409|12032949|FG001|STARTED|Randomized||31
10867694|NCT03529409|12032950|FG002|STARTED|Randomized||5
10867695|NCT03529409|12032948|FG000|COMPLETED|Randomized||30
10867696|NCT03529409|12032949|FG001|COMPLETED|Randomized||31
10867697|NCT03529409|12032950|FG002|COMPLETED|Randomized||0
10867698|NCT03529409|12032948|FG000|NOT COMPLETED|Randomized||0
10867699|NCT03529409|12032949|FG001|NOT COMPLETED|Randomized||0
10867700|NCT03529409|12032950|FG002|NOT COMPLETED|Randomized||5
10867701|NCT03529409|12032948|FG000|STARTED|Post-treatment Assessment||30
10867702|NCT03529409|12032949|FG001|STARTED|Post-treatment Assessment||31
10867703|NCT03529409|12032950|FG002|STARTED|Post-treatment Assessment||0
10867704|NCT03529409|12032948|FG000|COMPLETED|Post-treatment Assessment||26
10867705|NCT03529409|12032949|FG001|COMPLETED|Post-treatment Assessment||26
10867706|NCT03529409|12032950|FG002|COMPLETED|Post-treatment Assessment||0
10867707|NCT03529409|12032948|FG000|NOT COMPLETED|Post-treatment Assessment||4
10867708|NCT03529409|12032949|FG001|NOT COMPLETED|Post-treatment Assessment||5
10867709|NCT03529409|12032950|FG002|NOT COMPLETED|Post-treatment Assessment||0
10867710|NCT03529409|12032948|FG000|STARTED|Follow-up Assessment|All participants were eligible for Follow-Up regardless of Post-Treatment attendance.|28
10867711|NCT03529409|12032949|FG001|STARTED|Follow-up Assessment|All participants (n=31) were eligible for Follow-Up regardless of Post-Treatment attendance|30
10867712|NCT03529409|12032950|FG002|STARTED|Follow-up Assessment||0
10867713|NCT03529409|12032948|FG000|COMPLETED|Follow-up Assessment||27
10867714|NCT03529409|12032949|FG001|COMPLETED|Follow-up Assessment||29
10867715|NCT03529409|12032950|FG002|COMPLETED|Follow-up Assessment||0
10867716|NCT03529409|12032948|FG000|NOT COMPLETED|Follow-up Assessment||1
10867717|NCT03529409|12032949|FG001|NOT COMPLETED|Follow-up Assessment||1
10867718|NCT03529409|12032950|FG002|NOT COMPLETED|Follow-up Assessment||0
10867719|NCT03516812|12032957|FG000|STARTED|Overall Study||36
10867720|NCT03516812|12032957|FG000|COMPLETED|Overall Study||30
10867721|NCT03516812|12032957|FG000|NOT COMPLETED|Overall Study||6
10867722|NCT03477396|12032961|FG000|STARTED|Overall Study||2
10867723|NCT03477396|12032961|FG000|COMPLETED|Overall Study||2
10867724|NCT03477396|12032961|FG000|NOT COMPLETED|Overall Study||0
10867725|NCT03463577|12032971|FG000|STARTED|Overall Study||16606
10867726|NCT03463577|12032972|FG001|STARTED|Overall Study||16606
10867727|NCT03463577|12032973|FG002|STARTED|Overall Study||65
10867728|NCT03463577|12032974|FG003|STARTED|Overall Study||16350
10867729|NCT03463577|12032975|FG004|STARTED|Overall Study||16088
10867730|NCT03463577|12032976|FG005|STARTED|Overall Study||68
10867731|NCT03463577|12032971|FG000|COMPLETED|Overall Study||16366
10867732|NCT03463577|12032972|FG001|COMPLETED|Overall Study||16166
10867733|NCT03463577|12032973|FG002|COMPLETED|Overall Study||65
10867734|NCT03463577|12032974|FG003|COMPLETED|Overall Study||16335
10867735|NCT03463577|12032975|FG004|COMPLETED|Overall Study||16071
10867736|NCT03463577|12032976|FG005|COMPLETED|Overall Study||68
10867737|NCT03463577|12032971|FG000|NOT COMPLETED|Overall Study||240
10867738|NCT03463577|12032972|FG001|NOT COMPLETED|Overall Study||440
10867739|NCT03463577|12032973|FG002|NOT COMPLETED|Overall Study||0
10867740|NCT03463577|12032974|FG003|NOT COMPLETED|Overall Study||15
10867741|NCT03463577|12032975|FG004|NOT COMPLETED|Overall Study||17
10867742|NCT03463577|12032976|FG005|NOT COMPLETED|Overall Study||0
10867743|NCT03373760|12032992|FG000|STARTED|Overall Study||58
10867744|NCT03373760|12032992|FG000|COMPLETED|Overall Study||0
10867745|NCT03373760|12032992|FG000|NOT COMPLETED|Overall Study||58
10867746|NCT03253627|12033001|FG000|STARTED|Overall Study||12
10867747|NCT03253627|12033002|FG001|STARTED|Overall Study||11
10867748|NCT03253627|12033001|FG000|Post-intervention|Overall Study||11
10867749|NCT03253627|12033002|FG001|Post-intervention|Overall Study||9
10867750|NCT03253627|12033001|FG000|COMPLETED|Overall Study||10
10867751|NCT03253627|12033002|FG001|COMPLETED|Overall Study||7
10867752|NCT03253627|12033001|FG000|NOT COMPLETED|Overall Study||2
10867753|NCT03253627|12033002|FG001|NOT COMPLETED|Overall Study||4
10867754|NCT03168555|12033008|FG000|STARTED|Visit 1 (Pro-operative)||23
10867755|NCT03168555|12033008|FG000|COMPLETED|Visit 1 (Pro-operative)||22
10867756|NCT03168555|12033008|FG000|NOT COMPLETED|Visit 1 (Pro-operative)||1
10867757|NCT03168555|12033008|FG000|STARTED|Visit 2 (Post-operative)||22
10867758|NCT03168555|12033008|FG000|COMPLETED|Visit 2 (Post-operative)||18
10867759|NCT03168555|12033008|FG000|NOT COMPLETED|Visit 2 (Post-operative)||4
10867760|NCT03135119|12033017|FG000|STARTED|Overall Study||16
10867761|NCT03135119|12033018|FG001|STARTED|Overall Study||17
10867762|NCT03135119|12033017|FG000|COMPLETED|Overall Study||11
10867763|NCT03135119|12033018|FG001|COMPLETED|Overall Study||14
10867764|NCT03135119|12033017|FG000|NOT COMPLETED|Overall Study||5
10867765|NCT03135119|12033018|FG001|NOT COMPLETED|Overall Study||3
10867766|NCT03128411|12033024|FG000|STARTED|Treatment Phase||60
10418320|NCT00804999|11562953|FG003|NOT COMPLETED|Overall Study||0
10418321|NCT00805025|11562963|FG000|STARTED|Overall Study||131
10418322|NCT00805025|11562963|FG000|Enrolled and Treated|Overall Study||89
10418323|NCT00805025|11562963|FG000|COMPLETED|Overall Study||82
10418324|NCT00805025|11562963|FG000|NOT COMPLETED|Overall Study||49
10418325|NCT00805038|11562969|FG000|STARTED|Overall Study||75
10418326|NCT00805038|11562970|FG001|STARTED|Overall Study||92
10418327|NCT00805038|11562969|FG000|COMPLETED|Overall Study||75
10418328|NCT00805038|11562970|FG001|COMPLETED|Overall Study||92
10418329|NCT00805038|11562969|FG000|NOT COMPLETED|Overall Study||0
10418330|NCT00805038|11562970|FG001|NOT COMPLETED|Overall Study||0
10418331|NCT00805142|11562978|FG000|STARTED|Titration Period||36
10418332|NCT00805142|11562979|FG001|STARTED|Titration Period||42
10418333|NCT00805142|11562978|FG000|COMPLETED|Titration Period||30
10418334|NCT00805142|11562979|FG001|COMPLETED|Titration Period||32
10418335|NCT00805142|11562978|FG000|NOT COMPLETED|Titration Period||6
10418336|NCT00805142|11562979|FG001|NOT COMPLETED|Titration Period||10
10418337|NCT00805142|11562978|FG000|STARTED|Maintenance Period||30
10418338|NCT00805142|11562979|FG001|STARTED|Maintenance Period||32
10418339|NCT00805142|11562978|FG000|COMPLETED|Maintenance Period||30
10418340|NCT00805142|11562979|FG001|COMPLETED|Maintenance Period||30
10418341|NCT00805142|11562978|FG000|NOT COMPLETED|Maintenance Period||0
10418342|NCT00805142|11562979|FG001|NOT COMPLETED|Maintenance Period||2
10418343|NCT00805194|11562994|FG000|STARTED|Overall Study|randomised patients|655
10418344|NCT00805194|11562995|FG001|STARTED|Overall Study|randomised patients|659
10418345|NCT00805194|11562994|FG000|COMPLETED|Overall Study||6
10418346|NCT00805194|11562995|FG001|COMPLETED|Overall Study||5
10418347|NCT00805194|11562994|FG000|NOT COMPLETED|Overall Study||649
10418348|NCT00805194|11562995|FG001|NOT COMPLETED|Overall Study||654
10418349|NCT00805207|11563015|FG000|STARTED|Overall Study||1
10418350|NCT00805207|11563016|FG001|STARTED|Overall Study||9
10418351|NCT00805207|11563017|FG002|STARTED|Overall Study||12
10418352|NCT00805207|11563018|FG003|STARTED|Overall Study||6
10418353|NCT00805207|11563019|FG004|STARTED|Overall Study||3
10418354|NCT00805207|11563020|FG005|STARTED|Overall Study||12
10418355|NCT00805207|11563021|FG006|STARTED|Overall Study||6
10418356|NCT00805207|11563022|FG007|STARTED|Overall Study||6
10418357|NCT00805207|11563023|FG008|STARTED|Overall Study||6
10755571|NCT03068754|11919357|FG001|NOT COMPLETED|Open Label Extension Period (OLE)||0
10755572|NCT03068754|11919358|FG002|NOT COMPLETED|Open Label Extension Period (OLE)||21
10755573|NCT03068754|11919359|FG003|NOT COMPLETED|Open Label Extension Period (OLE)||6
10755574|NCT03068767|11919371|FG000|STARTED|Overall Study|from August 2017 to September 2018|75
10755575|NCT03068767|11919372|FG001|STARTED|Overall Study|from August 2017 to September 2018|74
10755576|NCT03068767|11919371|FG000|COMPLETED|Overall Study|December 2018|65
10755577|NCT03068767|11919372|FG001|COMPLETED|Overall Study|December 2018|71
10755578|NCT03068767|11919371|FG000|NOT COMPLETED|Overall Study||10
10755579|NCT03068767|11919372|FG001|NOT COMPLETED|Overall Study||3
10755580|NCT03068897|11919382|FG000|STARTED|Overall Study||80
10755581|NCT03068897|11919383|FG001|STARTED|Overall Study||80
10755582|NCT03068897|11919384|FG002|STARTED|Overall Study||80
10755583|NCT03068897|11919385|FG003|STARTED|Overall Study||80
10755584|NCT03068897|11919382|FG000|COMPLETED|Overall Study||76
10755585|NCT03068897|11919383|FG001|COMPLETED|Overall Study||76
10755586|NCT03068897|11919384|FG002|COMPLETED|Overall Study||79
10755587|NCT03068897|11919385|FG003|COMPLETED|Overall Study||74
10755588|NCT03068897|11919382|FG000|NOT COMPLETED|Overall Study||4
10755589|NCT03068897|11919383|FG001|NOT COMPLETED|Overall Study||4
10755590|NCT03068897|11919384|FG002|NOT COMPLETED|Overall Study||1
10755591|NCT03068897|11919385|FG003|NOT COMPLETED|Overall Study||6
10755592|NCT03068949|11919399|FG000|STARTED|Overall Study||113
10755593|NCT03068949|11919400|FG001|STARTED|Overall Study||102
10755594|NCT03068949|11919401|FG002|STARTED|Overall Study||122
10755595|NCT03068949|11919402|FG003|STARTED|Overall Study||76
10755596|NCT03068949|11919399|FG000|COMPLETED|Overall Study||105
10755597|NCT03068949|11919400|FG001|COMPLETED|Overall Study||90
10418358|NCT00805207|11563015|FG000|COMPLETED|Overall Study||1
10418359|NCT00805207|11563016|FG001|COMPLETED|Overall Study||7
10418360|NCT00805207|11563017|FG002|COMPLETED|Overall Study||11
10418361|NCT00805207|11563018|FG003|COMPLETED|Overall Study||6
10418362|NCT00805207|11563019|FG004|COMPLETED|Overall Study||2
10755598|NCT03068949|11919401|FG002|COMPLETED|Overall Study||113
10755599|NCT03068949|11919402|FG003|COMPLETED|Overall Study||63
10755600|NCT03068949|11919399|FG000|NOT COMPLETED|Overall Study||8
10755601|NCT03068949|11919400|FG001|NOT COMPLETED|Overall Study||12
10755602|NCT03068949|11919401|FG002|NOT COMPLETED|Overall Study||9
10755603|NCT03068949|11919402|FG003|NOT COMPLETED|Overall Study||13
10755604|NCT03069313|11919412|FG000|STARTED|Overall Study||41
10755605|NCT03069313|11919412|FG000|COMPLETED|Overall Study||36
10755606|NCT03069313|11919412|FG000|NOT COMPLETED|Overall Study||5
10867767|NCT03128411|12033024|FG000|Received Treatment|Treatment Phase||60
10867768|NCT03128411|12033024|FG000|COMPLETED|Treatment Phase||36
10867769|NCT03128411|12033024|FG000|NOT COMPLETED|Treatment Phase||24
10867770|NCT03128411|12033024|FG000|STARTED|Long Term Follow-up Phase|Participants who discontinued treatment phase, entered in long term follow up phase.|24
10867771|NCT03128411|12033024|FG000|COMPLETED|Long Term Follow-up Phase||22
10867772|NCT03128411|12033024|FG000|NOT COMPLETED|Long Term Follow-up Phase||2
10867773|NCT03097328|12033028|FG000|STARTED|Overall Study||39
10867774|NCT03097328|12033028|FG000|Treated|Overall Study||38
10867775|NCT03097328|12033028|FG000|COMPLETED|Overall Study||0
10867776|NCT03097328|12033028|FG000|NOT COMPLETED|Overall Study||39
10867777|NCT03068715|12033034|FG000|STARTED|Overall Study||15
10867778|NCT03068715|12033035|FG001|STARTED|Overall Study||15
10867779|NCT03068715|12033034|FG000|COMPLETED|Overall Study||14
10867780|NCT03068715|12033035|FG001|COMPLETED|Overall Study||15
10867781|NCT03068715|12033034|FG000|NOT COMPLETED|Overall Study||1
10867782|NCT03068715|12033035|FG001|NOT COMPLETED|Overall Study||0
10867783|NCT02981472|12033045|FG000|STARTED|Pre-Treatment Period||129
10867784|NCT02981472|12033046|FG001|STARTED|Pre-Treatment Period||63
10867785|NCT02981472|12033045|FG000|COMPLETED|Pre-Treatment Period||126
10418363|NCT00805207|11563020|FG005|COMPLETED|Overall Study||9
10418364|NCT00805207|11563021|FG006|COMPLETED|Overall Study||6
10418365|NCT00805207|11563022|FG007|COMPLETED|Overall Study||6
10418366|NCT00805207|11563023|FG008|COMPLETED|Overall Study||6
10418367|NCT00805207|11563015|FG000|NOT COMPLETED|Overall Study||0
10418368|NCT00805207|11563016|FG001|NOT COMPLETED|Overall Study||2
10418369|NCT00805207|11563017|FG002|NOT COMPLETED|Overall Study||1
10418370|NCT00805207|11563018|FG003|NOT COMPLETED|Overall Study||0
10418371|NCT00805207|11563019|FG004|NOT COMPLETED|Overall Study||1
10418372|NCT00805207|11563020|FG005|NOT COMPLETED|Overall Study||3
10418373|NCT00805207|11563021|FG006|NOT COMPLETED|Overall Study||0
10418374|NCT00805207|11563022|FG007|NOT COMPLETED|Overall Study||0
10418375|NCT00805207|11563023|FG008|NOT COMPLETED|Overall Study||0
10418376|NCT00805285|11563047|FG000|STARTED|Overall Study||1
10418377|NCT00805285|11563047|FG000|COMPLETED|Overall Study||0
10418378|NCT00805285|11563047|FG000|NOT COMPLETED|Overall Study||1
10418379|NCT00805389|11563056|FG000|STARTED|Overall Study||143
10418380|NCT00805389|11563057|FG001|STARTED|Overall Study||142
10418381|NCT00805389|11563058|FG002|STARTED|Overall Study||141
10418382|NCT00805389|11563059|FG003|STARTED|Overall Study||145
10418383|NCT00805389|11563060|FG004|STARTED|Overall Study||142
10418384|NCT00805389|11563056|FG000|COMPLETED|Overall Study||136
10418385|NCT00805389|11563057|FG001|COMPLETED|Overall Study||137
10418386|NCT00805389|11563058|FG002|COMPLETED|Overall Study||129
10418387|NCT00805389|11563059|FG003|COMPLETED|Overall Study||128
10418388|NCT00805389|11563060|FG004|COMPLETED|Overall Study||129
10418389|NCT00805389|11563056|FG000|NOT COMPLETED|Overall Study||7
10418390|NCT00805389|11563057|FG001|NOT COMPLETED|Overall Study||5
10418391|NCT00805389|11563058|FG002|NOT COMPLETED|Overall Study||12
10418392|NCT00805389|11563059|FG003|NOT COMPLETED|Overall Study||17
10418393|NCT00805389|11563060|FG004|NOT COMPLETED|Overall Study||13
10418394|NCT00805441|11563084|FG000|STARTED|Overall Study||94
10418395|NCT00805441|11563085|FG001|STARTED|Overall Study||96
10418396|NCT00805441|11563084|FG000|Full Analysis Set (FAS)|Overall Study|All randomized participants who received ≥1 dose study drug and contributed to post-baseline data.|92
10418397|NCT00805441|11563085|FG001|Full Analysis Set (FAS)|Overall Study|All randomized participants who received ≥1 dose study drug and contributed to post-baseline data.|91
10418398|NCT00805441|11563084|FG000|COMPLETED|Overall Study||60
10418399|NCT00805441|11563085|FG001|COMPLETED|Overall Study||60
10418400|NCT00805441|11563084|FG000|NOT COMPLETED|Overall Study||34
10418401|NCT00805441|11563085|FG001|NOT COMPLETED|Overall Study||36
10418402|NCT00805467|11563095|FG000|STARTED|Overall Study|Patients who received treatment|1
10418403|NCT00805467|11563096|FG001|STARTED|Overall Study|Patients who received treatment|59
10418404|NCT00805467|11563097|FG002|STARTED|Overall Study|Patients who received treatment|183
10418405|NCT00805467|11563098|FG003|STARTED|Overall Study|Patients who received treatment|381
10418406|NCT00805467|11563095|FG000|Enrolled But Did Not Receive Treatment|Overall Study||0
10418407|NCT00805467|11563096|FG001|Enrolled But Did Not Receive Treatment|Overall Study||0
10418408|NCT00805467|11563097|FG002|Enrolled But Did Not Receive Treatment|Overall Study||0
10418409|NCT00805467|11563098|FG003|Enrolled But Did Not Receive Treatment|Overall Study||0
10418410|NCT00805467|11563095|FG000|COMPLETED|Overall Study|Ongoing when study terminated|1
10867786|NCT02981472|12033046|FG001|COMPLETED|Pre-Treatment Period||62
10867787|NCT02981472|12033045|FG000|NOT COMPLETED|Pre-Treatment Period||3
10867788|NCT02981472|12033046|FG001|NOT COMPLETED|Pre-Treatment Period||1
10867789|NCT02981472|12033045|FG000|STARTED|Treatment Period||126
10867790|NCT02981472|12033046|FG001|STARTED|Treatment Period||62
10294784|NCT02439749|11427535|FG000|STARTED|Overall Study||182
10294785|NCT02439749|11427536|FG001|STARTED|Overall Study||184
10294786|NCT02439749|11427535|FG000|COMPLETED|Overall Study||153
10294787|NCT02439749|11427536|FG001|COMPLETED|Overall Study||147
10294788|NCT02439749|11427535|FG000|NOT COMPLETED|Overall Study||29
10294789|NCT02439749|11427536|FG001|NOT COMPLETED|Overall Study||37
10294790|NCT02435511|11427544|FG000|STARTED|Overall Study|Defined as enrolled and completed baseline|202
10294791|NCT02435511|11427545|FG001|STARTED|Overall Study|Defined as enrolled and completed baseline|209
10294792|NCT02435511|11427544|FG000|COMPLETED|Overall Study|Defined as completing the 3 month follow-up, not necessarily all time points|158
10294793|NCT02435511|11427545|FG001|COMPLETED|Overall Study|Defined as completing the 3 month follow-up; not necessarily all time points|174
10867791|NCT02981472|12033045|FG000|COMPLETED|Treatment Period||119
10867792|NCT02981472|12033046|FG001|COMPLETED|Treatment Period||60
10867793|NCT02981472|12033045|FG000|NOT COMPLETED|Treatment Period||7
10867794|NCT02981472|12033046|FG001|NOT COMPLETED|Treatment Period||2
10867795|NCT02853760|12033058|FG000|STARTED|First Intervention (3 Hours)||7
10867796|NCT02853760|12033059|FG001|STARTED|First Intervention (3 Hours)||10
10867797|NCT02853760|12033060|FG002|STARTED|First Intervention (3 Hours)||7
10867798|NCT02853760|12033061|FG003|STARTED|First Intervention (3 Hours)||8
10867799|NCT02853760|12033062|FG004|STARTED|First Intervention (3 Hours)||8
10867800|NCT02853760|12033063|FG005|STARTED|First Intervention (3 Hours)||7
10867801|NCT02853760|12033058|FG000|COMPLETED|First Intervention (3 Hours)||7
10867802|NCT02853760|12033059|FG001|COMPLETED|First Intervention (3 Hours)||10
10867803|NCT02853760|12033060|FG002|COMPLETED|First Intervention (3 Hours)||7
10867804|NCT02853760|12033061|FG003|COMPLETED|First Intervention (3 Hours)||8
10867805|NCT02853760|12033062|FG004|COMPLETED|First Intervention (3 Hours)||8
10867806|NCT02853760|12033063|FG005|COMPLETED|First Intervention (3 Hours)||7
10867807|NCT02853760|12033058|FG000|NOT COMPLETED|First Intervention (3 Hours)||0
10867808|NCT02853760|12033059|FG001|NOT COMPLETED|First Intervention (3 Hours)||0
10867809|NCT02853760|12033060|FG002|NOT COMPLETED|First Intervention (3 Hours)||0
10867810|NCT02853760|12033061|FG003|NOT COMPLETED|First Intervention (3 Hours)||0
10867811|NCT02853760|12033062|FG004|NOT COMPLETED|First Intervention (3 Hours)||0
10867812|NCT02853760|12033063|FG005|NOT COMPLETED|First Intervention (3 Hours)||0
10867813|NCT02853760|12033058|FG000|STARTED|Washout (1 Week)||7
10867814|NCT02853760|12033059|FG001|STARTED|Washout (1 Week)||10
10867815|NCT02853760|12033060|FG002|STARTED|Washout (1 Week)||7
10867816|NCT02853760|12033061|FG003|STARTED|Washout (1 Week)||8
10867817|NCT02853760|12033062|FG004|STARTED|Washout (1 Week)||8
10867818|NCT02853760|12033063|FG005|STARTED|Washout (1 Week)||7
10867819|NCT02853760|12033058|FG000|COMPLETED|Washout (1 Week)||7
10867820|NCT02853760|12033059|FG001|COMPLETED|Washout (1 Week)||10
10867821|NCT02853760|12033060|FG002|COMPLETED|Washout (1 Week)||6
10867822|NCT02853760|12033061|FG003|COMPLETED|Washout (1 Week)||6
10867823|NCT02853760|12033062|FG004|COMPLETED|Washout (1 Week)||8
10867824|NCT02853760|12033063|FG005|COMPLETED|Washout (1 Week)||5
10867825|NCT02853760|12033058|FG000|NOT COMPLETED|Washout (1 Week)||0
10867826|NCT02853760|12033059|FG001|NOT COMPLETED|Washout (1 Week)||0
10867827|NCT02853760|12033060|FG002|NOT COMPLETED|Washout (1 Week)||1
10867828|NCT02853760|12033061|FG003|NOT COMPLETED|Washout (1 Week)||2
10867829|NCT02853760|12033062|FG004|NOT COMPLETED|Washout (1 Week)||0
10867830|NCT02853760|12033063|FG005|NOT COMPLETED|Washout (1 Week)||2
10294794|NCT02435511|11427544|FG000|NOT COMPLETED|Overall Study||44
10294795|NCT02435511|11427545|FG001|NOT COMPLETED|Overall Study||35
10294796|NCT02411448|11427554|FG000|STARTED|Overall Study||14
10294797|NCT02411448|11427555|FG001|STARTED|Overall Study||224
10294798|NCT02411448|11427556|FG002|STARTED|Overall Study||225
10294799|NCT02411448|11427554|FG000|Received at Least One Dose of Study Drug|Overall Study||14
10294800|NCT02411448|11427555|FG001|Received at Least One Dose of Study Drug|Overall Study||221
10294801|NCT02411448|11427556|FG002|Received at Least One Dose of Study Drug|Overall Study||225
10294802|NCT02411448|11427554|FG000|COMPLETED|Overall Study||10
10294803|NCT02411448|11427555|FG001|COMPLETED|Overall Study||141
10294804|NCT02411448|11427556|FG002|COMPLETED|Overall Study||173
10294805|NCT02411448|11427554|FG000|NOT COMPLETED|Overall Study||4
10294806|NCT02411448|11427555|FG001|NOT COMPLETED|Overall Study||83
10294807|NCT02411448|11427556|FG002|NOT COMPLETED|Overall Study||52
10294808|NCT02371369|11427570|FG000|STARTED|Part 1||61
10294809|NCT02371369|11427571|FG001|STARTED|Part 1||59
10294810|NCT02371369|11427570|FG000|COMPLETED|Part 1||52
10294811|NCT02371369|11427571|FG001|COMPLETED|Part 1||48
10294812|NCT02371369|11427570|FG000|NOT COMPLETED|Part 1||9
10294813|NCT02371369|11427571|FG001|NOT COMPLETED|Part 1||11
10294814|NCT02371369|11427570|FG000|STARTED|Part 2|N=48; Only participants who were eligible to receive treatment in Part 2.|48
10294815|NCT02371369|11427571|FG001|STARTED|Part 2|N=30; Only participants who were eligible to receive treatment in Part 2.|30
10294816|NCT02371369|11427570|FG000|COMPLETED|Part 2||0
10294817|NCT02371369|11427571|FG001|COMPLETED|Part 2||0
10294818|NCT02371369|11427570|FG000|NOT COMPLETED|Part 2||48
10294819|NCT02371369|11427571|FG001|NOT COMPLETED|Part 2||30
10294820|NCT02282917|11427593|FG000|STARTED|Overall Study||7
10294821|NCT02282917|11427593|FG000|COMPLETED|Overall Study||5
10294822|NCT02282917|11427593|FG000|NOT COMPLETED|Overall Study||2
10294823|NCT01849783|11427597|FG000|STARTED|Overall Study||41
10294824|NCT01849783|11427597|FG000|COMPLETED|Overall Study||19
10294825|NCT01849783|11427597|FG000|NOT COMPLETED|Overall Study||22
10314784|NCT00168428|11448520|FG000|STARTED|Open-Label Phase (OL)|Number of DB Botulinum toxin type A patients who rolled into OL phase|305
10314785|NCT00168428|11448521|FG001|STARTED|Open-Label Phase (OL)|Number of DB Placebo patients who rolled into OL phase|329
10314786|NCT00168428|11448520|FG000|COMPLETED|Open-Label Phase (OL)||261
10314787|NCT00168428|11448521|FG001|COMPLETED|Open-Label Phase (OL)||261
10314788|NCT00168428|11448520|FG000|NOT COMPLETED|Open-Label Phase (OL)||44
10314789|NCT00168428|11448521|FG001|NOT COMPLETED|Open-Label Phase (OL)||68
10867831|NCT02853760|12033058|FG000|STARTED|Second Intervention (3 Hours)||7
10867832|NCT02853760|12033059|FG001|STARTED|Second Intervention (3 Hours)||10
10867833|NCT02853760|12033060|FG002|STARTED|Second Intervention (3 Hours)||6
10867834|NCT02853760|12033061|FG003|STARTED|Second Intervention (3 Hours)||6
10867835|NCT02853760|12033062|FG004|STARTED|Second Intervention (3 Hours)||8
10867836|NCT02853760|12033063|FG005|STARTED|Second Intervention (3 Hours)||5
10867837|NCT02853760|12033058|FG000|COMPLETED|Second Intervention (3 Hours)||7
10867838|NCT02853760|12033059|FG001|COMPLETED|Second Intervention (3 Hours)||10
10867839|NCT02853760|12033060|FG002|COMPLETED|Second Intervention (3 Hours)||6
10867840|NCT02853760|12033061|FG003|COMPLETED|Second Intervention (3 Hours)||6
10867841|NCT02853760|12033062|FG004|COMPLETED|Second Intervention (3 Hours)||8
10867842|NCT02853760|12033063|FG005|COMPLETED|Second Intervention (3 Hours)||5
10867843|NCT02853760|12033058|FG000|NOT COMPLETED|Second Intervention (3 Hours)||0
10867844|NCT02853760|12033059|FG001|NOT COMPLETED|Second Intervention (3 Hours)||0
10867845|NCT02853760|12033060|FG002|NOT COMPLETED|Second Intervention (3 Hours)||0
10867846|NCT02853760|12033061|FG003|NOT COMPLETED|Second Intervention (3 Hours)||0
10867847|NCT02853760|12033062|FG004|NOT COMPLETED|Second Intervention (3 Hours)||0
10867848|NCT02853760|12033063|FG005|NOT COMPLETED|Second Intervention (3 Hours)||0
10867849|NCT02853760|12033058|FG000|STARTED|Washout (1 Week)||7
10867850|NCT02853760|12033059|FG001|STARTED|Washout (1 Week)||10
10867851|NCT02853760|12033060|FG002|STARTED|Washout (1 Week)||6
10867852|NCT02853760|12033061|FG003|STARTED|Washout (1 Week)||6
10867853|NCT02853760|12033062|FG004|STARTED|Washout (1 Week)||8
10867854|NCT02853760|12033063|FG005|STARTED|Washout (1 Week)||5
10867855|NCT02853760|12033058|FG000|COMPLETED|Washout (1 Week)||7
10867856|NCT02853760|12033059|FG001|COMPLETED|Washout (1 Week)||10
10867857|NCT02853760|12033060|FG002|COMPLETED|Washout (1 Week)||6
10867858|NCT02853760|12033061|FG003|COMPLETED|Washout (1 Week)||6
10867859|NCT02853760|12033062|FG004|COMPLETED|Washout (1 Week)||8
10867860|NCT02853760|12033063|FG005|COMPLETED|Washout (1 Week)||5
10867861|NCT02853760|12033058|FG000|NOT COMPLETED|Washout (1 Week)||0
10867862|NCT02853760|12033059|FG001|NOT COMPLETED|Washout (1 Week)||0
10867863|NCT02853760|12033060|FG002|NOT COMPLETED|Washout (1 Week)||0
10867864|NCT02853760|12033061|FG003|NOT COMPLETED|Washout (1 Week)||0
10867865|NCT02853760|12033062|FG004|NOT COMPLETED|Washout (1 Week)||0
10867866|NCT02853760|12033063|FG005|NOT COMPLETED|Washout (1 Week)||0
10867867|NCT02853760|12033058|FG000|STARTED|Third Intervention (3 Hours)||7
10867868|NCT02853760|12033059|FG001|STARTED|Third Intervention (3 Hours)||10
10867869|NCT02853760|12033060|FG002|STARTED|Third Intervention (3 Hours)||6
10867870|NCT02853760|12033061|FG003|STARTED|Third Intervention (3 Hours)||6
10867871|NCT02853760|12033062|FG004|STARTED|Third Intervention (3 Hours)||8
10867872|NCT02853760|12033063|FG005|STARTED|Third Intervention (3 Hours)||5
10867873|NCT02853760|12033058|FG000|COMPLETED|Third Intervention (3 Hours)||7
10867874|NCT02853760|12033059|FG001|COMPLETED|Third Intervention (3 Hours)||10
10867875|NCT02853760|12033060|FG002|COMPLETED|Third Intervention (3 Hours)||6
10867876|NCT02853760|12033061|FG003|COMPLETED|Third Intervention (3 Hours)||6
10867877|NCT02853760|12033062|FG004|COMPLETED|Third Intervention (3 Hours)||8
10867878|NCT02853760|12033063|FG005|COMPLETED|Third Intervention (3 Hours)||5
10867879|NCT02853760|12033058|FG000|NOT COMPLETED|Third Intervention (3 Hours)||0
10867880|NCT02853760|12033059|FG001|NOT COMPLETED|Third Intervention (3 Hours)||0
10867881|NCT02853760|12033060|FG002|NOT COMPLETED|Third Intervention (3 Hours)||0
10867882|NCT02853760|12033061|FG003|NOT COMPLETED|Third Intervention (3 Hours)||0
10867883|NCT02853760|12033062|FG004|NOT COMPLETED|Third Intervention (3 Hours)||0
10867884|NCT02853760|12033063|FG005|NOT COMPLETED|Third Intervention (3 Hours)||0
10867885|NCT02789657|12033075|FG000|STARTED|Overall Study||27
10867886|NCT02789657|12033076|FG001|STARTED|Overall Study||3
10867887|NCT02789657|12033077|FG002|STARTED|Overall Study||0
10867888|NCT02789657|12033078|FG003|STARTED|Overall Study||2
10867889|NCT02789657|12033075|FG000|COMPLETED|Overall Study||25
10867890|NCT02789657|12033076|FG001|COMPLETED|Overall Study||3
10867891|NCT02789657|12033077|FG002|COMPLETED|Overall Study||0
10867892|NCT02789657|12033078|FG003|COMPLETED|Overall Study||2
10867893|NCT02789657|12033075|FG000|NOT COMPLETED|Overall Study||2
10867894|NCT02789657|12033076|FG001|NOT COMPLETED|Overall Study||0
10867895|NCT02789657|12033077|FG002|NOT COMPLETED|Overall Study||0
10867896|NCT02789657|12033078|FG003|NOT COMPLETED|Overall Study||0
10867897|NCT02743871|12033101|FG000|STARTED|Overall Study||6
10867898|NCT02743871|12033102|FG001|STARTED|Overall Study||6
10867899|NCT02743871|12033103|FG002|STARTED|Overall Study||6
10867900|NCT02743871|12033104|FG003|STARTED|Overall Study||3
10867901|NCT02743871|12033105|FG004|STARTED|Overall Study||4
10867902|NCT02743871|12033106|FG005|STARTED|Overall Study||6
10867903|NCT02743871|12033107|FG006|STARTED|Overall Study||6
10867904|NCT02743871|12033108|FG007|STARTED|Overall Study||8
10867905|NCT02743871|12033109|FG008|STARTED|Overall Study||2
10867906|NCT02743871|12033110|FG009|STARTED|Overall Study||2
10867907|NCT02743871|12033111|FG010|STARTED|Overall Study||11
10867908|NCT02743871|12033112|FG011|STARTED|Overall Study||9
10867909|NCT02743871|12033113|FG012|STARTED|Overall Study||20
10867910|NCT02743871|12033114|FG013|STARTED|Overall Study||8
10867911|NCT02743871|12033101|FG000|COMPLETED|Overall Study||5
10867912|NCT02743871|12033102|FG001|COMPLETED|Overall Study||6
10867913|NCT02743871|12033103|FG002|COMPLETED|Overall Study||6
10867914|NCT02743871|12033104|FG003|COMPLETED|Overall Study||2
10867915|NCT02743871|12033105|FG004|COMPLETED|Overall Study||4
10867916|NCT02743871|12033106|FG005|COMPLETED|Overall Study||6
10867917|NCT02743871|12033107|FG006|COMPLETED|Overall Study||5
10867918|NCT02743871|12033108|FG007|COMPLETED|Overall Study||8
10867919|NCT02743871|12033109|FG008|COMPLETED|Overall Study||2
10867920|NCT02743871|12033110|FG009|COMPLETED|Overall Study||2
10867921|NCT02743871|12033111|FG010|COMPLETED|Overall Study||10
10867922|NCT02743871|12033112|FG011|COMPLETED|Overall Study||6
10867923|NCT02743871|12033113|FG012|COMPLETED|Overall Study||5
10867924|NCT02743871|12033114|FG013|COMPLETED|Overall Study||1
10867925|NCT02743871|12033101|FG000|NOT COMPLETED|Overall Study||1
10867926|NCT02743871|12033102|FG001|NOT COMPLETED|Overall Study||0
10867927|NCT02743871|12033103|FG002|NOT COMPLETED|Overall Study||0
10867928|NCT02743871|12033104|FG003|NOT COMPLETED|Overall Study||1
10867929|NCT02743871|12033105|FG004|NOT COMPLETED|Overall Study||0
10867930|NCT02743871|12033106|FG005|NOT COMPLETED|Overall Study||0
10867931|NCT02743871|12033107|FG006|NOT COMPLETED|Overall Study||1
10867932|NCT02743871|12033108|FG007|NOT COMPLETED|Overall Study||0
10867933|NCT02743871|12033109|FG008|NOT COMPLETED|Overall Study||0
10867934|NCT02743871|12033110|FG009|NOT COMPLETED|Overall Study||0
10867935|NCT02743871|12033111|FG010|NOT COMPLETED|Overall Study||1
10867936|NCT02743871|12033112|FG011|NOT COMPLETED|Overall Study||3
10867937|NCT02743871|12033113|FG012|NOT COMPLETED|Overall Study||15
10867938|NCT02743871|12033114|FG013|NOT COMPLETED|Overall Study||7
10867939|NCT02707198|12033159|FG000|STARTED|Overall Study||2
10867940|NCT02707198|12033160|FG001|STARTED|Overall Study||0
10867941|NCT02707198|12033161|FG002|STARTED|Overall Study||0
10867942|NCT02707198|12033159|FG000|COMPLETED|Overall Study||2
10867943|NCT02707198|12033160|FG001|COMPLETED|Overall Study||0
10867944|NCT02707198|12033161|FG002|COMPLETED|Overall Study||0
10867945|NCT02707198|12033159|FG000|NOT COMPLETED|Overall Study||0
10867946|NCT02707198|12033160|FG001|NOT COMPLETED|Overall Study||0
10867947|NCT02707198|12033161|FG002|NOT COMPLETED|Overall Study||0
10418411|NCT00805467|11563096|FG001|COMPLETED|Overall Study|Ongoing when study terminated|25
10418412|NCT00805467|11563097|FG002|COMPLETED|Overall Study|Ongoing when study terminated|80
10418413|NCT00805467|11563098|FG003|COMPLETED|Overall Study|Ongoing when study terminated|144
10418414|NCT00805467|11563095|FG000|NOT COMPLETED|Overall Study||0
10418415|NCT00805467|11563096|FG001|NOT COMPLETED|Overall Study||34
10418416|NCT00805467|11563097|FG002|NOT COMPLETED|Overall Study||103
10418417|NCT00805467|11563098|FG003|NOT COMPLETED|Overall Study||237
10418418|NCT00805480|11563112|FG000|STARTED|Overall Study||30
10418419|NCT00805480|11563113|FG001|STARTED|Overall Study||29
10418420|NCT00805480|11563114|FG002|STARTED|Overall Study||31
10418421|NCT00805480|11563115|FG003|STARTED|Overall Study||10
10418422|NCT00805480|11563112|FG000|Pharmacodynamic Analysis Set|Overall Study||30
10418423|NCT00805480|11563113|FG001|Pharmacodynamic Analysis Set|Overall Study||25
10418424|NCT00805480|11563114|FG002|Pharmacodynamic Analysis Set|Overall Study||29
10418425|NCT00805480|11563115|FG003|Pharmacodynamic Analysis Set|Overall Study||10
10418426|NCT00805480|11563112|FG000|COMPLETED|Overall Study||16
10418427|NCT00805480|11563113|FG001|COMPLETED|Overall Study||22
10418428|NCT00805480|11563114|FG002|COMPLETED|Overall Study||19
10418429|NCT00805480|11563115|FG003|COMPLETED|Overall Study||5
10418430|NCT00805480|11563112|FG000|NOT COMPLETED|Overall Study||14
10418431|NCT00805480|11563113|FG001|NOT COMPLETED|Overall Study||7
10418432|NCT00805480|11563114|FG002|NOT COMPLETED|Overall Study||12
10418433|NCT00805480|11563115|FG003|NOT COMPLETED|Overall Study||5
10418434|NCT00805493|11563128|FG000|STARTED|Overall Study||3
10418435|NCT00805493|11563129|FG001|STARTED|Overall Study||2
10755615|NCT03069365|11919425|FG000|STARTED|Overall Study||101
10755616|NCT03069365|11919425|FG000|COMPLETED|Overall Study||100
10755617|NCT03069365|11919425|FG000|NOT COMPLETED|Overall Study||1
10755618|NCT03069482|11919431|FG000|STARTED|Overall Study||34
10755619|NCT03069482|11919432|FG001|STARTED|Overall Study||29
10755620|NCT03069482|11919431|FG000|COMPLETED|Overall Study||33
10755621|NCT03069482|11919432|FG001|COMPLETED|Overall Study||28
10755622|NCT03069482|11919431|FG000|NOT COMPLETED|Overall Study||1
10418436|NCT00805493|11563130|FG002|STARTED|Overall Study||1
10755623|NCT03069482|11919432|FG001|NOT COMPLETED|Overall Study||1
10755624|NCT03069677|11919443|FG000|STARTED|Overall Study||80
10755625|NCT03069677|11919444|FG001|STARTED|Overall Study||80
10867951|NCT02614261|12033176|FG000|STARTED|Double-Blind Treatment Phase||559
10867952|NCT02614261|12033177|FG001|STARTED|Double-Blind Treatment Phase||279
10867953|NCT02614261|12033178|FG002|STARTED|Double-Blind Treatment Phase||279
10867954|NCT02614261|12033179|FG003|STARTED|Double-Blind Treatment Phase||0
10867955|NCT02614261|12033176|FG000|Received at Least One Dose of Study Drug|Double-Blind Treatment Phase||558
10867956|NCT02614261|12033177|FG001|Received at Least One Dose of Study Drug|Double-Blind Treatment Phase||278
10294826|NCT01741480|11427609|FG000|STARTED|Overall Study||285
10294827|NCT01741480|11427610|FG001|STARTED|Overall Study||286
10294828|NCT01741480|11427609|FG000|COMPLETED|Overall Study||285
10294829|NCT01741480|11427610|FG001|COMPLETED|Overall Study||286
10294830|NCT01741480|11427609|FG000|NOT COMPLETED|Overall Study||0
10294831|NCT01741480|11427610|FG001|NOT COMPLETED|Overall Study||0
10294832|NCT01737021|11427618|FG000|STARTED|Overall Study||22
10294833|NCT01737021|11427619|FG001|STARTED|Overall Study||9
10294834|NCT01737021|11427618|FG000|COMPLETED|Overall Study||17
10294835|NCT01737021|11427619|FG001|COMPLETED|Overall Study||6
10418437|NCT00805493|11563128|FG000|COMPLETED|Overall Study||1
10418438|NCT00805493|11563129|FG001|COMPLETED|Overall Study||2
10418439|NCT00805493|11563130|FG002|COMPLETED|Overall Study||0
10418440|NCT00805493|11563128|FG000|NOT COMPLETED|Overall Study||2
10418441|NCT00805493|11563129|FG001|NOT COMPLETED|Overall Study||0
10418442|NCT00805493|11563130|FG002|NOT COMPLETED|Overall Study||1
10418443|NCT00805532|11563143|FG000|STARTED|Overall Study||42
10418444|NCT00805532|11563144|FG001|STARTED|Overall Study||39
10418445|NCT00805532|11563143|FG000|COMPLETED|Overall Study|We did intent-to-treat analyses so 42 participants' data were analyzed.|42
10418446|NCT00805532|11563144|FG001|COMPLETED|Overall Study||38
10418447|NCT00805532|11563143|FG000|NOT COMPLETED|Overall Study||0
10418448|NCT00805532|11563144|FG001|NOT COMPLETED|Overall Study||1
10418449|NCT00805545|11563154|FG000|STARTED|Overall Study||200
10418450|NCT00805545|11563155|FG001|STARTED|Overall Study||200
10418451|NCT00805545|11563154|FG000|COMPLETED|Overall Study||194
10418452|NCT00805545|11563155|FG001|COMPLETED|Overall Study||197
10418453|NCT00805545|11563154|FG000|NOT COMPLETED|Overall Study||6
10418454|NCT00805545|11563155|FG001|NOT COMPLETED|Overall Study||3
10418455|NCT00805675|11563164|FG000|STARTED|Overall Study||16
10418456|NCT00805675|11563165|FG001|STARTED|Overall Study||14
10418457|NCT00805675|11563166|FG002|STARTED|Overall Study||16
10418458|NCT00805675|11563164|FG000|COMPLETED|Overall Study||16
10418459|NCT00805675|11563165|FG001|COMPLETED|Overall Study||14
10418460|NCT00805675|11563166|FG002|COMPLETED|Overall Study||15
10418461|NCT00805675|11563164|FG000|NOT COMPLETED|Overall Study||0
10418462|NCT00805675|11563165|FG001|NOT COMPLETED|Overall Study||0
10418463|NCT00805675|11563166|FG002|NOT COMPLETED|Overall Study||1
10418464|NCT00805740|11563176|FG000|STARTED|Overall Study||28
10418465|NCT00805740|11563177|FG001|STARTED|Overall Study||13
10418466|NCT00805740|11563176|FG000|Treated|Overall Study||26
10418467|NCT00805740|11563177|FG001|Treated|Overall Study||13
10418468|NCT00805740|11563176|FG000|COMPLETED|Overall Study||17
10418469|NCT00805740|11563177|FG001|COMPLETED|Overall Study||9
10418470|NCT00805740|11563176|FG000|NOT COMPLETED|Overall Study||11
10418471|NCT00805740|11563177|FG001|NOT COMPLETED|Overall Study||4
10418472|NCT00805766|11563183|FG000|STARTED|Screening Period||45
10418473|NCT00805766|11563183|FG000|COMPLETED|Screening Period||39
10418474|NCT00805766|11563183|FG000|NOT COMPLETED|Screening Period||6
10418475|NCT00805766|11563183|FG000|STARTED|Increased Dose Period||39
10418476|NCT00805766|11563183|FG000|COMPLETED|Increased Dose Period||26
10418477|NCT00805766|11563183|FG000|NOT COMPLETED|Increased Dose Period||13
10418478|NCT00805792|11563191|FG000|STARTED|Overall Study||33
10418479|NCT00805792|11563191|FG000|COMPLETED|Overall Study||28
10418480|NCT00805792|11563191|FG000|NOT COMPLETED|Overall Study||5
10418481|NCT00805870|11563197|FG000|STARTED|Overall Study||10
10418482|NCT00805870|11563198|FG001|STARTED|Overall Study||10
10418483|NCT00805870|11563197|FG000|COMPLETED|Overall Study||10
10418484|NCT00805870|11563198|FG001|COMPLETED|Overall Study||10
10418485|NCT00805870|11563197|FG000|NOT COMPLETED|Overall Study||0
10418486|NCT00805870|11563198|FG001|NOT COMPLETED|Overall Study||0
10418487|NCT00805935|11563208|FG000|STARTED|Overall Study||25
10418488|NCT00805935|11563209|FG001|STARTED|Overall Study||27
10418489|NCT00805935|11563210|FG002|STARTED|Overall Study||28
10418490|NCT00805935|11563211|FG003|STARTED|Overall Study||30
10418491|NCT00805935|11563208|FG000|COMPLETED|Overall Study||12
10418492|NCT00805935|11563209|FG001|COMPLETED|Overall Study||8
10418493|NCT00805935|11563210|FG002|COMPLETED|Overall Study||13
10418494|NCT00805935|11563211|FG003|COMPLETED|Overall Study||19
10418495|NCT00805935|11563208|FG000|NOT COMPLETED|Overall Study||13
10418496|NCT00805935|11563209|FG001|NOT COMPLETED|Overall Study||19
10418497|NCT00805935|11563210|FG002|NOT COMPLETED|Overall Study||15
10418498|NCT00805935|11563211|FG003|NOT COMPLETED|Overall Study||11
10418499|NCT00805948|11563225|FG000|STARTED|Overall Study||154
10418500|NCT00805948|11563226|FG001|STARTED|Overall Study||195
10545881|NCT01500317|11699405|FG002|STARTED|Overall Study||13
10294836|NCT01737021|11427618|FG000|NOT COMPLETED|Overall Study||5
10294837|NCT01737021|11427619|FG001|NOT COMPLETED|Overall Study||3
10418501|NCT00805948|11563225|FG000|COMPLETED|Overall Study||86
10418502|NCT00805948|11563226|FG001|COMPLETED|Overall Study||99
10418503|NCT00805948|11563225|FG000|NOT COMPLETED|Overall Study||68
10418504|NCT00805948|11563226|FG001|NOT COMPLETED|Overall Study||96
10418505|NCT00806026|11563239|FG000|STARTED|Overall Study||185
10418506|NCT00806026|11563240|FG001|STARTED|Overall Study||183
10418507|NCT00806026|11563241|FG002|STARTED|Overall Study||182
10867957|NCT02614261|12033178|FG002|Received at Least One Dose of Study Drug|Double-Blind Treatment Phase||277
10867958|NCT02614261|12033179|FG003|Received at Least One Dose of Study Drug|Double-Blind Treatment Phase||0
10867959|NCT02614261|12033176|FG000|Safety Population|Double-Blind Treatment Phase||558
10867960|NCT02614261|12033177|FG001|Safety Population|Double-Blind Treatment Phase|5 participants discontinued after receiving loading dose of 240mg. They were included under 240mg arm for safety analysis.|273
10867961|NCT02614261|12033178|FG002|Safety Population|Double-Blind Treatment Phase||282
10867962|NCT02614261|12033179|FG003|Safety Population|Double-Blind Treatment Phase||0
10867963|NCT02614261|12033176|FG000|COMPLETED|Double-Blind Treatment Phase||509
10867964|NCT02614261|12033177|FG001|COMPLETED|Double-Blind Treatment Phase||262
10867965|NCT02614261|12033178|FG002|COMPLETED|Double-Blind Treatment Phase||266
10867966|NCT02614261|12033179|FG003|COMPLETED|Double-Blind Treatment Phase||0
10867967|NCT02614261|12033176|FG000|NOT COMPLETED|Double-Blind Treatment Phase||50
10867968|NCT02614261|12033177|FG001|NOT COMPLETED|Double-Blind Treatment Phase||17
10867969|NCT02614261|12033178|FG002|NOT COMPLETED|Double-Blind Treatment Phase||13
10867970|NCT02614261|12033179|FG003|NOT COMPLETED|Double-Blind Treatment Phase||0
10867971|NCT02614261|12033176|FG000|STARTED|Open-Label Extension Phase|Participants from double-blind treatment phase had the option to enter the open-label extension phase or proceed directly to the follow-up phase.|501
10867972|NCT02614261|12033177|FG001|STARTED|Open-Label Extension Phase|Participants from double-blind treatment phase had the option to enter the open-label extension phase or proceed directly to the follow-up phase.|259
10867973|NCT02614261|12033178|FG002|STARTED|Open-Label Extension Phase|Participants from double-blind treatment phase had the option to enter the open-label extension phase or proceed directly to the follow-up phase.|262
10867974|NCT02614261|12033179|FG003|STARTED|Open-Label Extension Phase||0
10867975|NCT02614261|12033176|FG000|Safety Population|Open-Label Extension Phase||501
10867976|NCT02614261|12033177|FG001|Safety Population|Open-Label Extension Phase||259
10867977|NCT02614261|12033178|FG002|Safety Population|Open-Label Extension Phase||262
10867978|NCT02614261|12033179|FG003|Safety Population|Open-Label Extension Phase||0
10867979|NCT02614261|12033176|FG000|COMPLETED|Open-Label Extension Phase||413
10867980|NCT02614261|12033177|FG001|COMPLETED|Open-Label Extension Phase||204
10867981|NCT02614261|12033178|FG002|COMPLETED|Open-Label Extension Phase||208
10867982|NCT02614261|12033179|FG003|COMPLETED|Open-Label Extension Phase||0
10867983|NCT02614261|12033176|FG000|NOT COMPLETED|Open-Label Extension Phase||88
10867984|NCT02614261|12033177|FG001|NOT COMPLETED|Open-Label Extension Phase||55
10867985|NCT02614261|12033178|FG002|NOT COMPLETED|Open-Label Extension Phase||54
10867986|NCT02614261|12033179|FG003|NOT COMPLETED|Open-Label Extension Phase||0
10867987|NCT02614261|12033176|FG000|STARTED|Follow-up Phase|Participants from double-blind treatment or open-label extension phases entered the follow-up phase.|453
10867988|NCT02614261|12033177|FG001|STARTED|Follow-up Phase|Participants from double-blind treatment or open-label extension phases entered the follow-up phase.|228
10867989|NCT02614261|12033178|FG002|STARTED|Follow-up Phase|Participants from double-blind treatment or open-label extension phases entered the follow-up phase.|231
10867990|NCT02614261|12033179|FG003|STARTED|Follow-up Phase||0
10867991|NCT02614261|12033176|FG000|Entered From Double-blind Treatment Phase|Follow-up Phase||15
10867992|NCT02614261|12033177|FG001|Entered From Double-blind Treatment Phase|Follow-up Phase|1 among these participants discontinued from double-blind treatment phase after receiving 240mg loading dose and entered Follow-up phase.|5
10867993|NCT02614261|12033178|FG002|Entered From Double-blind Treatment Phase|Follow-up Phase||3
10867994|NCT02614261|12033179|FG003|Entered From Double-blind Treatment Phase|Follow-up Phase||0
10867995|NCT02614261|12033176|FG000|Safety Population (Entered From Double-blind Treatment Phase)|Follow-up Phase||15
10867996|NCT02614261|12033177|FG001|Safety Population (Entered From Double-blind Treatment Phase)|Follow-up Phase|1 participant who discontinued from double-blind treatment phase after receiving 240mg loading dose and entered Follow-up phase was included under 240mg arm for safety analysis.|4
10867997|NCT02614261|12033178|FG002|Safety Population (Entered From Double-blind Treatment Phase)|Follow-up Phase||4
10867998|NCT02614261|12033179|FG003|Safety Population (Entered From Double-blind Treatment Phase)|Follow-up Phase||0
10867999|NCT02614261|12033176|FG000|Entered From Open-label Extension Phase|Follow-up Phase||438
10868000|NCT02614261|12033177|FG001|Entered From Open-label Extension Phase|Follow-up Phase||223
10868001|NCT02614261|12033178|FG002|Entered From Open-label Extension Phase|Follow-up Phase||228
10868002|NCT02614261|12033179|FG003|Entered From Open-label Extension Phase|Follow-up Phase||0
10868003|NCT02614261|12033176|FG000|Safety Population (Entered From Open-label Extension Phase)|Follow-up Phase||438
10868004|NCT02614261|12033177|FG001|Safety Population (Entered From Open-label Extension Phase)|Follow-up Phase||223
10868005|NCT02614261|12033178|FG002|Safety Population (Entered From Open-label Extension Phase)|Follow-up Phase||228
10868006|NCT02614261|12033179|FG003|Safety Population (Entered From Open-label Extension Phase)|Follow-up Phase||0
10868007|NCT02614261|12033176|FG000|COMPLETED|Follow-up Phase||421
10868008|NCT02614261|12033177|FG001|COMPLETED|Follow-up Phase||217
10868009|NCT02614261|12033178|FG002|COMPLETED|Follow-up Phase||217
10868010|NCT02614261|12033179|FG003|COMPLETED|Follow-up Phase||0
10868011|NCT02614261|12033176|FG000|NOT COMPLETED|Follow-up Phase||32
10868012|NCT02614261|12033177|FG001|NOT COMPLETED|Follow-up Phase||11
10868013|NCT02614261|12033178|FG002|NOT COMPLETED|Follow-up Phase||14
10868014|NCT02614261|12033179|FG003|NOT COMPLETED|Follow-up Phase||0
10868015|NCT02614261|12033176|FG000|STARTED|Israel Addendum|Main study arm.|0
10868016|NCT02614261|12033177|FG001|STARTED|Israel Addendum|Main study arm.|0
10868017|NCT02614261|12033178|FG002|STARTED|Israel Addendum|Main study arm.|0
10868018|NCT02614261|12033179|FG003|STARTED|Israel Addendum|Eligible participants from main study enrolled in Israel addendum.|29
10868019|NCT02614261|12033176|FG000|Safety Population|Israel Addendum||0
10868020|NCT02614261|12033177|FG001|Safety Population|Israel Addendum||0
10868021|NCT02614261|12033178|FG002|Safety Population|Israel Addendum||0
10868022|NCT02614261|12033179|FG003|Safety Population|Israel Addendum||29
10868023|NCT02614261|12033176|FG000|COMPLETED|Israel Addendum||0
10868024|NCT02614261|12033177|FG001|COMPLETED|Israel Addendum||0
10868025|NCT02614261|12033178|FG002|COMPLETED|Israel Addendum||0
10868026|NCT02614261|12033179|FG003|COMPLETED|Israel Addendum||25
10868027|NCT02614261|12033176|FG000|NOT COMPLETED|Israel Addendum||0
10868028|NCT02614261|12033177|FG001|NOT COMPLETED|Israel Addendum||0
10868029|NCT02614261|12033178|FG002|NOT COMPLETED|Israel Addendum||0
10868030|NCT02614261|12033179|FG003|NOT COMPLETED|Israel Addendum||4
10294838|NCT01505465|11427627|FG000|STARTED|Overall Study||25
10294839|NCT01505465|11427628|FG001|STARTED|Overall Study||25
10294840|NCT01505465|11427627|FG000|COMPLETED|Overall Study||19
10418508|NCT00806026|11563242|FG003|STARTED|Overall Study||61
10418509|NCT00806026|11563243|FG004|STARTED|Overall Study||59
10418510|NCT00806026|11563244|FG005|STARTED|Overall Study||61
10418511|NCT00806026|11563239|FG000|Treated|Overall Study||182
10418512|NCT00806026|11563240|FG001|Treated|Overall Study||178
10418513|NCT00806026|11563241|FG002|Treated|Overall Study||180
10418514|NCT00806026|11563242|FG003|Treated|Overall Study||59
10418515|NCT00806026|11563243|FG004|Treated|Overall Study||59
10418516|NCT00806026|11563244|FG005|Treated|Overall Study||61
10418517|NCT00806026|11563239|FG000|COMPLETED|Overall Study||93
10418518|NCT00806026|11563240|FG001|COMPLETED|Overall Study||82
10418519|NCT00806026|11563241|FG002|COMPLETED|Overall Study||89
10418520|NCT00806026|11563242|FG003|COMPLETED|Overall Study||32
10418521|NCT00806026|11563243|FG004|COMPLETED|Overall Study||29
10418522|NCT00806026|11563244|FG005|COMPLETED|Overall Study||29
10418523|NCT00806026|11563239|FG000|NOT COMPLETED|Overall Study||92
10418524|NCT00806026|11563240|FG001|NOT COMPLETED|Overall Study||101
10418525|NCT00806026|11563241|FG002|NOT COMPLETED|Overall Study||93
10418526|NCT00806026|11563242|FG003|NOT COMPLETED|Overall Study||29
10418527|NCT00806026|11563243|FG004|NOT COMPLETED|Overall Study||30
10418528|NCT00806026|11563244|FG005|NOT COMPLETED|Overall Study||32
10418529|NCT00806078|11563258|FG000|STARTED|First Intervention||9
10418530|NCT00806078|11563259|FG001|STARTED|First Intervention||9
10418531|NCT00806078|11563258|FG000|COMPLETED|First Intervention||9
10418532|NCT00806078|11563259|FG001|COMPLETED|First Intervention||9
10418533|NCT00806078|11563258|FG000|NOT COMPLETED|First Intervention||0
10418534|NCT00806078|11563259|FG001|NOT COMPLETED|First Intervention||0
10418535|NCT00806078|11563258|FG000|STARTED|7 Day Washout Period||9
10418536|NCT00806078|11563259|FG001|STARTED|7 Day Washout Period||9
10418537|NCT00806078|11563258|FG000|COMPLETED|7 Day Washout Period||9
10418538|NCT00806078|11563259|FG001|COMPLETED|7 Day Washout Period||9
10418539|NCT00806078|11563258|FG000|NOT COMPLETED|7 Day Washout Period||0
10418540|NCT00806078|11563259|FG001|NOT COMPLETED|7 Day Washout Period||0
10418541|NCT00806078|11563258|FG000|STARTED|Second Intervention||9
10418542|NCT00806078|11563259|FG001|STARTED|Second Intervention||9
10418543|NCT00806078|11563258|FG000|COMPLETED|Second Intervention||9
10418544|NCT00806078|11563259|FG001|COMPLETED|Second Intervention||9
10418545|NCT00806078|11563258|FG000|NOT COMPLETED|Second Intervention||0
10418546|NCT00806078|11563259|FG001|NOT COMPLETED|Second Intervention||0
10418547|NCT00806156|11563267|FG000|STARTED|Overall Study||39
10418548|NCT00806156|11563268|FG001|STARTED|Overall Study||139
10418549|NCT00806156|11563267|FG000|COMPLETED|Overall Study||0
10418550|NCT00806156|11563268|FG001|COMPLETED|Overall Study||0
10418551|NCT00806156|11563267|FG000|NOT COMPLETED|Overall Study||39
10868046|NCT02513667|12033230|FG000|STARTED|Overall Study||8
10868047|NCT02513667|12033231|FG001|STARTED|Overall Study||6
10868048|NCT02513667|12033230|FG000|COMPLETED|Overall Study||8
10868049|NCT02513667|12033231|FG001|COMPLETED|Overall Study||5
10868050|NCT02513667|12033230|FG000|NOT COMPLETED|Overall Study||0
10294841|NCT01505465|11427628|FG001|COMPLETED|Overall Study||18
10294842|NCT01505465|11427627|FG000|NOT COMPLETED|Overall Study||6
10294843|NCT01505465|11427628|FG001|NOT COMPLETED|Overall Study||7
10294844|NCT01333943|11427636|FG000|STARTED|Overall Study||47
10294845|NCT01333943|11427637|FG001|STARTED|Overall Study||47
10294846|NCT01333943|11427636|FG000|COMPLETED|Overall Study||46
10294847|NCT01333943|11427637|FG001|COMPLETED|Overall Study||47
10294848|NCT01333943|11427636|FG000|NOT COMPLETED|Overall Study||1
10294849|NCT01333943|11427637|FG001|NOT COMPLETED|Overall Study||0
10294850|NCT01322646|11427645|FG000|STARTED|Overall Study||86
10294851|NCT01322646|11427646|FG001|STARTED|Overall Study||86
10294852|NCT01322646|11427645|FG000|COMPLETED|Overall Study||83
10294853|NCT01322646|11427646|FG001|COMPLETED|Overall Study||84
10868051|NCT02513667|12033231|FG001|NOT COMPLETED|Overall Study||1
10868052|NCT02415556|12033241|FG000|STARTED|Overall Study||57
10868053|NCT02415556|12033242|FG001|STARTED|Overall Study||58
10868054|NCT02415556|12033243|FG002|STARTED|Overall Study||65
10868055|NCT02415556|12033244|FG003|STARTED|Overall Study||64
10868056|NCT02415556|12033241|FG000|COMPLETED|Overall Study||32
10868057|NCT02415556|12033242|FG001|COMPLETED|Overall Study||37
10868058|NCT02415556|12033243|FG002|COMPLETED|Overall Study||43
10868059|NCT02415556|12033244|FG003|COMPLETED|Overall Study||44
10868060|NCT02415556|12033241|FG000|NOT COMPLETED|Overall Study||25
10868061|NCT02415556|12033242|FG001|NOT COMPLETED|Overall Study||21
10868062|NCT02415556|12033243|FG002|NOT COMPLETED|Overall Study||22
10868063|NCT02415556|12033244|FG003|NOT COMPLETED|Overall Study||20
10868064|NCT02389374|12033257|FG000|STARTED|Overall Study||55
10868065|NCT02389374|12033258|FG001|STARTED|Overall Study||115
10868066|NCT02389374|12033259|FG002|STARTED|Overall Study||11
10868067|NCT02389374|12033257|FG000|COMPLETED|Overall Study||46
10868068|NCT02389374|12033258|FG001|COMPLETED|Overall Study||87
10868069|NCT02389374|12033259|FG002|COMPLETED|Overall Study||10
10868070|NCT02389374|12033257|FG000|NOT COMPLETED|Overall Study||9
10868071|NCT02389374|12033258|FG001|NOT COMPLETED|Overall Study||28
10868072|NCT02389374|12033259|FG002|NOT COMPLETED|Overall Study||1
10868073|NCT02386839|12033270|FG000|STARTED|Overall Study||36
10868074|NCT02386839|12033271|FG001|STARTED|Overall Study||40
10868075|NCT02386839|12033270|FG000|COMPLETED|Overall Study||20
10868076|NCT02386839|12033271|FG001|COMPLETED|Overall Study||25
10868077|NCT02386839|12033270|FG000|NOT COMPLETED|Overall Study||16
10868078|NCT02386839|12033271|FG001|NOT COMPLETED|Overall Study||15
10868097|NCT02312258|12033299|FG000|STARTED|Overall Study||281
10868098|NCT02312258|12033300|FG001|STARTED|Overall Study||425
10868099|NCT02312258|12033299|FG000|COMPLETED|Overall Study||30
10868100|NCT02312258|12033300|FG001|COMPLETED|Overall Study||66
10868101|NCT02312258|12033299|FG000|NOT COMPLETED|Overall Study||251
10868102|NCT02312258|12033300|FG001|NOT COMPLETED|Overall Study||359
10868103|NCT02213380|12033308|FG000|STARTED|Underwent Randomization||476
10868104|NCT02213380|12033309|FG001|STARTED|Underwent Randomization||474
10868105|NCT02213380|12033308|FG000|COMPLETED|Underwent Randomization||471
10868106|NCT02213380|12033309|FG001|COMPLETED|Underwent Randomization||471
10868107|NCT02213380|12033308|FG000|NOT COMPLETED|Underwent Randomization||5
10868108|NCT02213380|12033309|FG001|NOT COMPLETED|Underwent Randomization||3
10868109|NCT02213380|12033308|FG000|STARTED|Per-protocol Analysis||471
10868110|NCT02213380|12033309|FG001|STARTED|Per-protocol Analysis||471
10868111|NCT02213380|12033308|FG000|COMPLETED|Per-protocol Analysis||439
10868112|NCT02213380|12033309|FG001|COMPLETED|Per-protocol Analysis||435
10868113|NCT02213380|12033308|FG000|NOT COMPLETED|Per-protocol Analysis||32
10868114|NCT02213380|12033309|FG001|NOT COMPLETED|Per-protocol Analysis||36
10868121|NCT02113592|12033326|FG000|STARTED|Overall Study||433
10868122|NCT02113592|12033327|FG001|STARTED|Overall Study||417
10868123|NCT02113592|12033326|FG000|COMPLETED|Overall Study||414
10868124|NCT02113592|12033327|FG001|COMPLETED|Overall Study||402
10868125|NCT02113592|12033326|FG000|NOT COMPLETED|Overall Study||19
10868126|NCT02113592|12033327|FG001|NOT COMPLETED|Overall Study||15
10868151|NCT02075320|12033368|FG000|STARTED|Overall Study||50
10868152|NCT02075320|12033368|FG000|COMPLETED|Overall Study||48
10868153|NCT02075320|12033368|FG000|NOT COMPLETED|Overall Study||2
10868154|NCT02007512|12033376|FG000|STARTED|Double Blind Treatment Period||63
10868155|NCT02007512|12033377|FG001|STARTED|Double Blind Treatment Period||64
10868156|NCT02007512|12033378|FG002|STARTED|Double Blind Treatment Period||60
10868157|NCT02007512|12033379|FG003|STARTED|Double Blind Treatment Period||60
10868158|NCT02007512|12033376|FG000|Treated|Double Blind Treatment Period||62
10868159|NCT02007512|12033377|FG001|Treated|Double Blind Treatment Period||63
10868160|NCT02007512|12033378|FG002|Treated|Double Blind Treatment Period||60
10868161|NCT02007512|12033379|FG003|Treated|Double Blind Treatment Period||60
10868162|NCT02007512|12033376|FG000|COMPLETED|Double Blind Treatment Period||0
10868163|NCT02007512|12033377|FG001|COMPLETED|Double Blind Treatment Period||0
10868164|NCT02007512|12033378|FG002|COMPLETED|Double Blind Treatment Period||0
10868165|NCT02007512|12033379|FG003|COMPLETED|Double Blind Treatment Period||0
10868166|NCT02007512|12033376|FG000|NOT COMPLETED|Double Blind Treatment Period||63
10868167|NCT02007512|12033377|FG001|NOT COMPLETED|Double Blind Treatment Period||64
10868168|NCT02007512|12033378|FG002|NOT COMPLETED|Double Blind Treatment Period||60
10868169|NCT02007512|12033379|FG003|NOT COMPLETED|Double Blind Treatment Period||60
10868170|NCT02007512|12033376|FG000|STARTED|Open Label Treatment Period||0
10868171|NCT02007512|12033377|FG001|STARTED|Open Label Treatment Period|Of the participants with disease progression in double blind period, 21 entered open label period.|21
10868172|NCT02007512|12033378|FG002|STARTED|Open Label Treatment Period||0
10868173|NCT02007512|12033379|FG003|STARTED|Open Label Treatment Period|Of the participants with disease progression in double blind period, 12 entered open label period.|12
10868174|NCT02007512|12033376|FG000|COMPLETED|Open Label Treatment Period||0
10868175|NCT02007512|12033377|FG001|COMPLETED|Open Label Treatment Period||0
10868176|NCT02007512|12033378|FG002|COMPLETED|Open Label Treatment Period||0
10868177|NCT02007512|12033379|FG003|COMPLETED|Open Label Treatment Period||0
10868178|NCT02007512|12033376|FG000|NOT COMPLETED|Open Label Treatment Period||0
10868179|NCT02007512|12033377|FG001|NOT COMPLETED|Open Label Treatment Period||21
10868180|NCT02007512|12033378|FG002|NOT COMPLETED|Open Label Treatment Period||0
10868181|NCT02007512|12033379|FG003|NOT COMPLETED|Open Label Treatment Period||12
10868182|NCT01999179|12033392|FG000|STARTED|Overall Study||27
10868183|NCT01999179|12033392|FG000|COMPLETED|Overall Study||20
10868184|NCT01999179|12033392|FG000|NOT COMPLETED|Overall Study||7
10868185|NCT01858688|12033396|FG000|STARTED|Overall Study||101
10868186|NCT01858688|12033396|FG000|Biopsied at Baseline|Overall Study||97
10868187|NCT01858688|12033396|FG000|MRI Assessed|Overall Study||91
10868188|NCT01858688|12033396|FG000|COMPLETED|Overall Study||81
10868189|NCT01858688|12033396|FG000|NOT COMPLETED|Overall Study||20
10868190|NCT01796197|12033400|FG000|STARTED|Overall Study||23
10868191|NCT01796197|12033400|FG000|COMPLETED|Overall Study||21
10868192|NCT01796197|12033400|FG000|NOT COMPLETED|Overall Study||2
10868193|NCT01751906|12033406|FG000|STARTED|Overall Study||1322
10868194|NCT01751906|12033407|FG001|STARTED|Overall Study||686
10868195|NCT01751906|12033406|FG000|COMPLETED|Overall Study||1059
10868196|NCT01751906|12033407|FG001|COMPLETED|Overall Study||555
10868197|NCT01751906|12033406|FG000|NOT COMPLETED|Overall Study||263
10868198|NCT01751906|12033407|FG001|NOT COMPLETED|Overall Study||131
10868199|NCT01551550|12033415|FG000|STARTED|Overall Study||41
10868200|NCT01551550|12033416|FG001|STARTED|Overall Study||41
10868201|NCT01551550|12033415|FG000|COMPLETED|Overall Study||41
10868202|NCT01551550|12033416|FG001|COMPLETED|Overall Study||40
10868203|NCT01551550|12033415|FG000|NOT COMPLETED|Overall Study||0
10868204|NCT01551550|12033416|FG001|NOT COMPLETED|Overall Study||1
10868205|NCT01372254|12033424|FG000|STARTED|Overall Study||47
10868206|NCT01372254|12033425|FG001|STARTED|Overall Study||49
10868207|NCT01372254|12033424|FG000|COMPLETED|Overall Study||43
10868208|NCT01372254|12033425|FG001|COMPLETED|Overall Study||46
10868209|NCT01372254|12033424|FG000|NOT COMPLETED|Overall Study||4
10868210|NCT01372254|12033425|FG001|NOT COMPLETED|Overall Study||3
10868211|NCT01351766|12033431|FG000|STARTED|Overall Study||39
10868212|NCT01351766|12033431|FG000|COMPLETED|Overall Study||36
10868213|NCT01351766|12033431|FG000|NOT COMPLETED|Overall Study||3
10868214|NCT01199380|12033437|FG000|STARTED|Overall Study||88
10868215|NCT01199380|12033438|FG001|STARTED|Overall Study||96
10868216|NCT01199380|12033437|FG000|COMPLETED|Overall Study||78
10868217|NCT01199380|12033438|FG001|COMPLETED|Overall Study||81
10868218|NCT01199380|12033437|FG000|NOT COMPLETED|Overall Study||10
10868219|NCT01199380|12033438|FG001|NOT COMPLETED|Overall Study||15
10868220|NCT00810017|12033444|FG000|STARTED|Overall Study||2
10868221|NCT00810017|12033444|FG000|COMPLETED|Overall Study||0
10868222|NCT00810017|12033444|FG000|NOT COMPLETED|Overall Study||2
10868223|NCT00669669|12033448|FG000|STARTED|Overall Study||12
10868224|NCT00669669|12033448|FG000|COMPLETED|Overall Study||11
10868225|NCT00669669|12033448|FG000|NOT COMPLETED|Overall Study||1
10868235|NCT00314366|12033475|FG000|STARTED|Overall Study||11
10868236|NCT00314366|12033476|FG001|STARTED|Overall Study||10
10868237|NCT00314366|12033475|FG000|COMPLETED|Overall Study||10
10868238|NCT00314366|12033476|FG001|COMPLETED|Overall Study||10
10868239|NCT00314366|12033475|FG000|NOT COMPLETED|Overall Study||1
10868240|NCT00314366|12033476|FG001|NOT COMPLETED|Overall Study||0
10868241|NCT00187226|12033491|FG000|STARTED|Overall Study||88
10868242|NCT00187226|12033492|FG001|STARTED|Overall Study||49
10868243|NCT00187226|12033493|FG002|STARTED|Overall Study||28
10868244|NCT00187226|12033494|FG003|STARTED|Overall Study||2
10868245|NCT00187226|12033495|FG004|STARTED|Overall Study||34
10868246|NCT00187226|12033496|FG005|STARTED|Overall Study||1
10868247|NCT00187226|12033491|FG000|COMPLETED|Overall Study||88
10868248|NCT00187226|12033492|FG001|COMPLETED|Overall Study||49
10868249|NCT00187226|12033493|FG002|COMPLETED|Overall Study||28
10868250|NCT00187226|12033494|FG003|COMPLETED|Overall Study||2
10868251|NCT00187226|12033495|FG004|COMPLETED|Overall Study||34
10868252|NCT00187226|12033496|FG005|COMPLETED|Overall Study||1
10868253|NCT00187226|12033491|FG000|NOT COMPLETED|Overall Study||0
10868254|NCT00187226|12033492|FG001|NOT COMPLETED|Overall Study||0
10868255|NCT00187226|12033493|FG002|NOT COMPLETED|Overall Study||0
10868256|NCT00187226|12033494|FG003|NOT COMPLETED|Overall Study||0
10868257|NCT00187226|12033495|FG004|NOT COMPLETED|Overall Study||0
10868258|NCT00187226|12033496|FG005|NOT COMPLETED|Overall Study||0
10868259|NCT00119847|12033512|FG000|STARTED|Overall Study||149
10868260|NCT00119847|12033513|FG001|STARTED|Overall Study||151
10868261|NCT00119847|12033512|FG000|COMPLETED|Overall Study||118
10868262|NCT00119847|12033513|FG001|COMPLETED|Overall Study||119
10868263|NCT00119847|12033512|FG000|NOT COMPLETED|Overall Study||31
10868264|NCT00119847|12033513|FG001|NOT COMPLETED|Overall Study||32
10868265|NCT04748783|12033524|FG000|STARTED|Overall Study||0
10868266|NCT04748783|12033525|FG001|STARTED|Overall Study||1
10868267|NCT04748783|12033526|FG002|STARTED|Overall Study||0
10868268|NCT04748783|12033527|FG003|STARTED|Overall Study||0
10868269|NCT04748783|12033528|FG004|STARTED|Overall Study||1
10868270|NCT04748783|12033524|FG000|COMPLETED|Overall Study||0
10868271|NCT04748783|12033525|FG001|COMPLETED|Overall Study||1
10868272|NCT04748783|12033526|FG002|COMPLETED|Overall Study||0
10868273|NCT04748783|12033527|FG003|COMPLETED|Overall Study||0
10868274|NCT04748783|12033528|FG004|COMPLETED|Overall Study||1
10868275|NCT04748783|12033524|FG000|NOT COMPLETED|Overall Study||0
10868276|NCT04748783|12033525|FG001|NOT COMPLETED|Overall Study||0
10868277|NCT04748783|12033526|FG002|NOT COMPLETED|Overall Study||0
10868278|NCT04748783|12033527|FG003|NOT COMPLETED|Overall Study||0
10868279|NCT04748783|12033528|FG004|NOT COMPLETED|Overall Study||0
10868283|NCT04405570|12033549|FG000|STARTED|Overall Study||23
10868284|NCT04405570|12033550|FG001|STARTED|Overall Study||64
10868285|NCT04405570|12033551|FG002|STARTED|Overall Study||55
10868286|NCT04405570|12033552|FG003|STARTED|Overall Study||62
10868287|NCT04405570|12033549|FG000|Number of Subjects Randomized Not Dosed|Overall Study||0
10868288|NCT04405570|12033550|FG001|Number of Subjects Randomized Not Dosed|Overall Study||2
10868289|NCT04405570|12033551|FG002|Number of Subjects Randomized Not Dosed|Overall Study||0
10868379|NCT02153632|12033660|FG000|NOT COMPLETED|Overall Study||18
10868290|NCT04405570|12033552|FG003|Number of Subjects Randomized Not Dosed|Overall Study||0
10868291|NCT04405570|12033549|FG000|Number of Subjects in the Safety Population|Overall Study||23
10868292|NCT04405570|12033550|FG001|Number of Subjects in the Safety Population|Overall Study||62
10868293|NCT04405570|12033551|FG002|Number of Subjects in the Safety Population|Overall Study||55
10868294|NCT04405570|12033552|FG003|Number of Subjects in the Safety Population|Overall Study||62
10868295|NCT04405570|12033549|FG000|Number of Subjects in the mITT Population|Overall Study||23
10868296|NCT04405570|12033550|FG001|Number of Subjects in the mITT Population|Overall Study||61
10868297|NCT04405570|12033551|FG002|Number of Subjects in the mITT Population|Overall Study||53
10868298|NCT04405570|12033552|FG003|Number of Subjects in the mITT Population|Overall Study||61
10868299|NCT04405570|12033549|FG000|COMPLETED|Overall Study||23
10868300|NCT04405570|12033550|FG001|COMPLETED|Overall Study||59
10868301|NCT04405570|12033551|FG002|COMPLETED|Overall Study||52
10868302|NCT04405570|12033552|FG003|COMPLETED|Overall Study||61
10868303|NCT04405570|12033549|FG000|NOT COMPLETED|Overall Study||0
10868304|NCT04405570|12033550|FG001|NOT COMPLETED|Overall Study||5
10868305|NCT04405570|12033551|FG002|NOT COMPLETED|Overall Study||3
10868306|NCT04405570|12033552|FG003|NOT COMPLETED|Overall Study||1
10868307|NCT04135937|12033565|FG000|STARTED|Overall Study||12
10868308|NCT04135937|12033565|FG000|COMPLETED|Overall Study||9
10868309|NCT04135937|12033565|FG000|NOT COMPLETED|Overall Study||3
10868310|NCT03989232|12033571|FG000|STARTED|Overall Study||481
10868311|NCT03989232|12033572|FG001|STARTED|Overall Study||480
10868312|NCT03989232|12033571|FG000|Exposed|Overall Study||480
10868313|NCT03989232|12033572|FG001|Exposed|Overall Study||479
10868314|NCT03989232|12033571|FG000|Safety Analysis Set (SAS)|Overall Study||480
10868315|NCT03989232|12033572|FG001|Safety Analysis Set (SAS)|Overall Study||479
10868316|NCT03989232|12033571|FG000|Full Analysis Set (FAS)|Overall Study||481
10868317|NCT03989232|12033572|FG001|Full Analysis Set (FAS)|Overall Study||480
10868318|NCT03989232|12033571|FG000|COMPLETED|Overall Study||471
10868319|NCT03989232|12033572|FG001|COMPLETED|Overall Study||462
10868320|NCT03989232|12033571|FG000|NOT COMPLETED|Overall Study||10
10868321|NCT03989232|12033572|FG001|NOT COMPLETED|Overall Study||18
10868322|NCT03896295|12033580|FG000|STARTED|Overall Study||7
10868323|NCT03896295|12033581|FG001|STARTED|Overall Study||30
10868324|NCT03896295|12033580|FG000|COMPLETED|Overall Study||0
10868325|NCT03896295|12033581|FG001|COMPLETED|Overall Study||0
10868326|NCT03896295|12033580|FG000|NOT COMPLETED|Overall Study||7
10868327|NCT03896295|12033581|FG001|NOT COMPLETED|Overall Study||30
10868328|NCT03213457|12033595|FG000|STARTED|Overall Study||194
10868329|NCT03213457|12033596|FG001|STARTED|Overall Study||98
10868330|NCT03213457|12033597|FG002|STARTED|Overall Study||389
10868331|NCT03213457|12033595|FG000|Randomized and Treated|Overall Study||193
10868332|NCT03213457|12033596|FG001|Randomized and Treated|Overall Study||97
10868333|NCT03213457|12033597|FG002|Randomized and Treated|Overall Study||389
10868334|NCT03213457|12033595|FG000|COMPLETED|Overall Study||106
10868335|NCT03213457|12033596|FG001|COMPLETED|Overall Study||59
10868336|NCT03213457|12033597|FG002|COMPLETED|Overall Study||215
10868337|NCT03213457|12033595|FG000|NOT COMPLETED|Overall Study||88
10868338|NCT03213457|12033596|FG001|NOT COMPLETED|Overall Study||39
10868339|NCT03213457|12033597|FG002|NOT COMPLETED|Overall Study||174
10868340|NCT02982720|12033605|FG000|STARTED|Overall Study||4
10868341|NCT02982720|12033605|FG000|COMPLETED|Overall Study||0
10868342|NCT02982720|12033605|FG000|NOT COMPLETED|Overall Study||4
10868343|NCT02548754|12033611|FG000|STARTED|Overall Study||26
10868344|NCT02548754|12033612|FG001|STARTED|Overall Study||27
10868345|NCT02548754|12033611|FG000|COMPLETED|Overall Study||24
10868346|NCT02548754|12033612|FG001|COMPLETED|Overall Study||23
10868347|NCT02548754|12033611|FG000|NOT COMPLETED|Overall Study||2
10868348|NCT02548754|12033612|FG001|NOT COMPLETED|Overall Study||4
10868349|NCT02375672|12033618|FG000|STARTED|Overall Study||30
10868350|NCT02375672|12033618|FG000|COMPLETED|Overall Study||10
10868351|NCT02375672|12033618|FG000|NOT COMPLETED|Overall Study||20
10868352|NCT02329327|12033624|FG000|STARTED|Overall Study||477
10868353|NCT02329327|12033625|FG001|STARTED|Overall Study||2
10868354|NCT02329327|12033624|FG000|Received At Least 1 Dose of Study Drug|Overall Study||477
10868355|NCT02329327|12033625|FG001|Received At Least 1 Dose of Study Drug|Overall Study||2
10868356|NCT02329327|12033624|FG000|Efficacy Population|Overall Study||347
10868357|NCT02329327|12033625|FG001|Efficacy Population|Overall Study||2
10868358|NCT02329327|12033624|FG000|Death|Overall Study||3
10868359|NCT02329327|12033625|FG001|Death|Overall Study||0
10868360|NCT02329327|12033624|FG000|COMPLETED|Overall Study||392
10868361|NCT02329327|12033625|FG001|COMPLETED|Overall Study||2
10868362|NCT02329327|12033624|FG000|NOT COMPLETED|Overall Study||85
10868363|NCT02329327|12033625|FG001|NOT COMPLETED|Overall Study||0
10868364|NCT02153645|12033647|FG000|STARTED|Overall Study||30
10868365|NCT02153645|12033648|FG001|STARTED|Overall Study||29
10868366|NCT02153645|12033649|FG002|STARTED|Overall Study||28
10868367|NCT02153645|12033647|FG000|COMPLETED|Overall Study||17
10868368|NCT02153645|12033648|FG001|COMPLETED|Overall Study||19
10868369|NCT02153645|12033649|FG002|COMPLETED|Overall Study||18
10868370|NCT02153645|12033647|FG000|NOT COMPLETED|Overall Study||13
10868371|NCT02153645|12033648|FG001|NOT COMPLETED|Overall Study||10
10868372|NCT02153645|12033649|FG002|NOT COMPLETED|Overall Study||10
10868373|NCT02153632|12033660|FG000|STARTED|Overall Study||45
10868374|NCT02153632|12033661|FG001|STARTED|Overall Study||46
10868375|NCT02153632|12033662|FG002|STARTED|Overall Study||44
10868376|NCT02153632|12033660|FG000|COMPLETED|Overall Study||27
10868377|NCT02153632|12033661|FG001|COMPLETED|Overall Study||27
10868378|NCT02153632|12033662|FG002|COMPLETED|Overall Study||25
10868380|NCT02153632|12033661|FG001|NOT COMPLETED|Overall Study||19
10868381|NCT02153632|12033662|FG002|NOT COMPLETED|Overall Study||19
10868382|NCT01689909|12033672|FG000|STARTED|Overall Study||51
10868383|NCT01689909|12033673|FG001|STARTED|Overall Study||52
10868384|NCT01689909|12033672|FG000|COMPLETED|Overall Study||51
10868385|NCT01689909|12033673|FG001|COMPLETED|Overall Study||52
10868386|NCT01689909|12033672|FG000|NOT COMPLETED|Overall Study||0
10868387|NCT01689909|12033673|FG001|NOT COMPLETED|Overall Study||0
10868388|NCT01566149|12033683|FG000|STARTED|Overall Study||24
10868389|NCT01566149|12033684|FG001|STARTED|Overall Study||25
10868390|NCT01566149|12033683|FG000|COMPLETED|Overall Study||21
10868391|NCT01566149|12033684|FG001|COMPLETED|Overall Study||23
10868392|NCT01566149|12033683|FG000|NOT COMPLETED|Overall Study||3
10868393|NCT01566149|12033684|FG001|NOT COMPLETED|Overall Study||2
10868394|NCT01481935|12033692|FG000|STARTED|Overall Study||97
10868395|NCT01481935|12033693|FG001|STARTED|Overall Study||93
10868396|NCT01481935|12033692|FG000|COMPLETED|Overall Study||97
10868397|NCT01481935|12033693|FG001|COMPLETED|Overall Study||93
10868398|NCT01481935|12033692|FG000|NOT COMPLETED|Overall Study||0
10868399|NCT01481935|12033693|FG001|NOT COMPLETED|Overall Study||0
10868400|NCT01386125|12033701|FG000|STARTED|Overall Study||375
10418552|NCT00806156|11563268|FG001|NOT COMPLETED|Overall Study||139
10418553|NCT00806195|11563290|FG000|STARTED|Overall Study||4363
10418554|NCT00806195|11563291|FG001|STARTED|Overall Study||1483
10418555|NCT00806195|11563292|FG002|STARTED|Overall Study||1409
10418556|NCT00806195|11563293|FG003|STARTED|Overall Study||489
10418557|NCT00806195|11563290|FG000|COMPLETED|Overall Study||3849
10418558|NCT00806195|11563291|FG001|COMPLETED|Overall Study||1321
10418559|NCT00806195|11563292|FG002|COMPLETED|Overall Study||1139
10418560|NCT00806195|11563293|FG003|COMPLETED|Overall Study||383
10418561|NCT00806195|11563290|FG000|NOT COMPLETED|Overall Study||514
10418562|NCT00806195|11563291|FG001|NOT COMPLETED|Overall Study||162
10418563|NCT00806195|11563292|FG002|NOT COMPLETED|Overall Study||270
10418564|NCT00806195|11563293|FG003|NOT COMPLETED|Overall Study||106
10418565|NCT00806221|11563305|FG000|STARTED|Overall Study||22
10418566|NCT00806221|11563305|FG000|COMPLETED|Overall Study||20
10418567|NCT00806221|11563305|FG000|NOT COMPLETED|Overall Study||2
10418568|NCT00806234|11563312|FG000|STARTED|Overall Study||47
10418569|NCT00806234|11563313|FG001|STARTED|Overall Study||31
10418570|NCT00806234|11563314|FG002|STARTED|Overall Study||49
10418571|NCT00806234|11563312|FG000|COMPLETED|Overall Study||34
10418572|NCT00806234|11563313|FG001|COMPLETED|Overall Study||19
10418573|NCT00806234|11563314|FG002|COMPLETED|Overall Study||37
10418574|NCT00806234|11563312|FG000|NOT COMPLETED|Overall Study||13
10418575|NCT00806234|11563313|FG001|NOT COMPLETED|Overall Study||12
10418576|NCT00806234|11563314|FG002|NOT COMPLETED|Overall Study||12
10418577|NCT00806260|11563328|FG000|STARTED|Period 1 (1 Day)||15
10418578|NCT00806260|11563329|FG001|STARTED|Period 1 (1 Day)||8
10418579|NCT00806260|11563330|FG002|STARTED|Period 1 (1 Day)||8
10418580|NCT00806260|11563331|FG003|STARTED|Period 1 (1 Day)||14
10418581|NCT00806260|11563332|FG004|STARTED|Period 1 (1 Day)||18
10418582|NCT00806260|11563333|FG005|STARTED|Period 1 (1 Day)||17
10418583|NCT00806260|11563328|FG000|COMPLETED|Period 1 (1 Day)||15
10418584|NCT00806260|11563329|FG001|COMPLETED|Period 1 (1 Day)||8
10418585|NCT00806260|11563330|FG002|COMPLETED|Period 1 (1 Day)||8
10418586|NCT00806260|11563331|FG003|COMPLETED|Period 1 (1 Day)||14
10418587|NCT00806260|11563332|FG004|COMPLETED|Period 1 (1 Day)|did not move onto Periods 2 and 3 due to adjusted design of study|15
10418588|NCT00806260|11563333|FG005|COMPLETED|Period 1 (1 Day)|did not move onto Periods 2 and 3 due to adjusted design of study|17
10418589|NCT00806260|11563328|FG000|NOT COMPLETED|Period 1 (1 Day)||0
10418590|NCT00806260|11563329|FG001|NOT COMPLETED|Period 1 (1 Day)||0
10418591|NCT00806260|11563330|FG002|NOT COMPLETED|Period 1 (1 Day)||0
10418592|NCT00806260|11563331|FG003|NOT COMPLETED|Period 1 (1 Day)||0
10418593|NCT00806260|11563332|FG004|NOT COMPLETED|Period 1 (1 Day)||3
10418594|NCT00806260|11563333|FG005|NOT COMPLETED|Period 1 (1 Day)||0
10418595|NCT00806260|11563328|FG000|STARTED|Period 2||15
10418596|NCT00806260|11563329|FG001|STARTED|Period 2||8
10418597|NCT00806260|11563330|FG002|STARTED|Period 2||8
10418598|NCT00806260|11563331|FG003|STARTED|Period 2||14
10418599|NCT00806260|11563332|FG004|STARTED|Period 2||0
10418600|NCT00806260|11563333|FG005|STARTED|Period 2||0
10418601|NCT00806260|11563328|FG000|COMPLETED|Period 2||13
10545882|NCT01500317|11699403|FG000|COMPLETED|Overall Study||10
10545883|NCT01500317|11699404|FG001|COMPLETED|Overall Study||10
10545884|NCT01500317|11699405|FG002|COMPLETED|Overall Study||13
10545885|NCT01500317|11699403|FG000|NOT COMPLETED|Overall Study||3
10545886|NCT01500317|11699404|FG001|NOT COMPLETED|Overall Study||2
10545887|NCT01500317|11699405|FG002|NOT COMPLETED|Overall Study||0
10545888|NCT01500382|11699417|FG000|STARTED|Treatment Period 1||1
10545889|NCT01500382|11699418|FG001|STARTED|Treatment Period 1||1
10545890|NCT01500382|11699419|FG002|STARTED|Treatment Period 1||1
10545891|NCT01500382|11699420|FG003|STARTED|Treatment Period 1||1
10545892|NCT01500382|11699417|FG000|COMPLETED|Treatment Period 1||1
10545893|NCT01500382|11699418|FG001|COMPLETED|Treatment Period 1||1
10545894|NCT01500382|11699419|FG002|COMPLETED|Treatment Period 1||1
10545895|NCT01500382|11699420|FG003|COMPLETED|Treatment Period 1||1
10545896|NCT01500382|11699417|FG000|NOT COMPLETED|Treatment Period 1||0
10545897|NCT01500382|11699418|FG001|NOT COMPLETED|Treatment Period 1||0
10545898|NCT01500382|11699419|FG002|NOT COMPLETED|Treatment Period 1||0
10545899|NCT01500382|11699420|FG003|NOT COMPLETED|Treatment Period 1||0
10545900|NCT01500382|11699417|FG000|STARTED|Washout Period||1
10545901|NCT01500382|11699418|FG001|STARTED|Washout Period||1
10545902|NCT01500382|11699419|FG002|STARTED|Washout Period||1
10545903|NCT01500382|11699420|FG003|STARTED|Washout Period||1
10545904|NCT01500382|11699417|FG000|COMPLETED|Washout Period||1
10545905|NCT01500382|11699418|FG001|COMPLETED|Washout Period||1
10545906|NCT01500382|11699419|FG002|COMPLETED|Washout Period||0
10545907|NCT01500382|11699420|FG003|COMPLETED|Washout Period||1
10545908|NCT01500382|11699417|FG000|NOT COMPLETED|Washout Period||0
10545909|NCT01500382|11699418|FG001|NOT COMPLETED|Washout Period||0
10545910|NCT01500382|11699419|FG002|NOT COMPLETED|Washout Period||1
10545911|NCT01500382|11699420|FG003|NOT COMPLETED|Washout Period||0
10545912|NCT01500382|11699417|FG000|STARTED|Treatment Period 2||1
10545913|NCT01500382|11699418|FG001|STARTED|Treatment Period 2||1
10545914|NCT01500382|11699419|FG002|STARTED|Treatment Period 2||0
10868401|NCT01386125|12033702|FG001|STARTED|Overall Study||373
10418602|NCT00806260|11563329|FG001|COMPLETED|Period 2||8
10418603|NCT00806260|11563330|FG002|COMPLETED|Period 2||6
10418604|NCT00806260|11563331|FG003|COMPLETED|Period 2||12
10418605|NCT00806260|11563332|FG004|COMPLETED|Period 2||0
10418606|NCT00806260|11563333|FG005|COMPLETED|Period 2||0
10868402|NCT01386125|12033701|FG000|COMPLETED|Overall Study||350
10868403|NCT01386125|12033702|FG001|COMPLETED|Overall Study||336
10868404|NCT01386125|12033701|FG000|NOT COMPLETED|Overall Study||25
10868405|NCT01386125|12033702|FG001|NOT COMPLETED|Overall Study||37
10868406|NCT01257568|12033708|FG000|STARTED|Overall Study||40
10868407|NCT01257568|12033708|FG000|COMPLETED|Overall Study||7
10868408|NCT01257568|12033708|FG000|NOT COMPLETED|Overall Study||33
10868409|NCT01165424|12033714|FG000|STARTED|Overall Study||80
10868410|NCT01165424|12033714|FG000|COMPLETED|Overall Study||76
10868411|NCT01165424|12033714|FG000|NOT COMPLETED|Overall Study||4
10868412|NCT01135134|12033720|FG000|STARTED|Overall Study||220
10868413|NCT01135134|12033721|FG001|STARTED|Overall Study||113
10868414|NCT01135134|12033720|FG000|COMPLETED|Overall Study||218
10868415|NCT01135134|12033721|FG001|COMPLETED|Overall Study||112
10868416|NCT01135134|12033720|FG000|NOT COMPLETED|Overall Study||2
10868417|NCT01135134|12033721|FG001|NOT COMPLETED|Overall Study||1
10868418|NCT00867165|12033729|FG000|STARTED|Overall Study||93
10868419|NCT00867165|12033730|FG001|STARTED|Overall Study||45
10868420|NCT00867165|12033729|FG000|COMPLETED|Overall Study||89
10868421|NCT00867165|12033730|FG001|COMPLETED|Overall Study||45
10868422|NCT00867165|12033729|FG000|NOT COMPLETED|Overall Study||4
10868423|NCT00867165|12033730|FG001|NOT COMPLETED|Overall Study||0
10868424|NCT00733005|12033738|FG000|STARTED|Overall Study||162
10868425|NCT00733005|12033739|FG001|STARTED|Overall Study||162
10868426|NCT00733005|12033738|FG000|COMPLETED|Overall Study||160
10868427|NCT00733005|12033739|FG001|COMPLETED|Overall Study||159
10868428|NCT00733005|12033738|FG000|NOT COMPLETED|Overall Study||2
10868429|NCT00733005|12033739|FG001|NOT COMPLETED|Overall Study||3
10868430|NCT00732381|12033747|FG000|STARTED|Overall Study||176
10868431|NCT00732381|12033748|FG001|STARTED|Overall Study||175
10868432|NCT00732381|12033747|FG000|COMPLETED|Overall Study||174
10868433|NCT00732381|12033748|FG001|COMPLETED|Overall Study||174
10868434|NCT00732381|12033747|FG000|NOT COMPLETED|Overall Study||2
10868435|NCT00732381|12033748|FG001|NOT COMPLETED|Overall Study||1
10868436|NCT00654095|12033754|FG000|STARTED|Overall Study||146
10868437|NCT00654095|12033754|FG000|COMPLETED|Overall Study||114
10868438|NCT00654095|12033754|FG000|NOT COMPLETED|Overall Study||32
10868439|NCT00653523|12033758|FG000|STARTED|Overall Study||151
10868440|NCT00653523|12033758|FG000|COMPLETED|Overall Study||132
10868441|NCT00653523|12033758|FG000|NOT COMPLETED|Overall Study||19
10868442|NCT00599027|12033764|FG000|STARTED|Overall Study||26
10868443|NCT00599027|12033765|FG001|STARTED|Overall Study||25
10868444|NCT00599027|12033764|FG000|COMPLETED|Overall Study||25
10868445|NCT00599027|12033765|FG001|COMPLETED|Overall Study||22
10868446|NCT00599027|12033764|FG000|NOT COMPLETED|Overall Study||1
10868447|NCT00599027|12033765|FG001|NOT COMPLETED|Overall Study||3
10868448|NCT00552032|12033773|FG000|STARTED|Overall Study||66
10868449|NCT00552032|12033774|FG001|STARTED|Overall Study||66
10868450|NCT00552032|12033773|FG000|COMPLETED|Overall Study||49
10868451|NCT00552032|12033774|FG001|COMPLETED|Overall Study||47
10868452|NCT00552032|12033773|FG000|NOT COMPLETED|Overall Study||17
10868453|NCT00552032|12033774|FG001|NOT COMPLETED|Overall Study||19
10868454|NCT00546052|12033780|FG000|STARTED|Overall Study||1738
10868455|NCT00546052|12033780|FG000|Week 4|Overall Study||1714
10868456|NCT00546052|12033780|FG000|Week 8|Overall Study||1680
10868457|NCT00546052|12033780|FG000|Week 12|Overall Study||1650
10868458|NCT00546052|12033780|FG000|Week 32|Overall Study||1583
10868459|NCT00546052|12033780|FG000|Week 52|Overall Study||1511
10868460|NCT00546052|12033780|FG000|COMPLETED|Overall Study||1511
10868461|NCT00546052|12033780|FG000|NOT COMPLETED|Overall Study||227
10868462|NCT00442117|12033789|FG000|STARTED|Overall Study||85
10868463|NCT00442117|12033790|FG001|STARTED|Overall Study||87
10868464|NCT00442117|12033789|FG000|COMPLETED|Overall Study||47
10868465|NCT00442117|12033790|FG001|COMPLETED|Overall Study||49
10868466|NCT00442117|12033789|FG000|NOT COMPLETED|Overall Study||38
10868467|NCT00442117|12033790|FG001|NOT COMPLETED|Overall Study||38
10868468|NCT00424008|12033798|FG000|STARTED|Overall Study||371
10868469|NCT00424008|12033799|FG001|STARTED|Overall Study||351
10868470|NCT00424008|12033798|FG000|COMPLETED|Overall Study||22
10868471|NCT00424008|12033799|FG001|COMPLETED|Overall Study||16
10868472|NCT00424008|12033798|FG000|NOT COMPLETED|Overall Study||349
10418607|NCT00806260|11563328|FG000|NOT COMPLETED|Period 2||2
10418608|NCT00806260|11563329|FG001|NOT COMPLETED|Period 2||0
10418609|NCT00806260|11563330|FG002|NOT COMPLETED|Period 2||2
10418610|NCT00806260|11563331|FG003|NOT COMPLETED|Period 2||2
10418611|NCT00806260|11563332|FG004|NOT COMPLETED|Period 2||0
10418612|NCT00806260|11563333|FG005|NOT COMPLETED|Period 2||0
10418613|NCT00806260|11563328|FG000|STARTED|Period 3||13
10418614|NCT00806260|11563329|FG001|STARTED|Period 3||8
10418615|NCT00806260|11563330|FG002|STARTED|Period 3||6
10418616|NCT00806260|11563331|FG003|STARTED|Period 3||12
10418617|NCT00806260|11563332|FG004|STARTED|Period 3||0
10868473|NCT00424008|12033799|FG001|NOT COMPLETED|Overall Study||335
10418618|NCT00806260|11563333|FG005|STARTED|Period 3||0
10868474|NCT00423176|12033808|FG000|STARTED|Overall Study||114
10868475|NCT00423176|12033809|FG001|STARTED|Overall Study||123
10868476|NCT00423176|12033808|FG000|COMPLETED|Overall Study||98
10868477|NCT00423176|12033809|FG001|COMPLETED|Overall Study||94
10418619|NCT00806260|11563328|FG000|COMPLETED|Period 3||12
10868478|NCT00423176|12033808|FG000|NOT COMPLETED|Overall Study||16
10868479|NCT00423176|12033809|FG001|NOT COMPLETED|Overall Study||29
10868480|NCT00383240|12033819|FG000|STARTED|Overall Study||191
10868481|NCT00383240|12033820|FG001|STARTED|Overall Study||192
10868482|NCT00383240|12033821|FG002|STARTED|Overall Study||202
10868483|NCT00383240|12033822|FG003|STARTED|Overall Study||196
10868484|NCT00383240|12033819|FG000|COMPLETED|Overall Study||156
10868485|NCT00383240|12033820|FG001|COMPLETED|Overall Study||159
10868486|NCT00383240|12033821|FG002|COMPLETED|Overall Study||117
10868487|NCT00383240|12033822|FG003|COMPLETED|Overall Study||119
10868488|NCT00383240|12033819|FG000|NOT COMPLETED|Overall Study||35
10868489|NCT00383240|12033820|FG001|NOT COMPLETED|Overall Study||33
10868490|NCT00383240|12033821|FG002|NOT COMPLETED|Overall Study||85
10868491|NCT00383240|12033822|FG003|NOT COMPLETED|Overall Study||77
10868492|NCT02797067|12033835|FG000|STARTED|Overall Study||685
10868493|NCT02797067|12033836|FG001|STARTED|Overall Study||685
10868494|NCT02797067|12033835|FG000|COMPLETED|Overall Study||685
10868495|NCT02797067|12033836|FG001|COMPLETED|Overall Study||685
10868496|NCT02797067|12033835|FG000|NOT COMPLETED|Overall Study||0
10868497|NCT02797067|12033836|FG001|NOT COMPLETED|Overall Study||0
10868498|NCT02787499|12033844|FG000|STARTED|Overall Study||423
10868499|NCT02787499|12033845|FG001|STARTED|Overall Study||417
10868500|NCT02787499|12033844|FG000|COMPLETED|Overall Study||423
10868501|NCT02787499|12033845|FG001|COMPLETED|Overall Study||417
10868502|NCT02787499|12033844|FG000|NOT COMPLETED|Overall Study||0
10868503|NCT02787499|12033845|FG001|NOT COMPLETED|Overall Study||0
10868504|NCT02765399|12033853|FG000|STARTED|Overall Study||16
10868505|NCT02765399|12033854|FG001|STARTED|Overall Study||7
10868506|NCT02765399|12033853|FG000|COMPLETED|Overall Study||15
10868507|NCT02765399|12033854|FG001|COMPLETED|Overall Study||7
10868508|NCT02765399|12033853|FG000|NOT COMPLETED|Overall Study||1
10868509|NCT02765399|12033854|FG001|NOT COMPLETED|Overall Study||0
10868518|NCT04468074|12033871|FG000|STARTED|Overall Study||31
10868519|NCT04468074|12033872|FG001|STARTED|Overall Study||30
10868520|NCT04468074|12033871|FG000|COMPLETED|Overall Study||30
10868521|NCT04468074|12033872|FG001|COMPLETED|Overall Study||30
10868522|NCT04468074|12033871|FG000|NOT COMPLETED|Overall Study||1
10868523|NCT04468074|12033872|FG001|NOT COMPLETED|Overall Study||0
10868532|NCT03894969|12033892|FG000|STARTED|Overall Study||134
10868533|NCT03894969|12033893|FG001|STARTED|Overall Study||134
10868534|NCT03894969|12033894|FG002|STARTED|Overall Study||122
10868535|NCT03894969|12033895|FG003|STARTED|Overall Study||135
10868536|NCT03894969|12033896|FG004|STARTED|Overall Study||16
10868537|NCT03894969|12033892|FG000|COMPLETED|Overall Study||129
10868538|NCT03894969|12033893|FG001|COMPLETED|Overall Study||129
10868539|NCT03894969|12033894|FG002|COMPLETED|Overall Study||118
10868540|NCT03894969|12033895|FG003|COMPLETED|Overall Study||128
10868541|NCT03894969|12033896|FG004|COMPLETED|Overall Study||2
10868542|NCT03894969|12033892|FG000|NOT COMPLETED|Overall Study||5
10868543|NCT03894969|12033893|FG001|NOT COMPLETED|Overall Study||5
10868544|NCT03894969|12033894|FG002|NOT COMPLETED|Overall Study||4
10868545|NCT03894969|12033895|FG003|NOT COMPLETED|Overall Study||7
10868546|NCT03894969|12033896|FG004|NOT COMPLETED|Overall Study||14
10868547|NCT03523273|12033912|FG000|STARTED|Overall Study||67
10868548|NCT03523273|12033913|FG001|STARTED|Overall Study||69
10868549|NCT03523273|12033912|FG000|COMPLETED|Overall Study||59
10868550|NCT03523273|12033913|FG001|COMPLETED|Overall Study||65
10868551|NCT03523273|12033912|FG000|NOT COMPLETED|Overall Study||8
10868552|NCT03523273|12033913|FG001|NOT COMPLETED|Overall Study||4
10868553|NCT03464136|12033921|FG000|STARTED|Overall Study||195
10868554|NCT03464136|12033922|FG001|STARTED|Overall Study||191
10868555|NCT03464136|12033921|FG000|COMPLETED|Overall Study||165
10868556|NCT03464136|12033922|FG001|COMPLETED|Overall Study||166
10868557|NCT03464136|12033921|FG000|NOT COMPLETED|Overall Study||30
10868558|NCT03464136|12033922|FG001|NOT COMPLETED|Overall Study||25
10868559|NCT03338816|12033930|FG000|STARTED|6-Month Double-blind Period||46
10868560|NCT03338816|12033931|FG001|STARTED|6-Month Double-blind Period||48
10868561|NCT03338816|12033932|FG002|STARTED|6-Month Double-blind Period||0
10868562|NCT03338816|12033933|FG003|STARTED|6-Month Double-blind Period||0
10868563|NCT03338816|12033930|FG000|COMPLETED|6-Month Double-blind Period||46
10868564|NCT03338816|12033931|FG001|COMPLETED|6-Month Double-blind Period|1 participant discontinued treatment during the 6-month DB period due to an adverse event but completed the 6-month DB Visit|48
10868565|NCT03338816|12033932|FG002|COMPLETED|6-Month Double-blind Period||0
10868566|NCT03338816|12033933|FG003|COMPLETED|6-Month Double-blind Period||0
10868567|NCT03338816|12033930|FG000|NOT COMPLETED|6-Month Double-blind Period||0
10868568|NCT03338816|12033931|FG001|NOT COMPLETED|6-Month Double-blind Period||0
10868569|NCT03338816|12033932|FG002|NOT COMPLETED|6-Month Double-blind Period||0
10868570|NCT03338816|12033933|FG003|NOT COMPLETED|6-Month Double-blind Period||0
10868571|NCT03338816|12033930|FG000|STARTED|6-Month DB + Open-Label Extension Period||0
10868572|NCT03338816|12033931|FG001|STARTED|6-Month DB + Open-Label Extension Period||0
10868573|NCT03338816|12033932|FG002|STARTED|6-Month DB + Open-Label Extension Period||46
10868574|NCT03338816|12033933|FG003|STARTED|6-Month DB + Open-Label Extension Period||47
10868575|NCT03338816|12033930|FG000|COMPLETED|6-Month DB + Open-Label Extension Period||0
10868576|NCT03338816|12033931|FG001|COMPLETED|6-Month DB + Open-Label Extension Period||0
10868577|NCT03338816|12033932|FG002|COMPLETED|6-Month DB + Open-Label Extension Period||38
10868578|NCT03338816|12033933|FG003|COMPLETED|6-Month DB + Open-Label Extension Period||41
10868579|NCT03338816|12033930|FG000|NOT COMPLETED|6-Month DB + Open-Label Extension Period||0
10868580|NCT03338816|12033931|FG001|NOT COMPLETED|6-Month DB + Open-Label Extension Period||0
10868581|NCT03338816|12033932|FG002|NOT COMPLETED|6-Month DB + Open-Label Extension Period||8
10868582|NCT03338816|12033933|FG003|NOT COMPLETED|6-Month DB + Open-Label Extension Period||6
10868583|NCT03318809|12033944|FG000|STARTED|Overall Study||6
10868584|NCT03318809|12033945|FG001|STARTED|Overall Study||6
10868585|NCT03318809|12033944|FG000|COMPLETED|Overall Study||6
10868586|NCT03318809|12033945|FG001|COMPLETED|Overall Study||6
10868587|NCT03318809|12033944|FG000|NOT COMPLETED|Overall Study||0
10868588|NCT03318809|12033945|FG001|NOT COMPLETED|Overall Study||0
10868589|NCT03317496|12033955|FG000|STARTED|Phase 1b Lead-in: Treatment||6
10868590|NCT03317496|12033956|FG001|STARTED|Phase 1b Lead-in: Treatment||13
10868591|NCT03317496|12033957|FG002|STARTED|Phase 1b Lead-in: Treatment||6
10868592|NCT03317496|12033958|FG003|STARTED|Phase 1b Lead-in: Treatment||6
10868593|NCT03317496|12033959|FG004|STARTED|Phase 1b Lead-in: Treatment||0
10868594|NCT03317496|12033955|FG000|COMPLETED|Phase 1b Lead-in: Treatment||0
10868595|NCT03317496|12033956|FG001|COMPLETED|Phase 1b Lead-in: Treatment||0
10868596|NCT03317496|12033957|FG002|COMPLETED|Phase 1b Lead-in: Treatment||0
10868597|NCT03317496|12033958|FG003|COMPLETED|Phase 1b Lead-in: Treatment||0
10868598|NCT03317496|12033959|FG004|COMPLETED|Phase 1b Lead-in: Treatment||0
10868599|NCT03317496|12033955|FG000|NOT COMPLETED|Phase 1b Lead-in: Treatment||6
10868600|NCT03317496|12033956|FG001|NOT COMPLETED|Phase 1b Lead-in: Treatment||13
10868601|NCT03317496|12033957|FG002|NOT COMPLETED|Phase 1b Lead-in: Treatment||6
10868602|NCT03317496|12033958|FG003|NOT COMPLETED|Phase 1b Lead-in: Treatment||6
10868603|NCT03317496|12033959|FG004|NOT COMPLETED|Phase 1b Lead-in: Treatment||0
10868604|NCT03317496|12033955|FG000|STARTED|Phase 1b Lead-in: Follow-up|Eligible participants entered follow-up period following discontinuation of study treatment.|4
10868605|NCT03317496|12033956|FG001|STARTED|Phase 1b Lead-in: Follow-up|Eligible participants entered follow-up period following discontinuation of study treatment.|11
10868606|NCT03317496|12033957|FG002|STARTED|Phase 1b Lead-in: Follow-up|Eligible participants entered follow-up period following discontinuation of study treatment.|5
10868607|NCT03317496|12033958|FG003|STARTED|Phase 1b Lead-in: Follow-up|Eligible participants entered follow-up period following discontinuation of study treatment.|4
10868608|NCT03317496|12033959|FG004|STARTED|Phase 1b Lead-in: Follow-up||0
10868609|NCT03317496|12033955|FG000|COMPLETED|Phase 1b Lead-in: Follow-up||0
10868610|NCT03317496|12033956|FG001|COMPLETED|Phase 1b Lead-in: Follow-up||0
10868611|NCT03317496|12033957|FG002|COMPLETED|Phase 1b Lead-in: Follow-up||0
10868612|NCT03317496|12033958|FG003|COMPLETED|Phase 1b Lead-in: Follow-up||0
10868613|NCT03317496|12033959|FG004|COMPLETED|Phase 1b Lead-in: Follow-up||0
10868614|NCT03317496|12033955|FG000|NOT COMPLETED|Phase 1b Lead-in: Follow-up||4
10868615|NCT03317496|12033956|FG001|NOT COMPLETED|Phase 1b Lead-in: Follow-up||11
10868616|NCT03317496|12033957|FG002|NOT COMPLETED|Phase 1b Lead-in: Follow-up||5
10868617|NCT03317496|12033958|FG003|NOT COMPLETED|Phase 1b Lead-in: Follow-up||4
10868618|NCT03317496|12033959|FG004|NOT COMPLETED|Phase 1b Lead-in: Follow-up||0
10868619|NCT03317496|12033955|FG000|STARTED|Phase 2: Treatment|Participants of Phase 1b Lead-in: Avelumab 800 mg + Pemetrexed/Carboplatin did not enter Phase 2.|0
10868620|NCT03317496|12033956|FG001|STARTED|Phase 2: Treatment|Participants of Phase 1b Lead-in: Avelumab 800 mg + Gemcitabine/Cisplatin did not enter Phase 2.|0
10868621|NCT03317496|12033957|FG002|STARTED|Phase 2: Treatment|Participants of Phase 1b Lead-in: Avelumab 1200 mg + Pemetrexed/Carboplatin did not enter Phase 2.|0
10868622|NCT03317496|12033958|FG003|STARTED|Phase 2: Treatment|Participants of Phase 1b Lead-in: Avelumab 1200 mg + Gemcitabine/Cisplatin did not enter Phase 2.|0
10868623|NCT03317496|12033959|FG004|STARTED|Phase 2: Treatment|Additional participants were enrolled in Phase 2.|35
10868624|NCT03317496|12033955|FG000|COMPLETED|Phase 2: Treatment||0
10868625|NCT03317496|12033956|FG001|COMPLETED|Phase 2: Treatment||0
10868626|NCT03317496|12033957|FG002|COMPLETED|Phase 2: Treatment||0
10868627|NCT03317496|12033958|FG003|COMPLETED|Phase 2: Treatment||0
10868628|NCT03317496|12033959|FG004|COMPLETED|Phase 2: Treatment||0
10868629|NCT03317496|12033955|FG000|NOT COMPLETED|Phase 2: Treatment||0
10868630|NCT03317496|12033956|FG001|NOT COMPLETED|Phase 2: Treatment||0
10868631|NCT03317496|12033957|FG002|NOT COMPLETED|Phase 2: Treatment||0
10868632|NCT03317496|12033958|FG003|NOT COMPLETED|Phase 2: Treatment||0
10868633|NCT03317496|12033959|FG004|NOT COMPLETED|Phase 2: Treatment||35
10868634|NCT03317496|12033955|FG000|STARTED|Phase 2: Follow-up||0
10868635|NCT03317496|12033956|FG001|STARTED|Phase 2: Follow-up||0
10868636|NCT03317496|12033957|FG002|STARTED|Phase 2: Follow-up||0
10868637|NCT03317496|12033958|FG003|STARTED|Phase 2: Follow-up||0
10868638|NCT03317496|12033959|FG004|STARTED|Phase 2: Follow-up|Eligible participants entered follow-up period following discontinuation of study treatment.|25
10868639|NCT03317496|12033955|FG000|COMPLETED|Phase 2: Follow-up||0
10868640|NCT03317496|12033956|FG001|COMPLETED|Phase 2: Follow-up||0
10868641|NCT03317496|12033957|FG002|COMPLETED|Phase 2: Follow-up||0
10868642|NCT03317496|12033958|FG003|COMPLETED|Phase 2: Follow-up||0
10868643|NCT03317496|12033959|FG004|COMPLETED|Phase 2: Follow-up||0
10868644|NCT03317496|12033955|FG000|NOT COMPLETED|Phase 2: Follow-up||0
10868645|NCT03317496|12033956|FG001|NOT COMPLETED|Phase 2: Follow-up||0
10868646|NCT03317496|12033957|FG002|NOT COMPLETED|Phase 2: Follow-up||0
10868647|NCT03317496|12033958|FG003|NOT COMPLETED|Phase 2: Follow-up||0
10868648|NCT03317496|12033959|FG004|NOT COMPLETED|Phase 2: Follow-up||25
10294854|NCT01322646|11427645|FG000|NOT COMPLETED|Overall Study||3
10294855|NCT01322646|11427646|FG001|NOT COMPLETED|Overall Study||2
10294856|NCT01090024|11427652|FG000|STARTED|Period 1||6
10294857|NCT01090024|11427653|FG001|STARTED|Period 1||6
10868649|NCT03260894|12033972|FG000|STARTED|Overall Study||64
10868650|NCT03260894|12033973|FG001|STARTED|Overall Study||65
10868651|NCT03260894|12033972|FG000|Intention-to-Treat (ITT)|Overall Study||64
10868652|NCT03260894|12033973|FG001|Intention-to-Treat (ITT)|Overall Study||65
10868653|NCT03260894|12033972|FG000|All Subjects as Treated (ASaT)|Overall Study||64
10868654|NCT03260894|12033973|FG001|All Subjects as Treated (ASaT)|Overall Study||63
10868655|NCT03260894|12033972|FG000|COMPLETED|Overall Study||18
10868656|NCT03260894|12033973|FG001|COMPLETED|Overall Study||15
10868657|NCT03260894|12033972|FG000|NOT COMPLETED|Overall Study||46
10868658|NCT03260894|12033973|FG001|NOT COMPLETED|Overall Study||50
10868659|NCT03215810|12033979|FG000|STARTED|Overall Study||20
10868660|NCT03215810|12033979|FG000|COMPLETED|Overall Study||16
10868661|NCT03215810|12033979|FG000|NOT COMPLETED|Overall Study||4
10868662|NCT03123822|12033986|FG000|STARTED|Overall Study||1
10868663|NCT03123822|12033987|FG001|STARTED|Overall Study||1
10868664|NCT03123822|12033988|FG002|STARTED|Overall Study||3
10868665|NCT03123822|12033986|FG000|COMPLETED|Overall Study||1
10868666|NCT03123822|12033987|FG001|COMPLETED|Overall Study||1
10868667|NCT03123822|12033988|FG002|COMPLETED|Overall Study||3
10868668|NCT03123822|12033986|FG000|NOT COMPLETED|Overall Study||0
10868669|NCT03123822|12033987|FG001|NOT COMPLETED|Overall Study||0
10868670|NCT03123822|12033988|FG002|NOT COMPLETED|Overall Study||0
10868671|NCT03067129|12034000|FG000|STARTED|Overall Study||47
10868672|NCT03067129|12034001|FG001|STARTED|Overall Study||29
10868673|NCT03067129|12034002|FG002|STARTED|Overall Study||27
10868674|NCT03067129|12034003|FG003|STARTED|Overall Study||24
10868675|NCT03067129|12034000|FG000|COMPLETED|Overall Study||2
10868676|NCT03067129|12034001|FG001|COMPLETED|Overall Study||1
10868677|NCT03067129|12034002|FG002|COMPLETED|Overall Study||0
10868678|NCT03067129|12034003|FG003|COMPLETED|Overall Study||0
10868679|NCT03067129|12034000|FG000|NOT COMPLETED|Overall Study||45
10868680|NCT03067129|12034001|FG001|NOT COMPLETED|Overall Study||28
10868681|NCT03067129|12034002|FG002|NOT COMPLETED|Overall Study||27
10868682|NCT03067129|12034003|FG003|NOT COMPLETED|Overall Study||24
10868683|NCT03053102|12034021|FG000|STARTED|Study Part 1: 28-Day Treatment||10
10868684|NCT03053102|12034021|FG000|Received at Least 1 Dose of Study Drug|Study Part 1: 28-Day Treatment||10
10868685|NCT03053102|12034021|FG000|COMPLETED|Study Part 1: 28-Day Treatment||10
10868686|NCT03053102|12034021|FG000|NOT COMPLETED|Study Part 1: 28-Day Treatment||0
10868687|NCT03053102|12034021|FG000|STARTED|Study Part 2: 84-Day Treatment||10
10868688|NCT03053102|12034021|FG000|COMPLETED|Study Part 2: 84-Day Treatment||8
10868689|NCT03053102|12034021|FG000|NOT COMPLETED|Study Part 2: 84-Day Treatment||2
10868690|NCT02964078|12034026|FG000|STARTED|Overall Study||27
10868691|NCT02964078|12034026|FG000|COMPLETED|Overall Study||27
10868692|NCT02964078|12034026|FG000|NOT COMPLETED|Overall Study||0
10868705|NCT02920476|12034050|FG000|STARTED|Overall Study||4
10868706|NCT02920476|12034050|FG000|COMPLETED|Overall Study||3
10868707|NCT02920476|12034050|FG000|NOT COMPLETED|Overall Study||1
10868708|NCT02875860|12034056|FG000|STARTED|Overall Study||2
10868709|NCT02875860|12034057|FG001|STARTED|Overall Study||3
10868710|NCT02875860|12034056|FG000|COMPLETED|Overall Study||2
10868711|NCT02875860|12034057|FG001|COMPLETED|Overall Study||2
10868712|NCT02875860|12034056|FG000|NOT COMPLETED|Overall Study||0
10868713|NCT02875860|12034057|FG001|NOT COMPLETED|Overall Study||1
10868714|NCT02779855|12034066|FG000|STARTED|Overall Study||4
10868715|NCT02779855|12034067|FG001|STARTED|Overall Study||6
10868716|NCT02779855|12034068|FG002|STARTED|Overall Study||40
10868717|NCT02779855|12034066|FG000|COMPLETED|Overall Study||3
10868718|NCT02779855|12034067|FG001|COMPLETED|Overall Study||6
10868719|NCT02779855|12034068|FG002|COMPLETED|Overall Study||40
10868720|NCT02779855|12034066|FG000|NOT COMPLETED|Overall Study||1
10868721|NCT02779855|12034067|FG001|NOT COMPLETED|Overall Study||0
10868722|NCT02779855|12034068|FG002|NOT COMPLETED|Overall Study||0
10868723|NCT02663271|12034077|FG000|STARTED|Overall Study||9
10868724|NCT02663271|12034077|FG000|COMPLETED|Overall Study||3
10868725|NCT02663271|12034077|FG000|NOT COMPLETED|Overall Study||6
10868732|NCT02573493|12034094|FG000|STARTED|Overall Study||40
10868733|NCT02573493|12034095|FG001|STARTED|Overall Study||40
10868734|NCT02573493|12034096|FG002|STARTED|Overall Study||15
10868735|NCT02573493|12034097|FG003|STARTED|Overall Study||1
10868736|NCT02573493|12034094|FG000|COMPLETED|Overall Study||40
10868737|NCT02573493|12034095|FG001|COMPLETED|Overall Study||40
10868738|NCT02573493|12034096|FG002|COMPLETED|Overall Study||15
10868739|NCT02573493|12034097|FG003|COMPLETED|Overall Study||0
10868740|NCT02573493|12034094|FG000|NOT COMPLETED|Overall Study||0
10868741|NCT02573493|12034095|FG001|NOT COMPLETED|Overall Study||0
10868742|NCT02573493|12034096|FG002|NOT COMPLETED|Overall Study||0
10868743|NCT02573493|12034097|FG003|NOT COMPLETED|Overall Study||1
10868744|NCT02414607|12034123|FG000|STARTED|Overall Study||11
10868745|NCT02414607|12034124|FG001|STARTED|Overall Study||13
10868746|NCT02414607|12034123|FG000|COMPLETED|Overall Study||9
10868747|NCT02414607|12034124|FG001|COMPLETED|Overall Study||11
10868748|NCT02414607|12034123|FG000|NOT COMPLETED|Overall Study||2
10868749|NCT02414607|12034124|FG001|NOT COMPLETED|Overall Study||2
10868750|NCT02279173|12034130|FG000|STARTED|Overall Study||203
10868751|NCT02279173|12034130|FG000|Received Treatment|Overall Study||203
10868752|NCT02279173|12034130|FG000|Enrolled Under Protocol Supplement|Overall Study||79
10868753|NCT02279173|12034130|FG000|COMPLETED|Overall Study||109
10868754|NCT02279173|12034130|FG000|NOT COMPLETED|Overall Study||94
10294858|NCT01090024|11427654|FG002|STARTED|Period 1||6
10294859|NCT01090024|11427655|FG003|STARTED|Period 1||6
10294860|NCT01090024|11427656|FG004|STARTED|Period 1||6
10294861|NCT01090024|11427657|FG005|STARTED|Period 1||6
10294862|NCT01090024|11427658|FG006|STARTED|Period 1||6
10294863|NCT01090024|11427659|FG007|STARTED|Period 1||6
10294864|NCT01090024|11427660|FG008|STARTED|Period 1||6
10294865|NCT01090024|11427661|FG009|STARTED|Period 1||6
10294866|NCT01090024|11427662|FG010|STARTED|Period 1||6
10294867|NCT01090024|11427663|FG011|STARTED|Period 1||6
10294868|NCT01090024|11427664|FG012|STARTED|Period 1||6
10294869|NCT01090024|11427665|FG013|STARTED|Period 1||6
10294870|NCT01090024|11427666|FG014|STARTED|Period 1||6
10294871|NCT01090024|11427667|FG015|STARTED|Period 1||6
10294872|NCT01090024|11427668|FG016|STARTED|Period 1||6
10294873|NCT01090024|11427669|FG017|STARTED|Period 1||6
10294874|NCT01090024|11427652|FG000|COMPLETED|Period 1||6
10294875|NCT01090024|11427653|FG001|COMPLETED|Period 1||5
10294876|NCT01090024|11427654|FG002|COMPLETED|Period 1||6
10294877|NCT01090024|11427655|FG003|COMPLETED|Period 1||5
10294878|NCT01090024|11427656|FG004|COMPLETED|Period 1||6
10294879|NCT01090024|11427657|FG005|COMPLETED|Period 1||6
10294880|NCT01090024|11427658|FG006|COMPLETED|Period 1||6
10294881|NCT01090024|11427659|FG007|COMPLETED|Period 1||6
10294882|NCT01090024|11427660|FG008|COMPLETED|Period 1||6
10294883|NCT01090024|11427661|FG009|COMPLETED|Period 1||5
10294884|NCT01090024|11427662|FG010|COMPLETED|Period 1||6
10294885|NCT01090024|11427663|FG011|COMPLETED|Period 1||5
10294886|NCT01090024|11427664|FG012|COMPLETED|Period 1||6
10294887|NCT01090024|11427665|FG013|COMPLETED|Period 1||6
10294888|NCT01090024|11427666|FG014|COMPLETED|Period 1||5
10294889|NCT01090024|11427667|FG015|COMPLETED|Period 1||6
10294890|NCT01090024|11427668|FG016|COMPLETED|Period 1||6
10294891|NCT01090024|11427669|FG017|COMPLETED|Period 1||5
10294892|NCT01090024|11427652|FG000|NOT COMPLETED|Period 1||0
10294893|NCT01090024|11427653|FG001|NOT COMPLETED|Period 1||1
10294894|NCT01090024|11427654|FG002|NOT COMPLETED|Period 1||0
10294895|NCT01090024|11427655|FG003|NOT COMPLETED|Period 1||1
10294896|NCT01090024|11427656|FG004|NOT COMPLETED|Period 1||0
10294897|NCT01090024|11427657|FG005|NOT COMPLETED|Period 1||0
10294898|NCT01090024|11427658|FG006|NOT COMPLETED|Period 1||0
10418620|NCT00806260|11563329|FG001|COMPLETED|Period 3||7
10418621|NCT00806260|11563330|FG002|COMPLETED|Period 3||5
10418622|NCT00806260|11563331|FG003|COMPLETED|Period 3||12
10418623|NCT00806260|11563332|FG004|COMPLETED|Period 3||0
10418624|NCT00806260|11563333|FG005|COMPLETED|Period 3||0
10418625|NCT00806260|11563328|FG000|NOT COMPLETED|Period 3||1
10418626|NCT00806260|11563329|FG001|NOT COMPLETED|Period 3||1
10418627|NCT00806260|11563330|FG002|NOT COMPLETED|Period 3||1
10418628|NCT00806260|11563331|FG003|NOT COMPLETED|Period 3||0
10294899|NCT01090024|11427659|FG007|NOT COMPLETED|Period 1||0
10294900|NCT01090024|11427660|FG008|NOT COMPLETED|Period 1||0
10294901|NCT01090024|11427661|FG009|NOT COMPLETED|Period 1||1
10294902|NCT01090024|11427662|FG010|NOT COMPLETED|Period 1||0
10294903|NCT01090024|11427663|FG011|NOT COMPLETED|Period 1||1
10294904|NCT01090024|11427664|FG012|NOT COMPLETED|Period 1||0
10294905|NCT01090024|11427665|FG013|NOT COMPLETED|Period 1||0
10294906|NCT01090024|11427666|FG014|NOT COMPLETED|Period 1||1
10294907|NCT01090024|11427667|FG015|NOT COMPLETED|Period 1||0
10294908|NCT01090024|11427668|FG016|NOT COMPLETED|Period 1||0
10294909|NCT01090024|11427669|FG017|NOT COMPLETED|Period 1||1
10294910|NCT01090024|11427652|FG000|STARTED|Period 2||6
10294911|NCT01090024|11427653|FG001|STARTED|Period 2||5
10294912|NCT01090024|11427654|FG002|STARTED|Period 2||6
10294913|NCT01090024|11427655|FG003|STARTED|Period 2||5
10294914|NCT01090024|11427656|FG004|STARTED|Period 2||6
10294915|NCT01090024|11427657|FG005|STARTED|Period 2||6
10294916|NCT01090024|11427658|FG006|STARTED|Period 2||6
10294917|NCT01090024|11427659|FG007|STARTED|Period 2||6
10294918|NCT01090024|11427660|FG008|STARTED|Period 2||6
10294919|NCT01090024|11427661|FG009|STARTED|Period 2||5
10294920|NCT01090024|11427662|FG010|STARTED|Period 2||6
10294921|NCT01090024|11427663|FG011|STARTED|Period 2||5
10294922|NCT01090024|11427664|FG012|STARTED|Period 2||6
10294923|NCT01090024|11427665|FG013|STARTED|Period 2||6
10294924|NCT01090024|11427666|FG014|STARTED|Period 2||5
10294925|NCT01090024|11427667|FG015|STARTED|Period 2||6
10294926|NCT01090024|11427668|FG016|STARTED|Period 2||6
10294927|NCT01090024|11427669|FG017|STARTED|Period 2||5
10294928|NCT01090024|11427652|FG000|COMPLETED|Period 2||5
10294929|NCT01090024|11427653|FG001|COMPLETED|Period 2||5
10418629|NCT00806260|11563332|FG004|NOT COMPLETED|Period 3||0
10418630|NCT00806260|11563333|FG005|NOT COMPLETED|Period 3||0
10418631|NCT00806286|11563348|FG000|STARTED|Overall Study||54
10418632|NCT00806286|11563349|FG001|STARTED|Overall Study||54
10418633|NCT00806286|11563350|FG002|STARTED|Overall Study||3
10418634|NCT00806286|11563348|FG000|COMPLETED|Overall Study||0
10418635|NCT00806286|11563349|FG001|COMPLETED|Overall Study||0
10418636|NCT00806286|11563350|FG002|COMPLETED|Overall Study||0
10418637|NCT00806286|11563348|FG000|NOT COMPLETED|Overall Study||54
10418638|NCT00806286|11563349|FG001|NOT COMPLETED|Overall Study||54
10418639|NCT00806286|11563350|FG002|NOT COMPLETED|Overall Study||3
10418640|NCT00806351|11563360|FG000|STARTED|Overall Study||15
10418641|NCT00806351|11563361|FG001|STARTED|Overall Study||6
10418642|NCT00806351|11563360|FG000|COMPLETED|Overall Study||10
10418643|NCT00806351|11563361|FG001|COMPLETED|Overall Study||2
10418644|NCT00806351|11563360|FG000|NOT COMPLETED|Overall Study||5
10418645|NCT00806351|11563361|FG001|NOT COMPLETED|Overall Study||4
10418646|NCT00806442|11563367|FG000|STARTED|Overall Study||18
10418647|NCT00806442|11563368|FG001|STARTED|Overall Study||21
10418648|NCT00806442|11563367|FG000|First Intervention (3 Wks)|Overall Study||18
10418649|NCT00806442|11563368|FG001|First Intervention (3 Wks)|Overall Study||21
10418650|NCT00806442|11563367|FG000|Washout (3 Wks)|Overall Study||15
10418651|NCT00806442|11563368|FG001|Washout (3 Wks)|Overall Study||14
10418652|NCT00806442|11563367|FG000|Second Intervention (3 Wks)|Overall Study||15
10418653|NCT00806442|11563368|FG001|Second Intervention (3 Wks)|Overall Study||14
10418654|NCT00806442|11563367|FG000|COMPLETED|Overall Study||14
10418655|NCT00806442|11563368|FG001|COMPLETED|Overall Study||14
10418656|NCT00806442|11563367|FG000|NOT COMPLETED|Overall Study||4
10418657|NCT00806442|11563368|FG001|NOT COMPLETED|Overall Study||7
10418658|NCT00806494|11563376|FG000|STARTED|Overall Study||331
10418659|NCT00806494|11563376|FG000|COMPLETED|Overall Study||251
10418660|NCT00806494|11563376|FG000|NOT COMPLETED|Overall Study||80
10418661|NCT00806546|11563381|FG000|STARTED|Overall Study|35 subjects were enrolled but did not treat for a total of 479 subjects in the safety population|514
10418662|NCT00806546|11563381|FG000|COMPLETED|Overall Study||207
10418663|NCT00806546|11563381|FG000|NOT COMPLETED|Overall Study||307
10418664|NCT00806585|11563390|FG000|STARTED|Overall Study||137
10418665|NCT00806585|11563391|FG001|STARTED|Overall Study||134
10418666|NCT00806585|11563392|FG002|STARTED|Overall Study||141
10418667|NCT00806585|11563393|FG003|STARTED|Overall Study||71
10418668|NCT00806585|11563394|FG004|STARTED|Overall Study||137
10418669|NCT00806585|11563390|FG000|COMPLETED|Overall Study||105
10418670|NCT00806585|11563391|FG001|COMPLETED|Overall Study||103
10418671|NCT00806585|11563392|FG002|COMPLETED|Overall Study||109
10418672|NCT00806585|11563393|FG003|COMPLETED|Overall Study||56
10418673|NCT00806585|11563394|FG004|COMPLETED|Overall Study||106
10418674|NCT00806585|11563390|FG000|NOT COMPLETED|Overall Study||32
10418675|NCT00806585|11563391|FG001|NOT COMPLETED|Overall Study||31
10418676|NCT00806585|11563392|FG002|NOT COMPLETED|Overall Study||32
10418677|NCT00806585|11563393|FG003|NOT COMPLETED|Overall Study||15
10418678|NCT00806585|11563394|FG004|NOT COMPLETED|Overall Study||31
10418679|NCT00806598|11563406|FG000|STARTED|Overall Study||48
10418680|NCT00806598|11563406|FG000|COMPLETED|Overall Study||48
10418681|NCT00806598|11563406|FG000|NOT COMPLETED|Overall Study||0
10418682|NCT00806624|11563413|FG000|STARTED|Overall Study||79
10418683|NCT00806624|11563414|FG001|STARTED|Overall Study||80
10418684|NCT00806624|11563415|FG002|STARTED|Overall Study||75
10418685|NCT00806624|11563413|FG000|COMPLETED|Overall Study||70
10418686|NCT00806624|11563414|FG001|COMPLETED|Overall Study||68
10418687|NCT00806624|11563415|FG002|COMPLETED|Overall Study||69
10418688|NCT00806624|11563413|FG000|NOT COMPLETED|Overall Study||9
10418689|NCT00806624|11563414|FG001|NOT COMPLETED|Overall Study||12
10418690|NCT00806624|11563415|FG002|NOT COMPLETED|Overall Study||6
10868824|NCT01844505|12034175|FG000|STARTED|Overall Study||313
10868825|NCT01844505|12034176|FG001|STARTED|Overall Study||313
10868826|NCT01844505|12034177|FG002|STARTED|Overall Study||311
10868827|NCT01844505|12034175|FG000|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|64
10868828|NCT01844505|12034176|FG001|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|44
10868829|NCT01844505|12034177|FG002|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|16
10868830|NCT01844505|12034175|FG000|NOT COMPLETED|Overall Study||249
10868831|NCT01844505|12034176|FG001|NOT COMPLETED|Overall Study||269
10868832|NCT01844505|12034177|FG002|NOT COMPLETED|Overall Study||295
10868833|NCT01781390|12034188|FG000|STARTED|Overall Study||35
10868834|NCT01781390|12034189|FG001|STARTED|Overall Study||35
10868835|NCT01781390|12034190|FG002|STARTED|Overall Study||36
10868836|NCT01781390|12034188|FG000|COMPLETED|Overall Study||32
10868837|NCT01781390|12034189|FG001|COMPLETED|Overall Study||28
10868838|NCT01781390|12034190|FG002|COMPLETED|Overall Study||32
10868839|NCT01781390|12034188|FG000|NOT COMPLETED|Overall Study||3
10868840|NCT01781390|12034189|FG001|NOT COMPLETED|Overall Study||7
10868841|NCT01781390|12034190|FG002|NOT COMPLETED|Overall Study||4
10868842|NCT01701674|12034198|FG000|STARTED|Overall Study||13
10868843|NCT01701674|12034198|FG000|COMPLETED|Overall Study||12
10868844|NCT01701674|12034198|FG000|NOT COMPLETED|Overall Study||1
10868845|NCT01575860|12034202|FG000|STARTED|Overall Study||8
10868846|NCT01575860|12034202|FG000|COMPLETED|Overall Study||6
10868847|NCT01575860|12034202|FG000|NOT COMPLETED|Overall Study||2
10868848|NCT01402908|12034209|FG000|STARTED|Overall Study||258
10868849|NCT01402908|12034210|FG001|STARTED|Overall Study||261
10868850|NCT01402908|12034209|FG000|COMPLETED|Overall Study||224
10868851|NCT01402908|12034210|FG001|COMPLETED|Overall Study||243
10868852|NCT01402908|12034209|FG000|NOT COMPLETED|Overall Study||34
10868853|NCT01402908|12034210|FG001|NOT COMPLETED|Overall Study||18
10868854|NCT01397201|12034221|FG000|STARTED|Overall Study||6
10868855|NCT01397201|12034222|FG001|STARTED|Overall Study||6
10868856|NCT01397201|12034223|FG002|STARTED|Overall Study||6
10868857|NCT01397201|12034224|FG003|STARTED|Overall Study||7
10868858|NCT01397201|12034225|FG004|STARTED|Overall Study||5
10418691|NCT00806676|11563426|FG000|STARTED|Overall Study||29
10418692|NCT00806676|11563427|FG001|STARTED|Overall Study||9
10418693|NCT00806676|11563428|FG002|STARTED|Overall Study||29
10418694|NCT00806676|11563426|FG000|COMPLETED|Overall Study||25
10418695|NCT00806676|11563427|FG001|COMPLETED|Overall Study||9
10418696|NCT00806676|11563428|FG002|COMPLETED|Overall Study||23
10418697|NCT00806676|11563426|FG000|NOT COMPLETED|Overall Study||4
10418698|NCT00806676|11563427|FG001|NOT COMPLETED|Overall Study||0
10418699|NCT00806676|11563428|FG002|NOT COMPLETED|Overall Study||6
10868859|NCT01397201|12034221|FG000|Treated|Overall Study||6
10868860|NCT01397201|12034222|FG001|Treated|Overall Study||6
10868861|NCT01397201|12034223|FG002|Treated|Overall Study||5
10294930|NCT01090024|11427654|FG002|COMPLETED|Period 2||6
10294931|NCT01090024|11427655|FG003|COMPLETED|Period 2||4
10294932|NCT01090024|11427656|FG004|COMPLETED|Period 2||6
10294933|NCT01090024|11427657|FG005|COMPLETED|Period 2||6
10294934|NCT01090024|11427658|FG006|COMPLETED|Period 2||6
10294935|NCT01090024|11427659|FG007|COMPLETED|Period 2||6
10294936|NCT01090024|11427660|FG008|COMPLETED|Period 2||6
10868862|NCT01397201|12034224|FG003|Treated|Overall Study||7
10868863|NCT01397201|12034225|FG004|Treated|Overall Study||5
10868864|NCT01397201|12034221|FG000|COMPLETED|Overall Study||1
10868865|NCT01397201|12034222|FG001|COMPLETED|Overall Study||0
10868866|NCT01397201|12034223|FG002|COMPLETED|Overall Study||0
10868867|NCT01397201|12034224|FG003|COMPLETED|Overall Study||2
10868868|NCT01397201|12034225|FG004|COMPLETED|Overall Study||1
10868869|NCT01397201|12034221|FG000|NOT COMPLETED|Overall Study||5
10868870|NCT01397201|12034222|FG001|NOT COMPLETED|Overall Study||6
10294937|NCT01090024|11427661|FG009|COMPLETED|Period 2||5
10294938|NCT01090024|11427662|FG010|COMPLETED|Period 2||6
10294939|NCT01090024|11427663|FG011|COMPLETED|Period 2||5
10294940|NCT01090024|11427664|FG012|COMPLETED|Period 2||6
10294941|NCT01090024|11427665|FG013|COMPLETED|Period 2||6
10294942|NCT01090024|11427666|FG014|COMPLETED|Period 2||5
10294943|NCT01090024|11427667|FG015|COMPLETED|Period 2||6
10294944|NCT01090024|11427668|FG016|COMPLETED|Period 2||6
10294945|NCT01090024|11427669|FG017|COMPLETED|Period 2||5
10294946|NCT01090024|11427652|FG000|NOT COMPLETED|Period 2||1
10294947|NCT01090024|11427653|FG001|NOT COMPLETED|Period 2||0
10294948|NCT01090024|11427654|FG002|NOT COMPLETED|Period 2||0
10294949|NCT01090024|11427655|FG003|NOT COMPLETED|Period 2||1
10294950|NCT01090024|11427656|FG004|NOT COMPLETED|Period 2||0
10294951|NCT01090024|11427657|FG005|NOT COMPLETED|Period 2||0
10294952|NCT01090024|11427658|FG006|NOT COMPLETED|Period 2||0
10294953|NCT01090024|11427659|FG007|NOT COMPLETED|Period 2||0
10294954|NCT01090024|11427660|FG008|NOT COMPLETED|Period 2||0
10294955|NCT01090024|11427661|FG009|NOT COMPLETED|Period 2||0
10294956|NCT01090024|11427662|FG010|NOT COMPLETED|Period 2||0
10294957|NCT01090024|11427663|FG011|NOT COMPLETED|Period 2||0
10294958|NCT01090024|11427664|FG012|NOT COMPLETED|Period 2||0
10294959|NCT01090024|11427665|FG013|NOT COMPLETED|Period 2||0
10294960|NCT01090024|11427666|FG014|NOT COMPLETED|Period 2||0
10294961|NCT01090024|11427667|FG015|NOT COMPLETED|Period 2||0
10294962|NCT01090024|11427668|FG016|NOT COMPLETED|Period 2||0
10294963|NCT01090024|11427669|FG017|NOT COMPLETED|Period 2||0
10294964|NCT01090024|11427652|FG000|STARTED|Period 3||5
10294965|NCT01090024|11427653|FG001|STARTED|Period 3||5
10294966|NCT01090024|11427654|FG002|STARTED|Period 3||6
10294967|NCT01090024|11427655|FG003|STARTED|Period 3||4
10294968|NCT01090024|11427656|FG004|STARTED|Period 3||6
10294969|NCT01090024|11427657|FG005|STARTED|Period 3||6
10294970|NCT01090024|11427658|FG006|STARTED|Period 3||6
10294971|NCT01090024|11427659|FG007|STARTED|Period 3||6
10294972|NCT01090024|11427660|FG008|STARTED|Period 3||6
10294973|NCT01090024|11427661|FG009|STARTED|Period 3||5
10294974|NCT01090024|11427662|FG010|STARTED|Period 3||6
10294975|NCT01090024|11427663|FG011|STARTED|Period 3||5
10294976|NCT01090024|11427664|FG012|STARTED|Period 3||6
10294977|NCT01090024|11427665|FG013|STARTED|Period 3||6
10294978|NCT01090024|11427666|FG014|STARTED|Period 3||5
10294979|NCT01090024|11427667|FG015|STARTED|Period 3||6
10294980|NCT01090024|11427668|FG016|STARTED|Period 3||6
10294981|NCT01090024|11427669|FG017|STARTED|Period 3||5
10294982|NCT01090024|11427652|FG000|Treated|Period 3||5
10294983|NCT01090024|11427653|FG001|Treated|Period 3||5
10294984|NCT01090024|11427654|FG002|Treated|Period 3||6
10294985|NCT01090024|11427655|FG003|Treated|Period 3||4
10294986|NCT01090024|11427656|FG004|Treated|Period 3||6
10294987|NCT01090024|11427657|FG005|Treated|Period 3||6
10294988|NCT01090024|11427658|FG006|Treated|Period 3||6
10294989|NCT01090024|11427659|FG007|Treated|Period 3||6
10294990|NCT01090024|11427660|FG008|Treated|Period 3||6
10294991|NCT01090024|11427661|FG009|Treated|Period 3||5
10294992|NCT01090024|11427662|FG010|Treated|Period 3||6
10294993|NCT01090024|11427663|FG011|Treated|Period 3||5
10294994|NCT01090024|11427664|FG012|Treated|Period 3||6
10294995|NCT01090024|11427665|FG013|Treated|Period 3||6
10294996|NCT01090024|11427666|FG014|Treated|Period 3||5
10294997|NCT01090024|11427667|FG015|Treated|Period 3||5
10294998|NCT01090024|11427668|FG016|Treated|Period 3||6
10294999|NCT01090024|11427669|FG017|Treated|Period 3||5
10295000|NCT01090024|11427652|FG000|COMPLETED|Period 3||5
10295001|NCT01090024|11427653|FG001|COMPLETED|Period 3||5
10295002|NCT01090024|11427654|FG002|COMPLETED|Period 3||6
10295003|NCT01090024|11427655|FG003|COMPLETED|Period 3||4
10295004|NCT01090024|11427656|FG004|COMPLETED|Period 3||6
10295005|NCT01090024|11427657|FG005|COMPLETED|Period 3||5
10295006|NCT01090024|11427658|FG006|COMPLETED|Period 3||6
10295007|NCT01090024|11427659|FG007|COMPLETED|Period 3||6
10295008|NCT01090024|11427660|FG008|COMPLETED|Period 3||5
10295009|NCT01090024|11427661|FG009|COMPLETED|Period 3||5
10868871|NCT01397201|12034223|FG002|NOT COMPLETED|Overall Study||6
10295010|NCT01090024|11427662|FG010|COMPLETED|Period 3||6
10295011|NCT01090024|11427663|FG011|COMPLETED|Period 3||5
10295012|NCT01090024|11427664|FG012|COMPLETED|Period 3||6
10295013|NCT01090024|11427665|FG013|COMPLETED|Period 3||6
10295014|NCT01090024|11427666|FG014|COMPLETED|Period 3||5
10295015|NCT01090024|11427667|FG015|COMPLETED|Period 3||5
10295016|NCT01090024|11427668|FG016|COMPLETED|Period 3||6
10295017|NCT01090024|11427669|FG017|COMPLETED|Period 3||5
10295018|NCT01090024|11427652|FG000|NOT COMPLETED|Period 3||0
10295019|NCT01090024|11427653|FG001|NOT COMPLETED|Period 3||0
10295020|NCT01090024|11427654|FG002|NOT COMPLETED|Period 3||0
10295021|NCT01090024|11427655|FG003|NOT COMPLETED|Period 3||0
10295022|NCT01090024|11427656|FG004|NOT COMPLETED|Period 3||0
10295023|NCT01090024|11427657|FG005|NOT COMPLETED|Period 3||1
10295024|NCT01090024|11427658|FG006|NOT COMPLETED|Period 3||0
10295025|NCT01090024|11427659|FG007|NOT COMPLETED|Period 3||0
10295026|NCT01090024|11427660|FG008|NOT COMPLETED|Period 3||1
10868872|NCT01397201|12034224|FG003|NOT COMPLETED|Overall Study||5
10868873|NCT01397201|12034225|FG004|NOT COMPLETED|Overall Study||4
10868874|NCT01397162|12034242|FG000|STARTED|Overall Study||8
10868875|NCT01397162|12034243|FG001|STARTED|Overall Study||5
10868876|NCT01397162|12034244|FG002|STARTED|Overall Study||4
10868877|NCT01397162|12034245|FG003|STARTED|Overall Study||6
10868878|NCT01397162|12034246|FG004|STARTED|Overall Study||6
10868879|NCT01397162|12034242|FG000|COMPLETED|Overall Study||1
10868880|NCT01397162|12034243|FG001|COMPLETED|Overall Study||1
10868881|NCT01397162|12034244|FG002|COMPLETED|Overall Study||1
10868882|NCT01397162|12034245|FG003|COMPLETED|Overall Study||1
10868883|NCT01397162|12034246|FG004|COMPLETED|Overall Study||3
10868884|NCT01397162|12034242|FG000|NOT COMPLETED|Overall Study||7
10868885|NCT01397162|12034243|FG001|NOT COMPLETED|Overall Study||4
10868886|NCT01397162|12034244|FG002|NOT COMPLETED|Overall Study||3
10868887|NCT01397162|12034245|FG003|NOT COMPLETED|Overall Study||5
10868888|NCT01397162|12034246|FG004|NOT COMPLETED|Overall Study||3
10868889|NCT01396278|12034268|FG000|STARTED|Overall Study||2
10868890|NCT01396278|12034269|FG001|STARTED|Overall Study||2
10868891|NCT01396278|12034270|FG002|STARTED|Overall Study||1
10868892|NCT01396278|12034271|FG003|STARTED|Overall Study||2
10868893|NCT01396278|12034272|FG004|STARTED|Overall Study||2
10868894|NCT01396278|12034268|FG000|COMPLETED|Overall Study||0
10868895|NCT01396278|12034269|FG001|COMPLETED|Overall Study||1
10868896|NCT01396278|12034270|FG002|COMPLETED|Overall Study||0
10868897|NCT01396278|12034271|FG003|COMPLETED|Overall Study||0
10868898|NCT01396278|12034272|FG004|COMPLETED|Overall Study||0
10868899|NCT01396278|12034268|FG000|NOT COMPLETED|Overall Study||2
10868900|NCT01396278|12034269|FG001|NOT COMPLETED|Overall Study||1
10868901|NCT01396278|12034270|FG002|NOT COMPLETED|Overall Study||1
10868902|NCT01396278|12034271|FG003|NOT COMPLETED|Overall Study||2
10868903|NCT01396278|12034272|FG004|NOT COMPLETED|Overall Study||2
10868904|NCT00783367|12034286|FG000|STARTED|Overall Study||27
10868905|NCT00783367|12034287|FG001|STARTED|Overall Study||23
10868906|NCT00783367|12034286|FG000|COMPLETED|Overall Study||27
10868907|NCT00783367|12034287|FG001|COMPLETED|Overall Study||23
10868908|NCT00783367|12034286|FG000|NOT COMPLETED|Overall Study||0
10868909|NCT00783367|12034287|FG001|NOT COMPLETED|Overall Study||0
10868910|NCT00247728|12034296|FG000|STARTED|Overall Study||58
10418700|NCT00806819|11563439|FG000|STARTED|Overall Study|randomised patients|353
10418701|NCT00806819|11563440|FG001|STARTED|Overall Study|randomised patients|360
10418702|NCT00806819|11563439|FG000|COMPLETED|Overall Study|On-treatment at analysis DBL date (15 February 2013)|7
10418703|NCT00806819|11563440|FG001|COMPLETED|Overall Study|On-treatment at analysis DBL date (15 February 2013)|2
10418704|NCT00806819|11563439|FG000|NOT COMPLETED|Overall Study||346
10418705|NCT00806819|11563440|FG001|NOT COMPLETED|Overall Study||358
10418706|NCT00806988|11563449|FG000|STARTED|Overall Study||150
10418707|NCT00806988|11563450|FG001|STARTED|Overall Study||151
10418708|NCT00806988|11563449|FG000|COMPLETED|Overall Study||123
10418709|NCT00806988|11563450|FG001|COMPLETED|Overall Study||108
10418710|NCT00806988|11563449|FG000|NOT COMPLETED|Overall Study||27
10418711|NCT00806988|11563450|FG001|NOT COMPLETED|Overall Study||43
10418712|NCT00807001|11563461|FG000|STARTED|Overall Study|For all groups, number of subjects who received at least one dose of study drug.|8
10418713|NCT00807001|11563462|FG001|STARTED|Overall Study||8
10418714|NCT00807001|11563463|FG002|STARTED|Overall Study||8
10418715|NCT00807001|11563464|FG003|STARTED|Overall Study||8
10418716|NCT00807001|11563465|FG004|STARTED|Overall Study||9
10418717|NCT00807001|11563461|FG000|COMPLETED|Overall Study||8
10418718|NCT00807001|11563462|FG001|COMPLETED|Overall Study||7
10418719|NCT00807001|11563463|FG002|COMPLETED|Overall Study||8
10418720|NCT00807001|11563464|FG003|COMPLETED|Overall Study||8
10418721|NCT00807001|11563465|FG004|COMPLETED|Overall Study||9
10418722|NCT00807001|11563461|FG000|NOT COMPLETED|Overall Study||0
10418723|NCT00807001|11563462|FG001|NOT COMPLETED|Overall Study||1
10418724|NCT00807001|11563463|FG002|NOT COMPLETED|Overall Study||0
10418725|NCT00807001|11563464|FG003|NOT COMPLETED|Overall Study||0
10418726|NCT00807001|11563465|FG004|NOT COMPLETED|Overall Study||0
10418727|NCT00807014|11563479|FG000|STARTED|Overall Study||83
10418728|NCT00807014|11563480|FG001|STARTED|Overall Study||85
10418729|NCT00807014|11563479|FG000|COMPLETED|Overall Study||56
10418730|NCT00807014|11563480|FG001|COMPLETED|Overall Study||58
10418731|NCT00807014|11563479|FG000|NOT COMPLETED|Overall Study||27
10418732|NCT00807014|11563480|FG001|NOT COMPLETED|Overall Study||27
10418733|NCT00807040|11563488|FG000|STARTED|Overall Study||126
10418734|NCT00807040|11563489|FG001|STARTED|Overall Study||125
10418735|NCT00807040|11563488|FG000|COMPLETED|Overall Study||90
10418736|NCT00807040|11563489|FG001|COMPLETED|Overall Study||84
10418737|NCT00807040|11563488|FG000|NOT COMPLETED|Overall Study||36
10868911|NCT00247728|12034297|FG001|STARTED|Overall Study||57
10868912|NCT00247728|12034298|FG002|STARTED|Overall Study||57
10868913|NCT00247728|12034296|FG000|COMPLETED|Overall Study||55
10868914|NCT00247728|12034297|FG001|COMPLETED|Overall Study||51
10868915|NCT00247728|12034298|FG002|COMPLETED|Overall Study||43
10868916|NCT00247728|12034296|FG000|NOT COMPLETED|Overall Study||3
10868917|NCT00247728|12034297|FG001|NOT COMPLETED|Overall Study||6
10868918|NCT00247728|12034298|FG002|NOT COMPLETED|Overall Study||14
10418738|NCT00807040|11563489|FG001|NOT COMPLETED|Overall Study||41
10418739|NCT00807092|11563497|FG000|STARTED|Overall Study||72
10418740|NCT00807092|11563498|FG001|STARTED|Overall Study||73
10418741|NCT00807092|11563497|FG000|Exposed to Drug|Overall Study|Subject was randomised, but not exposed to any trial drug|71
10418742|NCT00807092|11563498|FG001|Exposed to Drug|Overall Study||73
10868919|NCT00130442|12034310|FG000|STARTED|Overall Study||66
10868920|NCT00130442|12034311|FG001|STARTED|Overall Study||68
10868921|NCT00130442|12034310|FG000|COMPLETED|Overall Study||65
10868922|NCT00130442|12034311|FG001|COMPLETED|Overall Study||66
10868923|NCT00130442|12034310|FG000|NOT COMPLETED|Overall Study||1
10868924|NCT00130442|12034311|FG001|NOT COMPLETED|Overall Study||2
10295027|NCT01090024|11427661|FG009|NOT COMPLETED|Period 3||0
10295028|NCT01090024|11427662|FG010|NOT COMPLETED|Period 3||0
10295029|NCT01090024|11427663|FG011|NOT COMPLETED|Period 3||0
10295030|NCT01090024|11427664|FG012|NOT COMPLETED|Period 3||0
10295031|NCT01090024|11427665|FG013|NOT COMPLETED|Period 3||0
10295032|NCT01090024|11427666|FG014|NOT COMPLETED|Period 3||0
10295033|NCT01090024|11427667|FG015|NOT COMPLETED|Period 3||1
10295034|NCT01090024|11427668|FG016|NOT COMPLETED|Period 3||0
10295035|NCT01090024|11427669|FG017|NOT COMPLETED|Period 3||0
10295036|NCT00943722|11427684|FG000|STARTED|Base Study||648
10295037|NCT00943722|11427685|FG001|STARTED|Base Study||643
10295038|NCT00943722|11427686|FG002|STARTED|Base Study||644
10295039|NCT00943722|11427687|FG003|STARTED|Base Study||669
10295040|NCT00943722|11427688|FG004|STARTED|Base Study||470
10295041|NCT00943722|11427689|FG005|STARTED|Base Study||0
10295042|NCT00943722|11427690|FG006|STARTED|Base Study||0
10295043|NCT00943722|11427684|FG000|Vaccination 1|Base Study||646
10295044|NCT00943722|11427685|FG001|Vaccination 1|Base Study||642
10295045|NCT00943722|11427686|FG002|Vaccination 1|Base Study||644
10295046|NCT00943722|11427687|FG003|Vaccination 1|Base Study||666
10295047|NCT00943722|11427688|FG004|Vaccination 1|Base Study||468
10295048|NCT00943722|11427689|FG005|Vaccination 1|Base Study||0
10295049|NCT00943722|11427690|FG006|Vaccination 1|Base Study||0
10295050|NCT00943722|11427684|FG000|Vaccination 2|Base Study||637
10295051|NCT00943722|11427685|FG001|Vaccination 2|Base Study||633
10295052|NCT00943722|11427686|FG002|Vaccination 2|Base Study||638
10295053|NCT00943722|11427687|FG003|Vaccination 2|Base Study||658
10295054|NCT00943722|11427688|FG004|Vaccination 2|Base Study||462
10295055|NCT00943722|11427689|FG005|Vaccination 2|Base Study||0
10295056|NCT00943722|11427690|FG006|Vaccination 2|Base Study||0
10295057|NCT00943722|11427684|FG000|Vaccination 3|Base Study||635
10295058|NCT00943722|11427685|FG001|Vaccination 3|Base Study||627
10418743|NCT00807092|11563497|FG000|COMPLETED|Overall Study||71
10418744|NCT00807092|11563498|FG001|COMPLETED|Overall Study||69
10418745|NCT00807092|11563497|FG000|NOT COMPLETED|Overall Study||1
10418746|NCT00807092|11563498|FG001|NOT COMPLETED|Overall Study||4
10418747|NCT00807144|11563506|FG000|STARTED|Overall Study||52
10418748|NCT00807144|11563507|FG001|STARTED|Overall Study||50
10418749|NCT00807144|11563506|FG000|COMPLETED|Overall Study||52
10418750|NCT00807144|11563507|FG001|COMPLETED|Overall Study||49
10418751|NCT00807144|11563506|FG000|NOT COMPLETED|Overall Study||0
10418752|NCT00807144|11563507|FG001|NOT COMPLETED|Overall Study||1
10418753|NCT00807209|11563516|FG000|STARTED|Overall Study||1
10418754|NCT00807209|11563517|FG001|STARTED|Overall Study||1
10418755|NCT00807209|11563518|FG002|STARTED|Overall Study||1
10418756|NCT00807209|11563516|FG000|COMPLETED|Overall Study||1
10418757|NCT00807209|11563517|FG001|COMPLETED|Overall Study||1
10418758|NCT00807209|11563518|FG002|COMPLETED|Overall Study||1
10418759|NCT00807209|11563516|FG000|NOT COMPLETED|Overall Study||0
10418760|NCT00807209|11563517|FG001|NOT COMPLETED|Overall Study||0
10418761|NCT00807209|11563518|FG002|NOT COMPLETED|Overall Study||0
10418762|NCT00807235|11563528|FG000|STARTED|Overall Study||11
10418763|NCT00807235|11563529|FG001|STARTED|Overall Study||6
10418764|NCT00807235|11563528|FG000|COMPLETED|Overall Study||10
10418765|NCT00807235|11563529|FG001|COMPLETED|Overall Study||6
10418766|NCT00807235|11563528|FG000|NOT COMPLETED|Overall Study||1
10418767|NCT00807235|11563529|FG001|NOT COMPLETED|Overall Study||0
10418768|NCT00807248|11563539|FG000|STARTED|Overall Study||71
10418769|NCT00807248|11563540|FG001|STARTED|Overall Study||140
10418770|NCT00807248|11563541|FG002|STARTED|Overall Study||139
10295059|NCT00943722|11427686|FG002|Vaccination 3|Base Study||637
10295060|NCT00943722|11427687|FG003|Vaccination 3|Base Study||653
10295061|NCT00943722|11427688|FG004|Vaccination 3|Base Study||455
10418771|NCT00807248|11563542|FG003|STARTED|Overall Study||140
10418772|NCT00807248|11563539|FG000|COMPLETED|Overall Study||50
10418773|NCT00807248|11563540|FG001|COMPLETED|Overall Study||128
10418774|NCT00807248|11563541|FG002|COMPLETED|Overall Study||121
10295062|NCT00943722|11427689|FG005|Vaccination 3|Base Study||0
10295063|NCT00943722|11427690|FG006|Vaccination 3|Base Study||0
10418775|NCT00807248|11563542|FG003|COMPLETED|Overall Study||126
10868925|NCT04539262|12034327|FG000|STARTED|Overall Study||12
10868926|NCT04539262|12034328|FG001|STARTED|Overall Study||13
10868927|NCT04539262|12034329|FG002|STARTED|Overall Study||12
10868928|NCT04539262|12034330|FG003|STARTED|Overall Study||12
10868929|NCT04539262|12034331|FG004|STARTED|Overall Study||12
10868930|NCT04539262|12034332|FG005|STARTED|Overall Study||13
10868931|NCT04539262|12034333|FG006|STARTED|Overall Study||62
10868932|NCT04539262|12034334|FG007|STARTED|Overall Study||20
10868933|NCT04539262|12034327|FG000|COMPLETED|Overall Study||12
10868934|NCT04539262|12034328|FG001|COMPLETED|Overall Study||12
10868935|NCT04539262|12034329|FG002|COMPLETED|Overall Study||11
10868936|NCT04539262|12034330|FG003|COMPLETED|Overall Study||11
10868937|NCT04539262|12034331|FG004|COMPLETED|Overall Study||12
10868938|NCT04539262|12034332|FG005|COMPLETED|Overall Study||13
10868939|NCT04539262|12034333|FG006|COMPLETED|Overall Study||61
10868940|NCT04539262|12034334|FG007|COMPLETED|Overall Study||20
10868941|NCT04539262|12034327|FG000|NOT COMPLETED|Overall Study||0
10868942|NCT04539262|12034328|FG001|NOT COMPLETED|Overall Study||1
10868943|NCT04539262|12034329|FG002|NOT COMPLETED|Overall Study||1
10868944|NCT04539262|12034330|FG003|NOT COMPLETED|Overall Study||1
10868945|NCT04539262|12034331|FG004|NOT COMPLETED|Overall Study||0
10868946|NCT04539262|12034332|FG005|NOT COMPLETED|Overall Study||0
10868947|NCT04539262|12034333|FG006|NOT COMPLETED|Overall Study||1
10868948|NCT04539262|12034334|FG007|NOT COMPLETED|Overall Study||0
10868994|NCT04079881|12034404|FG000|STARTED|Overall Study||1
10868995|NCT04079881|12034405|FG001|STARTED|Overall Study||0
10868996|NCT04079881|12034404|FG000|COMPLETED|Overall Study||1
10868997|NCT04079881|12034405|FG001|COMPLETED|Overall Study||0
10868998|NCT04079881|12034404|FG000|NOT COMPLETED|Overall Study||0
10868999|NCT04079881|12034405|FG001|NOT COMPLETED|Overall Study||0
10869010|NCT03868839|12034422|FG000|STARTED|Overall Study||6
10869011|NCT03868839|12034422|FG000|COMPLETED|Overall Study||5
10869012|NCT03868839|12034422|FG000|NOT COMPLETED|Overall Study||1
10869013|NCT03847974|12034426|FG000|STARTED|Overall Study||32
10869014|NCT03847974|12034426|FG000|COMPLETED|Overall Study||26
10869015|NCT03847974|12034426|FG000|NOT COMPLETED|Overall Study||6
10869016|NCT03787095|12034432|FG000|STARTED|Overall Study||4
10869017|NCT03787095|12034433|FG001|STARTED|Overall Study||1
10869018|NCT03787095|12034432|FG000|COMPLETED|Overall Study||4
10869019|NCT03787095|12034433|FG001|COMPLETED|Overall Study|Participant had final visit at study week 7 in accordance with decision from team after the study was closed.|1
10869020|NCT03787095|12034432|FG000|NOT COMPLETED|Overall Study||0
10869021|NCT03787095|12034433|FG001|NOT COMPLETED|Overall Study||0
10869022|NCT03746951|12034442|FG000|STARTED|Overall Study||8
10869023|NCT03746951|12034443|FG001|STARTED|Overall Study||7
10869024|NCT03746951|12034442|FG000|COMPLETED|Overall Study||8
10869025|NCT03746951|12034443|FG001|COMPLETED|Overall Study||7
10869026|NCT03746951|12034442|FG000|NOT COMPLETED|Overall Study||0
10869027|NCT03746951|12034443|FG001|NOT COMPLETED|Overall Study||0
10869028|NCT03685747|12034449|FG000|STARTED|Overall Study||4
10869029|NCT03685747|12034449|FG000|COMPLETED|Overall Study||4
10869030|NCT03685747|12034449|FG000|NOT COMPLETED|Overall Study||0
10869031|NCT03671148|12034455|FG000|STARTED|Overall Study||220
10869032|NCT03671148|12034456|FG001|STARTED|Overall Study||224
10869033|NCT03671148|12034455|FG000|Received Study Drug|Overall Study||219
10869034|NCT03671148|12034456|FG001|Received Study Drug|Overall Study||224
10869035|NCT03671148|12034455|FG000|COMPLETED|Overall Study||199
10869036|NCT03671148|12034456|FG001|COMPLETED|Overall Study||215
10869037|NCT03671148|12034455|FG000|NOT COMPLETED|Overall Study||21
10869038|NCT03671148|12034456|FG001|NOT COMPLETED|Overall Study||9
10869039|NCT03640949|12034464|FG000|STARTED|Overall Study||237
10869040|NCT03640949|12034465|FG001|STARTED|Overall Study||264
10869041|NCT03640949|12034464|FG000|COMPLETED|Overall Study||237
10869042|NCT03640949|12034465|FG001|COMPLETED|Overall Study||264
10869043|NCT03640949|12034464|FG000|NOT COMPLETED|Overall Study||0
10869044|NCT03640949|12034465|FG001|NOT COMPLETED|Overall Study||0
10869045|NCT03615508|12034471|FG000|STARTED|Overall Study||1
10869046|NCT03615508|12034471|FG000|COMPLETED|Overall Study||1
10869047|NCT03615508|12034471|FG000|NOT COMPLETED|Overall Study||0
10869060|NCT03586687|12034497|FG000|STARTED|Overall Study||6
10869061|NCT03586687|12034498|FG001|STARTED|Overall Study||9
10868949|NCT04482439|12034355|FG000|STARTED|Overall Study||35
10868950|NCT04482439|12034355|FG000|COMPLETED|Overall Study||33
10868951|NCT04482439|12034355|FG000|NOT COMPLETED|Overall Study||2
10868952|NCT04465162|12034360|FG000|STARTED|Overall Study||73
10868953|NCT04465162|12034360|FG000|COMPLETED|Overall Study||73
10868954|NCT04465162|12034360|FG000|NOT COMPLETED|Overall Study||0
10868955|NCT04404725|12034364|FG000|STARTED|First Intervention||32
10868956|NCT04404725|12034365|FG001|STARTED|First Intervention||31
10868957|NCT04404725|12034364|FG000|COMPLETED|First Intervention||32
10868958|NCT04404725|12034365|FG001|COMPLETED|First Intervention||29
10868959|NCT04404725|12034364|FG000|NOT COMPLETED|First Intervention||0
10868960|NCT04404725|12034365|FG001|NOT COMPLETED|First Intervention||2
10868961|NCT04404725|12034364|FG000|STARTED|Second Intervention||32
10868962|NCT04404725|12034365|FG001|STARTED|Second Intervention||29
10868963|NCT04404725|12034364|FG000|COMPLETED|Second Intervention||31
10868964|NCT04404725|12034365|FG001|COMPLETED|Second Intervention||27
10868965|NCT04404725|12034364|FG000|NOT COMPLETED|Second Intervention||1
10868966|NCT04404725|12034365|FG001|NOT COMPLETED|Second Intervention||2
10868967|NCT04382586|12034373|FG000|STARTED|Overall Study||30
10868968|NCT04382586|12034374|FG001|STARTED|Overall Study||33
10868969|NCT04382586|12034373|FG000|COMPLETED|Overall Study||13
10868970|NCT04382586|12034374|FG001|COMPLETED|Overall Study||17
10868971|NCT04382586|12034373|FG000|NOT COMPLETED|Overall Study||17
10868972|NCT04382586|12034374|FG001|NOT COMPLETED|Overall Study||16
10868973|NCT04348656|12034382|FG000|STARTED|Overall Study||627
10868974|NCT04348656|12034383|FG001|STARTED|Overall Study||313
10868975|NCT04348656|12034382|FG000|Baseline Population|Overall Study||625
10868976|NCT04348656|12034383|FG001|Baseline Population|Overall Study||313
10868977|NCT04348656|12034382|FG000|Intention to Treat Analysis|Overall Study||614
10868978|NCT04348656|12034383|FG001|Intention to Treat Analysis|Overall Study||307
10868979|NCT04348656|12034382|FG000|Per Protocol Analysis|Overall Study||548
10868980|NCT04348656|12034383|FG001|Per Protocol Analysis|Overall Study||303
10868981|NCT04348656|12034382|FG000|COMPLETED|Overall Study||614
10868982|NCT04348656|12034383|FG001|COMPLETED|Overall Study||307
10868983|NCT04348656|12034382|FG000|NOT COMPLETED|Overall Study||13
10868984|NCT04348656|12034383|FG001|NOT COMPLETED|Overall Study||6
10868985|NCT04283253|12034389|FG000|STARTED|Overall Study||1
10868986|NCT04283253|12034389|FG000|COMPLETED|Overall Study||1
10868987|NCT04283253|12034389|FG000|NOT COMPLETED|Overall Study||0
10868988|NCT04246541|12034395|FG000|STARTED|Overall Study||25
10868989|NCT04246541|12034396|FG001|STARTED|Overall Study||23
10868990|NCT04246541|12034395|FG000|COMPLETED|Overall Study||22
10868991|NCT04246541|12034396|FG001|COMPLETED|Overall Study||20
10868992|NCT04246541|12034395|FG000|NOT COMPLETED|Overall Study||3
10868993|NCT04246541|12034396|FG001|NOT COMPLETED|Overall Study||3
10869062|NCT03586687|12034499|FG002|STARTED|Overall Study||4
10869063|NCT03586687|12034497|FG000|COMPLETED|Overall Study||6
10869064|NCT03586687|12034498|FG001|COMPLETED|Overall Study||9
10869065|NCT03586687|12034499|FG002|COMPLETED|Overall Study||4
10869066|NCT03586687|12034497|FG000|NOT COMPLETED|Overall Study||0
10869067|NCT03586687|12034498|FG001|NOT COMPLETED|Overall Study||0
10869068|NCT03586687|12034499|FG002|NOT COMPLETED|Overall Study||0
10869069|NCT03529773|12034547|FG000|STARTED|Overall Study||12
10869070|NCT03529773|12034548|FG001|STARTED|Overall Study||12
10869071|NCT03529773|12034549|FG002|STARTED|Overall Study||12
10869072|NCT03529773|12034550|FG003|STARTED|Overall Study||12
10869073|NCT03529773|12034551|FG004|STARTED|Overall Study||12
10869074|NCT03529773|12034552|FG005|STARTED|Overall Study||12
10869075|NCT03529773|12034553|FG006|STARTED|Overall Study||12
10869076|NCT03529773|12034554|FG007|STARTED|Overall Study||12
10869077|NCT03529773|12034555|FG008|STARTED|Overall Study||12
10869078|NCT03529773|12034556|FG009|STARTED|Overall Study||12
10869079|NCT03529773|12034557|FG010|STARTED|Overall Study||12
10869080|NCT03529773|12034558|FG011|STARTED|Overall Study||12
10869081|NCT03529773|12034559|FG012|STARTED|Overall Study||12
10869082|NCT03529773|12034560|FG013|STARTED|Overall Study||12
10869083|NCT03529773|12034561|FG014|STARTED|Overall Study||41
10869084|NCT03529773|12034562|FG015|STARTED|Overall Study||42
10869085|NCT03529773|12034563|FG016|STARTED|Overall Study||41
10869086|NCT03529773|12034564|FG017|STARTED|Overall Study||41
10869087|NCT03529773|12034565|FG018|STARTED|Overall Study||41
10869088|NCT03529773|12034566|FG019|STARTED|Overall Study||41
10869089|NCT03529773|12034567|FG020|STARTED|Overall Study||41
10869090|NCT03529773|12034568|FG021|STARTED|Overall Study||41
10869091|NCT03529773|12034569|FG022|STARTED|Overall Study||41
10869092|NCT03529773|12034570|FG023|STARTED|Overall Study||41
10869093|NCT03529773|12034571|FG024|STARTED|Overall Study||41
10869094|NCT03529773|12034572|FG025|STARTED|Overall Study||41
10869095|NCT03529773|12034573|FG026|STARTED|Overall Study||41
10869096|NCT03529773|12034574|FG027|STARTED|Overall Study||41
10869097|NCT03529773|12034575|FG028|STARTED|Overall Study||41
10869098|NCT03529773|12034576|FG029|STARTED|Overall Study||40
10869099|NCT03529773|12034577|FG030|STARTED|Overall Study||42
10869100|NCT03529773|12034578|FG031|STARTED|Overall Study||40
10869101|NCT03529773|12034579|FG032|STARTED|Overall Study||40
10869102|NCT03529773|12034580|FG033|STARTED|Overall Study||41
10869103|NCT03529773|12034581|FG034|STARTED|Overall Study||41
10869104|NCT03529773|12034582|FG035|STARTED|Overall Study||40
10869105|NCT03529773|12034583|FG036|STARTED|Overall Study||41
10869106|NCT03529773|12034584|FG037|STARTED|Overall Study||42
10869107|NCT03529773|12034585|FG038|STARTED|Overall Study||43
10869108|NCT03529773|12034586|FG039|STARTED|Overall Study||41
10869109|NCT03529773|12034547|FG000|COMPLETED|Overall Study||12
10869110|NCT03529773|12034548|FG001|COMPLETED|Overall Study||12
10869111|NCT03529773|12034549|FG002|COMPLETED|Overall Study||11
10869112|NCT03529773|12034550|FG003|COMPLETED|Overall Study||12
10869113|NCT03529773|12034551|FG004|COMPLETED|Overall Study||11
10869114|NCT03529773|12034552|FG005|COMPLETED|Overall Study||11
10869115|NCT03529773|12034553|FG006|COMPLETED|Overall Study||12
10869116|NCT03529773|12034554|FG007|COMPLETED|Overall Study||11
10869117|NCT03529773|12034555|FG008|COMPLETED|Overall Study||12
10869118|NCT03529773|12034556|FG009|COMPLETED|Overall Study||11
10869119|NCT03529773|12034557|FG010|COMPLETED|Overall Study||11
10869120|NCT03529773|12034558|FG011|COMPLETED|Overall Study||12
10869121|NCT03529773|12034559|FG012|COMPLETED|Overall Study||10
10869122|NCT03529773|12034560|FG013|COMPLETED|Overall Study||11
10869123|NCT03529773|12034561|FG014|COMPLETED|Overall Study||35
10869124|NCT03529773|12034562|FG015|COMPLETED|Overall Study||38
10869125|NCT03529773|12034563|FG016|COMPLETED|Overall Study||40
10869126|NCT03529773|12034564|FG017|COMPLETED|Overall Study||35
10869127|NCT03529773|12034565|FG018|COMPLETED|Overall Study||37
10869128|NCT03529773|12034566|FG019|COMPLETED|Overall Study||37
10869129|NCT03529773|12034567|FG020|COMPLETED|Overall Study||34
10869130|NCT03529773|12034568|FG021|COMPLETED|Overall Study||36
10869131|NCT03529773|12034569|FG022|COMPLETED|Overall Study||34
10869132|NCT03529773|12034570|FG023|COMPLETED|Overall Study||35
10869133|NCT03529773|12034571|FG024|COMPLETED|Overall Study||33
10869134|NCT03529773|12034572|FG025|COMPLETED|Overall Study||30
10869135|NCT03529773|12034573|FG026|COMPLETED|Overall Study||32
10869136|NCT03529773|12034574|FG027|COMPLETED|Overall Study||39
10869137|NCT03529773|12034575|FG028|COMPLETED|Overall Study||40
10869138|NCT03529773|12034576|FG029|COMPLETED|Overall Study||40
10869139|NCT03529773|12034577|FG030|COMPLETED|Overall Study||39
10869140|NCT03529773|12034578|FG031|COMPLETED|Overall Study||40
10869141|NCT03529773|12034579|FG032|COMPLETED|Overall Study||40
10869142|NCT03529773|12034580|FG033|COMPLETED|Overall Study||39
10869143|NCT03529773|12034581|FG034|COMPLETED|Overall Study||37
10869144|NCT03529773|12034582|FG035|COMPLETED|Overall Study||36
10869145|NCT03529773|12034583|FG036|COMPLETED|Overall Study||39
10869146|NCT03529773|12034584|FG037|COMPLETED|Overall Study||36
10869147|NCT03529773|12034585|FG038|COMPLETED|Overall Study||39
10869148|NCT03529773|12034586|FG039|COMPLETED|Overall Study||37
10869149|NCT03529773|12034547|FG000|NOT COMPLETED|Overall Study||0
10869150|NCT03529773|12034548|FG001|NOT COMPLETED|Overall Study||0
10869151|NCT03529773|12034549|FG002|NOT COMPLETED|Overall Study||1
10869152|NCT03529773|12034550|FG003|NOT COMPLETED|Overall Study||0
10869153|NCT03529773|12034551|FG004|NOT COMPLETED|Overall Study||1
10869154|NCT03529773|12034552|FG005|NOT COMPLETED|Overall Study||1
10869155|NCT03529773|12034553|FG006|NOT COMPLETED|Overall Study||0
10869156|NCT03529773|12034554|FG007|NOT COMPLETED|Overall Study||1
10869157|NCT03529773|12034555|FG008|NOT COMPLETED|Overall Study||0
10869158|NCT03529773|12034556|FG009|NOT COMPLETED|Overall Study||1
10869159|NCT03529773|12034557|FG010|NOT COMPLETED|Overall Study||1
10869160|NCT03529773|12034558|FG011|NOT COMPLETED|Overall Study||0
10869161|NCT03529773|12034559|FG012|NOT COMPLETED|Overall Study||2
10869162|NCT03529773|12034560|FG013|NOT COMPLETED|Overall Study||1
10869163|NCT03529773|12034561|FG014|NOT COMPLETED|Overall Study||6
10869164|NCT03529773|12034562|FG015|NOT COMPLETED|Overall Study||4
10869165|NCT03529773|12034563|FG016|NOT COMPLETED|Overall Study||1
10869166|NCT03529773|12034564|FG017|NOT COMPLETED|Overall Study||6
10869167|NCT03529773|12034565|FG018|NOT COMPLETED|Overall Study||4
10869168|NCT03529773|12034566|FG019|NOT COMPLETED|Overall Study||4
10869169|NCT03529773|12034567|FG020|NOT COMPLETED|Overall Study||7
10869170|NCT03529773|12034568|FG021|NOT COMPLETED|Overall Study||5
10869171|NCT03529773|12034569|FG022|NOT COMPLETED|Overall Study||7
10869172|NCT03529773|12034570|FG023|NOT COMPLETED|Overall Study||6
10869173|NCT03529773|12034571|FG024|NOT COMPLETED|Overall Study||8
10869174|NCT03529773|12034572|FG025|NOT COMPLETED|Overall Study||11
10869175|NCT03529773|12034573|FG026|NOT COMPLETED|Overall Study||9
10869176|NCT03529773|12034574|FG027|NOT COMPLETED|Overall Study||2
10869177|NCT03529773|12034575|FG028|NOT COMPLETED|Overall Study||1
10869178|NCT03529773|12034576|FG029|NOT COMPLETED|Overall Study||0
10869179|NCT03529773|12034577|FG030|NOT COMPLETED|Overall Study||3
10869180|NCT03529773|12034578|FG031|NOT COMPLETED|Overall Study||0
10869181|NCT03529773|12034579|FG032|NOT COMPLETED|Overall Study||0
10869182|NCT03529773|12034580|FG033|NOT COMPLETED|Overall Study||2
10869183|NCT03529773|12034581|FG034|NOT COMPLETED|Overall Study||4
10869184|NCT03529773|12034582|FG035|NOT COMPLETED|Overall Study||4
10869185|NCT03529773|12034583|FG036|NOT COMPLETED|Overall Study||2
10869186|NCT03529773|12034584|FG037|NOT COMPLETED|Overall Study||6
10869187|NCT03529773|12034585|FG038|NOT COMPLETED|Overall Study||4
10869188|NCT03529773|12034586|FG039|NOT COMPLETED|Overall Study||4
10869189|NCT03502070|12034689|FG000|STARTED|Overall Study||47
10869190|NCT03502070|12034689|FG000|COMPLETED|Overall Study||45
10869191|NCT03502070|12034689|FG000|NOT COMPLETED|Overall Study||2
10869192|NCT03485911|12034696|FG000|STARTED|Overall Study||41
10869193|NCT03485911|12034697|FG001|STARTED|Overall Study||40
10869194|NCT03485911|12034698|FG002|STARTED|Overall Study||40
10869195|NCT03485911|12034696|FG000|COMPLETED|Overall Study||40
10869196|NCT03485911|12034697|FG001|COMPLETED|Overall Study||38
10869197|NCT03485911|12034698|FG002|COMPLETED|Overall Study||36
10869198|NCT03485911|12034696|FG000|NOT COMPLETED|Overall Study||1
10869199|NCT03485911|12034697|FG001|NOT COMPLETED|Overall Study||2
10869200|NCT03485911|12034698|FG002|NOT COMPLETED|Overall Study||4
10869201|NCT03403634|12034706|FG000|STARTED|Overall Study|19 patients were accrued and completed consent.|19
10869202|NCT03403634|12034706|FG000|Treated|Overall Study|4 patients became ineligible prior to the start of treatment.|15
10869203|NCT03403634|12034706|FG000|COMPLETED|Overall Study||12
10869204|NCT03403634|12034706|FG000|NOT COMPLETED|Overall Study||7
10869205|NCT03382041|12034712|FG000|STARTED|Overall Study||7
10869206|NCT03382041|12034713|FG001|STARTED|Overall Study||13
10869207|NCT03382041|12034712|FG000|COMPLETED|Overall Study||3
10869208|NCT03382041|12034713|FG001|COMPLETED|Overall Study||4
10869209|NCT03382041|12034712|FG000|NOT COMPLETED|Overall Study||4
10869210|NCT03382041|12034713|FG001|NOT COMPLETED|Overall Study||9
10869211|NCT03201419|12034728|FG000|STARTED|Overall Study||60
10869212|NCT03201419|12034729|FG001|STARTED|Overall Study||27
10869213|NCT03201419|12034730|FG002|STARTED|Overall Study||24
10869214|NCT03201419|12034731|FG003|STARTED|Overall Study||14
10869215|NCT03201419|12034732|FG004|STARTED|Overall Study||13
10869216|NCT03201419|12034733|FG005|STARTED|Overall Study||34
10869217|NCT03201419|12034734|FG006|STARTED|Overall Study||87
10869218|NCT03201419|12034735|FG007|STARTED|Overall Study||26
10869219|NCT03201419|12034736|FG008|STARTED|Overall Study||17
10869220|NCT03201419|12034728|FG000|COMPLETED|Overall Study||52
10869221|NCT03201419|12034729|FG001|COMPLETED|Overall Study||24
10869222|NCT03201419|12034730|FG002|COMPLETED|Overall Study||22
10869223|NCT03201419|12034731|FG003|COMPLETED|Overall Study||14
10869224|NCT03201419|12034732|FG004|COMPLETED|Overall Study||12
10869225|NCT03201419|12034733|FG005|COMPLETED|Overall Study||33
10869226|NCT03201419|12034734|FG006|COMPLETED|Overall Study||81
10869227|NCT03201419|12034735|FG007|COMPLETED|Overall Study||25
10869228|NCT03201419|12034736|FG008|COMPLETED|Overall Study||15
10869229|NCT03201419|12034728|FG000|NOT COMPLETED|Overall Study||8
10869230|NCT03201419|12034729|FG001|NOT COMPLETED|Overall Study||3
10869231|NCT03201419|12034730|FG002|NOT COMPLETED|Overall Study||2
10869232|NCT03201419|12034731|FG003|NOT COMPLETED|Overall Study||0
10869233|NCT03201419|12034732|FG004|NOT COMPLETED|Overall Study||1
10869234|NCT03201419|12034733|FG005|NOT COMPLETED|Overall Study||1
10869235|NCT03201419|12034734|FG006|NOT COMPLETED|Overall Study||6
10869236|NCT03201419|12034735|FG007|NOT COMPLETED|Overall Study||1
10869237|NCT03201419|12034736|FG008|NOT COMPLETED|Overall Study||2
10869238|NCT03197766|12034772|FG000|STARTED|Overall Study||60
10869239|NCT03197766|12034773|FG001|STARTED|Overall Study||61
10869240|NCT03197766|12034772|FG000|COMPLETED|Overall Study||58
10869241|NCT03197766|12034773|FG001|COMPLETED|Overall Study||61
10869242|NCT03197766|12034772|FG000|NOT COMPLETED|Overall Study||2
10869243|NCT03197766|12034773|FG001|NOT COMPLETED|Overall Study||0
10869244|NCT05143801|12034779|FG000|STARTED|Overall Study||10
10869245|NCT05143801|12034779|FG000|COMPLETED|Overall Study||10
10869246|NCT05143801|12034779|FG000|NOT COMPLETED|Overall Study||0
10869247|NCT04516759|12034791|FG000|STARTED|Overall Study|excluding 2 subjects who were randomized but did not start treatment|80
10869248|NCT04516759|12034792|FG001|STARTED|Overall Study|excluding 1 subject who was randomized but did not start treatment|73
10869249|NCT04516759|12034791|FG000|COMPLETED|Overall Study||79
10869250|NCT04516759|12034792|FG001|COMPLETED|Overall Study||71
10869251|NCT04516759|12034791|FG000|NOT COMPLETED|Overall Study||1
10869252|NCT04516759|12034792|FG001|NOT COMPLETED|Overall Study||2
10869253|NCT03930446|12034800|FG000|STARTED|Overall Study||40
10869254|NCT03930446|12034801|FG001|STARTED|Overall Study||40
10869255|NCT03930446|12034800|FG000|COMPLETED|Overall Study||40
10869256|NCT03930446|12034801|FG001|COMPLETED|Overall Study||40
10869257|NCT03930446|12034800|FG000|NOT COMPLETED|Overall Study||0
10869258|NCT03930446|12034801|FG001|NOT COMPLETED|Overall Study||0
10869259|NCT03492099|12034807|FG000|STARTED|Overall Study||47
10869260|NCT03492099|12034807|FG000|COMPLETED|Overall Study||43
10869261|NCT03492099|12034807|FG000|NOT COMPLETED|Overall Study||4
10869262|NCT03409276|12034817|FG000|STARTED|Overall Study||2
10869263|NCT03409276|12034818|FG001|STARTED|Overall Study||10
10869264|NCT03409276|12034819|FG002|STARTED|Overall Study||6
10869265|NCT03409276|12034820|FG003|STARTED|Overall Study||21
10869266|NCT03409276|12034821|FG004|STARTED|Overall Study||21
10869267|NCT03409276|12034817|FG000|Month 2.5 Immunogenicity Cohort|Overall Study||2
10869268|NCT03409276|12034818|FG001|Month 2.5 Immunogenicity Cohort|Overall Study||10
10869269|NCT03409276|12034819|FG002|Month 2.5 Immunogenicity Cohort|Overall Study||0
10869270|NCT03409276|12034820|FG003|Month 2.5 Immunogenicity Cohort|Overall Study||0
10869271|NCT03409276|12034821|FG004|Month 2.5 Immunogenicity Cohort|Overall Study||0
10869272|NCT03409276|12034817|FG000|Month 8.5 Immunogenicity Cohort|Overall Study||0
10869273|NCT03409276|12034818|FG001|Month 8.5 Immunogenicity Cohort|Overall Study||0
10869274|NCT03409276|12034819|FG002|Month 8.5 Immunogenicity Cohort|Overall Study||6
10869275|NCT03409276|12034820|FG003|Month 8.5 Immunogenicity Cohort|Overall Study||19
10869276|NCT03409276|12034821|FG004|Month 8.5 Immunogenicity Cohort|Overall Study||16
10869277|NCT03409276|12034817|FG000|COMPLETED|Overall Study||2
10869278|NCT03409276|12034818|FG001|COMPLETED|Overall Study||10
10869279|NCT03409276|12034819|FG002|COMPLETED|Overall Study||6
10418776|NCT00807248|11563539|FG000|NOT COMPLETED|Overall Study||21
10869280|NCT03409276|12034820|FG003|COMPLETED|Overall Study||19
10869281|NCT03409276|12034821|FG004|COMPLETED|Overall Study||18
10869282|NCT03409276|12034817|FG000|NOT COMPLETED|Overall Study||0
10869283|NCT03409276|12034818|FG001|NOT COMPLETED|Overall Study||0
10869284|NCT03409276|12034819|FG002|NOT COMPLETED|Overall Study||0
10869285|NCT03409276|12034820|FG003|NOT COMPLETED|Overall Study||2
10869286|NCT03409276|12034821|FG004|NOT COMPLETED|Overall Study||3
10869287|NCT03312907|12034840|FG000|STARTED|Overall Study||72
10869288|NCT03312907|12034841|FG001|STARTED|Overall Study||144
10869289|NCT03312907|12034842|FG002|STARTED|Overall Study||76
10869290|NCT03312907|12034840|FG000|COMPLETED|Overall Study||55
10869291|NCT03312907|12034841|FG001|COMPLETED|Overall Study||114
10869292|NCT03312907|12034842|FG002|COMPLETED|Overall Study||57
10869293|NCT03312907|12034840|FG000|NOT COMPLETED|Overall Study||17
10869294|NCT03312907|12034841|FG001|NOT COMPLETED|Overall Study||30
10869295|NCT03312907|12034842|FG002|NOT COMPLETED|Overall Study||19
10869296|NCT03148756|12034852|FG000|STARTED|Overall Study||0
10869297|NCT03148756|12034853|FG001|STARTED|Overall Study||2
10869298|NCT03148756|12034852|FG000|COMPLETED|Overall Study||0
10869299|NCT03148756|12034853|FG001|COMPLETED|Overall Study||1
10869300|NCT03148756|12034852|FG000|NOT COMPLETED|Overall Study||0
10869301|NCT03148756|12034853|FG001|NOT COMPLETED|Overall Study||1
10869302|NCT03079102|12034861|FG000|STARTED|Overall Study||30
10869303|NCT03079102|12034862|FG001|STARTED|Overall Study||27
10869304|NCT03079102|12034861|FG000|COMPLETED|Overall Study||30
10869305|NCT03079102|12034862|FG001|COMPLETED|Overall Study|One subject had study drug discontinued by the PI after 3h of therapy due to progressive hemodynamic deterioration (worsening hypotension and shock). Discontinuation of study drug did not impact this deterioration.|26
10869306|NCT03079102|12034861|FG000|NOT COMPLETED|Overall Study||0
10869307|NCT03079102|12034862|FG001|NOT COMPLETED|Overall Study||1
10869308|NCT02944513|12034870|FG000|STARTED|Overall Study||35
10869309|NCT02944513|12034871|FG001|STARTED|Overall Study||33
10869310|NCT02944513|12034870|FG000|COMPLETED|Overall Study||31
10869311|NCT02944513|12034871|FG001|COMPLETED|Overall Study||32
10869312|NCT02944513|12034870|FG000|NOT COMPLETED|Overall Study||4
10869313|NCT02944513|12034871|FG001|NOT COMPLETED|Overall Study||1
10869314|NCT02913222|12034879|FG000|STARTED|Overall Study||23
10869315|NCT02913222|12034880|FG001|STARTED|Overall Study||23
10869316|NCT02913222|12034879|FG000|COMPLETED|Overall Study||22
10869317|NCT02913222|12034880|FG001|COMPLETED|Overall Study||21
10869318|NCT02913222|12034879|FG000|NOT COMPLETED|Overall Study||1
10869319|NCT02913222|12034880|FG001|NOT COMPLETED|Overall Study||2
10869320|NCT02734433|12034888|FG000|STARTED|Overall Study||3
10869321|NCT02734433|12034889|FG001|STARTED|Overall Study||8
10869322|NCT02734433|12034888|FG000|COMPLETED|Overall Study||1
10869323|NCT02734433|12034889|FG001|COMPLETED|Overall Study||0
10869324|NCT02734433|12034888|FG000|NOT COMPLETED|Overall Study||2
10869325|NCT02734433|12034889|FG001|NOT COMPLETED|Overall Study||8
10869326|NCT02474927|12034895|FG000|STARTED|Overall Study||22
10869327|NCT02474927|12034895|FG000|COMPLETED|Overall Study||22
10869328|NCT02474927|12034895|FG000|NOT COMPLETED|Overall Study||0
10869329|NCT02145507|12034901|FG000|STARTED|First Donation||82
10869330|NCT02145507|12034902|FG001|STARTED|First Donation||88
10869331|NCT02145507|12034901|FG000|Randomized to Have Blood Processed With SOLX (IP)|First Donation||52
10869332|NCT02145507|12034902|FG001|Randomized to Have Blood Processed With SOLX (IP)|First Donation||51
10869333|NCT02145507|12034901|FG000|Randomized to Have Blood Processed With AS-3 (CP)|First Donation||30
10869334|NCT02145507|12034902|FG001|Randomized to Have Blood Processed With AS-3 (CP)|First Donation||37
10869335|NCT02145507|12034901|FG000|COMPLETED|First Donation||70
10869336|NCT02145507|12034902|FG001|COMPLETED|First Donation||67
10869337|NCT02145507|12034901|FG000|NOT COMPLETED|First Donation||12
10869338|NCT02145507|12034902|FG001|NOT COMPLETED|First Donation||21
10869339|NCT02145507|12034901|FG000|STARTED|Second Donation||65
10869340|NCT02145507|12034902|FG001|STARTED|Second Donation|Note: Of the 65 participants who started the second period in Arm 2, there were 3 screen failures, therefore only n=62 participants received their alternate procedure.|65
10869341|NCT02145507|12034901|FG000|Blood Processed With AS-3 (CP)|Second Donation||39
10869342|NCT02145507|12034902|FG001|Blood Processed With AS-3 (CP)|Second Donation||35
10869343|NCT02145507|12034901|FG000|Blood Processed With SOLX (IP)|Second Donation||26
10869344|NCT02145507|12034902|FG001|Blood Processed With SOLX (IP)|Second Donation||27
10869345|NCT02145507|12034901|FG000|COMPLETED|Second Donation||63
10869346|NCT02145507|12034902|FG001|COMPLETED|Second Donation||60
10869347|NCT02145507|12034901|FG000|NOT COMPLETED|Second Donation||2
10869348|NCT02145507|12034902|FG001|NOT COMPLETED|Second Donation||5
10869349|NCT02048722|12034913|FG000|STARTED|2 Cycles of Treatment||31
10869350|NCT02048722|12034913|FG000|Attempted 1st Cycle|2 Cycles of Treatment||31
10869351|NCT02048722|12034913|FG000|Attempted 2nd Cycle|2 Cycles of Treatment||23
10869352|NCT02048722|12034913|FG000|COMPLETED|2 Cycles of Treatment||23
10869353|NCT02048722|12034913|FG000|NOT COMPLETED|2 Cycles of Treatment||8
10869354|NCT02048722|12034913|FG000|STARTED|Reached 1st Response/Continued Treatment||23
10869355|NCT02048722|12034913|FG000|Assessed for First Response|Reached 1st Response/Continued Treatment||23
10869356|NCT02048722|12034913|FG000|Went on to Cycle 3 and Beyond|Reached 1st Response/Continued Treatment||13
10869357|NCT02048722|12034913|FG000|COMPLETED|Reached 1st Response/Continued Treatment||13
10869358|NCT02048722|12034913|FG000|NOT COMPLETED|Reached 1st Response/Continued Treatment||10
10869359|NCT02048722|12034913|FG000|STARTED|Follow up 5 Years or Cut of Timepoint||31
10869360|NCT02048722|12034913|FG000|COMPLETED|Follow up 5 Years or Cut of Timepoint||4
10869361|NCT02048722|12034913|FG000|NOT COMPLETED|Follow up 5 Years or Cut of Timepoint||27
10869362|NCT01896102|12034917|FG000|STARTED|Overall Study||32
10869363|NCT01896102|12034917|FG000|COMPLETED|Overall Study||29
10869364|NCT01896102|12034917|FG000|NOT COMPLETED|Overall Study||3
10869365|NCT01885078|12034930|FG000|STARTED|Treatment Period||451
10869366|NCT01885078|12034931|FG001|STARTED|Treatment Period||1091
10869367|NCT01885078|12034932|FG002|STARTED|Treatment Period||180
10869368|NCT01885078|12034933|FG003|STARTED|Treatment Period||403
10869369|NCT01885078|12034934|FG004|STARTED|Treatment Period||117
10869370|NCT01885078|12034935|FG005|STARTED|Treatment Period||331
10869371|NCT01885078|12034936|FG006|STARTED|Treatment Period||221
10869372|NCT01885078|12034937|FG007|STARTED|Treatment Period||83
10869373|NCT01885078|12034938|FG008|STARTED|Treatment Period||0
10869374|NCT01885078|12034939|FG009|STARTED|Treatment Period||0
10869375|NCT01885078|12034930|FG000|Received at Least Once Dose of Study Drug|Treatment Period||451
10869376|NCT01885078|12034931|FG001|Received at Least Once Dose of Study Drug|Treatment Period||1090
10869377|NCT01885078|12034932|FG002|Received at Least Once Dose of Study Drug|Treatment Period||180
10869378|NCT01885078|12034933|FG003|Received at Least Once Dose of Study Drug|Treatment Period||403
10869379|NCT01885078|12034934|FG004|Received at Least Once Dose of Study Drug|Treatment Period||117
10869380|NCT01885078|12034935|FG005|Received at Least Once Dose of Study Drug|Treatment Period||331
10869381|NCT01885078|12034936|FG006|Received at Least Once Dose of Study Drug|Treatment Period||221
10869382|NCT01885078|12034937|FG007|Received at Least Once Dose of Study Drug|Treatment Period||83
10869383|NCT01885078|12034938|FG008|Received at Least Once Dose of Study Drug|Treatment Period||0
10869384|NCT01885078|12034939|FG009|Received at Least Once Dose of Study Drug|Treatment Period||0
10869385|NCT01885078|12034930|FG000|COMPLETED|Treatment Period||19
10869386|NCT01885078|12034931|FG001|COMPLETED|Treatment Period||64
10869387|NCT01885078|12034932|FG002|COMPLETED|Treatment Period||49
10869388|NCT01885078|12034933|FG003|COMPLETED|Treatment Period||120
10869389|NCT01885078|12034934|FG004|COMPLETED|Treatment Period||27
10869390|NCT01885078|12034935|FG005|COMPLETED|Treatment Period||81
10869391|NCT01885078|12034936|FG006|COMPLETED|Treatment Period||0
10869392|NCT01885078|12034937|FG007|COMPLETED|Treatment Period||55
10869393|NCT01885078|12034938|FG008|COMPLETED|Treatment Period||0
10869394|NCT01885078|12034939|FG009|COMPLETED|Treatment Period||0
10869395|NCT01885078|12034930|FG000|NOT COMPLETED|Treatment Period||432
10869396|NCT01885078|12034931|FG001|NOT COMPLETED|Treatment Period||1027
10869397|NCT01885078|12034932|FG002|NOT COMPLETED|Treatment Period||131
10869398|NCT01885078|12034933|FG003|NOT COMPLETED|Treatment Period||283
10869399|NCT01885078|12034934|FG004|NOT COMPLETED|Treatment Period||90
10869400|NCT01885078|12034935|FG005|NOT COMPLETED|Treatment Period||250
10869401|NCT01885078|12034936|FG006|NOT COMPLETED|Treatment Period||221
10869402|NCT01885078|12034937|FG007|NOT COMPLETED|Treatment Period||28
10869403|NCT01885078|12034938|FG008|NOT COMPLETED|Treatment Period||0
10869404|NCT01885078|12034939|FG009|NOT COMPLETED|Treatment Period||0
10869405|NCT01885078|12034930|FG000|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0
10869406|NCT01885078|12034931|FG001|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0
10869407|NCT01885078|12034932|FG002|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0
10869408|NCT01885078|12034933|FG003|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0
10869409|NCT01885078|12034934|FG004|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0
10869410|NCT01885078|12034935|FG005|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0
10869411|NCT01885078|12034936|FG006|STARTED|Step-down Period||0
10869412|NCT01885078|12034937|FG007|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0
10869413|NCT01885078|12034938|FG008|STARTED|Step-down Period|Eligible participants were offered the option of participating in the Step-Down Period.|592
10869414|NCT01885078|12034939|FG009|STARTED|Step-down Period|Eligible participants were offered the option of participating in the Step-Down Period.|594
10869415|NCT01885078|12034930|FG000|Complete Through Week 96|Step-down Period||0
10869416|NCT01885078|12034931|FG001|Complete Through Week 96|Step-down Period||0
10869417|NCT01885078|12034932|FG002|Complete Through Week 96|Step-down Period||0
10869418|NCT01885078|12034933|FG003|Complete Through Week 96|Step-down Period||0
10869419|NCT01885078|12034934|FG004|Complete Through Week 96|Step-down Period||0
10869420|NCT01885078|12034935|FG005|Complete Through Week 96|Step-down Period||0
10869421|NCT01885078|12034936|FG006|Complete Through Week 96|Step-down Period||0
10869422|NCT01885078|12034937|FG007|Complete Through Week 96|Step-down Period||0
10869423|NCT01885078|12034938|FG008|Complete Through Week 96|Step-down Period||407
10869424|NCT01885078|12034939|FG009|Complete Through Week 96|Step-down Period||455
10869425|NCT01885078|12034930|FG000|COMPLETED|Step-down Period||0
10869426|NCT01885078|12034931|FG001|COMPLETED|Step-down Period||0
10869427|NCT01885078|12034932|FG002|COMPLETED|Step-down Period||0
10869428|NCT01885078|12034933|FG003|COMPLETED|Step-down Period||0
10869429|NCT01885078|12034934|FG004|COMPLETED|Step-down Period||0
10869430|NCT01885078|12034935|FG005|COMPLETED|Step-down Period||0
10869431|NCT01885078|12034936|FG006|COMPLETED|Step-down Period||0
10869432|NCT01885078|12034937|FG007|COMPLETED|Step-down Period||0
10869433|NCT01885078|12034938|FG008|COMPLETED|Step-down Period||523
10869434|NCT01885078|12034939|FG009|COMPLETED|Step-down Period||533
10869435|NCT01885078|12034930|FG000|NOT COMPLETED|Step-down Period||0
10869436|NCT01885078|12034931|FG001|NOT COMPLETED|Step-down Period||0
10869437|NCT01885078|12034932|FG002|NOT COMPLETED|Step-down Period||0
10869438|NCT01885078|12034933|FG003|NOT COMPLETED|Step-down Period||0
10869439|NCT01885078|12034934|FG004|NOT COMPLETED|Step-down Period||0
10869440|NCT01885078|12034935|FG005|NOT COMPLETED|Step-down Period||0
10869441|NCT01885078|12034936|FG006|NOT COMPLETED|Step-down Period||0
10869442|NCT01885078|12034937|FG007|NOT COMPLETED|Step-down Period||0
10869443|NCT01885078|12034938|FG008|NOT COMPLETED|Step-down Period||69
10869444|NCT01885078|12034939|FG009|NOT COMPLETED|Step-down Period||61
10869445|NCT01047683|12034963|FG000|STARTED|Overall Study||76
10869446|NCT01047683|12034964|FG001|STARTED|Overall Study||76
10869447|NCT01047683|12034965|FG002|STARTED|Overall Study||77
10869448|NCT01047683|12034963|FG000|COMPLETED|Overall Study||71
10869449|NCT01047683|12034964|FG001|COMPLETED|Overall Study||70
10869450|NCT01047683|12034965|FG002|COMPLETED|Overall Study||74
10869451|NCT01047683|12034963|FG000|NOT COMPLETED|Overall Study||5
10869452|NCT01047683|12034964|FG001|NOT COMPLETED|Overall Study||6
10869453|NCT01047683|12034965|FG002|NOT COMPLETED|Overall Study||3
10869454|NCT01047501|12034976|FG000|STARTED|Overall Study||233
10869455|NCT01047501|12034977|FG001|STARTED|Overall Study||236
10869456|NCT01047501|12034978|FG002|STARTED|Overall Study||233
10869457|NCT01047501|12034976|FG000|COMPLETED|Overall Study||217
10869458|NCT01047501|12034977|FG001|COMPLETED|Overall Study||225
10869459|NCT01047501|12034978|FG002|COMPLETED|Overall Study||221
10869460|NCT01047501|12034976|FG000|NOT COMPLETED|Overall Study||16
10869461|NCT01047501|12034977|FG001|NOT COMPLETED|Overall Study||11
10869462|NCT01047501|12034978|FG002|NOT COMPLETED|Overall Study||12
10869463|NCT00981656|12034986|FG000|STARTED|Overall Study||37
10869464|NCT00981656|12034986|FG000|Eligible and Started Study Treatment|Overall Study||34
10869465|NCT00981656|12034986|FG000|COMPLETED|Overall Study||34
10869466|NCT00981656|12034986|FG000|NOT COMPLETED|Overall Study||3
10869467|NCT00838526|12034992|FG000|STARTED|Overall Study|Treated|59
10869468|NCT00838526|12034993|FG001|STARTED|Overall Study|Treated|176
10869469|NCT00838526|12034992|FG000|COMPLETED|Overall Study||35
10869470|NCT00838526|12034993|FG001|COMPLETED|Overall Study||137
10869471|NCT00838526|12034992|FG000|NOT COMPLETED|Overall Study||24
10869472|NCT00838526|12034993|FG001|NOT COMPLETED|Overall Study||39
10869473|NCT00126672|12034999|FG000|STARTED|Overall Study||36
10869474|NCT00126672|12034999|FG000|COMPLETED|Overall Study||28
10869475|NCT00126672|12034999|FG000|NOT COMPLETED|Overall Study||8
10869476|NCT03172780|12035006|FG000|STARTED|Overall Study||406
10869477|NCT03172780|12035007|FG001|STARTED|Overall Study||409
10869478|NCT03172780|12035008|FG002|STARTED|Overall Study||405
10869479|NCT03172780|12035006|FG000|COMPLETED|Overall Study||388
10869480|NCT03172780|12035007|FG001|COMPLETED|Overall Study||389
10869481|NCT03172780|12035008|FG002|COMPLETED|Overall Study||389
10869482|NCT03172780|12035006|FG000|NOT COMPLETED|Overall Study||18
10869483|NCT03172780|12035007|FG001|NOT COMPLETED|Overall Study||20
10869484|NCT03172780|12035008|FG002|NOT COMPLETED|Overall Study||16
10869485|NCT03151304|12035016|FG000|STARTED|Overall Study||64
10869486|NCT03151304|12035016|FG000|COMPLETED|Overall Study||0
10869487|NCT03151304|12035016|FG000|NOT COMPLETED|Overall Study||64
10295064|NCT00943722|11427684|FG000|At Least One Dose With Protocol-specified Safety Follow-up|Base Study||643
10295065|NCT00943722|11427685|FG001|At Least One Dose With Protocol-specified Safety Follow-up|Base Study||639
10295066|NCT00943722|11427686|FG002|At Least One Dose With Protocol-specified Safety Follow-up|Base Study||641
10295067|NCT00943722|11427687|FG003|At Least One Dose With Protocol-specified Safety Follow-up|Base Study||662
10295068|NCT00943722|11427688|FG004|At Least One Dose With Protocol-specified Safety Follow-up|Base Study||466
10295069|NCT00943722|11427689|FG005|At Least One Dose With Protocol-specified Safety Follow-up|Base Study||0
10295070|NCT00943722|11427690|FG006|At Least One Dose With Protocol-specified Safety Follow-up|Base Study||0
10295071|NCT00943722|11427684|FG000|COMPLETED|Base Study||623
10295072|NCT00943722|11427685|FG001|COMPLETED|Base Study||621
10295073|NCT00943722|11427686|FG002|COMPLETED|Base Study||631
10295074|NCT00943722|11427687|FG003|COMPLETED|Base Study||647
10295075|NCT00943722|11427688|FG004|COMPLETED|Base Study||444
10295076|NCT00943722|11427689|FG005|COMPLETED|Base Study||0
10295077|NCT00943722|11427690|FG006|COMPLETED|Base Study||0
10295078|NCT00943722|11427684|FG000|NOT COMPLETED|Base Study||25
10295079|NCT00943722|11427685|FG001|NOT COMPLETED|Base Study||22
10295080|NCT00943722|11427686|FG002|NOT COMPLETED|Base Study||13
10295081|NCT00943722|11427687|FG003|NOT COMPLETED|Base Study||22
10295082|NCT00943722|11427688|FG004|NOT COMPLETED|Base Study||26
10295083|NCT00943722|11427689|FG005|NOT COMPLETED|Base Study||0
10295084|NCT00943722|11427690|FG006|NOT COMPLETED|Base Study||0
10295085|NCT00943722|11427684|FG000|STARTED|First Extension Study: EXT 1||0
10295086|NCT00943722|11427685|FG001|STARTED|First Extension Study: EXT 1||0
10295087|NCT00943722|11427686|FG002|STARTED|First Extension Study: EXT 1||0
10295088|NCT00943722|11427687|FG003|STARTED|First Extension Study: EXT 1||0
10295089|NCT00943722|11427688|FG004|STARTED|First Extension Study: EXT 1||0
10295090|NCT00943722|11427689|FG005|STARTED|First Extension Study: EXT 1||1604
10295091|NCT00943722|11427690|FG006|STARTED|First Extension Study: EXT 1||568
10295092|NCT00943722|11427684|FG000|COMPLETED|First Extension Study: EXT 1||0
10295093|NCT00943722|11427685|FG001|COMPLETED|First Extension Study: EXT 1||0
10295094|NCT00943722|11427686|FG002|COMPLETED|First Extension Study: EXT 1||0
10295095|NCT00943722|11427687|FG003|COMPLETED|First Extension Study: EXT 1||0
10295096|NCT00943722|11427688|FG004|COMPLETED|First Extension Study: EXT 1||0
10295097|NCT00943722|11427689|FG005|COMPLETED|First Extension Study: EXT 1||1489
10295098|NCT00943722|11427690|FG006|COMPLETED|First Extension Study: EXT 1||527
10295099|NCT00943722|11427684|FG000|NOT COMPLETED|First Extension Study: EXT 1||0
10869488|NCT03113409|12035020|FG000|STARTED|Overall Study||10
10869489|NCT03113409|12035021|FG001|STARTED|Overall Study|Study procedure was never started|0
10869490|NCT03113409|12035022|FG002|STARTED|Overall Study|Study procedure was never started|0
10418777|NCT00807248|11563540|FG001|NOT COMPLETED|Overall Study||12
10418778|NCT00807248|11563541|FG002|NOT COMPLETED|Overall Study||18
10418779|NCT00807248|11563542|FG003|NOT COMPLETED|Overall Study||14
10418780|NCT00807456|11563552|FG000|STARTED|Overall Study||65
10418781|NCT00807456|11563552|FG000|COMPLETED|Overall Study||65
10418782|NCT00807456|11563552|FG000|NOT COMPLETED|Overall Study||0
10869491|NCT03113409|12035020|FG000|COMPLETED|Overall Study||5
10418783|NCT00807495|11563561|FG000|STARTED|Overall Study||22
10418784|NCT00807495|11563562|FG001|STARTED|Overall Study||13
10418785|NCT00807495|11563563|FG002|STARTED|Overall Study||5
10418786|NCT00807495|11563564|FG003|STARTED|Overall Study||1
10418787|NCT00807495|11563565|FG004|STARTED|Overall Study|An ATL participant had late on-study biopsy and was in DLBL, reducing ATL participants from 8 to 7.|7
10418788|NCT00807495|11563561|FG000|COMPLETED|Overall Study|Completed = participants who completed the study treatment to PD or symptomatic deterioration.|14
10418789|NCT00807495|11563562|FG001|COMPLETED|Overall Study||7
10418790|NCT00807495|11563563|FG002|COMPLETED|Overall Study||1
10418791|NCT00807495|11563564|FG003|COMPLETED|Overall Study||0
10418792|NCT00807495|11563565|FG004|COMPLETED|Overall Study||2
10418793|NCT00807495|11563561|FG000|NOT COMPLETED|Overall Study||8
10418794|NCT00807495|11563562|FG001|NOT COMPLETED|Overall Study||6
10418795|NCT00807495|11563563|FG002|NOT COMPLETED|Overall Study||4
10418796|NCT00807495|11563564|FG003|NOT COMPLETED|Overall Study||1
10418797|NCT00807495|11563565|FG004|NOT COMPLETED|Overall Study||5
10429430|NCT00863681|11575454|FG000|STARTED|Overall Study||231
10429431|NCT00863681|11575455|FG001|STARTED|Overall Study||109
10429432|NCT00863681|11575456|FG002|STARTED|Overall Study||56
10429433|NCT00863681|11575454|FG000|COMPLETED|Overall Study|Completed treatment|140
10429434|NCT00863681|11575455|FG001|COMPLETED|Overall Study|Completed treatment|66
10429435|NCT00863681|11575456|FG002|COMPLETED|Overall Study|Completed treatment|38
10429436|NCT00863681|11575454|FG000|NOT COMPLETED|Overall Study||91
10429437|NCT00863681|11575455|FG001|NOT COMPLETED|Overall Study||43
10429438|NCT00863681|11575456|FG002|NOT COMPLETED|Overall Study||18
10429439|NCT00863707|11575466|FG000|STARTED|Overall Study||174
10429440|NCT00863707|11575467|FG001|STARTED|Overall Study||337
10429441|NCT00863707|11575466|FG000|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|170
10429442|NCT00863707|11575467|FG001|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|334
10429443|NCT00863707|11575466|FG000|NOT COMPLETED|Overall Study||4
10429444|NCT00863707|11575467|FG001|NOT COMPLETED|Overall Study||3
10429445|NCT00863746|11575475|FG000|STARTED|Treatment||350
10429446|NCT00863746|11575476|FG001|STARTED|Treatment||353
10429447|NCT00863746|11575475|FG000|Participants Received Treatment|Treatment|Safety population|346
10429448|NCT00863746|11575476|FG001|Participants Received Treatment|Treatment|Safety population|351
10429449|NCT00863746|11575475|FG000|COMPLETED|Treatment||279
10429450|NCT00863746|11575476|FG001|COMPLETED|Treatment||318
10429451|NCT00863746|11575475|FG000|NOT COMPLETED|Treatment||71
10429452|NCT00863746|11575476|FG001|NOT COMPLETED|Treatment||35
10429453|NCT00863746|11575475|FG000|STARTED|Survival Follow up|298 patients of 317 patients (= 346 randomized - 29 deaths) entered the survival follow-up|298
10429454|NCT00863746|11575476|FG001|STARTED|Survival Follow up|331 patients of 339 patients (=353 randomized - 14 death) entered the survival follow-up.|331
10429455|NCT00863746|11575475|FG000|COMPLETED|Survival Follow up||45
10429456|NCT00863746|11575476|FG001|COMPLETED|Survival Follow up||51
10429457|NCT00863746|11575475|FG000|NOT COMPLETED|Survival Follow up||253
10429458|NCT00863746|11575476|FG001|NOT COMPLETED|Survival Follow up||280
10429459|NCT00863772|11575485|FG000|STARTED|Overall Study||74
10429460|NCT00863772|11575486|FG001|STARTED|Overall Study||74
10429461|NCT00863772|11575487|FG002|STARTED|Overall Study||72
10429462|NCT00863772|11575485|FG000|Treated|Overall Study||73
10429463|NCT00863772|11575486|FG001|Treated|Overall Study||74
10429464|NCT00863772|11575487|FG002|Treated|Overall Study||72
10429465|NCT00863772|11575485|FG000|COMPLETED|Overall Study||6
10429466|NCT00863772|11575486|FG001|COMPLETED|Overall Study||9
10429467|NCT00863772|11575487|FG002|COMPLETED|Overall Study||11
10429468|NCT00863772|11575485|FG000|NOT COMPLETED|Overall Study||68
10429469|NCT00863772|11575486|FG001|NOT COMPLETED|Overall Study||65
10429470|NCT00863772|11575487|FG002|NOT COMPLETED|Overall Study||61
10429471|NCT00863798|11575498|FG000|STARTED|Overall Study||227
10429472|NCT00863798|11575499|FG001|STARTED|Overall Study||228
10429473|NCT00863798|11575500|FG002|STARTED|Overall Study||227
10429474|NCT00863798|11575498|FG000|Treated|Overall Study||223
10429475|NCT00863798|11575499|FG001|Treated|Overall Study||226
10429476|NCT00863798|11575500|FG002|Treated|Overall Study||224
10429477|NCT00863798|11575498|FG000|COMPLETED|Overall Study||195
10429478|NCT00863798|11575499|FG001|COMPLETED|Overall Study||198
10429479|NCT00863798|11575500|FG002|COMPLETED|Overall Study||202
10429480|NCT00863798|11575498|FG000|NOT COMPLETED|Overall Study||32
10429481|NCT00863798|11575499|FG001|NOT COMPLETED|Overall Study||30
10429482|NCT00863798|11575500|FG002|NOT COMPLETED|Overall Study||25
10429483|NCT00863928|11575510|FG000|STARTED|Overall Study||94
10869492|NCT03113409|12035021|FG001|COMPLETED|Overall Study||0
10869493|NCT03113409|12035022|FG002|COMPLETED|Overall Study||0
10869494|NCT03113409|12035020|FG000|NOT COMPLETED|Overall Study||5
10869495|NCT03113409|12035021|FG001|NOT COMPLETED|Overall Study||0
10869496|NCT03113409|12035022|FG002|NOT COMPLETED|Overall Study||0
10869497|NCT02953340|12035028|FG000|STARTED|Overall Study||118
10869498|NCT02953340|12035029|FG001|STARTED|Overall Study||119
10869499|NCT02953340|12035028|FG000|Safety Population|Overall Study||117
10869500|NCT02953340|12035029|FG001|Safety Population|Overall Study||118
10869501|NCT02953340|12035028|FG000|Entered Safety Follow-up Period|Overall Study||117
10869502|NCT02953340|12035029|FG001|Entered Safety Follow-up Period|Overall Study||118
10869503|NCT02953340|12035028|FG000|COMPLETED|Overall Study||96
10869504|NCT02953340|12035029|FG001|COMPLETED|Overall Study||85
10869505|NCT02953340|12035028|FG000|NOT COMPLETED|Overall Study||22
10869506|NCT02953340|12035029|FG001|NOT COMPLETED|Overall Study||34
10869507|NCT02855944|12035043|FG000|STARTED|Period 1: Treatment||233
10869508|NCT02855944|12035044|FG001|STARTED|Period 1: Treatment||116
10869509|NCT02855944|12035043|FG000|COMPLETED|Period 1: Treatment||188
10869510|NCT02855944|12035044|FG001|COMPLETED|Period 1: Treatment||108
10869511|NCT02855944|12035043|FG000|NOT COMPLETED|Period 1: Treatment||45
10869512|NCT02855944|12035044|FG001|NOT COMPLETED|Period 1: Treatment||8
10869513|NCT02855944|12035043|FG000|STARTED|Period 2: Crossover to Rucaparib||0
10869514|NCT02855944|12035044|FG001|STARTED|Period 2: Crossover to Rucaparib||74
10869515|NCT02855944|12035043|FG000|COMPLETED|Period 2: Crossover to Rucaparib||0
10869516|NCT02855944|12035044|FG001|COMPLETED|Period 2: Crossover to Rucaparib||47
10869517|NCT02855944|12035043|FG000|NOT COMPLETED|Period 2: Crossover to Rucaparib||0
10869518|NCT02855944|12035044|FG001|NOT COMPLETED|Period 2: Crossover to Rucaparib||27
10869519|NCT02851407|12035053|FG000|STARTED|Overall Study||190
10869520|NCT02851407|12035054|FG001|STARTED|Overall Study||182
10869521|NCT02851407|12035053|FG000|COMPLETED|Overall Study||120
10869522|NCT02851407|12035054|FG001|COMPLETED|Overall Study||121
10869523|NCT02851407|12035053|FG000|NOT COMPLETED|Overall Study||70
10869524|NCT02851407|12035054|FG001|NOT COMPLETED|Overall Study||61
10869525|NCT02707276|12035064|FG000|STARTED|Overall Study||3
10869526|NCT02707276|12035065|FG001|STARTED|Overall Study||5
10869527|NCT02707276|12035066|FG002|STARTED|Overall Study||3
10869528|NCT02707276|12035067|FG003|STARTED|Overall Study||2
10869529|NCT02707276|12035064|FG000|COMPLETED|Overall Study||3
10869530|NCT02707276|12035065|FG001|COMPLETED|Overall Study||5
10869531|NCT02707276|12035066|FG002|COMPLETED|Overall Study||3
10869532|NCT02707276|12035067|FG003|COMPLETED|Overall Study||2
10869533|NCT02707276|12035064|FG000|NOT COMPLETED|Overall Study||0
10869534|NCT02707276|12035065|FG001|NOT COMPLETED|Overall Study||0
10869535|NCT02707276|12035066|FG002|NOT COMPLETED|Overall Study||0
10869536|NCT02707276|12035067|FG003|NOT COMPLETED|Overall Study||0
10869537|NCT02666430|12035079|FG000|STARTED|Baseline||64
10869538|NCT02666430|12035080|FG001|STARTED|Baseline||63
10869539|NCT02666430|12035079|FG000|COMPLETED|Baseline||64
10869540|NCT02666430|12035080|FG001|COMPLETED|Baseline||63
10869541|NCT02666430|12035079|FG000|NOT COMPLETED|Baseline||0
10869542|NCT02666430|12035080|FG001|NOT COMPLETED|Baseline||0
10295100|NCT00943722|11427685|FG001|NOT COMPLETED|First Extension Study: EXT 1||0
10295101|NCT00943722|11427686|FG002|NOT COMPLETED|First Extension Study: EXT 1||0
10295102|NCT00943722|11427687|FG003|NOT COMPLETED|First Extension Study: EXT 1||0
10295103|NCT00943722|11427688|FG004|NOT COMPLETED|First Extension Study: EXT 1||0
10295104|NCT00943722|11427689|FG005|NOT COMPLETED|First Extension Study: EXT 1||115
10295105|NCT00943722|11427690|FG006|NOT COMPLETED|First Extension Study: EXT 1||41
10295106|NCT00943722|11427684|FG000|STARTED|Second Extension Study: EXT 2||0
10295107|NCT00943722|11427685|FG001|STARTED|Second Extension Study: EXT 2||0
10295108|NCT00943722|11427686|FG002|STARTED|Second Extension Study: EXT 2||0
10295109|NCT00943722|11427687|FG003|STARTED|Second Extension Study: EXT 2||0
10295110|NCT00943722|11427688|FG004|STARTED|Second Extension Study: EXT 2||0
10295111|NCT00943722|11427689|FG005|STARTED|Second Extension Study: EXT 2||971
10295112|NCT00943722|11427690|FG006|STARTED|Second Extension Study: EXT 2||301
10295113|NCT00943722|11427684|FG000|COMPLETED|Second Extension Study: EXT 2||0
10295114|NCT00943722|11427685|FG001|COMPLETED|Second Extension Study: EXT 2||0
10295115|NCT00943722|11427686|FG002|COMPLETED|Second Extension Study: EXT 2||0
10295116|NCT00943722|11427687|FG003|COMPLETED|Second Extension Study: EXT 2||0
10295117|NCT00943722|11427688|FG004|COMPLETED|Second Extension Study: EXT 2||0
10295118|NCT00943722|11427689|FG005|COMPLETED|Second Extension Study: EXT 2||720
10295119|NCT00943722|11427690|FG006|COMPLETED|Second Extension Study: EXT 2||202
10295120|NCT00943722|11427684|FG000|NOT COMPLETED|Second Extension Study: EXT 2||0
10295121|NCT00943722|11427685|FG001|NOT COMPLETED|Second Extension Study: EXT 2||0
10295122|NCT00943722|11427686|FG002|NOT COMPLETED|Second Extension Study: EXT 2||0
10295123|NCT00943722|11427687|FG003|NOT COMPLETED|Second Extension Study: EXT 2||0
10295124|NCT00943722|11427688|FG004|NOT COMPLETED|Second Extension Study: EXT 2||0
10295125|NCT00943722|11427689|FG005|NOT COMPLETED|Second Extension Study: EXT 2||251
10295126|NCT00943722|11427690|FG006|NOT COMPLETED|Second Extension Study: EXT 2||99
10295127|NCT00676663|11427715|FG000|STARTED|Overall Study||66
10295128|NCT00676663|11427716|FG001|STARTED|Overall Study||64
10295129|NCT00676663|11427715|FG000|COMPLETED|Overall Study||21
10295130|NCT00676663|11427716|FG001|COMPLETED|Overall Study||26
10295131|NCT00676663|11427715|FG000|NOT COMPLETED|Overall Study||45
10295132|NCT00676663|11427716|FG001|NOT COMPLETED|Overall Study||38
10295133|NCT00391365|11427726|FG000|STARTED|Overall Study||103
10295134|NCT00391365|11427727|FG001|STARTED|Overall Study||170
10295135|NCT00391365|11427726|FG000|COMPLETED|Overall Study||78
10295136|NCT00391365|11427727|FG001|COMPLETED|Overall Study||151
10295137|NCT00391365|11427726|FG000|NOT COMPLETED|Overall Study||25
10869543|NCT02666430|12035079|FG000|STARTED|Period 1||64
10869544|NCT02666430|12035080|FG001|STARTED|Period 1||63
10869545|NCT02666430|12035079|FG000|COMPLETED|Period 1||63
10869546|NCT02666430|12035080|FG001|COMPLETED|Period 1||62
10869547|NCT02666430|12035079|FG000|NOT COMPLETED|Period 1||1
10869548|NCT02666430|12035080|FG001|NOT COMPLETED|Period 1||1
10869549|NCT02666430|12035079|FG000|STARTED|Period 2||63
10869550|NCT02666430|12035080|FG001|STARTED|Period 2||62
10869551|NCT02666430|12035079|FG000|COMPLETED|Period 2||62
10869552|NCT02666430|12035080|FG001|COMPLETED|Period 2||58
10869553|NCT02666430|12035079|FG000|NOT COMPLETED|Period 2||1
10869554|NCT02666430|12035080|FG001|NOT COMPLETED|Period 2||4
10869555|NCT02666430|12035079|FG000|STARTED|Period 3||62
10869556|NCT02666430|12035080|FG001|STARTED|Period 3||58
10869557|NCT02666430|12035079|FG000|COMPLETED|Period 3||61
10869558|NCT02666430|12035080|FG001|COMPLETED|Period 3||58
10869559|NCT02666430|12035079|FG000|NOT COMPLETED|Period 3||1
10869560|NCT02666430|12035080|FG001|NOT COMPLETED|Period 3||0
10869561|NCT02643420|12035088|FG000|STARTED|Overall Study||196
10869562|NCT02643420|12035089|FG001|STARTED|Overall Study||210
10869563|NCT02643420|12035088|FG000|Safety Population|Overall Study|One participant was randomized to the Arm 2: Pegfilgrastim and TC but was inadvertently administered SPI-2012 on Cycle 1, Day 2 and was included in the Arm 1: SPI-2012 and TC for the Safety Population.|197
10869564|NCT02643420|12035089|FG001|Safety Population|Overall Study||208
10869565|NCT02643420|12035088|FG000|COMPLETED|Overall Study||142
10869566|NCT02643420|12035089|FG001|COMPLETED|Overall Study||145
10869567|NCT02643420|12035088|FG000|NOT COMPLETED|Overall Study||54
10869568|NCT02643420|12035089|FG001|NOT COMPLETED|Overall Study||65
10418798|NCT00807560|11563579|FG000|STARTED|Overall Study||38
10418799|NCT00807560|11563580|FG001|STARTED|Overall Study||39
10418800|NCT00807560|11563579|FG000|COMPLETED|Overall Study||38
10418801|NCT00807560|11563580|FG001|COMPLETED|Overall Study||39
10418802|NCT00807560|11563579|FG000|NOT COMPLETED|Overall Study||0
10418803|NCT00807560|11563580|FG001|NOT COMPLETED|Overall Study||0
10418804|NCT00807573|11563586|FG000|STARTED|Overall Study||44
10418805|NCT00807573|11563586|FG000|COMPLETED|Overall Study||42
10869569|NCT02639559|12035103|FG000|STARTED|Overall Study||25
10869570|NCT02639559|12035104|FG001|STARTED|Overall Study||25
10869571|NCT02639559|12035103|FG000|COMPLETED|Overall Study||24
10869572|NCT02639559|12035104|FG001|COMPLETED|Overall Study||22
10869573|NCT02639559|12035103|FG000|NOT COMPLETED|Overall Study||1
10869574|NCT02639559|12035104|FG001|NOT COMPLETED|Overall Study||3
10869575|NCT02569476|12035110|FG000|STARTED|Overall Study||119
10869576|NCT02569476|12035110|FG000|COMPLETED|Overall Study||0
10869577|NCT02569476|12035110|FG000|NOT COMPLETED|Overall Study||119
10869578|NCT02549209|12035120|FG000|STARTED|Overall Study||46
10869579|NCT02549209|12035120|FG000|COMPLETED|Overall Study||46
10869580|NCT02549209|12035120|FG000|NOT COMPLETED|Overall Study||0
10869581|NCT02496676|12035126|FG000|STARTED|Phase 1 - Period 1||2
10869582|NCT02496676|12035127|FG001|STARTED|Phase 1 - Period 1||3
10295138|NCT00391365|11427727|FG001|NOT COMPLETED|Overall Study||19
10314790|NCT00168454|11448533|FG000|STARTED|Overall Study||44
10314791|NCT00168454|11448534|FG001|STARTED|Overall Study||57
10314792|NCT00168454|11448535|FG002|STARTED|Overall Study||54
10314793|NCT00168454|11448536|FG003|STARTED|Overall Study||49
10314794|NCT00168454|11448537|FG004|STARTED|Overall Study||53
10314795|NCT00168454|11448538|FG005|STARTED|Overall Study||56
10314796|NCT00168454|11448533|FG000|COMPLETED|Overall Study||37
10314797|NCT00168454|11448534|FG001|COMPLETED|Overall Study||50
10314798|NCT00168454|11448535|FG002|COMPLETED|Overall Study||48
10314799|NCT00168454|11448536|FG003|COMPLETED|Overall Study||40
10314800|NCT00168454|11448537|FG004|COMPLETED|Overall Study||47
10314801|NCT00168454|11448538|FG005|COMPLETED|Overall Study||50
10314802|NCT00168454|11448533|FG000|NOT COMPLETED|Overall Study||7
10314803|NCT00168454|11448534|FG001|NOT COMPLETED|Overall Study||7
10314804|NCT00168454|11448535|FG002|NOT COMPLETED|Overall Study||6
10314805|NCT00168454|11448536|FG003|NOT COMPLETED|Overall Study||9
10314806|NCT00168454|11448537|FG004|NOT COMPLETED|Overall Study||6
10418806|NCT00807573|11563586|FG000|NOT COMPLETED|Overall Study||2
10418807|NCT00807586|11563592|FG000|STARTED|Overall Study||60
10418808|NCT00807586|11563593|FG001|STARTED|Overall Study||59
10418809|NCT00807586|11563592|FG000|COMPLETED|Overall Study||54
10418810|NCT00807586|11563593|FG001|COMPLETED|Overall Study||58
10418811|NCT00807586|11563592|FG000|NOT COMPLETED|Overall Study||6
10418812|NCT00807586|11563593|FG001|NOT COMPLETED|Overall Study||1
10418813|NCT00807599|11563601|FG000|STARTED|Overall Study||26
10418814|NCT00807599|11563602|FG001|STARTED|Overall Study||24
10418815|NCT00807599|11563603|FG002|STARTED|Overall Study||17
10418816|NCT00807599|11563601|FG000|COMPLETED|Overall Study||26
10418817|NCT00807599|11563602|FG001|COMPLETED|Overall Study||24
10418818|NCT00807599|11563603|FG002|COMPLETED|Overall Study||0
10869583|NCT02496676|12035126|FG000|COMPLETED|Phase 1 - Period 1||2
10314807|NCT00168454|11448538|FG005|NOT COMPLETED|Overall Study||6
10869584|NCT02496676|12035127|FG001|COMPLETED|Phase 1 - Period 1||2
10869585|NCT02496676|12035126|FG000|NOT COMPLETED|Phase 1 - Period 1||0
10869586|NCT02496676|12035127|FG001|NOT COMPLETED|Phase 1 - Period 1||1
10869587|NCT02496676|12035126|FG000|STARTED|Phase 1 - Period 2||2
10869588|NCT02496676|12035127|FG001|STARTED|Phase 1 - Period 2||2
10314808|NCT00168805|11448555|FG000|STARTED|Overall Study||679
10418819|NCT00807599|11563601|FG000|NOT COMPLETED|Overall Study||0
10418820|NCT00807599|11563602|FG001|NOT COMPLETED|Overall Study||0
10418821|NCT00807599|11563603|FG002|NOT COMPLETED|Overall Study||17
10418822|NCT00807664|11563611|FG000|STARTED|Overall Study||88
10869589|NCT02496676|12035126|FG000|COMPLETED|Phase 1 - Period 2||2
10869590|NCT02496676|12035127|FG001|COMPLETED|Phase 1 - Period 2||2
10869591|NCT02496676|12035126|FG000|NOT COMPLETED|Phase 1 - Period 2||0
10869592|NCT02496676|12035127|FG001|NOT COMPLETED|Phase 1 - Period 2||0
10869593|NCT02496676|12035126|FG000|STARTED|Washout Period||2
10869594|NCT02496676|12035127|FG001|STARTED|Washout Period||2
10869595|NCT02496676|12035126|FG000|COMPLETED|Washout Period||2
10869596|NCT02496676|12035127|FG001|COMPLETED|Washout Period||2
10295139|NCT04617860|11427737|FG000|STARTED|Overall Study||8
10295140|NCT04617860|11427738|FG001|STARTED|Overall Study||10
10295141|NCT04617860|11427739|FG002|STARTED|Overall Study||18
10295142|NCT04617860|11427737|FG000|Dose Modified to 8 mg|Overall Study||8
10295143|NCT04617860|11427738|FG001|Dose Modified to 8 mg|Overall Study||1
10295144|NCT04617860|11427739|FG002|Dose Modified to 8 mg|Overall Study||0
10295145|NCT04617860|11427737|FG000|Dose Modified to 16 mg|Overall Study||8
10295146|NCT04617860|11427738|FG001|Dose Modified to 16 mg|Overall Study||9
10295147|NCT04617860|11427739|FG002|Dose Modified to 16 mg|Overall Study||8
10295148|NCT04617860|11427737|FG000|Dose Modified to 32 mg|Overall Study||2
10295149|NCT04617860|11427738|FG001|Dose Modified to 32 mg|Overall Study||4
10295150|NCT04617860|11427739|FG002|Dose Modified to 32 mg|Overall Study||11
10295151|NCT04617860|11427737|FG000|COMPLETED|Overall Study||0
10295152|NCT04617860|11427738|FG001|COMPLETED|Overall Study||0
10295153|NCT04617860|11427739|FG002|COMPLETED|Overall Study||0
10295154|NCT04617860|11427737|FG000|NOT COMPLETED|Overall Study||8
10295155|NCT04617860|11427738|FG001|NOT COMPLETED|Overall Study||10
10295156|NCT04617860|11427739|FG002|NOT COMPLETED|Overall Study||18
10295157|NCT04617847|11427751|FG000|STARTED|Overall Study||3
10295158|NCT04617847|11427752|FG001|STARTED|Overall Study||24
10295159|NCT04617847|11427751|FG000|Dose Modified to 16 mg WVE-120101|Overall Study||3
10295160|NCT04617847|11427752|FG001|Dose Modified to 16 mg WVE-120101|Overall Study||1
10295161|NCT04617847|11427751|FG000|Dose Modified to 32 mg WVE-120101|Overall Study||0
10295162|NCT04617847|11427752|FG001|Dose Modified to 32 mg WVE-120101|Overall Study||5
10295163|NCT04617847|11427751|FG000|COMPLETED|Overall Study||0
10295164|NCT04617847|11427752|FG001|COMPLETED|Overall Study||0
10295165|NCT04617847|11427751|FG000|NOT COMPLETED|Overall Study||3
10295166|NCT04617847|11427752|FG001|NOT COMPLETED|Overall Study||24
10314809|NCT00168805|11448556|FG001|STARTED|Overall Study||703
10314810|NCT00168805|11448557|FG002|STARTED|Overall Study||694
10314811|NCT00168805|11448555|FG000|COMPLETED|Overall Study||608
10314812|NCT00168805|11448556|FG001|COMPLETED|Overall Study||625
10314813|NCT00168805|11448557|FG002|COMPLETED|Overall Study||616
10314814|NCT00168805|11448555|FG000|NOT COMPLETED|Overall Study||71
10314815|NCT00168805|11448556|FG001|NOT COMPLETED|Overall Study||78
10314816|NCT00168805|11448557|FG002|NOT COMPLETED|Overall Study||78
10314817|NCT00168805|11448555|FG000|STARTED|Treatment||679
10314818|NCT00168805|11448556|FG001|STARTED|Treatment||703
10314819|NCT00168805|11448557|FG002|STARTED|Treatment||694
10314820|NCT00168805|11448555|FG000|COMPLETED|Treatment||630
10314821|NCT00168805|11448556|FG001|COMPLETED|Treatment||647
10314822|NCT00168805|11448557|FG002|COMPLETED|Treatment||632
10314823|NCT00168805|11448555|FG000|NOT COMPLETED|Treatment||49
10314824|NCT00168805|11448556|FG001|NOT COMPLETED|Treatment||56
10314825|NCT00168805|11448557|FG002|NOT COMPLETED|Treatment||62
10314826|NCT00168818|11448568|FG000|STARTED|Overall Study||1146
10314827|NCT00168818|11448569|FG001|STARTED|Overall Study||1163
10314828|NCT00168818|11448570|FG002|STARTED|Overall Study||1154
10314829|NCT00168818|11448568|FG000|COMPLETED|Overall Study||1029
10314830|NCT00168818|11448569|FG001|COMPLETED|Overall Study||1054
10314831|NCT00168818|11448570|FG002|COMPLETED|Overall Study||1030
10314832|NCT00168818|11448568|FG000|NOT COMPLETED|Overall Study||117
10314833|NCT00168818|11448569|FG001|NOT COMPLETED|Overall Study||109
10314834|NCT00168818|11448570|FG002|NOT COMPLETED|Overall Study||124
10314835|NCT00168818|11448568|FG000|STARTED|Treatment||1146
10314836|NCT00168818|11448569|FG001|STARTED|Treatment||1163
10314837|NCT00168818|11448570|FG002|STARTED|Treatment||1154
10314838|NCT00168818|11448568|FG000|COMPLETED|Treatment||1013
10314839|NCT00168818|11448569|FG001|COMPLETED|Treatment||1012
10314840|NCT00168818|11448570|FG002|COMPLETED|Treatment||1021
10314841|NCT00168818|11448568|FG000|NOT COMPLETED|Treatment||133
10314842|NCT00168818|11448569|FG001|NOT COMPLETED|Treatment||151
10314843|NCT00168818|11448570|FG002|NOT COMPLETED|Treatment||133
10314844|NCT00168831|11448581|FG000|STARTED|Overall Study||338
10314845|NCT00168831|11448582|FG001|STARTED|Overall Study||335
10314846|NCT00168831|11448583|FG002|STARTED|Overall Study||334
10314847|NCT00168831|11448581|FG000|COMPLETED|Overall Study||278
10314848|NCT00168831|11448582|FG001|COMPLETED|Overall Study||254
10314849|NCT00168831|11448583|FG002|COMPLETED|Overall Study||220
10314850|NCT00168831|11448581|FG000|NOT COMPLETED|Overall Study||60
10314851|NCT00168831|11448582|FG001|NOT COMPLETED|Overall Study||81
10314852|NCT00168831|11448583|FG002|NOT COMPLETED|Overall Study||114
10314853|NCT00168844|11448594|FG000|STARTED|Overall Study||332
10314854|NCT00168844|11448595|FG001|STARTED|Overall Study||332
10314855|NCT00168844|11448596|FG002|STARTED|Overall Study||319
10314856|NCT00168844|11448594|FG000|COMPLETED|Overall Study||277
10314857|NCT00168844|11448595|FG001|COMPLETED|Overall Study||277
10314858|NCT00168844|11448596|FG002|COMPLETED|Overall Study||228
10314859|NCT00168844|11448594|FG000|NOT COMPLETED|Overall Study||55
10314860|NCT00168844|11448595|FG001|NOT COMPLETED|Overall Study||55
10314861|NCT00168844|11448596|FG002|NOT COMPLETED|Overall Study||91
10314862|NCT00169104|11448606|FG000|STARTED|Overall Study||13
10314863|NCT00169104|11448607|FG001|STARTED|Overall Study||10
10314864|NCT00169104|11448606|FG000|COMPLETED|Overall Study||11
10314865|NCT00169104|11448607|FG001|COMPLETED|Overall Study||8
10418823|NCT00807664|11563612|FG001|STARTED|Overall Study||94
10418824|NCT00807664|11563611|FG000|COMPLETED|Overall Study||77
10418825|NCT00807664|11563612|FG001|COMPLETED|Overall Study||75
10418826|NCT00807664|11563611|FG000|NOT COMPLETED|Overall Study||11
10418827|NCT00807664|11563612|FG001|NOT COMPLETED|Overall Study||19
10418828|NCT00807742|11563621|FG000|STARTED|Overall Study||172
10418829|NCT00807742|11563622|FG001|STARTED|Overall Study||168
10418830|NCT00807742|11563621|FG000|COMPLETED|Overall Study||126
10418831|NCT00807742|11563622|FG001|COMPLETED|Overall Study||114
10418832|NCT00807742|11563621|FG000|NOT COMPLETED|Overall Study||46
10869597|NCT02496676|12035126|FG000|NOT COMPLETED|Washout Period||0
10869598|NCT02496676|12035127|FG001|NOT COMPLETED|Washout Period||0
10869599|NCT02496676|12035126|FG000|STARTED|Phase 2 - IV MgSO4||2
10869600|NCT02496676|12035127|FG001|STARTED|Phase 2 - IV MgSO4||2
10869601|NCT02496676|12035126|FG000|COMPLETED|Phase 2 - IV MgSO4||2
10869602|NCT02496676|12035127|FG001|COMPLETED|Phase 2 - IV MgSO4||1
10869603|NCT02496676|12035126|FG000|NOT COMPLETED|Phase 2 - IV MgSO4||0
10869604|NCT02496676|12035127|FG001|NOT COMPLETED|Phase 2 - IV MgSO4||1
10869605|NCT02496676|12035126|FG000|STARTED|Phase 2 - Oral Magnesium||2
10869606|NCT02496676|12035127|FG001|STARTED|Phase 2 - Oral Magnesium||1
10869607|NCT02496676|12035126|FG000|COMPLETED|Phase 2 - Oral Magnesium||2
10869608|NCT02496676|12035127|FG001|COMPLETED|Phase 2 - Oral Magnesium||1
10869609|NCT02496676|12035126|FG000|NOT COMPLETED|Phase 2 - Oral Magnesium||0
10869610|NCT02496676|12035127|FG001|NOT COMPLETED|Phase 2 - Oral Magnesium||0
10869611|NCT02494141|12035143|FG000|STARTED|Overall Study||34
10869612|NCT02494141|12035144|FG001|STARTED|Overall Study||34
10869613|NCT02494141|12035143|FG000|COMPLETED|Overall Study||28
10869614|NCT02494141|12035144|FG001|COMPLETED|Overall Study||29
10869615|NCT02494141|12035143|FG000|NOT COMPLETED|Overall Study||6
10869616|NCT02494141|12035144|FG001|NOT COMPLETED|Overall Study||5
10869617|NCT02412618|12035152|FG000|STARTED|Overall Study||50
10869618|NCT02412618|12035153|FG001|STARTED|Overall Study||50
10869619|NCT02412618|12035152|FG000|COMPLETED|Overall Study||48
10869620|NCT02412618|12035153|FG001|COMPLETED|Overall Study||48
10869621|NCT02412618|12035152|FG000|NOT COMPLETED|Overall Study||2
10869622|NCT02412618|12035153|FG001|NOT COMPLETED|Overall Study||2
10869623|NCT02373683|12035161|FG000|STARTED|Overall Study||6
10869624|NCT02373683|12035162|FG001|STARTED|Overall Study||4
10869625|NCT02373683|12035161|FG000|COMPLETED|Overall Study||6
10869626|NCT02373683|12035162|FG001|COMPLETED|Overall Study||4
10869627|NCT02373683|12035161|FG000|NOT COMPLETED|Overall Study||0
10869628|NCT02373683|12035162|FG001|NOT COMPLETED|Overall Study||0
10869629|NCT02351180|12035170|FG000|STARTED|Overall Study||8
10869630|NCT02351180|12035171|FG001|STARTED|Overall Study||8
10869631|NCT02351180|12035170|FG000|COMPLETED|Overall Study||7
10869632|NCT02351180|12035171|FG001|COMPLETED|Overall Study||8
10869633|NCT02351180|12035170|FG000|NOT COMPLETED|Overall Study||1
10869634|NCT02351180|12035171|FG001|NOT COMPLETED|Overall Study||0
10869635|NCT02337764|12035177|FG000|STARTED|Overall Study||222
10869636|NCT02337764|12035177|FG000|COMPLETED|Overall Study||162
10869637|NCT02337764|12035177|FG000|NOT COMPLETED|Overall Study||60
10869638|NCT02337738|12035184|FG000|STARTED|Overall Study||141
10869639|NCT02337738|12035185|FG001|STARTED|Overall Study||134
10869640|NCT02337738|12035186|FG002|STARTED|Overall Study||129
10869641|NCT02337738|12035184|FG000|COMPLETED|Overall Study||119
10869642|NCT02337738|12035185|FG001|COMPLETED|Overall Study||104
10869643|NCT02337738|12035186|FG002|COMPLETED|Overall Study||103
10869644|NCT02337738|12035184|FG000|NOT COMPLETED|Overall Study||22
10869645|NCT02337738|12035185|FG001|NOT COMPLETED|Overall Study||30
10869646|NCT02337738|12035186|FG002|NOT COMPLETED|Overall Study||26
10869647|NCT02332187|12035196|FG000|STARTED|Overall Study||5
10869648|NCT02332187|12035197|FG001|STARTED|Overall Study||10
10869649|NCT02332187|12035196|FG000|COMPLETED|Overall Study||3
10869650|NCT02332187|12035197|FG001|COMPLETED|Overall Study||7
10869651|NCT02332187|12035196|FG000|NOT COMPLETED|Overall Study||2
10869652|NCT02332187|12035197|FG001|NOT COMPLETED|Overall Study||3
10869653|NCT02227875|12035205|FG000|STARTED|Overall Study||277
10869654|NCT02227875|12035206|FG001|STARTED|Overall Study||283
10869655|NCT02227875|12035205|FG000|COMPLETED|Overall Study||240
10869656|NCT02227875|12035206|FG001|COMPLETED|Overall Study||250
10869657|NCT02227875|12035205|FG000|NOT COMPLETED|Overall Study||37
10869658|NCT02227875|12035206|FG001|NOT COMPLETED|Overall Study||33
10869659|NCT02227862|12035214|FG000|STARTED|Overall Study||280
10869660|NCT02227862|12035215|FG001|STARTED|Overall Study||278
10869661|NCT02227862|12035214|FG000|Week 24|Overall Study||269
10869662|NCT02227862|12035215|FG001|Week 24|Overall Study||263
10869663|NCT02227862|12035214|FG000|COMPLETED|Overall Study||261
10869664|NCT02227862|12035215|FG001|COMPLETED|Overall Study||256
10869665|NCT02227862|12035214|FG000|NOT COMPLETED|Overall Study||19
10869666|NCT02227862|12035215|FG001|NOT COMPLETED|Overall Study||22
10869667|NCT02200939|12035223|FG000|STARTED|Overall Study||33
10869668|NCT02200939|12035224|FG001|STARTED|Overall Study||115
10869669|NCT02200939|12035223|FG000|COMPLETED|Overall Study||31
10869670|NCT02200939|12035224|FG001|COMPLETED|Overall Study||104
10869671|NCT02200939|12035223|FG000|NOT COMPLETED|Overall Study||2
10869672|NCT02200939|12035224|FG001|NOT COMPLETED|Overall Study||11
10869673|NCT02108964|12035242|FG000|STARTED|Overall Study||17
10869674|NCT02108964|12035243|FG001|STARTED|Overall Study||38
10869675|NCT02108964|12035244|FG002|STARTED|Overall Study||73
10418833|NCT00807742|11563622|FG001|NOT COMPLETED|Overall Study||54
10869676|NCT02108964|12035245|FG003|STARTED|Overall Study||8
10869677|NCT02108964|12035246|FG004|STARTED|Overall Study||28
10869678|NCT02108964|12035247|FG005|STARTED|Overall Study||5
10869679|NCT02108964|12035248|FG006|STARTED|Overall Study||11
10869680|NCT02108964|12035249|FG007|STARTED|Overall Study||45
10869681|NCT02108964|12035242|FG000|COMPLETED|Overall Study||3
10869682|NCT02108964|12035243|FG001|COMPLETED|Overall Study||6
10869683|NCT02108964|12035244|FG002|COMPLETED|Overall Study||8
10869684|NCT02108964|12035245|FG003|COMPLETED|Overall Study||2
10869685|NCT02108964|12035246|FG004|COMPLETED|Overall Study||3
10869686|NCT02108964|12035247|FG005|COMPLETED|Overall Study||0
10869687|NCT02108964|12035248|FG006|COMPLETED|Overall Study||0
10869688|NCT02108964|12035249|FG007|COMPLETED|Overall Study||33
10869689|NCT02108964|12035242|FG000|NOT COMPLETED|Overall Study||14
10869690|NCT02108964|12035243|FG001|NOT COMPLETED|Overall Study||32
10869691|NCT02108964|12035244|FG002|NOT COMPLETED|Overall Study||65
10869692|NCT02108964|12035245|FG003|NOT COMPLETED|Overall Study||6
10869693|NCT02108964|12035246|FG004|NOT COMPLETED|Overall Study||25
10869694|NCT02108964|12035247|FG005|NOT COMPLETED|Overall Study||5
10869695|NCT02108964|12035248|FG006|NOT COMPLETED|Overall Study||11
10869696|NCT02108964|12035249|FG007|NOT COMPLETED|Overall Study||12
10869697|NCT02022566|12035270|FG000|STARTED|Overall Study||227
10869698|NCT02022566|12035271|FG001|STARTED|Overall Study||90
10869699|NCT02022566|12035270|FG000|COMPLETED|Overall Study||169
10869700|NCT02022566|12035271|FG001|COMPLETED|Overall Study||49
10869701|NCT02022566|12035270|FG000|NOT COMPLETED|Overall Study||58
10869702|NCT02022566|12035271|FG001|NOT COMPLETED|Overall Study||41
10869703|NCT01989598|12035277|FG000|STARTED|Overall Study|Includes pts receiving Single agent Trametinib and pts who are receiving Trametinib with AKT Inhibitor GSK2141795|25
10869704|NCT01989598|12035277|FG000|Dual Therapy With Trametinib and GSK2141795|Overall Study|Patients with progressive disease or who achieve less than PR after 4 courses also received Akt inhibitor GSK2141795 PO daily on days 1-28 along with Tremetinib|12
10869705|NCT01989598|12035277|FG000|COMPLETED|Overall Study|Note: 25 patients enrolled, however, one patient unevaluable was not included in analysis|25
10869706|NCT01989598|12035277|FG000|NOT COMPLETED|Overall Study||0
10869707|NCT01939275|12035286|FG000|STARTED|Overall Study||8
10869708|NCT01939275|12035286|FG000|COMPLETED|Overall Study||8
10869709|NCT01939275|12035286|FG000|NOT COMPLETED|Overall Study||0
10869710|NCT01922895|12035292|FG000|STARTED|Overall Study||24
10869711|NCT01922895|12035293|FG001|STARTED|Overall Study||21
10869712|NCT01922895|12035292|FG000|COMPLETED|Overall Study||18
10869713|NCT01922895|12035293|FG001|COMPLETED|Overall Study||7
10869714|NCT01922895|12035292|FG000|NOT COMPLETED|Overall Study||6
10869715|NCT01922895|12035293|FG001|NOT COMPLETED|Overall Study||14
10869716|NCT01901289|12035299|FG000|STARTED|Overall Study||200
10869717|NCT01901289|12035299|FG000|12-Month Follow-up|Overall Study||194
10869718|NCT01901289|12035299|FG000|COMPLETED|Overall Study||115
10869719|NCT01901289|12035299|FG000|NOT COMPLETED|Overall Study||85
10869720|NCT01831895|12035303|FG000|STARTED|Overall Study||17
10869721|NCT01831895|12035303|FG000|COMPLETED|Overall Study||15
10869722|NCT01831895|12035303|FG000|NOT COMPLETED|Overall Study||2
10869723|NCT01831076|12035309|FG000|STARTED|Overall Study||31
10869724|NCT01831076|12035310|FG001|STARTED|Overall Study||5
10869725|NCT01831076|12035309|FG000|COMPLETED|Overall Study||30
10869726|NCT01831076|12035310|FG001|COMPLETED|Overall Study||4
10869727|NCT01831076|12035309|FG000|NOT COMPLETED|Overall Study||1
10869728|NCT01831076|12035310|FG001|NOT COMPLETED|Overall Study||1
10295167|NCT04426318|11427762|FG000|STARTED|Overall Study||346
10295168|NCT04426318|11427763|FG001|STARTED|Overall Study||320
10295169|NCT04426318|11427762|FG000|Failed Attention Checks|Overall Study||4
10295170|NCT04426318|11427763|FG001|Failed Attention Checks|Overall Study||6
10295171|NCT04426318|11427762|FG000|Downloaded HMP App|Overall Study||329
10295172|NCT04426318|11427763|FG001|Downloaded HMP App|Overall Study||0
10295173|NCT04426318|11427762|FG000|Completed T2 Assessment|Overall Study||281
10295174|NCT04426318|11427763|FG001|Completed T2 Assessment|Overall Study||280
10295175|NCT04426318|11427762|FG000|Completed T3 Assessment|Overall Study||261
10295176|NCT04426318|11427763|FG001|Completed T3 Assessment|Overall Study||274
10295177|NCT04426318|11427762|FG000|Completed T4 Assessment|Overall Study||261
10869729|NCT01595581|12035318|FG000|STARTED|Overall Study||7
10869730|NCT01595581|12035319|FG001|STARTED|Overall Study||7
10869731|NCT01595581|12035318|FG000|COMPLETED|Overall Study||6
10869732|NCT01595581|12035319|FG001|COMPLETED|Overall Study||7
10869733|NCT01595581|12035318|FG000|NOT COMPLETED|Overall Study||1
10869734|NCT01595581|12035319|FG001|NOT COMPLETED|Overall Study||0
10869735|NCT01514682|12035329|FG000|STARTED|Overall Study||19
10869736|NCT01514682|12035330|FG001|STARTED|Overall Study||20
10869737|NCT01514682|12035329|FG000|COMPLETED|Overall Study||13
10869738|NCT01514682|12035330|FG001|COMPLETED|Overall Study||14
10869739|NCT01514682|12035329|FG000|NOT COMPLETED|Overall Study||6
10418834|NCT00807768|11563630|FG000|STARTED|Overall Study||301
10418835|NCT00807768|11563631|FG001|STARTED|Overall Study||300
10418836|NCT00807768|11563630|FG000|COMPLETED|Overall Study||301
10418837|NCT00807768|11563631|FG001|COMPLETED|Overall Study||300
10418838|NCT00807768|11563630|FG000|NOT COMPLETED|Overall Study||0
10418839|NCT00807768|11563631|FG001|NOT COMPLETED|Overall Study||0
10418840|NCT00807846|11563639|FG000|STARTED|Overall Study||100
10418841|NCT00807846|11563640|FG001|STARTED|Overall Study||98
10869740|NCT01514682|12035330|FG001|NOT COMPLETED|Overall Study||6
10869741|NCT01453140|12035336|FG000|STARTED|Overall Study|3 patients were enrolled|3
10869742|NCT01453140|12035336|FG000|COMPLETED|Overall Study|All three patients experienced grade 4 limiting toxicities (possible treatment related)|0
10869743|NCT01453140|12035336|FG000|NOT COMPLETED|Overall Study||3
10869744|NCT01408641|12035346|FG000|STARTED|Overall Study||1
10869745|NCT01408641|12035347|FG001|STARTED|Overall Study||0
10869746|NCT01408641|12035346|FG000|COMPLETED|Overall Study||0
10869747|NCT01408641|12035347|FG001|COMPLETED|Overall Study||0
10869748|NCT01408641|12035346|FG000|NOT COMPLETED|Overall Study||1
10869749|NCT01408641|12035347|FG001|NOT COMPLETED|Overall Study||0
10869750|NCT01032265|12035355|FG000|STARTED|Overall Study||126
10869751|NCT01032265|12035356|FG001|STARTED|Overall Study||124
10869752|NCT01032265|12035355|FG000|COMPLETED|Overall Study||113
10869753|NCT01032265|12035356|FG001|COMPLETED|Overall Study||107
10869754|NCT01032265|12035355|FG000|NOT COMPLETED|Overall Study||13
10869755|NCT01032265|12035356|FG001|NOT COMPLETED|Overall Study||17
10869756|NCT00653068|12035366|FG000|STARTED|Overall Study||70
10869757|NCT00653068|12035366|FG000|COMPLETED|Overall Study||20
10869758|NCT00653068|12035366|FG000|NOT COMPLETED|Overall Study||50
10869759|NCT00193479|12035373|FG000|STARTED|Induction Chemotherapy||51
10869760|NCT00193479|12035373|FG000|COMPLETED|Induction Chemotherapy||48
10869761|NCT00193479|12035373|FG000|NOT COMPLETED|Induction Chemotherapy||3
10869762|NCT00193479|12035373|FG000|STARTED|Maintenance Rituximab||48
10869763|NCT00193479|12035373|FG000|COMPLETED|Maintenance Rituximab||44
10869764|NCT00193479|12035373|FG000|NOT COMPLETED|Maintenance Rituximab||4
10869765|NCT00193427|12035377|FG000|STARTED|Overall Study||75
10869766|NCT00193427|12035377|FG000|COMPLETED|Overall Study||26
10869767|NCT00193427|12035377|FG000|NOT COMPLETED|Overall Study||49
10869768|NCT00193414|12035382|FG000|STARTED|Overall Study||72
10869769|NCT00193414|12035382|FG000|COMPLETED|Overall Study||14
10869770|NCT00193414|12035382|FG000|NOT COMPLETED|Overall Study||58
10869771|NCT00085735|12035392|FG000|STARTED|Overall Study||64
10869772|NCT00085735|12035393|FG001|STARTED|Overall Study||64
10869773|NCT00085735|12035394|FG002|STARTED|Overall Study||63
10869774|NCT00085735|12035395|FG003|STARTED|Overall Study||65
10295178|NCT04426318|11427763|FG001|Completed T4 Assessment|Overall Study||275
10295179|NCT04426318|11427762|FG000|Completed T5 Assessment|Overall Study||284
10295180|NCT04426318|11427763|FG001|Completed T5 Assessment|Overall Study||293
10295181|NCT04426318|11427762|FG000|Completed T6 Assessment|Overall Study||286
10295182|NCT04426318|11427763|FG001|Completed T6 Assessment|Overall Study||293
10295183|NCT04426318|11427762|FG000|Final Intent to Treat Sample|Overall Study||344
10295184|NCT04426318|11427763|FG001|Final Intent to Treat Sample|Overall Study||318
10295185|NCT04426318|11427762|FG000|COMPLETED|Overall Study||344
10295186|NCT04426318|11427763|FG001|COMPLETED|Overall Study||318
10295187|NCT04426318|11427762|FG000|NOT COMPLETED|Overall Study||2
10295188|NCT04426318|11427763|FG001|NOT COMPLETED|Overall Study||2
10295189|NCT04063657|11427771|FG000|STARTED|Overall Study||1
10295190|NCT04063657|11427772|FG001|STARTED|Overall Study||0
10295191|NCT04063657|11427771|FG000|COMPLETED|Overall Study||0
10295192|NCT04063657|11427772|FG001|COMPLETED|Overall Study||0
10295193|NCT04063657|11427771|FG000|NOT COMPLETED|Overall Study||1
10295194|NCT04063657|11427772|FG001|NOT COMPLETED|Overall Study||0
10295195|NCT04042623|11427778|FG000|STARTED|Overall Study||1
10295196|NCT04042623|11427778|FG000|COMPLETED|Overall Study||0
10545915|NCT01500382|11699420|FG003|STARTED|Treatment Period 2||1
10545916|NCT01500382|11699417|FG000|COMPLETED|Treatment Period 2||1
10545917|NCT01500382|11699418|FG001|COMPLETED|Treatment Period 2||1
10295197|NCT04042623|11427778|FG000|NOT COMPLETED|Overall Study||1
10314866|NCT00169104|11448606|FG000|NOT COMPLETED|Overall Study||2
10314867|NCT00169104|11448607|FG001|NOT COMPLETED|Overall Study||2
10314868|NCT00169442|11448620|FG000|STARTED|Overall Study||119
10314869|NCT00169442|11448621|FG001|STARTED|Overall Study||124
10314870|NCT00169442|11448622|FG002|STARTED|Overall Study||167
10314871|NCT00169442|11448623|FG003|STARTED|Overall Study||250
10314872|NCT00169442|11448624|FG004|STARTED|Overall Study||42
10314873|NCT00169442|11448625|FG005|STARTED|Overall Study||43
10314874|NCT00169442|11448620|FG000|COMPLETED|Overall Study||119
10314875|NCT00169442|11448621|FG001|COMPLETED|Overall Study||123
10418842|NCT00807846|11563639|FG000|COMPLETED|Overall Study||88
10418843|NCT00807846|11563640|FG001|COMPLETED|Overall Study||94
10545918|NCT01500382|11699419|FG002|COMPLETED|Treatment Period 2||0
10869775|NCT00085735|12035396|FG004|STARTED|Overall Study||147
10869776|NCT00085735|12035397|FG005|STARTED|Overall Study||146
10869777|NCT00085735|12035392|FG000|COMPLETED|Overall Study||52
10869778|NCT00085735|12035393|FG001|COMPLETED|Overall Study||54
10295198|NCT03882047|11427785|FG000|STARTED|Overall Study||104
10295199|NCT03882047|11427786|FG001|STARTED|Overall Study||105
10295200|NCT03882047|11427787|FG002|STARTED|Overall Study||104
10295201|NCT03882047|11427785|FG000|Treated|Overall Study||104
10295202|NCT03882047|11427786|FG001|Treated|Overall Study||104
10295203|NCT03882047|11427787|FG002|Treated|Overall Study||103
10295204|NCT03882047|11427785|FG000|COMPLETED|Overall Study||98
10295205|NCT03882047|11427786|FG001|COMPLETED|Overall Study||95
10295206|NCT03882047|11427787|FG002|COMPLETED|Overall Study||88
10295207|NCT03882047|11427785|FG000|NOT COMPLETED|Overall Study||6
10295208|NCT03882047|11427786|FG001|NOT COMPLETED|Overall Study||10
10295209|NCT03882047|11427787|FG002|NOT COMPLETED|Overall Study||16
10295210|NCT03879772|11427800|FG000|STARTED|Overall Study||137
10295211|NCT03879772|11427801|FG001|STARTED|Overall Study||135
10295212|NCT03879772|11427802|FG002|STARTED|Overall Study||133
10295213|NCT03879772|11427803|FG003|STARTED|Overall Study||138
10295214|NCT03879772|11427804|FG004|STARTED|Overall Study||136
10295215|NCT03879772|11427800|FG000|COMPLETED|Overall Study||133
10295216|NCT03879772|11427801|FG001|COMPLETED|Overall Study||132
10295217|NCT03879772|11427802|FG002|COMPLETED|Overall Study||123
10295218|NCT03879772|11427803|FG003|COMPLETED|Overall Study||130
10295219|NCT03879772|11427804|FG004|COMPLETED|Overall Study||128
10295220|NCT03879772|11427800|FG000|NOT COMPLETED|Overall Study||4
10295221|NCT03879772|11427801|FG001|NOT COMPLETED|Overall Study||3
10295222|NCT03879772|11427802|FG002|NOT COMPLETED|Overall Study||10
10295223|NCT03879772|11427803|FG003|NOT COMPLETED|Overall Study||8
10295224|NCT03879772|11427804|FG004|NOT COMPLETED|Overall Study||8
10295225|NCT03861559|11427818|FG000|STARTED|Overall Study||101
10295226|NCT03861559|11427819|FG001|STARTED|Overall Study||100
10295227|NCT03861559|11427818|FG000|COMPLETED|Overall Study||99
10295228|NCT03861559|11427819|FG001|COMPLETED|Overall Study||95
10295229|NCT03861559|11427818|FG000|NOT COMPLETED|Overall Study||2
10295230|NCT03861559|11427819|FG001|NOT COMPLETED|Overall Study||5
10295231|NCT03855228|11427829|FG000|STARTED|Overall Study||169
10295232|NCT03855228|11427830|FG001|STARTED|Overall Study||176
10295233|NCT03855228|11427831|FG002|STARTED|Overall Study||182
10295234|NCT03855228|11427832|FG003|STARTED|Overall Study||177
10295235|NCT03855228|11427829|FG000|Treated|Overall Study||169
10295236|NCT03855228|11427830|FG001|Treated|Overall Study||176
10295237|NCT03855228|11427831|FG002|Treated|Overall Study|1 participant immediately dropped out prior to starting study intervention.|181
10295238|NCT03855228|11427832|FG003|Treated|Overall Study|1 participant immediately dropped out prior to starting study intervention.|176
10295239|NCT03855228|11427829|FG000|COMPLETED|Overall Study||166
10295240|NCT03855228|11427830|FG001|COMPLETED|Overall Study||167
10295241|NCT03855228|11427831|FG002|COMPLETED|Overall Study||174
10295242|NCT03855228|11427832|FG003|COMPLETED|Overall Study||158
10295243|NCT03855228|11427829|FG000|NOT COMPLETED|Overall Study||3
10295244|NCT03855228|11427830|FG001|NOT COMPLETED|Overall Study||9
10295245|NCT03855228|11427831|FG002|NOT COMPLETED|Overall Study||8
10295246|NCT03855228|11427832|FG003|NOT COMPLETED|Overall Study||19
10295247|NCT03855189|11427845|FG000|STARTED|Overall Study||113
10295248|NCT03855189|11427846|FG001|STARTED|Overall Study||116
10295249|NCT03855189|11427847|FG002|STARTED|Overall Study||116
10295250|NCT03855189|11427845|FG000|Treated|Overall Study|Does not include 1 participant who received first dose but was excluded from safety analysis.|112
10295251|NCT03855189|11427846|FG001|Treated|Overall Study||116
10295252|NCT03855189|11427847|FG002|Treated|Overall Study||116
10295253|NCT03855189|11427845|FG000|COMPLETED|Overall Study||103
10295254|NCT03855189|11427846|FG001|COMPLETED|Overall Study||109
10295255|NCT03855189|11427847|FG002|COMPLETED|Overall Study||110
10295256|NCT03855189|11427845|FG000|NOT COMPLETED|Overall Study||10
10295257|NCT03855189|11427846|FG001|NOT COMPLETED|Overall Study||7
10295258|NCT03855189|11427847|FG002|NOT COMPLETED|Overall Study||6
10295259|NCT03764631|11427857|FG000|STARTED|Overall Study||751
10295260|NCT03764631|11427858|FG001|STARTED|Overall Study||751
10295261|NCT03764631|11427857|FG000|COMPLETED|Overall Study||710
10295262|NCT03764631|11427858|FG001|COMPLETED|Overall Study||698
10295263|NCT03764631|11427857|FG000|NOT COMPLETED|Overall Study||41
10295264|NCT03764631|11427858|FG001|NOT COMPLETED|Overall Study||53
10295265|NCT03764072|11427870|FG000|STARTED|Overall Study||46
10295266|NCT03764072|11427871|FG001|STARTED|Overall Study||42
10295267|NCT03764072|11427872|FG002|STARTED|Overall Study||44
10295268|NCT03764072|11427873|FG003|STARTED|Overall Study||45
10295269|NCT03764072|11427874|FG004|STARTED|Overall Study||46
10295270|NCT03764072|11427875|FG005|STARTED|Overall Study||27
10295271|NCT03764072|11427870|FG000|COMPLETED|Overall Study||46
10295272|NCT03764072|11427871|FG001|COMPLETED|Overall Study||42
10295273|NCT03764072|11427872|FG002|COMPLETED|Overall Study||43
10295274|NCT03764072|11427873|FG003|COMPLETED|Overall Study||45
10295275|NCT03764072|11427874|FG004|COMPLETED|Overall Study||45
10295276|NCT03764072|11427875|FG005|COMPLETED|Overall Study||26
10295277|NCT03764072|11427870|FG000|NOT COMPLETED|Overall Study||0
10295278|NCT03764072|11427871|FG001|NOT COMPLETED|Overall Study||0
10295279|NCT03764072|11427872|FG002|NOT COMPLETED|Overall Study||1
10295280|NCT03764072|11427873|FG003|NOT COMPLETED|Overall Study||0
10295281|NCT03764072|11427874|FG004|NOT COMPLETED|Overall Study||1
10295282|NCT03764072|11427875|FG005|NOT COMPLETED|Overall Study||1
10295283|NCT03645408|11427896|FG000|STARTED|Overall Study||1
10869779|NCT00085735|12035394|FG002|COMPLETED|Overall Study||46
10869780|NCT00085735|12035395|FG003|COMPLETED|Overall Study||46
10869781|NCT00085735|12035396|FG004|COMPLETED|Overall Study||105
10869782|NCT00085735|12035397|FG005|COMPLETED|Overall Study||115
10869783|NCT00085735|12035392|FG000|NOT COMPLETED|Overall Study||12
10869784|NCT00085735|12035393|FG001|NOT COMPLETED|Overall Study||10
10869785|NCT00085735|12035394|FG002|NOT COMPLETED|Overall Study||17
10869786|NCT00085735|12035395|FG003|NOT COMPLETED|Overall Study||19
10869787|NCT00085735|12035396|FG004|NOT COMPLETED|Overall Study||42
10869788|NCT00085735|12035397|FG005|NOT COMPLETED|Overall Study||31
10869789|NCT00003042|12035426|FG000|STARTED|Overall Study||14
10869790|NCT00003042|12035427|FG001|STARTED|Overall Study||27
10869791|NCT00003042|12035426|FG000|COMPLETED|Overall Study||14
10869792|NCT00003042|12035427|FG001|COMPLETED|Overall Study||27
10869793|NCT00003042|12035426|FG000|NOT COMPLETED|Overall Study||0
10869794|NCT00003042|12035427|FG001|NOT COMPLETED|Overall Study||0
10418844|NCT00807846|11563639|FG000|NOT COMPLETED|Overall Study||12
10418845|NCT00807846|11563640|FG001|NOT COMPLETED|Overall Study||4
10418846|NCT00807885|11563655|FG000|STARTED|Overall Study||10
10418847|NCT00807885|11563656|FG001|STARTED|Overall Study||11
10418848|NCT00807885|11563657|FG002|STARTED|Overall Study||11
10418849|NCT00807885|11563658|FG003|STARTED|Overall Study||10
10418850|NCT00807885|11563659|FG004|STARTED|Overall Study||12
10418851|NCT00807885|11563660|FG005|STARTED|Overall Study||12
10869795|NCT04399356|12035435|FG000|STARTED|Overall Study||36
10869796|NCT04399356|12035436|FG001|STARTED|Overall Study||37
10869797|NCT04399356|12035435|FG000|COMPLETED|Overall Study||33
10869798|NCT04399356|12035436|FG001|COMPLETED|Overall Study||34
10869799|NCT04399356|12035435|FG000|NOT COMPLETED|Overall Study||3
10869800|NCT04399356|12035436|FG001|NOT COMPLETED|Overall Study||3
10869801|NCT04350905|12035442|FG000|STARTED|Overall Study||42
10869802|NCT04350905|12035442|FG000|COMPLETED|Overall Study||41
10869803|NCT04350905|12035442|FG000|NOT COMPLETED|Overall Study||1
10869804|NCT04236635|12035446|FG000|STARTED|Overall Study||2
10869805|NCT04236635|12035447|FG001|STARTED|Overall Study||1
10869806|NCT04236635|12035448|FG002|STARTED|Overall Study||1
10869807|NCT04236635|12035449|FG003|STARTED|Overall Study||4
10869808|NCT04236635|12035450|FG004|STARTED|Overall Study||1
10869809|NCT04236635|12035451|FG005|STARTED|Overall Study||1
10869810|NCT04236635|12035446|FG000|Safety Population|Overall Study||2
10869811|NCT04236635|12035447|FG001|Safety Population|Overall Study||1
10869812|NCT04236635|12035448|FG002|Safety Population|Overall Study||1
10869813|NCT04236635|12035449|FG003|Safety Population|Overall Study||4
10869814|NCT04236635|12035450|FG004|Safety Population|Overall Study||1
10869815|NCT04236635|12035451|FG005|Safety Population|Overall Study||1
10869816|NCT04236635|12035446|FG000|Evaluable Population|Overall Study||2
10869817|NCT04236635|12035447|FG001|Evaluable Population|Overall Study||1
10869818|NCT04236635|12035448|FG002|Evaluable Population|Overall Study||1
10869819|NCT04236635|12035449|FG003|Evaluable Population|Overall Study||2
10869820|NCT04236635|12035450|FG004|Evaluable Population|Overall Study||1
10869821|NCT04236635|12035451|FG005|Evaluable Population|Overall Study||1
10869822|NCT04236635|12035446|FG000|COMPLETED|Overall Study||2
10869823|NCT04236635|12035447|FG001|COMPLETED|Overall Study||1
10869824|NCT04236635|12035448|FG002|COMPLETED|Overall Study||1
10869825|NCT04236635|12035449|FG003|COMPLETED|Overall Study||4
10869826|NCT04236635|12035450|FG004|COMPLETED|Overall Study||1
10869827|NCT04236635|12035451|FG005|COMPLETED|Overall Study||1
10869828|NCT04236635|12035446|FG000|NOT COMPLETED|Overall Study||0
10869829|NCT04236635|12035447|FG001|NOT COMPLETED|Overall Study||0
10869830|NCT04236635|12035448|FG002|NOT COMPLETED|Overall Study||0
10869831|NCT04236635|12035449|FG003|NOT COMPLETED|Overall Study||0
10869832|NCT04236635|12035450|FG004|NOT COMPLETED|Overall Study||0
10869833|NCT04236635|12035451|FG005|NOT COMPLETED|Overall Study||0
10869834|NCT04156399|12035466|FG000|STARTED|Overall Study||6
10869835|NCT04156399|12035466|FG000|COMPLETED|Overall Study|Of the six participants who started the study, two completed all 10 acupuncture sessions, two completed 9 sessions, and one completed 8 sessions. The three who completed 8 or 9 sessions were unable to complete due to the COVID-19 lockdowns, however, we were able to collect post-test measures for them. Finally, one participant was hospitalized (unrelated to acupuncture) and could not complete the study nor provide post-test measures.|2
10869836|NCT04156399|12035466|FG000|NOT COMPLETED|Overall Study||4
10869837|NCT04115228|12035470|FG000|STARTED|Overall Study||10
10869838|NCT04115228|12035470|FG000|COMPLETED|Overall Study||10
10869839|NCT04115228|12035470|FG000|NOT COMPLETED|Overall Study||0
10869840|NCT04052620|12035476|FG000|STARTED|Overall Study||150
10869841|NCT04052620|12035477|FG001|STARTED|Overall Study||152
10869842|NCT04052620|12035476|FG000|COMPLETED|Overall Study||143
10869843|NCT04052620|12035477|FG001|COMPLETED|Overall Study||145
10869844|NCT04052620|12035476|FG000|NOT COMPLETED|Overall Study||7
10869845|NCT04052620|12035477|FG001|NOT COMPLETED|Overall Study||7
10545919|NCT01500382|11699420|FG003|COMPLETED|Treatment Period 2||1
10545920|NCT01500382|11699417|FG000|NOT COMPLETED|Treatment Period 2||0
10545921|NCT01500382|11699418|FG001|NOT COMPLETED|Treatment Period 2||0
10545922|NCT01500382|11699419|FG002|NOT COMPLETED|Treatment Period 2||0
10545923|NCT01500382|11699420|FG003|NOT COMPLETED|Treatment Period 2||0
10545924|NCT01500434|11699430|FG000|STARTED|Overall Study||102
10869854|NCT03826667|12035492|FG000|STARTED|Overall Study||464
10869855|NCT03826667|12035492|FG000|HEALICOIL™ PK Preloaded Suture Anchors|Overall Study||193
10869856|NCT03826667|12035492|FG000|BIORAPTOR™ 2.3 PK Suture Anchors/BIORAPTOR™ Curved 2.3 PK Suture Anchors|Overall Study||41
10869857|NCT03826667|12035492|FG000|MULTIFIX™ S Ultra Knotless Fixation System|Overall Study||78
10869858|NCT03826667|12035492|FG000|FOOTPRINT™ Ultra PK Suture Anchors|Overall Study||136
10869859|NCT03826667|12035492|FG000|TWINFIX™ Ultra PK Suture Anchors/TWINFIX™ Ultra Preloaded and With Needles|Overall Study||57
10869860|NCT03826667|12035492|FG000|SPEEDSCREW™ Knotless Fixation System|Overall Study||59
10869861|NCT03826667|12035492|FG000|SpeedLock Knotless Fixation Device|Overall Study||18
10869862|NCT03826667|12035492|FG000|COMPLETED|Overall Study||443
10869863|NCT03826667|12035492|FG000|NOT COMPLETED|Overall Study||21
10869864|NCT03600909|12035505|FG000|STARTED|Overall Study||0
10869865|NCT03600909|12035506|FG001|STARTED|Overall Study||3
10869866|NCT03600909|12035507|FG002|STARTED|Overall Study||0
10869867|NCT03600909|12035505|FG000|COMPLETED|Overall Study||0
10869868|NCT03600909|12035506|FG001|COMPLETED|Overall Study||0
10869869|NCT03600909|12035507|FG002|COMPLETED|Overall Study||0
10869870|NCT03600909|12035505|FG000|NOT COMPLETED|Overall Study||0
10545925|NCT01500434|11699430|FG000|COMPLETED|Overall Study||95
10869871|NCT03600909|12035506|FG001|NOT COMPLETED|Overall Study||3
10869872|NCT03600909|12035507|FG002|NOT COMPLETED|Overall Study||0
10418852|NCT00807885|11563661|FG006|STARTED|Overall Study||12
10418853|NCT00807885|11563662|FG007|STARTED|Overall Study||11
10418854|NCT00807885|11563663|FG008|STARTED|Overall Study||11
10418855|NCT00807885|11563655|FG000|COMPLETED|Overall Study||10
10418856|NCT00807885|11563656|FG001|COMPLETED|Overall Study||11
10418857|NCT00807885|11563657|FG002|COMPLETED|Overall Study||11
10418858|NCT00807885|11563658|FG003|COMPLETED|Overall Study||10
10418859|NCT00807885|11563659|FG004|COMPLETED|Overall Study||12
10418860|NCT00807885|11563660|FG005|COMPLETED|Overall Study|Subject completed treatment, but lost to follow-up|11
10418861|NCT00807885|11563661|FG006|COMPLETED|Overall Study||12
10418862|NCT00807885|11563662|FG007|COMPLETED|Overall Study||11
10418863|NCT00807885|11563663|FG008|COMPLETED|Overall Study||11
10418864|NCT00807885|11563655|FG000|NOT COMPLETED|Overall Study||0
10418865|NCT00807885|11563656|FG001|NOT COMPLETED|Overall Study||0
10418866|NCT00807885|11563657|FG002|NOT COMPLETED|Overall Study||0
10418867|NCT00807885|11563658|FG003|NOT COMPLETED|Overall Study||0
10418868|NCT00807885|11563659|FG004|NOT COMPLETED|Overall Study||0
10418869|NCT00807885|11563660|FG005|NOT COMPLETED|Overall Study||1
10418870|NCT00807885|11563661|FG006|NOT COMPLETED|Overall Study||0
10418871|NCT00807885|11563662|FG007|NOT COMPLETED|Overall Study||0
10418872|NCT00807885|11563663|FG008|NOT COMPLETED|Overall Study||0
10418873|NCT00807937|11563687|FG000|STARTED|Overall Study||93
10418874|NCT00807937|11563688|FG001|STARTED|Overall Study||92
10418875|NCT00807937|11563689|FG002|STARTED|Overall Study||92
10418876|NCT00807937|11563690|FG003|STARTED|Overall Study||92
10418877|NCT00807937|11563687|FG000|COMPLETED|Overall Study||66
10418878|NCT00807937|11563688|FG001|COMPLETED|Overall Study||67
10418879|NCT00807937|11563689|FG002|COMPLETED|Overall Study||78
10418880|NCT00807937|11563690|FG003|COMPLETED|Overall Study||77
10418881|NCT00807937|11563687|FG000|NOT COMPLETED|Overall Study||27
10418882|NCT00807937|11563688|FG001|NOT COMPLETED|Overall Study||25
10418883|NCT00807937|11563689|FG002|NOT COMPLETED|Overall Study||14
10418884|NCT00807937|11563690|FG003|NOT COMPLETED|Overall Study||15
10418885|NCT00807989|11563702|FG000|STARTED|Overall Study||107
10418886|NCT00807989|11563703|FG001|STARTED|Overall Study||100
10418887|NCT00807989|11563702|FG000|COMPLETED|Overall Study||104
10418888|NCT00807989|11563703|FG001|COMPLETED|Overall Study||98
10418889|NCT00807989|11563702|FG000|NOT COMPLETED|Overall Study||3
10545926|NCT01500434|11699430|FG000|NOT COMPLETED|Overall Study||7
10545927|NCT01500525|11699436|FG000|STARTED|Overall Study||286
10545928|NCT01500525|11699437|FG001|STARTED|Overall Study||301
10545929|NCT01500525|11699436|FG000|COMPLETED|Overall Study||286
10418890|NCT00807989|11563703|FG001|NOT COMPLETED|Overall Study||2
10418891|NCT00808015|11563709|FG000|STARTED|Overall Study||1377
10418892|NCT00808015|11563709|FG000|Treated|Overall Study||1373
10418893|NCT00808015|11563709|FG000|COMPLETED|Overall Study||1033
10418894|NCT00808015|11563709|FG000|NOT COMPLETED|Overall Study||344
10545930|NCT01500525|11699437|FG001|COMPLETED|Overall Study||301
10869876|NCT03366428|12035523|FG000|STARTED|Overall Study||51
10869877|NCT03366428|12035523|FG000|COMPLETED|Overall Study||0
10869878|NCT03366428|12035523|FG000|NOT COMPLETED|Overall Study||51
10869879|NCT03221660|12035529|FG000|STARTED|Overall Study||50
10869880|NCT03221660|12035529|FG000|COMPLETED|Overall Study||50
10869881|NCT03221660|12035529|FG000|NOT COMPLETED|Overall Study||0
10418895|NCT00808028|11563717|FG000|STARTED|Stage 1 (6 Months)||121
10418896|NCT00808028|11563718|FG001|STARTED|Stage 1 (6 Months)|Participants in rLP2086 60 mcg group participated only in Stage 1 and were not eligible for Stage 2|22
10418897|NCT00808028|11563719|FG002|STARTED|Stage 1 (6 Months)||198
10418898|NCT00808028|11563720|FG003|STARTED|Stage 1 (6 Months)||198
10418899|NCT00808028|11563717|FG000|COMPLETED|Stage 1 (6 Months)||116
10418900|NCT00808028|11563718|FG001|COMPLETED|Stage 1 (6 Months)|Participants in rLP2086 60 mcg group participated only in Stage 1 and were not eligible for Stage 2|21
10418901|NCT00808028|11563719|FG002|COMPLETED|Stage 1 (6 Months)||191
10418902|NCT00808028|11563720|FG003|COMPLETED|Stage 1 (6 Months)||183
10418903|NCT00808028|11563717|FG000|NOT COMPLETED|Stage 1 (6 Months)||5
10418904|NCT00808028|11563718|FG001|NOT COMPLETED|Stage 1 (6 Months)||1
10418905|NCT00808028|11563719|FG002|NOT COMPLETED|Stage 1 (6 Months)||7
10418906|NCT00808028|11563720|FG003|NOT COMPLETED|Stage 1 (6 Months)||15
10418907|NCT00808028|11563717|FG000|STARTED|Stage 2 (Followed up to 48 Months )|Out of 511 completed participants in Stage 1, 89 did not enter Stage 2|80
10418908|NCT00808028|11563718|FG001|STARTED|Stage 2 (Followed up to 48 Months )||0
10418909|NCT00808028|11563719|FG002|STARTED|Stage 2 (Followed up to 48 Months )||170
10418910|NCT00808028|11563720|FG003|STARTED|Stage 2 (Followed up to 48 Months )||151
10418911|NCT00808028|11563717|FG000|COMPLETED|Stage 2 (Followed up to 48 Months )|Out of 511 completed participants in Stage 1, 89 did not enter Stage 2|69
10418912|NCT00808028|11563718|FG001|COMPLETED|Stage 2 (Followed up to 48 Months )||0
10418913|NCT00808028|11563719|FG002|COMPLETED|Stage 2 (Followed up to 48 Months )||141
10418914|NCT00808028|11563720|FG003|COMPLETED|Stage 2 (Followed up to 48 Months )||128
10418915|NCT00808028|11563717|FG000|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||11
10418916|NCT00808028|11563718|FG001|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||0
10545931|NCT01500525|11699436|FG000|NOT COMPLETED|Overall Study||0
10545932|NCT01500525|11699437|FG001|NOT COMPLETED|Overall Study||0
10545933|NCT01500629|11699445|FG000|STARTED|Period 1 (Single Dose)||11
10545934|NCT01500629|11699446|FG001|STARTED|Period 1 (Single Dose)||10
10545935|NCT01500629|11699445|FG000|COMPLETED|Period 1 (Single Dose)||11
10545936|NCT01500629|11699446|FG001|COMPLETED|Period 1 (Single Dose)||10
10545937|NCT01500629|11699445|FG000|NOT COMPLETED|Period 1 (Single Dose)||0
10545938|NCT01500629|11699446|FG001|NOT COMPLETED|Period 1 (Single Dose)||0
10545939|NCT01500629|11699445|FG000|STARTED|Washout Period of 14 to 30 Days||11
10545940|NCT01500629|11699446|FG001|STARTED|Washout Period of 14 to 30 Days||10
10545941|NCT01500629|11699445|FG000|COMPLETED|Washout Period of 14 to 30 Days||10
10545942|NCT01500629|11699446|FG001|COMPLETED|Washout Period of 14 to 30 Days||10
10545943|NCT01500629|11699445|FG000|NOT COMPLETED|Washout Period of 14 to 30 Days||1
10545944|NCT01500629|11699446|FG001|NOT COMPLETED|Washout Period of 14 to 30 Days||0
10545945|NCT01500629|11699445|FG000|STARTED|Period 2 (Single Dose)||10
10545946|NCT01500629|11699446|FG001|STARTED|Period 2 (Single Dose)||10
10545947|NCT01500629|11699445|FG000|COMPLETED|Period 2 (Single Dose)||10
10545948|NCT01500629|11699446|FG001|COMPLETED|Period 2 (Single Dose)||10
10545949|NCT01500629|11699445|FG000|NOT COMPLETED|Period 2 (Single Dose)||0
10545950|NCT01500629|11699446|FG001|NOT COMPLETED|Period 2 (Single Dose)||0
10545951|NCT01500694|11699461|FG000|STARTED|Overall Study||131
10545952|NCT01500694|11699462|FG001|STARTED|Overall Study|Participants who received treatment were reported as Started.|83
10545953|NCT01500694|11699461|FG000|COMPLETED|Overall Study||79
10545954|NCT01500694|11699462|FG001|COMPLETED|Overall Study||54
10545955|NCT01500694|11699461|FG000|NOT COMPLETED|Overall Study||52
10545956|NCT01500694|11699462|FG001|NOT COMPLETED|Overall Study||29
10545957|NCT01500720|11699470|FG000|STARTED|Overall Study|Randomized|90
10545958|NCT01500720|11699471|FG001|STARTED|Overall Study|Randomized|89
10545959|NCT01500720|11699470|FG000|Treated|Overall Study||89
10545960|NCT01500720|11699471|FG001|Treated|Overall Study||88
10545961|NCT01500720|11699470|FG000|COMPLETED|Overall Study|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|85
10545962|NCT01500720|11699471|FG001|COMPLETED|Overall Study|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|80
10545963|NCT01500720|11699470|FG000|NOT COMPLETED|Overall Study||5
10545964|NCT01500720|11699471|FG001|NOT COMPLETED|Overall Study||9
10545965|NCT01500746|11699479|FG000|STARTED|Overall Study||4
10545966|NCT01500746|11699480|FG001|STARTED|Overall Study||4
10545967|NCT01500746|11699479|FG000|COMPLETED|Overall Study||4
10545968|NCT01500746|11699480|FG001|COMPLETED|Overall Study||4
10418917|NCT00808028|11563719|FG002|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||29
10418918|NCT00808028|11563720|FG003|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||23
10418919|NCT00808067|11563742|FG000|STARTED|Overall Study|Number of patients which are treated.|2927
10418920|NCT00808067|11563743|FG001|STARTED|Overall Study|Number of patients which are treated.|2956
10418921|NCT00808067|11563742|FG000|COMPLETED|Overall Study||2446
10418922|NCT00808067|11563743|FG001|COMPLETED|Overall Study||2438
10418923|NCT00808067|11563742|FG000|NOT COMPLETED|Overall Study||481
10418924|NCT00808067|11563743|FG001|NOT COMPLETED|Overall Study||518
10418925|NCT00808132|11563754|FG000|STARTED|Overall Study||455
10418926|NCT00808132|11563755|FG001|STARTED|Overall Study||481
10418927|NCT00808132|11563756|FG002|STARTED|Overall Study||239
10418928|NCT00808132|11563757|FG003|STARTED|Overall Study||228
10418929|NCT00808132|11563758|FG004|STARTED|Overall Study||483
10418930|NCT00808132|11563754|FG000|Treated|Overall Study||445
10418931|NCT00808132|11563755|FG001|Treated|Overall Study||474
10418932|NCT00808132|11563756|FG002|Treated|Overall Study||230
10418933|NCT00808132|11563757|FG003|Treated|Overall Study||220
10418934|NCT00808132|11563758|FG004|Treated|Overall Study||474
10418935|NCT00808132|11563754|FG000|COMPLETED|Overall Study||357
10418936|NCT00808132|11563755|FG001|COMPLETED|Overall Study||393
10418937|NCT00808132|11563756|FG002|COMPLETED|Overall Study||185
10418938|NCT00808132|11563757|FG003|COMPLETED|Overall Study||159
10418939|NCT00808132|11563758|FG004|COMPLETED|Overall Study||383
10418940|NCT00808132|11563754|FG000|NOT COMPLETED|Overall Study||98
10418941|NCT00808132|11563755|FG001|NOT COMPLETED|Overall Study||88
10418942|NCT00808132|11563756|FG002|NOT COMPLETED|Overall Study||54
10418943|NCT00808132|11563757|FG003|NOT COMPLETED|Overall Study||69
10418944|NCT00808132|11563758|FG004|NOT COMPLETED|Overall Study||100
10418945|NCT00808210|11563772|FG000|STARTED|Study Period + 48 Weeks of Follow-up||15
10869903|NCT02756611|12035546|FG000|STARTED|Overall Study||258
10869904|NCT02756611|12035546|FG000|COMPLETED|Overall Study||2
10869905|NCT02756611|12035546|FG000|NOT COMPLETED|Overall Study||256
10869906|NCT02724878|12035550|FG000|STARTED|Overall Study||65
10869907|NCT02724878|12035550|FG000|Treated|Overall Study||60
10869908|NCT02724878|12035550|FG000|Responders|Overall Study||20
10869909|NCT02724878|12035550|FG000|COMPLETED|Overall Study||0
10869910|NCT02724878|12035550|FG000|NOT COMPLETED|Overall Study||65
10869911|NCT02605993|12035558|FG000|STARTED|Treatment Period||6
10869912|NCT02605993|12035559|FG001|STARTED|Treatment Period||6
10869913|NCT02605993|12035560|FG002|STARTED|Treatment Period||7
10869914|NCT02605993|12035561|FG003|STARTED|Treatment Period||7
10869915|NCT02605993|12035558|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||6
10869916|NCT02605993|12035559|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||6
10869917|NCT02605993|12035560|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||7
10869918|NCT02605993|12035561|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||7
10869919|NCT02605993|12035558|FG000|COMPLETED|Treatment Period||6
10869920|NCT02605993|12035559|FG001|COMPLETED|Treatment Period||6
10869921|NCT02605993|12035560|FG002|COMPLETED|Treatment Period||7
10869922|NCT02605993|12035561|FG003|COMPLETED|Treatment Period||7
10869923|NCT02605993|12035558|FG000|NOT COMPLETED|Treatment Period||0
10869924|NCT02605993|12035559|FG001|NOT COMPLETED|Treatment Period||0
10869925|NCT02605993|12035560|FG002|NOT COMPLETED|Treatment Period||0
10869926|NCT02605993|12035561|FG003|NOT COMPLETED|Treatment Period||0
10295284|NCT03645408|11427897|FG001|STARTED|Overall Study||2
10295285|NCT03645408|11427896|FG000|COMPLETED|Overall Study||1
10295286|NCT03645408|11427897|FG001|COMPLETED|Overall Study||2
10295287|NCT03645408|11427896|FG000|NOT COMPLETED|Overall Study||0
10295288|NCT03645408|11427897|FG001|NOT COMPLETED|Overall Study||0
10295289|NCT03578809|11427907|FG000|STARTED|Overall Study||94
10295290|NCT03578809|11427908|FG001|STARTED|Overall Study||185
10295291|NCT03578809|11427909|FG002|STARTED|Overall Study||112
10295292|NCT03578809|11427910|FG003|STARTED|Overall Study||202
10295293|NCT03578809|11427907|FG000|Treated|Overall Study||90
10295294|NCT03578809|11427908|FG001|Treated|Overall Study||179
10295295|NCT03578809|11427909|FG002|Treated|Overall Study||111
10295296|NCT03578809|11427910|FG003|Treated|Overall Study||195
10295297|NCT03578809|11427907|FG000|COMPLETED|Overall Study||88
10295298|NCT03578809|11427908|FG001|COMPLETED|Overall Study||171
10295299|NCT03578809|11427909|FG002|COMPLETED|Overall Study||108
10295300|NCT03578809|11427910|FG003|COMPLETED|Overall Study||193
10295301|NCT03578809|11427907|FG000|NOT COMPLETED|Overall Study||6
10295302|NCT03578809|11427908|FG001|NOT COMPLETED|Overall Study||14
10295303|NCT03578809|11427909|FG002|NOT COMPLETED|Overall Study||4
10295304|NCT03578809|11427910|FG003|NOT COMPLETED|Overall Study||9
10314876|NCT00169442|11448622|FG002|COMPLETED|Overall Study||166
10314877|NCT00169442|11448623|FG003|COMPLETED|Overall Study||250
10314878|NCT00169442|11448624|FG004|COMPLETED|Overall Study||41
10869927|NCT02605993|12035558|FG000|STARTED|Extension Period||6
10869928|NCT02605993|12035559|FG001|STARTED|Extension Period||6
10869929|NCT02605993|12035560|FG002|STARTED|Extension Period||7
10869930|NCT02605993|12035561|FG003|STARTED|Extension Period||7
10869931|NCT02605993|12035558|FG000|COMPLETED|Extension Period||0
10869932|NCT02605993|12035559|FG001|COMPLETED|Extension Period||0
10869933|NCT02605993|12035560|FG002|COMPLETED|Extension Period||0
10869934|NCT02605993|12035561|FG003|COMPLETED|Extension Period||0
10869935|NCT02605993|12035558|FG000|NOT COMPLETED|Extension Period||6
10869936|NCT02605993|12035559|FG001|NOT COMPLETED|Extension Period||6
10869937|NCT02605993|12035560|FG002|NOT COMPLETED|Extension Period||7
10869938|NCT02605993|12035561|FG003|NOT COMPLETED|Extension Period||7
10869939|NCT02487095|12035576|FG000|STARTED|Phase I Dose Escalation||6
10869940|NCT02487095|12035577|FG001|STARTED|Phase I Dose Escalation||6
10869941|NCT02487095|12035578|FG002|STARTED|Phase I Dose Escalation||3
10869942|NCT02487095|12035579|FG003|STARTED|Phase I Dose Escalation||6
10869943|NCT02487095|12035580|FG004|STARTED|Phase I Dose Escalation||0
10869944|NCT02487095|12035576|FG000|COMPLETED|Phase I Dose Escalation||6
10869945|NCT02487095|12035577|FG001|COMPLETED|Phase I Dose Escalation||6
10869946|NCT02487095|12035578|FG002|COMPLETED|Phase I Dose Escalation||3
10869947|NCT02487095|12035579|FG003|COMPLETED|Phase I Dose Escalation||6
10869948|NCT02487095|12035580|FG004|COMPLETED|Phase I Dose Escalation||0
10869949|NCT02487095|12035576|FG000|NOT COMPLETED|Phase I Dose Escalation||0
10869950|NCT02487095|12035577|FG001|NOT COMPLETED|Phase I Dose Escalation||0
10869951|NCT02487095|12035578|FG002|NOT COMPLETED|Phase I Dose Escalation||0
10869952|NCT02487095|12035579|FG003|NOT COMPLETED|Phase I Dose Escalation||0
10869953|NCT02487095|12035580|FG004|NOT COMPLETED|Phase I Dose Escalation||0
10869954|NCT02487095|12035576|FG000|STARTED|Dose Expansion||0
10869955|NCT02487095|12035577|FG001|STARTED|Dose Expansion||0
10869956|NCT02487095|12035578|FG002|STARTED|Dose Expansion||0
10869957|NCT02487095|12035579|FG003|STARTED|Dose Expansion||0
10869958|NCT02487095|12035580|FG004|STARTED|Dose Expansion||41
10869959|NCT02487095|12035576|FG000|COMPLETED|Dose Expansion||0
10869960|NCT02487095|12035577|FG001|COMPLETED|Dose Expansion||0
10869961|NCT02487095|12035578|FG002|COMPLETED|Dose Expansion||0
10869962|NCT02487095|12035579|FG003|COMPLETED|Dose Expansion||0
10869963|NCT02487095|12035580|FG004|COMPLETED|Dose Expansion||40
10869964|NCT02487095|12035576|FG000|NOT COMPLETED|Dose Expansion||0
10869965|NCT02487095|12035577|FG001|NOT COMPLETED|Dose Expansion||0
10869966|NCT02487095|12035578|FG002|NOT COMPLETED|Dose Expansion||0
10869967|NCT02487095|12035579|FG003|NOT COMPLETED|Dose Expansion||0
10869968|NCT02487095|12035580|FG004|NOT COMPLETED|Dose Expansion||1
10869969|NCT02347917|12035602|FG000|STARTED|Overall Study||4
10869970|NCT02347917|12035603|FG001|STARTED|Overall Study||24
10869971|NCT02347917|12035602|FG000|Discontinued beforeBBI608 Administration|Overall Study||0
10869972|NCT02347917|12035603|FG001|Discontinued beforeBBI608 Administration|Overall Study||0
10869973|NCT02347917|12035602|FG000|Start BBI608 Administration|Overall Study||4
10869974|NCT02347917|12035603|FG001|Start BBI608 Administration|Overall Study||24
10869975|NCT02347917|12035602|FG000|Discontinued in DLT Evaluation Period|Overall Study||1
10869976|NCT02347917|12035603|FG001|Discontinued in DLT Evaluation Period|Overall Study||0
10869977|NCT02347917|12035602|FG000|Complete DLT Evaluation Period|Overall Study||3
10869978|NCT02347917|12035603|FG001|Complete DLT Evaluation Period|Overall Study||0
10869979|NCT02347917|12035602|FG000|Discontinued After BBI608 Administration|Overall Study||4
10869980|NCT02347917|12035603|FG001|Discontinued After BBI608 Administration|Overall Study||24
10869981|NCT02347917|12035602|FG000|Discontinued Before Survival Observation|Overall Study||0
10869982|NCT02347917|12035603|FG001|Discontinued Before Survival Observation|Overall Study||1
10869983|NCT02347917|12035602|FG000|COMPLETED|Overall Study||4
10869984|NCT02347917|12035603|FG001|COMPLETED|Overall Study||23
10869985|NCT02347917|12035602|FG000|NOT COMPLETED|Overall Study||0
10869986|NCT02347917|12035603|FG001|NOT COMPLETED|Overall Study||1
10869987|NCT02344108|12035617|FG000|STARTED|Overall Study||42
10869988|NCT02344108|12035617|FG000|COMPLETED|Overall Study||42
10869989|NCT02344108|12035617|FG000|NOT COMPLETED|Overall Study||0
10869990|NCT02335658|12035627|FG000|STARTED|Overall Study|97 subjects in Cohort 1 and 103 subjects in Cohort 2 started to receive DSP-5423P.|97
10869991|NCT02335658|12035628|FG001|STARTED|Overall Study||103
10869992|NCT02335658|12035627|FG000|COMPLETED|Overall Study|57 subjects in Cohort 1 and 59 subjects in Cohort 2 completed the study.|57
10869993|NCT02335658|12035628|FG001|COMPLETED|Overall Study||59
10869994|NCT02335658|12035627|FG000|NOT COMPLETED|Overall Study||40
10869995|NCT02335658|12035628|FG001|NOT COMPLETED|Overall Study||44
10869996|NCT02287584|12035639|FG000|STARTED|the Double-blind Phase||190
10869997|NCT02287584|12035640|FG001|STARTED|the Double-blind Phase||196
10869998|NCT02287584|12035641|FG002|STARTED|the Double-blind Phase||194
10869999|NCT02287584|12035642|FG003|STARTED|the Double-blind Phase||0
10870000|NCT02287584|12035643|FG004|STARTED|the Double-blind Phase||0
10870001|NCT02287584|12035644|FG005|STARTED|the Double-blind Phase||0
10870002|NCT02287584|12035639|FG000|COMPLETED|the Double-blind Phase||138
10870003|NCT02287584|12035640|FG001|COMPLETED|the Double-blind Phase||149
10870004|NCT02287584|12035641|FG002|COMPLETED|the Double-blind Phase||161
10870005|NCT02287584|12035642|FG003|COMPLETED|the Double-blind Phase||0
10870006|NCT02287584|12035643|FG004|COMPLETED|the Double-blind Phase||0
10870007|NCT02287584|12035644|FG005|COMPLETED|the Double-blind Phase||0
10870008|NCT02287584|12035639|FG000|NOT COMPLETED|the Double-blind Phase||52
10870009|NCT02287584|12035640|FG001|NOT COMPLETED|the Double-blind Phase||47
10870010|NCT02287584|12035641|FG002|NOT COMPLETED|the Double-blind Phase||33
10870011|NCT02287584|12035642|FG003|NOT COMPLETED|the Double-blind Phase||0
10870012|NCT02287584|12035643|FG004|NOT COMPLETED|the Double-blind Phase||0
10870013|NCT02287584|12035644|FG005|NOT COMPLETED|the Double-blind Phase||0
10870014|NCT02287584|12035639|FG000|STARTED|the Open-label Phase||0
10870015|NCT02287584|12035640|FG001|STARTED|the Open-label Phase||0
10870016|NCT02287584|12035641|FG002|STARTED|the Open-label Phase||0
10870017|NCT02287584|12035642|FG003|STARTED|the Open-label Phase||138
10870018|NCT02287584|12035643|FG004|STARTED|the Open-label Phase||149
10870019|NCT02287584|12035644|FG005|STARTED|the Open-label Phase||161
10870020|NCT02287584|12035639|FG000|Treated|the Open-label Phase||0
10870021|NCT02287584|12035640|FG001|Treated|the Open-label Phase||0
10870022|NCT02287584|12035641|FG002|Treated|the Open-label Phase||0
10870023|NCT02287584|12035642|FG003|Treated|the Open-label Phase||131
10870024|NCT02287584|12035643|FG004|Treated|the Open-label Phase||143
10870025|NCT02287584|12035644|FG005|Treated|the Open-label Phase||157
10870026|NCT02287584|12035639|FG000|COMPLETED|the Open-label Phase||0
10870027|NCT02287584|12035640|FG001|COMPLETED|the Open-label Phase||0
10870028|NCT02287584|12035641|FG002|COMPLETED|the Open-label Phase||0
10870029|NCT02287584|12035642|FG003|COMPLETED|the Open-label Phase||81
10870030|NCT02287584|12035643|FG004|COMPLETED|the Open-label Phase||87
10870031|NCT02287584|12035644|FG005|COMPLETED|the Open-label Phase||104
10870032|NCT02287584|12035639|FG000|NOT COMPLETED|the Open-label Phase||0
10870033|NCT02287584|12035640|FG001|NOT COMPLETED|the Open-label Phase||0
10870034|NCT02287584|12035641|FG002|NOT COMPLETED|the Open-label Phase||0
10870035|NCT02287584|12035642|FG003|NOT COMPLETED|the Open-label Phase||57
10870036|NCT02287584|12035643|FG004|NOT COMPLETED|the Open-label Phase||62
10870037|NCT02287584|12035644|FG005|NOT COMPLETED|the Open-label Phase||57
10870038|NCT02178566|12035660|FG000|STARTED|Overall Study||0
10870039|NCT02178566|12035661|FG001|STARTED|Overall Study|no data available|1
10870040|NCT02178566|12035660|FG000|COMPLETED|Overall Study||0
10870041|NCT02178566|12035661|FG001|COMPLETED|Overall Study|no data available|0
10870042|NCT02178566|12035660|FG000|NOT COMPLETED|Overall Study||0
10870043|NCT02178566|12035661|FG001|NOT COMPLETED|Overall Study||1
10870044|NCT02173301|12035671|FG000|STARTED|Overall Study||49
10870045|NCT02173301|12035672|FG001|STARTED|Overall Study||55
10870046|NCT02173301|12035673|FG002|STARTED|Overall Study||48
10870047|NCT02173301|12035674|FG003|STARTED|Overall Study||48
10870048|NCT02173301|12035671|FG000|COMPLETED|Overall Study||29
10870049|NCT02173301|12035672|FG001|COMPLETED|Overall Study||32
10870050|NCT02173301|12035673|FG002|COMPLETED|Overall Study||28
10870051|NCT02173301|12035674|FG003|COMPLETED|Overall Study||33
10870052|NCT02173301|12035671|FG000|NOT COMPLETED|Overall Study||20
10870053|NCT02173301|12035672|FG001|NOT COMPLETED|Overall Study||23
10870054|NCT02173301|12035673|FG002|NOT COMPLETED|Overall Study||20
10870055|NCT02173301|12035674|FG003|NOT COMPLETED|Overall Study||15
10870056|NCT01986114|12035684|FG000|STARTED|Overall Study||495
10870057|NCT01986114|12035684|FG000|COMPLETED|Overall Study||339
10870058|NCT01986114|12035684|FG000|NOT COMPLETED|Overall Study||156
10870059|NCT01986101|12035693|FG000|STARTED|Overall Study||172
10870060|NCT01986101|12035694|FG001|STARTED|Overall Study||184
10870061|NCT01986101|12035695|FG002|STARTED|Overall Study||169
10870062|NCT01986101|12035693|FG000|Intent-to-Treat Population|Overall Study||171
10295305|NCT03571204|11427926|FG000|STARTED|Overall Study||8
10295306|NCT03571204|11427927|FG001|STARTED|Overall Study||8
10295307|NCT03571204|11427928|FG002|STARTED|Overall Study||5
10295308|NCT03571204|11427926|FG000|COMPLETED|Overall Study||7
10295309|NCT03571204|11427927|FG001|COMPLETED|Overall Study||6
10295310|NCT03571204|11427928|FG002|COMPLETED|Overall Study||5
10295311|NCT03571204|11427926|FG000|NOT COMPLETED|Overall Study||1
10295312|NCT03571204|11427927|FG001|NOT COMPLETED|Overall Study||2
10295313|NCT03571204|11427928|FG002|NOT COMPLETED|Overall Study||0
10295314|NCT03523091|11427939|FG000|STARTED|Overall Study||1
10295315|NCT03523091|11427940|FG001|STARTED|Overall Study||5
10295316|NCT03523091|11427939|FG000|COMPLETED|Overall Study||0
10295317|NCT03523091|11427940|FG001|COMPLETED|Overall Study||1
10295318|NCT03523091|11427939|FG000|NOT COMPLETED|Overall Study||1
10295319|NCT03523091|11427940|FG001|NOT COMPLETED|Overall Study||4
10295320|NCT03503474|11427948|FG000|STARTED|Overall Study|The number of participant with a diarrhoeal sample that returned a positive test result at the coordinating laboratory. There is no intervention as this is an observational study only.|103
10295321|NCT03503474|11427949|FG001|STARTED|Overall Study|The number of participant with a diarrhoeal sample that returned a negative test result at the coordinating laboratory. There is no intervention as this is an observational study only.|3050
10295322|NCT03503474|11427948|FG000|COMPLETED|Overall Study||103
10295323|NCT03503474|11427949|FG001|COMPLETED|Overall Study||3050
10295324|NCT03503474|11427948|FG000|NOT COMPLETED|Overall Study||0
10295325|NCT03503474|11427949|FG001|NOT COMPLETED|Overall Study||0
10295326|NCT03476317|11427958|FG000|STARTED|Overall Study|Group 1 study was not completed|0
10295327|NCT03476317|11427959|FG001|STARTED|Overall Study|Group 1 study was not completed|0
10295328|NCT03476317|11427960|FG002|STARTED|Overall Study||10
10295329|NCT03476317|11427958|FG000|COMPLETED|Overall Study|Group 1 study was not completed|0
10295330|NCT03476317|11427959|FG001|COMPLETED|Overall Study|Group 1 study was not completed|0
10295331|NCT03476317|11427960|FG002|COMPLETED|Overall Study||10
10295332|NCT03476317|11427958|FG000|NOT COMPLETED|Overall Study||0
10295333|NCT03476317|11427959|FG001|NOT COMPLETED|Overall Study||0
10295334|NCT03476317|11427960|FG002|NOT COMPLETED|Overall Study||0
10295335|NCT03391960|11427968|FG000|STARTED|Overall Study|Units were not assessed for this Arm/Group. Data was collected from the health care worker surveys for the retrospective study to monitor compliance with the scrub-the-hub protocol (signed informed consent and were enrolled)|165
10870063|NCT01986101|12035694|FG001|Intent-to-Treat Population|Overall Study||182
10870064|NCT01986101|12035695|FG002|Intent-to-Treat Population|Overall Study||169
10870065|NCT01986101|12035693|FG000|Safety Population|Overall Study||172
10870066|NCT01986101|12035694|FG001|Safety Population|Overall Study||184
10870067|NCT01986101|12035695|FG002|Safety Population|Overall Study||169
10870068|NCT01986101|12035693|FG000|COMPLETED|Overall Study||139
10870069|NCT01986101|12035694|FG001|COMPLETED|Overall Study||157
10870070|NCT01986101|12035695|FG002|COMPLETED|Overall Study||137
10870071|NCT01986101|12035693|FG000|NOT COMPLETED|Overall Study||33
10870072|NCT01986101|12035694|FG001|NOT COMPLETED|Overall Study||27
10870073|NCT01986101|12035695|FG002|NOT COMPLETED|Overall Study||32
10870074|NCT01972035|12035708|FG000|STARTED|Overall Study||66
10870075|NCT01972035|12035709|FG001|STARTED|Overall Study||71
10870076|NCT01972035|12035708|FG000|COMPLETED|Overall Study||27
10870077|NCT01972035|12035709|FG001|COMPLETED|Overall Study||44
10870078|NCT01972035|12035708|FG000|NOT COMPLETED|Overall Study||39
10870079|NCT01972035|12035709|FG001|NOT COMPLETED|Overall Study||27
10870080|NCT01955980|12035717|FG000|STARTED|Overall Study||10
10870081|NCT01955980|12035718|FG001|STARTED|Overall Study||9
10870082|NCT01955980|12035717|FG000|COMPLETED|Overall Study||10
10870083|NCT01955980|12035718|FG001|COMPLETED|Overall Study||9
10870084|NCT01955980|12035717|FG000|NOT COMPLETED|Overall Study||0
10870085|NCT01955980|12035718|FG001|NOT COMPLETED|Overall Study||0
10870086|NCT01946711|12035727|FG000|STARTED|Overall Study||8
10870087|NCT01946711|12035728|FG001|STARTED|Overall Study||6
10870088|NCT01946711|12035727|FG000|COMPLETED|Overall Study||8
10870089|NCT01946711|12035728|FG001|COMPLETED|Overall Study||6
10870090|NCT01946711|12035727|FG000|NOT COMPLETED|Overall Study||0
10870091|NCT01946711|12035728|FG001|NOT COMPLETED|Overall Study||0
10870092|NCT01891994|12035734|FG000|STARTED|Overall Study||40
10870093|NCT01891994|12035734|FG000|COMPLETED|Overall Study||40
10870094|NCT01891994|12035734|FG000|NOT COMPLETED|Overall Study||0
10314879|NCT00169442|11448625|FG005|COMPLETED|Overall Study||41
10870101|NCT01813305|12035749|FG000|STARTED|Overall Study||98
10870102|NCT01813305|12035750|FG001|STARTED|Overall Study||26
10870103|NCT01813305|12035749|FG000|COMPLETED|Overall Study||63
10870104|NCT01813305|12035750|FG001|COMPLETED|Overall Study||18
10870105|NCT01813305|12035749|FG000|NOT COMPLETED|Overall Study||35
10870106|NCT01813305|12035750|FG001|NOT COMPLETED|Overall Study||8
10870107|NCT01680965|12035762|FG000|STARTED|Overall Study||3
10870108|NCT01680965|12035763|FG001|STARTED|Overall Study||3
10870109|NCT01680965|12035764|FG002|STARTED|Overall Study||6
10870110|NCT01680965|12035765|FG003|STARTED|Overall Study||32
10870111|NCT01680965|12035762|FG000|COMPLETED|Overall Study||3
10870112|NCT01680965|12035763|FG001|COMPLETED|Overall Study||3
10870113|NCT01680965|12035764|FG002|COMPLETED|Overall Study||6
10870114|NCT01680965|12035765|FG003|COMPLETED|Overall Study||26
10870115|NCT01680965|12035762|FG000|NOT COMPLETED|Overall Study||0
10870116|NCT01680965|12035763|FG001|NOT COMPLETED|Overall Study||0
10870117|NCT01680965|12035764|FG002|NOT COMPLETED|Overall Study||0
10870118|NCT01680965|12035765|FG003|NOT COMPLETED|Overall Study||6
10870119|NCT01614912|12035773|FG000|STARTED|Overall Study||284
10870120|NCT01614912|12035773|FG000|COMPLETED|Overall Study||159
10870121|NCT01614912|12035773|FG000|NOT COMPLETED|Overall Study||125
10870122|NCT01614899|12035780|FG000|STARTED|Overall Study||150
10870123|NCT01614899|12035781|FG001|STARTED|Overall Study||155
10870124|NCT01614899|12035782|FG002|STARTED|Overall Study||152
10870125|NCT01614899|12035780|FG000|COMPLETED|Overall Study||106
10870126|NCT01614899|12035781|FG001|COMPLETED|Overall Study||116
10870127|NCT01614899|12035782|FG002|COMPLETED|Overall Study||110
10870128|NCT01614899|12035780|FG000|NOT COMPLETED|Overall Study||44
10870129|NCT01614899|12035781|FG001|NOT COMPLETED|Overall Study||39
10870130|NCT01614899|12035782|FG002|NOT COMPLETED|Overall Study||42
10870131|NCT00711269|12035794|FG000|STARTED|Overall Study||131
10870132|NCT00711269|12035795|FG001|STARTED|Overall Study||131
10870133|NCT00711269|12035796|FG002|STARTED|Overall Study||133
10870134|NCT00711269|12035797|FG003|STARTED|Overall Study||65
10870135|NCT00711269|12035794|FG000|COMPLETED|Overall Study||87
10870136|NCT00711269|12035795|FG001|COMPLETED|Overall Study||83
10870137|NCT00711269|12035796|FG002|COMPLETED|Overall Study||83
10870138|NCT00711269|12035797|FG003|COMPLETED|Overall Study||51
10870139|NCT00711269|12035794|FG000|NOT COMPLETED|Overall Study||44
10870140|NCT00711269|12035795|FG001|NOT COMPLETED|Overall Study||48
10295336|NCT03391960|11427969|FG001|STARTED|Overall Study|No individual patient was recruited into the study. Data was collected from the compliance audits to monitor compliance with the disinfecting barrier cap protocol.|
10295337|NCT03391960|11427968|FG000|COMPLETED|Overall Study||165
10295338|NCT03391960|11427969|FG001|COMPLETED|Overall Study|No individual patient was recruited into the study. Data was collected from the compliance audits to monitor compliance with the disinfecting barrier cap protocol.|
10295339|NCT03391960|11427968|FG000|NOT COMPLETED|Overall Study||0
10295340|NCT03391960|11427969|FG001|NOT COMPLETED|Overall Study||
10295341|NCT03362190|11427988|FG000|STARTED|Overall Study||10
10295342|NCT03362190|11427989|FG001|STARTED|Overall Study||10
10295343|NCT03362190|11427990|FG002|STARTED|Overall Study||22
10295344|NCT03362190|11427991|FG003|STARTED|Overall Study||22
10295345|NCT03362190|11427988|FG000|COMPLETED|Overall Study||10
10295346|NCT03362190|11427989|FG001|COMPLETED|Overall Study||10
10295347|NCT03362190|11427990|FG002|COMPLETED|Overall Study||22
10295348|NCT03362190|11427991|FG003|COMPLETED|Overall Study||20
10295349|NCT03362190|11427988|FG000|NOT COMPLETED|Overall Study||0
10295350|NCT03362190|11427989|FG001|NOT COMPLETED|Overall Study||0
10295351|NCT03362190|11427990|FG002|NOT COMPLETED|Overall Study||0
10295352|NCT03362190|11427991|FG003|NOT COMPLETED|Overall Study||2
10295353|NCT03252522|11428006|FG000|STARTED|Overall Study||78
10295354|NCT03252522|11428007|FG001|STARTED|Overall Study||57
10295355|NCT03252522|11428008|FG002|STARTED|Overall Study||0
10295356|NCT03252522|11428006|FG000|COMPLETED|Overall Study||69
10295357|NCT03252522|11428007|FG001|COMPLETED|Overall Study||54
10295358|NCT03252522|11428008|FG002|COMPLETED|Overall Study||0
10295359|NCT03252522|11428006|FG000|NOT COMPLETED|Overall Study||9
10295360|NCT03252522|11428007|FG001|NOT COMPLETED|Overall Study||3
10295361|NCT03252522|11428008|FG002|NOT COMPLETED|Overall Study||0
10870141|NCT00711269|12035796|FG002|NOT COMPLETED|Overall Study||50
10870142|NCT00711269|12035797|FG003|NOT COMPLETED|Overall Study||14
10870143|NCT00152477|12035811|FG000|STARTED|Chemotherapy Period||50
10870144|NCT00152477|12035812|FG001|STARTED|Chemotherapy Period||56
10870145|NCT00152477|12035813|FG002|STARTED|Chemotherapy Period||59
10870146|NCT00152477|12035811|FG000|Part II|Chemotherapy Period||50
10870147|NCT00152477|12035812|FG001|Part II|Chemotherapy Period||53
10870148|NCT00152477|12035813|FG002|Part II|Chemotherapy Period||53
10870149|NCT00152477|12035811|FG000|COMPLETED|Chemotherapy Period||22
10870150|NCT00152477|12035812|FG001|COMPLETED|Chemotherapy Period||34
10870151|NCT00152477|12035813|FG002|COMPLETED|Chemotherapy Period||39
10870152|NCT00152477|12035811|FG000|NOT COMPLETED|Chemotherapy Period||28
10295374|NCT03225833|11428043|FG000|STARTED|Overall Study||16
10870153|NCT00152477|12035812|FG001|NOT COMPLETED|Chemotherapy Period||22
10870154|NCT00152477|12035813|FG002|NOT COMPLETED|Chemotherapy Period||20
10870155|NCT00152477|12035811|FG000|STARTED|Monotherapy Period|7 subjects completed the Chemotherapy period but did not enter the Monotherapy period.|15
10870156|NCT00152477|12035812|FG001|STARTED|Monotherapy Period|5 subjects completed the Chemotherapy period but did not enter the Monotherapy period.|29
10870157|NCT00152477|12035813|FG002|STARTED|Monotherapy Period|5 subjects completed the Chemotherapy period but did not enter the Monotherapy period.|34
10870158|NCT00152477|12035811|FG000|Part II|Monotherapy Period||13
10870159|NCT00152477|12035812|FG001|Part II|Monotherapy Period||26
10870160|NCT00152477|12035813|FG002|Part II|Monotherapy Period||29
10870161|NCT00152477|12035811|FG000|COMPLETED|Monotherapy Period||0
10870162|NCT00152477|12035812|FG001|COMPLETED|Monotherapy Period||0
10870163|NCT00152477|12035813|FG002|COMPLETED|Monotherapy Period||0
10870164|NCT00152477|12035811|FG000|NOT COMPLETED|Monotherapy Period||15
10870165|NCT00152477|12035812|FG001|NOT COMPLETED|Monotherapy Period||29
10870166|NCT00152477|12035813|FG002|NOT COMPLETED|Monotherapy Period||34
10295375|NCT03225833|11428044|FG001|STARTED|Overall Study||9
10870167|NCT04585646|12035824|FG000|STARTED|First Intervention||32
10870168|NCT04585646|12035825|FG001|STARTED|First Intervention||32
10870169|NCT04585646|12035824|FG000|COMPLETED|First Intervention||31
10870170|NCT04585646|12035825|FG001|COMPLETED|First Intervention||28
10870171|NCT04585646|12035824|FG000|NOT COMPLETED|First Intervention||1
10870172|NCT04585646|12035825|FG001|NOT COMPLETED|First Intervention||4
10870173|NCT04585646|12035824|FG000|STARTED|Second Intervention||31
10870174|NCT04585646|12035825|FG001|STARTED|Second Intervention||28
10870175|NCT04585646|12035824|FG000|COMPLETED|Second Intervention||31
10870176|NCT04585646|12035825|FG001|COMPLETED|Second Intervention||28
10870177|NCT04585646|12035824|FG000|NOT COMPLETED|Second Intervention||0
10870178|NCT04585646|12035825|FG001|NOT COMPLETED|Second Intervention||0
10870179|NCT04451330|12035834|FG000|STARTED|Overall Study||133
10870180|NCT04451330|12035835|FG001|STARTED|Overall Study||69
10870181|NCT04451330|12035834|FG000|COMPLETED|Overall Study||123
10870182|NCT04451330|12035835|FG001|COMPLETED|Overall Study||65
10870183|NCT04451330|12035834|FG000|NOT COMPLETED|Overall Study||10
10870184|NCT04451330|12035835|FG001|NOT COMPLETED|Overall Study||4
10870185|NCT04300010|12035844|FG000|STARTED|Overall Study||20
10870186|NCT04300010|12035845|FG001|STARTED|Overall Study||20
10870187|NCT04300010|12035846|FG002|STARTED|Overall Study||20
10870188|NCT04300010|12035847|FG003|STARTED|Overall Study||60
10870189|NCT04300010|12035844|FG000|COMPLETED|Overall Study||20
10870190|NCT04300010|12035845|FG001|COMPLETED|Overall Study||20
10870191|NCT04300010|12035846|FG002|COMPLETED|Overall Study||20
10870192|NCT04300010|12035847|FG003|COMPLETED|Overall Study||60
10870193|NCT04300010|12035844|FG000|NOT COMPLETED|Overall Study||0
10870194|NCT04300010|12035845|FG001|NOT COMPLETED|Overall Study||0
10870195|NCT04300010|12035846|FG002|NOT COMPLETED|Overall Study||0
10870196|NCT04300010|12035847|FG003|NOT COMPLETED|Overall Study||0
10870197|NCT04206670|12035858|FG000|STARTED|Overall Study||148
10870198|NCT04206670|12035859|FG001|STARTED|Overall Study||68
10870199|NCT04206670|12035858|FG000|COMPLETED|Overall Study||124
10870200|NCT04206670|12035859|FG001|COMPLETED|Overall Study||65
10870201|NCT04206670|12035858|FG000|NOT COMPLETED|Overall Study||24
10870202|NCT04206670|12035859|FG001|NOT COMPLETED|Overall Study||3
10870203|NCT04173962|12035868|FG000|STARTED|Overall Study||12
10870204|NCT04173962|12035869|FG001|STARTED|Overall Study||12
10870205|NCT04173962|12035868|FG000|COMPLETED|Overall Study||12
10870206|NCT04173962|12035869|FG001|COMPLETED|Overall Study||12
10870207|NCT04173962|12035868|FG000|NOT COMPLETED|Overall Study||0
10870208|NCT04173962|12035869|FG001|NOT COMPLETED|Overall Study||0
10870209|NCT04115189|12035877|FG000|STARTED|Overall Study||42
10870210|NCT04115189|12035878|FG001|STARTED|Overall Study||15
10870211|NCT04115189|12035877|FG000|COMPLETED|Overall Study||42
10870212|NCT04115189|12035878|FG001|COMPLETED|Overall Study||15
10870213|NCT04115189|12035877|FG000|NOT COMPLETED|Overall Study||0
10870214|NCT04115189|12035878|FG001|NOT COMPLETED|Overall Study||0
10870215|NCT04010695|12035888|FG000|STARTED|Overall Study||250
10870216|NCT04010695|12035888|FG000|COMPLETED|Overall Study||250
10870217|NCT04010695|12035888|FG000|NOT COMPLETED|Overall Study||0
10870218|NCT04003623|12035895|FG000|STARTED|Overall Study||1
10870219|NCT04003623|12035896|FG001|STARTED|Overall Study||0
10870220|NCT04003623|12035895|FG000|COMPLETED|Overall Study||0
10870221|NCT04003623|12035896|FG001|COMPLETED|Overall Study||0
10870222|NCT04003623|12035895|FG000|NOT COMPLETED|Overall Study||1
10870223|NCT04003623|12035896|FG001|NOT COMPLETED|Overall Study||0
10870224|NCT03967847|12035904|FG000|STARTED|Overall Study||21
10870225|NCT03967847|12035905|FG001|STARTED|Overall Study||23
10870226|NCT03967847|12035904|FG000|COMPLETED|Overall Study||21
10870227|NCT03967847|12035905|FG001|COMPLETED|Overall Study||23
10870228|NCT03967847|12035904|FG000|NOT COMPLETED|Overall Study||0
10870229|NCT03967847|12035905|FG001|NOT COMPLETED|Overall Study||0
10870230|NCT03828383|12035914|FG000|STARTED|Overall Study||41
10870231|NCT03828383|12035915|FG001|STARTED|Overall Study||37
10870232|NCT03828383|12035914|FG000|COMPLETED|Overall Study||34
10870233|NCT03828383|12035915|FG001|COMPLETED|Overall Study||30
10870234|NCT03828383|12035914|FG000|NOT COMPLETED|Overall Study||7
10870235|NCT03828383|12035915|FG001|NOT COMPLETED|Overall Study||7
10870254|NCT03717480|12035931|FG000|STARTED|Overall Study||2
10870255|NCT03717480|12035931|FG000|Receipt of Investigational Product/Study Treatment|Overall Study||1
10870256|NCT03717480|12035931|FG000|COMPLETED|Overall Study||1
10870257|NCT03717480|12035931|FG000|NOT COMPLETED|Overall Study||1
10870258|NCT03615066|12035938|FG000|STARTED|Main Study||26
10870259|NCT03615066|12035939|FG001|STARTED|Main Study||28
10870260|NCT03615066|12035940|FG002|STARTED|Main Study||13
10870261|NCT03615066|12035938|FG000|COMPLETED|Main Study|2 participants did not receive all doses of study treatments but were considered to have completed the Main Study because the participants entered the TFFU Phase.|26
10870262|NCT03615066|12035939|FG001|COMPLETED|Main Study|1 participant did not receive all doses of study treatments but was considered to have completed the Main Study because the participant entered the TFFU Phase.|27
10870263|NCT03615066|12035940|FG002|COMPLETED|Main Study||11
10870264|NCT03615066|12035938|FG000|NOT COMPLETED|Main Study||0
10870265|NCT03615066|12035939|FG001|NOT COMPLETED|Main Study||1
10870266|NCT03615066|12035940|FG002|NOT COMPLETED|Main Study||2
10870267|NCT03615066|12035938|FG000|STARTED|Treatment-free Follow-up (TFFU) Phase|13 participants who completed Main study did not enter TFFU phase.|13
10870268|NCT03615066|12035939|FG001|STARTED|Treatment-free Follow-up (TFFU) Phase|15 participants who completed Main study did not enter TFFU phase.|12
10870269|NCT03615066|12035940|FG002|STARTED|Treatment-free Follow-up (TFFU) Phase|9 participants who completed Main study did not enter TFFU phase.|2
10870270|NCT03615066|12035938|FG000|COMPLETED|Treatment-free Follow-up (TFFU) Phase||11
10870271|NCT03615066|12035939|FG001|COMPLETED|Treatment-free Follow-up (TFFU) Phase||11
10870272|NCT03615066|12035940|FG002|COMPLETED|Treatment-free Follow-up (TFFU) Phase||2
10870273|NCT03615066|12035938|FG000|NOT COMPLETED|Treatment-free Follow-up (TFFU) Phase||2
10870274|NCT03615066|12035939|FG001|NOT COMPLETED|Treatment-free Follow-up (TFFU) Phase||1
10870275|NCT03615066|12035940|FG002|NOT COMPLETED|Treatment-free Follow-up (TFFU) Phase||0
10870276|NCT03557931|12035955|FG000|STARTED|Overall Study||100
10870277|NCT03557931|12035956|FG001|STARTED|Overall Study||65
10870278|NCT03557931|12035957|FG002|STARTED|Overall Study||68
10870279|NCT03557931|12035955|FG000|COMPLETED|Overall Study||69
10870280|NCT03557931|12035956|FG001|COMPLETED|Overall Study||46
10870281|NCT03557931|12035957|FG002|COMPLETED|Overall Study||55
10870282|NCT03557931|12035955|FG000|NOT COMPLETED|Overall Study||31
10870283|NCT03557931|12035956|FG001|NOT COMPLETED|Overall Study||19
10870284|NCT03557931|12035957|FG002|NOT COMPLETED|Overall Study||13
10870285|NCT03251144|12035969|FG000|STARTED|Overall Study||15
10870286|NCT03251144|12035970|FG001|STARTED|Overall Study||11
10870287|NCT03251144|12035969|FG000|COMPLETED|Overall Study||15
10870288|NCT03251144|12035970|FG001|COMPLETED|Overall Study||11
10870289|NCT03251144|12035969|FG000|NOT COMPLETED|Overall Study||0
10870290|NCT03251144|12035970|FG001|NOT COMPLETED|Overall Study||0
10870291|NCT02596035|12035979|FG000|STARTED|Overall Study||97
10870292|NCT02596035|12035980|FG001|STARTED|Overall Study||44
10870293|NCT02596035|12035981|FG002|STARTED|Overall Study||1
10870294|NCT02596035|12035979|FG000|COMPLETED|Overall Study||11
10870295|NCT02596035|12035980|FG001|COMPLETED|Overall Study||0
10870296|NCT02596035|12035981|FG002|COMPLETED|Overall Study||0
10870297|NCT02596035|12035979|FG000|NOT COMPLETED|Overall Study||86
10870298|NCT02596035|12035980|FG001|NOT COMPLETED|Overall Study||44
10870299|NCT02596035|12035981|FG002|NOT COMPLETED|Overall Study||1
10870321|NCT02318095|12036004|FG000|STARTED|Overall Study||40
10870322|NCT02318095|12036004|FG000|COMPLETED|Overall Study||39
10870323|NCT02318095|12036004|FG000|NOT COMPLETED|Overall Study||1
10870324|NCT02155647|12036011|FG000|STARTED|Overall Study||88
10870325|NCT02155647|12036012|FG001|STARTED|Overall Study||116
10870326|NCT02155647|12036011|FG000|COMPLETED|Overall Study||47
10870327|NCT02155647|12036012|FG001|COMPLETED|Overall Study||64
10870328|NCT02155647|12036011|FG000|NOT COMPLETED|Overall Study||41
10870329|NCT02155647|12036012|FG001|NOT COMPLETED|Overall Study||52
10870330|NCT02032810|12036020|FG000|STARTED|Overall Study||6
10870331|NCT02032810|12036021|FG001|STARTED|Overall Study||11
10870332|NCT02032810|12036020|FG000|COMPLETED|Overall Study||6
10870333|NCT02032810|12036021|FG001|COMPLETED|Overall Study||11
10870334|NCT02032810|12036020|FG000|NOT COMPLETED|Overall Study||0
10870335|NCT02032810|12036021|FG001|NOT COMPLETED|Overall Study||0
10870336|NCT01979211|12036031|FG000|STARTED|Overall Study||24
10870337|NCT01979211|12036031|FG000|COMPLETED|Overall Study||24
10870338|NCT01979211|12036031|FG000|NOT COMPLETED|Overall Study||0
10870339|NCT01904903|12036035|FG000|STARTED|Overall Study||31
10870340|NCT01904903|12036035|FG000|COMPLETED|Overall Study||30
10870341|NCT01904903|12036035|FG000|NOT COMPLETED|Overall Study||1
10870342|NCT01827384|12036053|FG000|STARTED|Overall Study||13
10870343|NCT01827384|12036054|FG001|STARTED|Overall Study||1
10870344|NCT01827384|12036055|FG002|STARTED|Overall Study||9
10870345|NCT01827384|12036056|FG003|STARTED|Overall Study||1
10870346|NCT01827384|12036057|FG004|STARTED|Overall Study||1
10870347|NCT01827384|12036058|FG005|STARTED|Overall Study||22
10870348|NCT01827384|12036059|FG006|STARTED|Overall Study||2
10870349|NCT01827384|12036060|FG007|STARTED|Overall Study||1
10870350|NCT01827384|12036061|FG008|STARTED|Overall Study||2
10870351|NCT01827384|12036062|FG009|STARTED|Overall Study||15
10870352|NCT01827384|12036063|FG010|STARTED|Overall Study||7
10870353|NCT01827384|12036064|FG011|STARTED|Overall Study||1
10870354|NCT01827384|12036065|FG012|STARTED|Overall Study||2
10870355|NCT01827384|12036066|FG013|STARTED|Overall Study||131
10870356|NCT01827384|12036053|FG000|COMPLETED|Overall Study||13
10870357|NCT01827384|12036054|FG001|COMPLETED|Overall Study||1
10870358|NCT01827384|12036055|FG002|COMPLETED|Overall Study||9
10870359|NCT01827384|12036056|FG003|COMPLETED|Overall Study||1
10870360|NCT01827384|12036057|FG004|COMPLETED|Overall Study||1
10870361|NCT01827384|12036058|FG005|COMPLETED|Overall Study||22
10870362|NCT01827384|12036059|FG006|COMPLETED|Overall Study||2
10870363|NCT01827384|12036060|FG007|COMPLETED|Overall Study||1
10295376|NCT03225833|11428045|FG002|STARTED|Overall Study||9
10295377|NCT03225833|11428046|FG003|STARTED|Overall Study||9
10295378|NCT03225833|11428047|FG004|STARTED|Overall Study||8
10295379|NCT03225833|11428048|FG005|STARTED|Overall Study||10
10295380|NCT03225833|11428043|FG000|Single Dose Period Only|Overall Study||1
10295381|NCT03225833|11428044|FG001|Single Dose Period Only|Overall Study||1
10295382|NCT03225833|11428045|FG002|Single Dose Period Only|Overall Study||2
10295383|NCT03225833|11428046|FG003|Single Dose Period Only|Overall Study||0
10295384|NCT03225833|11428047|FG004|Single Dose Period Only|Overall Study||0
10295385|NCT03225833|11428048|FG005|Single Dose Period Only|Overall Study||4
10295386|NCT03225833|11428043|FG000|Multiple Dose Period Only|Overall Study||0
10295387|NCT03225833|11428044|FG001|Multiple Dose Period Only|Overall Study||0
10870364|NCT01827384|12036061|FG008|COMPLETED|Overall Study||2
10870365|NCT01827384|12036062|FG009|COMPLETED|Overall Study||15
10870366|NCT01827384|12036063|FG010|COMPLETED|Overall Study||7
10870367|NCT01827384|12036064|FG011|COMPLETED|Overall Study||1
10870368|NCT01827384|12036065|FG012|COMPLETED|Overall Study||2
10870369|NCT01827384|12036066|FG013|COMPLETED|Overall Study||0
10870370|NCT01827384|12036053|FG000|NOT COMPLETED|Overall Study||0
10870371|NCT01827384|12036054|FG001|NOT COMPLETED|Overall Study||0
10870372|NCT01827384|12036055|FG002|NOT COMPLETED|Overall Study||0
10870373|NCT01827384|12036056|FG003|NOT COMPLETED|Overall Study||0
10870374|NCT01827384|12036057|FG004|NOT COMPLETED|Overall Study||0
10870375|NCT01827384|12036058|FG005|NOT COMPLETED|Overall Study||0
10870376|NCT01827384|12036059|FG006|NOT COMPLETED|Overall Study||0
10870377|NCT01827384|12036060|FG007|NOT COMPLETED|Overall Study||0
10870378|NCT01827384|12036061|FG008|NOT COMPLETED|Overall Study||0
10870379|NCT01827384|12036062|FG009|NOT COMPLETED|Overall Study||0
10870380|NCT01827384|12036063|FG010|NOT COMPLETED|Overall Study||0
10870381|NCT01827384|12036064|FG011|NOT COMPLETED|Overall Study||0
10870382|NCT01827384|12036065|FG012|NOT COMPLETED|Overall Study||0
10870383|NCT01827384|12036066|FG013|NOT COMPLETED|Overall Study||131
10870384|NCT01778946|12036096|FG000|STARTED|Overall Study||7
10870385|NCT01778946|12036096|FG000|COMPLETED|Overall Study||4
10870386|NCT01778946|12036096|FG000|NOT COMPLETED|Overall Study||3
10870387|NCT01636258|12036102|FG000|STARTED|Overall Study||13
10870388|NCT01636258|12036103|FG001|STARTED|Overall Study||14
10870389|NCT01636258|12036102|FG000|COMPLETED|Overall Study||12
10870390|NCT01636258|12036103|FG001|COMPLETED|Overall Study||14
10870391|NCT01636258|12036102|FG000|NOT COMPLETED|Overall Study||1
10870392|NCT01636258|12036103|FG001|NOT COMPLETED|Overall Study||0
10545969|NCT01500746|11699479|FG000|NOT COMPLETED|Overall Study||0
10545970|NCT01500746|11699480|FG001|NOT COMPLETED|Overall Study||0
10545971|NCT01500759|11699488|FG000|STARTED|Overall Study||3686
10545972|NCT01500759|11699489|FG001|STARTED|Overall Study||3190
10545973|NCT01500759|11699488|FG000|COMPLETED|Overall Study||3686
10545974|NCT01500759|11699489|FG001|COMPLETED|Overall Study||3190
10545975|NCT01500759|11699488|FG000|NOT COMPLETED|Overall Study||0
10870420|NCT01517802|12036164|FG000|STARTED|Overall Study||31
10870421|NCT01517802|12036164|FG000|COMPLETED|Overall Study||30
10870422|NCT01517802|12036164|FG000|NOT COMPLETED|Overall Study||1
10870423|NCT00455325|12036168|FG000|STARTED|Cohort 1: Placebo||35
10870424|NCT00455325|12036169|FG001|STARTED|Cohort 1: Placebo||0
10870425|NCT00455325|12036170|FG002|STARTED|Cohort 1: Placebo||0
10870426|NCT00455325|12036171|FG003|STARTED|Cohort 1: Placebo||0
10870427|NCT00455325|12036168|FG000|COMPLETED|Cohort 1: Placebo||27
10870428|NCT00455325|12036169|FG001|COMPLETED|Cohort 1: Placebo||0
10418946|NCT00808210|11563773|FG001|STARTED|Study Period + 48 Weeks of Follow-up||13
10418947|NCT00808210|11563772|FG000|COMPLETED|Study Period + 48 Weeks of Follow-up||6
10418948|NCT00808210|11563773|FG001|COMPLETED|Study Period + 48 Weeks of Follow-up||4
10418949|NCT00808210|11563772|FG000|NOT COMPLETED|Study Period + 48 Weeks of Follow-up||9
10418950|NCT00808210|11563773|FG001|NOT COMPLETED|Study Period + 48 Weeks of Follow-up||9
10418951|NCT00808210|11563772|FG000|STARTED|Double-Blind TX Period||15
10418952|NCT00808210|11563773|FG001|STARTED|Double-Blind TX Period||13
10418953|NCT00808210|11563772|FG000|COMPLETED|Double-Blind TX Period||13
10418954|NCT00808210|11563773|FG001|COMPLETED|Double-Blind TX Period||10
10418955|NCT00808210|11563772|FG000|NOT COMPLETED|Double-Blind TX Period||2
10418956|NCT00808210|11563773|FG001|NOT COMPLETED|Double-Blind TX Period||3
10418957|NCT00808210|11563772|FG000|STARTED|Open Label Ocrelizumab Treatment Period||9
10418958|NCT00808210|11563773|FG001|STARTED|Open Label Ocrelizumab Treatment Period||4
10418959|NCT00808210|11563772|FG000|COMPLETED|Open Label Ocrelizumab Treatment Period||0
10418960|NCT00808210|11563773|FG001|COMPLETED|Open Label Ocrelizumab Treatment Period||0
10418961|NCT00808210|11563772|FG000|NOT COMPLETED|Open Label Ocrelizumab Treatment Period||9
10870429|NCT00455325|12036170|FG002|COMPLETED|Cohort 1: Placebo||0
10870430|NCT00455325|12036171|FG003|COMPLETED|Cohort 1: Placebo||0
10870431|NCT00455325|12036168|FG000|NOT COMPLETED|Cohort 1: Placebo||8
10870432|NCT00455325|12036169|FG001|NOT COMPLETED|Cohort 1: Placebo||0
10870433|NCT00455325|12036170|FG002|NOT COMPLETED|Cohort 1: Placebo||0
10870434|NCT00455325|12036171|FG003|NOT COMPLETED|Cohort 1: Placebo||0
10870435|NCT00455325|12036168|FG000|STARTED|Cohort 2: 80 mg Chloroquine Weekly||0
10870436|NCT00455325|12036169|FG001|STARTED|Cohort 2: 80 mg Chloroquine Weekly||27
10870437|NCT00455325|12036170|FG002|STARTED|Cohort 2: 80 mg Chloroquine Weekly||0
10870438|NCT00455325|12036171|FG003|STARTED|Cohort 2: 80 mg Chloroquine Weekly||0
10870439|NCT00455325|12036168|FG000|COMPLETED|Cohort 2: 80 mg Chloroquine Weekly||0
10870440|NCT00455325|12036169|FG001|COMPLETED|Cohort 2: 80 mg Chloroquine Weekly||26
10870441|NCT00455325|12036170|FG002|COMPLETED|Cohort 2: 80 mg Chloroquine Weekly||0
10870442|NCT00455325|12036171|FG003|COMPLETED|Cohort 2: 80 mg Chloroquine Weekly||0
10870443|NCT00455325|12036168|FG000|NOT COMPLETED|Cohort 2: 80 mg Chloroquine Weekly||0
10870444|NCT00455325|12036169|FG001|NOT COMPLETED|Cohort 2: 80 mg Chloroquine Weekly||1
10870445|NCT00455325|12036170|FG002|NOT COMPLETED|Cohort 2: 80 mg Chloroquine Weekly||0
10870446|NCT00455325|12036171|FG003|NOT COMPLETED|Cohort 2: 80 mg Chloroquine Weekly||0
10870447|NCT00455325|12036168|FG000|STARTED|Cohort 3: 80 mg Chloroquine Daily||0
10870448|NCT00455325|12036169|FG001|STARTED|Cohort 3: 80 mg Chloroquine Daily||0
10870449|NCT00455325|12036170|FG002|STARTED|Cohort 3: 80 mg Chloroquine Daily||26
10870450|NCT00455325|12036171|FG003|STARTED|Cohort 3: 80 mg Chloroquine Daily||0
10870451|NCT00455325|12036168|FG000|COMPLETED|Cohort 3: 80 mg Chloroquine Daily||0
10870452|NCT00455325|12036169|FG001|COMPLETED|Cohort 3: 80 mg Chloroquine Daily||0
10870453|NCT00455325|12036170|FG002|COMPLETED|Cohort 3: 80 mg Chloroquine Daily||25
10870454|NCT00455325|12036171|FG003|COMPLETED|Cohort 3: 80 mg Chloroquine Daily||0
10870455|NCT00455325|12036168|FG000|NOT COMPLETED|Cohort 3: 80 mg Chloroquine Daily||0
10870456|NCT00455325|12036169|FG001|NOT COMPLETED|Cohort 3: 80 mg Chloroquine Daily||0
10870457|NCT00455325|12036170|FG002|NOT COMPLETED|Cohort 3: 80 mg Chloroquine Daily||1
10870458|NCT00455325|12036171|FG003|NOT COMPLETED|Cohort 3: 80 mg Chloroquine Daily||0
10870459|NCT00455325|12036168|FG000|STARTED|Cohort 4: 250mg Chloroquine Daily||0
10870460|NCT00455325|12036169|FG001|STARTED|Cohort 4: 250mg Chloroquine Daily||0
10870461|NCT00455325|12036170|FG002|STARTED|Cohort 4: 250mg Chloroquine Daily||0
10870462|NCT00455325|12036171|FG003|STARTED|Cohort 4: 250mg Chloroquine Daily||25
10870463|NCT00455325|12036168|FG000|COMPLETED|Cohort 4: 250mg Chloroquine Daily||0
10870464|NCT00455325|12036169|FG001|COMPLETED|Cohort 4: 250mg Chloroquine Daily||0
10870465|NCT00455325|12036170|FG002|COMPLETED|Cohort 4: 250mg Chloroquine Daily||0
10870466|NCT00455325|12036171|FG003|COMPLETED|Cohort 4: 250mg Chloroquine Daily||25
10870467|NCT00455325|12036168|FG000|NOT COMPLETED|Cohort 4: 250mg Chloroquine Daily||0
10870468|NCT00455325|12036169|FG001|NOT COMPLETED|Cohort 4: 250mg Chloroquine Daily||0
10870469|NCT00455325|12036170|FG002|NOT COMPLETED|Cohort 4: 250mg Chloroquine Daily||0
10870470|NCT00455325|12036171|FG003|NOT COMPLETED|Cohort 4: 250mg Chloroquine Daily||0
10870471|NCT00321555|12036182|FG000|STARTED|Overall Study||15
10870472|NCT00321555|12036182|FG000|COMPLETED|Overall Study||9
10870473|NCT00321555|12036182|FG000|NOT COMPLETED|Overall Study||6
10870474|NCT04471935|12036186|FG000|STARTED|Overall Study||10
10870475|NCT04471935|12036186|FG000|COMPLETED|Overall Study||8
10870476|NCT04471935|12036186|FG000|NOT COMPLETED|Overall Study||2
10870477|NCT04180540|12036192|FG000|STARTED|Overall Study||55
10870478|NCT04180540|12036193|FG001|STARTED|Overall Study||54
10870479|NCT04180540|12036192|FG000|COMPLETED|Overall Study||53
10870480|NCT04180540|12036193|FG001|COMPLETED|Overall Study||54
10870481|NCT04180540|12036192|FG000|NOT COMPLETED|Overall Study||2
10870482|NCT04180540|12036193|FG001|NOT COMPLETED|Overall Study||0
10870483|NCT03912298|12036199|FG000|STARTED|Overall Study||7
10870484|NCT03912298|12036199|FG000|COMPLETED|Overall Study||7
10870485|NCT03912298|12036199|FG000|NOT COMPLETED|Overall Study||0
10870486|NCT04551677|12036206|FG000|STARTED|Overall Study||29
10870487|NCT04551677|12036207|FG001|STARTED|Overall Study||31
10870488|NCT04551677|12036208|FG002|STARTED|Overall Study||30
10870489|NCT04551677|12036206|FG000|Vaccinated|Overall Study||29
10870490|NCT04551677|12036207|FG001|Vaccinated|Overall Study||31
10870491|NCT04551677|12036208|FG002|Vaccinated|Overall Study||30
10870492|NCT04551677|12036206|FG000|COMPLETED|Overall Study||29
10870493|NCT04551677|12036207|FG001|COMPLETED|Overall Study||31
10870494|NCT04551677|12036208|FG002|COMPLETED|Overall Study||30
10870495|NCT04551677|12036206|FG000|NOT COMPLETED|Overall Study||0
10870496|NCT04551677|12036207|FG001|NOT COMPLETED|Overall Study||0
10870497|NCT04551677|12036208|FG002|NOT COMPLETED|Overall Study||0
10870498|NCT04498832|12036218|FG000|STARTED|Overall Study||1049
10870499|NCT04498832|12036219|FG001|STARTED|Overall Study||1051
10870500|NCT04498832|12036218|FG000|COMPLETED|Overall Study||1048
10870501|NCT04498832|12036219|FG001|COMPLETED|Overall Study||1047
10870502|NCT04498832|12036218|FG000|NOT COMPLETED|Overall Study||1
10870503|NCT04498832|12036219|FG001|NOT COMPLETED|Overall Study||4
10870504|NCT04109222|12036228|FG000|STARTED|Overall Study||30
10870505|NCT04109222|12036229|FG001|STARTED|Overall Study||30
10870506|NCT04109222|12036230|FG002|STARTED|Overall Study||30
10870507|NCT04109222|12036228|FG000|COMPLETED|Overall Study||29
10870508|NCT04109222|12036229|FG001|COMPLETED|Overall Study||30
10870509|NCT04109222|12036230|FG002|COMPLETED|Overall Study||30
10418962|NCT00808210|11563773|FG001|NOT COMPLETED|Open Label Ocrelizumab Treatment Period||4
10418963|NCT00808236|11563781|FG000|STARTED|Overall Study||96
10418964|NCT00808236|11563782|FG001|STARTED|Overall Study||104
10418965|NCT00808236|11563781|FG000|Met Eligibility Criteria|Overall Study|Pre-defined exclusions: DNAR(4); had pulse(2); CVA(2); Drug OD(2); On home oxygen(1); Unwitnessed(1)|84
10418966|NCT00808236|11563782|FG001|Met Eligibility Criteria|Overall Study|Pre-defined exclusions: Terminal(1); Asphyxia(1), In-hospital(1)|101
10418967|NCT00808236|11563781|FG000|Included in Analysis|Overall Study|Lost to Follow-Up: taken to non-participating hospital (1)|83
10418968|NCT00808236|11563782|FG001|Included in Analysis|Overall Study|Crossed over & withdrawn (1); Lost to Follow-Up: taken to non-participating hospital (1)|99
10418969|NCT00808236|11563781|FG000|Achieved ROSC|Overall Study||33
10418970|NCT00808236|11563782|FG001|Achieved ROSC|Overall Study||43
10418971|NCT00808236|11563781|FG000|Admitted to Hospital|Overall Study|Died during transport to hospital(2); DNAR determination was made at hospital(1)|30
10418972|NCT00808236|11563782|FG001|Admitted to Hospital|Overall Study|Died during transport to hospital(1)|42
10418973|NCT00808236|11563781|FG000|COMPLETED|Overall Study||14
10418974|NCT00808236|11563782|FG001|COMPLETED|Overall Study||13
10418975|NCT00808236|11563781|FG000|NOT COMPLETED|Overall Study||82
10418976|NCT00808236|11563782|FG001|NOT COMPLETED|Overall Study||91
10418977|NCT00808249|11563792|FG000|STARTED|Overall Study||107
10418978|NCT00808249|11563793|FG001|STARTED|Overall Study||106
10418979|NCT00808249|11563794|FG002|STARTED|Overall Study||105
10418980|NCT00808249|11563795|FG003|STARTED|Overall Study||106
10418981|NCT00808249|11563792|FG000|COMPLETED|Overall Study||90
10418982|NCT00808249|11563793|FG001|COMPLETED|Overall Study||91
10418983|NCT00808249|11563794|FG002|COMPLETED|Overall Study||83
10418984|NCT00808249|11563795|FG003|COMPLETED|Overall Study||90
10418985|NCT00808249|11563792|FG000|NOT COMPLETED|Overall Study||17
10418986|NCT00808249|11563793|FG001|NOT COMPLETED|Overall Study||15
10418987|NCT00808249|11563794|FG002|NOT COMPLETED|Overall Study||22
10418988|NCT00808249|11563795|FG003|NOT COMPLETED|Overall Study||16
10418989|NCT00808340|11563805|FG000|STARTED|First Intervention||4
10418990|NCT00808340|11563806|FG001|STARTED|First Intervention||9
10418991|NCT00808340|11563807|FG002|STARTED|First Intervention||7
10418992|NCT00808340|11563808|FG003|STARTED|First Intervention||3
10418993|NCT00808340|11563809|FG004|STARTED|First Intervention||5
10418994|NCT00808340|11563810|FG005|STARTED|First Intervention||6
10418995|NCT00808340|11563805|FG000|COMPLETED|First Intervention||4
10418996|NCT00808340|11563806|FG001|COMPLETED|First Intervention||9
10418997|NCT00808340|11563807|FG002|COMPLETED|First Intervention||7
10418998|NCT00808340|11563808|FG003|COMPLETED|First Intervention||3
10418999|NCT00808340|11563809|FG004|COMPLETED|First Intervention||5
10419000|NCT00808340|11563810|FG005|COMPLETED|First Intervention||6
10419001|NCT00808340|11563805|FG000|NOT COMPLETED|First Intervention||0
10419002|NCT00808340|11563806|FG001|NOT COMPLETED|First Intervention||0
10419003|NCT00808340|11563807|FG002|NOT COMPLETED|First Intervention||0
10419004|NCT00808340|11563808|FG003|NOT COMPLETED|First Intervention||0
10419005|NCT00808340|11563809|FG004|NOT COMPLETED|First Intervention||0
10870510|NCT04109222|12036228|FG000|NOT COMPLETED|Overall Study||1
10419006|NCT00808340|11563810|FG005|NOT COMPLETED|First Intervention||0
10870511|NCT04109222|12036229|FG001|NOT COMPLETED|Overall Study||0
10870512|NCT04109222|12036230|FG002|NOT COMPLETED|Overall Study||0
10870513|NCT04046939|12036242|FG000|STARTED|Screening Period||534
10870514|NCT04046939|12036243|FG001|STARTED|Screening Period||0
10870515|NCT04046939|12036244|FG002|STARTED|Screening Period||0
10870516|NCT04046939|12036245|FG003|STARTED|Screening Period||0
10870517|NCT04046939|12036242|FG000|Received Placebo During Run-In Period|Screening Period||144
10870518|NCT04046939|12036243|FG001|Received Placebo During Run-In Period|Screening Period||0
10870519|NCT04046939|12036244|FG002|Received Placebo During Run-In Period|Screening Period||0
10870520|NCT04046939|12036245|FG003|Received Placebo During Run-In Period|Screening Period||0
10870521|NCT04046939|12036242|FG000|COMPLETED|Screening Period||103
10870522|NCT04046939|12036243|FG001|COMPLETED|Screening Period||0
10870523|NCT04046939|12036244|FG002|COMPLETED|Screening Period||0
10870524|NCT04046939|12036245|FG003|COMPLETED|Screening Period||0
10870525|NCT04046939|12036242|FG000|NOT COMPLETED|Screening Period||431
10870526|NCT04046939|12036243|FG001|NOT COMPLETED|Screening Period||0
10870527|NCT04046939|12036244|FG002|NOT COMPLETED|Screening Period||0
10870528|NCT04046939|12036245|FG003|NOT COMPLETED|Screening Period||0
10870529|NCT04046939|12036242|FG000|STARTED|Primary Assessment Period||27
10870530|NCT04046939|12036243|FG001|STARTED|Primary Assessment Period||22
10870531|NCT04046939|12036244|FG002|STARTED|Primary Assessment Period||26
10870532|NCT04046939|12036245|FG003|STARTED|Primary Assessment Period||28
10870533|NCT04046939|12036242|FG000|COMPLETED|Primary Assessment Period||25
10870534|NCT04046939|12036243|FG001|COMPLETED|Primary Assessment Period||22
10870535|NCT04046939|12036244|FG002|COMPLETED|Primary Assessment Period||24
10870536|NCT04046939|12036245|FG003|COMPLETED|Primary Assessment Period||28
10870537|NCT04046939|12036242|FG000|NOT COMPLETED|Primary Assessment Period||2
10870538|NCT04046939|12036243|FG001|NOT COMPLETED|Primary Assessment Period||0
10870539|NCT04046939|12036244|FG002|NOT COMPLETED|Primary Assessment Period||2
10870540|NCT04046939|12036245|FG003|NOT COMPLETED|Primary Assessment Period||0
10870541|NCT04046939|12036242|FG000|STARTED|Eosinophil Recovery Period||25
10870542|NCT04046939|12036243|FG001|STARTED|Eosinophil Recovery Period||22
10870543|NCT04046939|12036244|FG002|STARTED|Eosinophil Recovery Period||24
10870544|NCT04046939|12036245|FG003|STARTED|Eosinophil Recovery Period||28
10870545|NCT04046939|12036242|FG000|COMPLETED|Eosinophil Recovery Period||24
10870546|NCT04046939|12036243|FG001|COMPLETED|Eosinophil Recovery Period||22
10870547|NCT04046939|12036244|FG002|COMPLETED|Eosinophil Recovery Period||24
10870548|NCT04046939|12036245|FG003|COMPLETED|Eosinophil Recovery Period||27
10870549|NCT04046939|12036242|FG000|NOT COMPLETED|Eosinophil Recovery Period||1
10870550|NCT04046939|12036243|FG001|NOT COMPLETED|Eosinophil Recovery Period||0
10870551|NCT04046939|12036244|FG002|NOT COMPLETED|Eosinophil Recovery Period||0
10870552|NCT04046939|12036245|FG003|NOT COMPLETED|Eosinophil Recovery Period||1
10870553|NCT03912259|12036263|FG000|STARTED|Overall Study||83
10870554|NCT03912259|12036264|FG001|STARTED|Overall Study||82
10870555|NCT03912259|12036263|FG000|COMPLETED|Overall Study||66
10870556|NCT03912259|12036264|FG001|COMPLETED|Overall Study||76
10870557|NCT03912259|12036263|FG000|NOT COMPLETED|Overall Study||17
10870558|NCT03912259|12036264|FG001|NOT COMPLETED|Overall Study||6
10870559|NCT03890367|12036274|FG000|STARTED|Overall Study||232
10870560|NCT03890367|12036275|FG001|STARTED|Overall Study||235
10870561|NCT03890367|12036276|FG002|STARTED|Overall Study||240
10870562|NCT03890367|12036274|FG000|Safety Analysis Set|Overall Study||230
10870563|NCT03890367|12036275|FG001|Safety Analysis Set|Overall Study||232
10870564|NCT03890367|12036276|FG002|Safety Analysis Set|Overall Study||239
10870565|NCT03890367|12036274|FG000|COMPLETED|Overall Study||228
10870566|NCT03890367|12036275|FG001|COMPLETED|Overall Study||229
10870567|NCT03890367|12036276|FG002|COMPLETED|Overall Study||239
10870568|NCT03890367|12036274|FG000|NOT COMPLETED|Overall Study||4
10870569|NCT03890367|12036275|FG001|NOT COMPLETED|Overall Study||6
10870570|NCT03890367|12036276|FG002|NOT COMPLETED|Overall Study||1
10870571|NCT03784898|12036284|FG000|STARTED|Overall Study||13
10870572|NCT03784898|12036284|FG000|COMPLETED|Overall Study||13
10870573|NCT03784898|12036284|FG000|NOT COMPLETED|Overall Study||0
10870574|NCT03607422|12036294|FG000|STARTED|Overall Study||242
10870575|NCT03607422|12036295|FG001|STARTED|Overall Study||243
10870576|NCT03607422|12036296|FG002|STARTED|Overall Study||247
10870577|NCT03607422|12036297|FG003|STARTED|Overall Study||60
10870578|NCT03607422|12036298|FG004|STARTED|Overall Study||58
10870579|NCT03607422|12036299|FG005|STARTED|Overall Study||62
10870580|NCT03607422|12036294|FG000|COMPLETED|Overall Study||204
10870581|NCT03607422|12036295|FG001|COMPLETED|Overall Study||233
10870582|NCT03607422|12036296|FG002|COMPLETED|Overall Study||235
10870583|NCT03607422|12036297|FG003|COMPLETED|Overall Study||55
10870584|NCT03607422|12036298|FG004|COMPLETED|Overall Study||55
10870585|NCT03607422|12036299|FG005|COMPLETED|Overall Study||59
10870586|NCT03607422|12036294|FG000|NOT COMPLETED|Overall Study||38
10870587|NCT03607422|12036295|FG001|NOT COMPLETED|Overall Study||10
10870588|NCT03607422|12036296|FG002|NOT COMPLETED|Overall Study||12
10870589|NCT03607422|12036297|FG003|NOT COMPLETED|Overall Study||5
10870590|NCT03607422|12036298|FG004|NOT COMPLETED|Overall Study||3
10870591|NCT03607422|12036299|FG005|NOT COMPLETED|Overall Study||3
10870592|NCT03600805|12036317|FG000|STARTED|Overall Study||28
10870593|NCT03600805|12036318|FG001|STARTED|Overall Study||14
10870594|NCT03600805|12036319|FG002|STARTED|Overall Study||14
10870595|NCT03600805|12036320|FG003|STARTED|Overall Study||27
10870596|NCT03600805|12036317|FG000|Week 52 Analysis Set Population|Overall Study||10
10870597|NCT03600805|12036318|FG001|Week 52 Analysis Set Population|Overall Study||6
10870598|NCT03600805|12036319|FG002|Week 52 Analysis Set Population|Overall Study||7
10870599|NCT03600805|12036320|FG003|Week 52 Analysis Set Population|Overall Study||13
10870600|NCT03600805|12036317|FG000|COMPLETED|Overall Study||9
10870601|NCT03600805|12036318|FG001|COMPLETED|Overall Study||6
10870602|NCT03600805|12036319|FG002|COMPLETED|Overall Study||6
10870603|NCT03600805|12036320|FG003|COMPLETED|Overall Study||8
10870604|NCT03600805|12036317|FG000|NOT COMPLETED|Overall Study||19
10870605|NCT03600805|12036318|FG001|NOT COMPLETED|Overall Study||8
10870606|NCT03600805|12036319|FG002|NOT COMPLETED|Overall Study||8
10870607|NCT03600805|12036320|FG003|NOT COMPLETED|Overall Study||19
10870608|NCT03584724|12036334|FG000|STARTED|Overall Study||25
10870609|NCT03584724|12036335|FG001|STARTED|Overall Study||24
10870610|NCT03584724|12036334|FG000|COMPLETED|Overall Study||18
10870611|NCT03584724|12036335|FG001|COMPLETED|Overall Study||23
10870612|NCT03584724|12036334|FG000|NOT COMPLETED|Overall Study||7
10870613|NCT03584724|12036335|FG001|NOT COMPLETED|Overall Study||1
10870614|NCT03434119|12036343|FG000|STARTED|Overall Study||116
10870615|NCT03434119|12036344|FG001|STARTED|Overall Study||125
10870616|NCT03434119|12036343|FG000|Treated|Overall Study||115
10870617|NCT03434119|12036344|FG001|Treated|Overall Study||125
10870618|NCT03434119|12036343|FG000|COMPLETED|Overall Study||9
10870619|NCT03434119|12036344|FG001|COMPLETED|Overall Study||12
10870620|NCT03434119|12036343|FG000|NOT COMPLETED|Overall Study||107
10870621|NCT03434119|12036344|FG001|NOT COMPLETED|Overall Study||113
10870622|NCT03417245|12036352|FG000|STARTED|Overall Study||40
10870623|NCT03417245|12036353|FG001|STARTED|Overall Study||80
10870624|NCT03417245|12036352|FG000|Treated|Overall Study||40
10870625|NCT03417245|12036353|FG001|Treated|Overall Study||79
10870626|NCT03417245|12036352|FG000|COMPLETED|Overall Study||37
10870627|NCT03417245|12036353|FG001|COMPLETED|Overall Study||79
10870628|NCT03417245|12036352|FG000|NOT COMPLETED|Overall Study||3
10870629|NCT03417245|12036353|FG001|NOT COMPLETED|Overall Study||1
10870630|NCT03417102|12036361|FG000|STARTED|Overall Study||19
10870631|NCT03417102|12036362|FG001|STARTED|Overall Study||38
10870632|NCT03417102|12036361|FG000|Safety Analysis Set|Overall Study||19
10870633|NCT03417102|12036362|FG001|Safety Analysis Set|Overall Study|3 participants were non-randomized but treated with Fitusiran considered in this arm for safety.|41
10870634|NCT03417102|12036361|FG000|COMPLETED|Overall Study||19
10870635|NCT03417102|12036362|FG001|COMPLETED|Overall Study||33
10870636|NCT03417102|12036361|FG000|NOT COMPLETED|Overall Study||0
10870637|NCT03417102|12036362|FG001|NOT COMPLETED|Overall Study||5
10870638|NCT03278626|12036368|FG000|STARTED|Overall Study||12
10870639|NCT03278626|12036368|FG000|COMPLETED|Overall Study||7
10870640|NCT03278626|12036368|FG000|NOT COMPLETED|Overall Study||5
10870641|NCT03211858|12036374|FG000|STARTED|Overall Study||301
10870642|NCT03211858|12036375|FG001|STARTED|Overall Study||296
10870643|NCT03211858|12036374|FG000|Treated|Overall Study||301
10870644|NCT03211858|12036375|FG001|Treated|Overall Study||296
10870645|NCT03211858|12036374|FG000|COMPLETED|Overall Study||264
10870646|NCT03211858|12036375|FG001|COMPLETED|Overall Study||263
10870647|NCT03211858|12036374|FG000|NOT COMPLETED|Overall Study||37
10870648|NCT03211858|12036375|FG001|NOT COMPLETED|Overall Study||33
10870649|NCT03093480|12036385|FG000|STARTED|Overall Study||16
10870650|NCT03093480|12036385|FG000|Tapering Period|Overall Study||10
10870651|NCT03093480|12036385|FG000|Follow-up Period|Overall Study||10
10870652|NCT03093480|12036385|FG000|COMPLETED|Overall Study||16
10870653|NCT03093480|12036385|FG000|NOT COMPLETED|Overall Study||0
10870654|NCT03077438|12036391|FG000|STARTED|Overall Study||499
10870655|NCT03077438|12036392|FG001|STARTED|Overall Study||501
10870656|NCT03077438|12036391|FG000|Safety Analysis Set (SafAS)|Overall Study||498
10870657|NCT03077438|12036392|FG001|Safety Analysis Set (SafAS)|Overall Study||494
10870658|NCT03077438|12036391|FG000|COMPLETED|Overall Study||487
10870659|NCT03077438|12036392|FG001|COMPLETED|Overall Study||487
10870660|NCT03077438|12036391|FG000|NOT COMPLETED|Overall Study||12
10870661|NCT03077438|12036392|FG001|NOT COMPLETED|Overall Study||14
10870662|NCT03045653|12036402|FG000|STARTED|Overall Study||30
10870663|NCT03045653|12036402|FG000|COMPLETED|Overall Study||30
10870664|NCT03045653|12036402|FG000|NOT COMPLETED|Overall Study||0
10870665|NCT02948959|12036408|FG000|STARTED|52 Weeks Treatment Period||135
10870666|NCT02948959|12036409|FG001|STARTED|52 Weeks Treatment Period||273
10870667|NCT02948959|12036408|FG000|Treated|52 Weeks Treatment Period||135
10870668|NCT02948959|12036409|FG001|Treated|52 Weeks Treatment Period||270
10870669|NCT02948959|12036408|FG000|Safety Population|52 Weeks Treatment Period|1 participant randomized to placebo received dupilumab; counted in dupilumab arm for safety analysis.|134
10870670|NCT02948959|12036409|FG001|Safety Population|52 Weeks Treatment Period|1 participant randomized to placebo received dupilumab; counted in dupilumab arm for safety analysis.|271
10870671|NCT02948959|12036408|FG000|Type 2 Inflammatory Asthma Phenotype Population|52 Weeks Treatment Period||114
10870672|NCT02948959|12036409|FG001|Type 2 Inflammatory Asthma Phenotype Population|52 Weeks Treatment Period||236
10870673|NCT02948959|12036408|FG000|Baseline Blood Eosinophils Count >=300 Cells Per Microlitre Population|52 Weeks Treatment Period||84
10870674|NCT02948959|12036409|FG001|Baseline Blood Eosinophils Count >=300 Cells Per Microlitre Population|52 Weeks Treatment Period||175
10870675|NCT02948959|12036408|FG000|COMPLETED|52 Weeks Treatment Period||130
10870676|NCT02948959|12036409|FG001|COMPLETED|52 Weeks Treatment Period||248
10870677|NCT02948959|12036408|FG000|NOT COMPLETED|52 Weeks Treatment Period||5
10870678|NCT02948959|12036409|FG001|NOT COMPLETED|52 Weeks Treatment Period||25
10870679|NCT02948959|12036408|FG000|STARTED|12 Weeks Follow-up Period||9
10870680|NCT02948959|12036409|FG001|STARTED|12 Weeks Follow-up Period||31
10870681|NCT02948959|12036408|FG000|COMPLETED|12 Weeks Follow-up Period||4
10870682|NCT02948959|12036409|FG001|COMPLETED|12 Weeks Follow-up Period||19
10870683|NCT02948959|12036408|FG000|NOT COMPLETED|12 Weeks Follow-up Period||5
10870684|NCT02948959|12036409|FG001|NOT COMPLETED|12 Weeks Follow-up Period||12
10870685|NCT02878603|12036425|FG000|STARTED|Overall Study||29
10870686|NCT02878603|12036426|FG001|STARTED|Overall Study||75
10870687|NCT02878603|12036425|FG000|COMPLETED|Overall Study||23
10870688|NCT02878603|12036426|FG001|COMPLETED|Overall Study||70
10870689|NCT02878603|12036425|FG000|NOT COMPLETED|Overall Study||6
10870690|NCT02878603|12036426|FG001|NOT COMPLETED|Overall Study||5
10870691|NCT02864407|12036432|FG000|STARTED|Overall Study||3223
10870692|NCT02864407|12036432|FG000|Effectiveness Analysis Set|Overall Study||2105
10870693|NCT02864407|12036432|FG000|Long-term Safety Analysis Set|Overall Study||813
10870694|NCT02864407|12036432|FG000|Long-term Effectiveness Analysis Set|Overall Study||767
10870695|NCT02864407|12036432|FG000|COMPLETED|Overall Study||3100
10870696|NCT02864407|12036432|FG000|NOT COMPLETED|Overall Study||123
10870697|NCT02846532|12036439|FG000|STARTED|Overall Study||12
10870698|NCT02846532|12036440|FG001|STARTED|Overall Study||66
10870699|NCT02846532|12036441|FG002|STARTED|Overall Study||34
10870700|NCT02846532|12036439|FG000|COMPLETED|Overall Study||11
10870701|NCT02846532|12036440|FG001|COMPLETED|Overall Study||63
10870702|NCT02846532|12036441|FG002|COMPLETED|Overall Study||33
10870703|NCT02846532|12036439|FG000|NOT COMPLETED|Overall Study||1
10870704|NCT02846532|12036440|FG001|NOT COMPLETED|Overall Study||3
10870705|NCT02846532|12036441|FG002|NOT COMPLETED|Overall Study||1
10870706|NCT02688933|12036451|FG000|STARTED|Overall Study||320
10870707|NCT02688933|12036452|FG001|STARTED|Overall Study||318
10870708|NCT02688933|12036451|FG000|COMPLETED|Overall Study||291
10870709|NCT02688933|12036452|FG001|COMPLETED|Overall Study||281
10870710|NCT02688933|12036451|FG000|NOT COMPLETED|Overall Study||29
10870711|NCT02688933|12036452|FG001|NOT COMPLETED|Overall Study||37
10870712|NCT02550197|12036460|FG000|STARTED|Overall Study||200
10870713|NCT02550197|12036461|FG001|STARTED|Overall Study||100
10870714|NCT02550197|12036460|FG000|COMPLETED|Overall Study||200
10870715|NCT02550197|12036461|FG001|COMPLETED|Overall Study||100
10870716|NCT02550197|12036460|FG000|NOT COMPLETED|Overall Study||0
10870717|NCT02550197|12036461|FG001|NOT COMPLETED|Overall Study||0
10870718|NCT02492165|12036471|FG000|STARTED|Overall Study||100
10870719|NCT02492165|12036472|FG001|STARTED|Overall Study||60
10870720|NCT02492165|12036473|FG002|STARTED|Overall Study||60
10870721|NCT02492165|12036474|FG003|STARTED|Overall Study||30
10870722|NCT02492165|12036471|FG000|COMPLETED|Overall Study||100
10870723|NCT02492165|12036472|FG001|COMPLETED|Overall Study||59
10870724|NCT02492165|12036473|FG002|COMPLETED|Overall Study||60
10870725|NCT02492165|12036474|FG003|COMPLETED|Overall Study||30
10870726|NCT02492165|12036471|FG000|NOT COMPLETED|Overall Study||0
10870727|NCT02492165|12036472|FG001|NOT COMPLETED|Overall Study||1
10870728|NCT02492165|12036473|FG002|NOT COMPLETED|Overall Study||0
10870729|NCT02492165|12036474|FG003|NOT COMPLETED|Overall Study||0
10870730|NCT02476006|12036484|FG000|STARTED|Overall Study||998
10870731|NCT02476006|12036484|FG000|Treated|Overall Study||994
10870732|NCT02476006|12036484|FG000|COMPLETED|Overall Study||878
10870733|NCT02476006|12036484|FG000|NOT COMPLETED|Overall Study||120
10870734|NCT02468414|12036490|FG000|STARTED|Overall Study||3
10870735|NCT02468414|12036491|FG001|STARTED|Overall Study||0
10870736|NCT02468414|12036490|FG000|Successfully Screened|Overall Study||2
10870737|NCT02468414|12036491|FG001|Successfully Screened|Overall Study||0
10295388|NCT03225833|11428045|FG002|Multiple Dose Period Only|Overall Study||0
10295389|NCT03225833|11428046|FG003|Multiple Dose Period Only|Overall Study||0
10295390|NCT03225833|11428047|FG004|Multiple Dose Period Only|Overall Study||0
10295391|NCT03225833|11428048|FG005|Multiple Dose Period Only|Overall Study||1
10295392|NCT03225833|11428043|FG000|Single Dose and Multiple Dose Periods|Overall Study||15
10295393|NCT03225833|11428044|FG001|Single Dose and Multiple Dose Periods|Overall Study||8
10295394|NCT03225833|11428045|FG002|Single Dose and Multiple Dose Periods|Overall Study||7
10295395|NCT03225833|11428046|FG003|Single Dose and Multiple Dose Periods|Overall Study||9
10295396|NCT03225833|11428047|FG004|Single Dose and Multiple Dose Periods|Overall Study||8
10870738|NCT02468414|12036490|FG000|Harvesting|Overall Study||1
10870739|NCT02468414|12036491|FG001|Harvesting|Overall Study||0
10870740|NCT02468414|12036490|FG000|Implantation|Overall Study||1
10870741|NCT02468414|12036491|FG001|Implantation|Overall Study||0
10870742|NCT02468414|12036490|FG000|Safety Follow-up|Overall Study||0
10870743|NCT02468414|12036491|FG001|Safety Follow-up|Overall Study||0
10870744|NCT02468414|12036490|FG000|COMPLETED|Overall Study||0
10870745|NCT02468414|12036491|FG001|COMPLETED|Overall Study||0
10870746|NCT02468414|12036490|FG000|NOT COMPLETED|Overall Study||3
10870747|NCT02468414|12036491|FG001|NOT COMPLETED|Overall Study||0
10870748|NCT02462876|12036497|FG000|STARTED|Overall Study||60
10870749|NCT02462876|12036497|FG000|COMPLETED|Overall Study||33
10870750|NCT02462876|12036497|FG000|NOT COMPLETED|Overall Study||27
10870751|NCT02332590|12036503|FG000|STARTED|DB Period (up to 24 Weeks)||185
10870752|NCT02332590|12036504|FG001|STARTED|DB Period (up to 24 Weeks)||184
10870753|NCT02332590|12036503|FG000|Treated|DB Period (up to 24 Weeks)||184
10870754|NCT02332590|12036504|FG001|Treated|DB Period (up to 24 Weeks)||184
10870755|NCT02332590|12036503|FG000|COMPLETED|DB Period (up to 24 Weeks)|155 participants entered OLE period and 1 did not enroll.|156
10870756|NCT02332590|12036504|FG001|COMPLETED|DB Period (up to 24 Weeks)||165
10870757|NCT02332590|12036503|FG000|NOT COMPLETED|DB Period (up to 24 Weeks)||29
10870758|NCT02332590|12036504|FG001|NOT COMPLETED|DB Period (up to 24 Weeks)||19
10870759|NCT02332590|12036503|FG000|STARTED|OLE Period (Week 24 up to Week 300)||155
10870760|NCT02332590|12036504|FG001|STARTED|OLE Period (Week 24 up to Week 300)||165
10870761|NCT02332590|12036503|FG000|COMPLETED|OLE Period (Week 24 up to Week 300)||108
10870762|NCT02332590|12036504|FG001|COMPLETED|OLE Period (Week 24 up to Week 300)||120
10870763|NCT02332590|12036503|FG000|NOT COMPLETED|OLE Period (Week 24 up to Week 300)||47
10870764|NCT02332590|12036504|FG001|NOT COMPLETED|OLE Period (Week 24 up to Week 300)||45
10870765|NCT02255656|12036512|FG000|STARTED|Overall Study||1062
10870766|NCT02255656|12036512|FG000|COMPLETED|Overall Study||592
10870767|NCT02255656|12036512|FG000|NOT COMPLETED|Overall Study||470
10870768|NCT02134028|12036531|FG000|STARTED|Overall Study||111
10870769|NCT02134028|12036532|FG001|STARTED|Overall Study||421
10870770|NCT02134028|12036533|FG002|STARTED|Overall Study||517
10870771|NCT02134028|12036534|FG003|STARTED|Overall Study||1013
10870772|NCT02134028|12036535|FG004|STARTED|Overall Study||97
10870773|NCT02134028|12036536|FG005|STARTED|Overall Study||90
10870774|NCT02134028|12036537|FG006|STARTED|Overall Study||19
10870775|NCT02134028|12036538|FG007|STARTED|Overall Study||14
10870776|NCT02134028|12036531|FG000|COMPLETED|Overall Study||102
10870777|NCT02134028|12036532|FG001|COMPLETED|Overall Study||379
10870778|NCT02134028|12036533|FG002|COMPLETED|Overall Study||465
10870779|NCT02134028|12036534|FG003|COMPLETED|Overall Study||908
10870780|NCT02134028|12036535|FG004|COMPLETED|Overall Study||83
10870781|NCT02134028|12036536|FG005|COMPLETED|Overall Study||76
10870782|NCT02134028|12036537|FG006|COMPLETED|Overall Study||15
10870783|NCT02134028|12036538|FG007|COMPLETED|Overall Study||11
10870784|NCT02134028|12036531|FG000|NOT COMPLETED|Overall Study||9
10870785|NCT02134028|12036532|FG001|NOT COMPLETED|Overall Study||42
10870786|NCT02134028|12036533|FG002|NOT COMPLETED|Overall Study||52
10870787|NCT02134028|12036534|FG003|NOT COMPLETED|Overall Study||105
10870788|NCT02134028|12036535|FG004|NOT COMPLETED|Overall Study||14
10870789|NCT02134028|12036536|FG005|NOT COMPLETED|Overall Study||14
10870790|NCT02134028|12036537|FG006|NOT COMPLETED|Overall Study||4
10870791|NCT02134028|12036538|FG007|NOT COMPLETED|Overall Study||3
10870792|NCT02037620|12036558|FG000|STARTED|Overall Study||5
10870793|NCT02037620|12036558|FG000|COMPLETED|Overall Study||4
10870794|NCT02037620|12036558|FG000|NOT COMPLETED|Overall Study||1
10870795|NCT01900444|12036562|FG000|STARTED|Overall Study||119
10870796|NCT01900444|12036562|FG000|COMPLETED|Overall Study||116
10870797|NCT01900444|12036562|FG000|NOT COMPLETED|Overall Study||3
10870798|NCT01887912|12036568|FG000|STARTED|Overall Study||6201
10870799|NCT01887912|12036569|FG001|STARTED|Overall Study||3101
10870800|NCT01887912|12036568|FG000|Safety Population|Overall Study||6113
10870801|NCT01887912|12036569|FG001|Safety Population|Overall Study||3057
10870802|NCT01887912|12036568|FG000|COMPLETED|Overall Study||4809
10870803|NCT01887912|12036569|FG001|COMPLETED|Overall Study||2370
10870804|NCT01887912|12036568|FG000|NOT COMPLETED|Overall Study||1392
10870805|NCT01887912|12036569|FG001|NOT COMPLETED|Overall Study||731
10870806|NCT01751126|12036578|FG000|STARTED|Period I||57
10870807|NCT01751126|12036579|FG001|STARTED|Period I||54
10870808|NCT01751126|12036580|FG002|STARTED|Period I||58
10870809|NCT01751126|12036578|FG000|COMPLETED|Period I||51
10870810|NCT01751126|12036579|FG001|COMPLETED|Period I||43
10870811|NCT01751126|12036580|FG002|COMPLETED|Period I||49
10870812|NCT01751126|12036578|FG000|NOT COMPLETED|Period I||6
10870813|NCT01751126|12036579|FG001|NOT COMPLETED|Period I||11
10870814|NCT01751126|12036580|FG002|NOT COMPLETED|Period I||9
10870815|NCT01751126|12036578|FG000|STARTED|Period II||72
10870816|NCT01751126|12036579|FG001|STARTED|Period II||70
10870817|NCT01751126|12036580|FG002|STARTED|Period II|Following completion of the first period of the trial, all patients were to be administered NOVA22007 (High or Low dose) for a safety 8-month follow-up period.|0
10870818|NCT01751126|12036578|FG000|COMPLETED|Period II||72
10870819|NCT01751126|12036579|FG001|COMPLETED|Period II||70
10870820|NCT01751126|12036580|FG002|COMPLETED|Period II||0
10870821|NCT01751126|12036578|FG000|NOT COMPLETED|Period II||0
10870822|NCT01751126|12036579|FG001|NOT COMPLETED|Period II||0
10870823|NCT01751126|12036580|FG002|NOT COMPLETED|Period II||0
10870824|NCT01437423|12036602|FG000|STARTED|Overall Study||662
10870825|NCT01437423|12036602|FG000|COMPLETED|Overall Study||647
10870826|NCT01437423|12036602|FG000|NOT COMPLETED|Overall Study||15
10870827|NCT01410890|12036608|FG000|STARTED|Overall Study||10
10870828|NCT01410890|12036609|FG001|STARTED|Overall Study||11
10870829|NCT01410890|12036608|FG000|Treated|Overall Study||10
10870830|NCT01410890|12036609|FG001|Treated|Overall Study||10
10870831|NCT01410890|12036608|FG000|COMPLETED|Overall Study||10
10870832|NCT01410890|12036609|FG001|COMPLETED|Overall Study||10
10870833|NCT01410890|12036608|FG000|NOT COMPLETED|Overall Study||0
10870834|NCT01410890|12036609|FG001|NOT COMPLETED|Overall Study||1
10870835|NCT01190228|12036620|FG000|STARTED|Overall Study||349
10870836|NCT01190228|12036621|FG001|STARTED|Overall Study||46
10870837|NCT01190228|12036622|FG002|STARTED|Overall Study||59
10870838|NCT01190228|12036620|FG000|COMPLETED|Overall Study||344
10870839|NCT01190228|12036621|FG001|COMPLETED|Overall Study||46
10870840|NCT01190228|12036622|FG002|COMPLETED|Overall Study||59
10870841|NCT01190228|12036620|FG000|NOT COMPLETED|Overall Study||5
10870842|NCT01190228|12036621|FG001|NOT COMPLETED|Overall Study||0
10870843|NCT01190228|12036622|FG002|NOT COMPLETED|Overall Study||0
10870844|NCT01146652|12036634|FG000|STARTED|Overall Study||1912
10870845|NCT01146652|12036635|FG001|STARTED|Overall Study||111
10870846|NCT01146652|12036634|FG000|Treated|Overall Study||1910
10870847|NCT01146652|12036635|FG001|Treated|Overall Study||111
10870848|NCT01146652|12036634|FG000|Enrolled in the Sub-study|Overall Study||110
10870849|NCT01146652|12036635|FG001|Enrolled in the Sub-study|Overall Study||14
10870850|NCT01146652|12036634|FG000|Discontinued From the Sub-study|Overall Study||1
10870851|NCT01146652|12036635|FG001|Discontinued From the Sub-study|Overall Study||2
10870852|NCT01146652|12036634|FG000|Switched Back to Main Study|Overall Study||108
10870853|NCT01146652|12036635|FG001|Switched Back to Main Study|Overall Study||13
10870854|NCT01146652|12036634|FG000|COMPLETED|Overall Study||961
10870855|NCT01146652|12036635|FG001|COMPLETED|Overall Study||66
10870856|NCT01146652|12036634|FG000|NOT COMPLETED|Overall Study||951
10870857|NCT01146652|12036635|FG001|NOT COMPLETED|Overall Study||45
10870858|NCT01049035|12036655|FG000|STARTED|Overall Study||107
10870859|NCT01049035|12036656|FG001|STARTED|Overall Study||108
10870860|NCT01049035|12036657|FG002|STARTED|Overall Study||107
10870861|NCT01049035|12036658|FG003|STARTED|Overall Study||75
10870862|NCT01049035|12036659|FG004|STARTED|Overall Study||75
10870863|NCT01049035|12036660|FG005|STARTED|Overall Study||54
10870864|NCT01049035|12036661|FG006|STARTED|Overall Study||54
10870865|NCT01049035|12036655|FG000|Safety Population|Overall Study||104
10870866|NCT01049035|12036656|FG001|Safety Population|Overall Study||102
10870867|NCT01049035|12036657|FG002|Safety Population|Overall Study||100
10870868|NCT01049035|12036658|FG003|Safety Population|Overall Study||74
10870869|NCT01049035|12036659|FG004|Safety Population|Overall Study||70
10870870|NCT01049035|12036660|FG005|Safety Population|Overall Study||52
10870871|NCT01049035|12036661|FG006|Safety Population|Overall Study||49
10870872|NCT01049035|12036655|FG000|COMPLETED|Overall Study||74
10870873|NCT01049035|12036656|FG001|COMPLETED|Overall Study||87
10870874|NCT01049035|12036657|FG002|COMPLETED|Overall Study||80
10870875|NCT01049035|12036658|FG003|COMPLETED|Overall Study||64
10870876|NCT01049035|12036659|FG004|COMPLETED|Overall Study||71
10870877|NCT01049035|12036660|FG005|COMPLETED|Overall Study||42
10870878|NCT01049035|12036661|FG006|COMPLETED|Overall Study||39
10870879|NCT01049035|12036655|FG000|NOT COMPLETED|Overall Study||33
10870880|NCT01049035|12036656|FG001|NOT COMPLETED|Overall Study||21
10870881|NCT01049035|12036657|FG002|NOT COMPLETED|Overall Study||27
10870882|NCT01049035|12036658|FG003|NOT COMPLETED|Overall Study||11
10870883|NCT01049035|12036659|FG004|NOT COMPLETED|Overall Study||4
10870884|NCT01049035|12036660|FG005|NOT COMPLETED|Overall Study||12
10870885|NCT01049035|12036661|FG006|NOT COMPLETED|Overall Study||15
10870898|NCT00727090|12036693|FG000|STARTED|Overall Study||3
10870899|NCT00727090|12036694|FG001|STARTED|Overall Study||3
10870900|NCT00727090|12036693|FG000|COMPLETED|Overall Study||3
10870901|NCT00727090|12036694|FG001|COMPLETED|Overall Study||3
10870902|NCT00727090|12036693|FG000|NOT COMPLETED|Overall Study||0
10870903|NCT00727090|12036694|FG001|NOT COMPLETED|Overall Study||0
10870904|NCT00726063|12036704|FG000|STARTED|Overall Study|Number of implants= 239|122
10870905|NCT00726063|12036705|FG001|STARTED|Overall Study|Number of implants= 246|119
10870906|NCT00726063|12036704|FG000|COMPLETED|Overall Study|Number of implants =230|113
10870907|NCT00726063|12036705|FG001|COMPLETED|Overall Study|Number of implants = 239|112
10870908|NCT00726063|12036704|FG000|NOT COMPLETED|Overall Study||9
10870909|NCT00726063|12036705|FG001|NOT COMPLETED|Overall Study||7
10870916|NCT00713206|12036722|FG000|STARTED|Overall Study||65
10870917|NCT00713206|12036723|FG001|STARTED|Overall Study||57
10870918|NCT00713206|12036722|FG000|COMPLETED|Overall Study||60
10870919|NCT00713206|12036723|FG001|COMPLETED|Overall Study||53
10870920|NCT00713206|12036722|FG000|NOT COMPLETED|Overall Study||5
10870921|NCT00713206|12036723|FG001|NOT COMPLETED|Overall Study||4
10419007|NCT00808340|11563805|FG000|STARTED|Second Intervention||4
10419008|NCT00808340|11563806|FG001|STARTED|Second Intervention||9
10419009|NCT00808340|11563807|FG002|STARTED|Second Intervention||7
10419010|NCT00808340|11563808|FG003|STARTED|Second Intervention||3
10419011|NCT00808340|11563809|FG004|STARTED|Second Intervention||5
10419012|NCT00808340|11563810|FG005|STARTED|Second Intervention||6
10419013|NCT00808340|11563805|FG000|COMPLETED|Second Intervention||4
10419014|NCT00808340|11563806|FG001|COMPLETED|Second Intervention||9
10419015|NCT00808340|11563807|FG002|COMPLETED|Second Intervention||7
10870922|NCT04654351|12036729|FG000|STARTED|Overall Study||2
10870923|NCT04654351|12036729|FG000|COMPLETED|Overall Study||2
10870924|NCT04654351|12036729|FG000|NOT COMPLETED|Overall Study||0
10870925|NCT04422990|12036736|FG000|STARTED|Overall Study||50
10870926|NCT04422990|12036737|FG001|STARTED|Overall Study||97
10870927|NCT04422990|12036736|FG000|COMPLETED|Overall Study||47
10870928|NCT04422990|12036737|FG001|COMPLETED|Overall Study||96
10870929|NCT04422990|12036736|FG000|NOT COMPLETED|Overall Study||3
10870930|NCT04422990|12036737|FG001|NOT COMPLETED|Overall Study||1
10870931|NCT04388319|12036746|FG000|STARTED|Enrolled in Study||26
10870932|NCT04388319|12036746|FG000|COMPLETED|Enrolled in Study||24
10870933|NCT04388319|12036746|FG000|NOT COMPLETED|Enrolled in Study||2
10870934|NCT04388319|12036746|FG000|STARTED|Treatment Period||24
10870935|NCT04388319|12036746|FG000|COMPLETED|Treatment Period||23
10870936|NCT04388319|12036746|FG000|NOT COMPLETED|Treatment Period||1
10870937|NCT04358549|12036752|FG000|STARTED|Overall Study||25
10870938|NCT04358549|12036753|FG001|STARTED|Overall Study||25
10870939|NCT04358549|12036752|FG000|ITT Population (Randomized Subjects)|Overall Study||25
10870940|NCT04358549|12036753|FG001|ITT Population (Randomized Subjects)|Overall Study||25
10295397|NCT03225833|11428048|FG005|Single Dose and Multiple Dose Periods|Overall Study||5
10295398|NCT03225833|11428043|FG000|COMPLETED|Overall Study||11
10295399|NCT03225833|11428044|FG001|COMPLETED|Overall Study||8
10295400|NCT03225833|11428045|FG002|COMPLETED|Overall Study||7
10295401|NCT03225833|11428046|FG003|COMPLETED|Overall Study||9
10295402|NCT03225833|11428047|FG004|COMPLETED|Overall Study||7
10295403|NCT03225833|11428048|FG005|COMPLETED|Overall Study||0
10295404|NCT03225833|11428043|FG000|NOT COMPLETED|Overall Study||5
10295405|NCT03225833|11428044|FG001|NOT COMPLETED|Overall Study||1
10295406|NCT03225833|11428045|FG002|NOT COMPLETED|Overall Study||2
10295407|NCT03225833|11428046|FG003|NOT COMPLETED|Overall Study||0
10295408|NCT03225833|11428047|FG004|NOT COMPLETED|Overall Study||1
10295409|NCT03225833|11428048|FG005|NOT COMPLETED|Overall Study||10
10295410|NCT03167242|11428079|FG000|STARTED|Overall Study||12
10295411|NCT03167242|11428080|FG001|STARTED|Overall Study||51
10295412|NCT03167242|11428081|FG002|STARTED|Overall Study||51
10295413|NCT03167242|11428082|FG003|STARTED|Overall Study||51
10295414|NCT03167242|11428083|FG004|STARTED|Overall Study||54
10295415|NCT03167242|11428084|FG005|STARTED|Overall Study||51
10295416|NCT03167242|11428085|FG006|STARTED|Overall Study||52
10295417|NCT03167242|11428086|FG007|STARTED|Overall Study||27
10295418|NCT03167242|11428087|FG008|STARTED|Overall Study||53
10295419|NCT03167242|11428088|FG009|STARTED|Overall Study||53
10295420|NCT03167242|11428089|FG010|STARTED|Overall Study||45
10295421|NCT03167242|11428090|FG011|STARTED|Overall Study||24
10295422|NCT03167242|11428079|FG000|Full Analysis Set (FAS)|Overall Study||12
10295423|NCT03167242|11428080|FG001|Full Analysis Set (FAS)|Overall Study||51
10295424|NCT03167242|11428081|FG002|Full Analysis Set (FAS)|Overall Study||51
10295425|NCT03167242|11428082|FG003|Full Analysis Set (FAS)|Overall Study||51
10295426|NCT03167242|11428083|FG004|Full Analysis Set (FAS)|Overall Study||54
10295427|NCT03167242|11428084|FG005|Full Analysis Set (FAS)|Overall Study||51
10295428|NCT03167242|11428085|FG006|Full Analysis Set (FAS)|Overall Study||52
10295429|NCT03167242|11428086|FG007|Full Analysis Set (FAS)|Overall Study||27
10295430|NCT03167242|11428087|FG008|Full Analysis Set (FAS)|Overall Study||52
10295431|NCT03167242|11428088|FG009|Full Analysis Set (FAS)|Overall Study||53
10295432|NCT03167242|11428089|FG010|Full Analysis Set (FAS)|Overall Study||45
10295433|NCT03167242|11428090|FG011|Full Analysis Set (FAS)|Overall Study||24
10295434|NCT03167242|11428079|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study||12
10295435|NCT03167242|11428080|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study||47
10295436|NCT03167242|11428081|FG002|Pharmacokinetics (PK) Analysis Set|Overall Study||51
10295437|NCT03167242|11428082|FG003|Pharmacokinetics (PK) Analysis Set|Overall Study||46
10295438|NCT03167242|11428083|FG004|Pharmacokinetics (PK) Analysis Set|Overall Study||48
10295439|NCT03167242|11428084|FG005|Pharmacokinetics (PK) Analysis Set|Overall Study||46
10295440|NCT03167242|11428085|FG006|Pharmacokinetics (PK) Analysis Set|Overall Study||45
10295441|NCT03167242|11428086|FG007|Pharmacokinetics (PK) Analysis Set|Overall Study||24
10295442|NCT03167242|11428087|FG008|Pharmacokinetics (PK) Analysis Set|Overall Study||48
10295443|NCT03167242|11428088|FG009|Pharmacokinetics (PK) Analysis Set|Overall Study||46
10295444|NCT03167242|11428089|FG010|Pharmacokinetics (PK) Analysis Set|Overall Study||41
10295445|NCT03167242|11428090|FG011|Pharmacokinetics (PK) Analysis Set|Overall Study||24
10295446|NCT03167242|11428079|FG000|Per-Protocol Set (PPS)|Overall Study||12
10295447|NCT03167242|11428080|FG001|Per-Protocol Set (PPS)|Overall Study||50
10295448|NCT03167242|11428081|FG002|Per-Protocol Set (PPS)|Overall Study||48
10295449|NCT03167242|11428082|FG003|Per-Protocol Set (PPS)|Overall Study||48
10295450|NCT03167242|11428083|FG004|Per-Protocol Set (PPS)|Overall Study||47
10295451|NCT03167242|11428084|FG005|Per-Protocol Set (PPS)|Overall Study||44
10295452|NCT03167242|11428085|FG006|Per-Protocol Set (PPS)|Overall Study||43
10419016|NCT00808340|11563808|FG003|COMPLETED|Second Intervention||3
10295453|NCT03167242|11428086|FG007|Per-Protocol Set (PPS)|Overall Study||25
10295454|NCT03167242|11428087|FG008|Per-Protocol Set (PPS)|Overall Study||48
10295455|NCT03167242|11428088|FG009|Per-Protocol Set (PPS)|Overall Study||46
10295456|NCT03167242|11428089|FG010|Per-Protocol Set (PPS)|Overall Study||40
10295457|NCT03167242|11428090|FG011|Per-Protocol Set (PPS)|Overall Study||22
10419017|NCT00808340|11563809|FG004|COMPLETED|Second Intervention||5
10419018|NCT00808340|11563810|FG005|COMPLETED|Second Intervention||6
10419019|NCT00808340|11563805|FG000|NOT COMPLETED|Second Intervention||0
10870941|NCT04358549|12036752|FG000|Safety Population (Patients Who Received Either Favipiravir + SOC or SOC Alone)|Overall Study||24
10870942|NCT04358549|12036753|FG001|Safety Population (Patients Who Received Either Favipiravir + SOC or SOC Alone)|Overall Study||25
10870943|NCT04358549|12036752|FG000|COMPLETED|Overall Study||15
10870944|NCT04358549|12036753|FG001|COMPLETED|Overall Study||17
10870945|NCT04358549|12036752|FG000|NOT COMPLETED|Overall Study||10
10870946|NCT04358549|12036753|FG001|NOT COMPLETED|Overall Study||8
10295458|NCT03167242|11428079|FG000|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||12
10295459|NCT03167242|11428080|FG001|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||5
10295460|NCT03167242|11428081|FG002|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||6
10295461|NCT03167242|11428082|FG003|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||6
10295462|NCT03167242|11428083|FG004|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||6
10295463|NCT03167242|11428084|FG005|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||12
10295464|NCT03167242|11428085|FG006|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||5
10295465|NCT03167242|11428086|FG007|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||0
10295466|NCT03167242|11428087|FG008|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||0
10295467|NCT03167242|11428088|FG009|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||0
10295468|NCT03167242|11428089|FG010|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||0
10295469|NCT03167242|11428090|FG011|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||0
10295470|NCT03167242|11428079|FG000|COMPLETED|Overall Study||12
10295471|NCT03167242|11428080|FG001|COMPLETED|Overall Study||50
10295472|NCT03167242|11428081|FG002|COMPLETED|Overall Study||48
10295473|NCT03167242|11428082|FG003|COMPLETED|Overall Study||50
10295474|NCT03167242|11428083|FG004|COMPLETED|Overall Study||53
10295475|NCT03167242|11428084|FG005|COMPLETED|Overall Study||49
10295476|NCT03167242|11428085|FG006|COMPLETED|Overall Study||50
10295477|NCT03167242|11428086|FG007|COMPLETED|Overall Study||26
10295478|NCT03167242|11428087|FG008|COMPLETED|Overall Study||52
10295479|NCT03167242|11428088|FG009|COMPLETED|Overall Study||53
10295480|NCT03167242|11428089|FG010|COMPLETED|Overall Study||43
10295481|NCT03167242|11428090|FG011|COMPLETED|Overall Study||23
10870947|NCT04229888|12036759|FG000|STARTED|Overall Study||14
10870948|NCT04229888|12036759|FG000|COMPLETED|Overall Study||14
10870949|NCT04229888|12036759|FG000|NOT COMPLETED|Overall Study||0
10870950|NCT04221828|12036766|FG000|STARTED|Overall Study||1
10870951|NCT04221828|12036766|FG000|COMPLETED|Overall Study||1
10870952|NCT04221828|12036766|FG000|NOT COMPLETED|Overall Study||0
10870953|NCT04095416|12036772|FG000|STARTED|Overall Study||13
10870954|NCT04095416|12036773|FG001|STARTED|Overall Study||19
10870955|NCT04095416|12036772|FG000|COMPLETED|Overall Study||10
10870956|NCT04095416|12036773|FG001|COMPLETED|Overall Study||19
10870957|NCT04095416|12036772|FG000|NOT COMPLETED|Overall Study||3
10870958|NCT04095416|12036773|FG001|NOT COMPLETED|Overall Study||0
10870959|NCT04532099|12036782|FG000|STARTED|First Wear Period (30 Days)||33
10870960|NCT04532099|12036783|FG001|STARTED|First Wear Period (30 Days)||33
10870961|NCT04532099|12036784|FG002|STARTED|First Wear Period (30 Days)||66
10870962|NCT04532099|12036782|FG000|COMPLETED|First Wear Period (30 Days)||32
10870963|NCT04532099|12036783|FG001|COMPLETED|First Wear Period (30 Days)||33
10870964|NCT04532099|12036784|FG002|COMPLETED|First Wear Period (30 Days)||66
10870965|NCT04532099|12036782|FG000|NOT COMPLETED|First Wear Period (30 Days)||1
10870966|NCT04532099|12036783|FG001|NOT COMPLETED|First Wear Period (30 Days)||0
10870967|NCT04532099|12036784|FG002|NOT COMPLETED|First Wear Period (30 Days)||0
10870968|NCT04532099|12036782|FG000|STARTED|Second Wear Period (30 Days)||32
10870969|NCT04532099|12036783|FG001|STARTED|Second Wear Period (30 Days)||33
10870970|NCT04532099|12036784|FG002|STARTED|Second Wear Period (30 Days)|Part B is single product; therefore, only one wear period.|0
10870971|NCT04532099|12036782|FG000|COMPLETED|Second Wear Period (30 Days)||32
10870972|NCT04532099|12036783|FG001|COMPLETED|Second Wear Period (30 Days)||33
10870973|NCT04532099|12036784|FG002|COMPLETED|Second Wear Period (30 Days)||0
10870974|NCT04532099|12036782|FG000|NOT COMPLETED|Second Wear Period (30 Days)||0
10870975|NCT04532099|12036783|FG001|NOT COMPLETED|Second Wear Period (30 Days)||0
10870976|NCT04532099|12036784|FG002|NOT COMPLETED|Second Wear Period (30 Days)||0
10870977|NCT04385199|12036798|FG000|STARTED|Overall Study||20
10870978|NCT04385199|12036799|FG001|STARTED|Overall Study||10
10870979|NCT04385199|12036798|FG000|COMPLETED|Overall Study||19
10870980|NCT04385199|12036799|FG001|COMPLETED|Overall Study||10
10870981|NCT04385199|12036798|FG000|NOT COMPLETED|Overall Study||1
10870982|NCT04385199|12036799|FG001|NOT COMPLETED|Overall Study||0
10419020|NCT00808340|11563806|FG001|NOT COMPLETED|Second Intervention||0
10419021|NCT00808340|11563807|FG002|NOT COMPLETED|Second Intervention||0
10419022|NCT00808340|11563808|FG003|NOT COMPLETED|Second Intervention||0
10419023|NCT00808340|11563809|FG004|NOT COMPLETED|Second Intervention||0
10419024|NCT00808340|11563810|FG005|NOT COMPLETED|Second Intervention||0
10419025|NCT00808340|11563805|FG000|STARTED|Third Intervention||4
10419026|NCT00808340|11563806|FG001|STARTED|Third Intervention||9
10419027|NCT00808340|11563807|FG002|STARTED|Third Intervention||7
10419028|NCT00808340|11563808|FG003|STARTED|Third Intervention||3
10419029|NCT00808340|11563809|FG004|STARTED|Third Intervention||5
10419030|NCT00808340|11563810|FG005|STARTED|Third Intervention||6
10419031|NCT00808340|11563805|FG000|COMPLETED|Third Intervention||4
10419032|NCT00808340|11563806|FG001|COMPLETED|Third Intervention||9
10419033|NCT00808340|11563807|FG002|COMPLETED|Third Intervention||7
10419034|NCT00808340|11563808|FG003|COMPLETED|Third Intervention||3
10419035|NCT00808340|11563809|FG004|COMPLETED|Third Intervention||5
10545976|NCT01500759|11699489|FG001|NOT COMPLETED|Overall Study||0
10870993|NCT04311177|12036817|FG000|STARTED|Overall Study||58
10870994|NCT04311177|12036818|FG001|STARTED|Overall Study||59
10870995|NCT04311177|12036817|FG000|COMPLETED|Overall Study||50
10295482|NCT03167242|11428079|FG000|NOT COMPLETED|Overall Study||0
10295483|NCT03167242|11428080|FG001|NOT COMPLETED|Overall Study||1
10295484|NCT03167242|11428081|FG002|NOT COMPLETED|Overall Study||3
10295485|NCT03167242|11428082|FG003|NOT COMPLETED|Overall Study||1
10295486|NCT03167242|11428083|FG004|NOT COMPLETED|Overall Study||1
10295487|NCT03167242|11428084|FG005|NOT COMPLETED|Overall Study||2
10295488|NCT03167242|11428085|FG006|NOT COMPLETED|Overall Study||2
10295489|NCT03167242|11428086|FG007|NOT COMPLETED|Overall Study||1
10295490|NCT03167242|11428087|FG008|NOT COMPLETED|Overall Study||1
10295491|NCT03167242|11428088|FG009|NOT COMPLETED|Overall Study||0
10295492|NCT03167242|11428089|FG010|NOT COMPLETED|Overall Study||2
10295493|NCT03167242|11428090|FG011|NOT COMPLETED|Overall Study||1
10295494|NCT03137537|11428128|FG000|STARTED|Overall Study||12
10295495|NCT03137537|11428129|FG001|STARTED|Overall Study||11
10295496|NCT03137537|11428128|FG000|COMPLETED|Overall Study||12
10295497|NCT03137537|11428129|FG001|COMPLETED|Overall Study||10
10295498|NCT03137537|11428128|FG000|NOT COMPLETED|Overall Study||0
10295499|NCT03137537|11428129|FG001|NOT COMPLETED|Overall Study||1
10870996|NCT04311177|12036818|FG001|COMPLETED|Overall Study||55
10870997|NCT04311177|12036817|FG000|NOT COMPLETED|Overall Study||8
10870998|NCT04311177|12036818|FG001|NOT COMPLETED|Overall Study||4
10870999|NCT04241133|12036826|FG000|STARTED|Overall Study||44
10871000|NCT04241133|12036827|FG001|STARTED|Overall Study||34
10871001|NCT04241133|12036826|FG000|COMPLETED|Overall Study||30
10871002|NCT04241133|12036827|FG001|COMPLETED|Overall Study||0
10871003|NCT04241133|12036826|FG000|NOT COMPLETED|Overall Study||14
10871004|NCT04241133|12036827|FG001|NOT COMPLETED|Overall Study||34
10871005|NCT04190693|12036837|FG000|STARTED|Overall Study||4
10871006|NCT04190693|12036838|FG001|STARTED|Overall Study||7
10871007|NCT04190693|12036839|FG002|STARTED|Overall Study||12
10871008|NCT04190693|12036840|FG003|STARTED|Overall Study||7
10871009|NCT04190693|12036837|FG000|COMPLETED|Overall Study||4
10871010|NCT04190693|12036838|FG001|COMPLETED|Overall Study||7
10871011|NCT04190693|12036839|FG002|COMPLETED|Overall Study||12
10871012|NCT04190693|12036840|FG003|COMPLETED|Overall Study||7
10871013|NCT04190693|12036837|FG000|NOT COMPLETED|Overall Study||0
10871014|NCT04190693|12036838|FG001|NOT COMPLETED|Overall Study||0
10871015|NCT04190693|12036839|FG002|NOT COMPLETED|Overall Study||0
10871016|NCT04190693|12036840|FG003|NOT COMPLETED|Overall Study||0
10871017|NCT04170608|12036850|FG000|STARTED|Overall Study||10
10871018|NCT04170608|12036850|FG000|COMPLETED|Overall Study||10
10871019|NCT04170608|12036850|FG000|NOT COMPLETED|Overall Study||0
10871020|NCT04150068|12036857|FG000|STARTED|Functional Mono/Oral Lead-in (14 Days)||24
10871021|NCT04150068|12036858|FG001|STARTED|Functional Mono/Oral Lead-in (14 Days)||12
10871022|NCT04150068|12036859|FG002|STARTED|Functional Mono/Oral Lead-in (14 Days)||36
10871023|NCT04150068|12036857|FG000|COMPLETED|Functional Mono/Oral Lead-in (14 Days)||24
10871024|NCT04150068|12036858|FG001|COMPLETED|Functional Mono/Oral Lead-in (14 Days)||12
10871025|NCT04150068|12036859|FG002|COMPLETED|Functional Mono/Oral Lead-in (14 Days)||36
10871026|NCT04150068|12036857|FG000|NOT COMPLETED|Functional Mono/Oral Lead-in (14 Days)||0
10871027|NCT04150068|12036858|FG001|NOT COMPLETED|Functional Mono/Oral Lead-in (14 Days)||0
10871028|NCT04150068|12036859|FG002|NOT COMPLETED|Functional Mono/Oral Lead-in (14 Days)||0
10871029|NCT04150068|12036857|FG000|STARTED|Maintenance Period (Week 26 Analysis)||24
10871030|NCT04150068|12036858|FG001|STARTED|Maintenance Period (Week 26 Analysis)||12
10871031|NCT04150068|12036859|FG002|STARTED|Maintenance Period (Week 26 Analysis)||36
10871032|NCT04150068|12036857|FG000|COMPLETED|Maintenance Period (Week 26 Analysis)||0
10871033|NCT04150068|12036858|FG001|COMPLETED|Maintenance Period (Week 26 Analysis)||0
10871034|NCT04150068|12036859|FG002|COMPLETED|Maintenance Period (Week 26 Analysis)||0
10871035|NCT04150068|12036857|FG000|NOT COMPLETED|Maintenance Period (Week 26 Analysis)||24
10871036|NCT04150068|12036858|FG001|NOT COMPLETED|Maintenance Period (Week 26 Analysis)||12
10871037|NCT04150068|12036859|FG002|NOT COMPLETED|Maintenance Period (Week 26 Analysis)||36
10871038|NCT04133519|12036868|FG000|STARTED|Overall Study||188
10871039|NCT04133519|12036869|FG001|STARTED|Overall Study||190
10871040|NCT04133519|12036868|FG000|COMPLETED|Overall Study||182
10871041|NCT04133519|12036869|FG001|COMPLETED|Overall Study||184
10871042|NCT04133519|12036868|FG000|NOT COMPLETED|Overall Study||6
10871043|NCT04133519|12036869|FG001|NOT COMPLETED|Overall Study||6
10871044|NCT04118270|12036877|FG000|STARTED|Overall Study||37
10871045|NCT04118270|12036878|FG001|STARTED|Overall Study||13
10871046|NCT04118270|12036877|FG000|Completed Provider Accuracy Assessment|Overall Study|Only the Providers were eligible for completing the Provider Accuracy Assessment.|0
10871047|NCT04118270|12036878|FG001|Completed Provider Accuracy Assessment|Overall Study||10
10871048|NCT04118270|12036877|FG000|COMPLETED|Overall Study||37
10871049|NCT04118270|12036878|FG001|COMPLETED|Overall Study||13
10871050|NCT04118270|12036877|FG000|NOT COMPLETED|Overall Study||0
10871051|NCT04118270|12036878|FG001|NOT COMPLETED|Overall Study||0
10871052|NCT04098367|12036889|FG000|STARTED|Overall Study||63
10419036|NCT00808340|11563810|FG005|COMPLETED|Third Intervention||6
10419037|NCT00808340|11563805|FG000|NOT COMPLETED|Third Intervention||0
10419038|NCT00808340|11563806|FG001|NOT COMPLETED|Third Intervention||0
10419039|NCT00808340|11563807|FG002|NOT COMPLETED|Third Intervention||0
10419040|NCT00808340|11563808|FG003|NOT COMPLETED|Third Intervention||0
10419041|NCT00808340|11563809|FG004|NOT COMPLETED|Third Intervention||0
10419042|NCT00808340|11563810|FG005|NOT COMPLETED|Third Intervention||0
10419043|NCT00808405|11563820|FG000|STARTED|Overall Study||61
10419044|NCT00808405|11563821|FG001|STARTED|Overall Study||27
10419045|NCT00808405|11563820|FG000|COMPLETED|Overall Study||61
10419046|NCT00808405|11563821|FG001|COMPLETED|Overall Study||27
10419047|NCT00808405|11563820|FG000|NOT COMPLETED|Overall Study||0
10419048|NCT00808405|11563821|FG001|NOT COMPLETED|Overall Study||0
10419049|NCT00808444|11563829|FG000|STARTED|Overall Study||233
10419050|NCT00808444|11563830|FG001|STARTED|Overall Study||233
10419051|NCT00808444|11563829|FG000|COMPLETED|Overall Study||232
10419052|NCT00808444|11563830|FG001|COMPLETED|Overall Study||232
10419053|NCT00808444|11563829|FG000|NOT COMPLETED|Overall Study||1
10419054|NCT00808444|11563830|FG001|NOT COMPLETED|Overall Study||1
10419055|NCT00808470|11563838|FG000|STARTED|Overall Study||37
10419056|NCT00808470|11563839|FG001|STARTED|Overall Study||35
10419057|NCT00808470|11563838|FG000|COMPLETED|Overall Study||35
10419058|NCT00808470|11563839|FG001|COMPLETED|Overall Study||35
10419059|NCT00808470|11563838|FG000|NOT COMPLETED|Overall Study||2
10419060|NCT00808470|11563839|FG001|NOT COMPLETED|Overall Study||0
10419061|NCT00808483|11563851|FG000|STARTED|From 3 to 5 Months After Surgery||35
10419062|NCT00808483|11563852|FG001|STARTED|From 3 to 5 Months After Surgery||33
10419063|NCT00808483|11563851|FG000|COMPLETED|From 3 to 5 Months After Surgery||33
10419064|NCT00808483|11563852|FG001|COMPLETED|From 3 to 5 Months After Surgery||32
10419065|NCT00808483|11563851|FG000|NOT COMPLETED|From 3 to 5 Months After Surgery||2
10419066|NCT00808483|11563852|FG001|NOT COMPLETED|From 3 to 5 Months After Surgery||1
10419067|NCT00808483|11563851|FG000|STARTED|From 5 Months to 12 Months||33
10419068|NCT00808483|11563852|FG001|STARTED|From 5 Months to 12 Months||32
10419069|NCT00808483|11563851|FG000|COMPLETED|From 5 Months to 12 Months||32
10419070|NCT00808483|11563852|FG001|COMPLETED|From 5 Months to 12 Months||32
10419071|NCT00808483|11563851|FG000|NOT COMPLETED|From 5 Months to 12 Months||1
10419072|NCT00808483|11563852|FG001|NOT COMPLETED|From 5 Months to 12 Months||0
10871053|NCT04098367|12036890|FG001|STARTED|Overall Study||65
10871054|NCT04098367|12036891|FG002|STARTED|Overall Study||65
10871055|NCT04098367|12036889|FG000|First Eye Implanted|Overall Study||63
10871056|NCT04098367|12036890|FG001|First Eye Implanted|Overall Study||65
10419073|NCT00808509|11563867|FG000|STARTED|Randomized Phase||17
10419074|NCT00808509|11563868|FG001|STARTED|Randomized Phase||16
10419075|NCT00808509|11563867|FG000|Received Rescue Therapy|Randomized Phase||0
10419076|NCT00808509|11563868|FG001|Received Rescue Therapy|Randomized Phase||9
10419077|NCT00808509|11563867|FG000|COMPLETED|Randomized Phase||15
10419078|NCT00808509|11563868|FG001|COMPLETED|Randomized Phase|Includes participants who received rescue therapy & follow-up for 12 weeks|11
10419079|NCT00808509|11563867|FG000|NOT COMPLETED|Randomized Phase||2
10419080|NCT00808509|11563868|FG001|NOT COMPLETED|Randomized Phase||5
10871057|NCT04098367|12036891|FG002|First Eye Implanted|Overall Study||65
10871058|NCT04098367|12036889|FG000|Second Eye Implanted|Overall Study||63
10871059|NCT04098367|12036890|FG001|Second Eye Implanted|Overall Study||65
10871060|NCT04098367|12036891|FG002|Second Eye Implanted|Overall Study||63
10871061|NCT04098367|12036889|FG000|COMPLETED|Overall Study||61
10871062|NCT04098367|12036890|FG001|COMPLETED|Overall Study||60
10871063|NCT04098367|12036891|FG002|COMPLETED|Overall Study||61
10871064|NCT04098367|12036889|FG000|NOT COMPLETED|Overall Study||2
10871065|NCT04098367|12036890|FG001|NOT COMPLETED|Overall Study||5
10871066|NCT04098367|12036891|FG002|NOT COMPLETED|Overall Study||4
10871067|NCT04091087|12036908|FG000|STARTED|Overall Study||33
10871068|NCT04091087|12036909|FG001|STARTED|Overall Study||33
10871069|NCT04091087|12036908|FG000|Treated|Overall Study||32
10871070|NCT04091087|12036909|FG001|Treated|Overall Study||33
10871071|NCT04091087|12036908|FG000|COMPLETED|Overall Study||23
10871072|NCT04091087|12036909|FG001|COMPLETED|Overall Study||26
10871073|NCT04091087|12036908|FG000|NOT COMPLETED|Overall Study||10
10871074|NCT04091087|12036909|FG001|NOT COMPLETED|Overall Study||7
10871075|NCT04009629|12036917|FG000|STARTED|Overall Study||23
10871076|NCT04009629|12036918|FG001|STARTED|Overall Study||38
10871077|NCT04009629|12036917|FG000|COMPLETED|Overall Study||21
10755626|NCT03069677|11919443|FG000|COMPLETED|Overall Study||77
10755627|NCT03069677|11919444|FG001|COMPLETED|Overall Study||77
10755628|NCT03069677|11919443|FG000|NOT COMPLETED|Overall Study||3
10755629|NCT03069677|11919444|FG001|NOT COMPLETED|Overall Study||3
10755630|NCT03069716|11919452|FG000|STARTED|Run-in Period (2 Weeks)||49
10755631|NCT03069716|11919453|FG001|STARTED|Run-in Period (2 Weeks)||0
10755632|NCT03069716|11919454|FG002|STARTED|Run-in Period (2 Weeks)||0
10755633|NCT03069716|11919452|FG000|COMPLETED|Run-in Period (2 Weeks)||42
10755634|NCT03069716|11919453|FG001|COMPLETED|Run-in Period (2 Weeks)||0
10755635|NCT03069716|11919454|FG002|COMPLETED|Run-in Period (2 Weeks)||0
10755636|NCT03069716|11919452|FG000|NOT COMPLETED|Run-in Period (2 Weeks)||7
10755637|NCT03069716|11919453|FG001|NOT COMPLETED|Run-in Period (2 Weeks)||0
10755638|NCT03069716|11919454|FG002|NOT COMPLETED|Run-in Period (2 Weeks)||0
10755639|NCT03069716|11919452|FG000|STARTED|Randomized Treatment||0
10755640|NCT03069716|11919453|FG001|STARTED|Randomized Treatment||20
10755641|NCT03069716|11919454|FG002|STARTED|Randomized Treatment||22
10755642|NCT03069716|11919452|FG000|COMPLETED|Randomized Treatment||0
10755643|NCT03069716|11919453|FG001|COMPLETED|Randomized Treatment||18
10755644|NCT03069716|11919454|FG002|COMPLETED|Randomized Treatment||22
10755645|NCT03069716|11919452|FG000|NOT COMPLETED|Randomized Treatment||0
10755646|NCT03069716|11919453|FG001|NOT COMPLETED|Randomized Treatment||2
10755647|NCT03069716|11919454|FG002|NOT COMPLETED|Randomized Treatment||0
10755648|NCT03069989|11919463|FG000|STARTED|Dosing Period 1 (Up to 2 Days)||3
10755649|NCT03069989|11919464|FG001|STARTED|Dosing Period 1 (Up to 2 Days)||5
10755650|NCT03069989|11919463|FG000|COMPLETED|Dosing Period 1 (Up to 2 Days)||3
10755651|NCT03069989|11919464|FG001|COMPLETED|Dosing Period 1 (Up to 2 Days)||5
10755652|NCT03069989|11919463|FG000|NOT COMPLETED|Dosing Period 1 (Up to 2 Days)||0
10755653|NCT03069989|11919464|FG001|NOT COMPLETED|Dosing Period 1 (Up to 2 Days)||0
10755654|NCT03069989|11919463|FG000|STARTED|Wash Out Period (Up to 28 Days))||3
10755655|NCT03069989|11919464|FG001|STARTED|Wash Out Period (Up to 28 Days))||5
10755656|NCT03069989|11919463|FG000|COMPLETED|Wash Out Period (Up to 28 Days))||3
10755657|NCT03069989|11919464|FG001|COMPLETED|Wash Out Period (Up to 28 Days))||5
10755658|NCT03069989|11919463|FG000|NOT COMPLETED|Wash Out Period (Up to 28 Days))||0
10755659|NCT03069989|11919464|FG001|NOT COMPLETED|Wash Out Period (Up to 28 Days))||0
10755660|NCT03069989|11919463|FG000|STARTED|Dosing Period 2 (Up to 16 Days)||3
10755661|NCT03069989|11919464|FG001|STARTED|Dosing Period 2 (Up to 16 Days)||5
10755662|NCT03069989|11919463|FG000|COMPLETED|Dosing Period 2 (Up to 16 Days)||2
10755663|NCT03069989|11919464|FG001|COMPLETED|Dosing Period 2 (Up to 16 Days)||5
10755664|NCT03069989|11919463|FG000|NOT COMPLETED|Dosing Period 2 (Up to 16 Days)||1
10755665|NCT03069989|11919464|FG001|NOT COMPLETED|Dosing Period 2 (Up to 16 Days)||0
10755666|NCT03070171|11919473|FG000|STARTED|Treatment Period 1 + Washout||80
10755667|NCT03070171|11919474|FG001|STARTED|Treatment Period 1 + Washout||80
10755668|NCT03070171|11919473|FG000|COMPLETED|Treatment Period 1 + Washout||80
10755669|NCT03070171|11919474|FG001|COMPLETED|Treatment Period 1 + Washout||80
10755670|NCT03070171|11919473|FG000|NOT COMPLETED|Treatment Period 1 + Washout||0
10755671|NCT03070171|11919474|FG001|NOT COMPLETED|Treatment Period 1 + Washout||0
10755672|NCT03070171|11919473|FG000|STARTED|Treatment Period 2 + Washout||80
10755673|NCT03070171|11919474|FG001|STARTED|Treatment Period 2 + Washout||80
10755674|NCT03070171|11919473|FG000|COMPLETED|Treatment Period 2 + Washout||80
10755675|NCT03070171|11919474|FG001|COMPLETED|Treatment Period 2 + Washout||79
10755676|NCT03070171|11919473|FG000|NOT COMPLETED|Treatment Period 2 + Washout||0
10871078|NCT04009629|12036918|FG001|COMPLETED|Overall Study||38
10871079|NCT04009629|12036917|FG000|NOT COMPLETED|Overall Study||2
10871080|NCT04009629|12036918|FG001|NOT COMPLETED|Overall Study||0
10871081|NCT03937908|12036927|FG000|STARTED|Overall Study||2
10871082|NCT03937908|12036928|FG001|STARTED|Overall Study||3
10871083|NCT03937908|12036927|FG000|COMPLETED|Overall Study||2
10871084|NCT03937908|12036928|FG001|COMPLETED|Overall Study||2
10871085|NCT03937908|12036927|FG000|NOT COMPLETED|Overall Study||0
10871086|NCT03937908|12036928|FG001|NOT COMPLETED|Overall Study||1
10871087|NCT03891264|12036934|FG000|STARTED|Overall Study||7
10871088|NCT03891264|12036934|FG000|Received Intervention|Overall Study||3
10871089|NCT03891264|12036934|FG000|COMPLETED|Overall Study||2
10871090|NCT03891264|12036934|FG000|NOT COMPLETED|Overall Study||5
10871091|NCT03839082|12036940|FG000|STARTED|Initial Randomization||33
10871092|NCT03839082|12036941|FG001|STARTED|Initial Randomization||37
10871093|NCT03839082|12036940|FG000|COMPLETED|Initial Randomization||7
10871094|NCT03839082|12036941|FG001|COMPLETED|Initial Randomization||12
10871095|NCT03839082|12036940|FG000|NOT COMPLETED|Initial Randomization||26
10871096|NCT03839082|12036941|FG001|NOT COMPLETED|Initial Randomization||25
10871097|NCT03839082|12036940|FG000|STARTED|Crossover to Other Arm||7
10871098|NCT03839082|12036941|FG001|STARTED|Crossover to Other Arm||12
10871099|NCT03839082|12036940|FG000|COMPLETED|Crossover to Other Arm||0
10871100|NCT03839082|12036941|FG001|COMPLETED|Crossover to Other Arm||0
10871101|NCT03839082|12036940|FG000|NOT COMPLETED|Crossover to Other Arm||7
10871102|NCT03839082|12036941|FG001|NOT COMPLETED|Crossover to Other Arm||12
10871103|NCT03835351|12036949|FG000|STARTED|Overall Study||241
10871104|NCT03835351|12036950|FG001|STARTED|Overall Study||250
10871105|NCT03835351|12036949|FG000|COMPLETED|Overall Study||241
10871106|NCT03835351|12036950|FG001|COMPLETED|Overall Study||250
10871107|NCT03835351|12036949|FG000|NOT COMPLETED|Overall Study||0
10871108|NCT03835351|12036950|FG001|NOT COMPLETED|Overall Study||0
10871119|NCT03823287|12036967|FG000|STARTED|Overall Study||334
10871120|NCT03823287|12036968|FG001|STARTED|Overall Study||337
10871121|NCT03823287|12036967|FG000|Received at Least One Dose of Study Drug|Overall Study||333
10871122|NCT03823287|12036968|FG001|Received at Least One Dose of Study Drug|Overall Study||336
10871123|NCT03823287|12036967|FG000|Completed up to Week 48|Overall Study||319
10871124|NCT03823287|12036968|FG001|Completed up to Week 48|Overall Study||323
10871125|NCT03823287|12036967|FG000|COMPLETED|Overall Study||0
10871126|NCT03823287|12036968|FG001|COMPLETED|Overall Study||0
10871127|NCT03823287|12036967|FG000|NOT COMPLETED|Overall Study||334
10871128|NCT03823287|12036968|FG001|NOT COMPLETED|Overall Study||337
10871129|NCT03815175|12036974|FG000|STARTED|Overall Study||1605
10871130|NCT03815175|12036974|FG000|COMPLETED|Overall Study||1439
10871131|NCT03815175|12036974|FG000|NOT COMPLETED|Overall Study||166
10871144|NCT03794024|12036990|FG000|STARTED|Overall Study||1
10871145|NCT03794024|12036991|FG001|STARTED|Overall Study||0
10871146|NCT03794024|12036990|FG000|COMPLETED|Overall Study||0
10871147|NCT03794024|12036991|FG001|COMPLETED|Overall Study||0
10871148|NCT03794024|12036990|FG000|NOT COMPLETED|Overall Study||1
10871149|NCT03794024|12036991|FG001|NOT COMPLETED|Overall Study||0
10871150|NCT03770455|12036997|FG000|STARTED|Overall Study||5
10871151|NCT03770455|12036997|FG000|COMPLETED|Overall Study||5
10871152|NCT03770455|12036997|FG000|NOT COMPLETED|Overall Study||0
10871153|NCT03714178|12037001|FG000|STARTED|Overall Study||71
10871154|NCT03714178|12037001|FG000|COMPLETED|Overall Study||71
10871155|NCT03714178|12037001|FG000|NOT COMPLETED|Overall Study||0
10871156|NCT03709342|12037005|FG000|STARTED|Overall Study||7
10871157|NCT03709342|12037005|FG000|COMPLETED|Overall Study||7
10871158|NCT03709342|12037005|FG000|NOT COMPLETED|Overall Study||0
10871159|NCT03691623|12037015|FG000|STARTED|Overall Study||39
10871160|NCT03691623|12037016|FG001|STARTED|Overall Study||38
10871161|NCT03691623|12037017|FG002|STARTED|Overall Study||38
10871162|NCT03691623|12037018|FG003|STARTED|Overall Study||21
10871163|NCT03691623|12037019|FG004|STARTED|Overall Study||21
10871164|NCT03691623|12037020|FG005|STARTED|Overall Study||21
10871165|NCT03691623|12037015|FG000|Inoculated With Challenge Virus|Overall Study||39
10871166|NCT03691623|12037016|FG001|Inoculated With Challenge Virus|Overall Study||38
10871167|NCT03691623|12037017|FG002|Inoculated With Challenge Virus|Overall Study||38
10871168|NCT03691623|12037018|FG003|Inoculated With Challenge Virus|Overall Study||21
10871169|NCT03691623|12037019|FG004|Inoculated With Challenge Virus|Overall Study||21
10871170|NCT03691623|12037020|FG005|Inoculated With Challenge Virus|Overall Study||21
10871171|NCT03691623|12037015|FG000|Received Treatment|Overall Study||38
10871172|NCT03691623|12037016|FG001|Received Treatment|Overall Study||38
10871173|NCT03691623|12037017|FG002|Received Treatment|Overall Study||38
10871174|NCT03691623|12037018|FG003|Received Treatment|Overall Study||21
10871175|NCT03691623|12037019|FG004|Received Treatment|Overall Study||21
10871176|NCT03691623|12037020|FG005|Received Treatment|Overall Study||21
10871177|NCT03691623|12037015|FG000|COMPLETED|Overall Study||39
10871178|NCT03691623|12037016|FG001|COMPLETED|Overall Study||38
10871179|NCT03691623|12037017|FG002|COMPLETED|Overall Study||38
10871180|NCT03691623|12037018|FG003|COMPLETED|Overall Study||21
10871181|NCT03691623|12037019|FG004|COMPLETED|Overall Study||21
10871182|NCT03691623|12037020|FG005|COMPLETED|Overall Study||21
10871183|NCT03691623|12037015|FG000|NOT COMPLETED|Overall Study||0
10871184|NCT03691623|12037016|FG001|NOT COMPLETED|Overall Study||0
10871185|NCT03691623|12037017|FG002|NOT COMPLETED|Overall Study||0
10871186|NCT03691623|12037018|FG003|NOT COMPLETED|Overall Study||0
10871187|NCT03691623|12037019|FG004|NOT COMPLETED|Overall Study||0
10871188|NCT03691623|12037020|FG005|NOT COMPLETED|Overall Study||0
10871189|NCT03604549|12037039|FG000|STARTED|Overall Study||29
10871190|NCT03604549|12037040|FG001|STARTED|Overall Study||29
10871191|NCT03604549|12037039|FG000|COMPLETED|Overall Study||24
10871192|NCT03604549|12037040|FG001|COMPLETED|Overall Study||24
10871193|NCT03604549|12037039|FG000|NOT COMPLETED|Overall Study||5
10871194|NCT03604549|12037040|FG001|NOT COMPLETED|Overall Study||5
10871195|NCT03603639|12037046|FG000|STARTED|Treatment Period 1 (Day 1)||1
10871196|NCT03603639|12037047|FG001|STARTED|Treatment Period 1 (Day 1)||1
10871197|NCT03603639|12037048|FG002|STARTED|Treatment Period 1 (Day 1)||1
10871198|NCT03603639|12037049|FG003|STARTED|Treatment Period 1 (Day 1)||1
10871199|NCT03603639|12037050|FG004|STARTED|Treatment Period 1 (Day 1)||1
10871200|NCT03603639|12037051|FG005|STARTED|Treatment Period 1 (Day 1)||1
10871201|NCT03603639|12037046|FG000|COMPLETED|Treatment Period 1 (Day 1)||1
10871202|NCT03603639|12037047|FG001|COMPLETED|Treatment Period 1 (Day 1)||1
10871203|NCT03603639|12037048|FG002|COMPLETED|Treatment Period 1 (Day 1)||1
10871204|NCT03603639|12037049|FG003|COMPLETED|Treatment Period 1 (Day 1)||1
10871205|NCT03603639|12037050|FG004|COMPLETED|Treatment Period 1 (Day 1)||1
10871206|NCT03603639|12037051|FG005|COMPLETED|Treatment Period 1 (Day 1)||1
10871207|NCT03603639|12037046|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10871208|NCT03603639|12037047|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10871209|NCT03603639|12037048|FG002|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10871210|NCT03603639|12037049|FG003|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10871211|NCT03603639|12037050|FG004|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10871212|NCT03603639|12037051|FG005|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10871213|NCT03603639|12037046|FG000|STARTED|Washout Period (at Least 3 Weeks)||1
10871214|NCT03603639|12037047|FG001|STARTED|Washout Period (at Least 3 Weeks)||1
10871215|NCT03603639|12037048|FG002|STARTED|Washout Period (at Least 3 Weeks)||1
10871216|NCT03603639|12037049|FG003|STARTED|Washout Period (at Least 3 Weeks)||1
10871217|NCT03603639|12037050|FG004|STARTED|Washout Period (at Least 3 Weeks)||1
10871218|NCT03603639|12037051|FG005|STARTED|Washout Period (at Least 3 Weeks)||1
10871219|NCT03603639|12037046|FG000|COMPLETED|Washout Period (at Least 3 Weeks)||1
10871220|NCT03603639|12037047|FG001|COMPLETED|Washout Period (at Least 3 Weeks)||1
10871221|NCT03603639|12037048|FG002|COMPLETED|Washout Period (at Least 3 Weeks)||1
10871222|NCT03603639|12037049|FG003|COMPLETED|Washout Period (at Least 3 Weeks)||1
10871223|NCT03603639|12037050|FG004|COMPLETED|Washout Period (at Least 3 Weeks)||1
10871224|NCT03603639|12037051|FG005|COMPLETED|Washout Period (at Least 3 Weeks)||1
10871225|NCT03603639|12037046|FG000|NOT COMPLETED|Washout Period (at Least 3 Weeks)||0
10871226|NCT03603639|12037047|FG001|NOT COMPLETED|Washout Period (at Least 3 Weeks)||0
10871227|NCT03603639|12037048|FG002|NOT COMPLETED|Washout Period (at Least 3 Weeks)||0
10871228|NCT03603639|12037049|FG003|NOT COMPLETED|Washout Period (at Least 3 Weeks)||0
10871229|NCT03603639|12037050|FG004|NOT COMPLETED|Washout Period (at Least 3 Weeks)||0
10871230|NCT03603639|12037051|FG005|NOT COMPLETED|Washout Period (at Least 3 Weeks)||0
10871231|NCT03603639|12037046|FG000|STARTED|Treatment Period 2 (Day 1)||1
10871232|NCT03603639|12037047|FG001|STARTED|Treatment Period 2 (Day 1)||1
10871233|NCT03603639|12037048|FG002|STARTED|Treatment Period 2 (Day 1)||1
10871234|NCT03603639|12037049|FG003|STARTED|Treatment Period 2 (Day 1)||1
10871235|NCT03603639|12037050|FG004|STARTED|Treatment Period 2 (Day 1)||1
10871236|NCT03603639|12037051|FG005|STARTED|Treatment Period 2 (Day 1)||1
10871237|NCT03603639|12037046|FG000|COMPLETED|Treatment Period 2 (Day 1)||1
10871238|NCT03603639|12037047|FG001|COMPLETED|Treatment Period 2 (Day 1)||1
10871239|NCT03603639|12037048|FG002|COMPLETED|Treatment Period 2 (Day 1)||1
10871240|NCT03603639|12037049|FG003|COMPLETED|Treatment Period 2 (Day 1)||1
10871241|NCT03603639|12037050|FG004|COMPLETED|Treatment Period 2 (Day 1)||1
10871242|NCT03603639|12037051|FG005|COMPLETED|Treatment Period 2 (Day 1)||1
10871243|NCT03603639|12037046|FG000|NOT COMPLETED|Treatment Period 2 (Day 1)||0
10871244|NCT03603639|12037047|FG001|NOT COMPLETED|Treatment Period 2 (Day 1)||0
10871245|NCT03603639|12037048|FG002|NOT COMPLETED|Treatment Period 2 (Day 1)||0
10871246|NCT03603639|12037049|FG003|NOT COMPLETED|Treatment Period 2 (Day 1)||0
10871247|NCT03603639|12037050|FG004|NOT COMPLETED|Treatment Period 2 (Day 1)||0
10871248|NCT03603639|12037051|FG005|NOT COMPLETED|Treatment Period 2 (Day 1)||0
10871249|NCT03603639|12037046|FG000|STARTED|Washout Period (at Least 3 Weeks)||1
10871250|NCT03603639|12037047|FG001|STARTED|Washout Period (at Least 3 Weeks)||1
10871251|NCT03603639|12037048|FG002|STARTED|Washout Period (at Least 3 Weeks)||1
10871252|NCT03603639|12037049|FG003|STARTED|Washout Period (at Least 3 Weeks)||1
10871253|NCT03603639|12037050|FG004|STARTED|Washout Period (at Least 3 Weeks)||1
10871254|NCT03603639|12037051|FG005|STARTED|Washout Period (at Least 3 Weeks)||1
10871255|NCT03603639|12037046|FG000|COMPLETED|Washout Period (at Least 3 Weeks)||1
10871256|NCT03603639|12037047|FG001|COMPLETED|Washout Period (at Least 3 Weeks)||1
10871257|NCT03603639|12037048|FG002|COMPLETED|Washout Period (at Least 3 Weeks)||0
10871258|NCT03603639|12037049|FG003|COMPLETED|Washout Period (at Least 3 Weeks)||0
10871259|NCT03603639|12037050|FG004|COMPLETED|Washout Period (at Least 3 Weeks)||0
10871260|NCT03603639|12037051|FG005|COMPLETED|Washout Period (at Least 3 Weeks)||0
10871261|NCT03603639|12037046|FG000|NOT COMPLETED|Washout Period (at Least 3 Weeks)||0
10871262|NCT03603639|12037047|FG001|NOT COMPLETED|Washout Period (at Least 3 Weeks)||0
10871263|NCT03603639|12037048|FG002|NOT COMPLETED|Washout Period (at Least 3 Weeks)||1
10871264|NCT03603639|12037049|FG003|NOT COMPLETED|Washout Period (at Least 3 Weeks)||1
10871265|NCT03603639|12037050|FG004|NOT COMPLETED|Washout Period (at Least 3 Weeks)||1
10871266|NCT03603639|12037051|FG005|NOT COMPLETED|Washout Period (at Least 3 Weeks)||1
10871267|NCT03603639|12037046|FG000|STARTED|Treatment Period 3 (Day 1)||1
10871268|NCT03603639|12037047|FG001|STARTED|Treatment Period 3 (Day 1)||1
10871269|NCT03603639|12037048|FG002|STARTED|Treatment Period 3 (Day 1)||0
10871270|NCT03603639|12037049|FG003|STARTED|Treatment Period 3 (Day 1)||0
10871271|NCT03603639|12037050|FG004|STARTED|Treatment Period 3 (Day 1)||0
10295506|NCT03113383|11428145|FG000|STARTED|Overall Study||4
10295507|NCT03113383|11428146|FG001|STARTED|Overall Study||0
10295508|NCT03113383|11428145|FG000|COMPLETED|Overall Study||0
10295509|NCT03113383|11428146|FG001|COMPLETED|Overall Study||0
10295510|NCT03113383|11428145|FG000|NOT COMPLETED|Overall Study||4
10295511|NCT03113383|11428146|FG001|NOT COMPLETED|Overall Study||0
10295512|NCT03028896|11428154|FG000|STARTED|Overall Study||66
10295513|NCT03028896|11428155|FG001|STARTED|Overall Study||66
10295514|NCT03028896|11428154|FG000|COMPLETED|Overall Study||63
10295515|NCT03028896|11428155|FG001|COMPLETED|Overall Study||66
10295516|NCT03028896|11428154|FG000|NOT COMPLETED|Overall Study||3
10295517|NCT03028896|11428155|FG001|NOT COMPLETED|Overall Study||0
10295518|NCT03008369|11428161|FG000|STARTED|Overall Study||3
10295519|NCT03008369|11428161|FG000|COMPLETED|Overall Study||3
10295520|NCT03008369|11428161|FG000|NOT COMPLETED|Overall Study||0
10314880|NCT00169442|11448620|FG000|NOT COMPLETED|Overall Study||0
10314881|NCT00169442|11448621|FG001|NOT COMPLETED|Overall Study||1
10314882|NCT00169442|11448622|FG002|NOT COMPLETED|Overall Study||1
10314883|NCT00169442|11448623|FG003|NOT COMPLETED|Overall Study||0
10314884|NCT00169442|11448624|FG004|NOT COMPLETED|Overall Study||1
10314885|NCT00169442|11448625|FG005|NOT COMPLETED|Overall Study||2
10314886|NCT00170157|11448641|FG000|STARTED|Treatment Period 1 Initial Randomization||54
10314887|NCT00170157|11448642|FG001|STARTED|Treatment Period 1 Initial Randomization||58
10314888|NCT00170157|11448641|FG000|COMPLETED|Treatment Period 1 Initial Randomization||54
10314889|NCT00170157|11448642|FG001|COMPLETED|Treatment Period 1 Initial Randomization||58
10314890|NCT00170157|11448641|FG000|NOT COMPLETED|Treatment Period 1 Initial Randomization||0
10314891|NCT00170157|11448642|FG001|NOT COMPLETED|Treatment Period 1 Initial Randomization||0
10314892|NCT00170157|11448641|FG000|STARTED|Washout Period of 14 Days|Participants initially randomized to this arm were not eligible for crossover.|0
10314893|NCT00170157|11448642|FG001|STARTED|Washout Period of 14 Days||58
10314894|NCT00170157|11448641|FG000|COMPLETED|Washout Period of 14 Days||0
10314895|NCT00170157|11448642|FG001|COMPLETED|Washout Period of 14 Days||41
10314896|NCT00170157|11448641|FG000|NOT COMPLETED|Washout Period of 14 Days||0
10314897|NCT00170157|11448642|FG001|NOT COMPLETED|Washout Period of 14 Days||17
10314898|NCT00170157|11448641|FG000|STARTED|Treatment Period 2 Crossover|Participants initially randomized to this arm were not eligible for crossover.|0
10314899|NCT00170157|11448642|FG001|STARTED|Treatment Period 2 Crossover||41
10314900|NCT00170157|11448641|FG000|COMPLETED|Treatment Period 2 Crossover||0
10314901|NCT00170157|11448642|FG001|COMPLETED|Treatment Period 2 Crossover||41
10314902|NCT00170157|11448641|FG000|NOT COMPLETED|Treatment Period 2 Crossover||0
10314903|NCT00170157|11448642|FG001|NOT COMPLETED|Treatment Period 2 Crossover||0
10314904|NCT00170625|11448648|FG000|STARTED|Overall Study||26
10314905|NCT00170625|11448648|FG000|COMPLETED|Overall Study||26
10314906|NCT00170625|11448648|FG000|NOT COMPLETED|Overall Study||0
10314907|NCT00170846|11448655|FG000|STARTED|Overall Study||123
10314908|NCT00170846|11448656|FG001|STARTED|Overall Study||127
10314909|NCT00170846|11448657|FG002|STARTED|Overall Study||144
10314910|NCT00170846|11448655|FG000|COMPLETED|Overall Study||112
10314911|NCT00170846|11448656|FG001|COMPLETED|Overall Study||108
10314912|NCT00170846|11448657|FG002|COMPLETED|Overall Study||131
10314913|NCT00170846|11448655|FG000|NOT COMPLETED|Overall Study||11
10314914|NCT00170846|11448656|FG001|NOT COMPLETED|Overall Study||19
10314915|NCT00170846|11448657|FG002|NOT COMPLETED|Overall Study||13
10314916|NCT00170950|11448667|FG000|STARTED|Overall Study||5744
10314917|NCT00170950|11448668|FG001|STARTED|Overall Study||5762
10314918|NCT00170950|11448667|FG000|COMPLETED|Overall Study||4859
10314919|NCT00170950|11448668|FG001|COMPLETED|Overall Study||4852
10314920|NCT00170950|11448667|FG000|NOT COMPLETED|Overall Study||885
10314921|NCT00170950|11448668|FG001|NOT COMPLETED|Overall Study||910
10314922|NCT00171054|11448676|FG000|STARTED|Overall Study||63
10314923|NCT00171054|11448677|FG001|STARTED|Overall Study||62
10314924|NCT00171054|11448676|FG000|COMPLETED|Overall Study||53
10314925|NCT00171054|11448677|FG001|COMPLETED|Overall Study||50
10314926|NCT00171054|11448676|FG000|NOT COMPLETED|Overall Study||10
10314927|NCT00171054|11448677|FG001|NOT COMPLETED|Overall Study||12
10314928|NCT00171158|11448683|FG000|STARTED|Core Study||260
10314929|NCT00171158|11448683|FG000|COMPLETED|Core Study||21
10314930|NCT00171158|11448683|FG000|NOT COMPLETED|Core Study||239
10314931|NCT00171158|11448683|FG000|STARTED|E2 Extension||8
10314932|NCT00171158|11448683|FG000|COMPLETED|E2 Extension||1
10314933|NCT00171158|11448683|FG000|NOT COMPLETED|E2 Extension||7
10314934|NCT00171210|11448689|FG000|STARTED|Overall Study||259
10314935|NCT00171210|11448690|FG001|STARTED|Overall Study||296
10314936|NCT00171210|11448689|FG000|STARTED EXTENSION STUDY|Overall Study||259
10314937|NCT00171210|11448690|FG001|STARTED EXTENSION STUDY|Overall Study||247
10314938|NCT00171210|11448689|FG000|COMPLETED|Overall Study||190
10314939|NCT00171210|11448690|FG001|COMPLETED|Overall Study||181
10314940|NCT00171210|11448689|FG000|NOT COMPLETED|Overall Study||69
10314941|NCT00171210|11448690|FG001|NOT COMPLETED|Overall Study||115
10871272|NCT03603639|12037051|FG005|STARTED|Treatment Period 3 (Day 1)||0
10871273|NCT03603639|12037046|FG000|COMPLETED|Treatment Period 3 (Day 1)||1
10871274|NCT03603639|12037047|FG001|COMPLETED|Treatment Period 3 (Day 1)||1
10871275|NCT03603639|12037048|FG002|COMPLETED|Treatment Period 3 (Day 1)||0
10871276|NCT03603639|12037049|FG003|COMPLETED|Treatment Period 3 (Day 1)||0
10871277|NCT03603639|12037050|FG004|COMPLETED|Treatment Period 3 (Day 1)||0
10871278|NCT03603639|12037051|FG005|COMPLETED|Treatment Period 3 (Day 1)||0
10871279|NCT03603639|12037046|FG000|NOT COMPLETED|Treatment Period 3 (Day 1)||0
10871280|NCT03603639|12037047|FG001|NOT COMPLETED|Treatment Period 3 (Day 1)||0
10871281|NCT03603639|12037048|FG002|NOT COMPLETED|Treatment Period 3 (Day 1)||0
10871282|NCT03603639|12037049|FG003|NOT COMPLETED|Treatment Period 3 (Day 1)||0
10871283|NCT03603639|12037050|FG004|NOT COMPLETED|Treatment Period 3 (Day 1)||0
10871284|NCT03603639|12037051|FG005|NOT COMPLETED|Treatment Period 3 (Day 1)||0
10871285|NCT03587636|12037063|FG000|STARTED|Overall Study||39
10871286|NCT03587636|12037064|FG001|STARTED|Overall Study||38
10871287|NCT03587636|12037063|FG000|COMPLETED|Overall Study||37
10871288|NCT03587636|12037064|FG001|COMPLETED|Overall Study||33
10871289|NCT03587636|12037063|FG000|NOT COMPLETED|Overall Study||2
10871290|NCT03587636|12037064|FG001|NOT COMPLETED|Overall Study||5
10871291|NCT03574129|12037072|FG000|STARTED|Overall Study||578
10871292|NCT03574129|12037073|FG001|STARTED|Overall Study||488
10871293|NCT03574129|12037072|FG000|COMPLETED|Overall Study||506
10871294|NCT03574129|12037073|FG001|COMPLETED|Overall Study||440
10871295|NCT03574129|12037072|FG000|NOT COMPLETED|Overall Study||72
10871296|NCT03574129|12037073|FG001|NOT COMPLETED|Overall Study||48
10871297|NCT03573336|12037094|FG000|STARTED|Overall Study||2
10871298|NCT03573336|12037095|FG001|STARTED|Overall Study||4
10871299|NCT03573336|12037096|FG002|STARTED|Overall Study||2
10871300|NCT03573336|12037094|FG000|Treated|Overall Study||2
10871301|NCT03573336|12037095|FG001|Treated|Overall Study||4
10871302|NCT03573336|12037096|FG002|Treated|Overall Study||2
10871303|NCT03573336|12037094|FG000|COMPLETED|Overall Study||0
10871304|NCT03573336|12037095|FG001|COMPLETED|Overall Study||0
10871305|NCT03573336|12037096|FG002|COMPLETED|Overall Study||0
10871306|NCT03573336|12037094|FG000|NOT COMPLETED|Overall Study||2
10871307|NCT03573336|12037095|FG001|NOT COMPLETED|Overall Study||4
10871308|NCT03573336|12037096|FG002|NOT COMPLETED|Overall Study||2
10871309|NCT03570697|12037106|FG000|STARTED|Overall Study||82
10871310|NCT03570697|12037107|FG001|STARTED|Overall Study||82
10871311|NCT03570697|12037106|FG000|Received at Least 1 Dose of Study Drug|Overall Study||81
10871312|NCT03570697|12037107|FG001|Received at Least 1 Dose of Study Drug|Overall Study||80
10871313|NCT03570697|12037106|FG000|COMPLETED|Overall Study||76
10871314|NCT03570697|12037107|FG001|COMPLETED|Overall Study||79
10871315|NCT03570697|12037106|FG000|NOT COMPLETED|Overall Study||6
10871316|NCT03570697|12037107|FG001|NOT COMPLETED|Overall Study||3
10871317|NCT03548051|12037115|FG000|STARTED|Overall Study||6
10871318|NCT03548051|12037116|FG001|STARTED|Overall Study||4
10871319|NCT03548051|12037115|FG000|COMPLETED|Overall Study||4
10871320|NCT03548051|12037116|FG001|COMPLETED|Overall Study||3
10871321|NCT03548051|12037115|FG000|NOT COMPLETED|Overall Study||2
10871322|NCT03548051|12037116|FG001|NOT COMPLETED|Overall Study||1
10871323|NCT03525886|12037126|FG000|STARTED|Cohort 1 (50 mg QHS)||8
10871324|NCT03525886|12037127|FG001|STARTED|Cohort 1 (50 mg QHS)||0
10871325|NCT03525886|12037128|FG002|STARTED|Cohort 1 (50 mg QHS)||0
10871326|NCT03525886|12037129|FG003|STARTED|Cohort 1 (50 mg QHS)||0
10871327|NCT03525886|12037126|FG000|COMPLETED|Cohort 1 (50 mg QHS)||8
10871328|NCT03525886|12037127|FG001|COMPLETED|Cohort 1 (50 mg QHS)||0
10871329|NCT03525886|12037128|FG002|COMPLETED|Cohort 1 (50 mg QHS)||0
10871330|NCT03525886|12037129|FG003|COMPLETED|Cohort 1 (50 mg QHS)||0
10871331|NCT03525886|12037126|FG000|NOT COMPLETED|Cohort 1 (50 mg QHS)||0
10871332|NCT03525886|12037127|FG001|NOT COMPLETED|Cohort 1 (50 mg QHS)||0
10871333|NCT03525886|12037128|FG002|NOT COMPLETED|Cohort 1 (50 mg QHS)||0
10871334|NCT03525886|12037129|FG003|NOT COMPLETED|Cohort 1 (50 mg QHS)||0
10871335|NCT03525886|12037126|FG000|STARTED|Cohort 2 (100 mg QHS)||0
10871336|NCT03525886|12037127|FG001|STARTED|Cohort 2 (100 mg QHS)||7
10871337|NCT03525886|12037128|FG002|STARTED|Cohort 2 (100 mg QHS)||0
10871338|NCT03525886|12037129|FG003|STARTED|Cohort 2 (100 mg QHS)||0
10871339|NCT03525886|12037126|FG000|COMPLETED|Cohort 2 (100 mg QHS)||0
10871340|NCT03525886|12037127|FG001|COMPLETED|Cohort 2 (100 mg QHS)||7
10871341|NCT03525886|12037128|FG002|COMPLETED|Cohort 2 (100 mg QHS)||0
10871342|NCT03525886|12037129|FG003|COMPLETED|Cohort 2 (100 mg QHS)||0
10871343|NCT03525886|12037126|FG000|NOT COMPLETED|Cohort 2 (100 mg QHS)||0
10871344|NCT03525886|12037127|FG001|NOT COMPLETED|Cohort 2 (100 mg QHS)||0
10871345|NCT03525886|12037128|FG002|NOT COMPLETED|Cohort 2 (100 mg QHS)||0
10871346|NCT03525886|12037129|FG003|NOT COMPLETED|Cohort 2 (100 mg QHS)||0
10871347|NCT03525886|12037126|FG000|STARTED|Cohort 3 (100 mg QPM)||0
10871348|NCT03525886|12037127|FG001|STARTED|Cohort 3 (100 mg QPM)||0
10871349|NCT03525886|12037128|FG002|STARTED|Cohort 3 (100 mg QPM)||8
10871350|NCT03525886|12037129|FG003|STARTED|Cohort 3 (100 mg QPM)||0
10871351|NCT03525886|12037126|FG000|COMPLETED|Cohort 3 (100 mg QPM)||0
10871352|NCT03525886|12037127|FG001|COMPLETED|Cohort 3 (100 mg QPM)||0
10871353|NCT03525886|12037128|FG002|COMPLETED|Cohort 3 (100 mg QPM)||8
10871354|NCT03525886|12037129|FG003|COMPLETED|Cohort 3 (100 mg QPM)||0
10871355|NCT03525886|12037126|FG000|NOT COMPLETED|Cohort 3 (100 mg QPM)||0
10871356|NCT03525886|12037127|FG001|NOT COMPLETED|Cohort 3 (100 mg QPM)||0
10871357|NCT03525886|12037128|FG002|NOT COMPLETED|Cohort 3 (100 mg QPM)||0
10871358|NCT03525886|12037129|FG003|NOT COMPLETED|Cohort 3 (100 mg QPM)||0
10871359|NCT03525886|12037126|FG000|STARTED|Cohort 4 (100 mg BID)||0
10871360|NCT03525886|12037127|FG001|STARTED|Cohort 4 (100 mg BID)||0
10871361|NCT03525886|12037128|FG002|STARTED|Cohort 4 (100 mg BID)||0
10871362|NCT03525886|12037129|FG003|STARTED|Cohort 4 (100 mg BID)||8
10871363|NCT03525886|12037126|FG000|COMPLETED|Cohort 4 (100 mg BID)||0
10871364|NCT03525886|12037127|FG001|COMPLETED|Cohort 4 (100 mg BID)||0
10871365|NCT03525886|12037128|FG002|COMPLETED|Cohort 4 (100 mg BID)||0
10871366|NCT03525886|12037129|FG003|COMPLETED|Cohort 4 (100 mg BID)||8
10871367|NCT03525886|12037126|FG000|NOT COMPLETED|Cohort 4 (100 mg BID)||0
10871368|NCT03525886|12037127|FG001|NOT COMPLETED|Cohort 4 (100 mg BID)||0
10871369|NCT03525886|12037128|FG002|NOT COMPLETED|Cohort 4 (100 mg BID)||0
10871370|NCT03525886|12037129|FG003|NOT COMPLETED|Cohort 4 (100 mg BID)||0
10871371|NCT03503318|12037142|FG000|STARTED|Overall Study||181
10871372|NCT03503318|12037143|FG001|STARTED|Overall Study||183
10871373|NCT03503318|12037144|FG002|STARTED|Overall Study||180
10871374|NCT03503318|12037142|FG000|Received at Least 1 Dose of Study Drug|Overall Study||179
10871375|NCT03503318|12037143|FG001|Received at Least 1 Dose of Study Drug|Overall Study||183
10871376|NCT03503318|12037144|FG002|Received at Least 1 Dose of Study Drug|Overall Study||180
10871377|NCT03503318|12037142|FG000|COMPLETED|Overall Study||142
10871378|NCT03503318|12037143|FG001|COMPLETED|Overall Study||144
10871379|NCT03503318|12037144|FG002|COMPLETED|Overall Study||140
10871380|NCT03503318|12037142|FG000|NOT COMPLETED|Overall Study||39
10871381|NCT03503318|12037143|FG001|NOT COMPLETED|Overall Study||39
10871382|NCT03503318|12037144|FG002|NOT COMPLETED|Overall Study||40
10871383|NCT03493854|12037154|FG000|STARTED|Neoadjuvant Treatment Phase (24 Weeks)|This includes all randomized participants.|252
10871384|NCT03493854|12037155|FG001|STARTED|Neoadjuvant Treatment Phase (24 Weeks)|This includes all randomized participants.|248
10871385|NCT03493854|12037154|FG000|Received at Least One Dose of Study Drug|Neoadjuvant Treatment Phase (24 Weeks)||252
10871386|NCT03493854|12037155|FG001|Received at Least One Dose of Study Drug|Neoadjuvant Treatment Phase (24 Weeks)||248
10871387|NCT03493854|12037154|FG000|COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||242
10871388|NCT03493854|12037155|FG001|COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||234
10871389|NCT03493854|12037154|FG000|NOT COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||10
10871390|NCT03493854|12037155|FG001|NOT COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||14
10871391|NCT03493854|12037154|FG000|STARTED|Surgery & Adjuvant Treatment (42 Weeks)||242
10871392|NCT03493854|12037155|FG001|STARTED|Surgery & Adjuvant Treatment (42 Weeks)||234
10871393|NCT03493854|12037154|FG000|Completed Surgery|Surgery & Adjuvant Treatment (42 Weeks)||239
10871394|NCT03493854|12037155|FG001|Completed Surgery|Surgery & Adjuvant Treatment (42 Weeks)||234
10871395|NCT03493854|12037154|FG000|COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||0
10871396|NCT03493854|12037155|FG001|COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||0
10871397|NCT03493854|12037154|FG000|NOT COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||242
10871398|NCT03493854|12037155|FG001|NOT COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||234
10871399|NCT03493854|12037154|FG000|STARTED|Treatment-Free Follow-Up (up to 3 Years)|Participants prematurely withdrew from treatment in other periods and entered the follow-up phase.|19
10871400|NCT03493854|12037155|FG001|STARTED|Treatment-Free Follow-Up (up to 3 Years)|Participants prematurely withdrew from treatment in other periods and entered the follow-up phase.|17
10871401|NCT03493854|12037154|FG000|COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||0
10871402|NCT03493854|12037155|FG001|COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||0
10871403|NCT03493854|12037154|FG000|NOT COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||19
10871404|NCT03493854|12037155|FG001|NOT COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||17
10871405|NCT03493451|12037164|FG000|STARTED|Overall Study||22
10871406|NCT03493451|12037165|FG001|STARTED|Overall Study||44
10871407|NCT03493451|12037166|FG002|STARTED|Overall Study||11
10871408|NCT03493451|12037164|FG000|COMPLETED|Overall Study||0
10871409|NCT03493451|12037165|FG001|COMPLETED|Overall Study||0
10871410|NCT03493451|12037166|FG002|COMPLETED|Overall Study||0
10871411|NCT03493451|12037164|FG000|NOT COMPLETED|Overall Study||22
10871412|NCT03493451|12037165|FG001|NOT COMPLETED|Overall Study||44
10871413|NCT03493451|12037166|FG002|NOT COMPLETED|Overall Study||11
10871414|NCT03476239|12037174|FG000|STARTED|Overall Study||121
10871415|NCT03476239|12037174|FG000|Received Blinatumomab|Overall Study||120
10871416|NCT03476239|12037174|FG000|Interim Analysis Set|Overall Study||90
10871417|NCT03476239|12037174|FG000|COMPLETED|Overall Study||23
10871418|NCT03476239|12037174|FG000|NOT COMPLETED|Overall Study||98
10871425|NCT03401749|12037190|FG000|STARTED|Overall Study||59
10871426|NCT03401749|12037191|FG001|STARTED|Overall Study||67
10871427|NCT03401749|12037192|FG002|STARTED|Overall Study||77
10871428|NCT03401749|12037190|FG000|COMPLETED|Overall Study||39
10871429|NCT03401749|12037191|FG001|COMPLETED|Overall Study||51
10871430|NCT03401749|12037192|FG002|COMPLETED|Overall Study||51
10871431|NCT03401749|12037190|FG000|NOT COMPLETED|Overall Study||20
10871432|NCT03401749|12037191|FG001|NOT COMPLETED|Overall Study||16
10871433|NCT03401749|12037192|FG002|NOT COMPLETED|Overall Study||26
10871434|NCT03337113|12037204|FG000|STARTED|Overall Study||13
10871435|NCT03337113|12037205|FG001|STARTED|Overall Study||12
10871436|NCT03337113|12037206|FG002|STARTED|Overall Study||12
10871437|NCT03337113|12037207|FG003|STARTED|Overall Study||13
10871438|NCT03337113|12037204|FG000|COMPLETED|Overall Study||12
10871439|NCT03337113|12037205|FG001|COMPLETED|Overall Study||9
10871440|NCT03337113|12037206|FG002|COMPLETED|Overall Study||11
10871441|NCT03337113|12037207|FG003|COMPLETED|Overall Study||11
10871442|NCT03337113|12037204|FG000|NOT COMPLETED|Overall Study||1
10871443|NCT03337113|12037205|FG001|NOT COMPLETED|Overall Study||3
10871444|NCT03337113|12037206|FG002|NOT COMPLETED|Overall Study||1
10871445|NCT03337113|12037207|FG003|NOT COMPLETED|Overall Study||2
10419081|NCT00808509|11563867|FG000|STARTED|Observation Phase|The observation phase was open to all participants|16
10419082|NCT00808509|11563868|FG001|STARTED|Observation Phase|The observation phase was open to all participants|15
10419083|NCT00808509|11563867|FG000|COMPLETED|Observation Phase||16
10419084|NCT00808509|11563868|FG001|COMPLETED|Observation Phase||15
10419085|NCT00808509|11563867|FG000|NOT COMPLETED|Observation Phase||0
10419086|NCT00808509|11563868|FG001|NOT COMPLETED|Observation Phase||0
10419087|NCT00808639|11563876|FG000|STARTED|Overall Study||39
10419088|NCT00808639|11563876|FG000|COMPLETED|Overall Study|One patient went off treatment due to disease progression before surgery.|38
10419089|NCT00808639|11563876|FG000|NOT COMPLETED|Overall Study||1
10419090|NCT00808665|11563882|FG000|STARTED|Overall Study||31
10419091|NCT00808665|11563883|FG001|STARTED|Overall Study||32
10419092|NCT00808665|11563882|FG000|Medication Started|Overall Study||30
10419093|NCT00808665|11563883|FG001|Medication Started|Overall Study||32
10419094|NCT00808665|11563882|FG000|Completed Intra-operative Dose|Overall Study||26
10419095|NCT00808665|11563883|FG001|Completed Intra-operative Dose|Overall Study||32
10419096|NCT00808665|11563882|FG000|Completed Post Operative Doses|Overall Study||25
10419097|NCT00808665|11563883|FG001|Completed Post Operative Doses|Overall Study||29
10419098|NCT00808665|11563882|FG000|COMPLETED|Overall Study||25
10419099|NCT00808665|11563883|FG001|COMPLETED|Overall Study||29
10871491|NCT03233048|12037241|FG000|STARTED|Overall Study||5
10871492|NCT03233048|12037241|FG000|COMPLETED|Overall Study||4
10871493|NCT03233048|12037241|FG000|NOT COMPLETED|Overall Study||1
10871494|NCT03138252|12037247|FG000|STARTED|Overall Study||90
10871495|NCT03138252|12037248|FG001|STARTED|Overall Study||90
10871496|NCT03138252|12037247|FG000|COMPLETED|Overall Study||90
10871497|NCT03138252|12037248|FG001|COMPLETED|Overall Study||90
10871498|NCT03138252|12037247|FG000|NOT COMPLETED|Overall Study||0
10871499|NCT03138252|12037248|FG001|NOT COMPLETED|Overall Study||0
10419100|NCT00808665|11563882|FG000|NOT COMPLETED|Overall Study||6
10419101|NCT00808665|11563883|FG001|NOT COMPLETED|Overall Study||3
10419102|NCT00808808|11563892|FG000|STARTED|Overall Study|Started includes all employees at participating sites.|4078
10419103|NCT00808808|11563893|FG001|STARTED|Overall Study|Started includes all employees at participating sites|3757
10419104|NCT00808808|11563894|FG002|STARTED|Overall Study|Started includes all employees at participating sites.|4387
10419105|NCT00808808|11563892|FG000|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|1392
10419106|NCT00808808|11563893|FG001|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|1489
10419107|NCT00808808|11563894|FG002|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|2132
10419108|NCT00808808|11563892|FG000|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1261
10419109|NCT00808808|11563893|FG001|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1320
10419110|NCT00808808|11563894|FG002|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1830
10419111|NCT00808808|11563892|FG000|NOT COMPLETED|Overall Study||2817
10419112|NCT00808808|11563893|FG001|NOT COMPLETED|Overall Study||2437
10419113|NCT00808808|11563894|FG002|NOT COMPLETED|Overall Study||2557
10419114|NCT00808834|11563908|FG000|STARTED|Period 1||97
10419115|NCT00808834|11563909|FG001|STARTED|Period 1||99
10419116|NCT00808834|11563908|FG000|COMPLETED|Period 1||97
10419117|NCT00808834|11563909|FG001|COMPLETED|Period 1||99
10419118|NCT00808834|11563908|FG000|NOT COMPLETED|Period 1||0
10419119|NCT00808834|11563909|FG001|NOT COMPLETED|Period 1||0
10419120|NCT00808834|11563908|FG000|STARTED|Period 2||97
10419121|NCT00808834|11563909|FG001|STARTED|Period 2||99
10419122|NCT00808834|11563908|FG000|COMPLETED|Period 2||97
10419123|NCT00808834|11563909|FG001|COMPLETED|Period 2||99
10419124|NCT00808834|11563908|FG000|NOT COMPLETED|Period 2||0
10419125|NCT00808834|11563909|FG001|NOT COMPLETED|Period 2||0
10419126|NCT00809055|11563917|FG000|STARTED|Overall Study||37
10419127|NCT00809055|11563918|FG001|STARTED|Overall Study||37
10419128|NCT00809055|11563917|FG000|COMPLETED|Overall Study||28
10419129|NCT00809055|11563918|FG001|COMPLETED|Overall Study||30
10419130|NCT00809055|11563917|FG000|NOT COMPLETED|Overall Study||9
10419131|NCT00809055|11563918|FG001|NOT COMPLETED|Overall Study||7
10419132|NCT00809094|11563926|FG000|STARTED|Overall Study||36
10419133|NCT00809094|11563927|FG001|STARTED|Overall Study||34
10419134|NCT00809094|11563926|FG000|COMPLETED|Overall Study||36
10419135|NCT00809094|11563927|FG001|COMPLETED|Overall Study||33
10419136|NCT00809094|11563926|FG000|NOT COMPLETED|Overall Study||0
10419137|NCT00809094|11563927|FG001|NOT COMPLETED|Overall Study||1
10419138|NCT00809133|11563947|FG000|STARTED|Overall Study||3
10419139|NCT00809133|11563948|FG001|STARTED|Overall Study||7
10419140|NCT00809133|11563949|FG002|STARTED|Overall Study||6
10419141|NCT00809133|11563950|FG003|STARTED|Overall Study||3
10419142|NCT00809133|11563951|FG004|STARTED|Overall Study||5
10419143|NCT00809133|11563952|FG005|STARTED|Overall Study||7
10419144|NCT00809133|11563953|FG006|STARTED|Overall Study||6
10419145|NCT00809133|11563954|FG007|STARTED|Overall Study||8
10419146|NCT00809133|11563955|FG008|STARTED|Overall Study||3
10419147|NCT00809133|11563956|FG009|STARTED|Overall Study||9
10295521|NCT02978326|11428168|FG000|STARTED|Part A (Up to 75 Days)||1
10295522|NCT02978326|11428169|FG001|STARTED|Part A (Up to 75 Days)||0
10295523|NCT02978326|11428170|FG002|STARTED|Part A (Up to 75 Days)||0
10295524|NCT02978326|11428168|FG000|COMPLETED|Part A (Up to 75 Days)||1
10295525|NCT02978326|11428169|FG001|COMPLETED|Part A (Up to 75 Days)||0
10295526|NCT02978326|11428170|FG002|COMPLETED|Part A (Up to 75 Days)||0
10295527|NCT02978326|11428168|FG000|NOT COMPLETED|Part A (Up to 75 Days)||0
10295528|NCT02978326|11428169|FG001|NOT COMPLETED|Part A (Up to 75 Days)||0
10295529|NCT02978326|11428170|FG002|NOT COMPLETED|Part A (Up to 75 Days)||0
10295530|NCT02978326|11428168|FG000|STARTED|Part B (Up to 45 Days)||0
10295531|NCT02978326|11428169|FG001|STARTED|Part B (Up to 45 Days)||76
10295532|NCT02978326|11428170|FG002|STARTED|Part B (Up to 45 Days)||77
10295533|NCT02978326|11428168|FG000|Received Study Drug|Part B (Up to 45 Days)||0
10295534|NCT02978326|11428169|FG001|Received Study Drug|Part B (Up to 45 Days)||73
10295535|NCT02978326|11428170|FG002|Received Study Drug|Part B (Up to 45 Days)|Two participants were randomized to placebo but received at least 1 dose of SAGE-217 in error and were included in the SAGE-217 group for 'Received Study Drug' and for 'Safety Analysis'.|78
10295536|NCT02978326|11428168|FG000|Safety Set (Part B)|Part B (Up to 45 Days)||0
10295537|NCT02978326|11428169|FG001|Safety Set (Part B)|Part B (Up to 45 Days)||73
10295538|NCT02978326|11428170|FG002|Safety Set (Part B)|Part B (Up to 45 Days)||78
10295539|NCT02978326|11428168|FG000|Efficacy Set (Part B)|Part B (Up to 45 Days)||0
10295540|NCT02978326|11428169|FG001|Efficacy Set (Part B)|Part B (Up to 45 Days)||74
10295541|NCT02978326|11428170|FG002|Efficacy Set (Part B)|Part B (Up to 45 Days)||76
10295542|NCT02978326|11428168|FG000|COMPLETED|Part B (Up to 45 Days)||0
10295543|NCT02978326|11428169|FG001|COMPLETED|Part B (Up to 45 Days)||69
10295544|NCT02978326|11428170|FG002|COMPLETED|Part B (Up to 45 Days)||73
10295545|NCT02978326|11428168|FG000|NOT COMPLETED|Part B (Up to 45 Days)||0
10295546|NCT02978326|11428169|FG001|NOT COMPLETED|Part B (Up to 45 Days)||7
10295547|NCT02978326|11428170|FG002|NOT COMPLETED|Part B (Up to 45 Days)||4
10295548|NCT02970929|11428180|FG000|STARTED|Overall Study||157
10295549|NCT02970929|11428180|FG000|Subjects Who Received Study Medication|Overall Study||156
10545977|NCT01501110|11699506|FG000|STARTED|Overall Study||34
10545978|NCT01501110|11699507|FG001|STARTED|Overall Study||34
10545979|NCT01501110|11699506|FG000|COMPLETED|Overall Study||34
10545980|NCT01501110|11699507|FG001|COMPLETED|Overall Study||33
10545981|NCT01501110|11699506|FG000|NOT COMPLETED|Overall Study||0
10545982|NCT01501110|11699507|FG001|NOT COMPLETED|Overall Study||1
10295550|NCT02970929|11428180|FG000|COMPLETED|Overall Study||105
10419148|NCT00809133|11563957|FG010|STARTED|Overall Study||6
10545983|NCT01501162|11699515|FG000|STARTED|Overall Study||65
10545984|NCT01501162|11699516|FG001|STARTED|Overall Study||65
10545985|NCT01501162|11699515|FG000|COMPLETED|Overall Study||57
10545986|NCT01501162|11699516|FG001|COMPLETED|Overall Study||60
10419149|NCT00809133|11563958|FG011|STARTED|Overall Study||8
10419150|NCT00809133|11563959|FG012|STARTED|Overall Study||5
10419151|NCT00809133|11563960|FG013|STARTED|Overall Study||7
10419152|NCT00809133|11563947|FG000|COMPLETED|Overall Study||0
10419153|NCT00809133|11563948|FG001|COMPLETED|Overall Study||0
10419154|NCT00809133|11563949|FG002|COMPLETED|Overall Study||0
10419155|NCT00809133|11563950|FG003|COMPLETED|Overall Study||0
10419156|NCT00809133|11563951|FG004|COMPLETED|Overall Study||0
10419157|NCT00809133|11563952|FG005|COMPLETED|Overall Study||0
10419158|NCT00809133|11563953|FG006|COMPLETED|Overall Study||0
10419159|NCT00809133|11563954|FG007|COMPLETED|Overall Study||0
10419160|NCT00809133|11563955|FG008|COMPLETED|Overall Study||0
10419161|NCT00809133|11563956|FG009|COMPLETED|Overall Study||0
10419162|NCT00809133|11563957|FG010|COMPLETED|Overall Study||0
10419163|NCT00809133|11563958|FG011|COMPLETED|Overall Study||0
10419164|NCT00809133|11563959|FG012|COMPLETED|Overall Study||0
10419165|NCT00809133|11563960|FG013|COMPLETED|Overall Study||0
10419166|NCT00809133|11563947|FG000|NOT COMPLETED|Overall Study||3
10419167|NCT00809133|11563948|FG001|NOT COMPLETED|Overall Study||7
10419168|NCT00809133|11563949|FG002|NOT COMPLETED|Overall Study||6
10419169|NCT00809133|11563950|FG003|NOT COMPLETED|Overall Study||3
10419170|NCT00809133|11563951|FG004|NOT COMPLETED|Overall Study||5
10419171|NCT00809133|11563952|FG005|NOT COMPLETED|Overall Study||7
10419172|NCT00809133|11563953|FG006|NOT COMPLETED|Overall Study||6
10419173|NCT00809133|11563954|FG007|NOT COMPLETED|Overall Study||8
10419174|NCT00809133|11563955|FG008|NOT COMPLETED|Overall Study||3
10419175|NCT00809133|11563956|FG009|NOT COMPLETED|Overall Study||9
10419176|NCT00809133|11563957|FG010|NOT COMPLETED|Overall Study||6
10419177|NCT00809133|11563958|FG011|NOT COMPLETED|Overall Study||8
10419178|NCT00809133|11563959|FG012|NOT COMPLETED|Overall Study||5
10419179|NCT00809133|11563960|FG013|NOT COMPLETED|Overall Study||7
10419180|NCT00809146|11564005|FG000|STARTED|Overall Study||448
10871530|NCT02943993|12037291|FG000|STARTED|Overall Study|Disposition data are based on Baseline Analysis Set (BAS) defined as All-Documented Patient Set participants with any documentation at the Baseline data collection point who fulfil the BAS criteria.|2655
10871531|NCT02943993|12037291|FG000|COMPLETED|Overall Study||2325
10871532|NCT02943993|12037291|FG000|NOT COMPLETED|Overall Study||330
10871533|NCT02939989|12037297|FG000|STARTED|Overall Study||5
10871534|NCT02939989|12037298|FG001|STARTED|Overall Study||28
10871535|NCT02939989|12037297|FG000|COMPLETED|Overall Study||5
10871536|NCT02939989|12037298|FG001|COMPLETED|Overall Study||28
10871537|NCT02939989|12037297|FG000|NOT COMPLETED|Overall Study||0
10871538|NCT02939989|12037298|FG001|NOT COMPLETED|Overall Study||0
10871539|NCT02877134|12037313|FG000|STARTED|Overall Study||72
10871540|NCT02877134|12037314|FG001|STARTED|Overall Study||73
10871541|NCT02877134|12037315|FG002|STARTED|Overall Study||48
10871542|NCT02877134|12037316|FG003|STARTED|Overall Study||50
10871543|NCT02877134|12037317|FG004|STARTED|Overall Study||49
10871544|NCT02877134|12037318|FG005|STARTED|Overall Study||49
10871545|NCT02877134|12037319|FG006|STARTED|Overall Study||47
10871546|NCT02877134|12037313|FG000|Placebo Non Responders at Week 12|Overall Study||44
10871547|NCT02877134|12037314|FG001|Placebo Non Responders at Week 12|Overall Study||0
10871548|NCT02877134|12037315|FG002|Placebo Non Responders at Week 12|Overall Study||31
10871549|NCT02877134|12037316|FG003|Placebo Non Responders at Week 12|Overall Study||0
10871550|NCT02877134|12037317|FG004|Placebo Non Responders at Week 12|Overall Study||0
10871551|NCT02877134|12037318|FG005|Placebo Non Responders at Week 12|Overall Study||0
10871552|NCT02877134|12037319|FG006|Placebo Non Responders at Week 12|Overall Study||0
10871553|NCT02877134|12037313|FG000|COMPLETED|Overall Study||58
10871554|NCT02877134|12037314|FG001|COMPLETED|Overall Study||48
10871555|NCT02877134|12037315|FG002|COMPLETED|Overall Study||42
10871556|NCT02877134|12037316|FG003|COMPLETED|Overall Study||37
10871557|NCT02877134|12037317|FG004|COMPLETED|Overall Study||43
10871558|NCT02877134|12037318|FG005|COMPLETED|Overall Study||42
10871559|NCT02877134|12037319|FG006|COMPLETED|Overall Study||46
10871560|NCT02877134|12037313|FG000|NOT COMPLETED|Overall Study||14
10871561|NCT02877134|12037314|FG001|NOT COMPLETED|Overall Study||25
10871562|NCT02877134|12037315|FG002|NOT COMPLETED|Overall Study||6
10871563|NCT02877134|12037316|FG003|NOT COMPLETED|Overall Study||13
10871564|NCT02877134|12037317|FG004|NOT COMPLETED|Overall Study||6
10871565|NCT02877134|12037318|FG005|NOT COMPLETED|Overall Study||7
10871566|NCT02877134|12037319|FG006|NOT COMPLETED|Overall Study||1
10871567|NCT02762708|12037341|FG000|STARTED|Study 1 - RYGB vs Caloric Restriction||3
10871568|NCT02762708|12037342|FG001|STARTED|Study 1 - RYGB vs Caloric Restriction||9
10871569|NCT02762708|12037343|FG002|STARTED|Study 1 - RYGB vs Caloric Restriction||0
10871570|NCT02762708|12037344|FG003|STARTED|Study 1 - RYGB vs Caloric Restriction||0
10871571|NCT02762708|12037341|FG000|COMPLETED|Study 1 - RYGB vs Caloric Restriction||3
10871572|NCT02762708|12037342|FG001|COMPLETED|Study 1 - RYGB vs Caloric Restriction||7
10871573|NCT02762708|12037343|FG002|COMPLETED|Study 1 - RYGB vs Caloric Restriction||0
10871574|NCT02762708|12037344|FG003|COMPLETED|Study 1 - RYGB vs Caloric Restriction||0
10871575|NCT02762708|12037341|FG000|NOT COMPLETED|Study 1 - RYGB vs Caloric Restriction||0
10871576|NCT02762708|12037342|FG001|NOT COMPLETED|Study 1 - RYGB vs Caloric Restriction||2
10871577|NCT02762708|12037343|FG002|NOT COMPLETED|Study 1 - RYGB vs Caloric Restriction||0
10871578|NCT02762708|12037344|FG003|NOT COMPLETED|Study 1 - RYGB vs Caloric Restriction||0
10871579|NCT02762708|12037341|FG000|STARTED|Study 2 - Exendin (9,39) Amide Study||0
10871580|NCT02762708|12037342|FG001|STARTED|Study 2 - Exendin (9,39) Amide Study||0
10871581|NCT02762708|12037343|FG002|STARTED|Study 2 - Exendin (9,39) Amide Study||1
10871582|NCT02762708|12037344|FG003|STARTED|Study 2 - Exendin (9,39) Amide Study||0
10871583|NCT02762708|12037341|FG000|COMPLETED|Study 2 - Exendin (9,39) Amide Study||0
10871584|NCT02762708|12037342|FG001|COMPLETED|Study 2 - Exendin (9,39) Amide Study||0
10871585|NCT02762708|12037343|FG002|COMPLETED|Study 2 - Exendin (9,39) Amide Study||1
10871586|NCT02762708|12037344|FG003|COMPLETED|Study 2 - Exendin (9,39) Amide Study||0
10871587|NCT02762708|12037341|FG000|NOT COMPLETED|Study 2 - Exendin (9,39) Amide Study||0
10871588|NCT02762708|12037342|FG001|NOT COMPLETED|Study 2 - Exendin (9,39) Amide Study||0
10871589|NCT02762708|12037343|FG002|NOT COMPLETED|Study 2 - Exendin (9,39) Amide Study||0
10871590|NCT02762708|12037344|FG003|NOT COMPLETED|Study 2 - Exendin (9,39) Amide Study||0
10871603|NCT02720952|12037363|FG000|STARTED|Overall Study||24
10871604|NCT02720952|12037363|FG000|COMPLETED|Overall Study||24
10871605|NCT02720952|12037363|FG000|NOT COMPLETED|Overall Study||0
10871624|NCT02557945|12037395|FG000|STARTED|Overall Study||3
10871625|NCT02557945|12037396|FG001|STARTED|Overall Study||3
10871626|NCT02557945|12037395|FG000|COMPLETED|Overall Study||3
10871627|NCT02557945|12037396|FG001|COMPLETED|Overall Study||3
10871628|NCT02557945|12037395|FG000|NOT COMPLETED|Overall Study||0
10871629|NCT02557945|12037396|FG001|NOT COMPLETED|Overall Study||0
10871630|NCT02553915|12037406|FG000|STARTED|Overall Study||15
10871631|NCT02553915|12037407|FG001|STARTED|Overall Study||15
10871632|NCT02553915|12037408|FG002|STARTED|Overall Study||15
10871633|NCT02553915|12037409|FG003|STARTED|Overall Study||16
10871634|NCT02553915|12037406|FG000|COMPLETED|Overall Study||11
10871635|NCT02553915|12037407|FG001|COMPLETED|Overall Study||14
10871636|NCT02553915|12037408|FG002|COMPLETED|Overall Study||12
10871637|NCT02553915|12037409|FG003|COMPLETED|Overall Study||13
10871638|NCT02553915|12037406|FG000|NOT COMPLETED|Overall Study||4
10871639|NCT02553915|12037407|FG001|NOT COMPLETED|Overall Study||1
10871640|NCT02553915|12037408|FG002|NOT COMPLETED|Overall Study||3
10871641|NCT02553915|12037409|FG003|NOT COMPLETED|Overall Study||3
10871642|NCT02550873|12037421|FG000|STARTED|Randomized Double Blind||78
10871643|NCT02550873|12037422|FG001|STARTED|Randomized Double Blind||39
10871644|NCT02550873|12037423|FG002|STARTED|Randomized Double Blind||0
10871645|NCT02550873|12037421|FG000|Received Treatment|Randomized Double Blind||77
10871646|NCT02550873|12037422|FG001|Received Treatment|Randomized Double Blind||39
10871647|NCT02550873|12037423|FG002|Received Treatment|Randomized Double Blind||0
10871648|NCT02550873|12037421|FG000|Continue to Open Label Extension|Randomized Double Blind||74
10871649|NCT02550873|12037422|FG001|Continue to Open Label Extension|Randomized Double Blind||37
10871650|NCT02550873|12037423|FG002|Continue to Open Label Extension|Randomized Double Blind||0
10871651|NCT02550873|12037421|FG000|COMPLETED|Randomized Double Blind||74
10871652|NCT02550873|12037422|FG001|COMPLETED|Randomized Double Blind||37
10871653|NCT02550873|12037423|FG002|COMPLETED|Randomized Double Blind||0
10871654|NCT02550873|12037421|FG000|NOT COMPLETED|Randomized Double Blind||4
10871655|NCT02550873|12037422|FG001|NOT COMPLETED|Randomized Double Blind||2
10871656|NCT02550873|12037423|FG002|NOT COMPLETED|Randomized Double Blind||0
10871657|NCT02550873|12037421|FG000|STARTED|Open Label Extension||0
10871658|NCT02550873|12037422|FG001|STARTED|Open Label Extension||0
10871659|NCT02550873|12037423|FG002|STARTED|Open Label Extension||111
10871660|NCT02550873|12037421|FG000|COMPLETED|Open Label Extension||0
10871661|NCT02550873|12037422|FG001|COMPLETED|Open Label Extension||0
10871662|NCT02550873|12037423|FG002|COMPLETED|Open Label Extension|Open Label extension is ongoing|0
10871663|NCT02550873|12037421|FG000|NOT COMPLETED|Open Label Extension||0
10871664|NCT02550873|12037422|FG001|NOT COMPLETED|Open Label Extension||0
10871665|NCT02550873|12037423|FG002|NOT COMPLETED|Open Label Extension||111
10871666|NCT02542267|12037445|FG000|STARTED|Overall Study||108
10871667|NCT02542267|12037445|FG000|COMPLETED|Overall Study||53
10871668|NCT02542267|12037445|FG000|NOT COMPLETED|Overall Study||55
10871669|NCT02462603|12037449|FG000|STARTED|Overall Study||44
10871670|NCT02462603|12037449|FG000|Received at Least 1 Dose of Study Drug|Overall Study||41
10871671|NCT02462603|12037449|FG000|EITT Population|Overall Study||40
10871672|NCT02462603|12037449|FG000|COMPLETED|Overall Study||40
10871673|NCT02462603|12037449|FG000|NOT COMPLETED|Overall Study||4
10871674|NCT02438410|12037453|FG000|STARTED|Overall Study||13
10871675|NCT02438410|12037453|FG000|COMPLETED|Overall Study||13
10871676|NCT02438410|12037453|FG000|NOT COMPLETED|Overall Study||0
10871677|NCT02420717|12037460|FG000|STARTED|Overall Study||5
10871678|NCT02420717|12037461|FG001|STARTED|Overall Study||3
10871679|NCT02420717|12037462|FG002|STARTED|Overall Study||3
10871680|NCT02420717|12037460|FG000|COMPLETED|Overall Study||3
10871681|NCT02420717|12037461|FG001|COMPLETED|Overall Study||3
10871682|NCT02420717|12037462|FG002|COMPLETED|Overall Study||3
10871683|NCT02420717|12037460|FG000|NOT COMPLETED|Overall Study||2
10871684|NCT02420717|12037461|FG001|NOT COMPLETED|Overall Study||0
10871685|NCT02420717|12037462|FG002|NOT COMPLETED|Overall Study||0
10871686|NCT02408068|12037470|FG000|STARTED|Treatment 1 (1.5 Days)||3
10871687|NCT02408068|12037471|FG001|STARTED|Treatment 1 (1.5 Days)||3
10871688|NCT02408068|12037472|FG002|STARTED|Treatment 1 (1.5 Days)||3
10871689|NCT02408068|12037473|FG003|STARTED|Treatment 1 (1.5 Days)||3
10871690|NCT02408068|12037474|FG004|STARTED|Treatment 1 (1.5 Days)||3
10871691|NCT02408068|12037475|FG005|STARTED|Treatment 1 (1.5 Days)||3
10871692|NCT02408068|12037470|FG000|COMPLETED|Treatment 1 (1.5 Days)||3
10871693|NCT02408068|12037471|FG001|COMPLETED|Treatment 1 (1.5 Days)||3
10871694|NCT02408068|12037472|FG002|COMPLETED|Treatment 1 (1.5 Days)||3
10871695|NCT02408068|12037473|FG003|COMPLETED|Treatment 1 (1.5 Days)||3
10871696|NCT02408068|12037474|FG004|COMPLETED|Treatment 1 (1.5 Days)||3
10871697|NCT02408068|12037475|FG005|COMPLETED|Treatment 1 (1.5 Days)||3
10871698|NCT02408068|12037470|FG000|NOT COMPLETED|Treatment 1 (1.5 Days)||0
10871699|NCT02408068|12037471|FG001|NOT COMPLETED|Treatment 1 (1.5 Days)||0
10871700|NCT02408068|12037472|FG002|NOT COMPLETED|Treatment 1 (1.5 Days)||0
10871701|NCT02408068|12037473|FG003|NOT COMPLETED|Treatment 1 (1.5 Days)||0
10871702|NCT02408068|12037474|FG004|NOT COMPLETED|Treatment 1 (1.5 Days)||0
10871703|NCT02408068|12037475|FG005|NOT COMPLETED|Treatment 1 (1.5 Days)||0
10871704|NCT02408068|12037470|FG000|STARTED|Washout Period 1 (7 Days)||3
10871705|NCT02408068|12037471|FG001|STARTED|Washout Period 1 (7 Days)||3
10871706|NCT02408068|12037472|FG002|STARTED|Washout Period 1 (7 Days)||3
10871707|NCT02408068|12037473|FG003|STARTED|Washout Period 1 (7 Days)||3
10871708|NCT02408068|12037474|FG004|STARTED|Washout Period 1 (7 Days)||3
10871709|NCT02408068|12037475|FG005|STARTED|Washout Period 1 (7 Days)||3
10871710|NCT02408068|12037470|FG000|COMPLETED|Washout Period 1 (7 Days)||3
10871711|NCT02408068|12037471|FG001|COMPLETED|Washout Period 1 (7 Days)||3
10871712|NCT02408068|12037472|FG002|COMPLETED|Washout Period 1 (7 Days)||3
10871713|NCT02408068|12037473|FG003|COMPLETED|Washout Period 1 (7 Days)||3
10871714|NCT02408068|12037474|FG004|COMPLETED|Washout Period 1 (7 Days)||3
10871715|NCT02408068|12037475|FG005|COMPLETED|Washout Period 1 (7 Days)||3
10871716|NCT02408068|12037470|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
10871717|NCT02408068|12037471|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
10871718|NCT02408068|12037472|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
10871719|NCT02408068|12037473|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
10871720|NCT02408068|12037474|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
10871721|NCT02408068|12037475|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
10871722|NCT02408068|12037470|FG000|STARTED|Treatment 2 (1.5 Days)||3
10871723|NCT02408068|12037471|FG001|STARTED|Treatment 2 (1.5 Days)||3
10871724|NCT02408068|12037472|FG002|STARTED|Treatment 2 (1.5 Days)||3
10871725|NCT02408068|12037473|FG003|STARTED|Treatment 2 (1.5 Days)||3
10871726|NCT02408068|12037474|FG004|STARTED|Treatment 2 (1.5 Days)||3
10871727|NCT02408068|12037475|FG005|STARTED|Treatment 2 (1.5 Days)||3
10871728|NCT02408068|12037470|FG000|COMPLETED|Treatment 2 (1.5 Days)||3
10871729|NCT02408068|12037471|FG001|COMPLETED|Treatment 2 (1.5 Days)||3
10871730|NCT02408068|12037472|FG002|COMPLETED|Treatment 2 (1.5 Days)||3
10871731|NCT02408068|12037473|FG003|COMPLETED|Treatment 2 (1.5 Days)||3
10871732|NCT02408068|12037474|FG004|COMPLETED|Treatment 2 (1.5 Days)||3
10871733|NCT02408068|12037475|FG005|COMPLETED|Treatment 2 (1.5 Days)||3
10871734|NCT02408068|12037470|FG000|NOT COMPLETED|Treatment 2 (1.5 Days)||0
10871735|NCT02408068|12037471|FG001|NOT COMPLETED|Treatment 2 (1.5 Days)||0
10871736|NCT02408068|12037472|FG002|NOT COMPLETED|Treatment 2 (1.5 Days)||0
10871737|NCT02408068|12037473|FG003|NOT COMPLETED|Treatment 2 (1.5 Days)||0
10871738|NCT02408068|12037474|FG004|NOT COMPLETED|Treatment 2 (1.5 Days)||0
10871739|NCT02408068|12037475|FG005|NOT COMPLETED|Treatment 2 (1.5 Days)||0
10871740|NCT02408068|12037470|FG000|STARTED|Washout Period 2 (7 Days)||3
10871741|NCT02408068|12037471|FG001|STARTED|Washout Period 2 (7 Days)||3
10871742|NCT02408068|12037472|FG002|STARTED|Washout Period 2 (7 Days)||3
10871743|NCT02408068|12037473|FG003|STARTED|Washout Period 2 (7 Days)||3
10871744|NCT02408068|12037474|FG004|STARTED|Washout Period 2 (7 Days)||3
10871745|NCT02408068|12037475|FG005|STARTED|Washout Period 2 (7 Days)||3
10871746|NCT02408068|12037470|FG000|COMPLETED|Washout Period 2 (7 Days)||3
10871747|NCT02408068|12037471|FG001|COMPLETED|Washout Period 2 (7 Days)||3
10871748|NCT02408068|12037472|FG002|COMPLETED|Washout Period 2 (7 Days)||3
10871749|NCT02408068|12037473|FG003|COMPLETED|Washout Period 2 (7 Days)||3
10871750|NCT02408068|12037474|FG004|COMPLETED|Washout Period 2 (7 Days)||3
10871751|NCT02408068|12037475|FG005|COMPLETED|Washout Period 2 (7 Days)||3
10871752|NCT02408068|12037470|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
10871753|NCT02408068|12037471|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
10871754|NCT02408068|12037472|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
10871755|NCT02408068|12037473|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
10871756|NCT02408068|12037474|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
10871757|NCT02408068|12037475|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
10871758|NCT02408068|12037470|FG000|STARTED|Treatment 3 (1.5 Days)||3
10871759|NCT02408068|12037471|FG001|STARTED|Treatment 3 (1.5 Days)||3
10871760|NCT02408068|12037472|FG002|STARTED|Treatment 3 (1.5 Days)||3
10871761|NCT02408068|12037473|FG003|STARTED|Treatment 3 (1.5 Days)||3
10871762|NCT02408068|12037474|FG004|STARTED|Treatment 3 (1.5 Days)||3
10871763|NCT02408068|12037475|FG005|STARTED|Treatment 3 (1.5 Days)||3
10871764|NCT02408068|12037470|FG000|COMPLETED|Treatment 3 (1.5 Days)||3
10871765|NCT02408068|12037471|FG001|COMPLETED|Treatment 3 (1.5 Days)||3
10871766|NCT02408068|12037472|FG002|COMPLETED|Treatment 3 (1.5 Days)||2
10871767|NCT02408068|12037473|FG003|COMPLETED|Treatment 3 (1.5 Days)||3
10871768|NCT02408068|12037474|FG004|COMPLETED|Treatment 3 (1.5 Days)||3
10871769|NCT02408068|12037475|FG005|COMPLETED|Treatment 3 (1.5 Days)||3
10871770|NCT02408068|12037470|FG000|NOT COMPLETED|Treatment 3 (1.5 Days)||0
10871771|NCT02408068|12037471|FG001|NOT COMPLETED|Treatment 3 (1.5 Days)||0
10871772|NCT02408068|12037472|FG002|NOT COMPLETED|Treatment 3 (1.5 Days)||1
10871773|NCT02408068|12037473|FG003|NOT COMPLETED|Treatment 3 (1.5 Days)||0
10871774|NCT02408068|12037474|FG004|NOT COMPLETED|Treatment 3 (1.5 Days)||0
10871775|NCT02408068|12037475|FG005|NOT COMPLETED|Treatment 3 (1.5 Days)||0
10295551|NCT02970929|11428180|FG000|NOT COMPLETED|Overall Study||52
10295552|NCT02963493|11428186|FG000|STARTED|Overall Study||157
10295553|NCT02963493|11428186|FG000|COMPLETED|Overall Study||157
10295554|NCT02963493|11428186|FG000|NOT COMPLETED|Overall Study||0
10295555|NCT02899078|11428197|FG000|STARTED|Overall Study||31
10295556|NCT02899078|11428197|FG000|COMPLETED|Overall Study||28
10295557|NCT02899078|11428197|FG000|NOT COMPLETED|Overall Study||3
10295567|NCT02797951|11428214|FG000|STARTED|Overall Study||165
10295568|NCT02797951|11428214|FG000|Received at Least One Dose of Study Drug|Overall Study||164
10295569|NCT02797951|11428214|FG000|COMPLETED|Overall Study||116
10295570|NCT02797951|11428214|FG000|NOT COMPLETED|Overall Study||49
10295571|NCT02753751|11428220|FG000|STARTED|Overall Study||2971
10295572|NCT02753751|11428221|FG001|STARTED|Overall Study||3059
10295573|NCT02753751|11428220|FG000|COMPLETED|Overall Study||2971
10295574|NCT02753751|11428221|FG001|COMPLETED|Overall Study||3059
10295575|NCT02753751|11428220|FG000|NOT COMPLETED|Overall Study||0
10295576|NCT02753751|11428221|FG001|NOT COMPLETED|Overall Study||0
10295577|NCT02748057|11428229|FG000|STARTED|Overall Study||114
10295578|NCT02748057|11428230|FG001|STARTED|Overall Study||21
10295579|NCT02748057|11428229|FG000|COMPLETED|Overall Study||109
10295580|NCT02748057|11428230|FG001|COMPLETED|Overall Study||19
10295581|NCT02748057|11428229|FG000|NOT COMPLETED|Overall Study||5
10295582|NCT02748057|11428230|FG001|NOT COMPLETED|Overall Study||2
10295583|NCT02741271|11428238|FG000|STARTED|Overall Study||91
10295584|NCT02741271|11428239|FG001|STARTED|Overall Study||90
10295585|NCT02741271|11428238|FG000|COMPLETED|Overall Study||89
10295586|NCT02741271|11428239|FG001|COMPLETED|Overall Study||88
10295587|NCT02741271|11428238|FG000|NOT COMPLETED|Overall Study||2
10295588|NCT02741271|11428239|FG001|NOT COMPLETED|Overall Study||2
10295589|NCT02741245|11428252|FG000|STARTED|Overall Study||35
10295590|NCT02741245|11428253|FG001|STARTED|Overall Study||72
10295591|NCT02741245|11428254|FG002|STARTED|Overall Study||71
10295592|NCT02741245|11428255|FG003|STARTED|Overall Study||71
10295593|NCT02741245|11428256|FG004|STARTED|Overall Study||72
10295594|NCT02741245|11428252|FG000|COMPLETED|Overall Study||35
10295595|NCT02741245|11428253|FG001|COMPLETED|Overall Study||71
10295596|NCT02741245|11428254|FG002|COMPLETED|Overall Study||71
10295597|NCT02741245|11428255|FG003|COMPLETED|Overall Study||67
10295598|NCT02741245|11428256|FG004|COMPLETED|Overall Study||70
10295599|NCT02741245|11428252|FG000|NOT COMPLETED|Overall Study||0
10295600|NCT02741245|11428253|FG001|NOT COMPLETED|Overall Study||1
10295601|NCT02741245|11428254|FG002|NOT COMPLETED|Overall Study||0
10295602|NCT02741245|11428255|FG003|NOT COMPLETED|Overall Study||4
10295603|NCT02741245|11428256|FG004|NOT COMPLETED|Overall Study||2
10295604|NCT02688608|11428268|FG000|STARTED|Overall Study||6
10295605|NCT02688608|11428268|FG000|COMPLETED|Overall Study||5
10295606|NCT02688608|11428268|FG000|NOT COMPLETED|Overall Study||1
10295619|NCT02634268|11428288|FG000|STARTED|Overall Study||346
10295620|NCT02634268|11428289|FG001|STARTED|Overall Study||338
10295621|NCT02634268|11428288|FG000|COMPLETED|Overall Study|In-person visit completion = 267 for both groups. Some participants completed only surveys because of Covid-19 restrictions.|287
10295622|NCT02634268|11428289|FG001|COMPLETED|Overall Study|In-person visit completion = 267 for both groups. Some participants completed only surveys because of Covid-19 restrictions.|291
10295623|NCT02634268|11428288|FG000|NOT COMPLETED|Overall Study||59
10295624|NCT02634268|11428289|FG001|NOT COMPLETED|Overall Study||47
10295625|NCT02605967|11428297|FG000|STARTED|Overall Study||82
10295626|NCT02605967|11428298|FG001|STARTED|Overall Study||40
10295627|NCT02605967|11428297|FG000|Safety Set|Overall Study||82
10295628|NCT02605967|11428298|FG001|Safety Set|Overall Study||39
10295629|NCT02605967|11428297|FG000|Crossover to Spartalizumab|Overall Study||0
10295630|NCT02605967|11428298|FG001|Crossover to Spartalizumab|Overall Study||27
10295631|NCT02605967|11428297|FG000|COMPLETED|Overall Study||0
10295632|NCT02605967|11428298|FG001|COMPLETED|Overall Study||0
10295633|NCT02605967|11428297|FG000|NOT COMPLETED|Overall Study||82
10295634|NCT02605967|11428298|FG001|NOT COMPLETED|Overall Study||40
10871776|NCT02174861|12037486|FG000|STARTED|Overall Study||609
10871777|NCT02174861|12037486|FG000|Enrolled in CHU Substudy|Overall Study||53
10871778|NCT02174861|12037486|FG000|COMPLETED|Overall Study||451
10871779|NCT02174861|12037486|FG000|NOT COMPLETED|Overall Study||158
10871780|NCT02052739|12037494|FG000|STARTED|Overall Study||19
10871781|NCT02052739|12037495|FG001|STARTED|Overall Study||6
10871782|NCT02052739|12037494|FG000|COMPLETED|Overall Study||14
10871783|NCT02052739|12037495|FG001|COMPLETED|Overall Study||5
10871784|NCT02052739|12037494|FG000|NOT COMPLETED|Overall Study||5
10871785|NCT02052739|12037495|FG001|NOT COMPLETED|Overall Study||1
10871786|NCT01944020|12037505|FG000|STARTED|Overall Study||17
10871787|NCT01944020|12037506|FG001|STARTED|Overall Study||12
10871788|NCT01944020|12037505|FG000|COMPLETED|Overall Study||12
10871789|NCT01944020|12037506|FG001|COMPLETED|Overall Study||12
10871790|NCT01944020|12037505|FG000|NOT COMPLETED|Overall Study||5
10871791|NCT01944020|12037506|FG001|NOT COMPLETED|Overall Study||0
10871792|NCT01689519|12037514|FG000|STARTED|Intent to Treat||247
10871793|NCT01689519|12037515|FG001|STARTED|Intent to Treat||248
10871794|NCT01689519|12037514|FG000|COMPLETED|Intent to Treat||0
10871795|NCT01689519|12037515|FG001|COMPLETED|Intent to Treat||0
10871796|NCT01689519|12037514|FG000|NOT COMPLETED|Intent to Treat||247
10871797|NCT01689519|12037515|FG001|NOT COMPLETED|Intent to Treat||248
10871798|NCT01689519|12037514|FG000|STARTED|Safety Population||248
10871799|NCT01689519|12037515|FG001|STARTED|Safety Population||245
10871800|NCT01689519|12037514|FG000|COMPLETED|Safety Population||0
10871801|NCT01689519|12037515|FG001|COMPLETED|Safety Population||0
10871802|NCT01689519|12037514|FG000|NOT COMPLETED|Safety Population||248
10871803|NCT01689519|12037515|FG001|NOT COMPLETED|Safety Population||245
10871804|NCT01622088|12037521|FG000|STARTED|Overall Study||616
10871805|NCT01622088|12037521|FG000|COMPLETED|Overall Study||0
10871806|NCT01622088|12037521|FG000|NOT COMPLETED|Overall Study||616
10871807|NCT01486264|12037528|FG000|STARTED|Overall Study||142
10871808|NCT01486264|12037529|FG001|STARTED|Overall Study||141
10871809|NCT01486264|12037528|FG000|Treated|Overall Study||142
10871810|NCT01486264|12037529|FG001|Treated|Overall Study||140
10871811|NCT01486264|12037528|FG000|COMPLETED|Overall Study||113
10871812|NCT01486264|12037529|FG001|COMPLETED|Overall Study||94
10871813|NCT01486264|12037528|FG000|NOT COMPLETED|Overall Study||29
10871814|NCT01486264|12037529|FG001|NOT COMPLETED|Overall Study||47
10871815|NCT01419080|12037535|FG000|STARTED|Overall Study||797
10871816|NCT01419080|12037535|FG000|COMPLETED|Overall Study||666
10871817|NCT01419080|12037535|FG000|NOT COMPLETED|Overall Study||131
10871818|NCT01317160|12037543|FG000|STARTED|Overall Study||75
10871819|NCT01317160|12037544|FG001|STARTED|Overall Study||75
10871820|NCT01317160|12037543|FG000|Allocation to Treatment|Overall Study|1 patient was incorrect included|74
10871821|NCT01317160|12037544|FG001|Allocation to Treatment|Overall Study|1 patient was incorrect included|74
10871822|NCT01317160|12037543|FG000|COMPLETED|Overall Study||71
10871823|NCT01317160|12037544|FG001|COMPLETED|Overall Study||69
10871824|NCT01317160|12037543|FG000|NOT COMPLETED|Overall Study||4
10871825|NCT01317160|12037544|FG001|NOT COMPLETED|Overall Study||6
10871826|NCT01234532|12037550|FG000|STARTED|Overall Study||5
10419181|NCT00809146|11564006|FG001|STARTED|Overall Study||445
10419182|NCT00809146|11564005|FG000|COMPLETED|Overall Study||448
10755677|NCT03070171|11919474|FG001|NOT COMPLETED|Treatment Period 2 + Washout||1
10871827|NCT01234532|12037550|FG000|COMPLETED|Overall Study||5
10871828|NCT01234532|12037550|FG000|NOT COMPLETED|Overall Study||0
10871829|NCT01154335|12037557|FG000|STARTED|Overall Study||7
10871830|NCT01154335|12037558|FG001|STARTED|Overall Study||6
10871831|NCT01154335|12037559|FG002|STARTED|Overall Study||5
10871832|NCT01154335|12037557|FG000|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
10871833|NCT01154335|12037558|FG001|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
10871834|NCT01154335|12037559|FG002|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
10871835|NCT01154335|12037557|FG000|NOT COMPLETED|Overall Study||7
10871836|NCT01154335|12037558|FG001|NOT COMPLETED|Overall Study||6
10871837|NCT01154335|12037559|FG002|NOT COMPLETED|Overall Study||5
10871838|NCT01143116|12037571|FG000|STARTED|Overall Study||10
10755678|NCT03070171|11919473|FG000|STARTED|Treatment Period 3 + Washout||80
10871839|NCT01143116|12037572|FG001|STARTED|Overall Study||10
10871840|NCT01143116|12037571|FG000|COMPLETED|Overall Study||10
10871841|NCT01143116|12037572|FG001|COMPLETED|Overall Study||10
10871842|NCT01143116|12037571|FG000|NOT COMPLETED|Overall Study||0
10871843|NCT01143116|12037572|FG001|NOT COMPLETED|Overall Study||0
10871844|NCT01094782|12037584|FG000|STARTED|Overall Study||39
10871845|NCT01094782|12037585|FG001|STARTED|Overall Study||39
10871846|NCT01094782|12037586|FG002|STARTED|Overall Study||34
10871847|NCT01094782|12037587|FG003|STARTED|Overall Study||56
10871848|NCT01094782|12037588|FG004|STARTED|Overall Study||42
10871849|NCT01094782|12037589|FG005|STARTED|Overall Study||38
10871850|NCT01094782|12037584|FG000|COMPLETED|Overall Study||31
10871851|NCT01094782|12037585|FG001|COMPLETED|Overall Study||29
10871852|NCT01094782|12037586|FG002|COMPLETED|Overall Study||31
10871853|NCT01094782|12037587|FG003|COMPLETED|Overall Study||45
10871854|NCT01094782|12037588|FG004|COMPLETED|Overall Study||31
10871855|NCT01094782|12037589|FG005|COMPLETED|Overall Study||30
10871856|NCT01094782|12037584|FG000|NOT COMPLETED|Overall Study||8
10871857|NCT01094782|12037585|FG001|NOT COMPLETED|Overall Study||10
10871858|NCT01094782|12037586|FG002|NOT COMPLETED|Overall Study||3
10871859|NCT01094782|12037587|FG003|NOT COMPLETED|Overall Study||11
10871860|NCT01094782|12037588|FG004|NOT COMPLETED|Overall Study||11
10871861|NCT01094782|12037589|FG005|NOT COMPLETED|Overall Study||8
10871862|NCT01033032|12037608|FG000|STARTED|Overall Study||3
10871863|NCT01033032|12037609|FG001|STARTED|Overall Study||3
10871864|NCT01033032|12037610|FG002|STARTED|Overall Study||3
10871865|NCT01033032|12037611|FG003|STARTED|Overall Study||6
10871866|NCT01033032|12037612|FG004|STARTED|Overall Study||63
10871867|NCT01033032|12037608|FG000|COMPLETED|Overall Study|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
10871868|NCT01033032|12037609|FG001|COMPLETED|Overall Study|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
10871869|NCT01033032|12037610|FG002|COMPLETED|Overall Study||3
10871870|NCT01033032|12037611|FG003|COMPLETED|Overall Study|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
10871871|NCT01033032|12037612|FG004|COMPLETED|Overall Study||0
10871872|NCT01033032|12037608|FG000|NOT COMPLETED|Overall Study||3
10871873|NCT01033032|12037609|FG001|NOT COMPLETED|Overall Study||3
10871874|NCT01033032|12037610|FG002|NOT COMPLETED|Overall Study||0
10871875|NCT01033032|12037611|FG003|NOT COMPLETED|Overall Study||6
10871876|NCT01033032|12037612|FG004|NOT COMPLETED|Overall Study||63
10419183|NCT00809146|11564006|FG001|COMPLETED|Overall Study||445
10419184|NCT00809146|11564005|FG000|NOT COMPLETED|Overall Study||0
10419185|NCT00809146|11564006|FG001|NOT COMPLETED|Overall Study||0
10419186|NCT00809159|11564016|FG000|STARTED|Part 1||24
10419187|NCT00809159|11564017|FG001|STARTED|Part 1||6
10419188|NCT00809159|11564018|FG002|STARTED|Part 1||0
10419189|NCT00809159|11564019|FG003|STARTED|Part 1||0
10419190|NCT00809159|11564020|FG004|STARTED|Part 1||0
10419191|NCT00809159|11564021|FG005|STARTED|Part 1||0
10871877|NCT00932737|12037625|FG000|STARTED|Overall Study||87
10871878|NCT00932737|12037626|FG001|STARTED|Overall Study||88
10871879|NCT00932737|12037625|FG000|COMPLETED|Overall Study||86
10871880|NCT00932737|12037626|FG001|COMPLETED|Overall Study||87
10871881|NCT00932737|12037625|FG000|NOT COMPLETED|Overall Study||1
10871882|NCT00932737|12037626|FG001|NOT COMPLETED|Overall Study||1
10871883|NCT00893516|12037634|FG000|STARTED|Overall Study||0
10871884|NCT00893516|12037635|FG001|STARTED|Overall Study||0
10871885|NCT00893516|12037634|FG000|COMPLETED|Overall Study||0
10871886|NCT00893516|12037635|FG001|COMPLETED|Overall Study||0
10871887|NCT00893516|12037634|FG000|NOT COMPLETED|Overall Study||0
10419192|NCT00809159|11564016|FG000|PK Analysis Set|Part 1||24
10419193|NCT00809159|11564017|FG001|PK Analysis Set|Part 1||6
10419194|NCT00809159|11564018|FG002|PK Analysis Set|Part 1||0
10871888|NCT00893516|12037635|FG001|NOT COMPLETED|Overall Study||0
10871889|NCT00848757|12037643|FG000|STARTED|Overall Study||65
10871890|NCT00848757|12037644|FG001|STARTED|Overall Study||65
10871891|NCT00848757|12037643|FG000|COMPLETED|Overall Study||61
10871892|NCT00848757|12037644|FG001|COMPLETED|Overall Study||61
10871893|NCT00848757|12037643|FG000|NOT COMPLETED|Overall Study||4
10871894|NCT00848757|12037644|FG001|NOT COMPLETED|Overall Study||4
10871895|NCT00710710|12037652|FG000|STARTED|Overall Study||45
10871896|NCT00710710|12037653|FG001|STARTED|Overall Study||44
10871897|NCT00710710|12037652|FG000|Treated|Overall Study||43
10871898|NCT00710710|12037653|FG001|Treated|Overall Study||43
10871899|NCT00710710|12037652|FG000|COMPLETED|Overall Study||0
10871900|NCT00710710|12037653|FG001|COMPLETED|Overall Study||0
10871901|NCT00710710|12037652|FG000|NOT COMPLETED|Overall Study||45
10871902|NCT00710710|12037653|FG001|NOT COMPLETED|Overall Study||44
10871903|NCT00608023|12037662|FG000|STARTED|Overall Study||92
10871904|NCT00608023|12037663|FG001|STARTED|Overall Study||85
10871905|NCT00608023|12037664|FG002|STARTED|Overall Study||86
10871906|NCT00608023|12037662|FG000|COMPLETED|Overall Study||80
10871907|NCT00608023|12037663|FG001|COMPLETED|Overall Study||63
10871908|NCT00608023|12037664|FG002|COMPLETED|Overall Study||72
10871909|NCT00608023|12037662|FG000|NOT COMPLETED|Overall Study||12
10871910|NCT00608023|12037663|FG001|NOT COMPLETED|Overall Study||22
10871911|NCT00608023|12037664|FG002|NOT COMPLETED|Overall Study||14
10871912|NCT00551616|12037677|FG000|STARTED|Overall Study||1104
10871913|NCT00551616|12037678|FG001|STARTED|Overall Study||1117
10871914|NCT00551616|12037677|FG000|COMPLETED|Overall Study||1056
10871915|NCT00551616|12037678|FG001|COMPLETED|Overall Study||1077
10871916|NCT00551616|12037677|FG000|NOT COMPLETED|Overall Study||48
10871917|NCT00551616|12037678|FG001|NOT COMPLETED|Overall Study||40
10419195|NCT00809159|11564019|FG003|PK Analysis Set|Part 1||0
10419196|NCT00809159|11564020|FG004|PK Analysis Set|Part 1||0
10419197|NCT00809159|11564021|FG005|PK Analysis Set|Part 1||0
10419198|NCT00809159|11564016|FG000|PD Analysis Set|Part 1||23
10419199|NCT00809159|11564017|FG001|PD Analysis Set|Part 1||6
10871921|NCT00492050|12037688|FG000|STARTED|Overall Study||37
10871922|NCT00492050|12037688|FG000|Inadequate Response to First Two Cycles|Overall Study||25
10419200|NCT00809159|11564018|FG002|PD Analysis Set|Part 1||0
10419201|NCT00809159|11564019|FG003|PD Analysis Set|Part 1||0
10419202|NCT00809159|11564020|FG004|PD Analysis Set|Part 1||0
10419203|NCT00809159|11564021|FG005|PD Analysis Set|Part 1||0
10419204|NCT00809159|11564016|FG000|COMPLETED|Part 1||16
10419205|NCT00809159|11564017|FG001|COMPLETED|Part 1||3
10419206|NCT00809159|11564018|FG002|COMPLETED|Part 1||0
10419207|NCT00809159|11564019|FG003|COMPLETED|Part 1||0
10871923|NCT00492050|12037688|FG000|Inadequate Response to First 3 Cycles|Overall Study||12
10871924|NCT00492050|12037688|FG000|If Adequate Response to First Two Cycles-participants Proceed to Stem Cell Collection|Overall Study||30
10871925|NCT00492050|12037688|FG000|COMPLETED|Overall Study||28
10871926|NCT00492050|12037688|FG000|NOT COMPLETED|Overall Study||9
10871927|NCT00456261|12037694|FG000|STARTED|Combination Therapy||55
10871928|NCT00456261|12037695|FG001|STARTED|Combination Therapy||55
10871929|NCT00456261|12037694|FG000|COMPLETED|Combination Therapy||3
10871930|NCT00456261|12037695|FG001|COMPLETED|Combination Therapy||29
10871931|NCT00456261|12037694|FG000|NOT COMPLETED|Combination Therapy||52
10871932|NCT00456261|12037695|FG001|NOT COMPLETED|Combination Therapy||26
10871933|NCT00456261|12037694|FG000|STARTED|Maintenance Therapy||3
10871934|NCT00456261|12037695|FG001|STARTED|Maintenance Therapy||29
10871935|NCT00456261|12037694|FG000|COMPLETED|Maintenance Therapy||3
10871936|NCT00456261|12037695|FG001|COMPLETED|Maintenance Therapy||29
10871937|NCT00456261|12037694|FG000|NOT COMPLETED|Maintenance Therapy||0
10871938|NCT00456261|12037695|FG001|NOT COMPLETED|Maintenance Therapy||0
10295641|NCT02570503|11428322|FG000|STARTED|Overall Study||34
10295642|NCT02570503|11428323|FG001|STARTED|Overall Study||30
10295643|NCT02570503|11428322|FG000|COMPLETED|Overall Study||34
10295644|NCT02570503|11428323|FG001|COMPLETED|Overall Study||30
10295645|NCT02570503|11428322|FG000|NOT COMPLETED|Overall Study||0
10295646|NCT02570503|11428323|FG001|NOT COMPLETED|Overall Study||0
10295647|NCT02553265|11428329|FG000|STARTED|Enrollment||9
10295648|NCT02553265|11428330|FG001|STARTED|Enrollment||7
10295649|NCT02553265|11428331|FG002|STARTED|Enrollment||6
10295650|NCT02553265|11428329|FG000|COMPLETED|Enrollment||9
10295651|NCT02553265|11428330|FG001|COMPLETED|Enrollment||7
10295652|NCT02553265|11428331|FG002|COMPLETED|Enrollment||5
10871939|NCT00448630|12037701|FG000|STARTED|Overall Study||328
10871940|NCT00448630|12037701|FG000|COMPLETED|Overall Study|Number of patients who remained on same medication to end of study.|301
10871941|NCT00448630|12037701|FG000|NOT COMPLETED|Overall Study||27
10871942|NCT00345345|12037718|FG000|STARTED|Overall Study||29
10871943|NCT00345345|12037718|FG000|COMPLETED|Overall Study||27
10871944|NCT00345345|12037718|FG000|NOT COMPLETED|Overall Study||2
10871957|NCT00085982|12037767|FG000|STARTED|Overall Study||11
10871958|NCT00085982|12037767|FG000|COMPLETED|Overall Study||5
10871959|NCT00085982|12037767|FG000|NOT COMPLETED|Overall Study||6
10871960|NCT00061945|12037773|FG000|STARTED|Registration Through Course 3||119
10871961|NCT00061945|12037774|FG001|STARTED|Registration Through Course 3||181
10871962|NCT00061945|12037773|FG000|COMPLETED|Registration Through Course 3||25
10871963|NCT00061945|12037774|FG001|COMPLETED|Registration Through Course 3||66
10295653|NCT02553265|11428329|FG000|NOT COMPLETED|Enrollment||0
10295654|NCT02553265|11428330|FG001|NOT COMPLETED|Enrollment||0
10295655|NCT02553265|11428331|FG002|NOT COMPLETED|Enrollment||1
10295656|NCT02553265|11428329|FG000|STARTED|First Intervention (28 Days)||9
10295657|NCT02553265|11428330|FG001|STARTED|First Intervention (28 Days)||7
10295658|NCT02553265|11428331|FG002|STARTED|First Intervention (28 Days)||5
10295659|NCT02553265|11428329|FG000|COMPLETED|First Intervention (28 Days)||8
10295660|NCT02553265|11428330|FG001|COMPLETED|First Intervention (28 Days)||7
10295661|NCT02553265|11428331|FG002|COMPLETED|First Intervention (28 Days)||4
10295662|NCT02553265|11428329|FG000|NOT COMPLETED|First Intervention (28 Days)||1
10295663|NCT02553265|11428330|FG001|NOT COMPLETED|First Intervention (28 Days)||0
10295664|NCT02553265|11428331|FG002|NOT COMPLETED|First Intervention (28 Days)||1
10295665|NCT02553265|11428329|FG000|STARTED|Second Intervention (28 Days)||8
10295666|NCT02553265|11428330|FG001|STARTED|Second Intervention (28 Days)||7
10295667|NCT02553265|11428331|FG002|STARTED|Second Intervention (28 Days)||4
10295668|NCT02553265|11428329|FG000|COMPLETED|Second Intervention (28 Days)||7
10295669|NCT02553265|11428330|FG001|COMPLETED|Second Intervention (28 Days)||7
10295670|NCT02553265|11428331|FG002|COMPLETED|Second Intervention (28 Days)||4
10295671|NCT02553265|11428329|FG000|NOT COMPLETED|Second Intervention (28 Days)||1
10295672|NCT02553265|11428330|FG001|NOT COMPLETED|Second Intervention (28 Days)||0
10295673|NCT02553265|11428331|FG002|NOT COMPLETED|Second Intervention (28 Days)||0
10295674|NCT02553265|11428329|FG000|STARTED|Third Intervention (28 Days)||7
10295675|NCT02553265|11428330|FG001|STARTED|Third Intervention (28 Days)||7
10295676|NCT02553265|11428331|FG002|STARTED|Third Intervention (28 Days)||4
10295677|NCT02553265|11428329|FG000|COMPLETED|Third Intervention (28 Days)||6
10295678|NCT02553265|11428330|FG001|COMPLETED|Third Intervention (28 Days)||7
10419208|NCT00809159|11564020|FG004|COMPLETED|Part 1||0
10419209|NCT00809159|11564021|FG005|COMPLETED|Part 1||0
10419210|NCT00809159|11564016|FG000|NOT COMPLETED|Part 1||8
10419211|NCT00809159|11564017|FG001|NOT COMPLETED|Part 1||3
10419212|NCT00809159|11564018|FG002|NOT COMPLETED|Part 1||0
10419213|NCT00809159|11564019|FG003|NOT COMPLETED|Part 1||0
10419214|NCT00809159|11564020|FG004|NOT COMPLETED|Part 1||0
10419215|NCT00809159|11564021|FG005|NOT COMPLETED|Part 1||0
10419216|NCT00809159|11564016|FG000|STARTED|Part 1 and 2||0
10419217|NCT00809159|11564017|FG001|STARTED|Part 1 and 2||0
10419218|NCT00809159|11564018|FG002|STARTED|Part 1 and 2||30
10419219|NCT00809159|11564019|FG003|STARTED|Part 1 and 2||12
10419220|NCT00809159|11564020|FG004|STARTED|Part 1 and 2||12
10419221|NCT00809159|11564021|FG005|STARTED|Part 1 and 2||6
10419222|NCT00809159|11564016|FG000|PK Analysis Set|Part 1 and 2||0
10419223|NCT00809159|11564017|FG001|PK Analysis Set|Part 1 and 2||0
10419224|NCT00809159|11564018|FG002|PK Analysis Set|Part 1 and 2||30
10419225|NCT00809159|11564019|FG003|PK Analysis Set|Part 1 and 2||12
10419226|NCT00809159|11564020|FG004|PK Analysis Set|Part 1 and 2||12
10419227|NCT00809159|11564021|FG005|PK Analysis Set|Part 1 and 2||6
10419228|NCT00809159|11564016|FG000|PD Analysis Set|Part 1 and 2||0
10419229|NCT00809159|11564017|FG001|PD Analysis Set|Part 1 and 2||0
10419230|NCT00809159|11564018|FG002|PD Analysis Set|Part 1 and 2||28
10419231|NCT00809159|11564019|FG003|PD Analysis Set|Part 1 and 2||12
10419232|NCT00809159|11564020|FG004|PD Analysis Set|Part 1 and 2||12
10419233|NCT00809159|11564021|FG005|PD Analysis Set|Part 1 and 2||6
10419234|NCT00809159|11564016|FG000|COMPLETED|Part 1 and 2||0
10755679|NCT03070171|11919474|FG001|STARTED|Treatment Period 3 + Washout||79
10755680|NCT03070171|11919473|FG000|COMPLETED|Treatment Period 3 + Washout||80
10755681|NCT03070171|11919474|FG001|COMPLETED|Treatment Period 3 + Washout||79
10871964|NCT00061945|12037773|FG000|NOT COMPLETED|Registration Through Course 3||94
10871965|NCT00061945|12037774|FG001|NOT COMPLETED|Registration Through Course 3||115
10871966|NCT00061945|12037773|FG000|STARTED|Course IV: Alemtuzumab||25
10871967|NCT00061945|12037774|FG001|STARTED|Course IV: Alemtuzumab||66
10871968|NCT00061945|12037773|FG000|COMPLETED|Course IV: Alemtuzumab||18
10871969|NCT00061945|12037774|FG001|COMPLETED|Course IV: Alemtuzumab||50
10755682|NCT03070171|11919473|FG000|NOT COMPLETED|Treatment Period 3 + Washout||0
10755683|NCT03070171|11919474|FG001|NOT COMPLETED|Treatment Period 3 + Washout||0
10755684|NCT03070171|11919473|FG000|STARTED|Treatment Period 4 + Washout||80
10755685|NCT03070171|11919474|FG001|STARTED|Treatment Period 4 + Washout||79
10755686|NCT03070171|11919473|FG000|COMPLETED|Treatment Period 4 + Washout||80
10755687|NCT03070171|11919474|FG001|COMPLETED|Treatment Period 4 + Washout||78
10755688|NCT03070171|11919473|FG000|NOT COMPLETED|Treatment Period 4 + Washout||0
10755689|NCT03070171|11919474|FG001|NOT COMPLETED|Treatment Period 4 + Washout||1
10755690|NCT03070431|11919480|FG000|STARTED|Overall Study||44
10755691|NCT03070431|11919480|FG000|COMPLETED|Overall Study||40
10755692|NCT03070431|11919480|FG000|NOT COMPLETED|Overall Study||4
10871970|NCT00061945|12037773|FG000|NOT COMPLETED|Course IV: Alemtuzumab||7
10871971|NCT00061945|12037774|FG001|NOT COMPLETED|Course IV: Alemtuzumab||16
10871972|NCT04018612|12037786|FG000|STARTED|Overall Study||44
10871973|NCT04018612|12037787|FG001|STARTED|Overall Study||44
10871974|NCT04018612|12037788|FG002|STARTED|Overall Study||22
10871975|NCT04018612|12037786|FG000|COMPLETED|Overall Study||43
10871976|NCT04018612|12037787|FG001|COMPLETED|Overall Study||44
10871977|NCT04018612|12037788|FG002|COMPLETED|Overall Study||21
10871978|NCT04018612|12037786|FG000|NOT COMPLETED|Overall Study||1
10871979|NCT04018612|12037787|FG001|NOT COMPLETED|Overall Study||0
10871980|NCT04018612|12037788|FG002|NOT COMPLETED|Overall Study||1
10871981|NCT03976648|12037798|FG000|STARTED|Overall Study||21
10871982|NCT03976648|12037799|FG001|STARTED|Overall Study||10
10871983|NCT03976648|12037798|FG000|COMPLETED|Overall Study||0
10871984|NCT03976648|12037799|FG001|COMPLETED|Overall Study||0
10871985|NCT03976648|12037798|FG000|NOT COMPLETED|Overall Study||21
10871986|NCT03976648|12037799|FG001|NOT COMPLETED|Overall Study||10
10871987|NCT03944486|12037805|FG000|STARTED|Overall Study||24
10871988|NCT03944486|12037805|FG000|COMPLETED|Overall Study||12
10871989|NCT03944486|12037805|FG000|NOT COMPLETED|Overall Study||12
10871990|NCT03619902|12037809|FG000|STARTED|Overall Study||8
10871991|NCT03619902|12037809|FG000|COMPLETED|Overall Study||6
10871992|NCT03619902|12037809|FG000|NOT COMPLETED|Overall Study||2
10871993|NCT03617523|12037818|FG000|STARTED|Overall Study||30
10419235|NCT00809159|11564017|FG001|COMPLETED|Part 1 and 2||0
10419236|NCT00809159|11564018|FG002|COMPLETED|Part 1 and 2||20
10419237|NCT00809159|11564019|FG003|COMPLETED|Part 1 and 2||7
10419238|NCT00809159|11564020|FG004|COMPLETED|Part 1 and 2||6
10419239|NCT00809159|11564021|FG005|COMPLETED|Part 1 and 2||3
10419240|NCT00809159|11564016|FG000|NOT COMPLETED|Part 1 and 2||0
10419241|NCT00809159|11564017|FG001|NOT COMPLETED|Part 1 and 2||0
10419242|NCT00809159|11564018|FG002|NOT COMPLETED|Part 1 and 2||10
10419243|NCT00809159|11564019|FG003|NOT COMPLETED|Part 1 and 2||5
10419244|NCT00809159|11564020|FG004|NOT COMPLETED|Part 1 and 2||6
10871994|NCT03617523|12037819|FG001|STARTED|Overall Study||30
10871995|NCT03617523|12037820|FG002|STARTED|Overall Study||61
10871996|NCT03617523|12037821|FG003|STARTED|Overall Study||59
10871997|NCT03617523|12037822|FG004|STARTED|Overall Study||60
10871998|NCT03617523|12037818|FG000|COMPLETED|Overall Study||30
10871999|NCT03617523|12037819|FG001|COMPLETED|Overall Study||30
10872000|NCT03617523|12037820|FG002|COMPLETED|Overall Study||61
10872001|NCT03617523|12037821|FG003|COMPLETED|Overall Study||59
10872002|NCT03617523|12037822|FG004|COMPLETED|Overall Study||60
10872003|NCT03617523|12037818|FG000|NOT COMPLETED|Overall Study||0
10872004|NCT03617523|12037819|FG001|NOT COMPLETED|Overall Study||0
10872005|NCT03617523|12037820|FG002|NOT COMPLETED|Overall Study||0
10872006|NCT03617523|12037821|FG003|NOT COMPLETED|Overall Study||0
10872007|NCT03617523|12037822|FG004|NOT COMPLETED|Overall Study||0
10295679|NCT02553265|11428331|FG002|COMPLETED|Third Intervention (28 Days)||3
10295680|NCT02553265|11428329|FG000|NOT COMPLETED|Third Intervention (28 Days)||1
10295681|NCT02553265|11428330|FG001|NOT COMPLETED|Third Intervention (28 Days)||0
10295682|NCT02553265|11428331|FG002|NOT COMPLETED|Third Intervention (28 Days)||1
10295683|NCT02550288|11428347|FG000|STARTED|Overall Study||35
10295684|NCT02550288|11428348|FG001|STARTED|Overall Study||68
10295685|NCT02550288|11428349|FG002|STARTED|Overall Study||69
10872008|NCT03546192|12037841|FG000|STARTED|Overall Study||60
10872009|NCT03546192|12037842|FG001|STARTED|Overall Study||60
10872010|NCT03546192|12037841|FG000|COMPLETED|Overall Study||60
10872011|NCT03546192|12037842|FG001|COMPLETED|Overall Study||60
10872012|NCT03546192|12037841|FG000|NOT COMPLETED|Overall Study||0
10872013|NCT03546192|12037842|FG001|NOT COMPLETED|Overall Study||0
10872014|NCT03517449|12037850|FG000|STARTED|Overall Study||411
10872015|NCT03517449|12037851|FG001|STARTED|Overall Study||416
10872016|NCT03517449|12037850|FG000|Treated|Overall Study||406
10872017|NCT03517449|12037851|FG001|Treated|Overall Study||388
10872018|NCT03517449|12037850|FG000|COMPLETED|Overall Study||0
10872019|NCT03517449|12037851|FG001|COMPLETED|Overall Study||0
10872020|NCT03517449|12037850|FG000|NOT COMPLETED|Overall Study||411
10872021|NCT03517449|12037851|FG001|NOT COMPLETED|Overall Study||416
10872022|NCT03470922|12037859|FG000|STARTED|Overall Study||355
10872023|NCT03470922|12037860|FG001|STARTED|Overall Study||359
10872024|NCT03470922|12037859|FG000|COMPLETED|Overall Study||237
10872025|NCT03470922|12037860|FG001|COMPLETED|Overall Study||227
10872026|NCT03470922|12037859|FG000|NOT COMPLETED|Overall Study||118
10872027|NCT03470922|12037860|FG001|NOT COMPLETED|Overall Study||132
10872028|NCT03308825|12037870|FG000|STARTED|Overall Study|1 child in Group 1 received a 0.5mL dose instead of a 0.25 mL dose and is included in Group 2.|59
10872029|NCT03308825|12037871|FG001|STARTED|Overall Study|1 child in Group 1 received a 0.5mL dose instead of a 0.25 mL dose and is included in Group 2.|61
10872030|NCT03308825|12037872|FG002|STARTED|Overall Study||60
10872031|NCT03308825|12037873|FG003|STARTED|Overall Study||60
10872032|NCT03308825|12037870|FG000|COMPLETED|Overall Study||57
10872033|NCT03308825|12037871|FG001|COMPLETED|Overall Study||57
10872034|NCT03308825|12037872|FG002|COMPLETED|Overall Study||59
10872035|NCT03308825|12037873|FG003|COMPLETED|Overall Study||60
10872036|NCT03308825|12037870|FG000|NOT COMPLETED|Overall Study||2
10872037|NCT03308825|12037871|FG001|NOT COMPLETED|Overall Study||4
10872038|NCT03308825|12037872|FG002|NOT COMPLETED|Overall Study||1
10872039|NCT03308825|12037873|FG003|NOT COMPLETED|Overall Study||0
10872040|NCT02915302|12037889|FG000|STARTED|Overall Study||955
10872041|NCT02915302|12037890|FG001|STARTED|Overall Study||995
10872042|NCT02915302|12037889|FG000|Vaccinated (Safety Analysis Set)|Overall Study||949
10872043|NCT02915302|12037890|FG001|Vaccinated (Safety Analysis Set)|Overall Study||992
10872044|NCT02915302|12037889|FG000|COMPLETED|Overall Study||890
10872045|NCT02915302|12037890|FG001|COMPLETED|Overall Study||917
10872046|NCT02915302|12037889|FG000|NOT COMPLETED|Overall Study||65
10872047|NCT02915302|12037890|FG001|NOT COMPLETED|Overall Study||78
10872048|NCT02908269|12037899|FG000|STARTED|Overall Study||60
10872049|NCT02908269|12037900|FG001|STARTED|Overall Study||60
10872050|NCT02908269|12037901|FG002|STARTED|Overall Study||60
10872051|NCT02908269|12037899|FG000|COMPLETED|Overall Study||60
10872052|NCT02908269|12037900|FG001|COMPLETED|Overall Study||60
10872053|NCT02908269|12037901|FG002|COMPLETED|Overall Study||60
10872054|NCT02908269|12037899|FG000|NOT COMPLETED|Overall Study||0
10872055|NCT02908269|12037900|FG001|NOT COMPLETED|Overall Study||0
10872056|NCT02908269|12037901|FG002|NOT COMPLETED|Overall Study||0
10872057|NCT02744040|12037913|FG000|STARTED|Overall Study||28
10872058|NCT02744040|12037914|FG001|STARTED|Overall Study||51
10872059|NCT02744040|12037915|FG002|STARTED|Overall Study||72
10872060|NCT02744040|12037913|FG000|COMPLETED|Overall Study||22
10872061|NCT02744040|12037914|FG001|COMPLETED|Overall Study||40
10872062|NCT02744040|12037915|FG002|COMPLETED|Overall Study||50
10872063|NCT02744040|12037913|FG000|NOT COMPLETED|Overall Study||6
10872064|NCT02744040|12037914|FG001|NOT COMPLETED|Overall Study||11
10872065|NCT02744040|12037915|FG002|NOT COMPLETED|Overall Study||22
10872066|NCT02698826|12037923|FG000|STARTED|Overall Study||16
10872067|NCT02698826|12037923|FG000|COMPLETED|Overall Study||2
10872068|NCT02698826|12037923|FG000|NOT COMPLETED|Overall Study||14
10872069|NCT02617589|12037931|FG000|STARTED|All Randomized||280
10872070|NCT02617589|12037932|FG001|STARTED|All Randomized||280
10872071|NCT02617589|12037931|FG000|COMPLETED|All Randomized||278
10872072|NCT02617589|12037932|FG001|COMPLETED|All Randomized||275
10872073|NCT02617589|12037931|FG000|NOT COMPLETED|All Randomized||2
10872074|NCT02617589|12037932|FG001|NOT COMPLETED|All Randomized||5
10872075|NCT02617589|12037931|FG000|STARTED|Treatment Period||278
10872076|NCT02617589|12037932|FG001|STARTED|Treatment Period||275
10872077|NCT02617589|12037931|FG000|COMPLETED|Treatment Period||4
10872078|NCT02617589|12037932|FG001|COMPLETED|Treatment Period||1
10872079|NCT02617589|12037931|FG000|NOT COMPLETED|Treatment Period||274
10872080|NCT02617589|12037932|FG001|NOT COMPLETED|Treatment Period||274
10872081|NCT02614859|12037940|FG000|STARTED|Overall Study||9
10872082|NCT02614859|12037941|FG001|STARTED|Overall Study||20
10872083|NCT02614859|12037940|FG000|COMPLETED|Overall Study||9
10872084|NCT02614859|12037941|FG001|COMPLETED|Overall Study||19
10872085|NCT02614859|12037940|FG000|NOT COMPLETED|Overall Study||0
10872086|NCT02614859|12037941|FG001|NOT COMPLETED|Overall Study||1
10872099|NCT02519348|12037973|FG000|STARTED|Overall Study||40
10872100|NCT02519348|12037974|FG001|STARTED|Overall Study||104
10872101|NCT02519348|12037975|FG002|STARTED|Overall Study||75
10872102|NCT02519348|12037976|FG003|STARTED|Overall Study||69
10872103|NCT02519348|12037977|FG004|STARTED|Overall Study||84
10872104|NCT02519348|12037978|FG005|STARTED|Overall Study||47
10872105|NCT02519348|12037979|FG006|STARTED|Overall Study||3
10872106|NCT02519348|12037980|FG007|STARTED|Overall Study||5
10872107|NCT02519348|12037981|FG008|STARTED|Overall Study||6
10872108|NCT02519348|12037973|FG000|Treated|Overall Study||40
10872109|NCT02519348|12037974|FG001|Treated|Overall Study||101
10872110|NCT02519348|12037975|FG002|Treated|Overall Study||74
10872111|NCT02519348|12037976|FG003|Treated|Overall Study||69
10872112|NCT02519348|12037977|FG004|Treated|Overall Study||82
10872113|NCT02519348|12037978|FG005|Treated|Overall Study||47
10872114|NCT02519348|12037979|FG006|Treated|Overall Study||3
10872115|NCT02519348|12037980|FG007|Treated|Overall Study||5
10872116|NCT02519348|12037981|FG008|Treated|Overall Study||5
10872117|NCT02519348|12037973|FG000|COMPLETED|Overall Study||0
10872118|NCT02519348|12037974|FG001|COMPLETED|Overall Study||0
10872119|NCT02519348|12037975|FG002|COMPLETED|Overall Study||0
10872120|NCT02519348|12037976|FG003|COMPLETED|Overall Study||0
10872121|NCT02519348|12037977|FG004|COMPLETED|Overall Study||0
10872122|NCT02519348|12037978|FG005|COMPLETED|Overall Study||0
10872123|NCT02519348|12037979|FG006|COMPLETED|Overall Study||0
10872124|NCT02519348|12037980|FG007|COMPLETED|Overall Study||0
10872125|NCT02519348|12037981|FG008|COMPLETED|Overall Study||0
10872126|NCT02519348|12037973|FG000|NOT COMPLETED|Overall Study||40
10872127|NCT02519348|12037974|FG001|NOT COMPLETED|Overall Study||104
10872128|NCT02519348|12037975|FG002|NOT COMPLETED|Overall Study||75
10872129|NCT02519348|12037976|FG003|NOT COMPLETED|Overall Study||69
10872130|NCT02519348|12037977|FG004|NOT COMPLETED|Overall Study||84
10872131|NCT02519348|12037978|FG005|NOT COMPLETED|Overall Study||47
10872132|NCT02519348|12037979|FG006|NOT COMPLETED|Overall Study||3
10872133|NCT02519348|12037980|FG007|NOT COMPLETED|Overall Study||5
10872134|NCT02519348|12037981|FG008|NOT COMPLETED|Overall Study||6
10295686|NCT02550288|11428350|FG003|STARTED|Overall Study||68
10295687|NCT02550288|11428351|FG004|STARTED|Overall Study||69
10295688|NCT02550288|11428347|FG000|COMPLETED|Overall Study||33
10295689|NCT02550288|11428348|FG001|COMPLETED|Overall Study||65
10295690|NCT02550288|11428349|FG002|COMPLETED|Overall Study||68
10295691|NCT02550288|11428350|FG003|COMPLETED|Overall Study||65
10295692|NCT02550288|11428351|FG004|COMPLETED|Overall Study||66
10295693|NCT02550288|11428347|FG000|NOT COMPLETED|Overall Study||2
10295694|NCT02550288|11428348|FG001|NOT COMPLETED|Overall Study||3
10295695|NCT02550288|11428349|FG002|NOT COMPLETED|Overall Study||1
10872135|NCT02429414|12038004|FG000|STARTED|Overall Study||42
10872136|NCT02429414|12038005|FG001|STARTED|Overall Study||38
10872137|NCT02429414|12038004|FG000|COMPLETED|Overall Study||42
10872138|NCT02429414|12038005|FG001|COMPLETED|Overall Study||37
10872139|NCT02429414|12038004|FG000|NOT COMPLETED|Overall Study||0
10872140|NCT02429414|12038005|FG001|NOT COMPLETED|Overall Study||1
10872141|NCT02267603|12038011|FG000|STARTED|Overall Study||50
10872142|NCT02267603|12038011|FG000|COMPLETED|Overall Study||6
10872143|NCT02267603|12038011|FG000|NOT COMPLETED|Overall Study||44
10872144|NCT02258659|12038015|FG000|STARTED|Overall Study||62
10872145|NCT02258659|12038015|FG000|COMPLETED|Overall Study||61
10872146|NCT02258659|12038015|FG000|NOT COMPLETED|Overall Study||1
10872147|NCT02111850|12038030|FG000|STARTED|Phase 1 Dose Escalation||1
10872148|NCT02111850|12038031|FG001|STARTED|Phase 1 Dose Escalation||1
10872149|NCT02111850|12038032|FG002|STARTED|Phase 1 Dose Escalation||1
10872150|NCT02111850|12038033|FG003|STARTED|Phase 1 Dose Escalation||1
10872151|NCT02111850|12038034|FG004|STARTED|Phase 1 Dose Escalation||2
10872152|NCT02111850|12038035|FG005|STARTED|Phase 1 Dose Escalation||1
10872153|NCT02111850|12038036|FG006|STARTED|Phase 1 Dose Escalation||1
10872154|NCT02111850|12038037|FG007|STARTED|Phase 1 Dose Escalation||1
10295696|NCT02550288|11428350|FG003|NOT COMPLETED|Overall Study||3
10295697|NCT02550288|11428351|FG004|NOT COMPLETED|Overall Study||3
10295698|NCT02510040|11428366|FG000|STARTED|Overall Study||81
10295699|NCT02510040|11428367|FG001|STARTED|Overall Study||114
10295700|NCT02510040|11428368|FG002|STARTED|Overall Study||22
10295701|NCT02510040|11428366|FG000|COMPLETED|Overall Study||63
10295702|NCT02510040|11428367|FG001|COMPLETED|Overall Study||111
10295703|NCT02510040|11428368|FG002|COMPLETED|Overall Study||21
10295704|NCT02510040|11428366|FG000|NOT COMPLETED|Overall Study||18
10295705|NCT02510040|11428367|FG001|NOT COMPLETED|Overall Study||3
10295706|NCT02510040|11428368|FG002|NOT COMPLETED|Overall Study||1
10419245|NCT00809159|11564021|FG005|NOT COMPLETED|Part 1 and 2||3
10419246|NCT00809185|11564035|FG000|STARTED|Overall Study||7
10419247|NCT00809185|11564035|FG000|COMPLETED|Overall Study||7
10419248|NCT00809185|11564035|FG000|NOT COMPLETED|Overall Study||0
10419249|NCT00809276|11564040|FG000|STARTED|Overall Study||92
10419250|NCT00809276|11564040|FG000|COMPLETED|Overall Study||92
10419251|NCT00809276|11564040|FG000|NOT COMPLETED|Overall Study||0
10419252|NCT00809328|11564044|FG000|STARTED|Overall Study||102
10419253|NCT00809328|11564044|FG000|COMPLETED|Overall Study||73
10419254|NCT00809328|11564044|FG000|NOT COMPLETED|Overall Study||29
10419255|NCT00809354|11564058|FG000|STARTED|Overall Study||288
10419256|NCT00809354|11564059|FG001|STARTED|Overall Study||289
10419257|NCT00809354|11564060|FG002|STARTED|Overall Study||286
10419258|NCT00809354|11564061|FG003|STARTED|Overall Study||288
10419259|NCT00809354|11564062|FG004|STARTED|Overall Study||288
10419260|NCT00809354|11564063|FG005|STARTED|Overall Study||256
10419261|NCT00809354|11564064|FG006|STARTED|Overall Study||255
10419262|NCT00809354|11564065|FG007|STARTED|Overall Study||257
10419263|NCT00809354|11564066|FG008|STARTED|Overall Study||256
10419264|NCT00809354|11564067|FG009|STARTED|Overall Study||257
10419265|NCT00809354|11564058|FG000|Treated|Overall Study||285
10419266|NCT00809354|11564059|FG001|Treated|Overall Study||288
10419267|NCT00809354|11564060|FG002|Treated|Overall Study||280
10419268|NCT00809354|11564061|FG003|Treated|Overall Study||288
10419269|NCT00809354|11564062|FG004|Treated|Overall Study||283
10419270|NCT00809354|11564063|FG005|Treated|Overall Study||256
10545987|NCT01501162|11699515|FG000|NOT COMPLETED|Overall Study||8
10545988|NCT01501162|11699516|FG001|NOT COMPLETED|Overall Study||5
10545989|NCT01501929|11699522|FG000|STARTED|First Intervention||8
10545990|NCT01501929|11699523|FG001|STARTED|First Intervention||17
10545991|NCT01501929|11699522|FG000|COMPLETED|First Intervention||8
10545992|NCT01501929|11699523|FG001|COMPLETED|First Intervention||17
10545993|NCT01501929|11699522|FG000|NOT COMPLETED|First Intervention||0
10545994|NCT01501929|11699523|FG001|NOT COMPLETED|First Intervention||0
10545995|NCT01501929|11699522|FG000|STARTED|Second Intervention||8
10545996|NCT01501929|11699523|FG001|STARTED|Second Intervention||17
10545997|NCT01501929|11699522|FG000|COMPLETED|Second Intervention||8
10545998|NCT01501929|11699523|FG001|COMPLETED|Second Intervention||17
10545999|NCT01501929|11699522|FG000|NOT COMPLETED|Second Intervention||0
10546000|NCT01501929|11699523|FG001|NOT COMPLETED|Second Intervention||0
10546001|NCT01502033|11699529|FG000|STARTED|Overall Study|Milestone (10 participants) met.|10
10546002|NCT01502033|11699529|FG000|COMPLETED|Overall Study|Milestone (10 participants) met|7
10546003|NCT01502033|11699529|FG000|NOT COMPLETED|Overall Study||3
10546004|NCT01502072|11699538|FG000|STARTED|Overall Study||14
10419271|NCT00809354|11564064|FG006|Treated|Overall Study||254
10872155|NCT02111850|12038038|FG008|STARTED|Phase 1 Dose Escalation||6
10419272|NCT00809354|11564065|FG007|Treated|Overall Study||256
10419273|NCT00809354|11564066|FG008|Treated|Overall Study||254
10419274|NCT00809354|11564067|FG009|Treated|Overall Study||256
10419275|NCT00809354|11564058|FG000|COMPLETED|Overall Study||33
10419276|NCT00809354|11564059|FG001|COMPLETED|Overall Study||31
10872156|NCT02111850|12038039|FG009|STARTED|Phase 1 Dose Escalation||0
10872157|NCT02111850|12038040|FG010|STARTED|Phase 1 Dose Escalation||0
10872158|NCT02111850|12038030|FG000|COMPLETED|Phase 1 Dose Escalation||1
10872159|NCT02111850|12038031|FG001|COMPLETED|Phase 1 Dose Escalation||1
10872160|NCT02111850|12038032|FG002|COMPLETED|Phase 1 Dose Escalation||1
10872161|NCT02111850|12038033|FG003|COMPLETED|Phase 1 Dose Escalation||1
10872162|NCT02111850|12038034|FG004|COMPLETED|Phase 1 Dose Escalation||1
10872163|NCT02111850|12038035|FG005|COMPLETED|Phase 1 Dose Escalation||1
10872164|NCT02111850|12038036|FG006|COMPLETED|Phase 1 Dose Escalation||1
10872165|NCT02111850|12038037|FG007|COMPLETED|Phase 1 Dose Escalation||1
10872166|NCT02111850|12038038|FG008|COMPLETED|Phase 1 Dose Escalation||6
10872167|NCT02111850|12038039|FG009|COMPLETED|Phase 1 Dose Escalation||0
10872168|NCT02111850|12038040|FG010|COMPLETED|Phase 1 Dose Escalation||0
10872169|NCT02111850|12038030|FG000|NOT COMPLETED|Phase 1 Dose Escalation||0
10872170|NCT02111850|12038031|FG001|NOT COMPLETED|Phase 1 Dose Escalation||0
10872171|NCT02111850|12038032|FG002|NOT COMPLETED|Phase 1 Dose Escalation||0
10872172|NCT02111850|12038033|FG003|NOT COMPLETED|Phase 1 Dose Escalation||0
10872173|NCT02111850|12038034|FG004|NOT COMPLETED|Phase 1 Dose Escalation||1
10872174|NCT02111850|12038035|FG005|NOT COMPLETED|Phase 1 Dose Escalation||0
10872175|NCT02111850|12038036|FG006|NOT COMPLETED|Phase 1 Dose Escalation||0
10872176|NCT02111850|12038037|FG007|NOT COMPLETED|Phase 1 Dose Escalation||0
10872177|NCT02111850|12038038|FG008|NOT COMPLETED|Phase 1 Dose Escalation||0
10872178|NCT02111850|12038039|FG009|NOT COMPLETED|Phase 1 Dose Escalation||0
10872179|NCT02111850|12038040|FG010|NOT COMPLETED|Phase 1 Dose Escalation||0
10872180|NCT02111850|12038030|FG000|STARTED|Phase 2 Maximum Tolerated Dose||0
10872181|NCT02111850|12038031|FG001|STARTED|Phase 2 Maximum Tolerated Dose||0
10872182|NCT02111850|12038032|FG002|STARTED|Phase 2 Maximum Tolerated Dose||0
10872183|NCT02111850|12038033|FG003|STARTED|Phase 2 Maximum Tolerated Dose||0
10872184|NCT02111850|12038034|FG004|STARTED|Phase 2 Maximum Tolerated Dose||0
10872185|NCT02111850|12038035|FG005|STARTED|Phase 2 Maximum Tolerated Dose||0
10872186|NCT02111850|12038036|FG006|STARTED|Phase 2 Maximum Tolerated Dose||0
10872187|NCT02111850|12038037|FG007|STARTED|Phase 2 Maximum Tolerated Dose||0
10872188|NCT02111850|12038038|FG008|STARTED|Phase 2 Maximum Tolerated Dose||0
10872189|NCT02111850|12038039|FG009|STARTED|Phase 2 Maximum Tolerated Dose||5
10872190|NCT02111850|12038040|FG010|STARTED|Phase 2 Maximum Tolerated Dose||1
10872191|NCT02111850|12038030|FG000|COMPLETED|Phase 2 Maximum Tolerated Dose||0
10872192|NCT02111850|12038031|FG001|COMPLETED|Phase 2 Maximum Tolerated Dose||0
10872193|NCT02111850|12038032|FG002|COMPLETED|Phase 2 Maximum Tolerated Dose||0
10872194|NCT02111850|12038033|FG003|COMPLETED|Phase 2 Maximum Tolerated Dose||0
10872195|NCT02111850|12038034|FG004|COMPLETED|Phase 2 Maximum Tolerated Dose||0
10872196|NCT02111850|12038035|FG005|COMPLETED|Phase 2 Maximum Tolerated Dose||0
10872197|NCT02111850|12038036|FG006|COMPLETED|Phase 2 Maximum Tolerated Dose||0
10872198|NCT02111850|12038037|FG007|COMPLETED|Phase 2 Maximum Tolerated Dose||0
10872199|NCT02111850|12038038|FG008|COMPLETED|Phase 2 Maximum Tolerated Dose||0
10872200|NCT02111850|12038039|FG009|COMPLETED|Phase 2 Maximum Tolerated Dose||5
10872201|NCT02111850|12038040|FG010|COMPLETED|Phase 2 Maximum Tolerated Dose||1
10872202|NCT02111850|12038030|FG000|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
10872203|NCT02111850|12038031|FG001|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
10872204|NCT02111850|12038032|FG002|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
10872205|NCT02111850|12038033|FG003|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
10872206|NCT02111850|12038034|FG004|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
10872207|NCT02111850|12038035|FG005|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
10872208|NCT02111850|12038036|FG006|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
10872209|NCT02111850|12038037|FG007|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
10872210|NCT02111850|12038038|FG008|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
10872211|NCT02111850|12038039|FG009|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
10872212|NCT02111850|12038040|FG010|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
10872213|NCT01983553|12038068|FG000|STARTED|Overall Study||2131
10872214|NCT01983553|12038069|FG001|STARTED|Overall Study||1072
10872215|NCT01983553|12038068|FG000|COMPLETED|Overall Study||2131
10872216|NCT01983553|12038069|FG001|COMPLETED|Overall Study||1072
10872217|NCT01983553|12038068|FG000|NOT COMPLETED|Overall Study||0
10872218|NCT01983553|12038069|FG001|NOT COMPLETED|Overall Study||0
10872219|NCT01760291|12038075|FG000|STARTED|Overall Study||576
10872220|NCT01760291|12038075|FG000|COMPLETED|Overall Study||340
10872221|NCT01760291|12038075|FG000|NOT COMPLETED|Overall Study||236
10872222|NCT01483027|12038081|FG000|STARTED|Overall Study||215
10872223|NCT01483027|12038082|FG001|STARTED|Overall Study||213
10872224|NCT01483027|12038081|FG000|COMPLETED|Overall Study||169
10419277|NCT00809354|11564060|FG002|COMPLETED|Overall Study||32
10419278|NCT00809354|11564061|FG003|COMPLETED|Overall Study||32
10419279|NCT00809354|11564062|FG004|COMPLETED|Overall Study||32
10419280|NCT00809354|11564063|FG005|COMPLETED|Overall Study||31
10419281|NCT00809354|11564064|FG006|COMPLETED|Overall Study||32
10419282|NCT00809354|11564065|FG007|COMPLETED|Overall Study||19
10419283|NCT00809354|11564066|FG008|COMPLETED|Overall Study||28
10419284|NCT00809354|11564067|FG009|COMPLETED|Overall Study||31
10419285|NCT00809354|11564058|FG000|NOT COMPLETED|Overall Study||255
10872225|NCT01483027|12038082|FG001|COMPLETED|Overall Study||153
10419286|NCT00809354|11564059|FG001|NOT COMPLETED|Overall Study||258
10419287|NCT00809354|11564060|FG002|NOT COMPLETED|Overall Study||254
10872226|NCT01483027|12038081|FG000|NOT COMPLETED|Overall Study||46
10872227|NCT01483027|12038082|FG001|NOT COMPLETED|Overall Study||60
10872228|NCT01472562|12038088|FG000|STARTED|Induction Phase (Week 1- 48)||38
10872229|NCT01472562|12038088|FG000|COMPLETED|Induction Phase (Week 1- 48)||27
10872230|NCT01472562|12038088|FG000|NOT COMPLETED|Induction Phase (Week 1- 48)||11
10872231|NCT01472562|12038088|FG000|STARTED|Maintenance Phase (Week 49 to PD)||27
10872232|NCT01472562|12038088|FG000|COMPLETED|Maintenance Phase (Week 49 to PD)||4
10872233|NCT01472562|12038088|FG000|NOT COMPLETED|Maintenance Phase (Week 49 to PD)||23
10872234|NCT01379781|12038094|FG000|STARTED|Overall Study||27
10872235|NCT01379781|12038095|FG001|STARTED|Overall Study||27
10872236|NCT01379781|12038094|FG000|COMPLETED|Overall Study||16
10872237|NCT01379781|12038095|FG001|COMPLETED|Overall Study||19
10872238|NCT01379781|12038094|FG000|NOT COMPLETED|Overall Study||11
10872239|NCT01379781|12038095|FG001|NOT COMPLETED|Overall Study||8
10872240|NCT00135200|12038101|FG000|STARTED|Overall Study||16
10872241|NCT00135200|12038101|FG000|COMPLETED|Overall Study||16
10872242|NCT00135200|12038101|FG000|NOT COMPLETED|Overall Study||0
10872243|NCT02513394|12038107|FG000|STARTED|Overall Study||2896
10872244|NCT02513394|12038108|FG001|STARTED|Overall Study||2900
10872245|NCT02513394|12038107|FG000|COMPLETED|Overall Study||2884
10872246|NCT02513394|12038108|FG001|COMPLETED|Overall Study||2877
10872247|NCT02513394|12038107|FG000|NOT COMPLETED|Overall Study||12
10872248|NCT02513394|12038108|FG001|NOT COMPLETED|Overall Study||23
10872249|NCT02498132|12038117|FG000|STARTED|Overall Study||24
10872250|NCT02498132|12038118|FG001|STARTED|Overall Study||19
10872251|NCT02498132|12038119|FG002|STARTED|Overall Study||9
10872252|NCT02498132|12038117|FG000|COMPLETED|Overall Study||22
10872253|NCT02498132|12038118|FG001|COMPLETED|Overall Study||18
10872254|NCT02498132|12038119|FG002|COMPLETED|Overall Study||9
10872255|NCT02498132|12038117|FG000|NOT COMPLETED|Overall Study||2
10872256|NCT02498132|12038118|FG001|NOT COMPLETED|Overall Study||1
10872257|NCT02498132|12038119|FG002|NOT COMPLETED|Overall Study||0
10872258|NCT02450760|12038129|FG000|STARTED|Overall Study||15
10872259|NCT02450760|12038130|FG001|STARTED|Overall Study||18
10872260|NCT02450760|12038129|FG000|COMPLETED|Overall Study||15
10872261|NCT02450760|12038130|FG001|COMPLETED|Overall Study||18
10872262|NCT02450760|12038129|FG000|NOT COMPLETED|Overall Study||0
10872263|NCT02450760|12038130|FG001|NOT COMPLETED|Overall Study||0
10872264|NCT02445339|12038143|FG000|STARTED|Overall Study||25
10872265|NCT02445339|12038144|FG001|STARTED|Overall Study||25
10872266|NCT02445339|12038143|FG000|COMPLETED|Overall Study||13
10872267|NCT02445339|12038144|FG001|COMPLETED|Overall Study||10
10872268|NCT02445339|12038143|FG000|NOT COMPLETED|Overall Study||12
10872269|NCT02445339|12038144|FG001|NOT COMPLETED|Overall Study||15
10872270|NCT03618056|12038150|FG000|STARTED|Overall Study||1
10872271|NCT03618056|12038150|FG000|COMPLETED|Overall Study||1
10872272|NCT03618056|12038150|FG000|NOT COMPLETED|Overall Study||0
10872273|NCT03503617|12038156|FG000|STARTED|Overall Study||14
10872274|NCT03503617|12038157|FG001|STARTED|Overall Study||13
10872275|NCT03503617|12038156|FG000|COMPLETED|Overall Study||14
10872276|NCT03503617|12038157|FG001|COMPLETED|Overall Study||10
10872277|NCT03503617|12038156|FG000|NOT COMPLETED|Overall Study||0
10419288|NCT00809354|11564061|FG003|NOT COMPLETED|Overall Study||256
10419289|NCT00809354|11564062|FG004|NOT COMPLETED|Overall Study||256
10419290|NCT00809354|11564063|FG005|NOT COMPLETED|Overall Study||225
10419291|NCT00809354|11564064|FG006|NOT COMPLETED|Overall Study||223
10419292|NCT00809354|11564065|FG007|NOT COMPLETED|Overall Study||238
10419293|NCT00809354|11564066|FG008|NOT COMPLETED|Overall Study||228
10419294|NCT00809354|11564067|FG009|NOT COMPLETED|Overall Study||226
10419295|NCT00809445|11564097|FG000|STARTED|1 Month Follow-up||429
10419296|NCT00809445|11564098|FG001|STARTED|1 Month Follow-up||433
10419297|NCT00809445|11564099|FG002|STARTED|1 Month Follow-up||419
10419298|NCT00809445|11564097|FG000|COMPLETED|1 Month Follow-up||427
10419299|NCT00809445|11564098|FG001|COMPLETED|1 Month Follow-up||429
10419300|NCT00809445|11564099|FG002|COMPLETED|1 Month Follow-up||415
10419301|NCT00809445|11564097|FG000|NOT COMPLETED|1 Month Follow-up||2
10419302|NCT00809445|11564098|FG001|NOT COMPLETED|1 Month Follow-up||4
10419303|NCT00809445|11564099|FG002|NOT COMPLETED|1 Month Follow-up||4
10419304|NCT00809445|11564097|FG000|STARTED|6 Month Follow-up||429
10419305|NCT00809445|11564098|FG001|STARTED|6 Month Follow-up||433
10419306|NCT00809445|11564099|FG002|STARTED|6 Month Follow-up||419
10419307|NCT00809445|11564097|FG000|COMPLETED|6 Month Follow-up||405
10419308|NCT00809445|11564098|FG001|COMPLETED|6 Month Follow-up||410
10419309|NCT00809445|11564099|FG002|COMPLETED|6 Month Follow-up||395
10419310|NCT00809445|11564097|FG000|NOT COMPLETED|6 Month Follow-up||24
10419311|NCT00809445|11564098|FG001|NOT COMPLETED|6 Month Follow-up||23
10419312|NCT00809445|11564099|FG002|NOT COMPLETED|6 Month Follow-up||24
10419313|NCT00809471|11564110|FG000|STARTED|Overall Study||130
10419314|NCT00809471|11564111|FG001|STARTED|Overall Study||129
10419315|NCT00809471|11564112|FG002|STARTED|Overall Study||131
10419316|NCT00809471|11564110|FG000|COMPLETED|Overall Study||110
10419317|NCT00809471|11564111|FG001|COMPLETED|Overall Study||109
10419318|NCT00809471|11564112|FG002|COMPLETED|Overall Study||114
10419319|NCT00809471|11564110|FG000|NOT COMPLETED|Overall Study||20
10419320|NCT00809471|11564111|FG001|NOT COMPLETED|Overall Study||20
10419321|NCT00809471|11564112|FG002|NOT COMPLETED|Overall Study||17
10419322|NCT00809523|11564122|FG000|STARTED|Overall Study||54
10419323|NCT00809523|11564123|FG001|STARTED|Overall Study||52
10419324|NCT00809523|11564122|FG000|COMPLETED|Overall Study||47
10419325|NCT00809523|11564123|FG001|COMPLETED|Overall Study||48
10419326|NCT00809523|11564122|FG000|NOT COMPLETED|Overall Study||7
10419327|NCT00809523|11564123|FG001|NOT COMPLETED|Overall Study||4
10419328|NCT00809614|11564131|FG000|STARTED|Overall Study||28
10419329|NCT00809614|11564132|FG001|STARTED|Overall Study||14
10419330|NCT00809614|11564131|FG000|Pharmacokinetic Safety Set|Overall Study||27
10419331|NCT00809614|11564132|FG001|Pharmacokinetic Safety Set|Overall Study||14
10419332|NCT00809614|11564131|FG000|Pharmacodynamic (PD) Set|Overall Study||24
10419333|NCT00809614|11564132|FG001|Pharmacodynamic (PD) Set|Overall Study||13
10419334|NCT00809614|11564131|FG000|COMPLETED|Overall Study||25
10755693|NCT03070470|11919495|FG000|STARTED|Overall Study||10
10755694|NCT03070470|11919496|FG001|STARTED|Overall Study||10
10419335|NCT00809614|11564132|FG001|COMPLETED|Overall Study||10
10419336|NCT00809614|11564131|FG000|NOT COMPLETED|Overall Study||3
10419337|NCT00809614|11564132|FG001|NOT COMPLETED|Overall Study||4
10419338|NCT00809757|11564141|FG000|STARTED|Overall Study||68
10419339|NCT00809757|11564142|FG001|STARTED|Overall Study||65
10419340|NCT00809757|11564143|FG002|STARTED|Overall Study||64
10872278|NCT03503617|12038157|FG001|NOT COMPLETED|Overall Study||3
10872279|NCT03298867|12038165|FG000|STARTED|Double-Masked 24-Week Treatment Period||42
10872280|NCT03298867|12038166|FG001|STARTED|Double-Masked 24-Week Treatment Period||41
10872281|NCT03298867|12038165|FG000|COMPLETED|Double-Masked 24-Week Treatment Period|36 participants who completed the double-masked treatment period as nonresponders chose to enroll in the OPTIC-X open-label extension study (NCT03461211).|40
10872282|NCT03298867|12038166|FG001|COMPLETED|Double-Masked 24-Week Treatment Period|3 participants who completed the double-masked treatment period as nonresponders chose to enroll in the OPTIC-X open-label extension study (NCT03461211).|39
10872283|NCT03298867|12038165|FG000|NOT COMPLETED|Double-Masked 24-Week Treatment Period||2
10872284|NCT03298867|12038166|FG001|NOT COMPLETED|Double-Masked 24-Week Treatment Period||2
10872285|NCT03298867|12038165|FG000|STARTED|48-Week Follow-Up Period (Weeks 24-72)||4
10872286|NCT03298867|12038166|FG001|STARTED|48-Week Follow-Up Period (Weeks 24-72)||36
10872287|NCT03298867|12038165|FG000|COMPLETED|48-Week Follow-Up Period (Weeks 24-72)||3
10872288|NCT03298867|12038166|FG001|COMPLETED|48-Week Follow-Up Period (Weeks 24-72)||20
10872289|NCT03298867|12038165|FG000|NOT COMPLETED|48-Week Follow-Up Period (Weeks 24-72)||1
10872290|NCT03298867|12038166|FG001|NOT COMPLETED|48-Week Follow-Up Period (Weeks 24-72)||16
10872291|NCT03298867|12038165|FG000|STARTED|48-Week Follow-Up Contact (Weeks 96-120)||3
10872292|NCT03298867|12038166|FG001|STARTED|48-Week Follow-Up Contact (Weeks 96-120)||20
10872293|NCT03298867|12038165|FG000|COMPLETED|48-Week Follow-Up Contact (Weeks 96-120)||3
10872294|NCT03298867|12038166|FG001|COMPLETED|48-Week Follow-Up Contact (Weeks 96-120)||19
10872295|NCT03298867|12038165|FG000|NOT COMPLETED|48-Week Follow-Up Contact (Weeks 96-120)||0
10872296|NCT03298867|12038166|FG001|NOT COMPLETED|48-Week Follow-Up Contact (Weeks 96-120)||1
10872297|NCT03220581|12038174|FG000|STARTED|Overall Study||28
10872298|NCT03220581|12038175|FG001|STARTED|Overall Study||32
10872299|NCT03220581|12038174|FG000|COMPLETED|Overall Study||25
10872300|NCT03220581|12038175|FG001|COMPLETED|Overall Study||25
10872301|NCT03220581|12038174|FG000|NOT COMPLETED|Overall Study||3
10872302|NCT03220581|12038175|FG001|NOT COMPLETED|Overall Study||7
10872303|NCT03099486|12038183|FG000|STARTED|Overall Study||2
10872304|NCT03099486|12038183|FG000|COMPLETED|Overall Study||2
10872305|NCT03099486|12038183|FG000|NOT COMPLETED|Overall Study||0
10872314|NCT02768870|12038196|FG000|STARTED|Overall Study||26
10872315|NCT02768870|12038196|FG000|Implanted With Device|Overall Study||24
10872316|NCT02768870|12038196|FG000|COMPLETED|Overall Study||0
10872317|NCT02768870|12038196|FG000|NOT COMPLETED|Overall Study||26
10872318|NCT02648698|12038202|FG000|STARTED|Overall Study||60
10872319|NCT02648698|12038203|FG001|STARTED|Overall Study||60
10872320|NCT02648698|12038202|FG000|COMPLETED|Overall Study||59
10872321|NCT02648698|12038203|FG001|COMPLETED|Overall Study||55
10872322|NCT02648698|12038202|FG000|NOT COMPLETED|Overall Study||1
10546005|NCT01502072|11699539|FG001|STARTED|Overall Study||10
10546006|NCT01502072|11699540|FG002|STARTED|Overall Study||20
10546007|NCT01502072|11699538|FG000|COMPLETED|Overall Study||13
10872323|NCT02648698|12038203|FG001|NOT COMPLETED|Overall Study||5
10419341|NCT00809757|11564141|FG000|COMPLETED|Overall Study||62
10419342|NCT00809757|11564142|FG001|COMPLETED|Overall Study||60
10419343|NCT00809757|11564143|FG002|COMPLETED|Overall Study||53
10419344|NCT00809757|11564141|FG000|NOT COMPLETED|Overall Study||6
10419345|NCT00809757|11564142|FG001|NOT COMPLETED|Overall Study||5
10419346|NCT00809757|11564143|FG002|NOT COMPLETED|Overall Study||11
10419347|NCT00809783|11564160|FG000|STARTED|Overall Study||525
10419348|NCT00809783|11564161|FG001|STARTED|Overall Study||832
10419349|NCT00809783|11564162|FG002|STARTED|Overall Study||790
10419350|NCT00809783|11564160|FG000|Treated|Overall Study||522
10419351|NCT00809783|11564161|FG001|Treated|Overall Study||832
10419352|NCT00809783|11564162|FG002|Treated|Overall Study||788
10419353|NCT00809783|11564160|FG000|COMPLETED|Overall Study||0
10419354|NCT00809783|11564161|FG001|COMPLETED|Overall Study||0
10872328|NCT02000882|12038213|FG000|STARTED|Overall Study||10
10872329|NCT02000882|12038213|FG000|COMPLETED|Overall Study||4
10872330|NCT02000882|12038213|FG000|NOT COMPLETED|Overall Study||6
10872331|NCT01654315|12038220|FG000|STARTED|Overall Study||15
10872332|NCT01654315|12038221|FG001|STARTED|Overall Study||10
10872333|NCT01654315|12038222|FG002|STARTED|Overall Study||9
10872334|NCT01654315|12038220|FG000|COMPLETED|Overall Study||15
10872335|NCT01654315|12038221|FG001|COMPLETED|Overall Study||10
10872336|NCT01654315|12038222|FG002|COMPLETED|Overall Study||9
10872337|NCT01654315|12038220|FG000|NOT COMPLETED|Overall Study||0
10872338|NCT01654315|12038221|FG001|NOT COMPLETED|Overall Study||0
10872339|NCT01654315|12038222|FG002|NOT COMPLETED|Overall Study||0
10872340|NCT01642004|12038232|FG000|STARTED|Randomization||135
10872341|NCT01642004|12038233|FG001|STARTED|Randomization||137
10872342|NCT01642004|12038232|FG000|COMPLETED|Randomization||131
10419355|NCT00809783|11564162|FG002|COMPLETED|Overall Study||0
10419356|NCT00809783|11564160|FG000|NOT COMPLETED|Overall Study||525
10419357|NCT00809783|11564161|FG001|NOT COMPLETED|Overall Study||832
10419358|NCT00809783|11564162|FG002|NOT COMPLETED|Overall Study||790
10872343|NCT01642004|12038233|FG001|COMPLETED|Randomization||129
10872344|NCT01642004|12038232|FG000|NOT COMPLETED|Randomization||4
10872345|NCT01642004|12038233|FG001|NOT COMPLETED|Randomization||8
10872346|NCT01642004|12038232|FG000|STARTED|Treatment||131
10872347|NCT01642004|12038233|FG001|STARTED|Treatment||129
10872348|NCT01642004|12038232|FG000|COMPLETED|Treatment||21
10872349|NCT01642004|12038233|FG001|COMPLETED|Treatment||2
10872350|NCT01642004|12038232|FG000|NOT COMPLETED|Treatment||110
10872351|NCT01642004|12038233|FG001|NOT COMPLETED|Treatment||127
10872352|NCT01326104|12038241|FG000|STARTED|Overall Study||7
10872353|NCT01326104|12038242|FG001|STARTED|Overall Study||19
10872354|NCT01326104|12038241|FG000|COMPLETED|Overall Study||7
10872355|NCT01326104|12038242|FG001|COMPLETED|Overall Study||15
10872356|NCT01326104|12038241|FG000|NOT COMPLETED|Overall Study||0
10872357|NCT01326104|12038242|FG001|NOT COMPLETED|Overall Study||4
10872358|NCT01244815|12038252|FG000|STARTED|Overall Study|Randomized|101
10872359|NCT01244815|12038253|FG001|STARTED|Overall Study|Randomized|105
10872360|NCT01244815|12038254|FG002|STARTED|Overall Study|Randomized|99
10872361|NCT01244815|12038255|FG003|STARTED|Overall Study|Randomized|99
10872362|NCT01244815|12038252|FG000|Treated|Overall Study||101
10872363|NCT01244815|12038253|FG001|Treated|Overall Study||104
10872364|NCT01244815|12038254|FG002|Treated|Overall Study||99
10872365|NCT01244815|12038255|FG003|Treated|Overall Study||99
10872366|NCT01244815|12038252|FG000|COMPLETED|Overall Study||87
10872367|NCT01244815|12038253|FG001|COMPLETED|Overall Study||88
10872368|NCT01244815|12038254|FG002|COMPLETED|Overall Study||88
10872369|NCT01244815|12038255|FG003|COMPLETED|Overall Study||87
10872370|NCT01244815|12038252|FG000|NOT COMPLETED|Overall Study||14
10872371|NCT01244815|12038253|FG001|NOT COMPLETED|Overall Study||17
10872372|NCT01244815|12038254|FG002|NOT COMPLETED|Overall Study||11
10872373|NCT01244815|12038255|FG003|NOT COMPLETED|Overall Study||12
10872374|NCT01142596|12038267|FG000|STARTED|Overall Study||44
10872375|NCT01142596|12038268|FG001|STARTED|Overall Study||157
10872376|NCT01142596|12038267|FG000|COMPLETED|Overall Study||15
10872377|NCT01142596|12038268|FG001|COMPLETED|Overall Study||71
10872378|NCT01142596|12038267|FG000|NOT COMPLETED|Overall Study||29
10872379|NCT01142596|12038268|FG001|NOT COMPLETED|Overall Study||86
10872380|NCT01098110|12038277|FG000|STARTED|Overall Study|Randomized participants|176
10872381|NCT01098110|12038278|FG001|STARTED|Overall Study|Randomized participants|182
10872382|NCT01098110|12038279|FG002|STARTED|Overall Study|Randomized participants|174
10872383|NCT01098110|12038277|FG000|Treated|Overall Study|Received at least one dose of trial medication|175
10872384|NCT01098110|12038278|FG001|Treated|Overall Study|Received at least one dose of trial medication|181
10872385|NCT01098110|12038279|FG002|Treated|Overall Study|Received at least one dose of trial medication|174
10872386|NCT01098110|12038277|FG000|COMPLETED|Overall Study||114
10872387|NCT01098110|12038278|FG001|COMPLETED|Overall Study||109
10872388|NCT01098110|12038279|FG002|COMPLETED|Overall Study||80
10872389|NCT01098110|12038277|FG000|NOT COMPLETED|Overall Study||62
10872390|NCT01098110|12038278|FG001|NOT COMPLETED|Overall Study||73
10872391|NCT01098110|12038279|FG002|NOT COMPLETED|Overall Study||94
10872392|NCT01006265|12038291|FG000|STARTED|Overall Study||119
10872393|NCT01006265|12038292|FG001|STARTED|Overall Study||116
10872394|NCT01006265|12038293|FG002|STARTED|Overall Study||108
10872395|NCT01006265|12038294|FG003|STARTED|Overall Study||121
10872396|NCT01006265|12038291|FG000|Treated|Overall Study||119
10872397|NCT01006265|12038292|FG001|Treated|Overall Study||114
10872398|NCT01006265|12038293|FG002|Treated|Overall Study||108
10872399|NCT01006265|12038294|FG003|Treated|Overall Study||121
10872400|NCT01006265|12038291|FG000|COMPLETED|Overall Study||113
10872401|NCT01006265|12038292|FG001|COMPLETED|Overall Study||107
10872402|NCT01006265|12038293|FG002|COMPLETED|Overall Study||99
10872403|NCT01006265|12038294|FG003|COMPLETED|Overall Study||116
10872404|NCT01006265|12038291|FG000|NOT COMPLETED|Overall Study||6
10872405|NCT01006265|12038292|FG001|NOT COMPLETED|Overall Study||9
10872406|NCT01006265|12038293|FG002|NOT COMPLETED|Overall Study||9
10872407|NCT01006265|12038294|FG003|NOT COMPLETED|Overall Study||5
10872408|NCT00591227|12038306|FG000|STARTED|Overall Study||89
10872409|NCT00591227|12038307|FG001|STARTED|Overall Study||87
10872410|NCT00591227|12038306|FG000|COMPLETED|Overall Study||89
10872411|NCT00591227|12038307|FG001|COMPLETED|Overall Study||87
10872412|NCT00591227|12038306|FG000|NOT COMPLETED|Overall Study||0
10419359|NCT00809809|11564172|FG000|STARTED|Overall Study||78
10419360|NCT00809809|11564173|FG001|STARTED|Overall Study||79
10419361|NCT00809809|11564172|FG000|COMPLETED|Overall Study|3 dropped from the study when it was discovered they met the exclusion criteria|75
10419362|NCT00809809|11564173|FG001|COMPLETED|Overall Study|2 dropped from the study when it was discovered they met the exclusion criteria|77
10872413|NCT00591227|12038307|FG001|NOT COMPLETED|Overall Study||0
10872414|NCT00534976|12038316|FG000|STARTED|Period 1: Placebo Run-in||33
10872415|NCT00534976|12038317|FG001|STARTED|Period 1: Placebo Run-in||33
10872416|NCT00534976|12038316|FG000|COMPLETED|Period 1: Placebo Run-in||33
10872417|NCT00534976|12038317|FG001|COMPLETED|Period 1: Placebo Run-in||33
10872418|NCT00534976|12038316|FG000|NOT COMPLETED|Period 1: Placebo Run-in||0
10872419|NCT00534976|12038317|FG001|NOT COMPLETED|Period 1: Placebo Run-in||0
10872420|NCT00534976|12038316|FG000|STARTED|Period 2: Treatment Montelukast/ Placebo||33
10872421|NCT00534976|12038317|FG001|STARTED|Period 2: Treatment Montelukast/ Placebo||33
10872422|NCT00534976|12038316|FG000|COMPLETED|Period 2: Treatment Montelukast/ Placebo||33
10872423|NCT00534976|12038317|FG001|COMPLETED|Period 2: Treatment Montelukast/ Placebo||32
10872424|NCT00534976|12038316|FG000|NOT COMPLETED|Period 2: Treatment Montelukast/ Placebo||0
10872425|NCT00534976|12038317|FG001|NOT COMPLETED|Period 2: Treatment Montelukast/ Placebo||1
10872426|NCT00534976|12038316|FG000|STARTED|Period 3: Crossover Placebo/ Montelukast||33
10872427|NCT00534976|12038317|FG001|STARTED|Period 3: Crossover Placebo/ Montelukast||32
10872428|NCT00534976|12038316|FG000|COMPLETED|Period 3: Crossover Placebo/ Montelukast||31
10872429|NCT00534976|12038317|FG001|COMPLETED|Period 3: Crossover Placebo/ Montelukast||32
10872430|NCT00534976|12038316|FG000|NOT COMPLETED|Period 3: Crossover Placebo/ Montelukast||2
10872431|NCT00534976|12038317|FG001|NOT COMPLETED|Period 3: Crossover Placebo/ Montelukast||0
10872432|NCT00337675|12038326|FG000|STARTED|Overall Study||589
10872433|NCT00337675|12038327|FG001|STARTED|Overall Study||591
10872434|NCT00337675|12038328|FG002|STARTED|Overall Study||591
10872435|NCT00337675|12038326|FG000|COMPLETED|Overall Study||492
10872436|NCT00337675|12038327|FG001|COMPLETED|Overall Study||488
10872437|NCT00337675|12038328|FG002|COMPLETED|Overall Study||492
10872438|NCT00337675|12038326|FG000|NOT COMPLETED|Overall Study||97
10872439|NCT00337675|12038327|FG001|NOT COMPLETED|Overall Study||103
10872440|NCT00337675|12038328|FG002|NOT COMPLETED|Overall Study||99
10872441|NCT00317772|12038340|FG000|STARTED|Overall Study||3
10872442|NCT00317772|12038341|FG001|STARTED|Overall Study||3
10872443|NCT00317772|12038342|FG002|STARTED|Overall Study||3
10872444|NCT00317772|12038343|FG003|STARTED|Overall Study||10
10872445|NCT00317772|12038340|FG000|COMPLETED|Overall Study||1
10872446|NCT00317772|12038341|FG001|COMPLETED|Overall Study||1
10872447|NCT00317772|12038342|FG002|COMPLETED|Overall Study||2
10872448|NCT00317772|12038343|FG003|COMPLETED|Overall Study||1
10872449|NCT00317772|12038340|FG000|NOT COMPLETED|Overall Study||2
10872450|NCT00317772|12038341|FG001|NOT COMPLETED|Overall Study||2
10872451|NCT00317772|12038342|FG002|NOT COMPLETED|Overall Study||1
10872452|NCT00317772|12038343|FG003|NOT COMPLETED|Overall Study||9
10872453|NCT00291486|12038359|FG000|STARTED|Overall Study||3
10872454|NCT00291486|12038360|FG001|STARTED|Overall Study||6
10872455|NCT00291486|12038361|FG002|STARTED|Overall Study||3
10872456|NCT00291486|12038362|FG003|STARTED|Overall Study||3
10872457|NCT00291486|12038363|FG004|STARTED|Overall Study||4
10872458|NCT00291486|12038359|FG000|COMPLETED|Overall Study||2
10872459|NCT00291486|12038360|FG001|COMPLETED|Overall Study||3
10872460|NCT00291486|12038361|FG002|COMPLETED|Overall Study||2
10872461|NCT00291486|12038362|FG003|COMPLETED|Overall Study||2
10872462|NCT00291486|12038363|FG004|COMPLETED|Overall Study||3
10872463|NCT00291486|12038359|FG000|NOT COMPLETED|Overall Study||1
10872464|NCT00291486|12038360|FG001|NOT COMPLETED|Overall Study||3
10872465|NCT00291486|12038361|FG002|NOT COMPLETED|Overall Study||1
10872466|NCT00291486|12038362|FG003|NOT COMPLETED|Overall Study||1
10872467|NCT00291486|12038363|FG004|NOT COMPLETED|Overall Study||1
10872468|NCT00284856|12038387|FG000|STARTED|Overall Study||347
10872469|NCT00284856|12038388|FG001|STARTED|Overall Study||336
10872470|NCT00284856|12038389|FG002|STARTED|Overall Study||336
10872471|NCT00284856|12038387|FG000|COMPLETED|Overall Study||296
10872472|NCT00284856|12038388|FG001|COMPLETED|Overall Study||286
10872473|NCT00284856|12038389|FG002|COMPLETED|Overall Study||276
10872474|NCT00284856|12038387|FG000|NOT COMPLETED|Overall Study||51
10872475|NCT00284856|12038388|FG001|NOT COMPLETED|Overall Study||50
10872476|NCT00284856|12038389|FG002|NOT COMPLETED|Overall Study||60
10872477|NCT00070707|12038399|FG000|STARTED|Overall Study||113
10872478|NCT00070707|12038400|FG001|STARTED|Overall Study||75
10872479|NCT00070707|12038399|FG000|COMPLETED|Overall Study||99
10872480|NCT00070707|12038400|FG001|COMPLETED|Overall Study||68
10872481|NCT00070707|12038399|FG000|NOT COMPLETED|Overall Study||14
10872482|NCT00070707|12038400|FG001|NOT COMPLETED|Overall Study||7
10872483|NCT02358993|12038408|FG000|STARTED|Overall Study||105
10872484|NCT02358993|12038409|FG001|STARTED|Overall Study||96
10872485|NCT02358993|12038408|FG000|COMPLETED|Overall Study||103
10872486|NCT02358993|12038409|FG001|COMPLETED|Overall Study||94
10872487|NCT02358993|12038408|FG000|NOT COMPLETED|Overall Study||2
10872488|NCT02358993|12038409|FG001|NOT COMPLETED|Overall Study||2
10872489|NCT03566199|12038415|FG000|STARTED|Overall Study||1
10872490|NCT03566199|12038416|FG001|STARTED|Overall Study||0
10872491|NCT03566199|12038417|FG002|STARTED|Overall Study||1
10872492|NCT03566199|12038418|FG003|STARTED|Overall Study||0
10872493|NCT03566199|12038419|FG004|STARTED|Overall Study||1
10872494|NCT03566199|12038420|FG005|STARTED|Overall Study||0
10872495|NCT03566199|12038421|FG006|STARTED|Overall Study||4
10872496|NCT03566199|12038422|FG007|STARTED|Overall Study||0
10872497|NCT03566199|12038415|FG000|COMPLETED|Overall Study||1
10872498|NCT03566199|12038416|FG001|COMPLETED|Overall Study||0
10872499|NCT03566199|12038417|FG002|COMPLETED|Overall Study||1
10872500|NCT03566199|12038418|FG003|COMPLETED|Overall Study||0
10872501|NCT03566199|12038419|FG004|COMPLETED|Overall Study||1
10872502|NCT03566199|12038420|FG005|COMPLETED|Overall Study||0
10872503|NCT03566199|12038421|FG006|COMPLETED|Overall Study||4
10872504|NCT03566199|12038422|FG007|COMPLETED|Overall Study||0
10872505|NCT03566199|12038415|FG000|NOT COMPLETED|Overall Study||0
10872506|NCT03566199|12038416|FG001|NOT COMPLETED|Overall Study||0
10872507|NCT03566199|12038417|FG002|NOT COMPLETED|Overall Study||0
10872508|NCT03566199|12038418|FG003|NOT COMPLETED|Overall Study||0
10872509|NCT03566199|12038419|FG004|NOT COMPLETED|Overall Study||0
10872510|NCT03566199|12038420|FG005|NOT COMPLETED|Overall Study||0
10872511|NCT03566199|12038421|FG006|NOT COMPLETED|Overall Study||0
10872512|NCT03566199|12038422|FG007|NOT COMPLETED|Overall Study||0
10872513|NCT04474197|12038430|FG000|STARTED|Overall Study||7
10872514|NCT04474197|12038431|FG001|STARTED|Overall Study||10
10872515|NCT04474197|12038432|FG002|STARTED|Overall Study||9
10872516|NCT04474197|12038433|FG003|STARTED|Overall Study||18
10872517|NCT04474197|12038430|FG000|COMPLETED|Overall Study||7
10872518|NCT04474197|12038431|FG001|COMPLETED|Overall Study||9
10872519|NCT04474197|12038432|FG002|COMPLETED|Overall Study||9
10872520|NCT04474197|12038433|FG003|COMPLETED|Overall Study||18
10872521|NCT04474197|12038430|FG000|NOT COMPLETED|Overall Study||0
10872522|NCT04474197|12038431|FG001|NOT COMPLETED|Overall Study||1
10872523|NCT04474197|12038432|FG002|NOT COMPLETED|Overall Study||0
10872524|NCT04474197|12038433|FG003|NOT COMPLETED|Overall Study||0
10872574|NCT03712345|12038511|FG000|STARTED|Overall Study||6
10872575|NCT03712345|12038512|FG001|STARTED|Overall Study||7
10872576|NCT03712345|12038513|FG002|STARTED|Overall Study|One participant was mistakenly randomized, but never treated because the participant was a screening failure.|7
10872577|NCT03712345|12038511|FG000|COMPLETED|Overall Study||6
10872578|NCT03712345|12038512|FG001|COMPLETED|Overall Study||7
10872579|NCT03712345|12038513|FG002|COMPLETED|Overall Study||6
10872580|NCT03712345|12038511|FG000|NOT COMPLETED|Overall Study||0
10872581|NCT03712345|12038512|FG001|NOT COMPLETED|Overall Study||0
10872582|NCT03712345|12038513|FG002|NOT COMPLETED|Overall Study||1
10872583|NCT03694275|12038523|FG000|STARTED|Overall Study||8
10872584|NCT03694275|12038524|FG001|STARTED|Overall Study||12
10872585|NCT03694275|12038523|FG000|COMPLETED|Overall Study||8
10872586|NCT03694275|12038524|FG001|COMPLETED|Overall Study||10
10872587|NCT03694275|12038523|FG000|NOT COMPLETED|Overall Study||0
10872588|NCT03694275|12038524|FG001|NOT COMPLETED|Overall Study||2
10872589|NCT03391232|12038533|FG000|STARTED|Part A - First Dose (1-12weeks)||5
10872590|NCT03391232|12038534|FG001|STARTED|Part A - First Dose (1-12weeks)||6
10872591|NCT03391232|12038533|FG000|COMPLETED|Part A - First Dose (1-12weeks)|This cohort finished the trial here after 12 weeks.|5
10872592|NCT03391232|12038534|FG001|COMPLETED|Part A - First Dose (1-12weeks)|After interim analysis this cohort continued the trial.|6
10872593|NCT03391232|12038533|FG000|NOT COMPLETED|Part A - First Dose (1-12weeks)||0
10872594|NCT03391232|12038534|FG001|NOT COMPLETED|Part A - First Dose (1-12weeks)||0
10872595|NCT03391232|12038533|FG000|STARTED|Part B - Additional 2 Doses (13-38weeks)||0
10872596|NCT03391232|12038534|FG001|STARTED|Part B - Additional 2 Doses (13-38weeks)||6
10872597|NCT03391232|12038533|FG000|COMPLETED|Part B - Additional 2 Doses (13-38weeks)||0
10872525|NCT04369950|12038450|FG000|STARTED|Overall Study||22
10872526|NCT04369950|12038451|FG001|STARTED|Overall Study||22
10872527|NCT04369950|12038450|FG000|COMPLETED|Overall Study||20
10872528|NCT04369950|12038451|FG001|COMPLETED|Overall Study||20
10872529|NCT04369950|12038450|FG000|NOT COMPLETED|Overall Study||2
10872530|NCT04369950|12038451|FG001|NOT COMPLETED|Overall Study||2
10872531|NCT04070326|12038459|FG000|STARTED|Baseline Observation-12 Weeks Before TP||4
10872532|NCT04070326|12038460|FG001|STARTED|Baseline Observation-12 Weeks Before TP||17
10872533|NCT04070326|12038459|FG000|COMPLETED|Baseline Observation-12 Weeks Before TP||4
10872534|NCT04070326|12038460|FG001|COMPLETED|Baseline Observation-12 Weeks Before TP||17
10872535|NCT04070326|12038459|FG000|NOT COMPLETED|Baseline Observation-12 Weeks Before TP||0
10872536|NCT04070326|12038460|FG001|NOT COMPLETED|Baseline Observation-12 Weeks Before TP||0
10872537|NCT04070326|12038459|FG000|STARTED|Treatment Period A (Weeks 1 to 26)||4
10872538|NCT04070326|12038460|FG001|STARTED|Treatment Period A (Weeks 1 to 26)||17
10872539|NCT04070326|12038459|FG000|COMPLETED|Treatment Period A (Weeks 1 to 26)||3
10872540|NCT04070326|12038460|FG001|COMPLETED|Treatment Period A (Weeks 1 to 26)||17
10872541|NCT04070326|12038459|FG000|NOT COMPLETED|Treatment Period A (Weeks 1 to 26)||1
10872542|NCT04070326|12038460|FG001|NOT COMPLETED|Treatment Period A (Weeks 1 to 26)||0
10872543|NCT04070326|12038459|FG000|STARTED|Treatment Period B (Weeks 27 to 52)||3
10872544|NCT04070326|12038460|FG001|STARTED|Treatment Period B (Weeks 27 to 52)||17
10872545|NCT04070326|12038459|FG000|COMPLETED|Treatment Period B (Weeks 27 to 52)||3
10872546|NCT04070326|12038460|FG001|COMPLETED|Treatment Period B (Weeks 27 to 52)||17
10872547|NCT04070326|12038459|FG000|NOT COMPLETED|Treatment Period B (Weeks 27 to 52)||0
10872548|NCT04070326|12038460|FG001|NOT COMPLETED|Treatment Period B (Weeks 27 to 52)||0
10872549|NCT04003610|12038471|FG000|STARTED|Overall Study||0
10872550|NCT04003610|12038472|FG001|STARTED|Overall Study||1
10872551|NCT04003610|12038473|FG002|STARTED|Overall Study||6
10872552|NCT04003610|12038471|FG000|COMPLETED|Overall Study||0
10872553|NCT04003610|12038472|FG001|COMPLETED|Overall Study||0
10872554|NCT04003610|12038473|FG002|COMPLETED|Overall Study||0
10872555|NCT04003610|12038471|FG000|NOT COMPLETED|Overall Study||0
10872556|NCT04003610|12038472|FG001|NOT COMPLETED|Overall Study||1
10872557|NCT04003610|12038473|FG002|NOT COMPLETED|Overall Study||6
10872558|NCT03920293|12038484|FG000|STARTED|Overall Study||86
10872559|NCT03920293|12038485|FG001|STARTED|Overall Study||89
10872560|NCT03920293|12038484|FG000|Received at Least 1 Dose of Study Drug|Overall Study||86
10872561|NCT03920293|12038485|FG001|Received at Least 1 Dose of Study Drug|Overall Study||89
10872562|NCT03920293|12038484|FG000|COMPLETED|Overall Study||79
10872563|NCT03920293|12038485|FG001|COMPLETED|Overall Study||83
10872564|NCT03920293|12038484|FG000|NOT COMPLETED|Overall Study||7
10872565|NCT03920293|12038485|FG001|NOT COMPLETED|Overall Study||6
10872566|NCT03907540|12038491|FG000|STARTED|Overall Study||5
10872567|NCT03907540|12038491|FG000|Completed Part 1|Overall Study||5
10872568|NCT03907540|12038491|FG000|Completed Part 2|Overall Study||5
10872569|NCT03907540|12038491|FG000|COMPLETED|Overall Study||5
10872570|NCT03907540|12038491|FG000|NOT COMPLETED|Overall Study||0
10872571|NCT03904108|12038504|FG000|STARTED|Overall Study||3
10872572|NCT03904108|12038504|FG000|COMPLETED|Overall Study||3
10872573|NCT03904108|12038504|FG000|NOT COMPLETED|Overall Study||0
10872598|NCT03391232|12038534|FG001|COMPLETED|Part B - Additional 2 Doses (13-38weeks)||3
10872599|NCT03391232|12038533|FG000|NOT COMPLETED|Part B - Additional 2 Doses (13-38weeks)||0
10872600|NCT03391232|12038534|FG001|NOT COMPLETED|Part B - Additional 2 Doses (13-38weeks)||3
10872601|NCT03323736|12038545|FG000|STARTED|Overall Study||241
10872602|NCT03323736|12038546|FG001|STARTED|Overall Study||59
10872603|NCT03323736|12038547|FG002|STARTED|Overall Study||70
10872604|NCT03323736|12038545|FG000|Treated|Overall Study||222
10872605|NCT03323736|12038546|FG001|Treated|Overall Study||47
10872606|NCT03323736|12038547|FG002|Treated|Overall Study||68
10872607|NCT03323736|12038545|FG000|COMPLETED|Overall Study||222
10872608|NCT03323736|12038546|FG001|COMPLETED|Overall Study||47
10872609|NCT03323736|12038547|FG002|COMPLETED|Overall Study||68
10872610|NCT03323736|12038545|FG000|NOT COMPLETED|Overall Study||19
10872611|NCT03323736|12038546|FG001|NOT COMPLETED|Overall Study||12
10872612|NCT03323736|12038547|FG002|NOT COMPLETED|Overall Study||2
10872619|NCT03073980|12038569|FG000|STARTED|Overall Study||53
10872620|NCT03073980|12038570|FG001|STARTED|Overall Study||54
10872621|NCT03073980|12038571|FG002|STARTED|Overall Study||54
10872622|NCT03073980|12038569|FG000|COMPLETED|Overall Study||43
10872623|NCT03073980|12038570|FG001|COMPLETED|Overall Study||52
10872624|NCT03073980|12038571|FG002|COMPLETED|Overall Study||43
10872625|NCT03073980|12038569|FG000|NOT COMPLETED|Overall Study||10
10872626|NCT03073980|12038570|FG001|NOT COMPLETED|Overall Study||2
10872627|NCT03073980|12038571|FG002|NOT COMPLETED|Overall Study||11
10872634|NCT02544074|12038613|FG000|STARTED|Overall Study||1
10872635|NCT02544074|12038614|FG001|STARTED|Overall Study||1
10872636|NCT02544074|12038615|FG002|STARTED|Overall Study||1
10872637|NCT02544074|12038616|FG003|STARTED|Overall Study||1
10872638|NCT02544074|12038617|FG004|STARTED|Overall Study||4
10872639|NCT02544074|12038618|FG005|STARTED|Overall Study||1
10872640|NCT02544074|12038619|FG006|STARTED|Overall Study||2
10872641|NCT02544074|12038620|FG007|STARTED|Overall Study||4
10872642|NCT02544074|12038621|FG008|STARTED|Overall Study||6
10872643|NCT02544074|12038622|FG009|STARTED|Overall Study||2
10872644|NCT02544074|12038623|FG010|STARTED|Overall Study||2
10872645|NCT02544074|12038624|FG011|STARTED|Overall Study||3
10872646|NCT02544074|12038625|FG012|STARTED|Overall Study||4
10872647|NCT02544074|12038626|FG013|STARTED|Overall Study||5
10872648|NCT02544074|12038627|FG014|STARTED|Overall Study||5
10872649|NCT02544074|12038628|FG015|STARTED|Overall Study||8
10872650|NCT02544074|12038629|FG016|STARTED|Overall Study||6
10872651|NCT02544074|12038630|FG017|STARTED|Overall Study||3
10872652|NCT02544074|12038631|FG018|STARTED|Overall Study||4
10872653|NCT02544074|12038632|FG019|STARTED|Overall Study||3
10872654|NCT02544074|12038633|FG020|STARTED|Overall Study||3
10872655|NCT02544074|12038613|FG000|COMPLETED|Overall Study||1
10872656|NCT02544074|12038614|FG001|COMPLETED|Overall Study||0
10872657|NCT02544074|12038615|FG002|COMPLETED|Overall Study||1
10872658|NCT02544074|12038616|FG003|COMPLETED|Overall Study||1
10872659|NCT02544074|12038617|FG004|COMPLETED|Overall Study||4
10872660|NCT02544074|12038618|FG005|COMPLETED|Overall Study||0
10872661|NCT02544074|12038619|FG006|COMPLETED|Overall Study||2
10872662|NCT02544074|12038620|FG007|COMPLETED|Overall Study||4
10872663|NCT02544074|12038621|FG008|COMPLETED|Overall Study||6
10872664|NCT02544074|12038622|FG009|COMPLETED|Overall Study||1
10872665|NCT02544074|12038623|FG010|COMPLETED|Overall Study||2
10872666|NCT02544074|12038624|FG011|COMPLETED|Overall Study||3
10872667|NCT02544074|12038625|FG012|COMPLETED|Overall Study||4
10872668|NCT02544074|12038626|FG013|COMPLETED|Overall Study||5
10872669|NCT02544074|12038627|FG014|COMPLETED|Overall Study||5
10872670|NCT02544074|12038628|FG015|COMPLETED|Overall Study||8
10872671|NCT02544074|12038629|FG016|COMPLETED|Overall Study||6
10872672|NCT02544074|12038630|FG017|COMPLETED|Overall Study||3
10872673|NCT02544074|12038631|FG018|COMPLETED|Overall Study||4
10872674|NCT02544074|12038632|FG019|COMPLETED|Overall Study||3
10872675|NCT02544074|12038633|FG020|COMPLETED|Overall Study||3
10872676|NCT02544074|12038613|FG000|NOT COMPLETED|Overall Study||0
10872677|NCT02544074|12038614|FG001|NOT COMPLETED|Overall Study||1
10872678|NCT02544074|12038615|FG002|NOT COMPLETED|Overall Study||0
10872679|NCT02544074|12038616|FG003|NOT COMPLETED|Overall Study||0
10872680|NCT02544074|12038617|FG004|NOT COMPLETED|Overall Study||0
10872681|NCT02544074|12038618|FG005|NOT COMPLETED|Overall Study||1
10872682|NCT02544074|12038619|FG006|NOT COMPLETED|Overall Study||0
10872683|NCT02544074|12038620|FG007|NOT COMPLETED|Overall Study||0
10872684|NCT02544074|12038621|FG008|NOT COMPLETED|Overall Study||0
10872685|NCT02544074|12038622|FG009|NOT COMPLETED|Overall Study||1
10872686|NCT02544074|12038623|FG010|NOT COMPLETED|Overall Study||0
10872687|NCT02544074|12038624|FG011|NOT COMPLETED|Overall Study||0
10872688|NCT02544074|12038625|FG012|NOT COMPLETED|Overall Study||0
10872689|NCT02544074|12038626|FG013|NOT COMPLETED|Overall Study||0
10872690|NCT02544074|12038627|FG014|NOT COMPLETED|Overall Study||0
10872691|NCT02544074|12038628|FG015|NOT COMPLETED|Overall Study||0
10872692|NCT02544074|12038629|FG016|NOT COMPLETED|Overall Study||0
10546008|NCT01502072|11699539|FG001|COMPLETED|Overall Study||9
10546009|NCT01502072|11699540|FG002|COMPLETED|Overall Study||20
10872693|NCT02544074|12038630|FG017|NOT COMPLETED|Overall Study||0
10872694|NCT02544074|12038631|FG018|NOT COMPLETED|Overall Study||0
10872695|NCT02544074|12038632|FG019|NOT COMPLETED|Overall Study||0
10872696|NCT02544074|12038633|FG020|NOT COMPLETED|Overall Study||0
10872697|NCT02317627|12038670|FG000|STARTED|Overall Study||13
10872698|NCT02317627|12038671|FG001|STARTED|Overall Study||13
10872699|NCT02317627|12038672|FG002|STARTED|Overall Study||12
10872700|NCT02317627|12038670|FG000|COMPLETED|Overall Study||11
10872701|NCT02317627|12038671|FG001|COMPLETED|Overall Study||8
10872702|NCT02317627|12038672|FG002|COMPLETED|Overall Study||8
10872703|NCT02317627|12038670|FG000|NOT COMPLETED|Overall Study||2
10872704|NCT02317627|12038671|FG001|NOT COMPLETED|Overall Study||5
10872705|NCT02317627|12038672|FG002|NOT COMPLETED|Overall Study||4
10872706|NCT01935128|12038686|FG000|STARTED|Overall Study||50
10419363|NCT00809809|11564172|FG000|NOT COMPLETED|Overall Study||3
10546010|NCT01502072|11699538|FG000|NOT COMPLETED|Overall Study||1
10546011|NCT01502072|11699539|FG001|NOT COMPLETED|Overall Study||1
10872707|NCT01935128|12038686|FG000|COMPLETED|Overall Study||43
10872708|NCT01935128|12038686|FG000|NOT COMPLETED|Overall Study||7
10872709|NCT01909934|12038690|FG000|STARTED|Overall Study||50
10872710|NCT01909934|12038690|FG000|COMPLETED|Overall Study||0
10872711|NCT01909934|12038690|FG000|NOT COMPLETED|Overall Study||50
10872712|NCT01841359|12038694|FG000|STARTED|Overall Study||22
10872713|NCT01841359|12038694|FG000|COMPLETED|Overall Study||14
10872714|NCT01841359|12038694|FG000|NOT COMPLETED|Overall Study||8
10872715|NCT01459666|12038703|FG000|STARTED|Overall Study||5
10872716|NCT01459666|12038704|FG001|STARTED|Overall Study||4
10872717|NCT01459666|12038703|FG000|COMPLETED|Overall Study||0
10872718|NCT01459666|12038704|FG001|COMPLETED|Overall Study||0
10872719|NCT01459666|12038703|FG000|NOT COMPLETED|Overall Study||5
10872720|NCT01459666|12038704|FG001|NOT COMPLETED|Overall Study||4
10872721|NCT01369199|12038710|FG000|STARTED|Overall Study||28
10872722|NCT01369199|12038710|FG000|End of Treatment (EOT)|Overall Study|1 withdrew consent before treatment,1 missed end of treatment (EOT) visit but completed follow-up.|26
10872723|NCT01369199|12038710|FG000|COMPLETED|Overall Study||25
10872724|NCT01369199|12038710|FG000|NOT COMPLETED|Overall Study||3
10872725|NCT01368497|12038714|FG000|STARTED|Overall Study||60
10872726|NCT01368497|12038714|FG000|End of Treatment|Overall Study|Five discontinued study drugs early and completed the follow-up period per protocol.|60
10872727|NCT01368497|12038714|FG000|COMPLETED|Overall Study||58
10872728|NCT01368497|12038714|FG000|NOT COMPLETED|Overall Study||2
10872729|NCT05096312|12038720|FG000|STARTED|Overall Study||11
10872730|NCT05096312|12038721|FG001|STARTED|Overall Study||12
10872731|NCT05096312|12038720|FG000|COMPLETED|Overall Study||8
10872732|NCT05096312|12038721|FG001|COMPLETED|Overall Study||8
10872733|NCT05096312|12038720|FG000|NOT COMPLETED|Overall Study||3
10872734|NCT05096312|12038721|FG001|NOT COMPLETED|Overall Study||4
10872741|NCT03560258|12038741|FG000|STARTED|Overall Study||22
10872742|NCT03560258|12038742|FG001|STARTED|Overall Study||11
10872743|NCT03560258|12038743|FG002|STARTED|Overall Study||12
10872744|NCT03560258|12038741|FG000|Received at Least 1 Dose of Treatment|Overall Study||22
10872745|NCT03560258|12038742|FG001|Received at Least 1 Dose of Treatment|Overall Study||10
10872746|NCT03560258|12038743|FG002|Received at Least 1 Dose of Treatment|Overall Study||12
10872747|NCT03560258|12038741|FG000|COMPLETED|Overall Study||19
10872748|NCT03560258|12038742|FG001|COMPLETED|Overall Study||10
10872749|NCT03560258|12038743|FG002|COMPLETED|Overall Study||11
10872750|NCT03560258|12038741|FG000|NOT COMPLETED|Overall Study||3
10872751|NCT03560258|12038742|FG001|NOT COMPLETED|Overall Study||1
10872752|NCT03560258|12038743|FG002|NOT COMPLETED|Overall Study||1
10872753|NCT03684304|12038753|FG000|STARTED|Overall Study||19
10872754|NCT03684304|12038754|FG001|STARTED|Overall Study||17
10872755|NCT03684304|12038753|FG000|COMPLETED|Overall Study||0
10872756|NCT03684304|12038754|FG001|COMPLETED|Overall Study||0
10872757|NCT03684304|12038753|FG000|NOT COMPLETED|Overall Study||19
10872758|NCT03684304|12038754|FG001|NOT COMPLETED|Overall Study||17
10872759|NCT03275168|12038762|FG000|STARTED|Overall Study||34
10872760|NCT03275168|12038763|FG001|STARTED|Overall Study||34
10872761|NCT03275168|12038762|FG000|COMPLETED|Overall Study||27
10872762|NCT03275168|12038763|FG001|COMPLETED|Overall Study||25
10872763|NCT03275168|12038762|FG000|NOT COMPLETED|Overall Study||7
10872764|NCT03275168|12038763|FG001|NOT COMPLETED|Overall Study||9
10872765|NCT04528641|12038775|FG000|STARTED|Overall Study||15
10872766|NCT04528641|12038776|FG001|STARTED|Overall Study||15
10872767|NCT04528641|12038777|FG002|STARTED|Overall Study||15
10872768|NCT04528641|12038778|FG003|STARTED|Overall Study||16
10872769|NCT04528641|12038779|FG004|STARTED|Overall Study||15
10872770|NCT04528641|12038780|FG005|STARTED|Overall Study||15
10872771|NCT04528641|12038775|FG000|COMPLETED|Overall Study||15
10872772|NCT04528641|12038776|FG001|COMPLETED|Overall Study||15
10872773|NCT04528641|12038777|FG002|COMPLETED|Overall Study||15
10872774|NCT04528641|12038778|FG003|COMPLETED|Overall Study||15
10872775|NCT04528641|12038779|FG004|COMPLETED|Overall Study||15
10872776|NCT04528641|12038780|FG005|COMPLETED|Overall Study||14
10872777|NCT04528641|12038775|FG000|NOT COMPLETED|Overall Study||0
10872778|NCT04528641|12038776|FG001|NOT COMPLETED|Overall Study||0
10872779|NCT04528641|12038777|FG002|NOT COMPLETED|Overall Study||0
10872780|NCT04528641|12038778|FG003|NOT COMPLETED|Overall Study||1
10872781|NCT04528641|12038779|FG004|NOT COMPLETED|Overall Study||0
10872782|NCT04528641|12038780|FG005|NOT COMPLETED|Overall Study||1
10872783|NCT04497883|12038799|FG000|STARTED|Treatment Period 1 (2 Days)||12
10872784|NCT04497883|12038800|FG001|STARTED|Treatment Period 1 (2 Days)||12
10872785|NCT04497883|12038801|FG002|STARTED|Treatment Period 1 (2 Days)||0
10872786|NCT04497883|12038802|FG003|STARTED|Treatment Period 1 (2 Days)||0
10872787|NCT04497883|12038799|FG000|COMPLETED|Treatment Period 1 (2 Days)||12
10872788|NCT04497883|12038800|FG001|COMPLETED|Treatment Period 1 (2 Days)||12
10872789|NCT04497883|12038801|FG002|COMPLETED|Treatment Period 1 (2 Days)||0
10872790|NCT04497883|12038802|FG003|COMPLETED|Treatment Period 1 (2 Days)||0
10872791|NCT04497883|12038799|FG000|NOT COMPLETED|Treatment Period 1 (2 Days)||0
10872792|NCT04497883|12038800|FG001|NOT COMPLETED|Treatment Period 1 (2 Days)||0
10872793|NCT04497883|12038801|FG002|NOT COMPLETED|Treatment Period 1 (2 Days)||0
10872794|NCT04497883|12038802|FG003|NOT COMPLETED|Treatment Period 1 (2 Days)||0
10872795|NCT04497883|12038799|FG000|STARTED|Washout Period 1 (72 Hours)||12
10872796|NCT04497883|12038800|FG001|STARTED|Washout Period 1 (72 Hours)||12
10872797|NCT04497883|12038801|FG002|STARTED|Washout Period 1 (72 Hours)||0
10872798|NCT04497883|12038802|FG003|STARTED|Washout Period 1 (72 Hours)||0
10872799|NCT04497883|12038799|FG000|COMPLETED|Washout Period 1 (72 Hours)||12
10872800|NCT04497883|12038800|FG001|COMPLETED|Washout Period 1 (72 Hours)||12
10872801|NCT04497883|12038801|FG002|COMPLETED|Washout Period 1 (72 Hours)||0
10872802|NCT04497883|12038802|FG003|COMPLETED|Washout Period 1 (72 Hours)||0
10872803|NCT04497883|12038799|FG000|NOT COMPLETED|Washout Period 1 (72 Hours)||0
10872804|NCT04497883|12038800|FG001|NOT COMPLETED|Washout Period 1 (72 Hours)||0
10872805|NCT04497883|12038801|FG002|NOT COMPLETED|Washout Period 1 (72 Hours)||0
10872806|NCT04497883|12038802|FG003|NOT COMPLETED|Washout Period 1 (72 Hours)||0
10872807|NCT04497883|12038799|FG000|STARTED|Treatment Period 2 (2 Days)||0
10872808|NCT04497883|12038800|FG001|STARTED|Treatment Period 2 (2 Days)||0
10872809|NCT04497883|12038801|FG002|STARTED|Treatment Period 2 (2 Days)||6
10872810|NCT04497883|12038802|FG003|STARTED|Treatment Period 2 (2 Days)||6
10872811|NCT04497883|12038799|FG000|COMPLETED|Treatment Period 2 (2 Days)||0
10872812|NCT04497883|12038800|FG001|COMPLETED|Treatment Period 2 (2 Days)||0
10872813|NCT04497883|12038801|FG002|COMPLETED|Treatment Period 2 (2 Days)||6
10872814|NCT04497883|12038802|FG003|COMPLETED|Treatment Period 2 (2 Days)||6
10872815|NCT04497883|12038799|FG000|NOT COMPLETED|Treatment Period 2 (2 Days)||0
10872816|NCT04497883|12038800|FG001|NOT COMPLETED|Treatment Period 2 (2 Days)||0
10872817|NCT04497883|12038801|FG002|NOT COMPLETED|Treatment Period 2 (2 Days)||0
10295764|NCT02463981|11428499|FG000|STARTED|Overall Study||21
10295765|NCT02463981|11428500|FG001|STARTED|Overall Study||16
10295766|NCT02463981|11428499|FG000|COMPLETED|Overall Study||18
10295767|NCT02463981|11428500|FG001|COMPLETED|Overall Study||14
10295768|NCT02463981|11428499|FG000|NOT COMPLETED|Overall Study||3
10295769|NCT02463981|11428500|FG001|NOT COMPLETED|Overall Study||2
10295770|NCT02460224|11428535|FG000|STARTED|Overall Study||17
10295771|NCT02460224|11428536|FG001|STARTED|Overall Study||12
10295772|NCT02460224|11428537|FG002|STARTED|Overall Study||6
10295773|NCT02460224|11428538|FG003|STARTED|Overall Study||6
10295774|NCT02460224|11428539|FG004|STARTED|Overall Study||6
10295775|NCT02460224|11428540|FG005|STARTED|Overall Study||30
10295776|NCT02460224|11428541|FG006|STARTED|Overall Study||30
10295777|NCT02460224|11428542|FG007|STARTED|Overall Study||5
10295778|NCT02460224|11428543|FG008|STARTED|Overall Study||6
10295779|NCT02460224|11428544|FG009|STARTED|Overall Study||11
10295780|NCT02460224|11428545|FG010|STARTED|Overall Study||5
10295781|NCT02460224|11428546|FG011|STARTED|Overall Study||6
10295782|NCT02460224|11428547|FG012|STARTED|Overall Study||6
10295783|NCT02460224|11428548|FG013|STARTED|Overall Study||6
10295784|NCT02460224|11428549|FG014|STARTED|Overall Study||5
10295785|NCT02460224|11428550|FG015|STARTED|Overall Study||6
10419364|NCT00809809|11564173|FG001|NOT COMPLETED|Overall Study||2
10419365|NCT00809835|11564183|FG000|STARTED|Overall Study||28
10419366|NCT00809835|11564184|FG001|STARTED|Overall Study||27
10419367|NCT00809835|11564185|FG002|STARTED|Overall Study||38
10419368|NCT00809835|11564186|FG003|STARTED|Overall Study||27
10419369|NCT00809835|11564183|FG000|COMPLETED|Overall Study||20
10419370|NCT00809835|11564184|FG001|COMPLETED|Overall Study||20
10419371|NCT00809835|11564185|FG002|COMPLETED|Overall Study||27
10419372|NCT00809835|11564186|FG003|COMPLETED|Overall Study||25
10419373|NCT00809835|11564183|FG000|NOT COMPLETED|Overall Study||8
10419374|NCT00809835|11564184|FG001|NOT COMPLETED|Overall Study||7
10419375|NCT00809835|11564185|FG002|NOT COMPLETED|Overall Study||11
10419376|NCT00809835|11564186|FG003|NOT COMPLETED|Overall Study||2
10419377|NCT00809848|11564201|FG000|STARTED|Overall Study||36
10419378|NCT00809848|11564202|FG001|STARTED|Overall Study||34
10419379|NCT00809848|11564203|FG002|STARTED|Overall Study||34
10419380|NCT00809848|11564204|FG003|STARTED|Overall Study||31
10419381|NCT00809848|11564205|FG004|STARTED|Overall Study||37
10755695|NCT03070470|11919497|FG002|STARTED|Overall Study||10
10755696|NCT03070470|11919498|FG003|STARTED|Overall Study||10
10755697|NCT03070470|11919499|FG004|STARTED|Overall Study||10
10755698|NCT03070470|11919500|FG005|STARTED|Overall Study||10
10755699|NCT03070470|11919495|FG000|COMPLETED|Overall Study||10
10755700|NCT03070470|11919496|FG001|COMPLETED|Overall Study||9
10755701|NCT03070470|11919497|FG002|COMPLETED|Overall Study||10
10755702|NCT03070470|11919498|FG003|COMPLETED|Overall Study||10
10755703|NCT03070470|11919499|FG004|COMPLETED|Overall Study||10
10755704|NCT03070470|11919500|FG005|COMPLETED|Overall Study||8
10295786|NCT02460224|11428551|FG016|STARTED|Overall Study||20
10295787|NCT02460224|11428552|FG017|STARTED|Overall Study||6
10295788|NCT02460224|11428553|FG018|STARTED|Overall Study||12
10295789|NCT02460224|11428554|FG019|STARTED|Overall Study||7
10295790|NCT02460224|11428555|FG020|STARTED|Overall Study||6
10295791|NCT02460224|11428556|FG021|STARTED|Overall Study||12
10295792|NCT02460224|11428557|FG022|STARTED|Overall Study||6
10295793|NCT02460224|11428558|FG023|STARTED|Overall Study||11
10295794|NCT02460224|11428559|FG024|STARTED|Overall Study||6
10295795|NCT02460224|11428560|FG025|STARTED|Overall Study||6
10295796|NCT02460224|11428561|FG026|STARTED|Overall Study||121
10295797|NCT02460224|11428562|FG027|STARTED|Overall Study||21
10295798|NCT02460224|11428563|FG028|STARTED|Overall Study||93
10295799|NCT02460224|11428535|FG000|Rest of the World Patients in the Dose Escalation Part|Overall Study||13
10295800|NCT02460224|11428536|FG001|Rest of the World Patients in the Dose Escalation Part|Overall Study||12
10295801|NCT02460224|11428537|FG002|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
10295802|NCT02460224|11428538|FG003|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
10314942|NCT00171223|11448699|FG000|STARTED|Overall Study||152
10314943|NCT00171223|11448700|FG001|STARTED|Overall Study||188
10314944|NCT00171223|11448701|FG002|STARTED|Overall Study||192
10314945|NCT00171223|11448699|FG000|COMPLETED|Overall Study||12
10314946|NCT00171223|11448700|FG001|COMPLETED|Overall Study||47
10314947|NCT00171223|11448701|FG002|COMPLETED|Overall Study||22
10314948|NCT00171223|11448699|FG000|NOT COMPLETED|Overall Study||140
10314949|NCT00171223|11448700|FG001|NOT COMPLETED|Overall Study||141
10314950|NCT00171223|11448701|FG002|NOT COMPLETED|Overall Study||170
10314951|NCT00171249|11448707|FG000|STARTED|Overall Study||77
10314952|NCT00171249|11448708|FG001|STARTED|Overall Study||5
10314953|NCT00171249|11448709|FG002|STARTED|Overall Study||5
10314954|NCT00171249|11448710|FG003|STARTED|Overall Study||158
10314955|NCT00171249|11448711|FG004|STARTED|Overall Study||3
10314956|NCT00171249|11448712|FG005|STARTED|Overall Study||43
10314957|NCT00171249|11448713|FG006|STARTED|Overall Study||2
10314958|NCT00171249|11448707|FG000|Completed Part 1|Overall Study||50
10872818|NCT04497883|12038802|FG003|NOT COMPLETED|Treatment Period 2 (2 Days)||0
10872819|NCT04497883|12038799|FG000|STARTED|Washout Period 2 (72 Hours)||0
10872820|NCT04497883|12038800|FG001|STARTED|Washout Period 2 (72 Hours)||0
10872821|NCT04497883|12038801|FG002|STARTED|Washout Period 2 (72 Hours)||6
10872822|NCT04497883|12038802|FG003|STARTED|Washout Period 2 (72 Hours)||6
10872823|NCT04497883|12038799|FG000|COMPLETED|Washout Period 2 (72 Hours)||0
10872824|NCT04497883|12038800|FG001|COMPLETED|Washout Period 2 (72 Hours)||0
10872825|NCT04497883|12038801|FG002|COMPLETED|Washout Period 2 (72 Hours)||6
10872826|NCT04497883|12038802|FG003|COMPLETED|Washout Period 2 (72 Hours)||6
10872827|NCT04497883|12038799|FG000|NOT COMPLETED|Washout Period 2 (72 Hours)||0
10872828|NCT04497883|12038800|FG001|NOT COMPLETED|Washout Period 2 (72 Hours)||0
10872829|NCT04497883|12038801|FG002|NOT COMPLETED|Washout Period 2 (72 Hours)||0
10872830|NCT04497883|12038802|FG003|NOT COMPLETED|Washout Period 2 (72 Hours)||0
10872831|NCT04497883|12038799|FG000|STARTED|Treatment Period 3 (2 Days)||0
10872832|NCT04497883|12038800|FG001|STARTED|Treatment Period 3 (2 Days)||0
10872833|NCT04497883|12038801|FG002|STARTED|Treatment Period 3 (2 Days)||6
10872834|NCT04497883|12038802|FG003|STARTED|Treatment Period 3 (2 Days)||6
10872835|NCT04497883|12038799|FG000|COMPLETED|Treatment Period 3 (2 Days)||0
10872836|NCT04497883|12038800|FG001|COMPLETED|Treatment Period 3 (2 Days)||0
10872837|NCT04497883|12038801|FG002|COMPLETED|Treatment Period 3 (2 Days)||6
10872838|NCT04497883|12038802|FG003|COMPLETED|Treatment Period 3 (2 Days)||6
10872839|NCT04497883|12038799|FG000|NOT COMPLETED|Treatment Period 3 (2 Days)||0
10872840|NCT04497883|12038800|FG001|NOT COMPLETED|Treatment Period 3 (2 Days)||0
10872841|NCT04497883|12038801|FG002|NOT COMPLETED|Treatment Period 3 (2 Days)||0
10872842|NCT04497883|12038802|FG003|NOT COMPLETED|Treatment Period 3 (2 Days)||0
10755705|NCT03070470|11919495|FG000|NOT COMPLETED|Overall Study||0
10419382|NCT00809848|11564201|FG000|COMPLETED|Overall Study||36
10419383|NCT00809848|11564202|FG001|COMPLETED|Overall Study||34
10419384|NCT00809848|11564203|FG002|COMPLETED|Overall Study||34
10419385|NCT00809848|11564204|FG003|COMPLETED|Overall Study||30
10419386|NCT00809848|11564205|FG004|COMPLETED|Overall Study||34
10419387|NCT00809848|11564201|FG000|NOT COMPLETED|Overall Study||0
10419388|NCT00809848|11564202|FG001|NOT COMPLETED|Overall Study||0
10419389|NCT00809848|11564203|FG002|NOT COMPLETED|Overall Study||0
10419390|NCT00809848|11564204|FG003|NOT COMPLETED|Overall Study||1
10419391|NCT00809848|11564205|FG004|NOT COMPLETED|Overall Study||3
10419392|NCT00809926|11564220|FG000|STARTED|Overall Study||232
10419393|NCT00809926|11564221|FG001|STARTED|Overall Study||219
10419394|NCT00809926|11564220|FG000|COMPLETED|Overall Study||201
10419395|NCT00809926|11564221|FG001|COMPLETED|Overall Study||196
10419396|NCT00809926|11564220|FG000|NOT COMPLETED|Overall Study||31
10419397|NCT00809926|11564221|FG001|NOT COMPLETED|Overall Study||23
10419398|NCT00809965|11564230|FG000|STARTED|Overall Study||5176
10419399|NCT00809965|11564231|FG001|STARTED|Overall Study||5174
10419400|NCT00809965|11564232|FG002|STARTED|Overall Study||5176
10419401|NCT00809965|11564230|FG000|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5125
10419402|NCT00809965|11564231|FG001|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5115
10419403|NCT00809965|11564232|FG002|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5110
10419404|NCT00809965|11564230|FG000|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5113
10419405|NCT00809965|11564231|FG001|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5114
10419478|NCT00810303|11564314|FG000|STARTED|Ezetimibe Alone - Day 6-15||12
10419406|NCT00809965|11564232|FG002|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5115
10419407|NCT00809965|11564230|FG000|COMPLETED|Overall Study||4393
10419408|NCT00809965|11564231|FG001|COMPLETED|Overall Study||4399
10419409|NCT00809965|11564232|FG002|COMPLETED|Overall Study||4332
10419410|NCT00809965|11564230|FG000|NOT COMPLETED|Overall Study||783
10419411|NCT00809965|11564231|FG001|NOT COMPLETED|Overall Study||775
10419412|NCT00809965|11564232|FG002|NOT COMPLETED|Overall Study||844
10419413|NCT00810043|11564242|FG000|STARTED|Overall Study||57
10419414|NCT00810043|11564243|FG001|STARTED|Overall Study||55
10419415|NCT00810043|11564244|FG002|STARTED|Overall Study||8
10419416|NCT00810043|11564242|FG000|COMPLETED|Overall Study||53
10419417|NCT00810043|11564243|FG001|COMPLETED|Overall Study||54
10419418|NCT00810043|11564244|FG002|COMPLETED|Overall Study||0
10419419|NCT00810043|11564242|FG000|NOT COMPLETED|Overall Study||4
10419420|NCT00810043|11564243|FG001|NOT COMPLETED|Overall Study||1
10419421|NCT00810043|11564244|FG002|NOT COMPLETED|Overall Study||8
10419422|NCT00810069|11564255|FG000|STARTED|Lead-in Period I||840
10419423|NCT00810069|11564256|FG001|STARTED|Lead-in Period I||0
10419424|NCT00810069|11564257|FG002|STARTED|Lead-in Period I||0
10419425|NCT00810069|11564255|FG000|COMPLETED|Lead-in Period I||566
10419426|NCT00810069|11564256|FG001|COMPLETED|Lead-in Period I||0
10419427|NCT00810069|11564257|FG002|COMPLETED|Lead-in Period I||0
10419428|NCT00810069|11564255|FG000|NOT COMPLETED|Lead-in Period I||274
10419429|NCT00810069|11564256|FG001|NOT COMPLETED|Lead-in Period I||0
10419430|NCT00810069|11564257|FG002|NOT COMPLETED|Lead-in Period I||0
10419431|NCT00810069|11564255|FG000|STARTED|Double-Blind Period II||0
10419432|NCT00810069|11564256|FG001|STARTED|Double-Blind Period II||282
10419433|NCT00810069|11564257|FG002|STARTED|Double-Blind Period II|At Week 8 - delayed intervention divided by response to treatment (nonresponders or responders).|284
10419434|NCT00810069|11564255|FG000|COMPLETED|Double-Blind Period II||0
10419435|NCT00810069|11564256|FG001|COMPLETED|Double-Blind Period II||226
10419436|NCT00810069|11564257|FG002|COMPLETED|Double-Blind Period II||212
10419437|NCT00810069|11564255|FG000|NOT COMPLETED|Double-Blind Period II||0
10419438|NCT00810069|11564256|FG001|NOT COMPLETED|Double-Blind Period II||56
10419439|NCT00810069|11564257|FG002|NOT COMPLETED|Double-Blind Period II||72
10419440|NCT00810082|11564268|FG000|STARTED|Overall Study||34
10419441|NCT00810082|11564269|FG001|STARTED|Overall Study||31
10419442|NCT00810082|11564268|FG000|COMPLETED|Overall Study||34
10419443|NCT00810082|11564269|FG001|COMPLETED|Overall Study||27
10419444|NCT00810082|11564268|FG000|NOT COMPLETED|Overall Study||0
10419445|NCT00810082|11564269|FG001|NOT COMPLETED|Overall Study||4
10419446|NCT00810095|11564275|FG000|STARTED|Overall Study||40
10419447|NCT00810095|11564275|FG000|COMPLETED|Overall Study||40
10419448|NCT00810095|11564275|FG000|NOT COMPLETED|Overall Study||0
10419449|NCT00810108|11564281|FG000|STARTED|Overall Study||6
10419450|NCT00810108|11564282|FG001|STARTED|Overall Study||7
10419451|NCT00810108|11564281|FG000|COMPLETED|Overall Study||5
10419452|NCT00810108|11564282|FG001|COMPLETED|Overall Study||7
10419453|NCT00810108|11564281|FG000|NOT COMPLETED|Overall Study||1
10419454|NCT00810108|11564282|FG001|NOT COMPLETED|Overall Study||0
10419455|NCT00810199|11564289|FG000|STARTED|Overall Study||279
10419456|NCT00810199|11564290|FG001|STARTED|Overall Study||277
10419457|NCT00810199|11564289|FG000|Received Study Drug|Overall Study||277
10419458|NCT00810199|11564290|FG001|Received Study Drug|Overall Study||276
10419459|NCT00810199|11564289|FG000|Completed Week 24|Overall Study||259
10419460|NCT00810199|11564290|FG001|Completed Week 24|Overall Study||250
10419461|NCT00810199|11564289|FG000|Completed Week 52|Overall Study||243
10419462|NCT00810199|11564290|FG001|Completed Week 52|Overall Study||229
10419463|NCT00810199|11564289|FG000|Completed Week 104|Overall Study||222
10755706|NCT03070470|11919496|FG001|NOT COMPLETED|Overall Study||1
10872843|NCT04034238|12038816|FG000|STARTED|Dose Escalation Phase||7
10872844|NCT04034238|12038817|FG001|STARTED|Dose Escalation Phase||3
10872845|NCT04034238|12038818|FG002|STARTED|Dose Escalation Phase||0
10872846|NCT04034238|12038819|FG003|STARTED|Dose Escalation Phase||2
10872847|NCT04034238|12038816|FG000|COMPLETED|Dose Escalation Phase||6
10872848|NCT04034238|12038817|FG001|COMPLETED|Dose Escalation Phase||3
10872849|NCT04034238|12038818|FG002|COMPLETED|Dose Escalation Phase||0
10872850|NCT04034238|12038819|FG003|COMPLETED|Dose Escalation Phase||0
10872851|NCT04034238|12038816|FG000|NOT COMPLETED|Dose Escalation Phase||1
10872852|NCT04034238|12038817|FG001|NOT COMPLETED|Dose Escalation Phase||0
10872853|NCT04034238|12038818|FG002|NOT COMPLETED|Dose Escalation Phase||0
10872854|NCT04034238|12038819|FG003|NOT COMPLETED|Dose Escalation Phase||2
10295803|NCT02460224|11428539|FG004|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
10295804|NCT02460224|11428540|FG005|Rest of the World Patients in the Dose Escalation Part|Overall Study||25
10419464|NCT00810199|11564290|FG001|Completed Week 104|Overall Study||201
10419465|NCT00810199|11564289|FG000|COMPLETED|Overall Study||220
10419466|NCT00810199|11564290|FG001|COMPLETED|Overall Study|Completed=Completed Treatment|195
10419467|NCT00810199|11564289|FG000|NOT COMPLETED|Overall Study||59
10419468|NCT00810199|11564290|FG001|NOT COMPLETED|Overall Study||82
10419469|NCT00810264|11564302|FG000|STARTED|Overall Study||2499
10419470|NCT00810264|11564302|FG000|COMPLETED|Overall Study||946
10419471|NCT00810264|11564302|FG000|NOT COMPLETED|Overall Study||1553
10419472|NCT00810277|11564310|FG000|STARTED|Overall Study||14
10419473|NCT00810277|11564310|FG000|COMPLETED|Overall Study||13
10419474|NCT00810277|11564310|FG000|NOT COMPLETED|Overall Study||1
10419475|NCT00810303|11564314|FG000|STARTED|Efavirenz Alone - Day 1-5||12
10419476|NCT00810303|11564314|FG000|COMPLETED|Efavirenz Alone - Day 1-5||12
10419477|NCT00810303|11564314|FG000|NOT COMPLETED|Efavirenz Alone - Day 1-5||0
10419479|NCT00810303|11564314|FG000|COMPLETED|Ezetimibe Alone - Day 6-15||12
10419480|NCT00810303|11564314|FG000|NOT COMPLETED|Ezetimibe Alone - Day 6-15||0
10419481|NCT00810303|11564314|FG000|STARTED|Ezetimibe and Efavirenz - Day 16-20||12
10419482|NCT00810303|11564314|FG000|COMPLETED|Ezetimibe and Efavirenz - Day 16-20||12
10419483|NCT00810303|11564314|FG000|NOT COMPLETED|Ezetimibe and Efavirenz - Day 16-20||0
10419484|NCT00810303|11564314|FG000|STARTED|Ezetimibe and Efavirenz - Day 21-30||12
10419485|NCT00810303|11564314|FG000|COMPLETED|Ezetimibe and Efavirenz - Day 21-30||12
10419486|NCT00810303|11564314|FG000|NOT COMPLETED|Ezetimibe and Efavirenz - Day 21-30||0
10419487|NCT00810342|11564324|FG000|STARTED|Month 1 Follow-up||154
10419488|NCT00810342|11564325|FG001|STARTED|Month 1 Follow-up||157
10419489|NCT00810342|11564324|FG000|COMPLETED|Month 1 Follow-up||149
10419490|NCT00810342|11564325|FG001|COMPLETED|Month 1 Follow-up||155
10419491|NCT00810342|11564324|FG000|NOT COMPLETED|Month 1 Follow-up||5
10419492|NCT00810342|11564325|FG001|NOT COMPLETED|Month 1 Follow-up||2
10419493|NCT00810342|11564324|FG000|STARTED|6-month Follow-up||149
10419494|NCT00810342|11564325|FG001|STARTED|6-month Follow-up||155
10419495|NCT00810342|11564324|FG000|COMPLETED|6-month Follow-up||125
10419496|NCT00810342|11564325|FG001|COMPLETED|6-month Follow-up||147
10419497|NCT00810342|11564324|FG000|NOT COMPLETED|6-month Follow-up||24
10419498|NCT00810342|11564325|FG001|NOT COMPLETED|6-month Follow-up||8
10419499|NCT00810342|11564324|FG000|STARTED|12-month Followup||125
10419500|NCT00810342|11564325|FG001|STARTED|12-month Followup||147
10419501|NCT00810342|11564324|FG000|COMPLETED|12-month Followup||113
10419502|NCT00810342|11564325|FG001|COMPLETED|12-month Followup||136
10419503|NCT00810342|11564324|FG000|NOT COMPLETED|12-month Followup||12
10419504|NCT00810342|11564325|FG001|NOT COMPLETED|12-month Followup||11
10419505|NCT00810355|11564336|FG000|STARTED|Overall Study||25
10419506|NCT00810355|11564337|FG001|STARTED|Overall Study||25
10419507|NCT00810355|11564338|FG002|STARTED|Overall Study||25
10419508|NCT00810355|11564336|FG000|COMPLETED|Overall Study||11
10419509|NCT00810355|11564337|FG001|COMPLETED|Overall Study||8
10419510|NCT00810355|11564338|FG002|COMPLETED|Overall Study||14
10419511|NCT00810355|11564336|FG000|NOT COMPLETED|Overall Study||14
10419512|NCT00810355|11564337|FG001|NOT COMPLETED|Overall Study||17
10419513|NCT00810355|11564338|FG002|NOT COMPLETED|Overall Study||11
10419514|NCT00810368|11564348|FG000|STARTED|Overall Study||18
10755707|NCT03070470|11919497|FG002|NOT COMPLETED|Overall Study||0
10755708|NCT03070470|11919498|FG003|NOT COMPLETED|Overall Study||0
10755709|NCT03070470|11919499|FG004|NOT COMPLETED|Overall Study||0
10755710|NCT03070470|11919500|FG005|NOT COMPLETED|Overall Study||2
10755711|NCT03070483|11919516|FG000|STARTED|Overall Study||5
10755712|NCT03070483|11919516|FG000|COMPLETED|Overall Study||3
10755713|NCT03070483|11919516|FG000|NOT COMPLETED|Overall Study||2
10755714|NCT03070548|11919521|FG000|STARTED|Overall Study||6
10755715|NCT03070548|11919521|FG000|COMPLETED|Overall Study||6
10755716|NCT03070548|11919521|FG000|NOT COMPLETED|Overall Study||0
10295805|NCT02460224|11428541|FG006|Rest of the World Patients in the Dose Escalation Part|Overall Study||24
10295806|NCT02460224|11428542|FG007|Rest of the World Patients in the Dose Escalation Part|Overall Study||5
10295807|NCT02460224|11428543|FG008|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
10295808|NCT02460224|11428544|FG009|Rest of the World Patients in the Dose Escalation Part|Overall Study||11
10295809|NCT02460224|11428545|FG010|Rest of the World Patients in the Dose Escalation Part|Overall Study||5
10295810|NCT02460224|11428546|FG011|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
10755717|NCT03070730|11919528|FG000|STARTED|Overall Study||0
10872855|NCT04034238|12038816|FG000|STARTED|Dose Expansion Phase||0
10872856|NCT04034238|12038817|FG001|STARTED|Dose Expansion Phase||0
10872857|NCT04034238|12038818|FG002|STARTED|Dose Expansion Phase||6
10872858|NCT04034238|12038819|FG003|STARTED|Dose Expansion Phase||1
10872859|NCT04034238|12038816|FG000|COMPLETED|Dose Expansion Phase||0
10872860|NCT04034238|12038817|FG001|COMPLETED|Dose Expansion Phase||0
10872861|NCT04034238|12038818|FG002|COMPLETED|Dose Expansion Phase||5
10872862|NCT04034238|12038819|FG003|COMPLETED|Dose Expansion Phase||0
10872863|NCT04034238|12038816|FG000|NOT COMPLETED|Dose Expansion Phase||0
10872864|NCT04034238|12038817|FG001|NOT COMPLETED|Dose Expansion Phase||0
10872865|NCT04034238|12038818|FG002|NOT COMPLETED|Dose Expansion Phase||1
10872866|NCT04034238|12038819|FG003|NOT COMPLETED|Dose Expansion Phase||1
10872867|NCT03984305|12038832|FG000|STARTED|Overall Study||23
10872868|NCT03984305|12038833|FG001|STARTED|Overall Study||18
10872869|NCT03984305|12038832|FG000|COMPLETED|Overall Study||0
10872870|NCT03984305|12038833|FG001|COMPLETED|Overall Study||0
10872871|NCT03984305|12038832|FG000|NOT COMPLETED|Overall Study||23
10872872|NCT03984305|12038833|FG001|NOT COMPLETED|Overall Study||18
10872873|NCT03982368|12038842|FG000|STARTED|Overall Study||87
10872874|NCT03982368|12038843|FG001|STARTED|Overall Study||86
10872875|NCT03982368|12038844|FG002|STARTED|Overall Study||88
10872876|NCT03982368|12038842|FG000|FAS Popuation|Overall Study||81
10872877|NCT03982368|12038843|FG001|FAS Popuation|Overall Study||82
10872878|NCT03982368|12038844|FG002|FAS Popuation|Overall Study||84
10872879|NCT03982368|12038842|FG000|PP Population|Overall Study||72
10872880|NCT03982368|12038843|FG001|PP Population|Overall Study||71
10872881|NCT03982368|12038844|FG002|PP Population|Overall Study||80
10872882|NCT03982368|12038842|FG000|COMPLETED|Overall Study||74
10872883|NCT03982368|12038843|FG001|COMPLETED|Overall Study||79
10872884|NCT03982368|12038844|FG002|COMPLETED|Overall Study||83
10872885|NCT03982368|12038842|FG000|NOT COMPLETED|Overall Study||13
10872886|NCT03982368|12038843|FG001|NOT COMPLETED|Overall Study||7
10872887|NCT03982368|12038844|FG002|NOT COMPLETED|Overall Study||5
10872888|NCT03952143|12038857|FG000|STARTED|Lead-In Period||628
10872889|NCT03952143|12038858|FG001|STARTED|Lead-In Period||0
10872890|NCT03952143|12038859|FG002|STARTED|Lead-In Period||0
10872891|NCT03952143|12038857|FG000|Participants Who Received at Least One Dose|Lead-In Period||628
10872892|NCT03952143|12038858|FG001|Participants Who Received at Least One Dose|Lead-In Period||0
10872893|NCT03952143|12038859|FG002|Participants Who Received at Least One Dose|Lead-In Period||0
10872894|NCT03952143|12038857|FG000|COMPLETED|Lead-In Period||595
10872895|NCT03952143|12038858|FG001|COMPLETED|Lead-In Period||0
10872896|NCT03952143|12038859|FG002|COMPLETED|Lead-In Period||0
10872897|NCT03952143|12038857|FG000|NOT COMPLETED|Lead-In Period||33
10872898|NCT03952143|12038858|FG001|NOT COMPLETED|Lead-In Period||0
10872899|NCT03952143|12038859|FG002|NOT COMPLETED|Lead-In Period||0
10872900|NCT03952143|12038857|FG000|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period|0
10872901|NCT03952143|12038858|FG001|STARTED|Treatment Period|Participants were randomized to either Insulin lispro or LY900014 in Treatment Period.|200
10872902|NCT03952143|12038859|FG002|STARTED|Treatment Period|Participants were randomized to either Insulin lispro or LY900014 in Treatment Period.|395
10872903|NCT03952143|12038857|FG000|Participants Who Received at Least One Dose|Treatment Period||0
10872904|NCT03952143|12038858|FG001|Participants Who Received at Least One Dose|Treatment Period||200
10872905|NCT03952143|12038859|FG002|Participants Who Received at Least One Dose|Treatment Period||395
10872906|NCT03952143|12038857|FG000|COMPLETED|Treatment Period||0
10872907|NCT03952143|12038858|FG001|COMPLETED|Treatment Period||191
10872908|NCT03952143|12038859|FG002|COMPLETED|Treatment Period||359
10872909|NCT03952143|12038857|FG000|NOT COMPLETED|Treatment Period||0
10872910|NCT03952143|12038858|FG001|NOT COMPLETED|Treatment Period||9
10872911|NCT03952143|12038859|FG002|NOT COMPLETED|Treatment Period||36
10872912|NCT03924752|12038866|FG000|STARTED|Overall Study||10
10872913|NCT03924752|12038866|FG000|COMPLETED|Overall Study||10
10872914|NCT03924752|12038866|FG000|NOT COMPLETED|Overall Study||0
10872915|NCT03829514|12038870|FG000|STARTED|Overall Study||10
10872916|NCT03829514|12038870|FG000|COMPLETED|Overall Study||10
10295811|NCT02460224|11428547|FG012|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
10295812|NCT02460224|11428548|FG013|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
10295813|NCT02460224|11428549|FG014|Rest of the World Patients in the Dose Escalation Part|Overall Study||5
10295814|NCT02460224|11428550|FG015|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
10295815|NCT02460224|11428551|FG016|Rest of the World Patients in the Dose Escalation Part|Overall Study||20
10295816|NCT02460224|11428552|FG017|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
10295817|NCT02460224|11428553|FG018|Rest of the World Patients in the Dose Escalation Part|Overall Study||12
10295818|NCT02460224|11428554|FG019|Rest of the World Patients in the Dose Escalation Part|Overall Study||7
10295819|NCT02460224|11428555|FG020|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
10295820|NCT02460224|11428556|FG021|Rest of the World Patients in the Dose Escalation Part|Overall Study||12
10295821|NCT02460224|11428557|FG022|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
10295822|NCT02460224|11428558|FG023|Rest of the World Patients in the Dose Escalation Part|Overall Study||11
10295823|NCT02460224|11428559|FG024|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
10295824|NCT02460224|11428560|FG025|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
10872917|NCT03829514|12038870|FG000|NOT COMPLETED|Overall Study||0
10872918|NCT03691428|12038876|FG000|STARTED|Overall Study||48
10872919|NCT03691428|12038877|FG001|STARTED|Overall Study||42
10872920|NCT03691428|12038876|FG000|COMPLETED|Overall Study||42
10872921|NCT03691428|12038877|FG001|COMPLETED|Overall Study||34
10872922|NCT03691428|12038876|FG000|NOT COMPLETED|Overall Study||6
10872923|NCT03691428|12038877|FG001|NOT COMPLETED|Overall Study||8
10872924|NCT03685708|12038886|FG000|STARTED|Overall Study||14
10872925|NCT03685708|12038887|FG001|STARTED|Overall Study||18
10872926|NCT03685708|12038888|FG002|STARTED|Overall Study||46
10872927|NCT03685708|12038886|FG000|COMPLETED|Overall Study||13
10872928|NCT03685708|12038887|FG001|COMPLETED|Overall Study||16
10872929|NCT03685708|12038888|FG002|COMPLETED|Overall Study||37
10872930|NCT03685708|12038886|FG000|NOT COMPLETED|Overall Study||1
10872931|NCT03685708|12038887|FG001|NOT COMPLETED|Overall Study||2
10872932|NCT03685708|12038888|FG002|NOT COMPLETED|Overall Study||9
10872933|NCT03669588|12038898|FG000|STARTED|Overall Study||84
10872934|NCT03669588|12038899|FG001|STARTED|Overall Study||83
10872935|NCT03669588|12038898|FG000|COMPLETED|Overall Study||80
10872936|NCT03669588|12038899|FG001|COMPLETED|Overall Study||76
10872937|NCT03669588|12038898|FG000|NOT COMPLETED|Overall Study||4
10872938|NCT03669588|12038899|FG001|NOT COMPLETED|Overall Study||7
10872939|NCT03531632|12038908|FG000|STARTED|Overall Study||5
10872940|NCT03531632|12038909|FG001|STARTED|Overall Study||3
10872941|NCT03531632|12038910|FG002|STARTED|Overall Study||28
10295825|NCT02460224|11428561|FG026|Rest of the World Patients in the Dose Escalation Part|Overall Study||0
10295826|NCT02460224|11428562|FG027|Rest of the World Patients in the Dose Escalation Part|Overall Study||0
10295827|NCT02460224|11428563|FG028|Rest of the World Patients in the Dose Escalation Part|Overall Study||0
10295828|NCT02460224|11428535|FG000|Japanese Patients in the Dose Escalation Part|Overall Study||4
10295829|NCT02460224|11428536|FG001|Japanese Patients in the Dose Escalation Part|Overall Study||0
10295830|NCT02460224|11428537|FG002|Japanese Patients in the Dose Escalation Part|Overall Study||0
10295831|NCT02460224|11428538|FG003|Japanese Patients in the Dose Escalation Part|Overall Study||0
10295832|NCT02460224|11428539|FG004|Japanese Patients in the Dose Escalation Part|Overall Study||0
10295833|NCT02460224|11428540|FG005|Japanese Patients in the Dose Escalation Part|Overall Study||5
10295834|NCT02460224|11428541|FG006|Japanese Patients in the Dose Escalation Part|Overall Study||6
10295835|NCT02460224|11428542|FG007|Japanese Patients in the Dose Escalation Part|Overall Study||0
10295836|NCT02460224|11428543|FG008|Japanese Patients in the Dose Escalation Part|Overall Study||0
10295837|NCT02460224|11428544|FG009|Japanese Patients in the Dose Escalation Part|Overall Study||0
10295838|NCT02460224|11428545|FG010|Japanese Patients in the Dose Escalation Part|Overall Study||0
10295839|NCT02460224|11428546|FG011|Japanese Patients in the Dose Escalation Part|Overall Study||0
10295840|NCT02460224|11428547|FG012|Japanese Patients in the Dose Escalation Part|Overall Study||0
10295841|NCT02460224|11428548|FG013|Japanese Patients in the Dose Escalation Part|Overall Study||0
10295842|NCT02460224|11428549|FG014|Japanese Patients in the Dose Escalation Part|Overall Study||0
10295843|NCT02460224|11428550|FG015|Japanese Patients in the Dose Escalation Part|Overall Study||0
10295844|NCT02460224|11428551|FG016|Japanese Patients in the Dose Escalation Part|Overall Study||0
10295845|NCT02460224|11428552|FG017|Japanese Patients in the Dose Escalation Part|Overall Study||0
10295846|NCT02460224|11428553|FG018|Japanese Patients in the Dose Escalation Part|Overall Study||0
10295847|NCT02460224|11428554|FG019|Japanese Patients in the Dose Escalation Part|Overall Study||0
10295848|NCT02460224|11428555|FG020|Japanese Patients in the Dose Escalation Part|Overall Study||0
10295849|NCT02460224|11428556|FG021|Japanese Patients in the Dose Escalation Part|Overall Study||0
10295850|NCT02460224|11428557|FG022|Japanese Patients in the Dose Escalation Part|Overall Study||0
10295851|NCT02460224|11428558|FG023|Japanese Patients in the Dose Escalation Part|Overall Study||0
10295852|NCT02460224|11428559|FG024|Japanese Patients in the Dose Escalation Part|Overall Study||0
10295853|NCT02460224|11428560|FG025|Japanese Patients in the Dose Escalation Part|Overall Study||0
10295854|NCT02460224|11428561|FG026|Japanese Patients in the Dose Escalation Part|Overall Study||0
10295855|NCT02460224|11428562|FG027|Japanese Patients in the Dose Escalation Part|Overall Study||0
10295856|NCT02460224|11428563|FG028|Japanese Patients in the Dose Escalation Part|Overall Study||0
10295857|NCT02460224|11428535|FG000|COMPLETED|Overall Study||0
10295858|NCT02460224|11428536|FG001|COMPLETED|Overall Study||0
10295859|NCT02460224|11428537|FG002|COMPLETED|Overall Study||0
10295860|NCT02460224|11428538|FG003|COMPLETED|Overall Study||0
10295861|NCT02460224|11428539|FG004|COMPLETED|Overall Study||0
10295862|NCT02460224|11428540|FG005|COMPLETED|Overall Study||0
10295863|NCT02460224|11428541|FG006|COMPLETED|Overall Study||0
10295864|NCT02460224|11428542|FG007|COMPLETED|Overall Study||0
10295865|NCT02460224|11428543|FG008|COMPLETED|Overall Study||0
10295866|NCT02460224|11428544|FG009|COMPLETED|Overall Study||0
10295867|NCT02460224|11428545|FG010|COMPLETED|Overall Study||0
10295868|NCT02460224|11428546|FG011|COMPLETED|Overall Study||0
10295869|NCT02460224|11428547|FG012|COMPLETED|Overall Study||0
10295870|NCT02460224|11428548|FG013|COMPLETED|Overall Study||0
10295871|NCT02460224|11428549|FG014|COMPLETED|Overall Study||0
10295872|NCT02460224|11428550|FG015|COMPLETED|Overall Study||0
10295873|NCT02460224|11428551|FG016|COMPLETED|Overall Study||0
10295874|NCT02460224|11428552|FG017|COMPLETED|Overall Study||0
10295875|NCT02460224|11428553|FG018|COMPLETED|Overall Study||0
10295876|NCT02460224|11428554|FG019|COMPLETED|Overall Study||0
10295877|NCT02460224|11428555|FG020|COMPLETED|Overall Study||0
10872942|NCT03531632|12038908|FG000|Safety Population|Overall Study|At least 1 dose of study drug|5
10872943|NCT03531632|12038909|FG001|Safety Population|Overall Study||3
10872944|NCT03531632|12038910|FG002|Safety Population|Overall Study||28
10872945|NCT03531632|12038908|FG000|Response Evaluable Population|Overall Study|All patients who received at least one dose of any study drug, had baseline measurable disease, and had at least one post-baseline radiographic tumor assessment or discontinued treatment due to clearly documented, clinically progressive disease or death.|5
10872946|NCT03531632|12038909|FG001|Response Evaluable Population|Overall Study||3
10872947|NCT03531632|12038910|FG002|Response Evaluable Population|Overall Study||24
10872948|NCT03531632|12038908|FG000|COMPLETED|Overall Study||0
10872949|NCT03531632|12038909|FG001|COMPLETED|Overall Study||0
10872950|NCT03531632|12038910|FG002|COMPLETED|Overall Study||2
10872951|NCT03531632|12038908|FG000|NOT COMPLETED|Overall Study||5
10872952|NCT03531632|12038909|FG001|NOT COMPLETED|Overall Study||3
10872953|NCT03531632|12038910|FG002|NOT COMPLETED|Overall Study||26
10872954|NCT03488030|12038921|FG000|STARTED|Overall Study||101
10872955|NCT03488030|12038922|FG001|STARTED|Overall Study||145
10872956|NCT03488030|12038921|FG000|COMPLETED|Overall Study||101
10872957|NCT03488030|12038922|FG001|COMPLETED|Overall Study||145
10872958|NCT03488030|12038921|FG000|NOT COMPLETED|Overall Study||0
10872959|NCT03488030|12038922|FG001|NOT COMPLETED|Overall Study||0
10419515|NCT00810368|11564349|FG001|STARTED|Overall Study||15
10419516|NCT00810368|11564348|FG000|COMPLETED|Overall Study||12
10419517|NCT00810368|11564349|FG001|COMPLETED|Overall Study||13
10419518|NCT00810368|11564348|FG000|NOT COMPLETED|Overall Study||6
10419519|NCT00810368|11564349|FG001|NOT COMPLETED|Overall Study||2
10419520|NCT00810394|11564357|FG000|STARTED|Overall Study||50
10419521|NCT00810394|11564357|FG000|Cycle 2 600mg Twice Daily|Overall Study||13
10419522|NCT00810394|11564357|FG000|Cycle 2 400mg Once Daily|Overall Study||22
10419523|NCT00810394|11564357|FG000|Cycle 3 800 mg Twice Daily|Overall Study||4
10419524|NCT00810394|11564357|FG000|Cycle 3 400mg Twice Daily|Overall Study||5
10419525|NCT00810394|11564357|FG000|COMPLETED|Overall Study||47
10419526|NCT00810394|11564357|FG000|NOT COMPLETED|Overall Study||3
10419527|NCT00810407|11564361|FG000|STARTED|Overall Study||594
10419528|NCT00810407|11564361|FG000|COMPLETED|Overall Study||588
10419529|NCT00810407|11564361|FG000|NOT COMPLETED|Overall Study||6
10419530|NCT00810459|11564365|FG000|STARTED|Overall Study||4
10872963|NCT03206073|12038941|FG000|STARTED|Overall Study||4
10872964|NCT03206073|12038942|FG001|STARTED|Overall Study||12
10872965|NCT03206073|12038943|FG002|STARTED|Overall Study||4
10872966|NCT03206073|12038944|FG003|STARTED|Overall Study||14
10872967|NCT03206073|12038941|FG000|COMPLETED|Overall Study||3
10872968|NCT03206073|12038942|FG001|COMPLETED|Overall Study||11
10872969|NCT03206073|12038943|FG002|COMPLETED|Overall Study||0
10872970|NCT03206073|12038944|FG003|COMPLETED|Overall Study||14
10872971|NCT03206073|12038941|FG000|NOT COMPLETED|Overall Study||1
10872972|NCT03206073|12038942|FG001|NOT COMPLETED|Overall Study||1
10872973|NCT03206073|12038943|FG002|NOT COMPLETED|Overall Study||4
10872974|NCT03206073|12038944|FG003|NOT COMPLETED|Overall Study||0
10872975|NCT03195127|12038956|FG000|STARTED|Overall Study||15
10872976|NCT03195127|12038957|FG001|STARTED|Overall Study||18
10872977|NCT03195127|12038956|FG000|COMPLETED|Overall Study||15
10872978|NCT03195127|12038957|FG001|COMPLETED|Overall Study||17
10872979|NCT03195127|12038956|FG000|NOT COMPLETED|Overall Study||0
10872980|NCT03195127|12038957|FG001|NOT COMPLETED|Overall Study||1
10872981|NCT03102034|12038969|FG000|STARTED|Overall Study||21
10872982|NCT03102034|12038970|FG001|STARTED|Overall Study||11
10872983|NCT03102034|12038969|FG000|COMPLETED|Overall Study||20
10872984|NCT03102034|12038970|FG001|COMPLETED|Overall Study||11
10872985|NCT03102034|12038969|FG000|NOT COMPLETED|Overall Study||1
10872986|NCT03102034|12038970|FG001|NOT COMPLETED|Overall Study||0
10872987|NCT03076164|12038976|FG000|STARTED|Overall Study||24
10872988|NCT03076164|12038976|FG000|COMPLETED|Overall Study||24
10872989|NCT03076164|12038976|FG000|NOT COMPLETED|Overall Study||0
10872990|NCT02723864|12038987|FG000|STARTED|Overall Study||3
10872991|NCT02723864|12038988|FG001|STARTED|Overall Study||3
10872992|NCT02723864|12038989|FG002|STARTED|Overall Study||6
10872993|NCT02723864|12038990|FG003|STARTED|Overall Study||7
10872994|NCT02723864|12038991|FG004|STARTED|Overall Study||3
10872995|NCT02723864|12038992|FG005|STARTED|Overall Study||25
10872996|NCT02723864|12038993|FG006|STARTED|Overall Study||6
10872997|NCT02723864|12038987|FG000|COMPLETED|Overall Study||2
10872998|NCT02723864|12038988|FG001|COMPLETED|Overall Study||2
10872999|NCT02723864|12038989|FG002|COMPLETED|Overall Study||5
10873000|NCT02723864|12038990|FG003|COMPLETED|Overall Study||7
10873001|NCT02723864|12038991|FG004|COMPLETED|Overall Study||2
10873002|NCT02723864|12038992|FG005|COMPLETED|Overall Study||14
10873003|NCT02723864|12038993|FG006|COMPLETED|Overall Study||4
10873004|NCT02723864|12038987|FG000|NOT COMPLETED|Overall Study||1
10873005|NCT02723864|12038988|FG001|NOT COMPLETED|Overall Study||1
10873006|NCT02723864|12038989|FG002|NOT COMPLETED|Overall Study||1
10873007|NCT02723864|12038990|FG003|NOT COMPLETED|Overall Study||0
10873008|NCT02723864|12038991|FG004|NOT COMPLETED|Overall Study||1
10873009|NCT02723864|12038992|FG005|NOT COMPLETED|Overall Study||11
10873010|NCT02723864|12038993|FG006|NOT COMPLETED|Overall Study||2
10873011|NCT02701556|12039032|FG000|STARTED|Overall Study||198
10873012|NCT02701556|12039033|FG001|STARTED|Overall Study||198
10873013|NCT02701556|12039032|FG000|COMPLETED|Overall Study||175
10873014|NCT02701556|12039033|FG001|COMPLETED|Overall Study||178
10873015|NCT02701556|12039032|FG000|NOT COMPLETED|Overall Study||23
10873016|NCT02701556|12039033|FG001|NOT COMPLETED|Overall Study||20
10873017|NCT02691013|12039041|FG000|STARTED|Overall Study||61
10873018|NCT02691013|12039042|FG001|STARTED|Overall Study||59
10873019|NCT02691013|12039041|FG000|COMPLETED|Overall Study||58
10873020|NCT02691013|12039042|FG001|COMPLETED|Overall Study||59
10873021|NCT02691013|12039041|FG000|NOT COMPLETED|Overall Study||3
10873022|NCT02691013|12039042|FG001|NOT COMPLETED|Overall Study||0
10873023|NCT02597062|12039050|FG000|STARTED|Overall Study||76
10873024|NCT02597062|12039050|FG000|COMPLETED|Overall Study||75
10295878|NCT02460224|11428556|FG021|COMPLETED|Overall Study||0
10295879|NCT02460224|11428557|FG022|COMPLETED|Overall Study||0
10295880|NCT02460224|11428558|FG023|COMPLETED|Overall Study||0
10295881|NCT02460224|11428559|FG024|COMPLETED|Overall Study||0
10295882|NCT02460224|11428560|FG025|COMPLETED|Overall Study||0
10295883|NCT02460224|11428561|FG026|COMPLETED|Overall Study||0
10295884|NCT02460224|11428562|FG027|COMPLETED|Overall Study||0
10295885|NCT02460224|11428563|FG028|COMPLETED|Overall Study||0
10295886|NCT02460224|11428535|FG000|NOT COMPLETED|Overall Study||17
10295887|NCT02460224|11428536|FG001|NOT COMPLETED|Overall Study||12
10295888|NCT02460224|11428537|FG002|NOT COMPLETED|Overall Study||6
10295889|NCT02460224|11428538|FG003|NOT COMPLETED|Overall Study||6
10295890|NCT02460224|11428539|FG004|NOT COMPLETED|Overall Study||6
10295891|NCT02460224|11428540|FG005|NOT COMPLETED|Overall Study||30
10295892|NCT02460224|11428541|FG006|NOT COMPLETED|Overall Study||30
10295893|NCT02460224|11428542|FG007|NOT COMPLETED|Overall Study||5
10873025|NCT02597062|12039050|FG000|NOT COMPLETED|Overall Study||1
10873026|NCT02130882|12039056|FG000|STARTED|Overall Study||10
10873027|NCT02130882|12039057|FG001|STARTED|Overall Study||10
10873028|NCT02130882|12039056|FG000|COMPLETED|Overall Study||10
10873029|NCT02130882|12039057|FG001|COMPLETED|Overall Study||9
10873030|NCT02130882|12039056|FG000|NOT COMPLETED|Overall Study||0
10873031|NCT02130882|12039057|FG001|NOT COMPLETED|Overall Study||1
10873032|NCT01850563|12039065|FG000|STARTED|Overall Study||22
10873033|NCT01850563|12039066|FG001|STARTED|Overall Study||19
10873034|NCT01850563|12039065|FG000|HBO Treatment Completed|Overall Study||19
10873035|NCT01850563|12039066|FG001|HBO Treatment Completed|Overall Study||0
10873036|NCT01850563|12039065|FG000|COMPLETED|Overall Study||19
10873037|NCT01850563|12039066|FG001|COMPLETED|Overall Study||19
10873038|NCT01850563|12039065|FG000|NOT COMPLETED|Overall Study||3
10873039|NCT01850563|12039066|FG001|NOT COMPLETED|Overall Study||0
10873040|NCT01827111|12039073|FG000|STARTED|Overall Study||19
10873041|NCT01827111|12039073|FG000|COMPLETED|Overall Study||18
10873042|NCT01827111|12039073|FG000|NOT COMPLETED|Overall Study||1
10873043|NCT01437111|12039077|FG000|STARTED|Overall Study||200
10873044|NCT01437111|12039077|FG000|Treated Participants|Overall Study||198
10873045|NCT01437111|12039077|FG000|COMPLETED|Overall Study||182
10873046|NCT01437111|12039077|FG000|NOT COMPLETED|Overall Study||18
10873047|NCT01057121|12039086|FG000|STARTED|Phase I: 10 mg/Day Lenalidomide||3
10873048|NCT01057121|12039087|FG001|STARTED|Phase I: 10 mg/Day Lenalidomide||0
10873049|NCT01057121|12039088|FG002|STARTED|Phase I: 10 mg/Day Lenalidomide||0
10873050|NCT01057121|12039089|FG003|STARTED|Phase I: 10 mg/Day Lenalidomide||0
10873051|NCT01057121|12039090|FG004|STARTED|Phase I: 10 mg/Day Lenalidomide||0
10873052|NCT01057121|12039086|FG000|COMPLETED|Phase I: 10 mg/Day Lenalidomide||3
10873053|NCT01057121|12039087|FG001|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
10873054|NCT01057121|12039088|FG002|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
10873055|NCT01057121|12039089|FG003|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
10873056|NCT01057121|12039090|FG004|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
10873057|NCT01057121|12039086|FG000|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
10873058|NCT01057121|12039087|FG001|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
10873059|NCT01057121|12039088|FG002|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
10873060|NCT01057121|12039089|FG003|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
10873061|NCT01057121|12039090|FG004|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
10873062|NCT01057121|12039086|FG000|STARTED|Phase I: 15 mg/Day Lenolidomide||0
10873063|NCT01057121|12039087|FG001|STARTED|Phase I: 15 mg/Day Lenolidomide||3
10873064|NCT01057121|12039088|FG002|STARTED|Phase I: 15 mg/Day Lenolidomide||0
10873065|NCT01057121|12039089|FG003|STARTED|Phase I: 15 mg/Day Lenolidomide||0
10873066|NCT01057121|12039090|FG004|STARTED|Phase I: 15 mg/Day Lenolidomide||0
10873067|NCT01057121|12039086|FG000|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
10873068|NCT01057121|12039087|FG001|COMPLETED|Phase I: 15 mg/Day Lenolidomide||3
10873069|NCT01057121|12039088|FG002|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
10873070|NCT01057121|12039089|FG003|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
10873071|NCT01057121|12039090|FG004|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
10873072|NCT01057121|12039086|FG000|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
10873073|NCT01057121|12039087|FG001|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
10873074|NCT01057121|12039088|FG002|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
10873075|NCT01057121|12039089|FG003|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
10873076|NCT01057121|12039090|FG004|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
10873077|NCT01057121|12039086|FG000|STARTED|Phase I: 20 mg/Day Lenalidomide||0
10873078|NCT01057121|12039087|FG001|STARTED|Phase I: 20 mg/Day Lenalidomide||0
10873079|NCT01057121|12039088|FG002|STARTED|Phase I: 20 mg/Day Lenalidomide||3
10873080|NCT01057121|12039089|FG003|STARTED|Phase I: 20 mg/Day Lenalidomide||0
10873081|NCT01057121|12039090|FG004|STARTED|Phase I: 20 mg/Day Lenalidomide||0
10873082|NCT01057121|12039086|FG000|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
10873083|NCT01057121|12039087|FG001|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
10873084|NCT01057121|12039088|FG002|COMPLETED|Phase I: 20 mg/Day Lenalidomide||3
10873085|NCT01057121|12039089|FG003|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
10873086|NCT01057121|12039090|FG004|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
10873087|NCT01057121|12039086|FG000|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
10873088|NCT01057121|12039087|FG001|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
10873089|NCT01057121|12039088|FG002|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
10873090|NCT01057121|12039089|FG003|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
10873091|NCT01057121|12039090|FG004|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
10873092|NCT01057121|12039086|FG000|STARTED|Phase I: 25 mg/Day Lenalidomide||0
10873093|NCT01057121|12039087|FG001|STARTED|Phase I: 25 mg/Day Lenalidomide||0
10873094|NCT01057121|12039088|FG002|STARTED|Phase I: 25 mg/Day Lenalidomide||0
10873095|NCT01057121|12039089|FG003|STARTED|Phase I: 25 mg/Day Lenalidomide||6
10873096|NCT01057121|12039090|FG004|STARTED|Phase I: 25 mg/Day Lenalidomide||0
10873097|NCT01057121|12039086|FG000|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
10873098|NCT01057121|12039087|FG001|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
10873099|NCT01057121|12039088|FG002|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
10873100|NCT01057121|12039089|FG003|COMPLETED|Phase I: 25 mg/Day Lenalidomide||6
10873101|NCT01057121|12039090|FG004|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
10873102|NCT01057121|12039086|FG000|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
10873103|NCT01057121|12039087|FG001|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
10873104|NCT01057121|12039088|FG002|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
10873105|NCT01057121|12039089|FG003|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
10873106|NCT01057121|12039090|FG004|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
10873107|NCT01057121|12039086|FG000|STARTED|Phase II: 25 mg/Day Lenalidomide||0
10873108|NCT01057121|12039087|FG001|STARTED|Phase II: 25 mg/Day Lenalidomide||0
10873109|NCT01057121|12039088|FG002|STARTED|Phase II: 25 mg/Day Lenalidomide||0
10873110|NCT01057121|12039089|FG003|STARTED|Phase II: 25 mg/Day Lenalidomide||0
10873111|NCT01057121|12039090|FG004|STARTED|Phase II: 25 mg/Day Lenalidomide||23
10873112|NCT01057121|12039086|FG000|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
10873113|NCT01057121|12039087|FG001|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
10873114|NCT01057121|12039088|FG002|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
10873115|NCT01057121|12039089|FG003|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
10873116|NCT01057121|12039090|FG004|COMPLETED|Phase II: 25 mg/Day Lenalidomide||23
10873117|NCT01057121|12039086|FG000|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
10873118|NCT01057121|12039087|FG001|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
10873119|NCT01057121|12039088|FG002|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
10873120|NCT01057121|12039089|FG003|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
10873121|NCT01057121|12039090|FG004|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
10873122|NCT01004263|12039114|FG000|STARTED|Overall Study|Participants who took study drug|606
10873123|NCT01004263|12039114|FG000|COMPLETED|Overall Study||427
10873124|NCT01004263|12039114|FG000|NOT COMPLETED|Overall Study||179
10873125|NCT01001234|12039123|FG000|STARTED|Overall Study|Participants who were randomized to study drug|492
10873126|NCT01001234|12039124|FG001|STARTED|Overall Study|Participants who were randomized to study drug|31
10873127|NCT01001234|12039125|FG002|STARTED|Overall Study|Participants who were randomized to study drug|409
10873128|NCT01001234|12039126|FG003|STARTED|Overall Study|Participants who were randomized to study drug|410
10873129|NCT01001234|12039127|FG004|STARTED|Overall Study|Participants who were randomized to study drug|40
10873130|NCT01001234|12039123|FG000|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|124
10873131|NCT01001234|12039124|FG001|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|8
10873132|NCT01001234|12039125|FG002|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|400
10873133|NCT01001234|12039126|FG003|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|405
10873134|NCT01001234|12039127|FG004|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|40
10873135|NCT01001234|12039123|FG000|Participants Not Treated|Overall Study|Participants who did not take study drug|368
10873136|NCT01001234|12039124|FG001|Participants Not Treated|Overall Study|Participants who did not take study drug|23
10873137|NCT01001234|12039125|FG002|Participants Not Treated|Overall Study|Participants who did not take study drug|9
10873138|NCT01001234|12039126|FG003|Participants Not Treated|Overall Study|Participants who did not take study drug|5
10873139|NCT01001234|12039127|FG004|Participants Not Treated|Overall Study|Participants who did not take study drug|0
10873140|NCT01001234|12039123|FG000|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|87
10873141|NCT01001234|12039124|FG001|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|5
10873142|NCT01001234|12039125|FG002|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|377
10873143|NCT01001234|12039126|FG003|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|385
10873144|NCT01001234|12039127|FG004|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|40
10873145|NCT01001234|12039123|FG000|NOT COMPLETED|Overall Study||405
10873146|NCT01001234|12039124|FG001|NOT COMPLETED|Overall Study||26
10873147|NCT01001234|12039125|FG002|NOT COMPLETED|Overall Study||32
10873148|NCT01001234|12039126|FG003|NOT COMPLETED|Overall Study||25
10873149|NCT01001234|12039127|FG004|NOT COMPLETED|Overall Study||0
10873150|NCT00924170|12039135|FG000|STARTED|Overall Study||10
10873151|NCT00924170|12039136|FG001|STARTED|Overall Study||8
10873152|NCT00924170|12039135|FG000|COMPLETED|Overall Study||3
10873153|NCT00924170|12039136|FG001|COMPLETED|Overall Study||0
10873154|NCT00924170|12039135|FG000|NOT COMPLETED|Overall Study||7
10873155|NCT00924170|12039136|FG001|NOT COMPLETED|Overall Study||8
10873156|NCT00894556|12039151|FG000|STARTED|Baseline Phase||0
10873157|NCT00894556|12039152|FG001|STARTED|Baseline Phase||0
10873158|NCT00894556|12039153|FG002|STARTED|Baseline Phase||0
10873159|NCT00894556|12039154|FG003|STARTED|Baseline Phase||194
10873160|NCT00894556|12039151|FG000|COMPLETED|Baseline Phase||0
10873161|NCT00894556|12039152|FG001|COMPLETED|Baseline Phase||0
10873162|NCT00894556|12039153|FG002|COMPLETED|Baseline Phase||0
10873163|NCT00894556|12039154|FG003|COMPLETED|Baseline Phase||109
10873164|NCT00894556|12039151|FG000|NOT COMPLETED|Baseline Phase||0
10873165|NCT00894556|12039152|FG001|NOT COMPLETED|Baseline Phase||0
10873166|NCT00894556|12039153|FG002|NOT COMPLETED|Baseline Phase||0
10873167|NCT00894556|12039154|FG003|NOT COMPLETED|Baseline Phase||85
10873168|NCT00894556|12039151|FG000|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|37
10873169|NCT00894556|12039152|FG001|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|36
10873170|NCT00894556|12039153|FG002|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|36
10873171|NCT00894556|12039154|FG003|STARTED|Treatment Phase||0
10873172|NCT00894556|12039151|FG000|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|33
10873173|NCT00894556|12039152|FG001|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|32
10873174|NCT00894556|12039153|FG002|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|35
10873175|NCT00894556|12039154|FG003|COMPLETED|Treatment Phase||0
10873176|NCT00894556|12039151|FG000|NOT COMPLETED|Treatment Phase||4
10873177|NCT00894556|12039152|FG001|NOT COMPLETED|Treatment Phase||4
10873178|NCT00894556|12039153|FG002|NOT COMPLETED|Treatment Phase||1
10873179|NCT00894556|12039154|FG003|NOT COMPLETED|Treatment Phase||0
10873180|NCT00840177|12039164|FG000|STARTED|Overall Study||36
10873181|NCT00840177|12039165|FG001|STARTED|Overall Study||29
10873182|NCT00840177|12039166|FG002|STARTED|Overall Study||50
10873183|NCT00840177|12039164|FG000|Treated|Overall Study||36
10873184|NCT00840177|12039165|FG001|Treated|Overall Study||29
10873185|NCT00840177|12039166|FG002|Treated|Overall Study||46
10873186|NCT00840177|12039164|FG000|Assessed for AEs|Overall Study||35
10873187|NCT00840177|12039165|FG001|Assessed for AEs|Overall Study||29
10873188|NCT00840177|12039166|FG002|Assessed for AEs|Overall Study||46
10873189|NCT00840177|12039164|FG000|COMPLETED|Overall Study||18
10873190|NCT00840177|12039165|FG001|COMPLETED|Overall Study||20
10873191|NCT00840177|12039166|FG002|COMPLETED|Overall Study||39
10873192|NCT00840177|12039164|FG000|NOT COMPLETED|Overall Study||18
10873193|NCT00840177|12039165|FG001|NOT COMPLETED|Overall Study||9
10873194|NCT00840177|12039166|FG002|NOT COMPLETED|Overall Study||11
10873195|NCT00820950|12039179|FG000|STARTED|Overall Study||6
10873196|NCT00820950|12039180|FG001|STARTED|Overall Study||6
10873197|NCT00820950|12039181|FG002|STARTED|Overall Study||6
10873198|NCT00820950|12039182|FG003|STARTED|Overall Study||6
10873199|NCT00820950|12039183|FG004|STARTED|Overall Study||6
10419531|NCT00810459|11564366|FG001|STARTED|Overall Study||2
10419532|NCT00810459|11564365|FG000|COMPLETED|Overall Study||4
10419533|NCT00810459|11564366|FG001|COMPLETED|Overall Study||2
10419534|NCT00810459|11564365|FG000|NOT COMPLETED|Overall Study||0
10419535|NCT00810459|11564366|FG001|NOT COMPLETED|Overall Study||0
10419536|NCT00810498|11564373|FG000|STARTED|Overall Study||6
10419537|NCT00810498|11564374|FG001|STARTED|Overall Study||5
10419538|NCT00810498|11564373|FG000|COMPLETED|Overall Study||6
10419539|NCT00810498|11564374|FG001|COMPLETED|Overall Study||5
10419540|NCT00810498|11564373|FG000|NOT COMPLETED|Overall Study||0
10419541|NCT00810498|11564374|FG001|NOT COMPLETED|Overall Study||0
10419542|NCT00810511|11564382|FG000|STARTED|Overall Study||107
10419543|NCT00810511|11564383|FG001|STARTED|Overall Study||106
10419544|NCT00810511|11564382|FG000|COMPLETED|Overall Study||97
10419545|NCT00810511|11564383|FG001|COMPLETED|Overall Study||102
10419546|NCT00810511|11564382|FG000|NOT COMPLETED|Overall Study||10
10419547|NCT00810511|11564383|FG001|NOT COMPLETED|Overall Study||4
10419548|NCT00810576|11564389|FG000|STARTED|Overall Study||1
10419549|NCT00810576|11564389|FG000|COMPLETED|Overall Study||1
10419550|NCT00810576|11564389|FG000|NOT COMPLETED|Overall Study||0
10419551|NCT00810602|11564393|FG000|STARTED|Overall Study||27
10419552|NCT00810602|11564394|FG001|STARTED|Overall Study||34
10419553|NCT00810602|11564393|FG000|COMPLETED|Overall Study||19
10419554|NCT00810602|11564394|FG001|COMPLETED|Overall Study||31
10419555|NCT00810602|11564393|FG000|NOT COMPLETED|Overall Study||8
10419556|NCT00810602|11564394|FG001|NOT COMPLETED|Overall Study||3
10419557|NCT00810615|11564400|FG000|STARTED|Overall Study||25
10419558|NCT00810615|11564401|FG001|STARTED|Overall Study||25
10419559|NCT00810615|11564400|FG000|COMPLETED|Overall Study|One male withdrawal due to personal reasons.|24
10419560|NCT00810615|11564401|FG001|COMPLETED|Overall Study|One male withdrawal due to personal reasons.|24
10419561|NCT00810615|11564400|FG000|NOT COMPLETED|Overall Study||1
10419562|NCT00810615|11564401|FG001|NOT COMPLETED|Overall Study||1
10419563|NCT00810641|11564422|FG000|STARTED|Overall Study||52
10419564|NCT00810641|11564423|FG001|STARTED|Overall Study||54
10419565|NCT00810641|11564424|FG002|STARTED|Overall Study||51
10419566|NCT00810641|11564422|FG000|COMPLETED|Overall Study||52
10419567|NCT00810641|11564423|FG001|COMPLETED|Overall Study||53
10419568|NCT00810641|11564424|FG002|COMPLETED|Overall Study||49
10419569|NCT00810641|11564422|FG000|NOT COMPLETED|Overall Study||0
10419570|NCT00810641|11564423|FG001|NOT COMPLETED|Overall Study||1
10419571|NCT00810641|11564424|FG002|NOT COMPLETED|Overall Study||2
10419572|NCT00810693|11564435|FG000|STARTED|Treatment Period||254
10419573|NCT00810693|11564436|FG001|STARTED|Treatment Period|1 randomized but not treated|64
10419574|NCT00810693|11564437|FG002|STARTED|Treatment Period|1 randomized but not treated|127
10419575|NCT00810693|11564435|FG000|Participants Received Treatment|Treatment Period||254
10419576|NCT00810693|11564436|FG001|Participants Received Treatment|Treatment Period||63
10419577|NCT00810693|11564437|FG002|Participants Received Treatment|Treatment Period||126
10419578|NCT00810693|11564435|FG000|COMPLETED|Treatment Period||237
10419579|NCT00810693|11564436|FG001|COMPLETED|Treatment Period||57
10419580|NCT00810693|11564437|FG002|COMPLETED|Treatment Period||111
10419581|NCT00810693|11564435|FG000|NOT COMPLETED|Treatment Period||17
10419582|NCT00810693|11564436|FG001|NOT COMPLETED|Treatment Period||7
10419583|NCT00810693|11564437|FG002|NOT COMPLETED|Treatment Period||16
10419584|NCT00810693|11564435|FG000|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|23
10419585|NCT00810693|11564436|FG001|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|7
10419586|NCT00810693|11564437|FG002|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|16
10419587|NCT00810693|11564435|FG000|COMPLETED|Follow-up Period (FUP)||15
10419588|NCT00810693|11564436|FG001|COMPLETED|Follow-up Period (FUP)||4
10419589|NCT00810693|11564437|FG002|COMPLETED|Follow-up Period (FUP)||12
10419590|NCT00810693|11564435|FG000|NOT COMPLETED|Follow-up Period (FUP)||8
10419591|NCT00810693|11564436|FG001|NOT COMPLETED|Follow-up Period (FUP)||3
10419592|NCT00810693|11564437|FG002|NOT COMPLETED|Follow-up Period (FUP)||4
10419593|NCT00810719|11564445|FG000|STARTED|Overall Study||30
10419594|NCT00810719|11564445|FG000|COMPLETED|Overall Study||30
10419595|NCT00810719|11564445|FG000|NOT COMPLETED|Overall Study||0
10419596|NCT00810771|11564452|FG000|STARTED|Overall Study||232
10419597|NCT00810771|11564453|FG001|STARTED|Overall Study||234
10419598|NCT00810771|11564454|FG002|STARTED|Overall Study||84
10419599|NCT00810771|11564452|FG000|COMPLETED|Overall Study||232
10419600|NCT00810771|11564453|FG001|COMPLETED|Overall Study||234
10419601|NCT00810771|11564454|FG002|COMPLETED|Overall Study||84
10419602|NCT00810771|11564452|FG000|NOT COMPLETED|Overall Study||0
10873200|NCT00820950|12039184|FG005|STARTED|Overall Study||6
10873201|NCT00820950|12039185|FG006|STARTED|Overall Study||6
10873202|NCT00820950|12039186|FG007|STARTED|Overall Study||6
10873203|NCT00820950|12039187|FG008|STARTED|Overall Study||5
10873204|NCT00820950|12039188|FG009|STARTED|Overall Study||5
10873205|NCT00820950|12039179|FG000|COMPLETED|Overall Study||5
10873206|NCT00820950|12039180|FG001|COMPLETED|Overall Study||5
10873207|NCT00820950|12039181|FG002|COMPLETED|Overall Study||6
10873208|NCT00820950|12039182|FG003|COMPLETED|Overall Study||6
10873209|NCT00820950|12039183|FG004|COMPLETED|Overall Study||6
10873210|NCT00820950|12039184|FG005|COMPLETED|Overall Study||6
10873211|NCT00820950|12039185|FG006|COMPLETED|Overall Study||5
10873212|NCT00820950|12039186|FG007|COMPLETED|Overall Study||5
10873213|NCT00820950|12039187|FG008|COMPLETED|Overall Study||5
10873214|NCT00820950|12039188|FG009|COMPLETED|Overall Study||5
10873215|NCT00820950|12039179|FG000|NOT COMPLETED|Overall Study||1
10873216|NCT00820950|12039180|FG001|NOT COMPLETED|Overall Study||1
10873217|NCT00820950|12039181|FG002|NOT COMPLETED|Overall Study||0
10873218|NCT00820950|12039182|FG003|NOT COMPLETED|Overall Study||0
10873219|NCT00820950|12039183|FG004|NOT COMPLETED|Overall Study||0
10873220|NCT00820950|12039184|FG005|NOT COMPLETED|Overall Study||0
10873221|NCT00820950|12039185|FG006|NOT COMPLETED|Overall Study||1
10873222|NCT00820950|12039186|FG007|NOT COMPLETED|Overall Study||1
10873223|NCT00820950|12039187|FG008|NOT COMPLETED|Overall Study||0
10873224|NCT00820950|12039188|FG009|NOT COMPLETED|Overall Study||0
10873225|NCT00806416|12039230|FG000|STARTED|Period 1 - Part I||107
10873226|NCT00806416|12039231|FG001|STARTED|Period 1 - Part I||107
10873227|NCT00806416|12039232|FG002|STARTED|Period 1 - Part I||0
10873228|NCT00806416|12039233|FG003|STARTED|Period 1 - Part I||0
10873229|NCT00806416|12039230|FG000|COMPLETED|Period 1 - Part I||104
10873230|NCT00806416|12039231|FG001|COMPLETED|Period 1 - Part I||103
10873231|NCT00806416|12039232|FG002|COMPLETED|Period 1 - Part I||0
10873232|NCT00806416|12039233|FG003|COMPLETED|Period 1 - Part I||0
10873233|NCT00806416|12039230|FG000|NOT COMPLETED|Period 1 - Part I||3
10873234|NCT00806416|12039231|FG001|NOT COMPLETED|Period 1 - Part I||4
10873235|NCT00806416|12039232|FG002|NOT COMPLETED|Period 1 - Part I||0
10873236|NCT00806416|12039233|FG003|NOT COMPLETED|Period 1 - Part I||0
10873237|NCT00806416|12039230|FG000|STARTED|Period 2 - Part I||104
10873238|NCT00806416|12039231|FG001|STARTED|Period 2 - Part I||103
10873239|NCT00806416|12039232|FG002|STARTED|Period 2 - Part I||0
10873240|NCT00806416|12039233|FG003|STARTED|Period 2 - Part I||0
10873241|NCT00806416|12039230|FG000|COMPLETED|Period 2 - Part I||104
10873242|NCT00806416|12039231|FG001|COMPLETED|Period 2 - Part I||103
10873243|NCT00806416|12039232|FG002|COMPLETED|Period 2 - Part I||0
10873244|NCT00806416|12039233|FG003|COMPLETED|Period 2 - Part I||0
10873245|NCT00806416|12039230|FG000|NOT COMPLETED|Period 2 - Part I||0
10873246|NCT00806416|12039231|FG001|NOT COMPLETED|Period 2 - Part I||0
10873247|NCT00806416|12039232|FG002|NOT COMPLETED|Period 2 - Part I||0
10873248|NCT00806416|12039233|FG003|NOT COMPLETED|Period 2 - Part I||0
10873249|NCT00806416|12039230|FG000|STARTED|Period 1 - Part II||0
10873250|NCT00806416|12039231|FG001|STARTED|Period 1 - Part II||0
10873251|NCT00806416|12039232|FG002|STARTED|Period 1 - Part II||14
10873252|NCT00806416|12039233|FG003|STARTED|Period 1 - Part II||16
10873253|NCT00806416|12039230|FG000|COMPLETED|Period 1 - Part II||0
10873254|NCT00806416|12039231|FG001|COMPLETED|Period 1 - Part II||0
10873255|NCT00806416|12039232|FG002|COMPLETED|Period 1 - Part II||14
10873256|NCT00806416|12039233|FG003|COMPLETED|Period 1 - Part II||14
10873257|NCT00806416|12039230|FG000|NOT COMPLETED|Period 1 - Part II||0
10873258|NCT00806416|12039231|FG001|NOT COMPLETED|Period 1 - Part II||0
10873259|NCT00806416|12039232|FG002|NOT COMPLETED|Period 1 - Part II||0
10873260|NCT00806416|12039233|FG003|NOT COMPLETED|Period 1 - Part II||2
10873261|NCT00806416|12039230|FG000|STARTED|Period 2 - Part II||0
10873262|NCT00806416|12039231|FG001|STARTED|Period 2 - Part II||0
10873263|NCT00806416|12039232|FG002|STARTED|Period 2 - Part II||14
10295894|NCT02460224|11428543|FG008|NOT COMPLETED|Overall Study||6
10295895|NCT02460224|11428544|FG009|NOT COMPLETED|Overall Study||11
10295896|NCT02460224|11428545|FG010|NOT COMPLETED|Overall Study||5
10295897|NCT02460224|11428546|FG011|NOT COMPLETED|Overall Study||6
10295898|NCT02460224|11428547|FG012|NOT COMPLETED|Overall Study||6
10295899|NCT02460224|11428548|FG013|NOT COMPLETED|Overall Study||6
10295900|NCT02460224|11428549|FG014|NOT COMPLETED|Overall Study||5
10295901|NCT02460224|11428550|FG015|NOT COMPLETED|Overall Study||6
10295902|NCT02460224|11428551|FG016|NOT COMPLETED|Overall Study||20
10295903|NCT02460224|11428552|FG017|NOT COMPLETED|Overall Study||6
10295904|NCT02460224|11428553|FG018|NOT COMPLETED|Overall Study||12
10295905|NCT02460224|11428554|FG019|NOT COMPLETED|Overall Study||7
10295906|NCT02460224|11428555|FG020|NOT COMPLETED|Overall Study||6
10295907|NCT02460224|11428556|FG021|NOT COMPLETED|Overall Study||12
10295908|NCT02460224|11428557|FG022|NOT COMPLETED|Overall Study||6
10295909|NCT02460224|11428558|FG023|NOT COMPLETED|Overall Study||11
10295910|NCT02460224|11428559|FG024|NOT COMPLETED|Overall Study||6
10295911|NCT02460224|11428560|FG025|NOT COMPLETED|Overall Study||6
10295912|NCT02460224|11428561|FG026|NOT COMPLETED|Overall Study||121
10295913|NCT02460224|11428562|FG027|NOT COMPLETED|Overall Study||21
10295914|NCT02460224|11428563|FG028|NOT COMPLETED|Overall Study||93
10295915|NCT02460159|11428637|FG000|STARTED|Overall Study||117
10295916|NCT02460159|11428638|FG001|STARTED|Overall Study||18
10873264|NCT00806416|12039233|FG003|STARTED|Period 2 - Part II||14
10873265|NCT00806416|12039230|FG000|COMPLETED|Period 2 - Part II||0
10873266|NCT00806416|12039231|FG001|COMPLETED|Period 2 - Part II||0
10295917|NCT02460159|11428637|FG000|COMPLETED|Overall Study||111
10295918|NCT02460159|11428638|FG001|COMPLETED|Overall Study||17
10873267|NCT00806416|12039232|FG002|COMPLETED|Period 2 - Part II||14
10873268|NCT00806416|12039233|FG003|COMPLETED|Period 2 - Part II||14
10873269|NCT00806416|12039230|FG000|NOT COMPLETED|Period 2 - Part II||0
10873270|NCT00806416|12039231|FG001|NOT COMPLETED|Period 2 - Part II||0
10873271|NCT00806416|12039232|FG002|NOT COMPLETED|Period 2 - Part II||0
10873272|NCT00806416|12039233|FG003|NOT COMPLETED|Period 2 - Part II||0
10419603|NCT00810771|11564453|FG001|NOT COMPLETED|Overall Study||0
10419604|NCT00810771|11564454|FG002|NOT COMPLETED|Overall Study||0
10755718|NCT03070730|11919529|FG001|STARTED|Overall Study||0
10755719|NCT03070730|11919530|FG002|STARTED|Overall Study||0
10419605|NCT00810797|11564464|FG000|STARTED|Overall Study||36
10419606|NCT00810797|11564464|FG000|COMPLETED|Overall Study||36
10419607|NCT00810797|11564464|FG000|NOT COMPLETED|Overall Study||0
10419608|NCT00810810|11564472|FG000|STARTED|Overall Study||124
10419609|NCT00810810|11564473|FG001|STARTED|Overall Study||49
10419610|NCT00810810|11564474|FG002|STARTED|Overall Study||56
10419611|NCT00810810|11564475|FG003|STARTED|Overall Study||51
10419612|NCT00810810|11564472|FG000|COMPLETED|Overall Study||124
10419613|NCT00810810|11564473|FG001|COMPLETED|Overall Study||38
10419614|NCT00810810|11564474|FG002|COMPLETED|Overall Study||45
10419615|NCT00810810|11564475|FG003|COMPLETED|Overall Study||38
10419616|NCT00810810|11564472|FG000|NOT COMPLETED|Overall Study||0
10419617|NCT00810810|11564473|FG001|NOT COMPLETED|Overall Study||11
10419618|NCT00810810|11564474|FG002|NOT COMPLETED|Overall Study||11
10419619|NCT00810810|11564475|FG003|NOT COMPLETED|Overall Study||13
10419620|NCT00810888|11564488|FG000|STARTED|Overall Study||10
10419621|NCT00810888|11564489|FG001|STARTED|Overall Study||9
10419622|NCT00810888|11564490|FG002|STARTED|Overall Study||73
10419623|NCT00810888|11564488|FG000|COMPLETED|Overall Study||10
10419624|NCT00810888|11564489|FG001|COMPLETED|Overall Study||9
10419625|NCT00810888|11564490|FG002|COMPLETED|Overall Study||73
10419626|NCT00810888|11564488|FG000|NOT COMPLETED|Overall Study||0
10419627|NCT00810888|11564489|FG001|NOT COMPLETED|Overall Study||0
10419628|NCT00810888|11564490|FG002|NOT COMPLETED|Overall Study||0
10419629|NCT00810901|11564500|FG000|STARTED|Overall Study||253
10419630|NCT00810901|11564501|FG001|STARTED|Overall Study||176
10419631|NCT00810901|11564500|FG000|1-month Follow up|Overall Study||242
10419632|NCT00810901|11564501|FG001|1-month Follow up|Overall Study||146
10419633|NCT00810901|11564500|FG000|6-month Follow-up|Overall Study||181
10419634|NCT00810901|11564501|FG001|6-month Follow-up|Overall Study||122
10419635|NCT00810901|11564500|FG000|COMPLETED|Overall Study||165
10419636|NCT00810901|11564501|FG001|COMPLETED|Overall Study||118
10419637|NCT00810901|11564500|FG000|NOT COMPLETED|Overall Study||88
10419638|NCT00810901|11564501|FG001|NOT COMPLETED|Overall Study||58
10419639|NCT00811018|11564507|FG000|STARTED|Overall Study||1192
10419640|NCT00811018|11564507|FG000|COMPLETED|Overall Study||224
10419641|NCT00811018|11564507|FG000|NOT COMPLETED|Overall Study||968
10755720|NCT03070730|11919528|FG000|COMPLETED|Overall Study||0
10873273|NCT00729651|12039243|FG000|STARTED|Overall Study||173
10873274|NCT00729651|12039244|FG001|STARTED|Overall Study||170
10873275|NCT00729651|12039243|FG000|COMPLETED|Overall Study||154
10873276|NCT00729651|12039244|FG001|COMPLETED|Overall Study||152
10873277|NCT00729651|12039243|FG000|NOT COMPLETED|Overall Study||19
10873278|NCT00729651|12039244|FG001|NOT COMPLETED|Overall Study||18
10873279|NCT00698815|12039253|FG000|STARTED|Overall Study||42
10873280|NCT00698815|12039254|FG001|STARTED|Overall Study||47
10873281|NCT00698815|12039255|FG002|STARTED|Overall Study||41
10873282|NCT00698815|12039253|FG000|COMPLETED|Overall Study||32
10873283|NCT00698815|12039254|FG001|COMPLETED|Overall Study||33
10873284|NCT00698815|12039255|FG002|COMPLETED|Overall Study||31
10873285|NCT00698815|12039253|FG000|NOT COMPLETED|Overall Study||10
10873286|NCT00698815|12039254|FG001|NOT COMPLETED|Overall Study||14
10873287|NCT00698815|12039255|FG002|NOT COMPLETED|Overall Study||10
10873288|NCT00698022|12039266|FG000|STARTED|Overall Study||30
10873289|NCT00698022|12039267|FG001|STARTED|Overall Study||30
10873290|NCT00698022|12039268|FG002|STARTED|Overall Study||16
10873291|NCT00698022|12039266|FG000|COMPLETED|Overall Study||14
10873292|NCT00698022|12039267|FG001|COMPLETED|Overall Study||20
10873293|NCT00698022|12039268|FG002|COMPLETED|Overall Study||14
10873294|NCT00698022|12039266|FG000|NOT COMPLETED|Overall Study||16
10873295|NCT00698022|12039267|FG001|NOT COMPLETED|Overall Study||10
10873296|NCT00698022|12039268|FG002|NOT COMPLETED|Overall Study||2
10873297|NCT00692913|12039278|FG000|STARTED|Overall Study||257
10873298|NCT00692913|12039279|FG001|STARTED|Overall Study||258
10873299|NCT00692913|12039278|FG000|COMPLETED|Overall Study||228
10873300|NCT00692913|12039279|FG001|COMPLETED|Overall Study||228
10873301|NCT00692913|12039278|FG000|NOT COMPLETED|Overall Study||29
10873302|NCT00692913|12039279|FG001|NOT COMPLETED|Overall Study||30
10873303|NCT00617994|12039290|FG000|STARTED|Overall Study||5
10873304|NCT00617994|12039291|FG001|STARTED|Overall Study||5
10873305|NCT00617994|12039292|FG002|STARTED|Overall Study||5
10873306|NCT00617994|12039293|FG003|STARTED|Overall Study||5
10873307|NCT00617994|12039294|FG004|STARTED|Overall Study||5
10873308|NCT00617994|12039290|FG000|COMPLETED|Overall Study||5
10873309|NCT00617994|12039291|FG001|COMPLETED|Overall Study||5
10873310|NCT00617994|12039292|FG002|COMPLETED|Overall Study||5
10873311|NCT00617994|12039293|FG003|COMPLETED|Overall Study||5
10873312|NCT00617994|12039294|FG004|COMPLETED|Overall Study||5
10873313|NCT00617994|12039290|FG000|NOT COMPLETED|Overall Study||0
10873314|NCT00617994|12039291|FG001|NOT COMPLETED|Overall Study||0
10873315|NCT00617994|12039292|FG002|NOT COMPLETED|Overall Study||0
10873316|NCT00617994|12039293|FG003|NOT COMPLETED|Overall Study||0
10873317|NCT00617994|12039294|FG004|NOT COMPLETED|Overall Study||0
10873318|NCT00617708|12039325|FG000|STARTED|Overall Study||10
10873319|NCT00617708|12039326|FG001|STARTED|Overall Study||60
10873320|NCT00617708|12039327|FG002|STARTED|Overall Study||64
10873321|NCT00617708|12039325|FG000|Eligible and Began Protocol Therapy|Overall Study||9
10873322|NCT00617708|12039326|FG001|Eligible and Began Protocol Therapy|Overall Study||57
10873323|NCT00617708|12039327|FG002|Eligible and Began Protocol Therapy|Overall Study||59
10873324|NCT00617708|12039325|FG000|COMPLETED|Overall Study||0
10873325|NCT00617708|12039326|FG001|COMPLETED|Overall Study||0
10873326|NCT00617708|12039327|FG002|COMPLETED|Overall Study||0
10873327|NCT00617708|12039325|FG000|NOT COMPLETED|Overall Study||10
10873328|NCT00617708|12039326|FG001|NOT COMPLETED|Overall Study||60
10873329|NCT00617708|12039327|FG002|NOT COMPLETED|Overall Study||64
10873330|NCT00516737|12039339|FG000|STARTED|Overall Study||103
10873331|NCT00516737|12039340|FG001|STARTED|Overall Study||104
10873332|NCT00516737|12039339|FG000|COMPLETED|Overall Study||92
10873333|NCT00516737|12039340|FG001|COMPLETED|Overall Study||96
10873334|NCT00516737|12039339|FG000|NOT COMPLETED|Overall Study||11
10873335|NCT00516737|12039340|FG001|NOT COMPLETED|Overall Study||8
10873336|NCT00358527|12039348|FG000|STARTED|Overall Study||267
10873337|NCT00358527|12039349|FG001|STARTED|Overall Study||134
10873338|NCT00358527|12039348|FG000|COMPLETED|Overall Study||254
10873339|NCT00358527|12039349|FG001|COMPLETED|Overall Study||131
10873340|NCT00358527|12039348|FG000|NOT COMPLETED|Overall Study||13
10873341|NCT00358527|12039349|FG001|NOT COMPLETED|Overall Study||3
10873342|NCT00326898|12039358|FG000|STARTED|Overall Study||647
10873343|NCT00326898|12039359|FG001|STARTED|Overall Study||649
10873344|NCT00326898|12039360|FG002|STARTED|Overall Study||647
10873345|NCT00326898|12039358|FG000|Patients With Toxicity Data|Overall Study||625
10873346|NCT00326898|12039359|FG001|Patients With Toxicity Data|Overall Study||628
10419642|NCT00811057|11564514|FG000|STARTED|Overall Study||90
10419643|NCT00811057|11564515|FG001|STARTED|Overall Study||114
10873347|NCT00326898|12039360|FG002|Patients With Toxicity Data|Overall Study||626
10873348|NCT00326898|12039358|FG000|Patients With Clear Cell Histology|Overall Study||542
10873349|NCT00326898|12039359|FG001|Patients With Clear Cell Histology|Overall Study||540
10873350|NCT00326898|12039360|FG002|Patients With Clear Cell Histology|Overall Study||540
10873351|NCT00326898|12039358|FG000|Patients With >=1 Follow-up MUGA Scan|Overall Study||513
10873352|NCT00326898|12039359|FG001|Patients With >=1 Follow-up MUGA Scan|Overall Study||510
10873353|NCT00326898|12039360|FG002|Patients With >=1 Follow-up MUGA Scan|Overall Study||580
10873354|NCT00326898|12039358|FG000|COMPLETED|Overall Study||296
10873355|NCT00326898|12039359|FG001|COMPLETED|Overall Study||306
10873356|NCT00326898|12039360|FG002|COMPLETED|Overall Study||444
10873357|NCT00326898|12039358|FG000|NOT COMPLETED|Overall Study||351
10873358|NCT00326898|12039359|FG001|NOT COMPLETED|Overall Study||343
10873359|NCT00326898|12039360|FG002|NOT COMPLETED|Overall Study||203
10873360|NCT00156065|12039371|FG000|STARTED|Overall Study||51
10419644|NCT00811057|11564516|FG002|STARTED|Overall Study||97
10873361|NCT00156065|12039372|FG001|STARTED|Overall Study||93
10873362|NCT00156065|12039373|FG002|STARTED|Overall Study||43
10873363|NCT00156065|12039371|FG000|COMPLETED|Overall Study||20
10873364|NCT00156065|12039372|FG001|COMPLETED|Overall Study||30
10873365|NCT00156065|12039373|FG002|COMPLETED|Overall Study||16
10873366|NCT00156065|12039371|FG000|NOT COMPLETED|Overall Study||31
10873367|NCT00156065|12039372|FG001|NOT COMPLETED|Overall Study||63
10873368|NCT00156065|12039373|FG002|NOT COMPLETED|Overall Study||27
10873369|NCT00150176|12039383|FG000|STARTED|Overall Study|subjects who were screened and received at least one dose of double-blind trial medication|194
10873370|NCT00150176|12039384|FG001|STARTED|Overall Study|subjects who were screened and received at least one dose of double-blind trial medication|192
10873371|NCT00150176|12039383|FG000|COMPLETED|Overall Study||135
10873372|NCT00150176|12039384|FG001|COMPLETED|Overall Study||72
10873373|NCT00150176|12039383|FG000|NOT COMPLETED|Overall Study||59
10873374|NCT00150176|12039384|FG001|NOT COMPLETED|Overall Study||120
10873375|NCT00145509|12039393|FG000|STARTED|Overall Study||41
10873376|NCT00145509|12039394|FG001|STARTED|Overall Study||36
10873377|NCT00145509|12039393|FG000|COMPLETED|Overall Study||19
10873378|NCT00145509|12039394|FG001|COMPLETED|Overall Study||15
10873379|NCT00145509|12039393|FG000|NOT COMPLETED|Overall Study||22
10873380|NCT00145509|12039394|FG001|NOT COMPLETED|Overall Study||21
10873381|NCT00145496|12039402|FG000|STARTED|Overall Study|Subjects who received randomized treatment assignment and at least one dose of study medication.|244
10873382|NCT00145496|12039403|FG001|STARTED|Overall Study|Subjects who received randomized treatment assignment and at least one dose of study medication.|224
10873383|NCT00145496|12039402|FG000|COMPLETED|Overall Study||121
10873384|NCT00145496|12039403|FG001|COMPLETED|Overall Study||143
10873385|NCT00145496|12039402|FG000|NOT COMPLETED|Overall Study||123
10873386|NCT00145496|12039403|FG001|NOT COMPLETED|Overall Study||81
10873387|NCT00145470|12039411|FG000|STARTED|Overall Study||167
10873388|NCT00145470|12039412|FG001|STARTED|Overall Study||159
10873389|NCT00145470|12039411|FG000|Treated|Overall Study||166
10873390|NCT00145470|12039412|FG001|Treated|Overall Study||158
10873391|NCT00145470|12039411|FG000|COMPLETED|Overall Study||55
10873392|NCT00145470|12039412|FG001|COMPLETED|Overall Study||61
10873393|NCT00145470|12039411|FG000|NOT COMPLETED|Overall Study||112
10873394|NCT00145470|12039412|FG001|NOT COMPLETED|Overall Study||98
10873395|NCT00129402|12039420|FG000|STARTED|Start Period1 to End Period1 (Week 1-6)||43
10873396|NCT00129402|12039421|FG001|STARTED|Start Period1 to End Period1 (Week 1-6)||40
10873397|NCT00129402|12039422|FG002|STARTED|Start Period1 to End Period1 (Week 1-6)||43
10873398|NCT00129402|12039423|FG003|STARTED|Start Period1 to End Period1 (Week 1-6)||40
10873399|NCT00129402|12039424|FG004|STARTED|Start Period1 to End Period1 (Week 1-6)||40
10873400|NCT00129402|12039425|FG005|STARTED|Start Period1 to End Period1 (Week 1-6)||42
10873401|NCT00129402|12039426|FG006|STARTED|Start Period1 to End Period1 (Week 1-6)||0
10873402|NCT00129402|12039420|FG000|COMPLETED|Start Period1 to End Period1 (Week 1-6)||43
10873403|NCT00129402|12039421|FG001|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
10873404|NCT00129402|12039422|FG002|COMPLETED|Start Period1 to End Period1 (Week 1-6)||41
10873405|NCT00129402|12039423|FG003|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
10873406|NCT00129402|12039424|FG004|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
10873407|NCT00129402|12039425|FG005|COMPLETED|Start Period1 to End Period1 (Week 1-6)||40
10873408|NCT00129402|12039426|FG006|COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
10873409|NCT00129402|12039420|FG000|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
10873410|NCT00129402|12039421|FG001|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
10873411|NCT00129402|12039422|FG002|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||2
10873412|NCT00129402|12039423|FG003|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
10873413|NCT00129402|12039424|FG004|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
10873414|NCT00129402|12039425|FG005|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||2
10873415|NCT00129402|12039426|FG006|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
10873416|NCT00129402|12039420|FG000|STARTED|Start Period2 to End Period2 (Week 7-33)||0
10873417|NCT00129402|12039421|FG001|STARTED|Start Period2 to End Period2 (Week 7-33)||0
10873418|NCT00129402|12039422|FG002|STARTED|Start Period2 to End Period2 (Week 7-33)|# of subjects were combined from the 3 arms in Period 1 who received ezetimibe with simvastatin|122
10873419|NCT00129402|12039423|FG003|STARTED|Start Period2 to End Period2 (Week 7-33)||0
10873420|NCT00129402|12039424|FG004|STARTED|Start Period2 to End Period2 (Week 7-33)||0
10873421|NCT00129402|12039425|FG005|STARTED|Start Period2 to End Period2 (Week 7-33)|# of subjects were combined from the 3 arms in Period 1 who received simvastatin monotherapy|118
10873422|NCT00129402|12039426|FG006|STARTED|Start Period2 to End Period2 (Week 7-33)||0
10873423|NCT00129402|12039420|FG000|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
10873424|NCT00129402|12039421|FG001|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
10873425|NCT00129402|12039422|FG002|COMPLETED|Start Period2 to End Period2 (Week 7-33)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|114
10873426|NCT00129402|12039423|FG003|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
10873427|NCT00129402|12039424|FG004|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
10873428|NCT00129402|12039425|FG005|COMPLETED|Start Period2 to End Period2 (Week 7-33)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|113
10873429|NCT00129402|12039426|FG006|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
10873430|NCT00129402|12039420|FG000|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
10873431|NCT00129402|12039421|FG001|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
10873432|NCT00129402|12039422|FG002|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||8
10873433|NCT00129402|12039423|FG003|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
10873434|NCT00129402|12039424|FG004|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
10873435|NCT00129402|12039425|FG005|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||5
10873436|NCT00129402|12039426|FG006|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
10873437|NCT00129402|12039420|FG000|STARTED|Start Period3 to End Period3(Week 34-53)||0
10873438|NCT00129402|12039421|FG001|STARTED|Start Period3 to End Period3(Week 34-53)||0
10873439|NCT00129402|12039422|FG002|STARTED|Start Period3 to End Period3(Week 34-53)||0
10873440|NCT00129402|12039423|FG003|STARTED|Start Period3 to End Period3(Week 34-53)||0
10873441|NCT00129402|12039424|FG004|STARTED|Start Period3 to End Period3(Week 34-53)||0
10873442|NCT00129402|12039425|FG005|STARTED|Start Period3 to End Period3(Week 34-53)||0
10873443|NCT00129402|12039426|FG006|STARTED|Start Period3 to End Period3(Week 34-53)|In Period 3, all subjects from Period 1 and Period 2 were combined into one treatment group.|228
10873444|NCT00129402|12039420|FG000|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
10873445|NCT00129402|12039421|FG001|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
10873446|NCT00129402|12039422|FG002|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
10873447|NCT00129402|12039423|FG003|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
10873448|NCT00129402|12039424|FG004|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
10873449|NCT00129402|12039425|FG005|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
10873450|NCT00129402|12039426|FG006|COMPLETED|Start Period3 to End Period3(Week 34-53)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|222
10873451|NCT00129402|12039420|FG000|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
10873452|NCT00129402|12039421|FG001|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
10873453|NCT00129402|12039422|FG002|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
10873454|NCT00129402|12039423|FG003|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
10873455|NCT00129402|12039424|FG004|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
10873456|NCT00129402|12039425|FG005|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
10873457|NCT00129402|12039426|FG006|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||6
10873458|NCT00101439|12039436|FG000|STARTED|Period 1||28
10873459|NCT00101439|12039437|FG001|STARTED|Period 1||30
10873460|NCT00101439|12039436|FG000|COMPLETED|Period 1||28
10873461|NCT00101439|12039437|FG001|COMPLETED|Period 1||30
10873462|NCT00101439|12039436|FG000|NOT COMPLETED|Period 1||0
10873463|NCT00101439|12039437|FG001|NOT COMPLETED|Period 1||0
10873464|NCT00101439|12039436|FG000|STARTED|Period 2||28
10873465|NCT00101439|12039437|FG001|STARTED|Period 2||30
10873466|NCT00101439|12039436|FG000|COMPLETED|Period 2||28
10873467|NCT00101439|12039437|FG001|COMPLETED|Period 2||28
10873468|NCT00101439|12039436|FG000|NOT COMPLETED|Period 2||0
10873469|NCT00101439|12039437|FG001|NOT COMPLETED|Period 2||2
10873470|NCT00096200|12039446|FG000|STARTED|Overall Study||9
10873471|NCT00096200|12039447|FG001|STARTED|Overall Study||30
10873472|NCT00096200|12039448|FG002|STARTED|Overall Study||5
10873473|NCT00096200|12039446|FG000|COMPLETED|Overall Study||8
10873474|NCT00096200|12039447|FG001|COMPLETED|Overall Study||23
10873475|NCT00096200|12039448|FG002|COMPLETED|Overall Study||5
10873476|NCT00096200|12039446|FG000|NOT COMPLETED|Overall Study||1
10873477|NCT00096200|12039447|FG001|NOT COMPLETED|Overall Study||7
10873478|NCT00096200|12039448|FG002|NOT COMPLETED|Overall Study||0
10295919|NCT02460159|11428637|FG000|NOT COMPLETED|Overall Study||6
10295920|NCT02460159|11428638|FG001|NOT COMPLETED|Overall Study||1
10419645|NCT00811057|11564514|FG000|COMPLETED|Overall Study||85
10419646|NCT00811057|11564515|FG001|COMPLETED|Overall Study||104
10419647|NCT00811057|11564516|FG002|COMPLETED|Overall Study||87
10419648|NCT00811057|11564514|FG000|NOT COMPLETED|Overall Study||5
10419649|NCT00811057|11564515|FG001|NOT COMPLETED|Overall Study||10
10419650|NCT00811057|11564516|FG002|NOT COMPLETED|Overall Study||10
10419651|NCT00811070|11564530|FG000|STARTED|Overall Study||7
10419652|NCT00811070|11564531|FG001|STARTED|Overall Study||7
10419653|NCT00811070|11564532|FG002|STARTED|Overall Study||3
10419654|NCT00811070|11564533|FG003|STARTED|Overall Study||28
10419655|NCT00811070|11564534|FG004|STARTED|Overall Study||7
10873479|NCT03257267|12039458|FG000|STARTED|Overall Study||304
10873480|NCT03257267|12039459|FG001|STARTED|Overall Study||304
10873481|NCT03257267|12039458|FG000|Full Analysis Set (FAS)|Overall Study||304
10873482|NCT03257267|12039459|FG001|Full Analysis Set (FAS)|Overall Study||304
10873483|NCT03257267|12039458|FG000|Safety Analysis Set (SAF)|Overall Study||300
10873484|NCT03257267|12039459|FG001|Safety Analysis Set (SAF)|Overall Study||290
10873485|NCT03257267|12039458|FG000|Completed Treatment|Overall Study||13
10873486|NCT03257267|12039459|FG001|Completed Treatment|Overall Study||0
10873487|NCT03257267|12039458|FG000|COMPLETED|Overall Study||7
10873488|NCT03257267|12039459|FG001|COMPLETED|Overall Study||0
10873489|NCT03257267|12039458|FG000|NOT COMPLETED|Overall Study||297
10873490|NCT03257267|12039459|FG001|NOT COMPLETED|Overall Study||304
10873491|NCT04581811|12039467|FG000|STARTED|Overall Study||26
10873492|NCT04581811|12039468|FG001|STARTED|Overall Study||26
10873493|NCT04581811|12039467|FG000|COMPLETED|Overall Study||26
10873494|NCT04581811|12039468|FG001|COMPLETED|Overall Study||26
10873495|NCT04581811|12039467|FG000|NOT COMPLETED|Overall Study||0
10873496|NCT04581811|12039468|FG001|NOT COMPLETED|Overall Study||0
10873500|NCT04263987|12039480|FG000|STARTED|Overall Study||30
10873501|NCT04263987|12039481|FG001|STARTED|Overall Study||30
10873502|NCT04263987|12039480|FG000|COMPLETED|Overall Study||30
10873503|NCT04263987|12039481|FG001|COMPLETED|Overall Study||30
10873504|NCT04263987|12039480|FG000|NOT COMPLETED|Overall Study||0
10873505|NCT04263987|12039481|FG001|NOT COMPLETED|Overall Study||0
10873506|NCT04223830|12039487|FG000|STARTED|Overall Study||200
10873507|NCT04223830|12039487|FG000|COMPLETED|Overall Study||190
10873508|NCT04223830|12039487|FG000|NOT COMPLETED|Overall Study||10
10873515|NCT04153188|12039503|FG000|STARTED|Overall Study||17
10873516|NCT04153188|12039504|FG001|STARTED|Overall Study||13
10873517|NCT04153188|12039503|FG000|COMPLETED|Overall Study||14
10873518|NCT04153188|12039504|FG001|COMPLETED|Overall Study||11
10873519|NCT04153188|12039503|FG000|NOT COMPLETED|Overall Study||3
10873520|NCT04153188|12039504|FG001|NOT COMPLETED|Overall Study||2
10873521|NCT04108429|12039510|FG000|STARTED|Overall Study||117
10873522|NCT04108429|12039510|FG000|COMPLETED|Overall Study||117
10873523|NCT04108429|12039510|FG000|NOT COMPLETED|Overall Study||0
10873542|NCT04233008|12039531|FG000|STARTED|Overall Study||89
10873543|NCT04233008|12039532|FG001|STARTED|Overall Study||89
10873544|NCT04233008|12039531|FG000|COMPLETED|Overall Study||89
10873545|NCT04233008|12039532|FG001|COMPLETED|Overall Study||89
10873546|NCT04233008|12039531|FG000|NOT COMPLETED|Overall Study||0
10873547|NCT04233008|12039532|FG001|NOT COMPLETED|Overall Study||0
10873548|NCT04179786|12039540|FG000|STARTED|Overall Study||91
10873549|NCT04179786|12039540|FG000|COMPLETED|Overall Study||83
10873550|NCT04179786|12039540|FG000|NOT COMPLETED|Overall Study||8
10873551|NCT04140292|12039546|FG000|STARTED|Overall Study||33
10873552|NCT04140292|12039547|FG001|STARTED|Overall Study||42
10873553|NCT04140292|12039546|FG000|COMPLETED|Overall Study||29
10873554|NCT04140292|12039547|FG001|COMPLETED|Overall Study||26
10873555|NCT04140292|12039546|FG000|NOT COMPLETED|Overall Study||4
10873556|NCT04140292|12039547|FG001|NOT COMPLETED|Overall Study||16
10873557|NCT04064229|12039554|FG000|STARTED|Overall Study||99
10873558|NCT04064229|12039554|FG000|COMPLETED|Overall Study||99
10873559|NCT04064229|12039554|FG000|NOT COMPLETED|Overall Study||0
10873560|NCT03993938|12039560|FG000|STARTED|Overall Study||30
10873561|NCT03993938|12039560|FG000|COMPLETED|Overall Study||30
10873562|NCT03993938|12039560|FG000|NOT COMPLETED|Overall Study||0
10873569|NCT03740724|12039573|FG000|STARTED|Overall Study||1
10873570|NCT03740724|12039573|FG000|COMPLETED|Overall Study||0
10873571|NCT03740724|12039573|FG000|NOT COMPLETED|Overall Study||1
10873578|NCT03553836|12039591|FG000|STARTED|Overall Study||487
10873579|NCT03553836|12039592|FG001|STARTED|Overall Study||489
10873580|NCT03553836|12039591|FG000|Treated|Overall Study||483
10873581|NCT03553836|12039592|FG001|Treated|Overall Study||486
10873582|NCT03553836|12039591|FG000|Re-challenged or Switched-over to Pembrolizumab|Overall Study||1
10873583|NCT03553836|12039592|FG001|Re-challenged or Switched-over to Pembrolizumab|Overall Study||45
10873584|NCT03553836|12039591|FG000|COMPLETED|Overall Study||0
10873585|NCT03553836|12039592|FG001|COMPLETED|Overall Study||0
10873586|NCT03553836|12039591|FG000|NOT COMPLETED|Overall Study||487
10873587|NCT03553836|12039592|FG001|NOT COMPLETED|Overall Study||489
10873588|NCT02979522|12039601|FG000|STARTED|Overall Study||8
10873589|NCT02979522|12039602|FG001|STARTED|Overall Study||51
10873590|NCT02979522|12039601|FG000|COMPLETED|Overall Study||8
10873591|NCT02979522|12039602|FG001|COMPLETED|Overall Study||51
10873592|NCT02979522|12039601|FG000|NOT COMPLETED|Overall Study||0
10873593|NCT02979522|12039602|FG001|NOT COMPLETED|Overall Study||0
10873594|NCT02954237|12039614|FG000|STARTED|Overall Study||91
10873595|NCT02954237|12039614|FG000|COMPLETED|Overall Study||48
10873596|NCT02954237|12039614|FG000|NOT COMPLETED|Overall Study||43
10873603|NCT02714218|12039630|FG000|STARTED|Pre-Treatment Period||180
10873604|NCT02714218|12039631|FG001|STARTED|Pre-Treatment Period||180
10873605|NCT02714218|12039632|FG002|STARTED|Pre-Treatment Period||27
10873606|NCT02714218|12039630|FG000|COMPLETED|Pre-Treatment Period||180
10873607|NCT02714218|12039631|FG001|COMPLETED|Pre-Treatment Period||178
10873608|NCT02714218|12039632|FG002|COMPLETED|Pre-Treatment Period||27
10873609|NCT02714218|12039630|FG000|NOT COMPLETED|Pre-Treatment Period||0
10873610|NCT02714218|12039631|FG001|NOT COMPLETED|Pre-Treatment Period||2
10873611|NCT02714218|12039632|FG002|NOT COMPLETED|Pre-Treatment Period||0
10873612|NCT02714218|12039630|FG000|STARTED|Treatment Period||180
10873613|NCT02714218|12039631|FG001|STARTED|Treatment Period||178
10873614|NCT02714218|12039632|FG002|STARTED|Treatment Period||27
10873615|NCT02714218|12039630|FG000|COMPLETED|Treatment Period||6
10873616|NCT02714218|12039631|FG001|COMPLETED|Treatment Period||2
10873617|NCT02714218|12039632|FG002|COMPLETED|Treatment Period||2
10873618|NCT02714218|12039630|FG000|NOT COMPLETED|Treatment Period||174
10873619|NCT02714218|12039631|FG001|NOT COMPLETED|Treatment Period||176
10873620|NCT02714218|12039632|FG002|NOT COMPLETED|Treatment Period||25
10873635|NCT02652949|12039649|FG000|STARTED|30-Day Follow-up for Primary Endpoint|The 30-day primary endpoint was evaluated when 87 subjects completed 30-day follow-up.|87
10873636|NCT02652949|12039649|FG000|COMPLETED|30-Day Follow-up for Primary Endpoint||86
10873637|NCT02652949|12039649|FG000|NOT COMPLETED|30-Day Follow-up for Primary Endpoint||1
10873638|NCT02652949|12039649|FG000|STARTED|30-Day Follow-up for Secondary Endpoint|The 30-day secondary endpoint was evaluated when 100 subjects completed 30-day follow-up.|100
10873639|NCT02652949|12039649|FG000|COMPLETED|30-Day Follow-up for Secondary Endpoint||99
10873640|NCT02652949|12039649|FG000|NOT COMPLETED|30-Day Follow-up for Secondary Endpoint||1
10873641|NCT02652949|12039649|FG000|STARTED|6-Month Follow-up Secondary Endpoint|Note that 6-month follow up is not mandatory for OUS subjects.|99
10873642|NCT02652949|12039649|FG000|COMPLETED|6-Month Follow-up Secondary Endpoint||91
10873643|NCT02652949|12039649|FG000|NOT COMPLETED|6-Month Follow-up Secondary Endpoint||8
10873644|NCT02652949|12039649|FG000|STARTED|12-Month Follow-up Secondary Endpoint||91
10873645|NCT02652949|12039649|FG000|COMPLETED|12-Month Follow-up Secondary Endpoint||87
10873646|NCT02652949|12039649|FG000|NOT COMPLETED|12-Month Follow-up Secondary Endpoint||4
10873647|NCT02652949|12039649|FG000|STARTED|24-Month Follow-up Secondary Endpoint||87
10419656|NCT00811070|11564535|FG005|STARTED|Overall Study||11
10873648|NCT02652949|12039649|FG000|COMPLETED|24-Month Follow-up Secondary Endpoint||53
10873649|NCT02652949|12039649|FG000|NOT COMPLETED|24-Month Follow-up Secondary Endpoint||34
10873650|NCT02652949|12039649|FG000|STARTED|36-Month Follow-up Secondary Endpoint||53
10873651|NCT02652949|12039649|FG000|COMPLETED|36-Month Follow-up Secondary Endpoint||49
10873652|NCT02652949|12039649|FG000|NOT COMPLETED|36-Month Follow-up Secondary Endpoint||4
10873653|NCT02649439|12039661|FG000|STARTED|Overall Study||40
10873654|NCT02649439|12039662|FG001|STARTED|Overall Study||40
10873655|NCT02649439|12039661|FG000|COMPLETED|Overall Study||13
10873656|NCT02649439|12039662|FG001|COMPLETED|Overall Study||12
10873657|NCT02649439|12039661|FG000|NOT COMPLETED|Overall Study||27
10873658|NCT02649439|12039662|FG001|NOT COMPLETED|Overall Study||28
10873674|NCT02579811|12039688|FG000|STARTED|Overall Study||40
10873675|NCT02579811|12039688|FG000|COMPLETED|Overall Study||40
10873676|NCT02579811|12039688|FG000|NOT COMPLETED|Overall Study||0
10873677|NCT02447718|12039694|FG000|STARTED|Overall Study||78
10873678|NCT02447718|12039695|FG001|STARTED|Overall Study||78
10873679|NCT02447718|12039694|FG000|Received Prevnar®13|Overall Study||74
10873680|NCT02447718|12039695|FG001|Received Prevnar®13|Overall Study|Do not receive vaccination|0
10873681|NCT02447718|12039694|FG000|Received Pediacel®|Overall Study||73
10873682|NCT02447718|12039695|FG001|Received Pediacel®|Overall Study|Do not receive vaccination|0
10873683|NCT02447718|12039694|FG000|Received Pneumovax® 23|Overall Study||73
10873684|NCT02447718|12039695|FG001|Received Pneumovax® 23|Overall Study|Do not receive vaccination|0
10873685|NCT02447718|12039694|FG000|COMPLETED|Overall Study||66
10873686|NCT02447718|12039695|FG001|COMPLETED|Overall Study||78
10873687|NCT02447718|12039694|FG000|NOT COMPLETED|Overall Study||12
10873688|NCT02447718|12039695|FG001|NOT COMPLETED|Overall Study||0
10873698|NCT01962948|12039713|FG000|STARTED|Overall Study||3
10873699|NCT01962948|12039714|FG001|STARTED|Overall Study||3
10873700|NCT01962948|12039715|FG002|STARTED|Overall Study||6
10873701|NCT01962948|12039716|FG003|STARTED|Overall Study||0
10873702|NCT01962948|12039713|FG000|COMPLETED|Overall Study||0
10873703|NCT01962948|12039714|FG001|COMPLETED|Overall Study||0
10873704|NCT01962948|12039715|FG002|COMPLETED|Overall Study||0
10873705|NCT01962948|12039716|FG003|COMPLETED|Overall Study||0
10873706|NCT01962948|12039713|FG000|NOT COMPLETED|Overall Study||3
10873707|NCT01962948|12039714|FG001|NOT COMPLETED|Overall Study||3
10873708|NCT01962948|12039715|FG002|NOT COMPLETED|Overall Study||6
10873709|NCT01962948|12039716|FG003|NOT COMPLETED|Overall Study||0
10873710|NCT01938001|12039725|FG000|STARTED|Overall Study||178
10873711|NCT01938001|12039726|FG001|STARTED|Overall Study||180
10873712|NCT01938001|12039725|FG000|Participants Received Treatment|Overall Study||176
10873713|NCT01938001|12039726|FG001|Participants Received Treatment|Overall Study||180
10873714|NCT01938001|12039725|FG000|Completed Treatment|Overall Study||124
10873715|NCT01938001|12039726|FG001|Completed Treatment|Overall Study||110
10873716|NCT01938001|12039725|FG000|COMPLETED|Overall Study||135
10873717|NCT01938001|12039726|FG001|COMPLETED|Overall Study||133
10873718|NCT01938001|12039725|FG000|NOT COMPLETED|Overall Study||43
10873719|NCT01938001|12039726|FG001|NOT COMPLETED|Overall Study||47
10873720|NCT01529008|12039734|FG000|STARTED|Screening||35
10873721|NCT01529008|12039735|FG001|STARTED|Screening||33
10873722|NCT01529008|12039734|FG000|COMPLETED|Screening||35
10873723|NCT01529008|12039735|FG001|COMPLETED|Screening||33
10873724|NCT01529008|12039734|FG000|NOT COMPLETED|Screening||0
10873725|NCT01529008|12039735|FG001|NOT COMPLETED|Screening||0
10873726|NCT01529008|12039734|FG000|STARTED|Bone Marrow Harvesting||35
10873727|NCT01529008|12039735|FG001|STARTED|Bone Marrow Harvesting||33
10873728|NCT01529008|12039734|FG000|COMPLETED|Bone Marrow Harvesting||34
10873729|NCT01529008|12039735|FG001|COMPLETED|Bone Marrow Harvesting||30
10873730|NCT01529008|12039734|FG000|NOT COMPLETED|Bone Marrow Harvesting||1
10873731|NCT01529008|12039735|FG001|NOT COMPLETED|Bone Marrow Harvesting||3
10873732|NCT01529008|12039734|FG000|STARTED|Treatment||34
10873733|NCT01529008|12039735|FG001|STARTED|Treatment||30
10873734|NCT01529008|12039734|FG000|COMPLETED|Treatment||25
10873735|NCT01529008|12039735|FG001|COMPLETED|Treatment||29
10873736|NCT01529008|12039734|FG000|NOT COMPLETED|Treatment||9
10873737|NCT01529008|12039735|FG001|NOT COMPLETED|Treatment||1
10873738|NCT01529008|12039734|FG000|STARTED|Efficacy Analysis||25
10873739|NCT01529008|12039735|FG001|STARTED|Efficacy Analysis||29
10873740|NCT01529008|12039734|FG000|COMPLETED|Efficacy Analysis||23
10873741|NCT01529008|12039735|FG001|COMPLETED|Efficacy Analysis||26
10873742|NCT01529008|12039734|FG000|NOT COMPLETED|Efficacy Analysis||2
10873743|NCT01529008|12039735|FG001|NOT COMPLETED|Efficacy Analysis||3
10873744|NCT01484691|12039744|FG000|STARTED|Overall Study||21
10873745|NCT01484691|12039745|FG001|STARTED|Overall Study||22
10873746|NCT01484691|12039746|FG002|STARTED|Overall Study||12
10873747|NCT01484691|12039744|FG000|COMPLETED|Overall Study||20
10873748|NCT01484691|12039745|FG001|COMPLETED|Overall Study||19
10873749|NCT01484691|12039746|FG002|COMPLETED|Overall Study||10
10873750|NCT01484691|12039744|FG000|NOT COMPLETED|Overall Study||1
10873751|NCT01484691|12039745|FG001|NOT COMPLETED|Overall Study||3
10873752|NCT01484691|12039746|FG002|NOT COMPLETED|Overall Study||2
10873753|NCT01125371|12039758|FG000|STARTED|Overall Study||146
10873754|NCT01125371|12039759|FG001|STARTED|Overall Study||145
10873755|NCT01125371|12039760|FG002|STARTED|Overall Study||148
10873756|NCT01125371|12039758|FG000|3 Months Follow up|Overall Study||127
10873757|NCT01125371|12039759|FG001|3 Months Follow up|Overall Study||131
10873758|NCT01125371|12039760|FG002|3 Months Follow up|Overall Study||135
10873759|NCT01125371|12039758|FG000|6 Months Follow up|Overall Study||125
10873760|NCT01125371|12039759|FG001|6 Months Follow up|Overall Study||133
10873761|NCT01125371|12039760|FG002|6 Months Follow up|Overall Study||131
10873762|NCT01125371|12039758|FG000|12 Months Follow up|Overall Study||120
10873763|NCT01125371|12039759|FG001|12 Months Follow up|Overall Study||130
10873764|NCT01125371|12039760|FG002|12 Months Follow up|Overall Study||129
10873765|NCT01125371|12039758|FG000|COMPLETED|Overall Study||120
10873766|NCT01125371|12039759|FG001|COMPLETED|Overall Study||130
10873767|NCT01125371|12039760|FG002|COMPLETED|Overall Study||129
10873768|NCT01125371|12039758|FG000|NOT COMPLETED|Overall Study||26
10873769|NCT01125371|12039759|FG001|NOT COMPLETED|Overall Study||15
10873770|NCT01125371|12039760|FG002|NOT COMPLETED|Overall Study||19
10419657|NCT00811070|11564530|FG000|COMPLETED|Overall Study||6
10419658|NCT00811070|11564531|FG001|COMPLETED|Overall Study||6
10419659|NCT00811070|11564532|FG002|COMPLETED|Overall Study||3
10419660|NCT00811070|11564533|FG003|COMPLETED|Overall Study||26
10419661|NCT00811070|11564534|FG004|COMPLETED|Overall Study||2
10419662|NCT00811070|11564535|FG005|COMPLETED|Overall Study||10
10419663|NCT00811070|11564530|FG000|NOT COMPLETED|Overall Study||1
10419664|NCT00811070|11564531|FG001|NOT COMPLETED|Overall Study||1
10419665|NCT00811070|11564532|FG002|NOT COMPLETED|Overall Study||0
10419666|NCT00811070|11564533|FG003|NOT COMPLETED|Overall Study||2
10419667|NCT00811070|11564534|FG004|NOT COMPLETED|Overall Study||5
10419668|NCT00811070|11564535|FG005|NOT COMPLETED|Overall Study||1
10419669|NCT00811135|11564551|FG000|STARTED|Overall Study||88
10419670|NCT00811135|11564551|FG000|COMPLETED|Overall Study||0
10419671|NCT00811135|11564551|FG000|NOT COMPLETED|Overall Study||88
10419672|NCT00811174|11564555|FG000|STARTED|Overall Study||5
10419673|NCT00811174|11564555|FG000|COMPLETED|Overall Study||2
10419674|NCT00811174|11564555|FG000|NOT COMPLETED|Overall Study||3
10419675|NCT00811187|11564561|FG000|STARTED|Overall Study||40
10419676|NCT00811187|11564562|FG001|STARTED|Overall Study||40
10419677|NCT00811187|11564561|FG000|COMPLETED|Overall Study||37
10419678|NCT00811187|11564562|FG001|COMPLETED|Overall Study||37
10419679|NCT00811187|11564561|FG000|NOT COMPLETED|Overall Study||3
10419680|NCT00811187|11564562|FG001|NOT COMPLETED|Overall Study||3
10419681|NCT00811252|11564571|FG000|STARTED|Overall Study||145
10419682|NCT00811252|11564572|FG001|STARTED|Overall Study||156
10419683|NCT00811252|11564573|FG002|STARTED|Overall Study||151
10419684|NCT00811252|11564571|FG000|COMPLETED|Overall Study||128
10419685|NCT00811252|11564572|FG001|COMPLETED|Overall Study||136
10419686|NCT00811252|11564573|FG002|COMPLETED|Overall Study||128
10419687|NCT00811252|11564571|FG000|NOT COMPLETED|Overall Study||17
10419688|NCT00811252|11564572|FG001|NOT COMPLETED|Overall Study||20
10419689|NCT00811252|11564573|FG002|NOT COMPLETED|Overall Study||23
10419690|NCT00811317|11564581|FG000|STARTED|Overall Study||11
10419691|NCT00811317|11564581|FG000|COMPLETED|Overall Study||11
10873771|NCT00400946|12039773|FG000|STARTED|Overall Study||231
10873772|NCT00400946|12039774|FG001|STARTED|Overall Study||232
10873773|NCT00400946|12039775|FG002|STARTED|Overall Study||42
10873774|NCT00400946|12039776|FG003|STARTED|Overall Study||51
10873775|NCT00400946|12039777|FG004|STARTED|Overall Study||244
10873776|NCT00400946|12039773|FG000|Evaluable for CNS Directed-Treatment|Overall Study||231
10873777|NCT00400946|12039774|FG001|Evaluable for CNS Directed-Treatment|Overall Study||232
10873778|NCT00400946|12039775|FG002|Evaluable for CNS Directed-Treatment|Overall Study||42
10873779|NCT00400946|12039776|FG003|Evaluable for CNS Directed-Treatment|Overall Study||21
10873780|NCT00400946|12039777|FG004|Evaluable for CNS Directed-Treatment|Overall Study||227
10873781|NCT00400946|12039773|FG000|Evaluable for Day 18 Marrow Morphology|Overall Study||158
10873782|NCT00400946|12039774|FG001|Evaluable for Day 18 Marrow Morphology|Overall Study||161
10873783|NCT00400946|12039775|FG002|Evaluable for Day 18 Marrow Morphology|Overall Study||19
10873784|NCT00400946|12039776|FG003|Evaluable for Day 18 Marrow Morphology|Overall Study||13
10873785|NCT00400946|12039777|FG004|Evaluable for Day 18 Marrow Morphology|Overall Study||152
10873786|NCT00400946|12039773|FG000|Evaluable for Day 32 MRD|Overall Study||166
10873787|NCT00400946|12039774|FG001|Evaluable for Day 32 MRD|Overall Study||167
10873788|NCT00400946|12039775|FG002|Evaluable for Day 32 MRD|Overall Study||33
10873789|NCT00400946|12039776|FG003|Evaluable for Day 32 MRD|Overall Study||12
10873790|NCT00400946|12039777|FG004|Evaluable for Day 32 MRD|Overall Study||168
10873791|NCT00400946|12039773|FG000|Eligible and Treated|Overall Study||231
10873792|NCT00400946|12039774|FG001|Eligible and Treated|Overall Study||232
10873793|NCT00400946|12039775|FG002|Eligible and Treated|Overall Study||42
10873794|NCT00400946|12039776|FG003|Eligible and Treated|Overall Study||46
10873795|NCT00400946|12039777|FG004|Eligible and Treated|Overall Study||243
10873796|NCT00400946|12039773|FG000|COMPLETED|Overall Study||217
10873797|NCT00400946|12039774|FG001|COMPLETED|Overall Study||221
10873798|NCT00400946|12039775|FG002|COMPLETED|Overall Study||40
10873799|NCT00400946|12039776|FG003|COMPLETED|Overall Study||4
10873800|NCT00400946|12039777|FG004|COMPLETED|Overall Study||206
10873801|NCT00400946|12039773|FG000|NOT COMPLETED|Overall Study||14
10873802|NCT00400946|12039774|FG001|NOT COMPLETED|Overall Study||11
10873803|NCT00400946|12039775|FG002|NOT COMPLETED|Overall Study||2
10873804|NCT00400946|12039776|FG003|NOT COMPLETED|Overall Study||47
10873805|NCT00400946|12039777|FG004|NOT COMPLETED|Overall Study||38
10873806|NCT00180414|12039797|FG000|STARTED|Overall Study||4
10873807|NCT00180414|12039798|FG001|STARTED|Overall Study||4
10873808|NCT00180414|12039797|FG000|COMPLETED|Overall Study||0
10873809|NCT00180414|12039798|FG001|COMPLETED|Overall Study||0
10873810|NCT00180414|12039797|FG000|NOT COMPLETED|Overall Study||4
10873811|NCT00180414|12039798|FG001|NOT COMPLETED|Overall Study||4
10873812|NCT04061915|12039806|FG000|STARTED|Overall Study||161
10873813|NCT04061915|12039807|FG001|STARTED|Overall Study||161
10873814|NCT04061915|12039806|FG000|COMPLETED|Overall Study||161
10873815|NCT04061915|12039807|FG001|COMPLETED|Overall Study||161
10873816|NCT04061915|12039806|FG000|NOT COMPLETED|Overall Study||0
10873817|NCT04061915|12039807|FG001|NOT COMPLETED|Overall Study||0
10873818|NCT03990766|12039816|FG000|STARTED|Overall Study||14
10873819|NCT03990766|12039817|FG001|STARTED|Overall Study||13
10873820|NCT03990766|12039816|FG000|COMPLETED|Overall Study||12
10873821|NCT03990766|12039817|FG001|COMPLETED|Overall Study||10
10873822|NCT03990766|12039816|FG000|NOT COMPLETED|Overall Study||2
10873823|NCT03990766|12039817|FG001|NOT COMPLETED|Overall Study||3
10873824|NCT03947333|12039825|FG000|STARTED|Overall Study||135
10873825|NCT03947333|12039826|FG001|STARTED|Overall Study||135
10873826|NCT03947333|12039825|FG000|COMPLETED|Overall Study||135
10873827|NCT03947333|12039826|FG001|COMPLETED|Overall Study||135
10873828|NCT03947333|12039825|FG000|NOT COMPLETED|Overall Study||0
10873829|NCT03947333|12039826|FG001|NOT COMPLETED|Overall Study||0
10873830|NCT03886220|12039835|FG000|STARTED|Treatment Period||28
10873831|NCT03886220|12039836|FG001|STARTED|Treatment Period||54
10873832|NCT03886220|12039835|FG000|COMPLETED|Treatment Period||23
10873833|NCT03886220|12039836|FG001|COMPLETED|Treatment Period||42
10873834|NCT03886220|12039835|FG000|NOT COMPLETED|Treatment Period||5
10873835|NCT03886220|12039836|FG001|NOT COMPLETED|Treatment Period||12
10873836|NCT03886220|12039835|FG000|STARTED|Post-Treatment Follow-Up Period||25
10873837|NCT03886220|12039836|FG001|STARTED|Post-Treatment Follow-Up Period||41
10873838|NCT03886220|12039835|FG000|COMPLETED|Post-Treatment Follow-Up Period||23
10873839|NCT03886220|12039836|FG001|COMPLETED|Post-Treatment Follow-Up Period||39
10873840|NCT03886220|12039835|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||2
10873841|NCT03886220|12039836|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||2
10314959|NCT00171249|11448708|FG001|Completed Part 1|Overall Study||0
10873842|NCT03800979|12039842|FG000|STARTED|Overall Study||19
10873843|NCT03800979|12039842|FG000|COMPLETED|Overall Study||19
10873844|NCT03800979|12039842|FG000|NOT COMPLETED|Overall Study||0
10873845|NCT03794661|12039846|FG000|STARTED|Overall Study||8
10873846|NCT03794661|12039846|FG000|COMPLETED|Overall Study||8
10873847|NCT03794661|12039846|FG000|NOT COMPLETED|Overall Study||0
10873848|NCT03691909|12039850|FG000|STARTED|Overall Study||15
10873849|NCT03691909|12039850|FG000|Per Protocol Population Day 1|Overall Study||15
10873850|NCT03691909|12039850|FG000|Per Protocol Population Week 1|Overall Study||15
10873851|NCT03691909|12039850|FG000|Per Protocol Population Week 4|Overall Study||14
10873852|NCT03691909|12039850|FG000|Per Protocol Population Week 8|Overall Study||13
10873853|NCT03691909|12039850|FG000|Per Protocol Population Week 12|Overall Study||15
10873854|NCT03691909|12039850|FG000|Per Protocol Population Week 26|Overall Study||14
10873855|NCT03691909|12039850|FG000|Per Protocol Population Week 52|Overall Study||13
10873856|NCT03691909|12039850|FG000|COMPLETED|Overall Study||15
10873857|NCT03691909|12039850|FG000|NOT COMPLETED|Overall Study||0
10296027|NCT02320396|11428707|FG000|STARTED|Overall Study||224
10296028|NCT02320396|11428708|FG001|STARTED|Overall Study||225
10296029|NCT02320396|11428707|FG000|Treated (Full Analysis Set)|Overall Study||223
10296030|NCT02320396|11428708|FG001|Treated (Full Analysis Set)|Overall Study||225
10296031|NCT02320396|11428707|FG000|COMPLETED|Overall Study||220
10296032|NCT02320396|11428708|FG001|COMPLETED|Overall Study||221
10296033|NCT02320396|11428707|FG000|NOT COMPLETED|Overall Study||4
10296034|NCT02320396|11428708|FG001|NOT COMPLETED|Overall Study||4
10873858|NCT03627091|12039858|FG000|STARTED|Overall Study||19
10873859|NCT03627091|12039859|FG001|STARTED|Overall Study||10
10873860|NCT03627091|12039860|FG002|STARTED|Overall Study||11
10873861|NCT03627091|12039858|FG000|COMPLETED|Overall Study||7
10873862|NCT03627091|12039859|FG001|COMPLETED|Overall Study||4
10296041|NCT02230410|11428726|FG000|STARTED|Overall Study||18
10873863|NCT03627091|12039860|FG002|COMPLETED|Overall Study||6
10873864|NCT03627091|12039858|FG000|NOT COMPLETED|Overall Study||12
10873865|NCT03627091|12039859|FG001|NOT COMPLETED|Overall Study||6
10873866|NCT03627091|12039860|FG002|NOT COMPLETED|Overall Study||5
10873867|NCT03568318|12039875|FG000|STARTED|Overall Study||264
10873868|NCT03568318|12039876|FG001|STARTED|Overall Study||261
10873869|NCT03568318|12039877|FG002|STARTED|Overall Study||260
10873870|NCT03568318|12039878|FG003|STARTED|Overall Study||63
10873871|NCT03568318|12039879|FG004|STARTED|Overall Study||60
10873872|NCT03568318|12039880|FG005|STARTED|Overall Study||60
10873873|NCT03568318|12039875|FG000|Received Study Drug|Overall Study||264
10873874|NCT03568318|12039876|FG001|Received Study Drug|Overall Study||261
10873875|NCT03568318|12039877|FG002|Received Study Drug|Overall Study||260
10873876|NCT03568318|12039878|FG003|Received Study Drug|Overall Study||62
10873877|NCT03568318|12039879|FG004|Received Study Drug|Overall Study||60
10873878|NCT03568318|12039880|FG005|Received Study Drug|Overall Study||60
10873879|NCT03568318|12039875|FG000|COMPLETED|Overall Study||244
10873880|NCT03568318|12039876|FG001|COMPLETED|Overall Study||249
10873881|NCT03568318|12039877|FG002|COMPLETED|Overall Study||250
10873882|NCT03568318|12039878|FG003|COMPLETED|Overall Study||59
10873883|NCT03568318|12039879|FG004|COMPLETED|Overall Study||58
10873884|NCT03568318|12039880|FG005|COMPLETED|Overall Study||60
10873885|NCT03568318|12039875|FG000|NOT COMPLETED|Overall Study||20
10873886|NCT03568318|12039876|FG001|NOT COMPLETED|Overall Study||12
10873887|NCT03568318|12039877|FG002|NOT COMPLETED|Overall Study||10
10873888|NCT03568318|12039878|FG003|NOT COMPLETED|Overall Study||4
10873889|NCT03568318|12039879|FG004|NOT COMPLETED|Overall Study||2
10873890|NCT03568318|12039880|FG005|NOT COMPLETED|Overall Study||0
10296042|NCT02230410|11428726|FG000|COMPLETED|Overall Study||15
10296043|NCT02230410|11428726|FG000|NOT COMPLETED|Overall Study||3
10873891|NCT03498560|12039894|FG000|STARTED|Overall Study||38
10873892|NCT03498560|12039894|FG000|Completed Baseline Assessment|Overall Study||32
10873893|NCT03498560|12039894|FG000|Completed PSG|Overall Study||25
10873894|NCT03498560|12039894|FG000|COMPLETED|Overall Study||17
10873895|NCT03498560|12039894|FG000|NOT COMPLETED|Overall Study||21
10873896|NCT03441360|12039902|FG000|STARTED|Overall Study||8
10873897|NCT03441360|12039903|FG001|STARTED|Overall Study||8
10873898|NCT03441360|12039904|FG002|STARTED|Overall Study||5
10873899|NCT03441360|12039902|FG000|COMPLETED|Overall Study||0
10873900|NCT03441360|12039903|FG001|COMPLETED|Overall Study||0
10873901|NCT03441360|12039904|FG002|COMPLETED|Overall Study||0
10873902|NCT03441360|12039902|FG000|NOT COMPLETED|Overall Study||8
10873903|NCT03441360|12039903|FG001|NOT COMPLETED|Overall Study||8
10873904|NCT03441360|12039904|FG002|NOT COMPLETED|Overall Study||5
10873905|NCT03368170|12039914|FG000|STARTED|Overall Study||39
10873906|NCT03368170|12039915|FG001|STARTED|Overall Study||36
10873907|NCT03368170|12039914|FG000|COMPLETED|Overall Study||37
10873908|NCT03368170|12039915|FG001|COMPLETED|Overall Study||35
10873909|NCT03368170|12039914|FG000|NOT COMPLETED|Overall Study||2
10873910|NCT03368170|12039915|FG001|NOT COMPLETED|Overall Study||1
10873911|NCT03336528|12039923|FG000|STARTED|Overall Study||92
10873912|NCT03336528|12039924|FG001|STARTED|Overall Study||88
10874001|NCT02921776|12040025|FG005|NOT COMPLETED|Overall Study||2
10873913|NCT03336528|12039923|FG000|Participated in Optional Outpatient Study|Overall Study||72
10873914|NCT03336528|12039924|FG001|Participated in Optional Outpatient Study|Overall Study||59
10873915|NCT03336528|12039923|FG000|COMPLETED|Overall Study||82
10873916|NCT03336528|12039924|FG001|COMPLETED|Overall Study||79
10873917|NCT03336528|12039923|FG000|NOT COMPLETED|Overall Study||10
10873918|NCT03336528|12039924|FG001|NOT COMPLETED|Overall Study||9
10873919|NCT03334409|12039934|FG000|STARTED|Overall Study||2
10873920|NCT03334409|12039935|FG001|STARTED|Overall Study||3
10873921|NCT03334409|12039934|FG000|COMPLETED|Overall Study||1
10873922|NCT03334409|12039935|FG001|COMPLETED|Overall Study||3
10873923|NCT03334409|12039934|FG000|NOT COMPLETED|Overall Study||1
10873924|NCT03334409|12039935|FG001|NOT COMPLETED|Overall Study||0
10873925|NCT03287843|12039943|FG000|STARTED|Overall Study||175
10873926|NCT03287843|12039944|FG001|STARTED|Overall Study||175
10873927|NCT03287843|12039943|FG000|Excluded|Overall Study|No surgery n=5 R2 resection n=5 Stage IV n=2|12
10873928|NCT03287843|12039944|FG001|Excluded|Overall Study|No surgery n=4 R2 resection n=2 Stage IV n=2|8
10873929|NCT03287843|12039943|FG000|Lost to Follow up|Overall Study||3
10873930|NCT03287843|12039944|FG001|Lost to Follow up|Overall Study||0
10873931|NCT03287843|12039943|FG000|COMPLETED|Overall Study||160
10873932|NCT03287843|12039944|FG001|COMPLETED|Overall Study||167
10873933|NCT03287843|12039943|FG000|NOT COMPLETED|Overall Study||15
10873934|NCT03287843|12039944|FG001|NOT COMPLETED|Overall Study||8
10873935|NCT03084536|12039953|FG000|STARTED|Overall Study||53
10873936|NCT03084536|12039954|FG001|STARTED|Overall Study||54
10873937|NCT03084536|12039955|FG002|STARTED|Overall Study||27
10873938|NCT03084536|12039953|FG000|COMPLETED|Overall Study||53
10873939|NCT03084536|12039954|FG001|COMPLETED|Overall Study||54
10873940|NCT03084536|12039955|FG002|COMPLETED|Overall Study||0
10873941|NCT03084536|12039953|FG000|NOT COMPLETED|Overall Study||0
10873942|NCT03084536|12039954|FG001|NOT COMPLETED|Overall Study||0
10873943|NCT03084536|12039955|FG002|NOT COMPLETED|Overall Study||27
10873944|NCT02996305|12039965|FG000|STARTED|Overall Study||29
10873945|NCT02996305|12039966|FG001|STARTED|Overall Study||29
10873946|NCT02996305|12039967|FG002|STARTED|Overall Study||30
10873947|NCT02996305|12039965|FG000|COMPLETED|Overall Study||26
10873948|NCT02996305|12039966|FG001|COMPLETED|Overall Study||27
10873949|NCT02996305|12039967|FG002|COMPLETED|Overall Study||25
10873950|NCT02996305|12039965|FG000|NOT COMPLETED|Overall Study||3
10873951|NCT02996305|12039966|FG001|NOT COMPLETED|Overall Study||2
10873952|NCT02996305|12039967|FG002|NOT COMPLETED|Overall Study||5
10873953|NCT02992119|12039982|FG000|STARTED|Overall Study||21
10873954|NCT02992119|12039983|FG001|STARTED|Overall Study||21
10873955|NCT02992119|12039984|FG002|STARTED|Overall Study||30
10873956|NCT02992119|12039985|FG003|STARTED|Overall Study||30
10873957|NCT02992119|12039986|FG004|STARTED|Overall Study||30
10873958|NCT02992119|12039987|FG005|STARTED|Overall Study||30
10873959|NCT02992119|12039988|FG006|STARTED|Overall Study||31
10873960|NCT02992119|12039982|FG000|COMPLETED|Overall Study||19
10873961|NCT02992119|12039983|FG001|COMPLETED|Overall Study||20
10873962|NCT02992119|12039984|FG002|COMPLETED|Overall Study||29
10873963|NCT02992119|12039985|FG003|COMPLETED|Overall Study||30
10873964|NCT02992119|12039986|FG004|COMPLETED|Overall Study||30
10873965|NCT02992119|12039987|FG005|COMPLETED|Overall Study||30
10873966|NCT02992119|12039988|FG006|COMPLETED|Overall Study||28
10873967|NCT02992119|12039982|FG000|NOT COMPLETED|Overall Study||2
10873968|NCT02992119|12039983|FG001|NOT COMPLETED|Overall Study||1
10873969|NCT02992119|12039984|FG002|NOT COMPLETED|Overall Study||1
10873970|NCT02992119|12039985|FG003|NOT COMPLETED|Overall Study||0
10873971|NCT02992119|12039986|FG004|NOT COMPLETED|Overall Study||0
10873972|NCT02992119|12039987|FG005|NOT COMPLETED|Overall Study||0
10873973|NCT02992119|12039988|FG006|NOT COMPLETED|Overall Study||3
10873974|NCT02988661|12040007|FG000|STARTED|Overall Study||168
10873975|NCT02988661|12040008|FG001|STARTED|Overall Study||531
10873976|NCT02988661|12040007|FG000|COMPLETED|Overall Study||165
10873977|NCT02988661|12040008|FG001|COMPLETED|Overall Study||447
10873978|NCT02988661|12040007|FG000|NOT COMPLETED|Overall Study||3
10873979|NCT02988661|12040008|FG001|NOT COMPLETED|Overall Study||84
10873980|NCT02921776|12040020|FG000|STARTED|Overall Study||13
10873981|NCT02921776|12040021|FG001|STARTED|Overall Study||23
10873982|NCT02921776|12040022|FG002|STARTED|Overall Study||7
10873983|NCT02921776|12040023|FG003|STARTED|Overall Study||31
10873984|NCT02921776|12040024|FG004|STARTED|Overall Study||32
10873985|NCT02921776|12040025|FG005|STARTED|Overall Study||7
10873986|NCT02921776|12040026|FG006|STARTED|Overall Study||18
10873987|NCT02921776|12040027|FG007|STARTED|Overall Study||16
10873988|NCT02921776|12040020|FG000|COMPLETED|Overall Study||11
10873989|NCT02921776|12040021|FG001|COMPLETED|Overall Study||15
10873990|NCT02921776|12040022|FG002|COMPLETED|Overall Study||7
10873991|NCT02921776|12040023|FG003|COMPLETED|Overall Study|Completed Primary outcome (daily measures) = 27 Completed Secondary outcomes (@ICU discharge) = 23|23
10873992|NCT02921776|12040024|FG004|COMPLETED|Overall Study|Completed Primary outcome (daily measures) = 27 Completed Secondary outcomes (@ICU discharge) = 26|26
10873993|NCT02921776|12040025|FG005|COMPLETED|Overall Study||5
10873994|NCT02921776|12040026|FG006|COMPLETED|Overall Study|"At discharge/ extubation =11~1-mos post-discharge = 8 3-mos post-discharge = 8"|7
10873995|NCT02921776|12040027|FG007|COMPLETED|Overall Study|"At discharge/ extubation =15~1-mos post-discharge = 12 3-mos post-discharge = 11"|9
10873996|NCT02921776|12040020|FG000|NOT COMPLETED|Overall Study||2
10873997|NCT02921776|12040021|FG001|NOT COMPLETED|Overall Study||8
10873998|NCT02921776|12040022|FG002|NOT COMPLETED|Overall Study||0
10873999|NCT02921776|12040023|FG003|NOT COMPLETED|Overall Study||8
10874000|NCT02921776|12040024|FG004|NOT COMPLETED|Overall Study||6
10874002|NCT02921776|12040026|FG006|NOT COMPLETED|Overall Study||11
10874003|NCT02921776|12040027|FG007|NOT COMPLETED|Overall Study||7
10874004|NCT02870348|12040051|FG000|STARTED|Overall Study||4
10874005|NCT02870348|12040051|FG000|COMPLETED|Overall Study||0
10874006|NCT02870348|12040051|FG000|NOT COMPLETED|Overall Study||4
10874007|NCT02841280|12040057|FG000|STARTED|Overall Study||81
10874008|NCT02841280|12040058|FG001|STARTED|Overall Study||79
10874009|NCT02841280|12040057|FG000|COMPLETED|Overall Study||67
10874010|NCT02841280|12040058|FG001|COMPLETED|Overall Study||73
10874011|NCT02841280|12040057|FG000|NOT COMPLETED|Overall Study||14
10874012|NCT02841280|12040058|FG001|NOT COMPLETED|Overall Study||6
10874013|NCT02786498|12040068|FG000|STARTED|Overall Study||27
10874014|NCT02786498|12040069|FG001|STARTED|Overall Study||24
10874015|NCT02786498|12040070|FG002|STARTED|Overall Study||24
10874016|NCT02786498|12040071|FG003|STARTED|Overall Study||27
10874017|NCT02786498|12040068|FG000|COMPLETED|Overall Study||25
10874018|NCT02786498|12040069|FG001|COMPLETED|Overall Study||24
10874019|NCT02786498|12040070|FG002|COMPLETED|Overall Study||24
10874020|NCT02786498|12040071|FG003|COMPLETED|Overall Study||26
10874021|NCT02786498|12040068|FG000|NOT COMPLETED|Overall Study||2
10874022|NCT02786498|12040069|FG001|NOT COMPLETED|Overall Study||0
10874023|NCT02786498|12040070|FG002|NOT COMPLETED|Overall Study||0
10874024|NCT02786498|12040071|FG003|NOT COMPLETED|Overall Study||1
10874025|NCT02771275|12040081|FG000|STARTED|Overall Study||13
10874026|NCT02771275|12040081|FG000|COMPLETED|Overall Study||0
10874027|NCT02771275|12040081|FG000|NOT COMPLETED|Overall Study||13
10874028|NCT02675426|12040088|FG000|STARTED|Overall Study||221
10874029|NCT02675426|12040089|FG001|STARTED|Overall Study||221
10874030|NCT02675426|12040090|FG002|STARTED|Overall Study||219
10874031|NCT02675426|12040088|FG000|Treated|Overall Study||221
10874032|NCT02675426|12040089|FG001|Treated|Overall Study||221
10874033|NCT02675426|12040090|FG002|Treated|Overall Study||219
10874034|NCT02675426|12040088|FG000|COMPLETED|Overall Study||208
10874035|NCT02675426|12040089|FG001|COMPLETED|Overall Study||213
10874036|NCT02675426|12040090|FG002|COMPLETED|Overall Study||201
10874037|NCT02675426|12040088|FG000|NOT COMPLETED|Overall Study||13
10874038|NCT02675426|12040089|FG001|NOT COMPLETED|Overall Study||8
10874039|NCT02675426|12040090|FG002|NOT COMPLETED|Overall Study||18
10419692|NCT00811317|11564581|FG000|NOT COMPLETED|Overall Study||0
10419693|NCT00811382|11564587|FG000|STARTED|Overall Study||88
10419694|NCT00811382|11564588|FG001|STARTED|Overall Study||75
10419695|NCT00811382|11564587|FG000|COMPLETED|Overall Study||88
10419696|NCT00811382|11564588|FG001|COMPLETED|Overall Study||75
10546012|NCT01502072|11699540|FG002|NOT COMPLETED|Overall Study||0
10546013|NCT01502228|11699548|FG000|STARTED|Overall Study||14
10546014|NCT01502228|11699548|FG000|COMPLETED|Overall Study||13
10546015|NCT01502228|11699548|FG000|NOT COMPLETED|Overall Study||1
10546016|NCT01502293|11699555|FG000|STARTED|Overall Study||30
10546017|NCT01502293|11699556|FG001|STARTED|Overall Study||17
10546018|NCT01502293|11699557|FG002|STARTED|Overall Study||4
10546019|NCT01502293|11699555|FG000|COMPLETED|Overall Study||5
10546020|NCT01502293|11699556|FG001|COMPLETED|Overall Study||0
10546021|NCT01502293|11699557|FG002|COMPLETED|Overall Study||0
10546022|NCT01502293|11699555|FG000|NOT COMPLETED|Overall Study||25
10419697|NCT00811382|11564587|FG000|NOT COMPLETED|Overall Study||0
10419698|NCT00811382|11564588|FG001|NOT COMPLETED|Overall Study||0
10419699|NCT00811395|11564602|FG000|STARTED|Initial Treatment (PDY6045 or PDY6046)||41
10419700|NCT00811395|11564603|FG001|STARTED|Initial Treatment (PDY6045 or PDY6046)|One participant received 7 mg instead of 14 mg as per randomization|37
10419701|NCT00811395|11564604|FG002|STARTED|Initial Treatment (PDY6045 or PDY6046)||38
10419702|NCT00811395|11564605|FG003|STARTED|Initial Treatment (PDY6045 or PDY6046)||40
10419703|NCT00811395|11564606|FG004|STARTED|Initial Treatment (PDY6045 or PDY6046)||42
10419704|NCT00811395|11564607|FG005|STARTED|Initial Treatment (PDY6045 or PDY6046)||41
10429484|NCT00863928|11575511|FG001|STARTED|Overall Study||41
10874154|NCT02498444|12040162|FG000|STARTED|Overall Study||16
10874155|NCT02498444|12040163|FG001|STARTED|Overall Study||18
10874156|NCT02498444|12040162|FG000|COMPLETED|Overall Study||12
10874157|NCT02498444|12040163|FG001|COMPLETED|Overall Study||18
10874158|NCT02498444|12040162|FG000|NOT COMPLETED|Overall Study||4
10874159|NCT02498444|12040163|FG001|NOT COMPLETED|Overall Study||0
10874160|NCT02487108|12040173|FG000|STARTED|Overall Study||142
10874161|NCT02487108|12040174|FG001|STARTED|Overall Study||142
10874162|NCT02487108|12040175|FG002|STARTED|Overall Study||143
10874163|NCT02487108|12040176|FG003|STARTED|Overall Study||142
10874164|NCT02487108|12040173|FG000|Received at Least 1 Dose of Study Drug|Overall Study||142
10874165|NCT02487108|12040174|FG001|Received at Least 1 Dose of Study Drug|Overall Study||142
10874166|NCT02487108|12040175|FG002|Received at Least 1 Dose of Study Drug|Overall Study||141
10874167|NCT02487108|12040176|FG003|Received at Least 1 Dose of Study Drug|Overall Study||142
10874168|NCT02487108|12040173|FG000|COMPLETED|Overall Study||126
10874169|NCT02487108|12040174|FG001|COMPLETED|Overall Study||126
10874170|NCT02487108|12040175|FG002|COMPLETED|Overall Study||117
10874171|NCT02487108|12040176|FG003|COMPLETED|Overall Study||131
10874172|NCT02487108|12040173|FG000|NOT COMPLETED|Overall Study||16
10874173|NCT02487108|12040174|FG001|NOT COMPLETED|Overall Study||16
10874174|NCT02487108|12040175|FG002|NOT COMPLETED|Overall Study||26
10874175|NCT02487108|12040176|FG003|NOT COMPLETED|Overall Study||11
10874176|NCT02455557|12040186|FG000|STARTED|Overall Study||66
10874177|NCT02455557|12040186|FG000|COMPLETED|Overall Study||64
10874178|NCT02455557|12040186|FG000|NOT COMPLETED|Overall Study||2
10874185|NCT02387996|12040199|FG000|STARTED|Overall Study||270
10874186|NCT02387996|12040199|FG000|COMPLETED|Overall Study|Completed equals continuing in the Treatment Period|66
10874187|NCT02387996|12040199|FG000|NOT COMPLETED|Overall Study||204
10874188|NCT02363010|12040206|FG000|STARTED|Overall Study||110
10874189|NCT02363010|12040207|FG001|STARTED|Overall Study||105
10874190|NCT02363010|12040208|FG002|STARTED|Overall Study||105
10874191|NCT02363010|12040206|FG000|COMPLETED|Overall Study||88
10874192|NCT02363010|12040207|FG001|COMPLETED|Overall Study||94
10874193|NCT02363010|12040208|FG002|COMPLETED|Overall Study||89
10874194|NCT02363010|12040206|FG000|NOT COMPLETED|Overall Study||22
10874195|NCT02363010|12040207|FG001|NOT COMPLETED|Overall Study||11
10874196|NCT02363010|12040208|FG002|NOT COMPLETED|Overall Study||16
10874197|NCT02351856|12040216|FG000|STARTED|Overall Study||8
10874198|NCT02351856|12040216|FG000|COMPLETED|Overall Study||0
10874199|NCT02351856|12040216|FG000|NOT COMPLETED|Overall Study||8
10874200|NCT02349386|12040224|FG000|STARTED|24-Week Double-Blind Main Study||9
10874201|NCT02349386|12040225|FG001|STARTED|24-Week Double-Blind Main Study||8
10874202|NCT02349386|12040226|FG002|STARTED|24-Week Double-Blind Main Study||9
10874203|NCT02349386|12040227|FG003|STARTED|24-Week Double-Blind Main Study||8
10874204|NCT02349386|12040224|FG000|COMPLETED|24-Week Double-Blind Main Study||3
10874205|NCT02349386|12040225|FG001|COMPLETED|24-Week Double-Blind Main Study||2
10874206|NCT02349386|12040226|FG002|COMPLETED|24-Week Double-Blind Main Study||4
10874207|NCT02349386|12040227|FG003|COMPLETED|24-Week Double-Blind Main Study||0
10874208|NCT02349386|12040224|FG000|NOT COMPLETED|24-Week Double-Blind Main Study||6
10874209|NCT02349386|12040225|FG001|NOT COMPLETED|24-Week Double-Blind Main Study||6
10874210|NCT02349386|12040226|FG002|NOT COMPLETED|24-Week Double-Blind Main Study||5
10874211|NCT02349386|12040227|FG003|NOT COMPLETED|24-Week Double-Blind Main Study||8
10874212|NCT02349386|12040224|FG000|STARTED|28-Week Double-Blind Optional Extension||3
10874213|NCT02349386|12040225|FG001|STARTED|28-Week Double-Blind Optional Extension||2
10874214|NCT02349386|12040226|FG002|STARTED|28-Week Double-Blind Optional Extension||4
10874215|NCT02349386|12040227|FG003|STARTED|28-Week Double-Blind Optional Extension||0
10874216|NCT02349386|12040224|FG000|COMPLETED|28-Week Double-Blind Optional Extension||1
10874217|NCT02349386|12040225|FG001|COMPLETED|28-Week Double-Blind Optional Extension||2
10874218|NCT02349386|12040226|FG002|COMPLETED|28-Week Double-Blind Optional Extension||1
10874219|NCT02349386|12040227|FG003|COMPLETED|28-Week Double-Blind Optional Extension||0
10874220|NCT02349386|12040224|FG000|NOT COMPLETED|28-Week Double-Blind Optional Extension||2
10874221|NCT02349386|12040225|FG001|NOT COMPLETED|28-Week Double-Blind Optional Extension||0
10874222|NCT02349386|12040226|FG002|NOT COMPLETED|28-Week Double-Blind Optional Extension||3
10874223|NCT02349386|12040227|FG003|NOT COMPLETED|28-Week Double-Blind Optional Extension||0
10874224|NCT02281500|12040237|FG000|STARTED|Overall Study||22
10874225|NCT02281500|12040237|FG000|COMPLETED|Overall Study||22
10874226|NCT02281500|12040237|FG000|NOT COMPLETED|Overall Study||0
10874233|NCT01905384|12040252|FG000|STARTED|Overall Study||3
10874234|NCT01905384|12040253|FG001|STARTED|Overall Study||3
10874235|NCT01905384|12040252|FG000|COMPLETED|Overall Study||3
10874236|NCT01905384|12040253|FG001|COMPLETED|Overall Study||3
10874237|NCT01905384|12040252|FG000|NOT COMPLETED|Overall Study||0
10874238|NCT01905384|12040253|FG001|NOT COMPLETED|Overall Study||0
10874239|NCT01904032|12040261|FG000|STARTED|Overall Study||64
10874240|NCT01904032|12040262|FG001|STARTED|Overall Study||65
10874241|NCT01904032|12040261|FG000|COMPLETED|Overall Study||57
10874242|NCT01904032|12040262|FG001|COMPLETED|Overall Study||62
10874243|NCT01904032|12040261|FG000|NOT COMPLETED|Overall Study||7
10874244|NCT01904032|12040262|FG001|NOT COMPLETED|Overall Study||3
10874245|NCT01876953|12040270|FG000|STARTED|Overall Study||17
10874246|NCT01876953|12040271|FG001|STARTED|Overall Study||3
10874247|NCT01876953|12040270|FG000|COMPLETED|Overall Study||17
10874248|NCT01876953|12040271|FG001|COMPLETED|Overall Study||3
10874249|NCT01876953|12040270|FG000|NOT COMPLETED|Overall Study||0
10874250|NCT01876953|12040271|FG001|NOT COMPLETED|Overall Study||0
10874251|NCT01764711|12040279|FG000|STARTED|Overall Study||8
10874252|NCT01764711|12040280|FG001|STARTED|Overall Study||5
10874253|NCT01764711|12040279|FG000|COMPLETED|Overall Study||8
10874254|NCT01764711|12040280|FG001|COMPLETED|Overall Study||5
10874255|NCT01764711|12040279|FG000|NOT COMPLETED|Overall Study||0
10874256|NCT01764711|12040280|FG001|NOT COMPLETED|Overall Study||0
10874257|NCT01632878|12040288|FG000|STARTED|Screening||1531
10874258|NCT01632878|12040288|FG000|COMPLETED|Screening||1263
10874259|NCT01632878|12040288|FG000|NOT COMPLETED|Screening||268
10874260|NCT01632878|12040288|FG000|STARTED|Treatment||1263
10874261|NCT01632878|12040288|FG000|COMPLETED|Treatment||1105
10874262|NCT01632878|12040288|FG000|NOT COMPLETED|Treatment||158
10874263|NCT01275846|12040292|FG000|STARTED|Overall Study||26
10874264|NCT01275846|12040292|FG000|COMPLETED|Overall Study||25
10874265|NCT01275846|12040292|FG000|NOT COMPLETED|Overall Study||1
10874266|NCT01097005|12040296|FG000|STARTED|Overall Study|number of participants who were enrolled for this study.|466
10874267|NCT01097005|12040296|FG000|Analysis of Safety|Overall Study|number of participants who could be measured for Adverse Events|441
10874268|NCT01097005|12040296|FG000|Analysis of NTM Lung Disease|Overall Study|number of participants who contributed to the Baseline data|340
10874269|NCT01097005|12040296|FG000|Analysis of Bacilli Negative Conversion|Overall Study|number of participants who were analysed for bacilli negative conversion|285
10874270|NCT01097005|12040296|FG000|Analysis of CGI|Overall Study|number of participants who were measured for Clinical Global Improvement (CGI)|249
10874271|NCT01097005|12040296|FG000|COMPLETED|Overall Study||101
10874272|NCT01097005|12040296|FG000|NOT COMPLETED|Overall Study||365
10874273|NCT01072682|12040302|FG000|STARTED|Overall Study||35
10874274|NCT01072682|12040302|FG000|COMPLETED|Overall Study||35
10874275|NCT01072682|12040302|FG000|NOT COMPLETED|Overall Study||0
10874276|NCT00931255|12040308|FG000|STARTED|Overall Study||17
10874277|NCT00931255|12040309|FG001|STARTED|Overall Study||15
10874278|NCT00931255|12040308|FG000|COMPLETED|Overall Study||15
10874279|NCT00931255|12040309|FG001|COMPLETED|Overall Study||12
10874280|NCT00931255|12040308|FG000|NOT COMPLETED|Overall Study||2
10874281|NCT00931255|12040309|FG001|NOT COMPLETED|Overall Study||3
10874282|NCT00540995|12040317|FG000|STARTED|Overall Study||23
10874283|NCT00540995|12040318|FG001|STARTED|Overall Study||2
10874284|NCT00540995|12040317|FG000|COMPLETED|Overall Study||23
10874285|NCT00540995|12040318|FG001|COMPLETED|Overall Study||2
10874286|NCT00540995|12040317|FG000|NOT COMPLETED|Overall Study||0
10874287|NCT00540995|12040318|FG001|NOT COMPLETED|Overall Study||0
10874288|NCT00418301|12040323|FG000|STARTED|Overall Study||15
10874289|NCT00418301|12040323|FG000|COMPLETED|Overall Study||12
10874290|NCT00418301|12040323|FG000|NOT COMPLETED|Overall Study||3
10296044|NCT02053246|11428730|FG000|STARTED|Overall Study||11
10296045|NCT02053246|11428730|FG000|COMPLETED|Overall Study||7
10296046|NCT02053246|11428730|FG000|NOT COMPLETED|Overall Study||4
10296047|NCT01980940|11428742|FG000|STARTED|Overall Study||5
10296048|NCT01980940|11428743|FG001|STARTED|Overall Study||5
10296049|NCT01980940|11428744|FG002|STARTED|Overall Study||5
10296050|NCT01980940|11428745|FG003|STARTED|Overall Study||3
10296051|NCT01980940|11428746|FG004|STARTED|Overall Study||2
10296052|NCT01980940|11428747|FG005|STARTED|Overall Study||2
10296053|NCT01980940|11428748|FG006|STARTED|Overall Study||24
10874291|NCT04498273|12040331|FG000|STARTED|Overall Study||165
10874292|NCT04498273|12040332|FG001|STARTED|Overall Study||164
10874293|NCT04498273|12040333|FG002|STARTED|Overall Study||164
10874294|NCT04498273|12040334|FG003|STARTED|Overall Study||164
10874295|NCT04498273|12040331|FG000|COMPLETED|Overall Study||134
10874296|NCT04498273|12040332|FG001|COMPLETED|Overall Study||140
10874297|NCT04498273|12040333|FG002|COMPLETED|Overall Study||143
10874298|NCT04498273|12040334|FG003|COMPLETED|Overall Study||133
10874299|NCT04498273|12040331|FG000|NOT COMPLETED|Overall Study||31
10874300|NCT04498273|12040332|FG001|NOT COMPLETED|Overall Study||24
10874301|NCT04498273|12040333|FG002|NOT COMPLETED|Overall Study||21
10874302|NCT04498273|12040334|FG003|NOT COMPLETED|Overall Study||31
10874309|NCT04537078|12040355|FG000|STARTED|Overall Study||45
10874310|NCT04537078|12040356|FG001|STARTED|Overall Study||45
10874311|NCT04537078|12040355|FG000|COMPLETED|Overall Study||41
10874312|NCT04537078|12040356|FG001|COMPLETED|Overall Study||42
10874313|NCT04537078|12040355|FG000|NOT COMPLETED|Overall Study||4
10874314|NCT04537078|12040356|FG001|NOT COMPLETED|Overall Study||3
10874315|NCT04425252|12040371|FG000|STARTED|Overall Study||8
10874316|NCT04425252|12040372|FG001|STARTED|Overall Study||15
10874317|NCT04425252|12040371|FG000|COMPLETED|Overall Study||4
10874318|NCT04425252|12040372|FG001|COMPLETED|Overall Study||13
10874319|NCT04425252|12040371|FG000|NOT COMPLETED|Overall Study||4
10874320|NCT04425252|12040372|FG001|NOT COMPLETED|Overall Study||2
10874321|NCT04368260|12040381|FG000|STARTED|Overall Study||40
10874322|NCT04368260|12040381|FG000|COMPLETED|Overall Study||40
10874323|NCT04368260|12040381|FG000|NOT COMPLETED|Overall Study||0
10874324|NCT03940326|12040389|FG000|STARTED|Overall Study||45
10874325|NCT03940326|12040390|FG001|STARTED|Overall Study||58
10874326|NCT03940326|12040389|FG000|COMPLETED|Overall Study||45
10874327|NCT03940326|12040390|FG001|COMPLETED|Overall Study||58
10874328|NCT03940326|12040389|FG000|NOT COMPLETED|Overall Study||0
10874329|NCT03940326|12040390|FG001|NOT COMPLETED|Overall Study||0
10874330|NCT03875313|12040401|FG000|STARTED|Overall Study||3
10874331|NCT03875313|12040402|FG001|STARTED|Overall Study||16
10874332|NCT03875313|12040403|FG002|STARTED|Overall Study||6
10874333|NCT03875313|12040404|FG003|STARTED|Overall Study||4
10874334|NCT03875313|12040405|FG004|STARTED|Overall Study||4
10874335|NCT03875313|12040401|FG000|COMPLETED|Overall Study||0
10874336|NCT03875313|12040402|FG001|COMPLETED|Overall Study||0
10874337|NCT03875313|12040403|FG002|COMPLETED|Overall Study||0
10874338|NCT03875313|12040404|FG003|COMPLETED|Overall Study||0
10874339|NCT03875313|12040405|FG004|COMPLETED|Overall Study||0
10874340|NCT03875313|12040401|FG000|NOT COMPLETED|Overall Study||3
10874341|NCT03875313|12040402|FG001|NOT COMPLETED|Overall Study||16
10874342|NCT03875313|12040403|FG002|NOT COMPLETED|Overall Study||6
10874343|NCT03875313|12040404|FG003|NOT COMPLETED|Overall Study||4
10874344|NCT03875313|12040405|FG004|NOT COMPLETED|Overall Study||4
10874345|NCT03694353|12040417|FG000|STARTED|Overall Study||37
10874346|NCT03694353|12040417|FG000|COMPLETED|Overall Study||35
10874347|NCT03694353|12040417|FG000|NOT COMPLETED|Overall Study||2
10874348|NCT03583554|12040421|FG000|STARTED|Period 1||4
10874349|NCT03583554|12040422|FG001|STARTED|Period 1||4
10874350|NCT03583554|12040423|FG002|STARTED|Period 1||4
10874351|NCT03583554|12040421|FG000|COMPLETED|Period 1||4
10874352|NCT03583554|12040422|FG001|COMPLETED|Period 1||4
10874353|NCT03583554|12040423|FG002|COMPLETED|Period 1||4
10874354|NCT03583554|12040421|FG000|NOT COMPLETED|Period 1||0
10874355|NCT03583554|12040422|FG001|NOT COMPLETED|Period 1||0
10874356|NCT03583554|12040423|FG002|NOT COMPLETED|Period 1||0
10874357|NCT03583554|12040421|FG000|STARTED|Period 2||4
10874358|NCT03583554|12040422|FG001|STARTED|Period 2||4
10874359|NCT03583554|12040423|FG002|STARTED|Period 2||4
10874360|NCT03583554|12040421|FG000|COMPLETED|Period 2||3
10874361|NCT03583554|12040422|FG001|COMPLETED|Period 2||4
10874362|NCT03583554|12040423|FG002|COMPLETED|Period 2||3
10874363|NCT03583554|12040421|FG000|NOT COMPLETED|Period 2||1
10874364|NCT03583554|12040422|FG001|NOT COMPLETED|Period 2||0
10874365|NCT03583554|12040423|FG002|NOT COMPLETED|Period 2||1
10874366|NCT03583554|12040421|FG000|STARTED|Period 3||3
10874367|NCT03583554|12040422|FG001|STARTED|Period 3||4
10874368|NCT03583554|12040423|FG002|STARTED|Period 3||3
10874369|NCT03583554|12040421|FG000|COMPLETED|Period 3||3
10874370|NCT03583554|12040422|FG001|COMPLETED|Period 3||4
10874371|NCT03583554|12040423|FG002|COMPLETED|Period 3||3
10874372|NCT03583554|12040421|FG000|NOT COMPLETED|Period 3||0
10874373|NCT03583554|12040422|FG001|NOT COMPLETED|Period 3||0
10874374|NCT03583554|12040423|FG002|NOT COMPLETED|Period 3||0
10874375|NCT03538717|12040434|FG000|STARTED|Overall Study||157
10874376|NCT03538717|12040434|FG000|COMPLETED|Overall Study||157
10874377|NCT03538717|12040434|FG000|NOT COMPLETED|Overall Study||0
10874378|NCT03408873|12040440|FG000|STARTED|Visit 1 Assessment (Baseline)||30
10874379|NCT03408873|12040440|FG000|COMPLETED|Visit 1 Assessment (Baseline)||27
10874380|NCT03408873|12040440|FG000|NOT COMPLETED|Visit 1 Assessment (Baseline)||3
10874381|NCT03408873|12040440|FG000|STARTED|Visit 2 Assessment||27
10874382|NCT03408873|12040440|FG000|COMPLETED|Visit 2 Assessment||26
10874383|NCT03408873|12040440|FG000|NOT COMPLETED|Visit 2 Assessment||1
10874384|NCT03408873|12040440|FG000|STARTED|Visit 3 Assessment||26
10874385|NCT03408873|12040440|FG000|COMPLETED|Visit 3 Assessment||25
10874386|NCT03408873|12040440|FG000|NOT COMPLETED|Visit 3 Assessment||1
10874387|NCT03408873|12040440|FG000|STARTED|Visit 4 Assessment||25
10874388|NCT03408873|12040440|FG000|COMPLETED|Visit 4 Assessment||23
10874389|NCT03408873|12040440|FG000|NOT COMPLETED|Visit 4 Assessment||2
10874390|NCT03408873|12040440|FG000|STARTED|Visit 5 Assessment||23
10874303|NCT05224453|12040346|FG000|STARTED|Overall Study||38
10419705|NCT00811395|11564602|FG000|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|38
10419706|NCT00811395|11564603|FG001|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|33
10419707|NCT00811395|11564604|FG002|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|36
10419708|NCT00811395|11564605|FG003|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|38
10419709|NCT00811395|11564606|FG004|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|37
10419710|NCT00811395|11564607|FG005|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|35
10419711|NCT00811395|11564602|FG000|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||3
10419712|NCT00811395|11564603|FG001|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||4
10419713|NCT00811395|11564604|FG002|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||2
10419714|NCT00811395|11564605|FG003|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||2
10419715|NCT00811395|11564606|FG004|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||5
10419716|NCT00811395|11564607|FG005|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||6
10419717|NCT00811395|11564602|FG000|STARTED|Extension Treatment|continued initial treatment|31
10419718|NCT00811395|11564603|FG001|STARTED|Extension Treatment|continued initial treatment|28
10419719|NCT00811395|11564604|FG002|STARTED|Extension Treatment|continued initial treatment|27
10755721|NCT03070730|11919529|FG001|COMPLETED|Overall Study||0
10755722|NCT03070730|11919530|FG002|COMPLETED|Overall Study||0
10755723|NCT03070730|11919528|FG000|NOT COMPLETED|Overall Study||0
10755724|NCT03070730|11919529|FG001|NOT COMPLETED|Overall Study||0
10755725|NCT03070730|11919530|FG002|NOT COMPLETED|Overall Study||0
10755726|NCT03070782|11919544|FG000|STARTED|Overall Study||48
10755727|NCT03070782|11919545|FG001|STARTED|Overall Study||48
10755728|NCT03070782|11919546|FG002|STARTED|Overall Study||47
10755729|NCT03070782|11919547|FG003|STARTED|Overall Study||48
10755730|NCT03070782|11919548|FG004|STARTED|Overall Study||48
10874304|NCT05224453|12040347|FG001|STARTED|Overall Study||38
10874305|NCT05224453|12040346|FG000|COMPLETED|Overall Study||36
10874306|NCT05224453|12040347|FG001|COMPLETED|Overall Study||35
10874307|NCT05224453|12040346|FG000|NOT COMPLETED|Overall Study||2
10874308|NCT05224453|12040347|FG001|NOT COMPLETED|Overall Study||3
10874391|NCT03408873|12040440|FG000|COMPLETED|Visit 5 Assessment||22
10874392|NCT03408873|12040440|FG000|NOT COMPLETED|Visit 5 Assessment||1
10874393|NCT03408873|12040440|FG000|STARTED|Visit 6 Assessment||22
10874394|NCT03408873|12040440|FG000|COMPLETED|Visit 6 Assessment||21
10874395|NCT03408873|12040440|FG000|NOT COMPLETED|Visit 6 Assessment||1
10874396|NCT03408873|12040440|FG000|STARTED|Visit 7 Assessment||21
10874397|NCT03408873|12040440|FG000|COMPLETED|Visit 7 Assessment||21
10874398|NCT03408873|12040440|FG000|NOT COMPLETED|Visit 7 Assessment||0
10874402|NCT03096288|12040453|FG000|STARTED|Overall Study||19
10874403|NCT03096288|12040454|FG001|STARTED|Overall Study||18
10874404|NCT03096288|12040455|FG002|STARTED|Overall Study||22
10874405|NCT03096288|12040456|FG003|STARTED|Overall Study||25
10874406|NCT03096288|12040453|FG000|COMPLETED|Overall Study||19
10874407|NCT03096288|12040454|FG001|COMPLETED|Overall Study||17
10874408|NCT03096288|12040455|FG002|COMPLETED|Overall Study||22
10874409|NCT03096288|12040456|FG003|COMPLETED|Overall Study||24
10874410|NCT03096288|12040453|FG000|NOT COMPLETED|Overall Study||0
10874411|NCT03096288|12040454|FG001|NOT COMPLETED|Overall Study||1
10874412|NCT03096288|12040455|FG002|NOT COMPLETED|Overall Study||0
10874413|NCT03096288|12040456|FG003|NOT COMPLETED|Overall Study||1
10874414|NCT02919436|12040468|FG000|STARTED|Overall Study||305
10874415|NCT02919436|12040469|FG001|STARTED|Overall Study||305
10874416|NCT02919436|12040468|FG000|COMPLETED|Overall Study||245
10874417|NCT02919436|12040469|FG001|COMPLETED|Overall Study||252
10874418|NCT02919436|12040468|FG000|NOT COMPLETED|Overall Study||60
10874419|NCT02919436|12040469|FG001|NOT COMPLETED|Overall Study||53
10874420|NCT02135484|12040477|FG000|STARTED|Overall Study||25
10874421|NCT02135484|12040477|FG000|COMPLETED|Overall Study||25
10874422|NCT02135484|12040477|FG000|NOT COMPLETED|Overall Study||0
10874423|NCT02028884|12040483|FG000|STARTED|Double-blind Period||42
10874424|NCT02028884|12040484|FG001|STARTED|Double-blind Period||41
10874425|NCT02028884|12040483|FG000|COMPLETED|Double-blind Period||24
10874426|NCT02028884|12040484|FG001|COMPLETED|Double-blind Period||18
10874427|NCT02028884|12040483|FG000|NOT COMPLETED|Double-blind Period||18
10874428|NCT02028884|12040484|FG001|NOT COMPLETED|Double-blind Period||23
10874429|NCT02028884|12040483|FG000|STARTED|Open-label Extension Period||24
10874430|NCT02028884|12040484|FG001|STARTED|Open-label Extension Period||18
10874431|NCT02028884|12040483|FG000|COMPLETED|Open-label Extension Period||0
10874432|NCT02028884|12040484|FG001|COMPLETED|Open-label Extension Period||0
10874433|NCT02028884|12040483|FG000|NOT COMPLETED|Open-label Extension Period||24
10874434|NCT02028884|12040484|FG001|NOT COMPLETED|Open-label Extension Period||18
10874435|NCT01983774|12040495|FG000|STARTED|Overall Study||9
10874436|NCT01983774|12040496|FG001|STARTED|Overall Study||8
10874437|NCT01983774|12040495|FG000|COMPLETED|Overall Study||8
10755731|NCT03070782|11919549|FG005|STARTED|Overall Study||47
10874438|NCT01983774|12040496|FG001|COMPLETED|Overall Study||7
10874439|NCT01983774|12040495|FG000|NOT COMPLETED|Overall Study||1
10874440|NCT01983774|12040496|FG001|NOT COMPLETED|Overall Study||1
10874441|NCT01974206|12040506|FG000|STARTED|Overall Study||74
10874442|NCT01974206|12040507|FG001|STARTED|Overall Study||76
10874443|NCT01974206|12040506|FG000|Received Treatment|Overall Study||74
10874444|NCT01974206|12040507|FG001|Received Treatment|Overall Study||75
10874445|NCT01974206|12040506|FG000|COMPLETED|Overall Study||68
10874446|NCT01974206|12040507|FG001|COMPLETED|Overall Study||75
10874447|NCT01974206|12040506|FG000|NOT COMPLETED|Overall Study||6
10874448|NCT01974206|12040507|FG001|NOT COMPLETED|Overall Study||1
10874449|NCT01970865|12040530|FG000|STARTED|Overall Study||3
10874450|NCT01970865|12040531|FG001|STARTED|Overall Study||3
10874451|NCT01970865|12040532|FG002|STARTED|Overall Study||3
10874452|NCT01970865|12040533|FG003|STARTED|Overall Study||13
10874453|NCT01970865|12040534|FG004|STARTED|Overall Study||17
10874454|NCT01970865|12040535|FG005|STARTED|Overall Study||3
10874455|NCT01970865|12040536|FG006|STARTED|Overall Study||3
10874456|NCT01970865|12040537|FG007|STARTED|Overall Study||3
10296054|NCT01980940|11428749|FG007|STARTED|Overall Study||24
10296055|NCT01980940|11428742|FG000|Treated|Overall Study||5
10296056|NCT01980940|11428743|FG001|Treated|Overall Study||5
10296057|NCT01980940|11428744|FG002|Treated|Overall Study||5
10296058|NCT01980940|11428745|FG003|Treated|Overall Study||3
10296059|NCT01980940|11428746|FG004|Treated|Overall Study||2
10296060|NCT01980940|11428747|FG005|Treated|Overall Study||2
10419720|NCT00811395|11564605|FG003|STARTED|Extension Treatment|continued initial treatment|37
10419721|NCT00811395|11564606|FG004|STARTED|Extension Treatment|continued initial treatment|30
10419722|NCT00811395|11564607|FG005|STARTED|Extension Treatment|continued initial treatment|29
10419723|NCT00811395|11564602|FG000|COMPLETED|Extension Treatment|completed 48-week treatment|29
10419724|NCT00811395|11564603|FG001|COMPLETED|Extension Treatment|completed 48-week treatment|22
10874457|NCT01970865|12040538|FG008|STARTED|Overall Study||3
10296061|NCT01980940|11428748|FG006|Treated|Overall Study||24
10296062|NCT01980940|11428749|FG007|Treated|Overall Study||24
10296063|NCT01980940|11428742|FG000|COMPLETED|Overall Study||5
10296064|NCT01980940|11428743|FG001|COMPLETED|Overall Study||5
10296065|NCT01980940|11428744|FG002|COMPLETED|Overall Study||5
10296066|NCT01980940|11428745|FG003|COMPLETED|Overall Study||3
10296067|NCT01980940|11428746|FG004|COMPLETED|Overall Study||2
10296068|NCT01980940|11428747|FG005|COMPLETED|Overall Study||0
10296069|NCT01980940|11428748|FG006|COMPLETED|Overall Study||24
10296070|NCT01980940|11428749|FG007|COMPLETED|Overall Study||24
10296071|NCT01980940|11428742|FG000|NOT COMPLETED|Overall Study||0
10296072|NCT01980940|11428743|FG001|NOT COMPLETED|Overall Study||0
10296073|NCT01980940|11428744|FG002|NOT COMPLETED|Overall Study||0
10296074|NCT01980940|11428745|FG003|NOT COMPLETED|Overall Study||0
10296075|NCT01980940|11428746|FG004|NOT COMPLETED|Overall Study||0
10296076|NCT01980940|11428747|FG005|NOT COMPLETED|Overall Study||2
10296077|NCT01980940|11428748|FG006|NOT COMPLETED|Overall Study||0
10296078|NCT01980940|11428749|FG007|NOT COMPLETED|Overall Study||0
10296079|NCT01923298|11428773|FG000|STARTED|Overall Study||14
10296080|NCT01923298|11428773|FG000|COMPLETED|Overall Study||14
10296081|NCT01923298|11428773|FG000|NOT COMPLETED|Overall Study||0
10296082|NCT01918033|11428780|FG000|STARTED|Overall Study||203
10296083|NCT01918033|11428781|FG001|STARTED|Overall Study||203
10296084|NCT01918033|11428782|FG002|STARTED|Overall Study||202
10296085|NCT01918033|11428780|FG000|Treated|Overall Study|One randomized participant did not receive study drug.|202
10296086|NCT01918033|11428781|FG001|Treated|Overall Study||203
10296087|NCT01918033|11428782|FG002|Treated|Overall Study|One randomized participant did not receive study drug.|201
10296088|NCT01918033|11428780|FG000|COMPLETED|Overall Study||198
10296089|NCT01918033|11428781|FG001|COMPLETED|Overall Study||201
10296090|NCT01918033|11428782|FG002|COMPLETED|Overall Study||199
10296091|NCT01918033|11428780|FG000|NOT COMPLETED|Overall Study||5
10296092|NCT01918033|11428781|FG001|NOT COMPLETED|Overall Study||2
10296093|NCT01918033|11428782|FG002|NOT COMPLETED|Overall Study||3
10296094|NCT01916980|11428792|FG000|STARTED|Overall Study||65
10296095|NCT01916980|11428793|FG001|STARTED|Overall Study||29
10296096|NCT01916980|11428792|FG000|COMPLETED|Overall Study||58
10296097|NCT01916980|11428793|FG001|COMPLETED|Overall Study||25
10296098|NCT01916980|11428792|FG000|NOT COMPLETED|Overall Study||7
10296099|NCT01916980|11428793|FG001|NOT COMPLETED|Overall Study||4
10296100|NCT01916967|11428802|FG000|STARTED|Overall Study||80
10296101|NCT01916967|11428803|FG001|STARTED|Overall Study||79
10296102|NCT01916967|11428804|FG002|STARTED|Overall Study||80
10296103|NCT01916967|11428802|FG000|COMPLETED|Overall Study||80
10296104|NCT01916967|11428803|FG001|COMPLETED|Overall Study||78
10296105|NCT01916967|11428804|FG002|COMPLETED|Overall Study||71
10296106|NCT01916967|11428802|FG000|NOT COMPLETED|Overall Study||0
10296107|NCT01916967|11428803|FG001|NOT COMPLETED|Overall Study||1
10296108|NCT01916967|11428804|FG002|NOT COMPLETED|Overall Study||9
10874458|NCT01970865|12040539|FG009|STARTED|Overall Study||4
10874459|NCT01970865|12040540|FG010|STARTED|Overall Study||30
10874460|NCT01970865|12040541|FG011|STARTED|Overall Study||27
10419725|NCT00811395|11564604|FG002|COMPLETED|Extension Treatment|completed 48-week treatment|24
10874461|NCT01970865|12040542|FG012|STARTED|Overall Study||60
10874462|NCT01970865|12040543|FG013|STARTED|Overall Study||66
10874463|NCT01970865|12040544|FG014|STARTED|Overall Study||46
10874464|NCT01970865|12040545|FG015|STARTED|Overall Study||47
10874465|NCT01970865|12040546|FG016|STARTED|Overall Study||3
10874466|NCT01970865|12040530|FG000|Received Treatment|Overall Study||3
10874467|NCT01970865|12040531|FG001|Received Treatment|Overall Study||3
10874468|NCT01970865|12040532|FG002|Received Treatment|Overall Study||3
10874469|NCT01970865|12040533|FG003|Received Treatment|Overall Study||12
10874470|NCT01970865|12040534|FG004|Received Treatment|Overall Study||17
10874471|NCT01970865|12040535|FG005|Received Treatment|Overall Study||3
10874472|NCT01970865|12040536|FG006|Received Treatment|Overall Study||3
10874473|NCT01970865|12040537|FG007|Received Treatment|Overall Study||3
10874474|NCT01970865|12040538|FG008|Received Treatment|Overall Study||3
10874475|NCT01970865|12040539|FG009|Received Treatment|Overall Study||4
10874476|NCT01970865|12040540|FG010|Received Treatment|Overall Study||30
10874477|NCT01970865|12040541|FG011|Received Treatment|Overall Study||27
10874478|NCT01970865|12040542|FG012|Received Treatment|Overall Study||60
10874479|NCT01970865|12040543|FG013|Received Treatment|Overall Study||65
10874480|NCT01970865|12040544|FG014|Received Treatment|Overall Study||46
10874481|NCT01970865|12040545|FG015|Received Treatment|Overall Study||47
10874482|NCT01970865|12040546|FG016|Received Treatment|Overall Study||3
10874483|NCT01970865|12040530|FG000|COMPLETED|Overall Study||0
10874484|NCT01970865|12040531|FG001|COMPLETED|Overall Study||0
10296121|NCT01893320|11428827|FG000|STARTED|Overall Study||7
10296122|NCT01893320|11428828|FG001|STARTED|Overall Study||59
10296123|NCT01893320|11428827|FG000|COMPLETED|Overall Study||7
10296124|NCT01893320|11428828|FG001|COMPLETED|Overall Study||59
10296125|NCT01893320|11428827|FG000|NOT COMPLETED|Overall Study||0
10296126|NCT01893320|11428828|FG001|NOT COMPLETED|Overall Study||0
10296127|NCT01870401|11428836|FG000|STARTED|Overall Study||287
10296128|NCT01870401|11428837|FG001|STARTED|Overall Study||155
10296129|NCT01870401|11428836|FG000|COMPLETED|Overall Study||137
10296130|NCT01870401|11428837|FG001|COMPLETED|Overall Study||59
10296131|NCT01870401|11428836|FG000|NOT COMPLETED|Overall Study||150
10296132|NCT01870401|11428837|FG001|NOT COMPLETED|Overall Study||96
10296133|NCT01867606|11428847|FG000|STARTED|Overall Study||26
10296134|NCT01867606|11428848|FG001|STARTED|Overall Study||32
10296135|NCT01867606|11428847|FG000|COMPLETED|Overall Study||16
10296136|NCT01867606|11428848|FG001|COMPLETED|Overall Study||17
10296137|NCT01867606|11428847|FG000|NOT COMPLETED|Overall Study||10
10296138|NCT01867606|11428848|FG001|NOT COMPLETED|Overall Study||15
10296139|NCT01857063|11428862|FG000|STARTED|Period 1 (7 Days)||110
10296140|NCT01857063|11428863|FG001|STARTED|Period 1 (7 Days)||110
10296141|NCT01857063|11428862|FG000|COMPLETED|Period 1 (7 Days)||108
10296142|NCT01857063|11428863|FG001|COMPLETED|Period 1 (7 Days)||106
10296143|NCT01857063|11428862|FG000|NOT COMPLETED|Period 1 (7 Days)||2
10296144|NCT01857063|11428863|FG001|NOT COMPLETED|Period 1 (7 Days)||4
10296145|NCT01857063|11428862|FG000|STARTED|Period 2 (7 Days)||108
10296146|NCT01857063|11428863|FG001|STARTED|Period 2 (7 Days)||106
10296147|NCT01857063|11428862|FG000|COMPLETED|Period 2 (7 Days)||104
10296148|NCT01857063|11428863|FG001|COMPLETED|Period 2 (7 Days)||104
10296149|NCT01857063|11428862|FG000|NOT COMPLETED|Period 2 (7 Days)||4
10296150|NCT01857063|11428863|FG001|NOT COMPLETED|Period 2 (7 Days)||2
10296151|NCT01854268|11428869|FG000|STARTED|Overall Study||25
10296152|NCT01854268|11428869|FG000|COMPLETED|Overall Study||25
10296153|NCT01854268|11428869|FG000|NOT COMPLETED|Overall Study||0
10296154|NCT01852812|11428876|FG000|STARTED|Overall Study||51
10296155|NCT01852812|11428877|FG001|STARTED|Overall Study||18
10296156|NCT01852812|11428878|FG002|STARTED|Overall Study||18
10296157|NCT01852812|11428876|FG000|COMPLETED|Overall Study||51
10296158|NCT01852812|11428877|FG001|COMPLETED|Overall Study||17
10296159|NCT01852812|11428878|FG002|COMPLETED|Overall Study||17
10296160|NCT01852812|11428876|FG000|NOT COMPLETED|Overall Study||0
10296161|NCT01852812|11428877|FG001|NOT COMPLETED|Overall Study||1
10296162|NCT01852812|11428878|FG002|NOT COMPLETED|Overall Study||1
10314960|NCT00171249|11448709|FG002|Completed Part 1|Overall Study||1
10314961|NCT00171249|11448710|FG003|Completed Part 1|Overall Study||125
10314962|NCT00171249|11448711|FG004|Completed Part 1|Overall Study||2
10314963|NCT00171249|11448712|FG005|Completed Part 1|Overall Study||6
10314964|NCT00171249|11448713|FG006|Completed Part 1|Overall Study||0
10314965|NCT00171249|11448707|FG000|COMPLETED|Overall Study||1
10314966|NCT00171249|11448708|FG001|COMPLETED|Overall Study||0
10314967|NCT00171249|11448709|FG002|COMPLETED|Overall Study||0
10874485|NCT01970865|12040532|FG002|COMPLETED|Overall Study||0
10874486|NCT01970865|12040533|FG003|COMPLETED|Overall Study||0
10314968|NCT00171249|11448710|FG003|COMPLETED|Overall Study||6
10314969|NCT00171249|11448711|FG004|COMPLETED|Overall Study||0
10314970|NCT00171249|11448712|FG005|COMPLETED|Overall Study||0
10314971|NCT00171249|11448713|FG006|COMPLETED|Overall Study||0
10314972|NCT00171249|11448707|FG000|NOT COMPLETED|Overall Study||76
10874487|NCT01970865|12040534|FG004|COMPLETED|Overall Study||0
10874488|NCT01970865|12040535|FG005|COMPLETED|Overall Study||0
10874489|NCT01970865|12040536|FG006|COMPLETED|Overall Study||0
10874490|NCT01970865|12040537|FG007|COMPLETED|Overall Study||0
10874491|NCT01970865|12040538|FG008|COMPLETED|Overall Study||0
10874492|NCT01970865|12040539|FG009|COMPLETED|Overall Study||0
10874493|NCT01970865|12040540|FG010|COMPLETED|Overall Study||0
10874494|NCT01970865|12040541|FG011|COMPLETED|Overall Study||0
10874495|NCT01970865|12040542|FG012|COMPLETED|Overall Study||0
10874496|NCT01970865|12040543|FG013|COMPLETED|Overall Study||0
10874497|NCT01970865|12040544|FG014|COMPLETED|Overall Study||0
10874498|NCT01970865|12040545|FG015|COMPLETED|Overall Study||0
10874499|NCT01970865|12040546|FG016|COMPLETED|Overall Study||0
10874500|NCT01970865|12040530|FG000|NOT COMPLETED|Overall Study||3
10874501|NCT01970865|12040531|FG001|NOT COMPLETED|Overall Study||3
10874502|NCT01970865|12040532|FG002|NOT COMPLETED|Overall Study||3
10874503|NCT01970865|12040533|FG003|NOT COMPLETED|Overall Study||13
10874504|NCT01970865|12040534|FG004|NOT COMPLETED|Overall Study||17
10874505|NCT01970865|12040535|FG005|NOT COMPLETED|Overall Study||3
10874506|NCT01970865|12040536|FG006|NOT COMPLETED|Overall Study||3
10874507|NCT01970865|12040537|FG007|NOT COMPLETED|Overall Study||3
10874508|NCT01970865|12040538|FG008|NOT COMPLETED|Overall Study||3
10874509|NCT01970865|12040539|FG009|NOT COMPLETED|Overall Study||4
10874510|NCT01970865|12040540|FG010|NOT COMPLETED|Overall Study||30
10874511|NCT01970865|12040541|FG011|NOT COMPLETED|Overall Study||27
10874512|NCT01970865|12040542|FG012|NOT COMPLETED|Overall Study||60
10874513|NCT01970865|12040543|FG013|NOT COMPLETED|Overall Study||66
10874514|NCT01970865|12040544|FG014|NOT COMPLETED|Overall Study||46
10874515|NCT01970865|12040545|FG015|NOT COMPLETED|Overall Study||47
10874516|NCT01970865|12040546|FG016|NOT COMPLETED|Overall Study||3
10874517|NCT00589420|12040607|FG000|STARTED|Overall Study||18
10874518|NCT00589420|12040607|FG000|COMPLETED|Overall Study||17
10874519|NCT00589420|12040607|FG000|NOT COMPLETED|Overall Study||1
10296163|NCT01828021|11428886|FG000|STARTED|Overall Study||25
10419726|NCT00811395|11564605|FG003|COMPLETED|Extension Treatment|completed 48-week treatment|34
10419727|NCT00811395|11564606|FG004|COMPLETED|Extension Treatment|completed 48-week treatment|30
10419728|NCT00811395|11564607|FG005|COMPLETED|Extension Treatment|completed 48-week treatment|27
10419729|NCT00811395|11564602|FG000|NOT COMPLETED|Extension Treatment||2
10419730|NCT00811395|11564603|FG001|NOT COMPLETED|Extension Treatment||6
10419731|NCT00811395|11564604|FG002|NOT COMPLETED|Extension Treatment||3
10419732|NCT00811395|11564605|FG003|NOT COMPLETED|Extension Treatment||3
10419733|NCT00811395|11564606|FG004|NOT COMPLETED|Extension Treatment||0
10419734|NCT00811395|11564607|FG005|NOT COMPLETED|Extension Treatment||2
10419735|NCT00811434|11564624|FG000|STARTED|First Intervention||7
10419736|NCT00811434|11564625|FG001|STARTED|First Intervention||5
10419737|NCT00811434|11564624|FG000|COMPLETED|First Intervention||4
10419738|NCT00811434|11564625|FG001|COMPLETED|First Intervention||5
10419739|NCT00811434|11564624|FG000|NOT COMPLETED|First Intervention||3
10419740|NCT00811434|11564625|FG001|NOT COMPLETED|First Intervention||0
10419741|NCT00811434|11564624|FG000|STARTED|Washout (1 Month)||4
10419742|NCT00811434|11564625|FG001|STARTED|Washout (1 Month)||5
10419743|NCT00811434|11564624|FG000|COMPLETED|Washout (1 Month)||4
10419744|NCT00811434|11564625|FG001|COMPLETED|Washout (1 Month)||5
10419745|NCT00811434|11564624|FG000|NOT COMPLETED|Washout (1 Month)||0
10419746|NCT00811434|11564625|FG001|NOT COMPLETED|Washout (1 Month)||0
10419747|NCT00811434|11564624|FG000|STARTED|Second Intervention||4
10419748|NCT00811434|11564625|FG001|STARTED|Second Intervention||5
10419749|NCT00811434|11564624|FG000|COMPLETED|Second Intervention||4
10419750|NCT00811434|11564625|FG001|COMPLETED|Second Intervention||5
10419751|NCT00811434|11564624|FG000|NOT COMPLETED|Second Intervention||0
10419752|NCT00811434|11564625|FG001|NOT COMPLETED|Second Intervention||0
10419753|NCT00811473|11564634|FG000|STARTED|Overall Study||93
10419754|NCT00811473|11564635|FG001|STARTED|Overall Study||100
10419755|NCT00811473|11564634|FG000|COMPLETED|Overall Study||70
10419756|NCT00811473|11564635|FG001|COMPLETED|Overall Study||74
10419757|NCT00811473|11564634|FG000|NOT COMPLETED|Overall Study||23
10419758|NCT00811473|11564635|FG001|NOT COMPLETED|Overall Study||26
10419759|NCT00811564|11564643|FG000|STARTED|Overall Study||73
10419760|NCT00811564|11564644|FG001|STARTED|Overall Study||75
10419761|NCT00811564|11564643|FG000|COMPLETED|Overall Study||64
10419762|NCT00811564|11564644|FG001|COMPLETED|Overall Study||73
10419763|NCT00811564|11564643|FG000|NOT COMPLETED|Overall Study||9
10419764|NCT00811564|11564644|FG001|NOT COMPLETED|Overall Study||2
10419765|NCT00811577|11564652|FG000|STARTED|Overall Study||126
10419766|NCT00811577|11564653|FG001|STARTED|Overall Study||24
10419767|NCT00811577|11564652|FG000|COMPLETED|Overall Study||116
10419768|NCT00811577|11564653|FG001|COMPLETED|Overall Study||23
10419769|NCT00811577|11564652|FG000|NOT COMPLETED|Overall Study||10
10419770|NCT00811577|11564653|FG001|NOT COMPLETED|Overall Study||1
10419771|NCT00811642|11564702|FG000|STARTED|Overall Study|63 participants were screened and enrolled; 62 participants from Safety Set (SS) started study drug.|62
10419772|NCT00811642|11564702|FG000|COMPLETED|Overall Study|The Per Protocol Set (PPS) includes the 47 participants who completed the study per protocol.|47
10419773|NCT00811642|11564702|FG000|NOT COMPLETED|Overall Study||15
10419774|NCT00811655|11564706|FG000|STARTED|Overall Study||6
10419775|NCT00811655|11564706|FG000|COMPLETED|Overall Study||5
10419776|NCT00811655|11564706|FG000|NOT COMPLETED|Overall Study||1
10419777|NCT00811720|11564712|FG000|STARTED|All Randomised Patients||298
10419778|NCT00811720|11564713|FG001|STARTED|All Randomised Patients||306
10419779|NCT00811720|11564712|FG000|COMPLETED|All Randomised Patients||296
10419780|NCT00811720|11564713|FG001|COMPLETED|All Randomised Patients||302
10419781|NCT00811720|11564712|FG000|NOT COMPLETED|All Randomised Patients||2
10419782|NCT00811720|11564713|FG001|NOT COMPLETED|All Randomised Patients||4
10419783|NCT00811720|11564712|FG000|STARTED|All Treated Patients||296
10419784|NCT00811720|11564713|FG001|STARTED|All Treated Patients||302
10419785|NCT00811720|11564712|FG000|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|200
10419786|NCT00811720|11564713|FG001|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|138
10419787|NCT00811720|11564712|FG000|NOT COMPLETED|All Treated Patients||96
10419788|NCT00811720|11564713|FG001|NOT COMPLETED|All Treated Patients||164
10419789|NCT00811733|11564721|FG000|STARTED|Overall Study||15
10419790|NCT00811733|11564722|FG001|STARTED|Overall Study||22
10419791|NCT00811733|11564721|FG000|COMPLETED|Overall Study||4
10419792|NCT00811733|11564722|FG001|COMPLETED|Overall Study||12
10419793|NCT00811733|11564721|FG000|NOT COMPLETED|Overall Study||11
10419794|NCT00811733|11564722|FG001|NOT COMPLETED|Overall Study||10
10419795|NCT00811798|11564728|FG000|STARTED|Overall Study||92
10419796|NCT00811798|11564728|FG000|COMPLETED|Overall Study||92
10419797|NCT00811798|11564728|FG000|NOT COMPLETED|Overall Study||0
10419798|NCT00811850|11564732|FG000|STARTED|Treatment Period 1: Combigan® or Cosopt®||15
10419799|NCT00811850|11564732|FG000|COMPLETED|Treatment Period 1: Combigan® or Cosopt®||15
10419800|NCT00811850|11564732|FG000|NOT COMPLETED|Treatment Period 1: Combigan® or Cosopt®||0
10419801|NCT00811850|11564732|FG000|STARTED|Treatment Period 2: Wash Out||15
10419802|NCT00811850|11564732|FG000|COMPLETED|Treatment Period 2: Wash Out||15
10419803|NCT00811850|11564732|FG000|NOT COMPLETED|Treatment Period 2: Wash Out||0
10419804|NCT00811850|11564732|FG000|STARTED|Treatment Period 3: Combigan® or Cosopt®||15
10419805|NCT00811850|11564732|FG000|COMPLETED|Treatment Period 3: Combigan® or Cosopt®||15
10419806|NCT00811850|11564732|FG000|NOT COMPLETED|Treatment Period 3: Combigan® or Cosopt®||0
10419807|NCT00811928|11564740|FG000|STARTED|Overall Study||129
10419808|NCT00811928|11564741|FG001|STARTED|Overall Study||123
10874520|NCT05043142|12040611|FG000|STARTED|Overall Study||3632
10874521|NCT05043142|12040611|FG000|COMPLETED|Overall Study||3443
10874522|NCT05043142|12040611|FG000|NOT COMPLETED|Overall Study||189
10874523|NCT04993339|12040617|FG000|STARTED|Overall Study||14
10874524|NCT04993339|12040618|FG001|STARTED|Overall Study||12
10874525|NCT04993339|12040617|FG000|COMPLETED|Overall Study||11
10874526|NCT04993339|12040618|FG001|COMPLETED|Overall Study||10
10874527|NCT04993339|12040617|FG000|NOT COMPLETED|Overall Study||3
10874528|NCT04993339|12040618|FG001|NOT COMPLETED|Overall Study||2
10296164|NCT01828021|11428886|FG000|COMPLETED|Overall Study||0
10296165|NCT01828021|11428886|FG000|NOT COMPLETED|Overall Study||25
10296166|NCT01709318|11428897|FG000|STARTED|Overall Study||82
10296167|NCT01709318|11428898|FG001|STARTED|Overall Study||85
10296168|NCT01709318|11428899|FG002|STARTED|Overall Study||77
10296169|NCT01709318|11428900|FG003|STARTED|Overall Study||78
10296170|NCT01709318|11428901|FG004|STARTED|Overall Study||78
10296171|NCT01709318|11428902|FG005|STARTED|Overall Study||84
10296172|NCT01709318|11428903|FG006|STARTED|Overall Study||182
10296173|NCT01709318|11428897|FG000|Treated|Overall Study||79
10296174|NCT01709318|11428898|FG001|Treated|Overall Study||85
10296175|NCT01709318|11428899|FG002|Treated|Overall Study||78
10296176|NCT01709318|11428900|FG003|Treated|Overall Study||77
10296177|NCT01709318|11428901|FG004|Treated|Overall Study||77
10296178|NCT01709318|11428902|FG005|Treated|Overall Study||86
10296179|NCT01709318|11428903|FG006|Treated|Overall Study||178
10296180|NCT01709318|11428897|FG000|COMPLETED|Overall Study||73
10296181|NCT01709318|11428898|FG001|COMPLETED|Overall Study||78
10296182|NCT01709318|11428899|FG002|COMPLETED|Overall Study||71
10296183|NCT01709318|11428900|FG003|COMPLETED|Overall Study||72
10296184|NCT01709318|11428901|FG004|COMPLETED|Overall Study||74
10296185|NCT01709318|11428902|FG005|COMPLETED|Overall Study||80
10296186|NCT01709318|11428903|FG006|COMPLETED|Overall Study||171
10296187|NCT01709318|11428897|FG000|NOT COMPLETED|Overall Study||9
10296188|NCT01709318|11428898|FG001|NOT COMPLETED|Overall Study||7
10296189|NCT01709318|11428899|FG002|NOT COMPLETED|Overall Study||6
10296190|NCT01709318|11428900|FG003|NOT COMPLETED|Overall Study||6
10296191|NCT01709318|11428901|FG004|NOT COMPLETED|Overall Study||4
10296192|NCT01709318|11428902|FG005|NOT COMPLETED|Overall Study||4
10296193|NCT01709318|11428903|FG006|NOT COMPLETED|Overall Study||11
10296194|NCT01698918|11428919|FG000|STARTED|First Line Treatment (Core+Extension)||202
10296195|NCT01698918|11428919|FG000|Dexamethasone Randomized Set (Stomatitis Sub-study)|First Line Treatment (Core+Extension)||11
10296196|NCT01698918|11428919|FG000|Standard of Care Randomized Set (Stomatitis Sub-study)|First Line Treatment (Core+Extension)||13
10296197|NCT01698918|11428919|FG000|COMPLETED|First Line Treatment (Core+Extension)||29
10296198|NCT01698918|11428919|FG000|NOT COMPLETED|First Line Treatment (Core+Extension)||173
10296199|NCT01698918|11428919|FG000|STARTED|Second Line Treatment (Core+Extension)||53
10296200|NCT01698918|11428919|FG000|COMPLETED|Second Line Treatment (Core+Extension)||7
10296201|NCT01698918|11428919|FG000|NOT COMPLETED|Second Line Treatment (Core+Extension)||46
10296202|NCT01673620|11428933|FG000|STARTED|Overall Study||47
10296203|NCT01673620|11428934|FG001|STARTED|Overall Study||22
10296204|NCT01673620|11428933|FG000|COMPLETED|Overall Study||46
10296205|NCT01673620|11428934|FG001|COMPLETED|Overall Study||22
10296206|NCT01673620|11428933|FG000|NOT COMPLETED|Overall Study||1
10296207|NCT01673620|11428934|FG001|NOT COMPLETED|Overall Study||0
10546023|NCT01502293|11699556|FG001|NOT COMPLETED|Overall Study||17
10546024|NCT01502293|11699557|FG002|NOT COMPLETED|Overall Study||4
10546025|NCT01502306|11699571|FG000|STARTED|Overall Study||1004
10296208|NCT01660243|11428944|FG000|STARTED|Overall Study||10
10296209|NCT01660243|11428945|FG001|STARTED|Overall Study||13
10296210|NCT01660243|11428946|FG002|STARTED|Overall Study||11
10296211|NCT01660243|11428947|FG003|STARTED|Overall Study||11
10296212|NCT01660243|11428944|FG000|COMPLETED|Overall Study||8
10296213|NCT01660243|11428945|FG001|COMPLETED|Overall Study||13
10296214|NCT01660243|11428946|FG002|COMPLETED|Overall Study||9
10296215|NCT01660243|11428947|FG003|COMPLETED|Overall Study||10
10419809|NCT00811928|11564740|FG000|COMPLETED|Overall Study||90
10546026|NCT01502306|11699572|FG001|STARTED|Overall Study||1405
10546027|NCT01502306|11699573|FG002|STARTED|Overall Study||1407
10296216|NCT01660243|11428944|FG000|NOT COMPLETED|Overall Study||2
10296217|NCT01660243|11428945|FG001|NOT COMPLETED|Overall Study||0
10296218|NCT01660243|11428946|FG002|NOT COMPLETED|Overall Study||2
10296219|NCT01660243|11428947|FG003|NOT COMPLETED|Overall Study||1
10296220|NCT01617187|11428961|FG000|STARTED|Randomization Through Start Treatment|Randomized|98
10296221|NCT01617187|11428962|FG001|STARTED|Randomization Through Start Treatment|Randomized|113
10546028|NCT01502306|11699571|FG000|COMPLETED|Overall Study||1004
10296222|NCT01617187|11428963|FG002|STARTED|Randomization Through Start Treatment|Randomized|46
10296223|NCT01617187|11428964|FG003|STARTED|Randomization Through Start Treatment|Randomized|103
10296224|NCT01617187|11428961|FG000|COMPLETED|Randomization Through Start Treatment||97
10296225|NCT01617187|11428962|FG001|COMPLETED|Randomization Through Start Treatment||113
10296226|NCT01617187|11428963|FG002|COMPLETED|Randomization Through Start Treatment||46
10296227|NCT01617187|11428964|FG003|COMPLETED|Randomization Through Start Treatment||101
10296228|NCT01617187|11428961|FG000|NOT COMPLETED|Randomization Through Start Treatment||1
10296229|NCT01617187|11428962|FG001|NOT COMPLETED|Randomization Through Start Treatment||0
10296230|NCT01617187|11428963|FG002|NOT COMPLETED|Randomization Through Start Treatment||0
10296231|NCT01617187|11428964|FG003|NOT COMPLETED|Randomization Through Start Treatment||2
10296232|NCT01617187|11428961|FG000|STARTED|Treatment Through Study Completion|Treated|97
10296233|NCT01617187|11428962|FG001|STARTED|Treatment Through Study Completion|Treated|113
10296234|NCT01617187|11428963|FG002|STARTED|Treatment Through Study Completion|Treated|46
10296235|NCT01617187|11428964|FG003|STARTED|Treatment Through Study Completion|Treated|101
10296236|NCT01617187|11428961|FG000|COMPLETED|Treatment Through Study Completion|Excludes the participant who did not receive study drug but completed study in database|86
10296237|NCT01617187|11428962|FG001|COMPLETED|Treatment Through Study Completion||102
10296238|NCT01617187|11428963|FG002|COMPLETED|Treatment Through Study Completion||41
10296239|NCT01617187|11428964|FG003|COMPLETED|Treatment Through Study Completion||91
10296240|NCT01617187|11428961|FG000|NOT COMPLETED|Treatment Through Study Completion||11
10296241|NCT01617187|11428962|FG001|NOT COMPLETED|Treatment Through Study Completion||11
10296242|NCT01617187|11428963|FG002|NOT COMPLETED|Treatment Through Study Completion||5
10296243|NCT01617187|11428964|FG003|NOT COMPLETED|Treatment Through Study Completion||10
10296244|NCT01611883|11428976|FG000|STARTED|Overall Study||75
10296245|NCT01611883|11428977|FG001|STARTED|Overall Study||77
10296246|NCT01611883|11428976|FG000|COMPLETED|Overall Study||74
10296247|NCT01611883|11428977|FG001|COMPLETED|Overall Study||76
10296248|NCT01611883|11428976|FG000|NOT COMPLETED|Overall Study||1
10296249|NCT01611883|11428977|FG001|NOT COMPLETED|Overall Study||1
10296250|NCT01572675|11428985|FG000|STARTED|Overall Study||268
10296251|NCT01572675|11428986|FG001|STARTED|Overall Study||279
10296252|NCT01572675|11428985|FG000|COMPLETED|Overall Study||31
10296253|NCT01572675|11428986|FG001|COMPLETED|Overall Study||56
10296254|NCT01572675|11428985|FG000|NOT COMPLETED|Overall Study||237
10296255|NCT01572675|11428986|FG001|NOT COMPLETED|Overall Study||223
10296256|NCT01554163|11429007|FG000|STARTED|Overall Study||120
10296257|NCT01554163|11429008|FG001|STARTED|Overall Study||119
10296258|NCT01554163|11429007|FG000|Number Treated|Overall Study||119
10296259|NCT01554163|11429008|FG001|Number Treated|Overall Study||119
10296260|NCT01554163|11429007|FG000|COMPLETED|Overall Study||112
10296261|NCT01554163|11429008|FG001|COMPLETED|Overall Study||109
10296262|NCT01554163|11429007|FG000|NOT COMPLETED|Overall Study||8
10296263|NCT01554163|11429008|FG001|NOT COMPLETED|Overall Study||10
10296264|NCT01502371|11429019|FG000|STARTED|Overall Study||120
10296265|NCT01502371|11429020|FG001|STARTED|Overall Study||113
10296266|NCT01502371|11429021|FG002|STARTED|Overall Study||108
10296267|NCT01502371|11429022|FG003|STARTED|Overall Study||125
10296268|NCT01502371|11429023|FG004|STARTED|Overall Study||112
10296269|NCT01502371|11429019|FG000|COMPLETED|Overall Study||79
10296270|NCT01502371|11429020|FG001|COMPLETED|Overall Study||81
10296271|NCT01502371|11429021|FG002|COMPLETED|Overall Study||83
10296272|NCT01502371|11429022|FG003|COMPLETED|Overall Study||88
10296273|NCT01502371|11429023|FG004|COMPLETED|Overall Study||60
10296274|NCT01502371|11429019|FG000|NOT COMPLETED|Overall Study||41
10296275|NCT01502371|11429020|FG001|NOT COMPLETED|Overall Study||32
10296276|NCT01502371|11429021|FG002|NOT COMPLETED|Overall Study||25
10296277|NCT01502371|11429022|FG003|NOT COMPLETED|Overall Study||37
10296278|NCT01502371|11429023|FG004|NOT COMPLETED|Overall Study||52
10296279|NCT01490190|11429036|FG000|STARTED|Overall Study||252
10296280|NCT01490190|11429036|FG000|COMPLETED|Overall Study||204
10296281|NCT01490190|11429036|FG000|NOT COMPLETED|Overall Study||48
10296282|NCT01471340|11429042|FG000|STARTED|Overall Study|This value corresponds to randomized participants who received at least of dose of study medication|5868
10296283|NCT01471340|11429043|FG001|STARTED|Overall Study|This value corresponds to randomized participants who received at least of dose of study medication|5861
10296284|NCT01471340|11429042|FG000|COMPLETED|Overall Study||5862
10296285|NCT01471340|11429043|FG001|COMPLETED|Overall Study||5855
10296286|NCT01471340|11429042|FG000|NOT COMPLETED|Overall Study||6
10296287|NCT01471340|11429043|FG001|NOT COMPLETED|Overall Study||6
10296288|NCT01462370|11429049|FG000|STARTED|Overall Study||69
10296289|NCT01462370|11429050|FG001|STARTED|Overall Study||70
10296290|NCT01462370|11429049|FG000|COMPLETED|Overall Study||68
10296291|NCT01462370|11429050|FG001|COMPLETED|Overall Study||65
10296292|NCT01462370|11429049|FG000|NOT COMPLETED|Overall Study||1
10296293|NCT01462370|11429050|FG001|NOT COMPLETED|Overall Study||5
10296294|NCT01436253|11429056|FG000|STARTED|Overall Study||2196
10296295|NCT01436253|11429056|FG000|COMPLETED|Overall Study||1897
10296296|NCT01436253|11429056|FG000|NOT COMPLETED|Overall Study||299
10296297|NCT01414192|11429064|FG000|STARTED|Overall Study||490
10296298|NCT01414192|11429065|FG001|STARTED|Overall Study||575
10296299|NCT01414192|11429066|FG002|STARTED|Overall Study||424
10296300|NCT01414192|11429067|FG003|STARTED|Overall Study||1726
10296301|NCT01414192|11429064|FG000|COMPLETED|Overall Study||490
10296302|NCT01414192|11429065|FG001|COMPLETED|Overall Study||575
10296303|NCT01414192|11429066|FG002|COMPLETED|Overall Study||424
10296304|NCT01414192|11429067|FG003|COMPLETED|Overall Study||1726
10296305|NCT01414192|11429064|FG000|NOT COMPLETED|Overall Study||0
10296306|NCT01414192|11429065|FG001|NOT COMPLETED|Overall Study||0
10296307|NCT01414192|11429066|FG002|NOT COMPLETED|Overall Study||0
10296308|NCT01414192|11429067|FG003|NOT COMPLETED|Overall Study||0
10296309|NCT01390415|11429083|FG000|STARTED|Overall Study||99
10296310|NCT01390415|11429084|FG001|STARTED|Overall Study||37
10296311|NCT01390415|11429083|FG000|COMPLETED|Overall Study||99
10296312|NCT01390415|11429084|FG001|COMPLETED|Overall Study||37
10296313|NCT01390415|11429083|FG000|NOT COMPLETED|Overall Study||0
10296314|NCT01390415|11429084|FG001|NOT COMPLETED|Overall Study||0
10296315|NCT01381679|11429090|FG000|STARTED|Overall Study||1682
10296316|NCT01381679|11429090|FG000|COMPLETED|Overall Study||794
10296317|NCT01381679|11429090|FG000|NOT COMPLETED|Overall Study||888
10296318|NCT01370603|11429096|FG000|STARTED|Period 1||164
10296319|NCT01370603|11429097|FG001|STARTED|Period 1||164
10296320|NCT01370603|11429096|FG000|COMPLETED|Period 1||150
10296321|NCT01370603|11429097|FG001|COMPLETED|Period 1||154
10296322|NCT01370603|11429096|FG000|NOT COMPLETED|Period 1||14
10296323|NCT01370603|11429097|FG001|NOT COMPLETED|Period 1||10
10419810|NCT00811928|11564741|FG001|COMPLETED|Overall Study||90
10419811|NCT00811928|11564740|FG000|NOT COMPLETED|Overall Study||39
10419812|NCT00811928|11564741|FG001|NOT COMPLETED|Overall Study||33
10419813|NCT00811941|11564749|FG000|STARTED|All Randomised Patients||166
10419814|NCT00811941|11564750|FG001|STARTED|All Randomised Patients||509
10419815|NCT00811941|11564749|FG000|COMPLETED|All Randomised Patients||164
10419816|NCT00811941|11564750|FG001|COMPLETED|All Randomised Patients||501
10419817|NCT00811941|11564749|FG000|NOT COMPLETED|All Randomised Patients||2
10419818|NCT00811941|11564750|FG001|NOT COMPLETED|All Randomised Patients||8
10419819|NCT00811941|11564749|FG000|STARTED|All Treated Patients||164
10419820|NCT00811941|11564750|FG001|STARTED|All Treated Patients||501
10419821|NCT00811941|11564749|FG000|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|112
10419822|NCT00811941|11564750|FG001|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|310
10419823|NCT00811941|11564749|FG000|NOT COMPLETED|All Treated Patients||52
10419824|NCT00811941|11564750|FG001|NOT COMPLETED|All Treated Patients||191
10419825|NCT00811954|11564759|FG000|STARTED|Overall Study||605
10419826|NCT00811954|11564760|FG001|STARTED|Overall Study||603
10419827|NCT00811954|11564761|FG002|STARTED|Overall Study||601
10419828|NCT00811954|11564759|FG000|COMPLETED|Overall Study||516
10419829|NCT00811954|11564760|FG001|COMPLETED|Overall Study||531
10419830|NCT00811954|11564761|FG002|COMPLETED|Overall Study||500
10419831|NCT00811954|11564759|FG000|NOT COMPLETED|Overall Study||89
10419832|NCT00811954|11564760|FG001|NOT COMPLETED|Overall Study||72
10419833|NCT00811954|11564761|FG002|NOT COMPLETED|Overall Study||101
10419834|NCT00812097|11564773|FG000|STARTED|Overall Study||572
10419835|NCT00812097|11564774|FG001|STARTED|Overall Study||190
10419836|NCT00812097|11564775|FG002|STARTED|Overall Study||124
10419837|NCT00812097|11564776|FG003|STARTED|Overall Study||69
10419838|NCT00812097|11564773|FG000|COMPLETED|Overall Study||327
10419839|NCT00812097|11564774|FG001|COMPLETED|Overall Study||101
10419840|NCT00812097|11564775|FG002|COMPLETED|Overall Study||67
10419841|NCT00812097|11564776|FG003|COMPLETED|Overall Study||34
10296324|NCT01370603|11429096|FG000|STARTED|Crossover Washout||150
10296325|NCT01370603|11429097|FG001|STARTED|Crossover Washout||154
10296326|NCT01370603|11429096|FG000|COMPLETED|Crossover Washout||141
10296327|NCT01370603|11429097|FG001|COMPLETED|Crossover Washout||150
10296328|NCT01370603|11429096|FG000|NOT COMPLETED|Crossover Washout||9
10296329|NCT01370603|11429097|FG001|NOT COMPLETED|Crossover Washout||4
10296330|NCT01370603|11429096|FG000|STARTED|Period 2||141
10296331|NCT01370603|11429097|FG001|STARTED|Period 2||150
10296332|NCT01370603|11429096|FG000|COMPLETED|Period 2||138
10296333|NCT01370603|11429097|FG001|COMPLETED|Period 2||146
10296334|NCT01370603|11429096|FG000|NOT COMPLETED|Period 2||3
10296335|NCT01370603|11429097|FG001|NOT COMPLETED|Period 2||4
10296336|NCT01370590|11429105|FG000|STARTED|Period 1||203
10296337|NCT01370590|11429106|FG001|STARTED|Period 1||203
10296338|NCT01370590|11429105|FG000|COMPLETED|Period 1||187
10296339|NCT01370590|11429106|FG001|COMPLETED|Period 1||192
10296340|NCT01370590|11429105|FG000|NOT COMPLETED|Period 1||16
10296341|NCT01370590|11429106|FG001|NOT COMPLETED|Period 1||11
10296342|NCT01370590|11429105|FG000|STARTED|Crossover Washout Period||187
10296343|NCT01370590|11429106|FG001|STARTED|Crossover Washout Period||192
10419842|NCT00812097|11564773|FG000|NOT COMPLETED|Overall Study||245
10419843|NCT00812097|11564774|FG001|NOT COMPLETED|Overall Study||89
10296344|NCT01370590|11429105|FG000|COMPLETED|Crossover Washout Period||181
10296345|NCT01370590|11429106|FG001|COMPLETED|Crossover Washout Period||186
10296346|NCT01370590|11429105|FG000|NOT COMPLETED|Crossover Washout Period||6
10296347|NCT01370590|11429106|FG001|NOT COMPLETED|Crossover Washout Period||6
10296348|NCT01370590|11429105|FG000|STARTED|Period 2||181
10296349|NCT01370590|11429106|FG001|STARTED|Period 2||186
10296350|NCT01370590|11429105|FG000|COMPLETED|Period 2||180
10296351|NCT01370590|11429106|FG001|COMPLETED|Period 2||184
10296352|NCT01370590|11429105|FG000|NOT COMPLETED|Period 2||1
10296353|NCT01370590|11429106|FG001|NOT COMPLETED|Period 2||2
10296354|NCT01368185|11429112|FG000|STARTED|Overall Study||1705
10296355|NCT01368185|11429112|FG000|COMPLETED|Overall Study||1705
10296356|NCT01368185|11429112|FG000|NOT COMPLETED|Overall Study||0
10296357|NCT01349907|11429118|FG000|STARTED|Overall Study|Enrolled and Treated|241
10296358|NCT01349907|11429119|FG001|STARTED|Overall Study|Enrolled and Treated|81
10296359|NCT01349907|11429118|FG000|COMPLETED|Overall Study||102
10296360|NCT01349907|11429119|FG001|COMPLETED|Overall Study||38
10296361|NCT01349907|11429118|FG000|NOT COMPLETED|Overall Study||139
10296362|NCT01349907|11429119|FG001|NOT COMPLETED|Overall Study||43
10296363|NCT01345786|11429129|FG000|STARTED|Overall Study|Number randomized|41
10296364|NCT01345786|11429130|FG001|STARTED|Overall Study|Number randomized|41
10296365|NCT01345786|11429131|FG002|STARTED|Overall Study|Number randomized|38
10296366|NCT01345786|11429132|FG003|STARTED|Overall Study|Number randomized|38
10296367|NCT01345786|11429129|FG000|Treated|Overall Study||41
10296368|NCT01345786|11429130|FG001|Treated|Overall Study||41
10296369|NCT01345786|11429131|FG002|Treated|Overall Study||37
10296370|NCT01345786|11429132|FG003|Treated|Overall Study||37
10296371|NCT01345786|11429129|FG000|COMPLETED|Overall Study||35
10296372|NCT01345786|11429130|FG001|COMPLETED|Overall Study||33
10296373|NCT01345786|11429131|FG002|COMPLETED|Overall Study||33
10296374|NCT01345786|11429132|FG003|COMPLETED|Overall Study||35
10296375|NCT01345786|11429129|FG000|NOT COMPLETED|Overall Study||6
10296376|NCT01345786|11429130|FG001|NOT COMPLETED|Overall Study||8
10296377|NCT01345786|11429131|FG002|NOT COMPLETED|Overall Study||5
10296378|NCT01345786|11429132|FG003|NOT COMPLETED|Overall Study||3
10296379|NCT01306929|11429142|FG000|STARTED|Overall Study||134
10296380|NCT01306929|11429142|FG000|COMPLETED|Overall Study||40
10296381|NCT01306929|11429142|FG000|NOT COMPLETED|Overall Study||94
10296382|NCT01294696|11429148|FG000|STARTED|Overall Study||1261
10296383|NCT01294696|11429148|FG000|COMPLETED|Overall Study||1187
10296384|NCT01294696|11429148|FG000|NOT COMPLETED|Overall Study||74
10296385|NCT01277822|11429155|FG000|STARTED|Overall Study||168
10296386|NCT01277822|11429156|FG001|STARTED|Overall Study||166
10296387|NCT01277822|11429155|FG000|COMPLETED|Overall Study||153
10296388|NCT01277822|11429156|FG001|COMPLETED|Overall Study||155
10296389|NCT01277822|11429155|FG000|NOT COMPLETED|Overall Study||15
10296390|NCT01277822|11429156|FG001|NOT COMPLETED|Overall Study||11
10296391|NCT01244763|11429168|FG000|STARTED|Overall Study||24
10296392|NCT01244763|11429169|FG001|STARTED|Overall Study||24
10419844|NCT00812097|11564775|FG002|NOT COMPLETED|Overall Study||57
10419845|NCT00812097|11564776|FG003|NOT COMPLETED|Overall Study||35
10429485|NCT00863928|11575510|FG000|COMPLETED|Overall Study||58
10429486|NCT00863928|11575511|FG001|COMPLETED|Overall Study||41
10429487|NCT00863928|11575510|FG000|NOT COMPLETED|Overall Study||36
10429488|NCT00863928|11575511|FG001|NOT COMPLETED|Overall Study||0
10429489|NCT00864032|11575517|FG000|STARTED|Overall Study||3
10429490|NCT00864032|11575518|FG001|STARTED|Overall Study||5
10429491|NCT00864032|11575519|FG002|STARTED|Overall Study||0
10429492|NCT00864032|11575517|FG000|COMPLETED|Overall Study||3
10429493|NCT00864032|11575518|FG001|COMPLETED|Overall Study||5
10429494|NCT00864032|11575519|FG002|COMPLETED|Overall Study||0
10429495|NCT00864032|11575517|FG000|NOT COMPLETED|Overall Study||0
10429496|NCT00864032|11575518|FG001|NOT COMPLETED|Overall Study||0
10429497|NCT00864032|11575519|FG002|NOT COMPLETED|Overall Study||0
10429498|NCT00864084|11575525|FG000|STARTED|Overall Study||14
10429499|NCT00864084|11575525|FG000|COMPLETED|Overall Study||11
10429500|NCT00864084|11575525|FG000|NOT COMPLETED|Overall Study||3
10429501|NCT00864097|11575538|FG000|STARTED|Overall Study||154
10429502|NCT00864097|11575539|FG001|STARTED|Overall Study||157
10429503|NCT00864097|11575540|FG002|STARTED|Overall Study||151
10429504|NCT00864097|11575541|FG003|STARTED|Overall Study||145
10429505|NCT00864097|11575538|FG000|Treated|Overall Study||152
10429506|NCT00864097|11575539|FG001|Treated|Overall Study||157
10429507|NCT00864097|11575540|FG002|Treated|Overall Study||150
10429508|NCT00864097|11575541|FG003|Treated|Overall Study||145
10429509|NCT00864097|11575538|FG000|COMPLETED|Overall Study||15
10429510|NCT00864097|11575539|FG001|COMPLETED|Overall Study||20
10429511|NCT00864097|11575540|FG002|COMPLETED|Overall Study||19
10429512|NCT00864097|11575541|FG003|COMPLETED|Overall Study||20
10429513|NCT00864097|11575538|FG000|NOT COMPLETED|Overall Study||139
10429514|NCT00864097|11575539|FG001|NOT COMPLETED|Overall Study||137
10429515|NCT00864097|11575540|FG002|NOT COMPLETED|Overall Study||132
10429516|NCT00864097|11575541|FG003|NOT COMPLETED|Overall Study||125
10429517|NCT00864123|11575553|FG000|STARTED|Overall Study||15
10429518|NCT00864123|11575554|FG001|STARTED|Overall Study||15
10429519|NCT00864123|11575553|FG000|COMPLETED|Overall Study||15
10296393|NCT01244763|11429170|FG002|STARTED|Overall Study||24
10296394|NCT01244763|11429171|FG003|STARTED|Overall Study||24
10296395|NCT01244763|11429172|FG004|STARTED|Overall Study||24
10296396|NCT01244763|11429173|FG005|STARTED|Overall Study||25
10296397|NCT01244763|11429168|FG000|Safety Population|Overall Study||24
10296398|NCT01244763|11429169|FG001|Safety Population|Overall Study||24
10429520|NCT00864123|11575554|FG001|COMPLETED|Overall Study||15
10429521|NCT00864123|11575553|FG000|NOT COMPLETED|Overall Study||0
10429522|NCT00864123|11575554|FG001|NOT COMPLETED|Overall Study||0
10429523|NCT00864253|11575562|FG000|STARTED|Overall Study||264
10429524|NCT00864253|11575563|FG001|STARTED|Overall Study||265
10429525|NCT00864253|11575562|FG000|Treated|Overall Study||257
10429526|NCT00864253|11575563|FG001|Treated|Overall Study||258
10429527|NCT00864253|11575562|FG000|COMPLETED|Overall Study|Completed = defined as discontinuation due to progressive disease|165
10429528|NCT00864253|11575563|FG001|COMPLETED|Overall Study|Completed = defined as discontinuation due to progressive disease|207
10429529|NCT00864253|11575562|FG000|NOT COMPLETED|Overall Study||99
10429530|NCT00864253|11575563|FG001|NOT COMPLETED|Overall Study||58
10429531|NCT00864383|11575574|FG000|STARTED|Per- Protocol||640
10429532|NCT00864383|11575575|FG001|STARTED|Per- Protocol||655
10429533|NCT00864383|11575576|FG002|STARTED|Per- Protocol||636
10296399|NCT01244763|11429170|FG002|Safety Population|Overall Study||24
10296400|NCT01244763|11429171|FG003|Safety Population|Overall Study||24
10296401|NCT01244763|11429172|FG004|Safety Population|Overall Study||24
10296402|NCT01244763|11429173|FG005|Safety Population|Overall Study||25
10296403|NCT01244763|11429168|FG000|Efficacy Evaluable (EE) Population|Overall Study||23
10296404|NCT01244763|11429169|FG001|Efficacy Evaluable (EE) Population|Overall Study||24
10296405|NCT01244763|11429170|FG002|Efficacy Evaluable (EE) Population|Overall Study||23
10296406|NCT01244763|11429171|FG003|Efficacy Evaluable (EE) Population|Overall Study||24
10296407|NCT01244763|11429172|FG004|Efficacy Evaluable (EE) Population|Overall Study||24
10296408|NCT01244763|11429173|FG005|Efficacy Evaluable (EE) Population|Overall Study||25
10296409|NCT01244763|11429168|FG000|COMPLETED|Overall Study||21
10296410|NCT01244763|11429169|FG001|COMPLETED|Overall Study||21
10296411|NCT01244763|11429170|FG002|COMPLETED|Overall Study||22
10296412|NCT01244763|11429171|FG003|COMPLETED|Overall Study||23
10296413|NCT01244763|11429172|FG004|COMPLETED|Overall Study||21
10296414|NCT01244763|11429173|FG005|COMPLETED|Overall Study||21
10296415|NCT01244763|11429168|FG000|NOT COMPLETED|Overall Study||3
10296416|NCT01244763|11429169|FG001|NOT COMPLETED|Overall Study||3
10296417|NCT01244763|11429170|FG002|NOT COMPLETED|Overall Study||2
10296418|NCT01244763|11429171|FG003|NOT COMPLETED|Overall Study||1
10296419|NCT01244763|11429172|FG004|NOT COMPLETED|Overall Study||3
10296420|NCT01244763|11429173|FG005|NOT COMPLETED|Overall Study||4
10296421|NCT01208207|11429190|FG000|STARTED|Part I||702
10296422|NCT01208207|11429191|FG001|STARTED|Part I||156
10296423|NCT01208207|11429192|FG002|STARTED|Part I||157
10296424|NCT01208207|11429193|FG003|STARTED|Part I||0
10296425|NCT01208207|11429194|FG004|STARTED|Part I||0
10296426|NCT01208207|11429195|FG005|STARTED|Part I||0
10296427|NCT01208207|11429196|FG006|STARTED|Part I||0
10296428|NCT01208207|11429190|FG000|COMPLETED|Part I||632
10296429|NCT01208207|11429191|FG001|COMPLETED|Part I||145
10296430|NCT01208207|11429192|FG002|COMPLETED|Part I||142
10296431|NCT01208207|11429193|FG003|COMPLETED|Part I||0
10296432|NCT01208207|11429194|FG004|COMPLETED|Part I||0
10296433|NCT01208207|11429195|FG005|COMPLETED|Part I||0
10296434|NCT01208207|11429196|FG006|COMPLETED|Part I||0
10296435|NCT01208207|11429190|FG000|NOT COMPLETED|Part I||70
10296436|NCT01208207|11429191|FG001|NOT COMPLETED|Part I||11
10296437|NCT01208207|11429192|FG002|NOT COMPLETED|Part I||15
10296438|NCT01208207|11429193|FG003|NOT COMPLETED|Part I||0
10296439|NCT01208207|11429194|FG004|NOT COMPLETED|Part I||0
10296440|NCT01208207|11429195|FG005|NOT COMPLETED|Part I||0
10296441|NCT01208207|11429196|FG006|NOT COMPLETED|Part I||0
10296442|NCT01208207|11429190|FG000|STARTED|Part II||0
10296443|NCT01208207|11429191|FG001|STARTED|Part II||0
10296444|NCT01208207|11429192|FG002|STARTED|Part II||0
10296445|NCT01208207|11429193|FG003|STARTED|Part II||314
10296446|NCT01208207|11429194|FG004|STARTED|Part II||318
10296447|NCT01208207|11429195|FG005|STARTED|Part II||145
10296448|NCT01208207|11429196|FG006|STARTED|Part II||142
10296449|NCT01208207|11429190|FG000|COMPLETED|Part II||0
10296450|NCT01208207|11429191|FG001|COMPLETED|Part II||0
10296451|NCT01208207|11429192|FG002|COMPLETED|Part II||0
10296452|NCT01208207|11429193|FG003|COMPLETED|Part II||282
10296453|NCT01208207|11429194|FG004|COMPLETED|Part II||295
10296454|NCT01208207|11429195|FG005|COMPLETED|Part II||129
10296455|NCT01208207|11429196|FG006|COMPLETED|Part II||131
10296456|NCT01208207|11429190|FG000|NOT COMPLETED|Part II||0
10296457|NCT01208207|11429191|FG001|NOT COMPLETED|Part II||0
10296458|NCT01208207|11429192|FG002|NOT COMPLETED|Part II||0
10296459|NCT01208207|11429193|FG003|NOT COMPLETED|Part II||32
10296460|NCT01208207|11429194|FG004|NOT COMPLETED|Part II||23
10296461|NCT01208207|11429195|FG005|NOT COMPLETED|Part II||16
10296462|NCT01208207|11429196|FG006|NOT COMPLETED|Part II||11
10296463|NCT01208181|11429221|FG000|STARTED|Part 1||818
10296464|NCT01208181|11429222|FG001|STARTED|Part 1||468
10296465|NCT01208181|11429223|FG002|STARTED|Part 1||0
10296466|NCT01208181|11429224|FG003|STARTED|Part 1||0
10296467|NCT01208181|11429225|FG004|STARTED|Part 1||118
10296468|NCT01208181|11429221|FG000|COMPLETED|Part 1|Six participants from this arm did not continue into Part II of the study|719
10296469|NCT01208181|11429222|FG001|COMPLETED|Part 1|Per protocol, participants in this arm did not continue into Part II of the study|413
10296470|NCT01208181|11429223|FG002|COMPLETED|Part 1||0
10296471|NCT01208181|11429224|FG003|COMPLETED|Part 1||0
10296472|NCT01208181|11429225|FG004|COMPLETED|Part 1|Per protocol, participants in this arm did not continue into Part II of the study|96
10296473|NCT01208181|11429221|FG000|NOT COMPLETED|Part 1||99
10296474|NCT01208181|11429222|FG001|NOT COMPLETED|Part 1||55
10296475|NCT01208181|11429223|FG002|NOT COMPLETED|Part 1||0
10296476|NCT01208181|11429224|FG003|NOT COMPLETED|Part 1||0
10296477|NCT01208181|11429225|FG004|NOT COMPLETED|Part 1||22
10296478|NCT01208181|11429221|FG000|STARTED|Part 2|Per protocol, there were no participants in this arm during Part II of the study|0
10296479|NCT01208181|11429222|FG001|STARTED|Part 2|Per protocol, there were no participants in this arm during Part II of the study|0
10296480|NCT01208181|11429223|FG002|STARTED|Part 2|Participants receiving etoricoxib 60 mg in Part I received etoricoxib 60 mg in Part II of the study|350
10296481|NCT01208181|11429224|FG003|STARTED|Part 2|Participants receiving etoricoxib 60 mg in Part I received etoricoxib 90 mg in Part II of the study|363
10296482|NCT01208181|11429225|FG004|STARTED|Part 2|Per protocol, participants did not receive placebo during Part II of the study|0
10296483|NCT01208181|11429221|FG000|COMPLETED|Part 2||0
10296484|NCT01208181|11429222|FG001|COMPLETED|Part 2||0
10296485|NCT01208181|11429223|FG002|COMPLETED|Part 2||334
10296486|NCT01208181|11429224|FG003|COMPLETED|Part 2||343
10296487|NCT01208181|11429225|FG004|COMPLETED|Part 2||0
10296488|NCT01208181|11429221|FG000|NOT COMPLETED|Part 2||0
10296489|NCT01208181|11429222|FG001|NOT COMPLETED|Part 2||0
10296490|NCT01208181|11429223|FG002|NOT COMPLETED|Part 2||16
10296491|NCT01208181|11429224|FG003|NOT COMPLETED|Part 2||20
10419846|NCT00812110|11564786|FG000|STARTED|Overall Study||292
10419847|NCT00812110|11564786|FG000|COMPLETED|Overall Study||292
10419848|NCT00812110|11564786|FG000|NOT COMPLETED|Overall Study||0
10419849|NCT00812253|11564792|FG000|STARTED|Overall Study||32
10419850|NCT00812253|11564793|FG001|STARTED|Overall Study||42
10419851|NCT00812253|11564792|FG000|COMPLETED|Overall Study||26
10419852|NCT00812253|11564793|FG001|COMPLETED|Overall Study||39
10419853|NCT00812253|11564792|FG000|NOT COMPLETED|Overall Study||6
10419854|NCT00812253|11564793|FG001|NOT COMPLETED|Overall Study||3
10419855|NCT00812331|11564804|FG000|STARTED|Overall Study||6
10419856|NCT00812331|11564805|FG001|STARTED|Overall Study||8
10419857|NCT00812331|11564806|FG002|STARTED|Overall Study||8
10419858|NCT00812331|11564807|FG003|STARTED|Overall Study||7
10419859|NCT00812331|11564808|FG004|STARTED|Overall Study||8
10419860|NCT00812331|11564804|FG000|COMPLETED|Overall Study||5
10419861|NCT00812331|11564805|FG001|COMPLETED|Overall Study||8
10419862|NCT00812331|11564806|FG002|COMPLETED|Overall Study||8
10419863|NCT00812331|11564807|FG003|COMPLETED|Overall Study||7
10419864|NCT00812331|11564808|FG004|COMPLETED|Overall Study||8
10419865|NCT00812331|11564804|FG000|NOT COMPLETED|Overall Study||1
10419866|NCT00812331|11564805|FG001|NOT COMPLETED|Overall Study||0
10419867|NCT00812331|11564806|FG002|NOT COMPLETED|Overall Study||0
10419868|NCT00812331|11564807|FG003|NOT COMPLETED|Overall Study||0
10419869|NCT00812331|11564808|FG004|NOT COMPLETED|Overall Study||0
10419870|NCT00812461|11564818|FG000|STARTED|All Randomised Patients||360
10419871|NCT00812461|11564819|FG001|STARTED|All Randomised Patients||358
10419872|NCT00812461|11564818|FG000|COMPLETED|All Randomised Patients||337
10419873|NCT00812461|11564819|FG001|COMPLETED|All Randomised Patients||341
10546029|NCT01502306|11699572|FG001|COMPLETED|Overall Study||1405
10546030|NCT01502306|11699573|FG002|COMPLETED|Overall Study||1407
10546031|NCT01502306|11699571|FG000|NOT COMPLETED|Overall Study||0
10546032|NCT01502306|11699572|FG001|NOT COMPLETED|Overall Study||0
10546033|NCT01502306|11699573|FG002|NOT COMPLETED|Overall Study||0
10546034|NCT01502332|11699583|FG000|STARTED|Overall Study||157
10546035|NCT01502332|11699584|FG001|STARTED|Overall Study||163
10546036|NCT01502332|11699583|FG000|COMPLETED|Overall Study||157
10546037|NCT01502332|11699584|FG001|COMPLETED|Overall Study||163
10546038|NCT01502332|11699583|FG000|NOT COMPLETED|Overall Study||0
10546039|NCT01502332|11699584|FG001|NOT COMPLETED|Overall Study||0
10546040|NCT01502410|11699594|FG000|STARTED|Overall Study||10
10546041|NCT01502410|11699595|FG001|STARTED|Overall Study||10
10546042|NCT01502410|11699596|FG002|STARTED|Overall Study||0
10546043|NCT01502410|11699597|FG003|STARTED|Overall Study||0
10546044|NCT01502410|11699594|FG000|COMPLETED|Overall Study||0
10546045|NCT01502410|11699595|FG001|COMPLETED|Overall Study||0
10546046|NCT01502410|11699596|FG002|COMPLETED|Overall Study||0
10546047|NCT01502410|11699597|FG003|COMPLETED|Overall Study||0
10546048|NCT01502410|11699594|FG000|NOT COMPLETED|Overall Study||10
10546049|NCT01502410|11699595|FG001|NOT COMPLETED|Overall Study||10
10546050|NCT01502410|11699596|FG002|NOT COMPLETED|Overall Study||0
10546051|NCT01502410|11699597|FG003|NOT COMPLETED|Overall Study||0
10546052|NCT01502423|11699608|FG000|STARTED|Overall Study||31
10546053|NCT01502423|11699609|FG001|STARTED|Overall Study||30
10546054|NCT01502423|11699608|FG000|COMPLETED|Overall Study||31
10546055|NCT01502423|11699609|FG001|COMPLETED|Overall Study||29
10546056|NCT01502423|11699608|FG000|NOT COMPLETED|Overall Study||0
10546057|NCT01502423|11699609|FG001|NOT COMPLETED|Overall Study||1
10296492|NCT01208181|11429225|FG004|NOT COMPLETED|Part 2||0
10296493|NCT01206517|11429248|FG000|STARTED|Overall Study||6
10296494|NCT01206517|11429249|FG001|STARTED|Overall Study||6
10296495|NCT01206517|11429250|FG002|STARTED|Overall Study||6
10296496|NCT01206517|11429251|FG003|STARTED|Overall Study||4
10296497|NCT01206517|11429252|FG004|STARTED|Overall Study||4
10296498|NCT01206517|11429253|FG005|STARTED|Overall Study||4
10296499|NCT01206517|11429248|FG000|COMPLETED|Overall Study||6
10296500|NCT01206517|11429249|FG001|COMPLETED|Overall Study||6
10296501|NCT01206517|11429250|FG002|COMPLETED|Overall Study||4
10296502|NCT01206517|11429251|FG003|COMPLETED|Overall Study||4
10296503|NCT01206517|11429252|FG004|COMPLETED|Overall Study||3
10296504|NCT01206517|11429253|FG005|COMPLETED|Overall Study||4
10296505|NCT01206517|11429248|FG000|NOT COMPLETED|Overall Study||0
10296506|NCT01206517|11429249|FG001|NOT COMPLETED|Overall Study||0
10296507|NCT01206517|11429250|FG002|NOT COMPLETED|Overall Study||2
10296508|NCT01206517|11429251|FG003|NOT COMPLETED|Overall Study||0
10296509|NCT01206517|11429252|FG004|NOT COMPLETED|Overall Study||1
10296510|NCT01206517|11429253|FG005|NOT COMPLETED|Overall Study||0
10296511|NCT01190267|11429266|FG000|STARTED|Overall Study||196
10296512|NCT01190267|11429267|FG001|STARTED|Overall Study||8
10296513|NCT01190267|11429266|FG000|COMPLETED|Overall Study||155
10296514|NCT01190267|11429267|FG001|COMPLETED|Overall Study||4
10296515|NCT01190267|11429266|FG000|NOT COMPLETED|Overall Study||41
10296516|NCT01190267|11429267|FG001|NOT COMPLETED|Overall Study||4
10296517|NCT01190254|11429276|FG000|STARTED|Overall Study||102
10419874|NCT00812461|11564818|FG000|NOT COMPLETED|All Randomised Patients||23
10419875|NCT00812461|11564819|FG001|NOT COMPLETED|All Randomised Patients||17
10419876|NCT00812461|11564818|FG000|STARTED|All Treated Patients||337
10419877|NCT00812461|11564819|FG001|STARTED|All Treated Patients||341
10546058|NCT01502631|11699617|FG000|STARTED|Overall Study||30
10546059|NCT01502631|11699618|FG001|STARTED|Overall Study||31
10296518|NCT01190254|11429277|FG001|STARTED|Overall Study||98
10296519|NCT01190254|11429278|FG002|STARTED|Overall Study||106
10296520|NCT01190254|11429276|FG000|Treated|Overall Study||102
10296521|NCT01190254|11429277|FG001|Treated|Overall Study||98
10296522|NCT01190254|11429278|FG002|Treated|Overall Study||106
10296523|NCT01190254|11429276|FG000|COMPLETED|Overall Study||81
10296524|NCT01190254|11429277|FG001|COMPLETED|Overall Study||81
10296525|NCT01190254|11429278|FG002|COMPLETED|Overall Study||84
10296526|NCT01190254|11429276|FG000|NOT COMPLETED|Overall Study||21
10296527|NCT01190254|11429277|FG001|NOT COMPLETED|Overall Study||17
10296528|NCT01190254|11429278|FG002|NOT COMPLETED|Overall Study||22
10296529|NCT01154036|11429289|FG000|STARTED|Phase I||120
10296530|NCT01154036|11429290|FG001|STARTED|Phase I||483
10296531|NCT01154036|11429291|FG002|STARTED|Phase I||944
10296532|NCT01154036|11429292|FG003|STARTED|Phase I||0
10296533|NCT01154036|11429293|FG004|STARTED|Phase I||0
10296534|NCT01154036|11429294|FG005|STARTED|Phase I||0
10296535|NCT01154036|11429295|FG006|STARTED|Phase I||0
10296536|NCT01154036|11429296|FG007|STARTED|Phase I||0
10296537|NCT01154036|11429289|FG000|COMPLETED|Phase I|Not all completers were eligible for Phase II|117
10296538|NCT01154036|11429290|FG001|COMPLETED|Phase I|Not all completers were eligible for Phase II|455
10296539|NCT01154036|11429291|FG002|COMPLETED|Phase I|Not all completers were eligible for Phase II|888
10296540|NCT01154036|11429292|FG003|COMPLETED|Phase I||0
10296541|NCT01154036|11429293|FG004|COMPLETED|Phase I||0
10296542|NCT01154036|11429294|FG005|COMPLETED|Phase I||0
10296543|NCT01154036|11429295|FG006|COMPLETED|Phase I||0
10296544|NCT01154036|11429296|FG007|COMPLETED|Phase I||0
10296545|NCT01154036|11429289|FG000|NOT COMPLETED|Phase I||3
10296546|NCT01154036|11429290|FG001|NOT COMPLETED|Phase I||28
10296547|NCT01154036|11429291|FG002|NOT COMPLETED|Phase I||56
10296548|NCT01154036|11429292|FG003|NOT COMPLETED|Phase I||0
10296549|NCT01154036|11429293|FG004|NOT COMPLETED|Phase I||0
10296550|NCT01154036|11429294|FG005|NOT COMPLETED|Phase I||0
10296551|NCT01154036|11429295|FG006|NOT COMPLETED|Phase I||0
10296552|NCT01154036|11429296|FG007|NOT COMPLETED|Phase I||0
10296553|NCT01154036|11429289|FG000|STARTED|Phase II||0
10296554|NCT01154036|11429290|FG001|STARTED|Phase II||0
10296555|NCT01154036|11429291|FG002|STARTED|Phase II||0
10296556|NCT01154036|11429292|FG003|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|28
10296557|NCT01154036|11429293|FG004|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|124
10296558|NCT01154036|11429294|FG005|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|126
10296559|NCT01154036|11429295|FG006|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|234
10296560|NCT01154036|11429296|FG007|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|206
10296561|NCT01154036|11429289|FG000|COMPLETED|Phase II||0
10296562|NCT01154036|11429290|FG001|COMPLETED|Phase II||0
10296563|NCT01154036|11429291|FG002|COMPLETED|Phase II||0
10296564|NCT01154036|11429292|FG003|COMPLETED|Phase II||27
10296565|NCT01154036|11429293|FG004|COMPLETED|Phase II||116
10296566|NCT01154036|11429294|FG005|COMPLETED|Phase II||121
10296567|NCT01154036|11429295|FG006|COMPLETED|Phase II||225
10296568|NCT01154036|11429296|FG007|COMPLETED|Phase II||200
10296569|NCT01154036|11429289|FG000|NOT COMPLETED|Phase II||0
10296570|NCT01154036|11429290|FG001|NOT COMPLETED|Phase II||0
10296571|NCT01154036|11429291|FG002|NOT COMPLETED|Phase II||0
10296572|NCT01154036|11429292|FG003|NOT COMPLETED|Phase II||1
10296573|NCT01154036|11429293|FG004|NOT COMPLETED|Phase II||8
10296574|NCT01154036|11429294|FG005|NOT COMPLETED|Phase II||5
10296575|NCT01154036|11429295|FG006|NOT COMPLETED|Phase II||9
10296576|NCT01154036|11429296|FG007|NOT COMPLETED|Phase II||6
10296577|NCT01101464|11429318|FG000|STARTED|Day 1 Through AM Dose of Day 5||4
10296578|NCT01101464|11429319|FG001|STARTED|Day 1 Through AM Dose of Day 5||4
10296579|NCT01101464|11429318|FG000|COMPLETED|Day 1 Through AM Dose of Day 5||4
10296580|NCT01101464|11429319|FG001|COMPLETED|Day 1 Through AM Dose of Day 5||4
10296581|NCT01101464|11429318|FG000|NOT COMPLETED|Day 1 Through AM Dose of Day 5||0
10296582|NCT01101464|11429319|FG001|NOT COMPLETED|Day 1 Through AM Dose of Day 5||0
10296583|NCT01101464|11429318|FG000|STARTED|PM Dose of Day 5 Through AM Dose of Day7||4
10296584|NCT01101464|11429319|FG001|STARTED|PM Dose of Day 5 Through AM Dose of Day7||4
10296585|NCT01101464|11429318|FG000|COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||4
10296586|NCT01101464|11429319|FG001|COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||4
10314973|NCT00171249|11448708|FG001|NOT COMPLETED|Overall Study||5
10419878|NCT00812461|11564818|FG000|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|205
10419879|NCT00812461|11564819|FG001|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|194
10419880|NCT00812461|11564818|FG000|NOT COMPLETED|All Treated Patients||132
10419881|NCT00812461|11564819|FG001|NOT COMPLETED|All Treated Patients||147
10419882|NCT00812487|11564827|FG000|STARTED|Overall Study||32
10419883|NCT00812487|11564828|FG001|STARTED|Overall Study||42
10419884|NCT00812487|11564827|FG000|COMPLETED|Overall Study||26
10419885|NCT00812487|11564828|FG001|COMPLETED|Overall Study||39
10419886|NCT00812487|11564827|FG000|NOT COMPLETED|Overall Study||6
10419887|NCT00812487|11564828|FG001|NOT COMPLETED|Overall Study||3
10419888|NCT00812565|11564842|FG000|STARTED|Overall Study||8
10419889|NCT00812565|11564843|FG001|STARTED|Overall Study||7
10419890|NCT00812565|11564844|FG002|STARTED|Overall Study||7
10419891|NCT00812565|11564845|FG003|STARTED|Overall Study||7
10419892|NCT00812565|11564846|FG004|STARTED|Overall Study||7
10419893|NCT00812565|11564847|FG005|STARTED|Overall Study||7
10296587|NCT01101464|11429318|FG000|NOT COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||0
10296588|NCT01101464|11429319|FG001|NOT COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||0
10296589|NCT01098071|11429327|FG000|STARTED|Overall Study||34
10296590|NCT01098071|11429327|FG000|COMPLETED|Overall Study||19
10296591|NCT01098071|11429327|FG000|NOT COMPLETED|Overall Study||15
10296592|NCT01077830|11429333|FG000|STARTED|Overall Study||677
10296593|NCT01077830|11429334|FG001|STARTED|Overall Study||682
10296594|NCT01077830|11429333|FG000|COMPLETED|Overall Study||677
10296595|NCT01077830|11429334|FG001|COMPLETED|Overall Study||682
10296596|NCT01077830|11429333|FG000|NOT COMPLETED|Overall Study||0
10296597|NCT01077830|11429334|FG001|NOT COMPLETED|Overall Study||0
10296598|NCT01070966|11429340|FG000|STARTED|Participants for Safety Evaluation||2089
10296599|NCT01070966|11429340|FG000|COMPLETED|Participants for Safety Evaluation||2011
10296600|NCT01070966|11429340|FG000|NOT COMPLETED|Participants for Safety Evaluation||78
10296601|NCT01070966|11429340|FG000|STARTED|Participants for Efficacy Evaluation||2011
10296602|NCT01070966|11429340|FG000|COMPLETED|Participants for Efficacy Evaluation||1929
10296603|NCT01070966|11429340|FG000|NOT COMPLETED|Participants for Efficacy Evaluation||82
10296604|NCT01070953|11429351|FG000|STARTED|Participants for Safety Evaluation||4467
10296605|NCT01070953|11429351|FG000|COMPLETED|Participants for Safety Evaluation||3536
10296606|NCT01070953|11429351|FG000|NOT COMPLETED|Participants for Safety Evaluation||931
10296607|NCT01070953|11429351|FG000|STARTED|Participants for Efficacy Evaluation||3536
10296608|NCT01070953|11429351|FG000|COMPLETED|Participants for Efficacy Evaluation||3309
10296609|NCT01070953|11429351|FG000|NOT COMPLETED|Participants for Efficacy Evaluation||227
10296610|NCT01030341|11429361|FG000|STARTED|Overall Study|45 participants met all enrollment criteria by completing the screening and run-in phases|45
10296611|NCT01030341|11429361|FG000|COMPLETED|Overall Study|42 participants completed the study|42
10296612|NCT01030341|11429361|FG000|NOT COMPLETED|Overall Study||3
10296613|NCT00979901|11429369|FG000|STARTED|Overall Study||352
10296614|NCT00979901|11429370|FG001|STARTED|Overall Study||348
10296615|NCT00979901|11429371|FG002|STARTED|Overall Study||602
10296616|NCT00979901|11429372|FG003|STARTED|Overall Study||275
10296617|NCT00979901|11429369|FG000|COMPLETED|Overall Study||334
10296618|NCT00979901|11429370|FG001|COMPLETED|Overall Study||336
10296619|NCT00979901|11429371|FG002|COMPLETED|Overall Study||573
10296620|NCT00979901|11429372|FG003|COMPLETED|Overall Study||159
10296621|NCT00979901|11429369|FG000|NOT COMPLETED|Overall Study||18
10296622|NCT00979901|11429370|FG001|NOT COMPLETED|Overall Study||12
10296623|NCT00979901|11429371|FG002|NOT COMPLETED|Overall Study||29
10296624|NCT00979901|11429372|FG003|NOT COMPLETED|Overall Study||116
10296625|NCT00963599|11429385|FG000|STARTED|Overall Study||149
10296626|NCT00963599|11429386|FG001|STARTED|Overall Study||155
10296627|NCT00963599|11429387|FG002|STARTED|Overall Study||301
10296628|NCT00963599|11429388|FG003|STARTED|Overall Study||302
10296629|NCT00963599|11429385|FG000|COMPLETED|Overall Study||143
10296630|NCT00963599|11429386|FG001|COMPLETED|Overall Study||149
10296631|NCT00963599|11429387|FG002|COMPLETED|Overall Study||292
10296632|NCT00963599|11429388|FG003|COMPLETED|Overall Study||288
10296633|NCT00963599|11429385|FG000|NOT COMPLETED|Overall Study||6
10296634|NCT00963599|11429386|FG001|NOT COMPLETED|Overall Study||6
10296635|NCT00963599|11429387|FG002|NOT COMPLETED|Overall Study||9
10296636|NCT00963599|11429388|FG003|NOT COMPLETED|Overall Study||14
10296637|NCT00954915|11429398|FG000|STARTED|Overall Study||1
10296638|NCT00954915|11429398|FG000|COMPLETED|Overall Study||1
10296639|NCT00954915|11429398|FG000|NOT COMPLETED|Overall Study||0
10296640|NCT00953680|11429403|FG000|STARTED|Period 1||38
10296641|NCT00953680|11429404|FG001|STARTED|Period 1||39
10296642|NCT00953680|11429403|FG000|COMPLETED|Period 1||38
10296643|NCT00953680|11429404|FG001|COMPLETED|Period 1||38
10296644|NCT00953680|11429403|FG000|NOT COMPLETED|Period 1||0
10296645|NCT00953680|11429404|FG001|NOT COMPLETED|Period 1||1
10296646|NCT00953680|11429403|FG000|STARTED|Period 2||38
10296647|NCT00953680|11429404|FG001|STARTED|Period 2||38
10296648|NCT00953680|11429403|FG000|COMPLETED|Period 2||38
10296649|NCT00953680|11429404|FG001|COMPLETED|Period 2||38
10296650|NCT00953680|11429403|FG000|NOT COMPLETED|Period 2||0
10296651|NCT00953680|11429404|FG001|NOT COMPLETED|Period 2||0
10296652|NCT00945035|11429410|FG000|STARTED|Period 1||18
10296653|NCT00945035|11429411|FG001|STARTED|Period 1||18
10296654|NCT00945035|11429410|FG000|COMPLETED|Period 1||18
10296655|NCT00945035|11429411|FG001|COMPLETED|Period 1||18
10296656|NCT00945035|11429410|FG000|NOT COMPLETED|Period 1||0
10296657|NCT00945035|11429411|FG001|NOT COMPLETED|Period 1||0
10296658|NCT00945035|11429410|FG000|STARTED|Period 2||18
10419894|NCT00812565|11564848|FG006|STARTED|Overall Study||8
10419895|NCT00812565|11564849|FG007|STARTED|Overall Study||7
10296659|NCT00945035|11429411|FG001|STARTED|Period 2||18
10296660|NCT00945035|11429410|FG000|COMPLETED|Period 2||18
10296661|NCT00945035|11429411|FG001|COMPLETED|Period 2||18
10296662|NCT00945035|11429410|FG000|NOT COMPLETED|Period 2||0
10296663|NCT00945035|11429411|FG001|NOT COMPLETED|Period 2||0
10296664|NCT00943852|11429417|FG000|STARTED|First Period of Treatment Intervention||2
10296665|NCT00943852|11429418|FG001|STARTED|First Period of Treatment Intervention||1
10296666|NCT00943852|11429419|FG002|STARTED|First Period of Treatment Intervention||1
10296667|NCT00943852|11429420|FG003|STARTED|First Period of Treatment Intervention||2
10296668|NCT00943852|11429421|FG004|STARTED|First Period of Treatment Intervention||1
10296669|NCT00943852|11429422|FG005|STARTED|First Period of Treatment Intervention||1
10296670|NCT00943852|11429423|FG006|STARTED|First Period of Treatment Intervention||2
10296671|NCT00943852|11429424|FG007|STARTED|First Period of Treatment Intervention||1
10419896|NCT00812565|11564842|FG000|COMPLETED|Overall Study||5
10296672|NCT00943852|11429425|FG008|STARTED|First Period of Treatment Intervention||1
10296673|NCT00943852|11429426|FG009|STARTED|First Period of Treatment Intervention||1
10296674|NCT00943852|11429417|FG000|COMPLETED|First Period of Treatment Intervention||2
10296675|NCT00943852|11429418|FG001|COMPLETED|First Period of Treatment Intervention||1
10296676|NCT00943852|11429419|FG002|COMPLETED|First Period of Treatment Intervention||1
10296677|NCT00943852|11429420|FG003|COMPLETED|First Period of Treatment Intervention||2
10296678|NCT00943852|11429421|FG004|COMPLETED|First Period of Treatment Intervention||1
10296679|NCT00943852|11429422|FG005|COMPLETED|First Period of Treatment Intervention||1
10296680|NCT00943852|11429423|FG006|COMPLETED|First Period of Treatment Intervention||2
10296681|NCT00943852|11429424|FG007|COMPLETED|First Period of Treatment Intervention||1
10296682|NCT00943852|11429425|FG008|COMPLETED|First Period of Treatment Intervention||1
10296683|NCT00943852|11429426|FG009|COMPLETED|First Period of Treatment Intervention||1
10296684|NCT00943852|11429417|FG000|NOT COMPLETED|First Period of Treatment Intervention||0
10296685|NCT00943852|11429418|FG001|NOT COMPLETED|First Period of Treatment Intervention||0
10296686|NCT00943852|11429419|FG002|NOT COMPLETED|First Period of Treatment Intervention||0
10296687|NCT00943852|11429420|FG003|NOT COMPLETED|First Period of Treatment Intervention||0
10296688|NCT00943852|11429421|FG004|NOT COMPLETED|First Period of Treatment Intervention||0
10296689|NCT00943852|11429422|FG005|NOT COMPLETED|First Period of Treatment Intervention||0
10296690|NCT00943852|11429423|FG006|NOT COMPLETED|First Period of Treatment Intervention||0
10296691|NCT00943852|11429424|FG007|NOT COMPLETED|First Period of Treatment Intervention||0
10296692|NCT00943852|11429425|FG008|NOT COMPLETED|First Period of Treatment Intervention||0
10296693|NCT00943852|11429426|FG009|NOT COMPLETED|First Period of Treatment Intervention||0
10296694|NCT00943852|11429417|FG000|STARTED|Washout Period After Period 1 Treatment||2
10296695|NCT00943852|11429418|FG001|STARTED|Washout Period After Period 1 Treatment||1
10296696|NCT00943852|11429419|FG002|STARTED|Washout Period After Period 1 Treatment||1
10296697|NCT00943852|11429420|FG003|STARTED|Washout Period After Period 1 Treatment||2
10296698|NCT00943852|11429421|FG004|STARTED|Washout Period After Period 1 Treatment||1
10296699|NCT00943852|11429422|FG005|STARTED|Washout Period After Period 1 Treatment||1
10296700|NCT00943852|11429423|FG006|STARTED|Washout Period After Period 1 Treatment||2
10296701|NCT00943852|11429424|FG007|STARTED|Washout Period After Period 1 Treatment||1
10296702|NCT00943852|11429425|FG008|STARTED|Washout Period After Period 1 Treatment||1
10296703|NCT00943852|11429426|FG009|STARTED|Washout Period After Period 1 Treatment||1
10296704|NCT00943852|11429417|FG000|COMPLETED|Washout Period After Period 1 Treatment||2
10296705|NCT00943852|11429418|FG001|COMPLETED|Washout Period After Period 1 Treatment||1
10296706|NCT00943852|11429419|FG002|COMPLETED|Washout Period After Period 1 Treatment||1
10296707|NCT00943852|11429420|FG003|COMPLETED|Washout Period After Period 1 Treatment||1
10296708|NCT00943852|11429421|FG004|COMPLETED|Washout Period After Period 1 Treatment||1
10296709|NCT00943852|11429422|FG005|COMPLETED|Washout Period After Period 1 Treatment||1
10296710|NCT00943852|11429423|FG006|COMPLETED|Washout Period After Period 1 Treatment||2
10296711|NCT00943852|11429424|FG007|COMPLETED|Washout Period After Period 1 Treatment||1
10296712|NCT00943852|11429425|FG008|COMPLETED|Washout Period After Period 1 Treatment||1
10296713|NCT00943852|11429426|FG009|COMPLETED|Washout Period After Period 1 Treatment||1
10296714|NCT00943852|11429417|FG000|NOT COMPLETED|Washout Period After Period 1 Treatment||0
10296715|NCT00943852|11429418|FG001|NOT COMPLETED|Washout Period After Period 1 Treatment||0
10296716|NCT00943852|11429419|FG002|NOT COMPLETED|Washout Period After Period 1 Treatment||0
10296717|NCT00943852|11429420|FG003|NOT COMPLETED|Washout Period After Period 1 Treatment||1
10296718|NCT00943852|11429421|FG004|NOT COMPLETED|Washout Period After Period 1 Treatment||0
10296719|NCT00943852|11429422|FG005|NOT COMPLETED|Washout Period After Period 1 Treatment||0
10296720|NCT00943852|11429423|FG006|NOT COMPLETED|Washout Period After Period 1 Treatment||0
10296721|NCT00943852|11429424|FG007|NOT COMPLETED|Washout Period After Period 1 Treatment||0
10296722|NCT00943852|11429425|FG008|NOT COMPLETED|Washout Period After Period 1 Treatment||0
10296723|NCT00943852|11429426|FG009|NOT COMPLETED|Washout Period After Period 1 Treatment||0
10296724|NCT00943852|11429417|FG000|STARTED|Second Period of Treatment Intervention||2
10296725|NCT00943852|11429418|FG001|STARTED|Second Period of Treatment Intervention||1
10296726|NCT00943852|11429419|FG002|STARTED|Second Period of Treatment Intervention||1
10296727|NCT00943852|11429420|FG003|STARTED|Second Period of Treatment Intervention||1
10296728|NCT00943852|11429421|FG004|STARTED|Second Period of Treatment Intervention||1
10296729|NCT00943852|11429422|FG005|STARTED|Second Period of Treatment Intervention||1
10296730|NCT00943852|11429423|FG006|STARTED|Second Period of Treatment Intervention||2
10296731|NCT00943852|11429424|FG007|STARTED|Second Period of Treatment Intervention||1
10296732|NCT00943852|11429425|FG008|STARTED|Second Period of Treatment Intervention||1
10296733|NCT00943852|11429426|FG009|STARTED|Second Period of Treatment Intervention||1
10296734|NCT00943852|11429417|FG000|COMPLETED|Second Period of Treatment Intervention||2
10296735|NCT00943852|11429418|FG001|COMPLETED|Second Period of Treatment Intervention||1
10296736|NCT00943852|11429419|FG002|COMPLETED|Second Period of Treatment Intervention||1
10296737|NCT00943852|11429420|FG003|COMPLETED|Second Period of Treatment Intervention||1
10296738|NCT00943852|11429421|FG004|COMPLETED|Second Period of Treatment Intervention||1
10296739|NCT00943852|11429422|FG005|COMPLETED|Second Period of Treatment Intervention||1
10296740|NCT00943852|11429423|FG006|COMPLETED|Second Period of Treatment Intervention||2
10296741|NCT00943852|11429424|FG007|COMPLETED|Second Period of Treatment Intervention||1
10296742|NCT00943852|11429425|FG008|COMPLETED|Second Period of Treatment Intervention||1
10296743|NCT00943852|11429426|FG009|COMPLETED|Second Period of Treatment Intervention||1
10296744|NCT00943852|11429417|FG000|NOT COMPLETED|Second Period of Treatment Intervention||0
10296745|NCT00943852|11429418|FG001|NOT COMPLETED|Second Period of Treatment Intervention||0
10296746|NCT00943852|11429419|FG002|NOT COMPLETED|Second Period of Treatment Intervention||0
10296747|NCT00943852|11429420|FG003|NOT COMPLETED|Second Period of Treatment Intervention||0
10296748|NCT00943852|11429421|FG004|NOT COMPLETED|Second Period of Treatment Intervention||0
10296749|NCT00943852|11429422|FG005|NOT COMPLETED|Second Period of Treatment Intervention||0
10296750|NCT00943852|11429423|FG006|NOT COMPLETED|Second Period of Treatment Intervention||0
10296751|NCT00943852|11429424|FG007|NOT COMPLETED|Second Period of Treatment Intervention||0
10296752|NCT00943852|11429425|FG008|NOT COMPLETED|Second Period of Treatment Intervention||0
10296753|NCT00943852|11429426|FG009|NOT COMPLETED|Second Period of Treatment Intervention||0
10296754|NCT00943852|11429417|FG000|STARTED|Washout Period After Period 2 Treatment||2
10296755|NCT00943852|11429418|FG001|STARTED|Washout Period After Period 2 Treatment||1
10296756|NCT00943852|11429419|FG002|STARTED|Washout Period After Period 2 Treatment||1
10296757|NCT00943852|11429420|FG003|STARTED|Washout Period After Period 2 Treatment||1
10419897|NCT00812565|11564843|FG001|COMPLETED|Overall Study||6
10419898|NCT00812565|11564844|FG002|COMPLETED|Overall Study||7
10419899|NCT00812565|11564845|FG003|COMPLETED|Overall Study||5
10419900|NCT00812565|11564846|FG004|COMPLETED|Overall Study||6
10419901|NCT00812565|11564847|FG005|COMPLETED|Overall Study||6
10419902|NCT00812565|11564848|FG006|COMPLETED|Overall Study||8
10419903|NCT00812565|11564849|FG007|COMPLETED|Overall Study||6
10419904|NCT00812565|11564842|FG000|NOT COMPLETED|Overall Study||3
10419905|NCT00812565|11564843|FG001|NOT COMPLETED|Overall Study||1
10419906|NCT00812565|11564844|FG002|NOT COMPLETED|Overall Study||0
10419907|NCT00812565|11564845|FG003|NOT COMPLETED|Overall Study||2
10419908|NCT00812565|11564846|FG004|NOT COMPLETED|Overall Study||1
10419909|NCT00812565|11564847|FG005|NOT COMPLETED|Overall Study||1
10419910|NCT00812565|11564848|FG006|NOT COMPLETED|Overall Study||0
10419911|NCT00812565|11564849|FG007|NOT COMPLETED|Overall Study||1
10419912|NCT00812604|11564869|FG000|STARTED|Overall Study||28
10419913|NCT00812604|11564870|FG001|STARTED|Overall Study||27
10419914|NCT00812604|11564869|FG000|COMPLETED|Overall Study||23
10419915|NCT00812604|11564870|FG001|COMPLETED|Overall Study||22
10419916|NCT00812604|11564869|FG000|NOT COMPLETED|Overall Study||5
10546060|NCT01502631|11699617|FG000|COMPLETED|Overall Study||10
10755732|NCT03070782|11919544|FG000|COMPLETED|Overall Study||41
10755733|NCT03070782|11919545|FG001|COMPLETED|Overall Study||47
10755734|NCT03070782|11919546|FG002|COMPLETED|Overall Study||43
10755735|NCT03070782|11919547|FG003|COMPLETED|Overall Study||43
10755736|NCT03070782|11919548|FG004|COMPLETED|Overall Study||36
10755737|NCT03070782|11919549|FG005|COMPLETED|Overall Study||40
10755738|NCT03070782|11919544|FG000|NOT COMPLETED|Overall Study||7
10755739|NCT03070782|11919545|FG001|NOT COMPLETED|Overall Study||1
10755740|NCT03070782|11919546|FG002|NOT COMPLETED|Overall Study||4
10419917|NCT00812604|11564870|FG001|NOT COMPLETED|Overall Study||5
10419918|NCT00812812|11564878|FG000|STARTED|Overall Study||27
10419919|NCT00812812|11564879|FG001|STARTED|Overall Study||29
10419920|NCT00812812|11564878|FG000|COMPLETED|Overall Study||24
10419921|NCT00812812|11564879|FG001|COMPLETED|Overall Study||25
10419922|NCT00812812|11564878|FG000|NOT COMPLETED|Overall Study||3
10419923|NCT00812812|11564879|FG001|NOT COMPLETED|Overall Study||4
10419924|NCT00812838|11564889|FG000|STARTED|Treatment Period of 16 Weeks||6
10419925|NCT00812838|11564890|FG001|STARTED|Treatment Period of 16 Weeks||6
10419926|NCT00812838|11564889|FG000|COMPLETED|Treatment Period of 16 Weeks||6
10419927|NCT00812838|11564890|FG001|COMPLETED|Treatment Period of 16 Weeks||6
10419928|NCT00812838|11564889|FG000|NOT COMPLETED|Treatment Period of 16 Weeks||0
10419929|NCT00812838|11564890|FG001|NOT COMPLETED|Treatment Period of 16 Weeks||0
10419930|NCT00812838|11564889|FG000|STARTED|Optional Crossover of 16 Weeks||0
10419931|NCT00812838|11564890|FG001|STARTED|Optional Crossover of 16 Weeks||4
10419932|NCT00812838|11564889|FG000|COMPLETED|Optional Crossover of 16 Weeks||0
10419933|NCT00812838|11564890|FG001|COMPLETED|Optional Crossover of 16 Weeks||4
10419934|NCT00812838|11564889|FG000|NOT COMPLETED|Optional Crossover of 16 Weeks||0
10419935|NCT00812838|11564890|FG001|NOT COMPLETED|Optional Crossover of 16 Weeks||0
10419936|NCT00812877|11564900|FG000|STARTED|Overall Study||195
10419937|NCT00812877|11564901|FG001|STARTED|Overall Study||181
10419938|NCT00812877|11564900|FG000|COMPLETED|Overall Study||158
10419939|NCT00812877|11564901|FG001|COMPLETED|Overall Study||130
10419940|NCT00812877|11564900|FG000|NOT COMPLETED|Overall Study||37
10419941|NCT00812877|11564901|FG001|NOT COMPLETED|Overall Study||51
10419942|NCT00812916|11564907|FG000|STARTED|Overall Study|206 enrolled (consented)|206
10755741|NCT03070782|11919547|FG003|NOT COMPLETED|Overall Study||5
10419943|NCT00812916|11564907|FG000|Data Available|Overall Study||205
10419944|NCT00812916|11564907|FG000|CFAE - Guided Ablation|Overall Study||203
10419945|NCT00812916|11564907|FG000|COMPLETED|Overall Study||203
10419946|NCT00812916|11564907|FG000|NOT COMPLETED|Overall Study||3
10419947|NCT00812929|11564913|FG000|STARTED|Treatment Period 1||5
10419948|NCT00812929|11564914|FG001|STARTED|Treatment Period 1||4
10419949|NCT00812929|11564915|FG002|STARTED|Treatment Period 1||5
10546061|NCT01502631|11699618|FG001|COMPLETED|Overall Study||11
10755742|NCT03070782|11919548|FG004|NOT COMPLETED|Overall Study||12
10419950|NCT00812929|11564916|FG003|STARTED|Treatment Period 1||4
10419951|NCT00812929|11564917|FG004|STARTED|Treatment Period 1||5
10419952|NCT00812929|11564918|FG005|STARTED|Treatment Period 1||5
10419953|NCT00812929|11564919|FG006|STARTED|Treatment Period 1||5
10296758|NCT00943852|11429421|FG004|STARTED|Washout Period After Period 2 Treatment||1
10296759|NCT00943852|11429422|FG005|STARTED|Washout Period After Period 2 Treatment||1
10296760|NCT00943852|11429423|FG006|STARTED|Washout Period After Period 2 Treatment||2
10296761|NCT00943852|11429424|FG007|STARTED|Washout Period After Period 2 Treatment||1
10296762|NCT00943852|11429425|FG008|STARTED|Washout Period After Period 2 Treatment||1
10296763|NCT00943852|11429426|FG009|STARTED|Washout Period After Period 2 Treatment||1
10296764|NCT00943852|11429417|FG000|COMPLETED|Washout Period After Period 2 Treatment||2
10296765|NCT00943852|11429418|FG001|COMPLETED|Washout Period After Period 2 Treatment||1
10296766|NCT00943852|11429419|FG002|COMPLETED|Washout Period After Period 2 Treatment||1
10296767|NCT00943852|11429420|FG003|COMPLETED|Washout Period After Period 2 Treatment||1
10296768|NCT00943852|11429421|FG004|COMPLETED|Washout Period After Period 2 Treatment||1
10296769|NCT00943852|11429422|FG005|COMPLETED|Washout Period After Period 2 Treatment||0
10296770|NCT00943852|11429423|FG006|COMPLETED|Washout Period After Period 2 Treatment||2
10296771|NCT00943852|11429424|FG007|COMPLETED|Washout Period After Period 2 Treatment||1
10296772|NCT00943852|11429425|FG008|COMPLETED|Washout Period After Period 2 Treatment||1
10419954|NCT00812929|11564920|FG007|STARTED|Treatment Period 1||5
10419955|NCT00812929|11564921|FG008|STARTED|Treatment Period 1||4
10419956|NCT00812929|11564922|FG009|STARTED|Treatment Period 1||5
10419957|NCT00812929|11564913|FG000|COMPLETED|Treatment Period 1||5
10419958|NCT00812929|11564914|FG001|COMPLETED|Treatment Period 1||4
10419959|NCT00812929|11564915|FG002|COMPLETED|Treatment Period 1||5
10419960|NCT00812929|11564916|FG003|COMPLETED|Treatment Period 1||4
10419961|NCT00812929|11564917|FG004|COMPLETED|Treatment Period 1||5
10419962|NCT00812929|11564918|FG005|COMPLETED|Treatment Period 1||5
10419963|NCT00812929|11564919|FG006|COMPLETED|Treatment Period 1||5
10419964|NCT00812929|11564920|FG007|COMPLETED|Treatment Period 1||5
10419965|NCT00812929|11564921|FG008|COMPLETED|Treatment Period 1||4
10419966|NCT00812929|11564922|FG009|COMPLETED|Treatment Period 1||5
10419967|NCT00812929|11564913|FG000|NOT COMPLETED|Treatment Period 1||0
10419968|NCT00812929|11564914|FG001|NOT COMPLETED|Treatment Period 1||0
10419969|NCT00812929|11564915|FG002|NOT COMPLETED|Treatment Period 1||0
10419970|NCT00812929|11564916|FG003|NOT COMPLETED|Treatment Period 1||0
10419971|NCT00812929|11564917|FG004|NOT COMPLETED|Treatment Period 1||0
10419972|NCT00812929|11564918|FG005|NOT COMPLETED|Treatment Period 1||0
10419973|NCT00812929|11564919|FG006|NOT COMPLETED|Treatment Period 1||0
10419974|NCT00812929|11564920|FG007|NOT COMPLETED|Treatment Period 1||0
10419975|NCT00812929|11564921|FG008|NOT COMPLETED|Treatment Period 1||0
10419976|NCT00812929|11564922|FG009|NOT COMPLETED|Treatment Period 1||0
10419977|NCT00812929|11564913|FG000|STARTED|Washout Period 1 (7 Days)||5
10419978|NCT00812929|11564914|FG001|STARTED|Washout Period 1 (7 Days)||4
10419979|NCT00812929|11564915|FG002|STARTED|Washout Period 1 (7 Days)||5
10419980|NCT00812929|11564916|FG003|STARTED|Washout Period 1 (7 Days)||4
10419981|NCT00812929|11564917|FG004|STARTED|Washout Period 1 (7 Days)||5
10419982|NCT00812929|11564918|FG005|STARTED|Washout Period 1 (7 Days)||5
10419983|NCT00812929|11564919|FG006|STARTED|Washout Period 1 (7 Days)||5
10419984|NCT00812929|11564920|FG007|STARTED|Washout Period 1 (7 Days)||5
10419985|NCT00812929|11564921|FG008|STARTED|Washout Period 1 (7 Days)||4
10419986|NCT00812929|11564922|FG009|STARTED|Washout Period 1 (7 Days)||5
10419987|NCT00812929|11564913|FG000|COMPLETED|Washout Period 1 (7 Days)||5
10419988|NCT00812929|11564914|FG001|COMPLETED|Washout Period 1 (7 Days)||4
10419989|NCT00812929|11564915|FG002|COMPLETED|Washout Period 1 (7 Days)||4
10419990|NCT00812929|11564916|FG003|COMPLETED|Washout Period 1 (7 Days)||4
10419991|NCT00812929|11564917|FG004|COMPLETED|Washout Period 1 (7 Days)||5
10419992|NCT00812929|11564918|FG005|COMPLETED|Washout Period 1 (7 Days)||5
10419993|NCT00812929|11564919|FG006|COMPLETED|Washout Period 1 (7 Days)||5
10419994|NCT00812929|11564920|FG007|COMPLETED|Washout Period 1 (7 Days)||5
10419995|NCT00812929|11564921|FG008|COMPLETED|Washout Period 1 (7 Days)||4
10419996|NCT00812929|11564922|FG009|COMPLETED|Washout Period 1 (7 Days)||5
10419997|NCT00812929|11564913|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
10419998|NCT00812929|11564914|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
10419999|NCT00812929|11564915|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||1
10420000|NCT00812929|11564916|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
10420001|NCT00812929|11564917|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
10420002|NCT00812929|11564918|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
10420003|NCT00812929|11564919|FG006|NOT COMPLETED|Washout Period 1 (7 Days)||0
10420004|NCT00812929|11564920|FG007|NOT COMPLETED|Washout Period 1 (7 Days)||0
10420005|NCT00812929|11564921|FG008|NOT COMPLETED|Washout Period 1 (7 Days)||0
10420006|NCT00812929|11564922|FG009|NOT COMPLETED|Washout Period 1 (7 Days)||0
10420007|NCT00812929|11564913|FG000|STARTED|Treatment Period 2||5
10420008|NCT00812929|11564914|FG001|STARTED|Treatment Period 2||4
10420009|NCT00812929|11564915|FG002|STARTED|Treatment Period 2||4
10420010|NCT00812929|11564916|FG003|STARTED|Treatment Period 2||4
10420011|NCT00812929|11564917|FG004|STARTED|Treatment Period 2||5
10420012|NCT00812929|11564918|FG005|STARTED|Treatment Period 2||5
10420013|NCT00812929|11564919|FG006|STARTED|Treatment Period 2||5
10420014|NCT00812929|11564920|FG007|STARTED|Treatment Period 2||5
10420015|NCT00812929|11564921|FG008|STARTED|Treatment Period 2||4
10420016|NCT00812929|11564922|FG009|STARTED|Treatment Period 2||5
10420017|NCT00812929|11564913|FG000|COMPLETED|Treatment Period 2||5
10420018|NCT00812929|11564914|FG001|COMPLETED|Treatment Period 2||4
10420019|NCT00812929|11564915|FG002|COMPLETED|Treatment Period 2||4
10420020|NCT00812929|11564916|FG003|COMPLETED|Treatment Period 2||4
10420021|NCT00812929|11564917|FG004|COMPLETED|Treatment Period 2||5
10420022|NCT00812929|11564918|FG005|COMPLETED|Treatment Period 2||5
10420023|NCT00812929|11564919|FG006|COMPLETED|Treatment Period 2||5
10420024|NCT00812929|11564920|FG007|COMPLETED|Treatment Period 2||5
10420025|NCT00812929|11564921|FG008|COMPLETED|Treatment Period 2||4
10420026|NCT00812929|11564922|FG009|COMPLETED|Treatment Period 2||5
10420027|NCT00812929|11564913|FG000|NOT COMPLETED|Treatment Period 2||0
10420028|NCT00812929|11564914|FG001|NOT COMPLETED|Treatment Period 2||0
10420029|NCT00812929|11564915|FG002|NOT COMPLETED|Treatment Period 2||0
10420030|NCT00812929|11564916|FG003|NOT COMPLETED|Treatment Period 2||0
10420031|NCT00812929|11564917|FG004|NOT COMPLETED|Treatment Period 2||0
10420032|NCT00812929|11564918|FG005|NOT COMPLETED|Treatment Period 2||0
10420033|NCT00812929|11564919|FG006|NOT COMPLETED|Treatment Period 2||0
10420034|NCT00812929|11564920|FG007|NOT COMPLETED|Treatment Period 2||0
10420035|NCT00812929|11564921|FG008|NOT COMPLETED|Treatment Period 2||0
10420036|NCT00812929|11564922|FG009|NOT COMPLETED|Treatment Period 2||0
10420037|NCT00812929|11564913|FG000|STARTED|Washout Period 2 (7 Days)||5
10420038|NCT00812929|11564914|FG001|STARTED|Washout Period 2 (7 Days)||4
10420039|NCT00812929|11564915|FG002|STARTED|Washout Period 2 (7 Days)||4
10420040|NCT00812929|11564916|FG003|STARTED|Washout Period 2 (7 Days)||4
10420041|NCT00812929|11564917|FG004|STARTED|Washout Period 2 (7 Days)||5
10420042|NCT00812929|11564918|FG005|STARTED|Washout Period 2 (7 Days)||5
10420043|NCT00812929|11564919|FG006|STARTED|Washout Period 2 (7 Days)||5
10420044|NCT00812929|11564920|FG007|STARTED|Washout Period 2 (7 Days)||5
10420045|NCT00812929|11564921|FG008|STARTED|Washout Period 2 (7 Days)||4
10420046|NCT00812929|11564922|FG009|STARTED|Washout Period 2 (7 Days)||5
10420047|NCT00812929|11564913|FG000|COMPLETED|Washout Period 2 (7 Days)||5
10420048|NCT00812929|11564914|FG001|COMPLETED|Washout Period 2 (7 Days)||4
10420049|NCT00812929|11564915|FG002|COMPLETED|Washout Period 2 (7 Days)||4
10420050|NCT00812929|11564916|FG003|COMPLETED|Washout Period 2 (7 Days)||4
10420051|NCT00812929|11564917|FG004|COMPLETED|Washout Period 2 (7 Days)||5
10420052|NCT00812929|11564918|FG005|COMPLETED|Washout Period 2 (7 Days)||5
10420053|NCT00812929|11564919|FG006|COMPLETED|Washout Period 2 (7 Days)||5
10420054|NCT00812929|11564920|FG007|COMPLETED|Washout Period 2 (7 Days)||5
10420055|NCT00812929|11564921|FG008|COMPLETED|Washout Period 2 (7 Days)||4
10420056|NCT00812929|11564922|FG009|COMPLETED|Washout Period 2 (7 Days)||4
10420057|NCT00812929|11564913|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
10420058|NCT00812929|11564914|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
10420059|NCT00812929|11564915|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
10420060|NCT00812929|11564916|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
10420061|NCT00812929|11564917|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
10420062|NCT00812929|11564918|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
10420063|NCT00812929|11564919|FG006|NOT COMPLETED|Washout Period 2 (7 Days)||0
10420064|NCT00812929|11564920|FG007|NOT COMPLETED|Washout Period 2 (7 Days)||0
10420065|NCT00812929|11564921|FG008|NOT COMPLETED|Washout Period 2 (7 Days)||0
10420066|NCT00812929|11564922|FG009|NOT COMPLETED|Washout Period 2 (7 Days)||1
10420067|NCT00812929|11564913|FG000|STARTED|Treatment Period 3||5
10420068|NCT00812929|11564914|FG001|STARTED|Treatment Period 3||4
10420069|NCT00812929|11564915|FG002|STARTED|Treatment Period 3||4
10420070|NCT00812929|11564916|FG003|STARTED|Treatment Period 3||4
10420071|NCT00812929|11564917|FG004|STARTED|Treatment Period 3||5
10420072|NCT00812929|11564918|FG005|STARTED|Treatment Period 3||5
10420073|NCT00812929|11564919|FG006|STARTED|Treatment Period 3||5
10420074|NCT00812929|11564920|FG007|STARTED|Treatment Period 3||5
10420075|NCT00812929|11564921|FG008|STARTED|Treatment Period 3||4
10755743|NCT03070782|11919549|FG005|NOT COMPLETED|Overall Study||7
10755744|NCT03070964|11919563|FG000|STARTED|Overall Study||14
10755745|NCT03070964|11919563|FG000|COMPLETED|Overall Study||0
10420076|NCT00812929|11564922|FG009|STARTED|Treatment Period 3||4
10420077|NCT00812929|11564913|FG000|COMPLETED|Treatment Period 3||5
10420078|NCT00812929|11564914|FG001|COMPLETED|Treatment Period 3||4
10420079|NCT00812929|11564915|FG002|COMPLETED|Treatment Period 3||4
10420080|NCT00812929|11564916|FG003|COMPLETED|Treatment Period 3||4
10420081|NCT00812929|11564917|FG004|COMPLETED|Treatment Period 3||5
10420082|NCT00812929|11564918|FG005|COMPLETED|Treatment Period 3||5
10420083|NCT00812929|11564919|FG006|COMPLETED|Treatment Period 3||5
10420084|NCT00812929|11564920|FG007|COMPLETED|Treatment Period 3||5
10420085|NCT00812929|11564921|FG008|COMPLETED|Treatment Period 3||4
10420086|NCT00812929|11564922|FG009|COMPLETED|Treatment Period 3||4
10420087|NCT00812929|11564913|FG000|NOT COMPLETED|Treatment Period 3||0
10420088|NCT00812929|11564914|FG001|NOT COMPLETED|Treatment Period 3||0
10420089|NCT00812929|11564915|FG002|NOT COMPLETED|Treatment Period 3||0
10420090|NCT00812929|11564916|FG003|NOT COMPLETED|Treatment Period 3||0
10420091|NCT00812929|11564917|FG004|NOT COMPLETED|Treatment Period 3||0
10420092|NCT00812929|11564918|FG005|NOT COMPLETED|Treatment Period 3||0
10420093|NCT00812929|11564919|FG006|NOT COMPLETED|Treatment Period 3||0
10420094|NCT00812929|11564920|FG007|NOT COMPLETED|Treatment Period 3||0
10420095|NCT00812929|11564921|FG008|NOT COMPLETED|Treatment Period 3||0
10420096|NCT00812929|11564922|FG009|NOT COMPLETED|Treatment Period 3||0
10420097|NCT00812929|11564913|FG000|STARTED|Washout Period 3 (7 Days)||5
10420098|NCT00812929|11564914|FG001|STARTED|Washout Period 3 (7 Days)||4
10420099|NCT00812929|11564915|FG002|STARTED|Washout Period 3 (7 Days)||4
10420100|NCT00812929|11564916|FG003|STARTED|Washout Period 3 (7 Days)||4
10420101|NCT00812929|11564917|FG004|STARTED|Washout Period 3 (7 Days)||5
10420102|NCT00812929|11564918|FG005|STARTED|Washout Period 3 (7 Days)||5
10755746|NCT03070964|11919563|FG000|NOT COMPLETED|Overall Study||14
10755747|NCT03071094|11919569|FG000|STARTED|Overall Study||7
10755748|NCT03071094|11919570|FG001|STARTED|Overall Study||5
10420103|NCT00812929|11564919|FG006|STARTED|Washout Period 3 (7 Days)||5
10420104|NCT00812929|11564920|FG007|STARTED|Washout Period 3 (7 Days)||5
10420105|NCT00812929|11564921|FG008|STARTED|Washout Period 3 (7 Days)||4
10420106|NCT00812929|11564922|FG009|STARTED|Washout Period 3 (7 Days)||4
10420107|NCT00812929|11564913|FG000|COMPLETED|Washout Period 3 (7 Days)||5
10420108|NCT00812929|11564914|FG001|COMPLETED|Washout Period 3 (7 Days)||4
10420109|NCT00812929|11564915|FG002|COMPLETED|Washout Period 3 (7 Days)||4
10420110|NCT00812929|11564916|FG003|COMPLETED|Washout Period 3 (7 Days)||4
10420111|NCT00812929|11564917|FG004|COMPLETED|Washout Period 3 (7 Days)||5
10420112|NCT00812929|11564918|FG005|COMPLETED|Washout Period 3 (7 Days)||4
10420113|NCT00812929|11564919|FG006|COMPLETED|Washout Period 3 (7 Days)||5
10420114|NCT00812929|11564920|FG007|COMPLETED|Washout Period 3 (7 Days)||5
10420115|NCT00812929|11564921|FG008|COMPLETED|Washout Period 3 (7 Days)||4
10420116|NCT00812929|11564922|FG009|COMPLETED|Washout Period 3 (7 Days)||4
10420117|NCT00812929|11564913|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
10420118|NCT00812929|11564914|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
10420119|NCT00812929|11564915|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
10420120|NCT00812929|11564916|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
10420121|NCT00812929|11564917|FG004|NOT COMPLETED|Washout Period 3 (7 Days)||0
10420122|NCT00812929|11564918|FG005|NOT COMPLETED|Washout Period 3 (7 Days)||1
10420123|NCT00812929|11564919|FG006|NOT COMPLETED|Washout Period 3 (7 Days)||0
10420124|NCT00812929|11564920|FG007|NOT COMPLETED|Washout Period 3 (7 Days)||0
10420125|NCT00812929|11564921|FG008|NOT COMPLETED|Washout Period 3 (7 Days)||0
10420126|NCT00812929|11564922|FG009|NOT COMPLETED|Washout Period 3 (7 Days)||0
10420127|NCT00812929|11564913|FG000|STARTED|Treatment Period 4||5
10420128|NCT00812929|11564914|FG001|STARTED|Treatment Period 4||4
10420129|NCT00812929|11564915|FG002|STARTED|Treatment Period 4||4
10420130|NCT00812929|11564916|FG003|STARTED|Treatment Period 4||4
10420131|NCT00812929|11564917|FG004|STARTED|Treatment Period 4||5
10420132|NCT00812929|11564918|FG005|STARTED|Treatment Period 4||4
10420133|NCT00812929|11564919|FG006|STARTED|Treatment Period 4||5
10420134|NCT00812929|11564920|FG007|STARTED|Treatment Period 4||5
10420135|NCT00812929|11564921|FG008|STARTED|Treatment Period 4||4
10420136|NCT00812929|11564922|FG009|STARTED|Treatment Period 4||4
10420137|NCT00812929|11564913|FG000|COMPLETED|Treatment Period 4||5
10420138|NCT00812929|11564914|FG001|COMPLETED|Treatment Period 4||4
10420139|NCT00812929|11564915|FG002|COMPLETED|Treatment Period 4||4
10420140|NCT00812929|11564916|FG003|COMPLETED|Treatment Period 4||4
10420141|NCT00812929|11564917|FG004|COMPLETED|Treatment Period 4||5
10420142|NCT00812929|11564918|FG005|COMPLETED|Treatment Period 4||4
10420143|NCT00812929|11564919|FG006|COMPLETED|Treatment Period 4||5
10420144|NCT00812929|11564920|FG007|COMPLETED|Treatment Period 4||5
10420145|NCT00812929|11564921|FG008|COMPLETED|Treatment Period 4||4
10420146|NCT00812929|11564922|FG009|COMPLETED|Treatment Period 4||4
10420147|NCT00812929|11564913|FG000|NOT COMPLETED|Treatment Period 4||0
10420148|NCT00812929|11564914|FG001|NOT COMPLETED|Treatment Period 4||0
10420149|NCT00812929|11564915|FG002|NOT COMPLETED|Treatment Period 4||0
10420150|NCT00812929|11564916|FG003|NOT COMPLETED|Treatment Period 4||0
10420151|NCT00812929|11564917|FG004|NOT COMPLETED|Treatment Period 4||0
10420152|NCT00812929|11564918|FG005|NOT COMPLETED|Treatment Period 4||0
10420153|NCT00812929|11564919|FG006|NOT COMPLETED|Treatment Period 4||0
10420154|NCT00812929|11564920|FG007|NOT COMPLETED|Treatment Period 4||0
10420155|NCT00812929|11564921|FG008|NOT COMPLETED|Treatment Period 4||0
10420156|NCT00812929|11564922|FG009|NOT COMPLETED|Treatment Period 4||0
10420157|NCT00812929|11564913|FG000|STARTED|Washout Period 4 (7 Days)||5
10420158|NCT00812929|11564914|FG001|STARTED|Washout Period 4 (7 Days)||4
10420159|NCT00812929|11564915|FG002|STARTED|Washout Period 4 (7 Days)||4
10420160|NCT00812929|11564916|FG003|STARTED|Washout Period 4 (7 Days)||4
10420161|NCT00812929|11564917|FG004|STARTED|Washout Period 4 (7 Days)||5
10420162|NCT00812929|11564918|FG005|STARTED|Washout Period 4 (7 Days)||4
10420163|NCT00812929|11564919|FG006|STARTED|Washout Period 4 (7 Days)||5
10420164|NCT00812929|11564920|FG007|STARTED|Washout Period 4 (7 Days)||5
10420165|NCT00812929|11564921|FG008|STARTED|Washout Period 4 (7 Days)||4
10420166|NCT00812929|11564922|FG009|STARTED|Washout Period 4 (7 Days)||4
10420167|NCT00812929|11564913|FG000|COMPLETED|Washout Period 4 (7 Days)||5
10420168|NCT00812929|11564914|FG001|COMPLETED|Washout Period 4 (7 Days)||4
10420169|NCT00812929|11564915|FG002|COMPLETED|Washout Period 4 (7 Days)||4
10420170|NCT00812929|11564916|FG003|COMPLETED|Washout Period 4 (7 Days)||4
10420171|NCT00812929|11564917|FG004|COMPLETED|Washout Period 4 (7 Days)||5
10420172|NCT00812929|11564918|FG005|COMPLETED|Washout Period 4 (7 Days)||4
10420173|NCT00812929|11564919|FG006|COMPLETED|Washout Period 4 (7 Days)||5
10420174|NCT00812929|11564920|FG007|COMPLETED|Washout Period 4 (7 Days)||5
10420175|NCT00812929|11564921|FG008|COMPLETED|Washout Period 4 (7 Days)||4
10420176|NCT00812929|11564922|FG009|COMPLETED|Washout Period 4 (7 Days)||4
10420177|NCT00812929|11564913|FG000|NOT COMPLETED|Washout Period 4 (7 Days)||0
10420178|NCT00812929|11564914|FG001|NOT COMPLETED|Washout Period 4 (7 Days)||0
10420179|NCT00812929|11564915|FG002|NOT COMPLETED|Washout Period 4 (7 Days)||0
10420180|NCT00812929|11564916|FG003|NOT COMPLETED|Washout Period 4 (7 Days)||0
10420181|NCT00812929|11564917|FG004|NOT COMPLETED|Washout Period 4 (7 Days)||0
10420182|NCT00812929|11564918|FG005|NOT COMPLETED|Washout Period 4 (7 Days)||0
10420183|NCT00812929|11564919|FG006|NOT COMPLETED|Washout Period 4 (7 Days)||0
10420184|NCT00812929|11564920|FG007|NOT COMPLETED|Washout Period 4 (7 Days)||0
10420185|NCT00812929|11564921|FG008|NOT COMPLETED|Washout Period 4 (7 Days)||0
10420186|NCT00812929|11564922|FG009|NOT COMPLETED|Washout Period 4 (7 Days)||0
10420187|NCT00812929|11564913|FG000|STARTED|Treatment Period 5||5
10420188|NCT00812929|11564914|FG001|STARTED|Treatment Period 5||4
10420189|NCT00812929|11564915|FG002|STARTED|Treatment Period 5||4
10420190|NCT00812929|11564916|FG003|STARTED|Treatment Period 5||4
10420191|NCT00812929|11564917|FG004|STARTED|Treatment Period 5||5
10420192|NCT00812929|11564918|FG005|STARTED|Treatment Period 5||4
10420193|NCT00812929|11564919|FG006|STARTED|Treatment Period 5||5
10420194|NCT00812929|11564920|FG007|STARTED|Treatment Period 5||5
10420195|NCT00812929|11564921|FG008|STARTED|Treatment Period 5||4
10420196|NCT00812929|11564922|FG009|STARTED|Treatment Period 5||4
10420197|NCT00812929|11564913|FG000|COMPLETED|Treatment Period 5||5
10420198|NCT00812929|11564914|FG001|COMPLETED|Treatment Period 5||4
10420199|NCT00812929|11564915|FG002|COMPLETED|Treatment Period 5||4
10420200|NCT00812929|11564916|FG003|COMPLETED|Treatment Period 5||4
10420201|NCT00812929|11564917|FG004|COMPLETED|Treatment Period 5||5
10420202|NCT00812929|11564918|FG005|COMPLETED|Treatment Period 5||4
10420203|NCT00812929|11564919|FG006|COMPLETED|Treatment Period 5||5
10420204|NCT00812929|11564920|FG007|COMPLETED|Treatment Period 5||5
10420205|NCT00812929|11564921|FG008|COMPLETED|Treatment Period 5||4
10420206|NCT00812929|11564922|FG009|COMPLETED|Treatment Period 5||4
10420207|NCT00812929|11564913|FG000|NOT COMPLETED|Treatment Period 5||0
10420208|NCT00812929|11564914|FG001|NOT COMPLETED|Treatment Period 5||0
10420209|NCT00812929|11564915|FG002|NOT COMPLETED|Treatment Period 5||0
10420210|NCT00812929|11564916|FG003|NOT COMPLETED|Treatment Period 5||0
10420211|NCT00812929|11564917|FG004|NOT COMPLETED|Treatment Period 5||0
10420212|NCT00812929|11564918|FG005|NOT COMPLETED|Treatment Period 5||0
10420213|NCT00812929|11564919|FG006|NOT COMPLETED|Treatment Period 5||0
10420214|NCT00812929|11564920|FG007|NOT COMPLETED|Treatment Period 5||0
10420215|NCT00812929|11564921|FG008|NOT COMPLETED|Treatment Period 5||0
10420216|NCT00812929|11564922|FG009|NOT COMPLETED|Treatment Period 5||0
10420217|NCT00812955|11564943|FG000|STARTED|Overall Study||119
10420218|NCT00812955|11564944|FG001|STARTED|Overall Study||118
10420219|NCT00812955|11564945|FG002|STARTED|Overall Study||119
10420220|NCT00812955|11564946|FG003|STARTED|Overall Study||118
10420221|NCT00812955|11564943|FG000|COMPLETED|Overall Study||109
10420222|NCT00812955|11564944|FG001|COMPLETED|Overall Study||111
10420223|NCT00812955|11564945|FG002|COMPLETED|Overall Study||113
10420224|NCT00812955|11564946|FG003|COMPLETED|Overall Study||110
10420225|NCT00812955|11564943|FG000|NOT COMPLETED|Overall Study||10
10420226|NCT00812955|11564944|FG001|NOT COMPLETED|Overall Study||7
10420227|NCT00812955|11564945|FG002|NOT COMPLETED|Overall Study||6
10420228|NCT00812955|11564946|FG003|NOT COMPLETED|Overall Study||8
10420229|NCT00812968|11564960|FG000|STARTED|Overall Study||11
10420230|NCT00812968|11564960|FG000|COMPLETED|Overall Study||0
10420231|NCT00812968|11564960|FG000|NOT COMPLETED|Overall Study||11
10420232|NCT00812981|11564968|FG000|STARTED|Overall Study||160
10420233|NCT00812981|11564969|FG001|STARTED|Overall Study||160
10420234|NCT00812981|11564968|FG000|COMPLETED|Overall Study||160
10420235|NCT00812981|11564969|FG001|COMPLETED|Overall Study||159
10420236|NCT00812981|11564968|FG000|NOT COMPLETED|Overall Study||0
10420237|NCT00812981|11564969|FG001|NOT COMPLETED|Overall Study||1
10420238|NCT00813098|11564978|FG000|STARTED|Overall Study||49
10420239|NCT00813098|11564979|FG001|STARTED|Overall Study||54
10420240|NCT00813098|11564980|FG002|STARTED|Overall Study||52
10420241|NCT00813098|11564978|FG000|COMPLETED|Overall Study||46
10420242|NCT00813098|11564979|FG001|COMPLETED|Overall Study||46
10420243|NCT00813098|11564980|FG002|COMPLETED|Overall Study||50
10420244|NCT00813098|11564978|FG000|NOT COMPLETED|Overall Study||3
10420245|NCT00813098|11564979|FG001|NOT COMPLETED|Overall Study||8
10420246|NCT00813098|11564980|FG002|NOT COMPLETED|Overall Study||2
10420247|NCT00813111|11564990|FG000|STARTED|Overall Study||66
10420248|NCT00813111|11564991|FG001|STARTED|Overall Study||70
10420249|NCT00813111|11564990|FG000|COMPLETED|Overall Study||64
10420250|NCT00813111|11564991|FG001|COMPLETED|Overall Study||70
10546062|NCT01502631|11699617|FG000|NOT COMPLETED|Overall Study||20
10546063|NCT01502631|11699618|FG001|NOT COMPLETED|Overall Study||20
10420251|NCT00813111|11564990|FG000|NOT COMPLETED|Overall Study||2
10420252|NCT00813111|11564991|FG001|NOT COMPLETED|Overall Study||0
10420253|NCT00813124|11564997|FG000|STARTED|Overall Study||24
10420254|NCT00813124|11564997|FG000|COMPLETED|Overall Study||12
10420255|NCT00813124|11564997|FG000|NOT COMPLETED|Overall Study||12
10420256|NCT00813150|11565003|FG000|STARTED|Treatment Period|Number of randomized and treated participants|46
10420257|NCT00813150|11565004|FG001|STARTED|Treatment Period|Number of randomized and treated participants|47
10420258|NCT00813150|11565003|FG000|Intent-to-treat Participants|Treatment Period||43
10420259|NCT00813150|11565004|FG001|Intent-to-treat Participants|Treatment Period||47
10420260|NCT00813150|11565003|FG000|COMPLETED|Treatment Period|Participants who completed 8 cycles of treatment|14
10420261|NCT00813150|11565004|FG001|COMPLETED|Treatment Period|Participants who completed 8 cycles of treatment|15
10420262|NCT00813150|11565003|FG000|NOT COMPLETED|Treatment Period||32
10420263|NCT00813150|11565004|FG001|NOT COMPLETED|Treatment Period||32
10420264|NCT00813150|11565003|FG000|STARTED|Long Term Follow-up|Number of participants who entered follow-up phase|26
10420265|NCT00813150|11565004|FG001|STARTED|Long Term Follow-up|Number of participants who entered follow-up phase|31
10420266|NCT00813150|11565003|FG000|COMPLETED|Long Term Follow-up|Number of participants who completed follow-up phase|2
10429534|NCT00864383|11575574|FG000|COMPLETED|Per- Protocol||510
10420267|NCT00813150|11565004|FG001|COMPLETED|Long Term Follow-up|Number of participants who completed follow-up phase|0
10420268|NCT00813150|11565003|FG000|NOT COMPLETED|Long Term Follow-up||24
10420269|NCT00813150|11565004|FG001|NOT COMPLETED|Long Term Follow-up||31
10420270|NCT00813176|11565012|FG000|STARTED|Overall Study||25
10420271|NCT00813176|11565013|FG001|STARTED|Overall Study||25
10420272|NCT00813176|11565012|FG000|COMPLETED|Overall Study||25
10420273|NCT00813176|11565013|FG001|COMPLETED|Overall Study||25
10420274|NCT00813176|11565012|FG000|NOT COMPLETED|Overall Study||0
10420275|NCT00813176|11565013|FG001|NOT COMPLETED|Overall Study||0
10420276|NCT00813293|11565023|FG000|STARTED|Overall Study||10
10420277|NCT00813293|11565024|FG001|STARTED|Overall Study||10
10420278|NCT00813293|11565023|FG000|Started Treatment|Overall Study||9
10420279|NCT00813293|11565024|FG001|Started Treatment|Overall Study||10
10420280|NCT00813293|11565023|FG000|Evaluable RFA|Overall Study||7
10420281|NCT00813293|11565024|FG001|Evaluable RFA|Overall Study||8
10420282|NCT00813293|11565023|FG000|COMPLETED|Overall Study||9
10420283|NCT00813293|11565024|FG001|COMPLETED|Overall Study||9
10420284|NCT00813293|11565023|FG000|NOT COMPLETED|Overall Study||1
10420285|NCT00813293|11565024|FG001|NOT COMPLETED|Overall Study||1
10420286|NCT00813319|11565032|FG000|STARTED|Overall Study||108
10420287|NCT00813319|11565033|FG001|STARTED|Overall Study||108
10420288|NCT00813319|11565032|FG000|COMPLETED|Overall Study|100 out of 108 have complete follow-up data, there were 8 missing charts 7 months post-randomization|108
10420367|NCT00813709|11565063|FG001|COMPLETED|Open Label Period||0
10420289|NCT00813319|11565033|FG001|COMPLETED|Overall Study|104 out of 108 have complete follow-up data, there were 4 missing charts 7 months post-randomization|108
10420290|NCT00813319|11565032|FG000|NOT COMPLETED|Overall Study||0
10420291|NCT00813319|11565033|FG001|NOT COMPLETED|Overall Study||0
10420292|NCT00813358|11565039|FG000|STARTED|Overall Study||115
10420293|NCT00813358|11565039|FG000|COMPLETED|Overall Study||46
10420294|NCT00813358|11565039|FG000|NOT COMPLETED|Overall Study||69
10420295|NCT00813488|11565043|FG000|STARTED|Titration Period 1||107
10420296|NCT00813488|11565044|FG001|STARTED|Titration Period 1||106
10420297|NCT00813488|11565043|FG000|COMPLETED|Titration Period 1||80
10420298|NCT00813488|11565044|FG001|COMPLETED|Titration Period 1||89
10420299|NCT00813488|11565043|FG000|NOT COMPLETED|Titration Period 1||27
10420300|NCT00813488|11565044|FG001|NOT COMPLETED|Titration Period 1||17
10420301|NCT00813488|11565043|FG000|STARTED|Titration Period 2||80
10420302|NCT00813488|11565044|FG001|STARTED|Titration Period 2||89
10420303|NCT00813488|11565043|FG000|COMPLETED|Titration Period 2||64
10420304|NCT00813488|11565044|FG001|COMPLETED|Titration Period 2||79
10420305|NCT00813488|11565043|FG000|NOT COMPLETED|Titration Period 2||16
10420306|NCT00813488|11565044|FG001|NOT COMPLETED|Titration Period 2||10
10420307|NCT00813488|11565043|FG000|STARTED|Double-blind Treatment Period 1|After titration subjects were re-randomized to these two treatment arms|72
10420308|NCT00813488|11565044|FG001|STARTED|Double-blind Treatment Period 1|After titration subjects were re-randomized to these two treatment arms|71
10420309|NCT00813488|11565043|FG000|COMPLETED|Double-blind Treatment Period 1||71
10420310|NCT00813488|11565044|FG001|COMPLETED|Double-blind Treatment Period 1||66
10420311|NCT00813488|11565043|FG000|NOT COMPLETED|Double-blind Treatment Period 1||1
10420312|NCT00813488|11565044|FG001|NOT COMPLETED|Double-blind Treatment Period 1||5
10420313|NCT00813488|11565043|FG000|STARTED|Double-blind Treatment Period 2||71
10420314|NCT00813488|11565044|FG001|STARTED|Double-blind Treatment Period 2||66
10420315|NCT00813488|11565043|FG000|COMPLETED|Double-blind Treatment Period 2||66
10420316|NCT00813488|11565044|FG001|COMPLETED|Double-blind Treatment Period 2||65
10420317|NCT00813488|11565043|FG000|NOT COMPLETED|Double-blind Treatment Period 2||5
10420318|NCT00813488|11565044|FG001|NOT COMPLETED|Double-blind Treatment Period 2||1
10420319|NCT00813488|11565043|FG000|STARTED|Open-label Extension|Patients completing double-blind periods were randomized to FBT or standard of care for open-label|65
10420320|NCT00813488|11565044|FG001|STARTED|Open-label Extension|Patients completing double-blind periods were randomized to FBT or standard of care for open-label|66
10420321|NCT00813488|11565043|FG000|COMPLETED|Open-label Extension|This group received FBT open--label|53
10420322|NCT00813488|11565044|FG001|COMPLETED|Open-label Extension|This group received standard of care (including immediate-release oxycodone)|59
10420323|NCT00813488|11565043|FG000|NOT COMPLETED|Open-label Extension||12
10420324|NCT00813488|11565044|FG001|NOT COMPLETED|Open-label Extension||7
10420325|NCT00813592|11565054|FG000|STARTED|Overall Study||2
10420326|NCT00813592|11565054|FG000|Treated|Overall Study|Two patients were treated.|2
10420327|NCT00813592|11565054|FG000|Response Assessment|Overall Study|One patient met the response assessment.|1
10420328|NCT00813592|11565054|FG000|COMPLETED|Overall Study||0
10420329|NCT00813592|11565054|FG000|NOT COMPLETED|Overall Study||2
10420330|NCT00813709|11565062|FG000|STARTED|Double Blind Period||84
10420331|NCT00813709|11565063|FG001|STARTED|Double Blind Period||117
10420332|NCT00813709|11565064|FG002|STARTED|Double Blind Period||99
10420333|NCT00813709|11565065|FG003|STARTED|Double Blind Period||0
10420334|NCT00813709|11565066|FG004|STARTED|Double Blind Period||0
10420335|NCT00813709|11565067|FG005|STARTED|Double Blind Period||0
10420336|NCT00813709|11565062|FG000|Treated|Double Blind Period||83
10420337|NCT00813709|11565063|FG001|Treated|Double Blind Period||114
10420338|NCT00813709|11565064|FG002|Treated|Double Blind Period||98
10420339|NCT00813709|11565065|FG003|Treated|Double Blind Period||0
10420340|NCT00813709|11565066|FG004|Treated|Double Blind Period||0
10420341|NCT00813709|11565067|FG005|Treated|Double Blind Period||0
10420342|NCT00813709|11565062|FG000|COMPLETED|Double Blind Period||53
10420343|NCT00813709|11565063|FG001|COMPLETED|Double Blind Period||76
10420344|NCT00813709|11565064|FG002|COMPLETED|Double Blind Period||68
10420345|NCT00813709|11565065|FG003|COMPLETED|Double Blind Period||0
10420346|NCT00813709|11565066|FG004|COMPLETED|Double Blind Period||0
10420347|NCT00813709|11565067|FG005|COMPLETED|Double Blind Period||0
10420348|NCT00813709|11565062|FG000|NOT COMPLETED|Double Blind Period||31
10420349|NCT00813709|11565063|FG001|NOT COMPLETED|Double Blind Period||41
10420350|NCT00813709|11565064|FG002|NOT COMPLETED|Double Blind Period||31
10420351|NCT00813709|11565065|FG003|NOT COMPLETED|Double Blind Period||0
10420352|NCT00813709|11565066|FG004|NOT COMPLETED|Double Blind Period||0
10420353|NCT00813709|11565067|FG005|NOT COMPLETED|Double Blind Period||0
10420354|NCT00813709|11565062|FG000|STARTED|Open Label Period||0
10420355|NCT00813709|11565063|FG001|STARTED|Open Label Period||0
10420356|NCT00813709|11565064|FG002|STARTED|Open Label Period||0
10420357|NCT00813709|11565065|FG003|STARTED|Open Label Period|49 participants in OL period initially + 9 participants from DB converted to CDMS during the study|58
10420358|NCT00813709|11565066|FG004|STARTED|Open Label Period|25 participants in OL period initially + 26 participants from DB converted to CDMS during the study|51
10420359|NCT00813709|11565067|FG005|STARTED|Open Label Period|28 participants in OL period initially + 18 participants from DB converted to CDMS during the study|46
10420360|NCT00813709|11565062|FG000|Treated|Open Label Period||0
10420361|NCT00813709|11565063|FG001|Treated|Open Label Period||0
10420362|NCT00813709|11565064|FG002|Treated|Open Label Period||0
10420363|NCT00813709|11565065|FG003|Treated|Open Label Period||57
10420364|NCT00813709|11565066|FG004|Treated|Open Label Period||51
10420365|NCT00813709|11565067|FG005|Treated|Open Label Period||45
10420366|NCT00813709|11565062|FG000|COMPLETED|Open Label Period||0
10420368|NCT00813709|11565064|FG002|COMPLETED|Open Label Period||0
10420369|NCT00813709|11565065|FG003|COMPLETED|Open Label Period||38
10420370|NCT00813709|11565066|FG004|COMPLETED|Open Label Period||41
10420371|NCT00813709|11565067|FG005|COMPLETED|Open Label Period||35
10420372|NCT00813709|11565062|FG000|NOT COMPLETED|Open Label Period||0
10420373|NCT00813709|11565063|FG001|NOT COMPLETED|Open Label Period||0
10420374|NCT00813709|11565064|FG002|NOT COMPLETED|Open Label Period||0
10420375|NCT00813709|11565065|FG003|NOT COMPLETED|Open Label Period||20
10420376|NCT00813709|11565066|FG004|NOT COMPLETED|Open Label Period||10
10420377|NCT00813709|11565067|FG005|NOT COMPLETED|Open Label Period||11
10420378|NCT00813748|11565098|FG000|STARTED|Main Observational Study||30
10420379|NCT00813748|11565099|FG001|STARTED|Main Observational Study||88
10420380|NCT00813748|11565098|FG000|COMPLETED|Main Observational Study||30
10420381|NCT00813748|11565099|FG001|COMPLETED|Main Observational Study||88
10420382|NCT00813748|11565098|FG000|NOT COMPLETED|Main Observational Study||0
10420383|NCT00813748|11565099|FG001|NOT COMPLETED|Main Observational Study||0
10420384|NCT00813748|11565098|FG000|STARTED|Skin Test Substudy|Included participants who discontinued omalizumab for at least 16 weeks but not more than 18 months.|3
10420385|NCT00813748|11565099|FG001|STARTED|Skin Test Substudy|Included participants who discontinued omalizumab for at least 16 weeks but not more than 18 months.|8
10420386|NCT00813748|11565098|FG000|COMPLETED|Skin Test Substudy||3
10420387|NCT00813748|11565099|FG001|COMPLETED|Skin Test Substudy||7
10420388|NCT00813748|11565098|FG000|NOT COMPLETED|Skin Test Substudy||0
10420389|NCT00813748|11565099|FG001|NOT COMPLETED|Skin Test Substudy||1
10420390|NCT00813761|11565109|FG000|STARTED|Phase 1 (Baseline to 4 Weeks)||121
10420391|NCT00813761|11565110|FG001|STARTED|Phase 1 (Baseline to 4 Weeks)||103
10420392|NCT00813761|11565111|FG002|STARTED|Phase 1 (Baseline to 4 Weeks)||115
10420393|NCT00813761|11565112|FG003|STARTED|Phase 1 (Baseline to 4 Weeks)||107
10420394|NCT00813761|11565109|FG000|COMPLETED|Phase 1 (Baseline to 4 Weeks)||117
10420395|NCT00813761|11565110|FG001|COMPLETED|Phase 1 (Baseline to 4 Weeks)||100
10420396|NCT00813761|11565111|FG002|COMPLETED|Phase 1 (Baseline to 4 Weeks)||103
10420397|NCT00813761|11565112|FG003|COMPLETED|Phase 1 (Baseline to 4 Weeks)||105
10420398|NCT00813761|11565109|FG000|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||4
10420399|NCT00813761|11565110|FG001|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||3
10420400|NCT00813761|11565111|FG002|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||12
10420401|NCT00813761|11565112|FG003|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||2
10420402|NCT00813761|11565109|FG000|STARTED|Phase 2 (4 Weeks to 24 Weeks)||117
10420403|NCT00813761|11565110|FG001|STARTED|Phase 2 (4 Weeks to 24 Weeks)||100
10420404|NCT00813761|11565111|FG002|STARTED|Phase 2 (4 Weeks to 24 Weeks)||103
10420405|NCT00813761|11565112|FG003|STARTED|Phase 2 (4 Weeks to 24 Weeks)||105
10420406|NCT00813761|11565109|FG000|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||101
10420407|NCT00813761|11565110|FG001|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||91
10420408|NCT00813761|11565111|FG002|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||94
10420409|NCT00813761|11565112|FG003|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||100
10420410|NCT00813761|11565109|FG000|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||16
10420411|NCT00813761|11565110|FG001|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||9
10420412|NCT00813761|11565111|FG002|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||9
10420413|NCT00813761|11565112|FG003|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||5
10420414|NCT00813800|11565128|FG000|STARTED|Overall Study||11
10420415|NCT00813800|11565128|FG000|COMPLETED|Overall Study||5
10420416|NCT00813800|11565128|FG000|NOT COMPLETED|Overall Study||6
10420417|NCT00813813|11565134|FG000|STARTED|Overall Study||7
10420418|NCT00813813|11565135|FG001|STARTED|Overall Study||25
10420419|NCT00813813|11565134|FG000|COMPLETED|Overall Study||4
10420420|NCT00813813|11565135|FG001|COMPLETED|Overall Study||16
10420421|NCT00813813|11565134|FG000|NOT COMPLETED|Overall Study||3
10420422|NCT00813813|11565135|FG001|NOT COMPLETED|Overall Study||9
10420423|NCT00813865|11565141|FG000|STARTED|Overall Study||8
10420424|NCT00813865|11565141|FG000|Safety Population|Overall Study||8
10420425|NCT00813865|11565141|FG000|Pharmacodynamic (PD) Population|Overall Study||8
10420426|NCT00813865|11565141|FG000|COMPLETED|Overall Study||1
10420427|NCT00813865|11565141|FG000|NOT COMPLETED|Overall Study||7
10420428|NCT00813904|11565145|FG000|STARTED|Overall Study||31
10420429|NCT00813904|11565145|FG000|COMPLETED|Overall Study||30
10420430|NCT00813904|11565145|FG000|NOT COMPLETED|Overall Study||1
10420431|NCT00813917|11565151|FG000|STARTED|Overall Study||38
10420432|NCT00813917|11565152|FG001|STARTED|Overall Study||38
10420433|NCT00813917|11565151|FG000|COMPLETED|Overall Study||32
10420434|NCT00813917|11565152|FG001|COMPLETED|Overall Study||32
10420435|NCT00813917|11565151|FG000|NOT COMPLETED|Overall Study||6
10420436|NCT00813917|11565152|FG001|NOT COMPLETED|Overall Study||6
10420437|NCT00813943|11565161|FG000|STARTED|Overall Study||88
10420438|NCT00813943|11565162|FG001|STARTED|Overall Study||88
10420439|NCT00813943|11565163|FG002|STARTED|Overall Study||89
10420440|NCT00813943|11565161|FG000|COMPLETED|Overall Study||83
10420441|NCT00813943|11565162|FG001|COMPLETED|Overall Study||83
10420442|NCT00813943|11565163|FG002|COMPLETED|Overall Study||86
10420443|NCT00813943|11565161|FG000|NOT COMPLETED|Overall Study||5
10420444|NCT00813943|11565162|FG001|NOT COMPLETED|Overall Study||5
10420445|NCT00813943|11565163|FG002|NOT COMPLETED|Overall Study||3
10420446|NCT00813982|11565172|FG000|STARTED|Overall Study||59
10420447|NCT00813982|11565172|FG000|COMPLETED|Overall Study||59
10420448|NCT00813982|11565172|FG000|NOT COMPLETED|Overall Study||0
10420449|NCT00813995|11565180|FG000|STARTED|Overall Study||197
10420450|NCT00813995|11565181|FG001|STARTED|Overall Study||198
10420451|NCT00813995|11565180|FG000|COMPLETED|Overall Study||174
10420452|NCT00813995|11565181|FG001|COMPLETED|Overall Study||182
10420453|NCT00813995|11565180|FG000|NOT COMPLETED|Overall Study||23
10420454|NCT00813995|11565181|FG001|NOT COMPLETED|Overall Study||16
10420455|NCT00814138|11565193|FG000|STARTED|Overall Study||25
10420456|NCT00814138|11565194|FG001|STARTED|Overall Study||25
10420457|NCT00814138|11565193|FG000|COMPLETED|Overall Study||24
10420458|NCT00814138|11565194|FG001|COMPLETED|Overall Study||18
10420459|NCT00814138|11565193|FG000|NOT COMPLETED|Overall Study||1
10420460|NCT00814138|11565194|FG001|NOT COMPLETED|Overall Study||7
10420461|NCT00814164|11565202|FG000|STARTED|Overall Study||21
10420462|NCT00814164|11565202|FG000|COMPLETED|Overall Study||2
10420463|NCT00814164|11565202|FG000|NOT COMPLETED|Overall Study||19
10420464|NCT00814177|11565208|FG000|STARTED|Overall Study||80
10420465|NCT00814177|11565209|FG001|STARTED|Overall Study||80
10420466|NCT00814177|11565208|FG000|COMPLETED|Overall Study||80
10420467|NCT00814177|11565209|FG001|COMPLETED|Overall Study||80
10420468|NCT00814177|11565208|FG000|NOT COMPLETED|Overall Study||0
10420469|NCT00814177|11565209|FG001|NOT COMPLETED|Overall Study||0
10420470|NCT00814255|11565218|FG000|STARTED|Overall Study||8
10420471|NCT00814255|11565219|FG001|STARTED|Overall Study||7
10420472|NCT00814255|11565220|FG002|STARTED|Overall Study||8
10420473|NCT00814255|11565218|FG000|COMPLETED|Overall Study||7
10420474|NCT00814255|11565219|FG001|COMPLETED|Overall Study||7
10420475|NCT00814255|11565220|FG002|COMPLETED|Overall Study||7
10420476|NCT00814255|11565218|FG000|NOT COMPLETED|Overall Study||1
10420477|NCT00814255|11565219|FG001|NOT COMPLETED|Overall Study||0
10420478|NCT00814255|11565220|FG002|NOT COMPLETED|Overall Study||1
10420479|NCT00814307|11565235|FG000|STARTED|Overall Study||244
10420480|NCT00814307|11565236|FG001|STARTED|Overall Study||245
10420481|NCT00814307|11565237|FG002|STARTED|Overall Study||61
10420482|NCT00814307|11565238|FG003|STARTED|Overall Study||61
10420483|NCT00814307|11565235|FG000|Treated|Overall Study||243
10420484|NCT00814307|11565236|FG001|Treated|Overall Study||245
10420485|NCT00814307|11565237|FG002|Treated|Overall Study||61
10420486|NCT00814307|11565238|FG003|Treated|Overall Study||61
10420487|NCT00814307|11565235|FG000|COMPLETED|Overall Study||232
10420488|NCT00814307|11565236|FG001|COMPLETED|Overall Study||218
10420489|NCT00814307|11565237|FG002|COMPLETED|Overall Study||54
10420490|NCT00814307|11565238|FG003|COMPLETED|Overall Study||51
10755749|NCT03071094|11919569|FG000|COMPLETED|Overall Study||5
10755750|NCT03071094|11919570|FG001|COMPLETED|Overall Study||4
10755751|NCT03071094|11919569|FG000|NOT COMPLETED|Overall Study||2
10755752|NCT03071094|11919570|FG001|NOT COMPLETED|Overall Study||1
10755753|NCT03071263|11919578|FG000|STARTED|Overall Study||147
10755754|NCT03071263|11919579|FG001|STARTED|Overall Study||148
10755755|NCT03071263|11919578|FG000|COMPLETED|Overall Study||144
10755756|NCT03071263|11919579|FG001|COMPLETED|Overall Study||141
10755757|NCT03071263|11919578|FG000|NOT COMPLETED|Overall Study||3
10755758|NCT03071263|11919579|FG001|NOT COMPLETED|Overall Study||7
10755759|NCT03071276|11919585|FG000|STARTED|Overall Study||37
10755760|NCT03071276|11919585|FG000|COMPLETED|Overall Study||22
10874529|NCT04992442|12040624|FG000|STARTED|Treatment Period 1||6
10420491|NCT00814307|11565235|FG000|NOT COMPLETED|Overall Study||12
10420492|NCT00814307|11565236|FG001|NOT COMPLETED|Overall Study||27
10420493|NCT00814307|11565237|FG002|NOT COMPLETED|Overall Study||7
10420494|NCT00814307|11565238|FG003|NOT COMPLETED|Overall Study||10
10420495|NCT00814320|11565252|FG000|STARTED|Epoch 1 (IV Treatment)||14
10420496|NCT00814320|11565253|FG001|STARTED|Epoch 1 (IV Treatment)||73
10420497|NCT00814320|11565252|FG000|COMPLETED|Epoch 1 (IV Treatment)||13
10420498|NCT00814320|11565253|FG001|COMPLETED|Epoch 1 (IV Treatment)||71
10420499|NCT00814320|11565252|FG000|NOT COMPLETED|Epoch 1 (IV Treatment)||1
10420500|NCT00814320|11565253|FG001|NOT COMPLETED|Epoch 1 (IV Treatment)||2
10420501|NCT00814320|11565252|FG000|STARTED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||13
10420502|NCT00814320|11565253|FG001|STARTED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||71
10420503|NCT00814320|11565252|FG000|COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||13
10755761|NCT03071276|11919585|FG000|NOT COMPLETED|Overall Study||15
10755762|NCT03071744|11919589|FG000|STARTED|Overall Study||6
10420504|NCT00814320|11565253|FG001|COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||70
10420505|NCT00814320|11565252|FG000|NOT COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||0
10420506|NCT00814320|11565253|FG001|NOT COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||1
10420507|NCT00814320|11565252|FG000|STARTED|"Epoch 2 Ramp-up (Ramp-up)"||13
10420508|NCT00814320|11565253|FG001|STARTED|"Epoch 2 Ramp-up (Ramp-up)"||70
10420509|NCT00814320|11565252|FG000|COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||11
10420510|NCT00814320|11565253|FG001|COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||70
10420511|NCT00814320|11565252|FG000|NOT COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||2
10420512|NCT00814320|11565253|FG001|NOT COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||0
10420513|NCT00814320|11565252|FG000|STARTED|Epoch 2 After Ramp-up (SC/rHuPH20)||11
10420514|NCT00814320|11565253|FG001|STARTED|Epoch 2 After Ramp-up (SC/rHuPH20)||70
10420515|NCT00814320|11565252|FG000|COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||8
10420516|NCT00814320|11565253|FG001|COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)|Three participants who switched to safety follow-up remained in the study.|60
10420517|NCT00814320|11565252|FG000|NOT COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||3
10420518|NCT00814320|11565253|FG001|NOT COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||10
10420519|NCT00814346|11565278|FG000|STARTED|Double-blind Phase (4 Weeks)||23
10420520|NCT00814346|11565279|FG001|STARTED|Double-blind Phase (4 Weeks)||26
10420521|NCT00814346|11565278|FG000|CNE|Double-blind Phase (4 Weeks)||10
10420522|NCT00814346|11565279|FG001|CNE|Double-blind Phase (4 Weeks)||13
10420523|NCT00814346|11565278|FG000|MC|Double-blind Phase (4 Weeks)||10
10420524|NCT00814346|11565279|FG001|MC|Double-blind Phase (4 Weeks)||11
10420525|NCT00814346|11565278|FG000|AD|Double-blind Phase (4 Weeks)||3
10420526|NCT00814346|11565279|FG001|AD|Double-blind Phase (4 Weeks)||2
10420527|NCT00814346|11565278|FG000|COMPLETED|Double-blind Phase (4 Weeks)||23
10420528|NCT00814346|11565279|FG001|COMPLETED|Double-blind Phase (4 Weeks)||23
10420529|NCT00814346|11565278|FG000|NOT COMPLETED|Double-blind Phase (4 Weeks)||0
10420530|NCT00814346|11565279|FG001|NOT COMPLETED|Double-blind Phase (4 Weeks)||3
10420531|NCT00814346|11565278|FG000|STARTED|Open Phase (17 Months)|Open period was treated with EGB761®. 41 subjects accepted follow-up open period(21 in CNE,20 in MC)|41
10420532|NCT00814346|11565279|FG001|STARTED|Open Phase (17 Months)|This was an open period, without placebo arm, the number of subject on placebo is 0.|0
10420533|NCT00814346|11565278|FG000|CNE|Open Phase (17 Months)||21
10420534|NCT00814346|11565279|FG001|CNE|Open Phase (17 Months)||0
10420535|NCT00814346|11565278|FG000|MC|Open Phase (17 Months)||20
10420536|NCT00814346|11565279|FG001|MC|Open Phase (17 Months)||0
10420537|NCT00814346|11565278|FG000|AD|Open Phase (17 Months)|Open period was not proposed to AD subjects.|0
10420538|NCT00814346|11565279|FG001|AD|Open Phase (17 Months)||0
10420539|NCT00814346|11565278|FG000|COMPLETED|Open Phase (17 Months)||31
10420540|NCT00814346|11565279|FG001|COMPLETED|Open Phase (17 Months)||0
10420541|NCT00814346|11565278|FG000|NOT COMPLETED|Open Phase (17 Months)||10
10420542|NCT00814346|11565279|FG001|NOT COMPLETED|Open Phase (17 Months)||0
10420543|NCT00814463|11565298|FG000|STARTED|Overall Study||1
10420544|NCT00814463|11565298|FG000|COMPLETED|Overall Study||0
10420545|NCT00814463|11565298|FG000|NOT COMPLETED|Overall Study||1
10420546|NCT00814489|11565306|FG000|STARTED|Overall Study||15
10420547|NCT00814489|11565307|FG001|STARTED|Overall Study||17
10420548|NCT00814489|11565308|FG002|STARTED|Overall Study||8
10420549|NCT00814489|11565306|FG000|COMPLETED|Overall Study||13
10420550|NCT00814489|11565307|FG001|COMPLETED|Overall Study||17
10420551|NCT00814489|11565308|FG002|COMPLETED|Overall Study||7
10420552|NCT00814489|11565306|FG000|NOT COMPLETED|Overall Study||2
10420553|NCT00814489|11565307|FG001|NOT COMPLETED|Overall Study||0
10420554|NCT00814489|11565308|FG002|NOT COMPLETED|Overall Study||1
10420555|NCT00814502|11565320|FG000|STARTED|Overall Study||8
10420556|NCT00814502|11565321|FG001|STARTED|Overall Study||9
10420557|NCT00814502|11565320|FG000|COMPLETED|Overall Study||7
10420558|NCT00814502|11565321|FG001|COMPLETED|Overall Study||7
10420559|NCT00814502|11565320|FG000|NOT COMPLETED|Overall Study||1
10420560|NCT00814502|11565321|FG001|NOT COMPLETED|Overall Study||2
10420561|NCT00814580|11565331|FG000|STARTED|Overall Study||194
10420562|NCT00814580|11565332|FG001|STARTED|Overall Study||188
10420563|NCT00814580|11565331|FG000|COMPLETED|Overall Study||163
10420564|NCT00814580|11565332|FG001|COMPLETED|Overall Study||141
10420565|NCT00814580|11565331|FG000|NOT COMPLETED|Overall Study||31
10420566|NCT00814580|11565332|FG001|NOT COMPLETED|Overall Study||47
10420567|NCT00814632|11565350|FG000|STARTED|Overall Study|Ten were allocated to treatment intervention however one was not treated due to lactose allergy.|9
10420568|NCT00814632|11565350|FG000|COMPLETED|Overall Study|Two subjects withdrew early due to lack of efficacy.|7
10420569|NCT00814632|11565350|FG000|NOT COMPLETED|Overall Study||2
10420570|NCT00814658|11565356|FG000|STARTED|Overall Study||9
10420571|NCT00814658|11565357|FG001|STARTED|Overall Study||12
10420572|NCT00814658|11565356|FG000|COMPLETED|Overall Study||5
10420573|NCT00814658|11565357|FG001|COMPLETED|Overall Study||8
10420574|NCT00814658|11565356|FG000|NOT COMPLETED|Overall Study||4
10420575|NCT00814658|11565357|FG001|NOT COMPLETED|Overall Study||4
10420576|NCT00814671|11565376|FG000|STARTED|Overall Study||54
10420577|NCT00814671|11565377|FG001|STARTED|Overall Study||48
10420578|NCT00814671|11565378|FG002|STARTED|Overall Study||51
10420579|NCT00814671|11565376|FG000|COMPLETED|Overall Study||47
10420580|NCT00814671|11565377|FG001|COMPLETED|Overall Study||44
10420581|NCT00814671|11565378|FG002|COMPLETED|Overall Study||49
10420582|NCT00814671|11565376|FG000|NOT COMPLETED|Overall Study||7
10546064|NCT01502644|11699627|FG000|STARTED|Enrolled at Visit 1 After Pre-screening||81
10420583|NCT00814671|11565377|FG001|NOT COMPLETED|Overall Study||4
10420584|NCT00814671|11565378|FG002|NOT COMPLETED|Overall Study||2
10420585|NCT00814697|11565390|FG000|STARTED|Overall Study||12
10420586|NCT00814697|11565390|FG000|COMPLETED|Overall Study||12
10420587|NCT00814697|11565390|FG000|NOT COMPLETED|Overall Study||0
10420588|NCT00814710|11565396|FG000|STARTED|Overall Study||240
10420589|NCT00814710|11565397|FG001|STARTED|Overall Study||120
10420590|NCT00814710|11565396|FG000|COMPLETED|Overall Study||232
10420591|NCT00814710|11565397|FG001|COMPLETED|Overall Study||117
10755763|NCT03071744|11919589|FG000|COMPLETED|Overall Study||4
10755764|NCT03071744|11919589|FG000|NOT COMPLETED|Overall Study||2
10755765|NCT03071887|11919593|FG000|STARTED|Overall Study||13
10755766|NCT03071887|11919593|FG000|COMPLETED|Overall Study||7
10755767|NCT03071887|11919593|FG000|NOT COMPLETED|Overall Study||6
10755768|NCT03072160|11919599|FG000|STARTED|Overall Study||13
10755769|NCT03072160|11919600|FG001|STARTED|Overall Study||4
10755770|NCT03072160|11919599|FG000|COMPLETED|Overall Study||2
10755771|NCT03072160|11919600|FG001|COMPLETED|Overall Study||0
10755772|NCT03072160|11919599|FG000|NOT COMPLETED|Overall Study||11
10755773|NCT03072160|11919600|FG001|NOT COMPLETED|Overall Study||4
10755774|NCT03072186|11919638|FG000|STARTED|Overall Study||23
10755775|NCT03072186|11919638|FG000|COMPLETED|Overall Study||17
10755776|NCT03072186|11919638|FG000|NOT COMPLETED|Overall Study||6
10755777|NCT03072550|11919642|FG000|STARTED|Overall Study||26
10755778|NCT03072550|11919642|FG000|COMPLETED|Overall Study||24
10755779|NCT03072550|11919642|FG000|NOT COMPLETED|Overall Study||2
10755780|NCT03072602|11919648|FG000|STARTED|Overall Study||39
10755781|NCT03072602|11919649|FG001|STARTED|Overall Study||42
10420639|NCT00815035|11565449|FG000|COMPLETED|Open Label Extension Phase||0
10755782|NCT03072602|11919648|FG000|Total Participant Screened for the Purpose of Eligibilty|Overall Study||47
10755783|NCT03072602|11919649|FG001|Total Participant Screened for the Purpose of Eligibilty|Overall Study||47
10755784|NCT03072602|11919648|FG000|Ineligible Participants|Overall Study||8
10755785|NCT03072602|11919649|FG001|Ineligible Participants|Overall Study||5
10755786|NCT03072602|11919648|FG000|Participant Received Standardized Meals|Overall Study||39
10755787|NCT03072602|11919649|FG001|Participant Received Standardized Meals|Overall Study||42
10755788|NCT03072602|11919648|FG000|Study Dropouts|Overall Study||4
10755789|NCT03072602|11919649|FG001|Study Dropouts|Overall Study||3
10755790|NCT03072602|11919648|FG000|Participants Returned for Glucose Challenge Protocol|Overall Study||35
10755791|NCT03072602|11919649|FG001|Participants Returned for Glucose Challenge Protocol|Overall Study||39
10755792|NCT03072602|11919648|FG000|Unable to Complete the Protocol|Overall Study||1
10755793|NCT03072602|11919649|FG001|Unable to Complete the Protocol|Overall Study||1
10755794|NCT03072602|11919648|FG000|COMPLETED|Overall Study||34
10755795|NCT03072602|11919649|FG001|COMPLETED|Overall Study||38
10755796|NCT03072602|11919648|FG000|NOT COMPLETED|Overall Study||5
10755797|NCT03072602|11919649|FG001|NOT COMPLETED|Overall Study||4
10755798|NCT03072719|11919657|FG000|STARTED|Overall Study||60
10755799|NCT03072719|11919658|FG001|STARTED|Overall Study||60
10755800|NCT03072719|11919657|FG000|COMPLETED|Overall Study||59
10755801|NCT03072719|11919658|FG001|COMPLETED|Overall Study||59
10755802|NCT03072719|11919657|FG000|NOT COMPLETED|Overall Study||1
10755803|NCT03072719|11919658|FG001|NOT COMPLETED|Overall Study||1
10755804|NCT03072732|11919666|FG000|STARTED|Overall Study||20
10755805|NCT03072732|11919667|FG001|STARTED|Overall Study||20
10755806|NCT03072732|11919666|FG000|COMPLETED|Overall Study||20
10755807|NCT03072732|11919667|FG001|COMPLETED|Overall Study||20
10755808|NCT03072732|11919666|FG000|NOT COMPLETED|Overall Study||0
10755809|NCT03072732|11919667|FG001|NOT COMPLETED|Overall Study||0
10755810|NCT03072875|11919673|FG000|STARTED|Overall Study||26
10874530|NCT04992442|12040624|FG000|COMPLETED|Treatment Period 1||6
10874531|NCT04992442|12040624|FG000|NOT COMPLETED|Treatment Period 1||0
10874532|NCT04992442|12040624|FG000|STARTED|Washout Period||6
10874533|NCT04992442|12040624|FG000|COMPLETED|Washout Period||6
10874534|NCT04992442|12040624|FG000|NOT COMPLETED|Washout Period||0
10874535|NCT04992442|12040624|FG000|STARTED|Treatment Period 2||6
10874536|NCT04992442|12040624|FG000|COMPLETED|Treatment Period 2||6
10874537|NCT04992442|12040624|FG000|NOT COMPLETED|Treatment Period 2||0
10420592|NCT00814710|11565396|FG000|NOT COMPLETED|Overall Study||8
10420593|NCT00814710|11565397|FG001|NOT COMPLETED|Overall Study||3
10420594|NCT00814775|11565405|FG000|STARTED|Overall Study||23
10755811|NCT03072875|11919673|FG000|COMPLETED|Overall Study||25
10755812|NCT03072875|11919673|FG000|NOT COMPLETED|Overall Study||1
10420595|NCT00814775|11565406|FG001|STARTED|Overall Study||20
10420596|NCT00814775|11565405|FG000|COMPLETED|Overall Study||23
10420597|NCT00814775|11565406|FG001|COMPLETED|Overall Study||20
10420598|NCT00814775|11565405|FG000|NOT COMPLETED|Overall Study||0
10420599|NCT00814775|11565406|FG001|NOT COMPLETED|Overall Study||0
10420600|NCT00814788|11565412|FG000|STARTED|Overall Study||24
10420601|NCT00814788|11565412|FG000|COMPLETED|Overall Study||24
10420602|NCT00814788|11565412|FG000|NOT COMPLETED|Overall Study||0
10420603|NCT00814801|11565421|FG000|STARTED|Overall Study||194
10420604|NCT00814801|11565422|FG001|STARTED|Overall Study||192
10420605|NCT00814801|11565423|FG002|STARTED|Overall Study||194
10420606|NCT00814801|11565421|FG000|COMPLETED|Overall Study||160
10420607|NCT00814801|11565422|FG001|COMPLETED|Overall Study||154
10420608|NCT00814801|11565423|FG002|COMPLETED|Overall Study||151
10420609|NCT00814801|11565421|FG000|NOT COMPLETED|Overall Study||34
10420610|NCT00814801|11565422|FG001|NOT COMPLETED|Overall Study||38
10420611|NCT00814801|11565423|FG002|NOT COMPLETED|Overall Study||43
10420612|NCT00814879|11565433|FG000|STARTED|By Week 24||28
10420613|NCT00814879|11565434|FG001|STARTED|By Week 24||30
10420614|NCT00814879|11565433|FG000|COMPLETED|By Week 24||27
10420615|NCT00814879|11565434|FG001|COMPLETED|By Week 24||29
10420616|NCT00814879|11565433|FG000|NOT COMPLETED|By Week 24||1
10420617|NCT00814879|11565434|FG001|NOT COMPLETED|By Week 24||1
10420618|NCT00814879|11565433|FG000|STARTED|By Week 48||27
10420619|NCT00814879|11565434|FG001|STARTED|By Week 48||29
10420620|NCT00814879|11565433|FG000|COMPLETED|By Week 48||25
10420621|NCT00814879|11565434|FG001|COMPLETED|By Week 48||26
10420622|NCT00814879|11565433|FG000|NOT COMPLETED|By Week 48||2
10420623|NCT00814879|11565434|FG001|NOT COMPLETED|By Week 48||3
10420624|NCT00814970|11565441|FG000|STARTED|Overall Study||196
10420625|NCT00814970|11565441|FG000|COMPLETED|Overall Study||146
10420626|NCT00814970|11565441|FG000|NOT COMPLETED|Overall Study||50
10420627|NCT00815035|11565449|FG000|STARTED|Blinded Phase||10
10420628|NCT00815035|11565450|FG001|STARTED|Blinded Phase||6
10420629|NCT00815035|11565451|FG002|STARTED|Blinded Phase||0
10420630|NCT00815035|11565449|FG000|COMPLETED|Blinded Phase||9
10420631|NCT00815035|11565450|FG001|COMPLETED|Blinded Phase||6
10420632|NCT00815035|11565451|FG002|COMPLETED|Blinded Phase||0
10420633|NCT00815035|11565449|FG000|NOT COMPLETED|Blinded Phase||1
10420634|NCT00815035|11565450|FG001|NOT COMPLETED|Blinded Phase||0
10420635|NCT00815035|11565451|FG002|NOT COMPLETED|Blinded Phase||0
10420636|NCT00815035|11565449|FG000|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|0
10420637|NCT00815035|11565450|FG001|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|0
10420638|NCT00815035|11565451|FG002|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|15
10420640|NCT00815035|11565450|FG001|COMPLETED|Open Label Extension Phase||0
10420641|NCT00815035|11565451|FG002|COMPLETED|Open Label Extension Phase||9
10420642|NCT00815035|11565449|FG000|NOT COMPLETED|Open Label Extension Phase||0
10420643|NCT00815035|11565450|FG001|NOT COMPLETED|Open Label Extension Phase||0
10420644|NCT00815035|11565451|FG002|NOT COMPLETED|Open Label Extension Phase||6
10420645|NCT00815087|11565462|FG000|STARTED|Overall Study||10
10420646|NCT00815087|11565463|FG001|STARTED|Overall Study||10
10420647|NCT00815087|11565462|FG000|COMPLETED|Overall Study||10
10420648|NCT00815087|11565463|FG001|COMPLETED|Overall Study||10
10420649|NCT00815087|11565462|FG000|NOT COMPLETED|Overall Study||0
10420650|NCT00815087|11565463|FG001|NOT COMPLETED|Overall Study||0
10420651|NCT00815191|11565471|FG000|STARTED|Overall Study||38
10420652|NCT00815191|11565472|FG001|STARTED|Overall Study||35
10420653|NCT00815191|11565471|FG000|COMPLETED|Overall Study||37
10420654|NCT00815191|11565472|FG001|COMPLETED|Overall Study||34
10420655|NCT00815191|11565471|FG000|NOT COMPLETED|Overall Study||1
10420656|NCT00815191|11565472|FG001|NOT COMPLETED|Overall Study||1
10420657|NCT00815295|11565481|FG000|STARTED|Overall Study||8
10420658|NCT00815295|11565482|FG001|STARTED|Overall Study||8
10420659|NCT00815295|11565483|FG002|STARTED|Overall Study||12
10420660|NCT00815295|11565481|FG000|COMPLETED|Overall Study||8
10420661|NCT00815295|11565482|FG001|COMPLETED|Overall Study||7
10420662|NCT00815295|11565483|FG002|COMPLETED|Overall Study||9
10420663|NCT00815295|11565481|FG000|NOT COMPLETED|Overall Study||0
10420664|NCT00815295|11565482|FG001|NOT COMPLETED|Overall Study||1
10420665|NCT00815295|11565483|FG002|NOT COMPLETED|Overall Study||3
10420666|NCT00815308|11565491|FG000|STARTED|Overall Study||55
10420667|NCT00815308|11565491|FG000|COMPLETED|Overall Study||45
10420668|NCT00815308|11565491|FG000|NOT COMPLETED|Overall Study||10
10420669|NCT00815347|11565495|FG000|STARTED|Overall Study||11
10420670|NCT00815347|11565495|FG000|COMPLETED|Overall Study||7
10420671|NCT00815347|11565495|FG000|NOT COMPLETED|Overall Study||4
10420672|NCT00815360|11565503|FG000|STARTED|Overall Study||11
10420673|NCT00815360|11565504|FG001|STARTED|Overall Study||11
10420674|NCT00815360|11565503|FG000|COMPLETED|Overall Study||11
10420675|NCT00815360|11565504|FG001|COMPLETED|Overall Study||11
10420676|NCT00815360|11565503|FG000|NOT COMPLETED|Overall Study||0
10420677|NCT00815360|11565504|FG001|NOT COMPLETED|Overall Study||0
10420678|NCT00815490|11565512|FG000|STARTED|Overall Study||9
10420679|NCT00815490|11565513|FG001|STARTED|Overall Study||9
10420680|NCT00815490|11565512|FG000|COMPLETED|Overall Study||9
10420681|NCT00815490|11565513|FG001|COMPLETED|Overall Study||9
10420682|NCT00815490|11565512|FG000|NOT COMPLETED|Overall Study||0
10420683|NCT00815490|11565513|FG001|NOT COMPLETED|Overall Study||0
10420684|NCT00815516|11565521|FG000|STARTED|Overall Study||20
10420685|NCT00815516|11565522|FG001|STARTED|Overall Study||10
10420686|NCT00815516|11565521|FG000|COMPLETED|Overall Study||16
10420687|NCT00815516|11565522|FG001|COMPLETED|Overall Study||9
10420688|NCT00815516|11565521|FG000|NOT COMPLETED|Overall Study||4
10420689|NCT00815516|11565522|FG001|NOT COMPLETED|Overall Study||1
10420690|NCT00815659|11565528|FG000|STARTED|Overall Study||97
10420691|NCT00815659|11565528|FG000|COMPLETED|Overall Study||74
10420692|NCT00815659|11565528|FG000|NOT COMPLETED|Overall Study||23
10420693|NCT00815685|11565532|FG000|STARTED|Overall Study||36
10420694|NCT00815685|11565532|FG000|COMPLETED|Overall Study|Complete pre and post-treatment serum samples were available for 14 participants.|14
10420695|NCT00815685|11565532|FG000|NOT COMPLETED|Overall Study||22
10420696|NCT00815698|11565538|FG000|STARTED|Overall Study||163
10420697|NCT00815698|11565539|FG001|STARTED|Overall Study||171
10420698|NCT00815698|11565538|FG000|COMPLETED|Overall Study||163
10420699|NCT00815698|11565539|FG001|COMPLETED|Overall Study||171
10420700|NCT00815698|11565538|FG000|NOT COMPLETED|Overall Study||0
10420701|NCT00815698|11565539|FG001|NOT COMPLETED|Overall Study||0
10420702|NCT00815776|11565548|FG000|STARTED|Overall Study||60
10420703|NCT00815776|11565549|FG001|STARTED|Overall Study||64
10420704|NCT00815776|11565550|FG002|STARTED|Overall Study||28
10420705|NCT00815776|11565548|FG000|COMPLETED|Overall Study||52
10420706|NCT00815776|11565549|FG001|COMPLETED|Overall Study||56
10420707|NCT00815776|11565550|FG002|COMPLETED|Overall Study||22
10420708|NCT00815776|11565548|FG000|NOT COMPLETED|Overall Study||8
10420709|NCT00815776|11565549|FG001|NOT COMPLETED|Overall Study||8
10420710|NCT00815776|11565550|FG002|NOT COMPLETED|Overall Study||6
10420711|NCT00815919|11565561|FG000|STARTED|Overall Study||22
10420712|NCT00815919|11565561|FG000|COMPLETED|Overall Study||18
10420713|NCT00815919|11565561|FG000|NOT COMPLETED|Overall Study||4
10420714|NCT00815997|11565567|FG000|STARTED|Overall Study||80
10420715|NCT00815997|11565568|FG001|STARTED|Overall Study||80
10420716|NCT00815997|11565567|FG000|COMPLETED|Overall Study||80
10420717|NCT00815997|11565568|FG001|COMPLETED|Overall Study||80
10420718|NCT00815997|11565567|FG000|NOT COMPLETED|Overall Study||0
10420719|NCT00815997|11565568|FG001|NOT COMPLETED|Overall Study||0
10420720|NCT00816023|11565580|FG000|STARTED|Overall Study||71
10420721|NCT00816023|11565581|FG001|STARTED|Overall Study||62
10420722|NCT00816023|11565582|FG002|STARTED|Overall Study||69
10420723|NCT00816023|11565583|FG003|STARTED|Overall Study||74
10420724|NCT00816023|11565580|FG000|Completed Therapy|Overall Study||65
10420725|NCT00816023|11565581|FG001|Completed Therapy|Overall Study||59
10420726|NCT00816023|11565582|FG002|Completed Therapy|Overall Study||61
10420727|NCT00816023|11565583|FG003|Completed Therapy|Overall Study||63
10420728|NCT00816023|11565580|FG000|COMPLETED|Overall Study||62
10420729|NCT00816023|11565581|FG001|COMPLETED|Overall Study||56
10420730|NCT00816023|11565582|FG002|COMPLETED|Overall Study||60
10420731|NCT00816023|11565583|FG003|COMPLETED|Overall Study||62
10420732|NCT00816023|11565580|FG000|NOT COMPLETED|Overall Study||9
10420733|NCT00816023|11565581|FG001|NOT COMPLETED|Overall Study||6
10420734|NCT00816023|11565582|FG002|NOT COMPLETED|Overall Study||9
10420735|NCT00816023|11565583|FG003|NOT COMPLETED|Overall Study||12
10420736|NCT00816036|11565595|FG000|STARTED|Overall Study||503
10420737|NCT00816036|11565596|FG001|STARTED|Overall Study||395
10420738|NCT00816036|11565595|FG000|COMPLETED|Overall Study||327
10420739|NCT00816036|11565596|FG001|COMPLETED|Overall Study||287
10420740|NCT00816036|11565595|FG000|NOT COMPLETED|Overall Study||176
10420741|NCT00816036|11565596|FG001|NOT COMPLETED|Overall Study||108
10420742|NCT00816062|11565602|FG000|STARTED|Overall Study||260
10420743|NCT00816062|11565602|FG000|COMPLETED|Overall Study||133
10420744|NCT00816062|11565602|FG000|NOT COMPLETED|Overall Study||127
10420745|NCT00816101|11565610|FG000|STARTED|Overall Study||13
10420746|NCT00816101|11565611|FG001|STARTED|Overall Study||8
10420747|NCT00816101|11565612|FG002|STARTED|Overall Study||5
10420748|NCT00816101|11565610|FG000|COMPLETED|Overall Study||13
10420749|NCT00816101|11565611|FG001|COMPLETED|Overall Study||8
10420750|NCT00816101|11565612|FG002|COMPLETED|Overall Study||5
10420751|NCT00816101|11565610|FG000|NOT COMPLETED|Overall Study||0
10420752|NCT00816101|11565611|FG001|NOT COMPLETED|Overall Study||0
10420753|NCT00816101|11565612|FG002|NOT COMPLETED|Overall Study||0
10420754|NCT00816166|11565622|FG000|STARTED|Overall Study|Of 59 randomized to Stent Arm, 4 were treated with Medical Therapy Only|59
10420755|NCT00816166|11565623|FG001|STARTED|Overall Study|Of 53 randomized to Medical Therapy Arm, 9 were treated with Stent+Medical Therapy|53
10420756|NCT00816166|11565622|FG000|ITT Population (Met Eligibility)|Overall Study|Of 59 randomized to Stent Arm, 1 subject failed to meet eligibility and was excluded from the ITT|58
10420757|NCT00816166|11565623|FG001|ITT Population (Met Eligibility)|Overall Study||53
10420758|NCT00816166|11565622|FG000|COMPLETED|Overall Study||49
10420759|NCT00816166|11565623|FG001|COMPLETED|Overall Study||41
10420760|NCT00816166|11565622|FG000|NOT COMPLETED|Overall Study||10
10420761|NCT00816166|11565623|FG001|NOT COMPLETED|Overall Study||12
10420762|NCT00816348|11565629|FG000|STARTED|Overall Study||15
10420763|NCT00816348|11565629|FG000|COMPLETED|Overall Study||15
10420764|NCT00816348|11565629|FG000|NOT COMPLETED|Overall Study||0
10420765|NCT00816361|11565640|FG000|STARTED|Overall Study||4
10420766|NCT00816361|11565641|FG001|STARTED|Overall Study||3
10420767|NCT00816361|11565642|FG002|STARTED|Overall Study||4
10420768|NCT00816361|11565643|FG003|STARTED|Overall Study||3
10420769|NCT00816361|11565644|FG004|STARTED|Overall Study||3
10420770|NCT00816361|11565645|FG005|STARTED|Overall Study||3
10420771|NCT00816361|11565646|FG006|STARTED|Overall Study||3
10420772|NCT00816361|11565647|FG007|STARTED|Overall Study||10
10420773|NCT00816361|11565648|FG008|STARTED|Overall Study||10
10420774|NCT00816361|11565640|FG000|COMPLETED|Overall Study||0
10420775|NCT00816361|11565641|FG001|COMPLETED|Overall Study||0
10420776|NCT00816361|11565642|FG002|COMPLETED|Overall Study||1
10546065|NCT01502644|11699628|FG001|STARTED|Enrolled at Visit 1 After Pre-screening||0
10546066|NCT01502644|11699629|FG002|STARTED|Enrolled at Visit 1 After Pre-screening||0
10546067|NCT01502644|11699630|FG003|STARTED|Enrolled at Visit 1 After Pre-screening||0
10546068|NCT01502644|11699627|FG000|COMPLETED|Enrolled at Visit 1 After Pre-screening|Participants who completed Visit 1 were assigned to 1 of the 3 NA groups for remainder of the trial|72
10546069|NCT01502644|11699628|FG001|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
10546070|NCT01502644|11699629|FG002|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
10546071|NCT01502644|11699630|FG003|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
10546072|NCT01502644|11699627|FG000|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||9
10546073|NCT01502644|11699628|FG001|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
10546074|NCT01502644|11699629|FG002|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
10546075|NCT01502644|11699630|FG003|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
10546076|NCT01502644|11699627|FG000|STARTED|Assigned to NA Groups||0
10546077|NCT01502644|11699628|FG001|STARTED|Assigned to NA Groups||30
10546078|NCT01502644|11699629|FG002|STARTED|Assigned to NA Groups||10
10546079|NCT01502644|11699630|FG003|STARTED|Assigned to NA Groups||32
10546080|NCT01502644|11699627|FG000|COMPLETED|Assigned to NA Groups||0
10546081|NCT01502644|11699628|FG001|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|24
10546082|NCT01502644|11699629|FG002|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|7
10546083|NCT01502644|11699630|FG003|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|24
10546084|NCT01502644|11699627|FG000|NOT COMPLETED|Assigned to NA Groups||0
10546085|NCT01502644|11699628|FG001|NOT COMPLETED|Assigned to NA Groups||6
10546086|NCT01502644|11699629|FG002|NOT COMPLETED|Assigned to NA Groups||3
10546087|NCT01502644|11699630|FG003|NOT COMPLETED|Assigned to NA Groups||8
10546088|NCT01502709|11699640|FG000|STARTED|Overall Study||5
10546089|NCT01502709|11699641|FG001|STARTED|Overall Study||0
10546090|NCT01502709|11699640|FG000|COMPLETED|Overall Study||1
10546091|NCT01502709|11699641|FG001|COMPLETED|Overall Study||0
10546092|NCT01502709|11699640|FG000|NOT COMPLETED|Overall Study||4
10546093|NCT01502709|11699641|FG001|NOT COMPLETED|Overall Study||0
10546094|NCT01502761|11699652|FG000|STARTED|Overall Study||4
10546095|NCT01502761|11699653|FG001|STARTED|Overall Study||0
10546096|NCT01502761|11699654|FG002|STARTED|Overall Study||0
10546097|NCT01502761|11699655|FG003|STARTED|Overall Study||0
10546098|NCT01502761|11699652|FG000|COMPLETED|Overall Study||4
10546099|NCT01502761|11699653|FG001|COMPLETED|Overall Study||0
10546100|NCT01502761|11699654|FG002|COMPLETED|Overall Study||0
10546101|NCT01502761|11699655|FG003|COMPLETED|Overall Study||0
10546102|NCT01502761|11699652|FG000|NOT COMPLETED|Overall Study||0
10546103|NCT01502761|11699653|FG001|NOT COMPLETED|Overall Study||0
10546104|NCT01502761|11699654|FG002|NOT COMPLETED|Overall Study||0
10546105|NCT01502761|11699655|FG003|NOT COMPLETED|Overall Study||0
10546106|NCT01502787|11699665|FG000|STARTED|Overall Study||11
10546107|NCT01502787|11699666|FG001|STARTED|Overall Study||10
10546108|NCT01502787|11699665|FG000|COMPLETED|Overall Study||11
10546109|NCT01502787|11699666|FG001|COMPLETED|Overall Study||10
10546110|NCT01502787|11699665|FG000|NOT COMPLETED|Overall Study||0
10546111|NCT01502787|11699666|FG001|NOT COMPLETED|Overall Study||0
10546112|NCT01502813|11699676|FG000|STARTED|Overall Study||40
10546113|NCT01502813|11699676|FG000|COMPLETED|Overall Study||40
10546114|NCT01502813|11699676|FG000|NOT COMPLETED|Overall Study||0
10546115|NCT01502956|11699682|FG000|STARTED|Overall Study||192
10546116|NCT01502956|11699683|FG001|STARTED|Overall Study||194
10546117|NCT01502956|11699682|FG000|COMPLETED|Overall Study||168
10546118|NCT01502956|11699683|FG001|COMPLETED|Overall Study||168
10546119|NCT01502956|11699682|FG000|NOT COMPLETED|Overall Study||24
10546120|NCT01502956|11699683|FG001|NOT COMPLETED|Overall Study||26
10546121|NCT01503021|11699691|FG000|STARTED|Overall Study||360
10546122|NCT01503021|11699692|FG001|STARTED|Overall Study||358
10546123|NCT01503021|11699691|FG000|Dosed|Overall Study||351
10546124|NCT01503021|11699692|FG001|Dosed|Overall Study||352
10546125|NCT01503021|11699691|FG000|Completed Treatment|Overall Study||333
10546126|NCT01503021|11699692|FG001|Completed Treatment|Overall Study|One patient completed the treatment period but discontinued prior to completing the follow-up visit.|333
10546127|NCT01503021|11699691|FG000|COMPLETED|Overall Study||333
10546128|NCT01503021|11699692|FG001|COMPLETED|Overall Study||332
10546129|NCT01503021|11699691|FG000|NOT COMPLETED|Overall Study||27
10546130|NCT01503021|11699692|FG001|NOT COMPLETED|Overall Study||26
10546131|NCT01503164|11699705|FG000|STARTED|Overall Study||55
10546132|NCT01503164|11699706|FG001|STARTED|Overall Study||56
10546133|NCT01503164|11699705|FG000|COMPLETED|Overall Study||53
10546134|NCT01503164|11699706|FG001|COMPLETED|Overall Study||55
10546135|NCT01503164|11699705|FG000|NOT COMPLETED|Overall Study||2
10546136|NCT01503164|11699706|FG001|NOT COMPLETED|Overall Study||1
10546137|NCT01503229|11699712|FG000|STARTED|Overall Study||30
10546138|NCT01503229|11699712|FG000|COMPLETED|Overall Study||29
10420777|NCT00816361|11565643|FG003|COMPLETED|Overall Study||0
10420778|NCT00816361|11565644|FG004|COMPLETED|Overall Study||1
10420779|NCT00816361|11565645|FG005|COMPLETED|Overall Study||0
10420780|NCT00816361|11565646|FG006|COMPLETED|Overall Study||0
10420781|NCT00816361|11565647|FG007|COMPLETED|Overall Study||1
10420782|NCT00816361|11565648|FG008|COMPLETED|Overall Study||0
10420783|NCT00816361|11565640|FG000|NOT COMPLETED|Overall Study||4
10420784|NCT00816361|11565641|FG001|NOT COMPLETED|Overall Study||3
10420785|NCT00816361|11565642|FG002|NOT COMPLETED|Overall Study||3
10420786|NCT00816361|11565643|FG003|NOT COMPLETED|Overall Study||3
10420787|NCT00816361|11565644|FG004|NOT COMPLETED|Overall Study||2
10420788|NCT00816361|11565645|FG005|NOT COMPLETED|Overall Study||3
10420789|NCT00816361|11565646|FG006|NOT COMPLETED|Overall Study||3
10420790|NCT00816361|11565647|FG007|NOT COMPLETED|Overall Study||9
10420791|NCT00816361|11565648|FG008|NOT COMPLETED|Overall Study||10
10420792|NCT00816400|11565678|FG000|STARTED|Overall Study||3
10420793|NCT00816400|11565679|FG001|STARTED|Overall Study||3
10420794|NCT00816400|11565680|FG002|STARTED|Overall Study||5
10420795|NCT00816400|11565681|FG003|STARTED|Overall Study||3
10420796|NCT00816400|11565682|FG004|STARTED|Overall Study||3
10420797|NCT00816400|11565683|FG005|STARTED|Overall Study||3
10420798|NCT00816400|11565684|FG006|STARTED|Overall Study||3
10420799|NCT00816400|11565685|FG007|STARTED|Overall Study||6
10420800|NCT00816400|11565686|FG008|STARTED|Overall Study||6
10420801|NCT00816400|11565678|FG000|COMPLETED|Overall Study||1
10420802|NCT00816400|11565679|FG001|COMPLETED|Overall Study||0
10420803|NCT00816400|11565680|FG002|COMPLETED|Overall Study||0
10420804|NCT00816400|11565681|FG003|COMPLETED|Overall Study||0
10420805|NCT00816400|11565682|FG004|COMPLETED|Overall Study||1
10420806|NCT00816400|11565683|FG005|COMPLETED|Overall Study||0
10420807|NCT00816400|11565684|FG006|COMPLETED|Overall Study||1
10546139|NCT01503229|11699712|FG000|NOT COMPLETED|Overall Study||1
10546140|NCT01503333|11699718|FG000|STARTED|Overall Study||777
10546141|NCT01503333|11699719|FG001|STARTED|Overall Study||766
10546142|NCT01503333|11699718|FG000|Completed Baseline|Overall Study||766
10546143|NCT01503333|11699719|FG001|Completed Baseline|Overall Study||753
10546144|NCT01503333|11699718|FG000|Completed Post-intervention|Overall Study||680
10546145|NCT01503333|11699719|FG001|Completed Post-intervention|Overall Study||706
10546146|NCT01503333|11699718|FG000|COMPLETED|Overall Study||437
10546147|NCT01503333|11699719|FG001|COMPLETED|Overall Study||461
10546148|NCT01503333|11699718|FG000|NOT COMPLETED|Overall Study||340
10546149|NCT01503333|11699719|FG001|NOT COMPLETED|Overall Study||305
10546150|NCT01503749|11699736|FG000|STARTED|Overall Study||3
10546151|NCT01503749|11699737|FG001|STARTED|Overall Study||3
10546152|NCT01503749|11699738|FG002|STARTED|Overall Study||3
10296773|NCT00943852|11429426|FG009|COMPLETED|Washout Period After Period 2 Treatment||1
10296774|NCT00943852|11429417|FG000|NOT COMPLETED|Washout Period After Period 2 Treatment||0
10296775|NCT00943852|11429418|FG001|NOT COMPLETED|Washout Period After Period 2 Treatment||0
10296776|NCT00943852|11429419|FG002|NOT COMPLETED|Washout Period After Period 2 Treatment||0
10296777|NCT00943852|11429420|FG003|NOT COMPLETED|Washout Period After Period 2 Treatment||0
10296778|NCT00943852|11429421|FG004|NOT COMPLETED|Washout Period After Period 2 Treatment||0
10546153|NCT01503749|11699736|FG000|COMPLETED|Overall Study||3
10546154|NCT01503749|11699737|FG001|COMPLETED|Overall Study||3
10546155|NCT01503749|11699738|FG002|COMPLETED|Overall Study||3
10546156|NCT01503749|11699736|FG000|NOT COMPLETED|Overall Study||0
10546157|NCT01503749|11699737|FG001|NOT COMPLETED|Overall Study||0
10546158|NCT01503749|11699738|FG002|NOT COMPLETED|Overall Study||0
10546159|NCT01504204|11699748|FG000|STARTED|Overall Study||10
10546160|NCT01504204|11699749|FG001|STARTED|Overall Study||10
10546161|NCT01504204|11699748|FG000|COMPLETED|Overall Study||9
10546162|NCT01504204|11699749|FG001|COMPLETED|Overall Study||9
10546163|NCT01504204|11699748|FG000|NOT COMPLETED|Overall Study||1
10546164|NCT01504204|11699749|FG001|NOT COMPLETED|Overall Study||1
10546165|NCT01504412|11699760|FG000|STARTED|Overall Study||89
10546166|NCT01504412|11699761|FG001|STARTED|Overall Study||87
10546167|NCT01504412|11699762|FG002|STARTED|Overall Study||90
10546168|NCT01504412|11699763|FG003|STARTED|Overall Study||94
10546169|NCT01504412|11699764|FG004|STARTED|Overall Study||90
10546170|NCT01504412|11699760|FG000|COMPLETED|Overall Study||84
10546171|NCT01504412|11699761|FG001|COMPLETED|Overall Study||75
10546172|NCT01504412|11699762|FG002|COMPLETED|Overall Study||86
10546173|NCT01504412|11699763|FG003|COMPLETED|Overall Study||75
10296779|NCT00943852|11429422|FG005|NOT COMPLETED|Washout Period After Period 2 Treatment||1
10296780|NCT00943852|11429423|FG006|NOT COMPLETED|Washout Period After Period 2 Treatment||0
10296781|NCT00943852|11429424|FG007|NOT COMPLETED|Washout Period After Period 2 Treatment||0
10296782|NCT00943852|11429425|FG008|NOT COMPLETED|Washout Period After Period 2 Treatment||0
10296783|NCT00943852|11429426|FG009|NOT COMPLETED|Washout Period After Period 2 Treatment||0
10296784|NCT00943852|11429417|FG000|STARTED|Third Period of Treatment Intervention||2
10296785|NCT00943852|11429418|FG001|STARTED|Third Period of Treatment Intervention||1
10296786|NCT00943852|11429419|FG002|STARTED|Third Period of Treatment Intervention||1
10296787|NCT00943852|11429420|FG003|STARTED|Third Period of Treatment Intervention||1
10420808|NCT00816400|11565685|FG007|COMPLETED|Overall Study||1
10420809|NCT00816400|11565686|FG008|COMPLETED|Overall Study||0
10420810|NCT00816400|11565678|FG000|NOT COMPLETED|Overall Study||2
10420811|NCT00816400|11565679|FG001|NOT COMPLETED|Overall Study||3
10420812|NCT00816400|11565680|FG002|NOT COMPLETED|Overall Study||5
10420813|NCT00816400|11565681|FG003|NOT COMPLETED|Overall Study||3
10420814|NCT00816400|11565682|FG004|NOT COMPLETED|Overall Study||2
10420815|NCT00816400|11565683|FG005|NOT COMPLETED|Overall Study||3
10420816|NCT00816400|11565684|FG006|NOT COMPLETED|Overall Study||2
10420817|NCT00816400|11565685|FG007|NOT COMPLETED|Overall Study||5
10420818|NCT00816400|11565686|FG008|NOT COMPLETED|Overall Study||6
10420819|NCT00816556|11565710|FG000|STARTED|Overall Study||20
10420820|NCT00816556|11565711|FG001|STARTED|Overall Study||21
10420821|NCT00816556|11565712|FG002|STARTED|Overall Study||22
10420822|NCT00816556|11565710|FG000|COMPLETED|Overall Study||18
10420823|NCT00816556|11565711|FG001|COMPLETED|Overall Study||19
10420824|NCT00816556|11565712|FG002|COMPLETED|Overall Study||19
10420825|NCT00816556|11565710|FG000|NOT COMPLETED|Overall Study||2
10420826|NCT00816556|11565711|FG001|NOT COMPLETED|Overall Study||2
10420827|NCT00816556|11565712|FG002|NOT COMPLETED|Overall Study||3
10420828|NCT00816595|11565722|FG000|STARTED|Overall Study||35
10420829|NCT00816595|11565723|FG001|STARTED|Overall Study||33
10420830|NCT00816595|11565722|FG000|COMPLETED|Overall Study||33
10420831|NCT00816595|11565723|FG001|COMPLETED|Overall Study||33
10420832|NCT00816595|11565722|FG000|NOT COMPLETED|Overall Study||2
10420833|NCT00816595|11565723|FG001|NOT COMPLETED|Overall Study||0
10420834|NCT00816751|11565733|FG000|STARTED|Overall Study||45
10420835|NCT00816751|11565734|FG001|STARTED|Overall Study||44
10420836|NCT00816751|11565733|FG000|COMPLETED|Overall Study||45
10420837|NCT00816751|11565734|FG001|COMPLETED|Overall Study||44
10420838|NCT00816751|11565733|FG000|NOT COMPLETED|Overall Study||0
10420839|NCT00816751|11565734|FG001|NOT COMPLETED|Overall Study||0
10420840|NCT00816829|11565742|FG000|STARTED|Overall Study||16
10420841|NCT00816829|11565743|FG001|STARTED|Overall Study||18
10420842|NCT00816829|11565742|FG000|COMPLETED|Overall Study||16
10420843|NCT00816829|11565743|FG001|COMPLETED|Overall Study||18
10420844|NCT00816829|11565742|FG000|NOT COMPLETED|Overall Study||0
10420845|NCT00816829|11565743|FG001|NOT COMPLETED|Overall Study||0
10420846|NCT00816907|11565751|FG000|STARTED|Overall Study||71
10420847|NCT00816907|11565752|FG001|STARTED|Overall Study||75
10420848|NCT00816907|11565751|FG000|COMPLETED|Overall Study||58
10420849|NCT00816907|11565752|FG001|COMPLETED|Overall Study||58
10420850|NCT00816907|11565751|FG000|NOT COMPLETED|Overall Study||13
10420851|NCT00816907|11565752|FG001|NOT COMPLETED|Overall Study||17
10420852|NCT00817063|11565762|FG000|STARTED|Overall Study||298
10420853|NCT00817063|11565763|FG001|STARTED|Overall Study||298
10420854|NCT00817063|11565762|FG000|COMPLETED|Overall Study||161
10420855|NCT00817063|11565763|FG001|COMPLETED|Overall Study||128
10420856|NCT00817063|11565762|FG000|NOT COMPLETED|Overall Study||137
10420857|NCT00817063|11565763|FG001|NOT COMPLETED|Overall Study||170
10420858|NCT00817089|11565773|FG000|STARTED|First Alcohol Challenge||6
10420859|NCT00817089|11565774|FG001|STARTED|First Alcohol Challenge||8
10420860|NCT00817089|11565775|FG002|STARTED|First Alcohol Challenge||4
10420861|NCT00817089|11565776|FG003|STARTED|First Alcohol Challenge||6
10420862|NCT00817089|11565773|FG000|COMPLETED|First Alcohol Challenge||6
10420863|NCT00817089|11565774|FG001|COMPLETED|First Alcohol Challenge||8
10420864|NCT00817089|11565775|FG002|COMPLETED|First Alcohol Challenge||4
10420865|NCT00817089|11565776|FG003|COMPLETED|First Alcohol Challenge||5
10420866|NCT00817089|11565773|FG000|NOT COMPLETED|First Alcohol Challenge||0
10420867|NCT00817089|11565774|FG001|NOT COMPLETED|First Alcohol Challenge||0
10420868|NCT00817089|11565775|FG002|NOT COMPLETED|First Alcohol Challenge||0
10420869|NCT00817089|11565776|FG003|NOT COMPLETED|First Alcohol Challenge||1
10420870|NCT00817089|11565773|FG000|STARTED|Second Alcohol Challenge||6
10420871|NCT00817089|11565774|FG001|STARTED|Second Alcohol Challenge||8
10420872|NCT00817089|11565775|FG002|STARTED|Second Alcohol Challenge||4
10420873|NCT00817089|11565776|FG003|STARTED|Second Alcohol Challenge||5
10420874|NCT00817089|11565773|FG000|COMPLETED|Second Alcohol Challenge||6
10420875|NCT00817089|11565774|FG001|COMPLETED|Second Alcohol Challenge||7
10420876|NCT00817089|11565775|FG002|COMPLETED|Second Alcohol Challenge||4
10420877|NCT00817089|11565776|FG003|COMPLETED|Second Alcohol Challenge||5
10420878|NCT00817089|11565773|FG000|NOT COMPLETED|Second Alcohol Challenge||0
10420879|NCT00817089|11565774|FG001|NOT COMPLETED|Second Alcohol Challenge||1
10420880|NCT00817089|11565775|FG002|NOT COMPLETED|Second Alcohol Challenge||0
10420881|NCT00817089|11565776|FG003|NOT COMPLETED|Second Alcohol Challenge||0
10420882|NCT00817206|11565792|FG000|STARTED|Overall Study||163
10420883|NCT00817206|11565793|FG001|STARTED|Overall Study||163
10420884|NCT00817206|11565792|FG000|COMPLETED|Overall Study||142
10420885|NCT00817206|11565793|FG001|COMPLETED|Overall Study||154
10420886|NCT00817206|11565792|FG000|NOT COMPLETED|Overall Study||21
10420887|NCT00817206|11565793|FG001|NOT COMPLETED|Overall Study||9
10420888|NCT00817219|11565799|FG000|STARTED|Overall Study||33
10420889|NCT00817219|11565799|FG000|COMPLETED|Overall Study||33
10420890|NCT00817219|11565799|FG000|NOT COMPLETED|Overall Study||0
10420891|NCT00817336|11565805|FG000|STARTED|Overall Study||8
10546174|NCT01504412|11699764|FG004|COMPLETED|Overall Study||77
10546175|NCT01504412|11699760|FG000|NOT COMPLETED|Overall Study||5
10420892|NCT00817336|11565806|FG001|STARTED|Overall Study||8
10420893|NCT00817336|11565805|FG000|COMPLETED|Overall Study||7
10420894|NCT00817336|11565806|FG001|COMPLETED|Overall Study||7
10420895|NCT00817336|11565805|FG000|NOT COMPLETED|Overall Study||1
10420896|NCT00817336|11565806|FG001|NOT COMPLETED|Overall Study||1
10420897|NCT00817414|11565816|FG000|STARTED|Overall Study||12
10420898|NCT00817414|11565817|FG001|STARTED|Overall Study||12
10420899|NCT00817414|11565818|FG002|STARTED|Overall Study||13
10420900|NCT00817414|11565819|FG003|STARTED|Overall Study||13
10420901|NCT00817414|11565820|FG004|STARTED|Overall Study||13
10420902|NCT00817414|11565816|FG000|COMPLETED|Overall Study||10
10420903|NCT00817414|11565817|FG001|COMPLETED|Overall Study||9
10420904|NCT00817414|11565818|FG002|COMPLETED|Overall Study||9
10420905|NCT00817414|11565819|FG003|COMPLETED|Overall Study||1
10420906|NCT00817414|11565820|FG004|COMPLETED|Overall Study||11
10420907|NCT00817414|11565816|FG000|NOT COMPLETED|Overall Study||2
10420908|NCT00817414|11565817|FG001|NOT COMPLETED|Overall Study||3
10420909|NCT00817414|11565818|FG002|NOT COMPLETED|Overall Study||4
10420910|NCT00817414|11565819|FG003|NOT COMPLETED|Overall Study||12
10420911|NCT00817414|11565820|FG004|NOT COMPLETED|Overall Study||2
10420912|NCT00817479|11565839|FG000|STARTED|Overall Study||6
10420913|NCT00817479|11565840|FG001|STARTED|Overall Study||14
10420914|NCT00817479|11565839|FG000|COMPLETED|Overall Study||5
10420915|NCT00817479|11565840|FG001|COMPLETED|Overall Study||13
10420916|NCT00817479|11565839|FG000|NOT COMPLETED|Overall Study||1
10420917|NCT00817479|11565840|FG001|NOT COMPLETED|Overall Study||1
10420918|NCT00817531|11565846|FG000|STARTED|Overall Study|22 patients were eligible for this study and started the treatment.|22
10420919|NCT00817531|11565846|FG000|COMPLETED|Overall Study|20 out of 22 patients finished study treatment. 2 patients stopped the treatment after the 1st week.|20
10420920|NCT00817531|11565846|FG000|NOT COMPLETED|Overall Study||2
10420921|NCT00817596|11565850|FG000|STARTED|Overall Study||110
10420922|NCT00817596|11565850|FG000|COMPLETED|Overall Study||62
10420923|NCT00817596|11565850|FG000|NOT COMPLETED|Overall Study||48
10420924|NCT00817635|11565859|FG000|STARTED|Overall Study||32
10420925|NCT00817635|11565860|FG001|STARTED|Overall Study||26
10420926|NCT00817635|11565861|FG002|STARTED|Overall Study||31
10420927|NCT00817635|11565862|FG003|STARTED|Overall Study||33
10420928|NCT00817635|11565863|FG004|STARTED|Overall Study||33
10420929|NCT00817635|11565859|FG000|COMPLETED|Overall Study||23
10420930|NCT00817635|11565860|FG001|COMPLETED|Overall Study||22
10420931|NCT00817635|11565861|FG002|COMPLETED|Overall Study||28
10420932|NCT00817635|11565862|FG003|COMPLETED|Overall Study||28
10420933|NCT00817635|11565863|FG004|COMPLETED|Overall Study||25
10420934|NCT00817635|11565859|FG000|NOT COMPLETED|Overall Study||9
10420935|NCT00817635|11565860|FG001|NOT COMPLETED|Overall Study||4
10420936|NCT00817635|11565861|FG002|NOT COMPLETED|Overall Study||3
10420937|NCT00817635|11565862|FG003|NOT COMPLETED|Overall Study||5
10420938|NCT00817635|11565863|FG004|NOT COMPLETED|Overall Study||8
10420939|NCT00817778|11565884|FG000|STARTED|Overall Study||19
10420940|NCT00817778|11565885|FG001|STARTED|Overall Study||8
10420941|NCT00817778|11565884|FG000|COMPLETED|Overall Study||16
10420942|NCT00817778|11565885|FG001|COMPLETED|Overall Study||5
10420943|NCT00817778|11565884|FG000|NOT COMPLETED|Overall Study||3
10420944|NCT00817778|11565885|FG001|NOT COMPLETED|Overall Study||3
10420945|NCT00817804|11565893|FG000|STARTED|Overall Study||1
10420946|NCT00817804|11565894|FG001|STARTED|Overall Study||2
10420947|NCT00817804|11565893|FG000|COMPLETED|Overall Study||1
10420948|NCT00817804|11565894|FG001|COMPLETED|Overall Study||2
10420949|NCT00817804|11565893|FG000|NOT COMPLETED|Overall Study||0
10420950|NCT00817804|11565894|FG001|NOT COMPLETED|Overall Study||0
10420951|NCT00817843|11565900|FG000|STARTED|First Period (6 Weeks)||50
10420952|NCT00817843|11565901|FG001|STARTED|First Period (6 Weeks)||50
10420953|NCT00817843|11565900|FG000|COMPLETED|First Period (6 Weeks)|All patients with >=1 postrandomization dose and measurement were analyzed|42
10420954|NCT00817843|11565901|FG001|COMPLETED|First Period (6 Weeks)||46
10420955|NCT00817843|11565900|FG000|NOT COMPLETED|First Period (6 Weeks)||8
10420956|NCT00817843|11565901|FG001|NOT COMPLETED|First Period (6 Weeks)||4
10420957|NCT00817843|11565900|FG000|STARTED|Washout Period (6 Weeks)||42
10420958|NCT00817843|11565901|FG001|STARTED|Washout Period (6 Weeks)||46
10420959|NCT00817843|11565900|FG000|COMPLETED|Washout Period (6 Weeks)||41
10420960|NCT00817843|11565901|FG001|COMPLETED|Washout Period (6 Weeks)||45
10420961|NCT00817843|11565900|FG000|NOT COMPLETED|Washout Period (6 Weeks)||1
10420962|NCT00817843|11565901|FG001|NOT COMPLETED|Washout Period (6 Weeks)||1
10420963|NCT00817843|11565900|FG000|STARTED|Second Period (6 Weeks)||41
10420964|NCT00817843|11565901|FG001|STARTED|Second Period (6 Weeks)||45
10420965|NCT00817843|11565900|FG000|COMPLETED|Second Period (6 Weeks)|All patients with >=1 postrandomization dose and measurement were analyzed|41
10420966|NCT00817843|11565901|FG001|COMPLETED|Second Period (6 Weeks)||44
10420967|NCT00817843|11565900|FG000|NOT COMPLETED|Second Period (6 Weeks)||0
10420968|NCT00817843|11565901|FG001|NOT COMPLETED|Second Period (6 Weeks)||1
10420969|NCT00817999|11565908|FG000|STARTED|Grapefruit Juice||15
10420970|NCT00817999|11565909|FG001|STARTED|Grapefruit Juice||17
10420971|NCT00817999|11565908|FG000|COMPLETED|Grapefruit Juice||15
10420972|NCT00817999|11565909|FG001|COMPLETED|Grapefruit Juice||17
10420973|NCT00817999|11565908|FG000|NOT COMPLETED|Grapefruit Juice||0
10420974|NCT00817999|11565909|FG001|NOT COMPLETED|Grapefruit Juice||0
10420975|NCT00817999|11565908|FG000|STARTED|No Grapefruit Juice||15
10420976|NCT00817999|11565909|FG001|STARTED|No Grapefruit Juice||17
10420977|NCT00817999|11565908|FG000|COMPLETED|No Grapefruit Juice||15
10420978|NCT00817999|11565909|FG001|COMPLETED|No Grapefruit Juice||17
10420979|NCT00817999|11565908|FG000|NOT COMPLETED|No Grapefruit Juice||0
10420980|NCT00817999|11565909|FG001|NOT COMPLETED|No Grapefruit Juice||0
10420981|NCT00818116|11565917|FG000|STARTED|Overall Study||34
10420982|NCT00818116|11565917|FG000|COMPLETED|Overall Study||34
10420983|NCT00818116|11565917|FG000|NOT COMPLETED|Overall Study||0
10429535|NCT00864383|11575575|FG001|COMPLETED|Per- Protocol||514
10429536|NCT00864383|11575576|FG002|COMPLETED|Per- Protocol||524
10429537|NCT00864383|11575574|FG000|NOT COMPLETED|Per- Protocol||130
10429538|NCT00864383|11575575|FG001|NOT COMPLETED|Per- Protocol||141
10429539|NCT00864383|11575576|FG002|NOT COMPLETED|Per- Protocol||112
10429540|NCT00864383|11575574|FG000|STARTED|Modified Intent to Treat||640
10420984|NCT00818168|11565921|FG000|STARTED|Overall Study||320
10420985|NCT00818168|11565921|FG000|COMPLETED|Overall Study|Includes 78 participants whose completer/non-completer status was not reported (missing)|250
10420986|NCT00818168|11565921|FG000|NOT COMPLETED|Overall Study||70
10420987|NCT00818207|11565927|FG000|STARTED|Overall Study||696
10420988|NCT00818207|11565928|FG001|STARTED|Overall Study||684
10420989|NCT00818207|11565927|FG000|COMPLETED|Overall Study||474
10420990|NCT00818207|11565928|FG001|COMPLETED|Overall Study||417
10420991|NCT00818207|11565927|FG000|NOT COMPLETED|Overall Study||222
10420992|NCT00818207|11565928|FG001|NOT COMPLETED|Overall Study||267
10420993|NCT00818246|11565934|FG000|STARTED|Overall Study||40
10420994|NCT00818246|11565934|FG000|COMPLETED|Overall Study|split-face study|35
10420995|NCT00818246|11565934|FG000|NOT COMPLETED|Overall Study||5
10420996|NCT00818259|11565945|FG000|STARTED|Randomization||12
10420997|NCT00818259|11565946|FG001|STARTED|Randomization||11
10420998|NCT00818259|11565947|FG002|STARTED|Randomization||19
10420999|NCT00818259|11565948|FG003|STARTED|Randomization||20
10421000|NCT00818259|11565949|FG004|STARTED|Randomization||19
10421001|NCT00818259|11565950|FG005|STARTED|Randomization||0
10421002|NCT00818259|11565951|FG006|STARTED|Randomization||5
10421003|NCT00818259|11565952|FG007|STARTED|Randomization||0
10421004|NCT00818259|11565953|FG008|STARTED|Randomization||6
10421005|NCT00818259|11565945|FG000|COMPLETED|Randomization||12
10421006|NCT00818259|11565946|FG001|COMPLETED|Randomization||11
10421007|NCT00818259|11565947|FG002|COMPLETED|Randomization||19
10421008|NCT00818259|11565948|FG003|COMPLETED|Randomization||20
10421009|NCT00818259|11565949|FG004|COMPLETED|Randomization||19
10421010|NCT00818259|11565950|FG005|COMPLETED|Randomization||0
10421011|NCT00818259|11565951|FG006|COMPLETED|Randomization||5
10421012|NCT00818259|11565952|FG007|COMPLETED|Randomization||0
10421013|NCT00818259|11565953|FG008|COMPLETED|Randomization||6
10421014|NCT00818259|11565945|FG000|NOT COMPLETED|Randomization||0
10421015|NCT00818259|11565946|FG001|NOT COMPLETED|Randomization||0
10421016|NCT00818259|11565947|FG002|NOT COMPLETED|Randomization||0
10421017|NCT00818259|11565948|FG003|NOT COMPLETED|Randomization||0
10421018|NCT00818259|11565949|FG004|NOT COMPLETED|Randomization||0
10421019|NCT00818259|11565950|FG005|NOT COMPLETED|Randomization||0
10421020|NCT00818259|11565951|FG006|NOT COMPLETED|Randomization||0
10421021|NCT00818259|11565952|FG007|NOT COMPLETED|Randomization||0
10421022|NCT00818259|11565953|FG008|NOT COMPLETED|Randomization||0
10421023|NCT00818259|11565945|FG000|STARTED|Part I|Newly enrolled participants|12
10421024|NCT00818259|11565946|FG001|STARTED|Part I|Newly enrolled participants|11
10421025|NCT00818259|11565947|FG002|STARTED|Part I||0
10421026|NCT00818259|11565948|FG003|STARTED|Part I||0
10421027|NCT00818259|11565949|FG004|STARTED|Part I||0
10421028|NCT00818259|11565950|FG005|STARTED|Part I||0
10421029|NCT00818259|11565951|FG006|STARTED|Part I||0
10421030|NCT00818259|11565952|FG007|STARTED|Part I||0
10421031|NCT00818259|11565953|FG008|STARTED|Part I||0
10421032|NCT00818259|11565945|FG000|COMPLETED|Part I||11
10421033|NCT00818259|11565946|FG001|COMPLETED|Part I||11
10421034|NCT00818259|11565947|FG002|COMPLETED|Part I||0
10421035|NCT00818259|11565948|FG003|COMPLETED|Part I||0
10421036|NCT00818259|11565949|FG004|COMPLETED|Part I||0
10421037|NCT00818259|11565950|FG005|COMPLETED|Part I||0
10421038|NCT00818259|11565951|FG006|COMPLETED|Part I||0
10421039|NCT00818259|11565952|FG007|COMPLETED|Part I||0
10421040|NCT00818259|11565953|FG008|COMPLETED|Part I||0
10421041|NCT00818259|11565945|FG000|NOT COMPLETED|Part I||1
10421042|NCT00818259|11565946|FG001|NOT COMPLETED|Part I||0
10421043|NCT00818259|11565947|FG002|NOT COMPLETED|Part I||0
10421044|NCT00818259|11565948|FG003|NOT COMPLETED|Part I||0
10421045|NCT00818259|11565949|FG004|NOT COMPLETED|Part I||0
10421046|NCT00818259|11565950|FG005|NOT COMPLETED|Part I||0
10421047|NCT00818259|11565951|FG006|NOT COMPLETED|Part I||0
10421048|NCT00818259|11565952|FG007|NOT COMPLETED|Part I||0
10421049|NCT00818259|11565953|FG008|NOT COMPLETED|Part I||0
10421050|NCT00818259|11565945|FG000|STARTED|Part II||0
10421051|NCT00818259|11565946|FG001|STARTED|Part II||0
10421052|NCT00818259|11565947|FG002|STARTED|Part II|Newly enrolled participants|19
10421053|NCT00818259|11565948|FG003|STARTED|Part II|Newly enrolled participants|20
10421054|NCT00818259|11565949|FG004|STARTED|Part II||0
10421055|NCT00818259|11565950|FG005|STARTED|Part II||0
10421056|NCT00818259|11565951|FG006|STARTED|Part II||0
10421057|NCT00818259|11565952|FG007|STARTED|Part II||0
10421058|NCT00818259|11565953|FG008|STARTED|Part II||0
10421059|NCT00818259|11565945|FG000|Treated|Part II||0
10421060|NCT00818259|11565946|FG001|Treated|Part II||0
10421061|NCT00818259|11565947|FG002|Treated|Part II||19
10421062|NCT00818259|11565948|FG003|Treated|Part II||19
10421063|NCT00818259|11565949|FG004|Treated|Part II||0
10421064|NCT00818259|11565950|FG005|Treated|Part II||0
10421065|NCT00818259|11565951|FG006|Treated|Part II||0
10421066|NCT00818259|11565952|FG007|Treated|Part II||0
10421067|NCT00818259|11565953|FG008|Treated|Part II||0
10421068|NCT00818259|11565945|FG000|COMPLETED|Part II||0
10421069|NCT00818259|11565946|FG001|COMPLETED|Part II||0
10421070|NCT00818259|11565947|FG002|COMPLETED|Part II||18
10421071|NCT00818259|11565948|FG003|COMPLETED|Part II||18
10421072|NCT00818259|11565949|FG004|COMPLETED|Part II||0
10421073|NCT00818259|11565950|FG005|COMPLETED|Part II||0
10421074|NCT00818259|11565951|FG006|COMPLETED|Part II||0
10421075|NCT00818259|11565952|FG007|COMPLETED|Part II||0
10421076|NCT00818259|11565953|FG008|COMPLETED|Part II||0
10421077|NCT00818259|11565945|FG000|NOT COMPLETED|Part II||0
10421078|NCT00818259|11565946|FG001|NOT COMPLETED|Part II||0
10421079|NCT00818259|11565947|FG002|NOT COMPLETED|Part II||1
10421080|NCT00818259|11565948|FG003|NOT COMPLETED|Part II||2
10421081|NCT00818259|11565949|FG004|NOT COMPLETED|Part II||0
10421082|NCT00818259|11565950|FG005|NOT COMPLETED|Part II||0
10421083|NCT00818259|11565951|FG006|NOT COMPLETED|Part II||0
10421084|NCT00818259|11565952|FG007|NOT COMPLETED|Part II||0
10421085|NCT00818259|11565953|FG008|NOT COMPLETED|Part II||0
10421086|NCT00818259|11565945|FG000|STARTED|Part III||0
10421087|NCT00818259|11565946|FG001|STARTED|Part III||0
10421088|NCT00818259|11565947|FG002|STARTED|Part III||0
10421089|NCT00818259|11565948|FG003|STARTED|Part III||0
10421090|NCT00818259|11565949|FG004|STARTED|Part III|Newly enrolled participants|19
10421091|NCT00818259|11565950|FG005|STARTED|Part III||0
10421092|NCT00818259|11565951|FG006|STARTED|Part III||0
10421093|NCT00818259|11565952|FG007|STARTED|Part III||0
10421094|NCT00818259|11565953|FG008|STARTED|Part III||0
10421095|NCT00818259|11565945|FG000|COMPLETED|Part III||0
10421096|NCT00818259|11565946|FG001|COMPLETED|Part III||0
10421097|NCT00818259|11565947|FG002|COMPLETED|Part III||0
10421098|NCT00818259|11565948|FG003|COMPLETED|Part III||0
10421099|NCT00818259|11565949|FG004|COMPLETED|Part III||19
10421100|NCT00818259|11565950|FG005|COMPLETED|Part III||0
10421101|NCT00818259|11565951|FG006|COMPLETED|Part III||0
10421102|NCT00818259|11565952|FG007|COMPLETED|Part III||0
10421103|NCT00818259|11565953|FG008|COMPLETED|Part III||0
10421104|NCT00818259|11565945|FG000|NOT COMPLETED|Part III||0
10421105|NCT00818259|11565946|FG001|NOT COMPLETED|Part III||0
10421106|NCT00818259|11565947|FG002|NOT COMPLETED|Part III||0
10421107|NCT00818259|11565948|FG003|NOT COMPLETED|Part III||0
10421108|NCT00818259|11565949|FG004|NOT COMPLETED|Part III||0
10421109|NCT00818259|11565950|FG005|NOT COMPLETED|Part III||0
10421110|NCT00818259|11565951|FG006|NOT COMPLETED|Part III||0
10421111|NCT00818259|11565952|FG007|NOT COMPLETED|Part III||0
10421112|NCT00818259|11565953|FG008|NOT COMPLETED|Part III||0
10421113|NCT00818259|11565945|FG000|STARTED|Part IV||0
10421114|NCT00818259|11565946|FG001|STARTED|Part IV||0
10421115|NCT00818259|11565947|FG002|STARTED|Part IV||0
10421116|NCT00818259|11565948|FG003|STARTED|Part IV||0
10421117|NCT00818259|11565949|FG004|STARTED|Part IV||0
10421118|NCT00818259|11565950|FG005|STARTED|Part IV|Participants continuing from Part III|15
10421119|NCT00818259|11565951|FG006|STARTED|Part IV|Newly enrolled participants|5
10421120|NCT00818259|11565952|FG007|STARTED|Part IV||0
10421121|NCT00818259|11565953|FG008|STARTED|Part IV||0
10421122|NCT00818259|11565945|FG000|COMPLETED|Part IV||0
10421123|NCT00818259|11565946|FG001|COMPLETED|Part IV||0
10421124|NCT00818259|11565947|FG002|COMPLETED|Part IV||0
10421125|NCT00818259|11565948|FG003|COMPLETED|Part IV||0
10421126|NCT00818259|11565949|FG004|COMPLETED|Part IV||0
10421127|NCT00818259|11565950|FG005|COMPLETED|Part IV||14
10421128|NCT00818259|11565951|FG006|COMPLETED|Part IV||5
10421129|NCT00818259|11565952|FG007|COMPLETED|Part IV||0
10421130|NCT00818259|11565953|FG008|COMPLETED|Part IV||0
10421131|NCT00818259|11565945|FG000|NOT COMPLETED|Part IV||0
10421132|NCT00818259|11565946|FG001|NOT COMPLETED|Part IV||0
10421133|NCT00818259|11565947|FG002|NOT COMPLETED|Part IV||0
10421134|NCT00818259|11565948|FG003|NOT COMPLETED|Part IV||0
10421135|NCT00818259|11565949|FG004|NOT COMPLETED|Part IV||0
10421136|NCT00818259|11565950|FG005|NOT COMPLETED|Part IV||1
10421137|NCT00818259|11565951|FG006|NOT COMPLETED|Part IV||0
10421138|NCT00818259|11565952|FG007|NOT COMPLETED|Part IV||0
10421139|NCT00818259|11565953|FG008|NOT COMPLETED|Part IV||0
10421140|NCT00818259|11565945|FG000|STARTED|Part V||0
10421141|NCT00818259|11565946|FG001|STARTED|Part V||0
10421142|NCT00818259|11565947|FG002|STARTED|Part V||0
10421143|NCT00818259|11565948|FG003|STARTED|Part V||0
10421144|NCT00818259|11565949|FG004|STARTED|Part V||0
10421145|NCT00818259|11565950|FG005|STARTED|Part V||0
10421146|NCT00818259|11565951|FG006|STARTED|Part V||0
10421147|NCT00818259|11565952|FG007|STARTED|Part V|Participants continuing from Part IV|17
10421148|NCT00818259|11565953|FG008|STARTED|Part V|Newly enrolled participants|6
10421149|NCT00818259|11565945|FG000|COMPLETED|Part V||0
10421150|NCT00818259|11565946|FG001|COMPLETED|Part V||0
10421151|NCT00818259|11565947|FG002|COMPLETED|Part V||0
10421152|NCT00818259|11565948|FG003|COMPLETED|Part V||0
10421153|NCT00818259|11565949|FG004|COMPLETED|Part V||0
10421154|NCT00818259|11565950|FG005|COMPLETED|Part V||0
10421155|NCT00818259|11565951|FG006|COMPLETED|Part V||0
10421156|NCT00818259|11565952|FG007|COMPLETED|Part V||16
10421157|NCT00818259|11565953|FG008|COMPLETED|Part V||6
10421158|NCT00818259|11565945|FG000|NOT COMPLETED|Part V||0
10421159|NCT00818259|11565946|FG001|NOT COMPLETED|Part V||0
10421160|NCT00818259|11565947|FG002|NOT COMPLETED|Part V||0
10421161|NCT00818259|11565948|FG003|NOT COMPLETED|Part V||0
10421162|NCT00818259|11565949|FG004|NOT COMPLETED|Part V||0
10421163|NCT00818259|11565950|FG005|NOT COMPLETED|Part V||0
10421164|NCT00818259|11565951|FG006|NOT COMPLETED|Part V||0
10421165|NCT00818259|11565952|FG007|NOT COMPLETED|Part V||1
10421166|NCT00818259|11565953|FG008|NOT COMPLETED|Part V||0
10421167|NCT00818272|11565969|FG000|STARTED|Overall Study||148
10421168|NCT00818272|11565969|FG000|COMPLETED|Overall Study||74
10421169|NCT00818272|11565969|FG000|NOT COMPLETED|Overall Study||74
10421170|NCT00818324|11565973|FG000|STARTED|Overall Study||154
10421171|NCT00818324|11565973|FG000|COMPLETED|Overall Study||127
10421172|NCT00818324|11565973|FG000|NOT COMPLETED|Overall Study||27
10421173|NCT00818337|11565977|FG000|STARTED|Overall Study||36
10421174|NCT00818337|11565977|FG000|COMPLETED|Overall Study||36
10421175|NCT00818337|11565977|FG000|NOT COMPLETED|Overall Study||0
10421176|NCT00818363|11565984|FG000|STARTED|Overall Study||40
10421177|NCT00818363|11565985|FG001|STARTED|Overall Study||20
10421178|NCT00818363|11565984|FG000|COMPLETED|Overall Study||40
10421179|NCT00818363|11565985|FG001|COMPLETED|Overall Study||19
10421180|NCT00818363|11565984|FG000|NOT COMPLETED|Overall Study||0
10421181|NCT00818363|11565985|FG001|NOT COMPLETED|Overall Study||1
10421182|NCT00818389|11565993|FG000|STARTED|Overall Study||40
10421183|NCT00818389|11565994|FG001|STARTED|Overall Study||44
10421184|NCT00818389|11565993|FG000|COMPLETED|Overall Study|4 subjects terminated study early before 1st interim analysis. Study terminated early for futility.|36
10421185|NCT00818389|11565994|FG001|COMPLETED|Overall Study|6 subjects terminated study early before 1st interim analysis. Study terminated early for futility.|38
10421186|NCT00818389|11565993|FG000|NOT COMPLETED|Overall Study||4
10421187|NCT00818389|11565994|FG001|NOT COMPLETED|Overall Study||6
10421188|NCT00818441|11566002|FG000|STARTED|Overall Study||89
10421189|NCT00818441|11566003|FG001|STARTED|Overall Study||30
10421190|NCT00818441|11566002|FG000|COMPLETED|Overall Study||0
10421191|NCT00818441|11566003|FG001|COMPLETED|Overall Study||0
10421192|NCT00818441|11566002|FG000|NOT COMPLETED|Overall Study||89
10421193|NCT00818441|11566003|FG001|NOT COMPLETED|Overall Study||30
10421194|NCT00818454|11566010|FG000|STARTED|Treatment Period 1||115
10421195|NCT00818454|11566011|FG001|STARTED|Treatment Period 1||111
10421196|NCT00818454|11566012|FG002|STARTED|Treatment Period 1||0
10421197|NCT00818454|11566013|FG003|STARTED|Treatment Period 1||0
10421198|NCT00818454|11566010|FG000|COMPLETED|Treatment Period 1||112
10421199|NCT00818454|11566011|FG001|COMPLETED|Treatment Period 1||110
10421200|NCT00818454|11566012|FG002|COMPLETED|Treatment Period 1||0
10421201|NCT00818454|11566013|FG003|COMPLETED|Treatment Period 1||0
10421202|NCT00818454|11566010|FG000|NOT COMPLETED|Treatment Period 1||3
10421203|NCT00818454|11566011|FG001|NOT COMPLETED|Treatment Period 1||1
10421204|NCT00818454|11566012|FG002|NOT COMPLETED|Treatment Period 1||0
10421205|NCT00818454|11566013|FG003|NOT COMPLETED|Treatment Period 1||0
10421206|NCT00818454|11566010|FG000|STARTED|Washout Period of 1 Week||112
10421207|NCT00818454|11566011|FG001|STARTED|Washout Period of 1 Week||110
10421208|NCT00818454|11566012|FG002|STARTED|Washout Period of 1 Week||0
10421209|NCT00818454|11566013|FG003|STARTED|Washout Period of 1 Week||0
10421210|NCT00818454|11566010|FG000|COMPLETED|Washout Period of 1 Week||108
10421211|NCT00818454|11566011|FG001|COMPLETED|Washout Period of 1 Week||107
10421212|NCT00818454|11566012|FG002|COMPLETED|Washout Period of 1 Week||0
10421213|NCT00818454|11566013|FG003|COMPLETED|Washout Period of 1 Week||0
10421214|NCT00818454|11566010|FG000|NOT COMPLETED|Washout Period of 1 Week||4
10421215|NCT00818454|11566011|FG001|NOT COMPLETED|Washout Period of 1 Week||3
10421216|NCT00818454|11566012|FG002|NOT COMPLETED|Washout Period of 1 Week||0
10421217|NCT00818454|11566013|FG003|NOT COMPLETED|Washout Period of 1 Week||0
10421218|NCT00818454|11566010|FG000|STARTED|Treatment Period 2||108
10421219|NCT00818454|11566011|FG001|STARTED|Treatment Period 2||107
10421220|NCT00818454|11566012|FG002|STARTED|Treatment Period 2||0
10421221|NCT00818454|11566013|FG003|STARTED|Treatment Period 2||0
10421222|NCT00818454|11566010|FG000|COMPLETED|Treatment Period 2||106
10421223|NCT00818454|11566011|FG001|COMPLETED|Treatment Period 2||106
10421224|NCT00818454|11566012|FG002|COMPLETED|Treatment Period 2||0
10421225|NCT00818454|11566013|FG003|COMPLETED|Treatment Period 2||0
10421226|NCT00818454|11566010|FG000|NOT COMPLETED|Treatment Period 2||2
10421227|NCT00818454|11566011|FG001|NOT COMPLETED|Treatment Period 2||1
10421228|NCT00818454|11566012|FG002|NOT COMPLETED|Treatment Period 2||0
10421229|NCT00818454|11566013|FG003|NOT COMPLETED|Treatment Period 2||0
10421230|NCT00818454|11566010|FG000|STARTED|Treatment Period 3||0
10421231|NCT00818454|11566011|FG001|STARTED|Treatment Period 3||0
10421232|NCT00818454|11566012|FG002|STARTED|Treatment Period 3||26
10421233|NCT00818454|11566013|FG003|STARTED|Treatment Period 3||139
10421234|NCT00818454|11566010|FG000|COMPLETED|Treatment Period 3||0
10421235|NCT00818454|11566011|FG001|COMPLETED|Treatment Period 3||0
10421236|NCT00818454|11566012|FG002|COMPLETED|Treatment Period 3||26
10421237|NCT00818454|11566013|FG003|COMPLETED|Treatment Period 3||138
10421238|NCT00818454|11566010|FG000|NOT COMPLETED|Treatment Period 3||0
10421239|NCT00818454|11566011|FG001|NOT COMPLETED|Treatment Period 3||0
10421240|NCT00818454|11566012|FG002|NOT COMPLETED|Treatment Period 3||0
10421241|NCT00818454|11566013|FG003|NOT COMPLETED|Treatment Period 3||1
10421242|NCT00818519|11566025|FG000|STARTED|Overall Study|2 excluded from FAS because study drug intake unknown or never administered|89
10421243|NCT00818519|11566026|FG001|STARTED|Overall Study|4 excluded from FAS because study drug intake unknown or never administered|90
10421244|NCT00818519|11566025|FG000|Participants Received Treatment|Overall Study|= Baseline|87
10421245|NCT00818519|11566026|FG001|Participants Received Treatment|Overall Study|= Baseline|86
10421246|NCT00818519|11566025|FG000|COMPLETED|Overall Study||75
10421247|NCT00818519|11566026|FG001|COMPLETED|Overall Study||71
10421248|NCT00818519|11566025|FG000|NOT COMPLETED|Overall Study||14
10421249|NCT00818519|11566026|FG001|NOT COMPLETED|Overall Study||19
10421250|NCT00818623|11566040|FG000|STARTED|Overall Study||26
10421251|NCT00818623|11566041|FG001|STARTED|Overall Study||12
10421252|NCT00818623|11566042|FG002|STARTED|Overall Study||13
10421253|NCT00818623|11566043|FG003|STARTED|Overall Study||24
10421254|NCT00818623|11566044|FG004|STARTED|Overall Study||27
10421255|NCT00818623|11566045|FG005|STARTED|Overall Study||24
10421256|NCT00818623|11566046|FG006|STARTED|Overall Study||27
10421257|NCT00818623|11566047|FG007|STARTED|Overall Study||27
10421258|NCT00818623|11566040|FG000|Intent-to-treat (ITT) Population|Overall Study|One participant in this group was randomized but never received any treatment.|25
10421259|NCT00818623|11566041|FG001|Intent-to-treat (ITT) Population|Overall Study||12
10421260|NCT00818623|11566042|FG002|Intent-to-treat (ITT) Population|Overall Study|One participant in this group was randomized but never received any treatment.|12
10421261|NCT00818623|11566043|FG003|Intent-to-treat (ITT) Population|Overall Study||24
10421262|NCT00818623|11566044|FG004|Intent-to-treat (ITT) Population|Overall Study|Three participants in this group were randomized but never received any treatment.|24
10421263|NCT00818623|11566045|FG005|Intent-to-treat (ITT) Population|Overall Study||24
10421264|NCT00818623|11566046|FG006|Intent-to-treat (ITT) Population|Overall Study|Three participants in this group were randomized but never received any treatment.|24
10421265|NCT00818623|11566047|FG007|Intent-to-treat (ITT) Population|Overall Study||27
10421266|NCT00818623|11566040|FG000|COMPLETED|Overall Study||24
10421267|NCT00818623|11566041|FG001|COMPLETED|Overall Study||8
10421268|NCT00818623|11566042|FG002|COMPLETED|Overall Study||9
10421269|NCT00818623|11566043|FG003|COMPLETED|Overall Study||19
10421270|NCT00818623|11566044|FG004|COMPLETED|Overall Study||23
10421271|NCT00818623|11566045|FG005|COMPLETED|Overall Study||21
10421272|NCT00818623|11566046|FG006|COMPLETED|Overall Study||23
10421273|NCT00818623|11566047|FG007|COMPLETED|Overall Study||26
10421274|NCT00818623|11566040|FG000|NOT COMPLETED|Overall Study||2
10421275|NCT00818623|11566041|FG001|NOT COMPLETED|Overall Study||4
10421276|NCT00818623|11566042|FG002|NOT COMPLETED|Overall Study||4
10421277|NCT00818623|11566043|FG003|NOT COMPLETED|Overall Study||5
10421278|NCT00818623|11566044|FG004|NOT COMPLETED|Overall Study||4
10421279|NCT00818623|11566045|FG005|NOT COMPLETED|Overall Study||3
10421280|NCT00818623|11566046|FG006|NOT COMPLETED|Overall Study||4
10421281|NCT00818623|11566047|FG007|NOT COMPLETED|Overall Study||1
10421282|NCT00818649|11566065|FG000|STARTED|Overall Study||16
10421283|NCT00818649|11566065|FG000|COMPLETED|Overall Study||12
10421284|NCT00818649|11566065|FG000|NOT COMPLETED|Overall Study||4
10421285|NCT00818662|11566074|FG000|STARTED|Overall Study||127
10421286|NCT00818662|11566075|FG001|STARTED|Overall Study||135
10421287|NCT00818662|11566076|FG002|STARTED|Overall Study||58
10421288|NCT00818662|11566077|FG003|STARTED|Overall Study||63
10421289|NCT00818662|11566074|FG000|COMPLETED|Overall Study||104
10421290|NCT00818662|11566075|FG001|COMPLETED|Overall Study||102
10421291|NCT00818662|11566076|FG002|COMPLETED|Overall Study||49
10421292|NCT00818662|11566077|FG003|COMPLETED|Overall Study||47
10421293|NCT00818662|11566074|FG000|NOT COMPLETED|Overall Study||23
10421294|NCT00818662|11566075|FG001|NOT COMPLETED|Overall Study||33
10421295|NCT00818662|11566076|FG002|NOT COMPLETED|Overall Study||9
10421296|NCT00818662|11566077|FG003|NOT COMPLETED|Overall Study||16
10421297|NCT00818753|11566091|FG000|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|22
10421298|NCT00818753|11566092|FG001|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|21
10421299|NCT00818753|11566093|FG002|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|10
10421300|NCT00818753|11566091|FG000|COMPLETED|Overall Study||19
10421301|NCT00818753|11566092|FG001|COMPLETED|Overall Study||21
10421302|NCT00818753|11566093|FG002|COMPLETED|Overall Study||9
10421303|NCT00818753|11566091|FG000|NOT COMPLETED|Overall Study||3
10421304|NCT00818753|11566092|FG001|NOT COMPLETED|Overall Study||0
10421305|NCT00818753|11566093|FG002|NOT COMPLETED|Overall Study||1
10421306|NCT00818766|11566103|FG000|STARTED|Overall Study||125
10421307|NCT00818766|11566104|FG001|STARTED|Overall Study||126
10421308|NCT00818766|11566103|FG000|Received Allocated Intervention|Overall Study|1 withdrew consent, 1 had active infection and 1 was given open-label antibiotic after surgery.|122
10421309|NCT00818766|11566104|FG001|Received Allocated Intervention|Overall Study||126
10421310|NCT00818766|11566103|FG000|Intent-to-Treat Population|Overall Study|1 participant was randomized twice but only counted once (per first randomization).|121
10429541|NCT00864383|11575575|FG001|STARTED|Modified Intent to Treat||655
10546176|NCT01504412|11699761|FG001|NOT COMPLETED|Overall Study||12
10546177|NCT01504412|11699762|FG002|NOT COMPLETED|Overall Study||4
10546178|NCT01504412|11699763|FG003|NOT COMPLETED|Overall Study||19
10546179|NCT01504412|11699764|FG004|NOT COMPLETED|Overall Study||13
10546180|NCT01504477|11699776|FG000|STARTED|Overall Study||6
10546181|NCT01504477|11699776|FG000|COMPLETED|Overall Study||6
10546182|NCT01504477|11699776|FG000|NOT COMPLETED|Overall Study||0
10546183|NCT01504672|11699782|FG000|STARTED|Overall Study||230
10546184|NCT01504672|11699783|FG001|STARTED|Overall Study||230
10546185|NCT01504672|11699782|FG000|COMPLETED|Overall Study||212
10546186|NCT01504672|11699783|FG001|COMPLETED|Overall Study||217
10546187|NCT01504672|11699782|FG000|NOT COMPLETED|Overall Study||18
10546188|NCT01504672|11699783|FG001|NOT COMPLETED|Overall Study||13
10546189|NCT01504711|11699791|FG000|STARTED|Overall Study||30
10546190|NCT01504711|11699791|FG000|COMPLETED|Overall Study||27
10546191|NCT01504711|11699791|FG000|NOT COMPLETED|Overall Study||3
10546192|NCT01504841|11699798|FG000|STARTED|Overall Study||20
10546193|NCT01504841|11699799|FG001|STARTED|Overall Study||6
10546194|NCT01504841|11699800|FG002|STARTED|Overall Study|No enrollments occurred into Cohort 3 during the study.|0
10546195|NCT01504841|11699798|FG000|COMPLETED|Overall Study||19
10546196|NCT01504841|11699799|FG001|COMPLETED|Overall Study||5
10546197|NCT01504841|11699800|FG002|COMPLETED|Overall Study||0
10546198|NCT01504841|11699798|FG000|NOT COMPLETED|Overall Study||1
10546199|NCT01504841|11699799|FG001|NOT COMPLETED|Overall Study||1
10546200|NCT01504841|11699800|FG002|NOT COMPLETED|Overall Study||0
10546201|NCT01504854|11699809|FG000|STARTED|Overall Study||64
10546202|NCT01504854|11699810|FG001|STARTED|Overall Study||55
10546203|NCT01504854|11699809|FG000|COMPLETED|Overall Study||56
10546204|NCT01504854|11699810|FG001|COMPLETED|Overall Study||48
10546205|NCT01504854|11699809|FG000|NOT COMPLETED|Overall Study||8
10546206|NCT01504854|11699810|FG001|NOT COMPLETED|Overall Study||7
10546207|NCT01504867|11699818|FG000|STARTED|Overall Study||202
10421311|NCT00818766|11566104|FG001|Intent-to-Treat Population|Overall Study|2 participants were randomized twice but only counted once (per first randomization).|124
10421312|NCT00818766|11566103|FG000|COMPLETED|Overall Study||110
10421313|NCT00818766|11566104|FG001|COMPLETED|Overall Study||116
10421314|NCT00818766|11566103|FG000|NOT COMPLETED|Overall Study||15
10421315|NCT00818766|11566104|FG001|NOT COMPLETED|Overall Study||10
10421316|NCT00818779|11566112|FG000|STARTED|Overall Study||22
10421317|NCT00818779|11566113|FG001|STARTED|Overall Study||16
10421318|NCT00818779|11566112|FG000|COMPLETED|Overall Study||16
10421319|NCT00818779|11566113|FG001|COMPLETED|Overall Study||15
10421320|NCT00818779|11566112|FG000|NOT COMPLETED|Overall Study||6
10421321|NCT00818779|11566113|FG001|NOT COMPLETED|Overall Study||1
10421322|NCT00818805|11566119|FG000|STARTED|First Intervention||25
10421323|NCT00818805|11566120|FG001|STARTED|First Intervention||25
10421324|NCT00818805|11566119|FG000|COMPLETED|First Intervention||25
10421325|NCT00818805|11566120|FG001|COMPLETED|First Intervention||25
10421326|NCT00818805|11566119|FG000|NOT COMPLETED|First Intervention||0
10421327|NCT00818805|11566120|FG001|NOT COMPLETED|First Intervention||0
10421328|NCT00818805|11566119|FG000|STARTED|Second Intervention||25
10421329|NCT00818805|11566120|FG001|STARTED|Second Intervention||25
10421330|NCT00818805|11566119|FG000|COMPLETED|Second Intervention||25
10421331|NCT00818805|11566120|FG001|COMPLETED|Second Intervention||25
10421332|NCT00818805|11566119|FG000|NOT COMPLETED|Second Intervention||0
10421333|NCT00818805|11566120|FG001|NOT COMPLETED|Second Intervention||0
10421334|NCT00818883|11566132|FG000|STARTED|Overall Study||303
10421335|NCT00818883|11566133|FG001|STARTED|Overall Study||306
10421336|NCT00818883|11566132|FG000|COMPLETED|Overall Study||252
10421337|NCT00818883|11566133|FG001|COMPLETED|Overall Study||260
10421338|NCT00818883|11566132|FG000|NOT COMPLETED|Overall Study||51
10421339|NCT00818883|11566133|FG001|NOT COMPLETED|Overall Study||46
10421340|NCT00818961|11566139|FG000|STARTED|Overall Study||36
10421341|NCT00818961|11566139|FG000|COMPLETED|Overall Study||36
10421342|NCT00818961|11566139|FG000|NOT COMPLETED|Overall Study||0
10421343|NCT00819013|11566147|FG000|STARTED|Overall Study||22
10421344|NCT00819013|11566148|FG001|STARTED|Overall Study||23
10421345|NCT00819013|11566149|FG002|STARTED|Overall Study||21
10421346|NCT00819013|11566150|FG003|STARTED|Overall Study||21
10421347|NCT00819013|11566147|FG000|COMPLETED|Overall Study||19
10421348|NCT00819013|11566148|FG001|COMPLETED|Overall Study||22
10421349|NCT00819013|11566149|FG002|COMPLETED|Overall Study||16
10421350|NCT00819013|11566150|FG003|COMPLETED|Overall Study||17
10421351|NCT00819013|11566147|FG000|NOT COMPLETED|Overall Study||3
10421352|NCT00819013|11566148|FG001|NOT COMPLETED|Overall Study||1
10421353|NCT00819013|11566149|FG002|NOT COMPLETED|Overall Study||5
10421354|NCT00819013|11566150|FG003|NOT COMPLETED|Overall Study||4
10421355|NCT00819039|11566163|FG000|STARTED|Overall Study||46
10421356|NCT00819039|11566164|FG001|STARTED|Overall Study||27
10421357|NCT00819039|11566165|FG002|STARTED|Overall Study||25
10421358|NCT00819039|11566163|FG000|COMPLETED|Overall Study||44
10421359|NCT00819039|11566164|FG001|COMPLETED|Overall Study||27
10421360|NCT00819039|11566165|FG002|COMPLETED|Overall Study||24
10421361|NCT00819039|11566163|FG000|NOT COMPLETED|Overall Study||2
10421362|NCT00819039|11566164|FG001|NOT COMPLETED|Overall Study||0
10421363|NCT00819039|11566165|FG002|NOT COMPLETED|Overall Study||1
10421364|NCT00819052|11566177|FG000|STARTED|Overall Study||148
10421365|NCT00819052|11566178|FG001|STARTED|Overall Study||295
10421366|NCT00819052|11566177|FG000|COMPLETED|Overall Study||142
10421367|NCT00819052|11566178|FG001|COMPLETED|Overall Study||281
10421368|NCT00819052|11566177|FG000|NOT COMPLETED|Overall Study||6
10421369|NCT00819052|11566178|FG001|NOT COMPLETED|Overall Study||14
10421370|NCT00819091|11566189|FG000|STARTED|Overall Study||84
10421371|NCT00819091|11566190|FG001|STARTED|Overall Study||161
10421372|NCT00819091|11566189|FG000|COMPLETED|Overall Study||77
10421373|NCT00819091|11566190|FG001|COMPLETED|Overall Study||151
10421374|NCT00819091|11566189|FG000|NOT COMPLETED|Overall Study||7
10421375|NCT00819091|11566190|FG001|NOT COMPLETED|Overall Study||10
10421376|NCT00819156|11566202|FG000|STARTED|Overall Study||30
10421377|NCT00819156|11566203|FG001|STARTED|Overall Study||33
10421378|NCT00819156|11566204|FG002|STARTED|Overall Study||32
10421379|NCT00819156|11566205|FG003|STARTED|Overall Study||30
10421380|NCT00819156|11566206|FG004|STARTED|Overall Study||33
10421381|NCT00819156|11566207|FG005|STARTED|Overall Study||31
10421382|NCT00819156|11566202|FG000|Randomised and Treated (ITT Population)|Overall Study||30
10421383|NCT00819156|11566203|FG001|Randomised and Treated (ITT Population)|Overall Study||32
10421384|NCT00819156|11566204|FG002|Randomised and Treated (ITT Population)|Overall Study||32
10421385|NCT00819156|11566205|FG003|Randomised and Treated (ITT Population)|Overall Study||30
10421386|NCT00819156|11566206|FG004|Randomised and Treated (ITT Population)|Overall Study||33
10421387|NCT00819156|11566207|FG005|Randomised and Treated (ITT Population)|Overall Study||30
10421388|NCT00819156|11566202|FG000|COMPLETED|Overall Study||20
10421389|NCT00819156|11566203|FG001|COMPLETED|Overall Study||23
10421390|NCT00819156|11566204|FG002|COMPLETED|Overall Study||26
10421391|NCT00819156|11566205|FG003|COMPLETED|Overall Study||28
10421392|NCT00819156|11566206|FG004|COMPLETED|Overall Study||27
10421393|NCT00819156|11566207|FG005|COMPLETED|Overall Study||23
10421394|NCT00819156|11566202|FG000|NOT COMPLETED|Overall Study||10
10421395|NCT00819156|11566203|FG001|NOT COMPLETED|Overall Study||10
10421396|NCT00819156|11566204|FG002|NOT COMPLETED|Overall Study||6
10421397|NCT00819156|11566205|FG003|NOT COMPLETED|Overall Study||2
10421398|NCT00819156|11566206|FG004|NOT COMPLETED|Overall Study||6
10421399|NCT00819156|11566207|FG005|NOT COMPLETED|Overall Study||8
10421400|NCT00819182|11566232|FG000|STARTED|Overall Study|Consented participants allocated to this arm.|88
10421401|NCT00819182|11566233|FG001|STARTED|Overall Study|Consented participants allocated to this arm.|86
10421402|NCT00819182|11566234|FG002|STARTED|Overall Study|Consented participants allocated to this arm.|44
10421403|NCT00819182|11566232|FG000|Week 16 Visit|Overall Study||75
10421404|NCT00819182|11566233|FG001|Week 16 Visit|Overall Study||78
10421405|NCT00819182|11566234|FG002|Week 16 Visit|Overall Study||43
10421406|NCT00819182|11566232|FG000|COMPLETED|Overall Study||75
10421407|NCT00819182|11566233|FG001|COMPLETED|Overall Study||78
10421408|NCT00819182|11566234|FG002|COMPLETED|Overall Study||43
10421409|NCT00819182|11566232|FG000|NOT COMPLETED|Overall Study||13
10421410|NCT00819182|11566233|FG001|NOT COMPLETED|Overall Study||8
10421411|NCT00819182|11566234|FG002|NOT COMPLETED|Overall Study||1
10421412|NCT00819234|11566242|FG000|STARTED|Overall Study||31
10421413|NCT00819234|11566243|FG001|STARTED|Overall Study||35
10421414|NCT00819234|11566244|FG002|STARTED|Overall Study||36
10421415|NCT00819234|11566245|FG003|STARTED|Overall Study||28
10421416|NCT00819234|11566246|FG004|STARTED|Overall Study||13
10421417|NCT00819234|11566247|FG005|STARTED|Overall Study||14
10421418|NCT00819234|11566248|FG006|STARTED|Overall Study||13
10421419|NCT00819234|11566249|FG007|STARTED|Overall Study||29
10421420|NCT00819234|11566250|FG008|STARTED|Overall Study||37
10421421|NCT00819234|11566251|FG009|STARTED|Overall Study||37
10421422|NCT00819234|11566242|FG000|COMPLETED|Overall Study||21
10421423|NCT00819234|11566243|FG001|COMPLETED|Overall Study||20
10421424|NCT00819234|11566244|FG002|COMPLETED|Overall Study||28
10421425|NCT00819234|11566245|FG003|COMPLETED|Overall Study||22
10421426|NCT00819234|11566246|FG004|COMPLETED|Overall Study||12
10421427|NCT00819234|11566247|FG005|COMPLETED|Overall Study||7
10421428|NCT00819234|11566248|FG006|COMPLETED|Overall Study||8
10421429|NCT00819234|11566249|FG007|COMPLETED|Overall Study||20
10421430|NCT00819234|11566250|FG008|COMPLETED|Overall Study||31
10421431|NCT00819234|11566251|FG009|COMPLETED|Overall Study||30
10421432|NCT00819234|11566242|FG000|NOT COMPLETED|Overall Study||10
10421433|NCT00819234|11566243|FG001|NOT COMPLETED|Overall Study||15
10421434|NCT00819234|11566244|FG002|NOT COMPLETED|Overall Study||8
10421435|NCT00819234|11566245|FG003|NOT COMPLETED|Overall Study||6
10421436|NCT00819234|11566246|FG004|NOT COMPLETED|Overall Study||1
10421437|NCT00819234|11566247|FG005|NOT COMPLETED|Overall Study||7
10421438|NCT00819234|11566248|FG006|NOT COMPLETED|Overall Study||5
10421439|NCT00819234|11566249|FG007|NOT COMPLETED|Overall Study||9
10421440|NCT00819234|11566250|FG008|NOT COMPLETED|Overall Study||6
10421441|NCT00819234|11566251|FG009|NOT COMPLETED|Overall Study||7
10421442|NCT00819247|11566309|FG000|STARTED|Overall Study||43
10421443|NCT00819247|11566310|FG001|STARTED|Overall Study||46
10421444|NCT00819247|11566311|FG002|STARTED|Overall Study||40
10421445|NCT00819247|11566309|FG000|Randomized|Overall Study||43
10421446|NCT00819247|11566310|FG001|Randomized|Overall Study||46
10421447|NCT00819247|11566311|FG002|Randomized|Overall Study||40
10421448|NCT00819247|11566309|FG000|Intent-to-treat Population|Overall Study|One randomised participant withdrew at Day 1.|42
10421449|NCT00819247|11566310|FG001|Intent-to-treat Population|Overall Study||46
10421450|NCT00819247|11566311|FG002|Intent-to-treat Population|Overall Study|One randomised participant withdrew at Day 1.|39
10421451|NCT00819247|11566309|FG000|Per Protocol Population|Overall Study|One participant- baseline testosterone outside normal range. Three participants- prohibited drugs.|38
10421452|NCT00819247|11566310|FG001|Per Protocol Population|Overall Study|Two participants - prohibited drugs|44
10421453|NCT00819247|11566311|FG002|Per Protocol Population|Overall Study|One participant - baseline testosterone outside normal range.|38
10421454|NCT00819247|11566309|FG000|COMPLETED|Overall Study||32
10421455|NCT00819247|11566310|FG001|COMPLETED|Overall Study||30
10421456|NCT00819247|11566311|FG002|COMPLETED|Overall Study||26
10421457|NCT00819247|11566309|FG000|NOT COMPLETED|Overall Study||11
10421458|NCT00819247|11566310|FG001|NOT COMPLETED|Overall Study||16
10421459|NCT00819247|11566311|FG002|NOT COMPLETED|Overall Study||14
10421460|NCT00819260|11566319|FG000|STARTED|Overall Study||31
10421461|NCT00819260|11566319|FG000|COMPLETED|Overall Study||31
10421462|NCT00819260|11566319|FG000|NOT COMPLETED|Overall Study||0
10421463|NCT00819286|11566327|FG000|STARTED|Overall Study||70
10421464|NCT00819286|11566328|FG001|STARTED|Overall Study||70
10421465|NCT00819286|11566327|FG000|COMPLETED|Overall Study||56
10421466|NCT00819286|11566328|FG001|COMPLETED|Overall Study||45
10421467|NCT00819286|11566327|FG000|NOT COMPLETED|Overall Study||14
10421468|NCT00819286|11566328|FG001|NOT COMPLETED|Overall Study||25
10421469|NCT00819390|11566338|FG000|STARTED|Overall Study||16
10421470|NCT00819390|11566339|FG001|STARTED|Overall Study||17
10421471|NCT00819390|11566340|FG002|STARTED|Overall Study||18
10421472|NCT00819390|11566341|FG003|STARTED|Overall Study||19
10421473|NCT00819390|11566338|FG000|COMPLETED|Overall Study||13
10421474|NCT00819390|11566339|FG001|COMPLETED|Overall Study||16
10421475|NCT00819390|11566340|FG002|COMPLETED|Overall Study||17
10421476|NCT00819390|11566341|FG003|COMPLETED|Overall Study||19
10421477|NCT00819390|11566338|FG000|NOT COMPLETED|Overall Study||3
10421478|NCT00819390|11566339|FG001|NOT COMPLETED|Overall Study||1
10421479|NCT00819390|11566340|FG002|NOT COMPLETED|Overall Study||1
10421480|NCT00819390|11566341|FG003|NOT COMPLETED|Overall Study||0
10421481|NCT00819403|11566356|FG000|STARTED|First Intervention (6 Weeks)||7
10421482|NCT00819403|11566357|FG001|STARTED|First Intervention (6 Weeks)||8
10421483|NCT00819403|11566356|FG000|COMPLETED|First Intervention (6 Weeks)||7
10421484|NCT00819403|11566357|FG001|COMPLETED|First Intervention (6 Weeks)||8
10429542|NCT00864383|11575576|FG002|STARTED|Modified Intent to Treat||636
10421485|NCT00819403|11566356|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
10421486|NCT00819403|11566357|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
10421487|NCT00819403|11566356|FG000|STARTED|Washout (14 Days)||7
10421488|NCT00819403|11566357|FG001|STARTED|Washout (14 Days)||8
10421489|NCT00819403|11566356|FG000|COMPLETED|Washout (14 Days)||7
10421490|NCT00819403|11566357|FG001|COMPLETED|Washout (14 Days)||8
10421491|NCT00819403|11566356|FG000|NOT COMPLETED|Washout (14 Days)||0
10421492|NCT00819403|11566357|FG001|NOT COMPLETED|Washout (14 Days)||0
10421493|NCT00819403|11566356|FG000|STARTED|Second Intervention (6 Weeks)||7
10421494|NCT00819403|11566357|FG001|STARTED|Second Intervention (6 Weeks)||8
10421495|NCT00819403|11566356|FG000|COMPLETED|Second Intervention (6 Weeks)||7
10421496|NCT00819403|11566357|FG001|COMPLETED|Second Intervention (6 Weeks)||8
10421497|NCT00819403|11566356|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
10421498|NCT00819403|11566357|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
10421499|NCT00819507|11566364|FG000|STARTED|Overall Study||25
10421500|NCT00819507|11566364|FG000|COMPLETED|Overall Study||25
10421501|NCT00819507|11566364|FG000|NOT COMPLETED|Overall Study||0
10421502|NCT00819585|11566375|FG000|STARTED|Core Study|Participants who started the core study are included in the randomized and full analysis sets.|55
10421503|NCT00819585|11566376|FG001|STARTED|Core Study||54
10421504|NCT00819585|11566377|FG002|STARTED|Core Study||54
10421505|NCT00819585|11566378|FG003|STARTED|Core Study||54
10421506|NCT00819585|11566379|FG004|STARTED|Core Study||53
10421507|NCT00819585|11566380|FG005|STARTED|Core Study||54
10421508|NCT00819585|11566381|FG006|STARTED|Core Study||108
10421509|NCT00819585|11566382|FG007|STARTED|Core Study|There were no participants in this arm during the core study.|0
10421510|NCT00819585|11566383|FG008|STARTED|Core Study|There were no participants in this arm during the core study.|0
10421511|NCT00819585|11566384|FG009|STARTED|Core Study|There were no participants in this arm during the core study.|0
10421512|NCT00819585|11566385|FG010|STARTED|Core Study|There were no participants in this arm during the core study.|0
10421513|NCT00819585|11566375|FG000|Received Study Medication|Core Study|Participants who received study medication are included in the safety population.|55
10421514|NCT00819585|11566376|FG001|Received Study Medication|Core Study||54
10421515|NCT00819585|11566377|FG002|Received Study Medication|Core Study||54
10421516|NCT00819585|11566378|FG003|Received Study Medication|Core Study||54
10421517|NCT00819585|11566379|FG004|Received Study Medication|Core Study||53
10421518|NCT00819585|11566380|FG005|Received Study Medication|Core Study|One participant in this treatment arm was HIV+ve and did not receive any study medication.|53
10421519|NCT00819585|11566381|FG006|Received Study Medication|Core Study||108
10421520|NCT00819585|11566382|FG007|Received Study Medication|Core Study||0
10421521|NCT00819585|11566383|FG008|Received Study Medication|Core Study||0
10421522|NCT00819585|11566384|FG009|Received Study Medication|Core Study||0
10421523|NCT00819585|11566385|FG010|Received Study Medication|Core Study||0
10421524|NCT00819585|11566375|FG000|COMPLETED|Core Study||49
10421525|NCT00819585|11566376|FG001|COMPLETED|Core Study||48
10421526|NCT00819585|11566377|FG002|COMPLETED|Core Study||48
10421527|NCT00819585|11566378|FG003|COMPLETED|Core Study||49
10421528|NCT00819585|11566379|FG004|COMPLETED|Core Study||50
10421529|NCT00819585|11566380|FG005|COMPLETED|Core Study||52
10421530|NCT00819585|11566381|FG006|COMPLETED|Core Study||95
10421531|NCT00819585|11566382|FG007|COMPLETED|Core Study||0
10421532|NCT00819585|11566383|FG008|COMPLETED|Core Study||0
10421533|NCT00819585|11566384|FG009|COMPLETED|Core Study||0
10421534|NCT00819585|11566385|FG010|COMPLETED|Core Study||0
10421535|NCT00819585|11566375|FG000|NOT COMPLETED|Core Study||6
10421536|NCT00819585|11566376|FG001|NOT COMPLETED|Core Study||6
10421537|NCT00819585|11566377|FG002|NOT COMPLETED|Core Study||6
10421538|NCT00819585|11566378|FG003|NOT COMPLETED|Core Study||5
10421539|NCT00819585|11566379|FG004|NOT COMPLETED|Core Study||3
10421540|NCT00819585|11566380|FG005|NOT COMPLETED|Core Study||2
10421541|NCT00819585|11566381|FG006|NOT COMPLETED|Core Study||13
10421542|NCT00819585|11566382|FG007|NOT COMPLETED|Core Study||0
10421543|NCT00819585|11566383|FG008|NOT COMPLETED|Core Study||0
10421544|NCT00819585|11566384|FG009|NOT COMPLETED|Core Study||0
10421545|NCT00819585|11566385|FG010|NOT COMPLETED|Core Study||0
10421546|NCT00819585|11566375|FG000|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
10421547|NCT00819585|11566376|FG001|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
10421548|NCT00819585|11566377|FG002|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
10421549|NCT00819585|11566378|FG003|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
10421550|NCT00819585|11566379|FG004|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
10421551|NCT00819585|11566380|FG005|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
10421552|NCT00819585|11566381|FG006|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
10421553|NCT00819585|11566382|FG007|STARTED|Extension Study||75
10421554|NCT00819585|11566383|FG008|STARTED|Extension Study||181
10421555|NCT00819585|11566384|FG009|STARTED|Extension Study||25
10421556|NCT00819585|11566385|FG010|STARTED|Extension Study||60
10421557|NCT00819585|11566375|FG000|COMPLETED|Extension Study||0
10421558|NCT00819585|11566376|FG001|COMPLETED|Extension Study||0
10421559|NCT00819585|11566377|FG002|COMPLETED|Extension Study||0
10421560|NCT00819585|11566378|FG003|COMPLETED|Extension Study||0
10421561|NCT00819585|11566379|FG004|COMPLETED|Extension Study||0
10421562|NCT00819585|11566380|FG005|COMPLETED|Extension Study||0
10421563|NCT00819585|11566381|FG006|COMPLETED|Extension Study||0
10421564|NCT00819585|11566382|FG007|COMPLETED|Extension Study||75
10421565|NCT00819585|11566383|FG008|COMPLETED|Extension Study||173
10421566|NCT00819585|11566384|FG009|COMPLETED|Extension Study||24
10421567|NCT00819585|11566385|FG010|COMPLETED|Extension Study||58
10421568|NCT00819585|11566375|FG000|NOT COMPLETED|Extension Study||0
10421569|NCT00819585|11566376|FG001|NOT COMPLETED|Extension Study||0
10421570|NCT00819585|11566377|FG002|NOT COMPLETED|Extension Study||0
10421571|NCT00819585|11566378|FG003|NOT COMPLETED|Extension Study||0
10421572|NCT00819585|11566379|FG004|NOT COMPLETED|Extension Study||0
10421573|NCT00819585|11566380|FG005|NOT COMPLETED|Extension Study||0
10421574|NCT00819585|11566381|FG006|NOT COMPLETED|Extension Study||0
10421575|NCT00819585|11566382|FG007|NOT COMPLETED|Extension Study||0
10421576|NCT00819585|11566383|FG008|NOT COMPLETED|Extension Study||8
10421577|NCT00819585|11566384|FG009|NOT COMPLETED|Extension Study||1
10421578|NCT00819585|11566385|FG010|NOT COMPLETED|Extension Study||2
10421579|NCT00819637|11566416|FG000|STARTED|Overall Study||2
10421580|NCT00819637|11566417|FG001|STARTED|Overall Study||0
10421581|NCT00819637|11566418|FG002|STARTED|Overall Study||0
10421582|NCT00819637|11566416|FG000|COMPLETED|Overall Study||2
10421583|NCT00819637|11566417|FG001|COMPLETED|Overall Study||0
10421584|NCT00819637|11566418|FG002|COMPLETED|Overall Study||0
10421585|NCT00819637|11566416|FG000|NOT COMPLETED|Overall Study||0
10546208|NCT01504867|11699819|FG001|STARTED|Overall Study||198
10546209|NCT01504867|11699818|FG000|COMPLETED|Overall Study||195
10546210|NCT01504867|11699819|FG001|COMPLETED|Overall Study||195
10546211|NCT01504867|11699818|FG000|NOT COMPLETED|Overall Study||7
10546212|NCT01504867|11699819|FG001|NOT COMPLETED|Overall Study||3
10546213|NCT01504958|11699828|FG000|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|10
10546214|NCT01504958|11699829|FG001|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|6
10546215|NCT01504958|11699830|FG002|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|6
10546216|NCT01504958|11699828|FG000|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|10
10546217|NCT01504958|11699829|FG001|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|6
10546218|NCT01504958|11699830|FG002|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|6
10546219|NCT01504958|11699828|FG000|NOT COMPLETED|Overall Study||0
10546220|NCT01504958|11699829|FG001|NOT COMPLETED|Overall Study||0
10546221|NCT01504958|11699830|FG002|NOT COMPLETED|Overall Study||0
10755813|NCT03072953|11919678|FG000|STARTED|Overall Study||2
10755814|NCT03072953|11919678|FG000|COMPLETED|Overall Study||2
10421586|NCT00819637|11566417|FG001|NOT COMPLETED|Overall Study||0
10421587|NCT00819637|11566418|FG002|NOT COMPLETED|Overall Study||0
10421588|NCT00819741|11566428|FG000|STARTED|Overall Study||218
10755815|NCT03072953|11919678|FG000|NOT COMPLETED|Overall Study||0
10755816|NCT03073005|11919686|FG000|STARTED|Overall Study||33
10755817|NCT03073005|11919687|FG001|STARTED|Overall Study||37
10755818|NCT03073005|11919688|FG002|STARTED|Overall Study||36
10755819|NCT03073005|11919689|FG003|STARTED|Overall Study||37
10755820|NCT03073005|11919686|FG000|Received Initial Training|Overall Study|29 pairs (29 patients plus their caregivers)|29
10755821|NCT03073005|11919687|FG001|Received Initial Training|Overall Study||29
10755822|NCT03073005|11919688|FG002|Received Initial Training|Overall Study|33 pairs (33 patients plus their caregivers)|33
10755823|NCT03073005|11919689|FG003|Received Initial Training|Overall Study||33
10755824|NCT03073005|11919686|FG000|COMPLETED|Overall Study|25 pairs (25 patients plus their caregivers)|25
10755825|NCT03073005|11919687|FG001|COMPLETED|Overall Study||25
10755826|NCT03073005|11919688|FG002|COMPLETED|Overall Study|24 pairs (24 patients plus their caregivers)|24
10755827|NCT03073005|11919689|FG003|COMPLETED|Overall Study||24
10755828|NCT03073005|11919686|FG000|NOT COMPLETED|Overall Study||8
10755829|NCT03073005|11919687|FG001|NOT COMPLETED|Overall Study||12
10755830|NCT03073005|11919688|FG002|NOT COMPLETED|Overall Study||12
10755831|NCT03073005|11919689|FG003|NOT COMPLETED|Overall Study||13
10755832|NCT03073109|11919704|FG000|STARTED|Overall Study||100
10755833|NCT03073109|11919705|FG001|STARTED|Overall Study||70
10755834|NCT03073109|11919704|FG000|COMPLETED|Overall Study||90
10755835|NCT03073109|11919705|FG001|COMPLETED|Overall Study||68
10755836|NCT03073109|11919704|FG000|NOT COMPLETED|Overall Study||10
10755837|NCT03073109|11919705|FG001|NOT COMPLETED|Overall Study||2
10755838|NCT03073148|11919727|FG000|STARTED|Overall Study||21
10755839|NCT03073148|11919728|FG001|STARTED|Overall Study||10
10755840|NCT03073148|11919729|FG002|STARTED|Overall Study||4
10755841|NCT03073148|11919727|FG000|COMPLETED|Overall Study||21
10755842|NCT03073148|11919728|FG001|COMPLETED|Overall Study||10
10755843|NCT03073148|11919729|FG002|COMPLETED|Overall Study||0
10755844|NCT03073148|11919727|FG000|NOT COMPLETED|Overall Study||0
10755845|NCT03073148|11919728|FG001|NOT COMPLETED|Overall Study||0
10755846|NCT03073148|11919729|FG002|NOT COMPLETED|Overall Study||4
10755847|NCT03073200|11919740|FG000|STARTED|Double Blind Treatment Period||56
10755848|NCT03073200|11919741|FG001|STARTED|Double Blind Treatment Period||115
10755849|NCT03073200|11919742|FG002|STARTED|Double Blind Treatment Period||30
10755850|NCT03073200|11919743|FG003|STARTED|Double Blind Treatment Period||0
10755851|NCT03073200|11919744|FG004|STARTED|Double Blind Treatment Period||0
10755852|NCT03073200|11919745|FG005|STARTED|Double Blind Treatment Period||0
10755853|NCT03073200|11919746|FG006|STARTED|Double Blind Treatment Period||0
10755854|NCT03073200|11919747|FG007|STARTED|Double Blind Treatment Period||0
10421589|NCT00819741|11566429|FG001|STARTED|Overall Study||215
10421590|NCT00819741|11566428|FG000|Exposed to Drug|Overall Study||218
10421591|NCT00819741|11566429|FG001|Exposed to Drug|Overall Study|One subject after randomisation was not exposed to the treatment due to non-compliance|214
10421592|NCT00819741|11566428|FG000|COMPLETED|Overall Study||196
10421593|NCT00819741|11566429|FG001|COMPLETED|Overall Study||201
10421594|NCT00819741|11566428|FG000|NOT COMPLETED|Overall Study||22
10421595|NCT00819741|11566429|FG001|NOT COMPLETED|Overall Study||14
10421596|NCT00819767|11566437|FG000|STARTED|Overall Study||33
10421597|NCT00819767|11566438|FG001|STARTED|Overall Study||35
10421598|NCT00819767|11566437|FG000|COMPLETED|Overall Study||32
10421599|NCT00819767|11566438|FG001|COMPLETED|Overall Study||33
10421600|NCT00819767|11566437|FG000|NOT COMPLETED|Overall Study||1
10421601|NCT00819767|11566438|FG001|NOT COMPLETED|Overall Study||2
10546222|NCT01504971|11699838|FG000|STARTED|Overall Study||95
10546223|NCT01504971|11699838|FG000|COMPLETED|Overall Study||82
10546224|NCT01504971|11699838|FG000|NOT COMPLETED|Overall Study||13
10546225|NCT01504997|11699846|FG000|STARTED|Overall Study||18
10546226|NCT01504997|11699846|FG000|COMPLETED|Overall Study||18
10546227|NCT01504997|11699846|FG000|NOT COMPLETED|Overall Study||0
10546228|NCT01505010|11699852|FG000|STARTED|Overall Study||9
10546229|NCT01505010|11699853|FG001|STARTED|Overall Study||8
10546230|NCT01505010|11699852|FG000|COMPLETED|Overall Study||9
10546231|NCT01505010|11699853|FG001|COMPLETED|Overall Study||6
10546232|NCT01505010|11699852|FG000|NOT COMPLETED|Overall Study||0
10546233|NCT01505010|11699853|FG001|NOT COMPLETED|Overall Study||2
10546234|NCT01505114|11699863|FG000|STARTED|Overall Study||148
10546235|NCT01505114|11699864|FG001|STARTED|Overall Study||148
10546236|NCT01505114|11699865|FG002|STARTED|Overall Study||147
10546237|NCT01505114|11699866|FG003|STARTED|Overall Study||151
10546238|NCT01505114|11699863|FG000|COMPLETED|Overall Study||123
10546239|NCT01505114|11699864|FG001|COMPLETED|Overall Study||135
10546240|NCT01505114|11699865|FG002|COMPLETED|Overall Study||129
10546241|NCT01505114|11699866|FG003|COMPLETED|Overall Study||128
10546242|NCT01505114|11699863|FG000|NOT COMPLETED|Overall Study||25
10546243|NCT01505114|11699864|FG001|NOT COMPLETED|Overall Study||13
10546244|NCT01505114|11699865|FG002|NOT COMPLETED|Overall Study||18
10546245|NCT01505114|11699866|FG003|NOT COMPLETED|Overall Study||23
10546246|NCT01505166|11699879|FG000|STARTED|Overall Study||3
10546247|NCT01505166|11699880|FG001|STARTED|Overall Study||0
10546248|NCT01505166|11699881|FG002|STARTED|Overall Study||0
10546249|NCT01505166|11699879|FG000|COMPLETED|Overall Study|"Completed means subject had successful Vigil manufacturing and had been given all the doses."|3
10546250|NCT01505166|11699880|FG001|COMPLETED|Overall Study||0
10546251|NCT01505166|11699881|FG002|COMPLETED|Overall Study||0
10546252|NCT01505166|11699879|FG000|NOT COMPLETED|Overall Study||0
10546253|NCT01505166|11699880|FG001|NOT COMPLETED|Overall Study||0
10546254|NCT01505166|11699881|FG002|NOT COMPLETED|Overall Study||0
10546255|NCT01505179|11699893|FG000|STARTED|Overall Study||6
10546256|NCT01505179|11699894|FG001|STARTED|Overall Study||4
10546257|NCT01505179|11699893|FG000|COMPLETED|Overall Study||6
10546258|NCT01505179|11699894|FG001|COMPLETED|Overall Study||4
10546259|NCT01505179|11699893|FG000|NOT COMPLETED|Overall Study||0
10546260|NCT01505179|11699894|FG001|NOT COMPLETED|Overall Study||0
10546261|NCT01505374|11699900|FG000|STARTED|Overall Study||30
10546262|NCT01505374|11699901|FG001|STARTED|Overall Study||30
10546263|NCT01505374|11699900|FG000|COMPLETED|Overall Study||29
10546264|NCT01505374|11699901|FG001|COMPLETED|Overall Study||30
10546265|NCT01505374|11699900|FG000|NOT COMPLETED|Overall Study||1
10546266|NCT01505374|11699901|FG001|NOT COMPLETED|Overall Study||0
10546267|NCT01505387|11699910|FG000|STARTED|Overall Study||25
10546268|NCT01505387|11699911|FG001|STARTED|Overall Study||25
10546269|NCT01505387|11699910|FG000|Treated|Overall Study||24
10546270|NCT01505387|11699911|FG001|Treated|Overall Study||24
10755893|NCT03073200|11919741|FG001|NOT COMPLETED|Double Blind Treatment Period||1
10546271|NCT01505387|11699910|FG000|COMPLETED|Overall Study|1 subject not included in intention to treat population as violated inclusion criteria|23
10546272|NCT01505387|11699911|FG001|COMPLETED|Overall Study||24
10546273|NCT01505387|11699910|FG000|NOT COMPLETED|Overall Study||2
10546274|NCT01505387|11699911|FG001|NOT COMPLETED|Overall Study||1
10546275|NCT01505491|11699920|FG000|STARTED|Overall Study||67
10546276|NCT01505491|11699921|FG001|STARTED|Overall Study||62
10546277|NCT01505491|11699922|FG002|STARTED|Overall Study||64
10546278|NCT01505491|11699920|FG000|COMPLETED|Overall Study||65
10546279|NCT01505491|11699921|FG001|COMPLETED|Overall Study||61
10546280|NCT01505491|11699922|FG002|COMPLETED|Overall Study||59
10546281|NCT01505491|11699920|FG000|NOT COMPLETED|Overall Study||2
10546282|NCT01505491|11699921|FG001|NOT COMPLETED|Overall Study||1
10546283|NCT01505491|11699922|FG002|NOT COMPLETED|Overall Study||5
10755855|NCT03073200|11919748|FG008|STARTED|Double Blind Treatment Period||0
10429543|NCT00864383|11575574|FG000|COMPLETED|Modified Intent to Treat||555
10546284|NCT01505530|11699933|FG000|STARTED|Overall Study||41
10546285|NCT01505530|11699934|FG001|STARTED|Overall Study||43
10546286|NCT01505530|11699935|FG002|STARTED|Overall Study||41
10546287|NCT01505530|11699933|FG000|Received At Least One Dose of Study Drug|Overall Study||41
10546288|NCT01505530|11699934|FG001|Received At Least One Dose of Study Drug|Overall Study||42
10546289|NCT01505530|11699935|FG002|Received At Least One Dose of Study Drug|Overall Study||41
10546290|NCT01505530|11699933|FG000|Completed One Cycle of Study Drug|Overall Study||29
10546291|NCT01505530|11699934|FG001|Completed One Cycle of Study Drug|Overall Study||27
10546292|NCT01505530|11699935|FG002|Completed One Cycle of Study Drug|Overall Study||31
10546293|NCT01505530|11699933|FG000|COMPLETED|Overall Study||0
10546294|NCT01505530|11699934|FG001|COMPLETED|Overall Study||0
10546295|NCT01505530|11699935|FG002|COMPLETED|Overall Study||0
10546296|NCT01505530|11699933|FG000|NOT COMPLETED|Overall Study||41
10546297|NCT01505530|11699934|FG001|NOT COMPLETED|Overall Study||43
10546298|NCT01505530|11699935|FG002|NOT COMPLETED|Overall Study||41
10546299|NCT01505634|11699946|FG000|STARTED|Overall Study||101
10546300|NCT01505634|11699947|FG001|STARTED|Overall Study||101
10546301|NCT01505634|11699948|FG002|STARTED|Overall Study||100
10546302|NCT01505634|11699946|FG000|Treated|Overall Study||99
10546303|NCT01505634|11699947|FG001|Treated|Overall Study||99
10546304|NCT01505634|11699948|FG002|Treated|Overall Study||100
10546305|NCT01505634|11699946|FG000|COMPLETED|Overall Study||92
10546306|NCT01505634|11699947|FG001|COMPLETED|Overall Study||91
10546307|NCT01505634|11699948|FG002|COMPLETED|Overall Study||94
10546308|NCT01505634|11699946|FG000|NOT COMPLETED|Overall Study||9
10755856|NCT03073200|11919749|FG009|STARTED|Double Blind Treatment Period||0
10755857|NCT03073200|11919750|FG010|STARTED|Double Blind Treatment Period||0
10755858|NCT03073200|11919751|FG011|STARTED|Double Blind Treatment Period||0
10755859|NCT03073200|11919752|FG012|STARTED|Double Blind Treatment Period||0
10755860|NCT03073200|11919753|FG013|STARTED|Double Blind Treatment Period||0
10755861|NCT03073200|11919754|FG014|STARTED|Double Blind Treatment Period||0
10755862|NCT03073200|11919740|FG000|Participants in Etanercept Approved Countries|Double Blind Treatment Period||19
10755863|NCT03073200|11919741|FG001|Participants in Etanercept Approved Countries|Double Blind Treatment Period||38
10755864|NCT03073200|11919742|FG002|Participants in Etanercept Approved Countries|Double Blind Treatment Period||30
10755865|NCT03073200|11919743|FG003|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
10755866|NCT03073200|11919744|FG004|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
10755867|NCT03073200|11919745|FG005|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
10755868|NCT03073200|11919746|FG006|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
10755869|NCT03073200|11919747|FG007|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
10755870|NCT03073200|11919748|FG008|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
10755871|NCT03073200|11919749|FG009|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
10755872|NCT03073200|11919750|FG010|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
10755873|NCT03073200|11919751|FG011|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
10755874|NCT03073200|11919752|FG012|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
10755875|NCT03073200|11919753|FG013|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
10755876|NCT03073200|11919754|FG014|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
10755877|NCT03073200|11919740|FG000|COMPLETED|Double Blind Treatment Period||54
10755878|NCT03073200|11919741|FG001|COMPLETED|Double Blind Treatment Period||114
10755879|NCT03073200|11919742|FG002|COMPLETED|Double Blind Treatment Period||30
10755880|NCT03073200|11919743|FG003|COMPLETED|Double Blind Treatment Period||0
10755881|NCT03073200|11919744|FG004|COMPLETED|Double Blind Treatment Period||0
10755882|NCT03073200|11919745|FG005|COMPLETED|Double Blind Treatment Period||0
10755883|NCT03073200|11919746|FG006|COMPLETED|Double Blind Treatment Period||0
10755884|NCT03073200|11919747|FG007|COMPLETED|Double Blind Treatment Period||0
10755885|NCT03073200|11919748|FG008|COMPLETED|Double Blind Treatment Period||0
10755886|NCT03073200|11919749|FG009|COMPLETED|Double Blind Treatment Period||0
10755887|NCT03073200|11919750|FG010|COMPLETED|Double Blind Treatment Period||0
10755888|NCT03073200|11919751|FG011|COMPLETED|Double Blind Treatment Period||0
10755889|NCT03073200|11919752|FG012|COMPLETED|Double Blind Treatment Period||0
10755890|NCT03073200|11919753|FG013|COMPLETED|Double Blind Treatment Period||0
10755891|NCT03073200|11919754|FG014|COMPLETED|Double Blind Treatment Period||0
10755892|NCT03073200|11919740|FG000|NOT COMPLETED|Double Blind Treatment Period||2
10755894|NCT03073200|11919742|FG002|NOT COMPLETED|Double Blind Treatment Period||0
10755895|NCT03073200|11919743|FG003|NOT COMPLETED|Double Blind Treatment Period||0
10755896|NCT03073200|11919744|FG004|NOT COMPLETED|Double Blind Treatment Period||0
10755897|NCT03073200|11919745|FG005|NOT COMPLETED|Double Blind Treatment Period||0
10755898|NCT03073200|11919746|FG006|NOT COMPLETED|Double Blind Treatment Period||0
10755899|NCT03073200|11919747|FG007|NOT COMPLETED|Double Blind Treatment Period||0
10755900|NCT03073200|11919748|FG008|NOT COMPLETED|Double Blind Treatment Period||0
10755901|NCT03073200|11919749|FG009|NOT COMPLETED|Double Blind Treatment Period||0
10755902|NCT03073200|11919750|FG010|NOT COMPLETED|Double Blind Treatment Period||0
10755903|NCT03073200|11919751|FG011|NOT COMPLETED|Double Blind Treatment Period||0
10755904|NCT03073200|11919752|FG012|NOT COMPLETED|Double Blind Treatment Period||0
10755905|NCT03073200|11919753|FG013|NOT COMPLETED|Double Blind Treatment Period||0
10755906|NCT03073200|11919754|FG014|NOT COMPLETED|Double Blind Treatment Period||0
10755907|NCT03073200|11919740|FG000|STARTED|Open-Label Maintenance Period|This period is to report Maintenance Period participants.|0
10755908|NCT03073200|11919741|FG001|STARTED|Open-Label Maintenance Period|This period is to report Maintenance Period participants.|0
10755909|NCT03073200|11919742|FG002|STARTED|Open-Label Maintenance Period|This period is to report Maintenance Period participants.|0
10546309|NCT01505634|11699947|FG001|NOT COMPLETED|Overall Study||10
10546310|NCT01505634|11699948|FG002|NOT COMPLETED|Overall Study||6
10546311|NCT01505647|11699958|FG000|STARTED|Day 1 Through Day 42 Follow-up||332
10546312|NCT01505647|11699959|FG001|STARTED|Day 1 Through Day 42 Follow-up||166
10546313|NCT01505647|11699958|FG000|Vaccinated|Day 1 Through Day 42 Follow-up||331
10546314|NCT01505647|11699959|FG001|Vaccinated|Day 1 Through Day 42 Follow-up||166
10546315|NCT01505647|11699958|FG000|COMPLETED|Day 1 Through Day 42 Follow-up||329
10546316|NCT01505647|11699959|FG001|COMPLETED|Day 1 Through Day 42 Follow-up||166
10546317|NCT01505647|11699958|FG000|NOT COMPLETED|Day 1 Through Day 42 Follow-up||3
10661309|NCT02258412|11823213|FG000|STARTED|Overall Study||26
10661310|NCT02258412|11823214|FG001|STARTED|Overall Study||25
10661311|NCT02258412|11823215|FG002|STARTED|Overall Study||61
10661312|NCT02258412|11823213|FG000|COMPLETED|Overall Study||26
10661313|NCT02258412|11823214|FG001|COMPLETED|Overall Study||25
10661314|NCT02258412|11823215|FG002|COMPLETED|Overall Study||61
10661315|NCT02258412|11823213|FG000|NOT COMPLETED|Overall Study||0
10661316|NCT02258412|11823214|FG001|NOT COMPLETED|Overall Study||0
10661317|NCT02258412|11823215|FG002|NOT COMPLETED|Overall Study||0
10661318|NCT02258464|11823224|FG000|STARTED|Overall Study||49
10661319|NCT02258464|11823225|FG001|STARTED|Overall Study||50
10661320|NCT02258464|11823224|FG000|COMPLETED|Overall Study||32
10661321|NCT02258464|11823225|FG001|COMPLETED|Overall Study||25
10661322|NCT02258464|11823224|FG000|NOT COMPLETED|Overall Study||17
10661323|NCT02258464|11823225|FG001|NOT COMPLETED|Overall Study||25
10661324|NCT02258477|11823231|FG000|STARTED|First Intervention (1 Week)||10
10661325|NCT02258477|11823232|FG001|STARTED|First Intervention (1 Week)||9
10661326|NCT02258477|11823233|FG002|STARTED|First Intervention (1 Week)||9
10661327|NCT02258477|11823234|FG003|STARTED|First Intervention (1 Week)||9
10661328|NCT02258477|11823231|FG000|COMPLETED|First Intervention (1 Week)||9
10661329|NCT02258477|11823232|FG001|COMPLETED|First Intervention (1 Week)||8
10661330|NCT02258477|11823233|FG002|COMPLETED|First Intervention (1 Week)||9
10661331|NCT02258477|11823234|FG003|COMPLETED|First Intervention (1 Week)||9
10661332|NCT02258477|11823231|FG000|NOT COMPLETED|First Intervention (1 Week)||1
10661333|NCT02258477|11823232|FG001|NOT COMPLETED|First Intervention (1 Week)||1
10661334|NCT02258477|11823233|FG002|NOT COMPLETED|First Intervention (1 Week)||0
10661335|NCT02258477|11823234|FG003|NOT COMPLETED|First Intervention (1 Week)||0
10661336|NCT02258477|11823231|FG000|STARTED|Second Intervention (1 Week)||9
10661337|NCT02258477|11823232|FG001|STARTED|Second Intervention (1 Week)||8
10661338|NCT02258477|11823233|FG002|STARTED|Second Intervention (1 Week)||9
10661339|NCT02258477|11823234|FG003|STARTED|Second Intervention (1 Week)||9
10661340|NCT02258477|11823231|FG000|COMPLETED|Second Intervention (1 Week)||9
10661341|NCT02258477|11823232|FG001|COMPLETED|Second Intervention (1 Week)||8
10661342|NCT02258477|11823233|FG002|COMPLETED|Second Intervention (1 Week)||8
10755910|NCT03073200|11919743|FG003|STARTED|Open-Label Maintenance Period|This period is to report Maintenance Period participants.|53
10755911|NCT03073200|11919744|FG004|STARTED|Open-Label Maintenance Period|This period is to report Maintenance Period participants.|113
10755912|NCT03073200|11919745|FG005|STARTED|Open-Label Maintenance Period|This period is to report Maintenance Period participants.|28
10755913|NCT03073200|11919746|FG006|STARTED|Open-Label Maintenance Period||0
10755914|NCT03073200|11919747|FG007|STARTED|Open-Label Maintenance Period||0
10755915|NCT03073200|11919748|FG008|STARTED|Open-Label Maintenance Period||0
10755916|NCT03073200|11919749|FG009|STARTED|Open-Label Maintenance Period||0
10755917|NCT03073200|11919750|FG010|STARTED|Open-Label Maintenance Period||0
10755918|NCT03073200|11919751|FG011|STARTED|Open-Label Maintenance Period||0
10874538|NCT04929522|12040640|FG000|STARTED|Overall Study||40
10874539|NCT04929522|12040641|FG001|STARTED|Overall Study||40
10874540|NCT04929522|12040642|FG002|STARTED|Overall Study||40
10874541|NCT04929522|12040643|FG003|STARTED|Overall Study||40
10874542|NCT04929522|12040640|FG000|COMPLETED|Overall Study||40
10874543|NCT04929522|12040641|FG001|COMPLETED|Overall Study||40
10874544|NCT04929522|12040642|FG002|COMPLETED|Overall Study||40
10874545|NCT04929522|12040643|FG003|COMPLETED|Overall Study||40
10874546|NCT04929522|12040640|FG000|NOT COMPLETED|Overall Study||0
10874547|NCT04929522|12040641|FG001|NOT COMPLETED|Overall Study||0
10874548|NCT04929522|12040642|FG002|NOT COMPLETED|Overall Study||0
10874549|NCT04929522|12040643|FG003|NOT COMPLETED|Overall Study||0
10661343|NCT02258477|11823234|FG003|COMPLETED|Second Intervention (1 Week)||8
10661344|NCT02258477|11823231|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
10546318|NCT01505647|11699959|FG001|NOT COMPLETED|Day 1 Through Day 42 Follow-up||0
10546319|NCT01505647|11699958|FG000|STARTED|Day 43 Through Day 182 Follow-up||329
10546320|NCT01505647|11699959|FG001|STARTED|Day 43 Through Day 182 Follow-up||166
10546321|NCT01505647|11699958|FG000|COMPLETED|Day 43 Through Day 182 Follow-up||328
10546322|NCT01505647|11699959|FG001|COMPLETED|Day 43 Through Day 182 Follow-up||163
10546323|NCT01505647|11699958|FG000|NOT COMPLETED|Day 43 Through Day 182 Follow-up||1
10546324|NCT01505647|11699959|FG001|NOT COMPLETED|Day 43 Through Day 182 Follow-up||3
10546325|NCT01505673|11699967|FG000|STARTED|Overall Study||35
10546326|NCT01505673|11699968|FG001|STARTED|Overall Study||36
10546327|NCT01505673|11699967|FG000|COMPLETED|Overall Study||32
10546328|NCT01505673|11699968|FG001|COMPLETED|Overall Study||34
10546329|NCT01505673|11699967|FG000|NOT COMPLETED|Overall Study||3
10546330|NCT01505673|11699968|FG001|NOT COMPLETED|Overall Study||2
10546331|NCT01505764|11699976|FG000|STARTED|Overall Study||6
10546332|NCT01505764|11699977|FG001|STARTED|Overall Study||3
10546333|NCT01505764|11699976|FG000|COMPLETED|Overall Study||3
10546334|NCT01505764|11699977|FG001|COMPLETED|Overall Study||2
10546335|NCT01505764|11699976|FG000|NOT COMPLETED|Overall Study||3
10546336|NCT01505764|11699977|FG001|NOT COMPLETED|Overall Study||1
10546337|NCT01505868|11699989|FG000|STARTED|Overall Study||4
10546338|NCT01505868|11699990|FG001|STARTED|Overall Study||3
10546339|NCT01505868|11699991|FG002|STARTED|Overall Study||3
10546340|NCT01505868|11699992|FG003|STARTED|Overall Study||79
10546341|NCT01505868|11699993|FG004|STARTED|Overall Study||81
10546342|NCT01505868|11699989|FG000|COMPLETED|Overall Study||3
10546343|NCT01505868|11699990|FG001|COMPLETED|Overall Study||3
10546344|NCT01505868|11699991|FG002|COMPLETED|Overall Study||3
10546345|NCT01505868|11699992|FG003|COMPLETED|Overall Study||79
10546346|NCT01505868|11699993|FG004|COMPLETED|Overall Study||81
10546347|NCT01505868|11699989|FG000|NOT COMPLETED|Overall Study||1
10546348|NCT01505868|11699990|FG001|NOT COMPLETED|Overall Study||0
10546349|NCT01505868|11699991|FG002|NOT COMPLETED|Overall Study||0
10546350|NCT01505868|11699992|FG003|NOT COMPLETED|Overall Study||0
10546351|NCT01505868|11699993|FG004|NOT COMPLETED|Overall Study||0
10546352|NCT01505881|11700007|FG000|STARTED|Overall Study||99
10546353|NCT01505881|11700008|FG001|STARTED|Overall Study||59
10546354|NCT01505881|11700007|FG000|COMPLETED|Overall Study||95
10546355|NCT01505881|11700008|FG001|COMPLETED|Overall Study||58
10546356|NCT01505881|11700007|FG000|NOT COMPLETED|Overall Study||4
10546357|NCT01505881|11700008|FG001|NOT COMPLETED|Overall Study||1
10546358|NCT01505933|11700017|FG000|STARTED|Overall Study||10
10546359|NCT01505933|11700018|FG001|STARTED|Overall Study||14
10546360|NCT01505933|11700017|FG000|COMPLETED|Overall Study||10
10546361|NCT01505933|11700018|FG001|COMPLETED|Overall Study||14
10546362|NCT01505933|11700017|FG000|NOT COMPLETED|Overall Study||0
10546363|NCT01505933|11700018|FG001|NOT COMPLETED|Overall Study||0
10546364|NCT01506193|11700027|FG000|STARTED|Overall Study||351
10546365|NCT01506193|11700028|FG001|STARTED|Overall Study||183
10546366|NCT01506193|11700029|FG002|STARTED|Overall Study||182
10546367|NCT01506193|11700027|FG000|COMPLETED|Overall Study||337
10546368|NCT01506193|11700028|FG001|COMPLETED|Overall Study||179
10546369|NCT01506193|11700029|FG002|COMPLETED|Overall Study||168
10546370|NCT01506193|11700027|FG000|NOT COMPLETED|Overall Study||14
10546371|NCT01506193|11700028|FG001|NOT COMPLETED|Overall Study||4
10546372|NCT01506193|11700029|FG002|NOT COMPLETED|Overall Study||14
10546373|NCT01506271|11700041|FG000|STARTED|Overall Study||118
10546374|NCT01506271|11700042|FG001|STARTED|Overall Study||116
10546375|NCT01506271|11700043|FG002|STARTED|Overall Study||117
10546376|NCT01506271|11700041|FG000|Treated|Overall Study||117
10546377|NCT01506271|11700042|FG001|Treated|Overall Study||116
10546378|NCT01506271|11700043|FG002|Treated|Overall Study||114
10546379|NCT01506271|11700041|FG000|COMPLETED|Overall Study||114
10546380|NCT01506271|11700042|FG001|COMPLETED|Overall Study||109
10546381|NCT01506271|11700043|FG002|COMPLETED|Overall Study||114
10546382|NCT01506271|11700041|FG000|NOT COMPLETED|Overall Study||4
10546383|NCT01506271|11700042|FG001|NOT COMPLETED|Overall Study||7
10546384|NCT01506271|11700043|FG002|NOT COMPLETED|Overall Study||3
10546385|NCT01506323|11700053|FG000|STARTED|Overall Study||89
10546386|NCT01506323|11700054|FG001|STARTED|Overall Study||84
10546387|NCT01506323|11700053|FG000|Post-treatment Completers|Overall Study||69
10546388|NCT01506323|11700054|FG001|Post-treatment Completers|Overall Study||72
10546389|NCT01506323|11700053|FG000|Post-treatment Completed CAPS|Overall Study||68
10546390|NCT01506323|11700054|FG001|Post-treatment Completed CAPS|Overall Study||72
10546391|NCT01506323|11700053|FG000|COMPLETED|Overall Study||65
10546392|NCT01506323|11700054|FG001|COMPLETED|Overall Study||71
10546393|NCT01506323|11700053|FG000|NOT COMPLETED|Overall Study||24
10546394|NCT01506323|11700054|FG001|NOT COMPLETED|Overall Study||13
10548300|NCT01518699|11702086|FG001|NOT COMPLETED|Period 3||0
10548301|NCT01518699|11702087|FG002|NOT COMPLETED|Period 3||0
10548302|NCT01518699|11702088|FG003|NOT COMPLETED|Period 3||0
10548303|NCT01518699|11702089|FG004|NOT COMPLETED|Period 3||0
10548304|NCT01518699|11702090|FG005|NOT COMPLETED|Period 3||0
10548305|NCT01518868|11702098|FG000|STARTED|Overall Study||63
10548306|NCT01518868|11702099|FG001|STARTED|Overall Study||63
10548307|NCT01518868|11702098|FG000|COMPLETED|Overall Study||59
10548308|NCT01518868|11702099|FG001|COMPLETED|Overall Study||59
10548309|NCT01518868|11702098|FG000|NOT COMPLETED|Overall Study||4
10548310|NCT01518868|11702099|FG001|NOT COMPLETED|Overall Study||4
10548311|NCT01518946|11702107|FG000|STARTED|Open-label Phase||24
10548312|NCT01518946|11702108|FG001|STARTED|Open-label Phase||0
10548313|NCT01518946|11702109|FG002|STARTED|Open-label Phase||0
10548314|NCT01518946|11702107|FG000|COMPLETED|Open-label Phase||20
10546395|NCT01506362|11700065|FG000|STARTED|Overall Study||22
10546396|NCT01506362|11700065|FG000|COMPLETED|Overall Study||16
10546397|NCT01506362|11700065|FG000|NOT COMPLETED|Overall Study||6
10546398|NCT01506453|11700071|FG000|STARTED|Overall Study||25
10546399|NCT01506453|11700072|FG001|STARTED|Overall Study||26
10546400|NCT01506453|11700071|FG000|COMPLETED|Overall Study||25
10546401|NCT01506453|11700072|FG001|COMPLETED|Overall Study||24
10546402|NCT01506453|11700071|FG000|NOT COMPLETED|Overall Study||0
10546403|NCT01506453|11700072|FG001|NOT COMPLETED|Overall Study||2
10546404|NCT01506479|11700081|FG000|STARTED|Overall Study||40
10546405|NCT01506479|11700082|FG001|STARTED|Overall Study||43
10546406|NCT01506479|11700083|FG002|STARTED|Overall Study||45
10546407|NCT01506479|11700081|FG000|COMPLETED|Overall Study||37
10546408|NCT01506479|11700082|FG001|COMPLETED|Overall Study||38
10546409|NCT01506479|11700083|FG002|COMPLETED|Overall Study||42
10546410|NCT01506479|11700081|FG000|NOT COMPLETED|Overall Study||3
10546411|NCT01506479|11700082|FG001|NOT COMPLETED|Overall Study||5
10546412|NCT01506479|11700083|FG002|NOT COMPLETED|Overall Study||3
10546413|NCT01506596|11700093|FG000|STARTED|Overall Study||42
10546414|NCT01506596|11700093|FG000|COMPLETED|Overall Study|One enrolled patient had ineligible pathology after starting treatment; was removed from treatment.|41
10546415|NCT01506596|11700093|FG000|NOT COMPLETED|Overall Study||1
10546416|NCT01506609|11700103|FG000|STARTED|Overall Study||2
10546417|NCT01506609|11700104|FG001|STARTED|Overall Study||1
10546418|NCT01506609|11700105|FG002|STARTED|Overall Study||1
10546419|NCT01506609|11700106|FG003|STARTED|Overall Study||99
10546420|NCT01506609|11700107|FG004|STARTED|Overall Study||97
10546421|NCT01506609|11700108|FG005|STARTED|Overall Study||94
10546422|NCT01506609|11700103|FG000|COMPLETED|Overall Study||0
10546423|NCT01506609|11700104|FG001|COMPLETED|Overall Study||0
10546424|NCT01506609|11700105|FG002|COMPLETED|Overall Study||0
10546425|NCT01506609|11700106|FG003|COMPLETED|Overall Study||0
10546426|NCT01506609|11700107|FG004|COMPLETED|Overall Study||1
10546427|NCT01506609|11700108|FG005|COMPLETED|Overall Study||0
10546428|NCT01506609|11700103|FG000|NOT COMPLETED|Overall Study||2
10546429|NCT01506609|11700104|FG001|NOT COMPLETED|Overall Study||1
10546430|NCT01506609|11700105|FG002|NOT COMPLETED|Overall Study||1
10546431|NCT01506609|11700106|FG003|NOT COMPLETED|Overall Study||99
10546432|NCT01506609|11700107|FG004|NOT COMPLETED|Overall Study||96
10546433|NCT01506609|11700108|FG005|NOT COMPLETED|Overall Study||94
10546434|NCT01506726|11700121|FG000|STARTED|Overall Study||6
10546435|NCT01506726|11700122|FG001|STARTED|Overall Study||5
10546436|NCT01506726|11700121|FG000|COMPLETED|Overall Study||5
10546437|NCT01506726|11700122|FG001|COMPLETED|Overall Study||3
10546438|NCT01506726|11700121|FG000|NOT COMPLETED|Overall Study||1
10546439|NCT01506726|11700122|FG001|NOT COMPLETED|Overall Study||2
10546440|NCT01506882|11700130|FG000|STARTED|Overall Study||61
10546441|NCT01506882|11700131|FG001|STARTED|Overall Study||10
10546442|NCT01506882|11700130|FG000|COMPLETED|Overall Study||39
10546443|NCT01506882|11700131|FG001|COMPLETED|Overall Study||3
10546444|NCT01506882|11700130|FG000|NOT COMPLETED|Overall Study||22
10546445|NCT01506882|11700131|FG001|NOT COMPLETED|Overall Study||7
10546446|NCT01506908|11700141|FG000|STARTED|Overall Study||162
10546447|NCT01506908|11700142|FG001|STARTED|Overall Study||161
10546448|NCT01506908|11700141|FG000|COMPLETED|Overall Study||161
10546449|NCT01506908|11700142|FG001|COMPLETED|Overall Study||161
10546450|NCT01506908|11700141|FG000|NOT COMPLETED|Overall Study||1
10546451|NCT01506908|11700142|FG001|NOT COMPLETED|Overall Study||0
10546452|NCT01506947|11700150|FG000|STARTED|Overall Study||65
10546453|NCT01506947|11700150|FG000|COMPLETED|Overall Study||49
10546454|NCT01506947|11700150|FG000|NOT COMPLETED|Overall Study||16
10546455|NCT01506960|11700156|FG000|STARTED|Overall Study||64
10546456|NCT01506960|11700156|FG000|COMPLETED|Overall Study||17
10546457|NCT01506960|11700156|FG000|NOT COMPLETED|Overall Study||47
10546458|NCT01507051|11700166|FG000|STARTED|Overall Study||29
10546459|NCT01507051|11700167|FG001|STARTED|Overall Study||31
10546460|NCT01507051|11700168|FG002|STARTED|Overall Study||29
10546461|NCT01507051|11700169|FG003|STARTED|Overall Study||7
10546462|NCT01507051|11700166|FG000|Warfarin run-in Phase|Overall Study||28
10546463|NCT01507051|11700167|FG001|Warfarin run-in Phase|Overall Study||28
10546464|NCT01507051|11700168|FG002|Warfarin run-in Phase|Overall Study||0
10546465|NCT01507051|11700169|FG003|Warfarin run-in Phase|Overall Study|Safety Population: in RG4|7
10546466|NCT01507051|11700166|FG000|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG1 and in RG4 (RG = Reporting Group for Safety Data)|28
10546467|NCT01507051|11700167|FG001|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG2 and in RG4|28
10546468|NCT01507051|11700168|FG002|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG3|28
10546469|NCT01507051|11700169|FG003|Received Placebo or Rivaroxaban|Overall Study||0
10755919|NCT03073200|11919752|FG012|STARTED|Open-Label Maintenance Period||0
10755920|NCT03073200|11919753|FG013|STARTED|Open-Label Maintenance Period||0
10546470|NCT01507051|11700166|FG000|COMPLETED|Overall Study||27
10546471|NCT01507051|11700167|FG001|COMPLETED|Overall Study||28
10546472|NCT01507051|11700168|FG002|COMPLETED|Overall Study||28
10546473|NCT01507051|11700169|FG003|COMPLETED|Overall Study||0
10546474|NCT01507051|11700166|FG000|NOT COMPLETED|Overall Study||2
10546475|NCT01507051|11700167|FG001|NOT COMPLETED|Overall Study||3
10755921|NCT03073200|11919754|FG014|STARTED|Open-Label Maintenance Period||0
10755922|NCT03073200|11919740|FG000|COMPLETED|Open-Label Maintenance Period||0
10546476|NCT01507051|11700168|FG002|NOT COMPLETED|Overall Study||1
10546477|NCT01507051|11700169|FG003|NOT COMPLETED|Overall Study||7
10546478|NCT01507090|11700179|FG000|STARTED|Overall Study||642
10546479|NCT01507090|11700179|FG000|COMPLETED|Overall Study||624
10546480|NCT01507090|11700179|FG000|NOT COMPLETED|Overall Study||18
10546481|NCT01507103|11700191|FG000|STARTED|Overall Study||41
10546482|NCT01507103|11700192|FG001|STARTED|Overall Study||41
10546483|NCT01507103|11700193|FG002|STARTED|Overall Study||42
10546484|NCT01507103|11700191|FG000|COMPLETED|Overall Study||41
10546485|NCT01507103|11700192|FG001|COMPLETED|Overall Study||41
10546486|NCT01507103|11700193|FG002|COMPLETED|Overall Study||42
10546487|NCT01507103|11700191|FG000|NOT COMPLETED|Overall Study||0
10546488|NCT01507103|11700192|FG001|NOT COMPLETED|Overall Study||0
10546489|NCT01507103|11700193|FG002|NOT COMPLETED|Overall Study||0
10546490|NCT01507155|11700201|FG000|STARTED|Overall Study||625
10546491|NCT01507155|11700202|FG001|STARTED|Overall Study||60
10546492|NCT01507155|11700201|FG000|COMPLETED|Overall Study||625
10546493|NCT01507155|11700202|FG001|COMPLETED|Overall Study||60
10546494|NCT01507155|11700201|FG000|NOT COMPLETED|Overall Study||0
10546495|NCT01507155|11700202|FG001|NOT COMPLETED|Overall Study||0
10546496|NCT01507181|11700209|FG000|STARTED|Overall Study||12
10546497|NCT01507181|11700210|FG001|STARTED|Overall Study||12
10546498|NCT01507181|11700209|FG000|COMPLETED|Overall Study||12
10546499|NCT01507181|11700210|FG001|COMPLETED|Overall Study||12
10546500|NCT01507181|11700209|FG000|NOT COMPLETED|Overall Study||0
10546501|NCT01507181|11700210|FG001|NOT COMPLETED|Overall Study||0
10546502|NCT01507220|11700218|FG000|STARTED|Overall Study||2
10546503|NCT01507220|11700219|FG001|STARTED|Overall Study||0
10546504|NCT01507220|11700218|FG000|COMPLETED|Overall Study||2
10546505|NCT01507220|11700219|FG001|COMPLETED|Overall Study||0
10546506|NCT01507220|11700218|FG000|NOT COMPLETED|Overall Study||0
10546507|NCT01507220|11700219|FG001|NOT COMPLETED|Overall Study||0
10546508|NCT01507246|11700227|FG000|STARTED|Overall Study||20
10546509|NCT01507246|11700228|FG001|STARTED|Overall Study||22
10546510|NCT01507246|11700227|FG000|COMPLETED|Overall Study||18
10546511|NCT01507246|11700228|FG001|COMPLETED|Overall Study||21
10546512|NCT01507246|11700227|FG000|NOT COMPLETED|Overall Study||2
10546513|NCT01507246|11700228|FG001|NOT COMPLETED|Overall Study||1
10546514|NCT01507298|11700239|FG000|STARTED|Overall Study||1
10546515|NCT01507298|11700240|FG001|STARTED|Overall Study||20
10546516|NCT01507298|11700239|FG000|COMPLETED|Overall Study||1
10546517|NCT01507298|11700240|FG001|COMPLETED|Overall Study||14
10546518|NCT01507298|11700239|FG000|NOT COMPLETED|Overall Study||0
10546519|NCT01507298|11700240|FG001|NOT COMPLETED|Overall Study||6
10546520|NCT01507350|11700247|FG000|STARTED|Overall Study||9
10546521|NCT01507350|11700247|FG000|COMPLETED|Overall Study||9
10546522|NCT01507350|11700247|FG000|NOT COMPLETED|Overall Study||0
10546523|NCT01507493|11700253|FG000|STARTED|Overall Study||22
10546524|NCT01507493|11700254|FG001|STARTED|Overall Study||178
10546525|NCT01507493|11700253|FG000|COMPLETED|Overall Study||22
10546526|NCT01507493|11700254|FG001|COMPLETED|Overall Study||178
10546527|NCT01507493|11700253|FG000|NOT COMPLETED|Overall Study||0
10546528|NCT01507493|11700254|FG001|NOT COMPLETED|Overall Study||0
10546529|NCT01507662|11700262|FG000|STARTED|Overall Study||3898
10546530|NCT01507662|11700263|FG001|STARTED|Overall Study||3851
10546531|NCT01507662|11700262|FG000|COMPLETED|Overall Study||3082
10546532|NCT01507662|11700263|FG001|COMPLETED|Overall Study||3020
10546533|NCT01507662|11700262|FG000|NOT COMPLETED|Overall Study||816
10546534|NCT01507662|11700263|FG001|NOT COMPLETED|Overall Study||831
10546535|NCT01507688|11700271|FG000|STARTED|Baseline to 6 Month Assessment||129
10546536|NCT01507688|11700272|FG001|STARTED|Baseline to 6 Month Assessment||129
10546537|NCT01507688|11700271|FG000|COMPLETED|Baseline to 6 Month Assessment||113
10546538|NCT01507688|11700272|FG001|COMPLETED|Baseline to 6 Month Assessment||119
10546539|NCT01507688|11700271|FG000|NOT COMPLETED|Baseline to 6 Month Assessment||16
10546540|NCT01507688|11700272|FG001|NOT COMPLETED|Baseline to 6 Month Assessment||10
10546541|NCT01507688|11700271|FG000|STARTED|6 Month to 12 Month Assessment||113
10546542|NCT01507688|11700272|FG001|STARTED|6 Month to 12 Month Assessment||119
10546543|NCT01507688|11700271|FG000|COMPLETED|6 Month to 12 Month Assessment||108
10546544|NCT01507688|11700272|FG001|COMPLETED|6 Month to 12 Month Assessment||116
10546545|NCT01507688|11700271|FG000|NOT COMPLETED|6 Month to 12 Month Assessment||5
10546546|NCT01507688|11700272|FG001|NOT COMPLETED|6 Month to 12 Month Assessment||3
10546547|NCT01507779|11700280|FG000|STARTED|Overall Study||23
10546548|NCT01507779|11700281|FG001|STARTED|Overall Study||25
10546549|NCT01507779|11700280|FG000|COMPLETED|Overall Study||23
10546550|NCT01507779|11700281|FG001|COMPLETED|Overall Study||25
10546551|NCT01507779|11700280|FG000|NOT COMPLETED|Overall Study||0
10546552|NCT01507779|11700281|FG001|NOT COMPLETED|Overall Study||0
10546553|NCT01507831|11700291|FG000|STARTED|Overall Study|Randomized|788
10546554|NCT01507831|11700292|FG001|STARTED|Overall Study|Randomized|1553
10546555|NCT01507831|11700291|FG000|Treated|Overall Study||788
10546556|NCT01507831|11700292|FG001|Treated|Overall Study||1550
10546557|NCT01507831|11700291|FG000|COMPLETED|Overall Study||595
10546558|NCT01507831|11700292|FG001|COMPLETED|Overall Study||1113
10546559|NCT01507831|11700291|FG000|NOT COMPLETED|Overall Study||193
10546560|NCT01507831|11700292|FG001|NOT COMPLETED|Overall Study||440
10546561|NCT01507896|11700298|FG000|STARTED|Overall Study|30 unique participants had 40 surgeries planned (participants could have multiple surgeries).|30
10546562|NCT01507896|11700298|FG000|COMPLETED|Overall Study|28 unique participants had 38 surgeries (participants could have multiple surgeries).|28
10546563|NCT01507896|11700298|FG000|NOT COMPLETED|Overall Study||2
10546564|NCT01507987|11700311|FG000|STARTED|Overall Study||982
10546565|NCT01507987|11700312|FG001|STARTED|Overall Study||670
10546566|NCT01507987|11700313|FG002|STARTED|Overall Study||458
10546567|NCT01507987|11700314|FG003|STARTED|Overall Study||737
10546568|NCT01507987|11700311|FG000|COMPLETED|Overall Study||618
10546569|NCT01507987|11700312|FG001|COMPLETED|Overall Study||335
10546570|NCT01507987|11700313|FG002|COMPLETED|Overall Study||252
10546571|NCT01507987|11700314|FG003|COMPLETED|Overall Study||480
10546572|NCT01507987|11700311|FG000|NOT COMPLETED|Overall Study||364
10546573|NCT01507987|11700312|FG001|NOT COMPLETED|Overall Study||335
10546574|NCT01507987|11700313|FG002|NOT COMPLETED|Overall Study||206
10546575|NCT01507987|11700314|FG003|NOT COMPLETED|Overall Study||257
10546576|NCT01508013|11700343|FG000|STARTED|Overall Study||214
10546577|NCT01508013|11700344|FG001|STARTED|Overall Study||229
10546578|NCT01508013|11700343|FG000|COMPLETED|Overall Study||182
10546579|NCT01508013|11700344|FG001|COMPLETED|Overall Study||206
10546580|NCT01508013|11700343|FG000|NOT COMPLETED|Overall Study||32
10546581|NCT01508013|11700344|FG001|NOT COMPLETED|Overall Study||23
10546582|NCT01508052|11700352|FG000|STARTED|Overall Study||20
10546583|NCT01508052|11700353|FG001|STARTED|Overall Study||20
10546584|NCT01508052|11700352|FG000|COMPLETED|Overall Study||20
10546585|NCT01508052|11700353|FG001|COMPLETED|Overall Study||20
10546586|NCT01508052|11700352|FG000|NOT COMPLETED|Overall Study||0
10546587|NCT01508052|11700353|FG001|NOT COMPLETED|Overall Study||0
10546588|NCT01508117|11700359|FG000|STARTED|Overall Study||1
10546589|NCT01508117|11700359|FG000|COMPLETED|Overall Study||1
10546590|NCT01508117|11700359|FG000|NOT COMPLETED|Overall Study||0
10546591|NCT01508130|11700365|FG000|STARTED|Overall Study||493
10546592|NCT01508130|11700366|FG001|STARTED|Overall Study||142
10546593|NCT01508130|11700365|FG000|mTRT|Overall Study||493
10546594|NCT01508130|11700366|FG001|mTRT|Overall Study||142
10546595|NCT01508130|11700365|FG000|COMPLETED|Overall Study||266
10546596|NCT01508130|11700366|FG001|COMPLETED|Overall Study||73
10546597|NCT01508130|11700365|FG000|NOT COMPLETED|Overall Study||227
10546598|NCT01508130|11700366|FG001|NOT COMPLETED|Overall Study||69
10546599|NCT01508169|11700376|FG000|STARTED|Overall Study||47
10546600|NCT01508169|11700377|FG001|STARTED|Overall Study||47
10546601|NCT01508169|11700376|FG000|COMPLETED|Overall Study||44
10546602|NCT01508169|11700377|FG001|COMPLETED|Overall Study||45
10546603|NCT01508169|11700376|FG000|NOT COMPLETED|Overall Study||3
10546604|NCT01508169|11700377|FG001|NOT COMPLETED|Overall Study||2
10546605|NCT01508325|11700391|FG000|STARTED|Overall Study||93
10546606|NCT01508325|11700392|FG001|STARTED|Overall Study||93
10546607|NCT01508325|11700391|FG000|COMPLETED|Overall Study||75
10546608|NCT01508325|11700392|FG001|COMPLETED|Overall Study||72
10755923|NCT03073200|11919741|FG001|COMPLETED|Open-Label Maintenance Period||0
10755924|NCT03073200|11919742|FG002|COMPLETED|Open-Label Maintenance Period||0
10755925|NCT03073200|11919743|FG003|COMPLETED|Open-Label Maintenance Period||49
10755926|NCT03073200|11919744|FG004|COMPLETED|Open-Label Maintenance Period||109
10755927|NCT03073200|11919745|FG005|COMPLETED|Open-Label Maintenance Period||28
10755928|NCT03073200|11919746|FG006|COMPLETED|Open-Label Maintenance Period||0
10755929|NCT03073200|11919747|FG007|COMPLETED|Open-Label Maintenance Period||0
10755930|NCT03073200|11919748|FG008|COMPLETED|Open-Label Maintenance Period||0
10546609|NCT01508325|11700391|FG000|NOT COMPLETED|Overall Study||18
10546610|NCT01508325|11700392|FG001|NOT COMPLETED|Overall Study||21
10546611|NCT01508455|11700398|FG000|STARTED|Overall Study||6
10546612|NCT01508455|11700398|FG000|COMPLETED|Overall Study||6
10546613|NCT01508455|11700398|FG000|NOT COMPLETED|Overall Study||0
10546614|NCT01508650|11700404|FG000|STARTED|Overall Study||12
10546615|NCT01508650|11700405|FG001|STARTED|Overall Study||15
10546616|NCT01508650|11700404|FG000|COMPLETED|Overall Study||12
10546617|NCT01508650|11700405|FG001|COMPLETED|Overall Study||12
10546618|NCT01508650|11700404|FG000|NOT COMPLETED|Overall Study||0
10661345|NCT02258477|11823232|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
10661346|NCT02258477|11823233|FG002|NOT COMPLETED|Second Intervention (1 Week)||1
10661347|NCT02258477|11823234|FG003|NOT COMPLETED|Second Intervention (1 Week)||1
10661348|NCT02258477|11823231|FG000|STARTED|Third Intervention (1 Week)||9
10661349|NCT02258477|11823232|FG001|STARTED|Third Intervention (1 Week)||8
10661350|NCT02258477|11823233|FG002|STARTED|Third Intervention (1 Week)||8
10661351|NCT02258477|11823234|FG003|STARTED|Third Intervention (1 Week)||8
10661352|NCT02258477|11823231|FG000|COMPLETED|Third Intervention (1 Week)||9
10661353|NCT02258477|11823232|FG001|COMPLETED|Third Intervention (1 Week)||8
10661354|NCT02258477|11823233|FG002|COMPLETED|Third Intervention (1 Week)||8
10661355|NCT02258477|11823234|FG003|COMPLETED|Third Intervention (1 Week)||8
10661356|NCT02258477|11823231|FG000|NOT COMPLETED|Third Intervention (1 Week)||0
10661357|NCT02258477|11823232|FG001|NOT COMPLETED|Third Intervention (1 Week)||0
10661358|NCT02258477|11823233|FG002|NOT COMPLETED|Third Intervention (1 Week)||0
10661359|NCT02258477|11823234|FG003|NOT COMPLETED|Third Intervention (1 Week)||0
10661360|NCT02258477|11823231|FG000|STARTED|Fourth Intervention (1 Week)||9
10661361|NCT02258477|11823232|FG001|STARTED|Fourth Intervention (1 Week)||8
10661362|NCT02258477|11823233|FG002|STARTED|Fourth Intervention (1 Week)||8
10661363|NCT02258477|11823234|FG003|STARTED|Fourth Intervention (1 Week)||8
10661364|NCT02258477|11823231|FG000|COMPLETED|Fourth Intervention (1 Week)||9
10661365|NCT02258477|11823232|FG001|COMPLETED|Fourth Intervention (1 Week)||8
10755931|NCT03073200|11919749|FG009|COMPLETED|Open-Label Maintenance Period||0
10755932|NCT03073200|11919750|FG010|COMPLETED|Open-Label Maintenance Period||0
10755933|NCT03073200|11919751|FG011|COMPLETED|Open-Label Maintenance Period||0
10755934|NCT03073200|11919752|FG012|COMPLETED|Open-Label Maintenance Period||0
10755935|NCT03073200|11919753|FG013|COMPLETED|Open-Label Maintenance Period||0
10546619|NCT01508650|11700405|FG001|NOT COMPLETED|Overall Study||3
10546620|NCT01508676|11700413|FG000|STARTED|Phase I (2 Weeks)||18
10546621|NCT01508676|11700414|FG001|STARTED|Phase I (2 Weeks)||17
10546622|NCT01508676|11700413|FG000|COMPLETED|Phase I (2 Weeks)||16
10546623|NCT01508676|11700414|FG001|COMPLETED|Phase I (2 Weeks)||14
10546624|NCT01508676|11700413|FG000|NOT COMPLETED|Phase I (2 Weeks)||2
10546625|NCT01508676|11700414|FG001|NOT COMPLETED|Phase I (2 Weeks)||3
10546626|NCT01508676|11700413|FG000|STARTED|Washout Period (1 Week)||16
10546627|NCT01508676|11700414|FG001|STARTED|Washout Period (1 Week)||14
10546628|NCT01508676|11700413|FG000|COMPLETED|Washout Period (1 Week)||16
10546629|NCT01508676|11700414|FG001|COMPLETED|Washout Period (1 Week)||14
10546630|NCT01508676|11700413|FG000|NOT COMPLETED|Washout Period (1 Week)||0
10546631|NCT01508676|11700414|FG001|NOT COMPLETED|Washout Period (1 Week)||0
10546632|NCT01508676|11700413|FG000|STARTED|Phase II (2 Weeks)||16
10546633|NCT01508676|11700414|FG001|STARTED|Phase II (2 Weeks)||14
10546634|NCT01508676|11700413|FG000|COMPLETED|Phase II (2 Weeks)||15
10546635|NCT01508676|11700414|FG001|COMPLETED|Phase II (2 Weeks)||13
10546636|NCT01508676|11700413|FG000|NOT COMPLETED|Phase II (2 Weeks)||1
10546637|NCT01508676|11700414|FG001|NOT COMPLETED|Phase II (2 Weeks)||1
10546638|NCT01508702|11700423|FG000|STARTED|Overall Study||107
10546639|NCT01508702|11700424|FG001|STARTED|Overall Study||107
10546640|NCT01508702|11700423|FG000|COMPLETED|Overall Study||84
10546641|NCT01508702|11700424|FG001|COMPLETED|Overall Study||94
10546642|NCT01508702|11700423|FG000|NOT COMPLETED|Overall Study||23
10546643|NCT01508702|11700424|FG001|NOT COMPLETED|Overall Study||13
10546644|NCT01508832|11700432|FG000|STARTED|Overall Study||6
10546645|NCT01508832|11700433|FG001|STARTED|Overall Study||6
10546646|NCT01508832|11700432|FG000|COMPLETED|Overall Study||6
10546647|NCT01508832|11700433|FG001|COMPLETED|Overall Study||6
10546648|NCT01508832|11700432|FG000|NOT COMPLETED|Overall Study||0
10546649|NCT01508832|11700433|FG001|NOT COMPLETED|Overall Study||0
10546650|NCT01508910|11700442|FG000|STARTED|Randomization||57
10546651|NCT01508910|11700443|FG001|STARTED|Randomization||27
10546652|NCT01508910|11700444|FG002|STARTED|Randomization||28
10546653|NCT01508910|11700445|FG003|STARTED|Randomization|Participants not randomized into Not Injected arm, but some were re-assigned here during treatment.|0
10546654|NCT01508910|11700442|FG000|COMPLETED|Randomization||57
10546655|NCT01508910|11700443|FG001|COMPLETED|Randomization||27
10546656|NCT01508910|11700444|FG002|COMPLETED|Randomization||28
10546657|NCT01508910|11700445|FG003|COMPLETED|Randomization||0
10546658|NCT01508910|11700442|FG000|NOT COMPLETED|Randomization||0
10546659|NCT01508910|11700443|FG001|NOT COMPLETED|Randomization||0
10546660|NCT01508910|11700444|FG002|NOT COMPLETED|Randomization||0
10546661|NCT01508910|11700445|FG003|NOT COMPLETED|Randomization||0
10546662|NCT01508910|11700442|FG000|STARTED|Treatment||50
10546663|NCT01508910|11700443|FG001|STARTED|Treatment||28
10546664|NCT01508910|11700444|FG002|STARTED|Treatment||28
10546665|NCT01508910|11700445|FG003|STARTED|Treatment|3 moved from Treatment (Tx) to Active Control (AC) Arm; 6 in Not injected Arm(4 from Tx ; 2 from AC)|6
10546666|NCT01508910|11700442|FG000|COMPLETED|Treatment||48
10546667|NCT01508910|11700443|FG001|COMPLETED|Treatment||24
10546668|NCT01508910|11700444|FG002|COMPLETED|Treatment||18
10546669|NCT01508910|11700445|FG003|COMPLETED|Treatment||3
10546670|NCT01508910|11700442|FG000|NOT COMPLETED|Treatment||2
10546671|NCT01508910|11700443|FG001|NOT COMPLETED|Treatment||4
10546672|NCT01508910|11700444|FG002|NOT COMPLETED|Treatment||10
10546673|NCT01508910|11700445|FG003|NOT COMPLETED|Treatment||3
10546674|NCT01508936|11700459|FG000|STARTED|Overall Study||102
10546675|NCT01508936|11700460|FG001|STARTED|Overall Study||409
10546676|NCT01508936|11700459|FG000|Randomized, Not Analyzed|Overall Study|Participants from two centers were omitted from all analyses.|4
10546677|NCT01508936|11700460|FG001|Randomized, Not Analyzed|Overall Study|Participants from two centers were omitted from all analyses.|11
10546678|NCT01508936|11700459|FG000|Randomized|Overall Study||98
10546679|NCT01508936|11700460|FG001|Randomized|Overall Study||398
10546680|NCT01508936|11700459|FG000|Randomized, Not Treated|Overall Study||1
10546681|NCT01508936|11700460|FG001|Randomized, Not Treated|Overall Study||3
10546682|NCT01508936|11700459|FG000|Safety Analysis Set|Overall Study||97
10546683|NCT01508936|11700460|FG001|Safety Analysis Set|Overall Study||395
10546684|NCT01508936|11700459|FG000|Full Analysis Set|Overall Study||97
10546685|NCT01508936|11700460|FG001|Full Analysis Set|Overall Study||395
10546686|NCT01508936|11700459|FG000|FEV1 Subpopulation Analysis Set|Overall Study||91
10546687|NCT01508936|11700460|FG001|FEV1 Subpopulation Analysis Set|Overall Study||346
10546688|NCT01508936|11700459|FG000|COMPLETED|Overall Study||79
10546689|NCT01508936|11700460|FG001|COMPLETED|Overall Study||330
10546690|NCT01508936|11700459|FG000|NOT COMPLETED|Overall Study||23
10546691|NCT01508936|11700460|FG001|NOT COMPLETED|Overall Study||79
10546692|NCT01509040|11700469|FG000|STARTED|Overall Study||0
10546693|NCT01509040|11700470|FG001|STARTED|Overall Study||2
10546694|NCT01509040|11700471|FG002|STARTED|Overall Study||0
10546695|NCT01509040|11700469|FG000|COMPLETED|Overall Study||0
10546696|NCT01509040|11700470|FG001|COMPLETED|Overall Study||1
10546697|NCT01509040|11700471|FG002|COMPLETED|Overall Study||0
10546698|NCT01509040|11700469|FG000|NOT COMPLETED|Overall Study||0
10546699|NCT01509040|11700470|FG001|NOT COMPLETED|Overall Study||1
10546700|NCT01509040|11700471|FG002|NOT COMPLETED|Overall Study||0
10546701|NCT01509079|11700488|FG000|STARTED|Overall Study||57
10546702|NCT01509079|11700489|FG001|STARTED|Overall Study||59
10546703|NCT01509079|11700488|FG000|COMPLETED|Overall Study||57
10546704|NCT01509079|11700489|FG001|COMPLETED|Overall Study||56
10546705|NCT01509079|11700488|FG000|NOT COMPLETED|Overall Study||0
10546706|NCT01509079|11700489|FG001|NOT COMPLETED|Overall Study||3
10546707|NCT01509105|11700495|FG000|STARTED|Overall Study||649
10546708|NCT01509105|11700495|FG000|COMPLETED|Overall Study||649
10546709|NCT01509105|11700495|FG000|NOT COMPLETED|Overall Study||0
10546710|NCT01509183|11700501|FG000|STARTED|Overall Study||250
10546711|NCT01509183|11700502|FG001|STARTED|Overall Study||245
10546712|NCT01509183|11700501|FG000|COMPLETED|Overall Study||141
10546713|NCT01509183|11700502|FG001|COMPLETED|Overall Study||134
10546714|NCT01509183|11700501|FG000|NOT COMPLETED|Overall Study||109
10546715|NCT01509183|11700502|FG001|NOT COMPLETED|Overall Study||111
10546716|NCT01509404|11700512|FG000|STARTED|Overall Study||20
10546717|NCT01509404|11700513|FG001|STARTED|Overall Study||20
10546718|NCT01509404|11700512|FG000|COMPLETED|Overall Study||20
10546719|NCT01509404|11700513|FG001|COMPLETED|Overall Study||20
10546720|NCT01509404|11700512|FG000|NOT COMPLETED|Overall Study||0
10546721|NCT01509404|11700513|FG001|NOT COMPLETED|Overall Study||0
10546722|NCT01509547|11700521|FG000|STARTED|Overall Study||77
10546723|NCT01509547|11700522|FG001|STARTED|Overall Study||80
10546724|NCT01509547|11700521|FG000|COMPLETED|Overall Study||42
10546725|NCT01509547|11700522|FG001|COMPLETED|Overall Study||41
10546726|NCT01509547|11700521|FG000|NOT COMPLETED|Overall Study||35
10546727|NCT01509547|11700522|FG001|NOT COMPLETED|Overall Study||39
10546728|NCT01509586|11700530|FG000|STARTED|Overall Study|Week 0|626
10546729|NCT01509586|11700531|FG001|STARTED|Overall Study|Week 0|610
10546730|NCT01509586|11700530|FG000|Week 3|Overall Study||574
10546731|NCT01509586|11700531|FG001|Week 3|Overall Study||585
10546732|NCT01509586|11700530|FG000|Week 6|Overall Study||551
10546733|NCT01509586|11700531|FG001|Week 6|Overall Study||585
10546734|NCT01509586|11700530|FG000|Week 10|Overall Study||537
10546735|NCT01509586|11700531|FG001|Week 10|Overall Study||574
10546736|NCT01509586|11700530|FG000|Week 14|Overall Study||528
10546737|NCT01509586|11700531|FG001|Week 14|Overall Study||566
10546738|NCT01509586|11700530|FG000|Week18|Overall Study||529
10546739|NCT01509586|11700531|FG001|Week18|Overall Study||555
10546740|NCT01509586|11700530|FG000|Week 32 (Month 6)|Overall Study||504
10546741|NCT01509586|11700531|FG001|Week 32 (Month 6)|Overall Study||523
10546742|NCT01509586|11700530|FG000|Week 46|Overall Study||483
10546743|NCT01509586|11700531|FG001|Week 46|Overall Study||494
10546744|NCT01509586|11700530|FG000|Week 58 (Month 12)|Overall Study||492
10755936|NCT03073200|11919754|FG014|COMPLETED|Open-Label Maintenance Period||0
10755937|NCT03073200|11919740|FG000|NOT COMPLETED|Open-Label Maintenance Period||0
10755938|NCT03073200|11919741|FG001|NOT COMPLETED|Open-Label Maintenance Period||0
10755939|NCT03073200|11919742|FG002|NOT COMPLETED|Open-Label Maintenance Period||0
10874550|NCT04927858|12040653|FG000|STARTED|Overall Study||460558
10546745|NCT01509586|11700531|FG001|Week 58 (Month 12)|Overall Study||499
10546746|NCT01509586|11700530|FG000|COMPLETED|Overall Study|final intent to treat sample|626
10546747|NCT01509586|11700531|FG001|COMPLETED|Overall Study|final intent to treat sample|610
10546748|NCT01509586|11700530|FG000|NOT COMPLETED|Overall Study||0
10546749|NCT01509586|11700531|FG001|NOT COMPLETED|Overall Study||0
10661366|NCT02258477|11823233|FG002|COMPLETED|Fourth Intervention (1 Week)||8
10661367|NCT02258477|11823234|FG003|COMPLETED|Fourth Intervention (1 Week)||8
10661368|NCT02258477|11823231|FG000|NOT COMPLETED|Fourth Intervention (1 Week)||0
10661369|NCT02258477|11823232|FG001|NOT COMPLETED|Fourth Intervention (1 Week)||0
10661370|NCT02258477|11823233|FG002|NOT COMPLETED|Fourth Intervention (1 Week)||0
10661371|NCT02258477|11823234|FG003|NOT COMPLETED|Fourth Intervention (1 Week)||0
10661372|NCT02258529|11823243|FG000|STARTED|Overall Study||10
10661373|NCT02258529|11823243|FG000|COMPLETED|Overall Study||0
10661374|NCT02258529|11823243|FG000|NOT COMPLETED|Overall Study||10
10661375|NCT02259010|11823247|FG000|STARTED|Overall Study||24
10661376|NCT02259010|11823247|FG000|COMPLETED|Overall Study|Completed=Completed protocol-specified dosing and PK assessment.|19
10661377|NCT02259010|11823247|FG000|NOT COMPLETED|Overall Study||5
10661378|NCT02259088|11823255|FG000|STARTED|Overall Study||307
10661379|NCT02259088|11823256|FG001|STARTED|Overall Study||77
10661380|NCT02259088|11823255|FG000|Full Analysis Set|Overall Study||307
10661381|NCT02259088|11823256|FG001|Full Analysis Set|Overall Study||77
10661382|NCT02259088|11823255|FG000|Treated (Safety Analysis Set)|Overall Study||307
10661383|NCT02259088|11823256|FG001|Treated (Safety Analysis Set)|Overall Study||75
10661384|NCT02259088|11823255|FG000|COMPLETED|Overall Study||279
10661385|NCT02259088|11823256|FG001|COMPLETED|Overall Study||63
10661386|NCT02259088|11823255|FG000|NOT COMPLETED|Overall Study||28
10661387|NCT02259088|11823256|FG001|NOT COMPLETED|Overall Study||14
10661388|NCT02259114|11823267|FG000|STARTED|Overall Study||21
10661389|NCT02259114|11823268|FG001|STARTED|Overall Study||4
10661390|NCT02259114|11823269|FG002|STARTED|Overall Study||13
10661391|NCT02259114|11823270|FG003|STARTED|Overall Study||3
10661392|NCT02259114|11823271|FG004|STARTED|Overall Study||6
10661393|NCT02259114|11823267|FG000|Treated|Overall Study|One participant was randomized but did not receive treatment due to a protocol violation.|20
10661394|NCT02259114|11823268|FG001|Treated|Overall Study||4
10755940|NCT03073200|11919743|FG003|NOT COMPLETED|Open-Label Maintenance Period||4
10755941|NCT03073200|11919744|FG004|NOT COMPLETED|Open-Label Maintenance Period||4
10755942|NCT03073200|11919745|FG005|NOT COMPLETED|Open-Label Maintenance Period||0
10546750|NCT01509612|11700540|FG000|STARTED|Overall Study||47
10546751|NCT01509612|11700541|FG001|STARTED|Overall Study||51
10546752|NCT01509612|11700542|FG002|STARTED|Overall Study||52
10546753|NCT01509612|11700540|FG000|COMPLETED|Overall Study||47
10546754|NCT01509612|11700541|FG001|COMPLETED|Overall Study||51
10546755|NCT01509612|11700542|FG002|COMPLETED|Overall Study||52
10546756|NCT01509612|11700540|FG000|NOT COMPLETED|Overall Study||0
10546757|NCT01509612|11700541|FG001|NOT COMPLETED|Overall Study||0
10546758|NCT01509612|11700542|FG002|NOT COMPLETED|Overall Study||0
10546759|NCT01509625|11700553|FG000|STARTED|Overall Study||272
10546760|NCT01509625|11700553|FG000|COMPLETED|Overall Study||263
10661395|NCT02259114|11823269|FG002|Treated|Overall Study||13
10661396|NCT02259114|11823270|FG003|Treated|Overall Study||3
10661397|NCT02259114|11823271|FG004|Treated|Overall Study||6
10661398|NCT02259114|11823267|FG000|COMPLETED|Overall Study||0
10661399|NCT02259114|11823268|FG001|COMPLETED|Overall Study||0
10661400|NCT02259114|11823269|FG002|COMPLETED|Overall Study||0
10661401|NCT02259114|11823270|FG003|COMPLETED|Overall Study||0
10661402|NCT02259114|11823271|FG004|COMPLETED|Overall Study||0
10661403|NCT02259114|11823267|FG000|NOT COMPLETED|Overall Study||21
10661404|NCT02259114|11823268|FG001|NOT COMPLETED|Overall Study||4
10661405|NCT02259114|11823269|FG002|NOT COMPLETED|Overall Study||13
10661406|NCT02259114|11823270|FG003|NOT COMPLETED|Overall Study||3
10661407|NCT02259114|11823271|FG004|NOT COMPLETED|Overall Study||6
10661408|NCT02259231|11823290|FG000|STARTED|Overall Study||6
10661409|NCT02259231|11823291|FG001|STARTED|Overall Study||6
10661410|NCT02259231|11823292|FG002|STARTED|Overall Study||6
10661411|NCT02259231|11823293|FG003|STARTED|Overall Study||6
10661412|NCT02259231|11823294|FG004|STARTED|Overall Study||6
10661413|NCT02259231|11823295|FG005|STARTED|Overall Study||6
10661414|NCT02259231|11823296|FG006|STARTED|Overall Study||5
10661415|NCT02259231|11823290|FG000|COMPLETED|Overall Study||0
10661416|NCT02259231|11823291|FG001|COMPLETED|Overall Study||0
10661417|NCT02259231|11823292|FG002|COMPLETED|Overall Study||0
10661418|NCT02259231|11823293|FG003|COMPLETED|Overall Study||0
10661419|NCT02259231|11823294|FG004|COMPLETED|Overall Study||0
10661420|NCT02259231|11823295|FG005|COMPLETED|Overall Study||0
10661421|NCT02259231|11823296|FG006|COMPLETED|Overall Study||0
10661422|NCT02259231|11823290|FG000|NOT COMPLETED|Overall Study||6
10661423|NCT02259231|11823291|FG001|NOT COMPLETED|Overall Study||6
10661424|NCT02259231|11823292|FG002|NOT COMPLETED|Overall Study||6
10661425|NCT02259231|11823293|FG003|NOT COMPLETED|Overall Study||6
10661426|NCT02259231|11823294|FG004|NOT COMPLETED|Overall Study||6
10661427|NCT02259231|11823295|FG005|NOT COMPLETED|Overall Study||6
10661428|NCT02259231|11823296|FG006|NOT COMPLETED|Overall Study||5
10661429|NCT02259348|11823312|FG000|STARTED|Overall Study||12
10661430|NCT02259348|11823312|FG000|One Year Post-transplant|Overall Study||2
10661431|NCT02259348|11823312|FG000|COMPLETED|Overall Study||2
10661432|NCT02259348|11823312|FG000|NOT COMPLETED|Overall Study||10
10661433|NCT02259400|11823318|FG000|STARTED|Overall Study||62
10661434|NCT02259400|11823319|FG001|STARTED|Overall Study||62
10661435|NCT02259400|11823318|FG000|COMPLETED|Overall Study||62
10661436|NCT02259400|11823319|FG001|COMPLETED|Overall Study||60
10661437|NCT02259400|11823318|FG000|NOT COMPLETED|Overall Study||0
10661438|NCT02259400|11823319|FG001|NOT COMPLETED|Overall Study||2
10661439|NCT02259582|11823328|FG000|STARTED|Overall Study||25
10661440|NCT02259582|11823329|FG001|STARTED|Overall Study||28
10661441|NCT02259582|11823330|FG002|STARTED|Overall Study||29
10661442|NCT02259582|11823328|FG000|COMPLETED|Overall Study||9
10661443|NCT02259582|11823329|FG001|COMPLETED|Overall Study||11
10661444|NCT02259582|11823330|FG002|COMPLETED|Overall Study||8
10661445|NCT02259582|11823328|FG000|NOT COMPLETED|Overall Study||16
10661446|NCT02259582|11823329|FG001|NOT COMPLETED|Overall Study||17
10661447|NCT02259582|11823330|FG002|NOT COMPLETED|Overall Study||21
10661448|NCT02259608|11823338|FG000|STARTED|Overall Study||15
10661449|NCT02259608|11823338|FG000|COMPLETED|Overall Study||15
10661450|NCT02259608|11823338|FG000|NOT COMPLETED|Overall Study||0
10661451|NCT02259699|11823344|FG000|STARTED|Overall Study||64
10661452|NCT02259699|11823345|FG001|STARTED|Overall Study||60
10661453|NCT02259699|11823344|FG000|COMPLETED|Overall Study||37
10661454|NCT02259699|11823345|FG001|COMPLETED|Overall Study||40
10661455|NCT02259699|11823344|FG000|NOT COMPLETED|Overall Study||27
10661456|NCT02259699|11823345|FG001|NOT COMPLETED|Overall Study||20
10661457|NCT02260154|11823351|FG000|STARTED|Overall Study||220
10661458|NCT02260154|11823351|FG000|COMPLETED|Overall Study||218
10661459|NCT02260154|11823351|FG000|NOT COMPLETED|Overall Study||2
10661460|NCT02260180|11823359|FG000|STARTED|Overall Study||39
10661461|NCT02260180|11823360|FG001|STARTED|Overall Study||39
10661462|NCT02260180|11823361|FG002|STARTED|Overall Study||41
10661463|NCT02260180|11823359|FG000|COMPLETED|Overall Study||37
10661464|NCT02260180|11823360|FG001|COMPLETED|Overall Study||39
10661465|NCT02260180|11823361|FG002|COMPLETED|Overall Study||40
10661466|NCT02260180|11823359|FG000|NOT COMPLETED|Overall Study||2
10661467|NCT02260180|11823360|FG001|NOT COMPLETED|Overall Study||0
10546761|NCT01509625|11700553|FG000|NOT COMPLETED|Overall Study||9
10546762|NCT01509638|11700568|FG000|STARTED|Overall Study||23
10546763|NCT01509638|11700569|FG001|STARTED|Overall Study||26
10546764|NCT01509638|11700568|FG000|COMPLETED|Overall Study||20
10546765|NCT01509638|11700569|FG001|COMPLETED|Overall Study||24
10661468|NCT02260180|11823361|FG002|NOT COMPLETED|Overall Study||1
10661469|NCT02260258|11823371|FG000|STARTED|Overall Study||39
10546766|NCT01509638|11700568|FG000|NOT COMPLETED|Overall Study||3
10546767|NCT01509638|11700569|FG001|NOT COMPLETED|Overall Study||2
10661470|NCT02260258|11823372|FG001|STARTED|Overall Study||44
10661471|NCT02260258|11823371|FG000|COMPLETED|Overall Study||37
10661472|NCT02260258|11823372|FG001|COMPLETED|Overall Study||43
10546768|NCT01509664|11700577|FG000|STARTED|Overall Study||49
10546769|NCT01509664|11700578|FG001|STARTED|Overall Study||49
10546770|NCT01509664|11700577|FG000|T2 Follow-up|Overall Study||45
10546771|NCT01509664|11700578|FG001|T2 Follow-up|Overall Study||38
10546772|NCT01509664|11700577|FG000|T3 Follow-up|Overall Study||40
10546773|NCT01509664|11700578|FG001|T3 Follow-up|Overall Study||33
10546774|NCT01509664|11700577|FG000|COMPLETED|Overall Study||34
10546775|NCT01509664|11700578|FG001|COMPLETED|Overall Study||28
10546776|NCT01509664|11700577|FG000|NOT COMPLETED|Overall Study||15
10546777|NCT01509664|11700578|FG001|NOT COMPLETED|Overall Study||21
10546778|NCT01509677|11700586|FG000|STARTED|Overall Study||79
10546779|NCT01509677|11700587|FG001|STARTED|Overall Study||79
10546780|NCT01509677|11700586|FG000|COMPLETED|Overall Study||76
10546781|NCT01509677|11700587|FG001|COMPLETED|Overall Study||73
10546782|NCT01509677|11700586|FG000|NOT COMPLETED|Overall Study||3
10546783|NCT01509677|11700587|FG001|NOT COMPLETED|Overall Study||6
10546784|NCT01509807|11700595|FG000|STARTED|Overall Study||16
10546785|NCT01509807|11700596|FG001|STARTED|Overall Study||17
10546786|NCT01509807|11700595|FG000|COMPLETED|Overall Study||15
10546787|NCT01509807|11700596|FG001|COMPLETED|Overall Study||16
10546788|NCT01509807|11700595|FG000|NOT COMPLETED|Overall Study||1
10546789|NCT01509807|11700596|FG001|NOT COMPLETED|Overall Study||1
10546790|NCT01509846|11700607|FG000|STARTED|Received Vaccination 1||5
10546791|NCT01509846|11700608|FG001|STARTED|Received Vaccination 1||20
10546792|NCT01509846|11700609|FG002|STARTED|Received Vaccination 1||20
10546793|NCT01509846|11700610|FG003|STARTED|Received Vaccination 1||20
10546794|NCT01509846|11700611|FG004|STARTED|Received Vaccination 1||17
10546795|NCT01509846|11700607|FG000|COMPLETED|Received Vaccination 1||5
10546796|NCT01509846|11700608|FG001|COMPLETED|Received Vaccination 1||20
10546797|NCT01509846|11700609|FG002|COMPLETED|Received Vaccination 1||20
10546798|NCT01509846|11700610|FG003|COMPLETED|Received Vaccination 1||20
10546799|NCT01509846|11700611|FG004|COMPLETED|Received Vaccination 1||17
10546800|NCT01509846|11700607|FG000|NOT COMPLETED|Received Vaccination 1||0
10546801|NCT01509846|11700608|FG001|NOT COMPLETED|Received Vaccination 1||0
10546802|NCT01509846|11700609|FG002|NOT COMPLETED|Received Vaccination 1||0
10546803|NCT01509846|11700610|FG003|NOT COMPLETED|Received Vaccination 1||0
10546804|NCT01509846|11700611|FG004|NOT COMPLETED|Received Vaccination 1||0
10546805|NCT01509846|11700607|FG000|STARTED|Received Vaccination 2||5
10546806|NCT01509846|11700608|FG001|STARTED|Received Vaccination 2||20
10546807|NCT01509846|11700609|FG002|STARTED|Received Vaccination 2||20
10546808|NCT01509846|11700610|FG003|STARTED|Received Vaccination 2||20
10661473|NCT02260258|11823371|FG000|NOT COMPLETED|Overall Study||2
10661474|NCT02260258|11823372|FG001|NOT COMPLETED|Overall Study||1
10661475|NCT02260388|11823383|FG000|STARTED|Overall Study||134
10661476|NCT02260388|11823384|FG001|STARTED|Overall Study||126
10661477|NCT02260388|11823385|FG002|STARTED|Overall Study||73
10661478|NCT02260388|11823386|FG003|STARTED|Overall Study||69
10661479|NCT02260388|11823383|FG000|COMPLETED|Overall Study||132
10661480|NCT02260388|11823384|FG001|COMPLETED|Overall Study||118
10661481|NCT02260388|11823385|FG002|COMPLETED|Overall Study||70
10661482|NCT02260388|11823386|FG003|COMPLETED|Overall Study||65
10661483|NCT02260388|11823383|FG000|NOT COMPLETED|Overall Study||2
10661484|NCT02260388|11823384|FG001|NOT COMPLETED|Overall Study||8
10661485|NCT02260388|11823385|FG002|NOT COMPLETED|Overall Study||3
10661486|NCT02260388|11823386|FG003|NOT COMPLETED|Overall Study||4
10661487|NCT02260401|11823398|FG000|STARTED|Overall Study||80
10661488|NCT02260401|11823399|FG001|STARTED|Overall Study||85
10661489|NCT02260401|11823398|FG000|COMPLETED|Overall Study||75
10661490|NCT02260401|11823399|FG001|COMPLETED|Overall Study||73
10661491|NCT02260401|11823398|FG000|NOT COMPLETED|Overall Study||5
10661492|NCT02260401|11823399|FG001|NOT COMPLETED|Overall Study||12
10661493|NCT02260440|11823405|FG000|STARTED|Overall Study||31
10661494|NCT02260440|11823405|FG000|COMPLETED|Overall Study||31
10661495|NCT02260440|11823405|FG000|NOT COMPLETED|Overall Study||0
10661496|NCT02260492|11823412|FG000|STARTED|Overall Study||418
10661497|NCT02260492|11823413|FG001|STARTED|Overall Study||419
10661498|NCT02260492|11823414|FG002|STARTED|Overall Study||42
10661499|NCT02260492|11823412|FG000|Completed Day 1|Overall Study||418
10661500|NCT02260492|11823413|FG001|Completed Day 1|Overall Study||419
10661501|NCT02260492|11823414|FG002|Completed Day 1|Overall Study||42
10661502|NCT02260492|11823412|FG000|COMPLETED|Overall Study||395
10661503|NCT02260492|11823413|FG001|COMPLETED|Overall Study||406
10661504|NCT02260492|11823414|FG002|COMPLETED|Overall Study||37
10546809|NCT01509846|11700611|FG004|STARTED|Received Vaccination 2||17
10546810|NCT01509846|11700607|FG000|COMPLETED|Received Vaccination 2||0
10546811|NCT01509846|11700608|FG001|COMPLETED|Received Vaccination 2||20
10661505|NCT02260492|11823412|FG000|NOT COMPLETED|Overall Study||23
10661506|NCT02260492|11823413|FG001|NOT COMPLETED|Overall Study||13
10661507|NCT02260492|11823414|FG002|NOT COMPLETED|Overall Study||5
10661508|NCT02260531|11823425|FG000|STARTED|Overall Study||21
10661509|NCT02260531|11823426|FG001|STARTED|Overall Study||7
10661510|NCT02260531|11823427|FG002|STARTED|Overall Study||8
10661511|NCT02260531|11823425|FG000|COMPLETED|Overall Study||21
10661512|NCT02260531|11823426|FG001|COMPLETED|Overall Study||7
10661513|NCT02260531|11823427|FG002|COMPLETED|Overall Study||8
10661514|NCT02260531|11823425|FG000|NOT COMPLETED|Overall Study||0
10661515|NCT02260531|11823426|FG001|NOT COMPLETED|Overall Study||0
10661516|NCT02260531|11823427|FG002|NOT COMPLETED|Overall Study||0
10661517|NCT02260622|11823444|FG000|STARTED|Overall Study||11
10661518|NCT02260622|11823445|FG001|STARTED|Overall Study||9
10661519|NCT02260622|11823444|FG000|COMPLETED|Overall Study||11
10546812|NCT01509846|11700609|FG002|COMPLETED|Received Vaccination 2||19
10546813|NCT01509846|11700610|FG003|COMPLETED|Received Vaccination 2||20
10546814|NCT01509846|11700611|FG004|COMPLETED|Received Vaccination 2||14
10546815|NCT01509846|11700607|FG000|NOT COMPLETED|Received Vaccination 2||5
10661520|NCT02260622|11823445|FG001|COMPLETED|Overall Study||9
10661521|NCT02260622|11823444|FG000|NOT COMPLETED|Overall Study||0
10661522|NCT02260622|11823445|FG001|NOT COMPLETED|Overall Study||0
10661523|NCT02260635|11823453|FG000|STARTED|Double-Blind Treatment Period||27
10661524|NCT02260635|11823454|FG001|STARTED|Double-Blind Treatment Period||27
10661525|NCT02260635|11823453|FG000|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||27
10661526|NCT02260635|11823454|FG001|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||26
10661527|NCT02260635|11823453|FG000|COMPLETED|Double-Blind Treatment Period||26
10661528|NCT02260635|11823454|FG001|COMPLETED|Double-Blind Treatment Period||25
10661529|NCT02260635|11823453|FG000|NOT COMPLETED|Double-Blind Treatment Period||1
10661530|NCT02260635|11823454|FG001|NOT COMPLETED|Double-Blind Treatment Period||2
10661531|NCT02260635|11823453|FG000|STARTED|Open-Label Extension||26
10661532|NCT02260635|11823454|FG001|STARTED|Open-Label Extension||25
10661533|NCT02260635|11823453|FG000|Received at Least One Dose of Study Drug|Open-Label Extension||26
10661534|NCT02260635|11823454|FG001|Received at Least One Dose of Study Drug|Open-Label Extension||25
10661535|NCT02260635|11823453|FG000|COMPLETED|Open-Label Extension||0
10661536|NCT02260635|11823454|FG001|COMPLETED|Open-Label Extension||0
10661537|NCT02260635|11823453|FG000|NOT COMPLETED|Open-Label Extension||26
10661538|NCT02260635|11823454|FG001|NOT COMPLETED|Open-Label Extension||25
10661539|NCT02260648|11823465|FG000|STARTED|Overall Study||53
10661540|NCT02260648|11823466|FG001|STARTED|Overall Study||46
10661541|NCT02260648|11823467|FG002|STARTED|Overall Study||50
10661542|NCT02260648|11823465|FG000|Received at Least One Dose of Study Drug|Overall Study||53
10661543|NCT02260648|11823466|FG001|Received at Least One Dose of Study Drug|Overall Study||46
10661544|NCT02260648|11823467|FG002|Received at Least One Dose of Study Drug|Overall Study||50
10661545|NCT02260648|11823465|FG000|COMPLETED|Overall Study||35
10661546|NCT02260648|11823466|FG001|COMPLETED|Overall Study||33
10661547|NCT02260648|11823467|FG002|COMPLETED|Overall Study||42
10661548|NCT02260648|11823465|FG000|NOT COMPLETED|Overall Study||18
10661549|NCT02260648|11823466|FG001|NOT COMPLETED|Overall Study||13
10661550|NCT02260648|11823467|FG002|NOT COMPLETED|Overall Study||8
10661551|NCT02260791|11823477|FG000|STARTED|Overall Study||366
10661552|NCT02260791|11823478|FG001|STARTED|Overall Study||362
10661553|NCT02260791|11823477|FG000|COMPLETED|Overall Study||333
10661554|NCT02260791|11823478|FG001|COMPLETED|Overall Study||328
10661555|NCT02260791|11823477|FG000|NOT COMPLETED|Overall Study||33
10661556|NCT02260791|11823478|FG001|NOT COMPLETED|Overall Study||34
10661557|NCT02260804|11823486|FG000|STARTED|Induction Study Period||130
10755943|NCT03073200|11919746|FG006|NOT COMPLETED|Open-Label Maintenance Period||0
10755944|NCT03073200|11919747|FG007|NOT COMPLETED|Open-Label Maintenance Period||0
10755945|NCT03073200|11919748|FG008|NOT COMPLETED|Open-Label Maintenance Period||0
10755946|NCT03073200|11919749|FG009|NOT COMPLETED|Open-Label Maintenance Period||0
10755947|NCT03073200|11919750|FG010|NOT COMPLETED|Open-Label Maintenance Period||0
10755948|NCT03073200|11919751|FG011|NOT COMPLETED|Open-Label Maintenance Period||0
10755949|NCT03073200|11919752|FG012|NOT COMPLETED|Open-Label Maintenance Period||0
10755950|NCT03073200|11919753|FG013|NOT COMPLETED|Open-Label Maintenance Period||0
10755951|NCT03073200|11919754|FG014|NOT COMPLETED|Open-Label Maintenance Period||0
10755952|NCT03073200|11919740|FG000|STARTED|Extension Period||0
10755953|NCT03073200|11919741|FG001|STARTED|Extension Period||0
10755954|NCT03073200|11919742|FG002|STARTED|Extension Period||0
10755955|NCT03073200|11919743|FG003|STARTED|Extension Period|This period is to report Extension Period participants.|0
10755956|NCT03073200|11919744|FG004|STARTED|Extension Period|This period is to report Extension Period participants.|0
10546816|NCT01509846|11700608|FG001|NOT COMPLETED|Received Vaccination 2||0
10546817|NCT01509846|11700609|FG002|NOT COMPLETED|Received Vaccination 2||1
10546818|NCT01509846|11700610|FG003|NOT COMPLETED|Received Vaccination 2||0
10546819|NCT01509846|11700611|FG004|NOT COMPLETED|Received Vaccination 2||3
10546820|NCT01509846|11700607|FG000|STARTED|Received Vaccination 3||0
10546821|NCT01509846|11700608|FG001|STARTED|Received Vaccination 3||20
10546822|NCT01509846|11700609|FG002|STARTED|Received Vaccination 3||19
10546823|NCT01509846|11700610|FG003|STARTED|Received Vaccination 3||20
10546824|NCT01509846|11700611|FG004|STARTED|Received Vaccination 3||14
10546825|NCT01509846|11700607|FG000|COMPLETED|Received Vaccination 3||0
10546826|NCT01509846|11700608|FG001|COMPLETED|Received Vaccination 3||19
10661558|NCT02260804|11823487|FG001|STARTED|Induction Study Period||128
10661559|NCT02260804|11823486|FG000|COMPLETED|Induction Study Period||128
10661560|NCT02260804|11823487|FG001|COMPLETED|Induction Study Period||128
10661561|NCT02260804|11823486|FG000|NOT COMPLETED|Induction Study Period||2
10661562|NCT02260804|11823487|FG001|NOT COMPLETED|Induction Study Period||0
10661563|NCT02260804|11823486|FG000|STARTED|1st Year of the Maintenance Period (MP1)|Five subjects completed the induction period but did not initiate this period in the CT-P10 group.|123
10661564|NCT02260804|11823487|FG001|STARTED|1st Year of the Maintenance Period (MP1)|Eight subjects completed the induction period but did not initiate this period in the Rituxan group.|120
10661565|NCT02260804|11823486|FG000|COMPLETED|1st Year of the Maintenance Period (MP1)||111
10661566|NCT02260804|11823487|FG001|COMPLETED|1st Year of the Maintenance Period (MP1)||105
10661567|NCT02260804|11823486|FG000|NOT COMPLETED|1st Year of the Maintenance Period (MP1)||12
10755957|NCT03073200|11919745|FG005|STARTED|Extension Period|This period is to report Extension Period participants.|0
10661568|NCT02260804|11823487|FG001|NOT COMPLETED|1st Year of the Maintenance Period (MP1)||15
10661569|NCT02260804|11823486|FG000|STARTED|2nd Year of the Maintenance Period (MP2)|One subject completed the MP1 but did not initiate this period in the CT-P10 group.|110
10661570|NCT02260804|11823487|FG001|STARTED|2nd Year of the Maintenance Period (MP2)|Two subjects completed the MP1 but did not initiate this period in the Rituxan group.|103
10755958|NCT03073200|11919746|FG006|STARTED|Extension Period|This period is to report Extension Period participants.|34
10755959|NCT03073200|11919747|FG007|STARTED|Extension Period|This period is to report Extension Period participants.|68
10755960|NCT03073200|11919748|FG008|STARTED|Extension Period|This period is to report Extension Period participants.|9
10755961|NCT03073200|11919749|FG009|STARTED|Extension Period||0
10755962|NCT03073200|11919750|FG010|STARTED|Extension Period||0
10755963|NCT03073200|11919751|FG011|STARTED|Extension Period||0
10755964|NCT03073200|11919752|FG012|STARTED|Extension Period||0
10755965|NCT03073200|11919753|FG013|STARTED|Extension Period||0
10755966|NCT03073200|11919754|FG014|STARTED|Extension Period||0
10755967|NCT03073200|11919740|FG000|COMPLETED|Extension Period||0
10755968|NCT03073200|11919741|FG001|COMPLETED|Extension Period||0
10755969|NCT03073200|11919742|FG002|COMPLETED|Extension Period||0
10755970|NCT03073200|11919743|FG003|COMPLETED|Extension Period||0
10755971|NCT03073200|11919744|FG004|COMPLETED|Extension Period||0
10755972|NCT03073200|11919745|FG005|COMPLETED|Extension Period||0
10755973|NCT03073200|11919746|FG006|COMPLETED|Extension Period||31
10755974|NCT03073200|11919747|FG007|COMPLETED|Extension Period||62
10755975|NCT03073200|11919748|FG008|COMPLETED|Extension Period||7
10755976|NCT03073200|11919749|FG009|COMPLETED|Extension Period||0
10755977|NCT03073200|11919750|FG010|COMPLETED|Extension Period||0
10755978|NCT03073200|11919751|FG011|COMPLETED|Extension Period||0
10755979|NCT03073200|11919752|FG012|COMPLETED|Extension Period||0
10755980|NCT03073200|11919753|FG013|COMPLETED|Extension Period||0
10755981|NCT03073200|11919754|FG014|COMPLETED|Extension Period||0
10755982|NCT03073200|11919740|FG000|NOT COMPLETED|Extension Period||0
10755983|NCT03073200|11919741|FG001|NOT COMPLETED|Extension Period||0
10755984|NCT03073200|11919742|FG002|NOT COMPLETED|Extension Period||0
10755985|NCT03073200|11919743|FG003|NOT COMPLETED|Extension Period||0
10755986|NCT03073200|11919744|FG004|NOT COMPLETED|Extension Period||0
10755987|NCT03073200|11919745|FG005|NOT COMPLETED|Extension Period||0
10755988|NCT03073200|11919746|FG006|NOT COMPLETED|Extension Period||3
10755989|NCT03073200|11919747|FG007|NOT COMPLETED|Extension Period||6
10755990|NCT03073200|11919748|FG008|NOT COMPLETED|Extension Period||2
10755991|NCT03073200|11919749|FG009|NOT COMPLETED|Extension Period||0
10755992|NCT03073200|11919750|FG010|NOT COMPLETED|Extension Period||0
10755993|NCT03073200|11919751|FG011|NOT COMPLETED|Extension Period||0
10755994|NCT03073200|11919752|FG012|NOT COMPLETED|Extension Period||0
10755995|NCT03073200|11919753|FG013|NOT COMPLETED|Extension Period||0
10755996|NCT03073200|11919754|FG014|NOT COMPLETED|Extension Period||0
10755997|NCT03073200|11919740|FG000|STARTED|Randomized Withdrawal Period||0
10755998|NCT03073200|11919741|FG001|STARTED|Randomized Withdrawal Period||0
10755999|NCT03073200|11919742|FG002|STARTED|Randomized Withdrawal Period||0
10756000|NCT03073200|11919743|FG003|STARTED|Randomized Withdrawal Period||0
10756001|NCT03073200|11919744|FG004|STARTED|Randomized Withdrawal Period||0
10756002|NCT03073200|11919745|FG005|STARTED|Randomized Withdrawal Period||0
10756003|NCT03073200|11919746|FG006|STARTED|Randomized Withdrawal Period|This period is to report randomized withdrawal period participants.|0
10756004|NCT03073200|11919747|FG007|STARTED|Randomized Withdrawal Period|This period is to report randomized withdrawal period participants.|0
10756005|NCT03073200|11919748|FG008|STARTED|Randomized Withdrawal Period|This period is to report randomized withdrawal period participants.|0
10756006|NCT03073200|11919749|FG009|STARTED|Randomized Withdrawal Period|This period is to report randomized withdrawal period participants.|33
10756007|NCT03073200|11919750|FG010|STARTED|Randomized Withdrawal Period|This period is to report randomized withdrawal period participants.|34
10756008|NCT03073200|11919751|FG011|STARTED|Randomized Withdrawal Period|This period is to report randomized withdrawal period participants.|33
10756009|NCT03073200|11919752|FG012|STARTED|Randomized Withdrawal Period||0
10756010|NCT03073200|11919753|FG013|STARTED|Randomized Withdrawal Period||0
10756011|NCT03073200|11919754|FG014|STARTED|Randomized Withdrawal Period||0
10756012|NCT03073200|11919740|FG000|COMPLETED|Randomized Withdrawal Period||0
10756013|NCT03073200|11919741|FG001|COMPLETED|Randomized Withdrawal Period||0
10756014|NCT03073200|11919742|FG002|COMPLETED|Randomized Withdrawal Period||0
10756015|NCT03073200|11919743|FG003|COMPLETED|Randomized Withdrawal Period||0
10756016|NCT03073200|11919744|FG004|COMPLETED|Randomized Withdrawal Period||0
10661571|NCT02260804|11823486|FG000|COMPLETED|2nd Year of the Maintenance Period (MP2)||101
10661572|NCT02260804|11823487|FG001|COMPLETED|2nd Year of the Maintenance Period (MP2)||97
10661573|NCT02260804|11823486|FG000|NOT COMPLETED|2nd Year of the Maintenance Period (MP2)||9
10661574|NCT02260804|11823487|FG001|NOT COMPLETED|2nd Year of the Maintenance Period (MP2)||6
10661575|NCT02260817|11823495|FG000|STARTED|Overall Study||14
10661576|NCT02260817|11823496|FG001|STARTED|Overall Study||95
10661577|NCT02260817|11823495|FG000|COMPLETED|Overall Study||14
10661578|NCT02260817|11823496|FG001|COMPLETED|Overall Study||58
10661579|NCT02260817|11823495|FG000|NOT COMPLETED|Overall Study||0
10661580|NCT02260817|11823496|FG001|NOT COMPLETED|Overall Study||37
10661581|NCT02260882|11823504|FG000|STARTED|Overall Study||161
10661582|NCT02260882|11823505|FG001|STARTED|Overall Study||82
10661583|NCT02260882|11823504|FG000|COMPLETED|Overall Study||161
10661584|NCT02260882|11823505|FG001|COMPLETED|Overall Study||81
10661585|NCT02260882|11823504|FG000|NOT COMPLETED|Overall Study||0
10661586|NCT02260882|11823505|FG001|NOT COMPLETED|Overall Study||1
10661587|NCT02260921|11823514|FG000|STARTED|Overall Study||121
10661588|NCT02260921|11823515|FG001|STARTED|Overall Study||59
10661589|NCT02260921|11823514|FG000|Per-Protocol Population|Overall Study||112
10661590|NCT02260921|11823515|FG001|Per-Protocol Population|Overall Study||56
10661591|NCT02260921|11823514|FG000|COMPLETED|Overall Study||107
10661592|NCT02260921|11823515|FG001|COMPLETED|Overall Study||55
10661593|NCT02260921|11823514|FG000|NOT COMPLETED|Overall Study||14
10661594|NCT02260921|11823515|FG001|NOT COMPLETED|Overall Study||4
10661595|NCT02260934|11823523|FG000|STARTED|Overall Study||22
10661596|NCT02260934|11823524|FG001|STARTED|Overall Study||21
10661597|NCT02260934|11823523|FG000|COMPLETED|Overall Study|At primary outcome timepoint: Ten participants engaged in ongoing scheduled study visits.|19
10661598|NCT02260934|11823524|FG001|COMPLETED|Overall Study|At primary outcome timepoint: Eleven participants engaged in ongoing scheduled study visits.|17
10661599|NCT02260934|11823523|FG000|NOT COMPLETED|Overall Study||3
10661600|NCT02260934|11823524|FG001|NOT COMPLETED|Overall Study||4
10661601|NCT02260986|11823540|FG000|STARTED|Overall Study||315
10661602|NCT02260986|11823541|FG001|STARTED|Overall Study||106
10661603|NCT02260986|11823542|FG002|STARTED|Overall Study||319
10661604|NCT02260986|11823540|FG000|Safety Population|Overall Study||315
10661605|NCT02260986|11823541|FG001|Safety Population|Overall Study|4 participants from Dupilumab 300 mg qw arm analyzed in Dupilumab 300 mg q2w arm|110
10661606|NCT02260986|11823542|FG002|Safety Population|Overall Study|4 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|315
10661607|NCT02260986|11823540|FG000|COMPLETED|Overall Study||225
10661608|NCT02260986|11823541|FG001|COMPLETED|Overall Study||93
10661609|NCT02260986|11823542|FG002|COMPLETED|Overall Study||278
10661610|NCT02260986|11823540|FG000|NOT COMPLETED|Overall Study||90
10661611|NCT02260986|11823541|FG001|NOT COMPLETED|Overall Study||13
10661612|NCT02260986|11823542|FG002|NOT COMPLETED|Overall Study||41
10661613|NCT02261428|11823557|FG000|STARTED|Overall Study|Washout (30 minutes)|10
10661614|NCT02261428|11823558|FG001|STARTED|Overall Study|Washout (30 minutes)|10
10661615|NCT02261428|11823557|FG000|COMPLETED|Overall Study||10
10661616|NCT02261428|11823558|FG001|COMPLETED|Overall Study||10
10661617|NCT02261428|11823557|FG000|NOT COMPLETED|Overall Study||0
10661618|NCT02261428|11823558|FG001|NOT COMPLETED|Overall Study||0
10661619|NCT02261467|11823578|FG000|STARTED|Overall Study||101
10661620|NCT02261467|11823579|FG001|STARTED|Overall Study||290
10661621|NCT02261467|11823578|FG000|COMPLETED|Overall Study||80
10661622|NCT02261467|11823579|FG001|COMPLETED|Overall Study||253
10661623|NCT02261467|11823578|FG000|NOT COMPLETED|Overall Study||21
10661624|NCT02261467|11823579|FG001|NOT COMPLETED|Overall Study||37
10661625|NCT02261493|11823588|FG000|STARTED|Overall Study||156
10661626|NCT02261493|11823589|FG001|STARTED|Overall Study||318
10661627|NCT02261493|11823590|FG002|STARTED|Overall Study||313
10661628|NCT02261493|11823588|FG000|COMPLETED|Overall Study||126
10661629|NCT02261493|11823589|FG001|COMPLETED|Overall Study||271
10661630|NCT02261493|11823590|FG002|COMPLETED|Overall Study||287
10661631|NCT02261493|11823588|FG000|NOT COMPLETED|Overall Study||30
10661632|NCT02261493|11823589|FG001|NOT COMPLETED|Overall Study||47
10661633|NCT02261493|11823590|FG002|NOT COMPLETED|Overall Study||26
10661634|NCT02261597|11823600|FG000|STARTED|Overall Study||22
10661635|NCT02261597|11823601|FG001|STARTED|Overall Study||22
10661636|NCT02261597|11823600|FG000|COMPLETED|Overall Study||22
10661637|NCT02261597|11823601|FG001|COMPLETED|Overall Study||22
10661638|NCT02261597|11823600|FG000|NOT COMPLETED|Overall Study||0
10661639|NCT02261597|11823601|FG001|NOT COMPLETED|Overall Study||0
10661640|NCT02261714|11823607|FG000|STARTED|Overall Study||32
10661641|NCT02261714|11823607|FG000|COMPLETED|Overall Study||4
10661642|NCT02261714|11823607|FG000|NOT COMPLETED|Overall Study||28
10661643|NCT02261727|11823615|FG000|STARTED|Overall Study||568
10661644|NCT02261727|11823616|FG001|STARTED|Overall Study||554
10661645|NCT02261727|11823617|FG002|STARTED|Overall Study||548
10661646|NCT02261727|11823615|FG000|COMPLETED|Overall Study||411
10661647|NCT02261727|11823616|FG001|COMPLETED|Overall Study||408
10661648|NCT02261727|11823617|FG002|COMPLETED|Overall Study||423
10661649|NCT02261727|11823615|FG000|NOT COMPLETED|Overall Study||157
10661650|NCT02261727|11823616|FG001|NOT COMPLETED|Overall Study||146
10756017|NCT03073200|11919745|FG005|COMPLETED|Randomized Withdrawal Period||0
10661651|NCT02261727|11823617|FG002|NOT COMPLETED|Overall Study||125
10661652|NCT02261805|11823625|FG000|STARTED|Overall Study||3
10661653|NCT02261805|11823626|FG001|STARTED|Overall Study||6
10661654|NCT02261805|11823627|FG002|STARTED|Overall Study||2
10661655|NCT02261805|11823625|FG000|COMPLETED|Overall Study||3
10661656|NCT02261805|11823626|FG001|COMPLETED|Overall Study||6
10661657|NCT02261805|11823627|FG002|COMPLETED|Overall Study||2
10661658|NCT02261805|11823625|FG000|NOT COMPLETED|Overall Study||0
10661659|NCT02261805|11823626|FG001|NOT COMPLETED|Overall Study||0
10661660|NCT02261805|11823627|FG002|NOT COMPLETED|Overall Study||0
10661661|NCT02261818|11823633|FG000|STARTED|Overall Study||30
10661662|NCT02261818|11823633|FG000|COMPLETED|Overall Study||27
10661663|NCT02261818|11823633|FG000|NOT COMPLETED|Overall Study||3
10661664|NCT02261948|11823639|FG000|STARTED|Overall Study||23
10661665|NCT02261948|11823640|FG001|STARTED|Overall Study||19
10661666|NCT02261948|11823639|FG000|COMPLETED|Overall Study||23
10661667|NCT02261948|11823640|FG001|COMPLETED|Overall Study||19
10661668|NCT02261948|11823639|FG000|NOT COMPLETED|Overall Study||0
10661669|NCT02261948|11823640|FG001|NOT COMPLETED|Overall Study||0
10661670|NCT02261961|11823648|FG000|STARTED|Overall Study||22
10661671|NCT02261961|11823649|FG001|STARTED|Overall Study||22
10661672|NCT02261961|11823648|FG000|COMPLETED|Overall Study||13
10661673|NCT02261961|11823649|FG001|COMPLETED|Overall Study|One subject listed as completed who withdrew but finished training phase and has usable data.|20
10661674|NCT02261961|11823648|FG000|NOT COMPLETED|Overall Study||9
10661675|NCT02261961|11823649|FG001|NOT COMPLETED|Overall Study||2
10661676|NCT02261974|11823668|FG000|STARTED|Overall Study||123
10756018|NCT03073200|11919746|FG006|COMPLETED|Randomized Withdrawal Period||0
10756019|NCT03073200|11919747|FG007|COMPLETED|Randomized Withdrawal Period||0
10756020|NCT03073200|11919748|FG008|COMPLETED|Randomized Withdrawal Period||0
10756021|NCT03073200|11919749|FG009|COMPLETED|Randomized Withdrawal Period||33
10756022|NCT03073200|11919750|FG010|COMPLETED|Randomized Withdrawal Period||32
10756023|NCT03073200|11919751|FG011|COMPLETED|Randomized Withdrawal Period||30
10756024|NCT03073200|11919752|FG012|COMPLETED|Randomized Withdrawal Period||0
10756025|NCT03073200|11919753|FG013|COMPLETED|Randomized Withdrawal Period||0
10756026|NCT03073200|11919754|FG014|COMPLETED|Randomized Withdrawal Period||0
10756027|NCT03073200|11919740|FG000|NOT COMPLETED|Randomized Withdrawal Period||0
10756028|NCT03073200|11919741|FG001|NOT COMPLETED|Randomized Withdrawal Period||0
10756029|NCT03073200|11919742|FG002|NOT COMPLETED|Randomized Withdrawal Period||0
10756030|NCT03073200|11919743|FG003|NOT COMPLETED|Randomized Withdrawal Period||0
10756031|NCT03073200|11919744|FG004|NOT COMPLETED|Randomized Withdrawal Period||0
10756032|NCT03073200|11919745|FG005|NOT COMPLETED|Randomized Withdrawal Period||0
10756033|NCT03073200|11919746|FG006|NOT COMPLETED|Randomized Withdrawal Period||0
10756034|NCT03073200|11919747|FG007|NOT COMPLETED|Randomized Withdrawal Period||0
10756035|NCT03073200|11919748|FG008|NOT COMPLETED|Randomized Withdrawal Period||0
10756036|NCT03073200|11919749|FG009|NOT COMPLETED|Randomized Withdrawal Period||0
10756037|NCT03073200|11919750|FG010|NOT COMPLETED|Randomized Withdrawal Period||2
10756038|NCT03073200|11919751|FG011|NOT COMPLETED|Randomized Withdrawal Period||3
10756039|NCT03073200|11919752|FG012|NOT COMPLETED|Randomized Withdrawal Period||0
10756040|NCT03073200|11919753|FG013|NOT COMPLETED|Randomized Withdrawal Period||0
10756041|NCT03073200|11919754|FG014|NOT COMPLETED|Randomized Withdrawal Period||0
10756042|NCT03073200|11919740|FG000|STARTED|Post-Treatment Follow-Up Period||0
10756043|NCT03073200|11919741|FG001|STARTED|Post-Treatment Follow-Up Period||0
10756044|NCT03073200|11919742|FG002|STARTED|Post-Treatment Follow-Up Period||0
10756045|NCT03073200|11919743|FG003|STARTED|Post-Treatment Follow-Up Period||0
10756046|NCT03073200|11919744|FG004|STARTED|Post-Treatment Follow-Up Period||0
10756047|NCT03073200|11919745|FG005|STARTED|Post-Treatment Follow-Up Period||0
10756048|NCT03073200|11919746|FG006|STARTED|Post-Treatment Follow-Up Period||0
10661677|NCT02261974|11823669|FG001|STARTED|Overall Study||63
10661678|NCT02261974|11823668|FG000|Treated|Overall Study||117
10661679|NCT02261974|11823669|FG001|Treated|Overall Study||57
10661680|NCT02261974|11823668|FG000|COMPLETED|Overall Study||108
10661681|NCT02261974|11823669|FG001|COMPLETED|Overall Study||56
10661682|NCT02261974|11823668|FG000|NOT COMPLETED|Overall Study||15
10661683|NCT02261974|11823669|FG001|NOT COMPLETED|Overall Study||7
10661684|NCT02262039|11823677|FG000|STARTED|Overall Study||14
10661685|NCT02262039|11823678|FG001|STARTED|Overall Study||27
10661686|NCT02262039|11823677|FG000|COMPLETED|Overall Study||14
10756049|NCT03073200|11919747|FG007|STARTED|Post-Treatment Follow-Up Period||0
10756050|NCT03073200|11919748|FG008|STARTED|Post-Treatment Follow-Up Period||0
10756051|NCT03073200|11919749|FG009|STARTED|Post-Treatment Follow-Up Period|This period is to report Follow-Up period participants.|0
10756052|NCT03073200|11919750|FG010|STARTED|Post-Treatment Follow-Up Period|This period is to report Follow-Up period participants.|0
10756053|NCT03073200|11919751|FG011|STARTED|Post-Treatment Follow-Up Period|This period is to report Follow-Up period participants.|0
10756054|NCT03073200|11919752|FG012|STARTED|Post-Treatment Follow-Up Period|This period is to report Follow-Up period participants.|6
10756055|NCT03073200|11919753|FG013|STARTED|Post-Treatment Follow-Up Period|This period is to report Follow-Up period participants.|166
10756056|NCT03073200|11919754|FG014|STARTED|Post-Treatment Follow-Up Period|This period is to report Follow-Up period participants.|2
10756057|NCT03073200|11919740|FG000|COMPLETED|Post-Treatment Follow-Up Period||0
10756058|NCT03073200|11919741|FG001|COMPLETED|Post-Treatment Follow-Up Period||0
10756059|NCT03073200|11919742|FG002|COMPLETED|Post-Treatment Follow-Up Period||0
10756060|NCT03073200|11919743|FG003|COMPLETED|Post-Treatment Follow-Up Period||0
10756061|NCT03073200|11919744|FG004|COMPLETED|Post-Treatment Follow-Up Period||0
10756062|NCT03073200|11919745|FG005|COMPLETED|Post-Treatment Follow-Up Period||0
10756063|NCT03073200|11919746|FG006|COMPLETED|Post-Treatment Follow-Up Period||0
10756064|NCT03073200|11919747|FG007|COMPLETED|Post-Treatment Follow-Up Period||0
10756065|NCT03073200|11919748|FG008|COMPLETED|Post-Treatment Follow-Up Period||0
10756066|NCT03073200|11919749|FG009|COMPLETED|Post-Treatment Follow-Up Period||0
10756067|NCT03073200|11919750|FG010|COMPLETED|Post-Treatment Follow-Up Period||0
10756068|NCT03073200|11919751|FG011|COMPLETED|Post-Treatment Follow-Up Period||0
10756069|NCT03073200|11919752|FG012|COMPLETED|Post-Treatment Follow-Up Period||6
10756070|NCT03073200|11919753|FG013|COMPLETED|Post-Treatment Follow-Up Period||139
10756071|NCT03073200|11919754|FG014|COMPLETED|Post-Treatment Follow-Up Period||1
10756072|NCT03073200|11919740|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||0
10756073|NCT03073200|11919741|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||0
10756074|NCT03073200|11919742|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||0
10756075|NCT03073200|11919743|FG003|NOT COMPLETED|Post-Treatment Follow-Up Period||0
10661687|NCT02262039|11823678|FG001|COMPLETED|Overall Study||27
10661688|NCT02262039|11823677|FG000|NOT COMPLETED|Overall Study||0
10661689|NCT02262039|11823678|FG001|NOT COMPLETED|Overall Study||0
10661690|NCT02262078|11823686|FG000|STARTED|Overall Study||13
10661691|NCT02262078|11823687|FG001|STARTED|Overall Study||13
10661692|NCT02262078|11823686|FG000|COMPLETED|Overall Study||13
10661693|NCT02262078|11823687|FG001|COMPLETED|Overall Study||13
10661694|NCT02262078|11823686|FG000|NOT COMPLETED|Overall Study||0
10661695|NCT02262078|11823687|FG001|NOT COMPLETED|Overall Study||0
10661696|NCT02262130|11823693|FG000|STARTED|Overall Study||10
10661697|NCT02262130|11823693|FG000|COMPLETED|Overall Study||10
10661698|NCT02262130|11823693|FG000|NOT COMPLETED|Overall Study||0
10661699|NCT02262260|11823699|FG000|STARTED|Overall Study||45
10661700|NCT02262260|11823700|FG001|STARTED|Overall Study||42
10661701|NCT02262260|11823699|FG000|COMPLETED|Overall Study||34
10661702|NCT02262260|11823700|FG001|COMPLETED|Overall Study||32
10661703|NCT02262260|11823699|FG000|NOT COMPLETED|Overall Study||11
10661704|NCT02262260|11823700|FG001|NOT COMPLETED|Overall Study||10
10661705|NCT02262364|11823706|FG000|STARTED|Study Enrollment||11
10661706|NCT02262364|11823706|FG000|COMPLETED|Study Enrollment||11
10661707|NCT02262364|11823706|FG000|NOT COMPLETED|Study Enrollment||0
10661708|NCT02262364|11823706|FG000|STARTED|Blood Draw for Device Processing||11
10661709|NCT02262364|11823706|FG000|COMPLETED|Blood Draw for Device Processing||10
10661710|NCT02262364|11823706|FG000|NOT COMPLETED|Blood Draw for Device Processing||1
10661711|NCT02262364|11823706|FG000|STARTED|Injection With APS||10
10661712|NCT02262364|11823706|FG000|COMPLETED|Injection With APS||10
10661713|NCT02262364|11823706|FG000|NOT COMPLETED|Injection With APS||0
10661714|NCT02262364|11823706|FG000|STARTED|Follow-Up Through 12 Months||10
10661715|NCT02262364|11823706|FG000|COMPLETED|Follow-Up Through 12 Months||10
10661716|NCT02262364|11823706|FG000|NOT COMPLETED|Follow-Up Through 12 Months||0
10661717|NCT02262377|11823712|FG000|STARTED|Overall Study||80
10661718|NCT02262377|11823713|FG001|STARTED|Overall Study||79
10661719|NCT02262377|11823712|FG000|COMPLETED|Overall Study||68
10661720|NCT02262377|11823713|FG001|COMPLETED|Overall Study||73
10661721|NCT02262377|11823712|FG000|NOT COMPLETED|Overall Study||12
10661722|NCT02262377|11823713|FG001|NOT COMPLETED|Overall Study||6
10661723|NCT02262507|11823720|FG000|STARTED|Overall Study||410
10661724|NCT02262507|11823720|FG000|COMPLETED|Overall Study||410
10661725|NCT02262507|11823720|FG000|NOT COMPLETED|Overall Study||0
10661726|NCT02262728|11823727|FG000|STARTED|Treatment Period (12 Weeks)||19
10661727|NCT02262728|11823728|FG001|STARTED|Treatment Period (12 Weeks)||21
10661728|NCT02262728|11823727|FG000|COMPLETED|Treatment Period (12 Weeks)|Participants who completed continued follow-up phase.|19
10661729|NCT02262728|11823728|FG001|COMPLETED|Treatment Period (12 Weeks)|Participants who completed continued follow-up phase.|21
10661730|NCT02262728|11823727|FG000|NOT COMPLETED|Treatment Period (12 Weeks)||0
10661731|NCT02262728|11823728|FG001|NOT COMPLETED|Treatment Period (12 Weeks)||0
10661732|NCT02262728|11823727|FG000|STARTED|Follow-up Phase (3 Years)||19
10661733|NCT02262728|11823728|FG001|STARTED|Follow-up Phase (3 Years)||21
10661734|NCT02262728|11823727|FG000|COMPLETED|Follow-up Phase (3 Years)||15
10661735|NCT02262728|11823728|FG001|COMPLETED|Follow-up Phase (3 Years)||18
10661736|NCT02262728|11823727|FG000|NOT COMPLETED|Follow-up Phase (3 Years)||4
10661737|NCT02262728|11823728|FG001|NOT COMPLETED|Follow-up Phase (3 Years)||3
10661738|NCT02262754|11823737|FG000|STARTED|Overall Study||74
10661739|NCT02262754|11823738|FG001|STARTED|Overall Study||74
10661740|NCT02262754|11823739|FG002|STARTED|Overall Study||74
10661741|NCT02262754|11823737|FG000|COMPLETED|Overall Study||58
10661742|NCT02262754|11823738|FG001|COMPLETED|Overall Study||65
10661743|NCT02262754|11823739|FG002|COMPLETED|Overall Study||65
10661744|NCT02262754|11823737|FG000|NOT COMPLETED|Overall Study||16
10661745|NCT02262754|11823738|FG001|NOT COMPLETED|Overall Study||9
10661746|NCT02262754|11823739|FG002|NOT COMPLETED|Overall Study||9
10661747|NCT02263040|11823751|FG000|STARTED|Overall Study||87
10661748|NCT02263040|11823752|FG001|STARTED|Overall Study||83
10661749|NCT02263040|11823751|FG000|COMPLETED|Overall Study||87
10661750|NCT02263040|11823752|FG001|COMPLETED|Overall Study||83
10661751|NCT02263040|11823751|FG000|NOT COMPLETED|Overall Study||0
10661752|NCT02263040|11823752|FG001|NOT COMPLETED|Overall Study||0
10661753|NCT02263079|11823765|FG000|STARTED|Overall Study||26
10661754|NCT02263079|11823766|FG001|STARTED|Overall Study||33
10661755|NCT02263079|11823767|FG002|STARTED|Overall Study||3
10661756|NCT02263079|11823765|FG000|COMPLETED|Overall Study||23
10661757|NCT02263079|11823766|FG001|COMPLETED|Overall Study||25
10661758|NCT02263079|11823767|FG002|COMPLETED|Overall Study|Completed study but not included in the analysis|3
10661759|NCT02263079|11823765|FG000|NOT COMPLETED|Overall Study||3
10661760|NCT02263079|11823766|FG001|NOT COMPLETED|Overall Study||8
10661761|NCT02263079|11823767|FG002|NOT COMPLETED|Overall Study||0
10661762|NCT02263118|11823779|FG000|STARTED|Overall Study||24
10661763|NCT02263118|11823780|FG001|STARTED|Overall Study||32
10661764|NCT02263118|11823781|FG002|STARTED|Overall Study||30
10661765|NCT02263118|11823782|FG003|STARTED|Overall Study||14
10661766|NCT02263118|11823779|FG000|COMPLETED|Overall Study||20
10661767|NCT02263118|11823780|FG001|COMPLETED|Overall Study||24
10661768|NCT02263118|11823781|FG002|COMPLETED|Overall Study||22
10661769|NCT02263118|11823782|FG003|COMPLETED|Overall Study||12
10661770|NCT02263118|11823779|FG000|NOT COMPLETED|Overall Study||4
10661771|NCT02263118|11823780|FG001|NOT COMPLETED|Overall Study||8
10661772|NCT02263118|11823781|FG002|NOT COMPLETED|Overall Study||8
10661773|NCT02263118|11823782|FG003|NOT COMPLETED|Overall Study||2
10661774|NCT02263131|11823796|FG000|STARTED|Overall Study||347
10661775|NCT02263131|11823797|FG001|STARTED|Overall Study||69
10661776|NCT02263131|11823796|FG000|COMPLETED|Overall Study||337
10661777|NCT02263131|11823797|FG001|COMPLETED|Overall Study||68
10661778|NCT02263131|11823796|FG000|NOT COMPLETED|Overall Study||10
10661779|NCT02263131|11823797|FG001|NOT COMPLETED|Overall Study||1
10661780|NCT02263326|11823805|FG000|STARTED|Overall Study||44
10661781|NCT02263326|11823806|FG001|STARTED|Overall Study||45
10661782|NCT02263326|11823805|FG000|COMPLETED|Overall Study||43
10661783|NCT02263326|11823806|FG001|COMPLETED|Overall Study||44
10661784|NCT02263326|11823805|FG000|NOT COMPLETED|Overall Study||1
10661785|NCT02263326|11823806|FG001|NOT COMPLETED|Overall Study||1
10661786|NCT02263547|11823812|FG000|STARTED|Overall Study||14
10661787|NCT02263547|11823812|FG000|COMPLETED|Overall Study||11
10661788|NCT02263547|11823812|FG000|NOT COMPLETED|Overall Study||3
10661789|NCT02263833|11823816|FG000|STARTED|Overall Study||742
10661790|NCT02263833|11823816|FG000|COMPLETED|Overall Study||742
10661791|NCT02263833|11823816|FG000|NOT COMPLETED|Overall Study||0
10661792|NCT02263911|11823820|FG000|STARTED|Period 1||4
10661793|NCT02263911|11823821|FG001|STARTED|Period 1||4
10661794|NCT02263911|11823822|FG002|STARTED|Period 1||4
10661795|NCT02263911|11823823|FG003|STARTED|Period 1||4
10661796|NCT02263911|11823820|FG000|COMPLETED|Period 1||4
10661797|NCT02263911|11823821|FG001|COMPLETED|Period 1||4
10661798|NCT02263911|11823822|FG002|COMPLETED|Period 1||4
10661799|NCT02263911|11823823|FG003|COMPLETED|Period 1||4
10661800|NCT02263911|11823820|FG000|NOT COMPLETED|Period 1||0
10661801|NCT02263911|11823821|FG001|NOT COMPLETED|Period 1||0
10661802|NCT02263911|11823822|FG002|NOT COMPLETED|Period 1||0
10661803|NCT02263911|11823823|FG003|NOT COMPLETED|Period 1||0
10661804|NCT02263911|11823820|FG000|STARTED|Period 1 Washout||4
10661805|NCT02263911|11823821|FG001|STARTED|Period 1 Washout||4
10661806|NCT02263911|11823822|FG002|STARTED|Period 1 Washout||4
10661807|NCT02263911|11823823|FG003|STARTED|Period 1 Washout||4
10661808|NCT02263911|11823820|FG000|COMPLETED|Period 1 Washout||4
10661809|NCT02263911|11823821|FG001|COMPLETED|Period 1 Washout||4
10661810|NCT02263911|11823822|FG002|COMPLETED|Period 1 Washout||4
10661811|NCT02263911|11823823|FG003|COMPLETED|Period 1 Washout||4
10661812|NCT02263911|11823820|FG000|NOT COMPLETED|Period 1 Washout||0
10661813|NCT02263911|11823821|FG001|NOT COMPLETED|Period 1 Washout||0
10661814|NCT02263911|11823822|FG002|NOT COMPLETED|Period 1 Washout||0
10661815|NCT02263911|11823823|FG003|NOT COMPLETED|Period 1 Washout||0
10661816|NCT02263911|11823820|FG000|STARTED|Period 2||4
10661817|NCT02263911|11823821|FG001|STARTED|Period 2||4
10661818|NCT02263911|11823822|FG002|STARTED|Period 2||4
10661819|NCT02263911|11823823|FG003|STARTED|Period 2||4
10661820|NCT02263911|11823820|FG000|COMPLETED|Period 2||4
10661821|NCT02263911|11823821|FG001|COMPLETED|Period 2||4
10661822|NCT02263911|11823822|FG002|COMPLETED|Period 2||4
10661823|NCT02263911|11823823|FG003|COMPLETED|Period 2||4
10661824|NCT02263911|11823820|FG000|NOT COMPLETED|Period 2||0
10661825|NCT02263911|11823821|FG001|NOT COMPLETED|Period 2||0
10661826|NCT02263911|11823822|FG002|NOT COMPLETED|Period 2||0
10661827|NCT02263911|11823823|FG003|NOT COMPLETED|Period 2||0
10661828|NCT02263911|11823820|FG000|STARTED|Period 2 Washout||4
10661829|NCT02263911|11823821|FG001|STARTED|Period 2 Washout||4
10661830|NCT02263911|11823822|FG002|STARTED|Period 2 Washout||4
10661831|NCT02263911|11823823|FG003|STARTED|Period 2 Washout||4
10661832|NCT02263911|11823820|FG000|COMPLETED|Period 2 Washout||4
10661833|NCT02263911|11823821|FG001|COMPLETED|Period 2 Washout||4
10661834|NCT02263911|11823822|FG002|COMPLETED|Period 2 Washout||4
10661835|NCT02263911|11823823|FG003|COMPLETED|Period 2 Washout||4
10661836|NCT02263911|11823820|FG000|NOT COMPLETED|Period 2 Washout||0
10661837|NCT02263911|11823821|FG001|NOT COMPLETED|Period 2 Washout||0
10661838|NCT02263911|11823822|FG002|NOT COMPLETED|Period 2 Washout||0
10661839|NCT02263911|11823823|FG003|NOT COMPLETED|Period 2 Washout||0
10661840|NCT02263911|11823820|FG000|STARTED|Period 3||4
10661841|NCT02263911|11823821|FG001|STARTED|Period 3||4
10661842|NCT02263911|11823822|FG002|STARTED|Period 3||4
10661843|NCT02263911|11823823|FG003|STARTED|Period 3||4
10661844|NCT02263911|11823820|FG000|COMPLETED|Period 3||4
10661845|NCT02263911|11823821|FG001|COMPLETED|Period 3||4
10661846|NCT02263911|11823822|FG002|COMPLETED|Period 3||4
10661847|NCT02263911|11823823|FG003|COMPLETED|Period 3||4
10661848|NCT02263911|11823820|FG000|NOT COMPLETED|Period 3||0
10661849|NCT02263911|11823821|FG001|NOT COMPLETED|Period 3||0
10661850|NCT02263911|11823822|FG002|NOT COMPLETED|Period 3||0
10661851|NCT02263911|11823823|FG003|NOT COMPLETED|Period 3||0
10661852|NCT02263911|11823820|FG000|STARTED|Period 3 Washout||4
10661853|NCT02263911|11823821|FG001|STARTED|Period 3 Washout||4
10661854|NCT02263911|11823822|FG002|STARTED|Period 3 Washout||4
10661855|NCT02263911|11823823|FG003|STARTED|Period 3 Washout||4
10661856|NCT02263911|11823820|FG000|COMPLETED|Period 3 Washout||4
10661857|NCT02263911|11823821|FG001|COMPLETED|Period 3 Washout||4
10661858|NCT02263911|11823822|FG002|COMPLETED|Period 3 Washout||4
10661859|NCT02263911|11823823|FG003|COMPLETED|Period 3 Washout||4
10661860|NCT02263911|11823820|FG000|NOT COMPLETED|Period 3 Washout||0
10661861|NCT02263911|11823821|FG001|NOT COMPLETED|Period 3 Washout||0
10661862|NCT02263911|11823822|FG002|NOT COMPLETED|Period 3 Washout||0
10661863|NCT02263911|11823823|FG003|NOT COMPLETED|Period 3 Washout||0
10661864|NCT02263911|11823820|FG000|STARTED|Period 4||4
10661865|NCT02263911|11823821|FG001|STARTED|Period 4||4
10661866|NCT02263911|11823822|FG002|STARTED|Period 4||4
10661867|NCT02263911|11823823|FG003|STARTED|Period 4||4
10661868|NCT02263911|11823820|FG000|COMPLETED|Period 4||4
10661869|NCT02263911|11823821|FG001|COMPLETED|Period 4||4
10661870|NCT02263911|11823822|FG002|COMPLETED|Period 4||4
10661871|NCT02263911|11823823|FG003|COMPLETED|Period 4||4
10661872|NCT02263911|11823820|FG000|NOT COMPLETED|Period 4||0
10661873|NCT02263911|11823821|FG001|NOT COMPLETED|Period 4||0
10661874|NCT02263911|11823822|FG002|NOT COMPLETED|Period 4||0
10661875|NCT02263911|11823823|FG003|NOT COMPLETED|Period 4||0
10661876|NCT02263911|11823820|FG000|STARTED|Period 4 Washout||4
10661877|NCT02263911|11823821|FG001|STARTED|Period 4 Washout||4
10661878|NCT02263911|11823822|FG002|STARTED|Period 4 Washout||4
10661879|NCT02263911|11823823|FG003|STARTED|Period 4 Washout||4
10661880|NCT02263911|11823820|FG000|COMPLETED|Period 4 Washout||4
10661881|NCT02263911|11823821|FG001|COMPLETED|Period 4 Washout||4
10661882|NCT02263911|11823822|FG002|COMPLETED|Period 4 Washout||4
10661883|NCT02263911|11823823|FG003|COMPLETED|Period 4 Washout||4
10661884|NCT02263911|11823820|FG000|NOT COMPLETED|Period 4 Washout||0
10661885|NCT02263911|11823821|FG001|NOT COMPLETED|Period 4 Washout||0
10661886|NCT02263911|11823822|FG002|NOT COMPLETED|Period 4 Washout||0
10661887|NCT02263911|11823823|FG003|NOT COMPLETED|Period 4 Washout||0
10661888|NCT02263911|11823820|FG000|STARTED|Period 5||4
10661889|NCT02263911|11823821|FG001|STARTED|Period 5||4
10661890|NCT02263911|11823822|FG002|STARTED|Period 5||4
10661891|NCT02263911|11823823|FG003|STARTED|Period 5||4
10661892|NCT02263911|11823820|FG000|COMPLETED|Period 5||4
10661893|NCT02263911|11823821|FG001|COMPLETED|Period 5||4
10661894|NCT02263911|11823822|FG002|COMPLETED|Period 5||4
10661895|NCT02263911|11823823|FG003|COMPLETED|Period 5||4
10661896|NCT02263911|11823820|FG000|NOT COMPLETED|Period 5||0
10661897|NCT02263911|11823821|FG001|NOT COMPLETED|Period 5||0
10661898|NCT02263911|11823822|FG002|NOT COMPLETED|Period 5||0
10661899|NCT02263911|11823823|FG003|NOT COMPLETED|Period 5||0
10661900|NCT02264249|11823840|FG000|STARTED|Overall Study||21
10661901|NCT02264249|11823841|FG001|STARTED|Overall Study||187
10661902|NCT02264249|11823842|FG002|STARTED|Overall Study||241
10661903|NCT02264249|11823840|FG000|COMPLETED|Overall Study||21
10661904|NCT02264249|11823841|FG001|COMPLETED|Overall Study||187
10661905|NCT02264249|11823842|FG002|COMPLETED|Overall Study||241
10661906|NCT02264249|11823840|FG000|NOT COMPLETED|Overall Study||0
10661907|NCT02264249|11823841|FG001|NOT COMPLETED|Overall Study||0
10661908|NCT02264249|11823842|FG002|NOT COMPLETED|Overall Study||0
10661909|NCT02264353|11823850|FG000|STARTED|Overall Study||20
10661910|NCT02264353|11823851|FG001|STARTED|Overall Study||24
10661911|NCT02264353|11823850|FG000|COMPLETED|Overall Study||17
10661912|NCT02264353|11823851|FG001|COMPLETED|Overall Study||24
10661913|NCT02264353|11823850|FG000|NOT COMPLETED|Overall Study||3
10661914|NCT02264353|11823851|FG001|NOT COMPLETED|Overall Study||0
10661915|NCT02264574|11823859|FG000|STARTED|Overall Study||113
10661916|NCT02264574|11823860|FG001|STARTED|Overall Study||116
10661917|NCT02264574|11823859|FG000|COMPLETED|Overall Study||84
10661918|NCT02264574|11823860|FG001|COMPLETED|Overall Study||86
10661919|NCT02264574|11823859|FG000|NOT COMPLETED|Overall Study||29
10661920|NCT02264574|11823860|FG001|NOT COMPLETED|Overall Study||30
10661921|NCT02264639|11823871|FG000|STARTED|Overall Study|Subjects in this arm participated in Cohort 1 only.|2
10661922|NCT02264639|11823872|FG001|STARTED|Overall Study|Subject in this arm participated in Cohort 2 only.|1
10661923|NCT02264639|11823873|FG002|STARTED|Overall Study|Subject in this arm participated in Cohorts 2, 3 and 4.|1
10661924|NCT02264639|11823874|FG003|STARTED|Overall Study|Subject in this arm participated in Cohorts 3 and 4; single-dose phase was not applicable.|1
10661925|NCT02264639|11823875|FG004|STARTED|Overall Study|Subjects in this arm participated in Cohort 4 only; single-dose phase was not applicable.|4
10661926|NCT02264639|11823871|FG000|COMPLETED|Overall Study||0
10661927|NCT02264639|11823872|FG001|COMPLETED|Overall Study||1
10661928|NCT02264639|11823873|FG002|COMPLETED|Overall Study||0
10661929|NCT02264639|11823874|FG003|COMPLETED|Overall Study||1
10661930|NCT02264639|11823875|FG004|COMPLETED|Overall Study||3
10661931|NCT02264639|11823871|FG000|NOT COMPLETED|Overall Study||2
10661932|NCT02264639|11823872|FG001|NOT COMPLETED|Overall Study||0
10661933|NCT02264639|11823873|FG002|NOT COMPLETED|Overall Study||1
10661934|NCT02264639|11823874|FG003|NOT COMPLETED|Overall Study||0
10661935|NCT02264639|11823875|FG004|NOT COMPLETED|Overall Study||1
10661936|NCT02264821|11823893|FG000|STARTED|Overall Study|Double Blind|64
10661937|NCT02264821|11823894|FG001|STARTED|Overall Study|Double Blind|64
10661938|NCT02264821|11823895|FG002|STARTED|Overall Study|Double Blind|64
10661939|NCT02264821|11823893|FG000|COMPLETED|Overall Study||63
10661940|NCT02264821|11823894|FG001|COMPLETED|Overall Study||61
10661941|NCT02264821|11823895|FG002|COMPLETED|Overall Study||58
10661942|NCT02264821|11823893|FG000|NOT COMPLETED|Overall Study||1
10661943|NCT02264821|11823894|FG001|NOT COMPLETED|Overall Study||3
10661944|NCT02264821|11823895|FG002|NOT COMPLETED|Overall Study||6
10661945|NCT02264990|11823905|FG000|STARTED|Overall Study||297
10661946|NCT02264990|11823906|FG001|STARTED|Overall Study||298
10661947|NCT02264990|11823905|FG000|Received Treatment|Overall Study||288
10661948|NCT02264990|11823906|FG001|Received Treatment|Overall Study||293
10661949|NCT02264990|11823905|FG000|Received Maintenance Therapy|Overall Study||148
10661950|NCT02264990|11823906|FG001|Received Maintenance Therapy|Overall Study||123
10661951|NCT02264990|11823905|FG000|COMPLETED|Overall Study||37
10661952|NCT02264990|11823906|FG001|COMPLETED|Overall Study||39
10661953|NCT02264990|11823905|FG000|NOT COMPLETED|Overall Study||260
10661954|NCT02264990|11823906|FG001|NOT COMPLETED|Overall Study||259
10661955|NCT02265224|11823913|FG000|STARTED|Overall Study||48
10661956|NCT02265224|11823913|FG000|COMPLETED|Overall Study||48
10661957|NCT02265224|11823913|FG000|NOT COMPLETED|Overall Study||0
10661958|NCT02265237|11823924|FG000|STARTED|As Enrolled (Overall Study)||59
10661959|NCT02265237|11823925|FG001|STARTED|As Enrolled (Overall Study)||61
10661960|NCT02265237|11823926|FG002|STARTED|As Enrolled (Overall Study)||61
10661961|NCT02265237|11823927|FG003|STARTED|As Enrolled (Overall Study)||3
10661962|NCT02265237|11823924|FG000|COMPLETED|As Enrolled (Overall Study)||54
10661963|NCT02265237|11823925|FG001|COMPLETED|As Enrolled (Overall Study)||58
10661964|NCT02265237|11823926|FG002|COMPLETED|As Enrolled (Overall Study)||51
10661965|NCT02265237|11823927|FG003|COMPLETED|As Enrolled (Overall Study)||2
10661966|NCT02265237|11823924|FG000|NOT COMPLETED|As Enrolled (Overall Study)||5
10661967|NCT02265237|11823925|FG001|NOT COMPLETED|As Enrolled (Overall Study)||3
10661968|NCT02265237|11823926|FG002|NOT COMPLETED|As Enrolled (Overall Study)||10
10661969|NCT02265237|11823927|FG003|NOT COMPLETED|As Enrolled (Overall Study)||1
10661970|NCT02265237|11823924|FG000|STARTED|As Treated (Overall Study)|One arm B subject received the drug for the duration for arm A and was included in arm A for safety.|60
10661971|NCT02265237|11823925|FG001|STARTED|As Treated (Overall Study)|One arm B subject received the drug for the duration for arm A and was included in arm A for safety.|60
10661972|NCT02265237|11823926|FG002|STARTED|As Treated (Overall Study)||61
10661973|NCT02265237|11823927|FG003|STARTED|As Treated (Overall Study)||3
10661974|NCT02265237|11823924|FG000|COMPLETED|As Treated (Overall Study)||55
10661975|NCT02265237|11823925|FG001|COMPLETED|As Treated (Overall Study)||57
10661976|NCT02265237|11823926|FG002|COMPLETED|As Treated (Overall Study)||51
10661977|NCT02265237|11823927|FG003|COMPLETED|As Treated (Overall Study)||2
10661978|NCT02265237|11823924|FG000|NOT COMPLETED|As Treated (Overall Study)||5
10661979|NCT02265237|11823925|FG001|NOT COMPLETED|As Treated (Overall Study)||3
10661980|NCT02265237|11823926|FG002|NOT COMPLETED|As Treated (Overall Study)||10
10661981|NCT02265237|11823927|FG003|NOT COMPLETED|As Treated (Overall Study)||1
10661982|NCT02265341|11823938|FG000|STARTED|Overall Study||12
10661983|NCT02265341|11823938|FG000|COMPLETED|Overall Study||12
10661984|NCT02265341|11823938|FG000|NOT COMPLETED|Overall Study||0
10661985|NCT02265510|11823956|FG000|STARTED|Overall Study||3
10661986|NCT02265510|11823957|FG001|STARTED|Overall Study||3
10661987|NCT02265510|11823958|FG002|STARTED|Overall Study||6
10661988|NCT02265510|11823959|FG003|STARTED|Overall Study||4
10756076|NCT03073200|11919744|FG004|NOT COMPLETED|Post-Treatment Follow-Up Period||0
10756077|NCT03073200|11919745|FG005|NOT COMPLETED|Post-Treatment Follow-Up Period||0
10756078|NCT03073200|11919746|FG006|NOT COMPLETED|Post-Treatment Follow-Up Period||0
10756079|NCT03073200|11919747|FG007|NOT COMPLETED|Post-Treatment Follow-Up Period||0
10756080|NCT03073200|11919748|FG008|NOT COMPLETED|Post-Treatment Follow-Up Period||0
10756081|NCT03073200|11919749|FG009|NOT COMPLETED|Post-Treatment Follow-Up Period||0
10756082|NCT03073200|11919750|FG010|NOT COMPLETED|Post-Treatment Follow-Up Period||0
10756083|NCT03073200|11919751|FG011|NOT COMPLETED|Post-Treatment Follow-Up Period||0
10756084|NCT03073200|11919752|FG012|NOT COMPLETED|Post-Treatment Follow-Up Period||0
10756085|NCT03073200|11919753|FG013|NOT COMPLETED|Post-Treatment Follow-Up Period||27
10756086|NCT03073200|11919754|FG014|NOT COMPLETED|Post-Treatment Follow-Up Period||1
10756087|NCT03073213|11919779|FG000|STARTED|Single Dose Period||12
10756088|NCT03073213|11919780|FG001|STARTED|Single Dose Period||0
10756089|NCT03073213|11919781|FG002|STARTED|Single Dose Period||0
10756090|NCT03073213|11919779|FG000|COMPLETED|Single Dose Period||12
10756091|NCT03073213|11919780|FG001|COMPLETED|Single Dose Period||0
10756092|NCT03073213|11919781|FG002|COMPLETED|Single Dose Period||0
10756093|NCT03073213|11919779|FG000|NOT COMPLETED|Single Dose Period||0
10756094|NCT03073213|11919780|FG001|NOT COMPLETED|Single Dose Period||0
10756095|NCT03073213|11919781|FG002|NOT COMPLETED|Single Dose Period||0
10756096|NCT03073213|11919779|FG000|STARTED|Multiple Dose Period||0
10756097|NCT03073213|11919780|FG001|STARTED|Multiple Dose Period|Participants who completed single dose had option to enroll into multiple dose.|14
10756098|NCT03073213|11919781|FG002|STARTED|Multiple Dose Period|Participants who completed single dose had option to enroll into multiple dose.|15
10756099|NCT03073213|11919779|FG000|Participants Enrolled From Single Dose|Multiple Dose Period||0
10756100|NCT03073213|11919780|FG001|Participants Enrolled From Single Dose|Multiple Dose Period||7
10756101|NCT03073213|11919781|FG002|Participants Enrolled From Single Dose|Multiple Dose Period||2
10756102|NCT03073213|11919779|FG000|COMPLETED|Multiple Dose Period||0
10756103|NCT03073213|11919780|FG001|COMPLETED|Multiple Dose Period||14
10756104|NCT03073213|11919781|FG002|COMPLETED|Multiple Dose Period||14
10756105|NCT03073213|11919779|FG000|NOT COMPLETED|Multiple Dose Period||0
10756106|NCT03073213|11919780|FG001|NOT COMPLETED|Multiple Dose Period||0
10756107|NCT03073213|11919781|FG002|NOT COMPLETED|Multiple Dose Period||1
10756108|NCT03073486|11919792|FG000|STARTED|Overall Study||493
10756109|NCT03073486|11919793|FG001|STARTED|Overall Study||251
10756110|NCT03073486|11919792|FG000|COMPLETED|Overall Study||405
10756111|NCT03073486|11919793|FG001|COMPLETED|Overall Study||207
10756112|NCT03073486|11919792|FG000|NOT COMPLETED|Overall Study||88
10756113|NCT03073486|11919793|FG001|NOT COMPLETED|Overall Study||44
10756114|NCT03073759|11919801|FG000|STARTED|Overall Study||2
10756115|NCT03073759|11919802|FG001|STARTED|Overall Study||2
10756116|NCT03073759|11919801|FG000|COMPLETED|Overall Study||2
10756117|NCT03073759|11919802|FG001|COMPLETED|Overall Study||2
10756118|NCT03073759|11919801|FG000|NOT COMPLETED|Overall Study||0
10756119|NCT03073759|11919802|FG001|NOT COMPLETED|Overall Study||0
10756120|NCT03073798|11919809|FG000|STARTED|Overall Study||12
10756121|NCT03073798|11919809|FG000|COMPLETED|Overall Study||10
10756122|NCT03073798|11919809|FG000|NOT COMPLETED|Overall Study||2
10756123|NCT03073876|11919816|FG000|STARTED|Overall Study||12
10756124|NCT03073876|11919817|FG001|STARTED|Overall Study||11
10756125|NCT03073876|11919816|FG000|COMPLETED|Overall Study||12
10661989|NCT02265510|11823960|FG004|STARTED|Overall Study||3
10661990|NCT02265510|11823961|FG005|STARTED|Overall Study||6
10661991|NCT02265510|11823962|FG006|STARTED|Overall Study||3
10661992|NCT02265510|11823963|FG007|STARTED|Overall Study||4
10661993|NCT02265510|11823964|FG008|STARTED|Overall Study||4
10661994|NCT02265510|11823965|FG009|STARTED|Overall Study||7
10661995|NCT02265510|11823966|FG010|STARTED|Overall Study||5
10661996|NCT02265510|11823967|FG011|STARTED|Overall Study||16
10661997|NCT02265510|11823968|FG012|STARTED|Overall Study||9
10661998|NCT02265510|11823969|FG013|STARTED|Overall Study||10
10661999|NCT02265510|11823956|FG000|COMPLETED|Overall Study||0
10662000|NCT02265510|11823957|FG001|COMPLETED|Overall Study||0
10662001|NCT02265510|11823958|FG002|COMPLETED|Overall Study||0
10662002|NCT02265510|11823959|FG003|COMPLETED|Overall Study||0
10662003|NCT02265510|11823960|FG004|COMPLETED|Overall Study||0
10662004|NCT02265510|11823961|FG005|COMPLETED|Overall Study||0
10662005|NCT02265510|11823962|FG006|COMPLETED|Overall Study||0
10662006|NCT02265510|11823963|FG007|COMPLETED|Overall Study||0
10662007|NCT02265510|11823964|FG008|COMPLETED|Overall Study||0
10662008|NCT02265510|11823965|FG009|COMPLETED|Overall Study||0
10662009|NCT02265510|11823966|FG010|COMPLETED|Overall Study||0
10662010|NCT02265510|11823967|FG011|COMPLETED|Overall Study||0
10662011|NCT02265510|11823968|FG012|COMPLETED|Overall Study||0
10662012|NCT02265510|11823969|FG013|COMPLETED|Overall Study||0
10662013|NCT02265510|11823956|FG000|NOT COMPLETED|Overall Study||3
10662014|NCT02265510|11823957|FG001|NOT COMPLETED|Overall Study||3
10662015|NCT02265510|11823958|FG002|NOT COMPLETED|Overall Study||6
10662016|NCT02265510|11823959|FG003|NOT COMPLETED|Overall Study||4
10662017|NCT02265510|11823960|FG004|NOT COMPLETED|Overall Study||3
10662018|NCT02265510|11823961|FG005|NOT COMPLETED|Overall Study||6
10662019|NCT02265510|11823962|FG006|NOT COMPLETED|Overall Study||3
10662020|NCT02265510|11823963|FG007|NOT COMPLETED|Overall Study||4
10662021|NCT02265510|11823964|FG008|NOT COMPLETED|Overall Study||4
10662022|NCT02265510|11823965|FG009|NOT COMPLETED|Overall Study||7
10662023|NCT02265510|11823966|FG010|NOT COMPLETED|Overall Study||5
10662024|NCT02265510|11823967|FG011|NOT COMPLETED|Overall Study||16
10662025|NCT02265510|11823968|FG012|NOT COMPLETED|Overall Study||9
10662026|NCT02265510|11823969|FG013|NOT COMPLETED|Overall Study||10
10662027|NCT02265705|11824027|FG000|STARTED|Treatment Period Week 0-24||145
10662028|NCT02265705|11824028|FG001|STARTED|Treatment Period Week 0-24||145
10662029|NCT02265705|11824029|FG002|STARTED|Treatment Period Week 0-24||0
10662030|NCT02265705|11824030|FG003|STARTED|Treatment Period Week 0-24||0
10662031|NCT02265705|11824031|FG004|STARTED|Treatment Period Week 0-24||0
10662032|NCT02265705|11824032|FG005|STARTED|Treatment Period Week 0-24||0
10662033|NCT02265705|11824033|FG006|STARTED|Treatment Period Week 0-24||0
10662034|NCT02265705|11824027|FG000|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||145
10662035|NCT02265705|11824028|FG001|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||145
10662036|NCT02265705|11824029|FG002|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
10662037|NCT02265705|11824030|FG003|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
10662038|NCT02265705|11824031|FG004|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
10662039|NCT02265705|11824032|FG005|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
10662040|NCT02265705|11824033|FG006|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
10662041|NCT02265705|11824027|FG000|Rescued|Treatment Period Week 0-24||59
10662042|NCT02265705|11824028|FG001|Rescued|Treatment Period Week 0-24||17
10662043|NCT02265705|11824029|FG002|Rescued|Treatment Period Week 0-24||0
10662044|NCT02265705|11824030|FG003|Rescued|Treatment Period Week 0-24||0
10662045|NCT02265705|11824031|FG004|Rescued|Treatment Period Week 0-24||0
10662046|NCT02265705|11824032|FG005|Rescued|Treatment Period Week 0-24||0
10662047|NCT02265705|11824033|FG006|Rescued|Treatment Period Week 0-24||0
10662048|NCT02265705|11824027|FG000|COMPLETED|Treatment Period Week 0-24|"Completers include rescued participants."|133
10662049|NCT02265705|11824028|FG001|COMPLETED|Treatment Period Week 0-24|"Completers include rescued participants."|136
10662050|NCT02265705|11824029|FG002|COMPLETED|Treatment Period Week 0-24||0
10662051|NCT02265705|11824030|FG003|COMPLETED|Treatment Period Week 0-24||0
10662052|NCT02265705|11824031|FG004|COMPLETED|Treatment Period Week 0-24||0
10662053|NCT02265705|11824032|FG005|COMPLETED|Treatment Period Week 0-24||0
10662054|NCT02265705|11824033|FG006|COMPLETED|Treatment Period Week 0-24||0
10662055|NCT02265705|11824027|FG000|NOT COMPLETED|Treatment Period Week 0-24||12
10662056|NCT02265705|11824028|FG001|NOT COMPLETED|Treatment Period Week 0-24||9
10662057|NCT02265705|11824029|FG002|NOT COMPLETED|Treatment Period Week 0-24||0
10662058|NCT02265705|11824030|FG003|NOT COMPLETED|Treatment Period Week 0-24||0
10662059|NCT02265705|11824031|FG004|NOT COMPLETED|Treatment Period Week 0-24||0
10662060|NCT02265705|11824032|FG005|NOT COMPLETED|Treatment Period Week 0-24||0
10662061|NCT02265705|11824033|FG006|NOT COMPLETED|Treatment Period Week 0-24||0
10662062|NCT02265705|11824027|FG000|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
10662063|NCT02265705|11824028|FG001|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
10662064|NCT02265705|11824029|FG002|STARTED|Rescue Period|Participants who were determined to be nonresponders based on tender/swollen joint count.|77
10662065|NCT02265705|11824030|FG003|STARTED|Rescue Period||0
10662066|NCT02265705|11824031|FG004|STARTED|Rescue Period||0
10662067|NCT02265705|11824032|FG005|STARTED|Rescue Period||0
10662068|NCT02265705|11824033|FG006|STARTED|Rescue Period||0
10662069|NCT02265705|11824027|FG000|COMPLETED|Rescue Period||0
10662070|NCT02265705|11824028|FG001|COMPLETED|Rescue Period||0
10662071|NCT02265705|11824029|FG002|COMPLETED|Rescue Period||74
10662072|NCT02265705|11824030|FG003|COMPLETED|Rescue Period||0
10662073|NCT02265705|11824031|FG004|COMPLETED|Rescue Period||0
10662074|NCT02265705|11824032|FG005|COMPLETED|Rescue Period||0
10662075|NCT02265705|11824033|FG006|COMPLETED|Rescue Period||0
10662076|NCT02265705|11824027|FG000|NOT COMPLETED|Rescue Period||0
10662077|NCT02265705|11824028|FG001|NOT COMPLETED|Rescue Period||0
10662078|NCT02265705|11824029|FG002|NOT COMPLETED|Rescue Period||3
10662079|NCT02265705|11824030|FG003|NOT COMPLETED|Rescue Period||0
10662080|NCT02265705|11824031|FG004|NOT COMPLETED|Rescue Period||0
10662081|NCT02265705|11824032|FG005|NOT COMPLETED|Rescue Period||0
10662082|NCT02265705|11824033|FG006|NOT COMPLETED|Rescue Period||0
10662083|NCT02265705|11824027|FG000|STARTED|Open Label Period||0
10662084|NCT02265705|11824028|FG001|STARTED|Open Label Period||0
10662085|NCT02265705|11824029|FG002|STARTED|Open Label Period||0
10662086|NCT02265705|11824030|FG003|STARTED|Open Label Period|Completed Wk 24 w/o rescue Tx, switched to or remained on active Tx, and entered Open Label Period.|74
10662087|NCT02265705|11824031|FG004|STARTED|Open Label Period|Completed Wk 24 w/o rescue Tx, switched to or remained on active Tx, and entered Open Label Period.|120
10756126|NCT03073876|11919817|FG001|COMPLETED|Overall Study||11
10756127|NCT03073876|11919816|FG000|NOT COMPLETED|Overall Study||0
10756128|NCT03073876|11919817|FG001|NOT COMPLETED|Overall Study||0
10756129|NCT03074162|11919834|FG000|STARTED|Period 1 Including Washout 1||8
10662088|NCT02265705|11824032|FG005|STARTED|Open Label Period||0
10662089|NCT02265705|11824033|FG006|STARTED|Open Label Period||0
10662090|NCT02265705|11824027|FG000|COMPLETED|Open Label Period||0
10662091|NCT02265705|11824028|FG001|COMPLETED|Open Label Period||0
10662092|NCT02265705|11824029|FG002|COMPLETED|Open Label Period||0
10662093|NCT02265705|11824030|FG003|COMPLETED|Open Label Period||72
10662094|NCT02265705|11824031|FG004|COMPLETED|Open Label Period||115
10662095|NCT02265705|11824032|FG005|COMPLETED|Open Label Period||0
10662096|NCT02265705|11824033|FG006|COMPLETED|Open Label Period||0
10662097|NCT02265705|11824027|FG000|NOT COMPLETED|Open Label Period||0
10662098|NCT02265705|11824028|FG001|NOT COMPLETED|Open Label Period||0
10662099|NCT02265705|11824029|FG002|NOT COMPLETED|Open Label Period||0
10662100|NCT02265705|11824030|FG003|NOT COMPLETED|Open Label Period||2
10662101|NCT02265705|11824031|FG004|NOT COMPLETED|Open Label Period||5
10662102|NCT02265705|11824032|FG005|NOT COMPLETED|Open Label Period||0
10662103|NCT02265705|11824033|FG006|NOT COMPLETED|Open Label Period||0
10662104|NCT02265705|11824027|FG000|STARTED|Follow-up Period||0
10662105|NCT02265705|11824028|FG001|STARTED|Follow-up Period||0
10662106|NCT02265705|11824029|FG002|STARTED|Follow-up Period||0
10662107|NCT02265705|11824030|FG003|STARTED|Follow-up Period||0
10662108|NCT02265705|11824031|FG004|STARTED|Follow-up Period||0
10662109|NCT02265705|11824032|FG005|STARTED|Follow-up Period|Participants from placebo who never rescued or switched and entered post-treatment follow-up period.|2
10662110|NCT02265705|11824033|FG006|STARTED|Follow-up Period|Participants who ever took baricitinib and entered the post-treatment follow-up period.|58
10662111|NCT02265705|11824027|FG000|COMPLETED|Follow-up Period||0
10662112|NCT02265705|11824028|FG001|COMPLETED|Follow-up Period||0
10662113|NCT02265705|11824029|FG002|COMPLETED|Follow-up Period||0
10662114|NCT02265705|11824030|FG003|COMPLETED|Follow-up Period||0
10662115|NCT02265705|11824031|FG004|COMPLETED|Follow-up Period||0
10662116|NCT02265705|11824032|FG005|COMPLETED|Follow-up Period||1
10662117|NCT02265705|11824033|FG006|COMPLETED|Follow-up Period||47
10662118|NCT02265705|11824027|FG000|NOT COMPLETED|Follow-up Period||0
10662119|NCT02265705|11824028|FG001|NOT COMPLETED|Follow-up Period||0
10662120|NCT02265705|11824029|FG002|NOT COMPLETED|Follow-up Period||0
10662121|NCT02265705|11824030|FG003|NOT COMPLETED|Follow-up Period||0
10662122|NCT02265705|11824031|FG004|NOT COMPLETED|Follow-up Period||0
10662123|NCT02265705|11824032|FG005|NOT COMPLETED|Follow-up Period||1
10662124|NCT02265705|11824033|FG006|NOT COMPLETED|Follow-up Period||11
10662125|NCT02265744|11824049|FG000|STARTED|Overall Study||69
10662126|NCT02265744|11824050|FG001|STARTED|Overall Study||68
10662127|NCT02265744|11824051|FG002|STARTED|Overall Study||68
10662128|NCT02265744|11824052|FG003|STARTED|Overall Study||70
10662129|NCT02265744|11824053|FG004|STARTED|Overall Study||71
10662130|NCT02265744|11824049|FG000|COMPLETED|Overall Study||49
10662131|NCT02265744|11824050|FG001|COMPLETED|Overall Study||53
10662132|NCT02265744|11824051|FG002|COMPLETED|Overall Study||51
10662133|NCT02265744|11824052|FG003|COMPLETED|Overall Study||47
10662134|NCT02265744|11824053|FG004|COMPLETED|Overall Study||58
10662135|NCT02265744|11824049|FG000|NOT COMPLETED|Overall Study||20
10662136|NCT02265744|11824050|FG001|NOT COMPLETED|Overall Study||15
10662137|NCT02265744|11824051|FG002|NOT COMPLETED|Overall Study||17
10662138|NCT02265744|11824052|FG003|NOT COMPLETED|Overall Study||23
10662139|NCT02265744|11824053|FG004|NOT COMPLETED|Overall Study||13
10662140|NCT02265783|11824065|FG000|STARTED|Overall Study||20
10662141|NCT02265783|11824065|FG000|COMPLETED|Overall Study|All subjects completed, one excluded from the analysis due to an issue with the data collection|20
10662142|NCT02265783|11824065|FG000|NOT COMPLETED|Overall Study||0
10662143|NCT02265796|11824071|FG000|STARTED|Overall Study||25
10662144|NCT02265796|11824072|FG001|STARTED|Overall Study||25
10662145|NCT02265796|11824071|FG000|COMPLETED|Overall Study||22
10662146|NCT02265796|11824072|FG001|COMPLETED|Overall Study||24
10662147|NCT02265796|11824071|FG000|NOT COMPLETED|Overall Study||3
10662148|NCT02265796|11824072|FG001|NOT COMPLETED|Overall Study||1
10662149|NCT02265848|11824080|FG000|STARTED|Overall Study|First subject for this study was randomized on October 1st 2014|11
10662150|NCT02265848|11824081|FG001|STARTED|Overall Study||11
10662151|NCT02265848|11824080|FG000|COMPLETED|Overall Study||11
10662152|NCT02265848|11824081|FG001|COMPLETED|Overall Study|Last subject for this study completed the visit on December 24, 2014|11
10662153|NCT02265848|11824080|FG000|NOT COMPLETED|Overall Study||0
10662154|NCT02265848|11824081|FG001|NOT COMPLETED|Overall Study||0
10662155|NCT02265913|11824090|FG000|STARTED|Overall Study||1357
10662156|NCT02265913|11824091|FG001|STARTED|Overall Study||1361
10662157|NCT02265913|11824092|FG002|STARTED|Overall Study||1358
10662158|NCT02265913|11824090|FG000|COMPLETED|Overall Study||793
10662159|NCT02265913|11824091|FG001|COMPLETED|Overall Study||810
10662160|NCT02265913|11824092|FG002|COMPLETED|Overall Study||813
10662161|NCT02265913|11824090|FG000|NOT COMPLETED|Overall Study||564
10662162|NCT02265913|11824091|FG001|NOT COMPLETED|Overall Study||551
10662163|NCT02265913|11824092|FG002|NOT COMPLETED|Overall Study||545
10662164|NCT02265952|11824100|FG000|STARTED|Main Study Period||9
10662165|NCT02265952|11824101|FG001|STARTED|Main Study Period||0
10662166|NCT02265952|11824100|FG000|COMPLETED|Main Study Period||9
10662167|NCT02265952|11824101|FG001|COMPLETED|Main Study Period||0
10662168|NCT02265952|11824100|FG000|NOT COMPLETED|Main Study Period||0
10662169|NCT02265952|11824101|FG001|NOT COMPLETED|Main Study Period||0
10662170|NCT02265952|11824100|FG000|STARTED|Open Label Extension (OLE) Period||0
10662171|NCT02265952|11824101|FG001|STARTED|Open Label Extension (OLE) Period||8
10662172|NCT02265952|11824100|FG000|COMPLETED|Open Label Extension (OLE) Period||0
10662173|NCT02265952|11824101|FG001|COMPLETED|Open Label Extension (OLE) Period||0
10662174|NCT02265952|11824100|FG000|NOT COMPLETED|Open Label Extension (OLE) Period||0
10662175|NCT02265952|11824101|FG001|NOT COMPLETED|Open Label Extension (OLE) Period||8
10662176|NCT02265965|11824109|FG000|STARTED|Overall Study||7
10662177|NCT02265965|11824110|FG001|STARTED|Overall Study||11
10662178|NCT02265965|11824109|FG000|COMPLETED|Overall Study||7
10662179|NCT02265965|11824110|FG001|COMPLETED|Overall Study||11
10662180|NCT02265965|11824109|FG000|NOT COMPLETED|Overall Study||0
10662181|NCT02265965|11824110|FG001|NOT COMPLETED|Overall Study||0
10662182|NCT02266004|11824116|FG000|STARTED|Overall Study||9
10662183|NCT02266004|11824116|FG000|COMPLETED|Overall Study||7
10662184|NCT02266004|11824116|FG000|NOT COMPLETED|Overall Study||2
10662185|NCT02266108|11824122|FG000|STARTED|Overall Study||80
10662186|NCT02266108|11824123|FG001|STARTED|Overall Study||71
10662187|NCT02266108|11824122|FG000|COMPLETED|Overall Study||80
10662188|NCT02266108|11824123|FG001|COMPLETED|Overall Study||71
10662189|NCT02266108|11824122|FG000|NOT COMPLETED|Overall Study||0
10662190|NCT02266108|11824123|FG001|NOT COMPLETED|Overall Study||0
10662191|NCT02266147|11824133|FG000|STARTED|PART 1: Dose Escalation||3
10662192|NCT02266147|11824134|FG001|STARTED|PART 1: Dose Escalation||3
10662193|NCT02266147|11824135|FG002|STARTED|PART 1: Dose Escalation||3
10662194|NCT02266147|11824136|FG003|STARTED|PART 1: Dose Escalation||4
10662195|NCT02266147|11824133|FG000|COMPLETED|PART 1: Dose Escalation||2
10662196|NCT02266147|11824134|FG001|COMPLETED|PART 1: Dose Escalation||0
10662197|NCT02266147|11824135|FG002|COMPLETED|PART 1: Dose Escalation||0
10662198|NCT02266147|11824136|FG003|COMPLETED|PART 1: Dose Escalation||0
10662199|NCT02266147|11824133|FG000|NOT COMPLETED|PART 1: Dose Escalation||1
10662200|NCT02266147|11824134|FG001|NOT COMPLETED|PART 1: Dose Escalation||3
10662201|NCT02266147|11824135|FG002|NOT COMPLETED|PART 1: Dose Escalation||3
10662202|NCT02266147|11824136|FG003|NOT COMPLETED|PART 1: Dose Escalation||4
10662203|NCT02266147|11824133|FG000|STARTED|PART 2: Dose Expansion|Participants were enrolled separately from Part 1; sponsor terminated the trial early during Part 2.|7
10662204|NCT02266147|11824134|FG001|STARTED|PART 2: Dose Expansion|No new participants were enrolled and sponsor terminated the trial early during Part 2.|0
10662205|NCT02266147|11824135|FG002|STARTED|PART 2: Dose Expansion|No new participants were enrolled and sponsor terminated the trial early during Part 2.|0
10662206|NCT02266147|11824136|FG003|STARTED|PART 2: Dose Expansion|Participants were enrolled separately from Part 1; sponsor terminated the trial early during Part 2.|9
10662207|NCT02266147|11824133|FG000|COMPLETED|PART 2: Dose Expansion||0
10662208|NCT02266147|11824134|FG001|COMPLETED|PART 2: Dose Expansion||0
10662209|NCT02266147|11824135|FG002|COMPLETED|PART 2: Dose Expansion||0
10662210|NCT02266147|11824136|FG003|COMPLETED|PART 2: Dose Expansion||0
10662211|NCT02266147|11824133|FG000|NOT COMPLETED|PART 2: Dose Expansion||7
10662212|NCT02266147|11824134|FG001|NOT COMPLETED|PART 2: Dose Expansion||0
10662213|NCT02266147|11824135|FG002|NOT COMPLETED|PART 2: Dose Expansion||0
10662214|NCT02266147|11824136|FG003|NOT COMPLETED|PART 2: Dose Expansion||9
10662215|NCT02266225|11824148|FG000|STARTED|Overall Study||48
10662216|NCT02266225|11824148|FG000|Enrolled in Intervention|Overall Study||44
10662217|NCT02266225|11824148|FG000|COMPLETED|Overall Study||32
10662218|NCT02266225|11824148|FG000|NOT COMPLETED|Overall Study||16
10662219|NCT02266277|11824159|FG000|STARTED|Overall Study||5000
10662220|NCT02266277|11824160|FG001|STARTED|Overall Study||5000
10662221|NCT02266277|11824161|FG002|STARTED|Overall Study||5000
10662222|NCT02266277|11824162|FG003|STARTED|Overall Study||5000
10662223|NCT02266277|11824163|FG004|STARTED|Overall Study||5000
10662224|NCT02266277|11824164|FG005|STARTED|Overall Study||5000
10662225|NCT02266277|11824159|FG000|COMPLETED|Overall Study||5000
10662226|NCT02266277|11824160|FG001|COMPLETED|Overall Study||5000
10662227|NCT02266277|11824161|FG002|COMPLETED|Overall Study||5000
10662228|NCT02266277|11824162|FG003|COMPLETED|Overall Study||5000
10662229|NCT02266277|11824163|FG004|COMPLETED|Overall Study||5000
10662230|NCT02266277|11824164|FG005|COMPLETED|Overall Study||5000
10662231|NCT02266277|11824159|FG000|NOT COMPLETED|Overall Study||0
10662232|NCT02266277|11824160|FG001|NOT COMPLETED|Overall Study||0
10662233|NCT02266277|11824161|FG002|NOT COMPLETED|Overall Study||0
10662234|NCT02266277|11824162|FG003|NOT COMPLETED|Overall Study||0
10662235|NCT02266277|11824163|FG004|NOT COMPLETED|Overall Study||0
10662236|NCT02266277|11824164|FG005|NOT COMPLETED|Overall Study||0
10662237|NCT02266381|11824183|FG000|STARTED|Overall Study||150
10662238|NCT02266381|11824184|FG001|STARTED|Overall Study||150
10662239|NCT02266381|11824185|FG002|STARTED|Overall Study||150
10662240|NCT02266381|11824183|FG000|COMPLETED|Overall Study||147
10662241|NCT02266381|11824184|FG001|COMPLETED|Overall Study||145
10662242|NCT02266381|11824185|FG002|COMPLETED|Overall Study||146
10662243|NCT02266381|11824183|FG000|NOT COMPLETED|Overall Study||3
10662244|NCT02266381|11824184|FG001|NOT COMPLETED|Overall Study||5
10662245|NCT02266381|11824185|FG002|NOT COMPLETED|Overall Study||4
10756130|NCT03074162|11919835|FG001|STARTED|Period 1 Including Washout 1||8
10756131|NCT03074162|11919836|FG002|STARTED|Period 1 Including Washout 1||8
10756132|NCT03074162|11919837|FG003|STARTED|Period 1 Including Washout 1||8
10756133|NCT03074162|11919838|FG004|STARTED|Period 1 Including Washout 1||8
10756134|NCT03074162|11919839|FG005|STARTED|Period 1 Including Washout 1||8
10756135|NCT03074162|11919834|FG000|COMPLETED|Period 1 Including Washout 1||8
10756136|NCT03074162|11919835|FG001|COMPLETED|Period 1 Including Washout 1||8
10756137|NCT03074162|11919836|FG002|COMPLETED|Period 1 Including Washout 1||7
10756138|NCT03074162|11919837|FG003|COMPLETED|Period 1 Including Washout 1||8
10756139|NCT03074162|11919838|FG004|COMPLETED|Period 1 Including Washout 1||8
10756140|NCT03074162|11919839|FG005|COMPLETED|Period 1 Including Washout 1||8
10756141|NCT03074162|11919834|FG000|NOT COMPLETED|Period 1 Including Washout 1||0
10756142|NCT03074162|11919835|FG001|NOT COMPLETED|Period 1 Including Washout 1||0
10756143|NCT03074162|11919836|FG002|NOT COMPLETED|Period 1 Including Washout 1||1
10756144|NCT03074162|11919837|FG003|NOT COMPLETED|Period 1 Including Washout 1||0
10756145|NCT03074162|11919838|FG004|NOT COMPLETED|Period 1 Including Washout 1||0
10756146|NCT03074162|11919839|FG005|NOT COMPLETED|Period 1 Including Washout 1||0
10756147|NCT03074162|11919834|FG000|STARTED|Period 2 Including Washout 2||8
10756148|NCT03074162|11919835|FG001|STARTED|Period 2 Including Washout 2||8
10756149|NCT03074162|11919836|FG002|STARTED|Period 2 Including Washout 2||7
10756150|NCT03074162|11919837|FG003|STARTED|Period 2 Including Washout 2||8
10756151|NCT03074162|11919838|FG004|STARTED|Period 2 Including Washout 2||8
10756152|NCT03074162|11919839|FG005|STARTED|Period 2 Including Washout 2||8
10756153|NCT03074162|11919834|FG000|COMPLETED|Period 2 Including Washout 2||8
10756154|NCT03074162|11919835|FG001|COMPLETED|Period 2 Including Washout 2||8
10756155|NCT03074162|11919836|FG002|COMPLETED|Period 2 Including Washout 2||6
10756156|NCT03074162|11919837|FG003|COMPLETED|Period 2 Including Washout 2||8
10756157|NCT03074162|11919838|FG004|COMPLETED|Period 2 Including Washout 2||8
10756158|NCT03074162|11919839|FG005|COMPLETED|Period 2 Including Washout 2||7
10756159|NCT03074162|11919834|FG000|NOT COMPLETED|Period 2 Including Washout 2||0
10756160|NCT03074162|11919835|FG001|NOT COMPLETED|Period 2 Including Washout 2||0
10756161|NCT03074162|11919836|FG002|NOT COMPLETED|Period 2 Including Washout 2||1
10756162|NCT03074162|11919837|FG003|NOT COMPLETED|Period 2 Including Washout 2||0
10756163|NCT03074162|11919838|FG004|NOT COMPLETED|Period 2 Including Washout 2||0
10756164|NCT03074162|11919839|FG005|NOT COMPLETED|Period 2 Including Washout 2||1
10756165|NCT03074162|11919834|FG000|STARTED|Period 3||8
10756166|NCT03074162|11919835|FG001|STARTED|Period 3||8
10756167|NCT03074162|11919836|FG002|STARTED|Period 3||6
10756168|NCT03074162|11919837|FG003|STARTED|Period 3||8
10756169|NCT03074162|11919838|FG004|STARTED|Period 3||8
10756170|NCT03074162|11919839|FG005|STARTED|Period 3||7
10756171|NCT03074162|11919834|FG000|COMPLETED|Period 3||7
10756172|NCT03074162|11919835|FG001|COMPLETED|Period 3||8
10756173|NCT03074162|11919836|FG002|COMPLETED|Period 3||6
10756174|NCT03074162|11919837|FG003|COMPLETED|Period 3||8
10756175|NCT03074162|11919838|FG004|COMPLETED|Period 3||7
10756176|NCT03074162|11919839|FG005|COMPLETED|Period 3||7
10756177|NCT03074162|11919834|FG000|NOT COMPLETED|Period 3||1
10756178|NCT03074162|11919835|FG001|NOT COMPLETED|Period 3||0
10756179|NCT03074162|11919836|FG002|NOT COMPLETED|Period 3||0
10756180|NCT03074162|11919837|FG003|NOT COMPLETED|Period 3||0
10756181|NCT03074162|11919838|FG004|NOT COMPLETED|Period 3||1
10756182|NCT03074162|11919839|FG005|NOT COMPLETED|Period 3||0
10756183|NCT03074331|11919847|FG000|STARTED|Overall Study||130
10756184|NCT03074331|11919847|FG000|COMPLETED|Overall Study||123
10756185|NCT03074331|11919847|FG000|NOT COMPLETED|Overall Study||7
10756186|NCT03074409|11919853|FG000|STARTED|Overall Study||41
10756187|NCT03074409|11919854|FG001|STARTED|Overall Study||42
10756188|NCT03074409|11919853|FG000|COMPLETED|Overall Study||37
10756189|NCT03074409|11919854|FG001|COMPLETED|Overall Study||38
10756190|NCT03074409|11919853|FG000|NOT COMPLETED|Overall Study||4
10756191|NCT03074409|11919854|FG001|NOT COMPLETED|Overall Study||4
10756192|NCT03074500|11919863|FG000|STARTED|Overall Study||11
10756193|NCT03074500|11919864|FG001|STARTED|Overall Study||11
10756194|NCT03074500|11919865|FG002|STARTED|Overall Study||11
10756195|NCT03074500|11919863|FG000|COMPLETED|Overall Study||10
10756196|NCT03074500|11919864|FG001|COMPLETED|Overall Study||10
10756197|NCT03074500|11919865|FG002|COMPLETED|Overall Study||10
10756198|NCT03074500|11919863|FG000|NOT COMPLETED|Overall Study||1
10756199|NCT03074500|11919864|FG001|NOT COMPLETED|Overall Study||1
10756200|NCT03074500|11919865|FG002|NOT COMPLETED|Overall Study||1
10756201|NCT03074630|11919875|FG000|STARTED|Overall Study||12
10756202|NCT03074630|11919875|FG000|COMPLETED|Overall Study||11
10756203|NCT03074630|11919875|FG000|NOT COMPLETED|Overall Study||1
10756204|NCT03074682|11919883|FG000|STARTED|Overall Study||18
10756205|NCT03074682|11919884|FG001|STARTED|Overall Study||18
10756206|NCT03074682|11919885|FG002|STARTED|Overall Study||18
10756207|NCT03074682|11919883|FG000|COMPLETED|Overall Study||18
10756208|NCT03074682|11919884|FG001|COMPLETED|Overall Study||18
10756209|NCT03074682|11919885|FG002|COMPLETED|Overall Study||18
10756210|NCT03074682|11919883|FG000|NOT COMPLETED|Overall Study||0
10756211|NCT03074682|11919884|FG001|NOT COMPLETED|Overall Study||0
10756212|NCT03074682|11919885|FG002|NOT COMPLETED|Overall Study||0
10756213|NCT03075085|11919895|FG000|STARTED|Overall Study||352
10756214|NCT03075085|11919896|FG001|STARTED|Overall Study||344
10756215|NCT03075085|11919895|FG000|COMPLETED|Overall Study||247
10756216|NCT03075085|11919896|FG001|COMPLETED|Overall Study||232
10756217|NCT03075085|11919895|FG000|NOT COMPLETED|Overall Study||105
10756218|NCT03075085|11919896|FG001|NOT COMPLETED|Overall Study||112
10756219|NCT03075163|11919904|FG000|STARTED|Overall Study||150
10756220|NCT03075163|11919905|FG001|STARTED|Overall Study||150
10756221|NCT03075163|11919904|FG000|COMPLETED|Overall Study||12
10756222|NCT03075163|11919905|FG001|COMPLETED|Overall Study||12
10756223|NCT03075163|11919904|FG000|NOT COMPLETED|Overall Study||138
10756224|NCT03075163|11919905|FG001|NOT COMPLETED|Overall Study||138
10756225|NCT03075267|11919914|FG000|STARTED|Overall Study||32
10756226|NCT03075267|11919915|FG001|STARTED|Overall Study||32
10756227|NCT03075267|11919916|FG002|STARTED|Overall Study||32
10756228|NCT03075267|11919914|FG000|COMPLETED|Overall Study||31
10756229|NCT03075267|11919915|FG001|COMPLETED|Overall Study||32
10756230|NCT03075267|11919916|FG002|COMPLETED|Overall Study||32
10756231|NCT03075267|11919914|FG000|NOT COMPLETED|Overall Study||1
10756232|NCT03075267|11919915|FG001|NOT COMPLETED|Overall Study||0
10756233|NCT03075267|11919916|FG002|NOT COMPLETED|Overall Study||0
10756234|NCT03075410|11919933|FG000|STARTED|Part A-Period 1 (14 Days)||2
10756235|NCT03075410|11919934|FG001|STARTED|Part A-Period 1 (14 Days)||1
10756236|NCT03075410|11919935|FG002|STARTED|Part A-Period 1 (14 Days)||2
10756237|NCT03075410|11919936|FG003|STARTED|Part A-Period 1 (14 Days)||1
10756238|NCT03075410|11919937|FG004|STARTED|Part A-Period 1 (14 Days)||2
10756239|NCT03075410|11919938|FG005|STARTED|Part A-Period 1 (14 Days)||1
10756240|NCT03075410|11919939|FG006|STARTED|Part A-Period 1 (14 Days)||0
10756241|NCT03075410|11919940|FG007|STARTED|Part A-Period 1 (14 Days)||0
10756242|NCT03075410|11919941|FG008|STARTED|Part A-Period 1 (14 Days)||0
10756243|NCT03075410|11919933|FG000|COMPLETED|Part A-Period 1 (14 Days)||2
10756244|NCT03075410|11919934|FG001|COMPLETED|Part A-Period 1 (14 Days)||1
10756245|NCT03075410|11919935|FG002|COMPLETED|Part A-Period 1 (14 Days)||2
10756246|NCT03075410|11919936|FG003|COMPLETED|Part A-Period 1 (14 Days)||1
10756247|NCT03075410|11919937|FG004|COMPLETED|Part A-Period 1 (14 Days)||2
10756248|NCT03075410|11919938|FG005|COMPLETED|Part A-Period 1 (14 Days)||1
10756249|NCT03075410|11919939|FG006|COMPLETED|Part A-Period 1 (14 Days)||0
10756250|NCT03075410|11919940|FG007|COMPLETED|Part A-Period 1 (14 Days)||0
10756251|NCT03075410|11919941|FG008|COMPLETED|Part A-Period 1 (14 Days)||0
10756252|NCT03075410|11919933|FG000|NOT COMPLETED|Part A-Period 1 (14 Days)||0
10756253|NCT03075410|11919934|FG001|NOT COMPLETED|Part A-Period 1 (14 Days)||0
10756254|NCT03075410|11919935|FG002|NOT COMPLETED|Part A-Period 1 (14 Days)||0
10756255|NCT03075410|11919936|FG003|NOT COMPLETED|Part A-Period 1 (14 Days)||0
10756256|NCT03075410|11919937|FG004|NOT COMPLETED|Part A-Period 1 (14 Days)||0
10756257|NCT03075410|11919938|FG005|NOT COMPLETED|Part A-Period 1 (14 Days)||0
10756258|NCT03075410|11919939|FG006|NOT COMPLETED|Part A-Period 1 (14 Days)||0
10756259|NCT03075410|11919940|FG007|NOT COMPLETED|Part A-Period 1 (14 Days)||0
10756260|NCT03075410|11919941|FG008|NOT COMPLETED|Part A-Period 1 (14 Days)||0
10756261|NCT03075410|11919933|FG000|STARTED|Part A-Washout Period 1 (14 Days)||2
10756262|NCT03075410|11919934|FG001|STARTED|Part A-Washout Period 1 (14 Days)||1
10756263|NCT03075410|11919935|FG002|STARTED|Part A-Washout Period 1 (14 Days)||2
10756264|NCT03075410|11919936|FG003|STARTED|Part A-Washout Period 1 (14 Days)||1
10756265|NCT03075410|11919937|FG004|STARTED|Part A-Washout Period 1 (14 Days)||2
10756266|NCT03075410|11919938|FG005|STARTED|Part A-Washout Period 1 (14 Days)||1
10756267|NCT03075410|11919939|FG006|STARTED|Part A-Washout Period 1 (14 Days)||0
10756268|NCT03075410|11919940|FG007|STARTED|Part A-Washout Period 1 (14 Days)||0
10756269|NCT03075410|11919941|FG008|STARTED|Part A-Washout Period 1 (14 Days)||0
10756270|NCT03075410|11919933|FG000|COMPLETED|Part A-Washout Period 1 (14 Days)||2
10756271|NCT03075410|11919934|FG001|COMPLETED|Part A-Washout Period 1 (14 Days)||1
10756272|NCT03075410|11919935|FG002|COMPLETED|Part A-Washout Period 1 (14 Days)||2
10756273|NCT03075410|11919936|FG003|COMPLETED|Part A-Washout Period 1 (14 Days)||1
10756274|NCT03075410|11919937|FG004|COMPLETED|Part A-Washout Period 1 (14 Days)||2
10756275|NCT03075410|11919938|FG005|COMPLETED|Part A-Washout Period 1 (14 Days)||1
10756276|NCT03075410|11919939|FG006|COMPLETED|Part A-Washout Period 1 (14 Days)||0
10756277|NCT03075410|11919940|FG007|COMPLETED|Part A-Washout Period 1 (14 Days)||0
10756278|NCT03075410|11919941|FG008|COMPLETED|Part A-Washout Period 1 (14 Days)||0
10756279|NCT03075410|11919933|FG000|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
10756280|NCT03075410|11919934|FG001|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
10756281|NCT03075410|11919935|FG002|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
10756282|NCT03075410|11919936|FG003|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
10756283|NCT03075410|11919937|FG004|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
10756284|NCT03075410|11919938|FG005|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
10756285|NCT03075410|11919939|FG006|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
10756286|NCT03075410|11919940|FG007|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
10756287|NCT03075410|11919941|FG008|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
10756288|NCT03075410|11919933|FG000|STARTED|Part A-Period 2 (14 Days)||2
10756289|NCT03075410|11919934|FG001|STARTED|Part A-Period 2 (14 Days)||1
10756290|NCT03075410|11919935|FG002|STARTED|Part A-Period 2 (14 Days)||2
10756291|NCT03075410|11919936|FG003|STARTED|Part A-Period 2 (14 Days)||1
10756292|NCT03075410|11919937|FG004|STARTED|Part A-Period 2 (14 Days)||2
10756293|NCT03075410|11919938|FG005|STARTED|Part A-Period 2 (14 Days)||1
10756294|NCT03075410|11919939|FG006|STARTED|Part A-Period 2 (14 Days)||0
10756295|NCT03075410|11919940|FG007|STARTED|Part A-Period 2 (14 Days)||0
10756296|NCT03075410|11919941|FG008|STARTED|Part A-Period 2 (14 Days)||0
10756297|NCT03075410|11919933|FG000|COMPLETED|Part A-Period 2 (14 Days)||1
10756298|NCT03075410|11919934|FG001|COMPLETED|Part A-Period 2 (14 Days)||1
10756299|NCT03075410|11919935|FG002|COMPLETED|Part A-Period 2 (14 Days)||1
10756300|NCT03075410|11919936|FG003|COMPLETED|Part A-Period 2 (14 Days)||1
10756301|NCT03075410|11919937|FG004|COMPLETED|Part A-Period 2 (14 Days)||2
10756302|NCT03075410|11919938|FG005|COMPLETED|Part A-Period 2 (14 Days)||1
10756303|NCT03075410|11919939|FG006|COMPLETED|Part A-Period 2 (14 Days)||0
10756304|NCT03075410|11919940|FG007|COMPLETED|Part A-Period 2 (14 Days)||0
10756305|NCT03075410|11919941|FG008|COMPLETED|Part A-Period 2 (14 Days)||0
10756306|NCT03075410|11919933|FG000|NOT COMPLETED|Part A-Period 2 (14 Days)||1
10756307|NCT03075410|11919934|FG001|NOT COMPLETED|Part A-Period 2 (14 Days)||0
10756308|NCT03075410|11919935|FG002|NOT COMPLETED|Part A-Period 2 (14 Days)||1
10756309|NCT03075410|11919936|FG003|NOT COMPLETED|Part A-Period 2 (14 Days)||0
10756310|NCT03075410|11919937|FG004|NOT COMPLETED|Part A-Period 2 (14 Days)||0
10756311|NCT03075410|11919938|FG005|NOT COMPLETED|Part A-Period 2 (14 Days)||0
10756312|NCT03075410|11919939|FG006|NOT COMPLETED|Part A-Period 2 (14 Days)||0
10756313|NCT03075410|11919940|FG007|NOT COMPLETED|Part A-Period 2 (14 Days)||0
10756314|NCT03075410|11919941|FG008|NOT COMPLETED|Part A-Period 2 (14 Days)||0
10756315|NCT03075410|11919933|FG000|STARTED|Part A-Washout Period 2 (14 Days)||1
10756316|NCT03075410|11919934|FG001|STARTED|Part A-Washout Period 2 (14 Days)||1
10756317|NCT03075410|11919935|FG002|STARTED|Part A-Washout Period 2 (14 Days)||1
10756318|NCT03075410|11919936|FG003|STARTED|Part A-Washout Period 2 (14 Days)||1
10756319|NCT03075410|11919937|FG004|STARTED|Part A-Washout Period 2 (14 Days)||2
10756320|NCT03075410|11919938|FG005|STARTED|Part A-Washout Period 2 (14 Days)||1
10756321|NCT03075410|11919939|FG006|STARTED|Part A-Washout Period 2 (14 Days)||0
10756322|NCT03075410|11919940|FG007|STARTED|Part A-Washout Period 2 (14 Days)||0
10756323|NCT03075410|11919941|FG008|STARTED|Part A-Washout Period 2 (14 Days)||0
10756324|NCT03075410|11919933|FG000|COMPLETED|Part A-Washout Period 2 (14 Days)||1
10756325|NCT03075410|11919934|FG001|COMPLETED|Part A-Washout Period 2 (14 Days)||1
10756326|NCT03075410|11919935|FG002|COMPLETED|Part A-Washout Period 2 (14 Days)||1
10756327|NCT03075410|11919936|FG003|COMPLETED|Part A-Washout Period 2 (14 Days)||1
10756328|NCT03075410|11919937|FG004|COMPLETED|Part A-Washout Period 2 (14 Days)||2
10756329|NCT03075410|11919938|FG005|COMPLETED|Part A-Washout Period 2 (14 Days)||1
10756330|NCT03075410|11919939|FG006|COMPLETED|Part A-Washout Period 2 (14 Days)||0
10756331|NCT03075410|11919940|FG007|COMPLETED|Part A-Washout Period 2 (14 Days)||0
10756332|NCT03075410|11919941|FG008|COMPLETED|Part A-Washout Period 2 (14 Days)||0
10756333|NCT03075410|11919933|FG000|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
10756334|NCT03075410|11919934|FG001|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
10756335|NCT03075410|11919935|FG002|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
10756336|NCT03075410|11919936|FG003|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
10756337|NCT03075410|11919937|FG004|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
10756338|NCT03075410|11919938|FG005|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
10756339|NCT03075410|11919939|FG006|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
10756340|NCT03075410|11919940|FG007|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
10756341|NCT03075410|11919941|FG008|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
10756342|NCT03075410|11919933|FG000|STARTED|Part A-Period 3 (14 Days)|Participants who withdrew in Period 2 were replaced (2 new participants entered Part A period 3).|2
10756343|NCT03075410|11919934|FG001|STARTED|Part A-Period 3 (14 Days)||1
10756344|NCT03075410|11919935|FG002|STARTED|Part A-Period 3 (14 Days)|Participants who withdrew in Period 2 were replaced (2 new participants entered Part A period 3).|2
10756345|NCT03075410|11919936|FG003|STARTED|Part A-Period 3 (14 Days)||1
10756346|NCT03075410|11919937|FG004|STARTED|Part A-Period 3 (14 Days)||2
10756347|NCT03075410|11919938|FG005|STARTED|Part A-Period 3 (14 Days)||1
10756348|NCT03075410|11919939|FG006|STARTED|Part A-Period 3 (14 Days)||0
10756349|NCT03075410|11919940|FG007|STARTED|Part A-Period 3 (14 Days)||0
10756350|NCT03075410|11919941|FG008|STARTED|Part A-Period 3 (14 Days)||0
10756351|NCT03075410|11919933|FG000|COMPLETED|Part A-Period 3 (14 Days)||1
10756352|NCT03075410|11919934|FG001|COMPLETED|Part A-Period 3 (14 Days)||1
10756353|NCT03075410|11919935|FG002|COMPLETED|Part A-Period 3 (14 Days)||2
10756354|NCT03075410|11919936|FG003|COMPLETED|Part A-Period 3 (14 Days)||1
10756355|NCT03075410|11919937|FG004|COMPLETED|Part A-Period 3 (14 Days)||2
10756356|NCT03075410|11919938|FG005|COMPLETED|Part A-Period 3 (14 Days)||1
10756357|NCT03075410|11919939|FG006|COMPLETED|Part A-Period 3 (14 Days)||0
10756358|NCT03075410|11919940|FG007|COMPLETED|Part A-Period 3 (14 Days)||0
10756359|NCT03075410|11919941|FG008|COMPLETED|Part A-Period 3 (14 Days)||0
10756360|NCT03075410|11919933|FG000|NOT COMPLETED|Part A-Period 3 (14 Days)||1
10756361|NCT03075410|11919934|FG001|NOT COMPLETED|Part A-Period 3 (14 Days)||0
10756362|NCT03075410|11919935|FG002|NOT COMPLETED|Part A-Period 3 (14 Days)||0
10756363|NCT03075410|11919936|FG003|NOT COMPLETED|Part A-Period 3 (14 Days)||0
10874551|NCT04927858|12040653|FG000|Treated With Empagliflozin|Overall Study||16985
10874552|NCT04927858|12040653|FG000|COMPLETED|Overall Study||460558
10756364|NCT03075410|11919937|FG004|NOT COMPLETED|Part A-Period 3 (14 Days)||0
10756365|NCT03075410|11919938|FG005|NOT COMPLETED|Part A-Period 3 (14 Days)||0
10756366|NCT03075410|11919939|FG006|NOT COMPLETED|Part A-Period 3 (14 Days)||0
10756367|NCT03075410|11919940|FG007|NOT COMPLETED|Part A-Period 3 (14 Days)||0
10756368|NCT03075410|11919941|FG008|NOT COMPLETED|Part A-Period 3 (14 Days)||0
10756369|NCT03075410|11919933|FG000|STARTED|Part A-Washout Period 3 (14 Days)||1
10756370|NCT03075410|11919934|FG001|STARTED|Part A-Washout Period 3 (14 Days)||1
10756371|NCT03075410|11919935|FG002|STARTED|Part A-Washout Period 3 (14 Days)||2
10756372|NCT03075410|11919936|FG003|STARTED|Part A-Washout Period 3 (14 Days)||1
10756373|NCT03075410|11919937|FG004|STARTED|Part A-Washout Period 3 (14 Days)||2
10756374|NCT03075410|11919938|FG005|STARTED|Part A-Washout Period 3 (14 Days)||1
10756375|NCT03075410|11919939|FG006|STARTED|Part A-Washout Period 3 (14 Days)||0
10756376|NCT03075410|11919940|FG007|STARTED|Part A-Washout Period 3 (14 Days)||0
10756377|NCT03075410|11919941|FG008|STARTED|Part A-Washout Period 3 (14 Days)||0
10756378|NCT03075410|11919933|FG000|COMPLETED|Part A-Washout Period 3 (14 Days)||1
10756379|NCT03075410|11919934|FG001|COMPLETED|Part A-Washout Period 3 (14 Days)||1
10756380|NCT03075410|11919935|FG002|COMPLETED|Part A-Washout Period 3 (14 Days)||2
10756381|NCT03075410|11919936|FG003|COMPLETED|Part A-Washout Period 3 (14 Days)||1
10756382|NCT03075410|11919937|FG004|COMPLETED|Part A-Washout Period 3 (14 Days)||2
10756383|NCT03075410|11919938|FG005|COMPLETED|Part A-Washout Period 3 (14 Days)||1
10756384|NCT03075410|11919939|FG006|COMPLETED|Part A-Washout Period 3 (14 Days)||0
10756385|NCT03075410|11919940|FG007|COMPLETED|Part A-Washout Period 3 (14 Days)||0
10756386|NCT03075410|11919941|FG008|COMPLETED|Part A-Washout Period 3 (14 Days)||0
10756387|NCT03075410|11919933|FG000|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
10756388|NCT03075410|11919934|FG001|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
10756389|NCT03075410|11919935|FG002|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
10756390|NCT03075410|11919936|FG003|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
10756391|NCT03075410|11919937|FG004|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
10756392|NCT03075410|11919938|FG005|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
10756393|NCT03075410|11919939|FG006|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
10756394|NCT03075410|11919940|FG007|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
10756395|NCT03075410|11919941|FG008|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
10756396|NCT03075410|11919933|FG000|STARTED|Part A-Period 4 (14 Days)||1
10756397|NCT03075410|11919934|FG001|STARTED|Part A-Period 4 (14 Days)||1
10756398|NCT03075410|11919935|FG002|STARTED|Part A-Period 4 (14 Days)||2
10756399|NCT03075410|11919936|FG003|STARTED|Part A-Period 4 (14 Days)||1
10756400|NCT03075410|11919937|FG004|STARTED|Part A-Period 4 (14 Days)||2
10756401|NCT03075410|11919938|FG005|STARTED|Part A-Period 4 (14 Days)||1
10756402|NCT03075410|11919939|FG006|STARTED|Part A-Period 4 (14 Days)||0
10756403|NCT03075410|11919940|FG007|STARTED|Part A-Period 4 (14 Days)||0
10756404|NCT03075410|11919941|FG008|STARTED|Part A-Period 4 (14 Days)||0
10756405|NCT03075410|11919933|FG000|COMPLETED|Part A-Period 4 (14 Days)||1
10756406|NCT03075410|11919934|FG001|COMPLETED|Part A-Period 4 (14 Days)||1
10756407|NCT03075410|11919935|FG002|COMPLETED|Part A-Period 4 (14 Days)||2
10756408|NCT03075410|11919936|FG003|COMPLETED|Part A-Period 4 (14 Days)||1
10756409|NCT03075410|11919937|FG004|COMPLETED|Part A-Period 4 (14 Days)||2
10756410|NCT03075410|11919938|FG005|COMPLETED|Part A-Period 4 (14 Days)||1
10756411|NCT03075410|11919939|FG006|COMPLETED|Part A-Period 4 (14 Days)||0
10756412|NCT03075410|11919940|FG007|COMPLETED|Part A-Period 4 (14 Days)||0
10756413|NCT03075410|11919941|FG008|COMPLETED|Part A-Period 4 (14 Days)||0
10756414|NCT03075410|11919933|FG000|NOT COMPLETED|Part A-Period 4 (14 Days)||0
10756415|NCT03075410|11919934|FG001|NOT COMPLETED|Part A-Period 4 (14 Days)||0
10756416|NCT03075410|11919935|FG002|NOT COMPLETED|Part A-Period 4 (14 Days)||0
10756417|NCT03075410|11919936|FG003|NOT COMPLETED|Part A-Period 4 (14 Days)||0
10756418|NCT03075410|11919937|FG004|NOT COMPLETED|Part A-Period 4 (14 Days)||0
10756419|NCT03075410|11919938|FG005|NOT COMPLETED|Part A-Period 4 (14 Days)||0
10756420|NCT03075410|11919939|FG006|NOT COMPLETED|Part A-Period 4 (14 Days)||0
10756421|NCT03075410|11919940|FG007|NOT COMPLETED|Part A-Period 4 (14 Days)||0
10756422|NCT03075410|11919941|FG008|NOT COMPLETED|Part A-Period 4 (14 Days)||0
10756423|NCT03075410|11919933|FG000|STARTED|Part B (up to 28 Days)||0
10756424|NCT03075410|11919934|FG001|STARTED|Part B (up to 28 Days)||0
10756425|NCT03075410|11919935|FG002|STARTED|Part B (up to 28 Days)||0
10756426|NCT03075410|11919936|FG003|STARTED|Part B (up to 28 Days)||0
10756427|NCT03075410|11919937|FG004|STARTED|Part B (up to 28 Days)||0
10756428|NCT03075410|11919938|FG005|STARTED|Part B (up to 28 Days)||0
10756429|NCT03075410|11919939|FG006|STARTED|Part B (up to 28 Days)||4
10756430|NCT03075410|11919940|FG007|STARTED|Part B (up to 28 Days)||7
10756431|NCT03075410|11919941|FG008|STARTED|Part B (up to 28 Days)||8
10756432|NCT03075410|11919933|FG000|COMPLETED|Part B (up to 28 Days)||0
10756433|NCT03075410|11919934|FG001|COMPLETED|Part B (up to 28 Days)||0
10756434|NCT03075410|11919935|FG002|COMPLETED|Part B (up to 28 Days)||0
10756435|NCT03075410|11919936|FG003|COMPLETED|Part B (up to 28 Days)||0
10756436|NCT03075410|11919937|FG004|COMPLETED|Part B (up to 28 Days)||0
10756437|NCT03075410|11919938|FG005|COMPLETED|Part B (up to 28 Days)||0
10756438|NCT03075410|11919939|FG006|COMPLETED|Part B (up to 28 Days)||4
10756439|NCT03075410|11919940|FG007|COMPLETED|Part B (up to 28 Days)||7
10756440|NCT03075410|11919941|FG008|COMPLETED|Part B (up to 28 Days)||8
10756441|NCT03075410|11919933|FG000|NOT COMPLETED|Part B (up to 28 Days)||0
10756442|NCT03075410|11919934|FG001|NOT COMPLETED|Part B (up to 28 Days)||0
10756443|NCT03075410|11919935|FG002|NOT COMPLETED|Part B (up to 28 Days)||0
10756444|NCT03075410|11919936|FG003|NOT COMPLETED|Part B (up to 28 Days)||0
10756445|NCT03075410|11919937|FG004|NOT COMPLETED|Part B (up to 28 Days)||0
10756446|NCT03075410|11919938|FG005|NOT COMPLETED|Part B (up to 28 Days)||0
10756447|NCT03075410|11919939|FG006|NOT COMPLETED|Part B (up to 28 Days)||0
10756448|NCT03075410|11919940|FG007|NOT COMPLETED|Part B (up to 28 Days)||0
10756449|NCT03075410|11919941|FG008|NOT COMPLETED|Part B (up to 28 Days)||0
10756450|NCT03075449|11919965|FG000|STARTED|Overall Study||170
10756451|NCT03075449|11919965|FG000|COMPLETED|Overall Study||170
10756452|NCT03075449|11919965|FG000|NOT COMPLETED|Overall Study||0
10778762|NCT03358407|11940528|FG009|COMPLETED|Part B: Overall Period (11 Weeks)||0
10778763|NCT03358407|11940519|FG000|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
10778764|NCT03358407|11940520|FG001|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
10778765|NCT03358407|11940521|FG002|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
10778766|NCT03358407|11940522|FG003|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
10778767|NCT03358407|11940523|FG004|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
10778768|NCT03358407|11940524|FG005|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
10778769|NCT03358407|11940525|FG006|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
10778770|NCT03358407|11940526|FG007|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
10778771|NCT03358407|11940527|FG008|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
10778772|NCT03358407|11940528|FG009|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
10778773|NCT03358576|11940558|FG000|STARTED|Overall Study||338
10778774|NCT03358576|11940559|FG001|STARTED|Overall Study||336
10778775|NCT03358576|11940558|FG000|COMPLETED|Overall Study||312
10778776|NCT03358576|11940559|FG001|COMPLETED|Overall Study||311
10778777|NCT03358576|11940558|FG000|NOT COMPLETED|Overall Study||26
10778778|NCT03358576|11940559|FG001|NOT COMPLETED|Overall Study||25
10778779|NCT03359395|11940567|FG000|STARTED|First Intervention A / B||49
10778780|NCT03359395|11940568|FG001|STARTED|First Intervention A / B||50
10778781|NCT03359395|11940567|FG000|COMPLETED|First Intervention A / B||46
10778782|NCT03359395|11940568|FG001|COMPLETED|First Intervention A / B||47
10778783|NCT03359395|11940567|FG000|NOT COMPLETED|First Intervention A / B||3
10778784|NCT03359395|11940568|FG001|NOT COMPLETED|First Intervention A / B||3
10778785|NCT03359395|11940567|FG000|STARTED|Second Intervention B/A||46
10778786|NCT03359395|11940568|FG001|STARTED|Second Intervention B/A||47
10778787|NCT03359395|11940567|FG000|COMPLETED|Second Intervention B/A||43
10778788|NCT03359395|11940568|FG001|COMPLETED|Second Intervention B/A||44
10778789|NCT03359395|11940567|FG000|NOT COMPLETED|Second Intervention B/A||3
10778790|NCT03359395|11940568|FG001|NOT COMPLETED|Second Intervention B/A||3
10778791|NCT03359473|11940578|FG000|STARTED|Overall Study||23
10778792|NCT03359473|11940579|FG001|STARTED|Overall Study||24
10778793|NCT03359473|11940580|FG002|STARTED|Overall Study||24
10778794|NCT03359473|11940581|FG003|STARTED|Overall Study||25
10778795|NCT03359473|11940578|FG000|COMPLETED|Overall Study||21
10778796|NCT03359473|11940579|FG001|COMPLETED|Overall Study||18
10778797|NCT03359473|11940580|FG002|COMPLETED|Overall Study||18
10778798|NCT03359473|11940581|FG003|COMPLETED|Overall Study||20
10778799|NCT03359473|11940578|FG000|NOT COMPLETED|Overall Study||2
10778800|NCT03359473|11940579|FG001|NOT COMPLETED|Overall Study||6
10778801|NCT03359473|11940580|FG002|NOT COMPLETED|Overall Study||6
10778802|NCT03359473|11940581|FG003|NOT COMPLETED|Overall Study||5
10778803|NCT03359590|11940594|FG000|STARTED|First Intervention||10
10778804|NCT03359590|11940595|FG001|STARTED|First Intervention||10
10778805|NCT03359590|11940594|FG000|Exposed|First Intervention||9
10778806|NCT03359590|11940595|FG001|Exposed|First Intervention||10
10778807|NCT03359590|11940594|FG000|Discontinued|First Intervention||1
10778808|NCT03359590|11940595|FG001|Discontinued|First Intervention||2
10778809|NCT03359590|11940594|FG000|COMPLETED|First Intervention||9
10778810|NCT03359590|11940595|FG001|COMPLETED|First Intervention||8
10778811|NCT03359590|11940594|FG000|NOT COMPLETED|First Intervention||1
10778812|NCT03359590|11940595|FG001|NOT COMPLETED|First Intervention||2
10778813|NCT03359590|11940594|FG000|STARTED|Second Intervention||9
10778814|NCT03359590|11940595|FG001|STARTED|Second Intervention||8
10778815|NCT03359590|11940594|FG000|Exposed|Second Intervention||9
10778816|NCT03359590|11940595|FG001|Exposed|Second Intervention||8
10778817|NCT03359590|11940594|FG000|Discontinued|Second Intervention||0
10778818|NCT03359590|11940595|FG001|Discontinued|Second Intervention||0
10778819|NCT03359590|11940594|FG000|COMPLETED|Second Intervention||9
10778820|NCT03359590|11940595|FG001|COMPLETED|Second Intervention||8
10778821|NCT03359590|11940594|FG000|NOT COMPLETED|Second Intervention||0
10778822|NCT03359590|11940595|FG001|NOT COMPLETED|Second Intervention||0
10778823|NCT03359629|11940603|FG000|STARTED|Overall Study||200
10778824|NCT03359629|11940604|FG001|STARTED|Overall Study||10
10778825|NCT03359629|11940603|FG000|COMPLETED|Overall Study||200
10778826|NCT03359629|11940604|FG001|COMPLETED|Overall Study||10
10778827|NCT03359629|11940603|FG000|NOT COMPLETED|Overall Study||0
10778828|NCT03359629|11940604|FG001|NOT COMPLETED|Overall Study||0
10778829|NCT03359850|11940612|FG000|STARTED|PK Phase (Up to Day 8)||9
10778830|NCT03359850|11940613|FG001|STARTED|PK Phase (Up to Day 8)||8
10778831|NCT03359850|11940612|FG000|COMPLETED|PK Phase (Up to Day 8)||8
10778832|NCT03359850|11940613|FG001|COMPLETED|PK Phase (Up to Day 8)||7
10778833|NCT03359850|11940612|FG000|NOT COMPLETED|PK Phase (Up to Day 8)||1
10778834|NCT03359850|11940613|FG001|NOT COMPLETED|PK Phase (Up to Day 8)||1
10778835|NCT03359850|11940612|FG000|STARTED|Extension Phase (Up to 28 Months)||8
10778836|NCT03359850|11940613|FG001|STARTED|Extension Phase (Up to 28 Months)||7
10778837|NCT03359850|11940612|FG000|COMPLETED|Extension Phase (Up to 28 Months)||0
10756453|NCT03075501|11919971|FG000|STARTED|Overall Study||89
10756454|NCT03075501|11919972|FG001|STARTED|Overall Study||44
10756455|NCT03075501|11919971|FG000|COMPLETED|Overall Study||74
10756456|NCT03075501|11919972|FG001|COMPLETED|Overall Study||35
10756457|NCT03075501|11919971|FG000|NOT COMPLETED|Overall Study||15
10756458|NCT03075501|11919972|FG001|NOT COMPLETED|Overall Study||9
10756459|NCT03075553|11919979|FG000|STARTED|Overall Study||12
10756460|NCT03075553|11919979|FG000|COMPLETED|Overall Study||12
10756461|NCT03075553|11919979|FG000|NOT COMPLETED|Overall Study||0
10756462|NCT03075644|11919985|FG000|STARTED|Overall Study||16
10756463|NCT03075644|11919986|FG001|STARTED|Overall Study||46
10756464|NCT03075644|11919985|FG000|Full Analysis Set (FAS)|Overall Study||16
10756465|NCT03075644|11919986|FG001|Full Analysis Set (FAS)|Overall Study||46
10756466|NCT03075644|11919985|FG000|Safety Analysis Set (SAS)|Overall Study||16
10756467|NCT03075644|11919986|FG001|Safety Analysis Set (SAS)|Overall Study||46
10756468|NCT03075644|11919985|FG000|COMPLETED|Overall Study||15
10756469|NCT03075644|11919986|FG001|COMPLETED|Overall Study||45
10756470|NCT03075644|11919985|FG000|NOT COMPLETED|Overall Study||1
10756471|NCT03075644|11919986|FG001|NOT COMPLETED|Overall Study||1
10756472|NCT03075761|11919995|FG000|STARTED|Overall Study||11
10756473|NCT03075761|11919996|FG001|STARTED|Overall Study||12
10756474|NCT03075761|11919995|FG000|COMPLETED|Overall Study||10
10756475|NCT03075761|11919996|FG001|COMPLETED|Overall Study||6
10756476|NCT03075761|11919995|FG000|NOT COMPLETED|Overall Study||1
10874553|NCT04927858|12040653|FG000|NOT COMPLETED|Overall Study||0
10756477|NCT03075761|11919996|FG001|NOT COMPLETED|Overall Study||6
10756478|NCT03075839|11920007|FG000|STARTED|Overall Study||33
10756479|NCT03075839|11920007|FG000|COMPLETED|Overall Study||29
10756480|NCT03075839|11920007|FG000|NOT COMPLETED|Overall Study||4
10756481|NCT03075878|11920011|FG000|STARTED|Overall Study||8
10756482|NCT03075878|11920011|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
10756483|NCT03075878|11920011|FG000|COMPLETED|Overall Study||7
10756484|NCT03075878|11920011|FG000|NOT COMPLETED|Overall Study||1
10756485|NCT03075891|11920017|FG000|STARTED|Overall Study||135
10756486|NCT03075891|11920018|FG001|STARTED|Overall Study||138
10756487|NCT03075891|11920017|FG000|COMPLETED|Overall Study||126
10756488|NCT03075891|11920018|FG001|COMPLETED|Overall Study||125
10756489|NCT03075891|11920017|FG000|NOT COMPLETED|Overall Study||9
10756490|NCT03075891|11920018|FG001|NOT COMPLETED|Overall Study||13
10756491|NCT03075904|11920026|FG000|STARTED|Overall Study||8
10756492|NCT03075904|11920026|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
10756493|NCT03075904|11920026|FG000|COMPLETED|Overall Study||4
10756494|NCT03075904|11920026|FG000|NOT COMPLETED|Overall Study||4
10756495|NCT03076190|11920032|FG000|STARTED|Overall Study||50
10756496|NCT03076190|11920033|FG001|STARTED|Overall Study||77
10756497|NCT03076190|11920032|FG000|COMPLETED|Overall Study||32
10756498|NCT03076190|11920033|FG001|COMPLETED|Overall Study||36
10756499|NCT03076190|11920032|FG000|NOT COMPLETED|Overall Study||18
10756500|NCT03076190|11920033|FG001|NOT COMPLETED|Overall Study||41
10756501|NCT03076333|11920042|FG000|STARTED|Overall Study||3
10756502|NCT03076333|11920042|FG000|COMPLETED|Overall Study||3
10756503|NCT03076333|11920042|FG000|NOT COMPLETED|Overall Study||0
10756504|NCT03076359|11920048|FG000|STARTED|Overall Study||170
10756505|NCT03076359|11920049|FG001|STARTED|Overall Study||150
10756506|NCT03076359|11920048|FG000|COMPLETED|Overall Study||170
10756507|NCT03076359|11920049|FG001|COMPLETED|Overall Study||150
10756508|NCT03076359|11920048|FG000|NOT COMPLETED|Overall Study||0
10756509|NCT03076359|11920049|FG001|NOT COMPLETED|Overall Study||0
10756510|NCT03076515|11920059|FG000|STARTED|Overall Study||58
10756511|NCT03076515|11920060|FG001|STARTED|Overall Study||62
10756512|NCT03076515|11920059|FG000|COMPLETED|Overall Study||33
10756513|NCT03076515|11920060|FG001|COMPLETED|Overall Study||33
10756514|NCT03076515|11920059|FG000|NOT COMPLETED|Overall Study||25
10756515|NCT03076515|11920060|FG001|NOT COMPLETED|Overall Study||29
10756516|NCT03076970|11920066|FG000|STARTED|Period 1||7
10756517|NCT03076970|11920067|FG001|STARTED|Period 1||7
10756518|NCT03076970|11920068|FG002|STARTED|Period 1||7
10756519|NCT03076970|11920069|FG003|STARTED|Period 1||7
10756520|NCT03076970|11920070|FG004|STARTED|Period 1||7
10756521|NCT03076970|11920071|FG005|STARTED|Period 1||7
10756522|NCT03076970|11920066|FG000|Received at Least 1 Dose of Study Drug|Period 1||7
10756523|NCT03076970|11920067|FG001|Received at Least 1 Dose of Study Drug|Period 1||7
10756524|NCT03076970|11920068|FG002|Received at Least 1 Dose of Study Drug|Period 1||7
10756525|NCT03076970|11920069|FG003|Received at Least 1 Dose of Study Drug|Period 1||7
10756526|NCT03076970|11920070|FG004|Received at Least 1 Dose of Study Drug|Period 1||7
10756527|NCT03076970|11920071|FG005|Received at Least 1 Dose of Study Drug|Period 1||7
10756528|NCT03076970|11920066|FG000|COMPLETED|Period 1||7
10756529|NCT03076970|11920067|FG001|COMPLETED|Period 1||7
10756530|NCT03076970|11920068|FG002|COMPLETED|Period 1||7
10756531|NCT03076970|11920069|FG003|COMPLETED|Period 1||7
10756532|NCT03076970|11920070|FG004|COMPLETED|Period 1||7
10756533|NCT03076970|11920071|FG005|COMPLETED|Period 1||7
10756534|NCT03076970|11920066|FG000|NOT COMPLETED|Period 1||0
10756535|NCT03076970|11920067|FG001|NOT COMPLETED|Period 1||0
10756536|NCT03076970|11920068|FG002|NOT COMPLETED|Period 1||0
10756537|NCT03076970|11920069|FG003|NOT COMPLETED|Period 1||0
10756538|NCT03076970|11920070|FG004|NOT COMPLETED|Period 1||0
10756539|NCT03076970|11920071|FG005|NOT COMPLETED|Period 1||0
10756540|NCT03076970|11920066|FG000|STARTED|Washout Period 1||7
10756541|NCT03076970|11920067|FG001|STARTED|Washout Period 1||7
10756542|NCT03076970|11920068|FG002|STARTED|Washout Period 1||7
10756543|NCT03076970|11920069|FG003|STARTED|Washout Period 1||7
10756544|NCT03076970|11920070|FG004|STARTED|Washout Period 1||7
10756545|NCT03076970|11920071|FG005|STARTED|Washout Period 1||7
10756546|NCT03076970|11920066|FG000|COMPLETED|Washout Period 1||7
10756547|NCT03076970|11920067|FG001|COMPLETED|Washout Period 1||7
10756548|NCT03076970|11920068|FG002|COMPLETED|Washout Period 1||7
10756549|NCT03076970|11920069|FG003|COMPLETED|Washout Period 1||7
10756550|NCT03076970|11920070|FG004|COMPLETED|Washout Period 1||7
10756551|NCT03076970|11920071|FG005|COMPLETED|Washout Period 1||7
10756552|NCT03076970|11920066|FG000|NOT COMPLETED|Washout Period 1||0
10756553|NCT03076970|11920067|FG001|NOT COMPLETED|Washout Period 1||0
10756554|NCT03076970|11920068|FG002|NOT COMPLETED|Washout Period 1||0
10756555|NCT03076970|11920069|FG003|NOT COMPLETED|Washout Period 1||0
10756556|NCT03076970|11920070|FG004|NOT COMPLETED|Washout Period 1||0
10756557|NCT03076970|11920071|FG005|NOT COMPLETED|Washout Period 1||0
10756558|NCT03076970|11920066|FG000|STARTED|Period 2||7
10756559|NCT03076970|11920067|FG001|STARTED|Period 2||7
10756560|NCT03076970|11920068|FG002|STARTED|Period 2||7
10756561|NCT03076970|11920069|FG003|STARTED|Period 2||7
10756562|NCT03076970|11920070|FG004|STARTED|Period 2||7
10756563|NCT03076970|11920071|FG005|STARTED|Period 2||7
10756564|NCT03076970|11920066|FG000|COMPLETED|Period 2||7
10756565|NCT03076970|11920067|FG001|COMPLETED|Period 2||7
10756566|NCT03076970|11920068|FG002|COMPLETED|Period 2||7
10756567|NCT03076970|11920069|FG003|COMPLETED|Period 2||7
10756568|NCT03076970|11920070|FG004|COMPLETED|Period 2||7
10756569|NCT03076970|11920071|FG005|COMPLETED|Period 2||7
10756570|NCT03076970|11920066|FG000|NOT COMPLETED|Period 2||0
10756571|NCT03076970|11920067|FG001|NOT COMPLETED|Period 2||0
10756572|NCT03076970|11920068|FG002|NOT COMPLETED|Period 2||0
10756573|NCT03076970|11920069|FG003|NOT COMPLETED|Period 2||0
10756574|NCT03076970|11920070|FG004|NOT COMPLETED|Period 2||0
10756575|NCT03076970|11920071|FG005|NOT COMPLETED|Period 2||0
10756576|NCT03076970|11920066|FG000|STARTED|Washout Period 2||7
10756577|NCT03076970|11920067|FG001|STARTED|Washout Period 2||7
10756578|NCT03076970|11920068|FG002|STARTED|Washout Period 2||7
10756579|NCT03076970|11920069|FG003|STARTED|Washout Period 2||7
10756580|NCT03076970|11920070|FG004|STARTED|Washout Period 2||7
10756581|NCT03076970|11920071|FG005|STARTED|Washout Period 2||7
10756582|NCT03076970|11920066|FG000|COMPLETED|Washout Period 2||7
10756583|NCT03076970|11920067|FG001|COMPLETED|Washout Period 2||7
10756584|NCT03076970|11920068|FG002|COMPLETED|Washout Period 2||7
10756585|NCT03076970|11920069|FG003|COMPLETED|Washout Period 2||7
10756586|NCT03076970|11920070|FG004|COMPLETED|Washout Period 2||6
10756587|NCT03076970|11920071|FG005|COMPLETED|Washout Period 2||7
10756588|NCT03076970|11920066|FG000|NOT COMPLETED|Washout Period 2||0
10756589|NCT03076970|11920067|FG001|NOT COMPLETED|Washout Period 2||0
10756590|NCT03076970|11920068|FG002|NOT COMPLETED|Washout Period 2||0
10756591|NCT03076970|11920069|FG003|NOT COMPLETED|Washout Period 2||0
10756592|NCT03076970|11920070|FG004|NOT COMPLETED|Washout Period 2||1
10756593|NCT03076970|11920071|FG005|NOT COMPLETED|Washout Period 2||0
10756594|NCT03076970|11920066|FG000|STARTED|Period 3||7
10756595|NCT03076970|11920067|FG001|STARTED|Period 3||7
10756596|NCT03076970|11920068|FG002|STARTED|Period 3||7
10756597|NCT03076970|11920069|FG003|STARTED|Period 3||7
10756598|NCT03076970|11920070|FG004|STARTED|Period 3||6
10756599|NCT03076970|11920071|FG005|STARTED|Period 3||7
10756600|NCT03076970|11920066|FG000|COMPLETED|Period 3||7
10756601|NCT03076970|11920067|FG001|COMPLETED|Period 3||7
10756602|NCT03076970|11920068|FG002|COMPLETED|Period 3||7
10756603|NCT03076970|11920069|FG003|COMPLETED|Period 3||7
10756604|NCT03076970|11920070|FG004|COMPLETED|Period 3||5
10756605|NCT03076970|11920071|FG005|COMPLETED|Period 3||6
10756606|NCT03076970|11920066|FG000|NOT COMPLETED|Period 3||0
10756607|NCT03076970|11920067|FG001|NOT COMPLETED|Period 3||0
10756608|NCT03076970|11920068|FG002|NOT COMPLETED|Period 3||0
10756609|NCT03076970|11920069|FG003|NOT COMPLETED|Period 3||0
10756610|NCT03076970|11920070|FG004|NOT COMPLETED|Period 3||1
10756611|NCT03076970|11920071|FG005|NOT COMPLETED|Period 3||1
10756612|NCT03076970|11920066|FG000|STARTED|Washout Period 3||7
10756613|NCT03076970|11920067|FG001|STARTED|Washout Period 3||7
10756614|NCT03076970|11920068|FG002|STARTED|Washout Period 3||7
10756615|NCT03076970|11920069|FG003|STARTED|Washout Period 3||7
10756616|NCT03076970|11920070|FG004|STARTED|Washout Period 3||5
10756617|NCT03076970|11920071|FG005|STARTED|Washout Period 3||6
10756618|NCT03076970|11920066|FG000|COMPLETED|Washout Period 3||7
10756619|NCT03076970|11920067|FG001|COMPLETED|Washout Period 3||7
10756620|NCT03076970|11920068|FG002|COMPLETED|Washout Period 3||7
10756621|NCT03076970|11920069|FG003|COMPLETED|Washout Period 3||7
10756622|NCT03076970|11920070|FG004|COMPLETED|Washout Period 3||5
10756623|NCT03076970|11920071|FG005|COMPLETED|Washout Period 3||6
10756624|NCT03076970|11920066|FG000|NOT COMPLETED|Washout Period 3||0
10756625|NCT03076970|11920067|FG001|NOT COMPLETED|Washout Period 3||0
10756626|NCT03076970|11920068|FG002|NOT COMPLETED|Washout Period 3||0
10756627|NCT03076970|11920069|FG003|NOT COMPLETED|Washout Period 3||0
10756628|NCT03076970|11920070|FG004|NOT COMPLETED|Washout Period 3||0
10756629|NCT03076970|11920071|FG005|NOT COMPLETED|Washout Period 3||0
10756630|NCT03076983|11920084|FG000|STARTED|Overall Study||55
10756631|NCT03076983|11920085|FG001|STARTED|Overall Study||25
10756632|NCT03076983|11920084|FG000|COMPLETED|Overall Study||55
10756633|NCT03076983|11920085|FG001|COMPLETED|Overall Study||25
10756634|NCT03076983|11920084|FG000|NOT COMPLETED|Overall Study||0
10756635|NCT03076983|11920085|FG001|NOT COMPLETED|Overall Study||0
10756636|NCT03076996|11920091|FG000|STARTED|Overall Study||41
10756637|NCT03076996|11920091|FG000|COMPLETED|Overall Study||35
10756638|NCT03076996|11920091|FG000|NOT COMPLETED|Overall Study||6
10756639|NCT03077165|11920101|FG000|STARTED|Overall Study||21
10756640|NCT03077165|11920102|FG001|STARTED|Overall Study||22
10756641|NCT03077165|11920103|FG002|STARTED|Overall Study||20
10756642|NCT03077165|11920104|FG003|STARTED|Overall Study||19
10756643|NCT03077165|11920105|FG004|STARTED|Overall Study||19
10756644|NCT03077165|11920106|FG005|STARTED|Overall Study||20
10756645|NCT03077165|11920101|FG000|COMPLETED|Overall Study||20
10756646|NCT03077165|11920102|FG001|COMPLETED|Overall Study||22
10756647|NCT03077165|11920103|FG002|COMPLETED|Overall Study||20
10756648|NCT03077165|11920104|FG003|COMPLETED|Overall Study||19
10756649|NCT03077165|11920105|FG004|COMPLETED|Overall Study||16
10756650|NCT03077165|11920106|FG005|COMPLETED|Overall Study||20
10756651|NCT03077165|11920101|FG000|NOT COMPLETED|Overall Study||1
10756652|NCT03077165|11920102|FG001|NOT COMPLETED|Overall Study||0
10756653|NCT03077165|11920103|FG002|NOT COMPLETED|Overall Study||0
10756654|NCT03077165|11920104|FG003|NOT COMPLETED|Overall Study||0
10756655|NCT03077165|11920105|FG004|NOT COMPLETED|Overall Study||3
10756656|NCT03077165|11920106|FG005|NOT COMPLETED|Overall Study||0
10756657|NCT03077607|11920122|FG000|STARTED|Period 1 (15 Days)||19
10756658|NCT03077607|11920123|FG001|STARTED|Period 1 (15 Days)||17
10756659|NCT03077607|11920122|FG000|Treated (With Any Study Drug)|Period 1 (15 Days)||19
10756660|NCT03077607|11920123|FG001|Treated (With Any Study Drug)|Period 1 (15 Days)||17
10756661|NCT03077607|11920122|FG000|Received Talazoparib|Period 1 (15 Days)||19
10756662|NCT03077607|11920123|FG001|Received Talazoparib|Period 1 (15 Days)||17
10756663|NCT03077607|11920122|FG000|COMPLETED|Period 1 (15 Days)||17
10756664|NCT03077607|11920123|FG001|COMPLETED|Period 1 (15 Days)||17
10756665|NCT03077607|11920122|FG000|NOT COMPLETED|Period 1 (15 Days)||2
10756666|NCT03077607|11920123|FG001|NOT COMPLETED|Period 1 (15 Days)||0
10756667|NCT03077607|11920122|FG000|STARTED|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
10756668|NCT03077607|11920123|FG001|STARTED|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
10756669|NCT03077607|11920122|FG000|Treated (With Any Study Drug)|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
10756670|NCT03077607|11920123|FG001|Treated (With Any Study Drug)|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
10756671|NCT03077607|11920122|FG000|Received Talazoparib|Period 2 (Arm A:21 Days; Arm B:23 Days)||15
10756672|NCT03077607|11920123|FG001|Received Talazoparib|Period 2 (Arm A:21 Days; Arm B:23 Days)||15
10756673|NCT03077607|11920122|FG000|COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||14
10756674|NCT03077607|11920123|FG001|COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||15
10756675|NCT03077607|11920122|FG000|NOT COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||3
10756676|NCT03077607|11920123|FG001|NOT COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||2
10756677|NCT03077646|11920143|FG000|STARTED|Overall Study||76
10756678|NCT03077646|11920144|FG001|STARTED|Overall Study||75
10756679|NCT03077646|11920145|FG002|STARTED|Overall Study||74
10756680|NCT03077646|11920143|FG000|COMPLETED|Overall Study|Of these 47, there were 25 paired samples for primary outcome|47
10756681|NCT03077646|11920144|FG001|COMPLETED|Overall Study|Of these 45, there were 27 paired samples for primary outcome|45
10756682|NCT03077646|11920145|FG002|COMPLETED|Overall Study|Of these 43, there were 20 paired samples for primary outcome|43
10756683|NCT03077646|11920143|FG000|NOT COMPLETED|Overall Study||29
10756684|NCT03077646|11920144|FG001|NOT COMPLETED|Overall Study||30
10756685|NCT03077646|11920145|FG002|NOT COMPLETED|Overall Study||31
10756686|NCT03077659|11920156|FG000|STARTED|Overall Study||3
10756687|NCT03077659|11920157|FG001|STARTED|Overall Study||3
10756688|NCT03077659|11920158|FG002|STARTED|Overall Study||10
10756689|NCT03077659|11920156|FG000|COMPLETED|Overall Study||3
10756690|NCT03077659|11920157|FG001|COMPLETED|Overall Study||3
10874554|NCT04919161|12040660|FG000|STARTED|Overall Study||16
10874555|NCT04919161|12040661|FG001|STARTED|Overall Study||16
10874556|NCT04919161|12040660|FG000|COMPLETED|Overall Study||15
10756691|NCT03077659|11920158|FG002|COMPLETED|Overall Study||9
10756692|NCT03077659|11920156|FG000|NOT COMPLETED|Overall Study||0
10756693|NCT03077659|11920157|FG001|NOT COMPLETED|Overall Study||0
10756694|NCT03077659|11920158|FG002|NOT COMPLETED|Overall Study||1
10756695|NCT03077711|11920171|FG000|STARTED|Overall Study||47
10756696|NCT03077711|11920172|FG001|STARTED|Overall Study||45
10756697|NCT03077711|11920171|FG000|COMPLETED|Overall Study||43
10756698|NCT03077711|11920172|FG001|COMPLETED|Overall Study||43
10756699|NCT03077711|11920171|FG000|NOT COMPLETED|Overall Study||4
10756700|NCT03077711|11920172|FG001|NOT COMPLETED|Overall Study||2
10756701|NCT03077724|11920182|FG000|STARTED|Overall Study||14
10756702|NCT03077724|11920183|FG001|STARTED|Overall Study||14
10874557|NCT04919161|12040661|FG001|COMPLETED|Overall Study||14
10874558|NCT04919161|12040660|FG000|NOT COMPLETED|Overall Study||1
10874559|NCT04919161|12040661|FG001|NOT COMPLETED|Overall Study||2
10874560|NCT04912700|12040692|FG000|STARTED|Overall Study||10880
10874561|NCT04912700|12040693|FG001|STARTED|Overall Study||825
10874562|NCT04912700|12040694|FG002|STARTED|Overall Study||129
10874563|NCT04912700|12040692|FG000|COMPLETED|Overall Study||10880
10874564|NCT04912700|12040693|FG001|COMPLETED|Overall Study||825
10874565|NCT04912700|12040694|FG002|COMPLETED|Overall Study||129
10874566|NCT04912700|12040692|FG000|NOT COMPLETED|Overall Study||0
10756703|NCT03077724|11920182|FG000|COMPLETED|Overall Study||6
10756704|NCT03077724|11920183|FG001|COMPLETED|Overall Study||12
10874567|NCT04912700|12040693|FG001|NOT COMPLETED|Overall Study||0
10874568|NCT04912700|12040694|FG002|NOT COMPLETED|Overall Study||0
10756705|NCT03077724|11920182|FG000|NOT COMPLETED|Overall Study||8
10756706|NCT03077724|11920183|FG001|NOT COMPLETED|Overall Study||2
10756707|NCT03077893|11920191|FG000|STARTED|Overall Study||18
10756708|NCT03077893|11920192|FG001|STARTED|Overall Study||19
10756709|NCT03077893|11920191|FG000|COMPLETED|Overall Study||14
10756710|NCT03077893|11920192|FG001|COMPLETED|Overall Study||16
10756711|NCT03077893|11920191|FG000|NOT COMPLETED|Overall Study||4
10756712|NCT03077893|11920192|FG001|NOT COMPLETED|Overall Study||3
10756713|NCT03077919|11920201|FG000|STARTED|Overall Study||74
10756714|NCT03077919|11920202|FG001|STARTED|Overall Study||39
10756715|NCT03077919|11920201|FG000|Week 2 Visit|Overall Study||74
10756716|NCT03077919|11920202|FG001|Week 2 Visit|Overall Study||39
10756717|NCT03077919|11920201|FG000|Week 4 Visit|Overall Study||73
10756718|NCT03077919|11920202|FG001|Week 4 Visit|Overall Study||38
10756719|NCT03077919|11920201|FG000|Week 6 Visit|Overall Study||73
10756720|NCT03077919|11920202|FG001|Week 6 Visit|Overall Study||38
10756721|NCT03077919|11920201|FG000|Week 8 Visit|Overall Study||71
10756722|NCT03077919|11920202|FG001|Week 8 Visit|Overall Study||38
10756723|NCT03077919|11920201|FG000|Final CAPS|Overall Study||70
10756724|NCT03077919|11920202|FG001|Final CAPS|Overall Study||38
10756725|NCT03077919|11920201|FG000|COMPLETED|Overall Study||70
10756726|NCT03077919|11920202|FG001|COMPLETED|Overall Study||38
10756727|NCT03077919|11920201|FG000|NOT COMPLETED|Overall Study||4
10756728|NCT03077919|11920202|FG001|NOT COMPLETED|Overall Study||1
10756729|NCT03078075|11920210|FG000|STARTED|Overall Study||111
10756730|NCT03078075|11920211|FG001|STARTED|Overall Study||114
10756731|NCT03078075|11920212|FG002|STARTED|Overall Study||59
10756732|NCT03078075|11920213|FG003|STARTED|Overall Study||10
10756733|NCT03078075|11920214|FG004|STARTED|Overall Study||109
10756734|NCT03078075|11920210|FG000|COMPLETED|Overall Study||106
10756735|NCT03078075|11920211|FG001|COMPLETED|Overall Study||103
10756736|NCT03078075|11920212|FG002|COMPLETED|Overall Study||19
10756737|NCT03078075|11920213|FG003|COMPLETED|Overall Study||9
10756738|NCT03078075|11920214|FG004|COMPLETED|Overall Study||78
10756739|NCT03078075|11920210|FG000|NOT COMPLETED|Overall Study||5
10756740|NCT03078075|11920211|FG001|NOT COMPLETED|Overall Study||11
10756741|NCT03078075|11920212|FG002|NOT COMPLETED|Overall Study||40
10756742|NCT03078075|11920213|FG003|NOT COMPLETED|Overall Study||1
10756743|NCT03078075|11920214|FG004|NOT COMPLETED|Overall Study||31
10756744|NCT03078127|11920240|FG000|STARTED|First Intervention||4
10756745|NCT03078127|11920241|FG001|STARTED|First Intervention||3
10756746|NCT03078127|11920242|FG002|STARTED|First Intervention||3
10756747|NCT03078127|11920240|FG000|COMPLETED|First Intervention||4
10756748|NCT03078127|11920241|FG001|COMPLETED|First Intervention||3
10756749|NCT03078127|11920242|FG002|COMPLETED|First Intervention||3
10756750|NCT03078127|11920240|FG000|NOT COMPLETED|First Intervention||0
10756751|NCT03078127|11920241|FG001|NOT COMPLETED|First Intervention||0
10756752|NCT03078127|11920242|FG002|NOT COMPLETED|First Intervention||0
10756753|NCT03078127|11920240|FG000|STARTED|Washout (3-21 Days)||4
10756754|NCT03078127|11920241|FG001|STARTED|Washout (3-21 Days)||3
10756755|NCT03078127|11920242|FG002|STARTED|Washout (3-21 Days)||3
10756756|NCT03078127|11920240|FG000|COMPLETED|Washout (3-21 Days)||4
10756757|NCT03078127|11920241|FG001|COMPLETED|Washout (3-21 Days)||3
10756758|NCT03078127|11920242|FG002|COMPLETED|Washout (3-21 Days)||3
10756759|NCT03078127|11920240|FG000|NOT COMPLETED|Washout (3-21 Days)||0
10756760|NCT03078127|11920241|FG001|NOT COMPLETED|Washout (3-21 Days)||0
10756761|NCT03078127|11920242|FG002|NOT COMPLETED|Washout (3-21 Days)||0
10756762|NCT03078127|11920240|FG000|STARTED|Second Intervention||4
10756763|NCT03078127|11920241|FG001|STARTED|Second Intervention||3
10756764|NCT03078127|11920242|FG002|STARTED|Second Intervention||3
10756765|NCT03078127|11920240|FG000|COMPLETED|Second Intervention||4
10756766|NCT03078127|11920241|FG001|COMPLETED|Second Intervention||3
10756767|NCT03078127|11920242|FG002|COMPLETED|Second Intervention||3
10756768|NCT03078127|11920240|FG000|NOT COMPLETED|Second Intervention||0
10756769|NCT03078127|11920241|FG001|NOT COMPLETED|Second Intervention||0
10756770|NCT03078127|11920242|FG002|NOT COMPLETED|Second Intervention||0
10756771|NCT03078127|11920240|FG000|STARTED|Washout (3-21 Days)||4
10756772|NCT03078127|11920241|FG001|STARTED|Washout (3-21 Days)||3
10756773|NCT03078127|11920242|FG002|STARTED|Washout (3-21 Days)||3
10756774|NCT03078127|11920240|FG000|COMPLETED|Washout (3-21 Days)||4
10756775|NCT03078127|11920241|FG001|COMPLETED|Washout (3-21 Days)||3
10756776|NCT03078127|11920242|FG002|COMPLETED|Washout (3-21 Days)||3
10756777|NCT03078127|11920240|FG000|NOT COMPLETED|Washout (3-21 Days)||0
10756778|NCT03078127|11920241|FG001|NOT COMPLETED|Washout (3-21 Days)||0
10756779|NCT03078127|11920242|FG002|NOT COMPLETED|Washout (3-21 Days)||0
10756780|NCT03078127|11920240|FG000|STARTED|Third Intervention||4
10756781|NCT03078127|11920241|FG001|STARTED|Third Intervention||3
10756782|NCT03078127|11920242|FG002|STARTED|Third Intervention||3
10756783|NCT03078127|11920240|FG000|COMPLETED|Third Intervention||4
10756784|NCT03078127|11920241|FG001|COMPLETED|Third Intervention||3
10756785|NCT03078127|11920242|FG002|COMPLETED|Third Intervention||3
10756786|NCT03078127|11920240|FG000|NOT COMPLETED|Third Intervention||0
10756787|NCT03078127|11920241|FG001|NOT COMPLETED|Third Intervention||0
10756788|NCT03078127|11920242|FG002|NOT COMPLETED|Third Intervention||0
10756789|NCT03078504|11920253|FG000|STARTED|Overall Study||6
10756790|NCT03078504|11920253|FG000|COMPLETED|Overall Study||6
10756791|NCT03078504|11920253|FG000|NOT COMPLETED|Overall Study||0
10756792|NCT03078556|11920259|FG000|STARTED|Treatment Period 1 (4 Days)||39
10756793|NCT03078556|11920260|FG001|STARTED|Treatment Period 1 (4 Days)||39
10756794|NCT03078556|11920261|FG002|STARTED|Treatment Period 1 (4 Days)||38
10756795|NCT03078556|11920262|FG003|STARTED|Treatment Period 1 (4 Days)||38
10756796|NCT03078556|11920259|FG000|COMPLETED|Treatment Period 1 (4 Days)||39
10756797|NCT03078556|11920260|FG001|COMPLETED|Treatment Period 1 (4 Days)||38
10756798|NCT03078556|11920261|FG002|COMPLETED|Treatment Period 1 (4 Days)||38
10756799|NCT03078556|11920262|FG003|COMPLETED|Treatment Period 1 (4 Days)||38
10756800|NCT03078556|11920259|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||0
10756801|NCT03078556|11920260|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||1
10756802|NCT03078556|11920261|FG002|NOT COMPLETED|Treatment Period 1 (4 Days)||0
10756803|NCT03078556|11920262|FG003|NOT COMPLETED|Treatment Period 1 (4 Days)||0
10756804|NCT03078556|11920259|FG000|STARTED|Washout Period 1 (7 Days)||39
10756805|NCT03078556|11920260|FG001|STARTED|Washout Period 1 (7 Days)||38
10756806|NCT03078556|11920261|FG002|STARTED|Washout Period 1 (7 Days)||38
10756807|NCT03078556|11920262|FG003|STARTED|Washout Period 1 (7 Days)||38
10756808|NCT03078556|11920259|FG000|COMPLETED|Washout Period 1 (7 Days)||37
10756809|NCT03078556|11920260|FG001|COMPLETED|Washout Period 1 (7 Days)||36
10756810|NCT03078556|11920261|FG002|COMPLETED|Washout Period 1 (7 Days)||37
10756811|NCT03078556|11920262|FG003|COMPLETED|Washout Period 1 (7 Days)||37
10756812|NCT03078556|11920259|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||2
10756813|NCT03078556|11920260|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||2
10756814|NCT03078556|11920261|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||1
10756815|NCT03078556|11920262|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||1
10756816|NCT03078556|11920259|FG000|STARTED|Treatment Period 2 (4 Days)||37
10756817|NCT03078556|11920260|FG001|STARTED|Treatment Period 2 (4 Days)||36
10756818|NCT03078556|11920261|FG002|STARTED|Treatment Period 2 (4 Days)||37
10756819|NCT03078556|11920262|FG003|STARTED|Treatment Period 2 (4 Days)||37
10756820|NCT03078556|11920259|FG000|COMPLETED|Treatment Period 2 (4 Days)||37
10756821|NCT03078556|11920260|FG001|COMPLETED|Treatment Period 2 (4 Days)||36
10756822|NCT03078556|11920261|FG002|COMPLETED|Treatment Period 2 (4 Days)||37
10756823|NCT03078556|11920262|FG003|COMPLETED|Treatment Period 2 (4 Days)||37
10756824|NCT03078556|11920259|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0
10756825|NCT03078556|11920260|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0
10756826|NCT03078556|11920261|FG002|NOT COMPLETED|Treatment Period 2 (4 Days)||0
10756827|NCT03078556|11920262|FG003|NOT COMPLETED|Treatment Period 2 (4 Days)||0
10756828|NCT03078556|11920259|FG000|STARTED|Washout Period 2 (7 Days)||9
10756829|NCT03078556|11920260|FG001|STARTED|Washout Period 2 (7 Days)||7
10756830|NCT03078556|11920261|FG002|STARTED|Washout Period 2 (7 Days)||7
10756831|NCT03078556|11920262|FG003|STARTED|Washout Period 2 (7 Days)||9
10756832|NCT03078556|11920259|FG000|COMPLETED|Washout Period 2 (7 Days)||9
10756833|NCT03078556|11920260|FG001|COMPLETED|Washout Period 2 (7 Days)||7
10756834|NCT03078556|11920261|FG002|COMPLETED|Washout Period 2 (7 Days)||7
10756835|NCT03078556|11920262|FG003|COMPLETED|Washout Period 2 (7 Days)||9
10756836|NCT03078556|11920259|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
10756837|NCT03078556|11920260|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
10756838|NCT03078556|11920261|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
10756839|NCT03078556|11920262|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
10756840|NCT03078556|11920259|FG000|STARTED|Treatment Period 3 (4 Days)||9
10756841|NCT03078556|11920260|FG001|STARTED|Treatment Period 3 (4 Days)||7
10756842|NCT03078556|11920261|FG002|STARTED|Treatment Period 3 (4 Days)||7
10756843|NCT03078556|11920262|FG003|STARTED|Treatment Period 3 (4 Days)||9
10756844|NCT03078556|11920259|FG000|COMPLETED|Treatment Period 3 (4 Days)||9
10756845|NCT03078556|11920260|FG001|COMPLETED|Treatment Period 3 (4 Days)||7
10756846|NCT03078556|11920261|FG002|COMPLETED|Treatment Period 3 (4 Days)||7
10756847|NCT03078556|11920262|FG003|COMPLETED|Treatment Period 3 (4 Days)||9
10756848|NCT03078556|11920259|FG000|NOT COMPLETED|Treatment Period 3 (4 Days)||0
10756849|NCT03078556|11920260|FG001|NOT COMPLETED|Treatment Period 3 (4 Days)||0
10756850|NCT03078556|11920261|FG002|NOT COMPLETED|Treatment Period 3 (4 Days)||0
10756851|NCT03078556|11920262|FG003|NOT COMPLETED|Treatment Period 3 (4 Days)||0
10756858|NCT03078595|11920298|FG000|STARTED|Overall Study||24
10756859|NCT03078595|11920299|FG001|STARTED|Overall Study||24
10756860|NCT03078595|11920298|FG000|COMPLETED|Overall Study||24
10756861|NCT03078595|11920299|FG001|COMPLETED|Overall Study||24
10756862|NCT03078595|11920298|FG000|NOT COMPLETED|Overall Study||0
10756863|NCT03078595|11920299|FG001|NOT COMPLETED|Overall Study||0
10756864|NCT03078647|11920308|FG000|STARTED|Overall Study||17
10756865|NCT03078647|11920309|FG001|STARTED|Overall Study||11
10756866|NCT03078647|11920310|FG002|STARTED|Overall Study||3
10756867|NCT03078647|11920308|FG000|COMPLETED|Overall Study||17
10756868|NCT03078647|11920309|FG001|COMPLETED|Overall Study||10
10756869|NCT03078647|11920310|FG002|COMPLETED|Overall Study||3
10756870|NCT03078647|11920308|FG000|NOT COMPLETED|Overall Study||0
10756871|NCT03078647|11920309|FG001|NOT COMPLETED|Overall Study||1
10756872|NCT03078647|11920310|FG002|NOT COMPLETED|Overall Study||0
10756873|NCT03078751|11920320|FG000|STARTED|Overall Study||26
10756874|NCT03078751|11920321|FG001|STARTED|Overall Study||28
10756875|NCT03078751|11920320|FG000|Untreated Participants|Overall Study||0
10756876|NCT03078751|11920321|FG001|Untreated Participants|Overall Study||4
10756877|NCT03078751|11920320|FG000|Safety Set|Overall Study||26
10756878|NCT03078751|11920321|FG001|Safety Set|Overall Study||24
10756879|NCT03078751|11920320|FG000|COMPLETED|Overall Study||13
10756880|NCT03078751|11920321|FG001|COMPLETED|Overall Study||0
10756881|NCT03078751|11920320|FG000|NOT COMPLETED|Overall Study||13
10756882|NCT03078751|11920321|FG001|NOT COMPLETED|Overall Study||28
10756883|NCT03078816|11920327|FG000|STARTED|Overall Study||5
10756884|NCT03078816|11920327|FG000|COMPLETED|Overall Study||4
10756885|NCT03078816|11920327|FG000|NOT COMPLETED|Overall Study||1
10756886|NCT03078907|11920333|FG000|STARTED|Overall Study||53
10756887|NCT03078907|11920334|FG001|STARTED|Overall Study||55
10756888|NCT03078907|11920333|FG000|COMPLETED|Overall Study||50
10756889|NCT03078907|11920334|FG001|COMPLETED|Overall Study||54
10756890|NCT03078907|11920333|FG000|NOT COMPLETED|Overall Study||3
10756891|NCT03078907|11920334|FG001|NOT COMPLETED|Overall Study||1
10756892|NCT03078946|11920342|FG000|STARTED|Overall Study||30
10756893|NCT03078946|11920343|FG001|STARTED|Overall Study||30
10756894|NCT03078946|11920342|FG000|COMPLETED|Overall Study||30
10756895|NCT03078946|11920343|FG001|COMPLETED|Overall Study||30
10756896|NCT03078946|11920342|FG000|NOT COMPLETED|Overall Study||0
10756897|NCT03078946|11920343|FG001|NOT COMPLETED|Overall Study||0
10756898|NCT03079375|11920352|FG000|STARTED|Overall Study||503
10756899|NCT03079375|11920353|FG001|STARTED|Overall Study||499
10756900|NCT03079375|11920354|FG002|STARTED|Overall Study||497
10756901|NCT03079375|11920352|FG000|COMPLETED|Overall Study||498
10756902|NCT03079375|11920353|FG001|COMPLETED|Overall Study||493
10756903|NCT03079375|11920354|FG002|COMPLETED|Overall Study||476
10756904|NCT03079375|11920352|FG000|NOT COMPLETED|Overall Study||5
10756905|NCT03079375|11920353|FG001|NOT COMPLETED|Overall Study||6
10756906|NCT03079375|11920354|FG002|NOT COMPLETED|Overall Study||21
10756907|NCT03079531|11920366|FG000|STARTED|Overall Study||24
10756908|NCT03079531|11920366|FG000|Attended ≥1 Post-baseline Visit|Overall Study||23
10756909|NCT03079531|11920366|FG000|COMPLETED|Overall Study||17
10756910|NCT03079531|11920366|FG000|NOT COMPLETED|Overall Study||7
10756911|NCT03080142|11920372|FG000|STARTED|Overall Study||42
10756912|NCT03080142|11920373|FG001|STARTED|Overall Study||44
10756913|NCT03080142|11920372|FG000|COMPLETED|Overall Study||42
10756914|NCT03080142|11920373|FG001|COMPLETED|Overall Study||44
10756915|NCT03080142|11920372|FG000|NOT COMPLETED|Overall Study||0
10756916|NCT03080142|11920373|FG001|NOT COMPLETED|Overall Study||0
10756917|NCT03080454|11920379|FG000|STARTED|Baseline||26
10756918|NCT03080454|11920379|FG000|COMPLETED|Baseline|Two participants (pts) dropped out after consent due to hospitalizations unrelated to the study.|24
10756919|NCT03080454|11920379|FG000|NOT COMPLETED|Baseline||2
10756920|NCT03080454|11920379|FG000|STARTED|Sham Doublestim (5days)||24
10756921|NCT03080454|11920379|FG000|COMPLETED|Sham Doublestim (5days)||24
10756922|NCT03080454|11920379|FG000|NOT COMPLETED|Sham Doublestim (5days)||0
10756923|NCT03080454|11920379|FG000|STARTED|Sham FU (7days)||24
10756924|NCT03080454|11920379|FG000|COMPLETED|Sham FU (7days)||24
10756925|NCT03080454|11920379|FG000|NOT COMPLETED|Sham FU (7days)||0
10756926|NCT03080454|11920379|FG000|STARTED|Anodal Doublestim (5 Days)||24
10756927|NCT03080454|11920379|FG000|COMPLETED|Anodal Doublestim (5 Days)||23
10756928|NCT03080454|11920379|FG000|NOT COMPLETED|Anodal Doublestim (5 Days)||1
10756929|NCT03080454|11920379|FG000|STARTED|Anodal FU (7 Days)||23
10756930|NCT03080454|11920379|FG000|COMPLETED|Anodal FU (7 Days)||19
10756931|NCT03080454|11920379|FG000|NOT COMPLETED|Anodal FU (7 Days)||4
10756932|NCT03080493|11920388|FG000|STARTED|Overall Study||61
10756933|NCT03080493|11920389|FG001|STARTED|Overall Study||60
10756934|NCT03080493|11920388|FG000|COMPLETED|Overall Study||60
10756935|NCT03080493|11920389|FG001|COMPLETED|Overall Study||58
10756936|NCT03080493|11920388|FG000|NOT COMPLETED|Overall Study||1
10756937|NCT03080493|11920389|FG001|NOT COMPLETED|Overall Study||2
10756938|NCT03080961|11920395|FG000|STARTED|Overall Study||46
10756939|NCT03080961|11920395|FG000|COMPLETED|Overall Study||43
10756940|NCT03080961|11920395|FG000|NOT COMPLETED|Overall Study||3
10756941|NCT03081117|11920406|FG000|STARTED|Overall Study||10
10756942|NCT03081117|11920407|FG001|STARTED|Overall Study||11
10756943|NCT03081117|11920406|FG000|Primary Outcome 1 (SAE)|Overall Study||10
10756944|NCT03081117|11920407|FG001|Primary Outcome 1 (SAE)|Overall Study||11
10756945|NCT03081117|11920406|FG000|Secondary Measures Collected at Week 24|Overall Study||8
10756946|NCT03081117|11920407|FG001|Secondary Measures Collected at Week 24|Overall Study||9
10756947|NCT03081117|11920406|FG000|Completed (ITT): Primary Outcome 2 (GDS)|Overall Study||7
10756948|NCT03081117|11920407|FG001|Completed (ITT): Primary Outcome 2 (GDS)|Overall Study||9
10756949|NCT03081117|11920406|FG000|COMPLETED|Overall Study||6
10756950|NCT03081117|11920407|FG001|COMPLETED|Overall Study||8
10756951|NCT03081117|11920406|FG000|NOT COMPLETED|Overall Study||4
10756952|NCT03081117|11920407|FG001|NOT COMPLETED|Overall Study||3
10756953|NCT03081884|11920413|FG000|STARTED|Overall Study||61
10756954|NCT03081884|11920413|FG000|COMPLETED|Overall Study||57
10756955|NCT03081884|11920413|FG000|NOT COMPLETED|Overall Study||4
10756956|NCT03082196|11920420|FG000|STARTED|Overall Study||142
10756957|NCT03082196|11920421|FG001|STARTED|Overall Study||142
10756958|NCT03082196|11920420|FG000|COMPLETED|Overall Study||133
10756959|NCT03082196|11920421|FG001|COMPLETED|Overall Study||129
10756960|NCT03082196|11920420|FG000|NOT COMPLETED|Overall Study||9
10756961|NCT03082196|11920421|FG001|NOT COMPLETED|Overall Study||13
10756962|NCT03082261|11920427|FG000|STARTED|Overall Study||269
10756963|NCT03082261|11920427|FG000|COMPLETED|Overall Study||149
10756964|NCT03082261|11920427|FG000|NOT COMPLETED|Overall Study||120
10756965|NCT03082586|11920437|FG000|STARTED|Overall Study|the patients received a total radiation dose of 57.2 Gy in this group|3
10756966|NCT03082586|11920438|FG001|STARTED|Overall Study|the patients received a total radiation dose of 64.4 Gy in this group|3
10756967|NCT03082586|11920439|FG002|STARTED|Overall Study|the patients received a total radiation dose of 71.6 Gy in this group|3
10756968|NCT03082586|11920440|FG003|STARTED|Overall Study|the patients received a total radiation dose of 78.8 Gy in this group|6
10756969|NCT03082586|11920441|FG004|STARTED|Overall Study|the patients received a total radiation dose of 86 Gy in this group|13
10756970|NCT03082586|11920442|FG005|STARTED|Overall Study|the patients received a total radiation dose of 93.2 Gy in this group|3
10756971|NCT03082586|11920437|FG000|COMPLETED|Overall Study|the patients received a total radiation dose of 57.2 Gy in this group|3
10756972|NCT03082586|11920438|FG001|COMPLETED|Overall Study|the patients received a total radiation dose of 64.4 Gy in this group|3
10756973|NCT03082586|11920439|FG002|COMPLETED|Overall Study|the patients received a total radiation dose of 71.6 Gy in this group|3
10756974|NCT03082586|11920440|FG003|COMPLETED|Overall Study|the patients received a total radiation dose of 78.8 Gy in this group|6
10756975|NCT03082586|11920441|FG004|COMPLETED|Overall Study|the patients received a total radiation dose of 86 Gy in this group|13
10756976|NCT03082586|11920442|FG005|COMPLETED|Overall Study|the patients received a total radiation dose of 93.2 Gy in this group|3
10756977|NCT03082586|11920437|FG000|NOT COMPLETED|Overall Study||0
10756978|NCT03082586|11920438|FG001|NOT COMPLETED|Overall Study||0
10756979|NCT03082586|11920439|FG002|NOT COMPLETED|Overall Study||0
10756980|NCT03082586|11920440|FG003|NOT COMPLETED|Overall Study||0
10756981|NCT03082586|11920441|FG004|NOT COMPLETED|Overall Study||0
10756982|NCT03082586|11920442|FG005|NOT COMPLETED|Overall Study||0
10756983|NCT03082599|11920464|FG000|STARTED|Overall Study||40
10756984|NCT03082599|11920465|FG001|STARTED|Overall Study||39
10756985|NCT03082599|11920464|FG000|COMPLETED|Overall Study||39
10756986|NCT03082599|11920465|FG001|COMPLETED|Overall Study||39
10756987|NCT03082599|11920464|FG000|NOT COMPLETED|Overall Study||1
10756988|NCT03082599|11920465|FG001|NOT COMPLETED|Overall Study||0
10756989|NCT03083093|11920473|FG000|STARTED|Overall Study||50
10756990|NCT03083093|11920474|FG001|STARTED|Overall Study||50
10756991|NCT03083093|11920473|FG000|COMPLETED|Overall Study||50
10756992|NCT03083093|11920474|FG001|COMPLETED|Overall Study||50
10756993|NCT03083093|11920473|FG000|NOT COMPLETED|Overall Study||0
10756994|NCT03083093|11920474|FG001|NOT COMPLETED|Overall Study||0
10756995|NCT03083132|11920482|FG000|STARTED|First 12 Weeks (Placebo vs Modafinil)||12
10756996|NCT03083132|11920483|FG001|STARTED|First 12 Weeks (Placebo vs Modafinil)||9
10756997|NCT03083132|11920482|FG000|COMPLETED|First 12 Weeks (Placebo vs Modafinil)||12
10756998|NCT03083132|11920483|FG001|COMPLETED|First 12 Weeks (Placebo vs Modafinil)||7
10756999|NCT03083132|11920482|FG000|NOT COMPLETED|First 12 Weeks (Placebo vs Modafinil)||0
10757000|NCT03083132|11920483|FG001|NOT COMPLETED|First 12 Weeks (Placebo vs Modafinil)||2
10757001|NCT03083132|11920482|FG000|STARTED|Last 12 Weeks (Drug for All Subjects)||12
10757002|NCT03083132|11920483|FG001|STARTED|Last 12 Weeks (Drug for All Subjects)||7
10757003|NCT03083132|11920482|FG000|COMPLETED|Last 12 Weeks (Drug for All Subjects)||11
10757004|NCT03083132|11920483|FG001|COMPLETED|Last 12 Weeks (Drug for All Subjects)||6
10757005|NCT03083132|11920482|FG000|NOT COMPLETED|Last 12 Weeks (Drug for All Subjects)||1
10757006|NCT03083132|11920483|FG001|NOT COMPLETED|Last 12 Weeks (Drug for All Subjects)||1
10757007|NCT03083379|11920491|FG000|STARTED|Overall Study||15
10757008|NCT03083379|11920492|FG001|STARTED|Overall Study||15
10757009|NCT03083379|11920491|FG000|COMPLETED|Overall Study||15
10757010|NCT03083379|11920492|FG001|COMPLETED|Overall Study||15
10757011|NCT03083379|11920491|FG000|NOT COMPLETED|Overall Study||0
10757012|NCT03083379|11920492|FG001|NOT COMPLETED|Overall Study||0
10757013|NCT03083470|11920503|FG000|STARTED|Overall Study||6
10757014|NCT03083470|11920504|FG001|STARTED|Overall Study||6
10757015|NCT03083470|11920505|FG002|STARTED|Overall Study||6
10757016|NCT03083470|11920506|FG003|STARTED|Overall Study||6
10757017|NCT03083470|11920507|FG004|STARTED|Overall Study||9
10757018|NCT03083470|11920503|FG000|COMPLETED|Overall Study||6
10757019|NCT03083470|11920504|FG001|COMPLETED|Overall Study||6
10757020|NCT03083470|11920505|FG002|COMPLETED|Overall Study||6
10757021|NCT03083470|11920506|FG003|COMPLETED|Overall Study||6
10757022|NCT03083470|11920507|FG004|COMPLETED|Overall Study||7
10757023|NCT03083470|11920503|FG000|NOT COMPLETED|Overall Study||0
10757024|NCT03083470|11920504|FG001|NOT COMPLETED|Overall Study||0
10757025|NCT03083470|11920505|FG002|NOT COMPLETED|Overall Study||0
10757026|NCT03083470|11920506|FG003|NOT COMPLETED|Overall Study||0
10757027|NCT03083470|11920507|FG004|NOT COMPLETED|Overall Study||2
10757028|NCT03083483|11920522|FG000|STARTED|Overall Study||24
10757029|NCT03083483|11920523|FG001|STARTED|Overall Study||22
10757030|NCT03083483|11920524|FG002|STARTED|Overall Study||23
10757031|NCT03083483|11920522|FG000|COMPLETED|Overall Study||20
10757032|NCT03083483|11920523|FG001|COMPLETED|Overall Study||20
10757033|NCT03083483|11920524|FG002|COMPLETED|Overall Study||20
10757034|NCT03083483|11920522|FG000|NOT COMPLETED|Overall Study||4
10757035|NCT03083483|11920523|FG001|NOT COMPLETED|Overall Study||2
10757036|NCT03083483|11920524|FG002|NOT COMPLETED|Overall Study||3
10757037|NCT03083639|11920534|FG000|STARTED|Intervention Period 1 (1 Day)||26
10757038|NCT03083639|11920535|FG001|STARTED|Intervention Period 1 (1 Day)||26
10757039|NCT03083639|11920534|FG000|COMPLETED|Intervention Period 1 (1 Day)||26
10757040|NCT03083639|11920535|FG001|COMPLETED|Intervention Period 1 (1 Day)||26
10757041|NCT03083639|11920534|FG000|NOT COMPLETED|Intervention Period 1 (1 Day)||0
10757042|NCT03083639|11920535|FG001|NOT COMPLETED|Intervention Period 1 (1 Day)||0
10757043|NCT03083639|11920534|FG000|STARTED|Washout Period (at Least 6 Days)||26
10757044|NCT03083639|11920535|FG001|STARTED|Washout Period (at Least 6 Days)||26
10757045|NCT03083639|11920534|FG000|COMPLETED|Washout Period (at Least 6 Days)||25
10757046|NCT03083639|11920535|FG001|COMPLETED|Washout Period (at Least 6 Days)||25
10757047|NCT03083639|11920534|FG000|NOT COMPLETED|Washout Period (at Least 6 Days)||1
10757048|NCT03083639|11920535|FG001|NOT COMPLETED|Washout Period (at Least 6 Days)||1
10757049|NCT03083639|11920534|FG000|STARTED|Intervention Period 2 (1 Day)||25
10757050|NCT03083639|11920535|FG001|STARTED|Intervention Period 2 (1 Day)||25
10757051|NCT03083639|11920534|FG000|COMPLETED|Intervention Period 2 (1 Day)||25
10757052|NCT03083639|11920535|FG001|COMPLETED|Intervention Period 2 (1 Day)||25
10757053|NCT03083639|11920534|FG000|NOT COMPLETED|Intervention Period 2 (1 Day)||0
10757054|NCT03083639|11920535|FG001|NOT COMPLETED|Intervention Period 2 (1 Day)||0
10757055|NCT03083769|11920543|FG000|STARTED|Overall Study||839
10757056|NCT03083769|11920544|FG001|STARTED|Overall Study||663
10757057|NCT03083769|11920543|FG000|COMPLETED|Overall Study||819
10757058|NCT03083769|11920544|FG001|COMPLETED|Overall Study||631
10757059|NCT03083769|11920543|FG000|NOT COMPLETED|Overall Study||20
10757060|NCT03083769|11920544|FG001|NOT COMPLETED|Overall Study||32
10757061|NCT03083847|11920560|FG000|STARTED|Pilot 1a||2
10757062|NCT03083847|11920561|FG001|STARTED|Pilot 1a||0
10757063|NCT03083847|11920562|FG002|STARTED|Pilot 1a||0
10757064|NCT03083847|11920563|FG003|STARTED|Pilot 1a||0
10757065|NCT03083847|11920564|FG004|STARTED|Pilot 1a||0
10757066|NCT03083847|11920565|FG005|STARTED|Pilot 1a||0
10757067|NCT03083847|11920566|FG006|STARTED|Pilot 1a||0
10757068|NCT03083847|11920567|FG007|STARTED|Pilot 1a||0
10757069|NCT03083847|11920568|FG008|STARTED|Pilot 1a||0
10757070|NCT03083847|11920569|FG009|STARTED|Pilot 1a||0
10757071|NCT03083847|11920560|FG000|COMPLETED|Pilot 1a||2
10757072|NCT03083847|11920561|FG001|COMPLETED|Pilot 1a||0
10757073|NCT03083847|11920562|FG002|COMPLETED|Pilot 1a||0
10757074|NCT03083847|11920563|FG003|COMPLETED|Pilot 1a||0
10757075|NCT03083847|11920564|FG004|COMPLETED|Pilot 1a||0
10757076|NCT03083847|11920565|FG005|COMPLETED|Pilot 1a||0
10757077|NCT03083847|11920566|FG006|COMPLETED|Pilot 1a||0
10757078|NCT03083847|11920567|FG007|COMPLETED|Pilot 1a||0
10757079|NCT03083847|11920568|FG008|COMPLETED|Pilot 1a||0
10757080|NCT03083847|11920569|FG009|COMPLETED|Pilot 1a||0
10757081|NCT03083847|11920560|FG000|NOT COMPLETED|Pilot 1a||0
10757082|NCT03083847|11920561|FG001|NOT COMPLETED|Pilot 1a||0
10757083|NCT03083847|11920562|FG002|NOT COMPLETED|Pilot 1a||0
10757084|NCT03083847|11920563|FG003|NOT COMPLETED|Pilot 1a||0
10757085|NCT03083847|11920564|FG004|NOT COMPLETED|Pilot 1a||0
10757086|NCT03083847|11920565|FG005|NOT COMPLETED|Pilot 1a||0
10757087|NCT03083847|11920566|FG006|NOT COMPLETED|Pilot 1a||0
10757088|NCT03083847|11920567|FG007|NOT COMPLETED|Pilot 1a||0
10757089|NCT03083847|11920568|FG008|NOT COMPLETED|Pilot 1a||0
10757090|NCT03083847|11920569|FG009|NOT COMPLETED|Pilot 1a||0
10757091|NCT03083847|11920560|FG000|STARTED|Pilot Ib & 5a||0
10757092|NCT03083847|11920561|FG001|STARTED|Pilot Ib & 5a||2
10757093|NCT03083847|11920562|FG002|STARTED|Pilot Ib & 5a||2
10757094|NCT03083847|11920563|FG003|STARTED|Pilot Ib & 5a||0
10757095|NCT03083847|11920564|FG004|STARTED|Pilot Ib & 5a||0
10757096|NCT03083847|11920565|FG005|STARTED|Pilot Ib & 5a||0
10757097|NCT03083847|11920566|FG006|STARTED|Pilot Ib & 5a||0
10757098|NCT03083847|11920567|FG007|STARTED|Pilot Ib & 5a||0
10757099|NCT03083847|11920568|FG008|STARTED|Pilot Ib & 5a||0
10757100|NCT03083847|11920569|FG009|STARTED|Pilot Ib & 5a||0
10757101|NCT03083847|11920560|FG000|COMPLETED|Pilot Ib & 5a||0
10757102|NCT03083847|11920561|FG001|COMPLETED|Pilot Ib & 5a||2
10757103|NCT03083847|11920562|FG002|COMPLETED|Pilot Ib & 5a||2
10757104|NCT03083847|11920563|FG003|COMPLETED|Pilot Ib & 5a||0
10757105|NCT03083847|11920564|FG004|COMPLETED|Pilot Ib & 5a||0
10757106|NCT03083847|11920565|FG005|COMPLETED|Pilot Ib & 5a||0
10757107|NCT03083847|11920566|FG006|COMPLETED|Pilot Ib & 5a||0
10757108|NCT03083847|11920567|FG007|COMPLETED|Pilot Ib & 5a||0
10757109|NCT03083847|11920568|FG008|COMPLETED|Pilot Ib & 5a||0
10757110|NCT03083847|11920569|FG009|COMPLETED|Pilot Ib & 5a||0
10757111|NCT03083847|11920560|FG000|NOT COMPLETED|Pilot Ib & 5a||0
10757112|NCT03083847|11920561|FG001|NOT COMPLETED|Pilot Ib & 5a||0
10757113|NCT03083847|11920562|FG002|NOT COMPLETED|Pilot Ib & 5a||0
10757114|NCT03083847|11920563|FG003|NOT COMPLETED|Pilot Ib & 5a||0
10757115|NCT03083847|11920564|FG004|NOT COMPLETED|Pilot Ib & 5a||0
10757116|NCT03083847|11920565|FG005|NOT COMPLETED|Pilot Ib & 5a||0
10757117|NCT03083847|11920566|FG006|NOT COMPLETED|Pilot Ib & 5a||0
10757118|NCT03083847|11920567|FG007|NOT COMPLETED|Pilot Ib & 5a||0
10757119|NCT03083847|11920568|FG008|NOT COMPLETED|Pilot Ib & 5a||0
10757120|NCT03083847|11920569|FG009|NOT COMPLETED|Pilot Ib & 5a||0
10757121|NCT03083847|11920560|FG000|STARTED|Pilot 1d & 5b||0
10757122|NCT03083847|11920561|FG001|STARTED|Pilot 1d & 5b||0
10757123|NCT03083847|11920562|FG002|STARTED|Pilot 1d & 5b||0
10757124|NCT03083847|11920563|FG003|STARTED|Pilot 1d & 5b||4
10757125|NCT03083847|11920564|FG004|STARTED|Pilot 1d & 5b||4
10757126|NCT03083847|11920565|FG005|STARTED|Pilot 1d & 5b||0
10757127|NCT03083847|11920566|FG006|STARTED|Pilot 1d & 5b||0
10757128|NCT03083847|11920567|FG007|STARTED|Pilot 1d & 5b||0
10757129|NCT03083847|11920568|FG008|STARTED|Pilot 1d & 5b||0
10757130|NCT03083847|11920569|FG009|STARTED|Pilot 1d & 5b||0
10757131|NCT03083847|11920560|FG000|COMPLETED|Pilot 1d & 5b||0
10757132|NCT03083847|11920561|FG001|COMPLETED|Pilot 1d & 5b||0
10757133|NCT03083847|11920562|FG002|COMPLETED|Pilot 1d & 5b||0
10757134|NCT03083847|11920563|FG003|COMPLETED|Pilot 1d & 5b||4
10757135|NCT03083847|11920564|FG004|COMPLETED|Pilot 1d & 5b||4
10757136|NCT03083847|11920565|FG005|COMPLETED|Pilot 1d & 5b||0
10757137|NCT03083847|11920566|FG006|COMPLETED|Pilot 1d & 5b||0
10757138|NCT03083847|11920567|FG007|COMPLETED|Pilot 1d & 5b||0
10757139|NCT03083847|11920568|FG008|COMPLETED|Pilot 1d & 5b||0
10757140|NCT03083847|11920569|FG009|COMPLETED|Pilot 1d & 5b||0
10757141|NCT03083847|11920560|FG000|NOT COMPLETED|Pilot 1d & 5b||0
10757142|NCT03083847|11920561|FG001|NOT COMPLETED|Pilot 1d & 5b||0
10757143|NCT03083847|11920562|FG002|NOT COMPLETED|Pilot 1d & 5b||0
10757144|NCT03083847|11920563|FG003|NOT COMPLETED|Pilot 1d & 5b||0
10757145|NCT03083847|11920564|FG004|NOT COMPLETED|Pilot 1d & 5b||0
10757146|NCT03083847|11920565|FG005|NOT COMPLETED|Pilot 1d & 5b||0
10757147|NCT03083847|11920566|FG006|NOT COMPLETED|Pilot 1d & 5b||0
10757148|NCT03083847|11920567|FG007|NOT COMPLETED|Pilot 1d & 5b||0
10757149|NCT03083847|11920568|FG008|NOT COMPLETED|Pilot 1d & 5b||0
10757150|NCT03083847|11920569|FG009|NOT COMPLETED|Pilot 1d & 5b||0
10757151|NCT03083847|11920560|FG000|STARTED|Main||0
10757152|NCT03083847|11920561|FG001|STARTED|Main||0
10757153|NCT03083847|11920562|FG002|STARTED|Main||0
10757154|NCT03083847|11920563|FG003|STARTED|Main||0
10757155|NCT03083847|11920564|FG004|STARTED|Main||0
10757156|NCT03083847|11920565|FG005|STARTED|Main||9
10757157|NCT03083847|11920566|FG006|STARTED|Main||10
10757158|NCT03083847|11920567|FG007|STARTED|Main||10
10757159|NCT03083847|11920568|FG008|STARTED|Main||4
10757160|NCT03083847|11920569|FG009|STARTED|Main||8
10757161|NCT03083847|11920560|FG000|COMPLETED|Main||0
10757162|NCT03083847|11920561|FG001|COMPLETED|Main||0
10757163|NCT03083847|11920562|FG002|COMPLETED|Main||0
10757164|NCT03083847|11920563|FG003|COMPLETED|Main||0
10757165|NCT03083847|11920564|FG004|COMPLETED|Main||0
10757166|NCT03083847|11920565|FG005|COMPLETED|Main||8
10757167|NCT03083847|11920566|FG006|COMPLETED|Main||9
10757168|NCT03083847|11920567|FG007|COMPLETED|Main||6
10757169|NCT03083847|11920568|FG008|COMPLETED|Main||4
10757170|NCT03083847|11920569|FG009|COMPLETED|Main||8
10757171|NCT03083847|11920560|FG000|NOT COMPLETED|Main||0
10757172|NCT03083847|11920561|FG001|NOT COMPLETED|Main||0
10757173|NCT03083847|11920562|FG002|NOT COMPLETED|Main||0
10757174|NCT03083847|11920563|FG003|NOT COMPLETED|Main||0
10757175|NCT03083847|11920564|FG004|NOT COMPLETED|Main||0
10757176|NCT03083847|11920565|FG005|NOT COMPLETED|Main||1
10757177|NCT03083847|11920566|FG006|NOT COMPLETED|Main||1
10757178|NCT03083847|11920567|FG007|NOT COMPLETED|Main||4
10757179|NCT03083847|11920568|FG008|NOT COMPLETED|Main||0
10757180|NCT03083847|11920569|FG009|NOT COMPLETED|Main||0
10757181|NCT03083990|11920599|FG000|STARTED|Overall Study||50
10757182|NCT03083990|11920600|FG001|STARTED|Overall Study||50
10757183|NCT03083990|11920599|FG000|COMPLETED|Overall Study||49
10757184|NCT03083990|11920600|FG001|COMPLETED|Overall Study||50
10757185|NCT03083990|11920599|FG000|NOT COMPLETED|Overall Study||1
10757186|NCT03083990|11920600|FG001|NOT COMPLETED|Overall Study||0
10757187|NCT03084302|11920606|FG000|STARTED|Overall Study||120
10757188|NCT03084302|11920606|FG000|COMPLETED|Overall Study||105
10757189|NCT03084302|11920606|FG000|NOT COMPLETED|Overall Study||15
10757190|NCT03084315|11920613|FG000|STARTED|Overall Study||116
10757191|NCT03084315|11920614|FG001|STARTED|Overall Study||118
10757192|NCT03084315|11920613|FG000|COMPLETED|Overall Study||106
10757193|NCT03084315|11920614|FG001|COMPLETED|Overall Study||109
10757194|NCT03084315|11920613|FG000|NOT COMPLETED|Overall Study||10
10757195|NCT03084315|11920614|FG001|NOT COMPLETED|Overall Study||9
10757196|NCT03084796|11920626|FG000|STARTED|Overall Study||121
10757197|NCT03084796|11920627|FG001|STARTED|Overall Study||123
10757198|NCT03084796|11920628|FG002|STARTED|Overall Study||122
10757199|NCT03084796|11920629|FG003|STARTED|Overall Study||123
10757200|NCT03084796|11920630|FG004|STARTED|Overall Study||121
10757201|NCT03084796|11920631|FG005|STARTED|Overall Study||123
10757202|NCT03084796|11920626|FG000|COMPLETED|Overall Study||114
10757203|NCT03084796|11920627|FG001|COMPLETED|Overall Study||113
10757204|NCT03084796|11920628|FG002|COMPLETED|Overall Study||110
10757205|NCT03084796|11920629|FG003|COMPLETED|Overall Study||119
10757206|NCT03084796|11920630|FG004|COMPLETED|Overall Study||110
10757207|NCT03084796|11920631|FG005|COMPLETED|Overall Study||116
10757208|NCT03084796|11920626|FG000|NOT COMPLETED|Overall Study||7
10757209|NCT03084796|11920627|FG001|NOT COMPLETED|Overall Study||10
10757210|NCT03084796|11920628|FG002|NOT COMPLETED|Overall Study||12
10757211|NCT03084796|11920629|FG003|NOT COMPLETED|Overall Study||4
10757212|NCT03084796|11920630|FG004|NOT COMPLETED|Overall Study||11
10757213|NCT03084796|11920631|FG005|NOT COMPLETED|Overall Study||7
10757214|NCT03085017|11920647|FG000|STARTED|Overall Study||30
10757215|NCT03085017|11920648|FG001|STARTED|Overall Study||27
10757216|NCT03085017|11920647|FG000|COMPLETED|Overall Study||30
10757217|NCT03085017|11920648|FG001|COMPLETED|Overall Study||24
10757218|NCT03085017|11920647|FG000|NOT COMPLETED|Overall Study||0
10757219|NCT03085017|11920648|FG001|NOT COMPLETED|Overall Study||3
10757220|NCT03085238|11920654|FG000|STARTED|Overall Study||23
10757221|NCT03085238|11920654|FG000|1 Month|Overall Study||23
10757222|NCT03085238|11920654|FG000|3 Months|Overall Study||22
10757223|NCT03085238|11920654|FG000|6 Months|Overall Study||19
10757224|NCT03085238|11920654|FG000|9 Months|Overall Study||16
10757225|NCT03085238|11920654|FG000|12 Months|Overall Study||14
10757226|NCT03085238|11920654|FG000|15 Months|Overall Study||11
10757227|NCT03085238|11920654|FG000|18 Months|Overall Study||7
10757228|NCT03085238|11920654|FG000|COMPLETED|Overall Study||19
10757229|NCT03085238|11920654|FG000|NOT COMPLETED|Overall Study||4
10757230|NCT03085758|11920670|FG000|STARTED|Overall Study||72
10757231|NCT03085758|11920671|FG001|STARTED|Overall Study||77
10757232|NCT03085758|11920672|FG002|STARTED|Overall Study||152
10757233|NCT03085758|11920670|FG000|COMPLETED|Overall Study||43
10757234|NCT03085758|11920671|FG001|COMPLETED|Overall Study||49
10757235|NCT03085758|11920672|FG002|COMPLETED|Overall Study||96
10757236|NCT03085758|11920670|FG000|NOT COMPLETED|Overall Study||29
10757237|NCT03085758|11920671|FG001|NOT COMPLETED|Overall Study||28
10757238|NCT03085758|11920672|FG002|NOT COMPLETED|Overall Study||56
10757239|NCT03085797|11920686|FG000|STARTED|Treatment Period (TP) (52 Weeks)||201
10757240|NCT03085797|11920687|FG001|STARTED|Treatment Period (TP) (52 Weeks)||206
10757241|NCT03085797|11920686|FG000|Completed Investigational Product (IP)|Treatment Period (TP) (52 Weeks)||167
10757242|NCT03085797|11920687|FG001|Completed Investigational Product (IP)|Treatment Period (TP) (52 Weeks)||183
10757243|NCT03085797|11920686|FG000|Not Completed IP|Treatment Period (TP) (52 Weeks)||34
10757244|NCT03085797|11920687|FG001|Not Completed IP|Treatment Period (TP) (52 Weeks)||23
10757245|NCT03085797|11920686|FG000|Withdrew IP Due to: Adverse Event|Treatment Period (TP) (52 Weeks)||4
10757246|NCT03085797|11920687|FG001|Withdrew IP Due to: Adverse Event|Treatment Period (TP) (52 Weeks)||4
10757247|NCT03085797|11920686|FG000|Withdrew IP Due to: Lack of Efficacy|Treatment Period (TP) (52 Weeks)||11
10757248|NCT03085797|11920687|FG001|Withdrew IP Due to: Lack of Efficacy|Treatment Period (TP) (52 Weeks)||5
10757249|NCT03085797|11920686|FG000|Withdrew IP Due to: Protocol Deviation|Treatment Period (TP) (52 Weeks)||1
10757250|NCT03085797|11920687|FG001|Withdrew IP Due to: Protocol Deviation|Treatment Period (TP) (52 Weeks)||0
10757251|NCT03085797|11920686|FG000|Withdrew IP Due to: Stopping Criteria|Treatment Period (TP) (52 Weeks)||1
10757252|NCT03085797|11920687|FG001|Withdrew IP Due to: Stopping Criteria|Treatment Period (TP) (52 Weeks)||1
10757253|NCT03085797|11920686|FG000|Withdrew IP Due to: Physician Decision|Treatment Period (TP) (52 Weeks)||2
10757254|NCT03085797|11920687|FG001|Withdrew IP Due to: Physician Decision|Treatment Period (TP) (52 Weeks)||1
10757255|NCT03085797|11920686|FG000|Withdrew IP Due to: Withdrawal by Par.|Treatment Period (TP) (52 Weeks)||15
10757256|NCT03085797|11920687|FG001|Withdrew IP Due to: Withdrawal by Par.|Treatment Period (TP) (52 Weeks)||12
10757257|NCT03085797|11920686|FG000|COMPLETED|Treatment Period (TP) (52 Weeks)||184
10757258|NCT03085797|11920687|FG001|COMPLETED|Treatment Period (TP) (52 Weeks)||189
10757259|NCT03085797|11920686|FG000|NOT COMPLETED|Treatment Period (TP) (52 Weeks)||17
10757260|NCT03085797|11920687|FG001|NOT COMPLETED|Treatment Period (TP) (52 Weeks)||17
10757261|NCT03085797|11920686|FG000|STARTED|No-treatment Follow-up Period (6 Months)|Only 65 Par. continued in FU to check maintenance of response after stopping treatment per protocol|65
10757262|NCT03085797|11920687|FG001|STARTED|No-treatment Follow-up Period (6 Months)|Only 69 Par. continued in FU to check maintenance of response after stopping treatment per protocol|69
10757263|NCT03085797|11920686|FG000|COMPLETED|No-treatment Follow-up Period (6 Months)||65
10757264|NCT03085797|11920687|FG001|COMPLETED|No-treatment Follow-up Period (6 Months)||68
10757265|NCT03085797|11920686|FG000|NOT COMPLETED|No-treatment Follow-up Period (6 Months)||0
10757266|NCT03085797|11920687|FG001|NOT COMPLETED|No-treatment Follow-up Period (6 Months)||1
10757267|NCT03085836|11920698|FG000|STARTED|Overall Study||12
10757268|NCT03085836|11920699|FG001|STARTED|Overall Study||11
10757269|NCT03085836|11920700|FG002|STARTED|Overall Study||10
10757270|NCT03085836|11920698|FG000|COMPLETED|Overall Study||12
10757271|NCT03085836|11920699|FG001|COMPLETED|Overall Study||11
10757272|NCT03085836|11920700|FG002|COMPLETED|Overall Study||10
10757273|NCT03085836|11920698|FG000|NOT COMPLETED|Overall Study||0
10757274|NCT03085836|11920699|FG001|NOT COMPLETED|Overall Study||0
10757275|NCT03085836|11920700|FG002|NOT COMPLETED|Overall Study||0
10757297|NCT03085927|11920742|FG000|STARTED|Overall Study||69
10757298|NCT03085927|11920743|FG001|STARTED|Overall Study||67
10757299|NCT03085927|11920742|FG000|Study Sessions|Overall Study|"Off Study reasons:~Child toxicity/side effects (n=1) Dyad withdrew (n=1) Dyad lost to follow-up (n=2)"|65
10757300|NCT03085927|11920743|FG001|Study Sessions|Overall Study|"Off Study reasons:~Dyad withdrew (n=3) Dyad became ineligible (n=1)"|63
10757301|NCT03085927|11920742|FG000|Time 2 Measures|Overall Study||65
10757302|NCT03085927|11920743|FG001|Time 2 Measures|Overall Study|"Off Study reasons:~Dyad withdrew (n=1)"|62
10757303|NCT03085927|11920742|FG000|COMPLETED|Overall Study|"Off Study reasons:~Death of child (n=1) Dyad lost to follow up (n=1)"|63
10757304|NCT03085927|11920743|FG001|COMPLETED|Overall Study|"Off Study reason:~Dyad lost to follow up (n=1)"|61
10757305|NCT03085927|11920742|FG000|NOT COMPLETED|Overall Study||6
10757306|NCT03085927|11920743|FG001|NOT COMPLETED|Overall Study||6
10757307|NCT03086018|11920751|FG000|STARTED|Field Testing||30
10757308|NCT03086018|11920751|FG000|COMPLETED|Field Testing||30
10757309|NCT03086018|11920751|FG000|NOT COMPLETED|Field Testing||0
10757310|NCT03086018|11920751|FG000|STARTED|Final Testing for End of Trial||30
10757311|NCT03086018|11920751|FG000|COMPLETED|Final Testing for End of Trial||28
10757312|NCT03086018|11920751|FG000|NOT COMPLETED|Final Testing for End of Trial||2
10757313|NCT03086057|11920761|FG000|STARTED|Stage 1: PrEP Uptake||55
10757314|NCT03086057|11920762|FG001|STARTED|Stage 1: PrEP Uptake||55
10757315|NCT03086057|11920763|FG002|STARTED|Stage 1: PrEP Uptake|This intervention was not provided until Stage 2|0
10757316|NCT03086057|11920764|FG003|STARTED|Stage 1: PrEP Uptake|This intervention was not provided until Stage 2|0
10757317|NCT03086057|11920761|FG000|COMPLETED|Stage 1: PrEP Uptake||44
10757318|NCT03086057|11920762|FG001|COMPLETED|Stage 1: PrEP Uptake||45
10757319|NCT03086057|11920763|FG002|COMPLETED|Stage 1: PrEP Uptake||0
10757320|NCT03086057|11920764|FG003|COMPLETED|Stage 1: PrEP Uptake||0
10757321|NCT03086057|11920761|FG000|NOT COMPLETED|Stage 1: PrEP Uptake||11
10757322|NCT03086057|11920762|FG001|NOT COMPLETED|Stage 1: PrEP Uptake||10
10757323|NCT03086057|11920763|FG002|NOT COMPLETED|Stage 1: PrEP Uptake||0
10757324|NCT03086057|11920764|FG003|NOT COMPLETED|Stage 1: PrEP Uptake||0
10757325|NCT03086057|11920761|FG000|STARTED|Stage 2: PrEP Adherence|This was only provided in Stage 1|0
10757326|NCT03086057|11920762|FG001|STARTED|Stage 2: PrEP Adherence|This was only provided in Stage 1|0
10757327|NCT03086057|11920763|FG002|STARTED|Stage 2: PrEP Adherence|Only individuals who completed Stage 1 AND initiated PrEP were randomized in Stage 2.|17
10757328|NCT03086057|11920764|FG003|STARTED|Stage 2: PrEP Adherence|Only individuals who completed Stage 1 AND initiated PrEP were randomized in Stage 2.|18
10757329|NCT03086057|11920761|FG000|COMPLETED|Stage 2: PrEP Adherence||0
10757330|NCT03086057|11920762|FG001|COMPLETED|Stage 2: PrEP Adherence||0
10757331|NCT03086057|11920763|FG002|COMPLETED|Stage 2: PrEP Adherence||11
10757332|NCT03086057|11920764|FG003|COMPLETED|Stage 2: PrEP Adherence||16
10757333|NCT03086057|11920761|FG000|NOT COMPLETED|Stage 2: PrEP Adherence||0
10757334|NCT03086057|11920762|FG001|NOT COMPLETED|Stage 2: PrEP Adherence||0
10757335|NCT03086057|11920763|FG002|NOT COMPLETED|Stage 2: PrEP Adherence||6
10757336|NCT03086057|11920764|FG003|NOT COMPLETED|Stage 2: PrEP Adherence||2
10757337|NCT03086135|11920774|FG000|STARTED|Overall Study||51
10757338|NCT03086135|11920774|FG000|COMPLETED|Overall Study||48
10757339|NCT03086135|11920774|FG000|NOT COMPLETED|Overall Study||3
10757340|NCT03086213|11920778|FG000|STARTED|Overall Study||24
10757341|NCT03086213|11920779|FG001|STARTED|Overall Study||24
10757342|NCT03086213|11920778|FG000|COMPLETED|Overall Study||24
10757343|NCT03086213|11920779|FG001|COMPLETED|Overall Study||24
10757344|NCT03086213|11920778|FG000|NOT COMPLETED|Overall Study||0
10757345|NCT03086213|11920779|FG001|NOT COMPLETED|Overall Study||0
10757346|NCT03086265|11920787|FG000|STARTED|Overall Study||10
10757347|NCT03086265|11920788|FG001|STARTED|Overall Study||10
10757348|NCT03086265|11920787|FG000|COMPLETED|Overall Study||10
10757349|NCT03086265|11920788|FG001|COMPLETED|Overall Study||10
10757350|NCT03086265|11920787|FG000|NOT COMPLETED|Overall Study||0
10757351|NCT03086265|11920788|FG001|NOT COMPLETED|Overall Study||0
10757352|NCT03086330|11920796|FG000|STARTED|Overall Study||151
10757353|NCT03086330|11920797|FG001|STARTED|Overall Study||151
10757354|NCT03086330|11920796|FG000|Exposed|Overall Study||150
10757355|NCT03086330|11920797|FG001|Exposed|Overall Study||151
10757356|NCT03086330|11920796|FG000|COMPLETED|Overall Study||147
10757357|NCT03086330|11920797|FG001|COMPLETED|Overall Study||147
10757358|NCT03086330|11920796|FG000|NOT COMPLETED|Overall Study||4
10757359|NCT03086330|11920797|FG001|NOT COMPLETED|Overall Study||4
10757366|NCT03086356|11920812|FG000|STARTED|Overall Study||12
10757367|NCT03086356|11920812|FG000|COMPLETED|Overall Study||12
10757368|NCT03086356|11920812|FG000|NOT COMPLETED|Overall Study||0
10757369|NCT03086408|11920818|FG000|STARTED|Overall Study||10
10757370|NCT03086408|11920819|FG001|STARTED|Overall Study||10
10757371|NCT03086408|11920818|FG000|COMPLETED|Overall Study||10
10757372|NCT03086408|11920819|FG001|COMPLETED|Overall Study||10
10757373|NCT03086408|11920818|FG000|NOT COMPLETED|Overall Study||0
10757374|NCT03086408|11920819|FG001|NOT COMPLETED|Overall Study||0
10757375|NCT03086447|11920827|FG000|STARTED|Overall Study||132
10757376|NCT03086447|11920828|FG001|STARTED|Overall Study||130
10757377|NCT03086447|11920827|FG000|COMPLETED|Overall Study||121
10757378|NCT03086447|11920828|FG001|COMPLETED|Overall Study||110
10757379|NCT03086447|11920827|FG000|NOT COMPLETED|Overall Study||11
10757380|NCT03086447|11920828|FG001|NOT COMPLETED|Overall Study||20
10757381|NCT03086460|11920834|FG000|STARTED|Study Participants||67
10757382|NCT03086460|11920834|FG000|Treatment A|Study Participants||39
10757383|NCT03086460|11920834|FG000|Treatment B|Study Participants||35
10757384|NCT03086460|11920834|FG000|Treatment C|Study Participants||37
10757385|NCT03086460|11920834|FG000|Treatment D|Study Participants||40
10757386|NCT03086460|11920834|FG000|Treatment E|Study Participants||40
10757387|NCT03086460|11920834|FG000|Treatment F|Study Participants||41
10757388|NCT03086460|11920834|FG000|COMPLETED|Study Participants||58
10757389|NCT03086460|11920834|FG000|NOT COMPLETED|Study Participants||9
10757390|NCT03086460|11920834|FG000|STARTED|Treatment A||39
10757391|NCT03086460|11920834|FG000|COMPLETED|Treatment A||35
10757392|NCT03086460|11920834|FG000|NOT COMPLETED|Treatment A||4
10757393|NCT03086460|11920834|FG000|STARTED|Treatment B||35
10757394|NCT03086460|11920834|FG000|COMPLETED|Treatment B||35
10757395|NCT03086460|11920834|FG000|NOT COMPLETED|Treatment B||0
10757396|NCT03086460|11920834|FG000|STARTED|Treatment C||37
10757397|NCT03086460|11920834|FG000|COMPLETED|Treatment C||35
10757398|NCT03086460|11920834|FG000|NOT COMPLETED|Treatment C||2
10757399|NCT03086460|11920834|FG000|STARTED|Treatment D||40
10757400|NCT03086460|11920834|FG000|COMPLETED|Treatment D||40
10757401|NCT03086460|11920834|FG000|NOT COMPLETED|Treatment D||0
10757402|NCT03086460|11920834|FG000|STARTED|Treatment E||40
10757403|NCT03086460|11920834|FG000|COMPLETED|Treatment E||36
10757404|NCT03086460|11920834|FG000|NOT COMPLETED|Treatment E||4
10757405|NCT03086460|11920834|FG000|STARTED|Treatment F||41
10757406|NCT03086460|11920834|FG000|COMPLETED|Treatment F||41
10757407|NCT03086460|11920834|FG000|NOT COMPLETED|Treatment F||0
10757408|NCT03086551|11920851|FG000|STARTED|First Intervention||5
10757409|NCT03086551|11920852|FG001|STARTED|First Intervention||5
10757410|NCT03086551|11920851|FG000|COMPLETED|First Intervention||4
10757411|NCT03086551|11920852|FG001|COMPLETED|First Intervention||4
10757412|NCT03086551|11920851|FG000|NOT COMPLETED|First Intervention||1
10757413|NCT03086551|11920852|FG001|NOT COMPLETED|First Intervention||1
10757414|NCT03086551|11920851|FG000|STARTED|Washout||4
10757415|NCT03086551|11920852|FG001|STARTED|Washout||4
10757416|NCT03086551|11920851|FG000|COMPLETED|Washout||1
10757417|NCT03086551|11920852|FG001|COMPLETED|Washout||1
10757418|NCT03086551|11920851|FG000|NOT COMPLETED|Washout||3
10757419|NCT03086551|11920852|FG001|NOT COMPLETED|Washout||3
10757420|NCT03086551|11920851|FG000|STARTED|Second Intervention||1
10757421|NCT03086551|11920852|FG001|STARTED|Second Intervention||1
10757422|NCT03086551|11920851|FG000|COMPLETED|Second Intervention||1
10757423|NCT03086551|11920852|FG001|COMPLETED|Second Intervention||1
10757424|NCT03086551|11920851|FG000|NOT COMPLETED|Second Intervention||0
10757425|NCT03086551|11920852|FG001|NOT COMPLETED|Second Intervention||0
10757426|NCT03086707|11920860|FG000|STARTED|Overall Study||7
10757427|NCT03086707|11920861|FG001|STARTED|Overall Study||7
10757428|NCT03086707|11920860|FG000|COMPLETED|Overall Study||7
10757429|NCT03086707|11920861|FG001|COMPLETED|Overall Study||7
10757430|NCT03086707|11920860|FG000|NOT COMPLETED|Overall Study||0
10757431|NCT03086707|11920861|FG001|NOT COMPLETED|Overall Study||0
10757438|NCT03087513|11920878|FG000|STARTED|First Intervention||40
10757439|NCT03087513|11920878|FG000|COMPLETED|First Intervention||40
10757440|NCT03087513|11920878|FG000|NOT COMPLETED|First Intervention||0
10757441|NCT03087513|11920878|FG000|STARTED|Second Intervention After 3 hr Washout||40
10757442|NCT03087513|11920878|FG000|COMPLETED|Second Intervention After 3 hr Washout||38
10757443|NCT03087513|11920878|FG000|NOT COMPLETED|Second Intervention After 3 hr Washout||2
10757444|NCT03087604|11920893|FG000|STARTED|Overall Study||50
10757445|NCT03087604|11920894|FG001|STARTED|Overall Study||50
10757446|NCT03087604|11920893|FG000|COMPLETED|Overall Study||50
10757447|NCT03087604|11920894|FG001|COMPLETED|Overall Study||50
10757448|NCT03087604|11920893|FG000|NOT COMPLETED|Overall Study||0
10757449|NCT03087604|11920894|FG001|NOT COMPLETED|Overall Study||0
10757450|NCT03087643|11920902|FG000|STARTED|Overall Study||26
10757451|NCT03087643|11920903|FG001|STARTED|Overall Study||25
10757452|NCT03087643|11920902|FG000|COMPLETED|Overall Study||22
10757453|NCT03087643|11920903|FG001|COMPLETED|Overall Study||19
10757454|NCT03087643|11920902|FG000|NOT COMPLETED|Overall Study||4
10757455|NCT03087643|11920903|FG001|NOT COMPLETED|Overall Study||6
10757456|NCT03087786|11920911|FG000|STARTED|Overall Study||50
10757457|NCT03087786|11920912|FG001|STARTED|Overall Study||50
10757458|NCT03087786|11920911|FG000|COMPLETED|Overall Study||48
10757459|NCT03087786|11920912|FG001|COMPLETED|Overall Study||50
10757460|NCT03087786|11920911|FG000|NOT COMPLETED|Overall Study||2
10757461|NCT03087786|11920912|FG001|NOT COMPLETED|Overall Study||0
10757462|NCT03087851|11920921|FG000|STARTED|Overall Study||20
10757463|NCT03087851|11920922|FG001|STARTED|Overall Study||20
10757464|NCT03087851|11920923|FG002|STARTED|Overall Study||21
10757465|NCT03087851|11920921|FG000|COMPLETED|Overall Study||20
10757466|NCT03087851|11920922|FG001|COMPLETED|Overall Study||19
10757467|NCT03087851|11920923|FG002|COMPLETED|Overall Study||19
10757468|NCT03087851|11920921|FG000|NOT COMPLETED|Overall Study||0
10757469|NCT03087851|11920922|FG001|NOT COMPLETED|Overall Study||1
10757470|NCT03087851|11920923|FG002|NOT COMPLETED|Overall Study||2
10757471|NCT03088267|11920931|FG000|STARTED|Overall Study||9
10757472|NCT03088267|11920932|FG001|STARTED|Overall Study||9
10757473|NCT03088267|11920931|FG000|COMPLETED|Overall Study||9
10757474|NCT03088267|11920932|FG001|COMPLETED|Overall Study||9
10757475|NCT03088267|11920931|FG000|NOT COMPLETED|Overall Study||0
10757476|NCT03088267|11920932|FG001|NOT COMPLETED|Overall Study||0
10757477|NCT03088345|11920941|FG000|STARTED|Overall Study||10
10757478|NCT03088345|11920942|FG001|STARTED|Overall Study||10
10757479|NCT03088345|11920941|FG000|COMPLETED|Overall Study||10
10757480|NCT03088345|11920942|FG001|COMPLETED|Overall Study||10
10757481|NCT03088345|11920941|FG000|NOT COMPLETED|Overall Study||0
10757482|NCT03088345|11920942|FG001|NOT COMPLETED|Overall Study||0
10757483|NCT03088748|11920950|FG000|STARTED|Overall Study||40
10757484|NCT03088748|11920951|FG001|STARTED|Overall Study||10
10757485|NCT03088748|11920950|FG000|COMPLETED|Overall Study||40
10757486|NCT03088748|11920951|FG001|COMPLETED|Overall Study||10
10757487|NCT03088748|11920950|FG000|NOT COMPLETED|Overall Study||0
10757488|NCT03088748|11920951|FG001|NOT COMPLETED|Overall Study||0
10757489|NCT03088800|11920960|FG000|STARTED|Overall Study||30
10757490|NCT03088800|11920961|FG001|STARTED|Overall Study||30
10757491|NCT03088800|11920962|FG002|STARTED|Overall Study||30
10757492|NCT03088800|11920960|FG000|COMPLETED|Overall Study||30
10757493|NCT03088800|11920961|FG001|COMPLETED|Overall Study||30
10757494|NCT03088800|11920962|FG002|COMPLETED|Overall Study||30
10757495|NCT03088800|11920960|FG000|NOT COMPLETED|Overall Study||0
10757496|NCT03088800|11920961|FG001|NOT COMPLETED|Overall Study||0
10757497|NCT03088800|11920962|FG002|NOT COMPLETED|Overall Study||0
10757498|NCT03088917|11920970|FG000|STARTED|Overall Study||106
10757499|NCT03088917|11920970|FG000|COMPLETED|Overall Study||10
10757500|NCT03088917|11920970|FG000|NOT COMPLETED|Overall Study||96
10757501|NCT03089047|11920978|FG000|STARTED|Overall Study||2
10757502|NCT03089047|11920979|FG001|STARTED|Overall Study||2
10757503|NCT03089047|11920978|FG000|COMPLETED|Overall Study||1
10757504|NCT03089047|11920979|FG001|COMPLETED|Overall Study||2
10757505|NCT03089047|11920978|FG000|NOT COMPLETED|Overall Study||1
10757506|NCT03089047|11920979|FG001|NOT COMPLETED|Overall Study||0
10757507|NCT03089216|11920989|FG000|STARTED|Overall Study||27
10757508|NCT03089216|11920990|FG001|STARTED|Overall Study||27
10757509|NCT03089216|11920991|FG002|STARTED|Overall Study||27
10757510|NCT03089216|11920992|FG003|STARTED|Overall Study||27
10757511|NCT03089216|11920989|FG000|COMPLETED|Overall Study||27
10757512|NCT03089216|11920990|FG001|COMPLETED|Overall Study||27
10757513|NCT03089216|11920991|FG002|COMPLETED|Overall Study||27
10757514|NCT03089216|11920992|FG003|COMPLETED|Overall Study||26
10757515|NCT03089216|11920989|FG000|NOT COMPLETED|Overall Study||0
10757516|NCT03089216|11920990|FG001|NOT COMPLETED|Overall Study||0
10757517|NCT03089216|11920991|FG002|NOT COMPLETED|Overall Study||0
10757518|NCT03089216|11920992|FG003|NOT COMPLETED|Overall Study||1
10757519|NCT03089580|11921006|FG000|STARTED|Overall Study||14
10757520|NCT03089580|11921006|FG000|COMPLETED|Overall Study||12
10757521|NCT03089580|11921006|FG000|NOT COMPLETED|Overall Study||2
10757522|NCT03089697|11921014|FG000|STARTED|Overall Study||13
10757523|NCT03089697|11921015|FG001|STARTED|Overall Study||12
10757524|NCT03089697|11921014|FG000|COMPLETED|Overall Study||11
10757525|NCT03089697|11921015|FG001|COMPLETED|Overall Study||10
10757526|NCT03089697|11921014|FG000|NOT COMPLETED|Overall Study||2
10757527|NCT03089697|11921015|FG001|NOT COMPLETED|Overall Study||2
10757528|NCT03089879|11921024|FG000|STARTED|Overall Study||7
10757529|NCT03089879|11921025|FG001|STARTED|Overall Study||2
10757530|NCT03089879|11921026|FG002|STARTED|Overall Study||26
10757531|NCT03089879|11921024|FG000|COMPLETED|Overall Study||7
10757532|NCT03089879|11921025|FG001|COMPLETED|Overall Study||2
10757533|NCT03089879|11921026|FG002|COMPLETED|Overall Study||26
10757534|NCT03089879|11921024|FG000|NOT COMPLETED|Overall Study||0
10757535|NCT03089879|11921025|FG001|NOT COMPLETED|Overall Study||0
10757536|NCT03089879|11921026|FG002|NOT COMPLETED|Overall Study||0
10757537|NCT03089944|11921035|FG000|STARTED|Overall Study||343
10757538|NCT03089944|11921035|FG000|COMPLETED|Overall Study||331
10757539|NCT03089944|11921035|FG000|NOT COMPLETED|Overall Study||12
10757540|NCT03090100|11921041|FG000|STARTED|Overall Study||534
10757541|NCT03090100|11921042|FG001|STARTED|Overall Study||514
10874569|NCT04912297|12040704|FG000|STARTED|Overall Study||99
10874570|NCT04912297|12040705|FG001|STARTED|Overall Study||87
10874571|NCT04912297|12040704|FG000|COMPLETED|Overall Study||68
10874572|NCT04912297|12040705|FG001|COMPLETED|Overall Study||54
10874573|NCT04912297|12040704|FG000|NOT COMPLETED|Overall Study||31
10874574|NCT04912297|12040705|FG001|NOT COMPLETED|Overall Study||33
10874581|NCT04904640|12040720|FG000|STARTED|Overall Study||150
10874582|NCT04904640|12040720|FG000|COMPLETED|Overall Study||150
10874583|NCT04904640|12040720|FG000|NOT COMPLETED|Overall Study||0
10296788|NCT00943852|11429421|FG004|STARTED|Third Period of Treatment Intervention||1
10757542|NCT03090100|11921041|FG000|Treated|Overall Study||534
10757543|NCT03090100|11921042|FG001|Treated|Overall Study||511
10757544|NCT03090100|11921041|FG000|COMPLETED|Overall Study||507
10757545|NCT03090100|11921042|FG001|COMPLETED|Overall Study||466
10757546|NCT03090100|11921041|FG000|NOT COMPLETED|Overall Study||27
10757547|NCT03090100|11921042|FG001|NOT COMPLETED|Overall Study||48
10757548|NCT03090256|11921048|FG000|STARTED|Overall Study||68
10757549|NCT03090256|11921048|FG000|COMPLETED|Overall Study||68
10757550|NCT03090256|11921048|FG000|NOT COMPLETED|Overall Study||0
10757551|NCT03090620|11921055|FG000|STARTED|Overall Study||9
10757552|NCT03090620|11921056|FG001|STARTED|Overall Study||10
10757553|NCT03090620|11921055|FG000|COMPLETED|Overall Study||9
10757554|NCT03090620|11921056|FG001|COMPLETED|Overall Study||10
10757555|NCT03090620|11921055|FG000|NOT COMPLETED|Overall Study||0
10757556|NCT03090620|11921056|FG001|NOT COMPLETED|Overall Study||0
10757557|NCT03090958|11921062|FG000|STARTED|Overall Study||20
10757558|NCT03090958|11921062|FG000|COMPLETED|Overall Study||20
10757559|NCT03090958|11921062|FG000|NOT COMPLETED|Overall Study||0
10757560|NCT03091179|11921068|FG000|STARTED|Overall Study||10
10757561|NCT03091179|11921069|FG001|STARTED|Overall Study||10
10757562|NCT03091179|11921068|FG000|COMPLETED|Overall Study||10
10757563|NCT03091179|11921069|FG001|COMPLETED|Overall Study||10
10757564|NCT03091179|11921068|FG000|NOT COMPLETED|Overall Study||0
10757565|NCT03091179|11921069|FG001|NOT COMPLETED|Overall Study||0
10778838|NCT03359850|11940613|FG001|COMPLETED|Extension Phase (Up to 28 Months)||1
10778839|NCT03359850|11940612|FG000|NOT COMPLETED|Extension Phase (Up to 28 Months)||8
10778840|NCT03359850|11940613|FG001|NOT COMPLETED|Extension Phase (Up to 28 Months)||6
10778841|NCT03359889|11940621|FG000|STARTED|Overall Study||5
10778842|NCT03359889|11940621|FG000|COMPLETED|Overall Study||5
10778843|NCT03359889|11940621|FG000|NOT COMPLETED|Overall Study||0
10778844|NCT03360071|11940627|FG000|STARTED|Overall Study||17
10778845|NCT03360071|11940628|FG001|STARTED|Overall Study||14
10778846|NCT03360071|11940627|FG000|COMPLETED|Overall Study||16
10778847|NCT03360071|11940628|FG001|COMPLETED|Overall Study||14
10778848|NCT03360071|11940627|FG000|NOT COMPLETED|Overall Study||1
10778849|NCT03360071|11940628|FG001|NOT COMPLETED|Overall Study||0
10778850|NCT03360110|11940634|FG000|STARTED|First Intervention||27
10778851|NCT03360110|11940635|FG001|STARTED|First Intervention||26
10778852|NCT03360110|11940634|FG000|COMPLETED|First Intervention||27
10778853|NCT03360110|11940635|FG001|COMPLETED|First Intervention||26
10778854|NCT03360110|11940634|FG000|NOT COMPLETED|First Intervention||0
10778855|NCT03360110|11940635|FG001|NOT COMPLETED|First Intervention||0
10778856|NCT03360110|11940634|FG000|STARTED|Second Intervention||27
10778857|NCT03360110|11940635|FG001|STARTED|Second Intervention||26
10778858|NCT03360110|11940634|FG000|COMPLETED|Second Intervention||27
10778859|NCT03360110|11940635|FG001|COMPLETED|Second Intervention||26
10778860|NCT03360110|11940634|FG000|NOT COMPLETED|Second Intervention||0
10778861|NCT03360110|11940635|FG001|NOT COMPLETED|Second Intervention||0
10778862|NCT03360344|11940656|FG000|STARTED|Overall Study||15
10778863|NCT03360344|11940657|FG001|STARTED|Overall Study||16
10778864|NCT03360344|11940658|FG002|STARTED|Overall Study||13
10778865|NCT03360344|11940656|FG000|COMPLETED|Overall Study||15
10778866|NCT03360344|11940657|FG001|COMPLETED|Overall Study||15
10778867|NCT03360344|11940658|FG002|COMPLETED|Overall Study||12
10778868|NCT03360344|11940656|FG000|NOT COMPLETED|Overall Study||0
10778869|NCT03360344|11940657|FG001|NOT COMPLETED|Overall Study||1
10778870|NCT03360344|11940658|FG002|NOT COMPLETED|Overall Study||1
10778871|NCT03360747|11940666|FG000|STARTED|Overall Study||3
10778872|NCT03360747|11940666|FG000|COMPLETED|Overall Study||2
10778873|NCT03360747|11940666|FG000|NOT COMPLETED|Overall Study||1
10778874|NCT03361137|11940675|FG000|STARTED|Overall Study||1
10778875|NCT03361137|11940676|FG001|STARTED|Overall Study||9
10778876|NCT03361137|11940677|FG002|STARTED|Overall Study||1
10778877|NCT03361137|11940678|FG003|STARTED|Overall Study||2
10778878|NCT03361137|11940679|FG004|STARTED|Overall Study||1
10778879|NCT03361137|11940675|FG000|COMPLETED|Overall Study||0
10778880|NCT03361137|11940676|FG001|COMPLETED|Overall Study||9
10778881|NCT03361137|11940677|FG002|COMPLETED|Overall Study||1
10778882|NCT03361137|11940678|FG003|COMPLETED|Overall Study||2
10778883|NCT03361137|11940679|FG004|COMPLETED|Overall Study||1
10778884|NCT03361137|11940675|FG000|NOT COMPLETED|Overall Study||1
10778885|NCT03361137|11940676|FG001|NOT COMPLETED|Overall Study||0
10778886|NCT03361137|11940677|FG002|NOT COMPLETED|Overall Study||0
10778887|NCT03361137|11940678|FG003|NOT COMPLETED|Overall Study||0
10778888|NCT03361137|11940679|FG004|NOT COMPLETED|Overall Study||0
10778889|NCT03361176|11940695|FG000|STARTED|Overall Study||10
10778890|NCT03361176|11940696|FG001|STARTED|Overall Study||20
10778891|NCT03361176|11940695|FG000|COMPLETED|Overall Study||9
10778892|NCT03361176|11940696|FG001|COMPLETED|Overall Study||15
10778893|NCT03361176|11940695|FG000|NOT COMPLETED|Overall Study||1
10778894|NCT03361176|11940696|FG001|NOT COMPLETED|Overall Study||5
10778895|NCT03361293|11940704|FG000|STARTED|Overall Study||20
10778896|NCT03361293|11940705|FG001|STARTED|Overall Study||24
10778897|NCT03361293|11940704|FG000|COMPLETED|Overall Study||19
10778898|NCT03361293|11940705|FG001|COMPLETED|Overall Study||19
10778899|NCT03361293|11940704|FG000|NOT COMPLETED|Overall Study||1
10778900|NCT03361293|11940705|FG001|NOT COMPLETED|Overall Study||5
10778901|NCT03361423|11940713|FG000|STARTED|Overall Study||126
10778902|NCT03361423|11940714|FG001|STARTED|Overall Study||126
10778903|NCT03361423|11940713|FG000|COMPLETED|Overall Study||99
10778904|NCT03361423|11940714|FG001|COMPLETED|Overall Study||103
10778905|NCT03361423|11940713|FG000|NOT COMPLETED|Overall Study||27
10778906|NCT03361423|11940714|FG001|NOT COMPLETED|Overall Study||23
10778907|NCT03361605|11940720|FG000|STARTED|Overall Study||29
10778908|NCT03361605|11940720|FG000|COMPLETED|Overall Study||26
10778909|NCT03361605|11940720|FG000|NOT COMPLETED|Overall Study||3
10778910|NCT03361917|11940726|FG000|STARTED|Overall Study||99
10778911|NCT03361917|11940727|FG001|STARTED|Overall Study||101
10778912|NCT03361917|11940726|FG000|COMPLETED|Overall Study||99
10778913|NCT03361917|11940727|FG001|COMPLETED|Overall Study||101
10778914|NCT03361917|11940726|FG000|NOT COMPLETED|Overall Study||0
10778915|NCT03361917|11940727|FG001|NOT COMPLETED|Overall Study||0
10778916|NCT03362879|11940733|FG000|STARTED|Overall Study||409
10778917|NCT03362879|11940733|FG000|COMPLETED|Overall Study||409
10778918|NCT03362879|11940733|FG000|NOT COMPLETED|Overall Study||0
10757566|NCT03091348|11921077|FG000|STARTED|Overall Study||2
10757567|NCT03091348|11921078|FG001|STARTED|Overall Study||2
10757568|NCT03091348|11921077|FG000|COMPLETED|Overall Study||0
10757569|NCT03091348|11921078|FG001|COMPLETED|Overall Study||1
10757570|NCT03091348|11921077|FG000|NOT COMPLETED|Overall Study||2
10757571|NCT03091348|11921078|FG001|NOT COMPLETED|Overall Study||1
10757572|NCT03091361|11921085|FG000|STARTED|Overall Study||30
10757573|NCT03091361|11921085|FG000|COMPLETED|Overall Study||30
10757574|NCT03091361|11921085|FG000|NOT COMPLETED|Overall Study||0
10757575|NCT03091400|11921091|FG000|STARTED|Phase 1 - 6 Weeks||5
10757576|NCT03091400|11921092|FG001|STARTED|Phase 1 - 6 Weeks||6
10757577|NCT03091400|11921091|FG000|COMPLETED|Phase 1 - 6 Weeks||5
10757578|NCT03091400|11921092|FG001|COMPLETED|Phase 1 - 6 Weeks||6
10757579|NCT03091400|11921091|FG000|NOT COMPLETED|Phase 1 - 6 Weeks||0
10757580|NCT03091400|11921092|FG001|NOT COMPLETED|Phase 1 - 6 Weeks||0
10757581|NCT03091400|11921091|FG000|STARTED|Washout - 2 Weeks||5
10757582|NCT03091400|11921092|FG001|STARTED|Washout - 2 Weeks||6
10757583|NCT03091400|11921091|FG000|COMPLETED|Washout - 2 Weeks||4
10757584|NCT03091400|11921092|FG001|COMPLETED|Washout - 2 Weeks||6
10757585|NCT03091400|11921091|FG000|NOT COMPLETED|Washout - 2 Weeks||1
10757586|NCT03091400|11921092|FG001|NOT COMPLETED|Washout - 2 Weeks||0
10757587|NCT03091400|11921091|FG000|STARTED|Phase 2 - 6 Weeks||4
10757588|NCT03091400|11921092|FG001|STARTED|Phase 2 - 6 Weeks||6
10757589|NCT03091400|11921091|FG000|COMPLETED|Phase 2 - 6 Weeks||4
10757590|NCT03091400|11921092|FG001|COMPLETED|Phase 2 - 6 Weeks||6
10757591|NCT03091400|11921091|FG000|NOT COMPLETED|Phase 2 - 6 Weeks||0
10757592|NCT03091400|11921092|FG001|NOT COMPLETED|Phase 2 - 6 Weeks||0
10757593|NCT03091439|11921100|FG000|STARTED|Overall Study||1
10757594|NCT03091439|11921101|FG001|STARTED|Overall Study||0
10757595|NCT03091439|11921100|FG000|COMPLETED|Overall Study||0
10757596|NCT03091439|11921101|FG001|COMPLETED|Overall Study||0
10757597|NCT03091439|11921100|FG000|NOT COMPLETED|Overall Study||1
10757598|NCT03091439|11921101|FG001|NOT COMPLETED|Overall Study||0
10757599|NCT03091478|11921107|FG000|STARTED|Overall Study||13
10757600|NCT03091478|11921107|FG000|COMPLETED|Overall Study||13
10757601|NCT03091478|11921107|FG000|NOT COMPLETED|Overall Study||0
10757602|NCT03091673|11921114|FG000|STARTED|First Dose||31
10757603|NCT03091673|11921115|FG001|STARTED|First Dose|All 31 subjects received the 0.5 mg dose during period 1.|0
10757604|NCT03091673|11921114|FG000|COMPLETED|First Dose||31
10757605|NCT03091673|11921115|FG001|COMPLETED|First Dose||0
10757606|NCT03091673|11921114|FG000|NOT COMPLETED|First Dose||0
10757607|NCT03091673|11921115|FG001|NOT COMPLETED|First Dose||0
10757608|NCT03091673|11921114|FG000|STARTED|Second Dose|No subjects received the 0.5 mg dose during period 2.|0
10757609|NCT03091673|11921115|FG001|STARTED|Second Dose|Only the 11 study subjects ages 12-<18 years were assigned the 1 mg dose during period 2.|11
10757610|NCT03091673|11921114|FG000|COMPLETED|Second Dose||0
10757611|NCT03091673|11921115|FG001|COMPLETED|Second Dose||11
10757612|NCT03091673|11921114|FG000|NOT COMPLETED|Second Dose||0
10757613|NCT03091673|11921115|FG001|NOT COMPLETED|Second Dose||0
10757614|NCT03091738|11921126|FG000|STARTED|Overall Study||10
10757615|NCT03091738|11921126|FG000|COMPLETED|Overall Study||8
10757616|NCT03091738|11921126|FG000|NOT COMPLETED|Overall Study||2
10757617|NCT03091751|11921130|FG000|STARTED|Overall Study||22
10757618|NCT03091751|11921130|FG000|COMPLETED|Overall Study||22
10757619|NCT03091751|11921130|FG000|NOT COMPLETED|Overall Study||0
10757620|NCT03091777|11921137|FG000|STARTED|Overall Study||289
10757621|NCT03091777|11921138|FG001|STARTED|Overall Study||288
10757622|NCT03091777|11921139|FG002|STARTED|Overall Study||294
10757623|NCT03091777|11921137|FG000|COMPLETED|Overall Study||257
10757624|NCT03091777|11921138|FG001|COMPLETED|Overall Study||255
10757625|NCT03091777|11921139|FG002|COMPLETED|Overall Study||257
10757626|NCT03091777|11921137|FG000|NOT COMPLETED|Overall Study||32
10757627|NCT03091777|11921138|FG001|NOT COMPLETED|Overall Study||33
10757628|NCT03091777|11921139|FG002|NOT COMPLETED|Overall Study||37
10757629|NCT03091920|11921150|FG000|STARTED|Overall Study||6
10757630|NCT03091920|11921151|FG001|STARTED|Overall Study||10
10757631|NCT03091920|11921152|FG002|STARTED|Overall Study||10
10757632|NCT03091920|11921150|FG000|COMPLETED|Overall Study||6
10757633|NCT03091920|11921151|FG001|COMPLETED|Overall Study||9
10757634|NCT03091920|11921152|FG002|COMPLETED|Overall Study||10
10757635|NCT03091920|11921150|FG000|NOT COMPLETED|Overall Study||0
10757636|NCT03091920|11921151|FG001|NOT COMPLETED|Overall Study||1
10757637|NCT03091920|11921152|FG002|NOT COMPLETED|Overall Study||0
10757638|NCT03092024|11921168|FG000|STARTED|Overall Study||24
10757639|NCT03092024|11921169|FG001|STARTED|Overall Study||16
10757640|NCT03092024|11921168|FG000|COMPLETED|Overall Study||24
10757641|NCT03092024|11921169|FG001|COMPLETED|Overall Study||16
10757642|NCT03092024|11921168|FG000|NOT COMPLETED|Overall Study||0
10757643|NCT03092024|11921169|FG001|NOT COMPLETED|Overall Study||0
10757644|NCT03092089|11921175|FG000|STARTED|Overall Study||15
10757645|NCT03092089|11921175|FG000|COMPLETED|Overall Study||15
10757646|NCT03092089|11921175|FG000|NOT COMPLETED|Overall Study||0
10757647|NCT03092375|11921183|FG000|STARTED|Overall Study||78
10757648|NCT03092375|11921184|FG001|STARTED|Overall Study||49
10757649|NCT03092375|11921185|FG002|STARTED|Overall Study||21
10757650|NCT03092375|11921186|FG003|STARTED|Overall Study||29
10757651|NCT03092375|11921183|FG000|COMPLETED|Overall Study||78
10757652|NCT03092375|11921184|FG001|COMPLETED|Overall Study||48
10757653|NCT03092375|11921185|FG002|COMPLETED|Overall Study||20
10757654|NCT03092375|11921186|FG003|COMPLETED|Overall Study||29
10757655|NCT03092375|11921183|FG000|NOT COMPLETED|Overall Study||0
10757656|NCT03092375|11921184|FG001|NOT COMPLETED|Overall Study||1
10757657|NCT03092375|11921185|FG002|NOT COMPLETED|Overall Study||1
10757658|NCT03092375|11921186|FG003|NOT COMPLETED|Overall Study||0
10757659|NCT03092479|11921205|FG000|STARTED|Overall Study||24
10757660|NCT03092479|11921206|FG001|STARTED|Overall Study||26
10757661|NCT03092479|11921205|FG000|COMPLETED|Overall Study||17
10757662|NCT03092479|11921206|FG001|COMPLETED|Overall Study||24
10757663|NCT03092479|11921205|FG000|NOT COMPLETED|Overall Study||7
10757664|NCT03092479|11921206|FG001|NOT COMPLETED|Overall Study||2
10757665|NCT03092726|11921214|FG000|STARTED|Overall Study||88
10757666|NCT03092726|11921215|FG001|STARTED|Overall Study||95
10757667|NCT03092726|11921214|FG000|Treated|Overall Study||88
10757668|NCT03092726|11921215|FG001|Treated|Overall Study||95
10757669|NCT03092726|11921214|FG000|COMPLETED|Overall Study||79
10757670|NCT03092726|11921215|FG001|COMPLETED|Overall Study||81
10757671|NCT03092726|11921214|FG000|NOT COMPLETED|Overall Study||9
10757672|NCT03092726|11921215|FG001|NOT COMPLETED|Overall Study||14
10757673|NCT03092752|11921221|FG000|STARTED|Overall Study||523585
10757674|NCT03092752|11921221|FG000|COMPLETED|Overall Study||162116
10757675|NCT03092752|11921221|FG000|NOT COMPLETED|Overall Study||361469
10757676|NCT03092791|11921250|FG000|STARTED|Overall Study||20
10757677|NCT03092791|11921251|FG001|STARTED|Overall Study||20
10757678|NCT03092791|11921252|FG002|STARTED|Overall Study||30
10757679|NCT03092791|11921253|FG003|STARTED|Overall Study||30
10757680|NCT03092791|11921254|FG004|STARTED|Overall Study||60
10757681|NCT03092791|11921255|FG005|STARTED|Overall Study||60
10757682|NCT03092791|11921256|FG006|STARTED|Overall Study||60
10757683|NCT03092791|11921257|FG007|STARTED|Overall Study||60
10757684|NCT03092791|11921250|FG000|COMPLETED|Overall Study||20
10757685|NCT03092791|11921251|FG001|COMPLETED|Overall Study||20
10757686|NCT03092791|11921252|FG002|COMPLETED|Overall Study||30
10757687|NCT03092791|11921253|FG003|COMPLETED|Overall Study||30
10757688|NCT03092791|11921254|FG004|COMPLETED|Overall Study||0
10757689|NCT03092791|11921255|FG005|COMPLETED|Overall Study||0
10757690|NCT03092791|11921256|FG006|COMPLETED|Overall Study||0
10757691|NCT03092791|11921257|FG007|COMPLETED|Overall Study||0
10757692|NCT03092791|11921250|FG000|NOT COMPLETED|Overall Study||0
10757693|NCT03092791|11921251|FG001|NOT COMPLETED|Overall Study||0
10757694|NCT03092791|11921252|FG002|NOT COMPLETED|Overall Study||0
10757695|NCT03092791|11921253|FG003|NOT COMPLETED|Overall Study||0
10757696|NCT03092791|11921254|FG004|NOT COMPLETED|Overall Study||60
10757697|NCT03092791|11921255|FG005|NOT COMPLETED|Overall Study||60
10757698|NCT03092791|11921256|FG006|NOT COMPLETED|Overall Study||60
10757699|NCT03092791|11921257|FG007|NOT COMPLETED|Overall Study||60
10757700|NCT03092934|11921279|FG000|STARTED|Overall Study||8
10757701|NCT03092934|11921280|FG001|STARTED|Overall Study||2
10757702|NCT03092934|11921281|FG002|STARTED|Overall Study||2
10757703|NCT03092934|11921282|FG003|STARTED|Overall Study||1
10757704|NCT03092934|11921279|FG000|Received at Least One Dose of Study Drug|Overall Study||8
10757705|NCT03092934|11921280|FG001|Received at Least One Dose of Study Drug|Overall Study||2
10757706|NCT03092934|11921281|FG002|Received at Least One Dose of Study Drug|Overall Study||2
10757707|NCT03092934|11921282|FG003|Received at Least One Dose of Study Drug|Overall Study||1
10757708|NCT03092934|11921279|FG000|COMPLETED|Overall Study||8
10757709|NCT03092934|11921280|FG001|COMPLETED|Overall Study||2
10757710|NCT03092934|11921281|FG002|COMPLETED|Overall Study||2
10757711|NCT03092934|11921282|FG003|COMPLETED|Overall Study||1
10757712|NCT03092934|11921279|FG000|NOT COMPLETED|Overall Study||0
10757713|NCT03092934|11921280|FG001|NOT COMPLETED|Overall Study||0
10757714|NCT03092934|11921281|FG002|NOT COMPLETED|Overall Study||0
10757715|NCT03092934|11921282|FG003|NOT COMPLETED|Overall Study||0
10757716|NCT03092960|11921294|FG000|STARTED|Overall Study||212
10757717|NCT03092960|11921295|FG001|STARTED|Overall Study||212
10757718|NCT03092960|11921294|FG000|COMPLETED|Overall Study||180
10757719|NCT03092960|11921295|FG001|COMPLETED|Overall Study||186
10757720|NCT03092960|11921294|FG000|NOT COMPLETED|Overall Study||32
10757721|NCT03092960|11921295|FG001|NOT COMPLETED|Overall Study||26
10757722|NCT03093025|11921304|FG000|STARTED|Overall Study||16
10757723|NCT03093025|11921305|FG001|STARTED|Overall Study|One participant did not take any dose of investigational product after randomization.|17
10757724|NCT03093025|11921306|FG002|STARTED|Overall Study||18
10757725|NCT03093025|11921304|FG000|COMPLETED|Overall Study||12
10757726|NCT03093025|11921305|FG001|COMPLETED|Overall Study||15
10757727|NCT03093025|11921306|FG002|COMPLETED|Overall Study||16
10757728|NCT03093025|11921304|FG000|NOT COMPLETED|Overall Study||4
10757729|NCT03093025|11921305|FG001|NOT COMPLETED|Overall Study||2
10757730|NCT03093025|11921306|FG002|NOT COMPLETED|Overall Study||2
10757731|NCT03093181|11921317|FG000|STARTED|Overall Study||44
10757732|NCT03093181|11921318|FG001|STARTED|Overall Study||44
10757733|NCT03093181|11921319|FG002|STARTED|Overall Study||44
10757734|NCT03093181|11921317|FG000|COMPLETED|Overall Study||41
10757735|NCT03093181|11921318|FG001|COMPLETED|Overall Study||42
10757736|NCT03093181|11921319|FG002|COMPLETED|Overall Study||41
10757737|NCT03093181|11921317|FG000|NOT COMPLETED|Overall Study||3
10757738|NCT03093181|11921318|FG001|NOT COMPLETED|Overall Study||2
10757739|NCT03093181|11921319|FG002|NOT COMPLETED|Overall Study||3
10757740|NCT03093207|11921329|FG000|STARTED|Overall Study||17
10757741|NCT03093207|11921330|FG001|STARTED|Overall Study||17
10757742|NCT03093207|11921329|FG000|COMPLETED|Overall Study||17
10757743|NCT03093207|11921330|FG001|COMPLETED|Overall Study||17
10757744|NCT03093207|11921329|FG000|NOT COMPLETED|Overall Study||0
10757745|NCT03093207|11921330|FG001|NOT COMPLETED|Overall Study||0
10757746|NCT03093272|11921336|FG000|STARTED|Overall Study||9
10757747|NCT03093272|11921336|FG000|COMPLETED|Overall Study||9
10757748|NCT03093272|11921336|FG000|NOT COMPLETED|Overall Study||0
10757749|NCT03093324|11921342|FG000|STARTED|Overall Study||254
10757750|NCT03093324|11921343|FG001|STARTED|Overall Study||252
10757751|NCT03093324|11921342|FG000|Safety Population|Overall Study||253
10757752|NCT03093324|11921343|FG001|Safety Population|Overall Study||251
10757753|NCT03093324|11921342|FG000|COMPLETED|Overall Study||245
10757754|NCT03093324|11921343|FG001|COMPLETED|Overall Study||233
10757755|NCT03093324|11921342|FG000|NOT COMPLETED|Overall Study||9
10757756|NCT03093324|11921343|FG001|NOT COMPLETED|Overall Study||19
10757757|NCT03093415|11921352|FG000|STARTED|Assessed for Eligibility --> Enrollment||165
10757758|NCT03093415|11921353|FG001|STARTED|Assessed for Eligibility --> Enrollment||135
10757759|NCT03093415|11921354|FG002|STARTED|Assessed for Eligibility --> Enrollment||50
10757760|NCT03093415|11921352|FG000|COMPLETED|Assessed for Eligibility --> Enrollment||25
10757761|NCT03093415|11921353|FG001|COMPLETED|Assessed for Eligibility --> Enrollment||25
10757762|NCT03093415|11921354|FG002|COMPLETED|Assessed for Eligibility --> Enrollment||50
10757763|NCT03093415|11921352|FG000|NOT COMPLETED|Assessed for Eligibility --> Enrollment||140
10757764|NCT03093415|11921353|FG001|NOT COMPLETED|Assessed for Eligibility --> Enrollment||110
10757765|NCT03093415|11921354|FG002|NOT COMPLETED|Assessed for Eligibility --> Enrollment||0
10757766|NCT03093415|11921352|FG000|STARTED|Enrollment to SVR12 Results|Pre-specified 25 participants to were enrolled.|25
10757767|NCT03093415|11921353|FG001|STARTED|Enrollment to SVR12 Results|Pre-specified 25 participants to were enrolled.|25
10757768|NCT03093415|11921354|FG002|STARTED|Enrollment to SVR12 Results|Prespecified 50 participants enrolled.|50
10757769|NCT03093415|11921352|FG000|COMPLETED|Enrollment to SVR12 Results||24
10757770|NCT03093415|11921353|FG001|COMPLETED|Enrollment to SVR12 Results||17
10757771|NCT03093415|11921354|FG002|COMPLETED|Enrollment to SVR12 Results||47
10757772|NCT03093415|11921352|FG000|NOT COMPLETED|Enrollment to SVR12 Results||1
10757773|NCT03093415|11921353|FG001|NOT COMPLETED|Enrollment to SVR12 Results||8
10757774|NCT03093415|11921354|FG002|NOT COMPLETED|Enrollment to SVR12 Results||3
10757775|NCT03093454|11921364|FG000|STARTED|Overall Study||28
10757776|NCT03093454|11921365|FG001|STARTED|Overall Study||30
10757777|NCT03093454|11921364|FG000|COMPLETED|Overall Study||22
10757778|NCT03093454|11921365|FG001|COMPLETED|Overall Study||27
10757779|NCT03093454|11921364|FG000|NOT COMPLETED|Overall Study||6
10757780|NCT03093454|11921365|FG001|NOT COMPLETED|Overall Study||3
10757781|NCT03093662|11921373|FG000|STARTED|First Intervention (3 Minutes)||18
10757782|NCT03093662|11921374|FG001|STARTED|First Intervention (3 Minutes)||19
10757783|NCT03093662|11921373|FG000|COMPLETED|First Intervention (3 Minutes)||18
10757784|NCT03093662|11921374|FG001|COMPLETED|First Intervention (3 Minutes)||19
10757785|NCT03093662|11921373|FG000|NOT COMPLETED|First Intervention (3 Minutes)||0
10757786|NCT03093662|11921374|FG001|NOT COMPLETED|First Intervention (3 Minutes)||0
10757787|NCT03093662|11921373|FG000|STARTED|Washout Period (5 Minutes)||18
10757788|NCT03093662|11921374|FG001|STARTED|Washout Period (5 Minutes)||19
10757789|NCT03093662|11921373|FG000|COMPLETED|Washout Period (5 Minutes)||18
10757790|NCT03093662|11921374|FG001|COMPLETED|Washout Period (5 Minutes)||19
10757791|NCT03093662|11921373|FG000|NOT COMPLETED|Washout Period (5 Minutes)||0
10757792|NCT03093662|11921374|FG001|NOT COMPLETED|Washout Period (5 Minutes)||0
10757793|NCT03093662|11921373|FG000|STARTED|Second Intervention (3 Minutes)||18
10757794|NCT03093662|11921374|FG001|STARTED|Second Intervention (3 Minutes)||19
10757795|NCT03093662|11921373|FG000|COMPLETED|Second Intervention (3 Minutes)||18
10757796|NCT03093662|11921374|FG001|COMPLETED|Second Intervention (3 Minutes)||19
10757797|NCT03093662|11921373|FG000|NOT COMPLETED|Second Intervention (3 Minutes)||0
10757798|NCT03093662|11921374|FG001|NOT COMPLETED|Second Intervention (3 Minutes)||0
10757799|NCT03093870|11921383|FG000|STARTED|Overall Study||24
10757800|NCT03093870|11921384|FG001|STARTED|Overall Study||64
10757801|NCT03093870|11921385|FG002|STARTED|Overall Study||63
10757802|NCT03093870|11921383|FG000|COMPLETED|Overall Study||0
10757803|NCT03093870|11921384|FG001|COMPLETED|Overall Study||23
10757804|NCT03093870|11921385|FG002|COMPLETED|Overall Study||22
10757805|NCT03093870|11921383|FG000|NOT COMPLETED|Overall Study||24
10757806|NCT03093870|11921384|FG001|NOT COMPLETED|Overall Study||41
10757807|NCT03093870|11921385|FG002|NOT COMPLETED|Overall Study||41
10757808|NCT03094195|11921396|FG000|STARTED|Double-Blind Treatment Period (DB)||43
10757809|NCT03094195|11921397|FG001|STARTED|Double-Blind Treatment Period (DB)||43
10757810|NCT03094195|11921398|FG002|STARTED|Double-Blind Treatment Period (DB)||43
10757811|NCT03094195|11921399|FG003|STARTED|Double-Blind Treatment Period (DB)||0
10757812|NCT03094195|11921400|FG004|STARTED|Double-Blind Treatment Period (DB)||0
10757813|NCT03094195|11921401|FG005|STARTED|Double-Blind Treatment Period (DB)||0
10757814|NCT03094195|11921402|FG006|STARTED|Double-Blind Treatment Period (DB)||0
10757815|NCT03094195|11921403|FG007|STARTED|Double-Blind Treatment Period (DB)||0
10757816|NCT03094195|11921396|FG000|COMPLETED|Double-Blind Treatment Period (DB)||28
10757817|NCT03094195|11921397|FG001|COMPLETED|Double-Blind Treatment Period (DB)||30
10757818|NCT03094195|11921398|FG002|COMPLETED|Double-Blind Treatment Period (DB)||29
10757819|NCT03094195|11921399|FG003|COMPLETED|Double-Blind Treatment Period (DB)||0
10757820|NCT03094195|11921400|FG004|COMPLETED|Double-Blind Treatment Period (DB)||0
10757821|NCT03094195|11921401|FG005|COMPLETED|Double-Blind Treatment Period (DB)||0
10757822|NCT03094195|11921402|FG006|COMPLETED|Double-Blind Treatment Period (DB)||0
10757823|NCT03094195|11921403|FG007|COMPLETED|Double-Blind Treatment Period (DB)||0
10757824|NCT03094195|11921396|FG000|NOT COMPLETED|Double-Blind Treatment Period (DB)||15
10757825|NCT03094195|11921397|FG001|NOT COMPLETED|Double-Blind Treatment Period (DB)||13
10757826|NCT03094195|11921398|FG002|NOT COMPLETED|Double-Blind Treatment Period (DB)||14
10757827|NCT03094195|11921399|FG003|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
10757828|NCT03094195|11921400|FG004|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
10757829|NCT03094195|11921401|FG005|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
10757830|NCT03094195|11921402|FG006|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
10757831|NCT03094195|11921403|FG007|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
10757832|NCT03094195|11921396|FG000|STARTED|Treatment Withdrawal Period (TW)||0
10757833|NCT03094195|11921397|FG001|STARTED|Treatment Withdrawal Period (TW)||0
10757834|NCT03094195|11921398|FG002|STARTED|Treatment Withdrawal Period (TW)||0
10757835|NCT03094195|11921399|FG003|STARTED|Treatment Withdrawal Period (TW)||13
10757836|NCT03094195|11921400|FG004|STARTED|Treatment Withdrawal Period (TW)||13
10757837|NCT03094195|11921401|FG005|STARTED|Treatment Withdrawal Period (TW)||15
10757838|NCT03094195|11921402|FG006|STARTED|Treatment Withdrawal Period (TW)||13
10757839|NCT03094195|11921403|FG007|STARTED|Treatment Withdrawal Period (TW)||26
10757840|NCT03094195|11921396|FG000|COMPLETED|Treatment Withdrawal Period (TW)||0
10757841|NCT03094195|11921397|FG001|COMPLETED|Treatment Withdrawal Period (TW)||0
10757842|NCT03094195|11921398|FG002|COMPLETED|Treatment Withdrawal Period (TW)||0
10757843|NCT03094195|11921399|FG003|COMPLETED|Treatment Withdrawal Period (TW)||13
10757844|NCT03094195|11921400|FG004|COMPLETED|Treatment Withdrawal Period (TW)||13
10757845|NCT03094195|11921401|FG005|COMPLETED|Treatment Withdrawal Period (TW)||15
10757846|NCT03094195|11921402|FG006|COMPLETED|Treatment Withdrawal Period (TW)||13
10757847|NCT03094195|11921403|FG007|COMPLETED|Treatment Withdrawal Period (TW)||26
10757848|NCT03094195|11921396|FG000|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
10757849|NCT03094195|11921397|FG001|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
10757850|NCT03094195|11921398|FG002|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
10757851|NCT03094195|11921399|FG003|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
10757852|NCT03094195|11921400|FG004|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
10757853|NCT03094195|11921401|FG005|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
10757854|NCT03094195|11921402|FG006|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
10757855|NCT03094195|11921403|FG007|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
10757856|NCT03094325|11921421|FG000|STARTED|Overall Study||10
10757857|NCT03094325|11921421|FG000|TEE Before Cardiopulmonary Bypass|Overall Study||10
10757858|NCT03094325|11921421|FG000|OPIE Before Cardiopulmonary Bypass|Overall Study||10
10757859|NCT03094325|11921421|FG000|TEE After Cardiopulmonary Bypass|Overall Study||10
10757860|NCT03094325|11921421|FG000|OPIE After Cardiopulmonary Bypass|Overall Study||10
10757861|NCT03094325|11921421|FG000|COMPLETED|Overall Study||10
10757862|NCT03094325|11921421|FG000|NOT COMPLETED|Overall Study||0
10757863|NCT03094611|11921427|FG000|STARTED|Overall Study||4
10757864|NCT03094611|11921427|FG000|COMPLETED|Overall Study||2
10757865|NCT03094611|11921427|FG000|NOT COMPLETED|Overall Study||2
10757872|NCT03094806|11921443|FG000|STARTED|Overall Study||44
10757873|NCT03094806|11921444|FG001|STARTED|Overall Study||47
10757874|NCT03094806|11921443|FG000|COMPLETED|Overall Study||44
10757875|NCT03094806|11921444|FG001|COMPLETED|Overall Study||47
10757876|NCT03094806|11921443|FG000|NOT COMPLETED|Overall Study||0
10757877|NCT03094806|11921444|FG001|NOT COMPLETED|Overall Study||0
10757878|NCT03095027|11921450|FG000|STARTED|Period 1, First Week of Wear||27
10757879|NCT03095027|11921451|FG001|STARTED|Period 1, First Week of Wear||24
10757880|NCT03095027|11921450|FG000|COMPLETED|Period 1, First Week of Wear||27
10757881|NCT03095027|11921451|FG001|COMPLETED|Period 1, First Week of Wear||24
10757882|NCT03095027|11921450|FG000|NOT COMPLETED|Period 1, First Week of Wear||0
10757883|NCT03095027|11921451|FG001|NOT COMPLETED|Period 1, First Week of Wear||0
10757884|NCT03095027|11921450|FG000|STARTED|Period 2, Second Week of Wear||27
10757885|NCT03095027|11921451|FG001|STARTED|Period 2, Second Week of Wear||24
10757886|NCT03095027|11921450|FG000|COMPLETED|Period 2, Second Week of Wear||26
10757887|NCT03095027|11921451|FG001|COMPLETED|Period 2, Second Week of Wear||24
10757888|NCT03095027|11921450|FG000|NOT COMPLETED|Period 2, Second Week of Wear||1
10757889|NCT03095027|11921451|FG001|NOT COMPLETED|Period 2, Second Week of Wear||0
10757890|NCT03095053|11921459|FG000|STARTED|Overall Study|All blastocysts scored morphologically PGT-A of the single best blastocyst from the cohort|109
10757891|NCT03095053|11921460|FG001|STARTED|Overall Study|All blastocysts scored morphologically|111
10778919|NCT03362944|11940738|FG000|STARTED|First Intervention||8
10874575|NCT04910165|12040713|FG000|STARTED|Overall Study||50
10874576|NCT04910165|12040714|FG001|STARTED|Overall Study||50
10874577|NCT04910165|12040713|FG000|COMPLETED|Overall Study||50
10874578|NCT04910165|12040714|FG001|COMPLETED|Overall Study||50
10874579|NCT04910165|12040713|FG000|NOT COMPLETED|Overall Study||0
10874580|NCT04910165|12040714|FG001|NOT COMPLETED|Overall Study||0
10874584|NCT04901897|12040731|FG000|STARTED|Overall Study||398
10874585|NCT04901897|12040732|FG001|STARTED|Overall Study||202
10874586|NCT04901897|12040733|FG002|STARTED|Overall Study||205
10874587|NCT04901897|12040731|FG000|COMPLETED|Overall Study||393
10874588|NCT04901897|12040732|FG001|COMPLETED|Overall Study||200
10874589|NCT04901897|12040733|FG002|COMPLETED|Overall Study||203
10874590|NCT04901897|12040731|FG000|NOT COMPLETED|Overall Study||5
10874591|NCT04901897|12040732|FG001|NOT COMPLETED|Overall Study||2
10874592|NCT04901897|12040733|FG002|NOT COMPLETED|Overall Study||2
10757892|NCT03095053|11921459|FG000|COMPLETED|Overall Study|29 excluded as blastocyst was predicted to be aneuploid|80
10757893|NCT03095053|11921460|FG001|COMPLETED|Overall Study||111
10757894|NCT03095053|11921459|FG000|NOT COMPLETED|Overall Study||29
10757895|NCT03095053|11921460|FG001|NOT COMPLETED|Overall Study||0
10757899|NCT03095508|11921472|FG000|STARTED|Overall Study||114
10757900|NCT03095508|11921473|FG001|STARTED|Overall Study||115
10757901|NCT03095508|11921472|FG000|Per Protocol Population|Overall Study||112
10757902|NCT03095508|11921473|FG001|Per Protocol Population|Overall Study||111
10757903|NCT03095508|11921472|FG000|Safety Population|Overall Study||114
10757904|NCT03095508|11921473|FG001|Safety Population|Overall Study||115
10757905|NCT03095508|11921472|FG000|ITT Population|Overall Study||114
10757906|NCT03095508|11921473|FG001|ITT Population|Overall Study||115
10757907|NCT03095508|11921472|FG000|COMPLETED|Overall Study||114
10757908|NCT03095508|11921473|FG001|COMPLETED|Overall Study||114
10757909|NCT03095508|11921472|FG000|NOT COMPLETED|Overall Study||0
10757910|NCT03095508|11921473|FG001|NOT COMPLETED|Overall Study||1
10757911|NCT03095521|11921481|FG000|STARTED|Overall Study||115
10757912|NCT03095521|11921482|FG001|STARTED|Overall Study||113
10757913|NCT03095521|11921481|FG000|Intent to Treat Population ITT|Overall Study||115
10757914|NCT03095521|11921482|FG001|Intent to Treat Population ITT|Overall Study||113
10757915|NCT03095521|11921481|FG000|Per Protocol Population PP|Overall Study||113
10757916|NCT03095521|11921482|FG001|Per Protocol Population PP|Overall Study||107
10757917|NCT03095521|11921481|FG000|Safety Population|Overall Study||115
10757918|NCT03095521|11921482|FG001|Safety Population|Overall Study||113
10757919|NCT03095521|11921481|FG000|COMPLETED|Overall Study||115
10757920|NCT03095521|11921482|FG001|COMPLETED|Overall Study||111
10757921|NCT03095521|11921481|FG000|NOT COMPLETED|Overall Study||0
10757922|NCT03095521|11921482|FG001|NOT COMPLETED|Overall Study||2
10757923|NCT03095599|11921490|FG000|STARTED|Overall Study||741
10757924|NCT03095599|11921491|FG001|STARTED|Overall Study||148
10757925|NCT03095599|11921490|FG000|Withdrawal Before Vaccination|Overall Study||1
10757926|NCT03095599|11921491|FG001|Withdrawal Before Vaccination|Overall Study||0
10757927|NCT03095599|11921490|FG000|Vaccinated|Overall Study||740
10757928|NCT03095599|11921491|FG001|Vaccinated|Overall Study||148
10757929|NCT03095599|11921490|FG000|COMPLETED|Overall Study||738
10757930|NCT03095599|11921491|FG001|COMPLETED|Overall Study||148
10757931|NCT03095599|11921490|FG000|NOT COMPLETED|Overall Study||3
10757932|NCT03095599|11921491|FG001|NOT COMPLETED|Overall Study||0
10757933|NCT03095638|11921501|FG000|STARTED|P1: Period 1 (4 Days)||7
10757934|NCT03095638|11921502|FG001|STARTED|P1: Period 1 (4 Days)||7
10757935|NCT03095638|11921503|FG002|STARTED|P1: Period 1 (4 Days)||0
10757936|NCT03095638|11921504|FG003|STARTED|P1: Period 1 (4 Days)||0
10757937|NCT03095638|11921505|FG004|STARTED|P1: Period 1 (4 Days)||0
10757938|NCT03095638|11921506|FG005|STARTED|P1: Period 1 (4 Days)||0
10757939|NCT03095638|11921507|FG006|STARTED|P1: Period 1 (4 Days)||0
10757940|NCT03095638|11921508|FG007|STARTED|P1: Period 1 (4 Days)||0
10757941|NCT03095638|11921501|FG000|COMPLETED|P1: Period 1 (4 Days)||7
10757942|NCT03095638|11921502|FG001|COMPLETED|P1: Period 1 (4 Days)||7
10757943|NCT03095638|11921503|FG002|COMPLETED|P1: Period 1 (4 Days)||0
10757944|NCT03095638|11921504|FG003|COMPLETED|P1: Period 1 (4 Days)||0
10757945|NCT03095638|11921505|FG004|COMPLETED|P1: Period 1 (4 Days)||0
10757946|NCT03095638|11921506|FG005|COMPLETED|P1: Period 1 (4 Days)||0
10757947|NCT03095638|11921507|FG006|COMPLETED|P1: Period 1 (4 Days)||0
10757948|NCT03095638|11921508|FG007|COMPLETED|P1: Period 1 (4 Days)||0
10757949|NCT03095638|11921501|FG000|NOT COMPLETED|P1: Period 1 (4 Days)||0
10757950|NCT03095638|11921502|FG001|NOT COMPLETED|P1: Period 1 (4 Days)||0
10757951|NCT03095638|11921503|FG002|NOT COMPLETED|P1: Period 1 (4 Days)||0
10757952|NCT03095638|11921504|FG003|NOT COMPLETED|P1: Period 1 (4 Days)||0
10757953|NCT03095638|11921505|FG004|NOT COMPLETED|P1: Period 1 (4 Days)||0
10757954|NCT03095638|11921506|FG005|NOT COMPLETED|P1: Period 1 (4 Days)||0
10757955|NCT03095638|11921507|FG006|NOT COMPLETED|P1: Period 1 (4 Days)||0
10757956|NCT03095638|11921508|FG007|NOT COMPLETED|P1: Period 1 (4 Days)||0
10757957|NCT03095638|11921501|FG000|STARTED|P1: Period 1, Washout (7 [-4 Hours])||7
10757958|NCT03095638|11921502|FG001|STARTED|P1: Period 1, Washout (7 [-4 Hours])||7
10757959|NCT03095638|11921503|FG002|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
10757960|NCT03095638|11921504|FG003|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
10757961|NCT03095638|11921505|FG004|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
10757962|NCT03095638|11921506|FG005|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
10757963|NCT03095638|11921507|FG006|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
10757964|NCT03095638|11921508|FG007|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
10757965|NCT03095638|11921501|FG000|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||7
10757966|NCT03095638|11921502|FG001|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||7
10757967|NCT03095638|11921503|FG002|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
10757968|NCT03095638|11921504|FG003|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
10757969|NCT03095638|11921505|FG004|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
10757970|NCT03095638|11921506|FG005|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
10757971|NCT03095638|11921507|FG006|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
10757972|NCT03095638|11921508|FG007|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
10757973|NCT03095638|11921501|FG000|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
10757974|NCT03095638|11921502|FG001|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
10757975|NCT03095638|11921503|FG002|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
10757976|NCT03095638|11921504|FG003|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
10757977|NCT03095638|11921505|FG004|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
10757978|NCT03095638|11921506|FG005|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
10757979|NCT03095638|11921507|FG006|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
10757980|NCT03095638|11921508|FG007|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
10757981|NCT03095638|11921501|FG000|STARTED|P1: Period 2 (4 Days)||7
10757982|NCT03095638|11921502|FG001|STARTED|P1: Period 2 (4 Days)||7
10757983|NCT03095638|11921503|FG002|STARTED|P1: Period 2 (4 Days)||0
10757984|NCT03095638|11921504|FG003|STARTED|P1: Period 2 (4 Days)||0
10757985|NCT03095638|11921505|FG004|STARTED|P1: Period 2 (4 Days)||0
10757986|NCT03095638|11921506|FG005|STARTED|P1: Period 2 (4 Days)||0
10757987|NCT03095638|11921507|FG006|STARTED|P1: Period 2 (4 Days)||0
10757988|NCT03095638|11921508|FG007|STARTED|P1: Period 2 (4 Days)||0
10757989|NCT03095638|11921501|FG000|COMPLETED|P1: Period 2 (4 Days)||7
10757990|NCT03095638|11921502|FG001|COMPLETED|P1: Period 2 (4 Days)||7
10757991|NCT03095638|11921503|FG002|COMPLETED|P1: Period 2 (4 Days)||0
10757992|NCT03095638|11921504|FG003|COMPLETED|P1: Period 2 (4 Days)||0
10757993|NCT03095638|11921505|FG004|COMPLETED|P1: Period 2 (4 Days)||0
10757994|NCT03095638|11921506|FG005|COMPLETED|P1: Period 2 (4 Days)||0
10757995|NCT03095638|11921507|FG006|COMPLETED|P1: Period 2 (4 Days)||0
10757996|NCT03095638|11921508|FG007|COMPLETED|P1: Period 2 (4 Days)||0
10757997|NCT03095638|11921501|FG000|NOT COMPLETED|P1: Period 2 (4 Days)||0
10757998|NCT03095638|11921502|FG001|NOT COMPLETED|P1: Period 2 (4 Days)||0
10757999|NCT03095638|11921503|FG002|NOT COMPLETED|P1: Period 2 (4 Days)||0
10758000|NCT03095638|11921504|FG003|NOT COMPLETED|P1: Period 2 (4 Days)||0
10758001|NCT03095638|11921505|FG004|NOT COMPLETED|P1: Period 2 (4 Days)||0
10758002|NCT03095638|11921506|FG005|NOT COMPLETED|P1: Period 2 (4 Days)||0
10758003|NCT03095638|11921507|FG006|NOT COMPLETED|P1: Period 2 (4 Days)||0
10758004|NCT03095638|11921508|FG007|NOT COMPLETED|P1: Period 2 (4 Days)||0
10758005|NCT03095638|11921501|FG000|STARTED|P1: Period 2, Washout (7[-4 Hours])||7
10758006|NCT03095638|11921502|FG001|STARTED|P1: Period 2, Washout (7[-4 Hours])||7
10758007|NCT03095638|11921503|FG002|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
10758008|NCT03095638|11921504|FG003|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
10758009|NCT03095638|11921505|FG004|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
10758010|NCT03095638|11921506|FG005|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
10758011|NCT03095638|11921507|FG006|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
10758012|NCT03095638|11921508|FG007|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
10758013|NCT03095638|11921501|FG000|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||7
10758014|NCT03095638|11921502|FG001|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||7
10758015|NCT03095638|11921503|FG002|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
10758016|NCT03095638|11921504|FG003|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
10758017|NCT03095638|11921505|FG004|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
10758018|NCT03095638|11921506|FG005|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
10758019|NCT03095638|11921507|FG006|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
10758020|NCT03095638|11921508|FG007|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
10758021|NCT03095638|11921501|FG000|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
10758022|NCT03095638|11921502|FG001|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
10758023|NCT03095638|11921503|FG002|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
10758024|NCT03095638|11921504|FG003|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
10758025|NCT03095638|11921505|FG004|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
10758026|NCT03095638|11921506|FG005|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
10758027|NCT03095638|11921507|FG006|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
10758028|NCT03095638|11921508|FG007|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
10758029|NCT03095638|11921501|FG000|STARTED|P2: Period 1 (4 Days)||0
10758030|NCT03095638|11921502|FG001|STARTED|P2: Period 1 (4 Days)||0
10758031|NCT03095638|11921503|FG002|STARTED|P2: Period 1 (4 Days)||4
10758032|NCT03095638|11921504|FG003|STARTED|P2: Period 1 (4 Days)||4
10758033|NCT03095638|11921505|FG004|STARTED|P2: Period 1 (4 Days)||4
10758034|NCT03095638|11921506|FG005|STARTED|P2: Period 1 (4 Days)||4
10758035|NCT03095638|11921507|FG006|STARTED|P2: Period 1 (4 Days)||4
10758036|NCT03095638|11921508|FG007|STARTED|P2: Period 1 (4 Days)||4
10758037|NCT03095638|11921501|FG000|COMPLETED|P2: Period 1 (4 Days)||0
10758038|NCT03095638|11921502|FG001|COMPLETED|P2: Period 1 (4 Days)||0
10758039|NCT03095638|11921503|FG002|COMPLETED|P2: Period 1 (4 Days)||4
10758040|NCT03095638|11921504|FG003|COMPLETED|P2: Period 1 (4 Days)||4
10758041|NCT03095638|11921505|FG004|COMPLETED|P2: Period 1 (4 Days)||4
10758042|NCT03095638|11921506|FG005|COMPLETED|P2: Period 1 (4 Days)||4
10758043|NCT03095638|11921507|FG006|COMPLETED|P2: Period 1 (4 Days)||4
10758044|NCT03095638|11921508|FG007|COMPLETED|P2: Period 1 (4 Days)||4
10758045|NCT03095638|11921501|FG000|NOT COMPLETED|P2: Period 1 (4 Days)||0
10758046|NCT03095638|11921502|FG001|NOT COMPLETED|P2: Period 1 (4 Days)||0
10758047|NCT03095638|11921503|FG002|NOT COMPLETED|P2: Period 1 (4 Days)||0
10758048|NCT03095638|11921504|FG003|NOT COMPLETED|P2: Period 1 (4 Days)||0
10758049|NCT03095638|11921505|FG004|NOT COMPLETED|P2: Period 1 (4 Days)||0
10758050|NCT03095638|11921506|FG005|NOT COMPLETED|P2: Period 1 (4 Days)||0
10758051|NCT03095638|11921507|FG006|NOT COMPLETED|P2: Period 1 (4 Days)||0
10758052|NCT03095638|11921508|FG007|NOT COMPLETED|P2: Period 1 (4 Days)||0
10758053|NCT03095638|11921501|FG000|STARTED|P2: Period 1, Washout (7[-4 Hours])||0
10758054|NCT03095638|11921502|FG001|STARTED|P2: Period 1, Washout (7[-4 Hours])||0
10758055|NCT03095638|11921503|FG002|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
10758056|NCT03095638|11921504|FG003|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
10758057|NCT03095638|11921505|FG004|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
10758058|NCT03095638|11921506|FG005|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
10758059|NCT03095638|11921507|FG006|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
10758060|NCT03095638|11921508|FG007|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
10758061|NCT03095638|11921501|FG000|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
10758062|NCT03095638|11921502|FG001|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
10758063|NCT03095638|11921503|FG002|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
10758064|NCT03095638|11921504|FG003|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
10758065|NCT03095638|11921505|FG004|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
10758066|NCT03095638|11921506|FG005|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
10758067|NCT03095638|11921507|FG006|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
10758068|NCT03095638|11921508|FG007|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
10758069|NCT03095638|11921501|FG000|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
10758070|NCT03095638|11921502|FG001|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
10758071|NCT03095638|11921503|FG002|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
10758072|NCT03095638|11921504|FG003|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
10758073|NCT03095638|11921505|FG004|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
10758074|NCT03095638|11921506|FG005|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
10758075|NCT03095638|11921507|FG006|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
10758076|NCT03095638|11921508|FG007|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
10758077|NCT03095638|11921501|FG000|STARTED|P2: Period 2 (4 Days)||0
10758078|NCT03095638|11921502|FG001|STARTED|P2: Period 2 (4 Days)||0
10758079|NCT03095638|11921503|FG002|STARTED|P2: Period 2 (4 Days)||4
10758080|NCT03095638|11921504|FG003|STARTED|P2: Period 2 (4 Days)||4
10758081|NCT03095638|11921505|FG004|STARTED|P2: Period 2 (4 Days)||4
10758082|NCT03095638|11921506|FG005|STARTED|P2: Period 2 (4 Days)||4
10758083|NCT03095638|11921507|FG006|STARTED|P2: Period 2 (4 Days)||4
10758084|NCT03095638|11921508|FG007|STARTED|P2: Period 2 (4 Days)||4
10758085|NCT03095638|11921501|FG000|COMPLETED|P2: Period 2 (4 Days)||0
10758086|NCT03095638|11921502|FG001|COMPLETED|P2: Period 2 (4 Days)||0
10758087|NCT03095638|11921503|FG002|COMPLETED|P2: Period 2 (4 Days)||4
10758088|NCT03095638|11921504|FG003|COMPLETED|P2: Period 2 (4 Days)||4
10758089|NCT03095638|11921505|FG004|COMPLETED|P2: Period 2 (4 Days)||4
10758090|NCT03095638|11921506|FG005|COMPLETED|P2: Period 2 (4 Days)||4
10758091|NCT03095638|11921507|FG006|COMPLETED|P2: Period 2 (4 Days)||4
10758092|NCT03095638|11921508|FG007|COMPLETED|P2: Period 2 (4 Days)||4
10758093|NCT03095638|11921501|FG000|NOT COMPLETED|P2: Period 2 (4 Days)||0
10758094|NCT03095638|11921502|FG001|NOT COMPLETED|P2: Period 2 (4 Days)||0
10758095|NCT03095638|11921503|FG002|NOT COMPLETED|P2: Period 2 (4 Days)||0
10758096|NCT03095638|11921504|FG003|NOT COMPLETED|P2: Period 2 (4 Days)||0
10758097|NCT03095638|11921505|FG004|NOT COMPLETED|P2: Period 2 (4 Days)||0
10758098|NCT03095638|11921506|FG005|NOT COMPLETED|P2: Period 2 (4 Days)||0
10758099|NCT03095638|11921507|FG006|NOT COMPLETED|P2: Period 2 (4 Days)||0
10758100|NCT03095638|11921508|FG007|NOT COMPLETED|P2: Period 2 (4 Days)||0
10758101|NCT03095638|11921501|FG000|STARTED|P2: Period 2, Washout (7[-4 Hours])||0
10758102|NCT03095638|11921502|FG001|STARTED|P2: Period 2, Washout (7[-4 Hours])||0
10758103|NCT03095638|11921503|FG002|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
10758104|NCT03095638|11921504|FG003|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
10758105|NCT03095638|11921505|FG004|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
10758106|NCT03095638|11921506|FG005|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
10758107|NCT03095638|11921507|FG006|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
10758108|NCT03095638|11921508|FG007|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
10758109|NCT03095638|11921501|FG000|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
10758110|NCT03095638|11921502|FG001|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
10758111|NCT03095638|11921503|FG002|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
10758112|NCT03095638|11921504|FG003|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
10758113|NCT03095638|11921505|FG004|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
10758114|NCT03095638|11921506|FG005|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
10758115|NCT03095638|11921507|FG006|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
10758116|NCT03095638|11921508|FG007|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
10758117|NCT03095638|11921501|FG000|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
10758118|NCT03095638|11921502|FG001|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
10758119|NCT03095638|11921503|FG002|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
10758120|NCT03095638|11921504|FG003|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
10758121|NCT03095638|11921505|FG004|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
10758122|NCT03095638|11921506|FG005|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
10758123|NCT03095638|11921507|FG006|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
10758124|NCT03095638|11921508|FG007|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
10758125|NCT03095638|11921501|FG000|STARTED|P2: Period 3 (4 Days)||0
10758126|NCT03095638|11921502|FG001|STARTED|P2: Period 3 (4 Days)||0
10758127|NCT03095638|11921503|FG002|STARTED|P2: Period 3 (4 Days)||4
10758128|NCT03095638|11921504|FG003|STARTED|P2: Period 3 (4 Days)||4
10758129|NCT03095638|11921505|FG004|STARTED|P2: Period 3 (4 Days)||4
10758130|NCT03095638|11921506|FG005|STARTED|P2: Period 3 (4 Days)||4
10758131|NCT03095638|11921507|FG006|STARTED|P2: Period 3 (4 Days)||4
10758132|NCT03095638|11921508|FG007|STARTED|P2: Period 3 (4 Days)||4
10758133|NCT03095638|11921501|FG000|COMPLETED|P2: Period 3 (4 Days)||0
10758134|NCT03095638|11921502|FG001|COMPLETED|P2: Period 3 (4 Days)||0
10758135|NCT03095638|11921503|FG002|COMPLETED|P2: Period 3 (4 Days)||4
10758136|NCT03095638|11921504|FG003|COMPLETED|P2: Period 3 (4 Days)||4
10758137|NCT03095638|11921505|FG004|COMPLETED|P2: Period 3 (4 Days)||4
10758138|NCT03095638|11921506|FG005|COMPLETED|P2: Period 3 (4 Days)||4
10758139|NCT03095638|11921507|FG006|COMPLETED|P2: Period 3 (4 Days)||4
10758140|NCT03095638|11921508|FG007|COMPLETED|P2: Period 3 (4 Days)||4
10758141|NCT03095638|11921501|FG000|NOT COMPLETED|P2: Period 3 (4 Days)||0
10758142|NCT03095638|11921502|FG001|NOT COMPLETED|P2: Period 3 (4 Days)||0
10758143|NCT03095638|11921503|FG002|NOT COMPLETED|P2: Period 3 (4 Days)||0
10758144|NCT03095638|11921504|FG003|NOT COMPLETED|P2: Period 3 (4 Days)||0
10758145|NCT03095638|11921505|FG004|NOT COMPLETED|P2: Period 3 (4 Days)||0
10758146|NCT03095638|11921506|FG005|NOT COMPLETED|P2: Period 3 (4 Days)||0
10758147|NCT03095638|11921507|FG006|NOT COMPLETED|P2: Period 3 (4 Days)||0
10758148|NCT03095638|11921508|FG007|NOT COMPLETED|P2: Period 3 (4 Days)||0
10758149|NCT03095638|11921501|FG000|STARTED|P2: Period 3, Washout (7[-4 Hours])||0
10758150|NCT03095638|11921502|FG001|STARTED|P2: Period 3, Washout (7[-4 Hours])||0
10758151|NCT03095638|11921503|FG002|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
10758152|NCT03095638|11921504|FG003|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
10758153|NCT03095638|11921505|FG004|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
10758154|NCT03095638|11921506|FG005|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
10758155|NCT03095638|11921507|FG006|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
10758156|NCT03095638|11921508|FG007|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
10758157|NCT03095638|11921501|FG000|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
10758158|NCT03095638|11921502|FG001|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
10758159|NCT03095638|11921503|FG002|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
10758160|NCT03095638|11921504|FG003|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
10758161|NCT03095638|11921505|FG004|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
10758162|NCT03095638|11921506|FG005|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
10758163|NCT03095638|11921507|FG006|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
10758164|NCT03095638|11921508|FG007|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
10758165|NCT03095638|11921501|FG000|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
10758166|NCT03095638|11921502|FG001|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
10758167|NCT03095638|11921503|FG002|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
10758168|NCT03095638|11921504|FG003|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
10758169|NCT03095638|11921505|FG004|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
10758170|NCT03095638|11921506|FG005|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
10758171|NCT03095638|11921507|FG006|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
10758172|NCT03095638|11921508|FG007|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
10758173|NCT03095651|11921536|FG000|STARTED|Overall Study||6
10758174|NCT03095651|11921537|FG001|STARTED|Overall Study||6
10758175|NCT03095651|11921538|FG002|STARTED|Overall Study||0
10758176|NCT03095651|11921539|FG003|STARTED|Overall Study||4
10758177|NCT03095651|11921540|FG004|STARTED|Overall Study||0
10758178|NCT03095651|11921541|FG005|STARTED|Overall Study||7
10758179|NCT03095651|11921542|FG006|STARTED|Overall Study||6
10758180|NCT03095651|11921543|FG007|STARTED|Overall Study||4
10758181|NCT03095651|11921536|FG000|COMPLETED|Overall Study||5
10758182|NCT03095651|11921537|FG001|COMPLETED|Overall Study||5
10758183|NCT03095651|11921538|FG002|COMPLETED|Overall Study||0
10758184|NCT03095651|11921539|FG003|COMPLETED|Overall Study||3
10758185|NCT03095651|11921540|FG004|COMPLETED|Overall Study||0
10758186|NCT03095651|11921541|FG005|COMPLETED|Overall Study||6
10758187|NCT03095651|11921542|FG006|COMPLETED|Overall Study||6
10758188|NCT03095651|11921543|FG007|COMPLETED|Overall Study||4
10758189|NCT03095651|11921536|FG000|NOT COMPLETED|Overall Study||1
10758190|NCT03095651|11921537|FG001|NOT COMPLETED|Overall Study||1
10758191|NCT03095651|11921538|FG002|NOT COMPLETED|Overall Study||0
10758192|NCT03095651|11921539|FG003|NOT COMPLETED|Overall Study||1
10758193|NCT03095651|11921540|FG004|NOT COMPLETED|Overall Study||0
10758194|NCT03095651|11921541|FG005|NOT COMPLETED|Overall Study||1
10758195|NCT03095651|11921542|FG006|NOT COMPLETED|Overall Study||0
10758196|NCT03095651|11921543|FG007|NOT COMPLETED|Overall Study||0
10758197|NCT03095885|11921561|FG000|STARTED|Overall Study||22
10758198|NCT03095885|11921561|FG000|COMPLETED|Overall Study||22
10758199|NCT03095885|11921561|FG000|NOT COMPLETED|Overall Study||0
10758200|NCT03095976|11921565|FG000|STARTED|Overall Study||4
10758201|NCT03095976|11921565|FG000|COMPLETED|Overall Study||4
10758202|NCT03095976|11921565|FG000|NOT COMPLETED|Overall Study||0
10758203|NCT03096314|11921571|FG000|STARTED|Screened Vitamin D Deficient||690
10758204|NCT03096314|11921572|FG001|STARTED|Screened Vitamin D Deficient|2 randomized but not included in analysis; 1 treated but inadequate consent and 1 withdrew.|668
10758205|NCT03096314|11921571|FG000|COMPLETED|Screened Vitamin D Deficient||681
10758206|NCT03096314|11921572|FG001|COMPLETED|Screened Vitamin D Deficient||656
10758207|NCT03096314|11921571|FG000|NOT COMPLETED|Screened Vitamin D Deficient||9
10758208|NCT03096314|11921572|FG001|NOT COMPLETED|Screened Vitamin D Deficient||12
10758209|NCT03096314|11921571|FG000|STARTED|Confirmed Vitamin D Deficient|Confirmed deficient (a prior primary analysis subgroup) is a subgroup of the screened deficient.|538
10758210|NCT03096314|11921572|FG001|STARTED|Confirmed Vitamin D Deficient|Confirmed deficient (a prior primary analysis subgroup) is a subgroup of the screened deficient.|540
10758211|NCT03096314|11921571|FG000|COMPLETED|Confirmed Vitamin D Deficient||531
10758212|NCT03096314|11921572|FG001|COMPLETED|Confirmed Vitamin D Deficient||528
10758213|NCT03096314|11921571|FG000|NOT COMPLETED|Confirmed Vitamin D Deficient||7
10758214|NCT03096314|11921572|FG001|NOT COMPLETED|Confirmed Vitamin D Deficient||12
10758215|NCT03096353|11921580|FG000|STARTED|Period 1||15
10758216|NCT03096353|11921581|FG001|STARTED|Period 1||13
10758217|NCT03096353|11921580|FG000|COMPLETED|Period 1||12
10758218|NCT03096353|11921581|FG001|COMPLETED|Period 1||12
10758219|NCT03096353|11921580|FG000|NOT COMPLETED|Period 1||3
10758220|NCT03096353|11921581|FG001|NOT COMPLETED|Period 1||1
10758221|NCT03096353|11921580|FG000|STARTED|Period 2||12
10758222|NCT03096353|11921581|FG001|STARTED|Period 2||12
10758223|NCT03096353|11921580|FG000|COMPLETED|Period 2||12
10758224|NCT03096353|11921581|FG001|COMPLETED|Period 2||12
10758225|NCT03096353|11921580|FG000|NOT COMPLETED|Period 2||0
10758226|NCT03096353|11921581|FG001|NOT COMPLETED|Period 2||0
10758227|NCT03096444|11921587|FG000|STARTED|Overall Study||13
10758228|NCT03096444|11921587|FG000|COMPLETED|Overall Study||13
10758229|NCT03096444|11921587|FG000|NOT COMPLETED|Overall Study||0
10758230|NCT03096483|11921599|FG000|STARTED|Overall Study||12
10758231|NCT03096483|11921599|FG000|COMPLETED|Overall Study||11
10758232|NCT03096483|11921599|FG000|NOT COMPLETED|Overall Study||1
10758233|NCT03096730|11921608|FG000|STARTED|Overall Study||30
10758234|NCT03096730|11921609|FG001|STARTED|Overall Study||30
10758235|NCT03096730|11921610|FG002|STARTED|Overall Study||30
10758236|NCT03096730|11921611|FG003|STARTED|Overall Study||30
10758237|NCT03096730|11921612|FG004|STARTED|Overall Study||30
10758238|NCT03096730|11921608|FG000|COMPLETED|Overall Study||27
10758239|NCT03096730|11921609|FG001|COMPLETED|Overall Study||27
10758240|NCT03096730|11921610|FG002|COMPLETED|Overall Study||27
10758241|NCT03096730|11921611|FG003|COMPLETED|Overall Study||27
10758242|NCT03096730|11921612|FG004|COMPLETED|Overall Study||27
10758243|NCT03096730|11921608|FG000|NOT COMPLETED|Overall Study||3
10758244|NCT03096730|11921609|FG001|NOT COMPLETED|Overall Study||3
10758245|NCT03096730|11921610|FG002|NOT COMPLETED|Overall Study||3
10758246|NCT03096730|11921611|FG003|NOT COMPLETED|Overall Study||3
10758247|NCT03096730|11921612|FG004|NOT COMPLETED|Overall Study||3
10758248|NCT03096847|11921627|FG000|STARTED|Overall Study||319
10758249|NCT03096847|11921628|FG001|STARTED|Overall Study||26
10758250|NCT03096847|11921629|FG002|STARTED|Overall Study||157
10758251|NCT03096847|11921627|FG000|Full Analysis Set|Overall Study||307
10758252|NCT03096847|11921628|FG001|Full Analysis Set|Overall Study||26
10758253|NCT03096847|11921629|FG002|Full Analysis Set|Overall Study||154
10758254|NCT03096847|11921627|FG000|COMPLETED|Overall Study|Only the primary reason for disc. is included in this table.|100
10758255|NCT03096847|11921628|FG001|COMPLETED|Overall Study|Only the primary reason for disc. is included in this table.|6
10758256|NCT03096847|11921629|FG002|COMPLETED|Overall Study|Only the primary reason for disc. is included in this table.|19
10758257|NCT03096847|11921627|FG000|NOT COMPLETED|Overall Study||219
10758258|NCT03096847|11921628|FG001|NOT COMPLETED|Overall Study||20
10758259|NCT03096847|11921629|FG002|NOT COMPLETED|Overall Study||138
10758260|NCT03096873|11921647|FG000|STARTED|Overall Study||20
10758261|NCT03096873|11921648|FG001|STARTED|Overall Study||20
10758262|NCT03096873|11921647|FG000|COMPLETED|Overall Study||20
10758263|NCT03096873|11921648|FG001|COMPLETED|Overall Study||20
10758264|NCT03096873|11921647|FG000|NOT COMPLETED|Overall Study||0
10758265|NCT03096873|11921648|FG001|NOT COMPLETED|Overall Study||0
10758266|NCT03097029|11921656|FG000|STARTED|Overall Study||15
10758267|NCT03097029|11921656|FG000|COMPLETED|Overall Study||14
10758268|NCT03097029|11921656|FG000|NOT COMPLETED|Overall Study||1
10758269|NCT03097133|11921662|FG000|STARTED|Overall Study||115
10758270|NCT03097133|11921663|FG001|STARTED|Overall Study||115
10758271|NCT03097133|11921662|FG000|Treated|Overall Study||113
10758272|NCT03097133|11921663|FG001|Treated|Overall Study||114
10758273|NCT03097133|11921662|FG000|COMPLETED|Overall Study||85
10758274|NCT03097133|11921663|FG001|COMPLETED|Overall Study||81
10758275|NCT03097133|11921662|FG000|NOT COMPLETED|Overall Study||30
10758276|NCT03097133|11921663|FG001|NOT COMPLETED|Overall Study||34
10758277|NCT03097289|11921669|FG000|STARTED|Overall Study||32
10758278|NCT03097289|11921669|FG000|COMPLETED|Overall Study||26
10758279|NCT03097289|11921669|FG000|NOT COMPLETED|Overall Study||6
10758280|NCT03097315|11921674|FG000|STARTED|Overall Study||38
10758281|NCT03097315|11921674|FG000|Intention-to-Treat Population|Overall Study||38
10758282|NCT03097315|11921674|FG000|Safety Population|Overall Study||38
10758283|NCT03097315|11921674|FG000|COMPLETED|Overall Study||37
10758284|NCT03097315|11921674|FG000|NOT COMPLETED|Overall Study||1
10758285|NCT03097341|11921683|FG000|STARTED|Overall Study||4
10758286|NCT03097341|11921684|FG001|STARTED|Overall Study||4
10758287|NCT03097341|11921685|FG002|STARTED|Overall Study||4
10758288|NCT03097341|11921686|FG003|STARTED|Overall Study||4
10758289|NCT03097341|11921687|FG004|STARTED|Overall Study||5
10758290|NCT03097341|11921683|FG000|COMPLETED|Overall Study||4
10758291|NCT03097341|11921684|FG001|COMPLETED|Overall Study||4
10758292|NCT03097341|11921685|FG002|COMPLETED|Overall Study||4
10758293|NCT03097341|11921686|FG003|COMPLETED|Overall Study||4
10758294|NCT03097341|11921687|FG004|COMPLETED|Overall Study||5
10758295|NCT03097341|11921683|FG000|NOT COMPLETED|Overall Study||0
10758296|NCT03097341|11921684|FG001|NOT COMPLETED|Overall Study||0
10758297|NCT03097341|11921685|FG002|NOT COMPLETED|Overall Study||0
10758298|NCT03097341|11921686|FG003|NOT COMPLETED|Overall Study||0
10758299|NCT03097341|11921687|FG004|NOT COMPLETED|Overall Study||0
10758300|NCT03097484|11921701|FG000|STARTED|Overall Study||19
10758301|NCT03097484|11921702|FG001|STARTED|Overall Study||19
10758302|NCT03097484|11921701|FG000|COMPLETED|Overall Study||19
10758303|NCT03097484|11921702|FG001|COMPLETED|Overall Study||19
10758304|NCT03097484|11921701|FG000|NOT COMPLETED|Overall Study||0
10758305|NCT03097484|11921702|FG001|NOT COMPLETED|Overall Study||0
10758306|NCT03097588|11921708|FG000|STARTED|Overall Study||43
10758307|NCT03097588|11921708|FG000|COMPLETED|Overall Study||42
10758308|NCT03097588|11921708|FG000|NOT COMPLETED|Overall Study||1
10758309|NCT03097614|11921712|FG000|STARTED|Overall Study||57
10758310|NCT03097614|11921712|FG000|COMPLETED|Overall Study||54
10758311|NCT03097614|11921712|FG000|NOT COMPLETED|Overall Study||3
10758312|NCT03097653|11921718|FG000|STARTED|Overall Study||472
10758313|NCT03097653|11921719|FG001|STARTED|Overall Study||529
10758314|NCT03097653|11921718|FG000|COMPLETED|Overall Study||472
10758315|NCT03097653|11921719|FG001|COMPLETED|Overall Study||529
10758316|NCT03097653|11921718|FG000|NOT COMPLETED|Overall Study||0
10758317|NCT03097653|11921719|FG001|NOT COMPLETED|Overall Study||0
10758324|NCT03097861|11921737|FG000|STARTED|Overall Study||145
10758325|NCT03097861|11921738|FG001|STARTED|Overall Study||276
10758326|NCT03097861|11921739|FG002|STARTED|Overall Study||131
10758327|NCT03097861|11921737|FG000|Safety Population|Overall Study||143
10758328|NCT03097861|11921738|FG001|Safety Population|Overall Study||275
10758329|NCT03097861|11921739|FG002|Safety Population|Overall Study||130
10758330|NCT03097861|11921737|FG000|Modified Intent to Treat|Overall Study||143
10758331|NCT03097861|11921738|FG001|Modified Intent to Treat|Overall Study||275
10758332|NCT03097861|11921739|FG002|Modified Intent to Treat|Overall Study||130
10758333|NCT03097861|11921737|FG000|Completers|Overall Study||129
10758334|NCT03097861|11921738|FG001|Completers|Overall Study||255
10758335|NCT03097861|11921739|FG002|Completers|Overall Study||121
10758336|NCT03097861|11921737|FG000|Per-protocol Population (PP)|Overall Study||126
10758337|NCT03097861|11921738|FG001|Per-protocol Population (PP)|Overall Study||234
10758338|NCT03097861|11921739|FG002|Per-protocol Population (PP)|Overall Study||113
10758339|NCT03097861|11921737|FG000|COMPLETED|Overall Study||138
10758340|NCT03097861|11921738|FG001|COMPLETED|Overall Study||254
10758341|NCT03097861|11921739|FG002|COMPLETED|Overall Study||122
10758342|NCT03097861|11921737|FG000|NOT COMPLETED|Overall Study||7
10758343|NCT03097861|11921738|FG001|NOT COMPLETED|Overall Study||22
10758344|NCT03097861|11921739|FG002|NOT COMPLETED|Overall Study||9
10758345|NCT03098030|11921753|FG000|STARTED|Overall Study||12
10758346|NCT03098030|11921754|FG001|STARTED|Overall Study||187
10758347|NCT03098030|11921755|FG002|STARTED|Overall Study||190
10758348|NCT03098030|11921756|FG003|STARTED|Overall Study||94
10758349|NCT03098030|11921753|FG000|COMPLETED|Overall Study|Represents number of subjects that had not discontinued the study at time of data lock.|2
10758350|NCT03098030|11921754|FG001|COMPLETED|Overall Study|Represents number of subjects that had not discontinued the study at time of data lock.|24
10758351|NCT03098030|11921755|FG002|COMPLETED|Overall Study|Represents number of subjects that had not discontinued the study at time of data lock.|24
10758352|NCT03098030|11921756|FG003|COMPLETED|Overall Study|Represents number of subjects that had not discontinued the study at time of data lock.|9
10758353|NCT03098030|11921753|FG000|NOT COMPLETED|Overall Study||10
10758354|NCT03098030|11921754|FG001|NOT COMPLETED|Overall Study||163
10758355|NCT03098030|11921755|FG002|NOT COMPLETED|Overall Study||166
10758356|NCT03098030|11921756|FG003|NOT COMPLETED|Overall Study||85
10758357|NCT03098173|11921767|FG000|STARTED|Overall Study||81
10758358|NCT03098173|11921768|FG001|STARTED|Overall Study||81
10758359|NCT03098173|11921767|FG000|COMPLETED|Overall Study||80
10758360|NCT03098173|11921768|FG001|COMPLETED|Overall Study||79
10758361|NCT03098173|11921767|FG000|NOT COMPLETED|Overall Study||1
10758362|NCT03098173|11921768|FG001|NOT COMPLETED|Overall Study||2
10758363|NCT03098420|11921779|FG000|STARTED|Overall Study||7
10758364|NCT03098420|11921780|FG001|STARTED|Overall Study||9
10758365|NCT03098420|11921781|FG002|STARTED|Overall Study||13
10874593|NCT04891874|12040743|FG000|STARTED|Overall Study|Participants in this period were recruited from August 1, 2015 to December 31, 2016.|38
10874594|NCT04891874|12040744|FG001|STARTED|Overall Study||38
10874595|NCT04891874|12040743|FG000|COMPLETED|Overall Study||38
10874596|NCT04891874|12040744|FG001|COMPLETED|Overall Study||38
10874597|NCT04891874|12040743|FG000|NOT COMPLETED|Overall Study||0
10874598|NCT04891874|12040744|FG001|NOT COMPLETED|Overall Study||0
10874599|NCT04883541|12040752|FG000|STARTED|Overall Study||46
10874600|NCT04883541|12040753|FG001|STARTED|Overall Study||69
10874601|NCT04883541|12040752|FG000|COMPLETED|Overall Study||30
10874602|NCT04883541|12040753|FG001|COMPLETED|Overall Study||60
10874603|NCT04883541|12040752|FG000|NOT COMPLETED|Overall Study||16
10874604|NCT04883541|12040753|FG001|NOT COMPLETED|Overall Study||9
10874605|NCT04881968|12040759|FG000|STARTED|Overall Study||1261
10874606|NCT04881968|12040759|FG000|COMPLETED|Overall Study||1261
10874607|NCT04881968|12040759|FG000|NOT COMPLETED|Overall Study||0
10874608|NCT04486560|12040763|FG000|STARTED|Overall Study||51
10874609|NCT04486560|12040763|FG000|COMPLETED|Overall Study||50
10874610|NCT04486560|12040763|FG000|NOT COMPLETED|Overall Study||1
10874611|NCT04357782|12040769|FG000|STARTED|Overall Study||10
10874612|NCT04357782|12040770|FG001|STARTED|Overall Study||10
10874613|NCT04357782|12040769|FG000|COMPLETED|Overall Study||9
10874614|NCT04357782|12040770|FG001|COMPLETED|Overall Study||8
10874615|NCT04357782|12040769|FG000|NOT COMPLETED|Overall Study||1
10874616|NCT04357782|12040770|FG001|NOT COMPLETED|Overall Study||2
10874617|NCT04090658|12040778|FG000|STARTED|Overall Study||20
10758366|NCT03098420|11921779|FG000|COMPLETED|Overall Study||7
10758367|NCT03098420|11921780|FG001|COMPLETED|Overall Study||9
10758368|NCT03098420|11921781|FG002|COMPLETED|Overall Study||13
10758369|NCT03098420|11921779|FG000|NOT COMPLETED|Overall Study||0
10758370|NCT03098420|11921780|FG001|NOT COMPLETED|Overall Study||0
10758371|NCT03098420|11921781|FG002|NOT COMPLETED|Overall Study||0
10758372|NCT03098433|11921789|FG000|STARTED|Overall Study||22
10758373|NCT03098433|11921789|FG000|COMPLETED|Overall Study||12
10758374|NCT03098433|11921789|FG000|NOT COMPLETED|Overall Study||10
10758375|NCT03098550|11921797|FG000|STARTED|Overall Study||41
10758376|NCT03098550|11921798|FG001|STARTED|Overall Study||21
10758377|NCT03098550|11921799|FG002|STARTED|Overall Study||43
10758378|NCT03098550|11921797|FG000|COMPLETED|Overall Study||0
10758379|NCT03098550|11921798|FG001|COMPLETED|Overall Study||1
10758380|NCT03098550|11921799|FG002|COMPLETED|Overall Study||0
10758381|NCT03098550|11921797|FG000|NOT COMPLETED|Overall Study||41
10758382|NCT03098550|11921798|FG001|NOT COMPLETED|Overall Study||20
10758383|NCT03098550|11921799|FG002|NOT COMPLETED|Overall Study||43
10758384|NCT03098615|11921811|FG000|STARTED|Overall Study||19
10758385|NCT03098615|11921811|FG000|COMPLETED|Overall Study||17
10758386|NCT03098615|11921811|FG000|NOT COMPLETED|Overall Study||2
10758387|NCT03098641|11921816|FG000|STARTED|Overall Study||272
10758388|NCT03098641|11921816|FG000|COMPLETED|Overall Study||220
10758389|NCT03098641|11921816|FG000|NOT COMPLETED|Overall Study||52
10758390|NCT03098745|11921820|FG000|STARTED|Day 1||7
10758391|NCT03098745|11921821|FG001|STARTED|Day 1||3
10758392|NCT03098745|11921822|FG002|STARTED|Day 1||8
10758393|NCT03098745|11921823|FG003|STARTED|Day 1||8
10758394|NCT03098745|11921824|FG004|STARTED|Day 1||10
10758395|NCT03098745|11921825|FG005|STARTED|Day 1||4
10758396|NCT03098745|11921820|FG000|COMPLETED|Day 1||7
10758397|NCT03098745|11921821|FG001|COMPLETED|Day 1||3
10758398|NCT03098745|11921822|FG002|COMPLETED|Day 1||8
10758399|NCT03098745|11921823|FG003|COMPLETED|Day 1||8
10758400|NCT03098745|11921824|FG004|COMPLETED|Day 1||10
10758401|NCT03098745|11921825|FG005|COMPLETED|Day 1||4
10758402|NCT03098745|11921820|FG000|NOT COMPLETED|Day 1||0
10758403|NCT03098745|11921821|FG001|NOT COMPLETED|Day 1||0
10758404|NCT03098745|11921822|FG002|NOT COMPLETED|Day 1||0
10758405|NCT03098745|11921823|FG003|NOT COMPLETED|Day 1||0
10758406|NCT03098745|11921824|FG004|NOT COMPLETED|Day 1||0
10758407|NCT03098745|11921825|FG005|NOT COMPLETED|Day 1||0
10758408|NCT03098745|11921820|FG000|STARTED|Day 2||7
10758409|NCT03098745|11921821|FG001|STARTED|Day 2||3
10758410|NCT03098745|11921822|FG002|STARTED|Day 2||8
10758411|NCT03098745|11921823|FG003|STARTED|Day 2||8
10758412|NCT03098745|11921824|FG004|STARTED|Day 2||10
10758413|NCT03098745|11921825|FG005|STARTED|Day 2||4
10758414|NCT03098745|11921820|FG000|COMPLETED|Day 2||7
10758415|NCT03098745|11921821|FG001|COMPLETED|Day 2||3
10758416|NCT03098745|11921822|FG002|COMPLETED|Day 2||8
10758417|NCT03098745|11921823|FG003|COMPLETED|Day 2||8
10758418|NCT03098745|11921824|FG004|COMPLETED|Day 2||10
10758419|NCT03098745|11921825|FG005|COMPLETED|Day 2||4
10758420|NCT03098745|11921820|FG000|NOT COMPLETED|Day 2||0
10758421|NCT03098745|11921821|FG001|NOT COMPLETED|Day 2||0
10758422|NCT03098745|11921822|FG002|NOT COMPLETED|Day 2||0
10758423|NCT03098745|11921823|FG003|NOT COMPLETED|Day 2||0
10758424|NCT03098745|11921824|FG004|NOT COMPLETED|Day 2||0
10758425|NCT03098745|11921825|FG005|NOT COMPLETED|Day 2||0
10758426|NCT03098745|11921820|FG000|STARTED|Day 3||7
10758427|NCT03098745|11921821|FG001|STARTED|Day 3||3
10758428|NCT03098745|11921822|FG002|STARTED|Day 3||8
10758429|NCT03098745|11921823|FG003|STARTED|Day 3||8
10758430|NCT03098745|11921824|FG004|STARTED|Day 3||10
10758431|NCT03098745|11921825|FG005|STARTED|Day 3||4
10758432|NCT03098745|11921820|FG000|COMPLETED|Day 3||7
10758433|NCT03098745|11921821|FG001|COMPLETED|Day 3||3
10758434|NCT03098745|11921822|FG002|COMPLETED|Day 3||8
10758435|NCT03098745|11921823|FG003|COMPLETED|Day 3||8
10758436|NCT03098745|11921824|FG004|COMPLETED|Day 3||10
10758437|NCT03098745|11921825|FG005|COMPLETED|Day 3||4
10758438|NCT03098745|11921820|FG000|NOT COMPLETED|Day 3||0
10758439|NCT03098745|11921821|FG001|NOT COMPLETED|Day 3||0
10758440|NCT03098745|11921822|FG002|NOT COMPLETED|Day 3||0
10758441|NCT03098745|11921823|FG003|NOT COMPLETED|Day 3||0
10758442|NCT03098745|11921824|FG004|NOT COMPLETED|Day 3||0
10758443|NCT03098745|11921825|FG005|NOT COMPLETED|Day 3||0
10758444|NCT03098966|11921834|FG000|STARTED|Overall Study||368
10758445|NCT03098966|11921834|FG000|COMPLETED|Overall Study||368
10758446|NCT03098966|11921834|FG000|NOT COMPLETED|Overall Study||0
10758447|NCT03098979|11921844|FG000|STARTED|Overall Study||76
10296789|NCT00943852|11429422|FG005|STARTED|Third Period of Treatment Intervention||0
10296790|NCT00943852|11429423|FG006|STARTED|Third Period of Treatment Intervention||2
10758448|NCT03098979|11921845|FG001|STARTED|Overall Study||27
10758449|NCT03098979|11921846|FG002|STARTED|Overall Study||50
10758450|NCT03098979|11921847|FG003|STARTED|Overall Study||51
10758451|NCT03098979|11921848|FG004|STARTED|Overall Study||50
10758452|NCT03098979|11921849|FG005|STARTED|Overall Study||51
10758453|NCT03098979|11921844|FG000|COMPLETED|Overall Study||70
10758454|NCT03098979|11921845|FG001|COMPLETED|Overall Study||25
10758455|NCT03098979|11921846|FG002|COMPLETED|Overall Study||46
10758456|NCT03098979|11921847|FG003|COMPLETED|Overall Study||46
10758457|NCT03098979|11921848|FG004|COMPLETED|Overall Study||41
10758458|NCT03098979|11921849|FG005|COMPLETED|Overall Study||47
10758459|NCT03098979|11921844|FG000|NOT COMPLETED|Overall Study||6
10758460|NCT03098979|11921845|FG001|NOT COMPLETED|Overall Study||2
10758461|NCT03098979|11921846|FG002|NOT COMPLETED|Overall Study||4
10758462|NCT03098979|11921847|FG003|NOT COMPLETED|Overall Study||5
10758463|NCT03098979|11921848|FG004|NOT COMPLETED|Overall Study||9
10758464|NCT03098979|11921849|FG005|NOT COMPLETED|Overall Study||4
10758465|NCT03099096|11921863|FG000|STARTED|Overall Study||159
10758466|NCT03099096|11921863|FG000|COMPLETED|Overall Study||157
10758467|NCT03099096|11921863|FG000|NOT COMPLETED|Overall Study||2
10758468|NCT03099161|11921870|FG000|STARTED|Overall Study||3
10758469|NCT03099161|11921871|FG001|STARTED|Overall Study||4
10758470|NCT03099161|11921872|FG002|STARTED|Overall Study||3
10758471|NCT03099161|11921870|FG000|COMPLETED|Overall Study||0
10758472|NCT03099161|11921871|FG001|COMPLETED|Overall Study||0
10758473|NCT03099161|11921872|FG002|COMPLETED|Overall Study||0
10758474|NCT03099161|11921870|FG000|NOT COMPLETED|Overall Study||3
10758475|NCT03099161|11921871|FG001|NOT COMPLETED|Overall Study||4
10758476|NCT03099161|11921872|FG002|NOT COMPLETED|Overall Study||3
10758477|NCT03099187|11921882|FG000|STARTED|Double-blind Treatment||127
10758478|NCT03099187|11921883|FG001|STARTED|Double-blind Treatment||126
10758479|NCT03099187|11921884|FG002|STARTED|Double-blind Treatment||0
10758480|NCT03099187|11921885|FG003|STARTED|Double-blind Treatment||0
10758481|NCT03099187|11921882|FG000|COMPLETED|Double-blind Treatment||94
10758482|NCT03099187|11921883|FG001|COMPLETED|Double-blind Treatment||110
10758483|NCT03099187|11921884|FG002|COMPLETED|Double-blind Treatment||0
10758484|NCT03099187|11921885|FG003|COMPLETED|Double-blind Treatment||0
10758485|NCT03099187|11921882|FG000|NOT COMPLETED|Double-blind Treatment||33
10758486|NCT03099187|11921883|FG001|NOT COMPLETED|Double-blind Treatment||16
10758487|NCT03099187|11921884|FG002|NOT COMPLETED|Double-blind Treatment||0
10758488|NCT03099187|11921885|FG003|NOT COMPLETED|Double-blind Treatment||0
10758489|NCT03099187|11921882|FG000|STARTED|12-month Safety Follow-up||0
10758490|NCT03099187|11921883|FG001|STARTED|12-month Safety Follow-up||0
10758491|NCT03099187|11921884|FG002|STARTED|12-month Safety Follow-up||94
10758492|NCT03099187|11921885|FG003|STARTED|12-month Safety Follow-up||110
10758493|NCT03099187|11921882|FG000|COMPLETED|12-month Safety Follow-up||0
10758494|NCT03099187|11921883|FG001|COMPLETED|12-month Safety Follow-up||0
10758495|NCT03099187|11921884|FG002|COMPLETED|12-month Safety Follow-up||75
10758496|NCT03099187|11921885|FG003|COMPLETED|12-month Safety Follow-up||84
10758497|NCT03099187|11921882|FG000|NOT COMPLETED|12-month Safety Follow-up||0
10758498|NCT03099187|11921883|FG001|NOT COMPLETED|12-month Safety Follow-up||0
10758499|NCT03099187|11921884|FG002|NOT COMPLETED|12-month Safety Follow-up||19
10758500|NCT03099187|11921885|FG003|NOT COMPLETED|12-month Safety Follow-up||26
10758501|NCT03099369|11921897|FG000|STARTED|Overall Study||11
10758502|NCT03099369|11921898|FG001|STARTED|Overall Study||9
10758503|NCT03099369|11921897|FG000|COMPLETED|Overall Study||5
10758504|NCT03099369|11921898|FG001|COMPLETED|Overall Study||5
10758505|NCT03099369|11921897|FG000|NOT COMPLETED|Overall Study||6
10758506|NCT03099369|11921898|FG001|NOT COMPLETED|Overall Study||4
10758507|NCT03099538|11921905|FG000|STARTED|Overall Study||4
10758508|NCT03099538|11921905|FG000|COMPLETED|Overall Study||1
10758509|NCT03099538|11921905|FG000|NOT COMPLETED|Overall Study||3
10758510|NCT03099655|11921909|FG000|STARTED|Overall Study||440
10758511|NCT03099655|11921909|FG000|COMPLETED|Overall Study|6-Month visit with original 4798 lead implanted|379
10758512|NCT03099655|11921909|FG000|NOT COMPLETED|Overall Study||61
10758513|NCT03099694|11921918|FG000|STARTED|Overall Study||170
10758514|NCT03099694|11921919|FG001|STARTED|Overall Study||170
10758515|NCT03099694|11921918|FG000|COMPLETED|Overall Study||150
10758516|NCT03099694|11921919|FG001|COMPLETED|Overall Study||152
10758517|NCT03099694|11921918|FG000|NOT COMPLETED|Overall Study||20
10758518|NCT03099694|11921919|FG001|NOT COMPLETED|Overall Study||18
10758519|NCT03100058|11921935|FG000|STARTED|Epoch 3 (24 Weeks of Treatment)||38
10758520|NCT03100058|11921936|FG001|STARTED|Epoch 3 (24 Weeks of Treatment)||38
10758521|NCT03100058|11921937|FG002|STARTED|Epoch 3 (24 Weeks of Treatment)||38
10758522|NCT03100058|11921938|FG003|STARTED|Epoch 3 (24 Weeks of Treatment)||77
10758523|NCT03100058|11921939|FG004|STARTED|Epoch 3 (24 Weeks of Treatment)||38
10758524|NCT03100058|11921940|FG005|STARTED|Epoch 3 (24 Weeks of Treatment)||39
10758525|NCT03100058|11921941|FG006|STARTED|Epoch 3 (24 Weeks of Treatment)||38
10758526|NCT03100058|11921942|FG007|STARTED|Epoch 3 (24 Weeks of Treatment)||76
10758527|NCT03100058|11921943|FG008|STARTED|Epoch 3 (24 Weeks of Treatment)||78
10758528|NCT03100058|11921944|FG009|STARTED|Epoch 3 (24 Weeks of Treatment)||0
10758529|NCT03100058|11921945|FG010|STARTED|Epoch 3 (24 Weeks of Treatment)||0
10758530|NCT03100058|11921946|FG011|STARTED|Epoch 3 (24 Weeks of Treatment)||0
10758531|NCT03100058|11921947|FG012|STARTED|Epoch 3 (24 Weeks of Treatment)||0
10758532|NCT03100058|11921935|FG000|COMPLETED|Epoch 3 (24 Weeks of Treatment)||35
10758533|NCT03100058|11921936|FG001|COMPLETED|Epoch 3 (24 Weeks of Treatment)||31
10758534|NCT03100058|11921937|FG002|COMPLETED|Epoch 3 (24 Weeks of Treatment)||29
10758535|NCT03100058|11921938|FG003|COMPLETED|Epoch 3 (24 Weeks of Treatment)||63
10758536|NCT03100058|11921939|FG004|COMPLETED|Epoch 3 (24 Weeks of Treatment)||36
10758537|NCT03100058|11921940|FG005|COMPLETED|Epoch 3 (24 Weeks of Treatment)||37
10758538|NCT03100058|11921941|FG006|COMPLETED|Epoch 3 (24 Weeks of Treatment)||30
10758539|NCT03100058|11921942|FG007|COMPLETED|Epoch 3 (24 Weeks of Treatment)||60
10758540|NCT03100058|11921943|FG008|COMPLETED|Epoch 3 (24 Weeks of Treatment)||73
10758541|NCT03100058|11921944|FG009|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
10758542|NCT03100058|11921945|FG010|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
10758543|NCT03100058|11921946|FG011|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
10758544|NCT03100058|11921947|FG012|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
10758545|NCT03100058|11921935|FG000|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||3
10758546|NCT03100058|11921936|FG001|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||7
10758547|NCT03100058|11921937|FG002|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||9
10758548|NCT03100058|11921938|FG003|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||14
10758549|NCT03100058|11921939|FG004|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||2
10758550|NCT03100058|11921940|FG005|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||2
10758551|NCT03100058|11921941|FG006|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||8
10758552|NCT03100058|11921942|FG007|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||16
10758553|NCT03100058|11921943|FG008|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||5
10758554|NCT03100058|11921944|FG009|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
10758555|NCT03100058|11921945|FG010|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
10758556|NCT03100058|11921946|FG011|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
10758557|NCT03100058|11921947|FG012|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
10758558|NCT03100058|11921935|FG000|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
10758559|NCT03100058|11921936|FG001|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
10758560|NCT03100058|11921937|FG002|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
10758561|NCT03100058|11921938|FG003|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
10758562|NCT03100058|11921939|FG004|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
10758563|NCT03100058|11921940|FG005|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
10758564|NCT03100058|11921941|FG006|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
10758565|NCT03100058|11921942|FG007|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
10758566|NCT03100058|11921943|FG008|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
10758567|NCT03100058|11921944|FG009|STARTED|Epoch 4 (Last 24 Weeks of the Study)||158
10758568|NCT03100058|11921945|FG010|STARTED|Epoch 4 (Last 24 Weeks of the Study)||163
10758569|NCT03100058|11921946|FG011|STARTED|Epoch 4 (Last 24 Weeks of the Study)||39
10758570|NCT03100058|11921947|FG012|STARTED|Epoch 4 (Last 24 Weeks of the Study)||34
10758571|NCT03100058|11921935|FG000|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
10758572|NCT03100058|11921936|FG001|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
10758573|NCT03100058|11921937|FG002|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
10758574|NCT03100058|11921938|FG003|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
10758575|NCT03100058|11921939|FG004|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
10758576|NCT03100058|11921940|FG005|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
10758577|NCT03100058|11921941|FG006|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
10758578|NCT03100058|11921942|FG007|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
10758579|NCT03100058|11921943|FG008|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
10758580|NCT03100058|11921944|FG009|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||153
10758581|NCT03100058|11921945|FG010|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||148
10758582|NCT03100058|11921946|FG011|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||36
10758583|NCT03100058|11921947|FG012|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||30
10758584|NCT03100058|11921935|FG000|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
10758585|NCT03100058|11921936|FG001|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
10758586|NCT03100058|11921937|FG002|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
10758587|NCT03100058|11921938|FG003|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
10758588|NCT03100058|11921939|FG004|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
10758589|NCT03100058|11921940|FG005|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
10758590|NCT03100058|11921941|FG006|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
10758591|NCT03100058|11921942|FG007|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
10758592|NCT03100058|11921943|FG008|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
10758593|NCT03100058|11921944|FG009|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||5
10758594|NCT03100058|11921945|FG010|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||15
10758595|NCT03100058|11921946|FG011|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||3
10758596|NCT03100058|11921947|FG012|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||4
10758597|NCT03100123|11921978|FG000|STARTED|Overall Study||0
10758598|NCT03100123|11921979|FG001|STARTED|Overall Study||1
10758599|NCT03100123|11921978|FG000|COMPLETED|Overall Study||0
10758600|NCT03100123|11921979|FG001|COMPLETED|Overall Study||1
10758601|NCT03100123|11921978|FG000|NOT COMPLETED|Overall Study||0
10758602|NCT03100123|11921979|FG001|NOT COMPLETED|Overall Study||0
10758603|NCT03100344|11921994|FG000|STARTED|Overall Study||57
10758604|NCT03100344|11921995|FG001|STARTED|Overall Study||55
10758605|NCT03100344|11921996|FG002|STARTED|Overall Study||57
10758606|NCT03100344|11921997|FG003|STARTED|Overall Study||57
10758607|NCT03100344|11921994|FG000|COMPLETED|Overall Study||43
10758608|NCT03100344|11921995|FG001|COMPLETED|Overall Study||44
10758609|NCT03100344|11921996|FG002|COMPLETED|Overall Study||50
10758610|NCT03100344|11921997|FG003|COMPLETED|Overall Study||45
10758611|NCT03100344|11921994|FG000|NOT COMPLETED|Overall Study||14
10758612|NCT03100344|11921995|FG001|NOT COMPLETED|Overall Study||11
10758613|NCT03100344|11921996|FG002|NOT COMPLETED|Overall Study||7
10758614|NCT03100344|11921997|FG003|NOT COMPLETED|Overall Study||12
10758615|NCT03100500|11922008|FG000|STARTED|Overall Study||51
10758616|NCT03100500|11922008|FG000|COMPLETED|Overall Study||51
10758617|NCT03100500|11922008|FG000|NOT COMPLETED|Overall Study||0
10758618|NCT03100825|11922012|FG000|STARTED|Overall Study||94
10758619|NCT03100825|11922012|FG000|COMPLETED|Overall Study||86
10758620|NCT03100825|11922012|FG000|NOT COMPLETED|Overall Study||8
10758621|NCT03100838|11922016|FG000|STARTED|Overall Study||16
10758622|NCT03100838|11922017|FG001|STARTED|Overall Study||16
10296791|NCT00943852|11429424|FG007|STARTED|Third Period of Treatment Intervention||1
10296792|NCT00943852|11429425|FG008|STARTED|Third Period of Treatment Intervention||1
10314974|NCT00171249|11448709|FG002|NOT COMPLETED|Overall Study||5
10758623|NCT03100838|11922018|FG002|STARTED|Overall Study||16
10758624|NCT03100838|11922019|FG003|STARTED|Overall Study||16
10758625|NCT03100838|11922016|FG000|COMPLETED|Overall Study||14
10758626|NCT03100838|11922017|FG001|COMPLETED|Overall Study||14
10758627|NCT03100838|11922018|FG002|COMPLETED|Overall Study||14
10758628|NCT03100838|11922019|FG003|COMPLETED|Overall Study||15
10758629|NCT03100838|11922016|FG000|NOT COMPLETED|Overall Study||2
10758630|NCT03100838|11922017|FG001|NOT COMPLETED|Overall Study||2
10758631|NCT03100838|11922018|FG002|NOT COMPLETED|Overall Study||2
10758632|NCT03100838|11922019|FG003|NOT COMPLETED|Overall Study||1
10758633|NCT03100864|11922029|FG000|STARTED|Overall Study||8
10758634|NCT03100864|11922029|FG000|COMPLETED|Overall Study||8
10758635|NCT03100864|11922029|FG000|NOT COMPLETED|Overall Study||0
10758636|NCT03100942|11922037|FG000|STARTED|Randomized Treatment Period||38
10758637|NCT03100942|11922038|FG001|STARTED|Randomized Treatment Period||38
10758638|NCT03100942|11922039|FG002|STARTED|Randomized Treatment Period||39
10758639|NCT03100942|11922040|FG003|STARTED|Randomized Treatment Period||37
10758640|NCT03100942|11922041|FG004|STARTED|Randomized Treatment Period||0
10758641|NCT03100942|11922042|FG005|STARTED|Randomized Treatment Period||0
10758642|NCT03100942|11922043|FG006|STARTED|Randomized Treatment Period||0
10758643|NCT03100942|11922037|FG000|COMPLETED|Randomized Treatment Period||26
10758644|NCT03100942|11922038|FG001|COMPLETED|Randomized Treatment Period||29
10758645|NCT03100942|11922039|FG002|COMPLETED|Randomized Treatment Period||33
10758646|NCT03100942|11922040|FG003|COMPLETED|Randomized Treatment Period||32
10758647|NCT03100942|11922041|FG004|COMPLETED|Randomized Treatment Period||0
10758648|NCT03100942|11922042|FG005|COMPLETED|Randomized Treatment Period||0
10758649|NCT03100942|11922043|FG006|COMPLETED|Randomized Treatment Period||0
10758650|NCT03100942|11922037|FG000|NOT COMPLETED|Randomized Treatment Period||12
10758651|NCT03100942|11922038|FG001|NOT COMPLETED|Randomized Treatment Period||9
10758652|NCT03100942|11922039|FG002|NOT COMPLETED|Randomized Treatment Period||6
10758653|NCT03100942|11922040|FG003|NOT COMPLETED|Randomized Treatment Period||5
10758654|NCT03100942|11922041|FG004|NOT COMPLETED|Randomized Treatment Period||0
10758655|NCT03100942|11922042|FG005|NOT COMPLETED|Randomized Treatment Period||0
10758656|NCT03100942|11922043|FG006|NOT COMPLETED|Randomized Treatment Period||0
10758657|NCT03100942|11922037|FG000|STARTED|Placebo Arm Re-Randomized||0
10758658|NCT03100942|11922038|FG001|STARTED|Placebo Arm Re-Randomized||0
10758659|NCT03100942|11922039|FG002|STARTED|Placebo Arm Re-Randomized||0
10758660|NCT03100942|11922040|FG003|STARTED|Placebo Arm Re-Randomized||0
10758661|NCT03100942|11922041|FG004|STARTED|Placebo Arm Re-Randomized||10
10758662|NCT03100942|11922042|FG005|STARTED|Placebo Arm Re-Randomized||12
10758663|NCT03100942|11922043|FG006|STARTED|Placebo Arm Re-Randomized||10
10758664|NCT03100942|11922037|FG000|COMPLETED|Placebo Arm Re-Randomized||0
10758665|NCT03100942|11922038|FG001|COMPLETED|Placebo Arm Re-Randomized||0
10758666|NCT03100942|11922039|FG002|COMPLETED|Placebo Arm Re-Randomized||0
10758667|NCT03100942|11922040|FG003|COMPLETED|Placebo Arm Re-Randomized||0
10758668|NCT03100942|11922041|FG004|COMPLETED|Placebo Arm Re-Randomized||10
10758669|NCT03100942|11922042|FG005|COMPLETED|Placebo Arm Re-Randomized||12
10758670|NCT03100942|11922043|FG006|COMPLETED|Placebo Arm Re-Randomized||9
10758671|NCT03100942|11922037|FG000|NOT COMPLETED|Placebo Arm Re-Randomized||0
10758672|NCT03100942|11922038|FG001|NOT COMPLETED|Placebo Arm Re-Randomized||0
10758673|NCT03100942|11922039|FG002|NOT COMPLETED|Placebo Arm Re-Randomized||0
10758674|NCT03100942|11922040|FG003|NOT COMPLETED|Placebo Arm Re-Randomized||0
10758675|NCT03100942|11922041|FG004|NOT COMPLETED|Placebo Arm Re-Randomized||0
10758676|NCT03100942|11922042|FG005|NOT COMPLETED|Placebo Arm Re-Randomized||0
10758677|NCT03100942|11922043|FG006|NOT COMPLETED|Placebo Arm Re-Randomized||1
10758678|NCT03100968|11922058|FG000|STARTED|Overall Study||75
10758679|NCT03100968|11922059|FG001|STARTED|Overall Study||75
10758680|NCT03100968|11922058|FG000|COMPLETED|Overall Study||75
10758681|NCT03100968|11922059|FG001|COMPLETED|Overall Study||75
10758682|NCT03100968|11922058|FG000|NOT COMPLETED|Overall Study||0
10758683|NCT03100968|11922059|FG001|NOT COMPLETED|Overall Study||0
10758684|NCT03101020|11922067|FG000|STARTED|Overall Study||10
10758685|NCT03101020|11922068|FG001|STARTED|Overall Study||10
10758686|NCT03101020|11922067|FG000|COMPLETED|Overall Study||9
10758687|NCT03101020|11922068|FG001|COMPLETED|Overall Study||7
10758688|NCT03101020|11922067|FG000|NOT COMPLETED|Overall Study||1
10758689|NCT03101020|11922068|FG001|NOT COMPLETED|Overall Study||3
10758690|NCT03101033|11922076|FG000|STARTED|Overall Study||32
10758691|NCT03101033|11922077|FG001|STARTED|Overall Study||60
10758692|NCT03101033|11922076|FG000|COMPLETED|Overall Study||27
10758693|NCT03101033|11922077|FG001|COMPLETED|Overall Study||51
10758694|NCT03101033|11922076|FG000|NOT COMPLETED|Overall Study||5
10758695|NCT03101033|11922077|FG001|NOT COMPLETED|Overall Study||9
10758696|NCT03101111|11922085|FG000|STARTED|Overall Study|First subject signed ICF (MV-CHIK group)|26
10758697|NCT03101111|11922086|FG001|STARTED|Overall Study|First subject signed ICF (MMR group)|8
10758698|NCT03101111|11922085|FG000|COMPLETED|Overall Study|End of Study Visit|23
10758699|NCT03101111|11922086|FG001|COMPLETED|Overall Study|End of Study Visit|7
10758700|NCT03101111|11922085|FG000|NOT COMPLETED|Overall Study||3
10758701|NCT03101111|11922086|FG001|NOT COMPLETED|Overall Study||1
10758702|NCT03101150|11922098|FG000|STARTED|Overall Study||86
10758703|NCT03101150|11922099|FG001|STARTED|Overall Study||93
10758704|NCT03101150|11922098|FG000|COMPLETED|Overall Study||81
10758705|NCT03101150|11922099|FG001|COMPLETED|Overall Study||83
10758706|NCT03101150|11922098|FG000|NOT COMPLETED|Overall Study||5
10758707|NCT03101150|11922099|FG001|NOT COMPLETED|Overall Study||10
10758708|NCT03101241|11922107|FG000|STARTED|Overall Study||48
10758709|NCT03101241|11922108|FG001|STARTED|Overall Study||47
10758710|NCT03101241|11922107|FG000|COMPLETED|Overall Study||37
10758711|NCT03101241|11922108|FG001|COMPLETED|Overall Study||42
10758712|NCT03101241|11922107|FG000|NOT COMPLETED|Overall Study||11
10758713|NCT03101241|11922108|FG001|NOT COMPLETED|Overall Study||5
10758714|NCT03101267|11922117|FG000|STARTED|Primary Study Period||50
10758715|NCT03101267|11922118|FG001|STARTED|Primary Study Period||50
10758716|NCT03101267|11922119|FG002|STARTED|Primary Study Period||50
10758717|NCT03101267|11922117|FG000|COMPLETED|Primary Study Period||47
10758718|NCT03101267|11922118|FG001|COMPLETED|Primary Study Period||48
10758719|NCT03101267|11922119|FG002|COMPLETED|Primary Study Period||47
10758720|NCT03101267|11922117|FG000|NOT COMPLETED|Primary Study Period||3
10758721|NCT03101267|11922118|FG001|NOT COMPLETED|Primary Study Period||2
10758722|NCT03101267|11922119|FG002|NOT COMPLETED|Primary Study Period||3
10758723|NCT03101267|11922117|FG000|STARTED|Pollinosis Symptoms Survey Period||47
10758724|NCT03101267|11922118|FG001|STARTED|Pollinosis Symptoms Survey Period||48
10758725|NCT03101267|11922119|FG002|STARTED|Pollinosis Symptoms Survey Period||47
10758726|NCT03101267|11922117|FG000|COMPLETED|Pollinosis Symptoms Survey Period||47
10758727|NCT03101267|11922118|FG001|COMPLETED|Pollinosis Symptoms Survey Period||48
10758728|NCT03101267|11922119|FG002|COMPLETED|Pollinosis Symptoms Survey Period||47
10758729|NCT03101267|11922117|FG000|NOT COMPLETED|Pollinosis Symptoms Survey Period||0
10758730|NCT03101267|11922118|FG001|NOT COMPLETED|Pollinosis Symptoms Survey Period||0
10758731|NCT03101267|11922119|FG002|NOT COMPLETED|Pollinosis Symptoms Survey Period||0
10758732|NCT03101293|11922129|FG000|STARTED|Intervention Period 1||7
10758733|NCT03101293|11922130|FG001|STARTED|Intervention Period 1||8
10758734|NCT03101293|11922129|FG000|COMPLETED|Intervention Period 1||7
10758735|NCT03101293|11922130|FG001|COMPLETED|Intervention Period 1||8
10758736|NCT03101293|11922129|FG000|NOT COMPLETED|Intervention Period 1||0
10758737|NCT03101293|11922130|FG001|NOT COMPLETED|Intervention Period 1||0
10758738|NCT03101293|11922129|FG000|STARTED|Washout Period (at Least 7 Days)||7
10758739|NCT03101293|11922130|FG001|STARTED|Washout Period (at Least 7 Days)||8
10758740|NCT03101293|11922129|FG000|COMPLETED|Washout Period (at Least 7 Days)||6
10874618|NCT04090658|12040779|FG001|STARTED|Overall Study||20
10874619|NCT04090658|12040778|FG000|COMPLETED|Overall Study||20
10874620|NCT04090658|12040779|FG001|COMPLETED|Overall Study||20
10874621|NCT04090658|12040778|FG000|NOT COMPLETED|Overall Study||0
10874622|NCT04090658|12040779|FG001|NOT COMPLETED|Overall Study||0
10758741|NCT03101293|11922130|FG001|COMPLETED|Washout Period (at Least 7 Days)||8
10758742|NCT03101293|11922129|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||1
10758743|NCT03101293|11922130|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
10758744|NCT03101293|11922129|FG000|STARTED|Intervention Period 2||6
10758745|NCT03101293|11922130|FG001|STARTED|Intervention Period 2||8
10758746|NCT03101293|11922129|FG000|COMPLETED|Intervention Period 2||6
10758747|NCT03101293|11922130|FG001|COMPLETED|Intervention Period 2||8
10758748|NCT03101293|11922129|FG000|NOT COMPLETED|Intervention Period 2||0
10758749|NCT03101293|11922130|FG001|NOT COMPLETED|Intervention Period 2||0
10758750|NCT03101358|11922140|FG000|STARTED|Overall Study||4
10758751|NCT03101358|11922141|FG001|STARTED|Overall Study||3
10758752|NCT03101358|11922142|FG002|STARTED|Overall Study||5
10758753|NCT03101358|11922143|FG003|STARTED|Overall Study||11
10758754|NCT03101358|11922140|FG000|Completed All Dosing|Overall Study||3
10758755|NCT03101358|11922141|FG001|Completed All Dosing|Overall Study||3
10758756|NCT03101358|11922142|FG002|Completed All Dosing|Overall Study||3
10758757|NCT03101358|11922143|FG003|Completed All Dosing|Overall Study||10
10758758|NCT03101358|11922140|FG000|COMPLETED|Overall Study||1
10758759|NCT03101358|11922141|FG001|COMPLETED|Overall Study||3
10758760|NCT03101358|11922142|FG002|COMPLETED|Overall Study||3
10758761|NCT03101358|11922143|FG003|COMPLETED|Overall Study||5
10758762|NCT03101358|11922140|FG000|NOT COMPLETED|Overall Study||3
10758763|NCT03101358|11922141|FG001|NOT COMPLETED|Overall Study||0
10758764|NCT03101358|11922142|FG002|NOT COMPLETED|Overall Study||2
10758765|NCT03101358|11922143|FG003|NOT COMPLETED|Overall Study||6
10758766|NCT03101371|11922156|FG000|STARTED|Overall Study||48
10758767|NCT03101371|11922157|FG001|STARTED|Overall Study||51
10758768|NCT03101371|11922156|FG000|COMPLETED|Overall Study||45
10758769|NCT03101371|11922157|FG001|COMPLETED|Overall Study||45
10758770|NCT03101371|11922156|FG000|NOT COMPLETED|Overall Study||3
10758771|NCT03101371|11922157|FG001|NOT COMPLETED|Overall Study||6
10758772|NCT03101462|11922165|FG000|STARTED|Overall Study||19
10758773|NCT03101462|11922166|FG001|STARTED|Overall Study||19
10758774|NCT03101462|11922165|FG000|COMPLETED|Overall Study||18
10758775|NCT03101462|11922166|FG001|COMPLETED|Overall Study||18
10758776|NCT03101462|11922165|FG000|NOT COMPLETED|Overall Study||1
10758777|NCT03101462|11922166|FG001|NOT COMPLETED|Overall Study||1
10758778|NCT03101514|11922172|FG000|STARTED|Overall Study||53
10758779|NCT03101514|11922172|FG000|COMPLETED|Overall Study||46
10758780|NCT03101514|11922172|FG000|NOT COMPLETED|Overall Study||7
10421610|NCT00819910|11566457|FG000|STARTED|Overall Study||10
10421611|NCT00819910|11566458|FG001|STARTED|Overall Study||10
10421612|NCT00819910|11566459|FG002|STARTED|Overall Study||10
10421613|NCT00819910|11566460|FG003|STARTED|Overall Study||11
10421614|NCT00819910|11566457|FG000|COMPLETED|Overall Study||8
10421615|NCT00819910|11566458|FG001|COMPLETED|Overall Study||9
10758781|NCT03101592|11922179|FG000|STARTED|Overall Study||3123
10758782|NCT03101592|11922180|FG001|STARTED|Overall Study||2896
10758783|NCT03101592|11922181|FG002|STARTED|Overall Study||3099
10758784|NCT03101592|11922179|FG000|COMPLETED|Overall Study||3012
10758785|NCT03101592|11922180|FG001|COMPLETED|Overall Study||2726
10758786|NCT03101592|11922181|FG002|COMPLETED|Overall Study||2981
10758787|NCT03101592|11922179|FG000|NOT COMPLETED|Overall Study||111
10758788|NCT03101592|11922180|FG001|NOT COMPLETED|Overall Study||170
10758789|NCT03101592|11922181|FG002|NOT COMPLETED|Overall Study||118
10758790|NCT03102190|11922195|FG000|STARTED|Overall Study||6
10758791|NCT03102190|11922195|FG000|COMPLETED|Overall Study||6
10758792|NCT03102190|11922195|FG000|NOT COMPLETED|Overall Study||0
10778920|NCT03362944|11940739|FG001|STARTED|First Intervention||8
10778921|NCT03362944|11940738|FG000|COMPLETED|First Intervention||8
10778922|NCT03362944|11940739|FG001|COMPLETED|First Intervention||8
10778923|NCT03362944|11940738|FG000|NOT COMPLETED|First Intervention||0
10778924|NCT03362944|11940739|FG001|NOT COMPLETED|First Intervention||0
10778925|NCT03362944|11940738|FG000|STARTED|Single Week Washout Period||8
10874623|NCT03811028|12040787|FG000|STARTED|Overall Study||3
10874624|NCT03811028|12040788|FG001|STARTED|Overall Study||3
10874625|NCT03811028|12040787|FG000|COMPLETED|Overall Study||3
10874626|NCT03811028|12040788|FG001|COMPLETED|Overall Study||3
10874627|NCT03811028|12040787|FG000|NOT COMPLETED|Overall Study||0
10874628|NCT03811028|12040788|FG001|NOT COMPLETED|Overall Study||0
10874629|NCT03760068|12040797|FG000|STARTED|Overall Study||238
10874630|NCT03760068|12040798|FG001|STARTED|Overall Study||240
10874631|NCT03760068|12040797|FG000|COMPLETED|Overall Study||224
10874632|NCT03760068|12040798|FG001|COMPLETED|Overall Study||217
10874633|NCT03760068|12040797|FG000|NOT COMPLETED|Overall Study||14
10874634|NCT03760068|12040798|FG001|NOT COMPLETED|Overall Study||23
10874635|NCT03742986|12040807|FG000|STARTED|Overall Study||4
10874636|NCT03742986|12040808|FG001|STARTED|Overall Study||4
10874637|NCT03742986|12040807|FG000|COMPLETED|Overall Study||4
10874638|NCT03742986|12040808|FG001|COMPLETED|Overall Study||4
10874639|NCT03742986|12040807|FG000|NOT COMPLETED|Overall Study||0
10421616|NCT00819910|11566459|FG002|COMPLETED|Overall Study||7
10421617|NCT00819910|11566460|FG003|COMPLETED|Overall Study||10
10778926|NCT03362944|11940739|FG001|STARTED|Single Week Washout Period||8
10778927|NCT03362944|11940738|FG000|COMPLETED|Single Week Washout Period||8
10778928|NCT03362944|11940739|FG001|COMPLETED|Single Week Washout Period||8
10778929|NCT03362944|11940738|FG000|NOT COMPLETED|Single Week Washout Period||0
10758793|NCT03102411|11922199|FG000|STARTED|Overall Study||1881
10758794|NCT03102411|11922199|FG000|COMPLETED|Overall Study||1718
10758795|NCT03102411|11922199|FG000|NOT COMPLETED|Overall Study||163
10758796|NCT03102437|11922206|FG000|STARTED|Overall Study||70
10758797|NCT03102437|11922207|FG001|STARTED|Overall Study||36
10758798|NCT03102437|11922206|FG000|COMPLETED|Overall Study||65
10758799|NCT03102437|11922207|FG001|COMPLETED|Overall Study||36
10758800|NCT03102437|11922206|FG000|NOT COMPLETED|Overall Study||5
10758801|NCT03102437|11922207|FG001|NOT COMPLETED|Overall Study||0
10758802|NCT03102645|11922215|FG000|STARTED|Overall Study||8
10758803|NCT03102645|11922216|FG001|STARTED|Overall Study||8
10758804|NCT03102645|11922215|FG000|COMPLETED|Overall Study||8
10758805|NCT03102645|11922216|FG001|COMPLETED|Overall Study||8
10758806|NCT03102645|11922215|FG000|NOT COMPLETED|Overall Study||0
10758807|NCT03102645|11922216|FG001|NOT COMPLETED|Overall Study||0
10758808|NCT03102710|11922226|FG000|STARTED|Overall Study||28
10758809|NCT03102710|11922227|FG001|STARTED|Overall Study||30
10758810|NCT03102710|11922228|FG002|STARTED|Overall Study||27
10758811|NCT03102710|11922226|FG000|COMPLETED|Overall Study||27
10758812|NCT03102710|11922227|FG001|COMPLETED|Overall Study||27
10758813|NCT03102710|11922228|FG002|COMPLETED|Overall Study||27
10758814|NCT03102710|11922226|FG000|NOT COMPLETED|Overall Study||1
10758815|NCT03102710|11922227|FG001|NOT COMPLETED|Overall Study||3
10758816|NCT03102710|11922228|FG002|NOT COMPLETED|Overall Study||0
10758817|NCT03102736|11922238|FG000|STARTED|Overall Study||7
10758818|NCT03102736|11922239|FG001|STARTED|Overall Study||9
10758819|NCT03102736|11922238|FG000|COMPLETED|Overall Study||7
10758820|NCT03102736|11922239|FG001|COMPLETED|Overall Study||9
10758821|NCT03102736|11922238|FG000|NOT COMPLETED|Overall Study||0
10758822|NCT03102736|11922239|FG001|NOT COMPLETED|Overall Study||0
10758823|NCT03102762|11922247|FG000|STARTED|Overall Study||35
10758824|NCT03102762|11922248|FG001|STARTED|Overall Study||35
10758825|NCT03102762|11922247|FG000|COMPLETED|Overall Study||34
10758826|NCT03102762|11922248|FG001|COMPLETED|Overall Study||35
10758827|NCT03102762|11922247|FG000|NOT COMPLETED|Overall Study||1
10758828|NCT03102762|11922248|FG001|NOT COMPLETED|Overall Study||0
10758829|NCT03102879|11922257|FG000|STARTED|Overall Study||18
10758830|NCT03102879|11922258|FG001|STARTED|Overall Study||18
10758831|NCT03102879|11922257|FG000|COMPLETED|Overall Study||18
10758832|NCT03102879|11922258|FG001|COMPLETED|Overall Study||18
10758833|NCT03102879|11922257|FG000|NOT COMPLETED|Overall Study||0
10758834|NCT03102879|11922258|FG001|NOT COMPLETED|Overall Study||0
10758835|NCT03102918|11922270|FG000|STARTED|Overall Study||5
10758836|NCT03102918|11922271|FG001|STARTED|Overall Study||5
10758837|NCT03102918|11922270|FG000|COMPLETED|Overall Study||4
10758838|NCT03102918|11922271|FG001|COMPLETED|Overall Study||5
10758839|NCT03102918|11922270|FG000|NOT COMPLETED|Overall Study||1
10758840|NCT03102918|11922271|FG001|NOT COMPLETED|Overall Study||0
10758841|NCT03103061|11922277|FG000|STARTED|Overall Study||24
10758842|NCT03103061|11922277|FG000|COMPLETED|Overall Study||24
10758843|NCT03103061|11922277|FG000|NOT COMPLETED|Overall Study||0
10758844|NCT03103100|11922284|FG000|STARTED|Overall Study||25
10758845|NCT03103100|11922285|FG001|STARTED|Overall Study||25
10758846|NCT03103100|11922286|FG002|STARTED|Overall Study||25
10758847|NCT03103100|11922284|FG000|COMPLETED|Overall Study||23
10758848|NCT03103100|11922285|FG001|COMPLETED|Overall Study||25
10758849|NCT03103100|11922286|FG002|COMPLETED|Overall Study||23
10758850|NCT03103100|11922284|FG000|NOT COMPLETED|Overall Study||2
10758851|NCT03103100|11922285|FG001|NOT COMPLETED|Overall Study||0
10758852|NCT03103100|11922286|FG002|NOT COMPLETED|Overall Study||2
10758853|NCT03103282|11922294|FG000|STARTED|Overall Study||65
10758854|NCT03103282|11922294|FG000|COMPLETED|Overall Study||65
10758855|NCT03103282|11922294|FG000|NOT COMPLETED|Overall Study||0
10758856|NCT03103438|11922305|FG000|STARTED|Overall Study||1
10758857|NCT03103438|11922306|FG001|STARTED|Overall Study||3
10758858|NCT03103438|11922307|FG002|STARTED|Overall Study||3
10758859|NCT03103438|11922308|FG003|STARTED|Overall Study||3
10758860|NCT03103438|11922309|FG004|STARTED|Overall Study||3
10758861|NCT03103438|11922310|FG005|STARTED|Overall Study||3
10758862|NCT03103438|11922311|FG006|STARTED|Overall Study||3
10758863|NCT03103438|11922305|FG000|COMPLETED|Overall Study||1
10758864|NCT03103438|11922306|FG001|COMPLETED|Overall Study||3
10758865|NCT03103438|11922307|FG002|COMPLETED|Overall Study||3
10758866|NCT03103438|11922308|FG003|COMPLETED|Overall Study||3
10758867|NCT03103438|11922309|FG004|COMPLETED|Overall Study||3
10758868|NCT03103438|11922310|FG005|COMPLETED|Overall Study||3
10758869|NCT03103438|11922311|FG006|COMPLETED|Overall Study||3
10874640|NCT03742986|12040808|FG001|NOT COMPLETED|Overall Study||0
10874641|NCT03628781|12040816|FG000|STARTED|Overall Study||85
10758870|NCT03103438|11922305|FG000|NOT COMPLETED|Overall Study||0
10758871|NCT03103438|11922306|FG001|NOT COMPLETED|Overall Study||0
10758872|NCT03103438|11922307|FG002|NOT COMPLETED|Overall Study||0
10758873|NCT03103438|11922308|FG003|NOT COMPLETED|Overall Study||0
10758874|NCT03103438|11922309|FG004|NOT COMPLETED|Overall Study||0
10758875|NCT03103438|11922310|FG005|NOT COMPLETED|Overall Study||0
10758876|NCT03103438|11922311|FG006|NOT COMPLETED|Overall Study||0
10758877|NCT03103503|11922327|FG000|STARTED|Overall Study||901
10758878|NCT03103503|11922327|FG000|COMPLETED|Overall Study||0
10758879|NCT03103503|11922327|FG000|NOT COMPLETED|Overall Study||901
10874642|NCT03628781|12040817|FG001|STARTED|Overall Study||84
10758880|NCT03103763|11922334|FG000|STARTED|Overall Study||44
10758881|NCT03103763|11922335|FG001|STARTED|Overall Study||44
10758882|NCT03103763|11922336|FG002|STARTED|Overall Study||44
10758883|NCT03103763|11922334|FG000|COMPLETED|Overall Study||29
10758884|NCT03103763|11922335|FG001|COMPLETED|Overall Study||36
10758885|NCT03103763|11922336|FG002|COMPLETED|Overall Study||37
10758886|NCT03103763|11922334|FG000|NOT COMPLETED|Overall Study||15
10758887|NCT03103763|11922335|FG001|NOT COMPLETED|Overall Study||8
10758888|NCT03103763|11922336|FG002|NOT COMPLETED|Overall Study||7
10758889|NCT03103906|11922346|FG000|STARTED|Overall Study||40
10758890|NCT03103906|11922347|FG001|STARTED|Overall Study||42
10296793|NCT00943852|11429426|FG009|STARTED|Third Period of Treatment Intervention||1
10296794|NCT00943852|11429417|FG000|COMPLETED|Third Period of Treatment Intervention||2
10296795|NCT00943852|11429418|FG001|COMPLETED|Third Period of Treatment Intervention||1
10296796|NCT00943852|11429419|FG002|COMPLETED|Third Period of Treatment Intervention||1
10296797|NCT00943852|11429420|FG003|COMPLETED|Third Period of Treatment Intervention||1
10296798|NCT00943852|11429421|FG004|COMPLETED|Third Period of Treatment Intervention||1
10296799|NCT00943852|11429422|FG005|COMPLETED|Third Period of Treatment Intervention||0
10296800|NCT00943852|11429423|FG006|COMPLETED|Third Period of Treatment Intervention||2
10296801|NCT00943852|11429424|FG007|COMPLETED|Third Period of Treatment Intervention||1
10296802|NCT00943852|11429425|FG008|COMPLETED|Third Period of Treatment Intervention||1
10296803|NCT00943852|11429426|FG009|COMPLETED|Third Period of Treatment Intervention||1
10296804|NCT00943852|11429417|FG000|NOT COMPLETED|Third Period of Treatment Intervention||0
10296805|NCT00943852|11429418|FG001|NOT COMPLETED|Third Period of Treatment Intervention||0
10296806|NCT00943852|11429419|FG002|NOT COMPLETED|Third Period of Treatment Intervention||0
10296807|NCT00943852|11429420|FG003|NOT COMPLETED|Third Period of Treatment Intervention||0
10296808|NCT00943852|11429421|FG004|NOT COMPLETED|Third Period of Treatment Intervention||0
10296809|NCT00943852|11429422|FG005|NOT COMPLETED|Third Period of Treatment Intervention||0
10296810|NCT00943852|11429423|FG006|NOT COMPLETED|Third Period of Treatment Intervention||0
10296811|NCT00943852|11429424|FG007|NOT COMPLETED|Third Period of Treatment Intervention||0
10296812|NCT00943852|11429425|FG008|NOT COMPLETED|Third Period of Treatment Intervention||0
10296813|NCT00943852|11429426|FG009|NOT COMPLETED|Third Period of Treatment Intervention||0
10296814|NCT00943852|11429417|FG000|STARTED|Washout Period After Period 3 Treatment||2
10296815|NCT00943852|11429418|FG001|STARTED|Washout Period After Period 3 Treatment||1
10296816|NCT00943852|11429419|FG002|STARTED|Washout Period After Period 3 Treatment||1
10296817|NCT00943852|11429420|FG003|STARTED|Washout Period After Period 3 Treatment||1
10296818|NCT00943852|11429421|FG004|STARTED|Washout Period After Period 3 Treatment||1
10296819|NCT00943852|11429422|FG005|STARTED|Washout Period After Period 3 Treatment||0
10296820|NCT00943852|11429423|FG006|STARTED|Washout Period After Period 3 Treatment||2
10296821|NCT00943852|11429424|FG007|STARTED|Washout Period After Period 3 Treatment||1
10296822|NCT00943852|11429425|FG008|STARTED|Washout Period After Period 3 Treatment||1
10296823|NCT00943852|11429426|FG009|STARTED|Washout Period After Period 3 Treatment||1
10296824|NCT00943852|11429417|FG000|COMPLETED|Washout Period After Period 3 Treatment||2
10296825|NCT00943852|11429418|FG001|COMPLETED|Washout Period After Period 3 Treatment||1
10296826|NCT00943852|11429419|FG002|COMPLETED|Washout Period After Period 3 Treatment||1
10296827|NCT00943852|11429420|FG003|COMPLETED|Washout Period After Period 3 Treatment||1
10296828|NCT00943852|11429421|FG004|COMPLETED|Washout Period After Period 3 Treatment||1
10296829|NCT00943852|11429422|FG005|COMPLETED|Washout Period After Period 3 Treatment||0
10296830|NCT00943852|11429423|FG006|COMPLETED|Washout Period After Period 3 Treatment||1
10296831|NCT00943852|11429424|FG007|COMPLETED|Washout Period After Period 3 Treatment||1
10296832|NCT00943852|11429425|FG008|COMPLETED|Washout Period After Period 3 Treatment||1
10296833|NCT00943852|11429426|FG009|COMPLETED|Washout Period After Period 3 Treatment||1
10296834|NCT00943852|11429417|FG000|NOT COMPLETED|Washout Period After Period 3 Treatment||0
10296835|NCT00943852|11429418|FG001|NOT COMPLETED|Washout Period After Period 3 Treatment||0
10296836|NCT00943852|11429419|FG002|NOT COMPLETED|Washout Period After Period 3 Treatment||0
10296837|NCT00943852|11429420|FG003|NOT COMPLETED|Washout Period After Period 3 Treatment||0
10296838|NCT00943852|11429421|FG004|NOT COMPLETED|Washout Period After Period 3 Treatment||0
10296839|NCT00943852|11429422|FG005|NOT COMPLETED|Washout Period After Period 3 Treatment||0
10296840|NCT00943852|11429423|FG006|NOT COMPLETED|Washout Period After Period 3 Treatment||1
10296841|NCT00943852|11429424|FG007|NOT COMPLETED|Washout Period After Period 3 Treatment||0
10296842|NCT00943852|11429425|FG008|NOT COMPLETED|Washout Period After Period 3 Treatment||0
10296843|NCT00943852|11429426|FG009|NOT COMPLETED|Washout Period After Period 3 Treatment||0
10296844|NCT00943852|11429417|FG000|STARTED|Fourth Period of Treatment Intervention||2
10296845|NCT00943852|11429418|FG001|STARTED|Fourth Period of Treatment Intervention||1
10296846|NCT00943852|11429419|FG002|STARTED|Fourth Period of Treatment Intervention||1
10296847|NCT00943852|11429420|FG003|STARTED|Fourth Period of Treatment Intervention||1
10296848|NCT00943852|11429421|FG004|STARTED|Fourth Period of Treatment Intervention||1
10296849|NCT00943852|11429422|FG005|STARTED|Fourth Period of Treatment Intervention||0
10296850|NCT00943852|11429423|FG006|STARTED|Fourth Period of Treatment Intervention||1
10296851|NCT00943852|11429424|FG007|STARTED|Fourth Period of Treatment Intervention||1
10296852|NCT00943852|11429425|FG008|STARTED|Fourth Period of Treatment Intervention||1
10296853|NCT00943852|11429426|FG009|STARTED|Fourth Period of Treatment Intervention||1
10314975|NCT00171249|11448710|FG003|NOT COMPLETED|Overall Study||152
10758891|NCT03103906|11922346|FG000|COMPLETED|Overall Study||36
10758892|NCT03103906|11922347|FG001|COMPLETED|Overall Study||39
10758893|NCT03103906|11922346|FG000|NOT COMPLETED|Overall Study||4
10758894|NCT03103906|11922347|FG001|NOT COMPLETED|Overall Study||3
10758895|NCT03103919|11922355|FG000|STARTED|Overall Study||20
10758896|NCT03103919|11922356|FG001|STARTED|Overall Study||19
10758897|NCT03103919|11922355|FG000|COMPLETED|Overall Study||18
10758898|NCT03103919|11922356|FG001|COMPLETED|Overall Study||17
10758899|NCT03103919|11922355|FG000|NOT COMPLETED|Overall Study||2
10758900|NCT03103919|11922356|FG001|NOT COMPLETED|Overall Study||2
10758901|NCT03104192|11922368|FG000|STARTED|Overall Study||9
10758902|NCT03104192|11922369|FG001|STARTED|Overall Study||27
10758903|NCT03104192|11922370|FG002|STARTED|Overall Study||16
10758904|NCT03104192|11922371|FG003|STARTED|Overall Study||17
10758905|NCT03104192|11922368|FG000|COMPLETED|Overall Study||9
10758906|NCT03104192|11922369|FG001|COMPLETED|Overall Study||23
10758907|NCT03104192|11922370|FG002|COMPLETED|Overall Study||14
10758908|NCT03104192|11922371|FG003|COMPLETED|Overall Study||14
10758909|NCT03104192|11922368|FG000|NOT COMPLETED|Overall Study||0
10758910|NCT03104192|11922369|FG001|NOT COMPLETED|Overall Study||4
10758911|NCT03104192|11922370|FG002|NOT COMPLETED|Overall Study||2
10758912|NCT03104192|11922371|FG003|NOT COMPLETED|Overall Study||3
10758913|NCT03104322|11922387|FG000|STARTED|Overall Study||7
10758914|NCT03104322|11922387|FG000|COMPLETED|Overall Study||6
10758915|NCT03104322|11922387|FG000|NOT COMPLETED|Overall Study||1
10758916|NCT03104647|11922391|FG000|STARTED|Overall Study||20
10758917|NCT03104647|11922391|FG000|COMPLETED|Overall Study||20
10758918|NCT03104647|11922391|FG000|NOT COMPLETED|Overall Study||0
10758919|NCT03104725|11922397|FG000|STARTED|Overall Study||2
10758920|NCT03104725|11922398|FG001|STARTED|Overall Study||4
10758921|NCT03104725|11922397|FG000|COMPLETED|Overall Study||2
10758922|NCT03104725|11922398|FG001|COMPLETED|Overall Study||4
10758923|NCT03104725|11922397|FG000|NOT COMPLETED|Overall Study||0
10758924|NCT03104725|11922398|FG001|NOT COMPLETED|Overall Study||0
10758925|NCT03104738|11922406|FG000|STARTED|Overall Study||20
10758926|NCT03104738|11922407|FG001|STARTED|Overall Study||20
10758927|NCT03104738|11922406|FG000|COMPLETED|Overall Study||20
10758928|NCT03104738|11922407|FG001|COMPLETED|Overall Study||20
10758929|NCT03104738|11922406|FG000|NOT COMPLETED|Overall Study||0
10758930|NCT03104738|11922407|FG001|NOT COMPLETED|Overall Study||0
10758931|NCT03104816|11922416|FG000|STARTED|Overall Study||11
10758932|NCT03104816|11922417|FG001|STARTED|Overall Study||11
10758933|NCT03104816|11922418|FG002|STARTED|Overall Study||6
10758934|NCT03104816|11922416|FG000|COMPLETED|Overall Study||9
10758935|NCT03104816|11922417|FG001|COMPLETED|Overall Study||9
10758936|NCT03104816|11922418|FG002|COMPLETED|Overall Study||4
10758937|NCT03104816|11922416|FG000|NOT COMPLETED|Overall Study||2
10758938|NCT03104816|11922417|FG001|NOT COMPLETED|Overall Study||2
10758939|NCT03104816|11922418|FG002|NOT COMPLETED|Overall Study||2
10758940|NCT03104985|11922428|FG000|STARTED|Overall Study||34
10758941|NCT03104985|11922429|FG001|STARTED|Overall Study||34
10758942|NCT03104985|11922428|FG000|COMPLETED|Overall Study||34
10758943|NCT03104985|11922429|FG001|COMPLETED|Overall Study||34
10758944|NCT03104985|11922428|FG000|NOT COMPLETED|Overall Study||0
10758945|NCT03104985|11922429|FG001|NOT COMPLETED|Overall Study||0
10758946|NCT03105297|11922435|FG000|STARTED|Baseline Phase (Day 1)||91
10758947|NCT03105297|11922435|FG000|COMPLETED|Baseline Phase (Day 1)||70
10758948|NCT03105297|11922435|FG000|NOT COMPLETED|Baseline Phase (Day 1)||21
10758949|NCT03105297|11922435|FG000|STARTED|Active Phase (Day 2-29)||70
10758950|NCT03105297|11922435|FG000|COMPLETED|Active Phase (Day 2-29)||70
10758951|NCT03105297|11922435|FG000|NOT COMPLETED|Active Phase (Day 2-29)||0
10758952|NCT03105297|11922435|FG000|STARTED|Nasal Resistance Phase (Day 30, 31)|14 participants withdrew from the study after the completion of active phase|56
10758953|NCT03105297|11922435|FG000|Treated|Nasal Resistance Phase (Day 30, 31)||55
10758954|NCT03105297|11922435|FG000|COMPLETED|Nasal Resistance Phase (Day 30, 31)||48
10758955|NCT03105297|11922435|FG000|NOT COMPLETED|Nasal Resistance Phase (Day 30, 31)||8
10758956|NCT03105362|11922446|FG000|STARTED|Overall Study||4
10758957|NCT03105362|11922446|FG000|Completed 1 Week of Study|Overall Study||4
10758958|NCT03105362|11922446|FG000|Completed 2 Weeks of Study|Overall Study||3
10758959|NCT03105362|11922446|FG000|Completed 2 Week Questionaire|Overall Study||2
10758960|NCT03105362|11922446|FG000|COMPLETED|Overall Study||2
10758961|NCT03105362|11922446|FG000|NOT COMPLETED|Overall Study||2
10758962|NCT03105479|11922453|FG000|STARTED|Overall Study||1
10758963|NCT03105479|11922454|FG001|STARTED|Overall Study||0
10758964|NCT03105479|11922455|FG002|STARTED|Overall Study||0
10758965|NCT03105479|11922456|FG003|STARTED|Overall Study||0
10758966|NCT03105479|11922457|FG004|STARTED|Overall Study||0
10758967|NCT03105479|11922458|FG005|STARTED|Overall Study||0
10758968|NCT03105479|11922459|FG006|STARTED|Overall Study||0
10758969|NCT03105479|11922453|FG000|COMPLETED|Overall Study||1
10758970|NCT03105479|11922454|FG001|COMPLETED|Overall Study||0
10758971|NCT03105479|11922455|FG002|COMPLETED|Overall Study||0
10758972|NCT03105479|11922456|FG003|COMPLETED|Overall Study||0
10758973|NCT03105479|11922457|FG004|COMPLETED|Overall Study||0
10758974|NCT03105479|11922458|FG005|COMPLETED|Overall Study||0
10758975|NCT03105479|11922459|FG006|COMPLETED|Overall Study||0
10758976|NCT03105479|11922453|FG000|NOT COMPLETED|Overall Study||0
10758977|NCT03105479|11922454|FG001|NOT COMPLETED|Overall Study||0
10758978|NCT03105479|11922455|FG002|NOT COMPLETED|Overall Study||0
10758979|NCT03105479|11922456|FG003|NOT COMPLETED|Overall Study||0
10758980|NCT03105479|11922457|FG004|NOT COMPLETED|Overall Study||0
10758981|NCT03105479|11922458|FG005|NOT COMPLETED|Overall Study||0
10758982|NCT03105479|11922459|FG006|NOT COMPLETED|Overall Study||0
10758986|NCT03106077|11922470|FG000|STARTED|Overall Study||96
10758987|NCT03106077|11922471|FG001|STARTED|Overall Study||0
10758988|NCT03106077|11922470|FG000|COMPLETED|Overall Study||2
10758989|NCT03106077|11922471|FG001|COMPLETED|Overall Study||0
10758990|NCT03106077|11922470|FG000|NOT COMPLETED|Overall Study||94
10758991|NCT03106077|11922471|FG001|NOT COMPLETED|Overall Study||0
10758992|NCT03106337|11922476|FG000|STARTED|Overall Study||35
10758993|NCT03106337|11922476|FG000|COMPLETED|Overall Study||35
10758994|NCT03106337|11922476|FG000|NOT COMPLETED|Overall Study||0
10758995|NCT03106636|11922483|FG000|STARTED|Overall Study||226
10758996|NCT03106636|11922484|FG001|STARTED|Overall Study||190
10758997|NCT03106636|11922483|FG000|COMPLETED|Overall Study||182
10758998|NCT03106636|11922484|FG001|COMPLETED|Overall Study||164
10758999|NCT03106636|11922483|FG000|NOT COMPLETED|Overall Study||44
10759000|NCT03106636|11922484|FG001|NOT COMPLETED|Overall Study||26
10759001|NCT03106753|11922492|FG000|STARTED|Overall Study||17
10759002|NCT03106753|11922493|FG001|STARTED|Overall Study||17
10759003|NCT03106753|11922492|FG000|COMPLETED|Overall Study||17
10759004|NCT03106753|11922493|FG001|COMPLETED|Overall Study||16
10759005|NCT03106753|11922492|FG000|NOT COMPLETED|Overall Study||0
10759006|NCT03106753|11922493|FG001|NOT COMPLETED|Overall Study||1
10759007|NCT03106844|11922501|FG000|STARTED|Overall Study||50
10759008|NCT03106844|11922501|FG000|COMPLETED|Overall Study||49
10759009|NCT03106844|11922501|FG000|NOT COMPLETED|Overall Study||1
10759010|NCT03106870|11922507|FG000|STARTED|Overall Study||31
10759011|NCT03106870|11922508|FG001|STARTED|Overall Study||31
10759012|NCT03106870|11922507|FG000|COMPLETED|Overall Study||31
10759013|NCT03106870|11922508|FG001|COMPLETED|Overall Study||31
10759014|NCT03106870|11922507|FG000|NOT COMPLETED|Overall Study||0
10759015|NCT03106870|11922508|FG001|NOT COMPLETED|Overall Study||0
10759016|NCT03107026|11922517|FG000|STARTED|Overall Study||163
10759017|NCT03107026|11922518|FG001|STARTED|Overall Study||161
10759018|NCT03107026|11922519|FG002|STARTED|Overall Study||162
10759019|NCT03107026|11922517|FG000|COMPLETED|Overall Study||131
10759020|NCT03107026|11922518|FG001|COMPLETED|Overall Study||123
10759021|NCT03107026|11922519|FG002|COMPLETED|Overall Study||106
10759022|NCT03107026|11922517|FG000|NOT COMPLETED|Overall Study||32
10759023|NCT03107026|11922518|FG001|NOT COMPLETED|Overall Study||38
10759024|NCT03107026|11922519|FG002|NOT COMPLETED|Overall Study||56
10759025|NCT03107052|11922530|FG000|STARTED|Overall Study||145
10759026|NCT03107052|11922531|FG001|STARTED|Overall Study||60
10759027|NCT03107052|11922532|FG002|STARTED|Overall Study||70
10759028|NCT03107052|11922530|FG000|Safety Analysis Set|Overall Study|1 participant assigned to 225 mg monthly arm but received 675 mg quarterly after >12 weeks remission|144
10759029|NCT03107052|11922531|FG001|Safety Analysis Set|Overall Study||60
10759030|NCT03107052|11922532|FG002|Safety Analysis Set|Overall Study|1 participant assigned to 225 mg monthly arm but received 675 mg quarterly after >12 weeks remission|71
10759031|NCT03107052|11922530|FG000|COMPLETED|Overall Study||26
10759032|NCT03107052|11922531|FG001|COMPLETED|Overall Study||14
10759033|NCT03107052|11922532|FG002|COMPLETED|Overall Study||29
10759034|NCT03107052|11922530|FG000|NOT COMPLETED|Overall Study||119
10759035|NCT03107052|11922531|FG001|NOT COMPLETED|Overall Study||46
10759036|NCT03107052|11922532|FG002|NOT COMPLETED|Overall Study||41
10759037|NCT03107091|11922540|FG000|STARTED|Overall Study||6
10759038|NCT03107091|11922540|FG000|COMPLETED|Overall Study||5
10759039|NCT03107091|11922540|FG000|NOT COMPLETED|Overall Study||1
10759040|NCT03107377|11922547|FG000|STARTED|Overall Study||426
10759041|NCT03107377|11922548|FG001|STARTED|Overall Study||434
10759042|NCT03107377|11922547|FG000|COMPLETED|Overall Study||335
10759043|NCT03107377|11922548|FG001|COMPLETED|Overall Study||335
10759044|NCT03107377|11922547|FG000|NOT COMPLETED|Overall Study||91
10759045|NCT03107377|11922548|FG001|NOT COMPLETED|Overall Study||99
10759046|NCT03107715|11922556|FG000|STARTED|Overall Study||132
10759047|NCT03107715|11922557|FG001|STARTED|Overall Study||111
10759048|NCT03107715|11922556|FG000|COMPLETED|Overall Study||128
10759049|NCT03107715|11922557|FG001|COMPLETED|Overall Study||104
10759050|NCT03107715|11922556|FG000|NOT COMPLETED|Overall Study||4
10759051|NCT03107715|11922557|FG001|NOT COMPLETED|Overall Study||7
10759052|NCT03107754|11922565|FG000|STARTED|Overall Study||48
10759053|NCT03107754|11922566|FG001|STARTED|Overall Study||50
10759054|NCT03107754|11922565|FG000|COMPLETED|Overall Study||48
10759055|NCT03107754|11922566|FG001|COMPLETED|Overall Study||50
10759056|NCT03107754|11922565|FG000|NOT COMPLETED|Overall Study||0
10759057|NCT03107754|11922566|FG001|NOT COMPLETED|Overall Study||0
10759058|NCT03107793|11922572|FG000|STARTED|Induction Period (16 Weeks)||500
10759059|NCT03107793|11922573|FG001|STARTED|Induction Period (16 Weeks)||0
10759060|NCT03107793|11922574|FG002|STARTED|Induction Period (16 Weeks)||0
10759061|NCT03107793|11922572|FG000|COMPLETED|Induction Period (16 Weeks)||490
10759062|NCT03107793|11922573|FG001|COMPLETED|Induction Period (16 Weeks)||0
10759063|NCT03107793|11922574|FG002|COMPLETED|Induction Period (16 Weeks)||0
10759064|NCT03107793|11922572|FG000|NOT COMPLETED|Induction Period (16 Weeks)||10
10759065|NCT03107793|11922573|FG001|NOT COMPLETED|Induction Period (16 Weeks)||0
10759066|NCT03107793|11922574|FG002|NOT COMPLETED|Induction Period (16 Weeks)||0
10759067|NCT03107793|11922572|FG000|STARTED|Maintenance Period (16-48 Week)||0
10759068|NCT03107793|11922573|FG001|STARTED|Maintenance Period (16-48 Week)||220
10759069|NCT03107793|11922574|FG002|STARTED|Maintenance Period (16-48 Week)||221
10759070|NCT03107793|11922572|FG000|COMPLETED|Maintenance Period (16-48 Week)||0
10759071|NCT03107793|11922573|FG001|COMPLETED|Maintenance Period (16-48 Week)||174
10759072|NCT03107793|11922574|FG002|COMPLETED|Maintenance Period (16-48 Week)||193
10759073|NCT03107793|11922572|FG000|NOT COMPLETED|Maintenance Period (16-48 Week)||0
10759074|NCT03107793|11922573|FG001|NOT COMPLETED|Maintenance Period (16-48 Week)||46
10759075|NCT03107793|11922574|FG002|NOT COMPLETED|Maintenance Period (16-48 Week)||28
10759076|NCT03108027|11922581|FG000|STARTED|Period 1||7
10759077|NCT03108027|11922582|FG001|STARTED|Period 1||6
10759078|NCT03108027|11922583|FG002|STARTED|Period 1||6
10759079|NCT03108027|11922584|FG003|STARTED|Period 1||6
10759080|NCT03108027|11922585|FG004|STARTED|Period 1||6
10759081|NCT03108027|11922586|FG005|STARTED|Period 1||6
10759082|NCT03108027|11922581|FG000|COMPLETED|Period 1||7
10759083|NCT03108027|11922582|FG001|COMPLETED|Period 1||6
10759084|NCT03108027|11922583|FG002|COMPLETED|Period 1||6
10759085|NCT03108027|11922584|FG003|COMPLETED|Period 1||4
10759086|NCT03108027|11922585|FG004|COMPLETED|Period 1||6
10759087|NCT03108027|11922586|FG005|COMPLETED|Period 1||6
10759088|NCT03108027|11922581|FG000|NOT COMPLETED|Period 1||0
10759089|NCT03108027|11922582|FG001|NOT COMPLETED|Period 1||0
10759090|NCT03108027|11922583|FG002|NOT COMPLETED|Period 1||0
10759091|NCT03108027|11922584|FG003|NOT COMPLETED|Period 1||2
10759092|NCT03108027|11922585|FG004|NOT COMPLETED|Period 1||0
10759093|NCT03108027|11922586|FG005|NOT COMPLETED|Period 1||0
10759094|NCT03108027|11922581|FG000|STARTED|Period 2||7
10759095|NCT03108027|11922582|FG001|STARTED|Period 2||6
10759096|NCT03108027|11922583|FG002|STARTED|Period 2||6
10759097|NCT03108027|11922584|FG003|STARTED|Period 2||4
10759098|NCT03108027|11922585|FG004|STARTED|Period 2||6
10759099|NCT03108027|11922586|FG005|STARTED|Period 2||6
10759100|NCT03108027|11922581|FG000|COMPLETED|Period 2||7
10759101|NCT03108027|11922582|FG001|COMPLETED|Period 2||6
10759102|NCT03108027|11922583|FG002|COMPLETED|Period 2||6
10759103|NCT03108027|11922584|FG003|COMPLETED|Period 2||4
10759104|NCT03108027|11922585|FG004|COMPLETED|Period 2||6
10759105|NCT03108027|11922586|FG005|COMPLETED|Period 2||6
10759106|NCT03108027|11922581|FG000|NOT COMPLETED|Period 2||0
10759107|NCT03108027|11922582|FG001|NOT COMPLETED|Period 2||0
10759108|NCT03108027|11922583|FG002|NOT COMPLETED|Period 2||0
10759109|NCT03108027|11922584|FG003|NOT COMPLETED|Period 2||0
10759110|NCT03108027|11922585|FG004|NOT COMPLETED|Period 2||0
10759111|NCT03108027|11922586|FG005|NOT COMPLETED|Period 2||0
10759112|NCT03108027|11922581|FG000|STARTED|Period 3||7
10759113|NCT03108027|11922582|FG001|STARTED|Period 3||6
10759114|NCT03108027|11922583|FG002|STARTED|Period 3||6
10759115|NCT03108027|11922584|FG003|STARTED|Period 3||4
10759116|NCT03108027|11922585|FG004|STARTED|Period 3||6
10759117|NCT03108027|11922586|FG005|STARTED|Period 3||6
10759118|NCT03108027|11922581|FG000|COMPLETED|Period 3||7
10759119|NCT03108027|11922582|FG001|COMPLETED|Period 3||5
10759120|NCT03108027|11922583|FG002|COMPLETED|Period 3||6
10759121|NCT03108027|11922584|FG003|COMPLETED|Period 3||4
10759122|NCT03108027|11922585|FG004|COMPLETED|Period 3||6
10759123|NCT03108027|11922586|FG005|COMPLETED|Period 3||6
10759124|NCT03108027|11922581|FG000|NOT COMPLETED|Period 3||0
10759125|NCT03108027|11922582|FG001|NOT COMPLETED|Period 3||1
10759126|NCT03108027|11922583|FG002|NOT COMPLETED|Period 3||0
10759127|NCT03108027|11922584|FG003|NOT COMPLETED|Period 3||0
10759128|NCT03108027|11922585|FG004|NOT COMPLETED|Period 3||0
10759129|NCT03108027|11922586|FG005|NOT COMPLETED|Period 3||0
10759130|NCT03108157|11922596|FG000|STARTED|Overall Study||176
10759131|NCT03108157|11922597|FG001|STARTED|Overall Study||176
10759132|NCT03108157|11922596|FG000|COMPLETED|Overall Study||161
10759133|NCT03108157|11922597|FG001|COMPLETED|Overall Study||172
10759134|NCT03108157|11922596|FG000|NOT COMPLETED|Overall Study||15
10759135|NCT03108157|11922597|FG001|NOT COMPLETED|Overall Study||4
10759136|NCT03108469|11922606|FG000|STARTED|Overall Study||15
10759137|NCT03108469|11922607|FG001|STARTED|Overall Study||15
10759138|NCT03108469|11922606|FG000|COMPLETED|Overall Study||11
10759139|NCT03108469|11922607|FG001|COMPLETED|Overall Study||11
10759140|NCT03108469|11922606|FG000|NOT COMPLETED|Overall Study||4
10759141|NCT03108469|11922607|FG001|NOT COMPLETED|Overall Study||4
10759142|NCT03108482|11922617|FG000|STARTED|Overall Study||183
10759143|NCT03108482|11922618|FG001|STARTED|Overall Study||183
10759144|NCT03108482|11922619|FG002|STARTED|Overall Study||182
10759145|NCT03108482|11922620|FG003|STARTED|Overall Study||89
10759146|NCT03108482|11922617|FG000|COMPLETED|Overall Study||183
10759147|NCT03108482|11922618|FG001|COMPLETED|Overall Study||179
10759148|NCT03108482|11922619|FG002|COMPLETED|Overall Study||180
10759149|NCT03108482|11922620|FG003|COMPLETED|Overall Study||86
10759150|NCT03108482|11922617|FG000|NOT COMPLETED|Overall Study||0
10759151|NCT03108482|11922618|FG001|NOT COMPLETED|Overall Study||4
10759152|NCT03108482|11922619|FG002|NOT COMPLETED|Overall Study||2
10759153|NCT03108482|11922620|FG003|NOT COMPLETED|Overall Study||3
10759154|NCT03108521|11922632|FG000|STARTED|Overall Study||83
10759155|NCT03108521|11922633|FG001|STARTED|Overall Study||36
10759156|NCT03108521|11922632|FG000|COMPLETED|Overall Study||71
10759157|NCT03108521|11922633|FG001|COMPLETED|Overall Study||36
10759158|NCT03108521|11922632|FG000|NOT COMPLETED|Overall Study||12
10759159|NCT03108521|11922633|FG001|NOT COMPLETED|Overall Study||0
10874643|NCT03628781|12040816|FG000|6-month Timepoint|Overall Study||63
10759172|NCT03109015|11922671|FG000|STARTED|Overall Study||4
10759173|NCT03109015|11922672|FG001|STARTED|Overall Study||3
10759174|NCT03109015|11922671|FG000|COMPLETED|Overall Study||4
10759175|NCT03109015|11922672|FG001|COMPLETED|Overall Study||3
10759176|NCT03109015|11922671|FG000|NOT COMPLETED|Overall Study||0
10759177|NCT03109015|11922672|FG001|NOT COMPLETED|Overall Study||0
10759178|NCT03109184|11922680|FG000|STARTED|Overall Study||60
10759179|NCT03109184|11922681|FG001|STARTED|Overall Study||59
10759180|NCT03109184|11922680|FG000|COMPLETED|Overall Study||53
10759181|NCT03109184|11922681|FG001|COMPLETED|Overall Study||52
10759182|NCT03109184|11922680|FG000|NOT COMPLETED|Overall Study||7
10759183|NCT03109184|11922681|FG001|NOT COMPLETED|Overall Study||7
10759184|NCT03109769|11922689|FG000|STARTED|Overall Study||22
10759185|NCT03109769|11922690|FG001|STARTED|Overall Study||22
10759186|NCT03109769|11922689|FG000|COMPLETED|Overall Study||22
10759187|NCT03109769|11922690|FG001|COMPLETED|Overall Study||22
10759188|NCT03109769|11922689|FG000|NOT COMPLETED|Overall Study||0
10759189|NCT03109769|11922690|FG001|NOT COMPLETED|Overall Study||0
10759190|NCT03109951|11922696|FG000|STARTED|Overall Study||187
10759191|NCT03109951|11922696|FG000|COMPLETED|Overall Study||187
10759192|NCT03109951|11922696|FG000|NOT COMPLETED|Overall Study||0
10759193|NCT03110003|11922702|FG000|STARTED|Overall Study||21
10759194|NCT03110003|11922703|FG001|STARTED|Overall Study||24
10759195|NCT03110003|11922702|FG000|COMPLETED|Overall Study||21
10874644|NCT03628781|12040817|FG001|6-month Timepoint|Overall Study||79
10874645|NCT03628781|12040816|FG000|12-month Timepoint|Overall Study||53
10874646|NCT03628781|12040817|FG001|12-month Timepoint|Overall Study||75
10874647|NCT03628781|12040816|FG000|COMPLETED|Overall Study||53
10874648|NCT03628781|12040817|FG001|COMPLETED|Overall Study||75
10874649|NCT03628781|12040816|FG000|NOT COMPLETED|Overall Study||32
10874650|NCT03628781|12040817|FG001|NOT COMPLETED|Overall Study||9
10874651|NCT03560206|12040825|FG000|STARTED|Overall Study||158
10874652|NCT03560206|12040826|FG001|STARTED|Overall Study||158
10874653|NCT03560206|12040825|FG000|COMPLETED|Overall Study||108
10874654|NCT03560206|12040826|FG001|COMPLETED|Overall Study||140
10874655|NCT03560206|12040825|FG000|NOT COMPLETED|Overall Study||50
10874656|NCT03560206|12040826|FG001|NOT COMPLETED|Overall Study||18
10874657|NCT03340766|12040835|FG000|STARTED|Overall Study||12
10874658|NCT03340766|12040836|FG001|STARTED|Overall Study||10
10874659|NCT03340766|12040837|FG002|STARTED|Overall Study||9
10874660|NCT03340766|12040835|FG000|Received Blinatumomab|Overall Study||12
10874661|NCT03340766|12040836|FG001|Received Blinatumomab|Overall Study||10
10874662|NCT03340766|12040837|FG002|Received Blinatumomab|Overall Study||9
10874663|NCT03340766|12040835|FG000|Received Pembrolizumab|Overall Study||10
10874664|NCT03340766|12040836|FG001|Received Pembrolizumab|Overall Study||7
10874665|NCT03340766|12040837|FG002|Received Pembrolizumab|Overall Study||7
10874666|NCT03340766|12040835|FG000|COMPLETED|Overall Study||1
10874667|NCT03340766|12040836|FG001|COMPLETED|Overall Study||0
10874668|NCT03340766|12040837|FG002|COMPLETED|Overall Study||0
10874669|NCT03340766|12040835|FG000|NOT COMPLETED|Overall Study||11
10874670|NCT03340766|12040836|FG001|NOT COMPLETED|Overall Study||10
10874671|NCT03340766|12040837|FG002|NOT COMPLETED|Overall Study||9
10296854|NCT00943852|11429417|FG000|COMPLETED|Fourth Period of Treatment Intervention||2
10296855|NCT00943852|11429418|FG001|COMPLETED|Fourth Period of Treatment Intervention||1
10296856|NCT00943852|11429419|FG002|COMPLETED|Fourth Period of Treatment Intervention||1
10296857|NCT00943852|11429420|FG003|COMPLETED|Fourth Period of Treatment Intervention||1
10296858|NCT00943852|11429421|FG004|COMPLETED|Fourth Period of Treatment Intervention||1
10296859|NCT00943852|11429422|FG005|COMPLETED|Fourth Period of Treatment Intervention||0
10296860|NCT00943852|11429423|FG006|COMPLETED|Fourth Period of Treatment Intervention||1
10296861|NCT00943852|11429424|FG007|COMPLETED|Fourth Period of Treatment Intervention||1
10296862|NCT00943852|11429425|FG008|COMPLETED|Fourth Period of Treatment Intervention||1
10296863|NCT00943852|11429426|FG009|COMPLETED|Fourth Period of Treatment Intervention||1
10296864|NCT00943852|11429417|FG000|NOT COMPLETED|Fourth Period of Treatment Intervention||0
10296865|NCT00943852|11429418|FG001|NOT COMPLETED|Fourth Period of Treatment Intervention||0
10296866|NCT00943852|11429419|FG002|NOT COMPLETED|Fourth Period of Treatment Intervention||0
10296867|NCT00943852|11429420|FG003|NOT COMPLETED|Fourth Period of Treatment Intervention||0
10296868|NCT00943852|11429421|FG004|NOT COMPLETED|Fourth Period of Treatment Intervention||0
10296869|NCT00943852|11429422|FG005|NOT COMPLETED|Fourth Period of Treatment Intervention||0
10296870|NCT00943852|11429423|FG006|NOT COMPLETED|Fourth Period of Treatment Intervention||0
10296871|NCT00943852|11429424|FG007|NOT COMPLETED|Fourth Period of Treatment Intervention||0
10296872|NCT00943852|11429425|FG008|NOT COMPLETED|Fourth Period of Treatment Intervention||0
10296873|NCT00943852|11429426|FG009|NOT COMPLETED|Fourth Period of Treatment Intervention||0
10296874|NCT00943852|11429417|FG000|STARTED|Washout Period After Period 4 Treatment||2
10296875|NCT00943852|11429418|FG001|STARTED|Washout Period After Period 4 Treatment||1
10296876|NCT00943852|11429419|FG002|STARTED|Washout Period After Period 4 Treatment||1
10296877|NCT00943852|11429420|FG003|STARTED|Washout Period After Period 4 Treatment||1
10759196|NCT03110003|11922703|FG001|COMPLETED|Overall Study||24
10759197|NCT03110003|11922702|FG000|NOT COMPLETED|Overall Study||0
10759198|NCT03110003|11922703|FG001|NOT COMPLETED|Overall Study||0
10759199|NCT03110029|11922711|FG000|STARTED|Overall Study||7
10759200|NCT03110029|11922712|FG001|STARTED|Overall Study||6
10759201|NCT03110029|11922711|FG000|COMPLETED|Overall Study||6
10759202|NCT03110029|11922712|FG001|COMPLETED|Overall Study||5
10759203|NCT03110029|11922711|FG000|NOT COMPLETED|Overall Study||1
10759204|NCT03110029|11922712|FG001|NOT COMPLETED|Overall Study||1
10759205|NCT03110185|11922720|FG000|STARTED|Overall Study||27
10759206|NCT03110185|11922721|FG001|STARTED|Overall Study||64
10759207|NCT03110185|11922720|FG000|COMPLETED|Overall Study||17
10759208|NCT03110185|11922721|FG001|COMPLETED|Overall Study||33
10759209|NCT03110185|11922720|FG000|NOT COMPLETED|Overall Study||10
10759210|NCT03110185|11922721|FG001|NOT COMPLETED|Overall Study||31
10759211|NCT03110458|11922733|FG000|STARTED|Overall Study||37
10759212|NCT03110458|11922734|FG001|STARTED|Overall Study||36
10759213|NCT03110458|11922735|FG002|STARTED|Overall Study||34
10759214|NCT03110458|11922733|FG000|COMPLETED|Overall Study||31
10759215|NCT03110458|11922734|FG001|COMPLETED|Overall Study||32
10759216|NCT03110458|11922735|FG002|COMPLETED|Overall Study||31
10759217|NCT03110458|11922733|FG000|NOT COMPLETED|Overall Study||6
10759218|NCT03110458|11922734|FG001|NOT COMPLETED|Overall Study||4
10759219|NCT03110458|11922735|FG002|NOT COMPLETED|Overall Study||3
10759220|NCT03110471|11922745|FG000|STARTED|Overall Study||30
10759221|NCT03110471|11922746|FG001|STARTED|Overall Study||30
10759222|NCT03110471|11922745|FG000|COMPLETED|Overall Study||30
10759223|NCT03110471|11922746|FG001|COMPLETED|Overall Study||30
10759224|NCT03110471|11922745|FG000|NOT COMPLETED|Overall Study||0
10759225|NCT03110471|11922746|FG001|NOT COMPLETED|Overall Study||0
10759226|NCT03110562|11922752|FG000|STARTED|Overall Study||195
10759227|NCT03110562|11922753|FG001|STARTED|Overall Study||207
10759228|NCT03110562|11922752|FG000|Treated|Overall Study||195
10759229|NCT03110562|11922753|FG001|Treated|Overall Study||204
10759230|NCT03110562|11922752|FG000|COMPLETED|Overall Study||0
10759231|NCT03110562|11922753|FG001|COMPLETED|Overall Study||0
10759232|NCT03110562|11922752|FG000|NOT COMPLETED|Overall Study||195
10759233|NCT03110562|11922753|FG001|NOT COMPLETED|Overall Study||207
10759234|NCT03110601|11922759|FG000|STARTED|Conventional SCS Parameters||25
10759235|NCT03110601|11922759|FG000|COMPLETED|Conventional SCS Parameters||24
10759236|NCT03110601|11922759|FG000|NOT COMPLETED|Conventional SCS Parameters||1
10759237|NCT03110601|11922759|FG000|STARTED|Washout Period||24
10759238|NCT03110601|11922759|FG000|COMPLETED|Washout Period||23
10759239|NCT03110601|11922759|FG000|NOT COMPLETED|Washout Period||1
10759240|NCT03110601|11922759|FG000|STARTED|Stimgenics SCS Parameters||23
10759241|NCT03110601|11922759|FG000|COMPLETED|Stimgenics SCS Parameters||20
10759242|NCT03110601|11922759|FG000|NOT COMPLETED|Stimgenics SCS Parameters||3
10759243|NCT03110692|11922768|FG000|STARTED|Overall Study||679
10759244|NCT03110692|11922769|FG001|STARTED|Overall Study||509
10759245|NCT03110692|11922768|FG000|COMPLETED|Overall Study||679
10759246|NCT03110692|11922769|FG001|COMPLETED|Overall Study||509
10759247|NCT03110692|11922768|FG000|NOT COMPLETED|Overall Study||0
10759248|NCT03110692|11922769|FG001|NOT COMPLETED|Overall Study||0
10759249|NCT03110770|11922780|FG000|STARTED|Overall Study||30
10759250|NCT03110770|11922781|FG001|STARTED|Overall Study||30
10759251|NCT03110770|11922782|FG002|STARTED|Overall Study||30
10759252|NCT03110770|11922783|FG003|STARTED|Overall Study||1170
10759253|NCT03110770|11922784|FG004|STARTED|Overall Study||1168
10759254|NCT03110770|11922780|FG000|Received First Product Administration|Overall Study||30
10759255|NCT03110770|11922781|FG001|Received First Product Administration|Overall Study||30
10759256|NCT03110770|11922782|FG002|Received First Product Administration|Overall Study||30
10759257|NCT03110770|11922783|FG003|Received First Product Administration|Overall Study||1162
10759258|NCT03110770|11922784|FG004|Received First Product Administration|Overall Study||1161
10759259|NCT03110770|11922780|FG000|Received Second Product Administration|Overall Study||30
10759260|NCT03110770|11922781|FG001|Received Second Product Administration|Overall Study||29
10759261|NCT03110770|11922782|FG002|Received Second Product Administration|Overall Study||29
10759262|NCT03110770|11922783|FG003|Received Second Product Administration|Overall Study||1126
10759263|NCT03110770|11922784|FG004|Received Second Product Administration|Overall Study||1127
10759264|NCT03110770|11922780|FG000|Received Third Product Administration|Overall Study||29
10759265|NCT03110770|11922781|FG001|Received Third Product Administration|Overall Study||27
10759266|NCT03110770|11922782|FG002|Received Third Product Administration|Overall Study||28
10759267|NCT03110770|11922783|FG003|Received Third Product Administration|Overall Study||1107
10759268|NCT03110770|11922784|FG004|Received Third Product Administration|Overall Study||1107
10759269|NCT03110770|11922780|FG000|COMPLETED|Overall Study||24
10759270|NCT03110770|11922781|FG001|COMPLETED|Overall Study||30
10759271|NCT03110770|11922782|FG002|COMPLETED|Overall Study||28
10759272|NCT03110770|11922783|FG003|COMPLETED|Overall Study||1037
10759273|NCT03110770|11922784|FG004|COMPLETED|Overall Study||1045
10759274|NCT03110770|11922780|FG000|NOT COMPLETED|Overall Study||6
10759275|NCT03110770|11922781|FG001|NOT COMPLETED|Overall Study||0
10759276|NCT03110770|11922782|FG002|NOT COMPLETED|Overall Study||2
10759277|NCT03110770|11922783|FG003|NOT COMPLETED|Overall Study||133
10759278|NCT03110770|11922784|FG004|NOT COMPLETED|Overall Study||123
10759279|NCT03111108|11922800|FG000|STARTED|Overall Study||53
10759280|NCT03111108|11922801|FG001|STARTED|Overall Study||64
10759281|NCT03111108|11922800|FG000|COMPLETED|Overall Study||52
10759282|NCT03111108|11922801|FG001|COMPLETED|Overall Study||63
10759283|NCT03111108|11922800|FG000|NOT COMPLETED|Overall Study||1
10314976|NCT00171249|11448711|FG004|NOT COMPLETED|Overall Study||3
10759284|NCT03111108|11922801|FG001|NOT COMPLETED|Overall Study||1
10759285|NCT03111316|11922811|FG000|STARTED|Overall Study||26
10759286|NCT03111316|11922812|FG001|STARTED|Overall Study||24
10759287|NCT03111316|11922813|FG002|STARTED|Overall Study||25
10759288|NCT03111316|11922814|FG003|STARTED|Overall Study||25
10759289|NCT03111316|11922811|FG000|COMPLETED|Overall Study||26
10759290|NCT03111316|11922812|FG001|COMPLETED|Overall Study||24
10759291|NCT03111316|11922813|FG002|COMPLETED|Overall Study||25
10759292|NCT03111316|11922814|FG003|COMPLETED|Overall Study||25
10759293|NCT03111316|11922811|FG000|NOT COMPLETED|Overall Study||0
10759294|NCT03111316|11922812|FG001|NOT COMPLETED|Overall Study||0
10759295|NCT03111316|11922813|FG002|NOT COMPLETED|Overall Study||0
10759296|NCT03111316|11922814|FG003|NOT COMPLETED|Overall Study||0
10759297|NCT03111381|11922826|FG000|STARTED|Overall Study||46
10759298|NCT03111381|11922827|FG001|STARTED|Overall Study||48
10759299|NCT03111381|11922826|FG000|COMPLETED|Overall Study||46
10759300|NCT03111381|11922827|FG001|COMPLETED|Overall Study||48
10759301|NCT03111381|11922826|FG000|NOT COMPLETED|Overall Study||0
10759302|NCT03111381|11922827|FG001|NOT COMPLETED|Overall Study||0
10759303|NCT03111407|11922835|FG000|STARTED|Overall Study||45
10759304|NCT03111407|11922836|FG001|STARTED|Overall Study||27
10759305|NCT03111407|11922835|FG000|COMPLETED|Overall Study||44
10759306|NCT03111407|11922836|FG001|COMPLETED|Overall Study||26
10759307|NCT03111407|11922835|FG000|NOT COMPLETED|Overall Study||1
10759308|NCT03111407|11922836|FG001|NOT COMPLETED|Overall Study||1
10759309|NCT03111550|11922846|FG000|STARTED|Overall Study|First eye|77
10759310|NCT03111550|11922847|FG001|STARTED|Overall Study|First eye|73
10759311|NCT03111550|11922848|FG002|STARTED|Overall Study|First eye|79
10759312|NCT03111550|11922846|FG000|COMPLETED|Overall Study||73
10759313|NCT03111550|11922847|FG001|COMPLETED|Overall Study||71
10759314|NCT03111550|11922848|FG002|COMPLETED|Overall Study||76
10759315|NCT03111550|11922846|FG000|NOT COMPLETED|Overall Study||4
10759316|NCT03111550|11922847|FG001|NOT COMPLETED|Overall Study||2
10759317|NCT03111550|11922848|FG002|NOT COMPLETED|Overall Study||3
10759318|NCT03111628|11922856|FG000|STARTED|Overall Study||18
10759319|NCT03111628|11922856|FG000|COMPLETED|Overall Study||18
10759320|NCT03111628|11922856|FG000|NOT COMPLETED|Overall Study||0
10759321|NCT03111940|11922863|FG000|STARTED|Overall Study||21
10759322|NCT03111940|11922864|FG001|STARTED|Overall Study||14
10759323|NCT03111940|11922863|FG000|COMPLETED|Overall Study||21
10759324|NCT03111940|11922864|FG001|COMPLETED|Overall Study||14
10759325|NCT03111940|11922863|FG000|NOT COMPLETED|Overall Study||0
10759326|NCT03111940|11922864|FG001|NOT COMPLETED|Overall Study||0
10759327|NCT03112473|11922876|FG000|STARTED|Overall Study||30
10759328|NCT03112473|11922877|FG001|STARTED|Overall Study||30
10759329|NCT03112473|11922878|FG002|STARTED|Overall Study||30
10759330|NCT03112473|11922879|FG003|STARTED|Overall Study||30
10759331|NCT03112473|11922876|FG000|COMPLETED|Overall Study||30
10759332|NCT03112473|11922877|FG001|COMPLETED|Overall Study||30
10759333|NCT03112473|11922878|FG002|COMPLETED|Overall Study||30
10759334|NCT03112473|11922879|FG003|COMPLETED|Overall Study||30
10759335|NCT03112473|11922876|FG000|NOT COMPLETED|Overall Study||0
10759336|NCT03112473|11922877|FG001|NOT COMPLETED|Overall Study||0
10759337|NCT03112473|11922878|FG002|NOT COMPLETED|Overall Study||0
10759338|NCT03112473|11922879|FG003|NOT COMPLETED|Overall Study||0
10759339|NCT03112863|11922894|FG000|STARTED|Overall Study||21
10759340|NCT03112863|11922895|FG001|STARTED|Overall Study||23
10759341|NCT03112863|11922894|FG000|COMPLETED|Overall Study||21
10759342|NCT03112863|11922895|FG001|COMPLETED|Overall Study||23
10759343|NCT03112863|11922894|FG000|NOT COMPLETED|Overall Study||0
10759344|NCT03112863|11922895|FG001|NOT COMPLETED|Overall Study||0
10759345|NCT03113656|11922903|FG000|STARTED|Overall Study||9
10759346|NCT03113656|11922904|FG001|STARTED|Overall Study||7
10759347|NCT03113656|11922903|FG000|COMPLETED|Overall Study||9
10759348|NCT03113656|11922904|FG001|COMPLETED|Overall Study||7
10759349|NCT03113656|11922903|FG000|NOT COMPLETED|Overall Study||0
10759350|NCT03113656|11922904|FG001|NOT COMPLETED|Overall Study||0
10759351|NCT03113916|11922912|FG000|STARTED|Overall Study||99
10759352|NCT03113916|11922913|FG001|STARTED|Overall Study||96
10759353|NCT03113916|11922912|FG000|COMPLETED|Overall Study||88
10759354|NCT03113916|11922913|FG001|COMPLETED|Overall Study||84
10759355|NCT03113916|11922912|FG000|NOT COMPLETED|Overall Study||11
10759356|NCT03113916|11922913|FG001|NOT COMPLETED|Overall Study||12
10759357|NCT03114124|11922926|FG000|STARTED|Overall Study||15
10759358|NCT03114124|11922927|FG001|STARTED|Overall Study||15
10759359|NCT03114124|11922926|FG000|COMPLETED|Overall Study||15
10759360|NCT03114124|11922927|FG001|COMPLETED|Overall Study||15
10759361|NCT03114124|11922926|FG000|NOT COMPLETED|Overall Study||0
10759362|NCT03114124|11922927|FG001|NOT COMPLETED|Overall Study||0
10759363|NCT03114488|11922933|FG000|STARTED|Time Period 1||19
10759364|NCT03114488|11922934|FG001|STARTED|Time Period 1||22
10759365|NCT03114488|11922933|FG000|COMPLETED|Time Period 1||19
10759366|NCT03114488|11922934|FG001|COMPLETED|Time Period 1||22
10759367|NCT03114488|11922933|FG000|NOT COMPLETED|Time Period 1||0
10759368|NCT03114488|11922934|FG001|NOT COMPLETED|Time Period 1||0
10759369|NCT03114488|11922933|FG000|STARTED|Time Period 2||19
10759370|NCT03114488|11922934|FG001|STARTED|Time Period 2||22
10759371|NCT03114488|11922933|FG000|COMPLETED|Time Period 2||18
10759372|NCT03114488|11922934|FG001|COMPLETED|Time Period 2||19
10759373|NCT03114488|11922933|FG000|NOT COMPLETED|Time Period 2||1
10759374|NCT03114488|11922934|FG001|NOT COMPLETED|Time Period 2||3
10759375|NCT03114657|11922946|FG000|STARTED|Overall Study||399
10759376|NCT03114657|11922947|FG001|STARTED|Overall Study||407
10759377|NCT03114657|11922946|FG000|COMPLETED|Overall Study||0
10759378|NCT03114657|11922947|FG001|COMPLETED|Overall Study||0
10759379|NCT03114657|11922946|FG000|NOT COMPLETED|Overall Study||399
10759380|NCT03114657|11922947|FG001|NOT COMPLETED|Overall Study||407
10759381|NCT03114683|11922954|FG000|STARTED|Overall Study||96
10759382|NCT03114683|11922954|FG000|COMPLETED|Overall Study||52
10759383|NCT03114683|11922954|FG000|NOT COMPLETED|Overall Study||44
10759384|NCT03114969|11922967|FG000|STARTED|Overall Study||50
10759385|NCT03114969|11922968|FG001|STARTED|Overall Study||50
10759386|NCT03114969|11922969|FG002|STARTED|Overall Study||50
10759387|NCT03114969|11922970|FG003|STARTED|Overall Study||50
10759388|NCT03114969|11922971|FG004|STARTED|Overall Study||51
10759389|NCT03114969|11922972|FG005|STARTED|Overall Study||49
10759390|NCT03114969|11922973|FG006|STARTED|Overall Study||50
10759391|NCT03114969|11922974|FG007|STARTED|Overall Study||50
10759392|NCT03114969|11922975|FG008|STARTED|Overall Study||50
10759393|NCT03114969|11922967|FG000|COMPLETED|Overall Study||50
10759394|NCT03114969|11922968|FG001|COMPLETED|Overall Study||50
10759395|NCT03114969|11922969|FG002|COMPLETED|Overall Study||46
10759396|NCT03114969|11922970|FG003|COMPLETED|Overall Study||48
10759397|NCT03114969|11922971|FG004|COMPLETED|Overall Study||51
10759398|NCT03114969|11922972|FG005|COMPLETED|Overall Study||48
10759399|NCT03114969|11922973|FG006|COMPLETED|Overall Study||49
10759400|NCT03114969|11922974|FG007|COMPLETED|Overall Study||50
10759401|NCT03114969|11922975|FG008|COMPLETED|Overall Study||48
10759402|NCT03114969|11922967|FG000|NOT COMPLETED|Overall Study||0
10759403|NCT03114969|11922968|FG001|NOT COMPLETED|Overall Study||0
10759404|NCT03114969|11922969|FG002|NOT COMPLETED|Overall Study||4
10759405|NCT03114969|11922970|FG003|NOT COMPLETED|Overall Study||2
10759406|NCT03114969|11922971|FG004|NOT COMPLETED|Overall Study||0
10759407|NCT03114969|11922972|FG005|NOT COMPLETED|Overall Study||1
10759408|NCT03114969|11922973|FG006|NOT COMPLETED|Overall Study||1
10759409|NCT03114969|11922974|FG007|NOT COMPLETED|Overall Study||0
10759410|NCT03114969|11922975|FG008|NOT COMPLETED|Overall Study||2
10759411|NCT03114995|11923005|FG000|STARTED|Overall Study||31
10759412|NCT03114995|11923006|FG001|STARTED|Overall Study||31
10759413|NCT03114995|11923007|FG002|STARTED|Overall Study||78
10759414|NCT03114995|11923005|FG000|COMPLETED|Overall Study||30
10759415|NCT03114995|11923006|FG001|COMPLETED|Overall Study||30
10759416|NCT03114995|11923007|FG002|COMPLETED|Overall Study||78
10759417|NCT03114995|11923005|FG000|NOT COMPLETED|Overall Study||1
10759418|NCT03114995|11923006|FG001|NOT COMPLETED|Overall Study||1
10759419|NCT03114995|11923007|FG002|NOT COMPLETED|Overall Study||0
10759420|NCT03115112|11923017|FG000|STARTED|Overall Study||192
10759421|NCT03115112|11923018|FG001|STARTED|Overall Study||194
10759422|NCT03115112|11923017|FG000|Intention-to-treat|Overall Study||191
10759423|NCT03115112|11923018|FG001|Intention-to-treat|Overall Study||193
10759424|NCT03115112|11923017|FG000|COMPLETED|Overall Study||180
10759425|NCT03115112|11923018|FG001|COMPLETED|Overall Study||189
10759426|NCT03115112|11923017|FG000|NOT COMPLETED|Overall Study||12
10759427|NCT03115112|11923018|FG001|NOT COMPLETED|Overall Study||5
10759428|NCT03115177|11923028|FG000|STARTED|Overall Study||27
10759429|NCT03115177|11923029|FG001|STARTED|Overall Study||29
10759430|NCT03115177|11923028|FG000|COMPLETED|Overall Study||27
10759431|NCT03115177|11923029|FG001|COMPLETED|Overall Study||29
10759432|NCT03115177|11923028|FG000|NOT COMPLETED|Overall Study||0
10759433|NCT03115177|11923029|FG001|NOT COMPLETED|Overall Study||0
10759434|NCT03115411|11923035|FG000|STARTED|Overall Study||23
10759435|NCT03115411|11923035|FG000|COMPLETED|Overall Study||23
10759436|NCT03115411|11923035|FG000|NOT COMPLETED|Overall Study||0
10759437|NCT03115476|11923042|FG000|STARTED|Main Trials (LP0084-119x)||407
10759438|NCT03115476|11923043|FG001|STARTED|Main Trials (LP0084-119x)||418
10759439|NCT03115476|11923044|FG002|STARTED|Main Trials (LP0084-119x)||409
10759440|NCT03115476|11923042|FG000|COMPLETED|Main Trials (LP0084-119x)||407
10759441|NCT03115476|11923043|FG001|COMPLETED|Main Trials (LP0084-119x)||418
10759442|NCT03115476|11923044|FG002|COMPLETED|Main Trials (LP0084-119x)||409
10759443|NCT03115476|11923042|FG000|NOT COMPLETED|Main Trials (LP0084-119x)||0
10759444|NCT03115476|11923043|FG001|NOT COMPLETED|Main Trials (LP0084-119x)||0
10759445|NCT03115476|11923044|FG002|NOT COMPLETED|Main Trials (LP0084-119x)||0
10759446|NCT03115476|11923042|FG000|STARTED|LP0084-1369||191
10759447|NCT03115476|11923043|FG001|STARTED|LP0084-1369||210
10759448|NCT03115476|11923044|FG002|STARTED|LP0084-1369||162
10759449|NCT03115476|11923042|FG000|COMPLETED|LP0084-1369|Trial was terminated by sponsor|0
10759450|NCT03115476|11923043|FG001|COMPLETED|LP0084-1369|Trial was terminated by sponsor|0
10759451|NCT03115476|11923044|FG002|COMPLETED|LP0084-1369|Trial was terminated by sponsor|0
10759452|NCT03115476|11923042|FG000|NOT COMPLETED|LP0084-1369||191
10759453|NCT03115476|11923043|FG001|NOT COMPLETED|LP0084-1369||210
10759454|NCT03115476|11923044|FG002|NOT COMPLETED|LP0084-1369||162
10759455|NCT03115580|11923054|FG000|STARTED|Overall Study||35
10759456|NCT03115580|11923055|FG001|STARTED|Overall Study||36
10759457|NCT03115580|11923054|FG000|COMPLETED|Overall Study||35
10759458|NCT03115580|11923055|FG001|COMPLETED|Overall Study||36
10759459|NCT03115580|11923054|FG000|NOT COMPLETED|Overall Study||0
10759460|NCT03115580|11923055|FG001|NOT COMPLETED|Overall Study||0
10759461|NCT03115801|11923063|FG000|STARTED|Overall Study||4
10759462|NCT03115801|11923064|FG001|STARTED|Overall Study||2
10759463|NCT03115801|11923063|FG000|COMPLETED|Overall Study||1
10759464|NCT03115801|11923064|FG001|COMPLETED|Overall Study||0
10759465|NCT03115801|11923063|FG000|NOT COMPLETED|Overall Study||3
10759466|NCT03115801|11923064|FG001|NOT COMPLETED|Overall Study||2
10759467|NCT03115827|11923070|FG000|STARTED|Overall Study||15
10759468|NCT03115827|11923070|FG000|COMPLETED|Overall Study||12
10759469|NCT03115827|11923070|FG000|NOT COMPLETED|Overall Study||3
10759470|NCT03116152|11923076|FG000|STARTED|Overall Study||95
10759471|NCT03116152|11923077|FG001|STARTED|Overall Study||95
10759472|NCT03116152|11923076|FG000|Treated|Overall Study||94
10759473|NCT03116152|11923077|FG001|Treated|Overall Study||87
10759474|NCT03116152|11923076|FG000|COMPLETED|Overall Study||4
10759475|NCT03116152|11923077|FG001|COMPLETED|Overall Study||0
10759476|NCT03116152|11923076|FG000|NOT COMPLETED|Overall Study||91
10759477|NCT03116152|11923077|FG001|NOT COMPLETED|Overall Study||95
10759478|NCT03116230|11923085|FG000|STARTED|Overall Study||19
10759479|NCT03116230|11923086|FG001|STARTED|Overall Study||19
10759480|NCT03116230|11923085|FG000|COMPLETED|Overall Study||15
10759481|NCT03116230|11923086|FG001|COMPLETED|Overall Study||17
10759482|NCT03116230|11923085|FG000|NOT COMPLETED|Overall Study||4
10759483|NCT03116230|11923086|FG001|NOT COMPLETED|Overall Study||2
10759484|NCT03116698|11923096|FG000|STARTED|Overall Study||62
10759485|NCT03116698|11923097|FG001|STARTED|Overall Study||57
10759486|NCT03116698|11923098|FG002|STARTED|Overall Study||62
10759487|NCT03116698|11923099|FG003|STARTED|Overall Study||57
10759488|NCT03116698|11923096|FG000|COMPLETED|Overall Study||56
10759489|NCT03116698|11923097|FG001|COMPLETED|Overall Study||51
10759490|NCT03116698|11923098|FG002|COMPLETED|Overall Study||54
10759491|NCT03116698|11923099|FG003|COMPLETED|Overall Study||55
10759492|NCT03116698|11923096|FG000|NOT COMPLETED|Overall Study||6
10759493|NCT03116698|11923097|FG001|NOT COMPLETED|Overall Study||6
10759494|NCT03116698|11923098|FG002|NOT COMPLETED|Overall Study||8
10759495|NCT03116698|11923099|FG003|NOT COMPLETED|Overall Study||2
10759496|NCT03116828|11923111|FG000|STARTED|Overall Study||44
10759497|NCT03116828|11923112|FG001|STARTED|Overall Study||58
10759498|NCT03116828|11923111|FG000|COMPLETED|Overall Study||36
10759499|NCT03116828|11923112|FG001|COMPLETED|Overall Study||37
10759500|NCT03116828|11923111|FG000|NOT COMPLETED|Overall Study||8
10759501|NCT03116828|11923112|FG001|NOT COMPLETED|Overall Study||21
10759502|NCT03116841|11923118|FG000|STARTED|Overall Study||3
10759503|NCT03116841|11923118|FG000|COMPLETED|Overall Study||3
10759504|NCT03116841|11923118|FG000|NOT COMPLETED|Overall Study||0
10759505|NCT03117140|11923126|FG000|STARTED|Overall Study||40
10759506|NCT03117140|11923127|FG001|STARTED|Overall Study||40
10759507|NCT03117140|11923128|FG002|STARTED|Overall Study||40
10759508|NCT03117140|11923129|FG003|STARTED|Overall Study||40
10759509|NCT03117140|11923126|FG000|COMPLETED|Overall Study||40
10759510|NCT03117140|11923127|FG001|COMPLETED|Overall Study||40
10759511|NCT03117140|11923128|FG002|COMPLETED|Overall Study||40
10759512|NCT03117140|11923129|FG003|COMPLETED|Overall Study||40
10759513|NCT03117140|11923126|FG000|NOT COMPLETED|Overall Study||0
10759514|NCT03117140|11923127|FG001|NOT COMPLETED|Overall Study||0
10759515|NCT03117140|11923128|FG002|NOT COMPLETED|Overall Study||0
10759516|NCT03117140|11923129|FG003|NOT COMPLETED|Overall Study||0
10759517|NCT03117361|11923142|FG000|STARTED|Overall Study||10
10759518|NCT03117361|11923142|FG000|COMPLETED|Overall Study||0
10759519|NCT03117361|11923142|FG000|NOT COMPLETED|Overall Study||10
10759520|NCT03117517|11923148|FG000|STARTED|Overall Study||53
10759521|NCT03117517|11923149|FG001|STARTED|Overall Study||53
10759522|NCT03117517|11923148|FG000|COMPLETED|Overall Study||48
10759523|NCT03117517|11923149|FG001|COMPLETED|Overall Study||49
10759524|NCT03117517|11923148|FG000|NOT COMPLETED|Overall Study||5
10759525|NCT03117517|11923149|FG001|NOT COMPLETED|Overall Study||4
10759526|NCT03117569|11923161|FG000|STARTED|Overall Study||127
10759527|NCT03117569|11923162|FG001|STARTED|Overall Study||253
10759528|NCT03117569|11923161|FG000|COMPLETED|Overall Study||123
10759529|NCT03117569|11923162|FG001|COMPLETED|Overall Study||241
10759530|NCT03117569|11923161|FG000|NOT COMPLETED|Overall Study||4
10759531|NCT03117569|11923162|FG001|NOT COMPLETED|Overall Study||12
10759532|NCT03117634|11923174|FG000|STARTED|Overall Study||41
10759533|NCT03117634|11923175|FG001|STARTED|Overall Study||13
10759534|NCT03117634|11923174|FG000|COMPLETED|Overall Study||39
10759535|NCT03117634|11923175|FG001|COMPLETED|Overall Study||13
10759536|NCT03117634|11923174|FG000|NOT COMPLETED|Overall Study||2
10759537|NCT03117634|11923175|FG001|NOT COMPLETED|Overall Study||0
10759538|NCT03117738|11923183|FG000|STARTED|Overall Study||11
10759539|NCT03117738|11923184|FG001|STARTED|Overall Study||10
10759540|NCT03117738|11923183|FG000|COMPLETED|Overall Study||7
10759541|NCT03117738|11923184|FG001|COMPLETED|Overall Study||5
10759542|NCT03117738|11923183|FG000|NOT COMPLETED|Overall Study||4
10759543|NCT03117738|11923184|FG001|NOT COMPLETED|Overall Study||5
10759544|NCT03118297|11923192|FG000|STARTED|Overall Study||32
10759545|NCT03118297|11923193|FG001|STARTED|Overall Study||33
10759546|NCT03118297|11923192|FG000|COMPLETED|Overall Study||32
10759547|NCT03118297|11923193|FG001|COMPLETED|Overall Study||31
10759548|NCT03118297|11923192|FG000|NOT COMPLETED|Overall Study||0
10759549|NCT03118297|11923193|FG001|NOT COMPLETED|Overall Study||2
10759550|NCT03118466|11923199|FG000|STARTED|Overall Study||40
10874675|NCT02706847|12040858|FG000|STARTED|Day 1 to Week 12||85
10874676|NCT02706847|12040859|FG001|STARTED|Day 1 to Week 12||84
10759551|NCT03118466|11923199|FG000|COMPLETED|Overall Study||40
10759552|NCT03118466|11923199|FG000|NOT COMPLETED|Overall Study||0
10759553|NCT03118518|11923205|FG000|STARTED|Overall Study||108
10759554|NCT03118518|11923206|FG001|STARTED|Overall Study||102
10759555|NCT03118518|11923205|FG000|Subject Treated According to Randomization Assignment|Overall Study||104
10759556|NCT03118518|11923206|FG001|Subject Treated According to Randomization Assignment|Overall Study||99
10759557|NCT03118518|11923205|FG000|COMPLETED|Overall Study||102
10759558|NCT03118518|11923206|FG001|COMPLETED|Overall Study||91
10874677|NCT02706847|12040860|FG002|STARTED|Day 1 to Week 12||165
10759559|NCT03118518|11923205|FG000|NOT COMPLETED|Overall Study||6
10759560|NCT03118518|11923206|FG001|NOT COMPLETED|Overall Study||11
10759561|NCT03118596|11923214|FG000|STARTED|Overall Study||90
10759562|NCT03118596|11923215|FG001|STARTED|Overall Study||90
10759563|NCT03118596|11923214|FG000|Treated|Overall Study||2
10759564|NCT03118596|11923215|FG001|Treated|Overall Study||0
10759565|NCT03118596|11923214|FG000|Failed|Overall Study||0
10759566|NCT03118596|11923215|FG001|Failed|Overall Study||4
10759567|NCT03118596|11923214|FG000|COMPLETED|Overall Study||90
10759568|NCT03118596|11923215|FG001|COMPLETED|Overall Study||86
10759569|NCT03118596|11923214|FG000|NOT COMPLETED|Overall Study||0
10759570|NCT03118596|11923215|FG001|NOT COMPLETED|Overall Study||4
10759571|NCT03118739|11923223|FG000|STARTED|Overall Study||32
10759572|NCT03118739|11923224|FG001|STARTED|Overall Study||28
10759573|NCT03118739|11923223|FG000|Completed 12 Weeks of Treatment|Overall Study||26
10759574|NCT03118739|11923224|FG001|Completed 12 Weeks of Treatment|Overall Study||25
10759575|NCT03118739|11923223|FG000|Completed 24 Weeks of Treatment|Overall Study||24
10759576|NCT03118739|11923224|FG001|Completed 24 Weeks of Treatment|Overall Study||25
10759577|NCT03118739|11923223|FG000|COMPLETED|Overall Study||25
10759578|NCT03118739|11923224|FG001|COMPLETED|Overall Study||24
10759579|NCT03118739|11923223|FG000|NOT COMPLETED|Overall Study||7
10759580|NCT03118739|11923224|FG001|NOT COMPLETED|Overall Study||4
10759581|NCT03118765|11923235|FG000|STARTED|Overall Study||30
10759582|NCT03118765|11923236|FG001|STARTED|Overall Study||32
10759583|NCT03118765|11923237|FG002|STARTED|Overall Study||31
10759584|NCT03118765|11923238|FG003|STARTED|Overall Study||32
10759585|NCT03118765|11923239|FG004|STARTED|Overall Study||30
10759586|NCT03118765|11923235|FG000|COMPLETED|Overall Study||26
10759587|NCT03118765|11923236|FG001|COMPLETED|Overall Study||30
10759588|NCT03118765|11923237|FG002|COMPLETED|Overall Study||26
10759589|NCT03118765|11923238|FG003|COMPLETED|Overall Study||29
10759590|NCT03118765|11923239|FG004|COMPLETED|Overall Study||28
10759591|NCT03118765|11923235|FG000|NOT COMPLETED|Overall Study||4
10759592|NCT03118765|11923236|FG001|NOT COMPLETED|Overall Study||2
10759593|NCT03118765|11923237|FG002|NOT COMPLETED|Overall Study||5
10759594|NCT03118765|11923238|FG003|NOT COMPLETED|Overall Study||3
10759595|NCT03118765|11923239|FG004|NOT COMPLETED|Overall Study||2
10778930|NCT03362944|11940739|FG001|NOT COMPLETED|Single Week Washout Period||0
10778931|NCT03362944|11940738|FG000|STARTED|Second Intervention||8
10778932|NCT03362944|11940739|FG001|STARTED|Second Intervention||8
10778933|NCT03362944|11940738|FG000|COMPLETED|Second Intervention||8
10778934|NCT03362944|11940739|FG001|COMPLETED|Second Intervention||8
10778935|NCT03362944|11940738|FG000|NOT COMPLETED|Second Intervention||0
10778936|NCT03362944|11940739|FG001|NOT COMPLETED|Second Intervention||0
10778937|NCT03362957|11940747|FG000|STARTED|Overall Study||14
10778938|NCT03362957|11940748|FG001|STARTED|Overall Study||7
10778939|NCT03362957|11940747|FG000|Crossover to Receive GAE Procedure|Overall Study||0
10778940|NCT03362957|11940748|FG001|Crossover to Receive GAE Procedure|Overall Study||7
10778941|NCT03362957|11940747|FG000|COMPLETED|Overall Study||14
10778942|NCT03362957|11940748|FG001|COMPLETED|Overall Study||7
10778943|NCT03362957|11940747|FG000|NOT COMPLETED|Overall Study||0
10778944|NCT03362957|11940748|FG001|NOT COMPLETED|Overall Study||0
10778945|NCT03363321|11940761|FG000|STARTED|Overall Study||5
10778946|NCT03363321|11940762|FG001|STARTED|Overall Study||4
10778947|NCT03363321|11940763|FG002|STARTED|Overall Study||4
10778948|NCT03363321|11940764|FG003|STARTED|Overall Study||5
10778949|NCT03363321|11940765|FG004|STARTED|Overall Study||2
10778950|NCT03363321|11940761|FG000|COMPLETED|Overall Study||5
10778951|NCT03363321|11940762|FG001|COMPLETED|Overall Study||3
10778952|NCT03363321|11940763|FG002|COMPLETED|Overall Study||4
10778953|NCT03363321|11940764|FG003|COMPLETED|Overall Study||4
10778954|NCT03363321|11940765|FG004|COMPLETED|Overall Study||2
10778955|NCT03363321|11940761|FG000|NOT COMPLETED|Overall Study||0
10778956|NCT03363321|11940762|FG001|NOT COMPLETED|Overall Study||1
10778957|NCT03363321|11940763|FG002|NOT COMPLETED|Overall Study||0
10778958|NCT03363321|11940764|FG003|NOT COMPLETED|Overall Study||1
10778959|NCT03363321|11940765|FG004|NOT COMPLETED|Overall Study||0
10778960|NCT03363776|11940781|FG000|STARTED|Overall Study||4
10778961|NCT03363776|11940782|FG001|STARTED|Overall Study||3
10778962|NCT03363776|11940783|FG002|STARTED|Overall Study||3
10778963|NCT03363776|11940781|FG000|COMPLETED|Overall Study||1
10778964|NCT03363776|11940782|FG001|COMPLETED|Overall Study||0
10314977|NCT00171249|11448712|FG005|NOT COMPLETED|Overall Study||43
10778965|NCT03363776|11940783|FG002|COMPLETED|Overall Study||1
10778966|NCT03363776|11940781|FG000|NOT COMPLETED|Overall Study||3
10778967|NCT03363776|11940782|FG001|NOT COMPLETED|Overall Study||3
10778968|NCT03363776|11940783|FG002|NOT COMPLETED|Overall Study||2
10778969|NCT03363854|11940793|FG000|STARTED|Initial Treatment Period||253
10778970|NCT03363854|11940794|FG001|STARTED|Initial Treatment Period||127
10778971|NCT03363854|11940795|FG002|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0
10778972|NCT03363854|11940796|FG003|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0
10778973|NCT03363854|11940797|FG004|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0
10778974|NCT03363854|11940798|FG005|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0
10778975|NCT03363854|11940799|FG006|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0
10778976|NCT03363854|11940800|FG007|STARTED|Initial Treatment Period|This treatment group applies to the safety follow-up period (see below).|0
10759596|NCT03118843|11923252|FG000|STARTED|Overall Study||31
10759597|NCT03118843|11923252|FG000|COMPLETED|Overall Study||31
10759598|NCT03118843|11923252|FG000|NOT COMPLETED|Overall Study||0
10759599|NCT03118934|11923259|FG000|STARTED|Overall Study||34
10759600|NCT03118934|11923260|FG001|STARTED|Overall Study||31
10759601|NCT03118934|11923261|FG002|STARTED|Overall Study||34
10759602|NCT03118934|11923262|FG003|STARTED|Overall Study||29
10759603|NCT03118934|11923263|FG004|STARTED|Overall Study||29
10759604|NCT03118934|11923264|FG005|STARTED|Overall Study||25
10759605|NCT03118934|11923259|FG000|Safety Analysis Set|Overall Study||34
10759606|NCT03118934|11923260|FG001|Safety Analysis Set|Overall Study||29
10759607|NCT03118934|11923261|FG002|Safety Analysis Set|Overall Study||34
10759608|NCT03118934|11923262|FG003|Safety Analysis Set|Overall Study||29
10759609|NCT03118934|11923263|FG004|Safety Analysis Set|Overall Study||26
10759610|NCT03118934|11923264|FG005|Safety Analysis Set|Overall Study||25
10874678|NCT02706847|12040861|FG003|STARTED|Day 1 to Week 12||165
10874679|NCT02706847|12040858|FG000|Received Study Treatment|Day 1 to Week 12||85
10874680|NCT02706847|12040859|FG001|Received Study Treatment|Day 1 to Week 12||84
10874681|NCT02706847|12040860|FG002|Received Study Treatment|Day 1 to Week 12||164
10874682|NCT02706847|12040861|FG003|Received Study Treatment|Day 1 to Week 12||165
10874683|NCT02706847|12040858|FG000|COMPLETED|Day 1 to Week 12||75
10874684|NCT02706847|12040859|FG001|COMPLETED|Day 1 to Week 12||76
10874685|NCT02706847|12040860|FG002|COMPLETED|Day 1 to Week 12||157
10874686|NCT02706847|12040861|FG003|COMPLETED|Day 1 to Week 12||149
10874687|NCT02706847|12040858|FG000|NOT COMPLETED|Day 1 to Week 12||10
10874688|NCT02706847|12040859|FG001|NOT COMPLETED|Day 1 to Week 12||8
10874689|NCT02706847|12040860|FG002|NOT COMPLETED|Day 1 to Week 12||8
10874690|NCT02706847|12040861|FG003|NOT COMPLETED|Day 1 to Week 12||16
10874691|NCT02706847|12040858|FG000|STARTED|Week 12 to Week 24||75
10874692|NCT02706847|12040859|FG001|STARTED|Week 12 to Week 24||76
10874693|NCT02706847|12040860|FG002|STARTED|Week 12 to Week 24||157
10874694|NCT02706847|12040861|FG003|STARTED|Week 12 to Week 24||149
10874695|NCT02706847|12040858|FG000|Received Study Treatment|Week 12 to Week 24||72
10874696|NCT02706847|12040859|FG001|Received Study Treatment|Week 12 to Week 24||75
10874697|NCT02706847|12040860|FG002|Received Study Treatment|Week 12 to Week 24||156
10874698|NCT02706847|12040861|FG003|Received Study Treatment|Week 12 to Week 24||148
10874699|NCT02706847|12040858|FG000|COMPLETED|Week 12 to Week 24||72
10874700|NCT02706847|12040859|FG001|COMPLETED|Week 12 to Week 24||74
10874701|NCT02706847|12040860|FG002|COMPLETED|Week 12 to Week 24||153
10874702|NCT02706847|12040861|FG003|COMPLETED|Week 12 to Week 24||135
10874703|NCT02706847|12040858|FG000|NOT COMPLETED|Week 12 to Week 24||3
10874704|NCT02706847|12040859|FG001|NOT COMPLETED|Week 12 to Week 24||2
10874705|NCT02706847|12040860|FG002|NOT COMPLETED|Week 12 to Week 24||4
10874706|NCT02706847|12040861|FG003|NOT COMPLETED|Week 12 to Week 24||14
10874707|NCT02564900|12040886|FG000|STARTED|Dose Escalation||3
10874708|NCT02564900|12040887|FG001|STARTED|Dose Escalation||3
10874709|NCT02564900|12040888|FG002|STARTED|Dose Escalation||3
10874710|NCT02564900|12040889|FG003|STARTED|Dose Escalation||6
10874711|NCT02564900|12040890|FG004|STARTED|Dose Escalation||6
10874712|NCT02564900|12040891|FG005|STARTED|Dose Escalation||6
10874713|NCT02564900|12040892|FG006|STARTED|Dose Escalation||0
10874714|NCT02564900|12040893|FG007|STARTED|Dose Escalation||0
10874715|NCT02564900|12040894|FG008|STARTED|Dose Escalation||0
10874716|NCT02564900|12040895|FG009|STARTED|Dose Escalation||0
10874717|NCT02564900|12040896|FG010|STARTED|Dose Escalation||0
10874718|NCT02564900|12040897|FG011|STARTED|Dose Escalation||0
10874719|NCT02564900|12040898|FG012|STARTED|Dose Escalation||0
10874720|NCT02564900|12040899|FG013|STARTED|Dose Escalation||0
10874721|NCT02564900|12040900|FG014|STARTED|Dose Escalation||0
10874722|NCT02564900|12040886|FG000|COMPLETED|Dose Escalation||0
10874723|NCT02564900|12040887|FG001|COMPLETED|Dose Escalation||0
10874724|NCT02564900|12040888|FG002|COMPLETED|Dose Escalation||0
10874725|NCT02564900|12040889|FG003|COMPLETED|Dose Escalation||0
10874726|NCT02564900|12040890|FG004|COMPLETED|Dose Escalation||0
10874727|NCT02564900|12040891|FG005|COMPLETED|Dose Escalation||0
10874728|NCT02564900|12040892|FG006|COMPLETED|Dose Escalation||0
10759611|NCT03118934|11923259|FG000|COMPLETED|Overall Study||34
10759612|NCT03118934|11923260|FG001|COMPLETED|Overall Study||30
10759613|NCT03118934|11923261|FG002|COMPLETED|Overall Study||33
10759614|NCT03118934|11923262|FG003|COMPLETED|Overall Study||28
10759615|NCT03118934|11923263|FG004|COMPLETED|Overall Study||27
10759616|NCT03118934|11923264|FG005|COMPLETED|Overall Study||23
10759617|NCT03118934|11923259|FG000|NOT COMPLETED|Overall Study||0
10759618|NCT03118934|11923260|FG001|NOT COMPLETED|Overall Study||1
10759619|NCT03118934|11923261|FG002|NOT COMPLETED|Overall Study||1
10874729|NCT02564900|12040893|FG007|COMPLETED|Dose Escalation||0
10874730|NCT02564900|12040894|FG008|COMPLETED|Dose Escalation||0
10874731|NCT02564900|12040895|FG009|COMPLETED|Dose Escalation||0
10874732|NCT02564900|12040896|FG010|COMPLETED|Dose Escalation||0
10874733|NCT02564900|12040897|FG011|COMPLETED|Dose Escalation||0
10874734|NCT02564900|12040898|FG012|COMPLETED|Dose Escalation||0
10874735|NCT02564900|12040899|FG013|COMPLETED|Dose Escalation||0
10874736|NCT02564900|12040900|FG014|COMPLETED|Dose Escalation||0
10874737|NCT02564900|12040886|FG000|NOT COMPLETED|Dose Escalation||3
10874738|NCT02564900|12040887|FG001|NOT COMPLETED|Dose Escalation||3
10874739|NCT02564900|12040888|FG002|NOT COMPLETED|Dose Escalation||3
10874740|NCT02564900|12040889|FG003|NOT COMPLETED|Dose Escalation||6
10874741|NCT02564900|12040890|FG004|NOT COMPLETED|Dose Escalation||6
10874742|NCT02564900|12040891|FG005|NOT COMPLETED|Dose Escalation||6
10874743|NCT02564900|12040892|FG006|NOT COMPLETED|Dose Escalation||0
10874744|NCT02564900|12040893|FG007|NOT COMPLETED|Dose Escalation||0
10759620|NCT03118934|11923262|FG003|NOT COMPLETED|Overall Study||1
10759621|NCT03118934|11923263|FG004|NOT COMPLETED|Overall Study||2
10759622|NCT03118934|11923264|FG005|NOT COMPLETED|Overall Study||2
10759623|NCT03118947|11923274|FG000|STARTED|Overall Study||78
10759624|NCT03118947|11923274|FG000|COMPLETED|Overall Study||49
10759625|NCT03118947|11923274|FG000|NOT COMPLETED|Overall Study||29
10759626|NCT03119025|11923278|FG000|STARTED|Overall Study||10
10759627|NCT03119025|11923278|FG000|COMPLETED|Overall Study||10
10759628|NCT03119025|11923278|FG000|NOT COMPLETED|Overall Study||0
10759629|NCT03119168|11923284|FG000|STARTED|Overall Study||129
10759630|NCT03119168|11923285|FG001|STARTED|Overall Study||139
10759631|NCT03119168|11923284|FG000|COMPLETED|Overall Study||129
10759632|NCT03119168|11923285|FG001|COMPLETED|Overall Study||139
10759633|NCT03119168|11923284|FG000|NOT COMPLETED|Overall Study||0
10759634|NCT03119168|11923285|FG001|NOT COMPLETED|Overall Study||0
10759635|NCT03119181|11923295|FG000|STARTED|Overall Study||19
10759636|NCT03119181|11923296|FG001|STARTED|Overall Study||21
10759637|NCT03119181|11923295|FG000|COMPLETED|Overall Study||19
10759638|NCT03119181|11923296|FG001|COMPLETED|Overall Study||21
10759639|NCT03119181|11923295|FG000|NOT COMPLETED|Overall Study||0
10759640|NCT03119181|11923296|FG001|NOT COMPLETED|Overall Study||0
10759641|NCT03119389|11923304|FG000|STARTED|Overall Study||6791
10759642|NCT03119389|11923305|FG001|STARTED|Overall Study||7627
10759643|NCT03119389|11923304|FG000|COMPLETED|Overall Study||6791
10759644|NCT03119389|11923305|FG001|COMPLETED|Overall Study||7627
10759645|NCT03119389|11923304|FG000|NOT COMPLETED|Overall Study||0
10759646|NCT03119389|11923305|FG001|NOT COMPLETED|Overall Study||0
10759647|NCT03119571|11923315|FG000|STARTED|Overall Study||31
10759648|NCT03119571|11923316|FG001|STARTED|Overall Study||34
10759649|NCT03119571|11923315|FG000|COMPLETED|Overall Study||31
10759650|NCT03119571|11923316|FG001|COMPLETED|Overall Study||34
10759651|NCT03119571|11923315|FG000|NOT COMPLETED|Overall Study||0
10759652|NCT03119571|11923316|FG001|NOT COMPLETED|Overall Study||0
10759653|NCT03119610|11923324|FG000|STARTED|Overall Study||13
10759654|NCT03119610|11923325|FG001|STARTED|Overall Study||10
10759655|NCT03119610|11923324|FG000|COMPLETED|Overall Study||12
10759656|NCT03119610|11923325|FG001|COMPLETED|Overall Study||9
10759657|NCT03119610|11923324|FG000|NOT COMPLETED|Overall Study||1
10759658|NCT03119610|11923325|FG001|NOT COMPLETED|Overall Study||1
10759659|NCT03119649|11923336|FG000|STARTED|Overall Study||11
10759660|NCT03119649|11923337|FG001|STARTED|Overall Study||10
10759661|NCT03119649|11923338|FG002|STARTED|Overall Study||10
10759662|NCT03119649|11923339|FG003|STARTED|Overall Study||14
10759663|NCT03119649|11923340|FG004|STARTED|Overall Study||14
10759664|NCT03119649|11923336|FG000|COMPLETED|Overall Study||11
10759665|NCT03119649|11923337|FG001|COMPLETED|Overall Study||10
10759666|NCT03119649|11923338|FG002|COMPLETED|Overall Study||10
10759667|NCT03119649|11923339|FG003|COMPLETED|Overall Study||14
10759668|NCT03119649|11923340|FG004|COMPLETED|Overall Study||14
10759669|NCT03119649|11923336|FG000|NOT COMPLETED|Overall Study||0
10759670|NCT03119649|11923337|FG001|NOT COMPLETED|Overall Study||0
10759671|NCT03119649|11923338|FG002|NOT COMPLETED|Overall Study||0
10759672|NCT03119649|11923339|FG003|NOT COMPLETED|Overall Study||0
10759673|NCT03119649|11923340|FG004|NOT COMPLETED|Overall Study||0
10759674|NCT03119688|11923356|FG000|STARTED|Overall Study||48
10759675|NCT03119688|11923356|FG000|COMPLETED|Overall Study||44
10759676|NCT03119688|11923356|FG000|NOT COMPLETED|Overall Study||4
10759677|NCT03119701|11923375|FG000|STARTED|6-day Dosing||29
10759678|NCT03119701|11923376|FG001|STARTED|6-day Dosing||11
10759679|NCT03119701|11923375|FG000|COMPLETED|6-day Dosing||22
10759680|NCT03119701|11923376|FG001|COMPLETED|6-day Dosing||8
10759681|NCT03119701|11923375|FG000|NOT COMPLETED|6-day Dosing||7
10759682|NCT03119701|11923376|FG001|NOT COMPLETED|6-day Dosing||3
10759683|NCT03119701|11923375|FG000|STARTED|Mid-term (Final) Follow-up at D90|3 patients who discontinued study drug due to adverse events were also followed up.|25
10759684|NCT03119701|11923376|FG001|STARTED|Mid-term (Final) Follow-up at D90|2 patients who did not receive 6 doses were also followed up.|10
10759685|NCT03119701|11923375|FG000|COMPLETED|Mid-term (Final) Follow-up at D90||22
10759686|NCT03119701|11923376|FG001|COMPLETED|Mid-term (Final) Follow-up at D90||9
10759687|NCT03119701|11923375|FG000|NOT COMPLETED|Mid-term (Final) Follow-up at D90||3
10759688|NCT03119701|11923376|FG001|NOT COMPLETED|Mid-term (Final) Follow-up at D90||1
10759689|NCT03119831|11923385|FG000|STARTED|Overall Study||14
10759690|NCT03119831|11923386|FG001|STARTED|Overall Study||14
10759691|NCT03119831|11923387|FG002|STARTED|Overall Study||14
10759692|NCT03119831|11923385|FG000|COMPLETED|Overall Study||14
10759693|NCT03119831|11923386|FG001|COMPLETED|Overall Study||14
10759694|NCT03119831|11923387|FG002|COMPLETED|Overall Study||14
10759695|NCT03119831|11923385|FG000|NOT COMPLETED|Overall Study||0
10759696|NCT03119831|11923386|FG001|NOT COMPLETED|Overall Study||0
10759697|NCT03119831|11923387|FG002|NOT COMPLETED|Overall Study||0
10759698|NCT03120013|11923398|FG000|STARTED|First Intervention (2 Weeks)||10
10759699|NCT03120013|11923399|FG001|STARTED|First Intervention (2 Weeks)||11
10759700|NCT03120013|11923398|FG000|Received Intervention|First Intervention (2 Weeks)||10
10759701|NCT03120013|11923399|FG001|Received Intervention|First Intervention (2 Weeks)||11
10759702|NCT03120013|11923398|FG000|COMPLETED|First Intervention (2 Weeks)||10
10759703|NCT03120013|11923399|FG001|COMPLETED|First Intervention (2 Weeks)||10
10759704|NCT03120013|11923398|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
10759705|NCT03120013|11923399|FG001|NOT COMPLETED|First Intervention (2 Weeks)||1
10759706|NCT03120013|11923398|FG000|STARTED|Washout (6 Months)||10
10759707|NCT03120013|11923399|FG001|STARTED|Washout (6 Months)||10
10759708|NCT03120013|11923398|FG000|COMPLETED|Washout (6 Months)||10
10759709|NCT03120013|11923399|FG001|COMPLETED|Washout (6 Months)||10
10759710|NCT03120013|11923398|FG000|NOT COMPLETED|Washout (6 Months)||0
10759711|NCT03120013|11923399|FG001|NOT COMPLETED|Washout (6 Months)||0
10759712|NCT03120013|11923398|FG000|STARTED|Second Intervention (2 Weeks)||10
10759713|NCT03120013|11923399|FG001|STARTED|Second Intervention (2 Weeks)||10
10759714|NCT03120013|11923398|FG000|COMPLETED|Second Intervention (2 Weeks)||10
10759715|NCT03120013|11923399|FG001|COMPLETED|Second Intervention (2 Weeks)||10
10759716|NCT03120013|11923398|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
10759717|NCT03120013|11923399|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
10759718|NCT03120351|11923407|FG000|STARTED|Overall Study||40
10759719|NCT03120351|11923408|FG001|STARTED|Overall Study||40
10759720|NCT03120351|11923407|FG000|COMPLETED|Overall Study||39
10759721|NCT03120351|11923408|FG001|COMPLETED|Overall Study||39
10759722|NCT03120351|11923407|FG000|NOT COMPLETED|Overall Study||1
10759723|NCT03120351|11923408|FG001|NOT COMPLETED|Overall Study||1
10759724|NCT03120520|11923418|FG000|STARTED|Overall Study||31
10759725|NCT03120520|11923419|FG001|STARTED|Overall Study||31
10759726|NCT03120520|11923420|FG002|STARTED|Overall Study||30
10759727|NCT03120520|11923421|FG003|STARTED|Overall Study||32
10759728|NCT03120520|11923418|FG000|COMPLETED|Overall Study||27
10759729|NCT03120520|11923419|FG001|COMPLETED|Overall Study||27
10759730|NCT03120520|11923420|FG002|COMPLETED|Overall Study||26
10759731|NCT03120520|11923421|FG003|COMPLETED|Overall Study||29
10759732|NCT03120520|11923418|FG000|NOT COMPLETED|Overall Study||4
10759733|NCT03120520|11923419|FG001|NOT COMPLETED|Overall Study||4
10759734|NCT03120520|11923420|FG002|NOT COMPLETED|Overall Study||4
10759735|NCT03120520|11923421|FG003|NOT COMPLETED|Overall Study||3
10759736|NCT03120832|11923434|FG000|STARTED|Overall Study||3
10759737|NCT03120832|11923435|FG001|STARTED|Overall Study||3
10759738|NCT03120832|11923436|FG002|STARTED|Overall Study||6
10759739|NCT03120832|11923434|FG000|COMPLETED|Overall Study||3
10759740|NCT03120832|11923435|FG001|COMPLETED|Overall Study||3
10759741|NCT03120832|11923436|FG002|COMPLETED|Overall Study||6
10759742|NCT03120832|11923434|FG000|NOT COMPLETED|Overall Study||0
10759743|NCT03120832|11923435|FG001|NOT COMPLETED|Overall Study||0
10759744|NCT03120832|11923436|FG002|NOT COMPLETED|Overall Study||0
10759745|NCT03121144|11923444|FG000|STARTED|Overall Study||34
10759746|NCT03121144|11923444|FG000|COMPLETED|Overall Study||34
10759747|NCT03121144|11923444|FG000|NOT COMPLETED|Overall Study||0
10759748|NCT03121365|11923450|FG000|STARTED|Baseline||55
10759749|NCT03121365|11923451|FG001|STARTED|Baseline||49
10759750|NCT03121365|11923450|FG000|COMPLETED|Baseline||54
10759751|NCT03121365|11923451|FG001|COMPLETED|Baseline||48
10759752|NCT03121365|11923450|FG000|NOT COMPLETED|Baseline||1
10759753|NCT03121365|11923451|FG001|NOT COMPLETED|Baseline||1
10759754|NCT03121365|11923450|FG000|STARTED|1 Months||54
10759755|NCT03121365|11923451|FG001|STARTED|1 Months||48
10759756|NCT03121365|11923450|FG000|COMPLETED|1 Months||52
10759757|NCT03121365|11923451|FG001|COMPLETED|1 Months||45
10759758|NCT03121365|11923450|FG000|NOT COMPLETED|1 Months||2
10759759|NCT03121365|11923451|FG001|NOT COMPLETED|1 Months||3
10759760|NCT03121365|11923450|FG000|STARTED|4 Months||54
10759761|NCT03121365|11923451|FG001|STARTED|4 Months||45
10759762|NCT03121365|11923450|FG000|COMPLETED|4 Months||51
10759763|NCT03121365|11923451|FG001|COMPLETED|4 Months||44
10759764|NCT03121365|11923450|FG000|NOT COMPLETED|4 Months||3
10759765|NCT03121365|11923451|FG001|NOT COMPLETED|4 Months||1
10759766|NCT03121365|11923450|FG000|STARTED|7 Months||54
10759767|NCT03121365|11923451|FG001|STARTED|7 Months||45
10759768|NCT03121365|11923450|FG000|COMPLETED|7 Months||44
10759769|NCT03121365|11923451|FG001|COMPLETED|7 Months||37
10759770|NCT03121365|11923450|FG000|NOT COMPLETED|7 Months||10
10759771|NCT03121365|11923451|FG001|NOT COMPLETED|7 Months||8
10759772|NCT03121612|11923461|FG000|STARTED|Overall Study||26
10759773|NCT03121612|11923462|FG001|STARTED|Overall Study||25
10759774|NCT03121612|11923461|FG000|COMPLETED|Overall Study||26
10759775|NCT03121612|11923462|FG001|COMPLETED|Overall Study||25
10759776|NCT03121612|11923461|FG000|NOT COMPLETED|Overall Study||0
10759777|NCT03121612|11923462|FG001|NOT COMPLETED|Overall Study||0
10759778|NCT03121820|11923472|FG000|STARTED|First Period||9
10759779|NCT03121820|11923473|FG001|STARTED|First Period||9
10759780|NCT03121820|11923472|FG000|COMPLETED|First Period||9
10759781|NCT03121820|11923473|FG001|COMPLETED|First Period||9
10759782|NCT03121820|11923472|FG000|NOT COMPLETED|First Period||0
10759783|NCT03121820|11923473|FG001|NOT COMPLETED|First Period||0
10759784|NCT03121820|11923472|FG000|STARTED|Second Period (After Washout)||9
10759785|NCT03121820|11923473|FG001|STARTED|Second Period (After Washout)||9
10759786|NCT03121820|11923472|FG000|COMPLETED|Second Period (After Washout)||9
10759787|NCT03121820|11923473|FG001|COMPLETED|Second Period (After Washout)||9
10759788|NCT03121820|11923472|FG000|NOT COMPLETED|Second Period (After Washout)||0
10759789|NCT03121820|11923473|FG001|NOT COMPLETED|Second Period (After Washout)||0
10759790|NCT03121950|11923481|FG000|STARTED|Overall Study||17
10759791|NCT03121950|11923482|FG001|STARTED|Overall Study||3
10759792|NCT03121950|11923481|FG000|COMPLETED|Overall Study||6
10759793|NCT03121950|11923482|FG001|COMPLETED|Overall Study||1
10759794|NCT03121950|11923481|FG000|NOT COMPLETED|Overall Study||11
10759795|NCT03121950|11923482|FG001|NOT COMPLETED|Overall Study||2
10759796|NCT03122145|11923492|FG000|STARTED|Overall Study|34 participants completed the first sub study under this IRB|37
10759797|NCT03122145|11923493|FG001|STARTED|Overall Study||12
10759798|NCT03122145|11923492|FG000|COMPLETED|Overall Study||34
10759799|NCT03122145|11923493|FG001|COMPLETED|Overall Study||12
10759800|NCT03122145|11923492|FG000|NOT COMPLETED|Overall Study||3
10759801|NCT03122145|11923493|FG001|NOT COMPLETED|Overall Study||0
10759802|NCT03122171|11923499|FG000|STARTED|Overall Study||6
10759803|NCT03122171|11923499|FG000|COMPLETED|Overall Study||5
10759804|NCT03122171|11923499|FG000|NOT COMPLETED|Overall Study||1
10759805|NCT03122184|11923505|FG000|STARTED|Overall Study||24
10759806|NCT03122184|11923506|FG001|STARTED|Overall Study||23
10759807|NCT03122184|11923505|FG000|COMPLETED|Overall Study||16
10759808|NCT03122184|11923506|FG001|COMPLETED|Overall Study||17
10759809|NCT03122184|11923505|FG000|NOT COMPLETED|Overall Study||8
10759810|NCT03122184|11923506|FG001|NOT COMPLETED|Overall Study||6
10759811|NCT03122223|11923516|FG000|STARTED|Overall Study||50
10759812|NCT03122223|11923517|FG001|STARTED|Overall Study||50
10759813|NCT03122223|11923518|FG002|STARTED|Overall Study||50
10759814|NCT03122223|11923519|FG003|STARTED|Overall Study||10
10759815|NCT03122223|11923516|FG000|Month 6.5 Immunogenicity Cohort|Overall Study||49
10759816|NCT03122223|11923517|FG001|Month 6.5 Immunogenicity Cohort|Overall Study||48
10759817|NCT03122223|11923518|FG002|Month 6.5 Immunogenicity Cohort|Overall Study||47
10759818|NCT03122223|11923519|FG003|Month 6.5 Immunogenicity Cohort|Overall Study||8
10759819|NCT03122223|11923516|FG000|Month 12 Immunogenicity Cohort|Overall Study||47
10759820|NCT03122223|11923517|FG001|Month 12 Immunogenicity Cohort|Overall Study||45
10759821|NCT03122223|11923518|FG002|Month 12 Immunogenicity Cohort|Overall Study||46
10759822|NCT03122223|11923519|FG003|Month 12 Immunogenicity Cohort|Overall Study||10
10759823|NCT03122223|11923516|FG000|COMPLETED|Overall Study||47
10759824|NCT03122223|11923517|FG001|COMPLETED|Overall Study||45
10759825|NCT03122223|11923518|FG002|COMPLETED|Overall Study||46
10759826|NCT03122223|11923519|FG003|COMPLETED|Overall Study||10
10759827|NCT03122223|11923516|FG000|NOT COMPLETED|Overall Study||3
10759828|NCT03122223|11923517|FG001|NOT COMPLETED|Overall Study||5
10759829|NCT03122223|11923518|FG002|NOT COMPLETED|Overall Study||4
10759830|NCT03122223|11923519|FG003|NOT COMPLETED|Overall Study||0
10759831|NCT03122457|11923529|FG000|STARTED|Overall Study||22
10759832|NCT03122457|11923529|FG000|COMPLETED|Overall Study||16
10759833|NCT03122457|11923529|FG000|NOT COMPLETED|Overall Study||6
10759834|NCT03122535|11923533|FG000|STARTED|Overall Study||115
10759835|NCT03122535|11923534|FG001|STARTED|Overall Study||115
10759836|NCT03122535|11923533|FG000|3 Months|Overall Study||92
10759837|NCT03122535|11923534|FG001|3 Months|Overall Study||92
10759838|NCT03122535|11923533|FG000|12 Months|Overall Study||42
10759839|NCT03122535|11923534|FG001|12 Months|Overall Study||42
10759840|NCT03122535|11923533|FG000|COMPLETED|Overall Study||42
10759841|NCT03122535|11923534|FG001|COMPLETED|Overall Study||42
10759842|NCT03122535|11923533|FG000|NOT COMPLETED|Overall Study||73
10759843|NCT03122535|11923534|FG001|NOT COMPLETED|Overall Study||73
10759844|NCT03122548|11923540|FG000|STARTED|Overall Study||5
10759845|NCT03122548|11923540|FG000|COMPLETED|Overall Study||0
10759846|NCT03122548|11923540|FG000|NOT COMPLETED|Overall Study||5
10759847|NCT03122587|11923547|FG000|STARTED|Overall Study||13
10759848|NCT03122587|11923548|FG001|STARTED|Overall Study||12
10759849|NCT03122587|11923549|FG002|STARTED|Overall Study||13
10759850|NCT03122587|11923547|FG000|COMPLETED|Overall Study||11
10759851|NCT03122587|11923548|FG001|COMPLETED|Overall Study||10
10759852|NCT03122587|11923549|FG002|COMPLETED|Overall Study||12
10759853|NCT03122587|11923547|FG000|NOT COMPLETED|Overall Study||2
10759854|NCT03122587|11923548|FG001|NOT COMPLETED|Overall Study||2
10759855|NCT03122587|11923549|FG002|NOT COMPLETED|Overall Study||1
10759856|NCT03122860|11923563|FG000|STARTED|Overall Study||117
10759857|NCT03122860|11923564|FG001|STARTED|Overall Study||116
10759858|NCT03122860|11923565|FG002|STARTED|Overall Study||117
10759859|NCT03122860|11923566|FG003|STARTED|Overall Study||116
10759860|NCT03122860|11923567|FG004|STARTED|Overall Study||117
10759861|NCT03122860|11923568|FG005|STARTED|Overall Study||117
10759862|NCT03122860|11923563|FG000|Full Analysis Set|Overall Study||116
10759863|NCT03122860|11923564|FG001|Full Analysis Set|Overall Study||115
10759864|NCT03122860|11923565|FG002|Full Analysis Set|Overall Study||115
10759865|NCT03122860|11923566|FG003|Full Analysis Set|Overall Study||116
10759866|NCT03122860|11923567|FG004|Full Analysis Set|Overall Study||116
10759867|NCT03122860|11923568|FG005|Full Analysis Set|Overall Study||117
10759868|NCT03122860|11923563|FG000|COMPLETED|Overall Study||107
10759869|NCT03122860|11923564|FG001|COMPLETED|Overall Study||111
10759870|NCT03122860|11923565|FG002|COMPLETED|Overall Study||105
10759871|NCT03122860|11923566|FG003|COMPLETED|Overall Study||105
10759872|NCT03122860|11923567|FG004|COMPLETED|Overall Study||102
10874745|NCT02564900|12040894|FG008|NOT COMPLETED|Dose Escalation||0
10759873|NCT03122860|11923568|FG005|COMPLETED|Overall Study||105
10759874|NCT03122860|11923563|FG000|NOT COMPLETED|Overall Study||10
10759875|NCT03122860|11923564|FG001|NOT COMPLETED|Overall Study||5
10759876|NCT03122860|11923565|FG002|NOT COMPLETED|Overall Study||12
10759877|NCT03122860|11923566|FG003|NOT COMPLETED|Overall Study||11
10759878|NCT03122860|11923567|FG004|NOT COMPLETED|Overall Study||15
10759879|NCT03122860|11923568|FG005|NOT COMPLETED|Overall Study||12
10759880|NCT03123055|11923583|FG000|STARTED|Overall Study||28
10759881|NCT03123055|11923583|FG000|COMPLETED|Overall Study||28
10759882|NCT03123055|11923583|FG000|NOT COMPLETED|Overall Study||0
10759883|NCT03123068|11923590|FG000|STARTED|Overall Study||22
10759884|NCT03123068|11923591|FG001|STARTED|Overall Study||20
10759885|NCT03123068|11923590|FG000|COMPLETED|Overall Study||22
10759886|NCT03123068|11923591|FG001|COMPLETED|Overall Study||20
10759887|NCT03123068|11923590|FG000|NOT COMPLETED|Overall Study||0
10759888|NCT03123068|11923591|FG001|NOT COMPLETED|Overall Study||0
10759889|NCT03123120|11923599|FG000|STARTED|Overall Study||8
10759890|NCT03123120|11923600|FG001|STARTED|Overall Study||14
10759891|NCT03123120|11923599|FG000|Safety Analysis Set (SAF)|Overall Study||7
10759892|NCT03123120|11923600|FG001|Safety Analysis Set (SAF)|Overall Study||15
10759893|NCT03123120|11923599|FG000|COMPLETED|Overall Study||8
10759894|NCT03123120|11923600|FG001|COMPLETED|Overall Study||12
10759895|NCT03123120|11923599|FG000|NOT COMPLETED|Overall Study||0
10874746|NCT02564900|12040895|FG009|NOT COMPLETED|Dose Escalation||0
10874747|NCT02564900|12040896|FG010|NOT COMPLETED|Dose Escalation||0
10874748|NCT02564900|12040897|FG011|NOT COMPLETED|Dose Escalation||0
10874749|NCT02564900|12040898|FG012|NOT COMPLETED|Dose Escalation||0
10874750|NCT02564900|12040899|FG013|NOT COMPLETED|Dose Escalation||0
10874751|NCT02564900|12040900|FG014|NOT COMPLETED|Dose Escalation||0
10874752|NCT02564900|12040886|FG000|STARTED|Dose Expansion||0
10874753|NCT02564900|12040887|FG001|STARTED|Dose Expansion||0
10874754|NCT02564900|12040888|FG002|STARTED|Dose Expansion||0
10874755|NCT02564900|12040889|FG003|STARTED|Dose Expansion||0
10874756|NCT02564900|12040890|FG004|STARTED|Dose Expansion||0
10874757|NCT02564900|12040891|FG005|STARTED|Dose Expansion||0
10874758|NCT02564900|12040892|FG006|STARTED|Dose Expansion||49
10874759|NCT02564900|12040893|FG007|STARTED|Dose Expansion||62
10874760|NCT02564900|12040894|FG008|STARTED|Dose Expansion||20
10874761|NCT02564900|12040895|FG009|STARTED|Dose Expansion||33
10874762|NCT02564900|12040896|FG010|STARTED|Dose Expansion||17
10874763|NCT02564900|12040897|FG011|STARTED|Dose Expansion||24
10874764|NCT02564900|12040898|FG012|STARTED|Dose Expansion||18
10874765|NCT02564900|12040899|FG013|STARTED|Dose Expansion||20
10874766|NCT02564900|12040900|FG014|STARTED|Dose Expansion||22
10874767|NCT02564900|12040886|FG000|Enrolled, But Not Dosed|Dose Expansion||0
10874768|NCT02564900|12040887|FG001|Enrolled, But Not Dosed|Dose Expansion||0
10874769|NCT02564900|12040888|FG002|Enrolled, But Not Dosed|Dose Expansion||0
10874770|NCT02564900|12040889|FG003|Enrolled, But Not Dosed|Dose Expansion||0
10874771|NCT02564900|12040890|FG004|Enrolled, But Not Dosed|Dose Expansion||0
10874772|NCT02564900|12040891|FG005|Enrolled, But Not Dosed|Dose Expansion||0
10874773|NCT02564900|12040892|FG006|Enrolled, But Not Dosed|Dose Expansion||1
10296878|NCT00943852|11429421|FG004|STARTED|Washout Period After Period 4 Treatment||1
10296879|NCT00943852|11429422|FG005|STARTED|Washout Period After Period 4 Treatment||0
10296880|NCT00943852|11429423|FG006|STARTED|Washout Period After Period 4 Treatment||1
10296881|NCT00943852|11429424|FG007|STARTED|Washout Period After Period 4 Treatment||1
10296882|NCT00943852|11429425|FG008|STARTED|Washout Period After Period 4 Treatment||1
10296883|NCT00943852|11429426|FG009|STARTED|Washout Period After Period 4 Treatment||1
10296884|NCT00943852|11429417|FG000|COMPLETED|Washout Period After Period 4 Treatment||1
10296885|NCT00943852|11429418|FG001|COMPLETED|Washout Period After Period 4 Treatment||1
10296886|NCT00943852|11429419|FG002|COMPLETED|Washout Period After Period 4 Treatment||0
10296887|NCT00943852|11429420|FG003|COMPLETED|Washout Period After Period 4 Treatment||0
10296888|NCT00943852|11429421|FG004|COMPLETED|Washout Period After Period 4 Treatment||1
10296889|NCT00943852|11429422|FG005|COMPLETED|Washout Period After Period 4 Treatment||0
10296890|NCT00943852|11429423|FG006|COMPLETED|Washout Period After Period 4 Treatment||0
10296891|NCT00943852|11429424|FG007|COMPLETED|Washout Period After Period 4 Treatment||0
10296892|NCT00943852|11429425|FG008|COMPLETED|Washout Period After Period 4 Treatment||1
10296893|NCT00943852|11429426|FG009|COMPLETED|Washout Period After Period 4 Treatment||1
10296894|NCT00943852|11429417|FG000|NOT COMPLETED|Washout Period After Period 4 Treatment||1
10296895|NCT00943852|11429418|FG001|NOT COMPLETED|Washout Period After Period 4 Treatment||0
10296896|NCT00943852|11429419|FG002|NOT COMPLETED|Washout Period After Period 4 Treatment||1
10296897|NCT00943852|11429420|FG003|NOT COMPLETED|Washout Period After Period 4 Treatment||1
10296898|NCT00943852|11429421|FG004|NOT COMPLETED|Washout Period After Period 4 Treatment||0
10296899|NCT00943852|11429422|FG005|NOT COMPLETED|Washout Period After Period 4 Treatment||0
10296900|NCT00943852|11429423|FG006|NOT COMPLETED|Washout Period After Period 4 Treatment||1
10296901|NCT00943852|11429424|FG007|NOT COMPLETED|Washout Period After Period 4 Treatment||1
10296902|NCT00943852|11429425|FG008|NOT COMPLETED|Washout Period After Period 4 Treatment||0
10296903|NCT00943852|11429426|FG009|NOT COMPLETED|Washout Period After Period 4 Treatment||0
10296904|NCT00943852|11429417|FG000|STARTED|Fifth Period of Treatment Intervention||1
10296905|NCT00943852|11429418|FG001|STARTED|Fifth Period of Treatment Intervention||1
10296906|NCT00943852|11429419|FG002|STARTED|Fifth Period of Treatment Intervention||0
10296907|NCT00943852|11429420|FG003|STARTED|Fifth Period of Treatment Intervention||0
10296908|NCT00943852|11429421|FG004|STARTED|Fifth Period of Treatment Intervention||1
10296909|NCT00943852|11429422|FG005|STARTED|Fifth Period of Treatment Intervention||0
10296910|NCT00943852|11429423|FG006|STARTED|Fifth Period of Treatment Intervention||0
10296911|NCT00943852|11429424|FG007|STARTED|Fifth Period of Treatment Intervention||0
10296912|NCT00943852|11429425|FG008|STARTED|Fifth Period of Treatment Intervention||1
10874774|NCT02564900|12040893|FG007|Enrolled, But Not Dosed|Dose Expansion||1
10874775|NCT02564900|12040894|FG008|Enrolled, But Not Dosed|Dose Expansion||0
10874776|NCT02564900|12040895|FG009|Enrolled, But Not Dosed|Dose Expansion||0
10874777|NCT02564900|12040896|FG010|Enrolled, But Not Dosed|Dose Expansion||0
10874778|NCT02564900|12040897|FG011|Enrolled, But Not Dosed|Dose Expansion||0
10874779|NCT02564900|12040898|FG012|Enrolled, But Not Dosed|Dose Expansion||0
10874780|NCT02564900|12040899|FG013|Enrolled, But Not Dosed|Dose Expansion||0
10874781|NCT02564900|12040900|FG014|Enrolled, But Not Dosed|Dose Expansion||1
10874782|NCT02564900|12040886|FG000|COMPLETED|Dose Expansion||0
10874783|NCT02564900|12040887|FG001|COMPLETED|Dose Expansion||0
10874784|NCT02564900|12040888|FG002|COMPLETED|Dose Expansion||0
10874785|NCT02564900|12040889|FG003|COMPLETED|Dose Expansion||0
10759896|NCT03123120|11923600|FG001|NOT COMPLETED|Overall Study||2
10759897|NCT03123263|11923608|FG000|STARTED|Overall Study||60
10759898|NCT03123263|11923608|FG000|COMPLETED|Overall Study||60
10759899|NCT03123263|11923608|FG000|NOT COMPLETED|Overall Study||0
10759900|NCT03123354|11923615|FG000|STARTED|Overall Study||44
10759901|NCT03123354|11923615|FG000|COMPLETED|Overall Study||38
10759902|NCT03123354|11923615|FG000|NOT COMPLETED|Overall Study||6
10759903|NCT03123471|11923621|FG000|STARTED|Placebo-controlled Phase||102
10759904|NCT03123471|11923622|FG001|STARTED|Placebo-controlled Phase||201
10759905|NCT03123471|11923621|FG000|Received at Least 1 Dose of Study Drug|Placebo-controlled Phase||102
10759906|NCT03123471|11923622|FG001|Received at Least 1 Dose of Study Drug|Placebo-controlled Phase||200
10759907|NCT03123471|11923621|FG000|COMPLETED|Placebo-controlled Phase||84
10759908|NCT03123471|11923622|FG001|COMPLETED|Placebo-controlled Phase||168
10759909|NCT03123471|11923621|FG000|NOT COMPLETED|Placebo-controlled Phase||18
10759910|NCT03123471|11923622|FG001|NOT COMPLETED|Placebo-controlled Phase||33
10759911|NCT03123471|11923621|FG000|STARTED|Apremilast Extension Phase||84
10759912|NCT03123471|11923622|FG001|STARTED|Apremilast Extension Phase|3 participants completed the first phase; did not enter in extension phase|165
10759913|NCT03123471|11923621|FG000|Received at Least 1 Dose of Study Drug|Apremilast Extension Phase||84
10759914|NCT03123471|11923622|FG001|Received at Least 1 Dose of Study Drug|Apremilast Extension Phase||163
10759915|NCT03123471|11923621|FG000|COMPLETED|Apremilast Extension Phase||76
10759916|NCT03123471|11923622|FG001|COMPLETED|Apremilast Extension Phase||140
10759917|NCT03123471|11923621|FG000|NOT COMPLETED|Apremilast Extension Phase||8
10759918|NCT03123471|11923622|FG001|NOT COMPLETED|Apremilast Extension Phase||25
10759919|NCT03123588|11923636|FG000|STARTED|Overall Study||6
10759920|NCT03123588|11923637|FG001|STARTED|Overall Study||6
10759921|NCT03123588|11923636|FG000|COMPLETED|Overall Study||0
10759922|NCT03123588|11923637|FG001|COMPLETED|Overall Study||0
10759923|NCT03123588|11923636|FG000|NOT COMPLETED|Overall Study||6
10759924|NCT03123588|11923637|FG001|NOT COMPLETED|Overall Study||6
10759925|NCT03123614|11923646|FG000|STARTED|Overall Study||57
10759926|NCT03123614|11923647|FG001|STARTED|Overall Study||74
10759927|NCT03123614|11923646|FG000|COMPLETED|Overall Study||57
10759928|NCT03123614|11923647|FG001|COMPLETED|Overall Study||74
10759929|NCT03123614|11923646|FG000|NOT COMPLETED|Overall Study||0
10759930|NCT03123614|11923647|FG001|NOT COMPLETED|Overall Study||0
10759931|NCT03123848|11923653|FG000|STARTED|Overall Study||8
10759932|NCT03123848|11923653|FG000|COMPLETED|Overall Study||8
10759933|NCT03123848|11923653|FG000|NOT COMPLETED|Overall Study||0
10759934|NCT03123861|11923661|FG000|STARTED|Overall Study||22
10759935|NCT03123861|11923662|FG001|STARTED|Overall Study||23
10759936|NCT03123861|11923661|FG000|Received Intervention|Overall Study||21
10759937|NCT03123861|11923662|FG001|Received Intervention|Overall Study||22
10759938|NCT03123861|11923661|FG000|COMPLETED|Overall Study||19
10759939|NCT03123861|11923662|FG001|COMPLETED|Overall Study||20
10759940|NCT03123861|11923661|FG000|NOT COMPLETED|Overall Study||3
10759941|NCT03123861|11923662|FG001|NOT COMPLETED|Overall Study||3
10759942|NCT03123874|11923670|FG000|STARTED|Overall Study||27
10759943|NCT03123874|11923671|FG001|STARTED|Overall Study||25
10759944|NCT03123874|11923670|FG000|COMPLETED|Overall Study||27
10759945|NCT03123874|11923671|FG001|COMPLETED|Overall Study||25
10759946|NCT03123874|11923670|FG000|NOT COMPLETED|Overall Study||0
10759947|NCT03123874|11923671|FG001|NOT COMPLETED|Overall Study||0
10759948|NCT03123939|11923681|FG000|STARTED|Overall Study||74
10759949|NCT03123939|11923681|FG000|CTL019 Infused|Overall Study||69
10759950|NCT03123939|11923681|FG000|Full Analysis Set (FAS)|Overall Study||69
10759951|NCT03123939|11923681|FG000|Cellular Kinetic Analysis Set (CKAS)|Overall Study||69
10759952|NCT03123939|11923681|FG000|Safety Set (SAF)|Overall Study||69
10759953|NCT03123939|11923681|FG000|COMPLETED|Overall Study||33
10759954|NCT03123939|11923681|FG000|NOT COMPLETED|Overall Study||41
10759955|NCT03124069|11923685|FG000|STARTED|Overall Study||37
10759956|NCT03124069|11923685|FG000|COMPLETED|Overall Study||37
10759957|NCT03124069|11923685|FG000|NOT COMPLETED|Overall Study||0
10759958|NCT03124108|11923694|FG000|STARTED|Overall Study||15
10759959|NCT03124108|11923695|FG001|STARTED|Overall Study||15
10759960|NCT03124108|11923696|FG002|STARTED|Overall Study||15
10759961|NCT03124108|11923694|FG000|COMPLETED|Overall Study||15
10759962|NCT03124108|11923695|FG001|COMPLETED|Overall Study||14
10759963|NCT03124108|11923696|FG002|COMPLETED|Overall Study||15
10759964|NCT03124108|11923694|FG000|NOT COMPLETED|Overall Study||0
10759965|NCT03124108|11923695|FG001|NOT COMPLETED|Overall Study||1
10759966|NCT03124108|11923696|FG002|NOT COMPLETED|Overall Study||0
10759967|NCT03124121|11923708|FG000|STARTED|Overall Study||42
10759968|NCT03124121|11923709|FG001|STARTED|Overall Study||70
10759969|NCT03124121|11923708|FG000|COMPLETED|Overall Study||39
10759970|NCT03124121|11923709|FG001|COMPLETED|Overall Study||67
10759971|NCT03124121|11923708|FG000|NOT COMPLETED|Overall Study||3
10759972|NCT03124121|11923709|FG001|NOT COMPLETED|Overall Study||3
10759973|NCT03124199|11923717|FG000|STARTED|Overall Study||40
10759974|NCT03124199|11923717|FG000|COMPLETED|Overall Study||36
10759975|NCT03124199|11923717|FG000|NOT COMPLETED|Overall Study||4
10759976|NCT03124342|11923723|FG000|STARTED|Overall Study||111
10759977|NCT03124342|11923724|FG001|STARTED|Overall Study||121
10759978|NCT03124342|11923723|FG000|COMPLETED|Overall Study||111
10759979|NCT03124342|11923724|FG001|COMPLETED|Overall Study||121
10759980|NCT03124342|11923723|FG000|NOT COMPLETED|Overall Study||0
10759981|NCT03124342|11923724|FG001|NOT COMPLETED|Overall Study||0
10759982|NCT03124368|11923733|FG000|STARTED|Overall Study||2
10759983|NCT03124368|11923734|FG001|STARTED|Overall Study||4
10759984|NCT03124368|11923733|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2
10759985|NCT03124368|11923734|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4
10759986|NCT03124368|11923733|FG000|COMPLETED|Overall Study||2
10759987|NCT03124368|11923734|FG001|COMPLETED|Overall Study||4
10759988|NCT03124368|11923733|FG000|NOT COMPLETED|Overall Study||0
10759989|NCT03124368|11923734|FG001|NOT COMPLETED|Overall Study||0
10759990|NCT03124381|11923747|FG000|STARTED|Overall Study||65
10759991|NCT03124381|11923748|FG001|STARTED|Overall Study||61
10759992|NCT03124381|11923747|FG000|COMPLETED|Overall Study||56
10759993|NCT03124381|11923748|FG001|COMPLETED|Overall Study||55
10759994|NCT03124381|11923747|FG000|NOT COMPLETED|Overall Study||9
10759995|NCT03124381|11923748|FG001|NOT COMPLETED|Overall Study||6
10759996|NCT03124407|11923758|FG000|STARTED|Overall Study||40
10759997|NCT03124407|11923759|FG001|STARTED|Overall Study||20
10759998|NCT03124407|11923760|FG002|STARTED|Overall Study||40
10759999|NCT03124407|11923761|FG003|STARTED|Overall Study||20
10760000|NCT03124407|11923758|FG000|COMPLETED|Overall Study||39
10760001|NCT03124407|11923759|FG001|COMPLETED|Overall Study||20
10760002|NCT03124407|11923760|FG002|COMPLETED|Overall Study||39
10760003|NCT03124407|11923761|FG003|COMPLETED|Overall Study||20
10760004|NCT03124407|11923758|FG000|NOT COMPLETED|Overall Study||1
10760005|NCT03124407|11923759|FG001|NOT COMPLETED|Overall Study||0
10760006|NCT03124407|11923760|FG002|NOT COMPLETED|Overall Study||1
10760007|NCT03124407|11923761|FG003|NOT COMPLETED|Overall Study||0
10760079|NCT03124602|11923821|FG000|STARTED|Overall Study||35
10760062|NCT03124537|11923801|FG000|STARTED|Overall Study||41
10760063|NCT03124537|11923802|FG001|STARTED|Overall Study||45
10760064|NCT03124537|11923801|FG000|COMPLETED|Overall Study||31
10760065|NCT03124537|11923802|FG001|COMPLETED|Overall Study||32
10760066|NCT03124537|11923801|FG000|NOT COMPLETED|Overall Study||10
10760067|NCT03124537|11923802|FG001|NOT COMPLETED|Overall Study||13
10760068|NCT03124550|11923808|FG000|STARTED|Overall Study||18
10760069|NCT03124550|11923808|FG000|COMPLETED|Overall Study||18
10760070|NCT03124550|11923808|FG000|NOT COMPLETED|Overall Study||0
10760071|NCT03124563|11923814|FG000|STARTED|Overall Study||32
10760072|NCT03124563|11923815|FG001|STARTED|Overall Study||31
10760073|NCT03124563|11923814|FG000|Pre-test|Overall Study||30
10760074|NCT03124563|11923815|FG001|Pre-test|Overall Study||30
10760075|NCT03124563|11923814|FG000|COMPLETED|Overall Study||30
10760076|NCT03124563|11923815|FG001|COMPLETED|Overall Study||29
10760077|NCT03124563|11923814|FG000|NOT COMPLETED|Overall Study||2
10760078|NCT03124563|11923815|FG001|NOT COMPLETED|Overall Study||2
10760080|NCT03124602|11923821|FG000|COMPLETED|Overall Study||25
10760081|NCT03124602|11923821|FG000|NOT COMPLETED|Overall Study||10
10760082|NCT03124693|11923825|FG000|STARTED|Overall Study||90
10760083|NCT03124693|11923825|FG000|COMPLETED|Overall Study||90
10760084|NCT03124693|11923825|FG000|NOT COMPLETED|Overall Study||0
10760085|NCT03124758|11923829|FG000|STARTED|Overall Study||354
10760086|NCT03124758|11923829|FG000|COMPLETED|Overall Study||354
10760087|NCT03124758|11923829|FG000|NOT COMPLETED|Overall Study||0
10760088|NCT03124771|11923833|FG000|STARTED|Overall Study||132
10760089|NCT03124771|11923833|FG000|COMPLETED|Overall Study||132
10760090|NCT03124771|11923833|FG000|NOT COMPLETED|Overall Study||0
10760091|NCT03124784|11923837|FG000|STARTED|Overall Study||27
10760092|NCT03124784|11923837|FG000|COMPLETED|Overall Study||25
10760093|NCT03124784|11923837|FG000|NOT COMPLETED|Overall Study||2
10760094|NCT03124797|11923841|FG000|STARTED|Overall Study||18
10760095|NCT03124797|11923841|FG000|COMPLETED|Overall Study||18
10760096|NCT03124797|11923841|FG000|NOT COMPLETED|Overall Study||0
10760097|NCT03124823|11923845|FG000|STARTED|Overall Study||11
10760098|NCT03124823|11923845|FG000|COMPLETED|Overall Study||11
10296913|NCT00943852|11429426|FG009|STARTED|Fifth Period of Treatment Intervention||1
10296914|NCT00943852|11429417|FG000|COMPLETED|Fifth Period of Treatment Intervention||1
10296915|NCT00943852|11429418|FG001|COMPLETED|Fifth Period of Treatment Intervention||1
10296916|NCT00943852|11429419|FG002|COMPLETED|Fifth Period of Treatment Intervention||0
10296917|NCT00943852|11429420|FG003|COMPLETED|Fifth Period of Treatment Intervention||0
10296918|NCT00943852|11429421|FG004|COMPLETED|Fifth Period of Treatment Intervention||1
10296919|NCT00943852|11429422|FG005|COMPLETED|Fifth Period of Treatment Intervention||0
10296920|NCT00943852|11429423|FG006|COMPLETED|Fifth Period of Treatment Intervention||0
10296921|NCT00943852|11429424|FG007|COMPLETED|Fifth Period of Treatment Intervention||0
10296922|NCT00943852|11429425|FG008|COMPLETED|Fifth Period of Treatment Intervention||1
10296923|NCT00943852|11429426|FG009|COMPLETED|Fifth Period of Treatment Intervention||1
10296924|NCT00943852|11429417|FG000|NOT COMPLETED|Fifth Period of Treatment Intervention||0
10296925|NCT00943852|11429418|FG001|NOT COMPLETED|Fifth Period of Treatment Intervention||0
10296926|NCT00943852|11429419|FG002|NOT COMPLETED|Fifth Period of Treatment Intervention||0
10296927|NCT00943852|11429420|FG003|NOT COMPLETED|Fifth Period of Treatment Intervention||0
10296928|NCT00943852|11429421|FG004|NOT COMPLETED|Fifth Period of Treatment Intervention||0
10296929|NCT00943852|11429422|FG005|NOT COMPLETED|Fifth Period of Treatment Intervention||0
10760099|NCT03124823|11923845|FG000|NOT COMPLETED|Overall Study||0
10760100|NCT03124836|11923849|FG000|STARTED|Overall Study||28
10760101|NCT03124836|11923849|FG000|COMPLETED|Overall Study||28
10760102|NCT03124836|11923849|FG000|NOT COMPLETED|Overall Study||0
10760103|NCT03124901|11923853|FG000|STARTED|Overall Study||147
10760104|NCT03124901|11923853|FG000|COMPLETED|Overall Study||147
10760105|NCT03124901|11923853|FG000|NOT COMPLETED|Overall Study||0
10760106|NCT03124927|11923857|FG000|STARTED|Overall Study||25
10760107|NCT03124927|11923857|FG000|COMPLETED|Overall Study||25
10760108|NCT03124927|11923857|FG000|NOT COMPLETED|Overall Study||0
10760109|NCT03124966|11923861|FG000|STARTED|Overall Study||118
10760110|NCT03124966|11923861|FG000|COMPLETED|Overall Study||118
10760111|NCT03124966|11923861|FG000|NOT COMPLETED|Overall Study||0
10760112|NCT03124979|11923865|FG000|STARTED|Overall Study||13
10760113|NCT03124979|11923865|FG000|COMPLETED|Overall Study||13
10760114|NCT03124979|11923865|FG000|NOT COMPLETED|Overall Study||0
10760115|NCT03125005|11923869|FG000|STARTED|Overall Study||51
10760116|NCT03125005|11923869|FG000|COMPLETED|Overall Study||51
10760117|NCT03125005|11923869|FG000|NOT COMPLETED|Overall Study||0
10760118|NCT03125018|11923873|FG000|STARTED|Overall Study||13
10760119|NCT03125018|11923873|FG000|COMPLETED|Overall Study||13
10760120|NCT03125018|11923873|FG000|NOT COMPLETED|Overall Study||0
10760121|NCT03125031|11923877|FG000|STARTED|Overall Study||44
10760122|NCT03125031|11923878|FG001|STARTED|Overall Study||44
10760123|NCT03125031|11923877|FG000|COMPLETED|Overall Study||44
10760124|NCT03125031|11923878|FG001|COMPLETED|Overall Study||44
10760125|NCT03125031|11923877|FG000|NOT COMPLETED|Overall Study||0
10760126|NCT03125031|11923878|FG001|NOT COMPLETED|Overall Study||0
10760127|NCT03125200|11923890|FG000|STARTED|Overall Study||2
10760128|NCT03125200|11923891|FG001|STARTED|Overall Study||2
10760129|NCT03125200|11923892|FG002|STARTED|Overall Study||2
10760130|NCT03125200|11923893|FG003|STARTED|Overall Study||5
10760131|NCT03125200|11923894|FG004|STARTED|Overall Study||4
10760132|NCT03125200|11923895|FG005|STARTED|Overall Study||3
10760133|NCT03125200|11923896|FG006|STARTED|Overall Study||3
10760134|NCT03125200|11923890|FG000|COMPLETED|Overall Study||0
10760135|NCT03125200|11923891|FG001|COMPLETED|Overall Study||0
10760136|NCT03125200|11923892|FG002|COMPLETED|Overall Study||0
10760137|NCT03125200|11923893|FG003|COMPLETED|Overall Study||0
10760138|NCT03125200|11923894|FG004|COMPLETED|Overall Study||0
10760139|NCT03125200|11923895|FG005|COMPLETED|Overall Study||0
10760140|NCT03125200|11923896|FG006|COMPLETED|Overall Study||0
10760141|NCT03125200|11923890|FG000|NOT COMPLETED|Overall Study||2
10760142|NCT03125200|11923891|FG001|NOT COMPLETED|Overall Study||2
10874786|NCT02564900|12040890|FG004|COMPLETED|Dose Expansion||0
10874787|NCT02564900|12040891|FG005|COMPLETED|Dose Expansion||0
10874788|NCT02564900|12040892|FG006|COMPLETED|Dose Expansion||0
10874789|NCT02564900|12040893|FG007|COMPLETED|Dose Expansion||0
10874790|NCT02564900|12040894|FG008|COMPLETED|Dose Expansion||0
10874791|NCT02564900|12040895|FG009|COMPLETED|Dose Expansion||0
10874792|NCT02564900|12040896|FG010|COMPLETED|Dose Expansion||0
10874793|NCT02564900|12040897|FG011|COMPLETED|Dose Expansion||0
10874794|NCT02564900|12040898|FG012|COMPLETED|Dose Expansion||0
10874795|NCT02564900|12040899|FG013|COMPLETED|Dose Expansion||0
10874796|NCT02564900|12040900|FG014|COMPLETED|Dose Expansion||0
10874797|NCT02564900|12040886|FG000|NOT COMPLETED|Dose Expansion||0
10874798|NCT02564900|12040887|FG001|NOT COMPLETED|Dose Expansion||0
10874799|NCT02564900|12040888|FG002|NOT COMPLETED|Dose Expansion||0
10874800|NCT02564900|12040889|FG003|NOT COMPLETED|Dose Expansion||0
10874801|NCT02564900|12040890|FG004|NOT COMPLETED|Dose Expansion||0
10874802|NCT02564900|12040891|FG005|NOT COMPLETED|Dose Expansion||0
10874803|NCT02564900|12040892|FG006|NOT COMPLETED|Dose Expansion||49
10874804|NCT02564900|12040893|FG007|NOT COMPLETED|Dose Expansion||62
10874805|NCT02564900|12040894|FG008|NOT COMPLETED|Dose Expansion||20
10874806|NCT02564900|12040895|FG009|NOT COMPLETED|Dose Expansion||33
10874807|NCT02564900|12040896|FG010|NOT COMPLETED|Dose Expansion||17
10874808|NCT02564900|12040897|FG011|NOT COMPLETED|Dose Expansion||24
10874809|NCT02564900|12040898|FG012|NOT COMPLETED|Dose Expansion||18
10874810|NCT02564900|12040899|FG013|NOT COMPLETED|Dose Expansion||20
10874811|NCT02564900|12040900|FG014|NOT COMPLETED|Dose Expansion||22
10874812|NCT02561299|12040943|FG000|STARTED|Overall Study||32
10874813|NCT02561299|12040944|FG001|STARTED|Overall Study||34
10874814|NCT02561299|12040943|FG000|COMPLETED|Overall Study||27
10874815|NCT02561299|12040944|FG001|COMPLETED|Overall Study||28
10874816|NCT02561299|12040943|FG000|NOT COMPLETED|Overall Study||5
10874817|NCT02561299|12040944|FG001|NOT COMPLETED|Overall Study||6
10874818|NCT02548143|12040952|FG000|STARTED|Overall Study||6
10874819|NCT02548143|12040953|FG001|STARTED|Overall Study||6
10874820|NCT02548143|12040952|FG000|COMPLETED|Overall Study||5
10874821|NCT02548143|12040953|FG001|COMPLETED|Overall Study||5
10874822|NCT02548143|12040952|FG000|NOT COMPLETED|Overall Study||1
10874823|NCT02548143|12040953|FG001|NOT COMPLETED|Overall Study||1
10760143|NCT03125200|11923892|FG002|NOT COMPLETED|Overall Study||2
10760144|NCT03125200|11923893|FG003|NOT COMPLETED|Overall Study||5
10760145|NCT03125200|11923894|FG004|NOT COMPLETED|Overall Study||4
10760146|NCT03125200|11923895|FG005|NOT COMPLETED|Overall Study||3
10760147|NCT03125200|11923896|FG006|NOT COMPLETED|Overall Study||3
10874824|NCT02448680|12040961|FG000|STARTED|Overall Study||12
10874825|NCT02448680|12040962|FG001|STARTED|Overall Study||13
10874826|NCT02448680|12040961|FG000|COMPLETED|Overall Study||11
10874827|NCT02448680|12040962|FG001|COMPLETED|Overall Study||10
10874828|NCT02448680|12040961|FG000|NOT COMPLETED|Overall Study||1
10874829|NCT02448680|12040962|FG001|NOT COMPLETED|Overall Study||3
10760148|NCT03125226|11923915|FG000|STARTED|Overall Study||12
10760149|NCT03125226|11923915|FG000|COMPLETED|Overall Study||12
10760150|NCT03125226|11923915|FG000|NOT COMPLETED|Overall Study||0
10760151|NCT03125395|11923919|FG000|STARTED|Overall Study||57
10760152|NCT03125395|11923919|FG000|Study 115B FAS|Overall Study||60
10760153|NCT03125395|11923919|FG000|Study 116 FAS|Overall Study||57
10760154|NCT03125395|11923919|FG000|Study 116 LCI Substudy Set|Overall Study||31
10760155|NCT03125395|11923919|FG000|COMPLETED|Overall Study||47
10760156|NCT03125395|11923919|FG000|NOT COMPLETED|Overall Study||10
10760157|NCT03125629|11923923|FG000|STARTED|Overall Study||53
10760158|NCT03125629|11923923|FG000|COMPLETED|Overall Study||50
10760159|NCT03125629|11923923|FG000|NOT COMPLETED|Overall Study||3
10760160|NCT03125915|11923939|FG000|STARTED|Baseline and Intervention||32
10760161|NCT03125915|11923940|FG001|STARTED|Baseline and Intervention||40
10760162|NCT03125915|11923941|FG002|STARTED|Baseline and Intervention||34
10760163|NCT03125915|11923942|FG003|STARTED|Baseline and Intervention||34
10760164|NCT03125915|11923939|FG000|COMPLETED|Baseline and Intervention||32
10760165|NCT03125915|11923940|FG001|COMPLETED|Baseline and Intervention||40
10760166|NCT03125915|11923941|FG002|COMPLETED|Baseline and Intervention||34
10760167|NCT03125915|11923942|FG003|COMPLETED|Baseline and Intervention||34
10760168|NCT03125915|11923939|FG000|NOT COMPLETED|Baseline and Intervention||0
10760169|NCT03125915|11923940|FG001|NOT COMPLETED|Baseline and Intervention||0
10760170|NCT03125915|11923941|FG002|NOT COMPLETED|Baseline and Intervention||0
10760171|NCT03125915|11923942|FG003|NOT COMPLETED|Baseline and Intervention||0
10760172|NCT03125915|11923939|FG000|STARTED|1 Month Follow up||32
10760173|NCT03125915|11923940|FG001|STARTED|1 Month Follow up||40
10760174|NCT03125915|11923941|FG002|STARTED|1 Month Follow up||34
10760175|NCT03125915|11923942|FG003|STARTED|1 Month Follow up||34
10760176|NCT03125915|11923939|FG000|COMPLETED|1 Month Follow up||29
10760177|NCT03125915|11923940|FG001|COMPLETED|1 Month Follow up||37
10760178|NCT03125915|11923941|FG002|COMPLETED|1 Month Follow up||32
10760179|NCT03125915|11923942|FG003|COMPLETED|1 Month Follow up||31
10760180|NCT03125915|11923939|FG000|NOT COMPLETED|1 Month Follow up||3
10760181|NCT03125915|11923940|FG001|NOT COMPLETED|1 Month Follow up||3
10760182|NCT03125915|11923941|FG002|NOT COMPLETED|1 Month Follow up||2
10760183|NCT03125915|11923942|FG003|NOT COMPLETED|1 Month Follow up||3
10760184|NCT03125915|11923939|FG000|STARTED|3 Month Follow-up||32
10760185|NCT03125915|11923940|FG001|STARTED|3 Month Follow-up||40
10760186|NCT03125915|11923941|FG002|STARTED|3 Month Follow-up||34
10760187|NCT03125915|11923942|FG003|STARTED|3 Month Follow-up||34
10760188|NCT03125915|11923939|FG000|COMPLETED|3 Month Follow-up||26
10760189|NCT03125915|11923940|FG001|COMPLETED|3 Month Follow-up||36
10760190|NCT03125915|11923941|FG002|COMPLETED|3 Month Follow-up||30
10760191|NCT03125915|11923942|FG003|COMPLETED|3 Month Follow-up||32
10760192|NCT03125915|11923939|FG000|NOT COMPLETED|3 Month Follow-up||6
10760193|NCT03125915|11923940|FG001|NOT COMPLETED|3 Month Follow-up||4
10760194|NCT03125915|11923941|FG002|NOT COMPLETED|3 Month Follow-up||4
10760195|NCT03125915|11923942|FG003|NOT COMPLETED|3 Month Follow-up||2
10760196|NCT03125915|11923939|FG000|STARTED|6 Month Follow-up||32
10760197|NCT03125915|11923940|FG001|STARTED|6 Month Follow-up||40
10760198|NCT03125915|11923941|FG002|STARTED|6 Month Follow-up||34
10760199|NCT03125915|11923942|FG003|STARTED|6 Month Follow-up||34
10760200|NCT03125915|11923939|FG000|COMPLETED|6 Month Follow-up||25
10760201|NCT03125915|11923940|FG001|COMPLETED|6 Month Follow-up||37
10760202|NCT03125915|11923941|FG002|COMPLETED|6 Month Follow-up||28
10760203|NCT03125915|11923942|FG003|COMPLETED|6 Month Follow-up||31
10760204|NCT03125915|11923939|FG000|NOT COMPLETED|6 Month Follow-up||7
10760205|NCT03125915|11923940|FG001|NOT COMPLETED|6 Month Follow-up||3
10760206|NCT03125915|11923941|FG002|NOT COMPLETED|6 Month Follow-up||6
10760207|NCT03125915|11923942|FG003|NOT COMPLETED|6 Month Follow-up||3
10760208|NCT03125941|11923954|FG000|STARTED|Overall Study||65
10760209|NCT03125941|11923955|FG001|STARTED|Overall Study||65
10760210|NCT03125941|11923954|FG000|Post-randomization Exclusion|Overall Study|procedure changed, did not receive intervention|1
10760211|NCT03125941|11923955|FG001|Post-randomization Exclusion|Overall Study|procedure changed, did not receive intervention|2
10760212|NCT03125941|11923954|FG000|COMPLETED|Overall Study||64
10760213|NCT03125941|11923955|FG001|COMPLETED|Overall Study||63
10760214|NCT03125941|11923954|FG000|NOT COMPLETED|Overall Study||1
10760215|NCT03125941|11923955|FG001|NOT COMPLETED|Overall Study||2
10760216|NCT03126227|11923963|FG000|STARTED|Overall Study||338
10760217|NCT03126227|11923964|FG001|STARTED|Overall Study||168
10760218|NCT03126227|11923963|FG000|COMPLETED|Overall Study||260
10760219|NCT03126227|11923964|FG001|COMPLETED|Overall Study||158
10760220|NCT03126227|11923963|FG000|NOT COMPLETED|Overall Study||78
10760221|NCT03126227|11923964|FG001|NOT COMPLETED|Overall Study||10
10760222|NCT03126344|11923973|FG000|STARTED|Overall Study||33
10760223|NCT03126344|11923974|FG001|STARTED|Overall Study||33
10760224|NCT03126344|11923975|FG002|STARTED|Overall Study||33
10760225|NCT03126344|11923973|FG000|COMPLETED|Overall Study||33
10760226|NCT03126344|11923974|FG001|COMPLETED|Overall Study||33
10760227|NCT03126344|11923975|FG002|COMPLETED|Overall Study||28
10760228|NCT03126344|11923973|FG000|NOT COMPLETED|Overall Study||0
10760229|NCT03126344|11923974|FG001|NOT COMPLETED|Overall Study||0
10760230|NCT03126344|11923975|FG002|NOT COMPLETED|Overall Study||5
10760231|NCT03126370|11923983|FG000|STARTED|TDF With a Boosted PI||10
10760232|NCT03126370|11923983|FG000|COMPLETED|TDF With a Boosted PI||10
10760233|NCT03126370|11923983|FG000|NOT COMPLETED|TDF With a Boosted PI||0
10760234|NCT03126370|11923983|FG000|STARTED|TAF With a Boosted PI||10
10760235|NCT03126370|11923983|FG000|COMPLETED|TAF With a Boosted PI||10
10760236|NCT03126370|11923983|FG000|NOT COMPLETED|TAF With a Boosted PI||0
10760237|NCT03126370|11923983|FG000|STARTED|TAF With a Boosted PI and LDV/SOF||10
10760238|NCT03126370|11923983|FG000|COMPLETED|TAF With a Boosted PI and LDV/SOF||10
10760239|NCT03126370|11923983|FG000|NOT COMPLETED|TAF With a Boosted PI and LDV/SOF||0
10760240|NCT03126370|11923983|FG000|STARTED|TAF With a Boosted PI||10
10760241|NCT03126370|11923983|FG000|COMPLETED|TAF With a Boosted PI||10
10760242|NCT03126370|11923983|FG000|NOT COMPLETED|TAF With a Boosted PI||0
10760243|NCT03126448|11923994|FG000|STARTED|Overall Study||56
10760244|NCT03126448|11923995|FG001|STARTED|Overall Study||49
10760245|NCT03126448|11923996|FG002|STARTED|Overall Study||37
10760246|NCT03126448|11923994|FG000|COMPLETED|Overall Study||43
10760247|NCT03126448|11923995|FG001|COMPLETED|Overall Study||41
10760248|NCT03126448|11923996|FG002|COMPLETED|Overall Study||27
10760249|NCT03126448|11923994|FG000|NOT COMPLETED|Overall Study||13
10760250|NCT03126448|11923995|FG001|NOT COMPLETED|Overall Study||8
10760251|NCT03126448|11923996|FG002|NOT COMPLETED|Overall Study||10
10760252|NCT03126682|11924006|FG000|STARTED|Overall Study||5
10760253|NCT03126682|11924007|FG001|STARTED|Overall Study||5
10760254|NCT03126682|11924006|FG000|COMPLETED|Overall Study||5
10760255|NCT03126682|11924007|FG001|COMPLETED|Overall Study||5
10760256|NCT03126682|11924006|FG000|NOT COMPLETED|Overall Study||0
10760257|NCT03126682|11924007|FG001|NOT COMPLETED|Overall Study||0
10760258|NCT03126760|11924015|FG000|STARTED|Overall Study||18
10760259|NCT03126760|11924016|FG001|STARTED|Overall Study||17
10760260|NCT03126760|11924015|FG000|Modified Intent to Treat (mITT)|Overall Study||18
10760261|NCT03126760|11924016|FG001|Modified Intent to Treat (mITT)|Overall Study||17
10760262|NCT03126760|11924015|FG000|Completed Treatment|Overall Study|One participant halted treatment for adverse event, but completed the study|17
10760263|NCT03126760|11924016|FG001|Completed Treatment|Overall Study||17
10760264|NCT03126760|11924015|FG000|COMPLETED|Overall Study||18
10760265|NCT03126760|11924016|FG001|COMPLETED|Overall Study||17
10760266|NCT03126760|11924015|FG000|NOT COMPLETED|Overall Study||0
10760267|NCT03126760|11924016|FG001|NOT COMPLETED|Overall Study||0
10760268|NCT03126786|11924024|FG000|STARTED|Overall Study||36
10760269|NCT03126786|11924025|FG001|STARTED|Overall Study||35
10760270|NCT03126786|11924024|FG000|COMPLETED|Overall Study||30
10760271|NCT03126786|11924025|FG001|COMPLETED|Overall Study||33
10760272|NCT03126786|11924024|FG000|NOT COMPLETED|Overall Study||6
10760273|NCT03126786|11924025|FG001|NOT COMPLETED|Overall Study||2
10760274|NCT03127228|11924033|FG000|STARTED|Overall Study||12
10760275|NCT03127228|11924034|FG001|STARTED|Overall Study||12
10760276|NCT03127228|11924033|FG000|COMPLETED|Overall Study||12
10760277|NCT03127228|11924034|FG001|COMPLETED|Overall Study||12
10760278|NCT03127228|11924033|FG000|NOT COMPLETED|Overall Study||0
10760279|NCT03127228|11924034|FG001|NOT COMPLETED|Overall Study||0
10760280|NCT03127358|11924043|FG000|STARTED|Overall Study|3/9/18:Date first participant was randomized to this arm.|3
10760281|NCT03127358|11924044|FG001|STARTED|Overall Study|3/22/18: Date first participant randomized to this arm.|3
10760282|NCT03127358|11924045|FG002|STARTED|Overall Study|3/14/18: Date first participant randomized to this arm..|5
10760283|NCT03127358|11924043|FG000|COMPLETED|Overall Study|12/26/18: Date of SVR for last participant randomized to this arm.|3
10760371|NCT03129178|11924143|FG000|STARTED|Overall Study||13
10760284|NCT03127358|11924044|FG001|COMPLETED|Overall Study|2/6/19: Date of SVR for last participant randomized to this arm.|3
10760285|NCT03127358|11924045|FG002|COMPLETED|Overall Study|11/20/18: Date of SVR for last participant randomized to this arm.|5
10760286|NCT03127358|11924043|FG000|NOT COMPLETED|Overall Study||0
10760287|NCT03127358|11924044|FG001|NOT COMPLETED|Overall Study||0
10760288|NCT03127358|11924045|FG002|NOT COMPLETED|Overall Study||0
10760293|NCT03127514|11924067|FG000|STARTED|Overall Study||48
10760294|NCT03127514|11924068|FG001|STARTED|Overall Study||89
10760295|NCT03127514|11924067|FG000|COMPLETED|Overall Study||38
10760296|NCT03127514|11924068|FG001|COMPLETED|Overall Study||67
10760297|NCT03127514|11924067|FG000|NOT COMPLETED|Overall Study||10
10760298|NCT03127514|11924068|FG001|NOT COMPLETED|Overall Study||22
10760299|NCT03127644|11924077|FG000|STARTED|Overall Study||34
10760300|NCT03127644|11924078|FG001|STARTED|Overall Study||36
10760301|NCT03127644|11924079|FG002|STARTED|Overall Study||33
10760302|NCT03127644|11924077|FG000|COMPLETED|Overall Study||34
10760303|NCT03127644|11924078|FG001|COMPLETED|Overall Study||36
10760304|NCT03127644|11924079|FG002|COMPLETED|Overall Study||31
10760305|NCT03127644|11924077|FG000|NOT COMPLETED|Overall Study||0
10760306|NCT03127644|11924078|FG001|NOT COMPLETED|Overall Study||0
10760307|NCT03127644|11924079|FG002|NOT COMPLETED|Overall Study||2
10760308|NCT03127943|11924089|FG000|STARTED|First Intervention||12
10760309|NCT03127943|11924090|FG001|STARTED|First Intervention||12
10760310|NCT03127943|11924089|FG000|COMPLETED|First Intervention||12
10760311|NCT03127943|11924090|FG001|COMPLETED|First Intervention||12
10760312|NCT03127943|11924089|FG000|NOT COMPLETED|First Intervention||0
10760313|NCT03127943|11924090|FG001|NOT COMPLETED|First Intervention||0
10760314|NCT03127943|11924089|FG000|STARTED|Washout (1 Week)||12
10760315|NCT03127943|11924090|FG001|STARTED|Washout (1 Week)||12
10760316|NCT03127943|11924089|FG000|COMPLETED|Washout (1 Week)||12
10760317|NCT03127943|11924090|FG001|COMPLETED|Washout (1 Week)||12
10760318|NCT03127943|11924089|FG000|NOT COMPLETED|Washout (1 Week)||0
10760319|NCT03127943|11924090|FG001|NOT COMPLETED|Washout (1 Week)||0
10760320|NCT03127943|11924089|FG000|STARTED|Second Intervention||12
10760321|NCT03127943|11924090|FG001|STARTED|Second Intervention||12
10760322|NCT03127943|11924089|FG000|COMPLETED|Second Intervention||12
10760323|NCT03127943|11924090|FG001|COMPLETED|Second Intervention||12
10760324|NCT03127943|11924089|FG000|NOT COMPLETED|Second Intervention||0
10760325|NCT03127943|11924090|FG001|NOT COMPLETED|Second Intervention||0
10760326|NCT03127956|11924096|FG000|STARTED|Overall Study||748
10760327|NCT03127956|11924096|FG000|COMPLETED|Overall Study||431
10760328|NCT03127956|11924096|FG000|NOT COMPLETED|Overall Study||317
10760329|NCT03128008|11924100|FG000|STARTED|Overall Study||10
10760330|NCT03128008|11924100|FG000|COMPLETED|Overall Study|9 participants are in follow up|1
10760331|NCT03128008|11924100|FG000|NOT COMPLETED|Overall Study||9
10760332|NCT03128086|11924107|FG000|STARTED|Overall Study||50
10760333|NCT03128086|11924108|FG001|STARTED|Overall Study||44
10760334|NCT03128086|11924107|FG000|COMPLETED|Overall Study||50
10760335|NCT03128086|11924108|FG001|COMPLETED|Overall Study||44
10760336|NCT03128086|11924107|FG000|NOT COMPLETED|Overall Study||0
10760337|NCT03128086|11924108|FG001|NOT COMPLETED|Overall Study||0
10760338|NCT03128099|11924117|FG000|STARTED|Overall Study||21
10760339|NCT03128099|11924118|FG001|STARTED|Overall Study||4
10760340|NCT03128099|11924119|FG002|STARTED|Overall Study||22
10760341|NCT03128099|11924117|FG000|Hour 1 (Low Dose) Started|Overall Study||21
10760342|NCT03128099|11924118|FG001|Hour 1 (Low Dose) Started|Overall Study||4
10760343|NCT03128099|11924119|FG002|Hour 1 (Low Dose) Started|Overall Study||22
10760344|NCT03128099|11924117|FG000|Hour 1 (Low Dose) Completed|Overall Study||19
10760345|NCT03128099|11924118|FG001|Hour 1 (Low Dose) Completed|Overall Study||4
10760346|NCT03128099|11924119|FG002|Hour 1 (Low Dose) Completed|Overall Study||21
10760347|NCT03128099|11924117|FG000|Hour 2 (High Dose)Started|Overall Study|Hour 2 of training not available to these participants|0
10760348|NCT03128099|11924118|FG001|Hour 2 (High Dose)Started|Overall Study||4
10760349|NCT03128099|11924119|FG002|Hour 2 (High Dose)Started|Overall Study|Hour 2 of training not available to these participants|0
10760350|NCT03128099|11924117|FG000|Hour 2 (High Dose) Completed|Overall Study||0
10760351|NCT03128099|11924118|FG001|Hour 2 (High Dose) Completed|Overall Study||0
10760352|NCT03128099|11924119|FG002|Hour 2 (High Dose) Completed|Overall Study||0
10760353|NCT03128099|11924117|FG000|COMPLETED|Overall Study||19
10760354|NCT03128099|11924118|FG001|COMPLETED|Overall Study|hour 2 training was completed by 0 participants|0
10760355|NCT03128099|11924119|FG002|COMPLETED|Overall Study||21
10760356|NCT03128099|11924117|FG000|NOT COMPLETED|Overall Study||2
10760357|NCT03128099|11924118|FG001|NOT COMPLETED|Overall Study||4
10760358|NCT03128099|11924119|FG002|NOT COMPLETED|Overall Study||1
10760359|NCT03128307|11924125|FG000|STARTED|Overall Study||604
10760360|NCT03128307|11924125|FG000|COMPLETED|Overall Study||570
10760361|NCT03128307|11924125|FG000|NOT COMPLETED|Overall Study||34
10760362|NCT03128372|11924129|FG000|STARTED|Overall Study||32
10760363|NCT03128372|11924129|FG000|COMPLETED|Overall Study||32
10760364|NCT03128372|11924129|FG000|NOT COMPLETED|Overall Study||0
10760365|NCT03128723|11924133|FG000|STARTED|Overall Study||45
10760366|NCT03128723|11924133|FG000|COMPLETED|Overall Study||43
10760367|NCT03128723|11924133|FG000|NOT COMPLETED|Overall Study||2
10760368|NCT03128892|11924137|FG000|STARTED|Overall Study||34
10760369|NCT03128892|11924137|FG000|COMPLETED|Overall Study||31
10760370|NCT03128892|11924137|FG000|NOT COMPLETED|Overall Study||3
10760372|NCT03129178|11924144|FG001|STARTED|Overall Study||13
10760373|NCT03129178|11924143|FG000|COMPLETED|Overall Study||12
10760374|NCT03129178|11924144|FG001|COMPLETED|Overall Study||11
10760375|NCT03129178|11924143|FG000|NOT COMPLETED|Overall Study||1
10760376|NCT03129178|11924144|FG001|NOT COMPLETED|Overall Study||2
10760377|NCT03129568|11924151|FG000|STARTED|Overall Study||5
10760378|NCT03129568|11924151|FG000|COMPLETED|Overall Study||5
10760379|NCT03129568|11924151|FG000|NOT COMPLETED|Overall Study||0
10760380|NCT03129945|11924157|FG000|STARTED|Overall Study||15
10760381|NCT03129945|11924158|FG001|STARTED|Overall Study||21
10760382|NCT03129945|11924157|FG000|COMPLETED|Overall Study||15
10760383|NCT03129945|11924158|FG001|COMPLETED|Overall Study||21
10760384|NCT03129945|11924157|FG000|NOT COMPLETED|Overall Study||0
10760385|NCT03129945|11924158|FG001|NOT COMPLETED|Overall Study||0
10778977|NCT03363854|11940793|FG000|COMPLETED|Initial Treatment Period||235
10778978|NCT03363854|11940794|FG001|COMPLETED|Initial Treatment Period||120
10778979|NCT03363854|11940795|FG002|COMPLETED|Initial Treatment Period||0
10778980|NCT03363854|11940796|FG003|COMPLETED|Initial Treatment Period||0
10778981|NCT03363854|11940797|FG004|COMPLETED|Initial Treatment Period||0
10778982|NCT03363854|11940798|FG005|COMPLETED|Initial Treatment Period||0
10778983|NCT03363854|11940799|FG006|COMPLETED|Initial Treatment Period||0
10778984|NCT03363854|11940800|FG007|COMPLETED|Initial Treatment Period||0
10778985|NCT03363854|11940793|FG000|NOT COMPLETED|Initial Treatment Period||18
10778986|NCT03363854|11940794|FG001|NOT COMPLETED|Initial Treatment Period||7
10778987|NCT03363854|11940795|FG002|NOT COMPLETED|Initial Treatment Period||0
10778988|NCT03363854|11940796|FG003|NOT COMPLETED|Initial Treatment Period||0
10778989|NCT03363854|11940797|FG004|NOT COMPLETED|Initial Treatment Period||0
10778990|NCT03363854|11940798|FG005|NOT COMPLETED|Initial Treatment Period||0
10778991|NCT03363854|11940799|FG006|NOT COMPLETED|Initial Treatment Period||0
10778992|NCT03363854|11940800|FG007|NOT COMPLETED|Initial Treatment Period||0
10778993|NCT03363854|11940793|FG000|STARTED|Continuation Treatment Period|This treatment group applies to the initial treatment period (see above).|0
10778994|NCT03363854|11940794|FG001|STARTED|Continuation Treatment Period|This treatment group applies to the initial treatment period (see above).|0
10778995|NCT03363854|11940795|FG002|STARTED|Continuation Treatment Period||69
10760386|NCT03130257|11924167|FG000|STARTED|Overall Study||172
10760387|NCT03130257|11924168|FG001|STARTED|Overall Study||170
10760388|NCT03130257|11924169|FG002|STARTED|Overall Study||168
10760389|NCT03130257|11924167|FG000|COMPLETED|Overall Study||171
10760390|NCT03130257|11924168|FG001|COMPLETED|Overall Study||170
10760391|NCT03130257|11924169|FG002|COMPLETED|Overall Study||166
10760392|NCT03130257|11924167|FG000|NOT COMPLETED|Overall Study||1
10760393|NCT03130257|11924168|FG001|NOT COMPLETED|Overall Study||0
10760394|NCT03130257|11924169|FG002|NOT COMPLETED|Overall Study||2
10760395|NCT03130738|11924180|FG000|STARTED|Overall Study||23
10760396|NCT03130738|11924181|FG001|STARTED|Overall Study||22
10760397|NCT03130738|11924182|FG002|STARTED|Overall Study||20
10760398|NCT03130738|11924180|FG000|COMPLETED|Overall Study||20
10760399|NCT03130738|11924181|FG001|COMPLETED|Overall Study||20
10760400|NCT03130738|11924182|FG002|COMPLETED|Overall Study||14
10760401|NCT03130738|11924180|FG000|NOT COMPLETED|Overall Study||3
10760402|NCT03130738|11924181|FG001|NOT COMPLETED|Overall Study||2
10760403|NCT03130738|11924182|FG002|NOT COMPLETED|Overall Study||6
10760404|NCT03131167|11924203|FG000|STARTED|Overall Study||6
10760405|NCT03131167|11924204|FG001|STARTED|Overall Study||5
10760406|NCT03131167|11924205|FG002|STARTED|Overall Study||5
10760407|NCT03131167|11924206|FG003|STARTED|Overall Study||5
10760408|NCT03131167|11924207|FG004|STARTED|Overall Study||6
10760409|NCT03131167|11924208|FG005|STARTED|Overall Study||5
10760410|NCT03131167|11924209|FG006|STARTED|Overall Study||5
10760411|NCT03131167|11924210|FG007|STARTED|Overall Study||5
10760412|NCT03131167|11924211|FG008|STARTED|Overall Study||2
10760413|NCT03131167|11924212|FG009|STARTED|Overall Study||5
10760414|NCT03131167|11924213|FG010|STARTED|Overall Study||4
10760415|NCT03131167|11924214|FG011|STARTED|Overall Study||5
10760416|NCT03131167|11924215|FG012|STARTED|Overall Study||5
10760417|NCT03131167|11924203|FG000|COMPLETED|Overall Study||6
10760418|NCT03131167|11924204|FG001|COMPLETED|Overall Study||5
10760419|NCT03131167|11924205|FG002|COMPLETED|Overall Study||5
10760420|NCT03131167|11924206|FG003|COMPLETED|Overall Study||5
10760421|NCT03131167|11924207|FG004|COMPLETED|Overall Study||6
10760422|NCT03131167|11924208|FG005|COMPLETED|Overall Study||4
10760423|NCT03131167|11924209|FG006|COMPLETED|Overall Study||5
10760424|NCT03131167|11924210|FG007|COMPLETED|Overall Study||5
10760425|NCT03131167|11924211|FG008|COMPLETED|Overall Study||2
10760426|NCT03131167|11924212|FG009|COMPLETED|Overall Study||5
10760427|NCT03131167|11924213|FG010|COMPLETED|Overall Study||4
10760428|NCT03131167|11924214|FG011|COMPLETED|Overall Study||5
10760429|NCT03131167|11924215|FG012|COMPLETED|Overall Study||5
10760430|NCT03131167|11924203|FG000|NOT COMPLETED|Overall Study||0
10760431|NCT03131167|11924204|FG001|NOT COMPLETED|Overall Study||0
10760432|NCT03131167|11924205|FG002|NOT COMPLETED|Overall Study||0
10760433|NCT03131167|11924206|FG003|NOT COMPLETED|Overall Study||0
10760434|NCT03131167|11924207|FG004|NOT COMPLETED|Overall Study||0
10760435|NCT03131167|11924208|FG005|NOT COMPLETED|Overall Study||1
10760436|NCT03131167|11924209|FG006|NOT COMPLETED|Overall Study||0
10760437|NCT03131167|11924210|FG007|NOT COMPLETED|Overall Study||0
10760438|NCT03131167|11924211|FG008|NOT COMPLETED|Overall Study||0
10760439|NCT03131167|11924212|FG009|NOT COMPLETED|Overall Study||0
10760440|NCT03131167|11924213|FG010|NOT COMPLETED|Overall Study||0
10760441|NCT03131167|11924214|FG011|NOT COMPLETED|Overall Study||0
10760442|NCT03131167|11924215|FG012|NOT COMPLETED|Overall Study||0
10760443|NCT03131206|11924248|FG000|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||5
10760444|NCT03131206|11924249|FG001|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
10760445|NCT03131206|11924250|FG002|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
10760446|NCT03131206|11924251|FG003|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
10760447|NCT03131206|11924248|FG000|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||5
10760448|NCT03131206|11924249|FG001|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
10760449|NCT03131206|11924250|FG002|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
10760450|NCT03131206|11924251|FG003|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
10760451|NCT03131206|11924248|FG000|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
10760452|NCT03131206|11924249|FG001|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
10760453|NCT03131206|11924250|FG002|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
10760454|NCT03131206|11924251|FG003|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
10760455|NCT03131206|11924248|FG000|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
10760456|NCT03131206|11924249|FG001|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
10760457|NCT03131206|11924250|FG002|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
10760458|NCT03131206|11924251|FG003|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
10760459|NCT03131206|11924248|FG000|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
10760460|NCT03131206|11924249|FG001|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
10760461|NCT03131206|11924250|FG002|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
10760462|NCT03131206|11924251|FG003|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
10760463|NCT03131206|11924248|FG000|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
10760464|NCT03131206|11924249|FG001|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
10760465|NCT03131206|11924250|FG002|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
10760466|NCT03131206|11924251|FG003|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
10760467|NCT03131453|11924268|FG000|STARTED|Overall Study||456
10760468|NCT03131453|11924269|FG001|STARTED|Overall Study||233
10760469|NCT03131453|11924270|FG002|STARTED|Overall Study||456
10760470|NCT03131453|11924268|FG000|Patient Misrandomized|Overall Study||1
10760471|NCT03131453|11924269|FG001|Patient Misrandomized|Overall Study||0
10760472|NCT03131453|11924270|FG002|Patient Misrandomized|Overall Study||0
10760473|NCT03131453|11924268|FG000|COMPLETED|Overall Study||0
10760474|NCT03131453|11924269|FG001|COMPLETED|Overall Study||0
10760475|NCT03131453|11924270|FG002|COMPLETED|Overall Study||0
10760476|NCT03131453|11924268|FG000|NOT COMPLETED|Overall Study||456
10760477|NCT03131453|11924269|FG001|NOT COMPLETED|Overall Study||233
10760478|NCT03131453|11924270|FG002|NOT COMPLETED|Overall Study||456
10760479|NCT03131479|11924283|FG000|STARTED|Overall Study||10
10760480|NCT03131479|11924284|FG001|STARTED|Overall Study||10
10760481|NCT03131479|11924285|FG002|STARTED|Overall Study||11
10760482|NCT03131479|11924286|FG003|STARTED|Overall Study||12
10760483|NCT03131479|11924287|FG004|STARTED|Overall Study||10
10760484|NCT03131479|11924283|FG000|Safety Analysis Set (SS)|Overall Study||10
10760485|NCT03131479|11924284|FG001|Safety Analysis Set (SS)|Overall Study||10
10760486|NCT03131479|11924285|FG002|Safety Analysis Set (SS)|Overall Study||11
10760487|NCT03131479|11924286|FG003|Safety Analysis Set (SS)|Overall Study||12
10760488|NCT03131479|11924287|FG004|Safety Analysis Set (SS)|Overall Study||10
10760489|NCT03131479|11924283|FG000|Pharmacokinetic Analysis Set (PAS)|Overall Study||10
10760490|NCT03131479|11924284|FG001|Pharmacokinetic Analysis Set (PAS)|Overall Study||10
10760491|NCT03131479|11924285|FG002|Pharmacokinetic Analysis Set (PAS)|Overall Study||11
10760492|NCT03131479|11924286|FG003|Pharmacokinetic Analysis Set (PAS)|Overall Study||12
10760493|NCT03131479|11924287|FG004|Pharmacokinetic Analysis Set (PAS)|Overall Study||10
10760494|NCT03131479|11924283|FG000|Pharcodynamic Analysis Set (PD)|Overall Study||10
10760495|NCT03131479|11924284|FG001|Pharcodynamic Analysis Set (PD)|Overall Study||10
10760496|NCT03131479|11924285|FG002|Pharcodynamic Analysis Set (PD)|Overall Study||11
10760497|NCT03131479|11924286|FG003|Pharcodynamic Analysis Set (PD)|Overall Study||12
10760498|NCT03131479|11924287|FG004|Pharcodynamic Analysis Set (PD)|Overall Study||10
10760499|NCT03131479|11924283|FG000|COMPLETED|Overall Study||10
10760500|NCT03131479|11924284|FG001|COMPLETED|Overall Study||10
10760501|NCT03131479|11924285|FG002|COMPLETED|Overall Study||10
10760502|NCT03131479|11924286|FG003|COMPLETED|Overall Study||10
10760503|NCT03131479|11924287|FG004|COMPLETED|Overall Study||10
10760504|NCT03131479|11924283|FG000|NOT COMPLETED|Overall Study||0
10760505|NCT03131479|11924284|FG001|NOT COMPLETED|Overall Study||0
10760506|NCT03131479|11924285|FG002|NOT COMPLETED|Overall Study||1
10760507|NCT03131479|11924286|FG003|NOT COMPLETED|Overall Study||2
10760508|NCT03131479|11924287|FG004|NOT COMPLETED|Overall Study||0
10760509|NCT03131570|11924301|FG000|STARTED|Overall Study||12
10760510|NCT03131570|11924302|FG001|STARTED|Overall Study||11
10760511|NCT03131570|11924301|FG000|COMPLETED|Overall Study||11
10760512|NCT03131570|11924302|FG001|COMPLETED|Overall Study||11
10760513|NCT03131570|11924301|FG000|NOT COMPLETED|Overall Study||1
10760514|NCT03131570|11924302|FG001|NOT COMPLETED|Overall Study||0
10760515|NCT03131596|11924310|FG000|STARTED|Overall Study||100
10760516|NCT03131596|11924311|FG001|STARTED|Overall Study||100
10760517|NCT03131596|11924310|FG000|COMPLETED|Overall Study||94
10546827|NCT01509846|11700609|FG002|COMPLETED|Received Vaccination 3||18
10546828|NCT01509846|11700610|FG003|COMPLETED|Received Vaccination 3||19
10546829|NCT01509846|11700611|FG004|COMPLETED|Received Vaccination 3||14
10546830|NCT01509846|11700607|FG000|NOT COMPLETED|Received Vaccination 3||0
10546831|NCT01509846|11700608|FG001|NOT COMPLETED|Received Vaccination 3||1
10546832|NCT01509846|11700609|FG002|NOT COMPLETED|Received Vaccination 3||1
10546833|NCT01509846|11700610|FG003|NOT COMPLETED|Received Vaccination 3||1
10546834|NCT01509846|11700611|FG004|NOT COMPLETED|Received Vaccination 3||0
10546835|NCT01509872|11700632|FG000|STARTED|Overall Study||26
10760518|NCT03131596|11924311|FG001|COMPLETED|Overall Study||97
10760519|NCT03131596|11924310|FG000|NOT COMPLETED|Overall Study||6
10760520|NCT03131596|11924311|FG001|NOT COMPLETED|Overall Study||3
10760521|NCT03131648|11924319|FG000|STARTED|Initial Treatment Period||603
10760522|NCT03131648|11924320|FG001|STARTED|Initial Treatment Period||199
10760523|NCT03131648|11924321|FG002|STARTED|Initial Treatment Period||0
10760524|NCT03131648|11924322|FG003|STARTED|Initial Treatment Period||0
10760525|NCT03131648|11924323|FG004|STARTED|Initial Treatment Period||0
10760526|NCT03131648|11924324|FG005|STARTED|Initial Treatment Period||0
10760527|NCT03131648|11924325|FG006|STARTED|Initial Treatment Period||0
10760528|NCT03131648|11924326|FG007|STARTED|Initial Treatment Period||0
10760529|NCT03131648|11924319|FG000|COMPLETED|Initial Treatment Period||550
10760530|NCT03131648|11924320|FG001|COMPLETED|Initial Treatment Period||179
10760531|NCT03131648|11924321|FG002|COMPLETED|Initial Treatment Period||0
10760532|NCT03131648|11924322|FG003|COMPLETED|Initial Treatment Period||0
10760533|NCT03131648|11924323|FG004|COMPLETED|Initial Treatment Period||0
10760534|NCT03131648|11924324|FG005|COMPLETED|Initial Treatment Period||0
10760535|NCT03131648|11924325|FG006|COMPLETED|Initial Treatment Period||0
10760536|NCT03131648|11924326|FG007|COMPLETED|Initial Treatment Period||0
10760537|NCT03131648|11924319|FG000|NOT COMPLETED|Initial Treatment Period||53
10760538|NCT03131648|11924320|FG001|NOT COMPLETED|Initial Treatment Period||20
10760539|NCT03131648|11924321|FG002|NOT COMPLETED|Initial Treatment Period||0
10760540|NCT03131648|11924322|FG003|NOT COMPLETED|Initial Treatment Period||0
10760541|NCT03131648|11924323|FG004|NOT COMPLETED|Initial Treatment Period||0
10760542|NCT03131648|11924324|FG005|NOT COMPLETED|Initial Treatment Period||0
10760543|NCT03131648|11924325|FG006|NOT COMPLETED|Initial Treatment Period||0
10546836|NCT01509872|11700633|FG001|STARTED|Overall Study||24
10546837|NCT01509872|11700632|FG000|Post-Intervention Assessment|Overall Study||26
10760544|NCT03131648|11924326|FG007|NOT COMPLETED|Initial Treatment Period||0
10760545|NCT03131648|11924319|FG000|STARTED|Open-label Treatment||0
10760546|NCT03131648|11924320|FG001|STARTED|Open-label Treatment||0
10760547|NCT03131648|11924321|FG002|STARTED|Open-label Treatment||0
10760548|NCT03131648|11924322|FG003|STARTED|Open-label Treatment||0
10760549|NCT03131648|11924323|FG004|STARTED|Open-label Treatment||0
10760550|NCT03131648|11924324|FG005|STARTED|Open-label Treatment||0
10760551|NCT03131648|11924325|FG006|STARTED|Open-label Treatment||564
10760552|NCT03131648|11924326|FG007|STARTED|Open-label Treatment||0
10760553|NCT03131648|11924319|FG000|COMPLETED|Open-label Treatment||0
10760554|NCT03131648|11924320|FG001|COMPLETED|Open-label Treatment||0
10760555|NCT03131648|11924321|FG002|COMPLETED|Open-label Treatment||0
10760556|NCT03131648|11924322|FG003|COMPLETED|Open-label Treatment||0
10760557|NCT03131648|11924323|FG004|COMPLETED|Open-label Treatment||0
10760558|NCT03131648|11924324|FG005|COMPLETED|Open-label Treatment||0
10760559|NCT03131648|11924325|FG006|COMPLETED|Open-label Treatment||446
10760560|NCT03131648|11924326|FG007|COMPLETED|Open-label Treatment||0
10760561|NCT03131648|11924319|FG000|NOT COMPLETED|Open-label Treatment||0
10760562|NCT03131648|11924320|FG001|NOT COMPLETED|Open-label Treatment||0
10760563|NCT03131648|11924321|FG002|NOT COMPLETED|Open-label Treatment||0
10760564|NCT03131648|11924322|FG003|NOT COMPLETED|Open-label Treatment||0
10760565|NCT03131648|11924323|FG004|NOT COMPLETED|Open-label Treatment||0
10760566|NCT03131648|11924324|FG005|NOT COMPLETED|Open-label Treatment||0
10760567|NCT03131648|11924325|FG006|NOT COMPLETED|Open-label Treatment||118
10760568|NCT03131648|11924326|FG007|NOT COMPLETED|Open-label Treatment||0
10760569|NCT03131648|11924319|FG000|STARTED|Maintenance Treatment Period||0
10760570|NCT03131648|11924320|FG001|STARTED|Maintenance Treatment Period||0
10760571|NCT03131648|11924321|FG002|STARTED|Maintenance Treatment Period||71
10760572|NCT03131648|11924322|FG003|STARTED|Maintenance Treatment Period||78
10760573|NCT03131648|11924323|FG004|STARTED|Maintenance Treatment Period||36
10760574|NCT03131648|11924324|FG005|STARTED|Maintenance Treatment Period||29
10760575|NCT03131648|11924325|FG006|STARTED|Maintenance Treatment Period||0
10760576|NCT03131648|11924326|FG007|STARTED|Maintenance Treatment Period||0
10760577|NCT03131648|11924319|FG000|COMPLETED|Maintenance Treatment Period||0
10760578|NCT03131648|11924320|FG001|COMPLETED|Maintenance Treatment Period||0
10760579|NCT03131648|11924321|FG002|COMPLETED|Maintenance Treatment Period||44
10760580|NCT03131648|11924322|FG003|COMPLETED|Maintenance Treatment Period||53
10760581|NCT03131648|11924323|FG004|COMPLETED|Maintenance Treatment Period||21
10760582|NCT03131648|11924324|FG005|COMPLETED|Maintenance Treatment Period||15
10760583|NCT03131648|11924325|FG006|COMPLETED|Maintenance Treatment Period||0
10760584|NCT03131648|11924326|FG007|COMPLETED|Maintenance Treatment Period||0
10760585|NCT03131648|11924319|FG000|NOT COMPLETED|Maintenance Treatment Period||0
10760586|NCT03131648|11924320|FG001|NOT COMPLETED|Maintenance Treatment Period||0
10760587|NCT03131648|11924321|FG002|NOT COMPLETED|Maintenance Treatment Period||27
10760588|NCT03131648|11924322|FG003|NOT COMPLETED|Maintenance Treatment Period||25
10760589|NCT03131648|11924323|FG004|NOT COMPLETED|Maintenance Treatment Period||15
10760590|NCT03131648|11924324|FG005|NOT COMPLETED|Maintenance Treatment Period||14
10760591|NCT03131648|11924325|FG006|NOT COMPLETED|Maintenance Treatment Period||0
10760592|NCT03131648|11924326|FG007|NOT COMPLETED|Maintenance Treatment Period||0
10760593|NCT03131648|11924319|FG000|STARTED|Open-label (Short Term Extension)||0
10760594|NCT03131648|11924320|FG001|STARTED|Open-label (Short Term Extension)||0
10760595|NCT03131648|11924321|FG002|STARTED|Open-label (Short Term Extension)||0
10760596|NCT03131648|11924322|FG003|STARTED|Open-label (Short Term Extension)||0
10760597|NCT03131648|11924323|FG004|STARTED|Open-label (Short Term Extension)||0
10760598|NCT03131648|11924324|FG005|STARTED|Open-label (Short Term Extension)||0
10760599|NCT03131648|11924325|FG006|STARTED|Open-label (Short Term Extension)||0
10760600|NCT03131648|11924326|FG007|STARTED|Open-label (Short Term Extension)||65
10760601|NCT03131648|11924319|FG000|COMPLETED|Open-label (Short Term Extension)||0
10760602|NCT03131648|11924320|FG001|COMPLETED|Open-label (Short Term Extension)||0
10760603|NCT03131648|11924321|FG002|COMPLETED|Open-label (Short Term Extension)||0
10760604|NCT03131648|11924322|FG003|COMPLETED|Open-label (Short Term Extension)||0
10760605|NCT03131648|11924323|FG004|COMPLETED|Open-label (Short Term Extension)||0
10760606|NCT03131648|11924324|FG005|COMPLETED|Open-label (Short Term Extension)||0
10760607|NCT03131648|11924325|FG006|COMPLETED|Open-label (Short Term Extension)||0
10760608|NCT03131648|11924326|FG007|COMPLETED|Open-label (Short Term Extension)||62
10760609|NCT03131648|11924319|FG000|NOT COMPLETED|Open-label (Short Term Extension)||0
10760610|NCT03131648|11924320|FG001|NOT COMPLETED|Open-label (Short Term Extension)||0
10760611|NCT03131648|11924321|FG002|NOT COMPLETED|Open-label (Short Term Extension)||0
10760612|NCT03131648|11924322|FG003|NOT COMPLETED|Open-label (Short Term Extension)||0
10760613|NCT03131648|11924323|FG004|NOT COMPLETED|Open-label (Short Term Extension)||0
10760614|NCT03131648|11924324|FG005|NOT COMPLETED|Open-label (Short Term Extension)||0
10760615|NCT03131648|11924325|FG006|NOT COMPLETED|Open-label (Short Term Extension)||0
10760616|NCT03131648|11924326|FG007|NOT COMPLETED|Open-label (Short Term Extension)||3
10760617|NCT03131687|11924349|FG000|STARTED|Overall Study||51
10760618|NCT03131687|11924350|FG001|STARTED|Overall Study||53
10760619|NCT03131687|11924351|FG002|STARTED|Overall Study||55
10760620|NCT03131687|11924352|FG003|STARTED|Overall Study||52
10760621|NCT03131687|11924353|FG004|STARTED|Overall Study||53
10760622|NCT03131687|11924354|FG005|STARTED|Overall Study||54
10760623|NCT03131687|11924349|FG000|Received at Least One Dose of Study Drug|Overall Study||51
10760624|NCT03131687|11924350|FG001|Received at Least One Dose of Study Drug|Overall Study||52
10760625|NCT03131687|11924351|FG002|Received at Least One Dose of Study Drug|Overall Study||55
10760626|NCT03131687|11924352|FG003|Received at Least One Dose of Study Drug|Overall Study||51
10760627|NCT03131687|11924353|FG004|Received at Least One Dose of Study Drug|Overall Study||53
10760628|NCT03131687|11924354|FG005|Received at Least One Dose of Study Drug|Overall Study||54
10760629|NCT03131687|11924349|FG000|COMPLETED|Overall Study||45
10760630|NCT03131687|11924350|FG001|COMPLETED|Overall Study||44
10760631|NCT03131687|11924351|FG002|COMPLETED|Overall Study||52
10760632|NCT03131687|11924352|FG003|COMPLETED|Overall Study||48
10760633|NCT03131687|11924353|FG004|COMPLETED|Overall Study||45
10760634|NCT03131687|11924354|FG005|COMPLETED|Overall Study||49
10760635|NCT03131687|11924349|FG000|NOT COMPLETED|Overall Study||6
10760636|NCT03131687|11924350|FG001|NOT COMPLETED|Overall Study||9
10760637|NCT03131687|11924351|FG002|NOT COMPLETED|Overall Study||3
10760638|NCT03131687|11924352|FG003|NOT COMPLETED|Overall Study||4
10760639|NCT03131687|11924353|FG004|NOT COMPLETED|Overall Study||8
10760640|NCT03131687|11924354|FG005|NOT COMPLETED|Overall Study||5
10760641|NCT03131713|11924383|FG000|STARTED|Overall Study||50
10760642|NCT03131713|11924384|FG001|STARTED|Overall Study|1 intervention subject was added on after the protocol was initiated.|51
10760643|NCT03131713|11924383|FG000|COMPLETED|Overall Study||45
10760644|NCT03131713|11924384|FG001|COMPLETED|Overall Study||51
10760645|NCT03131713|11924383|FG000|NOT COMPLETED|Overall Study||5
10760646|NCT03131713|11924384|FG001|NOT COMPLETED|Overall Study||0
10760647|NCT03131895|11924394|FG000|STARTED|Intervention Period 1 (2 Days)||28
10760648|NCT03131895|11924395|FG001|STARTED|Intervention Period 1 (2 Days)||28
10760649|NCT03131895|11924396|FG002|STARTED|Intervention Period 1 (2 Days)||30
10760650|NCT03131895|11924397|FG003|STARTED|Intervention Period 1 (2 Days)||30
10760651|NCT03131895|11924394|FG000|COMPLETED|Intervention Period 1 (2 Days)||28
10760652|NCT03131895|11924395|FG001|COMPLETED|Intervention Period 1 (2 Days)||28
10760653|NCT03131895|11924396|FG002|COMPLETED|Intervention Period 1 (2 Days)||30
10760654|NCT03131895|11924397|FG003|COMPLETED|Intervention Period 1 (2 Days)||30
10760655|NCT03131895|11924394|FG000|NOT COMPLETED|Intervention Period 1 (2 Days)||0
10760656|NCT03131895|11924395|FG001|NOT COMPLETED|Intervention Period 1 (2 Days)||0
10760657|NCT03131895|11924396|FG002|NOT COMPLETED|Intervention Period 1 (2 Days)||0
10760658|NCT03131895|11924397|FG003|NOT COMPLETED|Intervention Period 1 (2 Days)||0
10760659|NCT03131895|11924394|FG000|STARTED|Washout Period (at Least 5 Days)||28
10760660|NCT03131895|11924395|FG001|STARTED|Washout Period (at Least 5 Days)||28
10760661|NCT03131895|11924396|FG002|STARTED|Washout Period (at Least 5 Days)||30
10760662|NCT03131895|11924397|FG003|STARTED|Washout Period (at Least 5 Days)||30
10760663|NCT03131895|11924394|FG000|COMPLETED|Washout Period (at Least 5 Days)||27
10760664|NCT03131895|11924395|FG001|COMPLETED|Washout Period (at Least 5 Days)||23
10760665|NCT03131895|11924396|FG002|COMPLETED|Washout Period (at Least 5 Days)||26
10760666|NCT03131895|11924397|FG003|COMPLETED|Washout Period (at Least 5 Days)||25
10760667|NCT03131895|11924394|FG000|NOT COMPLETED|Washout Period (at Least 5 Days)||1
10760668|NCT03131895|11924395|FG001|NOT COMPLETED|Washout Period (at Least 5 Days)||5
10760669|NCT03131895|11924396|FG002|NOT COMPLETED|Washout Period (at Least 5 Days)||4
10760670|NCT03131895|11924397|FG003|NOT COMPLETED|Washout Period (at Least 5 Days)||5
10760671|NCT03131895|11924394|FG000|STARTED|Intervention Period 2 (2 Days)||27
10760672|NCT03131895|11924395|FG001|STARTED|Intervention Period 2 (2 Days)||23
10760673|NCT03131895|11924396|FG002|STARTED|Intervention Period 2 (2 Days)||26
10760674|NCT03131895|11924397|FG003|STARTED|Intervention Period 2 (2 Days)||25
10760675|NCT03131895|11924394|FG000|COMPLETED|Intervention Period 2 (2 Days)||26
10760676|NCT03131895|11924395|FG001|COMPLETED|Intervention Period 2 (2 Days)||22
10760677|NCT03131895|11924396|FG002|COMPLETED|Intervention Period 2 (2 Days)||26
10760678|NCT03131895|11924397|FG003|COMPLETED|Intervention Period 2 (2 Days)||25
10760679|NCT03131895|11924394|FG000|NOT COMPLETED|Intervention Period 2 (2 Days)||1
10760680|NCT03131895|11924395|FG001|NOT COMPLETED|Intervention Period 2 (2 Days)||1
10760681|NCT03131895|11924396|FG002|NOT COMPLETED|Intervention Period 2 (2 Days)||0
10760682|NCT03131895|11924397|FG003|NOT COMPLETED|Intervention Period 2 (2 Days)||0
10760683|NCT03131999|11924409|FG000|STARTED|Overall Study||8
10760684|NCT03131999|11924410|FG001|STARTED|Overall Study||8
10760685|NCT03131999|11924409|FG000|COMPLETED|Overall Study||8
10760686|NCT03131999|11924410|FG001|COMPLETED|Overall Study||7
10760687|NCT03131999|11924409|FG000|NOT COMPLETED|Overall Study||0
10760688|NCT03131999|11924410|FG001|NOT COMPLETED|Overall Study||1
10760689|NCT03132220|11924418|FG000|STARTED|Overall Study||65
10760690|NCT03132220|11924419|FG001|STARTED|Overall Study||66
10760691|NCT03132220|11924418|FG000|Began Study Sessions|Overall Study|65 participants randomized to intervention arm;17 lost to f/u prior to study start;48 began sessions|48
10760692|NCT03132220|11924419|FG001|Began Study Sessions|Overall Study|66 participants randomized to control arm;8 were lost to f/u prior to study start; 58 began sessions|58
10760693|NCT03132220|11924418|FG000|COMPLETED|Overall Study||47
10760694|NCT03132220|11924419|FG001|COMPLETED|Overall Study||54
10760695|NCT03132220|11924418|FG000|NOT COMPLETED|Overall Study||18
10760696|NCT03132220|11924419|FG001|NOT COMPLETED|Overall Study||12
10760697|NCT03132246|11924427|FG000|STARTED|Overall Study||260
10760698|NCT03132246|11924427|FG000|COMPLETED|Overall Study||156
10760699|NCT03132246|11924427|FG000|NOT COMPLETED|Overall Study||104
10760700|NCT03132298|11924436|FG000|STARTED|Overall Study||48
10760701|NCT03132298|11924437|FG001|STARTED|Overall Study||48
10760702|NCT03132298|11924436|FG000|COMPLETED|Overall Study||36
10760703|NCT03132298|11924437|FG001|COMPLETED|Overall Study||35
10760704|NCT03132298|11924436|FG000|NOT COMPLETED|Overall Study||12
10760705|NCT03132298|11924437|FG001|NOT COMPLETED|Overall Study||13
10760706|NCT03132571|11924445|FG000|STARTED|Overall Study||3
10760707|NCT03132571|11924446|FG001|STARTED|Overall Study||2
10760708|NCT03132571|11924445|FG000|COMPLETED|Overall Study||3
10760709|NCT03132571|11924446|FG001|COMPLETED|Overall Study||2
10760710|NCT03132571|11924445|FG000|NOT COMPLETED|Overall Study||0
10760711|NCT03132571|11924446|FG001|NOT COMPLETED|Overall Study||0
10760712|NCT03133481|11924454|FG000|STARTED|Overall Study||45
10760713|NCT03133481|11924455|FG001|STARTED|Overall Study||49
10760714|NCT03133481|11924454|FG000|COMPLETED|Overall Study||45
10760715|NCT03133481|11924455|FG001|COMPLETED|Overall Study||45
10760716|NCT03133481|11924454|FG000|NOT COMPLETED|Overall Study||0
10760717|NCT03133481|11924455|FG001|NOT COMPLETED|Overall Study||4
10760718|NCT03133676|11924470|FG000|STARTED|Overall Study||6
10760719|NCT03133676|11924471|FG001|STARTED|Overall Study||3
10760720|NCT03133676|11924472|FG002|STARTED|Overall Study||3
10760721|NCT03133676|11924473|FG003|STARTED|Overall Study||6
10760722|NCT03133676|11924474|FG004|STARTED|Overall Study||6
10760723|NCT03133676|11924475|FG005|STARTED|Overall Study||9
10760724|NCT03133676|11924476|FG006|STARTED|Overall Study||9
10760725|NCT03133676|11924477|FG007|STARTED|Overall Study||9
10760726|NCT03133676|11924478|FG008|STARTED|Overall Study||9
10760727|NCT03133676|11924470|FG000|COMPLETED|Overall Study||6
10760728|NCT03133676|11924471|FG001|COMPLETED|Overall Study||3
10760729|NCT03133676|11924472|FG002|COMPLETED|Overall Study||3
10760730|NCT03133676|11924473|FG003|COMPLETED|Overall Study||6
10760731|NCT03133676|11924474|FG004|COMPLETED|Overall Study||6
10760732|NCT03133676|11924475|FG005|COMPLETED|Overall Study||9
10760733|NCT03133676|11924476|FG006|COMPLETED|Overall Study||9
10760734|NCT03133676|11924477|FG007|COMPLETED|Overall Study||9
10760735|NCT03133676|11924478|FG008|COMPLETED|Overall Study||9
10760736|NCT03133676|11924470|FG000|NOT COMPLETED|Overall Study||0
10760737|NCT03133676|11924471|FG001|NOT COMPLETED|Overall Study||0
10760738|NCT03133676|11924472|FG002|NOT COMPLETED|Overall Study||0
10760739|NCT03133676|11924473|FG003|NOT COMPLETED|Overall Study||0
10760740|NCT03133676|11924474|FG004|NOT COMPLETED|Overall Study||0
10760741|NCT03133676|11924475|FG005|NOT COMPLETED|Overall Study||0
10760742|NCT03133676|11924476|FG006|NOT COMPLETED|Overall Study||0
10760743|NCT03133676|11924477|FG007|NOT COMPLETED|Overall Study||0
10760744|NCT03133676|11924478|FG008|NOT COMPLETED|Overall Study||0
10760745|NCT03133767|11924507|FG000|STARTED|Overall Study||79
10760746|NCT03133767|11924508|FG001|STARTED|Overall Study||78
10760747|NCT03133767|11924507|FG000|COMPLETED|Overall Study||41
10760748|NCT03133767|11924508|FG001|COMPLETED|Overall Study||53
10760749|NCT03133767|11924507|FG000|NOT COMPLETED|Overall Study||38
10760750|NCT03133767|11924508|FG001|NOT COMPLETED|Overall Study||25
10760751|NCT03134092|11924517|FG000|STARTED|Overall Study||434
10760752|NCT03134092|11924518|FG001|STARTED|Overall Study||435
10760753|NCT03134092|11924519|FG002|STARTED|Overall Study||433
10760754|NCT03134092|11924517|FG000|COMPLETED|Overall Study||434
10760755|NCT03134092|11924518|FG001|COMPLETED|Overall Study||435
10760756|NCT03134092|11924519|FG002|COMPLETED|Overall Study||433
10760757|NCT03134092|11924517|FG000|NOT COMPLETED|Overall Study||0
10760758|NCT03134092|11924518|FG001|NOT COMPLETED|Overall Study||0
10760759|NCT03134092|11924519|FG002|NOT COMPLETED|Overall Study||0
10760760|NCT03134144|11924533|FG000|STARTED|Overall Study||15
10760761|NCT03134144|11924534|FG001|STARTED|Overall Study||30
10760762|NCT03134144|11924533|FG000|COMPLETED|Overall Study||15
10760763|NCT03134144|11924534|FG001|COMPLETED|Overall Study||30
10760764|NCT03134144|11924533|FG000|NOT COMPLETED|Overall Study||0
10760765|NCT03134144|11924534|FG001|NOT COMPLETED|Overall Study||0
10760766|NCT03134183|11924547|FG000|STARTED|Overall Study||36
10760767|NCT03134183|11924548|FG001|STARTED|Overall Study||34
10760768|NCT03134183|11924547|FG000|COMPLETED|Overall Study||35
10760769|NCT03134183|11924548|FG001|COMPLETED|Overall Study||33
10760770|NCT03134183|11924547|FG000|NOT COMPLETED|Overall Study||1
10760771|NCT03134183|11924548|FG001|NOT COMPLETED|Overall Study||1
10760772|NCT03134209|11924557|FG000|STARTED|Overall Study||53
10760773|NCT03134209|11924558|FG001|STARTED|Overall Study||54
10760774|NCT03134209|11924559|FG002|STARTED|Overall Study||53
10760775|NCT03134209|11924557|FG000|COMPLETED|Overall Study||53
10760776|NCT03134209|11924558|FG001|COMPLETED|Overall Study||54
10760777|NCT03134209|11924559|FG002|COMPLETED|Overall Study||53
10760778|NCT03134209|11924557|FG000|NOT COMPLETED|Overall Study||0
10760779|NCT03134209|11924558|FG001|NOT COMPLETED|Overall Study||0
10760780|NCT03134209|11924559|FG002|NOT COMPLETED|Overall Study||0
10760781|NCT03134222|11924570|FG000|STARTED|Treatment Period (Up to Week 12)||19
10760782|NCT03134222|11924571|FG001|STARTED|Treatment Period (Up to Week 12)||18
10760783|NCT03134222|11924572|FG002|STARTED|Treatment Period (Up to Week 12)||10
10760784|NCT03134222|11924573|FG003|STARTED|Treatment Period (Up to Week 12)||0
10760785|NCT03134222|11924574|FG004|STARTED|Treatment Period (Up to Week 12)||0
10760786|NCT03134222|11924570|FG000|COMPLETED|Treatment Period (Up to Week 12)||14
10760787|NCT03134222|11924571|FG001|COMPLETED|Treatment Period (Up to Week 12)||14
10760788|NCT03134222|11924572|FG002|COMPLETED|Treatment Period (Up to Week 12)||8
10760789|NCT03134222|11924573|FG003|COMPLETED|Treatment Period (Up to Week 12)||0
10760790|NCT03134222|11924574|FG004|COMPLETED|Treatment Period (Up to Week 12)||0
10760791|NCT03134222|11924570|FG000|NOT COMPLETED|Treatment Period (Up to Week 12)||5
10760792|NCT03134222|11924571|FG001|NOT COMPLETED|Treatment Period (Up to Week 12)||4
10760793|NCT03134222|11924572|FG002|NOT COMPLETED|Treatment Period (Up to Week 12)||2
10760794|NCT03134222|11924573|FG003|NOT COMPLETED|Treatment Period (Up to Week 12)||0
10760795|NCT03134222|11924574|FG004|NOT COMPLETED|Treatment Period (Up to Week 12)||0
10760796|NCT03134222|11924570|FG000|STARTED|Treatment Period (Week 12 to 48)||14
10760797|NCT03134222|11924571|FG001|STARTED|Treatment Period (Week 12 to 48)||14
10760798|NCT03134222|11924572|FG002|STARTED|Treatment Period (Week 12 to 48)|Participants were rerandomized 1:1 to either Placebo to Lanraplenib or Placebo to Filgotinib arm.|0
10760799|NCT03134222|11924573|FG003|STARTED|Treatment Period (Week 12 to 48)|Participants were rerandomized from the Placebo arm.|4
10760800|NCT03134222|11924574|FG004|STARTED|Treatment Period (Week 12 to 48)|Participants were rerandomized from the Placebo arm.|4
10760801|NCT03134222|11924570|FG000|COMPLETED|Treatment Period (Week 12 to 48)||12
10760802|NCT03134222|11924571|FG001|COMPLETED|Treatment Period (Week 12 to 48)||11
10760803|NCT03134222|11924572|FG002|COMPLETED|Treatment Period (Week 12 to 48)||0
10760804|NCT03134222|11924573|FG003|COMPLETED|Treatment Period (Week 12 to 48)||3
10760805|NCT03134222|11924574|FG004|COMPLETED|Treatment Period (Week 12 to 48)||3
10760806|NCT03134222|11924570|FG000|NOT COMPLETED|Treatment Period (Week 12 to 48)||2
10760807|NCT03134222|11924571|FG001|NOT COMPLETED|Treatment Period (Week 12 to 48)||3
10760808|NCT03134222|11924572|FG002|NOT COMPLETED|Treatment Period (Week 12 to 48)||0
10760809|NCT03134222|11924573|FG003|NOT COMPLETED|Treatment Period (Week 12 to 48)||1
10760810|NCT03134222|11924574|FG004|NOT COMPLETED|Treatment Period (Week 12 to 48)||1
10760811|NCT03134248|11924584|FG000|STARTED|Week 1||7
10760812|NCT03134248|11924585|FG001|STARTED|Week 1||8
10760813|NCT03134248|11924586|FG002|STARTED|Week 1||9
10760814|NCT03134248|11924587|FG003|STARTED|Week 1||7
10760815|NCT03134248|11924588|FG004|STARTED|Week 1||9
10760816|NCT03134248|11924589|FG005|STARTED|Week 1||9
10760817|NCT03134248|11924584|FG000|COMPLETED|Week 1||7
10760818|NCT03134248|11924585|FG001|COMPLETED|Week 1||8
10760819|NCT03134248|11924586|FG002|COMPLETED|Week 1||9
10760820|NCT03134248|11924587|FG003|COMPLETED|Week 1||7
10760821|NCT03134248|11924588|FG004|COMPLETED|Week 1||9
10760822|NCT03134248|11924589|FG005|COMPLETED|Week 1||9
10760823|NCT03134248|11924584|FG000|NOT COMPLETED|Week 1||0
10760824|NCT03134248|11924585|FG001|NOT COMPLETED|Week 1||0
10760825|NCT03134248|11924586|FG002|NOT COMPLETED|Week 1||0
10760826|NCT03134248|11924587|FG003|NOT COMPLETED|Week 1||0
10760827|NCT03134248|11924588|FG004|NOT COMPLETED|Week 1||0
10760828|NCT03134248|11924589|FG005|NOT COMPLETED|Week 1||0
10760829|NCT03134248|11924584|FG000|STARTED|Week 2||7
10760830|NCT03134248|11924585|FG001|STARTED|Week 2||8
10760831|NCT03134248|11924586|FG002|STARTED|Week 2||9
10760832|NCT03134248|11924587|FG003|STARTED|Week 2||7
10296930|NCT00943852|11429423|FG006|NOT COMPLETED|Fifth Period of Treatment Intervention||0
10296931|NCT00943852|11429424|FG007|NOT COMPLETED|Fifth Period of Treatment Intervention||0
10296932|NCT00943852|11429425|FG008|NOT COMPLETED|Fifth Period of Treatment Intervention||0
10296933|NCT00943852|11429426|FG009|NOT COMPLETED|Fifth Period of Treatment Intervention||0
10296934|NCT00927953|11429438|FG000|STARTED|Overall Study||6
10296935|NCT00927953|11429439|FG001|STARTED|Overall Study||7
10296936|NCT00927953|11429438|FG000|COMPLETED|Overall Study||4
10296937|NCT00927953|11429439|FG001|COMPLETED|Overall Study||6
10296938|NCT00927953|11429438|FG000|NOT COMPLETED|Overall Study||2
10296939|NCT00927953|11429439|FG001|NOT COMPLETED|Overall Study||1
10296940|NCT00909389|11429446|FG000|STARTED|Overall Study||4748
10296941|NCT00909389|11429446|FG000|COMPLETED|Overall Study||4615
10296942|NCT00909389|11429446|FG000|NOT COMPLETED|Overall Study||133
10296943|NCT00820027|11429454|FG000|STARTED|Overall Study||224
10296944|NCT00820027|11429455|FG001|STARTED|Overall Study||230
10296945|NCT00820027|11429456|FG002|STARTED|Overall Study||224
10296946|NCT00820027|11429457|FG003|STARTED|Overall Study||98
10296947|NCT00820027|11429454|FG000|COMPLETED|Overall Study||198
10296948|NCT00820027|11429455|FG001|COMPLETED|Overall Study||216
10296949|NCT00820027|11429456|FG002|COMPLETED|Overall Study||203
10296950|NCT00820027|11429457|FG003|COMPLETED|Overall Study||85
10296951|NCT00820027|11429454|FG000|NOT COMPLETED|Overall Study||26
10296952|NCT00820027|11429455|FG001|NOT COMPLETED|Overall Study||14
10296953|NCT00820027|11429456|FG002|NOT COMPLETED|Overall Study||21
10296954|NCT00820027|11429457|FG003|NOT COMPLETED|Overall Study||13
10296955|NCT00788710|11429471|FG000|STARTED|Overall Study||144
10296956|NCT00788710|11429472|FG001|STARTED|Overall Study||142
10296957|NCT00788710|11429473|FG002|STARTED|Overall Study||144
10296958|NCT00788710|11429471|FG000|COMPLETED|Overall Study||139
10296959|NCT00788710|11429472|FG001|COMPLETED|Overall Study||134
10296960|NCT00788710|11429473|FG002|COMPLETED|Overall Study||138
10296961|NCT00788710|11429471|FG000|NOT COMPLETED|Overall Study||5
10296962|NCT00788710|11429472|FG001|NOT COMPLETED|Overall Study||8
10296963|NCT00788710|11429473|FG002|NOT COMPLETED|Overall Study||6
10296964|NCT00783224|11429485|FG000|STARTED|Overall Study||32
10760833|NCT03134248|11924588|FG004|STARTED|Week 2||9
10760834|NCT03134248|11924589|FG005|STARTED|Week 2||9
10760835|NCT03134248|11924584|FG000|COMPLETED|Week 2||7
10760836|NCT03134248|11924585|FG001|COMPLETED|Week 2||8
10760837|NCT03134248|11924586|FG002|COMPLETED|Week 2||9
10760838|NCT03134248|11924587|FG003|COMPLETED|Week 2||7
10760839|NCT03134248|11924588|FG004|COMPLETED|Week 2||9
10760840|NCT03134248|11924589|FG005|COMPLETED|Week 2||9
10760841|NCT03134248|11924584|FG000|NOT COMPLETED|Week 2||0
10760842|NCT03134248|11924585|FG001|NOT COMPLETED|Week 2||0
10760843|NCT03134248|11924586|FG002|NOT COMPLETED|Week 2||0
10760844|NCT03134248|11924587|FG003|NOT COMPLETED|Week 2||0
10760845|NCT03134248|11924588|FG004|NOT COMPLETED|Week 2||0
10296965|NCT00783224|11429486|FG001|STARTED|Overall Study||34
10296966|NCT00783224|11429487|FG002|STARTED|Overall Study||143
10760846|NCT03134248|11924589|FG005|NOT COMPLETED|Week 2||0
10760847|NCT03134248|11924584|FG000|STARTED|Week 3||7
10760848|NCT03134248|11924585|FG001|STARTED|Week 3||8
10760849|NCT03134248|11924586|FG002|STARTED|Week 3||9
10760850|NCT03134248|11924587|FG003|STARTED|Week 3||7
10760851|NCT03134248|11924588|FG004|STARTED|Week 3||9
10760852|NCT03134248|11924589|FG005|STARTED|Week 3||9
10760853|NCT03134248|11924584|FG000|COMPLETED|Week 3||7
10760854|NCT03134248|11924585|FG001|COMPLETED|Week 3||8
10760855|NCT03134248|11924586|FG002|COMPLETED|Week 3||9
10760856|NCT03134248|11924587|FG003|COMPLETED|Week 3||7
10760857|NCT03134248|11924588|FG004|COMPLETED|Week 3||9
10760858|NCT03134248|11924589|FG005|COMPLETED|Week 3||9
10760859|NCT03134248|11924584|FG000|NOT COMPLETED|Week 3||0
10760860|NCT03134248|11924585|FG001|NOT COMPLETED|Week 3||0
10760861|NCT03134248|11924586|FG002|NOT COMPLETED|Week 3||0
10760862|NCT03134248|11924587|FG003|NOT COMPLETED|Week 3||0
10760863|NCT03134248|11924588|FG004|NOT COMPLETED|Week 3||0
10760864|NCT03134248|11924589|FG005|NOT COMPLETED|Week 3||0
10760865|NCT03134313|11924599|FG000|STARTED|Overall Study||25
10874830|NCT02352103|12040972|FG000|STARTED|Overall Study||60
10874831|NCT02352103|12040973|FG001|STARTED|Overall Study||60
10874832|NCT02352103|12040972|FG000|COMPLETED|Overall Study||60
10874833|NCT02352103|12040973|FG001|COMPLETED|Overall Study||59
10874834|NCT02352103|12040972|FG000|NOT COMPLETED|Overall Study||0
10874835|NCT02352103|12040973|FG001|NOT COMPLETED|Overall Study||1
10874836|NCT02273362|12040982|FG000|STARTED|Overall Study||5
10874837|NCT02273362|12040983|FG001|STARTED|Overall Study||6
10874838|NCT02273362|12040984|FG002|STARTED|Overall Study||14
10874839|NCT02273362|12040982|FG000|COMPLETED|Overall Study||5
10874840|NCT02273362|12040983|FG001|COMPLETED|Overall Study||6
10874841|NCT02273362|12040984|FG002|COMPLETED|Overall Study||14
10874842|NCT02273362|12040982|FG000|NOT COMPLETED|Overall Study||0
10874843|NCT02273362|12040983|FG001|NOT COMPLETED|Overall Study||0
10874844|NCT02273362|12040984|FG002|NOT COMPLETED|Overall Study||0
10296967|NCT00783224|11429488|FG003|STARTED|Overall Study||142
10296968|NCT00783224|11429485|FG000|COMPLETED|Overall Study||32
10296969|NCT00783224|11429486|FG001|COMPLETED|Overall Study||34
10296970|NCT00783224|11429487|FG002|COMPLETED|Overall Study||142
10296971|NCT00783224|11429488|FG003|COMPLETED|Overall Study||140
10296972|NCT00783224|11429485|FG000|NOT COMPLETED|Overall Study||0
10296973|NCT00783224|11429486|FG001|NOT COMPLETED|Overall Study||0
10296974|NCT00783224|11429487|FG002|NOT COMPLETED|Overall Study||1
10296975|NCT00783224|11429488|FG003|NOT COMPLETED|Overall Study||2
10296976|NCT00780403|11429497|FG000|STARTED|First Intervention||109
10296977|NCT00780403|11429498|FG001|STARTED|First Intervention||111
10296978|NCT00780403|11429497|FG000|COMPLETED|First Intervention||109
10296979|NCT00780403|11429498|FG001|COMPLETED|First Intervention||111
10296980|NCT00780403|11429497|FG000|NOT COMPLETED|First Intervention||0
10296981|NCT00780403|11429498|FG001|NOT COMPLETED|First Intervention||0
10296982|NCT00780403|11429497|FG000|STARTED|Interval Between Doses (8-10 Minutes)||109
10296983|NCT00780403|11429498|FG001|STARTED|Interval Between Doses (8-10 Minutes)||111
10296984|NCT00780403|11429497|FG000|COMPLETED|Interval Between Doses (8-10 Minutes)||109
10296985|NCT00780403|11429498|FG001|COMPLETED|Interval Between Doses (8-10 Minutes)||111
10296986|NCT00780403|11429497|FG000|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
10296987|NCT00780403|11429498|FG001|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
10296988|NCT00780403|11429497|FG000|STARTED|Second Intervention||109
10296989|NCT00780403|11429498|FG001|STARTED|Second Intervention||111
10296990|NCT00780403|11429497|FG000|COMPLETED|Second Intervention||109
10296991|NCT00780403|11429498|FG001|COMPLETED|Second Intervention||111
10296992|NCT00780403|11429497|FG000|NOT COMPLETED|Second Intervention||0
10296993|NCT00780403|11429498|FG001|NOT COMPLETED|Second Intervention||0
10296994|NCT00779116|11429505|FG000|STARTED|First Intervention||109
10296995|NCT00779116|11429506|FG001|STARTED|First Intervention||108
10296996|NCT00779116|11429505|FG000|COMPLETED|First Intervention||109
10296997|NCT00779116|11429506|FG001|COMPLETED|First Intervention||108
10296998|NCT00779116|11429505|FG000|NOT COMPLETED|First Intervention||0
10296999|NCT00779116|11429506|FG001|NOT COMPLETED|First Intervention||0
10297000|NCT00779116|11429505|FG000|STARTED|Interval Between Doses (8-10 Minutes)||109
10297001|NCT00779116|11429506|FG001|STARTED|Interval Between Doses (8-10 Minutes)||108
10297002|NCT00779116|11429505|FG000|COMPLETED|Interval Between Doses (8-10 Minutes)||109
10297003|NCT00779116|11429506|FG001|COMPLETED|Interval Between Doses (8-10 Minutes)||108
10297004|NCT00779116|11429505|FG000|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
10297005|NCT00779116|11429506|FG001|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
10297006|NCT00779116|11429505|FG000|STARTED|Second Intervention||109
10297007|NCT00779116|11429506|FG001|STARTED|Second Intervention||108
10297008|NCT00779116|11429505|FG000|COMPLETED|Second Intervention||109
10297009|NCT00779116|11429506|FG001|COMPLETED|Second Intervention||108
10297010|NCT00779116|11429505|FG000|NOT COMPLETED|Second Intervention||0
10297011|NCT00779116|11429506|FG001|NOT COMPLETED|Second Intervention||0
10297012|NCT00778700|11429517|FG000|STARTED|Overall Study||50
10297013|NCT00778700|11429518|FG001|STARTED|Overall Study||51
10297014|NCT00778700|11429519|FG002|STARTED|Overall Study||49
10760866|NCT03134313|11924599|FG000|COMPLETED|Overall Study||25
10760867|NCT03134313|11924599|FG000|NOT COMPLETED|Overall Study||0
10760868|NCT03134326|11924603|FG000|STARTED|Overall Study||21
10760869|NCT03134326|11924603|FG000|COMPLETED|Overall Study||21
10760870|NCT03134326|11924603|FG000|NOT COMPLETED|Overall Study||0
10760871|NCT03134599|11924607|FG000|STARTED|Week 1||10
10760872|NCT03134599|11924608|FG001|STARTED|Week 1||10
10760873|NCT03134599|11924609|FG002|STARTED|Week 1||10
10760874|NCT03134599|11924610|FG003|STARTED|Week 1||11
10760875|NCT03134599|11924611|FG004|STARTED|Week 1||10
10760876|NCT03134599|11924612|FG005|STARTED|Week 1||9
10760877|NCT03134599|11924607|FG000|COMPLETED|Week 1||10
10760878|NCT03134599|11924608|FG001|COMPLETED|Week 1||10
10760879|NCT03134599|11924609|FG002|COMPLETED|Week 1||10
10760880|NCT03134599|11924610|FG003|COMPLETED|Week 1||11
10760881|NCT03134599|11924611|FG004|COMPLETED|Week 1||9
10760882|NCT03134599|11924612|FG005|COMPLETED|Week 1||9
10760883|NCT03134599|11924607|FG000|NOT COMPLETED|Week 1||0
10760884|NCT03134599|11924608|FG001|NOT COMPLETED|Week 1||0
10760885|NCT03134599|11924609|FG002|NOT COMPLETED|Week 1||0
10760886|NCT03134599|11924610|FG003|NOT COMPLETED|Week 1||0
10760887|NCT03134599|11924611|FG004|NOT COMPLETED|Week 1||1
10760888|NCT03134599|11924612|FG005|NOT COMPLETED|Week 1||0
10760889|NCT03134599|11924607|FG000|STARTED|Week 2||10
10760890|NCT03134599|11924608|FG001|STARTED|Week 2||10
10760891|NCT03134599|11924609|FG002|STARTED|Week 2||10
10760892|NCT03134599|11924610|FG003|STARTED|Week 2||11
10760893|NCT03134599|11924611|FG004|STARTED|Week 2||9
10760894|NCT03134599|11924612|FG005|STARTED|Week 2||9
10760895|NCT03134599|11924607|FG000|COMPLETED|Week 2||9
10760896|NCT03134599|11924608|FG001|COMPLETED|Week 2||10
10760897|NCT03134599|11924609|FG002|COMPLETED|Week 2||10
10760898|NCT03134599|11924610|FG003|COMPLETED|Week 2||10
10760899|NCT03134599|11924611|FG004|COMPLETED|Week 2||8
10760900|NCT03134599|11924612|FG005|COMPLETED|Week 2||9
10760901|NCT03134599|11924607|FG000|NOT COMPLETED|Week 2||1
10760902|NCT03134599|11924608|FG001|NOT COMPLETED|Week 2||0
10760903|NCT03134599|11924609|FG002|NOT COMPLETED|Week 2||0
10760904|NCT03134599|11924610|FG003|NOT COMPLETED|Week 2||1
10760905|NCT03134599|11924611|FG004|NOT COMPLETED|Week 2||1
10760906|NCT03134599|11924612|FG005|NOT COMPLETED|Week 2||0
10760907|NCT03134599|11924607|FG000|STARTED|Week 3||9
10760908|NCT03134599|11924608|FG001|STARTED|Week 3||10
10760909|NCT03134599|11924609|FG002|STARTED|Week 3||10
10760910|NCT03134599|11924610|FG003|STARTED|Week 3||10
10760911|NCT03134599|11924611|FG004|STARTED|Week 3||8
10760912|NCT03134599|11924612|FG005|STARTED|Week 3||9
10760913|NCT03134599|11924607|FG000|COMPLETED|Week 3||9
10760914|NCT03134599|11924608|FG001|COMPLETED|Week 3||10
10760915|NCT03134599|11924609|FG002|COMPLETED|Week 3||10
10760916|NCT03134599|11924610|FG003|COMPLETED|Week 3||9
10760917|NCT03134599|11924611|FG004|COMPLETED|Week 3||8
10760918|NCT03134599|11924612|FG005|COMPLETED|Week 3||8
10760919|NCT03134599|11924607|FG000|NOT COMPLETED|Week 3||0
10760920|NCT03134599|11924608|FG001|NOT COMPLETED|Week 3||0
10760921|NCT03134599|11924609|FG002|NOT COMPLETED|Week 3||0
10760922|NCT03134599|11924610|FG003|NOT COMPLETED|Week 3||1
10760923|NCT03134599|11924611|FG004|NOT COMPLETED|Week 3||0
10760924|NCT03134599|11924612|FG005|NOT COMPLETED|Week 3||1
10760925|NCT03134703|11924622|FG000|STARTED|Overall Study||6
10760926|NCT03134703|11924623|FG001|STARTED|Overall Study||5
10760927|NCT03134703|11924622|FG000|COMPLETED|Overall Study||0
10760928|NCT03134703|11924623|FG001|COMPLETED|Overall Study||3
10760929|NCT03134703|11924622|FG000|NOT COMPLETED|Overall Study||6
10760930|NCT03134703|11924623|FG001|NOT COMPLETED|Overall Study||2
10760931|NCT03134768|11924629|FG000|STARTED|Overall Study||50
10760932|NCT03134768|11924629|FG000|COMPLETED|Overall Study||50
10760933|NCT03134768|11924629|FG000|NOT COMPLETED|Overall Study||0
10760934|NCT03134911|11924635|FG000|STARTED|Overall Study||535
10760935|NCT03134911|11924635|FG000|COMPLETED|Overall Study||501
10760936|NCT03134911|11924635|FG000|NOT COMPLETED|Overall Study||34
10760937|NCT03134963|11924647|FG000|STARTED|Overall Study||12
10760938|NCT03134963|11924648|FG001|STARTED|Overall Study||13
10760939|NCT03134963|11924649|FG002|STARTED|Overall Study||3
10760940|NCT03134963|11924650|FG003|STARTED|Overall Study||14
10760941|NCT03134963|11924647|FG000|COMPLETED|Overall Study||12
10760942|NCT03134963|11924648|FG001|COMPLETED|Overall Study||13
10760943|NCT03134963|11924649|FG002|COMPLETED|Overall Study||3
10760944|NCT03134963|11924650|FG003|COMPLETED|Overall Study||14
10760945|NCT03134963|11924647|FG000|NOT COMPLETED|Overall Study||0
10760946|NCT03134963|11924648|FG001|NOT COMPLETED|Overall Study||0
10760947|NCT03134963|11924649|FG002|NOT COMPLETED|Overall Study||0
10760948|NCT03134963|11924650|FG003|NOT COMPLETED|Overall Study||0
10760949|NCT03134989|11924660|FG000|STARTED|Overall Study||80
10760950|NCT03134989|11924660|FG000|COMPLETED|Overall Study|Clinical investigation termination date: Last Subject, Final Visit 18-Jun-2020|80
10760951|NCT03134989|11924660|FG000|NOT COMPLETED|Overall Study||0
10760952|NCT03135015|11924667|FG000|STARTED|Overall Study||11
10760953|NCT03135015|11924668|FG001|STARTED|Overall Study||11
10760954|NCT03135015|11924667|FG000|Water Control|Overall Study||9
10760955|NCT03135015|11924668|FG001|Water Control|Overall Study||11
10760956|NCT03135015|11924667|FG000|Placebo Capsules|Overall Study||9
10760957|NCT03135015|11924668|FG001|Placebo Capsules|Overall Study||11
10760958|NCT03135015|11924667|FG000|2g Capsules|Overall Study||9
10760959|NCT03135015|11924668|FG001|2g Capsules|Overall Study||11
10760960|NCT03135015|11924667|FG000|4g Capsules|Overall Study||9
10760961|NCT03135015|11924668|FG001|4g Capsules|Overall Study||11
10760962|NCT03135015|11924667|FG000|2g Tablets|Overall Study||9
10760963|NCT03135015|11924668|FG001|2g Tablets|Overall Study||11
10760964|NCT03135015|11924667|FG000|4g Tablets|Overall Study||9
10760965|NCT03135015|11924668|FG001|4g Tablets|Overall Study||11
10760966|NCT03135015|11924667|FG000|COMPLETED|Overall Study||9
10760967|NCT03135015|11924668|FG001|COMPLETED|Overall Study||11
10760968|NCT03135015|11924667|FG000|NOT COMPLETED|Overall Study||2
10760969|NCT03135015|11924668|FG001|NOT COMPLETED|Overall Study||0
10760970|NCT03135028|11924718|FG000|STARTED|Overall Study||9
10760971|NCT03135028|11924718|FG000|COMPLETED|Overall Study||0
10760972|NCT03135028|11924718|FG000|NOT COMPLETED|Overall Study||9
10760973|NCT03135210|11924724|FG000|STARTED|Overall Study||2
10760974|NCT03135210|11924725|FG001|STARTED|Overall Study||2
10760975|NCT03135210|11924724|FG000|COMPLETED|Overall Study||2
10760976|NCT03135210|11924725|FG001|COMPLETED|Overall Study||1
10760977|NCT03135210|11924724|FG000|NOT COMPLETED|Overall Study||0
10760978|NCT03135210|11924725|FG001|NOT COMPLETED|Overall Study||1
10760979|NCT03135379|11924733|FG000|STARTED|Overall Study||62
10760980|NCT03135379|11924734|FG001|STARTED|Overall Study||62
10760981|NCT03135379|11924733|FG000|COMPLETED|Overall Study||61
10760982|NCT03135379|11924734|FG001|COMPLETED|Overall Study||59
10760983|NCT03135379|11924733|FG000|NOT COMPLETED|Overall Study||1
10760984|NCT03135379|11924734|FG001|NOT COMPLETED|Overall Study||3
10760985|NCT03135431|11924742|FG000|STARTED|Overall Study||20
10760986|NCT03135431|11924743|FG001|STARTED|Overall Study||20
10760987|NCT03135431|11924742|FG000|COMPLETED|Overall Study||18
10760988|NCT03135431|11924743|FG001|COMPLETED|Overall Study||20
10760989|NCT03135431|11924742|FG000|NOT COMPLETED|Overall Study||2
10760990|NCT03135431|11924743|FG001|NOT COMPLETED|Overall Study||0
10760991|NCT03135522|11924751|FG000|STARTED|Overall Study||17
10760992|NCT03135522|11924752|FG001|STARTED|Overall Study||17
10760993|NCT03135522|11924751|FG000|COMPLETED|Overall Study||16
10760994|NCT03135522|11924752|FG001|COMPLETED|Overall Study||17
10760995|NCT03135522|11924751|FG000|NOT COMPLETED|Overall Study||1
10760996|NCT03135522|11924752|FG001|NOT COMPLETED|Overall Study||0
10760997|NCT03135535|11924758|FG000|STARTED|Overall Study||30
10760998|NCT03135535|11924758|FG000|COMPLETED|Overall Study||30
10760999|NCT03135535|11924758|FG000|NOT COMPLETED|Overall Study||0
10761000|NCT03135548|11924765|FG000|STARTED|Overall Study||19
10761001|NCT03135548|11924766|FG001|STARTED|Overall Study||19
10761002|NCT03135548|11924767|FG002|STARTED|Overall Study||21
10761003|NCT03135548|11924765|FG000|COMPLETED|Overall Study||14
10761004|NCT03135548|11924766|FG001|COMPLETED|Overall Study||15
10761005|NCT03135548|11924767|FG002|COMPLETED|Overall Study||18
10761006|NCT03135548|11924765|FG000|NOT COMPLETED|Overall Study||5
10761007|NCT03135548|11924766|FG001|NOT COMPLETED|Overall Study||4
10761008|NCT03135548|11924767|FG002|NOT COMPLETED|Overall Study||3
10761009|NCT03135899|11924783|FG000|STARTED|Overall Study||1
10761010|NCT03135899|11924784|FG001|STARTED|Overall Study||1
10761011|NCT03135899|11924785|FG002|STARTED|Overall Study||1
10761012|NCT03135899|11924786|FG003|STARTED|Overall Study||1
10761013|NCT03135899|11924787|FG004|STARTED|Overall Study||8
10761014|NCT03135899|11924788|FG005|STARTED|Overall Study||9
10761015|NCT03135899|11924789|FG006|STARTED|Overall Study||8
10761016|NCT03135899|11924790|FG007|STARTED|Overall Study||8
10761017|NCT03135899|11924783|FG000|COMPLETED|Overall Study||1
10761018|NCT03135899|11924784|FG001|COMPLETED|Overall Study||1
10761019|NCT03135899|11924785|FG002|COMPLETED|Overall Study||1
10761020|NCT03135899|11924786|FG003|COMPLETED|Overall Study||1
10761021|NCT03135899|11924787|FG004|COMPLETED|Overall Study||8
10761022|NCT03135899|11924788|FG005|COMPLETED|Overall Study||7
10761023|NCT03135899|11924789|FG006|COMPLETED|Overall Study||7
10761024|NCT03135899|11924790|FG007|COMPLETED|Overall Study||8
10761025|NCT03135899|11924783|FG000|NOT COMPLETED|Overall Study||0
10761026|NCT03135899|11924784|FG001|NOT COMPLETED|Overall Study||0
10761027|NCT03135899|11924785|FG002|NOT COMPLETED|Overall Study||0
10761028|NCT03135899|11924786|FG003|NOT COMPLETED|Overall Study||0
10761029|NCT03135899|11924787|FG004|NOT COMPLETED|Overall Study||0
10761030|NCT03135899|11924788|FG005|NOT COMPLETED|Overall Study||2
10761031|NCT03135899|11924789|FG006|NOT COMPLETED|Overall Study||1
10761032|NCT03135899|11924790|FG007|NOT COMPLETED|Overall Study||0
10761033|NCT03136068|11924806|FG000|STARTED|Overall Study||88
10761034|NCT03136068|11924807|FG001|STARTED|Overall Study||90
10761035|NCT03136068|11924806|FG000|COMPLETED|Overall Study||86
10761036|NCT03136068|11924807|FG001|COMPLETED|Overall Study||89
10761037|NCT03136068|11924806|FG000|NOT COMPLETED|Overall Study||2
10761038|NCT03136068|11924807|FG001|NOT COMPLETED|Overall Study||1
10761039|NCT03136107|11924813|FG000|STARTED|Overall Study||26
10761040|NCT03136107|11924813|FG000|Test Product|Overall Study||26
10761041|NCT03136107|11924813|FG000|Reference Product|Overall Study||26
10761042|NCT03136107|11924813|FG000|Negative Control|Overall Study||26
10761043|NCT03136107|11924813|FG000|COMPLETED|Overall Study||25
10761044|NCT03136107|11924813|FG000|NOT COMPLETED|Overall Study||1
10761045|NCT03136159|11924823|FG000|STARTED|Overall Study||190
10761046|NCT03136159|11924824|FG001|STARTED|Overall Study||190
10761047|NCT03136159|11924823|FG000|COMPLETED|Overall Study||185
10761048|NCT03136159|11924824|FG001|COMPLETED|Overall Study||190
10761049|NCT03136159|11924823|FG000|NOT COMPLETED|Overall Study||5
10761050|NCT03136159|11924824|FG001|NOT COMPLETED|Overall Study||0
10761051|NCT03136198|11924832|FG000|STARTED|Overall Study||66
10761052|NCT03136198|11924833|FG001|STARTED|Overall Study||64
10761053|NCT03136198|11924832|FG000|COMPLETED|Overall Study||66
10761054|NCT03136198|11924833|FG001|COMPLETED|Overall Study||63
10761055|NCT03136198|11924832|FG000|NOT COMPLETED|Overall Study||0
10761056|NCT03136198|11924833|FG001|NOT COMPLETED|Overall Study||1
10761057|NCT03136328|11924839|FG000|STARTED|Overall Study||11
10761058|NCT03136328|11924839|FG000|COMPLETED|Overall Study||11
10761059|NCT03136328|11924839|FG000|NOT COMPLETED|Overall Study||0
10761060|NCT03136367|11924847|FG000|STARTED|T1 Consultation||66
10761061|NCT03136367|11924848|FG001|STARTED|T1 Consultation||248
10761062|NCT03136367|11924849|FG002|STARTED|T1 Consultation||257
10761063|NCT03136367|11924847|FG000|COMPLETED|T1 Consultation|received the intervention|64
10761064|NCT03136367|11924848|FG001|COMPLETED|T1 Consultation||241
10761065|NCT03136367|11924849|FG002|COMPLETED|T1 Consultation||256
10761066|NCT03136367|11924847|FG000|NOT COMPLETED|T1 Consultation||2
10761067|NCT03136367|11924848|FG001|NOT COMPLETED|T1 Consultation||7
10761068|NCT03136367|11924849|FG002|NOT COMPLETED|T1 Consultation||1
10761069|NCT03136367|11924847|FG000|STARTED|T2 Post-consultation||64
10761070|NCT03136367|11924848|FG001|STARTED|T2 Post-consultation||241
10761071|NCT03136367|11924849|FG002|STARTED|T2 Post-consultation||256
10761072|NCT03136367|11924847|FG000|COMPLETED|T2 Post-consultation||61
10761073|NCT03136367|11924848|FG001|COMPLETED|T2 Post-consultation||235
10761074|NCT03136367|11924849|FG002|COMPLETED|T2 Post-consultation||225
10761075|NCT03136367|11924847|FG000|NOT COMPLETED|T2 Post-consultation||3
10761076|NCT03136367|11924848|FG001|NOT COMPLETED|T2 Post-consultation||6
10761077|NCT03136367|11924849|FG002|NOT COMPLETED|T2 Post-consultation||31
10761078|NCT03136367|11924847|FG000|STARTED|T3 1 Week After Surgery||61
10761079|NCT03136367|11924848|FG001|STARTED|T3 1 Week After Surgery||235
10761080|NCT03136367|11924849|FG002|STARTED|T3 1 Week After Surgery||225
10761081|NCT03136367|11924847|FG000|COMPLETED|T3 1 Week After Surgery||51
10761082|NCT03136367|11924848|FG001|COMPLETED|T3 1 Week After Surgery||203
10761083|NCT03136367|11924849|FG002|COMPLETED|T3 1 Week After Surgery||194
10761084|NCT03136367|11924847|FG000|NOT COMPLETED|T3 1 Week After Surgery||10
10761085|NCT03136367|11924848|FG001|NOT COMPLETED|T3 1 Week After Surgery||32
10761086|NCT03136367|11924849|FG002|NOT COMPLETED|T3 1 Week After Surgery||31
10761087|NCT03136367|11924847|FG000|STARTED|T4 12 Weeks After Surgery||51
10761088|NCT03136367|11924848|FG001|STARTED|T4 12 Weeks After Surgery||203
10761089|NCT03136367|11924849|FG002|STARTED|T4 12 Weeks After Surgery||194
10761090|NCT03136367|11924847|FG000|COMPLETED|T4 12 Weeks After Surgery||49
10761091|NCT03136367|11924848|FG001|COMPLETED|T4 12 Weeks After Surgery||198
10761092|NCT03136367|11924849|FG002|COMPLETED|T4 12 Weeks After Surgery||185
10761093|NCT03136367|11924847|FG000|NOT COMPLETED|T4 12 Weeks After Surgery||2
10761094|NCT03136367|11924848|FG001|NOT COMPLETED|T4 12 Weeks After Surgery||5
10761095|NCT03136367|11924849|FG002|NOT COMPLETED|T4 12 Weeks After Surgery||9
10761096|NCT03136367|11924847|FG000|STARTED|T5 1 Year After Surgery||49
10761097|NCT03136367|11924848|FG001|STARTED|T5 1 Year After Surgery||198
10761098|NCT03136367|11924849|FG002|STARTED|T5 1 Year After Surgery||185
10761099|NCT03136367|11924847|FG000|COMPLETED|T5 1 Year After Surgery||13
10761100|NCT03136367|11924848|FG001|COMPLETED|T5 1 Year After Surgery||62
10761101|NCT03136367|11924849|FG002|COMPLETED|T5 1 Year After Surgery||56
10761102|NCT03136367|11924847|FG000|NOT COMPLETED|T5 1 Year After Surgery||36
10761103|NCT03136367|11924848|FG001|NOT COMPLETED|T5 1 Year After Surgery||136
10761104|NCT03136367|11924849|FG002|NOT COMPLETED|T5 1 Year After Surgery||129
10761105|NCT03136380|11924862|FG000|STARTED|Part 1, Period 1 (3 Days)||6
10761106|NCT03136380|11924863|FG001|STARTED|Part 1, Period 1 (3 Days)||6
10761107|NCT03136380|11924864|FG002|STARTED|Part 1, Period 1 (3 Days)||6
10761108|NCT03136380|11924865|FG003|STARTED|Part 1, Period 1 (3 Days)||0
10761109|NCT03136380|11924866|FG004|STARTED|Part 1, Period 1 (3 Days)||0
10761110|NCT03136380|11924862|FG000|COMPLETED|Part 1, Period 1 (3 Days)||6
10761111|NCT03136380|11924863|FG001|COMPLETED|Part 1, Period 1 (3 Days)||6
10761112|NCT03136380|11924864|FG002|COMPLETED|Part 1, Period 1 (3 Days)||6
10761113|NCT03136380|11924865|FG003|COMPLETED|Part 1, Period 1 (3 Days)||0
10761114|NCT03136380|11924866|FG004|COMPLETED|Part 1, Period 1 (3 Days)||0
10761115|NCT03136380|11924862|FG000|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
10761116|NCT03136380|11924863|FG001|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
10761117|NCT03136380|11924864|FG002|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
10761118|NCT03136380|11924865|FG003|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
10761119|NCT03136380|11924866|FG004|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
10761120|NCT03136380|11924862|FG000|STARTED|Part 1, Washout Period 1 (7 Days)||6
10761121|NCT03136380|11924863|FG001|STARTED|Part 1, Washout Period 1 (7 Days)||6
10761122|NCT03136380|11924864|FG002|STARTED|Part 1, Washout Period 1 (7 Days)||6
10761123|NCT03136380|11924865|FG003|STARTED|Part 1, Washout Period 1 (7 Days)||0
10761124|NCT03136380|11924866|FG004|STARTED|Part 1, Washout Period 1 (7 Days)||0
10761125|NCT03136380|11924862|FG000|COMPLETED|Part 1, Washout Period 1 (7 Days)||6
10761126|NCT03136380|11924863|FG001|COMPLETED|Part 1, Washout Period 1 (7 Days)||6
10761127|NCT03136380|11924864|FG002|COMPLETED|Part 1, Washout Period 1 (7 Days)||6
10761128|NCT03136380|11924865|FG003|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10761129|NCT03136380|11924866|FG004|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10761130|NCT03136380|11924862|FG000|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10761131|NCT03136380|11924863|FG001|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10761132|NCT03136380|11924864|FG002|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10761133|NCT03136380|11924865|FG003|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10761134|NCT03136380|11924866|FG004|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
10761135|NCT03136380|11924862|FG000|STARTED|Part 1, Period 2 (3 Days)||6
10761136|NCT03136380|11924863|FG001|STARTED|Part 1, Period 2 (3 Days)||6
10761137|NCT03136380|11924864|FG002|STARTED|Part 1, Period 2 (3 Days)||6
10761138|NCT03136380|11924865|FG003|STARTED|Part 1, Period 2 (3 Days)||0
10761139|NCT03136380|11924866|FG004|STARTED|Part 1, Period 2 (3 Days)||0
10761140|NCT03136380|11924862|FG000|COMPLETED|Part 1, Period 2 (3 Days)||6
10761141|NCT03136380|11924863|FG001|COMPLETED|Part 1, Period 2 (3 Days)||6
10761142|NCT03136380|11924864|FG002|COMPLETED|Part 1, Period 2 (3 Days)||6
10761143|NCT03136380|11924865|FG003|COMPLETED|Part 1, Period 2 (3 Days)||0
10761144|NCT03136380|11924866|FG004|COMPLETED|Part 1, Period 2 (3 Days)||0
10761145|NCT03136380|11924862|FG000|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
10761146|NCT03136380|11924863|FG001|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
10874845|NCT02178358|12040995|FG000|STARTED|Overall Study||20
10761147|NCT03136380|11924864|FG002|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
10761148|NCT03136380|11924865|FG003|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
10761149|NCT03136380|11924866|FG004|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
10761150|NCT03136380|11924862|FG000|STARTED|Part 1, Washout Period 2 (7 Days)||6
10761151|NCT03136380|11924863|FG001|STARTED|Part 1, Washout Period 2 (7 Days)||6
10761152|NCT03136380|11924864|FG002|STARTED|Part 1, Washout Period 2 (7 Days)||6
10761153|NCT03136380|11924865|FG003|STARTED|Part 1, Washout Period 2 (7 Days)||0
10761154|NCT03136380|11924866|FG004|STARTED|Part 1, Washout Period 2 (7 Days)||0
10761155|NCT03136380|11924862|FG000|COMPLETED|Part 1, Washout Period 2 (7 Days)||6
10761156|NCT03136380|11924863|FG001|COMPLETED|Part 1, Washout Period 2 (7 Days)||5
10761157|NCT03136380|11924864|FG002|COMPLETED|Part 1, Washout Period 2 (7 Days)||6
10761158|NCT03136380|11924865|FG003|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10761159|NCT03136380|11924866|FG004|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10761160|NCT03136380|11924862|FG000|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10761161|NCT03136380|11924863|FG001|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||1
10761162|NCT03136380|11924864|FG002|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10761163|NCT03136380|11924865|FG003|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10761164|NCT03136380|11924866|FG004|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
10761165|NCT03136380|11924862|FG000|STARTED|Part 1, Period 3 (4 Days)||6
10761166|NCT03136380|11924863|FG001|STARTED|Part 1, Period 3 (4 Days)||5
10761167|NCT03136380|11924864|FG002|STARTED|Part 1, Period 3 (4 Days)||6
10761168|NCT03136380|11924865|FG003|STARTED|Part 1, Period 3 (4 Days)||0
10761169|NCT03136380|11924866|FG004|STARTED|Part 1, Period 3 (4 Days)||0
10761170|NCT03136380|11924862|FG000|COMPLETED|Part 1, Period 3 (4 Days)||6
10761171|NCT03136380|11924863|FG001|COMPLETED|Part 1, Period 3 (4 Days)||5
10761172|NCT03136380|11924864|FG002|COMPLETED|Part 1, Period 3 (4 Days)||6
10761173|NCT03136380|11924865|FG003|COMPLETED|Part 1, Period 3 (4 Days)||0
10761174|NCT03136380|11924866|FG004|COMPLETED|Part 1, Period 3 (4 Days)||0
10761175|NCT03136380|11924862|FG000|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
10761176|NCT03136380|11924863|FG001|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
10761177|NCT03136380|11924864|FG002|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
10761178|NCT03136380|11924865|FG003|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
10761179|NCT03136380|11924866|FG004|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
10761180|NCT03136380|11924862|FG000|STARTED|Part 2, Period 1 (3 Days)||0
10761181|NCT03136380|11924863|FG001|STARTED|Part 2, Period 1 (3 Days)||0
10761182|NCT03136380|11924864|FG002|STARTED|Part 2, Period 1 (3 Days)||0
10761183|NCT03136380|11924865|FG003|STARTED|Part 2, Period 1 (3 Days)||8
10761184|NCT03136380|11924866|FG004|STARTED|Part 2, Period 1 (3 Days)||8
10761185|NCT03136380|11924862|FG000|COMPLETED|Part 2, Period 1 (3 Days)||0
10761186|NCT03136380|11924863|FG001|COMPLETED|Part 2, Period 1 (3 Days)||0
10761187|NCT03136380|11924864|FG002|COMPLETED|Part 2, Period 1 (3 Days)||0
10761188|NCT03136380|11924865|FG003|COMPLETED|Part 2, Period 1 (3 Days)||8
10761189|NCT03136380|11924866|FG004|COMPLETED|Part 2, Period 1 (3 Days)||8
10761190|NCT03136380|11924862|FG000|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
10761191|NCT03136380|11924863|FG001|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
10761192|NCT03136380|11924864|FG002|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
10761193|NCT03136380|11924865|FG003|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
10761194|NCT03136380|11924866|FG004|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
10761195|NCT03136380|11924862|FG000|STARTED|Part 2, Washout Period 1 (7 Days)||0
10761196|NCT03136380|11924863|FG001|STARTED|Part 2, Washout Period 1 (7 Days)||0
10761197|NCT03136380|11924864|FG002|STARTED|Part 2, Washout Period 1 (7 Days)||0
10761198|NCT03136380|11924865|FG003|STARTED|Part 2, Washout Period 1 (7 Days)||8
10761199|NCT03136380|11924866|FG004|STARTED|Part 2, Washout Period 1 (7 Days)||8
10761200|NCT03136380|11924862|FG000|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10874846|NCT02178358|12040996|FG001|STARTED|Overall Study||74
10874847|NCT02178358|12040997|FG002|STARTED|Overall Study||38
10874848|NCT02178358|12040995|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20
10874849|NCT02178358|12040996|FG001|Received at Least 1 Dose of Study Drug|Overall Study||74
10874850|NCT02178358|12040997|FG002|Received at Least 1 Dose of Study Drug|Overall Study||38
10874851|NCT02178358|12040995|FG000|COMPLETED|Overall Study||19
10874852|NCT02178358|12040996|FG001|COMPLETED|Overall Study||72
10874853|NCT02178358|12040997|FG002|COMPLETED|Overall Study||36
10874854|NCT02178358|12040995|FG000|NOT COMPLETED|Overall Study||1
10874855|NCT02178358|12040996|FG001|NOT COMPLETED|Overall Study||2
10874856|NCT02178358|12040997|FG002|NOT COMPLETED|Overall Study||2
10874857|NCT02073279|12041008|FG000|STARTED|Double-blind Period||32
10874858|NCT02073279|12041009|FG001|STARTED|Double-blind Period||63
10874859|NCT02073279|12041008|FG000|COMPLETED|Double-blind Period||17
10874860|NCT02073279|12041009|FG001|COMPLETED|Double-blind Period||16
10874861|NCT02073279|12041008|FG000|NOT COMPLETED|Double-blind Period||15
10874862|NCT02073279|12041009|FG001|NOT COMPLETED|Double-blind Period||47
10874863|NCT02073279|12041008|FG000|STARTED|Open-label Extension Period||17
10874864|NCT02073279|12041009|FG001|STARTED|Open-label Extension Period||16
10874865|NCT02073279|12041008|FG000|COMPLETED|Open-label Extension Period||0
10874866|NCT02073279|12041009|FG001|COMPLETED|Open-label Extension Period||0
10874867|NCT02073279|12041008|FG000|NOT COMPLETED|Open-label Extension Period||17
10874868|NCT02073279|12041009|FG001|NOT COMPLETED|Open-label Extension Period||16
10874869|NCT01544127|12041021|FG000|STARTED|Overall Study||33
10874870|NCT01544127|12041022|FG001|STARTED|Overall Study||33
10874871|NCT01544127|12041023|FG002|STARTED|Overall Study||66
10874872|NCT01544127|12041021|FG000|COMPLETED|Overall Study||22
10874873|NCT01544127|12041022|FG001|COMPLETED|Overall Study||27
10874874|NCT01544127|12041023|FG002|COMPLETED|Overall Study||52
10761201|NCT03136380|11924863|FG001|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10761202|NCT03136380|11924864|FG002|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10874875|NCT01544127|12041021|FG000|NOT COMPLETED|Overall Study||11
10874876|NCT01544127|12041022|FG001|NOT COMPLETED|Overall Study||6
10874877|NCT01544127|12041023|FG002|NOT COMPLETED|Overall Study||14
10874878|NCT00806390|12041034|FG000|STARTED|Overall Study||7
10874879|NCT00806390|12041035|FG001|STARTED|Overall Study||8
10874880|NCT00806390|12041034|FG000|COMPLETED|Overall Study||7
10874881|NCT00806390|12041035|FG001|COMPLETED|Overall Study||8
10874882|NCT00806390|12041034|FG000|NOT COMPLETED|Overall Study||0
10874883|NCT00806390|12041035|FG001|NOT COMPLETED|Overall Study||0
10874884|NCT00566618|12041041|FG000|STARTED|Overall Study||1
10874885|NCT00566618|12041042|FG001|STARTED|Overall Study||6
10874886|NCT00566618|12041043|FG002|STARTED|Overall Study||18
10874887|NCT00566618|12041041|FG000|COMPLETED|Overall Study||0
10874888|NCT00566618|12041042|FG001|COMPLETED|Overall Study||0
10874889|NCT00566618|12041043|FG002|COMPLETED|Overall Study||0
10874890|NCT00566618|12041041|FG000|NOT COMPLETED|Overall Study||1
10874891|NCT00566618|12041042|FG001|NOT COMPLETED|Overall Study||6
10874892|NCT00566618|12041043|FG002|NOT COMPLETED|Overall Study||18
10874893|NCT00442559|12041050|FG000|STARTED|Overall Study||100
10874894|NCT00442559|12041051|FG001|STARTED|Overall Study||91
10874895|NCT00442559|12041050|FG000|12 Weeks After Randomization|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|68
10874896|NCT00442559|12041051|FG001|12 Weeks After Randomization|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|60
10874897|NCT00442559|12041050|FG000|COMPLETED|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|66
10874898|NCT00442559|12041051|FG001|COMPLETED|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|56
10874899|NCT00442559|12041050|FG000|NOT COMPLETED|Overall Study||34
10874900|NCT00442559|12041051|FG001|NOT COMPLETED|Overall Study||35
10874901|NCT00117338|12041065|FG000|STARTED|Overall Study||145
10874902|NCT00117338|12041066|FG001|STARTED|Overall Study||131
10874903|NCT00117338|12041065|FG000|COMPLETED|Overall Study||140
10874904|NCT00117338|12041066|FG001|COMPLETED|Overall Study||127
10874905|NCT00117338|12041065|FG000|NOT COMPLETED|Overall Study||5
10874906|NCT00117338|12041066|FG001|NOT COMPLETED|Overall Study||4
10761203|NCT03136380|11924865|FG003|COMPLETED|Part 2, Washout Period 1 (7 Days)||8
10761204|NCT03136380|11924866|FG004|COMPLETED|Part 2, Washout Period 1 (7 Days)||8
10761205|NCT03136380|11924862|FG000|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10761206|NCT03136380|11924863|FG001|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10761207|NCT03136380|11924864|FG002|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10761208|NCT03136380|11924865|FG003|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10761209|NCT03136380|11924866|FG004|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10761210|NCT03136380|11924862|FG000|STARTED|Part 2, Period 2 (3 Days)||0
10761211|NCT03136380|11924863|FG001|STARTED|Part 2, Period 2 (3 Days)||0
10761212|NCT03136380|11924864|FG002|STARTED|Part 2, Period 2 (3 Days)||0
10761213|NCT03136380|11924865|FG003|STARTED|Part 2, Period 2 (3 Days)||8
10761214|NCT03136380|11924866|FG004|STARTED|Part 2, Period 2 (3 Days)||8
10761215|NCT03136380|11924862|FG000|COMPLETED|Part 2, Period 2 (3 Days)||0
10761216|NCT03136380|11924863|FG001|COMPLETED|Part 2, Period 2 (3 Days)||0
10761217|NCT03136380|11924864|FG002|COMPLETED|Part 2, Period 2 (3 Days)||0
10761218|NCT03136380|11924865|FG003|COMPLETED|Part 2, Period 2 (3 Days)||8
10761219|NCT03136380|11924866|FG004|COMPLETED|Part 2, Period 2 (3 Days)||8
10761220|NCT03136380|11924862|FG000|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
10761221|NCT03136380|11924863|FG001|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
10761222|NCT03136380|11924864|FG002|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
10761223|NCT03136380|11924865|FG003|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
10761224|NCT03136380|11924866|FG004|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
10761225|NCT03136484|11924886|FG000|STARTED|Overall Study||394
10761226|NCT03136484|11924887|FG001|STARTED|Overall Study||394
10761227|NCT03136484|11924886|FG000|Exposed|Overall Study||392
10761228|NCT03136484|11924887|FG001|Exposed|Overall Study||394
10761229|NCT03136484|11924886|FG000|COMPLETED|Overall Study||367
10761230|NCT03136484|11924887|FG001|COMPLETED|Overall Study||372
10761231|NCT03136484|11924886|FG000|NOT COMPLETED|Overall Study||27
10761232|NCT03136484|11924887|FG001|NOT COMPLETED|Overall Study||22
10761233|NCT03136861|11924900|FG000|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||285
10761234|NCT03136861|11924901|FG001|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||95
10761235|NCT03136861|11924902|FG002|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
10761236|NCT03136861|11924903|FG003|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
10761237|NCT03136861|11924904|FG004|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
10761238|NCT03136861|11924905|FG005|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
10761239|NCT03136861|11924906|FG006|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
10761240|NCT03136861|11924900|FG000|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||278
10761241|NCT03136861|11924901|FG001|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||89
10761242|NCT03136861|11924902|FG002|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
10761243|NCT03136861|11924903|FG003|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
10761244|NCT03136861|11924904|FG004|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
10761245|NCT03136861|11924905|FG005|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
10761246|NCT03136861|11924906|FG006|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
10761247|NCT03136861|11924900|FG000|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||7
10761248|NCT03136861|11924901|FG001|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||6
10546838|NCT01509872|11700633|FG001|Post-Intervention Assessment|Overall Study||24
10546839|NCT01509872|11700632|FG000|COMPLETED|Overall Study||25
10546840|NCT01509872|11700633|FG001|COMPLETED|Overall Study||24
10546841|NCT01509872|11700632|FG000|NOT COMPLETED|Overall Study||1
10546842|NCT01509872|11700633|FG001|NOT COMPLETED|Overall Study||0
10546843|NCT01509950|11700643|FG000|STARTED|Overall Study||7
10761249|NCT03136861|11924902|FG002|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
10761250|NCT03136861|11924903|FG003|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
10761251|NCT03136861|11924904|FG004|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
10761252|NCT03136861|11924905|FG005|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
10761253|NCT03136861|11924906|FG006|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
10761254|NCT03136861|11924900|FG000|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
10761255|NCT03136861|11924901|FG001|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
10761256|NCT03136861|11924902|FG002|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||90
10761257|NCT03136861|11924903|FG003|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||94
10761258|NCT03136861|11924904|FG004|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||94
10761259|NCT03136861|11924905|FG005|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||45
10761260|NCT03136861|11924906|FG006|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||44
10761261|NCT03136861|11924900|FG000|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
10761262|NCT03136861|11924901|FG001|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
10761263|NCT03136861|11924902|FG002|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||88
10761264|NCT03136861|11924903|FG003|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||93
10761265|NCT03136861|11924904|FG004|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||92
10761266|NCT03136861|11924905|FG005|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||45
10761267|NCT03136861|11924906|FG006|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||43
10761268|NCT03136861|11924900|FG000|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
10761269|NCT03136861|11924901|FG001|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
10761270|NCT03136861|11924902|FG002|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||2
10761271|NCT03136861|11924903|FG003|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||1
10761272|NCT03136861|11924904|FG004|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||2
10761273|NCT03136861|11924905|FG005|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
10761274|NCT03136861|11924906|FG006|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||1
10761275|NCT03136913|11924917|FG000|STARTED|Overall Study||13
10761276|NCT03136913|11924917|FG000|Subjects Received Both Intervention|Overall Study|10 subjects with 10 OFT and 10 CFT sites received clinical measurement before implant surgery|10
10761277|NCT03136913|11924917|FG000|COMPLETED|Overall Study|8 subjects with 8 OFT and 8 CFT sites received implant surgery|8
10761278|NCT03136913|11924917|FG000|NOT COMPLETED|Overall Study||5
10761279|NCT03137069|11924930|FG000|STARTED|Overall Study||13
10761280|NCT03137069|11924931|FG001|STARTED|Overall Study||28
10761281|NCT03137069|11924932|FG002|STARTED|Overall Study||23
10761282|NCT03137069|11924933|FG003|STARTED|Overall Study||23
10761283|NCT03137069|11924934|FG004|STARTED|Overall Study||24
10761284|NCT03137069|11924935|FG005|STARTED|Overall Study||23
10761285|NCT03137069|11924930|FG000|COMPLETED|Overall Study||12
10761286|NCT03137069|11924931|FG001|COMPLETED|Overall Study||22
10761287|NCT03137069|11924932|FG002|COMPLETED|Overall Study||20
10761288|NCT03137069|11924933|FG003|COMPLETED|Overall Study||17
10761289|NCT03137069|11924934|FG004|COMPLETED|Overall Study||22
10761290|NCT03137069|11924935|FG005|COMPLETED|Overall Study||21
10761291|NCT03137069|11924930|FG000|NOT COMPLETED|Overall Study||1
10761292|NCT03137069|11924931|FG001|NOT COMPLETED|Overall Study||6
10761293|NCT03137069|11924932|FG002|NOT COMPLETED|Overall Study||3
10761294|NCT03137069|11924933|FG003|NOT COMPLETED|Overall Study||6
10761295|NCT03137069|11924934|FG004|NOT COMPLETED|Overall Study||2
10761296|NCT03137069|11924935|FG005|NOT COMPLETED|Overall Study||2
10761297|NCT03137121|11924955|FG000|STARTED|Overall Study||15
10761298|NCT03137121|11924956|FG001|STARTED|Overall Study||15
10761299|NCT03137121|11924955|FG000|COMPLETED|Overall Study||15
10761300|NCT03137121|11924956|FG001|COMPLETED|Overall Study||14
10761301|NCT03137121|11924955|FG000|NOT COMPLETED|Overall Study||0
10761302|NCT03137121|11924956|FG001|NOT COMPLETED|Overall Study||1
10761303|NCT03137303|11924964|FG000|STARTED|T0: Time of Enrollment - Baseline Visit||231
10761304|NCT03137303|11924965|FG001|STARTED|T0: Time of Enrollment - Baseline Visit||171
10761305|NCT03137303|11924964|FG000|COMPLETED|T0: Time of Enrollment - Baseline Visit||231
10761306|NCT03137303|11924965|FG001|COMPLETED|T0: Time of Enrollment - Baseline Visit||171
10761307|NCT03137303|11924964|FG000|NOT COMPLETED|T0: Time of Enrollment - Baseline Visit||0
10761308|NCT03137303|11924965|FG001|NOT COMPLETED|T0: Time of Enrollment - Baseline Visit||0
10761309|NCT03137303|11924964|FG000|STARTED|T1: 3-month Follow-up||231
10761310|NCT03137303|11924965|FG001|STARTED|T1: 3-month Follow-up||171
10761311|NCT03137303|11924964|FG000|COMPLETED|T1: 3-month Follow-up||225
10761312|NCT03137303|11924965|FG001|COMPLETED|T1: 3-month Follow-up||161
10761313|NCT03137303|11924964|FG000|NOT COMPLETED|T1: 3-month Follow-up||6
10761314|NCT03137303|11924965|FG001|NOT COMPLETED|T1: 3-month Follow-up||10
10761315|NCT03137303|11924964|FG000|STARTED|T2: 6-month Follow-up||230
10761316|NCT03137303|11924965|FG001|STARTED|T2: 6-month Follow-up||167
10761317|NCT03137303|11924964|FG000|COMPLETED|T2: 6-month Follow-up||225
10761318|NCT03137303|11924965|FG001|COMPLETED|T2: 6-month Follow-up||162
10761319|NCT03137303|11924964|FG000|NOT COMPLETED|T2: 6-month Follow-up||5
10761320|NCT03137303|11924965|FG001|NOT COMPLETED|T2: 6-month Follow-up||5
10761321|NCT03137303|11924964|FG000|STARTED|T3: 9-month Follow-up||230
10761322|NCT03137303|11924965|FG001|STARTED|T3: 9-month Follow-up||167
10761323|NCT03137303|11924964|FG000|COMPLETED|T3: 9-month Follow-up||225
10761324|NCT03137303|11924965|FG001|COMPLETED|T3: 9-month Follow-up||163
10761325|NCT03137303|11924964|FG000|NOT COMPLETED|T3: 9-month Follow-up||5
10761326|NCT03137303|11924965|FG001|NOT COMPLETED|T3: 9-month Follow-up||4
10761327|NCT03137303|11924964|FG000|STARTED|T4: 12-month Follow-up||229
10761328|NCT03137303|11924965|FG001|STARTED|T4: 12-month Follow-up||167
10761329|NCT03137303|11924964|FG000|COMPLETED|T4: 12-month Follow-up||222
10761330|NCT03137303|11924965|FG001|COMPLETED|T4: 12-month Follow-up||162
10761331|NCT03137303|11924964|FG000|NOT COMPLETED|T4: 12-month Follow-up||7
10761332|NCT03137303|11924965|FG001|NOT COMPLETED|T4: 12-month Follow-up||5
10761333|NCT03137459|11924973|FG000|STARTED|2-month Assessment||455
10761334|NCT03137459|11924974|FG001|STARTED|2-month Assessment||454
10761335|NCT03137459|11924973|FG000|COMPLETED|2-month Assessment||387
10761336|NCT03137459|11924974|FG001|COMPLETED|2-month Assessment||412
10761337|NCT03137459|11924973|FG000|NOT COMPLETED|2-month Assessment||68
10761338|NCT03137459|11924974|FG001|NOT COMPLETED|2-month Assessment||42
10761339|NCT03137459|11924973|FG000|STARTED|4-month Assessment||442
10761340|NCT03137459|11924974|FG001|STARTED|4-month Assessment||451
10761341|NCT03137459|11924973|FG000|COMPLETED|4-month Assessment||364
10761342|NCT03137459|11924974|FG001|COMPLETED|4-month Assessment||405
10761343|NCT03137459|11924973|FG000|NOT COMPLETED|4-month Assessment||78
10761344|NCT03137459|11924974|FG001|NOT COMPLETED|4-month Assessment||46
10761345|NCT03137459|11924973|FG000|STARTED|6-months||434
10761346|NCT03137459|11924974|FG001|STARTED|6-months||447
10761347|NCT03137459|11924973|FG000|COMPLETED|6-months||413
10761348|NCT03137459|11924974|FG001|COMPLETED|6-months||430
10761349|NCT03137459|11924973|FG000|NOT COMPLETED|6-months||21
10761350|NCT03137459|11924974|FG001|NOT COMPLETED|6-months||17
10761351|NCT03137784|11924981|FG000|STARTED|Overall Study||24
10761352|NCT03137784|11924982|FG001|STARTED|Overall Study||25
10761353|NCT03137784|11924983|FG002|STARTED|Overall Study||25
10761354|NCT03137784|11924984|FG003|STARTED|Overall Study||24
10761355|NCT03137784|11924985|FG004|STARTED|Overall Study||25
10761356|NCT03137784|11924986|FG005|STARTED|Overall Study||25
10761357|NCT03137784|11924981|FG000|COMPLETED|Overall Study||22
10761358|NCT03137784|11924982|FG001|COMPLETED|Overall Study||24
10761359|NCT03137784|11924983|FG002|COMPLETED|Overall Study||25
10761360|NCT03137784|11924984|FG003|COMPLETED|Overall Study||24
10761361|NCT03137784|11924985|FG004|COMPLETED|Overall Study||24
10761362|NCT03137784|11924986|FG005|COMPLETED|Overall Study||25
10761363|NCT03137784|11924981|FG000|NOT COMPLETED|Overall Study||2
10761364|NCT03137784|11924982|FG001|NOT COMPLETED|Overall Study||1
10761365|NCT03137784|11924983|FG002|NOT COMPLETED|Overall Study||0
10761366|NCT03137784|11924984|FG003|NOT COMPLETED|Overall Study||0
10761367|NCT03137784|11924985|FG004|NOT COMPLETED|Overall Study||1
10761368|NCT03137784|11924986|FG005|NOT COMPLETED|Overall Study||0
10761369|NCT03137992|11924994|FG000|STARTED|Period 1 (Visit 2)||62
10761370|NCT03137992|11924995|FG001|STARTED|Period 1 (Visit 2)||63
10761371|NCT03137992|11924996|FG002|STARTED|Period 1 (Visit 2)||63
10761372|NCT03137992|11924997|FG003|STARTED|Period 1 (Visit 2)||63
10761373|NCT03137992|11924998|FG004|STARTED|Period 1 (Visit 2)||62
10761374|NCT03137992|11924999|FG005|STARTED|Period 1 (Visit 2)||61
10761375|NCT03137992|11924994|FG000|COMPLETED|Period 1 (Visit 2)||62
10761376|NCT03137992|11924995|FG001|COMPLETED|Period 1 (Visit 2)||63
10761377|NCT03137992|11924996|FG002|COMPLETED|Period 1 (Visit 2)||63
10761378|NCT03137992|11924997|FG003|COMPLETED|Period 1 (Visit 2)||63
10761379|NCT03137992|11924998|FG004|COMPLETED|Period 1 (Visit 2)||62
10761380|NCT03137992|11924999|FG005|COMPLETED|Period 1 (Visit 2)||61
10761381|NCT03137992|11924994|FG000|NOT COMPLETED|Period 1 (Visit 2)||0
10761382|NCT03137992|11924995|FG001|NOT COMPLETED|Period 1 (Visit 2)||0
10761383|NCT03137992|11924996|FG002|NOT COMPLETED|Period 1 (Visit 2)||0
10761384|NCT03137992|11924997|FG003|NOT COMPLETED|Period 1 (Visit 2)||0
10761385|NCT03137992|11924998|FG004|NOT COMPLETED|Period 1 (Visit 2)||0
10761386|NCT03137992|11924999|FG005|NOT COMPLETED|Period 1 (Visit 2)||0
10761387|NCT03137992|11924994|FG000|STARTED|Washout Period 1||62
10761388|NCT03137992|11924995|FG001|STARTED|Washout Period 1||63
10761389|NCT03137992|11924996|FG002|STARTED|Washout Period 1||63
10761390|NCT03137992|11924997|FG003|STARTED|Washout Period 1||63
10761391|NCT03137992|11924998|FG004|STARTED|Washout Period 1||62
10761392|NCT03137992|11924999|FG005|STARTED|Washout Period 1||61
10761393|NCT03137992|11924994|FG000|COMPLETED|Washout Period 1||59
10761394|NCT03137992|11924995|FG001|COMPLETED|Washout Period 1||59
10761395|NCT03137992|11924996|FG002|COMPLETED|Washout Period 1||61
10761396|NCT03137992|11924997|FG003|COMPLETED|Washout Period 1||63
10761397|NCT03137992|11924998|FG004|COMPLETED|Washout Period 1||60
10761398|NCT03137992|11924999|FG005|COMPLETED|Washout Period 1||59
10761399|NCT03137992|11924994|FG000|NOT COMPLETED|Washout Period 1||3
10761400|NCT03137992|11924995|FG001|NOT COMPLETED|Washout Period 1||4
10761401|NCT03137992|11924996|FG002|NOT COMPLETED|Washout Period 1||2
10761402|NCT03137992|11924997|FG003|NOT COMPLETED|Washout Period 1||0
10761403|NCT03137992|11924998|FG004|NOT COMPLETED|Washout Period 1||2
10761404|NCT03137992|11924999|FG005|NOT COMPLETED|Washout Period 1||2
10761405|NCT03137992|11924994|FG000|STARTED|Period 2 (Visit 3)||59
10761406|NCT03137992|11924995|FG001|STARTED|Period 2 (Visit 3)||59
10761407|NCT03137992|11924996|FG002|STARTED|Period 2 (Visit 3)||61
10761408|NCT03137992|11924997|FG003|STARTED|Period 2 (Visit 3)||63
10761409|NCT03137992|11924998|FG004|STARTED|Period 2 (Visit 3)||60
10761410|NCT03137992|11924999|FG005|STARTED|Period 2 (Visit 3)||59
10761411|NCT03137992|11924994|FG000|COMPLETED|Period 2 (Visit 3)||56
10761412|NCT03137992|11924995|FG001|COMPLETED|Period 2 (Visit 3)||52
10761413|NCT03137992|11924996|FG002|COMPLETED|Period 2 (Visit 3)||58
10761414|NCT03137992|11924997|FG003|COMPLETED|Period 2 (Visit 3)||58
10761415|NCT03137992|11924998|FG004|COMPLETED|Period 2 (Visit 3)||56
10761416|NCT03137992|11924999|FG005|COMPLETED|Period 2 (Visit 3)||51
10761417|NCT03137992|11924994|FG000|NOT COMPLETED|Period 2 (Visit 3)||3
10761418|NCT03137992|11924995|FG001|NOT COMPLETED|Period 2 (Visit 3)||7
10761419|NCT03137992|11924996|FG002|NOT COMPLETED|Period 2 (Visit 3)||3
10761420|NCT03137992|11924997|FG003|NOT COMPLETED|Period 2 (Visit 3)||5
10761421|NCT03137992|11924998|FG004|NOT COMPLETED|Period 2 (Visit 3)||4
10761422|NCT03137992|11924999|FG005|NOT COMPLETED|Period 2 (Visit 3)||8
10761423|NCT03137992|11924994|FG000|STARTED|Washout Period 2||56
10761424|NCT03137992|11924995|FG001|STARTED|Washout Period 2||52
10761425|NCT03137992|11924996|FG002|STARTED|Washout Period 2||58
10761426|NCT03137992|11924997|FG003|STARTED|Washout Period 2||58
10761427|NCT03137992|11924998|FG004|STARTED|Washout Period 2||56
10761428|NCT03137992|11924999|FG005|STARTED|Washout Period 2||51
10761429|NCT03137992|11924994|FG000|COMPLETED|Washout Period 2||54
10761430|NCT03137992|11924995|FG001|COMPLETED|Washout Period 2||50
10761431|NCT03137992|11924996|FG002|COMPLETED|Washout Period 2||58
10761432|NCT03137992|11924997|FG003|COMPLETED|Washout Period 2||57
10761433|NCT03137992|11924998|FG004|COMPLETED|Washout Period 2||53
10761434|NCT03137992|11924999|FG005|COMPLETED|Washout Period 2||50
10761435|NCT03137992|11924994|FG000|NOT COMPLETED|Washout Period 2||2
10761436|NCT03137992|11924995|FG001|NOT COMPLETED|Washout Period 2||2
10761437|NCT03137992|11924996|FG002|NOT COMPLETED|Washout Period 2||0
10761438|NCT03137992|11924997|FG003|NOT COMPLETED|Washout Period 2||1
10761439|NCT03137992|11924998|FG004|NOT COMPLETED|Washout Period 2||3
10761440|NCT03137992|11924999|FG005|NOT COMPLETED|Washout Period 2||1
10761441|NCT03137992|11924994|FG000|STARTED|Period 3 (Visit 04)||54
10761442|NCT03137992|11924995|FG001|STARTED|Period 3 (Visit 04)||50
10761443|NCT03137992|11924996|FG002|STARTED|Period 3 (Visit 04)||58
10761444|NCT03137992|11924997|FG003|STARTED|Period 3 (Visit 04)||57
10761445|NCT03137992|11924998|FG004|STARTED|Period 3 (Visit 04)||53
10761446|NCT03137992|11924999|FG005|STARTED|Period 3 (Visit 04)||50
10761447|NCT03137992|11924994|FG000|COMPLETED|Period 3 (Visit 04)||48
10761448|NCT03137992|11924995|FG001|COMPLETED|Period 3 (Visit 04)||48
10761449|NCT03137992|11924996|FG002|COMPLETED|Period 3 (Visit 04)||55
10761450|NCT03137992|11924997|FG003|COMPLETED|Period 3 (Visit 04)||57
10761451|NCT03137992|11924998|FG004|COMPLETED|Period 3 (Visit 04)||50
10761452|NCT03137992|11924999|FG005|COMPLETED|Period 3 (Visit 04)||47
10761453|NCT03137992|11924994|FG000|NOT COMPLETED|Period 3 (Visit 04)||6
10761454|NCT03137992|11924995|FG001|NOT COMPLETED|Period 3 (Visit 04)||2
10761455|NCT03137992|11924996|FG002|NOT COMPLETED|Period 3 (Visit 04)||3
10761456|NCT03137992|11924997|FG003|NOT COMPLETED|Period 3 (Visit 04)||0
10761457|NCT03137992|11924998|FG004|NOT COMPLETED|Period 3 (Visit 04)||3
10761458|NCT03137992|11924999|FG005|NOT COMPLETED|Period 3 (Visit 04)||3
10761459|NCT03137992|11924994|FG000|STARTED|Part 2 (Open-label Extension)||22
10761460|NCT03137992|11924995|FG001|STARTED|Part 2 (Open-label Extension)||17
10761461|NCT03137992|11924996|FG002|STARTED|Part 2 (Open-label Extension)||21
10761462|NCT03137992|11924997|FG003|STARTED|Part 2 (Open-label Extension)||25
10761463|NCT03137992|11924998|FG004|STARTED|Part 2 (Open-label Extension)||18
10761464|NCT03137992|11924999|FG005|STARTED|Part 2 (Open-label Extension)||22
10761465|NCT03137992|11924994|FG000|COMPLETED|Part 2 (Open-label Extension)||20
10761466|NCT03137992|11924995|FG001|COMPLETED|Part 2 (Open-label Extension)||17
10761467|NCT03137992|11924996|FG002|COMPLETED|Part 2 (Open-label Extension)||20
10761468|NCT03137992|11924997|FG003|COMPLETED|Part 2 (Open-label Extension)||24
10761469|NCT03137992|11924998|FG004|COMPLETED|Part 2 (Open-label Extension)||18
10761470|NCT03137992|11924999|FG005|COMPLETED|Part 2 (Open-label Extension)||21
10761471|NCT03137992|11924994|FG000|NOT COMPLETED|Part 2 (Open-label Extension)||2
10761472|NCT03137992|11924995|FG001|NOT COMPLETED|Part 2 (Open-label Extension)||0
10761473|NCT03137992|11924996|FG002|NOT COMPLETED|Part 2 (Open-label Extension)||1
10761474|NCT03137992|11924997|FG003|NOT COMPLETED|Part 2 (Open-label Extension)||1
10761475|NCT03137992|11924998|FG004|NOT COMPLETED|Part 2 (Open-label Extension)||0
10761476|NCT03137992|11924999|FG005|NOT COMPLETED|Part 2 (Open-label Extension)||1
10761477|NCT03138330|11925007|FG000|STARTED|Overall Study||95
10761478|NCT03138330|11925007|FG000|COMPLETED|Overall Study||91
10761479|NCT03138330|11925007|FG000|NOT COMPLETED|Overall Study||4
10761480|NCT03138382|11925013|FG000|STARTED|Overall Study||10
10761481|NCT03138382|11925014|FG001|STARTED|Overall Study||10
10761482|NCT03138382|11925013|FG000|COMPLETED|Overall Study||10
10761483|NCT03138382|11925014|FG001|COMPLETED|Overall Study||10
10761484|NCT03138382|11925013|FG000|NOT COMPLETED|Overall Study||0
10761485|NCT03138382|11925014|FG001|NOT COMPLETED|Overall Study||0
10761486|NCT03138577|11925027|FG000|STARTED|Overall Study||3
10761487|NCT03138577|11925028|FG001|STARTED|Overall Study||3
10761488|NCT03138577|11925029|FG002|STARTED|Overall Study||3
10761489|NCT03138577|11925030|FG003|STARTED|Overall Study||3
10761490|NCT03138577|11925031|FG004|STARTED|Overall Study||3
10761491|NCT03138577|11925032|FG005|STARTED|Overall Study||3
10761492|NCT03138577|11925033|FG006|STARTED|Overall Study||3
10761493|NCT03138577|11925027|FG000|COMPLETED|Overall Study||3
10761494|NCT03138577|11925028|FG001|COMPLETED|Overall Study||3
10761495|NCT03138577|11925029|FG002|COMPLETED|Overall Study||3
10761496|NCT03138577|11925030|FG003|COMPLETED|Overall Study||3
10761497|NCT03138577|11925031|FG004|COMPLETED|Overall Study||3
10761498|NCT03138577|11925032|FG005|COMPLETED|Overall Study||3
10761499|NCT03138577|11925033|FG006|COMPLETED|Overall Study||3
10761500|NCT03138577|11925027|FG000|NOT COMPLETED|Overall Study||0
10761501|NCT03138577|11925028|FG001|NOT COMPLETED|Overall Study||0
10761502|NCT03138577|11925029|FG002|NOT COMPLETED|Overall Study||0
10761503|NCT03138577|11925030|FG003|NOT COMPLETED|Overall Study||0
10761504|NCT03138577|11925031|FG004|NOT COMPLETED|Overall Study||0
10761505|NCT03138577|11925032|FG005|NOT COMPLETED|Overall Study||0
10761506|NCT03138577|11925033|FG006|NOT COMPLETED|Overall Study||0
10761507|NCT03138655|11925059|FG000|STARTED|Overall Study||10
10761508|NCT03138655|11925060|FG001|STARTED|Overall Study||9
10761509|NCT03138655|11925061|FG002|STARTED|Overall Study||11
10761510|NCT03138655|11925062|FG003|STARTED|Overall Study||10
10761511|NCT03138655|11925063|FG004|STARTED|Overall Study||13
10761512|NCT03138655|11925064|FG005|STARTED|Overall Study||12
10761513|NCT03138655|11925065|FG006|STARTED|Overall Study||12
10761514|NCT03138655|11925066|FG007|STARTED|Overall Study||12
10761515|NCT03138655|11925059|FG000|COMPLETED|Overall Study||7
10761516|NCT03138655|11925060|FG001|COMPLETED|Overall Study||7
10761517|NCT03138655|11925061|FG002|COMPLETED|Overall Study||9
10761518|NCT03138655|11925062|FG003|COMPLETED|Overall Study||7
10761519|NCT03138655|11925063|FG004|COMPLETED|Overall Study||11
10761520|NCT03138655|11925064|FG005|COMPLETED|Overall Study||7
10761521|NCT03138655|11925065|FG006|COMPLETED|Overall Study||9
10761522|NCT03138655|11925066|FG007|COMPLETED|Overall Study||10
10761523|NCT03138655|11925059|FG000|NOT COMPLETED|Overall Study||3
10761524|NCT03138655|11925060|FG001|NOT COMPLETED|Overall Study||2
10761525|NCT03138655|11925061|FG002|NOT COMPLETED|Overall Study||2
10761526|NCT03138655|11925062|FG003|NOT COMPLETED|Overall Study||3
10761527|NCT03138655|11925063|FG004|NOT COMPLETED|Overall Study||2
10761528|NCT03138655|11925064|FG005|NOT COMPLETED|Overall Study||5
10761529|NCT03138655|11925065|FG006|NOT COMPLETED|Overall Study||3
10761530|NCT03138655|11925066|FG007|NOT COMPLETED|Overall Study||2
10761531|NCT03138798|11925090|FG000|STARTED|Overall Study||173
10761532|NCT03138798|11925091|FG001|STARTED|Overall Study||175
10761533|NCT03138798|11925090|FG000|Randomized But Did Not Meet Eligibility|Overall Study||6
10761534|NCT03138798|11925091|FG001|Randomized But Did Not Meet Eligibility|Overall Study||4
10761535|NCT03138798|11925090|FG000|COMPLETED|Overall Study||167
10761536|NCT03138798|11925091|FG001|COMPLETED|Overall Study||171
10761537|NCT03138798|11925090|FG000|NOT COMPLETED|Overall Study||6
10761538|NCT03138798|11925091|FG001|NOT COMPLETED|Overall Study||4
10761539|NCT03138876|11925098|FG000|STARTED|Overall Study||20
10761540|NCT03138876|11925098|FG000|COMPLETED|Overall Study||20
10761541|NCT03138876|11925098|FG000|NOT COMPLETED|Overall Study||0
10761542|NCT03138967|11925104|FG000|STARTED|Overall Study||26
10761543|NCT03138967|11925105|FG001|STARTED|Overall Study||28
10761544|NCT03138967|11925104|FG000|Post-operative Day(POD) 1 Follow-up|Overall Study||25
10761545|NCT03138967|11925105|FG001|Post-operative Day(POD) 1 Follow-up|Overall Study||25
10761546|NCT03138967|11925104|FG000|Post-operative Day(POD) 7 Follow-up|Overall Study||25
10761547|NCT03138967|11925105|FG001|Post-operative Day(POD) 7 Follow-up|Overall Study||24
10761548|NCT03138967|11925104|FG000|COMPLETED|Overall Study||25
10761549|NCT03138967|11925105|FG001|COMPLETED|Overall Study||24
10761550|NCT03138967|11925104|FG000|NOT COMPLETED|Overall Study||1
10874907|NCT04851314|12041074|FG000|STARTED|Overall Study||55
10761551|NCT03138967|11925105|FG001|NOT COMPLETED|Overall Study||4
10761552|NCT03139032|11925111|FG000|STARTED|Overall Study||1
10761553|NCT03139032|11925111|FG000|COMPLETED|Overall Study||1
10761554|NCT03139032|11925111|FG000|NOT COMPLETED|Overall Study||0
10761555|NCT03139240|11925120|FG000|STARTED|Overall Study||48
10761556|NCT03139240|11925121|FG001|STARTED|Overall Study||48
10761557|NCT03139240|11925122|FG002|STARTED|Overall Study||38
10761558|NCT03139240|11925123|FG003|STARTED|Overall Study||38
10761559|NCT03139240|11925120|FG000|COMPLETED|Overall Study||48
10761560|NCT03139240|11925121|FG001|COMPLETED|Overall Study||47
10761561|NCT03139240|11925122|FG002|COMPLETED|Overall Study||37
10761562|NCT03139240|11925123|FG003|COMPLETED|Overall Study||38
10761563|NCT03139240|11925120|FG000|NOT COMPLETED|Overall Study||0
10761564|NCT03139240|11925121|FG001|NOT COMPLETED|Overall Study||1
10761565|NCT03139240|11925122|FG002|NOT COMPLETED|Overall Study||1
10761566|NCT03139240|11925123|FG003|NOT COMPLETED|Overall Study||0
10761567|NCT03139279|11925133|FG000|STARTED|Overall Study||58
10761568|NCT03139279|11925134|FG001|STARTED|Overall Study||56
10761569|NCT03139279|11925133|FG000|COMPLETED|Overall Study||51
10761570|NCT03139279|11925134|FG001|COMPLETED|Overall Study||50
10761571|NCT03139279|11925133|FG000|NOT COMPLETED|Overall Study||7
10761572|NCT03139279|11925134|FG001|NOT COMPLETED|Overall Study||6
10761573|NCT03139448|11925142|FG000|STARTED|Overall Study||85
10761574|NCT03139448|11925143|FG001|STARTED|Overall Study||89
10761575|NCT03139448|11925142|FG000|Intervention Started|Overall Study||79
10761576|NCT03139448|11925143|FG001|Intervention Started|Overall Study||70
10761577|NCT03139448|11925142|FG000|COMPLETED|Overall Study||73
10761578|NCT03139448|11925143|FG001|COMPLETED|Overall Study||63
10761579|NCT03139448|11925142|FG000|NOT COMPLETED|Overall Study||12
10761580|NCT03139448|11925143|FG001|NOT COMPLETED|Overall Study||26
10761581|NCT03139552|11925149|FG000|STARTED|Overall Study||150
10761582|NCT03139552|11925149|FG000|COMPLETED|Overall Study||147
10761583|NCT03139552|11925149|FG000|NOT COMPLETED|Overall Study||3
10761584|NCT03139578|11925160|FG000|STARTED|Period 1||12
10761585|NCT03139578|11925161|FG001|STARTED|Period 1||13
10761586|NCT03139578|11925162|FG002|STARTED|Period 1||12
10761587|NCT03139578|11925163|FG003|STARTED|Period 1||13
10761588|NCT03139578|11925160|FG000|Discontinued|Period 1||0
10761589|NCT03139578|11925161|FG001|Discontinued|Period 1||0
10761590|NCT03139578|11925162|FG002|Discontinued|Period 1||0
10761591|NCT03139578|11925163|FG003|Discontinued|Period 1||0
10761592|NCT03139578|11925160|FG000|COMPLETED|Period 1||12
10761593|NCT03139578|11925161|FG001|COMPLETED|Period 1||13
10761594|NCT03139578|11925162|FG002|COMPLETED|Period 1||12
10761595|NCT03139578|11925163|FG003|COMPLETED|Period 1||13
10761596|NCT03139578|11925160|FG000|NOT COMPLETED|Period 1||0
10761597|NCT03139578|11925161|FG001|NOT COMPLETED|Period 1||0
10761598|NCT03139578|11925162|FG002|NOT COMPLETED|Period 1||0
10761599|NCT03139578|11925163|FG003|NOT COMPLETED|Period 1||0
10761600|NCT03139578|11925160|FG000|STARTED|Period 2||12
10761601|NCT03139578|11925161|FG001|STARTED|Period 2||13
10761602|NCT03139578|11925162|FG002|STARTED|Period 2||12
10761603|NCT03139578|11925163|FG003|STARTED|Period 2||13
10297015|NCT00778700|11429520|FG003|STARTED|Overall Study||49
10297016|NCT00778700|11429517|FG000|COMPLETED|Overall Study||32
10297017|NCT00778700|11429518|FG001|COMPLETED|Overall Study||44
10297018|NCT00778700|11429519|FG002|COMPLETED|Overall Study||43
10297019|NCT00778700|11429520|FG003|COMPLETED|Overall Study||36
10297020|NCT00778700|11429517|FG000|NOT COMPLETED|Overall Study||18
10297021|NCT00778700|11429518|FG001|NOT COMPLETED|Overall Study||7
10297022|NCT00778700|11429519|FG002|NOT COMPLETED|Overall Study||6
10297023|NCT00778700|11429520|FG003|NOT COMPLETED|Overall Study||13
10297024|NCT00764478|11429537|FG000|STARTED|Overall Study||122
10297025|NCT00764478|11429538|FG001|STARTED|Overall Study||119
10297026|NCT00764478|11429539|FG002|STARTED|Overall Study||126
10297027|NCT00764478|11429537|FG000|COMPLETED|Overall Study||107
10297028|NCT00764478|11429538|FG001|COMPLETED|Overall Study||97
10297029|NCT00764478|11429539|FG002|COMPLETED|Overall Study||118
10297030|NCT00764478|11429537|FG000|NOT COMPLETED|Overall Study||15
10297031|NCT00764478|11429538|FG001|NOT COMPLETED|Overall Study||22
10297032|NCT00764478|11429539|FG002|NOT COMPLETED|Overall Study||8
10297033|NCT00761527|11429547|FG000|STARTED|Overall Study||2980
10297034|NCT00761527|11429547|FG000|Received One Dose of Study Medication|Overall Study||2978
10297035|NCT00761527|11429547|FG000|COMPLETED|Overall Study||2958
10297036|NCT00761527|11429547|FG000|NOT COMPLETED|Overall Study||22
10297037|NCT00757627|11429551|FG000|STARTED|Overall Study||500
10761604|NCT03139578|11925160|FG000|Discontinued|Period 2||0
10761605|NCT03139578|11925161|FG001|Discontinued|Period 2||0
10297038|NCT00757627|11429551|FG000|COMPLETED|Overall Study||419
10297039|NCT00757627|11429551|FG000|NOT COMPLETED|Overall Study||81
10297040|NCT00756938|11429563|FG000|STARTED|12-week Base Study||33
10761606|NCT03139578|11925162|FG002|Discontinued|Period 2||0
10761607|NCT03139578|11925163|FG003|Discontinued|Period 2||0
10297041|NCT00756938|11429564|FG001|STARTED|12-week Base Study||34
10761608|NCT03139578|11925160|FG000|COMPLETED|Period 2||12
10761609|NCT03139578|11925161|FG001|COMPLETED|Period 2||13
10761610|NCT03139578|11925162|FG002|COMPLETED|Period 2||12
10761611|NCT03139578|11925163|FG003|COMPLETED|Period 2||13
10761612|NCT03139578|11925160|FG000|NOT COMPLETED|Period 2||0
10761613|NCT03139578|11925161|FG001|NOT COMPLETED|Period 2||0
10297042|NCT00756938|11429565|FG002|STARTED|12-week Base Study||34
10761614|NCT03139578|11925162|FG002|NOT COMPLETED|Period 2||0
10761615|NCT03139578|11925163|FG003|NOT COMPLETED|Period 2||0
10761616|NCT03139604|11925175|FG000|STARTED|Overall Study||219
10761617|NCT03139604|11925176|FG001|STARTED|Overall Study||220
10761618|NCT03139604|11925175|FG000|COMPLETED|Overall Study|Participants were considered to have completed the study if they dies or discontinued study treatment for any reason|0
10761619|NCT03139604|11925176|FG001|COMPLETED|Overall Study|Participants were considered to have completed the study if they dies or discontinued study treatment for any reason|0
10761620|NCT03139604|11925175|FG000|NOT COMPLETED|Overall Study||219
10761621|NCT03139604|11925176|FG001|NOT COMPLETED|Overall Study||220
10761622|NCT03140254|11925183|FG000|STARTED|Overall Study||145
10761623|NCT03140254|11925183|FG000|Treatment IP - Groin|Overall Study||51
10761624|NCT03140254|11925183|FG000|Treatment IP - Abdomen|Overall Study||48
10761625|NCT03140254|11925183|FG000|Treatment AC - Groin|Overall Study||51
10761626|NCT03140254|11925183|FG000|Treatment AC - Abdomen|Overall Study||48
10761627|NCT03140254|11925183|FG000|Treatment VC - Groin|Overall Study||18
10761628|NCT03140254|11925183|FG000|Treatment VC - Abdomen|Overall Study||19
10761629|NCT03140254|11925183|FG000|COMPLETED|Overall Study||144
10761630|NCT03140254|11925183|FG000|NOT COMPLETED|Overall Study||1
10761631|NCT03140631|11925191|FG000|STARTED|Overall Study||73
10761632|NCT03140631|11925192|FG001|STARTED|Overall Study||77
10761633|NCT03140631|11925191|FG000|COMPLETED|Overall Study||73
10761634|NCT03140631|11925192|FG001|COMPLETED|Overall Study||77
10761635|NCT03140631|11925191|FG000|NOT COMPLETED|Overall Study||0
10761636|NCT03140631|11925192|FG001|NOT COMPLETED|Overall Study||0
10761637|NCT03140722|11925201|FG000|STARTED|Overall Study||0
10761638|NCT03140722|11925202|FG001|STARTED|Overall Study||2
10761639|NCT03140722|11925201|FG000|COMPLETED|Overall Study||0
10761640|NCT03140722|11925202|FG001|COMPLETED|Overall Study||2
10761641|NCT03140722|11925201|FG000|NOT COMPLETED|Overall Study||0
10761642|NCT03140722|11925202|FG001|NOT COMPLETED|Overall Study||0
10761643|NCT03141086|11925210|FG000|STARTED|Overall Study||7
10761644|NCT03141086|11925211|FG001|STARTED|Overall Study||17
10761645|NCT03141086|11925210|FG000|COMPLETED|Overall Study||6
10761646|NCT03141086|11925211|FG001|COMPLETED|Overall Study||12
10761647|NCT03141086|11925210|FG000|NOT COMPLETED|Overall Study||1
10761648|NCT03141086|11925211|FG001|NOT COMPLETED|Overall Study||5
10761649|NCT03141151|11925219|FG000|STARTED|Overall Study||59
10761650|NCT03141151|11925220|FG001|STARTED|Overall Study||58
10761651|NCT03141151|11925219|FG000|COMPLETED|Overall Study||53
10761652|NCT03141151|11925220|FG001|COMPLETED|Overall Study||54
10761653|NCT03141151|11925219|FG000|NOT COMPLETED|Overall Study||6
10761654|NCT03141151|11925220|FG001|NOT COMPLETED|Overall Study||4
10761655|NCT03141242|11925228|FG000|STARTED|Overall Study||55
10761656|NCT03141242|11925229|FG001|STARTED|Overall Study||55
10761657|NCT03141242|11925228|FG000|Received Allocated Intervenion|Overall Study|11 subjects didn't attend their scheduled group session; all were included in ITT analysis|44
10761658|NCT03141242|11925229|FG001|Received Allocated Intervenion|Overall Study||55
10761659|NCT03141242|11925228|FG000|6 Month Interview|Overall Study||51
10761660|NCT03141242|11925229|FG001|6 Month Interview|Overall Study||49
10761661|NCT03141242|11925228|FG000|COMPLETED|Overall Study||55
10761662|NCT03141242|11925229|FG001|COMPLETED|Overall Study||55
10761663|NCT03141242|11925228|FG000|NOT COMPLETED|Overall Study||0
10761664|NCT03141242|11925229|FG001|NOT COMPLETED|Overall Study||0
10761665|NCT03141281|11925240|FG000|STARTED|Overall Study||57
10761666|NCT03141281|11925241|FG001|STARTED|Overall Study||59
10761667|NCT03141281|11925242|FG002|STARTED|Overall Study||56
10761668|NCT03141281|11925243|FG003|STARTED|Overall Study||58
10761669|NCT03141281|11925240|FG000|Post-Test|Overall Study||50
10761670|NCT03141281|11925241|FG001|Post-Test|Overall Study||47
10761671|NCT03141281|11925242|FG002|Post-Test|Overall Study||50
10761672|NCT03141281|11925243|FG003|Post-Test|Overall Study||56
10761673|NCT03141281|11925240|FG000|COMPLETED|Overall Study||45
10761674|NCT03141281|11925241|FG001|COMPLETED|Overall Study||38
10761675|NCT03141281|11925242|FG002|COMPLETED|Overall Study||42
10761676|NCT03141281|11925243|FG003|COMPLETED|Overall Study||47
10761677|NCT03141281|11925240|FG000|NOT COMPLETED|Overall Study||12
10761678|NCT03141281|11925241|FG001|NOT COMPLETED|Overall Study||21
10761679|NCT03141281|11925242|FG002|NOT COMPLETED|Overall Study||14
10761680|NCT03141281|11925243|FG003|NOT COMPLETED|Overall Study||11
10761681|NCT03141307|11925255|FG000|STARTED|In-Hospital||471
10761682|NCT03141307|11925256|FG001|STARTED|In-Hospital||240
10761683|NCT03141307|11925255|FG000|COMPLETED|In-Hospital||467
10761684|NCT03141307|11925256|FG001|COMPLETED|In-Hospital||238
10761685|NCT03141307|11925255|FG000|NOT COMPLETED|In-Hospital||4
10761686|NCT03141307|11925256|FG001|NOT COMPLETED|In-Hospital||2
10761687|NCT03141307|11925255|FG000|STARTED|Follow-Up||467
10761688|NCT03141307|11925256|FG001|STARTED|Follow-Up||238
10761689|NCT03141307|11925255|FG000|COMPLETED|Follow-Up||370
10761690|NCT03141307|11925256|FG001|COMPLETED|Follow-Up||184
10761691|NCT03141307|11925255|FG000|NOT COMPLETED|Follow-Up||97
10761692|NCT03141307|11925256|FG001|NOT COMPLETED|Follow-Up||54
10761693|NCT03141372|11925264|FG000|STARTED|Overall Study||42
10761694|NCT03141372|11925265|FG001|STARTED|Overall Study||42
10761695|NCT03141372|11925264|FG000|COMPLETED|Overall Study||42
10761696|NCT03141372|11925265|FG001|COMPLETED|Overall Study||40
10761697|NCT03141372|11925264|FG000|NOT COMPLETED|Overall Study||0
10761698|NCT03141372|11925265|FG001|NOT COMPLETED|Overall Study||2
10761699|NCT03141528|11925275|FG000|STARTED|Overall Study||122
10761700|NCT03141528|11925276|FG001|STARTED|Overall Study||118
10761701|NCT03141528|11925275|FG000|COMPLETED|Overall Study||75
10761702|NCT03141528|11925276|FG001|COMPLETED|Overall Study||77
10761703|NCT03141528|11925275|FG000|NOT COMPLETED|Overall Study||47
10761704|NCT03141528|11925276|FG001|NOT COMPLETED|Overall Study||41
10761705|NCT03141788|11925282|FG000|STARTED|Overall Study||52
10761706|NCT03141788|11925282|FG000|COMPLETED|Overall Study||44
10761707|NCT03141788|11925282|FG000|NOT COMPLETED|Overall Study||8
10761708|NCT03141905|11925291|FG000|STARTED|Overall Study||176
10761709|NCT03141905|11925292|FG001|STARTED|Overall Study||166
10761710|NCT03141905|11925291|FG000|COMPLETED|Overall Study||152
10761711|NCT03141905|11925292|FG001|COMPLETED|Overall Study||147
10761712|NCT03141905|11925291|FG000|NOT COMPLETED|Overall Study||24
10761713|NCT03141905|11925292|FG001|NOT COMPLETED|Overall Study||19
10761714|NCT03141931|11925301|FG000|STARTED|Overall Study||61
10761715|NCT03141931|11925302|FG001|STARTED|Overall Study||58
10761716|NCT03141931|11925301|FG000|COMPLETED|Overall Study||49
10761717|NCT03141931|11925302|FG001|COMPLETED|Overall Study||52
10761718|NCT03141931|11925301|FG000|NOT COMPLETED|Overall Study||12
10761719|NCT03141931|11925302|FG001|NOT COMPLETED|Overall Study||6
10761720|NCT03142438|11925308|FG000|STARTED|Overall Study||57
10761721|NCT03142438|11925308|FG000|COMPLETED|Overall Study||57
10761722|NCT03142438|11925308|FG000|NOT COMPLETED|Overall Study||0
10761723|NCT03142451|11925314|FG000|STARTED|Overall Study||495
10761724|NCT03142451|11925315|FG001|STARTED|Overall Study||256
10761725|NCT03142451|11925314|FG000|COMPLETED|Overall Study||437
10761726|NCT03142451|11925315|FG001|COMPLETED|Overall Study||232
10761727|NCT03142451|11925314|FG000|NOT COMPLETED|Overall Study||58
10761728|NCT03142451|11925315|FG001|NOT COMPLETED|Overall Study||24
10761729|NCT03142750|11925323|FG000|STARTED|Overall Study||14
10761730|NCT03142750|11925324|FG001|STARTED|Overall Study||10
10761731|NCT03142750|11925323|FG000|COMPLETED|Overall Study||10
10761732|NCT03142750|11925324|FG001|COMPLETED|Overall Study||9
10761733|NCT03142750|11925323|FG000|NOT COMPLETED|Overall Study||4
10761734|NCT03142750|11925324|FG001|NOT COMPLETED|Overall Study||1
10761735|NCT03142932|11925336|FG000|STARTED|Overall Study||52
10761736|NCT03142932|11925337|FG001|STARTED|Overall Study||50
10761737|NCT03142932|11925336|FG000|COMPLETED|Overall Study||50
10761738|NCT03142932|11925337|FG001|COMPLETED|Overall Study||39
10761739|NCT03142932|11925336|FG000|NOT COMPLETED|Overall Study||2
10761740|NCT03142932|11925337|FG001|NOT COMPLETED|Overall Study||11
10761741|NCT03143101|11925346|FG000|STARTED|Overall Study||67
10761742|NCT03143101|11925347|FG001|STARTED|Overall Study||66
10761743|NCT03143101|11925348|FG002|STARTED|Overall Study||67
10761744|NCT03143101|11925346|FG000|COMPLETED|Overall Study||65
10761745|NCT03143101|11925347|FG001|COMPLETED|Overall Study||63
10761746|NCT03143101|11925348|FG002|COMPLETED|Overall Study||67
10761747|NCT03143101|11925346|FG000|NOT COMPLETED|Overall Study||2
10761748|NCT03143101|11925347|FG001|NOT COMPLETED|Overall Study||3
10761749|NCT03143101|11925348|FG002|NOT COMPLETED|Overall Study||0
10761750|NCT03143166|11925356|FG000|STARTED|Period 1||36
10761751|NCT03143166|11925356|FG000|COMPLETED|Period 1||36
10761752|NCT03143166|11925356|FG000|NOT COMPLETED|Period 1||0
10761753|NCT03143166|11925356|FG000|STARTED|Period 2 (Washout of at Least 4 Days)||36
10761754|NCT03143166|11925356|FG000|COMPLETED|Period 2 (Washout of at Least 4 Days)||35
10761755|NCT03143166|11925356|FG000|NOT COMPLETED|Period 2 (Washout of at Least 4 Days)||1
10761756|NCT03143569|11925364|FG000|STARTED|Overall Study||10
10761757|NCT03143569|11925365|FG001|STARTED|Overall Study||10
10761758|NCT03143569|11925364|FG000|COMPLETED|Overall Study||10
10761759|NCT03143569|11925365|FG001|COMPLETED|Overall Study||8
10761760|NCT03143569|11925364|FG000|NOT COMPLETED|Overall Study||0
10761761|NCT03143569|11925365|FG001|NOT COMPLETED|Overall Study||2
10761762|NCT03143855|11925375|FG000|STARTED|Overall Study||17
10761763|NCT03143855|11925376|FG001|STARTED|Overall Study||10
10761764|NCT03143855|11925375|FG000|COMPLETED|Overall Study||12
10761765|NCT03143855|11925376|FG001|COMPLETED|Overall Study||6
10761766|NCT03143855|11925375|FG000|NOT COMPLETED|Overall Study||5
10761767|NCT03143855|11925376|FG001|NOT COMPLETED|Overall Study||4
10761768|NCT03143894|11925384|FG000|STARTED|First Intervention (5 Days)||3
10761769|NCT03143894|11925385|FG001|STARTED|First Intervention (5 Days)||4
10761770|NCT03143894|11925384|FG000|COMPLETED|First Intervention (5 Days)||3
10761771|NCT03143894|11925385|FG001|COMPLETED|First Intervention (5 Days)||4
10761772|NCT03143894|11925384|FG000|NOT COMPLETED|First Intervention (5 Days)||0
10761773|NCT03143894|11925385|FG001|NOT COMPLETED|First Intervention (5 Days)||0
10761774|NCT03143894|11925384|FG000|STARTED|Washout (4 Weeks)||3
10761775|NCT03143894|11925385|FG001|STARTED|Washout (4 Weeks)||4
10761776|NCT03143894|11925384|FG000|COMPLETED|Washout (4 Weeks)||3
10761777|NCT03143894|11925385|FG001|COMPLETED|Washout (4 Weeks)||4
10761778|NCT03143894|11925384|FG000|NOT COMPLETED|Washout (4 Weeks)||0
10761779|NCT03143894|11925385|FG001|NOT COMPLETED|Washout (4 Weeks)||0
10761780|NCT03143894|11925384|FG000|STARTED|Second Intervention (5 Days)||3
10761781|NCT03143894|11925385|FG001|STARTED|Second Intervention (5 Days)||4
10761782|NCT03143894|11925384|FG000|COMPLETED|Second Intervention (5 Days)||3
10761783|NCT03143894|11925385|FG001|COMPLETED|Second Intervention (5 Days)||3
10761784|NCT03143894|11925384|FG000|NOT COMPLETED|Second Intervention (5 Days)||0
10761785|NCT03143894|11925385|FG001|NOT COMPLETED|Second Intervention (5 Days)||1
10761786|NCT03144089|11925395|FG000|STARTED|Overall Study||28
10761787|NCT03144089|11925396|FG001|STARTED|Overall Study||28
10761788|NCT03144089|11925395|FG000|COMPLETED|Overall Study||28
10761789|NCT03144089|11925396|FG001|COMPLETED|Overall Study||28
10761790|NCT03144089|11925395|FG000|NOT COMPLETED|Overall Study||0
10761791|NCT03144089|11925396|FG001|NOT COMPLETED|Overall Study||0
10761792|NCT03144180|11925406|FG000|STARTED|Overall Study||16
10761793|NCT03144180|11925407|FG001|STARTED|Overall Study||16
10761794|NCT03144180|11925406|FG000|COMPLETED|Overall Study||14
10761795|NCT03144180|11925407|FG001|COMPLETED|Overall Study||10
10761796|NCT03144180|11925406|FG000|NOT COMPLETED|Overall Study||2
10761797|NCT03144180|11925407|FG001|NOT COMPLETED|Overall Study||6
10761798|NCT03144518|11925417|FG000|STARTED|Primary Outcome (Mood)||52
10761799|NCT03144518|11925418|FG001|STARTED|Primary Outcome (Mood)||51
10761800|NCT03144518|11925417|FG000|COMPLETED|Primary Outcome (Mood)||52
10761801|NCT03144518|11925418|FG001|COMPLETED|Primary Outcome (Mood)||51
10761802|NCT03144518|11925417|FG000|NOT COMPLETED|Primary Outcome (Mood)||0
10761803|NCT03144518|11925418|FG001|NOT COMPLETED|Primary Outcome (Mood)||0
10761804|NCT03144518|11925417|FG000|STARTED|4 Weeks Post-Vaccination||52
10761805|NCT03144518|11925418|FG001|STARTED|4 Weeks Post-Vaccination||51
10761806|NCT03144518|11925417|FG000|COMPLETED|4 Weeks Post-Vaccination||51
10761807|NCT03144518|11925418|FG001|COMPLETED|4 Weeks Post-Vaccination||51
10761808|NCT03144518|11925417|FG000|NOT COMPLETED|4 Weeks Post-Vaccination||1
10761809|NCT03144518|11925418|FG001|NOT COMPLETED|4 Weeks Post-Vaccination||0
10761810|NCT03144518|11925417|FG000|STARTED|16 Week Post-Vaccination||52
10761811|NCT03144518|11925418|FG001|STARTED|16 Week Post-Vaccination||51
10761812|NCT03144518|11925417|FG000|COMPLETED|16 Week Post-Vaccination||49
10761813|NCT03144518|11925418|FG001|COMPLETED|16 Week Post-Vaccination||49
10761814|NCT03144518|11925417|FG000|NOT COMPLETED|16 Week Post-Vaccination||3
10761815|NCT03144518|11925418|FG001|NOT COMPLETED|16 Week Post-Vaccination||2
10761816|NCT03144635|11925425|FG000|STARTED|Overall Study||80
10761817|NCT03144635|11925425|FG000|COMPLETED|Overall Study||0
10761818|NCT03144635|11925425|FG000|NOT COMPLETED|Overall Study||80
10761819|NCT03144804|11925431|FG000|STARTED|Overall Study||36
10761820|NCT03144804|11925431|FG000|COMPLETED|Overall Study||32
10761821|NCT03144804|11925431|FG000|NOT COMPLETED|Overall Study||4
10778996|NCT03363854|11940796|FG003|STARTED|Continuation Treatment Period||69
10778997|NCT03363854|11940797|FG004|STARTED|Continuation Treatment Period||95
10778998|NCT03363854|11940798|FG005|STARTED|Continuation Treatment Period||79
10778999|NCT03363854|11940799|FG006|STARTED|Continuation Treatment Period||41
10874908|NCT04851314|12041075|FG001|STARTED|Overall Study||55
10874909|NCT04851314|12041074|FG000|COMPLETED|Overall Study||52
10874910|NCT04851314|12041075|FG001|COMPLETED|Overall Study||51
10874911|NCT04851314|12041074|FG000|NOT COMPLETED|Overall Study||3
10874912|NCT04851314|12041075|FG001|NOT COMPLETED|Overall Study||4
10779000|NCT03363854|11940800|FG007|STARTED|Continuation Treatment Period|This treatment group applies to the safety follow-up period (see below).|0
10779001|NCT03363854|11940793|FG000|COMPLETED|Continuation Treatment Period||0
10779002|NCT03363854|11940794|FG001|COMPLETED|Continuation Treatment Period||0
10779003|NCT03363854|11940795|FG002|COMPLETED|Continuation Treatment Period||68
10779004|NCT03363854|11940796|FG003|COMPLETED|Continuation Treatment Period||65
10779005|NCT03363854|11940797|FG004|COMPLETED|Continuation Treatment Period||87
10779006|NCT03363854|11940798|FG005|COMPLETED|Continuation Treatment Period||72
10779007|NCT03363854|11940799|FG006|COMPLETED|Continuation Treatment Period||38
10779008|NCT03363854|11940800|FG007|COMPLETED|Continuation Treatment Period||0
10779009|NCT03363854|11940793|FG000|NOT COMPLETED|Continuation Treatment Period||0
10779010|NCT03363854|11940794|FG001|NOT COMPLETED|Continuation Treatment Period||0
10779011|NCT03363854|11940795|FG002|NOT COMPLETED|Continuation Treatment Period||1
10779012|NCT03363854|11940796|FG003|NOT COMPLETED|Continuation Treatment Period||4
10779013|NCT03363854|11940797|FG004|NOT COMPLETED|Continuation Treatment Period||8
10761822|NCT03145064|11925435|FG000|STARTED|Overall Study||41
10761823|NCT03145064|11925435|FG000|Received At Least 1 Dose of Study Drug|Overall Study||41
10761824|NCT03145064|11925435|FG000|COMPLETED|Overall Study||0
10761825|NCT03145064|11925435|FG000|NOT COMPLETED|Overall Study||41
10761826|NCT03145207|11925440|FG000|STARTED|Overall Study|The same 12 volunteers completed each of the seven study sessions.|14
10761827|NCT03145207|11925440|FG000|COMPLETED|Overall Study||12
10761828|NCT03145207|11925440|FG000|NOT COMPLETED|Overall Study||2
10761829|NCT03145259|11925455|FG000|STARTED|Overall Study||12
10761830|NCT03145259|11925455|FG000|COMPLETED|Overall Study||12
10761831|NCT03145259|11925455|FG000|NOT COMPLETED|Overall Study||0
10761832|NCT03145818|11925466|FG000|STARTED|Overall Study||99
10761833|NCT03145818|11925467|FG001|STARTED|Overall Study||8
10761834|NCT03145818|11925468|FG002|STARTED|Overall Study||10
10761835|NCT03145818|11925469|FG003|STARTED|Overall Study||9
10761836|NCT03145818|11925466|FG000|COMPLETED|Overall Study||8
10761837|NCT03145818|11925467|FG001|COMPLETED|Overall Study||0
10761838|NCT03145818|11925468|FG002|COMPLETED|Overall Study||10
10761839|NCT03145818|11925469|FG003|COMPLETED|Overall Study||9
10761840|NCT03145818|11925466|FG000|NOT COMPLETED|Overall Study||91
10761841|NCT03145818|11925467|FG001|NOT COMPLETED|Overall Study||8
10761842|NCT03145818|11925468|FG002|NOT COMPLETED|Overall Study||0
10761843|NCT03145818|11925469|FG003|NOT COMPLETED|Overall Study||0
10761844|NCT03146403|11925479|FG000|STARTED|Overall Study||16
10761845|NCT03146403|11925480|FG001|STARTED|Overall Study||17
10761846|NCT03146403|11925479|FG000|COMPLETED|Overall Study||14
10761847|NCT03146403|11925480|FG001|COMPLETED|Overall Study||14
10761848|NCT03146403|11925479|FG000|NOT COMPLETED|Overall Study||2
10761849|NCT03146403|11925480|FG001|NOT COMPLETED|Overall Study||3
10761850|NCT03146585|11925489|FG000|STARTED|Overall Study||25
10761851|NCT03146585|11925490|FG001|STARTED|Overall Study||10
10761852|NCT03146585|11925491|FG002|STARTED|Overall Study||5
10761853|NCT03146585|11925489|FG000|COMPLETED|Overall Study||25
10761854|NCT03146585|11925490|FG001|COMPLETED|Overall Study||10
10761855|NCT03146585|11925491|FG002|COMPLETED|Overall Study||5
10761856|NCT03146585|11925489|FG000|NOT COMPLETED|Overall Study||0
10761857|NCT03146585|11925490|FG001|NOT COMPLETED|Overall Study||0
10761858|NCT03146585|11925491|FG002|NOT COMPLETED|Overall Study||0
10761859|NCT03146663|11925501|FG000|STARTED|Overall Study||25
10761860|NCT03146663|11925502|FG001|STARTED|Overall Study||28
10761861|NCT03146663|11925501|FG000|COMPLETED|Overall Study||24
10761862|NCT03146663|11925502|FG001|COMPLETED|Overall Study||27
10761863|NCT03146663|11925501|FG000|NOT COMPLETED|Overall Study||1
10761864|NCT03146663|11925502|FG001|NOT COMPLETED|Overall Study||1
10761865|NCT03146741|11925509|FG000|STARTED|Overall Study||20
10761866|NCT03146741|11925509|FG000|COMPLETED|Overall Study||10
10761867|NCT03146741|11925509|FG000|NOT COMPLETED|Overall Study||10
10761868|NCT03146806|11925513|FG000|STARTED|Overall Study||10
10761869|NCT03146806|11925513|FG000|COMPLETED|Overall Study||10
10761870|NCT03146806|11925513|FG000|NOT COMPLETED|Overall Study||0
10761871|NCT03147248|11925535|FG000|STARTED|Overall Study|This cohort is only for Part 1.|13
10761872|NCT03147248|11925536|FG001|STARTED|Overall Study|This cohort is only for Part 1.|11
10761873|NCT03147248|11925537|FG002|STARTED|Overall Study|This cohort is only for Part 1.|12
10761874|NCT03147248|11925538|FG003|STARTED|Overall Study|This cohort is only for Part 1.|12
10761875|NCT03147248|11925539|FG004|STARTED|Overall Study|This arm is for Part 2. All of the participants in Part 2 were screened only for Part 2.|167
10761876|NCT03147248|11925540|FG005|STARTED|Overall Study|This arm is for Part 2. All of the participants in Part 2 were screened only for Part 2.|176
10761877|NCT03147248|11925535|FG000|COMPLETED|Overall Study||12
10761878|NCT03147248|11925536|FG001|COMPLETED|Overall Study||9
10761879|NCT03147248|11925537|FG002|COMPLETED|Overall Study||10
10761880|NCT03147248|11925538|FG003|COMPLETED|Overall Study||10
10761881|NCT03147248|11925539|FG004|COMPLETED|Overall Study||141
10761882|NCT03147248|11925540|FG005|COMPLETED|Overall Study||145
10761883|NCT03147248|11925535|FG000|NOT COMPLETED|Overall Study||1
10761884|NCT03147248|11925536|FG001|NOT COMPLETED|Overall Study||2
10761885|NCT03147248|11925537|FG002|NOT COMPLETED|Overall Study||2
10761886|NCT03147248|11925538|FG003|NOT COMPLETED|Overall Study||2
10761887|NCT03147248|11925539|FG004|NOT COMPLETED|Overall Study||26
10761888|NCT03147248|11925540|FG005|NOT COMPLETED|Overall Study||31
10761889|NCT03147495|11925556|FG000|STARTED|Overall Study||40
10761890|NCT03147495|11925557|FG001|STARTED|Overall Study||46
10761891|NCT03147495|11925556|FG000|COMPLETED|Overall Study||40
10761892|NCT03147495|11925557|FG001|COMPLETED|Overall Study||40
10761893|NCT03147495|11925556|FG000|NOT COMPLETED|Overall Study||0
10761894|NCT03147495|11925557|FG001|NOT COMPLETED|Overall Study||6
10761895|NCT03147690|11925563|FG000|STARTED|Overall Study||74
10761896|NCT03147690|11925563|FG000|COMPLETED|Overall Study||71
10761897|NCT03147690|11925563|FG000|NOT COMPLETED|Overall Study||3
10761898|NCT03148067|11925580|FG000|STARTED|Overall Study||225
10761899|NCT03148067|11925580|FG000|COMPLETED|Overall Study||221
10761900|NCT03148067|11925580|FG000|NOT COMPLETED|Overall Study||4
10761901|NCT03148236|11925587|FG000|STARTED|Overall Study||10
10761902|NCT03148236|11925588|FG001|STARTED|Overall Study||10
10761903|NCT03148236|11925587|FG000|COMPLETED|Overall Study||10
10761904|NCT03148236|11925588|FG001|COMPLETED|Overall Study||10
10761905|NCT03148236|11925587|FG000|NOT COMPLETED|Overall Study||0
10761906|NCT03148236|11925588|FG001|NOT COMPLETED|Overall Study||0
10761907|NCT03148262|11925596|FG000|STARTED|Overall Study||31
10761908|NCT03148262|11925597|FG001|STARTED|Overall Study||32
10761909|NCT03148262|11925596|FG000|COMPLETED|Overall Study||28
10761910|NCT03148262|11925597|FG001|COMPLETED|Overall Study||31
10874913|NCT04845633|12041085|FG000|STARTED|Overall Study||12
10874914|NCT04845633|12041086|FG001|STARTED|Overall Study||12
10874915|NCT04845633|12041087|FG002|STARTED|Overall Study||12
10874916|NCT04845633|12041088|FG003|STARTED|Overall Study||12
10874917|NCT04845633|12041085|FG000|COMPLETED|Overall Study||12
10874918|NCT04845633|12041086|FG001|COMPLETED|Overall Study||12
10874919|NCT04845633|12041087|FG002|COMPLETED|Overall Study||12
10874920|NCT04845633|12041088|FG003|COMPLETED|Overall Study||12
10874921|NCT04845633|12041085|FG000|NOT COMPLETED|Overall Study||0
10874922|NCT04845633|12041086|FG001|NOT COMPLETED|Overall Study||0
10874923|NCT04845633|12041087|FG002|NOT COMPLETED|Overall Study||0
10874924|NCT04845633|12041088|FG003|NOT COMPLETED|Overall Study||0
10874925|NCT04823494|12041102|FG000|STARTED|Overall Study||21
10874926|NCT04823494|12041103|FG001|STARTED|Overall Study||19
10874927|NCT04823494|12041102|FG000|COMPLETED|Overall Study||19
10874928|NCT04823494|12041103|FG001|COMPLETED|Overall Study||18
10874929|NCT04823494|12041102|FG000|NOT COMPLETED|Overall Study||2
10874930|NCT04823494|12041103|FG001|NOT COMPLETED|Overall Study||1
10874934|NCT04814459|12041119|FG000|STARTED|Overall Study||72
10874935|NCT04814459|12041120|FG001|STARTED|Overall Study||72
10874936|NCT04814459|12041119|FG000|COMPLETED|Overall Study||72
10874937|NCT04814459|12041120|FG001|COMPLETED|Overall Study||72
10874938|NCT04814459|12041119|FG000|NOT COMPLETED|Overall Study||0
10874939|NCT04814459|12041120|FG001|NOT COMPLETED|Overall Study||0
10874940|NCT04799782|12041126|FG000|STARTED|First Intervention||8
10874941|NCT04799782|12041127|FG001|STARTED|First Intervention||7
10874942|NCT04799782|12041126|FG000|COMPLETED|First Intervention||8
10874943|NCT04799782|12041127|FG001|COMPLETED|First Intervention||7
10874944|NCT04799782|12041126|FG000|NOT COMPLETED|First Intervention||0
10874945|NCT04799782|12041127|FG001|NOT COMPLETED|First Intervention||0
10874946|NCT04799782|12041126|FG000|STARTED|Washout||8
10874947|NCT04799782|12041127|FG001|STARTED|Washout||7
10874948|NCT04799782|12041126|FG000|COMPLETED|Washout||6
10874949|NCT04799782|12041127|FG001|COMPLETED|Washout||4
10874950|NCT04799782|12041126|FG000|NOT COMPLETED|Washout||2
10874951|NCT04799782|12041127|FG001|NOT COMPLETED|Washout||3
10874952|NCT04799782|12041126|FG000|STARTED|Second Intervention||6
10874953|NCT04799782|12041127|FG001|STARTED|Second Intervention||4
10874954|NCT04799782|12041126|FG000|COMPLETED|Second Intervention||6
10874955|NCT04799782|12041127|FG001|COMPLETED|Second Intervention||4
10874956|NCT04799782|12041126|FG000|NOT COMPLETED|Second Intervention||0
10874957|NCT04799782|12041127|FG001|NOT COMPLETED|Second Intervention||0
10297043|NCT00756938|11429566|FG003|STARTED|12-week Base Study||0
10297044|NCT00756938|11429563|FG000|COMPLETED|12-week Base Study||31
10761911|NCT03148262|11925596|FG000|NOT COMPLETED|Overall Study||3
10761912|NCT03148262|11925597|FG001|NOT COMPLETED|Overall Study||1
10761913|NCT03148470|11925605|FG000|STARTED|Overall Study|21 Participants completed the Tasks following Sham-stimulation|21
10761914|NCT03148470|11925606|FG001|STARTED|Overall Study|20 Participants completed the Tasks following Sham-stimulation|20
10761915|NCT03148470|11925605|FG000|COMPLETED|Overall Study|20 Participants completed the Tasks following iTBS-stimulation|20
10761916|NCT03148470|11925606|FG001|COMPLETED|Overall Study|20 Participants completed the Tasks following cTBS-stimulation|20
10761917|NCT03148470|11925605|FG000|NOT COMPLETED|Overall Study||1
10761918|NCT03148470|11925606|FG001|NOT COMPLETED|Overall Study||0
10761919|NCT03148691|11925623|FG000|STARTED|Overall Study||50
10761920|NCT03148691|11925624|FG001|STARTED|Overall Study||103
10761921|NCT03148691|11925625|FG002|STARTED|Overall Study||100
10761922|NCT03148691|11925623|FG000|COMPLETED|Overall Study||47
10761923|NCT03148691|11925624|FG001|COMPLETED|Overall Study||101
10761924|NCT03148691|11925625|FG002|COMPLETED|Overall Study||92
10761925|NCT03148691|11925623|FG000|NOT COMPLETED|Overall Study||3
10761926|NCT03148691|11925624|FG001|NOT COMPLETED|Overall Study||2
10761927|NCT03148691|11925625|FG002|NOT COMPLETED|Overall Study||8
10761928|NCT03149042|11925633|FG000|STARTED|Overall Study||75
10761929|NCT03149042|11925633|FG000|COMPLETED|Overall Study||52
10761930|NCT03149042|11925633|FG000|NOT COMPLETED|Overall Study||23
10761931|NCT03149055|11925638|FG000|STARTED|Overall Study||99
10761932|NCT03149055|11925638|FG000|COMPLETED|Overall Study||95
10761933|NCT03149055|11925638|FG000|NOT COMPLETED|Overall Study||4
10761934|NCT03149172|11925645|FG000|STARTED|Overall Study||8
10761935|NCT03149172|11925646|FG001|STARTED|Overall Study||6
10761936|NCT03149172|11925647|FG002|STARTED|Overall Study||7
10761937|NCT03149172|11925645|FG000|COMPLETED|Overall Study||6
10761938|NCT03149172|11925646|FG001|COMPLETED|Overall Study||5
10761939|NCT03149172|11925647|FG002|COMPLETED|Overall Study||5
10761940|NCT03149172|11925645|FG000|NOT COMPLETED|Overall Study||2
10761941|NCT03149172|11925646|FG001|NOT COMPLETED|Overall Study||1
10761942|NCT03149172|11925647|FG002|NOT COMPLETED|Overall Study||2
10761943|NCT03149328|11925657|FG000|STARTED|Overall Study||284
10761944|NCT03149328|11925658|FG001|STARTED|Overall Study||259
10761945|NCT03149328|11925657|FG000|COMPLETED|Overall Study||200
10761946|NCT03149328|11925658|FG001|COMPLETED|Overall Study||213
10761947|NCT03149328|11925657|FG000|NOT COMPLETED|Overall Study||84
10761948|NCT03149328|11925658|FG001|NOT COMPLETED|Overall Study||46
10761949|NCT03149848|11925664|FG000|STARTED|Period 1 (Day 1 to Day 14)||15
10761950|NCT03149848|11925664|FG000|COMPLETED|Period 1 (Day 1 to Day 14)||14
10761951|NCT03149848|11925664|FG000|NOT COMPLETED|Period 1 (Day 1 to Day 14)||1
10761952|NCT03149848|11925664|FG000|STARTED|Period 2 (Day 15 to Day 28)||14
10761953|NCT03149848|11925664|FG000|COMPLETED|Period 2 (Day 15 to Day 28)||12
10761954|NCT03149848|11925664|FG000|NOT COMPLETED|Period 2 (Day 15 to Day 28)||2
10761955|NCT03149887|11925673|FG000|STARTED|Overall Study||27
10761956|NCT03149887|11925674|FG001|STARTED|Overall Study||27
10761957|NCT03149887|11925673|FG000|COMPLETED|Overall Study||27
10761958|NCT03149887|11925674|FG001|COMPLETED|Overall Study||27
10761959|NCT03149887|11925673|FG000|NOT COMPLETED|Overall Study||0
10761960|NCT03149887|11925674|FG001|NOT COMPLETED|Overall Study||0
10761961|NCT03149991|11925682|FG000|STARTED|Overall Study||25
10761962|NCT03149991|11925683|FG001|STARTED|Overall Study||26
10761963|NCT03149991|11925682|FG000|Completed Primary Endpoint (Day 14)|Overall Study||25
10761964|NCT03149991|11925683|FG001|Completed Primary Endpoint (Day 14)|Overall Study||24
10761965|NCT03149991|11925682|FG000|Exited|Overall Study||4
10761966|NCT03149991|11925683|FG001|Exited|Overall Study||2
10761967|NCT03149991|11925682|FG000|COMPLETED|Overall Study||21
10761968|NCT03149991|11925683|FG001|COMPLETED|Overall Study||24
10761969|NCT03149991|11925682|FG000|NOT COMPLETED|Overall Study||4
10761970|NCT03149991|11925683|FG001|NOT COMPLETED|Overall Study||2
10761971|NCT03150043|11925689|FG000|STARTED|Overall Study||65
10761972|NCT03150043|11925689|FG000|COMPLETED|Overall Study||65
10761973|NCT03150043|11925689|FG000|NOT COMPLETED|Overall Study||0
10761992|NCT03150082|11925722|FG000|STARTED|Treatment Period 1 (Up to 4 Weeks)||13
10761993|NCT03150082|11925723|FG001|STARTED|Treatment Period 1 (Up to 4 Weeks)||13
10761994|NCT03150082|11925722|FG000|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||12
10761995|NCT03150082|11925723|FG001|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||13
10761996|NCT03150082|11925722|FG000|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||1
10761997|NCT03150082|11925723|FG001|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||0
10761998|NCT03150082|11925722|FG000|STARTED|Washout Period (Up to 4 Weeks)||12
10761999|NCT03150082|11925723|FG001|STARTED|Washout Period (Up to 4 Weeks)||13
10762000|NCT03150082|11925722|FG000|COMPLETED|Washout Period (Up to 4 Weeks)||12
10762001|NCT03150082|11925723|FG001|COMPLETED|Washout Period (Up to 4 Weeks)||13
10762002|NCT03150082|11925722|FG000|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
10762003|NCT03150082|11925723|FG001|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
10762004|NCT03150082|11925722|FG000|STARTED|Treatment Period 2 (Up to 4 Weeks)||12
10762005|NCT03150082|11925723|FG001|STARTED|Treatment Period 2 (Up to 4 Weeks)||13
10762006|NCT03150082|11925722|FG000|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||12
10762007|NCT03150082|11925723|FG001|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||13
10762008|NCT03150082|11925722|FG000|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0
10762009|NCT03150082|11925723|FG001|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0
10762010|NCT03150108|11925733|FG000|STARTED|Overall Study||12
10762011|NCT03150108|11925734|FG001|STARTED|Overall Study||12
10762012|NCT03150108|11925733|FG000|COMPLETED|Overall Study||12
10762013|NCT03150108|11925734|FG001|COMPLETED|Overall Study||12
10762014|NCT03150108|11925733|FG000|NOT COMPLETED|Overall Study||0
10762015|NCT03150108|11925734|FG001|NOT COMPLETED|Overall Study||0
10762016|NCT03150199|11925751|FG000|STARTED|Overall Study||30
10762017|NCT03150199|11925752|FG001|STARTED|Overall Study||30
10762018|NCT03150199|11925751|FG000|COMPLETED|Overall Study||30
10762019|NCT03150199|11925752|FG001|COMPLETED|Overall Study||30
10762020|NCT03150199|11925751|FG000|NOT COMPLETED|Overall Study||0
10762021|NCT03150199|11925752|FG001|NOT COMPLETED|Overall Study||0
10762022|NCT03150485|11925759|FG000|STARTED|Overall Study||2
10762023|NCT03150485|11925760|FG001|STARTED|Overall Study||9
10762024|NCT03150485|11925761|FG002|STARTED|Overall Study||4
10762025|NCT03150485|11925762|FG003|STARTED|Overall Study||5
10762026|NCT03150485|11925763|FG004|STARTED|Overall Study||2
10762027|NCT03150485|11925764|FG005|STARTED|Overall Study||1
10762028|NCT03150485|11925759|FG000|COMPLETED|Overall Study||2
10762029|NCT03150485|11925760|FG001|COMPLETED|Overall Study||8
10762030|NCT03150485|11925761|FG002|COMPLETED|Overall Study||4
10762031|NCT03150485|11925762|FG003|COMPLETED|Overall Study||5
10762032|NCT03150485|11925763|FG004|COMPLETED|Overall Study||2
10762033|NCT03150485|11925764|FG005|COMPLETED|Overall Study||1
10762034|NCT03150485|11925759|FG000|NOT COMPLETED|Overall Study||0
10762035|NCT03150485|11925760|FG001|NOT COMPLETED|Overall Study||1
10762036|NCT03150485|11925761|FG002|NOT COMPLETED|Overall Study||0
10762037|NCT03150485|11925762|FG003|NOT COMPLETED|Overall Study||0
10762038|NCT03150485|11925763|FG004|NOT COMPLETED|Overall Study||0
10762039|NCT03150485|11925764|FG005|NOT COMPLETED|Overall Study||0
10762040|NCT03150589|11925771|FG000|STARTED|Overall Study||351
10762041|NCT03150589|11925772|FG001|STARTED|Overall Study||354
10762042|NCT03150589|11925771|FG000|COMPLETED|Overall Study||307
10762043|NCT03150589|11925772|FG001|COMPLETED|Overall Study||327
10762044|NCT03150589|11925771|FG000|NOT COMPLETED|Overall Study||44
10762045|NCT03150589|11925772|FG001|NOT COMPLETED|Overall Study||27
10762046|NCT03150719|11925780|FG000|STARTED|Overall Study||47
10762047|NCT03150719|11925781|FG001|STARTED|Overall Study||50
10762048|NCT03150719|11925780|FG000|COMPLETED|Overall Study||46
10762049|NCT03150719|11925781|FG001|COMPLETED|Overall Study||48
10762050|NCT03150719|11925780|FG000|NOT COMPLETED|Overall Study||1
10762051|NCT03150719|11925781|FG001|NOT COMPLETED|Overall Study||2
10762052|NCT03150758|11925787|FG000|STARTED|Overall Study||6
10762053|NCT03150758|11925787|FG000|COMPLETED|Overall Study||6
10762054|NCT03150758|11925787|FG000|NOT COMPLETED|Overall Study||0
10762055|NCT03150875|11925793|FG000|STARTED|Overall Study||145
10762056|NCT03150875|11925794|FG001|STARTED|Overall Study||145
10762057|NCT03150875|11925793|FG000|Treated|Overall Study||144
10762058|NCT03150875|11925794|FG001|Treated|Overall Study||130
10762059|NCT03150875|11925793|FG000|Crossover to Certain Treatment|Overall Study||0
10762060|NCT03150875|11925794|FG001|Crossover to Certain Treatment|Overall Study||0
10762061|NCT03150875|11925793|FG000|COMPLETED|Overall Study||0
10762062|NCT03150875|11925794|FG001|COMPLETED|Overall Study||0
10762063|NCT03150875|11925793|FG000|NOT COMPLETED|Overall Study||145
10762064|NCT03150875|11925794|FG001|NOT COMPLETED|Overall Study||145
10762065|NCT03151148|11925802|FG000|STARTED|Overall Study||36
10762066|NCT03151148|11925803|FG001|STARTED|Overall Study||18
10762067|NCT03151148|11925802|FG000|COMPLETED|Overall Study||34
10762068|NCT03151148|11925803|FG001|COMPLETED|Overall Study||18
10762069|NCT03151148|11925802|FG000|NOT COMPLETED|Overall Study||2
10762070|NCT03151148|11925803|FG001|NOT COMPLETED|Overall Study||0
10762071|NCT03151265|11925812|FG000|STARTED|Overall Study||20
10762072|NCT03151265|11925813|FG001|STARTED|Overall Study||20
10762073|NCT03151265|11925812|FG000|COMPLETED|Overall Study||20
10762074|NCT03151265|11925813|FG001|COMPLETED|Overall Study||20
10762075|NCT03151265|11925812|FG000|NOT COMPLETED|Overall Study||0
10762076|NCT03151265|11925813|FG001|NOT COMPLETED|Overall Study||0
10762077|NCT03151395|11925819|FG000|STARTED|Overall Study||197
10762078|NCT03151395|11925819|FG000|COMPLETED|Overall Study||182
10762079|NCT03151395|11925819|FG000|NOT COMPLETED|Overall Study||15
10762080|NCT03151434|11925826|FG000|STARTED|Overall Study||53
10762081|NCT03151434|11925827|FG001|STARTED|Overall Study||47
10762082|NCT03151434|11925828|FG002|STARTED|Overall Study||47
10762083|NCT03151434|11925826|FG000|COMPLETED|Overall Study||40
10762084|NCT03151434|11925827|FG001|COMPLETED|Overall Study||40
10762085|NCT03151434|11925828|FG002|COMPLETED|Overall Study||40
10762086|NCT03151434|11925826|FG000|NOT COMPLETED|Overall Study||13
10762087|NCT03151434|11925827|FG001|NOT COMPLETED|Overall Study||7
10762088|NCT03151434|11925828|FG002|NOT COMPLETED|Overall Study||7
10762089|NCT03151551|11925841|FG000|STARTED|Open-Label Treatment Period||283
10762090|NCT03151551|11925842|FG001|STARTED|Open-Label Treatment Period||283
10762091|NCT03151551|11925841|FG000|Received at Least One Dose of Study Drug|Open-Label Treatment Period||283
10762092|NCT03151551|11925842|FG001|Received at Least One Dose of Study Drug|Open-Label Treatment Period||283
10762093|NCT03151551|11925841|FG000|IXE 160 mg at Baseline, 80 mg Q2W/Q4W|Open-Label Treatment Period||49
10762094|NCT03151551|11925842|FG001|IXE 160 mg at Baseline, 80 mg Q2W/Q4W|Open-Label Treatment Period|Row represents Ixekizumab data only.|0
10762095|NCT03151551|11925841|FG000|IXE 160 mg at Baseline, 80 mg Q4W|Open-Label Treatment Period||218
10762096|NCT03151551|11925842|FG001|IXE 160 mg at Baseline, 80 mg Q4W|Open-Label Treatment Period|Row represents Ixekizumab data only.|0
10762097|NCT03151551|11925841|FG000|ADA 80 mg at Baseline, 40 mg Q2W|Open-Label Treatment Period|Row represents adalimumab data only.|0
10762098|NCT03151551|11925842|FG001|ADA 80 mg at Baseline, 40 mg Q2W|Open-Label Treatment Period||51
10762099|NCT03151551|11925841|FG000|ADA 40 mg at Baseline, 40 mg Q2W|Open-Label Treatment Period|Row represents adalimumab data only.|0
10762100|NCT03151551|11925842|FG001|ADA 40 mg at Baseline, 40 mg Q2W|Open-Label Treatment Period||219
10762101|NCT03151551|11925841|FG000|COMPLETED|Open-Label Treatment Period||265
10762102|NCT03151551|11925842|FG001|COMPLETED|Open-Label Treatment Period||259
10762103|NCT03151551|11925841|FG000|NOT COMPLETED|Open-Label Treatment Period||18
10762104|NCT03151551|11925842|FG001|NOT COMPLETED|Open-Label Treatment Period||24
10762105|NCT03151551|11925841|FG000|STARTED|Post-Treatment Follow-Up Period|All participants who received at least one dose of study drug could enter the follow-up period.|265
10762106|NCT03151551|11925842|FG001|STARTED|Post-Treatment Follow-Up Period|All participants who received at least one dose of study drug could enter the follow-up period.|258
10762107|NCT03151551|11925841|FG000|COMPLETED|Post-Treatment Follow-Up Period||240
10762108|NCT03151551|11925842|FG001|COMPLETED|Post-Treatment Follow-Up Period||230
10762109|NCT03151551|11925841|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||25
10762110|NCT03151551|11925842|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||28
10762111|NCT03152019|11925852|FG000|STARTED|Overall Study||25
10762112|NCT03152019|11925853|FG001|STARTED|Overall Study||25
10762113|NCT03152019|11925852|FG000|COMPLETED|Overall Study||25
10762114|NCT03152019|11925853|FG001|COMPLETED|Overall Study||24
10762115|NCT03152019|11925852|FG000|NOT COMPLETED|Overall Study||0
10762116|NCT03152019|11925853|FG001|NOT COMPLETED|Overall Study||1
10762117|NCT03152084|11925861|FG000|STARTED|Overall Study||17
10762118|NCT03152084|11925862|FG001|STARTED|Overall Study||7
10762119|NCT03152084|11925861|FG000|COMPLETED|Overall Study||17
10762120|NCT03152084|11925862|FG001|COMPLETED|Overall Study||7
10762121|NCT03152084|11925861|FG000|NOT COMPLETED|Overall Study||0
10762122|NCT03152084|11925862|FG001|NOT COMPLETED|Overall Study||0
10762123|NCT03152110|11925868|FG000|STARTED|Overall Study||10
10762124|NCT03152110|11925868|FG000|COMPLETED|Overall Study||7
10762125|NCT03152110|11925868|FG000|NOT COMPLETED|Overall Study||3
10762126|NCT03152136|11925876|FG000|STARTED|Overall Study||32
10762127|NCT03152136|11925877|FG001|STARTED|Overall Study||15
10762128|NCT03152136|11925878|FG002|STARTED|Overall Study||15
10762129|NCT03152136|11925876|FG000|COMPLETED|Overall Study||29
10762130|NCT03152136|11925877|FG001|COMPLETED|Overall Study||15
10762131|NCT03152136|11925878|FG002|COMPLETED|Overall Study||14
10762132|NCT03152136|11925876|FG000|NOT COMPLETED|Overall Study||3
10762133|NCT03152136|11925877|FG001|NOT COMPLETED|Overall Study||0
10762134|NCT03152136|11925878|FG002|NOT COMPLETED|Overall Study||1
10762135|NCT03152552|11925890|FG000|STARTED|Treatment Period 1 (12 Weeks)||15
10762136|NCT03152552|11925891|FG001|STARTED|Treatment Period 1 (12 Weeks)||16
10762137|NCT03152552|11925892|FG002|STARTED|Treatment Period 1 (12 Weeks)||31
10762138|NCT03152552|11925893|FG003|STARTED|Treatment Period 1 (12 Weeks)||30
10762139|NCT03152552|11925894|FG004|STARTED|Treatment Period 1 (12 Weeks)||33
10762140|NCT03152552|11925890|FG000|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||15
10762141|NCT03152552|11925891|FG001|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||16
10762142|NCT03152552|11925892|FG002|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||30
10762143|NCT03152552|11925893|FG003|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||30
10762144|NCT03152552|11925894|FG004|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||33
10762145|NCT03152552|11925890|FG000|COMPLETED|Treatment Period 1 (12 Weeks)||7
10762146|NCT03152552|11925891|FG001|COMPLETED|Treatment Period 1 (12 Weeks)||5
10762147|NCT03152552|11925892|FG002|COMPLETED|Treatment Period 1 (12 Weeks)||10
10762148|NCT03152552|11925893|FG003|COMPLETED|Treatment Period 1 (12 Weeks)||10
10762149|NCT03152552|11925894|FG004|COMPLETED|Treatment Period 1 (12 Weeks)||12
10762150|NCT03152552|11925890|FG000|NOT COMPLETED|Treatment Period 1 (12 Weeks)||8
10762151|NCT03152552|11925891|FG001|NOT COMPLETED|Treatment Period 1 (12 Weeks)||11
10762152|NCT03152552|11925892|FG002|NOT COMPLETED|Treatment Period 1 (12 Weeks)||21
10762153|NCT03152552|11925893|FG003|NOT COMPLETED|Treatment Period 1 (12 Weeks)||20
10762154|NCT03152552|11925894|FG004|NOT COMPLETED|Treatment Period 1 (12 Weeks)||21
10762155|NCT03152552|11925890|FG000|STARTED|Treatment Period 2 (24 Weeks)||7
10762156|NCT03152552|11925891|FG001|STARTED|Treatment Period 2 (24 Weeks)||5
10779014|NCT03363854|11940798|FG005|NOT COMPLETED|Continuation Treatment Period||7
10762157|NCT03152552|11925892|FG002|STARTED|Treatment Period 2 (24 Weeks)|All patients who entered Treatment Period 2 (EPOCH 4)|9
10762158|NCT03152552|11925893|FG003|STARTED|Treatment Period 2 (24 Weeks)|All patients who entered Treatment Period 2 (EPOCH 4)|9
10762159|NCT03152552|11925894|FG004|STARTED|Treatment Period 2 (24 Weeks)|All patients who entered Treatment Period 2 (EPOCH 4)|11
10762160|NCT03152552|11925890|FG000|COMPLETED|Treatment Period 2 (24 Weeks)||1
10762161|NCT03152552|11925891|FG001|COMPLETED|Treatment Period 2 (24 Weeks)||0
10762162|NCT03152552|11925892|FG002|COMPLETED|Treatment Period 2 (24 Weeks)||0
10762163|NCT03152552|11925893|FG003|COMPLETED|Treatment Period 2 (24 Weeks)||0
10762164|NCT03152552|11925894|FG004|COMPLETED|Treatment Period 2 (24 Weeks)||0
10762165|NCT03152552|11925890|FG000|NOT COMPLETED|Treatment Period 2 (24 Weeks)||6
10762166|NCT03152552|11925891|FG001|NOT COMPLETED|Treatment Period 2 (24 Weeks)||5
10762167|NCT03152552|11925892|FG002|NOT COMPLETED|Treatment Period 2 (24 Weeks)||9
10762168|NCT03152552|11925893|FG003|NOT COMPLETED|Treatment Period 2 (24 Weeks)||9
10762169|NCT03152552|11925894|FG004|NOT COMPLETED|Treatment Period 2 (24 Weeks)||11
10762170|NCT03152591|11925909|FG000|STARTED|Overall Study||15
10762171|NCT03152591|11925910|FG001|STARTED|Overall Study||14
10762172|NCT03152591|11925909|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||14
10762173|NCT03152591|11925910|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||0
10762174|NCT03152591|11925909|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||15
10762175|NCT03152591|11925910|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||14
10762176|NCT03152591|11925909|FG000|COMPLETED|Overall Study||15
10762177|NCT03152591|11925910|FG001|COMPLETED|Overall Study||14
10762178|NCT03152591|11925909|FG000|NOT COMPLETED|Overall Study||0
10762179|NCT03152591|11925910|FG001|NOT COMPLETED|Overall Study||0
10762180|NCT03153956|11925918|FG000|STARTED|Overall Study||39
10762181|NCT03153956|11925919|FG001|STARTED|Overall Study||38
10762182|NCT03153956|11925918|FG000|COMPLETED|Overall Study||39
10762183|NCT03153956|11925919|FG001|COMPLETED|Overall Study||38
10762184|NCT03153956|11925918|FG000|NOT COMPLETED|Overall Study||0
10762185|NCT03153956|11925919|FG001|NOT COMPLETED|Overall Study||0
10762186|NCT03154047|11925925|FG000|STARTED|Overall Study||80
10762187|NCT03154047|11925925|FG000|Number of Patients Dosed|Overall Study||80
10762188|NCT03154047|11925925|FG000|COMPLETED|Overall Study||0
10762189|NCT03154047|11925925|FG000|NOT COMPLETED|Overall Study||80
10762190|NCT03154086|11925944|FG000|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
10762191|NCT03154086|11925945|FG001|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
10762192|NCT03154086|11925946|FG002|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
10762193|NCT03154086|11925947|FG003|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
10762194|NCT03154086|11925948|FG004|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10762195|NCT03154086|11925949|FG005|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10762196|NCT03154086|11925950|FG006|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10762197|NCT03154086|11925951|FG007|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10762198|NCT03154086|11925952|FG008|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10762199|NCT03154086|11925953|FG009|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10762200|NCT03154086|11925954|FG010|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10762201|NCT03154086|11925955|FG011|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10762202|NCT03154086|11925956|FG012|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10762203|NCT03154086|11925957|FG013|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10762204|NCT03154086|11925958|FG014|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10762205|NCT03154086|11925944|FG000|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
10762206|NCT03154086|11925945|FG001|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
10762207|NCT03154086|11925946|FG002|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
10762208|NCT03154086|11925947|FG003|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
10762209|NCT03154086|11925948|FG004|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10762210|NCT03154086|11925949|FG005|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10762211|NCT03154086|11925950|FG006|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10762212|NCT03154086|11925951|FG007|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10762213|NCT03154086|11925952|FG008|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10762214|NCT03154086|11925953|FG009|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10762215|NCT03154086|11925954|FG010|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10762216|NCT03154086|11925955|FG011|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10762217|NCT03154086|11925956|FG012|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10762218|NCT03154086|11925957|FG013|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10762219|NCT03154086|11925958|FG014|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10762220|NCT03154086|11925944|FG000|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10762221|NCT03154086|11925945|FG001|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10762222|NCT03154086|11925946|FG002|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10762223|NCT03154086|11925947|FG003|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10762224|NCT03154086|11925948|FG004|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10762225|NCT03154086|11925949|FG005|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10762226|NCT03154086|11925950|FG006|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10762227|NCT03154086|11925951|FG007|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10762228|NCT03154086|11925952|FG008|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10762229|NCT03154086|11925953|FG009|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10762230|NCT03154086|11925954|FG010|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10762231|NCT03154086|11925955|FG011|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10762232|NCT03154086|11925956|FG012|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10762233|NCT03154086|11925957|FG013|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10762234|NCT03154086|11925958|FG014|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
10762235|NCT03154086|11925944|FG000|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
10762236|NCT03154086|11925945|FG001|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
10762237|NCT03154086|11925946|FG002|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
10762238|NCT03154086|11925947|FG003|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
10762239|NCT03154086|11925948|FG004|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10762240|NCT03154086|11925949|FG005|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10762241|NCT03154086|11925950|FG006|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10762242|NCT03154086|11925951|FG007|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10762243|NCT03154086|11925952|FG008|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10762244|NCT03154086|11925953|FG009|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10762245|NCT03154086|11925954|FG010|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10762246|NCT03154086|11925955|FG011|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10762247|NCT03154086|11925956|FG012|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10762248|NCT03154086|11925957|FG013|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10762249|NCT03154086|11925958|FG014|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10762250|NCT03154086|11925944|FG000|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
10762251|NCT03154086|11925945|FG001|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
10762252|NCT03154086|11925946|FG002|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
10762253|NCT03154086|11925947|FG003|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||1
10762254|NCT03154086|11925948|FG004|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10762255|NCT03154086|11925949|FG005|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10762256|NCT03154086|11925950|FG006|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10762257|NCT03154086|11925951|FG007|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10762258|NCT03154086|11925952|FG008|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10762259|NCT03154086|11925953|FG009|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10762260|NCT03154086|11925954|FG010|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10762261|NCT03154086|11925955|FG011|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10762262|NCT03154086|11925956|FG012|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10762263|NCT03154086|11925957|FG013|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10762264|NCT03154086|11925958|FG014|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10762265|NCT03154086|11925944|FG000|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10762266|NCT03154086|11925945|FG001|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10762267|NCT03154086|11925946|FG002|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10762268|NCT03154086|11925947|FG003|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||1
10762269|NCT03154086|11925948|FG004|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10762270|NCT03154086|11925949|FG005|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10762271|NCT03154086|11925950|FG006|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10762272|NCT03154086|11925951|FG007|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10762273|NCT03154086|11925952|FG008|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10762274|NCT03154086|11925953|FG009|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10762275|NCT03154086|11925954|FG010|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10762276|NCT03154086|11925955|FG011|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10762277|NCT03154086|11925956|FG012|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10762278|NCT03154086|11925957|FG013|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10762279|NCT03154086|11925958|FG014|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
10762280|NCT03154086|11925944|FG000|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2
10762281|NCT03154086|11925945|FG001|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2
10762282|NCT03154086|11925946|FG002|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2
10762283|NCT03154086|11925947|FG003|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)|One replacement participant (par) was enrolled and dosed|2
10762284|NCT03154086|11925948|FG004|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10874931|NCT04821245|12041111|FG000|STARTED|Overall Study||36
10874932|NCT04821245|12041111|FG000|COMPLETED|Overall Study||27
10874933|NCT04821245|12041111|FG000|NOT COMPLETED|Overall Study||9
10762285|NCT03154086|11925949|FG005|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10762286|NCT03154086|11925950|FG006|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10762287|NCT03154086|11925951|FG007|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10762288|NCT03154086|11925952|FG008|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10762289|NCT03154086|11925953|FG009|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10762290|NCT03154086|11925954|FG010|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10762291|NCT03154086|11925955|FG011|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10762292|NCT03154086|11925956|FG012|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10762293|NCT03154086|11925957|FG013|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10762294|NCT03154086|11925958|FG014|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10762295|NCT03154086|11925944|FG000|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
10762296|NCT03154086|11925945|FG001|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
10762297|NCT03154086|11925946|FG002|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
10762298|NCT03154086|11925947|FG003|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
10762299|NCT03154086|11925948|FG004|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10762300|NCT03154086|11925949|FG005|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10762301|NCT03154086|11925950|FG006|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10762302|NCT03154086|11925951|FG007|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10762303|NCT03154086|11925952|FG008|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10762304|NCT03154086|11925953|FG009|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10762305|NCT03154086|11925954|FG010|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10762306|NCT03154086|11925955|FG011|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10762307|NCT03154086|11925956|FG012|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10762308|NCT03154086|11925957|FG013|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10762309|NCT03154086|11925958|FG014|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10762310|NCT03154086|11925944|FG000|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10762311|NCT03154086|11925945|FG001|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10762312|NCT03154086|11925946|FG002|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10762313|NCT03154086|11925947|FG003|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10762314|NCT03154086|11925948|FG004|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10762315|NCT03154086|11925949|FG005|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10762316|NCT03154086|11925950|FG006|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10762317|NCT03154086|11925951|FG007|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10762318|NCT03154086|11925952|FG008|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10762319|NCT03154086|11925953|FG009|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10762320|NCT03154086|11925954|FG010|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10762321|NCT03154086|11925955|FG011|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10762322|NCT03154086|11925956|FG012|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10762323|NCT03154086|11925957|FG013|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10762324|NCT03154086|11925958|FG014|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10762325|NCT03154086|11925944|FG000|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
10762326|NCT03154086|11925945|FG001|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
10762327|NCT03154086|11925946|FG002|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
10762328|NCT03154086|11925947|FG003|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
10762329|NCT03154086|11925948|FG004|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10762330|NCT03154086|11925949|FG005|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10762331|NCT03154086|11925950|FG006|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10762332|NCT03154086|11925951|FG007|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10762333|NCT03154086|11925952|FG008|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10762334|NCT03154086|11925953|FG009|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10762335|NCT03154086|11925954|FG010|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10762336|NCT03154086|11925955|FG011|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10762337|NCT03154086|11925956|FG012|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10762338|NCT03154086|11925957|FG013|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10762339|NCT03154086|11925958|FG014|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10762340|NCT03154086|11925944|FG000|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
10762341|NCT03154086|11925945|FG001|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||1
10762342|NCT03154086|11925946|FG002|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
10762343|NCT03154086|11925947|FG003|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
10762344|NCT03154086|11925948|FG004|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10762345|NCT03154086|11925949|FG005|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10762346|NCT03154086|11925950|FG006|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10762347|NCT03154086|11925951|FG007|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10762348|NCT03154086|11925952|FG008|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10762349|NCT03154086|11925953|FG009|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10762350|NCT03154086|11925954|FG010|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10762351|NCT03154086|11925955|FG011|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10762352|NCT03154086|11925956|FG012|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10762353|NCT03154086|11925957|FG013|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10762354|NCT03154086|11925958|FG014|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10762355|NCT03154086|11925944|FG000|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10762356|NCT03154086|11925945|FG001|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||1
10762357|NCT03154086|11925946|FG002|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10762358|NCT03154086|11925947|FG003|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10762359|NCT03154086|11925948|FG004|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10762360|NCT03154086|11925949|FG005|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10762361|NCT03154086|11925950|FG006|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10762362|NCT03154086|11925951|FG007|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10762363|NCT03154086|11925952|FG008|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10762364|NCT03154086|11925953|FG009|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10762365|NCT03154086|11925954|FG010|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10762366|NCT03154086|11925955|FG011|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10762367|NCT03154086|11925956|FG012|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10762368|NCT03154086|11925957|FG013|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10762369|NCT03154086|11925958|FG014|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10762370|NCT03154086|11925944|FG000|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2
10762371|NCT03154086|11925945|FG001|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)|One replacement par was enrolled and dosed|2
10762372|NCT03154086|11925946|FG002|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2
10762373|NCT03154086|11925947|FG003|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2
10762374|NCT03154086|11925948|FG004|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10762375|NCT03154086|11925949|FG005|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10762376|NCT03154086|11925950|FG006|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10762377|NCT03154086|11925951|FG007|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10762378|NCT03154086|11925952|FG008|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10762379|NCT03154086|11925953|FG009|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10762380|NCT03154086|11925954|FG010|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10762381|NCT03154086|11925955|FG011|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10762382|NCT03154086|11925956|FG012|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10762383|NCT03154086|11925957|FG013|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10762384|NCT03154086|11925958|FG014|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10762385|NCT03154086|11925944|FG000|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
10762386|NCT03154086|11925945|FG001|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
10762387|NCT03154086|11925946|FG002|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
10762388|NCT03154086|11925947|FG003|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
10762389|NCT03154086|11925948|FG004|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10762390|NCT03154086|11925949|FG005|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10297045|NCT00756938|11429564|FG001|COMPLETED|12-week Base Study||34
10297046|NCT00756938|11429565|FG002|COMPLETED|12-week Base Study||32
10297047|NCT00756938|11429566|FG003|COMPLETED|12-week Base Study||0
10297048|NCT00756938|11429563|FG000|NOT COMPLETED|12-week Base Study||2
10297049|NCT00756938|11429564|FG001|NOT COMPLETED|12-week Base Study||0
10297050|NCT00756938|11429565|FG002|NOT COMPLETED|12-week Base Study||2
10297051|NCT00756938|11429566|FG003|NOT COMPLETED|12-week Base Study||0
10297052|NCT00756938|11429563|FG000|STARTED|Optional Extension||0
10297053|NCT00756938|11429564|FG001|STARTED|Optional Extension||0
10297054|NCT00756938|11429565|FG002|STARTED|Optional Extension||0
10297055|NCT00756938|11429566|FG003|STARTED|Optional Extension|7 participants who completed base study opted not to enter extension|90
10297056|NCT00756938|11429563|FG000|COMPLETED|Optional Extension||0
10297057|NCT00756938|11429564|FG001|COMPLETED|Optional Extension||0
10297058|NCT00756938|11429565|FG002|COMPLETED|Optional Extension||0
10297059|NCT00756938|11429566|FG003|COMPLETED|Optional Extension||53
10297060|NCT00756938|11429563|FG000|NOT COMPLETED|Optional Extension||0
10297061|NCT00756938|11429564|FG001|NOT COMPLETED|Optional Extension||0
10297062|NCT00756938|11429565|FG002|NOT COMPLETED|Optional Extension||0
10297063|NCT00756938|11429566|FG003|NOT COMPLETED|Optional Extension||37
10297064|NCT00730132|11429584|FG000|STARTED|Overall Study||712
10297065|NCT00730132|11429584|FG000|COMPLETED|Overall Study||557
10297066|NCT00730132|11429584|FG000|NOT COMPLETED|Overall Study||155
10297067|NCT00728416|11429593|FG000|STARTED|Overall Study||168
10297068|NCT00728416|11429594|FG001|STARTED|Overall Study||165
10297069|NCT00728416|11429593|FG000|COMPLETED|Overall Study||166
10297070|NCT00728416|11429594|FG001|COMPLETED|Overall Study||163
10297071|NCT00728416|11429593|FG000|NOT COMPLETED|Overall Study||2
10297072|NCT00728416|11429594|FG001|NOT COMPLETED|Overall Study||2
10297073|NCT00724477|11429600|FG000|STARTED|Overall Study|This safety population (SAF)analysed consisted of all patients who took at least one tablet of INEGY|1663
10297074|NCT00724477|11429600|FG000|COMPLETED|Overall Study||1663
10297075|NCT00724477|11429600|FG000|NOT COMPLETED|Overall Study||0
10297076|NCT00723736|11429604|FG000|STARTED|Overall Study||100
10297077|NCT00723736|11429604|FG000|COMPLETED|Overall Study|Subject's caregiver did not wish to continue, reasons unrelated.|99
10297078|NCT00723736|11429604|FG000|NOT COMPLETED|Overall Study||1
10297079|NCT00705081|11429610|FG000|STARTED|Overall Study||255
10297080|NCT00705081|11429611|FG001|STARTED|Overall Study||198
10297081|NCT00705081|11429610|FG000|COMPLETED|Overall Study||255
10297082|NCT00705081|11429611|FG001|COMPLETED|Overall Study||198
10297083|NCT00705081|11429610|FG000|NOT COMPLETED|Overall Study||0
10297084|NCT00705081|11429611|FG001|NOT COMPLETED|Overall Study||0
10297085|NCT00704769|11429617|FG000|STARTED|Overall Study||591
10297086|NCT00704769|11429617|FG000|COMPLETED|Overall Study||591
10762391|NCT03154086|11925950|FG006|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10762392|NCT03154086|11925951|FG007|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10762393|NCT03154086|11925952|FG008|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10762394|NCT03154086|11925953|FG009|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10762395|NCT03154086|11925954|FG010|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10762396|NCT03154086|11925955|FG011|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10762397|NCT03154086|11925956|FG012|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10762398|NCT03154086|11925957|FG013|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10762399|NCT03154086|11925958|FG014|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10762400|NCT03154086|11925944|FG000|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10762401|NCT03154086|11925945|FG001|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10762402|NCT03154086|11925946|FG002|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10762403|NCT03154086|11925947|FG003|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10762404|NCT03154086|11925948|FG004|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10762405|NCT03154086|11925949|FG005|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10762406|NCT03154086|11925950|FG006|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10762407|NCT03154086|11925951|FG007|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10762408|NCT03154086|11925952|FG008|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10762409|NCT03154086|11925953|FG009|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10762410|NCT03154086|11925954|FG010|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10762411|NCT03154086|11925955|FG011|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10762412|NCT03154086|11925956|FG012|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10762413|NCT03154086|11925957|FG013|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10762414|NCT03154086|11925958|FG014|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10762415|NCT03154086|11925944|FG000|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
10762416|NCT03154086|11925945|FG001|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
10762417|NCT03154086|11925946|FG002|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
10762418|NCT03154086|11925947|FG003|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
10762419|NCT03154086|11925948|FG004|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10762420|NCT03154086|11925949|FG005|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10762421|NCT03154086|11925950|FG006|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10762422|NCT03154086|11925951|FG007|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10762423|NCT03154086|11925952|FG008|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10762424|NCT03154086|11925953|FG009|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10762425|NCT03154086|11925954|FG010|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10762426|NCT03154086|11925955|FG011|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10762427|NCT03154086|11925956|FG012|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10762428|NCT03154086|11925957|FG013|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10762429|NCT03154086|11925958|FG014|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10762430|NCT03154086|11925944|FG000|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
10762431|NCT03154086|11925945|FG001|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
10762432|NCT03154086|11925946|FG002|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||1
10762433|NCT03154086|11925947|FG003|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
10762434|NCT03154086|11925948|FG004|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10762435|NCT03154086|11925949|FG005|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10762436|NCT03154086|11925950|FG006|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10762437|NCT03154086|11925951|FG007|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10762438|NCT03154086|11925952|FG008|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10762439|NCT03154086|11925953|FG009|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10762440|NCT03154086|11925954|FG010|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10762441|NCT03154086|11925955|FG011|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10762442|NCT03154086|11925956|FG012|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10762443|NCT03154086|11925957|FG013|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10762444|NCT03154086|11925958|FG014|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10762445|NCT03154086|11925944|FG000|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10762446|NCT03154086|11925945|FG001|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10762447|NCT03154086|11925946|FG002|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||1
10762448|NCT03154086|11925947|FG003|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10762449|NCT03154086|11925948|FG004|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10762450|NCT03154086|11925949|FG005|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10762451|NCT03154086|11925950|FG006|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10762452|NCT03154086|11925951|FG007|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10762453|NCT03154086|11925952|FG008|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10762454|NCT03154086|11925953|FG009|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10762455|NCT03154086|11925954|FG010|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10762456|NCT03154086|11925955|FG011|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10762457|NCT03154086|11925956|FG012|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10762458|NCT03154086|11925957|FG013|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10762459|NCT03154086|11925958|FG014|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10762460|NCT03154086|11925944|FG000|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)|1 par was not dosed on day of dosing due to elevated lab; hence 1 replacement was enrolled and dosed|3
10762461|NCT03154086|11925945|FG001|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||2
10762462|NCT03154086|11925946|FG002|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||1
10762463|NCT03154086|11925947|FG003|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||2
10297087|NCT00704769|11429617|FG000|NOT COMPLETED|Overall Study||0
10297088|NCT00704535|11429621|FG000|STARTED|Overall Study||4105
10297089|NCT00704535|11429621|FG000|COMPLETED|Overall Study||3959
10297090|NCT00704535|11429621|FG000|NOT COMPLETED|Overall Study||146
10297091|NCT00694369|11429630|FG000|STARTED|Overall Study||46
10297092|NCT00694369|11429631|FG001|STARTED|Overall Study||191
10297093|NCT00694369|11429632|FG002|STARTED|Overall Study||97
10297094|NCT00694369|11429633|FG003|STARTED|Overall Study||192
10297095|NCT00694369|11429634|FG004|STARTED|Overall Study||62
10297096|NCT00694369|11429630|FG000|COMPLETED|Overall Study||45
10297097|NCT00694369|11429631|FG001|COMPLETED|Overall Study||188
10297098|NCT00694369|11429632|FG002|COMPLETED|Overall Study||95
10297099|NCT00694369|11429633|FG003|COMPLETED|Overall Study||189
10297100|NCT00694369|11429634|FG004|COMPLETED|Overall Study||56
10297101|NCT00694369|11429630|FG000|NOT COMPLETED|Overall Study||1
10297102|NCT00694369|11429631|FG001|NOT COMPLETED|Overall Study||3
10297103|NCT00694369|11429632|FG002|NOT COMPLETED|Overall Study||2
10297104|NCT00694369|11429633|FG003|NOT COMPLETED|Overall Study||3
10297105|NCT00694369|11429634|FG004|NOT COMPLETED|Overall Study||6
10297106|NCT00671528|11429649|FG000|STARTED|Overall Study||1
10297107|NCT00671528|11429650|FG001|STARTED|Overall Study||1
10297108|NCT00671528|11429651|FG002|STARTED|Overall Study||1
10297109|NCT00671528|11429649|FG000|COMPLETED|Overall Study||1
10297110|NCT00671528|11429650|FG001|COMPLETED|Overall Study||1
10297111|NCT00671528|11429651|FG002|COMPLETED|Overall Study||1
10297112|NCT00671528|11429649|FG000|NOT COMPLETED|Overall Study||0
10297113|NCT00671528|11429650|FG001|NOT COMPLETED|Overall Study||0
10297114|NCT00671528|11429651|FG002|NOT COMPLETED|Overall Study||0
10297115|NCT00667823|11429659|FG000|STARTED|Overall Study||550
10297116|NCT00667823|11429659|FG000|COMPLETED|Overall Study||334
10297117|NCT00667823|11429659|FG000|NOT COMPLETED|Overall Study||216
10297118|NCT00652327|11429665|FG000|STARTED|Overall Study|Participants who recieved randomized treatment assignment to ezetimibe and ongoing statin|42
10297119|NCT00652327|11429666|FG001|STARTED|Overall Study|Participants who recieved randomized treatment assignment to double the dose of ongoing statin|41
10297120|NCT00652327|11429665|FG000|COMPLETED|Overall Study||42
10297121|NCT00652327|11429666|FG001|COMPLETED|Overall Study||36
10297122|NCT00652327|11429665|FG000|NOT COMPLETED|Overall Study||0
10297123|NCT00652327|11429666|FG001|NOT COMPLETED|Overall Study||5
10297124|NCT00604500|11429672|FG000|STARTED|Overall Study||272
10297125|NCT00604500|11429672|FG000|COMPLETED|Overall Study|There were 233 participants who took at least 90% of the labeled actuations (Completer Population).|261
10297126|NCT00604500|11429672|FG000|NOT COMPLETED|Overall Study||11
10297127|NCT00568178|11429678|FG000|STARTED|Double Blind Base Study||122
10297128|NCT00568178|11429679|FG001|STARTED|Double Blind Base Study||124
10297129|NCT00568178|11429680|FG002|STARTED|Double Blind Base Study||30
10297130|NCT00568178|11429681|FG003|STARTED|Double Blind Base Study||30
10297131|NCT00568178|11429682|FG004|STARTED|Double Blind Base Study||0
10297132|NCT00568178|11429683|FG005|STARTED|Double Blind Base Study||0
10297133|NCT00568178|11429678|FG000|COMPLETED|Double Blind Base Study||116
10297134|NCT00568178|11429679|FG001|COMPLETED|Double Blind Base Study||118
10297135|NCT00568178|11429680|FG002|COMPLETED|Double Blind Base Study||29
10297136|NCT00568178|11429681|FG003|COMPLETED|Double Blind Base Study||25
10297137|NCT00568178|11429682|FG004|COMPLETED|Double Blind Base Study||0
10297138|NCT00568178|11429683|FG005|COMPLETED|Double Blind Base Study||0
10297139|NCT00568178|11429678|FG000|NOT COMPLETED|Double Blind Base Study||6
10297140|NCT00568178|11429679|FG001|NOT COMPLETED|Double Blind Base Study||6
10297141|NCT00568178|11429680|FG002|NOT COMPLETED|Double Blind Base Study||1
10297142|NCT00568178|11429681|FG003|NOT COMPLETED|Double Blind Base Study||5
10297143|NCT00568178|11429682|FG004|NOT COMPLETED|Double Blind Base Study||0
10297144|NCT00568178|11429683|FG005|NOT COMPLETED|Double Blind Base Study||0
10297145|NCT00568178|11429678|FG000|STARTED|Open Label Extension||0
10297146|NCT00568178|11429679|FG001|STARTED|Open Label Extension||0
10297147|NCT00568178|11429680|FG002|STARTED|Open Label Extension||0
10297148|NCT00568178|11429681|FG003|STARTED|Open Label Extension||0
10297149|NCT00568178|11429682|FG004|STARTED|Open Label Extension||134
10297150|NCT00568178|11429683|FG005|STARTED|Open Label Extension||134
10297151|NCT00568178|11429678|FG000|COMPLETED|Open Label Extension||0
10297152|NCT00568178|11429679|FG001|COMPLETED|Open Label Extension||0
10297153|NCT00568178|11429680|FG002|COMPLETED|Open Label Extension||0
10297154|NCT00568178|11429681|FG003|COMPLETED|Open Label Extension||0
10297155|NCT00568178|11429682|FG004|COMPLETED|Open Label Extension||55
10297156|NCT00568178|11429683|FG005|COMPLETED|Open Label Extension||54
10297157|NCT00568178|11429678|FG000|NOT COMPLETED|Open Label Extension||0
10297158|NCT00568178|11429679|FG001|NOT COMPLETED|Open Label Extension||0
10297159|NCT00568178|11429680|FG002|NOT COMPLETED|Open Label Extension||0
10297160|NCT00568178|11429681|FG003|NOT COMPLETED|Open Label Extension||0
10297161|NCT00568178|11429682|FG004|NOT COMPLETED|Open Label Extension||79
10762464|NCT03154086|11925948|FG004|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10762465|NCT03154086|11925949|FG005|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10762466|NCT03154086|11925950|FG006|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10762467|NCT03154086|11925951|FG007|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10762468|NCT03154086|11925952|FG008|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10762469|NCT03154086|11925953|FG009|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10762470|NCT03154086|11925954|FG010|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10762471|NCT03154086|11925955|FG011|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10762472|NCT03154086|11925956|FG012|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10762473|NCT03154086|11925957|FG013|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10762474|NCT03154086|11925958|FG014|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10762475|NCT03154086|11925944|FG000|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||2
10762476|NCT03154086|11925945|FG001|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||2
10762477|NCT03154086|11925946|FG002|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||1
10762478|NCT03154086|11925947|FG003|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||2
10762479|NCT03154086|11925948|FG004|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10762480|NCT03154086|11925949|FG005|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10762481|NCT03154086|11925950|FG006|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10762482|NCT03154086|11925951|FG007|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10762483|NCT03154086|11925952|FG008|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10762484|NCT03154086|11925953|FG009|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10762485|NCT03154086|11925954|FG010|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10762486|NCT03154086|11925955|FG011|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10762487|NCT03154086|11925956|FG012|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10762488|NCT03154086|11925957|FG013|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10762489|NCT03154086|11925958|FG014|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10762490|NCT03154086|11925944|FG000|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||1
10762491|NCT03154086|11925945|FG001|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10762492|NCT03154086|11925946|FG002|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10762493|NCT03154086|11925947|FG003|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10762494|NCT03154086|11925948|FG004|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10762495|NCT03154086|11925949|FG005|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10762496|NCT03154086|11925950|FG006|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10762497|NCT03154086|11925951|FG007|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10762498|NCT03154086|11925952|FG008|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10762499|NCT03154086|11925953|FG009|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10762500|NCT03154086|11925954|FG010|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10762501|NCT03154086|11925955|FG011|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10762502|NCT03154086|11925956|FG012|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10762503|NCT03154086|11925957|FG013|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10762504|NCT03154086|11925958|FG014|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10762505|NCT03154086|11925944|FG000|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10762506|NCT03154086|11925945|FG001|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10762507|NCT03154086|11925946|FG002|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10762508|NCT03154086|11925947|FG003|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10762509|NCT03154086|11925948|FG004|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||6
10762510|NCT03154086|11925949|FG005|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||2
10762511|NCT03154086|11925950|FG006|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10762512|NCT03154086|11925951|FG007|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10762513|NCT03154086|11925952|FG008|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10762514|NCT03154086|11925953|FG009|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10762515|NCT03154086|11925954|FG010|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10762516|NCT03154086|11925955|FG011|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10762517|NCT03154086|11925956|FG012|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10762518|NCT03154086|11925957|FG013|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10762519|NCT03154086|11925958|FG014|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10762520|NCT03154086|11925944|FG000|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10762521|NCT03154086|11925945|FG001|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10762522|NCT03154086|11925946|FG002|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10762523|NCT03154086|11925947|FG003|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10762524|NCT03154086|11925948|FG004|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||6
10762525|NCT03154086|11925949|FG005|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||2
10762526|NCT03154086|11925950|FG006|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10762527|NCT03154086|11925951|FG007|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10762528|NCT03154086|11925952|FG008|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10762529|NCT03154086|11925953|FG009|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10762530|NCT03154086|11925954|FG010|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10762531|NCT03154086|11925955|FG011|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10762532|NCT03154086|11925956|FG012|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10762533|NCT03154086|11925957|FG013|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10762534|NCT03154086|11925958|FG014|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10762535|NCT03154086|11925944|FG000|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10762536|NCT03154086|11925945|FG001|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10762537|NCT03154086|11925946|FG002|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10762538|NCT03154086|11925947|FG003|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10762539|NCT03154086|11925948|FG004|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10762540|NCT03154086|11925949|FG005|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10762541|NCT03154086|11925950|FG006|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10762542|NCT03154086|11925951|FG007|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10762543|NCT03154086|11925952|FG008|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10762544|NCT03154086|11925953|FG009|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10762545|NCT03154086|11925954|FG010|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10762546|NCT03154086|11925955|FG011|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10762547|NCT03154086|11925956|FG012|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10762548|NCT03154086|11925957|FG013|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10762549|NCT03154086|11925958|FG014|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10762550|NCT03154086|11925944|FG000|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10762551|NCT03154086|11925945|FG001|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10762552|NCT03154086|11925946|FG002|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10762553|NCT03154086|11925947|FG003|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10762554|NCT03154086|11925948|FG004|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||6
10762555|NCT03154086|11925949|FG005|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||2
10762556|NCT03154086|11925950|FG006|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10762557|NCT03154086|11925951|FG007|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10762558|NCT03154086|11925952|FG008|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10762559|NCT03154086|11925953|FG009|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10762560|NCT03154086|11925954|FG010|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10762561|NCT03154086|11925955|FG011|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10762562|NCT03154086|11925956|FG012|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10762563|NCT03154086|11925957|FG013|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10762564|NCT03154086|11925958|FG014|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10762565|NCT03154086|11925944|FG000|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10762566|NCT03154086|11925945|FG001|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10762567|NCT03154086|11925946|FG002|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10762568|NCT03154086|11925947|FG003|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10762569|NCT03154086|11925948|FG004|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||6
10762570|NCT03154086|11925949|FG005|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||2
10762571|NCT03154086|11925950|FG006|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10762572|NCT03154086|11925951|FG007|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10762573|NCT03154086|11925952|FG008|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10762574|NCT03154086|11925953|FG009|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10762575|NCT03154086|11925954|FG010|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10762576|NCT03154086|11925955|FG011|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10762577|NCT03154086|11925956|FG012|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10762578|NCT03154086|11925957|FG013|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10762579|NCT03154086|11925958|FG014|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10762580|NCT03154086|11925944|FG000|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10762581|NCT03154086|11925945|FG001|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10762582|NCT03154086|11925946|FG002|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10762583|NCT03154086|11925947|FG003|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10762584|NCT03154086|11925948|FG004|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10762585|NCT03154086|11925949|FG005|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10762586|NCT03154086|11925950|FG006|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10762587|NCT03154086|11925951|FG007|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10762588|NCT03154086|11925952|FG008|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10762589|NCT03154086|11925953|FG009|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10762590|NCT03154086|11925954|FG010|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10762591|NCT03154086|11925955|FG011|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10762592|NCT03154086|11925956|FG012|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10762593|NCT03154086|11925957|FG013|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10762594|NCT03154086|11925958|FG014|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10762595|NCT03154086|11925944|FG000|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10762596|NCT03154086|11925945|FG001|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10762597|NCT03154086|11925946|FG002|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10762598|NCT03154086|11925947|FG003|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10762599|NCT03154086|11925948|FG004|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||6
10762600|NCT03154086|11925949|FG005|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||2
10762601|NCT03154086|11925950|FG006|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10762602|NCT03154086|11925951|FG007|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10762603|NCT03154086|11925952|FG008|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10762604|NCT03154086|11925953|FG009|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10762605|NCT03154086|11925954|FG010|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10762606|NCT03154086|11925955|FG011|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10762607|NCT03154086|11925956|FG012|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10762608|NCT03154086|11925957|FG013|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10762609|NCT03154086|11925958|FG014|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10762610|NCT03154086|11925944|FG000|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10762611|NCT03154086|11925945|FG001|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10762612|NCT03154086|11925946|FG002|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10762613|NCT03154086|11925947|FG003|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10762614|NCT03154086|11925948|FG004|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||6
10762615|NCT03154086|11925949|FG005|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||2
10762616|NCT03154086|11925950|FG006|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10762617|NCT03154086|11925951|FG007|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10762618|NCT03154086|11925952|FG008|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10762619|NCT03154086|11925953|FG009|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10762620|NCT03154086|11925954|FG010|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10762621|NCT03154086|11925955|FG011|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10762622|NCT03154086|11925956|FG012|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10762623|NCT03154086|11925957|FG013|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10762624|NCT03154086|11925958|FG014|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10762625|NCT03154086|11925944|FG000|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10762626|NCT03154086|11925945|FG001|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10762627|NCT03154086|11925946|FG002|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10762628|NCT03154086|11925947|FG003|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10762629|NCT03154086|11925948|FG004|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10762630|NCT03154086|11925949|FG005|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10762631|NCT03154086|11925950|FG006|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10762632|NCT03154086|11925951|FG007|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10762633|NCT03154086|11925952|FG008|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10762634|NCT03154086|11925953|FG009|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10762635|NCT03154086|11925954|FG010|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10762636|NCT03154086|11925955|FG011|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10762637|NCT03154086|11925956|FG012|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10762638|NCT03154086|11925957|FG013|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10762639|NCT03154086|11925958|FG014|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10762640|NCT03154086|11925944|FG000|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10762641|NCT03154086|11925945|FG001|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10762642|NCT03154086|11925946|FG002|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10762643|NCT03154086|11925947|FG003|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10762644|NCT03154086|11925948|FG004|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10762645|NCT03154086|11925949|FG005|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10762646|NCT03154086|11925950|FG006|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||2
10762647|NCT03154086|11925951|FG007|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||2
10762648|NCT03154086|11925952|FG008|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||4
10762649|NCT03154086|11925953|FG009|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10762650|NCT03154086|11925954|FG010|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10762651|NCT03154086|11925955|FG011|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10762652|NCT03154086|11925956|FG012|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10762653|NCT03154086|11925957|FG013|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10762654|NCT03154086|11925958|FG014|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10762655|NCT03154086|11925944|FG000|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10762656|NCT03154086|11925945|FG001|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10762657|NCT03154086|11925946|FG002|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10762658|NCT03154086|11925947|FG003|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10762659|NCT03154086|11925948|FG004|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10762660|NCT03154086|11925949|FG005|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10762661|NCT03154086|11925950|FG006|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||2
10762662|NCT03154086|11925951|FG007|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||2
10762663|NCT03154086|11925952|FG008|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||4
10762664|NCT03154086|11925953|FG009|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10762665|NCT03154086|11925954|FG010|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10762666|NCT03154086|11925955|FG011|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10762667|NCT03154086|11925956|FG012|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10762668|NCT03154086|11925957|FG013|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10762669|NCT03154086|11925958|FG014|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10762670|NCT03154086|11925944|FG000|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10762671|NCT03154086|11925945|FG001|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10762672|NCT03154086|11925946|FG002|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10762673|NCT03154086|11925947|FG003|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10762674|NCT03154086|11925948|FG004|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10762675|NCT03154086|11925949|FG005|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10762676|NCT03154086|11925950|FG006|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10762677|NCT03154086|11925951|FG007|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10762678|NCT03154086|11925952|FG008|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10762679|NCT03154086|11925953|FG009|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10762680|NCT03154086|11925954|FG010|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10762681|NCT03154086|11925955|FG011|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10762682|NCT03154086|11925956|FG012|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10762683|NCT03154086|11925957|FG013|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10762684|NCT03154086|11925958|FG014|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10762685|NCT03154086|11925944|FG000|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10762686|NCT03154086|11925945|FG001|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10762687|NCT03154086|11925946|FG002|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10762688|NCT03154086|11925947|FG003|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10762689|NCT03154086|11925948|FG004|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10762690|NCT03154086|11925949|FG005|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10762691|NCT03154086|11925950|FG006|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
10762692|NCT03154086|11925951|FG007|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
10762693|NCT03154086|11925952|FG008|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||4
10762694|NCT03154086|11925953|FG009|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10762695|NCT03154086|11925954|FG010|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10762696|NCT03154086|11925955|FG011|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10762697|NCT03154086|11925956|FG012|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10762698|NCT03154086|11925957|FG013|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10762699|NCT03154086|11925958|FG014|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10762700|NCT03154086|11925944|FG000|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10762701|NCT03154086|11925945|FG001|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10762702|NCT03154086|11925946|FG002|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10762703|NCT03154086|11925947|FG003|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10762704|NCT03154086|11925948|FG004|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10762705|NCT03154086|11925949|FG005|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10762706|NCT03154086|11925950|FG006|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
10762707|NCT03154086|11925951|FG007|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
10762708|NCT03154086|11925952|FG008|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||4
10762709|NCT03154086|11925953|FG009|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10762710|NCT03154086|11925954|FG010|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10762711|NCT03154086|11925955|FG011|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10762712|NCT03154086|11925956|FG012|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10762713|NCT03154086|11925957|FG013|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10762714|NCT03154086|11925958|FG014|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10762715|NCT03154086|11925944|FG000|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10762716|NCT03154086|11925945|FG001|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10762717|NCT03154086|11925946|FG002|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10762718|NCT03154086|11925947|FG003|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10762719|NCT03154086|11925948|FG004|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10762720|NCT03154086|11925949|FG005|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10762721|NCT03154086|11925950|FG006|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10762722|NCT03154086|11925951|FG007|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10762723|NCT03154086|11925952|FG008|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10762724|NCT03154086|11925953|FG009|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10762725|NCT03154086|11925954|FG010|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10762726|NCT03154086|11925955|FG011|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10762727|NCT03154086|11925956|FG012|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10762728|NCT03154086|11925957|FG013|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10762729|NCT03154086|11925958|FG014|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10762730|NCT03154086|11925944|FG000|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10762731|NCT03154086|11925945|FG001|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10762732|NCT03154086|11925946|FG002|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10762733|NCT03154086|11925947|FG003|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10762734|NCT03154086|11925948|FG004|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10762735|NCT03154086|11925949|FG005|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10762736|NCT03154086|11925950|FG006|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||2
10762737|NCT03154086|11925951|FG007|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||2
10762738|NCT03154086|11925952|FG008|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)|1 par was unwell on Day-1 of Period 2 and discontinued; hence,1 replacement was enrolled and dosed|5
10762739|NCT03154086|11925953|FG009|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10762740|NCT03154086|11925954|FG010|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10762741|NCT03154086|11925955|FG011|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10762742|NCT03154086|11925956|FG012|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10762743|NCT03154086|11925957|FG013|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10762744|NCT03154086|11925958|FG014|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10762745|NCT03154086|11925944|FG000|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10762746|NCT03154086|11925945|FG001|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10762747|NCT03154086|11925946|FG002|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10762748|NCT03154086|11925947|FG003|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10762749|NCT03154086|11925948|FG004|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10762750|NCT03154086|11925949|FG005|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10762751|NCT03154086|11925950|FG006|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||2
10762752|NCT03154086|11925951|FG007|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||1
10762753|NCT03154086|11925952|FG008|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||4
10762754|NCT03154086|11925953|FG009|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10762755|NCT03154086|11925954|FG010|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10762756|NCT03154086|11925955|FG011|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10762757|NCT03154086|11925956|FG012|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10762758|NCT03154086|11925957|FG013|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10762759|NCT03154086|11925958|FG014|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10762760|NCT03154086|11925944|FG000|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10762761|NCT03154086|11925945|FG001|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10762762|NCT03154086|11925946|FG002|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10762763|NCT03154086|11925947|FG003|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10762764|NCT03154086|11925948|FG004|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10762765|NCT03154086|11925949|FG005|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10762766|NCT03154086|11925950|FG006|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10762767|NCT03154086|11925951|FG007|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||1
10762768|NCT03154086|11925952|FG008|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||1
10762769|NCT03154086|11925953|FG009|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10762770|NCT03154086|11925954|FG010|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10762771|NCT03154086|11925955|FG011|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10762772|NCT03154086|11925956|FG012|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10762773|NCT03154086|11925957|FG013|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10762774|NCT03154086|11925958|FG014|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10762775|NCT03154086|11925944|FG000|STARTED|Part B (Up to 25 Days)||0
10762776|NCT03154086|11925945|FG001|STARTED|Part B (Up to 25 Days)||0
10762777|NCT03154086|11925946|FG002|STARTED|Part B (Up to 25 Days)||0
10762778|NCT03154086|11925947|FG003|STARTED|Part B (Up to 25 Days)||0
10762779|NCT03154086|11925948|FG004|STARTED|Part B (Up to 25 Days)||0
10762780|NCT03154086|11925949|FG005|STARTED|Part B (Up to 25 Days)||0
10762781|NCT03154086|11925950|FG006|STARTED|Part B (Up to 25 Days)||0
10762782|NCT03154086|11925951|FG007|STARTED|Part B (Up to 25 Days)||0
10762783|NCT03154086|11925952|FG008|STARTED|Part B (Up to 25 Days)||0
10762784|NCT03154086|11925953|FG009|STARTED|Part B (Up to 25 Days)||10
10762785|NCT03154086|11925954|FG010|STARTED|Part B (Up to 25 Days)||6
10762786|NCT03154086|11925955|FG011|STARTED|Part B (Up to 25 Days)||6
10762787|NCT03154086|11925956|FG012|STARTED|Part B (Up to 25 Days)||6
10762788|NCT03154086|11925957|FG013|STARTED|Part B (Up to 25 Days)||6
10762789|NCT03154086|11925958|FG014|STARTED|Part B (Up to 25 Days)||6
10762790|NCT03154086|11925944|FG000|COMPLETED|Part B (Up to 25 Days)||0
10762791|NCT03154086|11925945|FG001|COMPLETED|Part B (Up to 25 Days)||0
10762792|NCT03154086|11925946|FG002|COMPLETED|Part B (Up to 25 Days)||0
10762793|NCT03154086|11925947|FG003|COMPLETED|Part B (Up to 25 Days)||0
10762794|NCT03154086|11925948|FG004|COMPLETED|Part B (Up to 25 Days)||0
10762795|NCT03154086|11925949|FG005|COMPLETED|Part B (Up to 25 Days)||0
10762796|NCT03154086|11925950|FG006|COMPLETED|Part B (Up to 25 Days)||0
10762797|NCT03154086|11925951|FG007|COMPLETED|Part B (Up to 25 Days)||0
10762798|NCT03154086|11925952|FG008|COMPLETED|Part B (Up to 25 Days)||0
10762799|NCT03154086|11925953|FG009|COMPLETED|Part B (Up to 25 Days)||10
10762800|NCT03154086|11925954|FG010|COMPLETED|Part B (Up to 25 Days)||5
10762801|NCT03154086|11925955|FG011|COMPLETED|Part B (Up to 25 Days)||6
10762802|NCT03154086|11925956|FG012|COMPLETED|Part B (Up to 25 Days)||6
10762803|NCT03154086|11925957|FG013|COMPLETED|Part B (Up to 25 Days)||6
10762804|NCT03154086|11925958|FG014|COMPLETED|Part B (Up to 25 Days)||6
10762805|NCT03154086|11925944|FG000|NOT COMPLETED|Part B (Up to 25 Days)||0
10762806|NCT03154086|11925945|FG001|NOT COMPLETED|Part B (Up to 25 Days)||0
10762807|NCT03154086|11925946|FG002|NOT COMPLETED|Part B (Up to 25 Days)||0
10762808|NCT03154086|11925947|FG003|NOT COMPLETED|Part B (Up to 25 Days)||0
10762809|NCT03154086|11925948|FG004|NOT COMPLETED|Part B (Up to 25 Days)||0
10762810|NCT03154086|11925949|FG005|NOT COMPLETED|Part B (Up to 25 Days)||0
10762811|NCT03154086|11925950|FG006|NOT COMPLETED|Part B (Up to 25 Days)||0
10762812|NCT03154086|11925951|FG007|NOT COMPLETED|Part B (Up to 25 Days)||0
10762813|NCT03154086|11925952|FG008|NOT COMPLETED|Part B (Up to 25 Days)||0
10762814|NCT03154086|11925953|FG009|NOT COMPLETED|Part B (Up to 25 Days)||0
10762815|NCT03154086|11925954|FG010|NOT COMPLETED|Part B (Up to 25 Days)||1
10762816|NCT03154086|11925955|FG011|NOT COMPLETED|Part B (Up to 25 Days)||0
10762817|NCT03154086|11925956|FG012|NOT COMPLETED|Part B (Up to 25 Days)||0
10762818|NCT03154086|11925957|FG013|NOT COMPLETED|Part B (Up to 25 Days)||0
10762819|NCT03154086|11925958|FG014|NOT COMPLETED|Part B (Up to 25 Days)||0
10762820|NCT03154333|11926016|FG000|STARTED|Overall Study||28
10762821|NCT03154333|11926017|FG001|STARTED|Overall Study||26
10762822|NCT03154333|11926016|FG000|COMPLETED|Overall Study||21
10762823|NCT03154333|11926017|FG001|COMPLETED|Overall Study||21
10762824|NCT03154333|11926016|FG000|NOT COMPLETED|Overall Study||7
10762825|NCT03154333|11926017|FG001|NOT COMPLETED|Overall Study||5
10762826|NCT03154476|11926026|FG000|STARTED|Overall Study||10
10762827|NCT03154476|11926027|FG001|STARTED|Overall Study||10
10762828|NCT03154476|11926026|FG000|COMPLETED|Overall Study||6
10762829|NCT03154476|11926027|FG001|COMPLETED|Overall Study||6
10762830|NCT03154476|11926026|FG000|NOT COMPLETED|Overall Study||4
10762831|NCT03154476|11926027|FG001|NOT COMPLETED|Overall Study||4
10762832|NCT03154658|11926035|FG000|STARTED|Overall Study||33
10762833|NCT03154658|11926036|FG001|STARTED|Overall Study||33
10762834|NCT03154658|11926035|FG000|COMPLETED|Overall Study||32
10762835|NCT03154658|11926036|FG001|COMPLETED|Overall Study||32
10762836|NCT03154658|11926035|FG000|NOT COMPLETED|Overall Study||1
10762837|NCT03154658|11926036|FG001|NOT COMPLETED|Overall Study||1
10762838|NCT03154710|11926044|FG000|STARTED|Overall Study||27
10762839|NCT03154710|11926045|FG001|STARTED|Overall Study||25
10762840|NCT03154710|11926044|FG000|COMPLETED|Overall Study||20
10762841|NCT03154710|11926045|FG001|COMPLETED|Overall Study||20
10762842|NCT03154710|11926044|FG000|NOT COMPLETED|Overall Study||7
10762843|NCT03154710|11926045|FG001|NOT COMPLETED|Overall Study||5
10762844|NCT03155178|11926055|FG000|STARTED|Overall Study||69
10762845|NCT03155178|11926056|FG001|STARTED|Overall Study||69
10762846|NCT03155178|11926057|FG002|STARTED|Overall Study||69
10762847|NCT03155178|11926058|FG003|STARTED|Overall Study||69
10762848|NCT03155178|11926055|FG000|COMPLETED|Overall Study||62
10762849|NCT03155178|11926056|FG001|COMPLETED|Overall Study||62
10762850|NCT03155178|11926057|FG002|COMPLETED|Overall Study||62
10762851|NCT03155178|11926058|FG003|COMPLETED|Overall Study||62
10762852|NCT03155178|11926055|FG000|NOT COMPLETED|Overall Study||7
10762853|NCT03155178|11926056|FG001|NOT COMPLETED|Overall Study||7
10762854|NCT03155178|11926057|FG002|NOT COMPLETED|Overall Study||7
10762855|NCT03155178|11926058|FG003|NOT COMPLETED|Overall Study||7
10762856|NCT03155269|11926074|FG000|STARTED|Overall Study||57
10762857|NCT03155269|11926075|FG001|STARTED|Overall Study||57
10762858|NCT03155269|11926074|FG000|COMPLETED|Overall Study||52
10762859|NCT03155269|11926075|FG001|COMPLETED|Overall Study||50
10762860|NCT03155269|11926074|FG000|NOT COMPLETED|Overall Study||5
10762861|NCT03155269|11926075|FG001|NOT COMPLETED|Overall Study||7
10762862|NCT03155724|11926081|FG000|STARTED|Overall Study||53
10762863|NCT03155724|11926081|FG000|COMPLETED|Overall Study||42
10762864|NCT03155724|11926081|FG000|NOT COMPLETED|Overall Study||11
10762865|NCT03155945|11926087|FG000|STARTED|Overall Study||6
10762866|NCT03155945|11926088|FG001|STARTED|Overall Study||8
10762867|NCT03155945|11926087|FG000|COMPLETED|Overall Study||6
10762868|NCT03155945|11926088|FG001|COMPLETED|Overall Study||5
10762869|NCT03155945|11926087|FG000|NOT COMPLETED|Overall Study||0
10762870|NCT03155945|11926088|FG001|NOT COMPLETED|Overall Study||3
10762871|NCT03156270|11926094|FG000|STARTED|Overall Study||20
10762872|NCT03156270|11926094|FG000|COMPLETED|Overall Study||18
10762873|NCT03156270|11926094|FG000|NOT COMPLETED|Overall Study||2
10762874|NCT03156543|11926102|FG000|STARTED|Overall Study||9
10762875|NCT03156543|11926103|FG001|STARTED|Overall Study||23
10762876|NCT03156543|11926102|FG000|COMPLETED|Overall Study||8
10762877|NCT03156543|11926103|FG001|COMPLETED|Overall Study||23
10762878|NCT03156543|11926102|FG000|NOT COMPLETED|Overall Study||1
10762879|NCT03156543|11926103|FG001|NOT COMPLETED|Overall Study||0
10762880|NCT03156621|11926111|FG000|STARTED|Double-Blind Treatment Period (DBTP)||24
10762881|NCT03156621|11926112|FG001|STARTED|Double-Blind Treatment Period (DBTP)||45
10762882|NCT03156621|11926111|FG000|COMPLETED|Double-Blind Treatment Period (DBTP)||24
10762883|NCT03156621|11926112|FG001|COMPLETED|Double-Blind Treatment Period (DBTP)||45
10762884|NCT03156621|11926111|FG000|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||0
10762885|NCT03156621|11926112|FG001|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||0
10762886|NCT03156621|11926111|FG000|STARTED|Open-Label Treatment Period (OLTP)||24
10762887|NCT03156621|11926112|FG001|STARTED|Open-Label Treatment Period (OLTP)||45
10762888|NCT03156621|11926111|FG000|COMPLETED|Open-Label Treatment Period (OLTP)||24
10762889|NCT03156621|11926112|FG001|COMPLETED|Open-Label Treatment Period (OLTP)||42
10762890|NCT03156621|11926111|FG000|NOT COMPLETED|Open-Label Treatment Period (OLTP)||0
10762891|NCT03156621|11926112|FG001|NOT COMPLETED|Open-Label Treatment Period (OLTP)||3
10762892|NCT03157089|11926123|FG000|STARTED|Overall Study||12
10762893|NCT03157089|11926124|FG001|STARTED|Overall Study||12
10762894|NCT03157089|11926123|FG000|Treated|Overall Study||12
10762895|NCT03157089|11926124|FG001|Treated|Overall Study||12
10762896|NCT03157089|11926123|FG000|COMPLETED|Overall Study||0
10762897|NCT03157089|11926124|FG001|COMPLETED|Overall Study||0
10762898|NCT03157089|11926123|FG000|NOT COMPLETED|Overall Study||12
10762899|NCT03157089|11926124|FG001|NOT COMPLETED|Overall Study||12
10762900|NCT03157232|11926131|FG000|STARTED|Overall Study||18
10762901|NCT03157232|11926131|FG000|COMPLETED|Overall Study||18
10762902|NCT03157232|11926131|FG000|NOT COMPLETED|Overall Study||0
10762903|NCT03157531|11926135|FG000|STARTED|Overall Study||97
10762904|NCT03157531|11926135|FG000|Analyzed at 30 Days For MAEs|Overall Study||93
10762905|NCT03157531|11926135|FG000|COMPLETED|Overall Study||91
10762906|NCT03157531|11926135|FG000|NOT COMPLETED|Overall Study||6
10762907|NCT03157583|11926139|FG000|STARTED|Overall Study||8
10762908|NCT03157583|11926139|FG000|COMPLETED|Overall Study||7
10762909|NCT03157583|11926139|FG000|NOT COMPLETED|Overall Study||1
10762910|NCT03158012|11926159|FG000|STARTED|Overall Study||8
10762911|NCT03158012|11926160|FG001|STARTED|Overall Study||7
10762912|NCT03158012|11926159|FG000|COMPLETED|Overall Study||8
10762913|NCT03158012|11926160|FG001|COMPLETED|Overall Study||6
10762914|NCT03158012|11926159|FG000|NOT COMPLETED|Overall Study||0
10762915|NCT03158012|11926160|FG001|NOT COMPLETED|Overall Study||1
10762916|NCT03158038|11926168|FG000|STARTED|Overall Study||240
10762917|NCT03158038|11926169|FG001|STARTED|Overall Study||60
10762918|NCT03158038|11926168|FG000|COMPLETED|Overall Study||240
10762919|NCT03158038|11926169|FG001|COMPLETED|Overall Study||60
10762920|NCT03158038|11926168|FG000|NOT COMPLETED|Overall Study||0
10762921|NCT03158038|11926169|FG001|NOT COMPLETED|Overall Study||0
10762922|NCT03158116|11926175|FG000|STARTED|Overall Study||5
10762923|NCT03158116|11926175|FG000|COMPLETED|Overall Study||5
10762924|NCT03158116|11926175|FG000|NOT COMPLETED|Overall Study||0
10762925|NCT03158220|11926181|FG000|STARTED|Overall Study||570
10762926|NCT03158220|11926182|FG001|STARTED|Overall Study||642
10762927|NCT03158220|11926181|FG000|Vaccination 1|Overall Study||570
10762928|NCT03158220|11926182|FG001|Vaccination 1|Overall Study||640
10762929|NCT03158220|11926181|FG000|Vaccination 2|Overall Study||563
10762930|NCT03158220|11926182|FG001|Vaccination 2|Overall Study||635
10762931|NCT03158220|11926181|FG000|Vaccination 3|Overall Study||556
10762932|NCT03158220|11926182|FG001|Vaccination 3|Overall Study||629
10762933|NCT03158220|11926181|FG000|COMPLETED|Overall Study||553
10762934|NCT03158220|11926182|FG001|COMPLETED|Overall Study||626
10762935|NCT03158220|11926181|FG000|NOT COMPLETED|Overall Study||17
10762936|NCT03158220|11926182|FG001|NOT COMPLETED|Overall Study||16
10762937|NCT03158272|11926192|FG000|STARTED|Overall Study||3
10762938|NCT03158272|11926193|FG001|STARTED|Overall Study||4
10762939|NCT03158272|11926194|FG002|STARTED|Overall Study||6
10762940|NCT03158272|11926195|FG003|STARTED|Overall Study||6
10762941|NCT03158272|11926192|FG000|COMPLETED|Overall Study||0
10762942|NCT03158272|11926193|FG001|COMPLETED|Overall Study||0
10762943|NCT03158272|11926194|FG002|COMPLETED|Overall Study||0
10762944|NCT03158272|11926195|FG003|COMPLETED|Overall Study||0
10762945|NCT03158272|11926192|FG000|NOT COMPLETED|Overall Study||3
10762946|NCT03158272|11926193|FG001|NOT COMPLETED|Overall Study||4
10297162|NCT00568178|11429683|FG005|NOT COMPLETED|Open Label Extension||80
10297163|NCT00545844|11429697|FG000|STARTED|Overall Study||313
10762947|NCT03158272|11926194|FG002|NOT COMPLETED|Overall Study||6
10762948|NCT03158272|11926195|FG003|NOT COMPLETED|Overall Study||6
10762949|NCT03158311|11926210|FG000|STARTED|Overall Study||474
10762950|NCT03158311|11926211|FG001|STARTED|Overall Study||476
10762951|NCT03158311|11926212|FG002|STARTED|Overall Study||476
10762952|NCT03158311|11926210|FG000|Full Analysis Set (FAS)|Overall Study||474
10762953|NCT03158311|11926211|FG001|Full Analysis Set (FAS)|Overall Study||476
10762954|NCT03158311|11926212|FG002|Full Analysis Set (FAS)|Overall Study||475
10762955|NCT03158311|11926210|FG000|Safety Set (SAF)|Overall Study||474
10762956|NCT03158311|11926211|FG001|Safety Set (SAF)|Overall Study||476
10762957|NCT03158311|11926212|FG002|Safety Set (SAF)|Overall Study||475
10762958|NCT03158311|11926210|FG000|COMPLETED|Overall Study||452
10762959|NCT03158311|11926211|FG001|COMPLETED|Overall Study||460
10762960|NCT03158311|11926212|FG002|COMPLETED|Overall Study||448
10762961|NCT03158311|11926210|FG000|NOT COMPLETED|Overall Study||22
10762962|NCT03158311|11926211|FG001|NOT COMPLETED|Overall Study||16
10762963|NCT03158311|11926212|FG002|NOT COMPLETED|Overall Study||28
10762964|NCT03158714|11926223|FG000|STARTED|Overall Study|Number of participants enrolled and Started represents number of individual participants rather than couples|626
10762965|NCT03158714|11926224|FG001|STARTED|Overall Study|Number of participants enrolled and Started represents number of individual participants rather than couples|626
10762966|NCT03158714|11926225|FG002|STARTED|Overall Study|Number of participants enrolled and Started represents number of individual participants rather than couples|606
10762967|NCT03158714|11926223|FG000|COMPLETED|Overall Study|Participated in half or more of program.|445
10762968|NCT03158714|11926224|FG001|COMPLETED|Overall Study|Participated in half or more of program.|398
10762969|NCT03158714|11926225|FG002|COMPLETED|Overall Study|All control group participants completed the control protocol (no program).|606
10762970|NCT03158714|11926223|FG000|NOT COMPLETED|Overall Study||181
10762971|NCT03158714|11926224|FG001|NOT COMPLETED|Overall Study||228
10762972|NCT03158714|11926225|FG002|NOT COMPLETED|Overall Study||0
10762973|NCT03159091|11926235|FG000|STARTED|Overall Study||121
10762974|NCT03159091|11926236|FG001|STARTED|Overall Study||117
10762975|NCT03159091|11926235|FG000|COMPLETED|Overall Study||116
10762976|NCT03159091|11926236|FG001|COMPLETED|Overall Study||113
10762977|NCT03159091|11926235|FG000|NOT COMPLETED|Overall Study||5
10762978|NCT03159091|11926236|FG001|NOT COMPLETED|Overall Study||4
10762979|NCT03159143|11926242|FG000|STARTED|Overall Study||22
10762980|NCT03159143|11926242|FG000|COMPLETED|Overall Study||22
10762981|NCT03159143|11926242|FG000|NOT COMPLETED|Overall Study||0
10762982|NCT03159260|11926248|FG000|STARTED|Overall Study||28
10762983|NCT03159260|11926249|FG001|STARTED|Overall Study||29
10762984|NCT03159260|11926248|FG000|COMPLETED|Overall Study||25
10762985|NCT03159260|11926249|FG001|COMPLETED|Overall Study||25
10762986|NCT03159260|11926248|FG000|NOT COMPLETED|Overall Study||3
10762987|NCT03159260|11926249|FG001|NOT COMPLETED|Overall Study||4
10762988|NCT03159299|11926257|FG000|STARTED|Overall Study||26
10762989|NCT03159299|11926258|FG001|STARTED|Overall Study||21
10762990|NCT03159299|11926257|FG000|COMPLETED|Overall Study||24
10762991|NCT03159299|11926258|FG001|COMPLETED|Overall Study||20
10762992|NCT03159299|11926257|FG000|NOT COMPLETED|Overall Study||2
10762993|NCT03159299|11926258|FG001|NOT COMPLETED|Overall Study||1
10762994|NCT03159455|11926270|FG000|STARTED|Overall Study||9
10762995|NCT03159455|11926271|FG001|STARTED|Overall Study||9
10762996|NCT03159455|11926272|FG002|STARTED|Overall Study||9
10762997|NCT03159455|11926273|FG003|STARTED|Overall Study||9
10762998|NCT03159455|11926274|FG004|STARTED|Overall Study||3
10762999|NCT03159455|11926275|FG005|STARTED|Overall Study||9
10763000|NCT03159455|11926270|FG000|COMPLETED|Overall Study||9
10763001|NCT03159455|11926271|FG001|COMPLETED|Overall Study||9
10763002|NCT03159455|11926272|FG002|COMPLETED|Overall Study||9
10763003|NCT03159455|11926273|FG003|COMPLETED|Overall Study||9
10763004|NCT03159455|11926274|FG004|COMPLETED|Overall Study||3
10763005|NCT03159455|11926275|FG005|COMPLETED|Overall Study||8
10763006|NCT03159455|11926270|FG000|NOT COMPLETED|Overall Study||0
10763007|NCT03159455|11926271|FG001|NOT COMPLETED|Overall Study||0
10763008|NCT03159455|11926272|FG002|NOT COMPLETED|Overall Study||0
10763009|NCT03159455|11926273|FG003|NOT COMPLETED|Overall Study||0
10763010|NCT03159455|11926274|FG004|NOT COMPLETED|Overall Study||0
10763011|NCT03159455|11926275|FG005|NOT COMPLETED|Overall Study||1
10763012|NCT03159468|11926299|FG000|STARTED|Overall Study||35
10763013|NCT03159468|11926300|FG001|STARTED|Overall Study||35
10763014|NCT03159468|11926301|FG002|STARTED|Overall Study||37
10763015|NCT03159468|11926302|FG003|STARTED|Overall Study||34
10763016|NCT03159468|11926303|FG004|STARTED|Overall Study||34
10763017|NCT03159468|11926304|FG005|STARTED|Overall Study||34
10763018|NCT03159468|11926299|FG000|COMPLETED|Overall Study||35
10763019|NCT03159468|11926300|FG001|COMPLETED|Overall Study||35
10763020|NCT03159468|11926301|FG002|COMPLETED|Overall Study||34
10763021|NCT03159468|11926302|FG003|COMPLETED|Overall Study||34
10763022|NCT03159468|11926303|FG004|COMPLETED|Overall Study||34
10763023|NCT03159468|11926304|FG005|COMPLETED|Overall Study||34
10763024|NCT03159468|11926299|FG000|NOT COMPLETED|Overall Study||0
10763025|NCT03159468|11926300|FG001|NOT COMPLETED|Overall Study||0
10763026|NCT03159468|11926301|FG002|NOT COMPLETED|Overall Study||3
10763027|NCT03159468|11926302|FG003|NOT COMPLETED|Overall Study||0
10763028|NCT03159468|11926303|FG004|NOT COMPLETED|Overall Study||0
10763029|NCT03159468|11926304|FG005|NOT COMPLETED|Overall Study||0
10763030|NCT03159611|11926320|FG000|STARTED|Overall Study||95
10763031|NCT03159611|11926321|FG001|STARTED|Overall Study||87
10763032|NCT03159611|11926320|FG000|COMPLETED|Overall Study||72
10763033|NCT03159611|11926321|FG001|COMPLETED|Overall Study||72
10763034|NCT03159611|11926320|FG000|NOT COMPLETED|Overall Study||23
10763035|NCT03159611|11926321|FG001|NOT COMPLETED|Overall Study||15
10763036|NCT03159624|11926329|FG000|STARTED|Overall Study||21
10763037|NCT03159624|11926330|FG001|STARTED|Overall Study||26
10763038|NCT03159624|11926329|FG000|COMPLETED|Overall Study||21
10763039|NCT03159624|11926330|FG001|COMPLETED|Overall Study||25
10763040|NCT03159624|11926329|FG000|NOT COMPLETED|Overall Study||0
10763041|NCT03159624|11926330|FG001|NOT COMPLETED|Overall Study||1
10763042|NCT03160027|11926340|FG000|STARTED|Overall Study||6
10763043|NCT03160027|11926341|FG001|STARTED|Overall Study||4
10763044|NCT03160027|11926342|FG002|STARTED|Overall Study||6
10763045|NCT03160027|11926343|FG003|STARTED|Overall Study||4
10763046|NCT03160027|11926340|FG000|COMPLETED|Overall Study||6
10763047|NCT03160027|11926341|FG001|COMPLETED|Overall Study||4
10763048|NCT03160027|11926342|FG002|COMPLETED|Overall Study||6
10763049|NCT03160027|11926343|FG003|COMPLETED|Overall Study||4
10763050|NCT03160027|11926340|FG000|NOT COMPLETED|Overall Study||0
10763051|NCT03160027|11926341|FG001|NOT COMPLETED|Overall Study||0
10763052|NCT03160027|11926342|FG002|NOT COMPLETED|Overall Study||0
10763053|NCT03160027|11926343|FG003|NOT COMPLETED|Overall Study||0
10763054|NCT03160170|11926356|FG000|STARTED|Overall Study||10
10763055|NCT03160170|11926357|FG001|STARTED|Overall Study||10
10763056|NCT03160170|11926356|FG000|COMPLETED|Overall Study||10
10763057|NCT03160170|11926357|FG001|COMPLETED|Overall Study||10
10763058|NCT03160170|11926356|FG000|NOT COMPLETED|Overall Study||0
10763059|NCT03160170|11926357|FG001|NOT COMPLETED|Overall Study||0
10763060|NCT03160287|11926363|FG000|STARTED|Overall Study||24
10763061|NCT03160287|11926363|FG000|COMPLETED|Overall Study||22
10763062|NCT03160287|11926363|FG000|NOT COMPLETED|Overall Study||2
10763063|NCT03160560|11926371|FG000|STARTED|First Intervention (3 Weeks)||25
10763064|NCT03160560|11926372|FG001|STARTED|First Intervention (3 Weeks)||25
10763065|NCT03160560|11926373|FG002|STARTED|First Intervention (3 Weeks)||25
10763066|NCT03160560|11926374|FG003|STARTED|First Intervention (3 Weeks)||25
10763067|NCT03160560|11926371|FG000|COMPLETED|First Intervention (3 Weeks)||23
10763068|NCT03160560|11926372|FG001|COMPLETED|First Intervention (3 Weeks)||24
10763069|NCT03160560|11926373|FG002|COMPLETED|First Intervention (3 Weeks)||24
10763070|NCT03160560|11926374|FG003|COMPLETED|First Intervention (3 Weeks)||25
10763071|NCT03160560|11926371|FG000|NOT COMPLETED|First Intervention (3 Weeks)||2
10763072|NCT03160560|11926372|FG001|NOT COMPLETED|First Intervention (3 Weeks)||1
10763073|NCT03160560|11926373|FG002|NOT COMPLETED|First Intervention (3 Weeks)||1
10763074|NCT03160560|11926374|FG003|NOT COMPLETED|First Intervention (3 Weeks)||0
10763075|NCT03160560|11926371|FG000|STARTED|Washout (2 Weeks)||23
10763076|NCT03160560|11926372|FG001|STARTED|Washout (2 Weeks)||24
10763077|NCT03160560|11926373|FG002|STARTED|Washout (2 Weeks)||24
10763078|NCT03160560|11926374|FG003|STARTED|Washout (2 Weeks)||25
10763079|NCT03160560|11926371|FG000|COMPLETED|Washout (2 Weeks)||23
10763080|NCT03160560|11926372|FG001|COMPLETED|Washout (2 Weeks)||24
10763081|NCT03160560|11926373|FG002|COMPLETED|Washout (2 Weeks)||24
10763082|NCT03160560|11926374|FG003|COMPLETED|Washout (2 Weeks)||25
10763083|NCT03160560|11926371|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10763084|NCT03160560|11926372|FG001|NOT COMPLETED|Washout (2 Weeks)||0
10763085|NCT03160560|11926373|FG002|NOT COMPLETED|Washout (2 Weeks)||0
10763086|NCT03160560|11926374|FG003|NOT COMPLETED|Washout (2 Weeks)||0
10763087|NCT03160560|11926371|FG000|STARTED|Second Intervention (3 Weeks)||23
10763088|NCT03160560|11926372|FG001|STARTED|Second Intervention (3 Weeks)||24
10763089|NCT03160560|11926373|FG002|STARTED|Second Intervention (3 Weeks)||24
10763090|NCT03160560|11926374|FG003|STARTED|Second Intervention (3 Weeks)||25
10763091|NCT03160560|11926371|FG000|COMPLETED|Second Intervention (3 Weeks)||22
10763092|NCT03160560|11926372|FG001|COMPLETED|Second Intervention (3 Weeks)||24
10763093|NCT03160560|11926373|FG002|COMPLETED|Second Intervention (3 Weeks)||24
10763094|NCT03160560|11926374|FG003|COMPLETED|Second Intervention (3 Weeks)||25
10763095|NCT03160560|11926371|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||1
10763096|NCT03160560|11926372|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
10763097|NCT03160560|11926373|FG002|NOT COMPLETED|Second Intervention (3 Weeks)||0
10763098|NCT03160560|11926374|FG003|NOT COMPLETED|Second Intervention (3 Weeks)||0
10763099|NCT03160573|11926388|FG000|STARTED|First Sequence (3 Weeks)||23
10763100|NCT03160573|11926389|FG001|STARTED|First Sequence (3 Weeks)||26
10763101|NCT03160573|11926390|FG002|STARTED|First Sequence (3 Weeks)||25
10763102|NCT03160573|11926391|FG003|STARTED|First Sequence (3 Weeks)||25
10763103|NCT03160573|11926388|FG000|COMPLETED|First Sequence (3 Weeks)||22
10763104|NCT03160573|11926389|FG001|COMPLETED|First Sequence (3 Weeks)||23
10763105|NCT03160573|11926390|FG002|COMPLETED|First Sequence (3 Weeks)||23
10763106|NCT03160573|11926391|FG003|COMPLETED|First Sequence (3 Weeks)||23
10763107|NCT03160573|11926388|FG000|NOT COMPLETED|First Sequence (3 Weeks)||1
10763108|NCT03160573|11926389|FG001|NOT COMPLETED|First Sequence (3 Weeks)||3
10763109|NCT03160573|11926390|FG002|NOT COMPLETED|First Sequence (3 Weeks)||2
10763110|NCT03160573|11926391|FG003|NOT COMPLETED|First Sequence (3 Weeks)||2
10763111|NCT03160573|11926388|FG000|STARTED|Washout (2 Weeks)||22
10763112|NCT03160573|11926389|FG001|STARTED|Washout (2 Weeks)||23
10763113|NCT03160573|11926390|FG002|STARTED|Washout (2 Weeks)||23
10763114|NCT03160573|11926391|FG003|STARTED|Washout (2 Weeks)||23
10763115|NCT03160573|11926388|FG000|COMPLETED|Washout (2 Weeks)||22
10763116|NCT03160573|11926389|FG001|COMPLETED|Washout (2 Weeks)||23
10763117|NCT03160573|11926390|FG002|COMPLETED|Washout (2 Weeks)||23
10763118|NCT03160573|11926391|FG003|COMPLETED|Washout (2 Weeks)||23
10763119|NCT03160573|11926388|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10763120|NCT03160573|11926389|FG001|NOT COMPLETED|Washout (2 Weeks)||0
10763121|NCT03160573|11926390|FG002|NOT COMPLETED|Washout (2 Weeks)||0
10763122|NCT03160573|11926391|FG003|NOT COMPLETED|Washout (2 Weeks)||0
10763123|NCT03160573|11926388|FG000|STARTED|Second Sequence (3 Weeks)||22
10763124|NCT03160573|11926389|FG001|STARTED|Second Sequence (3 Weeks)||23
10763125|NCT03160573|11926390|FG002|STARTED|Second Sequence (3 Weeks)||23
10763126|NCT03160573|11926391|FG003|STARTED|Second Sequence (3 Weeks)||23
10763127|NCT03160573|11926388|FG000|COMPLETED|Second Sequence (3 Weeks)||22
10763128|NCT03160573|11926389|FG001|COMPLETED|Second Sequence (3 Weeks)||23
10763129|NCT03160573|11926390|FG002|COMPLETED|Second Sequence (3 Weeks)||23
10763130|NCT03160573|11926391|FG003|COMPLETED|Second Sequence (3 Weeks)||23
10763131|NCT03160573|11926388|FG000|NOT COMPLETED|Second Sequence (3 Weeks)||0
10763132|NCT03160573|11926389|FG001|NOT COMPLETED|Second Sequence (3 Weeks)||0
10763133|NCT03160573|11926390|FG002|NOT COMPLETED|Second Sequence (3 Weeks)||0
10763134|NCT03160573|11926391|FG003|NOT COMPLETED|Second Sequence (3 Weeks)||0
10763135|NCT03160703|11926405|FG000|STARTED|Overall Study||55
10763136|NCT03160703|11926406|FG001|STARTED|Overall Study||55
10763137|NCT03160703|11926407|FG002|STARTED|Overall Study||55
10763138|NCT03160703|11926408|FG003|STARTED|Overall Study||55
10763139|NCT03160703|11926405|FG000|COMPLETED|Overall Study||55
10763140|NCT03160703|11926406|FG001|COMPLETED|Overall Study||55
10763141|NCT03160703|11926407|FG002|COMPLETED|Overall Study||55
10763142|NCT03160703|11926408|FG003|COMPLETED|Overall Study||54
10763143|NCT03160703|11926405|FG000|NOT COMPLETED|Overall Study||0
10763144|NCT03160703|11926406|FG001|NOT COMPLETED|Overall Study||0
10763145|NCT03160703|11926407|FG002|NOT COMPLETED|Overall Study||0
10763146|NCT03160703|11926408|FG003|NOT COMPLETED|Overall Study||1
10763150|NCT03160885|11926424|FG000|STARTED|Initial Treatment Period||593
10763151|NCT03160885|11926425|FG001|STARTED|Initial Treatment Period||201
10763152|NCT03160885|11926426|FG002|STARTED|Initial Treatment Period||0
10763153|NCT03160885|11926427|FG003|STARTED|Initial Treatment Period||0
10763154|NCT03160885|11926428|FG004|STARTED|Initial Treatment Period||0
10763155|NCT03160885|11926429|FG005|STARTED|Initial Treatment Period||0
10763156|NCT03160885|11926430|FG006|STARTED|Initial Treatment Period||0
10763157|NCT03160885|11926424|FG000|COMPLETED|Initial Treatment Period||558
10763158|NCT03160885|11926425|FG001|COMPLETED|Initial Treatment Period||179
10763159|NCT03160885|11926426|FG002|COMPLETED|Initial Treatment Period||0
10763160|NCT03160885|11926427|FG003|COMPLETED|Initial Treatment Period||0
10763161|NCT03160885|11926428|FG004|COMPLETED|Initial Treatment Period||0
10763162|NCT03160885|11926429|FG005|COMPLETED|Initial Treatment Period||0
10763163|NCT03160885|11926430|FG006|COMPLETED|Initial Treatment Period||0
10763164|NCT03160885|11926424|FG000|NOT COMPLETED|Initial Treatment Period||35
10763165|NCT03160885|11926425|FG001|NOT COMPLETED|Initial Treatment Period||22
10763166|NCT03160885|11926426|FG002|NOT COMPLETED|Initial Treatment Period||0
10763167|NCT03160885|11926427|FG003|NOT COMPLETED|Initial Treatment Period||0
10763168|NCT03160885|11926428|FG004|NOT COMPLETED|Initial Treatment Period||0
10763169|NCT03160885|11926429|FG005|NOT COMPLETED|Initial Treatment Period||0
10763170|NCT03160885|11926430|FG006|NOT COMPLETED|Initial Treatment Period||0
10763171|NCT03160885|11926424|FG000|STARTED|Open-label Treatment||0
10763172|NCT03160885|11926425|FG001|STARTED|Open-label Treatment||0
10763173|NCT03160885|11926426|FG002|STARTED|Open-label Treatment||0
10763174|NCT03160885|11926427|FG003|STARTED|Open-label Treatment||0
10763175|NCT03160885|11926428|FG004|STARTED|Open-label Treatment||0
10763176|NCT03160885|11926429|FG005|STARTED|Open-label Treatment||0
10763177|NCT03160885|11926430|FG006|STARTED|Open-label Treatment||560
10763178|NCT03160885|11926424|FG000|COMPLETED|Open-label Treatment||0
10763179|NCT03160885|11926425|FG001|COMPLETED|Open-label Treatment||0
10763180|NCT03160885|11926426|FG002|COMPLETED|Open-label Treatment||0
10763181|NCT03160885|11926427|FG003|COMPLETED|Open-label Treatment||0
10763182|NCT03160885|11926428|FG004|COMPLETED|Open-label Treatment||0
10763183|NCT03160885|11926429|FG005|COMPLETED|Open-label Treatment||0
10763184|NCT03160885|11926430|FG006|COMPLETED|Open-label Treatment||423
10763185|NCT03160885|11926424|FG000|NOT COMPLETED|Open-label Treatment||0
10763186|NCT03160885|11926425|FG001|NOT COMPLETED|Open-label Treatment||0
10763187|NCT03160885|11926426|FG002|NOT COMPLETED|Open-label Treatment||0
10763188|NCT03160885|11926427|FG003|NOT COMPLETED|Open-label Treatment||0
10763189|NCT03160885|11926428|FG004|NOT COMPLETED|Open-label Treatment||0
10763190|NCT03160885|11926429|FG005|NOT COMPLETED|Open-label Treatment||0
10763191|NCT03160885|11926430|FG006|NOT COMPLETED|Open-label Treatment||137
10763192|NCT03160885|11926424|FG000|STARTED|Maintenance Treatment Period||0
10763193|NCT03160885|11926425|FG001|STARTED|Maintenance Treatment Period||0
10763194|NCT03160885|11926426|FG002|STARTED|Maintenance Treatment Period||91
10763195|NCT03160885|11926427|FG003|STARTED|Maintenance Treatment Period||90
10763196|NCT03160885|11926428|FG004|STARTED|Maintenance Treatment Period||46
10763197|NCT03160885|11926429|FG005|STARTED|Maintenance Treatment Period||31
10763198|NCT03160885|11926430|FG006|STARTED|Maintenance Treatment Period||0
10763199|NCT03160885|11926424|FG000|COMPLETED|Maintenance Treatment Period||0
10763200|NCT03160885|11926425|FG001|COMPLETED|Maintenance Treatment Period||0
10763201|NCT03160885|11926426|FG002|COMPLETED|Maintenance Treatment Period||52
10763202|NCT03160885|11926427|FG003|COMPLETED|Maintenance Treatment Period||50
10763203|NCT03160885|11926428|FG004|COMPLETED|Maintenance Treatment Period||15
10763204|NCT03160885|11926429|FG005|COMPLETED|Maintenance Treatment Period||16
10763205|NCT03160885|11926430|FG006|COMPLETED|Maintenance Treatment Period||0
10763206|NCT03160885|11926424|FG000|NOT COMPLETED|Maintenance Treatment Period||0
10763207|NCT03160885|11926425|FG001|NOT COMPLETED|Maintenance Treatment Period||0
10763208|NCT03160885|11926426|FG002|NOT COMPLETED|Maintenance Treatment Period||39
10763209|NCT03160885|11926427|FG003|NOT COMPLETED|Maintenance Treatment Period||40
10763210|NCT03160885|11926428|FG004|NOT COMPLETED|Maintenance Treatment Period||31
10763211|NCT03160885|11926429|FG005|NOT COMPLETED|Maintenance Treatment Period||15
10763212|NCT03160885|11926430|FG006|NOT COMPLETED|Maintenance Treatment Period||0
10763213|NCT03160898|11926451|FG000|STARTED|Overall Study||115
10297164|NCT00545844|11429697|FG000|COMPLETED|Overall Study||301
10297165|NCT00545844|11429697|FG000|NOT COMPLETED|Overall Study||12
10297166|NCT00511433|11429705|FG000|STARTED|Overall Study||32
10297167|NCT00511433|11429706|FG001|STARTED|Overall Study||16
10297168|NCT00511433|11429705|FG000|COMPLETED|Overall Study||26
10297169|NCT00511433|11429706|FG001|COMPLETED|Overall Study||15
10297170|NCT00511433|11429705|FG000|NOT COMPLETED|Overall Study||6
10297171|NCT00511433|11429706|FG001|NOT COMPLETED|Overall Study||1
10297172|NCT00511355|11429716|FG000|STARTED|Overall Study||60
10297173|NCT00511355|11429717|FG001|STARTED|Overall Study||61
10297174|NCT00511355|11429716|FG000|COMPLETED|Overall Study||53
10297175|NCT00511355|11429717|FG001|COMPLETED|Overall Study||52
10297176|NCT00511355|11429716|FG000|NOT COMPLETED|Overall Study||7
10297177|NCT00511355|11429717|FG001|NOT COMPLETED|Overall Study||9
10297178|NCT00511342|11429727|FG000|STARTED|Overall Study||56
10297179|NCT00511342|11429728|FG001|STARTED|Overall Study||54
10297180|NCT00511342|11429727|FG000|COMPLETED|Overall Study||43
10297181|NCT00511342|11429728|FG001|COMPLETED|Overall Study||32
10297182|NCT00511342|11429727|FG000|NOT COMPLETED|Overall Study||13
10297183|NCT00511342|11429728|FG001|NOT COMPLETED|Overall Study||22
10297184|NCT00511199|11429736|FG000|STARTED|Overall Study||1591
10297185|NCT00511199|11429737|FG001|STARTED|Overall Study||535
10297186|NCT00511199|11429736|FG000|COMPLETED|Overall Study||1142
10297187|NCT00511199|11429737|FG001|COMPLETED|Overall Study||410
10297188|NCT00511199|11429736|FG000|NOT COMPLETED|Overall Study||449
10297189|NCT00511199|11429737|FG001|NOT COMPLETED|Overall Study||125
10297190|NCT00491504|11429749|FG000|STARTED|Overall Study|All subjects who received MFNS only on Day 1|77
10297191|NCT00491504|11429750|FG001|STARTED|Overall Study|All subjects who received placebo only on Day 1|78
10297192|NCT00491504|11429751|FG002|STARTED|Overall Study|All subjects who received MFNS on Day 1 through Day 7|78
10297193|NCT00491504|11429752|FG003|STARTED|Overall Study|All subjects who received placebo on Day 1 through Day 7|77
10297194|NCT00491504|11429749|FG000|COMPLETED|Overall Study||77
10297195|NCT00491504|11429750|FG001|COMPLETED|Overall Study||77
10297196|NCT00491504|11429751|FG002|COMPLETED|Overall Study||74
10297197|NCT00491504|11429752|FG003|COMPLETED|Overall Study||73
10297198|NCT00491504|11429749|FG000|NOT COMPLETED|Overall Study||0
10297199|NCT00491504|11429750|FG001|NOT COMPLETED|Overall Study||1
10297200|NCT00491504|11429751|FG002|NOT COMPLETED|Overall Study||4
10297201|NCT00491504|11429752|FG003|NOT COMPLETED|Overall Study||4
10297202|NCT00468312|11429762|FG000|STARTED|Overall Study||220
10297203|NCT00468312|11429763|FG001|STARTED|Overall Study||209
10297204|NCT00468312|11429762|FG000|COMPLETED|Overall Study||216
10297205|NCT00468312|11429763|FG001|COMPLETED|Overall Study||204
10297206|NCT00468312|11429762|FG000|NOT COMPLETED|Overall Study||4
10297207|NCT00468312|11429763|FG001|NOT COMPLETED|Overall Study||5
10314978|NCT00171249|11448713|FG006|NOT COMPLETED|Overall Study||2
10314979|NCT00171301|11448724|FG000|STARTED|Overall Study||162
10314980|NCT00171301|11448725|FG001|STARTED|Overall Study|2 participants in this group never received deferasirox.|71
10314981|NCT00171301|11448724|FG000|Received Deferasirox|Overall Study||162
10314982|NCT00171301|11448725|FG001|Received Deferasirox|Overall Study||69
10314983|NCT00171301|11448724|FG000|COMPLETED|Overall Study||154
10314984|NCT00171301|11448725|FG001|COMPLETED|Overall Study||62
10314985|NCT00171301|11448724|FG000|NOT COMPLETED|Overall Study||8
10314986|NCT00171301|11448725|FG001|NOT COMPLETED|Overall Study||9
10314987|NCT00171314|11448734|FG000|STARTED|Overall Study|2 patients in each arm were randomized but not treated.|263
10314988|NCT00171314|11448735|FG001|STARTED|Overall Study||264
10763214|NCT03160898|11926452|FG001|STARTED|Overall Study|1 patient withdrew consent before study drug dosing and was therefore excluded from safety analysis|113
10763215|NCT03160898|11926453|FG002|STARTED|Overall Study||113
10763216|NCT03160898|11926454|FG003|STARTED|Overall Study||117
10763217|NCT03160898|11926451|FG000|COMPLETED|Overall Study||95
10763218|NCT03160898|11926452|FG001|COMPLETED|Overall Study||100
10763219|NCT03160898|11926453|FG002|COMPLETED|Overall Study||97
10763220|NCT03160898|11926454|FG003|COMPLETED|Overall Study||98
10763221|NCT03160898|11926451|FG000|NOT COMPLETED|Overall Study||20
10763222|NCT03160898|11926452|FG001|NOT COMPLETED|Overall Study||13
10763223|NCT03160898|11926453|FG002|NOT COMPLETED|Overall Study||16
10763224|NCT03160898|11926454|FG003|NOT COMPLETED|Overall Study||19
10763225|NCT03161158|11926467|FG000|STARTED|Overall Study||18
10763226|NCT03161158|11926468|FG001|STARTED|Overall Study||19
10763227|NCT03161158|11926467|FG000|COMPLETED|Overall Study||9
10763228|NCT03161158|11926468|FG001|COMPLETED|Overall Study||13
10763229|NCT03161158|11926467|FG000|NOT COMPLETED|Overall Study||9
10763230|NCT03161158|11926468|FG001|NOT COMPLETED|Overall Study||6
10763231|NCT03161327|11926474|FG000|STARTED|Overall Study||238
10763232|NCT03161327|11926474|FG000|COMPLETED|Overall Study||238
10763233|NCT03161327|11926474|FG000|NOT COMPLETED|Overall Study||0
10763234|NCT03161405|11926479|FG000|STARTED|First Intervention Period (3 Days)||12
10763235|NCT03161405|11926479|FG000|COMPLETED|First Intervention Period (3 Days)||12
10763236|NCT03161405|11926479|FG000|NOT COMPLETED|First Intervention Period (3 Days)||0
10763237|NCT03161405|11926479|FG000|STARTED|Washout Period (at Least 4 Days)||12
10763238|NCT03161405|11926479|FG000|COMPLETED|Washout Period (at Least 4 Days)||12
10763239|NCT03161405|11926479|FG000|NOT COMPLETED|Washout Period (at Least 4 Days)||0
10763240|NCT03161405|11926479|FG000|STARTED|Second Intervention Period (6 Days)||12
10763241|NCT03161405|11926479|FG000|COMPLETED|Second Intervention Period (6 Days)||11
10763242|NCT03161405|11926479|FG000|NOT COMPLETED|Second Intervention Period (6 Days)||1
10763243|NCT03161483|11926490|FG000|STARTED|Overall Study||83
10763244|NCT03161483|11926491|FG001|STARTED|Overall Study||42
10763245|NCT03161483|11926492|FG002|STARTED|Overall Study||82
10763246|NCT03161483|11926493|FG003|STARTED|Overall Study||81
10763247|NCT03161483|11926490|FG000|COMPLETED|Overall Study||73
10763248|NCT03161483|11926491|FG001|COMPLETED|Overall Study||39
10763249|NCT03161483|11926492|FG002|COMPLETED|Overall Study||62
10763250|NCT03161483|11926493|FG003|COMPLETED|Overall Study||73
10763251|NCT03161483|11926490|FG000|NOT COMPLETED|Overall Study||10
10763252|NCT03161483|11926491|FG001|NOT COMPLETED|Overall Study||3
10763253|NCT03161483|11926492|FG002|NOT COMPLETED|Overall Study||20
10763254|NCT03161483|11926493|FG003|NOT COMPLETED|Overall Study||8
10763255|NCT03161938|11926505|FG000|STARTED|Overall Study||32
10763256|NCT03161938|11926506|FG001|STARTED|Overall Study||32
10763257|NCT03161938|11926505|FG000|COMPLETED|Overall Study||32
10763258|NCT03161938|11926506|FG001|COMPLETED|Overall Study||32
10763259|NCT03161938|11926505|FG000|NOT COMPLETED|Overall Study||0
10763260|NCT03161938|11926506|FG001|NOT COMPLETED|Overall Study||0
10763261|NCT03162055|11926514|FG000|STARTED|Overall Study||559
10763262|NCT03162055|11926515|FG001|STARTED|Overall Study||560
10763263|NCT03162055|11926514|FG000|Received Treatment|Overall Study||557
10763264|NCT03162055|11926515|FG001|Received Treatment|Overall Study||560
10763265|NCT03162055|11926514|FG000|Safety Analysis Set|Overall Study||552
10763266|NCT03162055|11926515|FG001|Safety Analysis Set|Overall Study||552
10763267|NCT03162055|11926514|FG000|Full Analysis Set (FAS)|Overall Study||552
10763268|NCT03162055|11926515|FG001|Full Analysis Set (FAS)|Overall Study||552
10763269|NCT03162055|11926514|FG000|Per Protocol (PP) Analysis Set|Overall Study||506
10763270|NCT03162055|11926515|FG001|Per Protocol (PP) Analysis Set|Overall Study||510
10763271|NCT03162055|11926514|FG000|COMPLETED|Overall Study||497
10763272|NCT03162055|11926515|FG001|COMPLETED|Overall Study||517
10763273|NCT03162055|11926514|FG000|NOT COMPLETED|Overall Study||62
10763274|NCT03162055|11926515|FG001|NOT COMPLETED|Overall Study||43
10763275|NCT03162328|11926521|FG000|STARTED|Screening Period||84
10763276|NCT03162328|11926522|FG001|STARTED|Screening Period||0
10763277|NCT03162328|11926523|FG002|STARTED|Screening Period||0
10763278|NCT03162328|11926521|FG000|COMPLETED|Screening Period||62
10763279|NCT03162328|11926522|FG001|COMPLETED|Screening Period||0
10763280|NCT03162328|11926523|FG002|COMPLETED|Screening Period||0
10763281|NCT03162328|11926521|FG000|NOT COMPLETED|Screening Period||22
10763282|NCT03162328|11926522|FG001|NOT COMPLETED|Screening Period||0
10763283|NCT03162328|11926523|FG002|NOT COMPLETED|Screening Period||0
10763284|NCT03162328|11926521|FG000|STARTED|Study Period||0
10763285|NCT03162328|11926522|FG001|STARTED|Study Period||30
10763286|NCT03162328|11926523|FG002|STARTED|Study Period||32
10763287|NCT03162328|11926521|FG000|COMPLETED|Study Period||0
10763288|NCT03162328|11926522|FG001|COMPLETED|Study Period||30
10763289|NCT03162328|11926523|FG002|COMPLETED|Study Period||31
10763290|NCT03162328|11926521|FG000|NOT COMPLETED|Study Period||0
10763291|NCT03162328|11926522|FG001|NOT COMPLETED|Study Period||0
10763292|NCT03162328|11926523|FG002|NOT COMPLETED|Study Period||1
10763293|NCT03162354|11926536|FG000|STARTED|Overall Study||183
10763294|NCT03162354|11926537|FG001|STARTED|Overall Study||237
10763295|NCT03162354|11926536|FG000|COMPLETED|Overall Study||183
10763296|NCT03162354|11926537|FG001|COMPLETED|Overall Study||237
10763297|NCT03162354|11926536|FG000|NOT COMPLETED|Overall Study||0
10763298|NCT03162354|11926537|FG001|NOT COMPLETED|Overall Study||0
10763299|NCT03162458|11926550|FG000|STARTED|Overall Study||71
10763300|NCT03162458|11926551|FG001|STARTED|Overall Study||71
10763301|NCT03162458|11926550|FG000|COMPLETED|Overall Study||71
10763302|NCT03162458|11926551|FG001|COMPLETED|Overall Study||71
10763303|NCT03162458|11926550|FG000|NOT COMPLETED|Overall Study||0
10763304|NCT03162458|11926551|FG001|NOT COMPLETED|Overall Study||0
10763305|NCT03162614|11926563|FG000|STARTED|Overall Study||26
10763306|NCT03162614|11926564|FG001|STARTED|Overall Study||26
10763307|NCT03162614|11926565|FG002|STARTED|Overall Study||26
10763308|NCT03162614|11926566|FG003|STARTED|Overall Study||26
10763309|NCT03162614|11926567|FG004|STARTED|Overall Study||26
10763310|NCT03162614|11926568|FG005|STARTED|Overall Study||24
10763311|NCT03162614|11926563|FG000|COMPLETED|Overall Study||20
10763312|NCT03162614|11926564|FG001|COMPLETED|Overall Study||21
10763313|NCT03162614|11926565|FG002|COMPLETED|Overall Study||22
10763314|NCT03162614|11926566|FG003|COMPLETED|Overall Study||19
10763315|NCT03162614|11926567|FG004|COMPLETED|Overall Study||21
10763316|NCT03162614|11926568|FG005|COMPLETED|Overall Study||24
10763317|NCT03162614|11926563|FG000|NOT COMPLETED|Overall Study||6
10763318|NCT03162614|11926564|FG001|NOT COMPLETED|Overall Study||5
10763319|NCT03162614|11926565|FG002|NOT COMPLETED|Overall Study||4
10763320|NCT03162614|11926566|FG003|NOT COMPLETED|Overall Study||7
10421618|NCT00819910|11566457|FG000|NOT COMPLETED|Overall Study||2
10763321|NCT03162614|11926567|FG004|NOT COMPLETED|Overall Study||5
10763322|NCT03162614|11926568|FG005|NOT COMPLETED|Overall Study||0
10763323|NCT03162796|11926585|FG000|STARTED|Placebo Controlled Period: Week 0 - 24||126
10421619|NCT00819910|11566458|FG001|NOT COMPLETED|Overall Study||1
10421620|NCT00819910|11566459|FG002|NOT COMPLETED|Overall Study||3
10421621|NCT00819910|11566460|FG003|NOT COMPLETED|Overall Study||1
10421622|NCT00820040|11566472|FG000|STARTED|Overall Study||10
10421623|NCT00820040|11566472|FG000|Safety Evaluable Population|Overall Study||8
10421624|NCT00820040|11566472|FG000|Full Analysis Set|Overall Study||8
10763324|NCT03162796|11926586|FG001|STARTED|Placebo Controlled Period: Week 0 - 24||127
10763325|NCT03162796|11926587|FG002|STARTED|Placebo Controlled Period: Week 0 - 24||128
10763326|NCT03162796|11926585|FG000|COMPLETED|Placebo Controlled Period: Week 0 - 24||114
10763327|NCT03162796|11926586|FG001|COMPLETED|Placebo Controlled Period: Week 0 - 24||123
10763328|NCT03162796|11926587|FG002|COMPLETED|Placebo Controlled Period: Week 0 - 24||125
10763329|NCT03162796|11926585|FG000|NOT COMPLETED|Placebo Controlled Period: Week 0 - 24||12
10763330|NCT03162796|11926586|FG001|NOT COMPLETED|Placebo Controlled Period: Week 0 - 24||4
10763331|NCT03162796|11926587|FG002|NOT COMPLETED|Placebo Controlled Period: Week 0 - 24||3
10763332|NCT03162796|11926585|FG000|STARTED|Active Treatment Period: Week 24 - 52||114
10763333|NCT03162796|11926586|FG001|STARTED|Active Treatment Period: Week 24 - 52||123
10763334|NCT03162796|11926587|FG002|STARTED|Active Treatment Period: Week 24 - 52||125
10763335|NCT03162796|11926585|FG000|COMPLETED|Active Treatment Period: Week 24 - 52||107
10763336|NCT03162796|11926586|FG001|COMPLETED|Active Treatment Period: Week 24 - 52||116
10763337|NCT03162796|11926587|FG002|COMPLETED|Active Treatment Period: Week 24 - 52||124
10763338|NCT03162796|11926585|FG000|NOT COMPLETED|Active Treatment Period: Week 24 - 52||7
10763339|NCT03162796|11926586|FG001|NOT COMPLETED|Active Treatment Period: Week 24 - 52||7
10763340|NCT03162796|11926587|FG002|NOT COMPLETED|Active Treatment Period: Week 24 - 52||1
10763341|NCT03162796|11926585|FG000|STARTED|Safety Follow-up: Week 52 - 60||107
10763342|NCT03162796|11926586|FG001|STARTED|Safety Follow-up: Week 52 - 60||116
10763343|NCT03162796|11926587|FG002|STARTED|Safety Follow-up: Week 52 - 60||124
10763344|NCT03162796|11926585|FG000|COMPLETED|Safety Follow-up: Week 52 - 60||106
10763345|NCT03162796|11926586|FG001|COMPLETED|Safety Follow-up: Week 52 - 60||114
10763346|NCT03162796|11926587|FG002|COMPLETED|Safety Follow-up: Week 52 - 60||123
10763347|NCT03162796|11926585|FG000|NOT COMPLETED|Safety Follow-up: Week 52 - 60||1
10763348|NCT03162796|11926586|FG001|NOT COMPLETED|Safety Follow-up: Week 52 - 60||2
10763349|NCT03162796|11926587|FG002|NOT COMPLETED|Safety Follow-up: Week 52 - 60||1
10763350|NCT03163017|11926600|FG000|STARTED|Overall Study||30
10763351|NCT03163017|11926600|FG000|COMPLETED|Overall Study||30
10763352|NCT03163017|11926600|FG000|NOT COMPLETED|Overall Study||0
10763353|NCT03163134|11926606|FG000|STARTED|Overall Study||85
10763354|NCT03163134|11926607|FG001|STARTED|Overall Study||85
10763355|NCT03163134|11926606|FG000|COMPLETED|Overall Study||85
10763356|NCT03163134|11926607|FG001|COMPLETED|Overall Study||85
10763357|NCT03163134|11926606|FG000|NOT COMPLETED|Overall Study||0
10763358|NCT03163134|11926607|FG001|NOT COMPLETED|Overall Study||0
10779015|NCT03363854|11940799|FG006|NOT COMPLETED|Continuation Treatment Period||3
10779016|NCT03363854|11940800|FG007|NOT COMPLETED|Continuation Treatment Period||0
10779017|NCT03363854|11940793|FG000|STARTED|Safety Follow-up Period|This treatment group applies to the initial treatment period (see above).|0
10779018|NCT03363854|11940794|FG001|STARTED|Safety Follow-up Period|This treatment group applies to the initial treatment period (see above).|0
10779019|NCT03363854|11940795|FG002|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0
10779020|NCT03363854|11940796|FG003|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0
10779021|NCT03363854|11940797|FG004|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0
10779022|NCT03363854|11940798|FG005|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0
10779023|NCT03363854|11940799|FG006|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0
10779024|NCT03363854|11940800|FG007|STARTED|Safety Follow-up Period||278
10779025|NCT03363854|11940793|FG000|COMPLETED|Safety Follow-up Period||0
10779026|NCT03363854|11940794|FG001|COMPLETED|Safety Follow-up Period||0
10779027|NCT03363854|11940795|FG002|COMPLETED|Safety Follow-up Period||0
10779028|NCT03363854|11940796|FG003|COMPLETED|Safety Follow-up Period||0
10779029|NCT03363854|11940797|FG004|COMPLETED|Safety Follow-up Period||0
10779030|NCT03363854|11940798|FG005|COMPLETED|Safety Follow-up Period||0
10779031|NCT03363854|11940799|FG006|COMPLETED|Safety Follow-up Period||0
10779032|NCT03363854|11940800|FG007|COMPLETED|Safety Follow-up Period||62
10779033|NCT03363854|11940793|FG000|NOT COMPLETED|Safety Follow-up Period||0
10779034|NCT03363854|11940794|FG001|NOT COMPLETED|Safety Follow-up Period||0
10779035|NCT03363854|11940795|FG002|NOT COMPLETED|Safety Follow-up Period||0
10779036|NCT03363854|11940796|FG003|NOT COMPLETED|Safety Follow-up Period||0
10779037|NCT03363854|11940797|FG004|NOT COMPLETED|Safety Follow-up Period||0
10779038|NCT03363854|11940798|FG005|NOT COMPLETED|Safety Follow-up Period||0
10779039|NCT03363854|11940799|FG006|NOT COMPLETED|Safety Follow-up Period||0
10779040|NCT03363854|11940800|FG007|NOT COMPLETED|Safety Follow-up Period||216
10779041|NCT03363906|11940823|FG000|STARTED|Period 1 (Reference or Test)||15
10779042|NCT03363906|11940824|FG001|STARTED|Period 1 (Reference or Test)||12
10779043|NCT03363906|11940823|FG000|Received at Least One Dose of Study Drug|Period 1 (Reference or Test)||15
10779044|NCT03363906|11940824|FG001|Received at Least One Dose of Study Drug|Period 1 (Reference or Test)||11
10779045|NCT03363906|11940823|FG000|COMPLETED|Period 1 (Reference or Test)||14
10779046|NCT03363906|11940824|FG001|COMPLETED|Period 1 (Reference or Test)||10
10779047|NCT03363906|11940823|FG000|NOT COMPLETED|Period 1 (Reference or Test)||1
10779048|NCT03363906|11940824|FG001|NOT COMPLETED|Period 1 (Reference or Test)||2
10779049|NCT03363906|11940823|FG000|STARTED|Period 2 (Test or Reference)||14
10779050|NCT03363906|11940824|FG001|STARTED|Period 2 (Test or Reference)||10
10779051|NCT03363906|11940823|FG000|Received at Least One Dose of Study Drug|Period 2 (Test or Reference)||12
10779052|NCT03363906|11940824|FG001|Received at Least One Dose of Study Drug|Period 2 (Test or Reference)||9
10779053|NCT03363906|11940823|FG000|COMPLETED|Period 2 (Test or Reference)||10
10763359|NCT03163303|11926615|FG000|STARTED|Overall Study||85
10763360|NCT03163303|11926616|FG001|STARTED|Overall Study||94
10763361|NCT03163303|11926615|FG000|COMPLETED|Overall Study||85
10763362|NCT03163303|11926616|FG001|COMPLETED|Overall Study||94
10763363|NCT03163303|11926615|FG000|NOT COMPLETED|Overall Study||0
10763364|NCT03163303|11926616|FG001|NOT COMPLETED|Overall Study||0
10763365|NCT03163342|11926622|FG000|STARTED|Overall Study||20
10763366|NCT03163342|11926622|FG000|COMPLETED|Overall Study||20
10763367|NCT03163342|11926622|FG000|NOT COMPLETED|Overall Study||0
10763368|NCT03163446|11926628|FG000|STARTED|Overall Study||73
10763369|NCT03163446|11926629|FG001|STARTED|Overall Study||48
10763370|NCT03163446|11926628|FG000|COMPLETED|Overall Study||45
10763371|NCT03163446|11926629|FG001|COMPLETED|Overall Study||31
10763372|NCT03163446|11926628|FG000|NOT COMPLETED|Overall Study||28
10763373|NCT03163446|11926629|FG001|NOT COMPLETED|Overall Study||17
10763374|NCT03163472|11926643|FG000|STARTED|Overall Study||15
10763375|NCT03163472|11926644|FG001|STARTED|Overall Study||15
10763376|NCT03163472|11926643|FG000|COMPLETED|Overall Study||15
10763377|NCT03163472|11926644|FG001|COMPLETED|Overall Study||15
10763378|NCT03163472|11926643|FG000|NOT COMPLETED|Overall Study||0
10763379|NCT03163472|11926644|FG001|NOT COMPLETED|Overall Study||0
10763380|NCT03163758|11926654|FG000|STARTED|Overall Study||21
10763381|NCT03163758|11926655|FG001|STARTED|Overall Study||21
10763382|NCT03163758|11926654|FG000|COMPLETED|Overall Study||13
10763383|NCT03163758|11926655|FG001|COMPLETED|Overall Study||14
10763384|NCT03163758|11926654|FG000|NOT COMPLETED|Overall Study||8
10763385|NCT03163758|11926655|FG001|NOT COMPLETED|Overall Study||7
10763386|NCT03164538|11926663|FG000|STARTED|Overall Study||35
10763387|NCT03164538|11926664|FG001|STARTED|Overall Study||35
10763388|NCT03164538|11926663|FG000|COMPLETED|Overall Study||28
10763389|NCT03164538|11926664|FG001|COMPLETED|Overall Study||29
10763390|NCT03164538|11926663|FG000|NOT COMPLETED|Overall Study||7
10763391|NCT03164538|11926664|FG001|NOT COMPLETED|Overall Study||6
10763392|NCT03164551|11926672|FG000|STARTED|Overall Study||200
10763393|NCT03164551|11926673|FG001|STARTED|Overall Study||208
10763394|NCT03164551|11926672|FG000|COMPLETED|Overall Study||171
10763395|NCT03164551|11926673|FG001|COMPLETED|Overall Study||192
10763396|NCT03164551|11926672|FG000|NOT COMPLETED|Overall Study||29
10763397|NCT03164551|11926673|FG001|NOT COMPLETED|Overall Study||16
10763398|NCT03164629|11926681|FG000|STARTED|Overall Study||25
10763399|NCT03164629|11926682|FG001|STARTED|Overall Study||25
10763400|NCT03164629|11926681|FG000|COMPLETED|Overall Study||25
10763401|NCT03164629|11926682|FG001|COMPLETED|Overall Study||25
10763402|NCT03164629|11926681|FG000|NOT COMPLETED|Overall Study||0
10763403|NCT03164629|11926682|FG001|NOT COMPLETED|Overall Study||0
10763404|NCT03165045|11926688|FG000|STARTED|Visit 1||1351
10763405|NCT03165045|11926688|FG000|COMPLETED|Visit 1||1322
10763406|NCT03165045|11926688|FG000|NOT COMPLETED|Visit 1||29
10763407|NCT03165045|11926688|FG000|STARTED|Visit 2||1322
10763408|NCT03165045|11926688|FG000|COMPLETED|Visit 2||1140
10763409|NCT03165045|11926688|FG000|NOT COMPLETED|Visit 2||182
10763410|NCT03165058|11926696|FG000|STARTED|Overall Study||21
10763411|NCT03165058|11926697|FG001|STARTED|Overall Study||11
10763412|NCT03165058|11926696|FG000|COMPLETED|Overall Study||21
10763413|NCT03165058|11926697|FG001|COMPLETED|Overall Study||11
10763414|NCT03165058|11926696|FG000|NOT COMPLETED|Overall Study||0
10763415|NCT03165058|11926697|FG001|NOT COMPLETED|Overall Study||0
10763416|NCT03165110|11926703|FG000|STARTED|Overall Study||47
10763417|NCT03165110|11926703|FG000|COMPLETED|Overall Study||46
10763418|NCT03165110|11926703|FG000|NOT COMPLETED|Overall Study||1
10763419|NCT03165175|11926709|FG000|STARTED|1-month to 3-month||41
10763420|NCT03165175|11926710|FG001|STARTED|1-month to 3-month||39
10763421|NCT03165175|11926709|FG000|COMPLETED|1-month to 3-month||35
10763422|NCT03165175|11926710|FG001|COMPLETED|1-month to 3-month||39
10763423|NCT03165175|11926709|FG000|NOT COMPLETED|1-month to 3-month||6
10763424|NCT03165175|11926710|FG001|NOT COMPLETED|1-month to 3-month||0
10763425|NCT03165175|11926709|FG000|STARTED|Baseline to 3-month||35
10763426|NCT03165175|11926710|FG001|STARTED|Baseline to 3-month||39
10763427|NCT03165175|11926709|FG000|COMPLETED|Baseline to 3-month||31
10763428|NCT03165175|11926710|FG001|COMPLETED|Baseline to 3-month||39
10763429|NCT03165175|11926709|FG000|NOT COMPLETED|Baseline to 3-month||4
10763430|NCT03165175|11926710|FG001|NOT COMPLETED|Baseline to 3-month||0
10763431|NCT03165617|11926718|FG000|STARTED|Overall Study||2258
10763432|NCT03165617|11926719|FG001|STARTED|Overall Study||2256
10763433|NCT03165617|11926718|FG000|COMPLETED|Overall Study||2249
10763434|NCT03165617|11926719|FG001|COMPLETED|Overall Study||2247
10763435|NCT03165617|11926718|FG000|NOT COMPLETED|Overall Study||9
10763436|NCT03165617|11926719|FG001|NOT COMPLETED|Overall Study||9
10763437|NCT03165981|11926745|FG000|STARTED|Overall Study||110
10763438|NCT03165981|11926746|FG001|STARTED|Overall Study||111
10763439|NCT03165981|11926745|FG000|Per Protocol Population|Overall Study||99
10763440|NCT03165981|11926746|FG001|Per Protocol Population|Overall Study||107
10763441|NCT03165981|11926745|FG000|COMPLETED|Overall Study||99
10763442|NCT03165981|11926746|FG001|COMPLETED|Overall Study||107
10763443|NCT03165981|11926745|FG000|NOT COMPLETED|Overall Study||11
10763444|NCT03165981|11926746|FG001|NOT COMPLETED|Overall Study||4
10763445|NCT03166124|11926754|FG000|STARTED|Treatment Period 1||20
10763446|NCT03166124|11926755|FG001|STARTED|Treatment Period 1||20
10763447|NCT03166124|11926756|FG002|STARTED|Treatment Period 1||19
10763448|NCT03166124|11926757|FG003|STARTED|Treatment Period 1||21
10763449|NCT03166124|11926754|FG000|Received at Least One Dose of Study Drug|Treatment Period 1||20
10763450|NCT03166124|11926755|FG001|Received at Least One Dose of Study Drug|Treatment Period 1||20
10763451|NCT03166124|11926756|FG002|Received at Least One Dose of Study Drug|Treatment Period 1||18
10763452|NCT03166124|11926757|FG003|Received at Least One Dose of Study Drug|Treatment Period 1||21
10763453|NCT03166124|11926754|FG000|COMPLETED|Treatment Period 1||20
10763454|NCT03166124|11926755|FG001|COMPLETED|Treatment Period 1||20
10763455|NCT03166124|11926756|FG002|COMPLETED|Treatment Period 1||18
10763456|NCT03166124|11926757|FG003|COMPLETED|Treatment Period 1||21
10763457|NCT03166124|11926754|FG000|NOT COMPLETED|Treatment Period 1||0
10763458|NCT03166124|11926755|FG001|NOT COMPLETED|Treatment Period 1||0
10763459|NCT03166124|11926756|FG002|NOT COMPLETED|Treatment Period 1||1
10763460|NCT03166124|11926757|FG003|NOT COMPLETED|Treatment Period 1||0
10763461|NCT03166124|11926754|FG000|STARTED|Wash-out Period||20
10763462|NCT03166124|11926755|FG001|STARTED|Wash-out Period||20
10763463|NCT03166124|11926756|FG002|STARTED|Wash-out Period||18
10763464|NCT03166124|11926757|FG003|STARTED|Wash-out Period||21
10763465|NCT03166124|11926754|FG000|COMPLETED|Wash-out Period||20
10763466|NCT03166124|11926755|FG001|COMPLETED|Wash-out Period||18
10763467|NCT03166124|11926756|FG002|COMPLETED|Wash-out Period||17
10763468|NCT03166124|11926757|FG003|COMPLETED|Wash-out Period||20
10763469|NCT03166124|11926754|FG000|NOT COMPLETED|Wash-out Period||0
10763470|NCT03166124|11926755|FG001|NOT COMPLETED|Wash-out Period||2
10763471|NCT03166124|11926756|FG002|NOT COMPLETED|Wash-out Period||1
10763472|NCT03166124|11926757|FG003|NOT COMPLETED|Wash-out Period||1
10763473|NCT03166124|11926754|FG000|STARTED|Treatment Period 2||20
10763474|NCT03166124|11926755|FG001|STARTED|Treatment Period 2||18
10763475|NCT03166124|11926756|FG002|STARTED|Treatment Period 2||17
10763476|NCT03166124|11926757|FG003|STARTED|Treatment Period 2||20
10763477|NCT03166124|11926754|FG000|COMPLETED|Treatment Period 2||20
10763478|NCT03166124|11926755|FG001|COMPLETED|Treatment Period 2||18
10763479|NCT03166124|11926756|FG002|COMPLETED|Treatment Period 2||17
10763480|NCT03166124|11926757|FG003|COMPLETED|Treatment Period 2||20
10763481|NCT03166124|11926754|FG000|NOT COMPLETED|Treatment Period 2||0
10763482|NCT03166124|11926755|FG001|NOT COMPLETED|Treatment Period 2||0
10763483|NCT03166124|11926756|FG002|NOT COMPLETED|Treatment Period 2||0
10763484|NCT03166124|11926757|FG003|NOT COMPLETED|Treatment Period 2||0
10763485|NCT03166215|11926770|FG000|STARTED|Part 1 (Double-blind TP: Days 1 - 30)||4
10763486|NCT03166215|11926771|FG001|STARTED|Part 1 (Double-blind TP: Days 1 - 30)||14
10763487|NCT03166215|11926772|FG002|STARTED|Part 1 (Double-blind TP: Days 1 - 30)||0
10763488|NCT03166215|11926770|FG000|COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||4
10763489|NCT03166215|11926771|FG001|COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||12
10763490|NCT03166215|11926772|FG002|COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||0
10763491|NCT03166215|11926770|FG000|NOT COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||0
10763492|NCT03166215|11926771|FG001|NOT COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||2
10763493|NCT03166215|11926772|FG002|NOT COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||0
10763494|NCT03166215|11926770|FG000|STARTED|Part 2 (Open-Label TP: Days 31 - 85)||0
10763495|NCT03166215|11926771|FG001|STARTED|Part 2 (Open-Label TP: Days 31 - 85)||0
10763496|NCT03166215|11926772|FG002|STARTED|Part 2 (Open-Label TP: Days 31 - 85)||16
10763497|NCT03166215|11926770|FG000|COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
10763498|NCT03166215|11926771|FG001|COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
10763499|NCT03166215|11926772|FG002|COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||14
10763500|NCT03166215|11926770|FG000|NOT COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
10763501|NCT03166215|11926771|FG001|NOT COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
10763502|NCT03166215|11926772|FG002|NOT COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||2
10763503|NCT03166735|11926788|FG000|STARTED|Overall Study||33
10763504|NCT03166735|11926789|FG001|STARTED|Overall Study||16
10763505|NCT03166735|11926790|FG002|STARTED|Overall Study||16
10763506|NCT03166735|11926791|FG003|STARTED|Overall Study||17
10763507|NCT03166735|11926792|FG004|STARTED|Overall Study||32
10763508|NCT03166735|11926788|FG000|Treated|Overall Study||32
10763509|NCT03166735|11926789|FG001|Treated|Overall Study||16
10763510|NCT03166735|11926790|FG002|Treated|Overall Study||16
10763511|NCT03166735|11926791|FG003|Treated|Overall Study||17
10763512|NCT03166735|11926792|FG004|Treated|Overall Study||32
10763513|NCT03166735|11926788|FG000|COMPLETED|Overall Study||32
10763514|NCT03166735|11926789|FG001|COMPLETED|Overall Study||13
10763515|NCT03166735|11926790|FG002|COMPLETED|Overall Study||13
10763516|NCT03166735|11926791|FG003|COMPLETED|Overall Study||16
10763517|NCT03166735|11926792|FG004|COMPLETED|Overall Study||28
10763518|NCT03166735|11926788|FG000|NOT COMPLETED|Overall Study||1
10763519|NCT03166735|11926789|FG001|NOT COMPLETED|Overall Study||3
10763520|NCT03166735|11926790|FG002|NOT COMPLETED|Overall Study||3
10763521|NCT03166735|11926791|FG003|NOT COMPLETED|Overall Study||1
10763522|NCT03166735|11926792|FG004|NOT COMPLETED|Overall Study||4
10763523|NCT03167073|11926807|FG000|STARTED|Overall Study||85
10763524|NCT03167073|11926808|FG001|STARTED|Overall Study||85
10763525|NCT03167073|11926807|FG000|COMPLETED|Overall Study||84
10763526|NCT03167073|11926808|FG001|COMPLETED|Overall Study||85
10763527|NCT03167073|11926807|FG000|NOT COMPLETED|Overall Study||1
10763528|NCT03167073|11926808|FG001|NOT COMPLETED|Overall Study||0
10763529|NCT03167151|11926817|FG000|STARTED|Overall Study||3
10763530|NCT03167151|11926818|FG001|STARTED|Overall Study||3
10763531|NCT03167151|11926819|FG002|STARTED|Overall Study||3
10763532|NCT03167151|11926817|FG000|COMPLETED|Overall Study||2
10763533|NCT03167151|11926818|FG001|COMPLETED|Overall Study||2
10763534|NCT03167151|11926819|FG002|COMPLETED|Overall Study||2
10763535|NCT03167151|11926817|FG000|NOT COMPLETED|Overall Study||1
10763536|NCT03167151|11926818|FG001|NOT COMPLETED|Overall Study||1
10763537|NCT03167151|11926819|FG002|NOT COMPLETED|Overall Study||1
10763538|NCT03167359|11926827|FG000|STARTED|Overall Study||74
10763539|NCT03167359|11926827|FG000|COMPLETED|Overall Study||72
10763540|NCT03167359|11926827|FG000|NOT COMPLETED|Overall Study||2
10763541|NCT03167411|11926833|FG000|STARTED|Overall Study||10
10763542|NCT03167411|11926834|FG001|STARTED|Overall Study||10
10763543|NCT03167411|11926833|FG000|COMPLETED|Overall Study||10
10763544|NCT03167411|11926834|FG001|COMPLETED|Overall Study||9
10763545|NCT03167411|11926833|FG000|NOT COMPLETED|Overall Study||0
10763546|NCT03167411|11926834|FG001|NOT COMPLETED|Overall Study||1
10763547|NCT03167541|11926840|FG000|STARTED|First Intervention||9
10763548|NCT03167541|11926841|FG001|STARTED|First Intervention||9
10763549|NCT03167541|11926840|FG000|COMPLETED|First Intervention||9
10763550|NCT03167541|11926841|FG001|COMPLETED|First Intervention||9
10763551|NCT03167541|11926840|FG000|NOT COMPLETED|First Intervention||0
10763552|NCT03167541|11926841|FG001|NOT COMPLETED|First Intervention||0
10763553|NCT03167541|11926840|FG000|STARTED|Washout: 5-8 Days||9
10763554|NCT03167541|11926841|FG001|STARTED|Washout: 5-8 Days||9
10763555|NCT03167541|11926840|FG000|COMPLETED|Washout: 5-8 Days||9
10763556|NCT03167541|11926841|FG001|COMPLETED|Washout: 5-8 Days||9
10763557|NCT03167541|11926840|FG000|NOT COMPLETED|Washout: 5-8 Days||0
10763558|NCT03167541|11926841|FG001|NOT COMPLETED|Washout: 5-8 Days||0
10763559|NCT03167541|11926840|FG000|STARTED|Second Intervention||9
10763560|NCT03167541|11926841|FG001|STARTED|Second Intervention||9
10763561|NCT03167541|11926840|FG000|COMPLETED|Second Intervention||9
10763562|NCT03167541|11926841|FG001|COMPLETED|Second Intervention||9
10763563|NCT03167541|11926840|FG000|NOT COMPLETED|Second Intervention||0
10763564|NCT03167541|11926841|FG001|NOT COMPLETED|Second Intervention||0
10763565|NCT03168022|11926848|FG000|STARTED|Overall Study||21
10763566|NCT03168022|11926849|FG001|STARTED|Overall Study||22
10763567|NCT03168022|11926848|FG000|COMPLETED|Overall Study||21
10763568|NCT03168022|11926849|FG001|COMPLETED|Overall Study||21
10763569|NCT03168022|11926848|FG000|NOT COMPLETED|Overall Study||0
10763570|NCT03168022|11926849|FG001|NOT COMPLETED|Overall Study||1
10763571|NCT03168295|11926860|FG000|STARTED|Overall Study||3
10763572|NCT03168295|11926861|FG001|STARTED|Overall Study||3
10763573|NCT03168295|11926862|FG002|STARTED|Overall Study||4
10763574|NCT03168295|11926863|FG003|STARTED|Overall Study||4
10763575|NCT03168295|11926864|FG004|STARTED|Overall Study||20
10763576|NCT03168295|11926860|FG000|COMPLETED|Overall Study||3
10763577|NCT03168295|11926861|FG001|COMPLETED|Overall Study||3
10763578|NCT03168295|11926862|FG002|COMPLETED|Overall Study||4
10763579|NCT03168295|11926863|FG003|COMPLETED|Overall Study||4
10763580|NCT03168295|11926864|FG004|COMPLETED|Overall Study||20
10763581|NCT03168295|11926860|FG000|NOT COMPLETED|Overall Study||0
10763582|NCT03168295|11926861|FG001|NOT COMPLETED|Overall Study||0
10763583|NCT03168295|11926862|FG002|NOT COMPLETED|Overall Study||0
10763584|NCT03168295|11926863|FG003|NOT COMPLETED|Overall Study||0
10763585|NCT03168295|11926864|FG004|NOT COMPLETED|Overall Study||0
10763586|NCT03168308|11926877|FG000|STARTED|Overall Study||48
10763587|NCT03168308|11926878|FG001|STARTED|Overall Study||44
10763588|NCT03168308|11926877|FG000|COMPLETED|Overall Study||48
10763589|NCT03168308|11926878|FG001|COMPLETED|Overall Study||44
10763590|NCT03168308|11926877|FG000|NOT COMPLETED|Overall Study||0
10763591|NCT03168308|11926878|FG001|NOT COMPLETED|Overall Study||0
10763592|NCT03168321|11926886|FG000|STARTED|Overall Study||402
10763593|NCT03168321|11926887|FG001|STARTED|Overall Study||411
10763594|NCT03168321|11926886|FG000|COMPLETED|Overall Study||347
10763595|NCT03168321|11926887|FG001|COMPLETED|Overall Study||356
10763596|NCT03168321|11926886|FG000|NOT COMPLETED|Overall Study||55
10763597|NCT03168321|11926887|FG001|NOT COMPLETED|Overall Study||55
10763598|NCT03168334|11926895|FG000|STARTED|Overall Study||397
10763599|NCT03168334|11926896|FG001|STARTED|Overall Study||404
10763600|NCT03168334|11926895|FG000|COMPLETED|Overall Study||345
10763601|NCT03168334|11926896|FG001|COMPLETED|Overall Study||366
10763602|NCT03168334|11926895|FG000|NOT COMPLETED|Overall Study||52
10763603|NCT03168334|11926896|FG001|NOT COMPLETED|Overall Study||38
10763604|NCT03168425|11926904|FG000|STARTED|Overall Study||94
10763605|NCT03168425|11926905|FG001|STARTED|Overall Study||96
10763606|NCT03168425|11926904|FG000|COMPLETED|Overall Study||87
10763607|NCT03168425|11926905|FG001|COMPLETED|Overall Study||85
10763608|NCT03168425|11926904|FG000|NOT COMPLETED|Overall Study||7
10763609|NCT03168425|11926905|FG001|NOT COMPLETED|Overall Study||11
10763610|NCT03168542|11926912|FG000|STARTED|Overall Study||7
10763611|NCT03168542|11926913|FG001|STARTED|Overall Study||5
10763612|NCT03168542|11926914|FG002|STARTED|Overall Study||9
10763613|NCT03168542|11926912|FG000|COMPLETED|Overall Study||7
10763614|NCT03168542|11926913|FG001|COMPLETED|Overall Study||5
10763615|NCT03168542|11926914|FG002|COMPLETED|Overall Study||9
10763616|NCT03168542|11926912|FG000|NOT COMPLETED|Overall Study||0
10763617|NCT03168542|11926913|FG001|NOT COMPLETED|Overall Study||0
10763618|NCT03168542|11926914|FG002|NOT COMPLETED|Overall Study||0
10763619|NCT03168711|11926921|FG000|STARTED|Overall Study||14
10763620|NCT03168711|11926922|FG001|STARTED|Overall Study||9
10763621|NCT03168711|11926921|FG000|COMPLETED|Overall Study||12
10763622|NCT03168711|11926922|FG001|COMPLETED|Overall Study||7
10763623|NCT03168711|11926921|FG000|NOT COMPLETED|Overall Study||2
10763624|NCT03168711|11926922|FG001|NOT COMPLETED|Overall Study||2
10763625|NCT03168841|11926928|FG000|STARTED|Overall Study||40
10763626|NCT03168841|11926928|FG000|COMPLETED|Overall Study||36
10763627|NCT03168841|11926928|FG000|NOT COMPLETED|Overall Study||4
10763628|NCT03168919|11926932|FG000|STARTED|Overall Study||5
10763629|NCT03168919|11926932|FG000|COMPLETED|Overall Study||3
10763630|NCT03168919|11926932|FG000|NOT COMPLETED|Overall Study||2
10763631|NCT03169062|11926940|FG000|STARTED|Overall Study||10
10763632|NCT03169062|11926940|FG000|COMPLETED|Overall Study||10
10763633|NCT03169062|11926940|FG000|NOT COMPLETED|Overall Study||0
10763634|NCT03169153|11926944|FG000|STARTED|Period 1, First 30 Days of Wear||42
10763635|NCT03169153|11926945|FG001|STARTED|Period 1, First 30 Days of Wear||39
10763636|NCT03169153|11926944|FG000|COMPLETED|Period 1, First 30 Days of Wear||39
10763637|NCT03169153|11926945|FG001|COMPLETED|Period 1, First 30 Days of Wear||35
10763638|NCT03169153|11926944|FG000|NOT COMPLETED|Period 1, First 30 Days of Wear||3
10763639|NCT03169153|11926945|FG001|NOT COMPLETED|Period 1, First 30 Days of Wear||4
10763640|NCT03169153|11926944|FG000|STARTED|Period 2, Second 30 Days of Wear||39
10763641|NCT03169153|11926945|FG001|STARTED|Period 2, Second 30 Days of Wear|One subject discontinued after completing Period 1 and was not exposed in Period 2.|34
10763642|NCT03169153|11926944|FG000|COMPLETED|Period 2, Second 30 Days of Wear||37
10763643|NCT03169153|11926945|FG001|COMPLETED|Period 2, Second 30 Days of Wear||32
10763644|NCT03169153|11926944|FG000|NOT COMPLETED|Period 2, Second 30 Days of Wear||2
10763645|NCT03169153|11926945|FG001|NOT COMPLETED|Period 2, Second 30 Days of Wear||2
10763646|NCT03169244|11926953|FG000|STARTED|Overall Study||22
10763647|NCT03169244|11926954|FG001|STARTED|Overall Study||20
10763648|NCT03169244|11926953|FG000|Randomly Assigned|Overall Study||22
10763649|NCT03169244|11926954|FG001|Randomly Assigned|Overall Study||20
10763650|NCT03169244|11926953|FG000|Received Intervention|Overall Study||22
10763651|NCT03169244|11926954|FG001|Received Intervention|Overall Study||18
10763652|NCT03169244|11926953|FG000|COMPLETED|Overall Study||17
10763653|NCT03169244|11926954|FG001|COMPLETED|Overall Study||16
10763654|NCT03169244|11926953|FG000|NOT COMPLETED|Overall Study||5
10763655|NCT03169244|11926954|FG001|NOT COMPLETED|Overall Study||4
10763656|NCT03169816|11926962|FG000|STARTED|Overall Study||33
10763657|NCT03169816|11926963|FG001|STARTED|Overall Study||16
10763658|NCT03169816|11926962|FG000|COMPLETED|Overall Study||6
10763659|NCT03169816|11926963|FG001|COMPLETED|Overall Study||3
10763660|NCT03169816|11926962|FG000|NOT COMPLETED|Overall Study||27
10763661|NCT03169816|11926963|FG001|NOT COMPLETED|Overall Study||13
10763662|NCT03170154|11926969|FG000|STARTED|Overall Study||350
10763663|NCT03170154|11926969|FG000|Rotational Stability Sub-study|Overall Study||141
10763664|NCT03170154|11926969|FG000|COMPLETED|Overall Study||342
10763665|NCT03170154|11926969|FG000|NOT COMPLETED|Overall Study||8
10763666|NCT03170193|11926985|FG000|STARTED|Overall Study||12
10763667|NCT03170193|11926986|FG001|STARTED|Overall Study||6
10763668|NCT03170193|11926987|FG002|STARTED|Overall Study||6
10763669|NCT03170193|11926988|FG003|STARTED|Overall Study||6
10763670|NCT03170193|11926989|FG004|STARTED|Overall Study||6
10763671|NCT03170193|11926990|FG005|STARTED|Overall Study||6
10763672|NCT03170193|11926991|FG006|STARTED|Overall Study||6
10763673|NCT03170193|11926985|FG000|COMPLETED|Overall Study||11
10763674|NCT03170193|11926986|FG001|COMPLETED|Overall Study||5
10763675|NCT03170193|11926987|FG002|COMPLETED|Overall Study||6
10763676|NCT03170193|11926988|FG003|COMPLETED|Overall Study||5
10763677|NCT03170193|11926989|FG004|COMPLETED|Overall Study||6
10763678|NCT03170193|11926990|FG005|COMPLETED|Overall Study||6
10763679|NCT03170193|11926991|FG006|COMPLETED|Overall Study||6
10763680|NCT03170193|11926985|FG000|NOT COMPLETED|Overall Study||1
10763681|NCT03170193|11926986|FG001|NOT COMPLETED|Overall Study||1
10763682|NCT03170193|11926987|FG002|NOT COMPLETED|Overall Study||0
10763683|NCT03170193|11926988|FG003|NOT COMPLETED|Overall Study||1
10763684|NCT03170193|11926989|FG004|NOT COMPLETED|Overall Study||0
10763685|NCT03170193|11926990|FG005|NOT COMPLETED|Overall Study||0
10763686|NCT03170193|11926991|FG006|NOT COMPLETED|Overall Study||0
10763687|NCT03170219|11927015|FG000|STARTED|Overall Study||7
10763688|NCT03170219|11927016|FG001|STARTED|Overall Study||4
10763689|NCT03170219|11927015|FG000|COMPLETED|Overall Study||7
10763690|NCT03170219|11927016|FG001|COMPLETED|Overall Study||4
10763691|NCT03170219|11927015|FG000|NOT COMPLETED|Overall Study||0
10763692|NCT03170219|11927016|FG001|NOT COMPLETED|Overall Study||0
10763693|NCT03170232|11927024|FG000|STARTED|Overall Study||27
10763694|NCT03170232|11927025|FG001|STARTED|Overall Study||27
10763695|NCT03170232|11927024|FG000|COMPLETED|Overall Study||0
10763696|NCT03170232|11927025|FG001|COMPLETED|Overall Study||0
10763697|NCT03170232|11927024|FG000|NOT COMPLETED|Overall Study||27
10763698|NCT03170232|11927025|FG001|NOT COMPLETED|Overall Study||27
10763699|NCT03170271|11927033|FG000|STARTED|Overall Study||431
10763700|NCT03170271|11927034|FG001|STARTED|Overall Study||229
10763701|NCT03170271|11927033|FG000|Received Treatment|Overall Study||427
10763702|NCT03170271|11927034|FG001|Received Treatment|Overall Study||229
10763703|NCT03170271|11927033|FG000|COMPLETED|Overall Study||398
10763704|NCT03170271|11927034|FG001|COMPLETED|Overall Study||218
10763705|NCT03170271|11927033|FG000|NOT COMPLETED|Overall Study||33
10763706|NCT03170271|11927034|FG001|NOT COMPLETED|Overall Study||11
10763707|NCT03170388|11927045|FG000|STARTED|Overall Study||147
10763708|NCT03170388|11927046|FG001|STARTED|Overall Study||150
10763709|NCT03170388|11927047|FG002|STARTED|Overall Study||146
10763710|NCT03170388|11927048|FG003|STARTED|Overall Study||150
10763711|NCT03170388|11927049|FG004|STARTED|Overall Study||148
10763712|NCT03170388|11927045|FG000|COMPLETED|Overall Study||125
10763713|NCT03170388|11927046|FG001|COMPLETED|Overall Study||132
10763714|NCT03170388|11927047|FG002|COMPLETED|Overall Study||133
10763715|NCT03170388|11927048|FG003|COMPLETED|Overall Study||132
10763716|NCT03170388|11927049|FG004|COMPLETED|Overall Study||127
10763717|NCT03170388|11927045|FG000|NOT COMPLETED|Overall Study||22
10763718|NCT03170388|11927046|FG001|NOT COMPLETED|Overall Study||18
10763719|NCT03170388|11927047|FG002|NOT COMPLETED|Overall Study||13
10763720|NCT03170388|11927048|FG003|NOT COMPLETED|Overall Study||18
10763721|NCT03170388|11927049|FG004|NOT COMPLETED|Overall Study||21
10763722|NCT03170544|11927073|FG000|STARTED|Part 1||10
10763723|NCT03170544|11927074|FG001|STARTED|Part 1||6
10763724|NCT03170544|11927075|FG002|STARTED|Part 1||6
10763725|NCT03170544|11927076|FG003|STARTED|Part 1||7
10763726|NCT03170544|11927077|FG004|STARTED|Part 1||6
10763727|NCT03170544|11927078|FG005|STARTED|Part 1||6
10763728|NCT03170544|11927079|FG006|STARTED|Part 1||0
10763729|NCT03170544|11927080|FG007|STARTED|Part 1||0
10763730|NCT03170544|11927081|FG008|STARTED|Part 1||0
10763731|NCT03170544|11927082|FG009|STARTED|Part 1||0
10763732|NCT03170544|11927083|FG010|STARTED|Part 1||0
10763733|NCT03170544|11927084|FG011|STARTED|Part 1||0
10763734|NCT03170544|11927073|FG000|COMPLETED|Part 1||9
10763735|NCT03170544|11927074|FG001|COMPLETED|Part 1||6
10763736|NCT03170544|11927075|FG002|COMPLETED|Part 1||6
10763737|NCT03170544|11927076|FG003|COMPLETED|Part 1||6
10763738|NCT03170544|11927077|FG004|COMPLETED|Part 1||6
10763739|NCT03170544|11927078|FG005|COMPLETED|Part 1||6
10763740|NCT03170544|11927079|FG006|COMPLETED|Part 1||0
10763741|NCT03170544|11927080|FG007|COMPLETED|Part 1||0
10763742|NCT03170544|11927081|FG008|COMPLETED|Part 1||0
10763743|NCT03170544|11927082|FG009|COMPLETED|Part 1||0
10763744|NCT03170544|11927083|FG010|COMPLETED|Part 1||0
10763745|NCT03170544|11927084|FG011|COMPLETED|Part 1||0
10763746|NCT03170544|11927073|FG000|NOT COMPLETED|Part 1||1
10763747|NCT03170544|11927074|FG001|NOT COMPLETED|Part 1||0
10763748|NCT03170544|11927075|FG002|NOT COMPLETED|Part 1||0
10763749|NCT03170544|11927076|FG003|NOT COMPLETED|Part 1||1
10763750|NCT03170544|11927077|FG004|NOT COMPLETED|Part 1||0
10763751|NCT03170544|11927078|FG005|NOT COMPLETED|Part 1||0
10763752|NCT03170544|11927079|FG006|NOT COMPLETED|Part 1||0
10763753|NCT03170544|11927080|FG007|NOT COMPLETED|Part 1||0
10763754|NCT03170544|11927081|FG008|NOT COMPLETED|Part 1||0
10763755|NCT03170544|11927082|FG009|NOT COMPLETED|Part 1||0
10763756|NCT03170544|11927083|FG010|NOT COMPLETED|Part 1||0
10763757|NCT03170544|11927084|FG011|NOT COMPLETED|Part 1||0
10763758|NCT03170544|11927073|FG000|STARTED|Part 2||0
10763759|NCT03170544|11927074|FG001|STARTED|Part 2||0
10763760|NCT03170544|11927075|FG002|STARTED|Part 2||0
10763761|NCT03170544|11927076|FG003|STARTED|Part 2||0
10763762|NCT03170544|11927077|FG004|STARTED|Part 2||0
10763763|NCT03170544|11927078|FG005|STARTED|Part 2||0
10763764|NCT03170544|11927079|FG006|STARTED|Part 2||4
10763765|NCT03170544|11927080|FG007|STARTED|Part 2||0
10763766|NCT03170544|11927081|FG008|STARTED|Part 2||0
10763767|NCT03170544|11927082|FG009|STARTED|Part 2||0
10763768|NCT03170544|11927083|FG010|STARTED|Part 2||0
10763769|NCT03170544|11927084|FG011|STARTED|Part 2||0
10763770|NCT03170544|11927073|FG000|COMPLETED|Part 2||0
10763771|NCT03170544|11927074|FG001|COMPLETED|Part 2||0
10763772|NCT03170544|11927075|FG002|COMPLETED|Part 2||0
10763773|NCT03170544|11927076|FG003|COMPLETED|Part 2||0
10763774|NCT03170544|11927077|FG004|COMPLETED|Part 2||0
10763775|NCT03170544|11927078|FG005|COMPLETED|Part 2||0
10763776|NCT03170544|11927079|FG006|COMPLETED|Part 2||4
10763777|NCT03170544|11927080|FG007|COMPLETED|Part 2||0
10763778|NCT03170544|11927081|FG008|COMPLETED|Part 2||0
10763779|NCT03170544|11927082|FG009|COMPLETED|Part 2||0
10763780|NCT03170544|11927083|FG010|COMPLETED|Part 2||0
10763781|NCT03170544|11927084|FG011|COMPLETED|Part 2||0
10763782|NCT03170544|11927073|FG000|NOT COMPLETED|Part 2||0
10763783|NCT03170544|11927074|FG001|NOT COMPLETED|Part 2||0
10763784|NCT03170544|11927075|FG002|NOT COMPLETED|Part 2||0
10763785|NCT03170544|11927076|FG003|NOT COMPLETED|Part 2||0
10763786|NCT03170544|11927077|FG004|NOT COMPLETED|Part 2||0
10763787|NCT03170544|11927078|FG005|NOT COMPLETED|Part 2||0
10763788|NCT03170544|11927079|FG006|NOT COMPLETED|Part 2||0
10763789|NCT03170544|11927080|FG007|NOT COMPLETED|Part 2||0
10763790|NCT03170544|11927081|FG008|NOT COMPLETED|Part 2||0
10763791|NCT03170544|11927082|FG009|NOT COMPLETED|Part 2||0
10763792|NCT03170544|11927083|FG010|NOT COMPLETED|Part 2||0
10763793|NCT03170544|11927084|FG011|NOT COMPLETED|Part 2||0
10763794|NCT03170544|11927073|FG000|STARTED|Part 3||0
10763795|NCT03170544|11927074|FG001|STARTED|Part 3||0
10763796|NCT03170544|11927075|FG002|STARTED|Part 3||0
10763797|NCT03170544|11927076|FG003|STARTED|Part 3||0
10763798|NCT03170544|11927077|FG004|STARTED|Part 3||0
10763799|NCT03170544|11927078|FG005|STARTED|Part 3||0
10763800|NCT03170544|11927079|FG006|STARTED|Part 3||0
10763801|NCT03170544|11927080|FG007|STARTED|Part 3||4
10763802|NCT03170544|11927081|FG008|STARTED|Part 3||6
10763803|NCT03170544|11927082|FG009|STARTED|Part 3||6
10763804|NCT03170544|11927083|FG010|STARTED|Part 3||0
10763805|NCT03170544|11927084|FG011|STARTED|Part 3||0
10763806|NCT03170544|11927073|FG000|COMPLETED|Part 3||0
10763807|NCT03170544|11927074|FG001|COMPLETED|Part 3||0
10763808|NCT03170544|11927075|FG002|COMPLETED|Part 3||0
10763809|NCT03170544|11927076|FG003|COMPLETED|Part 3||0
10763810|NCT03170544|11927077|FG004|COMPLETED|Part 3||0
10763811|NCT03170544|11927078|FG005|COMPLETED|Part 3||0
10763812|NCT03170544|11927079|FG006|COMPLETED|Part 3||0
10763813|NCT03170544|11927080|FG007|COMPLETED|Part 3||4
10763814|NCT03170544|11927081|FG008|COMPLETED|Part 3||6
10763815|NCT03170544|11927082|FG009|COMPLETED|Part 3||6
10763816|NCT03170544|11927083|FG010|COMPLETED|Part 3||0
10763817|NCT03170544|11927084|FG011|COMPLETED|Part 3||0
10763818|NCT03170544|11927073|FG000|NOT COMPLETED|Part 3||0
10763819|NCT03170544|11927074|FG001|NOT COMPLETED|Part 3||0
10763820|NCT03170544|11927075|FG002|NOT COMPLETED|Part 3||0
10763821|NCT03170544|11927076|FG003|NOT COMPLETED|Part 3||0
10763822|NCT03170544|11927077|FG004|NOT COMPLETED|Part 3||0
10763823|NCT03170544|11927078|FG005|NOT COMPLETED|Part 3||0
10763824|NCT03170544|11927079|FG006|NOT COMPLETED|Part 3||0
10763825|NCT03170544|11927080|FG007|NOT COMPLETED|Part 3||0
10763826|NCT03170544|11927081|FG008|NOT COMPLETED|Part 3||0
10763827|NCT03170544|11927082|FG009|NOT COMPLETED|Part 3||0
10763828|NCT03170544|11927083|FG010|NOT COMPLETED|Part 3||0
10763829|NCT03170544|11927084|FG011|NOT COMPLETED|Part 3||0
10763830|NCT03170544|11927073|FG000|STARTED|Part 4||0
10763831|NCT03170544|11927074|FG001|STARTED|Part 4||0
10763832|NCT03170544|11927075|FG002|STARTED|Part 4||0
10763833|NCT03170544|11927076|FG003|STARTED|Part 4||0
10763834|NCT03170544|11927077|FG004|STARTED|Part 4||0
10763835|NCT03170544|11927078|FG005|STARTED|Part 4||0
10763836|NCT03170544|11927079|FG006|STARTED|Part 4||0
10763837|NCT03170544|11927080|FG007|STARTED|Part 4||0
10763838|NCT03170544|11927081|FG008|STARTED|Part 4||0
10763839|NCT03170544|11927082|FG009|STARTED|Part 4||0
10763840|NCT03170544|11927083|FG010|STARTED|Part 4||3
10763841|NCT03170544|11927084|FG011|STARTED|Part 4||6
10763842|NCT03170544|11927073|FG000|COMPLETED|Part 4||0
10763843|NCT03170544|11927074|FG001|COMPLETED|Part 4||0
10763844|NCT03170544|11927075|FG002|COMPLETED|Part 4||0
10763845|NCT03170544|11927076|FG003|COMPLETED|Part 4||0
10763846|NCT03170544|11927077|FG004|COMPLETED|Part 4||0
10763847|NCT03170544|11927078|FG005|COMPLETED|Part 4||0
10763848|NCT03170544|11927079|FG006|COMPLETED|Part 4||0
10763849|NCT03170544|11927080|FG007|COMPLETED|Part 4||0
10763850|NCT03170544|11927081|FG008|COMPLETED|Part 4||0
10763851|NCT03170544|11927082|FG009|COMPLETED|Part 4||0
10763852|NCT03170544|11927083|FG010|COMPLETED|Part 4||3
10763853|NCT03170544|11927084|FG011|COMPLETED|Part 4||6
10763854|NCT03170544|11927073|FG000|NOT COMPLETED|Part 4||0
10763855|NCT03170544|11927074|FG001|NOT COMPLETED|Part 4||0
10763856|NCT03170544|11927075|FG002|NOT COMPLETED|Part 4||0
10763857|NCT03170544|11927076|FG003|NOT COMPLETED|Part 4||0
10763858|NCT03170544|11927077|FG004|NOT COMPLETED|Part 4||0
10763859|NCT03170544|11927078|FG005|NOT COMPLETED|Part 4||0
10763860|NCT03170544|11927079|FG006|NOT COMPLETED|Part 4||0
10763861|NCT03170544|11927080|FG007|NOT COMPLETED|Part 4||0
10763862|NCT03170544|11927081|FG008|NOT COMPLETED|Part 4||0
10763863|NCT03170544|11927082|FG009|NOT COMPLETED|Part 4||0
10763864|NCT03170544|11927083|FG010|NOT COMPLETED|Part 4||0
10763865|NCT03170544|11927084|FG011|NOT COMPLETED|Part 4||0
10763866|NCT03170609|11927174|FG000|STARTED|Overall Study||53
10763867|NCT03170609|11927175|FG001|STARTED|Overall Study||52
10763868|NCT03170609|11927176|FG002|STARTED|Overall Study||52
10763869|NCT03170609|11927177|FG003|STARTED|Overall Study||52
10763870|NCT03170609|11927178|FG004|STARTED|Overall Study||52
10763871|NCT03170609|11927179|FG005|STARTED|Overall Study||52
10763872|NCT03170609|11927180|FG006|STARTED|Overall Study||52
10763873|NCT03170609|11927174|FG000|Vaccinated|Overall Study||52
10763874|NCT03170609|11927175|FG001|Vaccinated|Overall Study||52
10763875|NCT03170609|11927176|FG002|Vaccinated|Overall Study||52
10763876|NCT03170609|11927177|FG003|Vaccinated|Overall Study||52
10763877|NCT03170609|11927178|FG004|Vaccinated|Overall Study||52
10763878|NCT03170609|11927179|FG005|Vaccinated|Overall Study||52
10763879|NCT03170609|11927180|FG006|Vaccinated|Overall Study||52
10763880|NCT03170609|11927174|FG000|COMPLETED|Overall Study||50
10763881|NCT03170609|11927175|FG001|COMPLETED|Overall Study||50
10763882|NCT03170609|11927176|FG002|COMPLETED|Overall Study||46
10763883|NCT03170609|11927177|FG003|COMPLETED|Overall Study||50
10763884|NCT03170609|11927178|FG004|COMPLETED|Overall Study||51
10763885|NCT03170609|11927179|FG005|COMPLETED|Overall Study||50
10763886|NCT03170609|11927180|FG006|COMPLETED|Overall Study||51
10763887|NCT03170609|11927174|FG000|NOT COMPLETED|Overall Study||3
10763888|NCT03170609|11927175|FG001|NOT COMPLETED|Overall Study||2
10763889|NCT03170609|11927176|FG002|NOT COMPLETED|Overall Study||6
10763890|NCT03170609|11927177|FG003|NOT COMPLETED|Overall Study||2
10763891|NCT03170609|11927178|FG004|NOT COMPLETED|Overall Study||1
10763892|NCT03170609|11927179|FG005|NOT COMPLETED|Overall Study||2
10763893|NCT03170609|11927180|FG006|NOT COMPLETED|Overall Study||1
10763894|NCT03170661|11927198|FG000|STARTED|Overall Study||49
10763895|NCT03170661|11927199|FG001|STARTED|Overall Study||49
10763896|NCT03170661|11927198|FG000|COMPLETED|Overall Study||49
10763897|NCT03170661|11927199|FG001|COMPLETED|Overall Study||49
10763898|NCT03170661|11927198|FG000|NOT COMPLETED|Overall Study||0
10763899|NCT03170661|11927199|FG001|NOT COMPLETED|Overall Study||0
10763900|NCT03171051|11927207|FG000|STARTED|Overall Study||10
10763901|NCT03171051|11927207|FG000|COMPLETED|Overall Study||10
10763902|NCT03171051|11927207|FG000|NOT COMPLETED|Overall Study||0
10763903|NCT03171415|11927217|FG000|STARTED|Overall Study||6
10763904|NCT03171415|11927218|FG001|STARTED|Overall Study||6
10763905|NCT03171415|11927219|FG002|STARTED|Overall Study||6
10763906|NCT03171415|11927220|FG003|STARTED|Overall Study||6
10763907|NCT03171415|11927221|FG004|STARTED|Overall Study||9
10763908|NCT03171415|11927217|FG000|COMPLETED|Overall Study||6
10763909|NCT03171415|11927218|FG001|COMPLETED|Overall Study||6
10763910|NCT03171415|11927219|FG002|COMPLETED|Overall Study||6
10763911|NCT03171415|11927220|FG003|COMPLETED|Overall Study||6
10763912|NCT03171415|11927221|FG004|COMPLETED|Overall Study||7
10763913|NCT03171415|11927217|FG000|NOT COMPLETED|Overall Study||0
10763914|NCT03171415|11927218|FG001|NOT COMPLETED|Overall Study||0
10763915|NCT03171415|11927219|FG002|NOT COMPLETED|Overall Study||0
10763916|NCT03171415|11927220|FG003|NOT COMPLETED|Overall Study||0
10763917|NCT03171415|11927221|FG004|NOT COMPLETED|Overall Study||2
10763918|NCT03172130|11927246|FG000|STARTED|Overall Study||12
10763919|NCT03172130|11927247|FG001|STARTED|Overall Study||10
10763920|NCT03172130|11927246|FG000|COMPLETED|Overall Study||9
10763921|NCT03172130|11927247|FG001|COMPLETED|Overall Study||9
10763922|NCT03172130|11927246|FG000|NOT COMPLETED|Overall Study||3
10763923|NCT03172130|11927247|FG001|NOT COMPLETED|Overall Study||1
10763924|NCT03172325|11927255|FG000|STARTED|Overall Study||68
10763925|NCT03172325|11927256|FG001|STARTED|Overall Study||68
10763926|NCT03172325|11927255|FG000|COMPLETED|Overall Study||64
10763927|NCT03172325|11927256|FG001|COMPLETED|Overall Study||64
10763928|NCT03172325|11927255|FG000|NOT COMPLETED|Overall Study||4
10763929|NCT03172325|11927256|FG001|NOT COMPLETED|Overall Study||4
10763930|NCT03172364|11927264|FG000|STARTED|Overall Study||55
10763931|NCT03172364|11927265|FG001|STARTED|Overall Study||58
10763932|NCT03172364|11927264|FG000|COMPLETED|Overall Study||53
10763933|NCT03172364|11927265|FG001|COMPLETED|Overall Study||57
10763934|NCT03172364|11927264|FG000|NOT COMPLETED|Overall Study||2
10763935|NCT03172364|11927265|FG001|NOT COMPLETED|Overall Study||1
10763936|NCT03172481|11927273|FG000|STARTED|Open-label||156
10763937|NCT03172481|11927274|FG001|STARTED|Open-label||0
10763938|NCT03172481|11927273|FG000|COMPLETED|Open-label||148
10763939|NCT03172481|11927274|FG001|COMPLETED|Open-label||0
10763940|NCT03172481|11927273|FG000|NOT COMPLETED|Open-label||8
10763941|NCT03172481|11927274|FG001|NOT COMPLETED|Open-label||0
10763942|NCT03172481|11927273|FG000|STARTED|Double-blind||75
10763943|NCT03172481|11927274|FG001|STARTED|Double-blind|From 148 subjects who completed the Open-label period, 73 randomly received Placebo|73
10763944|NCT03172481|11927273|FG000|COMPLETED|Double-blind||74
10763945|NCT03172481|11927274|FG001|COMPLETED|Double-blind||73
10763946|NCT03172481|11927273|FG000|NOT COMPLETED|Double-blind||1
10763947|NCT03172481|11927274|FG001|NOT COMPLETED|Double-blind||0
10763948|NCT03172494|11927283|FG000|STARTED|Overall Study||361
10763949|NCT03172494|11927284|FG001|STARTED|Overall Study||179
10763950|NCT03172494|11927285|FG002|STARTED|Overall Study||180
10763951|NCT03172494|11927283|FG000|Full Analysis Set (FAS)|Overall Study||361
10763952|NCT03172494|11927284|FG001|Full Analysis Set (FAS)|Overall Study||179
10763953|NCT03172494|11927285|FG002|Full Analysis Set (FAS)|Overall Study||180
10763954|NCT03172494|11927283|FG000|Safety Analysis Set (SAS)|Overall Study||358
10763955|NCT03172494|11927284|FG001|Safety Analysis Set (SAS)|Overall Study||175
10763956|NCT03172494|11927285|FG002|Safety Analysis Set (SAS)|Overall Study||180
10763957|NCT03172494|11927283|FG000|Exposed|Overall Study||358
10763958|NCT03172494|11927284|FG001|Exposed|Overall Study||175
10763959|NCT03172494|11927285|FG002|Exposed|Overall Study||180
10763960|NCT03172494|11927283|FG000|COMPLETED|Overall Study||341
10763961|NCT03172494|11927284|FG001|COMPLETED|Overall Study||167
10763962|NCT03172494|11927285|FG002|COMPLETED|Overall Study||151
10763963|NCT03172494|11927283|FG000|NOT COMPLETED|Overall Study||20
10763964|NCT03172494|11927284|FG001|NOT COMPLETED|Overall Study||12
10297208|NCT00453063|11429771|FG000|STARTED|Overall Study||211
10297209|NCT00453063|11429772|FG001|STARTED|Overall Study||215
10297210|NCT00453063|11429771|FG000|COMPLETED|Overall Study||208
10297211|NCT00453063|11429772|FG001|COMPLETED|Overall Study||212
10297212|NCT00453063|11429771|FG000|NOT COMPLETED|Overall Study||3
10297213|NCT00453063|11429772|FG001|NOT COMPLETED|Overall Study||3
10297214|NCT00447603|11429778|FG000|STARTED|Screening||40
10297215|NCT00447603|11429779|FG001|STARTED|Screening||0
10297216|NCT00447603|11429780|FG002|STARTED|Screening||0
10297217|NCT00447603|11429778|FG000|COMPLETED|Screening||19
10297218|NCT00447603|11429779|FG001|COMPLETED|Screening||0
10297219|NCT00447603|11429780|FG002|COMPLETED|Screening||0
10297220|NCT00447603|11429778|FG000|NOT COMPLETED|Screening||21
10297221|NCT00447603|11429779|FG001|NOT COMPLETED|Screening||0
10297222|NCT00447603|11429780|FG002|NOT COMPLETED|Screening||0
10297223|NCT00447603|11429778|FG000|STARTED|Filter Period||0
10297224|NCT00447603|11429779|FG001|STARTED|Filter Period|The study was discontinued early; no participant entered treatment period|4
10297225|NCT00447603|11429780|FG002|STARTED|Filter Period|The study was discontinued early; no participant entered treatment period|15
10297226|NCT00447603|11429778|FG000|COMPLETED|Filter Period||0
10297227|NCT00447603|11429779|FG001|COMPLETED|Filter Period||0
10297228|NCT00447603|11429780|FG002|COMPLETED|Filter Period||0
10297229|NCT00447603|11429778|FG000|NOT COMPLETED|Filter Period||0
10297230|NCT00447603|11429779|FG001|NOT COMPLETED|Filter Period||4
10297231|NCT00447603|11429780|FG002|NOT COMPLETED|Filter Period||15
10297232|NCT00442351|11429790|FG000|STARTED|Overall Study|Due to poor enrollment and a high screening failure rate, this study was terminated early.|17
10297233|NCT00442351|11429791|FG001|STARTED|Overall Study||9
10297234|NCT00442351|11429790|FG000|COMPLETED|Overall Study||10
10297235|NCT00442351|11429791|FG001|COMPLETED|Overall Study||3
10297236|NCT00442351|11429790|FG000|NOT COMPLETED|Overall Study||7
10297237|NCT00442351|11429791|FG001|NOT COMPLETED|Overall Study||6
10297238|NCT00423488|11429799|FG000|STARTED|Overall Study||42
10297239|NCT00423488|11429800|FG001|STARTED|Overall Study||51
10297240|NCT00423488|11429799|FG000|COMPLETED|Overall Study||37
10297241|NCT00423488|11429800|FG001|COMPLETED|Overall Study||50
10297242|NCT00423488|11429799|FG000|NOT COMPLETED|Overall Study||5
10297243|NCT00423488|11429800|FG001|NOT COMPLETED|Overall Study||1
10297244|NCT00413972|11429810|FG000|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
10297245|NCT00413972|11429811|FG001|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
10763965|NCT03172494|11927285|FG002|NOT COMPLETED|Overall Study||29
10763966|NCT03172702|11927294|FG000|STARTED|Overall Study||150
10763967|NCT03172702|11927294|FG000|Received Treatment in CP|Overall Study||150
10763968|NCT03172702|11927294|FG000|Received Treatment in MP|Overall Study||150
10763969|NCT03172702|11927294|FG000|COMPLETED|Overall Study||122
10763970|NCT03172702|11927294|FG000|NOT COMPLETED|Overall Study||28
10763971|NCT03172884|11927303|FG000|STARTED|Overall Study||8
10763972|NCT03172884|11927304|FG001|STARTED|Overall Study||6
10763973|NCT03172884|11927305|FG002|STARTED|Overall Study||8
10763974|NCT03172884|11927306|FG003|STARTED|Overall Study||8
10763975|NCT03172884|11927303|FG000|COMPLETED|Overall Study||8
10763976|NCT03172884|11927304|FG001|COMPLETED|Overall Study||6
10763977|NCT03172884|11927305|FG002|COMPLETED|Overall Study||8
10297246|NCT00413972|11429812|FG002|STARTED|Overall Study||98
10297247|NCT00413972|11429813|FG003|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
10297248|NCT00413972|11429810|FG000|COMPLETED|Overall Study||91
10297249|NCT00413972|11429811|FG001|COMPLETED|Overall Study||90
10297250|NCT00413972|11429812|FG002|COMPLETED|Overall Study||88
10297251|NCT00413972|11429813|FG003|COMPLETED|Overall Study||95
10297252|NCT00413972|11429810|FG000|NOT COMPLETED|Overall Study||7
10297253|NCT00413972|11429811|FG001|NOT COMPLETED|Overall Study||8
10297254|NCT00413972|11429812|FG002|NOT COMPLETED|Overall Study||10
10297255|NCT00413972|11429813|FG003|NOT COMPLETED|Overall Study||3
10297256|NCT00413062|11429825|FG000|STARTED|Overall Study||1666
10297257|NCT00413062|11429826|FG001|STARTED|Overall Study||554
10297258|NCT00413062|11429825|FG000|COMPLETED|Overall Study||988
10297259|NCT00413062|11429826|FG001|COMPLETED|Overall Study||344
10297260|NCT00413062|11429825|FG000|NOT COMPLETED|Overall Study||678
10297261|NCT00413062|11429826|FG001|NOT COMPLETED|Overall Study||210
10297262|NCT00391170|11429836|FG000|STARTED|Overall Study||27
10297263|NCT00391170|11429837|FG001|STARTED|Overall Study||27
10297264|NCT00391170|11429836|FG000|COMPLETED|Overall Study||21
10297265|NCT00391170|11429837|FG001|COMPLETED|Overall Study||23
10297266|NCT00391170|11429836|FG000|NOT COMPLETED|Overall Study||6
10297267|NCT00391170|11429837|FG001|NOT COMPLETED|Overall Study||4
10297268|NCT00359138|11429846|FG000|STARTED|Overall Study||12
10297269|NCT00359138|11429847|FG001|STARTED|Overall Study||12
10297270|NCT00359138|11429848|FG002|STARTED|Overall Study||12
10297271|NCT00359138|11429846|FG000|COMPLETED|Overall Study||12
10297272|NCT00359138|11429847|FG001|COMPLETED|Overall Study||12
10297273|NCT00359138|11429848|FG002|COMPLETED|Overall Study||12
10297274|NCT00359138|11429846|FG000|NOT COMPLETED|Overall Study||0
10297275|NCT00359138|11429847|FG001|NOT COMPLETED|Overall Study||0
10297276|NCT00359138|11429848|FG002|NOT COMPLETED|Overall Study||0
10297277|NCT00350701|11429859|FG000|STARTED|Overall Study||17
10297278|NCT00350701|11429860|FG001|STARTED|Overall Study||17
10297279|NCT00350701|11429861|FG002|STARTED|Overall Study||15
10297280|NCT00350701|11429859|FG000|COMPLETED|Overall Study||17
10297281|NCT00350701|11429860|FG001|COMPLETED|Overall Study||17
10297282|NCT00350701|11429861|FG002|COMPLETED|Overall Study||15
10297283|NCT00350701|11429859|FG000|NOT COMPLETED|Overall Study||0
10297284|NCT00350701|11429860|FG001|NOT COMPLETED|Overall Study||0
10297285|NCT00350701|11429861|FG002|NOT COMPLETED|Overall Study||0
10297286|NCT00319449|11429871|FG000|STARTED|Overall Study||10
10297287|NCT00319449|11429872|FG001|STARTED|Overall Study||12
10297288|NCT00319449|11429871|FG000|COMPLETED|Overall Study||8
10297289|NCT00319449|11429872|FG001|COMPLETED|Overall Study||12
10297290|NCT00319449|11429871|FG000|NOT COMPLETED|Overall Study||2
10297291|NCT00319449|11429872|FG001|NOT COMPLETED|Overall Study||0
10297292|NCT00305344|11429878|FG000|STARTED|Overall Study||23
10297293|NCT00305344|11429878|FG000|COMPLETED|Overall Study||23
10297294|NCT00305344|11429878|FG000|NOT COMPLETED|Overall Study||0
10297295|NCT00289887|11429884|FG000|STARTED|Overall Study||127
10297296|NCT00289887|11429885|FG001|STARTED|Overall Study||134
10297297|NCT00289887|11429884|FG000|COMPLETED|Overall Study||105
10297298|NCT00289887|11429885|FG001|COMPLETED|Overall Study||105
10297299|NCT00289887|11429884|FG000|NOT COMPLETED|Overall Study||22
10297300|NCT00289887|11429885|FG001|NOT COMPLETED|Overall Study||29
10297301|NCT00281320|11429893|FG000|STARTED|Overall Study||61
10297302|NCT00281320|11429894|FG001|STARTED|Overall Study||61
10297303|NCT00281320|11429893|FG000|COMPLETED|Overall Study||36
10297304|NCT00281320|11429894|FG001|COMPLETED|Overall Study||40
10297305|NCT00281320|11429893|FG000|NOT COMPLETED|Overall Study||25
10297306|NCT00281320|11429894|FG001|NOT COMPLETED|Overall Study||21
10297307|NCT00276016|11429912|FG000|STARTED|Intervention 1||7
10297308|NCT00276016|11429913|FG001|STARTED|Intervention 1||7
10297309|NCT00276016|11429914|FG002|STARTED|Intervention 1||7
10297310|NCT00276016|11429915|FG003|STARTED|Intervention 1||6
10297311|NCT00276016|11429916|FG004|STARTED|Intervention 1||6
10297312|NCT00276016|11429917|FG005|STARTED|Intervention 1||6
10297313|NCT00276016|11429912|FG000|COMPLETED|Intervention 1||7
10297314|NCT00276016|11429913|FG001|COMPLETED|Intervention 1||6
10421625|NCT00820040|11566472|FG000|COMPLETED|Overall Study||7
10421626|NCT00820040|11566472|FG000|NOT COMPLETED|Overall Study||3
10297315|NCT00276016|11429914|FG002|COMPLETED|Intervention 1||7
10297316|NCT00276016|11429915|FG003|COMPLETED|Intervention 1||6
10297317|NCT00276016|11429916|FG004|COMPLETED|Intervention 1||6
10297318|NCT00276016|11429917|FG005|COMPLETED|Intervention 1||6
10297319|NCT00276016|11429912|FG000|NOT COMPLETED|Intervention 1||0
10297320|NCT00276016|11429913|FG001|NOT COMPLETED|Intervention 1||1
10297321|NCT00276016|11429914|FG002|NOT COMPLETED|Intervention 1||0
10297322|NCT00276016|11429915|FG003|NOT COMPLETED|Intervention 1||0
10297323|NCT00276016|11429916|FG004|NOT COMPLETED|Intervention 1||0
10297324|NCT00276016|11429917|FG005|NOT COMPLETED|Intervention 1||0
10297325|NCT00276016|11429912|FG000|STARTED|Wash Out 1||7
10297326|NCT00276016|11429913|FG001|STARTED|Wash Out 1||6
10421627|NCT00820170|11566481|FG000|STARTED|Overall Study||3
10421628|NCT00820170|11566482|FG001|STARTED|Overall Study||5
10763978|NCT03172884|11927306|FG003|COMPLETED|Overall Study||8
10763979|NCT03172884|11927303|FG000|NOT COMPLETED|Overall Study||0
10763980|NCT03172884|11927304|FG001|NOT COMPLETED|Overall Study||0
10763981|NCT03172884|11927305|FG002|NOT COMPLETED|Overall Study||0
10763982|NCT03172884|11927306|FG003|NOT COMPLETED|Overall Study||0
10763983|NCT03173170|11927316|FG000|STARTED|First Intervention Period (6 Days)||10
10763984|NCT03173170|11927316|FG000|COMPLETED|First Intervention Period (6 Days)||10
10763985|NCT03173170|11927316|FG000|NOT COMPLETED|First Intervention Period (6 Days)||0
10763986|NCT03173170|11927316|FG000|STARTED|Washout Period (at Least 7 Days)||10
10763987|NCT03173170|11927316|FG000|COMPLETED|Washout Period (at Least 7 Days)||10
10763988|NCT03173170|11927316|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
10763989|NCT03173170|11927316|FG000|STARTED|Intervention Period 2 (9 Days)||10
10763990|NCT03173170|11927316|FG000|COMPLETED|Intervention Period 2 (9 Days)||10
10763991|NCT03173170|11927316|FG000|NOT COMPLETED|Intervention Period 2 (9 Days)||0
10763992|NCT03173313|11927326|FG000|STARTED|Overall Study||58
10763993|NCT03173313|11927327|FG001|STARTED|Overall Study||53
10763994|NCT03173313|11927326|FG000|Informed Consent Signed|Overall Study||58
10763995|NCT03173313|11927327|FG001|Informed Consent Signed|Overall Study||53
10763996|NCT03173313|11927326|FG000|Randomized|Overall Study||58
10763997|NCT03173313|11927327|FG001|Randomized|Overall Study||53
10763998|NCT03173313|11927326|FG000|Cooled|Overall Study||54
10763999|NCT03173313|11927327|FG001|Cooled|Overall Study||0
10764000|NCT03173313|11927326|FG000|4-6 Day Follow-up|Overall Study||57
10764001|NCT03173313|11927327|FG001|4-6 Day Follow-up|Overall Study||53
10764002|NCT03173313|11927326|FG000|30-day Follow-up|Overall Study||52
10764003|NCT03173313|11927327|FG001|30-day Follow-up|Overall Study||51
10764004|NCT03173313|11927326|FG000|12-month Follow-up|Overall Study||49
10764005|NCT03173313|11927327|FG001|12-month Follow-up|Overall Study||48
10764006|NCT03173313|11927326|FG000|COMPLETED|Overall Study||49
10764007|NCT03173313|11927327|FG001|COMPLETED|Overall Study||48
10764008|NCT03173313|11927326|FG000|NOT COMPLETED|Overall Study||9
10764009|NCT03173313|11927327|FG001|NOT COMPLETED|Overall Study||5
10764010|NCT03173547|11927335|FG000|STARTED|Overall Study||40
10764011|NCT03173547|11927336|FG001|STARTED|Overall Study||40
10764012|NCT03173547|11927335|FG000|COMPLETED|Overall Study||36
10764013|NCT03173547|11927336|FG001|COMPLETED|Overall Study||38
10764014|NCT03173547|11927335|FG000|NOT COMPLETED|Overall Study||4
10764015|NCT03173547|11927336|FG001|NOT COMPLETED|Overall Study||2
10421629|NCT00820170|11566483|FG002|STARTED|Overall Study||3
10421630|NCT00820170|11566484|FG003|STARTED|Overall Study||40
10421631|NCT00820170|11566485|FG004|STARTED|Overall Study||4
10421632|NCT00820170|11566481|FG000|COMPLETED|Overall Study||3
10421633|NCT00820170|11566482|FG001|COMPLETED|Overall Study||5
10421634|NCT00820170|11566483|FG002|COMPLETED|Overall Study||3
10764029|NCT03174158|11927359|FG000|STARTED|Overall Study||39
10764030|NCT03174158|11927360|FG001|STARTED|Overall Study||39
10764031|NCT03174158|11927361|FG002|STARTED|Overall Study||36
10764032|NCT03174158|11927362|FG003|STARTED|Overall Study||39
10764033|NCT03174158|11927359|FG000|COMPLETED|Overall Study||35
10764034|NCT03174158|11927360|FG001|COMPLETED|Overall Study||37
10764035|NCT03174158|11927361|FG002|COMPLETED|Overall Study||34
10764036|NCT03174158|11927362|FG003|COMPLETED|Overall Study||38
10764037|NCT03174158|11927359|FG000|NOT COMPLETED|Overall Study||4
10764038|NCT03174158|11927360|FG001|NOT COMPLETED|Overall Study||2
10764039|NCT03174158|11927361|FG002|NOT COMPLETED|Overall Study||2
10764040|NCT03174158|11927362|FG003|NOT COMPLETED|Overall Study||1
10764041|NCT03174366|11927380|FG000|STARTED|Overall Study||7
10764042|NCT03174366|11927380|FG000|COMPLETED|Overall Study||7
10764043|NCT03174366|11927380|FG000|NOT COMPLETED|Overall Study||0
10764044|NCT03174925|11927384|FG000|STARTED|Overall Study||55
10764045|NCT03174925|11927384|FG000|COMPLETED|Overall Study||52
10764046|NCT03174925|11927384|FG000|NOT COMPLETED|Overall Study||3
10764047|NCT03175120|11927390|FG000|STARTED|Overall Study||302
10764048|NCT03175120|11927391|FG001|STARTED|Overall Study||151
10764049|NCT03175120|11927390|FG000|Treated|Overall Study||301
10764050|NCT03175120|11927391|FG001|Treated|Overall Study||151
10764051|NCT03175120|11927390|FG000|Full Analysis Set (FAS)|Overall Study||302
10764052|NCT03175120|11927391|FG001|Full Analysis Set (FAS)|Overall Study||151
10764053|NCT03175120|11927390|FG000|Safety Analysis Set (SAS)|Overall Study||301
10764054|NCT03175120|11927391|FG001|Safety Analysis Set (SAS)|Overall Study||151
10764055|NCT03175120|11927390|FG000|COMPLETED|Overall Study||290
10764056|NCT03175120|11927391|FG001|COMPLETED|Overall Study||139
10764057|NCT03175120|11927390|FG000|NOT COMPLETED|Overall Study||12
10764058|NCT03175120|11927391|FG001|NOT COMPLETED|Overall Study||12
10764059|NCT03175172|11927397|FG000|STARTED|Overall Study||10
10764060|NCT03175172|11927397|FG000|COMPLETED|Overall Study||0
10764061|NCT03175172|11927397|FG000|NOT COMPLETED|Overall Study||10
10764062|NCT03175562|11927401|FG000|STARTED|Overall Study||240
10764063|NCT03175562|11927401|FG000|Test Product|Overall Study||240
10764064|NCT03175562|11927401|FG000|Negative Control|Overall Study||240
10764065|NCT03175562|11927401|FG000|COMPLETED|Overall Study||224
10764066|NCT03175562|11927401|FG000|NOT COMPLETED|Overall Study||16
10764067|NCT03175731|11927410|FG000|STARTED|Overall Study||53
10764068|NCT03175731|11927411|FG001|STARTED|Overall Study||53
10764069|NCT03175731|11927410|FG000|COMPLETED|Overall Study||46
10764070|NCT03175731|11927411|FG001|COMPLETED|Overall Study||48
10764071|NCT03175731|11927410|FG000|NOT COMPLETED|Overall Study||7
10764072|NCT03175731|11927411|FG001|NOT COMPLETED|Overall Study||5
10764073|NCT03176238|11927419|FG000|STARTED|Overall Study||199
10764074|NCT03176238|11927420|FG001|STARTED|Overall Study||36
10764075|NCT03176238|11927419|FG000|COMPLETED|Overall Study||0
10764076|NCT03176238|11927420|FG001|COMPLETED|Overall Study||0
10764077|NCT03176238|11927419|FG000|NOT COMPLETED|Overall Study||199
10764078|NCT03176238|11927420|FG001|NOT COMPLETED|Overall Study||36
10764079|NCT03176407|11927430|FG000|STARTED|Overall Study||30
10764080|NCT03176407|11927430|FG000|COMPLETED|Overall Study||27
10764081|NCT03176407|11927430|FG000|NOT COMPLETED|Overall Study||3
10764082|NCT03176459|11927438|FG000|STARTED|Overall Study||96
10764083|NCT03176459|11927439|FG001|STARTED|Overall Study||90
10764084|NCT03176459|11927438|FG000|COMPLETED|Overall Study||91
10764085|NCT03176459|11927439|FG001|COMPLETED|Overall Study||83
10764086|NCT03176459|11927438|FG000|NOT COMPLETED|Overall Study||5
10764087|NCT03176459|11927439|FG001|NOT COMPLETED|Overall Study||7
10764088|NCT03176654|11927447|FG000|STARTED|Overall Study||13
10764089|NCT03176654|11927448|FG001|STARTED|Overall Study||15
10764090|NCT03176654|11927447|FG000|COMPLETED|Overall Study||13
10764091|NCT03176654|11927448|FG001|COMPLETED|Overall Study||15
10764092|NCT03176654|11927447|FG000|NOT COMPLETED|Overall Study||0
10764093|NCT03176654|11927448|FG001|NOT COMPLETED|Overall Study||0
10764094|NCT03176784|11927458|FG000|STARTED|Overall Study||314
10764095|NCT03176784|11927459|FG001|STARTED|Overall Study||315
10764096|NCT03176784|11927460|FG002|STARTED|Overall Study||311
10764097|NCT03176784|11927461|FG003|STARTED|Overall Study||311
10764098|NCT03176784|11927458|FG000|COMPLETED|Overall Study||209
10764099|NCT03176784|11927459|FG001|COMPLETED|Overall Study||202
10764100|NCT03176784|11927460|FG002|COMPLETED|Overall Study||198
10764101|NCT03176784|11927461|FG003|COMPLETED|Overall Study||241
10764102|NCT03176784|11927458|FG000|NOT COMPLETED|Overall Study||105
10764103|NCT03176784|11927459|FG001|NOT COMPLETED|Overall Study||113
10764104|NCT03176784|11927460|FG002|NOT COMPLETED|Overall Study||113
10764105|NCT03176784|11927461|FG003|NOT COMPLETED|Overall Study||70
10764106|NCT03177395|11927475|FG000|STARTED|Overall Study||6
10764107|NCT03177395|11927476|FG001|STARTED|Overall Study||6
10764108|NCT03177395|11927477|FG002|STARTED|Overall Study||6
10764109|NCT03177395|11927478|FG003|STARTED|Overall Study||6
10764110|NCT03177395|11927475|FG000|COMPLETED|Overall Study||6
10764111|NCT03177395|11927476|FG001|COMPLETED|Overall Study||6
10764112|NCT03177395|11927477|FG002|COMPLETED|Overall Study||6
10764113|NCT03177395|11927478|FG003|COMPLETED|Overall Study||6
10764114|NCT03177395|11927475|FG000|NOT COMPLETED|Overall Study||0
10764115|NCT03177395|11927476|FG001|NOT COMPLETED|Overall Study||0
10764116|NCT03177395|11927477|FG002|NOT COMPLETED|Overall Study||0
10764117|NCT03177395|11927478|FG003|NOT COMPLETED|Overall Study||0
10764118|NCT03177512|11927492|FG000|STARTED|Overall Study||40
10764119|NCT03177512|11927493|FG001|STARTED|Overall Study||21
10764120|NCT03177512|11927492|FG000|COMPLETED|Overall Study||31
10764121|NCT03177512|11927493|FG001|COMPLETED|Overall Study||18
10764122|NCT03177512|11927492|FG000|NOT COMPLETED|Overall Study||9
10764123|NCT03177512|11927493|FG001|NOT COMPLETED|Overall Study||3
10764124|NCT03177603|11927503|FG000|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||4
10764125|NCT03177603|11927504|FG001|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
10764126|NCT03177603|11927505|FG002|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
10764127|NCT03177603|11927506|FG003|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
10764128|NCT03177603|11927503|FG000|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||4
10764129|NCT03177603|11927504|FG001|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
10764130|NCT03177603|11927505|FG002|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
10764131|NCT03177603|11927506|FG003|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
10764132|NCT03177603|11927503|FG000|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
10764133|NCT03177603|11927504|FG001|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
10764134|NCT03177603|11927505|FG002|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
10764135|NCT03177603|11927506|FG003|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
10764136|NCT03177603|11927503|FG000|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
10764137|NCT03177603|11927504|FG001|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||5
10764138|NCT03177603|11927505|FG002|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
10764139|NCT03177603|11927506|FG003|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
10764140|NCT03177603|11927503|FG000|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
10764141|NCT03177603|11927504|FG001|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||5
10764142|NCT03177603|11927505|FG002|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
10764143|NCT03177603|11927506|FG003|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
10764144|NCT03177603|11927503|FG000|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
10764145|NCT03177603|11927504|FG001|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
10764146|NCT03177603|11927505|FG002|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
10764147|NCT03177603|11927506|FG003|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
10764148|NCT03177603|11927503|FG000|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
10764149|NCT03177603|11927504|FG001|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
10764150|NCT03177603|11927505|FG002|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||6
10764151|NCT03177603|11927506|FG003|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
10764152|NCT03177603|11927503|FG000|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
10764153|NCT03177603|11927504|FG001|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
10764154|NCT03177603|11927505|FG002|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||6
10764155|NCT03177603|11927506|FG003|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
10764156|NCT03177603|11927503|FG000|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
10764157|NCT03177603|11927504|FG001|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
10764158|NCT03177603|11927505|FG002|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
10764159|NCT03177603|11927506|FG003|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
10764160|NCT03177603|11927503|FG000|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
10764161|NCT03177603|11927504|FG001|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
10764162|NCT03177603|11927505|FG002|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
10764163|NCT03177603|11927506|FG003|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||8
10764164|NCT03177603|11927503|FG000|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
10764165|NCT03177603|11927504|FG001|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
10764166|NCT03177603|11927505|FG002|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
10764167|NCT03177603|11927506|FG003|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||8
10764168|NCT03177603|11927503|FG000|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
10764169|NCT03177603|11927504|FG001|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
10764170|NCT03177603|11927505|FG002|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
10764171|NCT03177603|11927506|FG003|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
10764172|NCT03177798|11927518|FG000|STARTED|Overall Study||5
10764173|NCT03177798|11927519|FG001|STARTED|Overall Study||6
10764174|NCT03177798|11927518|FG000|Intervention 1|Overall Study||5
10764175|NCT03177798|11927519|FG001|Intervention 1|Overall Study||6
10764176|NCT03177798|11927518|FG000|Washout|Overall Study||5
10764177|NCT03177798|11927519|FG001|Washout|Overall Study||6
10764178|NCT03177798|11927518|FG000|Intervention 2|Overall Study||5
10764179|NCT03177798|11927519|FG001|Intervention 2|Overall Study||6
10764180|NCT03177798|11927518|FG000|COMPLETED|Overall Study||5
10764181|NCT03177798|11927519|FG001|COMPLETED|Overall Study||6
10764182|NCT03177798|11927518|FG000|NOT COMPLETED|Overall Study||0
10764183|NCT03177798|11927519|FG001|NOT COMPLETED|Overall Study||0
10764184|NCT03178266|11927529|FG000|STARTED|Overall Study||21
10764185|NCT03178266|11927530|FG001|STARTED|Overall Study||20
10764186|NCT03178266|11927529|FG000|COMPLETED|Overall Study||21
10764187|NCT03178266|11927530|FG001|COMPLETED|Overall Study||16
10764188|NCT03178266|11927529|FG000|NOT COMPLETED|Overall Study||0
10764189|NCT03178266|11927530|FG001|NOT COMPLETED|Overall Study||4
10764190|NCT03178344|11927536|FG000|STARTED|First Session||10
10764191|NCT03178344|11927537|FG001|STARTED|First Session||10
10764192|NCT03178344|11927536|FG000|COMPLETED|First Session||10
10764193|NCT03178344|11927537|FG001|COMPLETED|First Session||10
10764194|NCT03178344|11927536|FG000|NOT COMPLETED|First Session||0
10764195|NCT03178344|11927537|FG001|NOT COMPLETED|First Session||0
10764196|NCT03178344|11927536|FG000|STARTED|Washout Period (5-9 Days)||10
10764197|NCT03178344|11927537|FG001|STARTED|Washout Period (5-9 Days)||10
10764198|NCT03178344|11927536|FG000|COMPLETED|Washout Period (5-9 Days)||10
10764199|NCT03178344|11927537|FG001|COMPLETED|Washout Period (5-9 Days)||10
10764200|NCT03178344|11927536|FG000|NOT COMPLETED|Washout Period (5-9 Days)||0
10764201|NCT03178344|11927537|FG001|NOT COMPLETED|Washout Period (5-9 Days)||0
10764202|NCT03178344|11927536|FG000|STARTED|Second Session||10
10764203|NCT03178344|11927537|FG001|STARTED|Second Session||10
10764204|NCT03178344|11927536|FG000|COMPLETED|Second Session||10
10764205|NCT03178344|11927537|FG001|COMPLETED|Second Session||10
10764206|NCT03178344|11927536|FG000|NOT COMPLETED|Second Session||0
10764207|NCT03178344|11927537|FG001|NOT COMPLETED|Second Session||0
10764208|NCT03178669|11927548|FG000|STARTED|Overall Study||40
10764209|NCT03178669|11927549|FG001|STARTED|Overall Study||43
10764210|NCT03178669|11927550|FG002|STARTED|Overall Study||42
10764211|NCT03178669|11927551|FG003|STARTED|Overall Study||42
10764212|NCT03178669|11927552|FG004|STARTED|Overall Study||44
10764213|NCT03178669|11927548|FG000|Completed Week 6|Overall Study||35
10764214|NCT03178669|11927549|FG001|Completed Week 6|Overall Study||42
10764215|NCT03178669|11927550|FG002|Completed Week 6|Overall Study||36
10764216|NCT03178669|11927551|FG003|Completed Week 6|Overall Study||38
10764217|NCT03178669|11927552|FG004|Completed Week 6|Overall Study||42
10764218|NCT03178669|11927548|FG000|COMPLETED|Overall Study||35
10764219|NCT03178669|11927549|FG001|COMPLETED|Overall Study||42
10764220|NCT03178669|11927550|FG002|COMPLETED|Overall Study||35
10764221|NCT03178669|11927551|FG003|COMPLETED|Overall Study||38
10764222|NCT03178669|11927552|FG004|COMPLETED|Overall Study||40
10764223|NCT03178669|11927548|FG000|NOT COMPLETED|Overall Study||5
10764224|NCT03178669|11927549|FG001|NOT COMPLETED|Overall Study||1
10764225|NCT03178669|11927550|FG002|NOT COMPLETED|Overall Study||7
10764226|NCT03178669|11927551|FG003|NOT COMPLETED|Overall Study||4
10764227|NCT03178669|11927552|FG004|NOT COMPLETED|Overall Study||4
10764228|NCT03178773|11927566|FG000|STARTED|Overall Study||86
10764229|NCT03178773|11927567|FG001|STARTED|Overall Study||80
10764230|NCT03178773|11927566|FG000|3month Phone Follow up|Overall Study||49
10764231|NCT03178773|11927567|FG001|3month Phone Follow up|Overall Study||51
10764232|NCT03178773|11927566|FG000|6month in Person Follow up|Overall Study||54
10764233|NCT03178773|11927567|FG001|6month in Person Follow up|Overall Study||46
10764234|NCT03178773|11927566|FG000|9month Follow up Phone|Overall Study||36
10764235|NCT03178773|11927567|FG001|9month Follow up Phone|Overall Study||51
10764236|NCT03178773|11927566|FG000|COMPLETED|Overall Study||47
10297327|NCT00276016|11429914|FG002|STARTED|Wash Out 1||7
10764237|NCT03178773|11927567|FG001|COMPLETED|Overall Study||40
10764238|NCT03178773|11927566|FG000|NOT COMPLETED|Overall Study||39
10764239|NCT03178773|11927567|FG001|NOT COMPLETED|Overall Study||40
10764240|NCT03178851|11927577|FG000|STARTED|Overall Study||92
10764241|NCT03178851|11927578|FG001|STARTED|Overall Study||11
10764242|NCT03178851|11927579|FG002|STARTED|Overall Study||52
10764243|NCT03178851|11927577|FG000|COMPLETED|Overall Study||0
10764244|NCT03178851|11927578|FG001|COMPLETED|Overall Study||0
10764245|NCT03178851|11927579|FG002|COMPLETED|Overall Study||0
10764246|NCT03178851|11927577|FG000|NOT COMPLETED|Overall Study||92
10764247|NCT03178851|11927578|FG001|NOT COMPLETED|Overall Study||11
10764248|NCT03178851|11927579|FG002|NOT COMPLETED|Overall Study||52
10764249|NCT03178942|11927590|FG000|STARTED|Overall Study||129
10764250|NCT03178942|11927591|FG001|STARTED|Overall Study||125
10764251|NCT03178942|11927590|FG000|COMPLETED|Overall Study||126
10764252|NCT03178942|11927591|FG001|COMPLETED|Overall Study||123
10764253|NCT03178942|11927590|FG000|NOT COMPLETED|Overall Study||3
10764254|NCT03178942|11927591|FG001|NOT COMPLETED|Overall Study||2
10764255|NCT03179319|11927599|FG000|STARTED|Overall Study||40
10764256|NCT03179319|11927600|FG001|STARTED|Overall Study||20
10764257|NCT03179319|11927599|FG000|3 Month Visit|Overall Study||37
10764258|NCT03179319|11927600|FG001|3 Month Visit|Overall Study||20
10764259|NCT03179319|11927599|FG000|COMPLETED|Overall Study||34
10764260|NCT03179319|11927600|FG001|COMPLETED|Overall Study||20
10764261|NCT03179319|11927599|FG000|NOT COMPLETED|Overall Study||6
10764262|NCT03179319|11927600|FG001|NOT COMPLETED|Overall Study||0
10764263|NCT03179345|11927610|FG000|STARTED|Overall Study||8
10764264|NCT03179345|11927611|FG001|STARTED|Overall Study||8
10764265|NCT03179345|11927612|FG002|STARTED|Overall Study||8
10764266|NCT03179345|11927613|FG003|STARTED|Overall Study||8
10764267|NCT03179345|11927610|FG000|Received Gralise®|Overall Study||8
10764268|NCT03179345|11927611|FG001|Received Gralise®|Overall Study||7
10764269|NCT03179345|11927612|FG002|Received Gralise®|Overall Study||7
10764270|NCT03179345|11927613|FG003|Received Gralise®|Overall Study||6
10764271|NCT03179345|11927610|FG000|Received Neurontin®|Overall Study||8
10764272|NCT03179345|11927611|FG001|Received Neurontin®|Overall Study||8
10764273|NCT03179345|11927612|FG002|Received Neurontin®|Overall Study||7
10764274|NCT03179345|11927613|FG003|Received Neurontin®|Overall Study||8
10764275|NCT03179345|11927610|FG000|Received Lyrica®|Overall Study||8
10764276|NCT03179345|11927611|FG001|Received Lyrica®|Overall Study||7
10764277|NCT03179345|11927612|FG002|Received Lyrica®|Overall Study||8
10764278|NCT03179345|11927613|FG003|Received Lyrica®|Overall Study||8
10764279|NCT03179345|11927610|FG000|Received Placebo|Overall Study||8
10764280|NCT03179345|11927611|FG001|Received Placebo|Overall Study||7
10764281|NCT03179345|11927612|FG002|Received Placebo|Overall Study||7
10764282|NCT03179345|11927613|FG003|Received Placebo|Overall Study||8
10764283|NCT03179345|11927610|FG000|COMPLETED|Overall Study||8
10764284|NCT03179345|11927611|FG001|COMPLETED|Overall Study||7
10764285|NCT03179345|11927612|FG002|COMPLETED|Overall Study||7
10764286|NCT03179345|11927613|FG003|COMPLETED|Overall Study||6
10764287|NCT03179345|11927610|FG000|NOT COMPLETED|Overall Study||0
10764288|NCT03179345|11927611|FG001|NOT COMPLETED|Overall Study||1
10764289|NCT03179345|11927612|FG002|NOT COMPLETED|Overall Study||1
10764290|NCT03179345|11927613|FG003|NOT COMPLETED|Overall Study||2
10764291|NCT03179410|11927629|FG000|STARTED|Overall Study||15
10764292|NCT03179410|11927629|FG000|COMPLETED|Overall Study||15
10764293|NCT03179410|11927629|FG000|NOT COMPLETED|Overall Study||0
10764294|NCT03179787|11927633|FG000|STARTED|Overall Study||528
10764295|NCT03179787|11927633|FG000|COMPLETED|Overall Study||510
10764296|NCT03179787|11927633|FG000|NOT COMPLETED|Overall Study||18
10764297|NCT03179891|11927637|FG000|STARTED|First Intervention||13
10764298|NCT03179891|11927638|FG001|STARTED|First Intervention||22
10764299|NCT03179891|11927637|FG000|COMPLETED|First Intervention||11
10764300|NCT03179891|11927638|FG001|COMPLETED|First Intervention||20
10764301|NCT03179891|11927637|FG000|NOT COMPLETED|First Intervention||2
10764302|NCT03179891|11927638|FG001|NOT COMPLETED|First Intervention||2
10764303|NCT03179891|11927637|FG000|STARTED|Second Intervention (After 14 Days)||11
10764304|NCT03179891|11927638|FG001|STARTED|Second Intervention (After 14 Days)||20
10764305|NCT03179891|11927637|FG000|COMPLETED|Second Intervention (After 14 Days)||11
10764306|NCT03179891|11927638|FG001|COMPLETED|Second Intervention (After 14 Days)||20
10764307|NCT03179891|11927637|FG000|NOT COMPLETED|Second Intervention (After 14 Days)||0
10764308|NCT03179891|11927638|FG001|NOT COMPLETED|Second Intervention (After 14 Days)||0
10764309|NCT03180138|11927650|FG000|STARTED|Overall Study||204
10764310|NCT03180138|11927651|FG001|STARTED|Overall Study||201
10764311|NCT03180138|11927652|FG002|STARTED|Overall Study||203
10764312|NCT03180138|11927650|FG000|COMPLETED|Overall Study||182
10764313|NCT03180138|11927651|FG001|COMPLETED|Overall Study||188
10764314|NCT03180138|11927652|FG002|COMPLETED|Overall Study||179
10764315|NCT03180138|11927650|FG000|NOT COMPLETED|Overall Study||22
10764316|NCT03180138|11927651|FG001|NOT COMPLETED|Overall Study||13
10764317|NCT03180138|11927652|FG002|NOT COMPLETED|Overall Study||24
10764318|NCT03180385|11927662|FG000|STARTED|Overall Study||0
10764319|NCT03180385|11927663|FG001|STARTED|Overall Study||2
10764320|NCT03180385|11927662|FG000|COMPLETED|Overall Study||0
10764321|NCT03180385|11927663|FG001|COMPLETED|Overall Study||2
10764322|NCT03180385|11927662|FG000|NOT COMPLETED|Overall Study||0
10764323|NCT03180385|11927663|FG001|NOT COMPLETED|Overall Study||0
10764324|NCT03180489|11927671|FG000|STARTED|Overall Study||33
10764325|NCT03180489|11927672|FG001|STARTED|Overall Study||29
10764326|NCT03180489|11927671|FG000|COMPLETED|Overall Study||25
10764327|NCT03180489|11927672|FG001|COMPLETED|Overall Study||25
10764328|NCT03180489|11927671|FG000|NOT COMPLETED|Overall Study||8
10764329|NCT03180489|11927672|FG001|NOT COMPLETED|Overall Study||4
10764330|NCT03180515|11927678|FG000|STARTED|Aim 1||12
10764331|NCT03180515|11927678|FG000|COMPLETED|Aim 1||12
10764332|NCT03180515|11927678|FG000|NOT COMPLETED|Aim 1||0
10764333|NCT03180515|11927678|FG000|STARTED|Aim 2||12
10764334|NCT03180515|11927678|FG000|COMPLETED|Aim 2||12
10764335|NCT03180515|11927678|FG000|NOT COMPLETED|Aim 2||0
10764336|NCT03180515|11927678|FG000|STARTED|Aim 3||1
10764337|NCT03180515|11927678|FG000|COMPLETED|Aim 3||1
10764338|NCT03180515|11927678|FG000|NOT COMPLETED|Aim 3||0
10764339|NCT03180528|11927694|FG000|STARTED|Overall Study||30
10764340|NCT03180528|11927694|FG000|COMPLETED|Overall Study||27
10764341|NCT03180528|11927694|FG000|NOT COMPLETED|Overall Study||3
10764342|NCT03180619|11927701|FG000|STARTED|Overall Study||78
10764343|NCT03180619|11927702|FG001|STARTED|Overall Study||15
10764344|NCT03180619|11927703|FG002|STARTED|Overall Study||31
10764345|NCT03180619|11927701|FG000|COMPLETED|Overall Study||67
10764346|NCT03180619|11927702|FG001|COMPLETED|Overall Study||14
10764347|NCT03180619|11927703|FG002|COMPLETED|Overall Study||25
10764348|NCT03180619|11927701|FG000|NOT COMPLETED|Overall Study||11
10764349|NCT03180619|11927702|FG001|NOT COMPLETED|Overall Study||1
10764350|NCT03180619|11927703|FG002|NOT COMPLETED|Overall Study||6
10779054|NCT03363906|11940824|FG001|COMPLETED|Period 2 (Test or Reference)||9
10779055|NCT03363906|11940823|FG000|NOT COMPLETED|Period 2 (Test or Reference)||4
10779056|NCT03363906|11940824|FG001|NOT COMPLETED|Period 2 (Test or Reference)||1
10779057|NCT03364023|11940830|FG000|STARTED|Overall Study||183
10779058|NCT03364023|11940830|FG000|COMPLETED|Overall Study||166
10779059|NCT03364023|11940830|FG000|NOT COMPLETED|Overall Study||17
10779060|NCT03364049|11940838|FG000|STARTED|Overall Study||6
10779061|NCT03364049|11940839|FG001|STARTED|Overall Study||6
10779062|NCT03364049|11940840|FG002|STARTED|Overall Study||6
10779063|NCT03364049|11940841|FG003|STARTED|Overall Study||15
10779064|NCT03364049|11940838|FG000|COMPLETED|Overall Study||0
10779065|NCT03364049|11940839|FG001|COMPLETED|Overall Study||0
10779066|NCT03364049|11940840|FG002|COMPLETED|Overall Study||0
10779067|NCT03364049|11940841|FG003|COMPLETED|Overall Study||0
10779068|NCT03364049|11940838|FG000|NOT COMPLETED|Overall Study||6
10779069|NCT03364049|11940839|FG001|NOT COMPLETED|Overall Study||6
10779070|NCT03364049|11940840|FG002|NOT COMPLETED|Overall Study||6
10779071|NCT03364049|11940841|FG003|NOT COMPLETED|Overall Study||15
10779072|NCT03364192|11940851|FG000|STARTED|Overall Study||28
10421635|NCT00820170|11566484|FG003|COMPLETED|Overall Study||40
10421636|NCT00820170|11566485|FG004|COMPLETED|Overall Study||0
10779073|NCT03364192|11940851|FG000|COMPLETED|Overall Study||12
10779074|NCT03364192|11940851|FG000|NOT COMPLETED|Overall Study||16
10779075|NCT03364309|11940859|FG000|STARTED|Induction Period||88
10779076|NCT03364309|11940860|FG001|STARTED|Induction Period||174
10779077|NCT03364309|11940861|FG002|STARTED|Induction Period||176
10779078|NCT03364309|11940862|FG003|STARTED|Induction Period||0
10779079|NCT03364309|11940863|FG004|STARTED|Induction Period||0
10779080|NCT03364309|11940864|FG005|STARTED|Induction Period||0
10779081|NCT03364309|11940865|FG006|STARTED|Induction Period||0
10779082|NCT03364309|11940866|FG007|STARTED|Induction Period||0
10779083|NCT03364309|11940867|FG008|STARTED|Induction Period||0
10779084|NCT03364309|11940868|FG009|STARTED|Induction Period||0
10779085|NCT03364309|11940869|FG010|STARTED|Induction Period||0
10779086|NCT03364309|11940870|FG011|STARTED|Induction Period||0
10764351|NCT05091047|11927718|FG000|STARTED|Overall Study||8
10764352|NCT05091047|11927718|FG000|COMPLETED|Overall Study||8
10764353|NCT05091047|11927718|FG000|NOT COMPLETED|Overall Study||0
10764360|NCT04450108|11927733|FG000|STARTED|Overall Study||122
10764361|NCT04450108|11927733|FG000|COMPLETED|Overall Study||120
10764362|NCT04450108|11927733|FG000|NOT COMPLETED|Overall Study||2
10764363|NCT04448756|11927740|FG000|STARTED|Overall Study||49
10764364|NCT04448756|11927741|FG001|STARTED|Overall Study||54
10764365|NCT04448756|11927742|FG002|STARTED|Overall Study||46
10764366|NCT04448756|11927740|FG000|COMPLETED|Overall Study||46
10764367|NCT04448756|11927741|FG001|COMPLETED|Overall Study||49
10764368|NCT04448756|11927742|FG002|COMPLETED|Overall Study||45
10764369|NCT04448756|11927740|FG000|NOT COMPLETED|Overall Study||3
10764370|NCT04448756|11927741|FG001|NOT COMPLETED|Overall Study||5
10764371|NCT04448756|11927742|FG002|NOT COMPLETED|Overall Study||1
10764372|NCT04397718|11927752|FG000|STARTED|Overall Study||34
10764373|NCT04397718|11927753|FG001|STARTED|Overall Study||62
10764374|NCT04397718|11927752|FG000|COMPLETED|Overall Study||27
10764375|NCT04397718|11927753|FG001|COMPLETED|Overall Study||47
10764376|NCT04397718|11927752|FG000|NOT COMPLETED|Overall Study||7
10764377|NCT04397718|11927753|FG001|NOT COMPLETED|Overall Study||15
10764378|NCT04352127|11927762|FG000|STARTED|Overall Study||29
10764379|NCT04352127|11927763|FG001|STARTED|Overall Study||26
10764380|NCT04352127|11927764|FG002|STARTED|Overall Study||50
10764381|NCT04352127|11927762|FG000|COMPLETED|Overall Study||25
10764382|NCT04352127|11927763|FG001|COMPLETED|Overall Study||25
10764383|NCT04352127|11927764|FG002|COMPLETED|Overall Study||50
10764384|NCT04352127|11927762|FG000|NOT COMPLETED|Overall Study||4
10764385|NCT04352127|11927763|FG001|NOT COMPLETED|Overall Study||1
10764386|NCT04352127|11927764|FG002|NOT COMPLETED|Overall Study||0
10764387|NCT04253756|11927772|FG000|STARTED|Overall Study||26
10764388|NCT04253756|11927772|FG000|Procedure 1: 18 Guage|Overall Study||12
10764389|NCT04253756|11927772|FG000|Procedure 1: 20 Gauge|Overall Study||14
10764390|NCT04253756|11927772|FG000|Procedure 2: 18 Gauge|Overall Study||9
10764391|NCT04253756|11927772|FG000|Procedure 2: 20 Gauge|Overall Study||7
10764392|NCT04253756|11927772|FG000|Procedure 3: 18 Gauge|Overall Study||6
10764393|NCT04253756|11927772|FG000|Procedure 3: 20 Gauge|Overall Study||5
10764394|NCT04253756|11927772|FG000|Procedure 4: 18 Gauge|Overall Study||5
10764395|NCT04253756|11927772|FG000|Procedure 4: 20 Gauge|Overall Study||3
10764396|NCT04253756|11927772|FG000|Procedure 5: 18 Gauge|Overall Study||2
10764397|NCT04253756|11927772|FG000|Procedure 5: 20 Gauge|Overall Study||3
10764398|NCT04253756|11927772|FG000|Procedure 6: 18 Gauge|Overall Study||1
10764399|NCT04253756|11927772|FG000|Procedure 6: 20 Gauge|Overall Study||2
10764400|NCT04253756|11927772|FG000|Procedure 7: 18 Gauge|Overall Study||1
10764401|NCT04253756|11927772|FG000|Procedure 7: 20 Gauge|Overall Study||1
10764402|NCT04253756|11927772|FG000|Procedure 8: 18 Gauge|Overall Study||0
10764403|NCT04253756|11927772|FG000|Procedure 8: 20 Gauge|Overall Study||2
10764404|NCT04253756|11927772|FG000|COMPLETED|Overall Study||21
10764405|NCT04253756|11927772|FG000|NOT COMPLETED|Overall Study||5
10764414|NCT03975920|11927790|FG000|STARTED|Overall Study|Due to inclusion criteria protocol deviation, data from 1 participant was not used in the analysis.|84
10764415|NCT03975920|11927791|FG001|STARTED|Overall Study|Due to inclusion criteria protocol deviation, data from 1 participant was not used in the analysis.|87
10764416|NCT03975920|11927790|FG000|1-Month Follow-up Survey|Overall Study||80
10764417|NCT03975920|11927791|FG001|1-Month Follow-up Survey|Overall Study||85
10764418|NCT03975920|11927790|FG000|3-Month Follow-up Survey|Overall Study||78
10764419|NCT03975920|11927791|FG001|3-Month Follow-up Survey|Overall Study||84
10764420|NCT03975920|11927790|FG000|6-Month Follow-up Survey|Overall Study||80
10764421|NCT03975920|11927791|FG001|6-Month Follow-up Survey|Overall Study||83
10764422|NCT03975920|11927790|FG000|COMPLETED|Overall Study||80
10764423|NCT03975920|11927791|FG001|COMPLETED|Overall Study||83
10764424|NCT03975920|11927790|FG000|NOT COMPLETED|Overall Study||4
10764425|NCT03975920|11927791|FG001|NOT COMPLETED|Overall Study||4
10764432|NCT03746483|11927809|FG000|STARTED|Overall Study||21
10764433|NCT03746483|11927810|FG001|STARTED|Overall Study||20
10764434|NCT03746483|11927809|FG000|COMPLETED|Overall Study||15
10764435|NCT03746483|11927810|FG001|COMPLETED|Overall Study||17
10764436|NCT03746483|11927809|FG000|NOT COMPLETED|Overall Study||6
10764437|NCT03746483|11927810|FG001|NOT COMPLETED|Overall Study||3
10764438|NCT03717155|11927818|FG000|STARTED|Overall Study||43
10764439|NCT03717155|11927818|FG000|COMPLETED|Overall Study||43
10764440|NCT03717155|11927818|FG000|NOT COMPLETED|Overall Study||0
10764441|NCT03694327|11927824|FG000|STARTED|Overall Study||79
10764442|NCT03694327|11927825|FG001|STARTED|Overall Study||79
10764443|NCT03694327|11927824|FG000|COMPLETED|Overall Study||66
10764354|NCT04957498|11927724|FG000|STARTED|Overall Study||20
10764355|NCT04957498|11927725|FG001|STARTED|Overall Study||20
10764356|NCT04957498|11927724|FG000|COMPLETED|Overall Study||19
10764357|NCT04957498|11927725|FG001|COMPLETED|Overall Study||18
10764358|NCT04957498|11927724|FG000|NOT COMPLETED|Overall Study||1
10764359|NCT04957498|11927725|FG001|NOT COMPLETED|Overall Study||2
10764444|NCT03694327|11927825|FG001|COMPLETED|Overall Study||56
10764445|NCT03694327|11927824|FG000|NOT COMPLETED|Overall Study||13
10764446|NCT03694327|11927825|FG001|NOT COMPLETED|Overall Study||23
10764447|NCT03624036|11927835|FG000|STARTED|Overall Study||7
10764448|NCT03624036|11927836|FG001|STARTED|Overall Study||3
10764449|NCT03624036|11927837|FG002|STARTED|Overall Study||3
10764450|NCT03624036|11927838|FG003|STARTED|Overall Study||3
10764451|NCT03624036|11927835|FG000|COMPLETED|Overall Study||0
10764452|NCT03624036|11927836|FG001|COMPLETED|Overall Study||0
10764453|NCT03624036|11927837|FG002|COMPLETED|Overall Study||0
10764454|NCT03624036|11927838|FG003|COMPLETED|Overall Study||0
10764455|NCT03624036|11927835|FG000|NOT COMPLETED|Overall Study||7
10764456|NCT03624036|11927836|FG001|NOT COMPLETED|Overall Study||3
10764457|NCT03624036|11927837|FG002|NOT COMPLETED|Overall Study||3
10764458|NCT03624036|11927838|FG003|NOT COMPLETED|Overall Study||3
10764459|NCT03137160|11927848|FG000|STARTED|Overall Study||4
10764460|NCT03137160|11927848|FG000|COMPLETED|Overall Study||2
10764461|NCT03137160|11927848|FG000|NOT COMPLETED|Overall Study||2
10764462|NCT03057951|11927854|FG000|STARTED|Overall Study||2991
10764463|NCT03057951|11927855|FG001|STARTED|Overall Study||2997
10764464|NCT03057951|11927854|FG000|Treated|Overall Study||2989
10764465|NCT03057951|11927855|FG001|Treated|Overall Study||2996
10764466|NCT03057951|11927854|FG000|COMPLETED|Overall Study||2046
10764467|NCT03057951|11927855|FG001|COMPLETED|Overall Study||2051
10764468|NCT03057951|11927854|FG000|NOT COMPLETED|Overall Study||945
10764469|NCT03057951|11927855|FG001|NOT COMPLETED|Overall Study||946
10764470|NCT03007888|11927861|FG000|STARTED|First Intervention (14 Days)||15
10764471|NCT03007888|11927862|FG001|STARTED|First Intervention (14 Days)||13
10764472|NCT03007888|11927861|FG000|COMPLETED|First Intervention (14 Days)||14
10764473|NCT03007888|11927862|FG001|COMPLETED|First Intervention (14 Days)||13
10764474|NCT03007888|11927861|FG000|NOT COMPLETED|First Intervention (14 Days)||1
10764475|NCT03007888|11927862|FG001|NOT COMPLETED|First Intervention (14 Days)||0
10764476|NCT03007888|11927861|FG000|STARTED|Washout (7 Days)||14
10764477|NCT03007888|11927862|FG001|STARTED|Washout (7 Days)||13
10764478|NCT03007888|11927861|FG000|COMPLETED|Washout (7 Days)||14
10764479|NCT03007888|11927862|FG001|COMPLETED|Washout (7 Days)||13
10764480|NCT03007888|11927861|FG000|NOT COMPLETED|Washout (7 Days)||0
10764481|NCT03007888|11927862|FG001|NOT COMPLETED|Washout (7 Days)||0
10764482|NCT03007888|11927861|FG000|STARTED|Second Interventions (14 Days)||14
10764483|NCT03007888|11927862|FG001|STARTED|Second Interventions (14 Days)||13
10764484|NCT03007888|11927861|FG000|COMPLETED|Second Interventions (14 Days)||14
10764485|NCT03007888|11927862|FG001|COMPLETED|Second Interventions (14 Days)||13
10764486|NCT03007888|11927861|FG000|NOT COMPLETED|Second Interventions (14 Days)||0
10764487|NCT03007888|11927862|FG001|NOT COMPLETED|Second Interventions (14 Days)||0
10764488|NCT02971033|11927874|FG000|STARTED|Overall Study||1
10764489|NCT02971033|11927875|FG001|STARTED|Overall Study||1
10764490|NCT02971033|11927876|FG002|STARTED|Overall Study||0
10764491|NCT02971033|11927874|FG000|COMPLETED|Overall Study||1
10764492|NCT02971033|11927875|FG001|COMPLETED|Overall Study||1
10764493|NCT02971033|11927876|FG002|COMPLETED|Overall Study||0
10764494|NCT02971033|11927874|FG000|NOT COMPLETED|Overall Study||0
10764495|NCT02971033|11927875|FG001|NOT COMPLETED|Overall Study||0
10764496|NCT02971033|11927876|FG002|NOT COMPLETED|Overall Study||0
10764500|NCT02949934|11927894|FG000|STARTED|Natural Drinking Period||16
10764501|NCT02949934|11927895|FG001|STARTED|Natural Drinking Period||12
10764502|NCT02949934|11927896|FG002|STARTED|Natural Drinking Period||17
10764503|NCT02949934|11927897|FG003|STARTED|Natural Drinking Period||16
10764504|NCT02949934|11927898|FG004|STARTED|Natural Drinking Period||15
10764505|NCT02949934|11927899|FG005|STARTED|Natural Drinking Period||14
10764506|NCT02949934|11927894|FG000|COMPLETED|Natural Drinking Period||15
10764507|NCT02949934|11927895|FG001|COMPLETED|Natural Drinking Period||12
10764508|NCT02949934|11927896|FG002|COMPLETED|Natural Drinking Period||17
10764509|NCT02949934|11927897|FG003|COMPLETED|Natural Drinking Period||15
10764510|NCT02949934|11927898|FG004|COMPLETED|Natural Drinking Period||14
10764511|NCT02949934|11927899|FG005|COMPLETED|Natural Drinking Period||14
10764512|NCT02949934|11927894|FG000|NOT COMPLETED|Natural Drinking Period||1
10764513|NCT02949934|11927895|FG001|NOT COMPLETED|Natural Drinking Period||0
10764514|NCT02949934|11927896|FG002|NOT COMPLETED|Natural Drinking Period||0
10764515|NCT02949934|11927897|FG003|NOT COMPLETED|Natural Drinking Period||1
10764516|NCT02949934|11927898|FG004|NOT COMPLETED|Natural Drinking Period||1
10764517|NCT02949934|11927899|FG005|NOT COMPLETED|Natural Drinking Period||0
10764518|NCT02949934|11927894|FG000|STARTED|Neuroimaging||15
10764519|NCT02949934|11927895|FG001|STARTED|Neuroimaging||12
10764520|NCT02949934|11927896|FG002|STARTED|Neuroimaging||17
10764521|NCT02949934|11927897|FG003|STARTED|Neuroimaging||15
10764522|NCT02949934|11927898|FG004|STARTED|Neuroimaging||14
10764523|NCT02949934|11927899|FG005|STARTED|Neuroimaging||14
10764524|NCT02949934|11927894|FG000|COMPLETED|Neuroimaging||12
10764525|NCT02949934|11927895|FG001|COMPLETED|Neuroimaging||12
10764526|NCT02949934|11927896|FG002|COMPLETED|Neuroimaging||15
10764527|NCT02949934|11927897|FG003|COMPLETED|Neuroimaging||15
10764528|NCT02949934|11927898|FG004|COMPLETED|Neuroimaging||12
10764529|NCT02949934|11927899|FG005|COMPLETED|Neuroimaging||12
10764530|NCT02949934|11927894|FG000|NOT COMPLETED|Neuroimaging||3
10764531|NCT02949934|11927895|FG001|NOT COMPLETED|Neuroimaging||0
10764532|NCT02949934|11927896|FG002|NOT COMPLETED|Neuroimaging||2
10764533|NCT02949934|11927897|FG003|NOT COMPLETED|Neuroimaging||0
10764534|NCT02949934|11927898|FG004|NOT COMPLETED|Neuroimaging||2
10764535|NCT02949934|11927899|FG005|NOT COMPLETED|Neuroimaging||2
10764536|NCT02949934|11927894|FG000|STARTED|Bar Laboratory||13
10764537|NCT02949934|11927895|FG001|STARTED|Bar Laboratory||12
10764538|NCT02949934|11927896|FG002|STARTED|Bar Laboratory||17
10764539|NCT02949934|11927897|FG003|STARTED|Bar Laboratory||15
10764540|NCT02949934|11927898|FG004|STARTED|Bar Laboratory||13
10764541|NCT02949934|11927899|FG005|STARTED|Bar Laboratory||14
10764542|NCT02949934|11927894|FG000|COMPLETED|Bar Laboratory||12
10764543|NCT02949934|11927895|FG001|COMPLETED|Bar Laboratory||7
10764544|NCT02949934|11927896|FG002|COMPLETED|Bar Laboratory||10
10764545|NCT02949934|11927897|FG003|COMPLETED|Bar Laboratory||11
10764546|NCT02949934|11927898|FG004|COMPLETED|Bar Laboratory||7
10764547|NCT02949934|11927899|FG005|COMPLETED|Bar Laboratory||13
10764548|NCT02949934|11927894|FG000|NOT COMPLETED|Bar Laboratory||1
10764549|NCT02949934|11927895|FG001|NOT COMPLETED|Bar Laboratory||5
10764550|NCT02949934|11927896|FG002|NOT COMPLETED|Bar Laboratory||7
10764551|NCT02949934|11927897|FG003|NOT COMPLETED|Bar Laboratory||4
10764552|NCT02949934|11927898|FG004|NOT COMPLETED|Bar Laboratory||6
10764553|NCT02949934|11927899|FG005|NOT COMPLETED|Bar Laboratory||1
10764554|NCT02796001|11927916|FG000|STARTED|Overall Study||20
10764555|NCT02796001|11927917|FG001|STARTED|Overall Study||22
10764556|NCT02796001|11927918|FG002|STARTED|Overall Study||4
10764557|NCT02796001|11927916|FG000|COMPLETED|Overall Study||20
10764558|NCT02796001|11927917|FG001|COMPLETED|Overall Study||22
10764559|NCT02796001|11927918|FG002|COMPLETED|Overall Study||4
10764560|NCT02796001|11927916|FG000|NOT COMPLETED|Overall Study||0
10764561|NCT02796001|11927917|FG001|NOT COMPLETED|Overall Study||0
10764562|NCT02796001|11927918|FG002|NOT COMPLETED|Overall Study||0
10764563|NCT02658656|11927927|FG000|STARTED|Screening||78
10764564|NCT02658656|11927928|FG001|STARTED|Screening||83
10764565|NCT02658656|11927929|FG002|STARTED|Screening||263
10764566|NCT02658656|11927927|FG000|COMPLETED|Screening||78
10764567|NCT02658656|11927928|FG001|COMPLETED|Screening||83
10764568|NCT02658656|11927929|FG002|COMPLETED|Screening||0
10764569|NCT02658656|11927927|FG000|NOT COMPLETED|Screening||0
10764570|NCT02658656|11927928|FG001|NOT COMPLETED|Screening||0
10764571|NCT02658656|11927929|FG002|NOT COMPLETED|Screening||263
10764572|NCT02658656|11927927|FG000|STARTED|Randomization||78
10764573|NCT02658656|11927928|FG001|STARTED|Randomization||83
10764574|NCT02658656|11927929|FG002|STARTED|Randomization||0
10764575|NCT02658656|11927927|FG000|COMPLETED|Randomization||45
10764576|NCT02658656|11927928|FG001|COMPLETED|Randomization||57
10764577|NCT02658656|11927929|FG002|COMPLETED|Randomization||0
10764578|NCT02658656|11927927|FG000|NOT COMPLETED|Randomization||33
10764579|NCT02658656|11927928|FG001|NOT COMPLETED|Randomization||26
10764580|NCT02658656|11927929|FG002|NOT COMPLETED|Randomization||0
10764581|NCT02536170|11927939|FG000|STARTED|Overall Study||36
10764582|NCT02536170|11927940|FG001|STARTED|Overall Study||36
10764583|NCT02536170|11927941|FG002|STARTED|Overall Study||36
10764584|NCT02536170|11927939|FG000|COMPLETED|Overall Study||36
10764585|NCT02536170|11927940|FG001|COMPLETED|Overall Study||36
10764586|NCT02536170|11927941|FG002|COMPLETED|Overall Study||36
10764587|NCT02536170|11927939|FG000|NOT COMPLETED|Overall Study||0
10764588|NCT02536170|11927940|FG001|NOT COMPLETED|Overall Study||0
10764589|NCT02536170|11927941|FG002|NOT COMPLETED|Overall Study||0
10779087|NCT03364309|11940871|FG012|STARTED|Induction Period||0
10779088|NCT03364309|11940872|FG013|STARTED|Induction Period||0
10779089|NCT03364309|11940873|FG014|STARTED|Induction Period||0
10779090|NCT03364309|11940874|FG015|STARTED|Induction Period||0
10779091|NCT03364309|11940875|FG016|STARTED|Induction Period||0
10779092|NCT03364309|11940876|FG017|STARTED|Induction Period||0
10779093|NCT03364309|11940877|FG018|STARTED|Induction Period||0
10779094|NCT03364309|11940859|FG000|Received at Least One Dose of Study Drug|Induction Period||88
10779095|NCT03364309|11940860|FG001|Received at Least One Dose of Study Drug|Induction Period||174
10779096|NCT03364309|11940861|FG002|Received at Least One Dose of Study Drug|Induction Period||176
10779097|NCT03364309|11940862|FG003|Received at Least One Dose of Study Drug|Induction Period||0
10779098|NCT03364309|11940863|FG004|Received at Least One Dose of Study Drug|Induction Period||0
10779099|NCT03364309|11940864|FG005|Received at Least One Dose of Study Drug|Induction Period||0
10779100|NCT03364309|11940865|FG006|Received at Least One Dose of Study Drug|Induction Period||0
10779101|NCT03364309|11940866|FG007|Received at Least One Dose of Study Drug|Induction Period||0
10779102|NCT03364309|11940867|FG008|Received at Least One Dose of Study Drug|Induction Period||0
10779103|NCT03364309|11940868|FG009|Received at Least One Dose of Study Drug|Induction Period||0
10779104|NCT03364309|11940869|FG010|Received at Least One Dose of Study Drug|Induction Period||0
10779105|NCT03364309|11940870|FG011|Received at Least One Dose of Study Drug|Induction Period||0
10779106|NCT03364309|11940871|FG012|Received at Least One Dose of Study Drug|Induction Period||0
10779107|NCT03364309|11940872|FG013|Received at Least One Dose of Study Drug|Induction Period||0
10779108|NCT03364309|11940873|FG014|Received at Least One Dose of Study Drug|Induction Period||0
10779109|NCT03364309|11940874|FG015|Received at Least One Dose of Study Drug|Induction Period||0
10779110|NCT03364309|11940875|FG016|Received at Least One Dose of Study Drug|Induction Period||0
10779111|NCT03364309|11940876|FG017|Received at Least One Dose of Study Drug|Induction Period||0
10297328|NCT00276016|11429915|FG003|STARTED|Wash Out 1||6
10297329|NCT00276016|11429916|FG004|STARTED|Wash Out 1||6
10297330|NCT00276016|11429917|FG005|STARTED|Wash Out 1||6
10297331|NCT00276016|11429912|FG000|COMPLETED|Wash Out 1||7
10297332|NCT00276016|11429913|FG001|COMPLETED|Wash Out 1||6
10297333|NCT00276016|11429914|FG002|COMPLETED|Wash Out 1||7
10297334|NCT00276016|11429915|FG003|COMPLETED|Wash Out 1||6
10297335|NCT00276016|11429916|FG004|COMPLETED|Wash Out 1||6
10297336|NCT00276016|11429917|FG005|COMPLETED|Wash Out 1||6
10297337|NCT00276016|11429912|FG000|NOT COMPLETED|Wash Out 1||0
10297338|NCT00276016|11429913|FG001|NOT COMPLETED|Wash Out 1||0
10297339|NCT00276016|11429914|FG002|NOT COMPLETED|Wash Out 1||0
10297340|NCT00276016|11429915|FG003|NOT COMPLETED|Wash Out 1||0
10297341|NCT00276016|11429916|FG004|NOT COMPLETED|Wash Out 1||0
10297342|NCT00276016|11429917|FG005|NOT COMPLETED|Wash Out 1||0
10297343|NCT00276016|11429912|FG000|STARTED|Intervention 2||7
10297344|NCT00276016|11429913|FG001|STARTED|Intervention 2||6
10297345|NCT00276016|11429914|FG002|STARTED|Intervention 2||7
10297346|NCT00276016|11429915|FG003|STARTED|Intervention 2||6
10297347|NCT00276016|11429916|FG004|STARTED|Intervention 2||6
10297348|NCT00276016|11429917|FG005|STARTED|Intervention 2||6
10297349|NCT00276016|11429912|FG000|COMPLETED|Intervention 2||7
10297350|NCT00276016|11429913|FG001|COMPLETED|Intervention 2||6
10297351|NCT00276016|11429914|FG002|COMPLETED|Intervention 2||7
10297352|NCT00276016|11429915|FG003|COMPLETED|Intervention 2||6
10297353|NCT00276016|11429916|FG004|COMPLETED|Intervention 2||6
10297354|NCT00276016|11429917|FG005|COMPLETED|Intervention 2||6
10297355|NCT00276016|11429912|FG000|NOT COMPLETED|Intervention 2||0
10297356|NCT00276016|11429913|FG001|NOT COMPLETED|Intervention 2||0
10297357|NCT00276016|11429914|FG002|NOT COMPLETED|Intervention 2||0
10297358|NCT00276016|11429915|FG003|NOT COMPLETED|Intervention 2||0
10297359|NCT00276016|11429916|FG004|NOT COMPLETED|Intervention 2||0
10297360|NCT00276016|11429917|FG005|NOT COMPLETED|Intervention 2||0
10764596|NCT01801189|11927976|FG000|STARTED|Overall Study||28
10764597|NCT01801189|11927977|FG001|STARTED|Overall Study||33
10764598|NCT01801189|11927976|FG000|COMPLETED|Overall Study||28
10764599|NCT01801189|11927977|FG001|COMPLETED|Overall Study||33
10764600|NCT01801189|11927976|FG000|NOT COMPLETED|Overall Study||0
10764601|NCT01801189|11927977|FG001|NOT COMPLETED|Overall Study||0
10764602|NCT01667081|11927985|FG000|STARTED|Overall Study||1909
10764603|NCT01667081|11927986|FG001|STARTED|Overall Study||526
10764604|NCT01667081|11927985|FG000|COMPLETED|Overall Study||132
10764605|NCT01667081|11927986|FG001|COMPLETED|Overall Study||169
10764606|NCT01667081|11927985|FG000|NOT COMPLETED|Overall Study||1777
10764607|NCT01667081|11927986|FG001|NOT COMPLETED|Overall Study||357
10764613|NCT00634504|11928010|FG000|STARTED|Overall Study||11
10764614|NCT00634504|11928011|FG001|STARTED|Overall Study||9
10764615|NCT00634504|11928010|FG000|COMPLETED|Overall Study||10
10764616|NCT00634504|11928011|FG001|COMPLETED|Overall Study||9
10764617|NCT00634504|11928010|FG000|NOT COMPLETED|Overall Study||1
10764618|NCT00634504|11928011|FG001|NOT COMPLETED|Overall Study||0
10764619|NCT00392821|11928020|FG000|STARTED|Overall Study||3
10764620|NCT00392821|11928021|FG001|STARTED|Overall Study||6
10764621|NCT00392821|11928022|FG002|STARTED|Overall Study||69
10764622|NCT00392821|11928020|FG000|COMPLETED|Overall Study||0
10764623|NCT00392821|11928021|FG001|COMPLETED|Overall Study||0
10764624|NCT00392821|11928022|FG002|COMPLETED|Overall Study||0
10764625|NCT00392821|11928020|FG000|NOT COMPLETED|Overall Study||3
10764626|NCT00392821|11928021|FG001|NOT COMPLETED|Overall Study||6
10764627|NCT00392821|11928022|FG002|NOT COMPLETED|Overall Study||69
10764628|NCT00352027|11928028|FG000|STARTED|Overall Study||80
10764629|NCT00352027|11928028|FG000|COMPLETED|Overall Study||77
10764630|NCT00352027|11928028|FG000|NOT COMPLETED|Overall Study||3
10764631|NCT00104676|11928056|FG000|STARTED|Overall Study||98
10764632|NCT00104676|11928057|FG001|STARTED|Overall Study||105
10764633|NCT00104676|11928056|FG000|COMPLETED|Overall Study||91
10764634|NCT00104676|11928057|FG001|COMPLETED|Overall Study||91
10764635|NCT00104676|11928056|FG000|NOT COMPLETED|Overall Study||7
10764636|NCT00104676|11928057|FG001|NOT COMPLETED|Overall Study||14
10779112|NCT03364309|11940877|FG018|Received at Least One Dose of Study Drug|Induction Period||0
10779113|NCT03364309|11940859|FG000|COMPLETED|Induction Period||82
10779114|NCT03364309|11940860|FG001|COMPLETED|Induction Period||170
10764637|NCT04426500|11928066|FG000|STARTED|Overall Study||28
10764638|NCT04426500|11928067|FG001|STARTED|Overall Study||64
10764639|NCT04426500|11928068|FG002|STARTED|Overall Study||56
10764640|NCT04426500|11928066|FG000|COMPLETED|Overall Study||28
10764641|NCT04426500|11928067|FG001|COMPLETED|Overall Study||64
10764642|NCT04426500|11928068|FG002|COMPLETED|Overall Study||56
10764643|NCT04426500|11928066|FG000|NOT COMPLETED|Overall Study||0
10764644|NCT04426500|11928067|FG001|NOT COMPLETED|Overall Study||0
10764645|NCT04426500|11928068|FG002|NOT COMPLETED|Overall Study||0
10764646|NCT04042103|11928076|FG000|STARTED|Overall Study||21
10764647|NCT04042103|11928076|FG000|COMPLETED|Overall Study||19
10764648|NCT04042103|11928076|FG000|NOT COMPLETED|Overall Study||2
10764649|NCT04004208|11928082|FG000|STARTED|Overall Study||75
10764650|NCT04004208|11928083|FG001|STARTED|Overall Study||38
10764651|NCT04004208|11928082|FG000|SAF|Overall Study||75
10764652|NCT04004208|11928083|FG001|SAF|Overall Study||38
10764653|NCT04004208|11928082|FG000|PKS|Overall Study||75
10764654|NCT04004208|11928083|FG001|PKS|Overall Study||0
10764655|NCT04004208|11928082|FG000|AAS|Overall Study||75
10764656|NCT04004208|11928083|FG001|AAS|Overall Study||0
10764657|NCT04004208|11928082|FG000|COMPLETED|Overall Study||68
10764658|NCT04004208|11928083|FG001|COMPLETED|Overall Study||36
10764659|NCT04004208|11928082|FG000|NOT COMPLETED|Overall Study||7
10764660|NCT04004208|11928083|FG001|NOT COMPLETED|Overall Study||2
10764661|NCT03817190|11928091|FG000|STARTED|Overall Study||110
10764662|NCT03817190|11928092|FG001|STARTED|Overall Study||109
10764663|NCT03817190|11928091|FG000|COMPLETED|Overall Study||50
10764664|NCT03817190|11928092|FG001|COMPLETED|Overall Study||50
10764665|NCT03817190|11928091|FG000|NOT COMPLETED|Overall Study||60
10764666|NCT03817190|11928092|FG001|NOT COMPLETED|Overall Study||59
10764667|NCT03447782|11928098|FG000|STARTED|Overall Study||45
10764668|NCT03447782|11928098|FG000|COMPLETED|Overall Study||25
10764669|NCT03447782|11928098|FG000|NOT COMPLETED|Overall Study||20
10764670|NCT03041311|11928104|FG000|STARTED|Overall Study||54
10764671|NCT03041311|11928105|FG001|STARTED|Overall Study||53
10764672|NCT03041311|11928104|FG000|COMPLETED|Overall Study||0
10764673|NCT03041311|11928105|FG001|COMPLETED|Overall Study||0
10764674|NCT03041311|11928104|FG000|NOT COMPLETED|Overall Study||54
10764675|NCT03041311|11928105|FG001|NOT COMPLETED|Overall Study||53
10764676|NCT03020914|11928121|FG000|STARTED|Overall Study||10
10764677|NCT03020914|11928122|FG001|STARTED|Overall Study||9
10764678|NCT03020914|11928121|FG000|COMPLETED|Overall Study||9
10764679|NCT03020914|11928122|FG001|COMPLETED|Overall Study||9
10764680|NCT03020914|11928121|FG000|NOT COMPLETED|Overall Study||1
10764681|NCT03020914|11928122|FG001|NOT COMPLETED|Overall Study||0
10764682|NCT02803307|11928130|FG000|STARTED|Overall Study||20
10764683|NCT02803307|11928131|FG001|STARTED|Overall Study||20
10764684|NCT02803307|11928130|FG000|COMPLETED|Overall Study||20
10764685|NCT02803307|11928131|FG001|COMPLETED|Overall Study||20
10764686|NCT02803307|11928130|FG000|NOT COMPLETED|Overall Study||0
10764687|NCT02803307|11928131|FG001|NOT COMPLETED|Overall Study||0
10764688|NCT02698891|11928137|FG000|STARTED|Overall Study||127
10764689|NCT02698891|11928137|FG000|Treated|Overall Study||125
10764690|NCT02698891|11928137|FG000|COMPLETED|Overall Study||115
10764691|NCT02698891|11928137|FG000|NOT COMPLETED|Overall Study||12
10764692|NCT02537678|11928143|FG000|STARTED|Baseline to Post-treatment|91 parents/guardians and 91 children started.|91
10764693|NCT02537678|11928144|FG001|STARTED|Baseline to Post-treatment|92 parents/guardians and 92 children started.|92
10764694|NCT02537678|11928143|FG000|Completed Post-treatment|Baseline to Post-treatment|61 parents/guardians and 61 children completed post-treatment.|61
10764695|NCT02537678|11928144|FG001|Completed Post-treatment|Baseline to Post-treatment|71 parents/guardians and 71 children completed post-treatment.|71
10764696|NCT02537678|11928143|FG000|COMPLETED|Baseline to Post-treatment|61 parent/guardian-child dyads completed.|61
10764697|NCT02537678|11928144|FG001|COMPLETED|Baseline to Post-treatment|71 parent/guardian-child dyads completed.|71
10764698|NCT02537678|11928143|FG000|NOT COMPLETED|Baseline to Post-treatment||30
10764699|NCT02537678|11928144|FG001|NOT COMPLETED|Baseline to Post-treatment||21
10764700|NCT02537678|11928143|FG000|STARTED|Post-treatment to 6 Month Assessment|61 parents/guardians and 61 children started.|61
10764701|NCT02537678|11928144|FG001|STARTED|Post-treatment to 6 Month Assessment|71 parents/guardians and 71 children started.|71
10764702|NCT02537678|11928143|FG000|COMPLETED|Post-treatment to 6 Month Assessment|53 parents/guardians and 53 children completed.|53
10764703|NCT02537678|11928144|FG001|COMPLETED|Post-treatment to 6 Month Assessment|64 parents/guardians and 64 children completed.|64
10764704|NCT02537678|11928143|FG000|NOT COMPLETED|Post-treatment to 6 Month Assessment||8
10764705|NCT02537678|11928144|FG001|NOT COMPLETED|Post-treatment to 6 Month Assessment||7
10764706|NCT02537678|11928143|FG000|STARTED|6 Month to 12 Month Assessment|53 parent/guardians and 53 children started.|53
10764707|NCT02537678|11928144|FG001|STARTED|6 Month to 12 Month Assessment|64 parent/guardians and 64 children started.|64
10764708|NCT02537678|11928143|FG000|COMPLETED|6 Month to 12 Month Assessment|53 parent/guardians and 53 children completed.|53
10764709|NCT02537678|11928144|FG001|COMPLETED|6 Month to 12 Month Assessment|63 parent/guardians and 63 children completed.|63
10764710|NCT02537678|11928143|FG000|NOT COMPLETED|6 Month to 12 Month Assessment||0
10764711|NCT02537678|11928144|FG001|NOT COMPLETED|6 Month to 12 Month Assessment||1
10764712|NCT02400476|11928160|FG000|STARTED|Overall Study||137
10764713|NCT02400476|11928161|FG001|STARTED|Overall Study||64
10764714|NCT02400476|11928162|FG002|STARTED|Overall Study||136
10764715|NCT02400476|11928163|FG003|STARTED|Overall Study||104
10764716|NCT02400476|11928164|FG004|STARTED|Overall Study||60
10764717|NCT02400476|11928165|FG005|STARTED|Overall Study||62
10764718|NCT02400476|11928160|FG000|COMPLETED|Overall Study||76
10764719|NCT02400476|11928161|FG001|COMPLETED|Overall Study||52
10764720|NCT02400476|11928162|FG002|COMPLETED|Overall Study||95
10764721|NCT02400476|11928163|FG003|COMPLETED|Overall Study||74
10764722|NCT02400476|11928164|FG004|COMPLETED|Overall Study||45
10764723|NCT02400476|11928165|FG005|COMPLETED|Overall Study||46
10764724|NCT02400476|11928160|FG000|NOT COMPLETED|Overall Study||61
10764725|NCT02400476|11928161|FG001|NOT COMPLETED|Overall Study||12
10764726|NCT02400476|11928162|FG002|NOT COMPLETED|Overall Study||41
10764727|NCT02400476|11928163|FG003|NOT COMPLETED|Overall Study||30
10764728|NCT02400476|11928164|FG004|NOT COMPLETED|Overall Study||15
10764729|NCT02400476|11928165|FG005|NOT COMPLETED|Overall Study||16
10764733|NCT01818986|11928183|FG000|STARTED|Overall Study||20
10764734|NCT01818986|11928183|FG000|COMPLETED|Overall Study||20
10764735|NCT01818986|11928183|FG000|NOT COMPLETED|Overall Study||0
10764736|NCT01507545|11928189|FG000|STARTED|Overall Study||84
10764737|NCT01507545|11928190|FG001|STARTED|Overall Study||42
10764738|NCT01507545|11928189|FG000|Treated/Safety Set|Overall Study||82
10764739|NCT01507545|11928190|FG001|Treated/Safety Set|Overall Study||40
10764740|NCT01507545|11928189|FG000|COMPLETED|Overall Study||0
10764741|NCT01507545|11928190|FG001|COMPLETED|Overall Study||0
10764742|NCT01507545|11928189|FG000|NOT COMPLETED|Overall Study||84
10764743|NCT01507545|11928190|FG001|NOT COMPLETED|Overall Study||42
10764744|NCT01463670|11928196|FG000|STARTED|Overall Study||11
10764745|NCT01463670|11928196|FG000|COMPLETED|Overall Study||11
10764746|NCT01463670|11928196|FG000|NOT COMPLETED|Overall Study||0
10764747|NCT00920816|11928204|FG000|STARTED|Overall Study||192
10764748|NCT00920816|11928205|FG001|STARTED|Overall Study||96
10764749|NCT00920816|11928206|FG002|STARTED|Overall Study||135
10764750|NCT00920816|11928207|FG003|STARTED|Overall Study||69
10764751|NCT00920816|11928204|FG000|Treated|Overall Study||189
10764752|NCT00920816|11928205|FG001|Treated|Overall Study||96
10764753|NCT00920816|11928206|FG002|Treated|Overall Study||135
10764754|NCT00920816|11928207|FG003|Treated|Overall Study||69
10764755|NCT00920816|11928204|FG000|Participants From China (Excluded From Safety Analysis)|Overall Study||16
10764756|NCT00920816|11928205|FG001|Participants From China (Excluded From Safety Analysis)|Overall Study||8
10764757|NCT00920816|11928206|FG002|Participants From China (Excluded From Safety Analysis)|Overall Study||124
10764758|NCT00920816|11928207|FG003|Participants From China (Excluded From Safety Analysis)|Overall Study||64
10764759|NCT00920816|11928204|FG000|COMPLETED|Overall Study||0
10764760|NCT00920816|11928205|FG001|COMPLETED|Overall Study||0
10764761|NCT00920816|11928206|FG002|COMPLETED|Overall Study||0
10764762|NCT00920816|11928207|FG003|COMPLETED|Overall Study||0
10764763|NCT00920816|11928204|FG000|NOT COMPLETED|Overall Study||192
10764764|NCT00920816|11928205|FG001|NOT COMPLETED|Overall Study||96
10764765|NCT00920816|11928206|FG002|NOT COMPLETED|Overall Study||135
10764766|NCT00920816|11928207|FG003|NOT COMPLETED|Overall Study||69
10764767|NCT03180645|11928220|FG000|STARTED|Overall Study||24
10764768|NCT03180645|11928221|FG001|STARTED|Overall Study||24
10764769|NCT03180645|11928222|FG002|STARTED|Overall Study||24
10764770|NCT03180645|11928220|FG000|COMPLETED|Overall Study||24
10764771|NCT03180645|11928221|FG001|COMPLETED|Overall Study||23
10764772|NCT03180645|11928222|FG002|COMPLETED|Overall Study||22
10764773|NCT03180645|11928220|FG000|NOT COMPLETED|Overall Study||0
10764774|NCT03180645|11928221|FG001|NOT COMPLETED|Overall Study||1
10764775|NCT03180645|11928222|FG002|NOT COMPLETED|Overall Study||2
10764776|NCT03180801|11928237|FG000|STARTED|Overall Study||50
10764777|NCT03180801|11928238|FG001|STARTED|Overall Study||52
10764778|NCT03180801|11928239|FG002|STARTED|Overall Study||51
10764779|NCT03180801|11928237|FG000|Safety Population|Overall Study||50
10764780|NCT03180801|11928238|FG001|Safety Population|Overall Study||52
10764781|NCT03180801|11928239|FG002|Safety Population|Overall Study||51
10764782|NCT03180801|11928237|FG000|Intention to Treat|Overall Study||42
10764783|NCT03180801|11928238|FG001|Intention to Treat|Overall Study||40
10764784|NCT03180801|11928239|FG002|Intention to Treat|Overall Study||41
10764785|NCT03180801|11928237|FG000|COMPLETED|Overall Study||42
10764786|NCT03180801|11928238|FG001|COMPLETED|Overall Study||40
10764787|NCT03180801|11928239|FG002|COMPLETED|Overall Study||41
10764788|NCT03180801|11928237|FG000|NOT COMPLETED|Overall Study||8
10764789|NCT03180801|11928238|FG001|NOT COMPLETED|Overall Study||12
10764790|NCT03180801|11928239|FG002|NOT COMPLETED|Overall Study||10
10764791|NCT03181009|11928252|FG000|STARTED|Overall Study||30
10764792|NCT03181009|11928253|FG001|STARTED|Overall Study||30
10764793|NCT03181009|11928252|FG000|COMPLETED|Overall Study||30
10764794|NCT03181009|11928253|FG001|COMPLETED|Overall Study||28
10764795|NCT03181009|11928252|FG000|NOT COMPLETED|Overall Study||0
10764796|NCT03181009|11928253|FG001|NOT COMPLETED|Overall Study||2
10764797|NCT03181308|11928261|FG000|STARTED|Overall Study||3
10764798|NCT03181308|11928262|FG001|STARTED|Overall Study||8
10764799|NCT03181308|11928261|FG000|COMPLETED|Overall Study||3
10764800|NCT03181308|11928262|FG001|COMPLETED|Overall Study||8
10764801|NCT03181308|11928261|FG000|NOT COMPLETED|Overall Study||0
10764802|NCT03181308|11928262|FG001|NOT COMPLETED|Overall Study||0
10764803|NCT03181451|11928271|FG000|STARTED|Overall Study||12
10764804|NCT03181451|11928272|FG001|STARTED|Overall Study||13
10764805|NCT03181451|11928273|FG002|STARTED|Overall Study||12
10764806|NCT03181451|11928271|FG000|COMPLETED|Overall Study||12
10764807|NCT03181451|11928272|FG001|COMPLETED|Overall Study||11
10764808|NCT03181451|11928273|FG002|COMPLETED|Overall Study||12
10764809|NCT03181451|11928271|FG000|NOT COMPLETED|Overall Study||0
10764810|NCT03181451|11928272|FG001|NOT COMPLETED|Overall Study||2
10764811|NCT03181451|11928273|FG002|NOT COMPLETED|Overall Study||0
10764812|NCT03181503|11928285|FG000|STARTED|Overall Study||36
10764813|NCT03181503|11928286|FG001|STARTED|Overall Study||34
10764814|NCT03181503|11928285|FG000|Treated|Overall Study||36
10764815|NCT03181503|11928286|FG001|Treated|Overall Study||34
10764816|NCT03181503|11928285|FG000|COMPLETED|Overall Study||29
10764817|NCT03181503|11928286|FG001|COMPLETED|Overall Study||31
10764818|NCT03181503|11928285|FG000|NOT COMPLETED|Overall Study||7
10764819|NCT03181503|11928286|FG001|NOT COMPLETED|Overall Study||3
10764820|NCT03181594|11928295|FG000|STARTED|Initial Study Protocol (12-month FU)||100
10764821|NCT03181594|11928295|FG000|30-day Follow-up|Initial Study Protocol (12-month FU)||99
10764822|NCT03181594|11928295|FG000|90-day Follow-up|Initial Study Protocol (12-month FU)||98
10764823|NCT03181594|11928295|FG000|6-month Follow-up|Initial Study Protocol (12-month FU)||98
10764824|NCT03181594|11928295|FG000|9-month Follow-up|Initial Study Protocol (12-month FU)||95
10764825|NCT03181594|11928295|FG000|12-month Follow-up|Initial Study Protocol (12-month FU)||91
10764826|NCT03181594|11928295|FG000|COMPLETED|Initial Study Protocol (12-month FU)||91
10779115|NCT03364309|11940861|FG002|COMPLETED|Induction Period||175
10297361|NCT00276016|11429912|FG000|STARTED|Wash Out 2||7
10297362|NCT00276016|11429913|FG001|STARTED|Wash Out 2||6
10297363|NCT00276016|11429914|FG002|STARTED|Wash Out 2||7
10297364|NCT00276016|11429915|FG003|STARTED|Wash Out 2||6
10297365|NCT00276016|11429916|FG004|STARTED|Wash Out 2||6
10297366|NCT00276016|11429917|FG005|STARTED|Wash Out 2||6
10297367|NCT00276016|11429912|FG000|COMPLETED|Wash Out 2||7
10297368|NCT00276016|11429913|FG001|COMPLETED|Wash Out 2||6
10297369|NCT00276016|11429914|FG002|COMPLETED|Wash Out 2||7
10297370|NCT00276016|11429915|FG003|COMPLETED|Wash Out 2||6
10297371|NCT00276016|11429916|FG004|COMPLETED|Wash Out 2||6
10297372|NCT00276016|11429917|FG005|COMPLETED|Wash Out 2||6
10297373|NCT00276016|11429912|FG000|NOT COMPLETED|Wash Out 2||0
10297374|NCT00276016|11429913|FG001|NOT COMPLETED|Wash Out 2||0
10297375|NCT00276016|11429914|FG002|NOT COMPLETED|Wash Out 2||0
10297376|NCT00276016|11429915|FG003|NOT COMPLETED|Wash Out 2||0
10297377|NCT00276016|11429916|FG004|NOT COMPLETED|Wash Out 2||0
10297378|NCT00276016|11429917|FG005|NOT COMPLETED|Wash Out 2||0
10297379|NCT00276016|11429912|FG000|STARTED|Intervention 3||7
10297380|NCT00276016|11429913|FG001|STARTED|Intervention 3||6
10297381|NCT00276016|11429914|FG002|STARTED|Intervention 3||7
10297382|NCT00276016|11429915|FG003|STARTED|Intervention 3||6
10297383|NCT00276016|11429916|FG004|STARTED|Intervention 3||6
10297384|NCT00276016|11429917|FG005|STARTED|Intervention 3||6
10297385|NCT00276016|11429912|FG000|COMPLETED|Intervention 3||7
10297386|NCT00276016|11429913|FG001|COMPLETED|Intervention 3||6
10297387|NCT00276016|11429914|FG002|COMPLETED|Intervention 3||7
10297388|NCT00276016|11429915|FG003|COMPLETED|Intervention 3||6
10297389|NCT00276016|11429916|FG004|COMPLETED|Intervention 3||6
10297390|NCT00276016|11429917|FG005|COMPLETED|Intervention 3||6
10297391|NCT00276016|11429912|FG000|NOT COMPLETED|Intervention 3||0
10297392|NCT00276016|11429913|FG001|NOT COMPLETED|Intervention 3||0
10297393|NCT00276016|11429914|FG002|NOT COMPLETED|Intervention 3||0
10297394|NCT00276016|11429915|FG003|NOT COMPLETED|Intervention 3||0
10297395|NCT00276016|11429916|FG004|NOT COMPLETED|Intervention 3||0
10297396|NCT00276016|11429917|FG005|NOT COMPLETED|Intervention 3||0
10297397|NCT00265343|11429928|FG000|STARTED|Overall Study||134
10297398|NCT00265343|11429929|FG001|STARTED|Overall Study||172
10297399|NCT00265343|11429928|FG000|COMPLETED|Overall Study||113
10297400|NCT00265343|11429929|FG001|COMPLETED|Overall Study||153
10297401|NCT00265343|11429928|FG000|NOT COMPLETED|Overall Study||21
10764827|NCT03181594|11928295|FG000|NOT COMPLETED|Initial Study Protocol (12-month FU)||9
10764828|NCT03181594|11928295|FG000|STARTED|Long-term Extension (15-24 Month FU)||62
10764829|NCT03181594|11928295|FG000|15-month Follow-up|Long-term Extension (15-24 Month FU)||56
10764830|NCT03181594|11928295|FG000|18-month Follow-up|Long-term Extension (15-24 Month FU)||57
10764831|NCT03181594|11928295|FG000|21-month Follow-up|Long-term Extension (15-24 Month FU)||55
10764832|NCT03181594|11928295|FG000|24-month Follow-up|Long-term Extension (15-24 Month FU)||57
10764833|NCT03181594|11928295|FG000|COMPLETED|Long-term Extension (15-24 Month FU)||57
10764834|NCT03181594|11928295|FG000|NOT COMPLETED|Long-term Extension (15-24 Month FU)||5
10764835|NCT03181724|11928301|FG000|STARTED|Overall Study||45
10764836|NCT03181724|11928302|FG001|STARTED|Overall Study||45
10764837|NCT03181724|11928301|FG000|COMPLETED|Overall Study||45
10764838|NCT03181724|11928302|FG001|COMPLETED|Overall Study||45
10764839|NCT03181724|11928301|FG000|NOT COMPLETED|Overall Study||0
10764840|NCT03181724|11928302|FG001|NOT COMPLETED|Overall Study||0
10764841|NCT03181932|11928310|FG000|STARTED|Period 1 (Double-blind Period)||90
10764842|NCT03181932|11928311|FG001|STARTED|Period 1 (Double-blind Period)||98
10764843|NCT03181932|11928310|FG000|COMPLETED|Period 1 (Double-blind Period)||79
10764844|NCT03181932|11928311|FG001|COMPLETED|Period 1 (Double-blind Period)||85
10764845|NCT03181932|11928310|FG000|NOT COMPLETED|Period 1 (Double-blind Period)||11
10764846|NCT03181932|11928311|FG001|NOT COMPLETED|Period 1 (Double-blind Period)||13
10764847|NCT03181932|11928310|FG000|STARTED|Period 2 (Open-label Period)||75
10764848|NCT03181932|11928311|FG001|STARTED|Period 2 (Open-label Period)||83
10764849|NCT03181932|11928310|FG000|COMPLETED|Period 2 (Open-label Period)||67
10764850|NCT03181932|11928311|FG001|COMPLETED|Period 2 (Open-label Period)||70
10764851|NCT03181932|11928310|FG000|NOT COMPLETED|Period 2 (Open-label Period)||8
10764852|NCT03181932|11928311|FG001|NOT COMPLETED|Period 2 (Open-label Period)||13
10764853|NCT03181958|11928321|FG000|STARTED|Overall Study||497
10764854|NCT03181958|11928322|FG001|STARTED|Overall Study||501
10764855|NCT03181958|11928323|FG002|STARTED|Overall Study||495
10764856|NCT03181958|11928321|FG000|COMPLETED|Overall Study||480
10764857|NCT03181958|11928322|FG001|COMPLETED|Overall Study||480
10764858|NCT03181958|11928323|FG002|COMPLETED|Overall Study||480
10764859|NCT03181958|11928321|FG000|NOT COMPLETED|Overall Study||17
10764860|NCT03181958|11928322|FG001|NOT COMPLETED|Overall Study||21
10764861|NCT03181958|11928323|FG002|NOT COMPLETED|Overall Study||15
10764862|NCT03182582|11928331|FG000|STARTED|Treatment 1||12
10764863|NCT03182582|11928332|FG001|STARTED|Treatment 1||10
10764864|NCT03182582|11928331|FG000|COMPLETED|Treatment 1||12
10764865|NCT03182582|11928332|FG001|COMPLETED|Treatment 1||10
10764866|NCT03182582|11928331|FG000|NOT COMPLETED|Treatment 1||0
10764867|NCT03182582|11928332|FG001|NOT COMPLETED|Treatment 1||0
10764868|NCT03182582|11928331|FG000|STARTED|Treatment 2||12
10764869|NCT03182582|11928332|FG001|STARTED|Treatment 2||10
10764870|NCT03182582|11928331|FG000|COMPLETED|Treatment 2||12
10764871|NCT03182582|11928332|FG001|COMPLETED|Treatment 2||10
10764872|NCT03182582|11928331|FG000|NOT COMPLETED|Treatment 2||0
10764873|NCT03182582|11928332|FG001|NOT COMPLETED|Treatment 2||0
10764874|NCT03182725|11928345|FG000|STARTED|Treatment Arm 1 (First Half of Study)||16
10764875|NCT03182725|11928346|FG001|STARTED|Treatment Arm 1 (First Half of Study)||10
10764876|NCT03182725|11928345|FG000|COMPLETED|Treatment Arm 1 (First Half of Study)||16
10764877|NCT03182725|11928346|FG001|COMPLETED|Treatment Arm 1 (First Half of Study)||7
10764878|NCT03182725|11928345|FG000|NOT COMPLETED|Treatment Arm 1 (First Half of Study)||0
10764879|NCT03182725|11928346|FG001|NOT COMPLETED|Treatment Arm 1 (First Half of Study)||3
10764880|NCT03182725|11928345|FG000|STARTED|Treatment Arm 2 (Second Half of Study)||16
10764881|NCT03182725|11928346|FG001|STARTED|Treatment Arm 2 (Second Half of Study)|One participant withdrew during crossover and therefore did not start Treatment Arm 2.|6
10764882|NCT03182725|11928345|FG000|COMPLETED|Treatment Arm 2 (Second Half of Study)||16
10764883|NCT03182725|11928346|FG001|COMPLETED|Treatment Arm 2 (Second Half of Study)||6
10764884|NCT03182725|11928345|FG000|NOT COMPLETED|Treatment Arm 2 (Second Half of Study)||0
10764885|NCT03182725|11928346|FG001|NOT COMPLETED|Treatment Arm 2 (Second Half of Study)||0
10764886|NCT03182738|11928354|FG000|STARTED|Overall Study||50
10764887|NCT03182738|11928355|FG001|STARTED|Overall Study||50
10764888|NCT03182738|11928354|FG000|COMPLETED|Overall Study||41
10764889|NCT03182738|11928355|FG001|COMPLETED|Overall Study||45
10764890|NCT03182738|11928354|FG000|NOT COMPLETED|Overall Study||9
10764891|NCT03182738|11928355|FG001|NOT COMPLETED|Overall Study||5
10764892|NCT03182920|11928363|FG000|STARTED|Period 1||9
10764893|NCT03182920|11928364|FG001|STARTED|Period 1||9
10764894|NCT03182920|11928365|FG002|STARTED|Period 1||17
10764895|NCT03182920|11928363|FG000|COMPLETED|Period 1||9
10764896|NCT03182920|11928364|FG001|COMPLETED|Period 1||9
10764897|NCT03182920|11928365|FG002|COMPLETED|Period 1||17
10764898|NCT03182920|11928363|FG000|NOT COMPLETED|Period 1||0
10764899|NCT03182920|11928364|FG001|NOT COMPLETED|Period 1||0
10764900|NCT03182920|11928365|FG002|NOT COMPLETED|Period 1||0
10764901|NCT03182920|11928363|FG000|STARTED|Washout Period||9
10764902|NCT03182920|11928364|FG001|STARTED|Washout Period||9
10764903|NCT03182920|11928365|FG002|STARTED|Washout Period||0
10764904|NCT03182920|11928363|FG000|COMPLETED|Washout Period||9
10764905|NCT03182920|11928364|FG001|COMPLETED|Washout Period||9
10764906|NCT03182920|11928365|FG002|COMPLETED|Washout Period||0
10764907|NCT03182920|11928363|FG000|NOT COMPLETED|Washout Period||0
10764908|NCT03182920|11928364|FG001|NOT COMPLETED|Washout Period||0
10764909|NCT03182920|11928365|FG002|NOT COMPLETED|Washout Period||0
10764910|NCT03182920|11928363|FG000|STARTED|Period 2||9
10764911|NCT03182920|11928364|FG001|STARTED|Period 2||9
10764912|NCT03182920|11928365|FG002|STARTED|Period 2|Young participants on Lasmiditan did not move to study period 2.|0
10764913|NCT03182920|11928363|FG000|COMPLETED|Period 2||9
10764914|NCT03182920|11928364|FG001|COMPLETED|Period 2||9
10764915|NCT03182920|11928365|FG002|COMPLETED|Period 2||0
10764916|NCT03182920|11928363|FG000|NOT COMPLETED|Period 2||0
10764917|NCT03182920|11928364|FG001|NOT COMPLETED|Period 2||0
10764918|NCT03182920|11928365|FG002|NOT COMPLETED|Period 2||0
10764919|NCT03182933|11928374|FG000|STARTED|Overall Study||32
10764920|NCT03182933|11928375|FG001|STARTED|Overall Study||32
10764921|NCT03182933|11928374|FG000|COMPLETED|Overall Study||31
10764922|NCT03182933|11928375|FG001|COMPLETED|Overall Study||32
10764923|NCT03182933|11928374|FG000|NOT COMPLETED|Overall Study||1
10764924|NCT03182933|11928375|FG001|NOT COMPLETED|Overall Study||0
10764925|NCT03183063|11928384|FG000|STARTED|Overall Study||20
10764926|NCT03183063|11928385|FG001|STARTED|Overall Study||4
10764927|NCT03183063|11928386|FG002|STARTED|Overall Study||115
10764928|NCT03183063|11928384|FG000|COMPLETED|Overall Study||15
10764929|NCT03183063|11928385|FG001|COMPLETED|Overall Study||0
10764930|NCT03183063|11928386|FG002|COMPLETED|Overall Study||111
10764931|NCT03183063|11928384|FG000|NOT COMPLETED|Overall Study||5
10764932|NCT03183063|11928385|FG001|NOT COMPLETED|Overall Study||4
10764933|NCT03183063|11928386|FG002|NOT COMPLETED|Overall Study||4
10764934|NCT03183518|11928400|FG000|STARTED|Overall Study||36
10764935|NCT03183518|11928400|FG000|Test Product|Overall Study||36
10764936|NCT03183518|11928400|FG000|Negative Control|Overall Study||36
10764937|NCT03183518|11928400|FG000|COMPLETED|Overall Study||33
10764938|NCT03183518|11928400|FG000|NOT COMPLETED|Overall Study||3
10764939|NCT03183869|11928407|FG000|STARTED|Overall Study||4
10764940|NCT03183869|11928408|FG001|STARTED|Overall Study||7
10764941|NCT03183869|11928407|FG000|COMPLETED|Overall Study||0
10764942|NCT03183869|11928408|FG001|COMPLETED|Overall Study||2
10764943|NCT03183869|11928407|FG000|NOT COMPLETED|Overall Study||4
10764944|NCT03183869|11928408|FG001|NOT COMPLETED|Overall Study||5
10764945|NCT03183908|11928416|FG000|STARTED|Overall Study||378
10764946|NCT03183908|11928417|FG001|STARTED|Overall Study||379
10764947|NCT03183908|11928416|FG000|COMPLETED|Overall Study||378
10764948|NCT03183908|11928417|FG001|COMPLETED|Overall Study||377
10764949|NCT03183908|11928416|FG000|NOT COMPLETED|Overall Study||0
10764950|NCT03183908|11928417|FG001|NOT COMPLETED|Overall Study||2
10764951|NCT03184077|11928429|FG000|STARTED|Overall Study||166
10764952|NCT03184077|11928430|FG001|STARTED|Overall Study||152
10764953|NCT03184077|11928429|FG000|COMPLETED|Overall Study||145
10764954|NCT03184077|11928430|FG001|COMPLETED|Overall Study||131
10764955|NCT03184077|11928429|FG000|NOT COMPLETED|Overall Study||21
10764956|NCT03184077|11928430|FG001|NOT COMPLETED|Overall Study||21
10764957|NCT03184428|11928436|FG000|STARTED|Overall Study||3785
10764958|NCT03184428|11928436|FG000|COMPLETED|Overall Study||2963
10764959|NCT03184428|11928436|FG000|NOT COMPLETED|Overall Study||822
10764960|NCT03184441|11928452|FG000|STARTED|Overall Study||11
10764961|NCT03184441|11928452|FG000|COMPLETED|Overall Study|Last subject completed study|10
10764962|NCT03184441|11928452|FG000|NOT COMPLETED|Overall Study||1
10764963|NCT03184519|11928459|FG000|STARTED|Overall Study||156
10764964|NCT03184519|11928459|FG000|COMPLETED|Overall Study||129
10764965|NCT03184519|11928459|FG000|NOT COMPLETED|Overall Study||27
10764966|NCT03184558|11928463|FG000|STARTED|Overall Study||29
10764967|NCT03184558|11928463|FG000|COMPLETED|Overall Study||0
10764968|NCT03184558|11928463|FG000|NOT COMPLETED|Overall Study||29
10764969|NCT03184701|11928467|FG000|STARTED|Overall Study||45
10764970|NCT03184701|11928467|FG000|COMPLETED|Overall Study||28
10764971|NCT03184701|11928467|FG000|NOT COMPLETED|Overall Study||17
10764972|NCT03184987|11928474|FG000|STARTED|Overall Study||47
10764973|NCT03184987|11928475|FG001|STARTED|Overall Study||9
10764974|NCT03184987|11928476|FG002|STARTED|Overall Study||55
10764975|NCT03184987|11928474|FG000|COMPLETED|Overall Study||46
10764976|NCT03184987|11928475|FG001|COMPLETED|Overall Study||8
10764977|NCT03184987|11928476|FG002|COMPLETED|Overall Study||51
10764978|NCT03184987|11928474|FG000|NOT COMPLETED|Overall Study||1
10764979|NCT03184987|11928475|FG001|NOT COMPLETED|Overall Study||1
10764980|NCT03184987|11928476|FG002|NOT COMPLETED|Overall Study||4
10764981|NCT03185065|11928488|FG000|STARTED|Period 1 (6 Weeks)||35
10764982|NCT03185065|11928489|FG001|STARTED|Period 1 (6 Weeks)||34
10764983|NCT03185065|11928490|FG002|STARTED|Period 1 (6 Weeks)||35
10764984|NCT03185065|11928491|FG003|STARTED|Period 1 (6 Weeks)||37
10764985|NCT03185065|11928488|FG000|COMPLETED|Period 1 (6 Weeks)||32
10764986|NCT03185065|11928489|FG001|COMPLETED|Period 1 (6 Weeks)||33
10764987|NCT03185065|11928490|FG002|COMPLETED|Period 1 (6 Weeks)||32
10764988|NCT03185065|11928491|FG003|COMPLETED|Period 1 (6 Weeks)||36
10764989|NCT03185065|11928488|FG000|NOT COMPLETED|Period 1 (6 Weeks)||3
10764990|NCT03185065|11928489|FG001|NOT COMPLETED|Period 1 (6 Weeks)||1
10764991|NCT03185065|11928490|FG002|NOT COMPLETED|Period 1 (6 Weeks)||3
10764992|NCT03185065|11928491|FG003|NOT COMPLETED|Period 1 (6 Weeks)||1
10764993|NCT03185065|11928488|FG000|STARTED|Washout (2 Weeks)||32
10764994|NCT03185065|11928489|FG001|STARTED|Washout (2 Weeks)||33
10764995|NCT03185065|11928490|FG002|STARTED|Washout (2 Weeks)||32
10764996|NCT03185065|11928491|FG003|STARTED|Washout (2 Weeks)||36
10764997|NCT03185065|11928488|FG000|COMPLETED|Washout (2 Weeks)||32
10764998|NCT03185065|11928489|FG001|COMPLETED|Washout (2 Weeks)||31
10764999|NCT03185065|11928490|FG002|COMPLETED|Washout (2 Weeks)||32
10765000|NCT03185065|11928491|FG003|COMPLETED|Washout (2 Weeks)||35
10765001|NCT03185065|11928488|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10765002|NCT03185065|11928489|FG001|NOT COMPLETED|Washout (2 Weeks)||2
10765003|NCT03185065|11928490|FG002|NOT COMPLETED|Washout (2 Weeks)||0
10765004|NCT03185065|11928491|FG003|NOT COMPLETED|Washout (2 Weeks)||1
10765005|NCT03185065|11928488|FG000|STARTED|Period 2 (6 Weeks)||32
10765006|NCT03185065|11928489|FG001|STARTED|Period 2 (6 Weeks)||31
10765007|NCT03185065|11928490|FG002|STARTED|Period 2 (6 Weeks)||32
10765008|NCT03185065|11928491|FG003|STARTED|Period 2 (6 Weeks)||35
10765009|NCT03185065|11928488|FG000|COMPLETED|Period 2 (6 Weeks)||32
10765010|NCT03185065|11928489|FG001|COMPLETED|Period 2 (6 Weeks)||31
10765011|NCT03185065|11928490|FG002|COMPLETED|Period 2 (6 Weeks)||32
10765012|NCT03185065|11928491|FG003|COMPLETED|Period 2 (6 Weeks)||34
10765013|NCT03185065|11928488|FG000|NOT COMPLETED|Period 2 (6 Weeks)||0
10765014|NCT03185065|11928489|FG001|NOT COMPLETED|Period 2 (6 Weeks)||0
10765015|NCT03185065|11928490|FG002|NOT COMPLETED|Period 2 (6 Weeks)||0
10765016|NCT03185065|11928491|FG003|NOT COMPLETED|Period 2 (6 Weeks)||1
10765017|NCT03185065|11928488|FG000|STARTED|Washout (2 Weeks)||32
10765018|NCT03185065|11928489|FG001|STARTED|Washout (2 Weeks)||31
10765019|NCT03185065|11928490|FG002|STARTED|Washout (2 Weeks)||32
10765020|NCT03185065|11928491|FG003|STARTED|Washout (2 Weeks)||34
10765021|NCT03185065|11928488|FG000|COMPLETED|Washout (2 Weeks)||31
10765022|NCT03185065|11928489|FG001|COMPLETED|Washout (2 Weeks)||29
10765023|NCT03185065|11928490|FG002|COMPLETED|Washout (2 Weeks)||31
10765024|NCT03185065|11928491|FG003|COMPLETED|Washout (2 Weeks)||32
10765025|NCT03185065|11928488|FG000|NOT COMPLETED|Washout (2 Weeks)||1
10765026|NCT03185065|11928489|FG001|NOT COMPLETED|Washout (2 Weeks)||2
10765027|NCT03185065|11928490|FG002|NOT COMPLETED|Washout (2 Weeks)||1
10765028|NCT03185065|11928491|FG003|NOT COMPLETED|Washout (2 Weeks)||2
10765029|NCT03185065|11928488|FG000|STARTED|Period 3 (6 Weeks)||31
10765030|NCT03185065|11928489|FG001|STARTED|Period 3 (6 Weeks)||29
10765031|NCT03185065|11928490|FG002|STARTED|Period 3 (6 Weeks)||31
10765032|NCT03185065|11928491|FG003|STARTED|Period 3 (6 Weeks)||32
10421637|NCT00820170|11566481|FG000|NOT COMPLETED|Overall Study||0
10421638|NCT00820170|11566482|FG001|NOT COMPLETED|Overall Study||0
10421639|NCT00820170|11566483|FG002|NOT COMPLETED|Overall Study||0
10765033|NCT03185065|11928488|FG000|COMPLETED|Period 3 (6 Weeks)||31
10765034|NCT03185065|11928489|FG001|COMPLETED|Period 3 (6 Weeks)||29
10765035|NCT03185065|11928490|FG002|COMPLETED|Period 3 (6 Weeks)||29
10765036|NCT03185065|11928491|FG003|COMPLETED|Period 3 (6 Weeks)||32
10765037|NCT03185065|11928488|FG000|NOT COMPLETED|Period 3 (6 Weeks)||0
10765038|NCT03185065|11928489|FG001|NOT COMPLETED|Period 3 (6 Weeks)||0
10765039|NCT03185065|11928490|FG002|NOT COMPLETED|Period 3 (6 Weeks)||2
10765040|NCT03185065|11928491|FG003|NOT COMPLETED|Period 3 (6 Weeks)||0
10765041|NCT03185065|11928488|FG000|STARTED|Washout (2 Weeks)||31
10765042|NCT03185065|11928489|FG001|STARTED|Washout (2 Weeks)||29
10765043|NCT03185065|11928490|FG002|STARTED|Washout (2 Weeks)||29
10765044|NCT03185065|11928491|FG003|STARTED|Washout (2 Weeks)||32
10765045|NCT03185065|11928488|FG000|COMPLETED|Washout (2 Weeks)||31
10765046|NCT03185065|11928489|FG001|COMPLETED|Washout (2 Weeks)||28
10765047|NCT03185065|11928490|FG002|COMPLETED|Washout (2 Weeks)||27
10765048|NCT03185065|11928491|FG003|COMPLETED|Washout (2 Weeks)||32
10765049|NCT03185065|11928488|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10765050|NCT03185065|11928489|FG001|NOT COMPLETED|Washout (2 Weeks)||1
10765051|NCT03185065|11928490|FG002|NOT COMPLETED|Washout (2 Weeks)||2
10765052|NCT03185065|11928491|FG003|NOT COMPLETED|Washout (2 Weeks)||0
10765053|NCT03185065|11928488|FG000|STARTED|Period 4 (6 Weeks)||31
10765054|NCT03185065|11928489|FG001|STARTED|Period 4 (6 Weeks)||28
10765055|NCT03185065|11928490|FG002|STARTED|Period 4 (6 Weeks)||27
10765056|NCT03185065|11928491|FG003|STARTED|Period 4 (6 Weeks)||32
10765057|NCT03185065|11928488|FG000|COMPLETED|Period 4 (6 Weeks)||31
10765058|NCT03185065|11928489|FG001|COMPLETED|Period 4 (6 Weeks)||27
10765059|NCT03185065|11928490|FG002|COMPLETED|Period 4 (6 Weeks)||26
10765060|NCT03185065|11928491|FG003|COMPLETED|Period 4 (6 Weeks)||31
10765061|NCT03185065|11928488|FG000|NOT COMPLETED|Period 4 (6 Weeks)||0
10765062|NCT03185065|11928489|FG001|NOT COMPLETED|Period 4 (6 Weeks)||1
10765063|NCT03185065|11928490|FG002|NOT COMPLETED|Period 4 (6 Weeks)||1
10765064|NCT03185065|11928491|FG003|NOT COMPLETED|Period 4 (6 Weeks)||1
10765065|NCT03185182|11928502|FG000|STARTED|Overall Study||5
10765066|NCT03185182|11928502|FG000|COMPLETED|Overall Study||5
10765067|NCT03185182|11928502|FG000|NOT COMPLETED|Overall Study||0
10779116|NCT03364309|11940862|FG003|COMPLETED|Induction Period||0
10779117|NCT03364309|11940863|FG004|COMPLETED|Induction Period||0
10779118|NCT03364309|11940864|FG005|COMPLETED|Induction Period||0
10779119|NCT03364309|11940865|FG006|COMPLETED|Induction Period||0
10779120|NCT03364309|11940866|FG007|COMPLETED|Induction Period||0
10779121|NCT03364309|11940867|FG008|COMPLETED|Induction Period||0
10779122|NCT03364309|11940868|FG009|COMPLETED|Induction Period||0
10779123|NCT03364309|11940869|FG010|COMPLETED|Induction Period||0
10765068|NCT03185455|11928509|FG000|STARTED|Overall Study||103
10765069|NCT03185455|11928510|FG001|STARTED|Overall Study||103
10765070|NCT03185455|11928509|FG000|COMPLETED|Overall Study||103
10765071|NCT03185455|11928510|FG001|COMPLETED|Overall Study||103
10765072|NCT03185455|11928509|FG000|NOT COMPLETED|Overall Study||0
10765073|NCT03185455|11928510|FG001|NOT COMPLETED|Overall Study||0
10765074|NCT03185481|11928516|FG000|STARTED|Overall Study||5
10765075|NCT03185481|11928516|FG000|COMPLETED|Overall Study||0
10765076|NCT03185481|11928516|FG000|NOT COMPLETED|Overall Study||5
10765077|NCT03185546|11928528|FG000|STARTED|Baseline Through Week 12||6
10765078|NCT03185546|11928529|FG001|STARTED|Baseline Through Week 12||10
10765079|NCT03185546|11928530|FG002|STARTED|Baseline Through Week 12||5
10765080|NCT03185546|11928531|FG003|STARTED|Baseline Through Week 12||5
10765081|NCT03185546|11928532|FG004|STARTED|Baseline Through Week 12||6
10765082|NCT03185546|11928533|FG005|STARTED|Baseline Through Week 12||6
10765083|NCT03185546|11928534|FG006|STARTED|Baseline Through Week 12||7
10765084|NCT03185546|11928535|FG007|STARTED|Baseline Through Week 12||5
10765085|NCT03185546|11928528|FG000|COMPLETED|Baseline Through Week 12||2
10765086|NCT03185546|11928529|FG001|COMPLETED|Baseline Through Week 12||7
10765087|NCT03185546|11928530|FG002|COMPLETED|Baseline Through Week 12||4
10765088|NCT03185546|11928531|FG003|COMPLETED|Baseline Through Week 12||4
10765089|NCT03185546|11928532|FG004|COMPLETED|Baseline Through Week 12||5
10765090|NCT03185546|11928533|FG005|COMPLETED|Baseline Through Week 12||4
10765091|NCT03185546|11928534|FG006|COMPLETED|Baseline Through Week 12||4
10765092|NCT03185546|11928535|FG007|COMPLETED|Baseline Through Week 12||2
10765093|NCT03185546|11928528|FG000|NOT COMPLETED|Baseline Through Week 12||4
10765094|NCT03185546|11928529|FG001|NOT COMPLETED|Baseline Through Week 12||3
10765095|NCT03185546|11928530|FG002|NOT COMPLETED|Baseline Through Week 12||1
10765096|NCT03185546|11928531|FG003|NOT COMPLETED|Baseline Through Week 12||1
10765097|NCT03185546|11928532|FG004|NOT COMPLETED|Baseline Through Week 12||1
10765098|NCT03185546|11928533|FG005|NOT COMPLETED|Baseline Through Week 12||2
10765099|NCT03185546|11928534|FG006|NOT COMPLETED|Baseline Through Week 12||3
10765100|NCT03185546|11928535|FG007|NOT COMPLETED|Baseline Through Week 12||3
10765101|NCT03185546|11928528|FG000|STARTED|Week 12 Through Day 30 Follow up||2
10765102|NCT03185546|11928529|FG001|STARTED|Week 12 Through Day 30 Follow up||7
10765103|NCT03185546|11928530|FG002|STARTED|Week 12 Through Day 30 Follow up||4
10765104|NCT03185546|11928531|FG003|STARTED|Week 12 Through Day 30 Follow up||4
10765105|NCT03185546|11928532|FG004|STARTED|Week 12 Through Day 30 Follow up||5
10765106|NCT03185546|11928533|FG005|STARTED|Week 12 Through Day 30 Follow up||4
10765107|NCT03185546|11928534|FG006|STARTED|Week 12 Through Day 30 Follow up||4
10765108|NCT03185546|11928535|FG007|STARTED|Week 12 Through Day 30 Follow up||2
10765109|NCT03185546|11928528|FG000|COMPLETED|Week 12 Through Day 30 Follow up||2
10765110|NCT03185546|11928529|FG001|COMPLETED|Week 12 Through Day 30 Follow up||7
10765111|NCT03185546|11928530|FG002|COMPLETED|Week 12 Through Day 30 Follow up||4
10765112|NCT03185546|11928531|FG003|COMPLETED|Week 12 Through Day 30 Follow up||3
10765113|NCT03185546|11928532|FG004|COMPLETED|Week 12 Through Day 30 Follow up||5
10765114|NCT03185546|11928533|FG005|COMPLETED|Week 12 Through Day 30 Follow up||4
10765115|NCT03185546|11928534|FG006|COMPLETED|Week 12 Through Day 30 Follow up||3
10765116|NCT03185546|11928535|FG007|COMPLETED|Week 12 Through Day 30 Follow up||2
10765117|NCT03185546|11928528|FG000|NOT COMPLETED|Week 12 Through Day 30 Follow up||0
10765118|NCT03185546|11928529|FG001|NOT COMPLETED|Week 12 Through Day 30 Follow up||0
10765119|NCT03185546|11928530|FG002|NOT COMPLETED|Week 12 Through Day 30 Follow up||0
10765120|NCT03185546|11928531|FG003|NOT COMPLETED|Week 12 Through Day 30 Follow up||1
10765121|NCT03185546|11928532|FG004|NOT COMPLETED|Week 12 Through Day 30 Follow up||0
10765122|NCT03185546|11928533|FG005|NOT COMPLETED|Week 12 Through Day 30 Follow up||0
10765123|NCT03185546|11928534|FG006|NOT COMPLETED|Week 12 Through Day 30 Follow up||1
10765124|NCT03185546|11928535|FG007|NOT COMPLETED|Week 12 Through Day 30 Follow up||0
10765125|NCT03186261|11928556|FG000|STARTED|Overall Study||22
10765126|NCT03186261|11928557|FG001|STARTED|Overall Study||22
10765127|NCT03186261|11928556|FG000|COMPLETED|Overall Study||22
10765128|NCT03186261|11928557|FG001|COMPLETED|Overall Study||22
10765129|NCT03186261|11928556|FG000|NOT COMPLETED|Overall Study||0
10765130|NCT03186261|11928557|FG001|NOT COMPLETED|Overall Study||0
10765131|NCT03186378|11928565|FG000|STARTED|Overall Study||17
10765132|NCT03186378|11928566|FG001|STARTED|Overall Study||16
10765133|NCT03186378|11928565|FG000|COMPLETED|Overall Study||16
10765134|NCT03186378|11928566|FG001|COMPLETED|Overall Study||16
10765135|NCT03186378|11928565|FG000|NOT COMPLETED|Overall Study||1
10765136|NCT03186378|11928566|FG001|NOT COMPLETED|Overall Study||0
10765137|NCT03186677|11928577|FG000|STARTED|Period 1||3
10765138|NCT03186677|11928578|FG001|STARTED|Period 1||3
10765139|NCT03186677|11928579|FG002|STARTED|Period 1||3
10765140|NCT03186677|11928580|FG003|STARTED|Period 1||0
10765141|NCT03186677|11928581|FG004|STARTED|Period 1||0
10765142|NCT03186677|11928577|FG000|COMPLETED|Period 1||3
10765143|NCT03186677|11928578|FG001|COMPLETED|Period 1||3
10765144|NCT03186677|11928579|FG002|COMPLETED|Period 1||3
10765145|NCT03186677|11928580|FG003|COMPLETED|Period 1||0
10765146|NCT03186677|11928581|FG004|COMPLETED|Period 1||0
10765147|NCT03186677|11928577|FG000|NOT COMPLETED|Period 1||0
10765148|NCT03186677|11928578|FG001|NOT COMPLETED|Period 1||0
10765149|NCT03186677|11928579|FG002|NOT COMPLETED|Period 1||0
10765150|NCT03186677|11928580|FG003|NOT COMPLETED|Period 1||0
10765151|NCT03186677|11928581|FG004|NOT COMPLETED|Period 1||0
10765152|NCT03186677|11928577|FG000|STARTED|Period 2||0
10765153|NCT03186677|11928578|FG001|STARTED|Period 2||0
10765154|NCT03186677|11928579|FG002|STARTED|Period 2||0
10765155|NCT03186677|11928580|FG003|STARTED|Period 2||5
10765156|NCT03186677|11928581|FG004|STARTED|Period 2||2
10765157|NCT03186677|11928577|FG000|COMPLETED|Period 2||0
10765158|NCT03186677|11928578|FG001|COMPLETED|Period 2||0
10765159|NCT03186677|11928579|FG002|COMPLETED|Period 2||0
10765160|NCT03186677|11928580|FG003|COMPLETED|Period 2||5
10765161|NCT03186677|11928581|FG004|COMPLETED|Period 2||2
10765162|NCT03186677|11928577|FG000|NOT COMPLETED|Period 2||0
10765163|NCT03186677|11928578|FG001|NOT COMPLETED|Period 2||0
10765164|NCT03186677|11928579|FG002|NOT COMPLETED|Period 2||0
10765165|NCT03186677|11928580|FG003|NOT COMPLETED|Period 2||0
10765166|NCT03186677|11928581|FG004|NOT COMPLETED|Period 2||0
10765167|NCT03186781|11928599|FG000|STARTED|Overall Study||5
10765168|NCT03186781|11928600|FG001|STARTED|Overall Study||5
10765169|NCT03186781|11928601|FG002|STARTED|Overall Study||10
10765170|NCT03186781|11928602|FG003|STARTED|Overall Study||10
10765171|NCT03186781|11928603|FG004|STARTED|Overall Study||10
10765172|NCT03186781|11928604|FG005|STARTED|Overall Study||10
10765173|NCT03186781|11928599|FG000|Received First Product Administration|Overall Study||5
10765174|NCT03186781|11928600|FG001|Received First Product Administration|Overall Study||5
10765175|NCT03186781|11928601|FG002|Received First Product Administration|Overall Study||10
10765176|NCT03186781|11928602|FG003|Received First Product Administration|Overall Study||10
10765177|NCT03186781|11928603|FG004|Received First Product Administration|Overall Study||10
10765178|NCT03186781|11928604|FG005|Received First Product Administration|Overall Study||10
10765179|NCT03186781|11928599|FG000|Received All Product Administrations|Overall Study||5
10765180|NCT03186781|11928600|FG001|Received All Product Administrations|Overall Study||5
10765181|NCT03186781|11928601|FG002|Received All Product Administrations|Overall Study|2nd dose not given due to unrelated intercurrent illness (n=1) and lost to follow up (n=1)|8
10765182|NCT03186781|11928602|FG003|Received All Product Administrations|Overall Study|PI decided not to give 2nd dose to limit variation in environmental exposure to flu between subjects|9
10765183|NCT03186781|11928603|FG004|Received All Product Administrations|Overall Study|2nd dose not given due to subject decision to withdraw (n=2)|8
10765184|NCT03186781|11928604|FG005|Received All Product Administrations|Overall Study|PI decided not to give 2nd dose to limit variation in environmental exposure to flu between subjects|9
10765185|NCT03186781|11928599|FG000|COMPLETED|Overall Study||5
10765186|NCT03186781|11928600|FG001|COMPLETED|Overall Study||5
10765187|NCT03186781|11928601|FG002|COMPLETED|Overall Study||9
10765188|NCT03186781|11928602|FG003|COMPLETED|Overall Study||10
10765189|NCT03186781|11928603|FG004|COMPLETED|Overall Study||7
10765190|NCT03186781|11928604|FG005|COMPLETED|Overall Study||10
10765191|NCT03186781|11928599|FG000|NOT COMPLETED|Overall Study||0
10765192|NCT03186781|11928600|FG001|NOT COMPLETED|Overall Study||0
10765193|NCT03186781|11928601|FG002|NOT COMPLETED|Overall Study||1
10765194|NCT03186781|11928602|FG003|NOT COMPLETED|Overall Study||0
10765195|NCT03186781|11928603|FG004|NOT COMPLETED|Overall Study||3
10765196|NCT03186781|11928604|FG005|NOT COMPLETED|Overall Study||0
10765197|NCT03187002|11928624|FG000|STARTED|Overall Study||55
10765198|NCT03187002|11928625|FG001|STARTED|Overall Study||54
10765199|NCT03187002|11928624|FG000|COMPLETED|Overall Study||55
10765200|NCT03187002|11928625|FG001|COMPLETED|Overall Study||54
10765201|NCT03187002|11928624|FG000|NOT COMPLETED|Overall Study||0
10765202|NCT03187002|11928625|FG001|NOT COMPLETED|Overall Study||0
10765203|NCT03187119|11928633|FG000|STARTED|Overall Study||22
10765204|NCT03187119|11928634|FG001|STARTED|Overall Study||23
10765205|NCT03187119|11928633|FG000|COMPLETED|Overall Study||20
10765206|NCT03187119|11928634|FG001|COMPLETED|Overall Study||18
10765207|NCT03187119|11928633|FG000|NOT COMPLETED|Overall Study||2
10765208|NCT03187119|11928634|FG001|NOT COMPLETED|Overall Study||5
10765209|NCT03187132|11928642|FG000|STARTED|Inpatient Trauma Only||12
10765210|NCT03187132|11928643|FG001|STARTED|Inpatient Trauma Only||12
10765211|NCT03187132|11928642|FG000|COMPLETED|Inpatient Trauma Only||8
10765212|NCT03187132|11928643|FG001|COMPLETED|Inpatient Trauma Only||0
10765213|NCT03187132|11928642|FG000|NOT COMPLETED|Inpatient Trauma Only||4
10765214|NCT03187132|11928643|FG001|NOT COMPLETED|Inpatient Trauma Only||12
10765215|NCT03187132|11928642|FG000|STARTED|Inpatient Trauma+Pain Clinic, no Opioid||4
10765216|NCT03187132|11928643|FG001|STARTED|Inpatient Trauma+Pain Clinic, no Opioid||5
10765217|NCT03187132|11928642|FG000|COMPLETED|Inpatient Trauma+Pain Clinic, no Opioid||3
10765218|NCT03187132|11928643|FG001|COMPLETED|Inpatient Trauma+Pain Clinic, no Opioid||0
10765219|NCT03187132|11928642|FG000|NOT COMPLETED|Inpatient Trauma+Pain Clinic, no Opioid||1
10765220|NCT03187132|11928643|FG001|NOT COMPLETED|Inpatient Trauma+Pain Clinic, no Opioid||5
10765221|NCT03187132|11928642|FG000|STARTED|Inpatient Trauma+Pain Clinic||11
10765222|NCT03187132|11928643|FG001|STARTED|Inpatient Trauma+Pain Clinic||7
10765223|NCT03187132|11928642|FG000|COMPLETED|Inpatient Trauma+Pain Clinic||8
10765224|NCT03187132|11928643|FG001|COMPLETED|Inpatient Trauma+Pain Clinic||0
10765225|NCT03187132|11928642|FG000|NOT COMPLETED|Inpatient Trauma+Pain Clinic||3
10765226|NCT03187132|11928643|FG001|NOT COMPLETED|Inpatient Trauma+Pain Clinic||7
10765227|NCT03187132|11928642|FG000|STARTED|Pain Clinic Only, Fully Remote||76
10765228|NCT03187132|11928643|FG001|STARTED|Pain Clinic Only, Fully Remote||118
10765229|NCT03187132|11928642|FG000|COMPLETED|Pain Clinic Only, Fully Remote||43
10765230|NCT03187132|11928643|FG001|COMPLETED|Pain Clinic Only, Fully Remote||64
10765231|NCT03187132|11928642|FG000|NOT COMPLETED|Pain Clinic Only, Fully Remote||33
10765232|NCT03187132|11928643|FG001|NOT COMPLETED|Pain Clinic Only, Fully Remote||54
10765233|NCT03187197|11928652|FG000|STARTED|Overall Study||153
10765234|NCT03187197|11928653|FG001|STARTED|Overall Study||1097
10765235|NCT03187197|11928654|FG002|STARTED|Overall Study||55
10765236|NCT03187197|11928652|FG000|Started (Eligible Participants as FAS)|Overall Study||139
10765237|NCT03187197|11928653|FG001|Started (Eligible Participants as FAS)|Overall Study||1052
10765238|NCT03187197|11928654|FG002|Started (Eligible Participants as FAS)|Overall Study||54
10765239|NCT03187197|11928652|FG000|COMPLETED|Overall Study||107
10765240|NCT03187197|11928653|FG001|COMPLETED|Overall Study||704
10765241|NCT03187197|11928654|FG002|COMPLETED|Overall Study||32
10765242|NCT03187197|11928652|FG000|NOT COMPLETED|Overall Study||46
10765243|NCT03187197|11928653|FG001|NOT COMPLETED|Overall Study||393
10765244|NCT03187197|11928654|FG002|NOT COMPLETED|Overall Study||23
10765245|NCT03187301|11928662|FG000|STARTED|Titration Period||7
10765246|NCT03187301|11928663|FG001|STARTED|Titration Period||7
10765247|NCT03187301|11928664|FG002|STARTED|Titration Period||7
10765248|NCT03187301|11928665|FG003|STARTED|Titration Period||6
10765249|NCT03187301|11928666|FG004|STARTED|Titration Period||7
10765250|NCT03187301|11928667|FG005|STARTED|Titration Period||7
10765251|NCT03187301|11928668|FG006|STARTED|Titration Period||7
10765252|NCT03187301|11928662|FG000|COMPLETED|Titration Period||7
10765253|NCT03187301|11928663|FG001|COMPLETED|Titration Period||7
10765254|NCT03187301|11928664|FG002|COMPLETED|Titration Period||7
10765255|NCT03187301|11928665|FG003|COMPLETED|Titration Period||6
10765256|NCT03187301|11928666|FG004|COMPLETED|Titration Period||7
10765257|NCT03187301|11928667|FG005|COMPLETED|Titration Period||7
10765258|NCT03187301|11928668|FG006|COMPLETED|Titration Period||0
10765259|NCT03187301|11928662|FG000|NOT COMPLETED|Titration Period||0
10765260|NCT03187301|11928663|FG001|NOT COMPLETED|Titration Period||0
10765261|NCT03187301|11928664|FG002|NOT COMPLETED|Titration Period||0
10765262|NCT03187301|11928665|FG003|NOT COMPLETED|Titration Period||0
10765263|NCT03187301|11928666|FG004|NOT COMPLETED|Titration Period||0
10765264|NCT03187301|11928667|FG005|NOT COMPLETED|Titration Period||0
10765265|NCT03187301|11928668|FG006|NOT COMPLETED|Titration Period||7
10765266|NCT03187301|11928662|FG000|STARTED|Pre-Intervention||7
10765267|NCT03187301|11928663|FG001|STARTED|Pre-Intervention||7
10765268|NCT03187301|11928664|FG002|STARTED|Pre-Intervention||7
10765269|NCT03187301|11928665|FG003|STARTED|Pre-Intervention||6
10765270|NCT03187301|11928666|FG004|STARTED|Pre-Intervention||7
10765271|NCT03187301|11928667|FG005|STARTED|Pre-Intervention||7
10765272|NCT03187301|11928668|FG006|STARTED|Pre-Intervention||0
10765273|NCT03187301|11928662|FG000|COMPLETED|Pre-Intervention||6
10765274|NCT03187301|11928663|FG001|COMPLETED|Pre-Intervention||7
10765275|NCT03187301|11928664|FG002|COMPLETED|Pre-Intervention||7
10765276|NCT03187301|11928665|FG003|COMPLETED|Pre-Intervention||6
10765277|NCT03187301|11928666|FG004|COMPLETED|Pre-Intervention||7
10765278|NCT03187301|11928667|FG005|COMPLETED|Pre-Intervention||7
10765279|NCT03187301|11928668|FG006|COMPLETED|Pre-Intervention||0
10765280|NCT03187301|11928662|FG000|NOT COMPLETED|Pre-Intervention||1
10765281|NCT03187301|11928663|FG001|NOT COMPLETED|Pre-Intervention||0
10765282|NCT03187301|11928664|FG002|NOT COMPLETED|Pre-Intervention||0
10765283|NCT03187301|11928665|FG003|NOT COMPLETED|Pre-Intervention||0
10765284|NCT03187301|11928666|FG004|NOT COMPLETED|Pre-Intervention||0
10765285|NCT03187301|11928667|FG005|NOT COMPLETED|Pre-Intervention||0
10765286|NCT03187301|11928668|FG006|NOT COMPLETED|Pre-Intervention||0
10765287|NCT03187301|11928662|FG000|STARTED|First Intervention||6
10765288|NCT03187301|11928663|FG001|STARTED|First Intervention||7
10765289|NCT03187301|11928664|FG002|STARTED|First Intervention||7
10765290|NCT03187301|11928665|FG003|STARTED|First Intervention||6
10765291|NCT03187301|11928666|FG004|STARTED|First Intervention||7
10765292|NCT03187301|11928667|FG005|STARTED|First Intervention||7
10765293|NCT03187301|11928668|FG006|STARTED|First Intervention||0
10765294|NCT03187301|11928662|FG000|COMPLETED|First Intervention||6
10765295|NCT03187301|11928663|FG001|COMPLETED|First Intervention||7
10765296|NCT03187301|11928664|FG002|COMPLETED|First Intervention||7
10765297|NCT03187301|11928665|FG003|COMPLETED|First Intervention||6
10765298|NCT03187301|11928666|FG004|COMPLETED|First Intervention||7
10765299|NCT03187301|11928667|FG005|COMPLETED|First Intervention||7
10765300|NCT03187301|11928668|FG006|COMPLETED|First Intervention||0
10765301|NCT03187301|11928662|FG000|NOT COMPLETED|First Intervention||0
10765302|NCT03187301|11928663|FG001|NOT COMPLETED|First Intervention||0
10765303|NCT03187301|11928664|FG002|NOT COMPLETED|First Intervention||0
10765304|NCT03187301|11928665|FG003|NOT COMPLETED|First Intervention||0
10765305|NCT03187301|11928666|FG004|NOT COMPLETED|First Intervention||0
10765306|NCT03187301|11928667|FG005|NOT COMPLETED|First Intervention||0
10765307|NCT03187301|11928668|FG006|NOT COMPLETED|First Intervention||0
10765308|NCT03187301|11928662|FG000|STARTED|First Washout||6
10765309|NCT03187301|11928663|FG001|STARTED|First Washout||7
10765310|NCT03187301|11928664|FG002|STARTED|First Washout||7
10765311|NCT03187301|11928665|FG003|STARTED|First Washout||6
10765312|NCT03187301|11928666|FG004|STARTED|First Washout||7
10297402|NCT00265343|11429929|FG001|NOT COMPLETED|Overall Study||19
10297403|NCT00264147|11429940|FG000|STARTED|Treatment I Period||161
10297404|NCT00264147|11429941|FG001|STARTED|Treatment I Period||154
10297405|NCT00264147|11429942|FG002|STARTED|Treatment I Period||151
10297406|NCT00264147|11429943|FG003|STARTED|Treatment I Period||140
10297407|NCT00264147|11429944|FG004|STARTED|Treatment I Period||155
10297408|NCT00264147|11429945|FG005|STARTED|Treatment I Period||0
10297409|NCT00264147|11429940|FG000|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|63
10297410|NCT00264147|11429941|FG001|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|71
10297411|NCT00264147|11429942|FG002|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|74
10297412|NCT00264147|11429943|FG003|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|68
10297413|NCT00264147|11429944|FG004|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|99
10297414|NCT00264147|11429945|FG005|COMPLETED|Treatment I Period||0
10297415|NCT00264147|11429940|FG000|NOT COMPLETED|Treatment I Period||98
10297416|NCT00264147|11429941|FG001|NOT COMPLETED|Treatment I Period||83
10297417|NCT00264147|11429942|FG002|NOT COMPLETED|Treatment I Period||77
10297418|NCT00264147|11429943|FG003|NOT COMPLETED|Treatment I Period||72
10297419|NCT00264147|11429944|FG004|NOT COMPLETED|Treatment I Period||56
10297420|NCT00264147|11429945|FG005|NOT COMPLETED|Treatment I Period||0
10297421|NCT00264147|11429940|FG000|STARTED|Treatment II Period||0
10297422|NCT00264147|11429941|FG001|STARTED|Treatment II Period||0
10297423|NCT00264147|11429942|FG002|STARTED|Treatment II Period||0
10297424|NCT00264147|11429943|FG003|STARTED|Treatment II Period||0
10297425|NCT00264147|11429944|FG004|STARTED|Treatment II Period|Etoricoxib 10 mg (38), 30 mg (28), 60 mg (33), 90 mg (45) and placebo (36) reassigned to 90 mg (180)|180
10297426|NCT00264147|11429945|FG005|STARTED|Treatment II Period|Etoricoxib 10 mg (34), 30 mg (37), 60 mg (29), and placebo (49) reassigned to diclofenac (149)|149
10297427|NCT00264147|11429940|FG000|COMPLETED|Treatment II Period||0
10297428|NCT00264147|11429941|FG001|COMPLETED|Treatment II Period||0
10297429|NCT00264147|11429942|FG002|COMPLETED|Treatment II Period||0
10297430|NCT00264147|11429943|FG003|COMPLETED|Treatment II Period||0
10297431|NCT00264147|11429944|FG004|COMPLETED|Treatment II Period||147
10297432|NCT00264147|11429945|FG005|COMPLETED|Treatment II Period||116
10297433|NCT00264147|11429940|FG000|NOT COMPLETED|Treatment II Period||0
10297434|NCT00264147|11429941|FG001|NOT COMPLETED|Treatment II Period||0
10297435|NCT00264147|11429942|FG002|NOT COMPLETED|Treatment II Period||0
10297436|NCT00264147|11429943|FG003|NOT COMPLETED|Treatment II Period||0
10297437|NCT00264147|11429944|FG004|NOT COMPLETED|Treatment II Period||33
10297438|NCT00264147|11429945|FG005|NOT COMPLETED|Treatment II Period||33
10297439|NCT00202878|11429961|FG000|STARTED|Overall Study||9067
10297440|NCT00202878|11429962|FG001|STARTED|Overall Study||9077
10297441|NCT00202878|11429961|FG000|COMPLETED|Overall Study||6868
10297442|NCT00202878|11429962|FG001|COMPLETED|Overall Study||6860
10297443|NCT00202878|11429961|FG000|NOT COMPLETED|Overall Study||2199
10297444|NCT00202878|11429962|FG001|NOT COMPLETED|Overall Study||2217
10297445|NCT00174265|11429970|FG000|STARTED|Overall Study|85 participants received randomized treatment assignment and at least one dose of study medication.|86
10297446|NCT00174265|11429971|FG001|STARTED|Overall Study||110
10297447|NCT00174265|11429970|FG000|COMPLETED|Overall Study||57
10421640|NCT00820170|11566484|FG003|NOT COMPLETED|Overall Study||0
10297448|NCT00174265|11429971|FG001|COMPLETED|Overall Study||89
10297449|NCT00174265|11429970|FG000|NOT COMPLETED|Overall Study||29
10765313|NCT03187301|11928667|FG005|STARTED|First Washout||7
10765314|NCT03187301|11928668|FG006|STARTED|First Washout||0
10765315|NCT03187301|11928662|FG000|COMPLETED|First Washout||6
10765316|NCT03187301|11928663|FG001|COMPLETED|First Washout||7
10765317|NCT03187301|11928664|FG002|COMPLETED|First Washout||7
10765318|NCT03187301|11928665|FG003|COMPLETED|First Washout||6
10765319|NCT03187301|11928666|FG004|COMPLETED|First Washout||7
10765320|NCT03187301|11928667|FG005|COMPLETED|First Washout||7
10765321|NCT03187301|11928668|FG006|COMPLETED|First Washout||0
10765322|NCT03187301|11928662|FG000|NOT COMPLETED|First Washout||0
10765323|NCT03187301|11928663|FG001|NOT COMPLETED|First Washout||0
10765324|NCT03187301|11928664|FG002|NOT COMPLETED|First Washout||0
10765325|NCT03187301|11928665|FG003|NOT COMPLETED|First Washout||0
10765326|NCT03187301|11928666|FG004|NOT COMPLETED|First Washout||0
10765327|NCT03187301|11928667|FG005|NOT COMPLETED|First Washout||0
10765328|NCT03187301|11928668|FG006|NOT COMPLETED|First Washout||0
10765329|NCT03187301|11928662|FG000|STARTED|Second Intervention||6
10765330|NCT03187301|11928663|FG001|STARTED|Second Intervention||7
10765331|NCT03187301|11928664|FG002|STARTED|Second Intervention||7
10765332|NCT03187301|11928665|FG003|STARTED|Second Intervention||6
10765333|NCT03187301|11928666|FG004|STARTED|Second Intervention||7
10765334|NCT03187301|11928667|FG005|STARTED|Second Intervention||7
10765335|NCT03187301|11928668|FG006|STARTED|Second Intervention||0
10765336|NCT03187301|11928662|FG000|COMPLETED|Second Intervention||6
10765337|NCT03187301|11928663|FG001|COMPLETED|Second Intervention||7
10765338|NCT03187301|11928664|FG002|COMPLETED|Second Intervention||7
10765339|NCT03187301|11928665|FG003|COMPLETED|Second Intervention||6
10765340|NCT03187301|11928666|FG004|COMPLETED|Second Intervention||7
10765341|NCT03187301|11928667|FG005|COMPLETED|Second Intervention||7
10765342|NCT03187301|11928668|FG006|COMPLETED|Second Intervention||0
10765343|NCT03187301|11928662|FG000|NOT COMPLETED|Second Intervention||0
10765344|NCT03187301|11928663|FG001|NOT COMPLETED|Second Intervention||0
10765345|NCT03187301|11928664|FG002|NOT COMPLETED|Second Intervention||0
10765346|NCT03187301|11928665|FG003|NOT COMPLETED|Second Intervention||0
10765347|NCT03187301|11928666|FG004|NOT COMPLETED|Second Intervention||0
10765348|NCT03187301|11928667|FG005|NOT COMPLETED|Second Intervention||0
10765349|NCT03187301|11928668|FG006|NOT COMPLETED|Second Intervention||0
10765350|NCT03187301|11928662|FG000|STARTED|Second Washout||6
10765351|NCT03187301|11928663|FG001|STARTED|Second Washout||7
10765352|NCT03187301|11928664|FG002|STARTED|Second Washout||7
10765353|NCT03187301|11928665|FG003|STARTED|Second Washout||6
10765354|NCT03187301|11928666|FG004|STARTED|Second Washout||7
10765355|NCT03187301|11928667|FG005|STARTED|Second Washout||7
10765356|NCT03187301|11928668|FG006|STARTED|Second Washout||0
10765357|NCT03187301|11928662|FG000|COMPLETED|Second Washout||6
10765358|NCT03187301|11928663|FG001|COMPLETED|Second Washout||7
10765359|NCT03187301|11928664|FG002|COMPLETED|Second Washout||7
10765360|NCT03187301|11928665|FG003|COMPLETED|Second Washout||6
10765361|NCT03187301|11928666|FG004|COMPLETED|Second Washout||7
10765362|NCT03187301|11928667|FG005|COMPLETED|Second Washout||7
10765363|NCT03187301|11928668|FG006|COMPLETED|Second Washout||0
10765364|NCT03187301|11928662|FG000|NOT COMPLETED|Second Washout||0
10765365|NCT03187301|11928663|FG001|NOT COMPLETED|Second Washout||0
10765366|NCT03187301|11928664|FG002|NOT COMPLETED|Second Washout||0
10765367|NCT03187301|11928665|FG003|NOT COMPLETED|Second Washout||0
10765368|NCT03187301|11928666|FG004|NOT COMPLETED|Second Washout||0
10765369|NCT03187301|11928667|FG005|NOT COMPLETED|Second Washout||0
10765370|NCT03187301|11928668|FG006|NOT COMPLETED|Second Washout||0
10765371|NCT03187301|11928662|FG000|STARTED|Third Intervention||6
10765372|NCT03187301|11928663|FG001|STARTED|Third Intervention||7
10765373|NCT03187301|11928664|FG002|STARTED|Third Intervention||7
10765374|NCT03187301|11928665|FG003|STARTED|Third Intervention||6
10765375|NCT03187301|11928666|FG004|STARTED|Third Intervention||7
10765376|NCT03187301|11928667|FG005|STARTED|Third Intervention||7
10765377|NCT03187301|11928668|FG006|STARTED|Third Intervention||0
10765378|NCT03187301|11928662|FG000|COMPLETED|Third Intervention||6
10765379|NCT03187301|11928663|FG001|COMPLETED|Third Intervention||7
10765380|NCT03187301|11928664|FG002|COMPLETED|Third Intervention||7
10765381|NCT03187301|11928665|FG003|COMPLETED|Third Intervention||6
10765382|NCT03187301|11928666|FG004|COMPLETED|Third Intervention||7
10765383|NCT03187301|11928667|FG005|COMPLETED|Third Intervention||7
10765384|NCT03187301|11928668|FG006|COMPLETED|Third Intervention||0
10765385|NCT03187301|11928662|FG000|NOT COMPLETED|Third Intervention||0
10765386|NCT03187301|11928663|FG001|NOT COMPLETED|Third Intervention||0
10765387|NCT03187301|11928664|FG002|NOT COMPLETED|Third Intervention||0
10765388|NCT03187301|11928665|FG003|NOT COMPLETED|Third Intervention||0
10765389|NCT03187301|11928666|FG004|NOT COMPLETED|Third Intervention||0
10765390|NCT03187301|11928667|FG005|NOT COMPLETED|Third Intervention||0
10765391|NCT03187301|11928668|FG006|NOT COMPLETED|Third Intervention||0
10765392|NCT03187418|11928689|FG000|STARTED|Overall Study||52
10765393|NCT03187418|11928689|FG000|COMPLETED|Overall Study||52
10765394|NCT03187418|11928689|FG000|NOT COMPLETED|Overall Study||0
10765395|NCT03187678|11928693|FG000|STARTED|Period 1 (Oral Selexipag)||20
10765396|NCT03187678|11928693|FG000|COMPLETED|Period 1 (Oral Selexipag)||20
10765397|NCT03187678|11928693|FG000|NOT COMPLETED|Period 1 (Oral Selexipag)||0
10765398|NCT03187678|11928693|FG000|STARTED|Period 2 (Intravenous Selexipag)||20
10765399|NCT03187678|11928693|FG000|COMPLETED|Period 2 (Intravenous Selexipag)||20
10765400|NCT03187678|11928693|FG000|NOT COMPLETED|Period 2 (Intravenous Selexipag)||0
10765401|NCT03187678|11928693|FG000|STARTED|Period 3 (Oral Selexipag)||20
10765402|NCT03187678|11928693|FG000|COMPLETED|Period 3 (Oral Selexipag)||20
10765403|NCT03187678|11928693|FG000|NOT COMPLETED|Period 3 (Oral Selexipag)||0
10765404|NCT03187730|11928699|FG000|STARTED|Overall Study||208
10765405|NCT03187730|11928700|FG001|STARTED|Overall Study||202
10765406|NCT03187730|11928699|FG000|COMPLETED|Overall Study||129
10765407|NCT03187730|11928700|FG001|COMPLETED|Overall Study||154
10765408|NCT03187730|11928699|FG000|NOT COMPLETED|Overall Study||79
10765409|NCT03187730|11928700|FG001|NOT COMPLETED|Overall Study||48
10765410|NCT03187756|11928706|FG000|STARTED|Overall Study||6
10765411|NCT03187756|11928706|FG000|COMPLETED|Overall Study||2
10765412|NCT03187756|11928706|FG000|NOT COMPLETED|Overall Study||4
10765413|NCT03188055|11928712|FG000|STARTED|Overall Study||48
10765414|NCT03188055|11928713|FG001|STARTED|Overall Study|Family members consented (24/48 had patient enroll along with them as patient had DMC).|48
10765415|NCT03188055|11928714|FG002|STARTED|Overall Study||62
10765489|NCT03188185|11928737|FG003|COMPLETED|Stage 1||0
10765416|NCT03188055|11928715|FG003|STARTED|Overall Study|Family members consented (19/38 had patient enroll along with them as patient had DMC).|38
10765417|NCT03188055|11928716|FG004|STARTED|Overall Study||59
10765418|NCT03188055|11928717|FG005|STARTED|Overall Study|Anonymous survey, cannot ascertain if same participant completed it for both pre- and post-intervention.|
10765419|NCT03188055|11928712|FG000|Patients Who Provided Self-Consent|Overall Study||0
10765420|NCT03188055|11928713|FG001|Patients Who Provided Self-Consent|Overall Study||24
10765421|NCT03188055|11928714|FG002|Patients Who Provided Self-Consent|Overall Study||0
10765422|NCT03188055|11928715|FG003|Patients Who Provided Self-Consent|Overall Study||19
10765423|NCT03188055|11928716|FG004|Patients Who Provided Self-Consent|Overall Study||0
10765424|NCT03188055|11928717|FG005|Patients Who Provided Self-Consent|Overall Study||0
10765425|NCT03188055|11928712|FG000|MDS Pre-Intervention Survey Responses|Overall Study||0
10765426|NCT03188055|11928713|FG001|MDS Pre-Intervention Survey Responses|Overall Study||0
10765427|NCT03188055|11928714|FG002|MDS Pre-Intervention Survey Responses|Overall Study||0
10765428|NCT03188055|11928715|FG003|MDS Pre-Intervention Survey Responses|Overall Study||0
10765429|NCT03188055|11928716|FG004|MDS Pre-Intervention Survey Responses|Overall Study||0
10765430|NCT03188055|11928717|FG005|MDS Pre-Intervention Survey Responses|Overall Study||99
10297450|NCT00174265|11429971|FG001|NOT COMPLETED|Overall Study||21
10297451|NCT00159783|11429980|FG000|STARTED|Overall Study||32
10297452|NCT00159783|11429981|FG001|STARTED|Overall Study||79
10297453|NCT00159783|11429982|FG002|STARTED|Overall Study||107
10297454|NCT00159783|11429980|FG000|COMPLETED|Overall Study||13
10297455|NCT00159783|11429981|FG001|COMPLETED|Overall Study||52
10297456|NCT00159783|11429982|FG002|COMPLETED|Overall Study||68
10297457|NCT00159783|11429980|FG000|NOT COMPLETED|Overall Study||19
10765431|NCT03188055|11928712|FG000|MDS Post-Intervention Survey Responses|Overall Study||0
10765432|NCT03188055|11928713|FG001|MDS Post-Intervention Survey Responses|Overall Study||0
10765433|NCT03188055|11928714|FG002|MDS Post-Intervention Survey Responses|Overall Study||0
10765434|NCT03188055|11928715|FG003|MDS Post-Intervention Survey Responses|Overall Study||0
10765435|NCT03188055|11928716|FG004|MDS Post-Intervention Survey Responses|Overall Study||0
10765436|NCT03188055|11928717|FG005|MDS Post-Intervention Survey Responses|Overall Study||134
10765437|NCT03188055|11928712|FG000|Patient Survey 1|Overall Study||0
10765438|NCT03188055|11928713|FG001|Patient Survey 1|Overall Study||16
10297458|NCT00159783|11429981|FG001|NOT COMPLETED|Overall Study||27
10297459|NCT00159783|11429982|FG002|NOT COMPLETED|Overall Study||39
10297460|NCT00092677|11429993|FG000|STARTED|Overall Study||944
10765439|NCT03188055|11928714|FG002|Patient Survey 1|Overall Study||0
10765440|NCT03188055|11928715|FG003|Patient Survey 1|Overall Study||13
10765441|NCT03188055|11928716|FG004|Patient Survey 1|Overall Study||0
10765442|NCT03188055|11928717|FG005|Patient Survey 1|Overall Study||0
10765443|NCT03188055|11928712|FG000|Nurse Survey 1|Overall Study||0
10765444|NCT03188055|11928713|FG001|Nurse Survey 1|Overall Study||32
10765445|NCT03188055|11928714|FG002|Nurse Survey 1|Overall Study||0
10765446|NCT03188055|11928715|FG003|Nurse Survey 1|Overall Study||27
10765447|NCT03188055|11928716|FG004|Nurse Survey 1|Overall Study||0
10765448|NCT03188055|11928717|FG005|Nurse Survey 1|Overall Study||0
10765449|NCT03188055|11928712|FG000|Family Survey 1|Overall Study||0
10765450|NCT03188055|11928713|FG001|Family Survey 1|Overall Study||37
10765451|NCT03188055|11928714|FG002|Family Survey 1|Overall Study||0
10765452|NCT03188055|11928715|FG003|Family Survey 1|Overall Study||38
10765453|NCT03188055|11928716|FG004|Family Survey 1|Overall Study||0
10765454|NCT03188055|11928717|FG005|Family Survey 1|Overall Study||0
10765455|NCT03188055|11928712|FG000|Family Survey 2|Overall Study||0
10765456|NCT03188055|11928713|FG001|Family Survey 2|Overall Study||34
10765457|NCT03188055|11928714|FG002|Family Survey 2|Overall Study||0
10765458|NCT03188055|11928715|FG003|Family Survey 2|Overall Study||35
10765459|NCT03188055|11928716|FG004|Family Survey 2|Overall Study||0
10765460|NCT03188055|11928717|FG005|Family Survey 2|Overall Study||0
10765461|NCT03188055|11928712|FG000|Family Survey 3|Overall Study||0
10765462|NCT03188055|11928713|FG001|Family Survey 3|Overall Study||29
10765463|NCT03188055|11928714|FG002|Family Survey 3|Overall Study||0
10765464|NCT03188055|11928715|FG003|Family Survey 3|Overall Study||26
10765465|NCT03188055|11928716|FG004|Family Survey 3|Overall Study||0
10765466|NCT03188055|11928717|FG005|Family Survey 3|Overall Study||0
10765467|NCT03188055|11928712|FG000|COMPLETED|Overall Study||48
10765468|NCT03188055|11928713|FG001|COMPLETED|Overall Study||29
10765469|NCT03188055|11928714|FG002|COMPLETED|Overall Study||43
10765470|NCT03188055|11928715|FG003|COMPLETED|Overall Study||26
10765471|NCT03188055|11928716|FG004|COMPLETED|Overall Study||59
10765472|NCT03188055|11928717|FG005|COMPLETED|Overall Study|Anonymous survey, cannot ascertain if same participant completed it for both pre- and post-intervention.|
10765473|NCT03188055|11928712|FG000|NOT COMPLETED|Overall Study||0
10765474|NCT03188055|11928713|FG001|NOT COMPLETED|Overall Study||19
10765475|NCT03188055|11928714|FG002|NOT COMPLETED|Overall Study||19
10765476|NCT03188055|11928715|FG003|NOT COMPLETED|Overall Study||12
10765477|NCT03188055|11928716|FG004|NOT COMPLETED|Overall Study||0
10765478|NCT03188055|11928717|FG005|NOT COMPLETED|Overall Study||
10765479|NCT03188120|11928728|FG000|STARTED|Overall Study||193
10765480|NCT03188120|11928728|FG000|COMPLETED|Overall Study||146
10765481|NCT03188120|11928728|FG000|NOT COMPLETED|Overall Study||47
10765482|NCT03188185|11928734|FG000|STARTED|Stage 1||198
10765483|NCT03188185|11928735|FG001|STARTED|Stage 1||80
10765484|NCT03188185|11928736|FG002|STARTED|Stage 1||0
10765485|NCT03188185|11928737|FG003|STARTED|Stage 1||0
10765486|NCT03188185|11928734|FG000|COMPLETED|Stage 1||179
10765487|NCT03188185|11928735|FG001|COMPLETED|Stage 1||64
10765488|NCT03188185|11928736|FG002|COMPLETED|Stage 1||0
10765490|NCT03188185|11928734|FG000|NOT COMPLETED|Stage 1||19
10765491|NCT03188185|11928735|FG001|NOT COMPLETED|Stage 1||16
10765492|NCT03188185|11928736|FG002|NOT COMPLETED|Stage 1||0
10765493|NCT03188185|11928737|FG003|NOT COMPLETED|Stage 1||0
10765494|NCT03188185|11928734|FG000|STARTED|Stage 2||0
10765495|NCT03188185|11928735|FG001|STARTED|Stage 2||0
10765496|NCT03188185|11928736|FG002|STARTED|Stage 2||64
10765497|NCT03188185|11928737|FG003|STARTED|Stage 2||63
10765498|NCT03188185|11928734|FG000|COMPLETED|Stage 2||0
10765499|NCT03188185|11928735|FG001|COMPLETED|Stage 2||0
10765500|NCT03188185|11928736|FG002|COMPLETED|Stage 2||55
10765501|NCT03188185|11928737|FG003|COMPLETED|Stage 2||57
10765502|NCT03188185|11928734|FG000|NOT COMPLETED|Stage 2||0
10765503|NCT03188185|11928735|FG001|NOT COMPLETED|Stage 2||0
10765504|NCT03188185|11928736|FG002|NOT COMPLETED|Stage 2||9
10765505|NCT03188185|11928737|FG003|NOT COMPLETED|Stage 2||6
10765506|NCT03188263|11928749|FG000|STARTED|Overall Study||10
10765507|NCT03188263|11928750|FG001|STARTED|Overall Study||0
10765508|NCT03188263|11928749|FG000|COMPLETED|Overall Study||6
10297461|NCT00092677|11429994|FG001|STARTED|Overall Study||929
10765509|NCT03188263|11928750|FG001|COMPLETED|Overall Study||0
10765510|NCT03188263|11928749|FG000|NOT COMPLETED|Overall Study||4
10765511|NCT03188263|11928750|FG001|NOT COMPLETED|Overall Study||0
10765512|NCT03188523|11928758|FG000|STARTED|Overall Study||6
10765513|NCT03188523|11928759|FG001|STARTED|Overall Study||6
10765514|NCT03188523|11928760|FG002|STARTED|Overall Study||0
10765515|NCT03188523|11928761|FG003|STARTED|Overall Study||0
10765516|NCT03188523|11928758|FG000|COMPLETED|Overall Study||6
10765517|NCT03188523|11928759|FG001|COMPLETED|Overall Study||6
10765518|NCT03188523|11928760|FG002|COMPLETED|Overall Study||0
10765519|NCT03188523|11928761|FG003|COMPLETED|Overall Study||0
10297462|NCT00092677|11429993|FG000|COMPLETED|Overall Study|EZ/Simva: 694 (on drug), 140 (after drug discon), 105 (at death)|939
10765520|NCT03188523|11928758|FG000|NOT COMPLETED|Overall Study||0
10765521|NCT03188523|11928759|FG001|NOT COMPLETED|Overall Study||0
10765522|NCT03188523|11928760|FG002|NOT COMPLETED|Overall Study||0
10765523|NCT03188523|11928761|FG003|NOT COMPLETED|Overall Study||0
10765524|NCT03188536|11928767|FG000|STARTED|Overall Study||282
10765525|NCT03188536|11928767|FG000|COMPLETED|Overall Study||276
10765526|NCT03188536|11928767|FG000|NOT COMPLETED|Overall Study||6
10765527|NCT03188718|11928771|FG000|STARTED|Overall Study||45
10765528|NCT03188718|11928771|FG000|COMPLETED|Overall Study||37
10765529|NCT03188718|11928771|FG000|NOT COMPLETED|Overall Study||8
10765530|NCT03188991|11928779|FG000|STARTED|Overall Study||3
10765531|NCT03188991|11928780|FG001|STARTED|Overall Study||3
10765532|NCT03188991|11928781|FG002|STARTED|Overall Study||3
10765533|NCT03188991|11928782|FG003|STARTED|Overall Study||11
10765534|NCT03188991|11928779|FG000|COMPLETED|Overall Study||3
10765535|NCT03188991|11928780|FG001|COMPLETED|Overall Study||3
10765536|NCT03188991|11928781|FG002|COMPLETED|Overall Study||3
10765537|NCT03188991|11928782|FG003|COMPLETED|Overall Study||10
10765538|NCT03188991|11928779|FG000|NOT COMPLETED|Overall Study||0
10765539|NCT03188991|11928780|FG001|NOT COMPLETED|Overall Study||0
10765540|NCT03188991|11928781|FG002|NOT COMPLETED|Overall Study||0
10765541|NCT03188991|11928782|FG003|NOT COMPLETED|Overall Study||1
10765542|NCT03189134|11928792|FG000|STARTED|Overall Study||6
10765543|NCT03189134|11928792|FG000|COMPLETED|Overall Study||6
10765544|NCT03189134|11928792|FG000|NOT COMPLETED|Overall Study||0
10765545|NCT03189446|11928796|FG000|STARTED|Overall Study||32
10765546|NCT03189446|11928796|FG000|COMPLETED|Overall Study||27
10765547|NCT03189446|11928796|FG000|NOT COMPLETED|Overall Study||5
10765548|NCT03189524|11928803|FG000|STARTED|Overall Study||11
10765549|NCT03189524|11928804|FG001|STARTED|Overall Study||10
10765550|NCT03189524|11928805|FG002|STARTED|Overall Study||23
10765551|NCT03189524|11928803|FG000|Received at Least 1 Dose of Study Drug|Overall Study||11
10765552|NCT03189524|11928804|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
10765553|NCT03189524|11928805|FG002|Received at Least 1 Dose of Study Drug|Overall Study||23
10765554|NCT03189524|11928803|FG000|COMPLETED|Overall Study||0
10765555|NCT03189524|11928804|FG001|COMPLETED|Overall Study||0
10765556|NCT03189524|11928805|FG002|COMPLETED|Overall Study||0
10765557|NCT03189524|11928803|FG000|NOT COMPLETED|Overall Study||11
10765558|NCT03189524|11928804|FG001|NOT COMPLETED|Overall Study||10
10765559|NCT03189524|11928805|FG002|NOT COMPLETED|Overall Study||23
10765560|NCT03189589|11928819|FG000|STARTED|Overall Study||6
10765561|NCT03189589|11928820|FG001|STARTED|Overall Study||6
10765562|NCT03189589|11928819|FG000|COMPLETED|Overall Study||6
10765563|NCT03189589|11928820|FG001|COMPLETED|Overall Study||6
10765564|NCT03189589|11928819|FG000|NOT COMPLETED|Overall Study||0
10765565|NCT03189589|11928820|FG001|NOT COMPLETED|Overall Study||0
10765566|NCT03189745|11928828|FG000|STARTED|Overall Study||170
10765567|NCT03189745|11928829|FG001|STARTED|Overall Study||59
10765568|NCT03189745|11928828|FG000|COMPLETED|Overall Study||169
10765569|NCT03189745|11928829|FG001|COMPLETED|Overall Study||58
10765570|NCT03189745|11928828|FG000|NOT COMPLETED|Overall Study||1
10765571|NCT03189745|11928829|FG001|NOT COMPLETED|Overall Study||1
10765572|NCT03190005|11928842|FG000|STARTED|Overall Study||5
10765573|NCT03190005|11928843|FG001|STARTED|Overall Study||5
10765574|NCT03190005|11928844|FG002|STARTED|Overall Study||5
10765575|NCT03190005|11928845|FG003|STARTED|Overall Study||5
10765576|NCT03190005|11928846|FG004|STARTED|Overall Study||5
10765577|NCT03190005|11928847|FG005|STARTED|Overall Study||5
10765578|NCT03190005|11928848|FG006|STARTED|Overall Study||5
10765579|NCT03190005|11928842|FG000|COMPLETED|Overall Study||5
10765580|NCT03190005|11928843|FG001|COMPLETED|Overall Study||5
10765581|NCT03190005|11928844|FG002|COMPLETED|Overall Study||5
10765582|NCT03190005|11928845|FG003|COMPLETED|Overall Study||5
10765583|NCT03190005|11928846|FG004|COMPLETED|Overall Study||5
10765584|NCT03190005|11928847|FG005|COMPLETED|Overall Study||5
10765585|NCT03190005|11928848|FG006|COMPLETED|Overall Study||5
10765586|NCT03190005|11928842|FG000|NOT COMPLETED|Overall Study||0
10765587|NCT03190005|11928843|FG001|NOT COMPLETED|Overall Study||0
10765588|NCT03190005|11928844|FG002|NOT COMPLETED|Overall Study||0
10765589|NCT03190005|11928845|FG003|NOT COMPLETED|Overall Study||0
10765590|NCT03190005|11928846|FG004|NOT COMPLETED|Overall Study||0
10765591|NCT03190005|11928847|FG005|NOT COMPLETED|Overall Study||0
10765592|NCT03190005|11928848|FG006|NOT COMPLETED|Overall Study||0
10765593|NCT03190083|11928864|FG000|STARTED|Overall Study||16
10765594|NCT03190083|11928864|FG000|COMPLETED|Overall Study||16
10765595|NCT03190083|11928864|FG000|NOT COMPLETED|Overall Study||0
10765596|NCT03190213|11928868|FG000|STARTED|Overall Study||6
10765597|NCT03190213|11928868|FG000|COMPLETED|Overall Study||6
10765598|NCT03190213|11928868|FG000|NOT COMPLETED|Overall Study||0
10765599|NCT03190993|11928874|FG000|STARTED|Overall Study||10
10765600|NCT03190993|11928875|FG001|STARTED|Overall Study||10
10765601|NCT03190993|11928874|FG000|COMPLETED|Overall Study||10
10765602|NCT03190993|11928875|FG001|COMPLETED|Overall Study||10
10765603|NCT03190993|11928874|FG000|NOT COMPLETED|Overall Study||0
10765604|NCT03190993|11928875|FG001|NOT COMPLETED|Overall Study||0
10765605|NCT03191396|11928883|FG000|STARTED|Overall Study||290
10765606|NCT03191396|11928884|FG001|STARTED|Overall Study||287
10765607|NCT03191396|11928883|FG000|COMPLETED|Overall Study||287
10765608|NCT03191396|11928884|FG001|COMPLETED|Overall Study||282
10765609|NCT03191396|11928883|FG000|NOT COMPLETED|Overall Study||3
10765610|NCT03191396|11928884|FG001|NOT COMPLETED|Overall Study||5
10765611|NCT03191552|11928893|FG000|STARTED|Overall Study||9
10765612|NCT03191552|11928894|FG001|STARTED|Overall Study||9
10765613|NCT03191552|11928895|FG002|STARTED|Overall Study||8
10765614|NCT03191552|11928893|FG000|COMPLETED|Overall Study||8
10765615|NCT03191552|11928894|FG001|COMPLETED|Overall Study||8
10765616|NCT03191552|11928895|FG002|COMPLETED|Overall Study||8
10765617|NCT03191552|11928893|FG000|NOT COMPLETED|Overall Study||1
10765618|NCT03191552|11928894|FG001|NOT COMPLETED|Overall Study||1
10765619|NCT03191552|11928895|FG002|NOT COMPLETED|Overall Study||0
10765620|NCT03191630|11928909|FG000|STARTED|Overall Study||30
10765621|NCT03191630|11928910|FG001|STARTED|Overall Study||30
10765622|NCT03191630|11928909|FG000|COMPLETED|Overall Study||23
10765623|NCT03191630|11928910|FG001|COMPLETED|Overall Study||23
10765624|NCT03191630|11928909|FG000|NOT COMPLETED|Overall Study||7
10765625|NCT03191630|11928910|FG001|NOT COMPLETED|Overall Study||7
10765626|NCT03191799|11928918|FG000|STARTED|Overall Study||195
10765627|NCT03191799|11928918|FG000|Received at Least One Dose of Emicizumab|Overall Study||193
10765628|NCT03191799|11928918|FG000|Dose Up-Titrated to 3 mg/kg QW|Overall Study||2
10765629|NCT03191799|11928918|FG000|COMPLETED|Overall Study||186
10765630|NCT03191799|11928918|FG000|NOT COMPLETED|Overall Study||9
10765631|NCT03192137|11928924|FG000|STARTED|Overall Study||173
10765632|NCT03192137|11928925|FG001|STARTED|Overall Study||87
10765633|NCT03192137|11928924|FG000|COMPLETED|Overall Study||123
10765634|NCT03192137|11928925|FG001|COMPLETED|Overall Study||29
10765635|NCT03192137|11928924|FG000|NOT COMPLETED|Overall Study||50
10765636|NCT03192137|11928925|FG001|NOT COMPLETED|Overall Study||58
10765637|NCT03192150|11928933|FG000|STARTED|Overall Study||163
10765638|NCT03192150|11928934|FG001|STARTED|Overall Study||83
10765639|NCT03192150|11928933|FG000|COMPLETED|Overall Study||108
10765640|NCT03192150|11928934|FG001|COMPLETED|Overall Study||29
10765641|NCT03192150|11928933|FG000|NOT COMPLETED|Overall Study||55
10765642|NCT03192150|11928934|FG001|NOT COMPLETED|Overall Study||54
10765643|NCT03192176|11928948|FG000|STARTED|Overall Study||44
10765644|NCT03192176|11928949|FG001|STARTED|Overall Study||45
10765645|NCT03192176|11928950|FG002|STARTED|Overall Study||44
10765646|NCT03192176|11928951|FG003|STARTED|Overall Study||45
10765647|NCT03192176|11928952|FG004|STARTED|Overall Study||44
10765648|NCT03192176|11928953|FG005|STARTED|Overall Study||45
10765649|NCT03192176|11928954|FG006|STARTED|Overall Study||45
10765650|NCT03192176|11928955|FG007|STARTED|Overall Study||44
10765651|NCT03192176|11928948|FG000|Treated|Overall Study||43
10765652|NCT03192176|11928949|FG001|Treated|Overall Study||45
10765653|NCT03192176|11928950|FG002|Treated|Overall Study||43
10765654|NCT03192176|11928951|FG003|Treated|Overall Study||45
10765655|NCT03192176|11928952|FG004|Treated|Overall Study||44
10765656|NCT03192176|11928953|FG005|Treated|Overall Study||43
10765657|NCT03192176|11928954|FG006|Treated|Overall Study||45
10765658|NCT03192176|11928955|FG007|Treated|Overall Study||44
10765659|NCT03192176|11928948|FG000|COMPLETED|Overall Study||37
10765660|NCT03192176|11928949|FG001|COMPLETED|Overall Study||40
10765661|NCT03192176|11928950|FG002|COMPLETED|Overall Study||38
10765662|NCT03192176|11928951|FG003|COMPLETED|Overall Study||33
10765663|NCT03192176|11928952|FG004|COMPLETED|Overall Study||32
10765664|NCT03192176|11928953|FG005|COMPLETED|Overall Study||34
10765665|NCT03192176|11928954|FG006|COMPLETED|Overall Study||36
10765666|NCT03192176|11928955|FG007|COMPLETED|Overall Study||37
10765667|NCT03192176|11928948|FG000|NOT COMPLETED|Overall Study||7
10765668|NCT03192176|11928949|FG001|NOT COMPLETED|Overall Study||5
10765669|NCT03192176|11928950|FG002|NOT COMPLETED|Overall Study||6
10765670|NCT03192176|11928951|FG003|NOT COMPLETED|Overall Study||12
10765671|NCT03192176|11928952|FG004|NOT COMPLETED|Overall Study||12
10765672|NCT03192176|11928953|FG005|NOT COMPLETED|Overall Study||11
10765673|NCT03192176|11928954|FG006|NOT COMPLETED|Overall Study||9
10765674|NCT03192176|11928955|FG007|NOT COMPLETED|Overall Study||7
10765675|NCT03192306|11928976|FG000|STARTED|Overall Study||227
10765676|NCT03192306|11928977|FG001|STARTED|Overall Study||224
10765677|NCT03192306|11928976|FG000|Modified Intent to Treat (MITT)|Overall Study||76
10765678|NCT03192306|11928977|FG001|Modified Intent to Treat (MITT)|Overall Study||80
10765679|NCT03192306|11928976|FG000|COMPLETED|Overall Study||75
10765680|NCT03192306|11928977|FG001|COMPLETED|Overall Study||79
10765681|NCT03192306|11928976|FG000|NOT COMPLETED|Overall Study||152
10765682|NCT03192306|11928977|FG001|NOT COMPLETED|Overall Study||145
10765683|NCT03192475|11928985|FG000|STARTED|Overall Study||162
10765684|NCT03192475|11928986|FG001|STARTED|Overall Study||160
10765685|NCT03192475|11928985|FG000|COMPLETED|Overall Study||149
10765686|NCT03192475|11928986|FG001|COMPLETED|Overall Study||151
10765687|NCT03192475|11928985|FG000|NOT COMPLETED|Overall Study||13
10765688|NCT03192475|11928986|FG001|NOT COMPLETED|Overall Study||9
10765689|NCT03192488|11928993|FG000|STARTED|First Intervention (d1)||1
10765690|NCT03192488|11928994|FG001|STARTED|First Intervention (d1)||5
10765691|NCT03192488|11928995|FG002|STARTED|First Intervention (d1)||2
10765692|NCT03192488|11928996|FG003|STARTED|First Intervention (d1)||1
10765693|NCT03192488|11928997|FG004|STARTED|First Intervention (d1)||1
10765694|NCT03192488|11928998|FG005|STARTED|First Intervention (d1)||1
10765695|NCT03192488|11928993|FG000|COMPLETED|First Intervention (d1)||1
10765696|NCT03192488|11928994|FG001|COMPLETED|First Intervention (d1)||5
10765697|NCT03192488|11928995|FG002|COMPLETED|First Intervention (d1)||2
10765698|NCT03192488|11928996|FG003|COMPLETED|First Intervention (d1)||1
10765699|NCT03192488|11928997|FG004|COMPLETED|First Intervention (d1)||1
10765700|NCT03192488|11928998|FG005|COMPLETED|First Intervention (d1)||1
10765701|NCT03192488|11928993|FG000|NOT COMPLETED|First Intervention (d1)||0
10765702|NCT03192488|11928994|FG001|NOT COMPLETED|First Intervention (d1)||0
10765703|NCT03192488|11928995|FG002|NOT COMPLETED|First Intervention (d1)||0
10765704|NCT03192488|11928996|FG003|NOT COMPLETED|First Intervention (d1)||0
10765705|NCT03192488|11928997|FG004|NOT COMPLETED|First Intervention (d1)||0
10765706|NCT03192488|11928998|FG005|NOT COMPLETED|First Intervention (d1)||0
10765707|NCT03192488|11928993|FG000|STARTED|First Washout (>6d)||1
10765708|NCT03192488|11928994|FG001|STARTED|First Washout (>6d)||5
10765709|NCT03192488|11928995|FG002|STARTED|First Washout (>6d)||2
10765710|NCT03192488|11928996|FG003|STARTED|First Washout (>6d)||1
10765711|NCT03192488|11928997|FG004|STARTED|First Washout (>6d)||1
10765712|NCT03192488|11928998|FG005|STARTED|First Washout (>6d)||1
10765713|NCT03192488|11928993|FG000|COMPLETED|First Washout (>6d)||1
10765714|NCT03192488|11928994|FG001|COMPLETED|First Washout (>6d)||5
10765715|NCT03192488|11928995|FG002|COMPLETED|First Washout (>6d)||1
10765716|NCT03192488|11928996|FG003|COMPLETED|First Washout (>6d)||1
10765717|NCT03192488|11928997|FG004|COMPLETED|First Washout (>6d)||1
10765718|NCT03192488|11928998|FG005|COMPLETED|First Washout (>6d)||0
10765719|NCT03192488|11928993|FG000|NOT COMPLETED|First Washout (>6d)||0
10765720|NCT03192488|11928994|FG001|NOT COMPLETED|First Washout (>6d)||0
10765721|NCT03192488|11928995|FG002|NOT COMPLETED|First Washout (>6d)||1
10765722|NCT03192488|11928996|FG003|NOT COMPLETED|First Washout (>6d)||0
10765723|NCT03192488|11928997|FG004|NOT COMPLETED|First Washout (>6d)||0
10765724|NCT03192488|11928998|FG005|NOT COMPLETED|First Washout (>6d)||1
10765725|NCT03192488|11928993|FG000|STARTED|Second Intervention (d1)||1
10765726|NCT03192488|11928994|FG001|STARTED|Second Intervention (d1)||5
10765727|NCT03192488|11928995|FG002|STARTED|Second Intervention (d1)||1
10765728|NCT03192488|11928996|FG003|STARTED|Second Intervention (d1)||1
10765729|NCT03192488|11928997|FG004|STARTED|Second Intervention (d1)||1
10765730|NCT03192488|11928998|FG005|STARTED|Second Intervention (d1)||0
10765731|NCT03192488|11928993|FG000|COMPLETED|Second Intervention (d1)||1
10765732|NCT03192488|11928994|FG001|COMPLETED|Second Intervention (d1)||5
10765733|NCT03192488|11928995|FG002|COMPLETED|Second Intervention (d1)||1
10765734|NCT03192488|11928996|FG003|COMPLETED|Second Intervention (d1)||1
10765735|NCT03192488|11928997|FG004|COMPLETED|Second Intervention (d1)||1
10765736|NCT03192488|11928998|FG005|COMPLETED|Second Intervention (d1)||0
10765737|NCT03192488|11928993|FG000|NOT COMPLETED|Second Intervention (d1)||0
10765738|NCT03192488|11928994|FG001|NOT COMPLETED|Second Intervention (d1)||0
10765739|NCT03192488|11928995|FG002|NOT COMPLETED|Second Intervention (d1)||0
10765740|NCT03192488|11928996|FG003|NOT COMPLETED|Second Intervention (d1)||0
10765741|NCT03192488|11928997|FG004|NOT COMPLETED|Second Intervention (d1)||0
10765742|NCT03192488|11928998|FG005|NOT COMPLETED|Second Intervention (d1)||0
10765743|NCT03192488|11928993|FG000|STARTED|Second Washout (>6d)||1
10765744|NCT03192488|11928994|FG001|STARTED|Second Washout (>6d)||5
10765745|NCT03192488|11928995|FG002|STARTED|Second Washout (>6d)||1
10765746|NCT03192488|11928996|FG003|STARTED|Second Washout (>6d)||1
10765747|NCT03192488|11928997|FG004|STARTED|Second Washout (>6d)||1
10765748|NCT03192488|11928998|FG005|STARTED|Second Washout (>6d)||0
10765749|NCT03192488|11928993|FG000|COMPLETED|Second Washout (>6d)||1
10765750|NCT03192488|11928994|FG001|COMPLETED|Second Washout (>6d)||5
10765751|NCT03192488|11928995|FG002|COMPLETED|Second Washout (>6d)||1
10765752|NCT03192488|11928996|FG003|COMPLETED|Second Washout (>6d)||1
10765753|NCT03192488|11928997|FG004|COMPLETED|Second Washout (>6d)||1
10765754|NCT03192488|11928998|FG005|COMPLETED|Second Washout (>6d)||0
10765755|NCT03192488|11928993|FG000|NOT COMPLETED|Second Washout (>6d)||0
10765756|NCT03192488|11928994|FG001|NOT COMPLETED|Second Washout (>6d)||0
10765757|NCT03192488|11928995|FG002|NOT COMPLETED|Second Washout (>6d)||0
10765758|NCT03192488|11928996|FG003|NOT COMPLETED|Second Washout (>6d)||0
10765759|NCT03192488|11928997|FG004|NOT COMPLETED|Second Washout (>6d)||0
10765760|NCT03192488|11928998|FG005|NOT COMPLETED|Second Washout (>6d)||0
10765761|NCT03192488|11928993|FG000|STARTED|Third Intervention (d1)||1
10765762|NCT03192488|11928994|FG001|STARTED|Third Intervention (d1)||5
10765763|NCT03192488|11928995|FG002|STARTED|Third Intervention (d1)||1
10765764|NCT03192488|11928996|FG003|STARTED|Third Intervention (d1)||1
10765765|NCT03192488|11928997|FG004|STARTED|Third Intervention (d1)||1
10765766|NCT03192488|11928998|FG005|STARTED|Third Intervention (d1)||0
10765767|NCT03192488|11928993|FG000|COMPLETED|Third Intervention (d1)||1
10765768|NCT03192488|11928994|FG001|COMPLETED|Third Intervention (d1)||5
10765769|NCT03192488|11928995|FG002|COMPLETED|Third Intervention (d1)||1
10765770|NCT03192488|11928996|FG003|COMPLETED|Third Intervention (d1)||1
10765771|NCT03192488|11928997|FG004|COMPLETED|Third Intervention (d1)||0
10765772|NCT03192488|11928998|FG005|COMPLETED|Third Intervention (d1)||0
10765773|NCT03192488|11928993|FG000|NOT COMPLETED|Third Intervention (d1)||0
10765774|NCT03192488|11928994|FG001|NOT COMPLETED|Third Intervention (d1)||0
10765775|NCT03192488|11928995|FG002|NOT COMPLETED|Third Intervention (d1)||0
10765776|NCT03192488|11928996|FG003|NOT COMPLETED|Third Intervention (d1)||0
10765777|NCT03192488|11928997|FG004|NOT COMPLETED|Third Intervention (d1)||1
10765778|NCT03192488|11928998|FG005|NOT COMPLETED|Third Intervention (d1)||0
10765779|NCT03192826|11929015|FG000|STARTED|Overall Study||27
10765780|NCT03192826|11929016|FG001|STARTED|Overall Study||27
10765781|NCT03192826|11929017|FG002|STARTED|Overall Study||25
10765782|NCT03192826|11929015|FG000|COMPLETED|Overall Study||27
10765783|NCT03192826|11929016|FG001|COMPLETED|Overall Study||27
10765784|NCT03192826|11929017|FG002|COMPLETED|Overall Study||25
10765785|NCT03192826|11929015|FG000|NOT COMPLETED|Overall Study||0
10765786|NCT03192826|11929016|FG001|NOT COMPLETED|Overall Study||0
10765787|NCT03192826|11929017|FG002|NOT COMPLETED|Overall Study||0
10765788|NCT03192904|11929027|FG000|STARTED|Overall Study||35
10765789|NCT03192904|11929028|FG001|STARTED|Overall Study||35
10765790|NCT03192904|11929027|FG000|COMPLETED|Overall Study||32
10765791|NCT03192904|11929028|FG001|COMPLETED|Overall Study||33
10765792|NCT03192904|11929027|FG000|NOT COMPLETED|Overall Study||3
10765793|NCT03192904|11929028|FG001|NOT COMPLETED|Overall Study||2
10765794|NCT03193021|11929036|FG000|STARTED|Overall Study||100
10765795|NCT03193021|11929037|FG001|STARTED|Overall Study||104
10765796|NCT03193021|11929036|FG000|COMPLETED|Overall Study||99
10765797|NCT03193021|11929037|FG001|COMPLETED|Overall Study||103
10765798|NCT03193021|11929036|FG000|NOT COMPLETED|Overall Study||1
10765799|NCT03193021|11929037|FG001|NOT COMPLETED|Overall Study||1
10765800|NCT03193047|11929045|FG000|STARTED|Overall Study||31
10765801|NCT03193047|11929046|FG001|STARTED|Overall Study||28
10765802|NCT03193047|11929045|FG000|COMPLETED|Overall Study||29
10765803|NCT03193047|11929046|FG001|COMPLETED|Overall Study||28
10765804|NCT03193047|11929045|FG000|NOT COMPLETED|Overall Study||2
10765805|NCT03193047|11929046|FG001|NOT COMPLETED|Overall Study||0
10765806|NCT03193398|11929056|FG000|STARTED|Overall Study||53
10765807|NCT03193398|11929057|FG001|STARTED|Overall Study||51
10765808|NCT03193398|11929056|FG000|COMPLETED|Overall Study||38
10765809|NCT03193398|11929057|FG001|COMPLETED|Overall Study||35
10765810|NCT03193398|11929056|FG000|NOT COMPLETED|Overall Study||15
10765811|NCT03193398|11929057|FG001|NOT COMPLETED|Overall Study||16
10765812|NCT03193593|11929070|FG000|STARTED|Overall Study||18
10765813|NCT03193593|11929071|FG001|STARTED|Overall Study||4
10765814|NCT03193593|11929072|FG002|STARTED|Overall Study||4
10765815|NCT03193593|11929073|FG003|STARTED|Overall Study||4
10765816|NCT03193593|11929074|FG004|STARTED|Overall Study||8
10765817|NCT03193593|11929075|FG005|STARTED|Overall Study||16
10765818|NCT03193593|11929076|FG006|STARTED|Overall Study||12
10765819|NCT03193593|11929070|FG000|COMPLETED|Overall Study||14
10765820|NCT03193593|11929071|FG001|COMPLETED|Overall Study||3
10765821|NCT03193593|11929072|FG002|COMPLETED|Overall Study||3
10765822|NCT03193593|11929073|FG003|COMPLETED|Overall Study||4
10765823|NCT03193593|11929074|FG004|COMPLETED|Overall Study||7
10765824|NCT03193593|11929075|FG005|COMPLETED|Overall Study||13
10765825|NCT03193593|11929076|FG006|COMPLETED|Overall Study||8
10765826|NCT03193593|11929070|FG000|NOT COMPLETED|Overall Study||4
10765827|NCT03193593|11929071|FG001|NOT COMPLETED|Overall Study||1
10765828|NCT03193593|11929072|FG002|NOT COMPLETED|Overall Study||1
10765829|NCT03193593|11929073|FG003|NOT COMPLETED|Overall Study||0
10765830|NCT03193593|11929074|FG004|NOT COMPLETED|Overall Study||1
10765831|NCT03193593|11929075|FG005|NOT COMPLETED|Overall Study||3
10765832|NCT03193593|11929076|FG006|NOT COMPLETED|Overall Study||4
10765833|NCT03193736|11929092|FG000|STARTED|Overall Study||26
10765834|NCT03193736|11929092|FG000|Received Implant|Overall Study||25
10765835|NCT03193736|11929092|FG000|COMPLETED|Overall Study||21
10765836|NCT03193736|11929092|FG000|NOT COMPLETED|Overall Study||5
10765837|NCT03194217|11929100|FG000|STARTED|Overall Study||60
10765838|NCT03194217|11929101|FG001|STARTED|Overall Study||60
10765839|NCT03194217|11929102|FG002|STARTED|Overall Study||60
10765840|NCT03194217|11929103|FG003|STARTED|Overall Study||64
10765841|NCT03194217|11929100|FG000|COMPLETED|Overall Study||60
10765842|NCT03194217|11929101|FG001|COMPLETED|Overall Study||57
10765843|NCT03194217|11929102|FG002|COMPLETED|Overall Study||56
10765844|NCT03194217|11929103|FG003|COMPLETED|Overall Study||60
10765845|NCT03194217|11929100|FG000|NOT COMPLETED|Overall Study||0
10765846|NCT03194217|11929101|FG001|NOT COMPLETED|Overall Study||3
10765847|NCT03194217|11929102|FG002|NOT COMPLETED|Overall Study||4
10765848|NCT03194217|11929103|FG003|NOT COMPLETED|Overall Study||4
10765849|NCT03194334|11929116|FG000|STARTED|0-3 Months||10
10765850|NCT03194334|11929117|FG001|STARTED|0-3 Months||15
10765851|NCT03194334|11929118|FG002|STARTED|0-3 Months||15
10765852|NCT03194334|11929116|FG000|COMPLETED|0-3 Months||10
10765853|NCT03194334|11929117|FG001|COMPLETED|0-3 Months||15
10765854|NCT03194334|11929118|FG002|COMPLETED|0-3 Months||14
10765855|NCT03194334|11929116|FG000|NOT COMPLETED|0-3 Months||0
10765856|NCT03194334|11929117|FG001|NOT COMPLETED|0-3 Months||0
10765857|NCT03194334|11929118|FG002|NOT COMPLETED|0-3 Months||1
10765858|NCT03194334|11929116|FG000|STARTED|3-6 Months||10
10765859|NCT03194334|11929117|FG001|STARTED|3-6 Months||15
10765860|NCT03194334|11929118|FG002|STARTED|3-6 Months||14
10765861|NCT03194334|11929116|FG000|COMPLETED|3-6 Months||10
10765862|NCT03194334|11929117|FG001|COMPLETED|3-6 Months||15
10765863|NCT03194334|11929118|FG002|COMPLETED|3-6 Months||14
10765864|NCT03194334|11929116|FG000|NOT COMPLETED|3-6 Months||0
10765865|NCT03194334|11929117|FG001|NOT COMPLETED|3-6 Months||0
10765866|NCT03194334|11929118|FG002|NOT COMPLETED|3-6 Months||0
10765867|NCT03194373|11929127|FG000|STARTED|Overall Study||20
10765868|NCT03194373|11929127|FG000|Received Palbociclib and Carboplatin|Overall Study||19
10765869|NCT03194373|11929127|FG000|COMPLETED|Overall Study||18
10765870|NCT03194373|11929127|FG000|NOT COMPLETED|Overall Study||2
10765871|NCT03194464|11929131|FG000|STARTED|Overall Study||15
10765872|NCT03194464|11929131|FG000|COMPLETED|Overall Study||13
10765873|NCT03194464|11929131|FG000|NOT COMPLETED|Overall Study||2
10765874|NCT03194490|11929139|FG000|STARTED|Overall Study||20
10765875|NCT03194490|11929140|FG001|STARTED|Overall Study||23
10765876|NCT03194490|11929139|FG000|COMPLETED|Overall Study||18
10765877|NCT03194490|11929140|FG001|COMPLETED|Overall Study||20
10765878|NCT03194490|11929139|FG000|NOT COMPLETED|Overall Study||2
10765879|NCT03194490|11929140|FG001|NOT COMPLETED|Overall Study||3
10765880|NCT03194503|11929149|FG000|STARTED|Overall Study||458
10765881|NCT03194503|11929150|FG001|STARTED|Overall Study||1054
10765882|NCT03194503|11929149|FG000|COMPLETED|Overall Study||458
10765883|NCT03194503|11929150|FG001|COMPLETED|Overall Study||1054
10765884|NCT03194503|11929149|FG000|NOT COMPLETED|Overall Study||0
10765885|NCT03194503|11929150|FG001|NOT COMPLETED|Overall Study||0
10765886|NCT03194698|11929160|FG000|STARTED|Overall Study||10
10765887|NCT03194698|11929161|FG001|STARTED|Overall Study||10
10765888|NCT03194698|11929160|FG000|COMPLETED|Overall Study||10
10765889|NCT03194698|11929161|FG001|COMPLETED|Overall Study||10
10765890|NCT03194698|11929160|FG000|NOT COMPLETED|Overall Study||0
10765891|NCT03194698|11929161|FG001|NOT COMPLETED|Overall Study||0
10765892|NCT03194737|11929169|FG000|STARTED|Overall Study||52
10765893|NCT03194737|11929170|FG001|STARTED|Overall Study||49
10765894|NCT03194737|11929169|FG000|COMPLETED|Overall Study||47
10765895|NCT03194737|11929170|FG001|COMPLETED|Overall Study||49
10765896|NCT03194737|11929169|FG000|NOT COMPLETED|Overall Study||5
10765897|NCT03194737|11929170|FG001|NOT COMPLETED|Overall Study||0
10765898|NCT03194776|11929178|FG000|STARTED|Overall Study||23
10765899|NCT03194776|11929179|FG001|STARTED|Overall Study||23
10765900|NCT03194776|11929178|FG000|COMPLETED|Overall Study||23
10765901|NCT03194776|11929179|FG001|COMPLETED|Overall Study||23
10765902|NCT03194776|11929178|FG000|NOT COMPLETED|Overall Study||0
10765903|NCT03194776|11929179|FG001|NOT COMPLETED|Overall Study||0
10765904|NCT03195010|11929188|FG000|STARTED|Overall Study||2
10765905|NCT03195010|11929189|FG001|STARTED|Overall Study||2
10765906|NCT03195010|11929188|FG000|COMPLETED|Overall Study||2
10765907|NCT03195010|11929189|FG001|COMPLETED|Overall Study||2
10765908|NCT03195010|11929188|FG000|NOT COMPLETED|Overall Study||0
10765909|NCT03195010|11929189|FG001|NOT COMPLETED|Overall Study||0
10765910|NCT03195517|11929197|FG000|STARTED|Overall Study||33
10765911|NCT03195517|11929197|FG000|COMPLETED|Overall Study||33
10765912|NCT03195517|11929197|FG000|NOT COMPLETED|Overall Study||0
10765913|NCT03196076|11929208|FG000|STARTED|Overall Study||5
10765914|NCT03196076|11929209|FG001|STARTED|Overall Study||20
10765915|NCT03196076|11929210|FG002|STARTED|Overall Study||0
10765916|NCT03196076|11929208|FG000|COMPLETED|Overall Study||5
10765917|NCT03196076|11929209|FG001|COMPLETED|Overall Study||20
10765918|NCT03196076|11929210|FG002|COMPLETED|Overall Study||0
10765919|NCT03196076|11929208|FG000|NOT COMPLETED|Overall Study||0
10765920|NCT03196076|11929209|FG001|NOT COMPLETED|Overall Study||0
10765921|NCT03196076|11929210|FG002|NOT COMPLETED|Overall Study||0
10765922|NCT03196193|11929220|FG000|STARTED|Overall Study||121
10765923|NCT03196193|11929221|FG001|STARTED|Overall Study||119
10765924|NCT03196193|11929220|FG000|COMPLETED|Overall Study||118
10765925|NCT03196193|11929221|FG001|COMPLETED|Overall Study||119
10765926|NCT03196193|11929220|FG000|NOT COMPLETED|Overall Study||3
10765927|NCT03196193|11929221|FG001|NOT COMPLETED|Overall Study||0
10765928|NCT03196232|11929227|FG000|STARTED|Overall Study||3
10765929|NCT03196232|11929227|FG000|COMPLETED|Overall Study||3
10765930|NCT03196232|11929227|FG000|NOT COMPLETED|Overall Study||0
10765931|NCT03196284|11929233|FG000|STARTED|Main Part||17
10765932|NCT03196284|11929234|FG001|STARTED|Main Part||9
10765933|NCT03196284|11929235|FG002|STARTED|Main Part||0
10765934|NCT03196284|11929233|FG000|Concizumab 0.15 mg/kg|Main Part||15
10765935|NCT03196284|11929234|FG001|Concizumab 0.15 mg/kg|Main Part||0
10765936|NCT03196284|11929235|FG002|Concizumab 0.15 mg/kg|Main Part||0
10765937|NCT03196284|11929233|FG000|Concizumab 0.20 mg/kg|Main Part||2
10765938|NCT03196284|11929234|FG001|Concizumab 0.20 mg/kg|Main Part||0
10765939|NCT03196284|11929235|FG002|Concizumab 0.20 mg/kg|Main Part||0
10765940|NCT03196284|11929233|FG000|Concizumab 0.25 mg/kg|Main Part||0
10765941|NCT03196284|11929234|FG001|Concizumab 0.25 mg/kg|Main Part||0
10765942|NCT03196284|11929235|FG002|Concizumab 0.25 mg/kg|Main Part||0
10765943|NCT03196284|11929233|FG000|COMPLETED|Main Part||17
10765944|NCT03196284|11929234|FG001|COMPLETED|Main Part||8
10765945|NCT03196284|11929235|FG002|COMPLETED|Main Part||0
10765946|NCT03196284|11929233|FG000|NOT COMPLETED|Main Part||0
10765947|NCT03196284|11929234|FG001|NOT COMPLETED|Main Part||1
10765948|NCT03196284|11929235|FG002|NOT COMPLETED|Main Part||0
10765949|NCT03196284|11929233|FG000|STARTED|Extension Part|Participants who completed main part are presented in separate treatment arm.|0
10765950|NCT03196284|11929234|FG001|STARTED|Extension Part|Participants switched to treatment with concizumab in the extension part of the study.|0
10765951|NCT03196284|11929235|FG002|STARTED|Extension Part|Participants who completed the main part entered the extension part of the study.|25
10765952|NCT03196284|11929233|FG000|Concizumab 0.15 mg/kg|Extension Part||0
10765953|NCT03196284|11929234|FG001|Concizumab 0.15 mg/kg|Extension Part||0
10765954|NCT03196284|11929235|FG002|Concizumab 0.15 mg/kg|Extension Part||12
10765955|NCT03196284|11929233|FG000|Concizumab 0.20 mg/kg|Extension Part||0
10765956|NCT03196284|11929234|FG001|Concizumab 0.20 mg/kg|Extension Part||0
10765957|NCT03196284|11929235|FG002|Concizumab 0.20 mg/kg|Extension Part||9
10765958|NCT03196284|11929233|FG000|Concizumab 0.25 mg/kg|Extension Part||0
10765959|NCT03196284|11929234|FG001|Concizumab 0.25 mg/kg|Extension Part||0
10765960|NCT03196284|11929235|FG002|Concizumab 0.25 mg/kg|Extension Part||4
10765961|NCT03196284|11929233|FG000|COMPLETED|Extension Part||0
10765962|NCT03196284|11929234|FG001|COMPLETED|Extension Part||0
10765963|NCT03196284|11929235|FG002|COMPLETED|Extension Part||22
10765964|NCT03196284|11929233|FG000|NOT COMPLETED|Extension Part||0
10765965|NCT03196284|11929234|FG001|NOT COMPLETED|Extension Part||0
10765966|NCT03196284|11929235|FG002|NOT COMPLETED|Extension Part||3
10765967|NCT03196297|11929255|FG000|STARTED|Main Period||36
10765968|NCT03196297|11929255|FG000|Full Analysis Set (FAS)|Main Period||36
10765969|NCT03196297|11929255|FG000|Subject Analysis Set (SAS)|Main Period||36
10765970|NCT03196297|11929255|FG000|COMPLETED|Main Period||32
10765971|NCT03196297|11929255|FG000|NOT COMPLETED|Main Period||4
10765972|NCT03196297|11929255|FG000|STARTED|Extension Period||32
10765973|NCT03196297|11929255|FG000|FAS|Extension Period||32
10765974|NCT03196297|11929255|FG000|SAS|Extension Period||32
10765975|NCT03196297|11929255|FG000|COMPLETED|Extension Period||29
10765976|NCT03196297|11929255|FG000|NOT COMPLETED|Extension Period||3
10765977|NCT03196349|11929274|FG000|STARTED|Overall Study||17
10765978|NCT03196349|11929275|FG001|STARTED|Overall Study||14
10765979|NCT03196349|11929276|FG002|STARTED|Overall Study||13
10765980|NCT03196349|11929274|FG000|COMPLETED|Overall Study||0
10765981|NCT03196349|11929275|FG001|COMPLETED|Overall Study||0
10765982|NCT03196349|11929276|FG002|COMPLETED|Overall Study||0
10765983|NCT03196349|11929274|FG000|NOT COMPLETED|Overall Study||17
10765984|NCT03196349|11929275|FG001|NOT COMPLETED|Overall Study||14
10765985|NCT03196349|11929276|FG002|NOT COMPLETED|Overall Study||13
10765986|NCT03196505|11929286|FG000|STARTED|Overall Study||115
10765987|NCT03196505|11929287|FG001|STARTED|Overall Study||116
10765988|NCT03196505|11929286|FG000|COMPLETED|Overall Study||89
10765989|NCT03196505|11929287|FG001|COMPLETED|Overall Study||90
10765990|NCT03196505|11929286|FG000|NOT COMPLETED|Overall Study||26
10765991|NCT03196505|11929287|FG001|NOT COMPLETED|Overall Study||26
10765992|NCT03196635|11929293|FG000|STARTED|Overall Study||31
10765993|NCT03196635|11929293|FG000|COMPLETED|Overall Study||30
10765994|NCT03196635|11929293|FG000|NOT COMPLETED|Overall Study||1
10765995|NCT03196791|11929313|FG000|STARTED|Overall Study||98
10765996|NCT03196791|11929314|FG001|STARTED|Overall Study||98
10765997|NCT03196791|11929313|FG000|COMPLETED|Overall Study||88
10765998|NCT03196791|11929314|FG001|COMPLETED|Overall Study||93
10765999|NCT03196791|11929313|FG000|NOT COMPLETED|Overall Study||10
10766000|NCT03196791|11929314|FG001|NOT COMPLETED|Overall Study||5
10766001|NCT03196973|11929323|FG000|STARTED|Overall Study||197
10766002|NCT03196973|11929324|FG001|STARTED|Overall Study||196
10766003|NCT03196973|11929325|FG002|STARTED|Overall Study||100
10766004|NCT03196973|11929323|FG000|COMPLETED|Overall Study||188
10766005|NCT03196973|11929324|FG001|COMPLETED|Overall Study||184
10766006|NCT03196973|11929325|FG002|COMPLETED|Overall Study||95
10766007|NCT03196973|11929323|FG000|NOT COMPLETED|Overall Study||9
10766008|NCT03196973|11929324|FG001|NOT COMPLETED|Overall Study||12
10766009|NCT03196973|11929325|FG002|NOT COMPLETED|Overall Study||5
10766010|NCT03197025|11929333|FG000|STARTED|Overall Study||1
10766011|NCT03197025|11929333|FG000|COMPLETED|Overall Study||1
10766012|NCT03197025|11929333|FG000|NOT COMPLETED|Overall Study||0
10766013|NCT03197038|11929339|FG000|STARTED|Overall Study||22
10766014|NCT03197038|11929340|FG001|STARTED|Overall Study||17
10766015|NCT03197038|11929339|FG000|COMPLETED|Overall Study||18
10766016|NCT03197038|11929340|FG001|COMPLETED|Overall Study||17
10766017|NCT03197038|11929339|FG000|NOT COMPLETED|Overall Study||4
10766018|NCT03197038|11929340|FG001|NOT COMPLETED|Overall Study||0
10766019|NCT03197129|11929348|FG000|STARTED|Overall Study||60
10766020|NCT03197129|11929349|FG001|STARTED|Overall Study||62
10766021|NCT03197129|11929348|FG000|COMPLETED|Overall Study||56
10766022|NCT03197129|11929349|FG001|COMPLETED|Overall Study||57
10766023|NCT03197129|11929348|FG000|NOT COMPLETED|Overall Study||4
10766024|NCT03197129|11929349|FG001|NOT COMPLETED|Overall Study||5
10766025|NCT03197324|11929357|FG000|STARTED|Overall Study||10
10766026|NCT03197324|11929358|FG001|STARTED|Overall Study||10
10766027|NCT03197324|11929357|FG000|COMPLETED|Overall Study||10
10766028|NCT03197324|11929358|FG001|COMPLETED|Overall Study||9
10766029|NCT03197324|11929357|FG000|NOT COMPLETED|Overall Study||0
10766030|NCT03197324|11929358|FG001|NOT COMPLETED|Overall Study||1
10766031|NCT03197376|11929368|FG000|STARTED|Primary and Booster Phase||502
10766032|NCT03197376|11929369|FG001|STARTED|Primary and Booster Phase||501
10766033|NCT03197376|11929370|FG002|STARTED|Primary and Booster Phase||500
10766034|NCT03197376|11929371|FG003|STARTED|Primary and Booster Phase||747
10766035|NCT03197376|11929368|FG000|Vaccinated-Dose 1|Primary and Booster Phase||502
10766036|NCT03197376|11929369|FG001|Vaccinated-Dose 1|Primary and Booster Phase||501
10766037|NCT03197376|11929370|FG002|Vaccinated-Dose 1|Primary and Booster Phase||500
10766038|NCT03197376|11929371|FG003|Vaccinated-Dose 1|Primary and Booster Phase||747
10766039|NCT03197376|11929368|FG000|Vaccinated-Dose 2|Primary and Booster Phase||495
10766040|NCT03197376|11929369|FG001|Vaccinated-Dose 2|Primary and Booster Phase||495
10766041|NCT03197376|11929370|FG002|Vaccinated-Dose 2|Primary and Booster Phase||491
10766042|NCT03197376|11929371|FG003|Vaccinated-Dose 2|Primary and Booster Phase||738
10766043|NCT03197376|11929368|FG000|Vaccinated-Dose 3|Primary and Booster Phase||492
10766044|NCT03197376|11929369|FG001|Vaccinated-Dose 3|Primary and Booster Phase||493
10766045|NCT03197376|11929370|FG002|Vaccinated-Dose 3|Primary and Booster Phase||490
10766046|NCT03197376|11929371|FG003|Vaccinated-Dose 3|Primary and Booster Phase||731
10766047|NCT03197376|11929368|FG000|Primary Reactogenicity Cohort|Primary and Booster Phase||251
10766048|NCT03197376|11929369|FG001|Primary Reactogenicity Cohort|Primary and Booster Phase||243
10766049|NCT03197376|11929370|FG002|Primary Reactogenicity Cohort|Primary and Booster Phase||257
10766050|NCT03197376|11929371|FG003|Primary Reactogenicity Cohort|Primary and Booster Phase||364
10766051|NCT03197376|11929368|FG000|Booster Cohort|Primary and Booster Phase||150
10766052|NCT03197376|11929369|FG001|Booster Cohort|Primary and Booster Phase||151
10766053|NCT03197376|11929370|FG002|Booster Cohort|Primary and Booster Phase||150
10766054|NCT03197376|11929371|FG003|Booster Cohort|Primary and Booster Phase||224
10766055|NCT03197376|11929368|FG000|Received Booster Vaccine|Primary and Booster Phase||145
10766056|NCT03197376|11929369|FG001|Received Booster Vaccine|Primary and Booster Phase||144
10546844|NCT01509950|11700644|FG001|STARTED|Overall Study||8
10546845|NCT01509950|11700645|FG002|STARTED|Overall Study||0
10546846|NCT01509950|11700643|FG000|COMPLETED|Overall Study||7
10546847|NCT01509950|11700644|FG001|COMPLETED|Overall Study||8
10546848|NCT01509950|11700645|FG002|COMPLETED|Overall Study||0
10546849|NCT01509950|11700643|FG000|NOT COMPLETED|Overall Study||0
10766057|NCT03197376|11929370|FG002|Received Booster Vaccine|Primary and Booster Phase||139
10766058|NCT03197376|11929371|FG003|Received Booster Vaccine|Primary and Booster Phase||213
10766059|NCT03197376|11929368|FG000|COMPLETED|Primary and Booster Phase||487
10766060|NCT03197376|11929369|FG001|COMPLETED|Primary and Booster Phase||488
10766061|NCT03197376|11929370|FG002|COMPLETED|Primary and Booster Phase||480
10766062|NCT03197376|11929371|FG003|COMPLETED|Primary and Booster Phase||722
10766063|NCT03197376|11929368|FG000|NOT COMPLETED|Primary and Booster Phase||15
10766064|NCT03197376|11929369|FG001|NOT COMPLETED|Primary and Booster Phase||13
10315653|NCT00181714|11449603|FG000|NOT COMPLETED|Signed Consent/Enrolled||49
10546850|NCT01509950|11700644|FG001|NOT COMPLETED|Overall Study||0
10766065|NCT03197376|11929370|FG002|NOT COMPLETED|Primary and Booster Phase||20
10766066|NCT03197376|11929371|FG003|NOT COMPLETED|Primary and Booster Phase||25
10766067|NCT03197376|11929368|FG000|STARTED|Immune Persistence Phase||132
10766068|NCT03197376|11929369|FG001|STARTED|Immune Persistence Phase||133
10766069|NCT03197376|11929370|FG002|STARTED|Immune Persistence Phase||128
10766070|NCT03197376|11929371|FG003|STARTED|Immune Persistence Phase||195
10766071|NCT03197376|11929368|FG000|COMPLETED|Immune Persistence Phase||127
10766072|NCT03197376|11929369|FG001|COMPLETED|Immune Persistence Phase||129
10766073|NCT03197376|11929370|FG002|COMPLETED|Immune Persistence Phase||123
10766074|NCT03197376|11929371|FG003|COMPLETED|Immune Persistence Phase||190
10766075|NCT03197376|11929368|FG000|NOT COMPLETED|Immune Persistence Phase||5
10766076|NCT03197376|11929369|FG001|NOT COMPLETED|Immune Persistence Phase||4
10766077|NCT03197376|11929370|FG002|NOT COMPLETED|Immune Persistence Phase||5
10766078|NCT03197376|11929371|FG003|NOT COMPLETED|Immune Persistence Phase||5
10766079|NCT03197389|11929410|FG000|STARTED|Overall Study||16
10766080|NCT03197389|11929411|FG001|STARTED|Overall Study||5
10766081|NCT03197389|11929412|FG002|STARTED|Overall Study||18
10766082|NCT03197389|11929413|FG003|STARTED|Overall Study||9
10766083|NCT03197389|11929414|FG004|STARTED|Overall Study||1
10766084|NCT03197389|11929415|FG005|STARTED|Overall Study||5
10766085|NCT03197389|11929410|FG000|COMPLETED|Overall Study||16
10766086|NCT03197389|11929411|FG001|COMPLETED|Overall Study||5
10766087|NCT03197389|11929412|FG002|COMPLETED|Overall Study||18
10766088|NCT03197389|11929413|FG003|COMPLETED|Overall Study||9
10766089|NCT03197389|11929414|FG004|COMPLETED|Overall Study||1
10766090|NCT03197389|11929415|FG005|COMPLETED|Overall Study||5
10766091|NCT03197389|11929410|FG000|NOT COMPLETED|Overall Study||0
10766092|NCT03197389|11929411|FG001|NOT COMPLETED|Overall Study||0
10766093|NCT03197389|11929412|FG002|NOT COMPLETED|Overall Study||0
10766094|NCT03197389|11929413|FG003|NOT COMPLETED|Overall Study||0
10766095|NCT03197389|11929414|FG004|NOT COMPLETED|Overall Study||0
10766096|NCT03197389|11929415|FG005|NOT COMPLETED|Overall Study||0
10766097|NCT03197558|11929429|FG000|STARTED|Overall Study||30
10766098|NCT03197558|11929429|FG000|COMPLETED|Overall Study||29
10766099|NCT03197558|11929429|FG000|NOT COMPLETED|Overall Study||1
10766100|NCT03197883|11929435|FG000|STARTED|Overall Study||50
10766101|NCT03197883|11929436|FG001|STARTED|Overall Study||50
10766102|NCT03197883|11929435|FG000|COMPLETED|Overall Study||47
10766103|NCT03197883|11929436|FG001|COMPLETED|Overall Study||44
10766104|NCT03197883|11929435|FG000|NOT COMPLETED|Overall Study||3
10766105|NCT03197883|11929436|FG001|NOT COMPLETED|Overall Study||6
10766106|NCT03198000|11929445|FG000|STARTED|Overall Study||41
10766107|NCT03198000|11929446|FG001|STARTED|Overall Study||38
10766108|NCT03198000|11929447|FG002|STARTED|Overall Study||41
10766109|NCT03198000|11929445|FG000|COMPLETED|Overall Study||41
10766110|NCT03198000|11929446|FG001|COMPLETED|Overall Study||38
10766111|NCT03198000|11929447|FG002|COMPLETED|Overall Study||41
10766112|NCT03198000|11929445|FG000|NOT COMPLETED|Overall Study||0
10766113|NCT03198000|11929446|FG001|NOT COMPLETED|Overall Study||0
10766114|NCT03198000|11929447|FG002|NOT COMPLETED|Overall Study||0
10766115|NCT03198221|11929459|FG000|STARTED|Overall Study||3
10766116|NCT03198221|11929460|FG001|STARTED|Overall Study||2
10766117|NCT03198221|11929461|FG002|STARTED|Overall Study||7
10766118|NCT03198221|11929462|FG003|STARTED|Overall Study||2
10766119|NCT03198221|11929459|FG000|COMPLETED|Overall Study||3
10766120|NCT03198221|11929460|FG001|COMPLETED|Overall Study||2
10766121|NCT03198221|11929461|FG002|COMPLETED|Overall Study||7
10766122|NCT03198221|11929462|FG003|COMPLETED|Overall Study||2
10766123|NCT03198221|11929459|FG000|NOT COMPLETED|Overall Study||0
10766124|NCT03198221|11929460|FG001|NOT COMPLETED|Overall Study||0
10766125|NCT03198221|11929461|FG002|NOT COMPLETED|Overall Study||0
10766126|NCT03198221|11929462|FG003|NOT COMPLETED|Overall Study||0
10766127|NCT03198507|11929474|FG000|STARTED|Overall Study||228
10766128|NCT03198507|11929475|FG001|STARTED|Overall Study||227
10766129|NCT03198507|11929474|FG000|COMPLETED|Overall Study||227
10766130|NCT03198507|11929475|FG001|COMPLETED|Overall Study||227
10766131|NCT03198507|11929474|FG000|NOT COMPLETED|Overall Study||1
10766132|NCT03198507|11929475|FG001|NOT COMPLETED|Overall Study||0
10766133|NCT03198520|11929481|FG000|STARTED|Overall Study||46
10766134|NCT03198520|11929481|FG000|COMPLETED|Overall Study||40
10766135|NCT03198520|11929481|FG000|NOT COMPLETED|Overall Study||6
10766136|NCT03198715|11929498|FG000|STARTED|Overall Study||6
10766137|NCT03198715|11929499|FG001|STARTED|Overall Study||12
10766138|NCT03198715|11929500|FG002|STARTED|Overall Study||12
10766139|NCT03198715|11929501|FG003|STARTED|Overall Study||3
10766140|NCT03198715|11929502|FG004|STARTED|Overall Study||9
10766141|NCT03198715|11929498|FG000|COMPLETED|Overall Study||6
10766142|NCT03198715|11929499|FG001|COMPLETED|Overall Study||11
10766143|NCT03198715|11929500|FG002|COMPLETED|Overall Study||10
10766144|NCT03198715|11929501|FG003|COMPLETED|Overall Study||3
10766145|NCT03198715|11929502|FG004|COMPLETED|Overall Study||7
10766146|NCT03198715|11929498|FG000|NOT COMPLETED|Overall Study||0
10766147|NCT03198715|11929499|FG001|NOT COMPLETED|Overall Study||1
10766148|NCT03198715|11929500|FG002|NOT COMPLETED|Overall Study||2
10766149|NCT03198715|11929501|FG003|NOT COMPLETED|Overall Study||0
10766150|NCT03198715|11929502|FG004|NOT COMPLETED|Overall Study||2
10766151|NCT03198754|11929516|FG000|STARTED|Overall Study||38
10766152|NCT03198754|11929517|FG001|STARTED|Overall Study||35
10766153|NCT03198754|11929516|FG000|COMPLETED|Overall Study||27
10766154|NCT03198754|11929517|FG001|COMPLETED|Overall Study||27
10766155|NCT03198754|11929516|FG000|NOT COMPLETED|Overall Study||11
10766156|NCT03198754|11929517|FG001|NOT COMPLETED|Overall Study||8
10766157|NCT03198767|11929530|FG000|STARTED|Overall Study||8
10766158|NCT03198767|11929531|FG001|STARTED|Overall Study||8
10766159|NCT03198767|11929532|FG002|STARTED|Overall Study||8
10766160|NCT03198767|11929533|FG003|STARTED|Overall Study||6
10766161|NCT03198767|11929534|FG004|STARTED|Overall Study||8
10766162|NCT03198767|11929535|FG005|STARTED|Overall Study||8
10766163|NCT03198767|11929536|FG006|STARTED|Overall Study||8
10766164|NCT03198767|11929530|FG000|COMPLETED|Overall Study||8
10297463|NCT00092677|11429994|FG001|COMPLETED|Overall Study|Placebo: 698 (on drug), 120 (after drug discon), 100 (at death)|918
10297464|NCT00092677|11429993|FG000|NOT COMPLETED|Overall Study||5
10297465|NCT00092677|11429994|FG001|NOT COMPLETED|Overall Study||11
10297466|NCT00090259|11430002|FG000|STARTED|Overall Study||1913
10297467|NCT00090259|11430003|FG001|STARTED|Overall Study||1921
10297468|NCT00090259|11430002|FG000|COMPLETED|Overall Study|Completed follow-up: 963 on drug, 223 off drug, & 665 at death (death was considered an endpoint)|1851
10297469|NCT00090259|11430003|FG001|COMPLETED|Overall Study|Completed follow-up: 1005 on drug, 233 off drug,& 635 at death (death was considered an endpoint)|1873
10297470|NCT00090259|11430002|FG000|NOT COMPLETED|Overall Study||62
10297471|NCT00090259|11430003|FG001|NOT COMPLETED|Overall Study||48
10297472|NCT00003298|11430009|FG000|STARTED|Step 1 (Neoadjuvant Therapy)||39
10297473|NCT00003298|11430009|FG000|Eligible and Treated|Step 1 (Neoadjuvant Therapy)||38
10297474|NCT00003298|11430009|FG000|Complete 3 Cycles of Neoadjuvant Therapy|Step 1 (Neoadjuvant Therapy)||35
10297475|NCT00003298|11430009|FG000|COMPLETED|Step 1 (Neoadjuvant Therapy)||35
10297476|NCT00003298|11430009|FG000|NOT COMPLETED|Step 1 (Neoadjuvant Therapy)||4
10297477|NCT00003298|11430009|FG000|STARTED|Surgery||35
10297478|NCT00003298|11430009|FG000|COMPLETED|Surgery|1 patient did not complete neoadjuvant therapy but went to surgery anyway, not included here.|28
10297479|NCT00003298|11430009|FG000|NOT COMPLETED|Surgery||7
10297480|NCT00003298|11430009|FG000|STARTED|Re-register to Step 2 After Surgery||28
10766165|NCT03198767|11929531|FG001|COMPLETED|Overall Study||8
10766166|NCT03198767|11929532|FG002|COMPLETED|Overall Study||8
10766167|NCT03198767|11929533|FG003|COMPLETED|Overall Study||0
10766168|NCT03198767|11929534|FG004|COMPLETED|Overall Study||8
10766169|NCT03198767|11929535|FG005|COMPLETED|Overall Study||8
10766170|NCT03198767|11929536|FG006|COMPLETED|Overall Study||8
10766171|NCT03198767|11929530|FG000|NOT COMPLETED|Overall Study||0
10766172|NCT03198767|11929531|FG001|NOT COMPLETED|Overall Study||0
10766173|NCT03198767|11929532|FG002|NOT COMPLETED|Overall Study||0
10766174|NCT03198767|11929533|FG003|NOT COMPLETED|Overall Study||6
10766175|NCT03198767|11929534|FG004|NOT COMPLETED|Overall Study||0
10766176|NCT03198767|11929535|FG005|NOT COMPLETED|Overall Study||0
10766177|NCT03198767|11929536|FG006|NOT COMPLETED|Overall Study||0
10766178|NCT03198871|11929553|FG000|STARTED|Overall Study||90
10766179|NCT03198871|11929554|FG001|STARTED|Overall Study||90
10766180|NCT03198871|11929553|FG000|COMPLETED|Overall Study||76
10766181|NCT03198871|11929554|FG001|COMPLETED|Overall Study||78
10766182|NCT03198871|11929553|FG000|NOT COMPLETED|Overall Study||14
10766183|NCT03198871|11929554|FG001|NOT COMPLETED|Overall Study||12
10766184|NCT03198884|11929560|FG000|STARTED|Overall Study||20
10766185|NCT03198884|11929560|FG000|COMPLETED|Overall Study||20
10766186|NCT03198884|11929560|FG000|NOT COMPLETED|Overall Study||0
10766187|NCT03199079|11929576|FG000|STARTED|Overall Study||10
10766188|NCT03199079|11929577|FG001|STARTED|Overall Study||10
10766189|NCT03199079|11929576|FG000|COMPLETED|Overall Study||10
10766190|NCT03199079|11929577|FG001|COMPLETED|Overall Study||10
10766191|NCT03199079|11929576|FG000|NOT COMPLETED|Overall Study||0
10766192|NCT03199079|11929577|FG001|NOT COMPLETED|Overall Study||0
10766193|NCT03199118|11929585|FG000|STARTED|Overall Study||14
10766194|NCT03199118|11929586|FG001|STARTED|Overall Study||14
10766195|NCT03199118|11929585|FG000|COMPLETED|Overall Study|6 months follow-up|14
10766196|NCT03199118|11929586|FG001|COMPLETED|Overall Study|6 months follow-up|14
10766197|NCT03199118|11929585|FG000|NOT COMPLETED|Overall Study||0
10766198|NCT03199118|11929586|FG001|NOT COMPLETED|Overall Study||0
10766199|NCT03199872|11929597|FG000|STARTED|Overall Study||22
10766200|NCT03199872|11929597|FG000|COMPLETED|Overall Study||22
10766201|NCT03199872|11929597|FG000|NOT COMPLETED|Overall Study||0
10766202|NCT03199911|11929603|FG000|STARTED|Overall Study||208
10766203|NCT03199911|11929604|FG001|STARTED|Overall Study||193
10766204|NCT03199911|11929603|FG000|Did Not Proceed With Surgery|Overall Study||2
10766205|NCT03199911|11929604|FG001|Did Not Proceed With Surgery|Overall Study||1
10766206|NCT03199911|11929603|FG000|Received Allocated Treatment|Overall Study||206
10766207|NCT03199911|11929604|FG001|Received Allocated Treatment|Overall Study||192
10766208|NCT03199911|11929603|FG000|Lost to Follow-up|Overall Study||5
10766209|NCT03199911|11929604|FG001|Lost to Follow-up|Overall Study||5
10766210|NCT03199911|11929603|FG000|Primary Outcome Analyzed|Overall Study||201
10766211|NCT03199911|11929604|FG001|Primary Outcome Analyzed|Overall Study||187
10766212|NCT03199911|11929603|FG000|COMPLETED|Overall Study||201
10766213|NCT03199911|11929604|FG001|COMPLETED|Overall Study||187
10766214|NCT03199911|11929603|FG000|NOT COMPLETED|Overall Study||7
10766215|NCT03199911|11929604|FG001|NOT COMPLETED|Overall Study||6
10766230|NCT03200366|11929624|FG000|STARTED|Baseline Interview With Randomization||123
10766231|NCT03200366|11929625|FG001|STARTED|Baseline Interview With Randomization||120
10766232|NCT03200366|11929626|FG002|STARTED|Baseline Interview With Randomization||128
10766233|NCT03200366|11929624|FG000|COMPLETED|Baseline Interview With Randomization||123
10766234|NCT03200366|11929625|FG001|COMPLETED|Baseline Interview With Randomization||120
10766235|NCT03200366|11929626|FG002|COMPLETED|Baseline Interview With Randomization||128
10766236|NCT03200366|11929624|FG000|NOT COMPLETED|Baseline Interview With Randomization||0
10766237|NCT03200366|11929625|FG001|NOT COMPLETED|Baseline Interview With Randomization||0
10766238|NCT03200366|11929626|FG002|NOT COMPLETED|Baseline Interview With Randomization||0
10766239|NCT03200366|11929624|FG000|STARTED|Tailored DVD Intervention Given||123
10766240|NCT03200366|11929625|FG001|STARTED|Tailored DVD Intervention Given||120
10766241|NCT03200366|11929626|FG002|STARTED|Tailored DVD Intervention Given||0
10766242|NCT03200366|11929624|FG000|COMPLETED|Tailored DVD Intervention Given||123
10766243|NCT03200366|11929625|FG001|COMPLETED|Tailored DVD Intervention Given||120
10766244|NCT03200366|11929626|FG002|COMPLETED|Tailored DVD Intervention Given||0
10766245|NCT03200366|11929624|FG000|NOT COMPLETED|Tailored DVD Intervention Given||0
10766246|NCT03200366|11929625|FG001|NOT COMPLETED|Tailored DVD Intervention Given||0
10766247|NCT03200366|11929626|FG002|NOT COMPLETED|Tailored DVD Intervention Given||0
10766248|NCT03200366|11929624|FG000|STARTED|Patient Navigation Intervention Given||0
10766249|NCT03200366|11929625|FG001|STARTED|Patient Navigation Intervention Given||120
10766250|NCT03200366|11929626|FG002|STARTED|Patient Navigation Intervention Given||0
10766251|NCT03200366|11929624|FG000|COMPLETED|Patient Navigation Intervention Given||0
10766252|NCT03200366|11929625|FG001|COMPLETED|Patient Navigation Intervention Given||89
10766253|NCT03200366|11929626|FG002|COMPLETED|Patient Navigation Intervention Given||0
10766254|NCT03200366|11929624|FG000|NOT COMPLETED|Patient Navigation Intervention Given||0
10766255|NCT03200366|11929625|FG001|NOT COMPLETED|Patient Navigation Intervention Given||31
10766256|NCT03200366|11929626|FG002|NOT COMPLETED|Patient Navigation Intervention Given||0
10766257|NCT03200366|11929624|FG000|STARTED|6 Month Post-Baseline Interview||123
10766258|NCT03200366|11929625|FG001|STARTED|6 Month Post-Baseline Interview||118
10766259|NCT03200366|11929626|FG002|STARTED|6 Month Post-Baseline Interview||128
10766260|NCT03200366|11929624|FG000|COMPLETED|6 Month Post-Baseline Interview||93
10766261|NCT03200366|11929625|FG001|COMPLETED|6 Month Post-Baseline Interview||95
10766262|NCT03200366|11929626|FG002|COMPLETED|6 Month Post-Baseline Interview||109
10766263|NCT03200366|11929624|FG000|NOT COMPLETED|6 Month Post-Baseline Interview||30
10766264|NCT03200366|11929625|FG001|NOT COMPLETED|6 Month Post-Baseline Interview||23
10766265|NCT03200366|11929626|FG002|NOT COMPLETED|6 Month Post-Baseline Interview||19
10766266|NCT03200366|11929624|FG000|STARTED|9 Month Post-Baseline Interview||121
10766267|NCT03200366|11929625|FG001|STARTED|9 Month Post-Baseline Interview||116
10766268|NCT03200366|11929626|FG002|STARTED|9 Month Post-Baseline Interview||127
10766269|NCT03200366|11929624|FG000|COMPLETED|9 Month Post-Baseline Interview||97
10766270|NCT03200366|11929625|FG001|COMPLETED|9 Month Post-Baseline Interview||95
10766271|NCT03200366|11929626|FG002|COMPLETED|9 Month Post-Baseline Interview||116
10766272|NCT03200366|11929624|FG000|NOT COMPLETED|9 Month Post-Baseline Interview||24
10766273|NCT03200366|11929625|FG001|NOT COMPLETED|9 Month Post-Baseline Interview||21
10766274|NCT03200366|11929626|FG002|NOT COMPLETED|9 Month Post-Baseline Interview||11
10766275|NCT03200535|11929640|FG000|STARTED|Overall Study||1863
10766276|NCT03200535|11929641|FG001|STARTED|Overall Study||1863
10766277|NCT03200535|11929642|FG002|STARTED|Overall Study||1862
10766278|NCT03200535|11929643|FG003|STARTED|Overall Study||1000
10766279|NCT03200535|11929640|FG000|COMPLETED|Overall Study||1863
10766280|NCT03200535|11929641|FG001|COMPLETED|Overall Study||1863
10766281|NCT03200535|11929642|FG002|COMPLETED|Overall Study||1862
10766282|NCT03200535|11929643|FG003|COMPLETED|Overall Study||1000
10766283|NCT03200535|11929640|FG000|NOT COMPLETED|Overall Study||0
10766284|NCT03200535|11929641|FG001|NOT COMPLETED|Overall Study||0
10766285|NCT03200535|11929642|FG002|NOT COMPLETED|Overall Study||0
10766286|NCT03200535|11929643|FG003|NOT COMPLETED|Overall Study||0
10766287|NCT03200860|11929655|FG000|STARTED|Overall Study||41
10766288|NCT03200860|11929656|FG001|STARTED|Overall Study||39
10766289|NCT03200860|11929655|FG000|COMPLETED|Overall Study||40
10766290|NCT03200860|11929656|FG001|COMPLETED|Overall Study||39
10766291|NCT03200860|11929655|FG000|NOT COMPLETED|Overall Study||1
10766292|NCT03200860|11929656|FG001|NOT COMPLETED|Overall Study||0
10766293|NCT03200912|11929665|FG000|STARTED|Overall Study||170
10766294|NCT03200912|11929666|FG001|STARTED|Overall Study||169
10766295|NCT03200912|11929667|FG002|STARTED|Overall Study||168
10766296|NCT03200912|11929665|FG000|COMPLETED|Overall Study||166
10766297|NCT03200912|11929666|FG001|COMPLETED|Overall Study||166
10766298|NCT03200912|11929667|FG002|COMPLETED|Overall Study||164
10766299|NCT03200912|11929665|FG000|NOT COMPLETED|Overall Study||4
10766300|NCT03200912|11929666|FG001|NOT COMPLETED|Overall Study||3
10766301|NCT03200912|11929667|FG002|NOT COMPLETED|Overall Study||4
10766302|NCT03200925|11929677|FG000|STARTED|Overall Study||120
10766303|NCT03200925|11929678|FG001|STARTED|Overall Study||120
10766304|NCT03200925|11929677|FG000|COMPLETED|Overall Study||120
10766305|NCT03200925|11929678|FG001|COMPLETED|Overall Study||120
10766306|NCT03200925|11929677|FG000|NOT COMPLETED|Overall Study||0
10766307|NCT03200925|11929678|FG001|NOT COMPLETED|Overall Study||0
10766308|NCT03201003|11929686|FG000|STARTED|Overall Study||132
10766309|NCT03201003|11929687|FG001|STARTED|Overall Study||43
10766310|NCT03201003|11929686|FG000|COMPLETED|Overall Study||106
10766311|NCT03201003|11929687|FG001|COMPLETED|Overall Study||40
10766312|NCT03201003|11929686|FG000|NOT COMPLETED|Overall Study||26
10766313|NCT03201003|11929687|FG001|NOT COMPLETED|Overall Study||3
10766314|NCT03201211|11929696|FG000|STARTED|Overall Study||27
10766315|NCT03201211|11929697|FG001|STARTED|Overall Study||26
10766316|NCT03201211|11929698|FG002|STARTED|Overall Study||28
10766317|NCT03201211|11929696|FG000|COMPLETED|Overall Study||25
10766318|NCT03201211|11929697|FG001|COMPLETED|Overall Study||25
10766319|NCT03201211|11929698|FG002|COMPLETED|Overall Study||27
10766320|NCT03201211|11929696|FG000|NOT COMPLETED|Overall Study||2
10766321|NCT03201211|11929697|FG001|NOT COMPLETED|Overall Study||1
10766322|NCT03201211|11929698|FG002|NOT COMPLETED|Overall Study||1
10779124|NCT03364309|11940870|FG011|COMPLETED|Induction Period||0
10779125|NCT03364309|11940871|FG012|COMPLETED|Induction Period||0
10779126|NCT03364309|11940872|FG013|COMPLETED|Induction Period||0
10779127|NCT03364309|11940873|FG014|COMPLETED|Induction Period||0
10779128|NCT03364309|11940874|FG015|COMPLETED|Induction Period||0
10779129|NCT03364309|11940875|FG016|COMPLETED|Induction Period||0
10779130|NCT03364309|11940876|FG017|COMPLETED|Induction Period||0
10766332|NCT03201809|11929721|FG000|STARTED|Overall Study||6
10766333|NCT03201809|11929722|FG001|STARTED|Overall Study||6
10766334|NCT03201809|11929721|FG000|COMPLETED|Overall Study||4
10766335|NCT03201809|11929722|FG001|COMPLETED|Overall Study||6
10766336|NCT03201809|11929721|FG000|NOT COMPLETED|Overall Study||2
10766337|NCT03201809|11929722|FG001|NOT COMPLETED|Overall Study||0
10766338|NCT03201900|11929728|FG000|STARTED|Treatment Phase (Up to 62 Weeks)||91
10766339|NCT03201900|11929728|FG000|Treated|Treatment Phase (Up to 62 Weeks)||89
10766340|NCT03201900|11929728|FG000|COMPLETED|Treatment Phase (Up to 62 Weeks)||54
10766341|NCT03201900|11929728|FG000|NOT COMPLETED|Treatment Phase (Up to 62 Weeks)||37
10766342|NCT03201900|11929728|FG000|STARTED|Extension Phase (From Week 63 to 156)|Eligible participants who completed Treatment Phase and agreed to continue in the Extension Phase.|46
10766343|NCT03201900|11929728|FG000|COMPLETED|Extension Phase (From Week 63 to 156)||38
10766344|NCT03201900|11929728|FG000|NOT COMPLETED|Extension Phase (From Week 63 to 156)||8
10766345|NCT03202134|11929734|FG000|STARTED|Overall Study||55
10766346|NCT03202134|11929735|FG001|STARTED|Overall Study||149
10766347|NCT03202134|11929734|FG000|COMPLETED|Overall Study||55
10766348|NCT03202134|11929735|FG001|COMPLETED|Overall Study||149
10766349|NCT03202134|11929734|FG000|NOT COMPLETED|Overall Study||0
10766350|NCT03202134|11929735|FG001|NOT COMPLETED|Overall Study||0
10766351|NCT03202264|11929743|FG000|STARTED|Overall Study||30
10766352|NCT03202264|11929743|FG000|COMPLETED|Overall Study||14
10766353|NCT03202264|11929743|FG000|NOT COMPLETED|Overall Study||16
10766354|NCT03202472|11929747|FG000|STARTED|Overall Study||50
10766355|NCT03202472|11929747|FG000|COMPLETED|Overall Study||50
10766356|NCT03202472|11929747|FG000|NOT COMPLETED|Overall Study||0
10766357|NCT03202511|11929751|FG000|STARTED|Overall Study||8
10766358|NCT03202511|11929752|FG001|STARTED|Overall Study||7
10766359|NCT03202511|11929751|FG000|COMPLETED|Overall Study||7
10766360|NCT03202511|11929752|FG001|COMPLETED|Overall Study||7
10766361|NCT03202511|11929751|FG000|NOT COMPLETED|Overall Study||1
10766362|NCT03202511|11929752|FG001|NOT COMPLETED|Overall Study||0
10766363|NCT03202550|11929760|FG000|STARTED|Overall Study||13
10766364|NCT03202550|11929761|FG001|STARTED|Overall Study||11
10766365|NCT03202550|11929760|FG000|COMPLETED|Overall Study||13
10766366|NCT03202550|11929761|FG001|COMPLETED|Overall Study||11
10766367|NCT03202550|11929760|FG000|NOT COMPLETED|Overall Study||0
10766368|NCT03202550|11929761|FG001|NOT COMPLETED|Overall Study||0
10766369|NCT03203291|11929767|FG000|STARTED|Overall Study||12
10766370|NCT03203291|11929767|FG000|COMPLETED|Overall Study||11
10766371|NCT03203291|11929767|FG000|NOT COMPLETED|Overall Study||1
10766372|NCT03203447|11929773|FG000|STARTED|Overall Study|Two patients were randomized to the Active arm, but did not receive study drug.|162
10766373|NCT03203447|11929774|FG001|STARTED|Overall Study|One patient was randomized to the Control arm, but did not receive study drug.|163
10766374|NCT03203447|11929773|FG000|COMPLETED|Overall Study||0
10766375|NCT03203447|11929774|FG001|COMPLETED|Overall Study||0
10766376|NCT03203447|11929773|FG000|NOT COMPLETED|Overall Study||162
10766377|NCT03203447|11929774|FG001|NOT COMPLETED|Overall Study||163
10766378|NCT03203564|11929784|FG000|STARTED|Overall Study||8
10766379|NCT03203564|11929785|FG001|STARTED|Overall Study||8
10766380|NCT03203564|11929786|FG002|STARTED|Overall Study||8
10766381|NCT03203564|11929787|FG003|STARTED|Overall Study||9
10766382|NCT03203564|11929784|FG000|COMPLETED|Overall Study||8
10766383|NCT03203564|11929785|FG001|COMPLETED|Overall Study||8
10766384|NCT03203564|11929786|FG002|COMPLETED|Overall Study||8
10766385|NCT03203564|11929787|FG003|COMPLETED|Overall Study||9
10766386|NCT03203564|11929784|FG000|NOT COMPLETED|Overall Study||0
10766387|NCT03203564|11929785|FG001|NOT COMPLETED|Overall Study||0
10766388|NCT03203564|11929786|FG002|NOT COMPLETED|Overall Study||0
10766389|NCT03203564|11929787|FG003|NOT COMPLETED|Overall Study||0
10766390|NCT03203681|11929797|FG000|STARTED|Overall Study||60
10766391|NCT03203681|11929797|FG000|3 Month|Overall Study||44
10766392|NCT03203681|11929797|FG000|6 Months|Overall Study||33
10766393|NCT03203681|11929797|FG000|COMPLETED|Overall Study||33
10766394|NCT03203681|11929797|FG000|NOT COMPLETED|Overall Study||27
10766395|NCT03204279|11929803|FG000|STARTED|Overall Study||34
10766396|NCT03204279|11929804|FG001|STARTED|Overall Study||33
10766397|NCT03204279|11929803|FG000|COMPLETED|Overall Study||34
10766398|NCT03204279|11929804|FG001|COMPLETED|Overall Study||32
10766399|NCT03204279|11929803|FG000|NOT COMPLETED|Overall Study||0
10766400|NCT03204279|11929804|FG001|NOT COMPLETED|Overall Study||1
10766401|NCT03204526|11929811|FG000|STARTED|Overall Study||15
10766402|NCT03204526|11929811|FG000|COMPLETED|Overall Study||15
10766403|NCT03204526|11929811|FG000|NOT COMPLETED|Overall Study||0
10766404|NCT03204942|11929818|FG000|STARTED|Overall Study||23
10766405|NCT03204942|11929819|FG001|STARTED|Overall Study||23
10766406|NCT03204942|11929820|FG002|STARTED|Overall Study||23
10766407|NCT03204942|11929818|FG000|COMPLETED|Overall Study||23
10766408|NCT03204942|11929819|FG001|COMPLETED|Overall Study||23
10766409|NCT03204942|11929820|FG002|COMPLETED|Overall Study||23
10766410|NCT03204942|11929818|FG000|NOT COMPLETED|Overall Study||0
10766411|NCT03204942|11929819|FG001|NOT COMPLETED|Overall Study||0
10766412|NCT03204942|11929820|FG002|NOT COMPLETED|Overall Study||0
10766413|NCT03204981|11929833|FG000|STARTED|Overall Study||52
10766414|NCT03204981|11929833|FG000|COMPLETED|Overall Study||46
10766415|NCT03204981|11929833|FG000|NOT COMPLETED|Overall Study||6
10766416|NCT03205046|11929841|FG000|STARTED|Overall Study||13
10766417|NCT03205046|11929842|FG001|STARTED|Overall Study||12
10766418|NCT03205046|11929841|FG000|COMPLETED|Overall Study||0
10766419|NCT03205046|11929842|FG001|COMPLETED|Overall Study||2
10766420|NCT03205046|11929841|FG000|NOT COMPLETED|Overall Study||13
10766421|NCT03205046|11929842|FG001|NOT COMPLETED|Overall Study||10
10766422|NCT03205150|11929851|FG000|STARTED|Overall Study||43
10766423|NCT03205150|11929852|FG001|STARTED|Overall Study||43
10766424|NCT03205150|11929853|FG002|STARTED|Overall Study||21
10766425|NCT03205150|11929851|FG000|Safety Analysis Set|Overall Study||43
10766426|NCT03205150|11929852|FG001|Safety Analysis Set|Overall Study||43
10766427|NCT03205150|11929853|FG002|Safety Analysis Set|Overall Study||21
10766428|NCT03205150|11929851|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study|all patients with valid PK measurements|42
10766429|NCT03205150|11929852|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study|all patients with valid PK measurements|36
10766430|NCT03205150|11929853|FG002|Pharmacokinetics (PK) Analysis Set|Overall Study|Placebo patients were excluded from the PK analyses|0
10766431|NCT03205150|11929851|FG000|Pharmacodynamics (PD) Analysis Set|Overall Study|all patients with available PD data and no protocol deviations|43
10766432|NCT03205150|11929852|FG001|Pharmacodynamics (PD) Analysis Set|Overall Study|all patients with available PD data and no protocol deviations|41
10766433|NCT03205150|11929853|FG002|Pharmacodynamics (PD) Analysis Set|Overall Study|all patients with available PD data and no protocol deviations|21
10766434|NCT03205150|11929851|FG000|COMPLETED|Overall Study||41
10766435|NCT03205150|11929852|FG001|COMPLETED|Overall Study||36
10766436|NCT03205150|11929853|FG002|COMPLETED|Overall Study||19
10766437|NCT03205150|11929851|FG000|NOT COMPLETED|Overall Study||2
10766438|NCT03205150|11929852|FG001|NOT COMPLETED|Overall Study||7
10766439|NCT03205150|11929853|FG002|NOT COMPLETED|Overall Study||2
10766440|NCT03205488|11929865|FG000|STARTED|Overall Study||25
10766441|NCT03205488|11929866|FG001|STARTED|Overall Study||25
10766442|NCT03205488|11929867|FG002|STARTED|Overall Study||26
10766443|NCT03205488|11929865|FG000|COMPLETED|Overall Study||24
10766444|NCT03205488|11929866|FG001|COMPLETED|Overall Study||23
10766445|NCT03205488|11929867|FG002|COMPLETED|Overall Study||21
10766446|NCT03205488|11929865|FG000|NOT COMPLETED|Overall Study||1
10766447|NCT03205488|11929866|FG001|NOT COMPLETED|Overall Study||2
10766448|NCT03205488|11929867|FG002|NOT COMPLETED|Overall Study||5
10766449|NCT03205566|11929881|FG000|STARTED|Phase 1|One participant withdrawn and replaced. Data obtained from first participant still used in analysis|19
10766450|NCT03205566|11929882|FG001|STARTED|Phase 1|One participant withdrawn and replaced. Data obtained from first participant still used in analysis|19
10766451|NCT03205566|11929881|FG000|COMPLETED|Phase 1||18
10766452|NCT03205566|11929882|FG001|COMPLETED|Phase 1||18
10766453|NCT03205566|11929881|FG000|NOT COMPLETED|Phase 1||1
10766454|NCT03205566|11929882|FG001|NOT COMPLETED|Phase 1||1
10766455|NCT03205566|11929881|FG000|STARTED|Phase 2||18
10766456|NCT03205566|11929882|FG001|STARTED|Phase 2||18
10766457|NCT03205566|11929881|FG000|COMPLETED|Phase 2||18
10766458|NCT03205566|11929882|FG001|COMPLETED|Phase 2||18
10766459|NCT03205566|11929881|FG000|NOT COMPLETED|Phase 2||0
10766460|NCT03205566|11929882|FG001|NOT COMPLETED|Phase 2||0
10766461|NCT03206749|11929895|FG000|STARTED|Overall Study||80
10766462|NCT03206749|11929896|FG001|STARTED|Overall Study||81
10766463|NCT03206749|11929897|FG002|STARTED|Overall Study||82
10766464|NCT03206749|11929895|FG000|COMPLETED|Overall Study||75
10766465|NCT03206749|11929896|FG001|COMPLETED|Overall Study||78
10766466|NCT03206749|11929897|FG002|COMPLETED|Overall Study||75
10766467|NCT03206749|11929895|FG000|NOT COMPLETED|Overall Study||5
10766468|NCT03206749|11929896|FG001|NOT COMPLETED|Overall Study||3
10766469|NCT03206749|11929897|FG002|NOT COMPLETED|Overall Study||7
10766470|NCT03206788|11929908|FG000|STARTED|Overall Study||2
10766471|NCT03206788|11929909|FG001|STARTED|Overall Study||5
10766472|NCT03206788|11929908|FG000|COMPLETED|Overall Study||2
10766473|NCT03206788|11929909|FG001|COMPLETED|Overall Study||2
10766474|NCT03206788|11929908|FG000|NOT COMPLETED|Overall Study||0
10766475|NCT03206788|11929909|FG001|NOT COMPLETED|Overall Study||3
10766476|NCT03206918|11929915|FG000|STARTED|Overall Study||91
10766477|NCT03206918|11929915|FG000|COMPLETED|Overall Study||0
10766478|NCT03206918|11929915|FG000|NOT COMPLETED|Overall Study||91
10766479|NCT03206970|11929920|FG000|STARTED|Overall Study||86
10766480|NCT03206970|11929920|FG000|Received at Least 1 Dose of Study Drug|Overall Study||86
10766481|NCT03206970|11929920|FG000|COMPLETED|Overall Study||0
10766482|NCT03206970|11929920|FG000|NOT COMPLETED|Overall Study||86
10766483|NCT03207022|11929926|FG000|STARTED|Overall Study||12
10766484|NCT03207022|11929927|FG001|STARTED|Overall Study||12
10766485|NCT03207022|11929926|FG000|COMPLETED|Overall Study||12
10766486|NCT03207022|11929927|FG001|COMPLETED|Overall Study||12
10766487|NCT03207022|11929926|FG000|NOT COMPLETED|Overall Study||0
10766488|NCT03207022|11929927|FG001|NOT COMPLETED|Overall Study||0
10766489|NCT03207035|11929935|FG000|STARTED|Overall Study||10
10766490|NCT03207035|11929936|FG001|STARTED|Overall Study||10
10766491|NCT03207035|11929935|FG000|COMPLETED|Overall Study||10
10766492|NCT03207035|11929936|FG001|COMPLETED|Overall Study||10
10766493|NCT03207035|11929935|FG000|NOT COMPLETED|Overall Study||0
10766494|NCT03207035|11929936|FG001|NOT COMPLETED|Overall Study||0
10766495|NCT03207074|11929942|FG000|STARTED|Overall Study||150
10766496|NCT03207074|11929942|FG000|COMPLETED|Overall Study||150
10766497|NCT03207074|11929942|FG000|NOT COMPLETED|Overall Study||0
10766498|NCT03207243|11929948|FG000|STARTED|Overall Study||82
10766499|NCT03207243|11929949|FG001|STARTED|Overall Study||83
10766500|NCT03207243|11929948|FG000|COMPLETED|Overall Study||23
10766501|NCT03207243|11929949|FG001|COMPLETED|Overall Study||39
10766502|NCT03207243|11929948|FG000|NOT COMPLETED|Overall Study||59
10766503|NCT03207243|11929949|FG001|NOT COMPLETED|Overall Study||44
10766504|NCT03207386|11929956|FG000|STARTED|Overall Study||2647
10766505|NCT03207386|11929956|FG000|COMPLETED|Overall Study||1487
10766506|NCT03207386|11929956|FG000|NOT COMPLETED|Overall Study||1160
10766507|NCT03207399|11929963|FG000|STARTED|Overall Study||1
10766508|NCT03207399|11929963|FG000|COMPLETED|Overall Study||1
10766509|NCT03207399|11929963|FG000|NOT COMPLETED|Overall Study||0
10766510|NCT03207438|11929971|FG000|STARTED|Overall Study||167
10766511|NCT03207438|11929972|FG001|STARTED|Overall Study||166
10766512|NCT03207438|11929973|FG002|STARTED|Overall Study||875
10766513|NCT03207438|11929974|FG003|STARTED|Overall Study||582
10766514|NCT03207438|11929971|FG000|COMPLETED|Overall Study||148
10766515|NCT03207438|11929972|FG001|COMPLETED|Overall Study||145
10766516|NCT03207438|11929973|FG002|COMPLETED|Overall Study||643
10766517|NCT03207438|11929974|FG003|COMPLETED|Overall Study||470
10766518|NCT03207438|11929971|FG000|NOT COMPLETED|Overall Study||19
10766519|NCT03207438|11929972|FG001|NOT COMPLETED|Overall Study||21
10766520|NCT03207438|11929973|FG002|NOT COMPLETED|Overall Study||232
10766521|NCT03207438|11929974|FG003|NOT COMPLETED|Overall Study||112
10766522|NCT03207750|11929989|FG000|STARTED|Overall Study||632
10766523|NCT03207750|11929990|FG001|STARTED|Overall Study||640
10766524|NCT03207750|11929989|FG000|COMPLETED|Overall Study||574
10766525|NCT03207750|11929990|FG001|COMPLETED|Overall Study||574
10766526|NCT03207750|11929989|FG000|NOT COMPLETED|Overall Study||58
10766527|NCT03207750|11929990|FG001|NOT COMPLETED|Overall Study||66
10766528|NCT03207763|11929998|FG000|STARTED|Overall Study||8
10766529|NCT03207763|11929999|FG001|STARTED|Overall Study||25
10766530|NCT03207763|11929998|FG000|Eligible and Opted for Patches 2 and 3|Overall Study||5
10766531|NCT03207763|11929999|FG001|Eligible and Opted for Patches 2 and 3|Overall Study||23
10766532|NCT03207763|11929998|FG000|Completed Patches 2 and 3 Study|Overall Study||5
10766533|NCT03207763|11929999|FG001|Completed Patches 2 and 3 Study|Overall Study||23
10766534|NCT03207763|11929998|FG000|COMPLETED|Overall Study||7
10766535|NCT03207763|11929999|FG001|COMPLETED|Overall Study||25
10766536|NCT03207763|11929998|FG000|NOT COMPLETED|Overall Study||1
10766537|NCT03207763|11929999|FG001|NOT COMPLETED|Overall Study||0
10766538|NCT03208088|11930014|FG000|STARTED|Period 1||10
10766539|NCT03208088|11930015|FG001|STARTED|Period 1||9
10766540|NCT03208088|11930016|FG002|STARTED|Period 1||10
10766541|NCT03208088|11930017|FG003|STARTED|Period 1||9
10766542|NCT03208088|11930018|FG004|STARTED|Period 1||9
10766543|NCT03208088|11930019|FG005|STARTED|Period 1||9
10766544|NCT03208088|11930020|FG006|STARTED|Period 1||8
10766545|NCT03208088|11930021|FG007|STARTED|Period 1||10
10766546|NCT03208088|11930022|FG008|STARTED|Period 1||8
10766547|NCT03208088|11930023|FG009|STARTED|Period 1||9
10766548|NCT03208088|11930014|FG000|COMPLETED|Period 1||10
10766549|NCT03208088|11930015|FG001|COMPLETED|Period 1||9
10766550|NCT03208088|11930016|FG002|COMPLETED|Period 1||10
10766551|NCT03208088|11930017|FG003|COMPLETED|Period 1||9
10766552|NCT03208088|11930018|FG004|COMPLETED|Period 1||9
10766553|NCT03208088|11930019|FG005|COMPLETED|Period 1||9
10766554|NCT03208088|11930020|FG006|COMPLETED|Period 1||8
10766555|NCT03208088|11930021|FG007|COMPLETED|Period 1||10
10766556|NCT03208088|11930022|FG008|COMPLETED|Period 1||8
10766557|NCT03208088|11930023|FG009|COMPLETED|Period 1||9
10766558|NCT03208088|11930014|FG000|NOT COMPLETED|Period 1||0
10766559|NCT03208088|11930015|FG001|NOT COMPLETED|Period 1||0
10766560|NCT03208088|11930016|FG002|NOT COMPLETED|Period 1||0
10766561|NCT03208088|11930017|FG003|NOT COMPLETED|Period 1||0
10766562|NCT03208088|11930018|FG004|NOT COMPLETED|Period 1||0
10766563|NCT03208088|11930019|FG005|NOT COMPLETED|Period 1||0
10766564|NCT03208088|11930020|FG006|NOT COMPLETED|Period 1||0
10766565|NCT03208088|11930021|FG007|NOT COMPLETED|Period 1||0
10766566|NCT03208088|11930022|FG008|NOT COMPLETED|Period 1||0
10766567|NCT03208088|11930023|FG009|NOT COMPLETED|Period 1||0
10766568|NCT03208088|11930014|FG000|STARTED|Period 2||10
10766569|NCT03208088|11930015|FG001|STARTED|Period 2||9
10766570|NCT03208088|11930016|FG002|STARTED|Period 2||10
10766571|NCT03208088|11930017|FG003|STARTED|Period 2||9
10766572|NCT03208088|11930018|FG004|STARTED|Period 2||9
10766573|NCT03208088|11930019|FG005|STARTED|Period 2||9
10766574|NCT03208088|11930020|FG006|STARTED|Period 2||8
10766575|NCT03208088|11930021|FG007|STARTED|Period 2||10
10766576|NCT03208088|11930022|FG008|STARTED|Period 2||8
10766577|NCT03208088|11930023|FG009|STARTED|Period 2||9
10766578|NCT03208088|11930014|FG000|COMPLETED|Period 2||10
10766579|NCT03208088|11930015|FG001|COMPLETED|Period 2||9
10766580|NCT03208088|11930016|FG002|COMPLETED|Period 2||10
10766581|NCT03208088|11930017|FG003|COMPLETED|Period 2||9
10766582|NCT03208088|11930018|FG004|COMPLETED|Period 2||9
10766583|NCT03208088|11930019|FG005|COMPLETED|Period 2||9
10766584|NCT03208088|11930020|FG006|COMPLETED|Period 2||8
10766585|NCT03208088|11930021|FG007|COMPLETED|Period 2||10
10766586|NCT03208088|11930022|FG008|COMPLETED|Period 2||7
10766587|NCT03208088|11930023|FG009|COMPLETED|Period 2||9
10766588|NCT03208088|11930014|FG000|NOT COMPLETED|Period 2||0
10766589|NCT03208088|11930015|FG001|NOT COMPLETED|Period 2||0
10766590|NCT03208088|11930016|FG002|NOT COMPLETED|Period 2||0
10766591|NCT03208088|11930017|FG003|NOT COMPLETED|Period 2||0
10766592|NCT03208088|11930018|FG004|NOT COMPLETED|Period 2||0
10766593|NCT03208088|11930019|FG005|NOT COMPLETED|Period 2||0
10766594|NCT03208088|11930020|FG006|NOT COMPLETED|Period 2||0
10766595|NCT03208088|11930021|FG007|NOT COMPLETED|Period 2||0
10766596|NCT03208088|11930022|FG008|NOT COMPLETED|Period 2||1
10766597|NCT03208088|11930023|FG009|NOT COMPLETED|Period 2||0
10766598|NCT03208088|11930014|FG000|STARTED|Period 3||10
10766599|NCT03208088|11930015|FG001|STARTED|Period 3||9
10766600|NCT03208088|11930016|FG002|STARTED|Period 3||10
10766601|NCT03208088|11930017|FG003|STARTED|Period 3||9
10766602|NCT03208088|11930018|FG004|STARTED|Period 3||9
10766603|NCT03208088|11930019|FG005|STARTED|Period 3||9
10766604|NCT03208088|11930020|FG006|STARTED|Period 3||8
10766605|NCT03208088|11930021|FG007|STARTED|Period 3||10
10766606|NCT03208088|11930022|FG008|STARTED|Period 3||7
10766607|NCT03208088|11930023|FG009|STARTED|Period 3||9
10766608|NCT03208088|11930014|FG000|COMPLETED|Period 3||10
10766609|NCT03208088|11930015|FG001|COMPLETED|Period 3||9
10766610|NCT03208088|11930016|FG002|COMPLETED|Period 3||10
10766611|NCT03208088|11930017|FG003|COMPLETED|Period 3||8
10766612|NCT03208088|11930018|FG004|COMPLETED|Period 3||9
10766613|NCT03208088|11930019|FG005|COMPLETED|Period 3||9
10766614|NCT03208088|11930020|FG006|COMPLETED|Period 3||8
10766615|NCT03208088|11930021|FG007|COMPLETED|Period 3||10
10766616|NCT03208088|11930022|FG008|COMPLETED|Period 3||7
10766617|NCT03208088|11930023|FG009|COMPLETED|Period 3||9
10766618|NCT03208088|11930014|FG000|NOT COMPLETED|Period 3||0
10766619|NCT03208088|11930015|FG001|NOT COMPLETED|Period 3||0
10766620|NCT03208088|11930016|FG002|NOT COMPLETED|Period 3||0
10766621|NCT03208088|11930017|FG003|NOT COMPLETED|Period 3||1
10766622|NCT03208088|11930018|FG004|NOT COMPLETED|Period 3||0
10766623|NCT03208088|11930019|FG005|NOT COMPLETED|Period 3||0
10766624|NCT03208088|11930020|FG006|NOT COMPLETED|Period 3||0
10766625|NCT03208088|11930021|FG007|NOT COMPLETED|Period 3||0
10766626|NCT03208088|11930022|FG008|NOT COMPLETED|Period 3||0
10766627|NCT03208088|11930023|FG009|NOT COMPLETED|Period 3||0
10766628|NCT03208088|11930014|FG000|STARTED|Period 4||10
10766629|NCT03208088|11930015|FG001|STARTED|Period 4||9
10766630|NCT03208088|11930016|FG002|STARTED|Period 4||10
10766631|NCT03208088|11930017|FG003|STARTED|Period 4||8
10766632|NCT03208088|11930018|FG004|STARTED|Period 4||9
10766633|NCT03208088|11930019|FG005|STARTED|Period 4||9
10766634|NCT03208088|11930020|FG006|STARTED|Period 4||8
10766635|NCT03208088|11930021|FG007|STARTED|Period 4||10
10766636|NCT03208088|11930022|FG008|STARTED|Period 4||7
10766637|NCT03208088|11930023|FG009|STARTED|Period 4||9
10766638|NCT03208088|11930014|FG000|COMPLETED|Period 4||10
10766639|NCT03208088|11930015|FG001|COMPLETED|Period 4||9
10766640|NCT03208088|11930016|FG002|COMPLETED|Period 4||10
10766641|NCT03208088|11930017|FG003|COMPLETED|Period 4||7
10766642|NCT03208088|11930018|FG004|COMPLETED|Period 4||9
10766643|NCT03208088|11930019|FG005|COMPLETED|Period 4||9
10766644|NCT03208088|11930020|FG006|COMPLETED|Period 4||8
10766645|NCT03208088|11930021|FG007|COMPLETED|Period 4||10
10766646|NCT03208088|11930022|FG008|COMPLETED|Period 4||7
10766647|NCT03208088|11930023|FG009|COMPLETED|Period 4||9
10766648|NCT03208088|11930014|FG000|NOT COMPLETED|Period 4||0
10766649|NCT03208088|11930015|FG001|NOT COMPLETED|Period 4||0
10766650|NCT03208088|11930016|FG002|NOT COMPLETED|Period 4||0
10766651|NCT03208088|11930017|FG003|NOT COMPLETED|Period 4||1
10766652|NCT03208088|11930018|FG004|NOT COMPLETED|Period 4||0
10766653|NCT03208088|11930019|FG005|NOT COMPLETED|Period 4||0
10766654|NCT03208088|11930020|FG006|NOT COMPLETED|Period 4||0
10766655|NCT03208088|11930021|FG007|NOT COMPLETED|Period 4||0
10766656|NCT03208088|11930022|FG008|NOT COMPLETED|Period 4||0
10766657|NCT03208088|11930023|FG009|NOT COMPLETED|Period 4||0
10766658|NCT03208088|11930014|FG000|STARTED|Period 5||10
10766659|NCT03208088|11930015|FG001|STARTED|Period 5||9
10766660|NCT03208088|11930016|FG002|STARTED|Period 5||10
10766661|NCT03208088|11930017|FG003|STARTED|Period 5||7
10766662|NCT03208088|11930018|FG004|STARTED|Period 5||9
10766663|NCT03208088|11930019|FG005|STARTED|Period 5||9
10766664|NCT03208088|11930020|FG006|STARTED|Period 5||8
10766665|NCT03208088|11930021|FG007|STARTED|Period 5||10
10766666|NCT03208088|11930022|FG008|STARTED|Period 5||7
10766667|NCT03208088|11930023|FG009|STARTED|Period 5||9
10766668|NCT03208088|11930014|FG000|COMPLETED|Period 5||10
10766669|NCT03208088|11930015|FG001|COMPLETED|Period 5||9
10766670|NCT03208088|11930016|FG002|COMPLETED|Period 5||10
10766671|NCT03208088|11930017|FG003|COMPLETED|Period 5||7
10766672|NCT03208088|11930018|FG004|COMPLETED|Period 5||9
10766673|NCT03208088|11930019|FG005|COMPLETED|Period 5||9
10766674|NCT03208088|11930020|FG006|COMPLETED|Period 5||8
10766675|NCT03208088|11930021|FG007|COMPLETED|Period 5||10
10766676|NCT03208088|11930022|FG008|COMPLETED|Period 5||7
10766677|NCT03208088|11930023|FG009|COMPLETED|Period 5||9
10766678|NCT03208088|11930014|FG000|NOT COMPLETED|Period 5||0
10766679|NCT03208088|11930015|FG001|NOT COMPLETED|Period 5||0
10766680|NCT03208088|11930016|FG002|NOT COMPLETED|Period 5||0
10766681|NCT03208088|11930017|FG003|NOT COMPLETED|Period 5||0
10766682|NCT03208088|11930018|FG004|NOT COMPLETED|Period 5||0
10766683|NCT03208088|11930019|FG005|NOT COMPLETED|Period 5||0
10766684|NCT03208088|11930020|FG006|NOT COMPLETED|Period 5||0
10766685|NCT03208088|11930021|FG007|NOT COMPLETED|Period 5||0
10766686|NCT03208088|11930022|FG008|NOT COMPLETED|Period 5||0
10766687|NCT03208088|11930023|FG009|NOT COMPLETED|Period 5||0
10766688|NCT03208166|11930037|FG000|STARTED|Overall Study||1
10766689|NCT03208166|11930038|FG001|STARTED|Overall Study||1
10766690|NCT03208166|11930037|FG000|COMPLETED|Overall Study||1
10766691|NCT03208166|11930038|FG001|COMPLETED|Overall Study||1
10766692|NCT03208166|11930037|FG000|NOT COMPLETED|Overall Study||0
10766693|NCT03208166|11930038|FG001|NOT COMPLETED|Overall Study||0
10766694|NCT03208192|11930046|FG000|STARTED|Overall Study||32
10766695|NCT03208192|11930047|FG001|STARTED|Overall Study||36
10766696|NCT03208192|11930046|FG000|COMPLETED|Overall Study||32
10766697|NCT03208192|11930047|FG001|COMPLETED|Overall Study||36
10766698|NCT03208192|11930046|FG000|NOT COMPLETED|Overall Study||0
10766699|NCT03208192|11930047|FG001|NOT COMPLETED|Overall Study||0
10766700|NCT03208673|11930055|FG000|STARTED|Overall Study||32
10766701|NCT03208673|11930055|FG000|COMPLETED|Overall Study||32
10766702|NCT03208673|11930055|FG000|NOT COMPLETED|Overall Study||0
10766703|NCT03208933|11930059|FG000|STARTED|Overall Study||60
10766704|NCT03208933|11930059|FG000|COMPLETED|Overall Study||47
10766705|NCT03208933|11930059|FG000|NOT COMPLETED|Overall Study||13
10766706|NCT03209050|11930063|FG000|STARTED|Overall Study||30
10766707|NCT03209050|11930063|FG000|COMPLETED|Overall Study||27
10766708|NCT03209050|11930063|FG000|NOT COMPLETED|Overall Study||3
10766709|NCT03209362|11930070|FG000|STARTED|Overall Study||39
10766710|NCT03209362|11930071|FG001|STARTED|Overall Study||41
10766711|NCT03209362|11930070|FG000|COMPLETED|Overall Study||37
10766712|NCT03209362|11930071|FG001|COMPLETED|Overall Study||38
10766713|NCT03209362|11930070|FG000|NOT COMPLETED|Overall Study||2
10766714|NCT03209362|11930071|FG001|NOT COMPLETED|Overall Study||3
10766715|NCT03209492|11930077|FG000|STARTED|Overall Study||333
10766716|NCT03209492|11930077|FG000|COMPLETED|Overall Study||328
10766717|NCT03209492|11930077|FG000|NOT COMPLETED|Overall Study||5
10766718|NCT03209505|11930081|FG000|STARTED|Overall Study||10
10766719|NCT03209505|11930082|FG001|STARTED|Overall Study||10
10766720|NCT03209505|11930081|FG000|COMPLETED|Overall Study||10
10766721|NCT03209505|11930082|FG001|COMPLETED|Overall Study||10
10766722|NCT03209505|11930081|FG000|NOT COMPLETED|Overall Study||0
10766723|NCT03209505|11930082|FG001|NOT COMPLETED|Overall Study||0
10766724|NCT03209518|11930088|FG000|STARTED|Overall Study||312
10766725|NCT03209518|11930088|FG000|COMPLETED|Overall Study||310
10766726|NCT03209518|11930088|FG000|NOT COMPLETED|Overall Study||2
10766727|NCT03209570|11930094|FG000|STARTED|Overall Study||24
10766728|NCT03209570|11930095|FG001|STARTED|Overall Study||25
10766729|NCT03209570|11930094|FG000|COMPLETED|Overall Study||14
10766730|NCT03209570|11930095|FG001|COMPLETED|Overall Study||12
10766731|NCT03209570|11930094|FG000|NOT COMPLETED|Overall Study||10
10766732|NCT03209570|11930095|FG001|NOT COMPLETED|Overall Study||13
10766733|NCT03209882|11930103|FG000|STARTED|Overall Study||6
10766734|NCT03209882|11930104|FG001|STARTED|Overall Study||3
10766735|NCT03209882|11930103|FG000|COMPLETED|Overall Study||6
10766736|NCT03209882|11930104|FG001|COMPLETED|Overall Study||3
10766737|NCT03209882|11930103|FG000|NOT COMPLETED|Overall Study||0
10766738|NCT03209882|11930104|FG001|NOT COMPLETED|Overall Study||0
10766739|NCT03209973|11930112|FG000|STARTED|Overall Study||70
10766740|NCT03209973|11930112|FG000|Completed Primary Outcome Period|Overall Study||66
10766741|NCT03209973|11930112|FG000|COMPLETED|Overall Study||0
10766742|NCT03209973|11930112|FG000|NOT COMPLETED|Overall Study||70
10766743|NCT03210155|11930120|FG000|STARTED|Overall Study||0
10766744|NCT03210155|11930121|FG001|STARTED|Overall Study||1
10766745|NCT03210155|11930120|FG000|COMPLETED|Overall Study||0
10766746|NCT03210155|11930121|FG001|COMPLETED|Overall Study||1
10766747|NCT03210155|11930120|FG000|NOT COMPLETED|Overall Study||0
10766748|NCT03210155|11930121|FG001|NOT COMPLETED|Overall Study||0
10766749|NCT03210220|11930129|FG000|STARTED|Overall Study||20
10766750|NCT03210220|11930130|FG001|STARTED|Overall Study||20
10766751|NCT03210220|11930129|FG000|COMPLETED|Overall Study||19
10766752|NCT03210220|11930130|FG001|COMPLETED|Overall Study||20
10766753|NCT03210220|11930129|FG000|NOT COMPLETED|Overall Study||1
10766754|NCT03210220|11930130|FG001|NOT COMPLETED|Overall Study||0
10766755|NCT03210259|11930138|FG000|STARTED|12-Week Run-in Period||21
10766756|NCT03210259|11930139|FG001|STARTED|12-Week Run-in Period||118
10766757|NCT03210259|11930140|FG002|STARTED|12-Week Run-in Period||120
10766758|NCT03210259|11930138|FG000|COMPLETED|12-Week Run-in Period||0
10766759|NCT03210259|11930139|FG001|COMPLETED|12-Week Run-in Period||118
10766760|NCT03210259|11930140|FG002|COMPLETED|12-Week Run-in Period||120
10766761|NCT03210259|11930138|FG000|NOT COMPLETED|12-Week Run-in Period||21
10766762|NCT03210259|11930139|FG001|NOT COMPLETED|12-Week Run-in Period||0
10766763|NCT03210259|11930140|FG002|NOT COMPLETED|12-Week Run-in Period||0
10766764|NCT03210259|11930138|FG000|STARTED|48-Week Randomized Responder Period||0
10766765|NCT03210259|11930139|FG001|STARTED|48-Week Randomized Responder Period||118
10766766|NCT03210259|11930140|FG002|STARTED|48-Week Randomized Responder Period||120
10766767|NCT03210259|11930138|FG000|COMPLETED|48-Week Randomized Responder Period||0
10766768|NCT03210259|11930139|FG001|COMPLETED|48-Week Randomized Responder Period||107
10766769|NCT03210259|11930140|FG002|COMPLETED|48-Week Randomized Responder Period||91
10766770|NCT03210259|11930138|FG000|NOT COMPLETED|48-Week Randomized Responder Period||0
10766771|NCT03210259|11930139|FG001|NOT COMPLETED|48-Week Randomized Responder Period||11
10766772|NCT03210259|11930140|FG002|NOT COMPLETED|48-Week Randomized Responder Period||29
10766773|NCT03210337|11930149|FG000|STARTED|Overall Study||78
10766774|NCT03210337|11930150|FG001|STARTED|Overall Study||79
10766775|NCT03210337|11930149|FG000|COMPLETED|Overall Study||70
10766776|NCT03210337|11930150|FG001|COMPLETED|Overall Study||74
10766777|NCT03210337|11930149|FG000|NOT COMPLETED|Overall Study||8
10766778|NCT03210337|11930150|FG001|NOT COMPLETED|Overall Study||5
10766779|NCT03210376|11930158|FG000|STARTED|Overall Study||50
10766780|NCT03210376|11930159|FG001|STARTED|Overall Study||50
10766781|NCT03210376|11930158|FG000|COMPLETED|Overall Study||50
10766782|NCT03210376|11930159|FG001|COMPLETED|Overall Study||50
10766783|NCT03210376|11930158|FG000|NOT COMPLETED|Overall Study||0
10766784|NCT03210376|11930159|FG001|NOT COMPLETED|Overall Study||0
10766785|NCT03210519|11930167|FG000|STARTED|Overall Study||11
10766786|NCT03210519|11930168|FG001|STARTED|Overall Study||10
10766787|NCT03210519|11930167|FG000|COMPLETED|Overall Study||9
10766788|NCT03210519|11930168|FG001|COMPLETED|Overall Study||10
10766789|NCT03210519|11930167|FG000|NOT COMPLETED|Overall Study||2
10766790|NCT03210519|11930168|FG001|NOT COMPLETED|Overall Study||0
10766791|NCT03210701|11930174|FG000|STARTED|Overall Study||123
10766792|NCT03210701|11930174|FG000|COMPLETED|Overall Study||123
10766793|NCT03210701|11930174|FG000|NOT COMPLETED|Overall Study||0
10766794|NCT03210961|11930193|FG000|STARTED|Overall Study||4
10766795|NCT03210961|11930194|FG001|STARTED|Overall Study||9
10766796|NCT03210961|11930195|FG002|STARTED|Overall Study||1
10766797|NCT03210961|11930196|FG003|STARTED|Overall Study||2
10766798|NCT03210961|11930197|FG004|STARTED|Overall Study||6
10766799|NCT03210961|11930198|FG005|STARTED|Overall Study||6
10766800|NCT03210961|11930199|FG006|STARTED|Overall Study||8
10766801|NCT03210961|11930200|FG007|STARTED|Overall Study||7
10766802|NCT03210961|11930201|FG008|STARTED|Overall Study||8
10766803|NCT03210961|11930202|FG009|STARTED|Overall Study||6
10766804|NCT03210961|11930203|FG010|STARTED|Overall Study||7
10766805|NCT03210961|11930204|FG011|STARTED|Overall Study||5
10766806|NCT03210961|11930205|FG012|STARTED|Overall Study||14
10766807|NCT03210961|11930206|FG013|STARTED|Overall Study||15
10766808|NCT03210961|11930207|FG014|STARTED|Overall Study||11
10766809|NCT03210961|11930193|FG000|COMPLETED|Overall Study||4
10766810|NCT03210961|11930194|FG001|COMPLETED|Overall Study||9
10766811|NCT03210961|11930195|FG002|COMPLETED|Overall Study||1
10766812|NCT03210961|11930196|FG003|COMPLETED|Overall Study||1
10766813|NCT03210961|11930197|FG004|COMPLETED|Overall Study||6
10766814|NCT03210961|11930198|FG005|COMPLETED|Overall Study||6
10766815|NCT03210961|11930199|FG006|COMPLETED|Overall Study||7
10766816|NCT03210961|11930200|FG007|COMPLETED|Overall Study||7
10766817|NCT03210961|11930201|FG008|COMPLETED|Overall Study||8
10766818|NCT03210961|11930202|FG009|COMPLETED|Overall Study||6
10766819|NCT03210961|11930203|FG010|COMPLETED|Overall Study||6
10766820|NCT03210961|11930204|FG011|COMPLETED|Overall Study||5
10766821|NCT03210961|11930205|FG012|COMPLETED|Overall Study||12
10766822|NCT03210961|11930206|FG013|COMPLETED|Overall Study||11
10766823|NCT03210961|11930207|FG014|COMPLETED|Overall Study||9
10766824|NCT03210961|11930193|FG000|NOT COMPLETED|Overall Study||0
10766825|NCT03210961|11930194|FG001|NOT COMPLETED|Overall Study||0
10766826|NCT03210961|11930195|FG002|NOT COMPLETED|Overall Study||0
10766827|NCT03210961|11930196|FG003|NOT COMPLETED|Overall Study||1
10766828|NCT03210961|11930197|FG004|NOT COMPLETED|Overall Study||0
10766829|NCT03210961|11930198|FG005|NOT COMPLETED|Overall Study||0
10766830|NCT03210961|11930199|FG006|NOT COMPLETED|Overall Study||1
10766831|NCT03210961|11930200|FG007|NOT COMPLETED|Overall Study||0
10766832|NCT03210961|11930201|FG008|NOT COMPLETED|Overall Study||0
10766833|NCT03210961|11930202|FG009|NOT COMPLETED|Overall Study||0
10766834|NCT03210961|11930203|FG010|NOT COMPLETED|Overall Study||1
10766835|NCT03210961|11930204|FG011|NOT COMPLETED|Overall Study||0
10766836|NCT03210961|11930205|FG012|NOT COMPLETED|Overall Study||2
10766837|NCT03210961|11930206|FG013|NOT COMPLETED|Overall Study||4
10766838|NCT03210961|11930207|FG014|NOT COMPLETED|Overall Study||2
10766839|NCT03211117|11930258|FG000|STARTED|Overall Study||0
10766840|NCT03211117|11930259|FG001|STARTED|Overall Study||3
10766841|NCT03211117|11930258|FG000|COMPLETED|Overall Study||0
10766842|NCT03211117|11930259|FG001|COMPLETED|Overall Study||3
10766843|NCT03211117|11930258|FG000|NOT COMPLETED|Overall Study||0
10766844|NCT03211117|11930259|FG001|NOT COMPLETED|Overall Study||0
10766845|NCT03211156|11930267|FG000|STARTED|Overall Study||49
10766846|NCT03211156|11930268|FG001|STARTED|Overall Study||48
10766847|NCT03211156|11930267|FG000|Received Study Drug|Overall Study||47
10766848|NCT03211156|11930268|FG001|Received Study Drug|Overall Study||45
10766849|NCT03211156|11930267|FG000|COMPLETED|Overall Study||47
10766850|NCT03211156|11930268|FG001|COMPLETED|Overall Study||45
10766851|NCT03211156|11930267|FG000|NOT COMPLETED|Overall Study||2
10766852|NCT03211156|11930268|FG001|NOT COMPLETED|Overall Study||3
10766853|NCT03211234|11930277|FG000|STARTED|Overall Study||17
10766854|NCT03211234|11930278|FG001|STARTED|Overall Study||31
10766855|NCT03211234|11930279|FG002|STARTED|Overall Study||28
10766856|NCT03211234|11930277|FG000|COMPLETED|Overall Study||16
10766857|NCT03211234|11930278|FG001|COMPLETED|Overall Study||30
10766858|NCT03211234|11930279|FG002|COMPLETED|Overall Study||25
10766859|NCT03211234|11930277|FG000|NOT COMPLETED|Overall Study||1
10766860|NCT03211234|11930278|FG001|NOT COMPLETED|Overall Study||1
10766861|NCT03211234|11930279|FG002|NOT COMPLETED|Overall Study||3
10766862|NCT03212261|11930287|FG000|STARTED|Overall Study|Enrolled: eligible at time of approach and signed a consent.|37
10766863|NCT03212261|11930287|FG000|Remained Eligible|Overall Study||35
10766864|NCT03212261|11930287|FG000|Baseline Completion|Overall Study|Lost patients: Technology difficulties (n=2), Family Emergency (n=1), Too busy (n=3), LTFU (n=1)|30
10766865|NCT03212261|11930287|FG000|Program Initiation|Overall Study|Lost patients: Tech trouble no first visit (n=1), Too busy/no time (n=2), LTFU (n=1)|26
10766866|NCT03212261|11930287|FG000|Post-intervention Survey|Overall Study|Lost to follow up (n=4)|22
10766867|NCT03212261|11930287|FG000|One Month Follow-up|Overall Study|Lost to follow up (n=1)|21
10766868|NCT03212261|11930287|FG000|COMPLETED|Overall Study||21
10766869|NCT03212261|11930287|FG000|NOT COMPLETED|Overall Study||16
10766870|NCT03212326|11930292|FG000|STARTED|Overall Study||24
10766871|NCT03212326|11930292|FG000|COMPLETED|Overall Study||20
10766872|NCT03212326|11930292|FG000|NOT COMPLETED|Overall Study||4
10766873|NCT03212365|11930298|FG000|STARTED|Overall Study||151
10766874|NCT03212365|11930299|FG001|STARTED|Overall Study||144
10766875|NCT03212365|11930298|FG000|COMPLETED|Overall Study||128
10766876|NCT03212365|11930299|FG001|COMPLETED|Overall Study||130
10766877|NCT03212365|11930298|FG000|NOT COMPLETED|Overall Study||23
10766878|NCT03212365|11930299|FG001|NOT COMPLETED|Overall Study||14
10766879|NCT03212521|11930305|FG000|STARTED|Overall Study||230
10766880|NCT03212521|11930305|FG000|COMPLETED|Overall Study||223
10766881|NCT03212521|11930305|FG000|NOT COMPLETED|Overall Study||7
10766882|NCT03212638|11930311|FG000|STARTED|Period 1||8
10766883|NCT03212638|11930312|FG001|STARTED|Period 1||8
10766884|NCT03212638|11930313|FG002|STARTED|Period 1||8
10766885|NCT03212638|11930314|FG003|STARTED|Period 1||0
10766886|NCT03212638|11930315|FG004|STARTED|Period 1||0
10766887|NCT03212638|11930311|FG000|Received at Least 1 Dose of Study Drug|Period 1||8
10766888|NCT03212638|11930312|FG001|Received at Least 1 Dose of Study Drug|Period 1||8
10766889|NCT03212638|11930313|FG002|Received at Least 1 Dose of Study Drug|Period 1||8
10766890|NCT03212638|11930314|FG003|Received at Least 1 Dose of Study Drug|Period 1||0
10766891|NCT03212638|11930315|FG004|Received at Least 1 Dose of Study Drug|Period 1||0
10766892|NCT03212638|11930311|FG000|COMPLETED|Period 1||8
10766893|NCT03212638|11930312|FG001|COMPLETED|Period 1||8
10766894|NCT03212638|11930313|FG002|COMPLETED|Period 1||8
10766895|NCT03212638|11930314|FG003|COMPLETED|Period 1||0
10766896|NCT03212638|11930315|FG004|COMPLETED|Period 1||0
10766897|NCT03212638|11930311|FG000|NOT COMPLETED|Period 1||0
10766898|NCT03212638|11930312|FG001|NOT COMPLETED|Period 1||0
10766899|NCT03212638|11930313|FG002|NOT COMPLETED|Period 1||0
10766900|NCT03212638|11930314|FG003|NOT COMPLETED|Period 1||0
10766901|NCT03212638|11930315|FG004|NOT COMPLETED|Period 1||0
10766902|NCT03212638|11930311|FG000|STARTED|Period 2||8
10766903|NCT03212638|11930312|FG001|STARTED|Period 2||8
10766904|NCT03212638|11930313|FG002|STARTED|Period 2||8
10766905|NCT03212638|11930314|FG003|STARTED|Period 2||0
10766906|NCT03212638|11930315|FG004|STARTED|Period 2||0
10766907|NCT03212638|11930311|FG000|Received at Least 1 Dose of Study Drug|Period 2||8
10766908|NCT03212638|11930312|FG001|Received at Least 1 Dose of Study Drug|Period 2||8
10766909|NCT03212638|11930313|FG002|Received at Least 1 Dose of Study Drug|Period 2||8
10766910|NCT03212638|11930314|FG003|Received at Least 1 Dose of Study Drug|Period 2||0
10766911|NCT03212638|11930315|FG004|Received at Least 1 Dose of Study Drug|Period 2||0
10766912|NCT03212638|11930311|FG000|COMPLETED|Period 2||8
10766913|NCT03212638|11930312|FG001|COMPLETED|Period 2||8
10766914|NCT03212638|11930313|FG002|COMPLETED|Period 2||8
10766915|NCT03212638|11930314|FG003|COMPLETED|Period 2||0
10766916|NCT03212638|11930315|FG004|COMPLETED|Period 2||0
10766917|NCT03212638|11930311|FG000|NOT COMPLETED|Period 2||0
10766918|NCT03212638|11930312|FG001|NOT COMPLETED|Period 2||0
10766919|NCT03212638|11930313|FG002|NOT COMPLETED|Period 2||0
10766920|NCT03212638|11930314|FG003|NOT COMPLETED|Period 2||0
10766921|NCT03212638|11930315|FG004|NOT COMPLETED|Period 2||0
10766922|NCT03212638|11930311|FG000|STARTED|Period 3||8
10766923|NCT03212638|11930312|FG001|STARTED|Period 3||8
10766924|NCT03212638|11930313|FG002|STARTED|Period 3||8
10766925|NCT03212638|11930314|FG003|STARTED|Period 3||0
10766926|NCT03212638|11930315|FG004|STARTED|Period 3||0
10766927|NCT03212638|11930311|FG000|Received at Least 1 Dose of Study Drug|Period 3||8
10766928|NCT03212638|11930312|FG001|Received at Least 1 Dose of Study Drug|Period 3||8
10766929|NCT03212638|11930313|FG002|Received at Least 1 Dose of Study Drug|Period 3||8
10766930|NCT03212638|11930314|FG003|Received at Least 1 Dose of Study Drug|Period 3||0
10766931|NCT03212638|11930315|FG004|Received at Least 1 Dose of Study Drug|Period 3||0
10766932|NCT03212638|11930311|FG000|COMPLETED|Period 3||8
10766933|NCT03212638|11930312|FG001|COMPLETED|Period 3||8
10766934|NCT03212638|11930313|FG002|COMPLETED|Period 3||8
10766935|NCT03212638|11930314|FG003|COMPLETED|Period 3||0
10766936|NCT03212638|11930315|FG004|COMPLETED|Period 3||0
10766937|NCT03212638|11930311|FG000|NOT COMPLETED|Period 3||0
10766938|NCT03212638|11930312|FG001|NOT COMPLETED|Period 3||0
10766939|NCT03212638|11930313|FG002|NOT COMPLETED|Period 3||0
10766940|NCT03212638|11930314|FG003|NOT COMPLETED|Period 3||0
10766941|NCT03212638|11930315|FG004|NOT COMPLETED|Period 3||0
10766942|NCT03212638|11930311|FG000|STARTED|Period 4|Participants were not allowed to participate in Part B and have completed study.|0
10766943|NCT03212638|11930312|FG001|STARTED|Period 4|Participants were not allowed to participate in Part B and have completed study.|0
10766944|NCT03212638|11930313|FG002|STARTED|Period 4|Participants were not allowed to participate in Part B and have completed study.|0
10766945|NCT03212638|11930314|FG003|STARTED|Period 4|New Participants in Part B, no participants from Part A participated in Part B.|9
10766946|NCT03212638|11930315|FG004|STARTED|Period 4|New Participants in Part B, no participants from Part A participated in Part B.|9
10766947|NCT03212638|11930311|FG000|Received at Least 1 Dose of Study Drug|Period 4||0
10766948|NCT03212638|11930312|FG001|Received at Least 1 Dose of Study Drug|Period 4||0
10766949|NCT03212638|11930313|FG002|Received at Least 1 Dose of Study Drug|Period 4||0
10766950|NCT03212638|11930314|FG003|Received at Least 1 Dose of Study Drug|Period 4||9
10766951|NCT03212638|11930315|FG004|Received at Least 1 Dose of Study Drug|Period 4||9
10766952|NCT03212638|11930311|FG000|COMPLETED|Period 4||0
10766953|NCT03212638|11930312|FG001|COMPLETED|Period 4||0
10766954|NCT03212638|11930313|FG002|COMPLETED|Period 4||0
10766955|NCT03212638|11930314|FG003|COMPLETED|Period 4||9
10766956|NCT03212638|11930315|FG004|COMPLETED|Period 4||9
10766957|NCT03212638|11930311|FG000|NOT COMPLETED|Period 4||0
10766958|NCT03212638|11930312|FG001|NOT COMPLETED|Period 4||0
10766959|NCT03212638|11930313|FG002|NOT COMPLETED|Period 4||0
10766960|NCT03212638|11930314|FG003|NOT COMPLETED|Period 4||0
10766961|NCT03212638|11930315|FG004|NOT COMPLETED|Period 4||0
10766962|NCT03212638|11930311|FG000|STARTED|Period 5||0
10766963|NCT03212638|11930312|FG001|STARTED|Period 5||0
10766964|NCT03212638|11930313|FG002|STARTED|Period 5||0
10766965|NCT03212638|11930314|FG003|STARTED|Period 5||9
10766966|NCT03212638|11930315|FG004|STARTED|Period 5||9
10766967|NCT03212638|11930311|FG000|Received at Least 1 Dose of Study Drug|Period 5||0
10766968|NCT03212638|11930312|FG001|Received at Least 1 Dose of Study Drug|Period 5||0
10766969|NCT03212638|11930313|FG002|Received at Least 1 Dose of Study Drug|Period 5||0
10766970|NCT03212638|11930314|FG003|Received at Least 1 Dose of Study Drug|Period 5||9
10766971|NCT03212638|11930315|FG004|Received at Least 1 Dose of Study Drug|Period 5||9
10766972|NCT03212638|11930311|FG000|COMPLETED|Period 5||0
10766973|NCT03212638|11930312|FG001|COMPLETED|Period 5||0
10766974|NCT03212638|11930313|FG002|COMPLETED|Period 5||0
10766975|NCT03212638|11930314|FG003|COMPLETED|Period 5||9
10766976|NCT03212638|11930315|FG004|COMPLETED|Period 5||9
10766977|NCT03212638|11930311|FG000|NOT COMPLETED|Period 5||0
10766978|NCT03212638|11930312|FG001|NOT COMPLETED|Period 5||0
10766979|NCT03212638|11930313|FG002|NOT COMPLETED|Period 5||0
10766980|NCT03212638|11930314|FG003|NOT COMPLETED|Period 5||0
10766981|NCT03212638|11930315|FG004|NOT COMPLETED|Period 5||0
10766982|NCT03212690|11930327|FG000|STARTED|Overall Study||57
10766983|NCT03212690|11930327|FG000|COMPLETED|Overall Study||56
10766984|NCT03212690|11930327|FG000|NOT COMPLETED|Overall Study||1
10766985|NCT03213210|11930331|FG000|STARTED|Overall Study||5
10766986|NCT03213210|11930331|FG000|6-month Follow-up|Overall Study||3
10766987|NCT03213210|11930331|FG000|COMPLETED|Overall Study||0
10766988|NCT03213210|11930331|FG000|NOT COMPLETED|Overall Study||5
10766989|NCT03213366|11930337|FG000|STARTED|Overall Study||81
10766990|NCT03213366|11930338|FG001|STARTED|Overall Study||71
10766991|NCT03213366|11930337|FG000|COMPLETED|Overall Study||72
10766992|NCT03213366|11930338|FG001|COMPLETED|Overall Study||67
10766993|NCT03213366|11930337|FG000|NOT COMPLETED|Overall Study||9
10766994|NCT03213366|11930338|FG001|NOT COMPLETED|Overall Study||4
10766995|NCT03213405|11930348|FG000|STARTED|Overall Study||6
10766996|NCT03213405|11930349|FG001|STARTED|Overall Study||6
10766997|NCT03213405|11930350|FG002|STARTED|Overall Study||6
10766998|NCT03213405|11930351|FG003|STARTED|Overall Study||6
10766999|NCT03213405|11930348|FG000|COMPLETED|Overall Study||6
10767000|NCT03213405|11930349|FG001|COMPLETED|Overall Study||6
10767001|NCT03213405|11930350|FG002|COMPLETED|Overall Study||6
10767002|NCT03213405|11930351|FG003|COMPLETED|Overall Study||6
10767003|NCT03213405|11930348|FG000|NOT COMPLETED|Overall Study||0
10767004|NCT03213405|11930349|FG001|NOT COMPLETED|Overall Study||0
10767005|NCT03213405|11930350|FG002|NOT COMPLETED|Overall Study||0
10767006|NCT03213405|11930351|FG003|NOT COMPLETED|Overall Study||0
10767007|NCT03213509|11930363|FG000|STARTED|Overall Study||80
10767008|NCT03213509|11930364|FG001|STARTED|Overall Study||90
10767009|NCT03213509|11930363|FG000|COMPLETED|Overall Study||76
10767010|NCT03213509|11930364|FG001|COMPLETED|Overall Study||85
10767011|NCT03213509|11930363|FG000|NOT COMPLETED|Overall Study||4
10767012|NCT03213509|11930364|FG001|NOT COMPLETED|Overall Study||5
10767013|NCT03213626|11930371|FG000|STARTED|Overall Study||7
10767014|NCT03213626|11930371|FG000|COMPLETED|Overall Study||0
10767015|NCT03213626|11930371|FG000|NOT COMPLETED|Overall Study||7
10767022|NCT03214081|11930384|FG000|STARTED|Overall Study||1237
10767023|NCT03214081|11930384|FG000|COMPLETED|Overall Study||1174
10767024|NCT03214081|11930384|FG000|NOT COMPLETED|Overall Study||63
10767025|NCT03214094|11930388|FG000|STARTED|Overall Study||1119
10767026|NCT03214094|11930388|FG000|COMPLETED|Overall Study||1059
10767027|NCT03214094|11930388|FG000|NOT COMPLETED|Overall Study||60
10767028|NCT03214198|11930392|FG000|STARTED|Overall Study||1304
10767029|NCT03214198|11930392|FG000|COMPLETED|Overall Study||1268
10767030|NCT03214198|11930392|FG000|NOT COMPLETED|Overall Study||36
10767031|NCT03214224|11930396|FG000|STARTED|Overall Study|Subjects did both standard and remote assessments in the validation study. Total enrollment 49.|49
10767032|NCT03214224|11930396|FG000|COMPLETED|Overall Study|3 therapists enrolled. 3 ctrls enrolled (not incl. in analysis). 3 pts enr. but not completed.|40
10767033|NCT03214224|11930396|FG000|NOT COMPLETED|Overall Study||9
10767034|NCT03214367|11930406|FG000|STARTED|Lead-in Period||1316
10767035|NCT03214367|11930407|FG001|STARTED|Lead-in Period||0
10297481|NCT00003298|11430009|FG000|COMPLETED|Re-register to Step 2 After Surgery||10
10297482|NCT00003298|11430009|FG000|NOT COMPLETED|Re-register to Step 2 After Surgery||18
10297483|NCT00003298|11430009|FG000|STARTED|Step 2 (Adjuvant Therapy)||10
10297484|NCT00003298|11430009|FG000|Eligible and Treated on Step 2|Step 2 (Adjuvant Therapy)||7
10297485|NCT00003298|11430009|FG000|COMPLETED|Step 2 (Adjuvant Therapy)||4
10297486|NCT00003298|11430009|FG000|NOT COMPLETED|Step 2 (Adjuvant Therapy)||6
10297487|NCT00003377|11430019|FG000|STARTED|Period I||3
10297488|NCT00003377|11430020|FG001|STARTED|Period I||3
10297489|NCT00003377|11430021|FG002|STARTED|Period I||3
10297490|NCT00003377|11430022|FG003|STARTED|Period I||3
10297491|NCT00003377|11430023|FG004|STARTED|Period I||0
10297492|NCT00003377|11430019|FG000|COMPLETED|Period I||3
10297493|NCT00003377|11430020|FG001|COMPLETED|Period I||3
10297494|NCT00003377|11430021|FG002|COMPLETED|Period I||2
10297495|NCT00003377|11430022|FG003|COMPLETED|Period I||2
10297496|NCT00003377|11430023|FG004|COMPLETED|Period I||0
10297497|NCT00003377|11430019|FG000|NOT COMPLETED|Period I||0
10297498|NCT00003377|11430020|FG001|NOT COMPLETED|Period I||0
10297499|NCT00003377|11430021|FG002|NOT COMPLETED|Period I||1
10297500|NCT00003377|11430022|FG003|NOT COMPLETED|Period I||1
10297501|NCT00003377|11430023|FG004|NOT COMPLETED|Period I||0
10297502|NCT00003377|11430019|FG000|STARTED|Period II|Patients participated at this dose level only in Period I.|0
10297503|NCT00003377|11430020|FG001|STARTED|Period II|Patients participated at this dose level only in Period I.|0
10297504|NCT00003377|11430021|FG002|STARTED|Period II|Patients participated at this dose level only in Period I.|0
10297505|NCT00003377|11430022|FG003|STARTED|Period II|Patients participated at this dose level only in Period I.|0
10297506|NCT00003377|11430023|FG004|STARTED|Period II|All pts enrolled on Per II received cisplatin 40 mg/m2 & paclitaxel 40 mg/m2 concurrent w/ radiation|17
10297507|NCT00003377|11430019|FG000|COMPLETED|Period II||0
10297508|NCT00003377|11430020|FG001|COMPLETED|Period II||0
10297509|NCT00003377|11430021|FG002|COMPLETED|Period II||0
10297510|NCT00003377|11430022|FG003|COMPLETED|Period II||0
10297511|NCT00003377|11430023|FG004|COMPLETED|Period II||16
10297512|NCT00003377|11430019|FG000|NOT COMPLETED|Period II||0
10421641|NCT00820170|11566485|FG004|NOT COMPLETED|Overall Study||4
10421642|NCT00820222|11566504|FG000|STARTED|Overall Study||271
10421643|NCT00820222|11566505|FG001|STARTED|Overall Study||269
10421644|NCT00820222|11566504|FG000|COMPLETED|Overall Study||95
10767036|NCT03214367|11930408|FG002|STARTED|Lead-in Period||0
10767037|NCT03214367|11930409|FG003|STARTED|Lead-in Period||0
10767038|NCT03214367|11930410|FG004|STARTED|Lead-in Period||76
10767039|NCT03214367|11930411|FG005|STARTED|Lead-in Period||0
10767040|NCT03214367|11930412|FG006|STARTED|Lead-in Period||0
10767041|NCT03214367|11930413|FG007|STARTED|Lead-in Period||0
10767042|NCT03214367|11930406|FG000|COMPLETED|Lead-in Period||1222
10767043|NCT03214367|11930407|FG001|COMPLETED|Lead-in Period||0
10767044|NCT03214367|11930408|FG002|COMPLETED|Lead-in Period||0
10767045|NCT03214367|11930409|FG003|COMPLETED|Lead-in Period||0
10767046|NCT03214367|11930410|FG004|COMPLETED|Lead-in Period||74
10767047|NCT03214367|11930411|FG005|COMPLETED|Lead-in Period||0
10767048|NCT03214367|11930412|FG006|COMPLETED|Lead-in Period||0
10767049|NCT03214367|11930413|FG007|COMPLETED|Lead-in Period||0
10767050|NCT03214367|11930406|FG000|NOT COMPLETED|Lead-in Period||94
10767051|NCT03214367|11930407|FG001|NOT COMPLETED|Lead-in Period||0
10767052|NCT03214367|11930408|FG002|NOT COMPLETED|Lead-in Period||0
10767053|NCT03214367|11930409|FG003|NOT COMPLETED|Lead-in Period||0
10767054|NCT03214367|11930410|FG004|NOT COMPLETED|Lead-in Period||2
10767055|NCT03214367|11930411|FG005|NOT COMPLETED|Lead-in Period||0
10767056|NCT03214367|11930412|FG006|NOT COMPLETED|Lead-in Period||0
10767057|NCT03214367|11930413|FG007|NOT COMPLETED|Lead-in Period||0
10767058|NCT03214367|11930406|FG000|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0
10767059|NCT03214367|11930407|FG001|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|442
10767060|NCT03214367|11930408|FG002|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|451
10767061|NCT03214367|11930409|FG003|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|329
10767062|NCT03214367|11930410|FG004|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0
10767063|NCT03214367|11930411|FG005|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|31
10779131|NCT03364309|11940877|FG018|COMPLETED|Induction Period||0
10297513|NCT00003377|11430020|FG001|NOT COMPLETED|Period II||0
10297514|NCT00003377|11430021|FG002|NOT COMPLETED|Period II||0
10421645|NCT00820222|11566505|FG001|COMPLETED|Overall Study||79
10421646|NCT00820222|11566504|FG000|NOT COMPLETED|Overall Study||176
10421647|NCT00820222|11566505|FG001|NOT COMPLETED|Overall Study||190
10421648|NCT00820235|11566514|FG000|STARTED|Overall Study||48
10421649|NCT00820235|11566515|FG001|STARTED|Overall Study||49
10767064|NCT03214367|11930412|FG006|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|21
10767065|NCT03214367|11930413|FG007|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|22
10767066|NCT03214367|11930406|FG000|COMPLETED|Treatment Period||0
10767067|NCT03214367|11930407|FG001|COMPLETED|Treatment Period||408
10767068|NCT03214367|11930408|FG002|COMPLETED|Treatment Period||418
10767069|NCT03214367|11930409|FG003|COMPLETED|Treatment Period||310
10767070|NCT03214367|11930410|FG004|COMPLETED|Treatment Period||0
10767071|NCT03214367|11930411|FG005|COMPLETED|Treatment Period||28
10767072|NCT03214367|11930412|FG006|COMPLETED|Treatment Period||19
10767073|NCT03214367|11930413|FG007|COMPLETED|Treatment Period||21
10767074|NCT03214367|11930406|FG000|NOT COMPLETED|Treatment Period||0
10767075|NCT03214367|11930407|FG001|NOT COMPLETED|Treatment Period||34
10767076|NCT03214367|11930408|FG002|NOT COMPLETED|Treatment Period||33
10767077|NCT03214367|11930409|FG003|NOT COMPLETED|Treatment Period||19
10767078|NCT03214367|11930410|FG004|NOT COMPLETED|Treatment Period||0
10767079|NCT03214367|11930411|FG005|NOT COMPLETED|Treatment Period||3
10767080|NCT03214367|11930412|FG006|NOT COMPLETED|Treatment Period||2
10767081|NCT03214367|11930413|FG007|NOT COMPLETED|Treatment Period||1
10767082|NCT03214380|11930431|FG000|STARTED|Lead-in||750
10767083|NCT03214380|11930432|FG001|STARTED|Lead-in||0
10767084|NCT03214380|11930433|FG002|STARTED|Lead-in||0
10767085|NCT03214380|11930434|FG003|STARTED|Lead-in||183
10767086|NCT03214380|11930435|FG004|STARTED|Lead-in||0
10767087|NCT03214380|11930436|FG005|STARTED|Lead-in||0
10767088|NCT03214380|11930431|FG000|Received at Least 1 Dose Lead-in Insulin|Lead-in||750
10767089|NCT03214380|11930432|FG001|Received at Least 1 Dose Lead-in Insulin|Lead-in||0
10767090|NCT03214380|11930433|FG002|Received at Least 1 Dose Lead-in Insulin|Lead-in||0
10767091|NCT03214380|11930434|FG003|Received at Least 1 Dose Lead-in Insulin|Lead-in||183
10767092|NCT03214380|11930435|FG004|Received at Least 1 Dose Lead-in Insulin|Lead-in||0
10767093|NCT03214380|11930436|FG005|Received at Least 1 Dose Lead-in Insulin|Lead-in||0
10767094|NCT03214380|11930431|FG000|COMPLETED|Lead-in||673
10767095|NCT03214380|11930432|FG001|COMPLETED|Lead-in||0
10767096|NCT03214380|11930433|FG002|COMPLETED|Lead-in||0
10767097|NCT03214380|11930434|FG003|COMPLETED|Lead-in||164
10297515|NCT00003377|11430022|FG003|NOT COMPLETED|Period II||0
10767098|NCT03214380|11930435|FG004|COMPLETED|Lead-in||0
10767099|NCT03214380|11930436|FG005|COMPLETED|Lead-in||0
10767100|NCT03214380|11930431|FG000|NOT COMPLETED|Lead-in||77
10767101|NCT03214380|11930432|FG001|NOT COMPLETED|Lead-in||0
10767102|NCT03214380|11930433|FG002|NOT COMPLETED|Lead-in||0
10767103|NCT03214380|11930434|FG003|NOT COMPLETED|Lead-in||19
10767104|NCT03214380|11930435|FG004|NOT COMPLETED|Lead-in||0
10767105|NCT03214380|11930436|FG005|NOT COMPLETED|Lead-in||0
10767106|NCT03214380|11930431|FG000|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0
10767107|NCT03214380|11930432|FG001|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|337
10767108|NCT03214380|11930433|FG002|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|336
10767109|NCT03214380|11930434|FG003|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0
10767110|NCT03214380|11930435|FG004|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|82
10767111|NCT03214380|11930436|FG005|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|82
10767112|NCT03214380|11930431|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||0
10767113|NCT03214380|11930432|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||337
10767114|NCT03214380|11930433|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||336
10767115|NCT03214380|11930434|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||0
10767116|NCT03214380|11930435|FG004|Received at Least 1 Dose of Study Drug|Treatment Period||82
10767117|NCT03214380|11930436|FG005|Received at Least 1 Dose of Study Drug|Treatment Period||82
10767118|NCT03214380|11930431|FG000|COMPLETED|Treatment Period||0
10767119|NCT03214380|11930432|FG001|COMPLETED|Treatment Period||319
10767120|NCT03214380|11930433|FG002|COMPLETED|Treatment Period||320
10767121|NCT03214380|11930434|FG003|COMPLETED|Treatment Period||0
10767122|NCT03214380|11930435|FG004|COMPLETED|Treatment Period||73
10767123|NCT03214380|11930436|FG005|COMPLETED|Treatment Period||71
10767124|NCT03214380|11930431|FG000|NOT COMPLETED|Treatment Period||0
10767125|NCT03214380|11930432|FG001|NOT COMPLETED|Treatment Period||18
10767126|NCT03214380|11930433|FG002|NOT COMPLETED|Treatment Period||16
10767127|NCT03214380|11930434|FG003|NOT COMPLETED|Treatment Period||0
10767128|NCT03214380|11930435|FG004|NOT COMPLETED|Treatment Period||9
10767129|NCT03214380|11930436|FG005|NOT COMPLETED|Treatment Period||11
10767130|NCT03214406|11930450|FG000|STARTED|Overall Study||88
10767131|NCT03214406|11930451|FG001|STARTED|Overall Study||93
10767132|NCT03214406|11930450|FG000|COMPLETED|Overall Study||78
10767133|NCT03214406|11930451|FG001|COMPLETED|Overall Study||78
10767134|NCT03214406|11930450|FG000|NOT COMPLETED|Overall Study||10
10767135|NCT03214406|11930451|FG001|NOT COMPLETED|Overall Study||15
10767136|NCT03214588|11930460|FG000|STARTED|Overall Study||27
10767137|NCT03214588|11930461|FG001|STARTED|Overall Study||14
10767138|NCT03214588|11930462|FG002|STARTED|Overall Study||26
10767139|NCT03214588|11930460|FG000|COMPLETED|Overall Study||26
10767140|NCT03214588|11930461|FG001|COMPLETED|Overall Study||13
10767141|NCT03214588|11930462|FG002|COMPLETED|Overall Study||24
10767142|NCT03214588|11930460|FG000|NOT COMPLETED|Overall Study||1
10767143|NCT03214588|11930461|FG001|NOT COMPLETED|Overall Study||1
10767144|NCT03214588|11930462|FG002|NOT COMPLETED|Overall Study||2
10767145|NCT03214640|11930474|FG000|STARTED|Overall Study||31
10767146|NCT03214640|11930475|FG001|STARTED|Overall Study||32
10767147|NCT03214640|11930476|FG002|STARTED|Overall Study||31
10767148|NCT03214640|11930477|FG003|STARTED|Overall Study||34
10767149|NCT03214640|11930474|FG000|COMPLETED|Overall Study||30
10767150|NCT03214640|11930475|FG001|COMPLETED|Overall Study||30
10767151|NCT03214640|11930476|FG002|COMPLETED|Overall Study||30
10767152|NCT03214640|11930477|FG003|COMPLETED|Overall Study||30
10767153|NCT03214640|11930474|FG000|NOT COMPLETED|Overall Study||1
10767154|NCT03214640|11930475|FG001|NOT COMPLETED|Overall Study||2
10767155|NCT03214640|11930476|FG002|NOT COMPLETED|Overall Study||1
10767156|NCT03214640|11930477|FG003|NOT COMPLETED|Overall Study||4
10767157|NCT03214952|11930487|FG000|STARTED|Overall Study||3183
10767158|NCT03214952|11930487|FG000|COMPLETED|Overall Study||3125
10767159|NCT03214952|11930487|FG000|NOT COMPLETED|Overall Study||58
10767160|NCT03215667|11930491|FG000|STARTED|Overall Study||9
10767161|NCT03215667|11930491|FG000|COMPLETED|Overall Study||5
10767162|NCT03215667|11930491|FG000|NOT COMPLETED|Overall Study||4
10767163|NCT03215758|11930497|FG000|STARTED|Overall Study||339
10767164|NCT03215758|11930498|FG001|STARTED|Overall Study||336
10767165|NCT03215758|11930497|FG000|COMPLETED|Overall Study||334
10767166|NCT03215758|11930498|FG001|COMPLETED|Overall Study||328
10767167|NCT03215758|11930497|FG000|NOT COMPLETED|Overall Study||5
10767168|NCT03215758|11930498|FG001|NOT COMPLETED|Overall Study||8
10767169|NCT03215771|11930504|FG000|STARTED|Overall Study||16
10767170|NCT03215771|11930504|FG000|Stroke Subjects|Overall Study||8
10767171|NCT03215771|11930504|FG000|TBI Subjects|Overall Study||8
10767172|NCT03215771|11930504|FG000|COMPLETED|Overall Study||13
10767173|NCT03215771|11930504|FG000|NOT COMPLETED|Overall Study||3
10767174|NCT03215901|11930512|FG000|STARTED|Overall Study||199
10767175|NCT03215901|11930513|FG001|STARTED|Overall Study||112
10767176|NCT03215901|11930514|FG002|STARTED|Overall Study||116
10767177|NCT03215901|11930512|FG000|COMPLETED|Overall Study||199
10767178|NCT03215901|11930513|FG001|COMPLETED|Overall Study||112
10767179|NCT03215901|11930514|FG002|COMPLETED|Overall Study||116
10421650|NCT00820235|11566516|FG002|STARTED|Overall Study||44
10767180|NCT03215901|11930512|FG000|NOT COMPLETED|Overall Study||0
10767181|NCT03215901|11930513|FG001|NOT COMPLETED|Overall Study||0
10767182|NCT03215901|11930514|FG002|NOT COMPLETED|Overall Study||0
10767183|NCT03216200|11930522|FG000|STARTED|Overall Study||5
10767184|NCT03216200|11930522|FG000|COMPLETED|Overall Study||5
10767185|NCT03216200|11930522|FG000|NOT COMPLETED|Overall Study||0
10767186|NCT03216226|11930528|FG000|STARTED|Overall Study||57
10767187|NCT03216226|11930529|FG001|STARTED|Overall Study||55
10767188|NCT03216226|11930528|FG000|Randomized and Treated|Overall Study||57
10767189|NCT03216226|11930529|FG001|Randomized and Treated|Overall Study||54
10767190|NCT03216226|11930528|FG000|COMPLETED|Overall Study||52
10767191|NCT03216226|11930529|FG001|COMPLETED|Overall Study||50
10767192|NCT03216226|11930528|FG000|NOT COMPLETED|Overall Study||5
10767193|NCT03216226|11930529|FG001|NOT COMPLETED|Overall Study||5
10767194|NCT03216265|11930538|FG000|STARTED|Overall Study||22
10767195|NCT03216265|11930539|FG001|STARTED|Overall Study||22
10767196|NCT03216265|11930540|FG002|STARTED|Overall Study||22
10767197|NCT03216265|11930538|FG000|COMPLETED|Overall Study||20
10767198|NCT03216265|11930539|FG001|COMPLETED|Overall Study||21
10767199|NCT03216265|11930540|FG002|COMPLETED|Overall Study||19
10767200|NCT03216265|11930538|FG000|NOT COMPLETED|Overall Study||2
10767201|NCT03216265|11930539|FG001|NOT COMPLETED|Overall Study||1
10767202|NCT03216265|11930540|FG002|NOT COMPLETED|Overall Study||3
10767203|NCT03216382|11930557|FG000|STARTED|Overall Study||41
10767204|NCT03216382|11930558|FG001|STARTED|Overall Study||54
10767205|NCT03216382|11930557|FG000|COMPLETED|Overall Study||34
10767206|NCT03216382|11930558|FG001|COMPLETED|Overall Study||44
10767207|NCT03216382|11930557|FG000|NOT COMPLETED|Overall Study||7
10767208|NCT03216382|11930558|FG001|NOT COMPLETED|Overall Study||10
10767209|NCT03216512|11930566|FG000|STARTED|Overall Study||17
10767210|NCT03216512|11930567|FG001|STARTED|Overall Study||14
10767211|NCT03216512|11930566|FG000|COMPLETED|Overall Study||17
10767212|NCT03216512|11930567|FG001|COMPLETED|Overall Study||13
10767213|NCT03216512|11930566|FG000|NOT COMPLETED|Overall Study||0
10767214|NCT03216512|11930567|FG001|NOT COMPLETED|Overall Study||1
10767215|NCT03216746|11930579|FG000|STARTED|Overall Study||72
10767216|NCT03216746|11930580|FG001|STARTED|Overall Study||79
10767217|NCT03216746|11930581|FG002|STARTED|Overall Study||68
10767218|NCT03216746|11930582|FG003|STARTED|Overall Study||69
10767219|NCT03216746|11930579|FG000|COMPLETED|Overall Study||66
10767220|NCT03216746|11930580|FG001|COMPLETED|Overall Study||71
10767221|NCT03216746|11930581|FG002|COMPLETED|Overall Study||63
10767222|NCT03216746|11930582|FG003|COMPLETED|Overall Study||63
10767223|NCT03216746|11930579|FG000|NOT COMPLETED|Overall Study||6
10767224|NCT03216746|11930580|FG001|NOT COMPLETED|Overall Study||8
10767225|NCT03216746|11930581|FG002|NOT COMPLETED|Overall Study||5
10767226|NCT03216746|11930582|FG003|NOT COMPLETED|Overall Study||6
10767227|NCT03216850|11930592|FG000|STARTED|Overall Study||15
10767228|NCT03216850|11930592|FG000|COMPLETED|Overall Study|6 patients did not complete the study because of the pre-analytical error.|9
10767229|NCT03216850|11930592|FG000|NOT COMPLETED|Overall Study||6
10767230|NCT03216902|11930602|FG000|STARTED|Overall Study||22
10767231|NCT03216902|11930603|FG001|STARTED|Overall Study||44
10767232|NCT03216902|11930604|FG002|STARTED|Overall Study||43
10767233|NCT03216902|11930605|FG003|STARTED|Overall Study||43
10767234|NCT03216902|11930606|FG004|STARTED|Overall Study||44
10767235|NCT03216902|11930607|FG005|STARTED|Overall Study||45
10767236|NCT03216902|11930602|FG000|COMPLETED|Overall Study||20
10767237|NCT03216902|11930603|FG001|COMPLETED|Overall Study||43
10767238|NCT03216902|11930604|FG002|COMPLETED|Overall Study||42
10767239|NCT03216902|11930605|FG003|COMPLETED|Overall Study||43
10767240|NCT03216902|11930606|FG004|COMPLETED|Overall Study||43
10767241|NCT03216902|11930607|FG005|COMPLETED|Overall Study||42
10767242|NCT03216902|11930602|FG000|NOT COMPLETED|Overall Study||2
10767243|NCT03216902|11930603|FG001|NOT COMPLETED|Overall Study||1
10767244|NCT03216902|11930604|FG002|NOT COMPLETED|Overall Study||1
10767245|NCT03216902|11930605|FG003|NOT COMPLETED|Overall Study||0
10767246|NCT03216902|11930606|FG004|NOT COMPLETED|Overall Study||1
10767247|NCT03216902|11930607|FG005|NOT COMPLETED|Overall Study||3
10767248|NCT03216954|11930629|FG000|STARTED|Overall Study||4
10767249|NCT03216954|11930630|FG001|STARTED|Overall Study||3
10767250|NCT03216954|11930631|FG002|STARTED|Overall Study||3
10767251|NCT03216954|11930632|FG003|STARTED|Overall Study||3
10767252|NCT03216954|11930633|FG004|STARTED|Overall Study||1
10767253|NCT03216954|11930629|FG000|COMPLETED|Overall Study||2
10767254|NCT03216954|11930630|FG001|COMPLETED|Overall Study||2
10767255|NCT03216954|11930631|FG002|COMPLETED|Overall Study||2
10767256|NCT03216954|11930632|FG003|COMPLETED|Overall Study||3
10767257|NCT03216954|11930633|FG004|COMPLETED|Overall Study||0
10767258|NCT03216954|11930629|FG000|NOT COMPLETED|Overall Study||2
10767259|NCT03216954|11930630|FG001|NOT COMPLETED|Overall Study||1
10767260|NCT03216954|11930631|FG002|NOT COMPLETED|Overall Study||1
10767261|NCT03216954|11930632|FG003|NOT COMPLETED|Overall Study||0
10767262|NCT03216954|11930633|FG004|NOT COMPLETED|Overall Study||1
10767263|NCT03217968|11930641|FG000|STARTED|Overall Study||59
10767264|NCT03217968|11930641|FG000|COMPLETED|Overall Study||48
10767265|NCT03217968|11930641|FG000|NOT COMPLETED|Overall Study||11
10767266|NCT03218397|11930647|FG000|STARTED|Overall Study||249
10767267|NCT03218397|11930648|FG001|STARTED|Overall Study||251
10767268|NCT03218397|11930647|FG000|COMPLETED|Overall Study||226
10767269|NCT03218397|11930648|FG001|COMPLETED|Overall Study||222
10767270|NCT03218397|11930647|FG000|NOT COMPLETED|Overall Study||23
10767271|NCT03218397|11930648|FG001|NOT COMPLETED|Overall Study||29
10767272|NCT03218566|11930654|FG000|STARTED|Overall Study||119
10767273|NCT03218566|11930654|FG000|COMPLETED|Overall Study||110
10767274|NCT03218566|11930654|FG000|NOT COMPLETED|Overall Study||9
10767275|NCT03218592|11930661|FG000|STARTED|Phase 1: 1 Dose||12
10767276|NCT03218592|11930662|FG001|STARTED|Phase 1: 1 Dose||12
10767277|NCT03218592|11930663|FG002|STARTED|Phase 1: 1 Dose||12
10767278|NCT03218592|11930661|FG000|COMPLETED|Phase 1: 1 Dose||12
10767279|NCT03218592|11930662|FG001|COMPLETED|Phase 1: 1 Dose||12
10767280|NCT03218592|11930663|FG002|COMPLETED|Phase 1: 1 Dose||12
10767281|NCT03218592|11930661|FG000|NOT COMPLETED|Phase 1: 1 Dose||0
10767282|NCT03218592|11930662|FG001|NOT COMPLETED|Phase 1: 1 Dose||0
10767283|NCT03218592|11930663|FG002|NOT COMPLETED|Phase 1: 1 Dose||0
10767284|NCT03218592|11930661|FG000|STARTED|Phase 2: Daily Doses x 28 Days||12
10767285|NCT03218592|11930662|FG001|STARTED|Phase 2: Daily Doses x 28 Days||12
10767286|NCT03218592|11930663|FG002|STARTED|Phase 2: Daily Doses x 28 Days||12
10767287|NCT03218592|11930661|FG000|COMPLETED|Phase 2: Daily Doses x 28 Days||12
10767288|NCT03218592|11930662|FG001|COMPLETED|Phase 2: Daily Doses x 28 Days||12
10767289|NCT03218592|11930663|FG002|COMPLETED|Phase 2: Daily Doses x 28 Days||12
10767290|NCT03218592|11930661|FG000|NOT COMPLETED|Phase 2: Daily Doses x 28 Days||0
10767291|NCT03218592|11930662|FG001|NOT COMPLETED|Phase 2: Daily Doses x 28 Days||0
10767292|NCT03218592|11930663|FG002|NOT COMPLETED|Phase 2: Daily Doses x 28 Days||0
10767293|NCT03218592|11930661|FG000|STARTED|Phase 3: 0 Doses Per Week||4
10767294|NCT03218592|11930662|FG001|STARTED|Phase 3: 0 Doses Per Week||4
10767295|NCT03218592|11930663|FG002|STARTED|Phase 3: 0 Doses Per Week||4
10767296|NCT03218592|11930661|FG000|4 Patients Per Group|Phase 3: 0 Doses Per Week||4
10767297|NCT03218592|11930662|FG001|4 Patients Per Group|Phase 3: 0 Doses Per Week||4
10767298|NCT03218592|11930663|FG002|4 Patients Per Group|Phase 3: 0 Doses Per Week||4
10767299|NCT03218592|11930661|FG000|COMPLETED|Phase 3: 0 Doses Per Week||4
10767300|NCT03218592|11930662|FG001|COMPLETED|Phase 3: 0 Doses Per Week||4
10767301|NCT03218592|11930663|FG002|COMPLETED|Phase 3: 0 Doses Per Week||4
10767302|NCT03218592|11930661|FG000|NOT COMPLETED|Phase 3: 0 Doses Per Week||0
10767303|NCT03218592|11930662|FG001|NOT COMPLETED|Phase 3: 0 Doses Per Week||0
10767304|NCT03218592|11930663|FG002|NOT COMPLETED|Phase 3: 0 Doses Per Week||0
10767305|NCT03218592|11930661|FG000|STARTED|Phase 3: 1 Dose Per Period||4
10767306|NCT03218592|11930662|FG001|STARTED|Phase 3: 1 Dose Per Period||4
10767307|NCT03218592|11930663|FG002|STARTED|Phase 3: 1 Dose Per Period||4
10767308|NCT03218592|11930661|FG000|4 Patients Per Group|Phase 3: 1 Dose Per Period||4
10767309|NCT03218592|11930662|FG001|4 Patients Per Group|Phase 3: 1 Dose Per Period||4
10767310|NCT03218592|11930663|FG002|4 Patients Per Group|Phase 3: 1 Dose Per Period||4
10767311|NCT03218592|11930661|FG000|COMPLETED|Phase 3: 1 Dose Per Period||4
10767312|NCT03218592|11930662|FG001|COMPLETED|Phase 3: 1 Dose Per Period||4
10767313|NCT03218592|11930663|FG002|COMPLETED|Phase 3: 1 Dose Per Period||4
10767314|NCT03218592|11930661|FG000|NOT COMPLETED|Phase 3: 1 Dose Per Period||0
10767315|NCT03218592|11930662|FG001|NOT COMPLETED|Phase 3: 1 Dose Per Period||0
10767316|NCT03218592|11930663|FG002|NOT COMPLETED|Phase 3: 1 Dose Per Period||0
10767317|NCT03218592|11930661|FG000|STARTED|Phase 3: 3 Doses Per Week||4
10767318|NCT03218592|11930662|FG001|STARTED|Phase 3: 3 Doses Per Week||4
10767319|NCT03218592|11930663|FG002|STARTED|Phase 3: 3 Doses Per Week||4
10767320|NCT03218592|11930661|FG000|4 Patients Per Group|Phase 3: 3 Doses Per Week||4
10767321|NCT03218592|11930662|FG001|4 Patients Per Group|Phase 3: 3 Doses Per Week||4
10767322|NCT03218592|11930663|FG002|4 Patients Per Group|Phase 3: 3 Doses Per Week||4
10767323|NCT03218592|11930661|FG000|COMPLETED|Phase 3: 3 Doses Per Week||4
10767324|NCT03218592|11930662|FG001|COMPLETED|Phase 3: 3 Doses Per Week||4
10767325|NCT03218592|11930663|FG002|COMPLETED|Phase 3: 3 Doses Per Week||4
10767326|NCT03218592|11930661|FG000|NOT COMPLETED|Phase 3: 3 Doses Per Week||0
10767327|NCT03218592|11930662|FG001|NOT COMPLETED|Phase 3: 3 Doses Per Week||0
10767328|NCT03218592|11930663|FG002|NOT COMPLETED|Phase 3: 3 Doses Per Week||0
10767329|NCT03218787|11930676|FG000|STARTED|Overall Study||2047
10767330|NCT03218787|11930676|FG000|COMPLETED|Overall Study||1841
10767331|NCT03218787|11930676|FG000|NOT COMPLETED|Overall Study||206
10767332|NCT03219216|11930682|FG000|STARTED|Overall Study||75
10767333|NCT03219216|11930683|FG001|STARTED|Overall Study||25
10767334|NCT03219216|11930682|FG000|COMPLETED|Overall Study||75
10767335|NCT03219216|11930683|FG001|COMPLETED|Overall Study||24
10767336|NCT03219216|11930682|FG000|NOT COMPLETED|Overall Study||0
10767337|NCT03219216|11930683|FG001|NOT COMPLETED|Overall Study||1
10767338|NCT03219294|11930690|FG000|STARTED|Overall Study||58
10767339|NCT03219294|11930691|FG001|STARTED|Overall Study||58
10767340|NCT03219294|11930690|FG000|COMPLETED|Overall Study||58
10767341|NCT03219294|11930691|FG001|COMPLETED|Overall Study||58
10767342|NCT03219294|11930690|FG000|NOT COMPLETED|Overall Study||0
10767343|NCT03219294|11930691|FG001|NOT COMPLETED|Overall Study||0
10767344|NCT03219320|11930701|FG000|STARTED|Overall Study||75
10767345|NCT03219320|11930702|FG001|STARTED|Overall Study||77
10767346|NCT03219320|11930703|FG002|STARTED|Overall Study||77
10767347|NCT03219320|11930704|FG003|STARTED|Overall Study||72
10767348|NCT03219320|11930701|FG000|COMPLETED|Overall Study||73
10767349|NCT03219320|11930702|FG001|COMPLETED|Overall Study||74
10767350|NCT03219320|11930703|FG002|COMPLETED|Overall Study||72
10767351|NCT03219320|11930704|FG003|COMPLETED|Overall Study||69
10767352|NCT03219320|11930701|FG000|NOT COMPLETED|Overall Study||2
10767353|NCT03219320|11930702|FG001|NOT COMPLETED|Overall Study||3
10767354|NCT03219320|11930703|FG002|NOT COMPLETED|Overall Study||5
10767355|NCT03219320|11930704|FG003|NOT COMPLETED|Overall Study||3
10779132|NCT03364309|11940859|FG000|NOT COMPLETED|Induction Period||6
10767356|NCT03219723|11930714|FG000|STARTED|Overall Study||560
10767357|NCT03219723|11930714|FG000|COMPLETED|Overall Study||550
10767358|NCT03219723|11930714|FG000|NOT COMPLETED|Overall Study||10
10767359|NCT03219840|11930718|FG000|STARTED|Overall Study||38
10767360|NCT03219840|11930719|FG001|STARTED|Overall Study||31
10767361|NCT03219840|11930718|FG000|Day 1 Visit for 1st Period|Overall Study||37
10767362|NCT03219840|11930719|FG001|Day 1 Visit for 1st Period|Overall Study||31
10767363|NCT03219840|11930718|FG000|1st Intervention Period of 21 Days|Overall Study||34
10767364|NCT03219840|11930719|FG001|1st Intervention Period of 21 Days|Overall Study||31
10767365|NCT03219840|11930718|FG000|Day 22 Visit for 1st Period|Overall Study||34
10767366|NCT03219840|11930719|FG001|Day 22 Visit for 1st Period|Overall Study||31
10767367|NCT03219840|11930718|FG000|Washout Period of 21 Days|Overall Study||34
10767368|NCT03219840|11930719|FG001|Washout Period of 21 Days|Overall Study||31
10767369|NCT03219840|11930718|FG000|Day 1 Visit for 2nd Period|Overall Study||34
10767370|NCT03219840|11930719|FG001|Day 1 Visit for 2nd Period|Overall Study||31
10767371|NCT03219840|11930718|FG000|2nd Intervention Period of 21 Days|Overall Study||34
10767372|NCT03219840|11930719|FG001|2nd Intervention Period of 21 Days|Overall Study||31
10767373|NCT03219840|11930718|FG000|Day 22 Visit for 2nd Period|Overall Study||34
10767374|NCT03219840|11930719|FG001|Day 22 Visit for 2nd Period|Overall Study||31
10767375|NCT03219840|11930718|FG000|COMPLETED|Overall Study||34
10767376|NCT03219840|11930719|FG001|COMPLETED|Overall Study||31
10767377|NCT03219840|11930718|FG000|NOT COMPLETED|Overall Study||4
10767378|NCT03219840|11930719|FG001|NOT COMPLETED|Overall Study||0
10767379|NCT03219866|11930727|FG000|STARTED|Overall Study||21
10767380|NCT03219866|11930728|FG001|STARTED|Overall Study||19
10767381|NCT03219866|11930727|FG000|COMPLETED|Overall Study||21
10767382|NCT03219866|11930728|FG001|COMPLETED|Overall Study||19
10767383|NCT03219866|11930727|FG000|NOT COMPLETED|Overall Study||0
10767384|NCT03219866|11930728|FG001|NOT COMPLETED|Overall Study||0
10767385|NCT03219892|11930736|FG000|STARTED|Overall Study||20
10767386|NCT03219892|11930737|FG001|STARTED|Overall Study||10
10767387|NCT03219892|11930736|FG000|COMPLETED|Overall Study||20
10767388|NCT03219892|11930737|FG001|COMPLETED|Overall Study||10
10767389|NCT03219892|11930736|FG000|NOT COMPLETED|Overall Study||0
10767390|NCT03219892|11930737|FG001|NOT COMPLETED|Overall Study||0
10767391|NCT03220048|11930746|FG000|STARTED|Overall Study||11
10767392|NCT03220048|11930747|FG001|STARTED|Overall Study||27
10767393|NCT03220048|11930748|FG002|STARTED|Overall Study||28
10767394|NCT03220048|11930746|FG000|COMPLETED|Overall Study||11
10767395|NCT03220048|11930747|FG001|COMPLETED|Overall Study||25
10767396|NCT03220048|11930748|FG002|COMPLETED|Overall Study||27
10767397|NCT03220048|11930746|FG000|NOT COMPLETED|Overall Study||0
10767398|NCT03220048|11930747|FG001|NOT COMPLETED|Overall Study||2
10767399|NCT03220048|11930748|FG002|NOT COMPLETED|Overall Study||1
10767400|NCT03220204|11930764|FG000|STARTED|Overall Study||15
10767401|NCT03220204|11930765|FG001|STARTED|Overall Study||15
10767402|NCT03220204|11930766|FG002|STARTED|Overall Study||15
10767403|NCT03220204|11930764|FG000|COMPLETED|Overall Study||14
10767404|NCT03220204|11930765|FG001|COMPLETED|Overall Study||13
10767405|NCT03220204|11930766|FG002|COMPLETED|Overall Study||12
10767406|NCT03220204|11930764|FG000|NOT COMPLETED|Overall Study||1
10767407|NCT03220204|11930765|FG001|NOT COMPLETED|Overall Study||2
10767408|NCT03220204|11930766|FG002|NOT COMPLETED|Overall Study||3
10767409|NCT03220217|11930780|FG000|STARTED|Overall Study||8
10767410|NCT03220217|11930781|FG001|STARTED|Overall Study||10
10767411|NCT03220217|11930782|FG002|STARTED|Overall Study||11
10767412|NCT03220217|11930780|FG000|COMPLETED|Overall Study||8
10767413|NCT03220217|11930781|FG001|COMPLETED|Overall Study||9
10767414|NCT03220217|11930782|FG002|COMPLETED|Overall Study||10
10767415|NCT03220217|11930780|FG000|NOT COMPLETED|Overall Study||0
10767416|NCT03220217|11930781|FG001|NOT COMPLETED|Overall Study||1
10767417|NCT03220217|11930782|FG002|NOT COMPLETED|Overall Study||1
10767418|NCT03220230|11930811|FG000|STARTED|Overall Study||4240
10767419|NCT03220230|11930811|FG000|COMPLETED|Overall Study||4240
10767420|NCT03220230|11930811|FG000|NOT COMPLETED|Overall Study||0
10767421|NCT03220412|11930817|FG000|STARTED|Overall Study||54
10767422|NCT03220412|11930818|FG001|STARTED|Overall Study||50
10767423|NCT03220412|11930817|FG000|COMPLETED|Overall Study||54
10767424|NCT03220412|11930818|FG001|COMPLETED|Overall Study||50
10767425|NCT03220412|11930817|FG000|NOT COMPLETED|Overall Study||0
10767426|NCT03220412|11930818|FG001|NOT COMPLETED|Overall Study||0
10767427|NCT03220737|11930833|FG000|STARTED|Main Study (Day 1 - 181)||163
10767428|NCT03220737|11930834|FG001|STARTED|Main Study (Day 1 - 181)||26
10767429|NCT03220737|11930835|FG002|STARTED|Main Study (Day 1 - 181)||158
10767430|NCT03220737|11930836|FG003|STARTED|Main Study (Day 1 - 181)||27
10767431|NCT03220737|11930837|FG004|STARTED|Main Study (Day 1 - 181)||150
10767432|NCT03220737|11930838|FG005|STARTED|Main Study (Day 1 - 181)||26
10767433|NCT03220737|11930839|FG006|STARTED|Main Study (Day 1 - 181)||2688
10297516|NCT00003377|11430023|FG004|NOT COMPLETED|Period II||1
10767434|NCT03220737|11930833|FG000|COMPLETED|Main Study (Day 1 - 181)||157
10767435|NCT03220737|11930834|FG001|COMPLETED|Main Study (Day 1 - 181)||24
10767436|NCT03220737|11930835|FG002|COMPLETED|Main Study (Day 1 - 181)||146
10767437|NCT03220737|11930836|FG003|COMPLETED|Main Study (Day 1 - 181)||24
10767438|NCT03220737|11930837|FG004|COMPLETED|Main Study (Day 1 - 181)||130
10767439|NCT03220737|11930838|FG005|COMPLETED|Main Study (Day 1 - 181)||25
10767440|NCT03220737|11930839|FG006|COMPLETED|Main Study (Day 1 - 181)||2687
10767441|NCT03220737|11930833|FG000|NOT COMPLETED|Main Study (Day 1 - 181)||6
10767442|NCT03220737|11930834|FG001|NOT COMPLETED|Main Study (Day 1 - 181)||2
10297517|NCT00003389|11430038|FG000|STARTED|Overall Study||428
10767443|NCT03220737|11930835|FG002|NOT COMPLETED|Main Study (Day 1 - 181)||12
10767444|NCT03220737|11930836|FG003|NOT COMPLETED|Main Study (Day 1 - 181)||3
10767445|NCT03220737|11930837|FG004|NOT COMPLETED|Main Study (Day 1 - 181)||20
10767446|NCT03220737|11930838|FG005|NOT COMPLETED|Main Study (Day 1 - 181)||1
10767447|NCT03220737|11930839|FG006|NOT COMPLETED|Main Study (Day 1 - 181)||1
10767448|NCT03220737|11930833|FG000|STARTED|Placebo Crossover (Day 181-365)|Only placebo subjects who opted to receive Vaxchora were included in the crossover group.|13
10767449|NCT03220737|11930834|FG001|STARTED|Placebo Crossover (Day 181-365)|Placebo subjects from Main study opted to cross over to the active group to receive Vaxchora.|0
10767450|NCT03220737|11930835|FG002|STARTED|Placebo Crossover (Day 181-365)|Only placebo subjects who opted to receive Vaxchora were included in the crossover group.|11
10767451|NCT03220737|11930836|FG003|STARTED|Placebo Crossover (Day 181-365)|Placebo subjects from Main study opted to cross over to the active group to receive Vaxchora|0
10767452|NCT03220737|11930837|FG004|STARTED|Placebo Crossover (Day 181-365)|Only placebo subjects who opted to receive Vaxchora were included in the crossover group.|7
10767453|NCT03220737|11930838|FG005|STARTED|Placebo Crossover (Day 181-365)|Placebo subjects from Main study opted to cross over to the active group to receive Vaxchora|0
10767454|NCT03220737|11930839|FG006|STARTED|Placebo Crossover (Day 181-365)||0
10767455|NCT03220737|11930833|FG000|COMPLETED|Placebo Crossover (Day 181-365)||13
10767456|NCT03220737|11930834|FG001|COMPLETED|Placebo Crossover (Day 181-365)||0
10767457|NCT03220737|11930835|FG002|COMPLETED|Placebo Crossover (Day 181-365)||11
10767458|NCT03220737|11930836|FG003|COMPLETED|Placebo Crossover (Day 181-365)||0
10767459|NCT03220737|11930837|FG004|COMPLETED|Placebo Crossover (Day 181-365)||5
10767460|NCT03220737|11930838|FG005|COMPLETED|Placebo Crossover (Day 181-365)||0
10767461|NCT03220737|11930839|FG006|COMPLETED|Placebo Crossover (Day 181-365)||0
10767462|NCT03220737|11930833|FG000|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
10767463|NCT03220737|11930834|FG001|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
10767464|NCT03220737|11930835|FG002|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
10767465|NCT03220737|11930836|FG003|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
10767466|NCT03220737|11930837|FG004|NOT COMPLETED|Placebo Crossover (Day 181-365)||2
10767467|NCT03220737|11930838|FG005|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
10767468|NCT03220737|11930839|FG006|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
10767469|NCT03220737|11930833|FG000|STARTED|Long-term Follow-up (Day 365-730)|Cohort 1 subjects from the main study had to opt to be included in the Long-term follow-up study.|73
10767470|NCT03220737|11930834|FG001|STARTED|Long-term Follow-up (Day 365-730)||0
10767471|NCT03220737|11930835|FG002|STARTED|Long-term Follow-up (Day 365-730)|Cohort 2 subjects were not eligible for the Long-term follow-up study.|0
10767472|NCT03220737|11930836|FG003|STARTED|Long-term Follow-up (Day 365-730)||0
10767473|NCT03220737|11930837|FG004|STARTED|Long-term Follow-up (Day 365-730)|Cohort 3 subjects were not eligible for the Long-term follow-up study.|0
10767474|NCT03220737|11930838|FG005|STARTED|Long-term Follow-up (Day 365-730)||0
10767475|NCT03220737|11930839|FG006|STARTED|Long-term Follow-up (Day 365-730)||0
10767476|NCT03220737|11930833|FG000|COMPLETED|Long-term Follow-up (Day 365-730)||62
10767477|NCT03220737|11930834|FG001|COMPLETED|Long-term Follow-up (Day 365-730)||0
10767478|NCT03220737|11930835|FG002|COMPLETED|Long-term Follow-up (Day 365-730)||0
10767479|NCT03220737|11930836|FG003|COMPLETED|Long-term Follow-up (Day 365-730)||0
10767480|NCT03220737|11930837|FG004|COMPLETED|Long-term Follow-up (Day 365-730)||0
10767481|NCT03220737|11930838|FG005|COMPLETED|Long-term Follow-up (Day 365-730)||0
10767482|NCT03220737|11930839|FG006|COMPLETED|Long-term Follow-up (Day 365-730)||0
10767483|NCT03220737|11930833|FG000|NOT COMPLETED|Long-term Follow-up (Day 365-730)||11
10767484|NCT03220737|11930834|FG001|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
10767485|NCT03220737|11930835|FG002|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
10767486|NCT03220737|11930836|FG003|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
10767487|NCT03220737|11930837|FG004|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
10767488|NCT03220737|11930838|FG005|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
10767489|NCT03220737|11930839|FG006|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
10767490|NCT03220958|11930863|FG000|STARTED|Overall Study||81
10767491|NCT03220958|11930864|FG001|STARTED|Overall Study||79
10767492|NCT03220958|11930863|FG000|COMPLETED|Overall Study||81
10767493|NCT03220958|11930864|FG001|COMPLETED|Overall Study||79
10767494|NCT03220958|11930863|FG000|NOT COMPLETED|Overall Study||0
10767495|NCT03220958|11930864|FG001|NOT COMPLETED|Overall Study||0
10767496|NCT03221192|11930870|FG000|STARTED|Overall Study||27
10767497|NCT03221192|11930870|FG000|COMPLETED|Overall Study||27
10767498|NCT03221192|11930870|FG000|NOT COMPLETED|Overall Study||0
10767499|NCT03221387|11930874|FG000|STARTED|Overall Study||30
10767500|NCT03221387|11930874|FG000|COMPLETED|Overall Study||28
10767501|NCT03221387|11930874|FG000|NOT COMPLETED|Overall Study||2
10767502|NCT03221595|11930880|FG000|STARTED|Overall Study||51
10767503|NCT03221595|11930881|FG001|STARTED|Overall Study||59
10767504|NCT03221595|11930880|FG000|COMPLETED|Overall Study||51
10767505|NCT03221595|11930881|FG001|COMPLETED|Overall Study||59
10767506|NCT03221595|11930880|FG000|NOT COMPLETED|Overall Study||0
10767507|NCT03221595|11930881|FG001|NOT COMPLETED|Overall Study||0
10767508|NCT03221738|11930887|FG000|STARTED|Overall Study||10
10767509|NCT03221738|11930887|FG000|COMPLETED|Overall Study||10
10767510|NCT03221738|11930887|FG000|NOT COMPLETED|Overall Study||0
10767511|NCT03221764|11930891|FG000|STARTED|Overall Study||20
10767512|NCT03221764|11930891|FG000|COMPLETED|Overall Study||20
10767513|NCT03221764|11930891|FG000|NOT COMPLETED|Overall Study||0
10767514|NCT03222037|11930895|FG000|STARTED|Period 1||21
10767515|NCT03222037|11930896|FG001|STARTED|Period 1||22
10767516|NCT03222037|11930895|FG000|COMPLETED|Period 1||21
10767517|NCT03222037|11930896|FG001|COMPLETED|Period 1||22
10767518|NCT03222037|11930895|FG000|NOT COMPLETED|Period 1||0
10767519|NCT03222037|11930896|FG001|NOT COMPLETED|Period 1||0
10767520|NCT03222037|11930895|FG000|STARTED|Period 2||21
10767521|NCT03222037|11930896|FG001|STARTED|Period 2||22
10767522|NCT03222037|11930895|FG000|COMPLETED|Period 2||21
10767523|NCT03222037|11930896|FG001|COMPLETED|Period 2||22
10767524|NCT03222037|11930895|FG000|NOT COMPLETED|Period 2||0
10767525|NCT03222037|11930896|FG001|NOT COMPLETED|Period 2||0
10767526|NCT03222141|11930902|FG000|STARTED|Overall Study||583
10767527|NCT03222141|11930902|FG000|COMPLETED|Overall Study||565
10767528|NCT03222141|11930902|FG000|NOT COMPLETED|Overall Study||18
10767529|NCT03222349|11930907|FG000|STARTED|Overall Study||11
10767530|NCT03222349|11930908|FG001|STARTED|Overall Study||13
10767531|NCT03222349|11930907|FG000|COMPLETED|Overall Study||3
10767532|NCT03222349|11930908|FG001|COMPLETED|Overall Study||6
10767533|NCT03222349|11930907|FG000|NOT COMPLETED|Overall Study||8
10767534|NCT03222349|11930908|FG001|NOT COMPLETED|Overall Study||7
10767535|NCT03222414|11930923|FG000|STARTED|Overall Study||0
10767536|NCT03222414|11930924|FG001|STARTED|Overall Study||1
10767537|NCT03222414|11930923|FG000|COMPLETED|Overall Study||0
10767538|NCT03222414|11930924|FG001|COMPLETED|Overall Study||1
10767539|NCT03222414|11930923|FG000|NOT COMPLETED|Overall Study||0
10767540|NCT03222414|11930924|FG001|NOT COMPLETED|Overall Study||0
10767541|NCT03222427|11930930|FG000|STARTED|Overall Study||8
10767542|NCT03222427|11930930|FG000|Received One Dose of Study Drug|Overall Study||8
10767543|NCT03222427|11930930|FG000|COMPLETED|Overall Study||8
10767544|NCT03222427|11930930|FG000|NOT COMPLETED|Overall Study||0
10767545|NCT03222505|11930937|FG000|STARTED|Overall Study||5
10767546|NCT03222505|11930938|FG001|STARTED|Overall Study||7
10767547|NCT03222505|11930937|FG000|COMPLETED|Overall Study||5
10767548|NCT03222505|11930938|FG001|COMPLETED|Overall Study||7
10767549|NCT03222505|11930937|FG000|NOT COMPLETED|Overall Study||0
10767550|NCT03222505|11930938|FG001|NOT COMPLETED|Overall Study||0
10767551|NCT03222583|11930947|FG000|STARTED|Overall Study||363
10767552|NCT03222583|11930948|FG001|STARTED|Overall Study||183
10767553|NCT03222583|11930947|FG000|Received Double-blind Treatment|Overall Study||362
10767554|NCT03222583|11930948|FG001|Received Double-blind Treatment|Overall Study||183
10767555|NCT03222583|11930947|FG000|Completed Double-blind Period|Overall Study||360
10767556|NCT03222583|11930948|FG001|Completed Double-blind Period|Overall Study||183
10767557|NCT03222583|11930947|FG000|Entered Open-label Period|Overall Study||0
10767558|NCT03222583|11930948|FG001|Entered Open-label Period|Overall Study||182
10767559|NCT03222583|11930947|FG000|Completed Open-label Period|Overall Study||0
10767560|NCT03222583|11930948|FG001|Completed Open-label Period|Overall Study||181
10767561|NCT03222583|11930947|FG000|COMPLETED|Overall Study||358
10767562|NCT03222583|11930948|FG001|COMPLETED|Overall Study||177
10767563|NCT03222583|11930947|FG000|NOT COMPLETED|Overall Study||5
10767564|NCT03222583|11930948|FG001|NOT COMPLETED|Overall Study||6
10767565|NCT03223246|11930956|FG000|STARTED|48-72 Hours||83
10767566|NCT03223246|11930957|FG001|STARTED|48-72 Hours||66
10767567|NCT03223246|11930956|FG000|COMPLETED|48-72 Hours||62
10767568|NCT03223246|11930957|FG001|COMPLETED|48-72 Hours||35
10767569|NCT03223246|11930956|FG000|NOT COMPLETED|48-72 Hours||21
10767570|NCT03223246|11930957|FG001|NOT COMPLETED|48-72 Hours||31
10767571|NCT03223246|11930956|FG000|STARTED|5-7 Days||83
10767572|NCT03223246|11930957|FG001|STARTED|5-7 Days||66
10767573|NCT03223246|11930956|FG000|COMPLETED|5-7 Days||41
10767574|NCT03223246|11930957|FG001|COMPLETED|5-7 Days||35
10767575|NCT03223246|11930956|FG000|NOT COMPLETED|5-7 Days||42
10767576|NCT03223246|11930957|FG001|NOT COMPLETED|5-7 Days||31
10767577|NCT03223272|11930963|FG000|STARTED|Overall Study||7
10767578|NCT03223272|11930963|FG000|COMPLETED|Overall Study||6
10767579|NCT03223272|11930963|FG000|NOT COMPLETED|Overall Study||1
10767580|NCT03223337|11930971|FG000|STARTED|Part 1 (Up to 16 Days)||8
10767581|NCT03223337|11930972|FG001|STARTED|Part 1 (Up to 16 Days)||8
10767582|NCT03223337|11930973|FG002|STARTED|Part 1 (Up to 16 Days)||0
10767583|NCT03223337|11930974|FG003|STARTED|Part 1 (Up to 16 Days)||0
10767584|NCT03223337|11930971|FG000|COMPLETED|Part 1 (Up to 16 Days)||8
10767585|NCT03223337|11930972|FG001|COMPLETED|Part 1 (Up to 16 Days)||8
10767586|NCT03223337|11930973|FG002|COMPLETED|Part 1 (Up to 16 Days)||0
10767587|NCT03223337|11930974|FG003|COMPLETED|Part 1 (Up to 16 Days)||0
10767588|NCT03223337|11930971|FG000|NOT COMPLETED|Part 1 (Up to 16 Days)||0
10767589|NCT03223337|11930972|FG001|NOT COMPLETED|Part 1 (Up to 16 Days)||0
10767590|NCT03223337|11930973|FG002|NOT COMPLETED|Part 1 (Up to 16 Days)||0
10767591|NCT03223337|11930974|FG003|NOT COMPLETED|Part 1 (Up to 16 Days)||0
10767592|NCT03223337|11930971|FG000|STARTED|Part 2 (Up to 16 Days)||0
10767593|NCT03223337|11930972|FG001|STARTED|Part 2 (Up to 16 Days)||0
10767594|NCT03223337|11930973|FG002|STARTED|Part 2 (Up to 16 Days)||12
10767595|NCT03223337|11930974|FG003|STARTED|Part 2 (Up to 16 Days)||9
10767596|NCT03223337|11930971|FG000|COMPLETED|Part 2 (Up to 16 Days)||0
10767597|NCT03223337|11930972|FG001|COMPLETED|Part 2 (Up to 16 Days)||0
10767598|NCT03223337|11930973|FG002|COMPLETED|Part 2 (Up to 16 Days)||12
10767599|NCT03223337|11930974|FG003|COMPLETED|Part 2 (Up to 16 Days)||9
10767600|NCT03223337|11930971|FG000|NOT COMPLETED|Part 2 (Up to 16 Days)||0
10767601|NCT03223337|11930972|FG001|NOT COMPLETED|Part 2 (Up to 16 Days)||0
10767602|NCT03223337|11930973|FG002|NOT COMPLETED|Part 2 (Up to 16 Days)||0
10767603|NCT03223337|11930974|FG003|NOT COMPLETED|Part 2 (Up to 16 Days)||0
10767604|NCT03223649|11930986|FG000|STARTED|Overall Study||52
10767605|NCT03223649|11930987|FG001|STARTED|Overall Study||57
10767606|NCT03223649|11930986|FG000|COMPLETED|Overall Study||42
10767607|NCT03223649|11930987|FG001|COMPLETED|Overall Study||51
10767608|NCT03223649|11930986|FG000|NOT COMPLETED|Overall Study||10
10767609|NCT03223649|11930987|FG001|NOT COMPLETED|Overall Study||6
10767610|NCT03223909|11930996|FG000|STARTED|Overall Study||120
10767611|NCT03223909|11930997|FG001|STARTED|Overall Study||109
10767612|NCT03223909|11930998|FG002|STARTED|Overall Study||97
10767613|NCT03223909|11930996|FG000|COMPLETED|Overall Study||72
10767614|NCT03223909|11930997|FG001|COMPLETED|Overall Study||64
10767615|NCT03223909|11930998|FG002|COMPLETED|Overall Study||81
10767616|NCT03223909|11930996|FG000|NOT COMPLETED|Overall Study||48
10767617|NCT03223909|11930997|FG001|NOT COMPLETED|Overall Study||45
10767618|NCT03223909|11930998|FG002|NOT COMPLETED|Overall Study||16
10767619|NCT03224130|11931008|FG000|STARTED|Overall Study||483
10767620|NCT03224130|11931009|FG001|STARTED|Overall Study||483
10767621|NCT03224130|11931008|FG000|COMPLETED|Overall Study||483
10767622|NCT03224130|11931009|FG001|COMPLETED|Overall Study||482
10767623|NCT03224130|11931008|FG000|NOT COMPLETED|Overall Study||0
10767624|NCT03224130|11931009|FG001|NOT COMPLETED|Overall Study||1
10767625|NCT03224182|11931017|FG000|STARTED|Overall Study||81
10767626|NCT03224182|11931018|FG001|STARTED|Overall Study||37
10767627|NCT03224182|11931017|FG000|Safety Population|Overall Study||73
10767628|NCT03224182|11931018|FG001|Safety Population|Overall Study||36
10767629|NCT03224182|11931017|FG000|COMPLETED|Overall Study||0
10767630|NCT03224182|11931018|FG001|COMPLETED|Overall Study||1
10767631|NCT03224182|11931017|FG000|NOT COMPLETED|Overall Study||81
10767632|NCT03224182|11931018|FG001|NOT COMPLETED|Overall Study||36
10767633|NCT03224234|11931028|FG000|STARTED|Main Study||40
10767634|NCT03224234|11931029|FG001|STARTED|Main Study||40
10767635|NCT03224234|11931028|FG000|COMPLETED|Main Study||35
10767636|NCT03224234|11931029|FG001|COMPLETED|Main Study||35
10767637|NCT03224234|11931028|FG000|NOT COMPLETED|Main Study||5
10767638|NCT03224234|11931029|FG001|NOT COMPLETED|Main Study||5
10767639|NCT03224234|11931028|FG000|STARTED|Pilot||11
10767640|NCT03224234|11931029|FG001|STARTED|Pilot||7
10767641|NCT03224234|11931028|FG000|COMPLETED|Pilot||11
10767642|NCT03224234|11931029|FG001|COMPLETED|Pilot||7
10767643|NCT03224234|11931028|FG000|NOT COMPLETED|Pilot||0
10767644|NCT03224234|11931029|FG001|NOT COMPLETED|Pilot||0
10767645|NCT03224299|11931041|FG000|STARTED|Overall Study||131
10767646|NCT03224299|11931042|FG001|STARTED|Overall Study||424
10767647|NCT03224299|11931041|FG000|Treated With IP#1|Overall Study||65
10767648|NCT03224299|11931042|FG001|Treated With IP#1|Overall Study||101
10767649|NCT03224299|11931041|FG000|Treated With IP#2|Overall Study||66
10767650|NCT03224299|11931042|FG001|Treated With IP#2|Overall Study||107
10767651|NCT03224299|11931041|FG000|Treated With AC|Overall Study||66
10767652|NCT03224299|11931042|FG001|Treated With AC|Overall Study||110
10767653|NCT03224299|11931041|FG000|Treated With NC|Overall Study||65
10767654|NCT03224299|11931042|FG001|Treated With NC|Overall Study||106
10767655|NCT03224299|11931041|FG000|COMPLETED|Overall Study||131
10767656|NCT03224299|11931042|FG001|COMPLETED|Overall Study||424
10767657|NCT03224299|11931041|FG000|NOT COMPLETED|Overall Study||0
10767658|NCT03224299|11931042|FG001|NOT COMPLETED|Overall Study||0
10767659|NCT03224325|11931063|FG000|STARTED|Overall Study||13
10767660|NCT03224325|11931064|FG001|STARTED|Overall Study||6
10767661|NCT03224325|11931065|FG002|STARTED|Overall Study||6
10767662|NCT03224325|11931066|FG003|STARTED|Overall Study||6
10767663|NCT03224325|11931067|FG004|STARTED|Overall Study||6
10767664|NCT03224325|11931068|FG005|STARTED|Overall Study||6
10767665|NCT03224325|11931069|FG006|STARTED|Overall Study||7
10767666|NCT03224325|11931063|FG000|COMPLETED|Overall Study||12
10767667|NCT03224325|11931064|FG001|COMPLETED|Overall Study||6
10767668|NCT03224325|11931065|FG002|COMPLETED|Overall Study||6
10767669|NCT03224325|11931066|FG003|COMPLETED|Overall Study||5
10767670|NCT03224325|11931067|FG004|COMPLETED|Overall Study||6
10767671|NCT03224325|11931068|FG005|COMPLETED|Overall Study||6
10767672|NCT03224325|11931069|FG006|COMPLETED|Overall Study||6
10767673|NCT03224325|11931063|FG000|NOT COMPLETED|Overall Study||1
10767674|NCT03224325|11931064|FG001|NOT COMPLETED|Overall Study||0
10767675|NCT03224325|11931065|FG002|NOT COMPLETED|Overall Study||0
10767676|NCT03224325|11931066|FG003|NOT COMPLETED|Overall Study||1
10767677|NCT03224325|11931067|FG004|NOT COMPLETED|Overall Study||0
10767678|NCT03224325|11931068|FG005|NOT COMPLETED|Overall Study||0
10767679|NCT03224325|11931069|FG006|NOT COMPLETED|Overall Study||1
10767680|NCT03224351|11931099|FG000|STARTED|Overall Study||10
10767681|NCT03224351|11931100|FG001|STARTED|Overall Study||11
10767682|NCT03224351|11931101|FG002|STARTED|Overall Study||20
10767683|NCT03224351|11931102|FG003|STARTED|Overall Study||22
10767684|NCT03224351|11931103|FG004|STARTED|Overall Study||11
10767685|NCT03224351|11931104|FG005|STARTED|Overall Study||18
10767686|NCT03224351|11931105|FG006|STARTED|Overall Study||6
10767687|NCT03224351|11931106|FG007|STARTED|Overall Study||19
10767688|NCT03224351|11931099|FG000|COMPLETED|Overall Study||10
10767689|NCT03224351|11931100|FG001|COMPLETED|Overall Study||11
10767690|NCT03224351|11931101|FG002|COMPLETED|Overall Study||20
10767691|NCT03224351|11931102|FG003|COMPLETED|Overall Study||22
10767692|NCT03224351|11931103|FG004|COMPLETED|Overall Study||11
10767693|NCT03224351|11931104|FG005|COMPLETED|Overall Study||18
10767694|NCT03224351|11931105|FG006|COMPLETED|Overall Study||6
10767695|NCT03224351|11931106|FG007|COMPLETED|Overall Study||19
10767696|NCT03224351|11931099|FG000|NOT COMPLETED|Overall Study||0
10767697|NCT03224351|11931100|FG001|NOT COMPLETED|Overall Study||0
10767698|NCT03224351|11931101|FG002|NOT COMPLETED|Overall Study||0
10767699|NCT03224351|11931102|FG003|NOT COMPLETED|Overall Study||0
10767700|NCT03224351|11931103|FG004|NOT COMPLETED|Overall Study||0
10767701|NCT03224351|11931104|FG005|NOT COMPLETED|Overall Study||0
10767702|NCT03224351|11931105|FG006|NOT COMPLETED|Overall Study||0
10767703|NCT03224351|11931106|FG007|NOT COMPLETED|Overall Study||0
10767704|NCT03224390|11931134|FG000|STARTED|Overall Study||56
10767705|NCT03224390|11931135|FG001|STARTED|Overall Study||56
10767706|NCT03224390|11931134|FG000|COMPLETED|Overall Study||29
10767707|NCT03224390|11931135|FG001|COMPLETED|Overall Study||21
10767708|NCT03224390|11931134|FG000|NOT COMPLETED|Overall Study||27
10767709|NCT03224390|11931135|FG001|NOT COMPLETED|Overall Study||35
10767710|NCT03224403|11931147|FG000|STARTED|Overall Study||59
10767711|NCT03224403|11931148|FG001|STARTED|Overall Study||249
10767712|NCT03224403|11931149|FG002|STARTED|Overall Study||232
10767713|NCT03224403|11931150|FG003|STARTED|Overall Study||124
10767714|NCT03224403|11931147|FG000|COMPLETED|Overall Study||59
10767715|NCT03224403|11931148|FG001|COMPLETED|Overall Study||249
10767716|NCT03224403|11931149|FG002|COMPLETED|Overall Study||232
10767717|NCT03224403|11931150|FG003|COMPLETED|Overall Study||124
10767718|NCT03224403|11931147|FG000|NOT COMPLETED|Overall Study||0
10767719|NCT03224403|11931148|FG001|NOT COMPLETED|Overall Study||0
10767720|NCT03224403|11931149|FG002|NOT COMPLETED|Overall Study||0
10767721|NCT03224403|11931150|FG003|NOT COMPLETED|Overall Study||0
10767722|NCT03224520|11931164|FG000|STARTED|Overall Study||371
10767723|NCT03224520|11931165|FG001|STARTED|Overall Study||370
10767724|NCT03224520|11931166|FG002|STARTED|Overall Study||374
10767725|NCT03224520|11931167|FG003|STARTED|Overall Study||372
10767726|NCT03224520|11931164|FG000|COMPLETED|Overall Study||205
10767727|NCT03224520|11931165|FG001|COMPLETED|Overall Study||207
10767728|NCT03224520|11931166|FG002|COMPLETED|Overall Study||190
10767729|NCT03224520|11931167|FG003|COMPLETED|Overall Study||199
10767730|NCT03224520|11931164|FG000|NOT COMPLETED|Overall Study||166
10767731|NCT03224520|11931165|FG001|NOT COMPLETED|Overall Study||163
10767732|NCT03224520|11931166|FG002|NOT COMPLETED|Overall Study||184
10767733|NCT03224520|11931167|FG003|NOT COMPLETED|Overall Study||173
10767734|NCT03224585|11931179|FG000|STARTED|Overall Study||2
10767735|NCT03224585|11931180|FG001|STARTED|Overall Study||3
10767736|NCT03224585|11931179|FG000|COMPLETED|Overall Study||2
10767737|NCT03224585|11931180|FG001|COMPLETED|Overall Study||3
10767738|NCT03224585|11931179|FG000|NOT COMPLETED|Overall Study||0
10767739|NCT03224585|11931180|FG001|NOT COMPLETED|Overall Study||0
10767740|NCT03224598|11931188|FG000|STARTED|Overall Study||9
10767741|NCT03224598|11931189|FG001|STARTED|Overall Study||17
10767742|NCT03224598|11931190|FG002|STARTED|Overall Study||13
10767743|NCT03224598|11931188|FG000|COMPLETED|Overall Study||9
10767744|NCT03224598|11931189|FG001|COMPLETED|Overall Study||14
10767745|NCT03224598|11931190|FG002|COMPLETED|Overall Study||13
10767746|NCT03224598|11931188|FG000|NOT COMPLETED|Overall Study||0
10767747|NCT03224598|11931189|FG001|NOT COMPLETED|Overall Study||3
10767748|NCT03224598|11931190|FG002|NOT COMPLETED|Overall Study||0
10767749|NCT03225001|11931198|FG000|STARTED|Overall Study||197
10767750|NCT03225001|11931198|FG000|Valve-Implanted|Overall Study||195
10767751|NCT03225001|11931198|FG000|COMPLETED|Overall Study||188
10767752|NCT03225001|11931198|FG000|NOT COMPLETED|Overall Study||9
10767753|NCT03225313|11931205|FG000|STARTED|Overall Study|25 Patients|25
10767754|NCT03225313|11931206|FG001|STARTED|Overall Study|25 Patients|25
10767755|NCT03225313|11931207|FG002|STARTED|Overall Study|25 Patients|25
10767756|NCT03225313|11931205|FG000|COMPLETED|Overall Study|25 Patients|25
10767757|NCT03225313|11931206|FG001|COMPLETED|Overall Study|25 Patients|25
10767758|NCT03225313|11931207|FG002|COMPLETED|Overall Study|25 Patients|25
10767759|NCT03225313|11931205|FG000|NOT COMPLETED|Overall Study||0
10767760|NCT03225313|11931206|FG001|NOT COMPLETED|Overall Study||0
10767761|NCT03225313|11931207|FG002|NOT COMPLETED|Overall Study||0
10767762|NCT03225573|11931217|FG000|STARTED|Overall Study||60
10767763|NCT03225573|11931217|FG000|COMPLETED|Overall Study||60
10767764|NCT03225573|11931217|FG000|NOT COMPLETED|Overall Study||0
10767765|NCT03225599|11931221|FG000|STARTED|Overall Study||9
10767766|NCT03225599|11931221|FG000|COMPLETED|Overall Study||7
10767767|NCT03225599|11931221|FG000|NOT COMPLETED|Overall Study||2
10767768|NCT03225859|11931225|FG000|STARTED|Overall Study||12
10767769|NCT03225859|11931225|FG000|COMPLETED|Overall Study||11
10767770|NCT03225859|11931225|FG000|NOT COMPLETED|Overall Study||1
10767771|NCT03226223|11931231|FG000|STARTED|Overall Study||10
10767772|NCT03226223|11931232|FG001|STARTED|Overall Study||8
10767773|NCT03226223|11931231|FG000|COMPLETED|Overall Study||8
10767774|NCT03226223|11931232|FG001|COMPLETED|Overall Study||6
10767775|NCT03226223|11931231|FG000|NOT COMPLETED|Overall Study||2
10767776|NCT03226223|11931232|FG001|NOT COMPLETED|Overall Study||2
10767777|NCT03226249|11931238|FG000|STARTED|PEM Induction Cycles 1-3, and PET#2||30
10767778|NCT03226249|11931238|FG000|PEM Cycle 1|PEM Induction Cycles 1-3, and PET#2||30
10767779|NCT03226249|11931238|FG000|PEM Cycle 2|PEM Induction Cycles 1-3, and PET#2||30
10767780|NCT03226249|11931238|FG000|PEM Cycle 3|PEM Induction Cycles 1-3, and PET#2||30
10767781|NCT03226249|11931238|FG000|PET#2|PEM Induction Cycles 1-3, and PET#2||30
10767782|NCT03226249|11931238|FG000|COMPLETED|PEM Induction Cycles 1-3, and PET#2||30
10767783|NCT03226249|11931238|FG000|NOT COMPLETED|PEM Induction Cycles 1-3, and PET#2||0
10767784|NCT03226249|11931238|FG000|STARTED|2 Cycles of AVD + PET#3||30
10767785|NCT03226249|11931238|FG000|AVD Cycle 1|2 Cycles of AVD + PET#3||30
10767786|NCT03226249|11931238|FG000|AVD Cycle 2|2 Cycles of AVD + PET#3||30
10767787|NCT03226249|11931238|FG000|PET#3|2 Cycles of AVD + PET#3||30
10767788|NCT03226249|11931238|FG000|COMPLETED|2 Cycles of AVD + PET#3||30
10767789|NCT03226249|11931238|FG000|NOT COMPLETED|2 Cycles of AVD + PET#3||0
10767790|NCT03226249|11931238|FG000|STARTED|2-4 Cycles of AVD +/- Chemo & RT, PET#4||30
10767791|NCT03226249|11931238|FG000|2-4 Cycles of AVD +/- Chemo & RT|2-4 Cycles of AVD +/- Chemo & RT, PET#4||29
10767792|NCT03226249|11931238|FG000|PET#4|2-4 Cycles of AVD +/- Chemo & RT, PET#4||29
10767793|NCT03226249|11931238|FG000|COMPLETED|2-4 Cycles of AVD +/- Chemo & RT, PET#4||29
10767794|NCT03226249|11931238|FG000|NOT COMPLETED|2-4 Cycles of AVD +/- Chemo & RT, PET#4||1
10767795|NCT03226249|11931238|FG000|STARTED|PEM Consolidation (1-2 Years)||29
10767796|NCT03226249|11931238|FG000|COMPLETED|PEM Consolidation (1-2 Years)||0
10767797|NCT03226249|11931238|FG000|NOT COMPLETED|PEM Consolidation (1-2 Years)||29
10767798|NCT03226249|11931238|FG000|STARTED|Survival Follow-up|All patients that are treated with one dose of study drug go into follow-up.|30
10297518|NCT00003389|11430039|FG001|STARTED|Overall Study||426
10297519|NCT00003389|11430038|FG000|Treated Pts w/ Toxicity Data Available|Overall Study||414
10297520|NCT00003389|11430039|FG001|Treated Pts w/ Toxicity Data Available|Overall Study||422
10297521|NCT00003389|11430038|FG000|Eligible Patients|Overall Study||395
10297522|NCT00003389|11430039|FG001|Eligible Patients|Overall Study||399
10297523|NCT00003389|11430038|FG000|COMPLETED|Overall Study||330
10297524|NCT00003389|11430039|FG001|COMPLETED|Overall Study||366
10297525|NCT00003389|11430038|FG000|NOT COMPLETED|Overall Study||98
10297526|NCT00003389|11430039|FG001|NOT COMPLETED|Overall Study||60
10297527|NCT00003404|11430045|FG000|STARTED|Overall Study||46
10297528|NCT00003404|11430045|FG000|COMPLETED|Overall Study||46
10297529|NCT00003404|11430045|FG000|NOT COMPLETED|Overall Study||0
10297530|NCT00003453|11430050|FG000|STARTED|Overall Study||6
10297531|NCT00003453|11430050|FG000|COMPLETED|Overall Study|One patient was not evaluable|5
10297532|NCT00003453|11430050|FG000|NOT COMPLETED|Overall Study||1
10297533|NCT00003456|11430054|FG000|STARTED|Overall Study||40
10297534|NCT00003456|11430054|FG000|COMPLETED|Overall Study||32
10297535|NCT00003456|11430054|FG000|NOT COMPLETED|Overall Study||8
10297536|NCT00003457|11430058|FG000|STARTED|Overall Study||40
10297537|NCT00003457|11430058|FG000|COMPLETED|Overall Study||31
10297538|NCT00003457|11430058|FG000|NOT COMPLETED|Overall Study||9
10297539|NCT00003459|11430062|FG000|STARTED|Overall Study||40
10297540|NCT00003459|11430062|FG000|COMPLETED|Overall Study|Nine patients were not evaluable.|31
10297541|NCT00003459|11430062|FG000|NOT COMPLETED|Overall Study||9
10297542|NCT00003460|11430066|FG000|STARTED|Overall Study||13
10297543|NCT00003460|11430066|FG000|COMPLETED|Overall Study|One patient was not evaluable.|12
10297544|NCT00003460|11430066|FG000|NOT COMPLETED|Overall Study||1
10297545|NCT00003468|11430070|FG000|STARTED|Overall Study||11
10297546|NCT00003468|11430070|FG000|COMPLETED|Overall Study|Two patients were not evaluable.|9
10297547|NCT00003468|11430070|FG000|NOT COMPLETED|Overall Study||2
10297548|NCT00003469|11430074|FG000|STARTED|Overall Study||4
10297549|NCT00003469|11430074|FG000|COMPLETED|Overall Study||4
10297550|NCT00003469|11430074|FG000|NOT COMPLETED|Overall Study||0
10297551|NCT00003470|11430078|FG000|STARTED|Overall Study||27
10297552|NCT00003470|11430078|FG000|COMPLETED|Overall Study||21
10297553|NCT00003470|11430078|FG000|NOT COMPLETED|Overall Study||6
10421651|NCT00820235|11566514|FG000|COMPLETED|Overall Study||33
10297554|NCT00003471|11430082|FG000|STARTED|Overall Study||7
10297555|NCT00003471|11430082|FG000|COMPLETED|Overall Study||3
10297556|NCT00003471|11430082|FG000|NOT COMPLETED|Overall Study||4
10297557|NCT00003472|11430086|FG000|STARTED|Overall Study||13
10297558|NCT00003472|11430086|FG000|COMPLETED|Overall Study||10
10297559|NCT00003472|11430086|FG000|NOT COMPLETED|Overall Study||3
10297560|NCT00003473|11430090|FG000|STARTED|Overall Study||20
10297561|NCT00003473|11430090|FG000|COMPLETED|Overall Study||17
10421652|NCT00820235|11566515|FG001|COMPLETED|Overall Study||28
10767799|NCT03226249|11931238|FG000|COMPLETED|Survival Follow-up||0
10767800|NCT03226249|11931238|FG000|NOT COMPLETED|Survival Follow-up||30
10767801|NCT03226275|11931246|FG000|STARTED|Treatment Period 1 (8 Days)||8
10767802|NCT03226275|11931247|FG001|STARTED|Treatment Period 1 (8 Days)||8
10767803|NCT03226275|11931248|FG002|STARTED|Treatment Period 1 (8 Days)||8
10767804|NCT03226275|11931249|FG003|STARTED|Treatment Period 1 (8 Days)||8
10767805|NCT03226275|11931246|FG000|COMPLETED|Treatment Period 1 (8 Days)||8
10767806|NCT03226275|11931247|FG001|COMPLETED|Treatment Period 1 (8 Days)||8
10767807|NCT03226275|11931248|FG002|COMPLETED|Treatment Period 1 (8 Days)||7
10767808|NCT03226275|11931249|FG003|COMPLETED|Treatment Period 1 (8 Days)||7
10767809|NCT03226275|11931246|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10767810|NCT03226275|11931247|FG001|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10767811|NCT03226275|11931248|FG002|NOT COMPLETED|Treatment Period 1 (8 Days)||1
10297562|NCT00003473|11430090|FG000|NOT COMPLETED|Overall Study||3
10297563|NCT00003474|11430094|FG000|STARTED|Overall Study||40
10297564|NCT00003474|11430094|FG000|COMPLETED|Overall Study||26
10297565|NCT00003474|11430094|FG000|NOT COMPLETED|Overall Study||14
10297566|NCT00003475|11430098|FG000|STARTED|Overall Study||40
10297567|NCT00003475|11430098|FG000|COMPLETED|Overall Study||27
10297568|NCT00003475|11430098|FG000|NOT COMPLETED|Overall Study||13
10297569|NCT00003476|11430103|FG000|STARTED|Overall Study||8
10297570|NCT00003476|11430103|FG000|COMPLETED|Overall Study||7
10297571|NCT00003476|11430103|FG000|NOT COMPLETED|Overall Study||1
10297572|NCT00003477|11430107|FG000|STARTED|Overall Study||12
10297573|NCT00003477|11430107|FG000|COMPLETED|Overall Study||8
10297574|NCT00003477|11430107|FG000|NOT COMPLETED|Overall Study||4
10297575|NCT00003483|11430111|FG000|STARTED|Overall Study||3
10297576|NCT00003483|11430111|FG000|COMPLETED|Overall Study||2
10297577|NCT00003483|11430111|FG000|NOT COMPLETED|Overall Study||1
10297578|NCT00003487|11430115|FG000|STARTED|Overall Study||8
10767812|NCT03226275|11931249|FG003|NOT COMPLETED|Treatment Period 1 (8 Days)||1
10297579|NCT00003487|11430115|FG000|COMPLETED|Overall Study||6
10297580|NCT00003487|11430115|FG000|NOT COMPLETED|Overall Study||2
10297581|NCT00003492|11430119|FG000|STARTED|Overall Study||9
10297582|NCT00003492|11430119|FG000|COMPLETED|Overall Study||3
10297583|NCT00003492|11430119|FG000|NOT COMPLETED|Overall Study||6
10297584|NCT00003498|11430123|FG000|STARTED|Overall Study||5
10297585|NCT00003498|11430123|FG000|COMPLETED|Overall Study||1
10767813|NCT03226275|11931246|FG000|STARTED|Treatment Period 2 (8 Days)||8
10767814|NCT03226275|11931247|FG001|STARTED|Treatment Period 2 (8 Days)||8
10767815|NCT03226275|11931248|FG002|STARTED|Treatment Period 2 (8 Days)||7
10767816|NCT03226275|11931249|FG003|STARTED|Treatment Period 2 (8 Days)||7
10767817|NCT03226275|11931246|FG000|COMPLETED|Treatment Period 2 (8 Days)||8
10767818|NCT03226275|11931247|FG001|COMPLETED|Treatment Period 2 (8 Days)||8
10767819|NCT03226275|11931248|FG002|COMPLETED|Treatment Period 2 (8 Days)||7
10767820|NCT03226275|11931249|FG003|COMPLETED|Treatment Period 2 (8 Days)||7
10767821|NCT03226275|11931246|FG000|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10767822|NCT03226275|11931247|FG001|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10767823|NCT03226275|11931248|FG002|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10767824|NCT03226275|11931249|FG003|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10767825|NCT03226353|11931259|FG000|STARTED|Overall Study||77
10767826|NCT03226353|11931259|FG000|Habitual Wearers of Proclear 1 Day|Overall Study||2
10767827|NCT03226353|11931259|FG000|Other Habitual Lens Types|Overall Study||75
10767915|NCT03227692|11931340|FG001|NOT COMPLETED|Overall Study||5
10767828|NCT03226353|11931259|FG000|COMPLETED|Overall Study|Study participants completed includes the Omafilcon A habitual wearers.|71
10767829|NCT03226353|11931259|FG000|NOT COMPLETED|Overall Study||6
10767830|NCT03226366|11931270|FG000|STARTED|Overall Study||911
10767831|NCT03226366|11931271|FG001|STARTED|Overall Study||495
10767832|NCT03226366|11931272|FG002|STARTED|Overall Study||1183
10767833|NCT03226366|11931273|FG003|STARTED|Overall Study||641
10767834|NCT03226366|11931270|FG000|COMPLETED|Overall Study||911
10767835|NCT03226366|11931271|FG001|COMPLETED|Overall Study||495
10767836|NCT03226366|11931272|FG002|COMPLETED|Overall Study||1183
10767837|NCT03226366|11931273|FG003|COMPLETED|Overall Study||641
10767838|NCT03226366|11931270|FG000|NOT COMPLETED|Overall Study||0
10767839|NCT03226366|11931271|FG001|NOT COMPLETED|Overall Study||0
10767840|NCT03226366|11931272|FG002|NOT COMPLETED|Overall Study||0
10767841|NCT03226366|11931273|FG003|NOT COMPLETED|Overall Study||0
10767842|NCT03226392|11931285|FG000|STARTED|Overall Study||352
10767843|NCT03226392|11931286|FG001|STARTED|Overall Study||352
10767844|NCT03226392|11931285|FG000|FAS|Overall Study||352
10767845|NCT03226392|11931286|FG001|FAS|Overall Study|"2 patients in the placebo were mis-randomized, not treated, not included due to technical problems"|350
10767846|NCT03226392|11931285|FG000|COMPLETED|Overall Study||341
10767847|NCT03226392|11931286|FG001|COMPLETED|Overall Study||344
10767848|NCT03226392|11931285|FG000|NOT COMPLETED|Overall Study||11
10767849|NCT03226392|11931286|FG001|NOT COMPLETED|Overall Study||8
10767850|NCT03226457|11931292|FG000|STARTED|Treatment 1: 6 Weeks||12
10767851|NCT03226457|11931293|FG001|STARTED|Treatment 1: 6 Weeks||11
10767852|NCT03226457|11931292|FG000|COMPLETED|Treatment 1: 6 Weeks||12
10767853|NCT03226457|11931293|FG001|COMPLETED|Treatment 1: 6 Weeks||11
10767854|NCT03226457|11931292|FG000|NOT COMPLETED|Treatment 1: 6 Weeks||0
10767855|NCT03226457|11931293|FG001|NOT COMPLETED|Treatment 1: 6 Weeks||0
10767856|NCT03226457|11931292|FG000|STARTED|Washout Period: Minimum 2 Weeks||12
10767857|NCT03226457|11931293|FG001|STARTED|Washout Period: Minimum 2 Weeks||11
10767858|NCT03226457|11931292|FG000|COMPLETED|Washout Period: Minimum 2 Weeks||12
10767859|NCT03226457|11931293|FG001|COMPLETED|Washout Period: Minimum 2 Weeks||11
10767860|NCT03226457|11931292|FG000|NOT COMPLETED|Washout Period: Minimum 2 Weeks||0
10767861|NCT03226457|11931293|FG001|NOT COMPLETED|Washout Period: Minimum 2 Weeks||0
10767862|NCT03226457|11931292|FG000|STARTED|Treatment 2: 6 Weeks||12
10767863|NCT03226457|11931293|FG001|STARTED|Treatment 2: 6 Weeks||11
10767864|NCT03226457|11931292|FG000|COMPLETED|Treatment 2: 6 Weeks||12
10767865|NCT03226457|11931293|FG001|COMPLETED|Treatment 2: 6 Weeks||11
10767866|NCT03226457|11931292|FG000|NOT COMPLETED|Treatment 2: 6 Weeks||0
10767867|NCT03226457|11931293|FG001|NOT COMPLETED|Treatment 2: 6 Weeks||0
10767868|NCT03226652|11931299|FG000|STARTED|Overall Study||101
10767869|NCT03226652|11931299|FG000|COMPLETED|Overall Study||101
10767870|NCT03226652|11931299|FG000|NOT COMPLETED|Overall Study||0
10767871|NCT03226691|11931303|FG000|STARTED|Overall Study||15
10421653|NCT00820235|11566516|FG002|COMPLETED|Overall Study||27
10767872|NCT03226691|11931303|FG000|COMPLETED|Overall Study||15
10767873|NCT03226691|11931303|FG000|NOT COMPLETED|Overall Study||0
10767874|NCT03226769|11931309|FG000|STARTED|Overall Study||29
10767875|NCT03226769|11931310|FG001|STARTED|Overall Study||28
10767876|NCT03226769|11931309|FG000|COMPLETED|Overall Study||29
10767877|NCT03226769|11931310|FG001|COMPLETED|Overall Study||27
10767878|NCT03226769|11931309|FG000|NOT COMPLETED|Overall Study||0
10767879|NCT03226769|11931310|FG001|NOT COMPLETED|Overall Study||1
10767880|NCT03226899|11931318|FG000|STARTED|Overall Study||118
10767881|NCT03226899|11931319|FG001|STARTED|Overall Study||124
10767882|NCT03226899|11931318|FG000|COMPLETED|Overall Study||0
10767883|NCT03226899|11931319|FG001|COMPLETED|Overall Study||0
10767884|NCT03226899|11931318|FG000|NOT COMPLETED|Overall Study||118
10767885|NCT03226899|11931319|FG001|NOT COMPLETED|Overall Study||124
10767886|NCT03227445|11931325|FG000|STARTED|Period 1 (28 Days)||60
10767887|NCT03227445|11931326|FG001|STARTED|Period 1 (28 Days)||59
10767888|NCT03227445|11931327|FG002|STARTED|Period 1 (28 Days)||60
10767889|NCT03227445|11931328|FG003|STARTED|Period 1 (28 Days)||60
10767890|NCT03227445|11931325|FG000|COMPLETED|Period 1 (28 Days)||58
10767891|NCT03227445|11931326|FG001|COMPLETED|Period 1 (28 Days)||57
10767892|NCT03227445|11931327|FG002|COMPLETED|Period 1 (28 Days)||59
10767893|NCT03227445|11931328|FG003|COMPLETED|Period 1 (28 Days)||58
10767894|NCT03227445|11931325|FG000|NOT COMPLETED|Period 1 (28 Days)||2
10767895|NCT03227445|11931326|FG001|NOT COMPLETED|Period 1 (28 Days)||2
10767896|NCT03227445|11931327|FG002|NOT COMPLETED|Period 1 (28 Days)||1
10767897|NCT03227445|11931328|FG003|NOT COMPLETED|Period 1 (28 Days)||2
10767898|NCT03227445|11931325|FG000|STARTED|Period 2 (28 Days)||58
10767899|NCT03227445|11931326|FG001|STARTED|Period 2 (28 Days)||57
10767900|NCT03227445|11931327|FG002|STARTED|Period 2 (28 Days)||59
10767901|NCT03227445|11931328|FG003|STARTED|Period 2 (28 Days)||58
10767902|NCT03227445|11931325|FG000|COMPLETED|Period 2 (28 Days)||57
10767903|NCT03227445|11931326|FG001|COMPLETED|Period 2 (28 Days)||56
10767904|NCT03227445|11931327|FG002|COMPLETED|Period 2 (28 Days)||57
10767905|NCT03227445|11931328|FG003|COMPLETED|Period 2 (28 Days)||55
10767906|NCT03227445|11931325|FG000|NOT COMPLETED|Period 2 (28 Days)||1
10767907|NCT03227445|11931326|FG001|NOT COMPLETED|Period 2 (28 Days)||1
10767908|NCT03227445|11931327|FG002|NOT COMPLETED|Period 2 (28 Days)||2
10767909|NCT03227445|11931328|FG003|NOT COMPLETED|Period 2 (28 Days)||3
10767910|NCT03227692|11931339|FG000|STARTED|Overall Study||47
10767911|NCT03227692|11931340|FG001|STARTED|Overall Study||46
10767912|NCT03227692|11931339|FG000|COMPLETED|Overall Study||42
10767913|NCT03227692|11931340|FG001|COMPLETED|Overall Study||41
10767914|NCT03227692|11931339|FG000|NOT COMPLETED|Overall Study||5
10767916|NCT03227861|11931346|FG000|STARTED|Main Study Period (Week 0 to Week 48)||109
10767917|NCT03227861|11931346|FG000|COMPLETED|Main Study Period (Week 0 to Week 48)||97
10767918|NCT03227861|11931346|FG000|NOT COMPLETED|Main Study Period (Week 0 to Week 48)||12
10767919|NCT03227861|11931346|FG000|STARTED|Extension Period (Week 48 to Week 96)|17 participants were not willing to enter extension study and discontinued after main study.|80
10767920|NCT03227861|11931346|FG000|COMPLETED|Extension Period (Week 48 to Week 96)||0
10767921|NCT03227861|11931346|FG000|NOT COMPLETED|Extension Period (Week 48 to Week 96)||80
10767922|NCT03228017|11931354|FG000|STARTED|Overall Study||45
10767923|NCT03228017|11931355|FG001|STARTED|Overall Study||18
10767924|NCT03228017|11931354|FG000|COMPLETED|Overall Study||45
10767925|NCT03228017|11931355|FG001|COMPLETED|Overall Study||18
10767926|NCT03228017|11931354|FG000|NOT COMPLETED|Overall Study||0
10767927|NCT03228017|11931355|FG001|NOT COMPLETED|Overall Study||0
10767928|NCT03228212|11931361|FG000|STARTED|Period 1||65
10767929|NCT03228212|11931362|FG001|STARTED|Period 1||65
10767930|NCT03228212|11931361|FG000|COMPLETED|Period 1||64
10767931|NCT03228212|11931362|FG001|COMPLETED|Period 1||64
10767932|NCT03228212|11931361|FG000|NOT COMPLETED|Period 1||1
10767933|NCT03228212|11931362|FG001|NOT COMPLETED|Period 1||1
10767934|NCT03228212|11931361|FG000|STARTED|Period 2||64
10767935|NCT03228212|11931362|FG001|STARTED|Period 2||64
10767936|NCT03228212|11931361|FG000|COMPLETED|Period 2||63
10767937|NCT03228212|11931362|FG001|COMPLETED|Period 2||64
10767938|NCT03228212|11931361|FG000|NOT COMPLETED|Period 2||1
10767939|NCT03228212|11931362|FG001|NOT COMPLETED|Period 2||0
10767940|NCT03228212|11931361|FG000|STARTED|Period 3||63
10767941|NCT03228212|11931362|FG001|STARTED|Period 3||64
10767942|NCT03228212|11931361|FG000|COMPLETED|Period 3||63
10767943|NCT03228212|11931362|FG001|COMPLETED|Period 3||64
10767944|NCT03228212|11931361|FG000|NOT COMPLETED|Period 3||0
10767945|NCT03228212|11931362|FG001|NOT COMPLETED|Period 3||0
10767946|NCT03228420|11931370|FG000|STARTED|Overall Study||113
10767947|NCT03228420|11931371|FG001|STARTED|Overall Study||103
10767948|NCT03228420|11931370|FG000|Month-1|Overall Study||95
10767949|NCT03228420|11931371|FG001|Month-1|Overall Study||101
10767950|NCT03228420|11931370|FG000|Month-3|Overall Study||93
10767951|NCT03228420|11931371|FG001|Month-3|Overall Study||98
10767952|NCT03228420|11931370|FG000|COMPLETED|Overall Study||93
10767953|NCT03228420|11931371|FG001|COMPLETED|Overall Study||98
10767954|NCT03228420|11931370|FG000|NOT COMPLETED|Overall Study||20
10767955|NCT03228420|11931371|FG001|NOT COMPLETED|Overall Study||5
10767956|NCT03228433|11931383|FG000|STARTED|Overall Study||10
10767957|NCT03228433|11931384|FG001|STARTED|Overall Study||6
10767958|NCT03228433|11931385|FG002|STARTED|Overall Study||6
10767959|NCT03228433|11931386|FG003|STARTED|Overall Study||6
10767960|NCT03228433|11931387|FG004|STARTED|Overall Study||6
10767961|NCT03228433|11931388|FG005|STARTED|Overall Study||6
10767962|NCT03228433|11931383|FG000|COMPLETED|Overall Study||9
10767963|NCT03228433|11931384|FG001|COMPLETED|Overall Study||6
10767964|NCT03228433|11931385|FG002|COMPLETED|Overall Study||6
10767965|NCT03228433|11931386|FG003|COMPLETED|Overall Study||5
10767966|NCT03228433|11931387|FG004|COMPLETED|Overall Study||6
10767967|NCT03228433|11931388|FG005|COMPLETED|Overall Study||6
10767968|NCT03228433|11931383|FG000|NOT COMPLETED|Overall Study||1
10767969|NCT03228433|11931384|FG001|NOT COMPLETED|Overall Study||0
10767970|NCT03228433|11931385|FG002|NOT COMPLETED|Overall Study||0
10767971|NCT03228433|11931386|FG003|NOT COMPLETED|Overall Study||1
10767972|NCT03228433|11931387|FG004|NOT COMPLETED|Overall Study||0
10767973|NCT03228433|11931388|FG005|NOT COMPLETED|Overall Study||0
10767974|NCT03228836|11931410|FG000|STARTED|Overall Study||28
10767975|NCT03228836|11931410|FG000|Treated|Overall Study||28
10767976|NCT03228836|11931410|FG000|COMPLETED|Overall Study||11
10767977|NCT03228836|11931410|FG000|NOT COMPLETED|Overall Study||17
10767978|NCT03228914|11931414|FG000|STARTED|Overall Study||20
10767979|NCT03228914|11931415|FG001|STARTED|Overall Study||20
10767980|NCT03228914|11931414|FG000|COMPLETED|Overall Study||20
10767981|NCT03228914|11931415|FG001|COMPLETED|Overall Study||20
10767982|NCT03228914|11931414|FG000|NOT COMPLETED|Overall Study||0
10767983|NCT03228914|11931415|FG001|NOT COMPLETED|Overall Study||0
10767984|NCT03229109|11931425|FG000|STARTED|Overall Study||50
10767985|NCT03229109|11931426|FG001|STARTED|Overall Study||50
10767986|NCT03229109|11931427|FG002|STARTED|Overall Study||50
10767987|NCT03229109|11931428|FG003|STARTED|Overall Study||51
10767988|NCT03229109|11931425|FG000|COMPLETED|Overall Study||50
10767989|NCT03229109|11931426|FG001|COMPLETED|Overall Study||50
10767990|NCT03229109|11931427|FG002|COMPLETED|Overall Study||50
10767991|NCT03229109|11931428|FG003|COMPLETED|Overall Study||50
10767992|NCT03229109|11931425|FG000|NOT COMPLETED|Overall Study||0
10767993|NCT03229109|11931426|FG001|NOT COMPLETED|Overall Study||0
10767994|NCT03229109|11931427|FG002|NOT COMPLETED|Overall Study||0
10767995|NCT03229109|11931428|FG003|NOT COMPLETED|Overall Study||1
10767996|NCT03229252|11931441|FG000|STARTED|Overall Study||31
10767997|NCT03229252|11931442|FG001|STARTED|Overall Study||15
10767998|NCT03229252|11931443|FG002|STARTED|Overall Study||45
10767999|NCT03229252|11931441|FG000|COMPLETED|Overall Study||29
10768000|NCT03229252|11931442|FG001|COMPLETED|Overall Study||15
10768001|NCT03229252|11931443|FG002|COMPLETED|Overall Study||39
10768002|NCT03229252|11931441|FG000|NOT COMPLETED|Overall Study||2
10768003|NCT03229252|11931442|FG001|NOT COMPLETED|Overall Study||0
10768004|NCT03229252|11931443|FG002|NOT COMPLETED|Overall Study||6
10768005|NCT03229486|11931453|FG000|STARTED|Overall Study||20
10768006|NCT03229486|11931454|FG001|STARTED|Overall Study||20
10768007|NCT03229486|11931453|FG000|COMPLETED|Overall Study||20
10768008|NCT03229486|11931454|FG001|COMPLETED|Overall Study||19
10768009|NCT03229486|11931453|FG000|NOT COMPLETED|Overall Study||0
10768010|NCT03229486|11931454|FG001|NOT COMPLETED|Overall Study||1
10768011|NCT03229759|11931460|FG000|STARTED|Overall Study||99
10768012|NCT03229759|11931460|FG000|Participants Treated|Overall Study||69
10768013|NCT03229759|11931460|FG000|Treated With Investigational Product|Overall Study||45
10768014|NCT03229759|11931460|FG000|Treated With Vehicle Control|Overall Study||47
10768015|NCT03229759|11931460|FG000|Treated With Saline Control|Overall Study||46
10768016|NCT03229759|11931460|FG000|COMPLETED|Overall Study||69
10768017|NCT03229759|11931460|FG000|NOT COMPLETED|Overall Study||30
10768018|NCT03230175|11931466|FG000|STARTED|Overall Study||32
10768019|NCT03230175|11931466|FG000|COMPLETED|Overall Study||30
10768020|NCT03230175|11931466|FG000|NOT COMPLETED|Overall Study||2
10768021|NCT03230864|11931473|FG000|STARTED|Prospective Confirmation (PC) Period||68
10768022|NCT03230864|11931474|FG001|STARTED|Prospective Confirmation (PC) Period||51
10768023|NCT03230864|11931475|FG002|STARTED|Prospective Confirmation (PC) Period||0
10768024|NCT03230864|11931476|FG003|STARTED|Prospective Confirmation (PC) Period||0
10768025|NCT03230864|11931473|FG000|COMPLETED|Prospective Confirmation (PC) Period||36
10768026|NCT03230864|11931474|FG001|COMPLETED|Prospective Confirmation (PC) Period||32
10768027|NCT03230864|11931475|FG002|COMPLETED|Prospective Confirmation (PC) Period||0
10768028|NCT03230864|11931476|FG003|COMPLETED|Prospective Confirmation (PC) Period||0
10768029|NCT03230864|11931473|FG000|NOT COMPLETED|Prospective Confirmation (PC) Period||32
10768030|NCT03230864|11931474|FG001|NOT COMPLETED|Prospective Confirmation (PC) Period||19
10768031|NCT03230864|11931475|FG002|NOT COMPLETED|Prospective Confirmation (PC) Period||0
10768032|NCT03230864|11931476|FG003|NOT COMPLETED|Prospective Confirmation (PC) Period||0
10768033|NCT03230864|11931473|FG000|STARTED|Double Blind Treatment (DBT) Period||0
10768034|NCT03230864|11931474|FG001|STARTED|Double Blind Treatment (DBT) Period||0
10768035|NCT03230864|11931475|FG002|STARTED|Double Blind Treatment (DBT) Period||35
10768036|NCT03230864|11931476|FG003|STARTED|Double Blind Treatment (DBT) Period||33
10768037|NCT03230864|11931473|FG000|COMPLETED|Double Blind Treatment (DBT) Period||0
10768038|NCT03230864|11931474|FG001|COMPLETED|Double Blind Treatment (DBT) Period||0
10768039|NCT03230864|11931475|FG002|COMPLETED|Double Blind Treatment (DBT) Period||27
10768040|NCT03230864|11931476|FG003|COMPLETED|Double Blind Treatment (DBT) Period||31
10768041|NCT03230864|11931473|FG000|NOT COMPLETED|Double Blind Treatment (DBT) Period||0
10768042|NCT03230864|11931474|FG001|NOT COMPLETED|Double Blind Treatment (DBT) Period||0
10768043|NCT03230864|11931475|FG002|NOT COMPLETED|Double Blind Treatment (DBT) Period||8
10768044|NCT03230864|11931476|FG003|NOT COMPLETED|Double Blind Treatment (DBT) Period||2
10768045|NCT03231228|11931488|FG000|STARTED|Overall Study||33
10768046|NCT03231228|11931489|FG001|STARTED|Overall Study||28
10768047|NCT03231228|11931488|FG000|COMPLETED|Overall Study||30
10768048|NCT03231228|11931489|FG001|COMPLETED|Overall Study||28
10768049|NCT03231228|11931488|FG000|NOT COMPLETED|Overall Study||3
10768050|NCT03231228|11931489|FG001|NOT COMPLETED|Overall Study||0
10768051|NCT03231345|11931495|FG000|STARTED|Overall Study||35
10768052|NCT03231345|11931495|FG000|COMPLETED|Overall Study||35
10768053|NCT03231345|11931495|FG000|NOT COMPLETED|Overall Study||0
10768054|NCT03231371|11931499|FG000|STARTED|Overall Study||22
10768055|NCT03231371|11931499|FG000|Optional and Age Limited (12 Yrs+) MRI|Overall Study||9
10768056|NCT03231371|11931499|FG000|COMPLETED|Overall Study||9
10768057|NCT03231371|11931499|FG000|NOT COMPLETED|Overall Study||13
10768058|NCT03231709|11931505|FG000|STARTED|Treatment Period 1||30
10768059|NCT03231709|11931506|FG001|STARTED|Treatment Period 1||30
10768060|NCT03231709|11931505|FG000|COMPLETED|Treatment Period 1||30
10768061|NCT03231709|11931506|FG001|COMPLETED|Treatment Period 1||29
10768062|NCT03231709|11931505|FG000|NOT COMPLETED|Treatment Period 1||0
10768063|NCT03231709|11931506|FG001|NOT COMPLETED|Treatment Period 1||1
10768064|NCT03231709|11931505|FG000|STARTED|Treatment Period 2||30
10768065|NCT03231709|11931506|FG001|STARTED|Treatment Period 2||29
10768066|NCT03231709|11931505|FG000|COMPLETED|Treatment Period 2||30
10768067|NCT03231709|11931506|FG001|COMPLETED|Treatment Period 2||28
10768068|NCT03231709|11931505|FG000|NOT COMPLETED|Treatment Period 2||0
10768069|NCT03231709|11931506|FG001|NOT COMPLETED|Treatment Period 2||1
10768070|NCT03231800|11931518|FG000|STARTED|Overall Study||48
10768071|NCT03231800|11931519|FG001|STARTED|Overall Study||47
10768072|NCT03231800|11931518|FG000|Safety Population|Overall Study||47
10768073|NCT03231800|11931519|FG001|Safety Population|Overall Study||47
10768074|NCT03231800|11931518|FG000|COMPLETED|Overall Study||45
10768075|NCT03231800|11931519|FG001|COMPLETED|Overall Study||44
10768076|NCT03231800|11931518|FG000|NOT COMPLETED|Overall Study||3
10768077|NCT03231800|11931519|FG001|NOT COMPLETED|Overall Study||3
10768078|NCT03231917|11931527|FG000|STARTED|Overall Study||60
10768079|NCT03231917|11931528|FG001|STARTED|Overall Study||61
10768080|NCT03231917|11931527|FG000|COMPLETED|Overall Study||60
10768081|NCT03231917|11931528|FG001|COMPLETED|Overall Study||61
10768082|NCT03231917|11931527|FG000|NOT COMPLETED|Overall Study||0
10768083|NCT03231917|11931528|FG001|NOT COMPLETED|Overall Study||0
10768084|NCT03231943|11931541|FG000|STARTED|Part 1, Period 1 (up to Day 15)||2
10768085|NCT03231943|11931542|FG001|STARTED|Part 1, Period 1 (up to Day 15)||2
10768086|NCT03231943|11931543|FG002|STARTED|Part 1, Period 1 (up to Day 15)||2
10768087|NCT03231943|11931544|FG003|STARTED|Part 1, Period 1 (up to Day 15)||2
10768088|NCT03231943|11931545|FG004|STARTED|Part 1, Period 1 (up to Day 15)||2
10768089|NCT03231943|11931546|FG005|STARTED|Part 1, Period 1 (up to Day 15)||2
10768090|NCT03231943|11931547|FG006|STARTED|Part 1, Period 1 (up to Day 15)||2
10768091|NCT03231943|11931548|FG007|STARTED|Part 1, Period 1 (up to Day 15)||2
10768092|NCT03231943|11931549|FG008|STARTED|Part 1, Period 1 (up to Day 15)||0
10768093|NCT03231943|11931550|FG009|STARTED|Part 1, Period 1 (up to Day 15)||0
10768094|NCT03231943|11931551|FG010|STARTED|Part 1, Period 1 (up to Day 15)||0
10768095|NCT03231943|11931552|FG011|STARTED|Part 1, Period 1 (up to Day 15)||0
10768096|NCT03231943|11931553|FG012|STARTED|Part 1, Period 1 (up to Day 15)||0
10768097|NCT03231943|11931541|FG000|COMPLETED|Part 1, Period 1 (up to Day 15)||2
10768098|NCT03231943|11931542|FG001|COMPLETED|Part 1, Period 1 (up to Day 15)||2
10768099|NCT03231943|11931543|FG002|COMPLETED|Part 1, Period 1 (up to Day 15)||2
10768100|NCT03231943|11931544|FG003|COMPLETED|Part 1, Period 1 (up to Day 15)||2
10768101|NCT03231943|11931545|FG004|COMPLETED|Part 1, Period 1 (up to Day 15)||2
10768102|NCT03231943|11931546|FG005|COMPLETED|Part 1, Period 1 (up to Day 15)||2
10768103|NCT03231943|11931547|FG006|COMPLETED|Part 1, Period 1 (up to Day 15)||2
10768104|NCT03231943|11931548|FG007|COMPLETED|Part 1, Period 1 (up to Day 15)||2
10768105|NCT03231943|11931549|FG008|COMPLETED|Part 1, Period 1 (up to Day 15)||0
10768106|NCT03231943|11931550|FG009|COMPLETED|Part 1, Period 1 (up to Day 15)||0
10768107|NCT03231943|11931551|FG010|COMPLETED|Part 1, Period 1 (up to Day 15)||0
10768108|NCT03231943|11931552|FG011|COMPLETED|Part 1, Period 1 (up to Day 15)||0
10768109|NCT03231943|11931553|FG012|COMPLETED|Part 1, Period 1 (up to Day 15)||0
10768110|NCT03231943|11931541|FG000|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
10768111|NCT03231943|11931542|FG001|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
10768112|NCT03231943|11931543|FG002|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
10768113|NCT03231943|11931544|FG003|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
10768114|NCT03231943|11931545|FG004|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
10768115|NCT03231943|11931546|FG005|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
10768116|NCT03231943|11931547|FG006|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
10768117|NCT03231943|11931548|FG007|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
10768118|NCT03231943|11931549|FG008|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
10768119|NCT03231943|11931550|FG009|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
10768120|NCT03231943|11931551|FG010|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
10768121|NCT03231943|11931552|FG011|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
10768122|NCT03231943|11931553|FG012|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
10768123|NCT03231943|11931541|FG000|STARTED|Part 1, Period 2 (up to Day 30)||2
10768124|NCT03231943|11931542|FG001|STARTED|Part 1, Period 2 (up to Day 30)||2
10768125|NCT03231943|11931543|FG002|STARTED|Part 1, Period 2 (up to Day 30)||2
10768126|NCT03231943|11931544|FG003|STARTED|Part 1, Period 2 (up to Day 30)||2
10768127|NCT03231943|11931545|FG004|STARTED|Part 1, Period 2 (up to Day 30)||2
10768128|NCT03231943|11931546|FG005|STARTED|Part 1, Period 2 (up to Day 30)||2
10768129|NCT03231943|11931547|FG006|STARTED|Part 1, Period 2 (up to Day 30)||2
10768130|NCT03231943|11931548|FG007|STARTED|Part 1, Period 2 (up to Day 30)||2
10768131|NCT03231943|11931549|FG008|STARTED|Part 1, Period 2 (up to Day 30)||0
10768132|NCT03231943|11931550|FG009|STARTED|Part 1, Period 2 (up to Day 30)||0
10768133|NCT03231943|11931551|FG010|STARTED|Part 1, Period 2 (up to Day 30)||0
10768134|NCT03231943|11931552|FG011|STARTED|Part 1, Period 2 (up to Day 30)||0
10768135|NCT03231943|11931553|FG012|STARTED|Part 1, Period 2 (up to Day 30)||0
10768136|NCT03231943|11931541|FG000|COMPLETED|Part 1, Period 2 (up to Day 30)||2
10768137|NCT03231943|11931542|FG001|COMPLETED|Part 1, Period 2 (up to Day 30)|Two participants withdrawn were replaced|0
10768138|NCT03231943|11931543|FG002|COMPLETED|Part 1, Period 2 (up to Day 30)|One participant withdrawn was replaced|1
10768139|NCT03231943|11931544|FG003|COMPLETED|Part 1, Period 2 (up to Day 30)||2
10768140|NCT03231943|11931545|FG004|COMPLETED|Part 1, Period 2 (up to Day 30)||2
10768141|NCT03231943|11931546|FG005|COMPLETED|Part 1, Period 2 (up to Day 30)||2
10768142|NCT03231943|11931547|FG006|COMPLETED|Part 1, Period 2 (up to Day 30)||2
10768143|NCT03231943|11931548|FG007|COMPLETED|Part 1, Period 2 (up to Day 30)||2
10768144|NCT03231943|11931549|FG008|COMPLETED|Part 1, Period 2 (up to Day 30)||0
10768145|NCT03231943|11931550|FG009|COMPLETED|Part 1, Period 2 (up to Day 30)||0
10768146|NCT03231943|11931551|FG010|COMPLETED|Part 1, Period 2 (up to Day 30)||0
10768147|NCT03231943|11931552|FG011|COMPLETED|Part 1, Period 2 (up to Day 30)||0
10768148|NCT03231943|11931553|FG012|COMPLETED|Part 1, Period 2 (up to Day 30)||0
10768149|NCT03231943|11931541|FG000|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
10768150|NCT03231943|11931542|FG001|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||2
10768151|NCT03231943|11931543|FG002|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||1
10768152|NCT03231943|11931544|FG003|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
10768153|NCT03231943|11931545|FG004|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
10768154|NCT03231943|11931546|FG005|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
10768155|NCT03231943|11931547|FG006|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
10768156|NCT03231943|11931548|FG007|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
10768157|NCT03231943|11931549|FG008|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
10768158|NCT03231943|11931550|FG009|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
10768159|NCT03231943|11931551|FG010|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
10768160|NCT03231943|11931552|FG011|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
10768161|NCT03231943|11931553|FG012|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
10768162|NCT03231943|11931541|FG000|STARTED|Part 1, Period 3 (up to Day 45)||2
10768163|NCT03231943|11931542|FG001|STARTED|Part 1, Period 3 (up to Day 45)||2
10768164|NCT03231943|11931543|FG002|STARTED|Part 1, Period 3 (up to Day 45)||2
10768165|NCT03231943|11931544|FG003|STARTED|Part 1, Period 3 (up to Day 45)||2
10768166|NCT03231943|11931545|FG004|STARTED|Part 1, Period 3 (up to Day 45)||2
10768167|NCT03231943|11931546|FG005|STARTED|Part 1, Period 3 (up to Day 45)||2
10768168|NCT03231943|11931547|FG006|STARTED|Part 1, Period 3 (up to Day 45)||2
10768169|NCT03231943|11931548|FG007|STARTED|Part 1, Period 3 (up to Day 45)||2
10768170|NCT03231943|11931549|FG008|STARTED|Part 1, Period 3 (up to Day 45)||0
10768171|NCT03231943|11931550|FG009|STARTED|Part 1, Period 3 (up to Day 45)||0
10768172|NCT03231943|11931551|FG010|STARTED|Part 1, Period 3 (up to Day 45)||0
10768173|NCT03231943|11931552|FG011|STARTED|Part 1, Period 3 (up to Day 45)||0
10768174|NCT03231943|11931553|FG012|STARTED|Part 1, Period 3 (up to Day 45)||0
10768175|NCT03231943|11931541|FG000|COMPLETED|Part 1, Period 3 (up to Day 45)|One participant withdrawn was replaced|1
10768176|NCT03231943|11931542|FG001|COMPLETED|Part 1, Period 3 (up to Day 45)||2
10768177|NCT03231943|11931543|FG002|COMPLETED|Part 1, Period 3 (up to Day 45)||2
10768178|NCT03231943|11931544|FG003|COMPLETED|Part 1, Period 3 (up to Day 45)||2
10768179|NCT03231943|11931545|FG004|COMPLETED|Part 1, Period 3 (up to Day 45)||2
10768180|NCT03231943|11931546|FG005|COMPLETED|Part 1, Period 3 (up to Day 45)||2
10768181|NCT03231943|11931547|FG006|COMPLETED|Part 1, Period 3 (up to Day 45)||2
10768182|NCT03231943|11931548|FG007|COMPLETED|Part 1, Period 3 (up to Day 45)||2
10768183|NCT03231943|11931549|FG008|COMPLETED|Part 1, Period 3 (up to Day 45)||0
10768184|NCT03231943|11931550|FG009|COMPLETED|Part 1, Period 3 (up to Day 45)||0
10768185|NCT03231943|11931551|FG010|COMPLETED|Part 1, Period 3 (up to Day 45)||0
10768186|NCT03231943|11931552|FG011|COMPLETED|Part 1, Period 3 (up to Day 45)||0
10768187|NCT03231943|11931553|FG012|COMPLETED|Part 1, Period 3 (up to Day 45)||0
10768188|NCT03231943|11931541|FG000|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||1
10768189|NCT03231943|11931542|FG001|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
10768190|NCT03231943|11931543|FG002|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
10768191|NCT03231943|11931544|FG003|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
10768192|NCT03231943|11931545|FG004|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
10768193|NCT03231943|11931546|FG005|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
10768194|NCT03231943|11931547|FG006|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
10768195|NCT03231943|11931548|FG007|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
10768196|NCT03231943|11931549|FG008|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
10768197|NCT03231943|11931550|FG009|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
10768198|NCT03231943|11931551|FG010|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
10768199|NCT03231943|11931552|FG011|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
10768200|NCT03231943|11931553|FG012|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
10768201|NCT03231943|11931541|FG000|STARTED|Part 1 Period 4 (up to Day 60)||2
10768202|NCT03231943|11931542|FG001|STARTED|Part 1 Period 4 (up to Day 60)||2
10768203|NCT03231943|11931543|FG002|STARTED|Part 1 Period 4 (up to Day 60)||2
10768204|NCT03231943|11931544|FG003|STARTED|Part 1 Period 4 (up to Day 60)||2
10768205|NCT03231943|11931545|FG004|STARTED|Part 1 Period 4 (up to Day 60)||2
10768206|NCT03231943|11931546|FG005|STARTED|Part 1 Period 4 (up to Day 60)||2
10768207|NCT03231943|11931547|FG006|STARTED|Part 1 Period 4 (up to Day 60)||2
10768208|NCT03231943|11931548|FG007|STARTED|Part 1 Period 4 (up to Day 60)||2
10768209|NCT03231943|11931549|FG008|STARTED|Part 1 Period 4 (up to Day 60)||0
10768210|NCT03231943|11931550|FG009|STARTED|Part 1 Period 4 (up to Day 60)||0
10768211|NCT03231943|11931551|FG010|STARTED|Part 1 Period 4 (up to Day 60)||0
10768212|NCT03231943|11931552|FG011|STARTED|Part 1 Period 4 (up to Day 60)||0
10768213|NCT03231943|11931553|FG012|STARTED|Part 1 Period 4 (up to Day 60)||0
10768214|NCT03231943|11931541|FG000|COMPLETED|Part 1 Period 4 (up to Day 60)||2
10768215|NCT03231943|11931542|FG001|COMPLETED|Part 1 Period 4 (up to Day 60)||2
10768216|NCT03231943|11931543|FG002|COMPLETED|Part 1 Period 4 (up to Day 60)||2
10768217|NCT03231943|11931544|FG003|COMPLETED|Part 1 Period 4 (up to Day 60)||2
10768218|NCT03231943|11931545|FG004|COMPLETED|Part 1 Period 4 (up to Day 60)||2
10768219|NCT03231943|11931546|FG005|COMPLETED|Part 1 Period 4 (up to Day 60)||2
10768220|NCT03231943|11931547|FG006|COMPLETED|Part 1 Period 4 (up to Day 60)||2
10768221|NCT03231943|11931548|FG007|COMPLETED|Part 1 Period 4 (up to Day 60)||2
10768222|NCT03231943|11931549|FG008|COMPLETED|Part 1 Period 4 (up to Day 60)||0
10768223|NCT03231943|11931550|FG009|COMPLETED|Part 1 Period 4 (up to Day 60)||0
10768224|NCT03231943|11931551|FG010|COMPLETED|Part 1 Period 4 (up to Day 60)||0
10768225|NCT03231943|11931552|FG011|COMPLETED|Part 1 Period 4 (up to Day 60)||0
10768226|NCT03231943|11931553|FG012|COMPLETED|Part 1 Period 4 (up to Day 60)||0
10768227|NCT03231943|11931541|FG000|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
10768228|NCT03231943|11931542|FG001|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
10768229|NCT03231943|11931543|FG002|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
10768230|NCT03231943|11931544|FG003|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
10768231|NCT03231943|11931545|FG004|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
10768232|NCT03231943|11931546|FG005|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
10768233|NCT03231943|11931547|FG006|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
10768234|NCT03231943|11931548|FG007|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
10768235|NCT03231943|11931549|FG008|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
10768236|NCT03231943|11931550|FG009|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
10768237|NCT03231943|11931551|FG010|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
10768238|NCT03231943|11931552|FG011|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
10768239|NCT03231943|11931553|FG012|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
10768240|NCT03231943|11931541|FG000|STARTED|Part 2||0
10768241|NCT03231943|11931542|FG001|STARTED|Part 2||0
10768242|NCT03231943|11931543|FG002|STARTED|Part 2||0
10768243|NCT03231943|11931544|FG003|STARTED|Part 2||0
10768244|NCT03231943|11931545|FG004|STARTED|Part 2||0
10768245|NCT03231943|11931546|FG005|STARTED|Part 2||0
10768246|NCT03231943|11931547|FG006|STARTED|Part 2||0
10768247|NCT03231943|11931548|FG007|STARTED|Part 2||0
10768248|NCT03231943|11931549|FG008|STARTED|Part 2||6
10768249|NCT03231943|11931550|FG009|STARTED|Part 2||6
10768250|NCT03231943|11931551|FG010|STARTED|Part 2||25
10768251|NCT03231943|11931552|FG011|STARTED|Part 2||7
10768252|NCT03231943|11931553|FG012|STARTED|Part 2||14
10768253|NCT03231943|11931541|FG000|COMPLETED|Part 2||0
10768254|NCT03231943|11931542|FG001|COMPLETED|Part 2||0
10768255|NCT03231943|11931543|FG002|COMPLETED|Part 2||0
10768256|NCT03231943|11931544|FG003|COMPLETED|Part 2||0
10768257|NCT03231943|11931545|FG004|COMPLETED|Part 2||0
10768258|NCT03231943|11931546|FG005|COMPLETED|Part 2||0
10768259|NCT03231943|11931547|FG006|COMPLETED|Part 2||0
10768260|NCT03231943|11931548|FG007|COMPLETED|Part 2||0
10768261|NCT03231943|11931549|FG008|COMPLETED|Part 2||6
10768262|NCT03231943|11931550|FG009|COMPLETED|Part 2||6
10768263|NCT03231943|11931551|FG010|COMPLETED|Part 2||24
10768264|NCT03231943|11931552|FG011|COMPLETED|Part 2||6
10768265|NCT03231943|11931553|FG012|COMPLETED|Part 2||14
10768266|NCT03231943|11931541|FG000|NOT COMPLETED|Part 2||0
10768267|NCT03231943|11931542|FG001|NOT COMPLETED|Part 2||0
10768268|NCT03231943|11931543|FG002|NOT COMPLETED|Part 2||0
10768269|NCT03231943|11931544|FG003|NOT COMPLETED|Part 2||0
10768270|NCT03231943|11931545|FG004|NOT COMPLETED|Part 2||0
10768271|NCT03231943|11931546|FG005|NOT COMPLETED|Part 2||0
10768272|NCT03231943|11931547|FG006|NOT COMPLETED|Part 2||0
10768273|NCT03231943|11931548|FG007|NOT COMPLETED|Part 2||0
10768274|NCT03231943|11931549|FG008|NOT COMPLETED|Part 2||0
10768275|NCT03231943|11931550|FG009|NOT COMPLETED|Part 2||0
10768276|NCT03231943|11931551|FG010|NOT COMPLETED|Part 2||1
10768277|NCT03231943|11931552|FG011|NOT COMPLETED|Part 2||1
10768278|NCT03231943|11931553|FG012|NOT COMPLETED|Part 2||0
10768279|NCT03231969|11931587|FG000|STARTED|Overall Study||30
10768280|NCT03231969|11931588|FG001|STARTED|Overall Study||30
10768281|NCT03231969|11931589|FG002|STARTED|Overall Study||31
10768282|NCT03231969|11931590|FG003|STARTED|Overall Study||30
10768283|NCT03231969|11931587|FG000|COMPLETED|Overall Study||28
10768284|NCT03231969|11931588|FG001|COMPLETED|Overall Study||28
10768285|NCT03231969|11931589|FG002|COMPLETED|Overall Study||30
10768286|NCT03231969|11931590|FG003|COMPLETED|Overall Study||30
10768287|NCT03231969|11931587|FG000|NOT COMPLETED|Overall Study||2
10768288|NCT03231969|11931588|FG001|NOT COMPLETED|Overall Study||2
10768289|NCT03231969|11931589|FG002|NOT COMPLETED|Overall Study||1
10768290|NCT03231969|11931590|FG003|NOT COMPLETED|Overall Study||0
10768291|NCT03232281|11931602|FG000|STARTED|Overall Study||150
10768292|NCT03232281|11931603|FG001|STARTED|Overall Study||150
10768293|NCT03232281|11931602|FG000|Received Treatment|Overall Study||149
10768294|NCT03232281|11931603|FG001|Received Treatment|Overall Study||150
10768295|NCT03232281|11931602|FG000|Completed Week 12|Overall Study||143
10768296|NCT03232281|11931603|FG001|Completed Week 12|Overall Study||148
10768297|NCT03232281|11931602|FG000|Completed Week 24|Overall Study||143
10768298|NCT03232281|11931603|FG001|Completed Week 24|Overall Study||144
10768299|NCT03232281|11931602|FG000|COMPLETED|Overall Study||143
10768300|NCT03232281|11931603|FG001|COMPLETED|Overall Study||144
10768301|NCT03232281|11931602|FG000|NOT COMPLETED|Overall Study||7
10768302|NCT03232281|11931603|FG001|NOT COMPLETED|Overall Study||6
10768303|NCT03232333|11931609|FG000|STARTED|Overall Study||53
10768304|NCT03232333|11931609|FG000|COMPLETED|Overall Study||38
10768305|NCT03232333|11931609|FG000|NOT COMPLETED|Overall Study||15
10768306|NCT03232567|11931617|FG000|STARTED|Overall Study||15
10768307|NCT03232567|11931618|FG001|STARTED|Overall Study||15
10768308|NCT03232567|11931619|FG002|STARTED|Overall Study||15
10768309|NCT03232567|11931620|FG003|STARTED|Overall Study||15
10768310|NCT03232567|11931617|FG000|COMPLETED|Overall Study||15
10768311|NCT03232567|11931618|FG001|COMPLETED|Overall Study||14
10768312|NCT03232567|11931619|FG002|COMPLETED|Overall Study||15
10768313|NCT03232567|11931620|FG003|COMPLETED|Overall Study||15
10768314|NCT03232567|11931617|FG000|NOT COMPLETED|Overall Study||0
10768315|NCT03232567|11931618|FG001|NOT COMPLETED|Overall Study||1
10768316|NCT03232567|11931619|FG002|NOT COMPLETED|Overall Study||0
10768317|NCT03232567|11931620|FG003|NOT COMPLETED|Overall Study||0
10768318|NCT03232580|11931630|FG000|STARTED|Overall Study||5
10768319|NCT03232580|11931630|FG000|COMPLETED|Overall Study||5
10768320|NCT03232580|11931630|FG000|NOT COMPLETED|Overall Study||0
10768321|NCT03232645|11931634|FG000|STARTED|Overall Study||62
10768322|NCT03232645|11931634|FG000|COMPLETED|Overall Study||58
10768323|NCT03232645|11931634|FG000|NOT COMPLETED|Overall Study||4
10768324|NCT03232749|11931639|FG000|STARTED|Overall Study||25
10768325|NCT03232749|11931639|FG000|COMPLETED|Overall Study||21
10768326|NCT03232749|11931639|FG000|NOT COMPLETED|Overall Study||4
10768327|NCT03232827|11931643|FG000|STARTED|Flavored-sweetened (FS)||80
10768328|NCT03232827|11931643|FG000|COMPLETED|Flavored-sweetened (FS)||80
10768329|NCT03232827|11931643|FG000|NOT COMPLETED|Flavored-sweetened (FS)||0
10768330|NCT03232827|11931643|FG000|STARTED|Unflavored-sweetened (US)||86
10768331|NCT03232827|11931643|FG000|COMPLETED|Unflavored-sweetened (US)||86
10768332|NCT03232827|11931643|FG000|NOT COMPLETED|Unflavored-sweetened (US)||0
10768333|NCT03232827|11931643|FG000|STARTED|Unflavored-very Low Sweetened (UU)||66
10768334|NCT03232827|11931643|FG000|COMPLETED|Unflavored-very Low Sweetened (UU)||66
10768335|NCT03232827|11931643|FG000|NOT COMPLETED|Unflavored-very Low Sweetened (UU)||0
10768336|NCT03232827|11931643|FG000|STARTED|Flavored-very Low Sweetened||66
10768337|NCT03232827|11931643|FG000|COMPLETED|Flavored-very Low Sweetened||66
10768338|NCT03232827|11931643|FG000|NOT COMPLETED|Flavored-very Low Sweetened||0
10768339|NCT03232983|11931653|FG000|STARTED|Period 1||7
10768340|NCT03232983|11931654|FG001|STARTED|Period 1||7
10768341|NCT03232983|11931655|FG002|STARTED|Period 1||7
10768342|NCT03232983|11931656|FG003|STARTED|Period 1||7
10297586|NCT00003498|11430123|FG000|NOT COMPLETED|Overall Study||4
10297587|NCT00003499|11430127|FG000|STARTED|Overall Study||31
10297588|NCT00003499|11430127|FG000|COMPLETED|Overall Study||23
10297589|NCT00003499|11430127|FG000|NOT COMPLETED|Overall Study||8
10297590|NCT00003508|11430131|FG000|STARTED|Overall Study||8
10297591|NCT00003508|11430131|FG000|COMPLETED|Overall Study||3
10421654|NCT00820235|11566514|FG000|NOT COMPLETED|Overall Study||15
10768343|NCT03232983|11931653|FG000|Received at Least One Dose of Study Drug|Period 1||7
10768344|NCT03232983|11931654|FG001|Received at Least One Dose of Study Drug|Period 1||7
10768345|NCT03232983|11931655|FG002|Received at Least One Dose of Study Drug|Period 1||7
10768346|NCT03232983|11931656|FG003|Received at Least One Dose of Study Drug|Period 1||7
10768347|NCT03232983|11931653|FG000|COMPLETED|Period 1||7
10768348|NCT03232983|11931654|FG001|COMPLETED|Period 1||7
10768349|NCT03232983|11931655|FG002|COMPLETED|Period 1||6
10297592|NCT00003508|11430131|FG000|NOT COMPLETED|Overall Study||5
10297593|NCT00003509|11430135|FG000|STARTED|Overall Study||13
10768350|NCT03232983|11931656|FG003|COMPLETED|Period 1||7
10768351|NCT03232983|11931653|FG000|NOT COMPLETED|Period 1||0
10768352|NCT03232983|11931654|FG001|NOT COMPLETED|Period 1||0
10768353|NCT03232983|11931655|FG002|NOT COMPLETED|Period 1||1
10768354|NCT03232983|11931656|FG003|NOT COMPLETED|Period 1||0
10768355|NCT03232983|11931653|FG000|STARTED|Washout Period 1||7
10768356|NCT03232983|11931654|FG001|STARTED|Washout Period 1||7
10768357|NCT03232983|11931655|FG002|STARTED|Washout Period 1||6
10768358|NCT03232983|11931656|FG003|STARTED|Washout Period 1||7
10768359|NCT03232983|11931653|FG000|COMPLETED|Washout Period 1||7
10768360|NCT03232983|11931654|FG001|COMPLETED|Washout Period 1||7
10768361|NCT03232983|11931655|FG002|COMPLETED|Washout Period 1||6
10768362|NCT03232983|11931656|FG003|COMPLETED|Washout Period 1||7
10768363|NCT03232983|11931653|FG000|NOT COMPLETED|Washout Period 1||0
10768364|NCT03232983|11931654|FG001|NOT COMPLETED|Washout Period 1||0
10768365|NCT03232983|11931655|FG002|NOT COMPLETED|Washout Period 1||0
10768366|NCT03232983|11931656|FG003|NOT COMPLETED|Washout Period 1||0
10768367|NCT03232983|11931653|FG000|STARTED|Period 2||7
10768368|NCT03232983|11931654|FG001|STARTED|Period 2||7
10768369|NCT03232983|11931655|FG002|STARTED|Period 2||6
10768370|NCT03232983|11931656|FG003|STARTED|Period 2||7
10768371|NCT03232983|11931653|FG000|COMPLETED|Period 2||7
10768372|NCT03232983|11931654|FG001|COMPLETED|Period 2||7
10768373|NCT03232983|11931655|FG002|COMPLETED|Period 2||6
10768374|NCT03232983|11931656|FG003|COMPLETED|Period 2||7
10768375|NCT03232983|11931653|FG000|NOT COMPLETED|Period 2||0
10768376|NCT03232983|11931654|FG001|NOT COMPLETED|Period 2||0
10768377|NCT03232983|11931655|FG002|NOT COMPLETED|Period 2||0
10768378|NCT03232983|11931656|FG003|NOT COMPLETED|Period 2||0
10768379|NCT03232983|11931653|FG000|STARTED|Washout Period 2||7
10768380|NCT03232983|11931654|FG001|STARTED|Washout Period 2||7
10768381|NCT03232983|11931655|FG002|STARTED|Washout Period 2||6
10768382|NCT03232983|11931656|FG003|STARTED|Washout Period 2||7
10768383|NCT03232983|11931653|FG000|COMPLETED|Washout Period 2||7
10768384|NCT03232983|11931654|FG001|COMPLETED|Washout Period 2||7
10768385|NCT03232983|11931655|FG002|COMPLETED|Washout Period 2||5
10768386|NCT03232983|11931656|FG003|COMPLETED|Washout Period 2||6
10768387|NCT03232983|11931653|FG000|NOT COMPLETED|Washout Period 2||0
10768388|NCT03232983|11931654|FG001|NOT COMPLETED|Washout Period 2||0
10768389|NCT03232983|11931655|FG002|NOT COMPLETED|Washout Period 2||1
10768390|NCT03232983|11931656|FG003|NOT COMPLETED|Washout Period 2||1
10768391|NCT03232983|11931653|FG000|STARTED|Period 3||7
10768392|NCT03232983|11931654|FG001|STARTED|Period 3||7
10768393|NCT03232983|11931655|FG002|STARTED|Period 3||5
10768394|NCT03232983|11931656|FG003|STARTED|Period 3||6
10768395|NCT03232983|11931653|FG000|COMPLETED|Period 3||7
10768396|NCT03232983|11931654|FG001|COMPLETED|Period 3||7
10768397|NCT03232983|11931655|FG002|COMPLETED|Period 3||5
10768398|NCT03232983|11931656|FG003|COMPLETED|Period 3||6
10768399|NCT03232983|11931653|FG000|NOT COMPLETED|Period 3||0
10768400|NCT03232983|11931654|FG001|NOT COMPLETED|Period 3||0
10768401|NCT03232983|11931655|FG002|NOT COMPLETED|Period 3||0
10768402|NCT03232983|11931656|FG003|NOT COMPLETED|Period 3||0
10768403|NCT03232983|11931653|FG000|STARTED|Washout Period 3||7
10768404|NCT03232983|11931654|FG001|STARTED|Washout Period 3||7
10768405|NCT03232983|11931655|FG002|STARTED|Washout Period 3||5
10768406|NCT03232983|11931656|FG003|STARTED|Washout Period 3||6
10768407|NCT03232983|11931653|FG000|COMPLETED|Washout Period 3||7
10768408|NCT03232983|11931654|FG001|COMPLETED|Washout Period 3||7
10768409|NCT03232983|11931655|FG002|COMPLETED|Washout Period 3||5
10768410|NCT03232983|11931656|FG003|COMPLETED|Washout Period 3||6
10768411|NCT03232983|11931653|FG000|NOT COMPLETED|Washout Period 3||0
10768412|NCT03232983|11931654|FG001|NOT COMPLETED|Washout Period 3||0
10768413|NCT03232983|11931655|FG002|NOT COMPLETED|Washout Period 3||0
10768414|NCT03232983|11931656|FG003|NOT COMPLETED|Washout Period 3||0
10768415|NCT03232983|11931653|FG000|STARTED|Period 4||7
10768416|NCT03232983|11931654|FG001|STARTED|Period 4||7
10768417|NCT03232983|11931655|FG002|STARTED|Period 4||5
10768418|NCT03232983|11931656|FG003|STARTED|Period 4||6
10768419|NCT03232983|11931653|FG000|COMPLETED|Period 4||6
10768420|NCT03232983|11931654|FG001|COMPLETED|Period 4||7
10768421|NCT03232983|11931655|FG002|COMPLETED|Period 4||5
10768422|NCT03232983|11931656|FG003|COMPLETED|Period 4||6
10768423|NCT03232983|11931653|FG000|NOT COMPLETED|Period 4||1
10768424|NCT03232983|11931654|FG001|NOT COMPLETED|Period 4||0
10768425|NCT03232983|11931655|FG002|NOT COMPLETED|Period 4||0
10768426|NCT03232983|11931656|FG003|NOT COMPLETED|Period 4||0
10768427|NCT03233009|11931668|FG000|STARTED|Overall Study||40
10768428|NCT03233009|11931668|FG000|Test Product 1|Overall Study||39
10768429|NCT03233009|11931668|FG000|Test Product 2|Overall Study||39
10768430|NCT03233009|11931668|FG000|Test Product 3|Overall Study||39
10768431|NCT03233009|11931668|FG000|Test Product 4|Overall Study||39
10768432|NCT03233009|11931668|FG000|Reference Product|Overall Study||39
10768433|NCT03233009|11931668|FG000|COMPLETED|Overall Study||39
10768434|NCT03233009|11931668|FG000|NOT COMPLETED|Overall Study||1
10768435|NCT03233230|11931685|FG000|STARTED|Overall Study||97
10768436|NCT03233230|11931686|FG001|STARTED|Overall Study||98
10768437|NCT03233230|11931687|FG002|STARTED|Overall Study||96
10768438|NCT03233230|11931688|FG003|STARTED|Overall Study||99
10768439|NCT03233230|11931685|FG000|COMPLETED|Overall Study||82
10768440|NCT03233230|11931686|FG001|COMPLETED|Overall Study||83
10768441|NCT03233230|11931687|FG002|COMPLETED|Overall Study||84
10768442|NCT03233230|11931688|FG003|COMPLETED|Overall Study||91
10768443|NCT03233230|11931685|FG000|NOT COMPLETED|Overall Study||15
10768444|NCT03233230|11931686|FG001|NOT COMPLETED|Overall Study||15
10768445|NCT03233230|11931687|FG002|NOT COMPLETED|Overall Study||12
10768446|NCT03233230|11931688|FG003|NOT COMPLETED|Overall Study||8
10768447|NCT03233308|11931698|FG000|STARTED|Overall Study||20
10768448|NCT03233308|11931698|FG000|COMPLETED|Overall Study||18
10768449|NCT03233308|11931698|FG000|NOT COMPLETED|Overall Study||2
10768450|NCT03233438|11931711|FG000|STARTED|Overall Study||48
10768451|NCT03233438|11931712|FG001|STARTED|Overall Study||43
10768452|NCT03233438|11931711|FG000|COMPLETED|Overall Study||42
10768453|NCT03233438|11931712|FG001|COMPLETED|Overall Study||32
10768454|NCT03233438|11931711|FG000|NOT COMPLETED|Overall Study||6
10768455|NCT03233438|11931712|FG001|NOT COMPLETED|Overall Study||11
10768456|NCT03233529|11931718|FG000|STARTED|Double-Blind Period (Day 1 to Day 15)||40
10768457|NCT03233529|11931718|FG000|COMPLETED|Double-Blind Period (Day 1 to Day 15)||39
10768458|NCT03233529|11931718|FG000|NOT COMPLETED|Double-Blind Period (Day 1 to Day 15)||1
10768459|NCT03233529|11931718|FG000|STARTED|Open-Label Period (Day 15 to Day 71)||39
10768460|NCT03233529|11931718|FG000|COMPLETED|Open-Label Period (Day 15 to Day 71)||38
10768461|NCT03233529|11931718|FG000|NOT COMPLETED|Open-Label Period (Day 15 to Day 71)||1
10768462|NCT03233737|11931731|FG000|STARTED|Overall Study||10
10768463|NCT03233737|11931732|FG001|STARTED|Overall Study||10
10768464|NCT03233737|11931733|FG002|STARTED|Overall Study||5
10768465|NCT03233737|11931734|FG003|STARTED|Overall Study||24
10768466|NCT03233737|11931735|FG004|STARTED|Overall Study||26
10768467|NCT03233737|11931731|FG000|COMPLETED|Overall Study||10
10768468|NCT03233737|11931732|FG001|COMPLETED|Overall Study||10
10768469|NCT03233737|11931733|FG002|COMPLETED|Overall Study||5
10768470|NCT03233737|11931734|FG003|COMPLETED|Overall Study||24
10768471|NCT03233737|11931735|FG004|COMPLETED|Overall Study||26
10768472|NCT03233737|11931731|FG000|NOT COMPLETED|Overall Study||0
10768473|NCT03233737|11931732|FG001|NOT COMPLETED|Overall Study||0
10768474|NCT03233737|11931733|FG002|NOT COMPLETED|Overall Study||0
10768475|NCT03233737|11931734|FG003|NOT COMPLETED|Overall Study||0
10768476|NCT03233737|11931735|FG004|NOT COMPLETED|Overall Study||0
10768477|NCT03234036|11931751|FG000|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||8
10768478|NCT03234036|11931752|FG001|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||8
10768479|NCT03234036|11931753|FG002|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||0
10768480|NCT03234036|11931754|FG003|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||0
10768481|NCT03234036|11931751|FG000|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||8
10768482|NCT03234036|11931752|FG001|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||8
10768483|NCT03234036|11931753|FG002|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
10768484|NCT03234036|11931754|FG003|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
10768485|NCT03234036|11931751|FG000|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
10768486|NCT03234036|11931752|FG001|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
10768487|NCT03234036|11931753|FG002|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
10768488|NCT03234036|11931754|FG003|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
10768489|NCT03234036|11931751|FG000|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||8
10768490|NCT03234036|11931752|FG001|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||8
10768491|NCT03234036|11931753|FG002|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||0
10768492|NCT03234036|11931754|FG003|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||0
10768493|NCT03234036|11931751|FG000|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||7
10768494|NCT03234036|11931752|FG001|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||7
10768495|NCT03234036|11931753|FG002|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
10768496|NCT03234036|11931754|FG003|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
10768497|NCT03234036|11931751|FG000|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||1
10768498|NCT03234036|11931752|FG001|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||1
10768499|NCT03234036|11931753|FG002|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
10768500|NCT03234036|11931754|FG003|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
10768501|NCT03234036|11931751|FG000|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||7
10768502|NCT03234036|11931752|FG001|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||7
10768503|NCT03234036|11931753|FG002|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||0
10768504|NCT03234036|11931754|FG003|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||0
10768505|NCT03234036|11931751|FG000|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||7
10768506|NCT03234036|11931752|FG001|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||7
10768507|NCT03234036|11931753|FG002|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
10768508|NCT03234036|11931754|FG003|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
10768509|NCT03234036|11931751|FG000|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
10768510|NCT03234036|11931752|FG001|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
10768511|NCT03234036|11931753|FG002|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
10768512|NCT03234036|11931754|FG003|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
10768513|NCT03234036|11931751|FG000|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||7
10768514|NCT03234036|11931752|FG001|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||7
10768515|NCT03234036|11931753|FG002|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||0
10768516|NCT03234036|11931754|FG003|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||0
10768517|NCT03234036|11931751|FG000|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||7
10768518|NCT03234036|11931752|FG001|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||7
10768519|NCT03234036|11931753|FG002|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
10768520|NCT03234036|11931754|FG003|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
10768521|NCT03234036|11931751|FG000|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
10768522|NCT03234036|11931752|FG001|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
10768523|NCT03234036|11931753|FG002|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
10768524|NCT03234036|11931754|FG003|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
10768525|NCT03234036|11931751|FG000|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||7
10768526|NCT03234036|11931752|FG001|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||7
10768527|NCT03234036|11931753|FG002|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||0
10768528|NCT03234036|11931754|FG003|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||0
10768529|NCT03234036|11931751|FG000|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||7
10779133|NCT03364309|11940860|FG001|NOT COMPLETED|Induction Period||4
10768530|NCT03234036|11931752|FG001|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||7
10768531|NCT03234036|11931753|FG002|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
10768532|NCT03234036|11931754|FG003|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
10768533|NCT03234036|11931751|FG000|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
10768534|NCT03234036|11931752|FG001|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
10768535|NCT03234036|11931753|FG002|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
10768536|NCT03234036|11931754|FG003|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
10768537|NCT03234036|11931751|FG000|STARTED|Part 2 (Up to 25 Days)||0
10768538|NCT03234036|11931752|FG001|STARTED|Part 2 (Up to 25 Days)||0
10768539|NCT03234036|11931753|FG002|STARTED|Part 2 (Up to 25 Days)||3
10768540|NCT03234036|11931754|FG003|STARTED|Part 2 (Up to 25 Days)||7
10768541|NCT03234036|11931751|FG000|COMPLETED|Part 2 (Up to 25 Days)||0
10768542|NCT03234036|11931752|FG001|COMPLETED|Part 2 (Up to 25 Days)||0
10768543|NCT03234036|11931753|FG002|COMPLETED|Part 2 (Up to 25 Days)||3
10768544|NCT03234036|11931754|FG003|COMPLETED|Part 2 (Up to 25 Days)||7
10768545|NCT03234036|11931751|FG000|NOT COMPLETED|Part 2 (Up to 25 Days)||0
10768546|NCT03234036|11931752|FG001|NOT COMPLETED|Part 2 (Up to 25 Days)||0
10768547|NCT03234036|11931753|FG002|NOT COMPLETED|Part 2 (Up to 25 Days)||0
10768548|NCT03234036|11931754|FG003|NOT COMPLETED|Part 2 (Up to 25 Days)||0
10768549|NCT03234374|11931772|FG000|STARTED|Overall Study||35
10768550|NCT03234374|11931773|FG001|STARTED|Overall Study||17
10768551|NCT03234374|11931772|FG000|COMPLETED|Overall Study||34
10768552|NCT03234374|11931773|FG001|COMPLETED|Overall Study||16
10768553|NCT03234374|11931772|FG000|NOT COMPLETED|Overall Study||1
10768554|NCT03234374|11931773|FG001|NOT COMPLETED|Overall Study||1
10768555|NCT03234465|11931781|FG000|STARTED|Overall Study||100
10768556|NCT03234465|11931782|FG001|STARTED|Overall Study||100
10768557|NCT03234465|11931781|FG000|COMPLETED|Overall Study||67
10768558|NCT03234465|11931782|FG001|COMPLETED|Overall Study||60
10768559|NCT03234465|11931781|FG000|NOT COMPLETED|Overall Study||33
10768560|NCT03234465|11931782|FG001|NOT COMPLETED|Overall Study||40
10768561|NCT03234608|11931790|FG000|STARTED|Overall Study||127
10768562|NCT03234608|11931791|FG001|STARTED|Overall Study||117
10768563|NCT03234608|11931790|FG000|COMPLETED|Overall Study||104
10768564|NCT03234608|11931791|FG001|COMPLETED|Overall Study||96
10421655|NCT00820235|11566515|FG001|NOT COMPLETED|Overall Study||21
10421656|NCT00820235|11566516|FG002|NOT COMPLETED|Overall Study||17
10421657|NCT00820248|11566526|FG000|STARTED|Overall Study||160
10421658|NCT00820248|11566527|FG001|STARTED|Overall Study||160
10421659|NCT00820248|11566526|FG000|Received Protocol Treatment|Overall Study||156
10421660|NCT00820248|11566527|FG001|Received Protocol Treatment|Overall Study||159
10421661|NCT00820248|11566526|FG000|COMPLETED|Overall Study||156
10421662|NCT00820248|11566527|FG001|COMPLETED|Overall Study||159
10421663|NCT00820248|11566526|FG000|NOT COMPLETED|Overall Study||4
10421664|NCT00820248|11566527|FG001|NOT COMPLETED|Overall Study||1
10421665|NCT00820443|11566533|FG000|STARTED|Pre-Op||253
10421666|NCT00820443|11566533|FG000|COMPLETED|Pre-Op||253
10768565|NCT03234608|11931790|FG000|NOT COMPLETED|Overall Study||23
10768566|NCT03234608|11931791|FG001|NOT COMPLETED|Overall Study||21
10768567|NCT03235050|11931802|FG000|STARTED|Overall Study||112
10768568|NCT03235050|11931803|FG001|STARTED|Overall Study||110
10768569|NCT03235050|11931804|FG002|STARTED|Overall Study||100
10768570|NCT03235050|11931805|FG003|STARTED|Overall Study||256
10768571|NCT03235050|11931806|FG004|STARTED|Overall Study||256
10768572|NCT03235050|11931802|FG000|COMPLETED|Overall Study||108
10768573|NCT03235050|11931803|FG001|COMPLETED|Overall Study||105
10768574|NCT03235050|11931804|FG002|COMPLETED|Overall Study||96
10768575|NCT03235050|11931805|FG003|COMPLETED|Overall Study||242
10768576|NCT03235050|11931806|FG004|COMPLETED|Overall Study||245
10768577|NCT03235050|11931802|FG000|NOT COMPLETED|Overall Study||4
10768578|NCT03235050|11931803|FG001|NOT COMPLETED|Overall Study||5
10768579|NCT03235050|11931804|FG002|NOT COMPLETED|Overall Study||4
10768580|NCT03235050|11931805|FG003|NOT COMPLETED|Overall Study||14
10768581|NCT03235050|11931806|FG004|NOT COMPLETED|Overall Study||11
10768582|NCT03235089|11931818|FG000|STARTED|Overall Study||31
10768583|NCT03235089|11931819|FG001|STARTED|Overall Study||31
10768584|NCT03235089|11931818|FG000|COMPLETED|Overall Study||28
10768585|NCT03235089|11931819|FG001|COMPLETED|Overall Study||28
10768586|NCT03235089|11931818|FG000|NOT COMPLETED|Overall Study||3
10768587|NCT03235089|11931819|FG001|NOT COMPLETED|Overall Study||3
10768588|NCT03235115|11931826|FG000|STARTED|First Intervention (1 Hour, Visit 2)||9
10768589|NCT03235115|11931827|FG001|STARTED|First Intervention (1 Hour, Visit 2)||6
10768590|NCT03235115|11931828|FG002|STARTED|First Intervention (1 Hour, Visit 2)||7
10768591|NCT03235115|11931829|FG003|STARTED|First Intervention (1 Hour, Visit 2)||6
10768592|NCT03235115|11931830|FG004|STARTED|First Intervention (1 Hour, Visit 2)||6
10768593|NCT03235115|11931831|FG005|STARTED|First Intervention (1 Hour, Visit 2)||6
10768594|NCT03235115|11931826|FG000|COMPLETED|First Intervention (1 Hour, Visit 2)||9
10768595|NCT03235115|11931827|FG001|COMPLETED|First Intervention (1 Hour, Visit 2)||6
10768596|NCT03235115|11931828|FG002|COMPLETED|First Intervention (1 Hour, Visit 2)||7
10768597|NCT03235115|11931829|FG003|COMPLETED|First Intervention (1 Hour, Visit 2)||6
10768598|NCT03235115|11931830|FG004|COMPLETED|First Intervention (1 Hour, Visit 2)||6
10768599|NCT03235115|11931831|FG005|COMPLETED|First Intervention (1 Hour, Visit 2)||5
10768600|NCT03235115|11931826|FG000|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
10768601|NCT03235115|11931827|FG001|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
10421667|NCT00820443|11566533|FG000|NOT COMPLETED|Pre-Op||0
10421668|NCT00820443|11566533|FG000|STARTED|Op||253
10768602|NCT03235115|11931828|FG002|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
10768603|NCT03235115|11931829|FG003|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
10768604|NCT03235115|11931830|FG004|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
10768605|NCT03235115|11931831|FG005|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||1
10768606|NCT03235115|11931826|FG000|STARTED|Second Intervention (1 Hour, Visit 4)||9
10768607|NCT03235115|11931827|FG001|STARTED|Second Intervention (1 Hour, Visit 4)||6
10768608|NCT03235115|11931828|FG002|STARTED|Second Intervention (1 Hour, Visit 4)||7
10768609|NCT03235115|11931829|FG003|STARTED|Second Intervention (1 Hour, Visit 4)||6
10768610|NCT03235115|11931830|FG004|STARTED|Second Intervention (1 Hour, Visit 4)||6
10768611|NCT03235115|11931831|FG005|STARTED|Second Intervention (1 Hour, Visit 4)||5
10768612|NCT03235115|11931826|FG000|COMPLETED|Second Intervention (1 Hour, Visit 4)||9
10768613|NCT03235115|11931827|FG001|COMPLETED|Second Intervention (1 Hour, Visit 4)||6
10768614|NCT03235115|11931828|FG002|COMPLETED|Second Intervention (1 Hour, Visit 4)||7
10768615|NCT03235115|11931829|FG003|COMPLETED|Second Intervention (1 Hour, Visit 4)||6
10768616|NCT03235115|11931830|FG004|COMPLETED|Second Intervention (1 Hour, Visit 4)||6
10768617|NCT03235115|11931831|FG005|COMPLETED|Second Intervention (1 Hour, Visit 4)||5
10768618|NCT03235115|11931826|FG000|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
10768619|NCT03235115|11931827|FG001|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
10768620|NCT03235115|11931828|FG002|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
10768621|NCT03235115|11931829|FG003|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
10768622|NCT03235115|11931830|FG004|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
10768623|NCT03235115|11931831|FG005|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
10768624|NCT03235115|11931826|FG000|STARTED|Third Intervention ( 1 Hour, Visit 6)||9
10768625|NCT03235115|11931827|FG001|STARTED|Third Intervention ( 1 Hour, Visit 6)||6
10768626|NCT03235115|11931828|FG002|STARTED|Third Intervention ( 1 Hour, Visit 6)||7
10768627|NCT03235115|11931829|FG003|STARTED|Third Intervention ( 1 Hour, Visit 6)||6
10768628|NCT03235115|11931830|FG004|STARTED|Third Intervention ( 1 Hour, Visit 6)||6
10768629|NCT03235115|11931831|FG005|STARTED|Third Intervention ( 1 Hour, Visit 6)||5
10768630|NCT03235115|11931826|FG000|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||9
10768631|NCT03235115|11931827|FG001|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6
10768632|NCT03235115|11931828|FG002|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||7
10768633|NCT03235115|11931829|FG003|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6
10768634|NCT03235115|11931830|FG004|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6
10768635|NCT03235115|11931831|FG005|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||5
10768636|NCT03235115|11931826|FG000|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
10768637|NCT03235115|11931827|FG001|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
10768638|NCT03235115|11931828|FG002|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
10768639|NCT03235115|11931829|FG003|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
10768640|NCT03235115|11931830|FG004|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
10768641|NCT03235115|11931831|FG005|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
10768642|NCT03235154|11931839|FG000|STARTED|Overall Study||11
10768643|NCT03235154|11931839|FG000|Completed Epclusa. Treatment|Overall Study||8
10768644|NCT03235154|11931839|FG000|12-wk Post-treatment HCV RNA Measured|Overall Study||7
10768645|NCT03235154|11931839|FG000|COMPLETED|Overall Study||7
10768646|NCT03235154|11931839|FG000|NOT COMPLETED|Overall Study||4
10779134|NCT03364309|11940861|FG002|NOT COMPLETED|Induction Period||1
10779135|NCT03364309|11940862|FG003|NOT COMPLETED|Induction Period||0
10779136|NCT03364309|11940863|FG004|NOT COMPLETED|Induction Period||0
10779137|NCT03364309|11940864|FG005|NOT COMPLETED|Induction Period||0
10779138|NCT03364309|11940865|FG006|NOT COMPLETED|Induction Period||0
10297594|NCT00003509|11430135|FG000|COMPLETED|Overall Study||8
10297595|NCT00003509|11430135|FG000|NOT COMPLETED|Overall Study||5
10297596|NCT00003511|11430139|FG000|STARTED|Overall Study||5
10297597|NCT00003511|11430139|FG000|COMPLETED|Overall Study||1
10297598|NCT00003511|11430139|FG000|NOT COMPLETED|Overall Study||4
10297599|NCT00003526|11430143|FG000|STARTED|Overall Study||8
10297600|NCT00003526|11430143|FG000|COMPLETED|Overall Study||2
10297601|NCT00003526|11430143|FG000|NOT COMPLETED|Overall Study||6
10297602|NCT00003531|11430147|FG000|STARTED|Overall Study||15
10297603|NCT00003531|11430147|FG000|COMPLETED|Overall Study||5
10297604|NCT00003531|11430147|FG000|NOT COMPLETED|Overall Study||10
10297605|NCT00003535|11430151|FG000|STARTED|Overall Study||9
10297606|NCT00003535|11430151|FG000|COMPLETED|Overall Study||4
10297607|NCT00003535|11430151|FG000|NOT COMPLETED|Overall Study||5
10297608|NCT00003537|11430155|FG000|STARTED|Overall Study||19
10297609|NCT00003537|11430155|FG000|COMPLETED|Overall Study||18
10297610|NCT00003537|11430155|FG000|NOT COMPLETED|Overall Study||1
10297611|NCT00003590|11430159|FG000|STARTED|Overall Study||29
10297612|NCT00003590|11430159|FG000|Eligible|Overall Study||28
10297613|NCT00003590|11430159|FG000|Eligible and Began Protocol Therapy|Overall Study||28
10297614|NCT00003590|11430159|FG000|COMPLETED|Overall Study|Patients were to receive Hydroxyurea up to 2 years in absence of progressive disease.|7
10297615|NCT00003590|11430159|FG000|NOT COMPLETED|Overall Study||22
10297616|NCT00003631|11430166|FG000|STARTED|Overall Study||50
10297617|NCT00003631|11430167|FG001|STARTED|Overall Study||44
10297618|NCT00003631|11430168|FG002|STARTED|Overall Study||24
10297619|NCT00003631|11430166|FG000|COMPLETED|Overall Study||47
10297620|NCT00003631|11430167|FG001|COMPLETED|Overall Study||43
10297621|NCT00003631|11430168|FG002|COMPLETED|Overall Study||15
10779139|NCT03364309|11940866|FG007|NOT COMPLETED|Induction Period||0
10297622|NCT00003631|11430166|FG000|NOT COMPLETED|Overall Study||3
10297623|NCT00003631|11430167|FG001|NOT COMPLETED|Overall Study||1
10297624|NCT00003631|11430168|FG002|NOT COMPLETED|Overall Study||9
10297625|NCT00003644|11430178|FG000|STARTED|Overall Study||289
10297626|NCT00003644|11430179|FG001|STARTED|Overall Study||282
10297627|NCT00003644|11430178|FG000|COMPLETED|Overall Study||274
10297628|NCT00003644|11430179|FG001|COMPLETED|Overall Study||268
10297629|NCT00003644|11430178|FG000|NOT COMPLETED|Overall Study||15
10297630|NCT00003644|11430179|FG001|NOT COMPLETED|Overall Study||14
10297631|NCT00003645|11430189|FG000|STARTED|Overall Study||30
10297632|NCT00003645|11430190|FG001|STARTED|Overall Study||34
10297633|NCT00003645|11430189|FG000|COMPLETED|Overall Study||18
10297634|NCT00003645|11430190|FG001|COMPLETED|Overall Study||22
10297635|NCT00003645|11430189|FG000|NOT COMPLETED|Overall Study||12
10297636|NCT00003645|11430190|FG001|NOT COMPLETED|Overall Study||12
10768647|NCT03235180|11931845|FG000|STARTED|Overall Study||9
10768648|NCT03235180|11931845|FG000|COMPLETED|Overall Study||9
10768649|NCT03235180|11931845|FG000|NOT COMPLETED|Overall Study||0
10768650|NCT03235284|11931852|FG000|STARTED|Overall Study||15
10768651|NCT03235284|11931853|FG001|STARTED|Overall Study||15
10768652|NCT03235284|11931854|FG002|STARTED|Overall Study||15
10768653|NCT03235284|11931852|FG000|COMPLETED|Overall Study||14
10768654|NCT03235284|11931853|FG001|COMPLETED|Overall Study||13
10768655|NCT03235284|11931854|FG002|COMPLETED|Overall Study||14
10768656|NCT03235284|11931852|FG000|NOT COMPLETED|Overall Study||1
10768657|NCT03235284|11931853|FG001|NOT COMPLETED|Overall Study||2
10768658|NCT03235284|11931854|FG002|NOT COMPLETED|Overall Study||1
10768659|NCT03235349|11931862|FG000|STARTED|Overall Study||160
10768660|NCT03235349|11931862|FG000|COMPLETED|Overall Study||158
10768661|NCT03235349|11931862|FG000|NOT COMPLETED|Overall Study||2
10768662|NCT03235414|11931866|FG000|STARTED|Overall Study||101
10768663|NCT03235414|11931866|FG000|COMPLETED|Overall Study||101
10768664|NCT03235414|11931866|FG000|NOT COMPLETED|Overall Study||0
10768665|NCT03235479|11931872|FG000|STARTED|Overall Study||582
10768666|NCT03235479|11931873|FG001|STARTED|Overall Study||580
10768667|NCT03235479|11931872|FG000|Treated|Overall Study||546
10768668|NCT03235479|11931873|FG001|Treated|Overall Study||549
10768669|NCT03235479|11931872|FG000|COMPLETED|Overall Study||541
10768670|NCT03235479|11931873|FG001|COMPLETED|Overall Study||540
10768671|NCT03235479|11931872|FG000|NOT COMPLETED|Overall Study||41
10768672|NCT03235479|11931873|FG001|NOT COMPLETED|Overall Study||40
10768673|NCT03235726|11931887|FG000|STARTED|Part 1 (Cohort A 60 mg - Day 1)||6
10768674|NCT03235726|11931888|FG001|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
10768675|NCT03235726|11931889|FG002|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
10768676|NCT03235726|11931890|FG003|STARTED|Part 1 (Cohort A 60 mg - Day 1)||2
10768677|NCT03235726|11931891|FG004|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
10768678|NCT03235726|11931892|FG005|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
10768679|NCT03235726|11931893|FG006|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
10768680|NCT03235726|11931894|FG007|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
10768681|NCT03235726|11931895|FG008|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
10768682|NCT03235726|11931896|FG009|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
10768683|NCT03235726|11931887|FG000|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||6
10768684|NCT03235726|11931888|FG001|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
10768685|NCT03235726|11931889|FG002|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
10768686|NCT03235726|11931890|FG003|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||2
10768687|NCT03235726|11931891|FG004|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
10768688|NCT03235726|11931892|FG005|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
10768689|NCT03235726|11931893|FG006|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
10768690|NCT03235726|11931894|FG007|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
10768691|NCT03235726|11931895|FG008|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
10768692|NCT03235726|11931896|FG009|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
10768693|NCT03235726|11931887|FG000|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
10768694|NCT03235726|11931888|FG001|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
10768695|NCT03235726|11931889|FG002|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
10768696|NCT03235726|11931890|FG003|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
10768697|NCT03235726|11931891|FG004|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
10768698|NCT03235726|11931892|FG005|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
10768699|NCT03235726|11931893|FG006|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
10768700|NCT03235726|11931894|FG007|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
10768701|NCT03235726|11931895|FG008|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
10768702|NCT03235726|11931896|FG009|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
10768703|NCT03235726|11931887|FG000|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
10768704|NCT03235726|11931888|FG001|STARTED|Part 1 (Cohort A 120 mg - Day 3)||6
10768705|NCT03235726|11931889|FG002|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
10768706|NCT03235726|11931890|FG003|STARTED|Part 1 (Cohort A 120 mg - Day 3)||2
10768707|NCT03235726|11931891|FG004|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
10768708|NCT03235726|11931892|FG005|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
10768709|NCT03235726|11931893|FG006|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
10768710|NCT03235726|11931894|FG007|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
10768711|NCT03235726|11931895|FG008|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
10768712|NCT03235726|11931896|FG009|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
10768713|NCT03235726|11931887|FG000|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
10768714|NCT03235726|11931888|FG001|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||6
10768715|NCT03235726|11931889|FG002|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
10768716|NCT03235726|11931890|FG003|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||2
10768717|NCT03235726|11931891|FG004|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
10768718|NCT03235726|11931892|FG005|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
10768719|NCT03235726|11931893|FG006|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
10768720|NCT03235726|11931894|FG007|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
10768721|NCT03235726|11931895|FG008|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
10768722|NCT03235726|11931896|FG009|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
10768723|NCT03235726|11931887|FG000|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
10768724|NCT03235726|11931888|FG001|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
10768725|NCT03235726|11931889|FG002|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
10768726|NCT03235726|11931890|FG003|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
10768727|NCT03235726|11931891|FG004|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
10768728|NCT03235726|11931892|FG005|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
10768729|NCT03235726|11931893|FG006|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
10768730|NCT03235726|11931894|FG007|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
10768731|NCT03235726|11931895|FG008|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
10768732|NCT03235726|11931896|FG009|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
10768733|NCT03235726|11931887|FG000|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10768734|NCT03235726|11931888|FG001|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10768735|NCT03235726|11931889|FG002|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||6
10768736|NCT03235726|11931890|FG003|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||2
10768737|NCT03235726|11931891|FG004|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10768738|NCT03235726|11931892|FG005|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10768739|NCT03235726|11931893|FG006|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10768740|NCT03235726|11931894|FG007|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10768741|NCT03235726|11931895|FG008|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10768742|NCT03235726|11931896|FG009|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10768743|NCT03235726|11931887|FG000|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10768744|NCT03235726|11931888|FG001|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10768745|NCT03235726|11931889|FG002|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||6
10768746|NCT03235726|11931890|FG003|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||2
10768747|NCT03235726|11931891|FG004|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10768748|NCT03235726|11931892|FG005|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10768749|NCT03235726|11931893|FG006|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10768750|NCT03235726|11931894|FG007|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10768751|NCT03235726|11931895|FG008|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10768752|NCT03235726|11931896|FG009|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10768753|NCT03235726|11931887|FG000|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10768754|NCT03235726|11931888|FG001|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10768755|NCT03235726|11931889|FG002|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10768756|NCT03235726|11931890|FG003|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10768757|NCT03235726|11931891|FG004|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10768758|NCT03235726|11931892|FG005|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10768759|NCT03235726|11931893|FG006|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10768760|NCT03235726|11931894|FG007|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10768761|NCT03235726|11931895|FG008|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10768762|NCT03235726|11931896|FG009|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
10768763|NCT03235726|11931887|FG000|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
10768764|NCT03235726|11931888|FG001|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
10768765|NCT03235726|11931889|FG002|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
10768766|NCT03235726|11931890|FG003|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
10768767|NCT03235726|11931891|FG004|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||12
10768768|NCT03235726|11931892|FG005|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||2
10768769|NCT03235726|11931893|FG006|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||14
10768770|NCT03235726|11931894|FG007|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
10768771|NCT03235726|11931895|FG008|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
10768772|NCT03235726|11931896|FG009|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
10768773|NCT03235726|11931887|FG000|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
10768774|NCT03235726|11931888|FG001|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
10768775|NCT03235726|11931889|FG002|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
10768776|NCT03235726|11931890|FG003|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
10768777|NCT03235726|11931891|FG004|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||10
10768778|NCT03235726|11931892|FG005|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||2
10768779|NCT03235726|11931893|FG006|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||14
10768780|NCT03235726|11931894|FG007|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
10768781|NCT03235726|11931895|FG008|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
10768782|NCT03235726|11931896|FG009|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
10768783|NCT03235726|11931887|FG000|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
10768784|NCT03235726|11931888|FG001|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
10768785|NCT03235726|11931889|FG002|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
10768786|NCT03235726|11931890|FG003|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
10768787|NCT03235726|11931891|FG004|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||2
10768788|NCT03235726|11931892|FG005|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
10768789|NCT03235726|11931893|FG006|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
10768790|NCT03235726|11931894|FG007|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
10768791|NCT03235726|11931895|FG008|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
10768792|NCT03235726|11931896|FG009|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
10768793|NCT03235726|11931887|FG000|STARTED|Part 2 (Cohort A - Day 1)||0
10768794|NCT03235726|11931888|FG001|STARTED|Part 2 (Cohort A - Day 1)||0
10768795|NCT03235726|11931889|FG002|STARTED|Part 2 (Cohort A - Day 1)||0
10768796|NCT03235726|11931890|FG003|STARTED|Part 2 (Cohort A - Day 1)||0
10768797|NCT03235726|11931891|FG004|STARTED|Part 2 (Cohort A - Day 1)||0
10768798|NCT03235726|11931892|FG005|STARTED|Part 2 (Cohort A - Day 1)||0
10768799|NCT03235726|11931893|FG006|STARTED|Part 2 (Cohort A - Day 1)||0
10768800|NCT03235726|11931894|FG007|STARTED|Part 2 (Cohort A - Day 1)||6
10768801|NCT03235726|11931895|FG008|STARTED|Part 2 (Cohort A - Day 1)||2
10768802|NCT03235726|11931896|FG009|STARTED|Part 2 (Cohort A - Day 1)||0
10768803|NCT03235726|11931887|FG000|COMPLETED|Part 2 (Cohort A - Day 1)||0
10768804|NCT03235726|11931888|FG001|COMPLETED|Part 2 (Cohort A - Day 1)||0
10768805|NCT03235726|11931889|FG002|COMPLETED|Part 2 (Cohort A - Day 1)||0
10768806|NCT03235726|11931890|FG003|COMPLETED|Part 2 (Cohort A - Day 1)||0
10768807|NCT03235726|11931891|FG004|COMPLETED|Part 2 (Cohort A - Day 1)||0
10768808|NCT03235726|11931892|FG005|COMPLETED|Part 2 (Cohort A - Day 1)||0
10768809|NCT03235726|11931893|FG006|COMPLETED|Part 2 (Cohort A - Day 1)||0
10768810|NCT03235726|11931894|FG007|COMPLETED|Part 2 (Cohort A - Day 1)||6
10768811|NCT03235726|11931895|FG008|COMPLETED|Part 2 (Cohort A - Day 1)||2
10768812|NCT03235726|11931896|FG009|COMPLETED|Part 2 (Cohort A - Day 1)||0
10768813|NCT03235726|11931887|FG000|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
10768814|NCT03235726|11931888|FG001|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
10768815|NCT03235726|11931889|FG002|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
10768816|NCT03235726|11931890|FG003|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
10768817|NCT03235726|11931891|FG004|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
10768818|NCT03235726|11931892|FG005|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
10768819|NCT03235726|11931893|FG006|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
10768820|NCT03235726|11931894|FG007|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
10768821|NCT03235726|11931895|FG008|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
10768822|NCT03235726|11931896|FG009|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
10768823|NCT03235726|11931887|FG000|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
10768824|NCT03235726|11931888|FG001|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
10768825|NCT03235726|11931889|FG002|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
10768826|NCT03235726|11931890|FG003|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
10768827|NCT03235726|11931891|FG004|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
10768828|NCT03235726|11931892|FG005|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
10768829|NCT03235726|11931893|FG006|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
10768830|NCT03235726|11931894|FG007|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
10768831|NCT03235726|11931895|FG008|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
10768832|NCT03235726|11931896|FG009|STARTED|Part 2 (Cohort B - Days 1 to 14)||8
10768833|NCT03235726|11931887|FG000|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
10768834|NCT03235726|11931888|FG001|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
10768835|NCT03235726|11931889|FG002|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
10768836|NCT03235726|11931890|FG003|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
10768837|NCT03235726|11931891|FG004|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
10768838|NCT03235726|11931892|FG005|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
10768839|NCT03235726|11931893|FG006|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
10768840|NCT03235726|11931894|FG007|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
10768841|NCT03235726|11931895|FG008|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
10768842|NCT03235726|11931896|FG009|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||8
10768843|NCT03235726|11931887|FG000|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
10768844|NCT03235726|11931888|FG001|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
10768845|NCT03235726|11931889|FG002|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
10768846|NCT03235726|11931890|FG003|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
10768847|NCT03235726|11931891|FG004|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
10768848|NCT03235726|11931892|FG005|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
10768849|NCT03235726|11931893|FG006|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
10768850|NCT03235726|11931894|FG007|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
10768851|NCT03235726|11931895|FG008|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
10768852|NCT03235726|11931896|FG009|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
10768853|NCT03236168|11931931|FG000|STARTED|Overall Study||118
10768854|NCT03236168|11931931|FG000|COMPLETED|Overall Study||107
10768855|NCT03236168|11931931|FG000|NOT COMPLETED|Overall Study||11
10768856|NCT03236246|11931937|FG000|STARTED|24-Week Dose Titration Period||104
10768857|NCT03236246|11931938|FG001|STARTED|24-Week Dose Titration Period||102
10768858|NCT03236246|11931937|FG000|COMPLETED|24-Week Dose Titration Period||80
10768859|NCT03236246|11931938|FG001|COMPLETED|24-Week Dose Titration Period||75
10768860|NCT03236246|11931937|FG000|NOT COMPLETED|24-Week Dose Titration Period||24
10768861|NCT03236246|11931938|FG001|NOT COMPLETED|24-Week Dose Titration Period||27
10768862|NCT03236246|11931937|FG000|STARTED|24-Week Dose Maintenance Period|Not all participants completing the Dose Titration Period opted to enter the Dose Maintenance Period|76
10768863|NCT03236246|11931938|FG001|STARTED|24-Week Dose Maintenance Period|Not all participants completing the Dose Titration Period opted to enter the Dose Maintenance Period|72
10768864|NCT03236246|11931937|FG000|COMPLETED|24-Week Dose Maintenance Period||73
10768865|NCT03236246|11931938|FG001|COMPLETED|24-Week Dose Maintenance Period||66
10768866|NCT03236246|11931937|FG000|NOT COMPLETED|24-Week Dose Maintenance Period||3
10768867|NCT03236246|11931938|FG001|NOT COMPLETED|24-Week Dose Maintenance Period||6
10768868|NCT03236506|11931947|FG000|STARTED|Overall Study||39
10768869|NCT03236506|11931948|FG001|STARTED|Overall Study||42
10768870|NCT03236506|11931949|FG002|STARTED|Overall Study||47
10768871|NCT03236506|11931947|FG000|COMPLETED|Overall Study||33
10768872|NCT03236506|11931948|FG001|COMPLETED|Overall Study||37
10768873|NCT03236506|11931949|FG002|COMPLETED|Overall Study||40
10768874|NCT03236506|11931947|FG000|NOT COMPLETED|Overall Study||6
10768875|NCT03236506|11931948|FG001|NOT COMPLETED|Overall Study||5
10768876|NCT03236506|11931949|FG002|NOT COMPLETED|Overall Study||7
10768877|NCT03236779|11931959|FG000|STARTED|Overall Study||51
10768878|NCT03236779|11931960|FG001|STARTED|Overall Study||51
10768879|NCT03236779|11931959|FG000|COMPLETED|Overall Study||38
10768880|NCT03236779|11931960|FG001|COMPLETED|Overall Study||30
10768881|NCT03236779|11931959|FG000|NOT COMPLETED|Overall Study||13
10768882|NCT03236779|11931960|FG001|NOT COMPLETED|Overall Study||21
10768883|NCT03237013|11931971|FG000|STARTED|Baseline to Immediate Post-treatment||73
10768884|NCT03237013|11931972|FG001|STARTED|Baseline to Immediate Post-treatment||73
10768885|NCT03237013|11931973|FG002|STARTED|Baseline to Immediate Post-treatment||73
10768886|NCT03237013|11931971|FG000|COMPLETED|Baseline to Immediate Post-treatment||73
10768887|NCT03237013|11931972|FG001|COMPLETED|Baseline to Immediate Post-treatment||73
10768888|NCT03237013|11931973|FG002|COMPLETED|Baseline to Immediate Post-treatment||73
10768889|NCT03237013|11931971|FG000|NOT COMPLETED|Baseline to Immediate Post-treatment||0
10768890|NCT03237013|11931972|FG001|NOT COMPLETED|Baseline to Immediate Post-treatment||0
10768891|NCT03237013|11931973|FG002|NOT COMPLETED|Baseline to Immediate Post-treatment||0
10768892|NCT03237013|11931971|FG000|STARTED|Immediate Post-treatment to 1-mo F/u||73
10768893|NCT03237013|11931972|FG001|STARTED|Immediate Post-treatment to 1-mo F/u||73
10768894|NCT03237013|11931973|FG002|STARTED|Immediate Post-treatment to 1-mo F/u||73
10768895|NCT03237013|11931971|FG000|COMPLETED|Immediate Post-treatment to 1-mo F/u||30
10768896|NCT03237013|11931972|FG001|COMPLETED|Immediate Post-treatment to 1-mo F/u||43
10768897|NCT03237013|11931973|FG002|COMPLETED|Immediate Post-treatment to 1-mo F/u||36
10768898|NCT03237013|11931971|FG000|NOT COMPLETED|Immediate Post-treatment to 1-mo F/u||43
10768899|NCT03237013|11931972|FG001|NOT COMPLETED|Immediate Post-treatment to 1-mo F/u||30
10768900|NCT03237013|11931973|FG002|NOT COMPLETED|Immediate Post-treatment to 1-mo F/u||37
10768901|NCT03237065|11931983|FG000|STARTED|Overall Study||61
10768902|NCT03237065|11931984|FG001|STARTED|Overall Study||61
10768903|NCT03237065|11931983|FG000|Safety Analysis Set|Overall Study|1 subject from ferric carboxymaltose group received iron isomaltoside/ferric derisomaltose in error.|62
10768904|NCT03237065|11931984|FG001|Safety Analysis Set|Overall Study||57
10768905|NCT03237065|11931983|FG000|COMPLETED|Overall Study||57
10768906|NCT03237065|11931984|FG001|COMPLETED|Overall Study||57
10768907|NCT03237065|11931983|FG000|NOT COMPLETED|Overall Study||4
10768908|NCT03237065|11931984|FG001|NOT COMPLETED|Overall Study||4
10768909|NCT03237156|11931994|FG000|STARTED|Overall Study||6
10768910|NCT03237156|11931995|FG001|STARTED|Overall Study||6
10768911|NCT03237156|11931996|FG002|STARTED|Overall Study||6
10768912|NCT03237156|11931997|FG003|STARTED|Overall Study||6
10768913|NCT03237156|11931994|FG000|COMPLETED|Overall Study||6
10768914|NCT03237156|11931995|FG001|COMPLETED|Overall Study||6
10768915|NCT03237156|11931996|FG002|COMPLETED|Overall Study||6
10768916|NCT03237156|11931997|FG003|COMPLETED|Overall Study||6
10768917|NCT03237156|11931994|FG000|NOT COMPLETED|Overall Study||0
10768918|NCT03237156|11931995|FG001|NOT COMPLETED|Overall Study||0
10768919|NCT03237156|11931996|FG002|NOT COMPLETED|Overall Study||0
10768920|NCT03237156|11931997|FG003|NOT COMPLETED|Overall Study||0
10768921|NCT03237481|11932013|FG000|STARTED|Overall Study||164
10768922|NCT03237481|11932014|FG001|STARTED|Overall Study||172
10768923|NCT03237481|11932015|FG002|STARTED|Overall Study||82
10768924|NCT03237481|11932013|FG000|COMPLETED|Overall Study||159
10768925|NCT03237481|11932014|FG001|COMPLETED|Overall Study||170
10768926|NCT03237481|11932015|FG002|COMPLETED|Overall Study||81
10768927|NCT03237481|11932013|FG000|NOT COMPLETED|Overall Study||5
10768928|NCT03237481|11932014|FG001|NOT COMPLETED|Overall Study||2
10768929|NCT03237481|11932015|FG002|NOT COMPLETED|Overall Study||1
10768930|NCT03237845|11932025|FG000|STARTED|Overall Study||594
10768931|NCT03237845|11932026|FG001|STARTED|Overall Study||592
10768932|NCT03237845|11932025|FG000|Treated|Overall Study||543
10768933|NCT03237845|11932026|FG001|Treated|Overall Study||543
10768934|NCT03237845|11932025|FG000|COMPLETED|Overall Study||538
10768935|NCT03237845|11932026|FG001|COMPLETED|Overall Study||542
10768936|NCT03237845|11932025|FG000|NOT COMPLETED|Overall Study||56
10768937|NCT03237845|11932026|FG001|NOT COMPLETED|Overall Study||50
10768938|NCT03237871|11932032|FG000|STARTED|Overall Study||17
10768939|NCT03237871|11932032|FG000|COMPLETED|Overall Study||11
10768940|NCT03237871|11932032|FG000|NOT COMPLETED|Overall Study||6
10768941|NCT03238001|11932036|FG000|STARTED|Visit 1 (Primary Endpoint Cohort)||436
10768942|NCT03238001|11932036|FG000|COMPLETED|Visit 1 (Primary Endpoint Cohort)||432
10768943|NCT03238001|11932036|FG000|NOT COMPLETED|Visit 1 (Primary Endpoint Cohort)||4
10768944|NCT03238001|11932036|FG000|STARTED|Visit 2 (Secondary Endpoint Cohort)||432
10768945|NCT03238001|11932036|FG000|COMPLETED|Visit 2 (Secondary Endpoint Cohort)||403
10768946|NCT03238001|11932036|FG000|NOT COMPLETED|Visit 2 (Secondary Endpoint Cohort)||29
10768947|NCT03238352|11932051|FG000|STARTED|Overall Study||43
10768948|NCT03238352|11932052|FG001|STARTED|Overall Study||23
10768949|NCT03238352|11932053|FG002|STARTED|Overall Study||23
10768950|NCT03238352|11932051|FG000|COMPLETED|Overall Study||43
10768951|NCT03238352|11932052|FG001|COMPLETED|Overall Study||20
10768952|NCT03238352|11932053|FG002|COMPLETED|Overall Study||22
10768953|NCT03238352|11932051|FG000|NOT COMPLETED|Overall Study||0
10768954|NCT03238352|11932052|FG001|NOT COMPLETED|Overall Study||3
10768955|NCT03238352|11932053|FG002|NOT COMPLETED|Overall Study||1
10768956|NCT03238417|11932063|FG000|STARTED|Overall||1330
10768957|NCT03238417|11932064|FG001|STARTED|Overall||2632
10768958|NCT03238417|11932063|FG000|COMPLETED|Overall||327
10768959|NCT03238417|11932064|FG001|COMPLETED|Overall||644
10768960|NCT03238417|11932063|FG000|NOT COMPLETED|Overall||1003
10768961|NCT03238417|11932064|FG001|NOT COMPLETED|Overall||1988
10768962|NCT03238417|11932063|FG000|STARTED|Baseline||513
10768963|NCT03238417|11932064|FG001|STARTED|Baseline||934
10768964|NCT03238417|11932063|FG000|COMPLETED|Baseline||124
10768965|NCT03238417|11932064|FG001|COMPLETED|Baseline||217
10768966|NCT03238417|11932063|FG000|NOT COMPLETED|Baseline||389
10768967|NCT03238417|11932064|FG001|NOT COMPLETED|Baseline||717
10768968|NCT03238417|11932063|FG000|STARTED|12-month||400
10768969|NCT03238417|11932064|FG001|STARTED|12-month||911
10768970|NCT03238417|11932063|FG000|COMPLETED|12-month||81
10768971|NCT03238417|11932064|FG001|COMPLETED|12-month||205
10768972|NCT03238417|11932063|FG000|NOT COMPLETED|12-month||319
10768973|NCT03238417|11932064|FG001|NOT COMPLETED|12-month||706
10768974|NCT03238417|11932063|FG000|STARTED|24-month||417
10768975|NCT03238417|11932064|FG001|STARTED|24-month||847
10768976|NCT03238417|11932063|FG000|COMPLETED|24-month||122
10768977|NCT03238417|11932064|FG001|COMPLETED|24-month||222
10768978|NCT03238417|11932063|FG000|NOT COMPLETED|24-month||295
10768979|NCT03238417|11932064|FG001|NOT COMPLETED|24-month||625
10768980|NCT03238651|11932075|FG000|STARTED|Overall Study||3
10768981|NCT03238651|11932076|FG001|STARTED|Overall Study||6
10768982|NCT03238651|11932077|FG002|STARTED|Overall Study||4
10768983|NCT03238651|11932078|FG003|STARTED|Overall Study||3
10768984|NCT03238651|11932079|FG004|STARTED|Overall Study||1
10768985|NCT03238651|11932075|FG000|COMPLETED|Overall Study||0
10768986|NCT03238651|11932076|FG001|COMPLETED|Overall Study||0
10768987|NCT03238651|11932077|FG002|COMPLETED|Overall Study||0
10768988|NCT03238651|11932078|FG003|COMPLETED|Overall Study||0
10768989|NCT03238651|11932079|FG004|COMPLETED|Overall Study||0
10768990|NCT03238651|11932075|FG000|NOT COMPLETED|Overall Study||3
10768991|NCT03238651|11932076|FG001|NOT COMPLETED|Overall Study||6
10768992|NCT03238651|11932077|FG002|NOT COMPLETED|Overall Study||4
10768993|NCT03238651|11932078|FG003|NOT COMPLETED|Overall Study||3
10768994|NCT03238651|11932079|FG004|NOT COMPLETED|Overall Study||1
10768995|NCT03238781|11932095|FG000|STARTED|Overall Study||137
10768996|NCT03238781|11932096|FG001|STARTED|Overall Study||104
10768997|NCT03238781|11932097|FG002|STARTED|Overall Study||102
10768998|NCT03238781|11932095|FG000|COMPLETED|Overall Study||111
10768999|NCT03238781|11932096|FG001|COMPLETED|Overall Study||87
10769000|NCT03238781|11932097|FG002|COMPLETED|Overall Study||82
10769001|NCT03238781|11932095|FG000|NOT COMPLETED|Overall Study||26
10769002|NCT03238781|11932096|FG001|NOT COMPLETED|Overall Study||17
10769003|NCT03238781|11932097|FG002|NOT COMPLETED|Overall Study||20
10769004|NCT03238911|11932107|FG000|STARTED|Overall Study||62
10769005|NCT03238911|11932108|FG001|STARTED|Overall Study||61
10769006|NCT03238911|11932107|FG000|Safety Analysis Set|Overall Study|1 subject from ferric carboxymaltose group received iron isomaltoside/ferric derisomaltose in error.|63
10769007|NCT03238911|11932108|FG001|Safety Analysis Set|Overall Study|1 subject from ferric carboxymaltose group received iron isomaltoside/ferric derisomaltose in error.|60
10769008|NCT03238911|11932107|FG000|COMPLETED|Overall Study||59
10769009|NCT03238911|11932108|FG001|COMPLETED|Overall Study||58
10769010|NCT03238911|11932107|FG000|NOT COMPLETED|Overall Study||3
10769011|NCT03238911|11932108|FG001|NOT COMPLETED|Overall Study||3
10769012|NCT03238924|11932117|FG000|STARTED|Overall Study||8
10769013|NCT03238924|11932118|FG001|STARTED|Overall Study||9
10769014|NCT03238924|11932117|FG000|COMPLETED|Overall Study||6
10769015|NCT03238924|11932118|FG001|COMPLETED|Overall Study||7
10769016|NCT03238924|11932117|FG000|NOT COMPLETED|Overall Study||2
10769017|NCT03238924|11932118|FG001|NOT COMPLETED|Overall Study||2
10769018|NCT03238963|11932126|FG000|STARTED|Overall Study||40
10769019|NCT03238963|11932127|FG001|STARTED|Overall Study||39
10769020|NCT03238963|11932126|FG000|COMPLETED|Overall Study||35
10769021|NCT03238963|11932127|FG001|COMPLETED|Overall Study||37
10769022|NCT03238963|11932126|FG000|NOT COMPLETED|Overall Study||5
10769023|NCT03238963|11932127|FG001|NOT COMPLETED|Overall Study||2
10769024|NCT03239106|11932133|FG000|STARTED|Overall Study||10
10769025|NCT03239106|11932133|FG000|COMPLETED|Overall Study||3
10769026|NCT03239106|11932133|FG000|NOT COMPLETED|Overall Study||7
10769027|NCT03239470|11932138|FG000|STARTED|Blood Donation||5
10769028|NCT03239470|11932139|FG001|STARTED|Blood Donation||0
10769029|NCT03239470|11932138|FG000|COMPLETED|Blood Donation||5
10769030|NCT03239470|11932139|FG001|COMPLETED|Blood Donation||0
10769031|NCT03239470|11932138|FG000|NOT COMPLETED|Blood Donation||0
10769032|NCT03239470|11932139|FG001|NOT COMPLETED|Blood Donation||0
10769033|NCT03239470|11932138|FG000|STARTED|Polyclonal Treg Infusion|Started includes all participants who completed the pre-infusion checklist at the infusion visit.|5
10769034|NCT03239470|11932139|FG001|STARTED|Polyclonal Treg Infusion||0
10769035|NCT03239470|11932138|FG000|COMPLETED|Polyclonal Treg Infusion|Participants who did not meet eligibility, per the pre-infusion checklist, did not complete study infusion.|4
10769036|NCT03239470|11932139|FG001|COMPLETED|Polyclonal Treg Infusion||0
10769037|NCT03239470|11932138|FG000|NOT COMPLETED|Polyclonal Treg Infusion||1
10769038|NCT03239470|11932139|FG001|NOT COMPLETED|Polyclonal Treg Infusion||0
10769039|NCT03239483|11932145|FG000|STARTED|Overall Study||19
10769040|NCT03239483|11932146|FG001|STARTED|Overall Study||9
10769041|NCT03239483|11932145|FG000|COMPLETED|Overall Study||17
10769042|NCT03239483|11932146|FG001|COMPLETED|Overall Study||9
10769043|NCT03239483|11932145|FG000|NOT COMPLETED|Overall Study||2
10769044|NCT03239483|11932146|FG001|NOT COMPLETED|Overall Study||0
10769045|NCT03239496|11932156|FG000|STARTED|Overall Study||200
10769046|NCT03239496|11932157|FG001|STARTED|Overall Study||178
10769047|NCT03239496|11932158|FG002|STARTED|Overall Study||178
10769048|NCT03239496|11932159|FG003|STARTED|Overall Study||217
10769049|NCT03239496|11932156|FG000|COMPLETED|Overall Study||186
10769050|NCT03239496|11932157|FG001|COMPLETED|Overall Study||168
10769051|NCT03239496|11932158|FG002|COMPLETED|Overall Study||166
10769052|NCT03239496|11932159|FG003|COMPLETED|Overall Study||203
10769053|NCT03239496|11932156|FG000|NOT COMPLETED|Overall Study||14
10769054|NCT03239496|11932157|FG001|NOT COMPLETED|Overall Study||10
10769055|NCT03239496|11932158|FG002|NOT COMPLETED|Overall Study||12
10769056|NCT03239496|11932159|FG003|NOT COMPLETED|Overall Study||14
10769057|NCT03239522|11932173|FG000|STARTED|Treatment Period 1 (Up to 7 Days)||6
10769058|NCT03239522|11932173|FG000|COMPLETED|Treatment Period 1 (Up to 7 Days)||6
10769059|NCT03239522|11932173|FG000|NOT COMPLETED|Treatment Period 1 (Up to 7 Days)||0
10769060|NCT03239522|11932173|FG000|STARTED|Washout Period (Up to 7 Days)||6
10769061|NCT03239522|11932173|FG000|COMPLETED|Washout Period (Up to 7 Days)||6
10769062|NCT03239522|11932173|FG000|NOT COMPLETED|Washout Period (Up to 7 Days)||0
10769063|NCT03239522|11932173|FG000|STARTED|Treatment Period 2 (Up to 15 Days)||6
10769064|NCT03239522|11932173|FG000|COMPLETED|Treatment Period 2 (Up to 15 Days)||6
10769065|NCT03239522|11932173|FG000|NOT COMPLETED|Treatment Period 2 (Up to 15 Days)||0
10769066|NCT03239574|11932184|FG000|STARTED|Overall Study||34
10769067|NCT03239574|11932184|FG000|COMPLETED|Overall Study||34
10769068|NCT03239574|11932184|FG000|NOT COMPLETED|Overall Study||0
10769069|NCT03239665|11932190|FG000|STARTED|Overall Study||175
10769070|NCT03239665|11932191|FG001|STARTED|Overall Study||160
10769071|NCT03239665|11932190|FG000|Met Inclusion Criteria|Overall Study||150
10769072|NCT03239665|11932191|FG001|Met Inclusion Criteria|Overall Study||144
10769073|NCT03239665|11932190|FG000|Submitted Survey Data|Overall Study||147
10769074|NCT03239665|11932191|FG001|Submitted Survey Data|Overall Study||140
10769075|NCT03239665|11932190|FG000|COMPLETED|Overall Study||147
10769076|NCT03239665|11932191|FG001|COMPLETED|Overall Study||140
10769077|NCT03239665|11932190|FG000|NOT COMPLETED|Overall Study||28
10769078|NCT03239665|11932191|FG001|NOT COMPLETED|Overall Study||20
10769079|NCT03239873|11932199|FG000|STARTED|Overall Study||300
10769080|NCT03239873|11932200|FG001|STARTED|Overall Study||300
10769081|NCT03239873|11932199|FG000|Vaccination 1|Overall Study||299
10769082|NCT03239873|11932200|FG001|Vaccination 1|Overall Study||300
10769083|NCT03239873|11932199|FG000|Vaccination 2|Overall Study||276
10769084|NCT03239873|11932200|FG001|Vaccination 2|Overall Study||282
10769085|NCT03239873|11932199|FG000|COMPLETED|Overall Study||268
10769086|NCT03239873|11932200|FG001|COMPLETED|Overall Study||273
10769087|NCT03239873|11932199|FG000|NOT COMPLETED|Overall Study||32
10769088|NCT03239873|11932200|FG001|NOT COMPLETED|Overall Study||27
10769089|NCT03240081|11932208|FG000|STARTED|Overall Study||25
10769090|NCT03240081|11932209|FG001|STARTED|Overall Study||25
10769091|NCT03240081|11932208|FG000|COMPLETED|Overall Study||25
10769092|NCT03240081|11932209|FG001|COMPLETED|Overall Study||22
10769093|NCT03240081|11932208|FG000|NOT COMPLETED|Overall Study||0
10769094|NCT03240081|11932209|FG001|NOT COMPLETED|Overall Study||3
10769095|NCT03240133|11932218|FG000|STARTED|Overall Study||33
10769096|NCT03240133|11932219|FG001|STARTED|Overall Study||14
10769097|NCT03240133|11932220|FG002|STARTED|Overall Study||11
10769098|NCT03240133|11932218|FG000|Completed Period 1|Overall Study||33
10769099|NCT03240133|11932219|FG001|Completed Period 1|Overall Study||14
10769100|NCT03240133|11932220|FG002|Completed Period 1|Overall Study||11
10769101|NCT03240133|11932218|FG000|Completed Period 2|Overall Study||32
10769102|NCT03240133|11932219|FG001|Completed Period 2|Overall Study||11
10769103|NCT03240133|11932220|FG002|Completed Period 2|Overall Study||11
10769104|NCT03240133|11932218|FG000|Completed Period 3|Overall Study||30
10769105|NCT03240133|11932219|FG001|Completed Period 3|Overall Study||11
10769106|NCT03240133|11932220|FG002|Completed Period 3|Overall Study||11
10769107|NCT03240133|11932218|FG000|COMPLETED|Overall Study||30
10769108|NCT03240133|11932219|FG001|COMPLETED|Overall Study||11
10769109|NCT03240133|11932220|FG002|COMPLETED|Overall Study||10
10769110|NCT03240133|11932218|FG000|NOT COMPLETED|Overall Study||3
10769111|NCT03240133|11932219|FG001|NOT COMPLETED|Overall Study||3
10769112|NCT03240133|11932220|FG002|NOT COMPLETED|Overall Study||1
10297637|NCT00003659|11430198|FG000|STARTED|Overall Study||39
10769113|NCT03240575|11932248|FG000|STARTED|Overall Study||146
10769114|NCT03240575|11932249|FG001|STARTED|Overall Study||145
10769115|NCT03240575|11932250|FG002|STARTED|Overall Study||6
10769116|NCT03240575|11932251|FG003|STARTED|Overall Study||5
10769117|NCT03240575|11932248|FG000|COMPLETED|Overall Study||144
10769118|NCT03240575|11932249|FG001|COMPLETED|Overall Study||131
10769119|NCT03240575|11932250|FG002|COMPLETED|Overall Study||6
10769120|NCT03240575|11932251|FG003|COMPLETED|Overall Study||3
10769121|NCT03240575|11932248|FG000|NOT COMPLETED|Overall Study||2
10769122|NCT03240575|11932249|FG001|NOT COMPLETED|Overall Study||14
10769123|NCT03240575|11932250|FG002|NOT COMPLETED|Overall Study||0
10769124|NCT03240575|11932251|FG003|NOT COMPLETED|Overall Study||2
10769125|NCT03241030|11932261|FG000|STARTED|Overall Study||50
10769126|NCT03241030|11932262|FG001|STARTED|Overall Study||52
10769127|NCT03241030|11932261|FG000|COMPLETED|Overall Study||49
10769128|NCT03241030|11932262|FG001|COMPLETED|Overall Study||51
10769129|NCT03241030|11932261|FG000|NOT COMPLETED|Overall Study||1
10769130|NCT03241030|11932262|FG001|NOT COMPLETED|Overall Study||1
10769131|NCT03241342|11932271|FG000|STARTED|Overall Study||163
10769132|NCT03241342|11932272|FG001|STARTED|Overall Study||163
10769133|NCT03241342|11932273|FG002|STARTED|Overall Study||165
10769134|NCT03241342|11932271|FG000|COMPLETED|Overall Study||141
10769135|NCT03241342|11932272|FG001|COMPLETED|Overall Study||132
10769136|NCT03241342|11932273|FG002|COMPLETED|Overall Study||138
10769137|NCT03241342|11932271|FG000|NOT COMPLETED|Overall Study||22
10769138|NCT03241342|11932272|FG001|NOT COMPLETED|Overall Study||31
10769139|NCT03241342|11932273|FG002|NOT COMPLETED|Overall Study||27
10769140|NCT03241368|11932281|FG000|STARTED|Overall Study||158
10769141|NCT03241368|11932281|FG000|COMPLETED|Overall Study||119
10769142|NCT03241368|11932281|FG000|NOT COMPLETED|Overall Study||39
10769143|NCT03241485|11932288|FG000|STARTED|Overall Study||42
10769144|NCT03241485|11932289|FG001|STARTED|Overall Study||37
10769145|NCT03241485|11932288|FG000|COMPLETED|Overall Study||37
10769146|NCT03241485|11932289|FG001|COMPLETED|Overall Study||33
10769147|NCT03241485|11932288|FG000|NOT COMPLETED|Overall Study||5
10769148|NCT03241485|11932289|FG001|NOT COMPLETED|Overall Study||4
10769149|NCT03241810|11932301|FG000|STARTED|Overall Study||11
10769150|NCT03241810|11932302|FG001|STARTED|Overall Study||11
10769151|NCT03241810|11932301|FG000|COMPLETED|Overall Study|Safety population: includes patients receiving at least one dose of study medication.|11
10769152|NCT03241810|11932302|FG001|COMPLETED|Overall Study|Safety population: includes patients receiving at least one dose of study medication.|11
10769153|NCT03241810|11932301|FG000|NOT COMPLETED|Overall Study||0
10769154|NCT03241810|11932302|FG001|NOT COMPLETED|Overall Study||0
10769155|NCT03241862|11932309|FG000|STARTED|Overall Study||20
10769156|NCT03241862|11932309|FG000|COMPLETED|Overall Study||20
10769157|NCT03241862|11932309|FG000|NOT COMPLETED|Overall Study||0
10769158|NCT03241927|11932313|FG000|STARTED|Overall Study||1
10769159|NCT03241927|11932314|FG001|STARTED|Overall Study||0
10769160|NCT03241927|11932313|FG000|COMPLETED|Overall Study||0
10769161|NCT03241927|11932314|FG001|COMPLETED|Overall Study||0
10769162|NCT03241927|11932313|FG000|NOT COMPLETED|Overall Study||1
10769163|NCT03241927|11932314|FG001|NOT COMPLETED|Overall Study||0
10769164|NCT03242018|11932323|FG000|STARTED|Overall Study||93
10769165|NCT03242018|11932324|FG001|STARTED|Overall Study||92
10769166|NCT03242018|11932325|FG002|STARTED|Overall Study||92
10769167|NCT03242018|11932323|FG000|COMPLETED|Overall Study||75
10769168|NCT03242018|11932324|FG001|COMPLETED|Overall Study||78
10769169|NCT03242018|11932325|FG002|COMPLETED|Overall Study||78
10769170|NCT03242018|11932323|FG000|NOT COMPLETED|Overall Study||18
10769171|NCT03242018|11932324|FG001|NOT COMPLETED|Overall Study||14
10769172|NCT03242018|11932325|FG002|NOT COMPLETED|Overall Study||14
10769173|NCT03242148|11932334|FG000|STARTED|Overall Study||38
10769174|NCT03242148|11932334|FG000|COMPLETED|Overall Study||38
10769175|NCT03242148|11932334|FG000|NOT COMPLETED|Overall Study||0
10769176|NCT03242252|11932341|FG000|STARTED|Overall Study||260
10769177|NCT03242252|11932342|FG001|STARTED|Overall Study||263
10769178|NCT03242252|11932343|FG002|STARTED|Overall Study||264
10769179|NCT03242252|11932341|FG000|COMPLETED|Overall Study||224
10769180|NCT03242252|11932342|FG001|COMPLETED|Overall Study||240
10769181|NCT03242252|11932343|FG002|COMPLETED|Overall Study||232
10769182|NCT03242252|11932341|FG000|NOT COMPLETED|Overall Study||36
10769183|NCT03242252|11932342|FG001|NOT COMPLETED|Overall Study||23
10769184|NCT03242252|11932343|FG002|NOT COMPLETED|Overall Study||32
10769185|NCT03242408|11932357|FG000|STARTED|Overall Study||100
10769186|NCT03242408|11932357|FG000|COMPLETED|Overall Study||98
10769187|NCT03242408|11932357|FG000|NOT COMPLETED|Overall Study||2
10769188|NCT03242434|11932363|FG000|STARTED|Overall Study||15
10769189|NCT03242434|11932364|FG001|STARTED|Overall Study||3
10769190|NCT03242434|11932363|FG000|COMPLETED|Overall Study||15
10769191|NCT03242434|11932364|FG001|COMPLETED|Overall Study||1
10769192|NCT03242434|11932363|FG000|NOT COMPLETED|Overall Study||0
10769193|NCT03242434|11932364|FG001|NOT COMPLETED|Overall Study||2
10769194|NCT03242590|11932371|FG000|STARTED|Overall Study||95
10769195|NCT03242590|11932371|FG000|COMPLETED|Overall Study||95
10769196|NCT03242590|11932371|FG000|NOT COMPLETED|Overall Study||0
10769197|NCT03242759|11932377|FG000|STARTED|Overall Study||88
10769198|NCT03242759|11932378|FG001|STARTED|Overall Study||13
10769199|NCT03242759|11932377|FG000|COMPLETED|Overall Study||53
10769200|NCT03242759|11932378|FG001|COMPLETED|Overall Study||6
10769201|NCT03242759|11932377|FG000|NOT COMPLETED|Overall Study||35
10769202|NCT03242759|11932378|FG001|NOT COMPLETED|Overall Study||7
10769203|NCT03242863|11932384|FG000|STARTED|Study Week 1||13
10769204|NCT03242863|11932385|FG001|STARTED|Study Week 1||16
10769205|NCT03242863|11932386|FG002|STARTED|Study Week 1||4
10769206|NCT03242863|11932387|FG003|STARTED|Study Week 1||4
10769207|NCT03242863|11932388|FG004|STARTED|Study Week 1||15
10769208|NCT03242863|11932389|FG005|STARTED|Study Week 1||5
10769209|NCT03242863|11932384|FG000|COMPLETED|Study Week 1||13
10769210|NCT03242863|11932385|FG001|COMPLETED|Study Week 1||15
10769211|NCT03242863|11932386|FG002|COMPLETED|Study Week 1||4
10769212|NCT03242863|11932387|FG003|COMPLETED|Study Week 1||4
10769213|NCT03242863|11932388|FG004|COMPLETED|Study Week 1||12
10769214|NCT03242863|11932389|FG005|COMPLETED|Study Week 1||5
10769215|NCT03242863|11932384|FG000|NOT COMPLETED|Study Week 1||0
10769216|NCT03242863|11932385|FG001|NOT COMPLETED|Study Week 1||1
10769217|NCT03242863|11932386|FG002|NOT COMPLETED|Study Week 1||0
10769218|NCT03242863|11932387|FG003|NOT COMPLETED|Study Week 1||0
10769219|NCT03242863|11932388|FG004|NOT COMPLETED|Study Week 1||3
10769220|NCT03242863|11932389|FG005|NOT COMPLETED|Study Week 1||0
10769221|NCT03242863|11932384|FG000|STARTED|Study Week 2||13
10769222|NCT03242863|11932385|FG001|STARTED|Study Week 2||15
10769223|NCT03242863|11932386|FG002|STARTED|Study Week 2||4
10769224|NCT03242863|11932387|FG003|STARTED|Study Week 2||4
10769225|NCT03242863|11932388|FG004|STARTED|Study Week 2||12
10769226|NCT03242863|11932389|FG005|STARTED|Study Week 2||5
10769227|NCT03242863|11932384|FG000|COMPLETED|Study Week 2||13
10769228|NCT03242863|11932385|FG001|COMPLETED|Study Week 2||15
10769229|NCT03242863|11932386|FG002|COMPLETED|Study Week 2||4
10769230|NCT03242863|11932387|FG003|COMPLETED|Study Week 2||4
10769231|NCT03242863|11932388|FG004|COMPLETED|Study Week 2||12
10769232|NCT03242863|11932389|FG005|COMPLETED|Study Week 2||5
10769233|NCT03242863|11932384|FG000|NOT COMPLETED|Study Week 2||0
10769234|NCT03242863|11932385|FG001|NOT COMPLETED|Study Week 2||0
10769235|NCT03242863|11932386|FG002|NOT COMPLETED|Study Week 2||0
10769236|NCT03242863|11932387|FG003|NOT COMPLETED|Study Week 2||0
10769237|NCT03242863|11932388|FG004|NOT COMPLETED|Study Week 2||0
10769238|NCT03242863|11932389|FG005|NOT COMPLETED|Study Week 2||0
10769239|NCT03242863|11932384|FG000|STARTED|Study Week 3||13
10769240|NCT03242863|11932385|FG001|STARTED|Study Week 3||15
10769241|NCT03242863|11932386|FG002|STARTED|Study Week 3||4
10769242|NCT03242863|11932387|FG003|STARTED|Study Week 3||4
10769243|NCT03242863|11932388|FG004|STARTED|Study Week 3||12
10769244|NCT03242863|11932389|FG005|STARTED|Study Week 3||5
10769245|NCT03242863|11932384|FG000|COMPLETED|Study Week 3||13
10769246|NCT03242863|11932385|FG001|COMPLETED|Study Week 3||15
10769247|NCT03242863|11932386|FG002|COMPLETED|Study Week 3||4
10769248|NCT03242863|11932387|FG003|COMPLETED|Study Week 3||4
10769249|NCT03242863|11932388|FG004|COMPLETED|Study Week 3||12
10769250|NCT03242863|11932389|FG005|COMPLETED|Study Week 3||5
10769251|NCT03242863|11932384|FG000|NOT COMPLETED|Study Week 3||0
10769252|NCT03242863|11932385|FG001|NOT COMPLETED|Study Week 3||0
10769253|NCT03242863|11932386|FG002|NOT COMPLETED|Study Week 3||0
10769254|NCT03242863|11932387|FG003|NOT COMPLETED|Study Week 3||0
10769255|NCT03242863|11932388|FG004|NOT COMPLETED|Study Week 3||0
10769256|NCT03242863|11932389|FG005|NOT COMPLETED|Study Week 3||0
10769257|NCT03242928|11932399|FG000|STARTED|Overall Study||31
10769258|NCT03242928|11932400|FG001|STARTED|Overall Study||37
10769259|NCT03242928|11932399|FG000|COMPLETED|Overall Study||22
10769260|NCT03242928|11932400|FG001|COMPLETED|Overall Study||32
10769261|NCT03242928|11932399|FG000|NOT COMPLETED|Overall Study||9
10769262|NCT03242928|11932400|FG001|NOT COMPLETED|Overall Study||5
10769263|NCT03242941|11932406|FG000|STARTED|Overall Study||16
10769264|NCT03242941|11932406|FG000|COMPLETED|Overall Study||14
10769265|NCT03242941|11932406|FG000|NOT COMPLETED|Overall Study||2
10769266|NCT03242954|11932415|FG000|STARTED|Overall Study||43
10769267|NCT03242954|11932416|FG001|STARTED|Overall Study||45
10769268|NCT03242954|11932417|FG002|STARTED|Overall Study||41
10769269|NCT03242954|11932418|FG003|STARTED|Overall Study||125
10769270|NCT03242954|11932415|FG000|COMPLETED|Overall Study||43
10769271|NCT03242954|11932416|FG001|COMPLETED|Overall Study||45
10297638|NCT00003659|11430198|FG000|COMPLETED|Overall Study||36
10297639|NCT00003659|11430198|FG000|NOT COMPLETED|Overall Study||3
10297640|NCT00003702|11430204|FG000|STARTED|Overall Study||120
10297641|NCT00003702|11430205|FG001|STARTED|Overall Study||120
10297642|NCT00003702|11430204|FG000|COMPLETED|Overall Study||107
10297643|NCT00003702|11430205|FG001|COMPLETED|Overall Study||109
10297644|NCT00003702|11430204|FG000|NOT COMPLETED|Overall Study||13
10297645|NCT00003702|11430205|FG001|NOT COMPLETED|Overall Study||11
10297646|NCT00003782|11430215|FG000|STARTED|Overall Study||1783
10297647|NCT00003782|11430216|FG001|STARTED|Overall Study||1784
10297648|NCT00003782|11430217|FG002|STARTED|Overall Study||1784
10297649|NCT00003782|11430215|FG000|COMPLETED|Overall Study||1753
10297650|NCT00003782|11430216|FG001|COMPLETED|Overall Study||1753
10297651|NCT00003782|11430217|FG002|COMPLETED|Overall Study||1758
10297652|NCT00003782|11430215|FG000|NOT COMPLETED|Overall Study||30
10297653|NCT00003782|11430216|FG001|NOT COMPLETED|Overall Study||31
10297654|NCT00003782|11430217|FG002|NOT COMPLETED|Overall Study||26
10297655|NCT00003816|11430230|FG000|STARTED|Overall Study||55
10297656|NCT00003816|11430231|FG001|STARTED|Overall Study||69
10297657|NCT00003816|11430232|FG002|STARTED|Overall Study||199
10297658|NCT00003816|11430233|FG003|STARTED|Overall Study||23
10297659|NCT00003816|11430234|FG004|STARTED|Overall Study||15
10297660|NCT00003816|11430230|FG000|COMPLETED|Overall Study||55
10297661|NCT00003816|11430231|FG001|COMPLETED|Overall Study||69
10297662|NCT00003816|11430232|FG002|COMPLETED|Overall Study||199
10297663|NCT00003816|11430233|FG003|COMPLETED|Overall Study||23
10297664|NCT00003816|11430234|FG004|COMPLETED|Overall Study||15
10297665|NCT00003816|11430230|FG000|NOT COMPLETED|Overall Study||0
10297666|NCT00003816|11430231|FG001|NOT COMPLETED|Overall Study||0
10297667|NCT00003816|11430232|FG002|NOT COMPLETED|Overall Study||0
10769272|NCT03242954|11932417|FG002|COMPLETED|Overall Study||41
10769273|NCT03242954|11932418|FG003|COMPLETED|Overall Study||125
10769274|NCT03242954|11932415|FG000|NOT COMPLETED|Overall Study||0
10769275|NCT03242954|11932416|FG001|NOT COMPLETED|Overall Study||0
10297668|NCT00003816|11430233|FG003|NOT COMPLETED|Overall Study||0
10297669|NCT00003816|11430234|FG004|NOT COMPLETED|Overall Study||0
10297670|NCT00003820|11430246|FG000|STARTED|Cycle 1 (Initial Treatment)||23
10297671|NCT00003820|11430247|FG001|STARTED|Cycle 1 (Initial Treatment)||16
10297672|NCT00003820|11430246|FG000|COMPLETED|Cycle 1 (Initial Treatment)||23
10297673|NCT00003820|11430247|FG001|COMPLETED|Cycle 1 (Initial Treatment)||16
10297674|NCT00003820|11430246|FG000|NOT COMPLETED|Cycle 1 (Initial Treatment)||0
10297675|NCT00003820|11430247|FG001|NOT COMPLETED|Cycle 1 (Initial Treatment)||0
10297676|NCT00003820|11430246|FG000|STARTED|Cycle 2 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
10769276|NCT03242954|11932417|FG002|NOT COMPLETED|Overall Study||0
10769277|NCT03242954|11932418|FG003|NOT COMPLETED|Overall Study||0
10769278|NCT03243084|11932430|FG000|STARTED|Session 1||11
10769279|NCT03243084|11932431|FG001|STARTED|Session 1||10
10769280|NCT03243084|11932430|FG000|COMPLETED|Session 1||11
10769281|NCT03243084|11932431|FG001|COMPLETED|Session 1||10
10769282|NCT03243084|11932430|FG000|NOT COMPLETED|Session 1||0
10769283|NCT03243084|11932431|FG001|NOT COMPLETED|Session 1||0
10769284|NCT03243084|11932430|FG000|STARTED|Washout (1-3 Weeks)||11
10769285|NCT03243084|11932431|FG001|STARTED|Washout (1-3 Weeks)||10
10769286|NCT03243084|11932430|FG000|COMPLETED|Washout (1-3 Weeks)||10
10769287|NCT03243084|11932431|FG001|COMPLETED|Washout (1-3 Weeks)||10
10769288|NCT03243084|11932430|FG000|NOT COMPLETED|Washout (1-3 Weeks)||1
10769289|NCT03243084|11932431|FG001|NOT COMPLETED|Washout (1-3 Weeks)||0
10769290|NCT03243084|11932430|FG000|STARTED|Session 2||10
10769291|NCT03243084|11932431|FG001|STARTED|Session 2||10
10769292|NCT03243084|11932430|FG000|COMPLETED|Session 2||10
10769293|NCT03243084|11932431|FG001|COMPLETED|Session 2||10
10769294|NCT03243084|11932430|FG000|NOT COMPLETED|Session 2||0
10769295|NCT03243084|11932431|FG001|NOT COMPLETED|Session 2||0
10769296|NCT03243305|11932438|FG000|STARTED|Overall Study||1384
10769297|NCT03243305|11932438|FG000|COMPLETED|Overall Study||449
10769298|NCT03243305|11932438|FG000|NOT COMPLETED|Overall Study||935
10769299|NCT03243630|11932442|FG000|STARTED|Overall Study||24
10769300|NCT03243630|11932442|FG000|Menthol E-liquid Saline|Overall Study||22
10769301|NCT03243630|11932442|FG000|Menthol E-liquid Higher|Overall Study||22
10769302|NCT03243630|11932442|FG000|Menthol E-liquid Lower|Overall Study||22
10769303|NCT03243630|11932442|FG000|Green Apple E-liquid Saline|Overall Study||20
10769304|NCT03243630|11932442|FG000|Green Apple E-liquid Higher|Overall Study||20
10769305|NCT03243630|11932442|FG000|Green Apple E-liquid Lower|Overall Study||20
10769306|NCT03243630|11932442|FG000|Green Apple and Menthol E-liquid Saline|Overall Study||21
10769307|NCT03243630|11932442|FG000|Green Apple and Menthol E-liquid Higher|Overall Study||21
10769308|NCT03243630|11932442|FG000|Green Apple and Menthol E-liquid Lower|Overall Study||21
10769309|NCT03243630|11932442|FG000|COMPLETED|Overall Study||22
10769310|NCT03243630|11932442|FG000|NOT COMPLETED|Overall Study||2
10769311|NCT03243981|11932450|FG000|STARTED|Overall Study||5
10769312|NCT03243981|11932450|FG000|COMPLETED|Overall Study||5
10769313|NCT03243981|11932450|FG000|NOT COMPLETED|Overall Study||0
10769314|NCT03244618|11932461|FG000|STARTED|Overall Study||132
10769315|NCT03244618|11932462|FG001|STARTED|Overall Study||131
10769316|NCT03244618|11932461|FG000|Week 2|Overall Study||128
10769317|NCT03244618|11932462|FG001|Week 2|Overall Study||125
10769318|NCT03244618|11932461|FG000|COMPLETED|Overall Study||125
10769319|NCT03244618|11932462|FG001|COMPLETED|Overall Study||122
10769320|NCT03244618|11932461|FG000|NOT COMPLETED|Overall Study||7
10769321|NCT03244618|11932462|FG001|NOT COMPLETED|Overall Study||9
10769322|NCT03244800|11932472|FG000|STARTED|Overall Study||13
10769323|NCT03244800|11932473|FG001|STARTED|Overall Study||26
10769324|NCT03244800|11932474|FG002|STARTED|Overall Study||6
10769325|NCT03244800|11932475|FG003|STARTED|Overall Study||20
10769326|NCT03244800|11932472|FG000|COMPLETED|Overall Study||13
10769327|NCT03244800|11932473|FG001|COMPLETED|Overall Study||25
10769328|NCT03244800|11932474|FG002|COMPLETED|Overall Study||6
10769329|NCT03244800|11932475|FG003|COMPLETED|Overall Study||18
10769330|NCT03244800|11932472|FG000|NOT COMPLETED|Overall Study||0
10769331|NCT03244800|11932473|FG001|NOT COMPLETED|Overall Study||1
10769332|NCT03244800|11932474|FG002|NOT COMPLETED|Overall Study||0
10769333|NCT03244800|11932475|FG003|NOT COMPLETED|Overall Study||2
10769334|NCT03244865|11932488|FG000|STARTED|Overall Study||35
10769335|NCT03244865|11932488|FG000|COMPLETED|Overall Study||35
10769336|NCT03244865|11932488|FG000|NOT COMPLETED|Overall Study||0
10769337|NCT03244917|11932494|FG000|STARTED|Overall Study||201
10769338|NCT03244917|11932495|FG001|STARTED|Overall Study||229
10769339|NCT03244917|11932494|FG000|COMPLETED|Overall Study||199
10769340|NCT03244917|11932495|FG001|COMPLETED|Overall Study||227
10769341|NCT03244917|11932494|FG000|NOT COMPLETED|Overall Study||2
10769342|NCT03244917|11932495|FG001|NOT COMPLETED|Overall Study||2
10769343|NCT03245372|11932503|FG000|STARTED|Overall Study||15
10315654|NCT00181714|11449603|FG000|STARTED|Began Treatment With OROS-MPH||154
10769344|NCT03245372|11932504|FG001|STARTED|Overall Study||15
10769345|NCT03245372|11932503|FG000|COMPLETED|Overall Study||15
10769346|NCT03245372|11932504|FG001|COMPLETED|Overall Study||15
10769347|NCT03245372|11932503|FG000|NOT COMPLETED|Overall Study||0
10769348|NCT03245372|11932504|FG001|NOT COMPLETED|Overall Study||0
10769349|NCT03245398|11932512|FG000|STARTED|Overall Study||93
10769350|NCT03245398|11932513|FG001|STARTED|Overall Study||93
10769351|NCT03245398|11932512|FG000|COMPLETED|Overall Study||92
10769352|NCT03245398|11932513|FG001|COMPLETED|Overall Study||93
10769353|NCT03245398|11932512|FG000|NOT COMPLETED|Overall Study||1
10769354|NCT03245398|11932513|FG001|NOT COMPLETED|Overall Study||0
10769355|NCT03245463|11932523|FG000|STARTED|Overall Study||12
10769356|NCT03245463|11932524|FG001|STARTED|Overall Study||12
10769357|NCT03245463|11932523|FG000|COMPLETED|Overall Study||12
10769358|NCT03245463|11932524|FG001|COMPLETED|Overall Study||12
10769359|NCT03245463|11932523|FG000|NOT COMPLETED|Overall Study||0
10769360|NCT03245463|11932524|FG001|NOT COMPLETED|Overall Study||0
10769361|NCT03245619|11932547|FG000|STARTED|Part A (Up to Day 22)||5
10769362|NCT03245619|11932548|FG001|STARTED|Part A (Up to Day 22)||6
10769363|NCT03245619|11932549|FG002|STARTED|Part A (Up to Day 22)||6
10769364|NCT03245619|11932550|FG003|STARTED|Part A (Up to Day 22)||1
10769365|NCT03245619|11932551|FG004|STARTED|Part A (Up to Day 22)||0
10769366|NCT03245619|11932552|FG005|STARTED|Part A (Up to Day 22)||0
10769367|NCT03245619|11932553|FG006|STARTED|Part A (Up to Day 22)||0
10769368|NCT03245619|11932554|FG007|STARTED|Part A (Up to Day 22)||0
10769369|NCT03245619|11932555|FG008|STARTED|Part A (Up to Day 22)||0
10769370|NCT03245619|11932556|FG009|STARTED|Part A (Up to Day 22)||0
10769371|NCT03245619|11932557|FG010|STARTED|Part A (Up to Day 22)||0
10769372|NCT03245619|11932558|FG011|STARTED|Part A (Up to Day 22)||0
10769373|NCT03245619|11932559|FG012|STARTED|Part A (Up to Day 22)||0
10769374|NCT03245619|11932560|FG013|STARTED|Part A (Up to Day 22)||0
10769375|NCT03245619|11932561|FG014|STARTED|Part A (Up to Day 22)||0
10769376|NCT03245619|11932562|FG015|STARTED|Part A (Up to Day 22)||0
10769377|NCT03245619|11932563|FG016|STARTED|Part A (Up to Day 22)||0
10769378|NCT03245619|11932547|FG000|COMPLETED|Part A (Up to Day 22)||1
10769379|NCT03245619|11932548|FG001|COMPLETED|Part A (Up to Day 22)||0
10769380|NCT03245619|11932549|FG002|COMPLETED|Part A (Up to Day 22)||0
10769381|NCT03245619|11932550|FG003|COMPLETED|Part A (Up to Day 22)||1
10769382|NCT03245619|11932551|FG004|COMPLETED|Part A (Up to Day 22)||0
10769383|NCT03245619|11932552|FG005|COMPLETED|Part A (Up to Day 22)||0
10769384|NCT03245619|11932553|FG006|COMPLETED|Part A (Up to Day 22)||0
10769385|NCT03245619|11932554|FG007|COMPLETED|Part A (Up to Day 22)||0
10769386|NCT03245619|11932555|FG008|COMPLETED|Part A (Up to Day 22)||0
10769387|NCT03245619|11932556|FG009|COMPLETED|Part A (Up to Day 22)||0
10769388|NCT03245619|11932557|FG010|COMPLETED|Part A (Up to Day 22)||0
10769389|NCT03245619|11932558|FG011|COMPLETED|Part A (Up to Day 22)||0
10769390|NCT03245619|11932559|FG012|COMPLETED|Part A (Up to Day 22)||0
10297677|NCT00003820|11430247|FG001|STARTED|Cycle 2 (Maintenance Treatment)|Pts with treatment response/stable disease at 6 mos, & eligible to continue.|16
10297678|NCT00003820|11430246|FG000|COMPLETED|Cycle 2 (Maintenance Treatment)||0
10297679|NCT00003820|11430247|FG001|COMPLETED|Cycle 2 (Maintenance Treatment)|Patients with treatment assessment at 12 months|16
10297680|NCT00003820|11430246|FG000|NOT COMPLETED|Cycle 2 (Maintenance Treatment)||0
10297681|NCT00003820|11430247|FG001|NOT COMPLETED|Cycle 2 (Maintenance Treatment)||0
10297682|NCT00003820|11430246|FG000|STARTED|Cycle 3 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
10297683|NCT00003820|11430247|FG001|STARTED|Cycle 3 (Maintenance Treatment)|Patients with treatment response/stable disease at 12 months|16
10297684|NCT00003820|11430246|FG000|COMPLETED|Cycle 3 (Maintenance Treatment)||0
10297685|NCT00003820|11430247|FG001|COMPLETED|Cycle 3 (Maintenance Treatment)|Patients with treatment assessment at 18 months|16
10297686|NCT00003820|11430246|FG000|NOT COMPLETED|Cycle 3 (Maintenance Treatment)||0
10297687|NCT00003820|11430247|FG001|NOT COMPLETED|Cycle 3 (Maintenance Treatment)||0
10297688|NCT00003820|11430246|FG000|STARTED|Cycle 4 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
10297689|NCT00003820|11430247|FG001|STARTED|Cycle 4 (Maintenance Treatment)|Patients with treatment response/stable disease at 18 months|16
10297690|NCT00003820|11430246|FG000|COMPLETED|Cycle 4 (Maintenance Treatment)||0
10297691|NCT00003820|11430247|FG001|COMPLETED|Cycle 4 (Maintenance Treatment)|Patients with treatment assessment at 24 months|16
10297692|NCT00003820|11430246|FG000|NOT COMPLETED|Cycle 4 (Maintenance Treatment)||0
10297693|NCT00003820|11430247|FG001|NOT COMPLETED|Cycle 4 (Maintenance Treatment)||0
10297694|NCT00003830|11430255|FG000|STARTED|Overall Study||2807
10297695|NCT00003830|11430256|FG001|STARTED|Overall Study||2804
10297696|NCT00003830|11430255|FG000|COMPLETED|Overall Study||1975
10297697|NCT00003830|11430256|FG001|COMPLETED|Overall Study||2011
10297698|NCT00003830|11430255|FG000|NOT COMPLETED|Overall Study||832
10297699|NCT00003830|11430256|FG001|NOT COMPLETED|Overall Study||793
10297700|NCT00003869|11430266|FG000|STARTED|Overall Study||94
10297701|NCT00003869|11430267|FG001|STARTED|Overall Study||92
10297702|NCT00003869|11430266|FG000|COMPLETED|Overall Study||53
10297703|NCT00003869|11430267|FG001|COMPLETED|Overall Study||80
10297704|NCT00003869|11430266|FG000|NOT COMPLETED|Overall Study||41
10297705|NCT00003869|11430267|FG001|NOT COMPLETED|Overall Study||12
10297706|NCT00003875|11430273|FG000|STARTED|Overall Study||30
10297707|NCT00003875|11430273|FG000|COMPLETED|Overall Study||29
10297708|NCT00003875|11430273|FG000|NOT COMPLETED|Overall Study||1
10297709|NCT00003895|11430279|FG000|STARTED|Overall Study||18
10297710|NCT00003895|11430280|FG001|STARTED|Overall Study||18
10297711|NCT00003895|11430279|FG000|COMPLETED|Overall Study||11
10297712|NCT00003895|11430280|FG001|COMPLETED|Overall Study||14
10297713|NCT00003895|11430279|FG000|NOT COMPLETED|Overall Study||7
10297714|NCT00003895|11430280|FG001|NOT COMPLETED|Overall Study||4
10297715|NCT00003896|11430286|FG000|STARTED|Overall Study||68
10421669|NCT00820443|11566533|FG000|COMPLETED|Op||253
10297716|NCT00003896|11430286|FG000|Eligible|Overall Study|2 eligible patients did not have any toxicity assessments reported.|63
10297717|NCT00003896|11430286|FG000|COMPLETED|Overall Study||39
10297718|NCT00003896|11430286|FG000|NOT COMPLETED|Overall Study||29
10297719|NCT00003901|11430291|FG000|STARTED|Overall Study||1047
10769391|NCT03245619|11932560|FG013|COMPLETED|Part A (Up to Day 22)||0
10769392|NCT03245619|11932561|FG014|COMPLETED|Part A (Up to Day 22)||0
10769393|NCT03245619|11932562|FG015|COMPLETED|Part A (Up to Day 22)||0
10769394|NCT03245619|11932563|FG016|COMPLETED|Part A (Up to Day 22)||0
10769395|NCT03245619|11932547|FG000|NOT COMPLETED|Part A (Up to Day 22)||4
10769396|NCT03245619|11932548|FG001|NOT COMPLETED|Part A (Up to Day 22)||6
10769397|NCT03245619|11932549|FG002|NOT COMPLETED|Part A (Up to Day 22)||6
10769398|NCT03245619|11932550|FG003|NOT COMPLETED|Part A (Up to Day 22)||0
10769399|NCT03245619|11932551|FG004|NOT COMPLETED|Part A (Up to Day 22)||0
10769400|NCT03245619|11932552|FG005|NOT COMPLETED|Part A (Up to Day 22)||0
10769401|NCT03245619|11932553|FG006|NOT COMPLETED|Part A (Up to Day 22)||0
10769402|NCT03245619|11932554|FG007|NOT COMPLETED|Part A (Up to Day 22)||0
10769403|NCT03245619|11932555|FG008|NOT COMPLETED|Part A (Up to Day 22)||0
10769404|NCT03245619|11932556|FG009|NOT COMPLETED|Part A (Up to Day 22)||0
10769405|NCT03245619|11932557|FG010|NOT COMPLETED|Part A (Up to Day 22)||0
10769406|NCT03245619|11932558|FG011|NOT COMPLETED|Part A (Up to Day 22)||0
10769407|NCT03245619|11932559|FG012|NOT COMPLETED|Part A (Up to Day 22)||0
10769408|NCT03245619|11932560|FG013|NOT COMPLETED|Part A (Up to Day 22)||0
10769409|NCT03245619|11932561|FG014|NOT COMPLETED|Part A (Up to Day 22)||0
10769410|NCT03245619|11932562|FG015|NOT COMPLETED|Part A (Up to Day 22)||0
10297720|NCT00003901|11430291|FG000|COMPLETED|Overall Study||1030
10297721|NCT00003901|11430291|FG000|NOT COMPLETED|Overall Study||17
10297722|NCT00003907|11430300|FG000|STARTED|Overall Study||19
10297723|NCT00003907|11430301|FG001|STARTED|Overall Study||31
10297724|NCT00003907|11430300|FG000|Eligible|Overall Study||18
10297725|NCT00003907|11430301|FG001|Eligible|Overall Study||29
10297726|NCT00003907|11430300|FG000|Received Protocol Therapy (Treated)|Overall Study||18
10297727|NCT00003907|11430301|FG001|Received Protocol Therapy (Treated)|Overall Study||31
10297728|NCT00003907|11430300|FG000|Eligible and Treated|Overall Study||17
10297729|NCT00003907|11430301|FG001|Eligible and Treated|Overall Study||29
10297730|NCT00003907|11430300|FG000|COMPLETED|Overall Study||6
10297731|NCT00003907|11430301|FG001|COMPLETED|Overall Study||8
10297732|NCT00003907|11430300|FG000|NOT COMPLETED|Overall Study||13
10297733|NCT00003907|11430301|FG001|NOT COMPLETED|Overall Study||23
10297734|NCT00003910|11430307|FG000|STARTED|Step 1|Of 59 (step 1), 4 pts were ineligible.|55
10297735|NCT00003910|11430308|FG001|STARTED|Step 1||0
10297736|NCT00003910|11430307|FG000|COMPLETED|Step 1||55
10297737|NCT00003910|11430308|FG001|COMPLETED|Step 1||0
10297738|NCT00003910|11430307|FG000|NOT COMPLETED|Step 1||0
10297739|NCT00003910|11430308|FG001|NOT COMPLETED|Step 1||0
10297740|NCT00003910|11430307|FG000|STARTED|Step 2||0
10297741|NCT00003910|11430308|FG001|STARTED|Step 2|The 16 includes 2 ineligible pts.|16
10297742|NCT00003910|11430307|FG000|COMPLETED|Step 2||0
10297743|NCT00003910|11430308|FG001|COMPLETED|Step 2||16
10297744|NCT00003910|11430307|FG000|NOT COMPLETED|Step 2||0
10297745|NCT00003910|11430308|FG001|NOT COMPLETED|Step 2||0
10297746|NCT00004031|11430316|FG000|STARTED|Overall Study||128
10297747|NCT00004031|11430317|FG001|STARTED|Overall Study||125
10297748|NCT00004031|11430316|FG000|Assessed for Adverse Events|Overall Study||123
10297749|NCT00004031|11430317|FG001|Assessed for Adverse Events|Overall Study||113
10297750|NCT00004031|11430316|FG000|COMPLETED|Overall Study||103
10297751|NCT00004031|11430317|FG001|COMPLETED|Overall Study||104
10297752|NCT00004031|11430316|FG000|NOT COMPLETED|Overall Study||25
10297753|NCT00004031|11430317|FG001|NOT COMPLETED|Overall Study||21
10297754|NCT00004054|11430327|FG000|STARTED|Overall Study||197
10297755|NCT00004054|11430328|FG001|STARTED|Overall Study||200
10297756|NCT00004054|11430327|FG000|COMPLETED|Overall Study||197
10297757|NCT00004054|11430328|FG001|COMPLETED|Overall Study||200
10297758|NCT00004054|11430327|FG000|NOT COMPLETED|Overall Study||0
10297759|NCT00004054|11430328|FG001|NOT COMPLETED|Overall Study||0
10297760|NCT00004088|11430334|FG000|STARTED|Overall Study||77
10297761|NCT00004088|11430334|FG000|COMPLETED|Overall Study||68
10297762|NCT00004088|11430334|FG000|NOT COMPLETED|Overall Study||9
10297763|NCT00004092|11430340|FG000|STARTED|Overall Study||21
10297764|NCT00004092|11430341|FG001|STARTED|Overall Study||51
10297765|NCT00004092|11430340|FG000|COMPLETED|Overall Study||21
10297766|NCT00004092|11430341|FG001|COMPLETED|Overall Study||51
10297767|NCT00004092|11430340|FG000|NOT COMPLETED|Overall Study||0
10297768|NCT00004092|11430341|FG001|NOT COMPLETED|Overall Study||0
10297769|NCT00004124|11430349|FG000|STARTED|Overall Study||481
10297770|NCT00004124|11430350|FG001|STARTED|Overall Study||480
10297771|NCT00004124|11430349|FG000|COMPLETED|Overall Study||469
10297772|NCT00004124|11430350|FG001|COMPLETED|Overall Study||460
10297773|NCT00004124|11430349|FG000|NOT COMPLETED|Overall Study||12
10297774|NCT00004124|11430350|FG001|NOT COMPLETED|Overall Study||20
10297775|NCT00004143|11430356|FG000|STARTED|Overall Study||2
10297776|NCT00004143|11430356|FG000|COMPLETED|Overall Study||2
10297777|NCT00004143|11430356|FG000|NOT COMPLETED|Overall Study||0
10297778|NCT00004146|11430360|FG000|STARTED|Overall Study||55
10297779|NCT00004146|11430360|FG000|COMPLETED|Overall Study||55
10297780|NCT00004146|11430360|FG000|NOT COMPLETED|Overall Study||0
10297781|NCT00004228|11430373|FG000|STARTED|Overall Study||60
10297782|NCT00004228|11430374|FG001|STARTED|Overall Study||66
10297783|NCT00004228|11430375|FG002|STARTED|Overall Study||65
10297784|NCT00004228|11430376|FG003|STARTED|Overall Study||13
10297785|NCT00004228|11430377|FG004|STARTED|Overall Study||67
10297786|NCT00004228|11430378|FG005|STARTED|Overall Study||65
10297787|NCT00004228|11430379|FG006|STARTED|Overall Study||57
10297788|NCT00004228|11430373|FG000|COMPLETED|Overall Study||51
10297789|NCT00004228|11430374|FG001|COMPLETED|Overall Study||51
10297790|NCT00004228|11430375|FG002|COMPLETED|Overall Study||46
10297791|NCT00004228|11430376|FG003|COMPLETED|Overall Study||6
10297792|NCT00004228|11430377|FG004|COMPLETED|Overall Study||51
10421670|NCT00820443|11566533|FG000|NOT COMPLETED|Op||0
10769411|NCT03245619|11932563|FG016|NOT COMPLETED|Part A (Up to Day 22)||0
10769412|NCT03245619|11932547|FG000|STARTED|Part B (Up to 34 Days)||0
10769413|NCT03245619|11932548|FG001|STARTED|Part B (Up to 34 Days)||0
10769414|NCT03245619|11932549|FG002|STARTED|Part B (Up to 34 Days)||0
10769415|NCT03245619|11932550|FG003|STARTED|Part B (Up to 34 Days)||0
10769416|NCT03245619|11932551|FG004|STARTED|Part B (Up to 34 Days)||0
10769417|NCT03245619|11932552|FG005|STARTED|Part B (Up to 34 Days)||0
10769418|NCT03245619|11932553|FG006|STARTED|Part B (Up to 34 Days)||0
10769419|NCT03245619|11932554|FG007|STARTED|Part B (Up to 34 Days)||0
10769420|NCT03245619|11932555|FG008|STARTED|Part B (Up to 34 Days)||0
10769421|NCT03245619|11932556|FG009|STARTED|Part B (Up to 34 Days)||0
10769422|NCT03245619|11932557|FG010|STARTED|Part B (Up to 34 Days)||0
10769423|NCT03245619|11932558|FG011|STARTED|Part B (Up to 34 Days)||0
10769424|NCT03245619|11932559|FG012|STARTED|Part B (Up to 34 Days)||0
10769425|NCT03245619|11932560|FG013|STARTED|Part B (Up to 34 Days)||0
10769426|NCT03245619|11932561|FG014|STARTED|Part B (Up to 34 Days)||0
10769427|NCT03245619|11932562|FG015|STARTED|Part B (Up to 34 Days)||0
10769428|NCT03245619|11932563|FG016|STARTED|Part B (Up to 34 Days)||0
10769429|NCT03245619|11932547|FG000|COMPLETED|Part B (Up to 34 Days)||0
10769430|NCT03245619|11932548|FG001|COMPLETED|Part B (Up to 34 Days)||0
10769431|NCT03245619|11932549|FG002|COMPLETED|Part B (Up to 34 Days)||0
10769432|NCT03245619|11932550|FG003|COMPLETED|Part B (Up to 34 Days)||0
10769433|NCT03245619|11932551|FG004|COMPLETED|Part B (Up to 34 Days)||0
10769434|NCT03245619|11932552|FG005|COMPLETED|Part B (Up to 34 Days)||0
10769435|NCT03245619|11932553|FG006|COMPLETED|Part B (Up to 34 Days)||0
10769436|NCT03245619|11932554|FG007|COMPLETED|Part B (Up to 34 Days)||0
10769437|NCT03245619|11932555|FG008|COMPLETED|Part B (Up to 34 Days)||0
10769438|NCT03245619|11932556|FG009|COMPLETED|Part B (Up to 34 Days)||0
10769439|NCT03245619|11932557|FG010|COMPLETED|Part B (Up to 34 Days)||0
10769440|NCT03245619|11932558|FG011|COMPLETED|Part B (Up to 34 Days)||0
10769441|NCT03245619|11932559|FG012|COMPLETED|Part B (Up to 34 Days)||0
10769442|NCT03245619|11932560|FG013|COMPLETED|Part B (Up to 34 Days)||0
10769443|NCT03245619|11932561|FG014|COMPLETED|Part B (Up to 34 Days)||0
10769444|NCT03245619|11932562|FG015|COMPLETED|Part B (Up to 34 Days)||0
10769445|NCT03245619|11932563|FG016|COMPLETED|Part B (Up to 34 Days)||0
10769446|NCT03245619|11932547|FG000|NOT COMPLETED|Part B (Up to 34 Days)||0
10769447|NCT03245619|11932548|FG001|NOT COMPLETED|Part B (Up to 34 Days)||0
10769448|NCT03245619|11932549|FG002|NOT COMPLETED|Part B (Up to 34 Days)||0
10769449|NCT03245619|11932550|FG003|NOT COMPLETED|Part B (Up to 34 Days)||0
10769450|NCT03245619|11932551|FG004|NOT COMPLETED|Part B (Up to 34 Days)||0
10769451|NCT03245619|11932552|FG005|NOT COMPLETED|Part B (Up to 34 Days)||0
10769452|NCT03245619|11932553|FG006|NOT COMPLETED|Part B (Up to 34 Days)||0
10769453|NCT03245619|11932554|FG007|NOT COMPLETED|Part B (Up to 34 Days)||0
10769454|NCT03245619|11932555|FG008|NOT COMPLETED|Part B (Up to 34 Days)||0
10769455|NCT03245619|11932556|FG009|NOT COMPLETED|Part B (Up to 34 Days)||0
10769456|NCT03245619|11932557|FG010|NOT COMPLETED|Part B (Up to 34 Days)||0
10769457|NCT03245619|11932558|FG011|NOT COMPLETED|Part B (Up to 34 Days)||0
10769458|NCT03245619|11932559|FG012|NOT COMPLETED|Part B (Up to 34 Days)||0
10769459|NCT03245619|11932560|FG013|NOT COMPLETED|Part B (Up to 34 Days)||0
10769460|NCT03245619|11932561|FG014|NOT COMPLETED|Part B (Up to 34 Days)||0
10769461|NCT03245619|11932562|FG015|NOT COMPLETED|Part B (Up to 34 Days)||0
10769462|NCT03245619|11932563|FG016|NOT COMPLETED|Part B (Up to 34 Days)||0
10769463|NCT03245619|11932547|FG000|STARTED|Part C (Up to 34 Days)||0
10769464|NCT03245619|11932548|FG001|STARTED|Part C (Up to 34 Days)||0
10769465|NCT03245619|11932549|FG002|STARTED|Part C (Up to 34 Days)||0
10769466|NCT03245619|11932550|FG003|STARTED|Part C (Up to 34 Days)||0
10769467|NCT03245619|11932551|FG004|STARTED|Part C (Up to 34 Days)||0
10769468|NCT03245619|11932552|FG005|STARTED|Part C (Up to 34 Days)||0
10769469|NCT03245619|11932553|FG006|STARTED|Part C (Up to 34 Days)||0
10769470|NCT03245619|11932554|FG007|STARTED|Part C (Up to 34 Days)||0
10769471|NCT03245619|11932555|FG008|STARTED|Part C (Up to 34 Days)||0
10769472|NCT03245619|11932556|FG009|STARTED|Part C (Up to 34 Days)||0
10769473|NCT03245619|11932557|FG010|STARTED|Part C (Up to 34 Days)||0
10769474|NCT03245619|11932558|FG011|STARTED|Part C (Up to 34 Days)||0
10769475|NCT03245619|11932559|FG012|STARTED|Part C (Up to 34 Days)||0
10769476|NCT03245619|11932560|FG013|STARTED|Part C (Up to 34 Days)||0
10769477|NCT03245619|11932561|FG014|STARTED|Part C (Up to 34 Days)||0
10769478|NCT03245619|11932562|FG015|STARTED|Part C (Up to 34 Days)||0
10769479|NCT03245619|11932563|FG016|STARTED|Part C (Up to 34 Days)||0
10769480|NCT03245619|11932547|FG000|COMPLETED|Part C (Up to 34 Days)||0
10769481|NCT03245619|11932548|FG001|COMPLETED|Part C (Up to 34 Days)||0
10769482|NCT03245619|11932549|FG002|COMPLETED|Part C (Up to 34 Days)||0
10769483|NCT03245619|11932550|FG003|COMPLETED|Part C (Up to 34 Days)||0
10769484|NCT03245619|11932551|FG004|COMPLETED|Part C (Up to 34 Days)||0
10769485|NCT03245619|11932552|FG005|COMPLETED|Part C (Up to 34 Days)||0
10769486|NCT03245619|11932553|FG006|COMPLETED|Part C (Up to 34 Days)||0
10769487|NCT03245619|11932554|FG007|COMPLETED|Part C (Up to 34 Days)||0
10769488|NCT03245619|11932555|FG008|COMPLETED|Part C (Up to 34 Days)||0
10769489|NCT03245619|11932556|FG009|COMPLETED|Part C (Up to 34 Days)||0
10769490|NCT03245619|11932557|FG010|COMPLETED|Part C (Up to 34 Days)||0
10769491|NCT03245619|11932558|FG011|COMPLETED|Part C (Up to 34 Days)||0
10769492|NCT03245619|11932559|FG012|COMPLETED|Part C (Up to 34 Days)||0
10769493|NCT03245619|11932560|FG013|COMPLETED|Part C (Up to 34 Days)||0
10769494|NCT03245619|11932561|FG014|COMPLETED|Part C (Up to 34 Days)||0
10769495|NCT03245619|11932562|FG015|COMPLETED|Part C (Up to 34 Days)||0
10769496|NCT03245619|11932563|FG016|COMPLETED|Part C (Up to 34 Days)||0
10769497|NCT03245619|11932547|FG000|NOT COMPLETED|Part C (Up to 34 Days)||0
10769498|NCT03245619|11932548|FG001|NOT COMPLETED|Part C (Up to 34 Days)||0
10769499|NCT03245619|11932549|FG002|NOT COMPLETED|Part C (Up to 34 Days)||0
10769500|NCT03245619|11932550|FG003|NOT COMPLETED|Part C (Up to 34 Days)||0
10769501|NCT03245619|11932551|FG004|NOT COMPLETED|Part C (Up to 34 Days)||0
10769502|NCT03245619|11932552|FG005|NOT COMPLETED|Part C (Up to 34 Days)||0
10769503|NCT03245619|11932553|FG006|NOT COMPLETED|Part C (Up to 34 Days)||0
10769504|NCT03245619|11932554|FG007|NOT COMPLETED|Part C (Up to 34 Days)||0
10769505|NCT03245619|11932555|FG008|NOT COMPLETED|Part C (Up to 34 Days)||0
10769506|NCT03245619|11932556|FG009|NOT COMPLETED|Part C (Up to 34 Days)||0
10769507|NCT03245619|11932557|FG010|NOT COMPLETED|Part C (Up to 34 Days)||0
10769508|NCT03245619|11932558|FG011|NOT COMPLETED|Part C (Up to 34 Days)||0
10769509|NCT03245619|11932559|FG012|NOT COMPLETED|Part C (Up to 34 Days)||0
10769510|NCT03245619|11932560|FG013|NOT COMPLETED|Part C (Up to 34 Days)||0
10769511|NCT03245619|11932561|FG014|NOT COMPLETED|Part C (Up to 34 Days)||0
10769512|NCT03245619|11932562|FG015|NOT COMPLETED|Part C (Up to 34 Days)||0
10769513|NCT03245619|11932563|FG016|NOT COMPLETED|Part C (Up to 34 Days)||0
10769514|NCT03245723|11932624|FG000|STARTED|Overall Study||32
10769515|NCT03245723|11932625|FG001|STARTED|Overall Study||18
10769516|NCT03245723|11932624|FG000|COMPLETED|Overall Study||27
10769517|NCT03245723|11932625|FG001|COMPLETED|Overall Study||17
10769518|NCT03245723|11932624|FG000|NOT COMPLETED|Overall Study||5
10769519|NCT03245723|11932625|FG001|NOT COMPLETED|Overall Study||1
10769520|NCT03245736|11932631|FG000|STARTED|Overall Study||5
10769521|NCT03245736|11932631|FG000|COMPLETED|Overall Study||0
10769522|NCT03245736|11932631|FG000|NOT COMPLETED|Overall Study||5
10769523|NCT03245762|11932637|FG000|STARTED|Overall Study||10
10769524|NCT03245762|11932638|FG001|STARTED|Overall Study||5
10769525|NCT03245762|11932637|FG000|COMPLETED|Overall Study||10
10769526|NCT03245762|11932638|FG001|COMPLETED|Overall Study||5
10769527|NCT03245762|11932637|FG000|NOT COMPLETED|Overall Study||0
10769528|NCT03245762|11932638|FG001|NOT COMPLETED|Overall Study||0
10769537|NCT03246152|11932655|FG000|STARTED|Overall Study||31
10769538|NCT03246152|11932655|FG000|COMPLETED|Overall Study||28
10769539|NCT03246152|11932655|FG000|NOT COMPLETED|Overall Study||3
10769540|NCT03246646|11932661|FG000|STARTED|Overall Study||26
10769541|NCT03246646|11932662|FG001|STARTED|Overall Study||26
10769542|NCT03246646|11932661|FG000|COMPLETED|Overall Study|15 participants completed either 6-month or 12-month follow-up or both.|15
10769543|NCT03246646|11932662|FG001|COMPLETED|Overall Study|Follow-up was limited to chart follow-up in CIC services|26
10769544|NCT03246646|11932661|FG000|NOT COMPLETED|Overall Study||11
10769545|NCT03246646|11932662|FG001|NOT COMPLETED|Overall Study||0
10769546|NCT03246672|11932668|FG000|STARTED|Overall Study||30
10769547|NCT03246672|11932668|FG000|Completed First Phone Call|Overall Study||29
10769548|NCT03246672|11932668|FG000|COMPLETED|Overall Study||28
10769549|NCT03246672|11932668|FG000|NOT COMPLETED|Overall Study||2
10769550|NCT03246724|11932676|FG000|STARTED|Overall Study||99
10769551|NCT03246724|11932677|FG001|STARTED|Overall Study||91
10769552|NCT03246724|11932678|FG002|STARTED|Overall Study||85
10769553|NCT03246724|11932679|FG003|STARTED|Overall Study||52
10769554|NCT03246724|11932676|FG000|COMPLETED|Overall Study||85
10769555|NCT03246724|11932677|FG001|COMPLETED|Overall Study||84
10769556|NCT03246724|11932678|FG002|COMPLETED|Overall Study||70
10769557|NCT03246724|11932679|FG003|COMPLETED|Overall Study||44
10769558|NCT03246724|11932676|FG000|NOT COMPLETED|Overall Study||14
10769559|NCT03246724|11932677|FG001|NOT COMPLETED|Overall Study||7
10769560|NCT03246724|11932678|FG002|NOT COMPLETED|Overall Study||15
10769561|NCT03246724|11932679|FG003|NOT COMPLETED|Overall Study||8
10769562|NCT03247322|11932691|FG000|STARTED|Overall Study||68
10769563|NCT03247322|11932692|FG001|STARTED|Overall Study||68
10769564|NCT03247322|11932691|FG000|COMPLETED|Overall Study||66
10769565|NCT03247322|11932692|FG001|COMPLETED|Overall Study||68
10769566|NCT03247322|11932691|FG000|NOT COMPLETED|Overall Study||2
10769567|NCT03247322|11932692|FG001|NOT COMPLETED|Overall Study||0
10769568|NCT03247517|11932703|FG000|STARTED|Overall Study||104
10769569|NCT03247517|11932704|FG001|STARTED|Overall Study||98
10769570|NCT03247517|11932705|FG002|STARTED|Overall Study|One subject randomized to the 400mg/day SPN-812 arm received 200mg/day SPN-812 during the trial|106
10769571|NCT03247517|11932703|FG000|COMPLETED|Overall Study||96
10769572|NCT03247517|11932704|FG001|COMPLETED|Overall Study||78
10769573|NCT03247517|11932705|FG002|COMPLETED|Overall Study||92
10769574|NCT03247517|11932703|FG000|NOT COMPLETED|Overall Study||8
10769575|NCT03247517|11932704|FG001|NOT COMPLETED|Overall Study||20
10769576|NCT03247517|11932705|FG002|NOT COMPLETED|Overall Study||14
10769577|NCT03247530|11932716|FG000|STARTED|Overall Study||159
10769578|NCT03247530|11932717|FG001|STARTED|Overall Study||154
10769579|NCT03247530|11932718|FG002|STARTED|Overall Study||161
10769580|NCT03247530|11932716|FG000|COMPLETED|Overall Study||132
10769581|NCT03247530|11932717|FG001|COMPLETED|Overall Study||126
10769582|NCT03247530|11932718|FG002|COMPLETED|Overall Study||141
10769583|NCT03247530|11932716|FG000|NOT COMPLETED|Overall Study||27
10769584|NCT03247530|11932717|FG001|NOT COMPLETED|Overall Study||28
10769585|NCT03247530|11932718|FG002|NOT COMPLETED|Overall Study||20
10769586|NCT03247543|11932732|FG000|STARTED|Overall Study||102
10769587|NCT03247543|11932733|FG001|STARTED|Overall Study||107
10769588|NCT03247543|11932734|FG002|STARTED|Overall Study|One subject randomized to the 400mg/day SPN-812 arm received Placebo during the trial.|101
10769589|NCT03247543|11932732|FG000|COMPLETED|Overall Study||85
10769590|NCT03247543|11932733|FG001|COMPLETED|Overall Study||88
10769591|NCT03247543|11932734|FG002|COMPLETED|Overall Study||78
10769592|NCT03247543|11932732|FG000|NOT COMPLETED|Overall Study||17
10769593|NCT03247543|11932733|FG001|NOT COMPLETED|Overall Study||19
10769594|NCT03247543|11932734|FG002|NOT COMPLETED|Overall Study||23
10769595|NCT03247556|11932747|FG000|STARTED|Overall Study||97
10769596|NCT03247556|11932748|FG001|STARTED|Overall Study||100
10769597|NCT03247556|11932749|FG002|STARTED|Overall Study||99
10769598|NCT03247556|11932747|FG000|COMPLETED|Overall Study||85
10769599|NCT03247556|11932748|FG001|COMPLETED|Overall Study||88
10769600|NCT03247556|11932749|FG002|COMPLETED|Overall Study||81
10769601|NCT03247556|11932747|FG000|NOT COMPLETED|Overall Study||12
10769602|NCT03247556|11932748|FG001|NOT COMPLETED|Overall Study||12
10769603|NCT03247556|11932749|FG002|NOT COMPLETED|Overall Study||18
10769604|NCT03247673|11932760|FG000|STARTED|Overall Study||46
10769605|NCT03247673|11932761|FG001|STARTED|Overall Study||47
10769606|NCT03247673|11932762|FG002|STARTED|Overall Study||48
10769607|NCT03247673|11932760|FG000|COMPLETED|Overall Study||45
10769608|NCT03247673|11932761|FG001|COMPLETED|Overall Study||47
10769609|NCT03247673|11932762|FG002|COMPLETED|Overall Study||44
10769610|NCT03247673|11932760|FG000|NOT COMPLETED|Overall Study||1
10769611|NCT03247673|11932761|FG001|NOT COMPLETED|Overall Study||0
10769612|NCT03247673|11932762|FG002|NOT COMPLETED|Overall Study||4
10769613|NCT03247686|11932772|FG000|STARTED|Overall Study||8
10769614|NCT03247686|11932773|FG001|STARTED|Overall Study||20
10769615|NCT03247686|11932772|FG000|COMPLETED|Overall Study||7
10297793|NCT00004228|11430378|FG005|COMPLETED|Overall Study||51
10297794|NCT00004228|11430379|FG006|COMPLETED|Overall Study||45
10297795|NCT00004228|11430373|FG000|NOT COMPLETED|Overall Study||9
10297796|NCT00004228|11430374|FG001|NOT COMPLETED|Overall Study||15
10297797|NCT00004228|11430375|FG002|NOT COMPLETED|Overall Study||19
10297798|NCT00004228|11430376|FG003|NOT COMPLETED|Overall Study||7
10297799|NCT00004228|11430377|FG004|NOT COMPLETED|Overall Study||16
10297800|NCT00004228|11430378|FG005|NOT COMPLETED|Overall Study||14
10297801|NCT00004228|11430379|FG006|NOT COMPLETED|Overall Study||12
10297802|NCT00004259|11430400|FG000|STARTED|Overall Study||98
10297803|NCT00004259|11430401|FG001|STARTED|Overall Study||103
10297804|NCT00004259|11430402|FG002|STARTED|Overall Study||15
10297805|NCT00004259|11430403|FG003|STARTED|Overall Study||14
10297806|NCT00004259|11430400|FG000|COMPLETED|Overall Study||97
10297807|NCT00004259|11430401|FG001|COMPLETED|Overall Study||99
10297808|NCT00004259|11430402|FG002|COMPLETED|Overall Study||15
10297809|NCT00004259|11430403|FG003|COMPLETED|Overall Study||14
10297810|NCT00004259|11430400|FG000|NOT COMPLETED|Overall Study||1
10297811|NCT00004259|11430401|FG001|NOT COMPLETED|Overall Study||4
10297812|NCT00004259|11430402|FG002|NOT COMPLETED|Overall Study||0
10297813|NCT00004259|11430403|FG003|NOT COMPLETED|Overall Study||0
10297814|NCT00004412|11430419|FG000|STARTED|Randomized Period||11
10297815|NCT00004412|11430420|FG001|STARTED|Randomized Period||12
10297816|NCT00004412|11430421|FG002|STARTED|Randomized Period||0
10297817|NCT00004412|11430419|FG000|COMPLETED|Randomized Period||8
10297818|NCT00004412|11430420|FG001|COMPLETED|Randomized Period||12
10297819|NCT00004412|11430421|FG002|COMPLETED|Randomized Period||0
10297820|NCT00004412|11430419|FG000|NOT COMPLETED|Randomized Period||3
10297821|NCT00004412|11430420|FG001|NOT COMPLETED|Randomized Period||0
10297822|NCT00004412|11430421|FG002|NOT COMPLETED|Randomized Period||0
10297823|NCT00004412|11430419|FG000|STARTED|Crossover Period|Eight subjects were randomized to Standard of Care dressing Arm|8
10297824|NCT00004412|11430420|FG001|STARTED|Crossover Period|Twelve patients were randomized to the Arginine Butyrate plus Standard local care dressing Arm|12
10297825|NCT00004412|11430421|FG002|STARTED|Crossover Period|Three of Randomized Period's Arm I elected to move to Crossover Period's Crossover Arm.|3
10297826|NCT00004412|11430419|FG000|COMPLETED|Crossover Period|Eight subjects in this arm completed study without crossing over.|8
10297827|NCT00004412|11430420|FG001|COMPLETED|Crossover Period|Twelve subjects in this arm completed the study.|12
10297828|NCT00004412|11430421|FG002|COMPLETED|Crossover Period|Three subjects, from Arm I, who crossed- over to Arm II completed the study.|3
10297829|NCT00004412|11430419|FG000|NOT COMPLETED|Crossover Period||0
10297830|NCT00004412|11430420|FG001|NOT COMPLETED|Crossover Period||0
10297831|NCT00004412|11430421|FG002|NOT COMPLETED|Crossover Period||0
10297832|NCT00004418|11430427|FG000|STARTED|Overall Study||126
10769616|NCT03247686|11932773|FG001|COMPLETED|Overall Study||18
10769617|NCT03247686|11932772|FG000|NOT COMPLETED|Overall Study||1
10769618|NCT03247686|11932773|FG001|NOT COMPLETED|Overall Study||2
10769619|NCT03247738|11932784|FG000|STARTED|Overall Study||25
10769620|NCT03247738|11932785|FG001|STARTED|Overall Study||25
10769621|NCT03247738|11932784|FG000|COMPLETED|Overall Study||25
10769622|NCT03247738|11932785|FG001|COMPLETED|Overall Study||25
10769623|NCT03247738|11932784|FG000|NOT COMPLETED|Overall Study||0
10769624|NCT03247738|11932785|FG001|NOT COMPLETED|Overall Study||0
10769625|NCT03247790|11932791|FG000|STARTED|Period 1: Migraine Attack||16
10769626|NCT03247790|11932791|FG000|Received at Least One Dose of Study Drug|Period 1: Migraine Attack||16
10769627|NCT03247790|11932791|FG000|COMPLETED|Period 1: Migraine Attack||16
10769628|NCT03247790|11932791|FG000|NOT COMPLETED|Period 1: Migraine Attack||0
10769629|NCT03247790|11932791|FG000|STARTED|Period 2: Inter-ictal Period||16
10769630|NCT03247790|11932791|FG000|COMPLETED|Period 2: Inter-ictal Period||16
10769631|NCT03247790|11932791|FG000|NOT COMPLETED|Period 2: Inter-ictal Period||0
10769632|NCT03247816|11932797|FG000|STARTED|Overall Study||59
10769633|NCT03247816|11932797|FG000|COMPLETED|Overall Study||30
10769634|NCT03247816|11932797|FG000|NOT COMPLETED|Overall Study||29
10769635|NCT03247985|11932805|FG000|STARTED|Overall Study||19
10769636|NCT03247985|11932806|FG001|STARTED|Overall Study||19
10769637|NCT03247985|11932805|FG000|COMPLETED|Overall Study||19
10769638|NCT03247985|11932806|FG001|COMPLETED|Overall Study||19
10769639|NCT03247985|11932805|FG000|NOT COMPLETED|Overall Study||0
10769640|NCT03247985|11932806|FG001|NOT COMPLETED|Overall Study||0
10769641|NCT03248037|11932814|FG000|STARTED|Overall Study|Fellow eyes could be enrolled and were automatically assigned to the opposite treatment arm.|95
10769642|NCT03248037|11932815|FG001|STARTED|Overall Study|Fellow eyes could be enrolled and were automatically assigned to the opposite treatment arm.|96
10769643|NCT03248037|11932814|FG000|COMPLETED|Overall Study||74
10769644|NCT03248037|11932815|FG001|COMPLETED|Overall Study||87
10769645|NCT03248037|11932814|FG000|NOT COMPLETED|Overall Study||21
10769646|NCT03248037|11932815|FG001|NOT COMPLETED|Overall Study||9
10769647|NCT03248440|11932823|FG000|STARTED|Overall Study||131
10769648|NCT03248440|11932824|FG001|STARTED|Overall Study||132
10769649|NCT03248440|11932823|FG000|COMPLETED|Overall Study||116
10769650|NCT03248440|11932824|FG001|COMPLETED|Overall Study||120
10769651|NCT03248440|11932823|FG000|NOT COMPLETED|Overall Study||15
10769652|NCT03248440|11932824|FG001|NOT COMPLETED|Overall Study||12
10769653|NCT03248492|11932835|FG000|STARTED|Overall Study||50
10769654|NCT03248492|11932836|FG001|STARTED|Overall Study||48
10769655|NCT03248492|11932837|FG002|STARTED|Overall Study||21
10769656|NCT03248492|11932838|FG003|STARTED|Overall Study||130
10769657|NCT03248492|11932839|FG004|STARTED|Overall Study||4
10769658|NCT03248492|11932835|FG000|COMPLETED|Overall Study||0
10769659|NCT03248492|11932836|FG001|COMPLETED|Overall Study||0
10769660|NCT03248492|11932837|FG002|COMPLETED|Overall Study||0
10769661|NCT03248492|11932838|FG003|COMPLETED|Overall Study||0
10769662|NCT03248492|11932839|FG004|COMPLETED|Overall Study||0
10769663|NCT03248492|11932835|FG000|NOT COMPLETED|Overall Study||50
10769664|NCT03248492|11932836|FG001|NOT COMPLETED|Overall Study||48
10769665|NCT03248492|11932837|FG002|NOT COMPLETED|Overall Study||21
10769666|NCT03248492|11932838|FG003|NOT COMPLETED|Overall Study||130
10769667|NCT03248492|11932839|FG004|NOT COMPLETED|Overall Study||4
10769668|NCT03248882|11932864|FG000|STARTED|Overall Study||61
10769669|NCT03248882|11932865|FG001|STARTED|Overall Study||63
10769670|NCT03248882|11932866|FG002|STARTED|Overall Study||62
10769671|NCT03248882|11932867|FG003|STARTED|Overall Study||58
10769672|NCT03248882|11932868|FG004|STARTED|Overall Study||61
10769673|NCT03248882|11932864|FG000|Received Treatment|Overall Study||61
10769674|NCT03248882|11932865|FG001|Received Treatment|Overall Study||63
10769675|NCT03248882|11932866|FG002|Received Treatment|Overall Study||62
10769676|NCT03248882|11932867|FG003|Received Treatment|Overall Study||58
10769677|NCT03248882|11932868|FG004|Received Treatment|Overall Study||61
10769678|NCT03248882|11932864|FG000|COMPLETED|Overall Study||54
10769679|NCT03248882|11932865|FG001|COMPLETED|Overall Study||58
10769680|NCT03248882|11932866|FG002|COMPLETED|Overall Study||55
10769681|NCT03248882|11932867|FG003|COMPLETED|Overall Study||48
10769682|NCT03248882|11932868|FG004|COMPLETED|Overall Study||48
10769683|NCT03248882|11932864|FG000|NOT COMPLETED|Overall Study||7
10769684|NCT03248882|11932865|FG001|NOT COMPLETED|Overall Study||5
10769685|NCT03248882|11932866|FG002|NOT COMPLETED|Overall Study||7
10769686|NCT03248882|11932867|FG003|NOT COMPLETED|Overall Study||10
10769687|NCT03248882|11932868|FG004|NOT COMPLETED|Overall Study||13
10769688|NCT03248947|11932880|FG000|STARTED|Overall Study||71
10769689|NCT03248947|11932880|FG000|COMPLETED|Overall Study||63
10769690|NCT03248947|11932880|FG000|NOT COMPLETED|Overall Study||8
10769691|NCT03249116|11932891|FG000|STARTED|Overall Study||25
10769692|NCT03249116|11932892|FG001|STARTED|Overall Study||25
10769693|NCT03249116|11932893|FG002|STARTED|Overall Study||25
10769694|NCT03249116|11932891|FG000|COMPLETED|Overall Study||25
10769695|NCT03249116|11932892|FG001|COMPLETED|Overall Study||25
10769696|NCT03249116|11932893|FG002|COMPLETED|Overall Study||25
10769697|NCT03249116|11932891|FG000|NOT COMPLETED|Overall Study||0
10769698|NCT03249116|11932892|FG001|NOT COMPLETED|Overall Study||0
10769699|NCT03249116|11932893|FG002|NOT COMPLETED|Overall Study||0
10769700|NCT03249272|11932905|FG000|STARTED|Overall Study||19
10769701|NCT03249272|11932906|FG001|STARTED|Overall Study||6
10769702|NCT03249272|11932907|FG002|STARTED|Overall Study||6
10769703|NCT03249272|11932905|FG000|COMPLETED|Overall Study||19
10769704|NCT03249272|11932906|FG001|COMPLETED|Overall Study||6
10769705|NCT03249272|11932907|FG002|COMPLETED|Overall Study||6
10769706|NCT03249272|11932905|FG000|NOT COMPLETED|Overall Study||0
10769707|NCT03249272|11932906|FG001|NOT COMPLETED|Overall Study||0
10769708|NCT03249272|11932907|FG002|NOT COMPLETED|Overall Study||0
10769709|NCT03249454|11932927|FG000|STARTED|Overall Study||1
10769710|NCT03249454|11932928|FG001|STARTED|Overall Study||1
10769711|NCT03249454|11932929|FG002|STARTED|Overall Study||2
10769712|NCT03249454|11932930|FG003|STARTED|Overall Study||1
10769713|NCT03249454|11932931|FG004|STARTED|Overall Study||1
10769714|NCT03249454|11932932|FG005|STARTED|Overall Study||2
10769715|NCT03249454|11932933|FG006|STARTED|Overall Study||1
10769716|NCT03249454|11932934|FG007|STARTED|Overall Study||1
10769717|NCT03249454|11932935|FG008|STARTED|Overall Study||1
10769718|NCT03249454|11932936|FG009|STARTED|Overall Study||1
10769719|NCT03249454|11932937|FG010|STARTED|Overall Study||1
10769720|NCT03249454|11932927|FG000|First Intervention (1 Day)|Overall Study||1
10769721|NCT03249454|11932928|FG001|First Intervention (1 Day)|Overall Study||1
10769722|NCT03249454|11932929|FG002|First Intervention (1 Day)|Overall Study||2
10769723|NCT03249454|11932930|FG003|First Intervention (1 Day)|Overall Study||1
10769724|NCT03249454|11932931|FG004|First Intervention (1 Day)|Overall Study||1
10769725|NCT03249454|11932932|FG005|First Intervention (1 Day)|Overall Study||2
10769726|NCT03249454|11932933|FG006|First Intervention (1 Day)|Overall Study||1
10769727|NCT03249454|11932934|FG007|First Intervention (1 Day)|Overall Study||1
10769728|NCT03249454|11932935|FG008|First Intervention (1 Day)|Overall Study||1
10769729|NCT03249454|11932936|FG009|First Intervention (1 Day)|Overall Study||0
10769730|NCT03249454|11932937|FG010|First Intervention (1 Day)|Overall Study||0
10769731|NCT03249454|11932927|FG000|Washout (1 Week)|Overall Study||1
10769732|NCT03249454|11932928|FG001|Washout (1 Week)|Overall Study||1
10769733|NCT03249454|11932929|FG002|Washout (1 Week)|Overall Study||2
10769734|NCT03249454|11932930|FG003|Washout (1 Week)|Overall Study||1
10769735|NCT03249454|11932931|FG004|Washout (1 Week)|Overall Study||1
10769736|NCT03249454|11932932|FG005|Washout (1 Week)|Overall Study||2
10769737|NCT03249454|11932933|FG006|Washout (1 Week)|Overall Study||1
10769738|NCT03249454|11932934|FG007|Washout (1 Week)|Overall Study||1
10769739|NCT03249454|11932935|FG008|Washout (1 Week)|Overall Study||1
10769740|NCT03249454|11932936|FG009|Washout (1 Week)|Overall Study||0
10769741|NCT03249454|11932937|FG010|Washout (1 Week)|Overall Study||0
10769742|NCT03249454|11932927|FG000|Second Intervention (1 Day)|Overall Study||1
10769743|NCT03249454|11932928|FG001|Second Intervention (1 Day)|Overall Study||1
10769744|NCT03249454|11932929|FG002|Second Intervention (1 Day)|Overall Study||2
10769745|NCT03249454|11932930|FG003|Second Intervention (1 Day)|Overall Study||1
10769746|NCT03249454|11932931|FG004|Second Intervention (1 Day)|Overall Study||1
10769747|NCT03249454|11932932|FG005|Second Intervention (1 Day)|Overall Study||2
10769748|NCT03249454|11932933|FG006|Second Intervention (1 Day)|Overall Study||1
10769749|NCT03249454|11932934|FG007|Second Intervention (1 Day)|Overall Study||1
10769750|NCT03249454|11932935|FG008|Second Intervention (1 Day)|Overall Study||1
10769751|NCT03249454|11932936|FG009|Second Intervention (1 Day)|Overall Study||0
10769752|NCT03249454|11932937|FG010|Second Intervention (1 Day)|Overall Study||0
10769753|NCT03249454|11932927|FG000|Washout (1 Week)|Overall Study||1
10769754|NCT03249454|11932928|FG001|Washout (1 Week)|Overall Study||1
10769755|NCT03249454|11932929|FG002|Washout (1 Week)|Overall Study||2
10769756|NCT03249454|11932930|FG003|Washout (1 Week)|Overall Study||1
10769757|NCT03249454|11932931|FG004|Washout (1 Week)|Overall Study||1
10769758|NCT03249454|11932932|FG005|Washout (1 Week)|Overall Study||2
10769759|NCT03249454|11932933|FG006|Washout (1 Week)|Overall Study||1
10769760|NCT03249454|11932934|FG007|Washout (1 Week)|Overall Study||1
10769761|NCT03249454|11932935|FG008|Washout (1 Week)|Overall Study||1
10769762|NCT03249454|11932936|FG009|Washout (1 Week)|Overall Study||0
10769763|NCT03249454|11932937|FG010|Washout (1 Week)|Overall Study||0
10769764|NCT03249454|11932927|FG000|Third Intervention (1 Day)|Overall Study||1
10769765|NCT03249454|11932928|FG001|Third Intervention (1 Day)|Overall Study||1
10769766|NCT03249454|11932929|FG002|Third Intervention (1 Day)|Overall Study||2
10769767|NCT03249454|11932930|FG003|Third Intervention (1 Day)|Overall Study||1
10769768|NCT03249454|11932931|FG004|Third Intervention (1 Day)|Overall Study||1
10769769|NCT03249454|11932932|FG005|Third Intervention (1 Day)|Overall Study||2
10769770|NCT03249454|11932933|FG006|Third Intervention (1 Day)|Overall Study||1
10769771|NCT03249454|11932934|FG007|Third Intervention (1 Day)|Overall Study||1
10769772|NCT03249454|11932935|FG008|Third Intervention (1 Day)|Overall Study||1
10769773|NCT03249454|11932936|FG009|Third Intervention (1 Day)|Overall Study||0
10769774|NCT03249454|11932937|FG010|Third Intervention (1 Day)|Overall Study||0
10769775|NCT03249454|11932927|FG000|Washout (1 Week)|Overall Study||1
10769776|NCT03249454|11932928|FG001|Washout (1 Week)|Overall Study||1
10769777|NCT03249454|11932929|FG002|Washout (1 Week)|Overall Study||2
10769778|NCT03249454|11932930|FG003|Washout (1 Week)|Overall Study||1
10769779|NCT03249454|11932931|FG004|Washout (1 Week)|Overall Study||1
10769780|NCT03249454|11932932|FG005|Washout (1 Week)|Overall Study||2
10769781|NCT03249454|11932933|FG006|Washout (1 Week)|Overall Study||1
10769782|NCT03249454|11932934|FG007|Washout (1 Week)|Overall Study||1
10769783|NCT03249454|11932935|FG008|Washout (1 Week)|Overall Study||1
10769784|NCT03249454|11932936|FG009|Washout (1 Week)|Overall Study||0
10769785|NCT03249454|11932937|FG010|Washout (1 Week)|Overall Study||0
10769786|NCT03249454|11932927|FG000|Fourth Intervention (1 Day)|Overall Study||1
10769787|NCT03249454|11932928|FG001|Fourth Intervention (1 Day)|Overall Study||1
10769788|NCT03249454|11932929|FG002|Fourth Intervention (1 Day)|Overall Study||2
10769789|NCT03249454|11932930|FG003|Fourth Intervention (1 Day)|Overall Study||1
10769790|NCT03249454|11932931|FG004|Fourth Intervention (1 Day)|Overall Study||1
10769791|NCT03249454|11932932|FG005|Fourth Intervention (1 Day)|Overall Study||2
10769792|NCT03249454|11932933|FG006|Fourth Intervention (1 Day)|Overall Study||1
10769793|NCT03249454|11932934|FG007|Fourth Intervention (1 Day)|Overall Study||1
10769794|NCT03249454|11932935|FG008|Fourth Intervention (1 Day)|Overall Study||1
10769795|NCT03249454|11932936|FG009|Fourth Intervention (1 Day)|Overall Study||0
10769796|NCT03249454|11932937|FG010|Fourth Intervention (1 Day)|Overall Study||0
10769797|NCT03249454|11932927|FG000|Washout (1 Week)|Overall Study||1
10297833|NCT00004418|11430427|FG000|COMPLETED|Overall Study|The definition of completed is until the subject wished to stop taking the oil.|126
10769798|NCT03249454|11932928|FG001|Washout (1 Week)|Overall Study||1
10769799|NCT03249454|11932929|FG002|Washout (1 Week)|Overall Study||2
10769800|NCT03249454|11932930|FG003|Washout (1 Week)|Overall Study||1
10769801|NCT03249454|11932931|FG004|Washout (1 Week)|Overall Study||1
10769802|NCT03249454|11932932|FG005|Washout (1 Week)|Overall Study||2
10769803|NCT03249454|11932933|FG006|Washout (1 Week)|Overall Study||1
10769804|NCT03249454|11932934|FG007|Washout (1 Week)|Overall Study||1
10769805|NCT03249454|11932935|FG008|Washout (1 Week)|Overall Study||1
10769806|NCT03249454|11932936|FG009|Washout (1 Week)|Overall Study||0
10769807|NCT03249454|11932937|FG010|Washout (1 Week)|Overall Study||0
10769808|NCT03249454|11932927|FG000|Fifth Intervention (1 Day)|Overall Study||1
10769809|NCT03249454|11932928|FG001|Fifth Intervention (1 Day)|Overall Study||1
10769810|NCT03249454|11932929|FG002|Fifth Intervention (1 Day)|Overall Study||2
10769811|NCT03249454|11932930|FG003|Fifth Intervention (1 Day)|Overall Study||1
10769812|NCT03249454|11932931|FG004|Fifth Intervention (1 Day)|Overall Study||1
10769813|NCT03249454|11932932|FG005|Fifth Intervention (1 Day)|Overall Study||2
10769814|NCT03249454|11932933|FG006|Fifth Intervention (1 Day)|Overall Study||1
10769815|NCT03249454|11932934|FG007|Fifth Intervention (1 Day)|Overall Study||1
10769816|NCT03249454|11932935|FG008|Fifth Intervention (1 Day)|Overall Study||1
10769817|NCT03249454|11932936|FG009|Fifth Intervention (1 Day)|Overall Study||0
10769818|NCT03249454|11932937|FG010|Fifth Intervention (1 Day)|Overall Study||0
10769819|NCT03249454|11932927|FG000|COMPLETED|Overall Study||1
10769820|NCT03249454|11932928|FG001|COMPLETED|Overall Study||1
10769821|NCT03249454|11932929|FG002|COMPLETED|Overall Study||2
10769822|NCT03249454|11932930|FG003|COMPLETED|Overall Study||1
10769823|NCT03249454|11932931|FG004|COMPLETED|Overall Study||1
10769824|NCT03249454|11932932|FG005|COMPLETED|Overall Study||2
10769825|NCT03249454|11932933|FG006|COMPLETED|Overall Study||1
10769826|NCT03249454|11932934|FG007|COMPLETED|Overall Study||1
10769827|NCT03249454|11932935|FG008|COMPLETED|Overall Study||1
10769828|NCT03249454|11932936|FG009|COMPLETED|Overall Study||0
10769829|NCT03249454|11932937|FG010|COMPLETED|Overall Study||0
10769830|NCT03249454|11932927|FG000|NOT COMPLETED|Overall Study||0
10769831|NCT03249454|11932928|FG001|NOT COMPLETED|Overall Study||0
10769832|NCT03249454|11932929|FG002|NOT COMPLETED|Overall Study||0
10769833|NCT03249454|11932930|FG003|NOT COMPLETED|Overall Study||0
10769834|NCT03249454|11932931|FG004|NOT COMPLETED|Overall Study||0
10769835|NCT03249454|11932932|FG005|NOT COMPLETED|Overall Study||0
10769836|NCT03249454|11932933|FG006|NOT COMPLETED|Overall Study||0
10769837|NCT03249454|11932934|FG007|NOT COMPLETED|Overall Study||0
10769838|NCT03249454|11932935|FG008|NOT COMPLETED|Overall Study||0
10769839|NCT03249454|11932936|FG009|NOT COMPLETED|Overall Study||1
10769840|NCT03249454|11932937|FG010|NOT COMPLETED|Overall Study||1
10769841|NCT03249584|11932950|FG000|STARTED|Overall Study||184
10769842|NCT03249584|11932951|FG001|STARTED|Overall Study||22
10769843|NCT03249584|11932950|FG000|Month 3|Overall Study||132
10769844|NCT03249584|11932951|FG001|Month 3|Overall Study||15
10769845|NCT03249584|11932950|FG000|Month 3 Primary/Secondary Objectives|Overall Study|As prespecified, the primary objective included the first 42 Thoracic/Lumbar RF Ablation subjects to complete Month 3.|42
10769846|NCT03249584|11932951|FG001|Month 3 Primary/Secondary Objectives|Overall Study|As prespecified, the secondary objective included all Periacetabulum/Iliac Crest/Sacrum RF Ablation subjects.|15
10769847|NCT03249584|11932950|FG000|Month 6|Overall Study||101
10769848|NCT03249584|11932951|FG001|Month 6|Overall Study||13
10769849|NCT03249584|11932950|FG000|COMPLETED|Overall Study||51
10769850|NCT03249584|11932951|FG001|COMPLETED|Overall Study||8
10769851|NCT03249584|11932950|FG000|NOT COMPLETED|Overall Study||133
10769852|NCT03249584|11932951|FG001|NOT COMPLETED|Overall Study||14
10769853|NCT03249779|11932956|FG000|STARTED|Overall Study||8
10769854|NCT03249779|11932956|FG000|COMPLETED|Overall Study||8
10769855|NCT03249779|11932956|FG000|NOT COMPLETED|Overall Study||0
10769856|NCT03249909|11932963|FG000|STARTED|Overall Study||78
10769857|NCT03249909|11932964|FG001|STARTED|Overall Study||15
10769858|NCT03249909|11932965|FG002|STARTED|Overall Study||16
10769859|NCT03249909|11932963|FG000|COMPLETED|Overall Study||72
10769860|NCT03249909|11932964|FG001|COMPLETED|Overall Study||14
10769861|NCT03249909|11932965|FG002|COMPLETED|Overall Study||16
10769862|NCT03249909|11932963|FG000|NOT COMPLETED|Overall Study||6
10769863|NCT03249909|11932964|FG001|NOT COMPLETED|Overall Study||1
10769864|NCT03249909|11932965|FG002|NOT COMPLETED|Overall Study||0
10769865|NCT03249935|11932976|FG000|STARTED|Overall Study||100
10769866|NCT03249935|11932976|FG000|COMPLETED|Overall Study||55
10769867|NCT03249935|11932976|FG000|NOT COMPLETED|Overall Study||45
10769868|NCT03250182|11932982|FG000|STARTED|Overall Study||30
10769869|NCT03250182|11932982|FG000|COMPLETED|Overall Study||29
10769870|NCT03250182|11932982|FG000|NOT COMPLETED|Overall Study||1
10769871|NCT03250234|11932988|FG000|STARTED|Overall Study||6
10769872|NCT03250234|11932989|FG001|STARTED|Overall Study||6
10769873|NCT03250234|11932988|FG000|COMPLETED|Overall Study||6
10769874|NCT03250234|11932989|FG001|COMPLETED|Overall Study||6
10769875|NCT03250234|11932988|FG000|NOT COMPLETED|Overall Study||0
10769876|NCT03250234|11932989|FG001|NOT COMPLETED|Overall Study||0
10769877|NCT03250689|11932997|FG000|STARTED|Overall Study||5
10769878|NCT03250689|11932998|FG001|STARTED|Overall Study||14
10769879|NCT03250689|11932997|FG000|COMPLETED|Overall Study||5
10769880|NCT03250689|11932998|FG001|COMPLETED|Overall Study||14
10769881|NCT03250689|11932997|FG000|NOT COMPLETED|Overall Study||0
10769882|NCT03250689|11932998|FG001|NOT COMPLETED|Overall Study||0
10769883|NCT03250845|11933005|FG000|STARTED|Multigam 5% Infusion (Baseline)||30
10769884|NCT03250845|11933005|FG000|COMPLETED|Multigam 5% Infusion (Baseline)||30
10769885|NCT03250845|11933005|FG000|NOT COMPLETED|Multigam 5% Infusion (Baseline)||0
10769886|NCT03250845|11933005|FG000|STARTED|Multigam 10% Infusion (3-4 Weeks Later)||30
10769887|NCT03250845|11933005|FG000|COMPLETED|Multigam 10% Infusion (3-4 Weeks Later)||30
10769888|NCT03250845|11933005|FG000|NOT COMPLETED|Multigam 10% Infusion (3-4 Weeks Later)||0
10779140|NCT03364309|11940867|FG008|NOT COMPLETED|Induction Period||0
10769889|NCT03251482|11933016|FG000|STARTED|Overall Study||39
10769890|NCT03251482|11933017|FG001|STARTED|Overall Study||41
10769891|NCT03251482|11933018|FG002|STARTED|Overall Study||43
10769892|NCT03251482|11933019|FG003|STARTED|Overall Study||122
10769893|NCT03251482|11933020|FG004|STARTED|Overall Study||63
10769894|NCT03251482|11933016|FG000|Treated|Overall Study||38
10769895|NCT03251482|11933017|FG001|Treated|Overall Study||40
10769896|NCT03251482|11933018|FG002|Treated|Overall Study||42
10769897|NCT03251482|11933019|FG003|Treated|Overall Study||122
10769898|NCT03251482|11933020|FG004|Treated|Overall Study||63
10769899|NCT03251482|11933016|FG000|COMPLETED|Overall Study||39
10769900|NCT03251482|11933017|FG001|COMPLETED|Overall Study||40
10769901|NCT03251482|11933018|FG002|COMPLETED|Overall Study||43
10769902|NCT03251482|11933019|FG003|COMPLETED|Overall Study||122
10769903|NCT03251482|11933020|FG004|COMPLETED|Overall Study||63
10769904|NCT03251482|11933016|FG000|NOT COMPLETED|Overall Study||0
10769905|NCT03251482|11933017|FG001|NOT COMPLETED|Overall Study||1
10769906|NCT03251482|11933018|FG002|NOT COMPLETED|Overall Study||0
10769907|NCT03251482|11933019|FG003|NOT COMPLETED|Overall Study||0
10769908|NCT03251482|11933020|FG004|NOT COMPLETED|Overall Study||0
10769909|NCT03251937|11933032|FG000|STARTED|Overall Study||40
10769910|NCT03251937|11933032|FG000|COMPLETED|Overall Study||37
10769911|NCT03251937|11933032|FG000|NOT COMPLETED|Overall Study||3
10769912|NCT03251963|11933038|FG000|STARTED|Overall Study||65
10769913|NCT03251963|11933039|FG001|STARTED|Overall Study||66
10769914|NCT03251963|11933038|FG000|COMPLETED|Overall Study||56
10769915|NCT03251963|11933039|FG001|COMPLETED|Overall Study||61
10769916|NCT03251963|11933038|FG000|NOT COMPLETED|Overall Study||9
10769917|NCT03251963|11933039|FG001|NOT COMPLETED|Overall Study||5
10769918|NCT03252015|11933049|FG000|STARTED|Overall Study||12
10769919|NCT03252015|11933050|FG001|STARTED|Overall Study||28
10769920|NCT03252015|11933051|FG002|STARTED|Overall Study||15
10769921|NCT03252015|11933052|FG003|STARTED|Overall Study||15
10769922|NCT03252015|11933049|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12
10769923|NCT03252015|11933050|FG001|Received at Least 1 Dose of Study Drug|Overall Study||28
10769924|NCT03252015|11933051|FG002|Received at Least 1 Dose of Study Drug|Overall Study||15
10769925|NCT03252015|11933052|FG003|Received at Least 1 Dose of Study Drug|Overall Study||15
10769926|NCT03252015|11933049|FG000|COMPLETED|Overall Study||11
10769927|NCT03252015|11933050|FG001|COMPLETED|Overall Study||27
10769928|NCT03252015|11933051|FG002|COMPLETED|Overall Study||14
10769929|NCT03252015|11933052|FG003|COMPLETED|Overall Study||14
10769930|NCT03252015|11933049|FG000|NOT COMPLETED|Overall Study||1
10769931|NCT03252015|11933050|FG001|NOT COMPLETED|Overall Study||1
10769932|NCT03252015|11933051|FG002|NOT COMPLETED|Overall Study||1
10769933|NCT03252015|11933052|FG003|NOT COMPLETED|Overall Study||1
10769934|NCT03252145|11933078|FG000|STARTED|Overall Study||13
10769935|NCT03252145|11933079|FG001|STARTED|Overall Study||15
10769936|NCT03252145|11933078|FG000|COMPLETED|Overall Study||11
10769937|NCT03252145|11933079|FG001|COMPLETED|Overall Study||13
10769938|NCT03252145|11933078|FG000|NOT COMPLETED|Overall Study||2
10769939|NCT03252145|11933079|FG001|NOT COMPLETED|Overall Study||2
10769940|NCT03252353|11933087|FG000|STARTED|Overall Study||28
10769941|NCT03252353|11933088|FG001|STARTED|Overall Study||28
10769942|NCT03252353|11933087|FG000|COMPLETED|Overall Study||28
10769943|NCT03252353|11933088|FG001|COMPLETED|Overall Study||28
10769944|NCT03252353|11933087|FG000|NOT COMPLETED|Overall Study||0
10769945|NCT03252353|11933088|FG001|NOT COMPLETED|Overall Study||0
10769946|NCT03252431|11933099|FG000|STARTED|Overall Study||197
10769947|NCT03252431|11933100|FG001|STARTED|Overall Study||196
10769948|NCT03252431|11933099|FG000|COMPLETED|Overall Study||186
10769949|NCT03252431|11933100|FG001|COMPLETED|Overall Study||187
10769950|NCT03252431|11933099|FG000|NOT COMPLETED|Overall Study||11
10769951|NCT03252431|11933100|FG001|NOT COMPLETED|Overall Study||9
10769952|NCT03252964|11933106|FG000|STARTED|Overall Study||52
10769953|NCT03252964|11933106|FG000|COMPLETED|Overall Study||20
10769954|NCT03252964|11933106|FG000|NOT COMPLETED|Overall Study||32
10769955|NCT03253094|11933116|FG000|STARTED|Overall Study||32
10769956|NCT03253094|11933117|FG001|STARTED|Overall Study||30
10769957|NCT03253094|11933118|FG002|STARTED|Overall Study||28
10769958|NCT03253094|11933119|FG003|STARTED|Overall Study||32
10769959|NCT03253094|11933120|FG004|STARTED|Overall Study||32
10769960|NCT03253094|11933121|FG005|STARTED|Overall Study||32
10769961|NCT03253094|11933116|FG000|Subjects Discontinued|Overall Study||4
10769962|NCT03253094|11933117|FG001|Subjects Discontinued|Overall Study||3
10769963|NCT03253094|11933118|FG002|Subjects Discontinued|Overall Study||6
10769964|NCT03253094|11933119|FG003|Subjects Discontinued|Overall Study||4
10769965|NCT03253094|11933120|FG004|Subjects Discontinued|Overall Study||5
10769966|NCT03253094|11933121|FG005|Subjects Discontinued|Overall Study||4
10769967|NCT03253094|11933116|FG000|COMPLETED|Overall Study||28
10769968|NCT03253094|11933117|FG001|COMPLETED|Overall Study||27
10769969|NCT03253094|11933118|FG002|COMPLETED|Overall Study||22
10769970|NCT03253094|11933119|FG003|COMPLETED|Overall Study||28
10769971|NCT03253094|11933120|FG004|COMPLETED|Overall Study||27
10769972|NCT03253094|11933121|FG005|COMPLETED|Overall Study||28
10769973|NCT03253094|11933116|FG000|NOT COMPLETED|Overall Study||4
10769974|NCT03253094|11933117|FG001|NOT COMPLETED|Overall Study||3
10769975|NCT03253094|11933118|FG002|NOT COMPLETED|Overall Study||6
10769976|NCT03253094|11933119|FG003|NOT COMPLETED|Overall Study||4
10769977|NCT03253094|11933120|FG004|NOT COMPLETED|Overall Study||5
10769978|NCT03253094|11933121|FG005|NOT COMPLETED|Overall Study||4
10769979|NCT03254108|11933140|FG000|STARTED|Overall Study||13
10769980|NCT03254108|11933141|FG001|STARTED|Overall Study||12
10769981|NCT03254108|11933142|FG002|STARTED|Overall Study||12
10769982|NCT03254108|11933143|FG003|STARTED|Overall Study||12
10769983|NCT03254108|11933144|FG004|STARTED|Overall Study||12
10769984|NCT03254108|11933140|FG000|Received Treatment|Overall Study||13
10769985|NCT03254108|11933141|FG001|Received Treatment|Overall Study||12
10769986|NCT03254108|11933142|FG002|Received Treatment|Overall Study||12
10769987|NCT03254108|11933143|FG003|Received Treatment|Overall Study||11
10769988|NCT03254108|11933144|FG004|Received Treatment|Overall Study||12
10769989|NCT03254108|11933140|FG000|COMPLETED|Overall Study||13
10769990|NCT03254108|11933141|FG001|COMPLETED|Overall Study||10
10769991|NCT03254108|11933142|FG002|COMPLETED|Overall Study||12
10769992|NCT03254108|11933143|FG003|COMPLETED|Overall Study||11
10769993|NCT03254108|11933144|FG004|COMPLETED|Overall Study||9
10769994|NCT03254108|11933140|FG000|NOT COMPLETED|Overall Study||0
10769995|NCT03254108|11933141|FG001|NOT COMPLETED|Overall Study||2
10769996|NCT03254108|11933142|FG002|NOT COMPLETED|Overall Study||0
10769997|NCT03254108|11933143|FG003|NOT COMPLETED|Overall Study||1
10769998|NCT03254108|11933144|FG004|NOT COMPLETED|Overall Study||3
10769999|NCT03254134|11933158|FG000|STARTED|Overall Study||5745
10770000|NCT03254134|11933159|FG001|STARTED|Overall Study||16745
10770001|NCT03254134|11933158|FG000|COMPLETED|Overall Study||5146
10770002|NCT03254134|11933159|FG001|COMPLETED|Overall Study||13115
10770003|NCT03254134|11933158|FG000|NOT COMPLETED|Overall Study||599
10770004|NCT03254134|11933159|FG001|NOT COMPLETED|Overall Study||3630
10770005|NCT03254147|11933165|FG000|STARTED|Overall Study|The number of patients meeting the inclusion and exclusion criteria|53969
10770006|NCT03254147|11933165|FG000|COMPLETED|Overall Study||53969
10770007|NCT03254147|11933165|FG000|NOT COMPLETED|Overall Study||0
10770008|NCT03254459|11933171|FG000|STARTED|Overall Study||50
10770009|NCT03254459|11933172|FG001|STARTED|Overall Study||50
10770010|NCT03254459|11933171|FG000|COMPLETED|Overall Study||40
10770011|NCT03254459|11933172|FG001|COMPLETED|Overall Study||27
10770012|NCT03254459|11933171|FG000|NOT COMPLETED|Overall Study||10
10770013|NCT03254459|11933172|FG001|NOT COMPLETED|Overall Study||23
10770014|NCT03254602|11933178|FG000|STARTED|Overall Study||33
10770015|NCT03254602|11933178|FG000|COMPLETED|Overall Study||29
10770016|NCT03254602|11933178|FG000|NOT COMPLETED|Overall Study||4
10770017|NCT03254719|11933182|FG000|STARTED|Overall Study||40
10770018|NCT03254719|11933182|FG000|COMPLETED|Overall Study||40
10770019|NCT03254719|11933182|FG000|NOT COMPLETED|Overall Study||0
10297834|NCT00004418|11430427|FG000|NOT COMPLETED|Overall Study||0
10297835|NCT00004445|11430431|FG000|STARTED|Overall Study||18
10297836|NCT00004445|11430431|FG000|COMPLETED|Overall Study||15
10297837|NCT00004445|11430431|FG000|NOT COMPLETED|Overall Study||3
10297838|NCT00004500|11430437|FG000|STARTED|Overall Study||38
10297839|NCT00004500|11430438|FG001|STARTED|Overall Study||31
10297840|NCT00004500|11430437|FG000|1 Year Follow-Up|Overall Study||24
10297841|NCT00004500|11430438|FG001|1 Year Follow-Up|Overall Study||24
10297842|NCT00004500|11430437|FG000|COMPLETED|Overall Study||38
10297843|NCT00004500|11430438|FG001|COMPLETED|Overall Study||31
10297844|NCT00004500|11430437|FG000|NOT COMPLETED|Overall Study||0
10297845|NCT00004500|11430438|FG001|NOT COMPLETED|Overall Study||0
10297846|NCT00004547|11430447|FG000|STARTED|Overall Study||83
10297847|NCT00004547|11430448|FG001|STARTED|Overall Study||48
10297848|NCT00004547|11430449|FG002|STARTED|Overall Study||57
10297849|NCT00004547|11430447|FG000|Not Evaluable|Overall Study||21
10297850|NCT00004547|11430448|FG001|Not Evaluable|Overall Study||9
10297851|NCT00004547|11430449|FG002|Not Evaluable|Overall Study||23
10297852|NCT00004547|11430447|FG000|COMPLETED|Overall Study||61
10297853|NCT00004547|11430448|FG001|COMPLETED|Overall Study||39
10297854|NCT00004547|11430449|FG002|COMPLETED|Overall Study||35
10297855|NCT00004547|11430447|FG000|NOT COMPLETED|Overall Study||22
10297856|NCT00004547|11430448|FG001|NOT COMPLETED|Overall Study||9
10297857|NCT00004547|11430449|FG002|NOT COMPLETED|Overall Study||22
10297858|NCT00004562|11430460|FG000|STARTED|Overall Study||1101
10297859|NCT00004562|11430461|FG001|STARTED|Overall Study||1100
10297860|NCT00004562|11430460|FG000|COMPLETED|Overall Study||999
10297861|NCT00004562|11430461|FG001|COMPLETED|Overall Study||1009
10297862|NCT00004562|11430460|FG000|NOT COMPLETED|Overall Study||102
10297863|NCT00004562|11430461|FG001|NOT COMPLETED|Overall Study||91
10297864|NCT00004563|11430469|FG000|STARTED|Overall Study||79
10297865|NCT00004563|11430470|FG001|STARTED|Overall Study||79
10297866|NCT00004563|11430469|FG000|COMPLETED|Overall Study||54
10297867|NCT00004563|11430470|FG001|COMPLETED|Overall Study||55
10297868|NCT00004563|11430469|FG000|NOT COMPLETED|Overall Study||25
10297869|NCT00004563|11430470|FG001|NOT COMPLETED|Overall Study||24
10297870|NCT00004635|11430478|FG000|STARTED|Period One||79
10297871|NCT00004635|11430479|FG001|STARTED|Period One||80
10297872|NCT00004635|11430478|FG000|Received Treatment|Period One||73
10770050|NCT03255291|11933201|FG000|STARTED|Overall Study||93
10770051|NCT03255291|11933202|FG001|STARTED|Overall Study||90
10770052|NCT03255291|11933203|FG002|STARTED|Overall Study||91
10770053|NCT03255291|11933204|FG003|STARTED|Overall Study||90
10770054|NCT03255291|11933205|FG004|STARTED|Overall Study||95
10770055|NCT03255291|11933206|FG005|STARTED|Overall Study||95
10770056|NCT03255291|11933201|FG000|COMPLETED|Overall Study||80
10770057|NCT03255291|11933202|FG001|COMPLETED|Overall Study||78
10770058|NCT03255291|11933203|FG002|COMPLETED|Overall Study||85
10770059|NCT03255291|11933204|FG003|COMPLETED|Overall Study||84
10770060|NCT03255291|11933205|FG004|COMPLETED|Overall Study||88
10770061|NCT03255291|11933206|FG005|COMPLETED|Overall Study||85
10770062|NCT03255291|11933201|FG000|NOT COMPLETED|Overall Study||13
10770063|NCT03255291|11933202|FG001|NOT COMPLETED|Overall Study||12
10770064|NCT03255291|11933203|FG002|NOT COMPLETED|Overall Study||6
10770065|NCT03255291|11933204|FG003|NOT COMPLETED|Overall Study||6
10770066|NCT03255291|11933205|FG004|NOT COMPLETED|Overall Study||7
10770067|NCT03255291|11933206|FG005|NOT COMPLETED|Overall Study||10
10770068|NCT03255382|11933226|FG000|STARTED|Overall Study||60
10770069|NCT03255382|11933227|FG001|STARTED|Overall Study||60
10770070|NCT03255382|11933226|FG000|COMPLETED|Overall Study||47
10770071|NCT03255382|11933227|FG001|COMPLETED|Overall Study||60
10770072|NCT03255382|11933226|FG000|NOT COMPLETED|Overall Study||13
10770073|NCT03255382|11933227|FG001|NOT COMPLETED|Overall Study||0
10770074|NCT03255655|11933236|FG000|STARTED|Overall Study||29
10770075|NCT03255655|11933237|FG001|STARTED|Overall Study||12
10770076|NCT03255655|11933236|FG000|COMPLETED|Overall Study||22
10770077|NCT03255655|11933237|FG001|COMPLETED|Overall Study||8
10770078|NCT03255655|11933236|FG000|NOT COMPLETED|Overall Study||7
10770079|NCT03255655|11933237|FG001|NOT COMPLETED|Overall Study||4
10770080|NCT03255733|11933243|FG000|STARTED|Overall Study||29
10770081|NCT03255733|11933243|FG000|COMPLETED|Overall Study||25
10770082|NCT03255733|11933243|FG000|NOT COMPLETED|Overall Study||4
10770083|NCT03255824|11933249|FG000|STARTED|Overall Study||69
10770084|NCT03255824|11933250|FG001|STARTED|Overall Study||75
10770085|NCT03255824|11933249|FG000|COMPLETED|Overall Study||67
10770086|NCT03255824|11933250|FG001|COMPLETED|Overall Study||74
10770087|NCT03255824|11933249|FG000|NOT COMPLETED|Overall Study||2
10770088|NCT03255824|11933250|FG001|NOT COMPLETED|Overall Study||1
10770089|NCT03255902|11933256|FG000|STARTED|Overall Study||7
10770090|NCT03255902|11933256|FG000|COMPLETED|Overall Study||5
10770091|NCT03255902|11933256|FG000|NOT COMPLETED|Overall Study||2
10770092|NCT03255941|11933264|FG000|STARTED|Overall Study||177
10770093|NCT03255941|11933265|FG001|STARTED|Overall Study||178
10770094|NCT03255941|11933266|FG002|STARTED|Overall Study||53
10770095|NCT03255941|11933267|FG003|STARTED|Overall Study||52
10770096|NCT03255941|11933264|FG000|Deemed Eligible to Receive DMPA|Overall Study||140
10770097|NCT03255941|11933265|FG001|Deemed Eligible to Receive DMPA|Overall Study||134
10770098|NCT03255941|11933266|FG002|Deemed Eligible to Receive DMPA|Overall Study||48
10770099|NCT03255941|11933267|FG003|Deemed Eligible to Receive DMPA|Overall Study||46
10770100|NCT03255941|11933264|FG000|COMPLETED|Overall Study||139
10770101|NCT03255941|11933265|FG001|COMPLETED|Overall Study||132
10770102|NCT03255941|11933266|FG002|COMPLETED|Overall Study||48
10770103|NCT03255941|11933267|FG003|COMPLETED|Overall Study||46
10770104|NCT03255941|11933264|FG000|NOT COMPLETED|Overall Study||38
10770105|NCT03255941|11933265|FG001|NOT COMPLETED|Overall Study||46
10770106|NCT03255941|11933266|FG002|NOT COMPLETED|Overall Study||5
10770107|NCT03255941|11933267|FG003|NOT COMPLETED|Overall Study||6
10770108|NCT03255980|11933293|FG000|STARTED|Overall Study||20
10770109|NCT03255980|11933294|FG001|STARTED|Overall Study||20
10770110|NCT03255980|11933295|FG002|STARTED|Overall Study||20
10770111|NCT03255980|11933296|FG003|STARTED|Overall Study||20
10770112|NCT03255980|11933293|FG000|COMPLETED|Overall Study||17
10770113|NCT03255980|11933294|FG001|COMPLETED|Overall Study||12
10770114|NCT03255980|11933295|FG002|COMPLETED|Overall Study||14
10770115|NCT03255980|11933296|FG003|COMPLETED|Overall Study||8
10770116|NCT03255980|11933293|FG000|NOT COMPLETED|Overall Study||3
10770117|NCT03255980|11933294|FG001|NOT COMPLETED|Overall Study||8
10770118|NCT03255980|11933295|FG002|NOT COMPLETED|Overall Study||6
10770119|NCT03255980|11933296|FG003|NOT COMPLETED|Overall Study||12
10770120|NCT03256136|11933310|FG000|STARTED|Overall Study||3
10770121|NCT03256136|11933311|FG001|STARTED|Overall Study||1
10297873|NCT00004635|11430479|FG001|Received Treatment|Period One||75
10297874|NCT00004635|11430478|FG000|COMPLETED|Period One||73
10297875|NCT00004635|11430479|FG001|COMPLETED|Period One||74
10297876|NCT00004635|11430478|FG000|NOT COMPLETED|Period One||6
10297877|NCT00004635|11430479|FG001|NOT COMPLETED|Period One||6
10297878|NCT00004635|11430478|FG000|STARTED|Period Two||44
10297879|NCT00004635|11430479|FG001|STARTED|Period Two||59
10297880|NCT00004635|11430478|FG000|COMPLETED|Period Two||38
10297881|NCT00004635|11430479|FG001|COMPLETED|Period Two||50
10297882|NCT00004635|11430478|FG000|NOT COMPLETED|Period Two||6
10297883|NCT00004635|11430479|FG001|NOT COMPLETED|Period Two||9
10297884|NCT00004732|11430490|FG000|STARTED|Overall Study||1262
10297885|NCT00004732|11430491|FG001|STARTED|Overall Study||1240
10297886|NCT00004732|11430490|FG000|COMPLETED|Overall Study||1193
10297887|NCT00004732|11430491|FG001|COMPLETED|Overall Study||1129
10297888|NCT00004732|11430490|FG000|NOT COMPLETED|Overall Study||69
10297889|NCT00004732|11430491|FG001|NOT COMPLETED|Overall Study||111
10297890|NCT00004859|11430501|FG000|STARTED|Overall Study||295
10297891|NCT00004859|11430502|FG001|STARTED|Overall Study||294
10297892|NCT00004859|11430501|FG000|Eligible|Overall Study||275
10297893|NCT00004859|11430502|FG001|Eligible|Overall Study||271
10297894|NCT00004859|11430501|FG000|Treated|Overall Study||289
10297895|NCT00004859|11430502|FG001|Treated|Overall Study||289
10297896|NCT00004859|11430501|FG000|Treated and Having Toxicity Data|Overall Study||289
10297897|NCT00004859|11430502|FG001|Treated and Having Toxicity Data|Overall Study|1 patient had missing record for toxicity|288
10297898|NCT00004859|11430501|FG000|COMPLETED|Overall Study||177
10297899|NCT00004859|11430502|FG001|COMPLETED|Overall Study||12
10297900|NCT00004859|11430501|FG000|NOT COMPLETED|Overall Study||118
10297901|NCT00004859|11430502|FG001|NOT COMPLETED|Overall Study||282
10297902|NCT00004888|11430512|FG000|STARTED|Overall Study|Of the 41 pts, 3 were ineligible.|38
10297903|NCT00004888|11430513|FG001|STARTED|Overall Study|Of the 48 pts, 2 were ineligible.|46
10297904|NCT00004888|11430512|FG000|COMPLETED|Overall Study||27
10297905|NCT00004888|11430513|FG001|COMPLETED|Overall Study||22
10297906|NCT00004888|11430512|FG000|NOT COMPLETED|Overall Study||11
10297907|NCT00004888|11430513|FG001|NOT COMPLETED|Overall Study||24
10297908|NCT00004978|11430521|FG000|STARTED|Overall Study|includes patients participating in Vanguard studies from the sites which participated in ESPRIT|2090
10297909|NCT00004978|11430522|FG001|STARTED|Overall Study|includes patients participating in Vanguard studies from the sites which participated in ESPRIT|2060
10297910|NCT00004978|11430521|FG000|COMPLETED|Overall Study||1846
10297911|NCT00004978|11430522|FG001|COMPLETED|Overall Study||1790
10297912|NCT00004978|11430521|FG000|NOT COMPLETED|Overall Study||244
10297913|NCT00004978|11430522|FG001|NOT COMPLETED|Overall Study||270
10297914|NCT00004980|11430530|FG000|STARTED|Overall Study||27
10297915|NCT00004980|11430531|FG001|STARTED|Overall Study||23
10297916|NCT00004980|11430530|FG000|COMPLETED|Overall Study||25
10297917|NCT00004980|11430531|FG001|COMPLETED|Overall Study||21
10297918|NCT00004980|11430530|FG000|NOT COMPLETED|Overall Study||2
10297919|NCT00004980|11430531|FG001|NOT COMPLETED|Overall Study||2
10297920|NCT00005047|11430541|FG000|STARTED|Overall Study||58
10297921|NCT00005047|11430542|FG001|STARTED|Overall Study||56
10297922|NCT00005047|11430543|FG002|STARTED|Overall Study||227
10297923|NCT00005047|11430544|FG003|STARTED|Overall Study||158
10297924|NCT00005047|11430541|FG000|COMPLETED|Overall Study||39
10770122|NCT03256136|11933312|FG002|STARTED|Overall Study||4
10770123|NCT03256136|11933313|FG003|STARTED|Overall Study||1
10770124|NCT03256136|11933310|FG000|COMPLETED|Overall Study||3
10770125|NCT03256136|11933311|FG001|COMPLETED|Overall Study||1
10770126|NCT03256136|11933312|FG002|COMPLETED|Overall Study||4
10297925|NCT00005047|11430542|FG001|COMPLETED|Overall Study||56
10297926|NCT00005047|11430543|FG002|COMPLETED|Overall Study||227
10297927|NCT00005047|11430544|FG003|COMPLETED|Overall Study||158
10297928|NCT00005047|11430541|FG000|NOT COMPLETED|Overall Study||19
10770127|NCT03256136|11933313|FG003|COMPLETED|Overall Study||1
10770128|NCT03256136|11933310|FG000|NOT COMPLETED|Overall Study||0
10770129|NCT03256136|11933311|FG001|NOT COMPLETED|Overall Study||0
10770130|NCT03256136|11933312|FG002|NOT COMPLETED|Overall Study||0
10770131|NCT03256136|11933313|FG003|NOT COMPLETED|Overall Study||0
10770132|NCT03256162|11933325|FG000|STARTED|Overall Study||13
10770133|NCT03256162|11933326|FG001|STARTED|Overall Study||12
10770134|NCT03256162|11933325|FG000|COMPLETED|Overall Study||8
10770135|NCT03256162|11933326|FG001|COMPLETED|Overall Study||8
10770136|NCT03256162|11933325|FG000|NOT COMPLETED|Overall Study||5
10770137|NCT03256162|11933326|FG001|NOT COMPLETED|Overall Study||4
10770138|NCT03256253|11933332|FG000|STARTED|Overall Study||18
10770139|NCT03256253|11933332|FG000|COMPLETED|Overall Study||6
10770140|NCT03256253|11933332|FG000|NOT COMPLETED|Overall Study||12
10770141|NCT03256526|11933339|FG000|STARTED|Overall Study||19
10770142|NCT03256526|11933340|FG001|STARTED|Overall Study||17
10770143|NCT03256526|11933341|FG002|STARTED|Overall Study||17
10770144|NCT03256526|11933339|FG000|COMPLETED|Overall Study||17
10770145|NCT03256526|11933340|FG001|COMPLETED|Overall Study||17
10770146|NCT03256526|11933341|FG002|COMPLETED|Overall Study||14
10770147|NCT03256526|11933339|FG000|NOT COMPLETED|Overall Study||2
10770148|NCT03256526|11933340|FG001|NOT COMPLETED|Overall Study||0
10770149|NCT03256526|11933341|FG002|NOT COMPLETED|Overall Study||3
10770150|NCT03256552|11933349|FG000|STARTED|Overall Study||66
10770151|NCT03256552|11933349|FG000|GP MDI 28.8 µg|Overall Study||61
10770152|NCT03256552|11933349|FG000|GP MDI 14.4 µg|Overall Study||63
10770153|NCT03256552|11933349|FG000|GP MDI 7.2 µg|Overall Study||62
10770154|NCT03256552|11933349|FG000|Placebo MDI|Overall Study||65
10770155|NCT03256552|11933349|FG000|COMPLETED|Overall Study||61
10770156|NCT03256552|11933349|FG000|NOT COMPLETED|Overall Study||5
10770157|NCT03256578|11933361|FG000|STARTED|Overall Study||204
10770158|NCT03256578|11933362|FG001|STARTED|Overall Study||206
10770159|NCT03256578|11933361|FG000|COMPLETED|Overall Study||138
10770160|NCT03256578|11933362|FG001|COMPLETED|Overall Study||150
10770161|NCT03256578|11933361|FG000|NOT COMPLETED|Overall Study||66
10770162|NCT03256578|11933362|FG001|NOT COMPLETED|Overall Study||56
10770163|NCT03256695|11933368|FG000|STARTED|Overall Study||405
10770164|NCT03256695|11933368|FG000|Used ABS eMDPI at Least Once|Overall Study||390
10770165|NCT03256695|11933368|FG000|COMPLETED|Overall Study||366
10770166|NCT03256695|11933368|FG000|NOT COMPLETED|Overall Study||39
10770167|NCT03256799|11933372|FG000|STARTED|Overall Study||1
10770168|NCT03256799|11933372|FG000|COMPLETED|Overall Study||1
10770169|NCT03256799|11933372|FG000|NOT COMPLETED|Overall Study||0
10770170|NCT03256851|11933378|FG000|STARTED|Overall Study||10
10770171|NCT03256851|11933379|FG001|STARTED|Overall Study||10
10770172|NCT03256851|11933378|FG000|COMPLETED|Overall Study||9
10770173|NCT03256851|11933379|FG001|COMPLETED|Overall Study||10
10770174|NCT03256851|11933378|FG000|NOT COMPLETED|Overall Study||1
10770175|NCT03256851|11933379|FG001|NOT COMPLETED|Overall Study||0
10770176|NCT03256968|11933385|FG000|STARTED|Overall Study||1
10770177|NCT03256968|11933385|FG000|COMPLETED|Overall Study||1
10770178|NCT03256968|11933385|FG000|NOT COMPLETED|Overall Study||0
10770179|NCT03257189|11933389|FG000|STARTED|Overall Study||30
10770180|NCT03257189|11933389|FG000|COMPLETED|Overall Study||30
10770181|NCT03257189|11933389|FG000|NOT COMPLETED|Overall Study||0
10770182|NCT03257202|11933393|FG000|STARTED|Overall Study||12
10770183|NCT03257202|11933393|FG000|COMPLETED|Overall Study||12
10770184|NCT03257202|11933393|FG000|NOT COMPLETED|Overall Study||0
10770185|NCT03257358|11933405|FG000|STARTED|Overall Study||165
10770186|NCT03257358|11933406|FG001|STARTED|Overall Study||217
10770187|NCT03257358|11933405|FG000|Never Received Treatment|Overall Study||2
10770188|NCT03257358|11933406|FG001|Never Received Treatment|Overall Study||0
10770189|NCT03257358|11933405|FG000|COMPLETED|Overall Study||94
10770190|NCT03257358|11933406|FG001|COMPLETED|Overall Study||183
10770191|NCT03257358|11933405|FG000|NOT COMPLETED|Overall Study||71
10770192|NCT03257358|11933406|FG001|NOT COMPLETED|Overall Study||34
10770193|NCT03257371|11933412|FG000|STARTED|Overall Study||10
10770194|NCT03257371|11933412|FG000|COMPLETED|Overall Study||9
10770195|NCT03257371|11933412|FG000|NOT COMPLETED|Overall Study||1
10770196|NCT03257410|11933418|FG000|STARTED|Overall Study||86
10770197|NCT03257410|11933419|FG001|STARTED|Overall Study||86
10770198|NCT03257410|11933418|FG000|COMPLETED|Overall Study||65
10770199|NCT03257410|11933419|FG001|COMPLETED|Overall Study||65
10770200|NCT03257410|11933418|FG000|NOT COMPLETED|Overall Study||21
10770201|NCT03257410|11933419|FG001|NOT COMPLETED|Overall Study||21
10770202|NCT03257657|11933427|FG000|STARTED|Overall Study||22
10770203|NCT03257657|11933428|FG001|STARTED|Overall Study||20
10770204|NCT03257657|11933427|FG000|COMPLETED|Overall Study||22
10770205|NCT03257657|11933428|FG001|COMPLETED|Overall Study||15
10770206|NCT03257657|11933427|FG000|NOT COMPLETED|Overall Study||0
10770207|NCT03257657|11933428|FG001|NOT COMPLETED|Overall Study||5
10770208|NCT03257813|11933437|FG000|STARTED|Overall Study||30
10770209|NCT03257813|11933438|FG001|STARTED|Overall Study||30
10770210|NCT03257813|11933437|FG000|COMPLETED|Overall Study||24
10770211|NCT03257813|11933438|FG001|COMPLETED|Overall Study||27
10770212|NCT03257813|11933437|FG000|NOT COMPLETED|Overall Study||6
10770213|NCT03257813|11933438|FG001|NOT COMPLETED|Overall Study||3
10770214|NCT03257865|11933449|FG000|STARTED|Overall Study||163
10770215|NCT03257865|11933450|FG001|STARTED|Overall Study||170
10770216|NCT03257865|11933449|FG000|Received at Least 1 Dose of Study Drug|Overall Study||162
10770217|NCT03257865|11933450|FG001|Received at Least 1 Dose of Study Drug|Overall Study||170
10770218|NCT03257865|11933449|FG000|COMPLETED|Overall Study||128
10770219|NCT03257865|11933450|FG001|COMPLETED|Overall Study||135
10770220|NCT03257865|11933449|FG000|NOT COMPLETED|Overall Study||35
10770221|NCT03257865|11933450|FG001|NOT COMPLETED|Overall Study||35
10770222|NCT03257995|11933456|FG000|STARTED|Overall Study||9
10770223|NCT03257995|11933457|FG001|STARTED|Overall Study||9
10770224|NCT03257995|11933458|FG002|STARTED|Overall Study||9
10770225|NCT03257995|11933459|FG003|STARTED|Overall Study||9
10770226|NCT03257995|11933460|FG004|STARTED|Overall Study||9
10770227|NCT03257995|11933461|FG005|STARTED|Overall Study||9
10770228|NCT03257995|11933456|FG000|COMPLETED|Overall Study||9
10770229|NCT03257995|11933457|FG001|COMPLETED|Overall Study||8
10770230|NCT03257995|11933458|FG002|COMPLETED|Overall Study||9
10770231|NCT03257995|11933459|FG003|COMPLETED|Overall Study||9
10770232|NCT03257995|11933460|FG004|COMPLETED|Overall Study||9
10770233|NCT03257995|11933461|FG005|COMPLETED|Overall Study||7
10770234|NCT03257995|11933456|FG000|NOT COMPLETED|Overall Study||0
10770235|NCT03257995|11933457|FG001|NOT COMPLETED|Overall Study||1
10770236|NCT03257995|11933458|FG002|NOT COMPLETED|Overall Study||0
10770237|NCT03257995|11933459|FG003|NOT COMPLETED|Overall Study||0
10770238|NCT03257995|11933460|FG004|NOT COMPLETED|Overall Study||0
10770239|NCT03257995|11933461|FG005|NOT COMPLETED|Overall Study||2
10770240|NCT03258645|11933473|FG000|STARTED|Overall Study||1489
10770241|NCT03258645|11933473|FG000|COMPLETED|Overall Study||1489
10770242|NCT03258645|11933473|FG000|NOT COMPLETED|Overall Study||0
10770243|NCT03258710|11933483|FG000|STARTED|Overall Study||75
10770244|NCT03258710|11933483|FG000|COMPLETED|Overall Study||72
10770245|NCT03258710|11933483|FG000|NOT COMPLETED|Overall Study||3
10770246|NCT03258762|11933489|FG000|STARTED|Overall Study||7
10770247|NCT03258762|11933490|FG001|STARTED|Overall Study||7
10770248|NCT03258762|11933489|FG000|COMPLETED|Overall Study||7
10770249|NCT03258762|11933490|FG001|COMPLETED|Overall Study||6
10770250|NCT03258762|11933489|FG000|NOT COMPLETED|Overall Study||0
10770251|NCT03258762|11933490|FG001|NOT COMPLETED|Overall Study||1
10770252|NCT03258814|11933499|FG000|STARTED|Overall Study||4
10770253|NCT03258814|11933500|FG001|STARTED|Overall Study||3
10770254|NCT03258814|11933501|FG002|STARTED|Overall Study||10
10770255|NCT03258814|11933499|FG000|COMPLETED|Overall Study||0
10770256|NCT03258814|11933500|FG001|COMPLETED|Overall Study||0
10770257|NCT03258814|11933501|FG002|COMPLETED|Overall Study||0
10770258|NCT03258814|11933499|FG000|NOT COMPLETED|Overall Study||4
10770259|NCT03258814|11933500|FG001|NOT COMPLETED|Overall Study||3
10770260|NCT03258814|11933501|FG002|NOT COMPLETED|Overall Study||10
10770261|NCT03259087|11933513|FG000|STARTED|Part 1 and Period 1 of Part 2||8
10770262|NCT03259087|11933514|FG001|STARTED|Part 1 and Period 1 of Part 2||8
10770263|NCT03259087|11933515|FG002|STARTED|Part 1 and Period 1 of Part 2||8
10770264|NCT03259087|11933516|FG003|STARTED|Part 1 and Period 1 of Part 2||10
10770265|NCT03259087|11933517|FG004|STARTED|Part 1 and Period 1 of Part 2||8
10770266|NCT03259087|11933513|FG000|COMPLETED|Part 1 and Period 1 of Part 2||8
10770267|NCT03259087|11933514|FG001|COMPLETED|Part 1 and Period 1 of Part 2||8
10770268|NCT03259087|11933515|FG002|COMPLETED|Part 1 and Period 1 of Part 2||8
10770269|NCT03259087|11933516|FG003|COMPLETED|Part 1 and Period 1 of Part 2||10
10770270|NCT03259087|11933517|FG004|COMPLETED|Part 1 and Period 1 of Part 2||7
10770271|NCT03259087|11933513|FG000|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
10770272|NCT03259087|11933514|FG001|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
10770273|NCT03259087|11933515|FG002|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
10770274|NCT03259087|11933516|FG003|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
10770275|NCT03259087|11933517|FG004|NOT COMPLETED|Part 1 and Period 1 of Part 2||1
10770276|NCT03259087|11933513|FG000|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
10770277|NCT03259087|11933514|FG001|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
10770278|NCT03259087|11933515|FG002|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
10770279|NCT03259087|11933516|FG003|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
10770280|NCT03259087|11933517|FG004|STARTED|Period 2 of Part 2||7
10770281|NCT03259087|11933513|FG000|COMPLETED|Period 2 of Part 2||0
10770282|NCT03259087|11933514|FG001|COMPLETED|Period 2 of Part 2||0
10770283|NCT03259087|11933515|FG002|COMPLETED|Period 2 of Part 2||0
10770284|NCT03259087|11933516|FG003|COMPLETED|Period 2 of Part 2||0
10770285|NCT03259087|11933517|FG004|COMPLETED|Period 2 of Part 2||6
10770286|NCT03259087|11933513|FG000|NOT COMPLETED|Period 2 of Part 2||0
10770287|NCT03259087|11933514|FG001|NOT COMPLETED|Period 2 of Part 2||0
10770288|NCT03259087|11933515|FG002|NOT COMPLETED|Period 2 of Part 2||0
10770289|NCT03259087|11933516|FG003|NOT COMPLETED|Period 2 of Part 2||0
10770290|NCT03259087|11933517|FG004|NOT COMPLETED|Period 2 of Part 2||1
10770291|NCT03259139|11933545|FG000|STARTED|Overall Study||42
10770292|NCT03259139|11933546|FG001|STARTED|Overall Study||42
10770293|NCT03259139|11933547|FG002|STARTED|Overall Study||42
10770294|NCT03259139|11933548|FG003|STARTED|Overall Study||42
10770295|NCT03259139|11933549|FG004|STARTED|Overall Study||41
10770296|NCT03259139|11933550|FG005|STARTED|Overall Study||41
10770297|NCT03259139|11933545|FG000|Eligible|Overall Study||41
10770298|NCT03259139|11933546|FG001|Eligible|Overall Study||41
10770299|NCT03259139|11933547|FG002|Eligible|Overall Study||41
10770300|NCT03259139|11933548|FG003|Eligible|Overall Study||41
10770301|NCT03259139|11933549|FG004|Eligible|Overall Study||41
10770302|NCT03259139|11933550|FG005|Eligible|Overall Study||41
10770303|NCT03259139|11933545|FG000|Outlier Elimination|Overall Study||41
10770304|NCT03259139|11933546|FG001|Outlier Elimination|Overall Study||41
10770305|NCT03259139|11933547|FG002|Outlier Elimination|Overall Study||41
10770306|NCT03259139|11933548|FG003|Outlier Elimination|Overall Study||41
10770307|NCT03259139|11933549|FG004|Outlier Elimination|Overall Study||39
10770308|NCT03259139|11933550|FG005|Outlier Elimination|Overall Study||39
10770309|NCT03259139|11933545|FG000|Found Handgun|Overall Study||38
10770310|NCT03259139|11933546|FG001|Found Handgun|Overall Study||38
10770311|NCT03259139|11933547|FG002|Found Handgun|Overall Study||37
10770312|NCT03259139|11933548|FG003|Found Handgun|Overall Study||37
10770313|NCT03259139|11933549|FG004|Found Handgun|Overall Study||35
10770314|NCT03259139|11933550|FG005|Found Handgun|Overall Study||35
10770315|NCT03259139|11933545|FG000|COMPLETED|Overall Study||38
10770316|NCT03259139|11933546|FG001|COMPLETED|Overall Study||38
10770317|NCT03259139|11933547|FG002|COMPLETED|Overall Study||37
10770318|NCT03259139|11933548|FG003|COMPLETED|Overall Study||37
10770319|NCT03259139|11933549|FG004|COMPLETED|Overall Study||35
10770320|NCT03259139|11933550|FG005|COMPLETED|Overall Study||35
10770321|NCT03259139|11933545|FG000|NOT COMPLETED|Overall Study||4
10770322|NCT03259139|11933546|FG001|NOT COMPLETED|Overall Study||4
10770323|NCT03259139|11933547|FG002|NOT COMPLETED|Overall Study||5
10770324|NCT03259139|11933548|FG003|NOT COMPLETED|Overall Study||5
10770325|NCT03259139|11933549|FG004|NOT COMPLETED|Overall Study||6
10770326|NCT03259139|11933550|FG005|NOT COMPLETED|Overall Study||6
10770327|NCT03259308|11933570|FG000|STARTED|Overall Study||56
10770328|NCT03259308|11933571|FG001|STARTED|Overall Study||111
10770329|NCT03259308|11933572|FG002|STARTED|Overall Study||112
10770330|NCT03259308|11933570|FG000|COMPLETED|Overall Study||49
10770331|NCT03259308|11933571|FG001|COMPLETED|Overall Study||103
10770332|NCT03259308|11933572|FG002|COMPLETED|Overall Study||105
10770333|NCT03259308|11933570|FG000|NOT COMPLETED|Overall Study||7
10770334|NCT03259308|11933571|FG001|NOT COMPLETED|Overall Study||8
10770335|NCT03259308|11933572|FG002|NOT COMPLETED|Overall Study||7
10770336|NCT03259334|11933583|FG000|STARTED|Overall Study||76
10770337|NCT03259334|11933584|FG001|STARTED|Overall Study||153
10770338|NCT03259334|11933585|FG002|STARTED|Overall Study||151
10770339|NCT03259334|11933583|FG000|Treated|Overall Study||76
10770340|NCT03259334|11933584|FG001|Treated|Overall Study||151
10770341|NCT03259334|11933585|FG002|Treated|Overall Study||151
10770342|NCT03259334|11933583|FG000|COMPLETED|Overall Study||66
10770343|NCT03259334|11933584|FG001|COMPLETED|Overall Study||136
10770344|NCT03259334|11933585|FG002|COMPLETED|Overall Study||138
10770345|NCT03259334|11933583|FG000|NOT COMPLETED|Overall Study||10
10770346|NCT03259334|11933584|FG001|NOT COMPLETED|Overall Study||17
10770347|NCT03259334|11933585|FG002|NOT COMPLETED|Overall Study||13
10770348|NCT03259490|11933595|FG000|STARTED|Period 1||15
10770349|NCT03259490|11933596|FG001|STARTED|Period 1||15
10770350|NCT03259490|11933595|FG000|COMPLETED|Period 1||15
10770351|NCT03259490|11933596|FG001|COMPLETED|Period 1||14
10770352|NCT03259490|11933595|FG000|NOT COMPLETED|Period 1||0
10770353|NCT03259490|11933596|FG001|NOT COMPLETED|Period 1||1
10770354|NCT03259490|11933595|FG000|STARTED|Period 2||15
10770355|NCT03259490|11933596|FG001|STARTED|Period 2||14
10770356|NCT03259490|11933595|FG000|COMPLETED|Period 2||14
10770357|NCT03259490|11933596|FG001|COMPLETED|Period 2||14
10770358|NCT03259490|11933595|FG000|NOT COMPLETED|Period 2||1
10770359|NCT03259490|11933596|FG001|NOT COMPLETED|Period 2||0
10770360|NCT03259555|11933604|FG000|STARTED|Overall Study||158
10770361|NCT03259555|11933605|FG001|STARTED|Overall Study||164
10770362|NCT03259555|11933604|FG000|Received At Least 1 Dose of Study Drug|Overall Study||158
10770363|NCT03259555|11933605|FG001|Received At Least 1 Dose of Study Drug|Overall Study||163
10770364|NCT03259555|11933604|FG000|COMPLETED|Overall Study||124
10770365|NCT03259555|11933605|FG001|COMPLETED|Overall Study||134
10770366|NCT03259555|11933604|FG000|NOT COMPLETED|Overall Study||34
10770367|NCT03259555|11933605|FG001|NOT COMPLETED|Overall Study||30
10770368|NCT03259789|11933614|FG000|STARTED|Overall Study||158
10770369|NCT03259789|11933615|FG001|STARTED|Overall Study||159
10770370|NCT03259789|11933616|FG002|STARTED|Overall Study||34
10770371|NCT03259789|11933614|FG000|COMPLETED|Overall Study||141
10770372|NCT03259789|11933615|FG001|COMPLETED|Overall Study||142
10770373|NCT03259789|11933616|FG002|COMPLETED|Overall Study||28
10770374|NCT03259789|11933614|FG000|NOT COMPLETED|Overall Study||17
10770375|NCT03259789|11933615|FG001|NOT COMPLETED|Overall Study||17
10770376|NCT03259789|11933616|FG002|NOT COMPLETED|Overall Study||6
10770377|NCT03260205|11933630|FG000|STARTED|Overall Study||46
10770378|NCT03260205|11933631|FG001|STARTED|Overall Study||40
10770379|NCT03260205|11933632|FG002|STARTED|Overall Study||37
10770380|NCT03260205|11933633|FG003|STARTED|Overall Study||37
10770381|NCT03260205|11933634|FG004|STARTED|Overall Study||39
10770382|NCT03260205|11933630|FG000|Received Treatment|Overall Study||45
10770383|NCT03260205|11933631|FG001|Received Treatment|Overall Study||39
10770384|NCT03260205|11933632|FG002|Received Treatment|Overall Study||35
10770385|NCT03260205|11933633|FG003|Received Treatment|Overall Study||34
10770386|NCT03260205|11933634|FG004|Received Treatment|Overall Study||38
10770387|NCT03260205|11933630|FG000|COMPLETED|Overall Study||37
10770388|NCT03260205|11933631|FG001|COMPLETED|Overall Study||32
10770389|NCT03260205|11933632|FG002|COMPLETED|Overall Study||26
10770390|NCT03260205|11933633|FG003|COMPLETED|Overall Study||30
10770391|NCT03260205|11933634|FG004|COMPLETED|Overall Study||25
10770392|NCT03260205|11933630|FG000|NOT COMPLETED|Overall Study||9
10770393|NCT03260205|11933631|FG001|NOT COMPLETED|Overall Study||8
10770394|NCT03260205|11933632|FG002|NOT COMPLETED|Overall Study||11
10770395|NCT03260205|11933633|FG003|NOT COMPLETED|Overall Study||7
10770396|NCT03260205|11933634|FG004|NOT COMPLETED|Overall Study||14
10770397|NCT03260426|11933653|FG000|STARTED|Overall Study||50
10770398|NCT03260426|11933654|FG001|STARTED|Overall Study||50
10770399|NCT03260426|11933653|FG000|COMPLETED|Overall Study||50
10770400|NCT03260426|11933654|FG001|COMPLETED|Overall Study||50
10770401|NCT03260426|11933653|FG000|NOT COMPLETED|Overall Study||0
10770402|NCT03260426|11933654|FG001|NOT COMPLETED|Overall Study||0
10770403|NCT03260595|11933663|FG000|STARTED|Overall Study||20
10770404|NCT03260595|11933664|FG001|STARTED|Overall Study||10
10770405|NCT03260595|11933665|FG002|STARTED|Overall Study||2
10770406|NCT03260595|11933663|FG000|COMPLETED|Overall Study||20
10770407|NCT03260595|11933664|FG001|COMPLETED|Overall Study||10
10770408|NCT03260595|11933665|FG002|COMPLETED|Overall Study||2
10770409|NCT03260595|11933663|FG000|NOT COMPLETED|Overall Study||0
10770410|NCT03260595|11933664|FG001|NOT COMPLETED|Overall Study||0
10770411|NCT03260595|11933665|FG002|NOT COMPLETED|Overall Study||0
10770412|NCT03260699|11933675|FG000|STARTED|Overall Study||5
10770413|NCT03260699|11933676|FG001|STARTED|Overall Study||4
10770414|NCT03260699|11933675|FG000|COMPLETED|Overall Study||5
10770415|NCT03260699|11933676|FG001|COMPLETED|Overall Study||2
10770416|NCT03260699|11933675|FG000|NOT COMPLETED|Overall Study||0
10770417|NCT03260699|11933676|FG001|NOT COMPLETED|Overall Study||2
10770418|NCT03260790|11933684|FG000|STARTED|Overall Study||8
10770419|NCT03260790|11933685|FG001|STARTED|Overall Study||9
10770420|NCT03260790|11933684|FG000|COMPLETED|Overall Study||8
10770421|NCT03260790|11933685|FG001|COMPLETED|Overall Study||9
10770422|NCT03260790|11933684|FG000|NOT COMPLETED|Overall Study||0
10770423|NCT03260790|11933685|FG001|NOT COMPLETED|Overall Study||0
10770424|NCT03261037|11933695|FG000|STARTED|Overall Study||68
10770425|NCT03261037|11933696|FG001|STARTED|Overall Study||62
10770426|NCT03261037|11933697|FG002|STARTED|Overall Study||9
10770427|NCT03261037|11933698|FG003|STARTED|Overall Study||39
10770428|NCT03261037|11933695|FG000|COMPLETED|Overall Study||64
10770429|NCT03261037|11933696|FG001|COMPLETED|Overall Study||41
10770430|NCT03261037|11933697|FG002|COMPLETED|Overall Study||9
10770431|NCT03261037|11933698|FG003|COMPLETED|Overall Study||11
10770432|NCT03261037|11933695|FG000|NOT COMPLETED|Overall Study||4
10770433|NCT03261037|11933696|FG001|NOT COMPLETED|Overall Study||21
10770434|NCT03261037|11933697|FG002|NOT COMPLETED|Overall Study||0
10770435|NCT03261037|11933698|FG003|NOT COMPLETED|Overall Study||28
10770436|NCT03261167|11933711|FG000|STARTED|Double Blind(Treatment cyc1,Upto Week48)||63
10770437|NCT03261167|11933712|FG001|STARTED|Double Blind(Treatment cyc1,Upto Week48)||61
10770438|NCT03261167|11933711|FG000|COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||60
10770439|NCT03261167|11933712|FG001|COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||57
10770440|NCT03261167|11933711|FG000|NOT COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||3
10770441|NCT03261167|11933712|FG001|NOT COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||4
10770442|NCT03261167|11933711|FG000|STARTED|Open-label(Treatment cycle2,Upto Week48)||60
10770443|NCT03261167|11933712|FG001|STARTED|Open-label(Treatment cycle2,Upto Week48)||57
10770444|NCT03261167|11933711|FG000|COMPLETED|Open-label(Treatment cycle2,Upto Week48)||58
10770445|NCT03261167|11933712|FG001|COMPLETED|Open-label(Treatment cycle2,Upto Week48)||57
10770446|NCT03261167|11933711|FG000|NOT COMPLETED|Open-label(Treatment cycle2,Upto Week48)||2
10770447|NCT03261167|11933712|FG001|NOT COMPLETED|Open-label(Treatment cycle2,Upto Week48)||0
10770448|NCT03261167|11933711|FG000|STARTED|Open-label(Treatment cycle3,Upto Week48)||55
10770449|NCT03261167|11933712|FG001|STARTED|Open-label(Treatment cycle3,Upto Week48)||56
10770450|NCT03261167|11933711|FG000|COMPLETED|Open-label(Treatment cycle3,Upto Week48)||54
10770451|NCT03261167|11933712|FG001|COMPLETED|Open-label(Treatment cycle3,Upto Week48)||55
10770452|NCT03261167|11933711|FG000|NOT COMPLETED|Open-label(Treatment cycle3,Upto Week48)||1
10770453|NCT03261167|11933712|FG001|NOT COMPLETED|Open-label(Treatment cycle3,Upto Week48)||1
10770454|NCT03261167|11933711|FG000|STARTED|Open-label(Treatment cycle4,Upto Week48)||43
10770455|NCT03261167|11933712|FG001|STARTED|Open-label(Treatment cycle4,Upto Week48)||40
10770456|NCT03261167|11933711|FG000|COMPLETED|Open-label(Treatment cycle4,Upto Week48)||43
10770457|NCT03261167|11933712|FG001|COMPLETED|Open-label(Treatment cycle4,Upto Week48)||40
10770458|NCT03261167|11933711|FG000|NOT COMPLETED|Open-label(Treatment cycle4,Upto Week48)||0
10770459|NCT03261167|11933712|FG001|NOT COMPLETED|Open-label(Treatment cycle4,Upto Week48)||0
10770460|NCT03261336|11933724|FG000|STARTED|Overall Study||1
10770461|NCT03261336|11933724|FG000|COMPLETED|Overall Study||0
10770462|NCT03261336|11933724|FG000|NOT COMPLETED|Overall Study||1
10770463|NCT03261947|11933733|FG000|STARTED|Overall Study||12
10770464|NCT03261947|11933734|FG001|STARTED|Overall Study||15
10770465|NCT03261947|11933735|FG002|STARTED|Overall Study||35
10770466|NCT03261947|11933736|FG003|STARTED|Overall Study||21
10770467|NCT03261947|11933737|FG004|STARTED|Overall Study||18
10770468|NCT03261947|11933733|FG000|COMPLETED|Overall Study||0
10770469|NCT03261947|11933734|FG001|COMPLETED|Overall Study||2
10770470|NCT03261947|11933735|FG002|COMPLETED|Overall Study||5
10770471|NCT03261947|11933736|FG003|COMPLETED|Overall Study||0
10770472|NCT03261947|11933737|FG004|COMPLETED|Overall Study||1
10770473|NCT03261947|11933733|FG000|NOT COMPLETED|Overall Study||12
10770474|NCT03261947|11933734|FG001|NOT COMPLETED|Overall Study||13
10770475|NCT03261947|11933735|FG002|NOT COMPLETED|Overall Study||30
10770476|NCT03261947|11933736|FG003|NOT COMPLETED|Overall Study||21
10770477|NCT03261947|11933737|FG004|NOT COMPLETED|Overall Study||17
10770478|NCT03261960|11933755|FG000|STARTED|Overall Study||190
10770479|NCT03261960|11933756|FG001|STARTED|Overall Study||199
10770480|NCT03261960|11933755|FG000|COMPLETED|Overall Study||176
10770481|NCT03261960|11933756|FG001|COMPLETED|Overall Study||185
10770482|NCT03261960|11933755|FG000|NOT COMPLETED|Overall Study||14
10770483|NCT03261960|11933756|FG001|NOT COMPLETED|Overall Study||14
10770484|NCT03261973|11933762|FG000|STARTED|Overall Study||47
10770485|NCT03261973|11933762|FG000|COMPLETED|Overall Study||43
10770486|NCT03261973|11933762|FG000|NOT COMPLETED|Overall Study||4
10770487|NCT03261999|11933766|FG000|STARTED|Overall Study||144
10770488|NCT03261999|11933766|FG000|ITT|Overall Study||144
10770489|NCT03261999|11933766|FG000|PP|Overall Study||132
10770490|NCT03261999|11933766|FG000|COMPLETED|Overall Study||129
10770491|NCT03261999|11933766|FG000|NOT COMPLETED|Overall Study||15
10770492|NCT03262012|11933774|FG000|STARTED|Overall Study||139
10770493|NCT03262012|11933775|FG001|STARTED|Overall Study||138
10770494|NCT03262012|11933776|FG002|STARTED|Overall Study||70
10770495|NCT03262012|11933777|FG003|STARTED|Overall Study||69
10770496|NCT03262012|11933774|FG000|COMPLETED|Overall Study||112
10770497|NCT03262012|11933775|FG001|COMPLETED|Overall Study||102
10770498|NCT03262012|11933776|FG002|COMPLETED|Overall Study||56
10770499|NCT03262012|11933777|FG003|COMPLETED|Overall Study||54
10770500|NCT03262012|11933774|FG000|NOT COMPLETED|Overall Study||27
10770501|NCT03262012|11933775|FG001|NOT COMPLETED|Overall Study||36
10770502|NCT03262012|11933776|FG002|NOT COMPLETED|Overall Study||14
10770503|NCT03262012|11933777|FG003|NOT COMPLETED|Overall Study||15
10770504|NCT03262038|11933789|FG000|STARTED|Overall Study||18
10770505|NCT03262038|11933790|FG001|STARTED|Overall Study||28
10770506|NCT03262038|11933789|FG000|COMPLETED|Overall Study||18
10770507|NCT03262038|11933790|FG001|COMPLETED|Overall Study||27
10770508|NCT03262038|11933789|FG000|NOT COMPLETED|Overall Study||0
10770509|NCT03262038|11933790|FG001|NOT COMPLETED|Overall Study||1
10770510|NCT03262233|11933800|FG000|STARTED|Overall Study||53
10770511|NCT03262233|11933801|FG001|STARTED|Overall Study||53
10770512|NCT03262233|11933802|FG002|STARTED|Overall Study||59
10770513|NCT03262233|11933803|FG003|STARTED|Overall Study||61
10770514|NCT03262233|11933800|FG000|COMPLETED|Overall Study||35
10770515|NCT03262233|11933801|FG001|COMPLETED|Overall Study||32
10770516|NCT03262233|11933802|FG002|COMPLETED|Overall Study||34
10770517|NCT03262233|11933803|FG003|COMPLETED|Overall Study||32
10770518|NCT03262233|11933800|FG000|NOT COMPLETED|Overall Study||18
10770519|NCT03262233|11933801|FG001|NOT COMPLETED|Overall Study||21
10770520|NCT03262233|11933802|FG002|NOT COMPLETED|Overall Study||25
10770521|NCT03262233|11933803|FG003|NOT COMPLETED|Overall Study||29
10770522|NCT03262389|11933814|FG000|STARTED|Overall Study||10
10770523|NCT03262389|11933814|FG000|COMPLETED|Overall Study||7
10770524|NCT03262389|11933814|FG000|NOT COMPLETED|Overall Study||3
10770525|NCT03262441|11933818|FG000|STARTED|Overall Study||5
10770526|NCT03262441|11933818|FG000|COMPLETED|Overall Study||4
10770527|NCT03262441|11933818|FG000|NOT COMPLETED|Overall Study||1
10770528|NCT03263442|11933824|FG000|STARTED|Inpatient Phase||30
10770529|NCT03263442|11933825|FG001|STARTED|Inpatient Phase||34
10770530|NCT03263442|11933824|FG000|COMPLETED|Inpatient Phase||28
10770531|NCT03263442|11933825|FG001|COMPLETED|Inpatient Phase||33
10770532|NCT03263442|11933824|FG000|NOT COMPLETED|Inpatient Phase||2
10770533|NCT03263442|11933825|FG001|NOT COMPLETED|Inpatient Phase||1
10770534|NCT03263442|11933824|FG000|STARTED|1-month Follow-Up||28
10770535|NCT03263442|11933825|FG001|STARTED|1-month Follow-Up||33
10770536|NCT03263442|11933824|FG000|COMPLETED|1-month Follow-Up||27
10770537|NCT03263442|11933825|FG001|COMPLETED|1-month Follow-Up||33
10770538|NCT03263442|11933824|FG000|NOT COMPLETED|1-month Follow-Up||1
10770539|NCT03263442|11933825|FG001|NOT COMPLETED|1-month Follow-Up||0
10770540|NCT03263442|11933824|FG000|STARTED|3-month Follow-Up||27
10770541|NCT03263442|11933825|FG001|STARTED|3-month Follow-Up||33
10770542|NCT03263442|11933824|FG000|COMPLETED|3-month Follow-Up||26
10770543|NCT03263442|11933825|FG001|COMPLETED|3-month Follow-Up||30
10770544|NCT03263442|11933824|FG000|NOT COMPLETED|3-month Follow-Up||1
10770545|NCT03263442|11933825|FG001|NOT COMPLETED|3-month Follow-Up||3
10770546|NCT03263442|11933824|FG000|STARTED|6-month Follow-Up||26
10770547|NCT03263442|11933825|FG001|STARTED|6-month Follow-Up||30
10770548|NCT03263442|11933824|FG000|COMPLETED|6-month Follow-Up||24
10770549|NCT03263442|11933825|FG001|COMPLETED|6-month Follow-Up||28
10770550|NCT03263442|11933824|FG000|NOT COMPLETED|6-month Follow-Up||2
10770551|NCT03263442|11933825|FG001|NOT COMPLETED|6-month Follow-Up||2
10770552|NCT03263702|11933835|FG000|STARTED|Overall Study||38
10770553|NCT03263702|11933836|FG001|STARTED|Overall Study||26
10770554|NCT03263702|11933835|FG000|COMPLETED|Overall Study||35
10770555|NCT03263702|11933836|FG001|COMPLETED|Overall Study||22
10770556|NCT03263702|11933835|FG000|NOT COMPLETED|Overall Study||3
10770557|NCT03263702|11933836|FG001|NOT COMPLETED|Overall Study||4
10770558|NCT03263780|11933842|FG000|STARTED|Overall Study||21
10770559|NCT03263780|11933842|FG000|COMPLETED|Overall Study|13 evaluable for primary outcome, but 11 total completed study.|11
10770560|NCT03263780|11933842|FG000|NOT COMPLETED|Overall Study||10
10770561|NCT03264066|11933852|FG000|STARTED|Overall Study||20
10770562|NCT03264066|11933853|FG001|STARTED|Overall Study||20
10770563|NCT03264066|11933854|FG002|STARTED|Overall Study||17
10770564|NCT03264066|11933855|FG003|STARTED|Overall Study||20
10770565|NCT03264066|11933856|FG004|STARTED|Overall Study||7
10770566|NCT03264066|11933857|FG005|STARTED|Overall Study||3
10770567|NCT03264066|11933852|FG000|COMPLETED|Overall Study||0
10770568|NCT03264066|11933853|FG001|COMPLETED|Overall Study||0
10770569|NCT03264066|11933854|FG002|COMPLETED|Overall Study||0
10770570|NCT03264066|11933855|FG003|COMPLETED|Overall Study||0
10770571|NCT03264066|11933856|FG004|COMPLETED|Overall Study||0
10770572|NCT03264066|11933857|FG005|COMPLETED|Overall Study||0
10770573|NCT03264066|11933852|FG000|NOT COMPLETED|Overall Study||20
10770574|NCT03264066|11933853|FG001|NOT COMPLETED|Overall Study||20
10770575|NCT03264066|11933854|FG002|NOT COMPLETED|Overall Study||17
10770576|NCT03264066|11933855|FG003|NOT COMPLETED|Overall Study||20
10770577|NCT03264066|11933856|FG004|NOT COMPLETED|Overall Study||7
10770578|NCT03264066|11933857|FG005|NOT COMPLETED|Overall Study||3
10770579|NCT03264092|11933875|FG000|STARTED|Overall Study||17
10770580|NCT03264092|11933876|FG001|STARTED|Overall Study||20
10770581|NCT03264092|11933877|FG002|STARTED|Overall Study||18
10770582|NCT03264092|11933875|FG000|COMPLETED|Overall Study||17
10770583|NCT03264092|11933876|FG001|COMPLETED|Overall Study||20
10770584|NCT03264092|11933877|FG002|COMPLETED|Overall Study||18
10770585|NCT03264092|11933875|FG000|NOT COMPLETED|Overall Study||0
10770586|NCT03264092|11933876|FG001|NOT COMPLETED|Overall Study||0
10770587|NCT03264092|11933877|FG002|NOT COMPLETED|Overall Study||0
10770588|NCT03264157|11933893|FG000|STARTED|Overall Study||81
10770589|NCT03264157|11933894|FG001|STARTED|Overall Study||81
10770590|NCT03264157|11933893|FG000|COMPLETED|Overall Study||68
10770591|NCT03264157|11933894|FG001|COMPLETED|Overall Study||74
10770592|NCT03264157|11933893|FG000|NOT COMPLETED|Overall Study||13
10770593|NCT03264157|11933894|FG001|NOT COMPLETED|Overall Study||7
10770594|NCT03264248|11933902|FG000|STARTED|Overall Study||9
10770595|NCT03264248|11933902|FG000|COMPLETED|Overall Study||9
10770596|NCT03264248|11933902|FG000|NOT COMPLETED|Overall Study||0
10770597|NCT03264456|11933906|FG000|STARTED|Overall Study||18
10770598|NCT03264456|11933906|FG000|COMPLETED|Overall Study||14
10770599|NCT03264456|11933906|FG000|NOT COMPLETED|Overall Study||4
10770600|NCT03265119|11933912|FG000|STARTED|Overall Study||34
10770601|NCT03265119|11933913|FG001|STARTED|Overall Study||35
10770602|NCT03265119|11933912|FG000|COMPLETED|Overall Study||24
10770603|NCT03265119|11933913|FG001|COMPLETED|Overall Study||28
10770604|NCT03265119|11933912|FG000|NOT COMPLETED|Overall Study||10
10770605|NCT03265119|11933913|FG001|NOT COMPLETED|Overall Study||7
10770606|NCT03265132|11933921|FG000|STARTED|Overall Study||6
10770607|NCT03265132|11933922|FG001|STARTED|Overall Study|One patient failed disease specific inclusion criteria and was excluded from efficacy analysis|6
10770608|NCT03265132|11933921|FG000|COMPLETED|Overall Study||6
10770609|NCT03265132|11933922|FG001|COMPLETED|Overall Study||0
10770610|NCT03265132|11933921|FG000|NOT COMPLETED|Overall Study||0
10770611|NCT03265132|11933922|FG001|NOT COMPLETED|Overall Study||6
10770612|NCT03265600|11933932|FG000|STARTED|Overall Study||92
10770613|NCT03265600|11933933|FG001|STARTED|Overall Study||44
10770614|NCT03265600|11933932|FG000|COMPLETED|Overall Study|Completed 8 or 9 week Action Plan Initiation Survey|68
10770615|NCT03265600|11933933|FG001|COMPLETED|Overall Study|Completed 8 or 9 week Action Plan Initiation Survey|32
10770616|NCT03265600|11933932|FG000|NOT COMPLETED|Overall Study||24
10770617|NCT03265600|11933933|FG001|NOT COMPLETED|Overall Study||12
10770618|NCT03265938|11933939|FG000|STARTED|Overall Study||100
10770619|NCT03265938|11933939|FG000|COMPLETED|Overall Study||92
10770620|NCT03265938|11933939|FG000|NOT COMPLETED|Overall Study||8
10770621|NCT03266094|11933944|FG000|STARTED|Overall Study||60
10770622|NCT03266094|11933944|FG000|COMPLETED|Overall Study||58
10770623|NCT03266094|11933944|FG000|NOT COMPLETED|Overall Study||2
10770624|NCT03266107|11933950|FG000|STARTED|Enrollment to Procedure||50
10770625|NCT03266107|11933950|FG000|COMPLETED|Enrollment to Procedure||47
10770626|NCT03266107|11933950|FG000|NOT COMPLETED|Enrollment to Procedure||3
10770627|NCT03266107|11933950|FG000|STARTED|3-Month Follow-up Visit||47
10770628|NCT03266107|11933950|FG000|COMPLETED|3-Month Follow-up Visit||46
10770629|NCT03266107|11933950|FG000|NOT COMPLETED|3-Month Follow-up Visit||1
10770630|NCT03266107|11933950|FG000|STARTED|12-Month Follow-up Visit||46
10770631|NCT03266107|11933950|FG000|COMPLETED|12-Month Follow-up Visit||45
10770632|NCT03266107|11933950|FG000|NOT COMPLETED|12-Month Follow-up Visit||1
10770633|NCT03266172|11933959|FG000|STARTED|Part A: Period 1(2 Days)||16
10770634|NCT03266172|11933960|FG001|STARTED|Part A: Period 1(2 Days)||0
10770635|NCT03266172|11933961|FG002|STARTED|Part A: Period 1(2 Days)||0
10770636|NCT03266172|11933959|FG000|COMPLETED|Part A: Period 1(2 Days)||15
10770637|NCT03266172|11933960|FG001|COMPLETED|Part A: Period 1(2 Days)||0
10770638|NCT03266172|11933961|FG002|COMPLETED|Part A: Period 1(2 Days)||0
10770639|NCT03266172|11933959|FG000|NOT COMPLETED|Part A: Period 1(2 Days)||1
10770640|NCT03266172|11933960|FG001|NOT COMPLETED|Part A: Period 1(2 Days)||0
10770641|NCT03266172|11933961|FG002|NOT COMPLETED|Part A: Period 1(2 Days)||0
10770642|NCT03266172|11933959|FG000|STARTED|Part A: Washout Period (7 Days)||15
10770643|NCT03266172|11933960|FG001|STARTED|Part A: Washout Period (7 Days)||0
10770644|NCT03266172|11933961|FG002|STARTED|Part A: Washout Period (7 Days)||0
10770645|NCT03266172|11933959|FG000|COMPLETED|Part A: Washout Period (7 Days)||13
10770646|NCT03266172|11933960|FG001|COMPLETED|Part A: Washout Period (7 Days)||0
10770647|NCT03266172|11933961|FG002|COMPLETED|Part A: Washout Period (7 Days)||0
10770648|NCT03266172|11933959|FG000|NOT COMPLETED|Part A: Washout Period (7 Days)||2
10770649|NCT03266172|11933960|FG001|NOT COMPLETED|Part A: Washout Period (7 Days)||0
10770650|NCT03266172|11933961|FG002|NOT COMPLETED|Part A: Washout Period (7 Days)||0
10770651|NCT03266172|11933959|FG000|STARTED|Part A: Period 2 (2 Days)||13
10770652|NCT03266172|11933960|FG001|STARTED|Part A: Period 2 (2 Days)||0
10770653|NCT03266172|11933961|FG002|STARTED|Part A: Period 2 (2 Days)||0
10770654|NCT03266172|11933959|FG000|COMPLETED|Part A: Period 2 (2 Days)||13
10770655|NCT03266172|11933960|FG001|COMPLETED|Part A: Period 2 (2 Days)||0
10770656|NCT03266172|11933961|FG002|COMPLETED|Part A: Period 2 (2 Days)||0
10770657|NCT03266172|11933959|FG000|NOT COMPLETED|Part A: Period 2 (2 Days)||0
10770658|NCT03266172|11933960|FG001|NOT COMPLETED|Part A: Period 2 (2 Days)||0
10770659|NCT03266172|11933961|FG002|NOT COMPLETED|Part A: Period 2 (2 Days)||0
10770660|NCT03266172|11933959|FG000|STARTED|Part A: Washout (7 Days)||13
10770661|NCT03266172|11933960|FG001|STARTED|Part A: Washout (7 Days)||0
10770662|NCT03266172|11933961|FG002|STARTED|Part A: Washout (7 Days)||0
10770663|NCT03266172|11933959|FG000|COMPLETED|Part A: Washout (7 Days)||13
10770664|NCT03266172|11933960|FG001|COMPLETED|Part A: Washout (7 Days)||0
10770665|NCT03266172|11933961|FG002|COMPLETED|Part A: Washout (7 Days)||0
10770666|NCT03266172|11933959|FG000|NOT COMPLETED|Part A: Washout (7 Days)||0
10770667|NCT03266172|11933960|FG001|NOT COMPLETED|Part A: Washout (7 Days)||0
10770668|NCT03266172|11933961|FG002|NOT COMPLETED|Part A: Washout (7 Days)||0
10770669|NCT03266172|11933959|FG000|STARTED|Part A: Period 3 (2 Days)|3 replacement participants were enrolled|16
10770670|NCT03266172|11933960|FG001|STARTED|Part A: Period 3 (2 Days)||0
10770671|NCT03266172|11933961|FG002|STARTED|Part A: Period 3 (2 Days)||0
10770672|NCT03266172|11933959|FG000|COMPLETED|Part A: Period 3 (2 Days)||16
10770673|NCT03266172|11933960|FG001|COMPLETED|Part A: Period 3 (2 Days)||0
10770674|NCT03266172|11933961|FG002|COMPLETED|Part A: Period 3 (2 Days)||0
10770675|NCT03266172|11933959|FG000|NOT COMPLETED|Part A: Period 3 (2 Days)||0
10770676|NCT03266172|11933960|FG001|NOT COMPLETED|Part A: Period 3 (2 Days)||0
10770677|NCT03266172|11933961|FG002|NOT COMPLETED|Part A: Period 3 (2 Days)||0
10770678|NCT03266172|11933959|FG000|STARTED|Part A: Washout (7 Days)||16
10770679|NCT03266172|11933960|FG001|STARTED|Part A: Washout (7 Days)||0
10770680|NCT03266172|11933961|FG002|STARTED|Part A: Washout (7 Days)||0
10770681|NCT03266172|11933959|FG000|COMPLETED|Part A: Washout (7 Days)||16
10770682|NCT03266172|11933960|FG001|COMPLETED|Part A: Washout (7 Days)||0
10770683|NCT03266172|11933961|FG002|COMPLETED|Part A: Washout (7 Days)||0
10770684|NCT03266172|11933959|FG000|NOT COMPLETED|Part A: Washout (7 Days)||0
10770685|NCT03266172|11933960|FG001|NOT COMPLETED|Part A: Washout (7 Days)||0
10770686|NCT03266172|11933961|FG002|NOT COMPLETED|Part A: Washout (7 Days)||0
10770687|NCT03266172|11933959|FG000|STARTED|Part A: Period 4 (2 Days)||16
10770688|NCT03266172|11933960|FG001|STARTED|Part A: Period 4 (2 Days)||0
10770689|NCT03266172|11933961|FG002|STARTED|Part A: Period 4 (2 Days)||0
10770690|NCT03266172|11933959|FG000|COMPLETED|Part A: Period 4 (2 Days)||16
10770691|NCT03266172|11933960|FG001|COMPLETED|Part A: Period 4 (2 Days)||0
10770692|NCT03266172|11933961|FG002|COMPLETED|Part A: Period 4 (2 Days)||0
10770693|NCT03266172|11933959|FG000|NOT COMPLETED|Part A: Period 4 (2 Days)||0
10770694|NCT03266172|11933960|FG001|NOT COMPLETED|Part A: Period 4 (2 Days)||0
10770695|NCT03266172|11933961|FG002|NOT COMPLETED|Part A: Period 4 (2 Days)||0
10770696|NCT03266172|11933959|FG000|STARTED|Part B: Period 1 (4 Days)|Participants from Part A did not enter Part B|0
10770697|NCT03266172|11933960|FG001|STARTED|Part B: Period 1 (4 Days)|New participants were enrolled in Part B of study|10
10770698|NCT03266172|11933961|FG002|STARTED|Part B: Period 1 (4 Days)||0
10770699|NCT03266172|11933959|FG000|COMPLETED|Part B: Period 1 (4 Days)||0
10770700|NCT03266172|11933960|FG001|COMPLETED|Part B: Period 1 (4 Days)||10
10770701|NCT03266172|11933961|FG002|COMPLETED|Part B: Period 1 (4 Days)||0
10770702|NCT03266172|11933959|FG000|NOT COMPLETED|Part B: Period 1 (4 Days)||0
10770703|NCT03266172|11933960|FG001|NOT COMPLETED|Part B: Period 1 (4 Days)||0
10770704|NCT03266172|11933961|FG002|NOT COMPLETED|Part B: Period 1 (4 Days)||0
10770705|NCT03266172|11933959|FG000|STARTED|Part B: Washout (7 Days)||0
10770706|NCT03266172|11933960|FG001|STARTED|Part B: Washout (7 Days)||10
10770707|NCT03266172|11933961|FG002|STARTED|Part B: Washout (7 Days)||0
10770708|NCT03266172|11933959|FG000|COMPLETED|Part B: Washout (7 Days)||0
10770709|NCT03266172|11933960|FG001|COMPLETED|Part B: Washout (7 Days)||10
10770710|NCT03266172|11933961|FG002|COMPLETED|Part B: Washout (7 Days)||0
10770711|NCT03266172|11933959|FG000|NOT COMPLETED|Part B: Washout (7 Days)||0
10770712|NCT03266172|11933960|FG001|NOT COMPLETED|Part B: Washout (7 Days)||0
10770713|NCT03266172|11933961|FG002|NOT COMPLETED|Part B: Washout (7 Days)||0
10770714|NCT03266172|11933959|FG000|STARTED|Part B: Period 2 (4 Days)||0
10770715|NCT03266172|11933960|FG001|STARTED|Part B: Period 2 (4 Days)||10
10770716|NCT03266172|11933961|FG002|STARTED|Part B: Period 2 (4 Days)||0
10770717|NCT03266172|11933959|FG000|COMPLETED|Part B: Period 2 (4 Days)||0
10770718|NCT03266172|11933960|FG001|COMPLETED|Part B: Period 2 (4 Days)||10
10770719|NCT03266172|11933961|FG002|COMPLETED|Part B: Period 2 (4 Days)||0
10770720|NCT03266172|11933959|FG000|NOT COMPLETED|Part B: Period 2 (4 Days)||0
10770721|NCT03266172|11933960|FG001|NOT COMPLETED|Part B: Period 2 (4 Days)||0
10770722|NCT03266172|11933961|FG002|NOT COMPLETED|Part B: Period 2 (4 Days)||0
10770723|NCT03266172|11933959|FG000|STARTED|Part B: Washout (7 Days)||0
10770724|NCT03266172|11933960|FG001|STARTED|Part B: Washout (7 Days)||10
10770725|NCT03266172|11933961|FG002|STARTED|Part B: Washout (7 Days)||0
10770726|NCT03266172|11933959|FG000|COMPLETED|Part B: Washout (7 Days)||0
10770727|NCT03266172|11933960|FG001|COMPLETED|Part B: Washout (7 Days)||8
10770728|NCT03266172|11933961|FG002|COMPLETED|Part B: Washout (7 Days)||0
10770729|NCT03266172|11933959|FG000|NOT COMPLETED|Part B: Washout (7 Days)||0
10770730|NCT03266172|11933960|FG001|NOT COMPLETED|Part B: Washout (7 Days)||2
10770731|NCT03266172|11933961|FG002|NOT COMPLETED|Part B: Washout (7 Days)||0
10770732|NCT03266172|11933959|FG000|STARTED|Part B: Period 3 (4 Days)||0
10770733|NCT03266172|11933960|FG001|STARTED|Part B: Period 3 (4 Days)|Two participants completed Washout Period but withdrew before the start of Period 3.|6
10770734|NCT03266172|11933961|FG002|STARTED|Part B: Period 3 (4 Days)||0
10770735|NCT03266172|11933959|FG000|COMPLETED|Part B: Period 3 (4 Days)||0
10770736|NCT03266172|11933960|FG001|COMPLETED|Part B: Period 3 (4 Days)||6
10770737|NCT03266172|11933961|FG002|COMPLETED|Part B: Period 3 (4 Days)||0
10770738|NCT03266172|11933959|FG000|NOT COMPLETED|Part B: Period 3 (4 Days)||0
10770739|NCT03266172|11933960|FG001|NOT COMPLETED|Part B: Period 3 (4 Days)||0
10770740|NCT03266172|11933961|FG002|NOT COMPLETED|Part B: Period 3 (4 Days)||0
10770741|NCT03266172|11933959|FG000|STARTED|Part C: Period 1(2 Days)||0
10770742|NCT03266172|11933960|FG001|STARTED|Part C: Period 1(2 Days)|Participants from Part B did not enter Part C|0
10770743|NCT03266172|11933961|FG002|STARTED|Part C: Period 1(2 Days)|New participants were enrolled in Part C of study|15
10770744|NCT03266172|11933959|FG000|COMPLETED|Part C: Period 1(2 Days)||0
10770745|NCT03266172|11933960|FG001|COMPLETED|Part C: Period 1(2 Days)||0
10770746|NCT03266172|11933961|FG002|COMPLETED|Part C: Period 1(2 Days)||15
10770747|NCT03266172|11933959|FG000|NOT COMPLETED|Part C: Period 1(2 Days)||0
10770748|NCT03266172|11933960|FG001|NOT COMPLETED|Part C: Period 1(2 Days)||0
10770749|NCT03266172|11933961|FG002|NOT COMPLETED|Part C: Period 1(2 Days)||0
10770750|NCT03266172|11933959|FG000|STARTED|Part C Washout Period (7 Days)||0
10770751|NCT03266172|11933960|FG001|STARTED|Part C Washout Period (7 Days)||0
10770752|NCT03266172|11933961|FG002|STARTED|Part C Washout Period (7 Days)||15
10770753|NCT03266172|11933959|FG000|COMPLETED|Part C Washout Period (7 Days)||0
10770754|NCT03266172|11933960|FG001|COMPLETED|Part C Washout Period (7 Days)||0
10770755|NCT03266172|11933961|FG002|COMPLETED|Part C Washout Period (7 Days)||15
10770756|NCT03266172|11933959|FG000|NOT COMPLETED|Part C Washout Period (7 Days)||0
10770757|NCT03266172|11933960|FG001|NOT COMPLETED|Part C Washout Period (7 Days)||0
10770758|NCT03266172|11933961|FG002|NOT COMPLETED|Part C Washout Period (7 Days)||0
10770759|NCT03266172|11933959|FG000|STARTED|Part C Period 2(2 Days)||0
10770760|NCT03266172|11933960|FG001|STARTED|Part C Period 2(2 Days)||0
10770761|NCT03266172|11933961|FG002|STARTED|Part C Period 2(2 Days)||15
10770762|NCT03266172|11933959|FG000|COMPLETED|Part C Period 2(2 Days)||0
10770763|NCT03266172|11933960|FG001|COMPLETED|Part C Period 2(2 Days)||0
10770764|NCT03266172|11933961|FG002|COMPLETED|Part C Period 2(2 Days)||15
10770765|NCT03266172|11933959|FG000|NOT COMPLETED|Part C Period 2(2 Days)||0
10770766|NCT03266172|11933960|FG001|NOT COMPLETED|Part C Period 2(2 Days)||0
10770767|NCT03266172|11933961|FG002|NOT COMPLETED|Part C Period 2(2 Days)||0
10770768|NCT03266172|11933959|FG000|STARTED|Part C Washout Period (7 Days)||0
10770769|NCT03266172|11933960|FG001|STARTED|Part C Washout Period (7 Days)||0
10770770|NCT03266172|11933961|FG002|STARTED|Part C Washout Period (7 Days)||15
10770771|NCT03266172|11933959|FG000|COMPLETED|Part C Washout Period (7 Days)||0
10770772|NCT03266172|11933960|FG001|COMPLETED|Part C Washout Period (7 Days)||0
10770773|NCT03266172|11933961|FG002|COMPLETED|Part C Washout Period (7 Days)||15
10770774|NCT03266172|11933959|FG000|NOT COMPLETED|Part C Washout Period (7 Days)||0
10770775|NCT03266172|11933960|FG001|NOT COMPLETED|Part C Washout Period (7 Days)||0
10770776|NCT03266172|11933961|FG002|NOT COMPLETED|Part C Washout Period (7 Days)||0
10770777|NCT03266172|11933959|FG000|STARTED|Part C Period 3(2 Days)||0
10770778|NCT03266172|11933960|FG001|STARTED|Part C Period 3(2 Days)||0
10770779|NCT03266172|11933961|FG002|STARTED|Part C Period 3(2 Days)|1 replacement participant enrolled|16
10770780|NCT03266172|11933959|FG000|COMPLETED|Part C Period 3(2 Days)||0
10770781|NCT03266172|11933960|FG001|COMPLETED|Part C Period 3(2 Days)||0
10770782|NCT03266172|11933961|FG002|COMPLETED|Part C Period 3(2 Days)||16
10770783|NCT03266172|11933959|FG000|NOT COMPLETED|Part C Period 3(2 Days)||0
10770784|NCT03266172|11933960|FG001|NOT COMPLETED|Part C Period 3(2 Days)||0
10770785|NCT03266172|11933961|FG002|NOT COMPLETED|Part C Period 3(2 Days)||0
10770786|NCT03266172|11933959|FG000|STARTED|Part C Washout Period (7 Days)||0
10770787|NCT03266172|11933960|FG001|STARTED|Part C Washout Period (7 Days)||0
10770788|NCT03266172|11933961|FG002|STARTED|Part C Washout Period (7 Days)||16
10770789|NCT03266172|11933959|FG000|COMPLETED|Part C Washout Period (7 Days)||0
10770790|NCT03266172|11933960|FG001|COMPLETED|Part C Washout Period (7 Days)||0
10770791|NCT03266172|11933961|FG002|COMPLETED|Part C Washout Period (7 Days)||16
10770792|NCT03266172|11933959|FG000|NOT COMPLETED|Part C Washout Period (7 Days)||0
10770793|NCT03266172|11933960|FG001|NOT COMPLETED|Part C Washout Period (7 Days)||0
10770794|NCT03266172|11933961|FG002|NOT COMPLETED|Part C Washout Period (7 Days)||0
10770795|NCT03266172|11933959|FG000|STARTED|Part C Period 4(2 Days)||0
10770796|NCT03266172|11933960|FG001|STARTED|Part C Period 4(2 Days)||0
10770797|NCT03266172|11933961|FG002|STARTED|Part C Period 4(2 Days)||16
10770798|NCT03266172|11933959|FG000|COMPLETED|Part C Period 4(2 Days)||0
10770799|NCT03266172|11933960|FG001|COMPLETED|Part C Period 4(2 Days)||0
10770800|NCT03266172|11933961|FG002|COMPLETED|Part C Period 4(2 Days)||16
10770801|NCT03266172|11933959|FG000|NOT COMPLETED|Part C Period 4(2 Days)||0
10770802|NCT03266172|11933960|FG001|NOT COMPLETED|Part C Period 4(2 Days)||0
10770803|NCT03266172|11933961|FG002|NOT COMPLETED|Part C Period 4(2 Days)||0
10770804|NCT03266172|11933959|FG000|STARTED|Part C Washout Period (7 Days)||0
10770805|NCT03266172|11933960|FG001|STARTED|Part C Washout Period (7 Days)||0
10770806|NCT03266172|11933961|FG002|STARTED|Part C Washout Period (7 Days)||16
10770807|NCT03266172|11933959|FG000|COMPLETED|Part C Washout Period (7 Days)||0
10770808|NCT03266172|11933960|FG001|COMPLETED|Part C Washout Period (7 Days)||0
10770809|NCT03266172|11933961|FG002|COMPLETED|Part C Washout Period (7 Days)||15
10770810|NCT03266172|11933959|FG000|NOT COMPLETED|Part C Washout Period (7 Days)||0
10770811|NCT03266172|11933960|FG001|NOT COMPLETED|Part C Washout Period (7 Days)||0
10770812|NCT03266172|11933961|FG002|NOT COMPLETED|Part C Washout Period (7 Days)||1
10770813|NCT03266172|11933959|FG000|STARTED|Part C Period 5(2 Days)||0
10770814|NCT03266172|11933960|FG001|STARTED|Part C Period 5(2 Days)||0
10770815|NCT03266172|11933961|FG002|STARTED|Part C Period 5(2 Days)||15
10770816|NCT03266172|11933959|FG000|COMPLETED|Part C Period 5(2 Days)||0
10770817|NCT03266172|11933960|FG001|COMPLETED|Part C Period 5(2 Days)||0
10770818|NCT03266172|11933961|FG002|COMPLETED|Part C Period 5(2 Days)||15
10770819|NCT03266172|11933959|FG000|NOT COMPLETED|Part C Period 5(2 Days)||0
10770820|NCT03266172|11933960|FG001|NOT COMPLETED|Part C Period 5(2 Days)||0
10770821|NCT03266172|11933961|FG002|NOT COMPLETED|Part C Period 5(2 Days)||0
10770822|NCT03266172|11933959|FG000|STARTED|Part C Washout Period (7 Days)||0
10770823|NCT03266172|11933960|FG001|STARTED|Part C Washout Period (7 Days)||0
10770824|NCT03266172|11933961|FG002|STARTED|Part C Washout Period (7 Days)||15
10770825|NCT03266172|11933959|FG000|COMPLETED|Part C Washout Period (7 Days)||0
10770826|NCT03266172|11933960|FG001|COMPLETED|Part C Washout Period (7 Days)||0
10770827|NCT03266172|11933961|FG002|COMPLETED|Part C Washout Period (7 Days)||14
10770828|NCT03266172|11933959|FG000|NOT COMPLETED|Part C Washout Period (7 Days)||0
10770829|NCT03266172|11933960|FG001|NOT COMPLETED|Part C Washout Period (7 Days)||0
10770830|NCT03266172|11933961|FG002|NOT COMPLETED|Part C Washout Period (7 Days)||1
10770831|NCT03266172|11933959|FG000|STARTED|Part C Period 6(2 Days)||0
10770832|NCT03266172|11933960|FG001|STARTED|Part C Period 6(2 Days)||0
10770833|NCT03266172|11933961|FG002|STARTED|Part C Period 6(2 Days)||14
10770834|NCT03266172|11933959|FG000|COMPLETED|Part C Period 6(2 Days)||0
10770835|NCT03266172|11933960|FG001|COMPLETED|Part C Period 6(2 Days)||0
10770836|NCT03266172|11933961|FG002|COMPLETED|Part C Period 6(2 Days)||14
10770837|NCT03266172|11933959|FG000|NOT COMPLETED|Part C Period 6(2 Days)||0
10770838|NCT03266172|11933960|FG001|NOT COMPLETED|Part C Period 6(2 Days)||0
10770839|NCT03266172|11933961|FG002|NOT COMPLETED|Part C Period 6(2 Days)||0
10770840|NCT03266419|11934013|FG000|STARTED|Overall Study||51
10770841|NCT03266419|11934014|FG001|STARTED|Overall Study||49
10770842|NCT03266419|11934013|FG000|COMPLETED|Overall Study||51
10770843|NCT03266419|11934014|FG001|COMPLETED|Overall Study||49
10770844|NCT03266419|11934013|FG000|NOT COMPLETED|Overall Study||0
10770845|NCT03266419|11934014|FG001|NOT COMPLETED|Overall Study||0
10770846|NCT03266588|11934023|FG000|STARTED|Observational Period||1605
10770847|NCT03266588|11934024|FG001|STARTED|Observational Period||786
10770848|NCT03266588|11934025|FG002|STARTED|Observational Period||476
10770849|NCT03266588|11934023|FG000|COMPLETED|Observational Period||1089
10546851|NCT01509950|11700645|FG002|NOT COMPLETED|Overall Study||0
10546852|NCT01510028|11700655|FG000|STARTED|Overall Study||6
10546853|NCT01510028|11700656|FG001|STARTED|Overall Study||6
10546854|NCT01510028|11700657|FG002|STARTED|Overall Study||6
10546855|NCT01510028|11700658|FG003|STARTED|Overall Study||6
10546856|NCT01510028|11700655|FG000|COMPLETED|Overall Study||5
10546857|NCT01510028|11700656|FG001|COMPLETED|Overall Study||6
10546858|NCT01510028|11700657|FG002|COMPLETED|Overall Study||6
10546859|NCT01510028|11700658|FG003|COMPLETED|Overall Study||6
10546860|NCT01510028|11700655|FG000|NOT COMPLETED|Overall Study||1
10546861|NCT01510028|11700656|FG001|NOT COMPLETED|Overall Study||0
10546862|NCT01510028|11700657|FG002|NOT COMPLETED|Overall Study||0
10770850|NCT03266588|11934024|FG001|COMPLETED|Observational Period||511
10770851|NCT03266588|11934025|FG002|COMPLETED|Observational Period||308
10770852|NCT03266588|11934023|FG000|NOT COMPLETED|Observational Period||516
10770853|NCT03266588|11934024|FG001|NOT COMPLETED|Observational Period||275
10770854|NCT03266588|11934025|FG002|NOT COMPLETED|Observational Period||168
10770855|NCT03266588|11934023|FG000|STARTED|Long-term Treatment Period||1089
10770856|NCT03266588|11934024|FG001|STARTED|Long-term Treatment Period||511
10770857|NCT03266588|11934025|FG002|STARTED|Long-term Treatment Period||308
10770858|NCT03266588|11934023|FG000|Treated|Long-term Treatment Period||1033
10770859|NCT03266588|11934024|FG001|Treated|Long-term Treatment Period||481
10770860|NCT03266588|11934025|FG002|Treated|Long-term Treatment Period||286
10770861|NCT03266588|11934023|FG000|COMPLETED|Long-term Treatment Period||683
10770862|NCT03266588|11934024|FG001|COMPLETED|Long-term Treatment Period||271
10770863|NCT03266588|11934025|FG002|COMPLETED|Long-term Treatment Period||243
10770864|NCT03266588|11934023|FG000|NOT COMPLETED|Long-term Treatment Period||406
10770865|NCT03266588|11934024|FG001|NOT COMPLETED|Long-term Treatment Period||240
10770866|NCT03266588|11934025|FG002|NOT COMPLETED|Long-term Treatment Period||65
10770867|NCT03267212|11934033|FG000|STARTED|First Intervention|Non-invasive ventilation|6
10770868|NCT03267212|11934034|FG001|STARTED|First Intervention|"First Intervention (1 day), Washout (2 days), and Second Intervention (1 day)"|9
10770869|NCT03267212|11934033|FG000|High SCI|First Intervention||2
10770870|NCT03267212|11934034|FG001|High SCI|First Intervention||5
10770871|NCT03267212|11934033|FG000|Low SCI|First Intervention||4
10770872|NCT03267212|11934034|FG001|Low SCI|First Intervention||4
10770873|NCT03267212|11934033|FG000|COMPLETED|First Intervention||5
10770874|NCT03267212|11934034|FG001|COMPLETED|First Intervention||6
10770875|NCT03267212|11934033|FG000|NOT COMPLETED|First Intervention||1
10770876|NCT03267212|11934034|FG001|NOT COMPLETED|First Intervention||3
10770877|NCT03267212|11934033|FG000|STARTED|Washout (Min 2 Days / Max 7 Days)||5
10770878|NCT03267212|11934034|FG001|STARTED|Washout (Min 2 Days / Max 7 Days)||6
10770879|NCT03267212|11934033|FG000|COMPLETED|Washout (Min 2 Days / Max 7 Days)||4
10770880|NCT03267212|11934034|FG001|COMPLETED|Washout (Min 2 Days / Max 7 Days)||6
10770881|NCT03267212|11934033|FG000|NOT COMPLETED|Washout (Min 2 Days / Max 7 Days)||1
10770882|NCT03267212|11934034|FG001|NOT COMPLETED|Washout (Min 2 Days / Max 7 Days)||0
10770883|NCT03267212|11934033|FG000|STARTED|Second Intervention||4
10770884|NCT03267212|11934034|FG001|STARTED|Second Intervention||6
10770885|NCT03267212|11934033|FG000|COMPLETED|Second Intervention||4
10770886|NCT03267212|11934034|FG001|COMPLETED|Second Intervention||6
10770887|NCT03267212|11934033|FG000|NOT COMPLETED|Second Intervention||0
10770888|NCT03267212|11934034|FG001|NOT COMPLETED|Second Intervention||0
10770889|NCT03267264|11934044|FG000|STARTED|Overall Study||66
10770890|NCT03267264|11934045|FG001|STARTED|Overall Study||49
10770891|NCT03267264|11934046|FG002|STARTED|Overall Study||68
10770892|NCT03267264|11934047|FG003|STARTED|Overall Study||65
10770893|NCT03267264|11934044|FG000|Sequence A(Nucleus)|Overall Study||34
10770894|NCT03267264|11934045|FG001|Sequence A(Nucleus)|Overall Study||25
10770895|NCT03267264|11934046|FG002|Sequence A(Nucleus)|Overall Study||33
10770896|NCT03267264|11934047|FG003|Sequence A(Nucleus)|Overall Study||33
10770897|NCT03267264|11934044|FG000|Sequence B(Comparator)|Overall Study||32
10770898|NCT03267264|11934045|FG001|Sequence B(Comparator)|Overall Study||24
10770899|NCT03267264|11934046|FG002|Sequence B(Comparator)|Overall Study||33
10770900|NCT03267264|11934047|FG003|Sequence B(Comparator)|Overall Study||32
10770901|NCT03267264|11934044|FG000|COMPLETED|Overall Study||65
10770902|NCT03267264|11934045|FG001|COMPLETED|Overall Study||49
10770903|NCT03267264|11934046|FG002|COMPLETED|Overall Study||66
10770904|NCT03267264|11934047|FG003|COMPLETED|Overall Study||61
10770905|NCT03267264|11934044|FG000|NOT COMPLETED|Overall Study||1
10770906|NCT03267264|11934045|FG001|NOT COMPLETED|Overall Study||0
10770907|NCT03267264|11934046|FG002|NOT COMPLETED|Overall Study||2
10770908|NCT03267264|11934047|FG003|NOT COMPLETED|Overall Study||4
10770909|NCT03267511|11934064|FG000|STARTED|Overall Study||31
10770910|NCT03267511|11934065|FG001|STARTED|Overall Study||31
10770911|NCT03267511|11934066|FG002|STARTED|Overall Study||30
10546863|NCT01510028|11700658|FG003|NOT COMPLETED|Overall Study||0
10770912|NCT03267511|11934067|FG003|STARTED|Overall Study||31
10770913|NCT03267511|11934064|FG000|COMPLETED|Overall Study||31
10770914|NCT03267511|11934065|FG001|COMPLETED|Overall Study||31
10770915|NCT03267511|11934066|FG002|COMPLETED|Overall Study||30
10770916|NCT03267511|11934067|FG003|COMPLETED|Overall Study||30
10770917|NCT03267511|11934064|FG000|NOT COMPLETED|Overall Study||0
10770918|NCT03267511|11934065|FG001|NOT COMPLETED|Overall Study||0
10770919|NCT03267511|11934066|FG002|NOT COMPLETED|Overall Study||0
10770920|NCT03267511|11934067|FG003|NOT COMPLETED|Overall Study||1
10770921|NCT03267576|11934081|FG000|STARTED|Period 1: Day 0 to 27||31
10770922|NCT03267576|11934082|FG001|STARTED|Period 1: Day 0 to 27||32
10770923|NCT03267576|11934081|FG000|COMPLETED|Period 1: Day 0 to 27||31
10770924|NCT03267576|11934082|FG001|COMPLETED|Period 1: Day 0 to 27||32
10770925|NCT03267576|11934081|FG000|NOT COMPLETED|Period 1: Day 0 to 27||0
10770926|NCT03267576|11934082|FG001|NOT COMPLETED|Period 1: Day 0 to 27||0
10770927|NCT03267576|11934081|FG000|STARTED|Washout Period: 16 Days||31
10770928|NCT03267576|11934082|FG001|STARTED|Washout Period: 16 Days||32
10770929|NCT03267576|11934081|FG000|COMPLETED|Washout Period: 16 Days||31
10770930|NCT03267576|11934082|FG001|COMPLETED|Washout Period: 16 Days||32
10770931|NCT03267576|11934081|FG000|NOT COMPLETED|Washout Period: 16 Days||0
10770932|NCT03267576|11934082|FG001|NOT COMPLETED|Washout Period: 16 Days||0
10770933|NCT03267576|11934081|FG000|STARTED|Period 2: Day 44 to 71||31
10770934|NCT03267576|11934082|FG001|STARTED|Period 2: Day 44 to 71||32
10770935|NCT03267576|11934081|FG000|COMPLETED|Period 2: Day 44 to 71||30
10770936|NCT03267576|11934082|FG001|COMPLETED|Period 2: Day 44 to 71||30
10770937|NCT03267576|11934081|FG000|NOT COMPLETED|Period 2: Day 44 to 71||1
10770938|NCT03267576|11934082|FG001|NOT COMPLETED|Period 2: Day 44 to 71||2
10770939|NCT03267940|11934094|FG000|STARTED|Run-in Portion (Max. Exposure: 508 Days)||9
10770940|NCT03267940|11934095|FG001|STARTED|Run-in Portion (Max. Exposure: 508 Days)||9
10770941|NCT03267940|11934096|FG002|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
10770942|NCT03267940|11934097|FG003|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
10770943|NCT03267940|11934098|FG004|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
10770944|NCT03267940|11934099|FG005|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
10770945|NCT03267940|11934094|FG000|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||9
10770946|NCT03267940|11934095|FG001|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||9
10770947|NCT03267940|11934096|FG002|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
10770948|NCT03267940|11934097|FG003|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
10297929|NCT00005047|11430542|FG001|NOT COMPLETED|Overall Study||0
10297930|NCT00005047|11430543|FG002|NOT COMPLETED|Overall Study||0
10297931|NCT00005047|11430544|FG003|NOT COMPLETED|Overall Study||0
10297932|NCT00005669|11430556|FG000|STARTED|Overall Study||53
10297933|NCT00005669|11430557|FG001|STARTED|Overall Study||47
10297934|NCT00005669|11430556|FG000|COMPLETED|Overall Study||45
10297935|NCT00005669|11430557|FG001|COMPLETED|Overall Study||40
10297936|NCT00005669|11430556|FG000|NOT COMPLETED|Overall Study||8
10297937|NCT00005669|11430557|FG001|NOT COMPLETED|Overall Study||7
10297938|NCT00005803|11430563|FG000|STARTED|Overall Study||76
10297939|NCT00005803|11430563|FG000|COMPLETED|Overall Study||54
10297940|NCT00005803|11430563|FG000|NOT COMPLETED|Overall Study||22
10297941|NCT00005879|11430572|FG000|STARTED|Overall Study||101
10297942|NCT00005879|11430573|FG001|STARTED|Overall Study||98
10297943|NCT00005879|11430572|FG000|COMPLETED|Overall Study||93
10297944|NCT00005879|11430573|FG001|COMPLETED|Overall Study||88
10297945|NCT00005879|11430572|FG000|NOT COMPLETED|Overall Study||8
10770949|NCT03267940|11934098|FG004|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
10770950|NCT03267940|11934099|FG005|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
10770951|NCT03267940|11934094|FG000|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||1
10770952|NCT03267940|11934095|FG001|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||2
10770953|NCT03267940|11934096|FG002|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
10770954|NCT03267940|11934097|FG003|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
10770955|NCT03267940|11934098|FG004|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
10770956|NCT03267940|11934099|FG005|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
10770957|NCT03267940|11934094|FG000|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||8
10770958|NCT03267940|11934095|FG001|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||7
10779141|NCT03364309|11940868|FG009|NOT COMPLETED|Induction Period||0
10779142|NCT03364309|11940869|FG010|NOT COMPLETED|Induction Period||0
10779143|NCT03364309|11940870|FG011|NOT COMPLETED|Induction Period||0
10779144|NCT03364309|11940871|FG012|NOT COMPLETED|Induction Period||0
10779145|NCT03364309|11940872|FG013|NOT COMPLETED|Induction Period||0
10779146|NCT03364309|11940873|FG014|NOT COMPLETED|Induction Period||0
10779147|NCT03364309|11940874|FG015|NOT COMPLETED|Induction Period||0
10779148|NCT03364309|11940875|FG016|NOT COMPLETED|Induction Period||0
10779149|NCT03364309|11940876|FG017|NOT COMPLETED|Induction Period||0
10779150|NCT03364309|11940877|FG018|NOT COMPLETED|Induction Period||0
10779151|NCT03364309|11940859|FG000|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|0
10779152|NCT03364309|11940860|FG001|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|0
10779153|NCT03364309|11940861|FG002|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|0
10779154|NCT03364309|11940862|FG003|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|47
10779155|NCT03364309|11940863|FG004|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|92
10779156|NCT03364309|11940864|FG005|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|50
10779157|NCT03364309|11940865|FG006|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|100
10779158|NCT03364309|11940866|FG007|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|3
10779159|NCT03364309|11940867|FG008|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|79
10770959|NCT03267940|11934096|FG002|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
10770960|NCT03267940|11934097|FG003|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
10770961|NCT03267940|11934098|FG004|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
10770962|NCT03267940|11934099|FG005|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
10770963|NCT03267940|11934094|FG000|STARTED|Expansion (Maximum Exposure: 421 Days)||0
10770964|NCT03267940|11934095|FG001|STARTED|Expansion (Maximum Exposure: 421 Days)||0
10770965|NCT03267940|11934096|FG002|STARTED|Expansion (Maximum Exposure: 421 Days)||24
10770966|NCT03267940|11934097|FG003|STARTED|Expansion (Maximum Exposure: 421 Days)||22
10770967|NCT03267940|11934098|FG004|STARTED|Expansion (Maximum Exposure: 421 Days)||11
10770968|NCT03267940|11934099|FG005|STARTED|Expansion (Maximum Exposure: 421 Days)||10
10770969|NCT03267940|11934094|FG000|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||0
10770970|NCT03267940|11934095|FG001|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||0
10770971|NCT03267940|11934096|FG002|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||24
10770972|NCT03267940|11934097|FG003|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||22
10770973|NCT03267940|11934098|FG004|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||11
10770974|NCT03267940|11934099|FG005|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||10
10770975|NCT03267940|11934094|FG000|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
10770976|NCT03267940|11934095|FG001|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
10770977|NCT03267940|11934096|FG002|COMPLETED|Expansion (Maximum Exposure: 421 Days)||3
10770978|NCT03267940|11934097|FG003|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
10770979|NCT03267940|11934098|FG004|COMPLETED|Expansion (Maximum Exposure: 421 Days)||1
10770980|NCT03267940|11934099|FG005|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
10770981|NCT03267940|11934094|FG000|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
10770982|NCT03267940|11934095|FG001|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
10770983|NCT03267940|11934096|FG002|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||21
10770984|NCT03267940|11934097|FG003|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||22
10770985|NCT03267940|11934098|FG004|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||10
10770986|NCT03267940|11934099|FG005|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||10
10770987|NCT03268343|11934117|FG000|STARTED|Overall Study||12
10770988|NCT03268343|11934118|FG001|STARTED|Overall Study||12
10770989|NCT03268343|11934117|FG000|COMPLETED|Overall Study||12
10770990|NCT03268343|11934118|FG001|COMPLETED|Overall Study||12
10770991|NCT03268343|11934117|FG000|NOT COMPLETED|Overall Study||0
10770992|NCT03268343|11934118|FG001|NOT COMPLETED|Overall Study||0
10770993|NCT03268590|11934125|FG000|STARTED|Overall Study||33
10770994|NCT03268590|11934125|FG000|COMPLETED|Overall Study|One participant did not complete MRI due to a previously undiagnosed subdermal metal shard in scalp.|32
10770995|NCT03268590|11934125|FG000|NOT COMPLETED|Overall Study||1
10770996|NCT03268746|11934132|FG000|STARTED|Overall Study||45
10770997|NCT03268746|11934132|FG000|COMPLETED|Overall Study||44
10770998|NCT03268746|11934132|FG000|NOT COMPLETED|Overall Study||1
10770999|NCT03268941|11934147|FG000|STARTED|Part 1 (Days 1 to 9)||12
10771000|NCT03268941|11934148|FG001|STARTED|Part 1 (Days 1 to 9)||14
10771001|NCT03268941|11934149|FG002|STARTED|Part 1 (Days 1 to 9)||12
10771002|NCT03268941|11934150|FG003|STARTED|Part 1 (Days 1 to 9)||13
10771003|NCT03268941|11934151|FG004|STARTED|Part 1 (Days 1 to 9)||0
10771004|NCT03268941|11934152|FG005|STARTED|Part 1 (Days 1 to 9)||0
10771005|NCT03268941|11934153|FG006|STARTED|Part 1 (Days 1 to 9)||0
10771006|NCT03268941|11934147|FG000|COMPLETED|Part 1 (Days 1 to 9)||11
10771007|NCT03268941|11934148|FG001|COMPLETED|Part 1 (Days 1 to 9)||14
10771008|NCT03268941|11934149|FG002|COMPLETED|Part 1 (Days 1 to 9)||12
10771009|NCT03268941|11934150|FG003|COMPLETED|Part 1 (Days 1 to 9)||11
10771010|NCT03268941|11934151|FG004|COMPLETED|Part 1 (Days 1 to 9)||0
10771011|NCT03268941|11934152|FG005|COMPLETED|Part 1 (Days 1 to 9)||0
10771012|NCT03268941|11934153|FG006|COMPLETED|Part 1 (Days 1 to 9)||0
10771013|NCT03268941|11934147|FG000|NOT COMPLETED|Part 1 (Days 1 to 9)||1
10771014|NCT03268941|11934148|FG001|NOT COMPLETED|Part 1 (Days 1 to 9)||0
10771015|NCT03268941|11934149|FG002|NOT COMPLETED|Part 1 (Days 1 to 9)||0
10771016|NCT03268941|11934150|FG003|NOT COMPLETED|Part 1 (Days 1 to 9)||2
10771017|NCT03268941|11934151|FG004|NOT COMPLETED|Part 1 (Days 1 to 9)||0
10771018|NCT03268941|11934152|FG005|NOT COMPLETED|Part 1 (Days 1 to 9)||0
10771019|NCT03268941|11934153|FG006|NOT COMPLETED|Part 1 (Days 1 to 9)||0
10771020|NCT03268941|11934147|FG000|STARTED|Part 2: Days 17 to 25||0
10771021|NCT03268941|11934148|FG001|STARTED|Part 2: Days 17 to 25||0
10771022|NCT03268941|11934149|FG002|STARTED|Part 2: Days 17 to 25||0
10771023|NCT03268941|11934150|FG003|STARTED|Part 2: Days 17 to 25||0
10771024|NCT03268941|11934151|FG004|STARTED|Part 2: Days 17 to 25||6
10771025|NCT03268941|11934152|FG005|STARTED|Part 2: Days 17 to 25||0
10771026|NCT03268941|11934153|FG006|STARTED|Part 2: Days 17 to 25||15
10771027|NCT03268941|11934147|FG000|Treated|Part 2: Days 17 to 25||0
10771028|NCT03268941|11934148|FG001|Treated|Part 2: Days 17 to 25||0
10771029|NCT03268941|11934149|FG002|Treated|Part 2: Days 17 to 25||0
10771030|NCT03268941|11934150|FG003|Treated|Part 2: Days 17 to 25||0
10771031|NCT03268941|11934151|FG004|Treated|Part 2: Days 17 to 25||6
10771032|NCT03268941|11934152|FG005|Treated|Part 2: Days 17 to 25||0
10771033|NCT03268941|11934153|FG006|Treated|Part 2: Days 17 to 25||13
10771034|NCT03268941|11934147|FG000|COMPLETED|Part 2: Days 17 to 25||0
10771035|NCT03268941|11934148|FG001|COMPLETED|Part 2: Days 17 to 25||0
10771036|NCT03268941|11934149|FG002|COMPLETED|Part 2: Days 17 to 25||0
10771037|NCT03268941|11934150|FG003|COMPLETED|Part 2: Days 17 to 25||0
10771038|NCT03268941|11934151|FG004|COMPLETED|Part 2: Days 17 to 25||6
10771039|NCT03268941|11934152|FG005|COMPLETED|Part 2: Days 17 to 25||0
10771040|NCT03268941|11934153|FG006|COMPLETED|Part 2: Days 17 to 25||13
10771041|NCT03268941|11934147|FG000|NOT COMPLETED|Part 2: Days 17 to 25||0
10771042|NCT03268941|11934148|FG001|NOT COMPLETED|Part 2: Days 17 to 25||0
10771043|NCT03268941|11934149|FG002|NOT COMPLETED|Part 2: Days 17 to 25||0
10771044|NCT03268941|11934150|FG003|NOT COMPLETED|Part 2: Days 17 to 25||0
10771045|NCT03268941|11934151|FG004|NOT COMPLETED|Part 2: Days 17 to 25||0
10771046|NCT03268941|11934152|FG005|NOT COMPLETED|Part 2: Days 17 to 25||0
10771047|NCT03268941|11934153|FG006|NOT COMPLETED|Part 2: Days 17 to 25||2
10771048|NCT03268941|11934147|FG000|STARTED|Part 2: Period 2: Fasted (Day 25)||0
10771049|NCT03268941|11934148|FG001|STARTED|Part 2: Period 2: Fasted (Day 25)||0
10771050|NCT03268941|11934149|FG002|STARTED|Part 2: Period 2: Fasted (Day 25)||0
10771051|NCT03268941|11934150|FG003|STARTED|Part 2: Period 2: Fasted (Day 25)||0
10771052|NCT03268941|11934151|FG004|STARTED|Part 2: Period 2: Fasted (Day 25)||0
10771053|NCT03268941|11934152|FG005|STARTED|Part 2: Period 2: Fasted (Day 25)||6
10771054|NCT03268941|11934153|FG006|STARTED|Part 2: Period 2: Fasted (Day 25)||0
10771055|NCT03268941|11934147|FG000|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
10771056|NCT03268941|11934148|FG001|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
10771057|NCT03268941|11934149|FG002|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
10771058|NCT03268941|11934150|FG003|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
10771059|NCT03268941|11934151|FG004|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
10771060|NCT03268941|11934152|FG005|COMPLETED|Part 2: Period 2: Fasted (Day 25)||6
10771061|NCT03268941|11934153|FG006|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
10771062|NCT03268941|11934147|FG000|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
10771063|NCT03268941|11934148|FG001|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
10771064|NCT03268941|11934149|FG002|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
10771065|NCT03268941|11934150|FG003|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
10771066|NCT03268941|11934151|FG004|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
10771067|NCT03268941|11934152|FG005|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
10771068|NCT03268941|11934153|FG006|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
10771069|NCT03269435|11934174|FG000|STARTED|Overall Study||51
10771070|NCT03269435|11934175|FG001|STARTED|Overall Study||48
10771071|NCT03269435|11934174|FG000|COMPLETED|Overall Study||51
10771072|NCT03269435|11934175|FG001|COMPLETED|Overall Study||48
10771073|NCT03269435|11934174|FG000|NOT COMPLETED|Overall Study||0
10771074|NCT03269435|11934175|FG001|NOT COMPLETED|Overall Study||0
10771075|NCT03269552|11934181|FG000|STARTED|Overall Study||4
10771076|NCT03269552|11934181|FG000|COMPLETED|Overall Study||2
10771077|NCT03269552|11934181|FG000|NOT COMPLETED|Overall Study||2
10771078|NCT03270085|11934188|FG000|STARTED|Overall Study||15
10771079|NCT03270085|11934189|FG001|STARTED|Overall Study||15
10771080|NCT03270085|11934188|FG000|COMPLETED|Overall Study||14
10771081|NCT03270085|11934189|FG001|COMPLETED|Overall Study||15
10771082|NCT03270085|11934188|FG000|NOT COMPLETED|Overall Study||1
10771083|NCT03270085|11934189|FG001|NOT COMPLETED|Overall Study||0
10779160|NCT03364309|11940868|FG009|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|31
10779161|NCT03364309|11940869|FG010|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|23
10779162|NCT03364309|11940870|FG011|STARTED|Maintenance Period||0
10779163|NCT03364309|11940871|FG012|STARTED|Maintenance Period||0
10779164|NCT03364309|11940872|FG013|STARTED|Maintenance Period||0
10779165|NCT03364309|11940873|FG014|STARTED|Maintenance Period||0
10779166|NCT03364309|11940874|FG015|STARTED|Maintenance Period||0
10779167|NCT03364309|11940875|FG016|STARTED|Maintenance Period||0
10779168|NCT03364309|11940876|FG017|STARTED|Maintenance Period||0
10779169|NCT03364309|11940877|FG018|STARTED|Maintenance Period||0
10779170|NCT03364309|11940859|FG000|Received at Least One Dose of Study Drug|Maintenance Period||0
10779171|NCT03364309|11940860|FG001|Received at Least One Dose of Study Drug|Maintenance Period||0
10779172|NCT03364309|11940861|FG002|Received at Least One Dose of Study Drug|Maintenance Period||0
10779173|NCT03364309|11940862|FG003|Received at Least One Dose of Study Drug|Maintenance Period||47
10779174|NCT03364309|11940863|FG004|Received at Least One Dose of Study Drug|Maintenance Period||92
10779175|NCT03364309|11940864|FG005|Received at Least One Dose of Study Drug|Maintenance Period||50
10779176|NCT03364309|11940865|FG006|Received at Least One Dose of Study Drug|Maintenance Period||100
10779177|NCT03364309|11940866|FG007|Received at Least One Dose of Study Drug|Maintenance Period||3
10779178|NCT03364309|11940867|FG008|Received at Least One Dose of Study Drug|Maintenance Period||79
10779179|NCT03364309|11940868|FG009|Received at Least One Dose of Study Drug|Maintenance Period||31
10779180|NCT03364309|11940869|FG010|Received at Least One Dose of Study Drug|Maintenance Period||23
10779181|NCT03364309|11940870|FG011|Received at Least One Dose of Study Drug|Maintenance Period||0
10779182|NCT03364309|11940871|FG012|Received at Least One Dose of Study Drug|Maintenance Period||0
10779183|NCT03364309|11940872|FG013|Received at Least One Dose of Study Drug|Maintenance Period||0
10779184|NCT03364309|11940873|FG014|Received at Least One Dose of Study Drug|Maintenance Period||0
10779185|NCT03364309|11940874|FG015|Received at Least One Dose of Study Drug|Maintenance Period||0
10779186|NCT03364309|11940875|FG016|Received at Least One Dose of Study Drug|Maintenance Period||0
10779187|NCT03364309|11940876|FG017|Received at Least One Dose of Study Drug|Maintenance Period||0
10779188|NCT03364309|11940877|FG018|Received at Least One Dose of Study Drug|Maintenance Period||0
10779189|NCT03364309|11940859|FG000|COMPLETED|Maintenance Period||0
10779190|NCT03364309|11940860|FG001|COMPLETED|Maintenance Period||0
10779191|NCT03364309|11940861|FG002|COMPLETED|Maintenance Period||0
10779192|NCT03364309|11940862|FG003|COMPLETED|Maintenance Period||3
10779193|NCT03364309|11940863|FG004|COMPLETED|Maintenance Period||80
10779194|NCT03364309|11940864|FG005|COMPLETED|Maintenance Period||4
10779195|NCT03364309|11940865|FG006|COMPLETED|Maintenance Period||84
10779196|NCT03364309|11940866|FG007|COMPLETED|Maintenance Period||1
10779197|NCT03364309|11940867|FG008|COMPLETED|Maintenance Period||73
10779198|NCT03364309|11940868|FG009|COMPLETED|Maintenance Period||27
10779199|NCT03364309|11940869|FG010|COMPLETED|Maintenance Period||17
10779200|NCT03364309|11940870|FG011|COMPLETED|Maintenance Period||0
10779201|NCT03364309|11940871|FG012|COMPLETED|Maintenance Period||0
10779202|NCT03364309|11940872|FG013|COMPLETED|Maintenance Period||0
10779203|NCT03364309|11940873|FG014|COMPLETED|Maintenance Period||0
10779204|NCT03364309|11940874|FG015|COMPLETED|Maintenance Period||0
10779205|NCT03364309|11940875|FG016|COMPLETED|Maintenance Period||0
10779206|NCT03364309|11940876|FG017|COMPLETED|Maintenance Period||0
10779207|NCT03364309|11940877|FG018|COMPLETED|Maintenance Period||0
10779208|NCT03364309|11940859|FG000|NOT COMPLETED|Maintenance Period||0
10779209|NCT03364309|11940860|FG001|NOT COMPLETED|Maintenance Period||0
10779210|NCT03364309|11940861|FG002|NOT COMPLETED|Maintenance Period||0
10779211|NCT03364309|11940862|FG003|NOT COMPLETED|Maintenance Period||44
10779212|NCT03364309|11940863|FG004|NOT COMPLETED|Maintenance Period||12
10779213|NCT03364309|11940864|FG005|NOT COMPLETED|Maintenance Period||46
10779214|NCT03364309|11940865|FG006|NOT COMPLETED|Maintenance Period||16
10779215|NCT03364309|11940866|FG007|NOT COMPLETED|Maintenance Period||2
10779216|NCT03364309|11940867|FG008|NOT COMPLETED|Maintenance Period||6
10779217|NCT03364309|11940868|FG009|NOT COMPLETED|Maintenance Period||4
10779218|NCT03364309|11940869|FG010|NOT COMPLETED|Maintenance Period||6
10779219|NCT03364309|11940870|FG011|NOT COMPLETED|Maintenance Period||0
10779220|NCT03364309|11940871|FG012|NOT COMPLETED|Maintenance Period||0
10779221|NCT03364309|11940872|FG013|NOT COMPLETED|Maintenance Period||0
10779222|NCT03364309|11940873|FG014|NOT COMPLETED|Maintenance Period||0
10779223|NCT03364309|11940874|FG015|NOT COMPLETED|Maintenance Period||0
10779224|NCT03364309|11940875|FG016|NOT COMPLETED|Maintenance Period||0
10779225|NCT03364309|11940876|FG017|NOT COMPLETED|Maintenance Period||0
10779226|NCT03364309|11940877|FG018|NOT COMPLETED|Maintenance Period||0
10779227|NCT03364309|11940859|FG000|STARTED|Re-treatment (Maintenance) Period||0
10779228|NCT03364309|11940860|FG001|STARTED|Re-treatment (Maintenance) Period||0
10779229|NCT03364309|11940861|FG002|STARTED|Re-treatment (Maintenance) Period||0
10779330|NCT03364309|11940867|FG008|NOT COMPLETED|Post-Treatment Followup Period||0
10771084|NCT03270332|11934197|FG000|STARTED|Overall Study||5
10771085|NCT03270332|11934198|FG001|STARTED|Overall Study||5
10771086|NCT03270332|11934197|FG000|COMPLETED|Overall Study||5
10771087|NCT03270332|11934198|FG001|COMPLETED|Overall Study||4
10771088|NCT03270332|11934197|FG000|NOT COMPLETED|Overall Study||0
10771089|NCT03270332|11934198|FG001|NOT COMPLETED|Overall Study||1
10771090|NCT03270436|11934208|FG000|STARTED|Baseline||213
10771091|NCT03270436|11934209|FG001|STARTED|Baseline||167
10771092|NCT03270436|11934208|FG000|COMPLETED|Baseline||212
10771093|NCT03270436|11934209|FG001|COMPLETED|Baseline||166
10771094|NCT03270436|11934208|FG000|NOT COMPLETED|Baseline||1
10771095|NCT03270436|11934209|FG001|NOT COMPLETED|Baseline||1
10771096|NCT03270436|11934208|FG000|STARTED|Immediate Post-Intervention||213
10771097|NCT03270436|11934209|FG001|STARTED|Immediate Post-Intervention||167
10771098|NCT03270436|11934208|FG000|COMPLETED|Immediate Post-Intervention||172
10771099|NCT03270436|11934209|FG001|COMPLETED|Immediate Post-Intervention||111
10771100|NCT03270436|11934208|FG000|NOT COMPLETED|Immediate Post-Intervention||41
10771101|NCT03270436|11934209|FG001|NOT COMPLETED|Immediate Post-Intervention||56
10771102|NCT03270436|11934208|FG000|STARTED|6 Months Post-Intervention||213
10771103|NCT03270436|11934209|FG001|STARTED|6 Months Post-Intervention||167
10771104|NCT03270436|11934208|FG000|COMPLETED|6 Months Post-Intervention||173
10771105|NCT03270436|11934209|FG001|COMPLETED|6 Months Post-Intervention||116
10771106|NCT03270436|11934208|FG000|NOT COMPLETED|6 Months Post-Intervention||40
10771107|NCT03270436|11934209|FG001|NOT COMPLETED|6 Months Post-Intervention||51
10771108|NCT03270514|11934217|FG000|STARTED|Overall Study||29
10771109|NCT03270514|11934218|FG001|STARTED|Overall Study||31
10771110|NCT03270514|11934217|FG000|COMPLETED|Overall Study||29
10771111|NCT03270514|11934218|FG001|COMPLETED|Overall Study||31
10771112|NCT03270514|11934217|FG000|NOT COMPLETED|Overall Study||0
10771113|NCT03270514|11934218|FG001|NOT COMPLETED|Overall Study||0
10771114|NCT03270644|11934224|FG000|STARTED|Day 1 Lasmiditan Reference||44
10771115|NCT03270644|11934224|FG000|Received at Least One Dose of Study Drug|Day 1 Lasmiditan Reference||44
10771116|NCT03270644|11934224|FG000|COMPLETED|Day 1 Lasmiditan Reference||43
10771117|NCT03270644|11934224|FG000|NOT COMPLETED|Day 1 Lasmiditan Reference||1
10771118|NCT03270644|11934224|FG000|STARTED|Day 4 - 10 Propranolol Reference||43
10771119|NCT03270644|11934224|FG000|Received at Least One Dose of Study Drug|Day 4 - 10 Propranolol Reference||43
10771120|NCT03270644|11934224|FG000|Day 9 Lasmiditan + Propranolol Test|Day 4 - 10 Propranolol Reference||42
10771121|NCT03270644|11934224|FG000|COMPLETED|Day 4 - 10 Propranolol Reference||42
10771122|NCT03270644|11934224|FG000|NOT COMPLETED|Day 4 - 10 Propranolol Reference||1
10771123|NCT03270657|11934235|FG000|STARTED|Overall Study||5
10771124|NCT03270657|11934235|FG000|COMPLETED|Overall Study||4
10771125|NCT03270657|11934235|FG000|NOT COMPLETED|Overall Study||1
10771126|NCT03270943|11934241|FG000|STARTED|Intervention Refinement||6
10771127|NCT03270943|11934242|FG001|STARTED|Intervention Refinement||9
10771128|NCT03270943|11934241|FG000|COMPLETED|Intervention Refinement||6
10771129|NCT03270943|11934242|FG001|COMPLETED|Intervention Refinement||6
10771130|NCT03270943|11934241|FG000|NOT COMPLETED|Intervention Refinement||0
10771131|NCT03270943|11934242|FG001|NOT COMPLETED|Intervention Refinement||3
10771132|NCT03270943|11934241|FG000|STARTED|Randomized (Willingness to be)||30
10771133|NCT03270943|11934242|FG001|STARTED|Randomized (Willingness to be)||32
10771134|NCT03270943|11934241|FG000|COMPLETED|Randomized (Willingness to be)||30
10771135|NCT03270943|11934242|FG001|COMPLETED|Randomized (Willingness to be)||31
10771136|NCT03270943|11934241|FG000|NOT COMPLETED|Randomized (Willingness to be)||0
10771137|NCT03270943|11934242|FG001|NOT COMPLETED|Randomized (Willingness to be)||1
10771138|NCT03271307|11934253|FG000|STARTED|Overall Study||1951
10421671|NCT00820443|11566533|FG000|STARTED|Immediately||253
10421672|NCT00820443|11566533|FG000|COMPLETED|Immediately||248
10771139|NCT03271307|11934254|FG001|STARTED|Overall Study||1837
10771140|NCT03271307|11934255|FG002|STARTED|Overall Study||2097
10771141|NCT03271307|11934256|FG003|STARTED|Overall Study||135
10771142|NCT03271307|11934257|FG004|STARTED|Overall Study||349
10771143|NCT03271307|11934253|FG000|COMPLETED|Overall Study||1951
10771144|NCT03271307|11934254|FG001|COMPLETED|Overall Study||1837
10771145|NCT03271307|11934255|FG002|COMPLETED|Overall Study||2097
10771146|NCT03271307|11934256|FG003|COMPLETED|Overall Study||107
10771147|NCT03271307|11934257|FG004|COMPLETED|Overall Study||258
10771148|NCT03271307|11934253|FG000|NOT COMPLETED|Overall Study||0
10771149|NCT03271307|11934254|FG001|NOT COMPLETED|Overall Study||0
10771150|NCT03271307|11934255|FG002|NOT COMPLETED|Overall Study||0
10771151|NCT03271307|11934256|FG003|NOT COMPLETED|Overall Study||28
10771152|NCT03271307|11934257|FG004|NOT COMPLETED|Overall Study||91
10771153|NCT03271424|11934275|FG000|STARTED|November 2015||20
10771154|NCT03271424|11934276|FG001|STARTED|November 2015||0
10771155|NCT03271424|11934277|FG002|STARTED|November 2015||0
10771156|NCT03271424|11934275|FG000|COMPLETED|November 2015||20
10421673|NCT00820443|11566533|FG000|NOT COMPLETED|Immediately||5
10771157|NCT03271424|11934276|FG001|COMPLETED|November 2015||0
10771158|NCT03271424|11934277|FG002|COMPLETED|November 2015||0
10771159|NCT03271424|11934275|FG000|NOT COMPLETED|November 2015||0
10771160|NCT03271424|11934276|FG001|NOT COMPLETED|November 2015||0
10771161|NCT03271424|11934277|FG002|NOT COMPLETED|November 2015||0
10771162|NCT03271424|11934275|FG000|STARTED|December 2015||0
10771163|NCT03271424|11934276|FG001|STARTED|December 2015||35
10421674|NCT00820443|11566533|FG000|STARTED|3 Month||253
10771164|NCT03271424|11934277|FG002|STARTED|December 2015||0
10771165|NCT03271424|11934275|FG000|COMPLETED|December 2015||0
10771166|NCT03271424|11934276|FG001|COMPLETED|December 2015||35
10771167|NCT03271424|11934277|FG002|COMPLETED|December 2015||0
10771168|NCT03271424|11934275|FG000|NOT COMPLETED|December 2015||0
10771169|NCT03271424|11934276|FG001|NOT COMPLETED|December 2015||0
10771170|NCT03271424|11934277|FG002|NOT COMPLETED|December 2015||0
10771171|NCT03271424|11934275|FG000|STARTED|April-May 2016||0
10771172|NCT03271424|11934276|FG001|STARTED|April-May 2016||0
10771173|NCT03271424|11934277|FG002|STARTED|April-May 2016||40
10771174|NCT03271424|11934275|FG000|COMPLETED|April-May 2016||0
10771175|NCT03271424|11934276|FG001|COMPLETED|April-May 2016||0
10771176|NCT03271424|11934277|FG002|COMPLETED|April-May 2016||40
10771177|NCT03271424|11934275|FG000|NOT COMPLETED|April-May 2016||0
10771178|NCT03271424|11934276|FG001|NOT COMPLETED|April-May 2016||0
10771179|NCT03271424|11934277|FG002|NOT COMPLETED|April-May 2016||0
10771180|NCT03271528|11934289|FG000|STARTED|Medication Dispense/Exposure Period 1||13
10771181|NCT03271528|11934290|FG001|STARTED|Medication Dispense/Exposure Period 1||14
10771182|NCT03271528|11934289|FG000|COMPLETED|Medication Dispense/Exposure Period 1||11
10771183|NCT03271528|11934290|FG001|COMPLETED|Medication Dispense/Exposure Period 1||12
10297946|NCT00005879|11430573|FG001|NOT COMPLETED|Overall Study||10
10771184|NCT03271528|11934289|FG000|NOT COMPLETED|Medication Dispense/Exposure Period 1||2
10771185|NCT03271528|11934290|FG001|NOT COMPLETED|Medication Dispense/Exposure Period 1||2
10771186|NCT03271528|11934289|FG000|STARTED|Alcohol Trial 1, Washout Period 1||11
10771187|NCT03271528|11934290|FG001|STARTED|Alcohol Trial 1, Washout Period 1||12
10771188|NCT03271528|11934289|FG000|COMPLETED|Alcohol Trial 1, Washout Period 1||9
10771189|NCT03271528|11934290|FG001|COMPLETED|Alcohol Trial 1, Washout Period 1||11
10771190|NCT03271528|11934289|FG000|NOT COMPLETED|Alcohol Trial 1, Washout Period 1||2
10771191|NCT03271528|11934290|FG001|NOT COMPLETED|Alcohol Trial 1, Washout Period 1||1
10771192|NCT03271528|11934289|FG000|STARTED|Medication Dispense/Exposure Period 2||9
10771193|NCT03271528|11934290|FG001|STARTED|Medication Dispense/Exposure Period 2||11
10771194|NCT03271528|11934289|FG000|COMPLETED|Medication Dispense/Exposure Period 2||8
10771195|NCT03271528|11934290|FG001|COMPLETED|Medication Dispense/Exposure Period 2||11
10771196|NCT03271528|11934289|FG000|NOT COMPLETED|Medication Dispense/Exposure Period 2||1
10771197|NCT03271528|11934290|FG001|NOT COMPLETED|Medication Dispense/Exposure Period 2||0
10771198|NCT03271528|11934289|FG000|STARTED|Alcohol Self-Administration Trial 2||8
10771199|NCT03271528|11934290|FG001|STARTED|Alcohol Self-Administration Trial 2||11
10771200|NCT03271528|11934289|FG000|COMPLETED|Alcohol Self-Administration Trial 2||8
10771201|NCT03271528|11934290|FG001|COMPLETED|Alcohol Self-Administration Trial 2||11
10771202|NCT03271528|11934289|FG000|NOT COMPLETED|Alcohol Self-Administration Trial 2||0
10771203|NCT03271528|11934290|FG001|NOT COMPLETED|Alcohol Self-Administration Trial 2||0
10771210|NCT03273166|11934305|FG000|STARTED|Overall Study||82
10771211|NCT03273166|11934305|FG000|COMPLETED|Overall Study||51
10771212|NCT03273166|11934305|FG000|NOT COMPLETED|Overall Study||31
10771213|NCT03273257|11934312|FG000|STARTED|Overall Study||7
10771214|NCT03273257|11934313|FG001|STARTED|Overall Study||7
10771215|NCT03273257|11934312|FG000|Started Treatment|Overall Study||7
10771216|NCT03273257|11934313|FG001|Started Treatment|Overall Study|Only 6 patients from the placebo group started treatment because 1 patient died after randomization (= study start), but before initiating treatment|6
10771217|NCT03273257|11934312|FG000|Underwent PEA|Overall Study||6
10771218|NCT03273257|11934313|FG001|Underwent PEA|Overall Study||5
10771219|NCT03273257|11934312|FG000|COMPLETED|Overall Study||3
10771220|NCT03273257|11934313|FG001|COMPLETED|Overall Study||3
10771221|NCT03273257|11934312|FG000|NOT COMPLETED|Overall Study||4
10771222|NCT03273257|11934313|FG001|NOT COMPLETED|Overall Study||4
10771223|NCT03273270|11934321|FG000|STARTED|Overall Study||12
10771224|NCT03273270|11934322|FG001|STARTED|Overall Study||8
10771225|NCT03273270|11934321|FG000|COMPLETED|Overall Study||12
10771226|NCT03273270|11934322|FG001|COMPLETED|Overall Study||8
10771227|NCT03273270|11934321|FG000|NOT COMPLETED|Overall Study||0
10771228|NCT03273270|11934322|FG001|NOT COMPLETED|Overall Study||0
10771229|NCT03273283|11934330|FG000|STARTED|Overall Study||99
10771230|NCT03273283|11934331|FG001|STARTED|Overall Study||101
10771231|NCT03273283|11934330|FG000|COMPLETED|Overall Study||72
10771232|NCT03273283|11934331|FG001|COMPLETED|Overall Study||81
10771233|NCT03273283|11934330|FG000|NOT COMPLETED|Overall Study||27
10771234|NCT03273283|11934331|FG001|NOT COMPLETED|Overall Study||20
10771235|NCT03273387|11934339|FG000|STARTED|Overall Study||13
10771236|NCT03273387|11934340|FG001|STARTED|Overall Study||13
10771237|NCT03273387|11934339|FG000|COMPLETED|Overall Study||10
10771238|NCT03273387|11934340|FG001|COMPLETED|Overall Study||10
10771239|NCT03273387|11934339|FG000|NOT COMPLETED|Overall Study||3
10771240|NCT03273387|11934340|FG001|NOT COMPLETED|Overall Study||3
10771241|NCT03273426|11934348|FG000|STARTED|Overall Study||20
10771242|NCT03273426|11934349|FG001|STARTED|Overall Study||20
10771243|NCT03273426|11934348|FG000|COMPLETED|Overall Study||20
10771244|NCT03273426|11934349|FG001|COMPLETED|Overall Study||20
10771245|NCT03273426|11934348|FG000|NOT COMPLETED|Overall Study||0
10771246|NCT03273426|11934349|FG001|NOT COMPLETED|Overall Study||0
10771247|NCT03273543|11934358|FG000|STARTED|Overall Study||10
10771248|NCT03273543|11934359|FG001|STARTED|Overall Study||10
10771249|NCT03273543|11934358|FG000|COMPLETED|Overall Study||10
10771250|NCT03273543|11934359|FG001|COMPLETED|Overall Study||10
10771251|NCT03273543|11934358|FG000|NOT COMPLETED|Overall Study||0
10771252|NCT03273543|11934359|FG001|NOT COMPLETED|Overall Study||0
10771253|NCT03273673|11934367|FG000|STARTED|Overall Study||18
10771254|NCT03273673|11934368|FG001|STARTED|Overall Study||22
10771255|NCT03273673|11934367|FG000|COMPLETED|Overall Study||14
10771256|NCT03273673|11934368|FG001|COMPLETED|Overall Study||22
10771257|NCT03273673|11934367|FG000|NOT COMPLETED|Overall Study||4
10771258|NCT03273673|11934368|FG001|NOT COMPLETED|Overall Study||0
10771259|NCT03273946|11934374|FG000|STARTED|Overall Study||158
10771260|NCT03273946|11934374|FG000|COMPLETED|Overall Study||149
10771261|NCT03273946|11934374|FG000|NOT COMPLETED|Overall Study||9
10771262|NCT03274076|11934380|FG000|STARTED|24 Weeks Double Blind||10
10771263|NCT03274076|11934381|FG001|STARTED|24 Weeks Double Blind||5
10771264|NCT03274076|11934382|FG002|STARTED|24 Weeks Double Blind||0
10771265|NCT03274076|11934383|FG003|STARTED|24 Weeks Double Blind||0
10771266|NCT03274076|11934380|FG000|COMPLETED|24 Weeks Double Blind||10
10771267|NCT03274076|11934381|FG001|COMPLETED|24 Weeks Double Blind||4
10771268|NCT03274076|11934382|FG002|COMPLETED|24 Weeks Double Blind||0
10771269|NCT03274076|11934383|FG003|COMPLETED|24 Weeks Double Blind||0
10771270|NCT03274076|11934380|FG000|NOT COMPLETED|24 Weeks Double Blind||0
10771271|NCT03274076|11934381|FG001|NOT COMPLETED|24 Weeks Double Blind||1
10771272|NCT03274076|11934382|FG002|NOT COMPLETED|24 Weeks Double Blind||0
10771273|NCT03274076|11934383|FG003|NOT COMPLETED|24 Weeks Double Blind||0
10771274|NCT03274076|11934380|FG000|STARTED|24 Weeks Open Label||0
10771275|NCT03274076|11934381|FG001|STARTED|24 Weeks Open Label||0
10771276|NCT03274076|11934382|FG002|STARTED|24 Weeks Open Label||10
10771277|NCT03274076|11934383|FG003|STARTED|24 Weeks Open Label||4
10771278|NCT03274076|11934380|FG000|COMPLETED|24 Weeks Open Label||0
10771279|NCT03274076|11934381|FG001|COMPLETED|24 Weeks Open Label||0
10771280|NCT03274076|11934382|FG002|COMPLETED|24 Weeks Open Label||8
10771281|NCT03274076|11934383|FG003|COMPLETED|24 Weeks Open Label||3
10771282|NCT03274076|11934380|FG000|NOT COMPLETED|24 Weeks Open Label||0
10771283|NCT03274076|11934381|FG001|NOT COMPLETED|24 Weeks Open Label||0
10771284|NCT03274076|11934382|FG002|NOT COMPLETED|24 Weeks Open Label||2
10771285|NCT03274076|11934383|FG003|NOT COMPLETED|24 Weeks Open Label||1
10771286|NCT03274440|11934402|FG000|STARTED|Overall Study||3
10771287|NCT03274440|11934403|FG001|STARTED|Overall Study||2
10771288|NCT03274440|11934404|FG002|STARTED|Overall Study||4
10771289|NCT03274440|11934405|FG003|STARTED|Overall Study||1
10771290|NCT03274440|11934406|FG004|STARTED|Overall Study||1
10771291|NCT03274440|11934407|FG005|STARTED|Overall Study||3
10771292|NCT03274440|11934402|FG000|COMPLETED|Overall Study||2
10771293|NCT03274440|11934403|FG001|COMPLETED|Overall Study||2
10771294|NCT03274440|11934404|FG002|COMPLETED|Overall Study||4
10771295|NCT03274440|11934405|FG003|COMPLETED|Overall Study||0
10771296|NCT03274440|11934406|FG004|COMPLETED|Overall Study||1
10771297|NCT03274440|11934407|FG005|COMPLETED|Overall Study||3
10771298|NCT03274440|11934402|FG000|NOT COMPLETED|Overall Study||1
10771299|NCT03274440|11934403|FG001|NOT COMPLETED|Overall Study||0
10771300|NCT03274440|11934404|FG002|NOT COMPLETED|Overall Study||0
10771301|NCT03274440|11934405|FG003|NOT COMPLETED|Overall Study||1
10771302|NCT03274440|11934406|FG004|NOT COMPLETED|Overall Study||0
10771303|NCT03274440|11934407|FG005|NOT COMPLETED|Overall Study||0
10771304|NCT03274453|11934419|FG000|STARTED|Overall Study||38
10771305|NCT03274453|11934420|FG001|STARTED|Overall Study||30
10771306|NCT03274453|11934421|FG002|STARTED|Overall Study||32
10771307|NCT03274453|11934422|FG003|STARTED|Overall Study||29
10771308|NCT03274453|11934419|FG000|COMPLETED|Overall Study||34
10771309|NCT03274453|11934420|FG001|COMPLETED|Overall Study||24
10771310|NCT03274453|11934421|FG002|COMPLETED|Overall Study||28
10771311|NCT03274453|11934422|FG003|COMPLETED|Overall Study||25
10771312|NCT03274453|11934419|FG000|NOT COMPLETED|Overall Study||4
10771313|NCT03274453|11934420|FG001|NOT COMPLETED|Overall Study||6
10771314|NCT03274453|11934421|FG002|NOT COMPLETED|Overall Study||4
10771315|NCT03274453|11934422|FG003|NOT COMPLETED|Overall Study||4
10771322|NCT03274518|11934443|FG000|STARTED|First Intervention||8
10771323|NCT03274518|11934444|FG001|STARTED|First Intervention|First intervention: expanded hemodialysis, for 30 days.|8
10771324|NCT03274518|11934443|FG000|COMPLETED|First Intervention||8
10771325|NCT03274518|11934444|FG001|COMPLETED|First Intervention||8
10771326|NCT03274518|11934443|FG000|NOT COMPLETED|First Intervention||0
10771327|NCT03274518|11934444|FG001|NOT COMPLETED|First Intervention||0
10771328|NCT03274518|11934443|FG000|STARTED|Washout Period||8
10771329|NCT03274518|11934444|FG001|STARTED|Washout Period|Patients returned from expanded hemodialysis to conventional hemodialysis for 15 days.|8
10771330|NCT03274518|11934443|FG000|COMPLETED|Washout Period||8
10771331|NCT03274518|11934444|FG001|COMPLETED|Washout Period||8
10771332|NCT03274518|11934443|FG000|NOT COMPLETED|Washout Period||0
10771333|NCT03274518|11934444|FG001|NOT COMPLETED|Washout Period||0
10771334|NCT03274518|11934443|FG000|STARTED|Second Intervention||8
10771335|NCT03274518|11934444|FG001|STARTED|Second Intervention|Second intervention: patients from this group underwent online hemodiafiltration for 30 days.|8
10771336|NCT03274518|11934443|FG000|COMPLETED|Second Intervention||8
10771337|NCT03274518|11934444|FG001|COMPLETED|Second Intervention||8
10771338|NCT03274518|11934443|FG000|NOT COMPLETED|Second Intervention||0
10771339|NCT03274518|11934444|FG001|NOT COMPLETED|Second Intervention||0
10771340|NCT03274856|11934452|FG000|STARTED|Overall Study||10
10771341|NCT03274856|11934453|FG001|STARTED|Overall Study||9
10771342|NCT03274856|11934452|FG000|COMPLETED|Overall Study||10
10771343|NCT03274856|11934453|FG001|COMPLETED|Overall Study||9
10771344|NCT03274856|11934452|FG000|NOT COMPLETED|Overall Study||0
10771345|NCT03274856|11934453|FG001|NOT COMPLETED|Overall Study||0
10771346|NCT03274986|11934463|FG000|STARTED|Overall Study||107
10771347|NCT03274986|11934464|FG001|STARTED|Overall Study||113
10771348|NCT03274986|11934463|FG000|Successful Implantation, as Treated|Overall Study||107
10771349|NCT03274986|11934464|FG001|Successful Implantation, as Treated|Overall Study||113
10771350|NCT03274986|11934463|FG000|COMPLETED|Overall Study||107
10771351|NCT03274986|11934464|FG001|COMPLETED|Overall Study||111
10771352|NCT03274986|11934463|FG000|NOT COMPLETED|Overall Study||0
10771353|NCT03274986|11934464|FG001|NOT COMPLETED|Overall Study||2
10771354|NCT03274999|11934477|FG000|STARTED|First Intervention (Day 0)||5
10771355|NCT03274999|11934478|FG001|STARTED|First Intervention (Day 0)||5
10771356|NCT03274999|11934477|FG000|COMPLETED|First Intervention (Day 0)||5
10771357|NCT03274999|11934478|FG001|COMPLETED|First Intervention (Day 0)||5
10771358|NCT03274999|11934477|FG000|NOT COMPLETED|First Intervention (Day 0)||0
10771359|NCT03274999|11934478|FG001|NOT COMPLETED|First Intervention (Day 0)||0
10771360|NCT03274999|11934477|FG000|STARTED|Second Intervention (Day 14)||5
10771361|NCT03274999|11934478|FG001|STARTED|Second Intervention (Day 14)||5
10771362|NCT03274999|11934477|FG000|COMPLETED|Second Intervention (Day 14)||5
10771363|NCT03274999|11934478|FG001|COMPLETED|Second Intervention (Day 14)||5
10771364|NCT03274999|11934477|FG000|NOT COMPLETED|Second Intervention (Day 14)||0
10771365|NCT03274999|11934478|FG001|NOT COMPLETED|Second Intervention (Day 14)||0
10771366|NCT03275246|11934484|FG000|STARTED|Overall Study||8
10771367|NCT03275246|11934484|FG000|COMPLETED|Overall Study||2
10771368|NCT03275246|11934484|FG000|NOT COMPLETED|Overall Study||6
10771369|NCT03275389|11934498|FG000|STARTED|Overall Study||45
10771370|NCT03275389|11934499|FG001|STARTED|Overall Study||46
10771371|NCT03275389|11934500|FG002|STARTED|Overall Study||47
10771372|NCT03275389|11934501|FG003|STARTED|Overall Study||47
10771373|NCT03275389|11934502|FG004|STARTED|Overall Study||48
10771374|NCT03275389|11934503|FG005|STARTED|Overall Study||47
10771375|NCT03275389|11934504|FG006|STARTED|Overall Study||47
10771376|NCT03275389|11934505|FG007|STARTED|Overall Study||48
10771377|NCT03275389|11934506|FG008|STARTED|Overall Study||46
10771378|NCT03275389|11934507|FG009|STARTED|Overall Study||47
10771379|NCT03275389|11934498|FG000|COMPLETED|Overall Study||34
10771380|NCT03275389|11934499|FG001|COMPLETED|Overall Study||30
10771381|NCT03275389|11934500|FG002|COMPLETED|Overall Study||24
10771382|NCT03275389|11934501|FG003|COMPLETED|Overall Study||25
10771383|NCT03275389|11934502|FG004|COMPLETED|Overall Study||32
10771384|NCT03275389|11934503|FG005|COMPLETED|Overall Study||29
10771385|NCT03275389|11934504|FG006|COMPLETED|Overall Study||22
10771386|NCT03275389|11934505|FG007|COMPLETED|Overall Study||30
10771387|NCT03275389|11934506|FG008|COMPLETED|Overall Study||31
10771388|NCT03275389|11934507|FG009|COMPLETED|Overall Study||29
10771389|NCT03275389|11934498|FG000|NOT COMPLETED|Overall Study||11
10771390|NCT03275389|11934499|FG001|NOT COMPLETED|Overall Study||16
10771391|NCT03275389|11934500|FG002|NOT COMPLETED|Overall Study||23
10771392|NCT03275389|11934501|FG003|NOT COMPLETED|Overall Study||22
10771393|NCT03275389|11934502|FG004|NOT COMPLETED|Overall Study||16
10771394|NCT03275389|11934503|FG005|NOT COMPLETED|Overall Study||18
10771395|NCT03275389|11934504|FG006|NOT COMPLETED|Overall Study||25
10771396|NCT03275389|11934505|FG007|NOT COMPLETED|Overall Study||18
10771397|NCT03275389|11934506|FG008|NOT COMPLETED|Overall Study||15
10771398|NCT03275389|11934507|FG009|NOT COMPLETED|Overall Study||18
10771399|NCT03275623|11934531|FG000|STARTED|Overall Study||30
10771400|NCT03275623|11934532|FG001|STARTED|Overall Study||30
10771401|NCT03275623|11934531|FG000|COMPLETED|Overall Study||25
10771402|NCT03275623|11934532|FG001|COMPLETED|Overall Study||28
10771403|NCT03275623|11934531|FG000|NOT COMPLETED|Overall Study||5
10771404|NCT03275623|11934532|FG001|NOT COMPLETED|Overall Study||2
10771405|NCT03275766|11934542|FG000|STARTED|Overall Study||12
10771406|NCT03275766|11934543|FG001|STARTED|Overall Study||12
10771407|NCT03275766|11934544|FG002|STARTED|Overall Study||11
10771408|NCT03275766|11934545|FG003|STARTED|Overall Study||10
10771409|NCT03275766|11934542|FG000|Received Intervention|Overall Study||9
10771410|NCT03275766|11934543|FG001|Received Intervention|Overall Study||11
10771411|NCT03275766|11934544|FG002|Received Intervention|Overall Study||10
10771412|NCT03275766|11934545|FG003|Received Intervention|Overall Study||9
10771413|NCT03275766|11934542|FG000|COMPLETED|Overall Study||7
10771414|NCT03275766|11934543|FG001|COMPLETED|Overall Study||5
10771415|NCT03275766|11934544|FG002|COMPLETED|Overall Study||7
10771416|NCT03275766|11934545|FG003|COMPLETED|Overall Study||4
10771417|NCT03275766|11934542|FG000|NOT COMPLETED|Overall Study||5
10771418|NCT03275766|11934543|FG001|NOT COMPLETED|Overall Study||7
10771419|NCT03275766|11934544|FG002|NOT COMPLETED|Overall Study||4
10771420|NCT03275766|11934545|FG003|NOT COMPLETED|Overall Study||6
10771421|NCT03275870|11934555|FG000|STARTED|Overall Study||17
10771422|NCT03275870|11934555|FG000|COMPLETED|Overall Study||3
10771423|NCT03275870|11934555|FG000|NOT COMPLETED|Overall Study||14
10771424|NCT03276026|11934561|FG000|STARTED|Overall Study||35
10771425|NCT03276026|11934562|FG001|STARTED|Overall Study||33
10771426|NCT03276026|11934561|FG000|COMPLETED|Overall Study||34
10771427|NCT03276026|11934562|FG001|COMPLETED|Overall Study||33
10771428|NCT03276026|11934561|FG000|NOT COMPLETED|Overall Study||1
10771429|NCT03276026|11934562|FG001|NOT COMPLETED|Overall Study||0
10771430|NCT03276078|11934568|FG000|STARTED|Overall Study||20
10771431|NCT03276078|11934568|FG000|COMPLETED|Overall Study||19
10771432|NCT03276078|11934568|FG000|NOT COMPLETED|Overall Study||1
10771433|NCT03276494|11934572|FG000|STARTED|Overall Study||6
10771434|NCT03276494|11934572|FG000|COMPLETED|Overall Study||5
10771435|NCT03276494|11934572|FG000|NOT COMPLETED|Overall Study||1
10771436|NCT03276637|11934576|FG000|STARTED|Overall Study||93
10771437|NCT03276637|11934576|FG000|Completed Pre Survey|Overall Study||93
10771438|NCT03276637|11934576|FG000|Underwent Sequencing|Overall Study||75
10771439|NCT03276637|11934576|FG000|Completed Post Survey|Overall Study||69
10771440|NCT03276637|11934576|FG000|COMPLETED|Overall Study||69
10771441|NCT03276637|11934576|FG000|NOT COMPLETED|Overall Study||24
10771442|NCT03276871|11934583|FG000|STARTED|Overall Study||21
10771443|NCT03276871|11934584|FG001|STARTED|Overall Study||19
10771444|NCT03276871|11934583|FG000|COMPLETED|Overall Study||21
10771445|NCT03276871|11934584|FG001|COMPLETED|Overall Study||19
10771446|NCT03276871|11934583|FG000|NOT COMPLETED|Overall Study||0
10771447|NCT03276871|11934584|FG001|NOT COMPLETED|Overall Study||0
10771448|NCT03276975|11934592|FG000|STARTED|Overall Study||8
10771449|NCT03276975|11934593|FG001|STARTED|Overall Study||7
10771450|NCT03276975|11934592|FG000|Crossover At 2 Months|Overall Study||0
10771451|NCT03276975|11934593|FG001|Crossover At 2 Months|Overall Study||7
10771452|NCT03276975|11934592|FG000|COMPLETED|Overall Study||7
10771453|NCT03276975|11934593|FG001|COMPLETED|Overall Study||7
10771454|NCT03276975|11934592|FG000|NOT COMPLETED|Overall Study||1
10771455|NCT03276975|11934593|FG001|NOT COMPLETED|Overall Study||0
10771456|NCT03277274|11934602|FG000|STARTED|Overall Study||8
10771457|NCT03277274|11934603|FG001|STARTED|Overall Study||10
10771458|NCT03277274|11934604|FG002|STARTED|Overall Study||7
10771459|NCT03277274|11934602|FG000|COMPLETED|Overall Study||8
10771460|NCT03277274|11934603|FG001|COMPLETED|Overall Study||10
10771461|NCT03277274|11934604|FG002|COMPLETED|Overall Study||7
10771462|NCT03277274|11934602|FG000|NOT COMPLETED|Overall Study||0
10771463|NCT03277274|11934603|FG001|NOT COMPLETED|Overall Study||0
10771464|NCT03277274|11934604|FG002|NOT COMPLETED|Overall Study||0
10771465|NCT03277352|11934612|FG000|STARTED|Overall Study||10
10771466|NCT03277352|11934612|FG000|COMPLETED|Overall Study||0
10771467|NCT03277352|11934612|FG000|NOT COMPLETED|Overall Study||10
10771468|NCT03277378|11934619|FG000|STARTED|Overall Study||135
10771469|NCT03277378|11934620|FG001|STARTED|Overall Study||135
10771470|NCT03277378|11934619|FG000|Received Lead Implant|Overall Study||129
10771471|NCT03277378|11934620|FG001|Received Lead Implant|Overall Study||123
10771472|NCT03277378|11934619|FG000|Completed Initial Trial|Overall Study||126
10771473|NCT03277378|11934620|FG001|Completed Initial Trial|Overall Study||122
10771474|NCT03277378|11934619|FG000|Qualified for Permanent Implant|Overall Study||103
10771475|NCT03277378|11934620|FG001|Qualified for Permanent Implant|Overall Study||93
10771476|NCT03277378|11934619|FG000|Not Qualified for Permanent Implant|Overall Study||19
10771477|NCT03277378|11934620|FG001|Not Qualified for Permanent Implant|Overall Study||20
10771478|NCT03277378|11934619|FG000|Completed Extended Trial With Tonic Stim|Overall Study||8
10771479|NCT03277378|11934620|FG001|Completed Extended Trial With Tonic Stim|Overall Study||12
10771480|NCT03277378|11934619|FG000|Exit Study|Overall Study||11
10771481|NCT03277378|11934620|FG001|Exit Study|Overall Study||8
10771482|NCT03277378|11934619|FG000|COMPLETED|Overall Study||111
10771483|NCT03277378|11934620|FG001|COMPLETED|Overall Study||101
10771484|NCT03277378|11934619|FG000|NOT COMPLETED|Overall Study||24
10771485|NCT03277378|11934620|FG001|NOT COMPLETED|Overall Study||34
10771486|NCT03277794|11934632|FG000|STARTED|Overall Study||31
10771487|NCT03277794|11934633|FG001|STARTED|Overall Study||34
10771488|NCT03277794|11934632|FG000|COMPLETED|Overall Study||28
10771489|NCT03277794|11934633|FG001|COMPLETED|Overall Study||30
10771490|NCT03277794|11934632|FG000|NOT COMPLETED|Overall Study||3
10771491|NCT03277794|11934633|FG001|NOT COMPLETED|Overall Study||4
10771492|NCT03277846|11934642|FG000|STARTED|Overall Study||50
10771493|NCT03277846|11934643|FG001|STARTED|Overall Study||51
10771494|NCT03277846|11934642|FG000|COMPLETED|Overall Study||38
10771495|NCT03277846|11934643|FG001|COMPLETED|Overall Study||40
10771496|NCT03277846|11934642|FG000|NOT COMPLETED|Overall Study||12
10771497|NCT03277846|11934643|FG001|NOT COMPLETED|Overall Study||11
10771498|NCT03278028|11934651|FG000|STARTED|Overall Study||81
10771499|NCT03278028|11934652|FG001|STARTED|Overall Study||78
10771500|NCT03278028|11934651|FG000|COMPLETED|Overall Study||77
10771501|NCT03278028|11934652|FG001|COMPLETED|Overall Study||76
10771502|NCT03278028|11934651|FG000|NOT COMPLETED|Overall Study||4
10771503|NCT03278028|11934652|FG001|NOT COMPLETED|Overall Study||2
10771504|NCT03278067|11934661|FG000|STARTED|Overall Study||16433
10771505|NCT03278067|11934662|FG001|STARTED|Overall Study||3310
10771506|NCT03278067|11934663|FG002|STARTED|Overall Study||4196
10771507|NCT03278067|11934661|FG000|COMPLETED|Overall Study||16433
10771508|NCT03278067|11934662|FG001|COMPLETED|Overall Study||3310
10771509|NCT03278067|11934663|FG002|COMPLETED|Overall Study||4196
10771510|NCT03278067|11934661|FG000|NOT COMPLETED|Overall Study||0
10771511|NCT03278067|11934662|FG001|NOT COMPLETED|Overall Study||0
10771512|NCT03278067|11934663|FG002|NOT COMPLETED|Overall Study||0
10771513|NCT03278106|11934676|FG000|STARTED|Overall Study||28
10771514|NCT03278106|11934676|FG000|COMPLETED|Overall Study||27
10771515|NCT03278106|11934676|FG000|NOT COMPLETED|Overall Study||1
10771516|NCT03278223|11934682|FG000|STARTED|Overall Study||125
10771517|NCT03278223|11934683|FG001|STARTED|Overall Study||69
10771518|NCT03278223|11934682|FG000|COMPLETED|Overall Study||122
10771519|NCT03278223|11934683|FG001|COMPLETED|Overall Study||65
10771520|NCT03278223|11934682|FG000|NOT COMPLETED|Overall Study||3
10771521|NCT03278223|11934683|FG001|NOT COMPLETED|Overall Study||4
10771522|NCT03278613|11934691|FG000|STARTED|Overall Study||111
10771523|NCT03278613|11934692|FG001|STARTED|Overall Study||55
10771524|NCT03278613|11934691|FG000|COMPLETED|Overall Study||108
10771525|NCT03278613|11934692|FG001|COMPLETED|Overall Study||54
10771526|NCT03278613|11934691|FG000|NOT COMPLETED|Overall Study||3
10771527|NCT03278613|11934692|FG001|NOT COMPLETED|Overall Study||1
10771528|NCT03278886|11934700|FG000|STARTED|Overall Study||8
10771529|NCT03278886|11934701|FG001|STARTED|Overall Study||3
10771530|NCT03278886|11934700|FG000|COMPLETED|Overall Study||8
10771531|NCT03278886|11934701|FG001|COMPLETED|Overall Study||2
10771532|NCT03278886|11934700|FG000|NOT COMPLETED|Overall Study||0
10771533|NCT03278886|11934701|FG001|NOT COMPLETED|Overall Study||1
10771534|NCT03279237|11934707|FG000|STARTED|Overall Study||25
10771535|NCT03279237|11934707|FG000|Chemo-radiation|Overall Study||23
10771536|NCT03279237|11934707|FG000|Surgical Resection|Overall Study||20
10771537|NCT03279237|11934707|FG000|COMPLETED|Overall Study||20
10771538|NCT03279237|11934707|FG000|NOT COMPLETED|Overall Study||5
10771539|NCT03279458|11934711|FG000|STARTED|Overall Study||40
10771540|NCT03279458|11934711|FG000|COMPLETED|Overall Study||40
10771541|NCT03279458|11934711|FG000|NOT COMPLETED|Overall Study||0
10771542|NCT03279731|11934719|FG000|STARTED|Overall Study||19
10771543|NCT03279731|11934720|FG001|STARTED|Overall Study||17
10771544|NCT03279731|11934719|FG000|COMPLETED|Overall Study||13
10771545|NCT03279731|11934720|FG001|COMPLETED|Overall Study||14
10771546|NCT03279731|11934719|FG000|NOT COMPLETED|Overall Study||6
10771547|NCT03279731|11934720|FG001|NOT COMPLETED|Overall Study||3
10771548|NCT03280108|11934730|FG000|STARTED|Overall Study||129
10771549|NCT03280108|11934731|FG001|STARTED|Overall Study||114
10771550|NCT03280108|11934730|FG000|COMPLETED|Overall Study||127
10771551|NCT03280108|11934731|FG001|COMPLETED|Overall Study||114
10771552|NCT03280108|11934730|FG000|NOT COMPLETED|Overall Study||2
10771553|NCT03280108|11934731|FG001|NOT COMPLETED|Overall Study||0
10771554|NCT03280121|11934742|FG000|STARTED|Overall Study||14
10771555|NCT03280121|11934742|FG000|COMPLETED|Overall Study||8
10771556|NCT03280121|11934742|FG000|NOT COMPLETED|Overall Study||6
10771557|NCT03280264|11934746|FG000|STARTED|Overall Study||18
10771558|NCT03280264|11934746|FG000|COMPLETED|Overall Study||15
10771559|NCT03280264|11934746|FG000|NOT COMPLETED|Overall Study||3
10771560|NCT03280381|11934753|FG000|STARTED|Overall Study||101
10771561|NCT03280381|11934754|FG001|STARTED|Overall Study||99
10771562|NCT03280381|11934753|FG000|COMPLETED|Overall Study||101
10771563|NCT03280381|11934754|FG001|COMPLETED|Overall Study||97
10771564|NCT03280381|11934753|FG000|NOT COMPLETED|Overall Study||0
10771565|NCT03280381|11934754|FG001|NOT COMPLETED|Overall Study||2
10771566|NCT03280537|11934763|FG000|STARTED|Overall Study||65
10771567|NCT03280537|11934764|FG001|STARTED|Overall Study||62
10771568|NCT03280537|11934763|FG000|COMPLETED|Overall Study||63
10771569|NCT03280537|11934764|FG001|COMPLETED|Overall Study||58
10771570|NCT03280537|11934763|FG000|NOT COMPLETED|Overall Study||2
10771571|NCT03280537|11934764|FG001|NOT COMPLETED|Overall Study||4
10771572|NCT03280550|11934772|FG000|STARTED|Overall Study||66
10771573|NCT03280550|11934773|FG001|STARTED|Overall Study||72
10771574|NCT03280550|11934772|FG000|COMPLETED|Overall Study||64
10771575|NCT03280550|11934773|FG001|COMPLETED|Overall Study||69
10771576|NCT03280550|11934772|FG000|NOT COMPLETED|Overall Study||2
10771577|NCT03280550|11934773|FG001|NOT COMPLETED|Overall Study||3
10771578|NCT03280615|11934781|FG000|STARTED|Overall Study||50
10771579|NCT03280615|11934782|FG001|STARTED|Overall Study||50
10771580|NCT03280615|11934781|FG000|COMPLETED|Overall Study||46
10771581|NCT03280615|11934782|FG001|COMPLETED|Overall Study||45
10771582|NCT03280615|11934781|FG000|NOT COMPLETED|Overall Study||4
10771583|NCT03280615|11934782|FG001|NOT COMPLETED|Overall Study||5
10771584|NCT03281200|11934788|FG000|STARTED|Overall Study||172
10771585|NCT03281200|11934788|FG000|COMPLETED|Overall Study||172
10771586|NCT03281200|11934788|FG000|NOT COMPLETED|Overall Study||0
10771587|NCT03281538|11934792|FG000|STARTED|Overall Study||288
10771588|NCT03281538|11934792|FG000|COMPLETED|Overall Study||133
10771589|NCT03281538|11934792|FG000|NOT COMPLETED|Overall Study||155
10771590|NCT03281577|11934800|FG000|STARTED|Overall Study||10
10771591|NCT03281577|11934801|FG001|STARTED|Overall Study||10
10771592|NCT03281577|11934802|FG002|STARTED|Overall Study||9
10771593|NCT03281577|11934803|FG003|STARTED|Overall Study||7
10771594|NCT03281577|11934800|FG000|COMPLETED|Overall Study||9
10771595|NCT03281577|11934801|FG001|COMPLETED|Overall Study||10
10771596|NCT03281577|11934802|FG002|COMPLETED|Overall Study||9
10771597|NCT03281577|11934803|FG003|COMPLETED|Overall Study||6
10771598|NCT03281577|11934800|FG000|NOT COMPLETED|Overall Study||1
10771599|NCT03281577|11934801|FG001|NOT COMPLETED|Overall Study||0
10421675|NCT00820443|11566533|FG000|COMPLETED|3 Month||244
10421676|NCT00820443|11566533|FG000|NOT COMPLETED|3 Month||9
10421677|NCT00820443|11566533|FG000|STARTED|6 Month||253
10421678|NCT00820443|11566533|FG000|COMPLETED|6 Month||233
10421679|NCT00820443|11566533|FG000|NOT COMPLETED|6 Month||20
10421680|NCT00820443|11566533|FG000|STARTED|12 Month||250
10421681|NCT00820443|11566533|FG000|COMPLETED|12 Month||226
10421682|NCT00820443|11566533|FG000|NOT COMPLETED|12 Month||24
10421683|NCT00820443|11566533|FG000|STARTED|24 Month||245
10421684|NCT00820443|11566533|FG000|COMPLETED|24 Month||202
10421685|NCT00820443|11566533|FG000|NOT COMPLETED|24 Month||43
10421686|NCT00820534|11566540|FG000|STARTED|Overall Study||64
10771600|NCT03281577|11934802|FG002|NOT COMPLETED|Overall Study||0
10771601|NCT03281577|11934803|FG003|NOT COMPLETED|Overall Study||1
10771602|NCT03281668|11934816|FG000|STARTED|Overall Study||29
10421687|NCT00820534|11566541|FG001|STARTED|Overall Study||62
10421688|NCT00820534|11566540|FG000|COMPLETED|Overall Study||64
10421689|NCT00820534|11566541|FG001|COMPLETED|Overall Study||62
10421690|NCT00820534|11566540|FG000|NOT COMPLETED|Overall Study||0
10421691|NCT00820534|11566541|FG001|NOT COMPLETED|Overall Study||0
10421692|NCT00820573|11566551|FG000|STARTED|Overall Study||4
10771603|NCT03281668|11934816|FG000|COMPLETED|Overall Study||21
10771604|NCT03281668|11934816|FG000|NOT COMPLETED|Overall Study||8
10771605|NCT03281876|11934822|FG000|STARTED|Overall Study||304
10771606|NCT03281876|11934823|FG001|STARTED|Overall Study||302
10771607|NCT03281876|11934822|FG000|COMPLETED|Overall Study||281
10771608|NCT03281876|11934823|FG001|COMPLETED|Overall Study||263
10771609|NCT03281876|11934822|FG000|NOT COMPLETED|Overall Study||23
10771610|NCT03281876|11934823|FG001|NOT COMPLETED|Overall Study||39
10771611|NCT03282071|11934831|FG000|STARTED|Overall Study||75
10771612|NCT03282071|11934832|FG001|STARTED|Overall Study||69
10771613|NCT03282071|11934831|FG000|COMPLETED|Overall Study||65
10771614|NCT03282071|11934832|FG001|COMPLETED|Overall Study||60
10771615|NCT03282071|11934831|FG000|NOT COMPLETED|Overall Study||10
10771616|NCT03282071|11934832|FG001|NOT COMPLETED|Overall Study||9
10771617|NCT03282227|11934840|FG000|STARTED|Overall Study||342
10771618|NCT03282227|11934840|FG000|Completed at Least 6 Months|Overall Study||257
10771619|NCT03282227|11934840|FG000|COMPLETED|Overall Study||127
10771620|NCT03282227|11934840|FG000|NOT COMPLETED|Overall Study||215
10771621|NCT03282357|11934844|FG000|STARTED|Overall Study||181
10771622|NCT03282357|11934844|FG000|Safety Evaluation Set|Overall Study||176
10771623|NCT03282357|11934844|FG000|COMPLETED|Overall Study||164
10771624|NCT03282357|11934844|FG000|NOT COMPLETED|Overall Study||17
10771625|NCT03282591|11934851|FG000|STARTED|Overall Study||92
10771626|NCT03282591|11934852|FG001|STARTED|Overall Study||93
10771627|NCT03282591|11934851|FG000|COMPLETED|Overall Study||88
10771628|NCT03282591|11934852|FG001|COMPLETED|Overall Study||89
10771629|NCT03282591|11934851|FG000|NOT COMPLETED|Overall Study||4
10771630|NCT03282591|11934852|FG001|NOT COMPLETED|Overall Study||4
10771631|NCT03282682|11934862|FG000|STARTED|Overall Study||6
10771632|NCT03282682|11934863|FG001|STARTED|Overall Study||8
10771633|NCT03282682|11934864|FG002|STARTED|Overall Study||8
10771634|NCT03282682|11934862|FG000|COMPLETED|Overall Study||6
10771635|NCT03282682|11934863|FG001|COMPLETED|Overall Study||8
10771636|NCT03282682|11934864|FG002|COMPLETED|Overall Study||8
10771637|NCT03282682|11934862|FG000|NOT COMPLETED|Overall Study||0
10771638|NCT03282682|11934863|FG001|NOT COMPLETED|Overall Study||0
10771639|NCT03282682|11934864|FG002|NOT COMPLETED|Overall Study||0
10771640|NCT03283098|11934874|FG000|STARTED|Overall Study||8
10771641|NCT03283098|11934875|FG001|STARTED|Overall Study||25
10771642|NCT03283098|11934874|FG000|COMPLETED|Overall Study||8
10771643|NCT03283098|11934875|FG001|COMPLETED|Overall Study||24
10771644|NCT03283098|11934874|FG000|NOT COMPLETED|Overall Study||0
10771645|NCT03283098|11934875|FG001|NOT COMPLETED|Overall Study||1
10771646|NCT03283319|11934887|FG000|STARTED|Overall Study||62
10771647|NCT03283319|11934888|FG001|STARTED|Overall Study||60
10771648|NCT03283319|11934889|FG002|STARTED|Overall Study||62
10771649|NCT03283319|11934890|FG003|STARTED|Overall Study||61
10771650|NCT03283319|11934891|FG004|STARTED|Overall Study||60
10771651|NCT03283319|11934892|FG005|STARTED|Overall Study||61
10771652|NCT03283319|11934887|FG000|COMPLETED|Overall Study||55
10771653|NCT03283319|11934888|FG001|COMPLETED|Overall Study||54
10771654|NCT03283319|11934889|FG002|COMPLETED|Overall Study||55
10771655|NCT03283319|11934890|FG003|COMPLETED|Overall Study||54
10771656|NCT03283319|11934891|FG004|COMPLETED|Overall Study||56
10771657|NCT03283319|11934892|FG005|COMPLETED|Overall Study||57
10771658|NCT03283319|11934887|FG000|NOT COMPLETED|Overall Study||7
10771659|NCT03283319|11934888|FG001|NOT COMPLETED|Overall Study||6
10771660|NCT03283319|11934889|FG002|NOT COMPLETED|Overall Study||7
10771661|NCT03283319|11934890|FG003|NOT COMPLETED|Overall Study||7
10771662|NCT03283319|11934891|FG004|NOT COMPLETED|Overall Study||4
10771663|NCT03283319|11934892|FG005|NOT COMPLETED|Overall Study||4
10771664|NCT03283436|11934908|FG000|STARTED|Overall Study||50
10771665|NCT03283436|11934909|FG001|STARTED|Overall Study||50
10771666|NCT03283436|11934908|FG000|COMPLETED|Overall Study||44
10771667|NCT03283436|11934909|FG001|COMPLETED|Overall Study||50
10771668|NCT03283436|11934908|FG000|NOT COMPLETED|Overall Study||6
10771669|NCT03283436|11934909|FG001|NOT COMPLETED|Overall Study||0
10771670|NCT03283553|11934917|FG000|STARTED|Patient Participant Flow||69
10771671|NCT03283553|11934918|FG001|STARTED|Patient Participant Flow||63
10771672|NCT03283553|11934917|FG000|Patient Baseline Interview|Patient Participant Flow||69
10771673|NCT03283553|11934918|FG001|Patient Baseline Interview|Patient Participant Flow||62
10771674|NCT03283553|11934917|FG000|Patient 3-Month Interview|Patient Participant Flow||67
10771675|NCT03283553|11934918|FG001|Patient 3-Month Interview|Patient Participant Flow||60
10771676|NCT03283553|11934917|FG000|Patient 9-Month Interview|Patient Participant Flow||63
10771677|NCT03283553|11934918|FG001|Patient 9-Month Interview|Patient Participant Flow||57
10771678|NCT03283553|11934917|FG000|Patient 12-Month Interview|Patient Participant Flow||59
10771679|NCT03283553|11934918|FG001|Patient 12-Month Interview|Patient Participant Flow||50
10771680|NCT03283553|11934917|FG000|COMPLETED|Patient Participant Flow||59
10771681|NCT03283553|11934918|FG001|COMPLETED|Patient Participant Flow||50
10771682|NCT03283553|11934917|FG000|NOT COMPLETED|Patient Participant Flow||10
10771683|NCT03283553|11934918|FG001|NOT COMPLETED|Patient Participant Flow||13
10771684|NCT03283553|11934917|FG000|STARTED|Care Partner Participant Flow||69
10771685|NCT03283553|11934918|FG001|STARTED|Care Partner Participant Flow||63
10771686|NCT03283553|11934917|FG000|Care Partner Baseline Interview|Care Partner Participant Flow||69
10771687|NCT03283553|11934918|FG001|Care Partner Baseline Interview|Care Partner Participant Flow||63
10771688|NCT03283553|11934917|FG000|Care Partner 3-Month Interview|Care Partner Participant Flow||69
10771689|NCT03283553|11934918|FG001|Care Partner 3-Month Interview|Care Partner Participant Flow||60
10771690|NCT03283553|11934917|FG000|Care Partner 9-Month Interview|Care Partner Participant Flow||64
10771691|NCT03283553|11934918|FG001|Care Partner 9-Month Interview|Care Partner Participant Flow||55
10771692|NCT03283553|11934917|FG000|Care Partner 12-Month Interview|Care Partner Participant Flow||59
10771693|NCT03283553|11934918|FG001|Care Partner 12-Month Interview|Care Partner Participant Flow||48
10771694|NCT03283553|11934917|FG000|COMPLETED|Care Partner Participant Flow||59
10771695|NCT03283553|11934918|FG001|COMPLETED|Care Partner Participant Flow||48
10771696|NCT03283553|11934917|FG000|NOT COMPLETED|Care Partner Participant Flow||10
10771697|NCT03283553|11934918|FG001|NOT COMPLETED|Care Partner Participant Flow||15
10771698|NCT03283696|11934928|FG000|STARTED|Overall Study||16
10771699|NCT03283696|11934929|FG001|STARTED|Overall Study||8
10771700|NCT03283696|11934928|FG000|Received at Least 1 Dose of Study Drug|Overall Study||16
10771701|NCT03283696|11934929|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
10771702|NCT03283696|11934928|FG000|COMPLETED|Overall Study||9
10771703|NCT03283696|11934929|FG001|COMPLETED|Overall Study||2
10771704|NCT03283696|11934928|FG000|NOT COMPLETED|Overall Study||7
10771705|NCT03283696|11934929|FG001|NOT COMPLETED|Overall Study||6
10771706|NCT03283787|11934938|FG000|STARTED|Overall Study||20
10771707|NCT03283787|11934939|FG001|STARTED|Overall Study||20
10771708|NCT03283787|11934940|FG002|STARTED|Overall Study||20
10771709|NCT03283787|11934938|FG000|COMPLETED|Overall Study||17
10771710|NCT03283787|11934939|FG001|COMPLETED|Overall Study||13
10771711|NCT03283787|11934940|FG002|COMPLETED|Overall Study||13
10771712|NCT03283787|11934938|FG000|NOT COMPLETED|Overall Study||3
10771713|NCT03283787|11934939|FG001|NOT COMPLETED|Overall Study||7
10771714|NCT03283787|11934940|FG002|NOT COMPLETED|Overall Study||7
10771715|NCT03284229|11934951|FG000|STARTED|Overall Study||28
10771716|NCT03284229|11934951|FG000|COMPLETED|Overall Study||25
10771717|NCT03284229|11934951|FG000|NOT COMPLETED|Overall Study||3
10771718|NCT03284359|11934958|FG000|STARTED|Overall Study||93
10771719|NCT03284359|11934959|FG001|STARTED|Overall Study||89
10771720|NCT03284359|11934958|FG000|COMPLETED|Overall Study||93
10771721|NCT03284359|11934959|FG001|COMPLETED|Overall Study||89
10771722|NCT03284359|11934958|FG000|NOT COMPLETED|Overall Study||0
10771723|NCT03284359|11934959|FG001|NOT COMPLETED|Overall Study||0
10771724|NCT03284398|11934967|FG000|STARTED|Overall Study||2753
10771725|NCT03284398|11934968|FG001|STARTED|Overall Study||970
10771726|NCT03284398|11934967|FG000|COMPLETED|Overall Study||2753
10771727|NCT03284398|11934968|FG001|COMPLETED|Overall Study||970
10771728|NCT03284398|11934967|FG000|NOT COMPLETED|Overall Study||0
10771729|NCT03284398|11934968|FG001|NOT COMPLETED|Overall Study||0
10771730|NCT03284411|11934980|FG000|STARTED|Overall Study||30
10771731|NCT03284411|11934980|FG000|COMPLETED|Overall Study||30
10771732|NCT03284411|11934980|FG000|NOT COMPLETED|Overall Study||0
10771733|NCT03284710|11934989|FG000|STARTED|Overall Study||36
10771734|NCT03284710|11934990|FG001|STARTED|Overall Study||36
10771735|NCT03284710|11934991|FG002|STARTED|Overall Study||36
10771736|NCT03284710|11934992|FG003|STARTED|Overall Study||24
10771737|NCT03284710|11934989|FG000|Month 6.5 Immunogenicity Timepoint|Overall Study||31
10771738|NCT03284710|11934990|FG001|Month 6.5 Immunogenicity Timepoint|Overall Study||31
10771739|NCT03284710|11934991|FG002|Month 6.5 Immunogenicity Timepoint|Overall Study||31
10771740|NCT03284710|11934992|FG003|Month 6.5 Immunogenicity Timepoint|Overall Study||18
10771741|NCT03284710|11934989|FG000|Month 12 Immunogenicity Timepoint|Overall Study||30
10771742|NCT03284710|11934990|FG001|Month 12 Immunogenicity Timepoint|Overall Study||31
10771743|NCT03284710|11934991|FG002|Month 12 Immunogenicity Timepoint|Overall Study||31
10771744|NCT03284710|11934992|FG003|Month 12 Immunogenicity Timepoint|Overall Study||17
10771745|NCT03284710|11934989|FG000|Month 12.5 Immunogenicity Timepoint|Overall Study||0
10771746|NCT03284710|11934990|FG001|Month 12.5 Immunogenicity Timepoint|Overall Study||0
10771747|NCT03284710|11934991|FG002|Month 12.5 Immunogenicity Timepoint|Overall Study||0
10771748|NCT03284710|11934992|FG003|Month 12.5 Immunogenicity Timepoint|Overall Study||0
10771749|NCT03284710|11934989|FG000|Month 18 Immunogenicity Timepoint|Overall Study||0
10771750|NCT03284710|11934990|FG001|Month 18 Immunogenicity Timepoint|Overall Study||0
10771751|NCT03284710|11934991|FG002|Month 18 Immunogenicity Timepoint|Overall Study||0
10771752|NCT03284710|11934992|FG003|Month 18 Immunogenicity Timepoint|Overall Study||0
10771753|NCT03284710|11934989|FG000|COMPLETED|Overall Study||30
10771754|NCT03284710|11934990|FG001|COMPLETED|Overall Study||31
10771755|NCT03284710|11934991|FG002|COMPLETED|Overall Study||32
10771756|NCT03284710|11934992|FG003|COMPLETED|Overall Study||16
10771757|NCT03284710|11934989|FG000|NOT COMPLETED|Overall Study||6
10771758|NCT03284710|11934990|FG001|NOT COMPLETED|Overall Study||5
10771759|NCT03284710|11934991|FG002|NOT COMPLETED|Overall Study||4
10771760|NCT03284710|11934992|FG003|NOT COMPLETED|Overall Study||8
10771761|NCT03285061|11935009|FG000|STARTED|Overall Study||37
10771762|NCT03285061|11935010|FG001|STARTED|Overall Study||38
10771763|NCT03285061|11935009|FG000|COMPLETED|Overall Study||36
10771764|NCT03285061|11935010|FG001|COMPLETED|Overall Study||36
10771765|NCT03285061|11935009|FG000|NOT COMPLETED|Overall Study||1
10771766|NCT03285061|11935010|FG001|NOT COMPLETED|Overall Study||2
10771767|NCT03285113|11935016|FG000|STARTED|Overall Study||10
10771768|NCT03285113|11935016|FG000|COMPLETED|Overall Study||8
10771769|NCT03285113|11935016|FG000|NOT COMPLETED|Overall Study||2
10771770|NCT03285295|11935025|FG000|STARTED|Alinity s HBsAg||17095
10771771|NCT03285295|11935026|FG001|STARTED|Alinity s HBsAg||438
10771772|NCT03285295|11935027|FG002|STARTED|Alinity s HBsAg||403
10771773|NCT03285295|11935028|FG003|STARTED|Alinity s HBsAg||0
10771774|NCT03285295|11935029|FG004|STARTED|Alinity s HBsAg||51
10771775|NCT03285295|11935025|FG000|COMPLETED|Alinity s HBsAg||16993
10771776|NCT03285295|11935026|FG001|COMPLETED|Alinity s HBsAg||432
10771777|NCT03285295|11935027|FG002|COMPLETED|Alinity s HBsAg||403
10771778|NCT03285295|11935028|FG003|COMPLETED|Alinity s HBsAg||0
10771779|NCT03285295|11935029|FG004|COMPLETED|Alinity s HBsAg||51
10771780|NCT03285295|11935025|FG000|NOT COMPLETED|Alinity s HBsAg||102
10771781|NCT03285295|11935026|FG001|NOT COMPLETED|Alinity s HBsAg||6
10771782|NCT03285295|11935027|FG002|NOT COMPLETED|Alinity s HBsAg||0
10771783|NCT03285295|11935028|FG003|NOT COMPLETED|Alinity s HBsAg||0
10771784|NCT03285295|11935029|FG004|NOT COMPLETED|Alinity s HBsAg||0
10771785|NCT03285295|11935025|FG000|STARTED|Alinity s HBsAg Confirmatory||8
10771786|NCT03285295|11935026|FG001|STARTED|Alinity s HBsAg Confirmatory||432
10771787|NCT03285295|11935027|FG002|STARTED|Alinity s HBsAg Confirmatory||3
10771788|NCT03285295|11935028|FG003|STARTED|Alinity s HBsAg Confirmatory||0
10771789|NCT03285295|11935029|FG004|STARTED|Alinity s HBsAg Confirmatory||0
10771790|NCT03285295|11935025|FG000|COMPLETED|Alinity s HBsAg Confirmatory||8
10771791|NCT03285295|11935026|FG001|COMPLETED|Alinity s HBsAg Confirmatory||432
10771792|NCT03285295|11935027|FG002|COMPLETED|Alinity s HBsAg Confirmatory||3
10771793|NCT03285295|11935028|FG003|COMPLETED|Alinity s HBsAg Confirmatory||0
10771794|NCT03285295|11935029|FG004|COMPLETED|Alinity s HBsAg Confirmatory||0
10771795|NCT03285295|11935025|FG000|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
10771796|NCT03285295|11935026|FG001|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
10771797|NCT03285295|11935027|FG002|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
10771798|NCT03285295|11935028|FG003|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
10771799|NCT03285295|11935029|FG004|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
10771800|NCT03285295|11935025|FG000|STARTED|Alinity s HBsAg Follow-Up||0
10771801|NCT03285295|11935026|FG001|STARTED|Alinity s HBsAg Follow-Up||0
10771802|NCT03285295|11935027|FG002|STARTED|Alinity s HBsAg Follow-Up||0
10771803|NCT03285295|11935028|FG003|STARTED|Alinity s HBsAg Follow-Up||0
10771804|NCT03285295|11935029|FG004|STARTED|Alinity s HBsAg Follow-Up||0
10771805|NCT03285295|11935025|FG000|COMPLETED|Alinity s HBsAg Follow-Up||0
10771806|NCT03285295|11935026|FG001|COMPLETED|Alinity s HBsAg Follow-Up||0
10771807|NCT03285295|11935027|FG002|COMPLETED|Alinity s HBsAg Follow-Up||0
10771808|NCT03285295|11935028|FG003|COMPLETED|Alinity s HBsAg Follow-Up||0
10771809|NCT03285295|11935029|FG004|COMPLETED|Alinity s HBsAg Follow-Up||0
10771810|NCT03285295|11935025|FG000|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
10771811|NCT03285295|11935026|FG001|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
10771812|NCT03285295|11935027|FG002|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
10771813|NCT03285295|11935028|FG003|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
10421693|NCT00820573|11566552|FG001|STARTED|Overall Study||4
10421694|NCT00820573|11566553|FG002|STARTED|Overall Study||4
10421695|NCT00820573|11566554|FG003|STARTED|Overall Study||4
10421696|NCT00820573|11566551|FG000|COMPLETED|Overall Study||4
10421697|NCT00820573|11566552|FG001|COMPLETED|Overall Study||4
10421698|NCT00820573|11566553|FG002|COMPLETED|Overall Study||4
10421699|NCT00820573|11566554|FG003|COMPLETED|Overall Study||4
10421700|NCT00820573|11566551|FG000|NOT COMPLETED|Overall Study||0
10771814|NCT03285295|11935029|FG004|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
10771815|NCT03285295|11935025|FG000|STARTED|Alinity s HTLV I/II||15968
10771816|NCT03285295|11935026|FG001|STARTED|Alinity s HTLV I/II||706
10771817|NCT03285295|11935027|FG002|STARTED|Alinity s HTLV I/II||502
10771818|NCT03285295|11935028|FG003|STARTED|Alinity s HTLV I/II||509
10771819|NCT03285295|11935029|FG004|STARTED|Alinity s HTLV I/II||0
10771820|NCT03285295|11935025|FG000|COMPLETED|Alinity s HTLV I/II||15877
10771821|NCT03285295|11935026|FG001|COMPLETED|Alinity s HTLV I/II||706
10771822|NCT03285295|11935027|FG002|COMPLETED|Alinity s HTLV I/II||502
10771823|NCT03285295|11935028|FG003|COMPLETED|Alinity s HTLV I/II||509
10771824|NCT03285295|11935029|FG004|COMPLETED|Alinity s HTLV I/II||0
10771825|NCT03285295|11935025|FG000|NOT COMPLETED|Alinity s HTLV I/II||91
10771826|NCT03285295|11935026|FG001|NOT COMPLETED|Alinity s HTLV I/II||0
10771827|NCT03285295|11935027|FG002|NOT COMPLETED|Alinity s HTLV I/II||0
10771828|NCT03285295|11935028|FG003|NOT COMPLETED|Alinity s HTLV I/II||0
10771829|NCT03285295|11935029|FG004|NOT COMPLETED|Alinity s HTLV I/II||0
10771830|NCT03285295|11935025|FG000|STARTED|Alinity s HTLV I/II Follow-Up||12
10771831|NCT03285295|11935026|FG001|STARTED|Alinity s HTLV I/II Follow-Up||0
10771832|NCT03285295|11935027|FG002|STARTED|Alinity s HTLV I/II Follow-Up||0
10771833|NCT03285295|11935028|FG003|STARTED|Alinity s HTLV I/II Follow-Up||0
10771834|NCT03285295|11935029|FG004|STARTED|Alinity s HTLV I/II Follow-Up||0
10771835|NCT03285295|11935025|FG000|COMPLETED|Alinity s HTLV I/II Follow-Up||8
10771836|NCT03285295|11935026|FG001|COMPLETED|Alinity s HTLV I/II Follow-Up||0
10771837|NCT03285295|11935027|FG002|COMPLETED|Alinity s HTLV I/II Follow-Up||0
10771838|NCT03285295|11935028|FG003|COMPLETED|Alinity s HTLV I/II Follow-Up||0
10771839|NCT03285295|11935029|FG004|COMPLETED|Alinity s HTLV I/II Follow-Up||0
10771840|NCT03285295|11935025|FG000|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||4
10771841|NCT03285295|11935026|FG001|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
10771842|NCT03285295|11935027|FG002|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
10771843|NCT03285295|11935028|FG003|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
10771844|NCT03285295|11935029|FG004|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
10771845|NCT03285295|11935025|FG000|STARTED|Alinity s Anti-HCV||17095
10771846|NCT03285295|11935026|FG001|STARTED|Alinity s Anti-HCV||402
10421701|NCT00820573|11566552|FG001|NOT COMPLETED|Overall Study||0
10421702|NCT00820573|11566553|FG002|NOT COMPLETED|Overall Study||0
10421703|NCT00820573|11566554|FG003|NOT COMPLETED|Overall Study||0
10421704|NCT00820599|11566573|FG000|STARTED|Overall Study||211
10771847|NCT03285295|11935027|FG002|STARTED|Alinity s Anti-HCV||407
10771848|NCT03285295|11935028|FG003|STARTED|Alinity s Anti-HCV||0
10771849|NCT03285295|11935029|FG004|STARTED|Alinity s Anti-HCV||0
10771850|NCT03285295|11935025|FG000|COMPLETED|Alinity s Anti-HCV||16999
10771851|NCT03285295|11935026|FG001|COMPLETED|Alinity s Anti-HCV||402
10771852|NCT03285295|11935027|FG002|COMPLETED|Alinity s Anti-HCV||407
10771853|NCT03285295|11935028|FG003|COMPLETED|Alinity s Anti-HCV||0
10771854|NCT03285295|11935029|FG004|COMPLETED|Alinity s Anti-HCV||0
10771855|NCT03285295|11935025|FG000|NOT COMPLETED|Alinity s Anti-HCV||96
10771856|NCT03285295|11935026|FG001|NOT COMPLETED|Alinity s Anti-HCV||0
10771857|NCT03285295|11935027|FG002|NOT COMPLETED|Alinity s Anti-HCV||0
10771858|NCT03285295|11935028|FG003|NOT COMPLETED|Alinity s Anti-HCV||0
10771859|NCT03285295|11935029|FG004|NOT COMPLETED|Alinity s Anti-HCV||0
10771860|NCT03285295|11935025|FG000|STARTED|Alinity s Anti-HCV Follow-Up||20
10771861|NCT03285295|11935026|FG001|STARTED|Alinity s Anti-HCV Follow-Up||0
10771862|NCT03285295|11935027|FG002|STARTED|Alinity s Anti-HCV Follow-Up||0
10771863|NCT03285295|11935028|FG003|STARTED|Alinity s Anti-HCV Follow-Up||0
10771864|NCT03285295|11935029|FG004|STARTED|Alinity s Anti-HCV Follow-Up||0
10771865|NCT03285295|11935025|FG000|COMPLETED|Alinity s Anti-HCV Follow-Up||2
10771866|NCT03285295|11935026|FG001|COMPLETED|Alinity s Anti-HCV Follow-Up||0
10771867|NCT03285295|11935027|FG002|COMPLETED|Alinity s Anti-HCV Follow-Up||0
10771868|NCT03285295|11935028|FG003|COMPLETED|Alinity s Anti-HCV Follow-Up||0
10771869|NCT03285295|11935029|FG004|COMPLETED|Alinity s Anti-HCV Follow-Up||0
10771870|NCT03285295|11935025|FG000|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||18
10771871|NCT03285295|11935026|FG001|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
10771872|NCT03285295|11935027|FG002|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
10771873|NCT03285295|11935028|FG003|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
10771874|NCT03285295|11935029|FG004|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
10771875|NCT03285295|11935025|FG000|STARTED|Alinity s HIV Ag/Ab Combo||17095
10771876|NCT03285295|11935026|FG001|STARTED|Alinity s HIV Ag/Ab Combo||1336
10771877|NCT03285295|11935027|FG002|STARTED|Alinity s HIV Ag/Ab Combo||605
10771878|NCT03285295|11935028|FG003|STARTED|Alinity s HIV Ag/Ab Combo|Individuals at Increased Risk of HIV Infection from HIV-2 Endemic Areas|535
10771879|NCT03285295|11935029|FG004|STARTED|Alinity s HIV Ag/Ab Combo||0
10771880|NCT03285295|11935025|FG000|COMPLETED|Alinity s HIV Ag/Ab Combo||16996
10771881|NCT03285295|11935026|FG001|COMPLETED|Alinity s HIV Ag/Ab Combo||1336
10771882|NCT03285295|11935027|FG002|COMPLETED|Alinity s HIV Ag/Ab Combo||605
10771883|NCT03285295|11935028|FG003|COMPLETED|Alinity s HIV Ag/Ab Combo|Individuals at Increased Risk of HIV Infection from HIV-2 Endemic Areas|535
10771884|NCT03285295|11935029|FG004|COMPLETED|Alinity s HIV Ag/Ab Combo||0
10771885|NCT03285295|11935025|FG000|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||99
10771886|NCT03285295|11935026|FG001|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
10771887|NCT03285295|11935027|FG002|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
10771888|NCT03285295|11935028|FG003|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
10771889|NCT03285295|11935029|FG004|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
10771890|NCT03285295|11935025|FG000|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||15
10771891|NCT03285295|11935026|FG001|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
10771892|NCT03285295|11935027|FG002|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
10771893|NCT03285295|11935028|FG003|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
10771894|NCT03285295|11935029|FG004|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
10771895|NCT03285295|11935025|FG000|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||4
10771896|NCT03285295|11935026|FG001|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
10771897|NCT03285295|11935027|FG002|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
10771898|NCT03285295|11935028|FG003|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
10771899|NCT03285295|11935029|FG004|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
10771900|NCT03285295|11935025|FG000|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||11
10771901|NCT03285295|11935026|FG001|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
10771902|NCT03285295|11935027|FG002|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
10771903|NCT03285295|11935028|FG003|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
10771904|NCT03285295|11935029|FG004|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
10771905|NCT03285295|11935025|FG000|STARTED|Alinity s Anti-HBc||15968
10771906|NCT03285295|11935026|FG001|STARTED|Alinity s Anti-HBc||405
10771907|NCT03285295|11935027|FG002|STARTED|Alinity s Anti-HBc||403
10771908|NCT03285295|11935028|FG003|STARTED|Alinity s Anti-HBc||0
10771909|NCT03285295|11935029|FG004|STARTED|Alinity s Anti-HBc||0
10771910|NCT03285295|11935025|FG000|COMPLETED|Alinity s Anti-HBc||15877
10771911|NCT03285295|11935026|FG001|COMPLETED|Alinity s Anti-HBc||404
10771912|NCT03285295|11935027|FG002|COMPLETED|Alinity s Anti-HBc||403
10771913|NCT03285295|11935028|FG003|COMPLETED|Alinity s Anti-HBc||0
10771914|NCT03285295|11935029|FG004|COMPLETED|Alinity s Anti-HBc||0
10771915|NCT03285295|11935025|FG000|NOT COMPLETED|Alinity s Anti-HBc||91
10771916|NCT03285295|11935026|FG001|NOT COMPLETED|Alinity s Anti-HBc||1
10771917|NCT03285295|11935027|FG002|NOT COMPLETED|Alinity s Anti-HBc||0
10771918|NCT03285295|11935028|FG003|NOT COMPLETED|Alinity s Anti-HBc||0
10771919|NCT03285295|11935029|FG004|NOT COMPLETED|Alinity s Anti-HBc||0
10771920|NCT03285295|11935025|FG000|STARTED|Alinity s Anti-HBc Follow-Up||16
10771921|NCT03285295|11935026|FG001|STARTED|Alinity s Anti-HBc Follow-Up||0
10771922|NCT03285295|11935027|FG002|STARTED|Alinity s Anti-HBc Follow-Up||0
10771923|NCT03285295|11935028|FG003|STARTED|Alinity s Anti-HBc Follow-Up||0
10771924|NCT03285295|11935029|FG004|STARTED|Alinity s Anti-HBc Follow-Up||0
10771925|NCT03285295|11935025|FG000|COMPLETED|Alinity s Anti-HBc Follow-Up||2
10771926|NCT03285295|11935026|FG001|COMPLETED|Alinity s Anti-HBc Follow-Up||0
10771927|NCT03285295|11935027|FG002|COMPLETED|Alinity s Anti-HBc Follow-Up||0
10771928|NCT03285295|11935028|FG003|COMPLETED|Alinity s Anti-HBc Follow-Up||0
10771929|NCT03285295|11935029|FG004|COMPLETED|Alinity s Anti-HBc Follow-Up||0
10771930|NCT03285295|11935025|FG000|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||14
10771931|NCT03285295|11935026|FG001|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
10771932|NCT03285295|11935027|FG002|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
10771933|NCT03285295|11935028|FG003|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
10771934|NCT03285295|11935029|FG004|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
10771935|NCT03285295|11935025|FG000|STARTED|Alinity s Chagas||16023
10771936|NCT03285295|11935026|FG001|STARTED|Alinity s Chagas||320
10771937|NCT03285295|11935027|FG002|STARTED|Alinity s Chagas||0
10771938|NCT03285295|11935028|FG003|STARTED|Alinity s Chagas||615
10771939|NCT03285295|11935029|FG004|STARTED|Alinity s Chagas||0
10771940|NCT03285295|11935025|FG000|COMPLETED|Alinity s Chagas||15804
10771941|NCT03285295|11935026|FG001|COMPLETED|Alinity s Chagas||320
10771942|NCT03285295|11935027|FG002|COMPLETED|Alinity s Chagas||0
10771943|NCT03285295|11935028|FG003|COMPLETED|Alinity s Chagas||615
10771944|NCT03285295|11935029|FG004|COMPLETED|Alinity s Chagas||0
10771945|NCT03285295|11935025|FG000|NOT COMPLETED|Alinity s Chagas||219
10771946|NCT03285295|11935026|FG001|NOT COMPLETED|Alinity s Chagas||0
10771947|NCT03285295|11935027|FG002|NOT COMPLETED|Alinity s Chagas||0
10771948|NCT03285295|11935028|FG003|NOT COMPLETED|Alinity s Chagas||0
10771949|NCT03285295|11935029|FG004|NOT COMPLETED|Alinity s Chagas||0
10771950|NCT03285295|11935025|FG000|STARTED|Alinity s Chagas Follow-Up||14
10771951|NCT03285295|11935026|FG001|STARTED|Alinity s Chagas Follow-Up||0
10771952|NCT03285295|11935027|FG002|STARTED|Alinity s Chagas Follow-Up||0
10771953|NCT03285295|11935028|FG003|STARTED|Alinity s Chagas Follow-Up||0
10771954|NCT03285295|11935029|FG004|STARTED|Alinity s Chagas Follow-Up||0
10771955|NCT03285295|11935025|FG000|COMPLETED|Alinity s Chagas Follow-Up||1
10771956|NCT03285295|11935026|FG001|COMPLETED|Alinity s Chagas Follow-Up||0
10771957|NCT03285295|11935027|FG002|COMPLETED|Alinity s Chagas Follow-Up||0
10771958|NCT03285295|11935028|FG003|COMPLETED|Alinity s Chagas Follow-Up||0
10771959|NCT03285295|11935029|FG004|COMPLETED|Alinity s Chagas Follow-Up||0
10771960|NCT03285295|11935025|FG000|NOT COMPLETED|Alinity s Chagas Follow-Up||13
10771961|NCT03285295|11935026|FG001|NOT COMPLETED|Alinity s Chagas Follow-Up||0
10771962|NCT03285295|11935027|FG002|NOT COMPLETED|Alinity s Chagas Follow-Up||0
10771963|NCT03285295|11935028|FG003|NOT COMPLETED|Alinity s Chagas Follow-Up||0
10771964|NCT03285295|11935029|FG004|NOT COMPLETED|Alinity s Chagas Follow-Up||0
10771965|NCT03285308|11935060|FG000|STARTED|Overall Study||167
10771966|NCT03285308|11935061|FG001|STARTED|Overall Study||169
10771967|NCT03285308|11935060|FG000|Safety Population|Overall Study||163
10771968|NCT03285308|11935061|FG001|Safety Population|Overall Study||163
10297947|NCT00005901|11430581|FG000|STARTED|Overall Study||19
10771969|NCT03285308|11935060|FG000|COMPLETED|Overall Study||147
10771970|NCT03285308|11935061|FG001|COMPLETED|Overall Study||146
10771971|NCT03285308|11935060|FG000|NOT COMPLETED|Overall Study||20
10771972|NCT03285308|11935061|FG001|NOT COMPLETED|Overall Study||23
10771973|NCT03285373|11935068|FG000|STARTED|Overall Study||314
10771974|NCT03285373|11935069|FG001|STARTED|Overall Study||253
10771975|NCT03285373|11935070|FG002|STARTED|Overall Study||266
10771976|NCT03285373|11935071|FG003|STARTED|Overall Study||130
10771977|NCT03285373|11935068|FG000|COMPLETED|Overall Study||314
10771978|NCT03285373|11935069|FG001|COMPLETED|Overall Study||253
10771979|NCT03285373|11935070|FG002|COMPLETED|Overall Study||266
10771980|NCT03285373|11935071|FG003|COMPLETED|Overall Study||130
10771981|NCT03285373|11935068|FG000|NOT COMPLETED|Overall Study||0
10771982|NCT03285373|11935069|FG001|NOT COMPLETED|Overall Study||0
10771983|NCT03285373|11935070|FG002|NOT COMPLETED|Overall Study||0
10771984|NCT03285373|11935071|FG003|NOT COMPLETED|Overall Study||0
10771985|NCT03285477|11935082|FG000|STARTED|Treatment and Response Assessment Period||176
10771986|NCT03285477|11935083|FG001|STARTED|Treatment and Response Assessment Period||175
10771987|NCT03285477|11935082|FG000|COMPLETED|Treatment and Response Assessment Period||174
10771988|NCT03285477|11935083|FG001|COMPLETED|Treatment and Response Assessment Period||175
10771989|NCT03285477|11935082|FG000|NOT COMPLETED|Treatment and Response Assessment Period||2
10771990|NCT03285477|11935083|FG001|NOT COMPLETED|Treatment and Response Assessment Period||0
10771991|NCT03285477|11935082|FG000|STARTED|Recurrence Follow-up Period||8
10771992|NCT03285477|11935083|FG001|STARTED|Recurrence Follow-up Period||77
10771993|NCT03285477|11935082|FG000|COMPLETED|Recurrence Follow-up Period||2
10771994|NCT03285477|11935083|FG001|COMPLETED|Recurrence Follow-up Period||22
10771995|NCT03285477|11935082|FG000|NOT COMPLETED|Recurrence Follow-up Period||6
10771996|NCT03285477|11935083|FG001|NOT COMPLETED|Recurrence Follow-up Period||55
10771997|NCT03285490|11935092|FG000|STARTED|Treatment and Response Assessment Period||173
10771998|NCT03285490|11935093|FG001|STARTED|Treatment and Response Assessment Period||178
10771999|NCT03285490|11935092|FG000|COMPLETED|Treatment and Response Assessment Period||173
10772000|NCT03285490|11935093|FG001|COMPLETED|Treatment and Response Assessment Period||178
10772001|NCT03285490|11935092|FG000|NOT COMPLETED|Treatment and Response Assessment Period||0
10772002|NCT03285490|11935093|FG001|NOT COMPLETED|Treatment and Response Assessment Period||0
10772003|NCT03285490|11935092|FG000|STARTED|Recurrence Follow-up Period||22
10772004|NCT03285490|11935093|FG001|STARTED|Recurrence Follow-up Period||97
10772005|NCT03285490|11935092|FG000|COMPLETED|Recurrence Follow-up Period||4
10772006|NCT03285490|11935093|FG001|COMPLETED|Recurrence Follow-up Period||36
10772007|NCT03285490|11935092|FG000|NOT COMPLETED|Recurrence Follow-up Period||18
10772008|NCT03285490|11935093|FG001|NOT COMPLETED|Recurrence Follow-up Period||61
10772009|NCT03285529|11935102|FG000|STARTED|Overall Study||30
10772010|NCT03285529|11935103|FG001|STARTED|Overall Study||30
10772011|NCT03285529|11935102|FG000|COMPLETED|Overall Study||30
10772012|NCT03285529|11935103|FG001|COMPLETED|Overall Study||30
10772013|NCT03285529|11935102|FG000|NOT COMPLETED|Overall Study||0
10772014|NCT03285529|11935103|FG001|NOT COMPLETED|Overall Study||0
10772015|NCT03285542|11935111|FG000|STARTED|Overall Study||30
10297948|NCT00005901|11430582|FG001|STARTED|Overall Study||15
10297949|NCT00005901|11430581|FG000|COMPLETED|Overall Study||19
10297950|NCT00005901|11430582|FG001|COMPLETED|Overall Study||15
10297951|NCT00005901|11430581|FG000|NOT COMPLETED|Overall Study||0
10297952|NCT00005901|11430582|FG001|NOT COMPLETED|Overall Study||0
10297953|NCT00005906|11430588|FG000|STARTED|Overall Study||4
10297954|NCT00005906|11430588|FG000|COMPLETED|Overall Study||1
10297955|NCT00005906|11430588|FG000|NOT COMPLETED|Overall Study||3
10297956|NCT00005908|11430592|FG000|STARTED|Overall Study||10
10297957|NCT00005908|11430593|FG001|STARTED|Overall Study||20
10297958|NCT00005908|11430592|FG000|COMPLETED|Overall Study||9
10297959|NCT00005908|11430593|FG001|COMPLETED|Overall Study||20
10297960|NCT00005908|11430592|FG000|NOT COMPLETED|Overall Study||1
10297961|NCT00005908|11430593|FG001|NOT COMPLETED|Overall Study||0
10314989|NCT00171314|11448734|FG000|Safety Population|Overall Study|"Treatment Actually Received = 251 from upfront Arm and 3 from delayed Arm"|254
10314990|NCT00171314|11448735|FG001|Safety Population|Overall Study|"Treatment Actually Received = 10 from upfront Arm and 259 from delayed Arm"|269
10314991|NCT00171314|11448734|FG000|COMPLETED|Overall Study||172
10314992|NCT00171314|11448735|FG001|COMPLETED|Overall Study||186
10314993|NCT00171314|11448734|FG000|NOT COMPLETED|Overall Study||91
10314994|NCT00171314|11448735|FG001|NOT COMPLETED|Overall Study||78
10314995|NCT00171340|11448743|FG000|STARTED|Overall Study||532
10314996|NCT00171340|11448744|FG001|STARTED|Overall Study||533
10314997|NCT00171340|11448743|FG000|COMPLETED|Overall Study||408
10314998|NCT00171340|11448744|FG001|COMPLETED|Overall Study||398
10314999|NCT00171340|11448743|FG000|NOT COMPLETED|Overall Study||124
10315000|NCT00171340|11448744|FG001|NOT COMPLETED|Overall Study||135
10315001|NCT00171704|11448754|FG000|STARTED|Overall Study||133
10772016|NCT03285542|11935112|FG001|STARTED|Overall Study||30
10772017|NCT03285542|11935111|FG000|COMPLETED|Overall Study||30
10772018|NCT03285542|11935112|FG001|COMPLETED|Overall Study||30
10772019|NCT03285542|11935111|FG000|NOT COMPLETED|Overall Study||0
10772020|NCT03285542|11935112|FG001|NOT COMPLETED|Overall Study||0
10772021|NCT03285555|11935120|FG000|STARTED|Overall Study||30
10772022|NCT03285555|11935121|FG001|STARTED|Overall Study||30
10772023|NCT03285555|11935120|FG000|COMPLETED|Overall Study||30
10772024|NCT03285555|11935121|FG001|COMPLETED|Overall Study||30
10772025|NCT03285555|11935120|FG000|NOT COMPLETED|Overall Study||0
10772026|NCT03285555|11935121|FG001|NOT COMPLETED|Overall Study||0
10772027|NCT03285594|11935130|FG000|STARTED|Overall Study||144
10772028|NCT03285594|11935131|FG001|STARTED|Overall Study||141
10772029|NCT03285594|11935132|FG002|STARTED|Overall Study||286
10772030|NCT03285594|11935130|FG000|Treated|Overall Study||144
10772031|NCT03285594|11935131|FG001|Treated|Overall Study||141
10772032|NCT03285594|11935132|FG002|Treated|Overall Study||285
10772033|NCT03285594|11935130|FG000|COMPLETED|Overall Study||129
10772034|NCT03285594|11935131|FG001|COMPLETED|Overall Study||130
10772035|NCT03285594|11935132|FG002|COMPLETED|Overall Study||249
10772036|NCT03285594|11935130|FG000|NOT COMPLETED|Overall Study||15
10772037|NCT03285594|11935131|FG001|NOT COMPLETED|Overall Study||11
10772038|NCT03285594|11935132|FG002|NOT COMPLETED|Overall Study||37
10772039|NCT03285646|11935143|FG000|STARTED|Overall Study||32
10772040|NCT03285646|11935144|FG001|STARTED|Overall Study||31
10772041|NCT03285646|11935143|FG000|COMPLETED|Overall Study||19
10772042|NCT03285646|11935144|FG001|COMPLETED|Overall Study||27
10772043|NCT03285646|11935143|FG000|NOT COMPLETED|Overall Study||13
10772044|NCT03285646|11935144|FG001|NOT COMPLETED|Overall Study||4
10772045|NCT03285711|11935153|FG000|STARTED|Blinded Phase (Up to Week 16)||4
10772046|NCT03285711|11935154|FG001|STARTED|Blinded Phase (Up to Week 16)||5
10772047|NCT03285711|11935155|FG002|STARTED|Blinded Phase (Up to Week 16)||0
10772048|NCT03285711|11935156|FG003|STARTED|Blinded Phase (Up to Week 16)||0
10772049|NCT03285711|11935153|FG000|COMPLETED|Blinded Phase (Up to Week 16)||1
10772050|NCT03285711|11935154|FG001|COMPLETED|Blinded Phase (Up to Week 16)||4
10772051|NCT03285711|11935155|FG002|COMPLETED|Blinded Phase (Up to Week 16)||0
10772052|NCT03285711|11935156|FG003|COMPLETED|Blinded Phase (Up to Week 16)||0
10772053|NCT03285711|11935153|FG000|NOT COMPLETED|Blinded Phase (Up to Week 16)||3
10772054|NCT03285711|11935154|FG001|NOT COMPLETED|Blinded Phase (Up to Week 16)||1
10772055|NCT03285711|11935155|FG002|NOT COMPLETED|Blinded Phase (Up to Week 16)||0
10772056|NCT03285711|11935156|FG003|NOT COMPLETED|Blinded Phase (Up to Week 16)||0
10772057|NCT03285711|11935153|FG000|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment to filgotinib.|0
10772058|NCT03285711|11935154|FG001|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment to lanraplenib.|3
10772059|NCT03285711|11935155|FG002|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment from lanraplenib.|1
10772060|NCT03285711|11935156|FG003|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment from filgotinib.|1
10772061|NCT03285711|11935153|FG000|COMPLETED|Blinded Phase (Week 16 to 32)||0
10772062|NCT03285711|11935154|FG001|COMPLETED|Blinded Phase (Week 16 to 32)||3
10772063|NCT03285711|11935155|FG002|COMPLETED|Blinded Phase (Week 16 to 32)||0
10772064|NCT03285711|11935156|FG003|COMPLETED|Blinded Phase (Week 16 to 32)||1
10772065|NCT03285711|11935153|FG000|NOT COMPLETED|Blinded Phase (Week 16 to 32)||0
10772066|NCT03285711|11935154|FG001|NOT COMPLETED|Blinded Phase (Week 16 to 32)||0
10772067|NCT03285711|11935155|FG002|NOT COMPLETED|Blinded Phase (Week 16 to 32)||1
10772068|NCT03285711|11935156|FG003|NOT COMPLETED|Blinded Phase (Week 16 to 32)||0
10772069|NCT03285711|11935153|FG000|STARTED|Extended Blinded Phase (Week 32 to 52)||0
10772070|NCT03285711|11935154|FG001|STARTED|Extended Blinded Phase (Week 32 to 52)||3
10772071|NCT03285711|11935155|FG002|STARTED|Extended Blinded Phase (Week 32 to 52)||0
10772072|NCT03285711|11935156|FG003|STARTED|Extended Blinded Phase (Week 32 to 52)||1
10772073|NCT03285711|11935153|FG000|COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
10772074|NCT03285711|11935154|FG001|COMPLETED|Extended Blinded Phase (Week 32 to 52)||2
10772075|NCT03285711|11935155|FG002|COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
10772076|NCT03285711|11935156|FG003|COMPLETED|Extended Blinded Phase (Week 32 to 52)||1
10772077|NCT03285711|11935153|FG000|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
10772078|NCT03285711|11935154|FG001|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||1
10772079|NCT03285711|11935155|FG002|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
10772080|NCT03285711|11935156|FG003|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
10772081|NCT03285724|11935166|FG000|STARTED|Overall Study||1
10772082|NCT03285724|11935166|FG000|COMPLETED|Overall Study||1
10772083|NCT03285724|11935166|FG000|NOT COMPLETED|Overall Study||0
10772084|NCT03285958|11935172|FG000|STARTED|Overall Study||33
10772085|NCT03285958|11935173|FG001|STARTED|Overall Study||24
10772086|NCT03285958|11935172|FG000|COMPLETED|Overall Study||28
10772087|NCT03285958|11935173|FG001|COMPLETED|Overall Study||23
10772088|NCT03285958|11935172|FG000|NOT COMPLETED|Overall Study||5
10772089|NCT03285958|11935173|FG001|NOT COMPLETED|Overall Study||1
10772090|NCT03285984|11935180|FG000|STARTED|Overall Study||56
10772091|NCT03285984|11935180|FG000|Received Test Product 1|Overall Study||56
10772092|NCT03285984|11935180|FG000|Received Test Product 2|Overall Study||56
10772093|NCT03285984|11935180|FG000|Received Test Product 3|Overall Study||56
10772094|NCT03285984|11935180|FG000|Received Test Product 4|Overall Study||56
10772095|NCT03285984|11935180|FG000|COMPLETED|Overall Study||56
10772096|NCT03285984|11935180|FG000|NOT COMPLETED|Overall Study||0
10772097|NCT03286218|11935192|FG000|STARTED|Qualification Phase Period 1||48
10772098|NCT03286218|11935193|FG001|STARTED|Qualification Phase Period 1||48
10772099|NCT03286218|11935194|FG002|STARTED|Qualification Phase Period 1||0
10772100|NCT03286218|11935195|FG003|STARTED|Qualification Phase Period 1||0
10772101|NCT03286218|11935196|FG004|STARTED|Qualification Phase Period 1||0
10772102|NCT03286218|11935197|FG005|STARTED|Qualification Phase Period 1||0
10772103|NCT03286218|11935198|FG006|STARTED|Qualification Phase Period 1||0
10772104|NCT03286218|11935199|FG007|STARTED|Qualification Phase Period 1||0
10772105|NCT03286218|11935200|FG008|STARTED|Qualification Phase Period 1||0
10772106|NCT03286218|11935201|FG009|STARTED|Qualification Phase Period 1||0
10772107|NCT03286218|11935202|FG010|STARTED|Qualification Phase Period 1||0
10772108|NCT03286218|11935203|FG011|STARTED|Qualification Phase Period 1||0
10772109|NCT03286218|11935192|FG000|Received at Least One Dose of Study Drug|Qualification Phase Period 1||47
10772110|NCT03286218|11935193|FG001|Received at Least One Dose of Study Drug|Qualification Phase Period 1||47
10772111|NCT03286218|11935194|FG002|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
10772112|NCT03286218|11935195|FG003|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
10772113|NCT03286218|11935196|FG004|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
10772114|NCT03286218|11935197|FG005|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
10772115|NCT03286218|11935198|FG006|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
10772116|NCT03286218|11935199|FG007|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
10772117|NCT03286218|11935200|FG008|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
10772118|NCT03286218|11935201|FG009|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
10772119|NCT03286218|11935202|FG010|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
10297962|NCT00005937|11430602|FG000|STARTED|Overall Study||42
10297963|NCT00005937|11430602|FG000|COMPLETED|Overall Study||37
10297964|NCT00005937|11430602|FG000|NOT COMPLETED|Overall Study||5
10297965|NCT00005947|11430608|FG000|STARTED|Overall Study||82
10297966|NCT00005947|11430609|FG001|STARTED|Overall Study||45
10297967|NCT00005947|11430608|FG000|COMPLETED|Overall Study||25
10297968|NCT00005947|11430609|FG001|COMPLETED|Overall Study||4
10297969|NCT00005947|11430608|FG000|NOT COMPLETED|Overall Study||57
10297970|NCT00005947|11430609|FG001|NOT COMPLETED|Overall Study||41
10297971|NCT00005957|11430619|FG000|STARTED|Overall Study||916
10297972|NCT00005957|11430620|FG001|STARTED|Overall Study||916
10297973|NCT00005957|11430619|FG000|COMPLETED|Overall Study||908
10297974|NCT00005957|11430620|FG001|COMPLETED|Overall Study||888
10297975|NCT00005957|11430619|FG000|NOT COMPLETED|Overall Study||8
10297976|NCT00005957|11430620|FG001|NOT COMPLETED|Overall Study||28
10297977|NCT00006011|11430629|FG000|STARTED|Overall Study|total number of participants enrolled, that received random treatment assignment to Arm 1 of study.|288
10297978|NCT00006011|11430630|FG001|STARTED|Overall Study|total number of participants enrolled, that received random treatment assignment to Arm 2 of study.|298
10297979|NCT00006011|11430631|FG002|STARTED|Overall Study|total number of participants enrolled, that only received radiation treatment.|73
10297980|NCT00006011|11430629|FG000|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|223
10297981|NCT00006011|11430630|FG001|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|221
10297982|NCT00006011|11430631|FG002|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|0
10297983|NCT00006011|11430629|FG000|NOT COMPLETED|Overall Study||65
10297984|NCT00006011|11430630|FG001|NOT COMPLETED|Overall Study||77
10297985|NCT00006011|11430631|FG002|NOT COMPLETED|Overall Study||73
10297986|NCT00006046|11430642|FG000|STARTED|Overall Study||7
10297987|NCT00006046|11430643|FG001|STARTED|Overall Study||0
10297988|NCT00006046|11430644|FG002|STARTED|Overall Study||0
10297989|NCT00006046|11430645|FG003|STARTED|Overall Study||0
10297990|NCT00006046|11430646|FG004|STARTED|Overall Study||0
10297991|NCT00006046|11430642|FG000|COMPLETED|Overall Study||2
10297992|NCT00006046|11430643|FG001|COMPLETED|Overall Study||0
10297993|NCT00006046|11430644|FG002|COMPLETED|Overall Study||0
10297994|NCT00006046|11430645|FG003|COMPLETED|Overall Study||0
10421705|NCT00820599|11566573|FG000|COMPLETED|Overall Study||80
10421706|NCT00820599|11566573|FG000|NOT COMPLETED|Overall Study||131
10421707|NCT00820612|11566579|FG000|STARTED|Overall Study||307
10421708|NCT00820612|11566580|FG001|STARTED|Overall Study||295
10421709|NCT00820612|11566579|FG000|COMPLETED|Overall Study||307
10421710|NCT00820612|11566580|FG001|COMPLETED|Overall Study||295
10421711|NCT00820612|11566579|FG000|NOT COMPLETED|Overall Study||0
10421712|NCT00820612|11566580|FG001|NOT COMPLETED|Overall Study||0
10421713|NCT00820664|11566589|FG000|STARTED|Overall Study||9
10421714|NCT00820664|11566590|FG001|STARTED|Overall Study||11
10421715|NCT00820664|11566591|FG002|STARTED|Overall Study||9
10421716|NCT00820664|11566589|FG000|COMPLETED|Overall Study||9
10421717|NCT00820664|11566590|FG001|COMPLETED|Overall Study||11
10421718|NCT00820664|11566591|FG002|COMPLETED|Overall Study||9
10421719|NCT00820664|11566589|FG000|NOT COMPLETED|Overall Study||0
10421720|NCT00820664|11566590|FG001|NOT COMPLETED|Overall Study||0
10421721|NCT00820664|11566591|FG002|NOT COMPLETED|Overall Study||0
10421722|NCT00820755|11566599|FG000|STARTED|Period 1: Combination Therapy Phase||583
10421723|NCT00820755|11566600|FG001|STARTED|Period 1: Combination Therapy Phase||0
10421724|NCT00820755|11566601|FG002|STARTED|Period 1: Combination Therapy Phase||0
10421725|NCT00820755|11566599|FG000|COMPLETED|Period 1: Combination Therapy Phase|2 of 313 participants excluded from maintenance phase analysis (reason: not eligible)|313
10421726|NCT00820755|11566600|FG001|COMPLETED|Period 1: Combination Therapy Phase||0
10421727|NCT00820755|11566601|FG002|COMPLETED|Period 1: Combination Therapy Phase||0
10779394|NCT03365778|11940976|FG000|NOT COMPLETED|Overall Study||0
10421728|NCT00820755|11566599|FG000|NOT COMPLETED|Period 1: Combination Therapy Phase||270
10421729|NCT00820755|11566600|FG001|NOT COMPLETED|Period 1: Combination Therapy Phase||0
10772120|NCT03286218|11935203|FG011|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
10772121|NCT03286218|11935192|FG000|COMPLETED|Qualification Phase Period 1||47
10772122|NCT03286218|11935193|FG001|COMPLETED|Qualification Phase Period 1||47
10772123|NCT03286218|11935194|FG002|COMPLETED|Qualification Phase Period 1||0
10772124|NCT03286218|11935195|FG003|COMPLETED|Qualification Phase Period 1||0
10772125|NCT03286218|11935196|FG004|COMPLETED|Qualification Phase Period 1||0
10772126|NCT03286218|11935197|FG005|COMPLETED|Qualification Phase Period 1||0
10772127|NCT03286218|11935198|FG006|COMPLETED|Qualification Phase Period 1||0
10772128|NCT03286218|11935199|FG007|COMPLETED|Qualification Phase Period 1||0
10772129|NCT03286218|11935200|FG008|COMPLETED|Qualification Phase Period 1||0
10772130|NCT03286218|11935201|FG009|COMPLETED|Qualification Phase Period 1||0
10772131|NCT03286218|11935202|FG010|COMPLETED|Qualification Phase Period 1||0
10772132|NCT03286218|11935203|FG011|COMPLETED|Qualification Phase Period 1||0
10772133|NCT03286218|11935192|FG000|NOT COMPLETED|Qualification Phase Period 1||1
10772134|NCT03286218|11935193|FG001|NOT COMPLETED|Qualification Phase Period 1||1
10772135|NCT03286218|11935194|FG002|NOT COMPLETED|Qualification Phase Period 1||0
10772136|NCT03286218|11935195|FG003|NOT COMPLETED|Qualification Phase Period 1||0
10772137|NCT03286218|11935196|FG004|NOT COMPLETED|Qualification Phase Period 1||0
10772138|NCT03286218|11935197|FG005|NOT COMPLETED|Qualification Phase Period 1||0
10772139|NCT03286218|11935198|FG006|NOT COMPLETED|Qualification Phase Period 1||0
10772140|NCT03286218|11935199|FG007|NOT COMPLETED|Qualification Phase Period 1||0
10772141|NCT03286218|11935200|FG008|NOT COMPLETED|Qualification Phase Period 1||0
10772142|NCT03286218|11935201|FG009|NOT COMPLETED|Qualification Phase Period 1||0
10772143|NCT03286218|11935202|FG010|NOT COMPLETED|Qualification Phase Period 1||0
10772144|NCT03286218|11935203|FG011|NOT COMPLETED|Qualification Phase Period 1||0
10772145|NCT03286218|11935192|FG000|STARTED|Qualification Phase Period 2||47
10772146|NCT03286218|11935193|FG001|STARTED|Qualification Phase Period 2||47
10772147|NCT03286218|11935194|FG002|STARTED|Qualification Phase Period 2||0
10772148|NCT03286218|11935195|FG003|STARTED|Qualification Phase Period 2||0
10772149|NCT03286218|11935196|FG004|STARTED|Qualification Phase Period 2||0
10772150|NCT03286218|11935197|FG005|STARTED|Qualification Phase Period 2||0
10772151|NCT03286218|11935198|FG006|STARTED|Qualification Phase Period 2||0
10772152|NCT03286218|11935199|FG007|STARTED|Qualification Phase Period 2||0
10772153|NCT03286218|11935200|FG008|STARTED|Qualification Phase Period 2||0
10772154|NCT03286218|11935201|FG009|STARTED|Qualification Phase Period 2||0
10772155|NCT03286218|11935202|FG010|STARTED|Qualification Phase Period 2||0
10772156|NCT03286218|11935203|FG011|STARTED|Qualification Phase Period 2||0
10772157|NCT03286218|11935192|FG000|COMPLETED|Qualification Phase Period 2||30
10772158|NCT03286218|11935193|FG001|COMPLETED|Qualification Phase Period 2||28
10772159|NCT03286218|11935194|FG002|COMPLETED|Qualification Phase Period 2||0
10772160|NCT03286218|11935195|FG003|COMPLETED|Qualification Phase Period 2||0
10772161|NCT03286218|11935196|FG004|COMPLETED|Qualification Phase Period 2||0
10772162|NCT03286218|11935197|FG005|COMPLETED|Qualification Phase Period 2||0
10772163|NCT03286218|11935198|FG006|COMPLETED|Qualification Phase Period 2||0
10772164|NCT03286218|11935199|FG007|COMPLETED|Qualification Phase Period 2||0
10772165|NCT03286218|11935200|FG008|COMPLETED|Qualification Phase Period 2||0
10772166|NCT03286218|11935201|FG009|COMPLETED|Qualification Phase Period 2||0
10772167|NCT03286218|11935202|FG010|COMPLETED|Qualification Phase Period 2||0
10772168|NCT03286218|11935203|FG011|COMPLETED|Qualification Phase Period 2||0
10772169|NCT03286218|11935192|FG000|NOT COMPLETED|Qualification Phase Period 2||17
10772170|NCT03286218|11935193|FG001|NOT COMPLETED|Qualification Phase Period 2||19
10772171|NCT03286218|11935194|FG002|NOT COMPLETED|Qualification Phase Period 2||0
10772172|NCT03286218|11935195|FG003|NOT COMPLETED|Qualification Phase Period 2||0
10772173|NCT03286218|11935196|FG004|NOT COMPLETED|Qualification Phase Period 2||0
10772174|NCT03286218|11935197|FG005|NOT COMPLETED|Qualification Phase Period 2||0
10772175|NCT03286218|11935198|FG006|NOT COMPLETED|Qualification Phase Period 2||0
10772176|NCT03286218|11935199|FG007|NOT COMPLETED|Qualification Phase Period 2||0
10772177|NCT03286218|11935200|FG008|NOT COMPLETED|Qualification Phase Period 2||0
10772178|NCT03286218|11935201|FG009|NOT COMPLETED|Qualification Phase Period 2||0
10772179|NCT03286218|11935202|FG010|NOT COMPLETED|Qualification Phase Period 2||0
10772180|NCT03286218|11935203|FG011|NOT COMPLETED|Qualification Phase Period 2||0
10772181|NCT03286218|11935192|FG000|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase prior to entering the Treatment Phase.|0
10772182|NCT03286218|11935193|FG001|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase prior to entering the Treatment Phase.|0
10772183|NCT03286218|11935194|FG002|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
10772184|NCT03286218|11935195|FG003|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
10772185|NCT03286218|11935196|FG004|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|5
10772186|NCT03286218|11935197|FG005|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
10772187|NCT03286218|11935198|FG006|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
10772188|NCT03286218|11935199|FG007|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
10772189|NCT03286218|11935200|FG008|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
10779331|NCT03364309|11940868|FG009|NOT COMPLETED|Post-Treatment Followup Period||0
10772190|NCT03286218|11935201|FG009|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
10772191|NCT03286218|11935202|FG010|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|5
10772192|NCT03286218|11935203|FG011|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
10772193|NCT03286218|11935192|FG000|Received at Least One Dose of Study Drug|Treatment Phase Period 1||0
10772194|NCT03286218|11935193|FG001|Received at Least One Dose of Study Drug|Treatment Phase Period 1||0
10772195|NCT03286218|11935194|FG002|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
10772196|NCT03286218|11935195|FG003|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
10772197|NCT03286218|11935196|FG004|Received at Least One Dose of Study Drug|Treatment Phase Period 1||5
10772198|NCT03286218|11935197|FG005|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
10772199|NCT03286218|11935198|FG006|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
10772200|NCT03286218|11935199|FG007|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
10772201|NCT03286218|11935200|FG008|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
10772202|NCT03286218|11935201|FG009|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
10772286|NCT03286218|11935201|FG009|COMPLETED|Treatment Phase Period 3||6
10772203|NCT03286218|11935202|FG010|Received at Least One Dose of Study Drug|Treatment Phase Period 1||5
10772204|NCT03286218|11935203|FG011|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
10772205|NCT03286218|11935192|FG000|COMPLETED|Treatment Phase Period 1||0
10772206|NCT03286218|11935193|FG001|COMPLETED|Treatment Phase Period 1||0
10772207|NCT03286218|11935194|FG002|COMPLETED|Treatment Phase Period 1||5
10772208|NCT03286218|11935195|FG003|COMPLETED|Treatment Phase Period 1||5
10772209|NCT03286218|11935196|FG004|COMPLETED|Treatment Phase Period 1||5
10772210|NCT03286218|11935197|FG005|COMPLETED|Treatment Phase Period 1||5
10772211|NCT03286218|11935198|FG006|COMPLETED|Treatment Phase Period 1||6
10772212|NCT03286218|11935199|FG007|COMPLETED|Treatment Phase Period 1||6
10772213|NCT03286218|11935200|FG008|COMPLETED|Treatment Phase Period 1||6
10772214|NCT03286218|11935201|FG009|COMPLETED|Treatment Phase Period 1||6
10772215|NCT03286218|11935202|FG010|COMPLETED|Treatment Phase Period 1||5
10772216|NCT03286218|11935203|FG011|COMPLETED|Treatment Phase Period 1||5
10772217|NCT03286218|11935192|FG000|NOT COMPLETED|Treatment Phase Period 1||0
10772218|NCT03286218|11935193|FG001|NOT COMPLETED|Treatment Phase Period 1||0
10772219|NCT03286218|11935194|FG002|NOT COMPLETED|Treatment Phase Period 1||1
10772220|NCT03286218|11935195|FG003|NOT COMPLETED|Treatment Phase Period 1||1
10772221|NCT03286218|11935196|FG004|NOT COMPLETED|Treatment Phase Period 1||0
10772222|NCT03286218|11935197|FG005|NOT COMPLETED|Treatment Phase Period 1||1
10772223|NCT03286218|11935198|FG006|NOT COMPLETED|Treatment Phase Period 1||0
10772224|NCT03286218|11935199|FG007|NOT COMPLETED|Treatment Phase Period 1||0
10772225|NCT03286218|11935200|FG008|NOT COMPLETED|Treatment Phase Period 1||0
10772226|NCT03286218|11935201|FG009|NOT COMPLETED|Treatment Phase Period 1||0
10772227|NCT03286218|11935202|FG010|NOT COMPLETED|Treatment Phase Period 1||0
10772228|NCT03286218|11935203|FG011|NOT COMPLETED|Treatment Phase Period 1||1
10772229|NCT03286218|11935192|FG000|STARTED|Treatment Phase Period 2||0
10772230|NCT03286218|11935193|FG001|STARTED|Treatment Phase Period 2||0
10772231|NCT03286218|11935194|FG002|STARTED|Treatment Phase Period 2||5
10772232|NCT03286218|11935195|FG003|STARTED|Treatment Phase Period 2||5
10772233|NCT03286218|11935196|FG004|STARTED|Treatment Phase Period 2||5
10772234|NCT03286218|11935197|FG005|STARTED|Treatment Phase Period 2||5
10772235|NCT03286218|11935198|FG006|STARTED|Treatment Phase Period 2||6
10772236|NCT03286218|11935199|FG007|STARTED|Treatment Phase Period 2||6
10772237|NCT03286218|11935200|FG008|STARTED|Treatment Phase Period 2||6
10772238|NCT03286218|11935201|FG009|STARTED|Treatment Phase Period 2||6
10772239|NCT03286218|11935202|FG010|STARTED|Treatment Phase Period 2||5
10772240|NCT03286218|11935203|FG011|STARTED|Treatment Phase Period 2||5
10772241|NCT03286218|11935192|FG000|COMPLETED|Treatment Phase Period 2||0
10772242|NCT03286218|11935193|FG001|COMPLETED|Treatment Phase Period 2||0
10772243|NCT03286218|11935194|FG002|COMPLETED|Treatment Phase Period 2||5
10772244|NCT03286218|11935195|FG003|COMPLETED|Treatment Phase Period 2||5
10772245|NCT03286218|11935196|FG004|COMPLETED|Treatment Phase Period 2||5
10772246|NCT03286218|11935197|FG005|COMPLETED|Treatment Phase Period 2||5
10772247|NCT03286218|11935198|FG006|COMPLETED|Treatment Phase Period 2||6
10772248|NCT03286218|11935199|FG007|COMPLETED|Treatment Phase Period 2||6
10772249|NCT03286218|11935200|FG008|COMPLETED|Treatment Phase Period 2||6
10772250|NCT03286218|11935201|FG009|COMPLETED|Treatment Phase Period 2||6
10772251|NCT03286218|11935202|FG010|COMPLETED|Treatment Phase Period 2||5
10772252|NCT03286218|11935203|FG011|COMPLETED|Treatment Phase Period 2||5
10772253|NCT03286218|11935192|FG000|NOT COMPLETED|Treatment Phase Period 2||0
10772254|NCT03286218|11935193|FG001|NOT COMPLETED|Treatment Phase Period 2||0
10772255|NCT03286218|11935194|FG002|NOT COMPLETED|Treatment Phase Period 2||0
10772256|NCT03286218|11935195|FG003|NOT COMPLETED|Treatment Phase Period 2||0
10772257|NCT03286218|11935196|FG004|NOT COMPLETED|Treatment Phase Period 2||0
10772258|NCT03286218|11935197|FG005|NOT COMPLETED|Treatment Phase Period 2||0
10772259|NCT03286218|11935198|FG006|NOT COMPLETED|Treatment Phase Period 2||0
10772260|NCT03286218|11935199|FG007|NOT COMPLETED|Treatment Phase Period 2||0
10772261|NCT03286218|11935200|FG008|NOT COMPLETED|Treatment Phase Period 2||0
10772262|NCT03286218|11935201|FG009|NOT COMPLETED|Treatment Phase Period 2||0
10772263|NCT03286218|11935202|FG010|NOT COMPLETED|Treatment Phase Period 2||0
10772264|NCT03286218|11935203|FG011|NOT COMPLETED|Treatment Phase Period 2||0
10772265|NCT03286218|11935192|FG000|STARTED|Treatment Phase Period 3||0
10772266|NCT03286218|11935193|FG001|STARTED|Treatment Phase Period 3||0
10772267|NCT03286218|11935194|FG002|STARTED|Treatment Phase Period 3||5
10772268|NCT03286218|11935195|FG003|STARTED|Treatment Phase Period 3||5
10772269|NCT03286218|11935196|FG004|STARTED|Treatment Phase Period 3||5
10772270|NCT03286218|11935197|FG005|STARTED|Treatment Phase Period 3||5
10772271|NCT03286218|11935198|FG006|STARTED|Treatment Phase Period 3||6
10772272|NCT03286218|11935199|FG007|STARTED|Treatment Phase Period 3||6
10772273|NCT03286218|11935200|FG008|STARTED|Treatment Phase Period 3||6
10772274|NCT03286218|11935201|FG009|STARTED|Treatment Phase Period 3||6
10772275|NCT03286218|11935202|FG010|STARTED|Treatment Phase Period 3||5
10772276|NCT03286218|11935203|FG011|STARTED|Treatment Phase Period 3||5
10772277|NCT03286218|11935192|FG000|COMPLETED|Treatment Phase Period 3||0
10772278|NCT03286218|11935193|FG001|COMPLETED|Treatment Phase Period 3||0
10772279|NCT03286218|11935194|FG002|COMPLETED|Treatment Phase Period 3||5
10772280|NCT03286218|11935195|FG003|COMPLETED|Treatment Phase Period 3||5
10772281|NCT03286218|11935196|FG004|COMPLETED|Treatment Phase Period 3||5
10772282|NCT03286218|11935197|FG005|COMPLETED|Treatment Phase Period 3||5
10772283|NCT03286218|11935198|FG006|COMPLETED|Treatment Phase Period 3||6
10772284|NCT03286218|11935199|FG007|COMPLETED|Treatment Phase Period 3||6
10772285|NCT03286218|11935200|FG008|COMPLETED|Treatment Phase Period 3||6
10772287|NCT03286218|11935202|FG010|COMPLETED|Treatment Phase Period 3||5
10772288|NCT03286218|11935203|FG011|COMPLETED|Treatment Phase Period 3||5
10772289|NCT03286218|11935192|FG000|NOT COMPLETED|Treatment Phase Period 3||0
10772290|NCT03286218|11935193|FG001|NOT COMPLETED|Treatment Phase Period 3||0
10772291|NCT03286218|11935194|FG002|NOT COMPLETED|Treatment Phase Period 3||0
10772292|NCT03286218|11935195|FG003|NOT COMPLETED|Treatment Phase Period 3||0
10772293|NCT03286218|11935196|FG004|NOT COMPLETED|Treatment Phase Period 3||0
10772294|NCT03286218|11935197|FG005|NOT COMPLETED|Treatment Phase Period 3||0
10772295|NCT03286218|11935198|FG006|NOT COMPLETED|Treatment Phase Period 3||0
10772296|NCT03286218|11935199|FG007|NOT COMPLETED|Treatment Phase Period 3||0
10772297|NCT03286218|11935200|FG008|NOT COMPLETED|Treatment Phase Period 3||0
10772298|NCT03286218|11935201|FG009|NOT COMPLETED|Treatment Phase Period 3||0
10772299|NCT03286218|11935202|FG010|NOT COMPLETED|Treatment Phase Period 3||0
10772300|NCT03286218|11935203|FG011|NOT COMPLETED|Treatment Phase Period 3||0
10772301|NCT03286218|11935192|FG000|STARTED|Treatment Phase Period 4||0
10772302|NCT03286218|11935193|FG001|STARTED|Treatment Phase Period 4||0
10772303|NCT03286218|11935194|FG002|STARTED|Treatment Phase Period 4||5
10772304|NCT03286218|11935195|FG003|STARTED|Treatment Phase Period 4||5
10772305|NCT03286218|11935196|FG004|STARTED|Treatment Phase Period 4||5
10772306|NCT03286218|11935197|FG005|STARTED|Treatment Phase Period 4||5
10772307|NCT03286218|11935198|FG006|STARTED|Treatment Phase Period 4||6
10772308|NCT03286218|11935199|FG007|STARTED|Treatment Phase Period 4||6
10772309|NCT03286218|11935200|FG008|STARTED|Treatment Phase Period 4||6
10772310|NCT03286218|11935201|FG009|STARTED|Treatment Phase Period 4||6
10772311|NCT03286218|11935202|FG010|STARTED|Treatment Phase Period 4||5
10772312|NCT03286218|11935203|FG011|STARTED|Treatment Phase Period 4||5
10772313|NCT03286218|11935192|FG000|COMPLETED|Treatment Phase Period 4||0
10772314|NCT03286218|11935193|FG001|COMPLETED|Treatment Phase Period 4||0
10772315|NCT03286218|11935194|FG002|COMPLETED|Treatment Phase Period 4||5
10772316|NCT03286218|11935195|FG003|COMPLETED|Treatment Phase Period 4||5
10772317|NCT03286218|11935196|FG004|COMPLETED|Treatment Phase Period 4||5
10772318|NCT03286218|11935197|FG005|COMPLETED|Treatment Phase Period 4||5
10772319|NCT03286218|11935198|FG006|COMPLETED|Treatment Phase Period 4||6
10772320|NCT03286218|11935199|FG007|COMPLETED|Treatment Phase Period 4||6
10772321|NCT03286218|11935200|FG008|COMPLETED|Treatment Phase Period 4||6
10772322|NCT03286218|11935201|FG009|COMPLETED|Treatment Phase Period 4||6
10772323|NCT03286218|11935202|FG010|COMPLETED|Treatment Phase Period 4||5
10772324|NCT03286218|11935203|FG011|COMPLETED|Treatment Phase Period 4||4
10772325|NCT03286218|11935192|FG000|NOT COMPLETED|Treatment Phase Period 4||0
10772326|NCT03286218|11935193|FG001|NOT COMPLETED|Treatment Phase Period 4||0
10772327|NCT03286218|11935194|FG002|NOT COMPLETED|Treatment Phase Period 4||0
10772328|NCT03286218|11935195|FG003|NOT COMPLETED|Treatment Phase Period 4||0
10772329|NCT03286218|11935196|FG004|NOT COMPLETED|Treatment Phase Period 4||0
10772330|NCT03286218|11935197|FG005|NOT COMPLETED|Treatment Phase Period 4||0
10772331|NCT03286218|11935198|FG006|NOT COMPLETED|Treatment Phase Period 4||0
10772332|NCT03286218|11935199|FG007|NOT COMPLETED|Treatment Phase Period 4||0
10772333|NCT03286218|11935200|FG008|NOT COMPLETED|Treatment Phase Period 4||0
10772334|NCT03286218|11935201|FG009|NOT COMPLETED|Treatment Phase Period 4||0
10772335|NCT03286218|11935202|FG010|NOT COMPLETED|Treatment Phase Period 4||0
10772336|NCT03286218|11935203|FG011|NOT COMPLETED|Treatment Phase Period 4||1
10772337|NCT03286218|11935192|FG000|STARTED|Treatment Phase Period 5||0
10772338|NCT03286218|11935193|FG001|STARTED|Treatment Phase Period 5||0
10772339|NCT03286218|11935194|FG002|STARTED|Treatment Phase Period 5||5
10772340|NCT03286218|11935195|FG003|STARTED|Treatment Phase Period 5||5
10772341|NCT03286218|11935196|FG004|STARTED|Treatment Phase Period 5||5
10772342|NCT03286218|11935197|FG005|STARTED|Treatment Phase Period 5||5
10772343|NCT03286218|11935198|FG006|STARTED|Treatment Phase Period 5||6
10772344|NCT03286218|11935199|FG007|STARTED|Treatment Phase Period 5||6
10772345|NCT03286218|11935200|FG008|STARTED|Treatment Phase Period 5||6
10772346|NCT03286218|11935201|FG009|STARTED|Treatment Phase Period 5||6
10772347|NCT03286218|11935202|FG010|STARTED|Treatment Phase Period 5||5
10772348|NCT03286218|11935203|FG011|STARTED|Treatment Phase Period 5||4
10772349|NCT03286218|11935192|FG000|COMPLETED|Treatment Phase Period 5||0
10772350|NCT03286218|11935193|FG001|COMPLETED|Treatment Phase Period 5||0
10772351|NCT03286218|11935194|FG002|COMPLETED|Treatment Phase Period 5||5
10772352|NCT03286218|11935195|FG003|COMPLETED|Treatment Phase Period 5||5
10772353|NCT03286218|11935196|FG004|COMPLETED|Treatment Phase Period 5||5
10772354|NCT03286218|11935197|FG005|COMPLETED|Treatment Phase Period 5||5
10772355|NCT03286218|11935198|FG006|COMPLETED|Treatment Phase Period 5||6
10772356|NCT03286218|11935199|FG007|COMPLETED|Treatment Phase Period 5||6
10772357|NCT03286218|11935200|FG008|COMPLETED|Treatment Phase Period 5||6
10772358|NCT03286218|11935201|FG009|COMPLETED|Treatment Phase Period 5||6
10772359|NCT03286218|11935202|FG010|COMPLETED|Treatment Phase Period 5||5
10772360|NCT03286218|11935203|FG011|COMPLETED|Treatment Phase Period 5||4
10772361|NCT03286218|11935192|FG000|NOT COMPLETED|Treatment Phase Period 5||0
10772362|NCT03286218|11935193|FG001|NOT COMPLETED|Treatment Phase Period 5||0
10772363|NCT03286218|11935194|FG002|NOT COMPLETED|Treatment Phase Period 5||0
10772364|NCT03286218|11935195|FG003|NOT COMPLETED|Treatment Phase Period 5||0
10772365|NCT03286218|11935196|FG004|NOT COMPLETED|Treatment Phase Period 5||0
10772366|NCT03286218|11935197|FG005|NOT COMPLETED|Treatment Phase Period 5||0
10772367|NCT03286218|11935198|FG006|NOT COMPLETED|Treatment Phase Period 5||0
10772368|NCT03286218|11935199|FG007|NOT COMPLETED|Treatment Phase Period 5||0
10772369|NCT03286218|11935200|FG008|NOT COMPLETED|Treatment Phase Period 5||0
10772370|NCT03286218|11935201|FG009|NOT COMPLETED|Treatment Phase Period 5||0
10772371|NCT03286218|11935202|FG010|NOT COMPLETED|Treatment Phase Period 5||0
10772372|NCT03286218|11935203|FG011|NOT COMPLETED|Treatment Phase Period 5||0
10772376|NCT03286400|11935234|FG000|STARTED|Overall Study||127
10772377|NCT03286400|11935234|FG000|COMPLETED|Overall Study||102
10772378|NCT03286400|11935234|FG000|NOT COMPLETED|Overall Study||25
10772379|NCT03286465|11935240|FG000|STARTED|Overall Study||100
10772380|NCT03286465|11935241|FG001|STARTED|Overall Study||100
10772381|NCT03286465|11935240|FG000|COMPLETED|Overall Study||100
10772382|NCT03286465|11935241|FG001|COMPLETED|Overall Study||100
10772383|NCT03286465|11935240|FG000|NOT COMPLETED|Overall Study||0
10772384|NCT03286465|11935241|FG001|NOT COMPLETED|Overall Study||0
10772385|NCT03286543|11935249|FG000|STARTED|Consented||47
10772386|NCT03286543|11935250|FG001|STARTED|Consented||0
10772387|NCT03286543|11935251|FG002|STARTED|Consented||0
10772388|NCT03286543|11935249|FG000|Randomized|Consented||45
10772389|NCT03286543|11935250|FG001|Randomized|Consented||0
10772390|NCT03286543|11935251|FG002|Randomized|Consented||0
10772391|NCT03286543|11935249|FG000|Enrolled|Consented||41
10772392|NCT03286543|11935250|FG001|Enrolled|Consented||0
10772393|NCT03286543|11935251|FG002|Enrolled|Consented||0
10772394|NCT03286543|11935249|FG000|Intent to Treat Set|Consented||37
10772395|NCT03286543|11935250|FG001|Intent to Treat Set|Consented||0
10772396|NCT03286543|11935251|FG002|Intent to Treat Set|Consented||0
10772397|NCT03286543|11935249|FG000|Per Protocol Set|Consented||23
10772398|NCT03286543|11935250|FG001|Per Protocol Set|Consented||0
10772399|NCT03286543|11935251|FG002|Per Protocol Set|Consented||0
10772400|NCT03286543|11935249|FG000|COMPLETED|Consented||28
10772401|NCT03286543|11935250|FG001|COMPLETED|Consented||0
10772402|NCT03286543|11935251|FG002|COMPLETED|Consented||0
10772403|NCT03286543|11935249|FG000|NOT COMPLETED|Consented||19
10772404|NCT03286543|11935250|FG001|NOT COMPLETED|Consented||0
10772405|NCT03286543|11935251|FG002|NOT COMPLETED|Consented||0
10772406|NCT03286543|11935249|FG000|STARTED|Study Enrollment||0
10772407|NCT03286543|11935250|FG001|STARTED|Study Enrollment||18
10772408|NCT03286543|11935251|FG002|STARTED|Study Enrollment||23
10772409|NCT03286543|11935249|FG000|Intent to Treat Set|Study Enrollment||0
10772410|NCT03286543|11935250|FG001|Intent to Treat Set|Study Enrollment||18
10772411|NCT03286543|11935251|FG002|Intent to Treat Set|Study Enrollment||19
10772412|NCT03286543|11935249|FG000|Per Protocol Set|Study Enrollment||0
10772413|NCT03286543|11935250|FG001|Per Protocol Set|Study Enrollment||7
10772414|NCT03286543|11935251|FG002|Per Protocol Set|Study Enrollment||16
10772415|NCT03286543|11935249|FG000|COMPLETED|Study Enrollment||0
10772416|NCT03286543|11935250|FG001|COMPLETED|Study Enrollment||12
10772417|NCT03286543|11935251|FG002|COMPLETED|Study Enrollment||16
10772418|NCT03286543|11935249|FG000|NOT COMPLETED|Study Enrollment||0
10772419|NCT03286543|11935250|FG001|NOT COMPLETED|Study Enrollment||6
10772420|NCT03286543|11935251|FG002|NOT COMPLETED|Study Enrollment||7
10772421|NCT03286751|11935257|FG000|STARTED|Period 1||7
10772422|NCT03286751|11935258|FG001|STARTED|Period 1||7
10772423|NCT03286751|11935259|FG002|STARTED|Period 1||7
10772424|NCT03286751|11935260|FG003|STARTED|Period 1||7
10772425|NCT03286751|11935261|FG004|STARTED|Period 1||7
10772426|NCT03286751|11935262|FG005|STARTED|Period 1||7
10772427|NCT03286751|11935257|FG000|Received at Least One Dose of Study Drug|Period 1||7
10772428|NCT03286751|11935258|FG001|Received at Least One Dose of Study Drug|Period 1||7
10772429|NCT03286751|11935259|FG002|Received at Least One Dose of Study Drug|Period 1||7
10772430|NCT03286751|11935260|FG003|Received at Least One Dose of Study Drug|Period 1||7
10772431|NCT03286751|11935261|FG004|Received at Least One Dose of Study Drug|Period 1||7
10772432|NCT03286751|11935262|FG005|Received at Least One Dose of Study Drug|Period 1||7
10772433|NCT03286751|11935257|FG000|COMPLETED|Period 1||7
10772434|NCT03286751|11935258|FG001|COMPLETED|Period 1||7
10772435|NCT03286751|11935259|FG002|COMPLETED|Period 1||7
10772436|NCT03286751|11935260|FG003|COMPLETED|Period 1||7
10772437|NCT03286751|11935261|FG004|COMPLETED|Period 1||7
10772438|NCT03286751|11935262|FG005|COMPLETED|Period 1||7
10772439|NCT03286751|11935257|FG000|NOT COMPLETED|Period 1||0
10772440|NCT03286751|11935258|FG001|NOT COMPLETED|Period 1||0
10772441|NCT03286751|11935259|FG002|NOT COMPLETED|Period 1||0
10772442|NCT03286751|11935260|FG003|NOT COMPLETED|Period 1||0
10772443|NCT03286751|11935261|FG004|NOT COMPLETED|Period 1||0
10772444|NCT03286751|11935262|FG005|NOT COMPLETED|Period 1||0
10772445|NCT03286751|11935257|FG000|STARTED|Washout Period 1||7
10772446|NCT03286751|11935258|FG001|STARTED|Washout Period 1||7
10772447|NCT03286751|11935259|FG002|STARTED|Washout Period 1||7
10772448|NCT03286751|11935260|FG003|STARTED|Washout Period 1||7
10772449|NCT03286751|11935261|FG004|STARTED|Washout Period 1||7
10772450|NCT03286751|11935262|FG005|STARTED|Washout Period 1||7
10772451|NCT03286751|11935257|FG000|COMPLETED|Washout Period 1||7
10772452|NCT03286751|11935258|FG001|COMPLETED|Washout Period 1||7
10772453|NCT03286751|11935259|FG002|COMPLETED|Washout Period 1||7
10772454|NCT03286751|11935260|FG003|COMPLETED|Washout Period 1||7
10772455|NCT03286751|11935261|FG004|COMPLETED|Washout Period 1||6
10772456|NCT03286751|11935262|FG005|COMPLETED|Washout Period 1||7
10772457|NCT03286751|11935257|FG000|NOT COMPLETED|Washout Period 1||0
10772458|NCT03286751|11935258|FG001|NOT COMPLETED|Washout Period 1||0
10772459|NCT03286751|11935259|FG002|NOT COMPLETED|Washout Period 1||0
10772460|NCT03286751|11935260|FG003|NOT COMPLETED|Washout Period 1||0
10772461|NCT03286751|11935261|FG004|NOT COMPLETED|Washout Period 1||1
10772462|NCT03286751|11935262|FG005|NOT COMPLETED|Washout Period 1||0
10772463|NCT03286751|11935257|FG000|STARTED|Period 2||7
10772464|NCT03286751|11935258|FG001|STARTED|Period 2||7
10772465|NCT03286751|11935259|FG002|STARTED|Period 2||7
10772466|NCT03286751|11935260|FG003|STARTED|Period 2||7
10772467|NCT03286751|11935261|FG004|STARTED|Period 2||6
10772468|NCT03286751|11935262|FG005|STARTED|Period 2||7
10772469|NCT03286751|11935257|FG000|COMPLETED|Period 2||7
10772470|NCT03286751|11935258|FG001|COMPLETED|Period 2||7
10772471|NCT03286751|11935259|FG002|COMPLETED|Period 2||7
10772472|NCT03286751|11935260|FG003|COMPLETED|Period 2||7
10772473|NCT03286751|11935261|FG004|COMPLETED|Period 2||6
10772474|NCT03286751|11935262|FG005|COMPLETED|Period 2||7
10772475|NCT03286751|11935257|FG000|NOT COMPLETED|Period 2||0
10772476|NCT03286751|11935258|FG001|NOT COMPLETED|Period 2||0
10772477|NCT03286751|11935259|FG002|NOT COMPLETED|Period 2||0
10772478|NCT03286751|11935260|FG003|NOT COMPLETED|Period 2||0
10772479|NCT03286751|11935261|FG004|NOT COMPLETED|Period 2||0
10772480|NCT03286751|11935262|FG005|NOT COMPLETED|Period 2||0
10772481|NCT03286751|11935257|FG000|STARTED|Washout Period 2||7
10772482|NCT03286751|11935258|FG001|STARTED|Washout Period 2||7
10772483|NCT03286751|11935259|FG002|STARTED|Washout Period 2||7
10772484|NCT03286751|11935260|FG003|STARTED|Washout Period 2||7
10772485|NCT03286751|11935261|FG004|STARTED|Washout Period 2||6
10772486|NCT03286751|11935262|FG005|STARTED|Washout Period 2||7
10772487|NCT03286751|11935257|FG000|COMPLETED|Washout Period 2||7
10772488|NCT03286751|11935258|FG001|COMPLETED|Washout Period 2||6
10772489|NCT03286751|11935259|FG002|COMPLETED|Washout Period 2||7
10772490|NCT03286751|11935260|FG003|COMPLETED|Washout Period 2||7
10772491|NCT03286751|11935261|FG004|COMPLETED|Washout Period 2||6
10772492|NCT03286751|11935262|FG005|COMPLETED|Washout Period 2||7
10772493|NCT03286751|11935257|FG000|NOT COMPLETED|Washout Period 2||0
10772494|NCT03286751|11935258|FG001|NOT COMPLETED|Washout Period 2||1
10772495|NCT03286751|11935259|FG002|NOT COMPLETED|Washout Period 2||0
10772496|NCT03286751|11935260|FG003|NOT COMPLETED|Washout Period 2||0
10772497|NCT03286751|11935261|FG004|NOT COMPLETED|Washout Period 2||0
10772498|NCT03286751|11935262|FG005|NOT COMPLETED|Washout Period 2||0
10772499|NCT03286751|11935257|FG000|STARTED|Period 3||7
10772500|NCT03286751|11935258|FG001|STARTED|Period 3||6
10772501|NCT03286751|11935259|FG002|STARTED|Period 3||7
10772502|NCT03286751|11935260|FG003|STARTED|Period 3||7
10772503|NCT03286751|11935261|FG004|STARTED|Period 3||6
10772504|NCT03286751|11935262|FG005|STARTED|Period 3||7
10772505|NCT03286751|11935257|FG000|COMPLETED|Period 3||7
10772506|NCT03286751|11935258|FG001|COMPLETED|Period 3||6
10772507|NCT03286751|11935259|FG002|COMPLETED|Period 3||7
10772508|NCT03286751|11935260|FG003|COMPLETED|Period 3||7
10772509|NCT03286751|11935261|FG004|COMPLETED|Period 3||6
10772510|NCT03286751|11935262|FG005|COMPLETED|Period 3||7
10772511|NCT03286751|11935257|FG000|NOT COMPLETED|Period 3||0
10772512|NCT03286751|11935258|FG001|NOT COMPLETED|Period 3||0
10772513|NCT03286751|11935259|FG002|NOT COMPLETED|Period 3||0
10772514|NCT03286751|11935260|FG003|NOT COMPLETED|Period 3||0
10772515|NCT03286751|11935261|FG004|NOT COMPLETED|Period 3||0
10772516|NCT03286751|11935262|FG005|NOT COMPLETED|Period 3||0
10772517|NCT03286751|11935257|FG000|STARTED|Washout Period 3||7
10772518|NCT03286751|11935258|FG001|STARTED|Washout Period 3||6
10772519|NCT03286751|11935259|FG002|STARTED|Washout Period 3||7
10772520|NCT03286751|11935260|FG003|STARTED|Washout Period 3||7
10772521|NCT03286751|11935261|FG004|STARTED|Washout Period 3||6
10772522|NCT03286751|11935262|FG005|STARTED|Washout Period 3||7
10772523|NCT03286751|11935257|FG000|COMPLETED|Washout Period 3||7
10772524|NCT03286751|11935258|FG001|COMPLETED|Washout Period 3||6
10772525|NCT03286751|11935259|FG002|COMPLETED|Washout Period 3||7
10772526|NCT03286751|11935260|FG003|COMPLETED|Washout Period 3||7
10772527|NCT03286751|11935261|FG004|COMPLETED|Washout Period 3||6
10772528|NCT03286751|11935262|FG005|COMPLETED|Washout Period 3||7
10772529|NCT03286751|11935257|FG000|NOT COMPLETED|Washout Period 3||0
10772530|NCT03286751|11935258|FG001|NOT COMPLETED|Washout Period 3||0
10772531|NCT03286751|11935259|FG002|NOT COMPLETED|Washout Period 3||0
10772532|NCT03286751|11935260|FG003|NOT COMPLETED|Washout Period 3||0
10772533|NCT03286751|11935261|FG004|NOT COMPLETED|Washout Period 3||0
10772534|NCT03286751|11935262|FG005|NOT COMPLETED|Washout Period 3||0
10772535|NCT03286751|11935257|FG000|STARTED|Period 4||7
10772536|NCT03286751|11935258|FG001|STARTED|Period 4||6
10772537|NCT03286751|11935259|FG002|STARTED|Period 4||7
10772538|NCT03286751|11935260|FG003|STARTED|Period 4||7
10772539|NCT03286751|11935261|FG004|STARTED|Period 4||6
10772540|NCT03286751|11935262|FG005|STARTED|Period 4||7
10772541|NCT03286751|11935257|FG000|COMPLETED|Period 4||7
10772542|NCT03286751|11935258|FG001|COMPLETED|Period 4||6
10772543|NCT03286751|11935259|FG002|COMPLETED|Period 4||7
10772544|NCT03286751|11935260|FG003|COMPLETED|Period 4||7
10772545|NCT03286751|11935261|FG004|COMPLETED|Period 4||6
10772546|NCT03286751|11935262|FG005|COMPLETED|Period 4||7
10772547|NCT03286751|11935257|FG000|NOT COMPLETED|Period 4||0
10772548|NCT03286751|11935258|FG001|NOT COMPLETED|Period 4||0
10772549|NCT03286751|11935259|FG002|NOT COMPLETED|Period 4||0
10772550|NCT03286751|11935260|FG003|NOT COMPLETED|Period 4||0
10772551|NCT03286751|11935261|FG004|NOT COMPLETED|Period 4||0
10772552|NCT03286751|11935262|FG005|NOT COMPLETED|Period 4||0
10772553|NCT03286751|11935257|FG000|STARTED|Washout Period 4||7
10772554|NCT03286751|11935258|FG001|STARTED|Washout Period 4||6
10772555|NCT03286751|11935259|FG002|STARTED|Washout Period 4||7
10772556|NCT03286751|11935260|FG003|STARTED|Washout Period 4||7
10772557|NCT03286751|11935261|FG004|STARTED|Washout Period 4||6
10772558|NCT03286751|11935262|FG005|STARTED|Washout Period 4||7
10772559|NCT03286751|11935257|FG000|COMPLETED|Washout Period 4||7
10772560|NCT03286751|11935258|FG001|COMPLETED|Washout Period 4||6
10772561|NCT03286751|11935259|FG002|COMPLETED|Washout Period 4||7
10772562|NCT03286751|11935260|FG003|COMPLETED|Washout Period 4||7
10772563|NCT03286751|11935261|FG004|COMPLETED|Washout Period 4||6
10772564|NCT03286751|11935262|FG005|COMPLETED|Washout Period 4||7
10772565|NCT03286751|11935257|FG000|NOT COMPLETED|Washout Period 4||0
10772566|NCT03286751|11935258|FG001|NOT COMPLETED|Washout Period 4||0
10772567|NCT03286751|11935259|FG002|NOT COMPLETED|Washout Period 4||0
10772568|NCT03286751|11935260|FG003|NOT COMPLETED|Washout Period 4||0
10772569|NCT03286751|11935261|FG004|NOT COMPLETED|Washout Period 4||0
10772570|NCT03286751|11935262|FG005|NOT COMPLETED|Washout Period 4||0
10772571|NCT03286751|11935257|FG000|STARTED|Period 5||7
10772572|NCT03286751|11935258|FG001|STARTED|Period 5||6
10772573|NCT03286751|11935259|FG002|STARTED|Period 5||7
10772574|NCT03286751|11935260|FG003|STARTED|Period 5||7
10772575|NCT03286751|11935261|FG004|STARTED|Period 5||6
10772576|NCT03286751|11935262|FG005|STARTED|Period 5||7
10772577|NCT03286751|11935257|FG000|COMPLETED|Period 5||7
10772578|NCT03286751|11935258|FG001|COMPLETED|Period 5||6
10772579|NCT03286751|11935259|FG002|COMPLETED|Period 5||7
10772580|NCT03286751|11935260|FG003|COMPLETED|Period 5||7
10772581|NCT03286751|11935261|FG004|COMPLETED|Period 5||6
10772582|NCT03286751|11935262|FG005|COMPLETED|Period 5||7
10772583|NCT03286751|11935257|FG000|NOT COMPLETED|Period 5||0
10772584|NCT03286751|11935258|FG001|NOT COMPLETED|Period 5||0
10772585|NCT03286751|11935259|FG002|NOT COMPLETED|Period 5||0
10772586|NCT03286751|11935260|FG003|NOT COMPLETED|Period 5||0
10772587|NCT03286751|11935261|FG004|NOT COMPLETED|Period 5||0
10772588|NCT03286751|11935262|FG005|NOT COMPLETED|Period 5||0
10772589|NCT03286751|11935257|FG000|STARTED|Washout Period 5||7
10772590|NCT03286751|11935258|FG001|STARTED|Washout Period 5||6
10772591|NCT03286751|11935259|FG002|STARTED|Washout Period 5||7
10772592|NCT03286751|11935260|FG003|STARTED|Washout Period 5||7
10772593|NCT03286751|11935261|FG004|STARTED|Washout Period 5||6
10772594|NCT03286751|11935262|FG005|STARTED|Washout Period 5||7
10772595|NCT03286751|11935257|FG000|COMPLETED|Washout Period 5||7
10772596|NCT03286751|11935258|FG001|COMPLETED|Washout Period 5||6
10772597|NCT03286751|11935259|FG002|COMPLETED|Washout Period 5||7
10772598|NCT03286751|11935260|FG003|COMPLETED|Washout Period 5||7
10772599|NCT03286751|11935261|FG004|COMPLETED|Washout Period 5||5
10772600|NCT03286751|11935262|FG005|COMPLETED|Washout Period 5||7
10772601|NCT03286751|11935257|FG000|NOT COMPLETED|Washout Period 5||0
10772602|NCT03286751|11935258|FG001|NOT COMPLETED|Washout Period 5||0
10772603|NCT03286751|11935259|FG002|NOT COMPLETED|Washout Period 5||0
10772604|NCT03286751|11935260|FG003|NOT COMPLETED|Washout Period 5||0
10772605|NCT03286751|11935261|FG004|NOT COMPLETED|Washout Period 5||1
10772606|NCT03286751|11935262|FG005|NOT COMPLETED|Washout Period 5||0
10772607|NCT03286751|11935257|FG000|STARTED|Period 6||7
10772608|NCT03286751|11935258|FG001|STARTED|Period 6||6
10772609|NCT03286751|11935259|FG002|STARTED|Period 6||7
10772610|NCT03286751|11935260|FG003|STARTED|Period 6||7
10772611|NCT03286751|11935261|FG004|STARTED|Period 6||5
10772612|NCT03286751|11935262|FG005|STARTED|Period 6||7
10772613|NCT03286751|11935257|FG000|COMPLETED|Period 6||7
10772614|NCT03286751|11935258|FG001|COMPLETED|Period 6||6
10772615|NCT03286751|11935259|FG002|COMPLETED|Period 6||7
10772616|NCT03286751|11935260|FG003|COMPLETED|Period 6||7
10772617|NCT03286751|11935261|FG004|COMPLETED|Period 6||5
10772618|NCT03286751|11935262|FG005|COMPLETED|Period 6||7
10772619|NCT03286751|11935257|FG000|NOT COMPLETED|Period 6||0
10772620|NCT03286751|11935258|FG001|NOT COMPLETED|Period 6||0
10772621|NCT03286751|11935259|FG002|NOT COMPLETED|Period 6||0
10772622|NCT03286751|11935260|FG003|NOT COMPLETED|Period 6||0
10772623|NCT03286751|11935261|FG004|NOT COMPLETED|Period 6||0
10772624|NCT03286751|11935262|FG005|NOT COMPLETED|Period 6||0
10772625|NCT03286829|11935280|FG000|STARTED|Overall Study||15
10772626|NCT03286829|11935281|FG001|STARTED|Overall Study||15
10772627|NCT03286829|11935282|FG002|STARTED|Overall Study||15
10772628|NCT03286829|11935283|FG003|STARTED|Overall Study||15
10772629|NCT03286829|11935280|FG000|COMPLETED|Overall Study||15
10772630|NCT03286829|11935281|FG001|COMPLETED|Overall Study||15
10772631|NCT03286829|11935282|FG002|COMPLETED|Overall Study||15
10772632|NCT03286829|11935283|FG003|COMPLETED|Overall Study||15
10772633|NCT03286829|11935280|FG000|NOT COMPLETED|Overall Study||0
10772634|NCT03286829|11935281|FG001|NOT COMPLETED|Overall Study||0
10772635|NCT03286829|11935282|FG002|NOT COMPLETED|Overall Study||0
10772636|NCT03286829|11935283|FG003|NOT COMPLETED|Overall Study||0
10772637|NCT03287219|11935297|FG000|STARTED|Overall Study||24
10772638|NCT03287219|11935298|FG001|STARTED|Overall Study||90
10772639|NCT03287219|11935297|FG000|COMPLETED|Overall Study||24
10772640|NCT03287219|11935298|FG001|COMPLETED|Overall Study||88
10772641|NCT03287219|11935297|FG000|NOT COMPLETED|Overall Study||0
10772642|NCT03287219|11935298|FG001|NOT COMPLETED|Overall Study||2
10772643|NCT03287310|11935343|FG000|STARTED|Overall Study||12
10772644|NCT03287310|11935344|FG001|STARTED|Overall Study||6
10772645|NCT03287310|11935345|FG002|STARTED|Overall Study||6
10772646|NCT03287310|11935346|FG003|STARTED|Overall Study||9
10772647|NCT03287310|11935347|FG004|STARTED|Overall Study||9
10772648|NCT03287310|11935348|FG005|STARTED|Overall Study||6
10772649|NCT03287310|11935343|FG000|COMPLETED|Overall Study||12
10772650|NCT03287310|11935344|FG001|COMPLETED|Overall Study||6
10772651|NCT03287310|11935345|FG002|COMPLETED|Overall Study||6
10772652|NCT03287310|11935346|FG003|COMPLETED|Overall Study||9
10772653|NCT03287310|11935347|FG004|COMPLETED|Overall Study||9
10772654|NCT03287310|11935348|FG005|COMPLETED|Overall Study||6
10772655|NCT03287310|11935343|FG000|NOT COMPLETED|Overall Study||0
10772656|NCT03287310|11935344|FG001|NOT COMPLETED|Overall Study||0
10772657|NCT03287310|11935345|FG002|NOT COMPLETED|Overall Study||0
10772658|NCT03287310|11935346|FG003|NOT COMPLETED|Overall Study||0
10772659|NCT03287310|11935347|FG004|NOT COMPLETED|Overall Study||0
10772660|NCT03287310|11935348|FG005|NOT COMPLETED|Overall Study||0
10772661|NCT03287622|11935372|FG000|STARTED|Overall Study||356
10772662|NCT03287622|11935373|FG001|STARTED|Overall Study||356
10772663|NCT03287622|11935372|FG000|Sub-randomized to Nudge/NoNudge|Overall Study||253
10772664|NCT03287622|11935373|FG001|Sub-randomized to Nudge/NoNudge|Overall Study||266
10772665|NCT03287622|11935372|FG000|COMPLETED|Overall Study||298
10772666|NCT03287622|11935373|FG001|COMPLETED|Overall Study||308
10772667|NCT03287622|11935372|FG000|NOT COMPLETED|Overall Study||58
10772668|NCT03287622|11935373|FG001|NOT COMPLETED|Overall Study||48
10772669|NCT03287635|11935386|FG000|STARTED|Overall Study||19
10772670|NCT03287635|11935386|FG000|COMPLETED|Overall Study||12
10772671|NCT03287635|11935386|FG000|NOT COMPLETED|Overall Study||7
10772672|NCT03287674|11935390|FG000|STARTED|Overall Study||7
10772673|NCT03287674|11935390|FG000|All Treated With TILs|Overall Study||6
10772674|NCT03287674|11935390|FG000|COMPLETED|Overall Study||6
10772675|NCT03287674|11935390|FG000|NOT COMPLETED|Overall Study||1
10772676|NCT03287791|11935398|FG000|STARTED|Overall Study||312
10772677|NCT03287791|11935399|FG001|STARTED|Overall Study||312
10772678|NCT03287791|11935400|FG002|STARTED|Overall Study||300
10772679|NCT03287791|11935398|FG000|Safety Population|Overall Study||306
10772680|NCT03287791|11935399|FG001|Safety Population|Overall Study||297
10772681|NCT03287791|11935400|FG002|Safety Population|Overall Study||291
10772682|NCT03287791|11935398|FG000|mITT Population|Overall Study||291
10772683|NCT03287791|11935399|FG001|mITT Population|Overall Study||291
10772684|NCT03287791|11935400|FG002|mITT Population|Overall Study||283
10772685|NCT03287791|11935398|FG000|PP Population|Overall Study||262
10772686|NCT03287791|11935399|FG001|PP Population|Overall Study||259
10772687|NCT03287791|11935400|FG002|PP Population|Overall Study||245
10772688|NCT03287791|11935398|FG000|COMPLETED|Overall Study||280
10772689|NCT03287791|11935399|FG001|COMPLETED|Overall Study||276
10772690|NCT03287791|11935400|FG002|COMPLETED|Overall Study||264
10772691|NCT03287791|11935398|FG000|NOT COMPLETED|Overall Study||32
10772692|NCT03287791|11935399|FG001|NOT COMPLETED|Overall Study||36
10772693|NCT03287791|11935400|FG002|NOT COMPLETED|Overall Study||36
10772694|NCT03287804|11935408|FG000|STARTED|Overall Study||12
10772695|NCT03287804|11935408|FG000|Leukaperesed|Overall Study||12
10772696|NCT03287804|11935408|FG000|Started Pre-conditioning Therapy|Overall Study||11
10772697|NCT03287804|11935408|FG000|Received Study Treatment|Overall Study||11
10772698|NCT03287804|11935408|FG000|COMPLETED|Overall Study||1
10772699|NCT03287804|11935408|FG000|NOT COMPLETED|Overall Study||11
10772700|NCT03287869|11935415|FG000|STARTED|Overall Study||188
10772701|NCT03287869|11935416|FG001|STARTED|Overall Study||193
10772702|NCT03287869|11935415|FG000|Analyzed For Safety (Safety Sample)|Overall Study||184
10772703|NCT03287869|11935416|FG001|Analyzed For Safety (Safety Sample)|Overall Study||184
10772704|NCT03287869|11935415|FG000|COMPLETED|Overall Study||105
10772705|NCT03287869|11935416|FG001|COMPLETED|Overall Study||100
10772706|NCT03287869|11935415|FG000|NOT COMPLETED|Overall Study||83
10772707|NCT03287869|11935416|FG001|NOT COMPLETED|Overall Study||93
10772708|NCT03288714|11935424|FG000|STARTED|Overall Study||59
10772709|NCT03288714|11935425|FG001|STARTED|Overall Study||62
10772710|NCT03288714|11935424|FG000|COMPLETED|Overall Study||49
10772711|NCT03288714|11935425|FG001|COMPLETED|Overall Study||59
10772712|NCT03288714|11935424|FG000|NOT COMPLETED|Overall Study||10
10772713|NCT03288714|11935425|FG001|NOT COMPLETED|Overall Study||3
10772714|NCT03288779|11935433|FG000|STARTED|Overall Study||6
10772715|NCT03288779|11935433|FG000|COMPLETED|Overall Study||3
10772716|NCT03288779|11935433|FG000|NOT COMPLETED|Overall Study||3
10772717|NCT03288987|11935439|FG000|STARTED|Overall Study||82
10772718|NCT03288987|11935440|FG001|STARTED|Overall Study||44
10772719|NCT03288987|11935439|FG000|Patients Receiving Medication|Overall Study||80
10772720|NCT03288987|11935440|FG001|Patients Receiving Medication|Overall Study||44
10772721|NCT03288987|11935439|FG000|COMPLETED|Overall Study|Per protocol population|72
10772722|NCT03288987|11935440|FG001|COMPLETED|Overall Study|Per protocol population|40
10772723|NCT03288987|11935439|FG000|NOT COMPLETED|Overall Study||10
10772724|NCT03288987|11935440|FG001|NOT COMPLETED|Overall Study||4
10772734|NCT03289208|11935462|FG000|STARTED|Overall Study||11
10772735|NCT03289208|11935463|FG001|STARTED|Overall Study||8
10772736|NCT03289208|11935464|FG002|STARTED|Overall Study||11
10772737|NCT03289208|11935462|FG000|COMPLETED|Overall Study||10
10772738|NCT03289208|11935463|FG001|COMPLETED|Overall Study||8
10772739|NCT03289208|11935464|FG002|COMPLETED|Overall Study||11
10772740|NCT03289208|11935462|FG000|NOT COMPLETED|Overall Study||1
10772741|NCT03289208|11935463|FG001|NOT COMPLETED|Overall Study||0
10772742|NCT03289208|11935464|FG002|NOT COMPLETED|Overall Study||0
10772743|NCT03289234|11935475|FG000|STARTED|Overall Study||8
10772744|NCT03289234|11935476|FG001|STARTED|Overall Study||6
10772745|NCT03289234|11935477|FG002|STARTED|Overall Study||8
10772746|NCT03289234|11935475|FG000|COMPLETED|Overall Study||8
10772747|NCT03289234|11935476|FG001|COMPLETED|Overall Study||6
10772748|NCT03289234|11935477|FG002|COMPLETED|Overall Study||8
10772749|NCT03289234|11935475|FG000|NOT COMPLETED|Overall Study||0
10772750|NCT03289234|11935476|FG001|NOT COMPLETED|Overall Study||0
10772751|NCT03289234|11935477|FG002|NOT COMPLETED|Overall Study||0
10772752|NCT03289455|11935488|FG000|STARTED|Overall Study||4
10772753|NCT03289455|11935489|FG001|STARTED|Overall Study||5
10772754|NCT03289455|11935490|FG002|STARTED|Overall Study||6
10772755|NCT03289455|11935488|FG000|COMPLETED|Overall Study|Completed = Received AUTO3 infusion and completed 24 months visit|0
10772756|NCT03289455|11935489|FG001|COMPLETED|Overall Study|Completed = Received AUTO3 infusion and completed 24 months visit|0
10772757|NCT03289455|11935490|FG002|COMPLETED|Overall Study|Completed = Received AUTO3 infusion and completed 24 months visit|0
10772758|NCT03289455|11935488|FG000|NOT COMPLETED|Overall Study||4
10772759|NCT03289455|11935489|FG001|NOT COMPLETED|Overall Study||5
10772760|NCT03289455|11935490|FG002|NOT COMPLETED|Overall Study||6
10772761|NCT03289481|11935501|FG000|STARTED|Overall Study||6
10772762|NCT03289481|11935502|FG001|STARTED|Overall Study||7
10772763|NCT03289481|11935501|FG000|COMPLETED|Overall Study||4
10772764|NCT03289481|11935502|FG001|COMPLETED|Overall Study||5
10772765|NCT03289481|11935501|FG000|NOT COMPLETED|Overall Study||2
10772766|NCT03289481|11935502|FG001|NOT COMPLETED|Overall Study||2
10772767|NCT03289533|11935509|FG000|STARTED|Overall Study||22
10772768|NCT03289533|11935509|FG000|COMPLETED|Overall Study||0
10772769|NCT03289533|11935509|FG000|NOT COMPLETED|Overall Study||22
10772770|NCT03289676|11935515|FG000|STARTED|Overall Study||27
10772771|NCT03289676|11935516|FG001|STARTED|Overall Study||26
10772772|NCT03289676|11935515|FG000|COMPLETED|Overall Study||23
10772773|NCT03289676|11935516|FG001|COMPLETED|Overall Study|Received 80% of the allotted intervention|25
10772774|NCT03289676|11935515|FG000|NOT COMPLETED|Overall Study||4
10772775|NCT03289676|11935516|FG001|NOT COMPLETED|Overall Study||1
10772776|NCT03289858|11935524|FG000|STARTED|Overall Study||27
10772777|NCT03289858|11935525|FG001|STARTED|Overall Study||28
10772778|NCT03289858|11935524|FG000|COMPLETED|Overall Study||25
10772779|NCT03289858|11935525|FG001|COMPLETED|Overall Study||28
10772780|NCT03289858|11935524|FG000|NOT COMPLETED|Overall Study||2
10772781|NCT03289858|11935525|FG001|NOT COMPLETED|Overall Study||0
10772782|NCT03290027|11935533|FG000|STARTED|Overall Study||277
10772783|NCT03290027|11935534|FG001|STARTED|Overall Study||273
10772784|NCT03290027|11935533|FG000|COMPLETED|Overall Study||219
10772785|NCT03290027|11935534|FG001|COMPLETED|Overall Study||228
10772786|NCT03290027|11935533|FG000|NOT COMPLETED|Overall Study||58
10772787|NCT03290027|11935534|FG001|NOT COMPLETED|Overall Study||45
10772791|NCT03290378|11935552|FG000|STARTED|Overall Study||140
10772792|NCT03290378|11935553|FG001|STARTED|Overall Study||133
10772793|NCT03290378|11935554|FG002|STARTED|Overall Study||136
10772794|NCT03290378|11935552|FG000|COMPLETED|Overall Study||137
10772795|NCT03290378|11935553|FG001|COMPLETED|Overall Study||123
10772796|NCT03290378|11935554|FG002|COMPLETED|Overall Study||120
10772797|NCT03290378|11935552|FG000|NOT COMPLETED|Overall Study||3
10772798|NCT03290378|11935553|FG001|NOT COMPLETED|Overall Study||10
10772799|NCT03290378|11935554|FG002|NOT COMPLETED|Overall Study||16
10772800|NCT03290768|11935562|FG000|STARTED|Overall Study||358
10772801|NCT03290768|11935562|FG000|COMPLETED|Overall Study||193
10772802|NCT03290768|11935562|FG000|NOT COMPLETED|Overall Study||165
10772803|NCT03291041|11935568|FG000|STARTED|Overall Study||13
10772804|NCT03291041|11935569|FG001|STARTED|Overall Study||12
10772805|NCT03291041|11935568|FG000|COMPLETED|Overall Study||13
10772806|NCT03291041|11935569|FG001|COMPLETED|Overall Study||12
10772807|NCT03291041|11935568|FG000|NOT COMPLETED|Overall Study||0
10772808|NCT03291041|11935569|FG001|NOT COMPLETED|Overall Study||0
10772809|NCT03291080|11935577|FG000|STARTED|First Cycle (2 Weeks)||11
10772810|NCT03291080|11935578|FG001|STARTED|First Cycle (2 Weeks)||9
10772811|NCT03291080|11935577|FG000|COMPLETED|First Cycle (2 Weeks)||11
10772812|NCT03291080|11935578|FG001|COMPLETED|First Cycle (2 Weeks)||9
10772813|NCT03291080|11935577|FG000|NOT COMPLETED|First Cycle (2 Weeks)||0
10772814|NCT03291080|11935578|FG001|NOT COMPLETED|First Cycle (2 Weeks)||0
10772815|NCT03291080|11935577|FG000|STARTED|Washout (2 Weeks)||11
10772816|NCT03291080|11935578|FG001|STARTED|Washout (2 Weeks)||9
10772817|NCT03291080|11935577|FG000|COMPLETED|Washout (2 Weeks)||11
10772818|NCT03291080|11935578|FG001|COMPLETED|Washout (2 Weeks)||9
10772819|NCT03291080|11935577|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10772820|NCT03291080|11935578|FG001|NOT COMPLETED|Washout (2 Weeks)||0
10772821|NCT03291080|11935577|FG000|STARTED|Second Cylcle (2 Weeks)||9
10772822|NCT03291080|11935578|FG001|STARTED|Second Cylcle (2 Weeks)||11
10772823|NCT03291080|11935577|FG000|COMPLETED|Second Cylcle (2 Weeks)||8
10772824|NCT03291080|11935578|FG001|COMPLETED|Second Cylcle (2 Weeks)||11
10772825|NCT03291080|11935577|FG000|NOT COMPLETED|Second Cylcle (2 Weeks)||1
10772826|NCT03291080|11935578|FG001|NOT COMPLETED|Second Cylcle (2 Weeks)||0
10772827|NCT03291197|11935585|FG000|STARTED|Overall Study||5
10772828|NCT03291197|11935585|FG000|COMPLETED|Overall Study||5
10772829|NCT03291197|11935585|FG000|NOT COMPLETED|Overall Study||0
10772830|NCT03291288|11935593|FG000|STARTED|Drug-drug Interaction Phase||32
10772831|NCT03291288|11935594|FG001|STARTED|Drug-drug Interaction Phase||0
10772832|NCT03291288|11935593|FG000|COMPLETED|Drug-drug Interaction Phase||26
10772833|NCT03291288|11935594|FG001|COMPLETED|Drug-drug Interaction Phase||0
10772834|NCT03291288|11935593|FG000|NOT COMPLETED|Drug-drug Interaction Phase||6
10772835|NCT03291288|11935594|FG001|NOT COMPLETED|Drug-drug Interaction Phase||0
10772836|NCT03291288|11935593|FG000|STARTED|Pexidartinib Only|This is a crossover trial; participants who completed Part 1 continued to Part 2.|0
10772837|NCT03291288|11935594|FG001|STARTED|Pexidartinib Only||26
10772838|NCT03291288|11935593|FG000|COMPLETED|Pexidartinib Only||0
10772839|NCT03291288|11935594|FG001|COMPLETED|Pexidartinib Only||24
10772840|NCT03291288|11935593|FG000|NOT COMPLETED|Pexidartinib Only||0
10772841|NCT03291288|11935594|FG001|NOT COMPLETED|Pexidartinib Only||2
10772842|NCT03291379|11935608|FG000|STARTED|Overall Study||8
10772843|NCT03291379|11935608|FG000|COMPLETED|Overall Study||8
10772844|NCT03291379|11935608|FG000|NOT COMPLETED|Overall Study||0
10772845|NCT03291613|11935613|FG000|STARTED|Overall Study||13
10772846|NCT03291613|11935613|FG000|COMPLETED|Overall Study||12
10772847|NCT03291613|11935613|FG000|NOT COMPLETED|Overall Study||1
10772848|NCT03292016|11935623|FG000|STARTED|First Intervention||1
10772849|NCT03292016|11935624|FG001|STARTED|First Intervention||1
10772850|NCT03292016|11935625|FG002|STARTED|First Intervention||2
10772851|NCT03292016|11935626|FG003|STARTED|First Intervention||1
10772852|NCT03292016|11935627|FG004|STARTED|First Intervention||1
10772853|NCT03292016|11935628|FG005|STARTED|First Intervention||2
10772854|NCT03292016|11935623|FG000|COMPLETED|First Intervention||1
10772855|NCT03292016|11935624|FG001|COMPLETED|First Intervention||1
10772856|NCT03292016|11935625|FG002|COMPLETED|First Intervention||2
10772857|NCT03292016|11935626|FG003|COMPLETED|First Intervention||1
10772858|NCT03292016|11935627|FG004|COMPLETED|First Intervention||1
10772859|NCT03292016|11935628|FG005|COMPLETED|First Intervention||2
10772860|NCT03292016|11935623|FG000|NOT COMPLETED|First Intervention||0
10772861|NCT03292016|11935624|FG001|NOT COMPLETED|First Intervention||0
10772862|NCT03292016|11935625|FG002|NOT COMPLETED|First Intervention||0
10772863|NCT03292016|11935626|FG003|NOT COMPLETED|First Intervention||0
10772864|NCT03292016|11935627|FG004|NOT COMPLETED|First Intervention||0
10772865|NCT03292016|11935628|FG005|NOT COMPLETED|First Intervention||0
10772866|NCT03292016|11935623|FG000|STARTED|First Washout||1
10772867|NCT03292016|11935624|FG001|STARTED|First Washout||1
10772868|NCT03292016|11935625|FG002|STARTED|First Washout||2
10772869|NCT03292016|11935626|FG003|STARTED|First Washout||1
10772870|NCT03292016|11935627|FG004|STARTED|First Washout||1
10772871|NCT03292016|11935628|FG005|STARTED|First Washout||2
10772872|NCT03292016|11935623|FG000|COMPLETED|First Washout||1
10772873|NCT03292016|11935624|FG001|COMPLETED|First Washout||1
10772874|NCT03292016|11935625|FG002|COMPLETED|First Washout||2
10772875|NCT03292016|11935626|FG003|COMPLETED|First Washout||1
10772876|NCT03292016|11935627|FG004|COMPLETED|First Washout||1
10772877|NCT03292016|11935628|FG005|COMPLETED|First Washout||2
10772878|NCT03292016|11935623|FG000|NOT COMPLETED|First Washout||0
10772879|NCT03292016|11935624|FG001|NOT COMPLETED|First Washout||0
10772880|NCT03292016|11935625|FG002|NOT COMPLETED|First Washout||0
10772881|NCT03292016|11935626|FG003|NOT COMPLETED|First Washout||0
10772882|NCT03292016|11935627|FG004|NOT COMPLETED|First Washout||0
10772883|NCT03292016|11935628|FG005|NOT COMPLETED|First Washout||0
10772884|NCT03292016|11935623|FG000|STARTED|Second Intervention||1
10772885|NCT03292016|11935624|FG001|STARTED|Second Intervention||1
10297995|NCT00006046|11430646|FG004|COMPLETED|Overall Study||0
10297996|NCT00006046|11430642|FG000|NOT COMPLETED|Overall Study||5
10297997|NCT00006046|11430643|FG001|NOT COMPLETED|Overall Study||0
10297998|NCT00006046|11430644|FG002|NOT COMPLETED|Overall Study||0
10297999|NCT00006046|11430645|FG003|NOT COMPLETED|Overall Study||0
10298000|NCT00006046|11430646|FG004|NOT COMPLETED|Overall Study||0
10298001|NCT00006099|11430660|FG000|STARTED|Overall Study||1
10298002|NCT00006099|11430661|FG001|STARTED|Overall Study||0
10298003|NCT00006099|11430660|FG000|COMPLETED|Overall Study||1
10298004|NCT00006099|11430661|FG001|COMPLETED|Overall Study||0
10298005|NCT00006099|11430660|FG000|NOT COMPLETED|Overall Study||0
10298006|NCT00006099|11430661|FG001|NOT COMPLETED|Overall Study||0
10298007|NCT00006101|11430669|FG000|STARTED|Overall Study||38
10298008|NCT00006101|11430670|FG001|STARTED|Overall Study||38
10298009|NCT00006101|11430669|FG000|COMPLETED|Overall Study||33
10298010|NCT00006101|11430670|FG001|COMPLETED|Overall Study||33
10298011|NCT00006101|11430669|FG000|NOT COMPLETED|Overall Study||5
10298012|NCT00006101|11430670|FG001|NOT COMPLETED|Overall Study||5
10298013|NCT00006110|11430678|FG000|STARTED|Overall Study||52
10298014|NCT00006110|11430679|FG001|STARTED|Overall Study||30
10298015|NCT00006110|11430678|FG000|COMPLETED|Overall Study||52
10298016|NCT00006110|11430679|FG001|COMPLETED|Overall Study||30
10298017|NCT00006110|11430678|FG000|NOT COMPLETED|Overall Study||0
10429544|NCT00864383|11575575|FG001|COMPLETED|Modified Intent to Treat||568
10772886|NCT03292016|11935625|FG002|STARTED|Second Intervention||2
10772887|NCT03292016|11935626|FG003|STARTED|Second Intervention||1
10772888|NCT03292016|11935627|FG004|STARTED|Second Intervention||1
10298018|NCT00006110|11430679|FG001|NOT COMPLETED|Overall Study||0
10298019|NCT00006151|11430693|FG000|STARTED|Overall Study||30
10298020|NCT00006151|11430694|FG001|STARTED|Overall Study||30
10298021|NCT00006151|11430693|FG000|COMPLETED|Overall Study||17
10298022|NCT00006151|11430694|FG001|COMPLETED|Overall Study||16
10298023|NCT00006151|11430693|FG000|NOT COMPLETED|Overall Study||13
10298024|NCT00006151|11430694|FG001|NOT COMPLETED|Overall Study||14
10298025|NCT00006156|11430702|FG000|STARTED|Overall Study||42
10772889|NCT03292016|11935628|FG005|STARTED|Second Intervention||2
10772890|NCT03292016|11935623|FG000|COMPLETED|Second Intervention||1
10772891|NCT03292016|11935624|FG001|COMPLETED|Second Intervention||1
10772892|NCT03292016|11935625|FG002|COMPLETED|Second Intervention||2
10772893|NCT03292016|11935626|FG003|COMPLETED|Second Intervention||1
10772894|NCT03292016|11935627|FG004|COMPLETED|Second Intervention||1
10772895|NCT03292016|11935628|FG005|COMPLETED|Second Intervention||2
10772896|NCT03292016|11935623|FG000|NOT COMPLETED|Second Intervention||0
10772897|NCT03292016|11935624|FG001|NOT COMPLETED|Second Intervention||0
10772898|NCT03292016|11935625|FG002|NOT COMPLETED|Second Intervention||0
10772899|NCT03292016|11935626|FG003|NOT COMPLETED|Second Intervention||0
10772900|NCT03292016|11935627|FG004|NOT COMPLETED|Second Intervention||0
10421730|NCT00820755|11566601|FG002|NOT COMPLETED|Period 1: Combination Therapy Phase||0
10772901|NCT03292016|11935628|FG005|NOT COMPLETED|Second Intervention||0
10772902|NCT03292016|11935623|FG000|STARTED|Second Washout||1
10772903|NCT03292016|11935624|FG001|STARTED|Second Washout||1
10772904|NCT03292016|11935625|FG002|STARTED|Second Washout||2
10772905|NCT03292016|11935626|FG003|STARTED|Second Washout||1
10772906|NCT03292016|11935627|FG004|STARTED|Second Washout||1
10772907|NCT03292016|11935628|FG005|STARTED|Second Washout||2
10772908|NCT03292016|11935623|FG000|COMPLETED|Second Washout||1
10772909|NCT03292016|11935624|FG001|COMPLETED|Second Washout||0
10772910|NCT03292016|11935625|FG002|COMPLETED|Second Washout||2
10772911|NCT03292016|11935626|FG003|COMPLETED|Second Washout||1
10772912|NCT03292016|11935627|FG004|COMPLETED|Second Washout||1
10772913|NCT03292016|11935628|FG005|COMPLETED|Second Washout||2
10772914|NCT03292016|11935623|FG000|NOT COMPLETED|Second Washout||0
10772915|NCT03292016|11935624|FG001|NOT COMPLETED|Second Washout||1
10772916|NCT03292016|11935625|FG002|NOT COMPLETED|Second Washout||0
10772917|NCT03292016|11935626|FG003|NOT COMPLETED|Second Washout||0
10772918|NCT03292016|11935627|FG004|NOT COMPLETED|Second Washout||0
10772919|NCT03292016|11935628|FG005|NOT COMPLETED|Second Washout||0
10772920|NCT03292016|11935623|FG000|STARTED|Third Intervention||1
10772921|NCT03292016|11935624|FG001|STARTED|Third Intervention||0
10772922|NCT03292016|11935625|FG002|STARTED|Third Intervention||2
10772923|NCT03292016|11935626|FG003|STARTED|Third Intervention||1
10772924|NCT03292016|11935627|FG004|STARTED|Third Intervention||1
10772925|NCT03292016|11935628|FG005|STARTED|Third Intervention||2
10772926|NCT03292016|11935623|FG000|COMPLETED|Third Intervention||1
10772927|NCT03292016|11935624|FG001|COMPLETED|Third Intervention||0
10772928|NCT03292016|11935625|FG002|COMPLETED|Third Intervention||2
10772929|NCT03292016|11935626|FG003|COMPLETED|Third Intervention||1
10772930|NCT03292016|11935627|FG004|COMPLETED|Third Intervention||1
10772931|NCT03292016|11935628|FG005|COMPLETED|Third Intervention||2
10772932|NCT03292016|11935623|FG000|NOT COMPLETED|Third Intervention||0
10772933|NCT03292016|11935624|FG001|NOT COMPLETED|Third Intervention||0
10772934|NCT03292016|11935625|FG002|NOT COMPLETED|Third Intervention||0
10772935|NCT03292016|11935626|FG003|NOT COMPLETED|Third Intervention||0
10772936|NCT03292016|11935627|FG004|NOT COMPLETED|Third Intervention||0
10772937|NCT03292016|11935628|FG005|NOT COMPLETED|Third Intervention||0
10772938|NCT03292406|11935639|FG000|STARTED|Overall Study||30
10772939|NCT03292406|11935640|FG001|STARTED|Overall Study||28
10772940|NCT03292406|11935641|FG002|STARTED|Overall Study||28
10772941|NCT03292406|11935639|FG000|Participants Treated|Overall Study||30
10772942|NCT03292406|11935640|FG001|Participants Treated|Overall Study||28
10772943|NCT03292406|11935641|FG002|Participants Treated|Overall Study||27
10772944|NCT03292406|11935639|FG000|COMPLETED|Overall Study||17
10772945|NCT03292406|11935640|FG001|COMPLETED|Overall Study||15
10772946|NCT03292406|11935641|FG002|COMPLETED|Overall Study||15
10772947|NCT03292406|11935639|FG000|NOT COMPLETED|Overall Study||13
10772948|NCT03292406|11935640|FG001|NOT COMPLETED|Overall Study||13
10772949|NCT03292406|11935641|FG002|NOT COMPLETED|Overall Study||13
10772950|NCT03292432|11935651|FG000|STARTED|Overall Study||46
10772951|NCT03292432|11935652|FG001|STARTED|Overall Study||43
10772952|NCT03292432|11935651|FG000|Started Study Intervention|Overall Study||45
10772953|NCT03292432|11935652|FG001|Started Study Intervention|Overall Study||43
10772954|NCT03292432|11935651|FG000|COMPLETED|Overall Study||31
10772955|NCT03292432|11935652|FG001|COMPLETED|Overall Study||32
10772956|NCT03292432|11935651|FG000|NOT COMPLETED|Overall Study||15
10772957|NCT03292432|11935652|FG001|NOT COMPLETED|Overall Study||11
10772958|NCT03292562|11935660|FG000|STARTED|Overall Study||35
10772959|NCT03292562|11935661|FG001|STARTED|Overall Study||31
10772960|NCT03292562|11935660|FG000|COMPLETED|Overall Study||29
10772961|NCT03292562|11935661|FG001|COMPLETED|Overall Study||30
10772962|NCT03292562|11935660|FG000|NOT COMPLETED|Overall Study||6
10772963|NCT03292562|11935661|FG001|NOT COMPLETED|Overall Study||1
10772964|NCT03292614|11935667|FG000|STARTED|Overall Study||25
10772965|NCT03292614|11935667|FG000|COMPLETED|Overall Study||25
10772966|NCT03292614|11935667|FG000|NOT COMPLETED|Overall Study||0
10772967|NCT03292640|11935673|FG000|STARTED|Overall Study||275
10772968|NCT03292640|11935674|FG001|STARTED|Overall Study||272
10772969|NCT03292640|11935673|FG000|COMPLETED|Overall Study||214
10772970|NCT03292640|11935674|FG001|COMPLETED|Overall Study||230
10772971|NCT03292640|11935673|FG000|NOT COMPLETED|Overall Study||61
10772972|NCT03292640|11935674|FG001|NOT COMPLETED|Overall Study||42
10298026|NCT00006156|11430703|FG001|STARTED|Overall Study||7
10298027|NCT00006156|11430702|FG000|COMPLETED|Overall Study||42
10298028|NCT00006156|11430703|FG001|COMPLETED|Overall Study||7
10298029|NCT00006156|11430702|FG000|NOT COMPLETED|Overall Study||0
10772973|NCT03292653|11935687|FG000|STARTED|Overall Study||11
10772974|NCT03292653|11935688|FG001|STARTED|Overall Study||10
10772975|NCT03292653|11935689|FG002|STARTED|Overall Study||11
10772976|NCT03292653|11935687|FG000|COMPLETED|Overall Study||10
10298030|NCT00006156|11430703|FG001|NOT COMPLETED|Overall Study||0
10772977|NCT03292653|11935688|FG001|COMPLETED|Overall Study||10
10772978|NCT03292653|11935689|FG002|COMPLETED|Overall Study||10
10772979|NCT03292653|11935687|FG000|NOT COMPLETED|Overall Study||1
10772980|NCT03292653|11935688|FG001|NOT COMPLETED|Overall Study||0
10772981|NCT03292653|11935689|FG002|NOT COMPLETED|Overall Study||1
10772982|NCT03292692|11935700|FG000|STARTED|Overall Study||302
10772983|NCT03292692|11935701|FG001|STARTED|Overall Study||298
10772984|NCT03292692|11935700|FG000|COMPLETED|Overall Study||264
10772985|NCT03292692|11935701|FG001|COMPLETED|Overall Study||260
10772986|NCT03292692|11935700|FG000|NOT COMPLETED|Overall Study||38
10772987|NCT03292692|11935701|FG001|NOT COMPLETED|Overall Study||38
10772988|NCT03292809|11935709|FG000|STARTED|Overall Study||162
10772989|NCT03292809|11935710|FG001|STARTED|Overall Study||166
10772990|NCT03292809|11935709|FG000|COMPLETED|Overall Study||155
10772991|NCT03292809|11935710|FG001|COMPLETED|Overall Study||163
10772992|NCT03292809|11935709|FG000|NOT COMPLETED|Overall Study||7
10772993|NCT03292809|11935710|FG001|NOT COMPLETED|Overall Study||3
10772994|NCT03292952|11935718|FG000|STARTED|Open-Label Dose Optimization||155
10772995|NCT03292952|11935719|FG001|STARTED|Open-Label Dose Optimization|All subjects were treated with open-label KP415 during the Open-Label Phase|0
10772996|NCT03292952|11935720|FG002|STARTED|Open-Label Dose Optimization|All subjects were treated with open-label KP415 during the Open-Label Phase|0
10772997|NCT03292952|11935718|FG000|COMPLETED|Open-Label Dose Optimization||150
10772998|NCT03292952|11935719|FG001|COMPLETED|Open-Label Dose Optimization||0
10772999|NCT03292952|11935720|FG002|COMPLETED|Open-Label Dose Optimization||0
10773000|NCT03292952|11935718|FG000|NOT COMPLETED|Open-Label Dose Optimization||5
10773001|NCT03292952|11935719|FG001|NOT COMPLETED|Open-Label Dose Optimization||0
10773002|NCT03292952|11935720|FG002|NOT COMPLETED|Open-Label Dose Optimization||0
10773003|NCT03292952|11935718|FG000|STARTED|Double-Blind Treatment Phase|Subjects were randomized to the double-blind Treatment Phase after Open-Label Dose Optimization|0
10773004|NCT03292952|11935719|FG001|STARTED|Double-Blind Treatment Phase||74
10773005|NCT03292952|11935720|FG002|STARTED|Double-Blind Treatment Phase||76
10773006|NCT03292952|11935718|FG000|COMPLETED|Double-Blind Treatment Phase||0
10773007|NCT03292952|11935719|FG001|COMPLETED|Double-Blind Treatment Phase||74
10773008|NCT03292952|11935720|FG002|COMPLETED|Double-Blind Treatment Phase||75
10773009|NCT03292952|11935718|FG000|NOT COMPLETED|Double-Blind Treatment Phase||0
10773010|NCT03292952|11935719|FG001|NOT COMPLETED|Double-Blind Treatment Phase||0
10773011|NCT03292952|11935720|FG002|NOT COMPLETED|Double-Blind Treatment Phase||1
10773024|NCT03293394|11935748|FG000|STARTED|First Intervention (2 Weeks)||20
10773025|NCT03293394|11935749|FG001|STARTED|First Intervention (2 Weeks)||10
10773026|NCT03293394|11935748|FG000|COMPLETED|First Intervention (2 Weeks)||20
10773027|NCT03293394|11935749|FG001|COMPLETED|First Intervention (2 Weeks)||10
10773028|NCT03293394|11935748|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
10773029|NCT03293394|11935749|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
10773030|NCT03293394|11935748|FG000|STARTED|Follow-up (6 Months)||20
10773031|NCT03293394|11935749|FG001|STARTED|Follow-up (6 Months)||10
10773032|NCT03293394|11935748|FG000|COMPLETED|Follow-up (6 Months)||16
10773033|NCT03293394|11935749|FG001|COMPLETED|Follow-up (6 Months)||8
10773034|NCT03293394|11935748|FG000|NOT COMPLETED|Follow-up (6 Months)||4
10773035|NCT03293394|11935749|FG001|NOT COMPLETED|Follow-up (6 Months)||2
10773036|NCT03293485|11935755|FG000|STARTED|Overall Study||83
10773037|NCT03293485|11935755|FG000|Treated|Overall Study||81
10773038|NCT03293485|11935755|FG000|COMPLETED|Overall Study||78
10773039|NCT03293485|11935755|FG000|NOT COMPLETED|Overall Study||5
10773040|NCT03293654|11935764|FG000|STARTED|Overall Study||38
10773041|NCT03293654|11935765|FG001|STARTED|Overall Study||38
10773042|NCT03293654|11935766|FG002|STARTED|Overall Study||38
10773043|NCT03293654|11935764|FG000|COMPLETED|Overall Study||38
10773044|NCT03293654|11935765|FG001|COMPLETED|Overall Study||37
10773045|NCT03293654|11935766|FG002|COMPLETED|Overall Study||38
10773046|NCT03293654|11935764|FG000|NOT COMPLETED|Overall Study||0
10773047|NCT03293654|11935765|FG001|NOT COMPLETED|Overall Study||1
10773048|NCT03293654|11935766|FG002|NOT COMPLETED|Overall Study||0
10773049|NCT03294213|11935774|FG000|STARTED|Overall Study||176
10773050|NCT03294213|11935774|FG000|COMPLETED|Overall Study||176
10773051|NCT03294213|11935774|FG000|NOT COMPLETED|Overall Study||0
10773052|NCT03294317|11935778|FG000|STARTED|Overall Study||70
10773053|NCT03294317|11935778|FG000|Implanted With Lead at HIS Bundle|Overall Study||61
10773054|NCT03294317|11935778|FG000|Subjects With Available CT|Overall Study||51
10773055|NCT03294317|11935778|FG000|COMPLETED|Overall Study||50
10773056|NCT03294317|11935778|FG000|NOT COMPLETED|Overall Study||20
10773057|NCT03294538|11935785|FG000|STARTED|Overall Study||268
10773058|NCT03294538|11935786|FG001|STARTED|Overall Study||262
10773059|NCT03294538|11935787|FG002|STARTED|Overall Study||133
10773060|NCT03294538|11935785|FG000|Safety Population|Overall Study||267
10773061|NCT03294538|11935786|FG001|Safety Population|Overall Study||262
10773062|NCT03294538|11935787|FG002|Safety Population|Overall Study||132
10773063|NCT03294538|11935785|FG000|mITT Population|Overall Study||267
10773064|NCT03294538|11935786|FG001|mITT Population|Overall Study||262
10773065|NCT03294538|11935787|FG002|mITT Population|Overall Study||132
10773066|NCT03294538|11935785|FG000|PP Population|Overall Study||244
10773067|NCT03294538|11935786|FG001|PP Population|Overall Study||227
10773068|NCT03294538|11935787|FG002|PP Population|Overall Study||126
10773069|NCT03294538|11935785|FG000|COMPLETED|Overall Study||263
10773070|NCT03294538|11935786|FG001|COMPLETED|Overall Study||257
10773071|NCT03294538|11935787|FG002|COMPLETED|Overall Study||131
10773072|NCT03294538|11935785|FG000|NOT COMPLETED|Overall Study||5
10773073|NCT03294538|11935786|FG001|NOT COMPLETED|Overall Study||5
10773074|NCT03294538|11935787|FG002|NOT COMPLETED|Overall Study||2
10773075|NCT03294629|11935797|FG000|STARTED|First Intervention (2 Weeks)||16
10773076|NCT03294629|11935798|FG001|STARTED|First Intervention (2 Weeks)||19
10773077|NCT03294629|11935797|FG000|COMPLETED|First Intervention (2 Weeks)||14
10773078|NCT03294629|11935798|FG001|COMPLETED|First Intervention (2 Weeks)||15
10773079|NCT03294629|11935797|FG000|NOT COMPLETED|First Intervention (2 Weeks)||2
10773080|NCT03294629|11935798|FG001|NOT COMPLETED|First Intervention (2 Weeks)||4
10773081|NCT03294629|11935797|FG000|STARTED|Second Intervention (2 Weeks)||14
10773082|NCT03294629|11935798|FG001|STARTED|Second Intervention (2 Weeks)||15
10773083|NCT03294629|11935797|FG000|COMPLETED|Second Intervention (2 Weeks)||12
10773084|NCT03294629|11935798|FG001|COMPLETED|Second Intervention (2 Weeks)||13
10773085|NCT03294629|11935797|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||2
10773086|NCT03294629|11935798|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||2
10773087|NCT03294681|11935804|FG000|STARTED|Overall Study||153
10773088|NCT03294681|11935804|FG000|COMPLETED|Overall Study||152
10773089|NCT03294681|11935804|FG000|NOT COMPLETED|Overall Study||1
10773090|NCT03294850|11935810|FG000|STARTED|Overall Study||4
10773091|NCT03294850|11935811|FG001|STARTED|Overall Study||10
10773092|NCT03294850|11935810|FG000|COMPLETED|Overall Study||4
10773093|NCT03294850|11935811|FG001|COMPLETED|Overall Study||10
10773094|NCT03294850|11935810|FG000|NOT COMPLETED|Overall Study||0
10773095|NCT03294850|11935811|FG001|NOT COMPLETED|Overall Study||0
10773096|NCT03294941|11935819|FG000|STARTED|Overall Study||4
10773097|NCT03294941|11935820|FG001|STARTED|Overall Study||13
10773098|NCT03294941|11935819|FG000|COMPLETED|Overall Study||4
10773099|NCT03294941|11935820|FG001|COMPLETED|Overall Study||11
10773100|NCT03294941|11935819|FG000|NOT COMPLETED|Overall Study||0
10773101|NCT03294941|11935820|FG001|NOT COMPLETED|Overall Study||2
10773102|NCT03295201|11935829|FG000|STARTED|Overall Study||11
10773103|NCT03295201|11935830|FG001|STARTED|Overall Study||11
10773104|NCT03295201|11935829|FG000|COMPLETED|Overall Study||10
10773105|NCT03295201|11935830|FG001|COMPLETED|Overall Study||9
10773106|NCT03295201|11935829|FG000|NOT COMPLETED|Overall Study||1
10773107|NCT03295201|11935830|FG001|NOT COMPLETED|Overall Study||2
10773108|NCT03295266|11935838|FG000|STARTED|Overall Study||5
10773109|NCT03295266|11935839|FG001|STARTED|Overall Study||4
10773110|NCT03295266|11935838|FG000|COMPLETED|Overall Study||5
10773111|NCT03295266|11935839|FG001|COMPLETED|Overall Study||4
10773112|NCT03295266|11935838|FG000|NOT COMPLETED|Overall Study||0
10773113|NCT03295266|11935839|FG001|NOT COMPLETED|Overall Study||0
10773114|NCT03295318|11935848|FG000|STARTED|Overall Study||150
10773115|NCT03295318|11935849|FG001|STARTED|Overall Study||150
10773116|NCT03295318|11935850|FG002|STARTED|Overall Study||76
10773117|NCT03295318|11935848|FG000|Received First Vaccination|Overall Study|1 subject withdrew consent after randomization, but prior to vaccination.|149
10773118|NCT03295318|11935849|FG001|Received First Vaccination|Overall Study||150
10773119|NCT03295318|11935850|FG002|Received First Vaccination|Overall Study||76
10773120|NCT03295318|11935848|FG000|Received Second Vaccination|Overall Study||144
10773121|NCT03295318|11935849|FG001|Received Second Vaccination|Overall Study||145
10773122|NCT03295318|11935850|FG002|Received Second Vaccination|Overall Study||73
10773123|NCT03295318|11935848|FG000|COMPLETED|Overall Study||144
10773124|NCT03295318|11935849|FG001|COMPLETED|Overall Study||145
10773125|NCT03295318|11935850|FG002|COMPLETED|Overall Study||71
10773126|NCT03295318|11935848|FG000|NOT COMPLETED|Overall Study||6
10773127|NCT03295318|11935849|FG001|NOT COMPLETED|Overall Study||5
10773128|NCT03295318|11935850|FG002|NOT COMPLETED|Overall Study||5
10773129|NCT03295630|11935876|FG000|STARTED|Overall Study||20
10773130|NCT03295630|11935876|FG000|COMPLETED|Overall Study||20
10773131|NCT03295630|11935876|FG000|NOT COMPLETED|Overall Study||0
10773132|NCT03295721|11935884|FG000|STARTED|Overall Study||157
10773133|NCT03295721|11935885|FG001|STARTED|Overall Study||100
10773134|NCT03295721|11935886|FG002|STARTED|Overall Study||155
10773135|NCT03295721|11935884|FG000|COMPLETED|Overall Study||154
10773136|NCT03295721|11935885|FG001|COMPLETED|Overall Study||99
10773137|NCT03295721|11935886|FG002|COMPLETED|Overall Study||152
10773138|NCT03295721|11935884|FG000|NOT COMPLETED|Overall Study||3
10773139|NCT03295721|11935885|FG001|NOT COMPLETED|Overall Study||1
10773140|NCT03295721|11935886|FG002|NOT COMPLETED|Overall Study||3
10773141|NCT03296072|11935895|FG000|STARTED|Treatment Period 1||10
10773142|NCT03296072|11935896|FG001|STARTED|Treatment Period 1||11
10773143|NCT03296072|11935897|FG002|STARTED|Treatment Period 1||10
10773144|NCT03296072|11935898|FG003|STARTED|Treatment Period 1||10
10773145|NCT03296072|11935899|FG004|STARTED|Treatment Period 1||10
10773146|NCT03296072|11935900|FG005|STARTED|Treatment Period 1||11
10773147|NCT03296072|11935895|FG000|COMPLETED|Treatment Period 1||10
10773148|NCT03296072|11935896|FG001|COMPLETED|Treatment Period 1||11
10773149|NCT03296072|11935897|FG002|COMPLETED|Treatment Period 1||10
10773150|NCT03296072|11935898|FG003|COMPLETED|Treatment Period 1||10
10773151|NCT03296072|11935899|FG004|COMPLETED|Treatment Period 1||10
10773152|NCT03296072|11935900|FG005|COMPLETED|Treatment Period 1||11
10773153|NCT03296072|11935895|FG000|NOT COMPLETED|Treatment Period 1||0
10773154|NCT03296072|11935896|FG001|NOT COMPLETED|Treatment Period 1||0
10773155|NCT03296072|11935897|FG002|NOT COMPLETED|Treatment Period 1||0
10773156|NCT03296072|11935898|FG003|NOT COMPLETED|Treatment Period 1||0
10773157|NCT03296072|11935899|FG004|NOT COMPLETED|Treatment Period 1||0
10773158|NCT03296072|11935900|FG005|NOT COMPLETED|Treatment Period 1||0
10773159|NCT03296072|11935895|FG000|STARTED|Treament Period 1: Wash Out Period||10
10773160|NCT03296072|11935896|FG001|STARTED|Treament Period 1: Wash Out Period||11
10773161|NCT03296072|11935897|FG002|STARTED|Treament Period 1: Wash Out Period||10
10773162|NCT03296072|11935898|FG003|STARTED|Treament Period 1: Wash Out Period||10
10773163|NCT03296072|11935899|FG004|STARTED|Treament Period 1: Wash Out Period||10
10773164|NCT03296072|11935900|FG005|STARTED|Treament Period 1: Wash Out Period||11
10773165|NCT03296072|11935895|FG000|COMPLETED|Treament Period 1: Wash Out Period||10
10773166|NCT03296072|11935896|FG001|COMPLETED|Treament Period 1: Wash Out Period||11
10773167|NCT03296072|11935897|FG002|COMPLETED|Treament Period 1: Wash Out Period||10
10773168|NCT03296072|11935898|FG003|COMPLETED|Treament Period 1: Wash Out Period||10
10773169|NCT03296072|11935899|FG004|COMPLETED|Treament Period 1: Wash Out Period||10
10773170|NCT03296072|11935900|FG005|COMPLETED|Treament Period 1: Wash Out Period||11
10773171|NCT03296072|11935895|FG000|NOT COMPLETED|Treament Period 1: Wash Out Period||0
10773172|NCT03296072|11935896|FG001|NOT COMPLETED|Treament Period 1: Wash Out Period||0
10773173|NCT03296072|11935897|FG002|NOT COMPLETED|Treament Period 1: Wash Out Period||0
10773174|NCT03296072|11935898|FG003|NOT COMPLETED|Treament Period 1: Wash Out Period||0
10773175|NCT03296072|11935899|FG004|NOT COMPLETED|Treament Period 1: Wash Out Period||0
10773176|NCT03296072|11935900|FG005|NOT COMPLETED|Treament Period 1: Wash Out Period||0
10773177|NCT03296072|11935895|FG000|STARTED|Treament Period 2||10
10773178|NCT03296072|11935896|FG001|STARTED|Treament Period 2||11
10773179|NCT03296072|11935897|FG002|STARTED|Treament Period 2||10
10773180|NCT03296072|11935898|FG003|STARTED|Treament Period 2||10
10773181|NCT03296072|11935899|FG004|STARTED|Treament Period 2||10
10773182|NCT03296072|11935900|FG005|STARTED|Treament Period 2||11
10773183|NCT03296072|11935895|FG000|COMPLETED|Treament Period 2||10
10773184|NCT03296072|11935896|FG001|COMPLETED|Treament Period 2||11
10773185|NCT03296072|11935897|FG002|COMPLETED|Treament Period 2||10
10773186|NCT03296072|11935898|FG003|COMPLETED|Treament Period 2||10
10773187|NCT03296072|11935899|FG004|COMPLETED|Treament Period 2||10
10773188|NCT03296072|11935900|FG005|COMPLETED|Treament Period 2||11
10773189|NCT03296072|11935895|FG000|NOT COMPLETED|Treament Period 2||0
10773190|NCT03296072|11935896|FG001|NOT COMPLETED|Treament Period 2||0
10773191|NCT03296072|11935897|FG002|NOT COMPLETED|Treament Period 2||0
10773192|NCT03296072|11935898|FG003|NOT COMPLETED|Treament Period 2||0
10773193|NCT03296072|11935899|FG004|NOT COMPLETED|Treament Period 2||0
10773194|NCT03296072|11935900|FG005|NOT COMPLETED|Treament Period 2||0
10773195|NCT03296072|11935895|FG000|STARTED|Treament Period 2: Wash Out Period||10
10773196|NCT03296072|11935896|FG001|STARTED|Treament Period 2: Wash Out Period||11
10773197|NCT03296072|11935897|FG002|STARTED|Treament Period 2: Wash Out Period||10
10773198|NCT03296072|11935898|FG003|STARTED|Treament Period 2: Wash Out Period||10
10773199|NCT03296072|11935899|FG004|STARTED|Treament Period 2: Wash Out Period||10
10773200|NCT03296072|11935900|FG005|STARTED|Treament Period 2: Wash Out Period||11
10773201|NCT03296072|11935895|FG000|COMPLETED|Treament Period 2: Wash Out Period||10
10773202|NCT03296072|11935896|FG001|COMPLETED|Treament Period 2: Wash Out Period||11
10773203|NCT03296072|11935897|FG002|COMPLETED|Treament Period 2: Wash Out Period||10
10773204|NCT03296072|11935898|FG003|COMPLETED|Treament Period 2: Wash Out Period||10
10773205|NCT03296072|11935899|FG004|COMPLETED|Treament Period 2: Wash Out Period||10
10773206|NCT03296072|11935900|FG005|COMPLETED|Treament Period 2: Wash Out Period||11
10773207|NCT03296072|11935895|FG000|NOT COMPLETED|Treament Period 2: Wash Out Period||0
10773208|NCT03296072|11935896|FG001|NOT COMPLETED|Treament Period 2: Wash Out Period||0
10773209|NCT03296072|11935897|FG002|NOT COMPLETED|Treament Period 2: Wash Out Period||0
10773210|NCT03296072|11935898|FG003|NOT COMPLETED|Treament Period 2: Wash Out Period||0
10773211|NCT03296072|11935899|FG004|NOT COMPLETED|Treament Period 2: Wash Out Period||0
10773212|NCT03296072|11935900|FG005|NOT COMPLETED|Treament Period 2: Wash Out Period||0
10773213|NCT03296072|11935895|FG000|STARTED|Treament Period 3||10
10773214|NCT03296072|11935896|FG001|STARTED|Treament Period 3||11
10773215|NCT03296072|11935897|FG002|STARTED|Treament Period 3||10
10773216|NCT03296072|11935898|FG003|STARTED|Treament Period 3||10
10773217|NCT03296072|11935899|FG004|STARTED|Treament Period 3||10
10773218|NCT03296072|11935900|FG005|STARTED|Treament Period 3||11
10773219|NCT03296072|11935895|FG000|COMPLETED|Treament Period 3||10
10773220|NCT03296072|11935896|FG001|COMPLETED|Treament Period 3||11
10773221|NCT03296072|11935897|FG002|COMPLETED|Treament Period 3||10
10773222|NCT03296072|11935898|FG003|COMPLETED|Treament Period 3||10
10773223|NCT03296072|11935899|FG004|COMPLETED|Treament Period 3||10
10773224|NCT03296072|11935900|FG005|COMPLETED|Treament Period 3||11
10773225|NCT03296072|11935895|FG000|NOT COMPLETED|Treament Period 3||0
10773226|NCT03296072|11935896|FG001|NOT COMPLETED|Treament Period 3||0
10773227|NCT03296072|11935897|FG002|NOT COMPLETED|Treament Period 3||0
10773228|NCT03296072|11935898|FG003|NOT COMPLETED|Treament Period 3||0
10773229|NCT03296072|11935899|FG004|NOT COMPLETED|Treament Period 3||0
10773230|NCT03296072|11935900|FG005|NOT COMPLETED|Treament Period 3||0
10773231|NCT03296163|11935910|FG000|STARTED|Combination Therapy||315
10773232|NCT03296163|11935911|FG001|STARTED|Combination Therapy||312
10773233|NCT03296163|11935910|FG000|COMPLETED|Combination Therapy||207
10773234|NCT03296163|11935911|FG001|COMPLETED|Combination Therapy||220
10773235|NCT03296163|11935910|FG000|NOT COMPLETED|Combination Therapy||108
10773236|NCT03296163|11935911|FG001|NOT COMPLETED|Combination Therapy||92
10773237|NCT03296163|11935910|FG000|STARTED|Monotherapy||207
10773238|NCT03296163|11935911|FG001|STARTED|Monotherapy||220
10773239|NCT03296163|11935910|FG000|COMPLETED|Monotherapy||68
10773240|NCT03296163|11935911|FG001|COMPLETED|Monotherapy||74
10773241|NCT03296163|11935910|FG000|NOT COMPLETED|Monotherapy||139
10773242|NCT03296163|11935911|FG001|NOT COMPLETED|Monotherapy||146
10773243|NCT03296280|11935919|FG000|STARTED|Overall Study||73
10773244|NCT03296280|11935920|FG001|STARTED|Overall Study||43
10773245|NCT03296280|11935919|FG000|COMPLETED|Overall Study||67
10773246|NCT03296280|11935920|FG001|COMPLETED|Overall Study||36
10773247|NCT03296280|11935919|FG000|NOT COMPLETED|Overall Study||6
10773248|NCT03296280|11935920|FG001|NOT COMPLETED|Overall Study||7
10773249|NCT03296345|11935926|FG000|STARTED|Overall Study||62
10773250|NCT03296345|11935926|FG000|COMPLETED|Overall Study||62
10773251|NCT03296345|11935926|FG000|NOT COMPLETED|Overall Study||0
10773252|NCT03296527|11935934|FG000|STARTED|Overall Study||500
10773253|NCT03296527|11935935|FG001|STARTED|Overall Study||511
10773254|NCT03296527|11935934|FG000|Full Analysis Set|Overall Study||499
10773255|NCT03296527|11935935|FG001|Full Analysis Set|Overall Study||510
10773256|NCT03296527|11935934|FG000|COMPLETED|Overall Study||465
10773257|NCT03296527|11935935|FG001|COMPLETED|Overall Study||458
10773258|NCT03296527|11935934|FG000|NOT COMPLETED|Overall Study||35
10773259|NCT03296527|11935935|FG001|NOT COMPLETED|Overall Study||53
10773260|NCT03296566|11935944|FG000|STARTED|Overall Study||145
10773261|NCT03296566|11935945|FG001|STARTED|Overall Study||152
10773262|NCT03296566|11935944|FG000|COMPLETED|Overall Study||126
10773263|NCT03296566|11935945|FG001|COMPLETED|Overall Study||103
10773264|NCT03296566|11935944|FG000|NOT COMPLETED|Overall Study||19
10773265|NCT03296566|11935945|FG001|NOT COMPLETED|Overall Study||49
10773266|NCT03296787|11935955|FG000|STARTED|Overall Study||8
10773267|NCT03296787|11935956|FG001|STARTED|Overall Study||8
10773268|NCT03296787|11935957|FG002|STARTED|Overall Study||9
10773269|NCT03296787|11935958|FG003|STARTED|Overall Study||7
10773270|NCT03296787|11935955|FG000|COMPLETED|Overall Study||8
10773271|NCT03296787|11935956|FG001|COMPLETED|Overall Study||8
10773272|NCT03296787|11935957|FG002|COMPLETED|Overall Study||9
10773273|NCT03296787|11935958|FG003|COMPLETED|Overall Study||7
10773274|NCT03296787|11935955|FG000|NOT COMPLETED|Overall Study||0
10773275|NCT03296787|11935956|FG001|NOT COMPLETED|Overall Study||0
10773276|NCT03296787|11935957|FG002|NOT COMPLETED|Overall Study||0
10773277|NCT03296787|11935958|FG003|NOT COMPLETED|Overall Study||0
10773278|NCT03296800|11935972|FG000|STARTED|Overall Study||16
10773279|NCT03296800|11935973|FG001|STARTED|Overall Study||16
10773280|NCT03296800|11935974|FG002|STARTED|Overall Study||16
10773281|NCT03296800|11935972|FG000|COMPLETED|Overall Study||16
10773282|NCT03296800|11935973|FG001|COMPLETED|Overall Study||16
10773283|NCT03296800|11935974|FG002|COMPLETED|Overall Study||16
10773284|NCT03296800|11935972|FG000|NOT COMPLETED|Overall Study||0
10773285|NCT03296800|11935973|FG001|NOT COMPLETED|Overall Study||0
10773286|NCT03296800|11935974|FG002|NOT COMPLETED|Overall Study||0
10773287|NCT03297021|11936000|FG000|STARTED|Overall Study||48
10773288|NCT03297021|11936001|FG001|STARTED|Overall Study||46
10773289|NCT03297021|11936002|FG002|STARTED|Overall Study||47
10773290|NCT03297021|11936000|FG000|COMPLETED|Overall Study||43
10773291|NCT03297021|11936001|FG001|COMPLETED|Overall Study||42
10773292|NCT03297021|11936002|FG002|COMPLETED|Overall Study||43
10773293|NCT03297021|11936000|FG000|NOT COMPLETED|Overall Study||5
10773294|NCT03297021|11936001|FG001|NOT COMPLETED|Overall Study||4
10773295|NCT03297021|11936002|FG002|NOT COMPLETED|Overall Study||4
10773296|NCT03297112|11936010|FG000|STARTED|Overall Study||12
10773297|NCT03297112|11936010|FG000|COMPLETED|Overall Study||12
10773298|NCT03297112|11936010|FG000|NOT COMPLETED|Overall Study||0
10773299|NCT03297216|11936016|FG000|STARTED|Overall Study||399
10773300|NCT03297216|11936017|FG001|STARTED|Overall Study||401
10773301|NCT03297216|11936016|FG000|Discontinued Intervention|Overall Study||5
10773302|NCT03297216|11936017|FG001|Discontinued Intervention|Overall Study||4
10773303|NCT03297216|11936016|FG000|Infants Born During Study|Overall Study||399
10773304|NCT03297216|11936017|FG001|Infants Born During Study|Overall Study||401
10773305|NCT03297216|11936016|FG000|COMPLETED|Overall Study||396
10773306|NCT03297216|11936017|FG001|COMPLETED|Overall Study||396
10773307|NCT03297216|11936016|FG000|NOT COMPLETED|Overall Study||3
10773308|NCT03297216|11936017|FG001|NOT COMPLETED|Overall Study||5
10773309|NCT03297294|11936032|FG000|STARTED|Double-Blind Treatment Period (DB)||70
10773310|NCT03297294|11936033|FG001|STARTED|Double-Blind Treatment Period (DB)||67
10773311|NCT03297294|11936034|FG002|STARTED|Double-Blind Treatment Period (DB)||0
10773312|NCT03297294|11936035|FG003|STARTED|Double-Blind Treatment Period (DB)||0
10773313|NCT03297294|11936036|FG004|STARTED|Double-Blind Treatment Period (DB)||0
10773314|NCT03297294|11936032|FG000|COMPLETED|Double-Blind Treatment Period (DB)||32
10773315|NCT03297294|11936033|FG001|COMPLETED|Double-Blind Treatment Period (DB)||30
10773316|NCT03297294|11936034|FG002|COMPLETED|Double-Blind Treatment Period (DB)||0
10773317|NCT03297294|11936035|FG003|COMPLETED|Double-Blind Treatment Period (DB)||0
10773318|NCT03297294|11936036|FG004|COMPLETED|Double-Blind Treatment Period (DB)||0
10773319|NCT03297294|11936032|FG000|NOT COMPLETED|Double-Blind Treatment Period (DB)||38
10773320|NCT03297294|11936033|FG001|NOT COMPLETED|Double-Blind Treatment Period (DB)||37
10773321|NCT03297294|11936034|FG002|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
10773322|NCT03297294|11936035|FG003|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
10773323|NCT03297294|11936036|FG004|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
10773324|NCT03297294|11936032|FG000|STARTED|Treatment Withdrawal Period (TW)||0
10773325|NCT03297294|11936033|FG001|STARTED|Treatment Withdrawal Period (TW)||0
10773326|NCT03297294|11936034|FG002|STARTED|Treatment Withdrawal Period (TW)||14
10773327|NCT03297294|11936035|FG003|STARTED|Treatment Withdrawal Period (TW)||12
10773328|NCT03297294|11936036|FG004|STARTED|Treatment Withdrawal Period (TW)||27
10773329|NCT03297294|11936032|FG000|COMPLETED|Treatment Withdrawal Period (TW)||0
10773330|NCT03297294|11936033|FG001|COMPLETED|Treatment Withdrawal Period (TW)||0
10773331|NCT03297294|11936034|FG002|COMPLETED|Treatment Withdrawal Period (TW)||14
10773332|NCT03297294|11936035|FG003|COMPLETED|Treatment Withdrawal Period (TW)||11
10773333|NCT03297294|11936036|FG004|COMPLETED|Treatment Withdrawal Period (TW)||27
10773334|NCT03297294|11936032|FG000|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
10773335|NCT03297294|11936033|FG001|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
10773336|NCT03297294|11936034|FG002|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
10773337|NCT03297294|11936035|FG003|NOT COMPLETED|Treatment Withdrawal Period (TW)||1
10773338|NCT03297294|11936036|FG004|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
10773339|NCT03297398|11936051|FG000|STARTED|Overall Study||36
10773340|NCT03297398|11936052|FG001|STARTED|Overall Study||40
10773341|NCT03297398|11936053|FG002|STARTED|Overall Study||38
10773342|NCT03297398|11936051|FG000|COMPLETED|Overall Study||28
10773343|NCT03297398|11936052|FG001|COMPLETED|Overall Study||23
10773344|NCT03297398|11936053|FG002|COMPLETED|Overall Study||23
10773345|NCT03297398|11936051|FG000|NOT COMPLETED|Overall Study||8
10773346|NCT03297398|11936052|FG001|NOT COMPLETED|Overall Study||17
10773347|NCT03297398|11936053|FG002|NOT COMPLETED|Overall Study||15
10773348|NCT03297944|11936061|FG000|STARTED|Overall Study||15
10773349|NCT03297944|11936061|FG000|2ALP/PLC|Overall Study||15
10773350|NCT03297944|11936061|FG000|1ALP/PLC|Overall Study||15
10773351|NCT03297944|11936061|FG000|0.5ALP/PLC|Overall Study||15
10773352|NCT03297944|11936061|FG000|ZOL/PLC|Overall Study||15
10773353|NCT03297944|11936061|FG000|PLC/PLC|Overall Study||15
10773354|NCT03297944|11936061|FG000|PLC/ALP|Overall Study||15
10773355|NCT03297944|11936061|FG000|COMPLETED|Overall Study||15
10773356|NCT03297944|11936061|FG000|NOT COMPLETED|Overall Study||0
10773357|NCT03298035|11936072|FG000|STARTED|Overall Study||10
10773358|NCT03298035|11936073|FG001|STARTED|Overall Study||9
10773359|NCT03298035|11936072|FG000|Received Intervention|Overall Study||9
10773360|NCT03298035|11936073|FG001|Received Intervention|Overall Study||7
10773361|NCT03298035|11936072|FG000|COMPLETED|Overall Study||9
10773362|NCT03298035|11936073|FG001|COMPLETED|Overall Study||7
10773363|NCT03298035|11936072|FG000|NOT COMPLETED|Overall Study||1
10773364|NCT03298035|11936073|FG001|NOT COMPLETED|Overall Study||2
10773365|NCT03298048|11936082|FG000|STARTED|Overall Study||4
10773366|NCT03298048|11936083|FG001|STARTED|Overall Study||3
10773367|NCT03298048|11936084|FG002|STARTED|Overall Study||8
10773368|NCT03298048|11936082|FG000|COMPLETED|Overall Study||4
10773369|NCT03298048|11936083|FG001|COMPLETED|Overall Study||3
10773370|NCT03298048|11936084|FG002|COMPLETED|Overall Study||8
10773371|NCT03298048|11936082|FG000|NOT COMPLETED|Overall Study||0
10773372|NCT03298048|11936083|FG001|NOT COMPLETED|Overall Study||0
10773373|NCT03298048|11936084|FG002|NOT COMPLETED|Overall Study||0
10773374|NCT03298113|11936094|FG000|STARTED|Overall Study|10 subjects were treated w/ Cavilon Advanced Skin Protectant. Study terminated due to low enrollment|10
10773375|NCT03298113|11936095|FG001|STARTED|Overall Study|10 subjects were treated with IAD Hospital Standard Care. Study terminated due to low enrollment.|10
10773376|NCT03298113|11936094|FG000|IAD 1A|Overall Study||3
10773377|NCT03298113|11936095|FG001|IAD 1A|Overall Study||4
10773378|NCT03298113|11936094|FG000|IAD 2A|Overall Study||7
10773379|NCT03298113|11936095|FG001|IAD 2A|Overall Study||6
10773380|NCT03298113|11936094|FG000|COMPLETED|Overall Study||10
10773381|NCT03298113|11936095|FG001|COMPLETED|Overall Study||10
10773382|NCT03298113|11936094|FG000|NOT COMPLETED|Overall Study||0
10773383|NCT03298113|11936095|FG001|NOT COMPLETED|Overall Study||0
10773384|NCT03298412|11936101|FG000|STARTED|Run-in Period||10
10773385|NCT03298412|11936101|FG000|COMPLETED|Run-in Period||1
10773386|NCT03298412|11936101|FG000|NOT COMPLETED|Run-in Period||9
10773387|NCT03298412|11936101|FG000|STARTED|Treatment Period||1
10773388|NCT03298412|11936101|FG000|COMPLETED|Treatment Period||1
10773389|NCT03298412|11936101|FG000|NOT COMPLETED|Treatment Period||0
10773390|NCT03298841|11936107|FG000|STARTED|Overall Study||25
10773391|NCT03298841|11936108|FG001|STARTED|Overall Study||25
10773392|NCT03298841|11936107|FG000|COMPLETED|Overall Study||25
10773393|NCT03298841|11936108|FG001|COMPLETED|Overall Study||25
10773394|NCT03298841|11936107|FG000|NOT COMPLETED|Overall Study||0
10773395|NCT03298841|11936108|FG001|NOT COMPLETED|Overall Study||0
10773396|NCT03298880|11936115|FG000|STARTED|Overall Study||75
10773397|NCT03298880|11936115|FG000|COMPLETED|Overall Study||75
10773398|NCT03298880|11936115|FG000|NOT COMPLETED|Overall Study||0
10773399|NCT03299101|11936126|FG000|STARTED|Overall Study||35
10773400|NCT03299101|11936126|FG000|COMPLETED|Overall Study||25
10773401|NCT03299101|11936126|FG000|NOT COMPLETED|Overall Study||10
10773402|NCT03299244|11936132|FG000|STARTED|Overall Study||317
10773403|NCT03299244|11936133|FG001|STARTED|Overall Study||320
10773404|NCT03299244|11936132|FG000|Received Treatment|Overall Study||315
10773405|NCT03299244|11936133|FG001|Received Treatment|Overall Study||318
10773406|NCT03299244|11936132|FG000|COMPLETED|Overall Study||270
10773407|NCT03299244|11936133|FG001|COMPLETED|Overall Study||282
10773408|NCT03299244|11936132|FG000|NOT COMPLETED|Overall Study||47
10773409|NCT03299244|11936133|FG001|NOT COMPLETED|Overall Study||38
10773410|NCT03299686|11936142|FG000|STARTED|Treatment Epoch||70
10773411|NCT03299686|11936143|FG001|STARTED|Treatment Epoch||48
10773412|NCT03299686|11936142|FG000|PD (Pharmacodynamics) Analysis Set|Treatment Epoch||69
10773413|NCT03299686|11936143|FG001|PD (Pharmacodynamics) Analysis Set|Treatment Epoch||48
10773414|NCT03299686|11936142|FG000|COMPLETED|Treatment Epoch||59
10773415|NCT03299686|11936143|FG001|COMPLETED|Treatment Epoch||44
10773416|NCT03299686|11936142|FG000|NOT COMPLETED|Treatment Epoch||11
10773417|NCT03299686|11936143|FG001|NOT COMPLETED|Treatment Epoch||4
10773418|NCT03299686|11936142|FG000|STARTED|Follow-up Epoch||59
10773419|NCT03299686|11936143|FG001|STARTED|Follow-up Epoch||44
10773420|NCT03299686|11936142|FG000|COMPLETED|Follow-up Epoch||59
10773421|NCT03299686|11936143|FG001|COMPLETED|Follow-up Epoch||43
10773422|NCT03299686|11936142|FG000|NOT COMPLETED|Follow-up Epoch||0
10773423|NCT03299686|11936143|FG001|NOT COMPLETED|Follow-up Epoch||1
10773424|NCT03299881|11936151|FG000|STARTED|Overall Study||39
10773425|NCT03299881|11936152|FG001|STARTED|Overall Study||38
10773426|NCT03299881|11936151|FG000|COMPLETED|Overall Study||22
10773427|NCT03299881|11936152|FG001|COMPLETED|Overall Study||25
10773428|NCT03299881|11936151|FG000|NOT COMPLETED|Overall Study||17
10773429|NCT03299881|11936152|FG001|NOT COMPLETED|Overall Study||13
10773430|NCT03300050|11936163|FG000|STARTED|Overall Study||20
10773431|NCT03300050|11936164|FG001|STARTED|Overall Study||15
10773432|NCT03300050|11936165|FG002|STARTED|Overall Study||5
10773433|NCT03300050|11936166|FG003|STARTED|Overall Study||16
10773434|NCT03300050|11936167|FG004|STARTED|Overall Study||10
10773435|NCT03300050|11936163|FG000|Received Treatment|Overall Study||19
10773436|NCT03300050|11936164|FG001|Received Treatment|Overall Study||14
10773437|NCT03300050|11936165|FG002|Received Treatment|Overall Study||3
10773438|NCT03300050|11936166|FG003|Received Treatment|Overall Study||15
10773439|NCT03300050|11936167|FG004|Received Treatment|Overall Study||10
10773440|NCT03300050|11936163|FG000|Received All Scheduled Treatments|Overall Study||16
10773441|NCT03300050|11936164|FG001|Received All Scheduled Treatments|Overall Study||13
10773442|NCT03300050|11936165|FG002|Received All Scheduled Treatments|Overall Study||2
10773443|NCT03300050|11936166|FG003|Received All Scheduled Treatments|Overall Study||15
10773444|NCT03300050|11936167|FG004|Received All Scheduled Treatments|Overall Study||10
10773445|NCT03300050|11936163|FG000|COMPLETED|Overall Study||17
10773446|NCT03300050|11936164|FG001|COMPLETED|Overall Study||13
10773447|NCT03300050|11936165|FG002|COMPLETED|Overall Study||2
10773448|NCT03300050|11936166|FG003|COMPLETED|Overall Study||15
10773449|NCT03300050|11936167|FG004|COMPLETED|Overall Study||9
10773450|NCT03300050|11936163|FG000|NOT COMPLETED|Overall Study||3
10773451|NCT03300050|11936164|FG001|NOT COMPLETED|Overall Study||2
10773452|NCT03300050|11936165|FG002|NOT COMPLETED|Overall Study||3
10773453|NCT03300050|11936166|FG003|NOT COMPLETED|Overall Study||1
10773454|NCT03300050|11936167|FG004|NOT COMPLETED|Overall Study||1
10773461|NCT03300570|11936190|FG000|STARTED|Overall Study||13
10773462|NCT03300570|11936191|FG001|STARTED|Overall Study||14
10773463|NCT03300570|11936190|FG000|COMPLETED|Overall Study||11
10773464|NCT03300570|11936191|FG001|COMPLETED|Overall Study||13
10773465|NCT03300570|11936190|FG000|NOT COMPLETED|Overall Study||2
10773466|NCT03300570|11936191|FG001|NOT COMPLETED|Overall Study||1
10773467|NCT03300674|11936200|FG000|STARTED|Overall Study||77
10773468|NCT03300674|11936201|FG001|STARTED|Overall Study||77
10773469|NCT03300674|11936200|FG000|COMPLETED|Overall Study||77
10773470|NCT03300674|11936201|FG001|COMPLETED|Overall Study||77
10773471|NCT03300674|11936200|FG000|NOT COMPLETED|Overall Study||0
10773472|NCT03300674|11936201|FG001|NOT COMPLETED|Overall Study||0
10773473|NCT03300752|11936209|FG000|STARTED|Overall Study||40
10773474|NCT03300752|11936210|FG001|STARTED|Overall Study||40
10773475|NCT03300752|11936209|FG000|COMPLETED|Overall Study||38
10773476|NCT03300752|11936210|FG001|COMPLETED|Overall Study||38
10773477|NCT03300752|11936209|FG000|NOT COMPLETED|Overall Study||2
10773478|NCT03300752|11936210|FG001|NOT COMPLETED|Overall Study||2
10773479|NCT03300843|11936216|FG000|STARTED|Overall Study||1
10773480|NCT03300843|11936216|FG000|COMPLETED|Overall Study||1
10773481|NCT03300843|11936216|FG000|NOT COMPLETED|Overall Study||0
10773482|NCT03301155|11936222|FG000|STARTED|Overall Study||528
10773483|NCT03301155|11936223|FG001|STARTED|Overall Study||508
10773484|NCT03301155|11936222|FG000|COMPLETED|Overall Study||520
10773485|NCT03301155|11936223|FG001|COMPLETED|Overall Study||501
10773486|NCT03301155|11936222|FG000|NOT COMPLETED|Overall Study||8
10773487|NCT03301155|11936223|FG001|NOT COMPLETED|Overall Study||7
10773488|NCT03301272|11936231|FG000|STARTED|First Intervention (30 Days)||7
10773489|NCT03301272|11936232|FG001|STARTED|First Intervention (30 Days)||9
10773490|NCT03301272|11936231|FG000|COMPLETED|First Intervention (30 Days)||7
10773491|NCT03301272|11936232|FG001|COMPLETED|First Intervention (30 Days)||9
10773492|NCT03301272|11936231|FG000|NOT COMPLETED|First Intervention (30 Days)||0
10773493|NCT03301272|11936232|FG001|NOT COMPLETED|First Intervention (30 Days)||0
10773494|NCT03301272|11936231|FG000|STARTED|Washout (90 Days From 1st Intervention)||7
10773495|NCT03301272|11936232|FG001|STARTED|Washout (90 Days From 1st Intervention)||9
10773496|NCT03301272|11936231|FG000|COMPLETED|Washout (90 Days From 1st Intervention)||7
10773497|NCT03301272|11936232|FG001|COMPLETED|Washout (90 Days From 1st Intervention)||9
10773498|NCT03301272|11936231|FG000|NOT COMPLETED|Washout (90 Days From 1st Intervention)||0
10773499|NCT03301272|11936232|FG001|NOT COMPLETED|Washout (90 Days From 1st Intervention)||0
10773500|NCT03301272|11936231|FG000|STARTED|Second Intervention (30 Days)||7
10773501|NCT03301272|11936232|FG001|STARTED|Second Intervention (30 Days)||9
10773502|NCT03301272|11936231|FG000|COMPLETED|Second Intervention (30 Days)||7
10773503|NCT03301272|11936232|FG001|COMPLETED|Second Intervention (30 Days)||9
10773504|NCT03301272|11936231|FG000|NOT COMPLETED|Second Intervention (30 Days)||0
10773505|NCT03301272|11936232|FG001|NOT COMPLETED|Second Intervention (30 Days)||0
10773506|NCT03301298|11936245|FG000|STARTED|Unfed Conditions||6
10773507|NCT03301298|11936246|FG001|STARTED|Unfed Conditions||6
10773508|NCT03301298|11936247|FG002|STARTED|Unfed Conditions||6
10773509|NCT03301298|11936248|FG003|STARTED|Unfed Conditions||6
10773510|NCT03301298|11936249|FG004|STARTED|Unfed Conditions||6
10773511|NCT03301298|11936250|FG005|STARTED|Unfed Conditions||6
10773512|NCT03301298|11936251|FG006|STARTED|Unfed Conditions||12
10773513|NCT03301298|11936245|FG000|COMPLETED|Unfed Conditions||6
10773514|NCT03301298|11936246|FG001|COMPLETED|Unfed Conditions||6
10773515|NCT03301298|11936247|FG002|COMPLETED|Unfed Conditions||6
10773516|NCT03301298|11936248|FG003|COMPLETED|Unfed Conditions||6
10773517|NCT03301298|11936249|FG004|COMPLETED|Unfed Conditions||6
10773518|NCT03301298|11936250|FG005|COMPLETED|Unfed Conditions||6
10773519|NCT03301298|11936251|FG006|COMPLETED|Unfed Conditions||12
10773520|NCT03301298|11936245|FG000|NOT COMPLETED|Unfed Conditions||0
10773521|NCT03301298|11936246|FG001|NOT COMPLETED|Unfed Conditions||0
10773522|NCT03301298|11936247|FG002|NOT COMPLETED|Unfed Conditions||0
10773523|NCT03301298|11936248|FG003|NOT COMPLETED|Unfed Conditions||0
10773524|NCT03301298|11936249|FG004|NOT COMPLETED|Unfed Conditions||0
10773525|NCT03301298|11936250|FG005|NOT COMPLETED|Unfed Conditions||0
10773526|NCT03301298|11936251|FG006|NOT COMPLETED|Unfed Conditions||0
10773527|NCT03301298|11936245|FG000|STARTED|Fed Conditions||0
10773528|NCT03301298|11936246|FG001|STARTED|Fed Conditions||0
10773529|NCT03301298|11936247|FG002|STARTED|Fed Conditions||0
10773530|NCT03301298|11936248|FG003|STARTED|Fed Conditions||0
10773531|NCT03301298|11936249|FG004|STARTED|Fed Conditions||5
10773532|NCT03301298|11936250|FG005|STARTED|Fed Conditions||0
10773533|NCT03301298|11936251|FG006|STARTED|Fed Conditions||2
10773534|NCT03301298|11936245|FG000|COMPLETED|Fed Conditions||0
10773535|NCT03301298|11936246|FG001|COMPLETED|Fed Conditions||0
10773536|NCT03301298|11936247|FG002|COMPLETED|Fed Conditions||0
10773537|NCT03301298|11936248|FG003|COMPLETED|Fed Conditions||0
10773538|NCT03301298|11936249|FG004|COMPLETED|Fed Conditions||5
10773539|NCT03301298|11936250|FG005|COMPLETED|Fed Conditions||0
10773540|NCT03301298|11936251|FG006|COMPLETED|Fed Conditions||2
10773541|NCT03301298|11936245|FG000|NOT COMPLETED|Fed Conditions||0
10773542|NCT03301298|11936246|FG001|NOT COMPLETED|Fed Conditions||0
10773543|NCT03301298|11936247|FG002|NOT COMPLETED|Fed Conditions||0
10773544|NCT03301298|11936248|FG003|NOT COMPLETED|Fed Conditions||0
10773545|NCT03301298|11936249|FG004|NOT COMPLETED|Fed Conditions||0
10773546|NCT03301298|11936250|FG005|NOT COMPLETED|Fed Conditions||0
10773547|NCT03301298|11936251|FG006|NOT COMPLETED|Fed Conditions||0
10773548|NCT03301623|11936270|FG000|STARTED|Overall Study||462
10773549|NCT03301623|11936271|FG001|STARTED|Overall Study||521
10773550|NCT03301623|11936270|FG000|COMPLETED|Overall Study||445
10773551|NCT03301623|11936271|FG001|COMPLETED|Overall Study||506
10773552|NCT03301623|11936270|FG000|NOT COMPLETED|Overall Study||17
10773553|NCT03301623|11936271|FG001|NOT COMPLETED|Overall Study||15
10773554|NCT03301649|11936280|FG000|STARTED|Overall Study||399
10773555|NCT03301649|11936281|FG001|STARTED|Overall Study||400
10773556|NCT03301649|11936282|FG002|STARTED|Overall Study||112
10773557|NCT03301649|11936280|FG000|Safety Population|Overall Study||399
10773558|NCT03301649|11936281|FG001|Safety Population|Overall Study||400
10773559|NCT03301649|11936282|FG002|Safety Population|Overall Study||112
10779385|NCT03365154|11940969|FG000|STARTED|Overall Study||10
10773560|NCT03301649|11936280|FG000|Modified Intent-to-treat(mITT)Population|Overall Study||372
10773561|NCT03301649|11936281|FG001|Modified Intent-to-treat(mITT)Population|Overall Study||380
10773562|NCT03301649|11936282|FG002|Modified Intent-to-treat(mITT)Population|Overall Study||111
10773563|NCT03301649|11936280|FG000|Per-protocol (PP) Population|Overall Study||345
10773564|NCT03301649|11936281|FG001|Per-protocol (PP) Population|Overall Study||354
10773565|NCT03301649|11936282|FG002|Per-protocol (PP) Population|Overall Study||103
10773566|NCT03301649|11936280|FG000|COMPLETED|Overall Study||356
10773567|NCT03301649|11936281|FG001|COMPLETED|Overall Study||356
10773568|NCT03301649|11936282|FG002|COMPLETED|Overall Study||27
10773569|NCT03301649|11936280|FG000|NOT COMPLETED|Overall Study||43
10773570|NCT03301649|11936281|FG001|NOT COMPLETED|Overall Study||44
10773571|NCT03301649|11936282|FG002|NOT COMPLETED|Overall Study||85
10773572|NCT03301714|11936293|FG000|STARTED|Overall Study||60
10773573|NCT03301714|11936294|FG001|STARTED|Overall Study||60
10773574|NCT03301714|11936295|FG002|STARTED|Overall Study||60
10773575|NCT03301714|11936293|FG000|COMPLETED|Overall Study||50
10773576|NCT03301714|11936294|FG001|COMPLETED|Overall Study||54
10773577|NCT03301714|11936295|FG002|COMPLETED|Overall Study||53
10773578|NCT03301714|11936293|FG000|NOT COMPLETED|Overall Study||10
10773579|NCT03301714|11936294|FG001|NOT COMPLETED|Overall Study||6
10773580|NCT03301714|11936295|FG002|NOT COMPLETED|Overall Study||7
10773581|NCT03301740|11936308|FG000|STARTED|Phase 1 Intervention (3 Weeks)||18
10773582|NCT03301740|11936309|FG001|STARTED|Phase 1 Intervention (3 Weeks)||16
10773583|NCT03301740|11936308|FG000|COMPLETED|Phase 1 Intervention (3 Weeks)||18
10773584|NCT03301740|11936309|FG001|COMPLETED|Phase 1 Intervention (3 Weeks)||16
10773585|NCT03301740|11936308|FG000|NOT COMPLETED|Phase 1 Intervention (3 Weeks)||0
10773586|NCT03301740|11936309|FG001|NOT COMPLETED|Phase 1 Intervention (3 Weeks)||0
10773587|NCT03301740|11936308|FG000|STARTED|First Washout (1 Week)||18
10773588|NCT03301740|11936309|FG001|STARTED|First Washout (1 Week)||16
10773589|NCT03301740|11936308|FG000|COMPLETED|First Washout (1 Week)||18
10773590|NCT03301740|11936309|FG001|COMPLETED|First Washout (1 Week)||16
10773591|NCT03301740|11936308|FG000|NOT COMPLETED|First Washout (1 Week)||0
10773592|NCT03301740|11936309|FG001|NOT COMPLETED|First Washout (1 Week)||0
10773593|NCT03301740|11936308|FG000|STARTED|Phase 2 Intervention (3 Weeks)||18
10773594|NCT03301740|11936309|FG001|STARTED|Phase 2 Intervention (3 Weeks)||16
10773595|NCT03301740|11936308|FG000|COMPLETED|Phase 2 Intervention (3 Weeks)||17
10773596|NCT03301740|11936309|FG001|COMPLETED|Phase 2 Intervention (3 Weeks)||16
10773597|NCT03301740|11936308|FG000|NOT COMPLETED|Phase 2 Intervention (3 Weeks)||1
10773598|NCT03301740|11936309|FG001|NOT COMPLETED|Phase 2 Intervention (3 Weeks)||0
10773599|NCT03301740|11936308|FG000|STARTED|Second Washout (1 Week)||17
10773600|NCT03301740|11936309|FG001|STARTED|Second Washout (1 Week)||16
10773601|NCT03301740|11936308|FG000|COMPLETED|Second Washout (1 Week)||17
10773602|NCT03301740|11936309|FG001|COMPLETED|Second Washout (1 Week)||16
10773603|NCT03301740|11936308|FG000|NOT COMPLETED|Second Washout (1 Week)||0
10773604|NCT03301740|11936309|FG001|NOT COMPLETED|Second Washout (1 Week)||0
10773605|NCT03301740|11936308|FG000|STARTED|Phase 3 Intervention (3 Weeks)||17
10773606|NCT03301740|11936309|FG001|STARTED|Phase 3 Intervention (3 Weeks)||16
10773607|NCT03301740|11936308|FG000|COMPLETED|Phase 3 Intervention (3 Weeks)||17
10773608|NCT03301740|11936309|FG001|COMPLETED|Phase 3 Intervention (3 Weeks)||16
10298031|NCT00006164|11430710|FG000|STARTED|Overall Study||517
10298032|NCT00006164|11430711|FG001|STARTED|Overall Study||533
10298033|NCT00006164|11430710|FG000|COMPLETED|Overall Study|70 Withdrew or were lost to followup; 158 Discontinued peginterferon but were followed|447
10298034|NCT00006164|11430711|FG001|COMPLETED|Overall Study|81 Withdrew or were lost to followup; 9 took peginterferon outside of protocol|452
10298035|NCT00006164|11430710|FG000|NOT COMPLETED|Overall Study||70
10298036|NCT00006164|11430711|FG001|NOT COMPLETED|Overall Study||81
10298037|NCT00006170|11430721|FG000|STARTED|Overall Study||106
10298038|NCT00006170|11430722|FG001|STARTED|Overall Study||87
10298039|NCT00006170|11430723|FG002|STARTED|Overall Study||89
10298040|NCT00006170|11430724|FG003|STARTED|Overall Study||67
10298041|NCT00006170|11430721|FG000|COMPLETED|Overall Study||57
10298042|NCT00006170|11430722|FG001|COMPLETED|Overall Study||37
10298043|NCT00006170|11430723|FG002|COMPLETED|Overall Study||46
10298044|NCT00006170|11430724|FG003|COMPLETED|Overall Study||28
10298045|NCT00006170|11430721|FG000|NOT COMPLETED|Overall Study||49
10298046|NCT00006170|11430722|FG001|NOT COMPLETED|Overall Study||50
10298047|NCT00006170|11430723|FG002|NOT COMPLETED|Overall Study||43
10298048|NCT00006170|11430724|FG003|NOT COMPLETED|Overall Study||39
10315002|NCT00171704|11448755|FG001|STARTED|Overall Study||130
10315003|NCT00171704|11448754|FG000|COMPLETED|Overall Study||89
10315004|NCT00171704|11448755|FG001|COMPLETED|Overall Study||81
10315005|NCT00171704|11448754|FG000|NOT COMPLETED|Overall Study||44
10315006|NCT00171704|11448755|FG001|NOT COMPLETED|Overall Study||49
10315007|NCT00171730|11448761|FG000|STARTED|Overall Study||30
10773609|NCT03301740|11936308|FG000|NOT COMPLETED|Phase 3 Intervention (3 Weeks)||0
10773610|NCT03301740|11936309|FG001|NOT COMPLETED|Phase 3 Intervention (3 Weeks)||0
10773611|NCT03301740|11936308|FG000|STARTED|Third Washout (1 Week)||17
10773612|NCT03301740|11936309|FG001|STARTED|Third Washout (1 Week)||16
10773613|NCT03301740|11936308|FG000|COMPLETED|Third Washout (1 Week)||17
10315008|NCT00171730|11448761|FG000|COMPLETED|Overall Study||15
10315009|NCT00171730|11448761|FG000|NOT COMPLETED|Overall Study||15
10315010|NCT00171834|11448778|FG000|STARTED|Overall Study||6
10315011|NCT00171834|11448779|FG001|STARTED|Overall Study||12
10315012|NCT00171834|11448780|FG002|STARTED|Overall Study||12
10315013|NCT00171834|11448781|FG003|STARTED|Overall Study||12
10315014|NCT00171834|11448782|FG004|STARTED|Overall Study||8
10773614|NCT03301740|11936309|FG001|COMPLETED|Third Washout (1 Week)||16
10773615|NCT03301740|11936308|FG000|NOT COMPLETED|Third Washout (1 Week)||0
10773616|NCT03301740|11936309|FG001|NOT COMPLETED|Third Washout (1 Week)||0
10773617|NCT03301740|11936308|FG000|STARTED|Phase 4 Intervention (3 Weeks)||17
10773618|NCT03301740|11936309|FG001|STARTED|Phase 4 Intervention (3 Weeks)||16
10773619|NCT03301740|11936308|FG000|COMPLETED|Phase 4 Intervention (3 Weeks)||16
10773620|NCT03301740|11936309|FG001|COMPLETED|Phase 4 Intervention (3 Weeks)||16
10773621|NCT03301740|11936308|FG000|NOT COMPLETED|Phase 4 Intervention (3 Weeks)||1
10773622|NCT03301740|11936309|FG001|NOT COMPLETED|Phase 4 Intervention (3 Weeks)||0
10773623|NCT03301779|11936315|FG000|STARTED|Overall Study||48
10773624|NCT03301779|11936316|FG001|STARTED|Overall Study||52
10773625|NCT03301779|11936315|FG000|COMPLETED|Overall Study||40
10773626|NCT03301779|11936316|FG001|COMPLETED|Overall Study||45
10773627|NCT03301779|11936315|FG000|NOT COMPLETED|Overall Study||8
10773628|NCT03301779|11936316|FG001|NOT COMPLETED|Overall Study||7
10773629|NCT03301831|11936324|FG000|STARTED|Overall Study||46
10773630|NCT03301831|11936325|FG001|STARTED|Overall Study||47
10773631|NCT03301831|11936324|FG000|COMPLETED|Overall Study||26
10773632|NCT03301831|11936325|FG001|COMPLETED|Overall Study||44
10773633|NCT03301831|11936324|FG000|NOT COMPLETED|Overall Study||20
10773634|NCT03301831|11936325|FG001|NOT COMPLETED|Overall Study||3
10773635|NCT03301844|11936333|FG000|STARTED|Overall Study|Each patient apply the Blephapad Combo wipes to one eye and standard treatment to the other eye.|19
10773636|NCT03301844|11936334|FG001|STARTED|Overall Study|Each patient apply the Blephapad Combo wipes to one eye and standard treatment to the other eye.|19
10773637|NCT03301844|11936333|FG000|COMPLETED|Overall Study||18
10773638|NCT03301844|11936334|FG001|COMPLETED|Overall Study||18
10773639|NCT03301844|11936333|FG000|NOT COMPLETED|Overall Study||1
10773640|NCT03301844|11936334|FG001|NOT COMPLETED|Overall Study||1
10773641|NCT03302091|11936342|FG000|STARTED|Overall Study||10
10773642|NCT03302091|11936343|FG001|STARTED|Overall Study||10
10773643|NCT03302091|11936342|FG000|COMPLETED|Overall Study||10
10773644|NCT03302091|11936343|FG001|COMPLETED|Overall Study||10
10773645|NCT03302091|11936342|FG000|NOT COMPLETED|Overall Study||0
10773646|NCT03302091|11936343|FG001|NOT COMPLETED|Overall Study||0
10773647|NCT03302416|11936349|FG000|STARTED|Overall Study||19
10773648|NCT03302416|11936349|FG000|COMPLETED|Overall Study||19
10773649|NCT03302416|11936349|FG000|NOT COMPLETED|Overall Study||0
10779230|NCT03364309|11940862|FG003|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
10779231|NCT03364309|11940863|FG004|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
10779232|NCT03364309|11940864|FG005|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
10779233|NCT03364309|11940865|FG006|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
10779234|NCT03364309|11940866|FG007|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
10779235|NCT03364309|11940867|FG008|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
10773650|NCT03302559|11936353|FG000|STARTED|Overall Study||29
10773651|NCT03302559|11936353|FG000|COMPLETED|Overall Study||23
10773652|NCT03302559|11936353|FG000|NOT COMPLETED|Overall Study||6
10773653|NCT03302741|11936359|FG000|STARTED|Overall Study||8
10773654|NCT03302741|11936360|FG001|STARTED|Overall Study||9
10773655|NCT03302741|11936359|FG000|COMPLETED|Overall Study||7
10773656|NCT03302741|11936360|FG001|COMPLETED|Overall Study||8
10773657|NCT03302741|11936359|FG000|NOT COMPLETED|Overall Study||1
10773658|NCT03302741|11936360|FG001|NOT COMPLETED|Overall Study||1
10773659|NCT03302767|11936366|FG000|STARTED|Overall Study||29
10773660|NCT03302767|11936366|FG000|COMPLETED|Overall Study||29
10773661|NCT03302767|11936366|FG000|NOT COMPLETED|Overall Study||0
10773662|NCT03302780|11936370|FG000|STARTED|Overall Study||3
10773663|NCT03302780|11936371|FG001|STARTED|Overall Study||3
10773664|NCT03302780|11936370|FG000|COMPLETED|Overall Study||3
10773665|NCT03302780|11936371|FG001|COMPLETED|Overall Study||3
10773666|NCT03302780|11936370|FG000|NOT COMPLETED|Overall Study||0
10773667|NCT03302780|11936371|FG001|NOT COMPLETED|Overall Study||0
10773668|NCT03302793|11936377|FG000|STARTED|Overall Study||6
10773669|NCT03302793|11936378|FG001|STARTED|Overall Study||6
10773670|NCT03302793|11936377|FG000|COMPLETED|Overall Study||6
10773671|NCT03302793|11936378|FG001|COMPLETED|Overall Study||4
10773672|NCT03302793|11936377|FG000|NOT COMPLETED|Overall Study||0
10773673|NCT03302793|11936378|FG001|NOT COMPLETED|Overall Study||2
10773674|NCT03302936|11936386|FG000|STARTED|Overall Study||49
10773675|NCT03302936|11936387|FG001|STARTED|Overall Study||49
10773676|NCT03302936|11936386|FG000|COMPLETED|Overall Study||46
10773677|NCT03302936|11936387|FG001|COMPLETED|Overall Study||45
10773678|NCT03302936|11936386|FG000|NOT COMPLETED|Overall Study||3
10773679|NCT03302936|11936387|FG001|NOT COMPLETED|Overall Study||4
10773680|NCT03302975|11936397|FG000|STARTED|Overall Study||16
10773681|NCT03302975|11936397|FG000|COMPLETED|Overall Study||12
10773682|NCT03302975|11936397|FG000|NOT COMPLETED|Overall Study||4
10773683|NCT03303079|11936404|FG000|STARTED|Overall Study||189
10773684|NCT03303079|11936405|FG001|STARTED|Overall Study||191
10773685|NCT03303079|11936406|FG002|STARTED|Overall Study||191
10773686|NCT03303079|11936404|FG000|COMPLETED|Overall Study||182
10773687|NCT03303079|11936405|FG001|COMPLETED|Overall Study||180
10773688|NCT03303079|11936406|FG002|COMPLETED|Overall Study||179
10773689|NCT03303079|11936404|FG000|NOT COMPLETED|Overall Study||7
10773690|NCT03303079|11936405|FG001|NOT COMPLETED|Overall Study||11
10773691|NCT03303079|11936406|FG002|NOT COMPLETED|Overall Study||12
10773692|NCT03303092|11936417|FG000|STARTED|Overall Study||121
10773693|NCT03303092|11936418|FG001|STARTED|Overall Study||119
10773694|NCT03303092|11936419|FG002|STARTED|Overall Study||117
10773695|NCT03303092|11936417|FG000|COMPLETED|Overall Study||118
10773696|NCT03303092|11936418|FG001|COMPLETED|Overall Study||113
10773697|NCT03303092|11936419|FG002|COMPLETED|Overall Study||112
10773698|NCT03303092|11936417|FG000|NOT COMPLETED|Overall Study||3
10773699|NCT03303092|11936418|FG001|NOT COMPLETED|Overall Study||6
10773700|NCT03303092|11936419|FG002|NOT COMPLETED|Overall Study||5
10773701|NCT03303105|11936429|FG000|STARTED|Overall Study||25
10773702|NCT03303105|11936430|FG001|STARTED|Overall Study||25
10773703|NCT03303105|11936429|FG000|COMPLETED|Overall Study||23
10773704|NCT03303105|11936430|FG001|COMPLETED|Overall Study||21
10773705|NCT03303105|11936429|FG000|NOT COMPLETED|Overall Study||2
10773706|NCT03303105|11936430|FG001|NOT COMPLETED|Overall Study||4
10773707|NCT03303144|11936436|FG000|STARTED|Triferic Via Hemodialysate (Day 3)||26
10773708|NCT03303144|11936437|FG001|STARTED|Triferic Via Hemodialysate (Day 3)||0
10773709|NCT03303144|11936438|FG002|STARTED|Triferic Via Hemodialysate (Day 3)||0
10773710|NCT03303144|11936436|FG000|COMPLETED|Triferic Via Hemodialysate (Day 3)||26
10773711|NCT03303144|11936437|FG001|COMPLETED|Triferic Via Hemodialysate (Day 3)||0
10773712|NCT03303144|11936438|FG002|COMPLETED|Triferic Via Hemodialysate (Day 3)||0
10773713|NCT03303144|11936436|FG000|NOT COMPLETED|Triferic Via Hemodialysate (Day 3)||0
10773714|NCT03303144|11936437|FG001|NOT COMPLETED|Triferic Via Hemodialysate (Day 3)||0
10773715|NCT03303144|11936438|FG002|NOT COMPLETED|Triferic Via Hemodialysate (Day 3)||0
10773716|NCT03303144|11936436|FG000|STARTED|Triferic Via IV Infusion (Day 8)||0
10773717|NCT03303144|11936437|FG001|STARTED|Triferic Via IV Infusion (Day 8)||26
10773718|NCT03303144|11936438|FG002|STARTED|Triferic Via IV Infusion (Day 8)||0
10773719|NCT03303144|11936436|FG000|COMPLETED|Triferic Via IV Infusion (Day 8)||0
10773720|NCT03303144|11936437|FG001|COMPLETED|Triferic Via IV Infusion (Day 8)||25
10773721|NCT03303144|11936438|FG002|COMPLETED|Triferic Via IV Infusion (Day 8)||0
10773722|NCT03303144|11936436|FG000|NOT COMPLETED|Triferic Via IV Infusion (Day 8)||0
10773723|NCT03303144|11936437|FG001|NOT COMPLETED|Triferic Via IV Infusion (Day 8)||1
10773724|NCT03303144|11936438|FG002|NOT COMPLETED|Triferic Via IV Infusion (Day 8)||0
10773725|NCT03303144|11936436|FG000|STARTED|Triferic Via IV Infusion (Day 10)||0
10773726|NCT03303144|11936437|FG001|STARTED|Triferic Via IV Infusion (Day 10)||0
10773727|NCT03303144|11936438|FG002|STARTED|Triferic Via IV Infusion (Day 10)||26
10773728|NCT03303144|11936436|FG000|COMPLETED|Triferic Via IV Infusion (Day 10)||0
10773729|NCT03303144|11936437|FG001|COMPLETED|Triferic Via IV Infusion (Day 10)||0
10773730|NCT03303144|11936438|FG002|COMPLETED|Triferic Via IV Infusion (Day 10)||25
10773731|NCT03303144|11936436|FG000|NOT COMPLETED|Triferic Via IV Infusion (Day 10)||0
10773732|NCT03303144|11936437|FG001|NOT COMPLETED|Triferic Via IV Infusion (Day 10)||0
10773733|NCT03303144|11936438|FG002|NOT COMPLETED|Triferic Via IV Infusion (Day 10)||1
10773734|NCT03303196|11936449|FG000|STARTED|Overall Study|Individuals who were assigned to BHBP admission then SC admission.|5
10773735|NCT03303196|11936450|FG001|STARTED|Overall Study|Individuals who were assigned to SC admission then BHBP admission.|5
10773736|NCT03303196|11936449|FG000|Washout|Overall Study||5
10773737|NCT03303196|11936450|FG001|Washout|Overall Study||5
10773738|NCT03303196|11936449|FG000|COMPLETED|Overall Study||5
10773739|NCT03303196|11936450|FG001|COMPLETED|Overall Study||5
10773740|NCT03303196|11936449|FG000|NOT COMPLETED|Overall Study||0
10773741|NCT03303196|11936450|FG001|NOT COMPLETED|Overall Study||0
10773742|NCT03303404|11936455|FG000|STARTED|Overall Study||22
10773743|NCT03303404|11936455|FG000|COMPLETED|Overall Study||22
10773744|NCT03303404|11936455|FG000|NOT COMPLETED|Overall Study||0
10773745|NCT03303417|11936459|FG000|STARTED|Overall Study||8
10773746|NCT03303417|11936460|FG001|STARTED|Overall Study||8
10773747|NCT03303417|11936459|FG000|COMPLETED|Overall Study||7
10773748|NCT03303417|11936460|FG001|COMPLETED|Overall Study||7
10773749|NCT03303417|11936459|FG000|NOT COMPLETED|Overall Study||1
10773750|NCT03303417|11936460|FG001|NOT COMPLETED|Overall Study||1
10773751|NCT03303521|11936468|FG000|STARTED|Overall Study||97
10773752|NCT03303521|11936469|FG001|STARTED|Overall Study||99
10773753|NCT03303521|11936468|FG000|COMPLETED|Overall Study||92
10773754|NCT03303521|11936469|FG001|COMPLETED|Overall Study||96
10773755|NCT03303521|11936468|FG000|NOT COMPLETED|Overall Study||5
10773756|NCT03303521|11936469|FG001|NOT COMPLETED|Overall Study||3
10773757|NCT03303794|11936477|FG000|STARTED|Overall Study||13
10773758|NCT03303794|11936478|FG001|STARTED|Overall Study||12
10773759|NCT03303794|11936477|FG000|COMPLETED|Overall Study||13
10773760|NCT03303794|11936478|FG001|COMPLETED|Overall Study||12
10773761|NCT03303794|11936477|FG000|NOT COMPLETED|Overall Study||0
10773762|NCT03303794|11936478|FG001|NOT COMPLETED|Overall Study||0
10773763|NCT03303911|11936486|FG000|STARTED|Overall Study||13
10773764|NCT03303911|11936487|FG001|STARTED|Overall Study||13
10773765|NCT03303911|11936486|FG000|COMPLETED|Overall Study||13
10773766|NCT03303911|11936487|FG001|COMPLETED|Overall Study||13
10773767|NCT03303911|11936486|FG000|NOT COMPLETED|Overall Study||0
10773768|NCT03303911|11936487|FG001|NOT COMPLETED|Overall Study||0
10773769|NCT03304054|11936496|FG000|STARTED|Overall Study||27
10773770|NCT03304054|11936497|FG001|STARTED|Overall Study||7
10773771|NCT03304054|11936498|FG002|STARTED|Overall Study||28
10773772|NCT03304054|11936499|FG003|STARTED|Overall Study||8
10773773|NCT03304054|11936500|FG004|STARTED|Overall Study||17
10773774|NCT03304054|11936501|FG005|STARTED|Overall Study||6
10773775|NCT03304054|11936496|FG000|COMPLETED|Overall Study||27
10773776|NCT03304054|11936497|FG001|COMPLETED|Overall Study||7
10773777|NCT03304054|11936498|FG002|COMPLETED|Overall Study||27
10773778|NCT03304054|11936499|FG003|COMPLETED|Overall Study||8
10773779|NCT03304054|11936500|FG004|COMPLETED|Overall Study||0
10773780|NCT03304054|11936501|FG005|COMPLETED|Overall Study||0
10773781|NCT03304054|11936496|FG000|NOT COMPLETED|Overall Study||0
10773782|NCT03304054|11936497|FG001|NOT COMPLETED|Overall Study||0
10773783|NCT03304054|11936498|FG002|NOT COMPLETED|Overall Study||1
10773784|NCT03304054|11936499|FG003|NOT COMPLETED|Overall Study||0
10773785|NCT03304054|11936500|FG004|NOT COMPLETED|Overall Study||17
10773786|NCT03304054|11936501|FG005|NOT COMPLETED|Overall Study||6
10773787|NCT03304106|11936512|FG000|STARTED|Overall Study||44
10773788|NCT03304106|11936513|FG001|STARTED|Overall Study||58
10773789|NCT03304106|11936512|FG000|COMPLETED|Overall Study||31
10773790|NCT03304106|11936513|FG001|COMPLETED|Overall Study||56
10773791|NCT03304106|11936512|FG000|NOT COMPLETED|Overall Study||13
10773792|NCT03304106|11936513|FG001|NOT COMPLETED|Overall Study||2
10773793|NCT03304119|11936521|FG000|STARTED|Overall Study||37
10773794|NCT03304119|11936522|FG001|STARTED|Overall Study||55
10773795|NCT03304119|11936521|FG000|COMPLETED|Overall Study||37
10773796|NCT03304119|11936522|FG001|COMPLETED|Overall Study||55
10773797|NCT03304119|11936521|FG000|NOT COMPLETED|Overall Study||0
10773798|NCT03304119|11936522|FG001|NOT COMPLETED|Overall Study||0
10773799|NCT03304184|11936530|FG000|STARTED|Overall Study||15
10773800|NCT03304184|11936531|FG001|STARTED|Overall Study||9
10773801|NCT03304184|11936530|FG000|COMPLETED|Overall Study||14
10773802|NCT03304184|11936531|FG001|COMPLETED|Overall Study||7
10773803|NCT03304184|11936530|FG000|NOT COMPLETED|Overall Study||1
10773804|NCT03304184|11936531|FG001|NOT COMPLETED|Overall Study||2
10773805|NCT03304522|11936540|FG000|STARTED|Overall Study||46
10773806|NCT03304522|11936541|FG001|STARTED|Overall Study||43
10773807|NCT03304522|11936540|FG000|COMPLETED|Overall Study||45
10773808|NCT03304522|11936541|FG001|COMPLETED|Overall Study||35
10773809|NCT03304522|11936540|FG000|NOT COMPLETED|Overall Study||1
10773810|NCT03304522|11936541|FG001|NOT COMPLETED|Overall Study||8
10773811|NCT03304626|11936549|FG000|STARTED|Overall Study||20
10773812|NCT03304626|11936550|FG001|STARTED|Overall Study||20
10773813|NCT03304626|11936549|FG000|COMPLETED|Overall Study||18
10773814|NCT03304626|11936550|FG001|COMPLETED|Overall Study||19
10773815|NCT03304626|11936549|FG000|NOT COMPLETED|Overall Study||2
10773816|NCT03304626|11936550|FG001|NOT COMPLETED|Overall Study||1
10773817|NCT03304873|11936559|FG000|STARTED|Overall Study||23
10773818|NCT03304873|11936560|FG001|STARTED|Overall Study||24
10773819|NCT03304873|11936559|FG000|COMPLETED|Overall Study||22
10773820|NCT03304873|11936560|FG001|COMPLETED|Overall Study||16
10773821|NCT03304873|11936559|FG000|NOT COMPLETED|Overall Study||1
10773822|NCT03304873|11936560|FG001|NOT COMPLETED|Overall Study||8
10773823|NCT03305081|11936568|FG000|STARTED|Overall Study||25
10773824|NCT03305081|11936569|FG001|STARTED|Overall Study||20
10773825|NCT03305081|11936568|FG000|COMPLETED|Overall Study||15
10773826|NCT03305081|11936569|FG001|COMPLETED|Overall Study||5
10773827|NCT03305081|11936568|FG000|NOT COMPLETED|Overall Study||10
10773828|NCT03305081|11936569|FG001|NOT COMPLETED|Overall Study||15
10773829|NCT03305159|11936577|FG000|STARTED|Overall Study||66
10773830|NCT03305159|11936578|FG001|STARTED|Overall Study||68
10773831|NCT03305159|11936577|FG000|COMPLETED|Overall Study||63
10773832|NCT03305159|11936578|FG001|COMPLETED|Overall Study||60
10773833|NCT03305159|11936577|FG000|NOT COMPLETED|Overall Study||3
10773834|NCT03305159|11936578|FG001|NOT COMPLETED|Overall Study||8
10773835|NCT03305419|11936592|FG000|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
10773836|NCT03305419|11936593|FG001|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
10773837|NCT03305419|11936594|FG002|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
10773838|NCT03305419|11936595|FG003|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
10773839|NCT03305419|11936596|FG004|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
10773840|NCT03305419|11936597|FG005|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
10773841|NCT03305419|11936598|FG006|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
10773842|NCT03305419|11936599|FG007|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
10773843|NCT03305419|11936592|FG000|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||3
10773844|NCT03305419|11936593|FG001|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||2
10773845|NCT03305419|11936594|FG002|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||3
10773846|NCT03305419|11936595|FG003|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||3
10773847|NCT03305419|11936596|FG004|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
10773848|NCT03305419|11936597|FG005|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
10773849|NCT03305419|11936598|FG006|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
10773850|NCT03305419|11936599|FG007|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
10773851|NCT03305419|11936592|FG000|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
10773852|NCT03305419|11936593|FG001|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||1
10773853|NCT03305419|11936594|FG002|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
10773854|NCT03305419|11936595|FG003|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
10773855|NCT03305419|11936596|FG004|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
10773856|NCT03305419|11936597|FG005|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
10773857|NCT03305419|11936598|FG006|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
10773858|NCT03305419|11936599|FG007|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
10773859|NCT03305419|11936592|FG000|STARTED|Part A Period 2 (1Day) + Washout (7days)||3
10773860|NCT03305419|11936593|FG001|STARTED|Part A Period 2 (1Day) + Washout (7days)|1 participant was added to GSK2982772 120 mg TID/240 mg TID/Placebo arm|3
10773861|NCT03305419|11936594|FG002|STARTED|Part A Period 2 (1Day) + Washout (7days)||3
10773862|NCT03305419|11936595|FG003|STARTED|Part A Period 2 (1Day) + Washout (7days)||3
10773863|NCT03305419|11936596|FG004|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
10773864|NCT03305419|11936597|FG005|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
10773865|NCT03305419|11936598|FG006|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
10773866|NCT03305419|11936599|FG007|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
10773867|NCT03305419|11936592|FG000|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||1
10773868|NCT03305419|11936593|FG001|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||3
10773869|NCT03305419|11936594|FG002|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||3
10773870|NCT03305419|11936595|FG003|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||3
10773871|NCT03305419|11936596|FG004|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
10773872|NCT03305419|11936597|FG005|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
10773873|NCT03305419|11936598|FG006|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
10773874|NCT03305419|11936599|FG007|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
10773875|NCT03305419|11936592|FG000|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||2
10773876|NCT03305419|11936593|FG001|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
10773877|NCT03305419|11936594|FG002|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
10773878|NCT03305419|11936595|FG003|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
10773879|NCT03305419|11936596|FG004|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
10773880|NCT03305419|11936597|FG005|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
10773881|NCT03305419|11936598|FG006|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
10773882|NCT03305419|11936599|FG007|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
10773883|NCT03305419|11936592|FG000|STARTED|Part A Period 3 (1Day) + Washout (7days)|2 participants were added to GSK2982772 120 mg TID/240 mg TID/360 mg BID arm after Washout Period.|3
10773884|NCT03305419|11936593|FG001|STARTED|Part A Period 3 (1Day) + Washout (7days)||3
10773885|NCT03305419|11936594|FG002|STARTED|Part A Period 3 (1Day) + Washout (7days)||3
10773886|NCT03305419|11936595|FG003|STARTED|Part A Period 3 (1Day) + Washout (7days)||3
10773887|NCT03305419|11936596|FG004|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
10773888|NCT03305419|11936597|FG005|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
10773889|NCT03305419|11936598|FG006|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
10773890|NCT03305419|11936599|FG007|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
10773891|NCT03305419|11936592|FG000|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
10773892|NCT03305419|11936593|FG001|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
10773893|NCT03305419|11936594|FG002|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
10773894|NCT03305419|11936595|FG003|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
10773895|NCT03305419|11936596|FG004|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
10773896|NCT03305419|11936597|FG005|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
10773897|NCT03305419|11936598|FG006|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
10773898|NCT03305419|11936599|FG007|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
10773899|NCT03305419|11936592|FG000|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
10773900|NCT03305419|11936593|FG001|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
10773901|NCT03305419|11936594|FG002|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
10773902|NCT03305419|11936595|FG003|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
10773903|NCT03305419|11936596|FG004|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
10773904|NCT03305419|11936597|FG005|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
10773905|NCT03305419|11936598|FG006|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
10773906|NCT03305419|11936599|FG007|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
10773907|NCT03305419|11936592|FG000|STARTED|Part B (14 Days)||0
10773908|NCT03305419|11936593|FG001|STARTED|Part B (14 Days)||0
10773909|NCT03305419|11936594|FG002|STARTED|Part B (14 Days)||0
10773910|NCT03305419|11936595|FG003|STARTED|Part B (14 Days)||0
10773911|NCT03305419|11936596|FG004|STARTED|Part B (14 Days)||14
10773912|NCT03305419|11936597|FG005|STARTED|Part B (14 Days)||20
10773913|NCT03305419|11936598|FG006|STARTED|Part B (14 Days)||13
10773914|NCT03305419|11936599|FG007|STARTED|Part B (14 Days)||0
10773915|NCT03305419|11936592|FG000|COMPLETED|Part B (14 Days)||0
10773916|NCT03305419|11936593|FG001|COMPLETED|Part B (14 Days)||0
10773917|NCT03305419|11936594|FG002|COMPLETED|Part B (14 Days)||0
10773918|NCT03305419|11936595|FG003|COMPLETED|Part B (14 Days)||0
10773919|NCT03305419|11936596|FG004|COMPLETED|Part B (14 Days)||11
10773920|NCT03305419|11936597|FG005|COMPLETED|Part B (14 Days)||10
10773921|NCT03305419|11936598|FG006|COMPLETED|Part B (14 Days)||8
10773922|NCT03305419|11936599|FG007|COMPLETED|Part B (14 Days)||0
10773923|NCT03305419|11936592|FG000|NOT COMPLETED|Part B (14 Days)||0
10773924|NCT03305419|11936593|FG001|NOT COMPLETED|Part B (14 Days)||0
10773925|NCT03305419|11936594|FG002|NOT COMPLETED|Part B (14 Days)||0
10773926|NCT03305419|11936595|FG003|NOT COMPLETED|Part B (14 Days)||0
10773927|NCT03305419|11936596|FG004|NOT COMPLETED|Part B (14 Days)||3
10773928|NCT03305419|11936597|FG005|NOT COMPLETED|Part B (14 Days)||10
10773929|NCT03305419|11936598|FG006|NOT COMPLETED|Part B (14 Days)||5
10773930|NCT03305419|11936599|FG007|NOT COMPLETED|Part B (14 Days)||0
10773931|NCT03305575|11936624|FG000|STARTED|Overall Study||5
10773932|NCT03305575|11936625|FG001|STARTED|Overall Study||5
10773933|NCT03305575|11936624|FG000|COMPLETED|Overall Study||4
10773934|NCT03305575|11936625|FG001|COMPLETED|Overall Study||5
10773935|NCT03305575|11936624|FG000|NOT COMPLETED|Overall Study||1
10773936|NCT03305575|11936625|FG001|NOT COMPLETED|Overall Study||0
10773937|NCT03305653|11936631|FG000|STARTED|Overall Study||21
10773938|NCT03305653|11936631|FG000|COMPLETED|Overall Study||21
10773939|NCT03305653|11936631|FG000|NOT COMPLETED|Overall Study||0
10773940|NCT03305666|11936637|FG000|STARTED|Overall Study||18
10773941|NCT03305666|11936638|FG001|STARTED|Overall Study||18
10773942|NCT03305666|11936637|FG000|COMPLETED|Overall Study||16
10773943|NCT03305666|11936638|FG001|COMPLETED|Overall Study||18
10773944|NCT03305666|11936637|FG000|NOT COMPLETED|Overall Study||2
10773945|NCT03305666|11936638|FG001|NOT COMPLETED|Overall Study||0
10773946|NCT03305731|11936644|FG000|STARTED|Overall Study||21
10773947|NCT03305731|11936644|FG000|Week 6|Overall Study||20
10773948|NCT03305731|11936644|FG000|Week 11|Overall Study||20
10773949|NCT03305731|11936644|FG000|COMPLETED|Overall Study||20
10773950|NCT03305731|11936644|FG000|NOT COMPLETED|Overall Study||1
10773951|NCT03305770|11936650|FG000|STARTED|Overall Study||70
10773952|NCT03305770|11936651|FG001|STARTED|Overall Study||37
10773953|NCT03305770|11936650|FG000|Enrolled Dispensed Analysis Set|Overall Study||70
10773954|NCT03305770|11936651|FG001|Enrolled Dispensed Analysis Set|Overall Study||36
10773955|NCT03305770|11936650|FG000|Completed Analysis Set|Overall Study||69
10773956|NCT03305770|11936651|FG001|Completed Analysis Set|Overall Study||36
10773957|NCT03305770|11936650|FG000|COMPLETED|Overall Study||69
10773958|NCT03305770|11936651|FG001|COMPLETED|Overall Study||36
10773959|NCT03305770|11936650|FG000|NOT COMPLETED|Overall Study||1
10773960|NCT03305770|11936651|FG001|NOT COMPLETED|Overall Study||1
10773961|NCT03305809|11936663|FG000|STARTED|Overall Study||86
10773962|NCT03305809|11936664|FG001|STARTED|Overall Study||86
10773963|NCT03305809|11936665|FG002|STARTED|Overall Study||85
10773964|NCT03305809|11936666|FG003|STARTED|Overall Study||87
10773965|NCT03305809|11936663|FG000|Received at Least One Dose of Study Drug|Overall Study||86
10773966|NCT03305809|11936664|FG001|Received at Least One Dose of Study Drug|Overall Study||86
10773967|NCT03305809|11936665|FG002|Received at Least One Dose of Study Drug|Overall Study||85
10773968|NCT03305809|11936666|FG003|Received at Least One Dose of Study Drug|Overall Study||87
10773969|NCT03305809|11936663|FG000|COMPLETED|Overall Study||79
10773970|NCT03305809|11936664|FG001|COMPLETED|Overall Study||78
10773971|NCT03305809|11936665|FG002|COMPLETED|Overall Study||66
10773972|NCT03305809|11936666|FG003|COMPLETED|Overall Study||60
10773973|NCT03305809|11936663|FG000|NOT COMPLETED|Overall Study||7
10773974|NCT03305809|11936664|FG001|NOT COMPLETED|Overall Study||8
10773975|NCT03305809|11936665|FG002|NOT COMPLETED|Overall Study||19
10773976|NCT03305809|11936666|FG003|NOT COMPLETED|Overall Study||27
10773977|NCT03305822|11936679|FG000|STARTED|Period 1||20
10773978|NCT03305822|11936680|FG001|STARTED|Period 1||18
10773979|NCT03305822|11936679|FG000|Received at Least 1 Dose of Study Drug|Period 1||20
10773980|NCT03305822|11936680|FG001|Received at Least 1 Dose of Study Drug|Period 1||18
10773981|NCT03305822|11936679|FG000|COMPLETED|Period 1||20
10773982|NCT03305822|11936680|FG001|COMPLETED|Period 1||18
10773983|NCT03305822|11936679|FG000|NOT COMPLETED|Period 1||0
10773984|NCT03305822|11936680|FG001|NOT COMPLETED|Period 1||0
10773985|NCT03305822|11936679|FG000|STARTED|Washout|Cross-over study. All participants from Period 1 went on to Washout and Period 2.|20
10773986|NCT03305822|11936680|FG001|STARTED|Washout|Cross-over study. All participants from Period 1 went on to Washout and Period 2.|18
10773987|NCT03305822|11936679|FG000|COMPLETED|Washout||20
10773988|NCT03305822|11936680|FG001|COMPLETED|Washout||18
10773989|NCT03305822|11936679|FG000|NOT COMPLETED|Washout||0
10773990|NCT03305822|11936680|FG001|NOT COMPLETED|Washout||0
10773991|NCT03305822|11936679|FG000|STARTED|Period 2||20
10773992|NCT03305822|11936680|FG001|STARTED|Period 2||18
10773993|NCT03305822|11936679|FG000|Received at Least 1 Dose of Study Drug|Period 2||20
10773994|NCT03305822|11936680|FG001|Received at Least 1 Dose of Study Drug|Period 2||18
10773995|NCT03305822|11936679|FG000|COMPLETED|Period 2||20
10773996|NCT03305822|11936680|FG001|COMPLETED|Period 2||18
10773997|NCT03305822|11936679|FG000|NOT COMPLETED|Period 2||0
10773998|NCT03305822|11936680|FG001|NOT COMPLETED|Period 2||0
10773999|NCT03305887|11936688|FG000|STARTED|Overall Study||91
10774000|NCT03305887|11936689|FG001|STARTED|Overall Study||93
10774001|NCT03305887|11936688|FG000|COMPLETED|Overall Study||80
10774002|NCT03305887|11936689|FG001|COMPLETED|Overall Study||83
10774003|NCT03305887|11936688|FG000|NOT COMPLETED|Overall Study||11
10774004|NCT03305887|11936689|FG001|NOT COMPLETED|Overall Study||10
10774005|NCT03306043|11936695|FG000|STARTED|Overall Study||102
10774006|NCT03306043|11936695|FG000|COMPLETED|Overall Study||98
10774007|NCT03306043|11936695|FG000|NOT COMPLETED|Overall Study||4
10774008|NCT03306199|11936699|FG000|STARTED|Overall Study||82
10774009|NCT03306199|11936699|FG000|COMPLETED|Overall Study||67
10774010|NCT03306199|11936699|FG000|NOT COMPLETED|Overall Study||15
10774014|NCT03306420|11936712|FG000|STARTED|Overall Study||3
10774015|NCT03306420|11936713|FG001|STARTED|Overall Study||3
10774016|NCT03306420|11936714|FG002|STARTED|Overall Study||3
10774017|NCT03306420|11936715|FG003|STARTED|Overall Study||3
10774018|NCT03306420|11936716|FG004|STARTED|Overall Study||3
10774019|NCT03306420|11936712|FG000|COMPLETED|Overall Study||3
10774020|NCT03306420|11936713|FG001|COMPLETED|Overall Study||3
10774021|NCT03306420|11936714|FG002|COMPLETED|Overall Study||3
10774022|NCT03306420|11936715|FG003|COMPLETED|Overall Study||3
10774023|NCT03306420|11936716|FG004|COMPLETED|Overall Study||3
10774024|NCT03306420|11936712|FG000|NOT COMPLETED|Overall Study||0
10774025|NCT03306420|11936713|FG001|NOT COMPLETED|Overall Study||0
10774026|NCT03306420|11936714|FG002|NOT COMPLETED|Overall Study||0
10774027|NCT03306420|11936715|FG003|NOT COMPLETED|Overall Study||0
10774028|NCT03306420|11936716|FG004|NOT COMPLETED|Overall Study||0
10774029|NCT03306433|11936728|FG000|STARTED|Overall Study||16
10774030|NCT03306433|11936728|FG000|UDMA-K18|Overall Study||12
10774031|NCT03306433|11936728|FG000|Adhesive Control|Overall Study||12
10774032|NCT03306433|11936728|FG000|UDMA-control|Overall Study||9
10774033|NCT03306433|11936728|FG000|COMPLETED|Overall Study||9
10774034|NCT03306433|11936728|FG000|NOT COMPLETED|Overall Study||7
10774035|NCT03306589|11936742|FG000|STARTED|Part 1 (69 Days)||2
10774036|NCT03306589|11936743|FG001|STARTED|Part 1 (69 Days)||4
10774037|NCT03306589|11936744|FG002|STARTED|Part 1 (69 Days)||2
10774038|NCT03306589|11936745|FG003|STARTED|Part 1 (69 Days)||4
10774039|NCT03306589|11936746|FG004|STARTED|Part 1 (69 Days)||0
10774040|NCT03306589|11936747|FG005|STARTED|Part 1 (69 Days)||0
10774041|NCT03306589|11936742|FG000|COMPLETED|Part 1 (69 Days)||2
10774042|NCT03306589|11936743|FG001|COMPLETED|Part 1 (69 Days)||4
10774043|NCT03306589|11936744|FG002|COMPLETED|Part 1 (69 Days)||2
10774044|NCT03306589|11936745|FG003|COMPLETED|Part 1 (69 Days)||4
10774045|NCT03306589|11936746|FG004|COMPLETED|Part 1 (69 Days)||0
10774046|NCT03306589|11936747|FG005|COMPLETED|Part 1 (69 Days)||0
10774047|NCT03306589|11936742|FG000|NOT COMPLETED|Part 1 (69 Days)||0
10774048|NCT03306589|11936743|FG001|NOT COMPLETED|Part 1 (69 Days)||0
10774049|NCT03306589|11936744|FG002|NOT COMPLETED|Part 1 (69 Days)||0
10774050|NCT03306589|11936745|FG003|NOT COMPLETED|Part 1 (69 Days)||0
10774051|NCT03306589|11936746|FG004|NOT COMPLETED|Part 1 (69 Days)||0
10774052|NCT03306589|11936747|FG005|NOT COMPLETED|Part 1 (69 Days)||0
10774053|NCT03306589|11936742|FG000|STARTED|Part 2 (69 Days)||0
10774054|NCT03306589|11936743|FG001|STARTED|Part 2 (69 Days)||0
10774055|NCT03306589|11936744|FG002|STARTED|Part 2 (69 Days)||0
10774056|NCT03306589|11936745|FG003|STARTED|Part 2 (69 Days)||0
10774057|NCT03306589|11936746|FG004|STARTED|Part 2 (69 Days)||0
10774058|NCT03306589|11936747|FG005|STARTED|Part 2 (69 Days)||0
10774059|NCT03306589|11936742|FG000|COMPLETED|Part 2 (69 Days)||0
10774060|NCT03306589|11936743|FG001|COMPLETED|Part 2 (69 Days)||0
10774061|NCT03306589|11936744|FG002|COMPLETED|Part 2 (69 Days)||0
10774062|NCT03306589|11936745|FG003|COMPLETED|Part 2 (69 Days)||0
10774063|NCT03306589|11936746|FG004|COMPLETED|Part 2 (69 Days)||0
10774064|NCT03306589|11936747|FG005|COMPLETED|Part 2 (69 Days)||0
10774065|NCT03306589|11936742|FG000|NOT COMPLETED|Part 2 (69 Days)||0
10774066|NCT03306589|11936743|FG001|NOT COMPLETED|Part 2 (69 Days)||0
10774067|NCT03306589|11936744|FG002|NOT COMPLETED|Part 2 (69 Days)||0
10774068|NCT03306589|11936745|FG003|NOT COMPLETED|Part 2 (69 Days)||0
10774069|NCT03306589|11936746|FG004|NOT COMPLETED|Part 2 (69 Days)||0
10774070|NCT03306589|11936747|FG005|NOT COMPLETED|Part 2 (69 Days)||0
10774071|NCT03306641|11936763|FG000|STARTED|First Intervention||23
10774072|NCT03306641|11936764|FG001|STARTED|First Intervention||22
10774073|NCT03306641|11936763|FG000|COMPLETED|First Intervention||23
10774074|NCT03306641|11936764|FG001|COMPLETED|First Intervention||22
10774075|NCT03306641|11936763|FG000|NOT COMPLETED|First Intervention||0
10774076|NCT03306641|11936764|FG001|NOT COMPLETED|First Intervention||0
10774077|NCT03306641|11936763|FG000|STARTED|Second Intervention||23
10774078|NCT03306641|11936764|FG001|STARTED|Second Intervention||22
10774079|NCT03306641|11936763|FG000|COMPLETED|Second Intervention||23
10774080|NCT03306641|11936764|FG001|COMPLETED|Second Intervention||22
10774081|NCT03306641|11936763|FG000|NOT COMPLETED|Second Intervention||0
10774082|NCT03306641|11936764|FG001|NOT COMPLETED|Second Intervention||0
10774083|NCT03307005|11936772|FG000|STARTED|Overall Study||3
10774084|NCT03307005|11936773|FG001|STARTED|Overall Study||2
10774085|NCT03307005|11936772|FG000|COMPLETED|Overall Study||3
10774086|NCT03307005|11936773|FG001|COMPLETED|Overall Study||2
10774087|NCT03307005|11936772|FG000|NOT COMPLETED|Overall Study||0
10774088|NCT03307005|11936773|FG001|NOT COMPLETED|Overall Study||0
10774089|NCT03307174|11936783|FG000|STARTED|Overall Study||60
10774090|NCT03307174|11936784|FG001|STARTED|Overall Study||60
10774091|NCT03307174|11936783|FG000|COMPLETED|Overall Study||46
10774092|NCT03307174|11936784|FG001|COMPLETED|Overall Study||53
10774093|NCT03307174|11936783|FG000|NOT COMPLETED|Overall Study||14
10774094|NCT03307174|11936784|FG001|NOT COMPLETED|Overall Study||7
10774095|NCT03307252|11936801|FG000|STARTED|Part 1, Period 1|Participants randomised in Part 1|4
10774096|NCT03307252|11936802|FG001|STARTED|Part 1, Period 1|Participants randomised in Part 1|4
10774097|NCT03307252|11936803|FG002|STARTED|Part 1, Period 1|Participants randomised in Part 1|4
10774098|NCT03307252|11936804|FG003|STARTED|Part 1, Period 1||0
10774099|NCT03307252|11936805|FG004|STARTED|Part 1, Period 1||0
10774100|NCT03307252|11936806|FG005|STARTED|Part 1, Period 1||0
10774101|NCT03307252|11936807|FG006|STARTED|Part 1, Period 1||0
10774102|NCT03307252|11936808|FG007|STARTED|Part 1, Period 1||0
10774103|NCT03307252|11936809|FG008|STARTED|Part 1, Period 1||0
10774104|NCT03307252|11936810|FG009|STARTED|Part 1, Period 1||0
10774105|NCT03307252|11936811|FG010|STARTED|Part 1, Period 1||0
10774106|NCT03307252|11936801|FG000|COMPLETED|Part 1, Period 1||4
10774107|NCT03307252|11936802|FG001|COMPLETED|Part 1, Period 1||4
10774108|NCT03307252|11936803|FG002|COMPLETED|Part 1, Period 1||4
10774109|NCT03307252|11936804|FG003|COMPLETED|Part 1, Period 1||0
10774110|NCT03307252|11936805|FG004|COMPLETED|Part 1, Period 1||0
10774111|NCT03307252|11936806|FG005|COMPLETED|Part 1, Period 1||0
10774112|NCT03307252|11936807|FG006|COMPLETED|Part 1, Period 1||0
10774113|NCT03307252|11936808|FG007|COMPLETED|Part 1, Period 1||0
10774114|NCT03307252|11936809|FG008|COMPLETED|Part 1, Period 1||0
10774115|NCT03307252|11936810|FG009|COMPLETED|Part 1, Period 1||0
10774116|NCT03307252|11936811|FG010|COMPLETED|Part 1, Period 1||0
10774117|NCT03307252|11936801|FG000|NOT COMPLETED|Part 1, Period 1||0
10774118|NCT03307252|11936802|FG001|NOT COMPLETED|Part 1, Period 1||0
10774119|NCT03307252|11936803|FG002|NOT COMPLETED|Part 1, Period 1||0
10774120|NCT03307252|11936804|FG003|NOT COMPLETED|Part 1, Period 1||0
10774121|NCT03307252|11936805|FG004|NOT COMPLETED|Part 1, Period 1||0
10774122|NCT03307252|11936806|FG005|NOT COMPLETED|Part 1, Period 1||0
10774123|NCT03307252|11936807|FG006|NOT COMPLETED|Part 1, Period 1||0
10774124|NCT03307252|11936808|FG007|NOT COMPLETED|Part 1, Period 1||0
10774125|NCT03307252|11936809|FG008|NOT COMPLETED|Part 1, Period 1||0
10774126|NCT03307252|11936810|FG009|NOT COMPLETED|Part 1, Period 1||0
10774127|NCT03307252|11936811|FG010|NOT COMPLETED|Part 1, Period 1||0
10774128|NCT03307252|11936801|FG000|STARTED|Part 1, Washout Period 1 (13 Days)||4
10774129|NCT03307252|11936802|FG001|STARTED|Part 1, Washout Period 1 (13 Days)||4
10774130|NCT03307252|11936803|FG002|STARTED|Part 1, Washout Period 1 (13 Days)||4
10774131|NCT03307252|11936804|FG003|STARTED|Part 1, Washout Period 1 (13 Days)||0
10774132|NCT03307252|11936805|FG004|STARTED|Part 1, Washout Period 1 (13 Days)||0
10774133|NCT03307252|11936806|FG005|STARTED|Part 1, Washout Period 1 (13 Days)||0
10774134|NCT03307252|11936807|FG006|STARTED|Part 1, Washout Period 1 (13 Days)||0
10774135|NCT03307252|11936808|FG007|STARTED|Part 1, Washout Period 1 (13 Days)||0
10774136|NCT03307252|11936809|FG008|STARTED|Part 1, Washout Period 1 (13 Days)||0
10774137|NCT03307252|11936810|FG009|STARTED|Part 1, Washout Period 1 (13 Days)||0
10774138|NCT03307252|11936811|FG010|STARTED|Part 1, Washout Period 1 (13 Days)||0
10774139|NCT03307252|11936801|FG000|COMPLETED|Part 1, Washout Period 1 (13 Days)||4
10774140|NCT03307252|11936802|FG001|COMPLETED|Part 1, Washout Period 1 (13 Days)||4
10774141|NCT03307252|11936803|FG002|COMPLETED|Part 1, Washout Period 1 (13 Days)||4
10774142|NCT03307252|11936804|FG003|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
10774143|NCT03307252|11936805|FG004|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
10774144|NCT03307252|11936806|FG005|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
10774145|NCT03307252|11936807|FG006|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
10774146|NCT03307252|11936808|FG007|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
10774147|NCT03307252|11936809|FG008|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
10774148|NCT03307252|11936810|FG009|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
10774149|NCT03307252|11936811|FG010|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
10774150|NCT03307252|11936801|FG000|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
10774151|NCT03307252|11936802|FG001|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
10774152|NCT03307252|11936803|FG002|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
10774153|NCT03307252|11936804|FG003|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
10774154|NCT03307252|11936805|FG004|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
10774155|NCT03307252|11936806|FG005|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
10774156|NCT03307252|11936807|FG006|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
10774157|NCT03307252|11936808|FG007|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
10774158|NCT03307252|11936809|FG008|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
10774159|NCT03307252|11936810|FG009|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
10774160|NCT03307252|11936811|FG010|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
10774161|NCT03307252|11936801|FG000|STARTED|Part 1, Period 2|Participants randomised in Part 1|4
10774162|NCT03307252|11936802|FG001|STARTED|Part 1, Period 2|Participants randomised in Part 1|4
10774163|NCT03307252|11936803|FG002|STARTED|Part 1, Period 2|Participants randomised in Part 1|4
10774164|NCT03307252|11936804|FG003|STARTED|Part 1, Period 2||0
10774165|NCT03307252|11936805|FG004|STARTED|Part 1, Period 2||0
10774166|NCT03307252|11936806|FG005|STARTED|Part 1, Period 2||0
10774167|NCT03307252|11936807|FG006|STARTED|Part 1, Period 2||0
10774168|NCT03307252|11936808|FG007|STARTED|Part 1, Period 2||0
10774169|NCT03307252|11936809|FG008|STARTED|Part 1, Period 2||0
10774170|NCT03307252|11936810|FG009|STARTED|Part 1, Period 2||0
10774171|NCT03307252|11936811|FG010|STARTED|Part 1, Period 2||0
10774172|NCT03307252|11936801|FG000|COMPLETED|Part 1, Period 2||4
10774173|NCT03307252|11936802|FG001|COMPLETED|Part 1, Period 2||4
10774174|NCT03307252|11936803|FG002|COMPLETED|Part 1, Period 2||4
10774175|NCT03307252|11936804|FG003|COMPLETED|Part 1, Period 2||0
10774176|NCT03307252|11936805|FG004|COMPLETED|Part 1, Period 2||0
10774177|NCT03307252|11936806|FG005|COMPLETED|Part 1, Period 2||0
10774178|NCT03307252|11936807|FG006|COMPLETED|Part 1, Period 2||0
10774179|NCT03307252|11936808|FG007|COMPLETED|Part 1, Period 2||0
10774180|NCT03307252|11936809|FG008|COMPLETED|Part 1, Period 2||0
10774181|NCT03307252|11936810|FG009|COMPLETED|Part 1, Period 2||0
10774182|NCT03307252|11936811|FG010|COMPLETED|Part 1, Period 2||0
10774183|NCT03307252|11936801|FG000|NOT COMPLETED|Part 1, Period 2||0
10774184|NCT03307252|11936802|FG001|NOT COMPLETED|Part 1, Period 2||0
10774185|NCT03307252|11936803|FG002|NOT COMPLETED|Part 1, Period 2||0
10774186|NCT03307252|11936804|FG003|NOT COMPLETED|Part 1, Period 2||0
10774187|NCT03307252|11936805|FG004|NOT COMPLETED|Part 1, Period 2||0
10774188|NCT03307252|11936806|FG005|NOT COMPLETED|Part 1, Period 2||0
10774189|NCT03307252|11936807|FG006|NOT COMPLETED|Part 1, Period 2||0
10774190|NCT03307252|11936808|FG007|NOT COMPLETED|Part 1, Period 2||0
10774191|NCT03307252|11936809|FG008|NOT COMPLETED|Part 1, Period 2||0
10774192|NCT03307252|11936810|FG009|NOT COMPLETED|Part 1, Period 2||0
10774193|NCT03307252|11936811|FG010|NOT COMPLETED|Part 1, Period 2||0
10774194|NCT03307252|11936801|FG000|STARTED|Part 1, Washout Period 2 (13 Days)||4
10774195|NCT03307252|11936802|FG001|STARTED|Part 1, Washout Period 2 (13 Days)||4
10774196|NCT03307252|11936803|FG002|STARTED|Part 1, Washout Period 2 (13 Days)||4
10774197|NCT03307252|11936804|FG003|STARTED|Part 1, Washout Period 2 (13 Days)||0
10774198|NCT03307252|11936805|FG004|STARTED|Part 1, Washout Period 2 (13 Days)||0
10774199|NCT03307252|11936806|FG005|STARTED|Part 1, Washout Period 2 (13 Days)||0
10774200|NCT03307252|11936807|FG006|STARTED|Part 1, Washout Period 2 (13 Days)||0
10774201|NCT03307252|11936808|FG007|STARTED|Part 1, Washout Period 2 (13 Days)||0
10774202|NCT03307252|11936809|FG008|STARTED|Part 1, Washout Period 2 (13 Days)||0
10774203|NCT03307252|11936810|FG009|STARTED|Part 1, Washout Period 2 (13 Days)||0
10774204|NCT03307252|11936811|FG010|STARTED|Part 1, Washout Period 2 (13 Days)||0
10774205|NCT03307252|11936801|FG000|COMPLETED|Part 1, Washout Period 2 (13 Days)||4
10774206|NCT03307252|11936802|FG001|COMPLETED|Part 1, Washout Period 2 (13 Days)||4
10774207|NCT03307252|11936803|FG002|COMPLETED|Part 1, Washout Period 2 (13 Days)||4
10774208|NCT03307252|11936804|FG003|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
10774209|NCT03307252|11936805|FG004|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
10774210|NCT03307252|11936806|FG005|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
10774211|NCT03307252|11936807|FG006|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
10774212|NCT03307252|11936808|FG007|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
10774213|NCT03307252|11936809|FG008|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
10774214|NCT03307252|11936810|FG009|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
10298049|NCT04323800|11430736|FG000|STARTED|Overall Study||87
10774215|NCT03307252|11936811|FG010|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
10774216|NCT03307252|11936801|FG000|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
10774217|NCT03307252|11936802|FG001|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
10774218|NCT03307252|11936803|FG002|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
10774219|NCT03307252|11936804|FG003|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
10774220|NCT03307252|11936805|FG004|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
10774221|NCT03307252|11936806|FG005|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
10774222|NCT03307252|11936807|FG006|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
10774223|NCT03307252|11936808|FG007|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
10774224|NCT03307252|11936809|FG008|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
10774225|NCT03307252|11936810|FG009|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
10774226|NCT03307252|11936811|FG010|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
10774227|NCT03307252|11936801|FG000|STARTED|Part 1, Period 3|Participants randomised in Part 1|4
10774228|NCT03307252|11936802|FG001|STARTED|Part 1, Period 3|Participants randomised in Part 1|4
10774229|NCT03307252|11936803|FG002|STARTED|Part 1, Period 3|Participants randomised in Part 1|4
10774230|NCT03307252|11936804|FG003|STARTED|Part 1, Period 3||0
10774231|NCT03307252|11936805|FG004|STARTED|Part 1, Period 3||0
10774232|NCT03307252|11936806|FG005|STARTED|Part 1, Period 3||0
10774233|NCT03307252|11936807|FG006|STARTED|Part 1, Period 3||0
10774234|NCT03307252|11936808|FG007|STARTED|Part 1, Period 3||0
10774235|NCT03307252|11936809|FG008|STARTED|Part 1, Period 3||0
10774236|NCT03307252|11936810|FG009|STARTED|Part 1, Period 3||0
10774237|NCT03307252|11936811|FG010|STARTED|Part 1, Period 3||0
10774238|NCT03307252|11936801|FG000|COMPLETED|Part 1, Period 3||4
10774239|NCT03307252|11936802|FG001|COMPLETED|Part 1, Period 3||4
10774240|NCT03307252|11936803|FG002|COMPLETED|Part 1, Period 3||4
10774241|NCT03307252|11936804|FG003|COMPLETED|Part 1, Period 3||0
10774242|NCT03307252|11936805|FG004|COMPLETED|Part 1, Period 3||0
10774243|NCT03307252|11936806|FG005|COMPLETED|Part 1, Period 3||0
10774244|NCT03307252|11936807|FG006|COMPLETED|Part 1, Period 3||0
10774245|NCT03307252|11936808|FG007|COMPLETED|Part 1, Period 3||0
10774246|NCT03307252|11936809|FG008|COMPLETED|Part 1, Period 3||0
10774247|NCT03307252|11936810|FG009|COMPLETED|Part 1, Period 3||0
10774248|NCT03307252|11936811|FG010|COMPLETED|Part 1, Period 3||0
10774249|NCT03307252|11936801|FG000|NOT COMPLETED|Part 1, Period 3||0
10774250|NCT03307252|11936802|FG001|NOT COMPLETED|Part 1, Period 3||0
10774251|NCT03307252|11936803|FG002|NOT COMPLETED|Part 1, Period 3||0
10774252|NCT03307252|11936804|FG003|NOT COMPLETED|Part 1, Period 3||0
10774253|NCT03307252|11936805|FG004|NOT COMPLETED|Part 1, Period 3||0
10774254|NCT03307252|11936806|FG005|NOT COMPLETED|Part 1, Period 3||0
10774255|NCT03307252|11936807|FG006|NOT COMPLETED|Part 1, Period 3||0
10774256|NCT03307252|11936808|FG007|NOT COMPLETED|Part 1, Period 3||0
10774257|NCT03307252|11936809|FG008|NOT COMPLETED|Part 1, Period 3||0
10774258|NCT03307252|11936810|FG009|NOT COMPLETED|Part 1, Period 3||0
10774259|NCT03307252|11936811|FG010|NOT COMPLETED|Part 1, Period 3||0
10774260|NCT03307252|11936801|FG000|STARTED|Part 2, Period 1||0
10774261|NCT03307252|11936802|FG001|STARTED|Part 2, Period 1||0
10774262|NCT03307252|11936803|FG002|STARTED|Part 2, Period 1||0
10774263|NCT03307252|11936804|FG003|STARTED|Part 2, Period 1|Participants randomized in Part 2|4
10774264|NCT03307252|11936805|FG004|STARTED|Part 2, Period 1|Participants randomized in Part 2|4
10774265|NCT03307252|11936806|FG005|STARTED|Part 2, Period 1|Participants randomized in Part 2|4
10774266|NCT03307252|11936807|FG006|STARTED|Part 2, Period 1|Participants randomized in Part 2|5
10298050|NCT04323800|11430737|FG001|STARTED|Overall Study||93
10298051|NCT04323800|11430736|FG000|COMPLETED|Overall Study||81
10298052|NCT04323800|11430737|FG001|COMPLETED|Overall Study||87
10298053|NCT04323800|11430736|FG000|NOT COMPLETED|Overall Study||6
10298054|NCT04323800|11430737|FG001|NOT COMPLETED|Overall Study||6
10298055|NCT04279925|11430745|FG000|STARTED|Overall Study||4
10298056|NCT04279925|11430746|FG001|STARTED|Overall Study||5
10298057|NCT04279925|11430745|FG000|COMPLETED|Overall Study||4
10298058|NCT04279925|11430746|FG001|COMPLETED|Overall Study||5
10298059|NCT04279925|11430745|FG000|NOT COMPLETED|Overall Study||0
10298060|NCT04279925|11430746|FG001|NOT COMPLETED|Overall Study||0
10298061|NCT04110145|11430757|FG000|STARTED|Double-Blind Treatment Period (4 Weeks)||7
10298062|NCT04110145|11430758|FG001|STARTED|Double-Blind Treatment Period (4 Weeks)||7
10298063|NCT04110145|11430759|FG002|STARTED|Double-Blind Treatment Period (4 Weeks)||6
10298064|NCT04110145|11430760|FG003|STARTED|Double-Blind Treatment Period (4 Weeks)||7
10298065|NCT04110145|11430761|FG004|STARTED|Double-Blind Treatment Period (4 Weeks)||8
10298066|NCT04110145|11430757|FG000|COMPLETED|Double-Blind Treatment Period (4 Weeks)||7
10298067|NCT04110145|11430758|FG001|COMPLETED|Double-Blind Treatment Period (4 Weeks)||7
10298068|NCT04110145|11430759|FG002|COMPLETED|Double-Blind Treatment Period (4 Weeks)||6
10298069|NCT04110145|11430760|FG003|COMPLETED|Double-Blind Treatment Period (4 Weeks)||6
10298070|NCT04110145|11430761|FG004|COMPLETED|Double-Blind Treatment Period (4 Weeks)||8
10298071|NCT04110145|11430757|FG000|NOT COMPLETED|Double-Blind Treatment Period (4 Weeks)||0
10298072|NCT04110145|11430758|FG001|NOT COMPLETED|Double-Blind Treatment Period (4 Weeks)||0
10298073|NCT04110145|11430759|FG002|NOT COMPLETED|Double-Blind Treatment Period (4 Weeks)||0
10298074|NCT04110145|11430760|FG003|NOT COMPLETED|Double-Blind Treatment Period (4 Weeks)||1
10298075|NCT04110145|11430761|FG004|NOT COMPLETED|Double-Blind Treatment Period (4 Weeks)||0
10298076|NCT04110145|11430757|FG000|STARTED|Post-Treatment Period (1 Week)||7
10298077|NCT04110145|11430758|FG001|STARTED|Post-Treatment Period (1 Week)||7
10298078|NCT04110145|11430759|FG002|STARTED|Post-Treatment Period (1 Week)||5
10298079|NCT04110145|11430760|FG003|STARTED|Post-Treatment Period (1 Week)||6
10298080|NCT04110145|11430761|FG004|STARTED|Post-Treatment Period (1 Week)||8
10298081|NCT04110145|11430757|FG000|COMPLETED|Post-Treatment Period (1 Week)||7
10298082|NCT04110145|11430758|FG001|COMPLETED|Post-Treatment Period (1 Week)||7
10429545|NCT00864383|11575576|FG002|COMPLETED|Modified Intent to Treat||551
10298083|NCT04110145|11430759|FG002|COMPLETED|Post-Treatment Period (1 Week)||5
10774267|NCT03307252|11936808|FG007|STARTED|Part 2, Period 1||0
10774268|NCT03307252|11936809|FG008|STARTED|Part 2, Period 1||0
10774269|NCT03307252|11936810|FG009|STARTED|Part 2, Period 1||0
10774270|NCT03307252|11936811|FG010|STARTED|Part 2, Period 1||0
10774271|NCT03307252|11936801|FG000|COMPLETED|Part 2, Period 1||0
10774272|NCT03307252|11936802|FG001|COMPLETED|Part 2, Period 1||0
10774273|NCT03307252|11936803|FG002|COMPLETED|Part 2, Period 1||0
10774274|NCT03307252|11936804|FG003|COMPLETED|Part 2, Period 1||4
10774275|NCT03307252|11936805|FG004|COMPLETED|Part 2, Period 1||4
10774276|NCT03307252|11936806|FG005|COMPLETED|Part 2, Period 1||3
10774277|NCT03307252|11936807|FG006|COMPLETED|Part 2, Period 1||5
10774278|NCT03307252|11936808|FG007|COMPLETED|Part 2, Period 1||0
10774279|NCT03307252|11936809|FG008|COMPLETED|Part 2, Period 1||0
10774280|NCT03307252|11936810|FG009|COMPLETED|Part 2, Period 1||0
10774281|NCT03307252|11936811|FG010|COMPLETED|Part 2, Period 1||0
10774282|NCT03307252|11936801|FG000|NOT COMPLETED|Part 2, Period 1||0
10774283|NCT03307252|11936802|FG001|NOT COMPLETED|Part 2, Period 1||0
10774284|NCT03307252|11936803|FG002|NOT COMPLETED|Part 2, Period 1||0
10774285|NCT03307252|11936804|FG003|NOT COMPLETED|Part 2, Period 1||0
10774286|NCT03307252|11936805|FG004|NOT COMPLETED|Part 2, Period 1||0
10774287|NCT03307252|11936806|FG005|NOT COMPLETED|Part 2, Period 1||1
10774288|NCT03307252|11936807|FG006|NOT COMPLETED|Part 2, Period 1||0
10774289|NCT03307252|11936808|FG007|NOT COMPLETED|Part 2, Period 1||0
10774290|NCT03307252|11936809|FG008|NOT COMPLETED|Part 2, Period 1||0
10774291|NCT03307252|11936810|FG009|NOT COMPLETED|Part 2, Period 1||0
10774292|NCT03307252|11936811|FG010|NOT COMPLETED|Part 2, Period 1||0
10774293|NCT03307252|11936801|FG000|STARTED|Part 2, Washout Period 1 (7 Days)||0
10774294|NCT03307252|11936802|FG001|STARTED|Part 2, Washout Period 1 (7 Days)||0
10774295|NCT03307252|11936803|FG002|STARTED|Part 2, Washout Period 1 (7 Days)||0
10774296|NCT03307252|11936804|FG003|STARTED|Part 2, Washout Period 1 (7 Days)||4
10774297|NCT03307252|11936805|FG004|STARTED|Part 2, Washout Period 1 (7 Days)||4
10774298|NCT03307252|11936806|FG005|STARTED|Part 2, Washout Period 1 (7 Days)||3
10774299|NCT03307252|11936807|FG006|STARTED|Part 2, Washout Period 1 (7 Days)||5
10774300|NCT03307252|11936808|FG007|STARTED|Part 2, Washout Period 1 (7 Days)||0
10774301|NCT03307252|11936809|FG008|STARTED|Part 2, Washout Period 1 (7 Days)||0
10774302|NCT03307252|11936810|FG009|STARTED|Part 2, Washout Period 1 (7 Days)||0
10774303|NCT03307252|11936811|FG010|STARTED|Part 2, Washout Period 1 (7 Days)||0
10774304|NCT03307252|11936801|FG000|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10774305|NCT03307252|11936802|FG001|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10774306|NCT03307252|11936803|FG002|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10774307|NCT03307252|11936804|FG003|COMPLETED|Part 2, Washout Period 1 (7 Days)||4
10774308|NCT03307252|11936805|FG004|COMPLETED|Part 2, Washout Period 1 (7 Days)||4
10774309|NCT03307252|11936806|FG005|COMPLETED|Part 2, Washout Period 1 (7 Days)||3
10774310|NCT03307252|11936807|FG006|COMPLETED|Part 2, Washout Period 1 (7 Days)||5
10774311|NCT03307252|11936808|FG007|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10774312|NCT03307252|11936809|FG008|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10774313|NCT03307252|11936810|FG009|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10774314|NCT03307252|11936811|FG010|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10774315|NCT03307252|11936801|FG000|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10774316|NCT03307252|11936802|FG001|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10774317|NCT03307252|11936803|FG002|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10774318|NCT03307252|11936804|FG003|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10774319|NCT03307252|11936805|FG004|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10774320|NCT03307252|11936806|FG005|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10774321|NCT03307252|11936807|FG006|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10774322|NCT03307252|11936808|FG007|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10774323|NCT03307252|11936809|FG008|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10774324|NCT03307252|11936810|FG009|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10774325|NCT03307252|11936811|FG010|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
10774326|NCT03307252|11936801|FG000|STARTED|Part 2, Period 2||0
10774327|NCT03307252|11936802|FG001|STARTED|Part 2, Period 2||0
10774328|NCT03307252|11936803|FG002|STARTED|Part 2, Period 2||0
10774329|NCT03307252|11936804|FG003|STARTED|Part 2, Period 2||4
10774330|NCT03307252|11936805|FG004|STARTED|Part 2, Period 2||4
10774331|NCT03307252|11936806|FG005|STARTED|Part 2, Period 2||3
10774332|NCT03307252|11936807|FG006|STARTED|Part 2, Period 2||5
10774333|NCT03307252|11936808|FG007|STARTED|Part 2, Period 2||0
10774334|NCT03307252|11936809|FG008|STARTED|Part 2, Period 2||0
10774335|NCT03307252|11936810|FG009|STARTED|Part 2, Period 2||0
10774336|NCT03307252|11936811|FG010|STARTED|Part 2, Period 2||0
10774337|NCT03307252|11936801|FG000|COMPLETED|Part 2, Period 2||0
10774338|NCT03307252|11936802|FG001|COMPLETED|Part 2, Period 2||0
10774339|NCT03307252|11936803|FG002|COMPLETED|Part 2, Period 2||0
10774340|NCT03307252|11936804|FG003|COMPLETED|Part 2, Period 2||4
10774341|NCT03307252|11936805|FG004|COMPLETED|Part 2, Period 2||4
10774342|NCT03307252|11936806|FG005|COMPLETED|Part 2, Period 2||3
10774343|NCT03307252|11936807|FG006|COMPLETED|Part 2, Period 2||5
10774344|NCT03307252|11936808|FG007|COMPLETED|Part 2, Period 2||0
10774345|NCT03307252|11936809|FG008|COMPLETED|Part 2, Period 2||0
10774346|NCT03307252|11936810|FG009|COMPLETED|Part 2, Period 2||0
10774347|NCT03307252|11936811|FG010|COMPLETED|Part 2, Period 2||0
10774348|NCT03307252|11936801|FG000|NOT COMPLETED|Part 2, Period 2||0
10774349|NCT03307252|11936802|FG001|NOT COMPLETED|Part 2, Period 2||0
10774350|NCT03307252|11936803|FG002|NOT COMPLETED|Part 2, Period 2||0
10774351|NCT03307252|11936804|FG003|NOT COMPLETED|Part 2, Period 2||0
10774352|NCT03307252|11936805|FG004|NOT COMPLETED|Part 2, Period 2||0
10774353|NCT03307252|11936806|FG005|NOT COMPLETED|Part 2, Period 2||0
10774354|NCT03307252|11936807|FG006|NOT COMPLETED|Part 2, Period 2||0
10774355|NCT03307252|11936808|FG007|NOT COMPLETED|Part 2, Period 2||0
10774356|NCT03307252|11936809|FG008|NOT COMPLETED|Part 2, Period 2||0
10774357|NCT03307252|11936810|FG009|NOT COMPLETED|Part 2, Period 2||0
10774358|NCT03307252|11936811|FG010|NOT COMPLETED|Part 2, Period 2||0
10774359|NCT03307252|11936801|FG000|STARTED|Part 2, Washout Period 2 (7 Days)||0
10774360|NCT03307252|11936802|FG001|STARTED|Part 2, Washout Period 2 (7 Days)||0
10774361|NCT03307252|11936803|FG002|STARTED|Part 2, Washout Period 2 (7 Days)||0
10774362|NCT03307252|11936804|FG003|STARTED|Part 2, Washout Period 2 (7 Days)||4
10774363|NCT03307252|11936805|FG004|STARTED|Part 2, Washout Period 2 (7 Days)||4
10774364|NCT03307252|11936806|FG005|STARTED|Part 2, Washout Period 2 (7 Days)||3
10774365|NCT03307252|11936807|FG006|STARTED|Part 2, Washout Period 2 (7 Days)||5
10774366|NCT03307252|11936808|FG007|STARTED|Part 2, Washout Period 2 (7 Days)||0
10774367|NCT03307252|11936809|FG008|STARTED|Part 2, Washout Period 2 (7 Days)||0
10774368|NCT03307252|11936810|FG009|STARTED|Part 2, Washout Period 2 (7 Days)||0
10774369|NCT03307252|11936811|FG010|STARTED|Part 2, Washout Period 2 (7 Days)||0
10774370|NCT03307252|11936801|FG000|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
10774371|NCT03307252|11936802|FG001|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
10774372|NCT03307252|11936803|FG002|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
10774373|NCT03307252|11936804|FG003|COMPLETED|Part 2, Washout Period 2 (7 Days)||4
10774374|NCT03307252|11936805|FG004|COMPLETED|Part 2, Washout Period 2 (7 Days)||4
10774375|NCT03307252|11936806|FG005|COMPLETED|Part 2, Washout Period 2 (7 Days)||3
10774376|NCT03307252|11936807|FG006|COMPLETED|Part 2, Washout Period 2 (7 Days)||5
10774377|NCT03307252|11936808|FG007|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
10774378|NCT03307252|11936809|FG008|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
10774379|NCT03307252|11936810|FG009|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
10774380|NCT03307252|11936811|FG010|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
10774381|NCT03307252|11936801|FG000|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
10774382|NCT03307252|11936802|FG001|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
10774383|NCT03307252|11936803|FG002|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
10774384|NCT03307252|11936804|FG003|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
10774385|NCT03307252|11936805|FG004|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
10774386|NCT03307252|11936806|FG005|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
10774387|NCT03307252|11936807|FG006|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
10774388|NCT03307252|11936808|FG007|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
10774389|NCT03307252|11936809|FG008|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
10774390|NCT03307252|11936810|FG009|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
10774391|NCT03307252|11936811|FG010|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
10774392|NCT03307252|11936801|FG000|STARTED|Part 2, Period 3||0
10774393|NCT03307252|11936802|FG001|STARTED|Part 2, Period 3||0
10774394|NCT03307252|11936803|FG002|STARTED|Part 2, Period 3||0
10774395|NCT03307252|11936804|FG003|STARTED|Part 2, Period 3||4
10774396|NCT03307252|11936805|FG004|STARTED|Part 2, Period 3||4
10774397|NCT03307252|11936806|FG005|STARTED|Part 2, Period 3||3
10774398|NCT03307252|11936807|FG006|STARTED|Part 2, Period 3||5
10774399|NCT03307252|11936808|FG007|STARTED|Part 2, Period 3||0
10774400|NCT03307252|11936809|FG008|STARTED|Part 2, Period 3||0
10774401|NCT03307252|11936810|FG009|STARTED|Part 2, Period 3||0
10774402|NCT03307252|11936811|FG010|STARTED|Part 2, Period 3||0
10774403|NCT03307252|11936801|FG000|COMPLETED|Part 2, Period 3||0
10774404|NCT03307252|11936802|FG001|COMPLETED|Part 2, Period 3||0
10774405|NCT03307252|11936803|FG002|COMPLETED|Part 2, Period 3||0
10774406|NCT03307252|11936804|FG003|COMPLETED|Part 2, Period 3||4
10774407|NCT03307252|11936805|FG004|COMPLETED|Part 2, Period 3||3
10774408|NCT03307252|11936806|FG005|COMPLETED|Part 2, Period 3||3
10774409|NCT03307252|11936807|FG006|COMPLETED|Part 2, Period 3||5
10774410|NCT03307252|11936808|FG007|COMPLETED|Part 2, Period 3||0
10774411|NCT03307252|11936809|FG008|COMPLETED|Part 2, Period 3||0
10774412|NCT03307252|11936810|FG009|COMPLETED|Part 2, Period 3||0
10774413|NCT03307252|11936811|FG010|COMPLETED|Part 2, Period 3||0
10774414|NCT03307252|11936801|FG000|NOT COMPLETED|Part 2, Period 3||0
10774415|NCT03307252|11936802|FG001|NOT COMPLETED|Part 2, Period 3||0
10774416|NCT03307252|11936803|FG002|NOT COMPLETED|Part 2, Period 3||0
10774417|NCT03307252|11936804|FG003|NOT COMPLETED|Part 2, Period 3||0
10774418|NCT03307252|11936805|FG004|NOT COMPLETED|Part 2, Period 3||1
10774419|NCT03307252|11936806|FG005|NOT COMPLETED|Part 2, Period 3||0
10774420|NCT03307252|11936807|FG006|NOT COMPLETED|Part 2, Period 3||0
10774421|NCT03307252|11936808|FG007|NOT COMPLETED|Part 2, Period 3||0
10774422|NCT03307252|11936809|FG008|NOT COMPLETED|Part 2, Period 3||0
10774423|NCT03307252|11936810|FG009|NOT COMPLETED|Part 2, Period 3||0
10774424|NCT03307252|11936811|FG010|NOT COMPLETED|Part 2, Period 3||0
10774425|NCT03307252|11936801|FG000|STARTED|Part 2, Washout Period 3 (7 Days)||0
10774426|NCT03307252|11936802|FG001|STARTED|Part 2, Washout Period 3 (7 Days)||0
10774427|NCT03307252|11936803|FG002|STARTED|Part 2, Washout Period 3 (7 Days)||0
10774428|NCT03307252|11936804|FG003|STARTED|Part 2, Washout Period 3 (7 Days)||4
10774429|NCT03307252|11936805|FG004|STARTED|Part 2, Washout Period 3 (7 Days)||3
10774430|NCT03307252|11936806|FG005|STARTED|Part 2, Washout Period 3 (7 Days)||3
10774431|NCT03307252|11936807|FG006|STARTED|Part 2, Washout Period 3 (7 Days)||5
10774432|NCT03307252|11936808|FG007|STARTED|Part 2, Washout Period 3 (7 Days)||0
10774433|NCT03307252|11936809|FG008|STARTED|Part 2, Washout Period 3 (7 Days)||0
10774434|NCT03307252|11936810|FG009|STARTED|Part 2, Washout Period 3 (7 Days)||0
10774435|NCT03307252|11936811|FG010|STARTED|Part 2, Washout Period 3 (7 Days)||0
10774436|NCT03307252|11936801|FG000|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
10774437|NCT03307252|11936802|FG001|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
10774438|NCT03307252|11936803|FG002|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
10774439|NCT03307252|11936804|FG003|COMPLETED|Part 2, Washout Period 3 (7 Days)||4
10774440|NCT03307252|11936805|FG004|COMPLETED|Part 2, Washout Period 3 (7 Days)||3
10774441|NCT03307252|11936806|FG005|COMPLETED|Part 2, Washout Period 3 (7 Days)||3
10774442|NCT03307252|11936807|FG006|COMPLETED|Part 2, Washout Period 3 (7 Days)||4
10774443|NCT03307252|11936808|FG007|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
10774444|NCT03307252|11936809|FG008|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
10774445|NCT03307252|11936810|FG009|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
10774446|NCT03307252|11936811|FG010|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
10774447|NCT03307252|11936801|FG000|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
10774448|NCT03307252|11936802|FG001|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
10774449|NCT03307252|11936803|FG002|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
10774450|NCT03307252|11936804|FG003|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
10774451|NCT03307252|11936805|FG004|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
10774452|NCT03307252|11936806|FG005|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
10774453|NCT03307252|11936807|FG006|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||1
10774454|NCT03307252|11936808|FG007|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
10774455|NCT03307252|11936809|FG008|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
10774456|NCT03307252|11936810|FG009|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
10774457|NCT03307252|11936811|FG010|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
10774458|NCT03307252|11936801|FG000|STARTED|Part 2, Period 4||0
10774459|NCT03307252|11936802|FG001|STARTED|Part 2, Period 4||0
10774460|NCT03307252|11936803|FG002|STARTED|Part 2, Period 4||0
10774461|NCT03307252|11936804|FG003|STARTED|Part 2, Period 4||4
10774462|NCT03307252|11936805|FG004|STARTED|Part 2, Period 4||3
10774463|NCT03307252|11936806|FG005|STARTED|Part 2, Period 4||3
10774464|NCT03307252|11936807|FG006|STARTED|Part 2, Period 4||5
10774465|NCT03307252|11936808|FG007|STARTED|Part 2, Period 4||0
10774466|NCT03307252|11936809|FG008|STARTED|Part 2, Period 4||0
10774467|NCT03307252|11936810|FG009|STARTED|Part 2, Period 4||0
10774468|NCT03307252|11936811|FG010|STARTED|Part 2, Period 4||0
10774469|NCT03307252|11936801|FG000|COMPLETED|Part 2, Period 4||0
10774470|NCT03307252|11936802|FG001|COMPLETED|Part 2, Period 4||0
10774471|NCT03307252|11936803|FG002|COMPLETED|Part 2, Period 4||0
10774472|NCT03307252|11936804|FG003|COMPLETED|Part 2, Period 4||4
10774473|NCT03307252|11936805|FG004|COMPLETED|Part 2, Period 4||3
10774474|NCT03307252|11936806|FG005|COMPLETED|Part 2, Period 4||3
10774475|NCT03307252|11936807|FG006|COMPLETED|Part 2, Period 4||4
10774476|NCT03307252|11936808|FG007|COMPLETED|Part 2, Period 4||0
10774477|NCT03307252|11936809|FG008|COMPLETED|Part 2, Period 4||0
10774478|NCT03307252|11936810|FG009|COMPLETED|Part 2, Period 4||0
10774479|NCT03307252|11936811|FG010|COMPLETED|Part 2, Period 4||0
10774480|NCT03307252|11936801|FG000|NOT COMPLETED|Part 2, Period 4||0
10774481|NCT03307252|11936802|FG001|NOT COMPLETED|Part 2, Period 4||0
10774482|NCT03307252|11936803|FG002|NOT COMPLETED|Part 2, Period 4||0
10774483|NCT03307252|11936804|FG003|NOT COMPLETED|Part 2, Period 4||0
10774484|NCT03307252|11936805|FG004|NOT COMPLETED|Part 2, Period 4||0
10774485|NCT03307252|11936806|FG005|NOT COMPLETED|Part 2, Period 4||0
10774486|NCT03307252|11936807|FG006|NOT COMPLETED|Part 2, Period 4||1
10774487|NCT03307252|11936808|FG007|NOT COMPLETED|Part 2, Period 4||0
10774488|NCT03307252|11936809|FG008|NOT COMPLETED|Part 2, Period 4||0
10774489|NCT03307252|11936810|FG009|NOT COMPLETED|Part 2, Period 4||0
10774490|NCT03307252|11936811|FG010|NOT COMPLETED|Part 2, Period 4||0
10774491|NCT03307252|11936801|FG000|STARTED|Part 3, Period 1||0
10774492|NCT03307252|11936802|FG001|STARTED|Part 3, Period 1||0
10774493|NCT03307252|11936803|FG002|STARTED|Part 3, Period 1||0
10774494|NCT03307252|11936804|FG003|STARTED|Part 3, Period 1||0
10774495|NCT03307252|11936805|FG004|STARTED|Part 3, Period 1||0
10774496|NCT03307252|11936806|FG005|STARTED|Part 3, Period 1||0
10774497|NCT03307252|11936807|FG006|STARTED|Part 3, Period 1||0
10774498|NCT03307252|11936808|FG007|STARTED|Part 3, Period 1||4
10774499|NCT03307252|11936809|FG008|STARTED|Part 3, Period 1||4
10774500|NCT03307252|11936810|FG009|STARTED|Part 3, Period 1||4
10774501|NCT03307252|11936811|FG010|STARTED|Part 3, Period 1||4
10774502|NCT03307252|11936801|FG000|COMPLETED|Part 3, Period 1||0
10774503|NCT03307252|11936802|FG001|COMPLETED|Part 3, Period 1||0
10774504|NCT03307252|11936803|FG002|COMPLETED|Part 3, Period 1||0
10774505|NCT03307252|11936804|FG003|COMPLETED|Part 3, Period 1||0
10774506|NCT03307252|11936805|FG004|COMPLETED|Part 3, Period 1||0
10774507|NCT03307252|11936806|FG005|COMPLETED|Part 3, Period 1||0
10774508|NCT03307252|11936807|FG006|COMPLETED|Part 3, Period 1||0
10774509|NCT03307252|11936808|FG007|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
10774510|NCT03307252|11936809|FG008|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
10774511|NCT03307252|11936810|FG009|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
10774512|NCT03307252|11936811|FG010|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
10774513|NCT03307252|11936801|FG000|NOT COMPLETED|Part 3, Period 1||0
10774514|NCT03307252|11936802|FG001|NOT COMPLETED|Part 3, Period 1||0
10774515|NCT03307252|11936803|FG002|NOT COMPLETED|Part 3, Period 1||0
10774516|NCT03307252|11936804|FG003|NOT COMPLETED|Part 3, Period 1||0
10774517|NCT03307252|11936805|FG004|NOT COMPLETED|Part 3, Period 1||0
10774518|NCT03307252|11936806|FG005|NOT COMPLETED|Part 3, Period 1||0
10774519|NCT03307252|11936807|FG006|NOT COMPLETED|Part 3, Period 1||0
10774520|NCT03307252|11936808|FG007|NOT COMPLETED|Part 3, Period 1||0
10774521|NCT03307252|11936809|FG008|NOT COMPLETED|Part 3, Period 1||0
10774522|NCT03307252|11936810|FG009|NOT COMPLETED|Part 3, Period 1||0
10774523|NCT03307252|11936811|FG010|NOT COMPLETED|Part 3, Period 1||0
10774524|NCT03307252|11936801|FG000|STARTED|Part 3, Washout Period 1 (7 Days)||0
10774525|NCT03307252|11936802|FG001|STARTED|Part 3, Washout Period 1 (7 Days)||0
10774526|NCT03307252|11936803|FG002|STARTED|Part 3, Washout Period 1 (7 Days)||0
10774527|NCT03307252|11936804|FG003|STARTED|Part 3, Washout Period 1 (7 Days)||0
10774528|NCT03307252|11936805|FG004|STARTED|Part 3, Washout Period 1 (7 Days)||0
10774529|NCT03307252|11936806|FG005|STARTED|Part 3, Washout Period 1 (7 Days)||0
10774530|NCT03307252|11936807|FG006|STARTED|Part 3, Washout Period 1 (7 Days)||0
10774531|NCT03307252|11936808|FG007|STARTED|Part 3, Washout Period 1 (7 Days)||4
10774532|NCT03307252|11936809|FG008|STARTED|Part 3, Washout Period 1 (7 Days)||4
10774533|NCT03307252|11936810|FG009|STARTED|Part 3, Washout Period 1 (7 Days)||4
10774534|NCT03307252|11936811|FG010|STARTED|Part 3, Washout Period 1 (7 Days)||4
10774535|NCT03307252|11936801|FG000|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
10774536|NCT03307252|11936802|FG001|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
10774537|NCT03307252|11936803|FG002|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
10774538|NCT03307252|11936804|FG003|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
10774539|NCT03307252|11936805|FG004|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
10774540|NCT03307252|11936806|FG005|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
10774541|NCT03307252|11936807|FG006|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
10774542|NCT03307252|11936808|FG007|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
10774543|NCT03307252|11936809|FG008|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
10774544|NCT03307252|11936810|FG009|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
10774545|NCT03307252|11936811|FG010|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
10774546|NCT03307252|11936801|FG000|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
10774547|NCT03307252|11936802|FG001|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
10774548|NCT03307252|11936803|FG002|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
10774549|NCT03307252|11936804|FG003|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
10774550|NCT03307252|11936805|FG004|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
10774551|NCT03307252|11936806|FG005|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
10774552|NCT03307252|11936807|FG006|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
10774553|NCT03307252|11936808|FG007|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
10774554|NCT03307252|11936809|FG008|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
10774555|NCT03307252|11936810|FG009|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
10774556|NCT03307252|11936811|FG010|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
10774557|NCT03307252|11936801|FG000|STARTED|Part 3, Period 2||0
10774558|NCT03307252|11936802|FG001|STARTED|Part 3, Period 2||0
10774559|NCT03307252|11936803|FG002|STARTED|Part 3, Period 2||0
10774560|NCT03307252|11936804|FG003|STARTED|Part 3, Period 2||0
10774561|NCT03307252|11936805|FG004|STARTED|Part 3, Period 2||0
10774562|NCT03307252|11936806|FG005|STARTED|Part 3, Period 2||0
10774563|NCT03307252|11936807|FG006|STARTED|Part 3, Period 2||0
10774564|NCT03307252|11936808|FG007|STARTED|Part 3, Period 2||4
10774565|NCT03307252|11936809|FG008|STARTED|Part 3, Period 2||4
10774566|NCT03307252|11936810|FG009|STARTED|Part 3, Period 2||4
10774567|NCT03307252|11936811|FG010|STARTED|Part 3, Period 2||4
10774568|NCT03307252|11936801|FG000|COMPLETED|Part 3, Period 2||0
10774569|NCT03307252|11936802|FG001|COMPLETED|Part 3, Period 2||0
10774570|NCT03307252|11936803|FG002|COMPLETED|Part 3, Period 2||0
10774571|NCT03307252|11936804|FG003|COMPLETED|Part 3, Period 2||0
10774572|NCT03307252|11936805|FG004|COMPLETED|Part 3, Period 2||0
10774573|NCT03307252|11936806|FG005|COMPLETED|Part 3, Period 2||0
10774574|NCT03307252|11936807|FG006|COMPLETED|Part 3, Period 2||0
10774575|NCT03307252|11936808|FG007|COMPLETED|Part 3, Period 2||4
10774576|NCT03307252|11936809|FG008|COMPLETED|Part 3, Period 2||4
10774577|NCT03307252|11936810|FG009|COMPLETED|Part 3, Period 2||4
10774578|NCT03307252|11936811|FG010|COMPLETED|Part 3, Period 2||4
10774579|NCT03307252|11936801|FG000|NOT COMPLETED|Part 3, Period 2||0
10774580|NCT03307252|11936802|FG001|NOT COMPLETED|Part 3, Period 2||0
10774581|NCT03307252|11936803|FG002|NOT COMPLETED|Part 3, Period 2||0
10774582|NCT03307252|11936804|FG003|NOT COMPLETED|Part 3, Period 2||0
10774583|NCT03307252|11936805|FG004|NOT COMPLETED|Part 3, Period 2||0
10774584|NCT03307252|11936806|FG005|NOT COMPLETED|Part 3, Period 2||0
10774585|NCT03307252|11936807|FG006|NOT COMPLETED|Part 3, Period 2||0
10774586|NCT03307252|11936808|FG007|NOT COMPLETED|Part 3, Period 2||0
10774587|NCT03307252|11936809|FG008|NOT COMPLETED|Part 3, Period 2||0
10774588|NCT03307252|11936810|FG009|NOT COMPLETED|Part 3, Period 2||0
10774589|NCT03307252|11936811|FG010|NOT COMPLETED|Part 3, Period 2||0
10774590|NCT03307252|11936801|FG000|STARTED|Part 3, Washout Period 2 (7 Days)||0
10774591|NCT03307252|11936802|FG001|STARTED|Part 3, Washout Period 2 (7 Days)||0
10774592|NCT03307252|11936803|FG002|STARTED|Part 3, Washout Period 2 (7 Days)||0
10774593|NCT03307252|11936804|FG003|STARTED|Part 3, Washout Period 2 (7 Days)||0
10774594|NCT03307252|11936805|FG004|STARTED|Part 3, Washout Period 2 (7 Days)||0
10774595|NCT03307252|11936806|FG005|STARTED|Part 3, Washout Period 2 (7 Days)||0
10774596|NCT03307252|11936807|FG006|STARTED|Part 3, Washout Period 2 (7 Days)||0
10774597|NCT03307252|11936808|FG007|STARTED|Part 3, Washout Period 2 (7 Days)||4
10774598|NCT03307252|11936809|FG008|STARTED|Part 3, Washout Period 2 (7 Days)||4
10774599|NCT03307252|11936810|FG009|STARTED|Part 3, Washout Period 2 (7 Days)||4
10774600|NCT03307252|11936811|FG010|STARTED|Part 3, Washout Period 2 (7 Days)||4
10774601|NCT03307252|11936801|FG000|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
10774602|NCT03307252|11936802|FG001|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
10774603|NCT03307252|11936803|FG002|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
10774604|NCT03307252|11936804|FG003|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
10774605|NCT03307252|11936805|FG004|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
10774606|NCT03307252|11936806|FG005|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
10774607|NCT03307252|11936807|FG006|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
10774608|NCT03307252|11936808|FG007|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
10774609|NCT03307252|11936809|FG008|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
10774610|NCT03307252|11936810|FG009|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
10774611|NCT03307252|11936811|FG010|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
10774612|NCT03307252|11936801|FG000|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
10774613|NCT03307252|11936802|FG001|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
10774614|NCT03307252|11936803|FG002|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
10774615|NCT03307252|11936804|FG003|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
10774616|NCT03307252|11936805|FG004|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
10774617|NCT03307252|11936806|FG005|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
10774618|NCT03307252|11936807|FG006|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
10774619|NCT03307252|11936808|FG007|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
10774620|NCT03307252|11936809|FG008|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
10774621|NCT03307252|11936810|FG009|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
10774622|NCT03307252|11936811|FG010|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
10774623|NCT03307252|11936801|FG000|STARTED|Part 3, Period 3||0
10774624|NCT03307252|11936802|FG001|STARTED|Part 3, Period 3||0
10774625|NCT03307252|11936803|FG002|STARTED|Part 3, Period 3||0
10298084|NCT04110145|11430760|FG003|COMPLETED|Post-Treatment Period (1 Week)||6
10298085|NCT04110145|11430761|FG004|COMPLETED|Post-Treatment Period (1 Week)||8
10298086|NCT04110145|11430757|FG000|NOT COMPLETED|Post-Treatment Period (1 Week)||0
10298087|NCT04110145|11430758|FG001|NOT COMPLETED|Post-Treatment Period (1 Week)||0
10298088|NCT04110145|11430759|FG002|NOT COMPLETED|Post-Treatment Period (1 Week)||0
10298089|NCT04110145|11430760|FG003|NOT COMPLETED|Post-Treatment Period (1 Week)||0
10298090|NCT04110145|11430761|FG004|NOT COMPLETED|Post-Treatment Period (1 Week)||0
10315015|NCT00171834|11448783|FG005|STARTED|Overall Study||35
10315016|NCT00171834|11448784|FG006|STARTED|Overall Study||4
10315017|NCT00171834|11448778|FG000|Completed 6 Cycles of Treatment|Overall Study||0
10774626|NCT03307252|11936804|FG003|STARTED|Part 3, Period 3||0
10774627|NCT03307252|11936805|FG004|STARTED|Part 3, Period 3||0
10774628|NCT03307252|11936806|FG005|STARTED|Part 3, Period 3||0
10774629|NCT03307252|11936807|FG006|STARTED|Part 3, Period 3||0
10774630|NCT03307252|11936808|FG007|STARTED|Part 3, Period 3||4
10774631|NCT03307252|11936809|FG008|STARTED|Part 3, Period 3||4
10774632|NCT03307252|11936810|FG009|STARTED|Part 3, Period 3||4
10774633|NCT03307252|11936811|FG010|STARTED|Part 3, Period 3||4
10774634|NCT03307252|11936801|FG000|COMPLETED|Part 3, Period 3||0
10774635|NCT03307252|11936802|FG001|COMPLETED|Part 3, Period 3||0
10774636|NCT03307252|11936803|FG002|COMPLETED|Part 3, Period 3||0
10774637|NCT03307252|11936804|FG003|COMPLETED|Part 3, Period 3||0
10774638|NCT03307252|11936805|FG004|COMPLETED|Part 3, Period 3||0
10774639|NCT03307252|11936806|FG005|COMPLETED|Part 3, Period 3||0
10774640|NCT03307252|11936807|FG006|COMPLETED|Part 3, Period 3||0
10774641|NCT03307252|11936808|FG007|COMPLETED|Part 3, Period 3||4
10774642|NCT03307252|11936809|FG008|COMPLETED|Part 3, Period 3||4
10774643|NCT03307252|11936810|FG009|COMPLETED|Part 3, Period 3||4
10774644|NCT03307252|11936811|FG010|COMPLETED|Part 3, Period 3||4
10774645|NCT03307252|11936801|FG000|NOT COMPLETED|Part 3, Period 3||0
10774646|NCT03307252|11936802|FG001|NOT COMPLETED|Part 3, Period 3||0
10774647|NCT03307252|11936803|FG002|NOT COMPLETED|Part 3, Period 3||0
10774648|NCT03307252|11936804|FG003|NOT COMPLETED|Part 3, Period 3||0
10774649|NCT03307252|11936805|FG004|NOT COMPLETED|Part 3, Period 3||0
10774650|NCT03307252|11936806|FG005|NOT COMPLETED|Part 3, Period 3||0
10774651|NCT03307252|11936807|FG006|NOT COMPLETED|Part 3, Period 3||0
10298091|NCT03986866|11430775|FG000|STARTED|Overall Study||55
10298092|NCT03986866|11430776|FG001|STARTED|Overall Study||55
10298093|NCT03986866|11430775|FG000|COMPLETED|Overall Study||53
10298094|NCT03986866|11430776|FG001|COMPLETED|Overall Study||50
10298095|NCT03986866|11430775|FG000|NOT COMPLETED|Overall Study||2
10298096|NCT03986866|11430776|FG001|NOT COMPLETED|Overall Study||5
10298097|NCT03636269|11430784|FG000|STARTED|Period 1: Double-blind Phase||235
10298098|NCT03636269|11430785|FG001|STARTED|Period 1: Double-blind Phase||236
10298099|NCT03636269|11430786|FG002|STARTED|Period 1: Double-blind Phase||0
10298100|NCT03636269|11430784|FG000|COMPLETED|Period 1: Double-blind Phase||206
10298101|NCT03636269|11430785|FG001|COMPLETED|Period 1: Double-blind Phase||223
10298102|NCT03636269|11430786|FG002|COMPLETED|Period 1: Double-blind Phase||0
10298103|NCT03636269|11430784|FG000|NOT COMPLETED|Period 1: Double-blind Phase||29
10298104|NCT03636269|11430785|FG001|NOT COMPLETED|Period 1: Double-blind Phase||13
10298105|NCT03636269|11430786|FG002|NOT COMPLETED|Period 1: Double-blind Phase||0
10298106|NCT03636269|11430784|FG000|STARTED|Period 2: Open-label Phase||0
10298107|NCT03636269|11430785|FG001|STARTED|Period 2: Open-label Phase||0
10298108|NCT03636269|11430786|FG002|STARTED|Period 2: Open-label Phase||399
10298109|NCT03636269|11430784|FG000|COMPLETED|Period 2: Open-label Phase||0
10298110|NCT03636269|11430785|FG001|COMPLETED|Period 2: Open-label Phase||0
10298111|NCT03636269|11430786|FG002|COMPLETED|Period 2: Open-label Phase||5
10298112|NCT03636269|11430784|FG000|NOT COMPLETED|Period 2: Open-label Phase||0
10298113|NCT03636269|11430785|FG001|NOT COMPLETED|Period 2: Open-label Phase||0
10298114|NCT03636269|11430786|FG002|NOT COMPLETED|Period 2: Open-label Phase||394
10298115|NCT03527264|11430799|FG000|STARTED|Overall Study||3
10298116|NCT03527264|11430800|FG001|STARTED|Overall Study||1
10298117|NCT03527264|11430801|FG002|STARTED|Overall Study||0
10298118|NCT03527264|11430802|FG003|STARTED|Overall Study||0
10298119|NCT03527264|11430799|FG000|COMPLETED|Overall Study||3
10298120|NCT03527264|11430800|FG001|COMPLETED|Overall Study||1
10298121|NCT03527264|11430801|FG002|COMPLETED|Overall Study||0
10298122|NCT03527264|11430802|FG003|COMPLETED|Overall Study||0
10298123|NCT03527264|11430799|FG000|NOT COMPLETED|Overall Study||0
10298124|NCT03527264|11430800|FG001|NOT COMPLETED|Overall Study||0
10298125|NCT03527264|11430801|FG002|NOT COMPLETED|Overall Study||0
10298126|NCT03527264|11430802|FG003|NOT COMPLETED|Overall Study||0
10298127|NCT03447314|11430826|FG000|STARTED|Part 1 (Up to 27 Months)||9
10298128|NCT03447314|11430827|FG001|STARTED|Part 1 (Up to 27 Months)||6
10298129|NCT03447314|11430828|FG002|STARTED|Part 1 (Up to 27 Months)||9
10298130|NCT03447314|11430829|FG003|STARTED|Part 1 (Up to 27 Months)||4
10298131|NCT03447314|11430830|FG004|STARTED|Part 1 (Up to 27 Months)||2
10298132|NCT03447314|11430831|FG005|STARTED|Part 1 (Up to 27 Months)||6
10298133|NCT03447314|11430832|FG006|STARTED|Part 1 (Up to 27 Months)||5
10298134|NCT03447314|11430833|FG007|STARTED|Part 1 (Up to 27 Months)||0
10298135|NCT03447314|11430834|FG008|STARTED|Part 1 (Up to 27 Months)||0
10298136|NCT03447314|11430835|FG009|STARTED|Part 1 (Up to 27 Months)||0
10298137|NCT03447314|11430836|FG010|STARTED|Part 1 (Up to 27 Months)||7
10298138|NCT03447314|11430837|FG011|STARTED|Part 1 (Up to 27 Months)||6
10298139|NCT03447314|11430838|FG012|STARTED|Part 1 (Up to 27 Months)||0
10298140|NCT03447314|11430839|FG013|STARTED|Part 1 (Up to 27 Months)||0
10298141|NCT03447314|11430840|FG014|STARTED|Part 1 (Up to 27 Months)||0
10298142|NCT03447314|11430841|FG015|STARTED|Part 1 (Up to 27 Months)||0
10298143|NCT03447314|11430842|FG016|STARTED|Part 1 (Up to 27 Months)||0
10298144|NCT03447314|11430843|FG017|STARTED|Part 1 (Up to 27 Months)||0
10298145|NCT03447314|11430826|FG000|COMPLETED|Part 1 (Up to 27 Months)||0
10298146|NCT03447314|11430827|FG001|COMPLETED|Part 1 (Up to 27 Months)||0
10298147|NCT03447314|11430828|FG002|COMPLETED|Part 1 (Up to 27 Months)||0
10298148|NCT03447314|11430829|FG003|COMPLETED|Part 1 (Up to 27 Months)||0
10298149|NCT03447314|11430830|FG004|COMPLETED|Part 1 (Up to 27 Months)||0
10298150|NCT03447314|11430831|FG005|COMPLETED|Part 1 (Up to 27 Months)||0
10298151|NCT03447314|11430832|FG006|COMPLETED|Part 1 (Up to 27 Months)||0
10298152|NCT03447314|11430833|FG007|COMPLETED|Part 1 (Up to 27 Months)||0
10298153|NCT03447314|11430834|FG008|COMPLETED|Part 1 (Up to 27 Months)||0
10298154|NCT03447314|11430835|FG009|COMPLETED|Part 1 (Up to 27 Months)||0
10298155|NCT03447314|11430836|FG010|COMPLETED|Part 1 (Up to 27 Months)||0
10298156|NCT03447314|11430837|FG011|COMPLETED|Part 1 (Up to 27 Months)||0
10298157|NCT03447314|11430838|FG012|COMPLETED|Part 1 (Up to 27 Months)||0
10298158|NCT03447314|11430839|FG013|COMPLETED|Part 1 (Up to 27 Months)||0
10298159|NCT03447314|11430840|FG014|COMPLETED|Part 1 (Up to 27 Months)||0
10298160|NCT03447314|11430841|FG015|COMPLETED|Part 1 (Up to 27 Months)||0
10298161|NCT03447314|11430842|FG016|COMPLETED|Part 1 (Up to 27 Months)||0
10298162|NCT03447314|11430843|FG017|COMPLETED|Part 1 (Up to 27 Months)||0
10298163|NCT03447314|11430826|FG000|NOT COMPLETED|Part 1 (Up to 27 Months)||9
10298164|NCT03447314|11430827|FG001|NOT COMPLETED|Part 1 (Up to 27 Months)||6
10298165|NCT03447314|11430828|FG002|NOT COMPLETED|Part 1 (Up to 27 Months)||9
10298166|NCT03447314|11430829|FG003|NOT COMPLETED|Part 1 (Up to 27 Months)||4
10298167|NCT03447314|11430830|FG004|NOT COMPLETED|Part 1 (Up to 27 Months)||2
10298168|NCT03447314|11430831|FG005|NOT COMPLETED|Part 1 (Up to 27 Months)||6
10298169|NCT03447314|11430832|FG006|NOT COMPLETED|Part 1 (Up to 27 Months)||5
10298170|NCT03447314|11430833|FG007|NOT COMPLETED|Part 1 (Up to 27 Months)||0
10298171|NCT03447314|11430834|FG008|NOT COMPLETED|Part 1 (Up to 27 Months)||0
10298172|NCT03447314|11430835|FG009|NOT COMPLETED|Part 1 (Up to 27 Months)||0
10298173|NCT03447314|11430836|FG010|NOT COMPLETED|Part 1 (Up to 27 Months)||7
10298174|NCT03447314|11430837|FG011|NOT COMPLETED|Part 1 (Up to 27 Months)||6
10298175|NCT03447314|11430838|FG012|NOT COMPLETED|Part 1 (Up to 27 Months)||0
10298176|NCT03447314|11430839|FG013|NOT COMPLETED|Part 1 (Up to 27 Months)||0
10298177|NCT03447314|11430840|FG014|NOT COMPLETED|Part 1 (Up to 27 Months)||0
10298178|NCT03447314|11430841|FG015|NOT COMPLETED|Part 1 (Up to 27 Months)||0
10298179|NCT03447314|11430842|FG016|NOT COMPLETED|Part 1 (Up to 27 Months)||0
10298180|NCT03447314|11430843|FG017|NOT COMPLETED|Part 1 (Up to 27 Months)||0
10298181|NCT03447314|11430826|FG000|STARTED|Part 2 (Up to 27 Months)||0
10298182|NCT03447314|11430827|FG001|STARTED|Part 2 (Up to 27 Months)||0
10298183|NCT03447314|11430828|FG002|STARTED|Part 2 (Up to 27 Months)||0
10298184|NCT03447314|11430829|FG003|STARTED|Part 2 (Up to 27 Months)||0
10298185|NCT03447314|11430830|FG004|STARTED|Part 2 (Up to 27 Months)||0
10298186|NCT03447314|11430831|FG005|STARTED|Part 2 (Up to 27 Months)||0
10298187|NCT03447314|11430832|FG006|STARTED|Part 2 (Up to 27 Months)||0
10298188|NCT03447314|11430833|FG007|STARTED|Part 2 (Up to 27 Months)||0
10298189|NCT03447314|11430834|FG008|STARTED|Part 2 (Up to 27 Months)||0
10298190|NCT03447314|11430835|FG009|STARTED|Part 2 (Up to 27 Months)||0
10298191|NCT03447314|11430836|FG010|STARTED|Part 2 (Up to 27 Months)||0
10298192|NCT03447314|11430837|FG011|STARTED|Part 2 (Up to 27 Months)||0
10298193|NCT03447314|11430838|FG012|STARTED|Part 2 (Up to 27 Months)||0
10298194|NCT03447314|11430839|FG013|STARTED|Part 2 (Up to 27 Months)||0
10298195|NCT03447314|11430840|FG014|STARTED|Part 2 (Up to 27 Months)||0
10298196|NCT03447314|11430841|FG015|STARTED|Part 2 (Up to 27 Months)||0
10298197|NCT03447314|11430842|FG016|STARTED|Part 2 (Up to 27 Months)||0
10298198|NCT03447314|11430843|FG017|STARTED|Part 2 (Up to 27 Months)||0
10298199|NCT03447314|11430826|FG000|COMPLETED|Part 2 (Up to 27 Months)||0
10298200|NCT03447314|11430827|FG001|COMPLETED|Part 2 (Up to 27 Months)||0
10298201|NCT03447314|11430828|FG002|COMPLETED|Part 2 (Up to 27 Months)||0
10298202|NCT03447314|11430829|FG003|COMPLETED|Part 2 (Up to 27 Months)||0
10298203|NCT03447314|11430830|FG004|COMPLETED|Part 2 (Up to 27 Months)||0
10298204|NCT03447314|11430831|FG005|COMPLETED|Part 2 (Up to 27 Months)||0
10298205|NCT03447314|11430832|FG006|COMPLETED|Part 2 (Up to 27 Months)||0
10298206|NCT03447314|11430833|FG007|COMPLETED|Part 2 (Up to 27 Months)||0
10298207|NCT03447314|11430834|FG008|COMPLETED|Part 2 (Up to 27 Months)||0
10298208|NCT03447314|11430835|FG009|COMPLETED|Part 2 (Up to 27 Months)||0
10298209|NCT03447314|11430836|FG010|COMPLETED|Part 2 (Up to 27 Months)||0
10298210|NCT03447314|11430837|FG011|COMPLETED|Part 2 (Up to 27 Months)||0
10298211|NCT03447314|11430838|FG012|COMPLETED|Part 2 (Up to 27 Months)||0
10298212|NCT03447314|11430839|FG013|COMPLETED|Part 2 (Up to 27 Months)||0
10298213|NCT03447314|11430840|FG014|COMPLETED|Part 2 (Up to 27 Months)||0
10298214|NCT03447314|11430841|FG015|COMPLETED|Part 2 (Up to 27 Months)||0
10298215|NCT03447314|11430842|FG016|COMPLETED|Part 2 (Up to 27 Months)||0
10298216|NCT03447314|11430843|FG017|COMPLETED|Part 2 (Up to 27 Months)||0
10298217|NCT03447314|11430826|FG000|NOT COMPLETED|Part 2 (Up to 27 Months)||0
10298218|NCT03447314|11430827|FG001|NOT COMPLETED|Part 2 (Up to 27 Months)||0
10298219|NCT03447314|11430828|FG002|NOT COMPLETED|Part 2 (Up to 27 Months)||0
10298220|NCT03447314|11430829|FG003|NOT COMPLETED|Part 2 (Up to 27 Months)||0
10298221|NCT03447314|11430830|FG004|NOT COMPLETED|Part 2 (Up to 27 Months)||0
10298222|NCT03447314|11430831|FG005|NOT COMPLETED|Part 2 (Up to 27 Months)||0
10298223|NCT03447314|11430832|FG006|NOT COMPLETED|Part 2 (Up to 27 Months)||0
10298224|NCT03447314|11430833|FG007|NOT COMPLETED|Part 2 (Up to 27 Months)||0
10298225|NCT03447314|11430834|FG008|NOT COMPLETED|Part 2 (Up to 27 Months)||0
10298226|NCT03447314|11430835|FG009|NOT COMPLETED|Part 2 (Up to 27 Months)||0
10298227|NCT03447314|11430836|FG010|NOT COMPLETED|Part 2 (Up to 27 Months)||0
10298228|NCT03447314|11430837|FG011|NOT COMPLETED|Part 2 (Up to 27 Months)||0
10298229|NCT03447314|11430838|FG012|NOT COMPLETED|Part 2 (Up to 27 Months)||0
10298230|NCT03447314|11430839|FG013|NOT COMPLETED|Part 2 (Up to 27 Months)||0
10298231|NCT03447314|11430840|FG014|NOT COMPLETED|Part 2 (Up to 27 Months)||0
10298232|NCT03447314|11430841|FG015|NOT COMPLETED|Part 2 (Up to 27 Months)||0
10298233|NCT03447314|11430842|FG016|NOT COMPLETED|Part 2 (Up to 27 Months)||0
10298234|NCT03447314|11430843|FG017|NOT COMPLETED|Part 2 (Up to 27 Months)||0
10298235|NCT03422653|11430886|FG000|STARTED|Period 1: Double-blind Phase||189
10298236|NCT03422653|11430887|FG001|STARTED|Period 1: Double-blind Phase||189
10298237|NCT03422653|11430888|FG002|STARTED|Period 1: Double-blind Phase||0
10298238|NCT03422653|11430886|FG000|COMPLETED|Period 1: Double-blind Phase||162
10298239|NCT03422653|11430887|FG001|COMPLETED|Period 1: Double-blind Phase||170
10298240|NCT03422653|11430888|FG002|COMPLETED|Period 1: Double-blind Phase||0
10298241|NCT03422653|11430886|FG000|NOT COMPLETED|Period 1: Double-blind Phase||27
10298242|NCT03422653|11430887|FG001|NOT COMPLETED|Period 1: Double-blind Phase||19
10298243|NCT03422653|11430888|FG002|NOT COMPLETED|Period 1: Double-blind Phase||0
10298244|NCT03422653|11430886|FG000|STARTED|Period 2: Open-label Phase||0
10298245|NCT03422653|11430887|FG001|STARTED|Period 2: Open-label Phase||0
10298246|NCT03422653|11430888|FG002|STARTED|Period 2: Open-label Phase||313
10298247|NCT03422653|11430886|FG000|COMPLETED|Period 2: Open-label Phase||0
10298248|NCT03422653|11430887|FG001|COMPLETED|Period 2: Open-label Phase||0
10298249|NCT03422653|11430888|FG002|COMPLETED|Period 2: Open-label Phase||189
10298250|NCT03422653|11430886|FG000|NOT COMPLETED|Period 2: Open-label Phase||0
10298251|NCT03422653|11430887|FG001|NOT COMPLETED|Period 2: Open-label Phase||0
10298252|NCT03422653|11430888|FG002|NOT COMPLETED|Period 2: Open-label Phase||124
10298253|NCT03320330|11430900|FG000|STARTED|Overall Study||6
10298254|NCT03320330|11430901|FG001|STARTED|Overall Study||6
10298255|NCT03320330|11430902|FG002|STARTED|Overall Study||14
10298256|NCT03320330|11430900|FG000|COMPLETED|Overall Study||0
10298257|NCT03320330|11430901|FG001|COMPLETED|Overall Study||1
10298258|NCT03320330|11430902|FG002|COMPLETED|Overall Study||0
10298259|NCT03320330|11430900|FG000|NOT COMPLETED|Overall Study||6
10298260|NCT03320330|11430901|FG001|NOT COMPLETED|Overall Study||5
10298261|NCT03320330|11430902|FG002|NOT COMPLETED|Overall Study||14
10298262|NCT03271151|11430913|FG000|STARTED|Overall Study||80
10298263|NCT03271151|11430914|FG001|STARTED|Overall Study||80
10298264|NCT03271151|11430913|FG000|COMPLETED|Overall Study||78
10298265|NCT03271151|11430914|FG001|COMPLETED|Overall Study||77
10298266|NCT03271151|11430913|FG000|NOT COMPLETED|Overall Study||2
10298267|NCT03271151|11430914|FG001|NOT COMPLETED|Overall Study||3
10774652|NCT03307252|11936808|FG007|NOT COMPLETED|Part 3, Period 3||0
10774653|NCT03307252|11936809|FG008|NOT COMPLETED|Part 3, Period 3||0
10298286|NCT03023813|11430946|FG000|STARTED|Overall Study||39
10298287|NCT03023813|11430947|FG001|STARTED|Overall Study||34
10298288|NCT03023813|11430948|FG002|STARTED|Overall Study||31
10298289|NCT03023813|11430946|FG000|COMPLETED|Overall Study||38
10298290|NCT03023813|11430947|FG001|COMPLETED|Overall Study||32
10298291|NCT03023813|11430948|FG002|COMPLETED|Overall Study||31
10298292|NCT03023813|11430946|FG000|NOT COMPLETED|Overall Study||1
10298293|NCT03023813|11430947|FG001|NOT COMPLETED|Overall Study||2
10298294|NCT03023813|11430948|FG002|NOT COMPLETED|Overall Study||0
10298295|NCT02993822|11430961|FG000|STARTED|Overall Study||79
10298296|NCT02993822|11430962|FG001|STARTED|Overall Study||78
10298297|NCT02993822|11430963|FG002|STARTED|Overall Study||79
10298298|NCT02993822|11430964|FG003|STARTED|Overall Study||79
10298299|NCT02993822|11430961|FG000|COMPLETED|Overall Study||69
10298300|NCT02993822|11430962|FG001|COMPLETED|Overall Study||74
10298301|NCT02993822|11430963|FG002|COMPLETED|Overall Study||69
10298302|NCT02993822|11430964|FG003|COMPLETED|Overall Study||75
10298303|NCT02993822|11430961|FG000|NOT COMPLETED|Overall Study||10
10298304|NCT02993822|11430962|FG001|NOT COMPLETED|Overall Study||4
10298305|NCT02993822|11430963|FG002|NOT COMPLETED|Overall Study||10
10298306|NCT02993822|11430964|FG003|NOT COMPLETED|Overall Study||4
10315018|NCT00171834|11448779|FG001|Completed 6 Cycles of Treatment|Overall Study||0
10315019|NCT00171834|11448780|FG002|Completed 6 Cycles of Treatment|Overall Study||1
10315020|NCT00171834|11448781|FG003|Completed 6 Cycles of Treatment|Overall Study||0
10315021|NCT00171834|11448782|FG004|Completed 6 Cycles of Treatment|Overall Study||2
10315022|NCT00171834|11448783|FG005|Completed 6 Cycles of Treatment|Overall Study||1
10315023|NCT00171834|11448784|FG006|Completed 6 Cycles of Treatment|Overall Study||0
10315024|NCT00171834|11448778|FG000|COMPLETED|Overall Study||0
10315025|NCT00171834|11448779|FG001|COMPLETED|Overall Study||0
10315026|NCT00171834|11448780|FG002|COMPLETED|Overall Study||0
10315027|NCT00171834|11448781|FG003|COMPLETED|Overall Study||0
10315028|NCT00171834|11448782|FG004|COMPLETED|Overall Study||0
10315029|NCT00171834|11448783|FG005|COMPLETED|Overall Study||0
10315030|NCT00171834|11448784|FG006|COMPLETED|Overall Study||0
10315031|NCT00171834|11448778|FG000|NOT COMPLETED|Overall Study||6
10315032|NCT00171834|11448779|FG001|NOT COMPLETED|Overall Study||12
10315033|NCT00171834|11448780|FG002|NOT COMPLETED|Overall Study||12
10315034|NCT00171834|11448781|FG003|NOT COMPLETED|Overall Study||12
10315035|NCT00171834|11448782|FG004|NOT COMPLETED|Overall Study||8
10315036|NCT00171834|11448783|FG005|NOT COMPLETED|Overall Study||35
10315037|NCT00171834|11448784|FG006|NOT COMPLETED|Overall Study||4
10298307|NCT02924324|11430976|FG000|STARTED|Overall Study||28
10298308|NCT02924324|11430977|FG001|STARTED|Overall Study||28
10298309|NCT02924324|11430976|FG000|COMPLETED|Overall Study||28
10298310|NCT02924324|11430977|FG001|COMPLETED|Overall Study||28
10298311|NCT02924324|11430976|FG000|NOT COMPLETED|Overall Study||0
10298312|NCT02924324|11430977|FG001|NOT COMPLETED|Overall Study||0
10298313|NCT02828917|11430983|FG000|STARTED|Overall Study||104
10298314|NCT02828917|11430983|FG000|COMPLETED|Overall Study||104
10298315|NCT02828917|11430983|FG000|NOT COMPLETED|Overall Study||0
10298316|NCT02753127|11430989|FG000|STARTED|Overall Study||624
10298317|NCT02753127|11430990|FG001|STARTED|Overall Study||629
10298318|NCT02753127|11430989|FG000|Discontinued Due to Death|Overall Study||507
10298319|NCT02753127|11430990|FG001|Discontinued Due to Death|Overall Study||499
10298320|NCT02753127|11430989|FG000|Completion of Survival Follow-Up Due to Study Completion|Overall Study||64
10298321|NCT02753127|11430990|FG001|Completion of Survival Follow-Up Due to Study Completion|Overall Study||62
10298322|NCT02753127|11430989|FG000|COMPLETED|Overall Study||571
10298323|NCT02753127|11430990|FG001|COMPLETED|Overall Study||561
10298324|NCT02753127|11430989|FG000|NOT COMPLETED|Overall Study||53
10298325|NCT02753127|11430990|FG001|NOT COMPLETED|Overall Study||68
10298326|NCT02744430|11431006|FG000|STARTED|Overall Study||17
10298327|NCT02744430|11431007|FG001|STARTED|Overall Study||16
10298328|NCT02744430|11431006|FG000|COMPLETED|Overall Study||17
10298329|NCT02744430|11431007|FG001|COMPLETED|Overall Study||16
10298330|NCT02744430|11431006|FG000|NOT COMPLETED|Overall Study||0
10298331|NCT02744430|11431007|FG001|NOT COMPLETED|Overall Study||0
10298338|NCT02260869|11431026|FG000|STARTED|Overall Study||38
10298339|NCT02260869|11431027|FG001|STARTED|Overall Study||37
10298340|NCT02260869|11431026|FG000|COMPLETED|Overall Study||31
10298341|NCT02260869|11431027|FG001|COMPLETED|Overall Study||29
10298342|NCT02260869|11431026|FG000|NOT COMPLETED|Overall Study||7
10298343|NCT02260869|11431027|FG001|NOT COMPLETED|Overall Study||8
10298344|NCT02255838|11431033|FG000|STARTED|Overall Study||6
10298345|NCT02255838|11431034|FG001|STARTED|Overall Study||6
10298346|NCT02255838|11431033|FG000|COMPLETED|Overall Study||6
10298347|NCT02255838|11431034|FG001|COMPLETED|Overall Study||6
10298348|NCT02255838|11431033|FG000|NOT COMPLETED|Overall Study||0
10298349|NCT02255838|11431034|FG001|NOT COMPLETED|Overall Study||0
10298350|NCT02151526|11431044|FG000|STARTED|Overall Study||3
10298351|NCT02151526|11431045|FG001|STARTED|Overall Study||4
10298352|NCT02151526|11431044|FG000|COMPLETED|Overall Study||3
10298353|NCT02151526|11431045|FG001|COMPLETED|Overall Study||4
10298354|NCT02151526|11431044|FG000|NOT COMPLETED|Overall Study||0
10298355|NCT02151526|11431045|FG001|NOT COMPLETED|Overall Study||0
10298356|NCT02119468|11431055|FG000|STARTED|Overall Study||7
10298357|NCT02119468|11431056|FG001|STARTED|Overall Study||25
10298358|NCT02119468|11431055|FG000|COMPLETED|Overall Study||7
10298359|NCT02119468|11431056|FG001|COMPLETED|Overall Study||25
10298360|NCT02119468|11431055|FG000|NOT COMPLETED|Overall Study||0
10298361|NCT02119468|11431056|FG001|NOT COMPLETED|Overall Study||0
10298362|NCT01960530|11431063|FG000|STARTED|Overall Study||14
10298363|NCT01960530|11431063|FG000|COMPLETED|Overall Study||14
10298364|NCT01960530|11431063|FG000|NOT COMPLETED|Overall Study||0
10298365|NCT01516216|11431080|FG000|STARTED|Overall Study||70
10298366|NCT01516216|11431081|FG001|STARTED|Overall Study||69
10298367|NCT01516216|11431080|FG000|AE Evaluable|Overall Study||67
10298368|NCT01516216|11431081|FG001|AE Evaluable|Overall Study||68
10298369|NCT01516216|11431080|FG000|Response Evaluable|Overall Study||62
10298370|NCT01516216|11431081|FG001|Response Evaluable|Overall Study||66
10298371|NCT01516216|11431080|FG000|COMPLETED|Overall Study||0
10298372|NCT01516216|11431081|FG001|COMPLETED|Overall Study||0
10298373|NCT01516216|11431080|FG000|NOT COMPLETED|Overall Study||70
10298374|NCT01516216|11431081|FG001|NOT COMPLETED|Overall Study||69
10298375|NCT00519818|11431089|FG000|STARTED|Overall Study||14
10298376|NCT00519818|11431089|FG000|COMPLETED|Overall Study||14
10298377|NCT00519818|11431089|FG000|NOT COMPLETED|Overall Study||0
10298378|NCT00006178|11431095|FG000|STARTED|Overall Study||12
10298379|NCT00006178|11431095|FG000|COMPLETED|Overall Study||12
10298380|NCT00006178|11431095|FG000|NOT COMPLETED|Overall Study||0
10298381|NCT00006184|11431101|FG000|STARTED|Overall Study||10
10298382|NCT00006184|11431102|FG001|STARTED|Overall Study||10
10298383|NCT00006184|11431101|FG000|COMPLETED|Overall Study||9
10298384|NCT00006184|11431102|FG001|COMPLETED|Overall Study||10
10298385|NCT00006184|11431101|FG000|NOT COMPLETED|Overall Study||1
10298386|NCT00006184|11431102|FG001|NOT COMPLETED|Overall Study||0
10298387|NCT00006227|11431108|FG000|STARTED|Overall Study||31
10298388|NCT00006227|11431108|FG000|COMPLETED|Overall Study||31
10298389|NCT00006227|11431108|FG000|NOT COMPLETED|Overall Study||0
10298390|NCT00006237|11431114|FG000|STARTED|Overall Study||212
10298391|NCT00006237|11431115|FG001|STARTED|Overall Study||220
10298392|NCT00006237|11431114|FG000|Eligible|Overall Study||203
10298393|NCT00006237|11431115|FG001|Eligible|Overall Study||200
10298394|NCT00006237|11431114|FG000|Eligible and Treated|Overall Study||203
10298395|NCT00006237|11431115|FG001|Eligible and Treated|Overall Study||199
10298396|NCT00006237|11431114|FG000|COMPLETED|Overall Study||87
10298397|NCT00006237|11431115|FG001|COMPLETED|Overall Study||159
10298398|NCT00006237|11431114|FG000|NOT COMPLETED|Overall Study||125
10298399|NCT00006237|11431115|FG001|NOT COMPLETED|Overall Study||61
10298400|NCT00006244|11431124|FG000|STARTED|Overall Study||36
10298401|NCT00006244|11431124|FG000|COMPLETED|Overall Study||36
10298402|NCT00006244|11431124|FG000|NOT COMPLETED|Overall Study||0
10298403|NCT00006289|11431130|FG000|STARTED|First Intervention (5 Weeks)||11
10298404|NCT00006289|11431131|FG001|STARTED|First Intervention (5 Weeks)||10
10298405|NCT00006289|11431130|FG000|COMPLETED|First Intervention (5 Weeks)||10
10298406|NCT00006289|11431131|FG001|COMPLETED|First Intervention (5 Weeks)||10
10298407|NCT00006289|11431130|FG000|NOT COMPLETED|First Intervention (5 Weeks)||1
10298408|NCT00006289|11431131|FG001|NOT COMPLETED|First Intervention (5 Weeks)||0
10298409|NCT00006289|11431130|FG000|STARTED|Washout (>= 1 Week)||10
10298410|NCT00006289|11431131|FG001|STARTED|Washout (>= 1 Week)||10
10298411|NCT00006289|11431130|FG000|COMPLETED|Washout (>= 1 Week)||10
10298412|NCT00006289|11431131|FG001|COMPLETED|Washout (>= 1 Week)||10
10298413|NCT00006289|11431130|FG000|NOT COMPLETED|Washout (>= 1 Week)||0
10298414|NCT00006289|11431131|FG001|NOT COMPLETED|Washout (>= 1 Week)||0
10298415|NCT00006289|11431130|FG000|STARTED|Second Intervention (5 Weeks)||10
10298416|NCT00006289|11431131|FG001|STARTED|Second Intervention (5 Weeks)||10
10298417|NCT00006289|11431130|FG000|COMPLETED|Second Intervention (5 Weeks)||9
10298418|NCT00006289|11431131|FG001|COMPLETED|Second Intervention (5 Weeks)||9
10298419|NCT00006289|11431130|FG000|NOT COMPLETED|Second Intervention (5 Weeks)||1
10298420|NCT00006289|11431131|FG001|NOT COMPLETED|Second Intervention (5 Weeks)||1
10298421|NCT00006305|11431151|FG000|STARTED|Overall Study||592
10298422|NCT00006305|11431152|FG001|STARTED|Overall Study||584
10298423|NCT00006305|11431153|FG002|STARTED|Overall Study||593
10298424|NCT00006305|11431154|FG003|STARTED|Overall Study||599
10298425|NCT00006305|11431151|FG000|COMPLETED|Overall Study||575
10298426|NCT00006305|11431152|FG001|COMPLETED|Overall Study||574
10298427|NCT00006305|11431153|FG002|COMPLETED|Overall Study||578
10298428|NCT00006305|11431154|FG003|COMPLETED|Overall Study||585
10298429|NCT00006305|11431151|FG000|NOT COMPLETED|Overall Study||17
10298430|NCT00006305|11431152|FG001|NOT COMPLETED|Overall Study||10
10298431|NCT00006305|11431153|FG002|NOT COMPLETED|Overall Study||15
10298432|NCT00006305|11431154|FG003|NOT COMPLETED|Overall Study||14
10298433|NCT00006389|11431164|FG000|STARTED|Overall Study||12
10298434|NCT00006389|11431164|FG000|COMPLETED|Overall Study||11
10298435|NCT00006389|11431164|FG000|NOT COMPLETED|Overall Study||1
10298436|NCT00006392|11431173|FG000|STARTED|Overall Study||8904
10298437|NCT00006392|11431174|FG001|STARTED|Overall Study||8910
10298438|NCT00006392|11431175|FG002|STARTED|Overall Study||8863
10298439|NCT00006392|11431176|FG003|STARTED|Overall Study||8856
10298440|NCT00006392|11431173|FG000|COMPLETED|Overall Study||8737
10298441|NCT00006392|11431174|FG001|COMPLETED|Overall Study||8752
10298442|NCT00006392|11431175|FG002|COMPLETED|Overall Study||8703
10298443|NCT00006392|11431176|FG003|COMPLETED|Overall Study||8696
10298444|NCT00006392|11431173|FG000|NOT COMPLETED|Overall Study||167
10298445|NCT00006392|11431174|FG001|NOT COMPLETED|Overall Study||158
10298446|NCT00006392|11431175|FG002|NOT COMPLETED|Overall Study||160
10298447|NCT00006392|11431176|FG003|NOT COMPLETED|Overall Study||160
10298448|NCT00006400|11431188|FG000|STARTED|Overall Study||96
10298449|NCT00006400|11431189|FG001|STARTED|Overall Study||97
10298450|NCT00006400|11431188|FG000|COMPLETED|Overall Study||83
10298451|NCT00006400|11431189|FG001|COMPLETED|Overall Study||84
10298452|NCT00006400|11431188|FG000|NOT COMPLETED|Overall Study||13
10298453|NCT00006400|11431189|FG001|NOT COMPLETED|Overall Study||13
10298454|NCT00006409|11431201|FG000|STARTED|Baseline||865
10298455|NCT00006409|11431202|FG001|STARTED|Baseline||856
10298456|NCT00006409|11431203|FG002|STARTED|Baseline||0
10298457|NCT00006409|11431204|FG003|STARTED|Baseline||0
10298458|NCT00006409|11431205|FG004|STARTED|Baseline||0
10298459|NCT00006409|11431206|FG005|STARTED|Baseline||0
10298460|NCT00006409|11431201|FG000|COMPLETED|Baseline||817
10298461|NCT00006409|11431202|FG001|COMPLETED|Baseline||786
10298462|NCT00006409|11431203|FG002|COMPLETED|Baseline||0
10298463|NCT00006409|11431204|FG003|COMPLETED|Baseline||0
10298464|NCT00006409|11431205|FG004|COMPLETED|Baseline||0
10298465|NCT00006409|11431206|FG005|COMPLETED|Baseline||0
10298466|NCT00006409|11431201|FG000|NOT COMPLETED|Baseline||48
10298467|NCT00006409|11431202|FG001|NOT COMPLETED|Baseline||70
10298468|NCT00006409|11431203|FG002|NOT COMPLETED|Baseline||0
10298469|NCT00006409|11431204|FG003|NOT COMPLETED|Baseline||0
10298470|NCT00006409|11431205|FG004|NOT COMPLETED|Baseline||0
10298471|NCT00006409|11431206|FG005|NOT COMPLETED|Baseline||0
10429546|NCT00864383|11575574|FG000|NOT COMPLETED|Modified Intent to Treat||85
10315038|NCT00171873|11448816|FG000|STARTED|Overall Study||42
10298472|NCT00006409|11431201|FG000|STARTED|Post-2 Year Intervention|6th grade/2003 sample was not followed over time|0
10298473|NCT00006409|11431202|FG001|STARTED|Post-2 Year Intervention|6th grade/2003 sample was not followed over time|0
10298474|NCT00006409|11431203|FG002|STARTED|Post-2 Year Intervention|Sample is independent of 6th-grade/2003 sample that was measured at baseline|1791
10298475|NCT00006409|11431204|FG003|STARTED|Post-2 Year Intervention|Sample is independent of 6th-grade/2003 sample that was measured at baseline|1713
10298476|NCT00006409|11431205|FG004|STARTED|Post-2 Year Intervention||0
10298477|NCT00006409|11431206|FG005|STARTED|Post-2 Year Intervention||0
10298478|NCT00006409|11431201|FG000|COMPLETED|Post-2 Year Intervention||0
10298479|NCT00006409|11431202|FG001|COMPLETED|Post-2 Year Intervention||0
10298480|NCT00006409|11431203|FG002|COMPLETED|Post-2 Year Intervention||1540
10298481|NCT00006409|11431204|FG003|COMPLETED|Post-2 Year Intervention||1545
10298482|NCT00006409|11431205|FG004|COMPLETED|Post-2 Year Intervention||0
10298483|NCT00006409|11431206|FG005|COMPLETED|Post-2 Year Intervention||0
10298484|NCT00006409|11431201|FG000|NOT COMPLETED|Post-2 Year Intervention||0
10298485|NCT00006409|11431202|FG001|NOT COMPLETED|Post-2 Year Intervention||0
10298486|NCT00006409|11431203|FG002|NOT COMPLETED|Post-2 Year Intervention||251
10298487|NCT00006409|11431204|FG003|NOT COMPLETED|Post-2 Year Intervention||168
10298488|NCT00006409|11431205|FG004|NOT COMPLETED|Post-2 Year Intervention||0
10298489|NCT00006409|11431206|FG005|NOT COMPLETED|Post-2 Year Intervention||0
10298490|NCT00006409|11431201|FG000|STARTED|Post-3 Year Intervention||0
10298491|NCT00006409|11431202|FG001|STARTED|Post-3 Year Intervention||0
10298492|NCT00006409|11431203|FG002|STARTED|Post-3 Year Intervention|8th-grade/2005 sample was not followed over time|0
10298493|NCT00006409|11431204|FG003|STARTED|Post-3 Year Intervention|8th-grade/2005 sample was not followed over time|0
10298494|NCT00006409|11431205|FG004|STARTED|Post-3 Year Intervention|Sample is independent of 8th-grade/2005 sample that was measured post-2 year intervention|1726
10298495|NCT00006409|11431206|FG005|STARTED|Post-3 Year Intervention|Sample is independent of 8th-grade/2005 sample that was measured post-2 year intervention|1776
10298496|NCT00006409|11431201|FG000|COMPLETED|Post-3 Year Intervention||0
10298497|NCT00006409|11431202|FG001|COMPLETED|Post-3 Year Intervention||0
10298498|NCT00006409|11431203|FG002|COMPLETED|Post-3 Year Intervention||0
10298499|NCT00006409|11431204|FG003|COMPLETED|Post-3 Year Intervention||0
10298500|NCT00006409|11431205|FG004|COMPLETED|Post-3 Year Intervention||1664
10298501|NCT00006409|11431206|FG005|COMPLETED|Post-3 Year Intervention||1714
10298502|NCT00006409|11431201|FG000|NOT COMPLETED|Post-3 Year Intervention||0
10298503|NCT00006409|11431202|FG001|NOT COMPLETED|Post-3 Year Intervention||0
10298504|NCT00006409|11431203|FG002|NOT COMPLETED|Post-3 Year Intervention||0
10298505|NCT00006409|11431204|FG003|NOT COMPLETED|Post-3 Year Intervention||0
10298506|NCT00006409|11431205|FG004|NOT COMPLETED|Post-3 Year Intervention||62
10298507|NCT00006409|11431206|FG005|NOT COMPLETED|Post-3 Year Intervention||62
10298508|NCT00006411|11431222|FG000|STARTED|Overall Study||707
10298509|NCT00006411|11431223|FG001|STARTED|Overall Study||383
10298510|NCT00006411|11431222|FG000|COMPLETED|Overall Study||707
10298511|NCT00006411|11431223|FG001|COMPLETED|Overall Study||383
10298512|NCT00006411|11431222|FG000|NOT COMPLETED|Overall Study||0
10298513|NCT00006411|11431223|FG001|NOT COMPLETED|Overall Study||0
10298514|NCT00006489|11431233|FG000|STARTED|Overall Study||42
10298515|NCT00006489|11431234|FG001|STARTED|Overall Study||40
10298516|NCT00006489|11431235|FG002|STARTED|Overall Study||40
10298517|NCT00006489|11431236|FG003|STARTED|Overall Study||43
10298518|NCT00006489|11431233|FG000|COMPLETED|Overall Study||29
10298519|NCT00006489|11431234|FG001|COMPLETED|Overall Study||26
10298520|NCT00006489|11431235|FG002|COMPLETED|Overall Study||25
10298521|NCT00006489|11431236|FG003|COMPLETED|Overall Study||32
10298522|NCT00006489|11431233|FG000|NOT COMPLETED|Overall Study||13
10298523|NCT00006489|11431234|FG001|NOT COMPLETED|Overall Study||14
10298524|NCT00006489|11431235|FG002|NOT COMPLETED|Overall Study||15
10298525|NCT00006489|11431236|FG003|NOT COMPLETED|Overall Study||11
10298526|NCT00006604|11431253|FG000|STARTED|Overall Study||6
10298527|NCT00006604|11431254|FG001|STARTED|Overall Study||2
10298528|NCT00006604|11431255|FG002|STARTED|Overall Study||5
10298529|NCT00006604|11431256|FG003|STARTED|Overall Study||6
10298530|NCT00006604|11431257|FG004|STARTED|Overall Study||5
10298531|NCT00006604|11431258|FG005|STARTED|Overall Study||5
10298532|NCT00006604|11431259|FG006|STARTED|Overall Study||21
10298533|NCT00006604|11431260|FG007|STARTED|Overall Study||5
10298534|NCT00006604|11431261|FG008|STARTED|Overall Study||5
10298535|NCT00006604|11431262|FG009|STARTED|Overall Study||25
10421731|NCT00820755|11566599|FG000|STARTED|Period 2: Maintenance Therapy Phase||0
10421732|NCT00820755|11566600|FG001|STARTED|Period 2: Maintenance Therapy Phase||157
10421733|NCT00820755|11566601|FG002|STARTED|Period 2: Maintenance Therapy Phase||154
10421734|NCT00820755|11566599|FG000|COMPLETED|Period 2: Maintenance Therapy Phase||0
10421735|NCT00820755|11566600|FG001|COMPLETED|Period 2: Maintenance Therapy Phase||112
10421736|NCT00820755|11566601|FG002|COMPLETED|Period 2: Maintenance Therapy Phase||109
10421737|NCT00820755|11566599|FG000|NOT COMPLETED|Period 2: Maintenance Therapy Phase||0
10421738|NCT00820755|11566600|FG001|NOT COMPLETED|Period 2: Maintenance Therapy Phase||45
10421739|NCT00820755|11566601|FG002|NOT COMPLETED|Period 2: Maintenance Therapy Phase||45
10421740|NCT00820872|11566609|FG000|STARTED|Overall Study||30
10421741|NCT00820872|11566609|FG000|COMPLETED|Overall Study||30
10421742|NCT00820872|11566609|FG000|NOT COMPLETED|Overall Study||0
10421743|NCT00820898|11566613|FG000|STARTED|Overall Study||24
10421744|NCT00820898|11566613|FG000|COMPLETED|Overall Study||23
10421745|NCT00820898|11566613|FG000|NOT COMPLETED|Overall Study||1
10421746|NCT00821015|11566623|FG000|STARTED|Overall Study||27
10421747|NCT00821015|11566623|FG000|COMPLETED|Overall Study||15
10421748|NCT00821015|11566623|FG000|NOT COMPLETED|Overall Study||12
10421749|NCT00821041|11566629|FG000|STARTED|Overall Study||59
10421750|NCT00821041|11566630|FG001|STARTED|Overall Study||59
10421751|NCT00821041|11566629|FG000|COMPLETED|Overall Study||59
10421752|NCT00821041|11566630|FG001|COMPLETED|Overall Study||59
10421753|NCT00821041|11566629|FG000|NOT COMPLETED|Overall Study||0
10421754|NCT00821041|11566630|FG001|NOT COMPLETED|Overall Study||0
10421755|NCT00821093|11566638|FG000|STARTED|Overall Study||560
10421756|NCT00821093|11566639|FG001|STARTED|Overall Study||563
10421757|NCT00821093|11566638|FG000|Exposed to Drug|Overall Study||559
10421758|NCT00821093|11566639|FG001|Exposed to Drug|Overall Study||562
10421759|NCT00821093|11566638|FG000|COMPLETED|Overall Study||511
10421760|NCT00821093|11566639|FG001|COMPLETED|Overall Study||523
10298536|NCT00006604|11431263|FG010|STARTED|Overall Study||21
10421761|NCT00821093|11566638|FG000|NOT COMPLETED|Overall Study||49
10421762|NCT00821093|11566639|FG001|NOT COMPLETED|Overall Study||40
10421763|NCT00821119|11566647|FG000|STARTED|Overall Study||100
10421764|NCT00821119|11566648|FG001|STARTED|Overall Study||100
10298537|NCT00006604|11431264|FG011|STARTED|Overall Study||12
10298538|NCT00006604|11431265|FG012|STARTED|Overall Study||26
10298539|NCT00006604|11431266|FG013|STARTED|Overall Study||6
10298540|NCT00006604|11431267|FG014|STARTED|Overall Study||24
10298541|NCT00006604|11431268|FG015|STARTED|Overall Study||6
10298542|NCT00006604|11431269|FG016|STARTED|Overall Study||15
10298543|NCT00006604|11431253|FG000|COMPLETED|Overall Study||4
10298544|NCT00006604|11431254|FG001|COMPLETED|Overall Study||2
10298545|NCT00006604|11431255|FG002|COMPLETED|Overall Study||1
10298546|NCT00006604|11431256|FG003|COMPLETED|Overall Study||1
10298547|NCT00006604|11431257|FG004|COMPLETED|Overall Study||3
10298548|NCT00006604|11431258|FG005|COMPLETED|Overall Study||2
10298549|NCT00006604|11431259|FG006|COMPLETED|Overall Study||12
10298550|NCT00006604|11431260|FG007|COMPLETED|Overall Study||2
10298551|NCT00006604|11431261|FG008|COMPLETED|Overall Study||4
10298552|NCT00006604|11431262|FG009|COMPLETED|Overall Study||6
10298553|NCT00006604|11431263|FG010|COMPLETED|Overall Study||13
10298554|NCT00006604|11431264|FG011|COMPLETED|Overall Study||6
10298555|NCT00006604|11431265|FG012|COMPLETED|Overall Study||22
10298556|NCT00006604|11431266|FG013|COMPLETED|Overall Study||0
10298557|NCT00006604|11431267|FG014|COMPLETED|Overall Study||14
10298558|NCT00006604|11431268|FG015|COMPLETED|Overall Study||1
10298559|NCT00006604|11431269|FG016|COMPLETED|Overall Study||6
10298560|NCT00006604|11431253|FG000|NOT COMPLETED|Overall Study||2
10298561|NCT00006604|11431254|FG001|NOT COMPLETED|Overall Study||0
10298562|NCT00006604|11431255|FG002|NOT COMPLETED|Overall Study||4
10298563|NCT00006604|11431256|FG003|NOT COMPLETED|Overall Study||5
10298564|NCT00006604|11431257|FG004|NOT COMPLETED|Overall Study||2
10298565|NCT00006604|11431258|FG005|NOT COMPLETED|Overall Study||3
10298566|NCT00006604|11431259|FG006|NOT COMPLETED|Overall Study||9
10298567|NCT00006604|11431260|FG007|NOT COMPLETED|Overall Study||3
10298568|NCT00006604|11431261|FG008|NOT COMPLETED|Overall Study||1
10298569|NCT00006604|11431262|FG009|NOT COMPLETED|Overall Study||19
10298570|NCT00006604|11431263|FG010|NOT COMPLETED|Overall Study||8
10298571|NCT00006604|11431264|FG011|NOT COMPLETED|Overall Study||6
10298572|NCT00006604|11431265|FG012|NOT COMPLETED|Overall Study||4
10298573|NCT00006604|11431266|FG013|NOT COMPLETED|Overall Study||6
10298574|NCT00006604|11431267|FG014|NOT COMPLETED|Overall Study||10
10298575|NCT00006604|11431268|FG015|NOT COMPLETED|Overall Study||5
10298576|NCT00006604|11431269|FG016|NOT COMPLETED|Overall Study||9
10298592|NCT00006903|11431309|FG000|STARTED|Overall Study||10
10298593|NCT00006903|11431310|FG001|STARTED|Overall Study||24
10298594|NCT00006903|11431311|FG002|STARTED|Overall Study||33
10298595|NCT00006903|11431309|FG000|COMPLETED|Overall Study||0
10298596|NCT00006903|11431310|FG001|COMPLETED|Overall Study||20
10298597|NCT00006903|11431311|FG002|COMPLETED|Overall Study||27
10298598|NCT00006903|11431309|FG000|NOT COMPLETED|Overall Study||10
10298599|NCT00006903|11431310|FG001|NOT COMPLETED|Overall Study||4
10298600|NCT00006903|11431311|FG002|NOT COMPLETED|Overall Study||6
10298601|NCT00007020|11431319|FG000|STARTED|Overall Study||85
10298602|NCT00007020|11431319|FG000|COMPLETED|Overall Study||41
10298603|NCT00007020|11431319|FG000|NOT COMPLETED|Overall Study||44
10298604|NCT00007345|11431327|FG000|STARTED|Overall Study||47
10298605|NCT00007345|11431328|FG001|STARTED|Overall Study||84
10298606|NCT00007345|11431327|FG000|COMPLETED|Overall Study||45
10298607|NCT00007345|11431328|FG001|COMPLETED|Overall Study||73
10298608|NCT00007345|11431327|FG000|NOT COMPLETED|Overall Study||2
10298609|NCT00007345|11431328|FG001|NOT COMPLETED|Overall Study||11
10298610|NCT00007475|11431337|FG000|STARTED|Overall Study|[ arm reflects un-assayed participants' disposition ]|12
10298611|NCT00007475|11431338|FG001|STARTED|Overall Study|[ arm reflects eventual participant disposition ]|1
10298612|NCT00007475|11431339|FG002|STARTED|Overall Study|[ arm reflects eventual participant disposition ]|2
10298613|NCT00007475|11431340|FG003|STARTED|Overall Study||0
10298614|NCT00007475|11431337|FG000|FSGS Permeability Factor (FPF) Assayed|Overall Study|FSGS Permeability Factor's provisional assay only applied to minority of early enrollees, by design.|0
10298615|NCT00007475|11431338|FG001|FSGS Permeability Factor (FPF) Assayed|Overall Study||1
10298616|NCT00007475|11431339|FG002|FSGS Permeability Factor (FPF) Assayed|Overall Study||2
10298617|NCT00007475|11431340|FG003|FSGS Permeability Factor (FPF) Assayed|Overall Study||0
10298618|NCT00007475|11431337|FG000|Initial Transplant|Overall Study||12
10298619|NCT00007475|11431338|FG001|Initial Transplant|Overall Study||1
10298620|NCT00007475|11431339|FG002|Initial Transplant|Overall Study||2
10298621|NCT00007475|11431340|FG003|Initial Transplant|Overall Study||0
10298622|NCT00007475|11431337|FG000|Post-initial Transplant Proteinuria|Overall Study||12
10298623|NCT00007475|11431338|FG001|Post-initial Transplant Proteinuria|Overall Study||1
10298624|NCT00007475|11431339|FG002|Post-initial Transplant Proteinuria|Overall Study||2
10298625|NCT00007475|11431340|FG003|Post-initial Transplant Proteinuria|Overall Study||0
10298626|NCT00007475|11431337|FG000|Initial Plasma Exchange|Overall Study||12
10546864|NCT01510145|11700670|FG000|STARTED|Overall Study||191
10546865|NCT01510145|11700670|FG000|COMPLETED|Overall Study||173
10546866|NCT01510145|11700670|FG000|NOT COMPLETED|Overall Study||18
10546867|NCT01510158|11700677|FG000|STARTED|Overall Study||202
10546868|NCT01510158|11700678|FG001|STARTED|Overall Study||203
10546869|NCT01510158|11700679|FG002|STARTED|Overall Study||202
10546870|NCT01510158|11700677|FG000|COMPLETED|Overall Study||151
10546871|NCT01510158|11700678|FG001|COMPLETED|Overall Study||150
10546872|NCT01510158|11700679|FG002|COMPLETED|Overall Study||152
10546873|NCT01510158|11700677|FG000|NOT COMPLETED|Overall Study||51
10546874|NCT01510158|11700678|FG001|NOT COMPLETED|Overall Study||53
10546875|NCT01510158|11700679|FG002|NOT COMPLETED|Overall Study||50
10546876|NCT01510327|11700687|FG000|STARTED|Overall Study||22
10546877|NCT01510327|11700687|FG000|COMPLETED|Overall Study||22
10546878|NCT01510327|11700687|FG000|NOT COMPLETED|Overall Study||0
10546879|NCT01510379|11700699|FG000|STARTED|Overall Study||49
10546880|NCT01510379|11700700|FG001|STARTED|Overall Study||51
10546881|NCT01510379|11700699|FG000|COMPLETED|Overall Study||49
10421765|NCT00821119|11566647|FG000|COMPLETED|Overall Study||100
10421766|NCT00821119|11566648|FG001|COMPLETED|Overall Study||100
10421767|NCT00821119|11566647|FG000|NOT COMPLETED|Overall Study||0
10421768|NCT00821119|11566648|FG001|NOT COMPLETED|Overall Study||0
10421769|NCT00821184|11566658|FG000|STARTED|Overall Study||6
10421770|NCT00821184|11566659|FG001|STARTED|Overall Study||6
10421771|NCT00821184|11566658|FG000|COMPLETED|Overall Study||6
10421772|NCT00821184|11566659|FG001|COMPLETED|Overall Study||6
10421773|NCT00821184|11566658|FG000|NOT COMPLETED|Overall Study||0
10421774|NCT00821184|11566659|FG001|NOT COMPLETED|Overall Study||0
10429547|NCT00864383|11575575|FG001|NOT COMPLETED|Modified Intent to Treat||87
10429548|NCT00864383|11575576|FG002|NOT COMPLETED|Modified Intent to Treat||85
10429549|NCT00864513|11575584|FG000|STARTED|Overall Study||15
10429550|NCT00864513|11575584|FG000|COMPLETED|Overall Study||12
10429551|NCT00864513|11575584|FG000|NOT COMPLETED|Overall Study||3
10298627|NCT00007475|11431338|FG001|Initial Plasma Exchange|Overall Study||1
10298628|NCT00007475|11431339|FG002|Initial Plasma Exchange|Overall Study||2
10298629|NCT00007475|11431340|FG003|Initial Plasma Exchange|Overall Study||0
10298630|NCT00007475|11431337|FG000|Initiate Cyclophosphamide|Overall Study||12
10298631|NCT00007475|11431338|FG001|Initiate Cyclophosphamide|Overall Study||1
10298632|NCT00007475|11431339|FG002|Initiate Cyclophosphamide|Overall Study||2
10298633|NCT00007475|11431340|FG003|Initiate Cyclophosphamide|Overall Study||0
10298634|NCT00007475|11431337|FG000|COMPLETED|Overall Study||8
10298635|NCT00007475|11431338|FG001|COMPLETED|Overall Study||1
10298636|NCT00007475|11431339|FG002|COMPLETED|Overall Study||2
10298637|NCT00007475|11431340|FG003|COMPLETED|Overall Study||0
10298638|NCT00007475|11431337|FG000|NOT COMPLETED|Overall Study||4
10298639|NCT00007475|11431338|FG001|NOT COMPLETED|Overall Study||0
10298640|NCT00007475|11431339|FG002|NOT COMPLETED|Overall Study||0
10298641|NCT00007475|11431340|FG003|NOT COMPLETED|Overall Study||0
10298642|NCT00007644|11431352|FG000|STARTED|Overall Study||364
10298643|NCT00007644|11431353|FG001|STARTED|Overall Study||367
10298644|NCT00007644|11431352|FG000|COMPLETED|Overall Study||364
10298645|NCT00007644|11431353|FG001|COMPLETED|Overall Study||367
10298646|NCT00007644|11431352|FG000|NOT COMPLETED|Overall Study||0
10298647|NCT00007644|11431353|FG001|NOT COMPLETED|Overall Study||0
10298648|NCT00008138|11431359|FG000|STARTED|Neoadjuvant Chemotherapy||58
10298649|NCT00008138|11431359|FG000|Eligible|Neoadjuvant Chemotherapy||58
10298650|NCT00008138|11431359|FG000|COMPLETED|Neoadjuvant Chemotherapy||38
10298651|NCT00008138|11431359|FG000|NOT COMPLETED|Neoadjuvant Chemotherapy||20
10298652|NCT00008138|11431359|FG000|STARTED|Interval Debulking||38
10298653|NCT00008138|11431359|FG000|Received Protocol Surgery|Interval Debulking||36
10298654|NCT00008138|11431359|FG000|COMPLETED|Interval Debulking||36
10298655|NCT00008138|11431359|FG000|NOT COMPLETED|Interval Debulking||2
10298656|NCT00008138|11431359|FG000|STARTED|Post-Cytoreduction Chemotherapy|Among 36 patients from previous period, 5 patients rejected and 5 patients are ineligible.|26
10298657|NCT00008138|11431359|FG000|COMPLETED|Post-Cytoreduction Chemotherapy||18
10298658|NCT00008138|11431359|FG000|NOT COMPLETED|Post-Cytoreduction Chemotherapy||8
10298659|NCT00008385|11431366|FG000|STARTED|Overall Study||521
10298660|NCT00008385|11431367|FG001|STARTED|Overall Study||1040
10298661|NCT00008385|11431366|FG000|Treated|Overall Study||477
10298662|NCT00008385|11431367|FG001|Treated|Overall Study||865
10298663|NCT00008385|11431366|FG000|Off Treatment Reasons Reported|Overall Study||398
10298664|NCT00008385|11431367|FG001|Off Treatment Reasons Reported|Overall Study||795
10298665|NCT00008385|11431366|FG000|COMPLETED|Overall Study||134
10298666|NCT00008385|11431367|FG001|COMPLETED|Overall Study||238
10298667|NCT00008385|11431366|FG000|NOT COMPLETED|Overall Study||387
10298668|NCT00008385|11431367|FG001|NOT COMPLETED|Overall Study||802
10298669|NCT00009737|11431375|FG000|STARTED|Overall Study||1004
10298670|NCT00009737|11431376|FG001|STARTED|Overall Study||983
10298671|NCT00009737|11431375|FG000|COMPLETED|Overall Study||834
10298672|NCT00009737|11431376|FG001|COMPLETED|Overall Study||860
10298673|NCT00009737|11431375|FG000|NOT COMPLETED|Overall Study||170
10298674|NCT00009737|11431376|FG001|NOT COMPLETED|Overall Study||123
10298675|NCT00009945|11431384|FG000|STARTED|Overall Study||1662
10298676|NCT00009945|11431385|FG001|STARTED|Overall Study||1661
10298677|NCT00009945|11431384|FG000|COMPLETED|Overall Study||1655
10298678|NCT00009945|11431385|FG001|COMPLETED|Overall Study||1656
10298679|NCT00009945|11431384|FG000|NOT COMPLETED|Overall Study||7
10298680|NCT00009945|11431385|FG001|NOT COMPLETED|Overall Study||5
10298681|NCT00010257|11431393|FG000|STARTED|Overall Study||25
10298682|NCT00010257|11431394|FG001|STARTED|Overall Study||21
10298683|NCT00010257|11431393|FG000|COMPLETED|Overall Study||24
10298684|NCT00010257|11431394|FG001|COMPLETED|Overall Study||21
10298685|NCT00010257|11431393|FG000|NOT COMPLETED|Overall Study||1
10298686|NCT00010257|11431394|FG001|NOT COMPLETED|Overall Study||0
10298687|NCT00010374|11431400|FG000|STARTED|Overall Study||54
10298688|NCT00010374|11431400|FG000|COMPLETED|Overall Study|One compassionate use participant was withheld from analysis per FDA instructions|53
10298689|NCT00010374|11431400|FG000|NOT COMPLETED|Overall Study||1
10298690|NCT00010439|11431405|FG000|STARTED|Overall Study||10
10298691|NCT00010439|11431405|FG000|6 Months|Overall Study||10
10298692|NCT00010439|11431405|FG000|COMPLETED|Overall Study||10
10298693|NCT00010439|11431405|FG000|NOT COMPLETED|Overall Study||0
10298694|NCT00010803|11431411|FG000|STARTED|Overall Study|Randomized|1545
10298695|NCT00010803|11431412|FG001|STARTED|Overall Study|Randomized|1524
10298696|NCT00010803|11431411|FG000|COMPLETED|Overall Study|Reached endpoint of dementia, death or completion|1448
10298697|NCT00010803|11431412|FG001|COMPLETED|Overall Study|Reached endpoint of dementia, death or completion|1426
10298698|NCT00010803|11431411|FG000|NOT COMPLETED|Overall Study||97
10298699|NCT00010803|11431412|FG001|NOT COMPLETED|Overall Study||98
10298700|NCT00011986|11431423|FG000|STARTED|Overall Study||864
10298701|NCT00011986|11431424|FG001|STARTED|Overall Study||864
10298702|NCT00011986|11431425|FG002|STARTED|Overall Study||862
10298703|NCT00011986|11431426|FG003|STARTED|Overall Study||861
10298704|NCT00011986|11431427|FG004|STARTED|Overall Study||861
10298705|NCT00011986|11431423|FG000|Initiated Treatment|Overall Study||862
10298706|NCT00011986|11431424|FG001|Initiated Treatment|Overall Study||860
10298707|NCT00011986|11431425|FG002|Initiated Treatment|Overall Study||854
10298708|NCT00011986|11431426|FG003|Initiated Treatment|Overall Study||846
10298709|NCT00011986|11431427|FG004|Initiated Treatment|Overall Study||851
10298710|NCT00011986|11431423|FG000|COMPLETED|Overall Study||864
10298711|NCT00011986|11431424|FG001|COMPLETED|Overall Study||864
10298712|NCT00011986|11431425|FG002|COMPLETED|Overall Study||862
10298713|NCT00011986|11431426|FG003|COMPLETED|Overall Study||861
10298714|NCT00011986|11431427|FG004|COMPLETED|Overall Study||861
10298715|NCT00011986|11431423|FG000|NOT COMPLETED|Overall Study||0
10298716|NCT00011986|11431424|FG001|NOT COMPLETED|Overall Study||0
10298717|NCT00011986|11431425|FG002|NOT COMPLETED|Overall Study||0
10298718|NCT00011986|11431426|FG003|NOT COMPLETED|Overall Study||0
10298719|NCT00011986|11431427|FG004|NOT COMPLETED|Overall Study||0
10298720|NCT00012012|11431446|FG000|STARTED|Overall Study||27
10298721|NCT00012012|11431447|FG001|STARTED|Overall Study||18
10298722|NCT00012012|11431446|FG000|COMPLETED|Overall Study||26
10298723|NCT00012012|11431447|FG001|COMPLETED|Overall Study||15
10298724|NCT00012012|11431446|FG000|NOT COMPLETED|Overall Study||1
10298725|NCT00012012|11431447|FG001|NOT COMPLETED|Overall Study||3
10298726|NCT00012298|11431460|FG000|STARTED|Overall Study||11
10298727|NCT00012298|11431461|FG001|STARTED|Overall Study||7
10298728|NCT00012298|11431462|FG002|STARTED|Overall Study||9
10298729|NCT00012298|11431463|FG003|STARTED|Overall Study||4
10298730|NCT00012298|11431464|FG004|STARTED|Overall Study||5
10298731|NCT00012298|11431465|FG005|STARTED|Overall Study||6
10298732|NCT00012298|11431466|FG006|STARTED|Overall Study||39
10298733|NCT00012298|11431460|FG000|COMPLETED|Overall Study||11
10298734|NCT00012298|11431461|FG001|COMPLETED|Overall Study||7
10298735|NCT00012298|11431462|FG002|COMPLETED|Overall Study||9
10298736|NCT00012298|11431463|FG003|COMPLETED|Overall Study||4
10298737|NCT00012298|11431464|FG004|COMPLETED|Overall Study||5
10298738|NCT00012298|11431465|FG005|COMPLETED|Overall Study||6
10298739|NCT00012298|11431466|FG006|COMPLETED|Overall Study||39
10298740|NCT00012298|11431460|FG000|NOT COMPLETED|Overall Study||0
10298741|NCT00012298|11431461|FG001|NOT COMPLETED|Overall Study||0
10298742|NCT00012298|11431462|FG002|NOT COMPLETED|Overall Study||0
10298743|NCT00012298|11431463|FG003|NOT COMPLETED|Overall Study||0
10298744|NCT00012298|11431464|FG004|NOT COMPLETED|Overall Study||0
10298745|NCT00012298|11431465|FG005|NOT COMPLETED|Overall Study||0
10298746|NCT00012298|11431466|FG006|NOT COMPLETED|Overall Study||0
10298747|NCT00013611|11431486|FG000|STARTED|Overall Study|138 were excluded from sites that did not re-consent 2/3 of patients to the amended protocol in 2003|849
10298748|NCT00013611|11431487|FG001|STARTED|Overall Study|138 were excluded from sites that did not re-consent 2/3 of patients to the amended protocol in 2003|846
10298749|NCT00013611|11431486|FG000|COMPLETED|Overall Study||758
10298750|NCT00013611|11431487|FG001|COMPLETED|Overall Study||746
10298751|NCT00013611|11431486|FG000|NOT COMPLETED|Overall Study||91
10298752|NCT00013611|11431487|FG001|NOT COMPLETED|Overall Study||100
10298753|NCT00014222|11431496|FG000|STARTED|Overall Study||701
10298754|NCT00014222|11431497|FG001|STARTED|Overall Study||701
10298755|NCT00014222|11431498|FG002|STARTED|Overall Study||702
10298756|NCT00014222|11431496|FG000|COMPLETED|Overall Study||680
10298757|NCT00014222|11431497|FG001|COMPLETED|Overall Study||688
10298758|NCT00014222|11431498|FG002|COMPLETED|Overall Study||675
10298759|NCT00014222|11431496|FG000|NOT COMPLETED|Overall Study||21
10298760|NCT00014222|11431497|FG001|NOT COMPLETED|Overall Study||13
10298761|NCT00014222|11431498|FG002|NOT COMPLETED|Overall Study||27
10298762|NCT00014495|11431510|FG000|STARTED|Overall Study||3
10298763|NCT00014495|11431511|FG001|STARTED|Overall Study||3
10298764|NCT00014495|11431512|FG002|STARTED|Overall Study||20
10298765|NCT00014495|11431513|FG003|STARTED|Overall Study||6
10298766|NCT00014495|11431510|FG000|COMPLETED|Overall Study||3
10298767|NCT00014495|11431511|FG001|COMPLETED|Overall Study||3
10298768|NCT00014495|11431512|FG002|COMPLETED|Overall Study||19
10298769|NCT00014495|11431513|FG003|COMPLETED|Overall Study||5
10298770|NCT00014495|11431510|FG000|NOT COMPLETED|Overall Study||0
10298771|NCT00014495|11431511|FG001|NOT COMPLETED|Overall Study||0
10298772|NCT00014495|11431512|FG002|NOT COMPLETED|Overall Study||1
10298773|NCT00014495|11431513|FG003|NOT COMPLETED|Overall Study||1
10298774|NCT00014911|11431520|FG000|STARTED|Overall Study||36
10298775|NCT00014911|11431520|FG000|COMPLETED|Overall Study|One subject experienced pneumonia, myocardial infarction, and acute renal failure|25
10298776|NCT00014911|11431520|FG000|NOT COMPLETED|Overall Study||11
10315039|NCT00171873|11448817|FG001|STARTED|Overall Study||43
10315040|NCT00171873|11448816|FG000|COMPLETED|Overall Study||33
10315041|NCT00171873|11448817|FG001|COMPLETED|Overall Study||40
10315042|NCT00171873|11448816|FG000|NOT COMPLETED|Overall Study||9
10315043|NCT00171873|11448817|FG001|NOT COMPLETED|Overall Study||3
10298777|NCT00015457|11431524|FG000|STARTED|First Intervention||8
10298778|NCT00015457|11431525|FG001|STARTED|First Intervention||8
10298779|NCT00015457|11431524|FG000|COMPLETED|First Intervention||8
10298780|NCT00015457|11431525|FG001|COMPLETED|First Intervention||5
10298781|NCT00015457|11431524|FG000|NOT COMPLETED|First Intervention||0
10298782|NCT00015457|11431525|FG001|NOT COMPLETED|First Intervention||3
10298783|NCT00015457|11431524|FG000|STARTED|Second Intervention||8
10298784|NCT00015457|11431525|FG001|STARTED|Second Intervention||5
10298785|NCT00015457|11431524|FG000|COMPLETED|Second Intervention||7
10298786|NCT00015457|11431525|FG001|COMPLETED|Second Intervention||5
10298787|NCT00015457|11431524|FG000|NOT COMPLETED|Second Intervention||1
10298788|NCT00015457|11431525|FG001|NOT COMPLETED|Second Intervention||0
10298789|NCT00015847|11431531|FG000|STARTED|Overall Study||25
10298790|NCT00015847|11431531|FG000|COMPLETED|Overall Study||25
10298791|NCT00015847|11431531|FG000|NOT COMPLETED|Overall Study||0
10298792|NCT00016354|11431535|FG000|STARTED|Overall Study||1
10298793|NCT00016354|11431536|FG001|STARTED|Overall Study||1
10298794|NCT00016354|11431537|FG002|STARTED|Overall Study||1
10298795|NCT00016354|11431538|FG003|STARTED|Overall Study||1
10298796|NCT00016354|11431539|FG004|STARTED|Overall Study||1
10298797|NCT00016354|11431540|FG005|STARTED|Overall Study||1
10298798|NCT00016354|11431541|FG006|STARTED|Overall Study||6
10298799|NCT00016354|11431542|FG007|STARTED|Overall Study||7
10298800|NCT00016354|11431535|FG000|COMPLETED|Overall Study||1
10298801|NCT00016354|11431536|FG001|COMPLETED|Overall Study||1
10298802|NCT00016354|11431537|FG002|COMPLETED|Overall Study||1
10298803|NCT00016354|11431538|FG003|COMPLETED|Overall Study||1
10298804|NCT00016354|11431539|FG004|COMPLETED|Overall Study||1
10298805|NCT00016354|11431540|FG005|COMPLETED|Overall Study||1
10298806|NCT00016354|11431541|FG006|COMPLETED|Overall Study||6
10298807|NCT00016354|11431542|FG007|COMPLETED|Overall Study||6
10298808|NCT00016354|11431535|FG000|NOT COMPLETED|Overall Study||0
10298809|NCT00016354|11431536|FG001|NOT COMPLETED|Overall Study||0
10421775|NCT04187989|11566669|FG000|STARTED|Overall Study - 3-Month Follow-Up||76
10421776|NCT04187989|11566670|FG001|STARTED|Overall Study - 3-Month Follow-Up||73
10421777|NCT04187989|11566669|FG000|COMPLETED|Overall Study - 3-Month Follow-Up||70
10421778|NCT04187989|11566670|FG001|COMPLETED|Overall Study - 3-Month Follow-Up||65
10421779|NCT04187989|11566669|FG000|NOT COMPLETED|Overall Study - 3-Month Follow-Up||6
10421780|NCT04187989|11566670|FG001|NOT COMPLETED|Overall Study - 3-Month Follow-Up||8
10421781|NCT04187989|11566669|FG000|STARTED|Overall Study - 6-Month Follow-Up||76
10421782|NCT04187989|11566670|FG001|STARTED|Overall Study - 6-Month Follow-Up||73
10421783|NCT04187989|11566669|FG000|COMPLETED|Overall Study - 6-Month Follow-Up||68
10421784|NCT04187989|11566670|FG001|COMPLETED|Overall Study - 6-Month Follow-Up||65
10421785|NCT04187989|11566669|FG000|NOT COMPLETED|Overall Study - 6-Month Follow-Up||8
10421786|NCT04187989|11566670|FG001|NOT COMPLETED|Overall Study - 6-Month Follow-Up||8
10421787|NCT04109118|11566676|FG000|STARTED|Overall Study||4
10421788|NCT04109118|11566676|FG000|COMPLETED|Overall Study||1
10421789|NCT04109118|11566676|FG000|NOT COMPLETED|Overall Study||3
10421796|NCT03846219|11566695|FG000|STARTED|Overall Study||72
10421797|NCT03846219|11566696|FG001|STARTED|Overall Study||69
10421798|NCT03846219|11566697|FG002|STARTED|Overall Study||69
10421799|NCT03846219|11566695|FG000|Patients Treated|Overall Study||71
10421800|NCT03846219|11566696|FG001|Patients Treated|Overall Study||69
10421801|NCT03846219|11566697|FG002|Patients Treated|Overall Study||69
10421802|NCT03846219|11566695|FG000|COMPLETED|Overall Study||69
10421803|NCT03846219|11566696|FG001|COMPLETED|Overall Study||65
10421804|NCT03846219|11566697|FG002|COMPLETED|Overall Study||64
10421805|NCT03846219|11566695|FG000|NOT COMPLETED|Overall Study||3
10421806|NCT03846219|11566696|FG001|NOT COMPLETED|Overall Study||4
10421807|NCT03846219|11566697|FG002|NOT COMPLETED|Overall Study||5
10421808|NCT03758404|11566716|FG000|STARTED|Overall Study||3
10421809|NCT03758404|11566717|FG001|STARTED|Overall Study||3
10421810|NCT03758404|11566718|FG002|STARTED|Overall Study||5
10421811|NCT03758404|11566716|FG000|COMPLETED|Overall Study||3
10421812|NCT03758404|11566717|FG001|COMPLETED|Overall Study||3
10421813|NCT03758404|11566718|FG002|COMPLETED|Overall Study||5
10421814|NCT03758404|11566716|FG000|NOT COMPLETED|Overall Study||0
10421815|NCT03758404|11566717|FG001|NOT COMPLETED|Overall Study||0
10421816|NCT03758404|11566718|FG002|NOT COMPLETED|Overall Study||0
10421817|NCT03698708|11566728|FG000|STARTED|Overall Study||17
10421818|NCT03698708|11566729|FG001|STARTED|Overall Study||20
10421819|NCT03698708|11566728|FG000|COMPLETED|Overall Study||13
10421820|NCT03698708|11566729|FG001|COMPLETED|Overall Study||16
10421821|NCT03698708|11566728|FG000|NOT COMPLETED|Overall Study||4
10421822|NCT03698708|11566729|FG001|NOT COMPLETED|Overall Study||4
10421823|NCT03608696|11566735|FG000|STARTED|Overall Study||10
10421824|NCT03608696|11566735|FG000|COMPLETED|Overall Study||10
10298810|NCT00016354|11431537|FG002|NOT COMPLETED|Overall Study||0
10298811|NCT00016354|11431538|FG003|NOT COMPLETED|Overall Study||0
10298812|NCT00016354|11431539|FG004|NOT COMPLETED|Overall Study||0
10298813|NCT00016354|11431540|FG005|NOT COMPLETED|Overall Study||0
10298814|NCT00016354|11431541|FG006|NOT COMPLETED|Overall Study||0
10298815|NCT00016354|11431542|FG007|NOT COMPLETED|Overall Study||1
10298816|NCT00016718|11431549|FG000|STARTED|Overall Study||6
10298817|NCT00016718|11431550|FG001|STARTED|Overall Study||21
10298818|NCT00016718|11431551|FG002|STARTED|Overall Study||16
10298819|NCT00016718|11431549|FG000|COMPLETED|Overall Study||6
10298820|NCT00016718|11431550|FG001|COMPLETED|Overall Study||21
10298821|NCT00016718|11431551|FG002|COMPLETED|Overall Study||16
10298822|NCT00016718|11431549|FG000|NOT COMPLETED|Overall Study||0
10298823|NCT00016718|11431550|FG001|NOT COMPLETED|Overall Study||0
10298824|NCT00016718|11431551|FG002|NOT COMPLETED|Overall Study||0
10298825|NCT00016913|11431559|FG000|STARTED|Overall Study||27
10298826|NCT00016913|11431559|FG000|COMPLETED|Overall Study||27
10298827|NCT00016913|11431559|FG000|NOT COMPLETED|Overall Study||0
10298828|NCT00017563|11431563|FG000|STARTED|Overall Study||57
10298829|NCT00017563|11431563|FG000|COMPLETED|Overall Study||56
10298830|NCT00017563|11431563|FG000|NOT COMPLETED|Overall Study||1
10298831|NCT00018031|11431567|FG000|STARTED|Overall Study||36
10298832|NCT00018031|11431567|FG000|COMPLETED|Overall Study||36
10298833|NCT00018031|11431567|FG000|NOT COMPLETED|Overall Study||0
10298834|NCT00019604|11431571|FG000|STARTED|Overall Study||44
10298835|NCT00019604|11431571|FG000|COMPLETED|Overall Study||5
10298836|NCT00019604|11431571|FG000|NOT COMPLETED|Overall Study||39
10298837|NCT00019682|11431577|FG000|STARTED|Overall Study||94
10298838|NCT00019682|11431578|FG001|STARTED|Overall Study||91
10298839|NCT00019682|11431577|FG000|COMPLETED|Overall Study||93
10298840|NCT00019682|11431578|FG001|COMPLETED|Overall Study||85
10298841|NCT00019682|11431577|FG000|NOT COMPLETED|Overall Study||1
10298842|NCT00019682|11431578|FG001|NOT COMPLETED|Overall Study||6
10298843|NCT00021229|11431587|FG000|STARTED|Overall Study||36
10298844|NCT00021229|11431588|FG001|STARTED|Overall Study||33
10298845|NCT00021229|11431589|FG002|STARTED|Overall Study||16
10298846|NCT00021229|11431587|FG000|Enrolled in Phase I|Overall Study||35
10298847|NCT00021229|11431588|FG001|Enrolled in Phase I|Overall Study||33
10298848|NCT00021229|11431589|FG002|Enrolled in Phase I|Overall Study||16
10298849|NCT00021229|11431587|FG000|Maximum Tolerated Dose (MTD) Estimation|Overall Study|12 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|23
10298850|NCT00021229|11431588|FG001|Maximum Tolerated Dose (MTD) Estimation|Overall Study|13 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|20
10298851|NCT00021229|11431589|FG002|Maximum Tolerated Dose (MTD) Estimation|Overall Study|4 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|12
10298852|NCT00021229|11431587|FG000|Enrolled in Phase II|Overall Study|Thirteen participants treated at the MTD in the phase I were also part of the phase II.|14
10298853|NCT00021229|11431588|FG001|Enrolled in Phase II|Overall Study|Participants from stratum IIA did not participate in the phase II part of the study.|0
10298854|NCT00021229|11431589|FG002|Enrolled in Phase II|Overall Study|Participants from stratum IIB did not participate in the phase II part of the study.|0
10298855|NCT00021229|11431587|FG000|COMPLETED|Overall Study|1 participant completed 13 courses of therapy|1
10298856|NCT00021229|11431588|FG001|COMPLETED|Overall Study||0
10298857|NCT00021229|11431589|FG002|COMPLETED|Overall Study||0
10298858|NCT00021229|11431587|FG000|NOT COMPLETED|Overall Study||35
10298859|NCT00021229|11431588|FG001|NOT COMPLETED|Overall Study||33
10298860|NCT00021229|11431589|FG002|NOT COMPLETED|Overall Study||16
10298861|NCT00021255|11431602|FG000|STARTED|Overall Study|Randomized|1073
10298862|NCT00021255|11431603|FG001|STARTED|Overall Study|Randomized|1074
10298863|NCT00021255|11431604|FG002|STARTED|Overall Study|Randomized|1075
10298864|NCT00021255|11431602|FG000|Treated|Overall Study||1045
10298865|NCT00021255|11431603|FG001|Treated|Overall Study||1072
10298866|NCT00021255|11431604|FG002|Treated|Overall Study||1057
10298867|NCT00021255|11431602|FG000|Safety Population|Overall Study|1018 participants received AC-T (1012 from AC-T arm, 6 from AC-TH arm).|1018
10298868|NCT00021255|11431603|FG001|Safety Population|Overall Study|1100 participants received AC-TH (1066 from AC-TH arm, 33 from AC-T arm and 1 from TCH arm).|1100
10298869|NCT00021255|11431604|FG002|Safety Population|Overall Study|1056 participants received TCH.|1056
10298870|NCT00021255|11431602|FG000|COMPLETED|Overall Study||952
10298871|NCT00021255|11431603|FG001|COMPLETED|Overall Study||804
10298872|NCT00021255|11431604|FG002|COMPLETED|Overall Study||926
10298873|NCT00021255|11431602|FG000|NOT COMPLETED|Overall Study||121
10298874|NCT00021255|11431603|FG001|NOT COMPLETED|Overall Study||270
10298875|NCT00021255|11431604|FG002|NOT COMPLETED|Overall Study||149
10298876|NCT00021541|11431614|FG000|STARTED|Period 1-First Treatment||31
10298877|NCT00021541|11431615|FG001|STARTED|Period 1-First Treatment|These are the patients randomized to receive placebo. Two of these patients were deemed ineligible.|31
10298878|NCT00021541|11431614|FG000|Pts Who Progressed to Second Treatment|Period 1-First Treatment||20
10298879|NCT00021541|11431615|FG001|Pts Who Progressed to Second Treatment|Period 1-First Treatment||23
10298880|NCT00021541|11431614|FG000|Ineligible Patients|Period 1-First Treatment||0
10298881|NCT00021541|11431615|FG001|Ineligible Patients|Period 1-First Treatment||2
10298882|NCT00021541|11431614|FG000|COMPLETED|Period 1-First Treatment||20
10298883|NCT00021541|11431615|FG001|COMPLETED|Period 1-First Treatment||23
10298884|NCT00021541|11431614|FG000|NOT COMPLETED|Period 1-First Treatment||11
10298885|NCT00021541|11431615|FG001|NOT COMPLETED|Period 1-First Treatment||8
10298886|NCT00021541|11431614|FG000|STARTED|Period 2-crossover||20
10298887|NCT00021541|11431615|FG001|STARTED|Period 2-crossover||23
10298888|NCT00021541|11431614|FG000|COMPLETED|Period 2-crossover||10
10298889|NCT00021541|11431615|FG001|COMPLETED|Period 2-crossover||12
10298890|NCT00021541|11431614|FG000|NOT COMPLETED|Period 2-crossover||10
10298891|NCT00021541|11431615|FG001|NOT COMPLETED|Period 2-crossover||11
10298892|NCT00022490|11431623|FG000|STARTED|Overall Study||24
10298893|NCT00022490|11431623|FG000|COMPLETED|Overall Study||24
10298894|NCT00022490|11431623|FG000|NOT COMPLETED|Overall Study||0
10298895|NCT00022516|11431629|FG000|STARTED|Overall Study||542
10298896|NCT00022516|11431630|FG001|STARTED|Overall Study||544
10298897|NCT00022516|11431629|FG000|COMPLETED|Overall Study||539
10298898|NCT00022516|11431630|FG001|COMPLETED|Overall Study||314
10298899|NCT00022516|11431629|FG000|NOT COMPLETED|Overall Study||3
10298900|NCT00022516|11431630|FG001|NOT COMPLETED|Overall Study||230
10298901|NCT00022633|11431638|FG000|STARTED|Overall Study||55
10298902|NCT00022633|11431639|FG001|STARTED|Overall Study||10
10298903|NCT00022633|11431638|FG000|Eligible|Overall Study||51
10298904|NCT00022633|11431639|FG001|Eligible|Overall Study||10
10298905|NCT00022633|11431638|FG000|COMPLETED|Overall Study||23
10298906|NCT00022633|11431639|FG001|COMPLETED|Overall Study||5
10298907|NCT00022633|11431638|FG000|NOT COMPLETED|Overall Study||32
10298908|NCT00022633|11431639|FG001|NOT COMPLETED|Overall Study||5
10298909|NCT00022659|11431644|FG000|STARTED|Overall Study||64
10298910|NCT00022659|11431644|FG000|COMPLETED|Overall Study|Eligible and treated patients.|62
10298911|NCT00022659|11431644|FG000|NOT COMPLETED|Overall Study||2
10298912|NCT00022672|11431654|FG000|STARTED|Main Phase: 24 Months||103
10298913|NCT00022672|11431655|FG001|STARTED|Main Phase: 24 Months||104
10298914|NCT00022672|11431654|FG000|Safety Set: Received Study Drug|Main Phase: 24 Months||103
10298915|NCT00022672|11431655|FG001|Safety Set: Received Study Drug|Main Phase: 24 Months||104
10298916|NCT00022672|11431654|FG000|COMPLETED|Main Phase: 24 Months||16
10298917|NCT00022672|11431655|FG001|COMPLETED|Main Phase: 24 Months||4
10298918|NCT00022672|11431654|FG000|NOT COMPLETED|Main Phase: 24 Months||87
10298919|NCT00022672|11431655|FG001|NOT COMPLETED|Main Phase: 24 Months||100
10298920|NCT00022672|11431654|FG000|STARTED|Extension Phase|2 patients completed Main Phase; but did not enter Extension (1-did not cooperate and 1-withdrew).|14
10298921|NCT00022672|11431655|FG001|STARTED|Extension Phase||58
10298922|NCT00022672|11431654|FG000|Safety Set: Received Study Drug|Extension Phase||14
10298923|NCT00022672|11431655|FG001|Safety Set: Received Study Drug|Extension Phase||58
10298924|NCT00022672|11431654|FG000|COMPLETED|Extension Phase||11
10298925|NCT00022672|11431655|FG001|COMPLETED|Extension Phase||7
10298926|NCT00022672|11431654|FG000|NOT COMPLETED|Extension Phase||3
10298927|NCT00022672|11431655|FG001|NOT COMPLETED|Extension Phase||51
10298928|NCT00022698|11431664|FG000|STARTED|Overall Study||15
10298929|NCT00022698|11431665|FG001|STARTED|Overall Study||52
10298930|NCT00022698|11431664|FG000|COMPLETED|Overall Study||7
10298931|NCT00022698|11431665|FG001|COMPLETED|Overall Study||17
10298932|NCT00022698|11431664|FG000|NOT COMPLETED|Overall Study||8
10298933|NCT00022698|11431665|FG001|NOT COMPLETED|Overall Study||35
10298934|NCT00022763|11431675|FG000|STARTED|Overall Study||24
10298935|NCT00022763|11431676|FG001|STARTED|Overall Study||28
10298936|NCT00022763|11431675|FG000|COMPLETED|Overall Study||15
10298937|NCT00022763|11431676|FG001|COMPLETED|Overall Study||11
10298938|NCT00022763|11431675|FG000|NOT COMPLETED|Overall Study||9
10298939|NCT00022763|11431676|FG001|NOT COMPLETED|Overall Study||17
10298940|NCT00023309|11431683|FG000|STARTED|Overall Study||22
10298941|NCT00023309|11431684|FG001|STARTED|Overall Study||19
10298942|NCT00023309|11431683|FG000|COMPLETED|Overall Study||22
10298943|NCT00023309|11431684|FG001|COMPLETED|Overall Study||19
10298944|NCT00023309|11431683|FG000|NOT COMPLETED|Overall Study||0
10298945|NCT00023309|11431684|FG001|NOT COMPLETED|Overall Study||0
10298946|NCT00023322|11431690|FG000|STARTED|Overall Study||13
10298947|NCT00023322|11431690|FG000|COMPLETED|Overall Study||12
10298948|NCT00023322|11431690|FG000|NOT COMPLETED|Overall Study||1
10298949|NCT00023452|11431696|FG000|STARTED|Overall Study||3908
10298950|NCT00023452|11431697|FG001|STARTED|Overall Study||4145
10298951|NCT00023452|11431696|FG000|Randomized|Overall Study||3190
10298952|NCT00023452|11431697|FG001|Randomized|Overall Study||3174
10298953|NCT00023452|11431696|FG000|Enrolled as Part of a Cluster|Overall Study||718
10298954|NCT00023452|11431697|FG001|Enrolled as Part of a Cluster|Overall Study||971
10298955|NCT00023452|11431696|FG000|Completed Treatment|Overall Study||2585
10298956|NCT00023452|11431697|FG001|Completed Treatment|Overall Study||3273
10298957|NCT00023452|11431696|FG000|Not Treated|Overall Study||149
10298958|NCT00023452|11431697|FG001|Not Treated|Overall Study||105
10298959|NCT00023452|11431696|FG000|Completed Study|Overall Study||3174
10298960|NCT00023452|11431697|FG001|Completed Study|Overall Study||3475
10298961|NCT00023452|11431696|FG000|COMPLETED|Overall Study||2585
10298962|NCT00023452|11431697|FG001|COMPLETED|Overall Study||3273
10298963|NCT00023452|11431696|FG000|NOT COMPLETED|Overall Study||1323
10298964|NCT00023452|11431697|FG001|NOT COMPLETED|Overall Study||872
10298965|NCT00023595|11431712|FG000|STARTED|5 Year Follow up||602
10298966|NCT00023595|11431713|FG001|STARTED|5 Year Follow up||534
10298967|NCT00023595|11431714|FG002|STARTED|5 Year Follow up||76
10298968|NCT00023595|11431715|FG003|STARTED|5 Year Follow up|76 of stratum B pts who were randomized to med therapy + CABG group belong to both H01 and H02.|423
10298969|NCT00023595|11431716|FG004|STARTED|5 Year Follow up||501
10298970|NCT00023595|11431712|FG000|COMPLETED|5 Year Follow up||600
10298971|NCT00023595|11431713|FG001|COMPLETED|5 Year Follow up||532
10298972|NCT00023595|11431714|FG002|COMPLETED|5 Year Follow up||75
10298973|NCT00023595|11431715|FG003|COMPLETED|5 Year Follow up||416
10298974|NCT00023595|11431716|FG004|COMPLETED|5 Year Follow up||498
10298975|NCT00023595|11431712|FG000|NOT COMPLETED|5 Year Follow up||2
10298976|NCT00023595|11431713|FG001|NOT COMPLETED|5 Year Follow up||2
10298977|NCT00023595|11431714|FG002|NOT COMPLETED|5 Year Follow up||1
10298978|NCT00023595|11431715|FG003|NOT COMPLETED|5 Year Follow up||7
10298979|NCT00023595|11431716|FG004|NOT COMPLETED|5 Year Follow up||3
10298980|NCT00023595|11431712|FG000|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|602
10315044|NCT00171925|11448825|FG000|STARTED|Overall Study||72
10298981|NCT00023595|11431713|FG001|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|534
10298982|NCT00023595|11431714|FG002|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|76
10298983|NCT00023595|11431715|FG003|STARTED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
10298984|NCT00023595|11431716|FG004|STARTED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
10298985|NCT00023595|11431712|FG000|COMPLETED|10 Year Follow up||590
10298986|NCT00023595|11431713|FG001|COMPLETED|10 Year Follow up||524
10298987|NCT00023595|11431714|FG002|COMPLETED|10 Year Follow up||73
10298988|NCT00023595|11431715|FG003|COMPLETED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
10298989|NCT00023595|11431716|FG004|COMPLETED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
10298990|NCT00023595|11431712|FG000|NOT COMPLETED|10 Year Follow up||12
10421825|NCT03608696|11566735|FG000|NOT COMPLETED|Overall Study||0
10421826|NCT03606668|11566739|FG000|STARTED|Overall Study||20
10298991|NCT00023595|11431713|FG001|NOT COMPLETED|10 Year Follow up||10
10298992|NCT00023595|11431714|FG002|NOT COMPLETED|10 Year Follow up||3
10298993|NCT00023595|11431715|FG003|NOT COMPLETED|10 Year Follow up||0
10298994|NCT00023595|11431716|FG004|NOT COMPLETED|10 Year Follow up||0
10298995|NCT00023673|11431742|FG000|STARTED|Overall Study||8
10298996|NCT00023673|11431743|FG001|STARTED|Overall Study||9
10298997|NCT00023673|11431744|FG002|STARTED|Overall Study||0
10298998|NCT00023673|11431745|FG003|STARTED|Overall Study||46
10298999|NCT00023673|11431742|FG000|COMPLETED|Overall Study|Phase I eligible patients starting protocol treatment are considered to have completed the study.|8
10299000|NCT00023673|11431743|FG001|COMPLETED|Overall Study|Phase I eligible patients starting protocol treatment are considered to have completed the study.|9
10299001|NCT00023673|11431744|FG002|COMPLETED|Overall Study|This arm was not used since further de-escalation was not required.|0
10299002|NCT00023673|11431745|FG003|COMPLETED|Overall Study|Phase II subjects contributing data to primary analysis are considered to have completed the study.|44
10299003|NCT00023673|11431742|FG000|NOT COMPLETED|Overall Study||0
10299004|NCT00023673|11431743|FG001|NOT COMPLETED|Overall Study||0
10299005|NCT00023673|11431744|FG002|NOT COMPLETED|Overall Study||0
10299006|NCT00023673|11431745|FG003|NOT COMPLETED|Overall Study||2
10299007|NCT00023712|11431757|FG000|STARTED|Overall Study|total number of participants enrolled on study|28
10299008|NCT00023712|11431758|FG001|STARTED|Overall Study|total number of participants enrolled on study|30
10299009|NCT00023712|11431757|FG000|COMPLETED|Overall Study|total number of participants eligible and evaluable|26
10299010|NCT00023712|11431758|FG001|COMPLETED|Overall Study|total number of participants eligible and evaluable|29
10299011|NCT00023712|11431757|FG000|NOT COMPLETED|Overall Study||2
10299012|NCT00023712|11431758|FG001|NOT COMPLETED|Overall Study||1
10299013|NCT00023764|11431774|FG000|STARTED|Overall Study||103
10299014|NCT00023764|11431774|FG000|COMPLETED|Overall Study||89
10299015|NCT00023764|11431774|FG000|NOT COMPLETED|Overall Study||14
10299016|NCT00024102|11431781|FG000|STARTED|Overall Study||326
10299017|NCT00024102|11431782|FG001|STARTED|Overall Study||307
10299018|NCT00024102|11431781|FG000|COMPLETED|Overall Study||326
10299019|NCT00024102|11431782|FG001|COMPLETED|Overall Study||307
10299020|NCT00024102|11431781|FG000|NOT COMPLETED|Overall Study||0
10299021|NCT00024102|11431782|FG001|NOT COMPLETED|Overall Study||0
10299022|NCT00024167|11431795|FG000|STARTED|Overall Study||65
10299023|NCT00024167|11431796|FG001|STARTED|Overall Study||62
10299024|NCT00024167|11431795|FG000|Induction Treatment Option 1 Completed|Overall Study||22
10299025|NCT00024167|11431796|FG001|Induction Treatment Option 1 Completed|Overall Study||21
10299026|NCT00024167|11431795|FG000|Induction Treatment Option 2 Completed|Overall Study||43
10299027|NCT00024167|11431796|FG001|Induction Treatment Option 2 Completed|Overall Study||41
10299028|NCT00024167|11431795|FG000|COMPLETED|Overall Study||12
10299029|NCT00024167|11431796|FG001|COMPLETED|Overall Study||15
10299030|NCT00024167|11431795|FG000|NOT COMPLETED|Overall Study||53
10299031|NCT00024167|11431796|FG001|NOT COMPLETED|Overall Study||47
10299032|NCT00024258|11431803|FG000|STARTED|Overall Study||22
10299033|NCT00024258|11431803|FG000|COMPLETED|Overall Study||13
10299034|NCT00024258|11431803|FG000|NOT COMPLETED|Overall Study||9
10299035|NCT00025155|11431807|FG000|STARTED|Overall Study||51
10299036|NCT00025155|11431807|FG000|COMPLETED|Overall Study|Patients who were eligible and received any study treatment.|49
10299037|NCT00025155|11431807|FG000|NOT COMPLETED|Overall Study||2
10299038|NCT00025233|11431816|FG000|STARTED|Overall Study||50
10299039|NCT00025233|11431816|FG000|COMPLETED|Overall Study||46
10299040|NCT00025233|11431816|FG000|NOT COMPLETED|Overall Study||4
10299041|NCT00025259|11431833|FG000|STARTED|Overall Study||52
10299042|NCT00025259|11431834|FG001|STARTED|Overall Study||381
10299043|NCT00025259|11431835|FG002|STARTED|Overall Study||382
10299044|NCT00025259|11431836|FG003|STARTED|Overall Study||571
10299045|NCT00025259|11431837|FG004|STARTED|Overall Study||42
10299046|NCT00025259|11431838|FG005|STARTED|Overall Study||153
10299047|NCT00025259|11431839|FG006|STARTED|Overall Study||153
10299048|NCT00025259|11431833|FG000|COMPLETED|Overall Study||7
10299049|NCT00025259|11431834|FG001|COMPLETED|Overall Study||292
10299050|NCT00025259|11431835|FG002|COMPLETED|Overall Study||301
10299051|NCT00025259|11431836|FG003|COMPLETED|Overall Study||457
10299052|NCT00025259|11431837|FG004|COMPLETED|Overall Study||6
10299053|NCT00025259|11431838|FG005|COMPLETED|Overall Study||101
10299054|NCT00025259|11431839|FG006|COMPLETED|Overall Study||102
10299055|NCT00025259|11431833|FG000|NOT COMPLETED|Overall Study||45
10299056|NCT00025259|11431834|FG001|NOT COMPLETED|Overall Study||89
10299057|NCT00025259|11431835|FG002|NOT COMPLETED|Overall Study||81
10299058|NCT00025259|11431836|FG003|NOT COMPLETED|Overall Study||114
10299059|NCT00025259|11431837|FG004|NOT COMPLETED|Overall Study||36
10299060|NCT00025259|11431838|FG005|NOT COMPLETED|Overall Study||52
10299061|NCT00025259|11431839|FG006|NOT COMPLETED|Overall Study||51
10299062|NCT00025506|11431858|FG000|STARTED|Overall Study||55
10299063|NCT00025506|11431858|FG000|COMPLETED|Overall Study|Eligible and treated patients.|45
10299064|NCT00025506|11431858|FG000|NOT COMPLETED|Overall Study||10
10299065|NCT00025662|11431867|FG000|STARTED|Overall Study||25
10299066|NCT00025662|11431867|FG000|COMPLETED|Overall Study|One patient who received a transplant did not meet eligibility and was a special exemption.|22
10299067|NCT00025662|11431867|FG000|NOT COMPLETED|Overall Study||3
10299068|NCT00025883|11431873|FG000|STARTED|Overall Study||103
10299069|NCT00025883|11431873|FG000|Generalized Lipodystrophy|Overall Study||63
10299070|NCT00025883|11431873|FG000|Partial Lipodystrophy|Overall Study||40
10299071|NCT00025883|11431873|FG000|COMPLETED|Overall Study||86
10299072|NCT00025883|11431873|FG000|NOT COMPLETED|Overall Study||17
10299073|NCT00026208|11431880|FG000|STARTED|Overall Study||72
10299074|NCT00026208|11431881|FG001|STARTED|Overall Study||4
10299075|NCT00026208|11431880|FG000|COMPLETED|Overall Study||71
10299076|NCT00026208|11431881|FG001|COMPLETED|Overall Study||4
10299077|NCT00026208|11431880|FG000|NOT COMPLETED|Overall Study||1
10299078|NCT00026208|11431881|FG001|NOT COMPLETED|Overall Study||0
10299079|NCT00026221|11431890|FG000|STARTED|Overall Study||16
10299080|NCT00026221|11431891|FG001|STARTED|Overall Study||16
10299081|NCT00026221|11431892|FG002|STARTED|Overall Study||25
10299082|NCT00026221|11431890|FG000|COMPLETED|Overall Study||16
10299083|NCT00026221|11431891|FG001|COMPLETED|Overall Study||16
10299084|NCT00026221|11431892|FG002|COMPLETED|Overall Study||25
10299085|NCT00026221|11431890|FG000|NOT COMPLETED|Overall Study||0
10299086|NCT00026221|11431891|FG001|NOT COMPLETED|Overall Study||0
10299087|NCT00026221|11431892|FG002|NOT COMPLETED|Overall Study||0
10299088|NCT00026494|11431904|FG000|STARTED|Overall Study||7
10299089|NCT00026494|11431905|FG001|STARTED|Overall Study||4
10299090|NCT00026494|11431906|FG002|STARTED|Overall Study||22
10299091|NCT00026494|11431907|FG003|STARTED|Overall Study||16
10299092|NCT00026494|11431904|FG000|COMPLETED|Overall Study||5
10299093|NCT00026494|11431905|FG001|COMPLETED|Overall Study||4
10299094|NCT00026494|11431906|FG002|COMPLETED|Overall Study||16
10299095|NCT00026494|11431907|FG003|COMPLETED|Overall Study||16
10299096|NCT00026494|11431904|FG000|NOT COMPLETED|Overall Study||2
10299097|NCT00026494|11431905|FG001|NOT COMPLETED|Overall Study||0
10299098|NCT00026494|11431906|FG002|NOT COMPLETED|Overall Study||6
10299099|NCT00026494|11431907|FG003|NOT COMPLETED|Overall Study||0
10299100|NCT00026793|11431917|FG000|STARTED|Overall Study||29
10299101|NCT00026793|11431917|FG000|COMPLETED|Overall Study||21
10299102|NCT00026793|11431917|FG000|NOT COMPLETED|Overall Study||8
10299103|NCT00027027|11431926|FG000|STARTED|Overall Study||3
10299104|NCT00027027|11431927|FG001|STARTED|Overall Study||3
10299105|NCT00027027|11431928|FG002|STARTED|Overall Study||4
10299106|NCT00027027|11431929|FG003|STARTED|Overall Study||3
10299107|NCT00027027|11431930|FG004|STARTED|Overall Study||8
10299108|NCT00027027|11431926|FG000|Discontinued Before 2 Treatment Cycles|Overall Study||0
10299109|NCT00027027|11431927|FG001|Discontinued Before 2 Treatment Cycles|Overall Study||0
10299110|NCT00027027|11431928|FG002|Discontinued Before 2 Treatment Cycles|Overall Study||1
10299111|NCT00027027|11431929|FG003|Discontinued Before 2 Treatment Cycles|Overall Study||0
10299112|NCT00027027|11431930|FG004|Discontinued Before 2 Treatment Cycles|Overall Study||1
10299113|NCT00027027|11431926|FG000|Completed 2 Cycles of Treatment|Overall Study||3
10299114|NCT00027027|11431927|FG001|Completed 2 Cycles of Treatment|Overall Study||3
10299115|NCT00027027|11431928|FG002|Completed 2 Cycles of Treatment|Overall Study||3
10299116|NCT00027027|11431929|FG003|Completed 2 Cycles of Treatment|Overall Study||3
10299117|NCT00027027|11431930|FG004|Completed 2 Cycles of Treatment|Overall Study||7
10299118|NCT00027027|11431926|FG000|Discontinued at Cycle 2|Overall Study||2
10299119|NCT00027027|11431927|FG001|Discontinued at Cycle 2|Overall Study||2
10299120|NCT00027027|11431928|FG002|Discontinued at Cycle 2|Overall Study||1
10299121|NCT00027027|11431929|FG003|Discontinued at Cycle 2|Overall Study||1
10299122|NCT00027027|11431930|FG004|Discontinued at Cycle 2|Overall Study||3
10299123|NCT00027027|11431926|FG000|Treated Beyond Cycle 2|Overall Study||1
10299124|NCT00027027|11431927|FG001|Treated Beyond Cycle 2|Overall Study||1
10299125|NCT00027027|11431928|FG002|Treated Beyond Cycle 2|Overall Study||2
10299126|NCT00027027|11431929|FG003|Treated Beyond Cycle 2|Overall Study||2
10421827|NCT03606668|11566739|FG000|COMPLETED|Overall Study||18
10421828|NCT03606668|11566739|FG000|NOT COMPLETED|Overall Study||2
10421829|NCT03575897|11566745|FG000|STARTED|Overall Study||25
10421830|NCT03575897|11566746|FG001|STARTED|Overall Study||25
10421831|NCT03575897|11566745|FG000|COMPLETED|Overall Study||13
10421832|NCT03575897|11566746|FG001|COMPLETED|Overall Study||12
10421833|NCT03575897|11566745|FG000|NOT COMPLETED|Overall Study||12
10421834|NCT03575897|11566746|FG001|NOT COMPLETED|Overall Study||13
10421835|NCT03343626|11566760|FG000|STARTED|Overall Study||31
10421836|NCT03343626|11566761|FG001|STARTED|Overall Study||31
10299127|NCT00027027|11431930|FG004|Treated Beyond Cycle 2|Overall Study||4
10299128|NCT00027027|11431926|FG000|COMPLETED|Overall Study||0
10299129|NCT00027027|11431927|FG001|COMPLETED|Overall Study||0
10421837|NCT03343626|11566762|FG002|STARTED|Overall Study||31
10421838|NCT03343626|11566763|FG003|STARTED|Overall Study||32
10421839|NCT03343626|11566764|FG004|STARTED|Overall Study||36
10421840|NCT03343626|11566765|FG005|STARTED|Overall Study||37
10421841|NCT03343626|11566766|FG006|STARTED|Overall Study||37
10299130|NCT00027027|11431928|FG002|COMPLETED|Overall Study||0
10299131|NCT00027027|11431929|FG003|COMPLETED|Overall Study||0
10299132|NCT00027027|11431930|FG004|COMPLETED|Overall Study||0
10299133|NCT00027027|11431926|FG000|NOT COMPLETED|Overall Study||3
10299134|NCT00027027|11431927|FG001|NOT COMPLETED|Overall Study||3
10299135|NCT00027027|11431928|FG002|NOT COMPLETED|Overall Study||4
10299136|NCT00027027|11431929|FG003|NOT COMPLETED|Overall Study||3
10299137|NCT00027027|11431930|FG004|NOT COMPLETED|Overall Study||8
10299138|NCT00027378|11431948|FG000|STARTED|Overall Study||24
10299139|NCT00027378|11431949|FG001|STARTED|Overall Study||26
10299140|NCT00027378|11431948|FG000|COMPLETED|Overall Study||24
10299141|NCT00027378|11431949|FG001|COMPLETED|Overall Study||23
10299142|NCT00027378|11431948|FG000|NOT COMPLETED|Overall Study||0
10299143|NCT00027378|11431949|FG001|NOT COMPLETED|Overall Study||3
10299144|NCT00027560|11431955|FG000|STARTED|Overall Study||51
10299145|NCT00027560|11431955|FG000|COMPLETED|Overall Study||50
10299146|NCT00027560|11431955|FG000|NOT COMPLETED|Overall Study||1
10299147|NCT00027846|11431964|FG000|STARTED|Overall Study||13
10299148|NCT00027846|11431965|FG001|STARTED|Overall Study||287
10299149|NCT00027846|11431966|FG002|STARTED|Overall Study||78
10299150|NCT00027846|11431964|FG000|COMPLETED|Overall Study||11
10299151|NCT00027846|11431965|FG001|COMPLETED|Overall Study||219
10299152|NCT00027846|11431966|FG002|COMPLETED|Overall Study||41
10299153|NCT00027846|11431964|FG000|NOT COMPLETED|Overall Study||2
10299154|NCT00027846|11431965|FG001|NOT COMPLETED|Overall Study||68
10299155|NCT00027846|11431966|FG002|NOT COMPLETED|Overall Study||37
10299156|NCT00028002|11431976|FG000|STARTED|Overall Study||63
10299157|NCT00028002|11431976|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|52
10299158|NCT00028002|11431976|FG000|NOT COMPLETED|Overall Study||11
10299159|NCT00028093|11431983|FG000|STARTED|Overall Study||25
10299160|NCT00028093|11431984|FG001|STARTED|Overall Study||25
10299161|NCT00028093|11431983|FG000|COMPLETED|Overall Study||25
10299162|NCT00028093|11431984|FG001|COMPLETED|Overall Study||25
10299163|NCT00028093|11431983|FG000|NOT COMPLETED|Overall Study||0
10299164|NCT00028093|11431984|FG001|NOT COMPLETED|Overall Study||0
10299165|NCT00028262|11431990|FG000|STARTED|Overall Study||10
10299166|NCT00028262|11431990|FG000|COMPLETED|Overall Study||9
10299167|NCT00028262|11431990|FG000|NOT COMPLETED|Overall Study||1
10299168|NCT00028769|11431994|FG000|STARTED|Overall Study||41
10299169|NCT00028769|11431994|FG000|Eligible|Overall Study||36
10299170|NCT00028769|11431994|FG000|Eligible and Began Protocol Therapy|Overall Study|One patient refused all protocol treatment and was not evaluable for the present analysis|35
10299171|NCT00028769|11431994|FG000|COMPLETED|Overall Study|Patients receive protocol treatments until evidence of disease progression|0
10299172|NCT00028769|11431994|FG000|NOT COMPLETED|Overall Study||41
10299173|NCT00029107|11432000|FG000|STARTED|Overall Study||12
10299174|NCT00029107|11432001|FG001|STARTED|Overall Study||12
10299175|NCT00029107|11432000|FG000|COMPLETED|Overall Study||12
10299176|NCT00029107|11432001|FG001|COMPLETED|Overall Study||12
10299177|NCT00029107|11432000|FG000|NOT COMPLETED|Overall Study||0
10299178|NCT00029107|11432001|FG001|NOT COMPLETED|Overall Study||0
10299179|NCT00029146|11432009|FG000|STARTED|Overall Study||97
10299180|NCT00029146|11432010|FG001|STARTED|Overall Study||98
10299181|NCT00029146|11432009|FG000|COMPLETED|Overall Study||95
10299182|NCT00029146|11432010|FG001|COMPLETED|Overall Study||97
10299183|NCT00029146|11432009|FG000|NOT COMPLETED|Overall Study||2
10299184|NCT00029146|11432010|FG001|NOT COMPLETED|Overall Study||1
10299185|NCT00029172|11432016|FG000|STARTED|Overall Study||188
10299186|NCT00029172|11432016|FG000|COMPLETED|Overall Study||182
10299187|NCT00029172|11432016|FG000|NOT COMPLETED|Overall Study||6
10299188|NCT00029536|11432024|FG000|STARTED|Overall Study||85
10299189|NCT00029536|11432025|FG001|STARTED|Overall Study||45
10299190|NCT00029536|11432026|FG002|STARTED|Overall Study||105
10299191|NCT00029536|11432027|FG003|STARTED|Overall Study||59
10299192|NCT00029536|11432024|FG000|COMPLETED|Overall Study||85
10299193|NCT00029536|11432025|FG001|COMPLETED|Overall Study||45
10299194|NCT00029536|11432026|FG002|COMPLETED|Overall Study||105
10299195|NCT00029536|11432027|FG003|COMPLETED|Overall Study||59
10299196|NCT00029536|11432024|FG000|NOT COMPLETED|Overall Study||0
10299197|NCT00029536|11432025|FG001|NOT COMPLETED|Overall Study||0
10299198|NCT00029536|11432026|FG002|NOT COMPLETED|Overall Study||0
10299199|NCT00029536|11432027|FG003|NOT COMPLETED|Overall Study||0
10299200|NCT00030147|11432043|FG000|STARTED|Overall Study||17
10299201|NCT00030147|11432044|FG001|STARTED|Overall Study||19
10299202|NCT00030147|11432045|FG002|STARTED|Overall Study||16
10299203|NCT00030147|11432046|FG003|STARTED|Overall Study||11
10299204|NCT00030147|11432043|FG000|COMPLETED|Overall Study||17
10299205|NCT00030147|11432044|FG001|COMPLETED|Overall Study||18
10299206|NCT00030147|11432045|FG002|COMPLETED|Overall Study||16
10299207|NCT00030147|11432046|FG003|COMPLETED|Overall Study||11
10299208|NCT00030147|11432043|FG000|NOT COMPLETED|Overall Study||0
10299209|NCT00030147|11432044|FG001|NOT COMPLETED|Overall Study||1
10299210|NCT00030147|11432045|FG002|NOT COMPLETED|Overall Study||0
10299211|NCT00030147|11432046|FG003|NOT COMPLETED|Overall Study||0
10299212|NCT00030264|11432056|FG000|STARTED|Overall Study||23
10299213|NCT00030264|11432056|FG000|COMPLETED|Overall Study||23
10299214|NCT00030264|11432056|FG000|NOT COMPLETED|Overall Study||0
10299215|NCT00030823|11432060|FG000|STARTED|Overall Study||14
10299216|NCT00030823|11432060|FG000|COMPLETED|Overall Study||13
10299217|NCT00030823|11432060|FG000|NOT COMPLETED|Overall Study||1
10299218|NCT00030901|11432066|FG000|STARTED|Initial Registration||619
10299219|NCT00030901|11432067|FG001|STARTED|Initial Registration||0
10299220|NCT00030901|11432068|FG002|STARTED|Initial Registration||0
10299221|NCT00030901|11432066|FG000|COMPLETED|Initial Registration||452
10299222|NCT00030901|11432067|FG001|COMPLETED|Initial Registration||0
10299223|NCT00030901|11432068|FG002|COMPLETED|Initial Registration||0
10299224|NCT00030901|11432066|FG000|NOT COMPLETED|Initial Registration||167
10299225|NCT00030901|11432067|FG001|NOT COMPLETED|Initial Registration||0
10299226|NCT00030901|11432068|FG002|NOT COMPLETED|Initial Registration||0
10299227|NCT00030901|11432066|FG000|STARTED|Randomization||0
10299228|NCT00030901|11432067|FG001|STARTED|Randomization||227
10299229|NCT00030901|11432068|FG002|STARTED|Randomization||225
10299230|NCT00030901|11432066|FG000|Eligible|Randomization||0
10299231|NCT00030901|11432067|FG001|Eligible|Randomization||212
10299232|NCT00030901|11432068|FG002|Eligible|Randomization||211
10299233|NCT00030901|11432066|FG000|COMPLETED|Randomization||0
10299234|NCT00030901|11432067|FG001|COMPLETED|Randomization||126
10299235|NCT00030901|11432068|FG002|COMPLETED|Randomization||137
10299236|NCT00030901|11432066|FG000|NOT COMPLETED|Randomization||0
10299237|NCT00030901|11432067|FG001|NOT COMPLETED|Randomization||101
10299238|NCT00030901|11432068|FG002|NOT COMPLETED|Randomization||88
10299239|NCT00030992|11432074|FG000|STARTED|Overall Study||102
10299240|NCT00030992|11432074|FG000|COMPLETED|Overall Study||102
10299241|NCT00030992|11432074|FG000|NOT COMPLETED|Overall Study||0
10299242|NCT00031447|11432080|FG000|STARTED|Overall Study||14
10299243|NCT00031447|11432081|FG001|STARTED|Overall Study||15
10299244|NCT00031447|11432080|FG000|COMPLETED|Overall Study||4
10299245|NCT00031447|11432081|FG001|COMPLETED|Overall Study||8
10299246|NCT00031447|11432080|FG000|NOT COMPLETED|Overall Study||10
10299247|NCT00031447|11432081|FG001|NOT COMPLETED|Overall Study||7
10299248|NCT00031460|11432089|FG000|STARTED|Overall Study||24
10299249|NCT00031460|11432090|FG001|STARTED|Overall Study||22
10299250|NCT00031460|11432089|FG000|COMPLETED|Overall Study||15
10299251|NCT00031460|11432090|FG001|COMPLETED|Overall Study||8
10299252|NCT00031460|11432089|FG000|NOT COMPLETED|Overall Study||9
10299253|NCT00031460|11432090|FG001|NOT COMPLETED|Overall Study||14
10299254|NCT00031486|11432098|FG000|STARTED|Overall Study||40
10299255|NCT00031486|11432099|FG001|STARTED|Overall Study||47
10299256|NCT00031486|11432098|FG000|COMPLETED|Overall Study||33
10299257|NCT00031486|11432099|FG001|COMPLETED|Overall Study||35
10299258|NCT00031486|11432098|FG000|NOT COMPLETED|Overall Study||7
10299259|NCT00031486|11432099|FG001|NOT COMPLETED|Overall Study||12
10299260|NCT00031551|11432109|FG000|STARTED|Overall Study||2
10299261|NCT00031551|11432110|FG001|STARTED|Overall Study||25
10299262|NCT00031551|11432109|FG000|COMPLETED|Overall Study||0
10299263|NCT00031551|11432110|FG001|COMPLETED|Overall Study||25
10299264|NCT00031551|11432109|FG000|NOT COMPLETED|Overall Study||2
10299265|NCT00031551|11432110|FG001|NOT COMPLETED|Overall Study||0
10299266|NCT00031590|11432120|FG000|STARTED|Overall Study||28
10299267|NCT00031590|11432120|FG000|COMPLETED|Overall Study||25
10299268|NCT00031590|11432120|FG000|NOT COMPLETED|Overall Study||3
10299269|NCT00031694|11432125|FG000|STARTED|Overall Study||19
10299270|NCT00031694|11432125|FG000|COMPLETED|Overall Study||0
10299271|NCT00031694|11432125|FG000|NOT COMPLETED|Overall Study||19
10299272|NCT00032487|11432132|FG000|STARTED|Overall Study||899
10299273|NCT00032487|11432133|FG001|STARTED|Overall Study||892
10299274|NCT00032487|11432132|FG000|COMPLETED|Overall Study||760
10299275|NCT00032487|11432133|FG001|COMPLETED|Overall Study||772
10299276|NCT00032487|11432132|FG000|NOT COMPLETED|Overall Study||139
10299277|NCT00032487|11432133|FG001|NOT COMPLETED|Overall Study||120
10299278|NCT00032591|11432141|FG000|STARTED|Screening|3745 patients provided informed consent and were screened for participation.|1873
10299279|NCT00032591|11432142|FG001|STARTED|Screening|Treatment assigned at randomization; screening counts by arm represent half of the total screened.|1872
10299280|NCT00032591|11432141|FG000|COMPLETED|Screening|823 were excluded from the study|1465
10299281|NCT00032591|11432142|FG001|COMPLETED|Screening||1457
10299282|NCT00032591|11432141|FG000|NOT COMPLETED|Screening||408
10299283|NCT00032591|11432142|FG001|NOT COMPLETED|Screening||415
10299284|NCT00032591|11432141|FG000|STARTED|Randomization|2922 underwent randomization|1465
10299285|NCT00032591|11432142|FG001|STARTED|Randomization||1457
10299286|NCT00032591|11432141|FG000|COMPLETED|Randomization|1465 were assigned to self-testing|1465
10299287|NCT00032591|11432142|FG001|COMPLETED|Randomization|1457 were assigned to clinic testing|1457
10299288|NCT00032591|11432141|FG000|NOT COMPLETED|Randomization||0
10299289|NCT00032591|11432142|FG001|NOT COMPLETED|Randomization||0
10299290|NCT00032591|11432141|FG000|STARTED|Follow-up|2 were lost to follow-up, both with Atrial Fibrillation, no Mechanical Heart Valves|1465
10299291|NCT00032591|11432142|FG001|STARTED|Follow-up|5 were lost to follow-up, all with Atrial Fibrillation, no Mechanical Heart Valves|1457
10299292|NCT00032591|11432141|FG000|COMPLETED|Follow-up|1463 were included in analysis with greater than 1 day of follow-up|1463
10299293|NCT00032591|11432142|FG001|COMPLETED|Follow-up|1452 were included in analysis with greater than 1 day of follow-up|1452
10299294|NCT00032591|11432141|FG000|NOT COMPLETED|Follow-up||2
10299295|NCT00032591|11432142|FG001|NOT COMPLETED|Follow-up||5
10299296|NCT00032630|11432150|FG000|STARTED|Overall Study||1099
10299297|NCT00032630|11432151|FG001|STARTED|Overall Study||1104
10299298|NCT00032630|11432150|FG000|COMPLETED|Overall Study||1050
10299299|NCT00032630|11432151|FG001|COMPLETED|Overall Study||1061
10299300|NCT00032630|11432150|FG000|NOT COMPLETED|Overall Study||49
10299301|NCT00032630|11432151|FG001|NOT COMPLETED|Overall Study||43
10299302|NCT00033371|11432159|FG000|STARTED|Overall Study||55
10299303|NCT00033371|11432160|FG001|STARTED|Overall Study||57
10299304|NCT00033371|11432159|FG000|COMPLETED|Overall Study||49
10299305|NCT00033371|11432160|FG001|COMPLETED|Overall Study||47
10299306|NCT00033371|11432159|FG000|NOT COMPLETED|Overall Study||6
10299307|NCT00033371|11432160|FG001|NOT COMPLETED|Overall Study||10
10299308|NCT00033514|11432172|FG000|STARTED|Overall Study||16
10299309|NCT00033514|11432173|FG001|STARTED|Overall Study||11
10299310|NCT00033514|11432172|FG000|COMPLETED|Overall Study||15
10299311|NCT00033514|11432173|FG001|COMPLETED|Overall Study||7
10299312|NCT00033514|11432172|FG000|NOT COMPLETED|Overall Study||1
10299313|NCT00033514|11432173|FG001|NOT COMPLETED|Overall Study||4
10299314|NCT00033540|11432180|FG000|STARTED|Overall Study||57
10299315|NCT00033540|11432180|FG000|Eligible|Overall Study||54
10299316|NCT00033540|11432180|FG000|Eligible and Began Protocol Therapy|Overall Study|One patient went off study prior to any toxicity assessments and is not evaluable for toxicities.|52
10299317|NCT00033540|11432180|FG000|COMPLETED|Overall Study||0
10299318|NCT00033540|11432180|FG000|NOT COMPLETED|Overall Study||57
10299325|NCT00033657|11432197|FG000|STARTED|Neoadjuvant Chemotherapy||50
10299326|NCT00033657|11432198|FG001|STARTED|Neoadjuvant Chemotherapy||47
10421842|NCT03343626|11566767|FG007|STARTED|Overall Study||36
10421843|NCT03343626|11566760|FG000|Safety Analysis Set|Overall Study||31
10421844|NCT03343626|11566761|FG001|Safety Analysis Set|Overall Study||31
10421845|NCT03343626|11566762|FG002|Safety Analysis Set|Overall Study||31
10421846|NCT03343626|11566763|FG003|Safety Analysis Set|Overall Study||32
10421847|NCT03343626|11566764|FG004|Safety Analysis Set|Overall Study||36
10421848|NCT03343626|11566765|FG005|Safety Analysis Set|Overall Study||37
10421849|NCT03343626|11566766|FG006|Safety Analysis Set|Overall Study||37
10421850|NCT03343626|11566767|FG007|Safety Analysis Set|Overall Study||36
10421851|NCT03343626|11566760|FG000|Full Analysis Set|Overall Study||30
10421852|NCT03343626|11566761|FG001|Full Analysis Set|Overall Study||28
10421853|NCT03343626|11566762|FG002|Full Analysis Set|Overall Study||31
10421854|NCT03343626|11566763|FG003|Full Analysis Set|Overall Study||30
10421855|NCT03343626|11566764|FG004|Full Analysis Set|Overall Study||34
10421856|NCT03343626|11566765|FG005|Full Analysis Set|Overall Study||34
10421857|NCT03343626|11566766|FG006|Full Analysis Set|Overall Study||34
10421858|NCT03343626|11566767|FG007|Full Analysis Set|Overall Study||34
10421859|NCT03343626|11566760|FG000|Per Protocol Set|Overall Study||28
10421860|NCT03343626|11566761|FG001|Per Protocol Set|Overall Study||25
10421861|NCT03343626|11566762|FG002|Per Protocol Set|Overall Study||29
10421862|NCT03343626|11566763|FG003|Per Protocol Set|Overall Study||30
10421863|NCT03343626|11566764|FG004|Per Protocol Set|Overall Study||34
10421864|NCT03343626|11566765|FG005|Per Protocol Set|Overall Study||33
10421865|NCT03343626|11566766|FG006|Per Protocol Set|Overall Study||34
10421866|NCT03343626|11566767|FG007|Per Protocol Set|Overall Study||33
10421867|NCT03343626|11566760|FG000|COMPLETED|Overall Study||25
10421868|NCT03343626|11566761|FG001|COMPLETED|Overall Study||26
10421869|NCT03343626|11566762|FG002|COMPLETED|Overall Study||29
10421870|NCT03343626|11566763|FG003|COMPLETED|Overall Study||24
10421871|NCT03343626|11566764|FG004|COMPLETED|Overall Study||29
10421872|NCT03343626|11566765|FG005|COMPLETED|Overall Study||32
10421873|NCT03343626|11566766|FG006|COMPLETED|Overall Study||32
10421874|NCT03343626|11566767|FG007|COMPLETED|Overall Study||25
10421875|NCT03343626|11566760|FG000|NOT COMPLETED|Overall Study||6
10421876|NCT03343626|11566761|FG001|NOT COMPLETED|Overall Study||5
10421877|NCT03343626|11566762|FG002|NOT COMPLETED|Overall Study||2
10421878|NCT03343626|11566763|FG003|NOT COMPLETED|Overall Study||8
10421879|NCT03343626|11566764|FG004|NOT COMPLETED|Overall Study||7
10421880|NCT03343626|11566765|FG005|NOT COMPLETED|Overall Study||5
10421881|NCT03343626|11566766|FG006|NOT COMPLETED|Overall Study||5
10421882|NCT03343626|11566767|FG007|NOT COMPLETED|Overall Study||11
10421883|NCT03088930|11566788|FG000|STARTED|Overall Study||3
10421884|NCT03088930|11566788|FG000|COMPLETED|Overall Study||3
10421885|NCT03088930|11566788|FG000|NOT COMPLETED|Overall Study||0
10421886|NCT02960204|11566796|FG000|STARTED|Overall Study||65
10421887|NCT02960204|11566797|FG001|STARTED|Overall Study||65
10421888|NCT02960204|11566798|FG002|STARTED|Overall Study||66
10421889|NCT02960204|11566799|FG003|STARTED|Overall Study||67
10421890|NCT02960204|11566796|FG000|Randomized|Overall Study||65
10421891|NCT02960204|11566797|FG001|Randomized|Overall Study||65
10421892|NCT02960204|11566798|FG002|Randomized|Overall Study||66
10421893|NCT02960204|11566799|FG003|Randomized|Overall Study||67
10421894|NCT02960204|11566796|FG000|Completed Week 24 of Study|Overall Study||62
10421895|NCT02960204|11566797|FG001|Completed Week 24 of Study|Overall Study||62
10421896|NCT02960204|11566798|FG002|Completed Week 24 of Study|Overall Study||60
10421897|NCT02960204|11566799|FG003|Completed Week 24 of Study|Overall Study||66
10421898|NCT02960204|11566796|FG000|Completed Week 48 of Study|Overall Study||55
10421899|NCT02960204|11566797|FG001|Completed Week 48 of Study|Overall Study||55
10421900|NCT02960204|11566798|FG002|Completed Week 48 of Study|Overall Study||50
10421901|NCT02960204|11566799|FG003|Completed Week 48 of Study|Overall Study||59
10421902|NCT02960204|11566796|FG000|COMPLETED|Overall Study||36
10421903|NCT02960204|11566797|FG001|COMPLETED|Overall Study||44
10421904|NCT02960204|11566798|FG002|COMPLETED|Overall Study||37
10421905|NCT02960204|11566799|FG003|COMPLETED|Overall Study||38
10421906|NCT02960204|11566796|FG000|NOT COMPLETED|Overall Study||29
10421907|NCT02960204|11566797|FG001|NOT COMPLETED|Overall Study||21
10299327|NCT00033657|11432197|FG000|Eligible|Neoadjuvant Chemotherapy||42
10299328|NCT00033657|11432198|FG001|Eligible|Neoadjuvant Chemotherapy||43
10299329|NCT00033657|11432197|FG000|Eligible and Treated|Neoadjuvant Chemotherapy||39
10299330|NCT00033657|11432198|FG001|Eligible and Treated|Neoadjuvant Chemotherapy||42
10299331|NCT00033657|11432197|FG000|COMPLETED|Neoadjuvant Chemotherapy||36
10299332|NCT00033657|11432198|FG001|COMPLETED|Neoadjuvant Chemotherapy||36
10299333|NCT00033657|11432197|FG000|NOT COMPLETED|Neoadjuvant Chemotherapy||14
10299334|NCT00033657|11432198|FG001|NOT COMPLETED|Neoadjuvant Chemotherapy||11
10299335|NCT00033657|11432197|FG000|STARTED|Surgical Resection||36
10299336|NCT00033657|11432198|FG001|STARTED|Surgical Resection||36
10299337|NCT00033657|11432197|FG000|COMPLETED|Surgical Resection||36
10299338|NCT00033657|11432198|FG001|COMPLETED|Surgical Resection||33
10299339|NCT00033657|11432197|FG000|NOT COMPLETED|Surgical Resection||0
10299340|NCT00033657|11432198|FG001|NOT COMPLETED|Surgical Resection||3
10299341|NCT00033657|11432197|FG000|STARTED|Adjuvant Chemotherapy||36
10299342|NCT00033657|11432198|FG001|STARTED|Adjuvant Chemotherapy||33
10299343|NCT00033657|11432197|FG000|COMPLETED|Adjuvant Chemotherapy||18
10421908|NCT02960204|11566798|FG002|NOT COMPLETED|Overall Study||29
10421909|NCT02960204|11566799|FG003|NOT COMPLETED|Overall Study||29
10421910|NCT02856269|11566811|FG000|STARTED|Overall Study||25
10421911|NCT02856269|11566812|FG001|STARTED|Overall Study||27
10421912|NCT02856269|11566811|FG000|COMPLETED|Overall Study||24
10421913|NCT02856269|11566812|FG001|COMPLETED|Overall Study||24
10421914|NCT02856269|11566811|FG000|NOT COMPLETED|Overall Study||1
10421915|NCT02856269|11566812|FG001|NOT COMPLETED|Overall Study||3
10421916|NCT02807363|11566822|FG000|STARTED|Dosing Period||9
10421917|NCT02807363|11566823|FG001|STARTED|Dosing Period||9
10421918|NCT02807363|11566824|FG002|STARTED|Dosing Period||5
10421919|NCT02807363|11566825|FG003|STARTED|Dosing Period||12
10421920|NCT02807363|11566822|FG000|COMPLETED|Dosing Period||9
10421921|NCT02807363|11566823|FG001|COMPLETED|Dosing Period||8
10421922|NCT02807363|11566824|FG002|COMPLETED|Dosing Period||5
10421923|NCT02807363|11566825|FG003|COMPLETED|Dosing Period||12
10421924|NCT02807363|11566822|FG000|NOT COMPLETED|Dosing Period||0
10421925|NCT02807363|11566823|FG001|NOT COMPLETED|Dosing Period||1
10421926|NCT02807363|11566824|FG002|NOT COMPLETED|Dosing Period||0
10421927|NCT02807363|11566825|FG003|NOT COMPLETED|Dosing Period||0
10421928|NCT02807363|11566822|FG000|STARTED|Post- Dosing Period||9
10421929|NCT02807363|11566823|FG001|STARTED|Post- Dosing Period||8
10421930|NCT02807363|11566824|FG002|STARTED|Post- Dosing Period||5
10421931|NCT02807363|11566825|FG003|STARTED|Post- Dosing Period||12
10421932|NCT02807363|11566822|FG000|COMPLETED|Post- Dosing Period||9
10421933|NCT02807363|11566823|FG001|COMPLETED|Post- Dosing Period||8
10421934|NCT02807363|11566824|FG002|COMPLETED|Post- Dosing Period||5
10421935|NCT02807363|11566825|FG003|COMPLETED|Post- Dosing Period||12
10421936|NCT02807363|11566822|FG000|NOT COMPLETED|Post- Dosing Period||0
10421937|NCT02807363|11566823|FG001|NOT COMPLETED|Post- Dosing Period||0
10421938|NCT02807363|11566824|FG002|NOT COMPLETED|Post- Dosing Period||0
10421939|NCT02807363|11566825|FG003|NOT COMPLETED|Post- Dosing Period||0
10421940|NCT02756403|11566841|FG000|STARTED|Overall Study||46
10421941|NCT02756403|11566842|FG001|STARTED|Overall Study||45
10421942|NCT02756403|11566843|FG002|STARTED|Overall Study||43
10421943|NCT02756403|11566844|FG003|STARTED|Overall Study||47
10421944|NCT02756403|11566841|FG000|COMPLETED|Overall Study||46
10421945|NCT02756403|11566842|FG001|COMPLETED|Overall Study||42
10421946|NCT02756403|11566843|FG002|COMPLETED|Overall Study||41
10421947|NCT02756403|11566844|FG003|COMPLETED|Overall Study||45
10421948|NCT02756403|11566841|FG000|NOT COMPLETED|Overall Study||0
10421949|NCT02756403|11566842|FG001|NOT COMPLETED|Overall Study||3
10421950|NCT02756403|11566843|FG002|NOT COMPLETED|Overall Study||2
10421951|NCT02756403|11566844|FG003|NOT COMPLETED|Overall Study||2
10421952|NCT02751502|11566854|FG000|STARTED|Overall Study||4
10421953|NCT02751502|11566854|FG000|COMPLETED|Overall Study||0
10421954|NCT02751502|11566854|FG000|NOT COMPLETED|Overall Study||4
10429552|NCT00864539|11575594|FG000|STARTED|Overall Study||104
10429553|NCT00864539|11575595|FG001|STARTED|Overall Study||95
10429554|NCT00864539|11575596|FG002|STARTED|Overall Study||102
10429555|NCT00864539|11575597|FG003|STARTED|Overall Study||96
10429556|NCT00864539|11575598|FG004|STARTED|Overall Study||103
10429557|NCT00864539|11575599|FG005|STARTED|Overall Study||85
10429558|NCT00864539|11575594|FG000|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|95
10429559|NCT00864539|11575595|FG001|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|72
10429560|NCT00864539|11575596|FG002|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|92
10429561|NCT00864539|11575597|FG003|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|89
10429562|NCT00864539|11575598|FG004|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|81
10429563|NCT00864539|11575599|FG005|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|71
10429564|NCT00864539|11575594|FG000|NOT COMPLETED|Overall Study||9
10429565|NCT00864539|11575595|FG001|NOT COMPLETED|Overall Study||23
10429566|NCT00864539|11575596|FG002|NOT COMPLETED|Overall Study||10
10429567|NCT00864539|11575597|FG003|NOT COMPLETED|Overall Study||7
10429568|NCT00864539|11575598|FG004|NOT COMPLETED|Overall Study||22
10429569|NCT00864539|11575599|FG005|NOT COMPLETED|Overall Study||14
10429570|NCT00864682|11575616|FG000|STARTED|Overall Study||52
10429571|NCT00864682|11575617|FG001|STARTED|Overall Study||51
10429572|NCT00864682|11575618|FG002|STARTED|Overall Study||53
10429573|NCT00864682|11575616|FG000|COMPLETED|Overall Study||50
10429574|NCT00864682|11575617|FG001|COMPLETED|Overall Study||50
10299344|NCT00033657|11432198|FG001|COMPLETED|Adjuvant Chemotherapy||16
10299345|NCT00033657|11432197|FG000|NOT COMPLETED|Adjuvant Chemotherapy||18
10299346|NCT00033657|11432198|FG001|NOT COMPLETED|Adjuvant Chemotherapy||17
10299347|NCT00033917|11432208|FG000|STARTED|Overall Study||209
10299348|NCT00033917|11432209|FG001|STARTED|Overall Study||222
10299349|NCT00033917|11432208|FG000|COMPLETED|Overall Study||209
10299350|NCT00033917|11432209|FG001|COMPLETED|Overall Study||222
10299351|NCT00033917|11432208|FG000|NOT COMPLETED|Overall Study||0
10299352|NCT00033917|11432209|FG001|NOT COMPLETED|Overall Study||0
10299353|NCT00035555|11432222|FG000|STARTED|Overall Study|Randomized patients|74
10299354|NCT00035555|11432223|FG001|STARTED|Overall Study|Randomized patients|71
10299355|NCT00035555|11432224|FG002|STARTED|Overall Study|Randomized patients|73
10299356|NCT00035555|11432222|FG000|Number Who Had Undergone Transplantation|Overall Study||74
10299357|NCT00035555|11432223|FG001|Number Who Had Undergone Transplantation|Overall Study||71
10299358|NCT00035555|11432224|FG002|Number Who Had Undergone Transplantation|Overall Study||73
10299359|NCT00035555|11432222|FG000|Number Who Received Study Drug|Overall Study||74
10299360|NCT00035555|11432223|FG001|Number Who Received Study Drug|Overall Study||71
10299361|NCT00035555|11432224|FG002|Number Who Received Study Drug|Overall Study||71
10299362|NCT00035555|11432222|FG000|COMPLETED|Overall Study||58
10299363|NCT00035555|11432223|FG001|COMPLETED|Overall Study||55
10299364|NCT00035555|11432224|FG002|COMPLETED|Overall Study||51
10299365|NCT00035555|11432222|FG000|NOT COMPLETED|Overall Study||16
10299366|NCT00035555|11432223|FG001|NOT COMPLETED|Overall Study||16
10299367|NCT00035555|11432224|FG002|NOT COMPLETED|Overall Study||22
10299368|NCT00035815|11432235|FG000|STARTED|Overall Study|Enrollment began June 2003, accrual was for 2 years, follow-up period was 2 years.|167
10299369|NCT00035815|11432236|FG001|STARTED|Overall Study|Enrollment began June 2003, accrual was for 2 years, follow-up period was 2 years.|163
10299370|NCT00035815|11432235|FG000|COMPLETED|Overall Study||150
10299371|NCT00035815|11432236|FG001|COMPLETED|Overall Study||152
10299372|NCT00035815|11432235|FG000|NOT COMPLETED|Overall Study||17
10299373|NCT00035815|11432236|FG001|NOT COMPLETED|Overall Study||11
10299374|NCT00035932|11432245|FG000|STARTED|Overall Study|120 randomized, 119 treated|119
10299375|NCT00035932|11432246|FG001|STARTED|Overall Study|115 randomized, 110 treated|110
10299376|NCT00035932|11432247|FG002|STARTED|Overall Study|123 randomized, 118 treated|118
10299377|NCT00035932|11432245|FG000|Discontinued Prior to Week 48 Visit|Overall Study||26
10299378|NCT00035932|11432246|FG001|Discontinued Prior to Week 48 Visit|Overall Study||29
10299379|NCT00035932|11432247|FG002|Discontinued Prior to Week 48 Visit|Overall Study||13
10299380|NCT00035932|11432245|FG000|Discontinued Between Weeks 48 and 96|Overall Study||26
10299381|NCT00035932|11432246|FG001|Discontinued Between Weeks 48 and 96|Overall Study||27
10299382|NCT00035932|11432247|FG002|Discontinued Between Weeks 48 and 96|Overall Study||30
10299383|NCT00035932|11432245|FG000|Discontinued on or After Week 96|Overall Study||4
10299384|NCT00035932|11432246|FG001|Discontinued on or After Week 96|Overall Study||4
10299385|NCT00035932|11432247|FG002|Discontinued on or After Week 96|Overall Study||6
10299386|NCT00035932|11432245|FG000|COMPLETED|Overall Study|63 remained on treatment, 0 completed at Week 96|63
10299387|NCT00035932|11432246|FG001|COMPLETED|Overall Study|50 remained on treatment, 0 completed at Week 96|50
10299388|NCT00035932|11432247|FG002|COMPLETED|Overall Study|59 remained on treatment, 10 completed at Week 96|69
10299389|NCT00035932|11432245|FG000|NOT COMPLETED|Overall Study||56
10299390|NCT00035932|11432246|FG001|NOT COMPLETED|Overall Study||60
10299391|NCT00035932|11432247|FG002|NOT COMPLETED|Overall Study||49
10299392|NCT00036270|11432262|FG000|STARTED|Randomized to Study Treatment||4904
10299393|NCT00036270|11432263|FG001|STARTED|Randomized to Study Treatment||4875
10299394|NCT00036270|11432262|FG000|COMPLETED|Randomized to Study Treatment||4898
10299395|NCT00036270|11432263|FG001|COMPLETED|Randomized to Study Treatment||4868
10299396|NCT00036270|11432262|FG000|NOT COMPLETED|Randomized to Study Treatment||6
10299397|NCT00036270|11432263|FG001|NOT COMPLETED|Randomized to Study Treatment||7
10299398|NCT00036270|11432262|FG000|STARTED|Study Treatment to 5 Year Report||4898
10299399|NCT00036270|11432263|FG001|STARTED|Study Treatment to 5 Year Report||4868
10299400|NCT00036270|11432262|FG000|Treated|Study Treatment to 5 Year Report||4852
10299401|NCT00036270|11432263|FG001|Treated|Study Treatment to 5 Year Report||4814
10299402|NCT00036270|11432262|FG000|COMPLETED|Study Treatment to 5 Year Report||2333
10299403|NCT00036270|11432263|FG001|COMPLETED|Study Treatment to 5 Year Report||1380
10299404|NCT00036270|11432262|FG000|NOT COMPLETED|Study Treatment to 5 Year Report||2565
10299405|NCT00036270|11432263|FG001|NOT COMPLETED|Study Treatment to 5 Year Report||3488
10299406|NCT00036569|11432269|FG000|STARTED|Overall Study||32
10299407|NCT00036569|11432269|FG000|COMPLETED|Overall Study||32
10299408|NCT00036569|11432269|FG000|NOT COMPLETED|Overall Study||0
10299409|NCT00036738|11432275|FG000|STARTED|Overall Study||28
10299410|NCT00036738|11432275|FG000|COMPLETED|Overall Study||28
10299411|NCT00036738|11432275|FG000|NOT COMPLETED|Overall Study||0
10299412|NCT00037830|11432282|FG000|STARTED|Overall Study||39
10299413|NCT00037830|11432283|FG001|STARTED|Overall Study||38
10299414|NCT00037830|11432284|FG002|STARTED|Overall Study||17
10299415|NCT00037830|11432282|FG000|COMPLETED|Overall Study||29
10299416|NCT00037830|11432283|FG001|COMPLETED|Overall Study||31
10299417|NCT00037830|11432284|FG002|COMPLETED|Overall Study||16
10299418|NCT00037830|11432282|FG000|NOT COMPLETED|Overall Study||10
10299419|NCT00037830|11432283|FG001|NOT COMPLETED|Overall Study||7
10299420|NCT00037830|11432284|FG002|NOT COMPLETED|Overall Study||1
10299421|NCT00038103|11432294|FG000|STARTED|Overall Study||55
10299422|NCT00038103|11432295|FG001|STARTED|Overall Study||56
10299423|NCT00038103|11432294|FG000|End of Treatment|Overall Study|patients remained on treatment until discontinued|53
10299424|NCT00038103|11432295|FG001|End of Treatment|Overall Study|patients remained on treatment until discontinued|56
10299425|NCT00038103|11432294|FG000|COMPLETED|Overall Study||0
10299426|NCT00038103|11432295|FG001|COMPLETED|Overall Study||0
10299427|NCT00038103|11432294|FG000|NOT COMPLETED|Overall Study||55
10299428|NCT00038103|11432295|FG001|NOT COMPLETED|Overall Study||56
10299429|NCT00038467|11432303|FG000|STARTED|Overall Study||2352
10299430|NCT00038467|11432304|FG001|STARTED|Overall Study||2372
10299431|NCT00038467|11432303|FG000|Treated|Overall Study|8 participants randomized to receive exemestane, received tamoxifen. Reported as per randomization.|2321
10299432|NCT00038467|11432304|FG001|Treated|Overall Study|7 participants randomized to receive tamoxifen, received exemestane. Reported as per randomization.|2337
10299433|NCT00038467|11432303|FG000|COMPLETED|Overall Study||1810
10299434|NCT00038467|11432304|FG001|COMPLETED|Overall Study||1830
10299435|NCT00038467|11432303|FG000|NOT COMPLETED|Overall Study||542
10299436|NCT00038467|11432304|FG001|NOT COMPLETED|Overall Study||542
10299437|NCT00038610|11432310|FG000|STARTED|Overall Study||54
10299438|NCT00038610|11432310|FG000|COMPLETED|Overall Study||54
10299439|NCT00038610|11432310|FG000|NOT COMPLETED|Overall Study||0
10299440|NCT00038649|11432314|FG000|STARTED|Overall Study||114
10299441|NCT00038649|11432314|FG000|COMPLETED|Overall Study||105
10299442|NCT00038649|11432314|FG000|NOT COMPLETED|Overall Study||9
10299443|NCT00038857|11432318|FG000|STARTED|Overall Study||29
10299444|NCT00038857|11432318|FG000|COMPLETED|Overall Study||28
10299445|NCT00038857|11432318|FG000|NOT COMPLETED|Overall Study||1
10299446|NCT00038948|11432324|FG000|STARTED|Overall Study||555
10299447|NCT00038948|11432325|FG001|STARTED|Overall Study||275
10299448|NCT00038948|11432324|FG000|COMPLETED|Overall Study||386
10299449|NCT00038948|11432325|FG001|COMPLETED|Overall Study||198
10299450|NCT00038948|11432324|FG000|NOT COMPLETED|Overall Study||169
10299451|NCT00038948|11432325|FG001|NOT COMPLETED|Overall Study||77
10299452|NCT00039130|11432337|FG000|STARTED|Overall Study||105
10299453|NCT00039130|11432337|FG000|COMPLETED|Overall Study||75
10299454|NCT00039130|11432337|FG000|NOT COMPLETED|Overall Study||30
10299455|NCT00039195|11432341|FG000|STARTED|Overall Study||98
10299456|NCT00039195|11432341|FG000|COMPLETED|Overall Study||98
10299457|NCT00039195|11432341|FG000|NOT COMPLETED|Overall Study||0
10299458|NCT00039377|11432345|FG000|STARTED|Initial Registration||57
10299459|NCT00039377|11432346|FG001|STARTED|Initial Registration||0
10299460|NCT00039377|11432347|FG002|STARTED|Initial Registration||0
10299461|NCT00039377|11432348|FG003|STARTED|Initial Registration||0
10299462|NCT00039377|11432345|FG000|COMPLETED|Initial Registration||35
10299463|NCT00039377|11432346|FG001|COMPLETED|Initial Registration||0
10299464|NCT00039377|11432347|FG002|COMPLETED|Initial Registration||0
10299465|NCT00039377|11432348|FG003|COMPLETED|Initial Registration||0
10299466|NCT00039377|11432345|FG000|NOT COMPLETED|Initial Registration||22
10299467|NCT00039377|11432346|FG001|NOT COMPLETED|Initial Registration||0
10299468|NCT00039377|11432347|FG002|NOT COMPLETED|Initial Registration||0
10299469|NCT00039377|11432348|FG003|NOT COMPLETED|Initial Registration||0
10299470|NCT00039377|11432345|FG000|STARTED|Course 5 (Transplant Assignments)|After Course I-IV, participants were grouped into autologous, allogeneic or no transplant arms.|0
10299471|NCT00039377|11432346|FG001|STARTED|Course 5 (Transplant Assignments)||15
10299472|NCT00039377|11432347|FG002|STARTED|Course 5 (Transplant Assignments)||19
10299473|NCT00039377|11432348|FG003|STARTED|Course 5 (Transplant Assignments)||1
10299474|NCT00039377|11432345|FG000|COMPLETED|Course 5 (Transplant Assignments)||0
10299475|NCT00039377|11432346|FG001|COMPLETED|Course 5 (Transplant Assignments)||15
10299476|NCT00039377|11432347|FG002|COMPLETED|Course 5 (Transplant Assignments)||19
10299477|NCT00039377|11432348|FG003|COMPLETED|Course 5 (Transplant Assignments)||1
10299478|NCT00039377|11432345|FG000|NOT COMPLETED|Course 5 (Transplant Assignments)||0
10299479|NCT00039377|11432346|FG001|NOT COMPLETED|Course 5 (Transplant Assignments)||0
10299480|NCT00039377|11432347|FG002|NOT COMPLETED|Course 5 (Transplant Assignments)||0
10299481|NCT00039377|11432348|FG003|NOT COMPLETED|Course 5 (Transplant Assignments)||0
10299482|NCT00039741|11432360|FG000|STARTED|Overall Study||66
10299483|NCT00039741|11432361|FG001|STARTED|Overall Study||68
10299484|NCT00039741|11432362|FG002|STARTED|Overall Study||65
10299485|NCT00039741|11432363|FG003|STARTED|Overall Study||64
10299486|NCT00039741|11432360|FG000|Death|Overall Study||0
10299487|NCT00039741|11432361|FG001|Death|Overall Study||1
10299488|NCT00039741|11432362|FG002|Death|Overall Study||0
10299489|NCT00039741|11432363|FG003|Death|Overall Study||0
10299490|NCT00039741|11432360|FG000|COMPLETED|Overall Study||51
10299491|NCT00039741|11432361|FG001|COMPLETED|Overall Study||56
10299492|NCT00039741|11432362|FG002|COMPLETED|Overall Study||54
10299493|NCT00039741|11432363|FG003|COMPLETED|Overall Study||50
10299494|NCT00039741|11432360|FG000|NOT COMPLETED|Overall Study||15
10299495|NCT00039741|11432361|FG001|NOT COMPLETED|Overall Study||12
10299496|NCT00039741|11432362|FG002|NOT COMPLETED|Overall Study||11
10299497|NCT00039741|11432363|FG003|NOT COMPLETED|Overall Study||14
10299498|NCT00039871|11432373|FG000|STARTED|Overall Study|Enrolled 2333; 21 subjects excluded due to GCP non-compliance|2312
10299499|NCT00039871|11432373|FG000|COMPLETED|Overall Study||928
10299500|NCT00039871|11432373|FG000|NOT COMPLETED|Overall Study||1384
10299501|NCT00040365|11432377|FG000|STARTED|Overall Study||30
10299502|NCT00040365|11432377|FG000|Completed Follow Up Phase|Overall Study||19
10299503|NCT00040365|11432377|FG000|COMPLETED|Overall Study||19
10299504|NCT00040365|11432377|FG000|NOT COMPLETED|Overall Study||11
10299505|NCT00040443|11432383|FG000|STARTED|Overall Study||84
10299506|NCT00040443|11432384|FG001|STARTED|Overall Study||91
10299507|NCT00040443|11432383|FG000|COMPLETED|Overall Study||84
10299508|NCT00040443|11432384|FG001|COMPLETED|Overall Study||91
10299509|NCT00040443|11432383|FG000|NOT COMPLETED|Overall Study||0
10299510|NCT00040443|11432384|FG001|NOT COMPLETED|Overall Study||0
10299511|NCT00040664|11432390|FG000|STARTED|Overall Study|All (69) enrolled on QD; 10 switched to twice daily. Participant flow not collected for this group.|69
10299512|NCT00040664|11432391|FG001|STARTED|Overall Study||17
10299513|NCT00040664|11432392|FG002|STARTED|Overall Study||17
10299514|NCT00040664|11432393|FG003|STARTED|Overall Study||35
10299515|NCT00040664|11432390|FG000|COMPLETED|Overall Study||16
10299516|NCT00040664|11432391|FG001|COMPLETED|Overall Study||4
10299517|NCT00040664|11432392|FG002|COMPLETED|Overall Study||4
10299518|NCT00040664|11432393|FG003|COMPLETED|Overall Study||8
10299519|NCT00040664|11432390|FG000|NOT COMPLETED|Overall Study||53
10299520|NCT00040664|11432391|FG001|NOT COMPLETED|Overall Study||13
10299521|NCT00040664|11432392|FG002|NOT COMPLETED|Overall Study||13
10299522|NCT00040664|11432393|FG003|NOT COMPLETED|Overall Study||27
10299523|NCT00040742|11432415|FG000|STARTED|Overall Study||188
10299524|NCT00040742|11432416|FG001|STARTED|Overall Study||183
10299525|NCT00040742|11432417|FG002|STARTED|Overall Study||187
10299526|NCT00040742|11432418|FG003|STARTED|Overall Study|One subject found to be ineligible after randomization. No baseline data collected.|186
10299527|NCT00040742|11432415|FG000|COMPLETED|Overall Study||149
10299528|NCT00040742|11432416|FG001|COMPLETED|Overall Study||134
10299529|NCT00040742|11432417|FG002|COMPLETED|Overall Study||141
10299530|NCT00040742|11432418|FG003|COMPLETED|Overall Study||152
10299531|NCT00040742|11432415|FG000|NOT COMPLETED|Overall Study||39
10299532|NCT00040742|11432416|FG001|NOT COMPLETED|Overall Study||49
10299533|NCT00040742|11432417|FG002|NOT COMPLETED|Overall Study||46
10299534|NCT00040742|11432418|FG003|NOT COMPLETED|Overall Study||34
10299535|NCT00040846|11432434|FG000|STARTED|Overall Study||60
10299536|NCT00040846|11432435|FG001|STARTED|Overall Study||0
10299537|NCT00040846|11432436|FG002|STARTED|Overall Study||0
10299538|NCT00040846|11432437|FG003|STARTED|Overall Study||0
10299539|NCT00040846|11432438|FG004|STARTED|Overall Study||0
10299540|NCT00040846|11432439|FG005|STARTED|Overall Study||0
10299541|NCT00040846|11432434|FG000|COMPLETED|Overall Study||60
10299542|NCT00040846|11432435|FG001|COMPLETED|Overall Study||0
10299543|NCT00040846|11432436|FG002|COMPLETED|Overall Study||0
10299544|NCT00040846|11432437|FG003|COMPLETED|Overall Study||0
10299545|NCT00040846|11432438|FG004|COMPLETED|Overall Study||0
10299546|NCT00040846|11432439|FG005|COMPLETED|Overall Study||0
10299547|NCT00040846|11432434|FG000|NOT COMPLETED|Overall Study||0
10299548|NCT00040846|11432435|FG001|NOT COMPLETED|Overall Study||0
10299549|NCT00040846|11432436|FG002|NOT COMPLETED|Overall Study||0
10299550|NCT00040846|11432437|FG003|NOT COMPLETED|Overall Study||0
10299551|NCT00040846|11432438|FG004|NOT COMPLETED|Overall Study||0
10299552|NCT00040846|11432439|FG005|NOT COMPLETED|Overall Study||0
10299553|NCT00040937|11432453|FG000|STARTED|Induction/PBSC Mobilization|147 registered to this period; 142 were eligible and analyzable; 140 were assessable for toxicity.|147
10299554|NCT00040937|11432453|FG000|COMPLETED|Induction/PBSC Mobilization||110
10299555|NCT00040937|11432453|FG000|NOT COMPLETED|Induction/PBSC Mobilization||37
10299556|NCT00040937|11432453|FG000|STARTED|Autologous PBSCT|108 registered to this period; 105 were eligible and analyzable; 105 were assessable for toxicity.|108
10299557|NCT00040937|11432453|FG000|COMPLETED|Autologous PBSCT||77
10299558|NCT00040937|11432453|FG000|NOT COMPLETED|Autologous PBSCT||31
10299559|NCT00040937|11432453|FG000|STARTED|Maintenance||76
10299560|NCT00040937|11432453|FG000|COMPLETED|Maintenance|Patients remained on protocol therapy until progression.|76
10299561|NCT00040937|11432453|FG000|NOT COMPLETED|Maintenance||0
10299562|NCT00041067|11432460|FG000|STARTED|Overall Study||76
10299563|NCT00041067|11432460|FG000|Eligible|Overall Study||74
10299564|NCT00041067|11432460|FG000|COMPLETED|Overall Study||0
10299565|NCT00041067|11432460|FG000|NOT COMPLETED|Overall Study||76
10299566|NCT00041080|11432467|FG000|STARTED|Overall Study|number patients enrolled on study|69
10299567|NCT00041080|11432468|FG001|STARTED|Overall Study|number patients enrolled on study|70
10299568|NCT00041080|11432467|FG000|COMPLETED|Overall Study||39
10299569|NCT00041080|11432468|FG001|COMPLETED|Overall Study||60
10299570|NCT00041080|11432467|FG000|NOT COMPLETED|Overall Study||30
10299571|NCT00041080|11432468|FG001|NOT COMPLETED|Overall Study||10
10299572|NCT00041119|11432478|FG000|STARTED|Overall Study||1142
10299573|NCT00041119|11432479|FG001|STARTED|Overall Study||789
10299574|NCT00041119|11432480|FG002|STARTED|Overall Study||1151
10299575|NCT00041119|11432481|FG003|STARTED|Overall Study||789
10299576|NCT00041119|11432478|FG000|COMPLETED|Overall Study||1142
10299577|NCT00041119|11432479|FG001|COMPLETED|Overall Study||789
10299578|NCT00041119|11432480|FG002|COMPLETED|Overall Study||1151
10299579|NCT00041119|11432481|FG003|COMPLETED|Overall Study||789
10299580|NCT00041119|11432478|FG000|NOT COMPLETED|Overall Study||0
10299581|NCT00041119|11432479|FG001|NOT COMPLETED|Overall Study||0
10299582|NCT00041119|11432480|FG002|NOT COMPLETED|Overall Study||0
10299583|NCT00041119|11432481|FG003|NOT COMPLETED|Overall Study||0
10299584|NCT00041132|11432495|FG000|STARTED|Overall Study||56
10299585|NCT00041132|11432495|FG000|Eligible|Overall Study||49
10299586|NCT00041132|11432495|FG000|Eligible and Began Protocol Therapy|Overall Study||49
10299587|NCT00041132|11432495|FG000|COMPLETED|Overall Study||26
10299588|NCT00041132|11432495|FG000|NOT COMPLETED|Overall Study||30
10299589|NCT00041470|11432499|FG000|STARTED|Overall Study||38
10299590|NCT00041470|11432499|FG000|COMPLETED|Overall Study||0
10299591|NCT00041470|11432499|FG000|NOT COMPLETED|Overall Study||38
10315045|NCT00171925|11448826|FG001|STARTED|Overall Study||71
10315046|NCT00171925|11448825|FG000|COMPLETED|Overall Study||42
10315047|NCT00171925|11448826|FG001|COMPLETED|Overall Study||40
10315048|NCT00171925|11448825|FG000|NOT COMPLETED|Overall Study||30
10299592|NCT00041717|11432505|FG000|STARTED|Overall Study||114
10299593|NCT00041717|11432506|FG001|STARTED|Overall Study||98
10299594|NCT00041717|11432505|FG000|COMPLETED|Overall Study||81
10299595|NCT00041717|11432506|FG001|COMPLETED|Overall Study||86
10299596|NCT00041717|11432505|FG000|NOT COMPLETED|Overall Study||33
10299597|NCT00041717|11432506|FG001|NOT COMPLETED|Overall Study||12
10299598|NCT00041756|11432517|FG000|STARTED|Overall Study||77
10299599|NCT00041756|11432518|FG001|STARTED|Overall Study||80
10299600|NCT00041756|11432519|FG002|STARTED|Overall Study||79
10299601|NCT00041756|11432520|FG003|STARTED|Overall Study||80
10299602|NCT00041756|11432521|FG004|STARTED|Overall Study||79
10299603|NCT00041756|11432517|FG000|COMPLETED|Overall Study||69
10299604|NCT00041756|11432518|FG001|COMPLETED|Overall Study||65
10299605|NCT00041756|11432519|FG002|COMPLETED|Overall Study||66
10299606|NCT00041756|11432520|FG003|COMPLETED|Overall Study||64
10299607|NCT00041756|11432521|FG004|COMPLETED|Overall Study||19
10299608|NCT00041756|11432517|FG000|NOT COMPLETED|Overall Study||8
10299609|NCT00041756|11432518|FG001|NOT COMPLETED|Overall Study||15
10299610|NCT00041756|11432519|FG002|NOT COMPLETED|Overall Study||13
10299611|NCT00041756|11432520|FG003|NOT COMPLETED|Overall Study||16
10299612|NCT00041756|11432521|FG004|NOT COMPLETED|Overall Study||60
10299613|NCT00041938|11432535|FG000|STARTED|Overall Study||1163
10299614|NCT00041938|11432536|FG001|STARTED|Overall Study||1142
10299615|NCT00041938|11432535|FG000|Completed Follow-up|Overall Study||761
10299616|NCT00041938|11432536|FG001|Completed Follow-up|Overall Study||745
10299617|NCT00041938|11432535|FG000|Primary Endpoint|Overall Study||320
10299618|NCT00041938|11432536|FG001|Primary Endpoint|Overall Study||302
10299619|NCT00041938|11432535|FG000|Only Vital Status Known|Overall Study||44
10299620|NCT00041938|11432536|FG001|Only Vital Status Known|Overall Study||46
10299621|NCT00041938|11432535|FG000|Lost to Follow-up|Overall Study||18
10299622|NCT00041938|11432536|FG001|Lost to Follow-up|Overall Study||17
10299623|NCT00041938|11432535|FG000|Withdrew Consent|Overall Study||20
10299624|NCT00041938|11432536|FG001|Withdrew Consent|Overall Study||14
10299625|NCT00041938|11432535|FG000|COMPLETED|Overall Study||1125
10299626|NCT00041938|11432536|FG001|COMPLETED|Overall Study||1111
10299627|NCT00041938|11432535|FG000|NOT COMPLETED|Overall Study||38
10299628|NCT00041938|11432536|FG001|NOT COMPLETED|Overall Study||31
10299629|NCT00042224|11432544|FG000|STARTED|Overall Study||20
10299630|NCT00042224|11432545|FG001|STARTED|Overall Study||19
10299631|NCT00042224|11432544|FG000|COMPLETED|Overall Study||17
10299632|NCT00042224|11432545|FG001|COMPLETED|Overall Study||16
10299633|NCT00042224|11432544|FG000|NOT COMPLETED|Overall Study||3
10299634|NCT00042224|11432545|FG001|NOT COMPLETED|Overall Study||3
10299635|NCT00042432|11432553|FG000|STARTED|Overall Study||27
10299636|NCT00042432|11432554|FG001|STARTED|Overall Study||27
10299637|NCT00042432|11432553|FG000|COMPLETED|Overall Study||18
10299638|NCT00042432|11432554|FG001|COMPLETED|Overall Study||20
10299639|NCT00042432|11432553|FG000|NOT COMPLETED|Overall Study||9
10299640|NCT00042432|11432554|FG001|NOT COMPLETED|Overall Study||7
10299641|NCT00042666|11432560|FG000|STARTED|Overall Study||55
10299642|NCT00042666|11432560|FG000|Received at Least 1 Dose of Study Drug|Overall Study||55
10299643|NCT00042666|11432560|FG000|Completed at Least 1 Cycle of Study Drug|Overall Study||42
10299644|NCT00042666|11432560|FG000|COMPLETED|Overall Study||1
10299645|NCT00042666|11432560|FG000|NOT COMPLETED|Overall Study||54
10299646|NCT00042939|11432567|FG000|STARTED|Overall Study||48
10299647|NCT00042939|11432568|FG001|STARTED|Overall Study||46
10299648|NCT00042939|11432567|FG000|Treated|Overall Study||46
10299649|NCT00042939|11432568|FG001|Treated|Overall Study||45
10299650|NCT00042939|11432567|FG000|Eligible and Began Protocol Therapy|Overall Study||44
10299651|NCT00042939|11432568|FG001|Eligible and Began Protocol Therapy|Overall Study||43
10299652|NCT00042939|11432567|FG000|Patients With EGFR Results Available|Overall Study||30
10299653|NCT00042939|11432568|FG001|Patients With EGFR Results Available|Overall Study||31
10299654|NCT00042939|11432567|FG000|COMPLETED|Overall Study||24
10299655|NCT00042939|11432568|FG001|COMPLETED|Overall Study||25
10299656|NCT00042939|11432567|FG000|NOT COMPLETED|Overall Study||24
10299657|NCT00042939|11432568|FG001|NOT COMPLETED|Overall Study||21
10299658|NCT00042991|11432581|FG000|STARTED|Overall Study||6
10299659|NCT00042991|11432582|FG001|STARTED|Overall Study|These 43 patients form the Phase-II cohort, seven contributing from the Phase-I trial.|43
10299660|NCT00042991|11432583|FG002|STARTED|Overall Study||7
10299661|NCT00042991|11432584|FG003|STARTED|Overall Study||2
10299662|NCT00042991|11432585|FG004|STARTED|Overall Study||3
10299663|NCT00042991|11432586|FG005|STARTED|Overall Study||5
10299664|NCT00042991|11432587|FG006|STARTED|Overall Study||3
10299665|NCT00042991|11432581|FG000|Phase-I Trial|Overall Study||6
10299666|NCT00042991|11432582|FG001|Phase-I Trial|Overall Study|These seven patients contributed to both Phase-I and Phase-II objectives.|7
10299667|NCT00042991|11432583|FG002|Phase-I Trial|Overall Study||7
10299668|NCT00042991|11432584|FG003|Phase-I Trial|Overall Study||2
10299669|NCT00042991|11432585|FG004|Phase-I Trial|Overall Study||3
10299670|NCT00042991|11432586|FG005|Phase-I Trial|Overall Study||5
10299671|NCT00042991|11432587|FG006|Phase-I Trial|Overall Study||3
10299672|NCT00042991|11432581|FG000|Phase-II Trial|Overall Study||0
10299673|NCT00042991|11432582|FG001|Phase-II Trial|Overall Study||36
10299674|NCT00042991|11432583|FG002|Phase-II Trial|Overall Study||0
10299675|NCT00042991|11432584|FG003|Phase-II Trial|Overall Study||0
10299676|NCT00042991|11432585|FG004|Phase-II Trial|Overall Study||0
10299677|NCT00042991|11432586|FG005|Phase-II Trial|Overall Study||0
10299678|NCT00042991|11432587|FG006|Phase-II Trial|Overall Study||0
10299679|NCT00042991|11432581|FG000|COMPLETED|Overall Study||0
10299680|NCT00042991|11432582|FG001|COMPLETED|Overall Study||3
10299681|NCT00042991|11432583|FG002|COMPLETED|Overall Study||1
10299682|NCT00042991|11432584|FG003|COMPLETED|Overall Study||0
10299683|NCT00042991|11432585|FG004|COMPLETED|Overall Study||0
10299684|NCT00042991|11432586|FG005|COMPLETED|Overall Study||0
10299685|NCT00042991|11432587|FG006|COMPLETED|Overall Study||1
10299686|NCT00042991|11432581|FG000|NOT COMPLETED|Overall Study||6
10299687|NCT00042991|11432582|FG001|NOT COMPLETED|Overall Study||40
10299688|NCT00042991|11432583|FG002|NOT COMPLETED|Overall Study||6
10299689|NCT00042991|11432584|FG003|NOT COMPLETED|Overall Study||2
10299690|NCT00042991|11432585|FG004|NOT COMPLETED|Overall Study||3
10299691|NCT00042991|11432586|FG005|NOT COMPLETED|Overall Study||5
10299692|NCT00042991|11432587|FG006|NOT COMPLETED|Overall Study||2
10299693|NCT00043186|11432614|FG000|STARTED|Overall Study||46
10299694|NCT00043186|11432615|FG001|STARTED|Overall Study||44
10299695|NCT00043186|11432616|FG002|STARTED|Overall Study||44
10299696|NCT00043186|11432617|FG003|STARTED|Overall Study||41
10299697|NCT00043186|11432618|FG004|STARTED|Overall Study||54
10299698|NCT00043186|11432619|FG005|STARTED|Overall Study||47
10299699|NCT00043186|11432620|FG006|STARTED|Overall Study||42
10299700|NCT00043186|11432621|FG007|STARTED|Overall Study||47
10299701|NCT00043186|11432622|FG008|STARTED|Overall Study||47
10299702|NCT00043186|11432614|FG000|COMPLETED|Overall Study||29
10299703|NCT00043186|11432615|FG001|COMPLETED|Overall Study||29
10299704|NCT00043186|11432616|FG002|COMPLETED|Overall Study||24
10299705|NCT00043186|11432617|FG003|COMPLETED|Overall Study||19
10299706|NCT00043186|11432618|FG004|COMPLETED|Overall Study||36
10299707|NCT00043186|11432619|FG005|COMPLETED|Overall Study||39
10299708|NCT00043186|11432620|FG006|COMPLETED|Overall Study||25
10299709|NCT00043186|11432621|FG007|COMPLETED|Overall Study||31
10299710|NCT00043186|11432622|FG008|COMPLETED|Overall Study||30
10299711|NCT00043186|11432614|FG000|NOT COMPLETED|Overall Study||17
10299712|NCT00043186|11432615|FG001|NOT COMPLETED|Overall Study||15
10299713|NCT00043186|11432616|FG002|NOT COMPLETED|Overall Study||20
10299714|NCT00043186|11432617|FG003|NOT COMPLETED|Overall Study||22
10299715|NCT00043186|11432618|FG004|NOT COMPLETED|Overall Study||18
10299716|NCT00043186|11432619|FG005|NOT COMPLETED|Overall Study||8
10299717|NCT00043186|11432620|FG006|NOT COMPLETED|Overall Study||17
10299718|NCT00043186|11432621|FG007|NOT COMPLETED|Overall Study||16
10299719|NCT00043186|11432622|FG008|NOT COMPLETED|Overall Study||17
10299720|NCT00043550|11432646|FG000|STARTED|Overall Study||55
10299721|NCT00043550|11432647|FG001|STARTED|Overall Study||51
10299722|NCT00043550|11432648|FG002|STARTED|Overall Study||50
10299723|NCT00043550|11432646|FG000|Week 8 Completed|Overall Study||35
10299724|NCT00043550|11432647|FG001|Week 8 Completed|Overall Study||40
10299725|NCT00043550|11432648|FG002|Week 8 Completed|Overall Study||35
10299726|NCT00043550|11432646|FG000|COMPLETED|Overall Study||33
10299727|NCT00043550|11432647|FG001|COMPLETED|Overall Study||39
10299728|NCT00043550|11432648|FG002|COMPLETED|Overall Study||30
10299729|NCT00043550|11432646|FG000|NOT COMPLETED|Overall Study||22
10299730|NCT00043550|11432647|FG001|NOT COMPLETED|Overall Study||12
10299731|NCT00043550|11432648|FG002|NOT COMPLETED|Overall Study||20
10299732|NCT00043979|11432658|FG000|STARTED|Period 1||30
10299733|NCT00043979|11432659|FG001|STARTED|Period 1||17
10299734|NCT00043979|11432660|FG002|STARTED|Period 1||13
10299735|NCT00043979|11432658|FG000|COMPLETED|Period 1||23
10299736|NCT00043979|11432659|FG001|COMPLETED|Period 1||13
10299737|NCT00043979|11432660|FG002|COMPLETED|Period 1||10
10299738|NCT00043979|11432658|FG000|NOT COMPLETED|Period 1||7
10299739|NCT00043979|11432659|FG001|NOT COMPLETED|Period 1||4
10299740|NCT00043979|11432660|FG002|NOT COMPLETED|Period 1||3
10299741|NCT00043979|11432658|FG000|STARTED|Period 2||0
10299742|NCT00043979|11432659|FG001|STARTED|Period 2||13
10299743|NCT00043979|11432660|FG002|STARTED|Period 2||10
10299744|NCT00043979|11432658|FG000|COMPLETED|Period 2||0
10299745|NCT00043979|11432659|FG001|COMPLETED|Period 2||13
10299746|NCT00043979|11432660|FG002|COMPLETED|Period 2||10
10299747|NCT00043979|11432658|FG000|NOT COMPLETED|Period 2||0
10299748|NCT00043979|11432659|FG001|NOT COMPLETED|Period 2||0
10299749|NCT00043979|11432660|FG002|NOT COMPLETED|Period 2||0
10299750|NCT00044005|11432669|FG000|STARTED|Overall Study||32
10299751|NCT00044005|11432670|FG001|STARTED|Overall Study||33
10299752|NCT00044005|11432671|FG002|STARTED|Overall Study||33
10299753|NCT00044005|11432669|FG000|COMPLETED|Overall Study||13
10299754|NCT00044005|11432670|FG001|COMPLETED|Overall Study||19
10546882|NCT01510379|11700700|FG001|COMPLETED|Overall Study||51
10546883|NCT01510379|11700699|FG000|NOT COMPLETED|Overall Study||0
10546884|NCT01510379|11700700|FG001|NOT COMPLETED|Overall Study||0
10546885|NCT01510457|11700708|FG000|STARTED|Overall Study||17
10546886|NCT01510457|11700709|FG001|STARTED|Overall Study||29
10546887|NCT01510457|11700708|FG000|COMPLETED|Overall Study||12
10299755|NCT00044005|11432671|FG002|COMPLETED|Overall Study||11
10299756|NCT00044005|11432669|FG000|NOT COMPLETED|Overall Study||19
10299757|NCT00044005|11432670|FG001|NOT COMPLETED|Overall Study||14
10299758|NCT00044005|11432671|FG002|NOT COMPLETED|Overall Study||22
10299759|NCT00044044|11432684|FG000|STARTED|Overall Study||71
10299760|NCT00044044|11432685|FG001|STARTED|Overall Study||69
10299761|NCT00044044|11432686|FG002|STARTED|Overall Study||71
10299762|NCT00044044|11432687|FG003|STARTED|Overall Study||73
10299763|NCT00044044|11432688|FG004|STARTED|Overall Study||72
10299764|NCT00044044|11432684|FG000|COMPLETED|Overall Study||27
10299765|NCT00044044|11432685|FG001|COMPLETED|Overall Study||28
10299766|NCT00044044|11432686|FG002|COMPLETED|Overall Study||31
10299767|NCT00044044|11432687|FG003|COMPLETED|Overall Study||29
10299768|NCT00044044|11432688|FG004|COMPLETED|Overall Study||36
10546888|NCT01510457|11700709|FG001|COMPLETED|Overall Study||26
10299769|NCT00044044|11432684|FG000|NOT COMPLETED|Overall Study||44
10299770|NCT00044044|11432685|FG001|NOT COMPLETED|Overall Study||41
10299771|NCT00044044|11432686|FG002|NOT COMPLETED|Overall Study||40
10299772|NCT00044044|11432687|FG003|NOT COMPLETED|Overall Study||44
10299773|NCT00044044|11432688|FG004|NOT COMPLETED|Overall Study||36
10299774|NCT00044083|11432702|FG000|STARTED|First Intervention (One Week)- HV's||74
10299775|NCT00044083|11432703|FG001|STARTED|First Intervention (One Week)- HV's||73
10299776|NCT00044083|11432702|FG000|COMPLETED|First Intervention (One Week)- HV's||64
10299777|NCT00044083|11432703|FG001|COMPLETED|First Intervention (One Week)- HV's||66
10299778|NCT00044083|11432702|FG000|NOT COMPLETED|First Intervention (One Week)- HV's||10
10299779|NCT00044083|11432703|FG001|NOT COMPLETED|First Intervention (One Week)- HV's||7
10299780|NCT00044083|11432702|FG000|STARTED|Second Intervention (One Week) HV's||64
10299781|NCT00044083|11432703|FG001|STARTED|Second Intervention (One Week) HV's||66
10299782|NCT00044083|11432702|FG000|COMPLETED|Second Intervention (One Week) HV's||64
10299783|NCT00044083|11432703|FG001|COMPLETED|Second Intervention (One Week) HV's||66
10299784|NCT00044083|11432702|FG000|NOT COMPLETED|Second Intervention (One Week) HV's||0
10299785|NCT00044083|11432703|FG001|NOT COMPLETED|Second Intervention (One Week) HV's||0
10299786|NCT00044083|11432702|FG000|STARTED|First Intervention (One Week) Patients||31
10299787|NCT00044083|11432703|FG001|STARTED|First Intervention (One Week) Patients||32
10299788|NCT00044083|11432702|FG000|COMPLETED|First Intervention (One Week) Patients||30
10299789|NCT00044083|11432703|FG001|COMPLETED|First Intervention (One Week) Patients||30
10299790|NCT00044083|11432702|FG000|NOT COMPLETED|First Intervention (One Week) Patients||1
10299791|NCT00044083|11432703|FG001|NOT COMPLETED|First Intervention (One Week) Patients||2
10299792|NCT00044083|11432702|FG000|STARTED|Second Intervention (One Week) Patients||30
10299793|NCT00044083|11432703|FG001|STARTED|Second Intervention (One Week) Patients||30
10299794|NCT00044083|11432702|FG000|COMPLETED|Second Intervention (One Week) Patients||30
10299795|NCT00044083|11432703|FG001|COMPLETED|Second Intervention (One Week) Patients||29
10299796|NCT00044083|11432702|FG000|NOT COMPLETED|Second Intervention (One Week) Patients||0
10421955|NCT02487797|11566860|FG000|STARTED|Overall Study||502
10421956|NCT02487797|11566861|FG001|STARTED|Overall Study||501
10421957|NCT02487797|11566860|FG000|COMPLETED|Overall Study||502
10421958|NCT02487797|11566861|FG001|COMPLETED|Overall Study||501
10421959|NCT02487797|11566860|FG000|NOT COMPLETED|Overall Study||0
10421960|NCT02487797|11566861|FG001|NOT COMPLETED|Overall Study||0
10421961|NCT02348359|11566871|FG000|STARTED|Overall Study||40
10421962|NCT02348359|11566872|FG001|STARTED|Overall Study||39
10421963|NCT02348359|11566873|FG002|STARTED|Overall Study||39
10421964|NCT02348359|11566874|FG003|STARTED|Overall Study||39
10421965|NCT02348359|11566871|FG000|COMPLETED|Overall Study||29
10421966|NCT02348359|11566872|FG001|COMPLETED|Overall Study||22
10421967|NCT02348359|11566873|FG002|COMPLETED|Overall Study||25
10421968|NCT02348359|11566874|FG003|COMPLETED|Overall Study||27
10421969|NCT02348359|11566871|FG000|NOT COMPLETED|Overall Study||11
10421970|NCT02348359|11566872|FG001|NOT COMPLETED|Overall Study||17
10421971|NCT02348359|11566873|FG002|NOT COMPLETED|Overall Study||14
10421972|NCT02348359|11566874|FG003|NOT COMPLETED|Overall Study||12
10421983|NCT01981096|11566895|FG000|STARTED|Overall Study||20
10421984|NCT01981096|11566896|FG001|STARTED|Overall Study||20
10421985|NCT01981096|11566895|FG000|Post-treatment|Overall Study||17
10421986|NCT01981096|11566896|FG001|Post-treatment|Overall Study||19
10421987|NCT01981096|11566895|FG000|COMPLETED|Overall Study||17
10421988|NCT01981096|11566896|FG001|COMPLETED|Overall Study||19
10421989|NCT01981096|11566895|FG000|NOT COMPLETED|Overall Study||3
10421990|NCT01981096|11566896|FG001|NOT COMPLETED|Overall Study||1
10421991|NCT01935336|11566906|FG000|STARTED|Overall Study|Only one subject was treated due to the black box warning RE: ponatinib-associated vascular issues. The protocol was modified with additional inclusion and exclusion criteria, which severely limited the number of cases treated with the drug|6
10421992|NCT01935336|11566907|FG001|STARTED|Overall Study|no subjects were treated in this arm|3
10421993|NCT01935336|11566908|FG002|STARTED|Overall Study|Only three subjects were treated due to the black box warning RE: ponatinib-associated vascular issues. The protocol was modified with additional inclusion and exclusion criteria, which severely limited the number of cases treated with the drug|47
10421994|NCT01935336|11566909|FG003|STARTED|Overall Study|No subjects were treated in this arm|66
10421995|NCT01935336|11566906|FG000|Started Treatment|Overall Study||1
10421996|NCT01935336|11566907|FG001|Started Treatment|Overall Study||0
10421997|NCT01935336|11566908|FG002|Started Treatment|Overall Study||3
10421998|NCT01935336|11566909|FG003|Started Treatment|Overall Study||0
10421999|NCT01935336|11566906|FG000|COMPLETED|Overall Study||0
10422000|NCT01935336|11566907|FG001|COMPLETED|Overall Study||0
10422001|NCT01935336|11566908|FG002|COMPLETED|Overall Study||0
10422002|NCT01935336|11566909|FG003|COMPLETED|Overall Study||0
10422003|NCT01935336|11566906|FG000|NOT COMPLETED|Overall Study||6
10422004|NCT01935336|11566907|FG001|NOT COMPLETED|Overall Study||3
10422005|NCT01935336|11566908|FG002|NOT COMPLETED|Overall Study||47
10299797|NCT00044083|11432703|FG001|NOT COMPLETED|Second Intervention (One Week) Patients||1
10299798|NCT00044213|11432740|FG000|STARTED|Overall Study||421
10299799|NCT00044213|11432741|FG001|STARTED|Overall Study||418
10299800|NCT00044213|11432742|FG002|STARTED|Overall Study||432
10299801|NCT00044213|11432743|FG003|STARTED|Overall Study||437
10299802|NCT00044213|11432740|FG000|COMPLETED|Overall Study||321
10299803|NCT00044213|11432741|FG001|COMPLETED|Overall Study||306
10299804|NCT00044213|11432742|FG002|COMPLETED|Overall Study||294
10299805|NCT00044213|11432743|FG003|COMPLETED|Overall Study||301
10299806|NCT00044213|11432740|FG000|NOT COMPLETED|Overall Study||100
10299807|NCT00044213|11432741|FG001|NOT COMPLETED|Overall Study||112
10299808|NCT00044213|11432742|FG002|NOT COMPLETED|Overall Study||138
10299809|NCT00044213|11432743|FG003|NOT COMPLETED|Overall Study||136
10299810|NCT00044512|11432753|FG000|STARTED|Treatment||137
10299811|NCT00044512|11432753|FG000|COMPLETED|Treatment||137
10299812|NCT00044512|11432753|FG000|NOT COMPLETED|Treatment||0
10299813|NCT00044512|11432753|FG000|STARTED|Follow Up||137
10299814|NCT00044512|11432753|FG000|COMPLETED|Follow Up||135
10299815|NCT00044512|11432753|FG000|NOT COMPLETED|Follow Up||2
10299816|NCT00044655|11432759|FG000|STARTED|Overall Study||102
10299817|NCT00044655|11432760|FG001|STARTED|Overall Study||117
10299818|NCT00044655|11432759|FG000|COMPLETED|Overall Study||82
10299819|NCT00044655|11432760|FG001|COMPLETED|Overall Study||79
10299820|NCT00044655|11432759|FG000|NOT COMPLETED|Overall Study||20
10299821|NCT00044655|11432760|FG001|NOT COMPLETED|Overall Study||38
10299822|NCT00045032|11432769|FG000|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1697
10299823|NCT00045032|11432770|FG001|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1702
10299824|NCT00045032|11432771|FG002|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1700
10299825|NCT00045032|11432769|FG000|Crossover to Adjuvant Herceptin|Overall Study||888
10299826|NCT00045032|11432770|FG001|Crossover to Adjuvant Herceptin|Overall Study|This milestone is not applicable to participants who were already randomized to Herceptin.|0
10299827|NCT00045032|11432771|FG002|Crossover to Adjuvant Herceptin|Overall Study|This milestone is not applicable to participants who were already randomized to Herceptin.|0
10299828|NCT00045032|11432769|FG000|COMPLETED|Overall Study||834
10299829|NCT00045032|11432770|FG001|COMPLETED|Overall Study||994
10299830|NCT00045032|11432771|FG002|COMPLETED|Overall Study||974
10299831|NCT00045032|11432769|FG000|NOT COMPLETED|Overall Study||863
10299832|NCT00045032|11432770|FG001|NOT COMPLETED|Overall Study||708
10299833|NCT00045032|11432771|FG002|NOT COMPLETED|Overall Study||726
10299834|NCT00045110|11432784|FG000|STARTED|100mg Phase 1 Dose Escalalation||6
10299835|NCT00045110|11432785|FG001|STARTED|100mg Phase 1 Dose Escalalation||59
10299836|NCT00045110|11432786|FG002|STARTED|100mg Phase 1 Dose Escalalation||45
10299837|NCT00045110|11432784|FG000|COMPLETED|100mg Phase 1 Dose Escalalation||6
10299838|NCT00045110|11432785|FG001|COMPLETED|100mg Phase 1 Dose Escalalation||53
10299839|NCT00045110|11432786|FG002|COMPLETED|100mg Phase 1 Dose Escalalation||43
10299840|NCT00045110|11432784|FG000|NOT COMPLETED|100mg Phase 1 Dose Escalalation||0
10299841|NCT00045110|11432785|FG001|NOT COMPLETED|100mg Phase 1 Dose Escalalation||6
10299842|NCT00045110|11432786|FG002|NOT COMPLETED|100mg Phase 1 Dose Escalalation||2
10299843|NCT00045110|11432784|FG000|STARTED|200mg Phase 1 Dose Escalation||4
10299844|NCT00045110|11432785|FG001|STARTED|200mg Phase 1 Dose Escalation||0
10299845|NCT00045110|11432786|FG002|STARTED|200mg Phase 1 Dose Escalation||0
10299846|NCT00045110|11432784|FG000|COMPLETED|200mg Phase 1 Dose Escalation||4
10299847|NCT00045110|11432785|FG001|COMPLETED|200mg Phase 1 Dose Escalation||0
10299848|NCT00045110|11432786|FG002|COMPLETED|200mg Phase 1 Dose Escalation||0
10299849|NCT00045110|11432784|FG000|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
10299850|NCT00045110|11432785|FG001|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
10299851|NCT00045110|11432786|FG002|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
10299852|NCT00045110|11432784|FG000|STARTED|275mg Phase 1 Dose Escalation||3
10299853|NCT00045110|11432785|FG001|STARTED|275mg Phase 1 Dose Escalation||0
10299854|NCT00045110|11432786|FG002|STARTED|275mg Phase 1 Dose Escalation||0
10299855|NCT00045110|11432784|FG000|COMPLETED|275mg Phase 1 Dose Escalation||3
10299856|NCT00045110|11432785|FG001|COMPLETED|275mg Phase 1 Dose Escalation||0
10299857|NCT00045110|11432786|FG002|COMPLETED|275mg Phase 1 Dose Escalation||0
10299858|NCT00045110|11432784|FG000|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
10299859|NCT00045110|11432785|FG001|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
10299860|NCT00045110|11432786|FG002|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
10299861|NCT00045110|11432784|FG000|STARTED|400mg Phase 1 Dose Escalation||3
10299862|NCT00045110|11432785|FG001|STARTED|400mg Phase 1 Dose Escalation||0
10299863|NCT00045110|11432786|FG002|STARTED|400mg Phase 1 Dose Escalation||0
10299864|NCT00045110|11432784|FG000|COMPLETED|400mg Phase 1 Dose Escalation||3
10299865|NCT00045110|11432785|FG001|COMPLETED|400mg Phase 1 Dose Escalation||0
10299866|NCT00045110|11432786|FG002|COMPLETED|400mg Phase 1 Dose Escalation||0
10299867|NCT00045110|11432784|FG000|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
10299868|NCT00045110|11432785|FG001|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
10299869|NCT00045110|11432786|FG002|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
10299870|NCT00045110|11432784|FG000|STARTED|525mg Phase 1 Dose Escalation||3
10422006|NCT01935336|11566909|FG003|NOT COMPLETED|Overall Study||66
10422007|NCT01712490|11566927|FG000|STARTED|Overall Study||664
10422008|NCT01712490|11566928|FG001|STARTED|Overall Study||670
10422009|NCT01712490|11566927|FG000|Treated|Overall Study||662
10422010|NCT01712490|11566928|FG001|Treated|Overall Study||659
10422011|NCT01712490|11566927|FG000|COMPLETED|Overall Study||0
10422012|NCT01712490|11566928|FG001|COMPLETED|Overall Study||0
10422013|NCT01712490|11566927|FG000|NOT COMPLETED|Overall Study||664
10422014|NCT01712490|11566928|FG001|NOT COMPLETED|Overall Study||670
10422015|NCT01702805|11566936|FG000|STARTED|Overall Study||911
10422016|NCT01702805|11566937|FG001|STARTED|Overall Study||913
10422017|NCT01702805|11566936|FG000|Completed Assessment for Neurodevelopmental Impairment|Overall Study||699
10422018|NCT01702805|11566937|FG001|Completed Assessment for Neurodevelopmental Impairment|Overall Study||712
10422019|NCT01702805|11566936|FG000|Died After Discharge|Overall Study||19
10422020|NCT01702805|11566937|FG001|Died After Discharge|Overall Study||10
10422021|NCT01702805|11566936|FG000|Died Before Discharge|Overall Study||127
10422022|NCT01702805|11566937|FG001|Died Before Discharge|Overall Study||125
10422023|NCT01702805|11566936|FG000|Survived to Discharge|Overall Study||781
10422024|NCT01702805|11566937|FG001|Survived to Discharge|Overall Study||781
10422025|NCT01702805|11566936|FG000|COMPLETED|Overall Study||845
10422026|NCT01702805|11566937|FG001|COMPLETED|Overall Study||847
10422027|NCT01702805|11566936|FG000|NOT COMPLETED|Overall Study||66
10422028|NCT01702805|11566937|FG001|NOT COMPLETED|Overall Study||66
10422029|NCT01499160|11566943|FG000|STARTED|Overall Study||7
10422030|NCT01499160|11566943|FG000|COMPLETED|Overall Study|"1 pt-withdrew consent~1pt-had cardiac toxicity"|5
10422031|NCT01499160|11566943|FG000|NOT COMPLETED|Overall Study||2
10422032|NCT01333436|11566950|FG000|STARTED|Overall Study||43
10422033|NCT01333436|11566951|FG001|STARTED|Overall Study||50
10422034|NCT01333436|11566950|FG000|COMPLETED|Overall Study||43
10422035|NCT01333436|11566951|FG001|COMPLETED|Overall Study||50
10422036|NCT01333436|11566950|FG000|NOT COMPLETED|Overall Study||0
10422037|NCT01333436|11566951|FG001|NOT COMPLETED|Overall Study||0
10422038|NCT01307631|11566957|FG000|STARTED|Overall Study||9
10422039|NCT01307631|11566958|FG001|STARTED|Overall Study||28
10422040|NCT01307631|11566957|FG000|COMPLETED|Overall Study||9
10422041|NCT01307631|11566958|FG001|COMPLETED|Overall Study||28
10422042|NCT01307631|11566957|FG000|NOT COMPLETED|Overall Study||0
10422043|NCT01307631|11566958|FG001|NOT COMPLETED|Overall Study||0
10422044|NCT01256086|11566968|FG000|STARTED|Treatment Day 1||11
10422045|NCT01256086|11566969|FG001|STARTED|Treatment Day 1||11
10422046|NCT01256086|11566970|FG002|STARTED|Treatment Day 1||11
10422047|NCT01256086|11566971|FG003|STARTED|Treatment Day 1||11
10422048|NCT01256086|11566968|FG000|COMPLETED|Treatment Day 1||11
10299871|NCT00045110|11432785|FG001|STARTED|525mg Phase 1 Dose Escalation||0
10422049|NCT01256086|11566969|FG001|COMPLETED|Treatment Day 1||11
10422050|NCT01256086|11566970|FG002|COMPLETED|Treatment Day 1||11
10422051|NCT01256086|11566971|FG003|COMPLETED|Treatment Day 1||11
10422052|NCT01256086|11566968|FG000|NOT COMPLETED|Treatment Day 1||0
10422053|NCT01256086|11566969|FG001|NOT COMPLETED|Treatment Day 1||0
10422054|NCT01256086|11566970|FG002|NOT COMPLETED|Treatment Day 1||0
10422055|NCT01256086|11566971|FG003|NOT COMPLETED|Treatment Day 1||0
10422056|NCT01256086|11566968|FG000|STARTED|Treatment Day 2||11
10422057|NCT01256086|11566969|FG001|STARTED|Treatment Day 2||10
10422058|NCT01256086|11566970|FG002|STARTED|Treatment Day 2||9
10422059|NCT01256086|11566971|FG003|STARTED|Treatment Day 2||11
10422060|NCT01256086|11566968|FG000|COMPLETED|Treatment Day 2||11
10422061|NCT01256086|11566969|FG001|COMPLETED|Treatment Day 2||10
10422062|NCT01256086|11566970|FG002|COMPLETED|Treatment Day 2||9
10299872|NCT00045110|11432786|FG002|STARTED|525mg Phase 1 Dose Escalation||0
10299873|NCT00045110|11432784|FG000|COMPLETED|525mg Phase 1 Dose Escalation||3
10299874|NCT00045110|11432785|FG001|COMPLETED|525mg Phase 1 Dose Escalation||0
10299875|NCT00045110|11432786|FG002|COMPLETED|525mg Phase 1 Dose Escalation||0
10299876|NCT00045110|11432784|FG000|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
10299877|NCT00045110|11432785|FG001|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
10299878|NCT00045110|11432786|FG002|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
10299879|NCT00045110|11432784|FG000|STARTED|650mg Phase 1 Dose Escalation||6
10299880|NCT00045110|11432785|FG001|STARTED|650mg Phase 1 Dose Escalation||0
10299881|NCT00045110|11432786|FG002|STARTED|650mg Phase 1 Dose Escalation||0
10299882|NCT00045110|11432784|FG000|COMPLETED|650mg Phase 1 Dose Escalation||6
10299883|NCT00045110|11432785|FG001|COMPLETED|650mg Phase 1 Dose Escalation||0
10299884|NCT00045110|11432786|FG002|COMPLETED|650mg Phase 1 Dose Escalation||0
10299885|NCT00045110|11432784|FG000|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
10299886|NCT00045110|11432785|FG001|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
10299887|NCT00045110|11432786|FG002|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
10299888|NCT00045110|11432784|FG000|STARTED|775mg Dose Escalation||7
10299889|NCT00045110|11432785|FG001|STARTED|775mg Dose Escalation||0
10299890|NCT00045110|11432786|FG002|STARTED|775mg Dose Escalation||0
10299891|NCT00045110|11432784|FG000|COMPLETED|775mg Dose Escalation||7
10299892|NCT00045110|11432785|FG001|COMPLETED|775mg Dose Escalation||0
10299893|NCT00045110|11432786|FG002|COMPLETED|775mg Dose Escalation||0
10299894|NCT00045110|11432784|FG000|NOT COMPLETED|775mg Dose Escalation||0
10299895|NCT00045110|11432785|FG001|NOT COMPLETED|775mg Dose Escalation||0
10299896|NCT00045110|11432786|FG002|NOT COMPLETED|775mg Dose Escalation||0
10299897|NCT00045162|11432805|FG000|STARTED|Overall Study||336
10299898|NCT00045162|11432806|FG001|STARTED|Overall Study||335
10299899|NCT00045162|11432805|FG000|COMPLETED|Overall Study||194
10299900|NCT00045162|11432806|FG001|COMPLETED|Overall Study||217
10299901|NCT00045162|11432805|FG000|NOT COMPLETED|Overall Study||142
10299902|NCT00045162|11432806|FG001|NOT COMPLETED|Overall Study||118
10299903|NCT00045305|11432812|FG000|STARTED|Overall Study||17
10299904|NCT00045305|11432812|FG000|Eligible and Treated|Overall Study||17
10299905|NCT00045305|11432812|FG000|COMPLETED|Overall Study||3
10299906|NCT00045305|11432812|FG000|NOT COMPLETED|Overall Study||14
10299907|NCT00045435|11432816|FG000|STARTED|Overall Study||17
10299908|NCT00045435|11432816|FG000|COMPLETED|Overall Study||17
10299909|NCT00045435|11432816|FG000|NOT COMPLETED|Overall Study||0
10299910|NCT00045487|11432820|FG000|STARTED|Overall Study||41
10299911|NCT00045487|11432820|FG000|COMPLETED|Overall Study||30
10299912|NCT00045487|11432820|FG000|NOT COMPLETED|Overall Study||11
10299913|NCT00045630|11432824|FG000|STARTED|Overall Study||77
10299914|NCT00045630|11432824|FG000|Eligible|Overall Study||75
10299915|NCT00045630|11432824|FG000|Eligible and Began Protocol Therapy|Overall Study||74
10299916|NCT00045630|11432824|FG000|COMPLETED|Overall Study||71
10299917|NCT00045630|11432824|FG000|NOT COMPLETED|Overall Study||6
10299918|NCT00045708|11432831|FG000|STARTED|Phase 1||21
10299919|NCT00045708|11432832|FG001|STARTED|Phase 1||17
10299920|NCT00045708|11432833|FG002|STARTED|Phase 1||0
10299921|NCT00045708|11432831|FG000|COMPLETED|Phase 1||21
10299922|NCT00045708|11432832|FG001|COMPLETED|Phase 1||16
10299923|NCT00045708|11432833|FG002|COMPLETED|Phase 1||0
10299924|NCT00045708|11432831|FG000|NOT COMPLETED|Phase 1||0
10299925|NCT00045708|11432832|FG001|NOT COMPLETED|Phase 1||1
10299926|NCT00045708|11432833|FG002|NOT COMPLETED|Phase 1||0
10299927|NCT00045708|11432831|FG000|STARTED|Phase 2||0
10299928|NCT00045708|11432832|FG001|STARTED|Phase 2||0
10299929|NCT00045708|11432833|FG002|STARTED|Phase 2||19
10299930|NCT00045708|11432831|FG000|COMPLETED|Phase 2||0
10299931|NCT00045708|11432832|FG001|COMPLETED|Phase 2||0
10299932|NCT00045708|11432833|FG002|COMPLETED|Phase 2||19
10299933|NCT00045708|11432831|FG000|NOT COMPLETED|Phase 2||0
10299934|NCT00045708|11432832|FG001|NOT COMPLETED|Phase 2||0
10299935|NCT00045708|11432833|FG002|NOT COMPLETED|Phase 2||0
10299936|NCT00045734|11432850|FG000|STARTED|Overall Study||23
10299937|NCT00045734|11432850|FG000|COMPLETED|Overall Study||22
10299938|NCT00045734|11432850|FG000|NOT COMPLETED|Overall Study||1
10299939|NCT00045942|11432863|FG000|STARTED|PKC412A2104 (Core)||20
10299940|NCT00045942|11432864|FG001|STARTED|PKC412A2104 (Core)||0
10299941|NCT00045942|11432865|FG002|STARTED|PKC412A2104 (Core)||0
10299942|NCT00045942|11432866|FG003|STARTED|PKC412A2104 (Core)||0
10299943|NCT00045942|11432867|FG004|STARTED|PKC412A2104 (Core)||0
10299944|NCT00045942|11432868|FG005|STARTED|PKC412A2104 (Core)||0
10299945|NCT00045942|11432869|FG006|STARTED|PKC412A2104 (Core)||0
10299946|NCT00045942|11432870|FG007|STARTED|PKC412A2104 (Core)||0
10299947|NCT00045942|11432871|FG008|STARTED|PKC412A2104 (Core)||0
10299948|NCT00045942|11432863|FG000|Core Primary Efficacy|PKC412A2104 (Core)||20
10299949|NCT00045942|11432864|FG001|Core Primary Efficacy|PKC412A2104 (Core)||0
10299950|NCT00045942|11432865|FG002|Core Primary Efficacy|PKC412A2104 (Core)||0
10299951|NCT00045942|11432866|FG003|Core Primary Efficacy|PKC412A2104 (Core)||0
10299952|NCT00045942|11432867|FG004|Core Primary Efficacy|PKC412A2104 (Core)||0
10299953|NCT00045942|11432868|FG005|Core Primary Efficacy|PKC412A2104 (Core)||0
10299954|NCT00045942|11432869|FG006|Core Primary Efficacy|PKC412A2104 (Core)||0
10299955|NCT00045942|11432870|FG007|Core Primary Efficacy|PKC412A2104 (Core)||0
10299956|NCT00045942|11432871|FG008|Core Primary Efficacy|PKC412A2104 (Core)||0
10299957|NCT00045942|11432863|FG000|COMPLETED|PKC412A2104 (Core)||0
10299958|NCT00045942|11432864|FG001|COMPLETED|PKC412A2104 (Core)||0
10299959|NCT00045942|11432865|FG002|COMPLETED|PKC412A2104 (Core)||0
10299960|NCT00045942|11432866|FG003|COMPLETED|PKC412A2104 (Core)||0
10299961|NCT00045942|11432867|FG004|COMPLETED|PKC412A2104 (Core)||0
10299962|NCT00045942|11432868|FG005|COMPLETED|PKC412A2104 (Core)||0
10299963|NCT00045942|11432869|FG006|COMPLETED|PKC412A2104 (Core)||0
10299964|NCT00045942|11432870|FG007|COMPLETED|PKC412A2104 (Core)||0
10299965|NCT00045942|11432871|FG008|COMPLETED|PKC412A2104 (Core)||0
10299966|NCT00045942|11432863|FG000|NOT COMPLETED|PKC412A2104 (Core)||20
10299967|NCT00045942|11432864|FG001|NOT COMPLETED|PKC412A2104 (Core)||0
10299968|NCT00045942|11432865|FG002|NOT COMPLETED|PKC412A2104 (Core)||0
10299969|NCT00045942|11432866|FG003|NOT COMPLETED|PKC412A2104 (Core)||0
10299970|NCT00045942|11432867|FG004|NOT COMPLETED|PKC412A2104 (Core)||0
10299971|NCT00045942|11432868|FG005|NOT COMPLETED|PKC412A2104 (Core)||0
10299972|NCT00045942|11432869|FG006|NOT COMPLETED|PKC412A2104 (Core)||0
10422063|NCT01256086|11566971|FG003|COMPLETED|Treatment Day 2||11
10422064|NCT01256086|11566968|FG000|NOT COMPLETED|Treatment Day 2||0
10422065|NCT01256086|11566969|FG001|NOT COMPLETED|Treatment Day 2||0
10422066|NCT01256086|11566970|FG002|NOT COMPLETED|Treatment Day 2||0
10422067|NCT01256086|11566971|FG003|NOT COMPLETED|Treatment Day 2||0
10422068|NCT01256086|11566968|FG000|STARTED|Treatment Day 3||11
10422069|NCT01256086|11566969|FG001|STARTED|Treatment Day 3||10
10422070|NCT01256086|11566970|FG002|STARTED|Treatment Day 3||9
10422071|NCT01256086|11566971|FG003|STARTED|Treatment Day 3||11
10422072|NCT01256086|11566968|FG000|COMPLETED|Treatment Day 3||11
10422073|NCT01256086|11566969|FG001|COMPLETED|Treatment Day 3||10
10422074|NCT01256086|11566970|FG002|COMPLETED|Treatment Day 3||9
10422075|NCT01256086|11566971|FG003|COMPLETED|Treatment Day 3||11
10422076|NCT01256086|11566968|FG000|NOT COMPLETED|Treatment Day 3||0
10422077|NCT01256086|11566969|FG001|NOT COMPLETED|Treatment Day 3||0
10422078|NCT01256086|11566970|FG002|NOT COMPLETED|Treatment Day 3||0
10422079|NCT01256086|11566971|FG003|NOT COMPLETED|Treatment Day 3||0
10422080|NCT01256086|11566968|FG000|STARTED|Treatment Day 4||11
10422081|NCT01256086|11566969|FG001|STARTED|Treatment Day 4||10
10422082|NCT01256086|11566970|FG002|STARTED|Treatment Day 4||9
10422083|NCT01256086|11566971|FG003|STARTED|Treatment Day 4||11
10422084|NCT01256086|11566968|FG000|COMPLETED|Treatment Day 4||11
10422085|NCT01256086|11566969|FG001|COMPLETED|Treatment Day 4||10
10422086|NCT01256086|11566970|FG002|COMPLETED|Treatment Day 4||9
10422087|NCT01256086|11566971|FG003|COMPLETED|Treatment Day 4||11
10422088|NCT01256086|11566968|FG000|NOT COMPLETED|Treatment Day 4||0
10422089|NCT01256086|11566969|FG001|NOT COMPLETED|Treatment Day 4||0
10422090|NCT01256086|11566970|FG002|NOT COMPLETED|Treatment Day 4||0
10422091|NCT01256086|11566971|FG003|NOT COMPLETED|Treatment Day 4||0
10422092|NCT01061151|11566985|FG000|STARTED|Protocol Version 2.0: 04/2011-09/2012||855
10422093|NCT01061151|11566986|FG001|STARTED|Protocol Version 2.0: 04/2011-09/2012||861
10422094|NCT01061151|11566987|FG002|STARTED|Protocol Version 2.0: 04/2011-09/2012||25
10422095|NCT01061151|11566988|FG003|STARTED|Protocol Version 2.0: 04/2011-09/2012||129
10422096|NCT01061151|11566985|FG000|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||853
10422097|NCT01061151|11566986|FG001|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||861
10422098|NCT01061151|11566987|FG002|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||24
10422099|NCT01061151|11566988|FG003|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||129
10422100|NCT01061151|11566985|FG000|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||623
10422101|NCT01061151|11566986|FG001|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||620
10422102|NCT01061151|11566987|FG002|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||16
10422103|NCT01061151|11566988|FG003|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||101
10422104|NCT01061151|11566985|FG000|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||232
10422105|NCT01061151|11566986|FG001|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||241
10422106|NCT01061151|11566987|FG002|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||9
10422107|NCT01061151|11566988|FG003|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||28
10422108|NCT01061151|11566985|FG000|STARTED|Protocol Version 3.0: 10/2012-10/2014||694
10422109|NCT01061151|11566986|FG001|STARTED|Protocol Version 3.0: 10/2012-10/2014||686
10422110|NCT01061151|11566987|FG002|STARTED|Protocol Version 3.0: 10/2012-10/2014||422
10422111|NCT01061151|11566988|FG003|STARTED|Protocol Version 3.0: 10/2012-10/2014||75
10422112|NCT01061151|11566985|FG000|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||694
10422113|NCT01061151|11566986|FG001|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||684
10422114|NCT01061151|11566987|FG002|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||421
10422115|NCT01061151|11566988|FG003|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||75
10422116|NCT01061151|11566985|FG000|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||542
10422117|NCT01061151|11566986|FG001|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||548
10422118|NCT01061151|11566987|FG002|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||345
10422119|NCT01061151|11566988|FG003|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||55
10422120|NCT01061151|11566985|FG000|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||152
10422121|NCT01061151|11566986|FG001|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||138
10422122|NCT01061151|11566987|FG002|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||77
10422123|NCT01061151|11566988|FG003|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||20
10422124|NCT00981058|11567010|FG000|STARTED|Overall Study||545
10422125|NCT00981058|11567011|FG001|STARTED|Overall Study||548
10422126|NCT00981058|11567010|FG000|Received at Least 1 Dose of Study Drug|Overall Study||538
10422127|NCT00981058|11567011|FG001|Received at Least 1 Dose of Study Drug|Overall Study||541
10422128|NCT00981058|11567010|FG000|Death Due to Any Cause|Overall Study||418
10422129|NCT00981058|11567011|FG001|Death Due to Any Cause|Overall Study||442
10422130|NCT00981058|11567010|FG000|COMPLETED|Overall Study||425
10299973|NCT00045942|11432870|FG007|NOT COMPLETED|PKC412A2104 (Core)||0
10299974|NCT00045942|11432871|FG008|NOT COMPLETED|PKC412A2104 (Core)||0
10299975|NCT00045942|11432863|FG000|STARTED|PKC412A2104E1||0
10299976|NCT00045942|11432864|FG001|STARTED|PKC412A2104E1||18
10299977|NCT00045942|11432865|FG002|STARTED|PKC412A2104E1||17
10299978|NCT00045942|11432866|FG003|STARTED|PKC412A2104E1||33
10299979|NCT00045942|11432867|FG004|STARTED|PKC412A2104E1||27
10299980|NCT00045942|11432868|FG005|STARTED|PKC412A2104E1||0
10299981|NCT00045942|11432869|FG006|STARTED|PKC412A2104E1||0
10299982|NCT00045942|11432870|FG007|STARTED|PKC412A2104E1||0
10299983|NCT00045942|11432871|FG008|STARTED|PKC412A2104E1||0
10299984|NCT00045942|11432863|FG000|Primary Efficacy|PKC412A2104E1||0
10299985|NCT00045942|11432864|FG001|Primary Efficacy|PKC412A2104E1||18
10299986|NCT00045942|11432865|FG002|Primary Efficacy|PKC412A2104E1||17
10299987|NCT00045942|11432866|FG003|Primary Efficacy|PKC412A2104E1||32
10299988|NCT00045942|11432867|FG004|Primary Efficacy|PKC412A2104E1||25
10299989|NCT00045942|11432868|FG005|Primary Efficacy|PKC412A2104E1||0
10299990|NCT00045942|11432869|FG006|Primary Efficacy|PKC412A2104E1||0
10299991|NCT00045942|11432870|FG007|Primary Efficacy|PKC412A2104E1||0
10299992|NCT00045942|11432871|FG008|Primary Efficacy|PKC412A2104E1||0
10299993|NCT00045942|11432863|FG000|COMPLETED|PKC412A2104E1||0
10299994|NCT00045942|11432864|FG001|COMPLETED|PKC412A2104E1||0
10299995|NCT00045942|11432865|FG002|COMPLETED|PKC412A2104E1||0
10299996|NCT00045942|11432866|FG003|COMPLETED|PKC412A2104E1||0
10299997|NCT00045942|11432867|FG004|COMPLETED|PKC412A2104E1||0
10299998|NCT00045942|11432868|FG005|COMPLETED|PKC412A2104E1||0
10299999|NCT00045942|11432869|FG006|COMPLETED|PKC412A2104E1||0
10300000|NCT00045942|11432870|FG007|COMPLETED|PKC412A2104E1||0
10300001|NCT00045942|11432871|FG008|COMPLETED|PKC412A2104E1||0
10300002|NCT00045942|11432863|FG000|NOT COMPLETED|PKC412A2104E1||0
10300003|NCT00045942|11432864|FG001|NOT COMPLETED|PKC412A2104E1||18
10300004|NCT00045942|11432865|FG002|NOT COMPLETED|PKC412A2104E1||17
10300005|NCT00045942|11432866|FG003|NOT COMPLETED|PKC412A2104E1||33
10300006|NCT00045942|11432867|FG004|NOT COMPLETED|PKC412A2104E1||27
10300007|NCT00045942|11432868|FG005|NOT COMPLETED|PKC412A2104E1||0
10300008|NCT00045942|11432869|FG006|NOT COMPLETED|PKC412A2104E1||0
10300009|NCT00045942|11432870|FG007|NOT COMPLETED|PKC412A2104E1||0
10300010|NCT00045942|11432871|FG008|NOT COMPLETED|PKC412A2104E1||0
10300011|NCT00045942|11432863|FG000|STARTED|PKC412A2104E2||0
10300012|NCT00045942|11432864|FG001|STARTED|PKC412A2104E2||0
10300013|NCT00045942|11432865|FG002|STARTED|PKC412A2104E2||0
10422131|NCT00981058|11567011|FG001|COMPLETED|Overall Study||451
10422132|NCT00981058|11567010|FG000|NOT COMPLETED|Overall Study||120
10422133|NCT00981058|11567011|FG001|NOT COMPLETED|Overall Study||97
10422134|NCT00885495|11567019|FG000|STARTED|Overall Study||8
10422135|NCT00885495|11567020|FG001|STARTED|Overall Study||9
10422136|NCT00885495|11567019|FG000|COMPLETED|Overall Study||6
10422137|NCT00885495|11567020|FG001|COMPLETED|Overall Study||6
10422138|NCT00885495|11567019|FG000|NOT COMPLETED|Overall Study||2
10422139|NCT00885495|11567020|FG001|NOT COMPLETED|Overall Study||3
10546889|NCT01510457|11700708|FG000|NOT COMPLETED|Overall Study||5
10546890|NCT01510457|11700709|FG001|NOT COMPLETED|Overall Study||3
10546891|NCT01510652|11700719|FG000|STARTED|Overall Study||719
10546892|NCT01510652|11700720|FG001|STARTED|Overall Study||355
10546893|NCT01510652|11700719|FG000|Baseline|Overall Study||718
10546894|NCT01510652|11700720|FG001|Baseline|Overall Study||348
10546895|NCT01510652|11700719|FG000|COMPLETED|Overall Study||627
10546896|NCT01510652|11700720|FG001|COMPLETED|Overall Study||288
10546897|NCT01510652|11700719|FG000|NOT COMPLETED|Overall Study||92
10546898|NCT01510652|11700720|FG001|NOT COMPLETED|Overall Study||67
10546899|NCT01510704|11700730|FG000|STARTED|Overall Study||54
10546900|NCT01510704|11700731|FG001|STARTED|Overall Study||58
10546901|NCT01510704|11700732|FG002|STARTED|Overall Study||50
10546902|NCT01510704|11700733|FG003|STARTED|Overall Study||53
10546903|NCT01510704|11700730|FG000|COMPLETED|Overall Study||54
10546904|NCT01510704|11700731|FG001|COMPLETED|Overall Study||58
10546905|NCT01510704|11700732|FG002|COMPLETED|Overall Study||50
10546906|NCT01510704|11700733|FG003|COMPLETED|Overall Study||53
10546907|NCT01510704|11700730|FG000|NOT COMPLETED|Overall Study||0
10546908|NCT01510704|11700731|FG001|NOT COMPLETED|Overall Study||0
10546909|NCT01510704|11700732|FG002|NOT COMPLETED|Overall Study||0
10546910|NCT01510704|11700733|FG003|NOT COMPLETED|Overall Study||0
10546911|NCT01510717|11700745|FG000|STARTED|Overall Study||155
10546912|NCT01510717|11700746|FG001|STARTED|Overall Study||165
10546913|NCT01510717|11700745|FG000|COMPLETED|Overall Study||153
10546914|NCT01510717|11700746|FG001|COMPLETED|Overall Study||160
10546915|NCT01510717|11700745|FG000|NOT COMPLETED|Overall Study||2
10546916|NCT01510717|11700746|FG001|NOT COMPLETED|Overall Study||5
10546917|NCT01510769|11700756|FG000|STARTED|Overall Study||106
10546918|NCT01510769|11700757|FG001|STARTED|Overall Study||109
10546919|NCT01510769|11700758|FG002|STARTED|Overall Study||109
10546920|NCT01510769|11700756|FG000|COMPLETED|Overall Study||79
10546921|NCT01510769|11700757|FG001|COMPLETED|Overall Study||84
10546922|NCT01510769|11700758|FG002|COMPLETED|Overall Study||87
10546923|NCT01510769|11700756|FG000|NOT COMPLETED|Overall Study||27
10546924|NCT01510769|11700757|FG001|NOT COMPLETED|Overall Study||25
10546925|NCT01510769|11700758|FG002|NOT COMPLETED|Overall Study||22
10546926|NCT01510834|11700766|FG000|STARTED|Overall Study||90
10546927|NCT01510834|11700766|FG000|COMPLETED|Overall Study||57
10546928|NCT01510834|11700766|FG000|NOT COMPLETED|Overall Study||33
10546929|NCT01510912|11700773|FG000|STARTED|Overall Study||602
10546930|NCT01510912|11700773|FG000|COMPLETED|Overall Study||360
10546931|NCT01510912|11700773|FG000|NOT COMPLETED|Overall Study||242
10546932|NCT01511016|11700779|FG000|STARTED|Overall Study||8
10546933|NCT01511016|11700780|FG001|STARTED|Overall Study||9
10546934|NCT01511016|11700779|FG000|COMPLETED|Overall Study||6
10546935|NCT01511016|11700780|FG001|COMPLETED|Overall Study||7
10546936|NCT01511016|11700779|FG000|NOT COMPLETED|Overall Study||2
10546937|NCT01511016|11700780|FG001|NOT COMPLETED|Overall Study||2
10546938|NCT01511055|11700787|FG000|STARTED|Overall Study||27
10546939|NCT01511055|11700787|FG000|COMPLETED|Overall Study||21
10546940|NCT01511055|11700787|FG000|NOT COMPLETED|Overall Study||6
10546941|NCT01511068|11700791|FG000|STARTED|Overall Study||2
10546942|NCT01511068|11700791|FG000|COMPLETED|Overall Study||2
10546943|NCT01511068|11700791|FG000|NOT COMPLETED|Overall Study||0
10300014|NCT00045942|11432866|FG003|STARTED|PKC412A2104E2||0
10300015|NCT00045942|11432867|FG004|STARTED|PKC412A2104E2||0
10300016|NCT00045942|11432868|FG005|STARTED|PKC412A2104E2||9
10300017|NCT00045942|11432869|FG006|STARTED|PKC412A2104E2||7
10422140|NCT00084799|11567033|FG000|STARTED|Overall Study||5
10422141|NCT00084799|11567034|FG001|STARTED|Overall Study||5
10422142|NCT00084799|11567033|FG000|COMPLETED|Overall Study||4
10546944|NCT01511107|11700797|FG000|STARTED|Overall Study|Randomized to the treatment group.|260
10546945|NCT01511107|11700798|FG001|STARTED|Overall Study|Randomized to the treatment group.|260
10546946|NCT01511107|11700797|FG000|COMPLETED|Overall Study|Completed - Assessed at a final visit in Sep or at the end of the respiratory season in Apr or May.|238
10546947|NCT01511107|11700798|FG001|COMPLETED|Overall Study|Completed - Assessed at a final visit in Sep or at the end of the respiratory season in Apr or May.|219
10546948|NCT01511107|11700797|FG000|NOT COMPLETED|Overall Study||22
10546949|NCT01511107|11700798|FG001|NOT COMPLETED|Overall Study||41
10546950|NCT01511250|11700814|FG000|STARTED|Overall Study||24
10546951|NCT01511250|11700815|FG001|STARTED|Overall Study||14
10546952|NCT01511250|11700816|FG002|STARTED|Overall Study||22
10546953|NCT01511250|11700817|FG003|STARTED|Overall Study||14
10546954|NCT01511250|11700818|FG004|STARTED|Overall Study||21
10422143|NCT00084799|11567034|FG001|COMPLETED|Overall Study||5
10422144|NCT00084799|11567033|FG000|NOT COMPLETED|Overall Study||1
10422145|NCT00084799|11567034|FG001|NOT COMPLETED|Overall Study||0
10422146|NCT00821236|11567043|FG000|STARTED|Overall Study||40
10422147|NCT00821236|11567043|FG000|COMPLETED|Overall Study||37
10422148|NCT00821236|11567043|FG000|NOT COMPLETED|Overall Study||3
10422149|NCT00821327|11567051|FG000|STARTED|Overall Study||36
10422150|NCT00821327|11567051|FG000|COMPLETED|Overall Study||1
10422151|NCT00821327|11567051|FG000|NOT COMPLETED|Overall Study||35
10422152|NCT00821431|11567057|FG000|STARTED|Overall Study||38
10422153|NCT00821431|11567058|FG001|STARTED|Overall Study||52
10422154|NCT00821431|11567057|FG000|COMPLETED|Overall Study||23
10422155|NCT00821431|11567058|FG001|COMPLETED|Overall Study||47
10422156|NCT00821431|11567057|FG000|NOT COMPLETED|Overall Study||15
10422157|NCT00821431|11567058|FG001|NOT COMPLETED|Overall Study||5
10422158|NCT00821509|11567067|FG000|STARTED|Overall Study||257
10422159|NCT00821509|11567068|FG001|STARTED|Overall Study||202
10422160|NCT00821509|11567069|FG002|STARTED|Overall Study||224
10422161|NCT00821509|11567067|FG000|COMPLETED|Overall Study|This is a result of 56 lost-to-follow-up and 44 new recruits|245
10422162|NCT00821509|11567068|FG001|COMPLETED|Overall Study|This is a result of 57 lost-to-follow-up and 46 new recruits|191
10422163|NCT00821509|11567069|FG002|COMPLETED|Overall Study|This is a result of 50 lost-to-follow-up and 16 new recruits|190
10422164|NCT00821509|11567067|FG000|NOT COMPLETED|Overall Study||12
10422165|NCT00821509|11567068|FG001|NOT COMPLETED|Overall Study||11
10422166|NCT00821509|11567069|FG002|NOT COMPLETED|Overall Study||34
10422167|NCT00821626|11567079|FG000|STARTED|Overall Study||60
10422168|NCT00821626|11567080|FG001|STARTED|Overall Study||33
10422169|NCT00821626|11567079|FG000|COMPLETED|Overall Study||60
10422170|NCT00821626|11567080|FG001|COMPLETED|Overall Study||33
10422171|NCT00821626|11567079|FG000|NOT COMPLETED|Overall Study||0
10422172|NCT00821626|11567080|FG001|NOT COMPLETED|Overall Study||0
10422173|NCT00821678|11567090|FG000|STARTED|Overall Study||133
10422174|NCT00821678|11567091|FG001|STARTED|Overall Study||132
10422175|NCT00821678|11567090|FG000|COMPLETED|Overall Study||112
10422176|NCT00821678|11567091|FG001|COMPLETED|Overall Study||118
10422177|NCT00821678|11567090|FG000|NOT COMPLETED|Overall Study||21
10422178|NCT00821678|11567091|FG001|NOT COMPLETED|Overall Study||14
10422179|NCT00821795|11567101|FG000|STARTED|Overall Study||50
10422180|NCT00821795|11567102|FG001|STARTED|Overall Study||64
10422181|NCT00821795|11567101|FG000|COMPLETED|Overall Study||44
10422182|NCT00821795|11567102|FG001|COMPLETED|Overall Study||60
10422183|NCT00821795|11567101|FG000|NOT COMPLETED|Overall Study||6
10422184|NCT00821795|11567102|FG001|NOT COMPLETED|Overall Study||4
10422185|NCT00821821|11567111|FG000|STARTED|Overall Study||12
10422186|NCT00821821|11567112|FG001|STARTED|Overall Study||13
10422187|NCT00821821|11567113|FG002|STARTED|Overall Study||11
10422188|NCT00821821|11567111|FG000|COMPLETED|Overall Study||12
10422189|NCT00821821|11567112|FG001|COMPLETED|Overall Study||13
10422190|NCT00821821|11567113|FG002|COMPLETED|Overall Study||11
10422191|NCT00821821|11567111|FG000|NOT COMPLETED|Overall Study||0
10422192|NCT00821821|11567112|FG001|NOT COMPLETED|Overall Study||0
10422193|NCT00821821|11567113|FG002|NOT COMPLETED|Overall Study||0
10422194|NCT00821873|11567123|FG000|STARTED|Overall Study||9
10422195|NCT00821873|11567123|FG000|COMPLETED|Overall Study||5
10422196|NCT00821873|11567123|FG000|NOT COMPLETED|Overall Study||4
10422197|NCT00821886|11567127|FG000|STARTED|Overall Study|Two patients were enrolled, but subsequently found to be ineligible|58
10422198|NCT00821886|11567127|FG000|COMPLETED|Overall Study||49
10422199|NCT00821886|11567127|FG000|NOT COMPLETED|Overall Study||9
10422200|NCT00821951|11567131|FG000|STARTED|Overall Study||17
10422201|NCT00821951|11567131|FG000|COMPLETED|Overall Study||12
10422202|NCT00821951|11567131|FG000|NOT COMPLETED|Overall Study||5
10422203|NCT00821964|11567135|FG000|STARTED|Overall Study||15
10422204|NCT00821964|11567135|FG000|Evaluable for Clinical Response|Overall Study||14
10422205|NCT00821964|11567135|FG000|Evaluable for Pathologic Response|Overall Study||7
10422206|NCT00821964|11567135|FG000|COMPLETED|Overall Study||9
10422207|NCT00821964|11567135|FG000|NOT COMPLETED|Overall Study||6
10422208|NCT00822094|11567144|FG000|STARTED|Overall Study||81
10422209|NCT00822094|11567145|FG001|STARTED|Overall Study||45
10422210|NCT00822094|11567144|FG000|COMPLETED|Overall Study||37
10422211|NCT00822094|11567145|FG001|COMPLETED|Overall Study||20
10422212|NCT00822094|11567144|FG000|NOT COMPLETED|Overall Study||44
10422213|NCT00822094|11567145|FG001|NOT COMPLETED|Overall Study||25
10422214|NCT00822107|11567151|FG000|STARTED|Overall Study||5
10422215|NCT00822107|11567151|FG000|COMPLETED|Overall Study||5
10422216|NCT00822107|11567151|FG000|NOT COMPLETED|Overall Study||0
10422217|NCT00822172|11567157|FG000|STARTED|Overall Study||80
10422218|NCT00822172|11567158|FG001|STARTED|Overall Study||83
10422219|NCT00822172|11567157|FG000|COMPLETED|Overall Study||65
10422220|NCT00822172|11567158|FG001|COMPLETED|Overall Study||64
10422221|NCT00822172|11567157|FG000|NOT COMPLETED|Overall Study||15
10422222|NCT00822172|11567158|FG001|NOT COMPLETED|Overall Study||19
10422223|NCT00822185|11567169|FG000|STARTED|Overall Study||6
10546955|NCT01511250|11700819|FG005|STARTED|Overall Study||17
10546956|NCT01511250|11700820|FG006|STARTED|Overall Study||23
10422224|NCT00822185|11567170|FG001|STARTED|Overall Study||6
10422225|NCT00822185|11567171|FG002|STARTED|Overall Study||6
10422226|NCT00822185|11567172|FG003|STARTED|Overall Study||6
10422227|NCT00822185|11567173|FG004|STARTED|Overall Study||8
10422228|NCT00822185|11567169|FG000|COMPLETED|Overall Study||6
10422229|NCT00822185|11567170|FG001|COMPLETED|Overall Study||6
10422230|NCT00822185|11567171|FG002|COMPLETED|Overall Study||6
10422231|NCT00822185|11567172|FG003|COMPLETED|Overall Study||6
10422232|NCT00822185|11567173|FG004|COMPLETED|Overall Study||8
10422233|NCT00822185|11567169|FG000|NOT COMPLETED|Overall Study||0
10422234|NCT00822185|11567170|FG001|NOT COMPLETED|Overall Study||0
10422235|NCT00822185|11567171|FG002|NOT COMPLETED|Overall Study||0
10422236|NCT00822185|11567172|FG003|NOT COMPLETED|Overall Study||0
10422237|NCT00822185|11567173|FG004|NOT COMPLETED|Overall Study||0
10422238|NCT00822237|11567187|FG000|STARTED|Dose 1 Vaccination|Number randomized|299
10422239|NCT00822237|11567188|FG001|STARTED|Dose 1 Vaccination|Number randomized|299
10422240|NCT00822237|11567187|FG000|COMPLETED|Dose 1 Vaccination||274
10422241|NCT00822237|11567188|FG001|COMPLETED|Dose 1 Vaccination||273
10422242|NCT00822237|11567187|FG000|NOT COMPLETED|Dose 1 Vaccination||25
10422243|NCT00822237|11567188|FG001|NOT COMPLETED|Dose 1 Vaccination||26
10422244|NCT00822237|11567187|FG000|STARTED|Dose 2 Vaccination|Number who received second dose|274
10422245|NCT00822237|11567188|FG001|STARTED|Dose 2 Vaccination|Number who received second dose|273
10422246|NCT00822237|11567187|FG000|COMPLETED|Dose 2 Vaccination||270
10422247|NCT00822237|11567188|FG001|COMPLETED|Dose 2 Vaccination||262
10422248|NCT00822237|11567187|FG000|NOT COMPLETED|Dose 2 Vaccination||4
10422249|NCT00822237|11567188|FG001|NOT COMPLETED|Dose 2 Vaccination||11
10422250|NCT00822328|11567195|FG000|STARTED|Overall Study||12
10422251|NCT00822328|11567196|FG001|STARTED|Overall Study||12
10422252|NCT00822328|11567195|FG000|COMPLETED|Overall Study||12
10422253|NCT00822328|11567196|FG001|COMPLETED|Overall Study||12
10422254|NCT00822328|11567195|FG000|NOT COMPLETED|Overall Study||0
10422255|NCT00822328|11567196|FG001|NOT COMPLETED|Overall Study||0
10422256|NCT00822354|11567204|FG000|STARTED|First Intervention (28 Days)||5
10422257|NCT00822354|11567205|FG001|STARTED|First Intervention (28 Days)||5
10422258|NCT00822354|11567204|FG000|COMPLETED|First Intervention (28 Days)||4
10422259|NCT00822354|11567205|FG001|COMPLETED|First Intervention (28 Days)||5
10422260|NCT00822354|11567204|FG000|NOT COMPLETED|First Intervention (28 Days)||1
10422261|NCT00822354|11567205|FG001|NOT COMPLETED|First Intervention (28 Days)||0
10422262|NCT00822354|11567204|FG000|STARTED|Washout (7 Days)||4
10422263|NCT00822354|11567205|FG001|STARTED|Washout (7 Days)||5
10422264|NCT00822354|11567204|FG000|COMPLETED|Washout (7 Days)||4
10422265|NCT00822354|11567205|FG001|COMPLETED|Washout (7 Days)||5
10422266|NCT00822354|11567204|FG000|NOT COMPLETED|Washout (7 Days)||0
10422267|NCT00822354|11567205|FG001|NOT COMPLETED|Washout (7 Days)||0
10422268|NCT00822354|11567204|FG000|STARTED|Second Intervention (28 Days)||4
10422269|NCT00822354|11567205|FG001|STARTED|Second Intervention (28 Days)||5
10422270|NCT00822354|11567204|FG000|COMPLETED|Second Intervention (28 Days)||3
10422271|NCT00822354|11567205|FG001|COMPLETED|Second Intervention (28 Days)||5
10422272|NCT00822354|11567204|FG000|NOT COMPLETED|Second Intervention (28 Days)||1
10422273|NCT00822354|11567205|FG001|NOT COMPLETED|Second Intervention (28 Days)||0
10422274|NCT00822510|11567215|FG000|STARTED|Overall Study||38
10422275|NCT00822510|11567216|FG001|STARTED|Overall Study||41
10422276|NCT00822510|11567215|FG000|COMPLETED|Overall Study||35
10422277|NCT00822510|11567216|FG001|COMPLETED|Overall Study||36
10422278|NCT00822510|11567215|FG000|NOT COMPLETED|Overall Study||3
10422279|NCT00822510|11567216|FG001|NOT COMPLETED|Overall Study||5
10422280|NCT00822523|11567227|FG000|STARTED|Overall Study||5
10422281|NCT00822523|11567228|FG001|STARTED|Overall Study||4
10422282|NCT00822523|11567229|FG002|STARTED|Overall Study||4
10422283|NCT00822523|11567227|FG000|COMPLETED|Overall Study||5
10422284|NCT00822523|11567228|FG001|COMPLETED|Overall Study||4
10422285|NCT00822523|11567229|FG002|COMPLETED|Overall Study||4
10422286|NCT00822523|11567227|FG000|NOT COMPLETED|Overall Study||0
10422287|NCT00822523|11567228|FG001|NOT COMPLETED|Overall Study||0
10422288|NCT00822523|11567229|FG002|NOT COMPLETED|Overall Study||0
10422289|NCT00822588|11567247|FG000|STARTED|Overall Study|7 participants excluded before surgery. No baseline data available|113
10422290|NCT00822588|11567248|FG001|STARTED|Overall Study|4 participants excluded before surgery. No baseline data available|114
10422291|NCT00822588|11567247|FG000|COMPLETED|Overall Study|APT/ITT analysis set|106
10422292|NCT00822588|11567248|FG001|COMPLETED|Overall Study|APT/ITT analysis set|110
10422293|NCT00822588|11567247|FG000|NOT COMPLETED|Overall Study||7
10422294|NCT00822588|11567248|FG001|NOT COMPLETED|Overall Study||4
10422295|NCT00822692|11567256|FG000|STARTED|Overall Study|July 1, 2008|63
10422296|NCT00822692|11567257|FG001|STARTED|Overall Study|July 1, 2008|76
10422297|NCT00822692|11567256|FG000|COMPLETED|Overall Study|June 1, 2009|46
10422298|NCT00822692|11567257|FG001|COMPLETED|Overall Study|June 1 , 2009|51
10422299|NCT00822692|11567256|FG000|NOT COMPLETED|Overall Study||17
10422300|NCT00822692|11567257|FG001|NOT COMPLETED|Overall Study||25
10422301|NCT00822757|11567265|FG000|STARTED|Overall Study||41
10422302|NCT00822757|11567266|FG001|STARTED|Overall Study||10
10422303|NCT00822757|11567265|FG000|COMPLETED|Overall Study||41
10422304|NCT00822757|11567266|FG001|COMPLETED|Overall Study||10
10422305|NCT00822757|11567265|FG000|NOT COMPLETED|Overall Study||0
10422306|NCT00822757|11567266|FG001|NOT COMPLETED|Overall Study||0
10422307|NCT00822770|11567274|FG000|STARTED|Overall Study||18
10422308|NCT00822770|11567275|FG001|STARTED|Overall Study||29
10422309|NCT00822770|11567274|FG000|COMPLETED|Overall Study||15
10422310|NCT00822770|11567275|FG001|COMPLETED|Overall Study||28
10422311|NCT00822770|11567274|FG000|NOT COMPLETED|Overall Study||3
10422312|NCT00822770|11567275|FG001|NOT COMPLETED|Overall Study||1
10422313|NCT00822900|11567283|FG000|STARTED|Overall Study||442
10422314|NCT00822900|11567284|FG001|STARTED|Overall Study||440
10422315|NCT00822900|11567283|FG000|COMPLETED|Overall Study||334
10422316|NCT00822900|11567284|FG001|COMPLETED|Overall Study||347
10422317|NCT00822900|11567283|FG000|NOT COMPLETED|Overall Study||108
10422318|NCT00822900|11567284|FG001|NOT COMPLETED|Overall Study||93
10422319|NCT00822926|11567292|FG000|STARTED|First Injection Visit||2
10422320|NCT00822926|11567293|FG001|STARTED|First Injection Visit||3
10422321|NCT00822926|11567292|FG000|COMPLETED|First Injection Visit||2
10422322|NCT00822926|11567293|FG001|COMPLETED|First Injection Visit||3
10422323|NCT00822926|11567292|FG000|NOT COMPLETED|First Injection Visit||0
10422324|NCT00822926|11567293|FG001|NOT COMPLETED|First Injection Visit||0
10422325|NCT00822926|11567292|FG000|STARTED|Washout (Varies Based on Scheduling)||2
10422326|NCT00822926|11567293|FG001|STARTED|Washout (Varies Based on Scheduling)||3
10422327|NCT00822926|11567292|FG000|COMPLETED|Washout (Varies Based on Scheduling)||2
10422328|NCT00822926|11567293|FG001|COMPLETED|Washout (Varies Based on Scheduling)||3
10422329|NCT00822926|11567292|FG000|NOT COMPLETED|Washout (Varies Based on Scheduling)||0
10422330|NCT00822926|11567293|FG001|NOT COMPLETED|Washout (Varies Based on Scheduling)||0
10422331|NCT00822926|11567292|FG000|STARTED|Second Injection Visit||2
10422332|NCT00822926|11567293|FG001|STARTED|Second Injection Visit||3
10422333|NCT00822926|11567292|FG000|COMPLETED|Second Injection Visit||1
10422334|NCT00822926|11567293|FG001|COMPLETED|Second Injection Visit||2
10422335|NCT00822926|11567292|FG000|NOT COMPLETED|Second Injection Visit||1
10422336|NCT00822926|11567293|FG001|NOT COMPLETED|Second Injection Visit||1
10422337|NCT00823043|11567302|FG000|STARTED|Overall Study||64
10422338|NCT00823043|11567303|FG001|STARTED|Overall Study||39
10422339|NCT00823043|11567302|FG000|COMPLETED|Overall Study||64
10422340|NCT00823043|11567303|FG001|COMPLETED|Overall Study||39
10422341|NCT00823043|11567302|FG000|NOT COMPLETED|Overall Study||0
10422342|NCT00823043|11567303|FG001|NOT COMPLETED|Overall Study||0
10422343|NCT00823069|11567308|FG000|STARTED|Overall Study||60
10422344|NCT00823069|11567308|FG000|COMPLETED|Overall Study||60
10422345|NCT00823069|11567308|FG000|NOT COMPLETED|Overall Study||0
10422346|NCT00823082|11567317|FG000|STARTED|Overall Study||100
10422347|NCT00823082|11567318|FG001|STARTED|Overall Study||100
10422348|NCT00823082|11567317|FG000|Safety Population|Overall Study||100
10422349|NCT00823082|11567318|FG001|Safety Population|Overall Study||99
10422350|NCT00823082|11567317|FG000|Intent-to-Treat/Per Protocol Populations|Overall Study||100
10422351|NCT00823082|11567318|FG001|Intent-to-Treat/Per Protocol Populations|Overall Study||94
10422352|NCT00823082|11567317|FG000|COMPLETED|Overall Study||100
10422353|NCT00823082|11567318|FG001|COMPLETED|Overall Study||99
10422354|NCT00823082|11567317|FG000|NOT COMPLETED|Overall Study||0
10422355|NCT00823082|11567318|FG001|NOT COMPLETED|Overall Study||1
10422356|NCT00823134|11567324|FG000|STARTED|Overall Study||23
10422357|NCT00823134|11567324|FG000|COMPLETED|Overall Study||22
10422358|NCT00823134|11567324|FG000|NOT COMPLETED|Overall Study||1
10422359|NCT00823199|11567329|FG000|STARTED|Overall Study||10
10422360|NCT00823199|11567329|FG000|COMPLETED|Overall Study||8
10422361|NCT00823199|11567329|FG000|NOT COMPLETED|Overall Study||2
10422362|NCT00823212|11567336|FG000|STARTED|Overall Study||762
10422363|NCT00823212|11567337|FG001|STARTED|Overall Study||768
10422364|NCT00823212|11567336|FG000|COMPLETED|Overall Study|12-month follow-up|727
10422365|NCT00823212|11567337|FG001|COMPLETED|Overall Study|12-month follow-up|735
10422366|NCT00823212|11567336|FG000|NOT COMPLETED|Overall Study||35
10422367|NCT00823212|11567337|FG001|NOT COMPLETED|Overall Study||33
10422368|NCT00823264|11567347|FG000|STARTED|Overall Study||10
10422369|NCT00823264|11567348|FG001|STARTED|Overall Study||7
10422370|NCT00823264|11567347|FG000|COMPLETED|Overall Study||8
10422371|NCT00823264|11567348|FG001|COMPLETED|Overall Study||7
10422372|NCT00823264|11567347|FG000|NOT COMPLETED|Overall Study||2
10422373|NCT00823264|11567348|FG001|NOT COMPLETED|Overall Study||0
10422374|NCT00823303|11567356|FG000|STARTED|Overall Study||54
10422375|NCT00823303|11567357|FG001|STARTED|Overall Study||56
10422376|NCT00823303|11567356|FG000|COMPLETED|Overall Study||45
10422377|NCT00823303|11567357|FG001|COMPLETED|Overall Study||45
10422378|NCT00823303|11567356|FG000|NOT COMPLETED|Overall Study||9
10422379|NCT00823303|11567357|FG001|NOT COMPLETED|Overall Study||11
10422380|NCT00823459|11567363|FG000|STARTED|Overall Study||58
10422381|NCT00823459|11567363|FG000|COMPLETED|Overall Study||58
10422382|NCT00823459|11567363|FG000|NOT COMPLETED|Overall Study||0
10422383|NCT00823472|11567370|FG000|STARTED|Overall Study||80
10422384|NCT00823472|11567371|FG001|STARTED|Overall Study||67
10422385|NCT00823472|11567370|FG000|COMPLETED|Overall Study||56
10422386|NCT00823472|11567371|FG001|COMPLETED|Overall Study||39
10422387|NCT00823472|11567370|FG000|NOT COMPLETED|Overall Study||24
10422388|NCT00823472|11567371|FG001|NOT COMPLETED|Overall Study||28
10422389|NCT00823615|11567377|FG000|STARTED|Period 1||19
10422390|NCT00823615|11567378|FG001|STARTED|Period 1||19
10422391|NCT00823615|11567377|FG000|COMPLETED|Period 1||19
10422392|NCT00823615|11567378|FG001|COMPLETED|Period 1||19
10422393|NCT00823615|11567377|FG000|NOT COMPLETED|Period 1||0
10422394|NCT00823615|11567378|FG001|NOT COMPLETED|Period 1||0
10422395|NCT00823615|11567377|FG000|STARTED|Period 2||19
10422396|NCT00823615|11567378|FG001|STARTED|Period 2||19
10422397|NCT00823615|11567377|FG000|COMPLETED|Period 2||16
10422398|NCT00823615|11567378|FG001|COMPLETED|Period 2||17
10422399|NCT00823615|11567377|FG000|NOT COMPLETED|Period 2||3
10422400|NCT00823615|11567378|FG001|NOT COMPLETED|Period 2||2
10422401|NCT00823719|11567386|FG000|STARTED|Overall Study||26
10422402|NCT00823719|11567387|FG001|STARTED|Overall Study||35
10422403|NCT00823719|11567386|FG000|COMPLETED|Overall Study||20
10422404|NCT00823719|11567387|FG001|COMPLETED|Overall Study||24
10422405|NCT00823719|11567386|FG000|NOT COMPLETED|Overall Study||6
10422406|NCT00823719|11567387|FG001|NOT COMPLETED|Overall Study||11
10422407|NCT00823797|11567397|FG000|STARTED|Overall Study||29
10422408|NCT00823797|11567398|FG001|STARTED|Overall Study||16
10422409|NCT00823797|11567397|FG000|COMPLETED|Overall Study||29
10422410|NCT00823797|11567398|FG001|COMPLETED|Overall Study||16
10422411|NCT00823797|11567397|FG000|NOT COMPLETED|Overall Study||0
10422412|NCT00823797|11567398|FG001|NOT COMPLETED|Overall Study||0
10429575|NCT00864682|11575618|FG002|COMPLETED|Overall Study||51
10429576|NCT00864682|11575616|FG000|NOT COMPLETED|Overall Study||2
10429577|NCT00864682|11575617|FG001|NOT COMPLETED|Overall Study||1
10429578|NCT00864682|11575618|FG002|NOT COMPLETED|Overall Study||2
10429579|NCT00864708|11575626|FG000|STARTED|Overall Study||1
10429580|NCT00864708|11575626|FG000|COMPLETED|Overall Study||1
10429581|NCT00864708|11575626|FG000|NOT COMPLETED|Overall Study||0
10429582|NCT00864721|11575632|FG000|STARTED|Overall Study||63
10429583|NCT00864721|11575632|FG000|COMPLETED|Overall Study||29
10429584|NCT00864721|11575632|FG000|NOT COMPLETED|Overall Study||34
10429585|NCT00864851|11575639|FG000|STARTED|Overall Study||20
10429586|NCT00864851|11575640|FG001|STARTED|Overall Study||19
10429587|NCT00864851|11575641|FG002|STARTED|Overall Study||5
10429588|NCT00864851|11575639|FG000|COMPLETED|Overall Study||17
10429589|NCT00864851|11575640|FG001|COMPLETED|Overall Study||18
10429590|NCT00864851|11575641|FG002|COMPLETED|Overall Study||5
10429591|NCT00864851|11575639|FG000|NOT COMPLETED|Overall Study||3
10429592|NCT00864851|11575640|FG001|NOT COMPLETED|Overall Study||1
10429593|NCT00864851|11575641|FG002|NOT COMPLETED|Overall Study||0
10429594|NCT00864916|11575653|FG000|STARTED|Overall Study||10
10429595|NCT00864916|11575654|FG001|STARTED|Overall Study||9
10429596|NCT00864916|11575653|FG000|COMPLETED|Overall Study||4
10429597|NCT00864916|11575654|FG001|COMPLETED|Overall Study||5
10429598|NCT00864916|11575653|FG000|NOT COMPLETED|Overall Study||6
10429599|NCT00864916|11575654|FG001|NOT COMPLETED|Overall Study||4
10429600|NCT00865020|11575662|FG000|STARTED|Overall Study||414
10429601|NCT00865020|11575663|FG001|STARTED|Overall Study||408
10429602|NCT00865020|11575662|FG000|COMPLETED|Overall Study||365
10429603|NCT00865020|11575663|FG001|COMPLETED|Overall Study||357
10429604|NCT00865020|11575662|FG000|NOT COMPLETED|Overall Study||49
10429605|NCT00865020|11575663|FG001|NOT COMPLETED|Overall Study||51
10429606|NCT00865046|11575672|FG000|STARTED|Overall Study||63
10429607|NCT00865046|11575673|FG001|STARTED|Overall Study||64
10429608|NCT00865046|11575674|FG002|STARTED|Overall Study||63
10429609|NCT00865046|11575672|FG000|COMPLETED|Overall Study||57
10429610|NCT00865046|11575673|FG001|COMPLETED|Overall Study||59
10429611|NCT00865046|11575674|FG002|COMPLETED|Overall Study||62
10429612|NCT00865046|11575672|FG000|NOT COMPLETED|Overall Study||6
10429613|NCT00865046|11575673|FG001|NOT COMPLETED|Overall Study||5
10429614|NCT00865046|11575674|FG002|NOT COMPLETED|Overall Study||1
10429615|NCT00865098|11575682|FG000|STARTED|Overall Study||22
10429616|NCT00865098|11575682|FG000|COMPLETED|Overall Study|Discontinued from the study due to progressive disease, after completing planned treatment schedule|21
10429617|NCT00865098|11575682|FG000|NOT COMPLETED|Overall Study||1
10429618|NCT00865124|11575689|FG000|STARTED|Overall Study||27
10429619|NCT00865124|11575690|FG001|STARTED|Overall Study||25
10429620|NCT00865124|11575691|FG002|STARTED|Overall Study||17
10429621|NCT00865124|11575689|FG000|COMPLETED|Overall Study||23
10429622|NCT00865124|11575690|FG001|COMPLETED|Overall Study||24
10429623|NCT00865124|11575691|FG002|COMPLETED|Overall Study||17
10429624|NCT00865124|11575689|FG000|NOT COMPLETED|Overall Study||4
10429625|NCT00865124|11575690|FG001|NOT COMPLETED|Overall Study||1
10429626|NCT00865124|11575691|FG002|NOT COMPLETED|Overall Study||0
10429627|NCT00865189|11575701|FG000|STARTED|Overall Study||46
10429628|NCT00865189|11575702|FG001|STARTED|Overall Study||45
10429629|NCT00865189|11575701|FG000|COMPLETED|Overall Study||34
10429630|NCT00865189|11575702|FG001|COMPLETED|Overall Study||26
10429631|NCT00865189|11575701|FG000|NOT COMPLETED|Overall Study||12
10429632|NCT00865189|11575702|FG001|NOT COMPLETED|Overall Study||19
10429633|NCT00865202|11575710|FG000|STARTED|Overall Study||152
10429634|NCT00865202|11575711|FG001|STARTED|Overall Study||149
10429635|NCT00865202|11575710|FG000|COMPLETED|Overall Study||152
10429636|NCT00865202|11575711|FG001|COMPLETED|Overall Study||149
10429637|NCT00865202|11575710|FG000|NOT COMPLETED|Overall Study||0
10429638|NCT00865202|11575711|FG001|NOT COMPLETED|Overall Study||0
10429639|NCT00865280|11575720|FG000|STARTED|Overall Study||70
10429640|NCT00865280|11575721|FG001|STARTED|Overall Study||73
10429641|NCT00865280|11575720|FG000|COMPLETED|Overall Study||64
10429642|NCT00865280|11575721|FG001|COMPLETED|Overall Study||70
10429643|NCT00865280|11575720|FG000|NOT COMPLETED|Overall Study||6
10429644|NCT00865280|11575721|FG001|NOT COMPLETED|Overall Study||3
10429645|NCT00865306|11575729|FG000|STARTED|Controlled Trial|35 assigned to CBT. One child in trial had 0 anxiety disorders, so we excluded her from analysis.|34
10429646|NCT00865306|11575730|FG001|STARTED|Controlled Trial||30
10429647|NCT00865306|11575729|FG000|COMPLETED|Controlled Trial||29
10429648|NCT00865306|11575730|FG001|COMPLETED|Controlled Trial||28
10429649|NCT00865306|11575729|FG000|NOT COMPLETED|Controlled Trial||5
10429650|NCT00865306|11575730|FG001|NOT COMPLETED|Controlled Trial||2
10429651|NCT00865306|11575729|FG000|STARTED|One-Year Follow-Up||29
10429652|NCT00865306|11575730|FG001|STARTED|One-Year Follow-Up|Only controls who opted for CBT after the waitlist (n=17) were included. 2 were lost (15 included).|15
10429653|NCT00865306|11575729|FG000|COMPLETED|One-Year Follow-Up||29
10429654|NCT00865306|11575730|FG001|COMPLETED|One-Year Follow-Up||15
10429655|NCT00865306|11575729|FG000|NOT COMPLETED|One-Year Follow-Up||0
10429656|NCT00865306|11575730|FG001|NOT COMPLETED|One-Year Follow-Up||0
10429657|NCT00865345|11575736|FG000|STARTED|Overall Study||63
10429658|NCT00865345|11575736|FG000|COMPLETED|Overall Study||61
10422413|NCT00823823|11567405|FG000|STARTED|Overall Study||109
10422414|NCT00823823|11567406|FG001|STARTED|Overall Study||107
10422415|NCT00823823|11567405|FG000|COMPLETED|Overall Study||101
10422416|NCT00823823|11567406|FG001|COMPLETED|Overall Study||101
10422417|NCT00823823|11567405|FG000|NOT COMPLETED|Overall Study||8
10422418|NCT00823823|11567406|FG001|NOT COMPLETED|Overall Study||6
10422419|NCT00823836|11567414|FG000|STARTED|NV and PR/XR Switching Phases||156
10422420|NCT00823836|11567415|FG001|STARTED|NV and PR/XR Switching Phases||146
10422421|NCT00823836|11567414|FG000|COMPLETED|NV and PR/XR Switching Phases||124
10422422|NCT00823836|11567415|FG001|COMPLETED|NV and PR/XR Switching Phases||117
10422423|NCT00823836|11567414|FG000|NOT COMPLETED|NV and PR/XR Switching Phases||32
10422424|NCT00823836|11567415|FG001|NOT COMPLETED|NV and PR/XR Switching Phases||29
10422425|NCT00823836|11567414|FG000|STARTED|Long-term Phase||73
10422426|NCT00823836|11567415|FG001|STARTED|Long-term Phase||84
10422427|NCT00823836|11567414|FG000|COMPLETED|Long-term Phase||68
10422428|NCT00823836|11567415|FG001|COMPLETED|Long-term Phase||79
10422429|NCT00823836|11567414|FG000|NOT COMPLETED|Long-term Phase||5
10422430|NCT00823836|11567415|FG001|NOT COMPLETED|Long-term Phase||5
10422431|NCT00823901|11567426|FG000|STARTED|Overall Study|Randomized to clindamycin/tretinoin gel|43
10422432|NCT00823901|11567427|FG001|STARTED|Overall Study|Randomized to placebo gel|40
10422433|NCT00823901|11567426|FG000|COMPLETED|Overall Study|Discontinued intervention (n=2) Only baseline completed (n=2)|39
10422434|NCT00823901|11567427|FG001|COMPLETED|Overall Study|Discontinued intervention (n=1) Only baseline completed (n=1)|38
10422435|NCT00823901|11567426|FG000|NOT COMPLETED|Overall Study||4
10422436|NCT00823901|11567427|FG001|NOT COMPLETED|Overall Study||2
10422437|NCT00823966|11567433|FG000|STARTED|Overall Study||3
10422438|NCT00823966|11567433|FG000|COMPLETED|Overall Study||3
10422439|NCT00823966|11567433|FG000|NOT COMPLETED|Overall Study||0
10422440|NCT00823979|11567440|FG000|STARTED|Overall Study||35
10422441|NCT00823979|11567441|FG001|STARTED|Overall Study||35
10422442|NCT00823979|11567442|FG002|STARTED|Overall Study||35
10422443|NCT00823979|11567440|FG000|Treated|Overall Study||31
10422444|NCT00823979|11567441|FG001|Treated|Overall Study||32
10422445|NCT00823979|11567442|FG002|Treated|Overall Study||34
10422446|NCT00823979|11567440|FG000|COMPLETED|Overall Study||6
10422447|NCT00823979|11567441|FG001|COMPLETED|Overall Study||3
10422448|NCT00823979|11567442|FG002|COMPLETED|Overall Study||11
10422449|NCT00823979|11567440|FG000|NOT COMPLETED|Overall Study||29
10422450|NCT00823979|11567441|FG001|NOT COMPLETED|Overall Study||32
10422451|NCT00823979|11567442|FG002|NOT COMPLETED|Overall Study||24
10422452|NCT00824005|11567452|FG000|STARTED|Overall Study||31
10422453|NCT00824005|11567453|FG001|STARTED|Overall Study||61
10422454|NCT00824005|11567452|FG000|COMPLETED|Overall Study||31
10422455|NCT00824005|11567453|FG001|COMPLETED|Overall Study||59
10422456|NCT00824005|11567452|FG000|NOT COMPLETED|Overall Study||0
10422457|NCT00824005|11567453|FG001|NOT COMPLETED|Overall Study||2
10422458|NCT00824044|11567461|FG000|STARTED|Overall Study||23
10422459|NCT00824044|11567462|FG001|STARTED|Overall Study||16
10422460|NCT00824044|11567461|FG000|COMPLETED|Overall Study||14
10422461|NCT00824044|11567462|FG001|COMPLETED|Overall Study||10
10422462|NCT00824044|11567461|FG000|NOT COMPLETED|Overall Study||9
10422463|NCT00824044|11567462|FG001|NOT COMPLETED|Overall Study||6
10422464|NCT00824070|11567475|FG000|STARTED|Overall Study||34
10422465|NCT00824070|11567476|FG001|STARTED|Overall Study||35
10422466|NCT00824070|11567477|FG002|STARTED|Overall Study||36
10422467|NCT00824070|11567475|FG000|COMPLETED|Overall Study||34
10422468|NCT00824070|11567476|FG001|COMPLETED|Overall Study||35
10422469|NCT00824070|11567477|FG002|COMPLETED|Overall Study||36
10422470|NCT00824070|11567475|FG000|NOT COMPLETED|Overall Study||0
10422471|NCT00824070|11567476|FG001|NOT COMPLETED|Overall Study||0
10422472|NCT00824070|11567477|FG002|NOT COMPLETED|Overall Study||0
10422473|NCT00824161|11567485|FG000|STARTED|Overall Study||28
10422474|NCT00824161|11567485|FG000|COMPLETED|Overall Study||26
10422475|NCT00824161|11567485|FG000|NOT COMPLETED|Overall Study||2
10422476|NCT00824265|11567492|FG000|STARTED|Treatment Phase||183
10422477|NCT00824265|11567493|FG001|STARTED|Treatment Phase||182
10422478|NCT00824265|11567492|FG000|COMPLETED|Treatment Phase||119
10422479|NCT00824265|11567493|FG001|COMPLETED|Treatment Phase||102
10422480|NCT00824265|11567492|FG000|NOT COMPLETED|Treatment Phase||64
10422481|NCT00824265|11567493|FG001|NOT COMPLETED|Treatment Phase||80
10422482|NCT00824265|11567492|FG000|STARTED|Follow-up Phase||172
10422483|NCT00824265|11567493|FG001|STARTED|Follow-up Phase||160
10422484|NCT00824265|11567492|FG000|COMPLETED|Follow-up Phase||154
10422485|NCT00824265|11567493|FG001|COMPLETED|Follow-up Phase||129
10422486|NCT00824265|11567492|FG000|NOT COMPLETED|Follow-up Phase||18
10422487|NCT00824265|11567493|FG001|NOT COMPLETED|Follow-up Phase||31
10422488|NCT00824265|11567492|FG000|STARTED|Survival Follow-up Phase||96
10422489|NCT00824265|11567493|FG001|STARTED|Survival Follow-up Phase||89
10422490|NCT00824265|11567492|FG000|COMPLETED|Survival Follow-up Phase||87
10422491|NCT00824265|11567493|FG001|COMPLETED|Survival Follow-up Phase||73
10422492|NCT00824265|11567492|FG000|NOT COMPLETED|Survival Follow-up Phase||9
10422493|NCT00824265|11567493|FG001|NOT COMPLETED|Survival Follow-up Phase||16
10422494|NCT00824291|11567505|FG000|STARTED|Overall Study||285
10422495|NCT00824291|11567506|FG001|STARTED|Overall Study||142
10422496|NCT00824291|11567505|FG000|COMPLETED|Overall Study||231
10422497|NCT00824291|11567506|FG001|COMPLETED|Overall Study||107
10422498|NCT00824291|11567505|FG000|NOT COMPLETED|Overall Study||54
10422499|NCT00824291|11567506|FG001|NOT COMPLETED|Overall Study||35
10422500|NCT00824369|11567518|FG000|STARTED|Overall Study||5
10422501|NCT00824369|11567519|FG001|STARTED|Overall Study||4
10422502|NCT00824369|11567520|FG002|STARTED|Overall Study||3
10422503|NCT00824369|11567521|FG003|STARTED|Overall Study||11
10422504|NCT00824369|11567522|FG004|STARTED|Overall Study||12
10422505|NCT00824369|11567523|FG005|STARTED|Overall Study||17
10422506|NCT00824369|11567518|FG000|COMPLETED|Overall Study||4
10422507|NCT00824369|11567519|FG001|COMPLETED|Overall Study||4
10422508|NCT00824369|11567520|FG002|COMPLETED|Overall Study||2
10422509|NCT00824369|11567521|FG003|COMPLETED|Overall Study||9
10422510|NCT00824369|11567522|FG004|COMPLETED|Overall Study||11
10422511|NCT00824369|11567523|FG005|COMPLETED|Overall Study||16
10422512|NCT00824369|11567518|FG000|NOT COMPLETED|Overall Study||1
10422513|NCT00824369|11567519|FG001|NOT COMPLETED|Overall Study||0
10422514|NCT00824369|11567520|FG002|NOT COMPLETED|Overall Study||1
10422515|NCT00824369|11567521|FG003|NOT COMPLETED|Overall Study||2
10422516|NCT00824369|11567522|FG004|NOT COMPLETED|Overall Study||1
10422517|NCT00824369|11567523|FG005|NOT COMPLETED|Overall Study||1
10422518|NCT00824382|11567541|FG000|STARTED|Overall Study||79
10422519|NCT00824382|11567542|FG001|STARTED|Overall Study||84
10422520|NCT00824382|11567543|FG002|STARTED|Overall Study||79
10422521|NCT00824382|11567544|FG003|STARTED|Overall Study||86
10422522|NCT00824382|11567541|FG000|COMPLETED|Overall Study||74
10422523|NCT00824382|11567542|FG001|COMPLETED|Overall Study||82
10422524|NCT00824382|11567543|FG002|COMPLETED|Overall Study||76
10422525|NCT00824382|11567544|FG003|COMPLETED|Overall Study||81
10422526|NCT00824382|11567541|FG000|NOT COMPLETED|Overall Study||5
10422527|NCT00824382|11567542|FG001|NOT COMPLETED|Overall Study||2
10422528|NCT00824382|11567543|FG002|NOT COMPLETED|Overall Study||3
10422529|NCT00824382|11567544|FG003|NOT COMPLETED|Overall Study||5
10422530|NCT00824408|11567561|FG000|STARTED|Run-in Phase||6
10422531|NCT00824408|11567562|FG001|STARTED|Run-in Phase||6
10422532|NCT00824408|11567563|FG002|STARTED|Run-in Phase||0
10422533|NCT00824408|11567564|FG003|STARTED|Run-in Phase||0
10422534|NCT00824408|11567565|FG004|STARTED|Run-in Phase||0
10422535|NCT00824408|11567561|FG000|COMPLETED|Run-in Phase||0
10422536|NCT00824408|11567562|FG001|COMPLETED|Run-in Phase||0
10422537|NCT00824408|11567563|FG002|COMPLETED|Run-in Phase||0
10422538|NCT00824408|11567564|FG003|COMPLETED|Run-in Phase||0
10422539|NCT00824408|11567565|FG004|COMPLETED|Run-in Phase||0
10422540|NCT00824408|11567561|FG000|NOT COMPLETED|Run-in Phase||6
10422541|NCT00824408|11567562|FG001|NOT COMPLETED|Run-in Phase||6
10422542|NCT00824408|11567563|FG002|NOT COMPLETED|Run-in Phase||0
10422543|NCT00824408|11567564|FG003|NOT COMPLETED|Run-in Phase||0
10422544|NCT00824408|11567565|FG004|NOT COMPLETED|Run-in Phase||0
10422545|NCT00824408|11567561|FG000|STARTED|Randomized Phase||0
10422546|NCT00824408|11567562|FG001|STARTED|Randomized Phase||0
10422547|NCT00824408|11567563|FG002|STARTED|Randomized Phase||37
10422548|NCT00824408|11567564|FG003|STARTED|Randomized Phase||47
10422549|NCT00824408|11567565|FG004|STARTED|Randomized Phase||47
10422550|NCT00824408|11567561|FG000|COMPLETED|Randomized Phase||0
10422551|NCT00824408|11567562|FG001|COMPLETED|Randomized Phase||0
10422552|NCT00824408|11567563|FG002|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
10422553|NCT00824408|11567564|FG003|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
10422554|NCT00824408|11567565|FG004|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
10422555|NCT00824408|11567561|FG000|NOT COMPLETED|Randomized Phase||0
10422556|NCT00824408|11567562|FG001|NOT COMPLETED|Randomized Phase||0
10422557|NCT00824408|11567563|FG002|NOT COMPLETED|Randomized Phase||36
10422558|NCT00824408|11567564|FG003|NOT COMPLETED|Randomized Phase||46
10422559|NCT00824408|11567565|FG004|NOT COMPLETED|Randomized Phase||46
10422560|NCT00824421|11567586|FG000|STARTED|Overall Study||66
10422561|NCT00824421|11567587|FG001|STARTED|Overall Study||66
10422562|NCT00824421|11567588|FG002|STARTED|Overall Study||63
10422563|NCT00824421|11567586|FG000|Treated|Overall Study||65
10422564|NCT00824421|11567587|FG001|Treated|Overall Study||65
10422565|NCT00824421|11567588|FG002|Treated|Overall Study||63
10422566|NCT00824421|11567586|FG000|COMPLETED|Overall Study||49
10422567|NCT00824421|11567587|FG001|COMPLETED|Overall Study||44
10422568|NCT00824421|11567588|FG002|COMPLETED|Overall Study||49
10422569|NCT00824421|11567586|FG000|NOT COMPLETED|Overall Study||17
10422570|NCT00824421|11567587|FG001|NOT COMPLETED|Overall Study||22
10422571|NCT00824421|11567588|FG002|NOT COMPLETED|Overall Study||14
10422572|NCT00824434|11567598|FG000|STARTED|Overall Study||100
10422573|NCT00824434|11567598|FG000|COMPLETED|Overall Study||100
10422574|NCT00824434|11567598|FG000|NOT COMPLETED|Overall Study||0
10422575|NCT00824460|11567608|FG000|STARTED|Overall Study||26
10422576|NCT00824460|11567609|FG001|STARTED|Overall Study||26
10422577|NCT00824460|11567610|FG002|STARTED|Overall Study||25
10422578|NCT00824460|11567611|FG003|STARTED|Overall Study||27
10422579|NCT00824460|11567612|FG004|STARTED|Overall Study||24
10422580|NCT00824460|11567613|FG005|STARTED|Overall Study||26
10422581|NCT00824460|11567608|FG000|COMPLETED|Overall Study||18
10422582|NCT00824460|11567609|FG001|COMPLETED|Overall Study||17
10422583|NCT00824460|11567610|FG002|COMPLETED|Overall Study||20
10422584|NCT00824460|11567611|FG003|COMPLETED|Overall Study||15
10422585|NCT00824460|11567612|FG004|COMPLETED|Overall Study||15
10422586|NCT00824460|11567613|FG005|COMPLETED|Overall Study||18
10422587|NCT00824460|11567608|FG000|NOT COMPLETED|Overall Study||8
10422588|NCT00824460|11567609|FG001|NOT COMPLETED|Overall Study||9
10422589|NCT00824460|11567610|FG002|NOT COMPLETED|Overall Study||5
10422590|NCT00824460|11567611|FG003|NOT COMPLETED|Overall Study||12
10422591|NCT00824460|11567612|FG004|NOT COMPLETED|Overall Study||9
10422592|NCT00824460|11567613|FG005|NOT COMPLETED|Overall Study||8
10422593|NCT00824473|11567637|FG000|STARTED|Overall Study|1 subject was randomized in error|255
10422594|NCT00824473|11567638|FG001|STARTED|Overall Study||251
10422595|NCT00824473|11567637|FG000|COMPLETED|Overall Study||240
10422596|NCT00824473|11567638|FG001|COMPLETED|Overall Study||238
10422597|NCT00824473|11567637|FG000|NOT COMPLETED|Overall Study||15
10422598|NCT00824473|11567638|FG001|NOT COMPLETED|Overall Study||13
10422599|NCT00824512|11567646|FG000|STARTED|Overall Study||11
10422600|NCT00824512|11567647|FG001|STARTED|Overall Study||11
10422601|NCT00824512|11567646|FG000|COMPLETED|Overall Study||11
10422602|NCT00824512|11567647|FG001|COMPLETED|Overall Study||11
10422603|NCT00824512|11567646|FG000|NOT COMPLETED|Overall Study||0
10422604|NCT00824512|11567647|FG001|NOT COMPLETED|Overall Study||0
10422605|NCT00824538|11567653|FG000|STARTED|Overall Study|13 patients entered the study|13
10422606|NCT00824538|11567653|FG000|COMPLETED|Overall Study||11
10422607|NCT00824538|11567653|FG000|NOT COMPLETED|Overall Study||2
10422608|NCT00824564|11567660|FG000|STARTED|Overall Study||42
10422609|NCT00824564|11567661|FG001|STARTED|Overall Study||40
10422610|NCT00824564|11567660|FG000|Treated|Overall Study||41
10422611|NCT00824564|11567661|FG001|Treated|Overall Study||40
10422612|NCT00824564|11567660|FG000|COMPLETED|Overall Study||34
10422613|NCT00824564|11567661|FG001|COMPLETED|Overall Study||30
10422614|NCT00824564|11567660|FG000|NOT COMPLETED|Overall Study||8
10422615|NCT00824564|11567661|FG001|NOT COMPLETED|Overall Study||10
10422616|NCT00824616|11567669|FG000|STARTED|Overall Study||34
10422617|NCT00824616|11567670|FG001|STARTED|Overall Study||34
10422618|NCT00824616|11567669|FG000|COMPLETED|Overall Study||28
10422619|NCT00824616|11567670|FG001|COMPLETED|Overall Study||27
10422620|NCT00824616|11567669|FG000|NOT COMPLETED|Overall Study||6
10422621|NCT00824616|11567670|FG001|NOT COMPLETED|Overall Study||7
10422622|NCT00824655|11567678|FG000|STARTED|Infant Series (5 Months of Age)||118
10422623|NCT00824655|11567679|FG001|STARTED|Infant Series (5 Months of Age)||0
10422624|NCT00824655|11567678|FG000|COMPLETED|Infant Series (5 Months of Age)||118
10422625|NCT00824655|11567679|FG001|COMPLETED|Infant Series (5 Months of Age)||0
10422626|NCT00824655|11567678|FG000|NOT COMPLETED|Infant Series (5 Months of Age)||0
10422627|NCT00824655|11567679|FG001|NOT COMPLETED|Infant Series (5 Months of Age)||0
10422628|NCT00824655|11567678|FG000|STARTED|After Infant Dose (6 Months of Age)||118
10422629|NCT00824655|11567679|FG001|STARTED|After Infant Dose (6 Months of Age)||0
10422630|NCT00824655|11567678|FG000|COMPLETED|After Infant Dose (6 Months of Age)||118
10422631|NCT00824655|11567679|FG001|COMPLETED|After Infant Dose (6 Months of Age)||0
10422632|NCT00824655|11567678|FG000|NOT COMPLETED|After Infant Dose (6 Months of Age)||0
10422633|NCT00824655|11567679|FG001|NOT COMPLETED|After Infant Dose (6 Months of Age)||0
10422634|NCT00824655|11567678|FG000|STARTED|Toddler Dose (12 Months of Age)||118
10422635|NCT00824655|11567679|FG001|STARTED|Toddler Dose (12 Months of Age)||116
10422636|NCT00824655|11567678|FG000|COMPLETED|Toddler Dose (12 Months of Age)||116
10422637|NCT00824655|11567679|FG001|COMPLETED|Toddler Dose (12 Months of Age)||116
10422638|NCT00824655|11567678|FG000|NOT COMPLETED|Toddler Dose (12 Months of Age)||2
10422639|NCT00824655|11567679|FG001|NOT COMPLETED|Toddler Dose (12 Months of Age)||0
10422640|NCT00824720|11567690|FG000|STARTED|Overall Study|3 subjects in the high dose group did not receive device - unable to insert.|19
10422641|NCT00824720|11567691|FG001|STARTED|Overall Study|1 subject in the low dose group did not receive device - unable to insert.|16
10422642|NCT00824720|11567692|FG002|STARTED|Overall Study||20
10422643|NCT00824720|11567690|FG000|COMPLETED|Overall Study||16
10422644|NCT00824720|11567691|FG001|COMPLETED|Overall Study||15
10422645|NCT00824720|11567692|FG002|COMPLETED|Overall Study||19
10422646|NCT00824720|11567690|FG000|NOT COMPLETED|Overall Study||3
10422647|NCT00824720|11567691|FG001|NOT COMPLETED|Overall Study||1
10422648|NCT00824720|11567692|FG002|NOT COMPLETED|Overall Study||1
10422649|NCT00824733|11567700|FG000|STARTED|Overall Study||6
10422650|NCT00824733|11567700|FG000|COMPLETED|Overall Study||6
10422651|NCT00824733|11567700|FG000|NOT COMPLETED|Overall Study||0
10422652|NCT00824746|11567704|FG000|STARTED|Overall Study||23
10422653|NCT00824746|11567704|FG000|COMPLETED|Overall Study||23
10422654|NCT00824746|11567704|FG000|NOT COMPLETED|Overall Study||0
10422655|NCT00824772|11567710|FG000|STARTED|Overall Study||204
10422656|NCT00824772|11567710|FG000|COMPLETED|Overall Study||196
10422657|NCT00824772|11567710|FG000|NOT COMPLETED|Overall Study||8
10422658|NCT00824824|11567716|FG000|STARTED|Overall Study||4
10422659|NCT00824824|11567717|FG001|STARTED|Overall Study||3
10422660|NCT00824824|11567716|FG000|COMPLETED|Overall Study||4
10422661|NCT00824824|11567717|FG001|COMPLETED|Overall Study||3
10422662|NCT00824824|11567716|FG000|NOT COMPLETED|Overall Study||0
10422663|NCT00824824|11567717|FG001|NOT COMPLETED|Overall Study||0
10422664|NCT00824850|11567725|FG000|STARTED|Overall Study||38
10422665|NCT00824850|11567726|FG001|STARTED|Overall Study||37
10422666|NCT00824850|11567725|FG000|Received Vaccination 13vPnC|Overall Study||38
10422667|NCT00824850|11567726|FG001|Received Vaccination 13vPnC|Overall Study||36
10422668|NCT00824850|11567725|FG000|COMPLETED|Overall Study||38
10422669|NCT00824850|11567726|FG001|COMPLETED|Overall Study||36
10422670|NCT00824850|11567725|FG000|NOT COMPLETED|Overall Study||0
10422671|NCT00824850|11567726|FG001|NOT COMPLETED|Overall Study||1
10422672|NCT00824993|11567740|FG000|STARTED|Overall Study||39
10422673|NCT00824993|11567741|FG001|STARTED|Overall Study||39
10422674|NCT00824993|11567740|FG000|6 Month Follow up|Overall Study||33
10422675|NCT00824993|11567741|FG001|6 Month Follow up|Overall Study||27
10422676|NCT00824993|11567740|FG000|COMPLETED|Overall Study||25
10422677|NCT00824993|11567741|FG001|COMPLETED|Overall Study||22
10422678|NCT00824993|11567740|FG000|NOT COMPLETED|Overall Study||14
10422679|NCT00824993|11567741|FG001|NOT COMPLETED|Overall Study||17
10422680|NCT00825162|11567750|FG000|STARTED|Overall Study||710
10422681|NCT00825162|11567751|FG001|STARTED|Overall Study||880
10422682|NCT00825162|11567752|FG002|STARTED|Overall Study||402
10422683|NCT00825162|11567750|FG000|COMPLETED|Overall Study||682
10422684|NCT00825162|11567751|FG001|COMPLETED|Overall Study||859
10422685|NCT00825162|11567752|FG002|COMPLETED|Overall Study||396
10422686|NCT00825162|11567750|FG000|NOT COMPLETED|Overall Study||28
10422687|NCT00825162|11567751|FG001|NOT COMPLETED|Overall Study||21
10422688|NCT00825162|11567752|FG002|NOT COMPLETED|Overall Study||6
10422689|NCT00825175|11567767|FG000|STARTED|Overall Study||10
10422690|NCT00825175|11567768|FG001|STARTED|Overall Study||12
10422691|NCT00825175|11567767|FG000|COMPLETED|Overall Study||10
10422692|NCT00825175|11567768|FG001|COMPLETED|Overall Study||7
10422693|NCT00825175|11567767|FG000|NOT COMPLETED|Overall Study||0
10422694|NCT00825175|11567768|FG001|NOT COMPLETED|Overall Study||5
10422695|NCT00825266|11567776|FG000|STARTED|Overall Study||1
10422696|NCT00825266|11567777|FG001|STARTED|Overall Study||1
10422697|NCT00825266|11567776|FG000|COMPLETED|Overall Study||1
10422698|NCT00825266|11567777|FG001|COMPLETED|Overall Study||1
10422699|NCT00825266|11567776|FG000|NOT COMPLETED|Overall Study||0
10422700|NCT00825266|11567777|FG001|NOT COMPLETED|Overall Study||0
10422701|NCT00825305|11567785|FG000|STARTED|Overall Study||550
10422702|NCT00825305|11567786|FG001|STARTED|Overall Study||275
10422703|NCT00825305|11567785|FG000|COMPLETED|Overall Study||533
10422704|NCT00825305|11567786|FG001|COMPLETED|Overall Study||252
10422705|NCT00825305|11567785|FG000|NOT COMPLETED|Overall Study||17
10422706|NCT00825305|11567786|FG001|NOT COMPLETED|Overall Study||23
10422707|NCT00825318|11567792|FG000|STARTED|Overall Study||13
10422708|NCT00825318|11567792|FG000|COMPLETED|Overall Study||12
10422709|NCT00825318|11567792|FG000|NOT COMPLETED|Overall Study||1
10422710|NCT00825344|11567802|FG000|STARTED|Overall Study||34
10422711|NCT00825344|11567803|FG001|STARTED|Overall Study||43
10422712|NCT00825344|11567802|FG000|COMPLETED|Overall Study||33
10422713|NCT00825344|11567803|FG001|COMPLETED|Overall Study||42
10422714|NCT00825344|11567802|FG000|NOT COMPLETED|Overall Study||1
10422715|NCT00825344|11567803|FG001|NOT COMPLETED|Overall Study||1
10422716|NCT00825370|11567811|FG000|STARTED|Overall Study||175
10422717|NCT00825370|11567812|FG001|STARTED|Overall Study||175
10422718|NCT00825370|11567811|FG000|COMPLETED|Overall Study||175
10422719|NCT00825370|11567812|FG001|COMPLETED|Overall Study||175
10422720|NCT00825370|11567811|FG000|NOT COMPLETED|Overall Study||0
10422721|NCT00825370|11567812|FG001|NOT COMPLETED|Overall Study||0
10422722|NCT00825500|11567821|FG000|STARTED|Overall Study||125
10422723|NCT00825500|11567822|FG001|STARTED|Overall Study||121
10422724|NCT00825500|11567823|FG002|STARTED|Overall Study||120
10422725|NCT00825500|11567821|FG000|COMPLETED|Overall Study||125
10422726|NCT00825500|11567822|FG001|COMPLETED|Overall Study||121
10422727|NCT00825500|11567823|FG002|COMPLETED|Overall Study||120
10422728|NCT00825500|11567821|FG000|NOT COMPLETED|Overall Study||0
10422729|NCT00825500|11567822|FG001|NOT COMPLETED|Overall Study||0
10774654|NCT03307252|11936810|FG009|NOT COMPLETED|Part 3, Period 3||0
10774655|NCT03307252|11936811|FG010|NOT COMPLETED|Part 3, Period 3||0
10774656|NCT03307252|11936801|FG000|STARTED|Part 3, Washout Period 3 (7 Days)||0
10422730|NCT00825500|11567823|FG002|NOT COMPLETED|Overall Study||0
10422731|NCT00825565|11567831|FG000|STARTED|Overall Study||8
10422732|NCT00825565|11567831|FG000|COMPLETED|Overall Study||8
10422733|NCT00825565|11567831|FG000|NOT COMPLETED|Overall Study||0
10422734|NCT00825630|11567845|FG000|STARTED|Overall Study||29
10422735|NCT00825630|11567846|FG001|STARTED|Overall Study||62
10422736|NCT00825630|11567847|FG002|STARTED|Overall Study||19
10774657|NCT03307252|11936802|FG001|STARTED|Part 3, Washout Period 3 (7 Days)||0
10422737|NCT00825630|11567848|FG003|STARTED|Overall Study||13
10422738|NCT00825630|11567845|FG000|COMPLETED|Overall Study||29
10422739|NCT00825630|11567846|FG001|COMPLETED|Overall Study||62
10422740|NCT00825630|11567847|FG002|COMPLETED|Overall Study||19
10774658|NCT03307252|11936803|FG002|STARTED|Part 3, Washout Period 3 (7 Days)||0
10774659|NCT03307252|11936804|FG003|STARTED|Part 3, Washout Period 3 (7 Days)||0
10774660|NCT03307252|11936805|FG004|STARTED|Part 3, Washout Period 3 (7 Days)||0
10774661|NCT03307252|11936806|FG005|STARTED|Part 3, Washout Period 3 (7 Days)||0
10774662|NCT03307252|11936807|FG006|STARTED|Part 3, Washout Period 3 (7 Days)||0
10774663|NCT03307252|11936808|FG007|STARTED|Part 3, Washout Period 3 (7 Days)||4
10774664|NCT03307252|11936809|FG008|STARTED|Part 3, Washout Period 3 (7 Days)||4
10774665|NCT03307252|11936810|FG009|STARTED|Part 3, Washout Period 3 (7 Days)||4
10774666|NCT03307252|11936811|FG010|STARTED|Part 3, Washout Period 3 (7 Days)||4
10774667|NCT03307252|11936801|FG000|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
10774668|NCT03307252|11936802|FG001|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
10774669|NCT03307252|11936803|FG002|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
10774670|NCT03307252|11936804|FG003|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
10774671|NCT03307252|11936805|FG004|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
10774672|NCT03307252|11936806|FG005|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
10774673|NCT03307252|11936807|FG006|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
10774674|NCT03307252|11936808|FG007|COMPLETED|Part 3, Washout Period 3 (7 Days)||4
10774675|NCT03307252|11936809|FG008|COMPLETED|Part 3, Washout Period 3 (7 Days)||4
10774676|NCT03307252|11936810|FG009|COMPLETED|Part 3, Washout Period 3 (7 Days)||4
10774677|NCT03307252|11936811|FG010|COMPLETED|Part 3, Washout Period 3 (7 Days)||3
10774678|NCT03307252|11936801|FG000|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
10774679|NCT03307252|11936802|FG001|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
10774680|NCT03307252|11936803|FG002|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
10774681|NCT03307252|11936804|FG003|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
10774682|NCT03307252|11936805|FG004|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
10774683|NCT03307252|11936806|FG005|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
10774684|NCT03307252|11936807|FG006|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
10774685|NCT03307252|11936808|FG007|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
10774686|NCT03307252|11936809|FG008|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
10774687|NCT03307252|11936810|FG009|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
10774688|NCT03307252|11936811|FG010|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||1
10774689|NCT03307252|11936801|FG000|STARTED|Part 3, Period 4||0
10774690|NCT03307252|11936802|FG001|STARTED|Part 3, Period 4||0
10774691|NCT03307252|11936803|FG002|STARTED|Part 3, Period 4||0
10774692|NCT03307252|11936804|FG003|STARTED|Part 3, Period 4||0
10774693|NCT03307252|11936805|FG004|STARTED|Part 3, Period 4||0
10774694|NCT03307252|11936806|FG005|STARTED|Part 3, Period 4||0
10774695|NCT03307252|11936807|FG006|STARTED|Part 3, Period 4||0
10774696|NCT03307252|11936808|FG007|STARTED|Part 3, Period 4||4
10774697|NCT03307252|11936809|FG008|STARTED|Part 3, Period 4||4
10774698|NCT03307252|11936810|FG009|STARTED|Part 3, Period 4||4
10774699|NCT03307252|11936811|FG010|STARTED|Part 3, Period 4||3
10774700|NCT03307252|11936801|FG000|COMPLETED|Part 3, Period 4||0
10774701|NCT03307252|11936802|FG001|COMPLETED|Part 3, Period 4||0
10774702|NCT03307252|11936803|FG002|COMPLETED|Part 3, Period 4||0
10774703|NCT03307252|11936804|FG003|COMPLETED|Part 3, Period 4||0
10774704|NCT03307252|11936805|FG004|COMPLETED|Part 3, Period 4||0
10774705|NCT03307252|11936806|FG005|COMPLETED|Part 3, Period 4||0
10774706|NCT03307252|11936807|FG006|COMPLETED|Part 3, Period 4||0
10774707|NCT03307252|11936808|FG007|COMPLETED|Part 3, Period 4||4
10774708|NCT03307252|11936809|FG008|COMPLETED|Part 3, Period 4||4
10774709|NCT03307252|11936810|FG009|COMPLETED|Part 3, Period 4||4
10774710|NCT03307252|11936811|FG010|COMPLETED|Part 3, Period 4||3
10774711|NCT03307252|11936801|FG000|NOT COMPLETED|Part 3, Period 4||0
10774712|NCT03307252|11936802|FG001|NOT COMPLETED|Part 3, Period 4||0
10774713|NCT03307252|11936803|FG002|NOT COMPLETED|Part 3, Period 4||0
10774714|NCT03307252|11936804|FG003|NOT COMPLETED|Part 3, Period 4||0
10774715|NCT03307252|11936805|FG004|NOT COMPLETED|Part 3, Period 4||0
10774716|NCT03307252|11936806|FG005|NOT COMPLETED|Part 3, Period 4||0
10774717|NCT03307252|11936807|FG006|NOT COMPLETED|Part 3, Period 4||0
10774718|NCT03307252|11936808|FG007|NOT COMPLETED|Part 3, Period 4||0
10774719|NCT03307252|11936809|FG008|NOT COMPLETED|Part 3, Period 4||0
10774720|NCT03307252|11936810|FG009|NOT COMPLETED|Part 3, Period 4||0
10774721|NCT03307252|11936811|FG010|NOT COMPLETED|Part 3, Period 4||0
10774722|NCT03307837|11936833|FG000|STARTED|Overall Study||6
10774723|NCT03307837|11936834|FG001|STARTED|Overall Study||6
10774724|NCT03307837|11936835|FG002|STARTED|Overall Study||6
10774725|NCT03307837|11936836|FG003|STARTED|Overall Study||6
10774726|NCT03307837|11936837|FG004|STARTED|Overall Study||6
10774727|NCT03307837|11936838|FG005|STARTED|Overall Study||10
10774728|NCT03307837|11936833|FG000|COMPLETED|Overall Study||5
10774729|NCT03307837|11936834|FG001|COMPLETED|Overall Study||5
10774730|NCT03307837|11936835|FG002|COMPLETED|Overall Study||5
10774731|NCT03307837|11936836|FG003|COMPLETED|Overall Study||6
10774732|NCT03307837|11936837|FG004|COMPLETED|Overall Study||6
10774733|NCT03307837|11936838|FG005|COMPLETED|Overall Study||8
10774734|NCT03307837|11936833|FG000|NOT COMPLETED|Overall Study||1
10774735|NCT03307837|11936834|FG001|NOT COMPLETED|Overall Study||1
10774736|NCT03307837|11936835|FG002|NOT COMPLETED|Overall Study||1
10774737|NCT03307837|11936836|FG003|NOT COMPLETED|Overall Study||0
10774738|NCT03307837|11936837|FG004|NOT COMPLETED|Overall Study||0
10774739|NCT03307837|11936838|FG005|NOT COMPLETED|Overall Study||2
10774740|NCT03308058|11936859|FG000|STARTED|Overall Study||23
10774741|NCT03308058|11936860|FG001|STARTED|Overall Study||23
10774742|NCT03308058|11936859|FG000|COMPLETED|Overall Study||23
10774743|NCT03308058|11936860|FG001|COMPLETED|Overall Study||23
10774744|NCT03308058|11936859|FG000|NOT COMPLETED|Overall Study||0
10774745|NCT03308058|11936860|FG001|NOT COMPLETED|Overall Study||0
10774746|NCT03308097|11936868|FG000|STARTED|Overall Study||33
10774747|NCT03308097|11936869|FG001|STARTED|Overall Study||32
10774748|NCT03308097|11936868|FG000|COMPLETED|Overall Study||31
10774749|NCT03308097|11936869|FG001|COMPLETED|Overall Study||31
10774750|NCT03308097|11936868|FG000|NOT COMPLETED|Overall Study||2
10774751|NCT03308097|11936869|FG001|NOT COMPLETED|Overall Study||1
10774752|NCT03308669|11936877|FG000|STARTED|Overall Study||10
10774753|NCT03308669|11936878|FG001|STARTED|Overall Study||20
10774754|NCT03308669|11936877|FG000|Received at Least One Dose of Study Drug|Overall Study||10
10774755|NCT03308669|11936878|FG001|Received at Least One Dose of Study Drug|Overall Study||20
10774756|NCT03308669|11936877|FG000|COMPLETED|Overall Study||10
10774757|NCT03308669|11936878|FG001|COMPLETED|Overall Study||20
10774758|NCT03308669|11936877|FG000|NOT COMPLETED|Overall Study||0
10774759|NCT03308669|11936878|FG001|NOT COMPLETED|Overall Study||0
10774760|NCT03308799|11936899|FG000|STARTED|Overall Study||342
10774761|NCT03308799|11936900|FG001|STARTED|Overall Study||337
10774762|NCT03308799|11936901|FG002|STARTED|Overall Study||115
10774763|NCT03308799|11936899|FG000|COMPLETED|Overall Study||320
10774764|NCT03308799|11936900|FG001|COMPLETED|Overall Study||309
10774765|NCT03308799|11936901|FG002|COMPLETED|Overall Study||94
10774766|NCT03308799|11936899|FG000|NOT COMPLETED|Overall Study||22
10774767|NCT03308799|11936900|FG001|NOT COMPLETED|Overall Study||28
10774768|NCT03308799|11936901|FG002|NOT COMPLETED|Overall Study||21
10774799|NCT03308968|11936934|FG000|STARTED|Double-Blind Period (12 Weeks)||279
10774800|NCT03308968|11936935|FG001|STARTED|Double-Blind Period (12 Weeks)||276
10774801|NCT03308968|11936936|FG002|STARTED|Double-Blind Period (12 Weeks)||283
10774802|NCT03308968|11936934|FG000|DB Safety Analysis Set|Double-Blind Period (12 Weeks)|2 participants (1 with CM and 1 with EM) randomized to placebo but received Fremanezumab monthly.|277
10774803|NCT03308968|11936935|FG001|DB Safety Analysis Set|Double-Blind Period (12 Weeks)||276
10774804|NCT03308968|11936936|FG002|DB Safety Analysis Set|Double-Blind Period (12 Weeks)|2 participants (1 with CM and 1 with EM) randomized to placebo but received Fremanezumab monthly.|285
10300018|NCT00045942|11432870|FG007|STARTED|PKC412A2104E2||7
10774805|NCT03308968|11936934|FG000|DB Modified ITT (mITT) Analysis Set|Double-Blind Period (12 Weeks)||278
10774806|NCT03308968|11936935|FG001|DB Modified ITT (mITT) Analysis Set|Double-Blind Period (12 Weeks)||276
10774807|NCT03308968|11936936|FG002|DB Modified ITT (mITT) Analysis Set|Double-Blind Period (12 Weeks)||283
10774808|NCT03308968|11936934|FG000|COMPLETED|Double-Blind Period (12 Weeks)||264
10774809|NCT03308968|11936935|FG001|COMPLETED|Double-Blind Period (12 Weeks)||271
10774810|NCT03308968|11936936|FG002|COMPLETED|Double-Blind Period (12 Weeks)||272
10774811|NCT03308968|11936934|FG000|NOT COMPLETED|Double-Blind Period (12 Weeks)||15
10774812|NCT03308968|11936935|FG001|NOT COMPLETED|Double-Blind Period (12 Weeks)||5
10774813|NCT03308968|11936936|FG002|NOT COMPLETED|Double-Blind Period (12 Weeks)||11
10774814|NCT03308968|11936934|FG000|STARTED|Open-Label Period (12 Weeks)||264
10774815|NCT03308968|11936935|FG001|STARTED|Open-Label Period (12 Weeks)||271
10774816|NCT03308968|11936936|FG002|STARTED|Open-Label Period (12 Weeks)||272
10774817|NCT03308968|11936934|FG000|OL mITT Analysis Set|Open-Label Period (12 Weeks)||263
10774818|NCT03308968|11936935|FG001|OL mITT Analysis Set|Open-Label Period (12 Weeks)||271
10774819|NCT03308968|11936936|FG002|OL mITT Analysis Set|Open-Label Period (12 Weeks)||272
10774820|NCT03308968|11936934|FG000|COMPLETED|Open-Label Period (12 Weeks)||253
10774821|NCT03308968|11936935|FG001|COMPLETED|Open-Label Period (12 Weeks)||259
10774822|NCT03308968|11936936|FG002|COMPLETED|Open-Label Period (12 Weeks)||260
10774823|NCT03308968|11936934|FG000|NOT COMPLETED|Open-Label Period (12 Weeks)||11
10774824|NCT03308968|11936935|FG001|NOT COMPLETED|Open-Label Period (12 Weeks)||12
10774825|NCT03308968|11936936|FG002|NOT COMPLETED|Open-Label Period (12 Weeks)||12
10774826|NCT03309020|11936949|FG000|STARTED|Overall Study||12
10774827|NCT03309020|11936950|FG001|STARTED|Overall Study||25
10774828|NCT03309020|11936949|FG000|Underwent Cataract Surgery|Overall Study||10
10774829|NCT03309020|11936950|FG001|Underwent Cataract Surgery|Overall Study||24
10774830|NCT03309020|11936949|FG000|COMPLETED|Overall Study||9
10774831|NCT03309020|11936950|FG001|COMPLETED|Overall Study||24
10774832|NCT03309020|11936949|FG000|NOT COMPLETED|Overall Study||3
10774833|NCT03309020|11936950|FG001|NOT COMPLETED|Overall Study||1
10774834|NCT03309202|11936962|FG000|STARTED|Overall Study||6
10774835|NCT03309202|11936963|FG001|STARTED|Overall Study||6
10774836|NCT03309202|11936964|FG002|STARTED|Overall Study||6
10774837|NCT03309202|11936965|FG003|STARTED|Overall Study||6
10774838|NCT03309202|11936962|FG000|COMPLETED|Overall Study||5
10774839|NCT03309202|11936963|FG001|COMPLETED|Overall Study||6
10774840|NCT03309202|11936964|FG002|COMPLETED|Overall Study||6
10774841|NCT03309202|11936965|FG003|COMPLETED|Overall Study||6
10774842|NCT03309202|11936962|FG000|NOT COMPLETED|Overall Study||1
10774843|NCT03309202|11936963|FG001|NOT COMPLETED|Overall Study||0
10774844|NCT03309202|11936964|FG002|NOT COMPLETED|Overall Study||0
10774845|NCT03309202|11936965|FG003|NOT COMPLETED|Overall Study||0
10774846|NCT03309449|11936978|FG000|STARTED|Overall Study||46
10774847|NCT03309449|11936979|FG001|STARTED|Overall Study||46
10774848|NCT03309449|11936980|FG002|STARTED|Overall Study||46
10774849|NCT03309449|11936978|FG000|COMPLETED|Overall Study||46
10774850|NCT03309449|11936979|FG001|COMPLETED|Overall Study||46
10774851|NCT03309449|11936980|FG002|COMPLETED|Overall Study||46
10774852|NCT03309449|11936978|FG000|NOT COMPLETED|Overall Study||0
10774853|NCT03309449|11936979|FG001|NOT COMPLETED|Overall Study||0
10774854|NCT03309449|11936980|FG002|NOT COMPLETED|Overall Study||0
10774855|NCT03309605|11936996|FG000|STARTED|Overall Study||6
10774856|NCT03309605|11936997|FG001|STARTED|Overall Study||5
10774857|NCT03309605|11936998|FG002|STARTED|Overall Study||6
10774858|NCT03309605|11936999|FG003|STARTED|Overall Study||6
10774859|NCT03309605|11937000|FG004|STARTED|Overall Study||6
10774860|NCT03309605|11937001|FG005|STARTED|Overall Study||6
10774861|NCT03309605|11937002|FG006|STARTED|Overall Study||6
10774862|NCT03309605|11937003|FG007|STARTED|Overall Study||21
10774863|NCT03309605|11936996|FG000|COMPLETED|Overall Study||6
10774864|NCT03309605|11936997|FG001|COMPLETED|Overall Study||5
10774865|NCT03309605|11936998|FG002|COMPLETED|Overall Study||6
10774866|NCT03309605|11936999|FG003|COMPLETED|Overall Study||5
10774867|NCT03309605|11937000|FG004|COMPLETED|Overall Study||5
10774868|NCT03309605|11937001|FG005|COMPLETED|Overall Study||6
10774869|NCT03309605|11937002|FG006|COMPLETED|Overall Study||3
10774870|NCT03309605|11937003|FG007|COMPLETED|Overall Study||19
10774871|NCT03309605|11936996|FG000|NOT COMPLETED|Overall Study||0
10774872|NCT03309605|11936997|FG001|NOT COMPLETED|Overall Study||0
10774873|NCT03309605|11936998|FG002|NOT COMPLETED|Overall Study||0
10774874|NCT03309605|11936999|FG003|NOT COMPLETED|Overall Study||1
10774875|NCT03309605|11937000|FG004|NOT COMPLETED|Overall Study||1
10774876|NCT03309605|11937001|FG005|NOT COMPLETED|Overall Study||0
10774877|NCT03309605|11937002|FG006|NOT COMPLETED|Overall Study||3
10774878|NCT03309605|11937003|FG007|NOT COMPLETED|Overall Study||2
10774879|NCT03309657|11937017|FG000|STARTED|Overall Study||10
10774880|NCT03309657|11937017|FG000|COMPLETED|Overall Study||10
10774881|NCT03309657|11937017|FG000|NOT COMPLETED|Overall Study||0
10774882|NCT03309696|11937023|FG000|STARTED|Overall Study|All five subjects in this arm were randomize to all sham and active tDCS and rTMS interventions.|5
10774883|NCT03309696|11937024|FG001|STARTED|Overall Study|All five subjects in this arm were randomize to all sham and active tDCS and rTMS interventions.|5
10774884|NCT03309696|11937025|FG002|STARTED|Overall Study||0
10774885|NCT03309696|11937026|FG003|STARTED|Overall Study||0
10774886|NCT03309696|11937023|FG000|COMPLETED|Overall Study||5
10774887|NCT03309696|11937024|FG001|COMPLETED|Overall Study||0
10774888|NCT03309696|11937025|FG002|COMPLETED|Overall Study||0
10774889|NCT03309696|11937026|FG003|COMPLETED|Overall Study||0
10774890|NCT03309696|11937023|FG000|NOT COMPLETED|Overall Study||0
10774891|NCT03309696|11937024|FG001|NOT COMPLETED|Overall Study||5
10774892|NCT03309696|11937025|FG002|NOT COMPLETED|Overall Study||0
10774893|NCT03309696|11937026|FG003|NOT COMPLETED|Overall Study||0
10774894|NCT03309787|11937037|FG000|STARTED|Overall Study||8
10774895|NCT03309787|11937038|FG001|STARTED|Overall Study||20
10774896|NCT03309787|11937039|FG002|STARTED|Overall Study||9
10774897|NCT03309787|11937037|FG000|COMPLETED|Overall Study||6
10774898|NCT03309787|11937038|FG001|COMPLETED|Overall Study||14
10774899|NCT03309787|11937039|FG002|COMPLETED|Overall Study||7
10774900|NCT03309787|11937037|FG000|NOT COMPLETED|Overall Study||2
10774901|NCT03309787|11937038|FG001|NOT COMPLETED|Overall Study||6
10774902|NCT03309787|11937039|FG002|NOT COMPLETED|Overall Study||2
10774903|NCT03309943|11937055|FG000|STARTED|Overall Study||22
10774904|NCT03309943|11937056|FG001|STARTED|Overall Study||22
10774905|NCT03309943|11937055|FG000|COMPLETED|Overall Study||22
10774906|NCT03309943|11937056|FG001|COMPLETED|Overall Study||20
10300019|NCT00045942|11432871|FG008|STARTED|PKC412A2104E2||6
10300020|NCT00045942|11432863|FG000|Primary Efficacy|PKC412A2104E2||0
10300021|NCT00045942|11432864|FG001|Primary Efficacy|PKC412A2104E2||0
10300022|NCT00045942|11432865|FG002|Primary Efficacy|PKC412A2104E2||0
10300023|NCT00045942|11432866|FG003|Primary Efficacy|PKC412A2104E2||0
10300024|NCT00045942|11432867|FG004|Primary Efficacy|PKC412A2104E2||0
10300025|NCT00045942|11432868|FG005|Primary Efficacy|PKC412A2104E2||9
10300026|NCT00045942|11432869|FG006|Primary Efficacy|PKC412A2104E2||7
10300027|NCT00045942|11432870|FG007|Primary Efficacy|PKC412A2104E2||7
10300028|NCT00045942|11432871|FG008|Primary Efficacy|PKC412A2104E2||6
10300029|NCT00045942|11432863|FG000|COMPLETED|PKC412A2104E2||0
10300030|NCT00045942|11432864|FG001|COMPLETED|PKC412A2104E2||0
10300031|NCT00045942|11432865|FG002|COMPLETED|PKC412A2104E2||0
10300032|NCT00045942|11432866|FG003|COMPLETED|PKC412A2104E2||0
10300033|NCT00045942|11432867|FG004|COMPLETED|PKC412A2104E2||0
10300034|NCT00045942|11432868|FG005|COMPLETED|PKC412A2104E2||0
10300035|NCT00045942|11432869|FG006|COMPLETED|PKC412A2104E2||0
10300036|NCT00045942|11432870|FG007|COMPLETED|PKC412A2104E2||0
10300037|NCT00045942|11432871|FG008|COMPLETED|PKC412A2104E2||0
10300038|NCT00045942|11432863|FG000|NOT COMPLETED|PKC412A2104E2||0
10300039|NCT00045942|11432864|FG001|NOT COMPLETED|PKC412A2104E2||0
10300040|NCT00045942|11432865|FG002|NOT COMPLETED|PKC412A2104E2||0
10300041|NCT00045942|11432866|FG003|NOT COMPLETED|PKC412A2104E2||0
10300042|NCT00045942|11432867|FG004|NOT COMPLETED|PKC412A2104E2||0
10300043|NCT00045942|11432868|FG005|NOT COMPLETED|PKC412A2104E2||9
10300044|NCT00045942|11432869|FG006|NOT COMPLETED|PKC412A2104E2||7
10300045|NCT00045942|11432870|FG007|NOT COMPLETED|PKC412A2104E2||7
10300046|NCT00045942|11432871|FG008|NOT COMPLETED|PKC412A2104E2||6
10300047|NCT00046228|11432898|FG000|STARTED|90 Days||806
10300048|NCT00046228|11432899|FG001|STARTED|90 Days||818
10300049|NCT00046228|11432900|FG002|STARTED|90 Days||828
10300050|NCT00046228|11432898|FG000|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|793
10300051|NCT00046228|11432899|FG001|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|810
10300052|NCT00046228|11432900|FG002|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|813
10300053|NCT00046228|11432898|FG000|NOT COMPLETED|90 Days||13
10300054|NCT00046228|11432899|FG001|NOT COMPLETED|90 Days||8
10300055|NCT00046228|11432900|FG002|NOT COMPLETED|90 Days||15
10300056|NCT00046228|11432898|FG000|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|806
10300057|NCT00046228|11432899|FG001|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|818
10300058|NCT00046228|11432900|FG002|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|828
10300059|NCT00046228|11432898|FG000|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window.|787
10300060|NCT00046228|11432899|FG001|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window.|804
10300061|NCT00046228|11432900|FG002|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window|816
10300062|NCT00046228|11432898|FG000|NOT COMPLETED|1 Year||19
10300063|NCT00046228|11432899|FG001|NOT COMPLETED|1 Year||14
10300064|NCT00046228|11432900|FG002|NOT COMPLETED|1 Year||12
10300065|NCT00046475|11432910|FG000|STARTED|Screening/Washout Period (Up to 2 Weeks)||140
10300066|NCT00046475|11432911|FG001|STARTED|Screening/Washout Period (Up to 2 Weeks)||0
10300067|NCT00046475|11432912|FG002|STARTED|Screening/Washout Period (Up to 2 Weeks)||0
10300068|NCT00046475|11432910|FG000|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||136
10300069|NCT00046475|11432911|FG001|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
10300070|NCT00046475|11432912|FG002|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
10300071|NCT00046475|11432910|FG000|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||4
10300072|NCT00046475|11432911|FG001|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
10300073|NCT00046475|11432912|FG002|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
10300074|NCT00046475|11432910|FG000|STARTED|Titration (1 Week)||136
10300075|NCT00046475|11432911|FG001|STARTED|Titration (1 Week)||0
10300076|NCT00046475|11432912|FG002|STARTED|Titration (1 Week)||0
10300077|NCT00046475|11432910|FG000|COMPLETED|Titration (1 Week)||136
10300078|NCT00046475|11432911|FG001|COMPLETED|Titration (1 Week)||0
10300079|NCT00046475|11432912|FG002|COMPLETED|Titration (1 Week)||0
10300080|NCT00046475|11432910|FG000|NOT COMPLETED|Titration (1 Week)||0
10300081|NCT00046475|11432911|FG001|NOT COMPLETED|Titration (1 Week)||0
10300082|NCT00046475|11432912|FG002|NOT COMPLETED|Titration (1 Week)||0
10300083|NCT00046475|11432910|FG000|STARTED|Treatment Period 1 (Up to 2 Weeks)||0
10300084|NCT00046475|11432911|FG001|STARTED|Treatment Period 1 (Up to 2 Weeks)|Patients did not meet the criteria for randomization, had an AE, or withdrew from the study.|45
10300085|NCT00046475|11432912|FG002|STARTED|Treatment Period 1 (Up to 2 Weeks)|Patients did not meet the criteria for randomization, had an AE, or withdrew from the study.|60
10300086|NCT00046475|11432910|FG000|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
10300087|NCT00046475|11432911|FG001|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||45
10300088|NCT00046475|11432912|FG002|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||59
10300089|NCT00046475|11432910|FG000|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
10300090|NCT00046475|11432911|FG001|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
10300091|NCT00046475|11432912|FG002|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||1
10300092|NCT00046475|11432910|FG000|STARTED|Treatment Period 2 (Up to 2 Weeks)||0
10300093|NCT00046475|11432911|FG001|STARTED|Treatment Period 2 (Up to 2 Weeks)||45
10422741|NCT00825630|11567848|FG003|COMPLETED|Overall Study||13
10300094|NCT00046475|11432912|FG002|STARTED|Treatment Period 2 (Up to 2 Weeks)||59
10300095|NCT00046475|11432910|FG000|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
10300096|NCT00046475|11432911|FG001|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||44
10300097|NCT00046475|11432912|FG002|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||59
10300098|NCT00046475|11432910|FG000|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
10300099|NCT00046475|11432911|FG001|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||1
10300100|NCT00046475|11432912|FG002|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
10300101|NCT00046566|11432925|FG000|STARTED|Intervention 1 (8 Weeks)|Soy protein 8 weeks|117
10300102|NCT00046566|11432926|FG001|STARTED|Intervention 1 (8 Weeks)|Milk protein 8 weeks|117
10300103|NCT00046566|11432927|FG002|STARTED|Intervention 1 (8 Weeks)|Carbohydrate 8 weeks|118
10300104|NCT00046566|11432925|FG000|COMPLETED|Intervention 1 (8 Weeks)||101
10300105|NCT00046566|11432926|FG001|COMPLETED|Intervention 1 (8 Weeks)||104
10300106|NCT00046566|11432927|FG002|COMPLETED|Intervention 1 (8 Weeks)||101
10300107|NCT00046566|11432925|FG000|NOT COMPLETED|Intervention 1 (8 Weeks)||16
10300108|NCT00046566|11432926|FG001|NOT COMPLETED|Intervention 1 (8 Weeks)||13
10300109|NCT00046566|11432927|FG002|NOT COMPLETED|Intervention 1 (8 Weeks)||17
10300110|NCT00046566|11432925|FG000|STARTED|Intervention 2 (8 Weeks)|Milk protein 8 weeks|101
10300111|NCT00046566|11432926|FG001|STARTED|Intervention 2 (8 Weeks)|Carbohydrate 8 weeks|104
10300112|NCT00046566|11432927|FG002|STARTED|Intervention 2 (8 Weeks)|Soy protein 8 weeks|101
10300113|NCT00046566|11432925|FG000|COMPLETED|Intervention 2 (8 Weeks)||93
10300114|NCT00046566|11432926|FG001|COMPLETED|Intervention 2 (8 Weeks)||92
10300115|NCT00046566|11432927|FG002|COMPLETED|Intervention 2 (8 Weeks)||88
10300116|NCT00046566|11432925|FG000|NOT COMPLETED|Intervention 2 (8 Weeks)||8
10300117|NCT00046566|11432926|FG001|NOT COMPLETED|Intervention 2 (8 Weeks)||12
10300118|NCT00046566|11432927|FG002|NOT COMPLETED|Intervention 2 (8 Weeks)||13
10300119|NCT00046566|11432925|FG000|STARTED|Intervention 3 (8 Weeks)||93
10300120|NCT00046566|11432926|FG001|STARTED|Intervention 3 (8 Weeks)||92
10300121|NCT00046566|11432927|FG002|STARTED|Intervention 3 (8 Weeks)||88
10300122|NCT00046566|11432925|FG000|COMPLETED|Intervention 3 (8 Weeks)||93
10300123|NCT00046566|11432926|FG001|COMPLETED|Intervention 3 (8 Weeks)||92
10300124|NCT00046566|11432927|FG002|COMPLETED|Intervention 3 (8 Weeks)||88
10422742|NCT00825630|11567845|FG000|NOT COMPLETED|Overall Study||0
10422743|NCT00825630|11567846|FG001|NOT COMPLETED|Overall Study||0
10422744|NCT00825630|11567847|FG002|NOT COMPLETED|Overall Study||0
10422745|NCT00825630|11567848|FG003|NOT COMPLETED|Overall Study||0
10422746|NCT00825682|11567860|FG000|STARTED|Overall Study||47
10422747|NCT00825682|11567861|FG001|STARTED|Overall Study||25
10422748|NCT00825682|11567860|FG000|COMPLETED|Overall Study||34
10422749|NCT00825682|11567861|FG001|COMPLETED|Overall Study||20
10422750|NCT00825682|11567860|FG000|NOT COMPLETED|Overall Study||13
10422751|NCT00825682|11567861|FG001|NOT COMPLETED|Overall Study||5
10422752|NCT00825734|11567868|FG000|STARTED|Phase I||4
10422753|NCT00825734|11567869|FG001|STARTED|Phase I||3
10422754|NCT00825734|11567870|FG002|STARTED|Phase I||3
10422755|NCT00825734|11567868|FG000|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
10422756|NCT00825734|11567869|FG001|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
10422757|NCT00825734|11567870|FG002|COMPLETED|Phase I||3
10422758|NCT00825734|11567868|FG000|NOT COMPLETED|Phase I||4
10422759|NCT00825734|11567869|FG001|NOT COMPLETED|Phase I||3
10422760|NCT00825734|11567870|FG002|NOT COMPLETED|Phase I||0
10422761|NCT00825734|11567868|FG000|STARTED|Phase II||0
10422762|NCT00825734|11567869|FG001|STARTED|Phase II||0
10422763|NCT00825734|11567870|FG002|STARTED|Phase II|Includes patients treated at MTD during Phase I and 73 additional patients enrolled for Phase II|76
10422764|NCT00825734|11567868|FG000|COMPLETED|Phase II||0
10422765|NCT00825734|11567869|FG001|COMPLETED|Phase II||0
10422766|NCT00825734|11567870|FG002|COMPLETED|Phase II||0
10422767|NCT00825734|11567868|FG000|NOT COMPLETED|Phase II||0
10422768|NCT00825734|11567869|FG001|NOT COMPLETED|Phase II||0
10422769|NCT00825734|11567870|FG002|NOT COMPLETED|Phase II||76
10422770|NCT00825786|11567877|FG000|STARTED|Overall Study||52
10422771|NCT00825786|11567878|FG001|STARTED|Overall Study||51
10422772|NCT00825786|11567877|FG000|COMPLETED|Overall Study||52
10422773|NCT00825786|11567878|FG001|COMPLETED|Overall Study||51
10422774|NCT00825786|11567877|FG000|NOT COMPLETED|Overall Study||0
10422775|NCT00825786|11567878|FG001|NOT COMPLETED|Overall Study||0
10422776|NCT00825812|11567888|FG000|STARTED|Overall Study||29
10422777|NCT00825812|11567889|FG001|STARTED|Overall Study||32
10422778|NCT00825812|11567890|FG002|STARTED|Overall Study||126
10422779|NCT00825812|11567891|FG003|STARTED|Overall Study||121
10422780|NCT00825812|11567888|FG000|TREATED|Overall Study||29
10422781|NCT00825812|11567889|FG001|TREATED|Overall Study||31
10422782|NCT00825812|11567890|FG002|TREATED|Overall Study||120
10422783|NCT00825812|11567891|FG003|TREATED|Overall Study||111
10422784|NCT00825812|11567888|FG000|COMPLETED|Overall Study||29
10422785|NCT00825812|11567889|FG001|COMPLETED|Overall Study||31
10422786|NCT00825812|11567890|FG002|COMPLETED|Overall Study||120
10422787|NCT00825812|11567891|FG003|COMPLETED|Overall Study||111
10422788|NCT00825812|11567888|FG000|NOT COMPLETED|Overall Study||0
10422789|NCT00825812|11567889|FG001|NOT COMPLETED|Overall Study||1
10422790|NCT00825812|11567890|FG002|NOT COMPLETED|Overall Study||6
10422791|NCT00825812|11567891|FG003|NOT COMPLETED|Overall Study||10
10422792|NCT00825825|11567901|FG000|STARTED|First Medication Period (14 Days)||6
10422793|NCT00825825|11567902|FG001|STARTED|First Medication Period (14 Days)||4
10422794|NCT00825825|11567903|FG002|STARTED|First Medication Period (14 Days)||3
10422795|NCT00825825|11567904|FG003|STARTED|First Medication Period (14 Days)||5
10300125|NCT00046566|11432925|FG000|NOT COMPLETED|Intervention 3 (8 Weeks)||0
10300126|NCT00046566|11432926|FG001|NOT COMPLETED|Intervention 3 (8 Weeks)||0
10300127|NCT00046566|11432927|FG002|NOT COMPLETED|Intervention 3 (8 Weeks)||0
10300128|NCT00046839|11432938|FG000|STARTED|Overall Study||8
10300129|NCT00046839|11432939|FG001|STARTED|Overall Study||13
10300130|NCT00046839|11432938|FG000|COMPLETED|Overall Study|Subjects contributing data to either primary analysis are considered to have completed the study.|7
10300131|NCT00046839|11432939|FG001|COMPLETED|Overall Study|Subjects contributing data to either primary analysis are considered to have completed the study.|11
10300132|NCT00046839|11432938|FG000|NOT COMPLETED|Overall Study||1
10300133|NCT00046839|11432939|FG001|NOT COMPLETED|Overall Study||2
10300134|NCT00046891|11432948|FG000|STARTED|Overall Study||113
10300135|NCT00046891|11432949|FG001|STARTED|Overall Study||113
10300136|NCT00046891|11432948|FG000|COMPLETED|Overall Study||84
10300137|NCT00046891|11432949|FG001|COMPLETED|Overall Study||83
10300138|NCT00046891|11432948|FG000|NOT COMPLETED|Overall Study||29
10300139|NCT00046891|11432949|FG001|NOT COMPLETED|Overall Study||30
10300140|NCT00046930|11432965|FG000|STARTED|Overall Study||224
10300141|NCT00046930|11432966|FG001|STARTED|Overall Study||225
10300142|NCT00046930|11432965|FG000|COMPLETED|Overall Study||212
10300143|NCT00046930|11432966|FG001|COMPLETED|Overall Study||221
10300144|NCT00046930|11432965|FG000|NOT COMPLETED|Overall Study||12
10300145|NCT00046930|11432966|FG001|NOT COMPLETED|Overall Study||4
10300146|NCT00047060|11432975|FG000|STARTED|Overall Study||5
10300147|NCT00047060|11432975|FG000|COMPLETED|Overall Study||3
10300148|NCT00047060|11432975|FG000|NOT COMPLETED|Overall Study||2
10300149|NCT00047320|11432979|FG000|STARTED|Overall Study||104
10300150|NCT00047320|11432979|FG000|COMPLETED|Overall Study||76
10300151|NCT00047320|11432979|FG000|NOT COMPLETED|Overall Study||28
10300152|NCT00047385|11432985|FG000|STARTED|Overall Study||26722
10300153|NCT00047385|11432986|FG001|STARTED|Overall Study||26732
10300154|NCT00047385|11432985|FG000|COMPLETED|Overall Study|Had at least one screening exam.|26455
10300155|NCT00047385|11432986|FG001|COMPLETED|Overall Study||26232
10300156|NCT00047385|11432985|FG000|NOT COMPLETED|Overall Study||267
10300157|NCT00047385|11432986|FG001|NOT COMPLETED|Overall Study||500
10300158|NCT00047463|11432994|FG000|STARTED|Overall Study||13
10300159|NCT00047463|11432995|FG001|STARTED|Overall Study||22
10300160|NCT00047463|11432994|FG000|COMPLETED|Overall Study||13
10300161|NCT00047463|11432995|FG001|COMPLETED|Overall Study||19
10300162|NCT00047463|11432994|FG000|NOT COMPLETED|Overall Study||0
10300163|NCT00047463|11432995|FG001|NOT COMPLETED|Overall Study||3
10300164|NCT00047619|11433006|FG000|STARTED|Overall Study||14
10300165|NCT00047619|11433007|FG001|STARTED|Overall Study||14
10300166|NCT00047619|11433006|FG000|COMPLETED|Overall Study||14
10300167|NCT00047619|11433007|FG001|COMPLETED|Overall Study||14
10300168|NCT00047619|11433006|FG000|NOT COMPLETED|Overall Study||0
10300169|NCT00047619|11433007|FG001|NOT COMPLETED|Overall Study||0
10300170|NCT00047697|11433015|FG000|STARTED|Overall Study||18
10300171|NCT00047697|11433016|FG001|STARTED|Overall Study||16
10300172|NCT00047697|11433015|FG000|COMPLETED|Overall Study||18
10300173|NCT00047697|11433016|FG001|COMPLETED|Overall Study||14
10422796|NCT00825825|11567905|FG004|STARTED|First Medication Period (14 Days)||4
10422797|NCT00825825|11567906|FG005|STARTED|First Medication Period (14 Days)||5
10422798|NCT00825825|11567901|FG000|COMPLETED|First Medication Period (14 Days)||3
10422799|NCT00825825|11567902|FG001|COMPLETED|First Medication Period (14 Days)||4
10422800|NCT00825825|11567903|FG002|COMPLETED|First Medication Period (14 Days)||2
10422801|NCT00825825|11567904|FG003|COMPLETED|First Medication Period (14 Days)||5
10422802|NCT00825825|11567905|FG004|COMPLETED|First Medication Period (14 Days)||4
10422803|NCT00825825|11567906|FG005|COMPLETED|First Medication Period (14 Days)||3
10422804|NCT00825825|11567901|FG000|NOT COMPLETED|First Medication Period (14 Days)||3
10422805|NCT00825825|11567902|FG001|NOT COMPLETED|First Medication Period (14 Days)||0
10422806|NCT00825825|11567903|FG002|NOT COMPLETED|First Medication Period (14 Days)||1
10422807|NCT00825825|11567904|FG003|NOT COMPLETED|First Medication Period (14 Days)||0
10422808|NCT00825825|11567905|FG004|NOT COMPLETED|First Medication Period (14 Days)||0
10422809|NCT00825825|11567906|FG005|NOT COMPLETED|First Medication Period (14 Days)||2
10422810|NCT00825825|11567901|FG000|STARTED|First Washout Period (14 Days)||3
10422811|NCT00825825|11567902|FG001|STARTED|First Washout Period (14 Days)||4
10422812|NCT00825825|11567903|FG002|STARTED|First Washout Period (14 Days)||2
10422813|NCT00825825|11567904|FG003|STARTED|First Washout Period (14 Days)||5
10422814|NCT00825825|11567905|FG004|STARTED|First Washout Period (14 Days)||4
10422815|NCT00825825|11567906|FG005|STARTED|First Washout Period (14 Days)||3
10422816|NCT00825825|11567901|FG000|COMPLETED|First Washout Period (14 Days)||3
10422817|NCT00825825|11567902|FG001|COMPLETED|First Washout Period (14 Days)||4
10422818|NCT00825825|11567903|FG002|COMPLETED|First Washout Period (14 Days)||2
10422819|NCT00825825|11567904|FG003|COMPLETED|First Washout Period (14 Days)||5
10422820|NCT00825825|11567905|FG004|COMPLETED|First Washout Period (14 Days)||4
10422821|NCT00825825|11567906|FG005|COMPLETED|First Washout Period (14 Days)||3
10422822|NCT00825825|11567901|FG000|NOT COMPLETED|First Washout Period (14 Days)||0
10422823|NCT00825825|11567902|FG001|NOT COMPLETED|First Washout Period (14 Days)||0
10422824|NCT00825825|11567903|FG002|NOT COMPLETED|First Washout Period (14 Days)||0
10422825|NCT00825825|11567904|FG003|NOT COMPLETED|First Washout Period (14 Days)||0
10300174|NCT00047697|11433015|FG000|NOT COMPLETED|Overall Study||0
10300175|NCT00047697|11433016|FG001|NOT COMPLETED|Overall Study||2
10300176|NCT00047879|11433025|FG000|STARTED|Overall Study||4
10300177|NCT00047879|11433026|FG001|STARTED|Overall Study||3
10300178|NCT00047879|11433025|FG000|COMPLETED|Overall Study||0
10300179|NCT00047879|11433026|FG001|COMPLETED|Overall Study||0
10300180|NCT00047879|11433025|FG000|NOT COMPLETED|Overall Study||4
10300181|NCT00047879|11433026|FG001|NOT COMPLETED|Overall Study||3
10300182|NCT00048035|11433038|FG000|STARTED|Core Period||15
10300183|NCT00048035|11433039|FG001|STARTED|Core Period||15
10300184|NCT00048035|11433040|FG002|STARTED|Core Period||15
10300185|NCT00048035|11433041|FG003|STARTED|Core Period||15
10300186|NCT00048035|11433042|FG004|STARTED|Core Period||16
10300187|NCT00048035|11433043|FG005|STARTED|Core Period||15
10300188|NCT00048035|11433044|FG006|STARTED|Core Period||0
10300189|NCT00048035|11433045|FG007|STARTED|Core Period||0
10300190|NCT00048035|11433038|FG000|COMPLETED|Core Period||11
10300191|NCT00048035|11433039|FG001|COMPLETED|Core Period||13
10300192|NCT00048035|11433040|FG002|COMPLETED|Core Period||14
10300193|NCT00048035|11433041|FG003|COMPLETED|Core Period||14
10300194|NCT00048035|11433042|FG004|COMPLETED|Core Period||15
10300195|NCT00048035|11433043|FG005|COMPLETED|Core Period||14
10300196|NCT00048035|11433044|FG006|COMPLETED|Core Period||0
10300197|NCT00048035|11433045|FG007|COMPLETED|Core Period||0
10300198|NCT00048035|11433038|FG000|NOT COMPLETED|Core Period||4
10300199|NCT00048035|11433039|FG001|NOT COMPLETED|Core Period||2
10300200|NCT00048035|11433040|FG002|NOT COMPLETED|Core Period||1
10300201|NCT00048035|11433041|FG003|NOT COMPLETED|Core Period||1
10300202|NCT00048035|11433042|FG004|NOT COMPLETED|Core Period||1
10300203|NCT00048035|11433043|FG005|NOT COMPLETED|Core Period||1
10300204|NCT00048035|11433044|FG006|NOT COMPLETED|Core Period||0
10300205|NCT00048035|11433045|FG007|NOT COMPLETED|Core Period||0
10300206|NCT00048035|11433038|FG000|STARTED|Extension Year 1||0
10300207|NCT00048035|11433039|FG001|STARTED|Extension Year 1||0
10300208|NCT00048035|11433040|FG002|STARTED|Extension Year 1||0
10300209|NCT00048035|11433041|FG003|STARTED|Extension Year 1||0
10300210|NCT00048035|11433042|FG004|STARTED|Extension Year 1||0
10300211|NCT00048035|11433043|FG005|STARTED|Extension Year 1||0
10300212|NCT00048035|11433044|FG006|STARTED|Extension Year 1|Participants (Cohorts 1, 3, and 5) who completed core, entered extension period (entry optional).|27
10300213|NCT00048035|11433045|FG007|STARTED|Extension Year 1|Participants (Cohorts 2, 4 and 6) who completed core, entered extension period (entry optional).|26
10300214|NCT00048035|11433038|FG000|COMPLETED|Extension Year 1||0
10300215|NCT00048035|11433039|FG001|COMPLETED|Extension Year 1||0
10300216|NCT00048035|11433040|FG002|COMPLETED|Extension Year 1||0
10300217|NCT00048035|11433041|FG003|COMPLETED|Extension Year 1||0
10300218|NCT00048035|11433042|FG004|COMPLETED|Extension Year 1||0
10300219|NCT00048035|11433043|FG005|COMPLETED|Extension Year 1||0
10300220|NCT00048035|11433044|FG006|COMPLETED|Extension Year 1||16
10300221|NCT00048035|11433045|FG007|COMPLETED|Extension Year 1||15
10300222|NCT00048035|11433038|FG000|NOT COMPLETED|Extension Year 1||0
10300223|NCT00048035|11433039|FG001|NOT COMPLETED|Extension Year 1||0
10300224|NCT00048035|11433040|FG002|NOT COMPLETED|Extension Year 1||0
10300225|NCT00048035|11433041|FG003|NOT COMPLETED|Extension Year 1||0
10300226|NCT00048035|11433042|FG004|NOT COMPLETED|Extension Year 1||0
10300227|NCT00048035|11433043|FG005|NOT COMPLETED|Extension Year 1||0
10300228|NCT00048035|11433044|FG006|NOT COMPLETED|Extension Year 1||11
10300229|NCT00048035|11433045|FG007|NOT COMPLETED|Extension Year 1||11
10300230|NCT00048035|11433038|FG000|STARTED|Extension Year 2||0
10300231|NCT00048035|11433039|FG001|STARTED|Extension Year 2||0
10300232|NCT00048035|11433040|FG002|STARTED|Extension Year 2||0
10300233|NCT00048035|11433041|FG003|STARTED|Extension Year 2||0
10300234|NCT00048035|11433042|FG004|STARTED|Extension Year 2||0
10300235|NCT00048035|11433043|FG005|STARTED|Extension Year 2||0
10300236|NCT00048035|11433044|FG006|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
10300237|NCT00048035|11433045|FG007|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|13
10300238|NCT00048035|11433038|FG000|COMPLETED|Extension Year 2||0
10300239|NCT00048035|11433039|FG001|COMPLETED|Extension Year 2||0
10300240|NCT00048035|11433040|FG002|COMPLETED|Extension Year 2||0
10300241|NCT00048035|11433041|FG003|COMPLETED|Extension Year 2||0
10300242|NCT00048035|11433042|FG004|COMPLETED|Extension Year 2||0
10300243|NCT00048035|11433043|FG005|COMPLETED|Extension Year 2||0
10300244|NCT00048035|11433044|FG006|COMPLETED|Extension Year 2||11
10300245|NCT00048035|11433045|FG007|COMPLETED|Extension Year 2||10
10300246|NCT00048035|11433038|FG000|NOT COMPLETED|Extension Year 2||0
10300247|NCT00048035|11433039|FG001|NOT COMPLETED|Extension Year 2||0
10300248|NCT00048035|11433040|FG002|NOT COMPLETED|Extension Year 2||0
10300249|NCT00048035|11433041|FG003|NOT COMPLETED|Extension Year 2||0
10300250|NCT00048035|11433042|FG004|NOT COMPLETED|Extension Year 2||0
10300251|NCT00048035|11433043|FG005|NOT COMPLETED|Extension Year 2||0
10300252|NCT00048035|11433044|FG006|NOT COMPLETED|Extension Year 2||3
10300253|NCT00048035|11433045|FG007|NOT COMPLETED|Extension Year 2||3
10300254|NCT00048048|11433069|FG000|STARTED|Core Treatment||6
10300255|NCT00048048|11433070|FG001|STARTED|Core Treatment||6
10300256|NCT00048048|11433071|FG002|STARTED|Core Treatment||10
10300257|NCT00048048|11433072|FG003|STARTED|Core Treatment||6
10300258|NCT00048048|11433073|FG004|STARTED|Core Treatment||6
10300259|NCT00048048|11433074|FG005|STARTED|Core Treatment||9
10300260|NCT00048048|11433075|FG006|STARTED|Core Treatment||6
10300261|NCT00048048|11433076|FG007|STARTED|Core Treatment||6
10300262|NCT00048048|11433077|FG008|STARTED|Core Treatment||10
10300263|NCT00048048|11433078|FG009|STARTED|Core Treatment||0
10300264|NCT00048048|11433079|FG010|STARTED|Core Treatment||0
10300265|NCT00048048|11433080|FG011|STARTED|Core Treatment||0
10300266|NCT00048048|11433069|FG000|COMPLETED|Core Treatment||6
10300267|NCT00048048|11433070|FG001|COMPLETED|Core Treatment||6
10300268|NCT00048048|11433071|FG002|COMPLETED|Core Treatment||9
10300269|NCT00048048|11433072|FG003|COMPLETED|Core Treatment||6
10300270|NCT00048048|11433073|FG004|COMPLETED|Core Treatment||6
10300271|NCT00048048|11433074|FG005|COMPLETED|Core Treatment||9
10300272|NCT00048048|11433075|FG006|COMPLETED|Core Treatment||6
10300273|NCT00048048|11433076|FG007|COMPLETED|Core Treatment||5
10300274|NCT00048048|11433077|FG008|COMPLETED|Core Treatment||10
10300275|NCT00048048|11433078|FG009|COMPLETED|Core Treatment||0
10300276|NCT00048048|11433079|FG010|COMPLETED|Core Treatment||0
10300277|NCT00048048|11433080|FG011|COMPLETED|Core Treatment||0
10300278|NCT00048048|11433069|FG000|NOT COMPLETED|Core Treatment||0
10300279|NCT00048048|11433070|FG001|NOT COMPLETED|Core Treatment||0
10300280|NCT00048048|11433071|FG002|NOT COMPLETED|Core Treatment||1
10300281|NCT00048048|11433072|FG003|NOT COMPLETED|Core Treatment||0
10300282|NCT00048048|11433073|FG004|NOT COMPLETED|Core Treatment||0
10300283|NCT00048048|11433074|FG005|NOT COMPLETED|Core Treatment||0
10300284|NCT00048048|11433075|FG006|NOT COMPLETED|Core Treatment||0
10300285|NCT00048048|11433076|FG007|NOT COMPLETED|Core Treatment||1
10300286|NCT00048048|11433077|FG008|NOT COMPLETED|Core Treatment||0
10300287|NCT00048048|11433078|FG009|NOT COMPLETED|Core Treatment||0
10300288|NCT00048048|11433079|FG010|NOT COMPLETED|Core Treatment||0
10300289|NCT00048048|11433080|FG011|NOT COMPLETED|Core Treatment||0
10300290|NCT00048048|11433069|FG000|STARTED|Extension Year 1||0
10300291|NCT00048048|11433070|FG001|STARTED|Extension Year 1||0
10300292|NCT00048048|11433071|FG002|STARTED|Extension Year 1||0
10300293|NCT00048048|11433072|FG003|STARTED|Extension Year 1||0
10300294|NCT00048048|11433073|FG004|STARTED|Extension Year 1||0
10300295|NCT00048048|11433074|FG005|STARTED|Extension Year 1||0
10300296|NCT00048048|11433075|FG006|STARTED|Extension Year 1||0
10300297|NCT00048048|11433076|FG007|STARTED|Extension Year 1||0
10300298|NCT00048048|11433077|FG008|STARTED|Extension Year 1||0
10300299|NCT00048048|11433078|FG009|STARTED|Extension Year 1|Participants (Cohorts 1, 2, and 3) who completed core, entered extension period (entry optional).|16
10300300|NCT00048048|11433079|FG010|STARTED|Extension Year 1|Participants (Cohorts 4, 5, and 6) who completed core, entered extension period (entry optional).|16
10300301|NCT00048048|11433080|FG011|STARTED|Extension Year 1|Participants (Cohorts 7, 8, and 9) who completed core, entered extension period (entry optional).|19
10300302|NCT00048048|11433069|FG000|COMPLETED|Extension Year 1||0
10300303|NCT00048048|11433070|FG001|COMPLETED|Extension Year 1||0
10300304|NCT00048048|11433071|FG002|COMPLETED|Extension Year 1||0
10300305|NCT00048048|11433072|FG003|COMPLETED|Extension Year 1||0
10300306|NCT00048048|11433073|FG004|COMPLETED|Extension Year 1||0
10300307|NCT00048048|11433074|FG005|COMPLETED|Extension Year 1||0
10300308|NCT00048048|11433075|FG006|COMPLETED|Extension Year 1||0
10300309|NCT00048048|11433076|FG007|COMPLETED|Extension Year 1||0
10300310|NCT00048048|11433077|FG008|COMPLETED|Extension Year 1||0
10300311|NCT00048048|11433078|FG009|COMPLETED|Extension Year 1||14
10300312|NCT00048048|11433079|FG010|COMPLETED|Extension Year 1||14
10300313|NCT00048048|11433080|FG011|COMPLETED|Extension Year 1||15
10300314|NCT00048048|11433069|FG000|NOT COMPLETED|Extension Year 1||0
10300315|NCT00048048|11433070|FG001|NOT COMPLETED|Extension Year 1||0
10300316|NCT00048048|11433071|FG002|NOT COMPLETED|Extension Year 1||0
10300317|NCT00048048|11433072|FG003|NOT COMPLETED|Extension Year 1||0
10300318|NCT00048048|11433073|FG004|NOT COMPLETED|Extension Year 1||0
10300319|NCT00048048|11433074|FG005|NOT COMPLETED|Extension Year 1||0
10300320|NCT00048048|11433075|FG006|NOT COMPLETED|Extension Year 1||0
10300321|NCT00048048|11433076|FG007|NOT COMPLETED|Extension Year 1||0
10300322|NCT00048048|11433077|FG008|NOT COMPLETED|Extension Year 1||0
10300323|NCT00048048|11433078|FG009|NOT COMPLETED|Extension Year 1||2
10300324|NCT00048048|11433079|FG010|NOT COMPLETED|Extension Year 1||2
10300325|NCT00048048|11433080|FG011|NOT COMPLETED|Extension Year 1||4
10300326|NCT00048048|11433069|FG000|STARTED|Extension Year 2||0
10300327|NCT00048048|11433070|FG001|STARTED|Extension Year 2||0
10300328|NCT00048048|11433071|FG002|STARTED|Extension Year 2||0
10300329|NCT00048048|11433072|FG003|STARTED|Extension Year 2||0
10300330|NCT00048048|11433073|FG004|STARTED|Extension Year 2||0
10300331|NCT00048048|11433074|FG005|STARTED|Extension Year 2||0
10300332|NCT00048048|11433075|FG006|STARTED|Extension Year 2||0
10300333|NCT00048048|11433076|FG007|STARTED|Extension Year 2||0
10300334|NCT00048048|11433077|FG008|STARTED|Extension Year 2||0
10300335|NCT00048048|11433078|FG009|STARTED|Extension Year 2|Twelve participants who completed Extension Year 1 were switched to RO0503821 (1x/2Week).|2
10300336|NCT00048048|11433079|FG010|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1 + 12 participants from RO0503821 (1X/Week).|23
10300337|NCT00048048|11433080|FG011|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|15
10300338|NCT00048048|11433069|FG000|COMPLETED|Extension Year 2||0
10300339|NCT00048048|11433070|FG001|COMPLETED|Extension Year 2||0
10300340|NCT00048048|11433071|FG002|COMPLETED|Extension Year 2||0
10300341|NCT00048048|11433072|FG003|COMPLETED|Extension Year 2||0
10300342|NCT00048048|11433073|FG004|COMPLETED|Extension Year 2||0
10300343|NCT00048048|11433074|FG005|COMPLETED|Extension Year 2||0
10300344|NCT00048048|11433075|FG006|COMPLETED|Extension Year 2||0
10300345|NCT00048048|11433076|FG007|COMPLETED|Extension Year 2||0
10300346|NCT00048048|11433077|FG008|COMPLETED|Extension Year 2||0
10300347|NCT00048048|11433078|FG009|COMPLETED|Extension Year 2||2
10300348|NCT00048048|11433079|FG010|COMPLETED|Extension Year 2||19
10300349|NCT00048048|11433080|FG011|COMPLETED|Extension Year 2||13
10422826|NCT00825825|11567905|FG004|NOT COMPLETED|First Washout Period (14 Days)||0
10300350|NCT00048048|11433069|FG000|NOT COMPLETED|Extension Year 2||0
10300351|NCT00048048|11433070|FG001|NOT COMPLETED|Extension Year 2||0
10300352|NCT00048048|11433071|FG002|NOT COMPLETED|Extension Year 2||0
10300353|NCT00048048|11433072|FG003|NOT COMPLETED|Extension Year 2||0
10300354|NCT00048048|11433073|FG004|NOT COMPLETED|Extension Year 2||0
10300355|NCT00048048|11433074|FG005|NOT COMPLETED|Extension Year 2||0
10300356|NCT00048048|11433075|FG006|NOT COMPLETED|Extension Year 2||0
10300357|NCT00048048|11433076|FG007|NOT COMPLETED|Extension Year 2||0
10300358|NCT00048048|11433077|FG008|NOT COMPLETED|Extension Year 2||0
10300359|NCT00048048|11433078|FG009|NOT COMPLETED|Extension Year 2||0
10300360|NCT00048048|11433079|FG010|NOT COMPLETED|Extension Year 2||4
10300361|NCT00048048|11433080|FG011|NOT COMPLETED|Extension Year 2||2
10300362|NCT00048061|11433111|FG000|STARTED|Overall Study||400
10300363|NCT00048061|11433112|FG001|STARTED|Overall Study||401
10300364|NCT00048061|11433113|FG002|STARTED|Overall Study||400
10300365|NCT00048061|11433114|FG003|STARTED|Overall Study||401
10300366|NCT00048061|11433111|FG000|COMPLETED|Overall Study||325
10300367|NCT00048061|11433112|FG001|COMPLETED|Overall Study||328
10300368|NCT00048061|11433113|FG002|COMPLETED|Overall Study||316
10300369|NCT00048061|11433114|FG003|COMPLETED|Overall Study||322
10300370|NCT00048061|11433111|FG000|NOT COMPLETED|Overall Study||75
10300371|NCT00048061|11433112|FG001|NOT COMPLETED|Overall Study||73
10300372|NCT00048061|11433113|FG002|NOT COMPLETED|Overall Study||84
10300373|NCT00048061|11433114|FG003|NOT COMPLETED|Overall Study||79
10300374|NCT00048074|11433127|FG000|STARTED|Overall Study||465
10300375|NCT00048074|11433128|FG001|STARTED|Overall Study||448
10300376|NCT00048074|11433129|FG002|STARTED|Overall Study||469
10300377|NCT00048074|11433127|FG000|COMPLETED|Overall Study||384
10300378|NCT00048074|11433128|FG001|COMPLETED|Overall Study||361
10300379|NCT00048074|11433129|FG002|COMPLETED|Overall Study||372
10300380|NCT00048074|11433127|FG000|NOT COMPLETED|Overall Study||81
10300381|NCT00048074|11433128|FG001|NOT COMPLETED|Overall Study||87
10300382|NCT00048074|11433129|FG002|NOT COMPLETED|Overall Study||97
10300383|NCT00048165|11433139|FG000|STARTED|Completed 6 Months Study||216
10300384|NCT00048165|11433140|FG001|STARTED|Completed 6 Months Study||218
10300385|NCT00048165|11433139|FG000|COMPLETED|Completed 6 Months Study||165
10300386|NCT00048165|11433140|FG001|COMPLETED|Completed 6 Months Study||170
10300387|NCT00048165|11433139|FG000|NOT COMPLETED|Completed 6 Months Study||51
10300388|NCT00048165|11433140|FG001|NOT COMPLETED|Completed 6 Months Study||48
10300389|NCT00048165|11433139|FG000|STARTED|Completed 12 Months Study||165
10300390|NCT00048165|11433140|FG001|STARTED|Completed 12 Months Study||170
10300391|NCT00048165|11433139|FG000|COMPLETED|Completed 12 Months Study||162
10300392|NCT00048165|11433140|FG001|COMPLETED|Completed 12 Months Study||167
10300393|NCT00048165|11433139|FG000|NOT COMPLETED|Completed 12 Months Study||3
10300394|NCT00048165|11433140|FG001|NOT COMPLETED|Completed 12 Months Study||3
10300395|NCT00048347|11433148|FG000|STARTED|Overall Study||18
10300396|NCT00048347|11433148|FG000|COMPLETED|Overall Study||16
10300397|NCT00048347|11433148|FG000|NOT COMPLETED|Overall Study||2
10300398|NCT00048542|11433156|FG000|STARTED|Double-Blind Phase|For all groups, started indicates when the subjects entered the double-blind treatment phase.|38
10300399|NCT00048542|11433157|FG001|STARTED|Double-Blind Phase||37
10300400|NCT00048542|11433158|FG002|STARTED|Double-Blind Phase||30
10300401|NCT00048542|11433159|FG003|STARTED|Double-Blind Phase||28
10300402|NCT00048542|11433160|FG004|STARTED|Double-Blind Phase||0
10300403|NCT00048542|11433161|FG005|STARTED|Double-Blind Phase||0
10300404|NCT00048542|11433162|FG006|STARTED|Double-Blind Phase||0
10300405|NCT00048542|11433163|FG007|STARTED|Double-Blind Phase||0
10300406|NCT00048542|11433156|FG000|COMPLETED|Double-Blind Phase||35
10300407|NCT00048542|11433157|FG001|COMPLETED|Double-Blind Phase||36
10300408|NCT00048542|11433158|FG002|COMPLETED|Double-Blind Phase||29
10300409|NCT00048542|11433159|FG003|COMPLETED|Double-Blind Phase||28
10300410|NCT00048542|11433160|FG004|COMPLETED|Double-Blind Phase||0
10300411|NCT00048542|11433161|FG005|COMPLETED|Double-Blind Phase||0
10300412|NCT00048542|11433162|FG006|COMPLETED|Double-Blind Phase||0
10300413|NCT00048542|11433163|FG007|COMPLETED|Double-Blind Phase||0
10300414|NCT00048542|11433156|FG000|NOT COMPLETED|Double-Blind Phase||3
10300415|NCT00048542|11433157|FG001|NOT COMPLETED|Double-Blind Phase||1
10300416|NCT00048542|11433158|FG002|NOT COMPLETED|Double-Blind Phase||1
10300417|NCT00048542|11433159|FG003|NOT COMPLETED|Double-Blind Phase||0
10300418|NCT00048542|11433160|FG004|NOT COMPLETED|Double-Blind Phase||0
10300419|NCT00048542|11433161|FG005|NOT COMPLETED|Double-Blind Phase||0
10300420|NCT00048542|11433162|FG006|NOT COMPLETED|Double-Blind Phase||0
10300421|NCT00048542|11433163|FG007|NOT COMPLETED|Double-Blind Phase||0
10300422|NCT00048542|11433156|FG000|STARTED|Open-Label Extension BSA Phase||0
10300423|NCT00048542|11433157|FG001|STARTED|Open-Label Extension BSA Phase||0
10300424|NCT00048542|11433158|FG002|STARTED|Open-Label Extension BSA Phase||0
10300425|NCT00048542|11433159|FG003|STARTED|Open-Label Extension BSA Phase||0
10300426|NCT00048542|11433160|FG004|STARTED|Open-Label Extension BSA Phase||71
10300427|NCT00048542|11433161|FG005|STARTED|Open-Label Extension BSA Phase||57
10300428|NCT00048542|11433162|FG006|STARTED|Open-Label Extension BSA Phase||0
10300429|NCT00048542|11433163|FG007|STARTED|Open-Label Extension BSA Phase||0
10300430|NCT00048542|11433156|FG000|COMPLETED|Open-Label Extension BSA Phase||0
10300431|NCT00048542|11433157|FG001|COMPLETED|Open-Label Extension BSA Phase||0
10300432|NCT00048542|11433158|FG002|COMPLETED|Open-Label Extension BSA Phase||0
10300433|NCT00048542|11433159|FG003|COMPLETED|Open-Label Extension BSA Phase||0
10300434|NCT00048542|11433160|FG004|COMPLETED|Open-Label Extension BSA Phase||59
10300435|NCT00048542|11433161|FG005|COMPLETED|Open-Label Extension BSA Phase||47
10300436|NCT00048542|11433162|FG006|COMPLETED|Open-Label Extension BSA Phase||0
10300437|NCT00048542|11433163|FG007|COMPLETED|Open-Label Extension BSA Phase||0
10300438|NCT00048542|11433156|FG000|NOT COMPLETED|Open-Label Extension BSA Phase||0
10300439|NCT00048542|11433157|FG001|NOT COMPLETED|Open-Label Extension BSA Phase||0
10300440|NCT00048542|11433158|FG002|NOT COMPLETED|Open-Label Extension BSA Phase||0
10300441|NCT00048542|11433159|FG003|NOT COMPLETED|Open-Label Extension BSA Phase||0
10300442|NCT00048542|11433160|FG004|NOT COMPLETED|Open-Label Extension BSA Phase||12
10300443|NCT00048542|11433161|FG005|NOT COMPLETED|Open-Label Extension BSA Phase||10
10300444|NCT00048542|11433162|FG006|NOT COMPLETED|Open-Label Extension BSA Phase||0
10300445|NCT00048542|11433163|FG007|NOT COMPLETED|Open-Label Extension BSA Phase||0
10300446|NCT00048542|11433156|FG000|STARTED|Open-Label Extension Fixed Dose Phase||0
10300447|NCT00048542|11433157|FG001|STARTED|Open-Label Extension Fixed Dose Phase||0
10300448|NCT00048542|11433158|FG002|STARTED|Open-Label Extension Fixed Dose Phase||0
10300449|NCT00048542|11433159|FG003|STARTED|Open-Label Extension Fixed Dose Phase||0
10300450|NCT00048542|11433160|FG004|STARTED|Open-Label Extension Fixed Dose Phase||0
10300451|NCT00048542|11433161|FG005|STARTED|Open-Label Extension Fixed Dose Phase||0
10300452|NCT00048542|11433162|FG006|STARTED|Open-Label Extension Fixed Dose Phase||59
10300453|NCT00048542|11433163|FG007|STARTED|Open-Label Extension Fixed Dose Phase||47
10300454|NCT00048542|11433156|FG000|COMPLETED|Open-Label Extension Fixed Dose Phase||0
10300455|NCT00048542|11433157|FG001|COMPLETED|Open-Label Extension Fixed Dose Phase||0
10300456|NCT00048542|11433158|FG002|COMPLETED|Open-Label Extension Fixed Dose Phase||0
10300457|NCT00048542|11433159|FG003|COMPLETED|Open-Label Extension Fixed Dose Phase||0
10300458|NCT00048542|11433160|FG004|COMPLETED|Open-Label Extension Fixed Dose Phase||0
10300459|NCT00048542|11433161|FG005|COMPLETED|Open-Label Extension Fixed Dose Phase||0
10300460|NCT00048542|11433162|FG006|COMPLETED|Open-Label Extension Fixed Dose Phase||37
10300461|NCT00048542|11433163|FG007|COMPLETED|Open-Label Extension Fixed Dose Phase||25
10300462|NCT00048542|11433156|FG000|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
10300463|NCT00048542|11433157|FG001|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
10300464|NCT00048542|11433158|FG002|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
10300465|NCT00048542|11433159|FG003|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
10300466|NCT00048542|11433160|FG004|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
10300467|NCT00048542|11433161|FG005|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
10300468|NCT00048542|11433162|FG006|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||22
10300469|NCT00048542|11433163|FG007|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||22
10300470|NCT00048568|11433194|FG000|STARTED|Double-Blind Period Days 1 to 169||433
10300471|NCT00048568|11433195|FG001|STARTED|Double-Blind Period Days 1 to 169||219
10300472|NCT00048568|11433196|FG002|STARTED|Double-Blind Period Days 1 to 169||0
10300473|NCT00048568|11433194|FG000|COMPLETED|Double-Blind Period Days 1 to 169||401
10300474|NCT00048568|11433195|FG001|COMPLETED|Double-Blind Period Days 1 to 169||174
10300475|NCT00048568|11433196|FG002|COMPLETED|Double-Blind Period Days 1 to 169||0
10300476|NCT00048568|11433194|FG000|NOT COMPLETED|Double-Blind Period Days 1 to 169||32
10300477|NCT00048568|11433195|FG001|NOT COMPLETED|Double-Blind Period Days 1 to 169||45
10300478|NCT00048568|11433196|FG002|NOT COMPLETED|Double-Blind Period Days 1 to 169||0
10300479|NCT00048568|11433194|FG000|STARTED|Double-Blind Period Days 170 to 365||401
10300480|NCT00048568|11433195|FG001|STARTED|Double-Blind Period Days 170 to 365||174
10300481|NCT00048568|11433196|FG002|STARTED|Double-Blind Period Days 170 to 365||0
10300482|NCT00048568|11433194|FG000|COMPLETED|Double-Blind Period Days 170 to 365||385
10300483|NCT00048568|11433195|FG001|COMPLETED|Double-Blind Period Days 170 to 365||162
10300484|NCT00048568|11433196|FG002|COMPLETED|Double-Blind Period Days 170 to 365||0
10300485|NCT00048568|11433194|FG000|NOT COMPLETED|Double-Blind Period Days 170 to 365||16
10300486|NCT00048568|11433195|FG001|NOT COMPLETED|Double-Blind Period Days 170 to 365||12
10300487|NCT00048568|11433196|FG002|NOT COMPLETED|Double-Blind Period Days 170 to 365||0
10300488|NCT00048568|11433194|FG000|STARTED|Open-Label Period||0
10300489|NCT00048568|11433195|FG001|STARTED|Open-Label Period||0
10300490|NCT00048568|11433196|FG002|STARTED|Open-Label Period||539
10300491|NCT00048568|11433194|FG000|COMPLETED|Open-Label Period||0
10300492|NCT00048568|11433195|FG001|COMPLETED|Open-Label Period||0
10300493|NCT00048568|11433196|FG002|COMPLETED|Open-Label Period||379
10300494|NCT00048568|11433194|FG000|NOT COMPLETED|Open-Label Period||0
10300495|NCT00048568|11433195|FG001|NOT COMPLETED|Open-Label Period||0
10300496|NCT00048568|11433196|FG002|NOT COMPLETED|Open-Label Period||160
10300497|NCT00048581|11433219|FG000|STARTED|Double-Blind Period||258
10300498|NCT00048581|11433220|FG001|STARTED|Double-Blind Period||133
10300499|NCT00048581|11433221|FG002|STARTED|Double-Blind Period||0
10300500|NCT00048581|11433219|FG000|COMPLETED|Double-Blind Period||223
10300501|NCT00048581|11433220|FG001|COMPLETED|Double-Blind Period||99
10300502|NCT00048581|11433221|FG002|COMPLETED|Double-Blind Period||0
10300503|NCT00048581|11433219|FG000|NOT COMPLETED|Double-Blind Period||35
10300504|NCT00048581|11433220|FG001|NOT COMPLETED|Double-Blind Period||34
10300505|NCT00048581|11433221|FG002|NOT COMPLETED|Double-Blind Period||0
10300506|NCT00048581|11433219|FG000|STARTED|Open-Label Period||0
10300507|NCT00048581|11433220|FG001|STARTED|Open-Label Period||0
10300508|NCT00048581|11433221|FG002|STARTED|Open-Label Period||317
10300509|NCT00048581|11433219|FG000|COMPLETED|Open-Label Period||0
10300510|NCT00048581|11433220|FG001|COMPLETED|Open-Label Period||0
10300511|NCT00048581|11433221|FG002|COMPLETED|Open-Label Period||150
10300512|NCT00048581|11433219|FG000|NOT COMPLETED|Open-Label Period||0
10300513|NCT00048581|11433220|FG001|NOT COMPLETED|Open-Label Period||0
10300514|NCT00048581|11433221|FG002|NOT COMPLETED|Open-Label Period||167
10300515|NCT00048724|11433236|FG000|STARTED|Overall Study||311
10300516|NCT00048724|11433237|FG001|STARTED|Overall Study||315
10300517|NCT00048724|11433236|FG000|COMPLETED|Overall Study||195
10300518|NCT00048724|11433237|FG001|COMPLETED|Overall Study||197
10300519|NCT00048724|11433236|FG000|NOT COMPLETED|Overall Study||116
10300520|NCT00048724|11433237|FG001|NOT COMPLETED|Overall Study||118
10300521|NCT00048737|11433243|FG000|STARTED|Overall Study||70
10300522|NCT00048737|11433243|FG000|COMPLETED|Overall Study||70
10300523|NCT00048737|11433243|FG000|NOT COMPLETED|Overall Study||0
10300524|NCT00048815|11433250|FG000|STARTED|Overall Study||24
10300525|NCT00048815|11433251|FG001|STARTED|Overall Study||26
10300526|NCT00048815|11433252|FG002|STARTED|Overall Study||23
10300527|NCT00048815|11433250|FG000|COMPLETED|Overall Study||18
10300528|NCT00048815|11433251|FG001|COMPLETED|Overall Study||22
10300529|NCT00048815|11433252|FG002|COMPLETED|Overall Study||19
10300530|NCT00048815|11433250|FG000|NOT COMPLETED|Overall Study||6
10300531|NCT00048815|11433251|FG001|NOT COMPLETED|Overall Study||4
10300532|NCT00048815|11433252|FG002|NOT COMPLETED|Overall Study||4
10300533|NCT00048893|11433260|FG000|STARTED|Overall Study||37
10300534|NCT00048893|11433260|FG000|COMPLETED|Overall Study||37
10300535|NCT00048893|11433260|FG000|NOT COMPLETED|Overall Study||0
10300536|NCT00048932|11433266|FG000|STARTED|Double Blind Period (DB)|Number Treated|959
10300537|NCT00048932|11433267|FG001|STARTED|Double Blind Period (DB)|Number Treated|482
10300538|NCT00048932|11433268|FG002|STARTED|Double Blind Period (DB)||0
10300539|NCT00048932|11433266|FG000|COMPLETED|Double Blind Period (DB)||836
10300540|NCT00048932|11433267|FG001|COMPLETED|Double Blind Period (DB)||395
10300541|NCT00048932|11433268|FG002|COMPLETED|Double Blind Period (DB)||0
10300542|NCT00048932|11433266|FG000|NOT COMPLETED|Double Blind Period (DB)||123
10300543|NCT00048932|11433267|FG001|NOT COMPLETED|Double Blind Period (DB)||87
10300544|NCT00048932|11433268|FG002|NOT COMPLETED|Double Blind Period (DB)||0
10300545|NCT00048932|11433266|FG000|STARTED|Open Label Period (OL)||0
10300546|NCT00048932|11433267|FG001|STARTED|Open Label Period (OL)||0
10300547|NCT00048932|11433268|FG002|STARTED|Open Label Period (OL)|47 participants who completed the double-blind did not enter the open-label|1184
10300548|NCT00048932|11433266|FG000|COMPLETED|Open Label Period (OL)||0
10300549|NCT00048932|11433267|FG001|COMPLETED|Open Label Period (OL)||0
10300550|NCT00048932|11433268|FG002|COMPLETED|Open Label Period (OL)||743
10300551|NCT00048932|11433266|FG000|NOT COMPLETED|Open Label Period (OL)||0
10300552|NCT00048932|11433267|FG001|NOT COMPLETED|Open Label Period (OL)||0
10300553|NCT00048932|11433268|FG002|NOT COMPLETED|Open Label Period (OL)||441
10300554|NCT00048997|11433279|FG000|STARTED|Overall Study||176
10300555|NCT00048997|11433280|FG001|STARTED|Overall Study||180
10300556|NCT00048997|11433279|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|163
10300557|NCT00048997|11433280|FG001|COMPLETED|Overall Study||177
10300558|NCT00048997|11433279|FG000|NOT COMPLETED|Overall Study||13
10300559|NCT00048997|11433280|FG001|NOT COMPLETED|Overall Study||3
10300560|NCT00049036|11433287|FG000|STARTED|Overall Study||51
10300561|NCT00049036|11433288|FG001|STARTED|Overall Study||55
10300562|NCT00049036|11433287|FG000|COMPLETED|Overall Study||51
10300563|NCT00049036|11433288|FG001|COMPLETED|Overall Study||55
10300564|NCT00049036|11433287|FG000|NOT COMPLETED|Overall Study||0
10300565|NCT00049036|11433288|FG001|NOT COMPLETED|Overall Study||0
10300566|NCT00049127|11433299|FG000|STARTED|Overall Study||12
10300567|NCT00049127|11433300|FG001|STARTED|Overall Study||0
10300568|NCT00049127|11433301|FG002|STARTED|Overall Study||40
10300569|NCT00049127|11433302|FG003|STARTED|Overall Study||0
10300570|NCT00049127|11433303|FG004|STARTED|Overall Study||12
10300571|NCT00049127|11433299|FG000|COMPLETED|Overall Study||12
10300572|NCT00049127|11433300|FG001|COMPLETED|Overall Study||0
10300573|NCT00049127|11433301|FG002|COMPLETED|Overall Study||39
10300574|NCT00049127|11433302|FG003|COMPLETED|Overall Study||0
10300575|NCT00049127|11433303|FG004|COMPLETED|Overall Study||12
10300576|NCT00049127|11433299|FG000|NOT COMPLETED|Overall Study||0
10300577|NCT00049127|11433300|FG001|NOT COMPLETED|Overall Study||0
10300578|NCT00049127|11433301|FG002|NOT COMPLETED|Overall Study||1
10300579|NCT00049127|11433302|FG003|NOT COMPLETED|Overall Study||0
10300580|NCT00049127|11433303|FG004|NOT COMPLETED|Overall Study||0
10300581|NCT00049257|11433315|FG000|STARTED|Carboplatin, Paclitaxel||58
10300582|NCT00049257|11433315|FG000|COMPLETED|Carboplatin, Paclitaxel|13 participants did not complete treatment|45
10300583|NCT00049257|11433315|FG000|NOT COMPLETED|Carboplatin, Paclitaxel||13
10300584|NCT00049257|11433315|FG000|STARTED|Follow-up Period for Survival Status||45
10300585|NCT00049257|11433315|FG000|COMPLETED|Follow-up Period for Survival Status||41
10300586|NCT00049257|11433315|FG000|NOT COMPLETED|Follow-up Period for Survival Status||4
10300587|NCT00049322|11433321|FG000|STARTED|Overall Study||15
10300588|NCT00049322|11433322|FG001|STARTED|Overall Study||15
10300589|NCT00049322|11433321|FG000|COMPLETED|Overall Study||14
10300590|NCT00049322|11433322|FG001|COMPLETED|Overall Study||9
10300591|NCT00049322|11433321|FG000|NOT COMPLETED|Overall Study||1
10300592|NCT00049322|11433322|FG001|NOT COMPLETED|Overall Study||6
10300593|NCT00049504|11433330|FG000|STARTED|Overall Study||55
10300594|NCT00049504|11433330|FG000|COMPLETED|Overall Study||55
10300595|NCT00049504|11433330|FG000|NOT COMPLETED|Overall Study||0
10300596|NCT00049517|11433336|FG000|STARTED|Induction||79
10300597|NCT00049517|11433337|FG001|STARTED|Induction||90
10300598|NCT00049517|11433338|FG002|STARTED|Induction||63
10300599|NCT00049517|11433339|FG003|STARTED|Induction||75
10300600|NCT00049517|11433340|FG004|STARTED|Induction||188
10300601|NCT00049517|11433341|FG005|STARTED|Induction||162
10300602|NCT00049517|11433336|FG000|Treated|Induction||79
10300603|NCT00049517|11433337|FG001|Treated|Induction||90
10300604|NCT00049517|11433338|FG002|Treated|Induction||63
10300605|NCT00049517|11433339|FG003|Treated|Induction||75
10300606|NCT00049517|11433340|FG004|Treated|Induction||186
10300607|NCT00049517|11433341|FG005|Treated|Induction||160
10300608|NCT00049517|11433336|FG000|COMPLETED|Induction||79
10300609|NCT00049517|11433337|FG001|COMPLETED|Induction||90
10300610|NCT00049517|11433338|FG002|COMPLETED|Induction||63
10300611|NCT00049517|11433339|FG003|COMPLETED|Induction||75
10300612|NCT00049517|11433340|FG004|COMPLETED|Induction||128
10300613|NCT00049517|11433341|FG005|COMPLETED|Induction||108
10300614|NCT00049517|11433336|FG000|NOT COMPLETED|Induction||0
10300615|NCT00049517|11433337|FG001|NOT COMPLETED|Induction||0
10300616|NCT00049517|11433338|FG002|NOT COMPLETED|Induction||0
10300617|NCT00049517|11433339|FG003|NOT COMPLETED|Induction||0
10300618|NCT00049517|11433340|FG004|NOT COMPLETED|Induction||60
10300619|NCT00049517|11433341|FG005|NOT COMPLETED|Induction||54
10300620|NCT00049517|11433336|FG000|STARTED|Conditioning/Transplant||79
10300621|NCT00049517|11433337|FG001|STARTED|Conditioning/Transplant||90
10300622|NCT00049517|11433338|FG002|STARTED|Conditioning/Transplant||63
10300623|NCT00049517|11433339|FG003|STARTED|Conditioning/Transplant||75
10300624|NCT00049517|11433340|FG004|STARTED|Conditioning/Transplant||21
10300625|NCT00049517|11433341|FG005|STARTED|Conditioning/Transplant||24
10300626|NCT00049517|11433336|FG000|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|Additional 20 patients received Autologous HCT without randomization.|59
10300627|NCT00049517|11433337|FG001|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|Additional 17 patients received Autologous HCT without randomization.|73
10300628|NCT00049517|11433338|FG002|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||63
10300629|NCT00049517|11433339|FG003|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||75
10300630|NCT00049517|11433340|FG004|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|These 21 patients received Allogeneic HCT without randomization.|0
10300631|NCT00049517|11433341|FG005|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|These 24 patients received Allogeneic HCT without randomization.|0
10300632|NCT00049517|11433336|FG000|COMPLETED|Conditioning/Transplant||27
10300633|NCT00049517|11433337|FG001|COMPLETED|Conditioning/Transplant||40
10300634|NCT00049517|11433338|FG002|COMPLETED|Conditioning/Transplant||25
10300635|NCT00049517|11433339|FG003|COMPLETED|Conditioning/Transplant||32
10300636|NCT00049517|11433340|FG004|COMPLETED|Conditioning/Transplant||15
10300637|NCT00049517|11433341|FG005|COMPLETED|Conditioning/Transplant||18
10300638|NCT00049517|11433336|FG000|NOT COMPLETED|Conditioning/Transplant||52
10300639|NCT00049517|11433337|FG001|NOT COMPLETED|Conditioning/Transplant||50
10300640|NCT00049517|11433338|FG002|NOT COMPLETED|Conditioning/Transplant||38
10300641|NCT00049517|11433339|FG003|NOT COMPLETED|Conditioning/Transplant||43
10300642|NCT00049517|11433340|FG004|NOT COMPLETED|Conditioning/Transplant||6
10300643|NCT00049517|11433341|FG005|NOT COMPLETED|Conditioning/Transplant||6
10300644|NCT00049530|11433349|FG000|STARTED|Overall Study||32
10300645|NCT00049530|11433349|FG000|Eligible and Treated|Overall Study||29
10300646|NCT00049530|11433349|FG000|COMPLETED|Overall Study||0
10300647|NCT00049530|11433349|FG000|NOT COMPLETED|Overall Study||32
10300648|NCT00049543|11433355|FG000|STARTED|Overall Study||251
10300649|NCT00049543|11433356|FG001|STARTED|Overall Study||252
10300650|NCT00049543|11433355|FG000|COMPLETED|Overall Study||249
10300651|NCT00049543|11433356|FG001|COMPLETED|Overall Study||243
10300652|NCT00049543|11433355|FG000|NOT COMPLETED|Overall Study||2
10300653|NCT00049543|11433356|FG001|NOT COMPLETED|Overall Study||9
10300654|NCT00049673|11433364|FG000|STARTED|Overall Study||166
10300655|NCT00049673|11433365|FG001|STARTED|Overall Study||166
10300656|NCT00049673|11433364|FG000|COMPLETED|Overall Study||165
10300657|NCT00049673|11433365|FG001|COMPLETED|Overall Study||163
10300658|NCT00049673|11433364|FG000|NOT COMPLETED|Overall Study||1
10300659|NCT00049673|11433365|FG001|NOT COMPLETED|Overall Study||3
10300660|NCT00049842|11433373|FG000|STARTED|Treatment Phase||270
10300661|NCT00049842|11433374|FG001|STARTED|Treatment Phase||270
10300662|NCT00049842|11433373|FG000|COMPLETED|Treatment Phase||177
10300663|NCT00049842|11433374|FG001|COMPLETED|Treatment Phase||192
10300664|NCT00049842|11433373|FG000|NOT COMPLETED|Treatment Phase||93
10300665|NCT00049842|11433374|FG001|NOT COMPLETED|Treatment Phase||78
10300666|NCT00049842|11433373|FG000|STARTED|Follow-up Phase|Population is all treatment phase completers plus some who discontinued the treatment phase.|218
10300667|NCT00049842|11433374|FG001|STARTED|Follow-up Phase|Population is all treatment phase completers plus some who discontinued the treatment phase.|194
10300668|NCT00049842|11433373|FG000|COMPLETED|Follow-up Phase||211
10300669|NCT00049842|11433374|FG001|COMPLETED|Follow-up Phase||189
10300670|NCT00049842|11433373|FG000|NOT COMPLETED|Follow-up Phase||7
10300671|NCT00049842|11433374|FG001|NOT COMPLETED|Follow-up Phase||5
10422827|NCT00825825|11567906|FG005|NOT COMPLETED|First Washout Period (14 Days)||0
10300672|NCT00050011|11433382|FG000|STARTED|Overall Study||301
10300673|NCT00050011|11433383|FG001|STARTED|Overall Study||301
10300674|NCT00050011|11433382|FG000|Intent-to-treat Population|Overall Study||300
10300675|NCT00050011|11433383|FG001|Intent-to-treat Population|Overall Study||300
10300676|NCT00050011|11433382|FG000|COMPLETED|Overall Study||180
10300677|NCT00050011|11433383|FG001|COMPLETED|Overall Study||175
10300678|NCT00050011|11433382|FG000|NOT COMPLETED|Overall Study||121
10300679|NCT00050011|11433383|FG001|NOT COMPLETED|Overall Study||126
10300680|NCT00050089|11433394|FG000|STARTED|Overall Study||106
10300681|NCT00050089|11433395|FG001|STARTED|Overall Study||98
10300682|NCT00050089|11433396|FG002|STARTED|Overall Study||86
10300683|NCT00050089|11433397|FG003|STARTED|Overall Study||78
10300684|NCT00050089|11433394|FG000|Baseline|Overall Study|15 participants randomized in the UK Option scheme (not displayed in the 2X2 baseline data)|91
10300685|NCT00050089|11433395|FG001|Baseline|Overall Study|14 participants randomized in the UK Option scheme (not shown in 2X2 baseline data)|84
10300686|NCT00050089|11433396|FG002|Baseline|Overall Study||86
10300687|NCT00050089|11433397|FG003|Baseline|Overall Study||78
10300688|NCT00050089|11433394|FG000|COMPLETED|Overall Study|For primary outcome assessment|106
10300689|NCT00050089|11433395|FG001|COMPLETED|Overall Study|For primary outcome assessment|98
10300690|NCT00050089|11433396|FG002|COMPLETED|Overall Study|For primary outcome assessment|86
10300691|NCT00050089|11433397|FG003|COMPLETED|Overall Study|For primary outcome assessment|78
10300692|NCT00050089|11433394|FG000|NOT COMPLETED|Overall Study||0
10300693|NCT00050089|11433395|FG001|NOT COMPLETED|Overall Study||0
10300694|NCT00050089|11433396|FG002|NOT COMPLETED|Overall Study||0
10300695|NCT00050089|11433397|FG003|NOT COMPLETED|Overall Study||0
10300696|NCT00050167|11433413|FG000|STARTED|Overall Study||302
10300697|NCT00050167|11433414|FG001|STARTED|Overall Study||301
10300698|NCT00050167|11433413|FG000|COMPLETED|Overall Study||301
10300699|NCT00050167|11433414|FG001|COMPLETED|Overall Study||300
10300700|NCT00050167|11433413|FG000|NOT COMPLETED|Overall Study||1
10300701|NCT00050167|11433414|FG001|NOT COMPLETED|Overall Study||1
10300702|NCT00050622|11433420|FG000|STARTED|Overall Study||154
10300703|NCT00050622|11433420|FG000|COMPLETED|Overall Study||153
10300704|NCT00050622|11433420|FG000|NOT COMPLETED|Overall Study||1
10300705|NCT00050778|11433447|FG000|STARTED|Overall Study|Randomized.|111
10300706|NCT00050778|11433448|FG001|STARTED|Overall Study||113
10300707|NCT00050778|11433449|FG002|STARTED|Overall Study||110
10300708|NCT00050778|11433447|FG000|Treated|Overall Study||107
10300709|NCT00050778|11433448|FG001|Treated|Overall Study||108
10300710|NCT00050778|11433449|FG002|Treated|Overall Study||108
10300711|NCT00050778|11433447|FG000|COMPLETED|Overall Study||66
10300712|NCT00050778|11433448|FG001|COMPLETED|Overall Study||92
10300713|NCT00050778|11433449|FG002|COMPLETED|Overall Study||92
10300714|NCT00050778|11433447|FG000|NOT COMPLETED|Overall Study||45
10300715|NCT00050778|11433448|FG001|NOT COMPLETED|Overall Study||21
10300716|NCT00050778|11433449|FG002|NOT COMPLETED|Overall Study||18
10300717|NCT00050960|11433461|FG000|STARTED|Overall Study||306
10300718|NCT00050960|11433462|FG001|STARTED|Overall Study||306
10300719|NCT00050960|11433461|FG000|COMPLETED|Overall Study|Represents number of patients with no primary reason for termination|4
10300720|NCT00050960|11433462|FG001|COMPLETED|Overall Study|Represents number of patients with no primary reason for termination|2
10300721|NCT00050960|11433461|FG000|NOT COMPLETED|Overall Study||302
10300722|NCT00050960|11433462|FG001|NOT COMPLETED|Overall Study||304
10300723|NCT00050986|11433468|FG000|STARTED|Overall Study||55
10300724|NCT00050986|11433468|FG000|COMPLETED|Overall Study|Two participants had withdrawn consents before the study treatment was initiated.|53
10300725|NCT00050986|11433468|FG000|NOT COMPLETED|Overall Study||2
10300726|NCT00051025|11433474|FG000|STARTED|Overall Study||5
10300727|NCT00051025|11433475|FG001|STARTED|Overall Study||4
10300728|NCT00051025|11433474|FG000|COMPLETED|Overall Study||3
10300729|NCT00051025|11433475|FG001|COMPLETED|Overall Study||0
10300730|NCT00051025|11433474|FG000|NOT COMPLETED|Overall Study||2
10300731|NCT00051025|11433475|FG001|NOT COMPLETED|Overall Study||4
10300732|NCT00051168|11433481|FG000|STARTED|Overall Study||502
10300733|NCT00051168|11433481|FG000|COMPLETED|Overall Study||367
10300734|NCT00051168|11433481|FG000|NOT COMPLETED|Overall Study||135
10300735|NCT00051311|11433487|FG000|STARTED|Overall Study||31
10300736|NCT00051311|11433488|FG001|STARTED|Overall Study||31
10300737|NCT00051311|11433487|FG000|COMPLETED|Overall Study||19
10300738|NCT00051311|11433488|FG001|COMPLETED|Overall Study||17
10300739|NCT00051311|11433487|FG000|NOT COMPLETED|Overall Study||12
10300740|NCT00051311|11433488|FG001|NOT COMPLETED|Overall Study||14
10300741|NCT00051363|11433494|FG000|STARTED|Overall Study||558
10300742|NCT00051363|11433495|FG001|STARTED|Overall Study||547
10300743|NCT00051363|11433494|FG000|Randomized & Analyzed|Overall Study||556
10300744|NCT00051363|11433495|FG001|Randomized & Analyzed|Overall Study||542
10300745|NCT00051363|11433494|FG000|Completed 2M Visit On-Treatment|Overall Study||456
10300746|NCT00051363|11433495|FG001|Completed 2M Visit On-Treatment|Overall Study||417
10300747|NCT00051363|11433494|FG000|Completed 2M Visit On-Study|Overall Study||468
10300748|NCT00051363|11433495|FG001|Completed 2M Visit On-Study|Overall Study||432
10300749|NCT00051363|11433494|FG000|Completed 6M Visit On-Treatment|Overall Study||427
10300750|NCT00051363|11433495|FG001|Completed 6M Visit On-Treatment|Overall Study||372
10300751|NCT00051363|11433494|FG000|Completed 6M Vist On-Study|Overall Study||443
10300752|NCT00051363|11433495|FG001|Completed 6M Vist On-Study|Overall Study||403
10300753|NCT00051363|11433494|FG000|COMPLETED|Overall Study||443
10300754|NCT00051363|11433495|FG001|COMPLETED|Overall Study||403
10300755|NCT00051363|11433494|FG000|NOT COMPLETED|Overall Study||115
10300756|NCT00051363|11433495|FG001|NOT COMPLETED|Overall Study||144
10300757|NCT00051558|11433503|FG000|STARTED|Overall Study||214
10300758|NCT00051558|11433504|FG001|STARTED|Overall Study||214
10300759|NCT00051558|11433503|FG000|COMPLETED|Overall Study||123
10300760|NCT00051558|11433504|FG001|COMPLETED|Overall Study||118
10300761|NCT00051558|11433503|FG000|NOT COMPLETED|Overall Study||91
10300762|NCT00051558|11433504|FG001|NOT COMPLETED|Overall Study||96
10300763|NCT00051636|11433512|FG000|STARTED|Period 1 - Core||90
10300764|NCT00051636|11433513|FG001|STARTED|Period 1 - Core||82
10300765|NCT00051636|11433512|FG000|COMPLETED|Period 1 - Core||86
10300766|NCT00051636|11433513|FG001|COMPLETED|Period 1 - Core||76
10300767|NCT00051636|11433512|FG000|NOT COMPLETED|Period 1 - Core||4
10300768|NCT00051636|11433513|FG001|NOT COMPLETED|Period 1 - Core||6
10300769|NCT00051636|11433512|FG000|STARTED|Period 2- Extended Observation Period||75
10300770|NCT00051636|11433513|FG001|STARTED|Period 2- Extended Observation Period||52
10315049|NCT00171925|11448826|FG001|NOT COMPLETED|Overall Study||31
10315050|NCT00171951|11448832|FG000|STARTED|Overall Study||19
10300771|NCT00051636|11433512|FG000|COMPLETED|Period 2- Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|5
10300772|NCT00051636|11433513|FG001|COMPLETED|Period 2- Extended Observation Period|Includes patients retreated for Paget's disease|22
10300773|NCT00051636|11433512|FG000|NOT COMPLETED|Period 2- Extended Observation Period||70
10300774|NCT00051636|11433513|FG001|NOT COMPLETED|Period 2- Extended Observation Period||30
10300775|NCT00052078|11433523|FG000|STARTED|Overall Study||133
10300776|NCT00052078|11433524|FG001|STARTED|Overall Study||139
10300777|NCT00052078|11433525|FG002|STARTED|Overall Study||140
10300778|NCT00052078|11433526|FG003|STARTED|Overall Study||76
10300779|NCT00052078|11433523|FG000|COMPLETED|Overall Study||110
10300780|NCT00052078|11433524|FG001|COMPLETED|Overall Study||133
10300781|NCT00052078|11433525|FG002|COMPLETED|Overall Study||127
10300782|NCT00052078|11433526|FG003|COMPLETED|Overall Study||61
10300783|NCT00052078|11433523|FG000|NOT COMPLETED|Overall Study||23
10300784|NCT00052078|11433524|FG001|NOT COMPLETED|Overall Study||6
10300785|NCT00052078|11433525|FG002|NOT COMPLETED|Overall Study||13
10300786|NCT00052078|11433526|FG003|NOT COMPLETED|Overall Study||15
10300787|NCT00052429|11433536|FG000|STARTED|Overall Study||25
10300788|NCT00052429|11433536|FG000|COMPLETED|Overall Study||25
10300789|NCT00052429|11433536|FG000|NOT COMPLETED|Overall Study||0
10300790|NCT00052442|11433545|FG000|STARTED|Overall Study||16
10300791|NCT00052442|11433546|FG001|STARTED|Overall Study||3
10300792|NCT00052442|11433547|FG002|STARTED|Overall Study||27
10300793|NCT00052442|11433548|FG003|STARTED|Overall Study||11
10300794|NCT00052442|11433549|FG004|STARTED|Overall Study||15
10300795|NCT00052442|11433545|FG000|COMPLETED|Overall Study||16
10300796|NCT00052442|11433546|FG001|COMPLETED|Overall Study||3
10300797|NCT00052442|11433547|FG002|COMPLETED|Overall Study||27
10300798|NCT00052442|11433548|FG003|COMPLETED|Overall Study||11
10300799|NCT00052442|11433549|FG004|COMPLETED|Overall Study||15
10300800|NCT00052442|11433545|FG000|NOT COMPLETED|Overall Study||0
10300801|NCT00052442|11433546|FG001|NOT COMPLETED|Overall Study||0
10300802|NCT00052442|11433547|FG002|NOT COMPLETED|Overall Study||0
10300803|NCT00052442|11433548|FG003|NOT COMPLETED|Overall Study||0
10300804|NCT00052442|11433549|FG004|NOT COMPLETED|Overall Study||0
10300805|NCT00052715|11433561|FG000|STARTED|Overall Study||31
10300806|NCT00052715|11433561|FG000|COMPLETED|Overall Study||30
10300807|NCT00052715|11433561|FG000|NOT COMPLETED|Overall Study||1
10300808|NCT00052910|11433567|FG000|STARTED|Overall Study||280
10300809|NCT00052910|11433568|FG001|STARTED|Overall Study||266
10300810|NCT00052910|11433567|FG000|COMPLETED|Overall Study||280
10300811|NCT00052910|11433568|FG001|COMPLETED|Overall Study||266
10300812|NCT00052910|11433567|FG000|NOT COMPLETED|Overall Study||0
10300813|NCT00052910|11433568|FG001|NOT COMPLETED|Overall Study||0
10300814|NCT00052962|11433576|FG000|STARTED|Overall Study||13
10300815|NCT00052962|11433577|FG001|STARTED|Overall Study||17
10300816|NCT00052962|11433576|FG000|COMPLETED|Overall Study||12
10300817|NCT00052962|11433577|FG001|COMPLETED|Overall Study||15
10300818|NCT00052962|11433576|FG000|NOT COMPLETED|Overall Study||1
10300819|NCT00052962|11433577|FG001|NOT COMPLETED|Overall Study||2
10300820|NCT00053014|11433583|FG000|STARTED|Overall Study||5
10300821|NCT00053014|11433583|FG000|COMPLETED|Overall Study||5
10300822|NCT00053014|11433583|FG000|NOT COMPLETED|Overall Study||0
10300823|NCT00053352|11433589|FG000|STARTED|Overall Study||190
10300824|NCT00053352|11433590|FG001|STARTED|Overall Study||112
10300825|NCT00053352|11433589|FG000|COMPLETED|Overall Study||169
10300826|NCT00053352|11433590|FG001|COMPLETED|Overall Study||102
10300827|NCT00053352|11433589|FG000|NOT COMPLETED|Overall Study||21
10300828|NCT00053352|11433590|FG001|NOT COMPLETED|Overall Study||10
10300829|NCT00053365|11433597|FG000|STARTED|Overall Study||61
10300830|NCT00053365|11433597|FG000|COMPLETED|Overall Study||55
10300831|NCT00053365|11433597|FG000|NOT COMPLETED|Overall Study||6
10300832|NCT00053417|11433607|FG000|STARTED|Overall Study||47
10300833|NCT00053417|11433608|FG001|STARTED|Overall Study||52
10300834|NCT00053417|11433609|FG002|STARTED|Overall Study||50
10300835|NCT00053417|11433610|FG003|STARTED|Overall Study||57
10300836|NCT00053417|11433607|FG000|COMPLETED|Overall Study||45
10300837|NCT00053417|11433608|FG001|COMPLETED|Overall Study||50
10300838|NCT00053417|11433609|FG002|COMPLETED|Overall Study||49
10300839|NCT00053417|11433610|FG003|COMPLETED|Overall Study||51
10300840|NCT00053417|11433607|FG000|NOT COMPLETED|Overall Study||2
10300841|NCT00053417|11433608|FG001|NOT COMPLETED|Overall Study||2
10300842|NCT00053417|11433609|FG002|NOT COMPLETED|Overall Study||1
10300843|NCT00053417|11433610|FG003|NOT COMPLETED|Overall Study||6
10300844|NCT00053482|11433625|FG000|STARTED|Overall Study||51
10300845|NCT00053482|11433626|FG001|STARTED|Overall Study||102
10300846|NCT00053482|11433627|FG002|STARTED|Overall Study||102
10300847|NCT00053482|11433628|FG003|STARTED|Overall Study||50
10300848|NCT00053482|11433629|FG004|STARTED|Overall Study||52
10300849|NCT00053482|11433625|FG000|COMPLETED|Overall Study||51
10300850|NCT00053482|11433626|FG001|COMPLETED|Overall Study||102
10300851|NCT00053482|11433627|FG002|COMPLETED|Overall Study||102
10300852|NCT00053482|11433628|FG003|COMPLETED|Overall Study||50
10300853|NCT00053482|11433629|FG004|COMPLETED|Overall Study||52
10300854|NCT00053482|11433625|FG000|NOT COMPLETED|Overall Study||0
10300855|NCT00053482|11433626|FG001|NOT COMPLETED|Overall Study||0
10300856|NCT00053482|11433627|FG002|NOT COMPLETED|Overall Study||0
10300857|NCT00053482|11433628|FG003|NOT COMPLETED|Overall Study||0
10300858|NCT00053482|11433629|FG004|NOT COMPLETED|Overall Study||0
10300859|NCT00041392|11433643|FG000|STARTED|Overall Study||198
10300860|NCT00041392|11433644|FG001|STARTED|Overall Study||191
10300861|NCT00041392|11433643|FG000|COMPLETED|Overall Study||198
10422828|NCT00825825|11567901|FG000|STARTED|Second Medication Period (14 Days)||3
10422829|NCT00825825|11567902|FG001|STARTED|Second Medication Period (14 Days)||4
10422830|NCT00825825|11567903|FG002|STARTED|Second Medication Period (14 Days)||2
10422831|NCT00825825|11567904|FG003|STARTED|Second Medication Period (14 Days)||5
10422832|NCT00825825|11567905|FG004|STARTED|Second Medication Period (14 Days)||4
10422833|NCT00825825|11567906|FG005|STARTED|Second Medication Period (14 Days)||3
10422834|NCT00825825|11567901|FG000|COMPLETED|Second Medication Period (14 Days)||1
10422835|NCT00825825|11567902|FG001|COMPLETED|Second Medication Period (14 Days)||4
10422836|NCT00825825|11567903|FG002|COMPLETED|Second Medication Period (14 Days)||2
10422837|NCT00825825|11567904|FG003|COMPLETED|Second Medication Period (14 Days)||3
10422838|NCT00825825|11567905|FG004|COMPLETED|Second Medication Period (14 Days)||3
10422839|NCT00825825|11567906|FG005|COMPLETED|Second Medication Period (14 Days)||3
10422840|NCT00825825|11567901|FG000|NOT COMPLETED|Second Medication Period (14 Days)||2
10422841|NCT00825825|11567902|FG001|NOT COMPLETED|Second Medication Period (14 Days)||0
10422842|NCT00825825|11567903|FG002|NOT COMPLETED|Second Medication Period (14 Days)||0
10422843|NCT00825825|11567904|FG003|NOT COMPLETED|Second Medication Period (14 Days)||2
10422844|NCT00825825|11567905|FG004|NOT COMPLETED|Second Medication Period (14 Days)||1
10422845|NCT00825825|11567906|FG005|NOT COMPLETED|Second Medication Period (14 Days)||0
10422846|NCT00825825|11567901|FG000|STARTED|Second Washout Period (14 Days)||1
10422847|NCT00825825|11567902|FG001|STARTED|Second Washout Period (14 Days)||4
10422848|NCT00825825|11567903|FG002|STARTED|Second Washout Period (14 Days)||2
10422849|NCT00825825|11567904|FG003|STARTED|Second Washout Period (14 Days)||3
10422850|NCT00825825|11567905|FG004|STARTED|Second Washout Period (14 Days)||3
10422851|NCT00825825|11567906|FG005|STARTED|Second Washout Period (14 Days)||3
10422852|NCT00825825|11567901|FG000|COMPLETED|Second Washout Period (14 Days)||1
10422853|NCT00825825|11567902|FG001|COMPLETED|Second Washout Period (14 Days)||4
10422854|NCT00825825|11567903|FG002|COMPLETED|Second Washout Period (14 Days)||2
10422855|NCT00825825|11567904|FG003|COMPLETED|Second Washout Period (14 Days)||3
10422856|NCT00825825|11567905|FG004|COMPLETED|Second Washout Period (14 Days)||3
10422857|NCT00825825|11567906|FG005|COMPLETED|Second Washout Period (14 Days)||3
10422858|NCT00825825|11567901|FG000|NOT COMPLETED|Second Washout Period (14 Days)||0
10422859|NCT00825825|11567902|FG001|NOT COMPLETED|Second Washout Period (14 Days)||0
10422860|NCT00825825|11567903|FG002|NOT COMPLETED|Second Washout Period (14 Days)||0
10422861|NCT00825825|11567904|FG003|NOT COMPLETED|Second Washout Period (14 Days)||0
10422862|NCT00825825|11567905|FG004|NOT COMPLETED|Second Washout Period (14 Days)||0
10422863|NCT00825825|11567906|FG005|NOT COMPLETED|Second Washout Period (14 Days)||0
10422864|NCT00825825|11567901|FG000|STARTED|Third Medication Period (14 Days)||1
10422865|NCT00825825|11567902|FG001|STARTED|Third Medication Period (14 Days)||4
10422866|NCT00825825|11567903|FG002|STARTED|Third Medication Period (14 Days)||2
10422867|NCT00825825|11567904|FG003|STARTED|Third Medication Period (14 Days)||3
10422868|NCT00825825|11567905|FG004|STARTED|Third Medication Period (14 Days)||3
10422869|NCT00825825|11567906|FG005|STARTED|Third Medication Period (14 Days)||3
10422870|NCT00825825|11567901|FG000|COMPLETED|Third Medication Period (14 Days)||1
10422871|NCT00825825|11567902|FG001|COMPLETED|Third Medication Period (14 Days)||2
10422872|NCT00825825|11567903|FG002|COMPLETED|Third Medication Period (14 Days)||2
10422873|NCT00825825|11567904|FG003|COMPLETED|Third Medication Period (14 Days)||3
10422874|NCT00825825|11567905|FG004|COMPLETED|Third Medication Period (14 Days)||3
10422875|NCT00825825|11567906|FG005|COMPLETED|Third Medication Period (14 Days)||1
10422876|NCT00825825|11567901|FG000|NOT COMPLETED|Third Medication Period (14 Days)||0
10422877|NCT00825825|11567902|FG001|NOT COMPLETED|Third Medication Period (14 Days)||2
10422878|NCT00825825|11567903|FG002|NOT COMPLETED|Third Medication Period (14 Days)||0
10422879|NCT00825825|11567904|FG003|NOT COMPLETED|Third Medication Period (14 Days)||0
10422880|NCT00825825|11567905|FG004|NOT COMPLETED|Third Medication Period (14 Days)||0
10422881|NCT00825825|11567906|FG005|NOT COMPLETED|Third Medication Period (14 Days)||2
10422882|NCT00825916|11567916|FG000|STARTED|Overall Study||19
10422883|NCT00825916|11567917|FG001|STARTED|Overall Study||20
10422884|NCT00825916|11567918|FG002|STARTED|Overall Study||20
10422885|NCT00825916|11567916|FG000|COMPLETED|Overall Study||15
10422886|NCT00825916|11567917|FG001|COMPLETED|Overall Study||18
10422887|NCT00825916|11567918|FG002|COMPLETED|Overall Study||19
10422888|NCT00825916|11567916|FG000|NOT COMPLETED|Overall Study||4
10422889|NCT00825916|11567917|FG001|NOT COMPLETED|Overall Study||2
10422890|NCT00825916|11567918|FG002|NOT COMPLETED|Overall Study||1
10422891|NCT00825994|11567959|FG000|STARTED|Overall Study||24
10422892|NCT00825994|11567959|FG000|COMPLETED|Overall Study||19
10422893|NCT00825994|11567959|FG000|NOT COMPLETED|Overall Study||5
10422894|NCT00826007|11567965|FG000|STARTED|Overall Study|Retrospective review|308
10422895|NCT00826007|11567966|FG001|STARTED|Overall Study||279
10422896|NCT00826007|11567965|FG000|COMPLETED|Overall Study|Retrospective review|308
10422897|NCT00826007|11567966|FG001|COMPLETED|Overall Study||279
10422898|NCT00826007|11567965|FG000|NOT COMPLETED|Overall Study||0
10422899|NCT00826007|11567966|FG001|NOT COMPLETED|Overall Study||0
10422900|NCT00826020|11567971|FG000|STARTED|Overall Study||72
10422901|NCT00826020|11567971|FG000|COMPLETED|Overall Study||72
10422902|NCT00826020|11567971|FG000|NOT COMPLETED|Overall Study||0
10422903|NCT00826111|11567977|FG000|STARTED|Overall Study||14
10422904|NCT00826111|11567978|FG001|STARTED|Overall Study||5
10422905|NCT00826111|11567977|FG000|COMPLETED|Overall Study||7
10422906|NCT00826111|11567978|FG001|COMPLETED|Overall Study||3
10422907|NCT00826111|11567977|FG000|NOT COMPLETED|Overall Study||7
10422908|NCT00826111|11567978|FG001|NOT COMPLETED|Overall Study||2
10422909|NCT00826150|11567990|FG000|STARTED|Overall Study||8
10422910|NCT00826150|11567991|FG001|STARTED|Overall Study||3
10422911|NCT00826150|11567992|FG002|STARTED|Overall Study||3
10422912|NCT00826150|11567990|FG000|COMPLETED|Overall Study||2
10422913|NCT00826150|11567991|FG001|COMPLETED|Overall Study||1
10422914|NCT00826150|11567992|FG002|COMPLETED|Overall Study||0
10422915|NCT00826150|11567990|FG000|NOT COMPLETED|Overall Study||6
10422916|NCT00826150|11567991|FG001|NOT COMPLETED|Overall Study||2
10422917|NCT00826150|11567992|FG002|NOT COMPLETED|Overall Study||3
10422918|NCT00826176|11568004|FG000|STARTED|Overall Study|enrolled|128
10422919|NCT00826176|11568005|FG001|STARTED|Overall Study|enrolled|36
10422920|NCT00826176|11568004|FG000|COMPLETED|Overall Study|treated and completed|115
10422921|NCT00826176|11568005|FG001|COMPLETED|Overall Study|treated and completed|36
10422922|NCT00826176|11568004|FG000|NOT COMPLETED|Overall Study||13
10422923|NCT00826176|11568005|FG001|NOT COMPLETED|Overall Study||0
10422924|NCT00826202|11568013|FG000|STARTED|Overall Study||20
10422925|NCT00826202|11568014|FG001|STARTED|Overall Study||24
10422926|NCT00826202|11568013|FG000|Completed Visit 4 (1st Efficacy Visit)|Overall Study||15
10422927|NCT00826202|11568014|FG001|Completed Visit 4 (1st Efficacy Visit)|Overall Study||20
10422928|NCT00826202|11568013|FG000|COMPLETED|Overall Study||10
10422929|NCT00826202|11568014|FG001|COMPLETED|Overall Study||11
10422930|NCT00826202|11568013|FG000|NOT COMPLETED|Overall Study||10
10422931|NCT00826202|11568014|FG001|NOT COMPLETED|Overall Study||13
10422932|NCT00826228|11568020|FG000|STARTED|Overall Study||12
10422933|NCT00826228|11568020|FG000|COMPLETED|Overall Study||11
10422934|NCT00826228|11568020|FG000|NOT COMPLETED|Overall Study||1
10422935|NCT00826241|11568025|FG000|STARTED|Overall Study||58
10422936|NCT00826241|11568025|FG000|COMPLETED|Overall Study||31
10422937|NCT00826241|11568025|FG000|NOT COMPLETED|Overall Study||27
10422938|NCT00826267|11568032|FG000|STARTED|Overall Study||10
10422939|NCT00826267|11568033|FG001|STARTED|Overall Study||8
10422940|NCT00826267|11568034|FG002|STARTED|Overall Study||11
10422941|NCT00826267|11568032|FG000|COMPLETED|Overall Study||9
10422942|NCT00826267|11568033|FG001|COMPLETED|Overall Study||8
10422943|NCT00826267|11568034|FG002|COMPLETED|Overall Study||11
10422944|NCT00826267|11568032|FG000|NOT COMPLETED|Overall Study||1
10422945|NCT00826267|11568033|FG001|NOT COMPLETED|Overall Study||0
10422946|NCT00826267|11568034|FG002|NOT COMPLETED|Overall Study||0
10422947|NCT00826280|11568046|FG000|STARTED|Overall Study||114
10422948|NCT00826280|11568047|FG001|STARTED|Overall Study||116
10422949|NCT00826280|11568048|FG002|STARTED|Overall Study||117
10422950|NCT00826280|11568046|FG000|Safety Analysis Set|Overall Study|Safety Analysis Set (SAF) was all randomized subjects who received at least one dose of regadenoson|113
10422951|NCT00826280|11568047|FG001|Safety Analysis Set|Overall Study|SAF was all randomized subjects who received at least one dose of regadenoson|116
10422952|NCT00826280|11568048|FG002|Safety Analysis Set|Overall Study|SAF was all randomized subjects who received at least one dose of regadenoson|116
10422953|NCT00826280|11568046|FG000|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|66
10422954|NCT00826280|11568047|FG001|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|71
10422955|NCT00826280|11568048|FG002|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|72
10422956|NCT00826280|11568046|FG000|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|66
10422957|NCT00826280|11568047|FG001|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|70
10422958|NCT00826280|11568048|FG002|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|71
10422959|NCT00826280|11568046|FG000|NOT COMPLETED|Overall Study||48
10422960|NCT00826280|11568047|FG001|NOT COMPLETED|Overall Study||46
10422961|NCT00826280|11568048|FG002|NOT COMPLETED|Overall Study||46
10422962|NCT00826449|11568058|FG000|STARTED|Overall Study||47
10422963|NCT00826449|11568058|FG000|Phase I|Overall Study||12
10422964|NCT00826449|11568058|FG000|Phase II|Overall Study||35
10422965|NCT00826449|11568058|FG000|COMPLETED|Overall Study||42
10422966|NCT00826449|11568058|FG000|NOT COMPLETED|Overall Study||5
10422967|NCT00826514|11568065|FG000|STARTED|Overall Study||30
10422968|NCT00826514|11568066|FG001|STARTED|Overall Study||32
10422969|NCT00826514|11568065|FG000|COMPLETED|Overall Study||27
10422970|NCT00826514|11568066|FG001|COMPLETED|Overall Study||27
10422971|NCT00826514|11568065|FG000|NOT COMPLETED|Overall Study||3
10422972|NCT00826514|11568066|FG001|NOT COMPLETED|Overall Study||5
10422973|NCT00826540|11568072|FG000|STARTED|Overall Study||83
10422974|NCT00826540|11568072|FG000|COMPLETED|Overall Study||79
10422975|NCT00826540|11568072|FG000|NOT COMPLETED|Overall Study||4
10422976|NCT00826618|11568076|FG000|STARTED|Overall Study||6
10422977|NCT00826618|11568076|FG000|COMPLETED|Overall Study||5
10422978|NCT00826618|11568076|FG000|NOT COMPLETED|Overall Study||1
10422979|NCT00826748|11568083|FG000|STARTED|Overall Study||6
10422980|NCT00826748|11568084|FG001|STARTED|Overall Study||4
10422981|NCT00826748|11568085|FG002|STARTED|Overall Study||12
10422982|NCT00826748|11568083|FG000|COMPLETED|Overall Study||6
10422983|NCT00826748|11568084|FG001|COMPLETED|Overall Study||4
10422984|NCT00826748|11568085|FG002|COMPLETED|Overall Study||8
10422985|NCT00826748|11568083|FG000|NOT COMPLETED|Overall Study||0
10422986|NCT00826748|11568084|FG001|NOT COMPLETED|Overall Study||0
10422987|NCT00826748|11568085|FG002|NOT COMPLETED|Overall Study||4
10422988|NCT00826800|11568093|FG000|STARTED|Overall Study||2
10422989|NCT00826800|11568093|FG000|COMPLETED|Overall Study||2
10422990|NCT00826800|11568093|FG000|NOT COMPLETED|Overall Study||0
10422991|NCT00826943|11568097|FG000|STARTED|Overall Study||6
10422992|NCT00826943|11568098|FG001|STARTED|Overall Study||6
10422993|NCT00826943|11568099|FG002|STARTED|Overall Study||4
10422994|NCT00826943|11568100|FG003|STARTED|Overall Study||5
10422995|NCT00826943|11568101|FG004|STARTED|Overall Study||7
10422996|NCT00826943|11568102|FG005|STARTED|Overall Study||2
10422997|NCT00826943|11568097|FG000|COMPLETED|Overall Study||6
10422998|NCT00826943|11568098|FG001|COMPLETED|Overall Study||6
10422999|NCT00826943|11568099|FG002|COMPLETED|Overall Study||4
10423000|NCT00826943|11568100|FG003|COMPLETED|Overall Study||5
10423001|NCT00826943|11568101|FG004|COMPLETED|Overall Study||6
10423002|NCT00826943|11568102|FG005|COMPLETED|Overall Study||2
10423003|NCT00826943|11568097|FG000|NOT COMPLETED|Overall Study||0
10423004|NCT00826943|11568098|FG001|NOT COMPLETED|Overall Study||0
10423005|NCT00826943|11568099|FG002|NOT COMPLETED|Overall Study||0
10423006|NCT00826943|11568100|FG003|NOT COMPLETED|Overall Study||0
10423007|NCT00826943|11568101|FG004|NOT COMPLETED|Overall Study||1
10423008|NCT00826943|11568102|FG005|NOT COMPLETED|Overall Study||0
10423009|NCT00827073|11568112|FG000|STARTED|Overall Study||20
10423010|NCT00827073|11568113|FG001|STARTED|Overall Study||20
10423011|NCT00827073|11568112|FG000|COMPLETED|Overall Study||20
10423012|NCT00827073|11568113|FG001|COMPLETED|Overall Study||20
10423013|NCT00827073|11568112|FG000|NOT COMPLETED|Overall Study||0
10423014|NCT00827073|11568113|FG001|NOT COMPLETED|Overall Study||0
10423015|NCT00827099|11568119|FG000|STARTED|Overall Study||5
10423016|NCT00827099|11568119|FG000|COMPLETED|Overall Study||5
10423017|NCT00827099|11568119|FG000|NOT COMPLETED|Overall Study||0
10423018|NCT00827112|11568125|FG000|STARTED|Overall Study||65
10423019|NCT00827112|11568126|FG001|STARTED|Overall Study||64
10423020|NCT00827112|11568125|FG000|Treated|Overall Study||60
10423021|NCT00827112|11568126|FG001|Treated|Overall Study||61
10423022|NCT00827112|11568125|FG000|COMPLETED|Overall Study||50
10423023|NCT00827112|11568126|FG001|COMPLETED|Overall Study||52
10423024|NCT00827112|11568125|FG000|NOT COMPLETED|Overall Study||15
10423025|NCT00827112|11568126|FG001|NOT COMPLETED|Overall Study||12
10423026|NCT00827242|11568134|FG000|STARTED|Overall Study||161
10423027|NCT00827242|11568135|FG001|STARTED|Overall Study||164
10423028|NCT00827242|11568134|FG000|COMPLETED|Overall Study||148
10423029|NCT00827242|11568135|FG001|COMPLETED|Overall Study||152
10423030|NCT00827242|11568134|FG000|NOT COMPLETED|Overall Study||13
10423031|NCT00827242|11568135|FG001|NOT COMPLETED|Overall Study||12
10423032|NCT00827255|11568141|FG000|STARTED|Overall Study||35
10423033|NCT00827255|11568141|FG000|COMPLETED|Overall Study||35
10423034|NCT00827255|11568141|FG000|NOT COMPLETED|Overall Study||0
10423035|NCT00827359|11568145|FG000|STARTED|Overall Study||25
10423036|NCT00827359|11568145|FG000|Treated|Overall Study||24
10423037|NCT00827359|11568145|FG000|COMPLETED|Overall Study||0
10423038|NCT00827359|11568145|FG000|NOT COMPLETED|Overall Study||25
10423039|NCT00827372|11568149|FG000|STARTED|Overall Study||10
10423040|NCT00827372|11568149|FG000|COMPLETED|Overall Study||2
10423041|NCT00827372|11568149|FG000|NOT COMPLETED|Overall Study||8
10423042|NCT00827502|11568154|FG000|STARTED|Overall Study||421
10423043|NCT00827502|11568154|FG000|Received Treatment (Number Treated)|Overall Study||410
10423044|NCT00827502|11568154|FG000|COMPLETED|Overall Study||400
10423045|NCT00827502|11568154|FG000|NOT COMPLETED|Overall Study||21
10546957|NCT01511250|11700821|FG007|STARTED|Overall Study||13
10546958|NCT01511250|11700822|FG008|STARTED|Overall Study||159
10546959|NCT01511250|11700823|FG009|STARTED|Overall Study||53
10546960|NCT01511250|11700814|FG000|COMPLETED|Overall Study||15
10546961|NCT01511250|11700815|FG001|COMPLETED|Overall Study||9
10546962|NCT01511250|11700816|FG002|COMPLETED|Overall Study||18
10546963|NCT01511250|11700817|FG003|COMPLETED|Overall Study||11
10546964|NCT01511250|11700818|FG004|COMPLETED|Overall Study||21
10546965|NCT01511250|11700819|FG005|COMPLETED|Overall Study||17
10546966|NCT01511250|11700820|FG006|COMPLETED|Overall Study||21
10546967|NCT01511250|11700821|FG007|COMPLETED|Overall Study||9
10546968|NCT01511250|11700822|FG008|COMPLETED|Overall Study||145
10546969|NCT01511250|11700823|FG009|COMPLETED|Overall Study||48
10546970|NCT01511250|11700814|FG000|NOT COMPLETED|Overall Study||9
10546971|NCT01511250|11700815|FG001|NOT COMPLETED|Overall Study||5
10546972|NCT01511250|11700816|FG002|NOT COMPLETED|Overall Study||4
10546973|NCT01511250|11700817|FG003|NOT COMPLETED|Overall Study||3
10546974|NCT01511250|11700818|FG004|NOT COMPLETED|Overall Study||0
10546975|NCT01511250|11700819|FG005|NOT COMPLETED|Overall Study||0
10546976|NCT01511250|11700820|FG006|NOT COMPLETED|Overall Study||2
10546977|NCT01511250|11700821|FG007|NOT COMPLETED|Overall Study||4
10546978|NCT01511250|11700822|FG008|NOT COMPLETED|Overall Study||14
10546979|NCT01511250|11700823|FG009|NOT COMPLETED|Overall Study||5
10546980|NCT01511315|11700845|FG000|STARTED|Overall Study||36
10546981|NCT01511315|11700845|FG000|COMPLETED|Overall Study||32
10546982|NCT01511315|11700845|FG000|NOT COMPLETED|Overall Study||4
10546983|NCT01511419|11700851|FG000|STARTED|Dose 1||30
10546984|NCT01511419|11700852|FG001|STARTED|Dose 1||10
10546985|NCT01511419|11700851|FG000|COMPLETED|Dose 1||30
10546986|NCT01511419|11700852|FG001|COMPLETED|Dose 1||10
10546987|NCT01511419|11700851|FG000|NOT COMPLETED|Dose 1||0
10423046|NCT00827541|11568160|FG000|STARTED|Overall Study||19
10423047|NCT00827541|11568161|FG001|STARTED|Overall Study||96
10423048|NCT00827541|11568160|FG000|COMPLETED|Overall Study||15
10546988|NCT01511419|11700852|FG001|NOT COMPLETED|Dose 1||0
10546989|NCT01511419|11700851|FG000|STARTED|Dose 2||30
10546990|NCT01511419|11700852|FG001|STARTED|Dose 2||10
10546991|NCT01511419|11700851|FG000|COMPLETED|Dose 2||29
10546992|NCT01511419|11700852|FG001|COMPLETED|Dose 2||10
10546993|NCT01511419|11700851|FG000|NOT COMPLETED|Dose 2||1
10423049|NCT00827541|11568161|FG001|COMPLETED|Overall Study||85
10423050|NCT00827541|11568160|FG000|NOT COMPLETED|Overall Study||4
10423051|NCT00827541|11568161|FG001|NOT COMPLETED|Overall Study||11
10423052|NCT00827606|11568169|FG000|STARTED|Overall Study||139
10423053|NCT00827606|11568170|FG001|STARTED|Overall Study||132
10423054|NCT00827606|11568169|FG000|COMPLETED|Overall Study||112
10423055|NCT00827606|11568170|FG001|COMPLETED|Overall Study||94
10423056|NCT00827606|11568169|FG000|NOT COMPLETED|Overall Study||27
10423057|NCT00827606|11568170|FG001|NOT COMPLETED|Overall Study||38
10423058|NCT00827632|11568184|FG000|STARTED|Overall Study||128
10423059|NCT00827632|11568185|FG001|STARTED|Overall Study||98
10423060|NCT00827632|11568184|FG000|COMPLETED|Overall Study||106
10423061|NCT00827632|11568185|FG001|COMPLETED|Overall Study||75
10423062|NCT00827632|11568184|FG000|NOT COMPLETED|Overall Study||22
10423063|NCT00827632|11568185|FG001|NOT COMPLETED|Overall Study||23
10423064|NCT00827775|11568193|FG000|STARTED|Overall Study||25
10423065|NCT00827775|11568194|FG001|STARTED|Overall Study||30
10423066|NCT00827775|11568193|FG000|COMPLETED|Overall Study||25
10423067|NCT00827775|11568194|FG001|COMPLETED|Overall Study||25
10423068|NCT00827775|11568193|FG000|NOT COMPLETED|Overall Study||0
10423069|NCT00827775|11568194|FG001|NOT COMPLETED|Overall Study||5
10423070|NCT00827827|11568202|FG000|STARTED|Overall Study||22
10423071|NCT00827827|11568203|FG001|STARTED|Overall Study||16
10423072|NCT00827827|11568202|FG000|COMPLETED|Overall Study||14
10423073|NCT00827827|11568203|FG001|COMPLETED|Overall Study||16
10423074|NCT00827827|11568202|FG000|NOT COMPLETED|Overall Study||8
10423075|NCT00827827|11568203|FG001|NOT COMPLETED|Overall Study||0
10423076|NCT00827918|11568213|FG000|STARTED|Overall Study||86
10423077|NCT00827918|11568214|FG001|STARTED|Overall Study||47
10423078|NCT00827918|11568215|FG002|STARTED|Overall Study||83
10423079|NCT00827918|11568213|FG000|COMPLETED|Overall Study||58
10423080|NCT00827918|11568214|FG001|COMPLETED|Overall Study||38
10423081|NCT00827918|11568215|FG002|COMPLETED|Overall Study||62
10423082|NCT00827918|11568213|FG000|NOT COMPLETED|Overall Study||28
10423083|NCT00827918|11568214|FG001|NOT COMPLETED|Overall Study||9
10423084|NCT00827918|11568215|FG002|NOT COMPLETED|Overall Study||21
10423085|NCT00827931|11568225|FG000|STARTED|Overall Study||49
10423086|NCT00827931|11568226|FG001|STARTED|Overall Study||45
10423087|NCT00827931|11568225|FG000|COMPLETED|Overall Study||43
10423088|NCT00827931|11568226|FG001|COMPLETED|Overall Study||39
10423089|NCT00827931|11568225|FG000|NOT COMPLETED|Overall Study||6
10423090|NCT00827931|11568226|FG001|NOT COMPLETED|Overall Study||6
10423091|NCT00827944|11568234|FG000|STARTED|Overall Study||304
10423092|NCT00827944|11568235|FG001|STARTED|Overall Study||299
10423093|NCT00827944|11568234|FG000|COMPLETED|Overall Study||241
10423094|NCT00827944|11568235|FG001|COMPLETED|Overall Study||240
10423095|NCT00827944|11568234|FG000|NOT COMPLETED|Overall Study||63
10423096|NCT00827944|11568235|FG001|NOT COMPLETED|Overall Study||59
10423097|NCT00827983|11568243|FG000|STARTED|Overall Study|All randomised patients|339
10423098|NCT00827983|11568244|FG001|STARTED|Overall Study|all randomised patients|344
10423099|NCT00827983|11568243|FG000|COMPLETED|Overall Study|patients who performed the pregnancy test|321
10423100|NCT00827983|11568244|FG001|COMPLETED|Overall Study|patients who performed the pregnancy test|328
10423101|NCT00827983|11568243|FG000|NOT COMPLETED|Overall Study||18
10423102|NCT00827983|11568244|FG001|NOT COMPLETED|Overall Study||16
10423103|NCT00828009|11568250|FG000|STARTED|Step 1 - Chemo RT/Consolidation Chemo||70
10423104|NCT00828009|11568250|FG000|Started Treatment|Step 1 - Chemo RT/Consolidation Chemo||68
10423105|NCT00828009|11568250|FG000|COMPLETED|Step 1 - Chemo RT/Consolidation Chemo||39
10423106|NCT00828009|11568250|FG000|NOT COMPLETED|Step 1 - Chemo RT/Consolidation Chemo||31
10423107|NCT00828009|11568250|FG000|STARTED|Step 2 - Maintenance Therapy|Among 39 pts with tx completion, 4 did not register to step 2 and 2 had PD at the end of step 1.|33
10423108|NCT00828009|11568250|FG000|COMPLETED|Step 2 - Maintenance Therapy|Max maintenance therapy was 34 cycles. No patients were off treatment due to completion of 34 cycles|0
10423109|NCT00828009|11568250|FG000|NOT COMPLETED|Step 2 - Maintenance Therapy||33
10423110|NCT00828061|11568255|FG000|STARTED|Period 1||4
10423111|NCT00828061|11568256|FG001|STARTED|Period 1||3
10423112|NCT00828061|11568257|FG002|STARTED|Period 1||3
10423113|NCT00828061|11568258|FG003|STARTED|Period 1||3
10423114|NCT00828061|11568259|FG004|STARTED|Period 1||3
10423115|NCT00828061|11568260|FG005|STARTED|Period 1||3
10423116|NCT00828061|11568255|FG000|COMPLETED|Period 1||4
10423117|NCT00828061|11568256|FG001|COMPLETED|Period 1||3
10423118|NCT00828061|11568257|FG002|COMPLETED|Period 1||3
10423119|NCT00828061|11568258|FG003|COMPLETED|Period 1||3
10423120|NCT00828061|11568259|FG004|COMPLETED|Period 1||3
10423121|NCT00828061|11568260|FG005|COMPLETED|Period 1||3
10423122|NCT00828061|11568255|FG000|NOT COMPLETED|Period 1||0
10423123|NCT00828061|11568256|FG001|NOT COMPLETED|Period 1||0
10423124|NCT00828061|11568257|FG002|NOT COMPLETED|Period 1||0
10423125|NCT00828061|11568258|FG003|NOT COMPLETED|Period 1||0
10423126|NCT00828061|11568259|FG004|NOT COMPLETED|Period 1||0
10423127|NCT00828061|11568260|FG005|NOT COMPLETED|Period 1||0
10423128|NCT00828061|11568255|FG000|STARTED|Period 2||4
10423129|NCT00828061|11568256|FG001|STARTED|Period 2||3
10423130|NCT00828061|11568257|FG002|STARTED|Period 2||3
10423131|NCT00828061|11568258|FG003|STARTED|Period 2||3
10423132|NCT00828061|11568259|FG004|STARTED|Period 2||3
10423133|NCT00828061|11568260|FG005|STARTED|Period 2||3
10423134|NCT00828061|11568255|FG000|COMPLETED|Period 2||4
10423135|NCT00828061|11568256|FG001|COMPLETED|Period 2||3
10423136|NCT00828061|11568257|FG002|COMPLETED|Period 2||3
10423137|NCT00828061|11568258|FG003|COMPLETED|Period 2||3
10423138|NCT00828061|11568259|FG004|COMPLETED|Period 2||3
10423139|NCT00828061|11568260|FG005|COMPLETED|Period 2||3
10423140|NCT00828061|11568255|FG000|NOT COMPLETED|Period 2||0
10423141|NCT00828061|11568256|FG001|NOT COMPLETED|Period 2||0
10423142|NCT00828061|11568257|FG002|NOT COMPLETED|Period 2||0
10423143|NCT00828061|11568258|FG003|NOT COMPLETED|Period 2||0
10423144|NCT00828061|11568259|FG004|NOT COMPLETED|Period 2||0
10423145|NCT00828061|11568260|FG005|NOT COMPLETED|Period 2||0
10546994|NCT01511419|11700852|FG001|NOT COMPLETED|Dose 2||0
10546995|NCT01511445|11700884|FG000|STARTED|Overall Study|Patient enrollment started in December, 2011.|53
10546996|NCT01511445|11700885|FG001|STARTED|Overall Study|Patient enrollment started in December, 2011.|51
10546997|NCT01511445|11700884|FG000|Surgeries Completed|Overall Study|All surgeries were completed by October, 2013.|53
10546998|NCT01511445|11700885|FG001|Surgeries Completed|Overall Study|All surgeries were completed by October, 2013.|51
10546999|NCT01511445|11700884|FG000|Primary Completion October, 2014|Overall Study|1 was excluded Bechterew's disease. 1 protocol violation. 3 were lost to follow-up.|48
10547000|NCT01511445|11700885|FG001|Primary Completion October, 2014|Overall Study|3 protocol violations. 1 lost to follow-up.|47
10547001|NCT01511445|11700884|FG000|Follow-up Completion|Overall Study|Two year follow-up was completed in November, 2015|48
10547002|NCT01511445|11700885|FG001|Follow-up Completion|Overall Study|Two year follow-up was completed in November, 2015|47
10547003|NCT01511445|11700884|FG000|COMPLETED|Overall Study|Data analysis was completed in February, 2016|48
10547004|NCT01511445|11700885|FG001|COMPLETED|Overall Study|Data analysis was completed in February, 2016|47
10547005|NCT01511445|11700884|FG000|NOT COMPLETED|Overall Study||5
10547006|NCT01511445|11700885|FG001|NOT COMPLETED|Overall Study||4
10547007|NCT01511536|11700894|FG000|STARTED|Phase 1||3
10547008|NCT01511536|11700895|FG001|STARTED|Phase 1||7
10547009|NCT01511536|11700896|FG002|STARTED|Phase 1|Phase 1 and phase 2 are separate populations.|0
10547010|NCT01511536|11700894|FG000|COMPLETED|Phase 1|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|3
10547011|NCT01511536|11700895|FG001|COMPLETED|Phase 1|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|6
10547012|NCT01511536|11700896|FG002|COMPLETED|Phase 1||0
10547013|NCT01511536|11700894|FG000|NOT COMPLETED|Phase 1||0
10547014|NCT01511536|11700895|FG001|NOT COMPLETED|Phase 1||1
10547015|NCT01511536|11700896|FG002|NOT COMPLETED|Phase 1||0
10547016|NCT01511536|11700894|FG000|STARTED|Phase 2||0
10547017|NCT01511536|11700895|FG001|STARTED|Phase 2||0
10547018|NCT01511536|11700896|FG002|STARTED|Phase 2||27
10547019|NCT01511536|11700894|FG000|COMPLETED|Phase 2||0
10547020|NCT01511536|11700895|FG001|COMPLETED|Phase 2||0
10547021|NCT01511536|11700896|FG002|COMPLETED|Phase 2|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|18
10547022|NCT01511536|11700894|FG000|NOT COMPLETED|Phase 2||0
10547023|NCT01511536|11700895|FG001|NOT COMPLETED|Phase 2||0
10547024|NCT01511536|11700896|FG002|NOT COMPLETED|Phase 2||9
10547025|NCT01511640|11700908|FG000|STARTED|First Intervention (11-15 Days)||7
10547026|NCT01511640|11700909|FG001|STARTED|First Intervention (11-15 Days)||8
10547027|NCT01511640|11700910|FG002|STARTED|First Intervention (11-15 Days)||7
10547028|NCT01511640|11700911|FG003|STARTED|First Intervention (11-15 Days)||8
10547029|NCT01511640|11700908|FG000|COMPLETED|First Intervention (11-15 Days)||5
10547030|NCT01511640|11700909|FG001|COMPLETED|First Intervention (11-15 Days)||8
10547031|NCT01511640|11700910|FG002|COMPLETED|First Intervention (11-15 Days)||7
10547032|NCT01511640|11700911|FG003|COMPLETED|First Intervention (11-15 Days)||7
10547033|NCT01511640|11700908|FG000|NOT COMPLETED|First Intervention (11-15 Days)||2
10547034|NCT01511640|11700909|FG001|NOT COMPLETED|First Intervention (11-15 Days)||0
10547035|NCT01511640|11700910|FG002|NOT COMPLETED|First Intervention (11-15 Days)||0
10547036|NCT01511640|11700911|FG003|NOT COMPLETED|First Intervention (11-15 Days)||1
10547037|NCT01511640|11700908|FG000|STARTED|Washout (6-10 Days)||5
10547038|NCT01511640|11700909|FG001|STARTED|Washout (6-10 Days)||8
10547039|NCT01511640|11700910|FG002|STARTED|Washout (6-10 Days)||7
10547040|NCT01511640|11700911|FG003|STARTED|Washout (6-10 Days)||7
10547041|NCT01511640|11700908|FG000|COMPLETED|Washout (6-10 Days)||5
10547042|NCT01511640|11700909|FG001|COMPLETED|Washout (6-10 Days)||8
10547043|NCT01511640|11700910|FG002|COMPLETED|Washout (6-10 Days)||7
10547044|NCT01511640|11700911|FG003|COMPLETED|Washout (6-10 Days)||6
10547045|NCT01511640|11700908|FG000|NOT COMPLETED|Washout (6-10 Days)||0
10547046|NCT01511640|11700909|FG001|NOT COMPLETED|Washout (6-10 Days)||0
10547047|NCT01511640|11700910|FG002|NOT COMPLETED|Washout (6-10 Days)||0
10547048|NCT01511640|11700911|FG003|NOT COMPLETED|Washout (6-10 Days)||1
10547049|NCT01511640|11700908|FG000|STARTED|Third Intervention (11-15 Days)||5
10547050|NCT01511640|11700909|FG001|STARTED|Third Intervention (11-15 Days)||8
10547051|NCT01511640|11700910|FG002|STARTED|Third Intervention (11-15 Days)||7
10547052|NCT01511640|11700911|FG003|STARTED|Third Intervention (11-15 Days)||6
10547053|NCT01511640|11700908|FG000|COMPLETED|Third Intervention (11-15 Days)||4
10547054|NCT01511640|11700909|FG001|COMPLETED|Third Intervention (11-15 Days)||7
10547055|NCT01511640|11700910|FG002|COMPLETED|Third Intervention (11-15 Days)||7
10547056|NCT01511640|11700911|FG003|COMPLETED|Third Intervention (11-15 Days)||6
10547057|NCT01511640|11700908|FG000|NOT COMPLETED|Third Intervention (11-15 Days)||1
10547058|NCT01511640|11700909|FG001|NOT COMPLETED|Third Intervention (11-15 Days)||1
10547059|NCT01511640|11700910|FG002|NOT COMPLETED|Third Intervention (11-15 Days)||0
10547060|NCT01511640|11700911|FG003|NOT COMPLETED|Third Intervention (11-15 Days)||0
10547061|NCT01511809|11700923|FG000|STARTED|Overall Study||58
10547062|NCT01511809|11700924|FG001|STARTED|Overall Study||59
10547063|NCT01511809|11700923|FG000|COMPLETED|Overall Study||51
10423146|NCT00828061|11568255|FG000|STARTED|Period 3||4
10423147|NCT00828061|11568256|FG001|STARTED|Period 3||3
10423148|NCT00828061|11568257|FG002|STARTED|Period 3||3
10423149|NCT00828061|11568258|FG003|STARTED|Period 3||3
10423150|NCT00828061|11568259|FG004|STARTED|Period 3||3
10423151|NCT00828061|11568260|FG005|STARTED|Period 3||3
10423152|NCT00828061|11568255|FG000|COMPLETED|Period 3||4
10423153|NCT00828061|11568256|FG001|COMPLETED|Period 3||3
10423154|NCT00828061|11568257|FG002|COMPLETED|Period 3||3
10423155|NCT00828061|11568258|FG003|COMPLETED|Period 3||3
10423156|NCT00828061|11568259|FG004|COMPLETED|Period 3||3
10423157|NCT00828061|11568260|FG005|COMPLETED|Period 3||3
10423158|NCT00828061|11568255|FG000|NOT COMPLETED|Period 3||0
10423159|NCT00828061|11568256|FG001|NOT COMPLETED|Period 3||0
10423160|NCT00828061|11568257|FG002|NOT COMPLETED|Period 3||0
10423161|NCT00828061|11568258|FG003|NOT COMPLETED|Period 3||0
10423162|NCT00828061|11568259|FG004|NOT COMPLETED|Period 3||0
10423163|NCT00828061|11568260|FG005|NOT COMPLETED|Period 3||0
10423164|NCT00828074|11568270|FG000|STARTED|Overall Study||6
10423165|NCT00828074|11568271|FG001|STARTED|Overall Study||5
10423166|NCT00828074|11568272|FG002|STARTED|Overall Study||35
10423167|NCT00828074|11568270|FG000|COMPLETED|Overall Study||6
10423168|NCT00828074|11568271|FG001|COMPLETED|Overall Study||5
10423169|NCT00828074|11568272|FG002|COMPLETED|Overall Study||35
10423170|NCT00828074|11568270|FG000|NOT COMPLETED|Overall Study||0
10423171|NCT00828074|11568271|FG001|NOT COMPLETED|Overall Study||0
10423172|NCT00828074|11568272|FG002|NOT COMPLETED|Overall Study||0
10423173|NCT00828113|11568284|FG000|STARTED|Overall Study||50
10423174|NCT00828113|11568285|FG001|STARTED|Overall Study||51
10423175|NCT00828113|11568284|FG000|COMPLETED|Overall Study||20
10423176|NCT00828113|11568285|FG001|COMPLETED|Overall Study||20
10423177|NCT00828113|11568284|FG000|NOT COMPLETED|Overall Study||30
10423178|NCT00828113|11568285|FG001|NOT COMPLETED|Overall Study||31
10423179|NCT00828139|11568295|FG000|STARTED|Overall Study||42
10423180|NCT00828139|11568296|FG001|STARTED|Overall Study||41
10423181|NCT00828139|11568297|FG002|STARTED|Overall Study||55
10423182|NCT00828139|11568298|FG003|STARTED|Overall Study||51
10423183|NCT00828139|11568295|FG000|COMPLETED|Overall Study||1
10423184|NCT00828139|11568296|FG001|COMPLETED|Overall Study||0
10423185|NCT00828139|11568297|FG002|COMPLETED|Overall Study||0
10423186|NCT00828139|11568298|FG003|COMPLETED|Overall Study||0
10423187|NCT00828139|11568295|FG000|NOT COMPLETED|Overall Study||41
10423188|NCT00828139|11568296|FG001|NOT COMPLETED|Overall Study||41
10423189|NCT00828139|11568297|FG002|NOT COMPLETED|Overall Study||55
10423190|NCT00828139|11568298|FG003|NOT COMPLETED|Overall Study||51
10423191|NCT00828178|11568310|FG000|STARTED|Overall Study||42
10423192|NCT00828178|11568311|FG001|STARTED|Overall Study|Eighty seven participants were randomized.|45
10423193|NCT00828178|11568310|FG000|COMPLETED|Overall Study||42
10423194|NCT00828178|11568311|FG001|COMPLETED|Overall Study|Two patients did not complete the study.|43
10423195|NCT00828178|11568310|FG000|NOT COMPLETED|Overall Study||0
10423196|NCT00828178|11568311|FG001|NOT COMPLETED|Overall Study||2
10423197|NCT00828191|11568321|FG000|STARTED|Overall Study|Randomized patients|400
10423198|NCT00828191|11568322|FG001|STARTED|Overall Study|Randomized patients|400
10423199|NCT00828191|11568321|FG000|COMPLETED|Overall Study|Patients with at least one embryo transferred.|392
10423200|NCT00828191|11568322|FG001|COMPLETED|Overall Study|Patients with at least one embryo transferred.|390
10423201|NCT00828191|11568321|FG000|NOT COMPLETED|Overall Study||8
10423202|NCT00828191|11568322|FG001|NOT COMPLETED|Overall Study||10
10423203|NCT00828204|11568330|FG000|STARTED|Main Study: Prior to Study Suspension||21
10423204|NCT00828204|11568331|FG001|STARTED|Main Study: Prior to Study Suspension|Main Subset was not enrolled until after study suspension (period 2, below).|0
10423205|NCT00828204|11568330|FG000|Completed Manual Injection|Main Study: Prior to Study Suspension||21
10423206|NCT00828204|11568331|FG001|Completed Manual Injection|Main Study: Prior to Study Suspension||0
10423207|NCT00828204|11568330|FG000|Continued With Autoinjector Injections|Main Study: Prior to Study Suspension||19
10423208|NCT00828204|11568331|FG001|Continued With Autoinjector Injections|Main Study: Prior to Study Suspension||0
10423209|NCT00828204|11568330|FG000|COMPLETED|Main Study: Prior to Study Suspension||7
10423210|NCT00828204|11568331|FG001|COMPLETED|Main Study: Prior to Study Suspension||0
10423211|NCT00828204|11568330|FG000|NOT COMPLETED|Main Study: Prior to Study Suspension||14
10423212|NCT00828204|11568331|FG001|NOT COMPLETED|Main Study: Prior to Study Suspension||0
10423213|NCT00828204|11568330|FG000|STARTED|Main Study: After Study Restart|Initial Subset participants did not continue after the study was suspended.|0
10423214|NCT00828204|11568331|FG001|STARTED|Main Study: After Study Restart|After a protocol amendment, the Main Subset participants were enrolled.|74
10423215|NCT00828204|11568330|FG000|Completed Manual Injection|Main Study: After Study Restart||0
10423216|NCT00828204|11568331|FG001|Completed Manual Injection|Main Study: After Study Restart||74
10423217|NCT00828204|11568330|FG000|Continued With Autoinjector Injections|Main Study: After Study Restart||0
10423218|NCT00828204|11568331|FG001|Continued With Autoinjector Injections|Main Study: After Study Restart||72
10423219|NCT00828204|11568330|FG000|COMPLETED|Main Study: After Study Restart||0
10423220|NCT00828204|11568331|FG001|COMPLETED|Main Study: After Study Restart||71
10423221|NCT00828204|11568330|FG000|NOT COMPLETED|Main Study: After Study Restart||0
10423222|NCT00828204|11568331|FG001|NOT COMPLETED|Main Study: After Study Restart||3
10423223|NCT00828204|11568330|FG000|STARTED|Extension Study|Participation in the Extension Study was not offered to Initial Subset after completing Main Study.|0
10423224|NCT00828204|11568331|FG001|STARTED|Extension Study|Participation in Extension Study was optional for Main Subset participants completing Main Study.|64
10423225|NCT00828204|11568330|FG000|COMPLETED|Extension Study||0
10423226|NCT00828204|11568331|FG001|COMPLETED|Extension Study||61
10423227|NCT00828204|11568330|FG000|NOT COMPLETED|Extension Study||0
10423228|NCT00828204|11568331|FG001|NOT COMPLETED|Extension Study||3
10423229|NCT00828295|11568340|FG000|STARTED|Overall Study||75
10423230|NCT00828295|11568341|FG001|STARTED|Overall Study||75
10423231|NCT00828295|11568340|FG000|COMPLETED|Overall Study||75
10423232|NCT00828295|11568341|FG001|COMPLETED|Overall Study||75
10423233|NCT00828295|11568340|FG000|NOT COMPLETED|Overall Study||0
10423234|NCT00828295|11568341|FG001|NOT COMPLETED|Overall Study||0
10423235|NCT00828347|11568349|FG000|STARTED|Overall Study||12
10423236|NCT00828347|11568350|FG001|STARTED|Overall Study||11
10423237|NCT00828347|11568349|FG000|COMPLETED|Overall Study||12
10423238|NCT00828347|11568350|FG001|COMPLETED|Overall Study||11
10423239|NCT00828347|11568349|FG000|NOT COMPLETED|Overall Study||0
10423240|NCT00828347|11568350|FG001|NOT COMPLETED|Overall Study||0
10423241|NCT00828412|11568358|FG000|STARTED|Overall Study||50
10423242|NCT00828412|11568359|FG001|STARTED|Overall Study||50
10423243|NCT00828412|11568358|FG000|COMPLETED|Overall Study||41
10423244|NCT00828412|11568359|FG001|COMPLETED|Overall Study||48
10423245|NCT00828412|11568358|FG000|NOT COMPLETED|Overall Study||9
10423246|NCT00828412|11568359|FG001|NOT COMPLETED|Overall Study||2
10423247|NCT00828451|11568365|FG000|STARTED|Overall Study||29
10423248|NCT00828451|11568365|FG000|COMPLETED|Overall Study||18
10423249|NCT00828451|11568365|FG000|NOT COMPLETED|Overall Study||11
10423250|NCT00828464|11568369|FG000|STARTED|Overall Study||30
10423251|NCT00828464|11568369|FG000|COMPLETED|Overall Study||29
10423252|NCT00828464|11568369|FG000|NOT COMPLETED|Overall Study||1
10423253|NCT00828516|11568373|FG000|STARTED|Clinical Phase: Series 1||35
10423254|NCT00828516|11568373|FG000|COMPLETED|Clinical Phase: Series 1||33
10423255|NCT00828516|11568373|FG000|NOT COMPLETED|Clinical Phase: Series 1||2
10423256|NCT00828516|11568373|FG000|STARTED|Clinical Phase: Series 2||30
10423257|NCT00828516|11568373|FG000|COMPLETED|Clinical Phase: Series 2||30
10423258|NCT00828516|11568373|FG000|NOT COMPLETED|Clinical Phase: Series 2||0
10423259|NCT00828542|11568379|FG000|STARTED|Overall Study||23
10423260|NCT00828542|11568380|FG001|STARTED|Overall Study||23
10423261|NCT00828542|11568379|FG000|COMPLETED|Overall Study||20
10423262|NCT00828542|11568380|FG001|COMPLETED|Overall Study||20
10423263|NCT00828542|11568379|FG000|NOT COMPLETED|Overall Study||3
10423264|NCT00828542|11568380|FG001|NOT COMPLETED|Overall Study||3
10423265|NCT00828568|11568389|FG000|STARTED|Randomized||184
10423266|NCT00828568|11568390|FG001|STARTED|Randomized||179
10423267|NCT00828568|11568391|FG002|STARTED|Randomized||62
10423268|NCT00828568|11568389|FG000|COMPLETED|Randomized||183
10423269|NCT00828568|11568390|FG001|COMPLETED|Randomized||179
10423270|NCT00828568|11568391|FG002|COMPLETED|Randomized||60
10423271|NCT00828568|11568389|FG000|NOT COMPLETED|Randomized||1
10423272|NCT00828568|11568390|FG001|NOT COMPLETED|Randomized||0
10423273|NCT00828568|11568391|FG002|NOT COMPLETED|Randomized||2
10423274|NCT00828568|11568389|FG000|STARTED|Treated - Received at Least One Dose||183
10423275|NCT00828568|11568390|FG001|STARTED|Treated - Received at Least One Dose||179
10423276|NCT00828568|11568391|FG002|STARTED|Treated - Received at Least One Dose||60
10423277|NCT00828568|11568389|FG000|COMPLETED|Treated - Received at Least One Dose||153
10423278|NCT00828568|11568390|FG001|COMPLETED|Treated - Received at Least One Dose||150
10423279|NCT00828568|11568391|FG002|COMPLETED|Treated - Received at Least One Dose||55
10423280|NCT00828568|11568389|FG000|NOT COMPLETED|Treated - Received at Least One Dose||30
10423281|NCT00828568|11568390|FG001|NOT COMPLETED|Treated - Received at Least One Dose||29
10423282|NCT00828568|11568391|FG002|NOT COMPLETED|Treated - Received at Least One Dose||5
10423283|NCT00828672|11568402|FG000|STARTED|Pre-treatment (Baseline)||43
10423284|NCT00828672|11568403|FG001|STARTED|Pre-treatment (Baseline)||41
10423285|NCT00828672|11568402|FG000|COMPLETED|Pre-treatment (Baseline)||43
10423286|NCT00828672|11568403|FG001|COMPLETED|Pre-treatment (Baseline)||41
10423287|NCT00828672|11568402|FG000|NOT COMPLETED|Pre-treatment (Baseline)||0
10423288|NCT00828672|11568403|FG001|NOT COMPLETED|Pre-treatment (Baseline)||0
10423289|NCT00828672|11568402|FG000|STARTED|Study Treatment||43
10423290|NCT00828672|11568403|FG001|STARTED|Study Treatment||41
10423291|NCT00828672|11568402|FG000|COMPLETED|Study Treatment||41
10547064|NCT01511809|11700924|FG001|COMPLETED|Overall Study||52
10547065|NCT01511809|11700923|FG000|NOT COMPLETED|Overall Study||7
10547066|NCT01511809|11700924|FG001|NOT COMPLETED|Overall Study||7
10547067|NCT01511939|11700933|FG000|STARTED|Overall Study|Includes 1 subject who was also taking aspirin.|9
10547068|NCT01511939|11700934|FG001|STARTED|Overall Study|Includes one patient who was also taking aspirin.|5
10547069|NCT01511939|11700935|FG002|STARTED|Overall Study||8
10547070|NCT01511939|11700933|FG000|COMPLETED|Overall Study||7
10774907|NCT03309943|11937055|FG000|NOT COMPLETED|Overall Study||0
10774908|NCT03309943|11937056|FG001|NOT COMPLETED|Overall Study||2
10774909|NCT03310021|11937082|FG000|STARTED|Overall Study||6
10774910|NCT03310021|11937083|FG001|STARTED|Overall Study||3
10774911|NCT03310021|11937084|FG002|STARTED|Overall Study||6
10774912|NCT03310021|11937085|FG003|STARTED|Overall Study||3
10774913|NCT03310021|11937086|FG004|STARTED|Overall Study||8
10774914|NCT03310021|11937087|FG005|STARTED|Overall Study||4
10774915|NCT03310021|11937088|FG006|STARTED|Overall Study||8
10774916|NCT03310021|11937089|FG007|STARTED|Overall Study||4
10774917|NCT03310021|11937090|FG008|STARTED|Overall Study||6
10774918|NCT03310021|11937091|FG009|STARTED|Overall Study||3
10774919|NCT03310021|11937092|FG010|STARTED|Overall Study||6
10774920|NCT03310021|11937093|FG011|STARTED|Overall Study||3
10774921|NCT03310021|11937094|FG012|STARTED|Overall Study||8
10423292|NCT00828672|11568403|FG001|COMPLETED|Study Treatment||39
10423293|NCT00828672|11568402|FG000|NOT COMPLETED|Study Treatment||2
10774922|NCT03310021|11937095|FG013|STARTED|Overall Study||4
10300862|NCT00041392|11433644|FG001|COMPLETED|Overall Study||191
10300863|NCT00041392|11433643|FG000|NOT COMPLETED|Overall Study||0
10300864|NCT00041392|11433644|FG001|NOT COMPLETED|Overall Study||0
10423294|NCT00828672|11568403|FG001|NOT COMPLETED|Study Treatment||2
10423295|NCT00828672|11568402|FG000|STARTED|Post-surgery (<30 Days)||41
10423296|NCT00828672|11568403|FG001|STARTED|Post-surgery (<30 Days)||39
10423297|NCT00828672|11568402|FG000|COMPLETED|Post-surgery (<30 Days)||41
10423298|NCT00828672|11568403|FG001|COMPLETED|Post-surgery (<30 Days)||38
10423299|NCT00828672|11568402|FG000|NOT COMPLETED|Post-surgery (<30 Days)||0
10423300|NCT00828672|11568403|FG001|NOT COMPLETED|Post-surgery (<30 Days)||1
10423301|NCT00828672|11568402|FG000|STARTED|Follow-up|Patient in Arm 1 with clinical complete response and no surgery is in follow up (joined this period)|42
10423302|NCT00828672|11568403|FG001|STARTED|Follow-up|Patients with no central review material and with adverse event are in followup (joined this period)|41
10423303|NCT00828672|11568402|FG000|COMPLETED|Follow-up||42
10423304|NCT00828672|11568403|FG001|COMPLETED|Follow-up||41
10423305|NCT00828672|11568402|FG000|NOT COMPLETED|Follow-up||0
10423306|NCT00828672|11568403|FG001|NOT COMPLETED|Follow-up||0
10423307|NCT00828711|11568412|FG000|STARTED|Overall Study||118
10423308|NCT00828711|11568413|FG001|STARTED|Overall Study||125
10423309|NCT00828711|11568414|FG002|STARTED|Overall Study||131
10423310|NCT00828711|11568412|FG000|COMPLETED|Overall Study||117
10423311|NCT00828711|11568413|FG001|COMPLETED|Overall Study||125
10423312|NCT00828711|11568414|FG002|COMPLETED|Overall Study||131
10423313|NCT00828711|11568412|FG000|NOT COMPLETED|Overall Study||1
10423314|NCT00828711|11568413|FG001|NOT COMPLETED|Overall Study||0
10423315|NCT00828711|11568414|FG002|NOT COMPLETED|Overall Study||0
10423316|NCT00828750|11568422|FG000|STARTED|Overall Study||19
10423317|NCT00828750|11568422|FG000|COMPLETED|Overall Study||15
10423318|NCT00828750|11568422|FG000|NOT COMPLETED|Overall Study||4
10429659|NCT00865345|11575736|FG000|NOT COMPLETED|Overall Study||2
10429660|NCT00865566|11575742|FG000|STARTED|Overall Study||1253
10429661|NCT00865566|11575743|FG001|STARTED|Overall Study||1251
10429662|NCT00865566|11575742|FG000|Modified Intent-to-Treat Population|Overall Study||1251
10429663|NCT00865566|11575743|FG001|Modified Intent-to-Treat Population|Overall Study||1245
10429664|NCT00865566|11575742|FG000|COMPLETED|Overall Study||629
10429665|NCT00865566|11575743|FG001|COMPLETED|Overall Study||564
10429666|NCT00865566|11575742|FG000|NOT COMPLETED|Overall Study||624
10429667|NCT00865566|11575743|FG001|NOT COMPLETED|Overall Study||687
10429668|NCT00865709|11575751|FG000|STARTED|Treatment||97
10429669|NCT00865709|11575752|FG001|STARTED|Treatment||101
10429670|NCT00865709|11575751|FG000|Received Treatment|Treatment|Safety population|97
10429671|NCT00865709|11575752|FG001|Received Treatment|Treatment|Safety population|101
10429672|NCT00865709|11575751|FG000|COMPLETED|Treatment|Patients who continued treatment at data cut-off or discontinued treatment due to PD or death|67
10429673|NCT00865709|11575752|FG001|COMPLETED|Treatment|Patients who continued treatment at data cut-off or discontinued treatment due to PD or death|83
10429674|NCT00865709|11575751|FG000|NOT COMPLETED|Treatment||30
10429675|NCT00865709|11575752|FG001|NOT COMPLETED|Treatment||18
10429676|NCT00865709|11575751|FG000|STARTED|Active Follow-up||25
10429677|NCT00865709|11575752|FG001|STARTED|Active Follow-up||16
10429678|NCT00865709|11575751|FG000|COMPLETED|Active Follow-up||17
10429679|NCT00865709|11575752|FG001|COMPLETED|Active Follow-up||15
10429680|NCT00865709|11575751|FG000|NOT COMPLETED|Active Follow-up||8
10429681|NCT00865709|11575752|FG001|NOT COMPLETED|Active Follow-up||1
10429682|NCT00865709|11575751|FG000|STARTED|Long Term Follow-up||70
10429683|NCT00865709|11575752|FG001|STARTED|Long Term Follow-up||82
10429684|NCT00865709|11575751|FG000|COMPLETED|Long Term Follow-up||24
10429685|NCT00865709|11575752|FG001|COMPLETED|Long Term Follow-up||33
10429686|NCT00865709|11575751|FG000|NOT COMPLETED|Long Term Follow-up||46
10429687|NCT00865709|11575752|FG001|NOT COMPLETED|Long Term Follow-up||49
10429688|NCT00865904|11575765|FG000|STARTED|Overall Study|Randomized.|19
10429689|NCT00865904|11575766|FG001|STARTED|Overall Study|Randomized.|18
10429690|NCT00865904|11575767|FG002|STARTED|Overall Study|Randomized.|18
10429691|NCT00865904|11575768|FG003|STARTED|Overall Study|Randomized.|18
10429692|NCT00865904|11575769|FG004|STARTED|Overall Study|Randomized.|20
10429693|NCT00865904|11575765|FG000|COMPLETED|Overall Study|Completed 14-day follow-up.|17
10429694|NCT00865904|11575766|FG001|COMPLETED|Overall Study|Completed 14-day follow-up.|18
10429695|NCT00865904|11575767|FG002|COMPLETED|Overall Study|Completed 14-day follow-up.|18
10429696|NCT00865904|11575768|FG003|COMPLETED|Overall Study|Completed 14-day follow-up.|17
10429697|NCT00865904|11575769|FG004|COMPLETED|Overall Study|Completed 14-day follow-up.|19
10429698|NCT00865904|11575765|FG000|NOT COMPLETED|Overall Study||2
10429699|NCT00865904|11575766|FG001|NOT COMPLETED|Overall Study||0
10429700|NCT00865904|11575767|FG002|NOT COMPLETED|Overall Study||0
10429701|NCT00865904|11575768|FG003|NOT COMPLETED|Overall Study||1
10429702|NCT00865904|11575769|FG004|NOT COMPLETED|Overall Study||1
10300865|NCT00053495|11433655|FG000|STARTED|Overall Study||51
10300866|NCT00053495|11433656|FG001|STARTED|Overall Study||101
10300867|NCT00053495|11433657|FG002|STARTED|Overall Study||101
10300868|NCT00053495|11433658|FG003|STARTED|Overall Study||51
10300869|NCT00053495|11433659|FG004|STARTED|Overall Study||49
10300870|NCT00053495|11433655|FG000|COMPLETED|Overall Study||51
10300871|NCT00053495|11433656|FG001|COMPLETED|Overall Study||101
10300872|NCT00053495|11433657|FG002|COMPLETED|Overall Study||101
10300873|NCT00053495|11433658|FG003|COMPLETED|Overall Study||51
10300874|NCT00053495|11433659|FG004|COMPLETED|Overall Study||49
10300875|NCT00053495|11433655|FG000|NOT COMPLETED|Overall Study||0
10429703|NCT00865969|11575785|FG000|STARTED|Overall Study||129
10429704|NCT00865969|11575785|FG000|COMPLETED|Overall Study||129
10300876|NCT00053495|11433656|FG001|NOT COMPLETED|Overall Study||0
10300877|NCT00053495|11433657|FG002|NOT COMPLETED|Overall Study||0
10300878|NCT00053495|11433658|FG003|NOT COMPLETED|Overall Study||0
10300879|NCT00053495|11433659|FG004|NOT COMPLETED|Overall Study||0
10300880|NCT00053677|11433673|FG000|STARTED|Overall Study||58
10300881|NCT00053677|11433674|FG001|STARTED|Overall Study||19
10300882|NCT00053677|11433673|FG000|COMPLETED|Overall Study||36
10300883|NCT00053677|11433674|FG001|COMPLETED|Overall Study||13
10300884|NCT00053677|11433673|FG000|NOT COMPLETED|Overall Study||22
10300885|NCT00053677|11433674|FG001|NOT COMPLETED|Overall Study||6
10300886|NCT00053703|11433683|FG000|STARTED|Overall Study||35
10300887|NCT00053703|11433684|FG001|STARTED|Overall Study||41
10300888|NCT00053703|11433685|FG002|STARTED|Overall Study||40
10300889|NCT00053703|11433683|FG000|COMPLETED|Overall Study||17
10300890|NCT00053703|11433684|FG001|COMPLETED|Overall Study||28
10300891|NCT00053703|11433685|FG002|COMPLETED|Overall Study||25
10300892|NCT00053703|11433683|FG000|NOT COMPLETED|Overall Study||18
10300893|NCT00053703|11433684|FG001|NOT COMPLETED|Overall Study||13
10300894|NCT00053703|11433685|FG002|NOT COMPLETED|Overall Study||15
10300895|NCT00053846|11433695|FG000|STARTED|Overall Study||213
10300896|NCT00053846|11433696|FG001|STARTED|Overall Study||219
10300897|NCT00053846|11433695|FG000|COMPLETED|Overall Study||187
10300898|NCT00053846|11433696|FG001|COMPLETED|Overall Study||192
10300899|NCT00053846|11433695|FG000|NOT COMPLETED|Overall Study||26
10300900|NCT00053846|11433696|FG001|NOT COMPLETED|Overall Study||27
10300901|NCT00053898|11433704|FG000|STARTED|Overall Study||1552
10300902|NCT00053898|11433705|FG001|STARTED|Overall Study||1552
10300903|NCT00053898|11433704|FG000|COMPLETED|Overall Study||1538
10300904|NCT00053898|11433705|FG001|COMPLETED|Overall Study||1539
10300905|NCT00053898|11433704|FG000|NOT COMPLETED|Overall Study||14
10300906|NCT00053898|11433705|FG001|NOT COMPLETED|Overall Study||13
10300907|NCT00053989|11433711|FG000|STARTED|Overall Study||41
10300908|NCT00053989|11433711|FG000|COMPLETED|Overall Study||41
10300909|NCT00053989|11433711|FG000|NOT COMPLETED|Overall Study||0
10300910|NCT00054028|11433717|FG000|STARTED|Overall Study||31
10300911|NCT00054028|11433717|FG000|Phase I|Overall Study||9
10300912|NCT00054028|11433717|FG000|Phase II|Overall Study||22
10300913|NCT00054028|11433717|FG000|COMPLETED|Overall Study||31
10300914|NCT00054028|11433717|FG000|NOT COMPLETED|Overall Study||0
10300915|NCT00054132|11433722|FG000|STARTED|Overall Study||38
10300916|NCT00054132|11433722|FG000|COMPLETED|Overall Study||37
10300917|NCT00054132|11433722|FG000|NOT COMPLETED|Overall Study||1
10300918|NCT00054275|11433727|FG000|STARTED|Overall Study||39
10300919|NCT00054275|11433727|FG000|COMPLETED|Overall Study||28
10300920|NCT00054275|11433727|FG000|NOT COMPLETED|Overall Study||11
10300921|NCT00054327|11433737|FG000|STARTED|Overall Study||11
10300922|NCT00054327|11433738|FG001|STARTED|Overall Study||4
10300923|NCT00054327|11433739|FG002|STARTED|Overall Study||3
10300924|NCT00054327|11433740|FG003|STARTED|Overall Study||4
10300925|NCT00054327|11433741|FG004|STARTED|Overall Study||10
10300926|NCT00054327|11433742|FG005|STARTED|Overall Study||2
10300927|NCT00054327|11433737|FG000|COMPLETED|Overall Study||10
10300928|NCT00054327|11433738|FG001|COMPLETED|Overall Study||4
10300929|NCT00054327|11433739|FG002|COMPLETED|Overall Study||3
10300930|NCT00054327|11433740|FG003|COMPLETED|Overall Study||4
10300931|NCT00054327|11433741|FG004|COMPLETED|Overall Study||10
10300932|NCT00054327|11433742|FG005|COMPLETED|Overall Study||2
10300933|NCT00054327|11433737|FG000|NOT COMPLETED|Overall Study||1
10300934|NCT00054327|11433738|FG001|NOT COMPLETED|Overall Study||0
10300935|NCT00054327|11433739|FG002|NOT COMPLETED|Overall Study||0
10300936|NCT00054327|11433740|FG003|NOT COMPLETED|Overall Study||0
10300937|NCT00054327|11433741|FG004|NOT COMPLETED|Overall Study||0
10300938|NCT00054327|11433742|FG005|NOT COMPLETED|Overall Study||0
10315051|NCT00171951|11448832|FG000|COMPLETED|Overall Study||3
10315052|NCT00171951|11448832|FG000|NOT COMPLETED|Overall Study||16
10315053|NCT00172042|11448841|FG000|STARTED|Overall Study||226
10315054|NCT00172042|11448842|FG001|STARTED|Overall Study||211
10315055|NCT00172042|11448841|FG000|COMPLETED|Overall Study||68
10315056|NCT00172042|11448842|FG001|COMPLETED|Overall Study||86
10315057|NCT00172042|11448841|FG000|NOT COMPLETED|Overall Study||158
10315058|NCT00172042|11448842|FG001|NOT COMPLETED|Overall Study||125
10315059|NCT00172185|11448852|FG000|STARTED|Overall Study||6
10315060|NCT00172185|11448853|FG001|STARTED|Overall Study||7
10315061|NCT00172185|11448854|FG002|STARTED|Overall Study||25
10315062|NCT00172185|11448855|FG003|STARTED|Overall Study||27
10315063|NCT00172185|11448852|FG000|COMPLETED|Overall Study||6
10315064|NCT00172185|11448853|FG001|COMPLETED|Overall Study||5
10315065|NCT00172185|11448854|FG002|COMPLETED|Overall Study||20
10315066|NCT00172185|11448855|FG003|COMPLETED|Overall Study||23
10315067|NCT00172185|11448852|FG000|NOT COMPLETED|Overall Study||0
10315068|NCT00172185|11448853|FG001|NOT COMPLETED|Overall Study||2
10315069|NCT00172185|11448854|FG002|NOT COMPLETED|Overall Study||5
10315070|NCT00172185|11448855|FG003|NOT COMPLETED|Overall Study||4
10315071|NCT00174187|11448871|FG000|STARTED|Period 1 (up to 3 Years)||15
10315072|NCT00174187|11448872|FG001|STARTED|Period 1 (up to 3 Years)||15
10315073|NCT00174187|11448873|FG002|STARTED|Period 1 (up to 3 Years)||0
10315074|NCT00174187|11448871|FG000|COMPLETED|Period 1 (up to 3 Years)||15
10315075|NCT00174187|11448872|FG001|COMPLETED|Period 1 (up to 3 Years)||11
10315076|NCT00174187|11448873|FG002|COMPLETED|Period 1 (up to 3 Years)||0
10315077|NCT00174187|11448871|FG000|NOT COMPLETED|Period 1 (up to 3 Years)||0
10315078|NCT00174187|11448872|FG001|NOT COMPLETED|Period 1 (up to 3 Years)||4
10315079|NCT00174187|11448873|FG002|NOT COMPLETED|Period 1 (up to 3 Years)||0
10300939|NCT00054353|11433758|FG000|STARTED|Overall Study||12
10300940|NCT00054353|11433759|FG001|STARTED|Overall Study||4
10300941|NCT00054353|11433758|FG000|COMPLETED|Overall Study||12
10300942|NCT00054353|11433759|FG001|COMPLETED|Overall Study||4
10300943|NCT00054353|11433758|FG000|NOT COMPLETED|Overall Study||0
10300944|NCT00054353|11433759|FG001|NOT COMPLETED|Overall Study||0
10300945|NCT00054639|11433769|FG000|STARTED|Overall Study||48
10300946|NCT00054639|11433769|FG000|COMPLETED|Overall Study||46
10300947|NCT00054639|11433769|FG000|NOT COMPLETED|Overall Study||2
10300948|NCT00054665|11433773|FG000|STARTED|Part A|5 participants only received Part A and 18 participants received Part B after Part A.|23
10300949|NCT00054665|11433774|FG001|STARTED|Part A||0
10300950|NCT00054665|11433773|FG000|COMPLETED|Part A||23
10300951|NCT00054665|11433774|FG001|COMPLETED|Part A||0
10300952|NCT00054665|11433773|FG000|NOT COMPLETED|Part A||0
10300953|NCT00054665|11433774|FG001|NOT COMPLETED|Part A||0
10300954|NCT00054665|11433773|FG000|STARTED|Part B||0
10300955|NCT00054665|11433774|FG001|STARTED|Part B|26 participants received only Part B|44
10300956|NCT00054665|11433773|FG000|COMPLETED|Part B||0
10300957|NCT00054665|11433774|FG001|COMPLETED|Part B||44
10300958|NCT00054665|11433773|FG000|NOT COMPLETED|Part B||0
10300959|NCT00054665|11433774|FG001|NOT COMPLETED|Part B||0
10300960|NCT00054691|11433782|FG000|STARTED|Overall Study||40
10300961|NCT00054691|11433782|FG000|COMPLETED|Overall Study||37
10300962|NCT00054691|11433782|FG000|NOT COMPLETED|Overall Study||3
10300963|NCT00054704|11433788|FG000|STARTED|Overall Study||8
10300964|NCT00054704|11433789|FG001|STARTED|Overall Study||11
10300965|NCT00054704|11433788|FG000|COMPLETED|Overall Study||3
10300966|NCT00054704|11433789|FG001|COMPLETED|Overall Study||6
10300967|NCT00054704|11433788|FG000|NOT COMPLETED|Overall Study||5
10300968|NCT00054704|11433789|FG001|NOT COMPLETED|Overall Study||5
10300969|NCT00054717|11433797|FG000|STARTED|Overall Study||313
10300970|NCT00054717|11433798|FG001|STARTED|Overall Study||317
10300971|NCT00054717|11433797|FG000|COMPLETED|Overall Study||51
10300972|NCT00054717|11433798|FG001|COMPLETED|Overall Study||18
10300973|NCT00054717|11433797|FG000|NOT COMPLETED|Overall Study||262
10300974|NCT00054717|11433798|FG001|NOT COMPLETED|Overall Study||299
10300975|NCT00054756|11433804|FG000|STARTED|Overall Study||96
10300976|NCT00054756|11433804|FG000|COMPLETED|Overall Study||94
10300977|NCT00054756|11433804|FG000|NOT COMPLETED|Overall Study||2
10300978|NCT00054847|11433810|FG000|STARTED|Overall Study||367
10300979|NCT00054847|11433811|FG001|STARTED|Overall Study||366
10300980|NCT00054847|11433810|FG000|COMPLETED|Overall Study||269
10300981|NCT00054847|11433811|FG001|COMPLETED|Overall Study||266
10300982|NCT00054847|11433810|FG000|NOT COMPLETED|Overall Study||98
10300983|NCT00054847|11433811|FG001|NOT COMPLETED|Overall Study||100
10300984|NCT00055237|11433823|FG000|STARTED|Overall Study||17
10300985|NCT00055237|11433824|FG001|STARTED|Overall Study||2
10300986|NCT00055237|11433823|FG000|COMPLETED|Overall Study||17
10300987|NCT00055237|11433824|FG001|COMPLETED|Overall Study||2
10300988|NCT00055237|11433823|FG000|NOT COMPLETED|Overall Study||0
10300989|NCT00055237|11433824|FG001|NOT COMPLETED|Overall Study||0
10300990|NCT00055471|11433832|FG000|STARTED|Period 1: Dose Escalation Period||3
10300991|NCT00055471|11433833|FG001|STARTED|Period 1: Dose Escalation Period|Dose level given only after lower dose was successfully administered.|10
10300992|NCT00055471|11433834|FG002|STARTED|Period 1: Dose Escalation Period|Dose level given only after lower dose was successfully administered.|3
10300993|NCT00055471|11433832|FG000|COMPLETED|Period 1: Dose Escalation Period||3
10300994|NCT00055471|11433833|FG001|COMPLETED|Period 1: Dose Escalation Period||8
10300995|NCT00055471|11433834|FG002|COMPLETED|Period 1: Dose Escalation Period||0
10300996|NCT00055471|11433832|FG000|NOT COMPLETED|Period 1: Dose Escalation Period||0
10300997|NCT00055471|11433833|FG001|NOT COMPLETED|Period 1: Dose Escalation Period||2
10300998|NCT00055471|11433834|FG002|NOT COMPLETED|Period 1: Dose Escalation Period||3
10300999|NCT00055471|11433832|FG000|STARTED|Period 2: Extension Period|Period 2 - attend Pts who,in the opinion of the Investigator,show benefit from treatment with ZD4054|3
10301000|NCT00055471|11433833|FG001|STARTED|Period 2: Extension Period|2 pts discontinued after completion of Period1,therefore 9 pts proceeded to participate in Period2|6
10301001|NCT00055471|11433834|FG002|STARTED|Period 2: Extension Period||0
10301002|NCT00055471|11433832|FG000|COMPLETED|Period 2: Extension Period||3
10301003|NCT00055471|11433833|FG001|COMPLETED|Period 2: Extension Period||6
10301004|NCT00055471|11433834|FG002|COMPLETED|Period 2: Extension Period||0
10301005|NCT00055471|11433832|FG000|NOT COMPLETED|Period 2: Extension Period||0
10301006|NCT00055471|11433833|FG001|NOT COMPLETED|Period 2: Extension Period||0
10301007|NCT00055471|11433834|FG002|NOT COMPLETED|Period 2: Extension Period||0
10301008|NCT00055497|11433846|FG000|STARTED|Overall Study||18
10301009|NCT00055497|11433847|FG001|STARTED|Overall Study||19
10301010|NCT00055497|11433848|FG002|STARTED|Overall Study||18
10301011|NCT00055497|11433849|FG003|STARTED|Overall Study|17 participants who discontinued at/before Week 4 are counted here because they were not randomized.|221
10301012|NCT00055497|11433846|FG000|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|13
10301013|NCT00055497|11433847|FG001|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|16
10301014|NCT00055497|11433848|FG002|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|16
10301015|NCT00055497|11433849|FG003|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|131
10301016|NCT00055497|11433846|FG000|NOT COMPLETED|Overall Study||5
10301017|NCT00055497|11433847|FG001|NOT COMPLETED|Overall Study||3
10301018|NCT00055497|11433848|FG002|NOT COMPLETED|Overall Study||2
10301019|NCT00055497|11433849|FG003|NOT COMPLETED|Overall Study||90
10301020|NCT00055601|11433866|FG000|STARTED|Overall Study||48
10301021|NCT00055601|11433867|FG001|STARTED|Overall Study||49
10301022|NCT00055601|11433866|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|46
10301023|NCT00055601|11433867|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|47
10301024|NCT00055601|11433866|FG000|NOT COMPLETED|Overall Study||2
10301025|NCT00055601|11433867|FG001|NOT COMPLETED|Overall Study||2
10301026|NCT00055692|11433873|FG000|STARTED|Overall Study||46
10301027|NCT00055692|11433873|FG000|COMPLETED|Overall Study||46
10301028|NCT00055692|11433873|FG000|NOT COMPLETED|Overall Study||0
10301029|NCT00056160|11433881|FG000|STARTED|Up to Unblinding (07 Jun 2005)||177
10301030|NCT00056160|11433882|FG001|STARTED|Up to Unblinding (07 Jun 2005)||176
10301031|NCT00056160|11433881|FG000|COMPLETED|Up to Unblinding (07 Jun 2005)||64
10301032|NCT00056160|11433882|FG001|COMPLETED|Up to Unblinding (07 Jun 2005)||13
10301033|NCT00056160|11433881|FG000|NOT COMPLETED|Up to Unblinding (07 Jun 2005)||113
10301034|NCT00056160|11433882|FG001|NOT COMPLETED|Up to Unblinding (07 Jun 2005)||163
10301035|NCT00056160|11433881|FG000|STARTED|Extended Follow-up Cutoff (23 Jul 2008)||177
10301036|NCT00056160|11433882|FG001|STARTED|Extended Follow-up Cutoff (23 Jul 2008)||0
10301037|NCT00056160|11433881|FG000|COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||6
10301038|NCT00056160|11433882|FG001|COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||0
10301039|NCT00056160|11433881|FG000|NOT COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||171
10301040|NCT00056160|11433882|FG001|NOT COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||0
10301041|NCT00056160|11433881|FG000|STARTED|Final Follow-up||6
10301042|NCT00056160|11433882|FG001|STARTED|Final Follow-up||0
10301043|NCT00056160|11433881|FG000|COMPLETED|Final Follow-up||0
10301044|NCT00056160|11433882|FG001|COMPLETED|Final Follow-up||0
10301045|NCT00056160|11433881|FG000|NOT COMPLETED|Final Follow-up||6
10301046|NCT00056160|11433882|FG001|NOT COMPLETED|Final Follow-up||0
10301047|NCT00056316|11433890|FG000|STARTED|Overall Study||33
10301048|NCT00056316|11433891|FG001|STARTED|Overall Study|over-enrolled due to potential higher rates of drop-out.|41
10301049|NCT00056316|11433890|FG000|COMPLETED|Overall Study||30
10301050|NCT00056316|11433891|FG001|COMPLETED|Overall Study||38
10301051|NCT00056316|11433890|FG000|NOT COMPLETED|Overall Study||3
10301052|NCT00056316|11433891|FG001|NOT COMPLETED|Overall Study||3
10301053|NCT00056407|11433899|FG000|STARTED|Overall Study||4126
10301054|NCT00056407|11433900|FG001|STARTED|Overall Study||4105
10301055|NCT00056407|11433899|FG000|COMPLETED|Overall Study||2915
10301056|NCT00056407|11433900|FG001|COMPLETED|Overall Study||2912
10301057|NCT00056407|11433899|FG000|NOT COMPLETED|Overall Study||1211
10301058|NCT00056407|11433900|FG001|NOT COMPLETED|Overall Study||1193
10301059|NCT00056472|11433908|FG000|STARTED|Overall Study||129
10301060|NCT00056472|11433909|FG001|STARTED|Overall Study||130
10301061|NCT00056472|11433908|FG000|COMPLETED|Overall Study||81
10301062|NCT00056472|11433909|FG001|COMPLETED|Overall Study||61
10301063|NCT00056472|11433908|FG000|NOT COMPLETED|Overall Study||48
10301064|NCT00056472|11433909|FG001|NOT COMPLETED|Overall Study||69
10301065|NCT00056498|11433917|FG000|STARTED|Overall Study||30
10301066|NCT00056498|11433918|FG001|STARTED|Overall Study||35
10301067|NCT00056498|11433917|FG000|COMPLETED|Overall Study||25
10301068|NCT00056498|11433918|FG001|COMPLETED|Overall Study||28
10301069|NCT00056498|11433917|FG000|NOT COMPLETED|Overall Study||5
10301070|NCT00056498|11433918|FG001|NOT COMPLETED|Overall Study||7
10301071|NCT00056550|11433924|FG000|STARTED|Overall Study||14
10301072|NCT00056550|11433924|FG000|COMPLETED|Overall Study||14
10301073|NCT00056550|11433924|FG000|NOT COMPLETED|Overall Study||0
10301074|NCT00056563|11433931|FG000|STARTED|Overall Study||121
10301075|NCT00056563|11433932|FG001|STARTED|Overall Study||134
10301076|NCT00056563|11433931|FG000|COMPLETED|Overall Study||121
10301077|NCT00056563|11433932|FG001|COMPLETED|Overall Study||134
10301078|NCT00056563|11433931|FG000|NOT COMPLETED|Overall Study||0
10301079|NCT00056563|11433932|FG001|NOT COMPLETED|Overall Study||0
10301080|NCT00056862|11433940|FG000|STARTED|Overall Study||31
10301081|NCT00056862|11433941|FG001|STARTED|Overall Study||27
10301082|NCT00056862|11433940|FG000|COMPLETED|Overall Study||30
10301083|NCT00056862|11433941|FG001|COMPLETED|Overall Study||27
10301084|NCT00056862|11433940|FG000|NOT COMPLETED|Overall Study||1
10301085|NCT00056862|11433941|FG001|NOT COMPLETED|Overall Study||0
10301086|NCT00057330|11433949|FG000|STARTED|Overall Study||4577
10301087|NCT00057330|11433950|FG001|STARTED|Overall Study||3746
10301088|NCT00057330|11433949|FG000|COMPLETED|Overall Study||3445
10301089|NCT00057330|11433950|FG001|COMPLETED|Overall Study||2826
10301090|NCT00057330|11433949|FG000|NOT COMPLETED|Overall Study||1132
10301091|NCT00057330|11433950|FG001|NOT COMPLETED|Overall Study||920
10301092|NCT00057551|11433959|FG000|STARTED|Overall Study||200
10301093|NCT00057551|11433960|FG001|STARTED|Overall Study||195
10301094|NCT00057551|11433961|FG002|STARTED|Overall Study||96
10301095|NCT00057551|11433959|FG000|COMPLETED|Overall Study||175
10301096|NCT00057551|11433960|FG001|COMPLETED|Overall Study||168
10301097|NCT00057551|11433961|FG002|COMPLETED|Overall Study||80
10301098|NCT00057551|11433959|FG000|NOT COMPLETED|Overall Study||25
10301099|NCT00057551|11433960|FG001|NOT COMPLETED|Overall Study||27
10301100|NCT00057551|11433961|FG002|NOT COMPLETED|Overall Study||16
10301101|NCT00057577|11433971|FG000|STARTED|Overall Study||227
10301102|NCT00057577|11433972|FG001|STARTED|Overall Study||225
10301103|NCT00057577|11433971|FG000|COMPLETED|Overall Study||227
10301104|NCT00057577|11433972|FG001|COMPLETED|Overall Study||225
10301105|NCT00057577|11433971|FG000|NOT COMPLETED|Overall Study||0
10301106|NCT00057577|11433972|FG001|NOT COMPLETED|Overall Study||0
10301107|NCT00057681|11433986|FG000|STARTED|Overall Study||137
10301108|NCT00057681|11433987|FG001|STARTED|Overall Study||139
10301109|NCT00057681|11433988|FG002|STARTED|Overall Study||103
10301110|NCT00057681|11433986|FG000|COMPLETED|Overall Study||72
10301111|NCT00057681|11433987|FG001|COMPLETED|Overall Study||67
10301112|NCT00057681|11433988|FG002|COMPLETED|Overall Study||69
10301113|NCT00057681|11433986|FG000|NOT COMPLETED|Overall Study||65
10301114|NCT00057681|11433987|FG001|NOT COMPLETED|Overall Study||72
10301115|NCT00057681|11433988|FG002|NOT COMPLETED|Overall Study||34
10301116|NCT00057746|11433999|FG000|STARTED|Overall Study||131
10301117|NCT00057746|11434000|FG001|STARTED|Overall Study||67
10301118|NCT00057746|11434001|FG002|STARTED|Overall Study||67
10423319|NCT00828841|11568430|FG000|STARTED|Overall Study||235
10423320|NCT00828841|11568431|FG001|STARTED|Overall Study||236
10423321|NCT00828841|11568432|FG002|STARTED|Overall Study||130
10423322|NCT00828841|11568430|FG000|COMPLETED|Overall Study||231
10423323|NCT00828841|11568431|FG001|COMPLETED|Overall Study||232
10423324|NCT00828841|11568432|FG002|COMPLETED|Overall Study||126
10423325|NCT00828841|11568430|FG000|NOT COMPLETED|Overall Study||4
10423326|NCT00828841|11568431|FG001|NOT COMPLETED|Overall Study||4
10423327|NCT00828841|11568432|FG002|NOT COMPLETED|Overall Study||4
10423328|NCT00828945|11568442|FG000|STARTED|Overall Study||257
10423329|NCT00828945|11568442|FG000|COMPLETED|Overall Study||216
10423330|NCT00828945|11568442|FG000|NOT COMPLETED|Overall Study||41
10423331|NCT00828984|11568449|FG000|STARTED|Overall Study||28
10423332|NCT00828984|11568450|FG001|STARTED|Overall Study||31
10423333|NCT00828984|11568451|FG002|STARTED|Overall Study||28
10423334|NCT00828984|11568449|FG000|Randomization|Overall Study||28
10423335|NCT00828984|11568450|FG001|Randomization|Overall Study||31
10423336|NCT00828984|11568451|FG002|Randomization|Overall Study||28
10423337|NCT00828984|11568449|FG000|Treatment|Overall Study||24
10423338|NCT00828984|11568450|FG001|Treatment|Overall Study||26
10423339|NCT00828984|11568451|FG002|Treatment|Overall Study||24
10423340|NCT00828984|11568449|FG000|Flexible Sigmoidoscopy|Overall Study||20
10423341|NCT00828984|11568450|FG001|Flexible Sigmoidoscopy|Overall Study||19
10423342|NCT00828984|11568451|FG002|Flexible Sigmoidoscopy|Overall Study||19
10423343|NCT00828984|11568449|FG000|Post Intervention Follow-Up|Overall Study||15
10423344|NCT00828984|11568450|FG001|Post Intervention Follow-Up|Overall Study||16
10423345|NCT00828984|11568451|FG002|Post Intervention Follow-Up|Overall Study||19
10423346|NCT00828984|11568449|FG000|COMPLETED|Overall Study||14
10423347|NCT00828984|11568450|FG001|COMPLETED|Overall Study||15
10423348|NCT00828984|11568451|FG002|COMPLETED|Overall Study||19
10423349|NCT00828984|11568449|FG000|NOT COMPLETED|Overall Study||14
10423350|NCT00828984|11568450|FG001|NOT COMPLETED|Overall Study||16
10423351|NCT00828984|11568451|FG002|NOT COMPLETED|Overall Study||9
10423352|NCT00829010|11568464|FG000|STARTED|Overall Study||83
10423353|NCT00829010|11568465|FG001|STARTED|Overall Study||101
10423354|NCT00829010|11568466|FG002|STARTED|Overall Study||100
10423355|NCT00829010|11568467|FG003|STARTED|Overall Study||100
10423356|NCT00829010|11568468|FG004|STARTED|Overall Study||100
10423357|NCT00829010|11568464|FG000|COMPLETED|Overall Study||73
10423358|NCT00829010|11568465|FG001|COMPLETED|Overall Study||92
10423359|NCT00829010|11568466|FG002|COMPLETED|Overall Study||97
10423360|NCT00829010|11568467|FG003|COMPLETED|Overall Study||92
10423361|NCT00829010|11568468|FG004|COMPLETED|Overall Study||98
10423362|NCT00829010|11568464|FG000|NOT COMPLETED|Overall Study||10
10423363|NCT00829010|11568465|FG001|NOT COMPLETED|Overall Study||9
10423364|NCT00829010|11568466|FG002|NOT COMPLETED|Overall Study||3
10423365|NCT00829010|11568467|FG003|NOT COMPLETED|Overall Study||8
10423366|NCT00829010|11568468|FG004|NOT COMPLETED|Overall Study||2
10423367|NCT00829036|11568480|FG000|STARTED|Overall Study||24
10423368|NCT00829036|11568480|FG000|COMPLETED|Overall Study||24
10423369|NCT00829036|11568480|FG000|NOT COMPLETED|Overall Study||0
10423370|NCT00829049|11568486|FG000|STARTED|Overall Study||77
10423371|NCT00829049|11568487|FG001|STARTED|Overall Study||88
10423372|NCT00829049|11568486|FG000|COMPLETED|Overall Study||60
10423373|NCT00829049|11568487|FG001|COMPLETED|Overall Study||68
10423374|NCT00829049|11568486|FG000|NOT COMPLETED|Overall Study||17
10423375|NCT00829049|11568487|FG001|NOT COMPLETED|Overall Study||20
10423376|NCT00829166|11568495|FG000|STARTED|Overall Study||495
10423377|NCT00829166|11568496|FG001|STARTED|Overall Study||496
10423378|NCT00829166|11568495|FG000|Treated|Overall Study||490
10423379|NCT00829166|11568496|FG001|Treated|Overall Study||488
10423380|NCT00829166|11568495|FG000|COMPLETED|Overall Study||0
10423381|NCT00829166|11568496|FG001|COMPLETED|Overall Study||0
10423382|NCT00829166|11568495|FG000|NOT COMPLETED|Overall Study||495
10423383|NCT00829166|11568496|FG001|NOT COMPLETED|Overall Study||496
10423384|NCT00829179|11568503|FG000|STARTED|Overall Study||20
10423385|NCT00829179|11568503|FG000|COMPLETED|Overall Study||19
10423386|NCT00829179|11568503|FG000|NOT COMPLETED|Overall Study||1
10423387|NCT00829244|11568509|FG000|STARTED|Overall Study||96
10301119|NCT00057746|11433999|FG000|COMPLETED|Overall Study||131
10423388|NCT00829244|11568510|FG001|STARTED|Overall Study||104
10423389|NCT00829244|11568509|FG000|COMPLETED|Overall Study||82
10423390|NCT00829244|11568510|FG001|COMPLETED|Overall Study||83
10423391|NCT00829244|11568509|FG000|NOT COMPLETED|Overall Study||14
10423392|NCT00829244|11568510|FG001|NOT COMPLETED|Overall Study||21
10423393|NCT00829283|11568518|FG000|STARTED|Overall Study||39
10423394|NCT00829283|11568519|FG001|STARTED|Overall Study||152
10423395|NCT00829283|11568518|FG000|COMPLETED|Overall Study||32
10423396|NCT00829283|11568519|FG001|COMPLETED|Overall Study||127
10423397|NCT00829283|11568518|FG000|NOT COMPLETED|Overall Study||7
10423398|NCT00829283|11568519|FG001|NOT COMPLETED|Overall Study||25
10301120|NCT00057746|11434000|FG001|COMPLETED|Overall Study||67
10301121|NCT00057746|11434001|FG002|COMPLETED|Overall Study||66
10301122|NCT00057746|11433999|FG000|NOT COMPLETED|Overall Study||0
10301123|NCT00057746|11434000|FG001|NOT COMPLETED|Overall Study||0
10301124|NCT00057746|11434001|FG002|NOT COMPLETED|Overall Study||1
10301125|NCT00057785|11434009|FG000|STARTED|Overall Study||68
10301126|NCT00057785|11434009|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|68
10301127|NCT00057785|11434009|FG000|NOT COMPLETED|Overall Study||0
10301128|NCT00057811|11434015|FG000|STARTED|Overall Study||51
10301129|NCT00057811|11434016|FG001|STARTED|Overall Study||46
10301130|NCT00057811|11434015|FG000|COMPLETED|Overall Study||41
10301131|NCT00057811|11434016|FG001|COMPLETED|Overall Study||34
10301132|NCT00057811|11434015|FG000|NOT COMPLETED|Overall Study||10
10301133|NCT00057811|11434016|FG001|NOT COMPLETED|Overall Study||12
10301134|NCT00057837|11434024|FG000|STARTED|Overall Study||70
10301135|NCT00057837|11434025|FG001|STARTED|Overall Study||70
10301136|NCT00057837|11434024|FG000|Treated|Overall Study||69
10301137|NCT00057837|11434025|FG001|Treated|Overall Study||68
10301138|NCT00057837|11434024|FG000|Eligible and Treated|Overall Study||66
10301139|NCT00057837|11434025|FG001|Eligible and Treated|Overall Study||66
10301140|NCT00057837|11434024|FG000|Patients With Response|Overall Study||46
10301141|NCT00057837|11434025|FG001|Patients With Response|Overall Study||38
10301142|NCT00057837|11434024|FG000|COMPLETED|Overall Study||39
10301143|NCT00057837|11434025|FG001|COMPLETED|Overall Study||31
10301144|NCT00057837|11434024|FG000|NOT COMPLETED|Overall Study||31
10301145|NCT00057837|11434025|FG001|NOT COMPLETED|Overall Study||39
10301146|NCT00057863|11434031|FG000|STARTED|Overall Study||35
10301147|NCT00057863|11434031|FG000|COMPLETED|Overall Study||32
10301148|NCT00057863|11434031|FG000|NOT COMPLETED|Overall Study||3
10301149|NCT00057876|11434037|FG000|STARTED|Overall Study||38
10301150|NCT00057876|11434038|FG001|STARTED|Overall Study||36
10301151|NCT00057876|11434037|FG000|Eligible|Overall Study||37
10301152|NCT00057876|11434038|FG001|Eligible|Overall Study||34
10301153|NCT00057876|11434037|FG000|Began Protocol Therapy|Overall Study||35
10301154|NCT00057876|11434038|FG001|Began Protocol Therapy|Overall Study||34
10301155|NCT00057876|11434037|FG000|Eligible and Treated|Overall Study||34
10301156|NCT00057876|11434038|FG001|Eligible and Treated|Overall Study||34
10301157|NCT00057876|11434037|FG000|COMPLETED|Overall Study||9
10301158|NCT00057876|11434038|FG001|COMPLETED|Overall Study||9
10301159|NCT00057876|11434037|FG000|NOT COMPLETED|Overall Study||29
10301160|NCT00057876|11434038|FG001|NOT COMPLETED|Overall Study||27
10301161|NCT00057941|11434046|FG000|STARTED|Overall Study||74
10301162|NCT00057941|11434047|FG001|STARTED|Overall Study||74
10301163|NCT00057941|11434046|FG000|Treated|Overall Study||74
10301164|NCT00057941|11434047|FG001|Treated|Overall Study||74
10301165|NCT00057941|11434046|FG000|Eligible|Overall Study||72
10301166|NCT00057941|11434047|FG001|Eligible|Overall Study||69
10301167|NCT00057941|11434046|FG000|COMPLETED|Overall Study||0
10301168|NCT00057941|11434047|FG001|COMPLETED|Overall Study||0
10301169|NCT00057941|11434046|FG000|NOT COMPLETED|Overall Study||74
10301170|NCT00057941|11434047|FG001|NOT COMPLETED|Overall Study||74
10301171|NCT00057954|11434053|FG000|STARTED|Overall Study||6
10301172|NCT00057954|11434053|FG000|COMPLETED|Overall Study||4
10301173|NCT00057954|11434053|FG000|NOT COMPLETED|Overall Study||2
10301174|NCT00058019|11434059|FG000|STARTED|Overall Study||39
10301175|NCT00058019|11434060|FG001|STARTED|Overall Study||12
10301176|NCT00058019|11434059|FG000|COMPLETED|Overall Study||39
10301177|NCT00058019|11434060|FG001|COMPLETED|Overall Study||12
10301178|NCT00058019|11434059|FG000|NOT COMPLETED|Overall Study||0
10301179|NCT00058019|11434060|FG001|NOT COMPLETED|Overall Study||0
10301180|NCT00058058|11434065|FG000|STARTED|Overall Study||1007
10301181|NCT00058058|11434065|FG000|COMPLETED|Overall Study||969
10301182|NCT00058058|11434065|FG000|NOT COMPLETED|Overall Study||38
10301183|NCT00058123|11434070|FG000|STARTED|Overall Study||55
10301184|NCT00058123|11434070|FG000|COMPLETED|Overall Study||45
10301185|NCT00058123|11434070|FG000|NOT COMPLETED|Overall Study||10
10301186|NCT00058214|11434075|FG000|STARTED|Overall Study||25
10301187|NCT00058214|11434075|FG000|COMPLETED|Overall Study||24
10301188|NCT00058214|11434075|FG000|NOT COMPLETED|Overall Study||1
10301189|NCT00058240|11434083|FG000|STARTED|First Dose Level||20
10301190|NCT00058240|11434084|FG001|STARTED|First Dose Level||3
10301191|NCT00058240|11434085|FG002|STARTED|First Dose Level||17
10301192|NCT00058240|11434086|FG003|STARTED|First Dose Level||12
10301193|NCT00058240|11434083|FG000|Treated|First Dose Level||20
10301194|NCT00058240|11434084|FG001|Treated|First Dose Level||3
10301195|NCT00058240|11434085|FG002|Treated|First Dose Level||17
10301196|NCT00058240|11434086|FG003|Treated|First Dose Level||12
10301197|NCT00058240|11434083|FG000|COMPLETED|First Dose Level||20
10301198|NCT00058240|11434084|FG001|COMPLETED|First Dose Level||3
10301199|NCT00058240|11434085|FG002|COMPLETED|First Dose Level||17
10301200|NCT00058240|11434086|FG003|COMPLETED|First Dose Level||12
10301201|NCT00058240|11434083|FG000|NOT COMPLETED|First Dose Level||0
10301202|NCT00058240|11434084|FG001|NOT COMPLETED|First Dose Level||0
10301203|NCT00058240|11434085|FG002|NOT COMPLETED|First Dose Level||0
10301204|NCT00058240|11434086|FG003|NOT COMPLETED|First Dose Level||0
10301205|NCT00058240|11434083|FG000|STARTED|Second Dose Level||0
10301206|NCT00058240|11434084|FG001|STARTED|Second Dose Level||0
10301207|NCT00058240|11434085|FG002|STARTED|Second Dose Level|2 patients were previously treated at Dose level 1, relapsed, and retreated at Dose level 3.|2
10301208|NCT00058240|11434086|FG003|STARTED|Second Dose Level|4 patients previously relapsed on a different Dose level and were retreated at Dose level 4.|4
10301209|NCT00058240|11434083|FG000|COMPLETED|Second Dose Level||0
10301210|NCT00058240|11434084|FG001|COMPLETED|Second Dose Level||0
10301211|NCT00058240|11434085|FG002|COMPLETED|Second Dose Level||2
10301212|NCT00058240|11434086|FG003|COMPLETED|Second Dose Level||4
10301213|NCT00058240|11434083|FG000|NOT COMPLETED|Second Dose Level||0
10301214|NCT00058240|11434084|FG001|NOT COMPLETED|Second Dose Level||0
10301215|NCT00058240|11434085|FG002|NOT COMPLETED|Second Dose Level||0
10301216|NCT00058240|11434086|FG003|NOT COMPLETED|Second Dose Level||0
10301217|NCT00058370|11434096|FG000|STARTED|Overall Study||6
10301218|NCT00058370|11434096|FG000|COMPLETED|Overall Study||6
10301219|NCT00058370|11434096|FG000|NOT COMPLETED|Overall Study||0
10301220|NCT00058422|11434100|FG000|STARTED|Overall Study||65
10301221|NCT00058422|11434100|FG000|COMPLETED|Overall Study||63
10301222|NCT00058422|11434100|FG000|NOT COMPLETED|Overall Study||2
10301223|NCT00058539|11434104|FG000|STARTED|Overall Study||42
10301224|NCT00058539|11434104|FG000|COMPLETED|Overall Study||0
10301225|NCT00058539|11434104|FG000|NOT COMPLETED|Overall Study||42
10301226|NCT00058552|11434110|FG000|STARTED|Overall Study||65
10301227|NCT00058552|11434111|FG001|STARTED|Overall Study||64
10301228|NCT00058552|11434110|FG000|COMPLETED|Overall Study||0
10301229|NCT00058552|11434111|FG001|COMPLETED|Overall Study||2
10301230|NCT00058552|11434110|FG000|NOT COMPLETED|Overall Study||65
10301231|NCT00058552|11434111|FG001|NOT COMPLETED|Overall Study||62
10301232|NCT00058825|11434119|FG000|STARTED|Overall Study||27
10301233|NCT00058825|11434119|FG000|COMPLETED|Overall Study||5
10301234|NCT00058825|11434119|FG000|NOT COMPLETED|Overall Study||22
10301235|NCT00059202|11434127|FG000|STARTED|Overall Study||76
10301236|NCT00059202|11434128|FG001|STARTED|Overall Study||74
10301237|NCT00059202|11434127|FG000|COMPLETED|Overall Study||70
10301238|NCT00059202|11434128|FG001|COMPLETED|Overall Study||59
10301239|NCT00059202|11434127|FG000|NOT COMPLETED|Overall Study||6
10301240|NCT00059202|11434128|FG001|NOT COMPLETED|Overall Study||15
10301241|NCT00059215|11434141|FG000|STARTED|Overall Study||200
10301242|NCT00059215|11434142|FG001|STARTED|Overall Study||200
10301243|NCT00059215|11434143|FG002|STARTED|Overall Study||251
10301244|NCT00059215|11434144|FG003|STARTED|Overall Study||254
10301245|NCT00059215|11434141|FG000|COMPLETED|Overall Study|One subject discontinued before receiving treatment and is not included in the evaluable set.|187
10301246|NCT00059215|11434142|FG001|COMPLETED|Overall Study||186
10301247|NCT00059215|11434143|FG002|COMPLETED|Overall Study||236
10301248|NCT00059215|11434144|FG003|COMPLETED|Overall Study||239
10301249|NCT00059215|11434141|FG000|NOT COMPLETED|Overall Study||13
10301250|NCT00059215|11434142|FG001|NOT COMPLETED|Overall Study||14
10301251|NCT00059215|11434143|FG002|NOT COMPLETED|Overall Study||15
10301252|NCT00059215|11434144|FG003|NOT COMPLETED|Overall Study||15
10301253|NCT00059228|11434157|FG000|STARTED|Overall Study||6
10301254|NCT00059228|11434158|FG001|STARTED|Overall Study||6
10301255|NCT00059228|11434157|FG000|COMPLETED|Overall Study||6
10301256|NCT00059228|11434158|FG001|COMPLETED|Overall Study||5
10301257|NCT00059228|11434157|FG000|NOT COMPLETED|Overall Study||0
10301258|NCT00059228|11434158|FG001|NOT COMPLETED|Overall Study||1
10301259|NCT00059332|11434166|FG000|STARTED|Overall Study||843
10301260|NCT00059332|11434167|FG001|STARTED|Overall Study||857
10301261|NCT00059332|11434166|FG000|COMPLETED|Overall Study||840
10301262|NCT00059332|11434167|FG001|COMPLETED|Overall Study||855
10301263|NCT00059332|11434166|FG000|NOT COMPLETED|Overall Study||3
10301264|NCT00059332|11434167|FG001|NOT COMPLETED|Overall Study||2
10301265|NCT00059475|11434181|FG000|STARTED|Overall Study||33
10301266|NCT00059475|11434182|FG001|STARTED|Overall Study||2
10301267|NCT00059475|11434183|FG002|STARTED|Overall Study||24
10301268|NCT00059475|11434184|FG003|STARTED|Overall Study||3
10301269|NCT00059475|11434185|FG004|STARTED|Overall Study||33
10301270|NCT00059475|11434186|FG005|STARTED|Overall Study||2
10301271|NCT00059475|11434187|FG006|STARTED|Overall Study||34
10301272|NCT00059475|11434188|FG007|STARTED|Overall Study||7
10301273|NCT00059475|11434181|FG000|COMPLETED|Overall Study||33
10301274|NCT00059475|11434182|FG001|COMPLETED|Overall Study||2
10301275|NCT00059475|11434183|FG002|COMPLETED|Overall Study||24
10301276|NCT00059475|11434184|FG003|COMPLETED|Overall Study||3
10301277|NCT00059475|11434185|FG004|COMPLETED|Overall Study||33
10301278|NCT00059475|11434186|FG005|COMPLETED|Overall Study||2
10301279|NCT00059475|11434187|FG006|COMPLETED|Overall Study||34
10301280|NCT00059475|11434188|FG007|COMPLETED|Overall Study||7
10301281|NCT00059475|11434181|FG000|NOT COMPLETED|Overall Study||0
10301282|NCT00059475|11434182|FG001|NOT COMPLETED|Overall Study||0
10301283|NCT00059475|11434183|FG002|NOT COMPLETED|Overall Study||0
10301284|NCT00059475|11434184|FG003|NOT COMPLETED|Overall Study||0
10301285|NCT00059475|11434185|FG004|NOT COMPLETED|Overall Study||0
10301286|NCT00059475|11434186|FG005|NOT COMPLETED|Overall Study||0
10301287|NCT00059475|11434187|FG006|NOT COMPLETED|Overall Study||0
10301288|NCT00059475|11434188|FG007|NOT COMPLETED|Overall Study||0
10301289|NCT00059787|11434213|FG000|STARTED|Overall Study||56
10301290|NCT00059787|11434213|FG000|COMPLETED|Overall Study||36
10301291|NCT00059787|11434213|FG000|NOT COMPLETED|Overall Study||20
10301292|NCT00059839|11434220|FG000|STARTED|Overall Study||65
10301293|NCT00059839|11434221|FG001|STARTED|Overall Study||64
10301294|NCT00059839|11434220|FG000|COMPLETED|Overall Study||53
10301295|NCT00059839|11434221|FG001|COMPLETED|Overall Study||47
10301296|NCT00059839|11434220|FG000|NOT COMPLETED|Overall Study||12
10301297|NCT00059839|11434221|FG001|NOT COMPLETED|Overall Study||17
10301298|NCT00060008|11434227|FG000|STARTED|Overall Study||18
10301299|NCT00060008|11434227|FG000|COMPLETED|Overall Study||18
10301300|NCT00060008|11434227|FG000|NOT COMPLETED|Overall Study||0
10301301|NCT00060333|11434232|FG000|STARTED|Overall Study||20
10301302|NCT00060333|11434232|FG000|COMPLETED|Overall Study||20
10301303|NCT00060333|11434232|FG000|NOT COMPLETED|Overall Study||0
10301304|NCT00060346|11434239|FG000|STARTED|Overall Study||16
10301305|NCT00060346|11434239|FG000|Eligible and Treated|Overall Study||16
10301306|NCT00060346|11434239|FG000|COMPLETED|Overall Study||16
10301307|NCT00060346|11434239|FG000|NOT COMPLETED|Overall Study||0
10301308|NCT00060424|11434243|FG000|STARTED|Overall Study||21
10301309|NCT00060424|11434243|FG000|COMPLETED|Overall Study||21
10301310|NCT00060424|11434243|FG000|NOT COMPLETED|Overall Study||0
10301311|NCT00060528|11434247|FG000|STARTED|Overall Study|32 participants are reported for the phase II portion.|8
10301312|NCT00060528|11434248|FG001|STARTED|Overall Study||9
10301313|NCT00060528|11434249|FG002|STARTED|Overall Study||7
10301314|NCT00060528|11434250|FG003|STARTED|Overall Study||8
10301315|NCT00060528|11434247|FG000|COMPLETED|Overall Study||8
10301316|NCT00060528|11434248|FG001|COMPLETED|Overall Study||9
10301317|NCT00060528|11434249|FG002|COMPLETED|Overall Study||7
10301318|NCT00060528|11434250|FG003|COMPLETED|Overall Study||8
10301319|NCT00060528|11434247|FG000|NOT COMPLETED|Overall Study||0
10301320|NCT00060528|11434248|FG001|NOT COMPLETED|Overall Study||0
10301321|NCT00060528|11434249|FG002|NOT COMPLETED|Overall Study||0
10301322|NCT00060528|11434250|FG003|NOT COMPLETED|Overall Study||0
10301323|NCT00060606|11434265|FG000|STARTED|Overall Study||91
10301324|NCT00060606|11434266|FG001|STARTED|Overall Study||92
10301325|NCT00060606|11434265|FG000|First Primary Outcome - Shunt at 12 Mont|Overall Study||91
10301326|NCT00060606|11434266|FG001|First Primary Outcome - Shunt at 12 Mont|Overall Study||92
10301327|NCT00060606|11434265|FG000|COMPLETED|Overall Study||91
10301328|NCT00060606|11434266|FG001|COMPLETED|Overall Study||91
10301329|NCT00060606|11434265|FG000|NOT COMPLETED|Overall Study||0
10301330|NCT00060606|11434266|FG001|NOT COMPLETED|Overall Study||1
10301331|NCT00060840|11434274|FG000|STARTED|Overall Study||73
10301332|NCT00060840|11434275|FG001|STARTED|Overall Study||77
10301333|NCT00060840|11434274|FG000|COMPLETED|Overall Study||69
10301334|NCT00060840|11434275|FG001|COMPLETED|Overall Study||68
10301335|NCT00060840|11434274|FG000|NOT COMPLETED|Overall Study||4
10301336|NCT00060840|11434275|FG001|NOT COMPLETED|Overall Study||9
10301337|NCT00060944|11434283|FG000|STARTED|Overall Study||136
10301338|NCT00060944|11434284|FG001|STARTED|Overall Study||134
10301339|NCT00060944|11434283|FG000|Treated|Overall Study||130
10301340|NCT00060944|11434284|FG001|Treated|Overall Study||130
10301341|NCT00060944|11434283|FG000|COMPLETED|Overall Study||0
10301342|NCT00060944|11434284|FG001|COMPLETED|Overall Study||0
10301343|NCT00060944|11434283|FG000|NOT COMPLETED|Overall Study||136
10301344|NCT00060944|11434284|FG001|NOT COMPLETED|Overall Study||134
10301345|NCT00061048|11434290|FG000|STARTED|Overall Study||29
10301346|NCT00061048|11434290|FG000|COMPLETED|Overall Study|Began protocol specified follow-up period.|7
10301347|NCT00061048|11434290|FG000|NOT COMPLETED|Overall Study||22
10301348|NCT00061373|11434296|FG000|STARTED|Overall Study||15
10301349|NCT00061373|11434297|FG001|STARTED|Overall Study||3
10301350|NCT00061373|11434296|FG000|Aspirin and Tinzaparin|Overall Study||15
10301351|NCT00061373|11434297|FG001|Aspirin and Tinzaparin|Overall Study||3
10301352|NCT00061373|11434296|FG000|COMPLETED|Overall Study||15
10301353|NCT00061373|11434297|FG001|COMPLETED|Overall Study||3
10301354|NCT00061373|11434296|FG000|NOT COMPLETED|Overall Study||0
10301355|NCT00061373|11434297|FG001|NOT COMPLETED|Overall Study||0
10301356|NCT00061633|11434305|FG000|STARTED|Overall Study||84
10301357|NCT00061633|11434306|FG001|STARTED|Overall Study||85
10301358|NCT00061633|11434305|FG000|COMPLETED|Overall Study||79
10301359|NCT00061633|11434306|FG001|COMPLETED|Overall Study||74
10301360|NCT00061633|11434305|FG000|NOT COMPLETED|Overall Study||5
10301361|NCT00061633|11434306|FG001|NOT COMPLETED|Overall Study||11
10301362|NCT00061893|11434312|FG000|STARTED|Overall Study||38
10301363|NCT00061893|11434312|FG000|COMPLETED|Overall Study||20
10301364|NCT00061893|11434312|FG000|NOT COMPLETED|Overall Study||18
10301365|NCT00061932|11434318|FG000|STARTED|Overall Study||29
10301366|NCT00061932|11434319|FG001|STARTED|Overall Study||12
10301367|NCT00061932|11434318|FG000|COMPLETED|Overall Study||16
10301368|NCT00061932|11434319|FG001|COMPLETED|Overall Study||8
10301369|NCT00061932|11434318|FG000|NOT COMPLETED|Overall Study||13
10301370|NCT00061932|11434319|FG001|NOT COMPLETED|Overall Study||4
10301371|NCT00062010|11434326|FG000|STARTED|Overall Study||37
10301372|NCT00062010|11434326|FG000|Eligible and Treated|Overall Study||34
10301373|NCT00062010|11434326|FG000|COMPLETED|Overall Study||34
10301374|NCT00062010|11434326|FG000|NOT COMPLETED|Overall Study||3
10301375|NCT00062166|11434330|FG000|STARTED|Overall Study||340
10301376|NCT00062166|11434330|FG000|COMPLETED|Overall Study||334
10301377|NCT00062166|11434330|FG000|NOT COMPLETED|Overall Study||6
10301378|NCT00062374|11434335|FG000|STARTED|Overall Study||55
10301379|NCT00062374|11434335|FG000|COMPLETED|Overall Study||43
10301380|NCT00062374|11434335|FG000|NOT COMPLETED|Overall Study||12
10301381|NCT00062439|11434339|FG000|STARTED|Induction Chemotherapy + Radiotherapy||46
10301382|NCT00062439|11434339|FG000|COMPLETED|Induction Chemotherapy + Radiotherapy||38
10301383|NCT00062439|11434339|FG000|NOT COMPLETED|Induction Chemotherapy + Radiotherapy||8
10301384|NCT00062439|11434339|FG000|STARTED|Post Chemoradiation Assessment||38
10301385|NCT00062439|11434339|FG000|COMPLETED|Post Chemoradiation Assessment||29
10301386|NCT00062439|11434339|FG000|NOT COMPLETED|Post Chemoradiation Assessment||9
10301387|NCT00062439|11434339|FG000|STARTED|Surgery||29
10301388|NCT00062439|11434339|FG000|COMPLETED|Surgery||22
10301389|NCT00062439|11434339|FG000|NOT COMPLETED|Surgery||7
10301390|NCT00062439|11434339|FG000|STARTED|Consolidation Chemotherapy||22
10301391|NCT00062439|11434339|FG000|COMPLETED|Consolidation Chemotherapy||20
10301392|NCT00062439|11434339|FG000|NOT COMPLETED|Consolidation Chemotherapy||2
10301393|NCT00062647|11434350|FG000|STARTED|Overall Study||30
10301394|NCT00062647|11434351|FG001|STARTED|Overall Study||30
10301395|NCT00062647|11434350|FG000|COMPLETED|Overall Study||14
10301396|NCT00062647|11434351|FG001|COMPLETED|Overall Study||17
10301397|NCT00062647|11434350|FG000|NOT COMPLETED|Overall Study||16
10301398|NCT00062647|11434351|FG001|NOT COMPLETED|Overall Study||13
10301399|NCT00062738|11434360|FG000|STARTED|Overall Study||17
10301400|NCT00062738|11434361|FG001|STARTED|Overall Study||18
10301401|NCT00062738|11434362|FG002|STARTED|Overall Study||17
10301402|NCT00062738|11434360|FG000|COMPLETED|Overall Study||17
10301403|NCT00062738|11434361|FG001|COMPLETED|Overall Study||18
10301404|NCT00062738|11434362|FG002|COMPLETED|Overall Study||17
10301405|NCT00062738|11434360|FG000|NOT COMPLETED|Overall Study||0
10301406|NCT00062738|11434361|FG001|NOT COMPLETED|Overall Study||0
10301407|NCT00062738|11434362|FG002|NOT COMPLETED|Overall Study||0
10301408|NCT00062764|11434373|FG000|STARTED|Overall Study||18
10301409|NCT00062764|11434373|FG000|COMPLETED|Overall Study||18
10301410|NCT00062764|11434373|FG000|NOT COMPLETED|Overall Study||0
10301411|NCT00062868|11434398|FG000|STARTED|Dose Level 1||3
10301412|NCT00062868|11434399|FG001|STARTED|Dose Level 1||0
10301413|NCT00062868|11434400|FG002|STARTED|Dose Level 1||0
10301414|NCT00062868|11434401|FG003|STARTED|Dose Level 1||3
10301415|NCT00062868|11434402|FG004|STARTED|Dose Level 1||0
10301416|NCT00062868|11434403|FG005|STARTED|Dose Level 1||0
10301417|NCT00062868|11434404|FG006|STARTED|Dose Level 1||4
10301418|NCT00062868|11434405|FG007|STARTED|Dose Level 1||0
10301419|NCT00062868|11434406|FG008|STARTED|Dose Level 1||0
10301420|NCT00062868|11434407|FG009|STARTED|Dose Level 1||3
10301421|NCT00062868|11434408|FG010|STARTED|Dose Level 1||0
10301422|NCT00062868|11434409|FG011|STARTED|Dose Level 1||0
10301423|NCT00062868|11434410|FG012|STARTED|Dose Level 1||3
10301424|NCT00062868|11434411|FG013|STARTED|Dose Level 1||0
10301425|NCT00062868|11434412|FG014|STARTED|Dose Level 1||0
10301426|NCT00062868|11434413|FG015|STARTED|Dose Level 1||3
10301427|NCT00062868|11434414|FG016|STARTED|Dose Level 1||0
10301428|NCT00062868|11434415|FG017|STARTED|Dose Level 1||0
10301429|NCT00062868|11434416|FG018|STARTED|Dose Level 1||16
10301430|NCT00062868|11434417|FG019|STARTED|Dose Level 1||2
10301431|NCT00062868|11434418|FG020|STARTED|Dose Level 1||3
10301432|NCT00062868|11434398|FG000|COMPLETED|Dose Level 1||1
10301433|NCT00062868|11434399|FG001|COMPLETED|Dose Level 1||0
10301434|NCT00062868|11434400|FG002|COMPLETED|Dose Level 1||0
10301435|NCT00062868|11434401|FG003|COMPLETED|Dose Level 1||1
10301436|NCT00062868|11434402|FG004|COMPLETED|Dose Level 1||0
10301437|NCT00062868|11434403|FG005|COMPLETED|Dose Level 1||0
10301438|NCT00062868|11434404|FG006|COMPLETED|Dose Level 1||1
10301439|NCT00062868|11434405|FG007|COMPLETED|Dose Level 1||0
10301440|NCT00062868|11434406|FG008|COMPLETED|Dose Level 1||0
10301441|NCT00062868|11434407|FG009|COMPLETED|Dose Level 1||3
10301442|NCT00062868|11434408|FG010|COMPLETED|Dose Level 1||0
10301443|NCT00062868|11434409|FG011|COMPLETED|Dose Level 1||0
10301444|NCT00062868|11434410|FG012|COMPLETED|Dose Level 1||2
10301445|NCT00062868|11434411|FG013|COMPLETED|Dose Level 1||0
10547071|NCT01511939|11700934|FG001|COMPLETED|Overall Study||4
10547072|NCT01511939|11700935|FG002|COMPLETED|Overall Study||8
10547073|NCT01511939|11700933|FG000|NOT COMPLETED|Overall Study||2
10547074|NCT01511939|11700934|FG001|NOT COMPLETED|Overall Study||1
10547075|NCT01511939|11700935|FG002|NOT COMPLETED|Overall Study||0
10547076|NCT01511978|11700945|FG000|STARTED|Overall Study||14
10547077|NCT01511978|11700946|FG001|STARTED|Overall Study||18
10547078|NCT01511978|11700945|FG000|COMPLETED|Overall Study||14
10547079|NCT01511978|11700946|FG001|COMPLETED|Overall Study||18
10547080|NCT01511978|11700945|FG000|NOT COMPLETED|Overall Study||0
10547081|NCT01511978|11700946|FG001|NOT COMPLETED|Overall Study||0
10547082|NCT01512108|11700956|FG000|STARTED|Overall Study||243
10301446|NCT00062868|11434412|FG014|COMPLETED|Dose Level 1||0
10301447|NCT00062868|11434413|FG015|COMPLETED|Dose Level 1||3
10301448|NCT00062868|11434414|FG016|COMPLETED|Dose Level 1||0
10301449|NCT00062868|11434415|FG017|COMPLETED|Dose Level 1||0
10301450|NCT00062868|11434416|FG018|COMPLETED|Dose Level 1||7
10301451|NCT00062868|11434417|FG019|COMPLETED|Dose Level 1||2
10301452|NCT00062868|11434418|FG020|COMPLETED|Dose Level 1||1
10301453|NCT00062868|11434398|FG000|NOT COMPLETED|Dose Level 1||2
10301454|NCT00062868|11434399|FG001|NOT COMPLETED|Dose Level 1||0
10301455|NCT00062868|11434400|FG002|NOT COMPLETED|Dose Level 1||0
10301456|NCT00062868|11434401|FG003|NOT COMPLETED|Dose Level 1||2
10301457|NCT00062868|11434402|FG004|NOT COMPLETED|Dose Level 1||0
10301458|NCT00062868|11434403|FG005|NOT COMPLETED|Dose Level 1||0
10301459|NCT00062868|11434404|FG006|NOT COMPLETED|Dose Level 1||3
10301460|NCT00062868|11434405|FG007|NOT COMPLETED|Dose Level 1||0
10301461|NCT00062868|11434406|FG008|NOT COMPLETED|Dose Level 1||0
10301462|NCT00062868|11434407|FG009|NOT COMPLETED|Dose Level 1||0
10301463|NCT00062868|11434408|FG010|NOT COMPLETED|Dose Level 1||0
10301464|NCT00062868|11434409|FG011|NOT COMPLETED|Dose Level 1||0
10301465|NCT00062868|11434410|FG012|NOT COMPLETED|Dose Level 1||1
10301466|NCT00062868|11434411|FG013|NOT COMPLETED|Dose Level 1||0
10547083|NCT01512108|11700957|FG001|STARTED|Overall Study||120
10547084|NCT01512108|11700956|FG000|Exposed|Overall Study|3 subjects withdrew prior to exposure to trial drug|240
10547085|NCT01512108|11700957|FG001|Exposed|Overall Study||120
10301467|NCT00062868|11434412|FG014|NOT COMPLETED|Dose Level 1||0
10301468|NCT00062868|11434413|FG015|NOT COMPLETED|Dose Level 1||0
10301469|NCT00062868|11434414|FG016|NOT COMPLETED|Dose Level 1||0
10301470|NCT00062868|11434415|FG017|NOT COMPLETED|Dose Level 1||0
10301471|NCT00062868|11434416|FG018|NOT COMPLETED|Dose Level 1||9
10301472|NCT00062868|11434417|FG019|NOT COMPLETED|Dose Level 1||0
10301473|NCT00062868|11434418|FG020|NOT COMPLETED|Dose Level 1||2
10301474|NCT00062868|11434398|FG000|STARTED|Dose Level 2||0
10301475|NCT00062868|11434399|FG001|STARTED|Dose Level 2||6
10301476|NCT00062868|11434400|FG002|STARTED|Dose Level 2||0
10301477|NCT00062868|11434401|FG003|STARTED|Dose Level 2||0
10301478|NCT00062868|11434402|FG004|STARTED|Dose Level 2||3
10301479|NCT00062868|11434403|FG005|STARTED|Dose Level 2||0
10301480|NCT00062868|11434404|FG006|STARTED|Dose Level 2||0
10301481|NCT00062868|11434405|FG007|STARTED|Dose Level 2||0
10301482|NCT00062868|11434406|FG008|STARTED|Dose Level 2||0
10301483|NCT00062868|11434407|FG009|STARTED|Dose Level 2||0
10301484|NCT00062868|11434408|FG010|STARTED|Dose Level 2||4
10301485|NCT00062868|11434409|FG011|STARTED|Dose Level 2||0
10301486|NCT00062868|11434410|FG012|STARTED|Dose Level 2||0
10301487|NCT00062868|11434411|FG013|STARTED|Dose Level 2||3
10301488|NCT00062868|11434412|FG014|STARTED|Dose Level 2||0
10301489|NCT00062868|11434413|FG015|STARTED|Dose Level 2||0
10301490|NCT00062868|11434414|FG016|STARTED|Dose Level 2||3
10301491|NCT00062868|11434415|FG017|STARTED|Dose Level 2||0
10301492|NCT00062868|11434416|FG018|STARTED|Dose Level 2||0
10301493|NCT00062868|11434417|FG019|STARTED|Dose Level 2||0
10301494|NCT00062868|11434418|FG020|STARTED|Dose Level 2||0
10301495|NCT00062868|11434398|FG000|COMPLETED|Dose Level 2||0
10301496|NCT00062868|11434399|FG001|COMPLETED|Dose Level 2||3
10301497|NCT00062868|11434400|FG002|COMPLETED|Dose Level 2||0
10301498|NCT00062868|11434401|FG003|COMPLETED|Dose Level 2||0
10301499|NCT00062868|11434402|FG004|COMPLETED|Dose Level 2||1
10301500|NCT00062868|11434403|FG005|COMPLETED|Dose Level 2||0
10301501|NCT00062868|11434404|FG006|COMPLETED|Dose Level 2||0
10301502|NCT00062868|11434405|FG007|COMPLETED|Dose Level 2||0
10301503|NCT00062868|11434406|FG008|COMPLETED|Dose Level 2||0
10301504|NCT00062868|11434407|FG009|COMPLETED|Dose Level 2||0
10301505|NCT00062868|11434408|FG010|COMPLETED|Dose Level 2||3
10301506|NCT00062868|11434409|FG011|COMPLETED|Dose Level 2||0
10301507|NCT00062868|11434410|FG012|COMPLETED|Dose Level 2||0
10301508|NCT00062868|11434411|FG013|COMPLETED|Dose Level 2||2
10301509|NCT00062868|11434412|FG014|COMPLETED|Dose Level 2||0
10301510|NCT00062868|11434413|FG015|COMPLETED|Dose Level 2||0
10301511|NCT00062868|11434414|FG016|COMPLETED|Dose Level 2||0
10301512|NCT00062868|11434415|FG017|COMPLETED|Dose Level 2||0
10301513|NCT00062868|11434416|FG018|COMPLETED|Dose Level 2||0
10301514|NCT00062868|11434417|FG019|COMPLETED|Dose Level 2||0
10301515|NCT00062868|11434418|FG020|COMPLETED|Dose Level 2||0
10301516|NCT00062868|11434398|FG000|NOT COMPLETED|Dose Level 2||0
10301517|NCT00062868|11434399|FG001|NOT COMPLETED|Dose Level 2||3
10301518|NCT00062868|11434400|FG002|NOT COMPLETED|Dose Level 2||0
10301519|NCT00062868|11434401|FG003|NOT COMPLETED|Dose Level 2||0
10301520|NCT00062868|11434402|FG004|NOT COMPLETED|Dose Level 2||2
10301521|NCT00062868|11434403|FG005|NOT COMPLETED|Dose Level 2||0
10301522|NCT00062868|11434404|FG006|NOT COMPLETED|Dose Level 2||0
10301523|NCT00062868|11434405|FG007|NOT COMPLETED|Dose Level 2||0
10301524|NCT00062868|11434406|FG008|NOT COMPLETED|Dose Level 2||0
10301525|NCT00062868|11434407|FG009|NOT COMPLETED|Dose Level 2||0
10301526|NCT00062868|11434408|FG010|NOT COMPLETED|Dose Level 2||1
10301527|NCT00062868|11434409|FG011|NOT COMPLETED|Dose Level 2||0
10301528|NCT00062868|11434410|FG012|NOT COMPLETED|Dose Level 2||0
10301529|NCT00062868|11434411|FG013|NOT COMPLETED|Dose Level 2||1
10301530|NCT00062868|11434412|FG014|NOT COMPLETED|Dose Level 2||0
10301531|NCT00062868|11434413|FG015|NOT COMPLETED|Dose Level 2||0
10301532|NCT00062868|11434414|FG016|NOT COMPLETED|Dose Level 2||3
10301533|NCT00062868|11434415|FG017|NOT COMPLETED|Dose Level 2||0
10301534|NCT00062868|11434416|FG018|NOT COMPLETED|Dose Level 2||0
10301535|NCT00062868|11434417|FG019|NOT COMPLETED|Dose Level 2||0
10301536|NCT00062868|11434418|FG020|NOT COMPLETED|Dose Level 2||0
10301537|NCT00062868|11434398|FG000|STARTED|Dose Level 3||0
10301538|NCT00062868|11434399|FG001|STARTED|Dose Level 3||0
10301539|NCT00062868|11434400|FG002|STARTED|Dose Level 3||3
10301540|NCT00062868|11434401|FG003|STARTED|Dose Level 3||0
10301541|NCT00062868|11434402|FG004|STARTED|Dose Level 3||0
10301542|NCT00062868|11434403|FG005|STARTED|Dose Level 3||0
10301543|NCT00062868|11434404|FG006|STARTED|Dose Level 3||0
10301544|NCT00062868|11434405|FG007|STARTED|Dose Level 3||0
10301545|NCT00062868|11434406|FG008|STARTED|Dose Level 3||0
10301546|NCT00062868|11434407|FG009|STARTED|Dose Level 3||0
10301547|NCT00062868|11434408|FG010|STARTED|Dose Level 3||0
10301548|NCT00062868|11434409|FG011|STARTED|Dose Level 3||5
10301549|NCT00062868|11434410|FG012|STARTED|Dose Level 3||0
10301550|NCT00062868|11434411|FG013|STARTED|Dose Level 3||0
10301551|NCT00062868|11434412|FG014|STARTED|Dose Level 3||3
10301552|NCT00062868|11434413|FG015|STARTED|Dose Level 3||0
10301553|NCT00062868|11434414|FG016|STARTED|Dose Level 3||0
10301554|NCT00062868|11434415|FG017|STARTED|Dose Level 3||4
10301555|NCT00062868|11434416|FG018|STARTED|Dose Level 3||0
10301556|NCT00062868|11434417|FG019|STARTED|Dose Level 3||0
10301557|NCT00062868|11434418|FG020|STARTED|Dose Level 3||0
10301558|NCT00062868|11434398|FG000|COMPLETED|Dose Level 3||0
10301559|NCT00062868|11434399|FG001|COMPLETED|Dose Level 3||0
10301560|NCT00062868|11434400|FG002|COMPLETED|Dose Level 3||1
10301561|NCT00062868|11434401|FG003|COMPLETED|Dose Level 3||0
10301562|NCT00062868|11434402|FG004|COMPLETED|Dose Level 3||0
10301563|NCT00062868|11434403|FG005|COMPLETED|Dose Level 3||0
10301564|NCT00062868|11434404|FG006|COMPLETED|Dose Level 3||0
10301565|NCT00062868|11434405|FG007|COMPLETED|Dose Level 3||0
10301566|NCT00062868|11434406|FG008|COMPLETED|Dose Level 3||0
10301567|NCT00062868|11434407|FG009|COMPLETED|Dose Level 3||0
10301568|NCT00062868|11434408|FG010|COMPLETED|Dose Level 3||0
10301569|NCT00062868|11434409|FG011|COMPLETED|Dose Level 3||4
10301570|NCT00062868|11434410|FG012|COMPLETED|Dose Level 3||0
10301571|NCT00062868|11434411|FG013|COMPLETED|Dose Level 3||0
10301572|NCT00062868|11434412|FG014|COMPLETED|Dose Level 3||2
10301573|NCT00062868|11434413|FG015|COMPLETED|Dose Level 3||0
10301574|NCT00062868|11434414|FG016|COMPLETED|Dose Level 3||0
10301575|NCT00062868|11434415|FG017|COMPLETED|Dose Level 3||3
10301576|NCT00062868|11434416|FG018|COMPLETED|Dose Level 3||0
10301577|NCT00062868|11434417|FG019|COMPLETED|Dose Level 3||0
10301578|NCT00062868|11434418|FG020|COMPLETED|Dose Level 3||0
10301579|NCT00062868|11434398|FG000|NOT COMPLETED|Dose Level 3||0
10301580|NCT00062868|11434399|FG001|NOT COMPLETED|Dose Level 3||0
10301581|NCT00062868|11434400|FG002|NOT COMPLETED|Dose Level 3||2
10301582|NCT00062868|11434401|FG003|NOT COMPLETED|Dose Level 3||0
10301583|NCT00062868|11434402|FG004|NOT COMPLETED|Dose Level 3||0
10301584|NCT00062868|11434403|FG005|NOT COMPLETED|Dose Level 3||0
10301585|NCT00062868|11434404|FG006|NOT COMPLETED|Dose Level 3||0
10301586|NCT00062868|11434405|FG007|NOT COMPLETED|Dose Level 3||0
10301587|NCT00062868|11434406|FG008|NOT COMPLETED|Dose Level 3||0
10301588|NCT00062868|11434407|FG009|NOT COMPLETED|Dose Level 3||0
10301589|NCT00062868|11434408|FG010|NOT COMPLETED|Dose Level 3||0
10301590|NCT00062868|11434409|FG011|NOT COMPLETED|Dose Level 3||1
10301591|NCT00062868|11434410|FG012|NOT COMPLETED|Dose Level 3||0
10301592|NCT00062868|11434411|FG013|NOT COMPLETED|Dose Level 3||0
10301593|NCT00062868|11434412|FG014|NOT COMPLETED|Dose Level 3||1
10301594|NCT00062868|11434413|FG015|NOT COMPLETED|Dose Level 3||0
10301595|NCT00062868|11434414|FG016|NOT COMPLETED|Dose Level 3||0
10301596|NCT00062868|11434415|FG017|NOT COMPLETED|Dose Level 3||1
10301597|NCT00062868|11434416|FG018|NOT COMPLETED|Dose Level 3||0
10301598|NCT00062868|11434417|FG019|NOT COMPLETED|Dose Level 3||0
10301599|NCT00062868|11434418|FG020|NOT COMPLETED|Dose Level 3||0
10301600|NCT00063154|11434462|FG000|STARTED|Overall Study||51
10301601|NCT00063154|11434462|FG000|COMPLETED|Overall Study||0
10301602|NCT00063154|11434462|FG000|NOT COMPLETED|Overall Study||51
10301603|NCT00063232|11434466|FG000|STARTED|Overall Study||26
10301604|NCT00063232|11434466|FG000|COMPLETED|Overall Study||26
10301605|NCT00063232|11434466|FG000|NOT COMPLETED|Overall Study||0
10301606|NCT00063258|11434472|FG000|STARTED|Overall Study||5
10301607|NCT00063258|11434473|FG001|STARTED|Overall Study||0
10301608|NCT00063258|11434472|FG000|COMPLETED|Overall Study||1
10301609|NCT00063258|11434473|FG001|COMPLETED|Overall Study||0
10301610|NCT00063258|11434472|FG000|NOT COMPLETED|Overall Study||4
10301611|NCT00063258|11434473|FG001|NOT COMPLETED|Overall Study||0
10301612|NCT00063362|11434481|FG000|STARTED|Overall Study||23
10301613|NCT00063362|11434482|FG001|STARTED|Overall Study||26
10301614|NCT00063362|11434481|FG000|COMPLETED|Overall Study||19
10301615|NCT00063362|11434482|FG001|COMPLETED|Overall Study||22
10301616|NCT00063362|11434481|FG000|NOT COMPLETED|Overall Study||4
10301617|NCT00063362|11434482|FG001|NOT COMPLETED|Overall Study||4
10423399|NCT00829296|11568527|FG000|STARTED|Overall Study||34
10423400|NCT00829296|11568528|FG001|STARTED|Overall Study||36
10423401|NCT00829296|11568527|FG000|COMPLETED|Overall Study||29
10423402|NCT00829296|11568528|FG001|COMPLETED|Overall Study||32
10423403|NCT00829296|11568527|FG000|NOT COMPLETED|Overall Study||5
10423404|NCT00829296|11568528|FG001|NOT COMPLETED|Overall Study||4
10423405|NCT00829387|11568536|FG000|STARTED|Overall Study||23
10423406|NCT00829387|11568537|FG001|STARTED|Overall Study||24
10423407|NCT00829387|11568536|FG000|COMPLETED|Overall Study||20
10301618|NCT00063570|11434490|FG000|STARTED|Overall Study||52
10301619|NCT00063570|11434491|FG001|STARTED|Overall Study||21
10301620|NCT00063570|11434490|FG000|COMPLETED|Overall Study|Completed for this study means patient received study drug and was eligible for efficacy analysis.|52
10301621|NCT00063570|11434491|FG001|COMPLETED|Overall Study|Completed for this study means patient received study drug and was eligible for efficacy analysis.|21
10301622|NCT00063570|11434490|FG000|NOT COMPLETED|Overall Study||0
10301623|NCT00063570|11434491|FG001|NOT COMPLETED|Overall Study||0
10301624|NCT00063622|11434500|FG000|STARTED|Overall Study||80
10301625|NCT00063622|11434501|FG001|STARTED|Overall Study||84
10423408|NCT00829387|11568537|FG001|COMPLETED|Overall Study||21
10423409|NCT00829387|11568536|FG000|NOT COMPLETED|Overall Study||3
10547086|NCT01512108|11700956|FG000|COMPLETED|Overall Study||221
10547087|NCT01512108|11700957|FG001|COMPLETED|Overall Study||111
10547088|NCT01512108|11700956|FG000|NOT COMPLETED|Overall Study||22
10547089|NCT01512108|11700957|FG001|NOT COMPLETED|Overall Study||9
10547090|NCT01512160|11700967|FG000|STARTED|Overall Study||22
10547091|NCT01512160|11700968|FG001|STARTED|Overall Study||23
10547092|NCT01512160|11700969|FG002|STARTED|Overall Study||22
10547093|NCT01512160|11700970|FG003|STARTED|Overall Study||23
10547094|NCT01512160|11700967|FG000|COMPLETED|Overall Study||20
10547095|NCT01512160|11700968|FG001|COMPLETED|Overall Study||23
10547096|NCT01512160|11700969|FG002|COMPLETED|Overall Study||22
10547097|NCT01512160|11700970|FG003|COMPLETED|Overall Study||22
10547098|NCT01512160|11700967|FG000|NOT COMPLETED|Overall Study||2
10547099|NCT01512160|11700968|FG001|NOT COMPLETED|Overall Study||0
10547100|NCT01512160|11700969|FG002|NOT COMPLETED|Overall Study||0
10547101|NCT01512160|11700970|FG003|NOT COMPLETED|Overall Study||1
10547102|NCT01512225|11700983|FG000|STARTED|Overall Study||45
10547103|NCT01512225|11700984|FG001|STARTED|Overall Study||45
10547104|NCT01512225|11700983|FG000|Provided Day 14 Volume|Overall Study||45
10547105|NCT01512225|11700984|FG001|Provided Day 14 Volume|Overall Study||40
10547106|NCT01512225|11700983|FG000|COMPLETED|Overall Study||45
10547107|NCT01512225|11700984|FG001|COMPLETED|Overall Study||45
10547108|NCT01512225|11700983|FG000|NOT COMPLETED|Overall Study||0
10547109|NCT01512225|11700984|FG001|NOT COMPLETED|Overall Study||0
10547110|NCT01512251|11700994|FG000|STARTED|Dose Level -1||3
10547111|NCT01512251|11700995|FG001|STARTED|Dose Level -1||5
10547112|NCT01512251|11700994|FG000|COMPLETED|Dose Level -1||3
10547113|NCT01512251|11700995|FG001|COMPLETED|Dose Level -1||5
10547114|NCT01512251|11700994|FG000|NOT COMPLETED|Dose Level -1||0
10547115|NCT01512251|11700995|FG001|NOT COMPLETED|Dose Level -1||0
10547116|NCT01512251|11700994|FG000|STARTED|Phase I, Dose 1||3
10547117|NCT01512251|11700995|FG001|STARTED|Phase I, Dose 1||5
10547118|NCT01512251|11700994|FG000|COMPLETED|Phase I, Dose 1||0
10547119|NCT01512251|11700995|FG001|COMPLETED|Phase I, Dose 1||0
10547120|NCT01512251|11700994|FG000|NOT COMPLETED|Phase I, Dose 1||3
10547121|NCT01512251|11700995|FG001|NOT COMPLETED|Phase I, Dose 1||5
10547122|NCT01512251|11700994|FG000|STARTED|Phase I, Dose 2||0
10547123|NCT01512251|11700995|FG001|STARTED|Phase I, Dose 2||0
10547124|NCT01512251|11700994|FG000|COMPLETED|Phase I, Dose 2||0
10547125|NCT01512251|11700995|FG001|COMPLETED|Phase I, Dose 2||0
10547126|NCT01512251|11700994|FG000|NOT COMPLETED|Phase I, Dose 2||0
10547127|NCT01512251|11700995|FG001|NOT COMPLETED|Phase I, Dose 2||0
10547128|NCT01512251|11700994|FG000|STARTED|Phase I, Dose 3||0
10547129|NCT01512251|11700995|FG001|STARTED|Phase I, Dose 3||0
10547130|NCT01512251|11700994|FG000|COMPLETED|Phase I, Dose 3||0
10547131|NCT01512251|11700995|FG001|COMPLETED|Phase I, Dose 3||0
10547132|NCT01512251|11700994|FG000|NOT COMPLETED|Phase I, Dose 3||0
10547133|NCT01512251|11700995|FG001|NOT COMPLETED|Phase I, Dose 3||0
10547134|NCT01512251|11700994|FG000|STARTED|Phase I, Dose 4||0
10547135|NCT01512251|11700995|FG001|STARTED|Phase I, Dose 4||0
10547136|NCT01512251|11700994|FG000|COMPLETED|Phase I, Dose 4||0
10547137|NCT01512251|11700995|FG001|COMPLETED|Phase I, Dose 4||0
10547138|NCT01512251|11700994|FG000|NOT COMPLETED|Phase I, Dose 4||0
10547139|NCT01512251|11700995|FG001|NOT COMPLETED|Phase I, Dose 4||0
10547140|NCT01512251|11700994|FG000|STARTED|Phase II||0
10547141|NCT01512251|11700995|FG001|STARTED|Phase II||0
10547142|NCT01512251|11700994|FG000|COMPLETED|Phase II||0
10547143|NCT01512251|11700995|FG001|COMPLETED|Phase II||0
10547144|NCT01512251|11700994|FG000|NOT COMPLETED|Phase II||0
10547145|NCT01512251|11700995|FG001|NOT COMPLETED|Phase II||0
10547146|NCT01512264|11701006|FG000|STARTED|Overall Study||7
10547147|NCT01512264|11701007|FG001|STARTED|Overall Study||7
10547148|NCT01512264|11701008|FG002|STARTED|Overall Study||7
10547149|NCT01512264|11701009|FG003|STARTED|Overall Study||7
10547150|NCT01512264|11701006|FG000|COMPLETED|Overall Study||7
10547151|NCT01512264|11701007|FG001|COMPLETED|Overall Study||7
10547152|NCT01512264|11701008|FG002|COMPLETED|Overall Study||7
10547153|NCT01512264|11701009|FG003|COMPLETED|Overall Study||6
10547154|NCT01512264|11701006|FG000|NOT COMPLETED|Overall Study||0
10547155|NCT01512264|11701007|FG001|NOT COMPLETED|Overall Study||0
10547156|NCT01512264|11701008|FG002|NOT COMPLETED|Overall Study||0
10547157|NCT01512264|11701009|FG003|NOT COMPLETED|Overall Study||1
10547158|NCT01512368|11701019|FG000|STARTED|Overall Study||63
10547159|NCT01512368|11701019|FG000|COMPLETED|Overall Study||60
10547160|NCT01512368|11701019|FG000|NOT COMPLETED|Overall Study||3
10547161|NCT01512446|11701025|FG000|STARTED|Overall Study||221
10547162|NCT01512446|11701026|FG001|STARTED|Overall Study||215
10547163|NCT01512446|11701025|FG000|Safety Analysis Set|Overall Study||197
10547164|NCT01512446|11701026|FG001|Safety Analysis Set|Overall Study||188
10547165|NCT01512446|11701025|FG000|COMPLETED|Overall Study||0
10547166|NCT01512446|11701026|FG001|COMPLETED|Overall Study||0
10547167|NCT01512446|11701025|FG000|NOT COMPLETED|Overall Study||221
10547168|NCT01512446|11701026|FG001|NOT COMPLETED|Overall Study||215
10547169|NCT01512667|11701034|FG000|STARTED|Overall Study||13
10547170|NCT01512667|11701035|FG001|STARTED|Overall Study||12
10547171|NCT01512667|11701034|FG000|Matched Participants|Overall Study||12
10547172|NCT01512667|11701035|FG001|Matched Participants|Overall Study||12
10547173|NCT01512667|11701034|FG000|Unmatched Participants|Overall Study|Participant was not matched to a healthy control participant.|1
10547174|NCT01512667|11701035|FG001|Unmatched Participants|Overall Study||0
10547175|NCT01512667|11701034|FG000|COMPLETED|Overall Study||13
10547176|NCT01512667|11701035|FG001|COMPLETED|Overall Study||12
10547177|NCT01512667|11701034|FG000|NOT COMPLETED|Overall Study||0
10547178|NCT01512667|11701035|FG001|NOT COMPLETED|Overall Study||0
10547179|NCT01512693|11701043|FG000|STARTED|Overall Study||8
10547180|NCT01512693|11701044|FG001|STARTED|Overall Study||9
10547181|NCT01512693|11701043|FG000|COMPLETED|Overall Study||8
10547182|NCT01512693|11701044|FG001|COMPLETED|Overall Study||8
10547183|NCT01512693|11701043|FG000|NOT COMPLETED|Overall Study||0
10547184|NCT01512693|11701044|FG001|NOT COMPLETED|Overall Study||1
10547185|NCT01512745|11701052|FG000|STARTED|Overall Study||176
10547186|NCT01512745|11701053|FG001|STARTED|Overall Study||91
10547187|NCT01512745|11701052|FG000|COMPLETED|Overall Study||136
10547188|NCT01512745|11701053|FG001|COMPLETED|Overall Study||71
10547189|NCT01512745|11701052|FG000|NOT COMPLETED|Overall Study||40
10547190|NCT01512745|11701053|FG001|NOT COMPLETED|Overall Study||20
10547191|NCT01512758|11701061|FG000|STARTED|Overall Study||30
10547192|NCT01512758|11701062|FG001|STARTED|Overall Study||6
10547193|NCT01512758|11701061|FG000|COMPLETED|Overall Study|Completed=Completed protocol-specified dosing and PK assessment.|30
10547194|NCT01512758|11701062|FG001|COMPLETED|Overall Study||6
10547195|NCT01512758|11701061|FG000|NOT COMPLETED|Overall Study||0
10547196|NCT01512758|11701062|FG001|NOT COMPLETED|Overall Study||0
10547197|NCT01512797|11701071|FG000|STARTED|Overall Study||16
10547198|NCT01512797|11701072|FG001|STARTED|Overall Study||16
10547199|NCT01512797|11701071|FG000|COMPLETED|Overall Study||16
10547200|NCT01512797|11701072|FG001|COMPLETED|Overall Study||16
10547201|NCT01512797|11701071|FG000|NOT COMPLETED|Overall Study||0
10547202|NCT01512797|11701072|FG001|NOT COMPLETED|Overall Study||0
10547203|NCT01512849|11701080|FG000|STARTED|Crossover Period 1||6
10547204|NCT01512849|11701081|FG001|STARTED|Crossover Period 1||6
10547205|NCT01512849|11701082|FG002|STARTED|Crossover Period 1||6
10547206|NCT01512849|11701083|FG003|STARTED|Crossover Period 1||6
10547207|NCT01512849|11701080|FG000|COMPLETED|Crossover Period 1||6
10547208|NCT01512849|11701081|FG001|COMPLETED|Crossover Period 1||6
10547209|NCT01512849|11701082|FG002|COMPLETED|Crossover Period 1||6
10547210|NCT01512849|11701083|FG003|COMPLETED|Crossover Period 1||6
10547211|NCT01512849|11701080|FG000|NOT COMPLETED|Crossover Period 1||0
10547212|NCT01512849|11701081|FG001|NOT COMPLETED|Crossover Period 1||0
10547213|NCT01512849|11701082|FG002|NOT COMPLETED|Crossover Period 1||0
10547214|NCT01512849|11701083|FG003|NOT COMPLETED|Crossover Period 1||0
10547215|NCT01512849|11701080|FG000|STARTED|Crossover Period 2||6
10547216|NCT01512849|11701081|FG001|STARTED|Crossover Period 2||6
10547217|NCT01512849|11701082|FG002|STARTED|Crossover Period 2||6
10547218|NCT01512849|11701083|FG003|STARTED|Crossover Period 2||6
10547219|NCT01512849|11701080|FG000|COMPLETED|Crossover Period 2||6
10547220|NCT01512849|11701081|FG001|COMPLETED|Crossover Period 2||6
10547221|NCT01512849|11701082|FG002|COMPLETED|Crossover Period 2||6
10547222|NCT01512849|11701083|FG003|COMPLETED|Crossover Period 2||6
10547223|NCT01512849|11701080|FG000|NOT COMPLETED|Crossover Period 2||0
10547224|NCT01512849|11701081|FG001|NOT COMPLETED|Crossover Period 2||0
10547225|NCT01512849|11701082|FG002|NOT COMPLETED|Crossover Period 2||0
10547226|NCT01512849|11701083|FG003|NOT COMPLETED|Crossover Period 2||0
10547227|NCT01512979|11701095|FG000|STARTED|Overall Study|Randomised and treated|159
10547228|NCT01512979|11701096|FG001|STARTED|Overall Study|Randomised and treated|157
10547229|NCT01512979|11701095|FG000|COMPLETED|Overall Study||140
10547230|NCT01512979|11701096|FG001|COMPLETED|Overall Study||135
10547231|NCT01512979|11701095|FG000|NOT COMPLETED|Overall Study||19
10547232|NCT01512979|11701096|FG001|NOT COMPLETED|Overall Study||22
10774923|NCT03310021|11937096|FG014|STARTED|Overall Study||6
10774924|NCT03310021|11937097|FG015|STARTED|Overall Study||3
10774925|NCT03310021|11937098|FG016|STARTED|Overall Study||10
10774926|NCT03310021|11937099|FG017|STARTED|Overall Study||5
10774927|NCT03310021|11937100|FG018|STARTED|Overall Study||8
10774928|NCT03310021|11937101|FG019|STARTED|Overall Study||3
10774929|NCT03310021|11937082|FG000|COMPLETED|Overall Study||6
10774930|NCT03310021|11937083|FG001|COMPLETED|Overall Study||3
10774931|NCT03310021|11937084|FG002|COMPLETED|Overall Study||6
10774932|NCT03310021|11937085|FG003|COMPLETED|Overall Study||3
10774933|NCT03310021|11937086|FG004|COMPLETED|Overall Study||8
10774934|NCT03310021|11937087|FG005|COMPLETED|Overall Study||4
10774935|NCT03310021|11937088|FG006|COMPLETED|Overall Study||7
10774936|NCT03310021|11937089|FG007|COMPLETED|Overall Study||4
10774937|NCT03310021|11937090|FG008|COMPLETED|Overall Study||6
10774938|NCT03310021|11937091|FG009|COMPLETED|Overall Study||3
10774939|NCT03310021|11937092|FG010|COMPLETED|Overall Study||5
10774940|NCT03310021|11937093|FG011|COMPLETED|Overall Study||3
10774941|NCT03310021|11937094|FG012|COMPLETED|Overall Study||8
10774942|NCT03310021|11937095|FG013|COMPLETED|Overall Study||4
10774943|NCT03310021|11937096|FG014|COMPLETED|Overall Study||6
10774944|NCT03310021|11937097|FG015|COMPLETED|Overall Study||3
10774945|NCT03310021|11937098|FG016|COMPLETED|Overall Study||10
10774946|NCT03310021|11937099|FG017|COMPLETED|Overall Study||5
10774947|NCT03310021|11937100|FG018|COMPLETED|Overall Study||8
10774948|NCT03310021|11937101|FG019|COMPLETED|Overall Study||3
10774949|NCT03310021|11937082|FG000|NOT COMPLETED|Overall Study||0
10774950|NCT03310021|11937083|FG001|NOT COMPLETED|Overall Study||0
10774951|NCT03310021|11937084|FG002|NOT COMPLETED|Overall Study||0
10547233|NCT01513122|11701104|FG000|STARTED|Overall Study||102
10547234|NCT01513122|11701105|FG001|STARTED|Overall Study||108
10547235|NCT01513122|11701104|FG000|COMPLETED|Overall Study||91
10547236|NCT01513122|11701105|FG001|COMPLETED|Overall Study||105
10547237|NCT01513122|11701104|FG000|NOT COMPLETED|Overall Study||11
10547238|NCT01513122|11701105|FG001|NOT COMPLETED|Overall Study||3
10547239|NCT01513148|11701113|FG000|STARTED|Overall Study||16
10547240|NCT01513148|11701114|FG001|STARTED|Overall Study||16
10547241|NCT01513148|11701113|FG000|COMPLETED|Overall Study||14
10547242|NCT01513148|11701114|FG001|COMPLETED|Overall Study||14
10547243|NCT01513148|11701113|FG000|NOT COMPLETED|Overall Study||2
10547244|NCT01513148|11701114|FG001|NOT COMPLETED|Overall Study||2
10547245|NCT01513239|11701163|FG000|STARTED|Period 1: Main Phase|Randomized participants|397
10547246|NCT01513239|11701164|FG001|STARTED|Period 1: Main Phase|Randomized participants|407
10547247|NCT01513239|11701165|FG002|STARTED|Period 1: Main Phase|Randomized participants|399
10547248|NCT01513239|11701166|FG003|STARTED|Period 1: Main Phase||0
10547249|NCT01513239|11701167|FG004|STARTED|Period 1: Main Phase||0
10547250|NCT01513239|11701168|FG005|STARTED|Period 1: Main Phase||0
10547251|NCT01513239|11701163|FG000|Treated|Period 1: Main Phase|Treated participants|391
10547252|NCT01513239|11701164|FG001|Treated|Period 1: Main Phase|Treated participants|396
10547253|NCT01513239|11701165|FG002|Treated|Period 1: Main Phase|Treated participants|381
10547254|NCT01513239|11701166|FG003|Treated|Period 1: Main Phase||0
10547255|NCT01513239|11701167|FG004|Treated|Period 1: Main Phase||0
10547256|NCT01513239|11701168|FG005|Treated|Period 1: Main Phase||0
10547257|NCT01513239|11701163|FG000|All Participants as Treated|Period 1: Main Phase|One participant randomized to receive MK-3415A (MK-3415 plus MK-6072) received only MK-3415|390
10547258|NCT01513239|11701164|FG001|All Participants as Treated|Period 1: Main Phase|Treatment actually received|396
10774952|NCT03310021|11937085|FG003|NOT COMPLETED|Overall Study||0
10774953|NCT03310021|11937086|FG004|NOT COMPLETED|Overall Study||0
10774954|NCT03310021|11937087|FG005|NOT COMPLETED|Overall Study||0
10774955|NCT03310021|11937088|FG006|NOT COMPLETED|Overall Study||1
10774956|NCT03310021|11937089|FG007|NOT COMPLETED|Overall Study||0
10774957|NCT03310021|11937090|FG008|NOT COMPLETED|Overall Study||0
10774958|NCT03310021|11937091|FG009|NOT COMPLETED|Overall Study||0
10774959|NCT03310021|11937092|FG010|NOT COMPLETED|Overall Study||1
10774960|NCT03310021|11937093|FG011|NOT COMPLETED|Overall Study||0
10774961|NCT03310021|11937094|FG012|NOT COMPLETED|Overall Study||0
10774962|NCT03310021|11937095|FG013|NOT COMPLETED|Overall Study||0
10774963|NCT03310021|11937096|FG014|NOT COMPLETED|Overall Study||0
10774964|NCT03310021|11937097|FG015|NOT COMPLETED|Overall Study||0
10774965|NCT03310021|11937098|FG016|NOT COMPLETED|Overall Study||0
10774966|NCT03310021|11937099|FG017|NOT COMPLETED|Overall Study||0
10774967|NCT03310021|11937100|FG018|NOT COMPLETED|Overall Study||0
10774968|NCT03310021|11937101|FG019|NOT COMPLETED|Overall Study||0
10774969|NCT03310268|11937146|FG000|STARTED|Overall Study||62
10774970|NCT03310268|11937147|FG001|STARTED|Overall Study||62
10774971|NCT03310268|11937148|FG002|STARTED|Overall Study||61
10774972|NCT03310268|11937146|FG000|COMPLETED|Overall Study||61
10774973|NCT03310268|11937147|FG001|COMPLETED|Overall Study||57
10774974|NCT03310268|11937148|FG002|COMPLETED|Overall Study||61
10774975|NCT03310268|11937146|FG000|NOT COMPLETED|Overall Study||1
10774976|NCT03310268|11937147|FG001|NOT COMPLETED|Overall Study||5
10774977|NCT03310268|11937148|FG002|NOT COMPLETED|Overall Study||0
10774978|NCT03310411|11937156|FG000|STARTED|Period 1||10
10774979|NCT03310411|11937157|FG001|STARTED|Period 1||10
10774980|NCT03310411|11937158|FG002|STARTED|Period 1||10
10774981|NCT03310411|11937159|FG003|STARTED|Period 1||10
10774982|NCT03310411|11937156|FG000|Received at Least 1 Dose of Study Drug|Period 1||10
10774983|NCT03310411|11937157|FG001|Received at Least 1 Dose of Study Drug|Period 1||10
10774984|NCT03310411|11937158|FG002|Received at Least 1 Dose of Study Drug|Period 1||10
10774985|NCT03310411|11937159|FG003|Received at Least 1 Dose of Study Drug|Period 1||10
10774986|NCT03310411|11937156|FG000|COMPLETED|Period 1||10
10774987|NCT03310411|11937157|FG001|COMPLETED|Period 1||10
10774988|NCT03310411|11937158|FG002|COMPLETED|Period 1||10
10774989|NCT03310411|11937159|FG003|COMPLETED|Period 1||9
10774990|NCT03310411|11937156|FG000|NOT COMPLETED|Period 1||0
10774991|NCT03310411|11937157|FG001|NOT COMPLETED|Period 1||0
10774992|NCT03310411|11937158|FG002|NOT COMPLETED|Period 1||0
10774993|NCT03310411|11937159|FG003|NOT COMPLETED|Period 1||1
10774994|NCT03310411|11937156|FG000|STARTED|Period 2||10
10774995|NCT03310411|11937157|FG001|STARTED|Period 2||10
10774996|NCT03310411|11937158|FG002|STARTED|Period 2||10
10774997|NCT03310411|11937159|FG003|STARTED|Period 2||9
10774998|NCT03310411|11937156|FG000|COMPLETED|Period 2||10
10774999|NCT03310411|11937157|FG001|COMPLETED|Period 2||10
10775000|NCT03310411|11937158|FG002|COMPLETED|Period 2||10
10775001|NCT03310411|11937159|FG003|COMPLETED|Period 2||9
10775002|NCT03310411|11937156|FG000|NOT COMPLETED|Period 2||0
10775003|NCT03310411|11937157|FG001|NOT COMPLETED|Period 2||0
10775004|NCT03310411|11937158|FG002|NOT COMPLETED|Period 2||0
10775005|NCT03310411|11937159|FG003|NOT COMPLETED|Period 2||0
10775006|NCT03310411|11937156|FG000|STARTED|Period 3||10
10775007|NCT03310411|11937157|FG001|STARTED|Period 3||10
10775008|NCT03310411|11937158|FG002|STARTED|Period 3||10
10775009|NCT03310411|11937159|FG003|STARTED|Period 3||9
10775010|NCT03310411|11937156|FG000|COMPLETED|Period 3||10
10775011|NCT03310411|11937157|FG001|COMPLETED|Period 3||10
10775012|NCT03310411|11937158|FG002|COMPLETED|Period 3||10
10775013|NCT03310411|11937159|FG003|COMPLETED|Period 3||9
10775014|NCT03310411|11937156|FG000|NOT COMPLETED|Period 3||0
10775015|NCT03310411|11937157|FG001|NOT COMPLETED|Period 3||0
10775016|NCT03310411|11937158|FG002|NOT COMPLETED|Period 3||0
10775017|NCT03310411|11937159|FG003|NOT COMPLETED|Period 3||0
10775018|NCT03310411|11937156|FG000|STARTED|Period Title: Period 4||10
10775019|NCT03310411|11937157|FG001|STARTED|Period Title: Period 4||10
10775020|NCT03310411|11937158|FG002|STARTED|Period Title: Period 4||10
10775021|NCT03310411|11937159|FG003|STARTED|Period Title: Period 4||9
10547259|NCT01513239|11701165|FG002|All Participants as Treated|Period 1: Main Phase|Treatment actually received|381
10547260|NCT01513239|11701166|FG003|All Participants as Treated|Period 1: Main Phase||0
10547261|NCT01513239|11701167|FG004|All Participants as Treated|Period 1: Main Phase||0
10547262|NCT01513239|11701168|FG005|All Participants as Treated|Period 1: Main Phase||0
10547263|NCT01513239|11701163|FG000|COMPLETED|Period 1: Main Phase||322
10547264|NCT01513239|11701164|FG001|COMPLETED|Period 1: Main Phase||337
10547265|NCT01513239|11701165|FG002|COMPLETED|Period 1: Main Phase||311
10547266|NCT01513239|11701166|FG003|COMPLETED|Period 1: Main Phase||0
10547267|NCT01513239|11701167|FG004|COMPLETED|Period 1: Main Phase||0
10547268|NCT01513239|11701168|FG005|COMPLETED|Period 1: Main Phase||0
10547269|NCT01513239|11701163|FG000|NOT COMPLETED|Period 1: Main Phase||75
10547270|NCT01513239|11701164|FG001|NOT COMPLETED|Period 1: Main Phase||70
10547271|NCT01513239|11701165|FG002|NOT COMPLETED|Period 1: Main Phase||88
10547272|NCT01513239|11701166|FG003|NOT COMPLETED|Period 1: Main Phase||0
10547273|NCT01513239|11701167|FG004|NOT COMPLETED|Period 1: Main Phase||0
10547274|NCT01513239|11701168|FG005|NOT COMPLETED|Period 1: Main Phase||0
10547275|NCT01513239|11701163|FG000|STARTED|Period 2: 9 Month Extension Phase||0
10547276|NCT01513239|11701164|FG001|STARTED|Period 2: 9 Month Extension Phase||0
10547277|NCT01513239|11701165|FG002|STARTED|Period 2: 9 Month Extension Phase||0
10547278|NCT01513239|11701166|FG003|STARTED|Period 2: 9 Month Extension Phase||112
10547279|NCT01513239|11701167|FG004|STARTED|Period 2: 9 Month Extension Phase||100
10547280|NCT01513239|11701168|FG005|STARTED|Period 2: 9 Month Extension Phase||83
10547281|NCT01513239|11701163|FG000|COMPLETED|Period 2: 9 Month Extension Phase||0
10547282|NCT01513239|11701164|FG001|COMPLETED|Period 2: 9 Month Extension Phase||0
10547283|NCT01513239|11701165|FG002|COMPLETED|Period 2: 9 Month Extension Phase||0
10547284|NCT01513239|11701166|FG003|COMPLETED|Period 2: 9 Month Extension Phase||102
10547285|NCT01513239|11701167|FG004|COMPLETED|Period 2: 9 Month Extension Phase||90
10547286|NCT01513239|11701168|FG005|COMPLETED|Period 2: 9 Month Extension Phase||78
10547287|NCT01513239|11701163|FG000|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
10547288|NCT01513239|11701164|FG001|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
10547289|NCT01513239|11701165|FG002|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
10547290|NCT01513239|11701166|FG003|NOT COMPLETED|Period 2: 9 Month Extension Phase||10
10547291|NCT01513239|11701167|FG004|NOT COMPLETED|Period 2: 9 Month Extension Phase||10
10547292|NCT01513239|11701168|FG005|NOT COMPLETED|Period 2: 9 Month Extension Phase||5
10547293|NCT01513291|11701182|FG000|STARTED|Treatment Period||120
10547294|NCT01513291|11701183|FG001|STARTED|Treatment Period||117
10547295|NCT01513291|11701184|FG002|STARTED|Treatment Period||0
10547296|NCT01513291|11701185|FG003|STARTED|Treatment Period||0
10547297|NCT01513291|11701186|FG004|STARTED|Treatment Period||0
10547298|NCT01513291|11701182|FG000|Treated|Treatment Period||120
10547299|NCT01513291|11701183|FG001|Treated|Treatment Period||115
10547300|NCT01513291|11701184|FG002|Treated|Treatment Period||0
10547301|NCT01513291|11701185|FG003|Treated|Treatment Period||0
10547302|NCT01513291|11701186|FG004|Treated|Treatment Period||0
10547303|NCT01513291|11701182|FG000|COMPLETED|Treatment Period||97
10547304|NCT01513291|11701183|FG001|COMPLETED|Treatment Period||101
10547305|NCT01513291|11701184|FG002|COMPLETED|Treatment Period||0
10547306|NCT01513291|11701185|FG003|COMPLETED|Treatment Period||0
10547307|NCT01513291|11701186|FG004|COMPLETED|Treatment Period||0
10547308|NCT01513291|11701182|FG000|NOT COMPLETED|Treatment Period||23
10547309|NCT01513291|11701183|FG001|NOT COMPLETED|Treatment Period||16
10547310|NCT01513291|11701184|FG002|NOT COMPLETED|Treatment Period||0
10547311|NCT01513291|11701185|FG003|NOT COMPLETED|Treatment Period||0
10547312|NCT01513291|11701186|FG004|NOT COMPLETED|Treatment Period||0
10775022|NCT03310411|11937156|FG000|COMPLETED|Period Title: Period 4||10
10775023|NCT03310411|11937157|FG001|COMPLETED|Period Title: Period 4||10
10775024|NCT03310411|11937158|FG002|COMPLETED|Period Title: Period 4||10
10775025|NCT03310411|11937159|FG003|COMPLETED|Period Title: Period 4||9
10775026|NCT03310411|11937156|FG000|NOT COMPLETED|Period Title: Period 4||0
10775027|NCT03310411|11937157|FG001|NOT COMPLETED|Period Title: Period 4||0
10775028|NCT03310411|11937158|FG002|NOT COMPLETED|Period Title: Period 4||0
10775029|NCT03310411|11937159|FG003|NOT COMPLETED|Period Title: Period 4||0
10775030|NCT03310450|11937178|FG000|STARTED|Overall Study||32
10775031|NCT03310450|11937179|FG001|STARTED|Overall Study||34
10775032|NCT03310450|11937180|FG002|STARTED|Overall Study||28
10775033|NCT03310450|11937178|FG000|COMPLETED|Overall Study||30
10775034|NCT03310450|11937179|FG001|COMPLETED|Overall Study||30
10775035|NCT03310450|11937180|FG002|COMPLETED|Overall Study||28
10775036|NCT03310450|11937178|FG000|NOT COMPLETED|Overall Study||2
10775037|NCT03310450|11937179|FG001|NOT COMPLETED|Overall Study||4
10775038|NCT03310450|11937180|FG002|NOT COMPLETED|Overall Study||0
10775039|NCT03310580|11937194|FG000|STARTED|Overall Study||15
10775040|NCT03310580|11937195|FG001|STARTED|Overall Study||15
10775041|NCT03310580|11937196|FG002|STARTED|Overall Study||12
10775042|NCT03310580|11937194|FG000|COMPLETED|Overall Study||15
10775043|NCT03310580|11937195|FG001|COMPLETED|Overall Study||14
10775044|NCT03310580|11937196|FG002|COMPLETED|Overall Study||12
10775045|NCT03310580|11937194|FG000|NOT COMPLETED|Overall Study||0
10775046|NCT03310580|11937195|FG001|NOT COMPLETED|Overall Study||1
10775047|NCT03310580|11937196|FG002|NOT COMPLETED|Overall Study||0
10775048|NCT03310723|11937207|FG000|STARTED|Overall Study||20
10775049|NCT03310723|11937208|FG001|STARTED|Overall Study||20
10775050|NCT03310723|11937207|FG000|COMPLETED|Overall Study||20
10775051|NCT03310723|11937208|FG001|COMPLETED|Overall Study||17
10775052|NCT03310723|11937207|FG000|NOT COMPLETED|Overall Study||0
10775053|NCT03310723|11937208|FG001|NOT COMPLETED|Overall Study||3
10547313|NCT01513291|11701182|FG000|STARTED|Run-out Period||0
10547314|NCT01513291|11701183|FG001|STARTED|Run-out Period||0
10775054|NCT03310775|11937216|FG000|STARTED|Overall Study||19
10775055|NCT03310775|11937217|FG001|STARTED|Overall Study||18
10775056|NCT03310775|11937216|FG000|COMPLETED|Overall Study||17
10775057|NCT03310775|11937217|FG001|COMPLETED|Overall Study||14
10775058|NCT03310775|11937216|FG000|NOT COMPLETED|Overall Study||2
10775059|NCT03310775|11937217|FG001|NOT COMPLETED|Overall Study||4
10775060|NCT03310970|11937223|FG000|STARTED|Overall Study||11
10775061|NCT03310970|11937224|FG001|STARTED|Overall Study||12
10775062|NCT03310970|11937223|FG000|COMPLETED|Overall Study||11
10775063|NCT03310970|11937224|FG001|COMPLETED|Overall Study||11
10775064|NCT03310970|11937223|FG000|NOT COMPLETED|Overall Study||0
10775065|NCT03310970|11937224|FG001|NOT COMPLETED|Overall Study||1
10775066|NCT03311230|11937235|FG000|STARTED|Overall Study||151
10775067|NCT03311230|11937236|FG001|STARTED|Overall Study||151
10775068|NCT03311230|11937237|FG002|STARTED|Overall Study||150
10775069|NCT03311230|11937238|FG003|STARTED|Overall Study||150
10775070|NCT03311230|11937235|FG000|COMPLETED|Overall Study||150
10775071|NCT03311230|11937236|FG001|COMPLETED|Overall Study||146
10775072|NCT03311230|11937237|FG002|COMPLETED|Overall Study||148
10775073|NCT03311230|11937238|FG003|COMPLETED|Overall Study||143
10775074|NCT03311230|11937235|FG000|NOT COMPLETED|Overall Study||1
10775075|NCT03311230|11937236|FG001|NOT COMPLETED|Overall Study||5
10775076|NCT03311230|11937237|FG002|NOT COMPLETED|Overall Study||2
10775077|NCT03311230|11937238|FG003|NOT COMPLETED|Overall Study||7
10775078|NCT03311373|11937248|FG000|STARTED|Overall Study||56
10775079|NCT03311373|11937248|FG000|COMPLETED|Overall Study||47
10775080|NCT03311373|11937248|FG000|NOT COMPLETED|Overall Study||9
10775081|NCT03311646|11937258|FG000|STARTED|Overall Study|Number who were eligible and consented.|31
10775082|NCT03311646|11937258|FG000|COMPLETED|Overall Study|Completed VLNC Condition|16
10775083|NCT03311646|11937258|FG000|NOT COMPLETED|Overall Study||15
10775084|NCT03311659|11937263|FG000|STARTED|Overall Study||447
10775085|NCT03311659|11937263|FG000|COMPLETED|Overall Study||446
10775086|NCT03311659|11937263|FG000|NOT COMPLETED|Overall Study||1
10775087|NCT03311724|11937271|FG000|STARTED|Overall Study||26
10775088|NCT03311724|11937272|FG001|STARTED|Overall Study||29
10775089|NCT03311724|11937273|FG002|STARTED|Overall Study||28
10775090|NCT03311724|11937274|FG003|STARTED|Overall Study||28
10775091|NCT03311724|11937271|FG000|Received At Least One Dose of Study Drug|Overall Study||26
10775092|NCT03311724|11937272|FG001|Received At Least One Dose of Study Drug|Overall Study||29
10775093|NCT03311724|11937273|FG002|Received At Least One Dose of Study Drug|Overall Study||28
10775094|NCT03311724|11937274|FG003|Received At Least One Dose of Study Drug|Overall Study||28
10775095|NCT03311724|11937271|FG000|Completed Treatment|Overall Study||20
10775096|NCT03311724|11937272|FG001|Completed Treatment|Overall Study||27
10775097|NCT03311724|11937273|FG002|Completed Treatment|Overall Study||22
10775098|NCT03311724|11937274|FG003|Completed Treatment|Overall Study||26
10775099|NCT03311724|11937271|FG000|COMPLETED|Overall Study||23
10775100|NCT03311724|11937272|FG001|COMPLETED|Overall Study||28
10775101|NCT03311724|11937273|FG002|COMPLETED|Overall Study||26
10775102|NCT03311724|11937274|FG003|COMPLETED|Overall Study||27
10775103|NCT03311724|11937271|FG000|NOT COMPLETED|Overall Study||3
10775104|NCT03311724|11937272|FG001|NOT COMPLETED|Overall Study||1
10775105|NCT03311724|11937273|FG002|NOT COMPLETED|Overall Study||2
10775106|NCT03311724|11937274|FG003|NOT COMPLETED|Overall Study||1
10775107|NCT03311841|11937292|FG000|STARTED|Period 1||6
10775108|NCT03311841|11937293|FG001|STARTED|Period 1||7
10775109|NCT03311841|11937294|FG002|STARTED|Period 1||6
10775110|NCT03311841|11937295|FG003|STARTED|Period 1||7
10775111|NCT03311841|11937296|FG004|STARTED|Period 1||6
10775112|NCT03311841|11937292|FG000|COMPLETED|Period 1||6
10775113|NCT03311841|11937293|FG001|COMPLETED|Period 1||7
10775114|NCT03311841|11937294|FG002|COMPLETED|Period 1||6
10775115|NCT03311841|11937295|FG003|COMPLETED|Period 1||7
10775116|NCT03311841|11937296|FG004|COMPLETED|Period 1||6
10775117|NCT03311841|11937292|FG000|NOT COMPLETED|Period 1||0
10775118|NCT03311841|11937293|FG001|NOT COMPLETED|Period 1||0
10775119|NCT03311841|11937294|FG002|NOT COMPLETED|Period 1||0
10775120|NCT03311841|11937295|FG003|NOT COMPLETED|Period 1||0
10775121|NCT03311841|11937296|FG004|NOT COMPLETED|Period 1||0
10775122|NCT03311841|11937292|FG000|STARTED|14-day Wash-out||6
10775123|NCT03311841|11937293|FG001|STARTED|14-day Wash-out||7
10775124|NCT03311841|11937294|FG002|STARTED|14-day Wash-out||6
10775125|NCT03311841|11937295|FG003|STARTED|14-day Wash-out||7
10775126|NCT03311841|11937296|FG004|STARTED|14-day Wash-out||6
10775127|NCT03311841|11937292|FG000|COMPLETED|14-day Wash-out||6
10775128|NCT03311841|11937293|FG001|COMPLETED|14-day Wash-out||6
10547315|NCT01513291|11701184|FG002|STARTED|Run-out Period|These participants were pre-randomized from participants in the Treatment Period: MK-6096 group|50
10547316|NCT01513291|11701185|FG003|STARTED|Run-out Period|These participants were pre-randomized from participants in the Treatment Period: MK-6096 group|47
10547317|NCT01513291|11701186|FG004|STARTED|Run-out Period|These participants were completers from the Treatment Period: Placebo group|101
10547318|NCT01513291|11701182|FG000|COMPLETED|Run-out Period||0
10547319|NCT01513291|11701183|FG001|COMPLETED|Run-out Period||0
10547320|NCT01513291|11701184|FG002|COMPLETED|Run-out Period||50
10547321|NCT01513291|11701185|FG003|COMPLETED|Run-out Period||45
10547322|NCT01513291|11701186|FG004|COMPLETED|Run-out Period||101
10547323|NCT01513291|11701182|FG000|NOT COMPLETED|Run-out Period||0
10547324|NCT01513291|11701183|FG001|NOT COMPLETED|Run-out Period||0
10547325|NCT01513291|11701184|FG002|NOT COMPLETED|Run-out Period||0
10547326|NCT01513291|11701185|FG003|NOT COMPLETED|Run-out Period||2
10775129|NCT03311841|11937294|FG002|COMPLETED|14-day Wash-out||6
10775130|NCT03311841|11937295|FG003|COMPLETED|14-day Wash-out||6
10775131|NCT03311841|11937296|FG004|COMPLETED|14-day Wash-out||6
10775132|NCT03311841|11937292|FG000|NOT COMPLETED|14-day Wash-out||0
10775133|NCT03311841|11937293|FG001|NOT COMPLETED|14-day Wash-out||1
10775134|NCT03311841|11937294|FG002|NOT COMPLETED|14-day Wash-out||0
10775135|NCT03311841|11937295|FG003|NOT COMPLETED|14-day Wash-out||1
10775136|NCT03311841|11937296|FG004|NOT COMPLETED|14-day Wash-out||0
10775137|NCT03311841|11937292|FG000|STARTED|Period 2||6
10775138|NCT03311841|11937293|FG001|STARTED|Period 2||6
10775139|NCT03311841|11937294|FG002|STARTED|Period 2||6
10775140|NCT03311841|11937295|FG003|STARTED|Period 2||6
10775141|NCT03311841|11937296|FG004|STARTED|Period 2||6
10775142|NCT03311841|11937292|FG000|COMPLETED|Period 2||6
10775143|NCT03311841|11937293|FG001|COMPLETED|Period 2||6
10775144|NCT03311841|11937294|FG002|COMPLETED|Period 2||6
10775145|NCT03311841|11937295|FG003|COMPLETED|Period 2||6
10775146|NCT03311841|11937296|FG004|COMPLETED|Period 2||6
10775147|NCT03311841|11937292|FG000|NOT COMPLETED|Period 2||0
10775148|NCT03311841|11937293|FG001|NOT COMPLETED|Period 2||0
10775149|NCT03311841|11937294|FG002|NOT COMPLETED|Period 2||0
10775150|NCT03311841|11937295|FG003|NOT COMPLETED|Period 2||0
10775151|NCT03311841|11937296|FG004|NOT COMPLETED|Period 2||0
10775152|NCT03312023|11937321|FG000|STARTED|Overall Study||8
10775153|NCT03312023|11937322|FG001|STARTED|Overall Study||5
10775154|NCT03312023|11937323|FG002|STARTED|Overall Study||4
10775155|NCT03312023|11937324|FG003|STARTED|Overall Study||4
10775156|NCT03312023|11937321|FG000|Completed Week 12|Overall Study||8
10775157|NCT03312023|11937322|FG001|Completed Week 12|Overall Study||5
10775158|NCT03312023|11937323|FG002|Completed Week 12|Overall Study||4
10775159|NCT03312023|11937324|FG003|Completed Week 12|Overall Study||4
10775160|NCT03312023|11937321|FG000|COMPLETED|Overall Study||8
10775161|NCT03312023|11937322|FG001|COMPLETED|Overall Study||5
10775162|NCT03312023|11937323|FG002|COMPLETED|Overall Study||4
10775163|NCT03312023|11937324|FG003|COMPLETED|Overall Study||4
10775164|NCT03312023|11937321|FG000|NOT COMPLETED|Overall Study||0
10775165|NCT03312023|11937322|FG001|NOT COMPLETED|Overall Study||0
10775166|NCT03312023|11937323|FG002|NOT COMPLETED|Overall Study||0
10775167|NCT03312023|11937324|FG003|NOT COMPLETED|Overall Study||0
10775168|NCT03312114|11937335|FG000|STARTED|Overall Study||5
10775169|NCT03312114|11937335|FG000|COMPLETED|Overall Study||0
10775170|NCT03312114|11937335|FG000|NOT COMPLETED|Overall Study||5
10775171|NCT03312218|11937342|FG000|STARTED|Overall Study||335
10775172|NCT03312218|11937343|FG001|STARTED|Overall Study||299
10775173|NCT03312218|11937342|FG000|COMPLETED|Overall Study||281
10775174|NCT03312218|11937343|FG001|COMPLETED|Overall Study||241
10775175|NCT03312218|11937342|FG000|NOT COMPLETED|Overall Study||54
10775176|NCT03312218|11937343|FG001|NOT COMPLETED|Overall Study||58
10775177|NCT03312231|11937354|FG000|STARTED|Overall Study||184
10775178|NCT03312231|11937355|FG001|STARTED|Overall Study||176
10775179|NCT03312231|11937356|FG002|STARTED|Overall Study||181
10775180|NCT03312231|11937357|FG003|STARTED|Overall Study||89
10775181|NCT03312231|11937358|FG004|STARTED|Overall Study||90
10775182|NCT03312231|11937354|FG000|COMPLETED|Overall Study||181
10775183|NCT03312231|11937355|FG001|COMPLETED|Overall Study||165
10775184|NCT03312231|11937356|FG002|COMPLETED|Overall Study||177
10775185|NCT03312231|11937357|FG003|COMPLETED|Overall Study||86
10775186|NCT03312231|11937358|FG004|COMPLETED|Overall Study||89
10775187|NCT03312231|11937354|FG000|NOT COMPLETED|Overall Study||3
10775188|NCT03312231|11937355|FG001|NOT COMPLETED|Overall Study||11
10775189|NCT03312231|11937356|FG002|NOT COMPLETED|Overall Study||4
10775190|NCT03312231|11937357|FG003|NOT COMPLETED|Overall Study||3
10775191|NCT03312231|11937358|FG004|NOT COMPLETED|Overall Study||1
10775192|NCT03312348|11937370|FG000|STARTED|Overall Study||30
10775193|NCT03312348|11937370|FG000|COMPLETED|Overall Study||30
10775194|NCT03312348|11937370|FG000|NOT COMPLETED|Overall Study||0
10775195|NCT03312517|11937374|FG000|STARTED|Overall Study||2
10775196|NCT03312517|11937375|FG001|STARTED|Overall Study||2
10775197|NCT03312517|11937376|FG002|STARTED|Overall Study||2
10775198|NCT03312517|11937377|FG003|STARTED|Overall Study||2
10775199|NCT03312517|11937378|FG004|STARTED|Overall Study||2
10775200|NCT03312517|11937379|FG005|STARTED|Overall Study||2
10775201|NCT03312517|11937374|FG000|COMPLETED|Overall Study||2
10775202|NCT03312517|11937375|FG001|COMPLETED|Overall Study||2
10775203|NCT03312517|11937376|FG002|COMPLETED|Overall Study||2
10775204|NCT03312517|11937377|FG003|COMPLETED|Overall Study||2
10775205|NCT03312517|11937378|FG004|COMPLETED|Overall Study||2
10775206|NCT03312517|11937379|FG005|COMPLETED|Overall Study||2
10775207|NCT03312517|11937374|FG000|NOT COMPLETED|Overall Study||0
10775208|NCT03312517|11937375|FG001|NOT COMPLETED|Overall Study||0
10775209|NCT03312517|11937376|FG002|NOT COMPLETED|Overall Study||0
10775210|NCT03312517|11937377|FG003|NOT COMPLETED|Overall Study||0
10775211|NCT03312517|11937378|FG004|NOT COMPLETED|Overall Study||0
10775212|NCT03312517|11937379|FG005|NOT COMPLETED|Overall Study||0
10775213|NCT03312543|11937389|FG000|STARTED|Before Treatment (Screening to Baseline)||61
10775214|NCT03312543|11937390|FG001|STARTED|Before Treatment (Screening to Baseline)||63
10775215|NCT03312543|11937389|FG000|COMPLETED|Before Treatment (Screening to Baseline)||60
10775216|NCT03312543|11937390|FG001|COMPLETED|Before Treatment (Screening to Baseline)||59
10775217|NCT03312543|11937389|FG000|NOT COMPLETED|Before Treatment (Screening to Baseline)||1
10775218|NCT03312543|11937390|FG001|NOT COMPLETED|Before Treatment (Screening to Baseline)||4
10775219|NCT03312543|11937389|FG000|STARTED|Treatment (Baseline to Week 12)||60
10775220|NCT03312543|11937390|FG001|STARTED|Treatment (Baseline to Week 12)||59
10775221|NCT03312543|11937389|FG000|COMPLETED|Treatment (Baseline to Week 12)||56
10775222|NCT03312543|11937390|FG001|COMPLETED|Treatment (Baseline to Week 12)||54
10775223|NCT03312543|11937389|FG000|NOT COMPLETED|Treatment (Baseline to Week 12)||4
10775224|NCT03312543|11937390|FG001|NOT COMPLETED|Treatment (Baseline to Week 12)||5
10775225|NCT03312543|11937389|FG000|STARTED|Regression (Week 12 to Week 24)||56
10775226|NCT03312543|11937390|FG001|STARTED|Regression (Week 12 to Week 24)||54
10775227|NCT03312543|11937389|FG000|COMPLETED|Regression (Week 12 to Week 24)||55
10775228|NCT03312543|11937390|FG001|COMPLETED|Regression (Week 12 to Week 24)||52
10775229|NCT03312543|11937389|FG000|NOT COMPLETED|Regression (Week 12 to Week 24)||1
10775230|NCT03312543|11937390|FG001|NOT COMPLETED|Regression (Week 12 to Week 24)||2
10775231|NCT03312595|11937396|FG000|STARTED|Overall Study||30
10775232|NCT03312595|11937396|FG000|COMPLETED|Overall Study||24
10775233|NCT03312595|11937396|FG000|NOT COMPLETED|Overall Study||6
10775234|NCT03312933|11937400|FG000|STARTED|Overall Study||100
10775235|NCT03312933|11937400|FG000|COMPLETED|Overall Study||46
10775236|NCT03312933|11937400|FG000|NOT COMPLETED|Overall Study||54
10775237|NCT03313037|11937406|FG000|STARTED|Overall Study||222
10775238|NCT03313037|11937407|FG001|STARTED|Overall Study||222
10775239|NCT03313037|11937406|FG000|Safety Population|Overall Study||221
10775240|NCT03313037|11937407|FG001|Safety Population|Overall Study||222
10775241|NCT03313037|11937406|FG000|Evaluable Immunogenicity Population(EIP)|Overall Study||210
10775242|NCT03313037|11937407|FG001|Evaluable Immunogenicity Population(EIP)|Overall Study||208
10775243|NCT03313037|11937406|FG000|COMPLETED|Overall Study||202
10775244|NCT03313037|11937407|FG001|COMPLETED|Overall Study||202
10775245|NCT03313037|11937406|FG000|NOT COMPLETED|Overall Study||20
10775246|NCT03313037|11937407|FG001|NOT COMPLETED|Overall Study||20
10775247|NCT03313050|11937417|FG000|STARTED|Stage 1: 6 Months||34
10775248|NCT03313050|11937418|FG001|STARTED|Stage 1: 6 Months||32
10775249|NCT03313050|11937419|FG002|STARTED|Stage 1: 6 Months||0
10775250|NCT03313050|11937420|FG003|STARTED|Stage 1: 6 Months||0
10775251|NCT03313050|11937417|FG000|Vaccinated|Stage 1: 6 Months||34
10775252|NCT03313050|11937418|FG001|Vaccinated|Stage 1: 6 Months||32
10775253|NCT03313050|11937419|FG002|Vaccinated|Stage 1: 6 Months||0
10775254|NCT03313050|11937420|FG003|Vaccinated|Stage 1: 6 Months||0
10775255|NCT03313050|11937417|FG000|COMPLETED|Stage 1: 6 Months||34
10775256|NCT03313050|11937418|FG001|COMPLETED|Stage 1: 6 Months||32
10775257|NCT03313050|11937419|FG002|COMPLETED|Stage 1: 6 Months||0
10775258|NCT03313050|11937420|FG003|COMPLETED|Stage 1: 6 Months||0
10775259|NCT03313050|11937417|FG000|NOT COMPLETED|Stage 1: 6 Months||0
10775260|NCT03313050|11937418|FG001|NOT COMPLETED|Stage 1: 6 Months||0
10775261|NCT03313050|11937419|FG002|NOT COMPLETED|Stage 1: 6 Months||0
10775262|NCT03313050|11937420|FG003|NOT COMPLETED|Stage 1: 6 Months||0
10775263|NCT03313050|11937417|FG000|STARTED|Stage 2: 12 Months|Stage 1 participants did not continue in Stage 2.|0
10775264|NCT03313050|11937418|FG001|STARTED|Stage 2: 12 Months|Stage 1 participants did not continue in Stage 2.|0
10775265|NCT03313050|11937419|FG002|STARTED|Stage 2: 12 Months|After Stage 1 safety was acceptable then Stage 2 followed with newer participants.|221
10775266|NCT03313050|11937420|FG003|STARTED|Stage 2: 12 Months|After Stage 1 safety was acceptable then Stage 2 followed with newer participants.|224
10775267|NCT03313050|11937417|FG000|Vaccinated|Stage 2: 12 Months||0
10775268|NCT03313050|11937418|FG001|Vaccinated|Stage 2: 12 Months||0
10775269|NCT03313050|11937419|FG002|Vaccinated|Stage 2: 12 Months||221
10775270|NCT03313050|11937420|FG003|Vaccinated|Stage 2: 12 Months||223
10775271|NCT03313050|11937417|FG000|COMPLETED|Stage 2: 12 Months||0
10775272|NCT03313050|11937418|FG001|COMPLETED|Stage 2: 12 Months||0
10775273|NCT03313050|11937419|FG002|COMPLETED|Stage 2: 12 Months||210
10775274|NCT03313050|11937420|FG003|COMPLETED|Stage 2: 12 Months||204
10775275|NCT03313050|11937417|FG000|NOT COMPLETED|Stage 2: 12 Months||0
10775276|NCT03313050|11937418|FG001|NOT COMPLETED|Stage 2: 12 Months||0
10775277|NCT03313050|11937419|FG002|NOT COMPLETED|Stage 2: 12 Months||11
10775278|NCT03313050|11937420|FG003|NOT COMPLETED|Stage 2: 12 Months||20
10775279|NCT03313076|11937434|FG000|STARTED|Overall Study||7
10775280|NCT03313076|11937435|FG001|STARTED|Overall Study||6
10775281|NCT03313076|11937436|FG002|STARTED|Overall Study||6
10775282|NCT03313076|11937437|FG003|STARTED|Overall Study||5
10775283|NCT03313076|11937434|FG000|COMPLETED|Overall Study||5
10775284|NCT03313076|11937435|FG001|COMPLETED|Overall Study||4
10775285|NCT03313076|11937436|FG002|COMPLETED|Overall Study||4
10775286|NCT03313076|11937437|FG003|COMPLETED|Overall Study||3
10775287|NCT03313076|11937434|FG000|NOT COMPLETED|Overall Study||2
10775288|NCT03313076|11937435|FG001|NOT COMPLETED|Overall Study||2
10775289|NCT03313076|11937436|FG002|NOT COMPLETED|Overall Study||2
10775290|NCT03313076|11937437|FG003|NOT COMPLETED|Overall Study||2
10775291|NCT03313310|11937455|FG000|STARTED|Phase 2||51
10775292|NCT03313310|11937456|FG001|STARTED|Phase 2|Phase 2 participants did not participate in Phase 3.|0
10775293|NCT03313310|11937455|FG000|COMPLETED|Phase 2||47
10775294|NCT03313310|11937456|FG001|COMPLETED|Phase 2|Phase 2 participants did not participate in Phase 3.|0
10775295|NCT03313310|11937455|FG000|NOT COMPLETED|Phase 2||4
10775296|NCT03313310|11937456|FG001|NOT COMPLETED|Phase 2||0
10775297|NCT03313310|11937455|FG000|STARTED|Phase 3|Phase 3 participants did not participate in Phase 2.|0
10775298|NCT03313310|11937456|FG001|STARTED|Phase 3||41
10775299|NCT03313310|11937455|FG000|COMPLETED|Phase 3|Phase 3 participants did not participate in Phase 2.|0
10775300|NCT03313310|11937456|FG001|COMPLETED|Phase 3||40
10775301|NCT03313310|11937455|FG000|NOT COMPLETED|Phase 3||0
10775302|NCT03313310|11937456|FG001|NOT COMPLETED|Phase 3||1
10775303|NCT03314233|11937462|FG000|STARTED|Overall Study|21 mothers provided informed consent for participation in the trial.|21
10775304|NCT03314233|11937462|FG000|COMPLETED|Overall Study|20 mothers who had provided informed consent met eligibility criteria at time of delivery.|20
10775305|NCT03314233|11937462|FG000|NOT COMPLETED|Overall Study||1
10775306|NCT03314519|11937468|FG000|STARTED|Overall Study||100
10775307|NCT03314519|11937469|FG001|STARTED|Overall Study||100
10775308|NCT03314519|11937468|FG000|COMPLETED|Overall Study||97
10775309|NCT03314519|11937469|FG001|COMPLETED|Overall Study||98
10775310|NCT03314519|11937468|FG000|NOT COMPLETED|Overall Study||3
10775311|NCT03314519|11937469|FG001|NOT COMPLETED|Overall Study||2
10775312|NCT03314662|11937478|FG000|STARTED|Overall Study||889
10775313|NCT03314662|11937479|FG001|STARTED|Overall Study||445
10775314|NCT03314662|11937480|FG002|STARTED|Overall Study||444
10775315|NCT03314662|11937478|FG000|Treated|Overall Study||888
10775316|NCT03314662|11937479|FG001|Treated|Overall Study||444
10775317|NCT03314662|11937480|FG002|Treated|Overall Study||444
10775318|NCT03314662|11937478|FG000|COMPLETED|Overall Study||881
10775319|NCT03314662|11937479|FG001|COMPLETED|Overall Study||440
10775320|NCT03314662|11937480|FG002|COMPLETED|Overall Study||439
10775321|NCT03314662|11937478|FG000|NOT COMPLETED|Overall Study||8
10775322|NCT03314662|11937479|FG001|NOT COMPLETED|Overall Study||5
10775323|NCT03314662|11937480|FG002|NOT COMPLETED|Overall Study||5
10775324|NCT03314753|11937498|FG000|STARTED|Overall Study||53
10775325|NCT03314753|11937499|FG001|STARTED|Overall Study||36
10775326|NCT03314753|11937498|FG000|COMPLETED|Overall Study||53
10775327|NCT03314753|11937499|FG001|COMPLETED|Overall Study||36
10775328|NCT03314753|11937498|FG000|NOT COMPLETED|Overall Study||0
10775329|NCT03314753|11937499|FG001|NOT COMPLETED|Overall Study||0
10775334|NCT03315104|11937512|FG000|STARTED|Overall Study||21
10775335|NCT03315104|11937513|FG001|STARTED|Overall Study||20
10775336|NCT03315104|11937514|FG002|STARTED|Overall Study||24
10775337|NCT03315104|11937512|FG000|Dosed (Safety Population)|Overall Study||19
10775338|NCT03315104|11937513|FG001|Dosed (Safety Population)|Overall Study||19
10775339|NCT03315104|11937514|FG002|Dosed (Safety Population)|Overall Study||22
10775340|NCT03315104|11937512|FG000|COMPLETED|Overall Study||18
10775341|NCT03315104|11937513|FG001|COMPLETED|Overall Study||16
10775342|NCT03315104|11937514|FG002|COMPLETED|Overall Study||19
10775343|NCT03315104|11937512|FG000|NOT COMPLETED|Overall Study||3
10775344|NCT03315104|11937513|FG001|NOT COMPLETED|Overall Study||4
10775345|NCT03315104|11937514|FG002|NOT COMPLETED|Overall Study||5
10775346|NCT03315208|11937524|FG000|STARTED|Overall Study||29
10775347|NCT03315208|11937525|FG001|STARTED|Overall Study||18
10775348|NCT03315208|11937524|FG000|COMPLETED|Overall Study||16
10775349|NCT03315208|11937525|FG001|COMPLETED|Overall Study||12
10775350|NCT03315208|11937524|FG000|NOT COMPLETED|Overall Study||13
10775351|NCT03315208|11937525|FG001|NOT COMPLETED|Overall Study||6
10775352|NCT03315286|11937534|FG000|STARTED|Overall Study||50
10775353|NCT03315286|11937535|FG001|STARTED|Overall Study||47
10775354|NCT03315286|11937534|FG000|COMPLETED|Overall Study||49
10775355|NCT03315286|11937535|FG001|COMPLETED|Overall Study||43
10775356|NCT03315286|11937534|FG000|NOT COMPLETED|Overall Study||1
10775357|NCT03315286|11937535|FG001|NOT COMPLETED|Overall Study||4
10775358|NCT03315559|11937541|FG000|STARTED|Treatment Period 1 (8 Days)||6
10775359|NCT03315559|11937541|FG000|COMPLETED|Treatment Period 1 (8 Days)||6
10775360|NCT03315559|11937541|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10775361|NCT03315559|11937541|FG000|STARTED|Washout Period (14 Days)||6
10775362|NCT03315559|11937541|FG000|COMPLETED|Washout Period (14 Days)||6
10775363|NCT03315559|11937541|FG000|NOT COMPLETED|Washout Period (14 Days)||0
10775364|NCT03315559|11937541|FG000|STARTED|Treatment Period 2 (15 Days)||6
10775365|NCT03315559|11937541|FG000|COMPLETED|Treatment Period 2 (15 Days)||6
10775366|NCT03315559|11937541|FG000|NOT COMPLETED|Treatment Period 2 (15 Days)||0
10775367|NCT03315572|11937550|FG000|STARTED|Overall Study||14
10775368|NCT03315572|11937551|FG001|STARTED|Overall Study||14
10775369|NCT03315572|11937550|FG000|COMPLETED|Overall Study||14
10775370|NCT03315572|11937551|FG001|COMPLETED|Overall Study||14
10775371|NCT03315572|11937550|FG000|NOT COMPLETED|Overall Study||0
10775372|NCT03315572|11937551|FG001|NOT COMPLETED|Overall Study||0
10775373|NCT03315689|11937560|FG000|STARTED|Double-blind Period = 28 Days||4
10775374|NCT03315689|11937561|FG001|STARTED|Double-blind Period = 28 Days||7
10775375|NCT03315689|11937560|FG000|COMPLETED|Double-blind Period = 28 Days||3
10775376|NCT03315689|11937561|FG001|COMPLETED|Double-blind Period = 28 Days||7
10775377|NCT03315689|11937560|FG000|NOT COMPLETED|Double-blind Period = 28 Days||1
10775378|NCT03315689|11937561|FG001|NOT COMPLETED|Double-blind Period = 28 Days||0
10775379|NCT03315689|11937560|FG000|STARTED|Open Label Extension = 52 Weeks||0
10775380|NCT03315689|11937561|FG001|STARTED|Open Label Extension = 52 Weeks||10
10775381|NCT03315689|11937560|FG000|COMPLETED|Open Label Extension = 52 Weeks||0
10775382|NCT03315689|11937561|FG001|COMPLETED|Open Label Extension = 52 Weeks||7
10775383|NCT03315689|11937560|FG000|NOT COMPLETED|Open Label Extension = 52 Weeks||0
10775384|NCT03315689|11937561|FG001|NOT COMPLETED|Open Label Extension = 52 Weeks||3
10775385|NCT03315702|11937569|FG000|STARTED|Overall Study||52
10775386|NCT03315702|11937569|FG000|COMPLETED|Overall Study||52
10775387|NCT03315702|11937569|FG000|NOT COMPLETED|Overall Study||0
10775388|NCT03315780|11937574|FG000|STARTED|Period 1||6
10775389|NCT03315780|11937575|FG001|STARTED|Period 1||6
10775390|NCT03315780|11937574|FG000|Received One Dose of Study Drug|Period 1||6
10775391|NCT03315780|11937575|FG001|Received One Dose of Study Drug|Period 1||6
10775392|NCT03315780|11937574|FG000|COMPLETED|Period 1||6
10775393|NCT03315780|11937575|FG001|COMPLETED|Period 1||6
10775394|NCT03315780|11937574|FG000|NOT COMPLETED|Period 1||0
10775395|NCT03315780|11937575|FG001|NOT COMPLETED|Period 1||0
10775396|NCT03315780|11937574|FG000|STARTED|Period 2||6
10775397|NCT03315780|11937575|FG001|STARTED|Period 2||6
10775398|NCT03315780|11937574|FG000|COMPLETED|Period 2||6
10775399|NCT03315780|11937575|FG001|COMPLETED|Period 2||6
10775400|NCT03315780|11937574|FG000|NOT COMPLETED|Period 2||0
10775401|NCT03315780|11937575|FG001|NOT COMPLETED|Period 2||0
10779236|NCT03364309|11940868|FG009|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
10779237|NCT03364309|11940869|FG010|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
10779238|NCT03364309|11940870|FG011|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|2
10779239|NCT03364309|11940871|FG012|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|43
10779240|NCT03364309|11940872|FG013|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|7
10779241|NCT03364309|11940873|FG014|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|45
10779242|NCT03364309|11940874|FG015|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|10
10779243|NCT03364309|11940875|FG016|STARTED|Re-treatment (Maintenance) Period||0
10779244|NCT03364309|11940876|FG017|STARTED|Re-treatment (Maintenance) Period||0
10779245|NCT03364309|11940877|FG018|STARTED|Re-treatment (Maintenance) Period||0
10779246|NCT03364309|11940859|FG000|COMPLETED|Re-treatment (Maintenance) Period||0
10779247|NCT03364309|11940860|FG001|COMPLETED|Re-treatment (Maintenance) Period||0
10779248|NCT03364309|11940861|FG002|COMPLETED|Re-treatment (Maintenance) Period||0
10779249|NCT03364309|11940862|FG003|COMPLETED|Re-treatment (Maintenance) Period||0
10779250|NCT03364309|11940863|FG004|COMPLETED|Re-treatment (Maintenance) Period||0
10779251|NCT03364309|11940864|FG005|COMPLETED|Re-treatment (Maintenance) Period||0
10779252|NCT03364309|11940865|FG006|COMPLETED|Re-treatment (Maintenance) Period||0
10779253|NCT03364309|11940866|FG007|COMPLETED|Re-treatment (Maintenance) Period||0
10779254|NCT03364309|11940867|FG008|COMPLETED|Re-treatment (Maintenance) Period||0
10779255|NCT03364309|11940868|FG009|COMPLETED|Re-treatment (Maintenance) Period||0
10779256|NCT03364309|11940869|FG010|COMPLETED|Re-treatment (Maintenance) Period||0
10779257|NCT03364309|11940870|FG011|COMPLETED|Re-treatment (Maintenance) Period||2
10779258|NCT03364309|11940871|FG012|COMPLETED|Re-treatment (Maintenance) Period||42
10779259|NCT03364309|11940872|FG013|COMPLETED|Re-treatment (Maintenance) Period||6
10779260|NCT03364309|11940873|FG014|COMPLETED|Re-treatment (Maintenance) Period||43
10779261|NCT03364309|11940874|FG015|COMPLETED|Re-treatment (Maintenance) Period||8
10779262|NCT03364309|11940875|FG016|COMPLETED|Re-treatment (Maintenance) Period||0
10779263|NCT03364309|11940876|FG017|COMPLETED|Re-treatment (Maintenance) Period||0
10779264|NCT03364309|11940877|FG018|COMPLETED|Re-treatment (Maintenance) Period||0
10779265|NCT03364309|11940859|FG000|NOT COMPLETED|Re-treatment (Maintenance) Period||0
10779266|NCT03364309|11940860|FG001|NOT COMPLETED|Re-treatment (Maintenance) Period||0
10779267|NCT03364309|11940861|FG002|NOT COMPLETED|Re-treatment (Maintenance) Period||0
10779268|NCT03364309|11940862|FG003|NOT COMPLETED|Re-treatment (Maintenance) Period||0
10779269|NCT03364309|11940863|FG004|NOT COMPLETED|Re-treatment (Maintenance) Period||0
10779270|NCT03364309|11940864|FG005|NOT COMPLETED|Re-treatment (Maintenance) Period||0
10779271|NCT03364309|11940865|FG006|NOT COMPLETED|Re-treatment (Maintenance) Period||0
10779272|NCT03364309|11940866|FG007|NOT COMPLETED|Re-treatment (Maintenance) Period||0
10779273|NCT03364309|11940867|FG008|NOT COMPLETED|Re-treatment (Maintenance) Period||0
10779274|NCT03364309|11940868|FG009|NOT COMPLETED|Re-treatment (Maintenance) Period||0
10779275|NCT03364309|11940869|FG010|NOT COMPLETED|Re-treatment (Maintenance) Period||0
10779276|NCT03364309|11940870|FG011|NOT COMPLETED|Re-treatment (Maintenance) Period||0
10779277|NCT03364309|11940871|FG012|NOT COMPLETED|Re-treatment (Maintenance) Period||1
10779278|NCT03364309|11940872|FG013|NOT COMPLETED|Re-treatment (Maintenance) Period||1
10779279|NCT03364309|11940873|FG014|NOT COMPLETED|Re-treatment (Maintenance) Period||2
10779280|NCT03364309|11940874|FG015|NOT COMPLETED|Re-treatment (Maintenance) Period||2
10779281|NCT03364309|11940875|FG016|NOT COMPLETED|Re-treatment (Maintenance) Period||0
10779282|NCT03364309|11940876|FG017|NOT COMPLETED|Re-treatment (Maintenance) Period||0
10779283|NCT03364309|11940877|FG018|NOT COMPLETED|Re-treatment (Maintenance) Period||0
10779284|NCT03364309|11940859|FG000|STARTED|Post-Treatment Followup Period||0
10779285|NCT03364309|11940860|FG001|STARTED|Post-Treatment Followup Period||0
10779286|NCT03364309|11940861|FG002|STARTED|Post-Treatment Followup Period||0
10779287|NCT03364309|11940862|FG003|STARTED|Post-Treatment Followup Period||0
10779288|NCT03364309|11940863|FG004|STARTED|Post-Treatment Followup Period||0
10779289|NCT03364309|11940864|FG005|STARTED|Post-Treatment Followup Period||0
10779290|NCT03364309|11940865|FG006|STARTED|Post-Treatment Followup Period||0
10779291|NCT03364309|11940866|FG007|STARTED|Post-Treatment Followup Period||0
10779292|NCT03364309|11940867|FG008|STARTED|Post-Treatment Followup Period||0
10779293|NCT03364309|11940868|FG009|STARTED|Post-Treatment Followup Period||0
10779294|NCT03364309|11940869|FG010|STARTED|Post-Treatment Followup Period||0
10779295|NCT03364309|11940870|FG011|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|0
10779296|NCT03364309|11940871|FG012|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|0
10779297|NCT03364309|11940872|FG013|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|0
10779386|NCT03365154|11940969|FG000|COMPLETED|Overall Study||10
10775402|NCT03315793|11937583|FG000|STARTED|Overall Study||75
10775403|NCT03315793|11937584|FG001|STARTED|Overall Study||74
10775404|NCT03315793|11937583|FG000|Received at Least 1 Dose of Study Drug|Overall Study||75
10775405|NCT03315793|11937584|FG001|Received at Least 1 Dose of Study Drug|Overall Study||74
10775406|NCT03315793|11937583|FG000|COMPLETED|Overall Study||70
10775407|NCT03315793|11937584|FG001|COMPLETED|Overall Study||71
10775408|NCT03315793|11937583|FG000|NOT COMPLETED|Overall Study||5
10775409|NCT03315793|11937584|FG001|NOT COMPLETED|Overall Study||3
10775410|NCT03315949|11937594|FG000|STARTED|Overall Study||176
10775411|NCT03315949|11937595|FG001|STARTED|Overall Study||176
10775412|NCT03315949|11937594|FG000|COMPLETED|Overall Study||171
10775413|NCT03315949|11937595|FG001|COMPLETED|Overall Study||166
10775414|NCT03315949|11937594|FG000|NOT COMPLETED|Overall Study||5
10775415|NCT03315949|11937595|FG001|NOT COMPLETED|Overall Study||10
10775416|NCT03316131|11937601|FG000|STARTED|Treatment Period 1||18
10775417|NCT03316131|11937602|FG001|STARTED|Treatment Period 1||18
10775418|NCT03316131|11937601|FG000|COMPLETED|Treatment Period 1||18
10775419|NCT03316131|11937602|FG001|COMPLETED|Treatment Period 1||18
10775420|NCT03316131|11937601|FG000|NOT COMPLETED|Treatment Period 1||0
10775421|NCT03316131|11937602|FG001|NOT COMPLETED|Treatment Period 1||0
10775422|NCT03316131|11937601|FG000|STARTED|Treatment Period 2||18
10775423|NCT03316131|11937602|FG001|STARTED|Treatment Period 2||18
10775424|NCT03316131|11937601|FG000|COMPLETED|Treatment Period 2||17
10775425|NCT03316131|11937602|FG001|COMPLETED|Treatment Period 2||18
10775426|NCT03316131|11937601|FG000|NOT COMPLETED|Treatment Period 2||1
10775427|NCT03316131|11937602|FG001|NOT COMPLETED|Treatment Period 2||0
10775428|NCT03316170|11937610|FG000|STARTED|Overall Study||24
10775429|NCT03316170|11937611|FG001|STARTED|Overall Study||25
10775430|NCT03316170|11937610|FG000|COMPLETED|Overall Study||17
10775431|NCT03316170|11937611|FG001|COMPLETED|Overall Study||18
10775432|NCT03316170|11937610|FG000|NOT COMPLETED|Overall Study||7
10775433|NCT03316170|11937611|FG001|NOT COMPLETED|Overall Study||7
10775434|NCT03316378|11937620|FG000|STARTED|Overall Study||23
10775435|NCT03316378|11937621|FG001|STARTED|Overall Study||23
10775436|NCT03316378|11937620|FG000|COMPLETED|Overall Study||23
10775437|NCT03316378|11937621|FG001|COMPLETED|Overall Study||23
10775438|NCT03316378|11937620|FG000|NOT COMPLETED|Overall Study||0
10775439|NCT03316378|11937621|FG001|NOT COMPLETED|Overall Study||0
10775440|NCT03316547|11937630|FG000|STARTED|Overall Study||39
10775441|NCT03316547|11937631|FG001|STARTED|Overall Study||31
10775442|NCT03316547|11937630|FG000|COMPLETED|Overall Study||21
10775443|NCT03316547|11937631|FG001|COMPLETED|Overall Study||18
10775444|NCT03316547|11937630|FG000|NOT COMPLETED|Overall Study||18
10775445|NCT03316547|11937631|FG001|NOT COMPLETED|Overall Study||13
10775446|NCT03316911|11937641|FG000|STARTED|Overall Study|2 did not complete baseline survey|122
10775447|NCT03316911|11937642|FG001|STARTED|Overall Study|3 did not complete baseline survey|139
10775448|NCT03316911|11937641|FG000|3-Month Follow-up Survey|Overall Study||93
10775449|NCT03316911|11937642|FG001|3-Month Follow-up Survey|Overall Study||112
10775450|NCT03316911|11937641|FG000|5-Month Follow-up Survey|Overall Study||89
10775451|NCT03316911|11937642|FG001|5-Month Follow-up Survey|Overall Study||110
10775452|NCT03316911|11937641|FG000|COMPLETED|Overall Study||89
10775453|NCT03316911|11937642|FG001|COMPLETED|Overall Study||110
10775454|NCT03316911|11937641|FG000|NOT COMPLETED|Overall Study||33
10775455|NCT03316911|11937642|FG001|NOT COMPLETED|Overall Study||29
10775456|NCT03316976|11937650|FG000|STARTED|Overall Study||20
10775457|NCT03316976|11937651|FG001|STARTED|Overall Study||20
10775458|NCT03316976|11937650|FG000|COMPLETED|Overall Study||20
10775459|NCT03316976|11937651|FG001|COMPLETED|Overall Study||20
10775460|NCT03316976|11937650|FG000|NOT COMPLETED|Overall Study||0
10775461|NCT03316976|11937651|FG001|NOT COMPLETED|Overall Study||0
10775462|NCT03317002|11937660|FG000|STARTED|Overall Study||52
10775463|NCT03317002|11937661|FG001|STARTED|Overall Study||25
10775464|NCT03317002|11937662|FG002|STARTED|Overall Study||52
10775465|NCT03317002|11937660|FG000|COMPLETED|Overall Study||50
10775466|NCT03317002|11937661|FG001|COMPLETED|Overall Study||24
10775467|NCT03317002|11937662|FG002|COMPLETED|Overall Study||51
10775468|NCT03317002|11937660|FG000|NOT COMPLETED|Overall Study||2
10775469|NCT03317002|11937661|FG001|NOT COMPLETED|Overall Study||1
10775470|NCT03317002|11937662|FG002|NOT COMPLETED|Overall Study||1
10775471|NCT03317288|11937670|FG000|STARTED|Overall Study||15
10775472|NCT03317288|11937670|FG000|COMPLETED|Overall Study||15
10775473|NCT03317288|11937670|FG000|NOT COMPLETED|Overall Study||0
10775474|NCT03317379|11937691|FG000|STARTED|Overall Study||20
10775475|NCT03317379|11937692|FG001|STARTED|Overall Study||18
10775476|NCT03317379|11937693|FG002|STARTED|Overall Study||22
10775477|NCT03317379|11937691|FG000|Completed Intervention|Overall Study||16
10775478|NCT03317379|11937692|FG001|Completed Intervention|Overall Study||6
10775479|NCT03317379|11937693|FG002|Completed Intervention|Overall Study||0
10775480|NCT03317379|11937691|FG000|COMPLETED|Overall Study||20
10775481|NCT03317379|11937692|FG001|COMPLETED|Overall Study||15
10775482|NCT03317379|11937693|FG002|COMPLETED|Overall Study||20
10775483|NCT03317379|11937691|FG000|NOT COMPLETED|Overall Study||0
10775484|NCT03317379|11937692|FG001|NOT COMPLETED|Overall Study||3
10775485|NCT03317379|11937693|FG002|NOT COMPLETED|Overall Study||2
10775486|NCT03317431|11937701|FG000|STARTED|Overall Study||46
10775487|NCT03317431|11937701|FG000|COMPLETED|Overall Study||46
10775488|NCT03317431|11937701|FG000|NOT COMPLETED|Overall Study||0
10775489|NCT03317444|11937707|FG000|STARTED|Overall Study||124
10775490|NCT03317444|11937708|FG001|STARTED|Overall Study||93
10775491|NCT03317444|11937707|FG000|COMPLETED|Overall Study||119
10775492|NCT03317444|11937708|FG001|COMPLETED|Overall Study||89
10775493|NCT03317444|11937707|FG000|NOT COMPLETED|Overall Study||5
10775494|NCT03317444|11937708|FG001|NOT COMPLETED|Overall Study||4
10775495|NCT03318315|11937717|FG000|STARTED|Overall Study||62
10775496|NCT03318315|11937718|FG001|STARTED|Overall Study||53
10775497|NCT03318315|11937719|FG002|STARTED|Overall Study||34
10775498|NCT03318315|11937717|FG000|Received First Vaccination|Overall Study||62
10775499|NCT03318315|11937718|FG001|Received First Vaccination|Overall Study||53
10775500|NCT03318315|11937719|FG002|Received First Vaccination|Overall Study||34
10775501|NCT03318315|11937717|FG000|Received Second Vaccination|Overall Study||59
10775502|NCT03318315|11937718|FG001|Received Second Vaccination|Overall Study||48
10775503|NCT03318315|11937719|FG002|Received Second Vaccination|Overall Study||0
10775504|NCT03318315|11937717|FG000|Received Third Vaccination|Overall Study||0
10775505|NCT03318315|11937718|FG001|Received Third Vaccination|Overall Study||46
10775506|NCT03318315|11937719|FG002|Received Third Vaccination|Overall Study||0
10775507|NCT03318315|11937717|FG000|COMPLETED|Overall Study||58
10775508|NCT03318315|11937718|FG001|COMPLETED|Overall Study||50
10775509|NCT03318315|11937719|FG002|COMPLETED|Overall Study||30
10775510|NCT03318315|11937717|FG000|NOT COMPLETED|Overall Study||4
10775511|NCT03318315|11937718|FG001|NOT COMPLETED|Overall Study||3
10775512|NCT03318315|11937719|FG002|NOT COMPLETED|Overall Study||4
10775513|NCT03318341|11937730|FG000|STARTED|Month 1||13
10775514|NCT03318341|11937731|FG001|STARTED|Month 1||13
10775515|NCT03318341|11937730|FG000|COMPLETED|Month 1||13
10775516|NCT03318341|11937731|FG001|COMPLETED|Month 1||12
10775517|NCT03318341|11937730|FG000|NOT COMPLETED|Month 1||0
10775518|NCT03318341|11937731|FG001|NOT COMPLETED|Month 1||1
10775519|NCT03318341|11937730|FG000|STARTED|Month 2||13
10775520|NCT03318341|11937731|FG001|STARTED|Month 2||12
10775521|NCT03318341|11937730|FG000|COMPLETED|Month 2||13
10775522|NCT03318341|11937731|FG001|COMPLETED|Month 2||12
10775523|NCT03318341|11937730|FG000|NOT COMPLETED|Month 2||0
10775524|NCT03318341|11937731|FG001|NOT COMPLETED|Month 2||0
10775525|NCT03318783|11937741|FG000|STARTED|Overall Study||10
10775526|NCT03318783|11937742|FG001|STARTED|Overall Study||10
10775527|NCT03318783|11937741|FG000|COMPLETED|Overall Study||10
10775528|NCT03318783|11937742|FG001|COMPLETED|Overall Study||8
10775529|NCT03318783|11937741|FG000|NOT COMPLETED|Overall Study||0
10775530|NCT03318783|11937742|FG001|NOT COMPLETED|Overall Study||2
10775531|NCT03319134|11937751|FG000|STARTED|Overall Study||15
10775532|NCT03319134|11937752|FG001|STARTED|Overall Study||15
10775533|NCT03319134|11937753|FG002|STARTED|Overall Study||15
10775534|NCT03319134|11937751|FG000|COMPLETED|Overall Study||15
10775535|NCT03319134|11937752|FG001|COMPLETED|Overall Study||15
10775536|NCT03319134|11937753|FG002|COMPLETED|Overall Study||15
10775537|NCT03319134|11937751|FG000|NOT COMPLETED|Overall Study||0
10775538|NCT03319134|11937752|FG001|NOT COMPLETED|Overall Study||0
10775539|NCT03319134|11937753|FG002|NOT COMPLETED|Overall Study||0
10775540|NCT03319173|11937763|FG000|STARTED|Overall Study||48
10775541|NCT03319173|11937764|FG001|STARTED|Overall Study||50
10775542|NCT03319173|11937763|FG000|COMPLETED|Overall Study||48
10775543|NCT03319173|11937764|FG001|COMPLETED|Overall Study||50
10775544|NCT03319173|11937763|FG000|NOT COMPLETED|Overall Study||0
10775545|NCT03319173|11937764|FG001|NOT COMPLETED|Overall Study||0
10775546|NCT03319212|11937776|FG000|STARTED|Overall Study||29
10775547|NCT03319212|11937777|FG001|STARTED|Overall Study||52
10775548|NCT03319212|11937776|FG000|COMPLETED|Overall Study||26
10775549|NCT03319212|11937777|FG001|COMPLETED|Overall Study||47
10775550|NCT03319212|11937776|FG000|NOT COMPLETED|Overall Study||3
10775551|NCT03319212|11937777|FG001|NOT COMPLETED|Overall Study||5
10775552|NCT03319277|11937784|FG000|STARTED|Overall Study||59
10775553|NCT03319277|11937785|FG001|STARTED|Overall Study||59
10775554|NCT03319277|11937784|FG000|COMPLETED|Overall Study||59
10775555|NCT03319277|11937785|FG001|COMPLETED|Overall Study||59
10775556|NCT03319277|11937784|FG000|NOT COMPLETED|Overall Study||0
10775557|NCT03319277|11937785|FG001|NOT COMPLETED|Overall Study||0
10775558|NCT03319719|11937791|FG000|STARTED|Overall Study||52
10775559|NCT03319719|11937791|FG000|COMPLETED|Overall Study||51
10775560|NCT03319719|11937791|FG000|NOT COMPLETED|Overall Study||1
10775561|NCT03319810|11937797|FG000|STARTED|Overall Study||5
10775562|NCT03319810|11937797|FG000|COMPLETED|Overall Study||5
10775563|NCT03319810|11937797|FG000|NOT COMPLETED|Overall Study||0
10775564|NCT03319953|11937805|FG000|STARTED|Period 1 (Day 1 to 14)||3
10775565|NCT03319953|11937806|FG001|STARTED|Period 1 (Day 1 to 14)||4
10775566|NCT03319953|11937807|FG002|STARTED|Period 1 (Day 1 to 14)||9
10775567|NCT03319953|11937808|FG003|STARTED|Period 1 (Day 1 to 14)||7
10775568|NCT03319953|11937805|FG000|COMPLETED|Period 1 (Day 1 to 14)||3
10775569|NCT03319953|11937806|FG001|COMPLETED|Period 1 (Day 1 to 14)||4
10775570|NCT03319953|11937807|FG002|COMPLETED|Period 1 (Day 1 to 14)||9
10775571|NCT03319953|11937808|FG003|COMPLETED|Period 1 (Day 1 to 14)||7
10775572|NCT03319953|11937805|FG000|NOT COMPLETED|Period 1 (Day 1 to 14)||0
10775573|NCT03319953|11937806|FG001|NOT COMPLETED|Period 1 (Day 1 to 14)||0
10775574|NCT03319953|11937807|FG002|NOT COMPLETED|Period 1 (Day 1 to 14)||0
10775575|NCT03319953|11937808|FG003|NOT COMPLETED|Period 1 (Day 1 to 14)||0
10775576|NCT03319953|11937805|FG000|STARTED|Washout Period (Day 15 to 49)||3
10775577|NCT03319953|11937806|FG001|STARTED|Washout Period (Day 15 to 49)||4
10775578|NCT03319953|11937807|FG002|STARTED|Washout Period (Day 15 to 49)||9
10775579|NCT03319953|11937808|FG003|STARTED|Washout Period (Day 15 to 49)||7
10775580|NCT03319953|11937805|FG000|COMPLETED|Washout Period (Day 15 to 49)||3
10775581|NCT03319953|11937806|FG001|COMPLETED|Washout Period (Day 15 to 49)||4
10775582|NCT03319953|11937807|FG002|COMPLETED|Washout Period (Day 15 to 49)||9
10301626|NCT00063622|11434502|FG002|STARTED|Overall Study||83
10423410|NCT00829387|11568537|FG001|NOT COMPLETED|Overall Study||3
10423411|NCT00829413|11568543|FG000|STARTED|Overall Study||353
10423412|NCT00829413|11568543|FG000|COMPLETED|Overall Study||259
10423413|NCT00829413|11568543|FG000|NOT COMPLETED|Overall Study||94
10423414|NCT00829439|11568554|FG000|STARTED|Overall Study||3
10423415|NCT00829439|11568555|FG001|STARTED|Overall Study||3
10423416|NCT00829439|11568556|FG002|STARTED|Overall Study||6
10423417|NCT00829439|11568557|FG003|STARTED|Overall Study||4
10423418|NCT00829439|11568554|FG000|COMPLETED|Overall Study||3
10423419|NCT00829439|11568555|FG001|COMPLETED|Overall Study||3
10423420|NCT00829439|11568556|FG002|COMPLETED|Overall Study||5
10423421|NCT00829439|11568557|FG003|COMPLETED|Overall Study||4
10775583|NCT03319953|11937808|FG003|COMPLETED|Washout Period (Day 15 to 49)||7
10775584|NCT03319953|11937805|FG000|NOT COMPLETED|Washout Period (Day 15 to 49)||0
10775585|NCT03319953|11937806|FG001|NOT COMPLETED|Washout Period (Day 15 to 49)||0
10775586|NCT03319953|11937807|FG002|NOT COMPLETED|Washout Period (Day 15 to 49)||0
10775587|NCT03319953|11937808|FG003|NOT COMPLETED|Washout Period (Day 15 to 49)||0
10775588|NCT03319953|11937805|FG000|STARTED|Period 2 (Day 49 to 154)||3
10775589|NCT03319953|11937806|FG001|STARTED|Period 2 (Day 49 to 154)||4
10775590|NCT03319953|11937807|FG002|STARTED|Period 2 (Day 49 to 154)||9
10775591|NCT03319953|11937808|FG003|STARTED|Period 2 (Day 49 to 154)||7
10775592|NCT03319953|11937805|FG000|Treated|Period 2 (Day 49 to 154)||2
10775593|NCT03319953|11937806|FG001|Treated|Period 2 (Day 49 to 154)||4
10775594|NCT03319953|11937807|FG002|Treated|Period 2 (Day 49 to 154)||8
10775595|NCT03319953|11937808|FG003|Treated|Period 2 (Day 49 to 154)||6
10775596|NCT03319953|11937805|FG000|COMPLETED|Period 2 (Day 49 to 154)||2
10775597|NCT03319953|11937806|FG001|COMPLETED|Period 2 (Day 49 to 154)||4
10775598|NCT03319953|11937807|FG002|COMPLETED|Period 2 (Day 49 to 154)||8
10775599|NCT03319953|11937808|FG003|COMPLETED|Period 2 (Day 49 to 154)||6
10775600|NCT03319953|11937805|FG000|NOT COMPLETED|Period 2 (Day 49 to 154)||1
10775601|NCT03319953|11937806|FG001|NOT COMPLETED|Period 2 (Day 49 to 154)||0
10775602|NCT03319953|11937807|FG002|NOT COMPLETED|Period 2 (Day 49 to 154)||1
10775603|NCT03319953|11937808|FG003|NOT COMPLETED|Period 2 (Day 49 to 154)||1
10775604|NCT03320057|11937816|FG000|STARTED|Overall Study||266
10775605|NCT03320057|11937817|FG001|STARTED|Overall Study|Includes pharmacists at study pharmacies that consented to training on mifepristone dispensing.|60
10775606|NCT03320057|11937816|FG000|Patient's Clinical Outcome Information Obtained|Overall Study||262
10775607|NCT03320057|11937817|FG001|Patient's Clinical Outcome Information Obtained|Overall Study|Clinical outcome data were not collected for pharmacists - this milestone does not apply|0
10775608|NCT03320057|11937816|FG000|Received Pharmacist Training|Overall Study||0
10775609|NCT03320057|11937817|FG001|Received Pharmacist Training|Overall Study||56
10775610|NCT03320057|11937816|FG000|Pharmacists Completed Baseline Survey|Overall Study||0
10775611|NCT03320057|11937817|FG001|Pharmacists Completed Baseline Survey|Overall Study||47
10775612|NCT03320057|11937816|FG000|COMPLETED|Overall Study||260
10775613|NCT03320057|11937817|FG001|COMPLETED|Overall Study|This includes pharmacists who completed the endline survey. Only trained pharmacists (n=56) were eligible.|43
10775614|NCT03320057|11937816|FG000|NOT COMPLETED|Overall Study||6
10775615|NCT03320057|11937817|FG001|NOT COMPLETED|Overall Study||17
10775616|NCT03320096|11937823|FG000|STARTED|Overall Study||20
10775617|NCT03320096|11937823|FG000|COMPLETED|Overall Study||20
10775618|NCT03320096|11937823|FG000|NOT COMPLETED|Overall Study||0
10775619|NCT03320369|11937827|FG000|STARTED|Overall Study||18
10775620|NCT03320369|11937827|FG000|COMPLETED|Overall Study||15
10775621|NCT03320369|11937827|FG000|NOT COMPLETED|Overall Study||3
10775628|NCT03320850|11937850|FG000|STARTED|Overall Study||18
10775629|NCT03320850|11937851|FG001|STARTED|Overall Study||12
10775630|NCT03320850|11937852|FG002|STARTED|Overall Study||18
10775631|NCT03320850|11937853|FG003|STARTED|Overall Study||22
10775632|NCT03320850|11937854|FG004|STARTED|Overall Study||19
10775633|NCT03320850|11937855|FG005|STARTED|Overall Study||58
10775634|NCT03320850|11937856|FG006|STARTED|Overall Study||57
10775635|NCT03320850|11937857|FG007|STARTED|Overall Study||60
10775636|NCT03320850|11937858|FG008|STARTED|Overall Study||60
10775637|NCT03320850|11937859|FG009|STARTED|Overall Study||59
10775638|NCT03320850|11937850|FG000|Safety Population|Overall Study||18
10775639|NCT03320850|11937851|FG001|Safety Population|Overall Study||12
10775640|NCT03320850|11937852|FG002|Safety Population|Overall Study||18
10775641|NCT03320850|11937853|FG003|Safety Population|Overall Study||22
10775642|NCT03320850|11937854|FG004|Safety Population|Overall Study||19
10775643|NCT03320850|11937855|FG005|Safety Population|Overall Study||57
10775644|NCT03320850|11937856|FG006|Safety Population|Overall Study||57
10775645|NCT03320850|11937857|FG007|Safety Population|Overall Study||60
10775646|NCT03320850|11937858|FG008|Safety Population|Overall Study||60
10775647|NCT03320850|11937859|FG009|Safety Population|Overall Study||58
10775648|NCT03320850|11937850|FG000|COMPLETED|Overall Study||18
10775649|NCT03320850|11937851|FG001|COMPLETED|Overall Study||12
10775650|NCT03320850|11937852|FG002|COMPLETED|Overall Study||18
10775651|NCT03320850|11937853|FG003|COMPLETED|Overall Study||21
10775652|NCT03320850|11937854|FG004|COMPLETED|Overall Study||17
10775653|NCT03320850|11937855|FG005|COMPLETED|Overall Study||49
10775654|NCT03320850|11937856|FG006|COMPLETED|Overall Study||50
10775655|NCT03320850|11937857|FG007|COMPLETED|Overall Study||53
10775656|NCT03320850|11937858|FG008|COMPLETED|Overall Study||50
10775657|NCT03320850|11937859|FG009|COMPLETED|Overall Study||50
10775658|NCT03320850|11937850|FG000|NOT COMPLETED|Overall Study||0
10775659|NCT03320850|11937851|FG001|NOT COMPLETED|Overall Study||0
10775660|NCT03320850|11937852|FG002|NOT COMPLETED|Overall Study||0
10775661|NCT03320850|11937853|FG003|NOT COMPLETED|Overall Study||1
10775662|NCT03320850|11937854|FG004|NOT COMPLETED|Overall Study||2
10775663|NCT03320850|11937855|FG005|NOT COMPLETED|Overall Study||9
10775664|NCT03320850|11937856|FG006|NOT COMPLETED|Overall Study||7
10775665|NCT03320850|11937857|FG007|NOT COMPLETED|Overall Study||7
10775666|NCT03320850|11937858|FG008|NOT COMPLETED|Overall Study||10
10775667|NCT03320850|11937859|FG009|NOT COMPLETED|Overall Study||9
10775668|NCT03320941|11937891|FG000|STARTED|Overall Study||19
10775669|NCT03320941|11937892|FG001|STARTED|Overall Study||19
10775670|NCT03320941|11937893|FG002|STARTED|Overall Study||28
10775671|NCT03320941|11937894|FG003|STARTED|Overall Study||31
10775672|NCT03320941|11937895|FG004|STARTED|Overall Study||29
10775673|NCT03320941|11937891|FG000|COMPLETED|Overall Study||19
10775674|NCT03320941|11937892|FG001|COMPLETED|Overall Study||19
10775675|NCT03320941|11937893|FG002|COMPLETED|Overall Study||28
10775676|NCT03320941|11937894|FG003|COMPLETED|Overall Study||30
10775677|NCT03320941|11937895|FG004|COMPLETED|Overall Study||29
10775678|NCT03320941|11937891|FG000|NOT COMPLETED|Overall Study||0
10775679|NCT03320941|11937892|FG001|NOT COMPLETED|Overall Study||0
10775680|NCT03320941|11937893|FG002|NOT COMPLETED|Overall Study||0
10775681|NCT03320941|11937894|FG003|NOT COMPLETED|Overall Study||1
10775682|NCT03320941|11937895|FG004|NOT COMPLETED|Overall Study||0
10775683|NCT03321006|11937909|FG000|STARTED|Overall Study||14
10775684|NCT03321006|11937910|FG001|STARTED|Overall Study||11
10775685|NCT03321006|11937909|FG000|COMPLETED|Overall Study||12
10775686|NCT03321006|11937910|FG001|COMPLETED|Overall Study||11
10775687|NCT03321006|11937909|FG000|NOT COMPLETED|Overall Study||2
10775688|NCT03321006|11937910|FG001|NOT COMPLETED|Overall Study||0
10775689|NCT03321097|11937918|FG000|STARTED|Overall Study||18
10775690|NCT03321097|11937919|FG001|STARTED|Overall Study||18
10775691|NCT03321097|11937918|FG000|COMPLETED|Overall Study||18
10775692|NCT03321097|11937919|FG001|COMPLETED|Overall Study||18
10775693|NCT03321097|11937918|FG000|NOT COMPLETED|Overall Study||0
10775694|NCT03321097|11937919|FG001|NOT COMPLETED|Overall Study||0
10775695|NCT03321253|11937925|FG000|STARTED|Overall Study||38
10775696|NCT03321253|11937925|FG000|COMPLETED|Overall Study||38
10775697|NCT03321253|11937925|FG000|NOT COMPLETED|Overall Study||0
10775698|NCT03321396|11937929|FG000|STARTED|Overall Study||13
10775699|NCT03321396|11937929|FG000|COMPLETED|Overall Study||12
10775700|NCT03321396|11937929|FG000|NOT COMPLETED|Overall Study||1
10775701|NCT03321721|11937936|FG000|STARTED|Overall Study||4
10775702|NCT03321721|11937937|FG001|STARTED|Overall Study||10
10775703|NCT03321721|11937938|FG002|STARTED|Overall Study||12
10775704|NCT03321721|11937936|FG000|COMPLETED|Overall Study||0
10775705|NCT03321721|11937937|FG001|COMPLETED|Overall Study||2
10775706|NCT03321721|11937938|FG002|COMPLETED|Overall Study||1
10775707|NCT03321721|11937936|FG000|NOT COMPLETED|Overall Study||4
10775708|NCT03321721|11937937|FG001|NOT COMPLETED|Overall Study||8
10775709|NCT03321721|11937938|FG002|NOT COMPLETED|Overall Study||11
10775710|NCT03322423|11937947|FG000|STARTED|Period 1||38
10775711|NCT03322423|11937948|FG001|STARTED|Period 1||40
10775712|NCT03322423|11937947|FG000|COMPLETED|Period 1||36
10775713|NCT03322423|11937948|FG001|COMPLETED|Period 1||38
10775714|NCT03322423|11937947|FG000|NOT COMPLETED|Period 1||2
10775715|NCT03322423|11937948|FG001|NOT COMPLETED|Period 1||2
10775716|NCT03322423|11937947|FG000|STARTED|Period 2||36
10775717|NCT03322423|11937948|FG001|STARTED|Period 2||38
10775718|NCT03322423|11937947|FG000|COMPLETED|Period 2||35
10775719|NCT03322423|11937948|FG001|COMPLETED|Period 2||36
10775720|NCT03322423|11937947|FG000|NOT COMPLETED|Period 2||1
10775721|NCT03322423|11937948|FG001|NOT COMPLETED|Period 2||2
10775722|NCT03322462|11937954|FG000|STARTED|Overall Study||155
10775723|NCT03322462|11937954|FG000|Flortaucipir PET Scan|Overall Study||155
10775724|NCT03322462|11937954|FG000|COMPLETED|Overall Study||152
10775725|NCT03322462|11937954|FG000|NOT COMPLETED|Overall Study||3
10775726|NCT03322514|11937962|FG000|STARTED|Overall Study||6
10775727|NCT03322514|11937963|FG001|STARTED|Overall Study||6
10775728|NCT03322514|11937962|FG000|COMPLETED|Overall Study||5
10775729|NCT03322514|11937963|FG001|COMPLETED|Overall Study||5
10775730|NCT03322514|11937962|FG000|NOT COMPLETED|Overall Study||1
10775731|NCT03322514|11937963|FG001|NOT COMPLETED|Overall Study||1
10775732|NCT03322657|11937971|FG000|STARTED|Overall Study||34
10775733|NCT03322657|11937972|FG001|STARTED|Overall Study||35
10775734|NCT03322657|11937971|FG000|COMPLETED|Overall Study||33
10775735|NCT03322657|11937972|FG001|COMPLETED|Overall Study||35
10775736|NCT03322657|11937971|FG000|NOT COMPLETED|Overall Study||1
10775737|NCT03322657|11937972|FG001|NOT COMPLETED|Overall Study||0
10775738|NCT03322930|11937980|FG000|STARTED|Overall Study|recruitment of 20 patients with retinitis pigmentosa|20
10775739|NCT03322930|11937981|FG001|STARTED|Overall Study|recruitment of 20 patients with macular degeneration|20
10775740|NCT03322930|11937980|FG000|COMPLETED|Overall Study||20
10775741|NCT03322930|11937981|FG001|COMPLETED|Overall Study||20
10775742|NCT03322930|11937980|FG000|NOT COMPLETED|Overall Study||0
10775743|NCT03322930|11937981|FG001|NOT COMPLETED|Overall Study||0
10775744|NCT03323086|11937989|FG000|STARTED|Overall Study||26
10775745|NCT03323086|11937990|FG001|STARTED|Overall Study||22
10775746|NCT03323086|11937989|FG000|COMPLETED|Overall Study||23
10775747|NCT03323086|11937990|FG001|COMPLETED|Overall Study||20
10775748|NCT03323086|11937989|FG000|NOT COMPLETED|Overall Study||3
10775749|NCT03323086|11937990|FG001|NOT COMPLETED|Overall Study||2
10775750|NCT03323164|11937998|FG000|STARTED|Overall Study||18
10775751|NCT03323164|11937999|FG001|STARTED|Overall Study||17
10775752|NCT03323164|11937998|FG000|COMPLETED|Overall Study||16
10775753|NCT03323164|11937999|FG001|COMPLETED|Overall Study||15
10775754|NCT03323164|11937998|FG000|NOT COMPLETED|Overall Study||2
10775755|NCT03323164|11937999|FG001|NOT COMPLETED|Overall Study||2
10775756|NCT03323307|11938009|FG000|STARTED|Overall Study||70
10775757|NCT03323307|11938009|FG000|COMPLETED|Overall Study||70
10775758|NCT03323307|11938009|FG000|NOT COMPLETED|Overall Study||0
10775759|NCT03323723|11938013|FG000|STARTED|Screening||73
10775760|NCT03323723|11938013|FG000|COMPLETED|Screening||64
10775761|NCT03323723|11938013|FG000|NOT COMPLETED|Screening||9
10775762|NCT03323723|11938013|FG000|STARTED|Baseline Phase||64
10775763|NCT03323723|11938013|FG000|COMPLETED|Baseline Phase||60
10775764|NCT03323723|11938013|FG000|NOT COMPLETED|Baseline Phase||4
10775765|NCT03323723|11938013|FG000|STARTED|Treatment Phase||60
10775766|NCT03323723|11938013|FG000|COMPLETED|Treatment Phase||51
10775767|NCT03323723|11938013|FG000|NOT COMPLETED|Treatment Phase||9
10775768|NCT03323801|11938018|FG000|STARTED|Overall Study||10
10775769|NCT03323801|11938018|FG000|COMPLETED|Overall Study||10
10775770|NCT03323801|11938018|FG000|NOT COMPLETED|Overall Study||0
10775771|NCT03323853|11938025|FG000|STARTED|Overall Study||213
10775772|NCT03323853|11938026|FG001|STARTED|Overall Study||238
10775773|NCT03323853|11938025|FG000|COMPLETED|Overall Study||213
10775774|NCT03323853|11938026|FG001|COMPLETED|Overall Study||238
10775775|NCT03323853|11938025|FG000|NOT COMPLETED|Overall Study||0
10775776|NCT03323853|11938026|FG001|NOT COMPLETED|Overall Study||0
10775777|NCT03324451|11938034|FG000|STARTED|Overall Study||97
10775778|NCT03324451|11938035|FG001|STARTED|Overall Study||54
10775779|NCT03324451|11938034|FG000|COMPLETED|Overall Study||65
10775780|NCT03324451|11938035|FG001|COMPLETED|Overall Study||41
10775781|NCT03324451|11938034|FG000|NOT COMPLETED|Overall Study||32
10775782|NCT03324451|11938035|FG001|NOT COMPLETED|Overall Study||13
10775783|NCT03324581|11938044|FG000|STARTED|Overall Study||77
10775784|NCT03324581|11938045|FG001|STARTED|Overall Study||80
10775785|NCT03324581|11938046|FG002|STARTED|Overall Study||82
10775786|NCT03324581|11938044|FG000|COMPLETED|Overall Study||38
10775787|NCT03324581|11938045|FG001|COMPLETED|Overall Study||44
10775788|NCT03324581|11938046|FG002|COMPLETED|Overall Study||57
10775789|NCT03324581|11938044|FG000|NOT COMPLETED|Overall Study||39
10775790|NCT03324581|11938045|FG001|NOT COMPLETED|Overall Study||36
10775791|NCT03324581|11938046|FG002|NOT COMPLETED|Overall Study||25
10775792|NCT03324607|11938054|FG000|STARTED|Overall Study||20
10775793|NCT03324607|11938054|FG000|COMPLETED|Overall Study||20
10775794|NCT03324607|11938054|FG000|NOT COMPLETED|Overall Study||0
10775795|NCT03325010|11938063|FG000|STARTED|Overall Study||64
10775796|NCT03325010|11938064|FG001|STARTED|Overall Study||63
10775797|NCT03325010|11938063|FG000|Safety Analysis Set|Overall Study||62
10775798|NCT03325010|11938064|FG001|Safety Analysis Set|Overall Study||59
10775799|NCT03325010|11938063|FG000|Full Analysis Set|Overall Study||61
10775800|NCT03325010|11938064|FG001|Full Analysis Set|Overall Study||58
10775801|NCT03325010|11938063|FG000|COMPLETED|Overall Study||55
10775802|NCT03325010|11938064|FG001|COMPLETED|Overall Study||43
10775803|NCT03325010|11938063|FG000|NOT COMPLETED|Overall Study||9
10775804|NCT03325010|11938064|FG001|NOT COMPLETED|Overall Study||20
10775805|NCT03325556|11938070|FG000|STARTED|Open-label Period||392
10775806|NCT03325556|11938071|FG001|STARTED|Open-label Period||0
10775807|NCT03325556|11938072|FG002|STARTED|Open-label Period||0
10775808|NCT03325556|11938070|FG000|COMPLETED|Open-label Period||217
10775809|NCT03325556|11938071|FG001|COMPLETED|Open-label Period||0
10775810|NCT03325556|11938072|FG002|COMPLETED|Open-label Period||0
10775811|NCT03325556|11938070|FG000|NOT COMPLETED|Open-label Period||175
10775812|NCT03325556|11938071|FG001|NOT COMPLETED|Open-label Period||0
10775813|NCT03325556|11938072|FG002|NOT COMPLETED|Open-label Period||0
10775814|NCT03325556|11938070|FG000|STARTED|Double-blind Period||0
10775815|NCT03325556|11938071|FG001|STARTED|Double-blind Period||105
10775816|NCT03325556|11938072|FG002|STARTED|Double-blind Period||112
10775817|NCT03325556|11938070|FG000|COMPLETED|Double-blind Period||0
10775818|NCT03325556|11938071|FG001|COMPLETED|Double-blind Period||44
10775819|NCT03325556|11938072|FG002|COMPLETED|Double-blind Period||35
10775820|NCT03325556|11938070|FG000|NOT COMPLETED|Double-blind Period||0
10775821|NCT03325556|11938071|FG001|NOT COMPLETED|Double-blind Period||61
10775822|NCT03325556|11938072|FG002|NOT COMPLETED|Double-blind Period||77
10775823|NCT03325673|11938081|FG000|STARTED|Overall Study||42
10775824|NCT03325673|11938082|FG001|STARTED|Overall Study||42
10775825|NCT03325673|11938081|FG000|COMPLETED|Overall Study||38
10775826|NCT03325673|11938082|FG001|COMPLETED|Overall Study||42
10775827|NCT03325673|11938081|FG000|NOT COMPLETED|Overall Study||4
10775828|NCT03325673|11938082|FG001|NOT COMPLETED|Overall Study||0
10775829|NCT03325816|11938090|FG000|STARTED|Overall Study||3
10775830|NCT03325816|11938091|FG001|STARTED|Overall Study||6
10775831|NCT03325816|11938090|FG000|COMPLETED|Overall Study||3
10775832|NCT03325816|11938091|FG001|COMPLETED|Overall Study||6
10775833|NCT03325816|11938090|FG000|NOT COMPLETED|Overall Study||0
10775834|NCT03325816|11938091|FG001|NOT COMPLETED|Overall Study||0
10775835|NCT03325881|11938101|FG000|STARTED|Overall Study||44
10775836|NCT03325881|11938102|FG001|STARTED|Overall Study||45
10775837|NCT03325881|11938101|FG000|Treated|Overall Study||43
10775838|NCT03325881|11938102|FG001|Treated|Overall Study||45
10775839|NCT03325881|11938101|FG000|COMPLETED|Overall Study||41
10775840|NCT03325881|11938102|FG001|COMPLETED|Overall Study||42
10775841|NCT03325881|11938101|FG000|NOT COMPLETED|Overall Study||3
10775842|NCT03325881|11938102|FG001|NOT COMPLETED|Overall Study||3
10775843|NCT03325894|11938112|FG000|STARTED|Overall Study||64
10775844|NCT03325894|11938113|FG001|STARTED|Overall Study||77
10775845|NCT03325894|11938112|FG000|COMPLETED|Overall Study||0
10775846|NCT03325894|11938113|FG001|COMPLETED|Overall Study||0
10775847|NCT03325894|11938112|FG000|NOT COMPLETED|Overall Study||64
10775848|NCT03325894|11938113|FG001|NOT COMPLETED|Overall Study||77
10775849|NCT03326323|11938122|FG000|STARTED|Overall Study||43
10775850|NCT03326323|11938122|FG000|COMPLETED|Overall Study||40
10775851|NCT03326323|11938122|FG000|NOT COMPLETED|Overall Study||3
10775852|NCT03326518|11938129|FG000|STARTED|Overall Study||19
10775853|NCT03326518|11938130|FG001|STARTED|Overall Study||12
10775854|NCT03326518|11938131|FG002|STARTED|Overall Study||14
10775855|NCT03326518|11938129|FG000|COMPLETED|Overall Study||16
10775856|NCT03326518|11938130|FG001|COMPLETED|Overall Study||12
10775857|NCT03326518|11938131|FG002|COMPLETED|Overall Study||13
10775858|NCT03326518|11938129|FG000|NOT COMPLETED|Overall Study||3
10775859|NCT03326518|11938130|FG001|NOT COMPLETED|Overall Study||0
10775860|NCT03326518|11938131|FG002|NOT COMPLETED|Overall Study||1
10775861|NCT03326843|11938139|FG000|STARTED|Overall Study||4
10775862|NCT03326843|11938139|FG000|COMPLETED|Overall Study||4
10775863|NCT03326843|11938139|FG000|NOT COMPLETED|Overall Study||0
10775864|NCT03326895|11938143|FG000|STARTED|Overall Study||168
10775865|NCT03326895|11938143|FG000|COMPLETED|Overall Study||168
10775866|NCT03326895|11938143|FG000|NOT COMPLETED|Overall Study||0
10775867|NCT03326986|11938150|FG000|STARTED|Overall Study||8
10775868|NCT03326986|11938151|FG001|STARTED|Overall Study||8
10775869|NCT03326986|11938152|FG002|STARTED|Overall Study||8
10775870|NCT03326986|11938150|FG000|COMPLETED|Overall Study||8
10775871|NCT03326986|11938151|FG001|COMPLETED|Overall Study||8
10775872|NCT03326986|11938152|FG002|COMPLETED|Overall Study||8
10775873|NCT03326986|11938150|FG000|NOT COMPLETED|Overall Study||0
10775874|NCT03326986|11938151|FG001|NOT COMPLETED|Overall Study||0
10775875|NCT03326986|11938152|FG002|NOT COMPLETED|Overall Study||0
10775876|NCT03326999|11938195|FG000|STARTED|Overall Study||30
10775877|NCT03326999|11938196|FG001|STARTED|Overall Study||30
10775878|NCT03326999|11938195|FG000|COMPLETED|Overall Study||30
10775879|NCT03326999|11938196|FG001|COMPLETED|Overall Study||30
10775880|NCT03326999|11938195|FG000|NOT COMPLETED|Overall Study||0
10775881|NCT03326999|11938196|FG001|NOT COMPLETED|Overall Study||0
10775882|NCT03327051|11938204|FG000|STARTED|Overall Study||19
10775883|NCT03327051|11938205|FG001|STARTED|Overall Study||20
10775884|NCT03327051|11938204|FG000|Received Treatment|Overall Study||16
10775885|NCT03327051|11938205|FG001|Received Treatment|Overall Study||16
10775886|NCT03327051|11938204|FG000|Attended Visit 2 (Week 0)|Overall Study||15
10775887|NCT03327051|11938205|FG001|Attended Visit 2 (Week 0)|Overall Study||15
10775888|NCT03327051|11938204|FG000|COMPLETED|Overall Study||14
10775889|NCT03327051|11938205|FG001|COMPLETED|Overall Study||15
10775890|NCT03327051|11938204|FG000|NOT COMPLETED|Overall Study||5
10775891|NCT03327051|11938205|FG001|NOT COMPLETED|Overall Study||5
10775892|NCT03327220|11938214|FG000|STARTED|Overall Study||62
10775893|NCT03327220|11938215|FG001|STARTED|Overall Study||62
10775894|NCT03327220|11938214|FG000|Safety Population: Received Study Treatment|Overall Study||59
10775895|NCT03327220|11938215|FG001|Safety Population: Received Study Treatment|Overall Study||60
10775896|NCT03327220|11938214|FG000|COMPLETED|Overall Study||57
10775897|NCT03327220|11938215|FG001|COMPLETED|Overall Study||58
10775898|NCT03327220|11938214|FG000|NOT COMPLETED|Overall Study||5
10775899|NCT03327220|11938215|FG001|NOT COMPLETED|Overall Study||4
10775900|NCT03327402|11938221|FG000|STARTED|Overall Study||24
10775901|NCT03327402|11938221|FG000|Rich PK Sampling Group|Overall Study||12
10775902|NCT03327402|11938221|FG000|Sparse PK Sampling Group|Overall Study||12
10775903|NCT03327402|11938221|FG000|COMPLETED|Overall Study||22
10775904|NCT03327402|11938221|FG000|NOT COMPLETED|Overall Study||2
10775905|NCT03327571|11938227|FG000|STARTED|Group 1: cHL||1598
10775906|NCT03327571|11938228|FG001|STARTED|Group 1: cHL||0
10775907|NCT03327571|11938227|FG000|COMPLETED|Group 1: cHL||1598
10775908|NCT03327571|11938228|FG001|COMPLETED|Group 1: cHL||0
10775909|NCT03327571|11938227|FG000|NOT COMPLETED|Group 1: cHL||0
10775910|NCT03327571|11938228|FG001|NOT COMPLETED|Group 1: cHL||0
10775911|NCT03327571|11938227|FG000|STARTED|Group 2: RRHL||0
10775912|NCT03327571|11938228|FG001|STARTED|Group 2: RRHL|105 RRHL only participants and 321 common participants who had CHL, and subsequently RRHL between 2010-2013.|426
10775913|NCT03327571|11938227|FG000|Participants Were Counted in Both Groups|Group 2: RRHL||0
10775914|NCT03327571|11938228|FG001|Participants Were Counted in Both Groups|Group 2: RRHL|Participants who were diagnosed with CHL, and subsequently RRHL between 2010 and 2013.|321
10775915|NCT03327571|11938227|FG000|COMPLETED|Group 2: RRHL||0
10775916|NCT03327571|11938228|FG001|COMPLETED|Group 2: RRHL||426
10775917|NCT03327571|11938227|FG000|NOT COMPLETED|Group 2: RRHL||0
10775918|NCT03327571|11938228|FG001|NOT COMPLETED|Group 2: RRHL||0
10775919|NCT03328182|11938235|FG000|STARTED|Overall Study||34
10775920|NCT03328182|11938235|FG000|COMPLETED|Overall Study||30
10775921|NCT03328182|11938235|FG000|NOT COMPLETED|Overall Study||4
10775922|NCT03328208|11938241|FG000|STARTED|Overall Study||37
10775923|NCT03328208|11938242|FG001|STARTED|Overall Study||35
10775924|NCT03328208|11938241|FG000|COMPLETED|Overall Study||37
10775925|NCT03328208|11938242|FG001|COMPLETED|Overall Study||35
10775926|NCT03328208|11938241|FG000|NOT COMPLETED|Overall Study||0
10775927|NCT03328208|11938242|FG001|NOT COMPLETED|Overall Study||0
10775928|NCT03328325|11938248|FG000|STARTED|Overall Study||152
10775929|NCT03328325|11938248|FG000|COMPLETED|Overall Study||141
10775930|NCT03328325|11938248|FG000|NOT COMPLETED|Overall Study||11
10775931|NCT03328624|11938252|FG000|STARTED|Overall Study||36
10775932|NCT03328624|11938252|FG000|COMPLETED|Overall Study||36
10775933|NCT03328624|11938252|FG000|NOT COMPLETED|Overall Study||0
10775934|NCT03328832|11938258|FG000|STARTED|Overall Study||35
10775935|NCT03328832|11938259|FG001|STARTED|Overall Study||35
10775936|NCT03328832|11938258|FG000|COMPLETED|Overall Study||35
10775937|NCT03328832|11938259|FG001|COMPLETED|Overall Study||34
10775938|NCT03328832|11938258|FG000|NOT COMPLETED|Overall Study||0
10775939|NCT03328832|11938259|FG001|NOT COMPLETED|Overall Study||1
10775940|NCT03328897|11938268|FG000|STARTED|Randomized-treatment Epoch||168
10775941|NCT03328897|11938269|FG001|STARTED|Randomized-treatment Epoch||167
10775942|NCT03328897|11938270|FG002|STARTED|Randomized-treatment Epoch||83
10775943|NCT03328897|11938268|FG000|Full Analysis Set (FAS)|Randomized-treatment Epoch||167
10775944|NCT03328897|11938269|FG001|Full Analysis Set (FAS)|Randomized-treatment Epoch||167
10775945|NCT03328897|11938270|FG002|Full Analysis Set (FAS)|Randomized-treatment Epoch||83
10775946|NCT03328897|11938268|FG000|COMPLETED|Randomized-treatment Epoch||152
10775947|NCT03328897|11938269|FG001|COMPLETED|Randomized-treatment Epoch||162
10775948|NCT03328897|11938270|FG002|COMPLETED|Randomized-treatment Epoch||81
10775949|NCT03328897|11938268|FG000|NOT COMPLETED|Randomized-treatment Epoch||16
10775950|NCT03328897|11938269|FG001|NOT COMPLETED|Randomized-treatment Epoch||5
10775951|NCT03328897|11938270|FG002|NOT COMPLETED|Randomized-treatment Epoch||2
10775952|NCT03328897|11938268|FG000|STARTED|Follow-up Epoch||161
10775953|NCT03328897|11938269|FG001|STARTED|Follow-up Epoch||163
10775954|NCT03328897|11938270|FG002|STARTED|Follow-up Epoch||81
10775955|NCT03328897|11938268|FG000|COMPLETED|Follow-up Epoch||153
10775956|NCT03328897|11938269|FG001|COMPLETED|Follow-up Epoch||160
10775957|NCT03328897|11938270|FG002|COMPLETED|Follow-up Epoch||79
10775958|NCT03328897|11938268|FG000|NOT COMPLETED|Follow-up Epoch||8
10775959|NCT03328897|11938269|FG001|NOT COMPLETED|Follow-up Epoch||3
10775960|NCT03328897|11938270|FG002|NOT COMPLETED|Follow-up Epoch||2
10775961|NCT03328949|11938278|FG000|STARTED|Overall Study||120
10775962|NCT03328949|11938278|FG000|COMPLETED|Overall Study||120
10775963|NCT03328949|11938278|FG000|NOT COMPLETED|Overall Study||0
10775964|NCT03329196|11938285|FG000|STARTED|Overall Study||151
10775965|NCT03329196|11938286|FG001|STARTED|Overall Study||153
10775966|NCT03329196|11938285|FG000|COMPLETED|Overall Study||111
10775967|NCT03329196|11938286|FG001|COMPLETED|Overall Study||123
10775968|NCT03329196|11938285|FG000|NOT COMPLETED|Overall Study||40
10775969|NCT03329196|11938286|FG001|NOT COMPLETED|Overall Study||30
10775970|NCT03329209|11938292|FG000|STARTED|Overall Study||16
10775971|NCT03329209|11938292|FG000|COMPLETED|Overall Study||16
10775972|NCT03329209|11938292|FG000|NOT COMPLETED|Overall Study||0
10775973|NCT03329352|11938296|FG000|STARTED|F&P Toffee Full Face Mask Validation||44
10775974|NCT03329352|11938296|FG000|COMPLETED|F&P Toffee Full Face Mask Validation||42
10775975|NCT03329352|11938296|FG000|NOT COMPLETED|F&P Toffee Full Face Mask Validation||2
10775976|NCT03329352|11938296|FG000|STARTED|Extension||29
10775977|NCT03329352|11938296|FG000|COMPLETED|Extension||22
10775978|NCT03329352|11938296|FG000|NOT COMPLETED|Extension||7
10775979|NCT03329573|11938306|FG000|STARTED|Treatment Period 1 (Up to 5 Days)||23
10775980|NCT03329573|11938307|FG001|STARTED|Treatment Period 1 (Up to 5 Days)||24
10775981|NCT03329573|11938308|FG002|STARTED|Treatment Period 1 (Up to 5 Days)||19
10775982|NCT03329573|11938309|FG003|STARTED|Treatment Period 1 (Up to 5 Days)||19
10775983|NCT03329573|11938306|FG000|COMPLETED|Treatment Period 1 (Up to 5 Days)||22
10775984|NCT03329573|11938307|FG001|COMPLETED|Treatment Period 1 (Up to 5 Days)||21
10775985|NCT03329573|11938308|FG002|COMPLETED|Treatment Period 1 (Up to 5 Days)||19
10775986|NCT03329573|11938309|FG003|COMPLETED|Treatment Period 1 (Up to 5 Days)||19
10775987|NCT03329573|11938306|FG000|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||1
10775988|NCT03329573|11938307|FG001|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||3
10775989|NCT03329573|11938308|FG002|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||0
10775990|NCT03329573|11938309|FG003|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||0
10775991|NCT03329573|11938306|FG000|STARTED|Washout Period (Day 6 to Day 11)||22
10775992|NCT03329573|11938307|FG001|STARTED|Washout Period (Day 6 to Day 11)||21
10775993|NCT03329573|11938308|FG002|STARTED|Washout Period (Day 6 to Day 11)||19
10775994|NCT03329573|11938309|FG003|STARTED|Washout Period (Day 6 to Day 11)||19
10775995|NCT03329573|11938306|FG000|COMPLETED|Washout Period (Day 6 to Day 11)||22
10775996|NCT03329573|11938307|FG001|COMPLETED|Washout Period (Day 6 to Day 11)||21
10775997|NCT03329573|11938308|FG002|COMPLETED|Washout Period (Day 6 to Day 11)||19
10775998|NCT03329573|11938309|FG003|COMPLETED|Washout Period (Day 6 to Day 11)||19
10775999|NCT03329573|11938306|FG000|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
10776000|NCT03329573|11938307|FG001|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
10776001|NCT03329573|11938308|FG002|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
10776002|NCT03329573|11938309|FG003|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
10776003|NCT03329573|11938306|FG000|STARTED|Treatment Period 2 (Day 12 to Day 26)||22
10776004|NCT03329573|11938307|FG001|STARTED|Treatment Period 2 (Day 12 to Day 26)||21
10776005|NCT03329573|11938308|FG002|STARTED|Treatment Period 2 (Day 12 to Day 26)||19
10776006|NCT03329573|11938309|FG003|STARTED|Treatment Period 2 (Day 12 to Day 26)||19
10776007|NCT03329573|11938306|FG000|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||21
10776008|NCT03329573|11938307|FG001|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||20
10776009|NCT03329573|11938308|FG002|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||19
10776010|NCT03329573|11938309|FG003|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||19
10776011|NCT03329573|11938306|FG000|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||1
10776012|NCT03329573|11938307|FG001|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||1
10776013|NCT03329573|11938308|FG002|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||0
10776014|NCT03329573|11938309|FG003|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||0
10776015|NCT03329846|11938321|FG000|STARTED|Overall Study||10
10776016|NCT03329846|11938322|FG001|STARTED|Overall Study||10
10776017|NCT03329846|11938321|FG000|COMPLETED|Overall Study||2
10776018|NCT03329846|11938322|FG001|COMPLETED|Overall Study||1
10776019|NCT03329846|11938321|FG000|NOT COMPLETED|Overall Study||8
10776020|NCT03329846|11938322|FG001|NOT COMPLETED|Overall Study||9
10776021|NCT03329885|11938334|FG000|STARTED|Overall Study||9
10776022|NCT03329885|11938335|FG001|STARTED|Overall Study||6
10776023|NCT03329885|11938336|FG002|STARTED|Overall Study||6
10776024|NCT03329885|11938337|FG003|STARTED|Overall Study||6
10776025|NCT03329885|11938338|FG004|STARTED|Overall Study||6
10776026|NCT03329885|11938339|FG005|STARTED|Overall Study||3
10776027|NCT03329885|11938340|FG006|STARTED|Overall Study||1
10776028|NCT03329885|11938341|FG007|STARTED|Overall Study||1
10776029|NCT03329885|11938342|FG008|STARTED|Overall Study|Due to early termination of study, Part C was cancelled and no patients were dosed|0
10776030|NCT03329885|11938334|FG000|COMPLETED|Overall Study||9
10776031|NCT03329885|11938335|FG001|COMPLETED|Overall Study||6
10776032|NCT03329885|11938336|FG002|COMPLETED|Overall Study||6
10776033|NCT03329885|11938337|FG003|COMPLETED|Overall Study||6
10776034|NCT03329885|11938338|FG004|COMPLETED|Overall Study||6
10776035|NCT03329885|11938339|FG005|COMPLETED|Overall Study||3
10776036|NCT03329885|11938340|FG006|COMPLETED|Overall Study||0
10776037|NCT03329885|11938341|FG007|COMPLETED|Overall Study||0
10776038|NCT03329885|11938342|FG008|COMPLETED|Overall Study||0
10776039|NCT03329885|11938334|FG000|NOT COMPLETED|Overall Study||0
10776040|NCT03329885|11938335|FG001|NOT COMPLETED|Overall Study||0
10776041|NCT03329885|11938336|FG002|NOT COMPLETED|Overall Study||0
10776042|NCT03329885|11938337|FG003|NOT COMPLETED|Overall Study||0
10776043|NCT03329885|11938338|FG004|NOT COMPLETED|Overall Study||0
10776044|NCT03329885|11938339|FG005|NOT COMPLETED|Overall Study||0
10776045|NCT03329885|11938340|FG006|NOT COMPLETED|Overall Study||1
10776046|NCT03329885|11938341|FG007|NOT COMPLETED|Overall Study||1
10776047|NCT03329885|11938342|FG008|NOT COMPLETED|Overall Study||0
10776048|NCT03329911|11938364|FG000|STARTED|Overall Study||326
10776049|NCT03329911|11938365|FG001|STARTED|Overall Study||325
10776050|NCT03329911|11938364|FG000|COMPLETED|Overall Study||209
10776051|NCT03329911|11938365|FG001|COMPLETED|Overall Study||222
10776052|NCT03329911|11938364|FG000|NOT COMPLETED|Overall Study||117
10776053|NCT03329911|11938365|FG001|NOT COMPLETED|Overall Study||103
10776054|NCT03329937|11938371|FG000|STARTED|Overall Study||21
10776055|NCT03329937|11938371|FG000|COMPLETED|Overall Study||21
10776056|NCT03329937|11938371|FG000|NOT COMPLETED|Overall Study||0
10776057|NCT03329989|11938375|FG000|STARTED|Overall Study||158
10776058|NCT03329989|11938375|FG000|COMPLETED|Overall Study||135
10776059|NCT03329989|11938375|FG000|NOT COMPLETED|Overall Study||23
10776060|NCT03330002|11938379|FG000|STARTED|Overall Study|Subjects that received the MANTA VCD|500
10776061|NCT03330002|11938379|FG000|COMPLETED|Overall Study|Subjects that received the MANTA VCD and completed 30 day follow-up visit|478
10776062|NCT03330002|11938379|FG000|NOT COMPLETED|Overall Study||22
10776063|NCT03330041|11938383|FG000|STARTED|Overall Study||50
10776064|NCT03330041|11938383|FG000|COMPLETED|Overall Study||48
10776065|NCT03330041|11938383|FG000|NOT COMPLETED|Overall Study||2
10776066|NCT03330119|11938391|FG000|STARTED|Overall Study||641
10776067|NCT03330119|11938392|FG001|STARTED|Overall Study||853
10776068|NCT03330119|11938391|FG000|COMPLETED|Overall Study||475
10776069|NCT03330119|11938392|FG001|COMPLETED|Overall Study||571
10776070|NCT03330119|11938391|FG000|NOT COMPLETED|Overall Study||166
10776071|NCT03330119|11938392|FG001|NOT COMPLETED|Overall Study||282
10776072|NCT03330236|11938400|FG000|STARTED|Overall Study||779
10776073|NCT03330236|11938401|FG001|STARTED|Overall Study||781
10776074|NCT03330236|11938400|FG000|Received Surgery|Overall Study||779
10776075|NCT03330236|11938401|FG001|Received Surgery|Overall Study||781
10776076|NCT03330236|11938400|FG000|Modified ITT|Overall Study||773
10776077|NCT03330236|11938401|FG001|Modified ITT|Overall Study||774
10776078|NCT03330236|11938400|FG000|COMPLETED|Overall Study||679
10776079|NCT03330236|11938401|FG001|COMPLETED|Overall Study||697
10776080|NCT03330236|11938400|FG000|NOT COMPLETED|Overall Study||100
10776081|NCT03330236|11938401|FG001|NOT COMPLETED|Overall Study||84
10776082|NCT03330262|11938409|FG000|STARTED|First Six Weeks||7
10776083|NCT03330262|11938410|FG001|STARTED|First Six Weeks||6
10776084|NCT03330262|11938409|FG000|COMPLETED|First Six Weeks||7
10776085|NCT03330262|11938410|FG001|COMPLETED|First Six Weeks||6
10776086|NCT03330262|11938409|FG000|NOT COMPLETED|First Six Weeks||0
10776087|NCT03330262|11938410|FG001|NOT COMPLETED|First Six Weeks||0
10776088|NCT03330262|11938409|FG000|STARTED|Second Six Weeks||7
10776089|NCT03330262|11938410|FG001|STARTED|Second Six Weeks||6
10776090|NCT03330262|11938409|FG000|COMPLETED|Second Six Weeks||5
10776091|NCT03330262|11938410|FG001|COMPLETED|Second Six Weeks||5
10776092|NCT03330262|11938409|FG000|NOT COMPLETED|Second Six Weeks||2
10776093|NCT03330262|11938410|FG001|NOT COMPLETED|Second Six Weeks||1
10776094|NCT03330275|11938419|FG000|STARTED|Visit 1 - Period 1||6
10776095|NCT03330275|11938420|FG001|STARTED|Visit 1 - Period 1||6
10776096|NCT03330275|11938421|FG002|STARTED|Visit 1 - Period 1||6
10776097|NCT03330275|11938422|FG003|STARTED|Visit 1 - Period 1||6
10776098|NCT03330275|11938423|FG004|STARTED|Visit 1 - Period 1||0
10776099|NCT03330275|11938424|FG005|STARTED|Visit 1 - Period 1||0
10776100|NCT03330275|11938425|FG006|STARTED|Visit 1 - Period 1||0
10776101|NCT03330275|11938426|FG007|STARTED|Visit 1 - Period 1||0
10776102|NCT03330275|11938427|FG008|STARTED|Visit 1 - Period 1||0
10776103|NCT03330275|11938428|FG009|STARTED|Visit 1 - Period 1||0
10776104|NCT03330275|11938419|FG000|COMPLETED|Visit 1 - Period 1||6
10776105|NCT03330275|11938420|FG001|COMPLETED|Visit 1 - Period 1||6
10776106|NCT03330275|11938421|FG002|COMPLETED|Visit 1 - Period 1||6
10776107|NCT03330275|11938422|FG003|COMPLETED|Visit 1 - Period 1||6
10776108|NCT03330275|11938423|FG004|COMPLETED|Visit 1 - Period 1||0
10776109|NCT03330275|11938424|FG005|COMPLETED|Visit 1 - Period 1||0
10776110|NCT03330275|11938425|FG006|COMPLETED|Visit 1 - Period 1||0
10776111|NCT03330275|11938426|FG007|COMPLETED|Visit 1 - Period 1||0
10776112|NCT03330275|11938427|FG008|COMPLETED|Visit 1 - Period 1||0
10776113|NCT03330275|11938428|FG009|COMPLETED|Visit 1 - Period 1||0
10776114|NCT03330275|11938419|FG000|NOT COMPLETED|Visit 1 - Period 1||0
10776115|NCT03330275|11938420|FG001|NOT COMPLETED|Visit 1 - Period 1||0
10776116|NCT03330275|11938421|FG002|NOT COMPLETED|Visit 1 - Period 1||0
10776117|NCT03330275|11938422|FG003|NOT COMPLETED|Visit 1 - Period 1||0
10776118|NCT03330275|11938423|FG004|NOT COMPLETED|Visit 1 - Period 1||0
10776119|NCT03330275|11938424|FG005|NOT COMPLETED|Visit 1 - Period 1||0
10776120|NCT03330275|11938425|FG006|NOT COMPLETED|Visit 1 - Period 1||0
10776121|NCT03330275|11938426|FG007|NOT COMPLETED|Visit 1 - Period 1||0
10776122|NCT03330275|11938427|FG008|NOT COMPLETED|Visit 1 - Period 1||0
10776123|NCT03330275|11938428|FG009|NOT COMPLETED|Visit 1 - Period 1||0
10776124|NCT03330275|11938419|FG000|STARTED|Visit 1 - Period 2||6
10776125|NCT03330275|11938420|FG001|STARTED|Visit 1 - Period 2||6
10776126|NCT03330275|11938421|FG002|STARTED|Visit 1 - Period 2||6
10776127|NCT03330275|11938422|FG003|STARTED|Visit 1 - Period 2||6
10776128|NCT03330275|11938423|FG004|STARTED|Visit 1 - Period 2||0
10776129|NCT03330275|11938424|FG005|STARTED|Visit 1 - Period 2||0
10776130|NCT03330275|11938425|FG006|STARTED|Visit 1 - Period 2||0
10776131|NCT03330275|11938426|FG007|STARTED|Visit 1 - Period 2||0
10776132|NCT03330275|11938427|FG008|STARTED|Visit 1 - Period 2||0
10776133|NCT03330275|11938428|FG009|STARTED|Visit 1 - Period 2||0
10776134|NCT03330275|11938419|FG000|COMPLETED|Visit 1 - Period 2||6
10776135|NCT03330275|11938420|FG001|COMPLETED|Visit 1 - Period 2||6
10776136|NCT03330275|11938421|FG002|COMPLETED|Visit 1 - Period 2||6
10776137|NCT03330275|11938422|FG003|COMPLETED|Visit 1 - Period 2||6
10776138|NCT03330275|11938423|FG004|COMPLETED|Visit 1 - Period 2||0
10776139|NCT03330275|11938424|FG005|COMPLETED|Visit 1 - Period 2||0
10776140|NCT03330275|11938425|FG006|COMPLETED|Visit 1 - Period 2||0
10776141|NCT03330275|11938426|FG007|COMPLETED|Visit 1 - Period 2||0
10776142|NCT03330275|11938427|FG008|COMPLETED|Visit 1 - Period 2||0
10776143|NCT03330275|11938428|FG009|COMPLETED|Visit 1 - Period 2||0
10776144|NCT03330275|11938419|FG000|NOT COMPLETED|Visit 1 - Period 2||0
10776145|NCT03330275|11938420|FG001|NOT COMPLETED|Visit 1 - Period 2||0
10776146|NCT03330275|11938421|FG002|NOT COMPLETED|Visit 1 - Period 2||0
10776147|NCT03330275|11938422|FG003|NOT COMPLETED|Visit 1 - Period 2||0
10776148|NCT03330275|11938423|FG004|NOT COMPLETED|Visit 1 - Period 2||0
10776149|NCT03330275|11938424|FG005|NOT COMPLETED|Visit 1 - Period 2||0
10776150|NCT03330275|11938425|FG006|NOT COMPLETED|Visit 1 - Period 2||0
10776151|NCT03330275|11938426|FG007|NOT COMPLETED|Visit 1 - Period 2||0
10776152|NCT03330275|11938427|FG008|NOT COMPLETED|Visit 1 - Period 2||0
10776153|NCT03330275|11938428|FG009|NOT COMPLETED|Visit 1 - Period 2||0
10776154|NCT03330275|11938419|FG000|STARTED|Visits 2, 3 and 4 - Period 1||0
10776155|NCT03330275|11938420|FG001|STARTED|Visits 2, 3 and 4 - Period 1||0
10776156|NCT03330275|11938421|FG002|STARTED|Visits 2, 3 and 4 - Period 1||0
10776157|NCT03330275|11938422|FG003|STARTED|Visits 2, 3 and 4 - Period 1||0
10776158|NCT03330275|11938423|FG004|STARTED|Visits 2, 3 and 4 - Period 1||4
10776159|NCT03330275|11938424|FG005|STARTED|Visits 2, 3 and 4 - Period 1||4
10776160|NCT03330275|11938425|FG006|STARTED|Visits 2, 3 and 4 - Period 1||4
10776161|NCT03330275|11938426|FG007|STARTED|Visits 2, 3 and 4 - Period 1||4
10776162|NCT03330275|11938427|FG008|STARTED|Visits 2, 3 and 4 - Period 1||4
10776163|NCT03330275|11938428|FG009|STARTED|Visits 2, 3 and 4 - Period 1||4
10776164|NCT03330275|11938419|FG000|COMPLETED|Visits 2, 3 and 4 - Period 1||0
10776165|NCT03330275|11938420|FG001|COMPLETED|Visits 2, 3 and 4 - Period 1||0
10776166|NCT03330275|11938421|FG002|COMPLETED|Visits 2, 3 and 4 - Period 1||0
10776167|NCT03330275|11938422|FG003|COMPLETED|Visits 2, 3 and 4 - Period 1||0
10776168|NCT03330275|11938423|FG004|COMPLETED|Visits 2, 3 and 4 - Period 1||4
10776169|NCT03330275|11938424|FG005|COMPLETED|Visits 2, 3 and 4 - Period 1||4
10776170|NCT03330275|11938425|FG006|COMPLETED|Visits 2, 3 and 4 - Period 1||4
10776171|NCT03330275|11938426|FG007|COMPLETED|Visits 2, 3 and 4 - Period 1||4
10776172|NCT03330275|11938427|FG008|COMPLETED|Visits 2, 3 and 4 - Period 1||4
10776173|NCT03330275|11938428|FG009|COMPLETED|Visits 2, 3 and 4 - Period 1||4
10776174|NCT03330275|11938419|FG000|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
10776175|NCT03330275|11938420|FG001|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
10776176|NCT03330275|11938421|FG002|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
10776177|NCT03330275|11938422|FG003|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
10776178|NCT03330275|11938423|FG004|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
10776179|NCT03330275|11938424|FG005|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
10776180|NCT03330275|11938425|FG006|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
10776181|NCT03330275|11938426|FG007|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
10776182|NCT03330275|11938427|FG008|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
10776183|NCT03330275|11938428|FG009|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
10776184|NCT03330275|11938419|FG000|STARTED|Visits 2, 3 and 4 - Period 2||0
10776185|NCT03330275|11938420|FG001|STARTED|Visits 2, 3 and 4 - Period 2||0
10776186|NCT03330275|11938421|FG002|STARTED|Visits 2, 3 and 4 - Period 2||0
10776187|NCT03330275|11938422|FG003|STARTED|Visits 2, 3 and 4 - Period 2||0
10776188|NCT03330275|11938423|FG004|STARTED|Visits 2, 3 and 4 - Period 2||4
10776189|NCT03330275|11938424|FG005|STARTED|Visits 2, 3 and 4 - Period 2||4
10776190|NCT03330275|11938425|FG006|STARTED|Visits 2, 3 and 4 - Period 2||4
10776191|NCT03330275|11938426|FG007|STARTED|Visits 2, 3 and 4 - Period 2||4
10776192|NCT03330275|11938427|FG008|STARTED|Visits 2, 3 and 4 - Period 2||4
10776193|NCT03330275|11938428|FG009|STARTED|Visits 2, 3 and 4 - Period 2||4
10776194|NCT03330275|11938419|FG000|COMPLETED|Visits 2, 3 and 4 - Period 2||0
10776195|NCT03330275|11938420|FG001|COMPLETED|Visits 2, 3 and 4 - Period 2||0
10776196|NCT03330275|11938421|FG002|COMPLETED|Visits 2, 3 and 4 - Period 2||0
10776197|NCT03330275|11938422|FG003|COMPLETED|Visits 2, 3 and 4 - Period 2||0
10776198|NCT03330275|11938423|FG004|COMPLETED|Visits 2, 3 and 4 - Period 2||4
10776199|NCT03330275|11938424|FG005|COMPLETED|Visits 2, 3 and 4 - Period 2||4
10776200|NCT03330275|11938425|FG006|COMPLETED|Visits 2, 3 and 4 - Period 2||4
10776201|NCT03330275|11938426|FG007|COMPLETED|Visits 2, 3 and 4 - Period 2||4
10776202|NCT03330275|11938427|FG008|COMPLETED|Visits 2, 3 and 4 - Period 2||4
10776203|NCT03330275|11938428|FG009|COMPLETED|Visits 2, 3 and 4 - Period 2||4
10776204|NCT03330275|11938419|FG000|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
10776205|NCT03330275|11938420|FG001|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
10776206|NCT03330275|11938421|FG002|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
10776207|NCT03330275|11938422|FG003|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
10776208|NCT03330275|11938423|FG004|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
10776209|NCT03330275|11938424|FG005|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
10776210|NCT03330275|11938425|FG006|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
10776211|NCT03330275|11938426|FG007|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
10776212|NCT03330275|11938427|FG008|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
10776213|NCT03330275|11938428|FG009|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
10776214|NCT03330275|11938419|FG000|STARTED|Visits 2, 3 and 4 - Period 3||0
10776215|NCT03330275|11938420|FG001|STARTED|Visits 2, 3 and 4 - Period 3||0
10776216|NCT03330275|11938421|FG002|STARTED|Visits 2, 3 and 4 - Period 3||0
10776217|NCT03330275|11938422|FG003|STARTED|Visits 2, 3 and 4 - Period 3||0
10776218|NCT03330275|11938423|FG004|STARTED|Visits 2, 3 and 4 - Period 3||4
10776219|NCT03330275|11938424|FG005|STARTED|Visits 2, 3 and 4 - Period 3||4
10776220|NCT03330275|11938425|FG006|STARTED|Visits 2, 3 and 4 - Period 3||4
10776221|NCT03330275|11938426|FG007|STARTED|Visits 2, 3 and 4 - Period 3||4
10776222|NCT03330275|11938427|FG008|STARTED|Visits 2, 3 and 4 - Period 3||4
10776223|NCT03330275|11938428|FG009|STARTED|Visits 2, 3 and 4 - Period 3||4
10776224|NCT03330275|11938419|FG000|COMPLETED|Visits 2, 3 and 4 - Period 3||0
10776225|NCT03330275|11938420|FG001|COMPLETED|Visits 2, 3 and 4 - Period 3||0
10776226|NCT03330275|11938421|FG002|COMPLETED|Visits 2, 3 and 4 - Period 3||0
10776227|NCT03330275|11938422|FG003|COMPLETED|Visits 2, 3 and 4 - Period 3||0
10776228|NCT03330275|11938423|FG004|COMPLETED|Visits 2, 3 and 4 - Period 3||4
10776229|NCT03330275|11938424|FG005|COMPLETED|Visits 2, 3 and 4 - Period 3||4
10776230|NCT03330275|11938425|FG006|COMPLETED|Visits 2, 3 and 4 - Period 3||4
10776231|NCT03330275|11938426|FG007|COMPLETED|Visits 2, 3 and 4 - Period 3||4
10776232|NCT03330275|11938427|FG008|COMPLETED|Visits 2, 3 and 4 - Period 3||4
10776233|NCT03330275|11938428|FG009|COMPLETED|Visits 2, 3 and 4 - Period 3||4
10776234|NCT03330275|11938419|FG000|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
10776235|NCT03330275|11938420|FG001|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
10776236|NCT03330275|11938421|FG002|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
10776237|NCT03330275|11938422|FG003|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
10776238|NCT03330275|11938423|FG004|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
10776239|NCT03330275|11938424|FG005|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
10776240|NCT03330275|11938425|FG006|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
10423422|NCT00829439|11568554|FG000|NOT COMPLETED|Overall Study||0
10423423|NCT00829439|11568555|FG001|NOT COMPLETED|Overall Study||0
10423424|NCT00829439|11568556|FG002|NOT COMPLETED|Overall Study||1
10776241|NCT03330275|11938426|FG007|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
10776242|NCT03330275|11938427|FG008|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
10776243|NCT03330275|11938428|FG009|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
10776244|NCT03330288|11938438|FG000|STARTED|Overall Study|Enrolled|824
10776245|NCT03330288|11938439|FG001|STARTED|Overall Study|Enrolled|278
10776246|NCT03330288|11938438|FG000|COMPLETED|Overall Study||794
10776247|NCT03330288|11938439|FG001|COMPLETED|Overall Study||270
10776248|NCT03330288|11938438|FG000|NOT COMPLETED|Overall Study||30
10776249|NCT03330288|11938439|FG001|NOT COMPLETED|Overall Study||8
10776250|NCT03330457|11938449|FG000|STARTED|Overall Study||6
10776251|NCT03330457|11938450|FG001|STARTED|Overall Study||3
10776252|NCT03330457|11938451|FG002|STARTED|Overall Study||6
10776253|NCT03330457|11938452|FG003|STARTED|Overall Study||3
10776254|NCT03330457|11938449|FG000|COMPLETED|Overall Study||6
10776255|NCT03330457|11938450|FG001|COMPLETED|Overall Study||3
10776256|NCT03330457|11938451|FG002|COMPLETED|Overall Study||6
10776257|NCT03330457|11938452|FG003|COMPLETED|Overall Study||3
10776258|NCT03330457|11938449|FG000|NOT COMPLETED|Overall Study||0
10776259|NCT03330457|11938450|FG001|NOT COMPLETED|Overall Study||0
10776260|NCT03330457|11938451|FG002|NOT COMPLETED|Overall Study||0
10776261|NCT03330457|11938452|FG003|NOT COMPLETED|Overall Study||0
10776262|NCT03330834|11938462|FG000|STARTED|Overall Study||1
10776263|NCT03330834|11938462|FG000|COMPLETED|Overall Study||1
10776264|NCT03330834|11938462|FG000|NOT COMPLETED|Overall Study||0
10776265|NCT03331042|11938470|FG000|STARTED|Overall Study||22
10776266|NCT03331042|11938471|FG001|STARTED|Overall Study||21
10776267|NCT03331042|11938472|FG002|STARTED|Overall Study||21
10776268|NCT03331042|11938473|FG003|STARTED|Overall Study||21
10776269|NCT03331042|11938470|FG000|COMPLETED|Overall Study||21
10776270|NCT03331042|11938471|FG001|COMPLETED|Overall Study||21
10776271|NCT03331042|11938472|FG002|COMPLETED|Overall Study||20
10776272|NCT03331042|11938473|FG003|COMPLETED|Overall Study||20
10776273|NCT03331042|11938470|FG000|NOT COMPLETED|Overall Study||1
10776274|NCT03331042|11938471|FG001|NOT COMPLETED|Overall Study||0
10776275|NCT03331042|11938472|FG002|NOT COMPLETED|Overall Study||1
10776276|NCT03331042|11938473|FG003|NOT COMPLETED|Overall Study||1
10776277|NCT03331185|11938491|FG000|STARTED|Overall Study||14
10776278|NCT03331185|11938492|FG001|STARTED|Overall Study||12
10776279|NCT03331185|11938491|FG000|COMPLETED|Overall Study||14
10776280|NCT03331185|11938492|FG001|COMPLETED|Overall Study||12
10776281|NCT03331185|11938491|FG000|NOT COMPLETED|Overall Study||0
10776282|NCT03331185|11938492|FG001|NOT COMPLETED|Overall Study||0
10776283|NCT03331315|11938500|FG000|STARTED|Overall Study||88
10776284|NCT03331315|11938501|FG001|STARTED|Overall Study||82
10776285|NCT03331315|11938500|FG000|COMPLETED|Overall Study||70
10776286|NCT03331315|11938501|FG001|COMPLETED|Overall Study||68
10776287|NCT03331315|11938500|FG000|NOT COMPLETED|Overall Study||18
10776288|NCT03331315|11938501|FG001|NOT COMPLETED|Overall Study||14
10776289|NCT03331666|11938511|FG000|STARTED|Overall Study||2
10776290|NCT03331666|11938512|FG001|STARTED|Overall Study||2
10776291|NCT03331666|11938511|FG000|COMPLETED|Overall Study||0
10776292|NCT03331666|11938512|FG001|COMPLETED|Overall Study||0
10776293|NCT03331666|11938511|FG000|NOT COMPLETED|Overall Study||2
10776294|NCT03331666|11938512|FG001|NOT COMPLETED|Overall Study||2
10776295|NCT03331835|11938520|FG000|STARTED|Overall Study||105
10776296|NCT03331835|11938521|FG001|STARTED|Overall Study||105
10776297|NCT03331835|11938520|FG000|COMPLETED|Overall Study||91
10776298|NCT03331835|11938521|FG001|COMPLETED|Overall Study||58
10776299|NCT03331835|11938520|FG000|NOT COMPLETED|Overall Study||14
10776300|NCT03331835|11938521|FG001|NOT COMPLETED|Overall Study||47
10776301|NCT03331965|11938529|FG000|STARTED|Overall Study||55
10776302|NCT03331965|11938530|FG001|STARTED|Overall Study||55
10776303|NCT03331965|11938529|FG000|COMPLETED|Overall Study||45
10776304|NCT03331965|11938530|FG001|COMPLETED|Overall Study||51
10776305|NCT03331965|11938529|FG000|NOT COMPLETED|Overall Study||10
10776306|NCT03331965|11938530|FG001|NOT COMPLETED|Overall Study||4
10776307|NCT03332160|11938538|FG000|STARTED|Overall Study||25
10776308|NCT03332160|11938539|FG001|STARTED|Overall Study||24
10776309|NCT03332160|11938538|FG000|COMPLETED|Overall Study||24
10776310|NCT03332160|11938539|FG001|COMPLETED|Overall Study||19
10776311|NCT03332160|11938538|FG000|NOT COMPLETED|Overall Study||1
10776312|NCT03332160|11938539|FG001|NOT COMPLETED|Overall Study||5
10776313|NCT03332212|11938550|FG000|STARTED|Overall Study||19
10776314|NCT03332212|11938551|FG001|STARTED|Overall Study||18
10776315|NCT03332212|11938552|FG002|STARTED|Overall Study||17
10776316|NCT03332212|11938553|FG003|STARTED|Overall Study||18
10776317|NCT03332212|11938550|FG000|Treated|Overall Study||19
10776318|NCT03332212|11938551|FG001|Treated|Overall Study||17
10776319|NCT03332212|11938552|FG002|Treated|Overall Study||17
10776320|NCT03332212|11938553|FG003|Treated|Overall Study||18
10776321|NCT03332212|11938550|FG000|COMPLETED|Overall Study||18
10776322|NCT03332212|11938551|FG001|COMPLETED|Overall Study||16
10776323|NCT03332212|11938552|FG002|COMPLETED|Overall Study||17
10776324|NCT03332212|11938553|FG003|COMPLETED|Overall Study||17
10776325|NCT03332212|11938550|FG000|NOT COMPLETED|Overall Study||1
10776326|NCT03332212|11938551|FG001|NOT COMPLETED|Overall Study||2
10776327|NCT03332212|11938552|FG002|NOT COMPLETED|Overall Study||0
10776328|NCT03332212|11938553|FG003|NOT COMPLETED|Overall Study||1
10776329|NCT03332459|11938564|FG000|STARTED|Overall Study||3
10776330|NCT03332459|11938565|FG001|STARTED|Overall Study||1
10776331|NCT03332459|11938566|FG002|STARTED|Overall Study||3
10776332|NCT03332459|11938564|FG000|COMPLETED|Overall Study||3
10776333|NCT03332459|11938565|FG001|COMPLETED|Overall Study||1
10776334|NCT03332459|11938566|FG002|COMPLETED|Overall Study||3
10776335|NCT03332459|11938564|FG000|NOT COMPLETED|Overall Study||0
10776336|NCT03332459|11938565|FG001|NOT COMPLETED|Overall Study||0
10776337|NCT03332459|11938566|FG002|NOT COMPLETED|Overall Study||0
10776338|NCT03332628|11938574|FG000|STARTED|Overall Study||113
10776339|NCT03332628|11938574|FG000|COMPLETED|Overall Study||111
10776340|NCT03332628|11938574|FG000|NOT COMPLETED|Overall Study||2
10776341|NCT03332771|11938583|FG000|STARTED|Overall Study||159
10776342|NCT03332771|11938584|FG001|STARTED|Overall Study||317
10776343|NCT03332771|11938585|FG002|STARTED|Overall Study||160
10776344|NCT03332771|11938586|FG003|STARTED|Overall Study||318
10776345|NCT03332771|11938583|FG000|COMPLETED|Overall Study||125
10776346|NCT03332771|11938584|FG001|COMPLETED|Overall Study||266
10776347|NCT03332771|11938585|FG002|COMPLETED|Overall Study||128
10776348|NCT03332771|11938586|FG003|COMPLETED|Overall Study||270
10776349|NCT03332771|11938583|FG000|NOT COMPLETED|Overall Study||34
10776350|NCT03332771|11938584|FG001|NOT COMPLETED|Overall Study||51
10776351|NCT03332771|11938585|FG002|NOT COMPLETED|Overall Study||32
10776352|NCT03332771|11938586|FG003|NOT COMPLETED|Overall Study||48
10779298|NCT03364309|11940873|FG014|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|0
10779299|NCT03364309|11940874|FG015|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|0
10779300|NCT03364309|11940875|FG016|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|11
10779301|NCT03364309|11940876|FG017|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|375
10779302|NCT03364309|11940877|FG018|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|2
10779303|NCT03364309|11940859|FG000|COMPLETED|Post-Treatment Followup Period||0
10779304|NCT03364309|11940860|FG001|COMPLETED|Post-Treatment Followup Period||0
10779305|NCT03364309|11940861|FG002|COMPLETED|Post-Treatment Followup Period||0
10779306|NCT03364309|11940862|FG003|COMPLETED|Post-Treatment Followup Period||0
10779307|NCT03364309|11940863|FG004|COMPLETED|Post-Treatment Followup Period||0
10779308|NCT03364309|11940864|FG005|COMPLETED|Post-Treatment Followup Period||0
10779309|NCT03364309|11940865|FG006|COMPLETED|Post-Treatment Followup Period||0
10779310|NCT03364309|11940866|FG007|COMPLETED|Post-Treatment Followup Period||0
10776353|NCT03332784|11938616|FG000|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
10776354|NCT03332784|11938617|FG001|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
10776355|NCT03332784|11938618|FG002|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
10776356|NCT03332784|11938619|FG003|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
10776357|NCT03332784|11938620|FG004|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
10776358|NCT03332784|11938621|FG005|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
10776359|NCT03332784|11938622|FG006|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
10776360|NCT03332784|11938623|FG007|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
10776361|NCT03332784|11938624|FG008|STARTED|Parts 1 and 2 - Period 1 (1 Day)||4
10776362|NCT03332784|11938625|FG009|STARTED|Parts 1 and 2 - Period 1 (1 Day)||6
10776363|NCT03332784|11938626|FG010|STARTED|Parts 1 and 2 - Period 1 (1 Day)||6
10776364|NCT03332784|11938627|FG011|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
10776365|NCT03332784|11938628|FG012|STARTED|Parts 1 and 2 - Period 1 (1 Day)||6
10776366|NCT03332784|11938629|FG013|STARTED|Parts 1 and 2 - Period 1 (1 Day)||4
10776367|NCT03332784|11938630|FG014|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|2
10776368|NCT03332784|11938631|FG015|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|2
10776369|NCT03332784|11938632|FG016|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|2
10776370|NCT03332784|11938633|FG017|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|2
10776371|NCT03332784|11938634|FG018|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|3
10776372|NCT03332784|11938635|FG019|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|3
10776373|NCT03332784|11938616|FG000|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
10776374|NCT03332784|11938617|FG001|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||1
10776375|NCT03332784|11938618|FG002|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
10776376|NCT03332784|11938619|FG003|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
10776377|NCT03332784|11938620|FG004|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
10776378|NCT03332784|11938621|FG005|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
10776379|NCT03332784|11938622|FG006|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
10776380|NCT03332784|11938623|FG007|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
10776381|NCT03332784|11938624|FG008|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||4
10776382|NCT03332784|11938625|FG009|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||6
10776383|NCT03332784|11938626|FG010|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||6
10776384|NCT03332784|11938627|FG011|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
10776385|NCT03332784|11938628|FG012|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||6
10776386|NCT03332784|11938629|FG013|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||4
10776387|NCT03332784|11938630|FG014|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||1
10776388|NCT03332784|11938631|FG015|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
10776389|NCT03332784|11938632|FG016|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
10776390|NCT03332784|11938633|FG017|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
10776391|NCT03332784|11938634|FG018|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||3
10776392|NCT03332784|11938635|FG019|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||3
10776393|NCT03332784|11938616|FG000|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
10776394|NCT03332784|11938617|FG001|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||1
10776395|NCT03332784|11938618|FG002|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
10776396|NCT03332784|11938619|FG003|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
10776397|NCT03332784|11938620|FG004|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
10776398|NCT03332784|11938621|FG005|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
10776399|NCT03332784|11938622|FG006|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
10776400|NCT03332784|11938623|FG007|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
10776401|NCT03332784|11938624|FG008|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
10776402|NCT03332784|11938625|FG009|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
10776403|NCT03332784|11938626|FG010|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
10776404|NCT03332784|11938627|FG011|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
10776405|NCT03332784|11938628|FG012|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
10776406|NCT03332784|11938629|FG013|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
10776407|NCT03332784|11938630|FG014|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||1
10776408|NCT03332784|11938631|FG015|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
10776409|NCT03332784|11938632|FG016|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
10776410|NCT03332784|11938633|FG017|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
10776411|NCT03332784|11938634|FG018|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
10776412|NCT03332784|11938635|FG019|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
10776413|NCT03332784|11938616|FG000|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
10776414|NCT03332784|11938617|FG001|STARTED|Parts 1 and 2- Period 2 (1 Day)||1
10776415|NCT03332784|11938618|FG002|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
10776416|NCT03332784|11938619|FG003|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
10776417|NCT03332784|11938620|FG004|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
10776418|NCT03332784|11938621|FG005|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
10776419|NCT03332784|11938622|FG006|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
10776420|NCT03332784|11938623|FG007|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
10776421|NCT03332784|11938624|FG008|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
10779311|NCT03364309|11940867|FG008|COMPLETED|Post-Treatment Followup Period||0
10776422|NCT03332784|11938625|FG009|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
10776423|NCT03332784|11938626|FG010|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
10776424|NCT03332784|11938627|FG011|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
10776425|NCT03332784|11938628|FG012|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
10776426|NCT03332784|11938629|FG013|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
10776427|NCT03332784|11938630|FG014|STARTED|Parts 1 and 2- Period 2 (1 Day)||1
10776428|NCT03332784|11938631|FG015|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
10776429|NCT03332784|11938632|FG016|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
10776430|NCT03332784|11938633|FG017|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
10776431|NCT03332784|11938634|FG018|STARTED|Parts 1 and 2- Period 2 (1 Day)||3
10776432|NCT03332784|11938635|FG019|STARTED|Parts 1 and 2- Period 2 (1 Day)||3
10776433|NCT03332784|11938616|FG000|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
10776434|NCT03332784|11938617|FG001|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||1
10776435|NCT03332784|11938618|FG002|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
10776436|NCT03332784|11938619|FG003|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
10776437|NCT03332784|11938620|FG004|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
10776438|NCT03332784|11938621|FG005|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
10776439|NCT03332784|11938622|FG006|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
10776440|NCT03332784|11938623|FG007|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
10776441|NCT03332784|11938624|FG008|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10776442|NCT03332784|11938625|FG009|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10776443|NCT03332784|11938626|FG010|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10776444|NCT03332784|11938627|FG011|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10776445|NCT03332784|11938628|FG012|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10776446|NCT03332784|11938629|FG013|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10776447|NCT03332784|11938630|FG014|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||1
10776448|NCT03332784|11938631|FG015|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
10776449|NCT03332784|11938632|FG016|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
10776450|NCT03332784|11938633|FG017|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
10776451|NCT03332784|11938634|FG018|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||3
10776452|NCT03332784|11938635|FG019|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||3
10776453|NCT03332784|11938616|FG000|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10776454|NCT03332784|11938617|FG001|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10776455|NCT03332784|11938618|FG002|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10776456|NCT03332784|11938619|FG003|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10776457|NCT03332784|11938620|FG004|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10776458|NCT03332784|11938621|FG005|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10776459|NCT03332784|11938622|FG006|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10776460|NCT03332784|11938623|FG007|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10776461|NCT03332784|11938624|FG008|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10776462|NCT03332784|11938625|FG009|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10776463|NCT03332784|11938626|FG010|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10776464|NCT03332784|11938627|FG011|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10776465|NCT03332784|11938628|FG012|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10776466|NCT03332784|11938629|FG013|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10776467|NCT03332784|11938630|FG014|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10776468|NCT03332784|11938631|FG015|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10776469|NCT03332784|11938632|FG016|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10776470|NCT03332784|11938633|FG017|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10776471|NCT03332784|11938634|FG018|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10776472|NCT03332784|11938635|FG019|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
10776473|NCT03332784|11938616|FG000|STARTED|Part 1- Period 3 (1 Day)||2
10776474|NCT03332784|11938617|FG001|STARTED|Part 1- Period 3 (1 Day)||1
10776475|NCT03332784|11938618|FG002|STARTED|Part 1- Period 3 (1 Day)||2
10776476|NCT03332784|11938619|FG003|STARTED|Part 1- Period 3 (1 Day)||2
10776477|NCT03332784|11938620|FG004|STARTED|Part 1- Period 3 (1 Day)||2
10776478|NCT03332784|11938621|FG005|STARTED|Part 1- Period 3 (1 Day)||2
10776479|NCT03332784|11938622|FG006|STARTED|Part 1- Period 3 (1 Day)||2
10776480|NCT03332784|11938623|FG007|STARTED|Part 1- Period 3 (1 Day)||2
10776481|NCT03332784|11938624|FG008|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
10776482|NCT03332784|11938625|FG009|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
10776483|NCT03332784|11938626|FG010|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
10776484|NCT03332784|11938627|FG011|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
10776485|NCT03332784|11938628|FG012|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
10776486|NCT03332784|11938629|FG013|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
10776487|NCT03332784|11938630|FG014|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
10776488|NCT03332784|11938631|FG015|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
10776489|NCT03332784|11938632|FG016|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
10776490|NCT03332784|11938633|FG017|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
10776491|NCT03332784|11938634|FG018|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
10776492|NCT03332784|11938635|FG019|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
10776493|NCT03332784|11938616|FG000|COMPLETED|Part 1- Period 3 (1 Day)||2
10776494|NCT03332784|11938617|FG001|COMPLETED|Part 1- Period 3 (1 Day)||1
10776495|NCT03332784|11938618|FG002|COMPLETED|Part 1- Period 3 (1 Day)||2
10776496|NCT03332784|11938619|FG003|COMPLETED|Part 1- Period 3 (1 Day)||2
10776497|NCT03332784|11938620|FG004|COMPLETED|Part 1- Period 3 (1 Day)||2
10776498|NCT03332784|11938621|FG005|COMPLETED|Part 1- Period 3 (1 Day)||2
10776499|NCT03332784|11938622|FG006|COMPLETED|Part 1- Period 3 (1 Day)||2
10776500|NCT03332784|11938623|FG007|COMPLETED|Part 1- Period 3 (1 Day)||2
10776501|NCT03332784|11938624|FG008|COMPLETED|Part 1- Period 3 (1 Day)||0
10776502|NCT03332784|11938625|FG009|COMPLETED|Part 1- Period 3 (1 Day)||0
10776503|NCT03332784|11938626|FG010|COMPLETED|Part 1- Period 3 (1 Day)||0
10776504|NCT03332784|11938627|FG011|COMPLETED|Part 1- Period 3 (1 Day)||0
10776505|NCT03332784|11938628|FG012|COMPLETED|Part 1- Period 3 (1 Day)||0
10776506|NCT03332784|11938629|FG013|COMPLETED|Part 1- Period 3 (1 Day)||0
10776507|NCT03332784|11938630|FG014|COMPLETED|Part 1- Period 3 (1 Day)||0
10776508|NCT03332784|11938631|FG015|COMPLETED|Part 1- Period 3 (1 Day)||0
10776509|NCT03332784|11938632|FG016|COMPLETED|Part 1- Period 3 (1 Day)||0
10776510|NCT03332784|11938633|FG017|COMPLETED|Part 1- Period 3 (1 Day)||0
10776511|NCT03332784|11938634|FG018|COMPLETED|Part 1- Period 3 (1 Day)||0
10776512|NCT03332784|11938635|FG019|COMPLETED|Part 1- Period 3 (1 Day)||0
10776513|NCT03332784|11938616|FG000|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
10776514|NCT03332784|11938617|FG001|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
10776515|NCT03332784|11938618|FG002|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
10776516|NCT03332784|11938619|FG003|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
10776517|NCT03332784|11938620|FG004|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
10776518|NCT03332784|11938621|FG005|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
10776519|NCT03332784|11938622|FG006|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
10776520|NCT03332784|11938623|FG007|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
10776521|NCT03332784|11938624|FG008|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
10776522|NCT03332784|11938625|FG009|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
10776523|NCT03332784|11938626|FG010|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
10776524|NCT03332784|11938627|FG011|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
10776525|NCT03332784|11938628|FG012|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
10776526|NCT03332784|11938629|FG013|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
10776527|NCT03332784|11938630|FG014|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
10776528|NCT03332784|11938631|FG015|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
10776529|NCT03332784|11938632|FG016|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
10776530|NCT03332784|11938633|FG017|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
10776531|NCT03332784|11938634|FG018|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
10776532|NCT03332784|11938635|FG019|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
10776533|NCT03332979|11938689|FG000|STARTED|Overall Study||150
10776534|NCT03332979|11938689|FG000|COMPLETED|Overall Study||150
10776535|NCT03332979|11938689|FG000|NOT COMPLETED|Overall Study||0
10776536|NCT03333109|11938696|FG000|STARTED|Double-blind Treatment Period (DBTP)||338
10776537|NCT03333109|11938697|FG001|STARTED|Double-blind Treatment Period (DBTP)||224
10776538|NCT03333109|11938698|FG002|STARTED|Double-blind Treatment Period (DBTP)||338
10776539|NCT03333109|11938696|FG000|Full Analysis Set|Double-blind Treatment Period (DBTP)||329
10776540|NCT03333109|11938697|FG001|Full Analysis Set|Double-blind Treatment Period (DBTP)||219
10776541|NCT03333109|11938698|FG002|Full Analysis Set|Double-blind Treatment Period (DBTP)||330
10776542|NCT03333109|11938696|FG000|Safety Analysis Set|Double-blind Treatment Period (DBTP)||335
10776543|NCT03333109|11938697|FG001|Safety Analysis Set|Double-blind Treatment Period (DBTP)||224
10776544|NCT03333109|11938698|FG002|Safety Analysis Set|Double-blind Treatment Period (DBTP)||335
10776545|NCT03333109|11938696|FG000|COMPLETED|Double-blind Treatment Period (DBTP)||321
10776546|NCT03333109|11938697|FG001|COMPLETED|Double-blind Treatment Period (DBTP)||218
10776547|NCT03333109|11938698|FG002|COMPLETED|Double-blind Treatment Period (DBTP)||326
10776548|NCT03333109|11938696|FG000|NOT COMPLETED|Double-blind Treatment Period (DBTP)||17
10776549|NCT03333109|11938697|FG001|NOT COMPLETED|Double-blind Treatment Period (DBTP)||6
10776550|NCT03333109|11938698|FG002|NOT COMPLETED|Double-blind Treatment Period (DBTP)||12
10776551|NCT03333109|11938696|FG000|STARTED|Safety Follow-up Period|Subjects discontinued from DBTP and still entered the safety follow-up.|324
10776552|NCT03333109|11938697|FG001|STARTED|Safety Follow-up Period||218
10776553|NCT03333109|11938698|FG002|STARTED|Safety Follow-up Period|Subjects discontinued from DBTP and still entered the safety follow-up.|328
10776554|NCT03333109|11938696|FG000|COMPLETED|Safety Follow-up Period||311
10776555|NCT03333109|11938697|FG001|COMPLETED|Safety Follow-up Period||214
10776556|NCT03333109|11938698|FG002|COMPLETED|Safety Follow-up Period||315
10776557|NCT03333109|11938696|FG000|NOT COMPLETED|Safety Follow-up Period||13
10776558|NCT03333109|11938697|FG001|NOT COMPLETED|Safety Follow-up Period||4
10776559|NCT03333109|11938698|FG002|NOT COMPLETED|Safety Follow-up Period||13
10776560|NCT03333317|11938709|FG000|STARTED|Overall Study||3
10776561|NCT03333317|11938710|FG001|STARTED|Overall Study||1
10776562|NCT03333317|11938711|FG002|STARTED|Overall Study||3
10776563|NCT03333317|11938709|FG000|COMPLETED|Overall Study||3
10776564|NCT03333317|11938710|FG001|COMPLETED|Overall Study||1
10776565|NCT03333317|11938711|FG002|COMPLETED|Overall Study||3
10776566|NCT03333317|11938709|FG000|NOT COMPLETED|Overall Study||0
10776567|NCT03333317|11938710|FG001|NOT COMPLETED|Overall Study||0
10776568|NCT03333317|11938711|FG002|NOT COMPLETED|Overall Study||0
10776569|NCT03333577|11938721|FG000|STARTED|Overall Study||32
10776570|NCT03333577|11938721|FG000|COMPLETED|Overall Study||25
10776571|NCT03333577|11938721|FG000|NOT COMPLETED|Overall Study||7
10776572|NCT03333876|11938727|FG000|STARTED|Screening Period||58
10776573|NCT03333876|11938727|FG000|COMPLETED|Screening Period||54
10776574|NCT03333876|11938727|FG000|NOT COMPLETED|Screening Period||4
10776575|NCT03333876|11938727|FG000|STARTED|Nasal Dilator||54
10776576|NCT03333876|11938727|FG000|COMPLETED|Nasal Dilator||48
10776577|NCT03333876|11938727|FG000|NOT COMPLETED|Nasal Dilator||6
10776578|NCT03333876|11938727|FG000|STARTED|Mandibular Advancement||54
10776579|NCT03333876|11938727|FG000|COMPLETED|Mandibular Advancement||50
10776580|NCT03333876|11938727|FG000|NOT COMPLETED|Mandibular Advancement||4
10776581|NCT03333876|11938727|FG000|STARTED|Positional Therapy||54
10776582|NCT03333876|11938727|FG000|COMPLETED|Positional Therapy||54
10776583|NCT03333876|11938727|FG000|NOT COMPLETED|Positional Therapy||0
10776584|NCT03333941|11938740|FG000|STARTED|Overall Study||76
10776585|NCT03333941|11938740|FG000|COMPLETED|Overall Study||63
10776586|NCT03333941|11938740|FG000|NOT COMPLETED|Overall Study||13
10776587|NCT03334175|11938746|FG000|STARTED|Overall Study||8
10776588|NCT03334175|11938747|FG001|STARTED|Overall Study||10
10776589|NCT03334175|11938746|FG000|COMPLETED|Overall Study||8
10776590|NCT03334175|11938747|FG001|COMPLETED|Overall Study||9
10776591|NCT03334175|11938746|FG000|NOT COMPLETED|Overall Study||0
10776592|NCT03334175|11938747|FG001|NOT COMPLETED|Overall Study||1
10776593|NCT03334188|11938755|FG000|STARTED|Overall Study||153
10776594|NCT03334188|11938756|FG001|STARTED|Overall Study||153
10776595|NCT03334188|11938755|FG000|COMPLETED|Overall Study||145
10776596|NCT03334188|11938756|FG001|COMPLETED|Overall Study||145
10776597|NCT03334188|11938755|FG000|NOT COMPLETED|Overall Study||8
10776598|NCT03334188|11938756|FG001|NOT COMPLETED|Overall Study||8
10776599|NCT03334214|11938765|FG000|STARTED|Overall Study||15
10776600|NCT03334214|11938766|FG001|STARTED|Overall Study||29
10776601|NCT03334214|11938765|FG000|COMPLETED|Overall Study||14
10776602|NCT03334214|11938766|FG001|COMPLETED|Overall Study||27
10776603|NCT03334214|11938765|FG000|NOT COMPLETED|Overall Study||1
10776604|NCT03334214|11938766|FG001|NOT COMPLETED|Overall Study||2
10776605|NCT03334396|11938781|FG000|STARTED|Overall Study||249
10776606|NCT03334396|11938782|FG001|STARTED|Overall Study||127
10776607|NCT03334396|11938783|FG002|STARTED|Overall Study||123
10776608|NCT03334396|11938784|FG003|STARTED|Overall Study||125
10776609|NCT03334396|11938785|FG004|STARTED|Overall Study||15
10776610|NCT03334396|11938786|FG005|STARTED|Overall Study||5
10776611|NCT03334396|11938787|FG006|STARTED|Overall Study||8
10776612|NCT03334396|11938788|FG007|STARTED|Overall Study||8
10776613|NCT03334396|11938781|FG000|Received at Least One Dose of Study Drug|Overall Study||249
10776614|NCT03334396|11938782|FG001|Received at Least One Dose of Study Drug|Overall Study||127
10776615|NCT03334396|11938783|FG002|Received at Least One Dose of Study Drug|Overall Study||123
10776616|NCT03334396|11938784|FG003|Received at Least One Dose of Study Drug|Overall Study||125
10776617|NCT03334396|11938785|FG004|Received at Least One Dose of Study Drug|Overall Study||15
10776618|NCT03334396|11938786|FG005|Received at Least One Dose of Study Drug|Overall Study||5
10776619|NCT03334396|11938787|FG006|Received at Least One Dose of Study Drug|Overall Study||8
10776620|NCT03334396|11938788|FG007|Received at Least One Dose of Study Drug|Overall Study||8
10776621|NCT03334396|11938781|FG000|COMPLETED|Overall Study||226
10776622|NCT03334396|11938782|FG001|COMPLETED|Overall Study||116
10776623|NCT03334396|11938783|FG002|COMPLETED|Overall Study||113
10776624|NCT03334396|11938784|FG003|COMPLETED|Overall Study||120
10776625|NCT03334396|11938785|FG004|COMPLETED|Overall Study||12
10776626|NCT03334396|11938786|FG005|COMPLETED|Overall Study||4
10776627|NCT03334396|11938787|FG006|COMPLETED|Overall Study||5
10776628|NCT03334396|11938788|FG007|COMPLETED|Overall Study||7
10776629|NCT03334396|11938781|FG000|NOT COMPLETED|Overall Study||23
10776630|NCT03334396|11938782|FG001|NOT COMPLETED|Overall Study||11
10776631|NCT03334396|11938783|FG002|NOT COMPLETED|Overall Study||10
10776632|NCT03334396|11938784|FG003|NOT COMPLETED|Overall Study||5
10776633|NCT03334396|11938785|FG004|NOT COMPLETED|Overall Study||3
10776634|NCT03334396|11938786|FG005|NOT COMPLETED|Overall Study||1
10776635|NCT03334396|11938787|FG006|NOT COMPLETED|Overall Study||3
10776636|NCT03334396|11938788|FG007|NOT COMPLETED|Overall Study||1
10776637|NCT03334422|11938809|FG000|STARTED|Overall Study||244
10776638|NCT03334422|11938810|FG001|STARTED|Overall Study||125
10776639|NCT03334422|11938811|FG002|STARTED|Overall Study||123
10776640|NCT03334422|11938812|FG003|STARTED|Overall Study||123
10776641|NCT03334422|11938809|FG000|Received at Least One Dose of Study Drug|Overall Study||244
10776642|NCT03334422|11938810|FG001|Received at Least One Dose of Study Drug|Overall Study||124
10776643|NCT03334422|11938811|FG002|Received at Least One Dose of Study Drug|Overall Study||123
10776644|NCT03334422|11938812|FG003|Received at Least One Dose of Study Drug|Overall Study||123
10776645|NCT03334422|11938809|FG000|COMPLETED|Overall Study||225
10776646|NCT03334422|11938810|FG001|COMPLETED|Overall Study||115
10776647|NCT03334422|11938811|FG002|COMPLETED|Overall Study||113
10776648|NCT03334422|11938812|FG003|COMPLETED|Overall Study||117
10776649|NCT03334422|11938809|FG000|NOT COMPLETED|Overall Study||19
10776650|NCT03334422|11938810|FG001|NOT COMPLETED|Overall Study||10
10776651|NCT03334422|11938811|FG002|NOT COMPLETED|Overall Study||10
10776652|NCT03334422|11938812|FG003|NOT COMPLETED|Overall Study||6
10776653|NCT03334448|11938827|FG000|STARTED|Period 1||12
10776654|NCT03334448|11938828|FG001|STARTED|Period 1||12
10776655|NCT03334448|11938829|FG002|STARTED|Period 1||13
10776656|NCT03334448|11938830|FG003|STARTED|Period 1||12
10776657|NCT03334448|11938827|FG000|Received at Least 1 Dose of Study Drug|Period 1||12
10776658|NCT03334448|11938828|FG001|Received at Least 1 Dose of Study Drug|Period 1||12
10776659|NCT03334448|11938829|FG002|Received at Least 1 Dose of Study Drug|Period 1||13
10776660|NCT03334448|11938830|FG003|Received at Least 1 Dose of Study Drug|Period 1||12
10776661|NCT03334448|11938827|FG000|COMPLETED|Period 1||12
10776662|NCT03334448|11938828|FG001|COMPLETED|Period 1||12
10776663|NCT03334448|11938829|FG002|COMPLETED|Period 1||13
10776664|NCT03334448|11938830|FG003|COMPLETED|Period 1||12
10776665|NCT03334448|11938827|FG000|NOT COMPLETED|Period 1||0
10776666|NCT03334448|11938828|FG001|NOT COMPLETED|Period 1||0
10776667|NCT03334448|11938829|FG002|NOT COMPLETED|Period 1||0
10776668|NCT03334448|11938830|FG003|NOT COMPLETED|Period 1||0
10776669|NCT03334448|11938827|FG000|STARTED|Washout||12
10776670|NCT03334448|11938828|FG001|STARTED|Washout||12
10776671|NCT03334448|11938829|FG002|STARTED|Washout||13
10776672|NCT03334448|11938830|FG003|STARTED|Washout||12
10776673|NCT03334448|11938827|FG000|COMPLETED|Washout||12
10776674|NCT03334448|11938828|FG001|COMPLETED|Washout||12
10776675|NCT03334448|11938829|FG002|COMPLETED|Washout||13
10776676|NCT03334448|11938830|FG003|COMPLETED|Washout||12
10776677|NCT03334448|11938827|FG000|NOT COMPLETED|Washout||0
10776678|NCT03334448|11938828|FG001|NOT COMPLETED|Washout||0
10776679|NCT03334448|11938829|FG002|NOT COMPLETED|Washout||0
10776680|NCT03334448|11938830|FG003|NOT COMPLETED|Washout||0
10776681|NCT03334448|11938827|FG000|STARTED|Period 2||12
10776682|NCT03334448|11938828|FG001|STARTED|Period 2||12
10776683|NCT03334448|11938829|FG002|STARTED|Period 2||13
10776684|NCT03334448|11938830|FG003|STARTED|Period 2||12
10776685|NCT03334448|11938827|FG000|Received at Least 1 Dose of Study Drug|Period 2||12
10776686|NCT03334448|11938828|FG001|Received at Least 1 Dose of Study Drug|Period 2||12
10776687|NCT03334448|11938829|FG002|Received at Least 1 Dose of Study Drug|Period 2||13
10776688|NCT03334448|11938830|FG003|Received at Least 1 Dose of Study Drug|Period 2||12
10776689|NCT03334448|11938827|FG000|COMPLETED|Period 2||12
10776690|NCT03334448|11938828|FG001|COMPLETED|Period 2||12
10776691|NCT03334448|11938829|FG002|COMPLETED|Period 2||13
10776692|NCT03334448|11938830|FG003|COMPLETED|Period 2||12
10776693|NCT03334448|11938827|FG000|NOT COMPLETED|Period 2||0
10776694|NCT03334448|11938828|FG001|NOT COMPLETED|Period 2||0
10776695|NCT03334448|11938829|FG002|NOT COMPLETED|Period 2||0
10776696|NCT03334448|11938830|FG003|NOT COMPLETED|Period 2||0
10776697|NCT03334448|11938827|FG000|STARTED|Washout||12
10776698|NCT03334448|11938828|FG001|STARTED|Washout||12
10776699|NCT03334448|11938829|FG002|STARTED|Washout||13
10776700|NCT03334448|11938830|FG003|STARTED|Washout||12
10776701|NCT03334448|11938827|FG000|COMPLETED|Washout||12
10776702|NCT03334448|11938828|FG001|COMPLETED|Washout||11
10776703|NCT03334448|11938829|FG002|COMPLETED|Washout||13
10776704|NCT03334448|11938830|FG003|COMPLETED|Washout||12
10776705|NCT03334448|11938827|FG000|NOT COMPLETED|Washout||0
10776706|NCT03334448|11938828|FG001|NOT COMPLETED|Washout||1
10776707|NCT03334448|11938829|FG002|NOT COMPLETED|Washout||0
10776708|NCT03334448|11938830|FG003|NOT COMPLETED|Washout||0
10776709|NCT03334448|11938827|FG000|STARTED|Period 3||12
10776710|NCT03334448|11938828|FG001|STARTED|Period 3||11
10776711|NCT03334448|11938829|FG002|STARTED|Period 3||13
10776712|NCT03334448|11938830|FG003|STARTED|Period 3||12
10776713|NCT03334448|11938827|FG000|Received at Least 1 Dose of Study Drug|Period 3||12
10776714|NCT03334448|11938828|FG001|Received at Least 1 Dose of Study Drug|Period 3||11
10776715|NCT03334448|11938829|FG002|Received at Least 1 Dose of Study Drug|Period 3||13
10776716|NCT03334448|11938830|FG003|Received at Least 1 Dose of Study Drug|Period 3||12
10776717|NCT03334448|11938827|FG000|COMPLETED|Period 3||12
10776718|NCT03334448|11938828|FG001|COMPLETED|Period 3||11
10776719|NCT03334448|11938829|FG002|COMPLETED|Period 3||13
10776720|NCT03334448|11938830|FG003|COMPLETED|Period 3||12
10776721|NCT03334448|11938827|FG000|NOT COMPLETED|Period 3||0
10776722|NCT03334448|11938828|FG001|NOT COMPLETED|Period 3||0
10776723|NCT03334448|11938829|FG002|NOT COMPLETED|Period 3||0
10776724|NCT03334448|11938830|FG003|NOT COMPLETED|Period 3||0
10776725|NCT03334448|11938827|FG000|STARTED|Washout||12
10776726|NCT03334448|11938828|FG001|STARTED|Washout||11
10776727|NCT03334448|11938829|FG002|STARTED|Washout||13
10776728|NCT03334448|11938830|FG003|STARTED|Washout||12
10776729|NCT03334448|11938827|FG000|COMPLETED|Washout||12
10776730|NCT03334448|11938828|FG001|COMPLETED|Washout||11
10776731|NCT03334448|11938829|FG002|COMPLETED|Washout||13
10776732|NCT03334448|11938830|FG003|COMPLETED|Washout||11
10776733|NCT03334448|11938827|FG000|NOT COMPLETED|Washout||0
10776734|NCT03334448|11938828|FG001|NOT COMPLETED|Washout||0
10776735|NCT03334448|11938829|FG002|NOT COMPLETED|Washout||0
10776736|NCT03334448|11938830|FG003|NOT COMPLETED|Washout||1
10776737|NCT03334448|11938827|FG000|STARTED|Period 4||12
10776738|NCT03334448|11938828|FG001|STARTED|Period 4||11
10776739|NCT03334448|11938829|FG002|STARTED|Period 4||13
10776740|NCT03334448|11938830|FG003|STARTED|Period 4||11
10776741|NCT03334448|11938827|FG000|Received at Least 1 Dose of Study Drug|Period 4||12
10776742|NCT03334448|11938828|FG001|Received at Least 1 Dose of Study Drug|Period 4||11
10776743|NCT03334448|11938829|FG002|Received at Least 1 Dose of Study Drug|Period 4||13
10776744|NCT03334448|11938830|FG003|Received at Least 1 Dose of Study Drug|Period 4||11
10776745|NCT03334448|11938827|FG000|COMPLETED|Period 4||12
10776746|NCT03334448|11938828|FG001|COMPLETED|Period 4||11
10776747|NCT03334448|11938829|FG002|COMPLETED|Period 4||13
10776748|NCT03334448|11938830|FG003|COMPLETED|Period 4||11
10776749|NCT03334448|11938827|FG000|NOT COMPLETED|Period 4||0
10776750|NCT03334448|11938828|FG001|NOT COMPLETED|Period 4||0
10776751|NCT03334448|11938829|FG002|NOT COMPLETED|Period 4||0
10776752|NCT03334448|11938830|FG003|NOT COMPLETED|Period 4||0
10776753|NCT03334630|11938838|FG000|STARTED|Overall Study||239
10776754|NCT03334630|11938839|FG001|STARTED|Overall Study||243
10776755|NCT03334630|11938838|FG000|COMPLETED|Overall Study||225
10776756|NCT03334630|11938839|FG001|COMPLETED|Overall Study||230
10776757|NCT03334630|11938838|FG000|NOT COMPLETED|Overall Study||14
10776758|NCT03334630|11938839|FG001|NOT COMPLETED|Overall Study||13
10776759|NCT03334695|11938847|FG000|STARTED|Overall Study||31
10776760|NCT03334695|11938848|FG001|STARTED|Overall Study||32
10776761|NCT03334695|11938847|FG000|COMPLETED|Overall Study||27
10776762|NCT03334695|11938848|FG001|COMPLETED|Overall Study||26
10776763|NCT03334695|11938847|FG000|NOT COMPLETED|Overall Study||4
10776764|NCT03334695|11938848|FG001|NOT COMPLETED|Overall Study||6
10776765|NCT03334721|11938858|FG000|STARTED|Overall Study||12
10776766|NCT03334721|11938859|FG001|STARTED|Overall Study||11
10776767|NCT03334721|11938858|FG000|COMPLETED|Overall Study||10
10776768|NCT03334721|11938859|FG001|COMPLETED|Overall Study||11
10776769|NCT03334721|11938858|FG000|NOT COMPLETED|Overall Study||2
10776770|NCT03334721|11938859|FG001|NOT COMPLETED|Overall Study||0
10776771|NCT03334734|11938869|FG000|STARTED|Overall Study||4
10776772|NCT03334734|11938870|FG001|STARTED|Overall Study||4
10776773|NCT03334734|11938871|FG002|STARTED|Overall Study||7
10776774|NCT03334734|11938872|FG003|STARTED|Overall Study||1
10776775|NCT03334734|11938869|FG000|COMPLETED|Overall Study||4
10776776|NCT03334734|11938870|FG001|COMPLETED|Overall Study||4
10776777|NCT03334734|11938871|FG002|COMPLETED|Overall Study||5
10776778|NCT03334734|11938872|FG003|COMPLETED|Overall Study||1
10776779|NCT03334734|11938869|FG000|NOT COMPLETED|Overall Study||0
10776780|NCT03334734|11938870|FG001|NOT COMPLETED|Overall Study||0
10776781|NCT03334734|11938871|FG002|NOT COMPLETED|Overall Study||2
10776782|NCT03334734|11938872|FG003|NOT COMPLETED|Overall Study||0
10776783|NCT03334747|11938891|FG000|STARTED|Treatment Phase||10
10776784|NCT03334747|11938892|FG001|STARTED|Treatment Phase||10
10776785|NCT03334747|11938893|FG002|STARTED|Treatment Phase||12
10776786|NCT03334747|11938894|FG003|STARTED|Treatment Phase||20
10776787|NCT03334747|11938895|FG004|STARTED|Treatment Phase||22
10776788|NCT03334747|11938896|FG005|STARTED|Treatment Phase||20
10776789|NCT03334747|11938897|FG006|STARTED|Treatment Phase||21
10776790|NCT03334747|11938898|FG007|STARTED|Treatment Phase||22
10776791|NCT03334747|11938899|FG008|STARTED|Treatment Phase||51
10776792|NCT03334747|11938891|FG000|COMPLETED|Treatment Phase||9
10776793|NCT03334747|11938892|FG001|COMPLETED|Treatment Phase||10
10776794|NCT03334747|11938893|FG002|COMPLETED|Treatment Phase||12
10776795|NCT03334747|11938894|FG003|COMPLETED|Treatment Phase||20
10776796|NCT03334747|11938895|FG004|COMPLETED|Treatment Phase||21
10776797|NCT03334747|11938896|FG005|COMPLETED|Treatment Phase||19
10776798|NCT03334747|11938897|FG006|COMPLETED|Treatment Phase||21
10776799|NCT03334747|11938898|FG007|COMPLETED|Treatment Phase||22
10776800|NCT03334747|11938899|FG008|COMPLETED|Treatment Phase||51
10776801|NCT03334747|11938891|FG000|NOT COMPLETED|Treatment Phase||1
10776802|NCT03334747|11938892|FG001|NOT COMPLETED|Treatment Phase||0
10776803|NCT03334747|11938893|FG002|NOT COMPLETED|Treatment Phase||0
10776804|NCT03334747|11938894|FG003|NOT COMPLETED|Treatment Phase||0
10776805|NCT03334747|11938895|FG004|NOT COMPLETED|Treatment Phase||1
10776806|NCT03334747|11938896|FG005|NOT COMPLETED|Treatment Phase||1
10776807|NCT03334747|11938897|FG006|NOT COMPLETED|Treatment Phase||0
10776808|NCT03334747|11938898|FG007|NOT COMPLETED|Treatment Phase||0
10776809|NCT03334747|11938899|FG008|NOT COMPLETED|Treatment Phase||0
10776810|NCT03334747|11938891|FG000|STARTED|Follow-Up Phase||9
10776811|NCT03334747|11938892|FG001|STARTED|Follow-Up Phase||10
10776812|NCT03334747|11938893|FG002|STARTED|Follow-Up Phase||12
10776813|NCT03334747|11938894|FG003|STARTED|Follow-Up Phase||20
10776814|NCT03334747|11938895|FG004|STARTED|Follow-Up Phase||21
10776815|NCT03334747|11938896|FG005|STARTED|Follow-Up Phase||19
10776816|NCT03334747|11938897|FG006|STARTED|Follow-Up Phase||21
10776817|NCT03334747|11938898|FG007|STARTED|Follow-Up Phase||22
10776818|NCT03334747|11938899|FG008|STARTED|Follow-Up Phase||51
10776819|NCT03334747|11938891|FG000|COMPLETED|Follow-Up Phase||9
10776820|NCT03334747|11938892|FG001|COMPLETED|Follow-Up Phase||10
10776821|NCT03334747|11938893|FG002|COMPLETED|Follow-Up Phase||12
10776822|NCT03334747|11938894|FG003|COMPLETED|Follow-Up Phase||20
10776823|NCT03334747|11938895|FG004|COMPLETED|Follow-Up Phase||21
10776824|NCT03334747|11938896|FG005|COMPLETED|Follow-Up Phase||19
10776825|NCT03334747|11938897|FG006|COMPLETED|Follow-Up Phase||20
10776826|NCT03334747|11938898|FG007|COMPLETED|Follow-Up Phase||22
10776827|NCT03334747|11938899|FG008|COMPLETED|Follow-Up Phase||50
10776828|NCT03334747|11938891|FG000|NOT COMPLETED|Follow-Up Phase||0
10776829|NCT03334747|11938892|FG001|NOT COMPLETED|Follow-Up Phase||0
10776830|NCT03334747|11938893|FG002|NOT COMPLETED|Follow-Up Phase||0
10776831|NCT03334747|11938894|FG003|NOT COMPLETED|Follow-Up Phase||0
10776832|NCT03334747|11938895|FG004|NOT COMPLETED|Follow-Up Phase||0
10776833|NCT03334747|11938896|FG005|NOT COMPLETED|Follow-Up Phase||0
10776834|NCT03334747|11938897|FG006|NOT COMPLETED|Follow-Up Phase||1
10776835|NCT03334747|11938898|FG007|NOT COMPLETED|Follow-Up Phase||0
10776836|NCT03334747|11938899|FG008|NOT COMPLETED|Follow-Up Phase||1
10776837|NCT03334812|11938921|FG000|STARTED|Overall Study||9
10776838|NCT03334812|11938922|FG001|STARTED|Overall Study||5
10776839|NCT03334812|11938923|FG002|STARTED|Overall Study||0
10776840|NCT03334812|11938924|FG003|STARTED|Overall Study||0
10776841|NCT03334812|11938921|FG000|COMPLETED|Overall Study||9
10776842|NCT03334812|11938922|FG001|COMPLETED|Overall Study||5
10776843|NCT03334812|11938923|FG002|COMPLETED|Overall Study||0
10776844|NCT03334812|11938924|FG003|COMPLETED|Overall Study||0
10776845|NCT03334812|11938921|FG000|NOT COMPLETED|Overall Study||0
10776846|NCT03334812|11938922|FG001|NOT COMPLETED|Overall Study||0
10776847|NCT03334812|11938923|FG002|NOT COMPLETED|Overall Study||0
10776848|NCT03334812|11938924|FG003|NOT COMPLETED|Overall Study||0
10776849|NCT03334825|11938932|FG000|STARTED|Overall Study||119
10776850|NCT03334825|11938933|FG001|STARTED|Overall Study||117
10776851|NCT03334825|11938932|FG000|COMPLETED|Overall Study||112
10776852|NCT03334825|11938933|FG001|COMPLETED|Overall Study||113
10776853|NCT03334825|11938932|FG000|NOT COMPLETED|Overall Study||7
10776854|NCT03334825|11938933|FG001|NOT COMPLETED|Overall Study||4
10776855|NCT03334903|11938941|FG000|STARTED|Overall Study||39
10776856|NCT03334903|11938942|FG001|STARTED|Overall Study||38
10776857|NCT03334903|11938941|FG000|COMPLETED|Overall Study||35
10776858|NCT03334903|11938942|FG001|COMPLETED|Overall Study||33
10776859|NCT03334903|11938941|FG000|NOT COMPLETED|Overall Study||4
10776860|NCT03334903|11938942|FG001|NOT COMPLETED|Overall Study||5
10776861|NCT03335150|11938950|FG000|STARTED|Overall Study||55
10776862|NCT03335150|11938951|FG001|STARTED|Overall Study||55
10776863|NCT03335150|11938950|FG000|Enrolled + Assigned Group|Overall Study||54
10776864|NCT03335150|11938951|FG001|Enrolled + Assigned Group|Overall Study||55
10776865|NCT03335150|11938950|FG000|PRE Testing Session|Overall Study||53
10776866|NCT03335150|11938951|FG001|PRE Testing Session|Overall Study||55
10776867|NCT03335150|11938950|FG000|Commenced Group|Overall Study||47
10776868|NCT03335150|11938951|FG001|Commenced Group|Overall Study||52
10776869|NCT03335150|11938950|FG000|POST Testing Session|Overall Study||45
10776870|NCT03335150|11938951|FG001|POST Testing Session|Overall Study||50
10776871|NCT03335150|11938950|FG000|COMPLETED|Overall Study||45
10776872|NCT03335150|11938951|FG001|COMPLETED|Overall Study||50
10776873|NCT03335150|11938950|FG000|NOT COMPLETED|Overall Study||10
10776874|NCT03335150|11938951|FG001|NOT COMPLETED|Overall Study||5
10776875|NCT03335254|11938977|FG000|STARTED|Period 1||9
10776876|NCT03335254|11938978|FG001|STARTED|Period 1||0
10776877|NCT03335254|11938979|FG002|STARTED|Period 1||0
10776878|NCT03335254|11938980|FG003|STARTED|Period 1||0
10776879|NCT03335254|11938981|FG004|STARTED|Period 1||0
10776880|NCT03335254|11938982|FG005|STARTED|Period 1||0
10776881|NCT03335254|11938983|FG006|STARTED|Period 1||0
10776882|NCT03335254|11938984|FG007|STARTED|Period 1||0
10776883|NCT03335254|11938985|FG008|STARTED|Period 1||0
10776884|NCT03335254|11938986|FG009|STARTED|Period 1||0
10776885|NCT03335254|11938987|FG010|STARTED|Period 1||0
10776886|NCT03335254|11938988|FG011|STARTED|Period 1||0
10776887|NCT03335254|11938989|FG012|STARTED|Period 1||0
10776888|NCT03335254|11938990|FG013|STARTED|Period 1||0
10776889|NCT03335254|11938991|FG014|STARTED|Period 1||0
10776890|NCT03335254|11938992|FG015|STARTED|Period 1||0
10776891|NCT03335254|11938993|FG016|STARTED|Period 1||0
10776892|NCT03335254|11938994|FG017|STARTED|Period 1||0
10776893|NCT03335254|11938995|FG018|STARTED|Period 1||0
10776894|NCT03335254|11938996|FG019|STARTED|Period 1||0
10776895|NCT03335254|11938977|FG000|COMPLETED|Period 1||9
10776896|NCT03335254|11938978|FG001|COMPLETED|Period 1||0
10776897|NCT03335254|11938979|FG002|COMPLETED|Period 1||0
10776898|NCT03335254|11938980|FG003|COMPLETED|Period 1||0
10776899|NCT03335254|11938981|FG004|COMPLETED|Period 1||0
10776900|NCT03335254|11938982|FG005|COMPLETED|Period 1||0
10776901|NCT03335254|11938983|FG006|COMPLETED|Period 1||0
10776902|NCT03335254|11938984|FG007|COMPLETED|Period 1||0
10776903|NCT03335254|11938985|FG008|COMPLETED|Period 1||0
10776904|NCT03335254|11938986|FG009|COMPLETED|Period 1||0
10776905|NCT03335254|11938987|FG010|COMPLETED|Period 1||0
10776906|NCT03335254|11938988|FG011|COMPLETED|Period 1||0
10776907|NCT03335254|11938989|FG012|COMPLETED|Period 1||0
10776908|NCT03335254|11938990|FG013|COMPLETED|Period 1||0
10776909|NCT03335254|11938991|FG014|COMPLETED|Period 1||0
10776910|NCT03335254|11938992|FG015|COMPLETED|Period 1||0
10776911|NCT03335254|11938993|FG016|COMPLETED|Period 1||0
10776912|NCT03335254|11938994|FG017|COMPLETED|Period 1||0
10776913|NCT03335254|11938995|FG018|COMPLETED|Period 1||0
10776914|NCT03335254|11938996|FG019|COMPLETED|Period 1||0
10776915|NCT03335254|11938977|FG000|NOT COMPLETED|Period 1||0
10776916|NCT03335254|11938978|FG001|NOT COMPLETED|Period 1||0
10776917|NCT03335254|11938979|FG002|NOT COMPLETED|Period 1||0
10776918|NCT03335254|11938980|FG003|NOT COMPLETED|Period 1||0
10776919|NCT03335254|11938981|FG004|NOT COMPLETED|Period 1||0
10776920|NCT03335254|11938982|FG005|NOT COMPLETED|Period 1||0
10776921|NCT03335254|11938983|FG006|NOT COMPLETED|Period 1||0
10776922|NCT03335254|11938984|FG007|NOT COMPLETED|Period 1||0
10776923|NCT03335254|11938985|FG008|NOT COMPLETED|Period 1||0
10776924|NCT03335254|11938986|FG009|NOT COMPLETED|Period 1||0
10776925|NCT03335254|11938987|FG010|NOT COMPLETED|Period 1||0
10776926|NCT03335254|11938988|FG011|NOT COMPLETED|Period 1||0
10776927|NCT03335254|11938989|FG012|NOT COMPLETED|Period 1||0
10776928|NCT03335254|11938990|FG013|NOT COMPLETED|Period 1||0
10776929|NCT03335254|11938991|FG014|NOT COMPLETED|Period 1||0
10776930|NCT03335254|11938992|FG015|NOT COMPLETED|Period 1||0
10776931|NCT03335254|11938993|FG016|NOT COMPLETED|Period 1||0
10776932|NCT03335254|11938994|FG017|NOT COMPLETED|Period 1||0
10776933|NCT03335254|11938995|FG018|NOT COMPLETED|Period 1||0
10776934|NCT03335254|11938996|FG019|NOT COMPLETED|Period 1||0
10776935|NCT03335254|11938977|FG000|STARTED|Period 2, Day 1-15||9
10776936|NCT03335254|11938978|FG001|STARTED|Period 2, Day 1-15||0
10776937|NCT03335254|11938979|FG002|STARTED|Period 2, Day 1-15||0
10776938|NCT03335254|11938980|FG003|STARTED|Period 2, Day 1-15||0
10776939|NCT03335254|11938981|FG004|STARTED|Period 2, Day 1-15||0
10776940|NCT03335254|11938982|FG005|STARTED|Period 2, Day 1-15||0
10776941|NCT03335254|11938983|FG006|STARTED|Period 2, Day 1-15||0
10776942|NCT03335254|11938984|FG007|STARTED|Period 2, Day 1-15||0
10776943|NCT03335254|11938985|FG008|STARTED|Period 2, Day 1-15||0
10776944|NCT03335254|11938986|FG009|STARTED|Period 2, Day 1-15||0
10776945|NCT03335254|11938987|FG010|STARTED|Period 2, Day 1-15||0
10776946|NCT03335254|11938988|FG011|STARTED|Period 2, Day 1-15||0
10776947|NCT03335254|11938989|FG012|STARTED|Period 2, Day 1-15||0
10776948|NCT03335254|11938990|FG013|STARTED|Period 2, Day 1-15||0
10776949|NCT03335254|11938991|FG014|STARTED|Period 2, Day 1-15||0
10776950|NCT03335254|11938992|FG015|STARTED|Period 2, Day 1-15||0
10776951|NCT03335254|11938993|FG016|STARTED|Period 2, Day 1-15||0
10776952|NCT03335254|11938994|FG017|STARTED|Period 2, Day 1-15||0
10776953|NCT03335254|11938995|FG018|STARTED|Period 2, Day 1-15||0
10776954|NCT03335254|11938996|FG019|STARTED|Period 2, Day 1-15||0
10776955|NCT03335254|11938977|FG000|COMPLETED|Period 2, Day 1-15||9
10776956|NCT03335254|11938978|FG001|COMPLETED|Period 2, Day 1-15||0
10776957|NCT03335254|11938979|FG002|COMPLETED|Period 2, Day 1-15||0
10776958|NCT03335254|11938980|FG003|COMPLETED|Period 2, Day 1-15||0
10776959|NCT03335254|11938981|FG004|COMPLETED|Period 2, Day 1-15||0
10776960|NCT03335254|11938982|FG005|COMPLETED|Period 2, Day 1-15||0
10776961|NCT03335254|11938983|FG006|COMPLETED|Period 2, Day 1-15||0
10776962|NCT03335254|11938984|FG007|COMPLETED|Period 2, Day 1-15||0
10776963|NCT03335254|11938985|FG008|COMPLETED|Period 2, Day 1-15||0
10776964|NCT03335254|11938986|FG009|COMPLETED|Period 2, Day 1-15||0
10776965|NCT03335254|11938987|FG010|COMPLETED|Period 2, Day 1-15||0
10776966|NCT03335254|11938988|FG011|COMPLETED|Period 2, Day 1-15||0
10776967|NCT03335254|11938989|FG012|COMPLETED|Period 2, Day 1-15||0
10776968|NCT03335254|11938990|FG013|COMPLETED|Period 2, Day 1-15||0
10776969|NCT03335254|11938991|FG014|COMPLETED|Period 2, Day 1-15||0
10776970|NCT03335254|11938992|FG015|COMPLETED|Period 2, Day 1-15||0
10776971|NCT03335254|11938993|FG016|COMPLETED|Period 2, Day 1-15||0
10776972|NCT03335254|11938994|FG017|COMPLETED|Period 2, Day 1-15||0
10776973|NCT03335254|11938995|FG018|COMPLETED|Period 2, Day 1-15||0
10776974|NCT03335254|11938996|FG019|COMPLETED|Period 2, Day 1-15||0
10776975|NCT03335254|11938977|FG000|NOT COMPLETED|Period 2, Day 1-15||0
10776976|NCT03335254|11938978|FG001|NOT COMPLETED|Period 2, Day 1-15||0
10776977|NCT03335254|11938979|FG002|NOT COMPLETED|Period 2, Day 1-15||0
10776978|NCT03335254|11938980|FG003|NOT COMPLETED|Period 2, Day 1-15||0
10776979|NCT03335254|11938981|FG004|NOT COMPLETED|Period 2, Day 1-15||0
10776980|NCT03335254|11938982|FG005|NOT COMPLETED|Period 2, Day 1-15||0
10776981|NCT03335254|11938983|FG006|NOT COMPLETED|Period 2, Day 1-15||0
10776982|NCT03335254|11938984|FG007|NOT COMPLETED|Period 2, Day 1-15||0
10776983|NCT03335254|11938985|FG008|NOT COMPLETED|Period 2, Day 1-15||0
10776984|NCT03335254|11938986|FG009|NOT COMPLETED|Period 2, Day 1-15||0
10776985|NCT03335254|11938987|FG010|NOT COMPLETED|Period 2, Day 1-15||0
10776986|NCT03335254|11938988|FG011|NOT COMPLETED|Period 2, Day 1-15||0
10776987|NCT03335254|11938989|FG012|NOT COMPLETED|Period 2, Day 1-15||0
10776988|NCT03335254|11938990|FG013|NOT COMPLETED|Period 2, Day 1-15||0
10776989|NCT03335254|11938991|FG014|NOT COMPLETED|Period 2, Day 1-15||0
10776990|NCT03335254|11938992|FG015|NOT COMPLETED|Period 2, Day 1-15||0
10776991|NCT03335254|11938993|FG016|NOT COMPLETED|Period 2, Day 1-15||0
10776992|NCT03335254|11938994|FG017|NOT COMPLETED|Period 2, Day 1-15||0
10776993|NCT03335254|11938995|FG018|NOT COMPLETED|Period 2, Day 1-15||0
10776994|NCT03335254|11938996|FG019|NOT COMPLETED|Period 2, Day 1-15||0
10776995|NCT03335254|11938977|FG000|STARTED|Period 3, Day 16-25||9
10776996|NCT03335254|11938978|FG001|STARTED|Period 3, Day 16-25||0
10776997|NCT03335254|11938979|FG002|STARTED|Period 3, Day 16-25||0
10776998|NCT03335254|11938980|FG003|STARTED|Period 3, Day 16-25||0
10776999|NCT03335254|11938981|FG004|STARTED|Period 3, Day 16-25||0
10777000|NCT03335254|11938982|FG005|STARTED|Period 3, Day 16-25||0
10777001|NCT03335254|11938983|FG006|STARTED|Period 3, Day 16-25||0
10777002|NCT03335254|11938984|FG007|STARTED|Period 3, Day 16-25||0
10777003|NCT03335254|11938985|FG008|STARTED|Period 3, Day 16-25||0
10777004|NCT03335254|11938986|FG009|STARTED|Period 3, Day 16-25||0
10777005|NCT03335254|11938987|FG010|STARTED|Period 3, Day 16-25||0
10777006|NCT03335254|11938988|FG011|STARTED|Period 3, Day 16-25||0
10777007|NCT03335254|11938989|FG012|STARTED|Period 3, Day 16-25||0
10777008|NCT03335254|11938990|FG013|STARTED|Period 3, Day 16-25||0
10777009|NCT03335254|11938991|FG014|STARTED|Period 3, Day 16-25||0
10777010|NCT03335254|11938992|FG015|STARTED|Period 3, Day 16-25||0
10777011|NCT03335254|11938993|FG016|STARTED|Period 3, Day 16-25||0
10777012|NCT03335254|11938994|FG017|STARTED|Period 3, Day 16-25||0
10777013|NCT03335254|11938995|FG018|STARTED|Period 3, Day 16-25||0
10777014|NCT03335254|11938996|FG019|STARTED|Period 3, Day 16-25||0
10777015|NCT03335254|11938977|FG000|COMPLETED|Period 3, Day 16-25||9
10777016|NCT03335254|11938978|FG001|COMPLETED|Period 3, Day 16-25||0
10777017|NCT03335254|11938979|FG002|COMPLETED|Period 3, Day 16-25||0
10777018|NCT03335254|11938980|FG003|COMPLETED|Period 3, Day 16-25||0
10777019|NCT03335254|11938981|FG004|COMPLETED|Period 3, Day 16-25||0
10777020|NCT03335254|11938982|FG005|COMPLETED|Period 3, Day 16-25||0
10777021|NCT03335254|11938983|FG006|COMPLETED|Period 3, Day 16-25||0
10777022|NCT03335254|11938984|FG007|COMPLETED|Period 3, Day 16-25||0
10777023|NCT03335254|11938985|FG008|COMPLETED|Period 3, Day 16-25||0
10777024|NCT03335254|11938986|FG009|COMPLETED|Period 3, Day 16-25||0
10777025|NCT03335254|11938987|FG010|COMPLETED|Period 3, Day 16-25||0
10777026|NCT03335254|11938988|FG011|COMPLETED|Period 3, Day 16-25||0
10777027|NCT03335254|11938989|FG012|COMPLETED|Period 3, Day 16-25||0
10777028|NCT03335254|11938990|FG013|COMPLETED|Period 3, Day 16-25||0
10777029|NCT03335254|11938991|FG014|COMPLETED|Period 3, Day 16-25||0
10777030|NCT03335254|11938992|FG015|COMPLETED|Period 3, Day 16-25||0
10777031|NCT03335254|11938993|FG016|COMPLETED|Period 3, Day 16-25||0
10777032|NCT03335254|11938994|FG017|COMPLETED|Period 3, Day 16-25||0
10777033|NCT03335254|11938995|FG018|COMPLETED|Period 3, Day 16-25||0
10777034|NCT03335254|11938996|FG019|COMPLETED|Period 3, Day 16-25||0
10777035|NCT03335254|11938977|FG000|NOT COMPLETED|Period 3, Day 16-25||0
10777036|NCT03335254|11938978|FG001|NOT COMPLETED|Period 3, Day 16-25||0
10777037|NCT03335254|11938979|FG002|NOT COMPLETED|Period 3, Day 16-25||0
10777038|NCT03335254|11938980|FG003|NOT COMPLETED|Period 3, Day 16-25||0
10777039|NCT03335254|11938981|FG004|NOT COMPLETED|Period 3, Day 16-25||0
10777040|NCT03335254|11938982|FG005|NOT COMPLETED|Period 3, Day 16-25||0
10777041|NCT03335254|11938983|FG006|NOT COMPLETED|Period 3, Day 16-25||0
10777042|NCT03335254|11938984|FG007|NOT COMPLETED|Period 3, Day 16-25||0
10777043|NCT03335254|11938985|FG008|NOT COMPLETED|Period 3, Day 16-25||0
10777044|NCT03335254|11938986|FG009|NOT COMPLETED|Period 3, Day 16-25||0
10777045|NCT03335254|11938987|FG010|NOT COMPLETED|Period 3, Day 16-25||0
10777046|NCT03335254|11938988|FG011|NOT COMPLETED|Period 3, Day 16-25||0
10777047|NCT03335254|11938989|FG012|NOT COMPLETED|Period 3, Day 16-25||0
10777048|NCT03335254|11938990|FG013|NOT COMPLETED|Period 3, Day 16-25||0
10777049|NCT03335254|11938991|FG014|NOT COMPLETED|Period 3, Day 16-25||0
10777050|NCT03335254|11938992|FG015|NOT COMPLETED|Period 3, Day 16-25||0
10777051|NCT03335254|11938993|FG016|NOT COMPLETED|Period 3, Day 16-25||0
10777052|NCT03335254|11938994|FG017|NOT COMPLETED|Period 3, Day 16-25||0
10777053|NCT03335254|11938995|FG018|NOT COMPLETED|Period 3, Day 16-25||0
10777054|NCT03335254|11938996|FG019|NOT COMPLETED|Period 3, Day 16-25||0
10777055|NCT03335254|11938977|FG000|STARTED|Period 3, Day 26-30||9
10777056|NCT03335254|11938978|FG001|STARTED|Period 3, Day 26-30||0
10777057|NCT03335254|11938979|FG002|STARTED|Period 3, Day 26-30||0
10777058|NCT03335254|11938980|FG003|STARTED|Period 3, Day 26-30||0
10777059|NCT03335254|11938981|FG004|STARTED|Period 3, Day 26-30||0
10777060|NCT03335254|11938982|FG005|STARTED|Period 3, Day 26-30||0
10777061|NCT03335254|11938983|FG006|STARTED|Period 3, Day 26-30||0
10777062|NCT03335254|11938984|FG007|STARTED|Period 3, Day 26-30||0
10777063|NCT03335254|11938985|FG008|STARTED|Period 3, Day 26-30||0
10777064|NCT03335254|11938986|FG009|STARTED|Period 3, Day 26-30||0
10777065|NCT03335254|11938987|FG010|STARTED|Period 3, Day 26-30||0
10777066|NCT03335254|11938988|FG011|STARTED|Period 3, Day 26-30||0
10777067|NCT03335254|11938989|FG012|STARTED|Period 3, Day 26-30||0
10777068|NCT03335254|11938990|FG013|STARTED|Period 3, Day 26-30||0
10777069|NCT03335254|11938991|FG014|STARTED|Period 3, Day 26-30||0
10777070|NCT03335254|11938992|FG015|STARTED|Period 3, Day 26-30||0
10777071|NCT03335254|11938993|FG016|STARTED|Period 3, Day 26-30||0
10777072|NCT03335254|11938994|FG017|STARTED|Period 3, Day 26-30||0
10777073|NCT03335254|11938995|FG018|STARTED|Period 3, Day 26-30||0
10777074|NCT03335254|11938996|FG019|STARTED|Period 3, Day 26-30||0
10777075|NCT03335254|11938977|FG000|COMPLETED|Period 3, Day 26-30||9
10777076|NCT03335254|11938978|FG001|COMPLETED|Period 3, Day 26-30||0
10777077|NCT03335254|11938979|FG002|COMPLETED|Period 3, Day 26-30||0
10777078|NCT03335254|11938980|FG003|COMPLETED|Period 3, Day 26-30||0
10777079|NCT03335254|11938981|FG004|COMPLETED|Period 3, Day 26-30||0
10777080|NCT03335254|11938982|FG005|COMPLETED|Period 3, Day 26-30||0
10777081|NCT03335254|11938983|FG006|COMPLETED|Period 3, Day 26-30||0
10777082|NCT03335254|11938984|FG007|COMPLETED|Period 3, Day 26-30||0
10777083|NCT03335254|11938985|FG008|COMPLETED|Period 3, Day 26-30||0
10777084|NCT03335254|11938986|FG009|COMPLETED|Period 3, Day 26-30||0
10777085|NCT03335254|11938987|FG010|COMPLETED|Period 3, Day 26-30||0
10777086|NCT03335254|11938988|FG011|COMPLETED|Period 3, Day 26-30||0
10777087|NCT03335254|11938989|FG012|COMPLETED|Period 3, Day 26-30||0
10777088|NCT03335254|11938990|FG013|COMPLETED|Period 3, Day 26-30||0
10777089|NCT03335254|11938991|FG014|COMPLETED|Period 3, Day 26-30||0
10777090|NCT03335254|11938992|FG015|COMPLETED|Period 3, Day 26-30||0
10777091|NCT03335254|11938993|FG016|COMPLETED|Period 3, Day 26-30||0
10777092|NCT03335254|11938994|FG017|COMPLETED|Period 3, Day 26-30||0
10777093|NCT03335254|11938995|FG018|COMPLETED|Period 3, Day 26-30||0
10777094|NCT03335254|11938996|FG019|COMPLETED|Period 3, Day 26-30||0
10777095|NCT03335254|11938977|FG000|NOT COMPLETED|Period 3, Day 26-30||0
10777096|NCT03335254|11938978|FG001|NOT COMPLETED|Period 3, Day 26-30||0
10777097|NCT03335254|11938979|FG002|NOT COMPLETED|Period 3, Day 26-30||0
10777098|NCT03335254|11938980|FG003|NOT COMPLETED|Period 3, Day 26-30||0
10777099|NCT03335254|11938981|FG004|NOT COMPLETED|Period 3, Day 26-30||0
10777100|NCT03335254|11938982|FG005|NOT COMPLETED|Period 3, Day 26-30||0
10777101|NCT03335254|11938983|FG006|NOT COMPLETED|Period 3, Day 26-30||0
10777102|NCT03335254|11938984|FG007|NOT COMPLETED|Period 3, Day 26-30||0
10777103|NCT03335254|11938985|FG008|NOT COMPLETED|Period 3, Day 26-30||0
10777104|NCT03335254|11938986|FG009|NOT COMPLETED|Period 3, Day 26-30||0
10777105|NCT03335254|11938987|FG010|NOT COMPLETED|Period 3, Day 26-30||0
10777106|NCT03335254|11938988|FG011|NOT COMPLETED|Period 3, Day 26-30||0
10777107|NCT03335254|11938989|FG012|NOT COMPLETED|Period 3, Day 26-30||0
10777108|NCT03335254|11938990|FG013|NOT COMPLETED|Period 3, Day 26-30||0
10777109|NCT03335254|11938991|FG014|NOT COMPLETED|Period 3, Day 26-30||0
10777110|NCT03335254|11938992|FG015|NOT COMPLETED|Period 3, Day 26-30||0
10777111|NCT03335254|11938993|FG016|NOT COMPLETED|Period 3, Day 26-30||0
10777112|NCT03335254|11938994|FG017|NOT COMPLETED|Period 3, Day 26-30||0
10777113|NCT03335254|11938995|FG018|NOT COMPLETED|Period 3, Day 26-30||0
10777114|NCT03335254|11938996|FG019|NOT COMPLETED|Period 3, Day 26-30||0
10777115|NCT03335566|11939027|FG000|STARTED|Overall Study||218
10777116|NCT03335566|11939028|FG001|STARTED|Overall Study||206
10777117|NCT03335566|11939027|FG000|COMPLETED|Overall Study||214
10777118|NCT03335566|11939028|FG001|COMPLETED|Overall Study||203
10777119|NCT03335566|11939027|FG000|NOT COMPLETED|Overall Study||4
10777120|NCT03335566|11939028|FG001|NOT COMPLETED|Overall Study||3
10777121|NCT03335761|11939037|FG000|STARTED|Overall Study||19
10777122|NCT03335761|11939038|FG001|STARTED|Overall Study||14
10777123|NCT03335761|11939039|FG002|STARTED|Overall Study||15
10777124|NCT03335761|11939037|FG000|Implanted With a Neurostimulator Device|Overall Study||18
10777125|NCT03335761|11939038|FG001|Implanted With a Neurostimulator Device|Overall Study||14
10777126|NCT03335761|11939039|FG002|Implanted With a Neurostimulator Device|Overall Study||14
10777127|NCT03335761|11939037|FG000|COMPLETED|Overall Study||17
10777128|NCT03335761|11939038|FG001|COMPLETED|Overall Study||13
10777129|NCT03335761|11939039|FG002|COMPLETED|Overall Study||13
10777130|NCT03335761|11939037|FG000|NOT COMPLETED|Overall Study||2
10777131|NCT03335761|11939038|FG001|NOT COMPLETED|Overall Study||1
10777132|NCT03335761|11939039|FG002|NOT COMPLETED|Overall Study||2
10777133|NCT03335800|11939047|FG000|STARTED|Overall Study||419927
10777134|NCT03335800|11939047|FG000|Received Irregular Pulse Notification|Overall Study||2161
10777135|NCT03335800|11939047|FG000|Attended First Study Visit|Overall Study||945
10777136|NCT03335800|11939047|FG000|ECG Patch Shipped|Overall Study||658
10777137|NCT03335800|11939047|FG000|ECG Patch Returned for Analysis|Overall Study||450
10777138|NCT03335800|11939047|FG000|Attended Second Study Visit|Overall Study||396
10777139|NCT03335800|11939047|FG000|COMPLETED|Overall Study||396
10777140|NCT03335800|11939047|FG000|NOT COMPLETED|Overall Study||419531
10777141|NCT03336450|11939051|FG000|STARTED|Overall Study||3
10777142|NCT03336450|11939051|FG000|COMPLETED|Overall Study||3
10777143|NCT03336450|11939051|FG000|NOT COMPLETED|Overall Study||0
10777144|NCT03336502|11939057|FG000|STARTED|Overall Study||30
10777145|NCT03336502|11939058|FG001|STARTED|Overall Study||40
10777146|NCT03336502|11939057|FG000|COMPLETED|Overall Study||26
10777147|NCT03336502|11939058|FG001|COMPLETED|Overall Study||31
10777148|NCT03336502|11939057|FG000|NOT COMPLETED|Overall Study||4
10777149|NCT03336502|11939058|FG001|NOT COMPLETED|Overall Study||9
10777150|NCT03336645|11939064|FG000|STARTED|Overall Study||25
10777151|NCT03336645|11939064|FG000|COMPLETED|Overall Study||25
10777152|NCT03336645|11939064|FG000|NOT COMPLETED|Overall Study||0
10777153|NCT03336853|11939070|FG000|STARTED|Overall Study||30
10777154|NCT03336853|11939071|FG001|STARTED|Overall Study||30
10423425|NCT00829439|11568557|FG003|NOT COMPLETED|Overall Study||0
10423426|NCT00829621|11568563|FG000|STARTED|Overall Study||8
10423427|NCT00829621|11568564|FG001|STARTED|Overall Study||12
10423428|NCT00829621|11568563|FG000|COMPLETED|Overall Study||4
10423429|NCT00829621|11568564|FG001|COMPLETED|Overall Study||8
10423430|NCT00829621|11568563|FG000|NOT COMPLETED|Overall Study||4
10423431|NCT00829621|11568564|FG001|NOT COMPLETED|Overall Study||4
10423432|NCT00829738|11568570|FG000|STARTED|Overall Study||4188
10423433|NCT00829738|11568570|FG000|COMPLETED|Overall Study||4180
10423434|NCT00829738|11568570|FG000|NOT COMPLETED|Overall Study||8
10423435|NCT00829829|11568578|FG000|STARTED|Overall Study||80
10423436|NCT00829829|11568579|FG001|STARTED|Overall Study||80
10423437|NCT00829829|11568580|FG002|STARTED|Overall Study||81
10423438|NCT00829829|11568578|FG000|Treated|Overall Study||79
10423439|NCT00829829|11568579|FG001|Treated|Overall Study||80
10423440|NCT00829829|11568580|FG002|Treated|Overall Study||81
10423441|NCT00829829|11568578|FG000|COMPLETED|Overall Study||58
10423442|NCT00829829|11568579|FG001|COMPLETED|Overall Study||64
10423443|NCT00829829|11568580|FG002|COMPLETED|Overall Study||70
10423444|NCT00829829|11568578|FG000|NOT COMPLETED|Overall Study||22
10423445|NCT00829829|11568579|FG001|NOT COMPLETED|Overall Study||16
10423446|NCT00829829|11568580|FG002|NOT COMPLETED|Overall Study||11
10423447|NCT00829933|11568593|FG000|STARTED|Overall Study||135
10423448|NCT00829933|11568594|FG001|STARTED|Overall Study||135
10423449|NCT00829933|11568595|FG002|STARTED|Overall Study||132
10423450|NCT00829933|11568596|FG003|STARTED|Overall Study||134
10423451|NCT00829933|11568593|FG000|Baseline Analysis Population|Overall Study||131
10423452|NCT00829933|11568594|FG001|Baseline Analysis Population|Overall Study||134
10423453|NCT00829933|11568595|FG002|Baseline Analysis Population|Overall Study||131
10423454|NCT00829933|11568596|FG003|Baseline Analysis Population|Overall Study||129
10423455|NCT00829933|11568593|FG000|COMPLETED|Overall Study||121
10423456|NCT00829933|11568594|FG001|COMPLETED|Overall Study||122
10423457|NCT00829933|11568595|FG002|COMPLETED|Overall Study||119
10423458|NCT00829933|11568596|FG003|COMPLETED|Overall Study||120
10423459|NCT00829933|11568593|FG000|NOT COMPLETED|Overall Study||14
10423460|NCT00829933|11568594|FG001|NOT COMPLETED|Overall Study||13
10423461|NCT00829933|11568595|FG002|NOT COMPLETED|Overall Study||13
10423462|NCT00829933|11568596|FG003|NOT COMPLETED|Overall Study||14
10423463|NCT00829985|11568608|FG000|STARTED|Overall Study||28
10423464|NCT00829985|11568609|FG001|STARTED|Overall Study||26
10423465|NCT00829985|11568608|FG000|COMPLETED|Overall Study||19
10423466|NCT00829985|11568609|FG001|COMPLETED|Overall Study||22
10423467|NCT00829985|11568608|FG000|NOT COMPLETED|Overall Study||9
10423468|NCT00829985|11568609|FG001|NOT COMPLETED|Overall Study||4
10423469|NCT00830037|11568617|FG000|STARTED|Overall Study||67
10423470|NCT00830037|11568618|FG001|STARTED|Overall Study||69
10423471|NCT00830037|11568617|FG000|COMPLETED|Overall Study||49
10423472|NCT00830037|11568618|FG001|COMPLETED|Overall Study||50
10423473|NCT00830037|11568617|FG000|NOT COMPLETED|Overall Study||18
10423474|NCT00830037|11568618|FG001|NOT COMPLETED|Overall Study||19
10423475|NCT00830063|11568628|FG000|STARTED|Overall Study||208
10423476|NCT00830063|11568629|FG001|STARTED|Overall Study||208
10423477|NCT00830063|11568630|FG002|STARTED|Overall Study||208
10423478|NCT00830063|11568631|FG003|STARTED|Overall Study||208
10423479|NCT00830063|11568628|FG000|Treated|Overall Study||208
10423480|NCT00830063|11568629|FG001|Treated|Overall Study||206
10423481|NCT00830063|11568630|FG002|Treated|Overall Study||208
10423482|NCT00830063|11568631|FG003|Treated|Overall Study||206
10423483|NCT00830063|11568628|FG000|COMPLETED|Overall Study||8
10423484|NCT00830063|11568629|FG001|COMPLETED|Overall Study||16
10423485|NCT00830063|11568630|FG002|COMPLETED|Overall Study||10
10423486|NCT00830063|11568631|FG003|COMPLETED|Overall Study||13
10423487|NCT00830063|11568628|FG000|NOT COMPLETED|Overall Study||200
10423488|NCT00830063|11568629|FG001|NOT COMPLETED|Overall Study||192
10423489|NCT00830063|11568630|FG002|NOT COMPLETED|Overall Study||198
10423490|NCT00830063|11568631|FG003|NOT COMPLETED|Overall Study||195
10423491|NCT00830076|11568643|FG000|STARTED|Sitagliptin + Placebo Metformin||18
10423492|NCT00830076|11568643|FG000|COMPLETED|Sitagliptin + Placebo Metformin||18
10423493|NCT00830076|11568643|FG000|NOT COMPLETED|Sitagliptin + Placebo Metformin||0
10423494|NCT00830076|11568643|FG000|STARTED|7-day Washout||18
10423495|NCT00830076|11568643|FG000|COMPLETED|7-day Washout||18
10423496|NCT00830076|11568643|FG000|NOT COMPLETED|7-day Washout||0
10423497|NCT00830076|11568643|FG000|STARTED|Metformin + Placebo Sitagliptin||18
10423498|NCT00830076|11568643|FG000|COMPLETED|Metformin + Placebo Sitagliptin||18
10423499|NCT00830076|11568643|FG000|NOT COMPLETED|Metformin + Placebo Sitagliptin||0
10423500|NCT00830076|11568643|FG000|STARTED|7-day Washout||18
10423501|NCT00830076|11568643|FG000|COMPLETED|7-day Washout||18
10423502|NCT00830076|11568643|FG000|NOT COMPLETED|7-day Washout||0
10423503|NCT00830076|11568643|FG000|STARTED|Sitagliptin + Metformin||18
10423504|NCT00830076|11568643|FG000|COMPLETED|Sitagliptin + Metformin||18
10423505|NCT00830076|11568643|FG000|NOT COMPLETED|Sitagliptin + Metformin||0
10423506|NCT00830076|11568643|FG000|STARTED|7-day Washout||18
10423507|NCT00830076|11568643|FG000|COMPLETED|7-day Washout||18
10423508|NCT00830076|11568643|FG000|NOT COMPLETED|7-day Washout||0
10423509|NCT00830076|11568643|FG000|STARTED|Placebo Sitagliptin + Placebo Metformin||18
10423510|NCT00830076|11568643|FG000|COMPLETED|Placebo Sitagliptin + Placebo Metformin||18
10423511|NCT00830076|11568643|FG000|NOT COMPLETED|Placebo Sitagliptin + Placebo Metformin||0
10423512|NCT00830115|11568650|FG000|STARTED|Overall Study||1045
10423513|NCT00830115|11568650|FG000|COMPLETED|Overall Study||1042
10423514|NCT00830115|11568650|FG000|NOT COMPLETED|Overall Study||3
10423515|NCT00830128|11568656|FG000|STARTED|Overall Study||106
10423516|NCT00830128|11568656|FG000|COMPLETED|Overall Study||87
10423517|NCT00830128|11568656|FG000|NOT COMPLETED|Overall Study||19
10423518|NCT00830167|11568662|FG000|STARTED|Overall Study|Treated|248
10423519|NCT00830167|11568663|FG001|STARTED|Overall Study|Treated|250
10423520|NCT00830167|11568662|FG000|COMPLETED|Overall Study||208
10423521|NCT00830167|11568663|FG001|COMPLETED|Overall Study||207
10423522|NCT00830167|11568662|FG000|NOT COMPLETED|Overall Study||40
10423523|NCT00830167|11568663|FG001|NOT COMPLETED|Overall Study||43
10423524|NCT00830180|11568669|FG000|STARTED|Overall Study||41
10423525|NCT00830180|11568669|FG000|Received Tanezumab in Parent Study A4091003|Overall Study||19
10423526|NCT00830180|11568669|FG000|Received Placebo in Parent Study A4091003|Overall Study||22
10423527|NCT00830180|11568669|FG000|COMPLETED|Overall Study||15
10423528|NCT00830180|11568669|FG000|NOT COMPLETED|Overall Study||26
10423529|NCT00830232|11568677|FG000|STARTED|Overall Study||20
10423530|NCT00830232|11568678|FG001|STARTED|Overall Study||20
10423531|NCT00830232|11568677|FG000|COMPLETED|Overall Study||20
10423532|NCT00830232|11568678|FG001|COMPLETED|Overall Study||20
10423533|NCT00830232|11568677|FG000|NOT COMPLETED|Overall Study||0
10423534|NCT00830232|11568678|FG001|NOT COMPLETED|Overall Study||0
10423535|NCT00830284|11568684|FG000|STARTED|Overall Study|The study was started in our Medical Surgical ICU October of 2008.|12
10423536|NCT00830284|11568684|FG000|COMPLETED|Overall Study||10
10423537|NCT00830284|11568684|FG000|NOT COMPLETED|Overall Study||2
10423538|NCT00830310|11568688|FG000|STARTED|Overall Study||43
10423539|NCT00830310|11568688|FG000|COMPLETED|Overall Study||30
10423540|NCT00830310|11568688|FG000|NOT COMPLETED|Overall Study||13
10423541|NCT00830362|11568694|FG000|STARTED|Overall Study|They received Propranolol and completed Test Session (Session 1). One subject left after day 1.|27
10423542|NCT00830362|11568695|FG001|STARTED|Overall Study|They received Propranolol and completed Test Session (Session 1). One subject left after day 1.|24
10423543|NCT00830362|11568694|FG000|Completed Sessions 1 and 2|Overall Study|Received propranolol and completed both Test and Retrieval sessions (Session 1 and 2).|26
10423544|NCT00830362|11568695|FG001|Completed Sessions 1 and 2|Overall Study|Received palcebo and completed both Test and Retrieval sessions (Session 1 and 2).|24
10423545|NCT00830362|11568694|FG000|COMPLETED|Overall Study|The enrolled subjects that completed all 3 testing sessions (were not lost to follow-up).|23
10423546|NCT00830362|11568695|FG001|COMPLETED|Overall Study|The enrolled subjects that completed all 3 testing sessions (were not lost to follow-up).|20
10423547|NCT00830362|11568694|FG000|NOT COMPLETED|Overall Study||4
10423548|NCT00830362|11568695|FG001|NOT COMPLETED|Overall Study||4
10423549|NCT00830375|11568701|FG000|STARTED|Overall Study||10
10423550|NCT00830375|11568701|FG000|COMPLETED|Overall Study||9
10423551|NCT00830375|11568701|FG000|NOT COMPLETED|Overall Study||1
10423552|NCT00830388|11568705|FG000|STARTED|Overall Study||11
10423553|NCT00830388|11568705|FG000|COMPLETED|Overall Study||11
10423554|NCT00830388|11568705|FG000|NOT COMPLETED|Overall Study||0
10423555|NCT00830440|11568711|FG000|STARTED|Overall Study||32
10423556|NCT00830440|11568712|FG001|STARTED|Overall Study||11
10423557|NCT00830440|11568711|FG000|Received Device|Overall Study||26
10423558|NCT00830440|11568712|FG001|Received Device|Overall Study||0
10423559|NCT00830440|11568711|FG000|Completed 12 Week Follow up|Overall Study||24
10423560|NCT00830440|11568712|FG001|Completed 12 Week Follow up|Overall Study||11
10423561|NCT00830440|11568711|FG000|Completed 16 Week Follow up|Overall Study||4
10423562|NCT00830440|11568712|FG001|Completed 16 Week Follow up|Overall Study||0
10423563|NCT00830440|11568711|FG000|Completed 24 Week Follow up|Overall Study||3
10423564|NCT00830440|11568712|FG001|Completed 24 Week Follow up|Overall Study||0
10423565|NCT00830440|11568711|FG000|COMPLETED|Overall Study||24
10423566|NCT00830440|11568712|FG001|COMPLETED|Overall Study||11
10423567|NCT00830440|11568711|FG000|NOT COMPLETED|Overall Study||8
10423568|NCT00830440|11568712|FG001|NOT COMPLETED|Overall Study||0
10423569|NCT00830518|11568721|FG000|STARTED|Overall Study||46
10423570|NCT00830518|11568722|FG001|STARTED|Overall Study||11
10423571|NCT00830518|11568721|FG000|COMPLETED|Overall Study|Completed = participants who completed study treatment.|0
10423572|NCT00830518|11568722|FG001|COMPLETED|Overall Study||0
10423573|NCT00830518|11568721|FG000|NOT COMPLETED|Overall Study||46
10423574|NCT00830518|11568722|FG001|NOT COMPLETED|Overall Study||11
10423575|NCT00830596|11568732|FG000|STARTED|Overall Study||74
10423576|NCT00830596|11568733|FG001|STARTED|Overall Study||74
10423577|NCT00830596|11568734|FG002|STARTED|Overall Study||73
10423578|NCT00830596|11568732|FG000|COMPLETED|Overall Study||72
10423579|NCT00830596|11568733|FG001|COMPLETED|Overall Study||72
10423580|NCT00830596|11568734|FG002|COMPLETED|Overall Study||67
10423581|NCT00830596|11568732|FG000|NOT COMPLETED|Overall Study||2
10423582|NCT00830596|11568733|FG001|NOT COMPLETED|Overall Study||2
10423583|NCT00830596|11568734|FG002|NOT COMPLETED|Overall Study||6
10423584|NCT00830765|11568744|FG000|STARTED|Overall Study||73
10423585|NCT00830765|11568745|FG001|STARTED|Overall Study||71
10423586|NCT00830765|11568744|FG000|COMPLETED|Overall Study||70
10423587|NCT00830765|11568745|FG001|COMPLETED|Overall Study||69
10423588|NCT00830765|11568744|FG000|NOT COMPLETED|Overall Study||3
10423589|NCT00830765|11568745|FG001|NOT COMPLETED|Overall Study||2
10423590|NCT00830791|11568757|FG000|STARTED|Overall Study||8
10423591|NCT00830791|11568758|FG001|STARTED|Overall Study||8
10423592|NCT00830791|11568759|FG002|STARTED|Overall Study||8
10423593|NCT00830791|11568760|FG003|STARTED|Overall Study||8
10423594|NCT00830791|11568761|FG004|STARTED|Overall Study||0
10423595|NCT00830791|11568762|FG005|STARTED|Overall Study||0
10423596|NCT00830791|11568757|FG000|COMPLETED|Overall Study||8
10423597|NCT00830791|11568758|FG001|COMPLETED|Overall Study||8
10423598|NCT00830791|11568759|FG002|COMPLETED|Overall Study||8
10423599|NCT00830791|11568760|FG003|COMPLETED|Overall Study||8
10423600|NCT00830791|11568761|FG004|COMPLETED|Overall Study||0
10423601|NCT00830791|11568762|FG005|COMPLETED|Overall Study||0
10423602|NCT00830791|11568757|FG000|NOT COMPLETED|Overall Study||0
10423603|NCT00830791|11568758|FG001|NOT COMPLETED|Overall Study||0
10423604|NCT00830791|11568759|FG002|NOT COMPLETED|Overall Study||0
10423605|NCT00830791|11568760|FG003|NOT COMPLETED|Overall Study||0
10423606|NCT00830791|11568761|FG004|NOT COMPLETED|Overall Study||0
10423607|NCT00830791|11568762|FG005|NOT COMPLETED|Overall Study||0
10423608|NCT00830804|11568775|FG000|STARTED|Overall Study|113 subjects enrolled. One subject never started study treatment and was excluded in all analysis.|112
10423609|NCT00830804|11568775|FG000|COMPLETED|Overall Study||97
10423610|NCT00830804|11568775|FG000|NOT COMPLETED|Overall Study||15
10423611|NCT00830869|11568792|FG000|STARTED|Period 1: Part 1||1
10423612|NCT00830869|11568793|FG001|STARTED|Period 1: Part 1||1
10423613|NCT00830869|11568794|FG002|STARTED|Period 1: Part 1||1
10423614|NCT00830869|11568795|FG003|STARTED|Period 1: Part 1||7
10423615|NCT00830869|11568796|FG004|STARTED|Period 1: Part 1||4
10423616|NCT00830869|11568797|FG005|STARTED|Period 1: Part 1||6
10423617|NCT00830869|11568798|FG006|STARTED|Period 1: Part 1||3
10423618|NCT00830869|11568799|FG007|STARTED|Period 1: Part 1||0
10423619|NCT00830869|11568800|FG008|STARTED|Period 1: Part 1||0
10423620|NCT00830869|11568801|FG009|STARTED|Period 1: Part 1||0
10423621|NCT00830869|11568802|FG010|STARTED|Period 1: Part 1||0
10423622|NCT00830869|11568803|FG011|STARTED|Period 1: Part 1||0
10423623|NCT00830869|11568792|FG000|COMPLETED|Period 1: Part 1||0
10423624|NCT00830869|11568793|FG001|COMPLETED|Period 1: Part 1||0
10423625|NCT00830869|11568794|FG002|COMPLETED|Period 1: Part 1||0
10423626|NCT00830869|11568795|FG003|COMPLETED|Period 1: Part 1||0
10423627|NCT00830869|11568796|FG004|COMPLETED|Period 1: Part 1||0
10423628|NCT00830869|11568797|FG005|COMPLETED|Period 1: Part 1||0
10423629|NCT00830869|11568798|FG006|COMPLETED|Period 1: Part 1||0
10423630|NCT00830869|11568799|FG007|COMPLETED|Period 1: Part 1||0
10423631|NCT00830869|11568800|FG008|COMPLETED|Period 1: Part 1||0
10423632|NCT00830869|11568801|FG009|COMPLETED|Period 1: Part 1||0
10423633|NCT00830869|11568802|FG010|COMPLETED|Period 1: Part 1||0
10423634|NCT00830869|11568803|FG011|COMPLETED|Period 1: Part 1||0
10423635|NCT00830869|11568792|FG000|NOT COMPLETED|Period 1: Part 1||1
10423636|NCT00830869|11568793|FG001|NOT COMPLETED|Period 1: Part 1||1
10423637|NCT00830869|11568794|FG002|NOT COMPLETED|Period 1: Part 1||1
10423638|NCT00830869|11568795|FG003|NOT COMPLETED|Period 1: Part 1||7
10423639|NCT00830869|11568796|FG004|NOT COMPLETED|Period 1: Part 1||4
10423640|NCT00830869|11568797|FG005|NOT COMPLETED|Period 1: Part 1||6
10423641|NCT00830869|11568798|FG006|NOT COMPLETED|Period 1: Part 1||3
10423642|NCT00830869|11568799|FG007|NOT COMPLETED|Period 1: Part 1||0
10423643|NCT00830869|11568800|FG008|NOT COMPLETED|Period 1: Part 1||0
10423644|NCT00830869|11568801|FG009|NOT COMPLETED|Period 1: Part 1||0
10423645|NCT00830869|11568802|FG010|NOT COMPLETED|Period 1: Part 1||0
10423646|NCT00830869|11568803|FG011|NOT COMPLETED|Period 1: Part 1||0
10423647|NCT00830869|11568792|FG000|STARTED|Period 2: Part 2||0
10423648|NCT00830869|11568793|FG001|STARTED|Period 2: Part 2||0
10423649|NCT00830869|11568794|FG002|STARTED|Period 2: Part 2||0
10423650|NCT00830869|11568795|FG003|STARTED|Period 2: Part 2||0
10423651|NCT00830869|11568796|FG004|STARTED|Period 2: Part 2||0
10423652|NCT00830869|11568797|FG005|STARTED|Period 2: Part 2||0
10423653|NCT00830869|11568798|FG006|STARTED|Period 2: Part 2||0
10423654|NCT00830869|11568799|FG007|STARTED|Period 2: Part 2||20
10423655|NCT00830869|11568800|FG008|STARTED|Period 2: Part 2||22
10423656|NCT00830869|11568801|FG009|STARTED|Period 2: Part 2||20
10423657|NCT00830869|11568802|FG010|STARTED|Period 2: Part 2||11
10423658|NCT00830869|11568803|FG011|STARTED|Period 2: Part 2||20
10423659|NCT00830869|11568792|FG000|COMPLETED|Period 2: Part 2||0
10423660|NCT00830869|11568793|FG001|COMPLETED|Period 2: Part 2||0
10423661|NCT00830869|11568794|FG002|COMPLETED|Period 2: Part 2||0
10423662|NCT00830869|11568795|FG003|COMPLETED|Period 2: Part 2||0
10423663|NCT00830869|11568796|FG004|COMPLETED|Period 2: Part 2||0
10423664|NCT00830869|11568797|FG005|COMPLETED|Period 2: Part 2||0
10423665|NCT00830869|11568798|FG006|COMPLETED|Period 2: Part 2||0
10423666|NCT00830869|11568799|FG007|COMPLETED|Period 2: Part 2||0
10423667|NCT00830869|11568800|FG008|COMPLETED|Period 2: Part 2||0
10423668|NCT00830869|11568801|FG009|COMPLETED|Period 2: Part 2||0
10423669|NCT00830869|11568802|FG010|COMPLETED|Period 2: Part 2||0
10423670|NCT00830869|11568803|FG011|COMPLETED|Period 2: Part 2||0
10423671|NCT00830869|11568792|FG000|NOT COMPLETED|Period 2: Part 2||0
10423672|NCT00830869|11568793|FG001|NOT COMPLETED|Period 2: Part 2||0
10423673|NCT00830869|11568794|FG002|NOT COMPLETED|Period 2: Part 2||0
10423674|NCT00830869|11568795|FG003|NOT COMPLETED|Period 2: Part 2||0
10423675|NCT00830869|11568796|FG004|NOT COMPLETED|Period 2: Part 2||0
10423676|NCT00830869|11568797|FG005|NOT COMPLETED|Period 2: Part 2||0
10423677|NCT00830869|11568798|FG006|NOT COMPLETED|Period 2: Part 2||0
10423678|NCT00830869|11568799|FG007|NOT COMPLETED|Period 2: Part 2||20
10423679|NCT00830869|11568800|FG008|NOT COMPLETED|Period 2: Part 2||22
10423680|NCT00830869|11568801|FG009|NOT COMPLETED|Period 2: Part 2||20
10423681|NCT00830869|11568802|FG010|NOT COMPLETED|Period 2: Part 2||11
10423682|NCT00830869|11568803|FG011|NOT COMPLETED|Period 2: Part 2||20
10423683|NCT00830947|11568832|FG000|STARTED|Overall Study||23
10423684|NCT00830947|11568833|FG001|STARTED|Overall Study||22
10423685|NCT00830947|11568832|FG000|COMPLETED|Overall Study||19
10423686|NCT00830947|11568833|FG001|COMPLETED|Overall Study||18
10423687|NCT00830947|11568832|FG000|NOT COMPLETED|Overall Study||4
10423688|NCT00830947|11568833|FG001|NOT COMPLETED|Overall Study||4
10429705|NCT00865969|11575785|FG000|NOT COMPLETED|Overall Study||0
10423771|NCT00831441|11568957|FG001|NOT COMPLETED|Randomized||3705
10423689|NCT00830960|11568845|FG000|STARTED|Overall Study|"Number of participants STARTED equals the number of participants randomized."|124
10423690|NCT00830960|11568846|FG001|STARTED|Overall Study||124
10423691|NCT00830960|11568847|FG002|STARTED|Overall Study||137
10423692|NCT00830960|11568848|FG003|STARTED|Overall Study||138
10423693|NCT00830960|11568849|FG004|STARTED|Overall Study||96
10423694|NCT00830960|11568850|FG005|STARTED|Overall Study|Total 720 participants were randomized; 1 was not included in a cohort as baseline weight missing.|100
10423695|NCT00830960|11568845|FG000|Received at Least 1 Dose of Study Drug|Overall Study|Baseline Characteristics (below) include those who received ≥1 dose study drug, not all who STARTED.|117
10423696|NCT00830960|11568846|FG001|Received at Least 1 Dose of Study Drug|Overall Study||122
10423697|NCT00830960|11568847|FG002|Received at Least 1 Dose of Study Drug|Overall Study||133
10423698|NCT00830960|11568848|FG003|Received at Least 1 Dose of Study Drug|Overall Study||135
10423699|NCT00830960|11568849|FG004|Received at Least 1 Dose of Study Drug|Overall Study||91
10423700|NCT00830960|11568850|FG005|Received at Least 1 Dose of Study Drug|Overall Study||93
10423701|NCT00830960|11568845|FG000|COMPLETED|Overall Study||91
10423702|NCT00830960|11568846|FG001|COMPLETED|Overall Study||96
10423703|NCT00830960|11568847|FG002|COMPLETED|Overall Study||108
10423704|NCT00830960|11568848|FG003|COMPLETED|Overall Study||106
10423705|NCT00830960|11568849|FG004|COMPLETED|Overall Study|6 participants not completed due to death; 1 additional death occurred after study discontinuation.|64
10423706|NCT00830960|11568850|FG005|COMPLETED|Overall Study||63
10423707|NCT00830960|11568845|FG000|NOT COMPLETED|Overall Study||33
10423708|NCT00830960|11568846|FG001|NOT COMPLETED|Overall Study||28
10423709|NCT00830960|11568847|FG002|NOT COMPLETED|Overall Study||29
10423710|NCT00830960|11568848|FG003|NOT COMPLETED|Overall Study||32
10423711|NCT00830960|11568849|FG004|NOT COMPLETED|Overall Study||32
10423712|NCT00830960|11568850|FG005|NOT COMPLETED|Overall Study||37
10423713|NCT00831129|11568889|FG000|STARTED|Overall Study||20
10423714|NCT00831129|11568890|FG001|STARTED|Overall Study||33
10423715|NCT00831129|11568889|FG000|COMPLETED|Overall Study||20
10423716|NCT00831129|11568890|FG001|COMPLETED|Overall Study||23
10423717|NCT00831129|11568889|FG000|NOT COMPLETED|Overall Study||0
10423718|NCT00831129|11568890|FG001|NOT COMPLETED|Overall Study||10
10423719|NCT00831181|11568896|FG000|STARTED|Overall Study||27
10423720|NCT00831181|11568896|FG000|COMPLETED|Overall Study||15
10423721|NCT00831181|11568896|FG000|NOT COMPLETED|Overall Study||12
10423722|NCT00831233|11568903|FG000|STARTED|Overall Study|Intention-to-treat (ITT) population.|29
10423723|NCT00831233|11568904|FG001|STARTED|Overall Study|ITT population.|13
10423724|NCT00831233|11568903|FG000|Full Analysis Set (FAS)|Overall Study|2 participants were randomised but never treated.|27
10423725|NCT00831233|11568904|FG001|Full Analysis Set (FAS)|Overall Study||13
10423726|NCT00831233|11568903|FG000|Per Protocol (PP) Analysis Set|Overall Study||26
10423727|NCT00831233|11568904|FG001|Per Protocol (PP) Analysis Set|Overall Study||11
10423728|NCT00831233|11568903|FG000|COMPLETED|Overall Study||26
10423729|NCT00831233|11568904|FG001|COMPLETED|Overall Study||12
10423730|NCT00831233|11568903|FG000|NOT COMPLETED|Overall Study||3
10423731|NCT00831233|11568904|FG001|NOT COMPLETED|Overall Study||1
10423732|NCT00831272|11568914|FG000|STARTED|Overall Study||38
10423733|NCT00831272|11568915|FG001|STARTED|Overall Study||44
10423734|NCT00831272|11568916|FG002|STARTED|Overall Study||73
10423735|NCT00831272|11568917|FG003|STARTED|Overall Study||66
10423736|NCT00831272|11568914|FG000|COMPLETED|Overall Study||30
10423737|NCT00831272|11568915|FG001|COMPLETED|Overall Study||37
10423738|NCT00831272|11568916|FG002|COMPLETED|Overall Study||63
10423739|NCT00831272|11568917|FG003|COMPLETED|Overall Study||56
10423740|NCT00831272|11568914|FG000|NOT COMPLETED|Overall Study||8
10423741|NCT00831272|11568915|FG001|NOT COMPLETED|Overall Study||7
10423742|NCT00831272|11568916|FG002|NOT COMPLETED|Overall Study||10
10423743|NCT00831272|11568917|FG003|NOT COMPLETED|Overall Study||10
10423744|NCT00831311|11568929|FG000|STARTED|Overall Study||312
10423745|NCT00831311|11568930|FG001|STARTED|Overall Study||312
10423746|NCT00831311|11568929|FG000|COMPLETED|Overall Study||300
10423747|NCT00831311|11568930|FG001|COMPLETED|Overall Study||304
10423748|NCT00831311|11568929|FG000|NOT COMPLETED|Overall Study||12
10423749|NCT00831311|11568930|FG001|NOT COMPLETED|Overall Study||8
10423750|NCT00831389|11568939|FG000|STARTED|Overall Study||6
10423751|NCT00831389|11568940|FG001|STARTED|Overall Study||7
10423752|NCT00831389|11568939|FG000|COMPLETED|Overall Study||6
10423753|NCT00831389|11568940|FG001|COMPLETED|Overall Study||6
10423754|NCT00831389|11568939|FG000|NOT COMPLETED|Overall Study||0
10423755|NCT00831389|11568940|FG001|NOT COMPLETED|Overall Study||1
10423756|NCT00831415|11568946|FG000|STARTED|Overall Study||304
10423757|NCT00831415|11568946|FG000|"Completers for Exposure"|Overall Study|Participants with ≥ 301 days of exposure to study drug and completed study day 308 evaluations.|227
10423758|NCT00831415|11568946|FG000|"Study Completers"|Overall Study|"Defined as participants whose conclusion of study participation status was study completed."|227
10423759|NCT00831415|11568946|FG000|COMPLETED|Overall Study|In addition to Completers for Study includes 2 participants who discontinued after on-therapy period|229
10423760|NCT00831415|11568946|FG000|NOT COMPLETED|Overall Study||75
10423761|NCT00831428|11568950|FG000|STARTED|Overall Study||97
10423762|NCT00831428|11568950|FG000|COMPLETED|Overall Study||97
10423763|NCT00831428|11568950|FG000|NOT COMPLETED|Overall Study||0
10423764|NCT00831441|11568956|FG000|STARTED|Randomized||3687
10423765|NCT00831441|11568957|FG001|STARTED|Randomized||3705
10423766|NCT00831441|11568956|FG000|Treated|Randomized||3643
10423767|NCT00831441|11568957|FG001|Treated|Randomized||3672
10423768|NCT00831441|11568956|FG000|COMPLETED|Randomized||0
10423769|NCT00831441|11568957|FG001|COMPLETED|Randomized||0
10423770|NCT00831441|11568956|FG000|NOT COMPLETED|Randomized||3687
10423772|NCT00831441|11568956|FG000|STARTED|Follow Up (30 Days)|3508 participants entered the follow up period.|3508
10423773|NCT00831441|11568957|FG001|STARTED|Follow Up (30 Days)|3529 participants entered the follow up period.|3529
10423774|NCT00831441|11568956|FG000|COMPLETED|Follow Up (30 Days)||3375
10423775|NCT00831441|11568957|FG001|COMPLETED|Follow Up (30 Days)||3355
10423776|NCT00831441|11568956|FG000|NOT COMPLETED|Follow Up (30 Days)||133
10423777|NCT00831441|11568957|FG001|NOT COMPLETED|Follow Up (30 Days)||174
10423778|NCT00831480|11568964|FG000|STARTED|Overall Study||9
10423779|NCT00831480|11568964|FG000|COMPLETED|Overall Study||7
10423780|NCT00831480|11568964|FG000|NOT COMPLETED|Overall Study||2
10423781|NCT00831493|11568968|FG000|STARTED|Overall Study||3
10423782|NCT00831493|11568968|FG000|COMPLETED|Overall Study||2
10423783|NCT00831493|11568968|FG000|NOT COMPLETED|Overall Study||1
10423784|NCT00831675|11568974|FG000|STARTED|Overall Study||12
10423785|NCT00831675|11568975|FG001|STARTED|Overall Study||18
10423786|NCT00831675|11568974|FG000|COMPLETED|Overall Study||12
10423787|NCT00831675|11568975|FG001|COMPLETED|Overall Study||18
10423788|NCT00831675|11568974|FG000|NOT COMPLETED|Overall Study||0
10423789|NCT00831675|11568975|FG001|NOT COMPLETED|Overall Study||0
10423790|NCT00831701|11568983|FG000|STARTED|Overall Study||50
10423791|NCT00831701|11568984|FG001|STARTED|Overall Study||50
10423792|NCT00831701|11568983|FG000|COMPLETED|Overall Study||45
10423793|NCT00831701|11568984|FG001|COMPLETED|Overall Study||45
10423794|NCT00831701|11568983|FG000|NOT COMPLETED|Overall Study||5
10423795|NCT00831701|11568984|FG001|NOT COMPLETED|Overall Study||5
10423796|NCT00831753|11568992|FG000|STARTED|Overall Study||132
10423797|NCT00831753|11568993|FG001|STARTED|Overall Study||131
10423798|NCT00831753|11568992|FG000|COMPLETED|Overall Study||132
10423799|NCT00831753|11568993|FG001|COMPLETED|Overall Study||131
10423800|NCT00831753|11568992|FG000|NOT COMPLETED|Overall Study||0
10423801|NCT00831753|11568993|FG001|NOT COMPLETED|Overall Study||0
10423802|NCT00831766|11569001|FG000|STARTED|Overall Study||23
10423803|NCT00831766|11569002|FG001|STARTED|Overall Study||28
10423804|NCT00831766|11569001|FG000|COMPLETED|Overall Study||23
10423805|NCT00831766|11569002|FG001|COMPLETED|Overall Study||28
10423806|NCT00831766|11569001|FG000|NOT COMPLETED|Overall Study||0
10423807|NCT00831766|11569002|FG001|NOT COMPLETED|Overall Study||0
10423808|NCT00831779|11569011|FG000|STARTED|Overall Study||21
10423809|NCT00831779|11569012|FG001|STARTED|Overall Study||23
10423810|NCT00831779|11569011|FG000|COMPLETED|Overall Study||20
10423811|NCT00831779|11569012|FG001|COMPLETED|Overall Study||22
10423812|NCT00831779|11569011|FG000|NOT COMPLETED|Overall Study||1
10423813|NCT00831779|11569012|FG001|NOT COMPLETED|Overall Study||1
10423814|NCT00831792|11569018|FG000|STARTED|Overall Study||46
10423815|NCT00831792|11569018|FG000|COMPLETED|Overall Study||40
10423816|NCT00831792|11569018|FG000|NOT COMPLETED|Overall Study||6
10423817|NCT00831844|11569032|FG000|STARTED|Overall Study||10
10423818|NCT00831844|11569033|FG001|STARTED|Overall Study||12
10423819|NCT00831844|11569034|FG002|STARTED|Overall Study||21
10423820|NCT00831844|11569035|FG003|STARTED|Overall Study||10
10423821|NCT00831844|11569036|FG004|STARTED|Overall Study||14
10423822|NCT00831844|11569037|FG005|STARTED|Overall Study||20
10423823|NCT00831844|11569038|FG006|STARTED|Overall Study||10
10423824|NCT00831844|11569039|FG007|STARTED|Overall Study||10
10423825|NCT00831844|11569040|FG008|STARTED|Overall Study||9
10423826|NCT00831844|11569041|FG009|STARTED|Overall Study||0
10423827|NCT00831844|11569032|FG000|COMPLETED|Overall Study||0
10423828|NCT00831844|11569033|FG001|COMPLETED|Overall Study||0
10423829|NCT00831844|11569034|FG002|COMPLETED|Overall Study||1
10423830|NCT00831844|11569035|FG003|COMPLETED|Overall Study||0
10423831|NCT00831844|11569036|FG004|COMPLETED|Overall Study||0
10423832|NCT00831844|11569037|FG005|COMPLETED|Overall Study||1
10423833|NCT00831844|11569038|FG006|COMPLETED|Overall Study||0
10423834|NCT00831844|11569039|FG007|COMPLETED|Overall Study||0
10423835|NCT00831844|11569040|FG008|COMPLETED|Overall Study||0
10423836|NCT00831844|11569041|FG009|COMPLETED|Overall Study||0
10423837|NCT00831844|11569032|FG000|NOT COMPLETED|Overall Study||10
10423838|NCT00831844|11569033|FG001|NOT COMPLETED|Overall Study||12
10423839|NCT00831844|11569034|FG002|NOT COMPLETED|Overall Study||20
10423840|NCT00831844|11569035|FG003|NOT COMPLETED|Overall Study||10
10423841|NCT00831844|11569036|FG004|NOT COMPLETED|Overall Study||14
10423842|NCT00831844|11569037|FG005|NOT COMPLETED|Overall Study||19
10423843|NCT00831844|11569038|FG006|NOT COMPLETED|Overall Study||10
10423844|NCT00831844|11569039|FG007|NOT COMPLETED|Overall Study||10
10423845|NCT00831844|11569040|FG008|NOT COMPLETED|Overall Study||9
10423846|NCT00831844|11569041|FG009|NOT COMPLETED|Overall Study||0
10423847|NCT00831987|11569065|FG000|STARTED|Overall Study||60
10423848|NCT00831987|11569066|FG001|STARTED|Overall Study||60
10423849|NCT00831987|11569065|FG000|COMPLETED|Overall Study||60
10423850|NCT00831987|11569066|FG001|COMPLETED|Overall Study||60
10423851|NCT00831987|11569065|FG000|NOT COMPLETED|Overall Study||0
10423852|NCT00831987|11569066|FG001|NOT COMPLETED|Overall Study||0
10423853|NCT00832000|11569072|FG000|STARTED|Overall Study|Mexiletine 200 mg orally three times daily|29
10423854|NCT00832000|11569073|FG001|STARTED|Overall Study|Placebo|30
10423855|NCT00832000|11569072|FG000|Crossed Over to Opposite Intervention|Overall Study|Placebo|25
10423856|NCT00832000|11569073|FG001|Crossed Over to Opposite Intervention|Overall Study|Mexiletine 200 mg orally three times daily|29
10423857|NCT00832000|11569072|FG000|COMPLETED|Overall Study||23
10423858|NCT00832000|11569073|FG001|COMPLETED|Overall Study||29
10423859|NCT00832000|11569072|FG000|NOT COMPLETED|Overall Study||6
10423860|NCT00832000|11569073|FG001|NOT COMPLETED|Overall Study||1
10423861|NCT00832078|11569108|FG000|STARTED|Test Day 1- 1 Period||13
10423862|NCT00832078|11569109|FG001|STARTED|Test Day 1- 1 Period||12
10423863|NCT00832078|11569108|FG000|COMPLETED|Test Day 1- 1 Period||13
10423864|NCT00832078|11569109|FG001|COMPLETED|Test Day 1- 1 Period||12
10423865|NCT00832078|11569108|FG000|NOT COMPLETED|Test Day 1- 1 Period||0
10423866|NCT00832078|11569109|FG001|NOT COMPLETED|Test Day 1- 1 Period||0
10423867|NCT00832078|11569108|FG000|STARTED|Test Day 1-2 Period||13
10423868|NCT00832078|11569109|FG001|STARTED|Test Day 1-2 Period||12
10423869|NCT00832078|11569108|FG000|COMPLETED|Test Day 1-2 Period||13
10423870|NCT00832078|11569109|FG001|COMPLETED|Test Day 1-2 Period||10
10423871|NCT00832078|11569108|FG000|NOT COMPLETED|Test Day 1-2 Period||0
10423872|NCT00832078|11569109|FG001|NOT COMPLETED|Test Day 1-2 Period||2
10423873|NCT00832078|11569108|FG000|STARTED|Test Day 2 - 1 Period||13
10423874|NCT00832078|11569109|FG001|STARTED|Test Day 2 - 1 Period||10
10423875|NCT00832078|11569108|FG000|COMPLETED|Test Day 2 - 1 Period||13
10423876|NCT00832078|11569109|FG001|COMPLETED|Test Day 2 - 1 Period||10
10423877|NCT00832078|11569108|FG000|NOT COMPLETED|Test Day 2 - 1 Period||0
10423878|NCT00832078|11569109|FG001|NOT COMPLETED|Test Day 2 - 1 Period||0
10423879|NCT00832078|11569108|FG000|STARTED|Test Day 2 - 2 Period||13
10423880|NCT00832078|11569109|FG001|STARTED|Test Day 2 - 2 Period||10
10423881|NCT00832078|11569108|FG000|COMPLETED|Test Day 2 - 2 Period||12
10423882|NCT00832078|11569109|FG001|COMPLETED|Test Day 2 - 2 Period||10
10423883|NCT00832078|11569108|FG000|NOT COMPLETED|Test Day 2 - 2 Period||1
10423884|NCT00832078|11569109|FG001|NOT COMPLETED|Test Day 2 - 2 Period||0
10423885|NCT00832091|11569117|FG000|STARTED|Overall Study||17
10423886|NCT00832091|11569118|FG001|STARTED|Overall Study||55
10423887|NCT00832091|11569117|FG000|COMPLETED|Overall Study||12
10423888|NCT00832091|11569118|FG001|COMPLETED|Overall Study||53
10423889|NCT00832091|11569117|FG000|NOT COMPLETED|Overall Study||5
10423890|NCT00832091|11569118|FG001|NOT COMPLETED|Overall Study||2
10423891|NCT00832117|11569126|FG000|STARTED|Overall Study||29
10423892|NCT00832117|11569126|FG000|COMPLETED|Overall Study||17
10423893|NCT00832117|11569126|FG000|NOT COMPLETED|Overall Study||12
10423894|NCT00832130|11569135|FG000|STARTED|Overall Study||69
10423895|NCT00832130|11569136|FG001|STARTED|Overall Study||70
10423896|NCT00832130|11569135|FG000|COMPLETED|Overall Study||69
10423897|NCT00832130|11569136|FG001|COMPLETED|Overall Study||70
10423898|NCT00832130|11569135|FG000|NOT COMPLETED|Overall Study||0
10423899|NCT00832130|11569136|FG001|NOT COMPLETED|Overall Study||0
10423900|NCT00832260|11569142|FG000|STARTED|Overall Study||70
10423901|NCT00832260|11569142|FG000|COMPLETED|Overall Study||70
10423902|NCT00832260|11569142|FG000|NOT COMPLETED|Overall Study||0
10423903|NCT00832338|11569146|FG000|STARTED|Overall Study||23
10423904|NCT00832338|11569146|FG000|COMPLETED|Overall Study||23
10423905|NCT00832338|11569146|FG000|NOT COMPLETED|Overall Study||0
10423906|NCT00832377|11569150|FG000|STARTED|Overall Study||37
10423907|NCT00832377|11569150|FG000|COMPLETED|Overall Study||36
10423908|NCT00832377|11569150|FG000|NOT COMPLETED|Overall Study||1
10423909|NCT00832390|11569157|FG000|STARTED|Overall Study||12
10423910|NCT00832390|11569158|FG001|STARTED|Overall Study||16
10423911|NCT00832390|11569159|FG002|STARTED|Overall Study||1
10423912|NCT00832390|11569157|FG000|COMPLETED|Overall Study||12
10423913|NCT00832390|11569158|FG001|COMPLETED|Overall Study||16
10423914|NCT00832390|11569159|FG002|COMPLETED|Overall Study||1
10423915|NCT00832390|11569157|FG000|NOT COMPLETED|Overall Study||0
10423916|NCT00832390|11569158|FG001|NOT COMPLETED|Overall Study||0
10423917|NCT00832390|11569159|FG002|NOT COMPLETED|Overall Study||0
10423918|NCT00832416|11569171|FG000|STARTED|Overall Study||110
10423919|NCT00832416|11569172|FG001|STARTED|Overall Study||113
10423920|NCT00832416|11569173|FG002|STARTED|Overall Study||115
10423921|NCT00832416|11569174|FG003|STARTED|Overall Study||227
10423922|NCT00832416|11569171|FG000|COMPLETED|Overall Study||64
10423923|NCT00832416|11569172|FG001|COMPLETED|Overall Study||60
10423924|NCT00832416|11569173|FG002|COMPLETED|Overall Study||54
10423925|NCT00832416|11569174|FG003|COMPLETED|Overall Study||144
10423926|NCT00832416|11569171|FG000|NOT COMPLETED|Overall Study||46
10423927|NCT00832416|11569172|FG001|NOT COMPLETED|Overall Study||53
10423928|NCT00832416|11569173|FG002|NOT COMPLETED|Overall Study||61
10423929|NCT00832416|11569174|FG003|NOT COMPLETED|Overall Study||83
10423930|NCT00832585|11569184|FG000|STARTED|Overall Study|Eight subjects were screened but only 5 started the study and received study drug.|5
10423931|NCT00832585|11569184|FG000|COMPLETED|Overall Study|Only three subjects completed all of the visits for the study as per protocol.|3
10423932|NCT00832585|11569184|FG000|NOT COMPLETED|Overall Study||2
10423933|NCT00832637|11569188|FG000|STARTED|Overall Study||33
10423934|NCT00832637|11569188|FG000|COMPLETED|Overall Study||33
10423935|NCT00832637|11569188|FG000|NOT COMPLETED|Overall Study||0
10423936|NCT00832650|11569195|FG000|STARTED|Overall Study||25
10423937|NCT00832650|11569196|FG001|STARTED|Overall Study||12
10423938|NCT00832650|11569197|FG002|STARTED|Overall Study||23
10423939|NCT00832650|11569195|FG000|Treated|Overall Study||25
10423940|NCT00832650|11569196|FG001|Treated|Overall Study||12
10423941|NCT00832650|11569197|FG002|Treated|Overall Study||22
10423942|NCT00832650|11569195|FG000|COMPLETED|Overall Study||25
10423943|NCT00832650|11569196|FG001|COMPLETED|Overall Study||12
10423944|NCT00832650|11569197|FG002|COMPLETED|Overall Study||22
10423945|NCT00832650|11569195|FG000|NOT COMPLETED|Overall Study||0
10423946|NCT00832650|11569196|FG001|NOT COMPLETED|Overall Study||0
10423947|NCT00832650|11569197|FG002|NOT COMPLETED|Overall Study||1
10423948|NCT00832767|11569207|FG000|STARTED|Overall Study||121
10423949|NCT00832767|11569208|FG001|STARTED|Overall Study||81
10423950|NCT00832767|11569207|FG000|COMPLETED|Overall Study||99
10423951|NCT00832767|11569208|FG001|COMPLETED|Overall Study||63
10423952|NCT00832767|11569207|FG000|NOT COMPLETED|Overall Study||22
10423953|NCT00832767|11569208|FG001|NOT COMPLETED|Overall Study||18
10423954|NCT00832780|11569216|FG000|STARTED|Overall Study||44
10423955|NCT00832780|11569216|FG000|COMPLETED|Overall Study||19
10423956|NCT00832780|11569216|FG000|NOT COMPLETED|Overall Study||25
10423957|NCT00832819|11569223|FG000|STARTED|Overall Study||6
10423958|NCT00832819|11569224|FG001|STARTED|Overall Study||6
10423959|NCT00832819|11569225|FG002|STARTED|Overall Study||16
10423960|NCT00832819|11569223|FG000|COMPLETED|Overall Study||6
10423961|NCT00832819|11569224|FG001|COMPLETED|Overall Study||5
10423962|NCT00832819|11569225|FG002|COMPLETED|Overall Study||15
10423963|NCT00832819|11569223|FG000|NOT COMPLETED|Overall Study||0
10423964|NCT00832819|11569224|FG001|NOT COMPLETED|Overall Study||1
10423965|NCT00832819|11569225|FG002|NOT COMPLETED|Overall Study||1
10423966|NCT00832871|11569231|FG000|STARTED|Overall Study||4
10423967|NCT00832871|11569231|FG000|COMPLETED|Overall Study||4
10423968|NCT00832871|11569231|FG000|NOT COMPLETED|Overall Study||0
10423969|NCT00832975|11569235|FG000|STARTED|Overall Study||157
10423970|NCT00832975|11569235|FG000|COMPLETED|Overall Study||118
10423971|NCT00832975|11569235|FG000|NOT COMPLETED|Overall Study||39
10423972|NCT00833027|11569239|FG000|STARTED|Overall Study||608
10423973|NCT00833027|11569239|FG000|COMPLETED|Overall Study||397
10423974|NCT00833027|11569239|FG000|NOT COMPLETED|Overall Study||211
10423975|NCT00833040|11569243|FG000|STARTED|Overall Study||6
10423976|NCT00833040|11569244|FG001|STARTED|Overall Study||6
10423977|NCT00833040|11569245|FG002|STARTED|Overall Study||6
10423978|NCT00833040|11569246|FG003|STARTED|Overall Study||6
10423979|NCT00833040|11569247|FG004|STARTED|Overall Study||5
10423980|NCT00833040|11569248|FG005|STARTED|Overall Study||5
10423981|NCT00833040|11569243|FG000|COMPLETED|Overall Study||6
10423982|NCT00833040|11569244|FG001|COMPLETED|Overall Study||6
10423983|NCT00833040|11569245|FG002|COMPLETED|Overall Study||6
10423984|NCT00833040|11569246|FG003|COMPLETED|Overall Study||6
10423985|NCT00833040|11569247|FG004|COMPLETED|Overall Study||5
10423986|NCT00833040|11569248|FG005|COMPLETED|Overall Study||4
10423987|NCT00833040|11569243|FG000|NOT COMPLETED|Overall Study||0
10423988|NCT00833040|11569244|FG001|NOT COMPLETED|Overall Study||0
10423989|NCT00833040|11569245|FG002|NOT COMPLETED|Overall Study||0
10423990|NCT00833040|11569246|FG003|NOT COMPLETED|Overall Study||0
10423991|NCT00833040|11569247|FG004|NOT COMPLETED|Overall Study||0
10423992|NCT00833040|11569248|FG005|NOT COMPLETED|Overall Study||1
10423993|NCT00833053|11569255|FG000|STARTED|Overall Study||19
10423994|NCT00833053|11569256|FG001|STARTED|Overall Study||20
10423995|NCT00833053|11569255|FG000|COMPLETED|Overall Study||10
10423996|NCT00833053|11569256|FG001|COMPLETED|Overall Study||17
10423997|NCT00833053|11569255|FG000|NOT COMPLETED|Overall Study||9
10423998|NCT00833053|11569256|FG001|NOT COMPLETED|Overall Study||3
10423999|NCT00833092|11569264|FG000|STARTED|Overall Study||54
10424000|NCT00833092|11569265|FG001|STARTED|Overall Study||57
10424001|NCT00833092|11569264|FG000|COMPLETED|Overall Study||50
10424002|NCT00833092|11569265|FG001|COMPLETED|Overall Study||50
10424003|NCT00833092|11569264|FG000|NOT COMPLETED|Overall Study||4
10424004|NCT00833092|11569265|FG001|NOT COMPLETED|Overall Study||7
10424005|NCT00833105|11569271|FG000|STARTED|Overall Study||13
10424006|NCT00833105|11569271|FG000|COMPLETED|Overall Study||10
10424007|NCT00833105|11569271|FG000|NOT COMPLETED|Overall Study||3
10424008|NCT00833248|11569279|FG000|STARTED|Overall Study||181
10424009|NCT00833248|11569280|FG001|STARTED|Overall Study||65
10424010|NCT00833248|11569279|FG000|Full Analysis Set (FAS)|Overall Study||180
10424011|NCT00833248|11569280|FG001|Full Analysis Set (FAS)|Overall Study||64
10424012|NCT00833248|11569279|FG000|Per Protocol (PP) Analysis Set|Overall Study||164
10424013|NCT00833248|11569280|FG001|Per Protocol (PP) Analysis Set|Overall Study||57
10424014|NCT00833248|11569279|FG000|Safety Analysis Set|Overall Study||181
10424015|NCT00833248|11569280|FG001|Safety Analysis Set|Overall Study||64
10424016|NCT00833248|11569279|FG000|COMPLETED|Overall Study||177
10424017|NCT00833248|11569280|FG001|COMPLETED|Overall Study||62
10424018|NCT00833248|11569279|FG000|NOT COMPLETED|Overall Study||4
10424019|NCT00833248|11569280|FG001|NOT COMPLETED|Overall Study||3
10424020|NCT00833261|11569286|FG000|STARTED|Overall Study||37
10424021|NCT00833261|11569286|FG000|COMPLETED|Overall Study|3 patients withdrew from the study prior to treatment & 1 receiving it did not complete the course.|33
10424022|NCT00833261|11569286|FG000|NOT COMPLETED|Overall Study||4
10424023|NCT00833365|11569292|FG000|STARTED|Overall Study||9
10424024|NCT00833365|11569293|FG001|STARTED|Overall Study||6
10424025|NCT00833365|11569292|FG000|COMPLETED|Overall Study||9
10424026|NCT00833365|11569293|FG001|COMPLETED|Overall Study||6
10424027|NCT00833365|11569292|FG000|NOT COMPLETED|Overall Study||0
10424028|NCT00833365|11569293|FG001|NOT COMPLETED|Overall Study||0
10424029|NCT00833417|11569301|FG000|STARTED|Overall Study||33
10424030|NCT00833417|11569302|FG001|STARTED|Overall Study||71
10424031|NCT00833417|11569301|FG000|COMPLETED|Overall Study||0
10424032|NCT00833417|11569302|FG001|COMPLETED|Overall Study||0
10424033|NCT00833417|11569301|FG000|NOT COMPLETED|Overall Study||33
10424034|NCT00833417|11569302|FG001|NOT COMPLETED|Overall Study||71
10424035|NCT00833443|11569311|FG000|STARTED|Overall Study||41
10424036|NCT00833443|11569312|FG001|STARTED|Overall Study||43
10424037|NCT00833443|11569311|FG000|COMPLETED|Overall Study||21
10424038|NCT00833443|11569312|FG001|COMPLETED|Overall Study||15
10424039|NCT00833443|11569311|FG000|NOT COMPLETED|Overall Study||20
10424040|NCT00833443|11569312|FG001|NOT COMPLETED|Overall Study||28
10424041|NCT00833469|11569320|FG000|STARTED|Overall Study||5
10424042|NCT00833469|11569320|FG000|COMPLETED|Overall Study||3
10424043|NCT00833469|11569320|FG000|NOT COMPLETED|Overall Study||2
10424044|NCT00833482|11569326|FG000|STARTED|Days 1-3|Participants who received treatment|24
10424045|NCT00833482|11569327|FG001|STARTED|Days 1-3|Participants who received treatment|0
10424046|NCT00833482|11569328|FG002|STARTED|Days 1-3||0
10424047|NCT00833482|11569329|FG003|STARTED|Days 1-3||8
10424048|NCT00833482|11569330|FG004|STARTED|Days 1-3||0
10424049|NCT00833482|11569331|FG005|STARTED|Days 1-3||0
10424050|NCT00833482|11569326|FG000|COMPLETED|Days 1-3||24
10424051|NCT00833482|11569327|FG001|COMPLETED|Days 1-3||0
10424052|NCT00833482|11569328|FG002|COMPLETED|Days 1-3||0
10424053|NCT00833482|11569329|FG003|COMPLETED|Days 1-3||8
10424054|NCT00833482|11569330|FG004|COMPLETED|Days 1-3||0
10424055|NCT00833482|11569331|FG005|COMPLETED|Days 1-3||0
10424056|NCT00833482|11569326|FG000|NOT COMPLETED|Days 1-3||0
10424057|NCT00833482|11569327|FG001|NOT COMPLETED|Days 1-3||0
10424058|NCT00833482|11569328|FG002|NOT COMPLETED|Days 1-3||0
10424059|NCT00833482|11569329|FG003|NOT COMPLETED|Days 1-3||0
10424060|NCT00833482|11569330|FG004|NOT COMPLETED|Days 1-3||0
10424061|NCT00833482|11569331|FG005|NOT COMPLETED|Days 1-3||0
10424062|NCT00833482|11569326|FG000|STARTED|Days 11-20||0
10424063|NCT00833482|11569327|FG001|STARTED|Days 11-20|Participants who received treatment.|24
10424064|NCT00833482|11569328|FG002|STARTED|Days 11-20||0
10424065|NCT00833482|11569329|FG003|STARTED|Days 11-20||0
10424066|NCT00833482|11569330|FG004|STARTED|Days 11-20||0
10424067|NCT00833482|11569331|FG005|STARTED|Days 11-20|Participants who received treatment.|8
10424068|NCT00833482|11569326|FG000|COMPLETED|Days 11-20||0
10424069|NCT00833482|11569327|FG001|COMPLETED|Days 11-20||21
10424070|NCT00833482|11569328|FG002|COMPLETED|Days 11-20||0
10424071|NCT00833482|11569329|FG003|COMPLETED|Days 11-20||0
10424072|NCT00833482|11569330|FG004|COMPLETED|Days 11-20||0
10424073|NCT00833482|11569331|FG005|COMPLETED|Days 11-20||8
10424074|NCT00833482|11569326|FG000|NOT COMPLETED|Days 11-20||0
10424075|NCT00833482|11569327|FG001|NOT COMPLETED|Days 11-20||3
10424076|NCT00833482|11569328|FG002|NOT COMPLETED|Days 11-20||0
10424077|NCT00833482|11569329|FG003|NOT COMPLETED|Days 11-20||0
10424078|NCT00833482|11569330|FG004|NOT COMPLETED|Days 11-20||0
10424079|NCT00833482|11569331|FG005|NOT COMPLETED|Days 11-20||0
10424080|NCT00833482|11569326|FG000|STARTED|Days 21-30||0
10424081|NCT00833482|11569327|FG001|STARTED|Days 21-30||0
10424082|NCT00833482|11569328|FG002|STARTED|Days 21-30||21
10424083|NCT00833482|11569329|FG003|STARTED|Days 21-30||0
10424084|NCT00833482|11569330|FG004|STARTED|Days 21-30||8
10424085|NCT00833482|11569331|FG005|STARTED|Days 21-30||0
10424086|NCT00833482|11569326|FG000|COMPLETED|Days 21-30||0
10424087|NCT00833482|11569327|FG001|COMPLETED|Days 21-30||0
10424088|NCT00833482|11569328|FG002|COMPLETED|Days 21-30||20
10424089|NCT00833482|11569329|FG003|COMPLETED|Days 21-30||0
10424090|NCT00833482|11569330|FG004|COMPLETED|Days 21-30||7
10424091|NCT00833482|11569331|FG005|COMPLETED|Days 21-30||0
10424092|NCT00833482|11569326|FG000|NOT COMPLETED|Days 21-30||0
10424093|NCT00833482|11569327|FG001|NOT COMPLETED|Days 21-30||0
10424094|NCT00833482|11569328|FG002|NOT COMPLETED|Days 21-30||1
10424095|NCT00833482|11569329|FG003|NOT COMPLETED|Days 21-30||0
10424096|NCT00833482|11569330|FG004|NOT COMPLETED|Days 21-30||1
10424097|NCT00833482|11569331|FG005|NOT COMPLETED|Days 21-30||0
10424098|NCT00833547|11569355|FG000|STARTED|Overall Study||13
10424099|NCT00833547|11569356|FG001|STARTED|Overall Study||12
10424100|NCT00833547|11569355|FG000|COMPLETED|Overall Study||11
10424101|NCT00833547|11569356|FG001|COMPLETED|Overall Study||10
10424102|NCT00833547|11569355|FG000|NOT COMPLETED|Overall Study||2
10424103|NCT00833547|11569356|FG001|NOT COMPLETED|Overall Study||2
10424104|NCT00833560|11569362|FG000|STARTED|Overall Study||395
10424105|NCT00833560|11569362|FG000|COMPLETED|Overall Study||353
10424106|NCT00833560|11569362|FG000|NOT COMPLETED|Overall Study||42
10424107|NCT00833638|11569369|FG000|STARTED|Phase 2: Double-blind Treatment Phase||121
10424108|NCT00833638|11569370|FG001|STARTED|Phase 2: Double-blind Treatment Phase||118
10424109|NCT00833638|11569371|FG002|STARTED|Phase 2: Double-blind Treatment Phase||133
10424110|NCT00833638|11569369|FG000|COMPLETED|Phase 2: Double-blind Treatment Phase||111
10424111|NCT00833638|11569370|FG001|COMPLETED|Phase 2: Double-blind Treatment Phase||108
10424112|NCT00833638|11569371|FG002|COMPLETED|Phase 2: Double-blind Treatment Phase||124
10424113|NCT00833638|11569369|FG000|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||10
10424114|NCT00833638|11569370|FG001|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||10
10424115|NCT00833638|11569371|FG002|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||9
10424116|NCT00833638|11569369|FG000|STARTED|Phase 3: Open-label Extension Phase||111
10424117|NCT00833638|11569370|FG001|STARTED|Phase 3: Open-label Extension Phase||108
10424118|NCT00833638|11569371|FG002|STARTED|Phase 3: Open-label Extension Phase||124
10424119|NCT00833638|11569369|FG000|COMPLETED|Phase 3: Open-label Extension Phase||110
10424120|NCT00833638|11569370|FG001|COMPLETED|Phase 3: Open-label Extension Phase||105
10424121|NCT00833638|11569371|FG002|COMPLETED|Phase 3: Open-label Extension Phase||122
10424122|NCT00833638|11569369|FG000|NOT COMPLETED|Phase 3: Open-label Extension Phase||1
10424123|NCT00833638|11569370|FG001|NOT COMPLETED|Phase 3: Open-label Extension Phase||3
10424124|NCT00833638|11569371|FG002|NOT COMPLETED|Phase 3: Open-label Extension Phase||2
10424125|NCT00833690|11569390|FG000|STARTED|Overall Study||25
10424126|NCT00833690|11569391|FG001|STARTED|Overall Study||24
10424127|NCT00833690|11569392|FG002|STARTED|Overall Study||26
10424128|NCT00833690|11569390|FG000|COMPLETED|Overall Study||21
10424129|NCT00833690|11569391|FG001|COMPLETED|Overall Study||22
10424130|NCT00833690|11569392|FG002|COMPLETED|Overall Study||26
10424131|NCT00833690|11569390|FG000|NOT COMPLETED|Overall Study||4
10424132|NCT00833690|11569391|FG001|NOT COMPLETED|Overall Study||2
10424133|NCT00833690|11569392|FG002|NOT COMPLETED|Overall Study||0
10424134|NCT00833703|11569402|FG000|STARTED|Overall Study|Included|23
10424135|NCT00833703|11569403|FG001|STARTED|Overall Study|Included|26
10424136|NCT00833703|11569402|FG000|Treated|Overall Study||23
10424137|NCT00833703|11569403|FG001|Treated|Overall Study||26
10424138|NCT00833703|11569402|FG000|Completed Treatment|Overall Study||22
10424139|NCT00833703|11569403|FG001|Completed Treatment|Overall Study||24
10424140|NCT00833703|11569402|FG000|COMPLETED|Overall Study|Completed follow-up|23
10424141|NCT00833703|11569403|FG001|COMPLETED|Overall Study|Completed follow-up|25
10424142|NCT00833703|11569402|FG000|NOT COMPLETED|Overall Study||0
10424143|NCT00833703|11569403|FG001|NOT COMPLETED|Overall Study||1
10424144|NCT00833755|11569413|FG000|STARTED|Overall Study||16
10424145|NCT00833755|11569414|FG001|STARTED|Overall Study||18
10424146|NCT00833755|11569415|FG002|STARTED|Overall Study||22
10424147|NCT00833755|11569416|FG003|STARTED|Overall Study||23
10424148|NCT00833755|11569413|FG000|COMPLETED|Overall Study||12
10424149|NCT00833755|11569414|FG001|COMPLETED|Overall Study||13
10424150|NCT00833755|11569415|FG002|COMPLETED|Overall Study||20
10424151|NCT00833755|11569416|FG003|COMPLETED|Overall Study||17
10424152|NCT00833755|11569413|FG000|NOT COMPLETED|Overall Study||4
10424153|NCT00833755|11569414|FG001|NOT COMPLETED|Overall Study||5
10424154|NCT00833755|11569415|FG002|NOT COMPLETED|Overall Study||2
10424155|NCT00833755|11569416|FG003|NOT COMPLETED|Overall Study||6
10424156|NCT00833781|11569429|FG000|STARTED|Overall Study||10
10424157|NCT00833781|11569430|FG001|STARTED|Overall Study||5
10424158|NCT00833781|11569429|FG000|COMPLETED|Overall Study||10
10424159|NCT00833781|11569430|FG001|COMPLETED|Overall Study||5
10424160|NCT00833781|11569429|FG000|NOT COMPLETED|Overall Study||0
10424161|NCT00833781|11569430|FG001|NOT COMPLETED|Overall Study||0
10424162|NCT00833794|11569437|FG000|STARTED|Open-label Phase|Enrolled. Population described in the baseline characteristics is 1023 patients (Open-Label safety).|1028
10424163|NCT00833794|11569438|FG001|STARTED|Open-label Phase|No Placebo arm during open-label phase.|0
10424164|NCT00833794|11569437|FG000|Entered run-in Period|Open-label Phase||1027
10424165|NCT00833794|11569438|FG001|Entered run-in Period|Open-label Phase||0
10424166|NCT00833794|11569437|FG000|Received Open-Label Treatment|Open-label Phase||1023
10424167|NCT00833794|11569438|FG001|Received Open-Label Treatment|Open-label Phase||0
10424168|NCT00833794|11569437|FG000|COMPLETED|Open-label Phase|Randomized in double-blind phase|646
10424169|NCT00833794|11569438|FG001|COMPLETED|Open-label Phase||0
10424170|NCT00833794|11569437|FG000|NOT COMPLETED|Open-label Phase||382
10424171|NCT00833794|11569438|FG001|NOT COMPLETED|Open-label Phase||0
10424172|NCT00833794|11569437|FG000|STARTED|Double-blind Phase|Of the 646 patients who completed the Open-Label phase, 432 were randomized to Tramadol Once A Day|432
10424173|NCT00833794|11569438|FG001|STARTED|Double-blind Phase|Of the 646 patients who completed the Open-Label phase, 214 were randomized to Placebo|214
10424174|NCT00833794|11569437|FG000|COMPLETED|Double-blind Phase||326
10424175|NCT00833794|11569438|FG001|COMPLETED|Double-blind Phase||165
10424176|NCT00833794|11569437|FG000|NOT COMPLETED|Double-blind Phase||106
10424177|NCT00833794|11569438|FG001|NOT COMPLETED|Double-blind Phase||49
10424178|NCT00833833|11569452|FG000|STARTED|Phase 1 (as of 01 April 2011)||6
10424179|NCT00833833|11569453|FG001|STARTED|Phase 1 (as of 01 April 2011)||8
10424180|NCT00833833|11569454|FG002|STARTED|Phase 1 (as of 01 April 2011)||14
10424181|NCT00833833|11569455|FG003|STARTED|Phase 1 (as of 01 April 2011)||10
10424182|NCT00833833|11569456|FG004|STARTED|Phase 1 (as of 01 April 2011)||0
10424183|NCT00833833|11569457|FG005|STARTED|Phase 1 (as of 01 April 2011)||0
10424184|NCT00833833|11569452|FG000|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|2
10424185|NCT00833833|11569453|FG001|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|3
10424186|NCT00833833|11569454|FG002|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|5
10424187|NCT00833833|11569455|FG003|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|4
10424188|NCT00833833|11569456|FG004|COMPLETED|Phase 1 (as of 01 April 2011)||0
10424189|NCT00833833|11569457|FG005|COMPLETED|Phase 1 (as of 01 April 2011)||0
10424190|NCT00833833|11569452|FG000|NOT COMPLETED|Phase 1 (as of 01 April 2011)||4
10424191|NCT00833833|11569453|FG001|NOT COMPLETED|Phase 1 (as of 01 April 2011)||5
10424192|NCT00833833|11569454|FG002|NOT COMPLETED|Phase 1 (as of 01 April 2011)||9
10424193|NCT00833833|11569455|FG003|NOT COMPLETED|Phase 1 (as of 01 April 2011)||6
10424194|NCT00833833|11569456|FG004|NOT COMPLETED|Phase 1 (as of 01 April 2011)||0
10424195|NCT00833833|11569457|FG005|NOT COMPLETED|Phase 1 (as of 01 April 2011)||0
10424196|NCT00833833|11569452|FG000|STARTED|Phase 2 (as of 01 April 2011)||0
10424197|NCT00833833|11569453|FG001|STARTED|Phase 2 (as of 01 April 2011)||0
10424198|NCT00833833|11569454|FG002|STARTED|Phase 2 (as of 01 April 2011)||0
10424199|NCT00833833|11569455|FG003|STARTED|Phase 2 (as of 01 April 2011)||0
10424200|NCT00833833|11569456|FG004|STARTED|Phase 2 (as of 01 April 2011)||113
10424201|NCT00833833|11569457|FG005|STARTED|Phase 2 (as of 01 April 2011)||108
10424202|NCT00833833|11569452|FG000|Safety Population|Phase 2 (as of 01 April 2011)||0
10424203|NCT00833833|11569453|FG001|Safety Population|Phase 2 (as of 01 April 2011)||0
10424204|NCT00833833|11569454|FG002|Safety Population|Phase 2 (as of 01 April 2011)||0
10424205|NCT00833833|11569455|FG003|Safety Population|Phase 2 (as of 01 April 2011)||0
10424206|NCT00833833|11569456|FG004|Safety Population|Phase 2 (as of 01 April 2011)||112
10424207|NCT00833833|11569457|FG005|Safety Population|Phase 2 (as of 01 April 2011)||107
10424208|NCT00833833|11569452|FG000|COMPLETED|Phase 2 (as of 01 April 2011)||0
10424209|NCT00833833|11569453|FG001|COMPLETED|Phase 2 (as of 01 April 2011)||0
10424210|NCT00833833|11569454|FG002|COMPLETED|Phase 2 (as of 01 April 2011)||0
10424211|NCT00833833|11569455|FG003|COMPLETED|Phase 2 (as of 01 April 2011)||0
10424212|NCT00833833|11569456|FG004|COMPLETED|Phase 2 (as of 01 April 2011)|Confirmed progressive disease|58
10424213|NCT00833833|11569457|FG005|COMPLETED|Phase 2 (as of 01 April 2011)|Confirmed progressive disease|47
10424214|NCT00833833|11569452|FG000|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
10424215|NCT00833833|11569453|FG001|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
10424216|NCT00833833|11569454|FG002|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
10424217|NCT00833833|11569455|FG003|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
10424218|NCT00833833|11569456|FG004|NOT COMPLETED|Phase 2 (as of 01 April 2011)||55
10424219|NCT00833833|11569457|FG005|NOT COMPLETED|Phase 2 (as of 01 April 2011)||61
10424220|NCT00833898|11569479|FG000|STARTED|Overall Study||74
10424221|NCT00833898|11569480|FG001|STARTED|Overall Study||74
10424222|NCT00833898|11569479|FG000|Month 1 (Post Transplantation)|Overall Study||72
10424223|NCT00833898|11569480|FG001|Month 1 (Post Transplantation)|Overall Study||74
10424224|NCT00833898|11569479|FG000|Month 3 (Post Transplantation)|Overall Study||66
10424225|NCT00833898|11569480|FG001|Month 3 (Post Transplantation)|Overall Study||64
10424226|NCT00833898|11569479|FG000|Month 6 (Post Transplantation)|Overall Study||59
10424227|NCT00833898|11569480|FG001|Month 6 (Post Transplantation)|Overall Study||54
10424228|NCT00833898|11569479|FG000|Month 12 (Post Transplantation)|Overall Study||50
10424229|NCT00833898|11569480|FG001|Month 12 (Post Transplantation)|Overall Study||50
10424230|NCT00833898|11569479|FG000|COMPLETED|Overall Study||34
10424231|NCT00833898|11569480|FG001|COMPLETED|Overall Study||38
10424232|NCT00833898|11569479|FG000|NOT COMPLETED|Overall Study||40
10424233|NCT00833898|11569480|FG001|NOT COMPLETED|Overall Study||36
10429706|NCT00866034|11575791|FG000|STARTED|Overall Study||308
10429707|NCT00866034|11575792|FG001|STARTED|Overall Study||309
10429708|NCT00866034|11575791|FG000|COMPLETED|Overall Study||292
10429709|NCT00866034|11575792|FG001|COMPLETED|Overall Study||301
10429710|NCT00866034|11575791|FG000|NOT COMPLETED|Overall Study||16
10429711|NCT00866034|11575792|FG001|NOT COMPLETED|Overall Study||8
10429712|NCT00866047|11575798|FG000|STARTED|Treatment Period||58
10429713|NCT00866047|11575798|FG000|COMPLETED|Treatment Period|Number who completed 16 cycles of treatment|10
10429714|NCT00866047|11575798|FG000|NOT COMPLETED|Treatment Period||48
10429715|NCT00866047|11575798|FG000|STARTED|Follow-up Period|All participants were to be followed after treatment|58
10429716|NCT00866047|11575798|FG000|COMPLETED|Follow-up Period|Completed survival follow-up due to death [25] or study completion [28]|53
10429717|NCT00866047|11575798|FG000|NOT COMPLETED|Follow-up Period||5
10429718|NCT00866177|11575802|FG000|STARTED|Overall Study||167
10429719|NCT00866177|11575802|FG000|COMPLETED|Overall Study||15
10429720|NCT00866177|11575802|FG000|NOT COMPLETED|Overall Study||152
10429869|NCT00867009|11576020|FG000|STARTED|Induction Period|Participants with Stage IIIB/IV non-squamous (NS) non-small cell lung cancer (NSCLC)|113
10429870|NCT00867009|11576020|FG000|Received at Least 1 Dose of Study Drug|Induction Period||113
10429871|NCT00867009|11576020|FG000|Protocol Qualified (PQ) Population|Induction Period|Stage IIIB/IV NS-NSCLC, no concurrent chemotherapy, measurable disease, ≥1 dose study drug.|109
10429872|NCT00867009|11576020|FG000|COMPLETED|Induction Period|Participants continued on the study in the Maintenance Period.|51
10429873|NCT00867009|11576020|FG000|NOT COMPLETED|Induction Period||62
10429874|NCT00867009|11576020|FG000|STARTED|Maintenance Period||51
10429875|NCT00867009|11576020|FG000|COMPLETED|Maintenance Period|Participant was considered completed if they had PD, death, or stopped receiving study drug.|47
10429876|NCT00867009|11576020|FG000|NOT COMPLETED|Maintenance Period||4
10429877|NCT00867035|11576026|FG000|STARTED|Baseline to 1 Hour||13
10429878|NCT00867035|11576027|FG001|STARTED|Baseline to 1 Hour||9
10429879|NCT00867035|11576026|FG000|COMPLETED|Baseline to 1 Hour||12
10429880|NCT00867035|11576027|FG001|COMPLETED|Baseline to 1 Hour||8
10429881|NCT00867035|11576026|FG000|NOT COMPLETED|Baseline to 1 Hour||1
10429882|NCT00867035|11576027|FG001|NOT COMPLETED|Baseline to 1 Hour||1
10429883|NCT00867035|11576026|FG000|STARTED|Baseline to 2 Hours||12
10429884|NCT00867035|11576027|FG001|STARTED|Baseline to 2 Hours||8
10429885|NCT00867035|11576026|FG000|COMPLETED|Baseline to 2 Hours||12
10429886|NCT00867035|11576027|FG001|COMPLETED|Baseline to 2 Hours||8
10429887|NCT00867035|11576026|FG000|NOT COMPLETED|Baseline to 2 Hours||0
10429888|NCT00867035|11576027|FG001|NOT COMPLETED|Baseline to 2 Hours||0
10429889|NCT00867035|11576026|FG000|STARTED|Baseline to 4 Hours||12
10429890|NCT00867035|11576027|FG001|STARTED|Baseline to 4 Hours||8
10429891|NCT00867035|11576026|FG000|COMPLETED|Baseline to 4 Hours||12
10429892|NCT00867035|11576027|FG001|COMPLETED|Baseline to 4 Hours||8
10429893|NCT00867035|11576026|FG000|NOT COMPLETED|Baseline to 4 Hours||0
10429894|NCT00867035|11576027|FG001|NOT COMPLETED|Baseline to 4 Hours||0
10429895|NCT00867035|11576026|FG000|STARTED|Baseline to 1 Week||12
10429896|NCT00867035|11576027|FG001|STARTED|Baseline to 1 Week||8
10429897|NCT00867035|11576026|FG000|COMPLETED|Baseline to 1 Week||11
10429898|NCT00867035|11576027|FG001|COMPLETED|Baseline to 1 Week||8
10429899|NCT00867035|11576026|FG000|NOT COMPLETED|Baseline to 1 Week||1
10429900|NCT00867035|11576027|FG001|NOT COMPLETED|Baseline to 1 Week||0
10429901|NCT00867087|11576033|FG000|STARTED|Overall Study||63
10429902|NCT00867087|11576033|FG000|COMPLETED|Overall Study||21
10429903|NCT00867087|11576033|FG000|NOT COMPLETED|Overall Study||42
10429904|NCT00867100|11576050|FG000|STARTED|Overall Study||5
10429905|NCT00867100|11576051|FG001|STARTED|Overall Study||5
10429906|NCT00867100|11576052|FG002|STARTED|Overall Study||8
10429907|NCT00867100|11576053|FG003|STARTED|Overall Study||8
10429908|NCT00867100|11576054|FG004|STARTED|Overall Study||14
10429909|NCT00867100|11576055|FG005|STARTED|Overall Study||6
10429910|NCT00867100|11576056|FG006|STARTED|Overall Study||7
10429911|NCT00867100|11576057|FG007|STARTED|Overall Study||3
10424234|NCT00833911|11569486|FG000|STARTED|Titration||392
10424235|NCT00833911|11569486|FG000|COMPLETED|Titration||371
10424236|NCT00833911|11569486|FG000|NOT COMPLETED|Titration||21
10424237|NCT00833911|11569486|FG000|STARTED|Maintenance Phase I||371
10424238|NCT00833911|11569486|FG000|COMPLETED|Maintenance Phase I||273
10424239|NCT00833911|11569486|FG000|NOT COMPLETED|Maintenance Phase I||98
10424240|NCT00833911|11569486|FG000|STARTED|Maintenance Phase II|97 patients chose not to continue into Maintenance Phase II|176
10424241|NCT00833911|11569486|FG000|COMPLETED|Maintenance Phase II||166
10424242|NCT00833911|11569486|FG000|NOT COMPLETED|Maintenance Phase II||10
10424243|NCT00833924|11569494|FG000|STARTED|Overall Study||120
10424244|NCT00833924|11569494|FG000|30-day|Overall Study||120
10424245|NCT00833924|11569494|FG000|12-month|Overall Study||113
10424246|NCT00833924|11569494|FG000|COMPLETED|Overall Study||11
10424247|NCT00833924|11569494|FG000|NOT COMPLETED|Overall Study||109
10424248|NCT00833976|11569498|FG000|STARTED|Overall Study||65
10424249|NCT00833976|11569498|FG000|COMPLETED|Overall Study||14
10424250|NCT00833976|11569498|FG000|NOT COMPLETED|Overall Study||51
10424251|NCT00833989|11569506|FG000|STARTED|Overall Study||17
10424252|NCT00833989|11569507|FG001|STARTED|Overall Study||8
10424253|NCT00833989|11569508|FG002|STARTED|Overall Study||9
10424254|NCT00833989|11569509|FG003|STARTED|Overall Study||8
10424255|NCT00833989|11569506|FG000|COMPLETED|Overall Study||14
10424256|NCT00833989|11569507|FG001|COMPLETED|Overall Study||8
10424257|NCT00833989|11569508|FG002|COMPLETED|Overall Study||8
10424258|NCT00833989|11569509|FG003|COMPLETED|Overall Study||6
10424259|NCT00833989|11569506|FG000|NOT COMPLETED|Overall Study||3
10424260|NCT00833989|11569507|FG001|NOT COMPLETED|Overall Study||0
10424261|NCT00833989|11569508|FG002|NOT COMPLETED|Overall Study||1
10424262|NCT00833989|11569509|FG003|NOT COMPLETED|Overall Study||2
10424263|NCT00834041|11569524|FG000|STARTED|Overall Study||19
10424264|NCT00834041|11569525|FG001|STARTED|Overall Study||20
10424265|NCT00834041|11569524|FG000|COMPLETED|Overall Study||18
10424266|NCT00834041|11569525|FG001|COMPLETED|Overall Study||19
10424267|NCT00834041|11569524|FG000|NOT COMPLETED|Overall Study||1
10424268|NCT00834041|11569525|FG001|NOT COMPLETED|Overall Study||1
10424269|NCT00834080|11569531|FG000|STARTED|Overall Study||38
10424270|NCT00834080|11569531|FG000|COMPLETED|Overall Study||15
10424271|NCT00834080|11569531|FG000|NOT COMPLETED|Overall Study||23
10424272|NCT00834106|11569537|FG000|STARTED|Base Study (Day 1 to Month 30)|Randomized participants|1503
10424273|NCT00834106|11569538|FG001|STARTED|Base Study (Day 1 to Month 30)|Randomized participants|1503
10424274|NCT00834106|11569537|FG000|Vaccinated|Base Study (Day 1 to Month 30)||1503
10424275|NCT00834106|11569538|FG001|Vaccinated|Base Study (Day 1 to Month 30)||1503
10424276|NCT00834106|11569537|FG000|Completed Vaccinations|Base Study (Day 1 to Month 30)||1473
10424277|NCT00834106|11569538|FG001|Completed Vaccinations|Base Study (Day 1 to Month 30)||1463
10424278|NCT00834106|11569537|FG000|COMPLETED|Base Study (Day 1 to Month 30)|Completed Month 30 follow-up|1401
10424279|NCT00834106|11569538|FG001|COMPLETED|Base Study (Day 1 to Month 30)|Completed Month 30 follow-up|1358
10424280|NCT00834106|11569537|FG000|NOT COMPLETED|Base Study (Day 1 to Month 30)||102
10424281|NCT00834106|11569538|FG001|NOT COMPLETED|Base Study (Day 1 to Month 30)||145
10424282|NCT00834106|11569537|FG000|STARTED|Extension Study (Month 42 to Month 90)|Some participants missed the Month 30 visit but returned for the Month 42 visit|1404
10424283|NCT00834106|11569538|FG001|STARTED|Extension Study (Month 42 to Month 90)|Some participants missed the Month 30 visit but returned for the Month 42 visit|1368
10424284|NCT00834106|11569537|FG000|COMPLETED|Extension Study (Month 42 to Month 90)||1308
10424285|NCT00834106|11569538|FG001|COMPLETED|Extension Study (Month 42 to Month 90)||1294
10424286|NCT00834106|11569537|FG000|NOT COMPLETED|Extension Study (Month 42 to Month 90)||96
10424287|NCT00834106|11569538|FG001|NOT COMPLETED|Extension Study (Month 42 to Month 90)||74
10424288|NCT00834171|11569546|FG000|STARTED|Overall Study||43
10424289|NCT00834171|11569547|FG001|STARTED|Overall Study||7
10424290|NCT00834171|11569546|FG000|COMPLETED|Overall Study||43
10424291|NCT00834171|11569547|FG001|COMPLETED|Overall Study||7
10424292|NCT00834171|11569546|FG000|NOT COMPLETED|Overall Study||0
10424293|NCT00834171|11569547|FG001|NOT COMPLETED|Overall Study||0
10424294|NCT00834210|11569555|FG000|STARTED|Overall Study||86
10424295|NCT00834210|11569556|FG001|STARTED|Overall Study||85
10424296|NCT00834210|11569555|FG000|COMPLETED|Overall Study||83
10424297|NCT00834210|11569556|FG001|COMPLETED|Overall Study||77
10424298|NCT00834210|11569555|FG000|NOT COMPLETED|Overall Study||3
10424299|NCT00834210|11569556|FG001|NOT COMPLETED|Overall Study||8
10424300|NCT00834236|11569564|FG000|STARTED|Overall Study||29
10424301|NCT00834236|11569565|FG001|STARTED|Overall Study||47
10424302|NCT00834236|11569564|FG000|COMPLETED|Overall Study||29
10424303|NCT00834236|11569565|FG001|COMPLETED|Overall Study||47
10424304|NCT00834236|11569564|FG000|NOT COMPLETED|Overall Study||0
10424305|NCT00834236|11569565|FG001|NOT COMPLETED|Overall Study||0
10424306|NCT00834288|11569573|FG000|STARTED|Treatment Phase I||13
10424307|NCT00834288|11569574|FG001|STARTED|Treatment Phase I||13
10424308|NCT00834288|11569573|FG000|COMPLETED|Treatment Phase I||13
10424309|NCT00834288|11569574|FG001|COMPLETED|Treatment Phase I||13
10424310|NCT00834288|11569573|FG000|NOT COMPLETED|Treatment Phase I||0
10424311|NCT00834288|11569574|FG001|NOT COMPLETED|Treatment Phase I||0
10424312|NCT00834288|11569573|FG000|STARTED|Treatment Phase II||13
10424313|NCT00834288|11569574|FG001|STARTED|Treatment Phase II||13
10424314|NCT00834288|11569573|FG000|COMPLETED|Treatment Phase II||13
10424315|NCT00834288|11569574|FG001|COMPLETED|Treatment Phase II||13
10424316|NCT00834288|11569573|FG000|NOT COMPLETED|Treatment Phase II||0
10424317|NCT00834288|11569574|FG001|NOT COMPLETED|Treatment Phase II||0
10424318|NCT00834366|11569582|FG000|STARTED|Treatment Period 1||13
10424319|NCT00834366|11569583|FG001|STARTED|Treatment Period 1||13
10424320|NCT00834366|11569582|FG000|COMPLETED|Treatment Period 1||12
10424321|NCT00834366|11569583|FG001|COMPLETED|Treatment Period 1||12
10424322|NCT00834366|11569582|FG000|NOT COMPLETED|Treatment Period 1||1
10424323|NCT00834366|11569583|FG001|NOT COMPLETED|Treatment Period 1||1
10424324|NCT00834366|11569582|FG000|STARTED|Treatment Period 2||12
10424325|NCT00834366|11569583|FG001|STARTED|Treatment Period 2||12
10424326|NCT00834366|11569582|FG000|COMPLETED|Treatment Period 2||12
10424327|NCT00834366|11569583|FG001|COMPLETED|Treatment Period 2||12
10424328|NCT00834366|11569582|FG000|NOT COMPLETED|Treatment Period 2||0
10424329|NCT00834366|11569583|FG001|NOT COMPLETED|Treatment Period 2||0
10424330|NCT00834483|11569591|FG000|STARTED|Overall Study||31
10424331|NCT00834483|11569592|FG001|STARTED|Overall Study||29
10424332|NCT00834483|11569591|FG000|COMPLETED|Overall Study||31
10424333|NCT00834483|11569592|FG001|COMPLETED|Overall Study||29
10424334|NCT00834483|11569591|FG000|NOT COMPLETED|Overall Study||0
10424335|NCT00834483|11569592|FG001|NOT COMPLETED|Overall Study||0
10424336|NCT00834626|11569598|FG000|STARTED|Overall Study||30
10424337|NCT00834626|11569598|FG000|1 Year Follow-up|Overall Study||30
10424338|NCT00834626|11569598|FG000|COMPLETED|Overall Study||30
10424339|NCT00834626|11569598|FG000|NOT COMPLETED|Overall Study||0
10424340|NCT00834652|11569605|FG000|STARTED|Overall Study||104
10424341|NCT00834652|11569606|FG001|STARTED|Overall Study||102
10424342|NCT00834652|11569605|FG000|COMPLETED|Overall Study||66
10424343|NCT00834652|11569606|FG001|COMPLETED|Overall Study||62
10424344|NCT00834652|11569605|FG000|NOT COMPLETED|Overall Study||38
10424345|NCT00834652|11569606|FG001|NOT COMPLETED|Overall Study||40
10424346|NCT00834678|11569612|FG000|STARTED|Overall Study||11
10424347|NCT00834678|11569612|FG000|COMPLETED|Overall Study||11
10424348|NCT00834678|11569612|FG000|NOT COMPLETED|Overall Study||0
10424349|NCT00834808|11569621|FG000|STARTED|Treatment Period 1 (Day 1)||9
10424350|NCT00834808|11569622|FG001|STARTED|Treatment Period 1 (Day 1)||9
10424351|NCT00834808|11569623|FG002|STARTED|Treatment Period 1 (Day 1)||9
10424352|NCT00834808|11569621|FG000|COMPLETED|Treatment Period 1 (Day 1)||9
10424353|NCT00834808|11569622|FG001|COMPLETED|Treatment Period 1 (Day 1)||9
10424354|NCT00834808|11569623|FG002|COMPLETED|Treatment Period 1 (Day 1)||9
10424355|NCT00834808|11569621|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10424356|NCT00834808|11569622|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10424357|NCT00834808|11569623|FG002|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10424358|NCT00834808|11569621|FG000|STARTED|Treatment Period 2 (Day 8)||9
10424359|NCT00834808|11569622|FG001|STARTED|Treatment Period 2 (Day 8)||9
10424360|NCT00834808|11569623|FG002|STARTED|Treatment Period 2 (Day 8)||9
10424361|NCT00834808|11569621|FG000|COMPLETED|Treatment Period 2 (Day 8)||9
10424362|NCT00834808|11569622|FG001|COMPLETED|Treatment Period 2 (Day 8)||9
10424363|NCT00834808|11569623|FG002|COMPLETED|Treatment Period 2 (Day 8)||9
10424364|NCT00834808|11569621|FG000|NOT COMPLETED|Treatment Period 2 (Day 8)||0
10424365|NCT00834808|11569622|FG001|NOT COMPLETED|Treatment Period 2 (Day 8)||0
10424366|NCT00834808|11569623|FG002|NOT COMPLETED|Treatment Period 2 (Day 8)||0
10424367|NCT00834808|11569621|FG000|STARTED|Treatment Period 3 (Day 15)||9
10424368|NCT00834808|11569622|FG001|STARTED|Treatment Period 3 (Day 15)||9
10424369|NCT00834808|11569623|FG002|STARTED|Treatment Period 3 (Day 15)||9
10424370|NCT00834808|11569621|FG000|COMPLETED|Treatment Period 3 (Day 15)||9
10424371|NCT00834808|11569622|FG001|COMPLETED|Treatment Period 3 (Day 15)||9
10424372|NCT00834808|11569623|FG002|COMPLETED|Treatment Period 3 (Day 15)||9
10424373|NCT00834808|11569621|FG000|NOT COMPLETED|Treatment Period 3 (Day 15)||0
10424374|NCT00834808|11569622|FG001|NOT COMPLETED|Treatment Period 3 (Day 15)||0
10424375|NCT00834808|11569623|FG002|NOT COMPLETED|Treatment Period 3 (Day 15)||0
10424376|NCT00834834|11569633|FG000|STARTED|Overall Study||42
10424377|NCT00834834|11569634|FG001|STARTED|Overall Study||42
10424378|NCT00834834|11569633|FG000|COMPLETED|Overall Study||38
10424379|NCT00834834|11569634|FG001|COMPLETED|Overall Study||39
10424380|NCT00834834|11569633|FG000|NOT COMPLETED|Overall Study||4
10424381|NCT00834834|11569634|FG001|NOT COMPLETED|Overall Study||3
10424382|NCT00834886|11569644|FG000|STARTED|Overall Study||10
10424383|NCT00834886|11569645|FG001|STARTED|Overall Study||10
10424384|NCT00834886|11569646|FG002|STARTED|Overall Study||10
10424385|NCT00834886|11569647|FG003|STARTED|Overall Study||10
10424386|NCT00834886|11569644|FG000|COMPLETED|Overall Study||10
10424387|NCT00834886|11569645|FG001|COMPLETED|Overall Study||9
10424388|NCT00834886|11569646|FG002|COMPLETED|Overall Study||9
10424389|NCT00834886|11569647|FG003|COMPLETED|Overall Study||10
10424390|NCT00834886|11569644|FG000|NOT COMPLETED|Overall Study||0
10424391|NCT00834886|11569645|FG001|NOT COMPLETED|Overall Study||1
10424392|NCT00834886|11569646|FG002|NOT COMPLETED|Overall Study||1
10424393|NCT00834886|11569647|FG003|NOT COMPLETED|Overall Study||0
10424394|NCT00834899|11569659|FG000|STARTED|Overall Study||9
10424395|NCT00834899|11569660|FG001|STARTED|Overall Study||4
10424396|NCT00834899|11569659|FG000|COMPLETED|Overall Study|One patient withdrew consent following completion of the study drug infusion.|8
10424397|NCT00834899|11569660|FG001|COMPLETED|Overall Study|One patient was withdrawn early because she did not meet eligibility criteria.|3
10424398|NCT00834899|11569659|FG000|NOT COMPLETED|Overall Study||1
10424399|NCT00834899|11569660|FG001|NOT COMPLETED|Overall Study||1
10424400|NCT00834912|11569672|FG000|STARTED|Treatment Period 1||6
10424401|NCT00834912|11569673|FG001|STARTED|Treatment Period 1||6
10424402|NCT00834912|11569674|FG002|STARTED|Treatment Period 1||6
10424403|NCT00834912|11569675|FG003|STARTED|Treatment Period 1||6
10424404|NCT00834912|11569676|FG004|STARTED|Treatment Period 1||6
10424405|NCT00834912|11569677|FG005|STARTED|Treatment Period 1||6
10424406|NCT00834912|11569672|FG000|COMPLETED|Treatment Period 1||6
10424407|NCT00834912|11569673|FG001|COMPLETED|Treatment Period 1|One subject completed all of treatment period 1 assessments but did not enter treatment period 2|5
10424408|NCT00834912|11569674|FG002|COMPLETED|Treatment Period 1||6
10424409|NCT00834912|11569675|FG003|COMPLETED|Treatment Period 1|One subject completed all of treatment period 1 assessments but did not enter treatment period 2|5
10424410|NCT00834912|11569676|FG004|COMPLETED|Treatment Period 1||6
10424411|NCT00834912|11569677|FG005|COMPLETED|Treatment Period 1||6
10424412|NCT00834912|11569672|FG000|NOT COMPLETED|Treatment Period 1||0
10424413|NCT00834912|11569673|FG001|NOT COMPLETED|Treatment Period 1||1
10424414|NCT00834912|11569674|FG002|NOT COMPLETED|Treatment Period 1||0
10424415|NCT00834912|11569675|FG003|NOT COMPLETED|Treatment Period 1||1
10424416|NCT00834912|11569676|FG004|NOT COMPLETED|Treatment Period 1||0
10424417|NCT00834912|11569677|FG005|NOT COMPLETED|Treatment Period 1||0
10424418|NCT00834912|11569672|FG000|STARTED|Treatment Period 2||6
10424419|NCT00834912|11569673|FG001|STARTED|Treatment Period 2||5
10424420|NCT00834912|11569674|FG002|STARTED|Treatment Period 2||6
10424421|NCT00834912|11569675|FG003|STARTED|Treatment Period 2||5
10424422|NCT00834912|11569676|FG004|STARTED|Treatment Period 2||6
10424423|NCT00834912|11569677|FG005|STARTED|Treatment Period 2||6
10424424|NCT00834912|11569672|FG000|COMPLETED|Treatment Period 2||6
10424425|NCT00834912|11569673|FG001|COMPLETED|Treatment Period 2||5
10424426|NCT00834912|11569674|FG002|COMPLETED|Treatment Period 2|One subject completed treatment period 2 but did not enter treatment period 3|5
10424427|NCT00834912|11569675|FG003|COMPLETED|Treatment Period 2||5
10424428|NCT00834912|11569676|FG004|COMPLETED|Treatment Period 2|One subject completed treatment period 2 but did not enter treatment period 3|5
10424429|NCT00834912|11569677|FG005|COMPLETED|Treatment Period 2||6
10424430|NCT00834912|11569672|FG000|NOT COMPLETED|Treatment Period 2||0
10424431|NCT00834912|11569673|FG001|NOT COMPLETED|Treatment Period 2||0
10424432|NCT00834912|11569674|FG002|NOT COMPLETED|Treatment Period 2||1
10424433|NCT00834912|11569675|FG003|NOT COMPLETED|Treatment Period 2||0
10424434|NCT00834912|11569676|FG004|NOT COMPLETED|Treatment Period 2||1
10424435|NCT00834912|11569677|FG005|NOT COMPLETED|Treatment Period 2||0
10424436|NCT00834912|11569672|FG000|STARTED|Treatment Period 3||6
10424437|NCT00834912|11569673|FG001|STARTED|Treatment Period 3||5
10424438|NCT00834912|11569674|FG002|STARTED|Treatment Period 3||5
10424439|NCT00834912|11569675|FG003|STARTED|Treatment Period 3||5
10424440|NCT00834912|11569676|FG004|STARTED|Treatment Period 3||5
10424441|NCT00834912|11569677|FG005|STARTED|Treatment Period 3||6
10424442|NCT00834912|11569672|FG000|COMPLETED|Treatment Period 3||6
10424443|NCT00834912|11569673|FG001|COMPLETED|Treatment Period 3||5
10424444|NCT00834912|11569674|FG002|COMPLETED|Treatment Period 3||5
10424445|NCT00834912|11569675|FG003|COMPLETED|Treatment Period 3||5
10424446|NCT00834912|11569676|FG004|COMPLETED|Treatment Period 3||5
10424447|NCT00834912|11569677|FG005|COMPLETED|Treatment Period 3||6
10424448|NCT00834912|11569672|FG000|NOT COMPLETED|Treatment Period 3||0
10424449|NCT00834912|11569673|FG001|NOT COMPLETED|Treatment Period 3||0
10424450|NCT00834912|11569674|FG002|NOT COMPLETED|Treatment Period 3||0
10424451|NCT00834912|11569675|FG003|NOT COMPLETED|Treatment Period 3||0
10424452|NCT00834912|11569676|FG004|NOT COMPLETED|Treatment Period 3||0
10424453|NCT00834912|11569677|FG005|NOT COMPLETED|Treatment Period 3||0
10424454|NCT00835003|11569687|FG000|STARTED|Overall Study||636
10424455|NCT00835003|11569688|FG001|STARTED|Overall Study||638
10424456|NCT00835003|11569687|FG000|COMPLETED|Overall Study||636
10424457|NCT00835003|11569688|FG001|COMPLETED|Overall Study||638
10424458|NCT00835003|11569687|FG000|NOT COMPLETED|Overall Study||0
10424459|NCT00835003|11569688|FG001|NOT COMPLETED|Overall Study||0
10424460|NCT00835068|11569696|FG000|STARTED|Overall Study||57
10424461|NCT00835068|11569697|FG001|STARTED|Overall Study||1
10424462|NCT00835068|11569696|FG000|COMPLETED|Overall Study||47
10424463|NCT00835068|11569697|FG001|COMPLETED|Overall Study||0
10424464|NCT00835068|11569696|FG000|NOT COMPLETED|Overall Study||10
10424465|NCT00835068|11569697|FG001|NOT COMPLETED|Overall Study||1
10424466|NCT00835120|11569703|FG000|STARTED|Overall Study||34
10424467|NCT00835120|11569703|FG000|COMPLETED|Overall Study||26
10424468|NCT00835120|11569703|FG000|NOT COMPLETED|Overall Study||8
10424469|NCT00835159|11569709|FG000|STARTED|Overall Study||11
10424470|NCT00835159|11569710|FG001|STARTED|Overall Study||17
10424471|NCT00835159|11569709|FG000|COMPLETED|Overall Study||11
10424472|NCT00835159|11569710|FG001|COMPLETED|Overall Study||17
10424473|NCT00835159|11569709|FG000|NOT COMPLETED|Overall Study||0
10424474|NCT00835159|11569710|FG001|NOT COMPLETED|Overall Study||0
10424475|NCT00835185|11569716|FG000|STARTED|Overall Study||44
10424476|NCT00835185|11569716|FG000|Received at Least 1 Dose of Study Drug|Overall Study||44
10424477|NCT00835185|11569716|FG000|COMPLETED|Overall Study||44
10424478|NCT00835185|11569716|FG000|NOT COMPLETED|Overall Study||0
10424479|NCT00835198|11569723|FG000|STARTED|Overall Study||82
10424480|NCT00835198|11569724|FG001|STARTED|Overall Study||81
10424481|NCT00835198|11569723|FG000|COMPLETED|Overall Study||74
10424482|NCT00835198|11569724|FG001|COMPLETED|Overall Study||74
10424483|NCT00835198|11569723|FG000|NOT COMPLETED|Overall Study||8
10424484|NCT00835198|11569724|FG001|NOT COMPLETED|Overall Study||7
10424485|NCT00835224|11569730|FG000|STARTED|Overall Study||34
10424486|NCT00835224|11569730|FG000|COMPLETED|Overall Study||24
10424487|NCT00835224|11569730|FG000|NOT COMPLETED|Overall Study||10
10424488|NCT00835237|11569746|FG000|STARTED|Overall Study||887
10424489|NCT00835237|11569747|FG001|STARTED|Overall Study||445
10424490|NCT00835237|11569746|FG000|COMPLETED|Overall Study||881
10424491|NCT00835237|11569747|FG001|COMPLETED|Overall Study||445
10424492|NCT00835237|11569746|FG000|NOT COMPLETED|Overall Study||6
10424493|NCT00835237|11569747|FG001|NOT COMPLETED|Overall Study||0
10424494|NCT00835341|11569755|FG000|STARTED|Overall Study||35
10424495|NCT00835341|11569756|FG001|STARTED|Overall Study||58
10424496|NCT00835341|11569755|FG000|COMPLETED|Overall Study||32
10424497|NCT00835341|11569756|FG001|COMPLETED|Overall Study||46
10424498|NCT00835341|11569755|FG000|NOT COMPLETED|Overall Study||3
10424499|NCT00835341|11569756|FG001|NOT COMPLETED|Overall Study||12
10424500|NCT00835380|11569762|FG000|STARTED|Overall Study||80
10424501|NCT00835380|11569762|FG000|COMPLETED|Overall Study||78
10424502|NCT00835380|11569762|FG000|NOT COMPLETED|Overall Study||2
10424503|NCT00835510|11569769|FG000|STARTED|Overall Study||219
10424504|NCT00835510|11569770|FG001|STARTED|Overall Study||221
10424505|NCT00835510|11569771|FG002|STARTED|Overall Study||108
10424506|NCT00835510|11569769|FG000|Positive Fungal Culture|Overall Study||149
10424507|NCT00835510|11569770|FG001|Positive Fungal Culture|Overall Study||155
10424508|NCT00835510|11569771|FG002|Positive Fungal Culture|Overall Study||71
10424509|NCT00835510|11569769|FG000|COMPLETED|Overall Study||143
10424510|NCT00835510|11569770|FG001|COMPLETED|Overall Study||152
10424511|NCT00835510|11569771|FG002|COMPLETED|Overall Study||70
10424512|NCT00835510|11569769|FG000|NOT COMPLETED|Overall Study||76
10424513|NCT00835510|11569770|FG001|NOT COMPLETED|Overall Study||69
10424514|NCT00835510|11569771|FG002|NOT COMPLETED|Overall Study||38
10424515|NCT00835731|11569781|FG000|STARTED|Overall Study||64
10424516|NCT00835731|11569782|FG001|STARTED|Overall Study||61
10424517|NCT00835731|11569781|FG000|COMPLETED|Overall Study||62
10424518|NCT00835731|11569782|FG001|COMPLETED|Overall Study||60
10424519|NCT00835731|11569781|FG000|NOT COMPLETED|Overall Study||2
10424520|NCT00835731|11569782|FG001|NOT COMPLETED|Overall Study||1
10424521|NCT00835770|11569790|FG000|STARTED|Overall Study||868
10424522|NCT00835770|11569791|FG001|STARTED|Overall Study||868
10424523|NCT00835770|11569790|FG000|COMPLETED|Overall Study||384
10424524|NCT00835770|11569791|FG001|COMPLETED|Overall Study||375
10424525|NCT00835770|11569790|FG000|NOT COMPLETED|Overall Study||484
10424526|NCT00835770|11569791|FG001|NOT COMPLETED|Overall Study||493
10424527|NCT00835861|11569805|FG000|STARTED|Overall Study||15
10424528|NCT00835861|11569806|FG001|STARTED|Overall Study||16
10424529|NCT00835861|11569805|FG000|COMPLETED|Overall Study||14
10424530|NCT00835861|11569806|FG001|COMPLETED|Overall Study||14
10424531|NCT00835861|11569805|FG000|NOT COMPLETED|Overall Study||1
10424532|NCT00835861|11569806|FG001|NOT COMPLETED|Overall Study||2
10424533|NCT00835900|11569814|FG000|STARTED|Overall Study||32
10424534|NCT00835900|11569815|FG001|STARTED|Overall Study||28
10424535|NCT00835900|11569814|FG000|COMPLETED|Overall Study||27
10424536|NCT00835900|11569815|FG001|COMPLETED|Overall Study||22
10424537|NCT00835900|11569814|FG000|NOT COMPLETED|Overall Study||5
10424538|NCT00835900|11569815|FG001|NOT COMPLETED|Overall Study||6
10424539|NCT00835926|11569823|FG000|STARTED|Overall Study||61
10424540|NCT00835926|11569824|FG001|STARTED|Overall Study||60
10424541|NCT00835926|11569823|FG000|COMPLETED|Overall Study||61
10424542|NCT00835926|11569824|FG001|COMPLETED|Overall Study||60
10424543|NCT00835926|11569823|FG000|NOT COMPLETED|Overall Study||0
10424544|NCT00835926|11569824|FG001|NOT COMPLETED|Overall Study||0
10424545|NCT00835978|11569834|FG000|STARTED|Overall Study||56
10424546|NCT00835978|11569835|FG001|STARTED|Overall Study||56
10424547|NCT00835978|11569836|FG002|STARTED|Overall Study||91
10424548|NCT00835978|11569837|FG003|STARTED|Overall Study||10
10424549|NCT00835978|11569834|FG000|Treated|Overall Study||56
10424550|NCT00835978|11569835|FG001|Treated|Overall Study||56
10424551|NCT00835978|11569836|FG002|Treated|Overall Study||91
10424552|NCT00835978|11569837|FG003|Treated|Overall Study||10
10424553|NCT00835978|11569834|FG000|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
10424554|NCT00835978|11569835|FG001|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
10424555|NCT00835978|11569836|FG002|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
10424556|NCT00835978|11569837|FG003|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
10424557|NCT00835978|11569834|FG000|NOT COMPLETED|Overall Study||56
10424558|NCT00835978|11569835|FG001|NOT COMPLETED|Overall Study||56
10424559|NCT00835978|11569836|FG002|NOT COMPLETED|Overall Study||91
10424560|NCT00835978|11569837|FG003|NOT COMPLETED|Overall Study||10
10424561|NCT00836017|11569852|FG000|STARTED|Overall Study||1046
10424562|NCT00836017|11569852|FG000|COMPLETED|Overall Study||502
10424563|NCT00836017|11569852|FG000|NOT COMPLETED|Overall Study||544
10424564|NCT00836095|11569858|FG000|STARTED|Overall Study||22
10424565|NCT00836095|11569859|FG001|STARTED|Overall Study||30
10424566|NCT00836095|11569858|FG000|COMPLETED|Overall Study||22
10424567|NCT00836095|11569859|FG001|COMPLETED|Overall Study||27
10424568|NCT00836095|11569858|FG000|NOT COMPLETED|Overall Study||0
10424569|NCT00836095|11569859|FG001|NOT COMPLETED|Overall Study||3
10424570|NCT00836186|11569865|FG000|STARTED|Overall Study||82
10424571|NCT00836186|11569865|FG000|COMPLETED|Overall Study||81
10424572|NCT00836186|11569865|FG000|NOT COMPLETED|Overall Study||1
10424573|NCT00836277|11569870|FG000|STARTED|Overall Study||24
10424574|NCT00836277|11569870|FG000|COMPLETED|Overall Study||18
10424575|NCT00836277|11569870|FG000|NOT COMPLETED|Overall Study||6
10424576|NCT00836342|11569877|FG000|STARTED|Overall Study||22
10424577|NCT00836342|11569878|FG001|STARTED|Overall Study||23
10424578|NCT00836342|11569879|FG002|STARTED|Overall Study||36
10424579|NCT00836342|11569877|FG000|COMPLETED|Overall Study||22
10424580|NCT00836342|11569878|FG001|COMPLETED|Overall Study||23
10424581|NCT00836342|11569879|FG002|COMPLETED|Overall Study||36
10424582|NCT00836342|11569877|FG000|NOT COMPLETED|Overall Study||0
10424583|NCT00836342|11569878|FG001|NOT COMPLETED|Overall Study||0
10424584|NCT00836342|11569879|FG002|NOT COMPLETED|Overall Study||0
10424585|NCT00836407|11569891|FG000|STARTED|Overall Study||15
10424586|NCT00836407|11569892|FG001|STARTED|Overall Study||15
10424587|NCT00836407|11569891|FG000|COMPLETED|Overall Study||4
10424588|NCT00836407|11569892|FG001|COMPLETED|Overall Study||7
10424589|NCT00836407|11569891|FG000|NOT COMPLETED|Overall Study||11
10424590|NCT00836407|11569892|FG001|NOT COMPLETED|Overall Study||8
10424591|NCT00836433|11569900|FG000|STARTED|Overall Study||361
10424592|NCT00836433|11569901|FG001|STARTED|Overall Study||328
10424593|NCT00836433|11569900|FG000|COMPLETED|Overall Study||349
10424594|NCT00836433|11569901|FG001|COMPLETED|Overall Study||321
10424595|NCT00836433|11569900|FG000|NOT COMPLETED|Overall Study||12
10424596|NCT00836433|11569901|FG001|NOT COMPLETED|Overall Study||7
10424597|NCT00836498|11569911|FG000|STARTED|Overall Study||44
10424598|NCT00836498|11569912|FG001|STARTED|Overall Study||22
10424599|NCT00836498|11569911|FG000|COMPLETED|Overall Study|Participant who discontinued the study vaccination due to AE completed the 180-day safety follow-up.|40
10424600|NCT00836498|11569912|FG001|COMPLETED|Overall Study||21
10424601|NCT00836498|11569911|FG000|NOT COMPLETED|Overall Study||4
10424602|NCT00836498|11569912|FG001|NOT COMPLETED|Overall Study||1
10424603|NCT00836589|11569919|FG000|STARTED|Overall Study||1997
10424604|NCT00836589|11569919|FG000|COMPLETED|Overall Study||731
10424605|NCT00836589|11569919|FG000|NOT COMPLETED|Overall Study||1266
10424606|NCT00836641|11569933|FG000|STARTED|Overall Study||36
10424607|NCT00836641|11569934|FG001|STARTED|Overall Study||34
10424608|NCT00836641|11569933|FG000|COMPLETED|Overall Study||36
10424609|NCT00836641|11569934|FG001|COMPLETED|Overall Study||34
10424610|NCT00836641|11569933|FG000|NOT COMPLETED|Overall Study||0
10424611|NCT00836641|11569934|FG001|NOT COMPLETED|Overall Study||0
10424612|NCT00836693|11569941|FG000|STARTED|Overall Study||147
10424613|NCT00836693|11569942|FG001|STARTED|Overall Study||70
10424614|NCT00836693|11569941|FG000|COMPLETED|Overall Study||130
10424615|NCT00836693|11569942|FG001|COMPLETED|Overall Study||64
10424616|NCT00836693|11569941|FG000|NOT COMPLETED|Overall Study||17
10424617|NCT00836693|11569942|FG001|NOT COMPLETED|Overall Study||6
10424618|NCT00836719|11569948|FG000|STARTED|Overall Study||10
10424619|NCT00836719|11569948|FG000|COMPLETED|Overall Study||10
10424620|NCT00836719|11569948|FG000|NOT COMPLETED|Overall Study||0
10424621|NCT00836745|11569952|FG000|STARTED|Overall Study||36
10424622|NCT00836745|11569952|FG000|COMPLETED|Overall Study||15
10424623|NCT00836745|11569952|FG000|NOT COMPLETED|Overall Study||21
10424624|NCT00836758|11569956|FG000|STARTED|Overall Study||115
10424625|NCT00836758|11569956|FG000|COMPLETED|Overall Study||115
10424626|NCT00836758|11569956|FG000|NOT COMPLETED|Overall Study||0
10424633|NCT00836875|11569973|FG000|STARTED|Overall Study||11
10424634|NCT00836875|11569974|FG001|STARTED|Overall Study||20
10424635|NCT00836875|11569973|FG000|COMPLETED|Overall Study||8
10424636|NCT00836875|11569974|FG001|COMPLETED|Overall Study||17
10424637|NCT00836875|11569973|FG000|NOT COMPLETED|Overall Study||3
10424638|NCT00836875|11569974|FG001|NOT COMPLETED|Overall Study||3
10424639|NCT00836888|11569984|FG000|STARTED|Overall Study||3
10424640|NCT00836888|11569985|FG001|STARTED|Overall Study||5
10424641|NCT00836888|11569986|FG002|STARTED|Overall Study||6
10424642|NCT00836888|11569987|FG003|STARTED|Overall Study||3
10424643|NCT00836888|11569984|FG000|COMPLETED|Overall Study||0
10424644|NCT00836888|11569985|FG001|COMPLETED|Overall Study||2
10424645|NCT00836888|11569986|FG002|COMPLETED|Overall Study||0
10424646|NCT00836888|11569987|FG003|COMPLETED|Overall Study||0
10424647|NCT00836888|11569984|FG000|NOT COMPLETED|Overall Study||3
10424648|NCT00836888|11569985|FG001|NOT COMPLETED|Overall Study||3
10424649|NCT00836888|11569986|FG002|NOT COMPLETED|Overall Study||6
10424650|NCT00836888|11569987|FG003|NOT COMPLETED|Overall Study||3
10424651|NCT00836927|11570002|FG000|STARTED|Overall Study||3
10424652|NCT00836927|11570003|FG001|STARTED|Overall Study||1
10424653|NCT00836927|11570004|FG002|STARTED|Overall Study|One participant received ridaforolimus 3 mg IV infusion before being switched to the oral tablet.|1
10424654|NCT00836927|11570005|FG003|STARTED|Overall Study||1
10424655|NCT00836927|11570006|FG004|STARTED|Overall Study||1
10424656|NCT00836927|11570002|FG000|Completed Dosing Through 03 Apr 2017|Overall Study||0
10424657|NCT00836927|11570003|FG001|Completed Dosing Through 03 Apr 2017|Overall Study|Participant continued to receive study drug past the data cut-off date of 03 Apr 2017|1
10424658|NCT00836927|11570004|FG002|Completed Dosing Through 03 Apr 2017|Overall Study|Participant continued to receive study drug past the data cut-off date of 03 Apr 2017|1
10424659|NCT00836927|11570005|FG003|Completed Dosing Through 03 Apr 2017|Overall Study||0
10424660|NCT00836927|11570006|FG004|Completed Dosing Through 03 Apr 2017|Overall Study||0
10424661|NCT00836927|11570002|FG000|COMPLETED|Overall Study||0
10424662|NCT00836927|11570003|FG001|COMPLETED|Overall Study|Participant completed treatment by 04 Feb 2018|1
10424663|NCT00836927|11570004|FG002|COMPLETED|Overall Study|Participant completed treatment by 04 Feb 2018|1
10424664|NCT00836927|11570005|FG003|COMPLETED|Overall Study||0
10424665|NCT00836927|11570006|FG004|COMPLETED|Overall Study||0
10424666|NCT00836927|11570002|FG000|NOT COMPLETED|Overall Study||3
10424667|NCT00836927|11570003|FG001|NOT COMPLETED|Overall Study||0
10424668|NCT00836927|11570004|FG002|NOT COMPLETED|Overall Study||0
10424669|NCT00836927|11570005|FG003|NOT COMPLETED|Overall Study||1
10424670|NCT00836927|11570006|FG004|NOT COMPLETED|Overall Study||1
10424671|NCT00836953|11570020|FG000|STARTED|Overall Study||33
10424672|NCT00836953|11570020|FG000|COMPLETED|Overall Study||31
10424673|NCT00836953|11570020|FG000|NOT COMPLETED|Overall Study||2
10424674|NCT00837031|11570024|FG000|STARTED|Overall Study||72
10424675|NCT00837031|11570024|FG000|COMPLETED|Overall Study||72
10424676|NCT00837031|11570024|FG000|NOT COMPLETED|Overall Study||0
10424683|NCT00837148|11570037|FG000|STARTED|Overall Study||37
10424684|NCT00837148|11570037|FG000|COMPLETED|Overall Study||35
10424685|NCT00837148|11570037|FG000|NOT COMPLETED|Overall Study||2
10424686|NCT00837161|11570041|FG000|STARTED|Overall Study||11
10424687|NCT00837161|11570041|FG000|COMPLETED|Overall Study||9
10424688|NCT00837161|11570041|FG000|NOT COMPLETED|Overall Study||2
10424689|NCT00837200|11570045|FG000|STARTED|Overall Study||13
10424690|NCT00837200|11570045|FG000|COMPLETED|Overall Study||13
10424691|NCT00837200|11570045|FG000|NOT COMPLETED|Overall Study||0
10424692|NCT00837213|11570051|FG000|STARTED|Overall Study||16
10424693|NCT00837213|11570052|FG001|STARTED|Overall Study||17
10424694|NCT00837213|11570051|FG000|COMPLETED|Overall Study||10
10424695|NCT00837213|11570052|FG001|COMPLETED|Overall Study||12
10424696|NCT00837213|11570051|FG000|NOT COMPLETED|Overall Study||6
10424697|NCT00837213|11570052|FG001|NOT COMPLETED|Overall Study||5
10424698|NCT00837252|11570058|FG000|STARTED|Overall Study||5
10424699|NCT00837252|11570058|FG000|COMPLETED|Overall Study||5
10424700|NCT00837252|11570058|FG000|NOT COMPLETED|Overall Study||0
10424701|NCT00837330|11570064|FG000|STARTED|Overall Study||10
10424702|NCT00837330|11570065|FG001|STARTED|Overall Study||10
10424703|NCT00837330|11570064|FG000|COMPLETED|Overall Study||9
10424704|NCT00837330|11570065|FG001|COMPLETED|Overall Study||7
10424705|NCT00837330|11570064|FG000|NOT COMPLETED|Overall Study||1
10424706|NCT00837330|11570065|FG001|NOT COMPLETED|Overall Study||3
10424707|NCT00837434|11570073|FG000|STARTED|Overall Study||43
10424708|NCT00837434|11570074|FG001|STARTED|Overall Study||20
10424709|NCT00837434|11570073|FG000|COMPLETED|Overall Study||34
10424710|NCT00837434|11570074|FG001|COMPLETED|Overall Study||19
10424711|NCT00837434|11570073|FG000|NOT COMPLETED|Overall Study||9
10424712|NCT00837434|11570074|FG001|NOT COMPLETED|Overall Study||1
10424713|NCT00837447|11570080|FG000|STARTED|Overall Study|Each of the 54 pts received a Nexgen CR on one side and a Nexgen CR-Flex on the contralateral side.|54
10424714|NCT00837447|11570080|FG000|COMPLETED|Overall Study|Each of the 54 pts received a Nexgen CR on one side and a Nexgen CR-Flex on the contralateral side.|54
10424715|NCT00837447|11570080|FG000|NOT COMPLETED|Overall Study||0
10424716|NCT00837473|11570085|FG000|STARTED|Overall Study||15
10424717|NCT00837473|11570085|FG000|COMPLETED|Overall Study||12
10424718|NCT00837473|11570085|FG000|NOT COMPLETED|Overall Study||3
10424719|NCT00837486|11570091|FG000|STARTED|Blinded-treatment Phase||16
10424720|NCT00837486|11570092|FG001|STARTED|Blinded-treatment Phase||14
10424721|NCT00837486|11570091|FG000|COMPLETED|Blinded-treatment Phase|One subject did not receive the allocated intervention.|15
10424722|NCT00837486|11570092|FG001|COMPLETED|Blinded-treatment Phase||14
10424723|NCT00837486|11570091|FG000|NOT COMPLETED|Blinded-treatment Phase||1
10424724|NCT00837486|11570092|FG001|NOT COMPLETED|Blinded-treatment Phase||0
10424725|NCT00837486|11570091|FG000|STARTED|Long-term Follow-up Phase - Open Label|All subjects received open-label stimulation during this phase.|29
10424726|NCT00837486|11570092|FG001|STARTED|Long-term Follow-up Phase - Open Label||0
10424727|NCT00837486|11570091|FG000|COMPLETED|Long-term Follow-up Phase - Open Label||24
10424728|NCT00837486|11570092|FG001|COMPLETED|Long-term Follow-up Phase - Open Label||0
10424729|NCT00837486|11570091|FG000|NOT COMPLETED|Long-term Follow-up Phase - Open Label||5
10424730|NCT00837486|11570092|FG001|NOT COMPLETED|Long-term Follow-up Phase - Open Label||0
10424731|NCT00837512|11570100|FG000|STARTED|First Intervention (6hrs) - RANDOMIZED||8
10424732|NCT00837512|11570101|FG001|STARTED|First Intervention (6hrs) - RANDOMIZED||8
10424733|NCT00837512|11570100|FG000|COMPLETED|First Intervention (6hrs) - RANDOMIZED||8
10424734|NCT00837512|11570101|FG001|COMPLETED|First Intervention (6hrs) - RANDOMIZED||8
10424735|NCT00837512|11570100|FG000|NOT COMPLETED|First Intervention (6hrs) - RANDOMIZED||0
10424736|NCT00837512|11570101|FG001|NOT COMPLETED|First Intervention (6hrs) - RANDOMIZED||0
10424737|NCT00837512|11570100|FG000|STARTED|Both Arms: Washout (7-28 Days)||8
10424738|NCT00837512|11570101|FG001|STARTED|Both Arms: Washout (7-28 Days)||8
10424739|NCT00837512|11570100|FG000|COMPLETED|Both Arms: Washout (7-28 Days)||8
10424740|NCT00837512|11570101|FG001|COMPLETED|Both Arms: Washout (7-28 Days)||8
10424741|NCT00837512|11570100|FG000|NOT COMPLETED|Both Arms: Washout (7-28 Days)||0
10424742|NCT00837512|11570101|FG001|NOT COMPLETED|Both Arms: Washout (7-28 Days)||0
10424743|NCT00837512|11570100|FG000|STARTED|2nd Intervention (6 Hrs) - RANDOMIZED||8
10424744|NCT00837512|11570101|FG001|STARTED|2nd Intervention (6 Hrs) - RANDOMIZED||8
10424745|NCT00837512|11570100|FG000|COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||8
10424746|NCT00837512|11570101|FG001|COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||8
10424747|NCT00837512|11570100|FG000|NOT COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||0
10424748|NCT00837512|11570101|FG001|NOT COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||0
10424749|NCT00837577|11570109|FG000|STARTED|Double-blind Period||70
10424750|NCT00837577|11570110|FG001|STARTED|Double-blind Period||63
10424751|NCT00837577|11570109|FG000|COMPLETED|Double-blind Period||68
10424752|NCT00837577|11570110|FG001|COMPLETED|Double-blind Period||63
10424753|NCT00837577|11570109|FG000|NOT COMPLETED|Double-blind Period||2
10424754|NCT00837577|11570110|FG001|NOT COMPLETED|Double-blind Period||0
10424755|NCT00837577|11570109|FG000|STARTED|Open-label Period||68
10424756|NCT00837577|11570110|FG001|STARTED|Open-label Period||63
10424757|NCT00837577|11570109|FG000|COMPLETED|Open-label Period||60
10424758|NCT00837577|11570110|FG001|COMPLETED|Open-label Period||54
10424759|NCT00837577|11570109|FG000|NOT COMPLETED|Open-label Period||8
10424760|NCT00837577|11570110|FG001|NOT COMPLETED|Open-label Period||9
10424761|NCT00837590|11570120|FG000|STARTED|Overall Study||6
10424762|NCT00837590|11570121|FG001|STARTED|Overall Study||5
10424763|NCT00837590|11570122|FG002|STARTED|Overall Study||5
10424764|NCT00837590|11570120|FG000|COMPLETED|Overall Study||6
10424765|NCT00837590|11570121|FG001|COMPLETED|Overall Study||4
10424766|NCT00837590|11570122|FG002|COMPLETED|Overall Study||4
10424767|NCT00837590|11570120|FG000|NOT COMPLETED|Overall Study||0
10424768|NCT00837590|11570121|FG001|NOT COMPLETED|Overall Study||1
10424769|NCT00837590|11570122|FG002|NOT COMPLETED|Overall Study||1
10424770|NCT00837616|11570132|FG000|STARTED|Overall Study||20
10424771|NCT00837616|11570133|FG001|STARTED|Overall Study||21
10424772|NCT00837616|11570132|FG000|COMPLETED|Overall Study||20
10424773|NCT00837616|11570133|FG001|COMPLETED|Overall Study||20
10424774|NCT00837616|11570132|FG000|NOT COMPLETED|Overall Study||0
10424775|NCT00837616|11570133|FG001|NOT COMPLETED|Overall Study||1
10424776|NCT00837694|11570145|FG000|STARTED|Overall Study||10
10424777|NCT00837694|11570146|FG001|STARTED|Overall Study||11
10424778|NCT00837694|11570147|FG002|STARTED|Overall Study||10
10424779|NCT00837694|11570148|FG003|STARTED|Overall Study||11
10424780|NCT00837694|11570149|FG004|STARTED|Overall Study||12
10424781|NCT00837694|11570150|FG005|STARTED|Overall Study||11
10424782|NCT00837694|11570145|FG000|COMPLETED|Overall Study||8
10424783|NCT00837694|11570146|FG001|COMPLETED|Overall Study||11
10424784|NCT00837694|11570147|FG002|COMPLETED|Overall Study||8
10424785|NCT00837694|11570148|FG003|COMPLETED|Overall Study||10
10424786|NCT00837694|11570149|FG004|COMPLETED|Overall Study||11
10424787|NCT00837694|11570150|FG005|COMPLETED|Overall Study||10
10424788|NCT00837694|11570145|FG000|NOT COMPLETED|Overall Study||2
10424789|NCT00837694|11570146|FG001|NOT COMPLETED|Overall Study||0
10424790|NCT00837694|11570147|FG002|NOT COMPLETED|Overall Study||2
10424791|NCT00837694|11570148|FG003|NOT COMPLETED|Overall Study||1
10424792|NCT00837694|11570149|FG004|NOT COMPLETED|Overall Study||1
10424793|NCT00837694|11570150|FG005|NOT COMPLETED|Overall Study||1
10424794|NCT00837759|11570164|FG000|STARTED|Overall Study||7
10424795|NCT00837759|11570164|FG000|COMPLETED|Overall Study||3
10424796|NCT00837759|11570164|FG000|NOT COMPLETED|Overall Study||4
10424797|NCT00837811|11570171|FG000|STARTED|Overall Study||60
10424798|NCT00837811|11570172|FG001|STARTED|Overall Study||121
10424799|NCT00837811|11570173|FG002|STARTED|Overall Study||1
10424800|NCT00837811|11570171|FG000|Received Any Amount of Study Drug|Overall Study||60
10424801|NCT00837811|11570172|FG001|Received Any Amount of Study Drug|Overall Study||121
10424802|NCT00837811|11570173|FG002|Received Any Amount of Study Drug|Overall Study||1
10424803|NCT00837811|11570171|FG000|Had at Least 1 Efficacy Assessment|Overall Study||59
10424804|NCT00837811|11570172|FG001|Had at Least 1 Efficacy Assessment|Overall Study||121
10424805|NCT00837811|11570173|FG002|Had at Least 1 Efficacy Assessment|Overall Study||1
10424806|NCT00837811|11570171|FG000|Included in Efficacy Analyses|Overall Study||59
10424807|NCT00837811|11570172|FG001|Included in Efficacy Analyses|Overall Study|Excludes participant from site with Good Clinical Practice (GCP) violations.|120
10424808|NCT00837811|11570173|FG002|Included in Efficacy Analyses|Overall Study||1
10424809|NCT00837811|11570171|FG000|COMPLETED|Overall Study||53
10424810|NCT00837811|11570172|FG001|COMPLETED|Overall Study||87
10424811|NCT00837811|11570173|FG002|COMPLETED|Overall Study||0
10424812|NCT00837811|11570171|FG000|NOT COMPLETED|Overall Study||7
10424813|NCT00837811|11570172|FG001|NOT COMPLETED|Overall Study||34
10424814|NCT00837811|11570173|FG002|NOT COMPLETED|Overall Study||1
10424815|NCT00837824|11570192|FG000|STARTED|Overall Study||11
10424816|NCT00837824|11570193|FG001|STARTED|Overall Study||9
10424817|NCT00837824|11570192|FG000|COMPLETED|Overall Study||11
10424818|NCT00837824|11570193|FG001|COMPLETED|Overall Study||9
10424819|NCT00837824|11570192|FG000|NOT COMPLETED|Overall Study||0
10424820|NCT00837824|11570193|FG001|NOT COMPLETED|Overall Study||0
10424821|NCT00837876|11570200|FG000|STARTED|Overall Study||37
10424822|NCT00837876|11570200|FG000|COMPLETED|Overall Study||0
10424823|NCT00837876|11570200|FG000|NOT COMPLETED|Overall Study||37
10424824|NCT00837902|11570206|FG000|STARTED|Overall Study||85
10424825|NCT00837902|11570207|FG001|STARTED|Overall Study||69
10424826|NCT00837902|11570206|FG000|COMPLETED|Overall Study||85
10424827|NCT00837902|11570207|FG001|COMPLETED|Overall Study||69
10424828|NCT00837902|11570206|FG000|NOT COMPLETED|Overall Study||0
10424829|NCT00837902|11570207|FG001|NOT COMPLETED|Overall Study||0
10424830|NCT00837967|11570214|FG000|STARTED|First Intervention||13
10424831|NCT00837967|11570215|FG001|STARTED|First Intervention||12
10424832|NCT00837967|11570214|FG000|COMPLETED|First Intervention||13
10424833|NCT00837967|11570215|FG001|COMPLETED|First Intervention||12
10424834|NCT00837967|11570214|FG000|NOT COMPLETED|First Intervention||0
10424835|NCT00837967|11570215|FG001|NOT COMPLETED|First Intervention||0
10424836|NCT00837967|11570214|FG000|STARTED|Washout Period of 7 - 14 Days||13
10424837|NCT00837967|11570215|FG001|STARTED|Washout Period of 7 - 14 Days||12
10424838|NCT00837967|11570214|FG000|COMPLETED|Washout Period of 7 - 14 Days||11
10424839|NCT00837967|11570215|FG001|COMPLETED|Washout Period of 7 - 14 Days||12
10424840|NCT00837967|11570214|FG000|NOT COMPLETED|Washout Period of 7 - 14 Days||2
10424841|NCT00837967|11570215|FG001|NOT COMPLETED|Washout Period of 7 - 14 Days||0
10424842|NCT00837967|11570214|FG000|STARTED|Second Intervention||11
10424843|NCT00837967|11570215|FG001|STARTED|Second Intervention||12
10424844|NCT00837967|11570214|FG000|COMPLETED|Second Intervention||11
10424845|NCT00837967|11570215|FG001|COMPLETED|Second Intervention||12
10424846|NCT00837967|11570214|FG000|NOT COMPLETED|Second Intervention||0
10424847|NCT00837967|11570215|FG001|NOT COMPLETED|Second Intervention||0
10424848|NCT00838006|11570224|FG000|STARTED|Overall Study||102
10424849|NCT00838006|11570225|FG001|STARTED|Overall Study||98
10424850|NCT00838006|11570226|FG002|STARTED|Overall Study||142
10424851|NCT00838006|11570224|FG000|3-month Post-deployment Follow-up|Overall Study||92
10424852|NCT00838006|11570225|FG001|3-month Post-deployment Follow-up|Overall Study||80
10424853|NCT00838006|11570226|FG002|3-month Post-deployment Follow-up|Overall Study||135
10424854|NCT00838006|11570224|FG000|COMPLETED|Overall Study||68
10424855|NCT00838006|11570225|FG001|COMPLETED|Overall Study||72
10424856|NCT00838006|11570226|FG002|COMPLETED|Overall Study||94
10424857|NCT00838006|11570224|FG000|NOT COMPLETED|Overall Study||34
10424858|NCT00838006|11570225|FG001|NOT COMPLETED|Overall Study||26
10424859|NCT00838006|11570226|FG002|NOT COMPLETED|Overall Study||48
10424860|NCT00838097|11570236|FG000|STARTED|Overall Study||321
10424861|NCT00838097|11570236|FG000|Received Darbepoetin Alfa|Overall Study||319
10424862|NCT00838097|11570236|FG000|COMPLETED|Overall Study||145
10424863|NCT00838097|11570236|FG000|NOT COMPLETED|Overall Study||176
10424864|NCT00838110|11570242|FG000|STARTED|Overall Study||127
10424865|NCT00838110|11570243|FG001|STARTED|Overall Study||128
10424866|NCT00838110|11570244|FG002|STARTED|Overall Study||243
10424867|NCT00838110|11570245|FG003|STARTED|Overall Study||244
10424868|NCT00838110|11570242|FG000|Treated|Overall Study||127
10424869|NCT00838110|11570243|FG001|Treated|Overall Study||127
10424870|NCT00838110|11570244|FG002|Treated|Overall Study||243
10424871|NCT00838110|11570245|FG003|Treated|Overall Study||244
10424872|NCT00838110|11570242|FG000|COMPLETED|Overall Study||105
10424873|NCT00838110|11570243|FG001|COMPLETED|Overall Study||106
10424874|NCT00838110|11570244|FG002|COMPLETED|Overall Study||226
10424875|NCT00838110|11570245|FG003|COMPLETED|Overall Study||226
10424876|NCT00838110|11570242|FG000|NOT COMPLETED|Overall Study||22
10424877|NCT00838110|11570243|FG001|NOT COMPLETED|Overall Study||22
10424878|NCT00838110|11570244|FG002|NOT COMPLETED|Overall Study||17
10424879|NCT00838110|11570245|FG003|NOT COMPLETED|Overall Study||18
10424880|NCT00838162|11570259|FG000|STARTED|Overall Study||9
10424881|NCT00838162|11570260|FG001|STARTED|Overall Study||8
10424882|NCT00838162|11570261|FG002|STARTED|Overall Study||8
10424883|NCT00838162|11570262|FG003|STARTED|Overall Study||8
10424884|NCT00838162|11570259|FG000|COMPLETED|Overall Study||9
10424885|NCT00838162|11570260|FG001|COMPLETED|Overall Study||8
10424886|NCT00838162|11570261|FG002|COMPLETED|Overall Study||8
10424887|NCT00838162|11570262|FG003|COMPLETED|Overall Study||8
10424888|NCT00838162|11570259|FG000|NOT COMPLETED|Overall Study||0
10424889|NCT00838162|11570260|FG001|NOT COMPLETED|Overall Study||0
10424890|NCT00838162|11570261|FG002|NOT COMPLETED|Overall Study||0
10424891|NCT00838162|11570262|FG003|NOT COMPLETED|Overall Study||0
10424892|NCT00838201|11570274|FG000|STARTED|Overall Study||186
10424893|NCT00838201|11570275|FG001|STARTED|Overall Study||198
10424894|NCT00838201|11570274|FG000|COMPLETED|Overall Study||144
10424895|NCT00838201|11570275|FG001|COMPLETED|Overall Study||145
10424896|NCT00838201|11570274|FG000|NOT COMPLETED|Overall Study||42
10424897|NCT00838201|11570275|FG001|NOT COMPLETED|Overall Study||53
10424898|NCT00838331|11570281|FG000|STARTED|Fresh Blood Transfusion||17
10424899|NCT00838331|11570281|FG000|COMPLETED|Fresh Blood Transfusion||17
10424900|NCT00838331|11570281|FG000|NOT COMPLETED|Fresh Blood Transfusion||0
10424901|NCT00838331|11570281|FG000|STARTED|Aged Blood Transfusion||17
10424902|NCT00838331|11570281|FG000|COMPLETED|Aged Blood Transfusion||8
10424903|NCT00838331|11570281|FG000|NOT COMPLETED|Aged Blood Transfusion||9
10424904|NCT00838435|11570285|FG000|STARTED|Part 1 (4 Weeks)||95
10424905|NCT00838435|11570285|FG000|COMPLETED|Part 1 (4 Weeks)||95
10424906|NCT00838435|11570285|FG000|NOT COMPLETED|Part 1 (4 Weeks)||0
10424907|NCT00838435|11570285|FG000|STARTED|PK Sub-Study 2 (4 Weeks)|1 subject declined participation in the PK Sub-Study.|94
10424908|NCT00838435|11570285|FG000|COMPLETED|PK Sub-Study 2 (4 Weeks)||93
10424909|NCT00838435|11570285|FG000|NOT COMPLETED|PK Sub-Study 2 (4 Weeks)||1
10424910|NCT00838435|11570285|FG000|STARTED|Safety/Efficacy Sub-Study 1 (6 Months)|65 of 95 subjects in Part 1 were determined responders & eligible for the Safety/Efficacy Sub-study.|65
10424911|NCT00838435|11570285|FG000|COMPLETED|Safety/Efficacy Sub-Study 1 (6 Months)||63
10424912|NCT00838435|11570285|FG000|NOT COMPLETED|Safety/Efficacy Sub-Study 1 (6 Months)||2
10424913|NCT00838435|11570285|FG000|STARTED|Part 2 (7 Years)|65 of 95 subjects in Part 1 were determined responders & eligible for the Part 2 of the study.|65
10424914|NCT00838435|11570285|FG000|COMPLETED|Part 2 (7 Years)||49
10424915|NCT00838435|11570285|FG000|NOT COMPLETED|Part 2 (7 Years)||16
10424916|NCT00838513|11570292|FG000|STARTED|Screening Period||23
10424917|NCT00838513|11570292|FG000|COMPLETED|Screening Period||20
10424918|NCT00838513|11570292|FG000|NOT COMPLETED|Screening Period||3
10424919|NCT00838513|11570292|FG000|STARTED|Observation Period (8 Weeks)||20
10424920|NCT00838513|11570292|FG000|COMPLETED|Observation Period (8 Weeks)||20
10424921|NCT00838513|11570292|FG000|NOT COMPLETED|Observation Period (8 Weeks)||0
10424922|NCT00838513|11570292|FG000|STARTED|Treatment Period (26 Weeks)||20
10424923|NCT00838513|11570292|FG000|COMPLETED|Treatment Period (26 Weeks)||20
10424924|NCT00838513|11570292|FG000|NOT COMPLETED|Treatment Period (26 Weeks)||0
10424925|NCT00838513|11570292|FG000|STARTED|Extension Treatment Period||19
10424926|NCT00838513|11570292|FG000|COMPLETED|Extension Treatment Period||18
10424927|NCT00838513|11570292|FG000|NOT COMPLETED|Extension Treatment Period||1
10424928|NCT00838513|11570292|FG000|STARTED|Post Treatment Period (Patients Who Disc||5
10424929|NCT00838513|11570292|FG000|COMPLETED|Post Treatment Period (Patients Who Disc||4
10424930|NCT00838513|11570292|FG000|NOT COMPLETED|Post Treatment Period (Patients Who Disc||1
10424931|NCT00838539|11570308|FG000|STARTED|Overall Study||3
10424932|NCT00838539|11570309|FG001|STARTED|Overall Study||6
10424933|NCT00838539|11570310|FG002|STARTED|Overall Study||5
10424934|NCT00838539|11570311|FG003|STARTED|Overall Study||4
10424935|NCT00838539|11570312|FG004|STARTED|Overall Study||6
10424936|NCT00838539|11570313|FG005|STARTED|Overall Study||4
10424937|NCT00838539|11570314|FG006|STARTED|Overall Study||7
10424938|NCT00838539|11570315|FG007|STARTED|Overall Study||6
10424939|NCT00838539|11570316|FG008|STARTED|Overall Study||5
10424940|NCT00838539|11570317|FG009|STARTED|Overall Study||8
10424941|NCT00838539|11570318|FG010|STARTED|Overall Study||5
10424942|NCT00838539|11570319|FG011|STARTED|Overall Study||4
10424943|NCT00838539|11570308|FG000|Received Treatment|Overall Study||3
10424944|NCT00838539|11570309|FG001|Received Treatment|Overall Study||5
10424945|NCT00838539|11570310|FG002|Received Treatment|Overall Study||5
10424946|NCT00838539|11570311|FG003|Received Treatment|Overall Study||4
10424947|NCT00838539|11570312|FG004|Received Treatment|Overall Study||4
10424948|NCT00838539|11570313|FG005|Received Treatment|Overall Study||4
10424949|NCT00838539|11570314|FG006|Received Treatment|Overall Study||7
10424950|NCT00838539|11570315|FG007|Received Treatment|Overall Study||6
10424951|NCT00838539|11570316|FG008|Received Treatment|Overall Study||5
10424952|NCT00838539|11570317|FG009|Received Treatment|Overall Study||8
10424953|NCT00838539|11570318|FG010|Received Treatment|Overall Study||5
10424954|NCT00838539|11570319|FG011|Received Treatment|Overall Study||4
10424955|NCT00838539|11570308|FG000|COMPLETED|Overall Study||0
10424956|NCT00838539|11570309|FG001|COMPLETED|Overall Study||0
10424957|NCT00838539|11570310|FG002|COMPLETED|Overall Study||0
10424958|NCT00838539|11570311|FG003|COMPLETED|Overall Study||0
10424959|NCT00838539|11570312|FG004|COMPLETED|Overall Study||0
10424960|NCT00838539|11570313|FG005|COMPLETED|Overall Study||0
10424961|NCT00838539|11570314|FG006|COMPLETED|Overall Study||2
10424962|NCT00838539|11570315|FG007|COMPLETED|Overall Study||0
10424963|NCT00838539|11570316|FG008|COMPLETED|Overall Study||0
10424964|NCT00838539|11570317|FG009|COMPLETED|Overall Study||0
10424965|NCT00838539|11570318|FG010|COMPLETED|Overall Study||0
10424966|NCT00838539|11570319|FG011|COMPLETED|Overall Study||0
10424967|NCT00838539|11570308|FG000|NOT COMPLETED|Overall Study||3
10424968|NCT00838539|11570309|FG001|NOT COMPLETED|Overall Study||6
10424969|NCT00838539|11570310|FG002|NOT COMPLETED|Overall Study||5
10424970|NCT00838539|11570311|FG003|NOT COMPLETED|Overall Study||4
10424971|NCT00838539|11570312|FG004|NOT COMPLETED|Overall Study||6
10424972|NCT00838539|11570313|FG005|NOT COMPLETED|Overall Study||4
10424973|NCT00838539|11570314|FG006|NOT COMPLETED|Overall Study||5
10424974|NCT00838539|11570315|FG007|NOT COMPLETED|Overall Study||6
10424975|NCT00838539|11570316|FG008|NOT COMPLETED|Overall Study||5
10424976|NCT00838539|11570317|FG009|NOT COMPLETED|Overall Study||8
10424977|NCT00838539|11570318|FG010|NOT COMPLETED|Overall Study||5
10424978|NCT00838539|11570319|FG011|NOT COMPLETED|Overall Study||4
10424979|NCT00838565|11570365|FG000|STARTED|Overall Study||9
10424980|NCT00838565|11570366|FG001|STARTED|Overall Study||7
10424981|NCT00838565|11570367|FG002|STARTED|Overall Study||6
10424982|NCT00838565|11570368|FG003|STARTED|Overall Study||6
10424983|NCT00838565|11570369|FG004|STARTED|Overall Study||6
10424984|NCT00838565|11570370|FG005|STARTED|Overall Study||7
10424985|NCT00838565|11570365|FG000|Treated|Overall Study||9
10424986|NCT00838565|11570366|FG001|Treated|Overall Study||6
10424987|NCT00838565|11570367|FG002|Treated|Overall Study||6
10424988|NCT00838565|11570368|FG003|Treated|Overall Study||6
10424989|NCT00838565|11570369|FG004|Treated|Overall Study||6
10424990|NCT00838565|11570370|FG005|Treated|Overall Study||7
10424991|NCT00838565|11570365|FG000|COMPLETED|Overall Study||9
10424992|NCT00838565|11570366|FG001|COMPLETED|Overall Study||4
10424993|NCT00838565|11570367|FG002|COMPLETED|Overall Study||5
10424994|NCT00838565|11570368|FG003|COMPLETED|Overall Study||6
10424995|NCT00838565|11570369|FG004|COMPLETED|Overall Study||6
10424996|NCT00838565|11570370|FG005|COMPLETED|Overall Study||5
10424997|NCT00838565|11570365|FG000|NOT COMPLETED|Overall Study||0
10424998|NCT00838565|11570366|FG001|NOT COMPLETED|Overall Study||3
10424999|NCT00838565|11570367|FG002|NOT COMPLETED|Overall Study||1
10425000|NCT00838565|11570368|FG003|NOT COMPLETED|Overall Study||0
10425001|NCT00838565|11570369|FG004|NOT COMPLETED|Overall Study||0
10425002|NCT00838565|11570370|FG005|NOT COMPLETED|Overall Study||2
10425003|NCT00838578|11570389|FG000|STARTED|Overall Study|In this Ph 1/2 study, 65 subjects were enrolled; 2 were protocol violators, so only 63 treated.|65
10425004|NCT00838578|11570389|FG000|COMPLETED|Overall Study||63
10425005|NCT00838578|11570389|FG000|NOT COMPLETED|Overall Study||2
10425006|NCT00838682|11570399|FG000|STARTED|Overall Study||54
10425007|NCT00838682|11570400|FG001|STARTED|Overall Study||52
10425008|NCT00838682|11570399|FG000|COMPLETED|Overall Study||29
10425009|NCT00838682|11570400|FG001|COMPLETED|Overall Study||33
10425010|NCT00838682|11570399|FG000|NOT COMPLETED|Overall Study||25
10425011|NCT00838682|11570400|FG001|NOT COMPLETED|Overall Study||19
10425012|NCT00838695|11570408|FG000|STARTED|Overall Study||42
10425013|NCT00838695|11570409|FG001|STARTED|Overall Study||64
10425014|NCT00838695|11570408|FG000|COMPLETED|Overall Study||42
10425015|NCT00838695|11570409|FG001|COMPLETED|Overall Study||64
10425016|NCT00838695|11570408|FG000|NOT COMPLETED|Overall Study||0
10425017|NCT00838695|11570409|FG001|NOT COMPLETED|Overall Study||0
10425018|NCT00838903|11570419|FG000|STARTED|Treatment Period (156 Weeks)||101
10425019|NCT00838903|11570420|FG001|STARTED|Treatment Period (156 Weeks)||302
10425020|NCT00838903|11570421|FG002|STARTED|Treatment Period (156 Weeks)||307
10425021|NCT00838903|11570422|FG003|STARTED|Treatment Period (156 Weeks)||302
10425022|NCT00838903|11570419|FG000|Missing Active Treatment Status|Treatment Period (156 Weeks)||1
10425023|NCT00838903|11570420|FG001|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
10425024|NCT00838903|11570421|FG002|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
10425025|NCT00838903|11570422|FG003|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
10425026|NCT00838903|11570419|FG000|COMPLETED|Treatment Period (156 Weeks)||55
10425027|NCT00838903|11570420|FG001|COMPLETED|Treatment Period (156 Weeks)||190
10425028|NCT00838903|11570421|FG002|COMPLETED|Treatment Period (156 Weeks)||191
10425029|NCT00838903|11570422|FG003|COMPLETED|Treatment Period (156 Weeks)||192
10425030|NCT00838903|11570419|FG000|NOT COMPLETED|Treatment Period (156 Weeks)||46
10425031|NCT00838903|11570420|FG001|NOT COMPLETED|Treatment Period (156 Weeks)||112
10425032|NCT00838903|11570421|FG002|NOT COMPLETED|Treatment Period (156 Weeks)||116
10425033|NCT00838903|11570422|FG003|NOT COMPLETED|Treatment Period (156 Weeks)||110
10425034|NCT00838903|11570419|FG000|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
10425035|NCT00838903|11570420|FG001|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|302
10425036|NCT00838903|11570421|FG002|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|307
10425037|NCT00838903|11570422|FG003|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|302
10425038|NCT00838903|11570419|FG000|COMPLETED|Follow-up Period (8 Weeks)||75
10425039|NCT00838903|11570420|FG001|COMPLETED|Follow-up Period (8 Weeks)||237
10425040|NCT00838903|11570421|FG002|COMPLETED|Follow-up Period (8 Weeks)||243
10425041|NCT00838903|11570422|FG003|COMPLETED|Follow-up Period (8 Weeks)||244
10425042|NCT00838903|11570419|FG000|NOT COMPLETED|Follow-up Period (8 Weeks)||26
10425043|NCT00838903|11570420|FG001|NOT COMPLETED|Follow-up Period (8 Weeks)||65
10425044|NCT00838903|11570421|FG002|NOT COMPLETED|Follow-up Period (8 Weeks)||64
10425045|NCT00838903|11570422|FG003|NOT COMPLETED|Follow-up Period (8 Weeks)||58
10425046|NCT00838916|11570434|FG000|STARTED|Treatment Period (156 Weeks)||504
10425047|NCT00838916|11570435|FG001|STARTED|Treatment Period (156 Weeks)||241
10425048|NCT00838916|11570434|FG000|COMPLETED|Treatment Period (156 Weeks)||308
10425049|NCT00838916|11570435|FG001|COMPLETED|Treatment Period (156 Weeks)||164
10425050|NCT00838916|11570434|FG000|NOT COMPLETED|Treatment Period (156 Weeks)||196
10425051|NCT00838916|11570435|FG001|NOT COMPLETED|Treatment Period (156 Weeks)||77
10425052|NCT00838916|11570434|FG000|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|504
10425053|NCT00838916|11570435|FG001|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|241
10425054|NCT00838916|11570434|FG000|COMPLETED|Follow-up Period (8 Weeks)||408
10425055|NCT00838916|11570435|FG001|COMPLETED|Follow-up Period (8 Weeks)||190
10425056|NCT00838916|11570434|FG000|NOT COMPLETED|Follow-up Period (8 Weeks)||96
10425057|NCT00838916|11570435|FG001|NOT COMPLETED|Follow-up Period (8 Weeks)||51
10425058|NCT00838929|11570444|FG000|STARTED|Overall Study||3
10425059|NCT00838929|11570445|FG001|STARTED|Overall Study||8
10425060|NCT00838929|11570446|FG002|STARTED|Overall Study||6
10425061|NCT00838929|11570444|FG000|COMPLETED|Overall Study||3
10425062|NCT00838929|11570445|FG001|COMPLETED|Overall Study||5
10425063|NCT00838929|11570446|FG002|COMPLETED|Overall Study||5
10425064|NCT00838929|11570444|FG000|NOT COMPLETED|Overall Study||0
10425065|NCT00838929|11570445|FG001|NOT COMPLETED|Overall Study||3
10425066|NCT00838929|11570446|FG002|NOT COMPLETED|Overall Study||1
10425067|NCT00839072|11570452|FG000|STARTED|First Intervention Period||12
10425068|NCT00839072|11570453|FG001|STARTED|First Intervention Period||12
10425069|NCT00839072|11570452|FG000|COMPLETED|First Intervention Period||10
10425070|NCT00839072|11570453|FG001|COMPLETED|First Intervention Period||11
10425071|NCT00839072|11570452|FG000|NOT COMPLETED|First Intervention Period||2
10425072|NCT00839072|11570453|FG001|NOT COMPLETED|First Intervention Period||1
10425073|NCT00839072|11570452|FG000|STARTED|Washout Period of 7 Days||10
10425074|NCT00839072|11570453|FG001|STARTED|Washout Period of 7 Days||11
10425075|NCT00839072|11570452|FG000|COMPLETED|Washout Period of 7 Days||10
10425076|NCT00839072|11570453|FG001|COMPLETED|Washout Period of 7 Days||11
10425077|NCT00839072|11570452|FG000|NOT COMPLETED|Washout Period of 7 Days||0
10425078|NCT00839072|11570453|FG001|NOT COMPLETED|Washout Period of 7 Days||0
10425079|NCT00839072|11570452|FG000|STARTED|Second Intervention Period||10
10425080|NCT00839072|11570453|FG001|STARTED|Second Intervention Period||11
10425081|NCT00839072|11570452|FG000|COMPLETED|Second Intervention Period||9
10425082|NCT00839072|11570453|FG001|COMPLETED|Second Intervention Period||11
10425083|NCT00839072|11570452|FG000|NOT COMPLETED|Second Intervention Period||1
10425084|NCT00839072|11570453|FG001|NOT COMPLETED|Second Intervention Period||0
10425085|NCT00839098|11570462|FG000|STARTED|Overall Study||3
10425086|NCT00839098|11570463|FG001|STARTED|Overall Study||12
10425087|NCT00839098|11570464|FG002|STARTED|Overall Study||13
10425088|NCT00839098|11570462|FG000|COMPLETED|Overall Study||1
10425089|NCT00839098|11570463|FG001|COMPLETED|Overall Study||11
10425090|NCT00839098|11570464|FG002|COMPLETED|Overall Study||6
10425091|NCT00839098|11570462|FG000|NOT COMPLETED|Overall Study||2
10425092|NCT00839098|11570463|FG001|NOT COMPLETED|Overall Study||1
10425093|NCT00839098|11570464|FG002|NOT COMPLETED|Overall Study||7
10425094|NCT00839241|11570474|FG000|STARTED|Overall Study||20
10425095|NCT00839241|11570475|FG001|STARTED|Overall Study||25
10425096|NCT00839241|11570474|FG000|COMPLETED|Overall Study||15
10425097|NCT00839241|11570475|FG001|COMPLETED|Overall Study||8
10425098|NCT00839241|11570474|FG000|NOT COMPLETED|Overall Study||5
10425099|NCT00839241|11570475|FG001|NOT COMPLETED|Overall Study||17
10425100|NCT00839254|11570489|FG000|STARTED|Overall Study||1849
10425101|NCT00839254|11570490|FG001|STARTED|Overall Study||1316
10425102|NCT00839254|11570491|FG002|STARTED|Overall Study||1069
10425103|NCT00839254|11570492|FG003|STARTED|Overall Study||859
10425104|NCT00839254|11570493|FG004|STARTED|Overall Study||241
10425105|NCT00839254|11570494|FG005|STARTED|Overall Study||204
10425106|NCT00839254|11570495|FG006|STARTED|Overall Study||368
10425107|NCT00839254|11570496|FG007|STARTED|Overall Study||271
10425108|NCT00839254|11570489|FG000|COMPLETED|Overall Study||1696
10425109|NCT00839254|11570490|FG001|COMPLETED|Overall Study||1224
10425110|NCT00839254|11570491|FG002|COMPLETED|Overall Study||979
10425111|NCT00839254|11570492|FG003|COMPLETED|Overall Study||797
10425112|NCT00839254|11570493|FG004|COMPLETED|Overall Study||204
10425113|NCT00839254|11570494|FG005|COMPLETED|Overall Study||178
10425114|NCT00839254|11570495|FG006|COMPLETED|Overall Study||340
10425115|NCT00839254|11570496|FG007|COMPLETED|Overall Study||256
10425116|NCT00839254|11570489|FG000|NOT COMPLETED|Overall Study||153
10425117|NCT00839254|11570490|FG001|NOT COMPLETED|Overall Study||92
10425118|NCT00839254|11570491|FG002|NOT COMPLETED|Overall Study||90
10425119|NCT00839254|11570492|FG003|NOT COMPLETED|Overall Study||62
10425120|NCT00839254|11570493|FG004|NOT COMPLETED|Overall Study||37
10425121|NCT00839254|11570494|FG005|NOT COMPLETED|Overall Study||26
10425122|NCT00839254|11570495|FG006|NOT COMPLETED|Overall Study||28
10425123|NCT00839254|11570496|FG007|NOT COMPLETED|Overall Study||15
10429721|NCT00866281|11575808|FG000|STARTED|Overall Study||7
10429722|NCT00866281|11575809|FG001|STARTED|Overall Study||15
10429723|NCT00866281|11575808|FG000|COMPLETED|Overall Study||0
10429724|NCT00866281|11575809|FG001|COMPLETED|Overall Study||0
10429725|NCT00866281|11575808|FG000|NOT COMPLETED|Overall Study||7
10429726|NCT00866281|11575809|FG001|NOT COMPLETED|Overall Study||15
10429727|NCT00866294|11575821|FG000|STARTED|Overall Study||172
10429728|NCT00866294|11575822|FG001|STARTED|Overall Study||161
10429729|NCT00866294|11575823|FG002|STARTED|Overall Study||83
10429730|NCT00866294|11575821|FG000|COMPLETED|Overall Study||139
10429731|NCT00866294|11575822|FG001|COMPLETED|Overall Study||141
10429732|NCT00866294|11575823|FG002|COMPLETED|Overall Study||72
10429733|NCT00866294|11575821|FG000|NOT COMPLETED|Overall Study||33
10429734|NCT00866294|11575822|FG001|NOT COMPLETED|Overall Study||20
10429735|NCT00866294|11575823|FG002|NOT COMPLETED|Overall Study||11
10429736|NCT00866307|11575839|FG000|STARTED|Induction||104
10429737|NCT00866307|11575840|FG001|STARTED|Induction||0
10429738|NCT00866307|11575841|FG002|STARTED|Induction||0
10429739|NCT00866307|11575839|FG000|COMPLETED|Induction||84
10429740|NCT00866307|11575840|FG001|COMPLETED|Induction||0
10429741|NCT00866307|11575841|FG002|COMPLETED|Induction||0
10429742|NCT00866307|11575839|FG000|NOT COMPLETED|Induction||20
10429743|NCT00866307|11575840|FG001|NOT COMPLETED|Induction||0
10429744|NCT00866307|11575841|FG002|NOT COMPLETED|Induction||0
10429745|NCT00866307|11575839|FG000|STARTED|Consolidation/Maintenance||0
10429746|NCT00866307|11575840|FG001|STARTED|Consolidation/Maintenance||54
10429747|NCT00866307|11575841|FG002|STARTED|Consolidation/Maintenance||30
10429748|NCT00866307|11575839|FG000|COMPLETED|Consolidation/Maintenance||0
10429749|NCT00866307|11575840|FG001|COMPLETED|Consolidation/Maintenance||45
10429750|NCT00866307|11575841|FG002|COMPLETED|Consolidation/Maintenance||14
10429751|NCT00866307|11575839|FG000|NOT COMPLETED|Consolidation/Maintenance||0
10429752|NCT00866307|11575840|FG001|NOT COMPLETED|Consolidation/Maintenance||9
10429753|NCT00866307|11575841|FG002|NOT COMPLETED|Consolidation/Maintenance||16
10429754|NCT00866320|11575847|FG000|STARTED|Overall Study||49
10429755|NCT00866320|11575847|FG000|COMPLETED|Overall Study|All patients that received treatment were analyzed.|43
10429756|NCT00866320|11575847|FG000|NOT COMPLETED|Overall Study||6
10429757|NCT00866333|11575856|FG000|STARTED|Overall Study||16
10429758|NCT00866333|11575857|FG001|STARTED|Overall Study||17
10429759|NCT00866333|11575858|FG002|STARTED|Overall Study||16
10429760|NCT00866333|11575856|FG000|COMPLETED|Overall Study||11
10429761|NCT00866333|11575857|FG001|COMPLETED|Overall Study||10
10429762|NCT00866333|11575858|FG002|COMPLETED|Overall Study||4
10429763|NCT00866333|11575856|FG000|NOT COMPLETED|Overall Study||5
10429764|NCT00866333|11575857|FG001|NOT COMPLETED|Overall Study||7
10429765|NCT00866333|11575858|FG002|NOT COMPLETED|Overall Study||12
10429766|NCT00866359|11575868|FG000|STARTED|Treatment Phase (Days 1 to 85)||56
10429767|NCT00866359|11575869|FG001|STARTED|Treatment Phase (Days 1 to 85)||55
10429768|NCT00866359|11575870|FG002|STARTED|Treatment Phase (Days 1 to 85)||0
10429769|NCT00866359|11575871|FG003|STARTED|Treatment Phase (Days 1 to 85)||0
10429770|NCT00866359|11575868|FG000|COMPLETED|Treatment Phase (Days 1 to 85)||45
10429771|NCT00866359|11575869|FG001|COMPLETED|Treatment Phase (Days 1 to 85)||50
10429772|NCT00866359|11575870|FG002|COMPLETED|Treatment Phase (Days 1 to 85)||0
10429773|NCT00866359|11575871|FG003|COMPLETED|Treatment Phase (Days 1 to 85)||0
10429774|NCT00866359|11575868|FG000|NOT COMPLETED|Treatment Phase (Days 1 to 85)||11
10429775|NCT00866359|11575869|FG001|NOT COMPLETED|Treatment Phase (Days 1 to 85)||5
10429776|NCT00866359|11575870|FG002|NOT COMPLETED|Treatment Phase (Days 1 to 85)||0
10429777|NCT00866359|11575871|FG003|NOT COMPLETED|Treatment Phase (Days 1 to 85)||0
10429778|NCT00866359|11575868|FG000|STARTED|Extension Phase (Day 86 to 169)||0
10429779|NCT00866359|11575869|FG001|STARTED|Extension Phase (Day 86 to 169)||0
10425124|NCT00839306|11570547|FG000|STARTED|Overall Study|Treated|60
10425125|NCT00839306|11570548|FG001|STARTED|Overall Study|Treated|177
10425126|NCT00839306|11570547|FG000|COMPLETED|Overall Study||35
10425127|NCT00839306|11570548|FG001|COMPLETED|Overall Study||134
10425128|NCT00839306|11570547|FG000|NOT COMPLETED|Overall Study||25
10425129|NCT00839306|11570548|FG001|NOT COMPLETED|Overall Study||43
10425130|NCT00839319|11570560|FG000|STARTED|Overall Study||8
10425131|NCT00839319|11570561|FG001|STARTED|Overall Study||8
10425132|NCT00839319|11570562|FG002|STARTED|Overall Study||8
10425133|NCT00839319|11570563|FG003|STARTED|Overall Study||8
10425134|NCT00839319|11570564|FG004|STARTED|Overall Study||8
10425135|NCT00839319|11570560|FG000|COMPLETED|Overall Study|1 withdrew consent prior to procedures; 1 excluded from analysis (low serum LH)|6
10425136|NCT00839319|11570561|FG001|COMPLETED|Overall Study|1 excluded from analysis (low serum LH)|7
10425137|NCT00839319|11570562|FG002|COMPLETED|Overall Study|1 dropped out after Day 1 visit, 2 excluded from analysis (low serum LH)|5
10425138|NCT00839319|11570563|FG003|COMPLETED|Overall Study|1 withdrawn by investigator for syncopal reaction , 2 excluded from analysis (low serum LH)|5
10425139|NCT00839319|11570564|FG004|COMPLETED|Overall Study||8
10425140|NCT00839319|11570560|FG000|NOT COMPLETED|Overall Study||2
10425141|NCT00839319|11570561|FG001|NOT COMPLETED|Overall Study||1
10425142|NCT00839319|11570562|FG002|NOT COMPLETED|Overall Study||3
10425143|NCT00839319|11570563|FG003|NOT COMPLETED|Overall Study||3
10425144|NCT00839319|11570564|FG004|NOT COMPLETED|Overall Study||0
10425145|NCT00839332|11570579|FG000|STARTED|Phase 1||50
10425146|NCT00839332|11570580|FG001|STARTED|Phase 1|Participants in Phase 2 did not participate in Phase 1.|0
10425147|NCT00839332|11570581|FG002|STARTED|Phase 1|Participants in Phase 2 did not participate in Phase 1.|0
10425148|NCT00839332|11570579|FG000|Received at Least 1 Dose of Study Drug|Phase 1||50
10425149|NCT00839332|11570580|FG001|Received at Least 1 Dose of Study Drug|Phase 1||0
10425150|NCT00839332|11570581|FG002|Received at Least 1 Dose of Study Drug|Phase 1||0
10425151|NCT00839332|11570579|FG000|COMPLETED|Phase 1||0
10425152|NCT00839332|11570580|FG001|COMPLETED|Phase 1||0
10425153|NCT00839332|11570581|FG002|COMPLETED|Phase 1||0
10425154|NCT00839332|11570579|FG000|NOT COMPLETED|Phase 1||50
10425155|NCT00839332|11570580|FG001|NOT COMPLETED|Phase 1||0
10425156|NCT00839332|11570581|FG002|NOT COMPLETED|Phase 1||0
10425157|NCT00839332|11570579|FG000|STARTED|Phase 2|Participants in Phase 1 did not participate in Phase 2.|0
10425158|NCT00839332|11570580|FG001|STARTED|Phase 2||68
10425159|NCT00839332|11570581|FG002|STARTED|Phase 2||39
10425160|NCT00839332|11570579|FG000|Received at Least 1 Dose of Study Drug|Phase 2||0
10425161|NCT00839332|11570580|FG001|Received at Least 1 Dose of Study Drug|Phase 2||65
10425162|NCT00839332|11570581|FG002|Received at Least 1 Dose of Study Drug|Phase 2||34
10425163|NCT00839332|11570579|FG000|COMPLETED|Phase 2||0
10425164|NCT00839332|11570580|FG001|COMPLETED|Phase 2||0
10425165|NCT00839332|11570581|FG002|COMPLETED|Phase 2||0
10425166|NCT00839332|11570579|FG000|NOT COMPLETED|Phase 2||0
10425167|NCT00839332|11570580|FG001|NOT COMPLETED|Phase 2||68
10425168|NCT00839332|11570581|FG002|NOT COMPLETED|Phase 2||39
10425169|NCT00839423|11570594|FG000|STARTED|Overall Study||105
10425170|NCT00839423|11570595|FG001|STARTED|Overall Study||108
10425171|NCT00839423|11570596|FG002|STARTED|Overall Study||100
10425172|NCT00839423|11570597|FG003|STARTED|Overall Study||113
10425173|NCT00839423|11570594|FG000|COMPLETED|Overall Study||87
10425174|NCT00839423|11570595|FG001|COMPLETED|Overall Study||98
10425175|NCT00839423|11570596|FG002|COMPLETED|Overall Study||82
10425176|NCT00839423|11570597|FG003|COMPLETED|Overall Study||93
10425177|NCT00839423|11570594|FG000|NOT COMPLETED|Overall Study||18
10425178|NCT00839423|11570595|FG001|NOT COMPLETED|Overall Study||10
10425179|NCT00839423|11570596|FG002|NOT COMPLETED|Overall Study||18
10425180|NCT00839423|11570597|FG003|NOT COMPLETED|Overall Study||20
10425181|NCT00839436|11570610|FG000|STARTED|Overall Study||3
10425182|NCT00839436|11570611|FG001|STARTED|Overall Study||5
10425183|NCT00839436|11570612|FG002|STARTED|Overall Study||1
10425184|NCT00839436|11570610|FG000|COMPLETED|Overall Study||2
10425185|NCT00839436|11570611|FG001|COMPLETED|Overall Study||4
10425186|NCT00839436|11570612|FG002|COMPLETED|Overall Study||0
10425187|NCT00839436|11570610|FG000|NOT COMPLETED|Overall Study||1
10425188|NCT00839436|11570611|FG001|NOT COMPLETED|Overall Study||1
10425189|NCT00839436|11570612|FG002|NOT COMPLETED|Overall Study||1
10425190|NCT00839527|11570623|FG000|STARTED|Treatment Period (TP) (156 Weeks)||115
10425191|NCT00839527|11570624|FG001|STARTED|Treatment Period (TP) (156 Weeks)||277
10425192|NCT00839527|11570625|FG002|STARTED|Treatment Period (TP) (156 Weeks)||271
10425193|NCT00839527|11570623|FG000|COMPLETED|Treatment Period (TP) (156 Weeks)||55
10425194|NCT00839527|11570624|FG001|COMPLETED|Treatment Period (TP) (156 Weeks)||159
10425195|NCT00839527|11570625|FG002|COMPLETED|Treatment Period (TP) (156 Weeks)||152
10425196|NCT00839527|11570623|FG000|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||60
10425197|NCT00839527|11570624|FG001|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||118
10425198|NCT00839527|11570625|FG002|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||119
10425199|NCT00839527|11570623|FG000|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. One par. did not participate in the FUP.|114
10425200|NCT00839527|11570624|FG001|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Four par. did not participate in the FUP.|273
10425201|NCT00839527|11570625|FG002|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Five par. did not participate in the FUP.|266
10425202|NCT00839527|11570623|FG000|COMPLETED|Follow-up Period (FUP) (8 Weeks)||86
10425203|NCT00839527|11570624|FG001|COMPLETED|Follow-up Period (FUP) (8 Weeks)||217
10425204|NCT00839527|11570625|FG002|COMPLETED|Follow-up Period (FUP) (8 Weeks)||204
10425205|NCT00839527|11570623|FG000|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||28
10425206|NCT00839527|11570624|FG001|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||56
10425207|NCT00839527|11570625|FG002|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||62
10425208|NCT00839540|11570638|FG000|STARTED|Overall Study||8
10425209|NCT00839540|11570639|FG001|STARTED|Overall Study||8
10425210|NCT00839540|11570640|FG002|STARTED|Overall Study||5
10425211|NCT00839540|11570638|FG000|COMPLETED|Overall Study||8
10425212|NCT00839540|11570639|FG001|COMPLETED|Overall Study||8
10425213|NCT00839540|11570640|FG002|COMPLETED|Overall Study||5
10425214|NCT00839540|11570638|FG000|NOT COMPLETED|Overall Study||0
10425215|NCT00839540|11570639|FG001|NOT COMPLETED|Overall Study||0
10425216|NCT00839540|11570640|FG002|NOT COMPLETED|Overall Study||0
10425217|NCT00839800|11570650|FG000|STARTED|Overall Study||1049
10425218|NCT00839800|11570651|FG001|STARTED|Overall Study||1042
10425219|NCT00839800|11570650|FG000|COMPLETED|Overall Study||956
10425220|NCT00839800|11570651|FG001|COMPLETED|Overall Study||932
10425221|NCT00839800|11570650|FG000|NOT COMPLETED|Overall Study||93
10425222|NCT00839800|11570651|FG001|NOT COMPLETED|Overall Study||110
10425223|NCT00839852|11570657|FG000|STARTED|Overall Study||93
10425224|NCT00839852|11570657|FG000|COMPLETED|Overall Study||46
10425225|NCT00839852|11570657|FG000|NOT COMPLETED|Overall Study||47
10425226|NCT00839917|11570663|FG000|STARTED|Overall Study||13
10425227|NCT00839917|11570664|FG001|STARTED|Overall Study||17
10425228|NCT00839917|11570663|FG000|COMPLETED|Overall Study|Study completers were randomized participants who received study vaccination and had follow-up data|12
10425229|NCT00839917|11570664|FG001|COMPLETED|Overall Study|Study completers were randomized participants who received study vaccination and had follow-up data|16
10425230|NCT00839917|11570663|FG000|NOT COMPLETED|Overall Study||1
10425231|NCT00839917|11570664|FG001|NOT COMPLETED|Overall Study||1
10425232|NCT00839956|11570670|FG000|STARTED|Overall Study||31
10425233|NCT00839956|11570670|FG000|COMPLETED|Overall Study||19
10425234|NCT00839956|11570670|FG000|NOT COMPLETED|Overall Study||12
10425235|NCT00839982|11570674|FG000|STARTED|Overall Study||4
10425236|NCT00839982|11570675|FG001|STARTED|Overall Study||26
10425237|NCT00839982|11570676|FG002|STARTED|Overall Study||2
10425238|NCT00839982|11570677|FG003|STARTED|Overall Study||3
10425239|NCT00839982|11570674|FG000|COMPLETED|Overall Study||4
10425240|NCT00839982|11570675|FG001|COMPLETED|Overall Study||26
10425241|NCT00839982|11570676|FG002|COMPLETED|Overall Study||2
10425242|NCT00839982|11570677|FG003|COMPLETED|Overall Study||3
10425243|NCT00839982|11570674|FG000|NOT COMPLETED|Overall Study||0
10425244|NCT00839982|11570675|FG001|NOT COMPLETED|Overall Study||0
10425245|NCT00839982|11570676|FG002|NOT COMPLETED|Overall Study||0
10425246|NCT00839982|11570677|FG003|NOT COMPLETED|Overall Study||0
10425247|NCT00840034|11570687|FG000|STARTED|Acute Treatment Phase||111
10425248|NCT00840034|11570688|FG001|STARTED|Acute Treatment Phase||116
10425249|NCT00840034|11570687|FG000|COMPLETED|Acute Treatment Phase||90
10425250|NCT00840034|11570688|FG001|COMPLETED|Acute Treatment Phase||80
10425251|NCT00840034|11570687|FG000|NOT COMPLETED|Acute Treatment Phase||21
10425252|NCT00840034|11570688|FG001|NOT COMPLETED|Acute Treatment Phase||36
10425253|NCT00840034|11570687|FG000|STARTED|Taper Phase|Completed Acute Treatment (AT) or discontinued ≥4 weeks of AT and chose to participate in Taper.|90
10425254|NCT00840034|11570688|FG001|STARTED|Taper Phase|Completed Acute Treatment (AT) or discontinued ≥4 weeks of AT and chose to participate in Taper.|82
10425255|NCT00840034|11570687|FG000|COMPLETED|Taper Phase||87
10425256|NCT00840034|11570688|FG001|COMPLETED|Taper Phase||80
10425257|NCT00840034|11570687|FG000|NOT COMPLETED|Taper Phase||3
10425258|NCT00840034|11570688|FG001|NOT COMPLETED|Taper Phase||2
10425259|NCT00840060|11570698|FG000|STARTED|Overall Study||20
10425260|NCT00840060|11570699|FG001|STARTED|Overall Study||20
10425261|NCT00840060|11570698|FG000|COMPLETED|Overall Study||19
10425262|NCT00840060|11570699|FG001|COMPLETED|Overall Study||19
10425263|NCT00840060|11570698|FG000|NOT COMPLETED|Overall Study||1
10425264|NCT00840060|11570699|FG001|NOT COMPLETED|Overall Study||1
10425265|NCT00840086|11570705|FG000|STARTED|Overall Study||150
10425266|NCT00840086|11570705|FG000|COMPLETED|Overall Study||146
10425267|NCT00840086|11570705|FG000|NOT COMPLETED|Overall Study||4
10425268|NCT00840294|11570714|FG000|STARTED|Overall Study||42
10425269|NCT00840294|11570715|FG001|STARTED|Overall Study||43
10425270|NCT00840294|11570714|FG000|COMPLETED|Overall Study|These are the subjects included in the baseline, outcomes, and adverse events tables|39
10425271|NCT00840294|11570715|FG001|COMPLETED|Overall Study|These are the subjects included in the baseline, outcomes, and adverse events tables|38
10425272|NCT00840294|11570714|FG000|NOT COMPLETED|Overall Study||3
10425273|NCT00840294|11570715|FG001|NOT COMPLETED|Overall Study||5
10425274|NCT00840307|11570721|FG000|STARTED|Overall Study||20
10425275|NCT00840307|11570721|FG000|COMPLETED|Overall Study||16
10425276|NCT00840307|11570721|FG000|NOT COMPLETED|Overall Study||4
10425277|NCT00840450|11570725|FG000|STARTED|Overall Study||12
10425278|NCT00840450|11570725|FG000|COMPLETED|Overall Study||9
10425279|NCT00840450|11570725|FG000|NOT COMPLETED|Overall Study||3
10425280|NCT00840463|11570731|FG000|STARTED|Overall Study||3
10425281|NCT00840463|11570732|FG001|STARTED|Overall Study||1
10425282|NCT00840463|11570731|FG000|COMPLETED|Overall Study||2
10425283|NCT00840463|11570732|FG001|COMPLETED|Overall Study||1
10425284|NCT00840463|11570731|FG000|NOT COMPLETED|Overall Study||1
10425285|NCT00840463|11570732|FG001|NOT COMPLETED|Overall Study||0
10425286|NCT00840658|11570742|FG000|STARTED|Overall Study||144
10425287|NCT00840658|11570743|FG001|STARTED|Overall Study||146
10425288|NCT00840658|11570744|FG002|STARTED|Overall Study||148
10425289|NCT00840658|11570745|FG003|STARTED|Overall Study||146
10429780|NCT00866359|11575870|FG002|STARTED|Extension Phase (Day 86 to 169)||45
10425290|NCT00840658|11570742|FG000|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|139
10425291|NCT00840658|11570743|FG001|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|143
10425292|NCT00840658|11570744|FG002|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|143
10425293|NCT00840658|11570745|FG003|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|142
10425294|NCT00840658|11570742|FG000|NOT COMPLETED|Overall Study||5
10425295|NCT00840658|11570743|FG001|NOT COMPLETED|Overall Study||3
10425296|NCT00840658|11570744|FG002|NOT COMPLETED|Overall Study||5
10425297|NCT00840658|11570745|FG003|NOT COMPLETED|Overall Study||4
10425298|NCT00840749|11570761|FG000|STARTED|Overall Study|includes patients who were screened but did not end up treated on protocol|31
10425299|NCT00840749|11570762|FG001|STARTED|Overall Study|includes patients who were screened but did not end up treated on protocol|27
10425300|NCT00840749|11570761|FG000|Treatment|Overall Study||20
10425301|NCT00840749|11570762|FG001|Treatment|Overall Study||16
10425302|NCT00840749|11570761|FG000|1 Month Post tx|Overall Study||19
10425303|NCT00840749|11570762|FG001|1 Month Post tx|Overall Study||15
10425304|NCT00840749|11570761|FG000|6 Months Post tx|Overall Study||16
10425305|NCT00840749|11570762|FG001|6 Months Post tx|Overall Study||10
10425306|NCT00840749|11570761|FG000|12 Months Post tx|Overall Study||14
10425307|NCT00840749|11570762|FG001|12 Months Post tx|Overall Study||7
10425308|NCT00840749|11570761|FG000|18 Months Post tx|Overall Study||12
10425309|NCT00840749|11570762|FG001|18 Months Post tx|Overall Study||6
10425310|NCT00840749|11570761|FG000|24 Months Post tx|Overall Study||9
10425311|NCT00840749|11570762|FG001|24 Months Post tx|Overall Study||3
10425312|NCT00840749|11570761|FG000|36 Months Post tx|Overall Study||1
10425313|NCT00840749|11570762|FG001|36 Months Post tx|Overall Study||0
10425314|NCT00840749|11570761|FG000|COMPLETED|Overall Study||0
10425315|NCT00840749|11570762|FG001|COMPLETED|Overall Study||0
10425316|NCT00840749|11570761|FG000|NOT COMPLETED|Overall Study||31
10425317|NCT00840749|11570762|FG001|NOT COMPLETED|Overall Study||27
10425318|NCT00840970|11570768|FG000|STARTED|Overall Study||7
10425319|NCT00840970|11570769|FG001|STARTED|Overall Study||38
10425320|NCT00840970|11570770|FG002|STARTED|Overall Study||5
10425321|NCT00840970|11570768|FG000|COMPLETED|Overall Study||7
10425322|NCT00840970|11570769|FG001|COMPLETED|Overall Study||38
10425323|NCT00840970|11570770|FG002|COMPLETED|Overall Study||4
10425324|NCT00840970|11570768|FG000|NOT COMPLETED|Overall Study||0
10425325|NCT00840970|11570769|FG001|NOT COMPLETED|Overall Study||0
10425326|NCT00840970|11570770|FG002|NOT COMPLETED|Overall Study||1
10425327|NCT00840996|11570782|FG000|STARTED|Overall Study||58
10425328|NCT00840996|11570783|FG001|STARTED|Overall Study||58
10425329|NCT00840996|11570782|FG000|COMPLETED|Overall Study||57
10425330|NCT00840996|11570783|FG001|COMPLETED|Overall Study||58
10425331|NCT00840996|11570782|FG000|NOT COMPLETED|Overall Study||1
10425332|NCT00840996|11570783|FG001|NOT COMPLETED|Overall Study||0
10425333|NCT00841087|11570791|FG000|STARTED|Overall Study||33
10425334|NCT00841087|11570792|FG001|STARTED|Overall Study||32
10425335|NCT00841087|11570791|FG000|COMPLETED|Overall Study||33
10425336|NCT00841087|11570792|FG001|COMPLETED|Overall Study||32
10425337|NCT00841087|11570791|FG000|NOT COMPLETED|Overall Study||0
10425338|NCT00841087|11570792|FG001|NOT COMPLETED|Overall Study||0
10425339|NCT00841100|11570798|FG000|STARTED|Acute Component (24 Hours)||21
10425340|NCT00841100|11570798|FG000|COMPLETED|Acute Component (24 Hours)||21
10425341|NCT00841100|11570798|FG000|NOT COMPLETED|Acute Component (24 Hours)||0
10425342|NCT00841100|11570798|FG000|STARTED|Phase 1 (28 Days)|3 participants from the acute phase elected not to continue to the Phase 1 component of the study.|18
10425343|NCT00841100|11570798|FG000|COMPLETED|Phase 1 (28 Days)||15
10425344|NCT00841100|11570798|FG000|NOT COMPLETED|Phase 1 (28 Days)||3
10425345|NCT00841100|11570798|FG000|STARTED|Phase 2 (2 Weeks)|Participants who were non-responsive on the Phase 1 component of the study continued on to Phase 2.|5
10425346|NCT00841100|11570798|FG000|COMPLETED|Phase 2 (2 Weeks)||5
10425347|NCT00841100|11570798|FG000|NOT COMPLETED|Phase 2 (2 Weeks)||0
10425348|NCT00841100|11570798|FG000|STARTED|Phase 3 (28 Days)|Participants who achieved a fasting blood phenylalanine of <600 umol/l can continue to Phase 3.|4
10425349|NCT00841100|11570798|FG000|COMPLETED|Phase 3 (28 Days)||4
10425350|NCT00841100|11570798|FG000|NOT COMPLETED|Phase 3 (28 Days)||0
10425351|NCT00841204|11570804|FG000|STARTED|Overall Study||25
10425352|NCT00841204|11570805|FG001|STARTED|Overall Study||25
10425353|NCT00841204|11570804|FG000|COMPLETED|Overall Study||25
10425354|NCT00841204|11570805|FG001|COMPLETED|Overall Study||25
10425355|NCT00841204|11570804|FG000|NOT COMPLETED|Overall Study||0
10425356|NCT00841204|11570805|FG001|NOT COMPLETED|Overall Study||0
10425357|NCT00841269|11570815|FG000|STARTED|Overall Study||20
10425358|NCT00841269|11570816|FG001|STARTED|Overall Study||22
10425359|NCT00841269|11570815|FG000|COMPLETED|Overall Study||12
10425360|NCT00841269|11570816|FG001|COMPLETED|Overall Study||13
10425361|NCT00841269|11570815|FG000|NOT COMPLETED|Overall Study||8
10425362|NCT00841269|11570816|FG001|NOT COMPLETED|Overall Study||9
10425363|NCT00841321|11570823|FG000|STARTED|Overall Study||59
10425364|NCT00841321|11570824|FG001|STARTED|Overall Study||61
10425365|NCT00841321|11570823|FG000|COMPLETED|Overall Study||58
10425366|NCT00841321|11570824|FG001|COMPLETED|Overall Study||58
10425367|NCT00841321|11570823|FG000|NOT COMPLETED|Overall Study||1
10425368|NCT00841321|11570824|FG001|NOT COMPLETED|Overall Study||3
10425369|NCT00841412|11570832|FG000|STARTED|Overall Study|200 of 222 consented residents completed baseline assessments across both groups.|120
10425370|NCT00841412|11570833|FG001|STARTED|Overall Study|80 residents were in the delayed intervention group, but all residents received intervention.|80
10429781|NCT00866359|11575871|FG003|STARTED|Extension Phase (Day 86 to 169)||50
10425371|NCT00841412|11570832|FG000|COMPLETED|Overall Study|130 residents completed all study phases across both groups, including follow-up.|80
10425372|NCT00841412|11570833|FG001|COMPLETED|Overall Study||50
10425373|NCT00841412|11570832|FG000|NOT COMPLETED|Overall Study||40
10425374|NCT00841412|11570833|FG001|NOT COMPLETED|Overall Study||30
10425375|NCT00841555|11570840|FG000|STARTED|Overall Study||3
10425376|NCT00841555|11570841|FG001|STARTED|Overall Study||3
10425377|NCT00841555|11570842|FG002|STARTED|Overall Study||3
10425378|NCT00841555|11570840|FG000|COMPLETED|Overall Study||3
10425379|NCT00841555|11570841|FG001|COMPLETED|Overall Study||3
10425380|NCT00841555|11570842|FG002|COMPLETED|Overall Study||3
10425381|NCT00841555|11570840|FG000|NOT COMPLETED|Overall Study||0
10425382|NCT00841555|11570841|FG001|NOT COMPLETED|Overall Study||0
10425383|NCT00841555|11570842|FG002|NOT COMPLETED|Overall Study||0
10425384|NCT00841568|11570848|FG000|STARTED|Overall Study||17
10425385|NCT00841568|11570848|FG000|COMPLETED|Overall Study||12
10425386|NCT00841568|11570848|FG000|NOT COMPLETED|Overall Study||5
10425387|NCT00841672|11570858|FG000|STARTED|Overall Study|One patient was mis-randomized and was not treated in the double-blind treatment period.|244
10425388|NCT00841672|11570859|FG001|STARTED|Overall Study||241
10425389|NCT00841672|11570858|FG000|COMPLETED|Overall Study||224
10425390|NCT00841672|11570859|FG001|COMPLETED|Overall Study||209
10425391|NCT00841672|11570858|FG000|NOT COMPLETED|Overall Study||20
10425392|NCT00841672|11570859|FG001|NOT COMPLETED|Overall Study||32
10425393|NCT00841763|11570867|FG000|STARTED|Overall Study||2691
10425394|NCT00841763|11570868|FG001|STARTED|Overall Study||681
10425395|NCT00841763|11570869|FG002|STARTED|Overall Study||219
10425396|NCT00841763|11570870|FG003|STARTED|Overall Study||56
10425397|NCT00841763|11570867|FG000|COMPLETED|Overall Study||2529
10425398|NCT00841763|11570868|FG001|COMPLETED|Overall Study||624
10425399|NCT00841763|11570869|FG002|COMPLETED|Overall Study||211
10425400|NCT00841763|11570870|FG003|COMPLETED|Overall Study||53
10425401|NCT00841763|11570867|FG000|NOT COMPLETED|Overall Study||162
10425402|NCT00841763|11570868|FG001|NOT COMPLETED|Overall Study||57
10425403|NCT00841763|11570869|FG002|NOT COMPLETED|Overall Study||8
10425404|NCT00841763|11570870|FG003|NOT COMPLETED|Overall Study||3
10425405|NCT00841776|11570917|FG000|STARTED|Overall Study||27
10425406|NCT00841776|11570918|FG001|STARTED|Overall Study||27
10425407|NCT00841776|11570917|FG000|COMPLETED|Overall Study||25
10425408|NCT00841776|11570918|FG001|COMPLETED|Overall Study||24
10425409|NCT00841776|11570917|FG000|NOT COMPLETED|Overall Study||2
10425410|NCT00841776|11570918|FG001|NOT COMPLETED|Overall Study||3
10425411|NCT00841828|11570926|FG000|STARTED|Overall Study||52
10425412|NCT00841828|11570927|FG001|STARTED|Overall Study||50
10425413|NCT00841828|11570926|FG000|COMPLETED|Overall Study||42
10425414|NCT00841828|11570927|FG001|COMPLETED|Overall Study||48
10425415|NCT00841828|11570926|FG000|NOT COMPLETED|Overall Study||10
10425416|NCT00841828|11570927|FG001|NOT COMPLETED|Overall Study||2
10425417|NCT00841906|11570937|FG000|STARTED|Overall Study||18
10425418|NCT00841906|11570938|FG001|STARTED|Overall Study||14
10425419|NCT00841906|11570937|FG000|COMPLETED|Overall Study||16
10425420|NCT00841906|11570938|FG001|COMPLETED|Overall Study||14
10425421|NCT00841906|11570937|FG000|NOT COMPLETED|Overall Study||2
10425422|NCT00841906|11570938|FG001|NOT COMPLETED|Overall Study||0
10425423|NCT00841971|11570948|FG000|STARTED|Overall Study||100
10425424|NCT00841971|11570949|FG001|STARTED|Overall Study||100
10425425|NCT00841971|11570948|FG000|COMPLETED|Overall Study||98
10425426|NCT00841971|11570949|FG001|COMPLETED|Overall Study||99
10425427|NCT00841971|11570948|FG000|NOT COMPLETED|Overall Study||2
10425428|NCT00841971|11570949|FG001|NOT COMPLETED|Overall Study||1
10425429|NCT00842023|11570957|FG000|STARTED|Overall Study||45
10425430|NCT00842023|11570958|FG001|STARTED|Overall Study||44
10425431|NCT00842023|11570957|FG000|COMPLETED|Overall Study||45
10425432|NCT00842023|11570958|FG001|COMPLETED|Overall Study||44
10425433|NCT00842023|11570957|FG000|NOT COMPLETED|Overall Study||0
10425434|NCT00842023|11570958|FG001|NOT COMPLETED|Overall Study||0
10425435|NCT00842075|11570969|FG000|STARTED|Overall Study||5
10425436|NCT00842075|11570970|FG001|STARTED|Overall Study||5
10425437|NCT00842075|11570969|FG000|COMPLETED|Overall Study||5
10425438|NCT00842075|11570970|FG001|COMPLETED|Overall Study||5
10425439|NCT00842075|11570969|FG000|NOT COMPLETED|Overall Study||0
10425440|NCT00842075|11570970|FG001|NOT COMPLETED|Overall Study||0
10425441|NCT00842153|11570978|FG000|STARTED|Overall Study||28
10425442|NCT00842153|11570979|FG001|STARTED|Overall Study||30
10425443|NCT00842153|11570978|FG000|COMPLETED|Overall Study||27
10425444|NCT00842153|11570979|FG001|COMPLETED|Overall Study||27
10425445|NCT00842153|11570978|FG000|NOT COMPLETED|Overall Study||1
10425446|NCT00842153|11570979|FG001|NOT COMPLETED|Overall Study||3
10425447|NCT00842231|11570985|FG000|STARTED|Overall Study||40
10425448|NCT00842231|11570985|FG000|COMPLETED|Overall Study||40
10425449|NCT00842231|11570985|FG000|NOT COMPLETED|Overall Study||0
10425450|NCT00842244|11570989|FG000|STARTED|Overall Study||22
10425451|NCT00842244|11570989|FG000|COMPLETED|Overall Study||1
10425452|NCT00842244|11570989|FG000|NOT COMPLETED|Overall Study||21
10425453|NCT00842257|11570996|FG000|STARTED|Overall Study||20
10425454|NCT00842257|11570996|FG000|COMPLETED|Overall Study||19
10425455|NCT00842257|11570996|FG000|NOT COMPLETED|Overall Study||1
10425456|NCT00842296|11571000|FG000|STARTED|Overall Study||326
10425457|NCT00842296|11571000|FG000|COMPLETED|Overall Study||326
10425458|NCT00842296|11571000|FG000|NOT COMPLETED|Overall Study||0
10425459|NCT00842309|11571006|FG000|STARTED|Overall Study|14 randomized. 2 withdrew prior to initiating DCS-not included in modified intent-to-treat analyses.|14
10425460|NCT00842309|11571007|FG001|STARTED|Overall Study||14
10425461|NCT00842309|11571006|FG000|COMPLETED|Overall Study||11
10425462|NCT00842309|11571007|FG001|COMPLETED|Overall Study||13
10425463|NCT00842309|11571006|FG000|NOT COMPLETED|Overall Study||3
10425464|NCT00842309|11571007|FG001|NOT COMPLETED|Overall Study||1
10425465|NCT00842335|11571013|FG000|STARTED|Overall Study||18
10425466|NCT00842335|11571013|FG000|COMPLETED|Overall Study||18
10425467|NCT00842335|11571013|FG000|NOT COMPLETED|Overall Study||0
10425468|NCT00842348|11571021|FG000|STARTED|Patients Randomised in Study 726||101
10425469|NCT00842348|11571022|FG001|STARTED|Patients Randomised in Study 726||103
10425470|NCT00842348|11571021|FG000|COMPLETED|Patients Randomised in Study 726|41 patients had stable disease and 1 patient had progressive disease.|42
10425471|NCT00842348|11571022|FG001|COMPLETED|Patients Randomised in Study 726|15 patients had stable disease and 32 patients had progressive disease.|47
10425472|NCT00842348|11571021|FG000|NOT COMPLETED|Patients Randomised in Study 726||59
10425473|NCT00842348|11571022|FG001|NOT COMPLETED|Patients Randomised in Study 726||56
10425474|NCT00842348|11571021|FG000|STARTED|Study 729||42
10425475|NCT00842348|11571022|FG001|STARTED|Study 729||47
10425476|NCT00842348|11571021|FG000|COMPLETED|Study 729|Enrolled in Study 729 and received at least one dose of open label lanreotide Autogel.|16
10425477|NCT00842348|11571022|FG001|COMPLETED|Study 729|Enrolled in Study 729 and received at least one dose of open label lanreotide Autogel.|9
10425478|NCT00842348|11571021|FG000|NOT COMPLETED|Study 729||26
10425479|NCT00842348|11571022|FG001|NOT COMPLETED|Study 729||38
10425480|NCT00842361|11571034|FG000|STARTED|Overall Study||33
10425481|NCT00842361|11571035|FG001|STARTED|Overall Study||33
10425482|NCT00842361|11571034|FG000|Exposed|Overall Study||33
10425483|NCT00842361|11571035|FG001|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|32
10425484|NCT00842361|11571034|FG000|COMPLETED|Overall Study||32
10425485|NCT00842361|11571035|FG001|COMPLETED|Overall Study||31
10425486|NCT00842361|11571034|FG000|NOT COMPLETED|Overall Study||1
10425487|NCT00842361|11571035|FG001|NOT COMPLETED|Overall Study||2
10425488|NCT00842543|11571045|FG000|STARTED|Overall Study||13
10425489|NCT00842543|11571046|FG001|STARTED|Overall Study||5
10425490|NCT00842543|11571047|FG002|STARTED|Overall Study||13
10425491|NCT00842543|11571048|FG003|STARTED|Overall Study||8
10425492|NCT00842543|11571045|FG000|COMPLETED|Overall Study||11
10425493|NCT00842543|11571046|FG001|COMPLETED|Overall Study||5
10425494|NCT00842543|11571047|FG002|COMPLETED|Overall Study||10
10425495|NCT00842543|11571048|FG003|COMPLETED|Overall Study||4
10425496|NCT00842543|11571045|FG000|NOT COMPLETED|Overall Study||2
10425497|NCT00842543|11571046|FG001|NOT COMPLETED|Overall Study||0
10425498|NCT00842543|11571047|FG002|NOT COMPLETED|Overall Study||3
10425499|NCT00842543|11571048|FG003|NOT COMPLETED|Overall Study||4
10425500|NCT00842608|11571064|FG000|STARTED|Overall Study||174
10425501|NCT00842608|11571065|FG001|STARTED|Overall Study||177
10425502|NCT00842608|11571066|FG002|STARTED|Overall Study||99
10425503|NCT00842608|11571067|FG003|STARTED|Overall Study||101
10425504|NCT00842608|11571064|FG000|COMPLETED|Overall Study||170
10425505|NCT00842608|11571065|FG001|COMPLETED|Overall Study||176
10425506|NCT00842608|11571066|FG002|COMPLETED|Overall Study||99
10425507|NCT00842608|11571067|FG003|COMPLETED|Overall Study||100
10425508|NCT00842608|11571064|FG000|NOT COMPLETED|Overall Study||4
10425509|NCT00842608|11571065|FG001|NOT COMPLETED|Overall Study||1
10425510|NCT00842608|11571066|FG002|NOT COMPLETED|Overall Study||0
10425511|NCT00842608|11571067|FG003|NOT COMPLETED|Overall Study||1
10425512|NCT00842712|11571084|FG000|STARTED|Safety Run-in Part||3
10425513|NCT00842712|11571085|FG001|STARTED|Safety Run-in Part||3
10425514|NCT00842712|11571086|FG002|STARTED|Safety Run-in Part||3
10425515|NCT00842712|11571087|FG003|STARTED|Safety Run-in Part||3
10425516|NCT00842712|11571088|FG004|STARTED|Safety Run-in Part||0
10425517|NCT00842712|11571089|FG005|STARTED|Safety Run-in Part||0
10425518|NCT00842712|11571090|FG006|STARTED|Safety Run-in Part||0
10425519|NCT00842712|11571084|FG000|COMPLETED|Safety Run-in Part||0
10425520|NCT00842712|11571085|FG001|COMPLETED|Safety Run-in Part||1
10425521|NCT00842712|11571086|FG002|COMPLETED|Safety Run-in Part||3
10425522|NCT00842712|11571087|FG003|COMPLETED|Safety Run-in Part||2
10425523|NCT00842712|11571088|FG004|COMPLETED|Safety Run-in Part||0
10425524|NCT00842712|11571089|FG005|COMPLETED|Safety Run-in Part||0
10425525|NCT00842712|11571090|FG006|COMPLETED|Safety Run-in Part||0
10425526|NCT00842712|11571084|FG000|NOT COMPLETED|Safety Run-in Part||3
10425527|NCT00842712|11571085|FG001|NOT COMPLETED|Safety Run-in Part||2
10425528|NCT00842712|11571086|FG002|NOT COMPLETED|Safety Run-in Part||0
10425529|NCT00842712|11571087|FG003|NOT COMPLETED|Safety Run-in Part||1
10425530|NCT00842712|11571088|FG004|NOT COMPLETED|Safety Run-in Part||0
10425531|NCT00842712|11571089|FG005|NOT COMPLETED|Safety Run-in Part||0
10425532|NCT00842712|11571090|FG006|NOT COMPLETED|Safety Run-in Part||0
10425533|NCT00842712|11571084|FG000|STARTED|Randomized Part||0
10425534|NCT00842712|11571085|FG001|STARTED|Randomized Part||0
10425535|NCT00842712|11571086|FG002|STARTED|Randomized Part||0
10425536|NCT00842712|11571087|FG003|STARTED|Randomized Part||0
10425537|NCT00842712|11571088|FG004|STARTED|Randomized Part||85
10425538|NCT00842712|11571089|FG005|STARTED|Randomized Part||51
10425539|NCT00842712|11571090|FG006|STARTED|Randomized Part||84
10425540|NCT00842712|11571084|FG000|Treated|Randomized Part||0
10425541|NCT00842712|11571085|FG001|Treated|Randomized Part||0
10425542|NCT00842712|11571086|FG002|Treated|Randomized Part||0
10425543|NCT00842712|11571087|FG003|Treated|Randomized Part||0
10425544|NCT00842712|11571088|FG004|Treated|Randomized Part||85
10425545|NCT00842712|11571089|FG005|Treated|Randomized Part||50
10425546|NCT00842712|11571090|FG006|Treated|Randomized Part||80
10425547|NCT00842712|11571084|FG000|COMPLETED|Randomized Part||0
10425548|NCT00842712|11571085|FG001|COMPLETED|Randomized Part||0
10425549|NCT00842712|11571086|FG002|COMPLETED|Randomized Part||0
10425550|NCT00842712|11571087|FG003|COMPLETED|Randomized Part||0
10425551|NCT00842712|11571088|FG004|COMPLETED|Randomized Part||85
10425552|NCT00842712|11571089|FG005|COMPLETED|Randomized Part||50
10425553|NCT00842712|11571090|FG006|COMPLETED|Randomized Part||78
10425554|NCT00842712|11571084|FG000|NOT COMPLETED|Randomized Part||0
10425555|NCT00842712|11571085|FG001|NOT COMPLETED|Randomized Part||0
10425556|NCT00842712|11571086|FG002|NOT COMPLETED|Randomized Part||0
10425557|NCT00842712|11571087|FG003|NOT COMPLETED|Randomized Part||0
10425558|NCT00842712|11571088|FG004|NOT COMPLETED|Randomized Part||0
10425559|NCT00842712|11571089|FG005|NOT COMPLETED|Randomized Part||1
10425560|NCT00842712|11571090|FG006|NOT COMPLETED|Randomized Part||6
10425561|NCT00842751|11571106|FG000|STARTED|Overall Study||11
10425562|NCT00842751|11571106|FG000|COMPLETED|Overall Study||11
10425563|NCT00842751|11571106|FG000|NOT COMPLETED|Overall Study||0
10425564|NCT00842764|11571119|FG000|STARTED|Overall Study||7
10425565|NCT00842764|11571119|FG000|COMPLETED|Overall Study||5
10425566|NCT00842764|11571119|FG000|NOT COMPLETED|Overall Study||2
10425567|NCT00842829|11571125|FG000|STARTED|Dose Titration Period||156
10425568|NCT00842829|11571126|FG001|STARTED|Dose Titration Period||174
10425569|NCT00842829|11571127|FG002|STARTED|Dose Titration Period||0
10425570|NCT00842829|11571125|FG000|Titration Safety Analysis Set|Dose Titration Period|Received at least one dose of study drug|145
10425571|NCT00842829|11571126|FG001|Titration Safety Analysis Set|Dose Titration Period|Received at least one dose of study drug|167
10425572|NCT00842829|11571127|FG002|Titration Safety Analysis Set|Dose Titration Period||0
10425573|NCT00842829|11571125|FG000|COMPLETED|Dose Titration Period||130
10425574|NCT00842829|11571126|FG001|COMPLETED|Dose Titration Period||151
10425575|NCT00842829|11571127|FG002|COMPLETED|Dose Titration Period||0
10425576|NCT00842829|11571125|FG000|NOT COMPLETED|Dose Titration Period||26
10425577|NCT00842829|11571126|FG001|NOT COMPLETED|Dose Titration Period||23
10425578|NCT00842829|11571127|FG002|NOT COMPLETED|Dose Titration Period||0
10425579|NCT00842829|11571125|FG000|STARTED|Treatment Period||0
10425580|NCT00842829|11571126|FG001|STARTED|Treatment Period||0
10425581|NCT00842829|11571127|FG002|STARTED|Treatment Period||281
10425582|NCT00842829|11571125|FG000|Safety Analysis Set|Treatment Period||0
10425583|NCT00842829|11571126|FG001|Safety Analysis Set|Treatment Period||0
10425584|NCT00842829|11571127|FG002|Safety Analysis Set|Treatment Period|Received at least one dose of study drug|223
10425585|NCT00842829|11571125|FG000|COMPLETED|Treatment Period||0
10425586|NCT00842829|11571126|FG001|COMPLETED|Treatment Period||0
10425587|NCT00842829|11571127|FG002|COMPLETED|Treatment Period||218
10425588|NCT00842829|11571125|FG000|NOT COMPLETED|Treatment Period||0
10425589|NCT00842829|11571126|FG001|NOT COMPLETED|Treatment Period||0
10425590|NCT00842829|11571127|FG002|NOT COMPLETED|Treatment Period||63
10425591|NCT00842829|11571125|FG000|STARTED|Continuation Period||0
10425592|NCT00842829|11571126|FG001|STARTED|Continuation Period||0
10425593|NCT00842829|11571127|FG002|STARTED|Continuation Period|Eligible for Continuation Period|88
10425594|NCT00842829|11571125|FG000|Continuation Safety Analysis Set|Continuation Period||0
10425595|NCT00842829|11571126|FG001|Continuation Safety Analysis Set|Continuation Period||0
10425596|NCT00842829|11571127|FG002|Continuation Safety Analysis Set|Continuation Period|Received at least one dose of study drug|87
10425597|NCT00842829|11571125|FG000|COMPLETED|Continuation Period||0
10425598|NCT00842829|11571126|FG001|COMPLETED|Continuation Period||0
10425599|NCT00842829|11571127|FG002|COMPLETED|Continuation Period||27
10425600|NCT00842829|11571125|FG000|NOT COMPLETED|Continuation Period||0
10425601|NCT00842829|11571126|FG001|NOT COMPLETED|Continuation Period||0
10425602|NCT00842829|11571127|FG002|NOT COMPLETED|Continuation Period||61
10425603|NCT00842946|11571141|FG000|STARTED|Overall Study||21
10425604|NCT00842946|11571142|FG001|STARTED|Overall Study||24
10425605|NCT00842946|11571141|FG000|COMPLETED|Overall Study||16
10425606|NCT00842946|11571142|FG001|COMPLETED|Overall Study||19
10425607|NCT00842946|11571141|FG000|NOT COMPLETED|Overall Study||5
10425608|NCT00842946|11571142|FG001|NOT COMPLETED|Overall Study||5
10425609|NCT00842985|11571148|FG000|STARTED|Screening||53
10425610|NCT00842985|11571148|FG000|COMPLETED|Screening||26
10425611|NCT00842985|11571148|FG000|NOT COMPLETED|Screening||27
10425612|NCT00842985|11571148|FG000|STARTED|First Intervention|Signed Consent|26
10425613|NCT00842985|11571148|FG000|COMPLETED|First Intervention|Completed 1st Intervention|20
10425614|NCT00842985|11571148|FG000|NOT COMPLETED|First Intervention||6
10425615|NCT00842985|11571148|FG000|STARTED|Washout Period of GE 4 Days||20
10425616|NCT00842985|11571148|FG000|COMPLETED|Washout Period of GE 4 Days||18
10425617|NCT00842985|11571148|FG000|NOT COMPLETED|Washout Period of GE 4 Days||2
10425618|NCT00842985|11571148|FG000|STARTED|Second Intervention||18
10425619|NCT00842985|11571148|FG000|COMPLETED|Second Intervention||17
10425620|NCT00842985|11571148|FG000|NOT COMPLETED|Second Intervention||1
10425621|NCT00842985|11571148|FG000|STARTED|Washout Period of GE 4 Days||17
10425622|NCT00842985|11571148|FG000|COMPLETED|Washout Period of GE 4 Days||15
10425623|NCT00842985|11571148|FG000|NOT COMPLETED|Washout Period of GE 4 Days||2
10425624|NCT00842985|11571148|FG000|STARTED|Third Intervention||15
10425625|NCT00842985|11571148|FG000|COMPLETED|Third Intervention||15
10425626|NCT00842985|11571148|FG000|NOT COMPLETED|Third Intervention||0
10425627|NCT00842985|11571148|FG000|STARTED|Washout Period of GE 4 Days||15
10425628|NCT00842985|11571148|FG000|COMPLETED|Washout Period of GE 4 Days||15
10425629|NCT00842985|11571148|FG000|NOT COMPLETED|Washout Period of GE 4 Days||0
10425630|NCT00842985|11571148|FG000|STARTED|Fourth Intervention||15
10425631|NCT00842985|11571148|FG000|COMPLETED|Fourth Intervention||15
10425632|NCT00842985|11571148|FG000|NOT COMPLETED|Fourth Intervention||0
10425633|NCT00843024|11571159|FG000|STARTED|Single-blind Placebo Run-In Phase||408
10425634|NCT00843024|11571160|FG001|STARTED|Single-blind Placebo Run-In Phase||457
10425635|NCT00843024|11571161|FG002|STARTED|Single-blind Placebo Run-In Phase||0
10425636|NCT00843024|11571162|FG003|STARTED|Single-blind Placebo Run-In Phase||0
10425637|NCT00843024|11571163|FG004|STARTED|Single-blind Placebo Run-In Phase||0
10425638|NCT00843024|11571164|FG005|STARTED|Single-blind Placebo Run-In Phase||0
10425639|NCT00843024|11571159|FG000|COMPLETED|Single-blind Placebo Run-In Phase||268
10425640|NCT00843024|11571160|FG001|COMPLETED|Single-blind Placebo Run-In Phase||321
10425641|NCT00843024|11571161|FG002|COMPLETED|Single-blind Placebo Run-In Phase||0
10425642|NCT00843024|11571162|FG003|COMPLETED|Single-blind Placebo Run-In Phase||0
10425643|NCT00843024|11571163|FG004|COMPLETED|Single-blind Placebo Run-In Phase||0
10425644|NCT00843024|11571164|FG005|COMPLETED|Single-blind Placebo Run-In Phase||0
10425645|NCT00843024|11571159|FG000|NOT COMPLETED|Single-blind Placebo Run-In Phase||140
10425646|NCT00843024|11571160|FG001|NOT COMPLETED|Single-blind Placebo Run-In Phase||136
10425647|NCT00843024|11571161|FG002|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
10425648|NCT00843024|11571162|FG003|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
10425649|NCT00843024|11571163|FG004|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
10425650|NCT00843024|11571164|FG005|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
10425651|NCT00843024|11571159|FG000|STARTED|Double-blind Treatment Phase||0
10425652|NCT00843024|11571160|FG001|STARTED|Double-blind Treatment Phase||0
10425653|NCT00843024|11571161|FG002|STARTED|Double-blind Treatment Phase||176
10425654|NCT00843024|11571162|FG003|STARTED|Double-blind Treatment Phase||119
10425655|NCT00843024|11571163|FG004|STARTED|Double-blind Treatment Phase||117
10425656|NCT00843024|11571164|FG005|STARTED|Double-blind Treatment Phase||177
10425657|NCT00843024|11571159|FG000|COMPLETED|Double-blind Treatment Phase||0
10425658|NCT00843024|11571160|FG001|COMPLETED|Double-blind Treatment Phase||0
10425659|NCT00843024|11571161|FG002|COMPLETED|Double-blind Treatment Phase||145
10425660|NCT00843024|11571162|FG003|COMPLETED|Double-blind Treatment Phase||96
10425661|NCT00843024|11571163|FG004|COMPLETED|Double-blind Treatment Phase||97
10425662|NCT00843024|11571164|FG005|COMPLETED|Double-blind Treatment Phase||152
10425663|NCT00843024|11571159|FG000|NOT COMPLETED|Double-blind Treatment Phase||0
10425664|NCT00843024|11571160|FG001|NOT COMPLETED|Double-blind Treatment Phase||0
10425665|NCT00843024|11571161|FG002|NOT COMPLETED|Double-blind Treatment Phase||31
10425666|NCT00843024|11571162|FG003|NOT COMPLETED|Double-blind Treatment Phase||23
10425667|NCT00843024|11571163|FG004|NOT COMPLETED|Double-blind Treatment Phase||20
10425668|NCT00843024|11571164|FG005|NOT COMPLETED|Double-blind Treatment Phase||25
10425669|NCT00843115|11571177|FG000|STARTED|Overall Study||370
10425670|NCT00843115|11571177|FG000|COMPLETED|Overall Study||304
10425671|NCT00843115|11571177|FG000|NOT COMPLETED|Overall Study||66
10425672|NCT00843167|11571183|FG000|STARTED|Treatment Period||27
10425673|NCT00843167|11571184|FG001|STARTED|Treatment Period||27
10425674|NCT00843167|11571183|FG000|COMPLETED|Treatment Period||24
10425675|NCT00843167|11571184|FG001|COMPLETED|Treatment Period||19
10425676|NCT00843167|11571183|FG000|NOT COMPLETED|Treatment Period||3
10425677|NCT00843167|11571184|FG001|NOT COMPLETED|Treatment Period||8
10425678|NCT00843167|11571183|FG000|STARTED|Follow-up||24
10425679|NCT00843167|11571184|FG001|STARTED|Follow-up||24
10425680|NCT00843167|11571183|FG000|Completed Final Visit|Follow-up||24
10425681|NCT00843167|11571184|FG001|Completed Final Visit|Follow-up||24
10425682|NCT00843167|11571183|FG000|COMPLETED|Follow-up||24
10425683|NCT00843167|11571184|FG001|COMPLETED|Follow-up||24
10425684|NCT00843167|11571183|FG000|NOT COMPLETED|Follow-up||0
10425685|NCT00843167|11571184|FG001|NOT COMPLETED|Follow-up||0
10425686|NCT00843180|11571196|FG000|STARTED|Overall Study||16
10425687|NCT00843180|11571197|FG001|STARTED|Overall Study||7
10425688|NCT00843180|11571196|FG000|COMPLETED|Overall Study||16
10425689|NCT00843180|11571197|FG001|COMPLETED|Overall Study||7
10425690|NCT00843180|11571196|FG000|NOT COMPLETED|Overall Study||0
10425691|NCT00843180|11571197|FG001|NOT COMPLETED|Overall Study||0
10425692|NCT00843193|11571205|FG000|STARTED|Overall Study||99
10425693|NCT00843193|11571206|FG001|STARTED|Overall Study||99
10425694|NCT00843193|11571205|FG000|COMPLETED|Overall Study||91
10425695|NCT00843193|11571206|FG001|COMPLETED|Overall Study||88
10425696|NCT00843193|11571205|FG000|NOT COMPLETED|Overall Study||8
10425697|NCT00843193|11571206|FG001|NOT COMPLETED|Overall Study||11
10425698|NCT00843284|11571213|FG000|STARTED|Overall Study||691
10425699|NCT00843284|11571213|FG000|COMPLETED|Overall Study||619
10425700|NCT00843284|11571213|FG000|NOT COMPLETED|Overall Study||72
10425701|NCT00843349|11571221|FG000|STARTED|Overall Study||11
10425702|NCT00843349|11571222|FG001|STARTED|Overall Study||11
10425703|NCT00843349|11571223|FG002|STARTED|Overall Study||10
10425704|NCT00843349|11571224|FG003|STARTED|Overall Study||11
10425705|NCT00843349|11571221|FG000|COMPLETED|Overall Study||8
10425706|NCT00843349|11571222|FG001|COMPLETED|Overall Study||11
10425707|NCT00843349|11571223|FG002|COMPLETED|Overall Study||10
10425708|NCT00843349|11571224|FG003|COMPLETED|Overall Study||10
10425709|NCT00843349|11571221|FG000|NOT COMPLETED|Overall Study||3
10425710|NCT00843349|11571222|FG001|NOT COMPLETED|Overall Study||0
10425711|NCT00843349|11571223|FG002|NOT COMPLETED|Overall Study||0
10425712|NCT00843349|11571224|FG003|NOT COMPLETED|Overall Study||1
10425713|NCT00843466|11571236|FG000|STARTED|Overall Study||24
10425714|NCT00843466|11571237|FG001|STARTED|Overall Study||18
10425715|NCT00843466|11571236|FG000|COMPLETED|Overall Study||24
10425716|NCT00843466|11571237|FG001|COMPLETED|Overall Study||18
10425717|NCT00843466|11571236|FG000|NOT COMPLETED|Overall Study||0
10425718|NCT00843466|11571237|FG001|NOT COMPLETED|Overall Study||0
10425719|NCT00843479|11571245|FG000|STARTED|Overall Study||12
10425720|NCT00843479|11571246|FG001|STARTED|Overall Study||12
10425721|NCT00843479|11571245|FG000|COMPLETED|Overall Study||12
10425722|NCT00843479|11571246|FG001|COMPLETED|Overall Study||12
10425723|NCT00843479|11571245|FG000|NOT COMPLETED|Overall Study||0
10425724|NCT00843479|11571246|FG001|NOT COMPLETED|Overall Study||0
10425725|NCT00843492|11571256|FG000|STARTED|Overall Study||622
10425726|NCT00843492|11571257|FG001|STARTED|Overall Study||621
10425727|NCT00843492|11571256|FG000|COMPLETED|Overall Study||614
10425728|NCT00843492|11571257|FG001|COMPLETED|Overall Study||607
10425729|NCT00843492|11571256|FG000|NOT COMPLETED|Overall Study||8
10425730|NCT00843492|11571257|FG001|NOT COMPLETED|Overall Study||14
10425731|NCT00843518|11571265|FG000|STARTED|Period 2 (Double-blind Treatment)||63
10425732|NCT00843518|11571266|FG001|STARTED|Period 2 (Double-blind Treatment)||69
10425733|NCT00843518|11571265|FG000|COMPLETED|Period 2 (Double-blind Treatment)||43
10425734|NCT00843518|11571266|FG001|COMPLETED|Period 2 (Double-blind Treatment)||49
10425735|NCT00843518|11571265|FG000|NOT COMPLETED|Period 2 (Double-blind Treatment)||20
10425736|NCT00843518|11571266|FG001|NOT COMPLETED|Period 2 (Double-blind Treatment)||20
10425737|NCT00843518|11571265|FG000|STARTED|Period 3 (Single-blind Washout)|1 LY451395 participant completed double-blind treatment, but did not enter washout period.|42
10425738|NCT00843518|11571266|FG001|STARTED|Period 3 (Single-blind Washout)||49
10425739|NCT00843518|11571265|FG000|COMPLETED|Period 3 (Single-blind Washout)||42
10425740|NCT00843518|11571266|FG001|COMPLETED|Period 3 (Single-blind Washout)||49
10425741|NCT00843518|11571265|FG000|NOT COMPLETED|Period 3 (Single-blind Washout)||0
10425742|NCT00843518|11571266|FG001|NOT COMPLETED|Period 3 (Single-blind Washout)||0
10425743|NCT00843531|11571276|FG000|STARTED|Overall Study||17
10425744|NCT00843531|11571276|FG000|COMPLETED|Overall Study||17
10425745|NCT00843531|11571276|FG000|NOT COMPLETED|Overall Study||0
10425746|NCT00843622|11571286|FG000|STARTED|Overall Study||125
10425747|NCT00843622|11571287|FG001|STARTED|Overall Study||125
10425748|NCT00843622|11571286|FG000|COMPLETED|Overall Study||82
10425749|NCT00843622|11571287|FG001|COMPLETED|Overall Study||70
10425750|NCT00843622|11571286|FG000|NOT COMPLETED|Overall Study||43
10425751|NCT00843622|11571287|FG001|NOT COMPLETED|Overall Study||55
10425752|NCT00843635|11571296|FG000|STARTED|Overall Study||15
10425753|NCT00843635|11571297|FG001|STARTED|Overall Study||15
10425754|NCT00843635|11571298|FG002|STARTED|Overall Study||5
10425755|NCT00843635|11571296|FG000|COMPLETED|Overall Study||13
10425756|NCT00843635|11571297|FG001|COMPLETED|Overall Study||13
10425757|NCT00843635|11571298|FG002|COMPLETED|Overall Study||5
10425758|NCT00843635|11571296|FG000|NOT COMPLETED|Overall Study||2
10425759|NCT00843635|11571297|FG001|NOT COMPLETED|Overall Study||2
10425760|NCT00843635|11571298|FG002|NOT COMPLETED|Overall Study||0
10425761|NCT00843713|11571312|FG000|STARTED|Overall Study||30
10425762|NCT00843713|11571313|FG001|STARTED|Overall Study||26
10425763|NCT00843713|11571312|FG000|COMPLETED|Overall Study||30
10425764|NCT00843713|11571313|FG001|COMPLETED|Overall Study||26
10425765|NCT00843713|11571312|FG000|NOT COMPLETED|Overall Study||0
10425766|NCT00843713|11571313|FG001|NOT COMPLETED|Overall Study||0
10425767|NCT00843726|11571321|FG000|STARTED|Overall Study||49
10425768|NCT00843726|11571322|FG001|STARTED|Overall Study||49
10425769|NCT00843726|11571321|FG000|COMPLETED|Overall Study||48
10425770|NCT00843726|11571322|FG001|COMPLETED|Overall Study||48
10425771|NCT00843726|11571321|FG000|NOT COMPLETED|Overall Study||1
10425772|NCT00843726|11571322|FG001|NOT COMPLETED|Overall Study||1
10425773|NCT00843778|11571329|FG000|STARTED|Overall Study||131
10425774|NCT00843778|11571329|FG000|COMPLETED|Overall Study||96
10425775|NCT00843778|11571329|FG000|NOT COMPLETED|Overall Study||35
10425776|NCT00843843|11571335|FG000|STARTED|Overall Study||8
10425777|NCT00843843|11571336|FG001|STARTED|Overall Study||8
10425778|NCT00843843|11571335|FG000|COMPLETED|Overall Study||6
10425779|NCT00843843|11571336|FG001|COMPLETED|Overall Study||6
10425780|NCT00843843|11571335|FG000|NOT COMPLETED|Overall Study||2
10425781|NCT00843843|11571336|FG001|NOT COMPLETED|Overall Study||2
10425782|NCT00843856|11571344|FG000|STARTED|Overall Study||20
10425783|NCT00843856|11571345|FG001|STARTED|Overall Study||20
10425784|NCT00843856|11571344|FG000|COMPLETED|Overall Study||19
10425785|NCT00843856|11571345|FG001|COMPLETED|Overall Study||18
10425786|NCT00843856|11571344|FG000|NOT COMPLETED|Overall Study||1
10425787|NCT00843856|11571345|FG001|NOT COMPLETED|Overall Study||2
10425788|NCT00844051|11571353|FG000|STARTED|Overall Study||2087
10425789|NCT00844051|11571354|FG001|STARTED|Overall Study||2368
10425790|NCT00844051|11571353|FG000|COMPLETED|Overall Study||2087
10425791|NCT00844051|11571354|FG001|COMPLETED|Overall Study||2368
10425792|NCT00844051|11571353|FG000|NOT COMPLETED|Overall Study||0
10425793|NCT00844051|11571354|FG001|NOT COMPLETED|Overall Study||0
10425794|NCT00844090|11571362|FG000|STARTED|Overall Study||52
10425795|NCT00844090|11571363|FG001|STARTED|Overall Study||54
10425796|NCT00844090|11571362|FG000|COMPLETED|Overall Study||46
10425797|NCT00844090|11571363|FG001|COMPLETED|Overall Study||46
10425798|NCT00844090|11571362|FG000|NOT COMPLETED|Overall Study||6
10425799|NCT00844090|11571363|FG001|NOT COMPLETED|Overall Study||8
10425800|NCT00844194|11571371|FG000|STARTED|Overall Study||78
10425801|NCT00844194|11571372|FG001|STARTED|Overall Study||30
10425802|NCT00844194|11571371|FG000|COMPLETED|Overall Study||53
10425803|NCT00844194|11571372|FG001|COMPLETED|Overall Study||22
10425804|NCT00844194|11571371|FG000|NOT COMPLETED|Overall Study||25
10425805|NCT00844194|11571372|FG001|NOT COMPLETED|Overall Study||8
10425806|NCT00844298|11571382|FG000|STARTED|Overall Study||91
10425807|NCT00844298|11571382|FG000|COMPLETED|Overall Study||91
10425808|NCT00844298|11571382|FG000|NOT COMPLETED|Overall Study||0
10425809|NCT00844376|11571386|FG000|STARTED|Period 1: First Intervention||6
10425810|NCT00844376|11571387|FG001|STARTED|Period 1: First Intervention||6
10425811|NCT00844376|11571386|FG000|COMPLETED|Period 1: First Intervention||5
10425812|NCT00844376|11571387|FG001|COMPLETED|Period 1: First Intervention||6
10425813|NCT00844376|11571386|FG000|NOT COMPLETED|Period 1: First Intervention||1
10425814|NCT00844376|11571387|FG001|NOT COMPLETED|Period 1: First Intervention||0
10425815|NCT00844376|11571386|FG000|STARTED|Period 2: Second Intervention||5
10425816|NCT00844376|11571387|FG001|STARTED|Period 2: Second Intervention||6
10425817|NCT00844376|11571386|FG000|COMPLETED|Period 2: Second Intervention|Total subjects administered Test drug = 12; total subjects administered Reference drug = 11.|5
10425818|NCT00844376|11571387|FG001|COMPLETED|Period 2: Second Intervention||6
10425819|NCT00844376|11571386|FG000|NOT COMPLETED|Period 2: Second Intervention||0
10425820|NCT00844376|11571387|FG001|NOT COMPLETED|Period 2: Second Intervention||0
10425821|NCT00844415|11571393|FG000|STARTED|Overall Study|Entered and treated.|9
10425822|NCT00844415|11571393|FG000|Pat. Received 75mg Followed by 100mg|Overall Study||3
10425823|NCT00844415|11571393|FG000|Pat. Received 100mg Followed by 125mg|Overall Study||3
10425824|NCT00844415|11571393|FG000|Pat. Received 125mg Followed by 150mg|Overall Study||2
10425825|NCT00844415|11571393|FG000|Pat. Received Single Dose 75mg|Overall Study||1
10425826|NCT00844415|11571393|FG000|COMPLETED|Overall Study|Completed.|8
10425827|NCT00844415|11571393|FG000|NOT COMPLETED|Overall Study||1
10425828|NCT00844428|11571398|FG000|STARTED|Screening Period||23
10425829|NCT00844428|11571398|FG000|COMPLETED|Screening Period||20
10425830|NCT00844428|11571398|FG000|NOT COMPLETED|Screening Period||3
10425831|NCT00844428|11571398|FG000|STARTED|Observation Period (8 Weeks)||20
10425832|NCT00844428|11571398|FG000|COMPLETED|Observation Period (8 Weeks)||20
10425833|NCT00844428|11571398|FG000|NOT COMPLETED|Observation Period (8 Weeks)||0
10425834|NCT00844428|11571398|FG000|STARTED|Treatment Period (26 Weeks)||20
10425835|NCT00844428|11571398|FG000|COMPLETED|Treatment Period (26 Weeks)||20
10425836|NCT00844428|11571398|FG000|NOT COMPLETED|Treatment Period (26 Weeks)||0
10425837|NCT00844428|11571398|FG000|STARTED|Extension Treatment Period||19
10425838|NCT00844428|11571398|FG000|COMPLETED|Extension Treatment Period||18
10425839|NCT00844428|11571398|FG000|NOT COMPLETED|Extension Treatment Period||1
10425840|NCT00844428|11571398|FG000|STARTED|Post Treatment Period (Patients Who Disc||5
10425841|NCT00844428|11571398|FG000|COMPLETED|Post Treatment Period (Patients Who Disc||4
10425842|NCT00844428|11571398|FG000|NOT COMPLETED|Post Treatment Period (Patients Who Disc||1
10425843|NCT00844519|11571404|FG000|STARTED|Overall Study||26
10425844|NCT00844519|11571405|FG001|STARTED|Overall Study||26
10425845|NCT00844519|11571404|FG000|COMPLETED|Overall Study||24
10425846|NCT00844519|11571405|FG001|COMPLETED|Overall Study||25
10425847|NCT00844519|11571404|FG000|NOT COMPLETED|Overall Study||2
10425848|NCT00844519|11571405|FG001|NOT COMPLETED|Overall Study||1
10425849|NCT00844532|11571411|FG000|STARTED|Overall Study||151
10425850|NCT00844532|11571411|FG000|COMPLETED|Overall Study||112
10425851|NCT00844532|11571411|FG000|NOT COMPLETED|Overall Study||39
10425852|NCT00844545|11571415|FG000|STARTED|Screening Period||17
10425853|NCT00844545|11571415|FG000|COMPLETED|Screening Period||17
10425854|NCT00844545|11571415|FG000|NOT COMPLETED|Screening Period||0
10425855|NCT00844545|11571415|FG000|STARTED|Treatment Period (26 Weeks)||17
10425856|NCT00844545|11571415|FG000|COMPLETED|Treatment Period (26 Weeks)||15
10425857|NCT00844545|11571415|FG000|NOT COMPLETED|Treatment Period (26 Weeks)||2
10425858|NCT00844545|11571415|FG000|STARTED|Extension Treatment Period||13
10425859|NCT00844545|11571415|FG000|COMPLETED|Extension Treatment Period||11
10425860|NCT00844545|11571415|FG000|NOT COMPLETED|Extension Treatment Period||2
10425861|NCT00844545|11571415|FG000|STARTED|Post Treatment Period||6
10425862|NCT00844545|11571415|FG000|COMPLETED|Post Treatment Period||5
10425863|NCT00844545|11571415|FG000|NOT COMPLETED|Post Treatment Period||1
10425864|NCT00844558|11571422|FG000|STARTED|Overall Study|"Received allocated intervention (n=33)~Did not receive allocated intervention (n=3)"|36
10425865|NCT00844558|11571423|FG001|STARTED|Overall Study|"Received allocated intervention (n=21)~Did not receive allocated intervention (n=1)"|22
10425866|NCT00844558|11571422|FG000|Received Allocated Intervention|Overall Study||33
10425867|NCT00844558|11571423|FG001|Received Allocated Intervention|Overall Study||21
10425868|NCT00844558|11571422|FG000|3 Month Visit|Overall Study|Discontinued intervention (n=4)|29
10425869|NCT00844558|11571423|FG001|3 Month Visit|Overall Study|"Lost to follow-up (n=1)~Discontinued Intervention (n=1)"|19
10425870|NCT00844558|11571422|FG000|6 Month Visit|Overall Study|Discontinued intervention (n=1)|28
10425871|NCT00844558|11571423|FG001|6 Month Visit|Overall Study|-Discontinued intervention (n=1)|18
10425872|NCT00844558|11571422|FG000|12 Month Visit|Overall Study|Discontinued intervention (n=4)|24
10425873|NCT00844558|11571423|FG001|12 Month Visit|Overall Study|-Discontinued intervention (n=0)|18
10425874|NCT00844558|11571422|FG000|COMPLETED|Overall Study||24
10425875|NCT00844558|11571423|FG001|COMPLETED|Overall Study||18
10425876|NCT00844558|11571422|FG000|NOT COMPLETED|Overall Study||12
10425877|NCT00844558|11571423|FG001|NOT COMPLETED|Overall Study||4
10425878|NCT00844597|11571440|FG000|STARTED|Overall Study||4
10425879|NCT00844597|11571441|FG001|STARTED|Overall Study||2
10425880|NCT00844597|11571442|FG002|STARTED|Overall Study||2
10425881|NCT00844597|11571443|FG003|STARTED|Overall Study||3
10425882|NCT00844597|11571444|FG004|STARTED|Overall Study||4
10425883|NCT00844597|11571445|FG005|STARTED|Overall Study||4
10425884|NCT00844597|11571440|FG000|COMPLETED|Overall Study||4
10425885|NCT00844597|11571441|FG001|COMPLETED|Overall Study||2
10425886|NCT00844597|11571442|FG002|COMPLETED|Overall Study||2
10425887|NCT00844597|11571443|FG003|COMPLETED|Overall Study||2
10425888|NCT00844597|11571444|FG004|COMPLETED|Overall Study||4
10425889|NCT00844597|11571445|FG005|COMPLETED|Overall Study||4
10425890|NCT00844597|11571440|FG000|NOT COMPLETED|Overall Study||0
10425891|NCT00844597|11571441|FG001|NOT COMPLETED|Overall Study||0
10425892|NCT00844597|11571442|FG002|NOT COMPLETED|Overall Study||0
10425893|NCT00844597|11571443|FG003|NOT COMPLETED|Overall Study||1
10425894|NCT00844597|11571444|FG004|NOT COMPLETED|Overall Study||0
10425895|NCT00844597|11571445|FG005|NOT COMPLETED|Overall Study||0
10425896|NCT00844649|11571463|FG000|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|431
10425897|NCT00844649|11571464|FG001|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|430
10425898|NCT00844649|11571463|FG000|Treated Population|Overall Study|Treated population = all randomized patients who received at least one dose of study drug|421
10425899|NCT00844649|11571464|FG001|Treated Population|Overall Study|Treated population = all randomized patients who received at least one dose of study drug|402
10425900|NCT00844649|11571463|FG000|COMPLETED|Overall Study|Completed = participants remaining on treatment at the time of the data cut off 17 Sept 2012|26
10425901|NCT00844649|11571464|FG001|COMPLETED|Overall Study|Completed = participants remaining on treatment at the time of the data cut off 17 Sept 2012|12
10425902|NCT00844649|11571463|FG000|NOT COMPLETED|Overall Study||405
10425903|NCT00844649|11571464|FG001|NOT COMPLETED|Overall Study||418
10425904|NCT00844714|11571472|FG000|STARTED|Overall Study||20
10425905|NCT00844714|11571472|FG000|COMPLETED|Overall Study||20
10425906|NCT00844714|11571472|FG000|NOT COMPLETED|Overall Study||0
10425907|NCT00844753|11571480|FG000|STARTED|Overall Study||32
10425908|NCT00844753|11571481|FG001|STARTED|Overall Study||32
10425909|NCT00844753|11571482|FG002|STARTED|Overall Study||32
10425910|NCT00844753|11571483|FG003|STARTED|Overall Study||32
10425911|NCT00844753|11571480|FG000|COMPLETED|Overall Study||24
10425912|NCT00844753|11571481|FG001|COMPLETED|Overall Study||29
10425913|NCT00844753|11571482|FG002|COMPLETED|Overall Study||25
10425914|NCT00844753|11571483|FG003|COMPLETED|Overall Study||21
10425915|NCT00844753|11571480|FG000|NOT COMPLETED|Overall Study||8
10425916|NCT00844753|11571481|FG001|NOT COMPLETED|Overall Study||3
10425917|NCT00844753|11571482|FG002|NOT COMPLETED|Overall Study||7
10425918|NCT00844753|11571483|FG003|NOT COMPLETED|Overall Study||11
10425919|NCT00844805|11571493|FG000|STARTED|Treatment Phase||106
10425920|NCT00844805|11571494|FG001|STARTED|Treatment Phase||52
10425921|NCT00844805|11571495|FG002|STARTED|Treatment Phase||0
10425922|NCT00844805|11571496|FG003|STARTED|Treatment Phase||0
10425923|NCT00844805|11571493|FG000|COMPLETED|Treatment Phase||96
10425924|NCT00844805|11571494|FG001|COMPLETED|Treatment Phase||45
10425925|NCT00844805|11571495|FG002|COMPLETED|Treatment Phase||0
10425926|NCT00844805|11571496|FG003|COMPLETED|Treatment Phase||0
10425927|NCT00844805|11571493|FG000|NOT COMPLETED|Treatment Phase||10
10425928|NCT00844805|11571494|FG001|NOT COMPLETED|Treatment Phase||7
10425929|NCT00844805|11571495|FG002|NOT COMPLETED|Treatment Phase||0
10425930|NCT00844805|11571496|FG003|NOT COMPLETED|Treatment Phase||0
10425931|NCT00844805|11571493|FG000|STARTED|Follow-Up Phase||0
10425932|NCT00844805|11571494|FG001|STARTED|Follow-Up Phase||0
10425933|NCT00844805|11571495|FG002|STARTED|Follow-Up Phase|Participants who met partial remission criteria at the end of treatment entered the Follow-Up Phase.|41
10425934|NCT00844805|11571496|FG003|STARTED|Follow-Up Phase|Participants who met partial remission criteria at the end of treatment entered the Follow-Up Phase.|41
10425935|NCT00844805|11571493|FG000|COMPLETED|Follow-Up Phase||0
10425936|NCT00844805|11571494|FG001|COMPLETED|Follow-Up Phase||0
10425937|NCT00844805|11571495|FG002|COMPLETED|Follow-Up Phase||32
10425938|NCT00844805|11571496|FG003|COMPLETED|Follow-Up Phase||32
10425939|NCT00844805|11571493|FG000|NOT COMPLETED|Follow-Up Phase||0
10425940|NCT00844805|11571494|FG001|NOT COMPLETED|Follow-Up Phase||0
10425941|NCT00844805|11571495|FG002|NOT COMPLETED|Follow-Up Phase||9
10425942|NCT00844805|11571496|FG003|NOT COMPLETED|Follow-Up Phase||9
10425943|NCT00844831|11571507|FG000|STARTED|Overall Study||25
10425944|NCT00844831|11571507|FG000|COMPLETED|Overall Study||19
10425945|NCT00844831|11571507|FG000|NOT COMPLETED|Overall Study||6
10425946|NCT00844844|11571515|FG000|STARTED|Screening Period||17
10425947|NCT00844844|11571515|FG000|COMPLETED|Screening Period||17
10425948|NCT00844844|11571515|FG000|NOT COMPLETED|Screening Period||0
10425949|NCT00844844|11571515|FG000|STARTED|Treatment Period (26 Weeks)||17
10425950|NCT00844844|11571515|FG000|COMPLETED|Treatment Period (26 Weeks)||15
10425951|NCT00844844|11571515|FG000|NOT COMPLETED|Treatment Period (26 Weeks)||2
10425952|NCT00844844|11571515|FG000|STARTED|Extension Treatment Period||13
10425953|NCT00844844|11571515|FG000|COMPLETED|Extension Treatment Period||11
10425954|NCT00844844|11571515|FG000|NOT COMPLETED|Extension Treatment Period||2
10425955|NCT00844844|11571515|FG000|STARTED|Post Treatment Period||6
10425956|NCT00844844|11571515|FG000|COMPLETED|Post Treatment Period||5
10425957|NCT00844844|11571515|FG000|NOT COMPLETED|Post Treatment Period||1
10425958|NCT00844857|11571521|FG000|STARTED|Overall Study||194
10425959|NCT00844857|11571522|FG001|STARTED|Overall Study||97
10425960|NCT00844857|11571521|FG000|Population Analyzed|Overall Study|Randomized participants who took at least 1 dose of study drug excluding 2 GCP noncompliant sites.|170
10425961|NCT00844857|11571522|FG001|Population Analyzed|Overall Study|randomized participants who took at least 1 dose of study drug excluding 2 GCP noncompliant sites.|85
10425962|NCT00844857|11571521|FG000|COMPLETED|Overall Study||116
10425963|NCT00844857|11571522|FG001|COMPLETED|Overall Study||60
10425964|NCT00844857|11571521|FG000|NOT COMPLETED|Overall Study||78
10425965|NCT00844857|11571522|FG001|NOT COMPLETED|Overall Study||37
10425966|NCT00844883|11571531|FG000|STARTED|Overall Study||50
10425967|NCT00844883|11571531|FG000|Patients Who Received TACE|Overall Study|2 patients withdrawn at Week 1 prior to TACE for intolerance to sorafenib|48
10425968|NCT00844883|11571531|FG000|COMPLETED|Overall Study||46
10425969|NCT00844883|11571531|FG000|NOT COMPLETED|Overall Study||4
10425970|NCT00844896|11571537|FG000|STARTED|Overall Study||29
10425971|NCT00844896|11571538|FG001|STARTED|Overall Study||28
10425972|NCT00844896|11571537|FG000|COMPLETED|Overall Study||17
10425973|NCT00844896|11571538|FG001|COMPLETED|Overall Study||11
10425974|NCT00844896|11571537|FG000|NOT COMPLETED|Overall Study||12
10425975|NCT00844896|11571538|FG001|NOT COMPLETED|Overall Study||17
10425976|NCT00845000|11571551|FG000|STARTED|Period 1||2
10425977|NCT00845000|11571552|FG001|STARTED|Period 1||2
10425978|NCT00845000|11571553|FG002|STARTED|Period 1||2
10425979|NCT00845000|11571554|FG003|STARTED|Period 1||2
10425980|NCT00845000|11571555|FG004|STARTED|Period 1||2
10425981|NCT00845000|11571556|FG005|STARTED|Period 1||2
10425982|NCT00845000|11571551|FG000|COMPLETED|Period 1||2
10425983|NCT00845000|11571552|FG001|COMPLETED|Period 1||2
10425984|NCT00845000|11571553|FG002|COMPLETED|Period 1||2
10425985|NCT00845000|11571554|FG003|COMPLETED|Period 1||2
10425986|NCT00845000|11571555|FG004|COMPLETED|Period 1||2
10425987|NCT00845000|11571556|FG005|COMPLETED|Period 1||2
10425988|NCT00845000|11571551|FG000|NOT COMPLETED|Period 1||0
10425989|NCT00845000|11571552|FG001|NOT COMPLETED|Period 1||0
10425990|NCT00845000|11571553|FG002|NOT COMPLETED|Period 1||0
10425991|NCT00845000|11571554|FG003|NOT COMPLETED|Period 1||0
10425992|NCT00845000|11571555|FG004|NOT COMPLETED|Period 1||0
10425993|NCT00845000|11571556|FG005|NOT COMPLETED|Period 1||0
10425994|NCT00845000|11571551|FG000|STARTED|Period 2||2
10425995|NCT00845000|11571552|FG001|STARTED|Period 2||2
10425996|NCT00845000|11571553|FG002|STARTED|Period 2||2
10425997|NCT00845000|11571554|FG003|STARTED|Period 2||2
10425998|NCT00845000|11571555|FG004|STARTED|Period 2||2
10425999|NCT00845000|11571556|FG005|STARTED|Period 2||2
10426000|NCT00845000|11571551|FG000|COMPLETED|Period 2||2
10426001|NCT00845000|11571552|FG001|COMPLETED|Period 2||2
10426002|NCT00845000|11571553|FG002|COMPLETED|Period 2||2
10426003|NCT00845000|11571554|FG003|COMPLETED|Period 2||2
10426004|NCT00845000|11571555|FG004|COMPLETED|Period 2||2
10426005|NCT00845000|11571556|FG005|COMPLETED|Period 2||2
10426006|NCT00845000|11571551|FG000|NOT COMPLETED|Period 2||0
10426007|NCT00845000|11571552|FG001|NOT COMPLETED|Period 2||0
10426008|NCT00845000|11571553|FG002|NOT COMPLETED|Period 2||0
10426009|NCT00845000|11571554|FG003|NOT COMPLETED|Period 2||0
10426010|NCT00845000|11571555|FG004|NOT COMPLETED|Period 2||0
10426011|NCT00845000|11571556|FG005|NOT COMPLETED|Period 2||0
10426012|NCT00845000|11571551|FG000|STARTED|Period 3||2
10426013|NCT00845000|11571552|FG001|STARTED|Period 3||2
10426014|NCT00845000|11571553|FG002|STARTED|Period 3||2
10426015|NCT00845000|11571554|FG003|STARTED|Period 3||2
10426016|NCT00845000|11571555|FG004|STARTED|Period 3||2
10426017|NCT00845000|11571556|FG005|STARTED|Period 3||2
10426018|NCT00845000|11571551|FG000|COMPLETED|Period 3||2
10426019|NCT00845000|11571552|FG001|COMPLETED|Period 3||2
10426020|NCT00845000|11571553|FG002|COMPLETED|Period 3||2
10426021|NCT00845000|11571554|FG003|COMPLETED|Period 3||2
10426022|NCT00845000|11571555|FG004|COMPLETED|Period 3||2
10426023|NCT00845000|11571556|FG005|COMPLETED|Period 3||2
10426024|NCT00845000|11571551|FG000|NOT COMPLETED|Period 3||0
10426025|NCT00845000|11571552|FG001|NOT COMPLETED|Period 3||0
10426026|NCT00845000|11571553|FG002|NOT COMPLETED|Period 3||0
10426027|NCT00845000|11571554|FG003|NOT COMPLETED|Period 3||0
10426028|NCT00845000|11571555|FG004|NOT COMPLETED|Period 3||0
10426029|NCT00845000|11571556|FG005|NOT COMPLETED|Period 3||0
10426030|NCT00845039|11571566|FG000|STARTED|Overall Study||2
10426031|NCT00845039|11571567|FG001|STARTED|Overall Study||2
10426032|NCT00845039|11571566|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2
10426033|NCT00845039|11571567|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2
10426034|NCT00845039|11571566|FG000|COMPLETED|Overall Study||2
10426035|NCT00845039|11571567|FG001|COMPLETED|Overall Study||2
10426036|NCT00845039|11571566|FG000|NOT COMPLETED|Overall Study||0
10426037|NCT00845039|11571567|FG001|NOT COMPLETED|Overall Study||0
10426038|NCT00845065|11571577|FG000|STARTED|Overall Study||67
10426039|NCT00845065|11571578|FG001|STARTED|Overall Study||134
10426040|NCT00845065|11571577|FG000|COMPLETED|Overall Study||20
10426041|NCT00845065|11571578|FG001|COMPLETED|Overall Study||79
10426042|NCT00845065|11571577|FG000|NOT COMPLETED|Overall Study||47
10426043|NCT00845065|11571578|FG001|NOT COMPLETED|Overall Study||55
10426044|NCT00845130|11571586|FG000|STARTED|Overall Study||20
10426045|NCT00845130|11571587|FG001|STARTED|Overall Study||22
10426046|NCT00845130|11571586|FG000|COMPLETED|Overall Study||16
10426047|NCT00845130|11571587|FG001|COMPLETED|Overall Study||19
10426048|NCT00845130|11571586|FG000|NOT COMPLETED|Overall Study||4
10426049|NCT00845130|11571587|FG001|NOT COMPLETED|Overall Study||3
10429782|NCT00866359|11575868|FG000|COMPLETED|Extension Phase (Day 86 to 169)||0
10429783|NCT00866359|11575869|FG001|COMPLETED|Extension Phase (Day 86 to 169)||0
10429784|NCT00866359|11575870|FG002|COMPLETED|Extension Phase (Day 86 to 169)||44
10429785|NCT00866359|11575871|FG003|COMPLETED|Extension Phase (Day 86 to 169)||47
10429786|NCT00866359|11575868|FG000|NOT COMPLETED|Extension Phase (Day 86 to 169)||0
10429787|NCT00866359|11575869|FG001|NOT COMPLETED|Extension Phase (Day 86 to 169)||0
10429788|NCT00866359|11575870|FG002|NOT COMPLETED|Extension Phase (Day 86 to 169)||1
10429789|NCT00866359|11575871|FG003|NOT COMPLETED|Extension Phase (Day 86 to 169)||3
10429790|NCT00866359|11575868|FG000|STARTED|Observational Follow-Up Phase||0
10429791|NCT00866359|11575869|FG001|STARTED|Observational Follow-Up Phase||0
10429792|NCT00866359|11575870|FG002|STARTED|Observational Follow-Up Phase|Includes those who entered the follow-up phase from both the placebo controlled or extension phase.|54
10429793|NCT00866359|11575871|FG003|STARTED|Observational Follow-Up Phase|Includes those who entered the follow-up phase from both the placebo controlled or extension phase.|54
10426050|NCT00845182|11571598|FG000|STARTED|Overall Study||13
10426051|NCT00845182|11571599|FG001|STARTED|Overall Study||15
10426052|NCT00845182|11571600|FG002|STARTED|Overall Study||15
10426053|NCT00845182|11571598|FG000|COMPLETED|Overall Study||10
10426054|NCT00845182|11571599|FG001|COMPLETED|Overall Study||11
10426055|NCT00845182|11571600|FG002|COMPLETED|Overall Study||9
10426056|NCT00845182|11571598|FG000|NOT COMPLETED|Overall Study||3
10426057|NCT00845182|11571599|FG001|NOT COMPLETED|Overall Study||4
10426058|NCT00845182|11571600|FG002|NOT COMPLETED|Overall Study||6
10426059|NCT00845195|11571614|FG000|STARTED|Overall Study||75
10426060|NCT00845195|11571615|FG001|STARTED|Overall Study||75
10426061|NCT00845195|11571614|FG000|COMPLETED|Overall Study||75
10426062|NCT00845195|11571615|FG001|COMPLETED|Overall Study||75
10426063|NCT00845195|11571614|FG000|NOT COMPLETED|Overall Study||0
10426064|NCT00845195|11571615|FG001|NOT COMPLETED|Overall Study||0
10426065|NCT00845429|11571624|FG000|STARTED|Overall Study||244
10426066|NCT00845429|11571625|FG001|STARTED|Overall Study||241
10426067|NCT00845429|11571626|FG002|STARTED|Overall Study||244
10426068|NCT00845429|11571624|FG000|COMPLETED|Overall Study||230
10426069|NCT00845429|11571625|FG001|COMPLETED|Overall Study||226
10426070|NCT00845429|11571626|FG002|COMPLETED|Overall Study||224
10426071|NCT00845429|11571624|FG000|NOT COMPLETED|Overall Study||14
10426072|NCT00845429|11571625|FG001|NOT COMPLETED|Overall Study||15
10426073|NCT00845429|11571626|FG002|NOT COMPLETED|Overall Study||20
10426074|NCT00845481|11571634|FG000|STARTED|Overall Study||24
10426075|NCT00845481|11571634|FG000|COMPLETED|Overall Study||24
10426076|NCT00845481|11571634|FG000|NOT COMPLETED|Overall Study||0
10426077|NCT00845507|11571645|FG000|STARTED|Overall Study||24
10426078|NCT00845507|11571646|FG001|STARTED|Overall Study||30
10426079|NCT00845507|11571645|FG000|COMPLETED|Overall Study||22
10426080|NCT00845507|11571646|FG001|COMPLETED|Overall Study||29
10426081|NCT00845507|11571645|FG000|NOT COMPLETED|Overall Study||2
10426082|NCT00845507|11571646|FG001|NOT COMPLETED|Overall Study||1
10426083|NCT00845520|11571655|FG000|STARTED|Overall Study||25
10426084|NCT00845520|11571656|FG001|STARTED|Overall Study||25
10426085|NCT00845520|11571657|FG002|STARTED|Overall Study||24
10426086|NCT00845520|11571655|FG000|COMPLETED|Overall Study||23
10426087|NCT00845520|11571656|FG001|COMPLETED|Overall Study||23
10426088|NCT00845520|11571657|FG002|COMPLETED|Overall Study||23
10426089|NCT00845520|11571655|FG000|NOT COMPLETED|Overall Study||2
10426090|NCT00845520|11571656|FG001|NOT COMPLETED|Overall Study||2
10426091|NCT00845520|11571657|FG002|NOT COMPLETED|Overall Study||1
10426092|NCT00845650|11571677|FG000|STARTED|Overall Study|1 subject not dosed|31
10426093|NCT00845650|11571678|FG001|STARTED|Overall Study||5
10426094|NCT00845650|11571679|FG002|STARTED|Overall Study||31
10426095|NCT00845650|11571680|FG003|STARTED|Overall Study||14
10426096|NCT00845650|11571681|FG004|STARTED|Overall Study|2 subjects not dosed|31
10426097|NCT00845650|11571682|FG005|STARTED|Overall Study|1 subject not dosed|17
10426098|NCT00845650|11571677|FG000|COMPLETED|Overall Study||30
10426099|NCT00845650|11571678|FG001|COMPLETED|Overall Study||5
10426100|NCT00845650|11571679|FG002|COMPLETED|Overall Study||28
10426101|NCT00845650|11571680|FG003|COMPLETED|Overall Study||13
10426102|NCT00845650|11571681|FG004|COMPLETED|Overall Study||28
10426103|NCT00845650|11571682|FG005|COMPLETED|Overall Study||15
10426104|NCT00845650|11571677|FG000|NOT COMPLETED|Overall Study||1
10426105|NCT00845650|11571678|FG001|NOT COMPLETED|Overall Study||0
10426106|NCT00845650|11571679|FG002|NOT COMPLETED|Overall Study||3
10426107|NCT00845650|11571680|FG003|NOT COMPLETED|Overall Study||1
10426108|NCT00845650|11571681|FG004|NOT COMPLETED|Overall Study||3
10426109|NCT00845650|11571682|FG005|NOT COMPLETED|Overall Study||2
10426110|NCT00845663|11571700|FG000|STARTED|Overall Study||49
10426111|NCT00845663|11571701|FG001|STARTED|Overall Study||49
10426112|NCT00845663|11571700|FG000|COMPLETED|Overall Study||49
10426113|NCT00845663|11571701|FG001|COMPLETED|Overall Study||49
10426114|NCT00845663|11571700|FG000|NOT COMPLETED|Overall Study||0
10426115|NCT00845663|11571701|FG001|NOT COMPLETED|Overall Study||0
10426116|NCT00845676|11571707|FG000|STARTED|Overall Study||21
10426117|NCT00845676|11571707|FG000|COMPLETED|Overall Study||19
10426118|NCT00845676|11571707|FG000|NOT COMPLETED|Overall Study||2
10426119|NCT00845728|11571714|FG000|STARTED|Overall Study||1723
10426120|NCT00845728|11571715|FG001|STARTED|Overall Study||1721
10426121|NCT00845728|11571714|FG000|Exposed|Overall Study||1721
10426122|NCT00845728|11571715|FG001|Exposed|Overall Study||1718
10426123|NCT00845728|11571714|FG000|COMPLETED|Overall Study||1337
10426124|NCT00845728|11571715|FG001|COMPLETED|Overall Study||1379
10426125|NCT00845728|11571714|FG000|NOT COMPLETED|Overall Study||386
10426126|NCT00845728|11571715|FG001|NOT COMPLETED|Overall Study||342
10426127|NCT00845832|11571724|FG000|STARTED|Treatment Period||4
10426128|NCT00845832|11571725|FG001|STARTED|Treatment Period||10
10426129|NCT00845832|11571726|FG002|STARTED|Treatment Period||10
10426130|NCT00845832|11571724|FG000|COMPLETED|Treatment Period||3
10426131|NCT00845832|11571725|FG001|COMPLETED|Treatment Period||7
10426132|NCT00845832|11571726|FG002|COMPLETED|Treatment Period||10
10426133|NCT00845832|11571724|FG000|NOT COMPLETED|Treatment Period||1
10426134|NCT00845832|11571725|FG001|NOT COMPLETED|Treatment Period||3
10426135|NCT00845832|11571726|FG002|NOT COMPLETED|Treatment Period||0
10426136|NCT00845832|11571724|FG000|STARTED|Safety Follow-Up|One participant from this group was re-assigned to TCZ (4 mg/kg) group.|3
10426137|NCT00845832|11571725|FG001|STARTED|Safety Follow-Up|All participants who withdrew from study were asked to return for safety follow-up.|9
10426138|NCT00845832|11571726|FG002|STARTED|Safety Follow-Up|One participant each from the placebo and TCZ (2 mg/kg) groups were re-assigned to this group.|12
10426139|NCT00845832|11571724|FG000|COMPLETED|Safety Follow-Up||2
10426140|NCT00845832|11571725|FG001|COMPLETED|Safety Follow-Up|One participant from this group was re-assigned to TCZ (4 mg/kg) group.|9
10426141|NCT00845832|11571726|FG002|COMPLETED|Safety Follow-Up||12
10426142|NCT00845832|11571724|FG000|NOT COMPLETED|Safety Follow-Up||1
10426143|NCT00845832|11571725|FG001|NOT COMPLETED|Safety Follow-Up||0
10426144|NCT00845832|11571726|FG002|NOT COMPLETED|Safety Follow-Up||0
10426145|NCT00845832|11571724|FG000|STARTED|Extended Safety Follow-Up||2
10426330|NCT00847145|11571970|FG002|STARTED|Overall Study||285
10426146|NCT00845832|11571725|FG001|STARTED|Extended Safety Follow-Up|Only participants who remained B cell depleted required extended safety follow-up.|5
10426147|NCT00845832|11571726|FG002|STARTED|Extended Safety Follow-Up|Only participants who remained B cell depleted required extended safety follow-up.|7
10426148|NCT00845832|11571724|FG000|COMPLETED|Extended Safety Follow-Up||2
10426149|NCT00845832|11571725|FG001|COMPLETED|Extended Safety Follow-Up||5
10426150|NCT00845832|11571726|FG002|COMPLETED|Extended Safety Follow-Up||0
10426151|NCT00845832|11571724|FG000|NOT COMPLETED|Extended Safety Follow-Up||0
10426152|NCT00845832|11571725|FG001|NOT COMPLETED|Extended Safety Follow-Up||0
10426153|NCT00845832|11571726|FG002|NOT COMPLETED|Extended Safety Follow-Up||7
10426154|NCT00845858|11571737|FG000|STARTED|Overall Study|"95 subjects received allocated intervention.~1 subject withdrew consent and was not dosed."|96
10426155|NCT00845858|11571738|FG001|STARTED|Overall Study|"95 subjects received allocated intervention.~1 subject was not eligible and was not dosed."|96
10426156|NCT00845858|11571739|FG002|STARTED|Overall Study||95
10426157|NCT00845858|11571737|FG000|COMPLETED|Overall Study||88
10426158|NCT00845858|11571738|FG001|COMPLETED|Overall Study||84
10426159|NCT00845858|11571739|FG002|COMPLETED|Overall Study||87
10426160|NCT00845858|11571737|FG000|NOT COMPLETED|Overall Study||8
10426161|NCT00845858|11571738|FG001|NOT COMPLETED|Overall Study||12
10426162|NCT00845858|11571739|FG002|NOT COMPLETED|Overall Study||8
10426163|NCT00845871|11571750|FG000|STARTED|Run-in Period||65
10426164|NCT00845871|11571750|FG000|COMPLETED|Run-in Period||65
10426165|NCT00845871|11571750|FG000|NOT COMPLETED|Run-in Period||0
10426166|NCT00845871|11571750|FG000|STARTED|Assessment Period||65
10426167|NCT00845871|11571750|FG000|COMPLETED|Assessment Period||58
10426168|NCT00845871|11571750|FG000|NOT COMPLETED|Assessment Period||7
10426169|NCT00845897|11571777|FG000|STARTED|Overall Study||5
10426170|NCT00845897|11571778|FG001|STARTED|Overall Study||7
10426171|NCT00845897|11571779|FG002|STARTED|Overall Study||5
10426172|NCT00845897|11571777|FG000|COMPLETED|Overall Study||3
10426173|NCT00845897|11571778|FG001|COMPLETED|Overall Study||2
10426174|NCT00845897|11571779|FG002|COMPLETED|Overall Study||2
10426175|NCT00845897|11571777|FG000|NOT COMPLETED|Overall Study||2
10426176|NCT00845897|11571778|FG001|NOT COMPLETED|Overall Study||5
10426177|NCT00845897|11571779|FG002|NOT COMPLETED|Overall Study||3
10426178|NCT00845975|11571789|FG000|STARTED|Overall Study||9
10426179|NCT00845975|11571790|FG001|STARTED|Overall Study||9
10426180|NCT00845975|11571789|FG000|COMPLETED|Overall Study||9
10426181|NCT00845975|11571790|FG001|COMPLETED|Overall Study||9
10426182|NCT00845975|11571789|FG000|NOT COMPLETED|Overall Study||0
10426183|NCT00845975|11571790|FG001|NOT COMPLETED|Overall Study||0
10426184|NCT00846027|11571796|FG000|STARTED|Overall Study||90
10426185|NCT00846027|11571796|FG000|Received Treatment|Overall Study||83
10426186|NCT00846027|11571796|FG000|COMPLETED|Overall Study||0
10426187|NCT00846027|11571796|FG000|NOT COMPLETED|Overall Study||90
10426188|NCT00846040|11571803|FG000|STARTED|Baseline: Days 1-5||10
10426189|NCT00846040|11571804|FG001|STARTED|Baseline: Days 1-5||10
10426190|NCT00846040|11571805|FG002|STARTED|Baseline: Days 1-5||23
10426191|NCT00846040|11571803|FG000|COMPLETED|Baseline: Days 1-5||9
10426192|NCT00846040|11571804|FG001|COMPLETED|Baseline: Days 1-5||10
10426193|NCT00846040|11571805|FG002|COMPLETED|Baseline: Days 1-5||23
10426194|NCT00846040|11571803|FG000|NOT COMPLETED|Baseline: Days 1-5||1
10426195|NCT00846040|11571804|FG001|NOT COMPLETED|Baseline: Days 1-5||0
10426196|NCT00846040|11571805|FG002|NOT COMPLETED|Baseline: Days 1-5||0
10426197|NCT00846040|11571803|FG000|STARTED|First Treatment Period: Days 6-14||9
10426198|NCT00846040|11571804|FG001|STARTED|First Treatment Period: Days 6-14||10
10426199|NCT00846040|11571805|FG002|STARTED|First Treatment Period: Days 6-14|This group participated in only the baseline period|0
10426200|NCT00846040|11571803|FG000|COMPLETED|First Treatment Period: Days 6-14||9
10426201|NCT00846040|11571804|FG001|COMPLETED|First Treatment Period: Days 6-14||10
10426202|NCT00846040|11571805|FG002|COMPLETED|First Treatment Period: Days 6-14||0
10426203|NCT00846040|11571803|FG000|NOT COMPLETED|First Treatment Period: Days 6-14||0
10426204|NCT00846040|11571804|FG001|NOT COMPLETED|First Treatment Period: Days 6-14||0
10426205|NCT00846040|11571805|FG002|NOT COMPLETED|First Treatment Period: Days 6-14||0
10426206|NCT00846040|11571803|FG000|STARTED|Washout: 2 Weeks to 10 Weeks||9
10426207|NCT00846040|11571804|FG001|STARTED|Washout: 2 Weeks to 10 Weeks||10
10426208|NCT00846040|11571805|FG002|STARTED|Washout: 2 Weeks to 10 Weeks||0
10426209|NCT00846040|11571803|FG000|COMPLETED|Washout: 2 Weeks to 10 Weeks||9
10426210|NCT00846040|11571804|FG001|COMPLETED|Washout: 2 Weeks to 10 Weeks||8
10426211|NCT00846040|11571805|FG002|COMPLETED|Washout: 2 Weeks to 10 Weeks||0
10426212|NCT00846040|11571803|FG000|NOT COMPLETED|Washout: 2 Weeks to 10 Weeks||0
10426213|NCT00846040|11571804|FG001|NOT COMPLETED|Washout: 2 Weeks to 10 Weeks||2
10426214|NCT00846040|11571805|FG002|NOT COMPLETED|Washout: 2 Weeks to 10 Weeks||0
10426215|NCT00846040|11571803|FG000|STARTED|Second Treatment: After Washout, 14 Day||9
10426216|NCT00846040|11571804|FG001|STARTED|Second Treatment: After Washout, 14 Day||8
10426217|NCT00846040|11571805|FG002|STARTED|Second Treatment: After Washout, 14 Day||0
10426218|NCT00846040|11571803|FG000|COMPLETED|Second Treatment: After Washout, 14 Day||9
10426219|NCT00846040|11571804|FG001|COMPLETED|Second Treatment: After Washout, 14 Day||8
10426220|NCT00846040|11571805|FG002|COMPLETED|Second Treatment: After Washout, 14 Day||0
10426221|NCT00846040|11571803|FG000|NOT COMPLETED|Second Treatment: After Washout, 14 Day||0
10426222|NCT00846040|11571804|FG001|NOT COMPLETED|Second Treatment: After Washout, 14 Day||0
10426223|NCT00846040|11571805|FG002|NOT COMPLETED|Second Treatment: After Washout, 14 Day||0
10426224|NCT00846053|11571816|FG000|STARTED|Overall Study|No milestones. Enrollment continued until end of study.|13
10426225|NCT00846053|11571817|FG001|STARTED|Overall Study||8
10426226|NCT00846053|11571816|FG000|COMPLETED|Overall Study|No milestones. Enrollment continued until end of study. 21 subjects enrolled.|10
10426227|NCT00846053|11571817|FG001|COMPLETED|Overall Study||8
10426228|NCT00846053|11571816|FG000|NOT COMPLETED|Overall Study||3
10426229|NCT00846053|11571817|FG001|NOT COMPLETED|Overall Study||0
10426230|NCT00846066|11571827|FG000|STARTED|Overall Study||27
10426231|NCT00846066|11571828|FG001|STARTED|Overall Study||29
10426232|NCT00846066|11571827|FG000|COMPLETED|Overall Study||27
10426233|NCT00846066|11571828|FG001|COMPLETED|Overall Study||29
10426234|NCT00846066|11571827|FG000|NOT COMPLETED|Overall Study||0
10426235|NCT00846066|11571828|FG001|NOT COMPLETED|Overall Study||0
10426236|NCT00846287|11571837|FG000|STARTED|Overall Study||16
10426237|NCT00846287|11571838|FG001|STARTED|Overall Study||15
10426238|NCT00846287|11571837|FG000|COMPLETED|Overall Study||6
10426239|NCT00846287|11571838|FG001|COMPLETED|Overall Study||10
10426240|NCT00846287|11571837|FG000|NOT COMPLETED|Overall Study||10
10426241|NCT00846287|11571838|FG001|NOT COMPLETED|Overall Study||5
10426242|NCT00846365|11571847|FG000|STARTED|Overall Study||372
10426243|NCT00846365|11571848|FG001|STARTED|Overall Study||357
10426244|NCT00846365|11571849|FG002|STARTED|Overall Study||356
10426245|NCT00846365|11571847|FG000|COMPLETED|Overall Study||317
10426246|NCT00846365|11571848|FG001|COMPLETED|Overall Study||308
10426247|NCT00846365|11571849|FG002|COMPLETED|Overall Study||323
10426248|NCT00846365|11571847|FG000|NOT COMPLETED|Overall Study||55
10426249|NCT00846365|11571848|FG001|NOT COMPLETED|Overall Study||49
10426250|NCT00846365|11571849|FG002|NOT COMPLETED|Overall Study||33
10426251|NCT00846391|11571860|FG000|STARTED|Overall Study||4
10426252|NCT00846391|11571861|FG001|STARTED|Overall Study||4
10426253|NCT00846391|11571862|FG002|STARTED|Overall Study||6
10426254|NCT00846391|11571860|FG000|COMPLETED|Overall Study||3
10426255|NCT00846391|11571861|FG001|COMPLETED|Overall Study||2
10426256|NCT00846391|11571862|FG002|COMPLETED|Overall Study||3
10426257|NCT00846391|11571860|FG000|NOT COMPLETED|Overall Study||1
10426258|NCT00846391|11571861|FG001|NOT COMPLETED|Overall Study||2
10426259|NCT00846391|11571862|FG002|NOT COMPLETED|Overall Study||3
10426260|NCT00846482|11571870|FG000|STARTED|Overall Study||64
10426261|NCT00846482|11571870|FG000|COMPLETED|Overall Study||54
10426262|NCT00846482|11571870|FG000|NOT COMPLETED|Overall Study||10
10426263|NCT00846495|11571877|FG000|STARTED|Overall Study||28
10426264|NCT00846495|11571878|FG001|STARTED|Overall Study||27
10426265|NCT00846495|11571877|FG000|COMPLETED|Overall Study||20
10426266|NCT00846495|11571878|FG001|COMPLETED|Overall Study||24
10426267|NCT00846495|11571877|FG000|NOT COMPLETED|Overall Study||8
10426268|NCT00846495|11571878|FG001|NOT COMPLETED|Overall Study||3
10426269|NCT00846521|11571884|FG000|STARTED|Overall Study||23
10426270|NCT00846521|11571884|FG000|COMPLETED|Overall Study||12
10426271|NCT00846521|11571884|FG000|NOT COMPLETED|Overall Study||11
10426272|NCT00846547|11571888|FG000|STARTED|Overall Study||32
10426273|NCT00846547|11571888|FG000|COMPLETED|Overall Study||25
10426274|NCT00846547|11571888|FG000|NOT COMPLETED|Overall Study||7
10426275|NCT00846573|11571895|FG000|STARTED|Overall Study||5
10426276|NCT00846573|11571896|FG001|STARTED|Overall Study||2
10426277|NCT00846573|11571897|FG002|STARTED|Overall Study||7
10426278|NCT00846573|11571898|FG003|STARTED|Overall Study||0
10426279|NCT00846573|11571895|FG000|COMPLETED|Overall Study||5
10426280|NCT00846573|11571896|FG001|COMPLETED|Overall Study||2
10426281|NCT00846573|11571897|FG002|COMPLETED|Overall Study||7
10426282|NCT00846573|11571898|FG003|COMPLETED|Overall Study||0
10426283|NCT00846573|11571895|FG000|NOT COMPLETED|Overall Study||0
10426284|NCT00846573|11571896|FG001|NOT COMPLETED|Overall Study||0
10426285|NCT00846573|11571897|FG002|NOT COMPLETED|Overall Study||0
10426286|NCT00846573|11571898|FG003|NOT COMPLETED|Overall Study||0
10426287|NCT00846586|11571908|FG000|STARTED|Overall Study||570
10426288|NCT00846586|11571909|FG001|STARTED|Overall Study||564
10426289|NCT00846586|11571908|FG000|Received Study Drug|Overall Study||570
10426290|NCT00846586|11571909|FG001|Received Study Drug|Overall Study|Three patients were not exposed to study treatment in this group.|561
10426291|NCT00846586|11571908|FG000|COMPLETED|Overall Study||531
10426292|NCT00846586|11571909|FG001|COMPLETED|Overall Study||529
10426293|NCT00846586|11571908|FG000|NOT COMPLETED|Overall Study||39
10426294|NCT00846586|11571909|FG001|NOT COMPLETED|Overall Study||35
10426295|NCT00846651|11571917|FG000|STARTED|Overall Study||41
10426296|NCT00846651|11571918|FG001|STARTED|Overall Study||41
10426297|NCT00846651|11571917|FG000|COMPLETED|Overall Study||37
10426298|NCT00846651|11571918|FG001|COMPLETED|Overall Study||37
10426299|NCT00846651|11571917|FG000|NOT COMPLETED|Overall Study||4
10426300|NCT00846651|11571918|FG001|NOT COMPLETED|Overall Study||4
10426301|NCT00846768|11571926|FG000|STARTED|Overall Study||11
10426302|NCT00846768|11571927|FG001|STARTED|Overall Study||12
10426303|NCT00846768|11571928|FG002|STARTED|Overall Study||12
10426304|NCT00846768|11571929|FG003|STARTED|Overall Study||12
10426305|NCT00846768|11571926|FG000|COMPLETED|Overall Study||11
10426306|NCT00846768|11571927|FG001|COMPLETED|Overall Study||11
10426307|NCT00846768|11571928|FG002|COMPLETED|Overall Study||12
10426308|NCT00846768|11571929|FG003|COMPLETED|Overall Study||12
10426309|NCT00846768|11571926|FG000|NOT COMPLETED|Overall Study||0
10426310|NCT00846768|11571927|FG001|NOT COMPLETED|Overall Study||1
10426311|NCT00846768|11571928|FG002|NOT COMPLETED|Overall Study||0
10426312|NCT00846768|11571929|FG003|NOT COMPLETED|Overall Study||0
10426313|NCT00846807|11571939|FG000|STARTED|Overall Study|Entered and treated.|5292
10426314|NCT00846807|11571939|FG000|COMPLETED|Overall Study|Completed treatment.|4660
10426315|NCT00846807|11571939|FG000|NOT COMPLETED|Overall Study||632
10426316|NCT00846846|11571943|FG000|STARTED|Overall Study||1018
10426317|NCT00846846|11571943|FG000|COMPLETED|Overall Study|Study ongoing but not recruiting participants.|943
10426318|NCT00846846|11571943|FG000|NOT COMPLETED|Overall Study||75
10426319|NCT00847015|11571947|FG000|STARTED|Overall Study||18
10426320|NCT00847015|11571947|FG000|COMPLETED|Overall Study||15
10426321|NCT00847015|11571947|FG000|NOT COMPLETED|Overall Study||3
10426322|NCT00847132|11571953|FG000|STARTED|Overall Study||90
10547327|NCT01513291|11701186|FG004|NOT COMPLETED|Run-out Period||0
10547328|NCT01513317|11701200|FG000|STARTED|Overall Study||50
10547329|NCT01513317|11701201|FG001|STARTED|Overall Study||26
10547330|NCT01513317|11701200|FG000|COMPLETED|Overall Study||16
10547331|NCT01513317|11701201|FG001|COMPLETED|Overall Study||2
10547332|NCT01513317|11701200|FG000|NOT COMPLETED|Overall Study||34
10547333|NCT01513317|11701201|FG001|NOT COMPLETED|Overall Study||24
10547334|NCT01513330|11701207|FG000|STARTED|SenSura Mio First,||64
10547335|NCT01513330|11701208|FG001|STARTED|SenSura Mio First,||58
10547336|NCT01513330|11701207|FG000|COMPLETED|SenSura Mio First,||60
10547337|NCT01513330|11701208|FG001|COMPLETED|SenSura Mio First,||56
10547338|NCT01513330|11701207|FG000|NOT COMPLETED|SenSura Mio First,||4
10547339|NCT01513330|11701208|FG001|NOT COMPLETED|SenSura Mio First,||2
10547340|NCT01513330|11701207|FG000|STARTED|Standard Care First,||60
10547341|NCT01513330|11701208|FG001|STARTED|Standard Care First,||56
10547342|NCT01513330|11701207|FG000|COMPLETED|Standard Care First,||56
10547343|NCT01513330|11701208|FG001|COMPLETED|Standard Care First,||52
10547344|NCT01513330|11701207|FG000|NOT COMPLETED|Standard Care First,||4
10547345|NCT01513330|11701208|FG001|NOT COMPLETED|Standard Care First,||4
10548315|NCT01518946|11702108|FG001|COMPLETED|Open-label Phase||0
10548316|NCT01518946|11702109|FG002|COMPLETED|Open-label Phase||0
10548317|NCT01518946|11702107|FG000|NOT COMPLETED|Open-label Phase||4
10548318|NCT01518946|11702108|FG001|NOT COMPLETED|Open-label Phase||0
10548319|NCT01518946|11702109|FG002|NOT COMPLETED|Open-label Phase||0
10548320|NCT01518946|11702107|FG000|STARTED|Randomized Phase (First Intervention)||0
10548321|NCT01518946|11702108|FG001|STARTED|Randomized Phase (First Intervention)||10
10548322|NCT01518946|11702109|FG002|STARTED|Randomized Phase (First Intervention)||10
10548323|NCT01518946|11702107|FG000|COMPLETED|Randomized Phase (First Intervention)||0
10548324|NCT01518946|11702108|FG001|COMPLETED|Randomized Phase (First Intervention)||9
10548325|NCT01518946|11702109|FG002|COMPLETED|Randomized Phase (First Intervention)||10
10548326|NCT01518946|11702107|FG000|NOT COMPLETED|Randomized Phase (First Intervention)||0
10548327|NCT01518946|11702108|FG001|NOT COMPLETED|Randomized Phase (First Intervention)||1
10548328|NCT01518946|11702109|FG002|NOT COMPLETED|Randomized Phase (First Intervention)||0
10548329|NCT01518946|11702107|FG000|STARTED|Randomized Phase (Second Intervention)||0
10548330|NCT01518946|11702108|FG001|STARTED|Randomized Phase (Second Intervention)||9
10548331|NCT01518946|11702109|FG002|STARTED|Randomized Phase (Second Intervention)||10
10548332|NCT01518946|11702107|FG000|COMPLETED|Randomized Phase (Second Intervention)||0
10548333|NCT01518946|11702108|FG001|COMPLETED|Randomized Phase (Second Intervention)||9
10548334|NCT01518946|11702109|FG002|COMPLETED|Randomized Phase (Second Intervention)||10
10548335|NCT01518946|11702107|FG000|NOT COMPLETED|Randomized Phase (Second Intervention)||0
10548336|NCT01518946|11702108|FG001|NOT COMPLETED|Randomized Phase (Second Intervention)||0
10548337|NCT01518946|11702109|FG002|NOT COMPLETED|Randomized Phase (Second Intervention)||0
10548338|NCT01518972|11702118|FG000|STARTED|Overall Study||15
10548339|NCT01518972|11702119|FG001|STARTED|Overall Study||15
10548340|NCT01518972|11702118|FG000|COMPLETED|Overall Study||9
10548341|NCT01518972|11702119|FG001|COMPLETED|Overall Study||11
10548342|NCT01518972|11702118|FG000|NOT COMPLETED|Overall Study||6
10548343|NCT01518972|11702119|FG001|NOT COMPLETED|Overall Study||4
10548344|NCT01519063|11702127|FG000|STARTED|Overall Study||26
10548345|NCT01519063|11702128|FG001|STARTED|Overall Study||30
10548346|NCT01519063|11702127|FG000|COMPLETED|Overall Study||19
10548347|NCT01519063|11702128|FG001|COMPLETED|Overall Study||25
10548348|NCT01519063|11702127|FG000|NOT COMPLETED|Overall Study||7
10548349|NCT01519063|11702128|FG001|NOT COMPLETED|Overall Study||5
10548350|NCT01519089|11702136|FG000|STARTED|Overall Study||47
10548351|NCT01519089|11702137|FG001|STARTED|Overall Study||48
10548352|NCT01519089|11702136|FG000|Received Treatment|Overall Study||47
10548353|NCT01519089|11702137|FG001|Received Treatment|Overall Study||47
10548354|NCT01519089|11702136|FG000|COMPLETED|Overall Study||40
10548355|NCT01519089|11702137|FG001|COMPLETED|Overall Study||33
10548356|NCT01519089|11702136|FG000|NOT COMPLETED|Overall Study||7
10548357|NCT01519089|11702137|FG001|NOT COMPLETED|Overall Study||15
10548358|NCT01519167|11702147|FG000|STARTED|Overall Study||1
10548359|NCT01519167|11702148|FG001|STARTED|Overall Study||89
10548360|NCT01519167|11702147|FG000|COMPLETED|Overall Study||1
10548361|NCT01519167|11702148|FG001|COMPLETED|Overall Study||81
10548362|NCT01519167|11702147|FG000|NOT COMPLETED|Overall Study||0
10548363|NCT01519167|11702148|FG001|NOT COMPLETED|Overall Study||8
10548364|NCT01519206|11702154|FG000|STARTED|Overall Study||32
10548365|NCT01519206|11702154|FG000|COMPLETED|Overall Study||27
10548366|NCT01519206|11702154|FG000|NOT COMPLETED|Overall Study||5
10548367|NCT01519245|11702167|FG000|STARTED|Overall Study||24
10548368|NCT01519245|11702168|FG001|STARTED|Overall Study||20
10548393|NCT01519284|11702196|FG004|STARTED|Overall Study||16
10426323|NCT00847132|11571954|FG001|STARTED|Overall Study||85
10426324|NCT00847132|11571953|FG000|COMPLETED|Overall Study||89
10426325|NCT00847132|11571954|FG001|COMPLETED|Overall Study||84
10426326|NCT00847132|11571953|FG000|NOT COMPLETED|Overall Study||1
10426327|NCT00847132|11571954|FG001|NOT COMPLETED|Overall Study||1
10426328|NCT00847145|11571968|FG000|STARTED|Overall Study||629
10426329|NCT00847145|11571969|FG001|STARTED|Overall Study||633
10426331|NCT00847145|11571971|FG003|STARTED|Overall Study||117
10426332|NCT00847145|11571972|FG004|STARTED|Overall Study||137
10426333|NCT00847145|11571973|FG005|STARTED|Overall Study||156
10426334|NCT00847145|11571974|FG006|STARTED|Overall Study||152
10426335|NCT00847145|11571975|FG007|STARTED|Overall Study||140
10426336|NCT00847145|11571968|FG000|COMPLETED|Overall Study||623
10426337|NCT00847145|11571969|FG001|COMPLETED|Overall Study||627
10426338|NCT00847145|11571970|FG002|COMPLETED|Overall Study||274
10547346|NCT01513447|11701216|FG000|STARTED|Overall Study||3
10547347|NCT01513447|11701217|FG001|STARTED|Overall Study||5
10547348|NCT01513447|11701216|FG000|COMPLETED|Overall Study||3
10547349|NCT01513447|11701217|FG001|COMPLETED|Overall Study||5
10547350|NCT01513447|11701216|FG000|NOT COMPLETED|Overall Study||0
10547351|NCT01513447|11701217|FG001|NOT COMPLETED|Overall Study||0
10547352|NCT01513460|11701226|FG000|STARTED|Overall Study||258
10547353|NCT01513460|11701227|FG001|STARTED|Overall Study||258
10547354|NCT01513460|11701228|FG002|STARTED|Overall Study||257
10547355|NCT01513460|11701226|FG000|Full Analysis Set|Overall Study||257
10547356|NCT01513460|11701227|FG001|Full Analysis Set|Overall Study||258
10547357|NCT01513460|11701228|FG002|Full Analysis Set|Overall Study||257
10547358|NCT01513460|11701226|FG000|Per-protocol Set|Overall Study||196
10547359|NCT01513460|11701227|FG001|Per-protocol Set|Overall Study||186
10547360|NCT01513460|11701228|FG002|Per-protocol Set|Overall Study||166
10547361|NCT01513460|11701226|FG000|COMPLETED|Overall Study||229
10547362|NCT01513460|11701227|FG001|COMPLETED|Overall Study||226
10547363|NCT01513460|11701228|FG002|COMPLETED|Overall Study||201
10547364|NCT01513460|11701226|FG000|NOT COMPLETED|Overall Study||29
10547365|NCT01513460|11701227|FG001|NOT COMPLETED|Overall Study||32
10547366|NCT01513460|11701228|FG002|NOT COMPLETED|Overall Study||56
10547367|NCT01513473|11701240|FG000|STARTED|Main Trial (26 Weeks)||174
10547368|NCT01513473|11701241|FG001|STARTED|Main Trial (26 Weeks)|1 subject was randomised but withdrew before the drug exposure.|176
10547369|NCT01513473|11701240|FG000|Exposed|Main Trial (26 Weeks)||174
10547370|NCT01513473|11701241|FG001|Exposed|Main Trial (26 Weeks)||175
10547371|NCT01513473|11701240|FG000|COMPLETED|Main Trial (26 Weeks)||170
10547372|NCT01513473|11701241|FG001|COMPLETED|Main Trial (26 Weeks)||165
10547373|NCT01513473|11701240|FG000|NOT COMPLETED|Main Trial (26 Weeks)||4
10547374|NCT01513473|11701241|FG001|NOT COMPLETED|Main Trial (26 Weeks)||11
10547375|NCT01513473|11701240|FG000|STARTED|Extension Trial (26 Weeks)|18 subjects did not consent to participate in the extension trial.|152
10547376|NCT01513473|11701241|FG001|STARTED|Extension Trial (26 Weeks)|37 subjects did not consent to participate in the extension trial.|128
10547377|NCT01513473|11701240|FG000|COMPLETED|Extension Trial (26 Weeks)||151
10547378|NCT01513473|11701241|FG001|COMPLETED|Extension Trial (26 Weeks)||122
10547379|NCT01513473|11701240|FG000|NOT COMPLETED|Extension Trial (26 Weeks)||1
10547380|NCT01513473|11701241|FG001|NOT COMPLETED|Extension Trial (26 Weeks)||6
10547381|NCT01513538|11701247|FG000|STARTED|Overall Study||578
10547382|NCT01513538|11701247|FG000|COMPLETED|Overall Study||573
10547383|NCT01513538|11701247|FG000|NOT COMPLETED|Overall Study||5
10547384|NCT01513551|11701254|FG000|STARTED|Overall Study||230
10547385|NCT01513551|11701255|FG001|STARTED|Overall Study||231
10547386|NCT01513551|11701256|FG002|STARTED|Overall Study||231
10547387|NCT01513551|11701254|FG000|Vaccinated|Overall Study||230
10547388|NCT01513551|11701255|FG001|Vaccinated|Overall Study||231
10547389|NCT01513551|11701256|FG002|Vaccinated|Overall Study||230
10547390|NCT01513551|11701254|FG000|COMPLETED|Overall Study||226
10547391|NCT01513551|11701255|FG001|COMPLETED|Overall Study||225
10547392|NCT01513551|11701256|FG002|COMPLETED|Overall Study||226
10547393|NCT01513551|11701254|FG000|NOT COMPLETED|Overall Study||4
10547394|NCT01513551|11701255|FG001|NOT COMPLETED|Overall Study||6
10547395|NCT01513551|11701256|FG002|NOT COMPLETED|Overall Study||5
10547396|NCT01513590|11701266|FG000|STARTED|Overall Study||197
10547397|NCT01513590|11701267|FG001|STARTED|Overall Study||197
10547398|NCT01513590|11701266|FG000|Exposed|Overall Study|"One (1) subject was withdrawn prior to exposure due to non fulfilment of inclusion criteria"|196
10547399|NCT01513590|11701267|FG001|Exposed|Overall Study|"Two (2) subjects were withdrawn prior to exposure due to withdrawal of consent"|195
10547400|NCT01513590|11701266|FG000|COMPLETED|Overall Study||187
10547401|NCT01513590|11701267|FG001|COMPLETED|Overall Study||184
10547402|NCT01513590|11701266|FG000|NOT COMPLETED|Overall Study||10
10547403|NCT01513590|11701267|FG001|NOT COMPLETED|Overall Study||13
10547404|NCT01513759|11701273|FG000|STARTED|Overall Study||150
10547405|NCT01513759|11701273|FG000|At Least One Device Successfully Placed|Overall Study||149
10547406|NCT01513759|11701273|FG000|COMPLETED|Overall Study||145
10547407|NCT01513759|11701273|FG000|NOT COMPLETED|Overall Study||5
10547408|NCT01513902|11701280|FG000|STARTED|Overall Study||8
10547409|NCT01513902|11701281|FG001|STARTED|Overall Study||9
10547410|NCT01513902|11701282|FG002|STARTED|Overall Study||9
10547411|NCT01513902|11701280|FG000|COMPLETED|Overall Study||8
10547412|NCT01513902|11701281|FG001|COMPLETED|Overall Study||9
10547413|NCT01513902|11701282|FG002|COMPLETED|Overall Study||9
10547414|NCT01513902|11701280|FG000|NOT COMPLETED|Overall Study||0
10547415|NCT01513902|11701281|FG001|NOT COMPLETED|Overall Study||0
10426339|NCT00847145|11571971|FG003|COMPLETED|Overall Study||116
10547416|NCT01513902|11701282|FG002|NOT COMPLETED|Overall Study||0
10547417|NCT01513967|11701298|FG000|STARTED|Overall Study||4
10547418|NCT01513967|11701299|FG001|STARTED|Overall Study||4
10547419|NCT01513967|11701300|FG002|STARTED|Overall Study||4
10547420|NCT01513967|11701301|FG003|STARTED|Overall Study||6
10547421|NCT01513967|11701302|FG004|STARTED|Overall Study||4
10547422|NCT01513967|11701303|FG005|STARTED|Overall Study||4
10547423|NCT01513967|11701304|FG006|STARTED|Overall Study||5
10547424|NCT01513967|11701305|FG007|STARTED|Overall Study||8
10547425|NCT01513967|11701298|FG000|COMPLETED|Overall Study||4
10547426|NCT01513967|11701299|FG001|COMPLETED|Overall Study||4
10547427|NCT01513967|11701300|FG002|COMPLETED|Overall Study||4
10547428|NCT01513967|11701301|FG003|COMPLETED|Overall Study||6
10547429|NCT01513967|11701302|FG004|COMPLETED|Overall Study||4
10547430|NCT01513967|11701303|FG005|COMPLETED|Overall Study||3
10547431|NCT01513967|11701304|FG006|COMPLETED|Overall Study||3
10547432|NCT01513967|11701305|FG007|COMPLETED|Overall Study||6
10547433|NCT01513967|11701298|FG000|NOT COMPLETED|Overall Study||0
10547434|NCT01513967|11701299|FG001|NOT COMPLETED|Overall Study||0
10547435|NCT01513967|11701300|FG002|NOT COMPLETED|Overall Study||0
10547436|NCT01513967|11701301|FG003|NOT COMPLETED|Overall Study||0
10547437|NCT01513967|11701302|FG004|NOT COMPLETED|Overall Study||0
10547438|NCT01513967|11701303|FG005|NOT COMPLETED|Overall Study||1
10547439|NCT01513967|11701304|FG006|NOT COMPLETED|Overall Study||2
10547440|NCT01513967|11701305|FG007|NOT COMPLETED|Overall Study||2
10547441|NCT01514136|11701325|FG000|STARTED|Test Period 1; Test A|26 subjects tested Test A|25
10547442|NCT01514136|11701326|FG001|STARTED|Test Period 1; Test A||0
10547443|NCT01514136|11701327|FG002|STARTED|Test Period 1; Test A||0
10547444|NCT01514136|11701328|FG003|STARTED|Test Period 1; Test A||0
10547445|NCT01514136|11701329|FG004|STARTED|Test Period 1; Test A||0
10547446|NCT01514136|11701330|FG005|STARTED|Test Period 1; Test A||0
10547447|NCT01514136|11701331|FG006|STARTED|Test Period 1; Test A||0
10547448|NCT01514136|11701332|FG007|STARTED|Test Period 1; Test A||0
10547449|NCT01514136|11701325|FG000|COMPLETED|Test Period 1; Test A||22
10547450|NCT01514136|11701326|FG001|COMPLETED|Test Period 1; Test A||0
10547451|NCT01514136|11701327|FG002|COMPLETED|Test Period 1; Test A||0
10547452|NCT01514136|11701328|FG003|COMPLETED|Test Period 1; Test A||0
10547453|NCT01514136|11701329|FG004|COMPLETED|Test Period 1; Test A||0
10547454|NCT01514136|11701330|FG005|COMPLETED|Test Period 1; Test A||0
10547455|NCT01514136|11701331|FG006|COMPLETED|Test Period 1; Test A||0
10547456|NCT01514136|11701332|FG007|COMPLETED|Test Period 1; Test A||0
10547457|NCT01514136|11701325|FG000|NOT COMPLETED|Test Period 1; Test A||3
10547458|NCT01514136|11701326|FG001|NOT COMPLETED|Test Period 1; Test A||0
10547459|NCT01514136|11701327|FG002|NOT COMPLETED|Test Period 1; Test A||0
10547460|NCT01514136|11701328|FG003|NOT COMPLETED|Test Period 1; Test A||0
10547461|NCT01514136|11701329|FG004|NOT COMPLETED|Test Period 1; Test A||0
10547462|NCT01514136|11701330|FG005|NOT COMPLETED|Test Period 1; Test A||0
10547463|NCT01514136|11701331|FG006|NOT COMPLETED|Test Period 1; Test A||0
10547464|NCT01514136|11701332|FG007|NOT COMPLETED|Test Period 1; Test A||0
10547465|NCT01514136|11701325|FG000|STARTED|Test Period 1; Test B||0
10547466|NCT01514136|11701326|FG001|STARTED|Test Period 1; Test B|2 new subjects were entered the investigation|24
10547467|NCT01514136|11701327|FG002|STARTED|Test Period 1; Test B||0
10547468|NCT01514136|11701328|FG003|STARTED|Test Period 1; Test B||0
10547469|NCT01514136|11701329|FG004|STARTED|Test Period 1; Test B||0
10547470|NCT01514136|11701330|FG005|STARTED|Test Period 1; Test B||0
10547471|NCT01514136|11701331|FG006|STARTED|Test Period 1; Test B||0
10547472|NCT01514136|11701332|FG007|STARTED|Test Period 1; Test B||0
10547473|NCT01514136|11701325|FG000|COMPLETED|Test Period 1; Test B||0
10547474|NCT01514136|11701326|FG001|COMPLETED|Test Period 1; Test B||23
10547475|NCT01514136|11701327|FG002|COMPLETED|Test Period 1; Test B||0
10547476|NCT01514136|11701328|FG003|COMPLETED|Test Period 1; Test B||0
10547477|NCT01514136|11701329|FG004|COMPLETED|Test Period 1; Test B||0
10547478|NCT01514136|11701330|FG005|COMPLETED|Test Period 1; Test B||0
10547479|NCT01514136|11701331|FG006|COMPLETED|Test Period 1; Test B||0
10547480|NCT01514136|11701332|FG007|COMPLETED|Test Period 1; Test B||0
10547481|NCT01514136|11701325|FG000|NOT COMPLETED|Test Period 1; Test B||0
10547482|NCT01514136|11701326|FG001|NOT COMPLETED|Test Period 1; Test B||1
10547483|NCT01514136|11701327|FG002|NOT COMPLETED|Test Period 1; Test B||0
10547484|NCT01514136|11701328|FG003|NOT COMPLETED|Test Period 1; Test B||0
10547485|NCT01514136|11701329|FG004|NOT COMPLETED|Test Period 1; Test B||0
10547486|NCT01514136|11701330|FG005|NOT COMPLETED|Test Period 1; Test B||0
10547487|NCT01514136|11701331|FG006|NOT COMPLETED|Test Period 1; Test B||0
10547488|NCT01514136|11701332|FG007|NOT COMPLETED|Test Period 1; Test B||0
10547489|NCT01514136|11701325|FG000|STARTED|Test Period 1; Test C||0
10547490|NCT01514136|11701326|FG001|STARTED|Test Period 1; Test C||0
10547491|NCT01514136|11701327|FG002|STARTED|Test Period 1; Test C|1 new subject was included in the investigation|24
10547492|NCT01514136|11701328|FG003|STARTED|Test Period 1; Test C||0
10547493|NCT01514136|11701329|FG004|STARTED|Test Period 1; Test C||0
10547494|NCT01514136|11701330|FG005|STARTED|Test Period 1; Test C||0
10547495|NCT01514136|11701331|FG006|STARTED|Test Period 1; Test C||0
10547496|NCT01514136|11701332|FG007|STARTED|Test Period 1; Test C||0
10547497|NCT01514136|11701325|FG000|COMPLETED|Test Period 1; Test C||0
10547498|NCT01514136|11701326|FG001|COMPLETED|Test Period 1; Test C||0
10547499|NCT01514136|11701327|FG002|COMPLETED|Test Period 1; Test C||24
10547500|NCT01514136|11701328|FG003|COMPLETED|Test Period 1; Test C||0
10547501|NCT01514136|11701329|FG004|COMPLETED|Test Period 1; Test C||0
10547502|NCT01514136|11701330|FG005|COMPLETED|Test Period 1; Test C||0
10547503|NCT01514136|11701331|FG006|COMPLETED|Test Period 1; Test C||0
10547504|NCT01514136|11701332|FG007|COMPLETED|Test Period 1; Test C||0
10547505|NCT01514136|11701325|FG000|NOT COMPLETED|Test Period 1; Test C||0
10547506|NCT01514136|11701326|FG001|NOT COMPLETED|Test Period 1; Test C||0
10547507|NCT01514136|11701327|FG002|NOT COMPLETED|Test Period 1; Test C||0
10547508|NCT01514136|11701328|FG003|NOT COMPLETED|Test Period 1; Test C||0
10547509|NCT01514136|11701329|FG004|NOT COMPLETED|Test Period 1; Test C||0
10547510|NCT01514136|11701330|FG005|NOT COMPLETED|Test Period 1; Test C||0
10547511|NCT01514136|11701331|FG006|NOT COMPLETED|Test Period 1; Test C||0
10547512|NCT01514136|11701332|FG007|NOT COMPLETED|Test Period 1; Test C||0
10547513|NCT01514136|11701325|FG000|STARTED|Test Period 1; Test D||0
10547514|NCT01514136|11701326|FG001|STARTED|Test Period 1; Test D||0
10547515|NCT01514136|11701327|FG002|STARTED|Test Period 1; Test D||0
10547516|NCT01514136|11701328|FG003|STARTED|Test Period 1; Test D|The two subject that were on holiday after test A re-entered the investigation|26
10547517|NCT01514136|11701329|FG004|STARTED|Test Period 1; Test D||0
10547518|NCT01514136|11701330|FG005|STARTED|Test Period 1; Test D||0
10547519|NCT01514136|11701331|FG006|STARTED|Test Period 1; Test D||0
10547520|NCT01514136|11701332|FG007|STARTED|Test Period 1; Test D||0
10547521|NCT01514136|11701325|FG000|COMPLETED|Test Period 1; Test D||0
10547522|NCT01514136|11701326|FG001|COMPLETED|Test Period 1; Test D||0
10547523|NCT01514136|11701327|FG002|COMPLETED|Test Period 1; Test D||0
10547524|NCT01514136|11701328|FG003|COMPLETED|Test Period 1; Test D||24
10547525|NCT01514136|11701329|FG004|COMPLETED|Test Period 1; Test D||0
10547526|NCT01514136|11701330|FG005|COMPLETED|Test Period 1; Test D||0
10547527|NCT01514136|11701331|FG006|COMPLETED|Test Period 1; Test D||0
10547528|NCT01514136|11701332|FG007|COMPLETED|Test Period 1; Test D||0
10547529|NCT01514136|11701325|FG000|NOT COMPLETED|Test Period 1; Test D||0
10547530|NCT01514136|11701326|FG001|NOT COMPLETED|Test Period 1; Test D||0
10547531|NCT01514136|11701327|FG002|NOT COMPLETED|Test Period 1; Test D||0
10547532|NCT01514136|11701328|FG003|NOT COMPLETED|Test Period 1; Test D||2
10547533|NCT01514136|11701329|FG004|NOT COMPLETED|Test Period 1; Test D||0
10547534|NCT01514136|11701330|FG005|NOT COMPLETED|Test Period 1; Test D||0
10547535|NCT01514136|11701331|FG006|NOT COMPLETED|Test Period 1; Test D||0
10547536|NCT01514136|11701332|FG007|NOT COMPLETED|Test Period 1; Test D||0
10547537|NCT01514136|11701325|FG000|STARTED|Test Period 2; Test A*||0
10547538|NCT01514136|11701326|FG001|STARTED|Test Period 2; Test A*||0
10547539|NCT01514136|11701327|FG002|STARTED|Test Period 2; Test A*||0
10547540|NCT01514136|11701328|FG003|STARTED|Test Period 2; Test A*||0
10547541|NCT01514136|11701329|FG004|STARTED|Test Period 2; Test A*|4 new subjects were included in the investigation|28
10547542|NCT01514136|11701330|FG005|STARTED|Test Period 2; Test A*||0
10547543|NCT01514136|11701331|FG006|STARTED|Test Period 2; Test A*||0
10547544|NCT01514136|11701332|FG007|STARTED|Test Period 2; Test A*||0
10547545|NCT01514136|11701325|FG000|COMPLETED|Test Period 2; Test A*||0
10547546|NCT01514136|11701326|FG001|COMPLETED|Test Period 2; Test A*||0
10547547|NCT01514136|11701327|FG002|COMPLETED|Test Period 2; Test A*||0
10547548|NCT01514136|11701328|FG003|COMPLETED|Test Period 2; Test A*||0
10547549|NCT01514136|11701329|FG004|COMPLETED|Test Period 2; Test A*||26
10547550|NCT01514136|11701330|FG005|COMPLETED|Test Period 2; Test A*||0
10547551|NCT01514136|11701331|FG006|COMPLETED|Test Period 2; Test A*||0
10547552|NCT01514136|11701332|FG007|COMPLETED|Test Period 2; Test A*||0
10547553|NCT01514136|11701325|FG000|NOT COMPLETED|Test Period 2; Test A*||0
10547554|NCT01514136|11701326|FG001|NOT COMPLETED|Test Period 2; Test A*||0
10547555|NCT01514136|11701327|FG002|NOT COMPLETED|Test Period 2; Test A*||0
10547556|NCT01514136|11701328|FG003|NOT COMPLETED|Test Period 2; Test A*||0
10547557|NCT01514136|11701329|FG004|NOT COMPLETED|Test Period 2; Test A*||2
10547558|NCT01514136|11701330|FG005|NOT COMPLETED|Test Period 2; Test A*||0
10547559|NCT01514136|11701331|FG006|NOT COMPLETED|Test Period 2; Test A*||0
10547560|NCT01514136|11701332|FG007|NOT COMPLETED|Test Period 2; Test A*||0
10547561|NCT01514136|11701325|FG000|STARTED|Test Period 2; Test B*||0
10547562|NCT01514136|11701326|FG001|STARTED|Test Period 2; Test B*||0
10547563|NCT01514136|11701327|FG002|STARTED|Test Period 2; Test B*||0
10547564|NCT01514136|11701328|FG003|STARTED|Test Period 2; Test B*||0
10547565|NCT01514136|11701329|FG004|STARTED|Test Period 2; Test B*||0
10547566|NCT01514136|11701330|FG005|STARTED|Test Period 2; Test B*|Two subjects did not test test A*, but had a break and continued again on Test B*|28
10547567|NCT01514136|11701331|FG006|STARTED|Test Period 2; Test B*||0
10547568|NCT01514136|11701332|FG007|STARTED|Test Period 2; Test B*||0
10547569|NCT01514136|11701325|FG000|COMPLETED|Test Period 2; Test B*||0
10547570|NCT01514136|11701326|FG001|COMPLETED|Test Period 2; Test B*||0
10547571|NCT01514136|11701327|FG002|COMPLETED|Test Period 2; Test B*||0
10547572|NCT01514136|11701328|FG003|COMPLETED|Test Period 2; Test B*||0
10547573|NCT01514136|11701329|FG004|COMPLETED|Test Period 2; Test B*||0
10547574|NCT01514136|11701330|FG005|COMPLETED|Test Period 2; Test B*||26
10547575|NCT01514136|11701331|FG006|COMPLETED|Test Period 2; Test B*||0
10547576|NCT01514136|11701332|FG007|COMPLETED|Test Period 2; Test B*||0
10547577|NCT01514136|11701325|FG000|NOT COMPLETED|Test Period 2; Test B*||0
10547578|NCT01514136|11701326|FG001|NOT COMPLETED|Test Period 2; Test B*||0
10547579|NCT01514136|11701327|FG002|NOT COMPLETED|Test Period 2; Test B*||0
10547580|NCT01514136|11701328|FG003|NOT COMPLETED|Test Period 2; Test B*||0
10547581|NCT01514136|11701329|FG004|NOT COMPLETED|Test Period 2; Test B*||0
10547582|NCT01514136|11701330|FG005|NOT COMPLETED|Test Period 2; Test B*||2
10547583|NCT01514136|11701331|FG006|NOT COMPLETED|Test Period 2; Test B*||0
10547584|NCT01514136|11701332|FG007|NOT COMPLETED|Test Period 2; Test B*||0
10547585|NCT01514136|11701325|FG000|STARTED|Test Period 2; Test C*||0
10547586|NCT01514136|11701326|FG001|STARTED|Test Period 2; Test C*||0
10547587|NCT01514136|11701327|FG002|STARTED|Test Period 2; Test C*||0
10547588|NCT01514136|11701328|FG003|STARTED|Test Period 2; Test C*||0
10547589|NCT01514136|11701329|FG004|STARTED|Test Period 2; Test C*||0
10547590|NCT01514136|11701330|FG005|STARTED|Test Period 2; Test C*||0
10547591|NCT01514136|11701331|FG006|STARTED|Test Period 2; Test C*||26
10547592|NCT01514136|11701332|FG007|STARTED|Test Period 2; Test C*||0
10547593|NCT01514136|11701325|FG000|COMPLETED|Test Period 2; Test C*||0
10547594|NCT01514136|11701326|FG001|COMPLETED|Test Period 2; Test C*||0
10547595|NCT01514136|11701327|FG002|COMPLETED|Test Period 2; Test C*||0
10547596|NCT01514136|11701328|FG003|COMPLETED|Test Period 2; Test C*||0
10547597|NCT01514136|11701329|FG004|COMPLETED|Test Period 2; Test C*||0
10547598|NCT01514136|11701330|FG005|COMPLETED|Test Period 2; Test C*||0
10547599|NCT01514136|11701331|FG006|COMPLETED|Test Period 2; Test C*||23
10547600|NCT01514136|11701332|FG007|COMPLETED|Test Period 2; Test C*||0
10547601|NCT01514136|11701325|FG000|NOT COMPLETED|Test Period 2; Test C*||0
10547602|NCT01514136|11701326|FG001|NOT COMPLETED|Test Period 2; Test C*||0
10547603|NCT01514136|11701327|FG002|NOT COMPLETED|Test Period 2; Test C*||0
10547604|NCT01514136|11701328|FG003|NOT COMPLETED|Test Period 2; Test C*||0
10547605|NCT01514136|11701329|FG004|NOT COMPLETED|Test Period 2; Test C*||0
10547606|NCT01514136|11701330|FG005|NOT COMPLETED|Test Period 2; Test C*||0
10547607|NCT01514136|11701331|FG006|NOT COMPLETED|Test Period 2; Test C*||3
10547608|NCT01514136|11701332|FG007|NOT COMPLETED|Test Period 2; Test C*||0
10547609|NCT01514136|11701325|FG000|STARTED|Test Period; Test D*||0
10547610|NCT01514136|11701326|FG001|STARTED|Test Period; Test D*||0
10547611|NCT01514136|11701327|FG002|STARTED|Test Period; Test D*||0
10547612|NCT01514136|11701328|FG003|STARTED|Test Period; Test D*||0
10547613|NCT01514136|11701329|FG004|STARTED|Test Period; Test D*||0
10547614|NCT01514136|11701330|FG005|STARTED|Test Period; Test D*||0
10547615|NCT01514136|11701331|FG006|STARTED|Test Period; Test D*||0
10547616|NCT01514136|11701332|FG007|STARTED|Test Period; Test D*||23
10547617|NCT01514136|11701325|FG000|COMPLETED|Test Period; Test D*||0
10547618|NCT01514136|11701326|FG001|COMPLETED|Test Period; Test D*||0
10547619|NCT01514136|11701327|FG002|COMPLETED|Test Period; Test D*||0
10547620|NCT01514136|11701328|FG003|COMPLETED|Test Period; Test D*||0
10547621|NCT01514136|11701329|FG004|COMPLETED|Test Period; Test D*||0
10547622|NCT01514136|11701330|FG005|COMPLETED|Test Period; Test D*||0
10547623|NCT01514136|11701331|FG006|COMPLETED|Test Period; Test D*||0
10547624|NCT01514136|11701332|FG007|COMPLETED|Test Period; Test D*||23
10547625|NCT01514136|11701325|FG000|NOT COMPLETED|Test Period; Test D*||0
10547626|NCT01514136|11701326|FG001|NOT COMPLETED|Test Period; Test D*||0
10547627|NCT01514136|11701327|FG002|NOT COMPLETED|Test Period; Test D*||0
10547628|NCT01514136|11701328|FG003|NOT COMPLETED|Test Period; Test D*||0
10547629|NCT01514136|11701329|FG004|NOT COMPLETED|Test Period; Test D*||0
10547630|NCT01514136|11701330|FG005|NOT COMPLETED|Test Period; Test D*||0
10547631|NCT01514136|11701331|FG006|NOT COMPLETED|Test Period; Test D*||0
10547632|NCT01514136|11701332|FG007|NOT COMPLETED|Test Period; Test D*||0
10547633|NCT01514149|11701363|FG000|STARTED|Overall Study||15
10547634|NCT01514149|11701364|FG001|STARTED|Overall Study||15
10547635|NCT01514149|11701365|FG002|STARTED|Overall Study||14
10547636|NCT01514149|11701366|FG003|STARTED|Overall Study||14
10547637|NCT01514149|11701367|FG004|STARTED|Overall Study||15
10547638|NCT01514149|11701363|FG000|COMPLETED|Overall Study||12
10547639|NCT01514149|11701364|FG001|COMPLETED|Overall Study||14
10547640|NCT01514149|11701365|FG002|COMPLETED|Overall Study||11
10547641|NCT01514149|11701366|FG003|COMPLETED|Overall Study||13
10547642|NCT01514149|11701367|FG004|COMPLETED|Overall Study||14
10547643|NCT01514149|11701363|FG000|NOT COMPLETED|Overall Study||3
10547644|NCT01514149|11701364|FG001|NOT COMPLETED|Overall Study||1
10547645|NCT01514149|11701365|FG002|NOT COMPLETED|Overall Study||3
10547646|NCT01514149|11701366|FG003|NOT COMPLETED|Overall Study||1
10547647|NCT01514149|11701367|FG004|NOT COMPLETED|Overall Study||1
10547648|NCT01514162|11701379|FG000|STARTED|Overall Study||245
10547649|NCT01514162|11701379|FG000|COMPLETED|Overall Study||160
10547650|NCT01514162|11701379|FG000|NOT COMPLETED|Overall Study||85
10547651|NCT01514201|11701387|FG000|STARTED|PHASE I: Veliparib + Radiation Therapy||6
10547652|NCT01514201|11701388|FG001|STARTED|PHASE I: Veliparib + Radiation Therapy||6
10547653|NCT01514201|11701389|FG002|STARTED|PHASE I: Veliparib + Radiation Therapy||6
10547654|NCT01514201|11701390|FG003|STARTED|PHASE I: Veliparib + Radiation Therapy||0
10547655|NCT01514201|11701387|FG000|COMPLETED|PHASE I: Veliparib + Radiation Therapy||5
10547656|NCT01514201|11701388|FG001|COMPLETED|PHASE I: Veliparib + Radiation Therapy||6
10547657|NCT01514201|11701389|FG002|COMPLETED|PHASE I: Veliparib + Radiation Therapy||6
10547658|NCT01514201|11701390|FG003|COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
10547659|NCT01514201|11701387|FG000|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||1
10547660|NCT01514201|11701388|FG001|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
10547661|NCT01514201|11701389|FG002|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
10547662|NCT01514201|11701390|FG003|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
10547663|NCT01514201|11701387|FG000|STARTED|PHASE I: Maintenance With Veliparib/TMZ||5
10547664|NCT01514201|11701388|FG001|STARTED|PHASE I: Maintenance With Veliparib/TMZ||6
10547665|NCT01514201|11701389|FG002|STARTED|PHASE I: Maintenance With Veliparib/TMZ||6
10547666|NCT01514201|11701390|FG003|STARTED|PHASE I: Maintenance With Veliparib/TMZ||0
10547667|NCT01514201|11701387|FG000|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
10547668|NCT01514201|11701388|FG001|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
10547669|NCT01514201|11701389|FG002|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
10547670|NCT01514201|11701390|FG003|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
10547671|NCT01514201|11701387|FG000|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||5
10547672|NCT01514201|11701388|FG001|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||6
10547673|NCT01514201|11701389|FG002|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||6
10547674|NCT01514201|11701390|FG003|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
10547675|NCT01514201|11701387|FG000|STARTED|PHASE II: Veliparib + Radiation Therapy||0
10547676|NCT01514201|11701388|FG001|STARTED|PHASE II: Veliparib + Radiation Therapy||0
10547677|NCT01514201|11701389|FG002|STARTED|PHASE II: Veliparib + Radiation Therapy||0
10547678|NCT01514201|11701390|FG003|STARTED|PHASE II: Veliparib + Radiation Therapy||47
10547679|NCT01514201|11701387|FG000|COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
10547680|NCT01514201|11701388|FG001|COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
10547681|NCT01514201|11701389|FG002|COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
10547682|NCT01514201|11701390|FG003|COMPLETED|PHASE II: Veliparib + Radiation Therapy||35
10547683|NCT01514201|11701387|FG000|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
10547684|NCT01514201|11701388|FG001|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
10547685|NCT01514201|11701389|FG002|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
10547686|NCT01514201|11701390|FG003|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||12
10547687|NCT01514201|11701387|FG000|STARTED|PHASE II: Maintenance With Veliparib/TMZ||0
10547688|NCT01514201|11701388|FG001|STARTED|PHASE II: Maintenance With Veliparib/TMZ||0
10547689|NCT01514201|11701389|FG002|STARTED|PHASE II: Maintenance With Veliparib/TMZ||0
10547690|NCT01514201|11701390|FG003|STARTED|PHASE II: Maintenance With Veliparib/TMZ||35
10547691|NCT01514201|11701387|FG000|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
10547692|NCT01514201|11701388|FG001|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
10547693|NCT01514201|11701389|FG002|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
10547694|NCT01514201|11701390|FG003|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||2
10547695|NCT01514201|11701387|FG000|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
10547696|NCT01514201|11701388|FG001|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
10547697|NCT01514201|11701389|FG002|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
10547698|NCT01514201|11701390|FG003|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||33
10547699|NCT01514240|11701412|FG000|STARTED|Overall Study||56
10547700|NCT01514240|11701413|FG001|STARTED|Overall Study||56
10547701|NCT01514240|11701412|FG000|COMPLETED|Overall Study||50
10547702|NCT01514240|11701413|FG001|COMPLETED|Overall Study||45
10547703|NCT01514240|11701412|FG000|NOT COMPLETED|Overall Study||6
10547704|NCT01514240|11701413|FG001|NOT COMPLETED|Overall Study||11
10547705|NCT01514279|11701422|FG000|STARTED|Overall Study||118
10547706|NCT01514279|11701423|FG001|STARTED|Overall Study||123
10547707|NCT01514279|11701424|FG002|STARTED|Overall Study||119
10547708|NCT01514279|11701422|FG000|COMPLETED|Overall Study||107
10547709|NCT01514279|11701423|FG001|COMPLETED|Overall Study||110
10547710|NCT01514279|11701424|FG002|COMPLETED|Overall Study||114
10547711|NCT01514279|11701422|FG000|NOT COMPLETED|Overall Study||11
10547712|NCT01514279|11701423|FG001|NOT COMPLETED|Overall Study||13
10547713|NCT01514279|11701424|FG002|NOT COMPLETED|Overall Study||5
10547714|NCT01514292|11701432|FG000|STARTED|Overall Study||72
10547715|NCT01514292|11701432|FG000|COMPLETED|Overall Study||72
10547716|NCT01514292|11701432|FG000|NOT COMPLETED|Overall Study||0
10547717|NCT01514318|11701436|FG000|STARTED|Overall Study||8
10547718|NCT01514318|11701436|FG000|COMPLETED|Overall Study||8
10547719|NCT01514318|11701436|FG000|NOT COMPLETED|Overall Study||0
10547720|NCT01514357|11701442|FG000|STARTED|Overall Study||12
10547721|NCT01514357|11701443|FG001|STARTED|Overall Study||0
10547722|NCT01514357|11701442|FG000|COMPLETED|Overall Study||8
10547723|NCT01514357|11701443|FG001|COMPLETED|Overall Study||0
10547724|NCT01514357|11701442|FG000|NOT COMPLETED|Overall Study||4
10547725|NCT01514357|11701443|FG001|NOT COMPLETED|Overall Study||0
10547726|NCT01514370|11701451|FG000|STARTED|Overall Study||40
10547727|NCT01514370|11701452|FG001|STARTED|Overall Study||40
10547728|NCT01514370|11701451|FG000|Safety Population|Overall Study|The Safety population consisted all randomized subjects who received at least 1 dose of study drug.|38
10547729|NCT01514370|11701452|FG001|Safety Population|Overall Study|The Safety population consisted all randomized subjects who received at least 1 dose of study drug.|40
10547730|NCT01514370|11701451|FG000|COMPLETED|Overall Study||29
10547731|NCT01514370|11701452|FG001|COMPLETED|Overall Study||24
10547732|NCT01514370|11701451|FG000|NOT COMPLETED|Overall Study||11
10547733|NCT01514370|11701452|FG001|NOT COMPLETED|Overall Study||16
10547734|NCT01514383|11701459|FG000|STARTED|Overall Study||34
10547735|NCT01514383|11701459|FG000|COMPLETED|Overall Study||34
10547736|NCT01514383|11701459|FG000|NOT COMPLETED|Overall Study||0
10547737|NCT01514396|11701464|FG000|STARTED|Overall Study||8
10547738|NCT01514396|11701464|FG000|COMPLETED|Overall Study||8
10547739|NCT01514396|11701464|FG000|NOT COMPLETED|Overall Study||0
10547740|NCT01514422|11701469|FG000|STARTED|Overall Study||20
10547741|NCT01514422|11701469|FG000|COMPLETED|Overall Study||19
10547742|NCT01514422|11701469|FG000|NOT COMPLETED|Overall Study||1
10547743|NCT01514448|11701475|FG000|STARTED|Overall Study||16
10547744|NCT01514448|11701476|FG001|STARTED|Overall Study||13
10547745|NCT01514448|11701475|FG000|Full Analysis Set (FAS)|Overall Study||12
10547746|NCT01514448|11701476|FG001|Full Analysis Set (FAS)|Overall Study||13
10547747|NCT01514448|11701475|FG000|COMPLETED|Overall Study||4
10547748|NCT01514448|11701476|FG001|COMPLETED|Overall Study||5
10547749|NCT01514448|11701475|FG000|NOT COMPLETED|Overall Study||12
10547750|NCT01514448|11701476|FG001|NOT COMPLETED|Overall Study||8
10547751|NCT01514461|11701486|FG000|STARTED|Overall Study||15
10547752|NCT01514461|11701487|FG001|STARTED|Overall Study||15
10547753|NCT01514461|11701488|FG002|STARTED|Overall Study||15
10547754|NCT01514461|11701486|FG000|COMPLETED|Overall Study||10
10547755|NCT01514461|11701487|FG001|COMPLETED|Overall Study||12
10547756|NCT01514461|11701488|FG002|COMPLETED|Overall Study||11
10547757|NCT01514461|11701486|FG000|NOT COMPLETED|Overall Study||5
10547758|NCT01514461|11701487|FG001|NOT COMPLETED|Overall Study||3
10547759|NCT01514461|11701488|FG002|NOT COMPLETED|Overall Study||4
10547760|NCT01514513|11701501|FG000|STARTED|Overall Study||21
10547761|NCT01514513|11701502|FG001|STARTED|Overall Study||21
10547762|NCT01514513|11701501|FG000|COMPLETED|Overall Study||20
10547763|NCT01514513|11701502|FG001|COMPLETED|Overall Study||20
10547764|NCT01514513|11701501|FG000|NOT COMPLETED|Overall Study||1
10547765|NCT01514513|11701502|FG001|NOT COMPLETED|Overall Study||1
10547766|NCT01514630|11701508|FG000|STARTED|Overall Study||14
10547767|NCT01514630|11701508|FG000|COMPLETED|Overall Study||11
10547768|NCT01514630|11701508|FG000|NOT COMPLETED|Overall Study||3
10547769|NCT01514734|11701512|FG000|STARTED|Overall Study||9
10547770|NCT01514734|11701512|FG000|COMPLETED|Overall Study||9
10547771|NCT01514734|11701512|FG000|NOT COMPLETED|Overall Study||0
10547772|NCT01514760|11701516|FG000|STARTED|Overall Study||22
10547773|NCT01514760|11701516|FG000|COMPLETED|Overall Study||20
10547774|NCT01514760|11701516|FG000|NOT COMPLETED|Overall Study||2
10547775|NCT01514786|11701522|FG000|STARTED|Overall Study||286
10547776|NCT01514786|11701523|FG001|STARTED|Overall Study||284
10547777|NCT01514786|11701522|FG000|COMPLETED|Overall Study||286
10547778|NCT01514786|11701523|FG001|COMPLETED|Overall Study||284
10547779|NCT01514786|11701522|FG000|NOT COMPLETED|Overall Study||0
10547780|NCT01514786|11701523|FG001|NOT COMPLETED|Overall Study||0
10547781|NCT01514864|11701531|FG000|STARTED|Overall Study||9
10547782|NCT01514864|11701532|FG001|STARTED|Overall Study||5
10547783|NCT01514864|11701531|FG000|COMPLETED|Overall Study|Study was terminated; no patients completed study treatment|0
10547784|NCT01514864|11701532|FG001|COMPLETED|Overall Study||0
10547785|NCT01514864|11701531|FG000|NOT COMPLETED|Overall Study||9
10547786|NCT01514864|11701532|FG001|NOT COMPLETED|Overall Study||5
10547787|NCT01515046|11701539|FG000|STARTED|Overall Study||1
10547788|NCT01515046|11701539|FG000|COMPLETED|Overall Study||1
10547789|NCT01515046|11701539|FG000|NOT COMPLETED|Overall Study||0
10547790|NCT01515072|11701545|FG000|STARTED|Overall Study||166
10547791|NCT01515072|11701546|FG001|STARTED|Overall Study||155
10547792|NCT01515072|11701545|FG000|COMPLETED|Overall Study|There were 566 total organs transplanted and 248 kidneys transplanted in the No RIPC group.|166
10547793|NCT01515072|11701546|FG001|COMPLETED|Overall Study|There were 513 total organs transplanted and 235 kidneys transplanted in the RIPC group|155
10547794|NCT01515072|11701545|FG000|NOT COMPLETED|Overall Study||0
10547795|NCT01515072|11701546|FG001|NOT COMPLETED|Overall Study||0
10547796|NCT01515176|11701568|FG000|STARTED|Overall Study||4
10547797|NCT01515176|11701569|FG001|STARTED|Overall Study||32
10547798|NCT01515176|11701568|FG000|COMPLETED|Overall Study||4
10547799|NCT01515176|11701569|FG001|COMPLETED|Overall Study||32
10547800|NCT01515176|11701568|FG000|NOT COMPLETED|Overall Study||0
10547801|NCT01515176|11701569|FG001|NOT COMPLETED|Overall Study||0
10547802|NCT01515189|11701579|FG000|STARTED|Induction|Includes 1 subject who was randomized but not treated due to an Adverse Event before treatment|365
10547803|NCT01515189|11701580|FG001|STARTED|Induction||362
10547804|NCT01515189|11701579|FG000|COMPLETED|Induction||128
10547805|NCT01515189|11701580|FG001|COMPLETED|Induction||130
10547806|NCT01515189|11701579|FG000|NOT COMPLETED|Induction||237
10547807|NCT01515189|11701580|FG001|NOT COMPLETED|Induction||232
10547808|NCT01515189|11701579|FG000|STARTED|First Re-Induction Phase||23
10547809|NCT01515189|11701580|FG001|STARTED|First Re-Induction Phase||32
10547810|NCT01515189|11701579|FG000|COMPLETED|First Re-Induction Phase||9
10547811|NCT01515189|11701580|FG001|COMPLETED|First Re-Induction Phase||17
10547812|NCT01515189|11701579|FG000|NOT COMPLETED|First Re-Induction Phase||14
10547813|NCT01515189|11701580|FG001|NOT COMPLETED|First Re-Induction Phase||15
10547814|NCT01515319|11701596|FG000|STARTED|Overall Study||3
10547815|NCT01515319|11701597|FG001|STARTED|Overall Study||3
10547816|NCT01515319|11701598|FG002|STARTED|Overall Study||6
10547817|NCT01515319|11701599|FG003|STARTED|Overall Study||6
10547818|NCT01515319|11701600|FG004|STARTED|Overall Study||6
10547819|NCT01515319|11701601|FG005|STARTED|Overall Study||6
10547820|NCT01515319|11701602|FG006|STARTED|Overall Study||10
10547821|NCT01515319|11701603|FG007|STARTED|Overall Study||6
10547822|NCT01515319|11701604|FG008|STARTED|Overall Study||14
10547823|NCT01515319|11701605|FG009|STARTED|Overall Study||8
10547824|NCT01515319|11701596|FG000|COMPLETED|Overall Study||3
10547825|NCT01515319|11701597|FG001|COMPLETED|Overall Study||3
10547826|NCT01515319|11701598|FG002|COMPLETED|Overall Study||6
10547827|NCT01515319|11701599|FG003|COMPLETED|Overall Study||6
10547828|NCT01515319|11701600|FG004|COMPLETED|Overall Study||6
10547829|NCT01515319|11701601|FG005|COMPLETED|Overall Study||6
10547830|NCT01515319|11701602|FG006|COMPLETED|Overall Study||9
10547831|NCT01515319|11701603|FG007|COMPLETED|Overall Study||6
10547832|NCT01515319|11701604|FG008|COMPLETED|Overall Study||9
10547833|NCT01515319|11701605|FG009|COMPLETED|Overall Study||8
10547834|NCT01515319|11701596|FG000|NOT COMPLETED|Overall Study||0
10547835|NCT01515319|11701597|FG001|NOT COMPLETED|Overall Study||0
10547836|NCT01515319|11701598|FG002|NOT COMPLETED|Overall Study||0
10547837|NCT01515319|11701599|FG003|NOT COMPLETED|Overall Study||0
10547838|NCT01515319|11701600|FG004|NOT COMPLETED|Overall Study||0
10547839|NCT01515319|11701601|FG005|NOT COMPLETED|Overall Study||0
10547840|NCT01515319|11701602|FG006|NOT COMPLETED|Overall Study||1
10547841|NCT01515319|11701603|FG007|NOT COMPLETED|Overall Study||0
10429916|NCT00867100|11576062|FG012|STARTED|Overall Study||6
10429917|NCT00867100|11576050|FG000|COMPLETED|Overall Study||5
10429918|NCT00867100|11576051|FG001|COMPLETED|Overall Study||4
10429919|NCT00867100|11576052|FG002|COMPLETED|Overall Study||8
10429920|NCT00867100|11576053|FG003|COMPLETED|Overall Study||8
10429921|NCT00867100|11576054|FG004|COMPLETED|Overall Study||14
10429922|NCT00867100|11576055|FG005|COMPLETED|Overall Study||6
10429923|NCT00867100|11576056|FG006|COMPLETED|Overall Study||6
10429924|NCT00867100|11576057|FG007|COMPLETED|Overall Study||3
10429925|NCT00867100|11576058|FG008|COMPLETED|Overall Study||6
10429926|NCT00867100|11576059|FG009|COMPLETED|Overall Study||6
10429927|NCT00867100|11576060|FG010|COMPLETED|Overall Study||3
10429928|NCT00867100|11576061|FG011|COMPLETED|Overall Study||6
10429929|NCT00867100|11576062|FG012|COMPLETED|Overall Study||6
10429930|NCT00867100|11576050|FG000|NOT COMPLETED|Overall Study||0
10429931|NCT00867100|11576051|FG001|NOT COMPLETED|Overall Study||1
10429932|NCT00867100|11576052|FG002|NOT COMPLETED|Overall Study||0
10429933|NCT00867100|11576053|FG003|NOT COMPLETED|Overall Study||0
10429934|NCT00867100|11576054|FG004|NOT COMPLETED|Overall Study||0
10429935|NCT00867100|11576055|FG005|NOT COMPLETED|Overall Study||0
10429936|NCT00867100|11576056|FG006|NOT COMPLETED|Overall Study||1
10429937|NCT00867100|11576057|FG007|NOT COMPLETED|Overall Study||0
10429938|NCT00867100|11576058|FG008|NOT COMPLETED|Overall Study||0
10429939|NCT00867100|11576059|FG009|NOT COMPLETED|Overall Study||0
10429940|NCT00867100|11576060|FG010|NOT COMPLETED|Overall Study||1
10429941|NCT00867100|11576061|FG011|NOT COMPLETED|Overall Study||0
10429942|NCT00867100|11576062|FG012|NOT COMPLETED|Overall Study||0
10429943|NCT00867113|11576094|FG000|STARTED|Treatment Period||91
10429944|NCT00867113|11576094|FG000|Safety Set|Treatment Period||91
10429945|NCT00867113|11576094|FG000|Full Analysis Set (FAS)|Treatment Period||91
10429946|NCT00867113|11576094|FG000|COMPLETED|Treatment Period||46
10429947|NCT00867113|11576094|FG000|NOT COMPLETED|Treatment Period||45
10429948|NCT00867113|11576094|FG000|STARTED|Post Treatment After Survival Follow-up||68
10429949|NCT00867113|11576094|FG000|COMPLETED|Post Treatment After Survival Follow-up||57
10429950|NCT00867113|11576094|FG000|NOT COMPLETED|Post Treatment After Survival Follow-up||11
10429951|NCT00867139|11576101|FG000|STARTED|Overall Study||2
10429952|NCT00867139|11576102|FG001|STARTED|Overall Study||1
10429953|NCT00867139|11576103|FG002|STARTED|Overall Study||4
10429954|NCT00867139|11576101|FG000|COMPLETED|Overall Study||2
10429955|NCT00867139|11576102|FG001|COMPLETED|Overall Study||1
10429956|NCT00867139|11576103|FG002|COMPLETED|Overall Study|One open-labeled patient withdrew on day 5.|3
10429957|NCT00867139|11576101|FG000|NOT COMPLETED|Overall Study||0
10429958|NCT00867139|11576102|FG001|NOT COMPLETED|Overall Study||0
10429959|NCT00867139|11576103|FG002|NOT COMPLETED|Overall Study||1
10429960|NCT00867217|11576121|FG000|STARTED|Overall Study||80
10429961|NCT00867217|11576122|FG001|STARTED|Overall Study||80
10429962|NCT00867217|11576121|FG000|COMPLETED|Overall Study||77
10429963|NCT00867217|11576122|FG001|COMPLETED|Overall Study||70
10429964|NCT00867217|11576121|FG000|NOT COMPLETED|Overall Study||3
10429965|NCT00867217|11576122|FG001|NOT COMPLETED|Overall Study||10
10429966|NCT00867308|11576130|FG000|STARTED|Overall Study||9
10429967|NCT00867308|11576131|FG001|STARTED|Overall Study||18
10429968|NCT00867308|11576130|FG000|COMPLETED|Overall Study||0
10429969|NCT00867308|11576131|FG001|COMPLETED|Overall Study||0
10429970|NCT00867308|11576130|FG000|NOT COMPLETED|Overall Study||9
10429971|NCT00867308|11576131|FG001|NOT COMPLETED|Overall Study||18
10429972|NCT00867334|11576139|FG000|STARTED|Overall Study||6
10429973|NCT00867334|11576140|FG001|STARTED|Overall Study||1
10429974|NCT00867334|11576139|FG000|COMPLETED|Overall Study||4
10429975|NCT00867334|11576140|FG001|COMPLETED|Overall Study||0
10429976|NCT00867334|11576139|FG000|NOT COMPLETED|Overall Study||2
10429977|NCT00867334|11576140|FG001|NOT COMPLETED|Overall Study||1
10429978|NCT00867360|11576148|FG000|STARTED|Overall Study||4
10429979|NCT00867360|11576149|FG001|STARTED|Overall Study||6
10429980|NCT00867360|11576148|FG000|COMPLETED|Overall Study||3
10429981|NCT00867360|11576149|FG001|COMPLETED|Overall Study||5
10429982|NCT00867360|11576148|FG000|NOT COMPLETED|Overall Study||1
10429983|NCT00867360|11576149|FG001|NOT COMPLETED|Overall Study||1
10429984|NCT00867451|11576158|FG000|STARTED|Overall Study||4
10429985|NCT00867451|11576159|FG001|STARTED|Overall Study||4
10429986|NCT00867451|11576158|FG000|COMPLETED|Overall Study||4
10429987|NCT00867451|11576159|FG001|COMPLETED|Overall Study||4
10429988|NCT00867451|11576158|FG000|NOT COMPLETED|Overall Study||0
10429989|NCT00867451|11576159|FG001|NOT COMPLETED|Overall Study||0
10429990|NCT00867490|11576169|FG000|STARTED|Phase 1 - Candesartan+HCTZ||186
10429991|NCT00867490|11576169|FG000|COMPLETED|Phase 1 - Candesartan+HCTZ||176
10429992|NCT00867490|11576169|FG000|NOT COMPLETED|Phase 1 - Candesartan+HCTZ||10
10429993|NCT00867490|11576169|FG000|STARTED|Phase 2 - Aliskiren+HCTZ|Only patients with mean sitting diastolic BP ≥ 90 mmHg at the end of Phase 1 entered this phase.|123
10429994|NCT00867490|11576169|FG000|COMPLETED|Phase 2 - Aliskiren+HCTZ||120
10429995|NCT00867490|11576169|FG000|NOT COMPLETED|Phase 2 - Aliskiren+HCTZ||3
10429996|NCT00867490|11576169|FG000|STARTED|Phase 3 - Aliskiren+HCTZ+Amlodipine|The first 60 patients with systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg entered this phase.|61
10429997|NCT00867490|11576169|FG000|COMPLETED|Phase 3 - Aliskiren+HCTZ+Amlodipine||61
10429998|NCT00867490|11576169|FG000|NOT COMPLETED|Phase 3 - Aliskiren+HCTZ+Amlodipine||0
10429999|NCT00867503|11576176|FG000|STARTED|Overall Study||10
10430000|NCT00867503|11576176|FG000|COMPLETED|Overall Study||9
10430001|NCT00867503|11576176|FG000|NOT COMPLETED|Overall Study||1
10430002|NCT00867529|11576182|FG000|STARTED|Overall Study||63
10430003|NCT00867529|11576182|FG000|COMPLETED|Overall Study||63
10430004|NCT00867529|11576182|FG000|NOT COMPLETED|Overall Study||0
10430005|NCT00867659|11576186|FG000|STARTED|Overall Study|October 2009|20
10430006|NCT00867659|11576186|FG000|COMPLETED|Overall Study|January 2010|20
10430007|NCT00867659|11576186|FG000|NOT COMPLETED|Overall Study||0
10430008|NCT00867789|11576193|FG000|STARTED|Overall Study||70
10430009|NCT00867789|11576194|FG001|STARTED|Overall Study||70
10430010|NCT00867789|11576193|FG000|COMPLETED|Overall Study||68
10430011|NCT00867789|11576194|FG001|COMPLETED|Overall Study||70
10430012|NCT00867789|11576193|FG000|NOT COMPLETED|Overall Study||2
10430013|NCT00867789|11576194|FG001|NOT COMPLETED|Overall Study||0
10430014|NCT00867815|11576200|FG000|STARTED|Overall Study||10
10430015|NCT00867815|11576200|FG000|COMPLETED|Overall Study||9
10430016|NCT00867815|11576200|FG000|NOT COMPLETED|Overall Study||1
10430017|NCT00867932|11576204|FG000|STARTED|Overall Study||7
10430018|NCT00867932|11576204|FG000|Induction Phase|Overall Study||7
10430019|NCT00867932|11576204|FG000|Maintenance Phase|Overall Study||7
10430020|NCT00867932|11576204|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7
10430021|NCT00867932|11576204|FG000|Intent-to-Treat (ITT) Population|Overall Study||7
10430022|NCT00867932|11576204|FG000|COMPLETED|Overall Study||7
10430023|NCT00867932|11576204|FG000|NOT COMPLETED|Overall Study||0
10430024|NCT00868101|11576210|FG000|STARTED|Overall Study||12
10430025|NCT00868101|11576211|FG001|STARTED|Overall Study||10
10430026|NCT00868101|11576210|FG000|COMPLETED|Overall Study||12
10430027|NCT00868101|11576211|FG001|COMPLETED|Overall Study||10
10430028|NCT00868101|11576210|FG000|NOT COMPLETED|Overall Study||0
10430029|NCT00868101|11576211|FG001|NOT COMPLETED|Overall Study||0
10430030|NCT00868140|11576221|FG000|STARTED|Overall Study||26
10430031|NCT00868140|11576222|FG001|STARTED|Overall Study||25
10430032|NCT00868140|11576221|FG000|COMPLETED|Overall Study||26
10430033|NCT00868140|11576222|FG001|COMPLETED|Overall Study||25
10430034|NCT00868140|11576221|FG000|NOT COMPLETED|Overall Study||0
10430035|NCT00868140|11576222|FG001|NOT COMPLETED|Overall Study||0
10430036|NCT00868166|11576232|FG000|STARTED|Overall Study||259
10430037|NCT00868166|11576233|FG001|STARTED|Overall Study||253
10430038|NCT00868166|11576232|FG000|COMPLETED|Overall Study||147
10430039|NCT00868166|11576233|FG001|COMPLETED|Overall Study||139
10430040|NCT00868166|11576232|FG000|NOT COMPLETED|Overall Study||112
10430041|NCT00868166|11576233|FG001|NOT COMPLETED|Overall Study||114
10430042|NCT00868192|11576239|FG000|STARTED|Overall Study||38
10430043|NCT00868192|11576239|FG000|COMPLETED|Overall Study||34
10430044|NCT00868192|11576239|FG000|NOT COMPLETED|Overall Study||4
10430045|NCT00868218|11576247|FG000|STARTED|Overall Study||15
10430046|NCT00868218|11576248|FG001|STARTED|Overall Study||15
10430047|NCT00868218|11576249|FG002|STARTED|Overall Study||15
10430048|NCT00868218|11576250|FG003|STARTED|Overall Study||15
10430049|NCT00868218|11576247|FG000|COMPLETED|Overall Study||15
10430050|NCT00868218|11576248|FG001|COMPLETED|Overall Study||15
10430051|NCT00868218|11576249|FG002|COMPLETED|Overall Study||15
10430052|NCT00868218|11576250|FG003|COMPLETED|Overall Study||15
10430053|NCT00868218|11576247|FG000|NOT COMPLETED|Overall Study||0
10430054|NCT00868218|11576248|FG001|NOT COMPLETED|Overall Study||0
10430055|NCT00868218|11576249|FG002|NOT COMPLETED|Overall Study||0
10430056|NCT00868218|11576250|FG003|NOT COMPLETED|Overall Study||0
10430057|NCT00868231|11576264|FG000|STARTED|Treatment Period 1||5
10430058|NCT00868231|11576265|FG001|STARTED|Treatment Period 1||5
10430059|NCT00868231|11576266|FG002|STARTED|Treatment Period 1||5
10430060|NCT00868231|11576267|FG003|STARTED|Treatment Period 1||5
10430061|NCT00868231|11576268|FG004|STARTED|Treatment Period 1||5
10430062|NCT00868231|11576269|FG005|STARTED|Treatment Period 1||5
10430063|NCT00868231|11576264|FG000|COMPLETED|Treatment Period 1||5
10430064|NCT00868231|11576265|FG001|COMPLETED|Treatment Period 1||5
10430065|NCT00868231|11576266|FG002|COMPLETED|Treatment Period 1||5
10430066|NCT00868231|11576267|FG003|COMPLETED|Treatment Period 1||5
10430067|NCT00868231|11576268|FG004|COMPLETED|Treatment Period 1||4
10430068|NCT00868231|11576269|FG005|COMPLETED|Treatment Period 1||5
10430069|NCT00868231|11576264|FG000|NOT COMPLETED|Treatment Period 1||0
10430070|NCT00868231|11576265|FG001|NOT COMPLETED|Treatment Period 1||0
10430071|NCT00868231|11576266|FG002|NOT COMPLETED|Treatment Period 1||0
10430072|NCT00868231|11576267|FG003|NOT COMPLETED|Treatment Period 1||0
10430073|NCT00868231|11576268|FG004|NOT COMPLETED|Treatment Period 1||1
10430074|NCT00868231|11576269|FG005|NOT COMPLETED|Treatment Period 1||0
10430075|NCT00868231|11576264|FG000|STARTED|Treatment Period 2||5
10430076|NCT00868231|11576265|FG001|STARTED|Treatment Period 2||5
10430077|NCT00868231|11576266|FG002|STARTED|Treatment Period 2||5
10430078|NCT00868231|11576267|FG003|STARTED|Treatment Period 2||5
10430079|NCT00868231|11576268|FG004|STARTED|Treatment Period 2||4
10430080|NCT00868231|11576269|FG005|STARTED|Treatment Period 2||5
10430081|NCT00868231|11576264|FG000|COMPLETED|Treatment Period 2||4
10430082|NCT00868231|11576265|FG001|COMPLETED|Treatment Period 2||5
10430083|NCT00868231|11576266|FG002|COMPLETED|Treatment Period 2||5
10430084|NCT00868231|11576267|FG003|COMPLETED|Treatment Period 2||5
10430085|NCT00868231|11576268|FG004|COMPLETED|Treatment Period 2||4
10430086|NCT00868231|11576269|FG005|COMPLETED|Treatment Period 2||5
10430087|NCT00868231|11576264|FG000|NOT COMPLETED|Treatment Period 2||1
10430088|NCT00868231|11576265|FG001|NOT COMPLETED|Treatment Period 2||0
10430089|NCT00868231|11576266|FG002|NOT COMPLETED|Treatment Period 2||0
10430090|NCT00868231|11576267|FG003|NOT COMPLETED|Treatment Period 2||0
10430091|NCT00868231|11576268|FG004|NOT COMPLETED|Treatment Period 2||0
10430092|NCT00868231|11576269|FG005|NOT COMPLETED|Treatment Period 2||0
10430093|NCT00868231|11576264|FG000|STARTED|Treatment Period 3||4
10430094|NCT00868231|11576265|FG001|STARTED|Treatment Period 3||5
10430095|NCT00868231|11576266|FG002|STARTED|Treatment Period 3||5
10430096|NCT00868231|11576267|FG003|STARTED|Treatment Period 3||5
10430097|NCT00868231|11576268|FG004|STARTED|Treatment Period 3||4
10430098|NCT00868231|11576269|FG005|STARTED|Treatment Period 3||5
10430099|NCT00868231|11576264|FG000|COMPLETED|Treatment Period 3||4
10430100|NCT00868231|11576265|FG001|COMPLETED|Treatment Period 3||5
10430101|NCT00868231|11576266|FG002|COMPLETED|Treatment Period 3||4
10430102|NCT00868231|11576267|FG003|COMPLETED|Treatment Period 3||5
10430103|NCT00868231|11576268|FG004|COMPLETED|Treatment Period 3||4
10430104|NCT00868231|11576269|FG005|COMPLETED|Treatment Period 3||5
10430105|NCT00868231|11576264|FG000|NOT COMPLETED|Treatment Period 3||0
10430106|NCT00868231|11576265|FG001|NOT COMPLETED|Treatment Period 3||0
10430107|NCT00868231|11576266|FG002|NOT COMPLETED|Treatment Period 3||1
10430108|NCT00868231|11576267|FG003|NOT COMPLETED|Treatment Period 3||0
10430109|NCT00868231|11576268|FG004|NOT COMPLETED|Treatment Period 3||0
10430110|NCT00868231|11576269|FG005|NOT COMPLETED|Treatment Period 3||0
10430111|NCT00868296|11576279|FG000|STARTED|Overall Study||12
10430112|NCT00868296|11576280|FG001|STARTED|Overall Study||46
10430113|NCT00868296|11576279|FG000|COMPLETED|Overall Study||12
10430114|NCT00868296|11576280|FG001|COMPLETED|Overall Study||43
10430115|NCT00868296|11576279|FG000|NOT COMPLETED|Overall Study||0
10430116|NCT00868296|11576280|FG001|NOT COMPLETED|Overall Study||3
10430117|NCT00868309|11576288|FG000|STARTED|Overall Study||6
10430118|NCT00868309|11576289|FG001|STARTED|Overall Study||6
10430119|NCT00868309|11576288|FG000|COMPLETED|Overall Study||6
10430120|NCT00868309|11576289|FG001|COMPLETED|Overall Study||6
10430121|NCT00868309|11576288|FG000|NOT COMPLETED|Overall Study||0
10430122|NCT00868309|11576289|FG001|NOT COMPLETED|Overall Study||0
10430123|NCT00868348|11576297|FG000|STARTED|Overall Study||30
10430124|NCT00868348|11576298|FG001|STARTED|Overall Study||30
10430125|NCT00868348|11576297|FG000|COMPLETED|Overall Study||30
10430126|NCT00868348|11576298|FG001|COMPLETED|Overall Study||30
10430127|NCT00868348|11576297|FG000|NOT COMPLETED|Overall Study||0
10430128|NCT00868348|11576298|FG001|NOT COMPLETED|Overall Study||0
10430129|NCT00868374|11576306|FG000|STARTED|Overall Study||12
10430130|NCT00868374|11576307|FG001|STARTED|Overall Study||11
10430131|NCT00868374|11576306|FG000|COMPLETED|Overall Study||5
10430132|NCT00868374|11576307|FG001|COMPLETED|Overall Study||4
10430133|NCT00868374|11576306|FG000|NOT COMPLETED|Overall Study||7
10430134|NCT00868374|11576307|FG001|NOT COMPLETED|Overall Study||7
10430135|NCT00868439|11576315|FG000|STARTED|Overall Study||56
10430136|NCT00868439|11576316|FG001|STARTED|Overall Study||49
10430137|NCT00868439|11576315|FG000|COMPLETED|Overall Study||48
10430138|NCT00868439|11576316|FG001|COMPLETED|Overall Study||40
10430139|NCT00868439|11576315|FG000|NOT COMPLETED|Overall Study||8
10430140|NCT00868439|11576316|FG001|NOT COMPLETED|Overall Study||9
10430141|NCT00868452|11576324|FG000|STARTED|Overall Study||183
10430142|NCT00868452|11576325|FG001|STARTED|Overall Study||165
10430143|NCT00868452|11576324|FG000|COMPLETED|Overall Study||143
10430144|NCT00868452|11576325|FG001|COMPLETED|Overall Study||136
10430145|NCT00868452|11576324|FG000|NOT COMPLETED|Overall Study||40
10430146|NCT00868452|11576325|FG001|NOT COMPLETED|Overall Study||29
10430147|NCT00868517|11576335|FG000|STARTED|Overall Study||12
10430148|NCT00868517|11576336|FG001|STARTED|Overall Study||12
10430149|NCT00868517|11576337|FG002|STARTED|Overall Study||11
10430150|NCT00868517|11576335|FG000|COMPLETED|Overall Study||8
10430151|NCT00868517|11576336|FG001|COMPLETED|Overall Study||8
10430152|NCT00868517|11576337|FG002|COMPLETED|Overall Study||9
10430153|NCT00868517|11576335|FG000|NOT COMPLETED|Overall Study||4
10430154|NCT00868517|11576336|FG001|NOT COMPLETED|Overall Study||4
10430155|NCT00868517|11576337|FG002|NOT COMPLETED|Overall Study||2
10430156|NCT00868530|11576345|FG000|STARTED|Overall Study||53
10430157|NCT00868530|11576345|FG000|COMPLETED|Overall Study||49
10430158|NCT00868530|11576345|FG000|NOT COMPLETED|Overall Study||4
10430159|NCT00868608|11576352|FG000|STARTED|Overall Study||72
10430160|NCT00868608|11576353|FG001|STARTED|Overall Study||4
10430161|NCT00868608|11576354|FG002|STARTED|Overall Study||5
10430162|NCT00868608|11576352|FG000|COMPLETED|Overall Study||49
10430163|NCT00868608|11576353|FG001|COMPLETED|Overall Study||1
10430164|NCT00868608|11576354|FG002|COMPLETED|Overall Study||0
10430165|NCT00868608|11576352|FG000|NOT COMPLETED|Overall Study||23
10430166|NCT00868608|11576353|FG001|NOT COMPLETED|Overall Study||3
10430167|NCT00868608|11576354|FG002|NOT COMPLETED|Overall Study||5
10430168|NCT00868699|11576365|FG000|STARTED|Overall Study||170
10430169|NCT00868699|11576366|FG001|STARTED|Overall Study||169
10430170|NCT00868699|11576367|FG002|STARTED|Overall Study||166
10430171|NCT00868699|11576365|FG000|Intent-to-Treat Population|Overall Study||162
10430172|NCT00868699|11576366|FG001|Intent-to-Treat Population|Overall Study||162
10430173|NCT00868699|11576367|FG002|Intent-to-Treat Population|Overall Study||161
10430174|NCT00868699|11576365|FG000|Safety Population|Overall Study||168
10430175|NCT00868699|11576366|FG001|Safety Population|Overall Study||167
10430176|NCT00868699|11576367|FG002|Safety Population|Overall Study||164
10430177|NCT00868699|11576365|FG000|COMPLETED|Overall Study||127
10430178|NCT00868699|11576366|FG001|COMPLETED|Overall Study||124
10430179|NCT00868699|11576367|FG002|COMPLETED|Overall Study||123
10430180|NCT00868699|11576365|FG000|NOT COMPLETED|Overall Study||43
10430181|NCT00868699|11576366|FG001|NOT COMPLETED|Overall Study||45
10430182|NCT00868699|11576367|FG002|NOT COMPLETED|Overall Study||43
10430183|NCT00868712|11576378|FG000|STARTED|Overall Study||31
10430184|NCT00868712|11576379|FG001|STARTED|Overall Study||11
10430185|NCT00868712|11576380|FG002|STARTED|Overall Study||28
10430186|NCT00868712|11576378|FG000|COMPLETED|Overall Study||31
10430187|NCT00868712|11576379|FG001|COMPLETED|Overall Study||11
10430188|NCT00868712|11576380|FG002|COMPLETED|Overall Study||28
10430189|NCT00868712|11576378|FG000|NOT COMPLETED|Overall Study||0
10430190|NCT00868712|11576379|FG001|NOT COMPLETED|Overall Study||0
10430191|NCT00868712|11576380|FG002|NOT COMPLETED|Overall Study||0
10430192|NCT00868751|11576388|FG000|STARTED|Overall Study||1
10430193|NCT00868751|11576388|FG000|COMPLETED|Overall Study||0
10430194|NCT00868751|11576388|FG000|NOT COMPLETED|Overall Study||1
10430195|NCT00868790|11576392|FG000|STARTED|Period 1||11
10430196|NCT00868790|11576393|FG001|STARTED|Period 1||8
10430197|NCT00868790|11576394|FG002|STARTED|Period 1||4
10430198|NCT00868790|11576395|FG003|STARTED|Period 1||4
10430199|NCT00868790|11576396|FG004|STARTED|Period 1||19
10430200|NCT00868790|11576397|FG005|STARTED|Period 1||3
10430201|NCT00868790|11576398|FG006|STARTED|Period 1||4
10430202|NCT00868790|11576399|FG007|STARTED|Period 1||20
10430203|NCT00868790|11576400|FG008|STARTED|Period 1||11
10430204|NCT00868790|11576401|FG009|STARTED|Period 1||3
10430205|NCT00868790|11576402|FG010|STARTED|Period 1||9
10430206|NCT00868790|11576403|FG011|STARTED|Period 1||4
10430207|NCT00868790|11576404|FG012|STARTED|Period 1||7
10430208|NCT00868790|11576405|FG013|STARTED|Period 1||11
10430209|NCT00868790|11576392|FG000|COMPLETED|Period 1||9
10430210|NCT00868790|11576393|FG001|COMPLETED|Period 1||7
10430211|NCT00868790|11576394|FG002|COMPLETED|Period 1||4
10430212|NCT00868790|11576395|FG003|COMPLETED|Period 1||4
10430213|NCT00868790|11576396|FG004|COMPLETED|Period 1||18
10430214|NCT00868790|11576397|FG005|COMPLETED|Period 1||2
10430215|NCT00868790|11576398|FG006|COMPLETED|Period 1||4
10430216|NCT00868790|11576399|FG007|COMPLETED|Period 1||17
10430217|NCT00868790|11576400|FG008|COMPLETED|Period 1||10
10430218|NCT00868790|11576401|FG009|COMPLETED|Period 1||3
10430219|NCT00868790|11576402|FG010|COMPLETED|Period 1||9
10430220|NCT00868790|11576403|FG011|COMPLETED|Period 1||4
10430221|NCT00868790|11576404|FG012|COMPLETED|Period 1||7
10430222|NCT00868790|11576405|FG013|COMPLETED|Period 1||9
10430223|NCT00868790|11576392|FG000|NOT COMPLETED|Period 1||2
10430224|NCT00868790|11576393|FG001|NOT COMPLETED|Period 1||1
10430225|NCT00868790|11576394|FG002|NOT COMPLETED|Period 1||0
10430226|NCT00868790|11576395|FG003|NOT COMPLETED|Period 1||0
10430227|NCT00868790|11576396|FG004|NOT COMPLETED|Period 1||1
10430228|NCT00868790|11576397|FG005|NOT COMPLETED|Period 1||1
10430229|NCT00868790|11576398|FG006|NOT COMPLETED|Period 1||0
10430230|NCT00868790|11576399|FG007|NOT COMPLETED|Period 1||3
10430231|NCT00868790|11576400|FG008|NOT COMPLETED|Period 1||1
10430232|NCT00868790|11576401|FG009|NOT COMPLETED|Period 1||0
10430233|NCT00868790|11576402|FG010|NOT COMPLETED|Period 1||0
10430234|NCT00868790|11576403|FG011|NOT COMPLETED|Period 1||0
10430235|NCT00868790|11576404|FG012|NOT COMPLETED|Period 1||0
10430236|NCT00868790|11576405|FG013|NOT COMPLETED|Period 1||2
10430237|NCT00868790|11576392|FG000|STARTED|Period 2||9
10430238|NCT00868790|11576393|FG001|STARTED|Period 2||7
10430239|NCT00868790|11576394|FG002|STARTED|Period 2||4
10430240|NCT00868790|11576395|FG003|STARTED|Period 2||4
10430241|NCT00868790|11576396|FG004|STARTED|Period 2||18
10430242|NCT00868790|11576397|FG005|STARTED|Period 2||2
10430243|NCT00868790|11576398|FG006|STARTED|Period 2||4
10430244|NCT00868790|11576399|FG007|STARTED|Period 2||17
10430245|NCT00868790|11576400|FG008|STARTED|Period 2||10
10430246|NCT00868790|11576401|FG009|STARTED|Period 2||3
10430247|NCT00868790|11576402|FG010|STARTED|Period 2||9
10430248|NCT00868790|11576403|FG011|STARTED|Period 2||4
10430249|NCT00868790|11576404|FG012|STARTED|Period 2||7
10430250|NCT00868790|11576405|FG013|STARTED|Period 2||9
10430251|NCT00868790|11576392|FG000|COMPLETED|Period 2||9
10430252|NCT00868790|11576393|FG001|COMPLETED|Period 2||6
10430253|NCT00868790|11576394|FG002|COMPLETED|Period 2||4
10430254|NCT00868790|11576395|FG003|COMPLETED|Period 2||4
10430255|NCT00868790|11576396|FG004|COMPLETED|Period 2||18
10430256|NCT00868790|11576397|FG005|COMPLETED|Period 2||1
10430257|NCT00868790|11576398|FG006|COMPLETED|Period 2||4
10430258|NCT00868790|11576399|FG007|COMPLETED|Period 2||17
10430259|NCT00868790|11576400|FG008|COMPLETED|Period 2||8
10430260|NCT00868790|11576401|FG009|COMPLETED|Period 2||3
10430261|NCT00868790|11576402|FG010|COMPLETED|Period 2||9
10430262|NCT00868790|11576403|FG011|COMPLETED|Period 2||4
10430263|NCT00868790|11576404|FG012|COMPLETED|Period 2||7
10430264|NCT00868790|11576405|FG013|COMPLETED|Period 2||8
10430265|NCT00868790|11576392|FG000|NOT COMPLETED|Period 2||0
10430266|NCT00868790|11576393|FG001|NOT COMPLETED|Period 2||1
10430267|NCT00868790|11576394|FG002|NOT COMPLETED|Period 2||0
10430268|NCT00868790|11576395|FG003|NOT COMPLETED|Period 2||0
10430269|NCT00868790|11576396|FG004|NOT COMPLETED|Period 2||0
10430270|NCT00868790|11576397|FG005|NOT COMPLETED|Period 2||1
10430271|NCT00868790|11576398|FG006|NOT COMPLETED|Period 2||0
10430272|NCT00868790|11576399|FG007|NOT COMPLETED|Period 2||0
10430273|NCT00868790|11576400|FG008|NOT COMPLETED|Period 2||2
10430274|NCT00868790|11576401|FG009|NOT COMPLETED|Period 2||0
10430275|NCT00868790|11576402|FG010|NOT COMPLETED|Period 2||0
10430276|NCT00868790|11576403|FG011|NOT COMPLETED|Period 2||0
10430277|NCT00868790|11576404|FG012|NOT COMPLETED|Period 2||0
10430278|NCT00868790|11576405|FG013|NOT COMPLETED|Period 2||1
10430279|NCT00868790|11576392|FG000|STARTED|Period 3||9
10430280|NCT00868790|11576393|FG001|STARTED|Period 3||6
10430281|NCT00868790|11576394|FG002|STARTED|Period 3||4
10430282|NCT00868790|11576395|FG003|STARTED|Period 3||4
10430283|NCT00868790|11576396|FG004|STARTED|Period 3||18
10430284|NCT00868790|11576397|FG005|STARTED|Period 3||1
10430285|NCT00868790|11576398|FG006|STARTED|Period 3||4
10430286|NCT00868790|11576399|FG007|STARTED|Period 3||17
10430287|NCT00868790|11576400|FG008|STARTED|Period 3||8
10430288|NCT00868790|11576401|FG009|STARTED|Period 3||3
10430289|NCT00868790|11576402|FG010|STARTED|Period 3||9
10430290|NCT00868790|11576403|FG011|STARTED|Period 3||4
10430291|NCT00868790|11576404|FG012|STARTED|Period 3||7
10430292|NCT00868790|11576405|FG013|STARTED|Period 3||8
10430293|NCT00868790|11576392|FG000|COMPLETED|Period 3||9
10430294|NCT00868790|11576393|FG001|COMPLETED|Period 3||6
10430295|NCT00868790|11576394|FG002|COMPLETED|Period 3||4
10430296|NCT00868790|11576395|FG003|COMPLETED|Period 3||3
10430297|NCT00868790|11576396|FG004|COMPLETED|Period 3||18
10430298|NCT00868790|11576397|FG005|COMPLETED|Period 3||1
10430299|NCT00868790|11576398|FG006|COMPLETED|Period 3||4
10430300|NCT00868790|11576399|FG007|COMPLETED|Period 3||17
10430301|NCT00868790|11576400|FG008|COMPLETED|Period 3||8
10430302|NCT00868790|11576401|FG009|COMPLETED|Period 3||2
10430303|NCT00868790|11576402|FG010|COMPLETED|Period 3||8
10430304|NCT00868790|11576403|FG011|COMPLETED|Period 3||4
10430305|NCT00868790|11576404|FG012|COMPLETED|Period 3||7
10430306|NCT00868790|11576405|FG013|COMPLETED|Period 3||8
10430307|NCT00868790|11576392|FG000|NOT COMPLETED|Period 3||0
10430308|NCT00868790|11576393|FG001|NOT COMPLETED|Period 3||0
10430309|NCT00868790|11576394|FG002|NOT COMPLETED|Period 3||0
10430310|NCT00868790|11576395|FG003|NOT COMPLETED|Period 3||1
10430311|NCT00868790|11576396|FG004|NOT COMPLETED|Period 3||0
10430312|NCT00868790|11576397|FG005|NOT COMPLETED|Period 3||0
10430313|NCT00868790|11576398|FG006|NOT COMPLETED|Period 3||0
10430314|NCT00868790|11576399|FG007|NOT COMPLETED|Period 3||0
10430315|NCT00868790|11576400|FG008|NOT COMPLETED|Period 3||0
10430316|NCT00868790|11576401|FG009|NOT COMPLETED|Period 3||1
10430317|NCT00868790|11576402|FG010|NOT COMPLETED|Period 3||1
10430318|NCT00868790|11576403|FG011|NOT COMPLETED|Period 3||0
10430319|NCT00868790|11576404|FG012|NOT COMPLETED|Period 3||0
10430320|NCT00868790|11576405|FG013|NOT COMPLETED|Period 3||0
10430321|NCT00868790|11576392|FG000|STARTED|Period 4||9
10430322|NCT00868790|11576393|FG001|STARTED|Period 4||6
10430323|NCT00868790|11576394|FG002|STARTED|Period 4||4
10430324|NCT00868790|11576395|FG003|STARTED|Period 4||3
10430325|NCT00868790|11576396|FG004|STARTED|Period 4||18
10430326|NCT00868790|11576397|FG005|STARTED|Period 4||1
10430327|NCT00868790|11576398|FG006|STARTED|Period 4||4
10430328|NCT00868790|11576399|FG007|STARTED|Period 4||17
10430329|NCT00868790|11576400|FG008|STARTED|Period 4||8
10430330|NCT00868790|11576401|FG009|STARTED|Period 4||2
10430331|NCT00868790|11576402|FG010|STARTED|Period 4||8
10430332|NCT00868790|11576403|FG011|STARTED|Period 4||4
10430333|NCT00868790|11576404|FG012|STARTED|Period 4||7
10430334|NCT00868790|11576405|FG013|STARTED|Period 4||8
10430335|NCT00868790|11576392|FG000|COMPLETED|Period 4||7
10430336|NCT00868790|11576393|FG001|COMPLETED|Period 4||6
10430337|NCT00868790|11576394|FG002|COMPLETED|Period 4|One non-completion due to abnormal alanine aminotransferase/aspartate aminotransferase (ALT/AST)|3
10430338|NCT00868790|11576395|FG003|COMPLETED|Period 4||3
10430339|NCT00868790|11576396|FG004|COMPLETED|Period 4||18
10430340|NCT00868790|11576397|FG005|COMPLETED|Period 4||1
10430341|NCT00868790|11576398|FG006|COMPLETED|Period 4||4
10430342|NCT00868790|11576399|FG007|COMPLETED|Period 4||14
10430343|NCT00868790|11576400|FG008|COMPLETED|Period 4||6
10430344|NCT00868790|11576401|FG009|COMPLETED|Period 4||2
10430345|NCT00868790|11576402|FG010|COMPLETED|Period 4||5
10430346|NCT00868790|11576403|FG011|COMPLETED|Period 4||3
10430347|NCT00868790|11576404|FG012|COMPLETED|Period 4||6
10430348|NCT00868790|11576405|FG013|COMPLETED|Period 4||7
10430349|NCT00868790|11576392|FG000|NOT COMPLETED|Period 4||2
10430350|NCT00868790|11576393|FG001|NOT COMPLETED|Period 4||0
10430351|NCT00868790|11576394|FG002|NOT COMPLETED|Period 4||1
10430352|NCT00868790|11576395|FG003|NOT COMPLETED|Period 4||0
10430353|NCT00868790|11576396|FG004|NOT COMPLETED|Period 4||0
10430354|NCT00868790|11576397|FG005|NOT COMPLETED|Period 4||0
10430355|NCT00868790|11576398|FG006|NOT COMPLETED|Period 4||0
10430356|NCT00868790|11576399|FG007|NOT COMPLETED|Period 4||3
10430357|NCT00868790|11576400|FG008|NOT COMPLETED|Period 4||2
10430358|NCT00868790|11576401|FG009|NOT COMPLETED|Period 4||0
10430359|NCT00868790|11576402|FG010|NOT COMPLETED|Period 4||3
10430360|NCT00868790|11576403|FG011|NOT COMPLETED|Period 4||1
10430361|NCT00868790|11576404|FG012|NOT COMPLETED|Period 4||1
10430362|NCT00868790|11576405|FG013|NOT COMPLETED|Period 4||1
10430363|NCT00868790|11576392|FG000|STARTED|Post-study||7
10430364|NCT00868790|11576393|FG001|STARTED|Post-study||6
10430365|NCT00868790|11576394|FG002|STARTED|Post-study||3
10430366|NCT00868790|11576395|FG003|STARTED|Post-study||3
10430367|NCT00868790|11576396|FG004|STARTED|Post-study||18
10430368|NCT00868790|11576397|FG005|STARTED|Post-study||1
10430369|NCT00868790|11576398|FG006|STARTED|Post-study||4
10430370|NCT00868790|11576399|FG007|STARTED|Post-study||14
10430371|NCT00868790|11576400|FG008|STARTED|Post-study||6
10430372|NCT00868790|11576401|FG009|STARTED|Post-study||2
10430373|NCT00868790|11576402|FG010|STARTED|Post-study||5
10430374|NCT00868790|11576403|FG011|STARTED|Post-study||3
10430375|NCT00868790|11576404|FG012|STARTED|Post-study||6
10430376|NCT00868790|11576405|FG013|STARTED|Post-study||7
10430377|NCT00868790|11576392|FG000|COMPLETED|Post-study||7
10430378|NCT00868790|11576393|FG001|COMPLETED|Post-study||6
10430379|NCT00868790|11576394|FG002|COMPLETED|Post-study||3
10430380|NCT00868790|11576395|FG003|COMPLETED|Post-study||3
10430381|NCT00868790|11576396|FG004|COMPLETED|Post-study||17
10430382|NCT00868790|11576397|FG005|COMPLETED|Post-study||1
10430383|NCT00868790|11576398|FG006|COMPLETED|Post-study||4
10430384|NCT00868790|11576399|FG007|COMPLETED|Post-study||12
10430385|NCT00868790|11576400|FG008|COMPLETED|Post-study||6
10430386|NCT00868790|11576401|FG009|COMPLETED|Post-study||1
10430387|NCT00868790|11576402|FG010|COMPLETED|Post-study||5
10430388|NCT00868790|11576403|FG011|COMPLETED|Post-study||3
10430389|NCT00868790|11576404|FG012|COMPLETED|Post-study||6
10430390|NCT00868790|11576405|FG013|COMPLETED|Post-study||7
10430391|NCT00868790|11576392|FG000|NOT COMPLETED|Post-study||0
10430392|NCT00868790|11576393|FG001|NOT COMPLETED|Post-study||0
10430393|NCT00868790|11576394|FG002|NOT COMPLETED|Post-study||0
10430394|NCT00868790|11576395|FG003|NOT COMPLETED|Post-study||0
10430395|NCT00868790|11576396|FG004|NOT COMPLETED|Post-study||1
10430396|NCT00868790|11576397|FG005|NOT COMPLETED|Post-study||0
10430397|NCT00868790|11576398|FG006|NOT COMPLETED|Post-study||0
10430398|NCT00868790|11576399|FG007|NOT COMPLETED|Post-study||2
10430399|NCT00868790|11576400|FG008|NOT COMPLETED|Post-study||0
10430400|NCT00868790|11576401|FG009|NOT COMPLETED|Post-study||1
10430401|NCT00868790|11576402|FG010|NOT COMPLETED|Post-study||0
10430402|NCT00868790|11576403|FG011|NOT COMPLETED|Post-study||0
10430403|NCT00868790|11576404|FG012|NOT COMPLETED|Post-study||0
10430404|NCT00868790|11576405|FG013|NOT COMPLETED|Post-study||0
10430405|NCT00868959|11576421|FG000|STARTED|Overall Study|817 represents total number of subjects who provided informed consent.|817
10430406|NCT00868959|11576421|FG000|COMPLETED|Overall Study||559
10430407|NCT00868959|11576421|FG000|NOT COMPLETED|Overall Study||258
10430408|NCT00869024|11576427|FG000|STARTED|Overall Study||16
10430409|NCT00869024|11576428|FG001|STARTED|Overall Study|One patient intent to treat, did not receive study product|9
10430410|NCT00869024|11576427|FG000|COMPLETED|Overall Study||14
10430411|NCT00869024|11576428|FG001|COMPLETED|Overall Study||4
10430412|NCT00869024|11576427|FG000|NOT COMPLETED|Overall Study||2
10430413|NCT00869024|11576428|FG001|NOT COMPLETED|Overall Study||5
10430414|NCT00869050|11576434|FG000|STARTED|Overall Study||41
10430415|NCT00869050|11576434|FG000|COMPLETED|Overall Study||38
10430416|NCT00869050|11576434|FG000|NOT COMPLETED|Overall Study||3
10430417|NCT00869089|11576438|FG000|STARTED|Overall Study||5
10430418|NCT00869089|11576438|FG000|COMPLETED|Overall Study||2
10430419|NCT00869089|11576438|FG000|NOT COMPLETED|Overall Study||3
10430420|NCT00869141|11576444|FG000|STARTED|Overall Study||26
10430421|NCT00869141|11576445|FG001|STARTED|Overall Study||26
10430422|NCT00869141|11576444|FG000|COMPLETED|Overall Study||26
10430423|NCT00869141|11576445|FG001|COMPLETED|Overall Study||26
10430424|NCT00869141|11576444|FG000|NOT COMPLETED|Overall Study||0
10430425|NCT00869141|11576445|FG001|NOT COMPLETED|Overall Study||0
10430426|NCT00869167|11576455|FG000|STARTED|Overall Study||2
10430427|NCT00869167|11576456|FG001|STARTED|Overall Study||1
10430428|NCT00869167|11576455|FG000|COMPLETED|Overall Study||2
10430429|NCT00869167|11576456|FG001|COMPLETED|Overall Study||0
10430430|NCT00869167|11576455|FG000|NOT COMPLETED|Overall Study||0
10430431|NCT00869167|11576456|FG001|NOT COMPLETED|Overall Study||1
10430432|NCT00869206|11576466|FG000|STARTED|Overall Study||911
10430433|NCT00869206|11576467|FG001|STARTED|Overall Study||911
10430434|NCT00869206|11576466|FG000|COMPLETED|Overall Study||882
10430435|NCT00869206|11576467|FG001|COMPLETED|Overall Study||884
10430436|NCT00869206|11576466|FG000|NOT COMPLETED|Overall Study||29
10430437|NCT00869206|11576467|FG001|NOT COMPLETED|Overall Study||27
10430438|NCT00869323|11576479|FG000|STARTED|Induction Therapy||3
10430439|NCT00869323|11576479|FG000|COMPLETED|Induction Therapy||3
10430440|NCT00869323|11576479|FG000|NOT COMPLETED|Induction Therapy||0
10430441|NCT00869323|11576479|FG000|STARTED|Maintenance Therapy|One participant removed from study after completing induction therapy due to progressive disease.|2
10430442|NCT00869323|11576479|FG000|COMPLETED|Maintenance Therapy||1
10430443|NCT00869323|11576479|FG000|NOT COMPLETED|Maintenance Therapy||1
10430444|NCT00869349|11576485|FG000|STARTED|Overall Study||39
10430445|NCT00869349|11576486|FG001|STARTED|Overall Study||40
10430446|NCT00869349|11576485|FG000|COMPLETED|Overall Study||32
10430447|NCT00869349|11576486|FG001|COMPLETED|Overall Study||36
10430448|NCT00869349|11576485|FG000|NOT COMPLETED|Overall Study||7
10430449|NCT00869349|11576486|FG001|NOT COMPLETED|Overall Study||4
10430450|NCT00869362|11576494|FG000|STARTED|Overall Study||15
10430451|NCT00869362|11576495|FG001|STARTED|Overall Study||16
10430452|NCT00869362|11576494|FG000|COMPLETED|Overall Study||14
10430453|NCT00869362|11576495|FG001|COMPLETED|Overall Study||11
10430454|NCT00869362|11576494|FG000|NOT COMPLETED|Overall Study||1
10430455|NCT00869362|11576495|FG001|NOT COMPLETED|Overall Study||5
10430456|NCT00869375|11576504|FG000|STARTED|Overall Study||3
10430457|NCT00869375|11576505|FG001|STARTED|Overall Study||3
10430458|NCT00869375|11576504|FG000|COMPLETED|Overall Study||3
10430459|NCT00869375|11576505|FG001|COMPLETED|Overall Study||3
10430460|NCT00869375|11576504|FG000|NOT COMPLETED|Overall Study||0
10430461|NCT00869375|11576505|FG001|NOT COMPLETED|Overall Study||0
10430462|NCT00869401|11576516|FG000|STARTED|Overall Study||3
10430463|NCT00869401|11576517|FG001|STARTED|Overall Study||3
10430464|NCT00869401|11576518|FG002|STARTED|Overall Study||7
10430465|NCT00869401|11576519|FG003|STARTED|Overall Study||138
10430466|NCT00869401|11576520|FG004|STARTED|Overall Study||66
10430467|NCT00869401|11576516|FG000|COMPLETED|Overall Study||3
10430468|NCT00869401|11576517|FG001|COMPLETED|Overall Study||3
10430469|NCT00869401|11576518|FG002|COMPLETED|Overall Study||7
10430470|NCT00869401|11576519|FG003|COMPLETED|Overall Study||133
10430471|NCT00869401|11576520|FG004|COMPLETED|Overall Study||63
10430472|NCT00869401|11576516|FG000|NOT COMPLETED|Overall Study||0
10430473|NCT00869401|11576517|FG001|NOT COMPLETED|Overall Study||0
10430474|NCT00869401|11576518|FG002|NOT COMPLETED|Overall Study||0
10430475|NCT00869401|11576519|FG003|NOT COMPLETED|Overall Study||5
10430476|NCT00869401|11576520|FG004|NOT COMPLETED|Overall Study||3
10430477|NCT00869440|11576536|FG000|STARTED|Overall Study||25
10430478|NCT00869440|11576537|FG001|STARTED|Overall Study||25
10430479|NCT00869440|11576538|FG002|STARTED|Overall Study||25
10430480|NCT00869440|11576539|FG003|STARTED|Overall Study||25
10430481|NCT00869440|11576536|FG000|COMPLETED|Overall Study||23
10430482|NCT00869440|11576537|FG001|COMPLETED|Overall Study||24
10430483|NCT00869440|11576538|FG002|COMPLETED|Overall Study||25
10430484|NCT00869440|11576539|FG003|COMPLETED|Overall Study||25
10430485|NCT00869440|11576536|FG000|NOT COMPLETED|Overall Study||2
10430486|NCT00869440|11576537|FG001|NOT COMPLETED|Overall Study||1
10430487|NCT00869440|11576538|FG002|NOT COMPLETED|Overall Study||0
10430488|NCT00869440|11576539|FG003|NOT COMPLETED|Overall Study||0
10430489|NCT00869518|11576551|FG000|STARTED|Overall Study||6
10430490|NCT00869518|11576552|FG001|STARTED|Overall Study||6
10430491|NCT00869518|11576551|FG000|COMPLETED|Overall Study||5
10430492|NCT00869518|11576552|FG001|COMPLETED|Overall Study||5
10430493|NCT00869518|11576551|FG000|NOT COMPLETED|Overall Study||1
10430494|NCT00869518|11576552|FG001|NOT COMPLETED|Overall Study||1
10430495|NCT00869557|11576560|FG000|STARTED|Randomized Phase||48
10430496|NCT00869557|11576561|FG001|STARTED|Randomized Phase||23
10430497|NCT00869557|11576560|FG000|COMPLETED|Randomized Phase||45
10430498|NCT00869557|11576561|FG001|COMPLETED|Randomized Phase||21
10430499|NCT00869557|11576560|FG000|NOT COMPLETED|Randomized Phase||3
10430500|NCT00869557|11576561|FG001|NOT COMPLETED|Randomized Phase||2
10430501|NCT00869557|11576560|FG000|STARTED|Extension Phase||45
10430502|NCT00869557|11576561|FG001|STARTED|Extension Phase|Seven participants completing randomized Atripla treatment did not enter open-label extension phase.|14
10430503|NCT00869557|11576560|FG000|COMPLETED|Extension Phase||35
10430504|NCT00869557|11576561|FG001|COMPLETED|Extension Phase||11
10430505|NCT00869557|11576560|FG000|NOT COMPLETED|Extension Phase||10
10430506|NCT00869557|11576561|FG001|NOT COMPLETED|Extension Phase||3
10430507|NCT00869609|11576570|FG000|STARTED|Overall Study||31
10430508|NCT00869609|11576571|FG001|STARTED|Overall Study||29
10430509|NCT00869609|11576570|FG000|COMPLETED|Overall Study||25
10430510|NCT00869609|11576571|FG001|COMPLETED|Overall Study||26
10430511|NCT00869609|11576570|FG000|NOT COMPLETED|Overall Study||6
10430512|NCT00869609|11576571|FG001|NOT COMPLETED|Overall Study||3
10430513|NCT00869622|11576579|FG000|STARTED|Overall Study||40
10430514|NCT00869622|11576580|FG001|STARTED|Overall Study||40
10430515|NCT00869622|11576579|FG000|COMPLETED|Overall Study||27
10430516|NCT00869622|11576580|FG001|COMPLETED|Overall Study||26
10430517|NCT00869622|11576579|FG000|NOT COMPLETED|Overall Study||13
10430518|NCT00869622|11576580|FG001|NOT COMPLETED|Overall Study||14
10430519|NCT00869778|11576590|FG000|STARTED|Overall Study||120
10430520|NCT00869778|11576591|FG001|STARTED|Overall Study||120
10430521|NCT00869778|11576592|FG002|STARTED|Overall Study||120
10430522|NCT00869778|11576590|FG000|COMPLETED|Overall Study||108
10430523|NCT00869778|11576591|FG001|COMPLETED|Overall Study||113
10430524|NCT00869778|11576592|FG002|COMPLETED|Overall Study||110
10430525|NCT00869778|11576590|FG000|NOT COMPLETED|Overall Study||12
10430526|NCT00869778|11576591|FG001|NOT COMPLETED|Overall Study||7
10430527|NCT00869778|11576592|FG002|NOT COMPLETED|Overall Study||10
10430528|NCT00869791|11576603|FG000|STARTED|Period 1 Treatment for 7 Days||14
10430529|NCT00869791|11576604|FG001|STARTED|Period 1 Treatment for 7 Days||13
10430530|NCT00869791|11576603|FG000|COMPLETED|Period 1 Treatment for 7 Days||14
10430531|NCT00869791|11576604|FG001|COMPLETED|Period 1 Treatment for 7 Days||13
10430532|NCT00869791|11576603|FG000|NOT COMPLETED|Period 1 Treatment for 7 Days||0
10430533|NCT00869791|11576604|FG001|NOT COMPLETED|Period 1 Treatment for 7 Days||0
10430534|NCT00869791|11576603|FG000|STARTED|Period 2 Treatment for 7 Days||14
10430535|NCT00869791|11576604|FG001|STARTED|Period 2 Treatment for 7 Days||13
10430536|NCT00869791|11576603|FG000|COMPLETED|Period 2 Treatment for 7 Days||14
10430537|NCT00869791|11576604|FG001|COMPLETED|Period 2 Treatment for 7 Days||13
10430538|NCT00869791|11576603|FG000|NOT COMPLETED|Period 2 Treatment for 7 Days||0
10430539|NCT00869791|11576604|FG001|NOT COMPLETED|Period 2 Treatment for 7 Days||0
10430540|NCT00869947|11576612|FG000|STARTED|Overall Study||8
10430541|NCT00869947|11576613|FG001|STARTED|Overall Study||8
10430542|NCT00869947|11576612|FG000|COMPLETED|Overall Study||8
10430543|NCT00869947|11576613|FG001|COMPLETED|Overall Study||8
10430544|NCT00869947|11576612|FG000|NOT COMPLETED|Overall Study||0
10430545|NCT00869947|11576613|FG001|NOT COMPLETED|Overall Study||0
10430546|NCT00869960|11576621|FG000|STARTED|Overall Study||24
10430547|NCT00869960|11576621|FG000|COMPLETED|Overall Study||22
10430548|NCT00869960|11576621|FG000|NOT COMPLETED|Overall Study||2
10430549|NCT00869999|11576625|FG000|STARTED|Overall Study||26
10430550|NCT00869999|11576625|FG000|COMPLETED|Overall Study||24
10430551|NCT00869999|11576625|FG000|NOT COMPLETED|Overall Study||2
10430552|NCT00870103|11576629|FG000|STARTED|Overall Study||64
10430553|NCT00870103|11576629|FG000|COMPLETED|Overall Study||60
10430554|NCT00870103|11576629|FG000|NOT COMPLETED|Overall Study||4
10430555|NCT00870194|11576635|FG000|STARTED|Overall Study||127
10430556|NCT00870194|11576636|FG001|STARTED|Overall Study||128
10430557|NCT00870194|11576635|FG000|Per Protocol Set|Overall Study||97
10430558|NCT00870194|11576636|FG001|Per Protocol Set|Overall Study||111
10430559|NCT00870194|11576635|FG000|COMPLETED|Overall Study||101
10430560|NCT00870194|11576636|FG001|COMPLETED|Overall Study||114
10430561|NCT00870194|11576635|FG000|NOT COMPLETED|Overall Study||26
10430562|NCT00870194|11576636|FG001|NOT COMPLETED|Overall Study||14
10430563|NCT00870233|11576642|FG000|STARTED|Overall Study||120
10430564|NCT00870233|11576642|FG000|COMPLETED|Overall Study||96
10430565|NCT00870233|11576642|FG000|NOT COMPLETED|Overall Study||24
10430566|NCT00870363|11576651|FG000|STARTED|Overall Study||10
10430567|NCT00870363|11576652|FG001|STARTED|Overall Study||11
10430568|NCT00870363|11576653|FG002|STARTED|Overall Study||11
10430569|NCT00870363|11576654|FG003|STARTED|Overall Study||12
10430570|NCT00870363|11576651|FG000|COMPLETED|Overall Study||10
10430571|NCT00870363|11576652|FG001|COMPLETED|Overall Study||8
10430572|NCT00870363|11576653|FG002|COMPLETED|Overall Study||8
10430573|NCT00870363|11576654|FG003|COMPLETED|Overall Study||12
10430574|NCT00870363|11576651|FG000|NOT COMPLETED|Overall Study||0
10430575|NCT00870363|11576652|FG001|NOT COMPLETED|Overall Study||3
10430576|NCT00870363|11576653|FG002|NOT COMPLETED|Overall Study||3
10430577|NCT00870363|11576654|FG003|NOT COMPLETED|Overall Study||0
10430578|NCT00870467|11576666|FG000|STARTED|Double-blind||171
10430579|NCT00870467|11576667|FG001|STARTED|Double-blind||163
10430580|NCT00870467|11576668|FG002|STARTED|Double-blind||0
10430581|NCT00870467|11576669|FG003|STARTED|Double-blind||0
10430582|NCT00870467|11576670|FG004|STARTED|Double-blind||0
10430583|NCT00870467|11576671|FG005|STARTED|Double-blind||0
10430584|NCT00870467|11576666|FG000|COMPLETED|Double-blind|10 participants who completed 26 weeks received open-label adalimumab 40 mg eow as rescue therapy|155
10430585|NCT00870467|11576667|FG001|COMPLETED|Double-blind|24 participants who completed 26 weeks received open-label adalimumab 40 mg eow as rescue therapy|151
10430586|NCT00870467|11576668|FG002|COMPLETED|Double-blind||0
10430587|NCT00870467|11576669|FG003|COMPLETED|Double-blind||0
10430588|NCT00870467|11576670|FG004|COMPLETED|Double-blind||0
10430589|NCT00870467|11576671|FG005|COMPLETED|Double-blind||0
10430590|NCT00870467|11576666|FG000|NOT COMPLETED|Double-blind||16
10430591|NCT00870467|11576667|FG001|NOT COMPLETED|Double-blind||12
10430592|NCT00870467|11576668|FG002|NOT COMPLETED|Double-blind||0
10430593|NCT00870467|11576669|FG003|NOT COMPLETED|Double-blind||0
10430594|NCT00870467|11576670|FG004|NOT COMPLETED|Double-blind||0
10430595|NCT00870467|11576671|FG005|NOT COMPLETED|Double-blind||0
10430596|NCT00870467|11576666|FG000|STARTED|Open-label||0
10430597|NCT00870467|11576667|FG001|STARTED|Open-label||0
10430598|NCT00870467|11576668|FG002|STARTED|Open-label||145
10430599|NCT00870467|11576669|FG003|STARTED|Open-label||127
10430600|NCT00870467|11576670|FG004|STARTED|Open-label||10
10430601|NCT00870467|11576671|FG005|STARTED|Open-label||24
10430602|NCT00870467|11576666|FG000|COMPLETED|Open-label||0
10430603|NCT00870467|11576667|FG001|COMPLETED|Open-label||0
10430604|NCT00870467|11576668|FG002|COMPLETED|Open-label||132
10430605|NCT00870467|11576669|FG003|COMPLETED|Open-label||120
10430606|NCT00870467|11576670|FG004|COMPLETED|Open-label||5
10430607|NCT00870467|11576671|FG005|COMPLETED|Open-label||21
10430608|NCT00870467|11576666|FG000|NOT COMPLETED|Open-label||0
10430609|NCT00870467|11576667|FG001|NOT COMPLETED|Open-label||0
10430610|NCT00870467|11576668|FG002|NOT COMPLETED|Open-label||13
10430611|NCT00870467|11576669|FG003|NOT COMPLETED|Open-label||7
10430612|NCT00870467|11576670|FG004|NOT COMPLETED|Open-label||5
10430613|NCT00870467|11576671|FG005|NOT COMPLETED|Open-label||3
10430614|NCT00870545|11576683|FG000|STARTED|Overall Study||86
10430615|NCT00870545|11576683|FG000|COMPLETED|Overall Study||69
10430616|NCT00870545|11576683|FG000|NOT COMPLETED|Overall Study||17
10430617|NCT00870584|11576689|FG000|STARTED|Overall Study||136
10430618|NCT00870584|11576690|FG001|STARTED|Overall Study||135
10430619|NCT00870584|11576689|FG000|COMPLETED|Overall Study||120
10430620|NCT00870584|11576690|FG001|COMPLETED|Overall Study||122
10430621|NCT00870584|11576689|FG000|NOT COMPLETED|Overall Study||16
10430622|NCT00870584|11576690|FG001|NOT COMPLETED|Overall Study||13
10430623|NCT00870727|11576698|FG000|STARTED|Overall Study||17
10430624|NCT00870727|11576699|FG001|STARTED|Overall Study||16
10430625|NCT00870727|11576698|FG000|COMPLETED|Overall Study||16
10430626|NCT00870727|11576699|FG001|COMPLETED|Overall Study||11
10430627|NCT00870727|11576698|FG000|NOT COMPLETED|Overall Study||1
10430628|NCT00870727|11576699|FG001|NOT COMPLETED|Overall Study||5
10430629|NCT00870740|11576711|FG000|STARTED|Overall Study|number randomized and dosed|86
10430630|NCT00870740|11576712|FG001|STARTED|Overall Study|number randomized and dosed|84
10430631|NCT00870740|11576713|FG002|STARTED|Overall Study|number randomized and dosed|86
10430632|NCT00870740|11576714|FG003|STARTED|Overall Study|number randomized and dosed|86
10430633|NCT00870740|11576715|FG004|STARTED|Overall Study|number randomized and dosed|88
10430634|NCT00870740|11576716|FG005|STARTED|Overall Study|number randomized and dosed|87
10430635|NCT00870740|11576711|FG000|COMPLETED|Overall Study||74
10430636|NCT00870740|11576712|FG001|COMPLETED|Overall Study||75
10430637|NCT00870740|11576713|FG002|COMPLETED|Overall Study||76
10430638|NCT00870740|11576714|FG003|COMPLETED|Overall Study||74
10430639|NCT00870740|11576715|FG004|COMPLETED|Overall Study||77
10430640|NCT00870740|11576716|FG005|COMPLETED|Overall Study||70
10430641|NCT00870740|11576711|FG000|NOT COMPLETED|Overall Study||12
10430642|NCT00870740|11576712|FG001|NOT COMPLETED|Overall Study||9
10430643|NCT00870740|11576713|FG002|NOT COMPLETED|Overall Study||10
10430644|NCT00870740|11576714|FG003|NOT COMPLETED|Overall Study||12
10430645|NCT00870740|11576715|FG004|NOT COMPLETED|Overall Study||11
10430646|NCT00870740|11576716|FG005|NOT COMPLETED|Overall Study||17
10430647|NCT00870870|11576745|FG000|STARTED|Overall Study||4
10430648|NCT00870870|11576746|FG001|STARTED|Overall Study||6
10430649|NCT00870870|11576747|FG002|STARTED|Overall Study||29
10430650|NCT00870870|11576748|FG003|STARTED|Overall Study||25
10430651|NCT00870870|11576745|FG000|COMPLETED|Overall Study||4
10430652|NCT00870870|11576746|FG001|COMPLETED|Overall Study||5
10430653|NCT00870870|11576747|FG002|COMPLETED|Overall Study||26
10430654|NCT00870870|11576748|FG003|COMPLETED|Overall Study||20
10430655|NCT00870870|11576745|FG000|NOT COMPLETED|Overall Study||0
10430656|NCT00870870|11576746|FG001|NOT COMPLETED|Overall Study||1
10430657|NCT00870870|11576747|FG002|NOT COMPLETED|Overall Study||3
10430658|NCT00870870|11576748|FG003|NOT COMPLETED|Overall Study||5
10430659|NCT00870896|11576763|FG000|STARTED|Overall Study||5
10430660|NCT00870896|11576763|FG000|COMPLETED|Overall Study||5
10430661|NCT00870896|11576763|FG000|NOT COMPLETED|Overall Study||0
10430662|NCT00871000|11576771|FG000|STARTED|Overall Study||151
10430663|NCT00871000|11576772|FG001|STARTED|Overall Study||152
10430664|NCT00871000|11576771|FG000|COMPLETED|Overall Study||150
10430665|NCT00871000|11576772|FG001|COMPLETED|Overall Study||152
10430666|NCT00871000|11576771|FG000|NOT COMPLETED|Overall Study||1
10430667|NCT00871000|11576772|FG001|NOT COMPLETED|Overall Study||0
10430668|NCT00871117|11576780|FG000|STARTED|Overall Study||239
10430669|NCT00871117|11576781|FG001|STARTED|Overall Study||237
10430670|NCT00871117|11576780|FG000|COMPLETED|Overall Study||234
10430671|NCT00871117|11576781|FG001|COMPLETED|Overall Study||227
10430672|NCT00871117|11576780|FG000|NOT COMPLETED|Overall Study||5
10430673|NCT00871117|11576781|FG001|NOT COMPLETED|Overall Study||10
10430674|NCT00871143|11576790|FG000|STARTED|Overall Study||21
10430675|NCT00871143|11576791|FG001|STARTED|Overall Study||25
10430676|NCT00871143|11576790|FG000|COMPLETED|Overall Study||21
10430677|NCT00871143|11576791|FG001|COMPLETED|Overall Study||25
10430678|NCT00871143|11576790|FG000|NOT COMPLETED|Overall Study||0
10430679|NCT00871143|11576791|FG001|NOT COMPLETED|Overall Study||0
10430680|NCT00871169|11576797|FG000|STARTED|Overall Study||61
10430681|NCT00871169|11576797|FG000|COMPLETED|Overall Study||58
10430682|NCT00871169|11576797|FG000|NOT COMPLETED|Overall Study||3
10430683|NCT00871234|11576801|FG000|STARTED|Overall Study||28
10430684|NCT00871234|11576801|FG000|COMPLETED|Overall Study||23
10430685|NCT00871234|11576801|FG000|NOT COMPLETED|Overall Study||5
10430686|NCT00871260|11576805|FG000|STARTED|Overall Study||20
10430687|NCT00871260|11576805|FG000|COMPLETED|Overall Study||20
10430688|NCT00871260|11576805|FG000|NOT COMPLETED|Overall Study||0
10430689|NCT00871286|11576811|FG000|STARTED|Overall Study||20
10430690|NCT00871286|11576812|FG001|STARTED|Overall Study||20
10430691|NCT00871286|11576811|FG000|COMPLETED|Overall Study||20
10430692|NCT00871286|11576812|FG001|COMPLETED|Overall Study||14
10430693|NCT00871286|11576811|FG000|NOT COMPLETED|Overall Study||0
10430694|NCT00871286|11576812|FG001|NOT COMPLETED|Overall Study||6
10430695|NCT00871338|11576820|FG000|STARTED|Prior to Booster||142
10430696|NCT00871338|11576821|FG001|STARTED|Prior to Booster||142
10430697|NCT00871338|11576820|FG000|COMPLETED|Prior to Booster||140
10430698|NCT00871338|11576821|FG001|COMPLETED|Prior to Booster||139
10430699|NCT00871338|11576820|FG000|NOT COMPLETED|Prior to Booster||2
10430700|NCT00871338|11576821|FG001|NOT COMPLETED|Prior to Booster||3
10430701|NCT00871338|11576820|FG000|STARTED|After Booster||139
10430702|NCT00871338|11576821|FG001|STARTED|After Booster||135
10430703|NCT00871338|11576820|FG000|COMPLETED|After Booster||139
10430704|NCT00871338|11576821|FG001|COMPLETED|After Booster||135
10430705|NCT00871338|11576820|FG000|NOT COMPLETED|After Booster||0
10430706|NCT00871338|11576821|FG001|NOT COMPLETED|After Booster||0
10430707|NCT00871377|11576827|FG000|STARTED|First Intervention (10 Weeks)||3
10430708|NCT00871377|11576828|FG001|STARTED|First Intervention (10 Weeks)||4
10430709|NCT00871377|11576829|FG002|STARTED|First Intervention (10 Weeks)||4
10430710|NCT00871377|11576830|FG003|STARTED|First Intervention (10 Weeks)||4
10430711|NCT00871377|11576831|FG004|STARTED|First Intervention (10 Weeks)||4
10430712|NCT00871377|11576832|FG005|STARTED|First Intervention (10 Weeks)||5
10430713|NCT00871377|11576827|FG000|COMPLETED|First Intervention (10 Weeks)||3
10430714|NCT00871377|11576828|FG001|COMPLETED|First Intervention (10 Weeks)||4
10430715|NCT00871377|11576829|FG002|COMPLETED|First Intervention (10 Weeks)||3
10430716|NCT00871377|11576830|FG003|COMPLETED|First Intervention (10 Weeks)||4
10430717|NCT00871377|11576831|FG004|COMPLETED|First Intervention (10 Weeks)||4
10430718|NCT00871377|11576832|FG005|COMPLETED|First Intervention (10 Weeks)||4
10430719|NCT00871377|11576827|FG000|NOT COMPLETED|First Intervention (10 Weeks)||0
10430720|NCT00871377|11576828|FG001|NOT COMPLETED|First Intervention (10 Weeks)||0
10430721|NCT00871377|11576829|FG002|NOT COMPLETED|First Intervention (10 Weeks)||1
10430722|NCT00871377|11576830|FG003|NOT COMPLETED|First Intervention (10 Weeks)||0
10430723|NCT00871377|11576831|FG004|NOT COMPLETED|First Intervention (10 Weeks)||0
10430724|NCT00871377|11576832|FG005|NOT COMPLETED|First Intervention (10 Weeks)||1
10430725|NCT00871377|11576827|FG000|STARTED|Washout (6 Weeks)||3
10430726|NCT00871377|11576828|FG001|STARTED|Washout (6 Weeks)||4
10430727|NCT00871377|11576829|FG002|STARTED|Washout (6 Weeks)||3
10430728|NCT00871377|11576830|FG003|STARTED|Washout (6 Weeks)||4
10430729|NCT00871377|11576831|FG004|STARTED|Washout (6 Weeks)||4
10430730|NCT00871377|11576832|FG005|STARTED|Washout (6 Weeks)||4
10430731|NCT00871377|11576827|FG000|COMPLETED|Washout (6 Weeks)||2
10430732|NCT00871377|11576828|FG001|COMPLETED|Washout (6 Weeks)||4
10430733|NCT00871377|11576829|FG002|COMPLETED|Washout (6 Weeks)||3
10430734|NCT00871377|11576830|FG003|COMPLETED|Washout (6 Weeks)||4
10430735|NCT00871377|11576831|FG004|COMPLETED|Washout (6 Weeks)||4
10430736|NCT00871377|11576832|FG005|COMPLETED|Washout (6 Weeks)||4
10430737|NCT00871377|11576827|FG000|NOT COMPLETED|Washout (6 Weeks)||1
10430738|NCT00871377|11576828|FG001|NOT COMPLETED|Washout (6 Weeks)||0
10430739|NCT00871377|11576829|FG002|NOT COMPLETED|Washout (6 Weeks)||0
10430740|NCT00871377|11576830|FG003|NOT COMPLETED|Washout (6 Weeks)||0
10430741|NCT00871377|11576831|FG004|NOT COMPLETED|Washout (6 Weeks)||0
10430742|NCT00871377|11576832|FG005|NOT COMPLETED|Washout (6 Weeks)||0
10430743|NCT00871377|11576827|FG000|STARTED|Second Intervention (10 Weeks)||2
10430744|NCT00871377|11576828|FG001|STARTED|Second Intervention (10 Weeks)||4
10430745|NCT00871377|11576829|FG002|STARTED|Second Intervention (10 Weeks)||3
10430746|NCT00871377|11576830|FG003|STARTED|Second Intervention (10 Weeks)||4
10430747|NCT00871377|11576831|FG004|STARTED|Second Intervention (10 Weeks)||4
10430748|NCT00871377|11576832|FG005|STARTED|Second Intervention (10 Weeks)||4
10430749|NCT00871377|11576827|FG000|COMPLETED|Second Intervention (10 Weeks)||2
10430750|NCT00871377|11576828|FG001|COMPLETED|Second Intervention (10 Weeks)||4
10430751|NCT00871377|11576829|FG002|COMPLETED|Second Intervention (10 Weeks)||3
10430752|NCT00871377|11576830|FG003|COMPLETED|Second Intervention (10 Weeks)||4
10430753|NCT00871377|11576831|FG004|COMPLETED|Second Intervention (10 Weeks)||4
10430754|NCT00871377|11576832|FG005|COMPLETED|Second Intervention (10 Weeks)||4
10430755|NCT00871377|11576827|FG000|NOT COMPLETED|Second Intervention (10 Weeks)||0
10430756|NCT00871377|11576828|FG001|NOT COMPLETED|Second Intervention (10 Weeks)||0
10430757|NCT00871377|11576829|FG002|NOT COMPLETED|Second Intervention (10 Weeks)||0
10430758|NCT00871377|11576830|FG003|NOT COMPLETED|Second Intervention (10 Weeks)||0
10430759|NCT00871377|11576831|FG004|NOT COMPLETED|Second Intervention (10 Weeks)||0
10430760|NCT00871377|11576832|FG005|NOT COMPLETED|Second Intervention (10 Weeks)||0
10430761|NCT00871377|11576827|FG000|STARTED|Washout (6 Weeks)||2
10430762|NCT00871377|11576828|FG001|STARTED|Washout (6 Weeks)||4
10430763|NCT00871377|11576829|FG002|STARTED|Washout (6 Weeks)||3
10430764|NCT00871377|11576830|FG003|STARTED|Washout (6 Weeks)||4
10430765|NCT00871377|11576831|FG004|STARTED|Washout (6 Weeks)||4
10430766|NCT00871377|11576832|FG005|STARTED|Washout (6 Weeks)||4
10430767|NCT00871377|11576827|FG000|COMPLETED|Washout (6 Weeks)||2
10430768|NCT00871377|11576828|FG001|COMPLETED|Washout (6 Weeks)||4
10430769|NCT00871377|11576829|FG002|COMPLETED|Washout (6 Weeks)||3
10430770|NCT00871377|11576830|FG003|COMPLETED|Washout (6 Weeks)||4
10430771|NCT00871377|11576831|FG004|COMPLETED|Washout (6 Weeks)||4
10430772|NCT00871377|11576832|FG005|COMPLETED|Washout (6 Weeks)||3
10430773|NCT00871377|11576827|FG000|NOT COMPLETED|Washout (6 Weeks)||0
10430774|NCT00871377|11576828|FG001|NOT COMPLETED|Washout (6 Weeks)||0
10430775|NCT00871377|11576829|FG002|NOT COMPLETED|Washout (6 Weeks)||0
10430776|NCT00871377|11576830|FG003|NOT COMPLETED|Washout (6 Weeks)||0
10430777|NCT00871377|11576831|FG004|NOT COMPLETED|Washout (6 Weeks)||0
10430778|NCT00871377|11576832|FG005|NOT COMPLETED|Washout (6 Weeks)||1
10430779|NCT00871377|11576827|FG000|STARTED|Third Intervention (10 Weeks)||2
10430780|NCT00871377|11576828|FG001|STARTED|Third Intervention (10 Weeks)||4
10430781|NCT00871377|11576829|FG002|STARTED|Third Intervention (10 Weeks)||3
10430782|NCT00871377|11576830|FG003|STARTED|Third Intervention (10 Weeks)||4
10430783|NCT00871377|11576831|FG004|STARTED|Third Intervention (10 Weeks)||4
10430784|NCT00871377|11576832|FG005|STARTED|Third Intervention (10 Weeks)||3
10430785|NCT00871377|11576827|FG000|COMPLETED|Third Intervention (10 Weeks)||2
10430786|NCT00871377|11576828|FG001|COMPLETED|Third Intervention (10 Weeks)||4
10430787|NCT00871377|11576829|FG002|COMPLETED|Third Intervention (10 Weeks)||3
10430788|NCT00871377|11576830|FG003|COMPLETED|Third Intervention (10 Weeks)||3
10430789|NCT00871377|11576831|FG004|COMPLETED|Third Intervention (10 Weeks)||4
10430790|NCT00871377|11576832|FG005|COMPLETED|Third Intervention (10 Weeks)||3
10430791|NCT00871377|11576827|FG000|NOT COMPLETED|Third Intervention (10 Weeks)||0
10430792|NCT00871377|11576828|FG001|NOT COMPLETED|Third Intervention (10 Weeks)||0
10430793|NCT00871377|11576829|FG002|NOT COMPLETED|Third Intervention (10 Weeks)||0
10430794|NCT00871377|11576830|FG003|NOT COMPLETED|Third Intervention (10 Weeks)||1
10430795|NCT00871377|11576831|FG004|NOT COMPLETED|Third Intervention (10 Weeks)||0
10430796|NCT00871377|11576832|FG005|NOT COMPLETED|Third Intervention (10 Weeks)||0
10430797|NCT00871403|11576843|FG000|STARTED|Combination Treatment Phase||9
10430798|NCT00871403|11576844|FG001|STARTED|Combination Treatment Phase||62
10430799|NCT00871403|11576845|FG002|STARTED|Combination Treatment Phase||35
10430800|NCT00871403|11576843|FG000|COMPLETED|Combination Treatment Phase|No particiapants completed Combination Treatement.|0
10430801|NCT00871403|11576844|FG001|COMPLETED|Combination Treatment Phase|These participants completed combination treatment|13
10430802|NCT00871403|11576845|FG002|COMPLETED|Combination Treatment Phase|These participants completed combination treatment|23
10430803|NCT00871403|11576843|FG000|NOT COMPLETED|Combination Treatment Phase||9
10430804|NCT00871403|11576844|FG001|NOT COMPLETED|Combination Treatment Phase||49
10430805|NCT00871403|11576845|FG002|NOT COMPLETED|Combination Treatment Phase||12
10430806|NCT00871403|11576843|FG000|STARTED|Monotherapy Treatment Phase||0
10430807|NCT00871403|11576844|FG001|STARTED|Monotherapy Treatment Phase||13
10430808|NCT00871403|11576845|FG002|STARTED|Monotherapy Treatment Phase||1
10430809|NCT00871403|11576843|FG000|COMPLETED|Monotherapy Treatment Phase||0
10430810|NCT00871403|11576844|FG001|COMPLETED|Monotherapy Treatment Phase||0
10430811|NCT00871403|11576845|FG002|COMPLETED|Monotherapy Treatment Phase||0
10430812|NCT00871403|11576843|FG000|NOT COMPLETED|Monotherapy Treatment Phase||0
10430813|NCT00871403|11576844|FG001|NOT COMPLETED|Monotherapy Treatment Phase||13
10430814|NCT00871403|11576845|FG002|NOT COMPLETED|Monotherapy Treatment Phase||1
10430815|NCT00871429|11576852|FG000|STARTED|Overall Study||99
10430816|NCT00871429|11576852|FG000|COMPLETED|Overall Study||75
10430817|NCT00871429|11576852|FG000|NOT COMPLETED|Overall Study||24
10430818|NCT00871494|11576860|FG000|STARTED|Overall Study||76
10430819|NCT00871494|11576860|FG000|COMPLETED|Overall Study||62
10430820|NCT00871494|11576860|FG000|NOT COMPLETED|Overall Study||14
10430821|NCT00871572|11576868|FG000|STARTED|Overall Study||10
10430822|NCT00871572|11576869|FG001|STARTED|Overall Study||17
10430823|NCT00871572|11576870|FG002|STARTED|Overall Study||34
10430824|NCT00871572|11576871|FG003|STARTED|Overall Study||26
10430825|NCT00871572|11576868|FG000|≥1 Post Baseline Value by Assigned Group|Overall Study||9
10430826|NCT00871572|11576869|FG001|≥1 Post Baseline Value by Assigned Group|Overall Study||17
10430827|NCT00871572|11576870|FG002|≥1 Post Baseline Value by Assigned Group|Overall Study||34
10430828|NCT00871572|11576871|FG003|≥1 Post Baseline Value by Assigned Group|Overall Study||25
10430829|NCT00871572|11576868|FG000|Received at Least 1 Dose of Study Drug|Overall Study||9
10430830|NCT00871572|11576869|FG001|Received at Least 1 Dose of Study Drug|Overall Study||17
10430831|NCT00871572|11576870|FG002|Received at Least 1 Dose of Study Drug|Overall Study||34
10430832|NCT00871572|11576871|FG003|Received at Least 1 Dose of Study Drug|Overall Study||25
10430833|NCT00871572|11576868|FG000|COMPLETED|Overall Study||8
10430834|NCT00871572|11576869|FG001|COMPLETED|Overall Study||11
10430835|NCT00871572|11576870|FG002|COMPLETED|Overall Study||30
10430836|NCT00871572|11576871|FG003|COMPLETED|Overall Study||19
10430837|NCT00871572|11576868|FG000|NOT COMPLETED|Overall Study||2
10430838|NCT00871572|11576869|FG001|NOT COMPLETED|Overall Study||6
10430839|NCT00871572|11576870|FG002|NOT COMPLETED|Overall Study||4
10430840|NCT00871572|11576871|FG003|NOT COMPLETED|Overall Study||7
10430841|NCT00871624|11576883|FG000|STARTED|Overall Study||18
10430842|NCT00871624|11576884|FG001|STARTED|Overall Study||18
10430843|NCT00871624|11576883|FG000|COMPLETED|Overall Study||16
10430844|NCT00871624|11576884|FG001|COMPLETED|Overall Study||17
10430845|NCT00871624|11576883|FG000|NOT COMPLETED|Overall Study||2
10430846|NCT00871624|11576884|FG001|NOT COMPLETED|Overall Study||1
10430847|NCT00871689|11576892|FG000|STARTED|Overall Study||2
10430848|NCT00871689|11576892|FG000|COMPLETED|Overall Study||2
10430849|NCT00871689|11576892|FG000|NOT COMPLETED|Overall Study||0
10430850|NCT00871715|11576899|FG000|STARTED|Overall Study||119
10430851|NCT00871715|11576900|FG001|STARTED|Overall Study||120
10430852|NCT00871715|11576901|FG002|STARTED|Overall Study||122
10430853|NCT00871715|11576899|FG000|Post-Intervention|Overall Study||112
10430854|NCT00871715|11576900|FG001|Post-Intervention|Overall Study||115
10430855|NCT00871715|11576901|FG002|Post-Intervention|Overall Study||115
10430856|NCT00871715|11576899|FG000|6-mo Follow-up|Overall Study||110
10430857|NCT00871715|11576900|FG001|6-mo Follow-up|Overall Study||113
10430858|NCT00871715|11576901|FG002|6-mo Follow-up|Overall Study||112
10430859|NCT00871715|11576899|FG000|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|104
10430860|NCT00871715|11576900|FG001|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|104
10430861|NCT00871715|11576901|FG002|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|96
10430862|NCT00871715|11576899|FG000|NOT COMPLETED|Overall Study||15
10430863|NCT00871715|11576900|FG001|NOT COMPLETED|Overall Study||16
10430864|NCT00871715|11576901|FG002|NOT COMPLETED|Overall Study||26
10430865|NCT00871728|11576910|FG000|STARTED|Overall Study||132
10430866|NCT00871728|11576910|FG000|Treated|Overall Study||130
10430867|NCT00871728|11576910|FG000|COMPLETED|Overall Study||112
10430868|NCT00871728|11576910|FG000|NOT COMPLETED|Overall Study||20
10430869|NCT00871741|11576916|FG000|STARTED|Overall Study||9
10430870|NCT00871741|11576917|FG001|STARTED|Overall Study||7
10430871|NCT00871741|11576916|FG000|COMPLETED|Overall Study||0
10430872|NCT00871741|11576917|FG001|COMPLETED|Overall Study||0
10430873|NCT00871741|11576916|FG000|NOT COMPLETED|Overall Study||9
10430874|NCT00871741|11576917|FG001|NOT COMPLETED|Overall Study||7
10430875|NCT00871780|11576923|FG000|STARTED|Overall Study|number enrolled|224
10430876|NCT00871780|11576923|FG000|Safety Analysis Population|Overall Study|participants who had ≥1 infusion of natalizumab during the study|218
10430877|NCT00871780|11576923|FG000|Efficacy Analysis Population|Overall Study|participants who had ≥1 infusion of natalizumab and completed at least 1 on-treatment evaluation|215
10430878|NCT00871780|11576923|FG000|COMPLETED|Overall Study||197
10430879|NCT00871780|11576923|FG000|NOT COMPLETED|Overall Study||27
10430880|NCT00871819|11576930|FG000|STARTED|Overall Study||20
10430881|NCT00871819|11576930|FG000|COMPLETED|Overall Study||20
10430882|NCT00871819|11576930|FG000|NOT COMPLETED|Overall Study||0
10430883|NCT00871845|11576936|FG000|STARTED|Overall Study||11
10430884|NCT00871845|11576937|FG001|STARTED|Overall Study||25
10430885|NCT00871845|11576936|FG000|COMPLETED|Overall Study||11
10430886|NCT00871845|11576937|FG001|COMPLETED|Overall Study||25
10430887|NCT00871845|11576936|FG000|NOT COMPLETED|Overall Study||0
10430888|NCT00871845|11576937|FG001|NOT COMPLETED|Overall Study||0
10430889|NCT00871858|11576949|FG000|STARTED|Overall Study||61
10430890|NCT00871858|11576950|FG001|STARTED|Overall Study||59
10430891|NCT00871858|11576949|FG000|Evaluable for Safety|Overall Study|1 patient refused to continue study and therefore did not received treatment.|60
10430892|NCT00871858|11576950|FG001|Evaluable for Safety|Overall Study|1 patient refused to continue study after randomization and therefore did not received treatment.|58
10430893|NCT00871858|11576949|FG000|COMPLETED|Overall Study||56
10430894|NCT00871858|11576950|FG001|COMPLETED|Overall Study||52
10430895|NCT00871858|11576949|FG000|NOT COMPLETED|Overall Study||5
10430896|NCT00871858|11576950|FG001|NOT COMPLETED|Overall Study||7
10430897|NCT00871871|11576958|FG000|STARTED|Part I||18
10430898|NCT00871871|11576959|FG001|STARTED|Part I||18
10430899|NCT00871871|11576960|FG002|STARTED|Part I||0
10430900|NCT00871871|11576961|FG003|STARTED|Part I||0
10430901|NCT00871871|11576958|FG000|COMPLETED|Part I||15
10430902|NCT00871871|11576959|FG001|COMPLETED|Part I||15
10430903|NCT00871871|11576960|FG002|COMPLETED|Part I||0
10430904|NCT00871871|11576961|FG003|COMPLETED|Part I||0
10430905|NCT00871871|11576958|FG000|NOT COMPLETED|Part I||3
10430906|NCT00871871|11576959|FG001|NOT COMPLETED|Part I||3
10430907|NCT00871871|11576960|FG002|NOT COMPLETED|Part I||0
10430908|NCT00871871|11576961|FG003|NOT COMPLETED|Part I||0
10430909|NCT00871871|11576958|FG000|STARTED|Part II||0
10430910|NCT00871871|11576959|FG001|STARTED|Part II||0
10430911|NCT00871871|11576960|FG002|STARTED|Part II||13
10430912|NCT00871871|11576961|FG003|STARTED|Part II||15
10430913|NCT00871871|11576958|FG000|COMPLETED|Part II||0
10430914|NCT00871871|11576959|FG001|COMPLETED|Part II||0
10430915|NCT00871871|11576960|FG002|COMPLETED|Part II||9
10430916|NCT00871871|11576961|FG003|COMPLETED|Part II||11
10430917|NCT00871871|11576958|FG000|NOT COMPLETED|Part II||0
10430918|NCT00871871|11576959|FG001|NOT COMPLETED|Part II||0
10430919|NCT00871871|11576960|FG002|NOT COMPLETED|Part II||4
10430920|NCT00871871|11576961|FG003|NOT COMPLETED|Part II||4
10430921|NCT00871923|11576971|FG000|STARTED|Overall Study||44
10430922|NCT00871923|11576971|FG000|COMPLETED|Overall Study||42
10430923|NCT00871923|11576971|FG000|NOT COMPLETED|Overall Study||2
10430924|NCT00871975|11576975|FG000|STARTED|Overall Study||155
10430925|NCT00871975|11576975|FG000|COMPLETED|Overall Study||133
10430926|NCT00871975|11576975|FG000|NOT COMPLETED|Overall Study||22
10430927|NCT00872001|11576981|FG000|STARTED|Overall Study||1536
10430928|NCT00872001|11576982|FG001|STARTED|Overall Study||1544
10430929|NCT00872001|11576981|FG000|COMPLETED|Overall Study||1400
10430930|NCT00872001|11576982|FG001|COMPLETED|Overall Study||1413
10430931|NCT00872001|11576981|FG000|NOT COMPLETED|Overall Study||136
10430932|NCT00872001|11576982|FG001|NOT COMPLETED|Overall Study||131
10430933|NCT00872027|11576992|FG000|STARTED|Overall Study||7
10430934|NCT00872027|11576993|FG001|STARTED|Overall Study||8
10430935|NCT00872027|11576992|FG000|COMPLETED|Overall Study||7
10430936|NCT00872027|11576993|FG001|COMPLETED|Overall Study||8
10430937|NCT00872027|11576992|FG000|NOT COMPLETED|Overall Study||0
10430938|NCT00872027|11576993|FG001|NOT COMPLETED|Overall Study||0
10430939|NCT00872079|11576999|FG000|STARTED|Overall Study||175
10430940|NCT00872079|11576999|FG000|COMPLETED|Overall Study||175
10430941|NCT00872079|11576999|FG000|NOT COMPLETED|Overall Study||0
10430942|NCT00872170|11577005|FG000|STARTED|Overall Study||14
10430943|NCT00872170|11577006|FG001|STARTED|Overall Study||13
10430944|NCT00872170|11577005|FG000|COMPLETED|Overall Study|One patient withdrew from study at week 2.|13
10430945|NCT00872170|11577006|FG001|COMPLETED|Overall Study||13
10430946|NCT00872170|11577005|FG000|NOT COMPLETED|Overall Study||1
10430947|NCT00872170|11577006|FG001|NOT COMPLETED|Overall Study||0
10430948|NCT00872339|11577014|FG000|STARTED|Overall Study||201
10430949|NCT00872339|11577015|FG001|STARTED|Overall Study||14
10430950|NCT00872339|11577016|FG002|STARTED|Overall Study||37
10430951|NCT00872339|11577014|FG000|COMPLETED|Overall Study||201
10430952|NCT00872339|11577015|FG001|COMPLETED|Overall Study||14
10430953|NCT00872339|11577016|FG002|COMPLETED|Overall Study||37
10430954|NCT00872339|11577014|FG000|NOT COMPLETED|Overall Study||0
10430955|NCT00872339|11577015|FG001|NOT COMPLETED|Overall Study||0
10430956|NCT00872339|11577016|FG002|NOT COMPLETED|Overall Study||0
10430957|NCT00872521|11577027|FG000|STARTED|Completed PAD Induction|Received allocated treatment|26
10430958|NCT00872521|11577028|FG001|STARTED|Completed PAD Induction|Received allocated treatment|72
10430959|NCT00872521|11577029|FG002|STARTED|Completed PAD Induction|Received allocated treatment|9
10430960|NCT00872521|11577027|FG000|COMPLETED|Completed PAD Induction|Completed PAD induction|21
10430961|NCT00872521|11577028|FG001|COMPLETED|Completed PAD Induction|Completed PAD induction|68
10430962|NCT00872521|11577029|FG002|COMPLETED|Completed PAD Induction|Completed PAD induction|9
10430963|NCT00872521|11577027|FG000|NOT COMPLETED|Completed PAD Induction||5
10430964|NCT00872521|11577028|FG001|NOT COMPLETED|Completed PAD Induction||4
10430965|NCT00872521|11577029|FG002|NOT COMPLETED|Completed PAD Induction||0
10430966|NCT00872521|11577027|FG000|STARTED|Primary Endpoint Analysis|Completed PAD induction|21
10430967|NCT00872521|11577028|FG001|STARTED|Primary Endpoint Analysis|Completed PAD induction|68
10430968|NCT00872521|11577029|FG002|STARTED|Primary Endpoint Analysis|Completed PAD induction|9
10430969|NCT00872521|11577027|FG000|COMPLETED|Primary Endpoint Analysis|participants analyzed|20
10430970|NCT00872521|11577028|FG001|COMPLETED|Primary Endpoint Analysis|participants analyzed|63
10430971|NCT00872521|11577029|FG002|COMPLETED|Primary Endpoint Analysis|participants analyzed|8
10430972|NCT00872521|11577027|FG000|NOT COMPLETED|Primary Endpoint Analysis||1
10430973|NCT00872521|11577028|FG001|NOT COMPLETED|Primary Endpoint Analysis||5
10430974|NCT00872521|11577029|FG002|NOT COMPLETED|Primary Endpoint Analysis||1
10430975|NCT00872521|11577027|FG000|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|20
10430976|NCT00872521|11577028|FG001|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|63
10430977|NCT00872521|11577029|FG002|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|8
10430978|NCT00872521|11577027|FG000|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|20
10430979|NCT00872521|11577028|FG001|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|60
10430980|NCT00872521|11577029|FG002|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|8
10430981|NCT00872521|11577027|FG000|NOT COMPLETED|Completed 3-month Follow up||0
10430982|NCT00872521|11577028|FG001|NOT COMPLETED|Completed 3-month Follow up||3
10430983|NCT00872521|11577029|FG002|NOT COMPLETED|Completed 3-month Follow up||0
10430984|NCT00872521|11577027|FG000|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|20
10430985|NCT00872521|11577028|FG001|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|60
10430986|NCT00872521|11577029|FG002|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|8
10430987|NCT00872521|11577027|FG000|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|20
10430988|NCT00872521|11577028|FG001|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|58
10430989|NCT00872521|11577029|FG002|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|7
10430990|NCT00872521|11577027|FG000|NOT COMPLETED|Secondary Endpoint Analysis||0
10430991|NCT00872521|11577028|FG001|NOT COMPLETED|Secondary Endpoint Analysis||2
10430992|NCT00872521|11577029|FG002|NOT COMPLETED|Secondary Endpoint Analysis||1
10430993|NCT00872534|11577050|FG000|STARTED|Overall Study||100
10430994|NCT00872534|11577051|FG001|STARTED|Overall Study||104
10430995|NCT00872534|11577050|FG000|COMPLETED|Overall Study||97
10430996|NCT00872534|11577051|FG001|COMPLETED|Overall Study||101
10430997|NCT00872534|11577050|FG000|NOT COMPLETED|Overall Study||3
10430998|NCT00872534|11577051|FG001|NOT COMPLETED|Overall Study||3
10430999|NCT00872599|11577057|FG000|STARTED|First Washout Period After Low Salt||16
10431000|NCT00872599|11577058|FG001|STARTED|First Washout Period After Low Salt||17
10431001|NCT00872599|11577057|FG000|COMPLETED|First Washout Period After Low Salt||16
10431002|NCT00872599|11577058|FG001|COMPLETED|First Washout Period After Low Salt||17
10431003|NCT00872599|11577057|FG000|NOT COMPLETED|First Washout Period After Low Salt||0
10431004|NCT00872599|11577058|FG001|NOT COMPLETED|First Washout Period After Low Salt||0
10431005|NCT00872599|11577057|FG000|STARTED|First Drug During High Salt Intake||16
10431006|NCT00872599|11577058|FG001|STARTED|First Drug During High Salt Intake||17
10431007|NCT00872599|11577057|FG000|COMPLETED|First Drug During High Salt Intake||16
10431008|NCT00872599|11577058|FG001|COMPLETED|First Drug During High Salt Intake||17
10431009|NCT00872599|11577057|FG000|NOT COMPLETED|First Drug During High Salt Intake||0
10431010|NCT00872599|11577058|FG001|NOT COMPLETED|First Drug During High Salt Intake||0
10431011|NCT00872599|11577057|FG000|STARTED|Second Washout Period||16
10431012|NCT00872599|11577058|FG001|STARTED|Second Washout Period||17
10431013|NCT00872599|11577057|FG000|COMPLETED|Second Washout Period||15
10431014|NCT00872599|11577058|FG001|COMPLETED|Second Washout Period||16
10431015|NCT00872599|11577057|FG000|NOT COMPLETED|Second Washout Period||1
10431016|NCT00872599|11577058|FG001|NOT COMPLETED|Second Washout Period||1
10431017|NCT00872599|11577057|FG000|STARTED|Second Drug During High Salt Intake||15
10431018|NCT00872599|11577058|FG001|STARTED|Second Drug During High Salt Intake||16
10431019|NCT00872599|11577057|FG000|COMPLETED|Second Drug During High Salt Intake||15
10431020|NCT00872599|11577058|FG001|COMPLETED|Second Drug During High Salt Intake||16
10431021|NCT00872599|11577057|FG000|NOT COMPLETED|Second Drug During High Salt Intake||0
10431022|NCT00872599|11577058|FG001|NOT COMPLETED|Second Drug During High Salt Intake||0
10431023|NCT00872729|11577064|FG000|STARTED|Overall Study||9
10431024|NCT00872729|11577064|FG000|COMPLETED|Overall Study||9
10431025|NCT00872729|11577064|FG000|NOT COMPLETED|Overall Study||0
10431026|NCT00872833|11577090|FG000|STARTED|Overall Study||15
10431027|NCT00872833|11577091|FG001|STARTED|Overall Study||17
10431028|NCT00872833|11577090|FG000|COMPLETED|Overall Study||15
10431029|NCT00872833|11577091|FG001|COMPLETED|Overall Study||17
10431030|NCT00872833|11577090|FG000|NOT COMPLETED|Overall Study||0
10431031|NCT00872833|11577091|FG001|NOT COMPLETED|Overall Study||0
10431032|NCT00872898|11577103|FG000|STARTED|Part One - Open Label, Pharmacokinetics||0
10431033|NCT00872898|11577104|FG001|STARTED|Part One - Open Label, Pharmacokinetics||4
10431034|NCT00872898|11577103|FG000|COMPLETED|Part One - Open Label, Pharmacokinetics||0
10431035|NCT00872898|11577104|FG001|COMPLETED|Part One - Open Label, Pharmacokinetics||4
10431036|NCT00872898|11577103|FG000|NOT COMPLETED|Part One - Open Label, Pharmacokinetics||0
10431037|NCT00872898|11577104|FG001|NOT COMPLETED|Part One - Open Label, Pharmacokinetics||0
10431038|NCT00872898|11577103|FG000|STARTED|Part Two - Double Blind||61
10431039|NCT00872898|11577104|FG001|STARTED|Part Two - Double Blind||60
10431040|NCT00872898|11577103|FG000|COMPLETED|Part Two - Double Blind||50
10431041|NCT00872898|11577104|FG001|COMPLETED|Part Two - Double Blind||54
10431042|NCT00872898|11577103|FG000|NOT COMPLETED|Part Two - Double Blind||11
10431043|NCT00872898|11577104|FG001|NOT COMPLETED|Part Two - Double Blind||6
10431044|NCT00872989|11577115|FG000|STARTED|Overall Study||66
10431045|NCT00872989|11577116|FG001|STARTED|Overall Study||63
10431046|NCT00872989|11577115|FG000|COMPLETED|Overall Study||1
10431047|NCT00872989|11577116|FG001|COMPLETED|Overall Study||0
10431048|NCT00872989|11577115|FG000|NOT COMPLETED|Overall Study||65
10431049|NCT00872989|11577116|FG001|NOT COMPLETED|Overall Study||63
10431050|NCT00873015|11577132|FG000|STARTED|Overall Study||9
10431051|NCT00873015|11577133|FG001|STARTED|Overall Study||4
10431052|NCT00873015|11577134|FG002|STARTED|Overall Study||3
10431053|NCT00873015|11577135|FG003|STARTED|Overall Study||3
10431054|NCT00873015|11577132|FG000|COMPLETED|Overall Study||9
10431055|NCT00873015|11577133|FG001|COMPLETED|Overall Study||3
10431056|NCT00873015|11577134|FG002|COMPLETED|Overall Study||3
10431057|NCT00873015|11577135|FG003|COMPLETED|Overall Study||3
10431058|NCT00873015|11577132|FG000|NOT COMPLETED|Overall Study||0
10431059|NCT00873015|11577133|FG001|NOT COMPLETED|Overall Study||1
10431060|NCT00873015|11577134|FG002|NOT COMPLETED|Overall Study||0
10431061|NCT00873015|11577135|FG003|NOT COMPLETED|Overall Study||0
10431062|NCT00873041|11577147|FG000|STARTED|Core Study||55
10431063|NCT00873041|11577148|FG001|STARTED|Core Study||55
10431064|NCT00873041|11577149|FG002|STARTED|Core Study||56
10431065|NCT00873041|11577147|FG000|COMPLETED|Core Study||48
10431066|NCT00873041|11577148|FG001|COMPLETED|Core Study||49
10431067|NCT00873041|11577149|FG002|COMPLETED|Core Study||51
10431068|NCT00873041|11577147|FG000|NOT COMPLETED|Core Study||7
10431069|NCT00873041|11577148|FG001|NOT COMPLETED|Core Study||6
10431070|NCT00873041|11577149|FG002|NOT COMPLETED|Core Study||5
10431071|NCT00873041|11577147|FG000|STARTED|Extension Study||41
10431072|NCT00873041|11577148|FG001|STARTED|Extension Study||44
10431073|NCT00873041|11577149|FG002|STARTED|Extension Study||48
10431074|NCT00873041|11577147|FG000|COMPLETED|Extension Study||40
10431075|NCT00873041|11577148|FG001|COMPLETED|Extension Study||44
10431076|NCT00873041|11577149|FG002|COMPLETED|Extension Study||46
10431077|NCT00873041|11577147|FG000|NOT COMPLETED|Extension Study||1
10431078|NCT00873041|11577148|FG001|NOT COMPLETED|Extension Study||0
10431079|NCT00873041|11577149|FG002|NOT COMPLETED|Extension Study||2
10431080|NCT00873093|11577169|FG000|STARTED|Overall Study||4
10431081|NCT00873093|11577170|FG001|STARTED|Overall Study||62
10431082|NCT00873093|11577171|FG002|STARTED|Overall Study||49
10431083|NCT00873093|11577172|FG003|STARTED|Overall Study||23
10431084|NCT00873093|11577173|FG004|STARTED|Overall Study||10
10431085|NCT00873093|11577169|FG000|COMPLETED|Overall Study||3
10431086|NCT00873093|11577170|FG001|COMPLETED|Overall Study||35
10431087|NCT00873093|11577171|FG002|COMPLETED|Overall Study||33
10431088|NCT00873093|11577172|FG003|COMPLETED|Overall Study||12
10431089|NCT00873093|11577173|FG004|COMPLETED|Overall Study||8
10431090|NCT00873093|11577169|FG000|NOT COMPLETED|Overall Study||1
10431091|NCT00873093|11577170|FG001|NOT COMPLETED|Overall Study||27
10431092|NCT00873093|11577171|FG002|NOT COMPLETED|Overall Study||16
10431093|NCT00873093|11577172|FG003|NOT COMPLETED|Overall Study||11
10431094|NCT00873093|11577173|FG004|NOT COMPLETED|Overall Study||2
10431095|NCT00873119|11577197|FG000|STARTED|Overall Study||44
10431096|NCT00873119|11577198|FG001|STARTED|Overall Study||45
10431097|NCT00873119|11577197|FG000|COMPLETED|Overall Study|Of 42 patients treated with belinostat, 23 patients received 6 or more treatment cycles.|0
10431098|NCT00873119|11577198|FG001|COMPLETED|Overall Study||19
10431099|NCT00873119|11577197|FG000|NOT COMPLETED|Overall Study||44
10431100|NCT00873119|11577198|FG001|NOT COMPLETED|Overall Study||26
10431101|NCT00873327|11577204|FG000|STARTED|Overall Study||32
10431102|NCT00873327|11577204|FG000|COMPLETED|Overall Study||32
10431103|NCT00873327|11577204|FG000|NOT COMPLETED|Overall Study||0
10431104|NCT00873457|11577208|FG000|STARTED|Overall Study||16
10431105|NCT00873457|11577208|FG000|COMPLETED|Overall Study||16
10431106|NCT00873457|11577208|FG000|NOT COMPLETED|Overall Study||0
10431107|NCT00873730|11577214|FG000|STARTED|Overall Study||54
10431108|NCT00873730|11577215|FG001|STARTED|Overall Study||54
10431109|NCT00873730|11577214|FG000|COMPLETED|Overall Study||48
10431110|NCT00873730|11577215|FG001|COMPLETED|Overall Study||49
10431111|NCT00873730|11577214|FG000|NOT COMPLETED|Overall Study||6
10431112|NCT00873730|11577215|FG001|NOT COMPLETED|Overall Study||5
10431113|NCT00873782|11577221|FG000|STARTED|Overall Study||16
10431114|NCT00873782|11577221|FG000|COMPLETED|Overall Study||16
10431115|NCT00873782|11577221|FG000|NOT COMPLETED|Overall Study||0
10431116|NCT00873821|11577227|FG000|STARTED|Overall Study||22
10431117|NCT00873821|11577228|FG001|STARTED|Overall Study||22
10431118|NCT00873821|11577227|FG000|COMPLETED|Overall Study||22
10431119|NCT00873821|11577228|FG001|COMPLETED|Overall Study||22
10431120|NCT00873821|11577227|FG000|NOT COMPLETED|Overall Study||0
10431121|NCT00873821|11577228|FG001|NOT COMPLETED|Overall Study||0
10431122|NCT00873860|11577238|FG000|STARTED|Overall Study||48
10431123|NCT00873860|11577239|FG001|STARTED|Overall Study||47
10431124|NCT00873860|11577240|FG002|STARTED|Overall Study||51
10431125|NCT00873860|11577241|FG003|STARTED|Overall Study||48
10431126|NCT00873860|11577238|FG000|Treated|Overall Study||47
10431127|NCT00873860|11577239|FG001|Treated|Overall Study||47
10431128|NCT00873860|11577240|FG002|Treated|Overall Study||51
10431129|NCT00873860|11577241|FG003|Treated|Overall Study||48
10431130|NCT00873860|11577238|FG000|COMPLETED|Overall Study||44
10431131|NCT00873860|11577239|FG001|COMPLETED|Overall Study||47
10431132|NCT00873860|11577240|FG002|COMPLETED|Overall Study||48
10431133|NCT00873860|11577241|FG003|COMPLETED|Overall Study||47
10431134|NCT00873860|11577238|FG000|NOT COMPLETED|Overall Study||4
10431135|NCT00873860|11577239|FG001|NOT COMPLETED|Overall Study||0
10431136|NCT00873860|11577240|FG002|NOT COMPLETED|Overall Study||3
10431137|NCT00873860|11577241|FG003|NOT COMPLETED|Overall Study||1
10431138|NCT00873873|11577258|FG000|STARTED|Overall Study||20
10431139|NCT00873873|11577259|FG001|STARTED|Overall Study||8
10431140|NCT00873873|11577260|FG002|STARTED|Overall Study||9
10431141|NCT00873873|11577261|FG003|STARTED|Overall Study||18
10431142|NCT00873873|11577258|FG000|COMPLETED|Overall Study||20
10431143|NCT00873873|11577259|FG001|COMPLETED|Overall Study||8
10431144|NCT00873873|11577260|FG002|COMPLETED|Overall Study||9
10431145|NCT00873873|11577261|FG003|COMPLETED|Overall Study||18
10431146|NCT00873873|11577258|FG000|NOT COMPLETED|Overall Study||0
10431147|NCT00873873|11577259|FG001|NOT COMPLETED|Overall Study||0
10431148|NCT00873873|11577260|FG002|NOT COMPLETED|Overall Study||0
10431149|NCT00873873|11577261|FG003|NOT COMPLETED|Overall Study||0
10431150|NCT00873912|11577273|FG000|STARTED|Overall Study||240
10431151|NCT00873912|11577274|FG001|STARTED|Overall Study||60
10431152|NCT00873912|11577273|FG000|COMPLETED|Overall Study||237
10431153|NCT00873912|11577274|FG001|COMPLETED|Overall Study||60
10431154|NCT00873912|11577273|FG000|NOT COMPLETED|Overall Study||3
10431155|NCT00873912|11577274|FG001|NOT COMPLETED|Overall Study||0
10431156|NCT00874029|11577280|FG000|STARTED|Overall Study||137
10431157|NCT00874029|11577280|FG000|COMPLETED|Overall Study||116
10431158|NCT00874029|11577280|FG000|NOT COMPLETED|Overall Study||21
10431159|NCT00874094|11577294|FG000|STARTED|Overall Study||15
10431160|NCT00874094|11577294|FG000|COMPLETED|Overall Study||15
10431161|NCT00874094|11577294|FG000|NOT COMPLETED|Overall Study||0
10431162|NCT00874120|11577300|FG000|STARTED|First Intervention||58
10431163|NCT00874120|11577301|FG001|STARTED|First Intervention||58
10431164|NCT00874120|11577300|FG000|COMPLETED|First Intervention||52
10431165|NCT00874120|11577301|FG001|COMPLETED|First Intervention||56
10431166|NCT00874120|11577300|FG000|NOT COMPLETED|First Intervention||6
10431167|NCT00874120|11577301|FG001|NOT COMPLETED|First Intervention||2
10431168|NCT00874120|11577300|FG000|STARTED|Wash-out Period||52
10431169|NCT00874120|11577301|FG001|STARTED|Wash-out Period||56
10431170|NCT00874120|11577300|FG000|COMPLETED|Wash-out Period||52
10431171|NCT00874120|11577301|FG001|COMPLETED|Wash-out Period||56
10431172|NCT00874120|11577300|FG000|NOT COMPLETED|Wash-out Period||0
10431173|NCT00874120|11577301|FG001|NOT COMPLETED|Wash-out Period||0
10431174|NCT00874120|11577300|FG000|STARTED|Second Intervention||52
10431175|NCT00874120|11577301|FG001|STARTED|Second Intervention||56
10431176|NCT00874120|11577300|FG000|COMPLETED|Second Intervention||50
10431177|NCT00874120|11577301|FG001|COMPLETED|Second Intervention||56
10431178|NCT00874120|11577300|FG000|NOT COMPLETED|Second Intervention||2
10431179|NCT00874120|11577301|FG001|NOT COMPLETED|Second Intervention||0
10431180|NCT00874237|11577307|FG000|STARTED|Overall Study||8
10431181|NCT00874237|11577308|FG001|STARTED|Overall Study||8
10431182|NCT00874237|11577309|FG002|STARTED|Overall Study||8
10431183|NCT00874237|11577310|FG003|STARTED|Overall Study||8
10431184|NCT00874237|11577311|FG004|STARTED|Overall Study||8
10431185|NCT00874237|11577312|FG005|STARTED|Overall Study||8
10431186|NCT00874237|11577307|FG000|COMPLETED|Overall Study||8
10431187|NCT00874237|11577308|FG001|COMPLETED|Overall Study||7
10431188|NCT00874237|11577309|FG002|COMPLETED|Overall Study||7
10431189|NCT00874237|11577310|FG003|COMPLETED|Overall Study||8
10431190|NCT00874237|11577311|FG004|COMPLETED|Overall Study||8
10431191|NCT00874237|11577312|FG005|COMPLETED|Overall Study||8
10431192|NCT00874237|11577307|FG000|NOT COMPLETED|Overall Study||0
10431193|NCT00874237|11577308|FG001|NOT COMPLETED|Overall Study||1
10431194|NCT00874237|11577309|FG002|NOT COMPLETED|Overall Study||1
10431195|NCT00874237|11577310|FG003|NOT COMPLETED|Overall Study||0
10431196|NCT00874237|11577311|FG004|NOT COMPLETED|Overall Study||0
10431197|NCT00874237|11577312|FG005|NOT COMPLETED|Overall Study||0
10431198|NCT00874250|11577322|FG000|STARTED|Overall Study||51
10431199|NCT00874250|11577322|FG000|COMPLETED|Overall Study||0
10431200|NCT00874250|11577322|FG000|NOT COMPLETED|Overall Study||51
10431201|NCT00874276|11577329|FG000|STARTED|Overall Study||6
10431202|NCT00874276|11577330|FG001|STARTED|Overall Study||8
10431203|NCT00874276|11577329|FG000|COMPLETED|Overall Study||5
10431204|NCT00874276|11577330|FG001|COMPLETED|Overall Study||7
10431205|NCT00874276|11577329|FG000|NOT COMPLETED|Overall Study||1
10431206|NCT00874276|11577330|FG001|NOT COMPLETED|Overall Study||1
10431207|NCT00874432|11577342|FG000|STARTED|Overall Study||8
10431208|NCT00874432|11577343|FG001|STARTED|Overall Study||4
10431209|NCT00874432|11577344|FG002|STARTED|Overall Study||17
10431210|NCT00874432|11577345|FG003|STARTED|Overall Study||14
10431211|NCT00874432|11577342|FG000|COMPLETED|Overall Study||5
10431212|NCT00874432|11577343|FG001|COMPLETED|Overall Study||2
10431213|NCT00874432|11577344|FG002|COMPLETED|Overall Study||9
10431214|NCT00874432|11577345|FG003|COMPLETED|Overall Study||11
10431215|NCT00874432|11577342|FG000|NOT COMPLETED|Overall Study||3
10431216|NCT00874432|11577343|FG001|NOT COMPLETED|Overall Study||2
10431217|NCT00874432|11577344|FG002|NOT COMPLETED|Overall Study||8
10431218|NCT00874432|11577345|FG003|NOT COMPLETED|Overall Study||3
10431219|NCT00874497|11577359|FG000|STARTED|Overall Study|This is the number of participants who were treated and were considered as safety population.|51
10431220|NCT00874497|11577360|FG001|STARTED|Overall Study|This is the number of participants who were treated and were considered as safety population.|33
10431221|NCT00874497|11577359|FG000|COMPLETED|Overall Study||23
10431222|NCT00874497|11577360|FG001|COMPLETED|Overall Study||15
10431223|NCT00874497|11577359|FG000|NOT COMPLETED|Overall Study||28
10431224|NCT00874497|11577360|FG001|NOT COMPLETED|Overall Study||18
10431225|NCT00874510|11577368|FG000|STARTED|Year 1||88
10431226|NCT00874510|11577369|FG001|STARTED|Year 1||85
10431227|NCT00874510|11577368|FG000|COMPLETED|Year 1||88
10431228|NCT00874510|11577369|FG001|COMPLETED|Year 1||85
10431229|NCT00874510|11577368|FG000|NOT COMPLETED|Year 1||0
10431230|NCT00874510|11577369|FG001|NOT COMPLETED|Year 1||0
10431231|NCT00874510|11577368|FG000|STARTED|Year 2||92
10431232|NCT00874510|11577369|FG001|STARTED|Year 2||87
10431233|NCT00874510|11577368|FG000|COMPLETED|Year 2||92
10431234|NCT00874510|11577369|FG001|COMPLETED|Year 2||87
10431235|NCT00874510|11577368|FG000|NOT COMPLETED|Year 2||0
10431236|NCT00874510|11577369|FG001|NOT COMPLETED|Year 2||0
10431237|NCT00874549|11577379|FG000|STARTED|Overall Study||51
10431238|NCT00874549|11577380|FG001|STARTED|Overall Study||56
10431239|NCT00874549|11577381|FG002|STARTED|Overall Study||51
10431240|NCT00874549|11577382|FG003|STARTED|Overall Study||58
10431241|NCT00874549|11577379|FG000|COMPLETED|Overall Study||50
10431242|NCT00874549|11577380|FG001|COMPLETED|Overall Study||55
10431243|NCT00874549|11577381|FG002|COMPLETED|Overall Study||47
10431244|NCT00874549|11577382|FG003|COMPLETED|Overall Study||56
10431245|NCT00874549|11577379|FG000|NOT COMPLETED|Overall Study||1
10431246|NCT00874549|11577380|FG001|NOT COMPLETED|Overall Study||1
10431247|NCT00874549|11577381|FG002|NOT COMPLETED|Overall Study||4
10431248|NCT00874549|11577382|FG003|NOT COMPLETED|Overall Study||2
10431249|NCT00874614|11577392|FG000|STARTED|Overall Study||74
10431250|NCT00874614|11577392|FG000|Received at Least One Therapeutic Dose|Overall Study||68
10431251|NCT00874614|11577392|FG000|Received Two Therapeutic Doses|Overall Study||50
10431252|NCT00874614|11577392|FG000|COMPLETED|Overall Study|As of December 2017|16
10431253|NCT00874614|11577392|FG000|NOT COMPLETED|Overall Study||58
10431254|NCT00874731|11577398|FG000|STARTED|Part 1, Day 1: Placebo||23
10431255|NCT00874731|11577399|FG001|STARTED|Part 1, Day 1: Placebo||0
10431256|NCT00874731|11577400|FG002|STARTED|Part 1, Day 1: Placebo||0
10431257|NCT00874731|11577398|FG000|COMPLETED|Part 1, Day 1: Placebo||22
10431258|NCT00874731|11577399|FG001|COMPLETED|Part 1, Day 1: Placebo||0
10431259|NCT00874731|11577400|FG002|COMPLETED|Part 1, Day 1: Placebo||0
10431260|NCT00874731|11577398|FG000|NOT COMPLETED|Part 1, Day 1: Placebo||1
10431261|NCT00874731|11577399|FG001|NOT COMPLETED|Part 1, Day 1: Placebo||0
10431262|NCT00874731|11577400|FG002|NOT COMPLETED|Part 1, Day 1: Placebo||0
10431263|NCT00874731|11577398|FG000|STARTED|Part 1, Day 2: Ridaforolimus 100 mg|"Participants completing Pt 1, Day 1, enter into the Pt 1, Day 2. Ridaforolimus 100 mg arm."|0
10431264|NCT00874731|11577399|FG001|STARTED|Part 1, Day 2: Ridaforolimus 100 mg|"Participants completing Pt 1, Day 1, started this period in Pt 1, Day 2. Ridaforolimus 100 mg arm."|22
10431265|NCT00874731|11577400|FG002|STARTED|Part 1, Day 2: Ridaforolimus 100 mg||0
10431266|NCT00874731|11577398|FG000|COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
10431267|NCT00874731|11577399|FG001|COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||22
10431268|NCT00874731|11577400|FG002|COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
10431269|NCT00874731|11577398|FG000|NOT COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
10431270|NCT00874731|11577399|FG001|NOT COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
10431271|NCT00874731|11577400|FG002|NOT COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
10431272|NCT00874731|11577398|FG000|STARTED|Washout Period||0
10431273|NCT00874731|11577399|FG001|STARTED|Washout Period||22
10431274|NCT00874731|11577400|FG002|STARTED|Washout Period||0
10431275|NCT00874731|11577398|FG000|COMPLETED|Washout Period||0
10431276|NCT00874731|11577399|FG001|COMPLETED|Washout Period||22
10431277|NCT00874731|11577400|FG002|COMPLETED|Washout Period||0
10431278|NCT00874731|11577398|FG000|NOT COMPLETED|Washout Period||0
10431279|NCT00874731|11577399|FG001|NOT COMPLETED|Washout Period||0
10431280|NCT00874731|11577400|FG002|NOT COMPLETED|Washout Period||0
10431281|NCT00874731|11577398|FG000|STARTED|Part 2: Ridaforolimus 40 mg||0
10431282|NCT00874731|11577399|FG001|STARTED|Part 2: Ridaforolimus 40 mg|"Participants completing Pt 1 and washout, enter into the Pt 2. Ridaforolimus 40 mg arm."|0
10431283|NCT00874731|11577400|FG002|STARTED|Part 2: Ridaforolimus 40 mg|"Participants completing Pt 1 and washout, started this period in Pt 2. Ridaforolimus 40 mg arm."|22
10431284|NCT00874731|11577398|FG000|COMPLETED|Part 2: Ridaforolimus 40 mg||0
10431285|NCT00874731|11577399|FG001|COMPLETED|Part 2: Ridaforolimus 40 mg||0
10431286|NCT00874731|11577400|FG002|COMPLETED|Part 2: Ridaforolimus 40 mg||0
10431287|NCT00874731|11577398|FG000|NOT COMPLETED|Part 2: Ridaforolimus 40 mg||0
10431288|NCT00874731|11577399|FG001|NOT COMPLETED|Part 2: Ridaforolimus 40 mg||0
10431289|NCT00874731|11577400|FG002|NOT COMPLETED|Part 2: Ridaforolimus 40 mg||22
10431290|NCT00874770|11577412|FG000|STARTED|Overall Study||12
10431291|NCT00874770|11577413|FG001|STARTED|Overall Study||12
10431292|NCT00874770|11577414|FG002|STARTED|Overall Study||12
10431293|NCT00874770|11577415|FG003|STARTED|Overall Study||12
10431294|NCT00874770|11577412|FG000|COMPLETED|Overall Study||7
10431295|NCT00874770|11577413|FG001|COMPLETED|Overall Study||11
10431296|NCT00874770|11577414|FG002|COMPLETED|Overall Study||8
10431297|NCT00874770|11577415|FG003|COMPLETED|Overall Study||7
10431298|NCT00874770|11577412|FG000|NOT COMPLETED|Overall Study||5
10431299|NCT00874770|11577413|FG001|NOT COMPLETED|Overall Study||1
10431300|NCT00874770|11577414|FG002|NOT COMPLETED|Overall Study||4
10431301|NCT00874770|11577415|FG003|NOT COMPLETED|Overall Study||5
10431302|NCT00874822|11577435|FG000|STARTED|Overall Study||216
10431303|NCT00874822|11577435|FG000|COMPLETED|Overall Study||208
10431304|NCT00874822|11577435|FG000|NOT COMPLETED|Overall Study||8
10431305|NCT00874848|11577441|FG000|STARTED|Overall Study||59
10431306|NCT00874848|11577442|FG001|STARTED|Overall Study||29
10431307|NCT00874848|11577441|FG000|Discontinued|Overall Study||59
10431308|NCT00874848|11577442|FG001|Discontinued|Overall Study||28
10431309|NCT00874848|11577441|FG000|COMPLETED|Overall Study|Pts who completed 18 tx cycles without progressive disease were defined as completing treatment.|0
10431310|NCT00874848|11577442|FG001|COMPLETED|Overall Study|Pts who completed 18 tx cycles without progressive disease were defined as completing treatment.|1
10431311|NCT00874848|11577441|FG000|NOT COMPLETED|Overall Study||59
10431312|NCT00874848|11577442|FG001|NOT COMPLETED|Overall Study||28
10431313|NCT00874887|11577450|FG000|STARTED|Overall Study||32
10431314|NCT00874887|11577451|FG001|STARTED|Overall Study||34
10431315|NCT00874887|11577450|FG000|COMPLETED|Overall Study||32
10431316|NCT00874887|11577451|FG001|COMPLETED|Overall Study||34
10431317|NCT00874887|11577450|FG000|NOT COMPLETED|Overall Study||0
10431318|NCT00874887|11577451|FG001|NOT COMPLETED|Overall Study||0
10431319|NCT00875017|11577463|FG000|STARTED|First Intervention||5
10431320|NCT00875017|11577464|FG001|STARTED|First Intervention||5
10431321|NCT00875017|11577465|FG002|STARTED|First Intervention||5
10431322|NCT00875017|11577466|FG003|STARTED|First Intervention||6
10431323|NCT00875017|11577467|FG004|STARTED|First Intervention||5
10431324|NCT00875017|11577468|FG005|STARTED|First Intervention||5
10431325|NCT00875017|11577463|FG000|COMPLETED|First Intervention||3
10431326|NCT00875017|11577464|FG001|COMPLETED|First Intervention||5
10431327|NCT00875017|11577465|FG002|COMPLETED|First Intervention||4
10431328|NCT00875017|11577466|FG003|COMPLETED|First Intervention||5
10431329|NCT00875017|11577467|FG004|COMPLETED|First Intervention||4
10431330|NCT00875017|11577468|FG005|COMPLETED|First Intervention||5
10431331|NCT00875017|11577463|FG000|NOT COMPLETED|First Intervention||2
10431332|NCT00875017|11577464|FG001|NOT COMPLETED|First Intervention||0
10431333|NCT00875017|11577465|FG002|NOT COMPLETED|First Intervention||1
10431334|NCT00875017|11577466|FG003|NOT COMPLETED|First Intervention||1
10431335|NCT00875017|11577467|FG004|NOT COMPLETED|First Intervention||1
10431336|NCT00875017|11577468|FG005|NOT COMPLETED|First Intervention||0
10431337|NCT00875017|11577463|FG000|STARTED|Washout||3
10431338|NCT00875017|11577464|FG001|STARTED|Washout||5
10431339|NCT00875017|11577465|FG002|STARTED|Washout||4
10431340|NCT00875017|11577466|FG003|STARTED|Washout||5
10431341|NCT00875017|11577467|FG004|STARTED|Washout||4
10431342|NCT00875017|11577468|FG005|STARTED|Washout||5
10431343|NCT00875017|11577463|FG000|COMPLETED|Washout||3
10431344|NCT00875017|11577464|FG001|COMPLETED|Washout||5
10431345|NCT00875017|11577465|FG002|COMPLETED|Washout||3
10431346|NCT00875017|11577466|FG003|COMPLETED|Washout||5
10431347|NCT00875017|11577467|FG004|COMPLETED|Washout||4
10431348|NCT00875017|11577468|FG005|COMPLETED|Washout||5
10431349|NCT00875017|11577463|FG000|NOT COMPLETED|Washout||0
10431350|NCT00875017|11577464|FG001|NOT COMPLETED|Washout||0
10431351|NCT00875017|11577465|FG002|NOT COMPLETED|Washout||1
10431352|NCT00875017|11577466|FG003|NOT COMPLETED|Washout||0
10431353|NCT00875017|11577467|FG004|NOT COMPLETED|Washout||0
10431354|NCT00875017|11577468|FG005|NOT COMPLETED|Washout||0
10431355|NCT00875017|11577463|FG000|STARTED|Second Intervention||3
10431356|NCT00875017|11577464|FG001|STARTED|Second Intervention||5
10431357|NCT00875017|11577465|FG002|STARTED|Second Intervention||3
10431358|NCT00875017|11577466|FG003|STARTED|Second Intervention||5
10431359|NCT00875017|11577467|FG004|STARTED|Second Intervention||4
10431360|NCT00875017|11577468|FG005|STARTED|Second Intervention||5
10431361|NCT00875017|11577463|FG000|COMPLETED|Second Intervention||3
10431362|NCT00875017|11577464|FG001|COMPLETED|Second Intervention||5
10431363|NCT00875017|11577465|FG002|COMPLETED|Second Intervention||3
10431364|NCT00875017|11577466|FG003|COMPLETED|Second Intervention||4
10431365|NCT00875017|11577467|FG004|COMPLETED|Second Intervention||4
10431366|NCT00875017|11577468|FG005|COMPLETED|Second Intervention||5
10431367|NCT00875017|11577463|FG000|NOT COMPLETED|Second Intervention||0
10431368|NCT00875017|11577464|FG001|NOT COMPLETED|Second Intervention||0
10431369|NCT00875017|11577465|FG002|NOT COMPLETED|Second Intervention||0
10431370|NCT00875017|11577466|FG003|NOT COMPLETED|Second Intervention||1
10431371|NCT00875017|11577467|FG004|NOT COMPLETED|Second Intervention||0
10431372|NCT00875017|11577468|FG005|NOT COMPLETED|Second Intervention||0
10431373|NCT00875017|11577463|FG000|STARTED|Washout||3
10431374|NCT00875017|11577464|FG001|STARTED|Washout||5
10431375|NCT00875017|11577465|FG002|STARTED|Washout||3
10431376|NCT00875017|11577466|FG003|STARTED|Washout||4
10431377|NCT00875017|11577467|FG004|STARTED|Washout||4
10431378|NCT00875017|11577468|FG005|STARTED|Washout||5
10431379|NCT00875017|11577463|FG000|COMPLETED|Washout||3
10431380|NCT00875017|11577464|FG001|COMPLETED|Washout||4
10431381|NCT00875017|11577465|FG002|COMPLETED|Washout||3
10431382|NCT00875017|11577466|FG003|COMPLETED|Washout||4
10431383|NCT00875017|11577467|FG004|COMPLETED|Washout||4
10431384|NCT00875017|11577468|FG005|COMPLETED|Washout||5
10431385|NCT00875017|11577463|FG000|NOT COMPLETED|Washout||0
10431386|NCT00875017|11577464|FG001|NOT COMPLETED|Washout||1
10431387|NCT00875017|11577465|FG002|NOT COMPLETED|Washout||0
10431388|NCT00875017|11577466|FG003|NOT COMPLETED|Washout||0
10431389|NCT00875017|11577467|FG004|NOT COMPLETED|Washout||0
10431390|NCT00875017|11577468|FG005|NOT COMPLETED|Washout||0
10431391|NCT00875017|11577463|FG000|STARTED|Third Intervention||3
10431392|NCT00875017|11577464|FG001|STARTED|Third Intervention||4
10431393|NCT00875017|11577465|FG002|STARTED|Third Intervention||3
10431394|NCT00875017|11577466|FG003|STARTED|Third Intervention||4
10431395|NCT00875017|11577467|FG004|STARTED|Third Intervention||4
10431396|NCT00875017|11577468|FG005|STARTED|Third Intervention||5
10431397|NCT00875017|11577463|FG000|COMPLETED|Third Intervention||3
10431398|NCT00875017|11577464|FG001|COMPLETED|Third Intervention||3
10431399|NCT00875017|11577465|FG002|COMPLETED|Third Intervention||2
10431400|NCT00875017|11577466|FG003|COMPLETED|Third Intervention||4
10431401|NCT00875017|11577467|FG004|COMPLETED|Third Intervention||4
10431402|NCT00875017|11577468|FG005|COMPLETED|Third Intervention||5
10431403|NCT00875017|11577463|FG000|NOT COMPLETED|Third Intervention||0
10431404|NCT00875017|11577464|FG001|NOT COMPLETED|Third Intervention||1
10431405|NCT00875017|11577465|FG002|NOT COMPLETED|Third Intervention||1
10431406|NCT00875017|11577466|FG003|NOT COMPLETED|Third Intervention||0
10431407|NCT00875017|11577467|FG004|NOT COMPLETED|Third Intervention||0
10431408|NCT00875017|11577468|FG005|NOT COMPLETED|Third Intervention||0
10431409|NCT00875017|11577463|FG000|STARTED|Washout||3
10431410|NCT00875017|11577464|FG001|STARTED|Washout||3
10431411|NCT00875017|11577465|FG002|STARTED|Washout||2
10431412|NCT00875017|11577466|FG003|STARTED|Washout||4
10431413|NCT00875017|11577467|FG004|STARTED|Washout||4
10431414|NCT00875017|11577468|FG005|STARTED|Washout||5
10431415|NCT00875017|11577463|FG000|COMPLETED|Washout||3
10431416|NCT00875017|11577464|FG001|COMPLETED|Washout||3
10431417|NCT00875017|11577465|FG002|COMPLETED|Washout||2
10431418|NCT00875017|11577466|FG003|COMPLETED|Washout||4
10431419|NCT00875017|11577467|FG004|COMPLETED|Washout||3
10431420|NCT00875017|11577468|FG005|COMPLETED|Washout||5
10431421|NCT00875017|11577463|FG000|NOT COMPLETED|Washout||0
10431422|NCT00875017|11577464|FG001|NOT COMPLETED|Washout||0
10431423|NCT00875017|11577465|FG002|NOT COMPLETED|Washout||0
10431424|NCT00875017|11577466|FG003|NOT COMPLETED|Washout||0
10431425|NCT00875017|11577467|FG004|NOT COMPLETED|Washout||1
10431426|NCT00875017|11577468|FG005|NOT COMPLETED|Washout||0
10431427|NCT00875017|11577463|FG000|STARTED|Fourth Intervention||3
10431428|NCT00875017|11577464|FG001|STARTED|Fourth Intervention||3
10431429|NCT00875017|11577465|FG002|STARTED|Fourth Intervention||2
10431430|NCT00875017|11577466|FG003|STARTED|Fourth Intervention||4
10431431|NCT00875017|11577467|FG004|STARTED|Fourth Intervention||3
10431432|NCT00875017|11577468|FG005|STARTED|Fourth Intervention||5
10431433|NCT00875017|11577463|FG000|COMPLETED|Fourth Intervention||3
10431434|NCT00875017|11577464|FG001|COMPLETED|Fourth Intervention||3
10431435|NCT00875017|11577465|FG002|COMPLETED|Fourth Intervention||2
10431436|NCT00875017|11577466|FG003|COMPLETED|Fourth Intervention||4
10431437|NCT00875017|11577467|FG004|COMPLETED|Fourth Intervention||3
10431438|NCT00875017|11577468|FG005|COMPLETED|Fourth Intervention||4
10431439|NCT00875017|11577463|FG000|NOT COMPLETED|Fourth Intervention||0
10431440|NCT00875017|11577464|FG001|NOT COMPLETED|Fourth Intervention||0
10431441|NCT00875017|11577465|FG002|NOT COMPLETED|Fourth Intervention||0
10431442|NCT00875017|11577466|FG003|NOT COMPLETED|Fourth Intervention||0
10431443|NCT00875017|11577467|FG004|NOT COMPLETED|Fourth Intervention||0
10431444|NCT00875017|11577468|FG005|NOT COMPLETED|Fourth Intervention||1
10431445|NCT00875056|11577484|FG000|STARTED|Overall Study||39
10431446|NCT00875056|11577485|FG001|STARTED|Overall Study||11
10431447|NCT00875056|11577486|FG002|STARTED|Overall Study||6
10431448|NCT00875056|11577484|FG000|COMPLETED|Overall Study||16
10431449|NCT00875056|11577485|FG001|COMPLETED|Overall Study||2
10431450|NCT00875056|11577486|FG002|COMPLETED|Overall Study||0
10431451|NCT00875056|11577484|FG000|NOT COMPLETED|Overall Study||23
10431452|NCT00875056|11577485|FG001|NOT COMPLETED|Overall Study||9
10431453|NCT00875056|11577486|FG002|NOT COMPLETED|Overall Study||6
10431454|NCT00875212|11577494|FG000|STARTED|Placebo Dentifrice||12
10431455|NCT00875212|11577494|FG000|COMPLETED|Placebo Dentifrice|all participants completed this group|12
10431456|NCT00875212|11577494|FG000|NOT COMPLETED|Placebo Dentifrice||0
10431457|NCT00875212|11577494|FG000|STARTED|CaGP Only Dentifrice||12
10431458|NCT00875212|11577494|FG000|COMPLETED|CaGP Only Dentifrice||12
10431459|NCT00875212|11577494|FG000|NOT COMPLETED|CaGP Only Dentifrice||0
10431460|NCT00875212|11577494|FG000|STARTED|Fluoride Only Dentifrice||12
10431461|NCT00875212|11577494|FG000|COMPLETED|Fluoride Only Dentifrice||12
10431462|NCT00875212|11577494|FG000|NOT COMPLETED|Fluoride Only Dentifrice||0
10431463|NCT00875212|11577494|FG000|STARTED|CaGP and Fluoride Dentifrice||12
10431464|NCT00875212|11577494|FG000|COMPLETED|CaGP and Fluoride Dentifrice||12
10431465|NCT00875212|11577494|FG000|NOT COMPLETED|CaGP and Fluoride Dentifrice||0
10431466|NCT00875277|11577505|FG000|STARTED|Overall Study||24
10431467|NCT00875277|11577505|FG000|COMPLETED|Overall Study||24
10431468|NCT00875277|11577505|FG000|NOT COMPLETED|Overall Study||0
10431469|NCT00875329|11577516|FG000|STARTED|Overall Study||97
10431470|NCT00875329|11577516|FG000|COMPLETED|Overall Study||97
10431471|NCT00875329|11577516|FG000|NOT COMPLETED|Overall Study||0
10431472|NCT00875342|11577522|FG000|STARTED|Overall Study||20
10431473|NCT00875342|11577523|FG001|STARTED|Overall Study||21
10431474|NCT00875342|11577522|FG000|COMPLETED|Overall Study||16
10431475|NCT00875342|11577523|FG001|COMPLETED|Overall Study||16
10431476|NCT00875342|11577522|FG000|NOT COMPLETED|Overall Study||4
10431477|NCT00875342|11577523|FG001|NOT COMPLETED|Overall Study||5
10431478|NCT00875420|11577534|FG000|STARTED|Overall Study||22
10431479|NCT00875420|11577535|FG001|STARTED|Overall Study||20
10431480|NCT00875420|11577536|FG002|STARTED|Overall Study||21
10431481|NCT00875420|11577537|FG003|STARTED|Overall Study||18
10431482|NCT00875420|11577538|FG004|STARTED|Overall Study||19
10431483|NCT00875420|11577534|FG000|COMPLETED|Overall Study||20
10431484|NCT00875420|11577535|FG001|COMPLETED|Overall Study||18
10431485|NCT00875420|11577536|FG002|COMPLETED|Overall Study||18
10431486|NCT00875420|11577537|FG003|COMPLETED|Overall Study||16
10431487|NCT00875420|11577538|FG004|COMPLETED|Overall Study||17
10431488|NCT00875420|11577534|FG000|NOT COMPLETED|Overall Study||2
10431489|NCT00875420|11577535|FG001|NOT COMPLETED|Overall Study||2
10431490|NCT00875420|11577536|FG002|NOT COMPLETED|Overall Study||3
10431491|NCT00875420|11577537|FG003|NOT COMPLETED|Overall Study||2
10431492|NCT00875420|11577538|FG004|NOT COMPLETED|Overall Study||2
10431493|NCT00875433|11577550|FG000|STARTED|Overall Study|Treated|60
10431494|NCT00875433|11577550|FG000|COMPLETED|Overall Study||0
10431495|NCT00875433|11577550|FG000|NOT COMPLETED|Overall Study||60
10431496|NCT00875485|11577556|FG000|STARTED|Year 11||99
10431497|NCT00875485|11577557|FG001|STARTED|Year 11||111
10431498|NCT00875485|11577556|FG000|COMPLETED|Year 11||99
10431499|NCT00875485|11577557|FG001|COMPLETED|Year 11||111
10431500|NCT00875485|11577556|FG000|NOT COMPLETED|Year 11||0
10431501|NCT00875485|11577557|FG001|NOT COMPLETED|Year 11||0
10431502|NCT00875485|11577556|FG000|STARTED|Year 12||101
10431503|NCT00875485|11577557|FG001|STARTED|Year 12||109
10431504|NCT00875485|11577556|FG000|COMPLETED|Year 12||101
10431505|NCT00875485|11577557|FG001|COMPLETED|Year 12||109
10431506|NCT00875485|11577556|FG000|NOT COMPLETED|Year 12||0
10431507|NCT00875485|11577557|FG001|NOT COMPLETED|Year 12||0
10431508|NCT00875485|11577556|FG000|STARTED|Year 13||102
10431509|NCT00875485|11577557|FG001|STARTED|Year 13||113
10431510|NCT00875485|11577556|FG000|COMPLETED|Year 13||102
10431511|NCT00875485|11577557|FG001|COMPLETED|Year 13||113
10431512|NCT00875485|11577556|FG000|NOT COMPLETED|Year 13||0
10431513|NCT00875485|11577557|FG001|NOT COMPLETED|Year 13||0
10431514|NCT00875485|11577556|FG000|STARTED|Year 14||100
10431515|NCT00875485|11577557|FG001|STARTED|Year 14||113
10431516|NCT00875485|11577556|FG000|COMPLETED|Year 14||100
10431517|NCT00875485|11577557|FG001|COMPLETED|Year 14||113
10431518|NCT00875485|11577556|FG000|NOT COMPLETED|Year 14||0
10431519|NCT00875485|11577557|FG001|NOT COMPLETED|Year 14||0
10431520|NCT00875485|11577556|FG000|STARTED|Year 15||98
10431521|NCT00875485|11577557|FG001|STARTED|Year 15||111
10431522|NCT00875485|11577556|FG000|COMPLETED|Year 15||98
10431523|NCT00875485|11577557|FG001|COMPLETED|Year 15||111
10431524|NCT00875485|11577556|FG000|NOT COMPLETED|Year 15||0
10431525|NCT00875485|11577557|FG001|NOT COMPLETED|Year 15||0
10431526|NCT00875485|11577556|FG000|STARTED|Challenge Dose Epoch||8
10431527|NCT00875485|11577557|FG001|STARTED|Challenge Dose Epoch||11
10431528|NCT00875485|11577556|FG000|COMPLETED|Challenge Dose Epoch||7
10431529|NCT00875485|11577557|FG001|COMPLETED|Challenge Dose Epoch||11
10431530|NCT00875485|11577556|FG000|NOT COMPLETED|Challenge Dose Epoch||1
10431531|NCT00875485|11577557|FG001|NOT COMPLETED|Challenge Dose Epoch||0
10431532|NCT00875550|11577565|FG000|STARTED|Overall Study||89
10431533|NCT00875550|11577566|FG001|STARTED|Overall Study||86
10431534|NCT00875550|11577565|FG000|COMPLETED|Overall Study||77
10431535|NCT00875550|11577566|FG001|COMPLETED|Overall Study||76
10431536|NCT00875550|11577565|FG000|NOT COMPLETED|Overall Study||12
10431537|NCT00875550|11577566|FG001|NOT COMPLETED|Overall Study||10
10431538|NCT00875563|11577574|FG000|STARTED|Overall Study||42
10431539|NCT00875563|11577574|FG000|COMPLETED|Overall Study||18
10431540|NCT00875563|11577574|FG000|NOT COMPLETED|Overall Study||24
10431541|NCT00875589|11577580|FG000|STARTED|Overall Study||15
10431542|NCT00875589|11577581|FG001|STARTED|Overall Study||11
10431543|NCT00875589|11577580|FG000|COMPLETED|Overall Study||15
10431544|NCT00875589|11577581|FG001|COMPLETED|Overall Study||11
10431545|NCT00875589|11577580|FG000|NOT COMPLETED|Overall Study||0
10431546|NCT00875589|11577581|FG001|NOT COMPLETED|Overall Study||0
10431547|NCT00875615|11577587|FG000|STARTED|Overall Study||11
10431548|NCT00875615|11577587|FG000|COMPLETED|Overall Study||10
10431549|NCT00875615|11577587|FG000|NOT COMPLETED|Overall Study||1
10431550|NCT00875641|11577594|FG000|STARTED|Overall Study||57931
10431551|NCT00875641|11577595|FG001|STARTED|Overall Study||173384
10431552|NCT00875641|11577596|FG002|STARTED|Overall Study||159344
10431553|NCT00875641|11577594|FG000|COMPLETED|Overall Study||57931
10431554|NCT00875641|11577595|FG001|COMPLETED|Overall Study||173384
10431555|NCT00875641|11577596|FG002|COMPLETED|Overall Study||159344
10431556|NCT00875641|11577594|FG000|NOT COMPLETED|Overall Study||0
10431557|NCT00875641|11577595|FG001|NOT COMPLETED|Overall Study||0
10431558|NCT00875641|11577596|FG002|NOT COMPLETED|Overall Study||0
10431559|NCT00875667|11577606|FG000|STARTED|Overall Study||170
10431560|NCT00875667|11577607|FG001|STARTED|Overall Study||84
10431561|NCT00875667|11577606|FG000|Crossover From IC to Lenalidomide|Overall Study|NA = Participants in the IC arm were able to crossover to lenalidomide|0
10431562|NCT00875667|11577607|FG001|Crossover From IC to Lenalidomide|Overall Study|Upon disease progression, participants crossed over to lenalidomide|40
10431563|NCT00875667|11577606|FG000|Participants Treated|Overall Study||167
10431564|NCT00875667|11577607|FG001|Participants Treated|Overall Study||83
10431565|NCT00875667|11577606|FG000|COMPLETED|Overall Study||0
10431566|NCT00875667|11577607|FG001|COMPLETED|Overall Study|Participants completed 6 cycles of IC single agent cytarabine, fludarabine, or gemcitabine.|11
10431567|NCT00875667|11577606|FG000|NOT COMPLETED|Overall Study||170
10431568|NCT00875667|11577607|FG001|NOT COMPLETED|Overall Study||73
10431569|NCT00875706|11577616|FG000|STARTED|Overall Study||8
10431570|NCT00875706|11577617|FG001|STARTED|Overall Study||24
10431571|NCT00875706|11577618|FG002|STARTED|Overall Study||13
10431572|NCT00875706|11577616|FG000|COMPLETED|Overall Study||7
10431573|NCT00875706|11577617|FG001|COMPLETED|Overall Study||24
10431574|NCT00875706|11577618|FG002|COMPLETED|Overall Study||13
10431575|NCT00875706|11577616|FG000|NOT COMPLETED|Overall Study||1
10431576|NCT00875706|11577617|FG001|NOT COMPLETED|Overall Study||0
10431577|NCT00875706|11577618|FG002|NOT COMPLETED|Overall Study||0
10431578|NCT00875797|11577628|FG000|STARTED|Overall Study||45
10431579|NCT00875797|11577629|FG001|STARTED|Overall Study||45
10431580|NCT00875797|11577628|FG000|COMPLETED|Overall Study||39
10431581|NCT00875797|11577629|FG001|COMPLETED|Overall Study||42
10431582|NCT00875797|11577628|FG000|NOT COMPLETED|Overall Study||6
10431583|NCT00875797|11577629|FG001|NOT COMPLETED|Overall Study||3
10431584|NCT00875810|11577638|FG000|STARTED|Overall Study||194
10431585|NCT00875810|11577638|FG000|Implanted|Overall Study||190
10431586|NCT00875810|11577638|FG000|Discharged|Overall Study||177
10431587|NCT00875810|11577638|FG000|3 Months Follow up|Overall Study||175
10431588|NCT00875810|11577638|FG000|6 Months Follow up|Overall Study||80
10431589|NCT00875810|11577638|FG000|12 Months Follow up|Overall Study||112
10431590|NCT00875810|11577638|FG000|24 Months Follow up|Overall Study||148
10431591|NCT00875810|11577638|FG000|COMPLETED|Overall Study||148
10431592|NCT00875810|11577638|FG000|NOT COMPLETED|Overall Study||46
10431593|NCT00875836|11577644|FG000|STARTED|Overall Study||88
10431594|NCT00875836|11577645|FG001|STARTED|Overall Study||87
10431595|NCT00875836|11577644|FG000|COMPLETED|Overall Study||45
10431596|NCT00875836|11577645|FG001|COMPLETED|Overall Study||47
10431597|NCT00875836|11577644|FG000|NOT COMPLETED|Overall Study||43
10431598|NCT00875836|11577645|FG001|NOT COMPLETED|Overall Study||40
10431599|NCT00875979|11577653|FG000|STARTED|Dose Escalation Phase - 3.0 mg/kg||3
10431600|NCT00875979|11577654|FG001|STARTED|Dose Escalation Phase - 3.0 mg/kg||0
10431601|NCT00875979|11577653|FG000|COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
10431602|NCT00875979|11577654|FG001|COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
10431603|NCT00875979|11577653|FG000|NOT COMPLETED|Dose Escalation Phase - 3.0 mg/kg||3
10431604|NCT00875979|11577654|FG001|NOT COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
10431605|NCT00875979|11577653|FG000|STARTED|Dose Escalation Phase - 3.6 mg/kg||0
10431606|NCT00875979|11577654|FG001|STARTED|Dose Escalation Phase - 3.6 mg/kg||6
10431607|NCT00875979|11577653|FG000|COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
10431608|NCT00875979|11577654|FG001|COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
10431609|NCT00875979|11577653|FG000|NOT COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
10431610|NCT00875979|11577654|FG001|NOT COMPLETED|Dose Escalation Phase - 3.6 mg/kg||6
10431611|NCT00875979|11577653|FG000|STARTED|Dose Expansion Phase - 3.6 mg/kg||0
10431612|NCT00875979|11577654|FG001|STARTED|Dose Expansion Phase - 3.6 mg/kg||58
10431613|NCT00875979|11577653|FG000|COMPLETED|Dose Expansion Phase - 3.6 mg/kg||0
10431614|NCT00875979|11577654|FG001|COMPLETED|Dose Expansion Phase - 3.6 mg/kg||11
10431615|NCT00875979|11577653|FG000|NOT COMPLETED|Dose Expansion Phase - 3.6 mg/kg||0
10431616|NCT00875979|11577654|FG001|NOT COMPLETED|Dose Expansion Phase - 3.6 mg/kg||47
10431617|NCT00876018|11577663|FG000|STARTED|Overall Study||100
10431618|NCT00876018|11577664|FG001|STARTED|Overall Study||100
10431619|NCT00876018|11577665|FG002|STARTED|Overall Study||100
10431620|NCT00876018|11577663|FG000|COMPLETED|Overall Study||95
10431621|NCT00876018|11577664|FG001|COMPLETED|Overall Study||95
10431622|NCT00876018|11577665|FG002|COMPLETED|Overall Study||97
10431623|NCT00876018|11577663|FG000|NOT COMPLETED|Overall Study||5
10431624|NCT00876018|11577664|FG001|NOT COMPLETED|Overall Study||5
10431625|NCT00876018|11577665|FG002|NOT COMPLETED|Overall Study||3
10431626|NCT00876187|11577680|FG000|STARTED|Overall Study||233
10431627|NCT00876187|11577681|FG001|STARTED|Overall Study||233
10431628|NCT00876187|11577682|FG002|STARTED|Overall Study||298
10431629|NCT00876187|11577683|FG003|STARTED|Overall Study||297
10431630|NCT00876187|11577684|FG004|STARTED|Overall Study||298
10431631|NCT00876187|11577680|FG000|Treated|Overall Study||230
10431632|NCT00876187|11577681|FG001|Treated|Overall Study||232
10431633|NCT00876187|11577682|FG002|Treated|Overall Study||295
10431634|NCT00876187|11577683|FG003|Treated|Overall Study||295
10431635|NCT00876187|11577684|FG004|Treated|Overall Study||295
10431636|NCT00876187|11577680|FG000|Completed Treatment|Overall Study|Participants who completed treatment at Week 16 visit.|128
10431637|NCT00876187|11577681|FG001|Completed Treatment|Overall Study|Participants who completed treatment at Week 16 visit.|146
10431638|NCT00876187|11577682|FG002|Completed Treatment|Overall Study|Participants who completed treatment at Week 16 visit.|193
10431639|NCT00876187|11577683|FG003|Completed Treatment|Overall Study|Participants who completed treatment at Week 16 visit.|188
10431640|NCT00876187|11577684|FG004|Completed Treatment|Overall Study|Participants who completed treatment at Week 16 visit.|185
10431641|NCT00876187|11577680|FG000|COMPLETED|Overall Study||23
10431642|NCT00876187|11577681|FG001|COMPLETED|Overall Study||18
10431643|NCT00876187|11577682|FG002|COMPLETED|Overall Study||19
10431644|NCT00876187|11577683|FG003|COMPLETED|Overall Study||22
10431645|NCT00876187|11577684|FG004|COMPLETED|Overall Study||27
10431646|NCT00876187|11577680|FG000|NOT COMPLETED|Overall Study||210
10431647|NCT00876187|11577681|FG001|NOT COMPLETED|Overall Study||215
10431648|NCT00876187|11577682|FG002|NOT COMPLETED|Overall Study||279
10431649|NCT00876187|11577683|FG003|NOT COMPLETED|Overall Study||275
10431650|NCT00876187|11577684|FG004|NOT COMPLETED|Overall Study||271
10431651|NCT00876200|11577701|FG000|STARTED|Overall Study||9
10431652|NCT00876200|11577702|FG001|STARTED|Overall Study||12
10431653|NCT00876200|11577701|FG000|COMPLETED|Overall Study||8
10431654|NCT00876200|11577702|FG001|COMPLETED|Overall Study||9
10431655|NCT00876200|11577701|FG000|NOT COMPLETED|Overall Study||1
10431656|NCT00876200|11577702|FG001|NOT COMPLETED|Overall Study||3
10431657|NCT00876265|11577708|FG000|STARTED|Overall Study||118
10431658|NCT00876265|11577708|FG000|COMPLETED|Overall Study||106
10431659|NCT00876265|11577708|FG000|NOT COMPLETED|Overall Study||12
10431660|NCT00876343|11577717|FG000|STARTED|Overall Study||194
10431661|NCT00876343|11577718|FG001|STARTED|Overall Study||197
10431662|NCT00876343|11577719|FG002|STARTED|Overall Study||195
10431663|NCT00876343|11577717|FG000|COMPLETED|Overall Study||177
10431664|NCT00876343|11577718|FG001|COMPLETED|Overall Study||180
10431665|NCT00876343|11577719|FG002|COMPLETED|Overall Study||183
10431666|NCT00876343|11577717|FG000|NOT COMPLETED|Overall Study||17
10431667|NCT00876343|11577718|FG001|NOT COMPLETED|Overall Study||17
10431668|NCT00876343|11577719|FG002|NOT COMPLETED|Overall Study||12
10431669|NCT00876395|11577729|FG000|STARTED|Overall Study||480
10431670|NCT00876395|11577730|FG001|STARTED|Overall Study||239
10431671|NCT00876395|11577729|FG000|Untreated|Overall Study||8
10431672|NCT00876395|11577730|FG001|Untreated|Overall Study||1
10431673|NCT00876395|11577729|FG000|COMPLETED|Overall Study||0
10431674|NCT00876395|11577730|FG001|COMPLETED|Overall Study||0
10431675|NCT00876395|11577729|FG000|NOT COMPLETED|Overall Study||480
10431676|NCT00876395|11577730|FG001|NOT COMPLETED|Overall Study||239
10431677|NCT00876447|11577743|FG000|STARTED|Overall Study||185
10431678|NCT00876447|11577744|FG001|STARTED|Overall Study||203
10431679|NCT00876447|11577743|FG000|COMPLETED|Overall Study||105
10431680|NCT00876447|11577744|FG001|COMPLETED|Overall Study||122
10431681|NCT00876447|11577743|FG000|NOT COMPLETED|Overall Study||80
10431682|NCT00876447|11577744|FG001|NOT COMPLETED|Overall Study||81
10548369|NCT01519245|11702167|FG000|Received Pre-pump IV TXA|Overall Study|Two patients included in in the final analysis did not receive pre-pump IV TXA.|21
10548370|NCT01519245|11702168|FG001|Received Pre-pump IV TXA|Overall Study|All patients meeting inclusion criteria received appropriate dosing, as per protocol.|18
10548371|NCT01519245|11702167|FG000|Received Post-pump IV TXA|Overall Study|A break in protocol, dosing was given in the operating room at the surgeon's preference.|6
10548372|NCT01519245|11702168|FG001|Received Post-pump IV TXA|Overall Study|A break in protocol, dosing was given in the operating room at the surgeon's preference.|2
10548373|NCT01519245|11702167|FG000|COMPLETED|Overall Study||23
10548374|NCT01519245|11702168|FG001|COMPLETED|Overall Study||18
10548375|NCT01519245|11702167|FG000|NOT COMPLETED|Overall Study||1
10548376|NCT01519245|11702168|FG001|NOT COMPLETED|Overall Study||2
10548377|NCT01519271|11702178|FG000|STARTED|Phase 1||14
10548378|NCT01519271|11702179|FG001|STARTED|Phase 1||14
10548379|NCT01519271|11702178|FG000|COMPLETED|Phase 1||14
10548380|NCT01519271|11702179|FG001|COMPLETED|Phase 1|1 participant discontinued participation in the middle of phase 1.|13
10548381|NCT01519271|11702178|FG000|NOT COMPLETED|Phase 1||0
10548382|NCT01519271|11702179|FG001|NOT COMPLETED|Phase 1||1
10548383|NCT01519271|11702178|FG000|STARTED|Phase 2|2 participants discontinued after Phase 1|12
10548384|NCT01519271|11702179|FG001|STARTED|Phase 2||14
10548385|NCT01519271|11702178|FG000|COMPLETED|Phase 2||12
10548386|NCT01519271|11702179|FG001|COMPLETED|Phase 2||14
10548387|NCT01519271|11702178|FG000|NOT COMPLETED|Phase 2||0
10548388|NCT01519271|11702179|FG001|NOT COMPLETED|Phase 2||0
10548389|NCT01519284|11702192|FG000|STARTED|Overall Study||16
10548390|NCT01519284|11702193|FG001|STARTED|Overall Study||16
10548391|NCT01519284|11702194|FG002|STARTED|Overall Study||18
10548392|NCT01519284|11702195|FG003|STARTED|Overall Study||16
10548417|NCT01519414|11702218|FG001|NOT COMPLETED|Pre Cross-over||0
10548418|NCT01519414|11702219|FG002|NOT COMPLETED|Pre Cross-over||0
10548419|NCT01519414|11702217|FG000|STARTED|Post Cross-over||52
10548420|NCT01519414|11702218|FG001|STARTED|Post Cross-over||14
10548421|NCT01519414|11702219|FG002|STARTED|Post Cross-over||12
10548422|NCT01519414|11702217|FG000|COMPLETED|Post Cross-over||52
10548423|NCT01519414|11702218|FG001|COMPLETED|Post Cross-over||14
10548424|NCT01519414|11702219|FG002|COMPLETED|Post Cross-over||12
10548425|NCT01519414|11702217|FG000|NOT COMPLETED|Post Cross-over||0
10548426|NCT01519414|11702218|FG001|NOT COMPLETED|Post Cross-over||0
10548427|NCT01519414|11702219|FG002|NOT COMPLETED|Post Cross-over||0
10548428|NCT01519427|11702230|FG000|STARTED|Overall Study||2
10548429|NCT01519427|11702230|FG000|COMPLETED|Overall Study||0
10548430|NCT01519427|11702230|FG000|NOT COMPLETED|Overall Study||2
10548431|NCT01519453|11702236|FG000|STARTED|Overall Study|Number of dyads (caregiver-child pairs) or 398 individuals|199
10548432|NCT01519453|11702237|FG001|STARTED|Overall Study|Number of dyads (caregiver-child pairs) or 398 individuals|199
10548433|NCT01519453|11702236|FG000|3 Month|Overall Study|Number of dyads (caregiver-child pairs) or 320 individuals|160
10548434|NCT01519453|11702237|FG001|3 Month|Overall Study|Number of dyads (caregiver-child pairs) or 362 individuals|181
10548435|NCT01519453|11702236|FG000|6 Month|Overall Study|Number of dyads (caregiver-child pairs) or 306 individuals|153
10548436|NCT01519453|11702237|FG001|6 Month|Overall Study|Number of dyads (caregiver-child pairs) or 350 individuals|175
10548437|NCT01519453|11702236|FG000|9 Month|Overall Study|Number of dyads (caregiver-child pairs) or 318 individuals|159
10548438|NCT01519453|11702237|FG001|9 Month|Overall Study|Number of dyads (caregiver-child pairs) or 332 individuals|166
10548439|NCT01519453|11702236|FG000|COMPLETED|Overall Study|Number of dyads (caregiver-child pairs) or 294 individuals|147
10548440|NCT01519453|11702237|FG001|COMPLETED|Overall Study|Number of dyads (caregiver-child pairs) or 326 individuals|163
10548441|NCT01519453|11702236|FG000|NOT COMPLETED|Overall Study||52
10548442|NCT01519453|11702237|FG001|NOT COMPLETED|Overall Study||36
10548443|NCT01519466|11702245|FG000|STARTED|Overall Study||33
10548444|NCT01519466|11702246|FG001|STARTED|Overall Study||16
10548445|NCT01519466|11702245|FG000|COMPLETED|Overall Study||33
10548446|NCT01519466|11702246|FG001|COMPLETED|Overall Study||16
10548447|NCT01519466|11702245|FG000|NOT COMPLETED|Overall Study||0
10548448|NCT01519466|11702246|FG001|NOT COMPLETED|Overall Study||0
10548449|NCT01519518|11702254|FG000|STARTED|Overall Study||914
10548450|NCT01519518|11702255|FG001|STARTED|Overall Study||915
10548451|NCT01519518|11702254|FG000|COMPLETED|Overall Study||907
10548452|NCT01519518|11702255|FG001|COMPLETED|Overall Study||905
10548453|NCT01519518|11702254|FG000|NOT COMPLETED|Overall Study||7
10548454|NCT01519518|11702255|FG001|NOT COMPLETED|Overall Study||10
10548455|NCT01519570|11702263|FG000|STARTED|Overall Study||500
10548456|NCT01519570|11702264|FG001|STARTED|Overall Study||2089
10548457|NCT01519570|11702263|FG000|COMPLETED|Overall Study||500
10548458|NCT01519570|11702264|FG001|COMPLETED|Overall Study||2089
10548459|NCT01519570|11702263|FG000|NOT COMPLETED|Overall Study||0
10548460|NCT01519570|11702264|FG001|NOT COMPLETED|Overall Study||0
10548461|NCT01519635|11702272|FG000|STARTED|Overall Study||12
10548462|NCT01519635|11702273|FG001|STARTED|Overall Study||12
10548463|NCT01519635|11702272|FG000|COMPLETED|Overall Study||11
10548464|NCT01519635|11702273|FG001|COMPLETED|Overall Study||9
10548465|NCT01519635|11702272|FG000|NOT COMPLETED|Overall Study||1
10548466|NCT01519635|11702273|FG001|NOT COMPLETED|Overall Study||3
10548467|NCT01519648|11702281|FG000|STARTED|Overall Study||502
10548468|NCT01519648|11702282|FG001|STARTED|Overall Study||306
10548469|NCT01519648|11702281|FG000|COMPLETED|Overall Study||502
10548470|NCT01519648|11702282|FG001|COMPLETED|Overall Study||306
10548471|NCT01519648|11702281|FG000|NOT COMPLETED|Overall Study||0
10548472|NCT01519648|11702282|FG001|NOT COMPLETED|Overall Study||0
10548473|NCT01519661|11702288|FG000|STARTED|Overall Study||157
10548474|NCT01519661|11702288|FG000|COMPLETED|Overall Study||96
10548475|NCT01519661|11702288|FG000|NOT COMPLETED|Overall Study||61
10548476|NCT01519674|11702296|FG000|STARTED|Overall Study||194
10548477|NCT01519674|11702297|FG001|STARTED|Overall Study||195
10548478|NCT01519674|11702298|FG002|STARTED|Overall Study||193
10548479|NCT01519674|11702296|FG000|Exposed|Overall Study||192
10548480|NCT01519674|11702297|FG001|Exposed|Overall Study||193
10548481|NCT01519674|11702298|FG002|Exposed|Overall Study||190
10548482|NCT01519674|11702296|FG000|COMPLETED|Overall Study||173
10548483|NCT01519674|11702297|FG001|COMPLETED|Overall Study||182
10548484|NCT01519674|11702298|FG002|COMPLETED|Overall Study||181
10548485|NCT01519674|11702296|FG000|NOT COMPLETED|Overall Study||21
10548486|NCT01519674|11702297|FG001|NOT COMPLETED|Overall Study||13
10548487|NCT01519674|11702298|FG002|NOT COMPLETED|Overall Study||12
10548488|NCT01519700|11702310|FG000|STARTED|Overall Study||54
10548489|NCT01519700|11702311|FG001|STARTED|Overall Study||55
10548490|NCT01519700|11702312|FG002|STARTED|Overall Study||55
10548491|NCT01519700|11702313|FG003|STARTED|Overall Study||54
10548492|NCT01519700|11702310|FG000|Treated Cycle 1 EP2006|Overall Study||53
10548493|NCT01519700|11702311|FG001|Treated Cycle 1 EP2006|Overall Study||54
10548494|NCT01519700|11702312|FG002|Treated Cycle 1 EP2006|Overall Study||0
10548495|NCT01519700|11702313|FG003|Treated Cycle 1 EP2006|Overall Study||0
10548496|NCT01519700|11702310|FG000|Treated Cycle 1 Neupogen|Overall Study||0
10548497|NCT01519700|11702311|FG001|Treated Cycle 1 Neupogen|Overall Study||0
10548498|NCT01519700|11702312|FG002|Treated Cycle 1 Neupogen|Overall Study||55
10548499|NCT01519700|11702313|FG003|Treated Cycle 1 Neupogen|Overall Study||52
10548500|NCT01519700|11702310|FG000|Treated Cycle 2 EP2006|Overall Study||52
10548501|NCT01519700|11702311|FG001|Treated Cycle 2 EP2006|Overall Study||0
10548502|NCT01519700|11702312|FG002|Treated Cycle 2 EP2006|Overall Study||55
10548503|NCT01519700|11702313|FG003|Treated Cycle 2 EP2006|Overall Study||0
10548504|NCT01519700|11702310|FG000|Treated Cycle 2 Neupogen|Overall Study||0
10548505|NCT01519700|11702311|FG001|Treated Cycle 2 Neupogen|Overall Study||52
10548506|NCT01519700|11702312|FG002|Treated Cycle 2 Neupogen|Overall Study||0
10548507|NCT01519700|11702313|FG003|Treated Cycle 2 Neupogen|Overall Study||51
10548508|NCT01519700|11702310|FG000|Treated Cycle 3 EP2006|Overall Study||51
10548509|NCT01519700|11702311|FG001|Treated Cycle 3 EP2006|Overall Study||51
10548510|NCT01519700|11702312|FG002|Treated Cycle 3 EP2006|Overall Study||0
10548511|NCT01519700|11702313|FG003|Treated Cycle 3 EP2006|Overall Study||0
10548512|NCT01519700|11702310|FG000|Treated Cycle 3 Neupogen|Overall Study||0
10548513|NCT01519700|11702311|FG001|Treated Cycle 3 Neupogen|Overall Study||0
10548514|NCT01519700|11702312|FG002|Treated Cycle 3 Neupogen|Overall Study||54
10548515|NCT01519700|11702313|FG003|Treated Cycle 3 Neupogen|Overall Study||51
10548516|NCT01519700|11702310|FG000|Treated Cycle 4 EP2006|Overall Study||51
10548517|NCT01519700|11702311|FG001|Treated Cycle 4 EP2006|Overall Study||0
10548518|NCT01519700|11702312|FG002|Treated Cycle 4 EP2006|Overall Study||50
10548519|NCT01519700|11702313|FG003|Treated Cycle 4 EP2006|Overall Study||0
10548520|NCT01519700|11702310|FG000|Treated Cycle 4 Neupogen|Overall Study||0
10548521|NCT01519700|11702311|FG001|Treated Cycle 4 Neupogen|Overall Study||51
10548522|NCT01519700|11702312|FG002|Treated Cycle 4 Neupogen|Overall Study||0
10548523|NCT01519700|11702313|FG003|Treated Cycle 4 Neupogen|Overall Study||50
10548524|NCT01519700|11702310|FG000|Treated Cycle 5 EP2006|Overall Study||46
10548525|NCT01519700|11702311|FG001|Treated Cycle 5 EP2006|Overall Study||49
10548526|NCT01519700|11702312|FG002|Treated Cycle 5 EP2006|Overall Study||0
10548527|NCT01519700|11702313|FG003|Treated Cycle 5 EP2006|Overall Study||0
10548528|NCT01519700|11702310|FG000|Treated Cycle 5 Neupogen|Overall Study||0
10548529|NCT01519700|11702311|FG001|Treated Cycle 5 Neupogen|Overall Study||0
10548530|NCT01519700|11702312|FG002|Treated Cycle 5 Neupogen|Overall Study||48
10548531|NCT01519700|11702313|FG003|Treated Cycle 5 Neupogen|Overall Study||50
10548532|NCT01519700|11702310|FG000|Treated Cycle 6 EP2006|Overall Study||45
10548533|NCT01519700|11702311|FG001|Treated Cycle 6 EP2006|Overall Study||0
10548534|NCT01519700|11702312|FG002|Treated Cycle 6 EP2006|Overall Study||48
10548535|NCT01519700|11702313|FG003|Treated Cycle 6 EP2006|Overall Study||0
10548536|NCT01519700|11702310|FG000|Treated Cycle 6 Neupogen|Overall Study||0
10548537|NCT01519700|11702311|FG001|Treated Cycle 6 Neupogen|Overall Study||49
10548538|NCT01519700|11702312|FG002|Treated Cycle 6 Neupogen|Overall Study||0
10548539|NCT01519700|11702313|FG003|Treated Cycle 6 Neupogen|Overall Study||49
10548540|NCT01519700|11702310|FG000|COMPLETED|Overall Study||45
10548541|NCT01519700|11702311|FG001|COMPLETED|Overall Study||49
10548542|NCT01519700|11702312|FG002|COMPLETED|Overall Study||48
10548543|NCT01519700|11702313|FG003|COMPLETED|Overall Study||47
10548544|NCT01519700|11702310|FG000|NOT COMPLETED|Overall Study||9
10548545|NCT01519700|11702311|FG001|NOT COMPLETED|Overall Study||6
10548546|NCT01519700|11702312|FG002|NOT COMPLETED|Overall Study||7
10548547|NCT01519700|11702313|FG003|NOT COMPLETED|Overall Study||7
10548548|NCT01519713|11702332|FG000|STARTED|Overall Study||194
10548549|NCT01519713|11702333|FG001|STARTED|Overall Study||2
10548550|NCT01519713|11702334|FG002|STARTED|Overall Study||4
10548551|NCT01519713|11702332|FG000|COMPLETED|Overall Study||194
10548552|NCT01519713|11702333|FG001|COMPLETED|Overall Study||2
10548553|NCT01519713|11702334|FG002|COMPLETED|Overall Study||4
10548554|NCT01519713|11702332|FG000|NOT COMPLETED|Overall Study||0
10548555|NCT01519713|11702333|FG001|NOT COMPLETED|Overall Study||0
10548556|NCT01519713|11702334|FG002|NOT COMPLETED|Overall Study||0
10548557|NCT01519765|11702344|FG000|STARTED|Overall Study||37
10548558|NCT01519765|11702345|FG001|STARTED|Overall Study||36
10548559|NCT01519765|11702344|FG000|COMPLETED|Overall Study||34
10548560|NCT01519765|11702345|FG001|COMPLETED|Overall Study||34
10548561|NCT01519765|11702344|FG000|NOT COMPLETED|Overall Study||3
10548562|NCT01519765|11702345|FG001|NOT COMPLETED|Overall Study||2
10548563|NCT01519778|11702352|FG000|STARTED|Overall Study||200
10548564|NCT01519778|11702352|FG000|COMPLETED|Overall Study||186
10548565|NCT01519778|11702352|FG000|NOT COMPLETED|Overall Study||14
10548566|NCT01519791|11702358|FG000|STARTED|Overall Study||219
10548567|NCT01519791|11702359|FG001|STARTED|Overall Study||660
10548568|NCT01519791|11702358|FG000|Completed Week 52|Overall Study||143
10548569|NCT01519791|11702359|FG001|Completed Week 52|Overall Study||500
10548570|NCT01519791|11702358|FG000|COMPLETED|Overall Study||67
10548571|NCT01519791|11702359|FG001|COMPLETED|Overall Study||292
10548572|NCT01519791|11702358|FG000|NOT COMPLETED|Overall Study||152
10548573|NCT01519791|11702359|FG001|NOT COMPLETED|Overall Study||368
10548574|NCT01519817|11702367|FG000|STARTED|Overall Study||4
10548575|NCT01519817|11702368|FG001|STARTED|Overall Study||3
10548576|NCT01519817|11702369|FG002|STARTED|Overall Study||16
10548577|NCT01519817|11702370|FG003|STARTED|Overall Study||11
10548578|NCT01519817|11702367|FG000|COMPLETED|Overall Study||3
10548579|NCT01519817|11702368|FG001|COMPLETED|Overall Study||3
10548580|NCT01519817|11702369|FG002|COMPLETED|Overall Study||16
10548581|NCT01519817|11702370|FG003|COMPLETED|Overall Study||10
10548582|NCT01519817|11702367|FG000|NOT COMPLETED|Overall Study||1
10548583|NCT01519817|11702368|FG001|NOT COMPLETED|Overall Study||0
10548584|NCT01519817|11702369|FG002|NOT COMPLETED|Overall Study||0
10548585|NCT01519817|11702370|FG003|NOT COMPLETED|Overall Study||1
10548586|NCT01519869|11702380|FG000|STARTED|Overall Study||28
10548587|NCT01519869|11702380|FG000|COMPLETED|Overall Study||27
10548588|NCT01519869|11702380|FG000|NOT COMPLETED|Overall Study||1
10548589|NCT01519882|11702386|FG000|STARTED|Overall Study||1
10548590|NCT01519882|11702387|FG001|STARTED|Overall Study||0
10548591|NCT01519882|11702386|FG000|COMPLETED|Overall Study||1
10548592|NCT01519882|11702387|FG001|COMPLETED|Overall Study||0
10548593|NCT01519882|11702386|FG000|NOT COMPLETED|Overall Study||0
10548594|NCT01519882|11702387|FG001|NOT COMPLETED|Overall Study||0
10548595|NCT01519921|11702395|FG000|STARTED|Overall Study||86
10548596|NCT01519921|11702396|FG001|STARTED|Overall Study||64
10548597|NCT01519921|11702395|FG000|COMPLETED|Overall Study||65
10548598|NCT01519921|11702396|FG001|COMPLETED|Overall Study||49
10548599|NCT01519921|11702395|FG000|NOT COMPLETED|Overall Study||21
10548600|NCT01519921|11702396|FG001|NOT COMPLETED|Overall Study||15
10548601|NCT01519934|11702402|FG000|STARTED|Overall Study||48
10548602|NCT01519934|11702402|FG000|COMPLETED|Overall Study||45
10548603|NCT01519934|11702402|FG000|NOT COMPLETED|Overall Study||3
10548604|NCT01519947|11702410|FG000|STARTED|Overall Study||19
10548605|NCT01519947|11702411|FG001|STARTED|Overall Study||11
10548606|NCT01519947|11702412|FG002|STARTED|Overall Study||15
10548607|NCT01519947|11702413|FG003|STARTED|Overall Study||42
10548608|NCT01519947|11702410|FG000|COMPLETED|Overall Study||17
10548609|NCT01519947|11702411|FG001|COMPLETED|Overall Study||7
10548610|NCT01519947|11702412|FG002|COMPLETED|Overall Study||8
10548611|NCT01519947|11702413|FG003|COMPLETED|Overall Study||34
10548612|NCT01519947|11702410|FG000|NOT COMPLETED|Overall Study||2
10548613|NCT01519947|11702411|FG001|NOT COMPLETED|Overall Study||4
10548614|NCT01519947|11702412|FG002|NOT COMPLETED|Overall Study||7
10548615|NCT01519947|11702413|FG003|NOT COMPLETED|Overall Study||8
10548616|NCT01520038|11702423|FG000|STARTED|Overall Study||2
10548617|NCT01520038|11702423|FG000|COMPLETED|Overall Study||1
10548618|NCT01520038|11702423|FG000|NOT COMPLETED|Overall Study||1
10548619|NCT01520207|11702429|FG000|STARTED|Overall Study||27
10548620|NCT01520207|11702430|FG001|STARTED|Overall Study||25
10548621|NCT01520207|11702429|FG000|COMPLETED|Overall Study||25
10548622|NCT01520207|11702430|FG001|COMPLETED|Overall Study||25
10548623|NCT01520207|11702429|FG000|NOT COMPLETED|Overall Study||2
10548624|NCT01520207|11702430|FG001|NOT COMPLETED|Overall Study||0
10548625|NCT01520324|11702436|FG000|STARTED|Overall Study||53
10548626|NCT01520324|11702436|FG000|COMPLETED|Overall Study||52
10548627|NCT01520324|11702436|FG000|NOT COMPLETED|Overall Study||1
10548628|NCT01520363|11702442|FG000|STARTED|Overall Study||26
10548629|NCT01520363|11702443|FG001|STARTED|Overall Study||26
10548630|NCT01520363|11702442|FG000|COMPLETED|Overall Study||24
10548631|NCT01520363|11702443|FG001|COMPLETED|Overall Study||26
10548632|NCT01520363|11702442|FG000|NOT COMPLETED|Overall Study||2
10548633|NCT01520363|11702443|FG001|NOT COMPLETED|Overall Study||0
10777155|NCT03336853|11939070|FG000|COMPLETED|Overall Study||30
10777156|NCT03336853|11939071|FG001|COMPLETED|Overall Study||30
10777157|NCT03336853|11939070|FG000|NOT COMPLETED|Overall Study||0
10777158|NCT03336853|11939071|FG001|NOT COMPLETED|Overall Study||0
10777159|NCT03337139|11939079|FG000|STARTED|Phase I||87
10777160|NCT03337139|11939080|FG001|STARTED|Phase I|There were not two conditions in Phase I: all participants received standard group LM treatment.|0
10777161|NCT03337139|11939079|FG000|COMPLETED|Phase I||77
10777162|NCT03337139|11939080|FG001|COMPLETED|Phase I||0
10777163|NCT03337139|11939079|FG000|NOT COMPLETED|Phase I||10
10777164|NCT03337139|11939080|FG001|NOT COMPLETED|Phase I||0
10777165|NCT03337139|11939079|FG000|STARTED|Phase II||38
10777166|NCT03337139|11939080|FG001|STARTED|Phase II||39
10777167|NCT03337139|11939079|FG000|26 Week Assessment|Phase II||34
10777168|NCT03337139|11939080|FG001|26 Week Assessment|Phase II||37
10777169|NCT03337139|11939079|FG000|COMPLETED|Phase II||33
10777170|NCT03337139|11939080|FG001|COMPLETED|Phase II||36
10777171|NCT03337139|11939079|FG000|NOT COMPLETED|Phase II||5
10777172|NCT03337139|11939080|FG001|NOT COMPLETED|Phase II||3
10777173|NCT03337152|11939088|FG000|STARTED|Overall Study||24
10777174|NCT03337152|11939089|FG001|STARTED|Overall Study||24
10777175|NCT03337152|11939088|FG000|COMPLETED|Overall Study||13
10777176|NCT03337152|11939089|FG001|COMPLETED|Overall Study||13
10777177|NCT03337152|11939088|FG000|NOT COMPLETED|Overall Study||11
10777178|NCT03337152|11939089|FG001|NOT COMPLETED|Overall Study||11
10777179|NCT03337308|11939101|FG000|STARTED|Overall Study||108
10777180|NCT03337308|11939102|FG001|STARTED|Overall Study||110
10777181|NCT03337308|11939103|FG002|STARTED|Overall Study||109
10777182|NCT03337308|11939104|FG003|STARTED|Overall Study||55
10777183|NCT03337308|11939101|FG000|COMPLETED|Overall Study||103
10777184|NCT03337308|11939102|FG001|COMPLETED|Overall Study||103
10777185|NCT03337308|11939103|FG002|COMPLETED|Overall Study||104
10777186|NCT03337308|11939104|FG003|COMPLETED|Overall Study||53
10777187|NCT03337308|11939101|FG000|NOT COMPLETED|Overall Study||5
10777188|NCT03337308|11939102|FG001|NOT COMPLETED|Overall Study||7
10777189|NCT03337308|11939103|FG002|NOT COMPLETED|Overall Study||5
10777190|NCT03337308|11939104|FG003|NOT COMPLETED|Overall Study||2
10777191|NCT03337477|11939116|FG000|STARTED|Overall Study||33
10777192|NCT03337477|11939117|FG001|STARTED|Overall Study||37
10777193|NCT03337477|11939116|FG000|COMPLETED|Overall Study||22
10777194|NCT03337477|11939117|FG001|COMPLETED|Overall Study||24
10777195|NCT03337477|11939116|FG000|NOT COMPLETED|Overall Study||11
10777196|NCT03337477|11939117|FG001|NOT COMPLETED|Overall Study||13
10777197|NCT03337490|11939128|FG000|STARTED|Overall Study||128
10777198|NCT03337490|11939129|FG001|STARTED|Overall Study||126
10777199|NCT03337490|11939130|FG002|STARTED|Overall Study||42
10777200|NCT03337490|11939128|FG000|COMPLETED|Overall Study||117
10777201|NCT03337490|11939129|FG001|COMPLETED|Overall Study||112
10777202|NCT03337490|11939130|FG002|COMPLETED|Overall Study||7
10777203|NCT03337490|11939128|FG000|NOT COMPLETED|Overall Study||11
10777204|NCT03337490|11939129|FG001|NOT COMPLETED|Overall Study||14
10779332|NCT03364309|11940869|FG010|NOT COMPLETED|Post-Treatment Followup Period||0
10779333|NCT03364309|11940870|FG011|NOT COMPLETED|Post-Treatment Followup Period||0
10779334|NCT03364309|11940871|FG012|NOT COMPLETED|Post-Treatment Followup Period||0
10779335|NCT03364309|11940872|FG013|NOT COMPLETED|Post-Treatment Followup Period||0
10779336|NCT03364309|11940873|FG014|NOT COMPLETED|Post-Treatment Followup Period||0
10779337|NCT03364309|11940874|FG015|NOT COMPLETED|Post-Treatment Followup Period||0
10779338|NCT03364309|11940875|FG016|NOT COMPLETED|Post-Treatment Followup Period||5
10779339|NCT03364309|11940876|FG017|NOT COMPLETED|Post-Treatment Followup Period||31
10779340|NCT03364309|11940877|FG018|NOT COMPLETED|Post-Treatment Followup Period||2
10779341|NCT03364335|11940906|FG000|STARTED|Overall Study||52
10779342|NCT03364335|11940907|FG001|STARTED|Overall Study||51
10779343|NCT03364335|11940908|FG002|STARTED|Overall Study||53
10779344|NCT03364335|11940909|FG003|STARTED|Overall Study||50
10779345|NCT03364335|11940910|FG004|STARTED|Overall Study||52
10779346|NCT03364335|11940906|FG000|COMPLETED|Overall Study||42
10779347|NCT03364335|11940907|FG001|COMPLETED|Overall Study||40
10779348|NCT03364335|11940908|FG002|COMPLETED|Overall Study||42
10779349|NCT03364335|11940909|FG003|COMPLETED|Overall Study||37
10779350|NCT03364335|11940910|FG004|COMPLETED|Overall Study||41
10779351|NCT03364335|11940906|FG000|NOT COMPLETED|Overall Study||10
10779352|NCT03364335|11940907|FG001|NOT COMPLETED|Overall Study||11
10779353|NCT03364335|11940908|FG002|NOT COMPLETED|Overall Study||11
10779354|NCT03364335|11940909|FG003|NOT COMPLETED|Overall Study||13
10779355|NCT03364335|11940910|FG004|NOT COMPLETED|Overall Study||11
10779356|NCT03364608|11940922|FG000|STARTED|Overall Study||86
10779357|NCT03364608|11940922|FG000|Placebo MDI|Overall Study||82
10779358|NCT03364608|11940922|FG000|AS MDI 90 µg|Overall Study||81
10779359|NCT03364608|11940922|FG000|AS MDI 180 µg|Overall Study||81
10779360|NCT03364608|11940922|FG000|Proventil 90 µg|Overall Study||82
10779361|NCT03364608|11940922|FG000|Proventil 180 µg|Overall Study||79
10779362|NCT03364608|11940922|FG000|COMPLETED|Overall Study||78
10779363|NCT03364608|11940922|FG000|NOT COMPLETED|Overall Study||8
10779364|NCT03364738|11940934|FG000|STARTED|Overall Study||22
10779365|NCT03364738|11940934|FG000|COMPLETED|Overall Study||14
10779366|NCT03364738|11940934|FG000|NOT COMPLETED|Overall Study||8
10779367|NCT03364751|11940943|FG000|STARTED|Overall Study||70
10779368|NCT03364751|11940944|FG001|STARTED|Overall Study||84
10779369|NCT03364751|11940945|FG002|STARTED|Overall Study||17
10779370|NCT03364751|11940946|FG003|STARTED|Overall Study||1
10779371|NCT03364751|11940943|FG000|COMPLETED|Overall Study||69
10779372|NCT03364751|11940944|FG001|COMPLETED|Overall Study||83
10779373|NCT03364751|11940945|FG002|COMPLETED|Overall Study||17
10779374|NCT03364751|11940946|FG003|COMPLETED|Overall Study||1
10779375|NCT03364751|11940943|FG000|NOT COMPLETED|Overall Study||1
10779376|NCT03364751|11940944|FG001|NOT COMPLETED|Overall Study||1
10779377|NCT03364751|11940945|FG002|NOT COMPLETED|Overall Study||0
10779378|NCT03364751|11940946|FG003|NOT COMPLETED|Overall Study||0
10779379|NCT03365011|11940962|FG000|STARTED|Overall Study||20
10779380|NCT03365011|11940963|FG001|STARTED|Overall Study||20
10779381|NCT03365011|11940962|FG000|COMPLETED|Overall Study||19
10779382|NCT03365011|11940963|FG001|COMPLETED|Overall Study||18
10779383|NCT03365011|11940962|FG000|NOT COMPLETED|Overall Study||1
10779384|NCT03365011|11940963|FG001|NOT COMPLETED|Overall Study||2
10779472|NCT03367793|11941019|FG003|STARTED|Treatment 3 Dispense to 2 Months Wear||5
10779473|NCT03367793|11941020|FG004|STARTED|Treatment 3 Dispense to 2 Months Wear||5
10779474|NCT03367793|11941021|FG005|STARTED|Treatment 3 Dispense to 2 Months Wear||5
10779475|NCT03367793|11941016|FG000|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5
10779476|NCT03367793|11941017|FG001|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5
10779477|NCT03367793|11941018|FG002|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5
10779478|NCT03367793|11941019|FG003|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5
10779479|NCT03367793|11941020|FG004|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5
10779480|NCT03367793|11941021|FG005|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5
10779481|NCT03367793|11941016|FG000|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0
10779482|NCT03367793|11941017|FG001|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0
10779483|NCT03367793|11941018|FG002|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0
10779484|NCT03367793|11941019|FG003|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0
10779485|NCT03367793|11941020|FG004|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0
10779486|NCT03367793|11941021|FG005|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0
10779487|NCT03368053|11941032|FG000|STARTED|Overall Study||36
10779488|NCT03368053|11941032|FG000|COMPLETED|Overall Study||36
10779489|NCT03368053|11941032|FG000|NOT COMPLETED|Overall Study||0
10779490|NCT03368235|11941038|FG000|STARTED|Overall Study||11
10779491|NCT03368235|11941039|FG001|STARTED|Overall Study||10
10779492|NCT03368235|11941038|FG000|COMPLETED|Overall Study||11
10779493|NCT03368235|11941039|FG001|COMPLETED|Overall Study||10
10779494|NCT03368235|11941038|FG000|NOT COMPLETED|Overall Study||0
10779495|NCT03368235|11941039|FG001|NOT COMPLETED|Overall Study||0
10779496|NCT03368807|11941045|FG000|STARTED|Period 1 (Blinded CGM)||79
10779497|NCT03368807|11941045|FG000|Received at Least 1 Dose of Study Drug|Period 1 (Blinded CGM)||78
10779498|NCT03368807|11941045|FG000|COMPLETED|Period 1 (Blinded CGM)||73
10779499|NCT03368807|11941045|FG000|NOT COMPLETED|Period 1 (Blinded CGM)||6
10779500|NCT03368807|11941045|FG000|STARTED|Period 2 (Unblinded CGM)||73
10779501|NCT03368807|11941045|FG000|COMPLETED|Period 2 (Unblinded CGM)||73
10779502|NCT03368807|11941045|FG000|NOT COMPLETED|Period 2 (Unblinded CGM)||0
10779503|NCT03368859|11941053|FG000|STARTED|Overall Study||36
10779504|NCT03368859|11941054|FG001|STARTED|Overall Study||34
10779395|NCT03365778|11940977|FG001|NOT COMPLETED|Overall Study||0
10779396|NCT03365778|11940978|FG002|NOT COMPLETED|Overall Study||0
10779397|NCT03365934|11940986|FG000|STARTED|Overall Study||35
10779398|NCT03365934|11940986|FG000|COMPLETED|Overall Study||33
10779399|NCT03365934|11940986|FG000|NOT COMPLETED|Overall Study||2
10779400|NCT03366207|11940995|FG000|STARTED|Overall Study||250
10779401|NCT03366207|11940995|FG000|COMPLETED|Overall Study||242
10779402|NCT03366207|11940995|FG000|NOT COMPLETED|Overall Study||8
10779415|NCT03367793|11941016|FG000|STARTED|Initial Acuity at Dispense Visit (10min)||5
10779416|NCT03367793|11941017|FG001|STARTED|Initial Acuity at Dispense Visit (10min)||5
10779417|NCT03367793|11941018|FG002|STARTED|Initial Acuity at Dispense Visit (10min)||5
10779418|NCT03367793|11941019|FG003|STARTED|Initial Acuity at Dispense Visit (10min)||5
10779419|NCT03367793|11941020|FG004|STARTED|Initial Acuity at Dispense Visit (10min)||5
10779420|NCT03367793|11941021|FG005|STARTED|Initial Acuity at Dispense Visit (10min)||5
10779421|NCT03367793|11941016|FG000|COMPLETED|Initial Acuity at Dispense Visit (10min)||5
10779422|NCT03367793|11941017|FG001|COMPLETED|Initial Acuity at Dispense Visit (10min)||5
10779423|NCT03367793|11941018|FG002|COMPLETED|Initial Acuity at Dispense Visit (10min)||5
10779424|NCT03367793|11941019|FG003|COMPLETED|Initial Acuity at Dispense Visit (10min)||5
10779425|NCT03367793|11941020|FG004|COMPLETED|Initial Acuity at Dispense Visit (10min)||5
10779426|NCT03367793|11941021|FG005|COMPLETED|Initial Acuity at Dispense Visit (10min)||5
10779427|NCT03367793|11941016|FG000|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0
10779428|NCT03367793|11941017|FG001|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0
10779429|NCT03367793|11941018|FG002|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0
10779430|NCT03367793|11941019|FG003|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0
10779431|NCT03367793|11941020|FG004|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0
10779432|NCT03367793|11941021|FG005|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0
10779433|NCT03367793|11941016|FG000|STARTED|Treatment 1 Dispense to 2 Months Wear||5
10779434|NCT03367793|11941017|FG001|STARTED|Treatment 1 Dispense to 2 Months Wear||5
10779435|NCT03367793|11941018|FG002|STARTED|Treatment 1 Dispense to 2 Months Wear||5
10779436|NCT03367793|11941019|FG003|STARTED|Treatment 1 Dispense to 2 Months Wear||5
10779437|NCT03367793|11941020|FG004|STARTED|Treatment 1 Dispense to 2 Months Wear||5
10779438|NCT03367793|11941021|FG005|STARTED|Treatment 1 Dispense to 2 Months Wear||5
10779439|NCT03367793|11941016|FG000|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5
10779440|NCT03367793|11941017|FG001|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5
10779441|NCT03367793|11941018|FG002|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5
10779442|NCT03367793|11941019|FG003|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5
10779443|NCT03367793|11941020|FG004|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5
10779444|NCT03367793|11941021|FG005|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5
10779445|NCT03367793|11941016|FG000|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0
10779446|NCT03367793|11941017|FG001|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0
10779447|NCT03367793|11941018|FG002|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0
10779448|NCT03367793|11941019|FG003|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0
10779449|NCT03367793|11941020|FG004|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0
10779450|NCT03367793|11941021|FG005|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0
10779451|NCT03367793|11941016|FG000|STARTED|Treatment 2 Dispense to 2 Months Wear||5
10779452|NCT03367793|11941017|FG001|STARTED|Treatment 2 Dispense to 2 Months Wear||5
10779453|NCT03367793|11941018|FG002|STARTED|Treatment 2 Dispense to 2 Months Wear||5
10779454|NCT03367793|11941019|FG003|STARTED|Treatment 2 Dispense to 2 Months Wear||5
10779455|NCT03367793|11941020|FG004|STARTED|Treatment 2 Dispense to 2 Months Wear||5
10779456|NCT03367793|11941021|FG005|STARTED|Treatment 2 Dispense to 2 Months Wear||5
10779457|NCT03367793|11941016|FG000|COMPLETED|Treatment 2 Dispense to 2 Months Wear||5
10779458|NCT03367793|11941017|FG001|COMPLETED|Treatment 2 Dispense to 2 Months Wear||5
10779459|NCT03367793|11941018|FG002|COMPLETED|Treatment 2 Dispense to 2 Months Wear||4
10779460|NCT03367793|11941019|FG003|COMPLETED|Treatment 2 Dispense to 2 Months Wear||5
10779461|NCT03367793|11941020|FG004|COMPLETED|Treatment 2 Dispense to 2 Months Wear||5
10779462|NCT03367793|11941021|FG005|COMPLETED|Treatment 2 Dispense to 2 Months Wear||5
10779463|NCT03367793|11941016|FG000|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||0
10779464|NCT03367793|11941017|FG001|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||0
10779465|NCT03367793|11941018|FG002|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||1
10779466|NCT03367793|11941019|FG003|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||0
10779467|NCT03367793|11941020|FG004|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||0
10779468|NCT03367793|11941021|FG005|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||0
10779469|NCT03367793|11941016|FG000|STARTED|Treatment 3 Dispense to 2 Months Wear||5
10779470|NCT03367793|11941017|FG001|STARTED|Treatment 3 Dispense to 2 Months Wear||5
10779471|NCT03367793|11941018|FG002|STARTED|Treatment 3 Dispense to 2 Months Wear||5
10779505|NCT03368859|11941053|FG000|COMPLETED|Overall Study||0
10779506|NCT03368859|11941054|FG001|COMPLETED|Overall Study||0
10779507|NCT03368859|11941053|FG000|NOT COMPLETED|Overall Study||36
10779508|NCT03368859|11941054|FG001|NOT COMPLETED|Overall Study||34
10779509|NCT03368898|11941063|FG000|STARTED|Overall Study||37
10779510|NCT03368898|11941064|FG001|STARTED|Overall Study||33
10779511|NCT03368898|11941065|FG002|STARTED|Overall Study||34
10779512|NCT03368898|11941063|FG000|COMPLETED|Overall Study||37
10779513|NCT03368898|11941064|FG001|COMPLETED|Overall Study||33
10779514|NCT03368898|11941065|FG002|COMPLETED|Overall Study||34
10779515|NCT03368898|11941063|FG000|NOT COMPLETED|Overall Study||0
10779516|NCT03368898|11941064|FG001|NOT COMPLETED|Overall Study||0
10779517|NCT03368898|11941065|FG002|NOT COMPLETED|Overall Study||0
10779518|NCT03369158|11941075|FG000|STARTED|Overall Study||14
10779519|NCT03369158|11941076|FG001|STARTED|Overall Study||15
10779520|NCT03369158|11941075|FG000|COMPLETED|Overall Study||14
10779521|NCT03369158|11941076|FG001|COMPLETED|Overall Study||15
10779522|NCT03369158|11941075|FG000|NOT COMPLETED|Overall Study||0
10779523|NCT03369158|11941076|FG001|NOT COMPLETED|Overall Study||0
10779524|NCT03369236|11941084|FG000|STARTED|Double-blind Treatment Period||6
10779525|NCT03369236|11941085|FG001|STARTED|Double-blind Treatment Period||7
10779526|NCT03369236|11941084|FG000|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||6
10779527|NCT03369236|11941085|FG001|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||7
10779528|NCT03369236|11941084|FG000|COMPLETED|Double-blind Treatment Period||6
10779529|NCT03369236|11941085|FG001|COMPLETED|Double-blind Treatment Period||6
10779530|NCT03369236|11941084|FG000|NOT COMPLETED|Double-blind Treatment Period||0
10779531|NCT03369236|11941085|FG001|NOT COMPLETED|Double-blind Treatment Period||1
10779532|NCT03369236|11941084|FG000|STARTED|Open-label Extension Period||6
10779533|NCT03369236|11941085|FG001|STARTED|Open-label Extension Period||6
10779534|NCT03369236|11941084|FG000|Received at Least 1 Dose of Study Drug|Open-label Extension Period|All participants received danicopan in the open-label extension period.|6
10779535|NCT03369236|11941085|FG001|Received at Least 1 Dose of Study Drug|Open-label Extension Period|All participants received danicopan in the open-label extension period.|6
10779536|NCT03369236|11941084|FG000|COMPLETED|Open-label Extension Period||1
10779537|NCT03369236|11941085|FG001|COMPLETED|Open-label Extension Period||0
10779538|NCT03369236|11941084|FG000|NOT COMPLETED|Open-label Extension Period||5
10779539|NCT03369236|11941085|FG001|NOT COMPLETED|Open-label Extension Period||6
10779540|NCT03369340|11941097|FG000|STARTED|Day 2||3
10779541|NCT03369340|11941098|FG001|STARTED|Day 2||3
10779542|NCT03369340|11941099|FG002|STARTED|Day 2||3
10779543|NCT03369340|11941100|FG003|STARTED|Day 2||3
10779544|NCT03369340|11941101|FG004|STARTED|Day 2||3
10779545|NCT03369340|11941102|FG005|STARTED|Day 2||3
10779546|NCT03369340|11941097|FG000|COMPLETED|Day 2||3
10779547|NCT03369340|11941098|FG001|COMPLETED|Day 2||3
10779548|NCT03369340|11941099|FG002|COMPLETED|Day 2||3
10779549|NCT03369340|11941100|FG003|COMPLETED|Day 2||3
10779550|NCT03369340|11941101|FG004|COMPLETED|Day 2||3
10779551|NCT03369340|11941102|FG005|COMPLETED|Day 2||3
10779552|NCT03369340|11941097|FG000|NOT COMPLETED|Day 2||0
10779553|NCT03369340|11941098|FG001|NOT COMPLETED|Day 2||0
10779554|NCT03369340|11941099|FG002|NOT COMPLETED|Day 2||0
10779555|NCT03369340|11941100|FG003|NOT COMPLETED|Day 2||0
10779556|NCT03369340|11941101|FG004|NOT COMPLETED|Day 2||0
10779557|NCT03369340|11941102|FG005|NOT COMPLETED|Day 2||0
10779558|NCT03369340|11941097|FG000|STARTED|Day 3||3
10779559|NCT03369340|11941098|FG001|STARTED|Day 3||3
10779560|NCT03369340|11941099|FG002|STARTED|Day 3||3
10779561|NCT03369340|11941100|FG003|STARTED|Day 3||3
10779562|NCT03369340|11941101|FG004|STARTED|Day 3||3
10779563|NCT03369340|11941102|FG005|STARTED|Day 3||3
10779564|NCT03369340|11941097|FG000|COMPLETED|Day 3||3
10779565|NCT03369340|11941098|FG001|COMPLETED|Day 3||3
10779566|NCT03369340|11941099|FG002|COMPLETED|Day 3||3
10779567|NCT03369340|11941100|FG003|COMPLETED|Day 3||3
10779568|NCT03369340|11941101|FG004|COMPLETED|Day 3||3
10779569|NCT03369340|11941102|FG005|COMPLETED|Day 3||3
10779570|NCT03369340|11941097|FG000|NOT COMPLETED|Day 3||0
10779571|NCT03369340|11941098|FG001|NOT COMPLETED|Day 3||0
10779572|NCT03369340|11941099|FG002|NOT COMPLETED|Day 3||0
10779573|NCT03369340|11941100|FG003|NOT COMPLETED|Day 3||0
10779574|NCT03369340|11941101|FG004|NOT COMPLETED|Day 3||0
10779575|NCT03369340|11941102|FG005|NOT COMPLETED|Day 3||0
10779576|NCT03369340|11941097|FG000|STARTED|Day 4||3
10779577|NCT03369340|11941098|FG001|STARTED|Day 4||3
10779578|NCT03369340|11941099|FG002|STARTED|Day 4||3
10779579|NCT03369340|11941100|FG003|STARTED|Day 4||3
10779580|NCT03369340|11941101|FG004|STARTED|Day 4||3
10779581|NCT03369340|11941102|FG005|STARTED|Day 4||3
10779582|NCT03369340|11941097|FG000|COMPLETED|Day 4||3
10779583|NCT03369340|11941098|FG001|COMPLETED|Day 4||3
10779584|NCT03369340|11941099|FG002|COMPLETED|Day 4||3
10779585|NCT03369340|11941100|FG003|COMPLETED|Day 4||3
10779586|NCT03369340|11941101|FG004|COMPLETED|Day 4||3
10779587|NCT03369340|11941102|FG005|COMPLETED|Day 4||3
10779588|NCT03369340|11941097|FG000|NOT COMPLETED|Day 4||0
10779589|NCT03369340|11941098|FG001|NOT COMPLETED|Day 4||0
10779590|NCT03369340|11941099|FG002|NOT COMPLETED|Day 4||0
10779591|NCT03369340|11941100|FG003|NOT COMPLETED|Day 4||0
10779592|NCT03369340|11941101|FG004|NOT COMPLETED|Day 4||0
10779593|NCT03369340|11941102|FG005|NOT COMPLETED|Day 4||0
10779594|NCT03369418|11941114|FG000|STARTED|Overall Study||16
10779595|NCT03369418|11941115|FG001|STARTED|Overall Study||14
10779596|NCT03369418|11941114|FG000|COMPLETED|Overall Study||13
10779597|NCT03369418|11941115|FG001|COMPLETED|Overall Study||11
10779598|NCT03369418|11941114|FG000|NOT COMPLETED|Overall Study||3
10779599|NCT03369418|11941115|FG001|NOT COMPLETED|Overall Study||3
10779600|NCT03369704|11941123|FG000|STARTED|Treatment Epoch||162
10779601|NCT03369704|11941124|FG001|STARTED|Treatment Epoch||175
10779602|NCT03369704|11941123|FG000|COMPLETED|Treatment Epoch||158
10779603|NCT03369704|11941124|FG001|COMPLETED|Treatment Epoch||172
10779604|NCT03369704|11941123|FG000|NOT COMPLETED|Treatment Epoch||4
10779605|NCT03369704|11941124|FG001|NOT COMPLETED|Treatment Epoch||3
10779606|NCT03369704|11941123|FG000|STARTED|Follow-up Epoch||161
10779607|NCT03369704|11941124|FG001|STARTED|Follow-up Epoch||174
10779608|NCT03369704|11941123|FG000|COMPLETED|Follow-up Epoch||160
10779609|NCT03369704|11941124|FG001|COMPLETED|Follow-up Epoch||174
10779610|NCT03369704|11941123|FG000|NOT COMPLETED|Follow-up Epoch||1
10779611|NCT03369704|11941124|FG001|NOT COMPLETED|Follow-up Epoch||0
10779612|NCT03369756|11941130|FG000|STARTED|Overall Study||43
10779613|NCT03369756|11941130|FG000|COMPLETED|Overall Study|36 completed 4 weeks of treatment; 40 were considered statistical completers|36
10779614|NCT03369756|11941130|FG000|NOT COMPLETED|Overall Study||7
10779615|NCT03369951|11941134|FG000|STARTED|Overall Study||58
10779616|NCT03369951|11941134|FG000|Received Study Drug|Overall Study||57
10779617|NCT03369951|11941134|FG000|COMPLETED|Overall Study||52
10779618|NCT03369951|11941134|FG000|NOT COMPLETED|Overall Study||6
10779619|NCT03370042|11941140|FG000|STARTED|Overall Study||10
10779620|NCT03370042|11941141|FG001|STARTED|Overall Study||10
10779621|NCT03370042|11941140|FG000|COMPLETED|Overall Study||10
10779622|NCT03370042|11941141|FG001|COMPLETED|Overall Study||10
10779623|NCT03370042|11941140|FG000|NOT COMPLETED|Overall Study||0
10779624|NCT03370042|11941141|FG001|NOT COMPLETED|Overall Study||0
10779625|NCT03370289|11941151|FG000|STARTED|Overall Study||55
10779626|NCT03370289|11941151|FG000|COMPLETED|Overall Study||50
10779627|NCT03370289|11941151|FG000|NOT COMPLETED|Overall Study||5
10779628|NCT03370302|11941161|FG000|STARTED|Dose Escalation Phase||3
10779629|NCT03370302|11941162|FG001|STARTED|Dose Escalation Phase||6
10779630|NCT03370302|11941163|FG002|STARTED|Dose Escalation Phase||7
10779631|NCT03370302|11941164|FG003|STARTED|Dose Escalation Phase||0
10779632|NCT03370302|11941165|FG004|STARTED|Dose Escalation Phase||3
10779633|NCT03370302|11941166|FG005|STARTED|Dose Escalation Phase||3
10779634|NCT03370302|11941161|FG000|COMPLETED|Dose Escalation Phase||0
10779635|NCT03370302|11941162|FG001|COMPLETED|Dose Escalation Phase||0
10779636|NCT03370302|11941163|FG002|COMPLETED|Dose Escalation Phase||0
10779637|NCT03370302|11941164|FG003|COMPLETED|Dose Escalation Phase||0
10779638|NCT03370302|11941165|FG004|COMPLETED|Dose Escalation Phase||0
10779639|NCT03370302|11941166|FG005|COMPLETED|Dose Escalation Phase||0
10779640|NCT03370302|11941161|FG000|NOT COMPLETED|Dose Escalation Phase||3
10779641|NCT03370302|11941162|FG001|NOT COMPLETED|Dose Escalation Phase||6
10779642|NCT03370302|11941163|FG002|NOT COMPLETED|Dose Escalation Phase||7
10779643|NCT03370302|11941164|FG003|NOT COMPLETED|Dose Escalation Phase||0
10779644|NCT03370302|11941165|FG004|NOT COMPLETED|Dose Escalation Phase||3
10779645|NCT03370302|11941166|FG005|NOT COMPLETED|Dose Escalation Phase||3
10779646|NCT03370302|11941161|FG000|STARTED|Dose Expansion Phase||0
10779647|NCT03370302|11941162|FG001|STARTED|Dose Expansion Phase||0
10779648|NCT03370302|11941163|FG002|STARTED|Dose Expansion Phase||0
10779649|NCT03370302|11941164|FG003|STARTED|Dose Expansion Phase||6
10779650|NCT03370302|11941165|FG004|STARTED|Dose Expansion Phase||0
10779651|NCT03370302|11941166|FG005|STARTED|Dose Expansion Phase||0
10779652|NCT03370302|11941161|FG000|COMPLETED|Dose Expansion Phase||0
10779653|NCT03370302|11941162|FG001|COMPLETED|Dose Expansion Phase||0
10779654|NCT03370302|11941163|FG002|COMPLETED|Dose Expansion Phase||0
10779655|NCT03370302|11941164|FG003|COMPLETED|Dose Expansion Phase||0
10779656|NCT03370302|11941165|FG004|COMPLETED|Dose Expansion Phase||0
10779657|NCT03370302|11941166|FG005|COMPLETED|Dose Expansion Phase||0
10779658|NCT03370302|11941161|FG000|NOT COMPLETED|Dose Expansion Phase||0
10779659|NCT03370302|11941162|FG001|NOT COMPLETED|Dose Expansion Phase||0
10779660|NCT03370302|11941163|FG002|NOT COMPLETED|Dose Expansion Phase||0
10779661|NCT03370302|11941164|FG003|NOT COMPLETED|Dose Expansion Phase||6
10779662|NCT03370302|11941165|FG004|NOT COMPLETED|Dose Expansion Phase||0
10779663|NCT03370302|11941166|FG005|NOT COMPLETED|Dose Expansion Phase||0
10779664|NCT03370419|11941184|FG000|STARTED|Overall Study||40
10779665|NCT03370419|11941184|FG000|COMPLETED|Overall Study||24
10779666|NCT03370419|11941184|FG000|NOT COMPLETED|Overall Study||16
10779667|NCT03370471|11941190|FG000|STARTED|Overall Study||23
10779668|NCT03370471|11941191|FG001|STARTED|Overall Study||5
10779669|NCT03370471|11941190|FG000|COMPLETED|Overall Study||16
10779670|NCT03370471|11941191|FG001|COMPLETED|Overall Study||3
10779671|NCT03370471|11941190|FG000|NOT COMPLETED|Overall Study||7
10779672|NCT03370471|11941191|FG001|NOT COMPLETED|Overall Study||2
10779673|NCT03370770|11941199|FG000|STARTED|Overall Study||204
10779674|NCT03370770|11941199|FG000|COMPLETED|Overall Study||98
10779675|NCT03370770|11941199|FG000|NOT COMPLETED|Overall Study||106
10874958|NCT05105711|12041133|FG000|STARTED|Overall Study||21
10874959|NCT05105711|12041133|FG000|COMPLETED|Overall Study||19
10874960|NCT05105711|12041133|FG000|NOT COMPLETED|Overall Study||2
10874961|NCT04762771|12041139|FG000|STARTED|Overall Study||1
10874962|NCT04762771|12041140|FG001|STARTED|Overall Study||1
10874963|NCT04762771|12041139|FG000|COMPLETED|Overall Study||1
10874964|NCT04762771|12041140|FG001|COMPLETED|Overall Study||1
10874965|NCT04762771|12041139|FG000|NOT COMPLETED|Overall Study||0
10874966|NCT04762771|12041140|FG001|NOT COMPLETED|Overall Study||0
10874973|NCT04481035|12041161|FG000|STARTED|Period 1||3
10874974|NCT04481035|12041162|FG001|STARTED|Period 1||2
10874975|NCT04481035|12041161|FG000|COMPLETED|Period 1||3
10874976|NCT04481035|12041162|FG001|COMPLETED|Period 1||2
10874977|NCT04481035|12041161|FG000|NOT COMPLETED|Period 1||0
10874978|NCT04481035|12041162|FG001|NOT COMPLETED|Period 1||0
10874979|NCT04481035|12041161|FG000|STARTED|Period 2||3
10874980|NCT04481035|12041162|FG001|STARTED|Period 2||2
10874981|NCT04481035|12041161|FG000|COMPLETED|Period 2||3
10874982|NCT04481035|12041162|FG001|COMPLETED|Period 2||2
10874983|NCT04481035|12041161|FG000|NOT COMPLETED|Period 2||0
10874984|NCT04481035|12041162|FG001|NOT COMPLETED|Period 2||0
10874985|NCT04480749|12041170|FG000|STARTED|Overall Study||50
10874986|NCT04480749|12041171|FG001|STARTED|Overall Study||50
10874987|NCT04480749|12041170|FG000|COMPLETED|Overall Study||50
10874988|NCT04480749|12041171|FG001|COMPLETED|Overall Study||50
10874989|NCT04480749|12041170|FG000|NOT COMPLETED|Overall Study||0
10874990|NCT04480749|12041171|FG001|NOT COMPLETED|Overall Study||0
10874991|NCT04426695|12041195|FG000|STARTED|Overall Study||21
10874992|NCT04426695|12041196|FG001|STARTED|Overall Study||19
10874993|NCT04426695|12041197|FG002|STARTED|Overall Study||20
10874994|NCT04426695|12041198|FG003|STARTED|Overall Study||208
10874995|NCT04426695|12041199|FG004|STARTED|Overall Study||211
10874996|NCT04426695|12041200|FG005|STARTED|Overall Study||210
10874997|NCT04426695|12041201|FG006|STARTED|Overall Study||251
10874998|NCT04426695|12041202|FG007|STARTED|Overall Study||252
10874999|NCT04426695|12041203|FG008|STARTED|Overall Study||252
10875000|NCT04426695|12041204|FG009|STARTED|Overall Study||201
10875001|NCT04426695|12041205|FG010|STARTED|Overall Study||205
10875002|NCT04426695|12041206|FG011|STARTED|Overall Study||203
10875003|NCT04426695|12041207|FG012|STARTED|Overall Study||52
10875004|NCT04426695|12041208|FG013|STARTED|Overall Study||58
10875005|NCT04426695|12041209|FG014|STARTED|Overall Study||54
10875006|NCT04426695|12041210|FG015|STARTED|Overall Study||12
10875007|NCT04426695|12041211|FG016|STARTED|Overall Study||12
10875008|NCT04426695|12041212|FG017|STARTED|Overall Study||11
10875009|NCT04426695|12041195|FG000|Treated|Overall Study||18
10875010|NCT04426695|12041196|FG001|Treated|Overall Study||18
10875011|NCT04426695|12041197|FG002|Treated|Overall Study||20
10875012|NCT04426695|12041198|FG003|Treated|Overall Study||204
10875013|NCT04426695|12041199|FG004|Treated|Overall Study||206
10875014|NCT04426695|12041200|FG005|Treated|Overall Study||205
10875015|NCT04426695|12041201|FG006|Treated|Overall Study||247
10875016|NCT04426695|12041202|FG007|Treated|Overall Study||246
10875017|NCT04426695|12041203|FG008|Treated|Overall Study||246
10875018|NCT04426695|12041204|FG009|Treated|Overall Study||198
10875019|NCT04426695|12041205|FG010|Treated|Overall Study||202
10875020|NCT04426695|12041206|FG011|Treated|Overall Study||197
10875021|NCT04426695|12041207|FG012|Treated|Overall Study||51
10875022|NCT04426695|12041208|FG013|Treated|Overall Study||56
10875023|NCT04426695|12041209|FG014|Treated|Overall Study||54
10875024|NCT04426695|12041210|FG015|Treated|Overall Study||12
10875025|NCT04426695|12041211|FG016|Treated|Overall Study||12
10875026|NCT04426695|12041212|FG017|Treated|Overall Study||11
10875027|NCT04426695|12041195|FG000|COMPLETED|Overall Study||13
10875028|NCT04426695|12041196|FG001|COMPLETED|Overall Study||12
10875029|NCT04426695|12041197|FG002|COMPLETED|Overall Study||16
10875030|NCT04426695|12041198|FG003|COMPLETED|Overall Study||146
10875031|NCT04426695|12041199|FG004|COMPLETED|Overall Study||153
10875032|NCT04426695|12041200|FG005|COMPLETED|Overall Study||148
10875033|NCT04426695|12041201|FG006|COMPLETED|Overall Study||186
10875034|NCT04426695|12041202|FG007|COMPLETED|Overall Study||195
10875035|NCT04426695|12041203|FG008|COMPLETED|Overall Study||189
10875036|NCT04426695|12041204|FG009|COMPLETED|Overall Study||157
10875037|NCT04426695|12041205|FG010|COMPLETED|Overall Study||165
10875038|NCT04426695|12041206|FG011|COMPLETED|Overall Study||166
10875039|NCT04426695|12041207|FG012|COMPLETED|Overall Study||33
10875040|NCT04426695|12041208|FG013|COMPLETED|Overall Study||28
10875041|NCT04426695|12041209|FG014|COMPLETED|Overall Study||31
10875042|NCT04426695|12041210|FG015|COMPLETED|Overall Study||5
10875043|NCT04426695|12041211|FG016|COMPLETED|Overall Study||4
10875044|NCT04426695|12041212|FG017|COMPLETED|Overall Study||7
10875045|NCT04426695|12041195|FG000|NOT COMPLETED|Overall Study||8
10875046|NCT04426695|12041196|FG001|NOT COMPLETED|Overall Study||7
10875047|NCT04426695|12041197|FG002|NOT COMPLETED|Overall Study||4
10875048|NCT04426695|12041198|FG003|NOT COMPLETED|Overall Study||62
10875049|NCT04426695|12041199|FG004|NOT COMPLETED|Overall Study||58
10875050|NCT04426695|12041200|FG005|NOT COMPLETED|Overall Study||62
10875051|NCT04426695|12041201|FG006|NOT COMPLETED|Overall Study||65
10875052|NCT04426695|12041202|FG007|NOT COMPLETED|Overall Study||57
10875053|NCT04426695|12041203|FG008|NOT COMPLETED|Overall Study||63
10875054|NCT04426695|12041204|FG009|NOT COMPLETED|Overall Study||44
10875055|NCT04426695|12041205|FG010|NOT COMPLETED|Overall Study||40
10875056|NCT04426695|12041206|FG011|NOT COMPLETED|Overall Study||37
10875057|NCT04426695|12041207|FG012|NOT COMPLETED|Overall Study||19
10875058|NCT04426695|12041208|FG013|NOT COMPLETED|Overall Study||30
10875059|NCT04426695|12041209|FG014|NOT COMPLETED|Overall Study||23
10875060|NCT04426695|12041210|FG015|NOT COMPLETED|Overall Study||7
10875061|NCT04426695|12041211|FG016|NOT COMPLETED|Overall Study||8
10875062|NCT04426695|12041212|FG017|NOT COMPLETED|Overall Study||4
10875063|NCT04209400|12041289|FG000|STARTED|Overall Study||50
10875064|NCT04209400|12041290|FG001|STARTED|Overall Study||50
10875065|NCT04209400|12041289|FG000|COMPLETED|Overall Study||50
10875066|NCT04209400|12041290|FG001|COMPLETED|Overall Study||49
10875067|NCT04209400|12041289|FG000|NOT COMPLETED|Overall Study||0
10875068|NCT04209400|12041290|FG001|NOT COMPLETED|Overall Study||1
10875069|NCT04153435|12041298|FG000|STARTED|Overall Study||197
10875070|NCT04153435|12041299|FG001|STARTED|Overall Study||200
10875071|NCT04153435|12041298|FG000|COMPLETED|Overall Study||197
10875072|NCT04153435|12041299|FG001|COMPLETED|Overall Study||200
10875073|NCT04153435|12041298|FG000|NOT COMPLETED|Overall Study||0
10875074|NCT04153435|12041299|FG001|NOT COMPLETED|Overall Study||0
10875135|NCT04067492|12041348|FG000|STARTED|Overall Study||15
10875136|NCT04067492|12041349|FG001|STARTED|Overall Study||6
10875137|NCT04067492|12041350|FG002|STARTED|Overall Study||6
10875138|NCT04067492|12041351|FG003|STARTED|Overall Study||6
10875139|NCT04067492|12041352|FG004|STARTED|Overall Study||5
10875140|NCT04067492|12041353|FG005|STARTED|Overall Study||9
10875141|NCT04067492|12041348|FG000|COMPLETED|Overall Study||15
10875142|NCT04067492|12041349|FG001|COMPLETED|Overall Study||5
10875143|NCT04067492|12041350|FG002|COMPLETED|Overall Study||6
10875144|NCT04067492|12041351|FG003|COMPLETED|Overall Study||5
10875145|NCT04067492|12041352|FG004|COMPLETED|Overall Study||5
10875146|NCT04067492|12041353|FG005|COMPLETED|Overall Study||8
10875147|NCT04067492|12041348|FG000|NOT COMPLETED|Overall Study||0
10875148|NCT04067492|12041349|FG001|NOT COMPLETED|Overall Study||1
10875149|NCT04067492|12041350|FG002|NOT COMPLETED|Overall Study||0
10875150|NCT04067492|12041351|FG003|NOT COMPLETED|Overall Study||1
10875151|NCT04067492|12041352|FG004|NOT COMPLETED|Overall Study||0
10875152|NCT04067492|12041353|FG005|NOT COMPLETED|Overall Study||1
10875165|NCT03788967|12041379|FG000|STARTED|Overall Study||685
10875166|NCT03788967|12041380|FG001|STARTED|Overall Study||687
10875167|NCT03788967|12041379|FG000|Micro-Intent-to-Treat (ITT) Population|Overall Study||449
10875168|NCT03788967|12041380|FG001|Micro-Intent-to-Treat (ITT) Population|Overall Study||419
10875169|NCT03788967|12041379|FG000|COMPLETED|Overall Study||653
10875170|NCT03788967|12041380|FG001|COMPLETED|Overall Study||663
10875171|NCT03788967|12041379|FG000|NOT COMPLETED|Overall Study||32
10875172|NCT03788967|12041380|FG001|NOT COMPLETED|Overall Study||24
10875173|NCT03721172|12041390|FG000|STARTED|Placebo-controlled Phase||298
10875174|NCT03721172|12041391|FG001|STARTED|Placebo-controlled Phase||297
10875175|NCT03721172|12041392|FG002|STARTED|Placebo-controlled Phase|This arm was not included in the placebo-controlled phase.|0
10875176|NCT03721172|12041390|FG000|Received at Least 1 Dose of Treatment|Placebo-controlled Phase||297
10875177|NCT03721172|12041391|FG001|Received at Least 1 Dose of Treatment|Placebo-controlled Phase||297
10875178|NCT03721172|12041392|FG002|Received at Least 1 Dose of Treatment|Placebo-controlled Phase|This arm was not included in the placebo-controlled phase.|0
10875179|NCT03721172|12041390|FG000|COMPLETED|Placebo-controlled Phase||246
10875180|NCT03721172|12041391|FG001|COMPLETED|Placebo-controlled Phase||258
10875181|NCT03721172|12041392|FG002|COMPLETED|Placebo-controlled Phase|This arm was not included in the placebo-controlled phase.|0
10875182|NCT03721172|12041390|FG000|NOT COMPLETED|Placebo-controlled Phase||52
10875183|NCT03721172|12041391|FG001|NOT COMPLETED|Placebo-controlled Phase||39
10875184|NCT03721172|12041392|FG002|NOT COMPLETED|Placebo-controlled Phase||0
10875185|NCT03721172|12041390|FG000|STARTED|Apremilast Extension Phase|This arm was not included in the extension phase.|0
10875186|NCT03721172|12041391|FG001|STARTED|Apremilast Extension Phase|This arm was not included in the extension phase.|0
10875187|NCT03721172|12041392|FG002|STARTED|Apremilast Extension Phase|1 participant did not enter the extension phase due to physician decision.|503
10875188|NCT03721172|12041390|FG000|Received at Least 1 Dose|Apremilast Extension Phase|This arm was not included in the extension phase.|0
10875189|NCT03721172|12041391|FG001|Received at Least 1 Dose|Apremilast Extension Phase|This arm was not included in the extension phase.|0
10875190|NCT03721172|12041392|FG002|Received at Least 1 Dose|Apremilast Extension Phase||503
10875191|NCT03721172|12041390|FG000|COMPLETED|Apremilast Extension Phase|This arm was not included in the extension phase.|0
10875192|NCT03721172|12041391|FG001|COMPLETED|Apremilast Extension Phase|This arm was not included in the extension phase.|0
10875193|NCT03721172|12041392|FG002|COMPLETED|Apremilast Extension Phase||437
10875194|NCT03721172|12041390|FG000|NOT COMPLETED|Apremilast Extension Phase||0
10875195|NCT03721172|12041391|FG001|NOT COMPLETED|Apremilast Extension Phase||0
10875196|NCT03721172|12041392|FG002|NOT COMPLETED|Apremilast Extension Phase||66
10875197|NCT03692052|12041400|FG000|STARTED|Core Period (Day 1 to Week 24)||20
10875198|NCT03692052|12041400|FG000|COMPLETED|Core Period (Day 1 to Week 24)||19
10875199|NCT03692052|12041400|FG000|NOT COMPLETED|Core Period (Day 1 to Week 24)||1
10875200|NCT03692052|12041400|FG000|STARTED|Extension Period (Week 25 to 10 Years)||19
10875201|NCT03692052|12041400|FG000|COMPLETED|Extension Period (Week 25 to 10 Years)||0
10875202|NCT03692052|12041400|FG000|NOT COMPLETED|Extension Period (Week 25 to 10 Years)||19
10875203|NCT03596918|12041404|FG000|STARTED|Overall Study||10
10875204|NCT03596918|12041404|FG000|COMPLETED|Overall Study||10
10875205|NCT03596918|12041404|FG000|NOT COMPLETED|Overall Study||0
10875209|NCT03529669|12041412|FG000|STARTED|Overall Study||41
10875210|NCT03529669|12041412|FG000|COMPLETED|Overall Study||41
10875211|NCT03529669|12041412|FG000|NOT COMPLETED|Overall Study||0
10875224|NCT03410992|12041431|FG000|STARTED|Initial Treatment Period: up to Wk16||86
10875225|NCT03410992|12041432|FG001|STARTED|Initial Treatment Period: up to Wk16||349
10875226|NCT03410992|12041433|FG002|STARTED|Initial Treatment Period: up to Wk16||0
10875227|NCT03410992|12041434|FG003|STARTED|Initial Treatment Period: up to Wk16||0
10875228|NCT03410992|12041435|FG004|STARTED|Initial Treatment Period: up to Wk16||0
10875229|NCT03410992|12041436|FG005|STARTED|Initial Treatment Period: up to Wk16||0
10875230|NCT03410992|12041437|FG006|STARTED|Initial Treatment Period: up to Wk16||0
10875231|NCT03410992|12041438|FG007|STARTED|Initial Treatment Period: up to Wk16||0
10875232|NCT03410992|12041439|FG008|STARTED|Initial Treatment Period: up to Wk16||0
10875233|NCT03410992|12041440|FG009|STARTED|Initial Treatment Period: up to Wk16||0
10875234|NCT03410992|12041441|FG010|STARTED|Initial Treatment Period: up to Wk16||0
10875235|NCT03410992|12041431|FG000|COMPLETED|Initial Treatment Period: up to Wk16||82
10875236|NCT03410992|12041432|FG001|COMPLETED|Initial Treatment Period: up to Wk16||340
10875237|NCT03410992|12041433|FG002|COMPLETED|Initial Treatment Period: up to Wk16||0
10875238|NCT03410992|12041434|FG003|COMPLETED|Initial Treatment Period: up to Wk16||0
10875239|NCT03410992|12041435|FG004|COMPLETED|Initial Treatment Period: up to Wk16||0
10875240|NCT03410992|12041436|FG005|COMPLETED|Initial Treatment Period: up to Wk16||0
10875241|NCT03410992|12041437|FG006|COMPLETED|Initial Treatment Period: up to Wk16||0
10875242|NCT03410992|12041438|FG007|COMPLETED|Initial Treatment Period: up to Wk16||0
10875243|NCT03410992|12041439|FG008|COMPLETED|Initial Treatment Period: up to Wk16||0
10875244|NCT03410992|12041440|FG009|COMPLETED|Initial Treatment Period: up to Wk16||0
10875245|NCT03410992|12041441|FG010|COMPLETED|Initial Treatment Period: up to Wk16||0
10875246|NCT03410992|12041431|FG000|NOT COMPLETED|Initial Treatment Period: up to Wk16||4
10875247|NCT03410992|12041432|FG001|NOT COMPLETED|Initial Treatment Period: up to Wk16||9
10875248|NCT03410992|12041433|FG002|NOT COMPLETED|Initial Treatment Period: up to Wk16||0
10875249|NCT03410992|12041434|FG003|NOT COMPLETED|Initial Treatment Period: up to Wk16||0
10875250|NCT03410992|12041435|FG004|NOT COMPLETED|Initial Treatment Period: up to Wk16||0
10875251|NCT03410992|12041436|FG005|NOT COMPLETED|Initial Treatment Period: up to Wk16||0
10875252|NCT03410992|12041437|FG006|NOT COMPLETED|Initial Treatment Period: up to Wk16||0
10875253|NCT03410992|12041438|FG007|NOT COMPLETED|Initial Treatment Period: up to Wk16||0
10875254|NCT03410992|12041439|FG008|NOT COMPLETED|Initial Treatment Period: up to Wk16||0
10875255|NCT03410992|12041440|FG009|NOT COMPLETED|Initial Treatment Period: up to Wk16||0
10875256|NCT03410992|12041441|FG010|NOT COMPLETED|Initial Treatment Period: up to Wk16||0
10875257|NCT03410992|12041431|FG000|STARTED|Week 16 Assessment||82
10875258|NCT03410992|12041432|FG001|STARTED|Week 16 Assessment||340
10875259|NCT03410992|12041433|FG002|STARTED|Week 16 Assessment||0
10875260|NCT03410992|12041434|FG003|STARTED|Week 16 Assessment||0
10875261|NCT03410992|12041435|FG004|STARTED|Week 16 Assessment||0
10875262|NCT03410992|12041436|FG005|STARTED|Week 16 Assessment||0
10875263|NCT03410992|12041437|FG006|STARTED|Week 16 Assessment||0
10875264|NCT03410992|12041438|FG007|STARTED|Week 16 Assessment||0
10875265|NCT03410992|12041439|FG008|STARTED|Week 16 Assessment||0
10875266|NCT03410992|12041440|FG009|STARTED|Week 16 Assessment||0
10875267|NCT03410992|12041441|FG010|STARTED|Week 16 Assessment||0
10875268|NCT03410992|12041431|FG000|Received Escape Treatment|Week 16 Assessment||81
10875269|NCT03410992|12041432|FG001|Received Escape Treatment|Week 16 Assessment||23
10875270|NCT03410992|12041433|FG002|Received Escape Treatment|Week 16 Assessment||0
10875271|NCT03410992|12041434|FG003|Received Escape Treatment|Week 16 Assessment||0
10875272|NCT03410992|12041435|FG004|Received Escape Treatment|Week 16 Assessment||0
10875273|NCT03410992|12041436|FG005|Received Escape Treatment|Week 16 Assessment||0
10875274|NCT03410992|12041437|FG006|Received Escape Treatment|Week 16 Assessment||0
10875275|NCT03410992|12041438|FG007|Received Escape Treatment|Week 16 Assessment||0
10875276|NCT03410992|12041439|FG008|Received Escape Treatment|Week 16 Assessment||0
10875277|NCT03410992|12041440|FG009|Received Escape Treatment|Week 16 Assessment||0
10875278|NCT03410992|12041441|FG010|Received Escape Treatment|Week 16 Assessment||0
10875279|NCT03410992|12041431|FG000|COMPLETED|Week 16 Assessment||1
10875280|NCT03410992|12041432|FG001|COMPLETED|Week 16 Assessment||311
10875281|NCT03410992|12041433|FG002|COMPLETED|Week 16 Assessment||0
10875282|NCT03410992|12041434|FG003|COMPLETED|Week 16 Assessment||0
10875283|NCT03410992|12041435|FG004|COMPLETED|Week 16 Assessment||0
10875284|NCT03410992|12041436|FG005|COMPLETED|Week 16 Assessment||0
10875285|NCT03410992|12041437|FG006|COMPLETED|Week 16 Assessment||0
10875286|NCT03410992|12041438|FG007|COMPLETED|Week 16 Assessment||0
10875287|NCT03410992|12041439|FG008|COMPLETED|Week 16 Assessment||0
10875288|NCT03410992|12041440|FG009|COMPLETED|Week 16 Assessment||0
10875289|NCT03410992|12041441|FG010|COMPLETED|Week 16 Assessment||0
10875290|NCT03410992|12041431|FG000|NOT COMPLETED|Week 16 Assessment||81
10875291|NCT03410992|12041432|FG001|NOT COMPLETED|Week 16 Assessment||29
10875292|NCT03410992|12041433|FG002|NOT COMPLETED|Week 16 Assessment||0
10875293|NCT03410992|12041434|FG003|NOT COMPLETED|Week 16 Assessment||0
10875294|NCT03410992|12041435|FG004|NOT COMPLETED|Week 16 Assessment||0
10875295|NCT03410992|12041436|FG005|NOT COMPLETED|Week 16 Assessment||0
10875296|NCT03410992|12041437|FG006|NOT COMPLETED|Week 16 Assessment||0
10875297|NCT03410992|12041438|FG007|NOT COMPLETED|Week 16 Assessment||0
10875298|NCT03410992|12041439|FG008|NOT COMPLETED|Week 16 Assessment||0
10875299|NCT03410992|12041440|FG009|NOT COMPLETED|Week 16 Assessment||0
10875300|NCT03410992|12041441|FG010|NOT COMPLETED|Week 16 Assessment||0
10875301|NCT03410992|12041431|FG000|STARTED|Randomized-Withdrawal Period: up to Wk56||0
10875302|NCT03410992|12041432|FG001|STARTED|Randomized-Withdrawal Period: up to Wk56||0
10875303|NCT03410992|12041433|FG002|STARTED|Randomized-Withdrawal Period: up to Wk56||1
10875304|NCT03410992|12041434|FG003|STARTED|Randomized-Withdrawal Period: up to Wk56||105
10875305|NCT03410992|12041435|FG004|STARTED|Randomized-Withdrawal Period: up to Wk56||100
10875306|NCT03410992|12041436|FG005|STARTED|Randomized-Withdrawal Period: up to Wk56||106
10875307|NCT03410992|12041437|FG006|STARTED|Randomized-Withdrawal Period: up to Wk56||0
10875308|NCT03410992|12041438|FG007|STARTED|Randomized-Withdrawal Period: up to Wk56||0
10875309|NCT03410992|12041439|FG008|STARTED|Randomized-Withdrawal Period: up to Wk56||0
10875310|NCT03410992|12041440|FG009|STARTED|Randomized-Withdrawal Period: up to Wk56||0
10875311|NCT03410992|12041441|FG010|STARTED|Randomized-Withdrawal Period: up to Wk56||0
10875312|NCT03410992|12041431|FG000|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0
10875313|NCT03410992|12041432|FG001|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0
10875314|NCT03410992|12041433|FG002|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0
10875315|NCT03410992|12041434|FG003|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||67
10875316|NCT03410992|12041435|FG004|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||4
10875317|NCT03410992|12041436|FG005|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||7
10875318|NCT03410992|12041437|FG006|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0
10875319|NCT03410992|12041438|FG007|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0
10875320|NCT03410992|12041439|FG008|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0
10875321|NCT03410992|12041440|FG009|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0
10875322|NCT03410992|12041441|FG010|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0
10875323|NCT03410992|12041431|FG000|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
10875324|NCT03410992|12041432|FG001|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
10875325|NCT03410992|12041433|FG002|COMPLETED|Randomized-Withdrawal Period: up to Wk56||1
10875326|NCT03410992|12041434|FG003|COMPLETED|Randomized-Withdrawal Period: up to Wk56||33
10875327|NCT03410992|12041435|FG004|COMPLETED|Randomized-Withdrawal Period: up to Wk56||93
10875328|NCT03410992|12041436|FG005|COMPLETED|Randomized-Withdrawal Period: up to Wk56||94
10875329|NCT03410992|12041437|FG006|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
10875330|NCT03410992|12041438|FG007|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
10875331|NCT03410992|12041439|FG008|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
10875332|NCT03410992|12041440|FG009|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
10875333|NCT03410992|12041441|FG010|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
10875334|NCT03410992|12041431|FG000|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
10875335|NCT03410992|12041432|FG001|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
10875336|NCT03410992|12041433|FG002|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
10875337|NCT03410992|12041434|FG003|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||72
10875338|NCT03410992|12041435|FG004|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||7
10875339|NCT03410992|12041436|FG005|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||12
10875340|NCT03410992|12041437|FG006|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
10875341|NCT03410992|12041438|FG007|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
10875342|NCT03410992|12041439|FG008|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
10875343|NCT03410992|12041440|FG009|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
10875344|NCT03410992|12041441|FG010|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
10875345|NCT03410992|12041431|FG000|STARTED|Escape Treatment: 12 Weeks||0
10875346|NCT03410992|12041432|FG001|STARTED|Escape Treatment: 12 Weeks||0
10875347|NCT03410992|12041433|FG002|STARTED|Escape Treatment: 12 Weeks||0
10875348|NCT03410992|12041434|FG003|STARTED|Escape Treatment: 12 Weeks||0
10875349|NCT03410992|12041435|FG004|STARTED|Escape Treatment: 12 Weeks||0
10875350|NCT03410992|12041436|FG005|STARTED|Escape Treatment: 12 Weeks||0
10875351|NCT03410992|12041437|FG006|STARTED|Escape Treatment: 12 Weeks||81
10875352|NCT03410992|12041438|FG007|STARTED|Escape Treatment: 12 Weeks||23
10875353|NCT03410992|12041439|FG008|STARTED|Escape Treatment: 12 Weeks||67
10875354|NCT03410992|12041440|FG009|STARTED|Escape Treatment: 12 Weeks||4
10875355|NCT03410992|12041441|FG010|STARTED|Escape Treatment: 12 Weeks||7
10875356|NCT03410992|12041431|FG000|COMPLETED|Escape Treatment: 12 Weeks||0
10875357|NCT03410992|12041432|FG001|COMPLETED|Escape Treatment: 12 Weeks||0
10875358|NCT03410992|12041433|FG002|COMPLETED|Escape Treatment: 12 Weeks||0
10875359|NCT03410992|12041434|FG003|COMPLETED|Escape Treatment: 12 Weeks||0
10875360|NCT03410992|12041435|FG004|COMPLETED|Escape Treatment: 12 Weeks||0
10875361|NCT03410992|12041436|FG005|COMPLETED|Escape Treatment: 12 Weeks||0
10875362|NCT03410992|12041437|FG006|COMPLETED|Escape Treatment: 12 Weeks||81
10875363|NCT03410992|12041438|FG007|COMPLETED|Escape Treatment: 12 Weeks||22
10875364|NCT03410992|12041439|FG008|COMPLETED|Escape Treatment: 12 Weeks||66
10875365|NCT03410992|12041440|FG009|COMPLETED|Escape Treatment: 12 Weeks||4
10875366|NCT03410992|12041441|FG010|COMPLETED|Escape Treatment: 12 Weeks||7
10875367|NCT03410992|12041431|FG000|NOT COMPLETED|Escape Treatment: 12 Weeks||0
10875368|NCT03410992|12041432|FG001|NOT COMPLETED|Escape Treatment: 12 Weeks||0
10875369|NCT03410992|12041433|FG002|NOT COMPLETED|Escape Treatment: 12 Weeks||0
10875370|NCT03410992|12041434|FG003|NOT COMPLETED|Escape Treatment: 12 Weeks||0
10875371|NCT03410992|12041435|FG004|NOT COMPLETED|Escape Treatment: 12 Weeks||0
10875372|NCT03410992|12041436|FG005|NOT COMPLETED|Escape Treatment: 12 Weeks||0
10875373|NCT03410992|12041437|FG006|NOT COMPLETED|Escape Treatment: 12 Weeks||0
10875374|NCT03410992|12041438|FG007|NOT COMPLETED|Escape Treatment: 12 Weeks||1
10875375|NCT03410992|12041439|FG008|NOT COMPLETED|Escape Treatment: 12 Weeks||1
10875376|NCT03410992|12041440|FG009|NOT COMPLETED|Escape Treatment: 12 Weeks||0
10875377|NCT03410992|12041441|FG010|NOT COMPLETED|Escape Treatment: 12 Weeks||0
10875378|NCT03370133|12041474|FG000|STARTED|Initial Treatment Period (WK 16)||83
10875379|NCT03370133|12041475|FG001|STARTED|Initial Treatment Period (WK 16)||321
10875380|NCT03370133|12041476|FG002|STARTED|Initial Treatment Period (WK 16)||163
10875381|NCT03370133|12041477|FG003|STARTED|Initial Treatment Period (WK 16)||0
10875382|NCT03370133|12041478|FG004|STARTED|Initial Treatment Period (WK 16)||0
10875383|NCT03370133|12041479|FG005|STARTED|Initial Treatment Period (WK 16)||0
10875384|NCT03370133|12041474|FG000|COMPLETED|Initial Treatment Period (WK 16)||74
10875385|NCT03370133|12041475|FG001|COMPLETED|Initial Treatment Period (WK 16)||306
10875386|NCT03370133|12041476|FG002|COMPLETED|Initial Treatment Period (WK 16)||157
10875387|NCT03370133|12041477|FG003|COMPLETED|Initial Treatment Period (WK 16)||0
10875388|NCT03370133|12041478|FG004|COMPLETED|Initial Treatment Period (WK 16)||0
10875389|NCT03370133|12041479|FG005|COMPLETED|Initial Treatment Period (WK 16)||0
10875390|NCT03370133|12041474|FG000|NOT COMPLETED|Initial Treatment Period (WK 16)||9
10875391|NCT03370133|12041475|FG001|NOT COMPLETED|Initial Treatment Period (WK 16)||15
10875392|NCT03370133|12041476|FG002|NOT COMPLETED|Initial Treatment Period (WK 16)||6
10875393|NCT03370133|12041477|FG003|NOT COMPLETED|Initial Treatment Period (WK 16)||0
10875394|NCT03370133|12041478|FG004|NOT COMPLETED|Initial Treatment Period (WK 16)||0
10875395|NCT03370133|12041479|FG005|NOT COMPLETED|Initial Treatment Period (WK 16)||0
10875396|NCT03370133|12041474|FG000|STARTED|Maintenance Treatment Period (WK 52)||0
10875397|NCT03370133|12041475|FG001|STARTED|Maintenance Treatment Period (WK 52)||0
10875398|NCT03370133|12041476|FG002|STARTED|Maintenance Treatment Period (WK 52)||0
10875399|NCT03370133|12041477|FG003|STARTED|Maintenance Treatment Period (WK 52)||74
10875400|NCT03370133|12041478|FG004|STARTED|Maintenance Treatment Period (WK 52)||306
10875401|NCT03370133|12041479|FG005|STARTED|Maintenance Treatment Period (WK 52)||157
10875402|NCT03370133|12041474|FG000|COMPLETED|Maintenance Treatment Period (WK 52)||0
10875403|NCT03370133|12041475|FG001|COMPLETED|Maintenance Treatment Period (WK 52)||0
10875404|NCT03370133|12041476|FG002|COMPLETED|Maintenance Treatment Period (WK 52)||0
10875405|NCT03370133|12041477|FG003|COMPLETED|Maintenance Treatment Period (WK 52)||69
10875406|NCT03370133|12041478|FG004|COMPLETED|Maintenance Treatment Period (WK 52)||283
10875407|NCT03370133|12041479|FG005|COMPLETED|Maintenance Treatment Period (WK 52)||141
10875408|NCT03370133|12041474|FG000|NOT COMPLETED|Maintenance Treatment Period (WK 52)||0
10875409|NCT03370133|12041475|FG001|NOT COMPLETED|Maintenance Treatment Period (WK 52)||0
10875410|NCT03370133|12041476|FG002|NOT COMPLETED|Maintenance Treatment Period (WK 52)||0
10875411|NCT03370133|12041477|FG003|NOT COMPLETED|Maintenance Treatment Period (WK 52)||5
10875412|NCT03370133|12041478|FG004|NOT COMPLETED|Maintenance Treatment Period (WK 52)||23
10875413|NCT03370133|12041479|FG005|NOT COMPLETED|Maintenance Treatment Period (WK 52)||16
10875420|NCT03291587|12041508|FG000|STARTED|Overall Study|5 were found ineligible after baseline|523
10875421|NCT03291587|12041509|FG001|STARTED|Overall Study|1 was found ineligible after baseline|571
10875422|NCT03291587|12041508|FG000|14 Day Follow-up|Overall Study|32 could not be reached, 1 not interested, 4 too busy to participate, 1 site withdrew, 1 previously consented and removed from study, 1 personal health reasons|483
10875423|NCT03291587|12041509|FG001|14 Day Follow-up|Overall Study|22 could not be reached, 1 too busy to participate, 1 not interested in participating.|547
10875424|NCT03291587|12041508|FG000|3 Month Follow-up|Overall Study|63 could not be reached, 2 refused to answer, 2 expired, 4 not interested in participating, 1 personal health reasons|445
10875425|NCT03291587|12041509|FG001|3 Month Follow-up|Overall Study|26 could not be reached, 2 expired, and 3 not interested in participating|538
10875426|NCT03291587|12041508|FG000|COMPLETED|Overall Study|62 could not be reached, 3 refused to answer, 2 not interested in participating, 1 personal health reason|442
10875427|NCT03291587|12041509|FG001|COMPLETED|Overall Study|43 could not be reached,2 refused to answer, 2 expired, and 2 not interested in participating|514
10875428|NCT03291587|12041508|FG000|NOT COMPLETED|Overall Study||81
10875429|NCT03291587|12041509|FG001|NOT COMPLETED|Overall Study||57
10875430|NCT03283982|12041518|FG000|STARTED|Overall Study||39
10875431|NCT03283982|12041519|FG001|STARTED|Overall Study||36
10875432|NCT03283982|12041518|FG000|COMPLETED|Overall Study||39
10875433|NCT03283982|12041519|FG001|COMPLETED|Overall Study||36
10875434|NCT03283982|12041518|FG000|NOT COMPLETED|Overall Study||0
10875435|NCT03283982|12041519|FG001|NOT COMPLETED|Overall Study||0
10875448|NCT02948829|12041543|FG000|STARTED|Overall Study||200
10875449|NCT02948829|12041543|FG000|COMPLETED|Overall Study||184
10875450|NCT02948829|12041543|FG000|NOT COMPLETED|Overall Study||16
10875451|NCT02866643|12041564|FG000|STARTED|Overall Study||48
10875452|NCT02866643|12041565|FG001|STARTED|Overall Study||47
10875453|NCT02866643|12041564|FG000|Intent-to-Treat (ITT) Population|Overall Study||38
10875454|NCT02866643|12041565|FG001|Intent-to-Treat (ITT) Population|Overall Study||39
10875455|NCT02866643|12041564|FG000|Per Protocol Population|Overall Study||35
10875456|NCT02866643|12041565|FG001|Per Protocol Population|Overall Study||35
10875457|NCT02866643|12041564|FG000|COMPLETED|Overall Study||35
10875458|NCT02866643|12041565|FG001|COMPLETED|Overall Study||35
10875459|NCT02866643|12041564|FG000|NOT COMPLETED|Overall Study||13
10875460|NCT02866643|12041565|FG001|NOT COMPLETED|Overall Study||12
10875461|NCT02819518|12041578|FG000|STARTED|Overall Study||11
10875462|NCT02819518|12041579|FG001|STARTED|Overall Study||14
10875463|NCT02819518|12041580|FG002|STARTED|Overall Study||10
10875464|NCT02819518|12041581|FG003|STARTED|Overall Study||566
10875465|NCT02819518|12041582|FG004|STARTED|Overall Study||281
10875466|NCT02819518|12041578|FG000|COMPLETED|Overall Study||0
10875467|NCT02819518|12041579|FG001|COMPLETED|Overall Study||0
10875468|NCT02819518|12041580|FG002|COMPLETED|Overall Study||0
10875469|NCT02819518|12041581|FG003|COMPLETED|Overall Study||0
10875470|NCT02819518|12041582|FG004|COMPLETED|Overall Study||0
10875471|NCT02819518|12041578|FG000|NOT COMPLETED|Overall Study||11
10875472|NCT02819518|12041579|FG001|NOT COMPLETED|Overall Study||14
10875473|NCT02819518|12041580|FG002|NOT COMPLETED|Overall Study||10
10875474|NCT02819518|12041581|FG003|NOT COMPLETED|Overall Study||566
10875475|NCT02819518|12041582|FG004|NOT COMPLETED|Overall Study||281
10875476|NCT02767856|12041598|FG000|STARTED|Overall Study||18
10875477|NCT02767856|12041599|FG001|STARTED|Overall Study||14
10875478|NCT02767856|12041598|FG000|COMPLETED|Overall Study||7
10875479|NCT02767856|12041599|FG001|COMPLETED|Overall Study||12
10875480|NCT02767856|12041598|FG000|NOT COMPLETED|Overall Study||11
10875481|NCT02767856|12041599|FG001|NOT COMPLETED|Overall Study||2
10875494|NCT02719691|12041621|FG000|STARTED|Overall Study||3
10875495|NCT02719691|12041622|FG001|STARTED|Overall Study||4
10875496|NCT02719691|12041623|FG002|STARTED|Overall Study||7
10875497|NCT02719691|12041624|FG003|STARTED|Overall Study||2
10875498|NCT02719691|12041625|FG004|STARTED|Overall Study||10
10875499|NCT02719691|12041626|FG005|STARTED|Overall Study||10
10875500|NCT02719691|12041627|FG006|STARTED|Overall Study||11
10875501|NCT02719691|12041621|FG000|COMPLETED|Overall Study||3
10875502|NCT02719691|12041622|FG001|COMPLETED|Overall Study||4
10875503|NCT02719691|12041623|FG002|COMPLETED|Overall Study||6
10875504|NCT02719691|12041624|FG003|COMPLETED|Overall Study||2
10875505|NCT02719691|12041625|FG004|COMPLETED|Overall Study||10
10875506|NCT02719691|12041626|FG005|COMPLETED|Overall Study||9
10875507|NCT02719691|12041627|FG006|COMPLETED|Overall Study||11
10875508|NCT02719691|12041621|FG000|NOT COMPLETED|Overall Study||0
10875509|NCT02719691|12041622|FG001|NOT COMPLETED|Overall Study||0
10875510|NCT02719691|12041623|FG002|NOT COMPLETED|Overall Study||1
10875511|NCT02719691|12041624|FG003|NOT COMPLETED|Overall Study||0
10875512|NCT02719691|12041625|FG004|NOT COMPLETED|Overall Study||0
10875513|NCT02719691|12041626|FG005|NOT COMPLETED|Overall Study||1
10875514|NCT02719691|12041627|FG006|NOT COMPLETED|Overall Study||0
10875515|NCT02613507|12041646|FG000|STARTED|Overall Study||338
10875516|NCT02613507|12041647|FG001|STARTED|Overall Study||166
10875517|NCT02613507|12041646|FG000|COMPLETED|Overall Study||50
10875518|NCT02613507|12041647|FG001|COMPLETED|Overall Study||2
10875519|NCT02613507|12041646|FG000|NOT COMPLETED|Overall Study||288
10875520|NCT02613507|12041647|FG001|NOT COMPLETED|Overall Study||164
10875521|NCT02586857|12041655|FG000|STARTED|Overall Study||15
10875522|NCT02586857|12041656|FG001|STARTED|Overall Study||9
10875523|NCT02586857|12041655|FG000|Enrolled|Overall Study||15
10875524|NCT02586857|12041656|FG001|Enrolled|Overall Study||9
10875525|NCT02586857|12041655|FG000|Received Study Medication|Overall Study||15
10875526|NCT02586857|12041656|FG001|Received Study Medication|Overall Study||9
10875527|NCT02586857|12041655|FG000|Discontinued Study|Overall Study||14
10875528|NCT02586857|12041656|FG001|Discontinued Study|Overall Study||9
10875529|NCT02586857|12041655|FG000|COMPLETED|Overall Study||14
10875530|NCT02586857|12041656|FG001|COMPLETED|Overall Study||9
10875531|NCT02586857|12041655|FG000|NOT COMPLETED|Overall Study||1
10875532|NCT02586857|12041656|FG001|NOT COMPLETED|Overall Study||0
10875533|NCT02412228|12041662|FG000|STARTED|Overall Study||12
10875534|NCT02412228|12041662|FG000|COMPLETED|Overall Study||12
10875535|NCT02412228|12041662|FG000|NOT COMPLETED|Overall Study||0
10875536|NCT02410213|12041666|FG000|STARTED|Overall Study||16
10875537|NCT02410213|12041667|FG001|STARTED|Overall Study||19
10875538|NCT02410213|12041666|FG000|COMPLETED|Overall Study||16
10875539|NCT02410213|12041667|FG001|COMPLETED|Overall Study||19
10875540|NCT02410213|12041666|FG000|NOT COMPLETED|Overall Study||0
10875541|NCT02410213|12041667|FG001|NOT COMPLETED|Overall Study||0
10875569|NCT02339506|12041684|FG000|STARTED|Period 1 (Placebo or Cosyntropin)||12
10875570|NCT02339506|12041685|FG001|STARTED|Period 1 (Placebo or Cosyntropin)||11
10875571|NCT02339506|12041684|FG000|COMPLETED|Period 1 (Placebo or Cosyntropin)||12
10875572|NCT02339506|12041685|FG001|COMPLETED|Period 1 (Placebo or Cosyntropin)||10
10875573|NCT02339506|12041684|FG000|NOT COMPLETED|Period 1 (Placebo or Cosyntropin)||0
10875574|NCT02339506|12041685|FG001|NOT COMPLETED|Period 1 (Placebo or Cosyntropin)||1
10875575|NCT02339506|12041684|FG000|STARTED|Washout (Period 2)||12
10875576|NCT02339506|12041685|FG001|STARTED|Washout (Period 2)||10
10875577|NCT02339506|12041684|FG000|COMPLETED|Washout (Period 2)||10
10875578|NCT02339506|12041685|FG001|COMPLETED|Washout (Period 2)||10
10875579|NCT02339506|12041684|FG000|NOT COMPLETED|Washout (Period 2)||2
10875580|NCT02339506|12041685|FG001|NOT COMPLETED|Washout (Period 2)||0
10875581|NCT02339506|12041684|FG000|STARTED|Period 3 (Placebo or Cosyntropin)||10
10875582|NCT02339506|12041685|FG001|STARTED|Period 3 (Placebo or Cosyntropin)||10
10875583|NCT02339506|12041684|FG000|COMPLETED|Period 3 (Placebo or Cosyntropin)||10
10875584|NCT02339506|12041685|FG001|COMPLETED|Period 3 (Placebo or Cosyntropin)||10
10875585|NCT02339506|12041684|FG000|NOT COMPLETED|Period 3 (Placebo or Cosyntropin)||0
10875586|NCT02339506|12041685|FG001|NOT COMPLETED|Period 3 (Placebo or Cosyntropin)||0
10875587|NCT02324504|12041691|FG000|STARTED|Overall Study||60
10875588|NCT02324504|12041691|FG000|COMPLETED|Overall Study||60
10875589|NCT02324504|12041691|FG000|NOT COMPLETED|Overall Study||0
10875590|NCT02206048|12041698|FG000|STARTED|Overall Study||9
10875591|NCT02206048|12041698|FG000|COMPLETED|Overall Study||8
10875592|NCT02206048|12041698|FG000|NOT COMPLETED|Overall Study||1
10875593|NCT02203305|12041705|FG000|STARTED|Overall Study||20
10875594|NCT02203305|12041706|FG001|STARTED|Overall Study||3
10875595|NCT02203305|12041707|FG002|STARTED|Overall Study||20
10875596|NCT02203305|12041705|FG000|COMPLETED|Overall Study||20
10875597|NCT02203305|12041706|FG001|COMPLETED|Overall Study||3
10875598|NCT02203305|12041707|FG002|COMPLETED|Overall Study||19
10875599|NCT02203305|12041705|FG000|NOT COMPLETED|Overall Study||0
10875600|NCT02203305|12041706|FG001|NOT COMPLETED|Overall Study||0
10875601|NCT02203305|12041707|FG002|NOT COMPLETED|Overall Study||1
10875602|NCT02068885|12041720|FG000|STARTED|Overall Study||57
10875603|NCT02068885|12041721|FG001|STARTED|Overall Study||53
10875604|NCT02068885|12041722|FG002|STARTED|Overall Study||54
10875605|NCT02068885|12041720|FG000|Provided Data at Midpoint Test Phase|Overall Study||56
10875606|NCT02068885|12041721|FG001|Provided Data at Midpoint Test Phase|Overall Study||50
10875607|NCT02068885|12041722|FG002|Provided Data at Midpoint Test Phase|Overall Study||48
10875608|NCT02068885|12041720|FG000|Provided Data at End of Test Phase|Overall Study||54
10875609|NCT02068885|12041721|FG001|Provided Data at End of Test Phase|Overall Study||48
10875610|NCT02068885|12041722|FG002|Provided Data at End of Test Phase|Overall Study||46
10875611|NCT02068885|12041720|FG000|Included in Intention-to-treat Analysis|Overall Study||56
10875612|NCT02068885|12041721|FG001|Included in Intention-to-treat Analysis|Overall Study||52
10875613|NCT02068885|12041722|FG002|Included in Intention-to-treat Analysis|Overall Study||54
10875614|NCT02068885|12041720|FG000|COMPLETED|Overall Study||54
10875615|NCT02068885|12041721|FG001|COMPLETED|Overall Study||48
10875616|NCT02068885|12041722|FG002|COMPLETED|Overall Study||46
10875617|NCT02068885|12041720|FG000|NOT COMPLETED|Overall Study||3
10875618|NCT02068885|12041721|FG001|NOT COMPLETED|Overall Study||5
10875619|NCT02068885|12041722|FG002|NOT COMPLETED|Overall Study||8
10875620|NCT02005471|12041733|FG000|STARTED|Overall Study||195
10875621|NCT02005471|12041734|FG001|STARTED|Overall Study||194
10875622|NCT02005471|12041733|FG000|Treated|Overall Study||188
10875623|NCT02005471|12041734|FG001|Treated|Overall Study||194
10875624|NCT02005471|12041733|FG000|COMPLETED|Overall Study||0
10875625|NCT02005471|12041734|FG001|COMPLETED|Overall Study||0
10875626|NCT02005471|12041733|FG000|NOT COMPLETED|Overall Study||195
10875627|NCT02005471|12041734|FG001|NOT COMPLETED|Overall Study||194
10875628|NCT01565941|12041745|FG000|STARTED|Overall Study||360
10875629|NCT01565941|12041746|FG001|STARTED|Overall Study||353
10875630|NCT01565941|12041745|FG000|COMPLETED|Overall Study||349
10875631|NCT01565941|12041746|FG001|COMPLETED|Overall Study||349
10875632|NCT01565941|12041745|FG000|NOT COMPLETED|Overall Study||11
10875633|NCT01565941|12041746|FG001|NOT COMPLETED|Overall Study||4
10875652|NCT00676715|12041784|FG000|STARTED|Overall Study||54
10875653|NCT00676715|12041785|FG001|STARTED|Overall Study||55
10875654|NCT00676715|12041786|FG002|STARTED|Overall Study||55
10875655|NCT00676715|12041787|FG003|STARTED|Overall Study||54
10875656|NCT00676715|12041784|FG000|COMPLETED|Overall Study||14
10875657|NCT00676715|12041785|FG001|COMPLETED|Overall Study||8
10875658|NCT00676715|12041786|FG002|COMPLETED|Overall Study||14
10875659|NCT00676715|12041787|FG003|COMPLETED|Overall Study||14
10875660|NCT00676715|12041784|FG000|NOT COMPLETED|Overall Study||40
10875661|NCT00676715|12041785|FG001|NOT COMPLETED|Overall Study||47
10875662|NCT00676715|12041786|FG002|NOT COMPLETED|Overall Study||41
10875663|NCT00676715|12041787|FG003|NOT COMPLETED|Overall Study||40
10875664|NCT00443599|12041799|FG000|STARTED|Overall Study|Randomly Assigned to Tight Glycemic Control|496
10875665|NCT00443599|12041800|FG001|STARTED|Overall Study|Randomly Assigned to Standard Care|493
10875666|NCT00443599|12041799|FG000|COMPLETED|Overall Study|Included in per-protocol analysis|490
10875667|NCT00443599|12041800|FG001|COMPLETED|Overall Study|Included in per-protocol analysis|490
10875668|NCT00443599|12041799|FG000|NOT COMPLETED|Overall Study||6
10875669|NCT00443599|12041800|FG001|NOT COMPLETED|Overall Study||3
10875670|NCT04753034|12041808|FG000|STARTED|Overall Study||31
10875671|NCT04753034|12041809|FG001|STARTED|Overall Study||32
10875672|NCT04753034|12041808|FG000|COMPLETED|Overall Study||29
10875673|NCT04753034|12041809|FG001|COMPLETED|Overall Study||31
10875674|NCT04753034|12041808|FG000|NOT COMPLETED|Overall Study||2
10875675|NCT04753034|12041809|FG001|NOT COMPLETED|Overall Study||1
10875676|NCT04638673|12041817|FG000|STARTED|Overall Study||6
10875677|NCT04638673|12041818|FG001|STARTED|Overall Study||6
10875678|NCT04638673|12041817|FG000|COMPLETED|Overall Study||6
10875679|NCT04638673|12041818|FG001|COMPLETED|Overall Study||6
10875680|NCT04638673|12041817|FG000|NOT COMPLETED|Overall Study||0
10875681|NCT04638673|12041818|FG001|NOT COMPLETED|Overall Study||0
10875682|NCT04531098|12041827|FG000|STARTED|Stage I||0
10875683|NCT04531098|12041828|FG001|STARTED|Stage I||67
10875684|NCT04531098|12041829|FG002|STARTED|Stage I||134
10875685|NCT04531098|12041827|FG000|COMPLETED|Stage I||0
10875686|NCT04531098|12041828|FG001|COMPLETED|Stage I||62
10875687|NCT04531098|12041829|FG002|COMPLETED|Stage I||116
10875688|NCT04531098|12041827|FG000|NOT COMPLETED|Stage I||0
10875689|NCT04531098|12041828|FG001|NOT COMPLETED|Stage I||5
10875690|NCT04531098|12041829|FG002|NOT COMPLETED|Stage I||18
10875691|NCT04531098|12041827|FG000|STARTED|Stage II||134
10875692|NCT04531098|12041828|FG001|STARTED|Stage II||67
10875693|NCT04531098|12041829|FG002|STARTED|Stage II||0
10875694|NCT04531098|12041827|FG000|COMPLETED|Stage II||121
10875695|NCT04531098|12041828|FG001|COMPLETED|Stage II||57
10875696|NCT04531098|12041829|FG002|COMPLETED|Stage II||0
10875697|NCT04531098|12041827|FG000|NOT COMPLETED|Stage II||13
10875698|NCT04531098|12041828|FG001|NOT COMPLETED|Stage II||10
10875699|NCT04531098|12041829|FG002|NOT COMPLETED|Stage II||0
10875700|NCT04484857|12041837|FG000|STARTED|Overall Study||283
10875701|NCT04484857|12041837|FG000|Received at Least 1 Dose of Study Drug|Overall Study||283
10875702|NCT04484857|12041837|FG000|Full Analysis Set|Overall Study||282
10875703|NCT04484857|12041837|FG000|COMPLETED|Overall Study||36
10875704|NCT04484857|12041837|FG000|NOT COMPLETED|Overall Study||247
10875705|NCT04434560|12041843|FG000|STARTED|Overall Study||1
10875706|NCT04434560|12041844|FG001|STARTED|Overall Study||0
10875707|NCT04434560|12041843|FG000|COMPLETED|Overall Study||1
10875708|NCT04434560|12041844|FG001|COMPLETED|Overall Study||0
10875709|NCT04434560|12041843|FG000|NOT COMPLETED|Overall Study||0
10875710|NCT04434560|12041844|FG001|NOT COMPLETED|Overall Study||0
10875711|NCT04382053|12041852|FG000|STARTED|Overall Study||71
10875712|NCT04382053|12041853|FG001|STARTED|Overall Study||72
10875713|NCT04382053|12041852|FG000|Safety Analysis Set|Overall Study|One participant that was randomized to the DFV890 + SoC arm did not attend any post-baseline visit|70
10875714|NCT04382053|12041853|FG001|Safety Analysis Set|Overall Study||72
10875715|NCT04382053|12041852|FG000|PD Analysis Set|Overall Study||62
10875716|NCT04382053|12041853|FG001|PD Analysis Set|Overall Study||68
10875717|NCT04382053|12041852|FG000|COMPLETED|Overall Study||62
10875718|NCT04382053|12041853|FG001|COMPLETED|Overall Study||59
10875719|NCT04382053|12041852|FG000|NOT COMPLETED|Overall Study||9
10875720|NCT04382053|12041853|FG001|NOT COMPLETED|Overall Study||13
10875721|NCT04353817|12041862|FG000|STARTED|Overall Study||61
10875722|NCT04353817|12041863|FG001|STARTED|Overall Study||60
10875723|NCT04353817|12041862|FG000|COMPLETED|Overall Study||61
10875724|NCT04353817|12041863|FG001|COMPLETED|Overall Study||59
10875725|NCT04353817|12041862|FG000|NOT COMPLETED|Overall Study||0
10875726|NCT04353817|12041863|FG001|NOT COMPLETED|Overall Study||1
10875727|NCT04278755|12041869|FG000|STARTED|Overall Study||8
10875728|NCT04278755|12041869|FG000|COMPLETED|Overall Study||7
10875729|NCT04278755|12041869|FG000|NOT COMPLETED|Overall Study||1
10875730|NCT04225221|12041875|FG000|STARTED|Lupron and Placebo Baseline (6 Weeks)||6
10875731|NCT04225221|12041876|FG001|STARTED|Lupron and Placebo Baseline (6 Weeks)||4
10875732|NCT04225221|12041875|FG000|COMPLETED|Lupron and Placebo Baseline (6 Weeks)||5
10875733|NCT04225221|12041876|FG001|COMPLETED|Lupron and Placebo Baseline (6 Weeks)||4
10875734|NCT04225221|12041875|FG000|NOT COMPLETED|Lupron and Placebo Baseline (6 Weeks)||1
10875735|NCT04225221|12041876|FG001|NOT COMPLETED|Lupron and Placebo Baseline (6 Weeks)||0
10875736|NCT04225221|12041875|FG000|STARTED|First Intervention (2 Weeks)||6
10875737|NCT04225221|12041876|FG001|STARTED|First Intervention (2 Weeks)||4
10875738|NCT04225221|12041875|FG000|COMPLETED|First Intervention (2 Weeks)||6
10875739|NCT04225221|12041876|FG001|COMPLETED|First Intervention (2 Weeks)||4
10875740|NCT04225221|12041875|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
10875741|NCT04225221|12041876|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
10875742|NCT04225221|12041875|FG000|STARTED|Washout (2 Weeks)||5
10875743|NCT04225221|12041876|FG001|STARTED|Washout (2 Weeks)||4
10875744|NCT04225221|12041875|FG000|COMPLETED|Washout (2 Weeks)||4
10875745|NCT04225221|12041876|FG001|COMPLETED|Washout (2 Weeks)||4
10875746|NCT04225221|12041875|FG000|NOT COMPLETED|Washout (2 Weeks)||1
10875747|NCT04225221|12041876|FG001|NOT COMPLETED|Washout (2 Weeks)||0
10875748|NCT04225221|12041875|FG000|STARTED|Second Intervention (2 Weeks)||5
10875749|NCT04225221|12041876|FG001|STARTED|Second Intervention (2 Weeks)||4
10875750|NCT04225221|12041875|FG000|COMPLETED|Second Intervention (2 Weeks)||5
10875751|NCT04225221|12041876|FG001|COMPLETED|Second Intervention (2 Weeks)||4
10875752|NCT04225221|12041875|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
10875753|NCT04225221|12041876|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
10875754|NCT04087720|12041883|FG000|STARTED|Overall Study||20
10875755|NCT04087720|12041883|FG000|COMPLETED|Overall Study||15
10875756|NCT04087720|12041883|FG000|NOT COMPLETED|Overall Study||5
10875757|NCT03951766|12041887|FG000|STARTED|Treatment Phase||100
10875758|NCT03951766|12041887|FG000|COMPLETED|Treatment Phase||99
10875759|NCT03951766|12041887|FG000|NOT COMPLETED|Treatment Phase||1
10875760|NCT03951766|12041887|FG000|STARTED|Follow-up Phase||99
10875761|NCT03951766|12041887|FG000|COMPLETED|Follow-up Phase||89
10875762|NCT03951766|12041887|FG000|NOT COMPLETED|Follow-up Phase||10
10875778|NCT03737110|12041919|FG000|STARTED|Run-in (RI) Period||86
10875779|NCT03737110|12041920|FG001|STARTED|Run-in (RI) Period||0
10875780|NCT03737110|12041921|FG002|STARTED|Run-in (RI) Period||0
10875781|NCT03737110|12041919|FG000|Continue to RW Period|Run-in (RI) Period||61
10875782|NCT03737110|12041920|FG001|Continue to RW Period|Run-in (RI) Period||0
10875783|NCT03737110|12041921|FG002|Continue to RW Period|Run-in (RI) Period||0
10875784|NCT03737110|12041919|FG000|Continue Directly to LTE Period|Run-in (RI) Period||15
10875785|NCT03737110|12041920|FG001|Continue Directly to LTE Period|Run-in (RI) Period||0
10875786|NCT03737110|12041921|FG002|Continue Directly to LTE Period|Run-in (RI) Period||0
10875787|NCT03737110|12041919|FG000|COMPLETED|Run-in (RI) Period||76
10875788|NCT03737110|12041920|FG001|COMPLETED|Run-in (RI) Period||0
10875789|NCT03737110|12041921|FG002|COMPLETED|Run-in (RI) Period||0
10875790|NCT03737110|12041919|FG000|NOT COMPLETED|Run-in (RI) Period||10
10875791|NCT03737110|12041920|FG001|NOT COMPLETED|Run-in (RI) Period||0
10875792|NCT03737110|12041921|FG002|NOT COMPLETED|Run-in (RI) Period||0
10875793|NCT03737110|12041919|FG000|STARTED|Randomized Withdrawal (RW) Period||0
10875794|NCT03737110|12041920|FG001|STARTED|Randomized Withdrawal (RW) Period||30
10875795|NCT03737110|12041921|FG002|STARTED|Randomized Withdrawal (RW) Period||31
10875796|NCT03737110|12041919|FG000|COMPLETED|Randomized Withdrawal (RW) Period||0
10875797|NCT03737110|12041920|FG001|COMPLETED|Randomized Withdrawal (RW) Period||29
10875798|NCT03737110|12041921|FG002|COMPLETED|Randomized Withdrawal (RW) Period||30
10875799|NCT03737110|12041919|FG000|NOT COMPLETED|Randomized Withdrawal (RW) Period||0
10875800|NCT03737110|12041920|FG001|NOT COMPLETED|Randomized Withdrawal (RW) Period||1
10875801|NCT03737110|12041921|FG002|NOT COMPLETED|Randomized Withdrawal (RW) Period||1
10875802|NCT03737110|12041919|FG000|STARTED|Long-Term Extension (LTE) Period|Participants who entered the LTE directly from RI after protocol-specified 22 adjudicated pericarditis recurrence events had accrued.|15
10875803|NCT03737110|12041920|FG001|STARTED|Long-Term Extension (LTE) Period|1 participant withdrew consent prior to entering LTE.|29
10875804|NCT03737110|12041921|FG002|STARTED|Long-Term Extension (LTE) Period||30
10875805|NCT03737110|12041919|FG000|COMPLETED|Long-Term Extension (LTE) Period||0
10875806|NCT03737110|12041920|FG001|COMPLETED|Long-Term Extension (LTE) Period||0
10875807|NCT03737110|12041921|FG002|COMPLETED|Long-Term Extension (LTE) Period||0
10875808|NCT03737110|12041919|FG000|NOT COMPLETED|Long-Term Extension (LTE) Period||15
10875809|NCT03737110|12041920|FG001|NOT COMPLETED|Long-Term Extension (LTE) Period||29
10875810|NCT03737110|12041921|FG002|NOT COMPLETED|Long-Term Extension (LTE) Period||30
10875811|NCT03660488|12041941|FG000|STARTED|Overall Study||31
10875812|NCT03660488|12041942|FG001|STARTED|Overall Study||27
10875813|NCT03660488|12041941|FG000|COMPLETED|Overall Study||31
10875814|NCT03660488|12041942|FG001|COMPLETED|Overall Study||27
10875815|NCT03660488|12041941|FG000|NOT COMPLETED|Overall Study||0
10875816|NCT03660488|12041942|FG001|NOT COMPLETED|Overall Study||0
10875817|NCT03653091|12041950|FG000|STARTED|First 24 Weeks||6
10875818|NCT03653091|12041951|FG001|STARTED|First 24 Weeks||3
10875819|NCT03653091|12041950|FG000|Intent-to-Treat|First 24 Weeks||6
10875820|NCT03653091|12041951|FG001|Intent-to-Treat|First 24 Weeks||3
10875821|NCT03653091|12041950|FG000|As-Treated|First 24 Weeks||5
10875822|NCT03653091|12041951|FG001|As-Treated|First 24 Weeks||4
10875823|NCT03653091|12041950|FG000|Safety|First 24 Weeks||5
10875824|NCT03653091|12041951|FG001|Safety|First 24 Weeks||4
10875825|NCT03653091|12041950|FG000|COMPLETED|First 24 Weeks||6
10875826|NCT03653091|12041951|FG001|COMPLETED|First 24 Weeks||3
10875827|NCT03653091|12041950|FG000|NOT COMPLETED|First 24 Weeks||0
10875828|NCT03653091|12041951|FG001|NOT COMPLETED|First 24 Weeks||0
10875829|NCT03653091|12041950|FG000|STARTED|Second 24 Weeks||5
10875830|NCT03653091|12041951|FG001|STARTED|Second 24 Weeks||4
10875831|NCT03653091|12041950|FG000|Crossed Over to DMR at Week 24|Second 24 Weeks||0
10875832|NCT03653091|12041951|FG001|Crossed Over to DMR at Week 24|Second 24 Weeks||3
10875833|NCT03653091|12041950|FG000|COMPLETED|Second 24 Weeks||5
10875834|NCT03653091|12041951|FG001|COMPLETED|Second 24 Weeks||3
10875835|NCT03653091|12041950|FG000|NOT COMPLETED|Second 24 Weeks||0
10875836|NCT03653091|12041951|FG001|NOT COMPLETED|Second 24 Weeks||1
10875837|NCT03649477|12041961|FG000|STARTED|Overall Study||44
10875838|NCT03649477|12041962|FG001|STARTED|Overall Study||43
10875839|NCT03649477|12041963|FG002|STARTED|Overall Study||43
10875840|NCT03649477|12041961|FG000|COMPLETED|Overall Study||42
10875841|NCT03649477|12041962|FG001|COMPLETED|Overall Study||43
10875842|NCT03649477|12041963|FG002|COMPLETED|Overall Study||43
10875843|NCT03649477|12041961|FG000|NOT COMPLETED|Overall Study||2
10875844|NCT03649477|12041962|FG001|NOT COMPLETED|Overall Study||0
10875845|NCT03649477|12041963|FG002|NOT COMPLETED|Overall Study||0
10875846|NCT03631706|12041973|FG000|STARTED|Overall Study||152
10875847|NCT03631706|12041974|FG001|STARTED|Overall Study||152
10875848|NCT03631706|12041973|FG000|Treated|Overall Study||151
10875849|NCT03631706|12041974|FG001|Treated|Overall Study||152
10875850|NCT03631706|12041973|FG000|COMPLETED|Overall Study||60
10875851|NCT03631706|12041974|FG001|COMPLETED|Overall Study||54
10875852|NCT03631706|12041973|FG000|NOT COMPLETED|Overall Study||92
10875853|NCT03631706|12041974|FG001|NOT COMPLETED|Overall Study||98
10875854|NCT03615482|12041982|FG000|STARTED|Overall Study||600
10875855|NCT03615482|12041983|FG001|STARTED|Overall Study||600
10875856|NCT03615482|12041982|FG000|Vaccinated|Overall Study||599
10875857|NCT03615482|12041983|FG001|Vaccinated|Overall Study||598
10875858|NCT03615482|12041982|FG000|COMPLETED|Overall Study||583
10875859|NCT03615482|12041983|FG001|COMPLETED|Overall Study||583
10875860|NCT03615482|12041982|FG000|NOT COMPLETED|Overall Study||17
10875861|NCT03615482|12041983|FG001|NOT COMPLETED|Overall Study||17
10875862|NCT03572933|12041991|FG000|STARTED|Overall Study||51
10875863|NCT03572933|12041992|FG001|STARTED|Overall Study||50
10875864|NCT03572933|12041991|FG000|COMPLETED|Overall Study||47
10875865|NCT03572933|12041992|FG001|COMPLETED|Overall Study||48
10875866|NCT03572933|12041991|FG000|NOT COMPLETED|Overall Study||4
10875867|NCT03572933|12041992|FG001|NOT COMPLETED|Overall Study||2
10875868|NCT03557892|12042000|FG000|STARTED|Overall Study||14
10875869|NCT03557892|12042001|FG001|STARTED|Overall Study||14
10875870|NCT03557892|12042000|FG000|COMPLETED|Overall Study||14
10875871|NCT03557892|12042001|FG001|COMPLETED|Overall Study||14
10875872|NCT03557892|12042000|FG000|NOT COMPLETED|Overall Study||0
10875873|NCT03557892|12042001|FG001|NOT COMPLETED|Overall Study||0
10875874|NCT03526861|12042010|FG000|STARTED|Initial Treatment Period||101
10875875|NCT03526861|12042011|FG001|STARTED|Initial Treatment Period||100
10875876|NCT03526861|12042012|FG002|STARTED|Initial Treatment Period||100
10875877|NCT03526861|12042013|FG003|STARTED|Initial Treatment Period||0
10875878|NCT03526861|12042014|FG004|STARTED|Initial Treatment Period||0
10875879|NCT03526861|12042015|FG005|STARTED|Initial Treatment Period||0
10875880|NCT03526861|12042016|FG006|STARTED|Initial Treatment Period||0
10875881|NCT03526861|12042017|FG007|STARTED|Initial Treatment Period||0
10875882|NCT03526861|12042018|FG008|STARTED|Initial Treatment Period||0
10875883|NCT03526861|12042010|FG000|COMPLETED|Initial Treatment Period||94
10875884|NCT03526861|12042011|FG001|COMPLETED|Initial Treatment Period||93
10875885|NCT03526861|12042012|FG002|COMPLETED|Initial Treatment Period||86
10875886|NCT03526861|12042013|FG003|COMPLETED|Initial Treatment Period||0
10875887|NCT03526861|12042014|FG004|COMPLETED|Initial Treatment Period||0
10875888|NCT03526861|12042015|FG005|COMPLETED|Initial Treatment Period||0
10875889|NCT03526861|12042016|FG006|COMPLETED|Initial Treatment Period||0
10875890|NCT03526861|12042017|FG007|COMPLETED|Initial Treatment Period||0
10875891|NCT03526861|12042018|FG008|COMPLETED|Initial Treatment Period||0
10875892|NCT03526861|12042010|FG000|NOT COMPLETED|Initial Treatment Period||7
10875893|NCT03526861|12042011|FG001|NOT COMPLETED|Initial Treatment Period||7
10875894|NCT03526861|12042012|FG002|NOT COMPLETED|Initial Treatment Period||14
10875895|NCT03526861|12042013|FG003|NOT COMPLETED|Initial Treatment Period||0
10875896|NCT03526861|12042014|FG004|NOT COMPLETED|Initial Treatment Period||0
10875897|NCT03526861|12042015|FG005|NOT COMPLETED|Initial Treatment Period||0
10875898|NCT03526861|12042016|FG006|NOT COMPLETED|Initial Treatment Period||0
10875899|NCT03526861|12042017|FG007|NOT COMPLETED|Initial Treatment Period||0
10875900|NCT03526861|12042018|FG008|NOT COMPLETED|Initial Treatment Period||0
10875901|NCT03526861|12042010|FG000|STARTED|Maintenance Treatment Period||0
10875902|NCT03526861|12042011|FG001|STARTED|Maintenance Treatment Period||0
10875903|NCT03526861|12042012|FG002|STARTED|Maintenance Treatment Period||0
10875904|NCT03526861|12042013|FG003|STARTED|Maintenance Treatment Period||13
10875905|NCT03526861|12042014|FG004|STARTED|Maintenance Treatment Period||14
10875906|NCT03526861|12042015|FG005|STARTED|Maintenance Treatment Period||12
10875907|NCT03526861|12042016|FG006|STARTED|Maintenance Treatment Period||14
10875908|NCT03526861|12042017|FG007|STARTED|Maintenance Treatment Period||6
10875909|NCT03526861|12042018|FG008|STARTED|Maintenance Treatment Period||0
10875910|NCT03526861|12042010|FG000|COMPLETED|Maintenance Treatment Period||0
10875911|NCT03526861|12042011|FG001|COMPLETED|Maintenance Treatment Period||0
10875912|NCT03526861|12042012|FG002|COMPLETED|Maintenance Treatment Period||0
10875913|NCT03526861|12042013|FG003|COMPLETED|Maintenance Treatment Period||5
10875914|NCT03526861|12042014|FG004|COMPLETED|Maintenance Treatment Period||8
10875915|NCT03526861|12042015|FG005|COMPLETED|Maintenance Treatment Period||8
10875916|NCT03526861|12042016|FG006|COMPLETED|Maintenance Treatment Period||8
10875917|NCT03526861|12042017|FG007|COMPLETED|Maintenance Treatment Period||4
10875918|NCT03526861|12042018|FG008|COMPLETED|Maintenance Treatment Period||0
10875919|NCT03526861|12042010|FG000|NOT COMPLETED|Maintenance Treatment Period||0
10875920|NCT03526861|12042011|FG001|NOT COMPLETED|Maintenance Treatment Period||0
10875921|NCT03526861|12042012|FG002|NOT COMPLETED|Maintenance Treatment Period||0
10875922|NCT03526861|12042013|FG003|NOT COMPLETED|Maintenance Treatment Period||8
10875923|NCT03526861|12042014|FG004|NOT COMPLETED|Maintenance Treatment Period||6
10875924|NCT03526861|12042015|FG005|NOT COMPLETED|Maintenance Treatment Period||4
10875925|NCT03526861|12042016|FG006|NOT COMPLETED|Maintenance Treatment Period||6
10875926|NCT03526861|12042017|FG007|NOT COMPLETED|Maintenance Treatment Period||2
10875927|NCT03526861|12042018|FG008|NOT COMPLETED|Maintenance Treatment Period||0
10875928|NCT03526861|12042010|FG000|STARTED|Open-label Treatment Period||0
10875929|NCT03526861|12042011|FG001|STARTED|Open-label Treatment Period||0
10875930|NCT03526861|12042012|FG002|STARTED|Open-label Treatment Period||0
10875931|NCT03526861|12042013|FG003|STARTED|Open-label Treatment Period||0
10875932|NCT03526861|12042014|FG004|STARTED|Open-label Treatment Period||0
10875933|NCT03526861|12042015|FG005|STARTED|Open-label Treatment Period||0
10875934|NCT03526861|12042016|FG006|STARTED|Open-label Treatment Period||0
10875935|NCT03526861|12042017|FG007|STARTED|Open-label Treatment Period||0
10875936|NCT03526861|12042018|FG008|STARTED|Open-label Treatment Period|226 subjects transferred to open-label treatment at Week 16. 24 subjects transferred to open-label treatment between Week 16 and Week 52.|242
10875937|NCT03526861|12042010|FG000|COMPLETED|Open-label Treatment Period||0
10875938|NCT03526861|12042011|FG001|COMPLETED|Open-label Treatment Period||0
10875939|NCT03526861|12042012|FG002|COMPLETED|Open-label Treatment Period||0
10875940|NCT03526861|12042013|FG003|COMPLETED|Open-label Treatment Period||0
10875941|NCT03526861|12042014|FG004|COMPLETED|Open-label Treatment Period||0
10875942|NCT03526861|12042015|FG005|COMPLETED|Open-label Treatment Period||0
10875943|NCT03526861|12042016|FG006|COMPLETED|Open-label Treatment Period||0
10875944|NCT03526861|12042017|FG007|COMPLETED|Open-label Treatment Period||0
10875945|NCT03526861|12042018|FG008|COMPLETED|Open-label Treatment Period||214
10875946|NCT03526861|12042010|FG000|NOT COMPLETED|Open-label Treatment Period||0
10875947|NCT03526861|12042011|FG001|NOT COMPLETED|Open-label Treatment Period||0
10875948|NCT03526861|12042012|FG002|NOT COMPLETED|Open-label Treatment Period||0
10875949|NCT03526861|12042013|FG003|NOT COMPLETED|Open-label Treatment Period||0
10875950|NCT03526861|12042014|FG004|NOT COMPLETED|Open-label Treatment Period||0
10875951|NCT03526861|12042015|FG005|NOT COMPLETED|Open-label Treatment Period||0
10875952|NCT03526861|12042016|FG006|NOT COMPLETED|Open-label Treatment Period||0
10875953|NCT03526861|12042017|FG007|NOT COMPLETED|Open-label Treatment Period||0
10875954|NCT03526861|12042018|FG008|NOT COMPLETED|Open-label Treatment Period||28
10875955|NCT03515226|12042040|FG000|STARTED|Overall Study||10
10875956|NCT03515226|12042041|FG001|STARTED|Overall Study||15
10875957|NCT03515226|12042040|FG000|COMPLETED|Overall Study||8
10875958|NCT03515226|12042041|FG001|COMPLETED|Overall Study||11
10875959|NCT03515226|12042040|FG000|NOT COMPLETED|Overall Study||2
10875960|NCT03515226|12042041|FG001|NOT COMPLETED|Overall Study||4
10875961|NCT03429049|12042050|FG000|STARTED|Overall Study||138
10875962|NCT03429049|12042051|FG001|STARTED|Overall Study||194
10875963|NCT03429049|12042050|FG000|Treated|Overall Study||136
10875964|NCT03429049|12042051|FG001|Treated|Overall Study||189
10875965|NCT03429049|12042050|FG000|COMPLETED|Overall Study||110
10875966|NCT03429049|12042051|FG001|COMPLETED|Overall Study||152
10875967|NCT03429049|12042050|FG000|NOT COMPLETED|Overall Study||28
10875968|NCT03429049|12042051|FG001|NOT COMPLETED|Overall Study||42
10875969|NCT03395639|12042059|FG000|STARTED|Main Treatment Period (0 to 4 Months)||110
10875970|NCT03395639|12042060|FG001|STARTED|Main Treatment Period (0 to 4 Months)||58
10875971|NCT03395639|12042061|FG002|STARTED|Main Treatment Period (0 to 4 Months)||0
10875972|NCT03395639|12042059|FG000|Modified Intent to Treat Population|Main Treatment Period (0 to 4 Months)||109
10875973|NCT03395639|12042060|FG001|Modified Intent to Treat Population|Main Treatment Period (0 to 4 Months)||58
10875974|NCT03395639|12042061|FG002|Modified Intent to Treat Population|Main Treatment Period (0 to 4 Months)||0
10875975|NCT03395639|12042059|FG000|COMPLETED|Main Treatment Period (0 to 4 Months)||107
10875976|NCT03395639|12042060|FG001|COMPLETED|Main Treatment Period (0 to 4 Months)||55
10875977|NCT03395639|12042061|FG002|COMPLETED|Main Treatment Period (0 to 4 Months)||0
10875978|NCT03395639|12042059|FG000|NOT COMPLETED|Main Treatment Period (0 to 4 Months)||3
10875979|NCT03395639|12042060|FG001|NOT COMPLETED|Main Treatment Period (0 to 4 Months)||3
10875980|NCT03395639|12042061|FG002|NOT COMPLETED|Main Treatment Period (0 to 4 Months)||0
10875981|NCT03395639|12042059|FG000|STARTED|Extension Period (4-13 Months)||0
10875982|NCT03395639|12042060|FG001|STARTED|Extension Period (4-13 Months)||0
10875983|NCT03395639|12042061|FG002|STARTED|Extension Period (4-13 Months)|15 participants who completed the Main Treatment Period did not participate in the Extension Period|147
10875984|NCT03395639|12042059|FG000|COMPLETED|Extension Period (4-13 Months)||0
10875985|NCT03395639|12042060|FG001|COMPLETED|Extension Period (4-13 Months)||0
10875986|NCT03395639|12042061|FG002|COMPLETED|Extension Period (4-13 Months)||144
10875987|NCT03395639|12042059|FG000|NOT COMPLETED|Extension Period (4-13 Months)||0
10875988|NCT03395639|12042060|FG001|NOT COMPLETED|Extension Period (4-13 Months)||0
10875989|NCT03395639|12042061|FG002|NOT COMPLETED|Extension Period (4-13 Months)||3
10875990|NCT03381274|12042073|FG000|STARTED|Overall Study||5
10875991|NCT03381274|12042074|FG001|STARTED|Overall Study||21
10875992|NCT03381274|12042075|FG002|STARTED|Overall Study||6
10875993|NCT03381274|12042076|FG003|STARTED|Overall Study||6
10875994|NCT03381274|12042077|FG004|STARTED|Overall Study||5
10875995|NCT03381274|12042073|FG000|COMPLETED|Overall Study||0
10875996|NCT03381274|12042074|FG001|COMPLETED|Overall Study||0
10875997|NCT03381274|12042075|FG002|COMPLETED|Overall Study||0
10875998|NCT03381274|12042076|FG003|COMPLETED|Overall Study||0
10875999|NCT03381274|12042077|FG004|COMPLETED|Overall Study||0
10876000|NCT03381274|12042073|FG000|NOT COMPLETED|Overall Study||5
10876001|NCT03381274|12042074|FG001|NOT COMPLETED|Overall Study||21
10876002|NCT03381274|12042075|FG002|NOT COMPLETED|Overall Study||6
10876003|NCT03381274|12042076|FG003|NOT COMPLETED|Overall Study||6
10876004|NCT03381274|12042077|FG004|NOT COMPLETED|Overall Study||5
10876008|NCT03338894|12042097|FG000|STARTED|Overall Study||66
10876009|NCT03338894|12042097|FG000|COMPLETED|Overall Study||56
10876010|NCT03338894|12042097|FG000|NOT COMPLETED|Overall Study||10
10876017|NCT03253926|12042109|FG000|STARTED|Overall Study||7
10876018|NCT03253926|12042110|FG001|STARTED|Overall Study||8
10876019|NCT03253926|12042109|FG000|COMPLETED|Overall Study||7
10876020|NCT03253926|12042110|FG001|COMPLETED|Overall Study||8
10876021|NCT03253926|12042109|FG000|NOT COMPLETED|Overall Study||0
10876022|NCT03253926|12042110|FG001|NOT COMPLETED|Overall Study||0
10876023|NCT03199963|12042118|FG000|STARTED|Blinded Phase - Overall Study||149
10876024|NCT03199963|12042119|FG001|STARTED|Blinded Phase - Overall Study||74
10876025|NCT03199963|12042118|FG000|Received at Least 1 Gel Application|Blinded Phase - Overall Study||149
10876026|NCT03199963|12042119|FG001|Received at Least 1 Gel Application|Blinded Phase - Overall Study||73
10876027|NCT03199963|12042118|FG000|COMPLETED|Blinded Phase - Overall Study||16
10876028|NCT03199963|12042119|FG001|COMPLETED|Blinded Phase - Overall Study||8
10876029|NCT03199963|12042118|FG000|NOT COMPLETED|Blinded Phase - Overall Study||133
10876030|NCT03199963|12042119|FG001|NOT COMPLETED|Blinded Phase - Overall Study||66
10876031|NCT03199963|12042118|FG000|STARTED|Optional Open-Label Phase - BHR-700||7
10876032|NCT03199963|12042119|FG001|STARTED|Optional Open-Label Phase - BHR-700||6
10876033|NCT03199963|12042118|FG000|COMPLETED|Optional Open-Label Phase - BHR-700||0
10876034|NCT03199963|12042119|FG001|COMPLETED|Optional Open-Label Phase - BHR-700||0
10876035|NCT03199963|12042118|FG000|NOT COMPLETED|Optional Open-Label Phase - BHR-700||7
10876036|NCT03199963|12042119|FG001|NOT COMPLETED|Optional Open-Label Phase - BHR-700||6
10876037|NCT03132636|12042133|FG000|STARTED|Overall Study||54
10876038|NCT03132636|12042134|FG001|STARTED|Overall Study||84
10876039|NCT03132636|12042133|FG000|COMPLETED|Overall Study||1
10876040|NCT03132636|12042134|FG001|COMPLETED|Overall Study||9
10876041|NCT03132636|12042133|FG000|NOT COMPLETED|Overall Study||53
10876042|NCT03132636|12042134|FG001|NOT COMPLETED|Overall Study||75
10876043|NCT03116399|12042142|FG000|STARTED|Overall Study||128
10876044|NCT03116399|12042143|FG001|STARTED|Overall Study||120
10876045|NCT03116399|12042142|FG000|6-month|Overall Study||98
10876046|NCT03116399|12042143|FG001|6-month|Overall Study||108
10876047|NCT03116399|12042142|FG000|9-month|Overall Study||91
10876048|NCT03116399|12042143|FG001|9-month|Overall Study||101
10876049|NCT03116399|12042142|FG000|COMPLETED|Overall Study||88
10876050|NCT03116399|12042143|FG001|COMPLETED|Overall Study||96
10876051|NCT03116399|12042142|FG000|NOT COMPLETED|Overall Study||40
10876052|NCT03116399|12042143|FG001|NOT COMPLETED|Overall Study||24
10876053|NCT03085680|12042151|FG000|STARTED|Overall Study||9
10876054|NCT03085680|12042152|FG001|STARTED|Overall Study||8
10876055|NCT03085680|12042151|FG000|COMPLETED|Overall Study||9
10876056|NCT03085680|12042152|FG001|COMPLETED|Overall Study||8
10876057|NCT03085680|12042151|FG000|NOT COMPLETED|Overall Study||0
10876058|NCT03085680|12042152|FG001|NOT COMPLETED|Overall Study||0
10876059|NCT03065218|12042158|FG000|STARTED|Overall Study||4
10876060|NCT03065218|12042158|FG000|COMPLETED|Overall Study||4
10876061|NCT03065218|12042158|FG000|NOT COMPLETED|Overall Study||0
10876062|NCT03029598|12042162|FG000|STARTED|Overall Study||29
10876063|NCT03029598|12042162|FG000|COMPLETED|Overall Study||29
10876064|NCT03029598|12042162|FG000|NOT COMPLETED|Overall Study||0
10876065|NCT02961374|12042166|FG000|STARTED|Overall Study||46
10876066|NCT02961374|12042166|FG000|COMPLETED|Overall Study||42
10876067|NCT02961374|12042166|FG000|NOT COMPLETED|Overall Study||4
10876068|NCT02946788|12042172|FG000|STARTED|Overall Study||8
10876069|NCT02946788|12042173|FG001|STARTED|Overall Study||10
10876070|NCT02946788|12042172|FG000|COMPLETED|Overall Study|October 2017|8
10876071|NCT02946788|12042173|FG001|COMPLETED|Overall Study|October 2017|9
10876072|NCT02946788|12042172|FG000|NOT COMPLETED|Overall Study||0
10876073|NCT02946788|12042173|FG001|NOT COMPLETED|Overall Study||1
10876074|NCT02904954|12042181|FG000|STARTED|Neoadjuvant (Preoperative) to Surgery||30
10876075|NCT02904954|12042182|FG001|STARTED|Neoadjuvant (Preoperative) to Surgery||30
10876076|NCT02904954|12042181|FG000|COMPLETED|Neoadjuvant (Preoperative) to Surgery|30 participants completed 2 neoadjuvant cycles. Surgical resection was not performed in 4 participants.|26
10876077|NCT02904954|12042182|FG001|COMPLETED|Neoadjuvant (Preoperative) to Surgery|30 participants completed the first neoadjuvant Durvalumab cycle combined with SBRT. Three subjects did not receive the 2nd cycle. Surgical resection was not performed in 4 participants.|26
10876078|NCT02904954|12042181|FG000|NOT COMPLETED|Neoadjuvant (Preoperative) to Surgery||4
10876079|NCT02904954|12042182|FG001|NOT COMPLETED|Neoadjuvant (Preoperative) to Surgery||4
10876080|NCT02904954|12042181|FG000|STARTED|Adjuvant Durvalumab||26
10876081|NCT02904954|12042182|FG001|STARTED|Adjuvant Durvalumab||26
10876082|NCT02904954|12042181|FG000|COMPLETED|Adjuvant Durvalumab||6
10876083|NCT02904954|12042182|FG001|COMPLETED|Adjuvant Durvalumab||11
10876084|NCT02904954|12042181|FG000|NOT COMPLETED|Adjuvant Durvalumab||20
10876085|NCT02904954|12042182|FG001|NOT COMPLETED|Adjuvant Durvalumab||15
10876112|NCT02784431|12042218|FG000|STARTED|Overall Study||20
10876113|NCT02784431|12042218|FG000|COMPLETED|Overall Study||0
10876114|NCT02784431|12042218|FG000|NOT COMPLETED|Overall Study||20
10876118|NCT02634307|12042229|FG000|STARTED|Overall Study||593
10876119|NCT02634307|12042230|FG001|STARTED|Overall Study||239
10876120|NCT02634307|12042231|FG002|STARTED|Overall Study||225
10876121|NCT02634307|12042229|FG000|Safety Population|Overall Study||593
10876122|NCT02634307|12042230|FG001|Safety Population|Overall Study||239
10876123|NCT02634307|12042231|FG002|Safety Population|Overall Study||225
10876124|NCT02634307|12042229|FG000|Full Analysis Set (FAS) Population|Overall Study||582
10876125|NCT02634307|12042230|FG001|Full Analysis Set (FAS) Population|Overall Study||235
10876126|NCT02634307|12042231|FG002|Full Analysis Set (FAS) Population|Overall Study||224
10876127|NCT02634307|12042229|FG000|COMPLETED|Overall Study||468
10876128|NCT02634307|12042230|FG001|COMPLETED|Overall Study||168
10876129|NCT02634307|12042231|FG002|COMPLETED|Overall Study||164
10876130|NCT02634307|12042229|FG000|NOT COMPLETED|Overall Study||125
10876131|NCT02634307|12042230|FG001|NOT COMPLETED|Overall Study||71
10876132|NCT02634307|12042231|FG002|NOT COMPLETED|Overall Study||61
10876136|NCT02575339|12042246|FG000|STARTED|Study Treatment||7
10876137|NCT02575339|12042247|FG001|STARTED|Study Treatment|This study was terminated at Phase I.|4
10876138|NCT02575339|12042248|FG002|STARTED|Study Treatment|This study was terminated at Phase I.|0
10876139|NCT02575339|12042246|FG000|COMPLETED|Study Treatment||0
10876140|NCT02575339|12042247|FG001|COMPLETED|Study Treatment||0
10876141|NCT02575339|12042248|FG002|COMPLETED|Study Treatment||0
10876142|NCT02575339|12042246|FG000|NOT COMPLETED|Study Treatment||7
10876143|NCT02575339|12042247|FG001|NOT COMPLETED|Study Treatment||4
10876144|NCT02575339|12042248|FG002|NOT COMPLETED|Study Treatment||0
10876145|NCT02575339|12042246|FG000|STARTED|Follow up||7
10876146|NCT02575339|12042247|FG001|STARTED|Follow up||4
10876147|NCT02575339|12042248|FG002|STARTED|Follow up||0
10876148|NCT02575339|12042246|FG000|COMPLETED|Follow up||0
10876149|NCT02575339|12042247|FG001|COMPLETED|Follow up||0
10876150|NCT02575339|12042248|FG002|COMPLETED|Follow up||0
10876151|NCT02575339|12042246|FG000|NOT COMPLETED|Follow up||7
10876152|NCT02575339|12042247|FG001|NOT COMPLETED|Follow up||4
10876153|NCT02575339|12042248|FG002|NOT COMPLETED|Follow up||0
10876154|NCT02521415|12042260|FG000|STARTED|Overall Study||43
10876155|NCT02521415|12042261|FG001|STARTED|Overall Study||44
10876156|NCT02521415|12042260|FG000|COMPLETED|Overall Study||43
10876157|NCT02521415|12042261|FG001|COMPLETED|Overall Study||44
10876158|NCT02521415|12042260|FG000|NOT COMPLETED|Overall Study||0
10876159|NCT02521415|12042261|FG001|NOT COMPLETED|Overall Study||0
10876181|NCT02367105|12042299|FG000|STARTED|Overall Study||41
10876182|NCT02367105|12042300|FG001|STARTED|Overall Study||42
10876183|NCT02367105|12042299|FG000|COMPLETED|Overall Study||36
10876184|NCT02367105|12042300|FG001|COMPLETED|Overall Study||34
10876185|NCT02367105|12042299|FG000|NOT COMPLETED|Overall Study||5
10876186|NCT02367105|12042300|FG001|NOT COMPLETED|Overall Study||8
10876193|NCT02282020|12042323|FG000|STARTED|Overall Study||178
10876194|NCT02282020|12042324|FG001|STARTED|Overall Study||88
10876195|NCT02282020|12042323|FG000|Received Treatment|Overall Study||178
10876196|NCT02282020|12042324|FG001|Received Treatment|Overall Study||76
10876197|NCT02282020|12042323|FG000|COMPLETED|Overall Study||19
10876198|NCT02282020|12042324|FG001|COMPLETED|Overall Study||0
10876199|NCT02282020|12042323|FG000|NOT COMPLETED|Overall Study||159
10876200|NCT02282020|12042324|FG001|NOT COMPLETED|Overall Study||88
10876204|NCT02243631|12042337|FG000|STARTED|Overall Study||3
10876205|NCT02243631|12042338|FG001|STARTED|Overall Study||5
10876206|NCT02243631|12042337|FG000|COMPLETED|Overall Study||3
10876207|NCT02243631|12042338|FG001|COMPLETED|Overall Study||4
10876208|NCT02243631|12042337|FG000|NOT COMPLETED|Overall Study||0
10876209|NCT02243631|12042338|FG001|NOT COMPLETED|Overall Study||1
10876210|NCT02213926|12042344|FG000|STARTED|Overall Study||124
10876211|NCT02213926|12042344|FG000|COMPLETED|Overall Study||0
10876212|NCT02213926|12042344|FG000|NOT COMPLETED|Overall Study||124
10876217|NCT02066181|12042354|FG000|STARTED|Overall Study||50
10876218|NCT02066181|12042355|FG001|STARTED|Overall Study||37
10876219|NCT02066181|12042354|FG000|Crossed Over|Overall Study||0
10876220|NCT02066181|12042355|FG001|Crossed Over|Overall Study||28
10876221|NCT02066181|12042354|FG000|COMPLETED|Overall Study||49
10876222|NCT02066181|12042355|FG001|COMPLETED|Overall Study||36
10876223|NCT02066181|12042354|FG000|NOT COMPLETED|Overall Study||1
10876224|NCT02066181|12042355|FG001|NOT COMPLETED|Overall Study||1
10876228|NCT02041533|12042370|FG000|STARTED|Overall Study||271
10876229|NCT02041533|12042371|FG001|STARTED|Overall Study||270
10876230|NCT02041533|12042370|FG000|Began Treatment|Overall Study||267
10876231|NCT02041533|12042371|FG001|Began Treatment|Overall Study||263
10876232|NCT02041533|12042370|FG000|COMPLETED|Overall Study|Completed = Participants continuing in the treatment period|43
10876233|NCT02041533|12042371|FG001|COMPLETED|Overall Study|Completed = Participants continuing in the treatment period|12
10876234|NCT02041533|12042370|FG000|NOT COMPLETED|Overall Study||228
10876235|NCT02041533|12042371|FG001|NOT COMPLETED|Overall Study||258
10876236|NCT01963728|12042379|FG000|STARTED|Overall Study||0
10876237|NCT01963728|12042380|FG001|STARTED|Overall Study||1
10876238|NCT01963728|12042379|FG000|COMPLETED|Overall Study|study terminated early|0
10876239|NCT01963728|12042380|FG001|COMPLETED|Overall Study|study terminated early|0
10876240|NCT01963728|12042379|FG000|NOT COMPLETED|Overall Study||0
10876241|NCT01963728|12042380|FG001|NOT COMPLETED|Overall Study||1
10876481|NCT01696981|12042541|FG000|STARTED|Overall Study||77455
10876482|NCT01696981|12042542|FG001|STARTED|Overall Study||77445
10876483|NCT01696981|12042541|FG000|COMPLETED|Overall Study||76254
10876484|NCT01696981|12042542|FG001|COMPLETED|Overall Study||67071
10876485|NCT01696981|12042541|FG000|NOT COMPLETED|Overall Study||1201
10876486|NCT01696981|12042542|FG001|NOT COMPLETED|Overall Study||10374
10876502|NCT01467466|12042577|FG000|STARTED|Overall Study||1300
10876503|NCT01467466|12042578|FG001|STARTED|Overall Study||1292
10876504|NCT01467466|12042579|FG002|STARTED|Overall Study||1294
10876505|NCT01467466|12042580|FG003|STARTED|Overall Study||1291
10876506|NCT01467466|12042577|FG000|COMPLETED|Overall Study||1191
10876507|NCT01467466|12042578|FG001|COMPLETED|Overall Study||1188
10876508|NCT01467466|12042579|FG002|COMPLETED|Overall Study||1190
10876509|NCT01467466|12042580|FG003|COMPLETED|Overall Study||1203
10876510|NCT01467466|12042577|FG000|NOT COMPLETED|Overall Study||109
10876511|NCT01467466|12042578|FG001|NOT COMPLETED|Overall Study||104
10876512|NCT01467466|12042579|FG002|NOT COMPLETED|Overall Study||104
10876513|NCT01467466|12042580|FG003|NOT COMPLETED|Overall Study||88
10876514|NCT01463072|12042590|FG000|STARTED|Overall Study||40
10876515|NCT01463072|12042590|FG000|COMPLETED|Overall Study||40
10876516|NCT01463072|12042590|FG000|NOT COMPLETED|Overall Study||0
10876733|NCT01318317|12042669|FG000|STARTED|Overall Study||1
10876734|NCT01318317|12042670|FG001|STARTED|Overall Study||4
10876735|NCT01318317|12042671|FG002|STARTED|Overall Study||3
10876736|NCT01318317|12042669|FG000|COMPLETED|Overall Study||1
10876737|NCT01318317|12042670|FG001|COMPLETED|Overall Study||4
10876738|NCT01318317|12042671|FG002|COMPLETED|Overall Study||3
10876739|NCT01318317|12042669|FG000|NOT COMPLETED|Overall Study||0
10876740|NCT01318317|12042670|FG001|NOT COMPLETED|Overall Study||0
10876741|NCT01318317|12042671|FG002|NOT COMPLETED|Overall Study||0
10876846|NCT01121224|12042800|FG000|STARTED|Overall Study||305
10876847|NCT01121224|12042801|FG001|STARTED|Overall Study||292
10876848|NCT01121224|12042800|FG000|COMPLETED|Overall Study||280
10876849|NCT01121224|12042801|FG001|COMPLETED|Overall Study||275
10876850|NCT01121224|12042800|FG000|NOT COMPLETED|Overall Study||25
10876851|NCT01121224|12042801|FG001|NOT COMPLETED|Overall Study||17
10876900|NCT01062425|12042859|FG000|STARTED|Overall Study||55
10876901|NCT01062425|12042860|FG001|STARTED|Overall Study||103
10876902|NCT01062425|12042859|FG000|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|52
10876903|NCT01062425|12042860|FG001|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|97
10876904|NCT01062425|12042859|FG000|NOT COMPLETED|Overall Study||3
10876905|NCT01062425|12042860|FG001|NOT COMPLETED|Overall Study||6
10877066|NCT00593840|12043052|FG000|STARTED|Overall Study||73
10877067|NCT00593840|12043052|FG000|COMPLETED|Overall Study||72
10877068|NCT00593840|12043052|FG000|NOT COMPLETED|Overall Study||1
10877226|NCT00381641|12043121|FG000|STARTED|Overall Study||38
10877227|NCT00381641|12043122|FG001|STARTED|Overall Study||25
10877228|NCT00381641|12043121|FG000|COMPLETED|Overall Study||38
10877229|NCT00381641|12043122|FG001|COMPLETED|Overall Study||23
10877230|NCT00381641|12043121|FG000|NOT COMPLETED|Overall Study||0
10877231|NCT00381641|12043122|FG001|NOT COMPLETED|Overall Study||2
10877276|NCT05439460|12043181|FG000|STARTED|First Intervention (Approx 5h on Study)||5
10877277|NCT05439460|12043182|FG001|STARTED|First Intervention (Approx 5h on Study)||0
10877278|NCT05439460|12043183|FG002|STARTED|First Intervention (Approx 5h on Study)||0
10877279|NCT05439460|12043181|FG000|COMPLETED|First Intervention (Approx 5h on Study)||5
10877280|NCT05439460|12043182|FG001|COMPLETED|First Intervention (Approx 5h on Study)||0
10877281|NCT05439460|12043183|FG002|COMPLETED|First Intervention (Approx 5h on Study)||0
10877282|NCT05439460|12043181|FG000|NOT COMPLETED|First Intervention (Approx 5h on Study)||0
10877283|NCT05439460|12043182|FG001|NOT COMPLETED|First Intervention (Approx 5h on Study)||0
10877284|NCT05439460|12043183|FG002|NOT COMPLETED|First Intervention (Approx 5h on Study)||0
10877285|NCT05439460|12043181|FG000|STARTED|Second Intervention (Approx 5h on Study)||0
10877286|NCT05439460|12043182|FG001|STARTED|Second Intervention (Approx 5h on Study)||5
10877287|NCT05439460|12043183|FG002|STARTED|Second Intervention (Approx 5h on Study)||0
10877288|NCT05439460|12043181|FG000|COMPLETED|Second Intervention (Approx 5h on Study)||0
10877289|NCT05439460|12043182|FG001|COMPLETED|Second Intervention (Approx 5h on Study)||5
10877290|NCT05439460|12043183|FG002|COMPLETED|Second Intervention (Approx 5h on Study)||0
10877291|NCT05439460|12043181|FG000|NOT COMPLETED|Second Intervention (Approx 5h on Study)||0
10877292|NCT05439460|12043182|FG001|NOT COMPLETED|Second Intervention (Approx 5h on Study)||0
10877293|NCT05439460|12043183|FG002|NOT COMPLETED|Second Intervention (Approx 5h on Study)||0
10877294|NCT05439460|12043181|FG000|STARTED|Third Intervention (Approx 5h on Study)||0
10877295|NCT05439460|12043182|FG001|STARTED|Third Intervention (Approx 5h on Study)||0
10877296|NCT05439460|12043183|FG002|STARTED|Third Intervention (Approx 5h on Study)||5
10877297|NCT05439460|12043181|FG000|COMPLETED|Third Intervention (Approx 5h on Study)||0
10877298|NCT05439460|12043182|FG001|COMPLETED|Third Intervention (Approx 5h on Study)||0
10877299|NCT05439460|12043183|FG002|COMPLETED|Third Intervention (Approx 5h on Study)||5
10877300|NCT05439460|12043181|FG000|NOT COMPLETED|Third Intervention (Approx 5h on Study)||0
10877301|NCT05439460|12043182|FG001|NOT COMPLETED|Third Intervention (Approx 5h on Study)||0
10877302|NCT05439460|12043183|FG002|NOT COMPLETED|Third Intervention (Approx 5h on Study)||0
10877303|NCT05405244|12043191|FG000|STARTED|First Intervention (Single 1-Day Visit)||28
10877304|NCT05405244|12043192|FG001|STARTED|First Intervention (Single 1-Day Visit)||27
10877305|NCT05405244|12043191|FG000|COMPLETED|First Intervention (Single 1-Day Visit)||28
10877306|NCT05405244|12043192|FG001|COMPLETED|First Intervention (Single 1-Day Visit)||27
10877307|NCT05405244|12043191|FG000|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0
10877308|NCT05405244|12043192|FG001|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0
10877309|NCT05405244|12043191|FG000|STARTED|Washout (2 Weeks)||28
10877310|NCT05405244|12043192|FG001|STARTED|Washout (2 Weeks)||27
10877311|NCT05405244|12043191|FG000|COMPLETED|Washout (2 Weeks)||24
10877312|NCT05405244|12043192|FG001|COMPLETED|Washout (2 Weeks)||26
10877313|NCT05405244|12043191|FG000|NOT COMPLETED|Washout (2 Weeks)||4
10877314|NCT05405244|12043192|FG001|NOT COMPLETED|Washout (2 Weeks)||1
10877315|NCT05405244|12043191|FG000|STARTED|Second Intervention (Single 1-Day Visit)||24
10877316|NCT05405244|12043192|FG001|STARTED|Second Intervention (Single 1-Day Visit)||26
10877317|NCT05405244|12043191|FG000|COMPLETED|Second Intervention (Single 1-Day Visit)||24
10877318|NCT05405244|12043192|FG001|COMPLETED|Second Intervention (Single 1-Day Visit)||26
10877319|NCT05405244|12043191|FG000|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0
10877320|NCT05405244|12043192|FG001|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0
10877321|NCT05271175|12043205|FG000|STARTED|Treatment||34
10877322|NCT05271175|12043206|FG001|STARTED|Treatment||33
10877323|NCT05271175|12043207|FG002|STARTED|Treatment||37
10877324|NCT05271175|12043205|FG000|COMPLETED|Treatment||29
10877325|NCT05271175|12043206|FG001|COMPLETED|Treatment||30
10877326|NCT05271175|12043207|FG002|COMPLETED|Treatment||30
10877327|NCT05271175|12043205|FG000|NOT COMPLETED|Treatment||5
10877328|NCT05271175|12043206|FG001|NOT COMPLETED|Treatment||3
10877329|NCT05271175|12043207|FG002|NOT COMPLETED|Treatment||7
10877330|NCT05271175|12043205|FG000|STARTED|One Week Follow up||29
10877331|NCT05271175|12043206|FG001|STARTED|One Week Follow up||30
10877332|NCT05271175|12043207|FG002|STARTED|One Week Follow up||30
10877333|NCT05271175|12043205|FG000|COMPLETED|One Week Follow up||19
10877334|NCT05271175|12043206|FG001|COMPLETED|One Week Follow up||23
10877335|NCT05271175|12043207|FG002|COMPLETED|One Week Follow up||25
10877336|NCT05271175|12043205|FG000|NOT COMPLETED|One Week Follow up||10
10877337|NCT05271175|12043206|FG001|NOT COMPLETED|One Week Follow up||7
10877338|NCT05271175|12043207|FG002|NOT COMPLETED|One Week Follow up||5
10877339|NCT05271175|12043205|FG000|STARTED|One Month Follow up||29
10877340|NCT05271175|12043206|FG001|STARTED|One Month Follow up||30
10877341|NCT05271175|12043207|FG002|STARTED|One Month Follow up||30
10877342|NCT05271175|12043205|FG000|COMPLETED|One Month Follow up||17
10877343|NCT05271175|12043206|FG001|COMPLETED|One Month Follow up||23
10877344|NCT05271175|12043207|FG002|COMPLETED|One Month Follow up||21
10877345|NCT05271175|12043205|FG000|NOT COMPLETED|One Month Follow up||12
10877346|NCT05271175|12043206|FG001|NOT COMPLETED|One Month Follow up||7
10877347|NCT05271175|12043207|FG002|NOT COMPLETED|One Month Follow up||9
10877348|NCT05271175|12043205|FG000|STARTED|Six Months Follow up||29
10877349|NCT05271175|12043206|FG001|STARTED|Six Months Follow up||30
10877350|NCT05271175|12043207|FG002|STARTED|Six Months Follow up||30
10877351|NCT05271175|12043205|FG000|COMPLETED|Six Months Follow up||21
10877352|NCT05271175|12043206|FG001|COMPLETED|Six Months Follow up||28
10877353|NCT05271175|12043207|FG002|COMPLETED|Six Months Follow up||28
10877354|NCT05271175|12043205|FG000|NOT COMPLETED|Six Months Follow up||8
10877355|NCT05271175|12043206|FG001|NOT COMPLETED|Six Months Follow up||2
10877356|NCT05271175|12043207|FG002|NOT COMPLETED|Six Months Follow up||2
10877357|NCT05200455|12043215|FG000|STARTED|Overall Study||34
10877358|NCT05200455|12043215|FG000|COMPLETED|Overall Study||30
10877359|NCT05200455|12043215|FG000|NOT COMPLETED|Overall Study||4
10877360|NCT05097144|12043220|FG000|STARTED|Overall Study||36
10877361|NCT05097144|12043220|FG000|COMPLETED|Overall Study||36
10877362|NCT05097144|12043220|FG000|NOT COMPLETED|Overall Study||0
10877363|NCT05091528|12043228|FG000|STARTED|Overall Study||0
10877364|NCT05091528|12043229|FG001|STARTED|Overall Study||1
10877365|NCT05091528|12043230|FG002|STARTED|Overall Study||0
10877366|NCT05091528|12043231|FG003|STARTED|Overall Study||1
10877367|NCT05091528|12043228|FG000|COMPLETED|Overall Study||0
10877368|NCT05091528|12043229|FG001|COMPLETED|Overall Study||0
10877369|NCT05091528|12043230|FG002|COMPLETED|Overall Study||0
10877370|NCT05091528|12043231|FG003|COMPLETED|Overall Study||0
10877371|NCT05091528|12043228|FG000|NOT COMPLETED|Overall Study||0
10877372|NCT05091528|12043229|FG001|NOT COMPLETED|Overall Study||1
10877373|NCT05091528|12043230|FG002|NOT COMPLETED|Overall Study||0
10877374|NCT05091528|12043231|FG003|NOT COMPLETED|Overall Study||1
10877375|NCT05090852|12043239|FG000|STARTED|Overall Study||31
10877376|NCT05090852|12043239|FG000|COMPLETED|Overall Study||26
10877377|NCT05090852|12043239|FG000|NOT COMPLETED|Overall Study||5
10877378|NCT05084885|12043243|FG000|STARTED|Baseline||3
10877379|NCT05084885|12043244|FG001|STARTED|Baseline||13
10877380|NCT05084885|12043243|FG000|COMPLETED|Baseline||3
10877381|NCT05084885|12043244|FG001|COMPLETED|Baseline|At the 12 month follow-up all people who completed the initial survey were again asked to complete the same measures. Only the baseline vs 12-month data is available. This was not a planned group, but was conducted during covid lockdown and we had no online access to the participants who had completed the survey. Our REB agree that we could use their data because they had consented to all followup survey at the beginning of the study.|13
10877382|NCT05084885|12043243|FG000|NOT COMPLETED|Baseline||0
10877383|NCT05084885|12043244|FG001|NOT COMPLETED|Baseline||0
10877384|NCT05084885|12043243|FG000|STARTED|Post Treatment||3
10877385|NCT05084885|12043244|FG001|STARTED|Post Treatment|None of the Non-Treatment group were asked to complete the post treatment survey.|0
10877386|NCT05084885|12043243|FG000|COMPLETED|Post Treatment||2
10877387|NCT05084885|12043244|FG001|COMPLETED|Post Treatment||0
10877388|NCT05084885|12043243|FG000|NOT COMPLETED|Post Treatment||1
10877389|NCT05084885|12043244|FG001|NOT COMPLETED|Post Treatment||0
10877390|NCT05084885|12043243|FG000|STARTED|Follow-up||2
10877391|NCT05084885|12043244|FG001|STARTED|Follow-up|At the 12 month follow-up all people who completed the initial survey were again asked to complete the same measures. Only the baseline vs 12-month data is available. This was not a planned group, but was conducted during covid lockdown and we had no online access to the participants who had completed the survey. Our REB agree that we could use their data because they had consented to all followup survey at the beginning of the study.|13
10877392|NCT05084885|12043243|FG000|COMPLETED|Follow-up||2
10877393|NCT05084885|12043244|FG001|COMPLETED|Follow-up||8
10877394|NCT05084885|12043243|FG000|NOT COMPLETED|Follow-up||0
10877395|NCT05084885|12043244|FG001|NOT COMPLETED|Follow-up||5
10877396|NCT05050318|12043253|FG000|STARTED|Overall Study||29
10877397|NCT05050318|12043254|FG001|STARTED|Overall Study||31
10877398|NCT05050318|12043255|FG002|STARTED|Overall Study||30
10877399|NCT05050318|12043253|FG000|Vaccinated|Overall Study||28
10877400|NCT05050318|12043254|FG001|Vaccinated|Overall Study||31
10877401|NCT05050318|12043255|FG002|Vaccinated|Overall Study||30
10877402|NCT05050318|12043253|FG000|COMPLETED|Overall Study||28
10877403|NCT05050318|12043254|FG001|COMPLETED|Overall Study||31
10877404|NCT05050318|12043255|FG002|COMPLETED|Overall Study||30
10877405|NCT05050318|12043253|FG000|NOT COMPLETED|Overall Study||1
10877406|NCT05050318|12043254|FG001|NOT COMPLETED|Overall Study||0
10877407|NCT05050318|12043255|FG002|NOT COMPLETED|Overall Study||0
10877408|NCT04942925|12043265|FG000|STARTED|First Wear Period (8 -0/+3 Days)||32
10877409|NCT04942925|12043266|FG001|STARTED|First Wear Period (8 -0/+3 Days)||28
10877410|NCT04942925|12043265|FG000|COMPLETED|First Wear Period (8 -0/+3 Days)||32
10877411|NCT04942925|12043266|FG001|COMPLETED|First Wear Period (8 -0/+3 Days)||26
10877412|NCT04942925|12043265|FG000|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||0
10877413|NCT04942925|12043266|FG001|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||2
10877414|NCT04942925|12043265|FG000|STARTED|Second Wear Period (8 -0/+3 Days)||32
10877415|NCT04942925|12043266|FG001|STARTED|Second Wear Period (8 -0/+3 Days)||26
10877416|NCT04942925|12043265|FG000|COMPLETED|Second Wear Period (8 -0/+3 Days)||32
10877417|NCT04942925|12043266|FG001|COMPLETED|Second Wear Period (8 -0/+3 Days)||26
10877418|NCT04942925|12043265|FG000|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||0
10877419|NCT04942925|12043266|FG001|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||0
10877420|NCT04908488|12043277|FG000|STARTED|First Wear Period (8 -0/+3 Days)||56
10877421|NCT04908488|12043278|FG001|STARTED|First Wear Period (8 -0/+3 Days)||58
10877422|NCT04908488|12043277|FG000|COMPLETED|First Wear Period (8 -0/+3 Days)||55
10877423|NCT04908488|12043278|FG001|COMPLETED|First Wear Period (8 -0/+3 Days)||58
10877424|NCT04908488|12043277|FG000|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||1
10877425|NCT04908488|12043278|FG001|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||0
10877426|NCT04908488|12043277|FG000|STARTED|Second Wear Period (8 -0/+3 Days)||55
10877427|NCT04908488|12043278|FG001|STARTED|Second Wear Period (8 -0/+3 Days)||58
10877428|NCT04908488|12043277|FG000|COMPLETED|Second Wear Period (8 -0/+3 Days)||54
10877429|NCT04908488|12043278|FG001|COMPLETED|Second Wear Period (8 -0/+3 Days)||58
10877430|NCT04908488|12043277|FG000|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||1
10877431|NCT04908488|12043278|FG001|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||0
10877432|NCT04899440|12043289|FG000|STARTED|Overall Study||15
10877433|NCT04899440|12043290|FG001|STARTED|Overall Study||15
10877434|NCT04899440|12043289|FG000|COMPLETED|Overall Study||15
10877435|NCT04899440|12043290|FG001|COMPLETED|Overall Study||15
10877436|NCT04899440|12043289|FG000|NOT COMPLETED|Overall Study||0
10877437|NCT04899440|12043290|FG001|NOT COMPLETED|Overall Study||0
10877438|NCT04899232|12043299|FG000|STARTED|Screening Period||20
10877439|NCT04899232|12043300|FG001|STARTED|Screening Period||20
10877440|NCT04899232|12043301|FG002|STARTED|Screening Period||12
10877441|NCT04899232|12043299|FG000|COMPLETED|Screening Period||15
10877442|NCT04899232|12043300|FG001|COMPLETED|Screening Period||20
10877443|NCT04899232|12043301|FG002|COMPLETED|Screening Period||12
10877444|NCT04899232|12043299|FG000|NOT COMPLETED|Screening Period||5
10877445|NCT04899232|12043300|FG001|NOT COMPLETED|Screening Period||0
10877446|NCT04899232|12043301|FG002|NOT COMPLETED|Screening Period||0
10877447|NCT04899232|12043299|FG000|STARTED|Treatment Period||15
10877448|NCT04899232|12043300|FG001|STARTED|Treatment Period||20
10877449|NCT04899232|12043301|FG002|STARTED|Treatment Period||12
10877450|NCT04899232|12043299|FG000|COMPLETED|Treatment Period||15
10877451|NCT04899232|12043300|FG001|COMPLETED|Treatment Period||20
10877452|NCT04899232|12043301|FG002|COMPLETED|Treatment Period||12
10877453|NCT04899232|12043299|FG000|NOT COMPLETED|Treatment Period||0
10877454|NCT04899232|12043300|FG001|NOT COMPLETED|Treatment Period||0
10877455|NCT04899232|12043301|FG002|NOT COMPLETED|Treatment Period||0
10877456|NCT04885296|12043309|FG000|STARTED|Period 1||117
10877457|NCT04885296|12043310|FG001|STARTED|Period 1||110
10877458|NCT04885296|12043309|FG000|COMPLETED|Period 1||112
10877459|NCT04885296|12043310|FG001|COMPLETED|Period 1||108
10877460|NCT04885296|12043309|FG000|NOT COMPLETED|Period 1||5
10877461|NCT04885296|12043310|FG001|NOT COMPLETED|Period 1||2
10877462|NCT04885296|12043309|FG000|STARTED|Period 2||112
10877463|NCT04885296|12043310|FG001|STARTED|Period 2||108
10877464|NCT04885296|12043309|FG000|COMPLETED|Period 2||112
10877465|NCT04885296|12043310|FG001|COMPLETED|Period 2||107
10877466|NCT04885296|12043309|FG000|NOT COMPLETED|Period 2||0
10877467|NCT04885296|12043310|FG001|NOT COMPLETED|Period 2||1
10877468|NCT04862065|12043319|FG000|STARTED|Screening||15581
10877469|NCT04862065|12043320|FG001|STARTED|Screening||403
10877470|NCT04862065|12043321|FG002|STARTED|Screening||404
10877471|NCT04862065|12043319|FG000|COMPLETED|Screening||15526
10877472|NCT04862065|12043320|FG001|COMPLETED|Screening||403
10877473|NCT04862065|12043321|FG002|COMPLETED|Screening||404
10877474|NCT04862065|12043319|FG000|NOT COMPLETED|Screening||55
10877475|NCT04862065|12043320|FG001|NOT COMPLETED|Screening||0
10877476|NCT04862065|12043321|FG002|NOT COMPLETED|Screening||0
10877477|NCT04862065|12043319|FG000|STARTED|Follow-Up||6
10877478|NCT04862065|12043320|FG001|STARTED|Follow-Up||0
10877479|NCT04862065|12043321|FG002|STARTED|Follow-Up||0
10877480|NCT04862065|12043319|FG000|COMPLETED|Follow-Up||3
10877481|NCT04862065|12043320|FG001|COMPLETED|Follow-Up||0
10877482|NCT04862065|12043321|FG002|COMPLETED|Follow-Up||0
10877483|NCT04862065|12043319|FG000|NOT COMPLETED|Follow-Up||3
10877484|NCT04862065|12043320|FG001|NOT COMPLETED|Follow-Up||0
10877485|NCT04862065|12043321|FG002|NOT COMPLETED|Follow-Up||0
10877486|NCT04824365|12043329|FG000|STARTED|Overall Study||15
10877487|NCT04824365|12043330|FG001|STARTED|Overall Study||15
10877488|NCT04824365|12043329|FG000|COMPLETED|Overall Study||15
10877489|NCT04824365|12043330|FG001|COMPLETED|Overall Study||15
10877490|NCT04824365|12043329|FG000|NOT COMPLETED|Overall Study||0
10877491|NCT04824365|12043330|FG001|NOT COMPLETED|Overall Study||0
10877492|NCT04822701|12043338|FG000|STARTED|Overall Study||4
10877493|NCT04822701|12043339|FG001|STARTED|Overall Study||1
10877494|NCT04822701|12043338|FG000|Treated|Overall Study||2
10877495|NCT04822701|12043339|FG001|Treated|Overall Study||1
10877496|NCT04822701|12043338|FG000|COMPLETED|Overall Study||0
10877497|NCT04822701|12043339|FG001|COMPLETED|Overall Study||1
10877498|NCT04822701|12043338|FG000|NOT COMPLETED|Overall Study||4
10877499|NCT04822701|12043339|FG001|NOT COMPLETED|Overall Study||0
10877500|NCT04784897|12043348|FG000|STARTED|Overall Study||60
10877501|NCT04784897|12043349|FG001|STARTED|Overall Study||16
10877502|NCT04784897|12043350|FG002|STARTED|Overall Study||44
10877503|NCT04784897|12043348|FG000|COMPLETED|Overall Study||56
10877504|NCT04784897|12043349|FG001|COMPLETED|Overall Study||14
10877505|NCT04784897|12043350|FG002|COMPLETED|Overall Study||42
10877506|NCT04784897|12043348|FG000|NOT COMPLETED|Overall Study||4
10877507|NCT04784897|12043349|FG001|NOT COMPLETED|Overall Study||2
10877508|NCT04784897|12043350|FG002|NOT COMPLETED|Overall Study||2
10877509|NCT04774328|12043364|FG000|STARTED|Overall Study||10
10877510|NCT04774328|12043365|FG001|STARTED|Overall Study||12
10877511|NCT04774328|12043366|FG002|STARTED|Overall Study||12
10877512|NCT04774328|12043364|FG000|Follow-up to 29 Days Post Surgery|Overall Study||10
10877513|NCT04774328|12043365|FG001|Follow-up to 29 Days Post Surgery|Overall Study||12
10877514|NCT04774328|12043366|FG002|Follow-up to 29 Days Post Surgery|Overall Study||12
10877515|NCT04774328|12043364|FG000|COMPLETED|Overall Study||10
10877516|NCT04774328|12043365|FG001|COMPLETED|Overall Study||12
10877517|NCT04774328|12043366|FG002|COMPLETED|Overall Study||12
10877518|NCT04774328|12043364|FG000|NOT COMPLETED|Overall Study||0
10877519|NCT04774328|12043365|FG001|NOT COMPLETED|Overall Study||0
10877520|NCT04774328|12043366|FG002|NOT COMPLETED|Overall Study||0
10877521|NCT04764669|12043379|FG000|STARTED|Overall Study||10
10877522|NCT04764669|12043380|FG001|STARTED|Overall Study||11
10877523|NCT04764669|12043381|FG002|STARTED|Overall Study||10
10877524|NCT04764669|12043382|FG003|STARTED|Overall Study||3
10877525|NCT04764669|12043379|FG000|COMPLETED|Overall Study||7
10877526|NCT04764669|12043380|FG001|COMPLETED|Overall Study||11
10877527|NCT04764669|12043381|FG002|COMPLETED|Overall Study||8
10877528|NCT04764669|12043382|FG003|COMPLETED|Overall Study||3
10877529|NCT04764669|12043379|FG000|NOT COMPLETED|Overall Study||3
10877530|NCT04764669|12043380|FG001|NOT COMPLETED|Overall Study||0
10877531|NCT04764669|12043381|FG002|NOT COMPLETED|Overall Study||2
10877532|NCT04764669|12043382|FG003|NOT COMPLETED|Overall Study||0
10877533|NCT04757805|12043392|FG000|STARTED|Overall Study||50
10877534|NCT04757805|12043392|FG000|COMPLETED|Overall Study||50
10877535|NCT04757805|12043392|FG000|NOT COMPLETED|Overall Study||0
10877536|NCT04741503|12043398|FG000|STARTED|Initial Enrollment||160
10877537|NCT04741503|12043399|FG001|STARTED|Initial Enrollment||164
10877538|NCT04741503|12043400|FG002|STARTED|Initial Enrollment||953
10877539|NCT04741503|12043398|FG000|COMPLETED|Initial Enrollment||160
10877540|NCT04741503|12043399|FG001|COMPLETED|Initial Enrollment||164
10877541|NCT04741503|12043400|FG002|COMPLETED|Initial Enrollment||0
10877542|NCT04741503|12043398|FG000|NOT COMPLETED|Initial Enrollment||0
10877543|NCT04741503|12043399|FG001|NOT COMPLETED|Initial Enrollment||0
10877544|NCT04741503|12043400|FG002|NOT COMPLETED|Initial Enrollment||953
10877545|NCT04741503|12043398|FG000|STARTED|Met Protocol Criteria for Data Inclusion||160
10877546|NCT04741503|12043399|FG001|STARTED|Met Protocol Criteria for Data Inclusion||164
10877547|NCT04741503|12043400|FG002|STARTED|Met Protocol Criteria for Data Inclusion||0
10877548|NCT04741503|12043398|FG000|COMPLETED|Met Protocol Criteria for Data Inclusion||137
10877549|NCT04741503|12043399|FG001|COMPLETED|Met Protocol Criteria for Data Inclusion||147
10877550|NCT04741503|12043400|FG002|COMPLETED|Met Protocol Criteria for Data Inclusion||0
10877551|NCT04741503|12043398|FG000|NOT COMPLETED|Met Protocol Criteria for Data Inclusion||23
10877552|NCT04741503|12043399|FG001|NOT COMPLETED|Met Protocol Criteria for Data Inclusion||17
10877553|NCT04741503|12043400|FG002|NOT COMPLETED|Met Protocol Criteria for Data Inclusion||0
10877554|NCT04734873|12043409|FG000|STARTED|Overall Study||16
10877555|NCT04734873|12043410|FG001|STARTED|Overall Study||14
10877556|NCT04734873|12043411|FG002|STARTED|Overall Study||12
10877557|NCT04734873|12043409|FG000|COMPLETED|Overall Study||14
10877558|NCT04734873|12043410|FG001|COMPLETED|Overall Study||11
10877559|NCT04734873|12043411|FG002|COMPLETED|Overall Study||9
10877560|NCT04734873|12043409|FG000|NOT COMPLETED|Overall Study||2
10877561|NCT04734873|12043410|FG001|NOT COMPLETED|Overall Study||3
10877562|NCT04734873|12043411|FG002|NOT COMPLETED|Overall Study||3
10877563|NCT04724967|12043419|FG000|STARTED|Overall Study||528
10877564|NCT04724967|12043419|FG000|COMPLETED|Overall Study||528
10877565|NCT04724967|12043419|FG000|NOT COMPLETED|Overall Study||0
10877566|NCT04724733|12043426|FG000|STARTED|Overall Study||22
10877567|NCT04724733|12043427|FG001|STARTED|Overall Study||22
10877568|NCT04724733|12043428|FG002|STARTED|Overall Study||23
10877569|NCT04724733|12043426|FG000|4 Weeks|Overall Study||22
10877570|NCT04724733|12043427|FG001|4 Weeks|Overall Study||21
10877571|NCT04724733|12043428|FG002|4 Weeks|Overall Study||23
10877572|NCT04724733|12043426|FG000|COMPLETED|Overall Study||21
10877573|NCT04724733|12043427|FG001|COMPLETED|Overall Study||21
10877574|NCT04724733|12043428|FG002|COMPLETED|Overall Study||22
10877575|NCT04724733|12043426|FG000|NOT COMPLETED|Overall Study||1
10877576|NCT04724733|12043427|FG001|NOT COMPLETED|Overall Study||1
10877577|NCT04724733|12043428|FG002|NOT COMPLETED|Overall Study||1
10877578|NCT04716010|12043440|FG000|STARTED|Overall Study||1039
10877579|NCT04716010|12043441|FG001|STARTED|Overall Study||1040
10877580|NCT04716010|12043442|FG002|STARTED|Overall Study||1039
10877581|NCT04716010|12043443|FG003|STARTED|Overall Study||1042
10877582|NCT04716010|12043440|FG000|COMPLETED|Overall Study||887
10877583|NCT04716010|12043441|FG001|COMPLETED|Overall Study||891
10877584|NCT04716010|12043442|FG002|COMPLETED|Overall Study||874
10877585|NCT04716010|12043443|FG003|COMPLETED|Overall Study||866
10877586|NCT04716010|12043440|FG000|NOT COMPLETED|Overall Study||152
10877587|NCT04716010|12043441|FG001|NOT COMPLETED|Overall Study||149
10877588|NCT04716010|12043442|FG002|NOT COMPLETED|Overall Study||165
10877589|NCT04716010|12043443|FG003|NOT COMPLETED|Overall Study||176
10877590|NCT04713748|12043453|FG000|STARTED|Overall Study||135
10877591|NCT04713748|12043453|FG000|COMPLETED|Overall Study||100
10877592|NCT04713748|12043453|FG000|NOT COMPLETED|Overall Study||35
10877593|NCT04699812|12043461|FG000|STARTED|Overall Study||78
10877594|NCT04699812|12043462|FG001|STARTED|Overall Study||82
10877595|NCT04699812|12043463|FG002|STARTED|Overall Study||366
10877596|NCT04699812|12043464|FG003|STARTED|Overall Study||47
10877597|NCT04699812|12043461|FG000|COMPLETED|Overall Study||70
10877598|NCT04699812|12043462|FG001|COMPLETED|Overall Study||64
10877599|NCT04699812|12043463|FG002|COMPLETED|Overall Study||304
10877600|NCT04699812|12043464|FG003|COMPLETED|Overall Study||45
10877601|NCT04699812|12043461|FG000|NOT COMPLETED|Overall Study||8
10877602|NCT04699812|12043462|FG001|NOT COMPLETED|Overall Study||18
10877603|NCT04699812|12043463|FG002|NOT COMPLETED|Overall Study||62
10877604|NCT04699812|12043464|FG003|NOT COMPLETED|Overall Study||2
10877605|NCT04685811|12043479|FG000|STARTED|Overall Study||16
10877606|NCT04685811|12043479|FG000|COMPLETED|Overall Study||16
10877607|NCT04685811|12043479|FG000|NOT COMPLETED|Overall Study||0
10877608|NCT04668274|12043487|FG000|STARTED|Part 1 Study Period 1||21
10877609|NCT04668274|12043488|FG001|STARTED|Part 1 Study Period 1||0
10877610|NCT04668274|12043489|FG002|STARTED|Part 1 Study Period 1||0
10877611|NCT04668274|12043490|FG003|STARTED|Part 1 Study Period 1||0
10877612|NCT04668274|12043487|FG000|COMPLETED|Part 1 Study Period 1||16
10877613|NCT04668274|12043488|FG001|COMPLETED|Part 1 Study Period 1||0
10877614|NCT04668274|12043489|FG002|COMPLETED|Part 1 Study Period 1||0
10877615|NCT04668274|12043490|FG003|COMPLETED|Part 1 Study Period 1||0
10877616|NCT04668274|12043487|FG000|NOT COMPLETED|Part 1 Study Period 1||5
10877617|NCT04668274|12043488|FG001|NOT COMPLETED|Part 1 Study Period 1||0
10877618|NCT04668274|12043489|FG002|NOT COMPLETED|Part 1 Study Period 1||0
10877619|NCT04668274|12043490|FG003|NOT COMPLETED|Part 1 Study Period 1||0
10877620|NCT04668274|12043487|FG000|STARTED|Part 1 Study Period 2||0
10877621|NCT04668274|12043488|FG001|STARTED|Part 1 Study Period 2||16
10877622|NCT04668274|12043489|FG002|STARTED|Part 1 Study Period 2||0
10877623|NCT04668274|12043490|FG003|STARTED|Part 1 Study Period 2||0
10877624|NCT04668274|12043487|FG000|COMPLETED|Part 1 Study Period 2||0
10877625|NCT04668274|12043488|FG001|COMPLETED|Part 1 Study Period 2||15
10877626|NCT04668274|12043489|FG002|COMPLETED|Part 1 Study Period 2||0
10877627|NCT04668274|12043490|FG003|COMPLETED|Part 1 Study Period 2||0
10877628|NCT04668274|12043487|FG000|NOT COMPLETED|Part 1 Study Period 2||0
10877629|NCT04668274|12043488|FG001|NOT COMPLETED|Part 1 Study Period 2||1
10877630|NCT04668274|12043489|FG002|NOT COMPLETED|Part 1 Study Period 2||0
10877631|NCT04668274|12043490|FG003|NOT COMPLETED|Part 1 Study Period 2||0
10877632|NCT04668274|12043487|FG000|STARTED|Part 1 Study Period 3||0
10877633|NCT04668274|12043488|FG001|STARTED|Part 1 Study Period 3||0
10877634|NCT04668274|12043489|FG002|STARTED|Part 1 Study Period 3||18
10877635|NCT04668274|12043490|FG003|STARTED|Part 1 Study Period 3||0
10877636|NCT04668274|12043487|FG000|COMPLETED|Part 1 Study Period 3||0
10877637|NCT04668274|12043488|FG001|COMPLETED|Part 1 Study Period 3||0
10877638|NCT04668274|12043489|FG002|COMPLETED|Part 1 Study Period 3|3 participants were directly enrolled in Study Period 3 in addition to the 15 participants from the Study Period 2.|15
10877639|NCT04668274|12043490|FG003|COMPLETED|Part 1 Study Period 3||0
10877640|NCT04668274|12043487|FG000|NOT COMPLETED|Part 1 Study Period 3||0
10877641|NCT04668274|12043488|FG001|NOT COMPLETED|Part 1 Study Period 3||0
10877642|NCT04668274|12043489|FG002|NOT COMPLETED|Part 1 Study Period 3||3
10877643|NCT04668274|12043490|FG003|NOT COMPLETED|Part 1 Study Period 3||0
10877644|NCT04668274|12043487|FG000|STARTED|Part 2 Study Period 4||0
10877645|NCT04668274|12043488|FG001|STARTED|Part 2 Study Period 4||0
10877646|NCT04668274|12043489|FG002|STARTED|Part 2 Study Period 4||0
10877647|NCT04668274|12043490|FG003|STARTED|Part 2 Study Period 4||15
10877648|NCT04668274|12043487|FG000|COMPLETED|Part 2 Study Period 4||0
10877649|NCT04668274|12043488|FG001|COMPLETED|Part 2 Study Period 4||0
10877650|NCT04668274|12043489|FG002|COMPLETED|Part 2 Study Period 4||0
10877651|NCT04668274|12043490|FG003|COMPLETED|Part 2 Study Period 4||14
10877652|NCT04668274|12043487|FG000|NOT COMPLETED|Part 2 Study Period 4||0
10877653|NCT04668274|12043488|FG001|NOT COMPLETED|Part 2 Study Period 4||0
10877654|NCT04668274|12043489|FG002|NOT COMPLETED|Part 2 Study Period 4||0
10877655|NCT04668274|12043490|FG003|NOT COMPLETED|Part 2 Study Period 4||1
10877656|NCT04666051|12043505|FG000|STARTED|Overall Study||16
10877657|NCT04666051|12043506|FG001|STARTED|Overall Study||16
10877658|NCT04666051|12043505|FG000|COMPLETED|Overall Study||16
10877659|NCT04666051|12043506|FG001|COMPLETED|Overall Study||16
10877660|NCT04666051|12043505|FG000|NOT COMPLETED|Overall Study||0
10877661|NCT04666051|12043506|FG001|NOT COMPLETED|Overall Study||0
10877662|NCT04664153|12043516|FG000|STARTED|Overall Study||34
10877663|NCT04664153|12043517|FG001|STARTED|Overall Study||36
10877664|NCT04664153|12043518|FG002|STARTED|Overall Study||17
10877665|NCT04664153|12043519|FG003|STARTED|Overall Study||17
10877666|NCT04664153|12043516|FG000|COMPLETED|Overall Study||27
10877667|NCT04664153|12043517|FG001|COMPLETED|Overall Study||33
10877668|NCT04664153|12043518|FG002|COMPLETED|Overall Study||13
10877669|NCT04664153|12043519|FG003|COMPLETED|Overall Study||15
10877670|NCT04664153|12043516|FG000|NOT COMPLETED|Overall Study||7
10877671|NCT04664153|12043517|FG001|NOT COMPLETED|Overall Study||3
10877672|NCT04664153|12043518|FG002|NOT COMPLETED|Overall Study||4
10877673|NCT04664153|12043519|FG003|NOT COMPLETED|Overall Study||2
10877674|NCT04663295|12043531|FG000|STARTED|Run-in Period||65
10877675|NCT04663295|12043531|FG000|COMPLETED|Run-in Period||62
10877676|NCT04663295|12043531|FG000|NOT COMPLETED|Run-in Period||3
10877677|NCT04663295|12043531|FG000|STARTED|Overall Study Period||62
10877678|NCT04663295|12043531|FG000|COMPLETED|Overall Study Period||60
10877679|NCT04663295|12043531|FG000|NOT COMPLETED|Overall Study Period||2
10877680|NCT04662671|12043542|FG000|STARTED|Overall Study||20
10877681|NCT04662671|12043543|FG001|STARTED|Overall Study||11
10877682|NCT04662671|12043542|FG000|COMPLETED|Overall Study||20
10877683|NCT04662671|12043543|FG001|COMPLETED|Overall Study||11
10877684|NCT04662671|12043542|FG000|NOT COMPLETED|Overall Study||0
10877685|NCT04662671|12043543|FG001|NOT COMPLETED|Overall Study||0
10877686|NCT04650282|12043553|FG000|STARTED|Overall Study||1
10877687|NCT04650282|12043554|FG001|STARTED|Overall Study||1
10877688|NCT04650282|12043553|FG000|COMPLETED|Overall Study||1
10877689|NCT04650282|12043554|FG001|COMPLETED|Overall Study||1
10877690|NCT04650282|12043553|FG000|NOT COMPLETED|Overall Study||0
10877691|NCT04650282|12043554|FG001|NOT COMPLETED|Overall Study||0
10877692|NCT04646369|12043563|FG000|STARTED|Overall Study||23
10877693|NCT04646369|12043564|FG001|STARTED|Overall Study||38
10877694|NCT04646369|12043565|FG002|STARTED|Overall Study||39
10877695|NCT04646369|12043563|FG000|COMPLETED|Overall Study||23
10877696|NCT04646369|12043564|FG001|COMPLETED|Overall Study||38
10877697|NCT04646369|12043565|FG002|COMPLETED|Overall Study||39
10877698|NCT04646369|12043563|FG000|NOT COMPLETED|Overall Study||0
10877699|NCT04646369|12043564|FG001|NOT COMPLETED|Overall Study||0
10877700|NCT04646369|12043565|FG002|NOT COMPLETED|Overall Study||0
10877701|NCT04646148|12043590|FG000|STARTED|Overall Study||0
10877702|NCT04646148|12043591|FG001|STARTED|Overall Study||1
10877703|NCT04646148|12043592|FG002|STARTED|Overall Study||0
10877704|NCT04646148|12043593|FG003|STARTED|Overall Study||1
10877705|NCT04646148|12043594|FG004|STARTED|Overall Study||1
10877706|NCT04646148|12043595|FG005|STARTED|Overall Study||2
10877707|NCT04646148|12043596|FG006|STARTED|Overall Study||1
10877708|NCT04646148|12043597|FG007|STARTED|Overall Study||2
10877709|NCT04646148|12043598|FG008|STARTED|Overall Study||1
10877710|NCT04646148|12043599|FG009|STARTED|Overall Study||2
10877711|NCT04646148|12043600|FG010|STARTED|Overall Study||1
10877712|NCT04646148|12043601|FG011|STARTED|Overall Study||2
10877713|NCT04646148|12043602|FG012|STARTED|Overall Study||1
10877714|NCT04646148|12043603|FG013|STARTED|Overall Study||1
10877715|NCT04646148|12043604|FG014|STARTED|Overall Study||2
10877716|NCT04646148|12043605|FG015|STARTED|Overall Study||2
10877717|NCT04646148|12043590|FG000|COMPLETED|Overall Study||0
10877718|NCT04646148|12043591|FG001|COMPLETED|Overall Study||0
10877719|NCT04646148|12043592|FG002|COMPLETED|Overall Study||0
10877720|NCT04646148|12043593|FG003|COMPLETED|Overall Study||1
10877721|NCT04646148|12043594|FG004|COMPLETED|Overall Study||0
10877722|NCT04646148|12043595|FG005|COMPLETED|Overall Study||1
10877723|NCT04646148|12043596|FG006|COMPLETED|Overall Study||0
10877724|NCT04646148|12043597|FG007|COMPLETED|Overall Study||1
10877725|NCT04646148|12043598|FG008|COMPLETED|Overall Study||1
10877726|NCT04646148|12043599|FG009|COMPLETED|Overall Study||2
10877727|NCT04646148|12043600|FG010|COMPLETED|Overall Study||1
10877728|NCT04646148|12043601|FG011|COMPLETED|Overall Study||2
10877729|NCT04646148|12043602|FG012|COMPLETED|Overall Study||1
10877730|NCT04646148|12043603|FG013|COMPLETED|Overall Study||1
10877731|NCT04646148|12043604|FG014|COMPLETED|Overall Study||2
10877732|NCT04646148|12043605|FG015|COMPLETED|Overall Study||0
10877733|NCT04646148|12043590|FG000|NOT COMPLETED|Overall Study||0
10877734|NCT04646148|12043591|FG001|NOT COMPLETED|Overall Study||1
10877735|NCT04646148|12043592|FG002|NOT COMPLETED|Overall Study||0
10877736|NCT04646148|12043593|FG003|NOT COMPLETED|Overall Study||0
10877737|NCT04646148|12043594|FG004|NOT COMPLETED|Overall Study||1
10877738|NCT04646148|12043595|FG005|NOT COMPLETED|Overall Study||1
10877739|NCT04646148|12043596|FG006|NOT COMPLETED|Overall Study||1
10877740|NCT04646148|12043597|FG007|NOT COMPLETED|Overall Study||1
10877741|NCT04646148|12043598|FG008|NOT COMPLETED|Overall Study||0
10877742|NCT04646148|12043599|FG009|NOT COMPLETED|Overall Study||0
10877743|NCT04646148|12043600|FG010|NOT COMPLETED|Overall Study||0
10877744|NCT04646148|12043601|FG011|NOT COMPLETED|Overall Study||0
10877745|NCT04646148|12043602|FG012|NOT COMPLETED|Overall Study||0
10877746|NCT04646148|12043603|FG013|NOT COMPLETED|Overall Study||0
10877747|NCT04646148|12043604|FG014|NOT COMPLETED|Overall Study||0
10877748|NCT04646148|12043605|FG015|NOT COMPLETED|Overall Study||2
10877749|NCT04645264|12043643|FG000|STARTED|Overall Study||3
10877750|NCT04645264|12043644|FG001|STARTED|Overall Study||2
10877751|NCT04645264|12043645|FG002|STARTED|Overall Study||2
10877752|NCT04645264|12043643|FG000|COMPLETED|Overall Study||3
10877753|NCT04645264|12043644|FG001|COMPLETED|Overall Study||2
10877754|NCT04645264|12043645|FG002|COMPLETED|Overall Study||2
10877755|NCT04645264|12043643|FG000|NOT COMPLETED|Overall Study||0
10877756|NCT04645264|12043644|FG001|NOT COMPLETED|Overall Study||0
10877757|NCT04645264|12043645|FG002|NOT COMPLETED|Overall Study||0
10877758|NCT04636398|12043653|FG000|STARTED|Overall Study||29
10877759|NCT04636398|12043653|FG000|COMPLETED|Overall Study||29
10877760|NCT04636398|12043653|FG000|NOT COMPLETED|Overall Study||0
10877761|NCT04623242|12043662|FG000|STARTED|Overall Study||52
10877762|NCT04623242|12043663|FG001|STARTED|Overall Study||52
10877763|NCT04623242|12043664|FG002|STARTED|Overall Study||40
10877764|NCT04623242|12043665|FG003|STARTED|Overall Study||49
10877765|NCT04623242|12043666|FG004|STARTED|Overall Study||69
10877766|NCT04623242|12043662|FG000|COMPLETED|Overall Study||39
10877767|NCT04623242|12043663|FG001|COMPLETED|Overall Study||36
10877768|NCT04623242|12043664|FG002|COMPLETED|Overall Study||30
10877769|NCT04623242|12043665|FG003|COMPLETED|Overall Study||26
10877770|NCT04623242|12043666|FG004|COMPLETED|Overall Study||69
10877771|NCT04623242|12043662|FG000|NOT COMPLETED|Overall Study||13
10877772|NCT04623242|12043663|FG001|NOT COMPLETED|Overall Study||16
10877773|NCT04623242|12043664|FG002|NOT COMPLETED|Overall Study||10
10877774|NCT04623242|12043665|FG003|NOT COMPLETED|Overall Study||23
10877775|NCT04623242|12043666|FG004|NOT COMPLETED|Overall Study||0
10877776|NCT04619992|12043683|FG000|STARTED|Overall Study||55
10877777|NCT04619992|12043684|FG001|STARTED|Overall Study||7
10877778|NCT04619992|12043683|FG000|COMPLETED|Overall Study||54
10877779|NCT04619992|12043684|FG001|COMPLETED|Overall Study||7
10877780|NCT04619992|12043683|FG000|NOT COMPLETED|Overall Study||1
10877781|NCT04619992|12043684|FG001|NOT COMPLETED|Overall Study||0
10877782|NCT04606199|12043690|FG000|STARTED|Overall Study||53
10877783|NCT04606199|12043690|FG000|COMPLETED|Overall Study||51
10877784|NCT04606199|12043690|FG000|NOT COMPLETED|Overall Study||2
10877785|NCT04590495|12043698|FG000|STARTED|Overall Study||21
10877786|NCT04590495|12043699|FG001|STARTED|Overall Study||19
10877787|NCT04590495|12043698|FG000|COMPLETED|Overall Study||21
10877788|NCT04590495|12043699|FG001|COMPLETED|Overall Study||19
10877789|NCT04590495|12043698|FG000|NOT COMPLETED|Overall Study||0
10877790|NCT04590495|12043699|FG001|NOT COMPLETED|Overall Study||0
10877791|NCT04589559|12043705|FG000|STARTED|Overall Study||10
10877792|NCT04589559|12043705|FG000|COMPLETED|Overall Study||10
10877793|NCT04589559|12043705|FG000|NOT COMPLETED|Overall Study||0
10877794|NCT04587453|12043711|FG000|STARTED|Treatment Period (Week 0 to Week 16)||53
10877795|NCT04587453|12043712|FG001|STARTED|Treatment Period (Week 0 to Week 16)||53
10877796|NCT04587453|12043711|FG000|Full Analysis Set|Treatment Period (Week 0 to Week 16)||53
10877797|NCT04587453|12043712|FG001|Full Analysis Set|Treatment Period (Week 0 to Week 16)||53
10877798|NCT04587453|12043711|FG000|Safety Analysis Set|Treatment Period (Week 0 to Week 16)||53
10877799|NCT04587453|12043712|FG001|Safety Analysis Set|Treatment Period (Week 0 to Week 16)||53
10877800|NCT04587453|12043711|FG000|COMPLETED|Treatment Period (Week 0 to Week 16)||53
10877801|NCT04587453|12043712|FG001|COMPLETED|Treatment Period (Week 0 to Week 16)||52
10877802|NCT04587453|12043711|FG000|NOT COMPLETED|Treatment Period (Week 0 to Week 16)||0
10877803|NCT04587453|12043712|FG001|NOT COMPLETED|Treatment Period (Week 0 to Week 16)||1
10877804|NCT04587453|12043711|FG000|STARTED|Safety Follow-up (Week 16 to Week 20)||8
10877805|NCT04587453|12043712|FG001|STARTED|Safety Follow-up (Week 16 to Week 20)||3
10877806|NCT04587453|12043711|FG000|Not Started|Safety Follow-up (Week 16 to Week 20)||45
10877807|NCT04587453|12043712|FG001|Not Started|Safety Follow-up (Week 16 to Week 20)||49
10877808|NCT04587453|12043711|FG000|Safety Follow-up Analysis Set|Safety Follow-up (Week 16 to Week 20)||8
10877809|NCT04587453|12043712|FG001|Safety Follow-up Analysis Set|Safety Follow-up (Week 16 to Week 20)|1 subject prematurely discontinued treatment before Week 16, but did have contact after last exposure date and was therefore included in the safety follow-up analysis set.|4
10877810|NCT04587453|12043711|FG000|COMPLETED|Safety Follow-up (Week 16 to Week 20)|1 participant transferred to ECZTEND (LP0162-1337) at the safety follow-up visit.|8
10877811|NCT04587453|12043712|FG001|COMPLETED|Safety Follow-up (Week 16 to Week 20)||3
10877812|NCT04587453|12043711|FG000|NOT COMPLETED|Safety Follow-up (Week 16 to Week 20)||0
10877813|NCT04587453|12043712|FG001|NOT COMPLETED|Safety Follow-up (Week 16 to Week 20)||0
10877814|NCT04584970|12043722|FG000|STARTED|Overall Study||11
10877815|NCT04584970|12043723|FG001|STARTED|Overall Study||12
10877816|NCT04584970|12043722|FG000|COMPLETED|Overall Study||10
10877817|NCT04584970|12043723|FG001|COMPLETED|Overall Study||9
10877818|NCT04584970|12043722|FG000|NOT COMPLETED|Overall Study||1
10877819|NCT04584970|12043723|FG001|NOT COMPLETED|Overall Study||3
10877820|NCT04584346|12043731|FG000|STARTED|Phase 1 - Inpatient (Blinded)||7
10877821|NCT04584346|12043732|FG001|STARTED|Phase 1 - Inpatient (Blinded)||9
10877822|NCT04584346|12043731|FG000|COMPLETED|Phase 1 - Inpatient (Blinded)||7
10877823|NCT04584346|12043732|FG001|COMPLETED|Phase 1 - Inpatient (Blinded)||9
10877824|NCT04584346|12043731|FG000|NOT COMPLETED|Phase 1 - Inpatient (Blinded)||0
10877825|NCT04584346|12043732|FG001|NOT COMPLETED|Phase 1 - Inpatient (Blinded)||0
10877826|NCT04584346|12043731|FG000|STARTED|Phase 2 - At Home (Unblinded)||7
10877827|NCT04584346|12043732|FG001|STARTED|Phase 2 - At Home (Unblinded)||9
10877828|NCT04584346|12043731|FG000|COMPLETED|Phase 2 - At Home (Unblinded)||7
10877829|NCT04584346|12043732|FG001|COMPLETED|Phase 2 - At Home (Unblinded)||8
10877830|NCT04584346|12043731|FG000|NOT COMPLETED|Phase 2 - At Home (Unblinded)||0
10877831|NCT04584346|12043732|FG001|NOT COMPLETED|Phase 2 - At Home (Unblinded)||1
10877832|NCT04583709|12043740|FG000|STARTED|Overall Study||20
10877833|NCT04583709|12043740|FG000|COMPLETED|Overall Study||20
10877834|NCT04583709|12043740|FG000|NOT COMPLETED|Overall Study||0
10877835|NCT04580303|12043746|FG000|STARTED|Overall Study||7
10877836|NCT04580303|12043747|FG001|STARTED|Overall Study||9
10877837|NCT04580303|12043748|FG002|STARTED|Overall Study||9
10877838|NCT04580303|12043749|FG003|STARTED|Overall Study||10
10877839|NCT04580303|12043746|FG000|COMPLETED|Overall Study||7
10877840|NCT04580303|12043747|FG001|COMPLETED|Overall Study||8
10877841|NCT04580303|12043748|FG002|COMPLETED|Overall Study||8
10877842|NCT04580303|12043749|FG003|COMPLETED|Overall Study||10
10877843|NCT04580303|12043746|FG000|NOT COMPLETED|Overall Study||0
10877844|NCT04580303|12043747|FG001|NOT COMPLETED|Overall Study||1
10877845|NCT04580303|12043748|FG002|NOT COMPLETED|Overall Study||1
10877846|NCT04580303|12043749|FG003|NOT COMPLETED|Overall Study||0
10877847|NCT04575584|12043765|FG000|STARTED|Overall Study||75
10877848|NCT04575584|12043766|FG001|STARTED|Overall Study||75
10877849|NCT04575584|12043767|FG002|STARTED|Overall Study||76
10877850|NCT04575584|12043768|FG003|STARTED|Overall Study||78
10877851|NCT04575584|12043769|FG004|STARTED|Overall Study|Study terminated prior to initiating Part 2|0
10877852|NCT04575584|12043770|FG005|STARTED|Overall Study|Study terminated prior to initiating Part 2|0
10877853|NCT04575584|12043765|FG000|Treated|Overall Study||73
10877854|NCT04575584|12043766|FG001|Treated|Overall Study||73
10877855|NCT04575584|12043767|FG002|Treated|Overall Study||72
10877856|NCT04575584|12043768|FG003|Treated|Overall Study||75
10877857|NCT04575584|12043769|FG004|Treated|Overall Study||0
10877858|NCT04575584|12043770|FG005|Treated|Overall Study||0
10877859|NCT04575584|12043765|FG000|COMPLETED|Overall Study||61
10877860|NCT04575584|12043766|FG001|COMPLETED|Overall Study||60
10877861|NCT04575584|12043767|FG002|COMPLETED|Overall Study||63
10877862|NCT04575584|12043768|FG003|COMPLETED|Overall Study||70
10877863|NCT04575584|12043769|FG004|COMPLETED|Overall Study||0
10877864|NCT04575584|12043770|FG005|COMPLETED|Overall Study||0
10877865|NCT04575584|12043765|FG000|NOT COMPLETED|Overall Study||14
10877866|NCT04575584|12043766|FG001|NOT COMPLETED|Overall Study||15
10877867|NCT04575584|12043767|FG002|NOT COMPLETED|Overall Study||13
10877868|NCT04575584|12043768|FG003|NOT COMPLETED|Overall Study||8
10877869|NCT04575584|12043769|FG004|NOT COMPLETED|Overall Study||0
10877870|NCT04575584|12043770|FG005|NOT COMPLETED|Overall Study||0
10877871|NCT04571515|12043789|FG000|STARTED|Overall Study||22
10877872|NCT04571515|12043790|FG001|STARTED|Overall Study||24
10877873|NCT04571515|12043791|FG002|STARTED|Overall Study||23
10877874|NCT04571515|12043792|FG003|STARTED|Overall Study||23
10877875|NCT04571515|12043793|FG004|STARTED|Overall Study||22
10877876|NCT04571515|12043789|FG000|COMPLETED|Overall Study||21
10877877|NCT04571515|12043790|FG001|COMPLETED|Overall Study||24
10877878|NCT04571515|12043791|FG002|COMPLETED|Overall Study||23
10877879|NCT04571515|12043792|FG003|COMPLETED|Overall Study||23
10877880|NCT04571515|12043793|FG004|COMPLETED|Overall Study||19
10877881|NCT04571515|12043789|FG000|NOT COMPLETED|Overall Study||1
10877882|NCT04571515|12043790|FG001|NOT COMPLETED|Overall Study||0
10877883|NCT04571515|12043791|FG002|NOT COMPLETED|Overall Study||0
10877884|NCT04571515|12043792|FG003|NOT COMPLETED|Overall Study||0
10877885|NCT04571515|12043793|FG004|NOT COMPLETED|Overall Study||3
10877886|NCT04567225|12043807|FG000|STARTED|Overall Study||39
10877887|NCT04567225|12043808|FG001|STARTED|Overall Study||0
10877888|NCT04567225|12043807|FG000|COMPLETED|Overall Study|Study withdrawn. The study was closed due to lack of proper resource availability. Since study could not be completed as planned, participants did not complete follow-up.|0
10877889|NCT04567225|12043808|FG001|COMPLETED|Overall Study|The study was closed due to lack of proper resource availability. Since study could not be completed as planned, this chart review portion was not completed and no analysis was performed.|0
10877890|NCT04567225|12043807|FG000|NOT COMPLETED|Overall Study||39
10877891|NCT04567225|12043808|FG001|NOT COMPLETED|Overall Study||0
10877892|NCT04562155|12043818|FG000|STARTED|Overall Study||75
10877893|NCT04562155|12043819|FG001|STARTED|Overall Study||78
10877894|NCT04562155|12043820|FG002|STARTED|Overall Study||80
10877895|NCT04562155|12043821|FG003|STARTED|Overall Study||77
10877896|NCT04562155|12043818|FG000|COMPLETED|Overall Study||64
10877897|NCT04562155|12043819|FG001|COMPLETED|Overall Study||69
10877898|NCT04562155|12043820|FG002|COMPLETED|Overall Study||67
10877899|NCT04562155|12043821|FG003|COMPLETED|Overall Study||71
10877900|NCT04562155|12043818|FG000|NOT COMPLETED|Overall Study||11
10877901|NCT04562155|12043819|FG001|NOT COMPLETED|Overall Study||9
10877902|NCT04562155|12043820|FG002|NOT COMPLETED|Overall Study||13
10877903|NCT04562155|12043821|FG003|NOT COMPLETED|Overall Study||6
10877904|NCT04560686|12043831|FG000|STARTED|Overall Study||1
10877905|NCT04560686|12043831|FG000|COMPLETED|Overall Study||1
10877906|NCT04560686|12043831|FG000|NOT COMPLETED|Overall Study||0
10877907|NCT04552743|12043835|FG000|STARTED|Overall Study||25
10877908|NCT04552743|12043835|FG000|COMPLETED|Overall Study||25
10877909|NCT04552743|12043835|FG000|NOT COMPLETED|Overall Study||0
10877910|NCT04551014|12043842|FG000|STARTED|Overall Study||105
10877911|NCT04551014|12043843|FG001|STARTED|Overall Study||109
10877912|NCT04551014|12043842|FG000|COMPLETED|Overall Study||105
10877913|NCT04551014|12043843|FG001|COMPLETED|Overall Study||109
10877914|NCT04551014|12043842|FG000|NOT COMPLETED|Overall Study||0
10877915|NCT04551014|12043843|FG001|NOT COMPLETED|Overall Study||0
10877916|NCT04546724|12043851|FG000|STARTED|Overall Study||3082
10877917|NCT04546724|12043852|FG001|STARTED|Overall Study||1033
10877918|NCT04546724|12043851|FG000|COMPLETED|Overall Study||2959
10877919|NCT04546724|12043852|FG001|COMPLETED|Overall Study||998
10877920|NCT04546724|12043851|FG000|NOT COMPLETED|Overall Study||123
10877921|NCT04546724|12043852|FG001|NOT COMPLETED|Overall Study||35
10877922|NCT04542525|12043862|FG000|STARTED|Overall Study||32
10877923|NCT04542525|12043862|FG000|Attempted Implantation|Overall Study||32
10877924|NCT04542525|12043862|FG000|Successful Implantation|Overall Study||32
10877925|NCT04542525|12043862|FG000|COMPLETED|Overall Study||32
10877926|NCT04542525|12043862|FG000|NOT COMPLETED|Overall Study||0
10877927|NCT04539275|12043871|FG000|STARTED|Overall Study||35
10877928|NCT04539275|12043872|FG001|STARTED|Overall Study||40
10877929|NCT04539275|12043871|FG000|Received Study Product|Overall Study||32
10877930|NCT04539275|12043872|FG001|Received Study Product|Overall Study||40
10877931|NCT04539275|12043871|FG000|COMPLETED|Overall Study||29
10877932|NCT04539275|12043872|FG001|COMPLETED|Overall Study||35
10877933|NCT04539275|12043871|FG000|NOT COMPLETED|Overall Study||6
10877934|NCT04539275|12043872|FG001|NOT COMPLETED|Overall Study||5
10877935|NCT04537806|12043880|FG000|STARTED|Overall Study||15
10877936|NCT04537806|12043881|FG001|STARTED|Overall Study||14
10877937|NCT04537806|12043880|FG000|Safety Analysis Set|Overall Study||14
10877938|NCT04537806|12043881|FG001|Safety Analysis Set|Overall Study||14
10877939|NCT04537806|12043880|FG000|Full Analysis Set|Overall Study||14
10877940|NCT04537806|12043881|FG001|Full Analysis Set|Overall Study||14
10877941|NCT04537806|12043880|FG000|COMPLETED|Overall Study||13
10877942|NCT04537806|12043881|FG001|COMPLETED|Overall Study||13
10877943|NCT04537806|12043880|FG000|NOT COMPLETED|Overall Study||2
10877944|NCT04537806|12043881|FG001|NOT COMPLETED|Overall Study||1
10877945|NCT04535947|12043889|FG000|STARTED|Overall Study||76
10877946|NCT04535947|12043890|FG001|STARTED|Overall Study||77
10877947|NCT04535947|12043889|FG000|COMPLETED|Overall Study||72
10877948|NCT04535947|12043890|FG001|COMPLETED|Overall Study||72
10877949|NCT04535947|12043889|FG000|NOT COMPLETED|Overall Study||4
10877950|NCT04535947|12043890|FG001|NOT COMPLETED|Overall Study||5
10877951|NCT04529850|12043896|FG000|STARTED|Overall Study||37
10877952|NCT04529850|12043896|FG000|COMPLETED|Overall Study||32
10877953|NCT04529850|12043896|FG000|NOT COMPLETED|Overall Study||5
10877954|NCT04529096|12043902|FG000|STARTED|Overall Study||100
10877955|NCT04529096|12043903|FG001|STARTED|Overall Study||49
10877956|NCT04529096|12043902|FG000|Received at Least 1 Dose of Study Drug|Overall Study||100
10877957|NCT04529096|12043903|FG001|Received at Least 1 Dose of Study Drug|Overall Study||49
10877958|NCT04529096|12043902|FG000|COMPLETED|Overall Study||86
10877959|NCT04529096|12043903|FG001|COMPLETED|Overall Study||43
10877960|NCT04529096|12043902|FG000|NOT COMPLETED|Overall Study||14
10877961|NCT04529096|12043903|FG001|NOT COMPLETED|Overall Study||6
10877962|NCT04527471|12043911|FG000|STARTED|Overall Study||30
10877963|NCT04527471|12043912|FG001|STARTED|Overall Study||15
10877964|NCT04527471|12043911|FG000|Hospitalized up to 7 Days|Overall Study||24
10877965|NCT04527471|12043912|FG001|Hospitalized up to 7 Days|Overall Study||12
10877966|NCT04527471|12043911|FG000|Hospitalized for > 7 Days|Overall Study||6
10877967|NCT04527471|12043912|FG001|Hospitalized for > 7 Days|Overall Study||3
10877968|NCT04527471|12043911|FG000|COMPLETED|Overall Study||28
10877969|NCT04527471|12043912|FG001|COMPLETED|Overall Study||15
10877970|NCT04527471|12043911|FG000|NOT COMPLETED|Overall Study||2
10877971|NCT04527471|12043912|FG001|NOT COMPLETED|Overall Study||0
10877972|NCT04513652|12043920|FG000|STARTED|Overall Study||60
10877973|NCT04513652|12043921|FG001|STARTED|Overall Study||60
10877974|NCT04513652|12043920|FG000|COMPLETED|Overall Study||60
10877975|NCT04513652|12043921|FG001|COMPLETED|Overall Study||60
10877976|NCT04513652|12043920|FG000|NOT COMPLETED|Overall Study||0
10877977|NCT04513652|12043921|FG001|NOT COMPLETED|Overall Study||0
10877978|NCT04511208|12043927|FG000|STARTED|First Surgery||8
10877979|NCT04511208|12043928|FG001|STARTED|First Surgery||7
10877980|NCT04511208|12043929|FG002|STARTED|First Surgery||8
10877981|NCT04511208|12043930|FG003|STARTED|First Surgery||7
10877982|NCT04511208|12043927|FG000|COMPLETED|First Surgery||8
10877983|NCT04511208|12043928|FG001|COMPLETED|First Surgery||7
10877984|NCT04511208|12043929|FG002|COMPLETED|First Surgery||8
10877985|NCT04511208|12043930|FG003|COMPLETED|First Surgery||7
10877986|NCT04511208|12043927|FG000|NOT COMPLETED|First Surgery||0
10877987|NCT04511208|12043928|FG001|NOT COMPLETED|First Surgery||0
10877988|NCT04511208|12043929|FG002|NOT COMPLETED|First Surgery||0
10877989|NCT04511208|12043930|FG003|NOT COMPLETED|First Surgery||0
10877990|NCT04511208|12043927|FG000|STARTED|Second Surgery||8
10877991|NCT04511208|12043928|FG001|STARTED|Second Surgery||7
10877992|NCT04511208|12043929|FG002|STARTED|Second Surgery||8
10877993|NCT04511208|12043930|FG003|STARTED|Second Surgery||7
10877994|NCT04511208|12043927|FG000|COMPLETED|Second Surgery||8
10877995|NCT04511208|12043928|FG001|COMPLETED|Second Surgery||7
10877996|NCT04511208|12043929|FG002|COMPLETED|Second Surgery||8
10877997|NCT04511208|12043930|FG003|COMPLETED|Second Surgery||7
10877998|NCT04511208|12043927|FG000|NOT COMPLETED|Second Surgery||0
10877999|NCT04511208|12043928|FG001|NOT COMPLETED|Second Surgery||0
10878000|NCT04511208|12043929|FG002|NOT COMPLETED|Second Surgery||0
10878001|NCT04511208|12043930|FG003|NOT COMPLETED|Second Surgery||0
10878002|NCT04511208|12043927|FG000|STARTED|Third Surgery||8
10878003|NCT04511208|12043928|FG001|STARTED|Third Surgery||7
10878004|NCT04511208|12043929|FG002|STARTED|Third Surgery||8
10878005|NCT04511208|12043930|FG003|STARTED|Third Surgery||7
10878006|NCT04511208|12043927|FG000|COMPLETED|Third Surgery||8
10878007|NCT04511208|12043928|FG001|COMPLETED|Third Surgery||7
10878008|NCT04511208|12043929|FG002|COMPLETED|Third Surgery||8
10878009|NCT04511208|12043930|FG003|COMPLETED|Third Surgery||7
10878010|NCT04511208|12043927|FG000|NOT COMPLETED|Third Surgery||0
10878011|NCT04511208|12043928|FG001|NOT COMPLETED|Third Surgery||0
10878012|NCT04511208|12043929|FG002|NOT COMPLETED|Third Surgery||0
10878013|NCT04511208|12043930|FG003|NOT COMPLETED|Third Surgery||0
10878014|NCT04511208|12043927|FG000|STARTED|Forth Surgery||8
10878015|NCT04511208|12043928|FG001|STARTED|Forth Surgery||7
10878016|NCT04511208|12043929|FG002|STARTED|Forth Surgery||8
10878017|NCT04511208|12043930|FG003|STARTED|Forth Surgery||7
10878018|NCT04511208|12043927|FG000|COMPLETED|Forth Surgery||8
10878019|NCT04511208|12043928|FG001|COMPLETED|Forth Surgery||7
10878020|NCT04511208|12043929|FG002|COMPLETED|Forth Surgery||8
10878021|NCT04511208|12043930|FG003|COMPLETED|Forth Surgery||7
10878022|NCT04511208|12043927|FG000|NOT COMPLETED|Forth Surgery||0
10878023|NCT04511208|12043928|FG001|NOT COMPLETED|Forth Surgery||0
10878024|NCT04511208|12043929|FG002|NOT COMPLETED|Forth Surgery||0
10878025|NCT04511208|12043930|FG003|NOT COMPLETED|Forth Surgery||0
10878026|NCT04510922|12043936|FG000|STARTED|Overall Study||9
10878027|NCT04510922|12043936|FG000|COMPLETED|Overall Study||9
10878028|NCT04510922|12043936|FG000|NOT COMPLETED|Overall Study||0
10878029|NCT04505722|12043942|FG000|STARTED|Overall Study||22174
10878030|NCT04505722|12043943|FG001|STARTED|Overall Study||22150
10878031|NCT04505722|12043942|FG000|Vaccinated|Overall Study||21898
10878032|NCT04505722|12043943|FG001|Vaccinated|Overall Study||21890
10878033|NCT04505722|12043942|FG000|Participants in Entire Double Blind Phase|Overall Study||21894
10878034|NCT04505722|12043943|FG001|Participants in Entire Double Blind Phase|Overall Study||21882
10878035|NCT04505722|12043942|FG000|COMPLETED|Overall Study||0
10878036|NCT04505722|12043943|FG001|COMPLETED|Overall Study||0
10878037|NCT04505722|12043942|FG000|NOT COMPLETED|Overall Study||22174
10878038|NCT04505722|12043943|FG001|NOT COMPLETED|Overall Study||22150
10878039|NCT04498169|12043951|FG000|STARTED|Modified Intent-to-Treat Population||20
10878040|NCT04498169|12043952|FG001|STARTED|Modified Intent-to-Treat Population||20
10878041|NCT04498169|12043951|FG000|COMPLETED|Modified Intent-to-Treat Population||19
10878042|NCT04498169|12043952|FG001|COMPLETED|Modified Intent-to-Treat Population||19
10878043|NCT04498169|12043951|FG000|NOT COMPLETED|Modified Intent-to-Treat Population||1
10878044|NCT04498169|12043952|FG001|NOT COMPLETED|Modified Intent-to-Treat Population||1
10878045|NCT04498169|12043951|FG000|STARTED|Safety Population||20
10878046|NCT04498169|12043952|FG001|STARTED|Safety Population||20
10878047|NCT04498169|12043951|FG000|COMPLETED|Safety Population||19
10878048|NCT04498169|12043952|FG001|COMPLETED|Safety Population||19
10878049|NCT04498169|12043951|FG000|NOT COMPLETED|Safety Population||1
10878050|NCT04498169|12043952|FG001|NOT COMPLETED|Safety Population||1
10878051|NCT04498169|12043951|FG000|STARTED|Per-Protocol Population||18
10878052|NCT04498169|12043952|FG001|STARTED|Per-Protocol Population||16
10878053|NCT04498169|12043951|FG000|COMPLETED|Per-Protocol Population||18
10878054|NCT04498169|12043952|FG001|COMPLETED|Per-Protocol Population||15
10878055|NCT04498169|12043951|FG000|NOT COMPLETED|Per-Protocol Population||0
10878056|NCT04498169|12043952|FG001|NOT COMPLETED|Per-Protocol Population||1
10878057|NCT04498169|12043951|FG000|STARTED|Study Completion||20
10878058|NCT04498169|12043952|FG001|STARTED|Study Completion||20
10878059|NCT04498169|12043951|FG000|COMPLETED|Study Completion||19
10878060|NCT04498169|12043952|FG001|COMPLETED|Study Completion||19
10878061|NCT04498169|12043951|FG000|NOT COMPLETED|Study Completion||1
10878062|NCT04498169|12043952|FG001|NOT COMPLETED|Study Completion||1
10878063|NCT04496414|12043958|FG000|STARTED|Overall Study||50
10878064|NCT04496414|12043958|FG000|COMPLETED|Overall Study||50
10878065|NCT04496414|12043958|FG000|NOT COMPLETED|Overall Study||0
10878066|NCT04490499|12043962|FG000|STARTED|Overall Study||207
10878067|NCT04490499|12043962|FG000|Vaccinated|Overall Study||205
10878068|NCT04490499|12043962|FG000|COMPLETED|Overall Study||205
10878069|NCT04490499|12043962|FG000|NOT COMPLETED|Overall Study||2
10878070|NCT04482647|12043966|FG000|STARTED|Overall Study||100
10878071|NCT04482647|12043966|FG000|COMPLETED|Overall Study||88
10878072|NCT04482647|12043966|FG000|NOT COMPLETED|Overall Study||12
10878073|NCT04476108|12043972|FG000|STARTED|Overall Study||84
10878074|NCT04476108|12043973|FG001|STARTED|Overall Study||41
10878075|NCT04476108|12043972|FG000|Received at Least 1 Dose of Study Drug|Overall Study||83
10878076|NCT04476108|12043973|FG001|Received at Least 1 Dose of Study Drug|Overall Study||41
10878077|NCT04476108|12043972|FG000|COMPLETED|Overall Study||76
10878078|NCT04476108|12043973|FG001|COMPLETED|Overall Study||38
10878079|NCT04476108|12043972|FG000|NOT COMPLETED|Overall Study||8
10878080|NCT04476108|12043973|FG001|NOT COMPLETED|Overall Study||3
10878081|NCT04470622|12043981|FG000|STARTED|Overall Study||12
10878082|NCT04470622|12043982|FG001|STARTED|Overall Study||14
10878083|NCT04470622|12043981|FG000|COMPLETED|Overall Study||12
10878084|NCT04470622|12043982|FG001|COMPLETED|Overall Study||11
10878085|NCT04470622|12043981|FG000|NOT COMPLETED|Overall Study||0
10878086|NCT04470622|12043982|FG001|NOT COMPLETED|Overall Study||3
10878087|NCT04464421|12043990|FG000|STARTED|Overall Study||24
10878088|NCT04464421|12043991|FG001|STARTED|Overall Study||24
10878089|NCT04464421|12043990|FG000|COMPLETED|Overall Study||22
10878090|NCT04464421|12043991|FG001|COMPLETED|Overall Study||22
10878091|NCT04464421|12043990|FG000|NOT COMPLETED|Overall Study||2
10878092|NCT04464421|12043991|FG001|NOT COMPLETED|Overall Study||2
10878093|NCT04458090|12043999|FG000|STARTED|Overall Study||72
10878094|NCT04458090|12044000|FG001|STARTED|Overall Study||72
10878095|NCT04458090|12043999|FG000|COMPLETED|Overall Study||72
10878096|NCT04458090|12044000|FG001|COMPLETED|Overall Study||72
10878097|NCT04458090|12043999|FG000|NOT COMPLETED|Overall Study||0
10878098|NCT04458090|12044000|FG001|NOT COMPLETED|Overall Study||0
10878099|NCT04456959|12044006|FG000|STARTED|Overall Study||28
10878100|NCT04456959|12044006|FG000|COMPLETED|Overall Study||28
10878101|NCT04456959|12044006|FG000|NOT COMPLETED|Overall Study||0
10878102|NCT04456686|12044012|FG000|STARTED|Overall Study||78
10878103|NCT04456686|12044013|FG001|STARTED|Overall Study||39
10878104|NCT04456686|12044012|FG000|Received at Least 1 Dose of Study Drug|Overall Study||77
10878105|NCT04456686|12044013|FG001|Received at Least 1 Dose of Study Drug|Overall Study||36
10878106|NCT04456686|12044012|FG000|COMPLETED|Overall Study||63
10878107|NCT04456686|12044013|FG001|COMPLETED|Overall Study||32
10878108|NCT04456686|12044012|FG000|NOT COMPLETED|Overall Study||15
10878109|NCT04456686|12044013|FG001|NOT COMPLETED|Overall Study||7
10878110|NCT04447404|12044021|FG000|STARTED|Overall Study||2
10878111|NCT04447404|12044022|FG001|STARTED|Overall Study||0
10878112|NCT04447404|12044021|FG000|COMPLETED|Overall Study||0
10878113|NCT04447404|12044022|FG001|COMPLETED|Overall Study||0
10878114|NCT04447404|12044021|FG000|NOT COMPLETED|Overall Study||2
10878115|NCT04447404|12044022|FG001|NOT COMPLETED|Overall Study||0
10878116|NCT04439344|12044028|FG000|STARTED|Overall Study||53
10878117|NCT04439344|12044028|FG000|Started Protocol Therapy|Overall Study||50
10878118|NCT04439344|12044028|FG000|Eligible|Overall Study||47
10878119|NCT04439344|12044028|FG000|COMPLETED|Overall Study||0
10878120|NCT04439344|12044028|FG000|NOT COMPLETED|Overall Study||53
10878121|NCT04439279|12044032|FG000|STARTED|Overall Study||35
10878122|NCT04439279|12044032|FG000|Started Protocol Therapy|Overall Study||35
10878123|NCT04439279|12044032|FG000|Eligible|Overall Study||33
10878124|NCT04439279|12044032|FG000|Reported Adverse Events Data|Overall Study|Adverse event was not assessed on one patient before discontinuing therapy due to withdraw/refusal|34
10878125|NCT04439279|12044032|FG000|COMPLETED|Overall Study|Treatment continued until disease progression or intolerability.|0
10878126|NCT04439279|12044032|FG000|NOT COMPLETED|Overall Study||35
10878127|NCT04439266|12044036|FG000|STARTED|Overall Study||5
10878128|NCT04439266|12044036|FG000|Eligible|Overall Study||4
10878129|NCT04439266|12044036|FG000|COMPLETED|Overall Study||0
10878130|NCT04439266|12044036|FG000|NOT COMPLETED|Overall Study||5
10878131|NCT04439253|12044040|FG000|STARTED|Overall Study||4
10878132|NCT04439253|12044040|FG000|COMPLETED|Overall Study||0
10878133|NCT04439253|12044040|FG000|NOT COMPLETED|Overall Study||4
10878134|NCT04439123|12044044|FG000|STARTED|Overall Study|All 35 patients enrolled were eligible and treated in the arm|35
10878135|NCT04439123|12044044|FG000|COMPLETED|Overall Study||0
10878136|NCT04439123|12044044|FG000|NOT COMPLETED|Overall Study||35
10878137|NCT04439110|12044048|FG000|STARTED|Overall Study||38
10878138|NCT04439110|12044048|FG000|Eligible|Overall Study||36
10878139|NCT04439110|12044048|FG000|COMPLETED|Overall Study||0
10878140|NCT04439110|12044048|FG000|NOT COMPLETED|Overall Study||38
10878141|NCT04438499|12044052|FG000|STARTED|Overall Study|31 participants represent the sensitivity analysis (intent to treat) population. Since there was a lack of efficacy in one participant which was determined to be due to anatomical factors (catheterization was unsuccessful), one additional participant was enrolled to meet the minimum requirement of 30 primary analysis population participants.|31
10878142|NCT04438499|12044052|FG000|COMPLETED|Overall Study|29 of 31 participants completed the study. One enrolled participant did not complete the study due to anatomical factors preventing catheterization and this participant was replaced to meet the minimum required 30 primary analysis population participants. A second enrolled participant did not complete the study due to a device deficiency and failure of the catheter during the procedure.|29
10878143|NCT04438499|12044052|FG000|NOT COMPLETED|Overall Study||2
10878144|NCT04435665|12044060|FG000|STARTED|Overall Study||12
10878145|NCT04435665|12044061|FG001|STARTED|Overall Study||11
10878146|NCT04435665|12044062|FG002|STARTED|Overall Study||12
10878147|NCT04435665|12044063|FG003|STARTED|Overall Study||13
10878148|NCT04435665|12044060|FG000|COMPLETED|Overall Study||12
10878149|NCT04435665|12044061|FG001|COMPLETED|Overall Study||11
10878150|NCT04435665|12044062|FG002|COMPLETED|Overall Study||12
10878151|NCT04435665|12044063|FG003|COMPLETED|Overall Study||12
10878152|NCT04435665|12044060|FG000|NOT COMPLETED|Overall Study||0
10878153|NCT04435665|12044061|FG001|NOT COMPLETED|Overall Study||0
10878154|NCT04435665|12044062|FG002|NOT COMPLETED|Overall Study||0
10878155|NCT04435665|12044063|FG003|NOT COMPLETED|Overall Study||1
10878156|NCT04427501|12044083|FG000|STARTED|Overall Study||156
10878157|NCT04427501|12044084|FG001|STARTED|Overall Study||101
10878158|NCT04427501|12044085|FG002|STARTED|Overall Study||107
10878159|NCT04427501|12044086|FG003|STARTED|Overall Study||101
10878160|NCT04427501|12044087|FG004|STARTED|Overall Study||112
10878161|NCT04427501|12044088|FG005|STARTED|Overall Study|Participants in Placebo for Phase 3: 2800 mg Bamlanivimab + 2800 mg Etesevimab and Phase 3: 700 mg Bamlanivimab + 1400 mg Etesevimab were combined to avoid double counting.|776
10878162|NCT04427501|12044089|FG006|STARTED|Overall Study||518
10878163|NCT04427501|12044090|FG007|STARTED|Overall Study||513
10878164|NCT04427501|12044091|FG008|STARTED|Overall Study||141
10878165|NCT04427501|12044092|FG009|STARTED|Overall Study||213
10878166|NCT04427501|12044083|FG000|Received at Least One Dose of Study Drug|Overall Study||156
10878167|NCT04427501|12044084|FG001|Received at Least One Dose of Study Drug|Overall Study||101
10878168|NCT04427501|12044085|FG002|Received at Least One Dose of Study Drug|Overall Study||107
10878169|NCT04427501|12044086|FG003|Received at Least One Dose of Study Drug|Overall Study||101
10878170|NCT04427501|12044087|FG004|Received at Least One Dose of Study Drug|Overall Study||112
10878171|NCT04427501|12044088|FG005|Received at Least One Dose of Study Drug|Overall Study||776
10878172|NCT04427501|12044089|FG006|Received at Least One Dose of Study Drug|Overall Study||518
10878173|NCT04427501|12044090|FG007|Received at Least One Dose of Study Drug|Overall Study||513
10878174|NCT04427501|12044091|FG008|Received at Least One Dose of Study Drug|Overall Study||141
10878175|NCT04427501|12044092|FG009|Received at Least One Dose of Study Drug|Overall Study||213
10878176|NCT04427501|12044083|FG000|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0
10878177|NCT04427501|12044084|FG001|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0
10878178|NCT04427501|12044085|FG002|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0
10878179|NCT04427501|12044086|FG003|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0
10878180|NCT04427501|12044087|FG004|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0
10878181|NCT04427501|12044088|FG005|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||517
10878182|NCT04427501|12044089|FG006|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0
10878183|NCT04427501|12044090|FG007|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0
10878184|NCT04427501|12044091|FG008|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0
10878185|NCT04427501|12044092|FG009|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0
10878186|NCT04427501|12044083|FG000|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0
10878187|NCT04427501|12044084|FG001|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0
10878188|NCT04427501|12044085|FG002|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0
10878189|NCT04427501|12044086|FG003|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0
10878190|NCT04427501|12044087|FG004|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0
10878191|NCT04427501|12044088|FG005|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||776
10878192|NCT04427501|12044089|FG006|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0
10878193|NCT04427501|12044090|FG007|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0
10878194|NCT04427501|12044091|FG008|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0
10878195|NCT04427501|12044092|FG009|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0
10878196|NCT04427501|12044083|FG000|COMPLETED|Overall Study||141
10878197|NCT04427501|12044084|FG001|COMPLETED|Overall Study||95
10878198|NCT04427501|12044085|FG002|COMPLETED|Overall Study||103
10878199|NCT04427501|12044086|FG003|COMPLETED|Overall Study||98
10878200|NCT04427501|12044087|FG004|COMPLETED|Overall Study||103
10878201|NCT04427501|12044088|FG005|COMPLETED|Overall Study||719
10878202|NCT04427501|12044089|FG006|COMPLETED|Overall Study||485
10878203|NCT04427501|12044090|FG007|COMPLETED|Overall Study||496
10878204|NCT04427501|12044091|FG008|COMPLETED|Overall Study||135
10878205|NCT04427501|12044092|FG009|COMPLETED|Overall Study||207
10878206|NCT04427501|12044083|FG000|NOT COMPLETED|Overall Study||15
10878207|NCT04427501|12044084|FG001|NOT COMPLETED|Overall Study||6
10878208|NCT04427501|12044085|FG002|NOT COMPLETED|Overall Study||4
10878209|NCT04427501|12044086|FG003|NOT COMPLETED|Overall Study||3
10878210|NCT04427501|12044087|FG004|NOT COMPLETED|Overall Study||9
10878211|NCT04427501|12044088|FG005|NOT COMPLETED|Overall Study||57
10878212|NCT04427501|12044089|FG006|NOT COMPLETED|Overall Study||33
10878213|NCT04427501|12044090|FG007|NOT COMPLETED|Overall Study||17
10878214|NCT04427501|12044091|FG008|NOT COMPLETED|Overall Study||6
10878215|NCT04427501|12044092|FG009|NOT COMPLETED|Overall Study||6
10878216|NCT04426630|12044125|FG000|STARTED|Overall Study||72
10878217|NCT04426630|12044125|FG000|COMPLETED|Overall Study||66
10878218|NCT04426630|12044125|FG000|NOT COMPLETED|Overall Study||6
10878219|NCT04421027|12044131|FG000|STARTED|Treatment Period||761
10878220|NCT04421027|12044132|FG001|STARTED|Treatment Period||764
10878221|NCT04421027|12044133|FG002|STARTED|Treatment Period||0
10878222|NCT04421027|12044134|FG003|STARTED|Treatment Period||0
10878223|NCT04421027|12044131|FG000|Received at Least One Dose of Study Drug|Treatment Period||752
10878224|NCT04421027|12044132|FG001|Received at Least One Dose of Study Drug|Treatment Period||750
10878225|NCT04421027|12044133|FG002|Received at Least One Dose of Study Drug|Treatment Period||0
10878226|NCT04421027|12044134|FG003|Received at Least One Dose of Study Drug|Treatment Period||0
10878227|NCT04421027|12044131|FG000|COMPLETED|Treatment Period||604
10878228|NCT04421027|12044132|FG001|COMPLETED|Treatment Period||644
10878229|NCT04421027|12044133|FG002|COMPLETED|Treatment Period||0
10878230|NCT04421027|12044134|FG003|COMPLETED|Treatment Period||0
10878231|NCT04421027|12044131|FG000|NOT COMPLETED|Treatment Period||157
10878232|NCT04421027|12044132|FG001|NOT COMPLETED|Treatment Period||120
10878233|NCT04421027|12044133|FG002|NOT COMPLETED|Treatment Period||0
10878234|NCT04421027|12044134|FG003|NOT COMPLETED|Treatment Period||0
10878235|NCT04421027|12044131|FG000|STARTED|Follow-Up Period||0
10878236|NCT04421027|12044132|FG001|STARTED|Follow-Up Period||0
10878237|NCT04421027|12044133|FG002|STARTED|Follow-Up Period||613
10878238|NCT04421027|12044134|FG003|STARTED|Follow-Up Period||645
10878239|NCT04421027|12044131|FG000|COMPLETED|Follow-Up Period||0
10878240|NCT04421027|12044132|FG001|COMPLETED|Follow-Up Period||0
10878241|NCT04421027|12044133|FG002|COMPLETED|Follow-Up Period||588
10878242|NCT04421027|12044134|FG003|COMPLETED|Follow-Up Period|One participants study disposition case report form was not completed, therefore the participant appeared as 'ongoing' at Day 60. The participant completed Day 60 Clinical Status Assessment (CSA) and is considered as completing the study.|615
10878243|NCT04421027|12044131|FG000|NOT COMPLETED|Follow-Up Period||0
10878244|NCT04421027|12044132|FG001|NOT COMPLETED|Follow-Up Period||0
10878245|NCT04421027|12044133|FG002|NOT COMPLETED|Follow-Up Period||25
10878246|NCT04421027|12044134|FG003|NOT COMPLETED|Follow-Up Period||30
10878247|NCT04413552|12044152|FG000|STARTED|Overall Study||6
10878248|NCT04413552|12044153|FG001|STARTED|Overall Study||6
10878249|NCT04413552|12044154|FG002|STARTED|Overall Study||6
10878250|NCT04413552|12044155|FG003|STARTED|Overall Study||6
10878251|NCT04413552|12044156|FG004|STARTED|Overall Study||6
10878252|NCT04413552|12044157|FG005|STARTED|Overall Study||6
10878253|NCT04413552|12044158|FG006|STARTED|Overall Study||7
10878254|NCT04413552|12044159|FG007|STARTED|Overall Study||6
10878255|NCT04413552|12044160|FG008|STARTED|Overall Study||16
10878256|NCT04413552|12044161|FG009|STARTED|Overall Study||8
10878257|NCT04413552|12044152|FG000|Received Study Drug|Overall Study||6
10878258|NCT04413552|12044153|FG001|Received Study Drug|Overall Study||6
10878259|NCT04413552|12044154|FG002|Received Study Drug|Overall Study||6
10878260|NCT04413552|12044155|FG003|Received Study Drug|Overall Study||6
10878261|NCT04413552|12044156|FG004|Received Study Drug|Overall Study||6
10878262|NCT04413552|12044157|FG005|Received Study Drug|Overall Study||6
10878263|NCT04413552|12044158|FG006|Received Study Drug|Overall Study||6
10878264|NCT04413552|12044159|FG007|Received Study Drug|Overall Study||6
10878265|NCT04413552|12044160|FG008|Received Study Drug|Overall Study||16
10878266|NCT04413552|12044161|FG009|Received Study Drug|Overall Study||8
10878267|NCT04413552|12044152|FG000|COMPLETED|Overall Study||6
10878268|NCT04413552|12044153|FG001|COMPLETED|Overall Study||6
10878269|NCT04413552|12044154|FG002|COMPLETED|Overall Study||6
10878270|NCT04413552|12044155|FG003|COMPLETED|Overall Study||6
10878271|NCT04413552|12044156|FG004|COMPLETED|Overall Study||6
10878272|NCT04413552|12044157|FG005|COMPLETED|Overall Study||6
10878273|NCT04413552|12044158|FG006|COMPLETED|Overall Study||6
10878274|NCT04413552|12044159|FG007|COMPLETED|Overall Study||6
10878275|NCT04413552|12044160|FG008|COMPLETED|Overall Study||16
10878276|NCT04413552|12044161|FG009|COMPLETED|Overall Study||8
10878277|NCT04413552|12044152|FG000|NOT COMPLETED|Overall Study||0
10878278|NCT04413552|12044153|FG001|NOT COMPLETED|Overall Study||0
10878279|NCT04413552|12044154|FG002|NOT COMPLETED|Overall Study||0
10878280|NCT04413552|12044155|FG003|NOT COMPLETED|Overall Study||0
10878281|NCT04413552|12044156|FG004|NOT COMPLETED|Overall Study||0
10878282|NCT04413552|12044157|FG005|NOT COMPLETED|Overall Study||0
10878283|NCT04413552|12044158|FG006|NOT COMPLETED|Overall Study||1
10878284|NCT04413552|12044159|FG007|NOT COMPLETED|Overall Study||0
10878285|NCT04413552|12044160|FG008|NOT COMPLETED|Overall Study||0
10878286|NCT04413552|12044161|FG009|NOT COMPLETED|Overall Study||0
10878287|NCT04412707|12044189|FG000|STARTED|Cycle 1||14
10878288|NCT04412707|12044190|FG001|STARTED|Cycle 1||13
10878289|NCT04412707|12044189|FG000|Discontinued|Cycle 1||1
10878290|NCT04412707|12044190|FG001|Discontinued|Cycle 1||5
10878291|NCT04412707|12044189|FG000|COMPLETED|Cycle 1||13
10878292|NCT04412707|12044190|FG001|COMPLETED|Cycle 1||8
10878293|NCT04412707|12044189|FG000|NOT COMPLETED|Cycle 1||1
10878294|NCT04412707|12044190|FG001|NOT COMPLETED|Cycle 1||5
10878295|NCT04412707|12044189|FG000|STARTED|Cycle 2||13
10878296|NCT04412707|12044190|FG001|STARTED|Cycle 2||8
10878297|NCT04412707|12044189|FG000|Discontinued|Cycle 2||3
10878298|NCT04412707|12044190|FG001|Discontinued|Cycle 2||1
10878299|NCT04412707|12044189|FG000|COMPLETED|Cycle 2||10
10878300|NCT04412707|12044190|FG001|COMPLETED|Cycle 2||7
10878301|NCT04412707|12044189|FG000|NOT COMPLETED|Cycle 2||3
10878302|NCT04412707|12044190|FG001|NOT COMPLETED|Cycle 2||1
10878303|NCT04412707|12044189|FG000|STARTED|Cycle 3 to End of Study (EOS)||10
10878304|NCT04412707|12044190|FG001|STARTED|Cycle 3 to End of Study (EOS)||7
10878305|NCT04412707|12044189|FG000|Ongoing in Study at Data Cut|Cycle 3 to End of Study (EOS)||0
10878306|NCT04412707|12044190|FG001|Ongoing in Study at Data Cut|Cycle 3 to End of Study (EOS)||0
10878307|NCT04412707|12044189|FG000|Discontinued Study in Cycle 3 or Later|Cycle 3 to End of Study (EOS)||10
10878308|NCT04412707|12044190|FG001|Discontinued Study in Cycle 3 or Later|Cycle 3 to End of Study (EOS)||7
10878309|NCT04412707|12044189|FG000|COMPLETED|Cycle 3 to End of Study (EOS)||0
10878310|NCT04412707|12044190|FG001|COMPLETED|Cycle 3 to End of Study (EOS)||0
10878311|NCT04412707|12044189|FG000|NOT COMPLETED|Cycle 3 to End of Study (EOS)||10
10878312|NCT04412707|12044190|FG001|NOT COMPLETED|Cycle 3 to End of Study (EOS)||7
10878313|NCT04410198|12044196|FG000|STARTED|Overall Study||203
10878314|NCT04410198|12044196|FG000|Received at Least 1 Dose of Study Drug|Overall Study||203
10878315|NCT04410198|12044196|FG000|Full Analysis Set|Overall Study||201
10878316|NCT04410198|12044196|FG000|COMPLETED|Overall Study||166
10878317|NCT04410198|12044196|FG000|NOT COMPLETED|Overall Study||37
10878318|NCT04404010|12044202|FG000|STARTED|Overall Study|1 participant was mistakenly consented, enrolled and randomized as part of study. After randomization, but prior to study testing we realized the participant was not eligible (they were not a PGY4 or 5), therefore they were excluded prior to any further study procedures commenced. Therefore, only 9 participants completed all study procedures/were followed for purposes of study.|10
10878319|NCT04404010|12044203|FG001|STARTED|Overall Study||9
10878320|NCT04404010|12044202|FG000|COMPLETED|Overall Study||9
10878321|NCT04404010|12044203|FG001|COMPLETED|Overall Study||9
10878322|NCT04404010|12044202|FG000|NOT COMPLETED|Overall Study||1
10878323|NCT04404010|12044203|FG001|NOT COMPLETED|Overall Study||0
10878324|NCT04401423|12044213|FG000|STARTED|Overall Study||11
10878325|NCT04401423|12044214|FG001|STARTED|Overall Study||11
10878326|NCT04401423|12044213|FG000|COMPLETED|Overall Study||6
10878327|NCT04401423|12044214|FG001|COMPLETED|Overall Study||9
10878328|NCT04401423|12044213|FG000|NOT COMPLETED|Overall Study||5
10878329|NCT04401423|12044214|FG001|NOT COMPLETED|Overall Study||2
10878330|NCT04398134|12044226|FG000|STARTED|Overall Study||32
10878331|NCT04398134|12044227|FG001|STARTED|Overall Study||11
10878332|NCT04398134|12044228|FG002|STARTED|Overall Study||33
10878333|NCT04398134|12044229|FG003|STARTED|Overall Study||12
10878334|NCT04398134|12044226|FG000|COMPLETED|Overall Study||0
10878335|NCT04398134|12044227|FG001|COMPLETED|Overall Study||0
10878336|NCT04398134|12044228|FG002|COMPLETED|Overall Study||0
10878337|NCT04398134|12044229|FG003|COMPLETED|Overall Study||0
10878338|NCT04398134|12044226|FG000|NOT COMPLETED|Overall Study||32
10878339|NCT04398134|12044227|FG001|NOT COMPLETED|Overall Study||11
10878340|NCT04398134|12044228|FG002|NOT COMPLETED|Overall Study||33
10878341|NCT04398134|12044229|FG003|NOT COMPLETED|Overall Study||12
10878342|NCT04398030|12044239|FG000|STARTED|Treatment Period 1 (1 Week)||3
10878343|NCT04398030|12044240|FG001|STARTED|Treatment Period 1 (1 Week)||4
10878344|NCT04398030|12044239|FG000|COMPLETED|Treatment Period 1 (1 Week)||3
10878345|NCT04398030|12044240|FG001|COMPLETED|Treatment Period 1 (1 Week)||3
10878346|NCT04398030|12044239|FG000|NOT COMPLETED|Treatment Period 1 (1 Week)||0
10878347|NCT04398030|12044240|FG001|NOT COMPLETED|Treatment Period 1 (1 Week)||1
10878348|NCT04398030|12044239|FG000|STARTED|Washout (2 Weeks)||3
10878349|NCT04398030|12044240|FG001|STARTED|Washout (2 Weeks)||3
10878350|NCT04398030|12044239|FG000|COMPLETED|Washout (2 Weeks)||3
10878351|NCT04398030|12044240|FG001|COMPLETED|Washout (2 Weeks)||3
10878352|NCT04398030|12044239|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10878353|NCT04398030|12044240|FG001|NOT COMPLETED|Washout (2 Weeks)||0
10878354|NCT04398030|12044239|FG000|STARTED|Treatment Period 2 (1 Week)||3
10878355|NCT04398030|12044240|FG001|STARTED|Treatment Period 2 (1 Week)||3
10878356|NCT04398030|12044239|FG000|COMPLETED|Treatment Period 2 (1 Week)||2
10878357|NCT04398030|12044240|FG001|COMPLETED|Treatment Period 2 (1 Week)||3
10878358|NCT04398030|12044239|FG000|NOT COMPLETED|Treatment Period 2 (1 Week)||1
10878359|NCT04398030|12044240|FG001|NOT COMPLETED|Treatment Period 2 (1 Week)||0
10878360|NCT04396847|12044248|FG000|STARTED|Overall Study||1
10878361|NCT04396847|12044249|FG001|STARTED|Overall Study||0
10878362|NCT04396847|12044248|FG000|COMPLETED|Overall Study||1
10878363|NCT04396847|12044249|FG001|COMPLETED|Overall Study||0
10878364|NCT04396847|12044248|FG000|NOT COMPLETED|Overall Study||0
10878365|NCT04396847|12044249|FG001|NOT COMPLETED|Overall Study||0
10878366|NCT04390191|12044257|FG000|STARTED|Overall Study||1
10878367|NCT04390191|12044258|FG001|STARTED|Overall Study||3
10878368|NCT04390191|12044257|FG000|COMPLETED|Overall Study||0
10878369|NCT04390191|12044258|FG001|COMPLETED|Overall Study||3
10878370|NCT04390191|12044257|FG000|NOT COMPLETED|Overall Study||1
10878371|NCT04390191|12044258|FG001|NOT COMPLETED|Overall Study||0
10878372|NCT04389840|12044270|FG000|STARTED|Overall Study||6
10878373|NCT04389840|12044271|FG001|STARTED|Overall Study||6
10878374|NCT04389840|12044272|FG002|STARTED|Overall Study||8
10878375|NCT04389840|12044273|FG003|STARTED|Overall Study||4
10878376|NCT04389840|12044274|FG004|STARTED|Overall Study||2
10878377|NCT04389840|12044275|FG005|STARTED|Overall Study||1
10878378|NCT04389840|12044270|FG000|Intent-to-Treat Analysis Set|Overall Study||6
10878379|NCT04389840|12044271|FG001|Intent-to-Treat Analysis Set|Overall Study||6
10878380|NCT04389840|12044272|FG002|Intent-to-Treat Analysis Set|Overall Study||8
10878381|NCT04389840|12044273|FG003|Intent-to-Treat Analysis Set|Overall Study||4
10878382|NCT04389840|12044274|FG004|Intent-to-Treat Analysis Set|Overall Study||2
10878383|NCT04389840|12044275|FG005|Intent-to-Treat Analysis Set|Overall Study||1
10878384|NCT04389840|12044270|FG000|Safety Analysis Set|Overall Study||6
10878385|NCT04389840|12044271|FG001|Safety Analysis Set|Overall Study||6
10878386|NCT04389840|12044272|FG002|Safety Analysis Set|Overall Study||8
10878387|NCT04389840|12044273|FG003|Safety Analysis Set|Overall Study|The excluded subject was randomized to receive placebo but never received treatment due to consent withdrawal.|3
10878388|NCT04389840|12044274|FG004|Safety Analysis Set|Overall Study||2
10878389|NCT04389840|12044275|FG005|Safety Analysis Set|Overall Study||1
10878390|NCT04389840|12044270|FG000|COMPLETED|Overall Study||4
10878391|NCT04389840|12044271|FG001|COMPLETED|Overall Study||5
10878392|NCT04389840|12044272|FG002|COMPLETED|Overall Study||8
10878393|NCT04389840|12044273|FG003|COMPLETED|Overall Study||3
10878394|NCT04389840|12044274|FG004|COMPLETED|Overall Study||1
10878395|NCT04389840|12044275|FG005|COMPLETED|Overall Study||1
10878396|NCT04389840|12044270|FG000|NOT COMPLETED|Overall Study||2
10878397|NCT04389840|12044271|FG001|NOT COMPLETED|Overall Study||1
10878398|NCT04389840|12044272|FG002|NOT COMPLETED|Overall Study||0
10878399|NCT04389840|12044273|FG003|NOT COMPLETED|Overall Study||1
10878400|NCT04389840|12044274|FG004|NOT COMPLETED|Overall Study||1
10878401|NCT04389840|12044275|FG005|NOT COMPLETED|Overall Study||0
10878402|NCT04388826|12044291|FG000|STARTED|Overall Study||19
10878403|NCT04388826|12044292|FG001|STARTED|Overall Study||20
10878404|NCT04388826|12044291|FG000|COMPLETED|Overall Study||15
10878405|NCT04388826|12044292|FG001|COMPLETED|Overall Study||18
10878406|NCT04388826|12044291|FG000|NOT COMPLETED|Overall Study||4
10878407|NCT04388826|12044292|FG001|NOT COMPLETED|Overall Study||2
10878408|NCT04382651|12044300|FG000|STARTED|Overall Study||69
10878409|NCT04382651|12044301|FG001|STARTED|Overall Study||71
10878410|NCT04382651|12044300|FG000|Safety Analysis Set|Overall Study||68
10878411|NCT04382651|12044301|FG001|Safety Analysis Set|Overall Study||70
10878412|NCT04382651|12044300|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study||63
10878413|NCT04382651|12044301|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study||0
10878414|NCT04382651|12044300|FG000|COMPLETED|Overall Study||38
10878415|NCT04382651|12044301|FG001|COMPLETED|Overall Study||43
10878416|NCT04382651|12044300|FG000|NOT COMPLETED|Overall Study||31
10878417|NCT04382651|12044301|FG001|NOT COMPLETED|Overall Study||28
10878418|NCT04382066|12044311|FG000|STARTED|Overall Study||15
10878419|NCT04382066|12044312|FG001|STARTED|Overall Study||15
10878420|NCT04382066|12044313|FG002|STARTED|Overall Study||15
10878421|NCT04382066|12044311|FG000|Completed 3-day Treatment|Overall Study||14
10878422|NCT04382066|12044312|FG001|Completed 3-day Treatment|Overall Study||15
10878423|NCT04382066|12044313|FG002|Completed 3-day Treatment|Overall Study||15
10878424|NCT04382066|12044311|FG000|COMPLETED|Overall Study||13
10878425|NCT04382066|12044312|FG001|COMPLETED|Overall Study||15
10878426|NCT04382066|12044313|FG002|COMPLETED|Overall Study||14
10878427|NCT04382066|12044311|FG000|NOT COMPLETED|Overall Study||2
10878428|NCT04382066|12044312|FG001|NOT COMPLETED|Overall Study||0
10878429|NCT04382066|12044313|FG002|NOT COMPLETED|Overall Study||1
10878430|NCT04375878|12044331|FG000|STARTED|Crossover First and Second Interventions||7
10878431|NCT04375878|12044332|FG001|STARTED|Crossover First and Second Interventions||7
10878432|NCT04375878|12044333|FG002|STARTED|Crossover First and Second Interventions||6
10878433|NCT04375878|12044334|FG003|STARTED|Crossover First and Second Interventions||7
10878434|NCT04375878|12044335|FG004|STARTED|Crossover First and Second Interventions||0
10878435|NCT04375878|12044336|FG005|STARTED|Crossover First and Second Interventions||0
10878436|NCT04375878|12044331|FG000|COMPLETED|Crossover First and Second Interventions||6
10878437|NCT04375878|12044332|FG001|COMPLETED|Crossover First and Second Interventions||6
10878438|NCT04375878|12044333|FG002|COMPLETED|Crossover First and Second Interventions||5
10878439|NCT04375878|12044334|FG003|COMPLETED|Crossover First and Second Interventions||7
10878440|NCT04375878|12044335|FG004|COMPLETED|Crossover First and Second Interventions||0
10878441|NCT04375878|12044336|FG005|COMPLETED|Crossover First and Second Interventions||0
10878442|NCT04375878|12044331|FG000|NOT COMPLETED|Crossover First and Second Interventions||1
10878443|NCT04375878|12044332|FG001|NOT COMPLETED|Crossover First and Second Interventions||1
10878444|NCT04375878|12044333|FG002|NOT COMPLETED|Crossover First and Second Interventions||1
10878445|NCT04375878|12044334|FG003|NOT COMPLETED|Crossover First and Second Interventions||0
10878446|NCT04375878|12044335|FG004|NOT COMPLETED|Crossover First and Second Interventions||0
10878447|NCT04375878|12044336|FG005|NOT COMPLETED|Crossover First and Second Interventions||0
10878448|NCT04375878|12044331|FG000|STARTED|Extension Phase|Only patients who completed period 1(Crossover: First and Second interventions) were eligible for participation in period 2.|0
10878449|NCT04375878|12044332|FG001|STARTED|Extension Phase|Only patients who completed period 1(Crossover: First and Second interventions) were eligible for participation in period 2.|0
10878450|NCT04375878|12044333|FG002|STARTED|Extension Phase|Only patients who completed period 1(Crossover: First and Second interventions) were eligible for participation in period 2.|0
10878451|NCT04375878|12044334|FG003|STARTED|Extension Phase|Only patients who completed period 1(Crossover: First and Second interventions) were eligible for participation in period 2.|0
10878452|NCT04375878|12044335|FG004|STARTED|Extension Phase|Although 24 participants were eligible for the Extension, not all elected to participate.|9
10878453|NCT04375878|12044336|FG005|STARTED|Extension Phase|Although 24 participants were eligible for the Extension, not all elected to participate.|8
10878454|NCT04375878|12044331|FG000|COMPLETED|Extension Phase||0
10878455|NCT04375878|12044332|FG001|COMPLETED|Extension Phase||0
10878456|NCT04375878|12044333|FG002|COMPLETED|Extension Phase||0
10878457|NCT04375878|12044334|FG003|COMPLETED|Extension Phase||0
10878458|NCT04375878|12044335|FG004|COMPLETED|Extension Phase||8
10878459|NCT04375878|12044336|FG005|COMPLETED|Extension Phase||8
10878460|NCT04375878|12044331|FG000|NOT COMPLETED|Extension Phase||0
10878461|NCT04375878|12044332|FG001|NOT COMPLETED|Extension Phase||0
10878462|NCT04375878|12044333|FG002|NOT COMPLETED|Extension Phase||0
10878463|NCT04375878|12044334|FG003|NOT COMPLETED|Extension Phase||0
10878464|NCT04375878|12044335|FG004|NOT COMPLETED|Extension Phase||1
10878465|NCT04375878|12044336|FG005|NOT COMPLETED|Extension Phase||0
10878466|NCT04363736|12044358|FG000|STARTED|Overall Study||49
10878467|NCT04363736|12044359|FG001|STARTED|Overall Study||48
10878468|NCT04363736|12044358|FG000|COMPLETED|Overall Study||30
10878469|NCT04363736|12044359|FG001|COMPLETED|Overall Study||35
10878470|NCT04363736|12044358|FG000|NOT COMPLETED|Overall Study||19
10878471|NCT04363736|12044359|FG001|NOT COMPLETED|Overall Study||13
10878472|NCT04354428|12044370|FG000|STARTED|Overall Study||83
10878473|NCT04354428|12044371|FG001|STARTED|Overall Study||71
10878474|NCT04354428|12044372|FG002|STARTED|Overall Study||77
10878475|NCT04354428|12044373|FG003|STARTED|Overall Study||29
10878476|NCT04354428|12044374|FG004|STARTED|Overall Study||29
10878477|NCT04354428|12044370|FG000|Completed Enrollment|Overall Study||80
10878478|NCT04354428|12044371|FG001|Completed Enrollment|Overall Study||65
10878479|NCT04354428|12044372|FG002|Completed Enrollment|Overall Study||74
10878480|NCT04354428|12044373|FG003|Completed Enrollment|Overall Study||27
10878481|NCT04354428|12044374|FG004|Completed Enrollment|Overall Study||28
10878482|NCT04354428|12044370|FG000|COMPLETED|Overall Study||75
10878483|NCT04354428|12044371|FG001|COMPLETED|Overall Study||62
10878484|NCT04354428|12044372|FG002|COMPLETED|Overall Study||71
10878485|NCT04354428|12044373|FG003|COMPLETED|Overall Study||19
10878486|NCT04354428|12044374|FG004|COMPLETED|Overall Study||25
10878487|NCT04354428|12044370|FG000|NOT COMPLETED|Overall Study||8
10878488|NCT04354428|12044371|FG001|NOT COMPLETED|Overall Study||9
10878489|NCT04354428|12044372|FG002|NOT COMPLETED|Overall Study||6
10878490|NCT04354428|12044373|FG003|NOT COMPLETED|Overall Study||10
10878491|NCT04354428|12044374|FG004|NOT COMPLETED|Overall Study||4
10878492|NCT04353596|12044388|FG000|STARTED|Overall Study||109
10878493|NCT04353596|12044389|FG001|STARTED|Overall Study||107
10878494|NCT04353596|12044388|FG000|Per Protocol|Overall Study||104
10878495|NCT04353596|12044389|FG001|Per Protocol|Overall Study||100
10878496|NCT04353596|12044388|FG000|COMPLETED|Overall Study||104
10878497|NCT04353596|12044389|FG001|COMPLETED|Overall Study||100
10878498|NCT04353596|12044388|FG000|NOT COMPLETED|Overall Study||5
10878499|NCT04353596|12044389|FG001|NOT COMPLETED|Overall Study||7
10878500|NCT04352439|12044395|FG000|STARTED|Overall Study||19
10878501|NCT04352439|12044395|FG000|COMPLETED|Overall Study||19
10878502|NCT04352439|12044395|FG000|NOT COMPLETED|Overall Study||0
10878503|NCT04350008|12044399|FG000|STARTED|Overall Study||110
10878504|NCT04350008|12044399|FG000|COMPLETED|Overall Study||110
10878505|NCT04350008|12044399|FG000|NOT COMPLETED|Overall Study||0
10878506|NCT04328077|12044407|FG000|STARTED|Overall Study||26
10878507|NCT04328077|12044408|FG001|STARTED|Overall Study||25
10878508|NCT04328077|12044409|FG002|STARTED|Overall Study||26
10878509|NCT04328077|12044410|FG003|STARTED|Overall Study||24
10878510|NCT04328077|12044407|FG000|COMPLETED|Overall Study||26
10878511|NCT04328077|12044408|FG001|COMPLETED|Overall Study||23
10878512|NCT04328077|12044409|FG002|COMPLETED|Overall Study||25
10878513|NCT04328077|12044410|FG003|COMPLETED|Overall Study||21
10878514|NCT04328077|12044407|FG000|NOT COMPLETED|Overall Study||0
10878515|NCT04328077|12044408|FG001|NOT COMPLETED|Overall Study||2
10878516|NCT04328077|12044409|FG002|NOT COMPLETED|Overall Study||1
10878517|NCT04328077|12044410|FG003|NOT COMPLETED|Overall Study||3
10878518|NCT04325828|12044426|FG000|STARTED|Overall Study||31
10878519|NCT04325828|12044426|FG000|COMPLETED|Overall Study||5
10878520|NCT04325828|12044426|FG000|NOT COMPLETED|Overall Study||26
10878521|NCT04318093|12044432|FG000|STARTED|Overall Study||13
10878522|NCT04318093|12044433|FG001|STARTED|Overall Study||12
10878523|NCT04318093|12044432|FG000|COMPLETED|Overall Study||10
10878524|NCT04318093|12044433|FG001|COMPLETED|Overall Study||9
10878525|NCT04318093|12044432|FG000|NOT COMPLETED|Overall Study||3
10878526|NCT04318093|12044433|FG001|NOT COMPLETED|Overall Study||3
10878527|NCT04314284|12044442|FG000|STARTED|Overall Study||69
10878528|NCT04314284|12044443|FG001|STARTED|Overall Study||81
10878529|NCT04314284|12044442|FG000|COMPLETED|Overall Study||65
10878530|NCT04314284|12044443|FG001|COMPLETED|Overall Study||68
10878531|NCT04314284|12044442|FG000|NOT COMPLETED|Overall Study||4
10878532|NCT04314284|12044443|FG001|NOT COMPLETED|Overall Study||13
10878533|NCT04298853|12044451|FG000|STARTED|Overall Study||9
10878534|NCT04298853|12044452|FG001|STARTED|Overall Study||8
10878535|NCT04298853|12044451|FG000|COMPLETED|Overall Study||9
10878536|NCT04298853|12044452|FG001|COMPLETED|Overall Study||8
10878537|NCT04298853|12044451|FG000|NOT COMPLETED|Overall Study||0
10878538|NCT04298853|12044452|FG001|NOT COMPLETED|Overall Study||0
10878539|NCT04283149|12044460|FG000|STARTED|Overall Study||327
10878540|NCT04283149|12044461|FG001|STARTED|Overall Study||327
10878541|NCT04283149|12044460|FG000|Postoperative Month 6|Overall Study||321
10878542|NCT04283149|12044461|FG001|Postoperative Month 6|Overall Study||321
10878543|NCT04283149|12044460|FG000|COMPLETED|Overall Study||0
10878544|NCT04283149|12044461|FG001|COMPLETED|Overall Study||0
10878545|NCT04283149|12044460|FG000|NOT COMPLETED|Overall Study||327
10878546|NCT04283149|12044461|FG001|NOT COMPLETED|Overall Study||327
10878547|NCT04281784|12044470|FG000|STARTED|Overall Study||1255
10878548|NCT04281784|12044471|FG001|STARTED|Overall Study||1257
10878549|NCT04281784|12044470|FG000|COMPLETED|Overall Study||1255
10878550|NCT04281784|12044471|FG001|COMPLETED|Overall Study||1257
10878551|NCT04281784|12044470|FG000|NOT COMPLETED|Overall Study||0
10878552|NCT04281784|12044471|FG001|NOT COMPLETED|Overall Study||0
10878553|NCT04274686|12044477|FG000|STARTED|Overall Study||13
10878554|NCT04274686|12044478|FG001|STARTED|Overall Study||12
10878555|NCT04274686|12044477|FG000|COMPLETED|Overall Study||12
10878556|NCT04274686|12044478|FG001|COMPLETED|Overall Study||12
10878557|NCT04274686|12044477|FG000|NOT COMPLETED|Overall Study||1
10878558|NCT04274686|12044478|FG001|NOT COMPLETED|Overall Study||0
10878559|NCT04253236|12044486|FG000|STARTED|Overall Study||5
10878560|NCT04253236|12044487|FG001|STARTED|Overall Study||0
10878561|NCT04253236|12044486|FG000|COMPLETED|Overall Study||2
10878562|NCT04253236|12044487|FG001|COMPLETED|Overall Study||0
10878563|NCT04253236|12044486|FG000|NOT COMPLETED|Overall Study||3
10878564|NCT04253236|12044487|FG001|NOT COMPLETED|Overall Study||0
10878565|NCT04252586|12044493|FG000|STARTED|Overall Study||21
10878566|NCT04252586|12044493|FG000|COMPLETED|Overall Study||0
10878567|NCT04252586|12044493|FG000|NOT COMPLETED|Overall Study||21
10878568|NCT04247425|12044498|FG000|STARTED|Overall Study||10
10878569|NCT04247425|12044498|FG000|COMPLETED|Overall Study||9
10878570|NCT04247425|12044498|FG000|NOT COMPLETED|Overall Study||1
10878571|NCT04245709|12044502|FG000|STARTED|Overall Study||25
10878572|NCT04245709|12044502|FG000|COMPLETED|Overall Study||11
10878573|NCT04245709|12044502|FG000|NOT COMPLETED|Overall Study||14
10878574|NCT04242173|12044506|FG000|STARTED|Overall Study||3
10878575|NCT04242173|12044506|FG000|COMPLETED|Overall Study||3
10878576|NCT04242173|12044506|FG000|NOT COMPLETED|Overall Study||0
10878577|NCT04236141|12044512|FG000|STARTED|Overall Study||28
10878578|NCT04236141|12044513|FG001|STARTED|Overall Study||14
10878579|NCT04236141|12044512|FG000|Safety Population|Overall Study||27
10878580|NCT04236141|12044513|FG001|Safety Population|Overall Study||14
10878581|NCT04236141|12044512|FG000|Pharmacokinetic-Evaluable Population|Overall Study||27
10878582|NCT04236141|12044513|FG001|Pharmacokinetic-Evaluable Population|Overall Study||0
10878583|NCT04236141|12044512|FG000|Immunogenicity-Evaluable Population (Baseline Evaluable)|Overall Study||27
10878584|NCT04236141|12044513|FG001|Immunogenicity-Evaluable Population (Baseline Evaluable)|Overall Study||14
10878585|NCT04236141|12044512|FG000|Immunogenicity-Evaluable Population (Post-Baseline Evaluable)|Overall Study||24
10878586|NCT04236141|12044513|FG001|Immunogenicity-Evaluable Population (Post-Baseline Evaluable)|Overall Study||0
10878587|NCT04236141|12044512|FG000|COMPLETED|Overall Study||15
10878588|NCT04236141|12044513|FG001|COMPLETED|Overall Study||5
10878589|NCT04236141|12044512|FG000|NOT COMPLETED|Overall Study||13
10878590|NCT04236141|12044513|FG001|NOT COMPLETED|Overall Study||9
10878591|NCT04233580|12044521|FG000|STARTED|Overall Study||20
10878592|NCT04233580|12044522|FG001|STARTED|Overall Study||20
10878593|NCT04233580|12044521|FG000|COMPLETED|Overall Study||15
10878594|NCT04233580|12044522|FG001|COMPLETED|Overall Study||16
10878595|NCT04233580|12044521|FG000|NOT COMPLETED|Overall Study||5
10878596|NCT04233580|12044522|FG001|NOT COMPLETED|Overall Study||4
10878597|NCT04232943|12044531|FG000|STARTED|Overall Study||32
10878598|NCT04232943|12044532|FG001|STARTED|Overall Study||33
10878599|NCT04232943|12044533|FG002|STARTED|Overall Study||22
10878600|NCT04232943|12044531|FG000|Received Study Vaccination|Overall Study||30
10878601|NCT04232943|12044532|FG001|Received Study Vaccination|Overall Study||30
10878602|NCT04232943|12044533|FG002|Received Study Vaccination|Overall Study||20
10878603|NCT04232943|12044531|FG000|Received bOPV Challenge on Day 29|Overall Study||29
10878604|NCT04232943|12044532|FG001|Received bOPV Challenge on Day 29|Overall Study||30
10878605|NCT04232943|12044533|FG002|Received bOPV Challenge on Day 29|Overall Study||20
10878606|NCT04232943|12044531|FG000|COMPLETED|Overall Study||29
10878607|NCT04232943|12044532|FG001|COMPLETED|Overall Study||29
10878608|NCT04232943|12044533|FG002|COMPLETED|Overall Study||20
10878609|NCT04232943|12044531|FG000|NOT COMPLETED|Overall Study||3
10878610|NCT04232943|12044532|FG001|NOT COMPLETED|Overall Study||4
10878611|NCT04232943|12044533|FG002|NOT COMPLETED|Overall Study||2
10878612|NCT04230876|12044544|FG000|STARTED|Overall Study||15
10878613|NCT04230876|12044545|FG001|STARTED|Overall Study||15
10878614|NCT04230876|12044544|FG000|COMPLETED|Overall Study||14
10878615|NCT04230876|12044545|FG001|COMPLETED|Overall Study||14
10878616|NCT04230876|12044544|FG000|NOT COMPLETED|Overall Study||1
10878617|NCT04230876|12044545|FG001|NOT COMPLETED|Overall Study||1
10878618|NCT04230213|12044551|FG000|STARTED|TP1: Week 0 (Day 1) to Week 10||445
10878619|NCT04230213|12044552|FG001|STARTED|TP1: Week 0 (Day 1) to Week 10||0
10878620|NCT04230213|12044553|FG002|STARTED|TP1: Week 0 (Day 1) to Week 10||0
10878621|NCT04230213|12044551|FG000|COMPLETED|TP1: Week 0 (Day 1) to Week 10||427
10878622|NCT04230213|12044552|FG001|COMPLETED|TP1: Week 0 (Day 1) to Week 10||0
10878623|NCT04230213|12044553|FG002|COMPLETED|TP1: Week 0 (Day 1) to Week 10||0
10878624|NCT04230213|12044551|FG000|NOT COMPLETED|TP1: Week 0 (Day 1) to Week 10||18
10878625|NCT04230213|12044552|FG001|NOT COMPLETED|TP1: Week 0 (Day 1) to Week 10||0
10878626|NCT04230213|12044553|FG002|NOT COMPLETED|TP1: Week 0 (Day 1) to Week 10||0
10878627|NCT04230213|12044551|FG000|STARTED|TP2: Week 10 to Week 16|TP1 ended when participants were randomized to Switching and Non-switching Arms|0
10878628|NCT04230213|12044552|FG001|STARTED|TP2: Week 10 to Week 16|Participants who completed TP1 were randomized to Switching arm.|213
10878629|NCT04230213|12044553|FG002|STARTED|TP2: Week 10 to Week 16|Participants who completed TP1 were randomized to Non-switching arm.|214
10878630|NCT04230213|12044551|FG000|COMPLETED|TP2: Week 10 to Week 16||0
10878631|NCT04230213|12044552|FG001|COMPLETED|TP2: Week 10 to Week 16||211
10878632|NCT04230213|12044553|FG002|COMPLETED|TP2: Week 10 to Week 16||211
10878633|NCT04230213|12044551|FG000|NOT COMPLETED|TP2: Week 10 to Week 16||0
10878634|NCT04230213|12044552|FG001|NOT COMPLETED|TP2: Week 10 to Week 16||2
10878635|NCT04230213|12044553|FG002|NOT COMPLETED|TP2: Week 10 to Week 16||3
10878636|NCT04230213|12044551|FG000|STARTED|TP3: Week 16 to Week 22||0
10878637|NCT04230213|12044552|FG001|STARTED|TP3: Week 16 to Week 22||211
10878638|NCT04230213|12044553|FG002|STARTED|TP3: Week 16 to Week 22||211
10878639|NCT04230213|12044551|FG000|COMPLETED|TP3: Week 16 to Week 22||0
10878640|NCT04230213|12044552|FG001|COMPLETED|TP3: Week 16 to Week 22||210
10878641|NCT04230213|12044553|FG002|COMPLETED|TP3: Week 16 to Week 22||204
10878642|NCT04230213|12044551|FG000|NOT COMPLETED|TP3: Week 16 to Week 22||0
10878643|NCT04230213|12044552|FG001|NOT COMPLETED|TP3: Week 16 to Week 22||1
10878644|NCT04230213|12044553|FG002|NOT COMPLETED|TP3: Week 16 to Week 22||7
10878645|NCT04230213|12044551|FG000|STARTED|TP4: Week 22 to Week 32||0
10878646|NCT04230213|12044552|FG001|STARTED|TP4: Week 22 to Week 32||210
10878647|NCT04230213|12044553|FG002|STARTED|TP4: Week 22 to Week 32||204
10878648|NCT04230213|12044551|FG000|COMPLETED|TP4: Week 22 to Week 32||0
10878649|NCT04230213|12044552|FG001|COMPLETED|TP4: Week 22 to Week 32||202
10878650|NCT04230213|12044553|FG002|COMPLETED|TP4: Week 22 to Week 32||196
10878651|NCT04230213|12044551|FG000|NOT COMPLETED|TP4: Week 22 to Week 32||0
10878652|NCT04230213|12044552|FG001|NOT COMPLETED|TP4: Week 22 to Week 32||8
10878653|NCT04230213|12044553|FG002|NOT COMPLETED|TP4: Week 22 to Week 32||8
10878654|NCT04230213|12044551|FG000|STARTED|Follow up: Week 32 to Week 36||0
10878655|NCT04230213|12044552|FG001|STARTED|Follow up: Week 32 to Week 36||202
10878656|NCT04230213|12044553|FG002|STARTED|Follow up: Week 32 to Week 36||196
10878657|NCT04230213|12044551|FG000|COMPLETED|Follow up: Week 32 to Week 36||0
10878658|NCT04230213|12044552|FG001|COMPLETED|Follow up: Week 32 to Week 36||201
10878659|NCT04230213|12044553|FG002|COMPLETED|Follow up: Week 32 to Week 36||194
10878660|NCT04230213|12044551|FG000|NOT COMPLETED|Follow up: Week 32 to Week 36||0
10878661|NCT04230213|12044552|FG001|NOT COMPLETED|Follow up: Week 32 to Week 36||1
10878662|NCT04230213|12044553|FG002|NOT COMPLETED|Follow up: Week 32 to Week 36||2
10878663|NCT04223791|12044563|FG000|STARTED|Overall Study||322
10878664|NCT04223791|12044564|FG001|STARTED|Overall Study||321
10878665|NCT04223791|12044563|FG000|Treated|Overall Study||322
10878666|NCT04223791|12044564|FG001|Treated|Overall Study||319
10878667|NCT04223791|12044563|FG000|COMPLETED|Overall Study||0
10878668|NCT04223791|12044564|FG001|COMPLETED|Overall Study||0
10878669|NCT04223791|12044563|FG000|NOT COMPLETED|Overall Study||322
10878670|NCT04223791|12044564|FG001|NOT COMPLETED|Overall Study||321
10878671|NCT04223778|12044572|FG000|STARTED|Overall Study||336
10878672|NCT04223778|12044573|FG001|STARTED|Overall Study||336
10878673|NCT04223778|12044572|FG000|COMPLETED|Overall Study||0
10878674|NCT04223778|12044573|FG001|COMPLETED|Overall Study||0
10878675|NCT04223778|12044572|FG000|NOT COMPLETED|Overall Study||336
10878676|NCT04223778|12044573|FG001|NOT COMPLETED|Overall Study||336
10878677|NCT04218695|12044581|FG000|STARTED|Overall Study||17
10878678|NCT04218695|12044582|FG001|STARTED|Overall Study||15
10878679|NCT04218695|12044581|FG000|COMPLETED|Overall Study||16
10878680|NCT04218695|12044582|FG001|COMPLETED|Overall Study||15
10878681|NCT04218695|12044581|FG000|NOT COMPLETED|Overall Study||1
10878682|NCT04218695|12044582|FG001|NOT COMPLETED|Overall Study||0
10878683|NCT04213989|12044590|FG000|STARTED|Overall Study||18
10878684|NCT04213989|12044591|FG001|STARTED|Overall Study||18
10878685|NCT04213989|12044590|FG000|COMPLETED|Overall Study||14
10878686|NCT04213989|12044591|FG001|COMPLETED|Overall Study||12
10878687|NCT04213989|12044590|FG000|NOT COMPLETED|Overall Study||4
10878688|NCT04213989|12044591|FG001|NOT COMPLETED|Overall Study||6
10878689|NCT04209075|12044599|FG000|STARTED|Overall Study||4
10878690|NCT04209075|12044600|FG001|STARTED|Overall Study||2
10878691|NCT04209075|12044599|FG000|COMPLETED|Overall Study||4
10878692|NCT04209075|12044600|FG001|COMPLETED|Overall Study||2
10878693|NCT04209075|12044599|FG000|NOT COMPLETED|Overall Study||0
10878694|NCT04209075|12044600|FG001|NOT COMPLETED|Overall Study||0
10878695|NCT04206085|12044611|FG000|STARTED|Overall Study||13
10878696|NCT04206085|12044612|FG001|STARTED|Overall Study||13
10878697|NCT04206085|12044613|FG002|STARTED|Overall Study||12
10878698|NCT04206085|12044611|FG000|COMPLETED|Overall Study||13
10878699|NCT04206085|12044612|FG001|COMPLETED|Overall Study||12
10878700|NCT04206085|12044613|FG002|COMPLETED|Overall Study||11
10878701|NCT04206085|12044611|FG000|NOT COMPLETED|Overall Study||0
10878702|NCT04206085|12044612|FG001|NOT COMPLETED|Overall Study||1
10878703|NCT04206085|12044613|FG002|NOT COMPLETED|Overall Study||1
10878704|NCT04202679|12044623|FG000|STARTED|Overall Study||82
10878705|NCT04202679|12044624|FG001|STARTED|Overall Study||78
10878706|NCT04202679|12044623|FG000|Treated|Overall Study||82
10878707|NCT04202679|12044624|FG001|Treated|Overall Study||77
10878708|NCT04202679|12044623|FG000|COMPLETED|Overall Study||57
10878709|NCT04202679|12044624|FG001|COMPLETED|Overall Study||75
10878710|NCT04202679|12044623|FG000|NOT COMPLETED|Overall Study||25
10878711|NCT04202679|12044624|FG001|NOT COMPLETED|Overall Study||3
10878712|NCT04189952|12044631|FG000|STARTED|Treatment Period||2
10878713|NCT04189952|12044631|FG000|COMPLETED|Treatment Period||2
10878714|NCT04189952|12044631|FG000|NOT COMPLETED|Treatment Period||0
10878715|NCT04189952|12044631|FG000|STARTED|Follow-up Period||2
10878716|NCT04189952|12044631|FG000|COMPLETED|Follow-up Period||0
10878717|NCT04189952|12044631|FG000|NOT COMPLETED|Follow-up Period||2
10878718|NCT04188392|12044635|FG000|STARTED|Overall Study||6
10878719|NCT04188392|12044635|FG000|Sleep Studies 1 and 2|Overall Study||6
10878720|NCT04188392|12044635|FG000|Mid-point Visit (Treatment Week-3)|Overall Study||6
10878721|NCT04188392|12044635|FG000|Sleep Study 3|Overall Study|1 subject could not complete sleep study 3 due to hospital-wide shut-downs during the COVID pandemic.|5
10878722|NCT04188392|12044635|FG000|COMPLETED|Overall Study||6
10878723|NCT04188392|12044635|FG000|NOT COMPLETED|Overall Study||0
10878724|NCT04182880|12044641|FG000|STARTED|Overall Study||5
10878725|NCT04182880|12044642|FG001|STARTED|Overall Study||15
10878726|NCT04182880|12044641|FG000|COMPLETED|Overall Study||4
10878727|NCT04182880|12044642|FG001|COMPLETED|Overall Study||15
10878728|NCT04182880|12044641|FG000|NOT COMPLETED|Overall Study||1
10878729|NCT04182880|12044642|FG001|NOT COMPLETED|Overall Study||0
10878730|NCT04180163|12044648|FG000|STARTED|Run-in Period (4 or up to 8 Weeks)||12
10878731|NCT04180163|12044648|FG000|COMPLETED|Run-in Period (4 or up to 8 Weeks)||12
10878732|NCT04180163|12044648|FG000|NOT COMPLETED|Run-in Period (4 or up to 8 Weeks)||0
10878733|NCT04180163|12044648|FG000|STARTED|Treatment Period A (Weeks 1 to 26)||12
10878734|NCT04180163|12044648|FG000|COMPLETED|Treatment Period A (Weeks 1 to 26)||12
10878735|NCT04180163|12044648|FG000|NOT COMPLETED|Treatment Period A (Weeks 1 to 26)||0
10878736|NCT04180163|12044648|FG000|STARTED|Treatment Period B (Weeks 27 to 52)||12
10878737|NCT04180163|12044648|FG000|COMPLETED|Treatment Period B (Weeks 27 to 52)||12
10878738|NCT04180163|12044648|FG000|NOT COMPLETED|Treatment Period B (Weeks 27 to 52)||0
10878739|NCT04180163|12044648|FG000|STARTED|Safety Follow-up Period (Weeks 53 to 56)||12
10878740|NCT04180163|12044648|FG000|COMPLETED|Safety Follow-up Period (Weeks 53 to 56)||12
10878741|NCT04180163|12044648|FG000|NOT COMPLETED|Safety Follow-up Period (Weeks 53 to 56)||0
10878742|NCT04178967|12044667|FG000|STARTED|Overall Study||150
10878743|NCT04178967|12044668|FG001|STARTED|Overall Study||295
10878744|NCT04178967|12044667|FG000|Received at Least One Dose of Study Drug|Overall Study||149
10878745|NCT04178967|12044668|FG001|Received at Least One Dose of Study Drug|Overall Study||295
10878746|NCT04178967|12044667|FG000|Re-randomized to Maintenance Blinded Treatment|Overall Study||25
10878747|NCT04178967|12044668|FG001|Re-randomized to Maintenance Blinded Treatment|Overall Study||148
10878748|NCT04178967|12044667|FG000|Enrolled to Escape Arm at Week 16|Overall Study||108
10878749|NCT04178967|12044668|FG001|Enrolled to Escape Arm at Week 16|Overall Study||125
10878750|NCT04178967|12044667|FG000|COMPLETED|Overall Study||133
10878751|NCT04178967|12044668|FG001|COMPLETED|Overall Study||273
10878752|NCT04178967|12044667|FG000|NOT COMPLETED|Overall Study||17
10878753|NCT04178967|12044668|FG001|NOT COMPLETED|Overall Study||22
10878754|NCT04176601|12044674|FG000|STARTED|Overall Study||30
10878755|NCT04176601|12044674|FG000|COMPLETED|Overall Study||25
10878756|NCT04176601|12044674|FG000|NOT COMPLETED|Overall Study||5
10878757|NCT04175392|12044680|FG000|STARTED|Overall Study||7
10878758|NCT04175392|12044681|FG001|STARTED|Overall Study||7
10878759|NCT04175392|12044680|FG000|COMPLETED|Overall Study||4
10878760|NCT04175392|12044681|FG001|COMPLETED|Overall Study||5
10878761|NCT04175392|12044680|FG000|NOT COMPLETED|Overall Study||3
10878762|NCT04175392|12044681|FG001|NOT COMPLETED|Overall Study||2
10878763|NCT04173572|12044689|FG000|STARTED|Overall Study||24
10878764|NCT04173572|12044690|FG001|STARTED|Overall Study||26
10878765|NCT04173572|12044689|FG000|Cohort 1|Overall Study||7
10878766|NCT04173572|12044690|FG001|Cohort 1|Overall Study||6
10878767|NCT04173572|12044689|FG000|Cohort 2|Overall Study||8
10878768|NCT04173572|12044690|FG001|Cohort 2|Overall Study||12
10878769|NCT04173572|12044689|FG000|Cohort 3|Overall Study||9
10878770|NCT04173572|12044690|FG001|Cohort 3|Overall Study||8
10878771|NCT04173572|12044689|FG000|COMPLETED|Overall Study||20
10878772|NCT04173572|12044690|FG001|COMPLETED|Overall Study||20
10878773|NCT04173572|12044689|FG000|NOT COMPLETED|Overall Study||4
10878774|NCT04173572|12044690|FG001|NOT COMPLETED|Overall Study||6
10878775|NCT04172831|12044698|FG000|STARTED|Overall Study||248
10878776|NCT04172831|12044699|FG001|STARTED|Overall Study||255
10878777|NCT04172831|12044698|FG000|COMPLETED|Overall Study||204
10878778|NCT04172831|12044699|FG001|COMPLETED|Overall Study||213
10878779|NCT04172831|12044698|FG000|NOT COMPLETED|Overall Study||44
10878780|NCT04172831|12044699|FG001|NOT COMPLETED|Overall Study||42
10878781|NCT04169373|12044709|FG000|STARTED|Overall Study||209
10878782|NCT04169373|12044710|FG001|STARTED|Overall Study||211
10878783|NCT04169373|12044711|FG002|STARTED|Overall Study||158
10878784|NCT04169373|12044712|FG003|STARTED|Overall Study||156
10878785|NCT04169373|12044709|FG000|Received Study Drug|Overall Study||209
10878786|NCT04169373|12044710|FG001|Received Study Drug|Overall Study||211
10878787|NCT04169373|12044711|FG002|Received Study Drug|Overall Study||157
10878788|NCT04169373|12044712|FG003|Received Study Drug|Overall Study||156
10878789|NCT04169373|12044709|FG000|COMPLETED|Overall Study||204
10878790|NCT04169373|12044710|FG001|COMPLETED|Overall Study||206
10878791|NCT04169373|12044711|FG002|COMPLETED|Overall Study||149
10878792|NCT04169373|12044712|FG003|COMPLETED|Overall Study||142
10878793|NCT04169373|12044709|FG000|NOT COMPLETED|Overall Study||5
10878794|NCT04169373|12044710|FG001|NOT COMPLETED|Overall Study||5
10878795|NCT04169373|12044711|FG002|NOT COMPLETED|Overall Study||9
10878796|NCT04169373|12044712|FG003|NOT COMPLETED|Overall Study||14
10878797|NCT04168775|12044722|FG000|STARTED|Overall Study||80
10878798|NCT04168775|12044722|FG000|COMPLETED|Overall Study||75
10878799|NCT04168775|12044722|FG000|NOT COMPLETED|Overall Study||5
10878800|NCT04168190|12044731|FG000|STARTED|Overall Study||30
10878801|NCT04168190|12044732|FG001|STARTED|Overall Study||30
10878802|NCT04168190|12044733|FG002|STARTED|Overall Study||30
10878803|NCT04168190|12044734|FG003|STARTED|Overall Study||254
10878804|NCT04168190|12044735|FG004|STARTED|Overall Study||256
10878805|NCT04168190|12044731|FG000|Treated|Overall Study||30
10878806|NCT04168190|12044732|FG001|Treated|Overall Study||30
10878807|NCT04168190|12044733|FG002|Treated|Overall Study||30
10878808|NCT04168190|12044734|FG003|Treated|Overall Study||254
10878809|NCT04168190|12044735|FG004|Treated|Overall Study||254
10878810|NCT04168190|12044731|FG000|COMPLETED|Overall Study||29
10878811|NCT04168190|12044732|FG001|COMPLETED|Overall Study||29
10878812|NCT04168190|12044733|FG002|COMPLETED|Overall Study||30
10878813|NCT04168190|12044734|FG003|COMPLETED|Overall Study||244
10878814|NCT04168190|12044735|FG004|COMPLETED|Overall Study||247
10878815|NCT04168190|12044731|FG000|NOT COMPLETED|Overall Study||1
10878816|NCT04168190|12044732|FG001|NOT COMPLETED|Overall Study||1
10878817|NCT04168190|12044733|FG002|NOT COMPLETED|Overall Study||0
10878818|NCT04168190|12044734|FG003|NOT COMPLETED|Overall Study||10
10878819|NCT04168190|12044735|FG004|NOT COMPLETED|Overall Study||9
10878820|NCT04166630|12044749|FG000|STARTED|Overall Study||5
10878821|NCT04166630|12044750|FG001|STARTED|Overall Study||17
10878822|NCT04166630|12044749|FG000|COMPLETED|Overall Study||5
10878823|NCT04166630|12044750|FG001|COMPLETED|Overall Study||16
10878824|NCT04166630|12044749|FG000|NOT COMPLETED|Overall Study||0
10878825|NCT04166630|12044750|FG001|NOT COMPLETED|Overall Study||1
10878826|NCT04165824|12044756|FG000|STARTED|Overall Study||185
10878827|NCT04165824|12044756|FG000|COMPLETED|Overall Study||139
10878828|NCT04165824|12044756|FG000|NOT COMPLETED|Overall Study||46
10878829|NCT04161131|12044760|FG000|STARTED|Overall Study||28
10878830|NCT04161131|12044760|FG000|Completed Baseline Surveys|Overall Study||27
10878831|NCT04161131|12044760|FG000|Received Intervention|Overall Study||22
10878832|NCT04161131|12044760|FG000|COMPLETED|Overall Study||22
10878833|NCT04161131|12044760|FG000|NOT COMPLETED|Overall Study||6
10878834|NCT04160078|12044764|FG000|STARTED|Overall Study||18
10878835|NCT04160078|12044764|FG000|COMPLETED|Overall Study||18
10878836|NCT04160078|12044764|FG000|NOT COMPLETED|Overall Study||0
10878837|NCT04154293|12044771|FG000|STARTED|Overall Study||12
10878838|NCT04154293|12044772|FG001|STARTED|Overall Study||11
10878839|NCT04154293|12044773|FG002|STARTED|Overall Study||11
10878840|NCT04154293|12044771|FG000|Number Who Received at Least 1 Dose|Overall Study||12
10878841|NCT04154293|12044772|FG001|Number Who Received at Least 1 Dose|Overall Study||11
10878842|NCT04154293|12044773|FG002|Number Who Received at Least 1 Dose|Overall Study||10
10878843|NCT04154293|12044771|FG000|COMPLETED|Overall Study||10
10878844|NCT04154293|12044772|FG001|COMPLETED|Overall Study||8
10878845|NCT04154293|12044773|FG002|COMPLETED|Overall Study||9
10878846|NCT04154293|12044771|FG000|NOT COMPLETED|Overall Study||2
10878847|NCT04154293|12044772|FG001|NOT COMPLETED|Overall Study||3
10878848|NCT04154293|12044773|FG002|NOT COMPLETED|Overall Study||2
10878849|NCT04152200|12044783|FG000|STARTED|Primary Analysis Period||6
10878850|NCT04152200|12044784|FG001|STARTED|Primary Analysis Period||15
10878851|NCT04152200|12044783|FG000|COMPLETED|Primary Analysis Period||6
10878852|NCT04152200|12044784|FG001|COMPLETED|Primary Analysis Period||15
10878853|NCT04152200|12044783|FG000|NOT COMPLETED|Primary Analysis Period||0
10878854|NCT04152200|12044784|FG001|NOT COMPLETED|Primary Analysis Period||0
10878855|NCT04152200|12044783|FG000|STARTED|Long-term Extension Period||6
10878856|NCT04152200|12044784|FG001|STARTED|Long-term Extension Period||15
10878857|NCT04152200|12044783|FG000|COMPLETED|Long-term Extension Period||0
10878858|NCT04152200|12044784|FG001|COMPLETED|Long-term Extension Period||0
10878859|NCT04152200|12044783|FG000|NOT COMPLETED|Long-term Extension Period||6
10878860|NCT04152200|12044784|FG001|NOT COMPLETED|Long-term Extension Period||15
10878861|NCT04146363|12044794|FG000|STARTED|Overall Study||141
10878862|NCT04146363|12044795|FG001|STARTED|Overall Study||283
10878863|NCT04146363|12044794|FG000|Received at Least One Dose of Study Drug|Overall Study||141
10878864|NCT04146363|12044795|FG001|Received at Least One Dose of Study Drug|Overall Study||282
10878865|NCT04146363|12044794|FG000|Re-randomized to Maintenance Blinded Treatment|Overall Study||24
10878866|NCT04146363|12044795|FG001|Re-randomized to Maintenance Blinded Treatment|Overall Study||157
10878867|NCT04146363|12044794|FG000|Enrolled to Escape Arm at Week 16|Overall Study||96
10878868|NCT04146363|12044795|FG001|Enrolled to Escape Arm at Week 16|Overall Study||106
10878869|NCT04146363|12044794|FG000|COMPLETED|Overall Study||120
10878870|NCT04146363|12044795|FG001|COMPLETED|Overall Study||263
10878871|NCT04146363|12044794|FG000|NOT COMPLETED|Overall Study||21
10878872|NCT04146363|12044795|FG001|NOT COMPLETED|Overall Study||20
10878873|NCT04142034|12044804|FG000|STARTED|Recruitment Period||535
10878874|NCT04142034|12044805|FG001|STARTED|Recruitment Period||23
10878875|NCT04142034|12044806|FG002|STARTED|Recruitment Period||0
10878876|NCT04142034|12044807|FG003|STARTED|Recruitment Period||0
10878877|NCT04142034|12044804|FG000|COMPLETED|Recruitment Period|The recruitment period included a hiatus in recruitment due to the pandemic|99
10878878|NCT04142034|12044805|FG001|COMPLETED|Recruitment Period|The recruitment period included a hiatus in recruitment due to the pandemic|5
10878879|NCT04142034|12044806|FG002|COMPLETED|Recruitment Period|the intervention arm is only relevant during period 2|0
10878880|NCT04142034|12044807|FG003|COMPLETED|Recruitment Period|intervention arm is only relevant in period 2|0
10878881|NCT04142034|12044804|FG000|NOT COMPLETED|Recruitment Period||436
10878882|NCT04142034|12044805|FG001|NOT COMPLETED|Recruitment Period||18
10878883|NCT04142034|12044806|FG002|NOT COMPLETED|Recruitment Period||0
10878884|NCT04142034|12044807|FG003|NOT COMPLETED|Recruitment Period||0
10878885|NCT04142034|12044804|FG000|STARTED|Intervention Period|Recruitment method is only relevant in period 1|0
10878886|NCT04142034|12044805|FG001|STARTED|Intervention Period|Recruitment method is only relevant in period 1|0
10878887|NCT04142034|12044806|FG002|STARTED|Intervention Period|There were 104 participants recruited into the intervention part of the study; half were randomized to the iAmHealthy + newsletter behavioral intervention.|52
10878888|NCT04142034|12044807|FG003|STARTED|Intervention Period|There were 104 participants recruited into the intervention part of the study; half were randomized to the Newsletter intervention.|52
10878889|NCT04142034|12044804|FG000|COMPLETED|Intervention Period||0
10878890|NCT04142034|12044805|FG001|COMPLETED|Intervention Period||0
10878891|NCT04142034|12044806|FG002|COMPLETED|Intervention Period||45
10878892|NCT04142034|12044807|FG003|COMPLETED|Intervention Period||50
10878893|NCT04142034|12044804|FG000|NOT COMPLETED|Intervention Period||0
10878894|NCT04142034|12044805|FG001|NOT COMPLETED|Intervention Period||0
10878895|NCT04142034|12044806|FG002|NOT COMPLETED|Intervention Period||7
10878896|NCT04142034|12044807|FG003|NOT COMPLETED|Intervention Period||2
10878897|NCT04132804|12044815|FG000|STARTED|Overall Study||31
10878898|NCT04132804|12044815|FG000|COMPLETED|Overall Study||20
10878899|NCT04132804|12044815|FG000|NOT COMPLETED|Overall Study||11
10878900|NCT04130919|12044822|FG000|STARTED|Blinded Treatment Phase||7
10878901|NCT04130919|12044823|FG001|STARTED|Blinded Treatment Phase||6
10878902|NCT04130919|12044824|FG002|STARTED|Blinded Treatment Phase||6
10878903|NCT04130919|12044825|FG003|STARTED|Blinded Treatment Phase||0
10878904|NCT04130919|12044826|FG004|STARTED|Blinded Treatment Phase||0
10878905|NCT04130919|12044827|FG005|STARTED|Blinded Treatment Phase||0
10878906|NCT04130919|12044822|FG000|COMPLETED|Blinded Treatment Phase||5
10878907|NCT04130919|12044823|FG001|COMPLETED|Blinded Treatment Phase||4
10878908|NCT04130919|12044824|FG002|COMPLETED|Blinded Treatment Phase||3
10878909|NCT04130919|12044825|FG003|COMPLETED|Blinded Treatment Phase||0
10878910|NCT04130919|12044826|FG004|COMPLETED|Blinded Treatment Phase||0
10878911|NCT04130919|12044827|FG005|COMPLETED|Blinded Treatment Phase||0
10878912|NCT04130919|12044822|FG000|NOT COMPLETED|Blinded Treatment Phase||2
10878913|NCT04130919|12044823|FG001|NOT COMPLETED|Blinded Treatment Phase||2
10878914|NCT04130919|12044824|FG002|NOT COMPLETED|Blinded Treatment Phase||3
10878915|NCT04130919|12044825|FG003|NOT COMPLETED|Blinded Treatment Phase||0
10878916|NCT04130919|12044826|FG004|NOT COMPLETED|Blinded Treatment Phase||0
10878917|NCT04130919|12044827|FG005|NOT COMPLETED|Blinded Treatment Phase||0
10878918|NCT04130919|12044822|FG000|STARTED|Open-label Treatment Phase|Participants who completed the Blinded Treatment phase and did not achieve the clinical response per modified MCS at Week 10 entered in Open-label Treatment phase to receive tilpisertib 300 mg.|0
10878919|NCT04130919|12044823|FG001|STARTED|Open-label Treatment Phase|Participants who completed the Blinded Treatment phase and did not achieve the clinical response per modified MCS at Week 10 entered in Open-label Treatment phase to receive tilpisertib 300 mg.|0
10878920|NCT04130919|12044824|FG002|STARTED|Open-label Treatment Phase|Participants who completed the Blinded Treatment phase and did not achieve the clinical response per modified MCS at Week 10 entered in Open-label Treatment phase to receive tilpisertib 300 mg.|0
10878921|NCT04130919|12044825|FG003|STARTED|Open-label Treatment Phase|Participants who completed the Blinded Treatment phase and did not achieve the clinical response per modified MCS at Week 10 entered in Open-label Treatment phase to receive tilpisertib 300 mg.|4
10878922|NCT04130919|12044826|FG004|STARTED|Open-label Treatment Phase|Participants who completed the Blinded Treatment phase and did not achieve the clinical response per modified MCS at Week 10 entered in Open-label Treatment phase to receive tilpisertib 300 mg.|3
10879009|NCT04093414|12044888|FG001|NOT COMPLETED|6month Follow up||3
10878923|NCT04130919|12044827|FG005|STARTED|Open-label Treatment Phase|Participants who completed the Blinded Treatment phase and did not achieve the clinical response per modified MCS at Week 10 entered in Open-label Treatment phase to receive tilpisertib 300 mg.|3
10878924|NCT04130919|12044822|FG000|COMPLETED|Open-label Treatment Phase||0
10878925|NCT04130919|12044823|FG001|COMPLETED|Open-label Treatment Phase||0
10878926|NCT04130919|12044824|FG002|COMPLETED|Open-label Treatment Phase||0
10878927|NCT04130919|12044825|FG003|COMPLETED|Open-label Treatment Phase||1
10878928|NCT04130919|12044826|FG004|COMPLETED|Open-label Treatment Phase||1
10878929|NCT04130919|12044827|FG005|COMPLETED|Open-label Treatment Phase||0
10878930|NCT04130919|12044822|FG000|NOT COMPLETED|Open-label Treatment Phase||0
10878931|NCT04130919|12044823|FG001|NOT COMPLETED|Open-label Treatment Phase||0
10878932|NCT04130919|12044824|FG002|NOT COMPLETED|Open-label Treatment Phase||0
10878933|NCT04130919|12044825|FG003|NOT COMPLETED|Open-label Treatment Phase||3
10878934|NCT04130919|12044826|FG004|NOT COMPLETED|Open-label Treatment Phase||2
10878935|NCT04130919|12044827|FG005|NOT COMPLETED|Open-label Treatment Phase||3
10878936|NCT04128696|12044843|FG000|STARTED|Overall Study||158
10878937|NCT04128696|12044844|FG001|STARTED|Overall Study||157
10878938|NCT04128696|12044843|FG000|Modified Intent to Treat (mITT) Population|Overall Study||157
10878939|NCT04128696|12044844|FG001|Modified Intent to Treat (mITT) Population|Overall Study||156
10878940|NCT04128696|12044843|FG000|Safety Population|Overall Study||159
10878941|NCT04128696|12044844|FG001|Safety Population|Overall Study||156
10878942|NCT04128696|12044843|FG000|COMPLETED|Overall Study||51
10878943|NCT04128696|12044844|FG001|COMPLETED|Overall Study||38
10878944|NCT04128696|12044843|FG000|NOT COMPLETED|Overall Study||107
10878945|NCT04128696|12044844|FG001|NOT COMPLETED|Overall Study||119
10878946|NCT04128267|12044850|FG000|STARTED|Overall Study||32
10878947|NCT04128267|12044850|FG000|COMPLETED|Overall Study||17
10878948|NCT04128267|12044850|FG000|NOT COMPLETED|Overall Study||15
10878949|NCT04124926|12044856|FG000|STARTED|Healing Phase||514
10878950|NCT04124926|12044857|FG001|STARTED|Healing Phase||513
10878951|NCT04124926|12044858|FG002|STARTED|Healing Phase||0
10878952|NCT04124926|12044859|FG003|STARTED|Healing Phase||0
10878953|NCT04124926|12044860|FG004|STARTED|Healing Phase||0
10878954|NCT04124926|12044856|FG000|Treated With Study Drug|Healing Phase||514
10878955|NCT04124926|12044857|FG001|Treated With Study Drug|Healing Phase||510
10878956|NCT04124926|12044858|FG002|Treated With Study Drug|Healing Phase||0
10878957|NCT04124926|12044859|FG003|Treated With Study Drug|Healing Phase||0
10878958|NCT04124926|12044860|FG004|Treated With Study Drug|Healing Phase||0
10878959|NCT04124926|12044856|FG000|COMPLETED|Healing Phase||483
10878960|NCT04124926|12044857|FG001|COMPLETED|Healing Phase||481
10878961|NCT04124926|12044858|FG002|COMPLETED|Healing Phase||0
10878962|NCT04124926|12044859|FG003|COMPLETED|Healing Phase||0
10878963|NCT04124926|12044860|FG004|COMPLETED|Healing Phase||0
10878964|NCT04124926|12044856|FG000|NOT COMPLETED|Healing Phase||31
10878965|NCT04124926|12044857|FG001|NOT COMPLETED|Healing Phase||32
10878966|NCT04124926|12044858|FG002|NOT COMPLETED|Healing Phase||0
10878967|NCT04124926|12044859|FG003|NOT COMPLETED|Healing Phase||0
10878968|NCT04124926|12044860|FG004|NOT COMPLETED|Healing Phase||0
10878969|NCT04124926|12044856|FG000|STARTED|Maintenance Phase||0
10878970|NCT04124926|12044857|FG001|STARTED|Maintenance Phase||0
10878971|NCT04124926|12044858|FG002|STARTED|Maintenance Phase||298
10878972|NCT04124926|12044859|FG003|STARTED|Maintenance Phase||298
10878973|NCT04124926|12044860|FG004|STARTED|Maintenance Phase||297
10878974|NCT04124926|12044856|FG000|Treated With Study Drug|Maintenance Phase||0
10878975|NCT04124926|12044857|FG001|Treated With Study Drug|Maintenance Phase||0
10878976|NCT04124926|12044858|FG002|Treated With Study Drug|Maintenance Phase||296
10878977|NCT04124926|12044859|FG003|Treated With Study Drug|Maintenance Phase||296
10878978|NCT04124926|12044860|FG004|Treated With Study Drug|Maintenance Phase||297
10878979|NCT04124926|12044856|FG000|COMPLETED|Maintenance Phase||0
10878980|NCT04124926|12044857|FG001|COMPLETED|Maintenance Phase||0
10878981|NCT04124926|12044858|FG002|COMPLETED|Maintenance Phase||274
10878982|NCT04124926|12044859|FG003|COMPLETED|Maintenance Phase||269
10878983|NCT04124926|12044860|FG004|COMPLETED|Maintenance Phase||269
10878984|NCT04124926|12044856|FG000|NOT COMPLETED|Maintenance Phase||0
10878985|NCT04124926|12044857|FG001|NOT COMPLETED|Maintenance Phase||0
10878986|NCT04124926|12044858|FG002|NOT COMPLETED|Maintenance Phase||24
10878987|NCT04124926|12044859|FG003|NOT COMPLETED|Maintenance Phase||29
10878988|NCT04124926|12044860|FG004|NOT COMPLETED|Maintenance Phase||28
10878989|NCT04123067|12044874|FG000|STARTED|Overall Study||0
10878990|NCT04123067|12044875|FG001|STARTED|Overall Study||1
10878991|NCT04123067|12044874|FG000|COMPLETED|Overall Study||0
10878992|NCT04123067|12044875|FG001|COMPLETED|Overall Study||0
10878993|NCT04123067|12044874|FG000|NOT COMPLETED|Overall Study||0
10878994|NCT04123067|12044875|FG001|NOT COMPLETED|Overall Study||1
10878995|NCT04096001|12044881|FG000|STARTED|Overall Study||101
10878996|NCT04096001|12044881|FG000|COMPLETED|Overall Study||51
10878997|NCT04096001|12044881|FG000|NOT COMPLETED|Overall Study||50
10878998|NCT04093414|12044887|FG000|STARTED|3 Month Follow up||3
10878999|NCT04093414|12044888|FG001|STARTED|3 Month Follow up||6
10879000|NCT04093414|12044887|FG000|COMPLETED|3 Month Follow up||3
10879001|NCT04093414|12044888|FG001|COMPLETED|3 Month Follow up||5
10879002|NCT04093414|12044887|FG000|NOT COMPLETED|3 Month Follow up||0
10879003|NCT04093414|12044888|FG001|NOT COMPLETED|3 Month Follow up||1
10879004|NCT04093414|12044887|FG000|STARTED|6month Follow up||3
10879005|NCT04093414|12044888|FG001|STARTED|6month Follow up||5
10879006|NCT04093414|12044887|FG000|COMPLETED|6month Follow up||2
10879007|NCT04093414|12044888|FG001|COMPLETED|6month Follow up||2
10879008|NCT04093414|12044887|FG000|NOT COMPLETED|6month Follow up||1
10879010|NCT04093414|12044887|FG000|STARTED|12 Month Follow up||2
10879011|NCT04093414|12044888|FG001|STARTED|12 Month Follow up||2
10879012|NCT04093414|12044887|FG000|COMPLETED|12 Month Follow up||2
10879013|NCT04093414|12044888|FG001|COMPLETED|12 Month Follow up||2
10879014|NCT04093414|12044887|FG000|NOT COMPLETED|12 Month Follow up||0
10879015|NCT04093414|12044888|FG001|NOT COMPLETED|12 Month Follow up||0
10879016|NCT04091360|12044900|FG000|STARTED|Part A (R, PC, PG) Single Dose||6
10879017|NCT04091360|12044901|FG001|STARTED|Part A (R, PC, PG) Single Dose||7
10879018|NCT04091360|12044902|FG002|STARTED|Part A (R, PC, PG) Single Dose||6
10879019|NCT04091360|12044903|FG003|STARTED|Part A (R, PC, PG) Single Dose||7
10879020|NCT04091360|12044904|FG004|STARTED|Part A (R, PC, PG) Single Dose||7
10879021|NCT04091360|12044905|FG005|STARTED|Part A (R, PC, PG) Single Dose||7
10879022|NCT04091360|12044906|FG006|STARTED|Part A (R, PC, PG) Single Dose||0
10879023|NCT04091360|12044907|FG007|STARTED|Part A (R, PC, PG) Single Dose||0
10879024|NCT04091360|12044908|FG008|STARTED|Part A (R, PC, PG) Single Dose||0
10879025|NCT04091360|12044909|FG009|STARTED|Part A (R, PC, PG) Single Dose||0
10879026|NCT04091360|12044900|FG000|COMPLETED|Part A (R, PC, PG) Single Dose||6
10879027|NCT04091360|12044901|FG001|COMPLETED|Part A (R, PC, PG) Single Dose||7
10879028|NCT04091360|12044902|FG002|COMPLETED|Part A (R, PC, PG) Single Dose||6
10879029|NCT04091360|12044903|FG003|COMPLETED|Part A (R, PC, PG) Single Dose||7
10879030|NCT04091360|12044904|FG004|COMPLETED|Part A (R, PC, PG) Single Dose||7
10879031|NCT04091360|12044905|FG005|COMPLETED|Part A (R, PC, PG) Single Dose||7
10879032|NCT04091360|12044906|FG006|COMPLETED|Part A (R, PC, PG) Single Dose||0
10879033|NCT04091360|12044907|FG007|COMPLETED|Part A (R, PC, PG) Single Dose||0
10879034|NCT04091360|12044908|FG008|COMPLETED|Part A (R, PC, PG) Single Dose||0
10879035|NCT04091360|12044909|FG009|COMPLETED|Part A (R, PC, PG) Single Dose||0
10879036|NCT04091360|12044900|FG000|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879037|NCT04091360|12044901|FG001|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879038|NCT04091360|12044902|FG002|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879039|NCT04091360|12044903|FG003|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879040|NCT04091360|12044904|FG004|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879041|NCT04091360|12044905|FG005|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879042|NCT04091360|12044906|FG006|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879043|NCT04091360|12044907|FG007|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879044|NCT04091360|12044908|FG008|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879045|NCT04091360|12044909|FG009|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879046|NCT04091360|12044900|FG000|STARTED|Part B (R, PC, XO) Twice Daily for 7 Day||0
10879047|NCT04091360|12044901|FG001|STARTED|Part B (R, PC, XO) Twice Daily for 7 Day||0
10879048|NCT04091360|12044902|FG002|STARTED|Part B (R, PC, XO) Twice Daily for 7 Day||0
10879049|NCT04091360|12044903|FG003|STARTED|Part B (R, PC, XO) Twice Daily for 7 Day||0
10879050|NCT04091360|12044904|FG004|STARTED|Part B (R, PC, XO) Twice Daily for 7 Day||0
10879051|NCT04091360|12044905|FG005|STARTED|Part B (R, PC, XO) Twice Daily for 7 Day||0
10879052|NCT04091360|12044906|FG006|STARTED|Part B (R, PC, XO) Twice Daily for 7 Day||8
10879053|NCT04091360|12044907|FG007|STARTED|Part B (R, PC, XO) Twice Daily for 7 Day||7
10879054|NCT04091360|12044908|FG008|STARTED|Part B (R, PC, XO) Twice Daily for 7 Day||7
10879055|NCT04091360|12044909|FG009|STARTED|Part B (R, PC, XO) Twice Daily for 7 Day||6
10879056|NCT04091360|12044900|FG000|COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||0
10879057|NCT04091360|12044901|FG001|COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||0
10879058|NCT04091360|12044902|FG002|COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||0
10879059|NCT04091360|12044903|FG003|COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||0
10879060|NCT04091360|12044904|FG004|COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||0
10879061|NCT04091360|12044905|FG005|COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||0
10879062|NCT04091360|12044906|FG006|COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||6
10879063|NCT04091360|12044907|FG007|COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||6
10879064|NCT04091360|12044908|FG008|COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||6
10879065|NCT04091360|12044909|FG009|COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||4
10879066|NCT04091360|12044900|FG000|NOT COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||0
10879067|NCT04091360|12044901|FG001|NOT COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||0
10879068|NCT04091360|12044902|FG002|NOT COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||0
10879069|NCT04091360|12044903|FG003|NOT COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||0
10879070|NCT04091360|12044904|FG004|NOT COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||0
10879071|NCT04091360|12044905|FG005|NOT COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||0
10879072|NCT04091360|12044906|FG006|NOT COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||2
10879073|NCT04091360|12044907|FG007|NOT COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||1
10879074|NCT04091360|12044908|FG008|NOT COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||1
10879075|NCT04091360|12044909|FG009|NOT COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||2
10879076|NCT04089553|12044933|FG000|STARTED|Overall Study||29
10879077|NCT04089553|12044934|FG001|STARTED|Overall Study||30
10879078|NCT04089553|12044933|FG000|COMPLETED|Overall Study||4
10879079|NCT04089553|12044934|FG001|COMPLETED|Overall Study||12
10879080|NCT04089553|12044933|FG000|NOT COMPLETED|Overall Study||25
10879081|NCT04089553|12044934|FG001|NOT COMPLETED|Overall Study||18
10879082|NCT04086472|12044946|FG000|STARTED|Overall Study||16
10879083|NCT04086472|12044947|FG001|STARTED|Overall Study||16
10879084|NCT04086472|12044948|FG002|STARTED|Overall Study||16
10879085|NCT04086472|12044949|FG003|STARTED|Overall Study||16
10879086|NCT04086472|12044950|FG004|STARTED|Overall Study||16
10879087|NCT04086472|12044946|FG000|Received MK-1654 or Placebo|Overall Study||16
10879088|NCT04086472|12044947|FG001|Received MK-1654 or Placebo|Overall Study||16
10879089|NCT04086472|12044948|FG002|Received MK-1654 or Placebo|Overall Study||16
10879090|NCT04086472|12044949|FG003|Received MK-1654 or Placebo|Overall Study||16
10879091|NCT04086472|12044950|FG004|Received MK-1654 or Placebo|Overall Study||16
10879092|NCT04086472|12044946|FG000|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||14
10879093|NCT04086472|12044947|FG001|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||14
10879094|NCT04086472|12044948|FG002|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||14
10879095|NCT04086472|12044949|FG003|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||13
10879096|NCT04086472|12044950|FG004|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||15
10879097|NCT04086472|12044946|FG000|Not Inoculated|Overall Study||2
10879098|NCT04086472|12044947|FG001|Not Inoculated|Overall Study||2
10879099|NCT04086472|12044948|FG002|Not Inoculated|Overall Study||2
10879100|NCT04086472|12044949|FG003|Not Inoculated|Overall Study||3
10879101|NCT04086472|12044950|FG004|Not Inoculated|Overall Study||1
10879102|NCT04086472|12044946|FG000|COMPLETED|Overall Study||12
10879103|NCT04086472|12044947|FG001|COMPLETED|Overall Study||14
10879104|NCT04086472|12044948|FG002|COMPLETED|Overall Study||14
10879105|NCT04086472|12044949|FG003|COMPLETED|Overall Study||13
10879106|NCT04086472|12044950|FG004|COMPLETED|Overall Study||14
10879107|NCT04086472|12044946|FG000|NOT COMPLETED|Overall Study||4
10879108|NCT04086472|12044947|FG001|NOT COMPLETED|Overall Study||2
10879109|NCT04086472|12044948|FG002|NOT COMPLETED|Overall Study||2
10879110|NCT04086472|12044949|FG003|NOT COMPLETED|Overall Study||3
10879111|NCT04086472|12044950|FG004|NOT COMPLETED|Overall Study||2
10879112|NCT04081727|12044964|FG000|STARTED|Overall Study||2
10879113|NCT04081727|12044965|FG001|STARTED|Overall Study||0
10879114|NCT04081727|12044964|FG000|As-treated Analysis|Overall Study||1
10879115|NCT04081727|12044965|FG001|As-treated Analysis|Overall Study||1
10879116|NCT04081727|12044964|FG000|COMPLETED|Overall Study||2
10879117|NCT04081727|12044965|FG001|COMPLETED|Overall Study||0
10879118|NCT04081727|12044964|FG000|NOT COMPLETED|Overall Study||0
10879119|NCT04081727|12044965|FG001|NOT COMPLETED|Overall Study||0
10879120|NCT04080882|12044975|FG000|STARTED|Overall Study||20
10879121|NCT04080882|12044976|FG001|STARTED|Overall Study||60
10879122|NCT04080882|12044975|FG000|COMPLETED|Overall Study||18
10879123|NCT04080882|12044976|FG001|COMPLETED|Overall Study||58
10879124|NCT04080882|12044975|FG000|NOT COMPLETED|Overall Study||2
10879125|NCT04080882|12044976|FG001|NOT COMPLETED|Overall Study||2
10879126|NCT04076696|12044982|FG000|STARTED|Overall Study||38
10879127|NCT04076696|12044982|FG000|COMPLETED|Overall Study||38
10879128|NCT04076696|12044982|FG000|NOT COMPLETED|Overall Study||0
10879129|NCT04075604|12044989|FG000|STARTED|Overall Study||2
10879130|NCT04075604|12044990|FG001|STARTED|Overall Study||9
10879131|NCT04075604|12044991|FG002|STARTED|Overall Study||12
10879132|NCT04075604|12044989|FG000|COMPLETED|Overall Study||1
10879133|NCT04075604|12044990|FG001|COMPLETED|Overall Study||3
10879134|NCT04075604|12044991|FG002|COMPLETED|Overall Study||6
10879135|NCT04075604|12044989|FG000|NOT COMPLETED|Overall Study||1
10879136|NCT04075604|12044990|FG001|NOT COMPLETED|Overall Study||6
10879137|NCT04075604|12044991|FG002|NOT COMPLETED|Overall Study||6
10879138|NCT04073186|12044999|FG000|STARTED|First Wearing Cycle||86
10879139|NCT04073186|12044999|FG000|COMPLETED|First Wearing Cycle||80
10879140|NCT04073186|12044999|FG000|NOT COMPLETED|First Wearing Cycle||6
10879141|NCT04073186|12044999|FG000|STARTED|Second Wearing Cycle||80
10879142|NCT04073186|12044999|FG000|COMPLETED|Second Wearing Cycle||79
10879143|NCT04073186|12044999|FG000|NOT COMPLETED|Second Wearing Cycle||1
10879144|NCT04072445|12045004|FG000|STARTED|Overall Study||28
10879145|NCT04072445|12045004|FG000|COMPLETED|Overall Study||27
10879146|NCT04072445|12045004|FG000|NOT COMPLETED|Overall Study||1
10879147|NCT04070833|12045013|FG000|STARTED|Overall Study||66
10879148|NCT04070833|12045014|FG001|STARTED|Overall Study||75
10879149|NCT04070833|12045015|FG002|STARTED|Overall Study||82
10879150|NCT04070833|12045016|FG003|STARTED|Overall Study||67
10879151|NCT04070833|12045013|FG000|COMPLETED|Overall Study||58
10879152|NCT04070833|12045014|FG001|COMPLETED|Overall Study||69
10879153|NCT04070833|12045015|FG002|COMPLETED|Overall Study||71
10879154|NCT04070833|12045016|FG003|COMPLETED|Overall Study||60
10879155|NCT04070833|12045013|FG000|NOT COMPLETED|Overall Study||8
10879156|NCT04070833|12045014|FG001|NOT COMPLETED|Overall Study||6
10879157|NCT04070833|12045015|FG002|NOT COMPLETED|Overall Study||11
10879158|NCT04070833|12045016|FG003|NOT COMPLETED|Overall Study||7
10879159|NCT04069702|12045026|FG000|STARTED|Overall Study||20
10879160|NCT04069702|12045026|FG000|COMPLETED|Overall Study||20
10879161|NCT04069702|12045026|FG000|NOT COMPLETED|Overall Study||0
10879162|NCT04068181|12045034|FG000|STARTED|Overall Study||27
10879163|NCT04068181|12045035|FG001|STARTED|Overall Study||15
10879164|NCT04068181|12045036|FG002|STARTED|Overall Study||15
10879165|NCT04068181|12045037|FG003|STARTED|Overall Study||15
10879166|NCT04068181|12045034|FG000|Received Talimogene Laherparepvec|Overall Study||26
10879167|NCT04068181|12045035|FG001|Received Talimogene Laherparepvec|Overall Study||15
10879168|NCT04068181|12045036|FG002|Received Talimogene Laherparepvec|Overall Study||15
10879169|NCT04068181|12045037|FG003|Received Talimogene Laherparepvec|Overall Study||15
10879170|NCT04068181|12045034|FG000|Received Pembrolizumab|Overall Study||26
10879171|NCT04068181|12045035|FG001|Received Pembrolizumab|Overall Study||15
10879172|NCT04068181|12045036|FG002|Received Pembrolizumab|Overall Study||15
10879173|NCT04068181|12045037|FG003|Received Pembrolizumab|Overall Study||15
10879174|NCT04068181|12045034|FG000|COMPLETED|Overall Study||0
10879175|NCT04068181|12045035|FG001|COMPLETED|Overall Study||0
10879176|NCT04068181|12045036|FG002|COMPLETED|Overall Study||0
10879177|NCT04068181|12045037|FG003|COMPLETED|Overall Study||0
10879178|NCT04068181|12045034|FG000|NOT COMPLETED|Overall Study||27
10879179|NCT04068181|12045035|FG001|NOT COMPLETED|Overall Study||15
10879180|NCT04068181|12045036|FG002|NOT COMPLETED|Overall Study||15
10879181|NCT04068181|12045037|FG003|NOT COMPLETED|Overall Study||15
10879182|NCT04067518|12045049|FG000|STARTED|Overall Study||3
10879183|NCT04067518|12045050|FG001|STARTED|Overall Study||25
10879184|NCT04067518|12045049|FG000|Safety Analysis Set|Overall Study|SR/IR: 3 participants; HR: 0 participants|3
10879185|NCT04067518|12045050|FG001|Safety Analysis Set|Overall Study|SR/IR: 21 participants; HR: 1 participant; Missing: 1 participant|23
10879186|NCT04067518|12045049|FG000|Full Analysis Set|Overall Study||0
10879187|NCT04067518|12045050|FG001|Full Analysis Set|Overall Study||23
10879188|NCT04067518|12045049|FG000|Immunogenicity Analysis Set|Overall Study||3
10879189|NCT04067518|12045050|FG001|Immunogenicity Analysis Set|Overall Study||22
10879190|NCT04067518|12045049|FG000|Pharmacokinetic Analysis Set|Overall Study||3
10879191|NCT04067518|12045050|FG001|Pharmacokinetic Analysis Set|Overall Study||23
10879192|NCT04067518|12045049|FG000|COMPLETED|Overall Study||0
10879193|NCT04067518|12045050|FG001|COMPLETED|Overall Study||0
10879194|NCT04067518|12045049|FG000|NOT COMPLETED|Overall Study||3
10879195|NCT04067518|12045050|FG001|NOT COMPLETED|Overall Study||25
10879196|NCT04063761|12045057|FG000|STARTED|Overall Study||20
10879197|NCT04063761|12045057|FG000|COMPLETED|Overall Study||20
10879198|NCT04063761|12045057|FG000|NOT COMPLETED|Overall Study||0
10879199|NCT04058054|12045061|FG000|STARTED|Overall Study||22
10879200|NCT04058054|12045062|FG001|STARTED|Overall Study||22
10879201|NCT04058054|12045063|FG002|STARTED|Overall Study||22
10879202|NCT04058054|12045064|FG003|STARTED|Overall Study||22
10879203|NCT04058054|12045065|FG004|STARTED|Overall Study||22
10879204|NCT04058054|12045061|FG000|COMPLETED|Overall Study||22
10879205|NCT04058054|12045062|FG001|COMPLETED|Overall Study||22
10879206|NCT04058054|12045063|FG002|COMPLETED|Overall Study||22
10879207|NCT04058054|12045064|FG003|COMPLETED|Overall Study||22
10879208|NCT04058054|12045065|FG004|COMPLETED|Overall Study||22
10879209|NCT04058054|12045061|FG000|NOT COMPLETED|Overall Study||0
10879210|NCT04058054|12045062|FG001|NOT COMPLETED|Overall Study||0
10879211|NCT04058054|12045063|FG002|NOT COMPLETED|Overall Study||0
10879212|NCT04058054|12045064|FG003|NOT COMPLETED|Overall Study||0
10879213|NCT04058054|12045065|FG004|NOT COMPLETED|Overall Study||0
10879214|NCT04057573|12045079|FG000|STARTED|24-Week Double-Blind Period||229
10879215|NCT04057573|12045080|FG001|STARTED|24-Week Double-Blind Period||115
10879216|NCT04057573|12045081|FG002|STARTED|24-Week Double-Blind Period||0
10879217|NCT04057573|12045082|FG003|STARTED|24-Week Double-Blind Period||0
10879218|NCT04057573|12045079|FG000|ITT Population|24-Week Double-Blind Period||229
10879219|NCT04057573|12045080|FG001|ITT Population|24-Week Double-Blind Period||115
10879220|NCT04057573|12045081|FG002|ITT Population|24-Week Double-Blind Period||0
10879221|NCT04057573|12045082|FG003|ITT Population|24-Week Double-Blind Period||0
10879222|NCT04057573|12045079|FG000|ITT Population, Excluding Non-compliant Site|24-Week Double-Blind Period||222
10879223|NCT04057573|12045080|FG001|ITT Population, Excluding Non-compliant Site|24-Week Double-Blind Period||109
10879224|NCT04057573|12045081|FG002|ITT Population, Excluding Non-compliant Site|24-Week Double-Blind Period||0
10879225|NCT04057573|12045082|FG003|ITT Population, Excluding Non-compliant Site|24-Week Double-Blind Period||0
10879226|NCT04057573|12045079|FG000|COMPLETED|24-Week Double-Blind Period||199
10879227|NCT04057573|12045080|FG001|COMPLETED|24-Week Double-Blind Period||98
10879228|NCT04057573|12045081|FG002|COMPLETED|24-Week Double-Blind Period||0
10879229|NCT04057573|12045082|FG003|COMPLETED|24-Week Double-Blind Period||0
10879230|NCT04057573|12045079|FG000|NOT COMPLETED|24-Week Double-Blind Period||30
10879231|NCT04057573|12045080|FG001|NOT COMPLETED|24-Week Double-Blind Period||17
10879232|NCT04057573|12045081|FG002|NOT COMPLETED|24-Week Double-Blind Period||0
10879233|NCT04057573|12045082|FG003|NOT COMPLETED|24-Week Double-Blind Period||0
10879234|NCT04057573|12045079|FG000|STARTED|28-Week Treatment Extension Period||0
10879235|NCT04057573|12045080|FG001|STARTED|28-Week Treatment Extension Period||0
10879236|NCT04057573|12045081|FG002|STARTED|28-Week Treatment Extension Period|Treatment-Extension Evaluable Population: all participants who applied ruxolitinib cream at least once in the TE period|199
10879237|NCT04057573|12045082|FG003|STARTED|28-Week Treatment Extension Period||98
10879238|NCT04057573|12045079|FG000|COMPLETED|28-Week Treatment Extension Period||0
10879239|NCT04057573|12045080|FG001|COMPLETED|28-Week Treatment Extension Period||0
10879240|NCT04057573|12045081|FG002|COMPLETED|28-Week Treatment Extension Period||178
10879241|NCT04057573|12045082|FG003|COMPLETED|28-Week Treatment Extension Period||79
10879242|NCT04057573|12045079|FG000|NOT COMPLETED|28-Week Treatment Extension Period||0
10879243|NCT04057573|12045080|FG001|NOT COMPLETED|28-Week Treatment Extension Period||0
10879244|NCT04057573|12045081|FG002|NOT COMPLETED|28-Week Treatment Extension Period||21
10879245|NCT04057573|12045082|FG003|NOT COMPLETED|28-Week Treatment Extension Period||19
10879246|NCT04057196|12045093|FG000|STARTED|Overall Study||30
10879247|NCT04057196|12045093|FG000|COMPLETED|Overall Study||24
10879248|NCT04057196|12045093|FG000|NOT COMPLETED|Overall Study||6
10879249|NCT04053387|12045097|FG000|STARTED|Overall Study||763
10879250|NCT04053387|12045097|FG000|COMPLETED|Overall Study||531
10879251|NCT04053387|12045097|FG000|NOT COMPLETED|Overall Study||232
10879252|NCT04052425|12045104|FG000|STARTED|24-Week Double-blind Period||221
10879253|NCT04052425|12045105|FG001|STARTED|24-Week Double-blind Period||109
10879254|NCT04052425|12045106|FG002|STARTED|24-Week Double-blind Period||0
10879255|NCT04052425|12045107|FG003|STARTED|24-Week Double-blind Period||0
10879256|NCT04052425|12045104|FG000|COMPLETED|24-Week Double-blind Period||193
10879257|NCT04052425|12045105|FG001|COMPLETED|24-Week Double-blind Period||90
10879258|NCT04052425|12045106|FG002|COMPLETED|24-Week Double-blind Period||0
10879259|NCT04052425|12045107|FG003|COMPLETED|24-Week Double-blind Period||0
10879260|NCT04052425|12045104|FG000|NOT COMPLETED|24-Week Double-blind Period||28
10879261|NCT04052425|12045105|FG001|NOT COMPLETED|24-Week Double-blind Period||19
10879262|NCT04052425|12045106|FG002|NOT COMPLETED|24-Week Double-blind Period||0
10879263|NCT04052425|12045107|FG003|NOT COMPLETED|24-Week Double-blind Period||0
10879264|NCT04052425|12045104|FG000|STARTED|28-Week Treatment-Extension Period||0
10879265|NCT04052425|12045105|FG001|STARTED|28-Week Treatment-Extension Period||0
10879266|NCT04052425|12045106|FG002|STARTED|28-Week Treatment-Extension Period|Treatment-Extension Evaluable Population: all participants who applied ruxolitinib cream at least once in the TE period|193
10879267|NCT04052425|12045107|FG003|STARTED|28-Week Treatment-Extension Period||90
10879268|NCT04052425|12045104|FG000|COMPLETED|28-Week Treatment-Extension Period||0
10879269|NCT04052425|12045105|FG001|COMPLETED|28-Week Treatment-Extension Period||0
10879270|NCT04052425|12045106|FG002|COMPLETED|28-Week Treatment-Extension Period||174
10879271|NCT04052425|12045107|FG003|COMPLETED|28-Week Treatment-Extension Period||80
10879272|NCT04052425|12045104|FG000|NOT COMPLETED|28-Week Treatment-Extension Period||0
10879273|NCT04052425|12045105|FG001|NOT COMPLETED|28-Week Treatment-Extension Period||0
10879274|NCT04052425|12045106|FG002|NOT COMPLETED|28-Week Treatment-Extension Period||19
10879275|NCT04052425|12045107|FG003|NOT COMPLETED|28-Week Treatment-Extension Period||10
10879276|NCT04051957|12045119|FG000|STARTED|Overall Study||7
10879277|NCT04051957|12045120|FG001|STARTED|Overall Study||2
10879278|NCT04051957|12045119|FG000|COMPLETED|Overall Study||5
10879279|NCT04051957|12045120|FG001|COMPLETED|Overall Study||2
10879280|NCT04051957|12045119|FG000|NOT COMPLETED|Overall Study||2
10879281|NCT04051957|12045120|FG001|NOT COMPLETED|Overall Study||0
10879282|NCT04049617|12045132|FG000|STARTED|Overall Study||3
10879283|NCT04049617|12045133|FG001|STARTED|Overall Study||3
10879284|NCT04049617|12045134|FG002|STARTED|Overall Study||6
10879285|NCT04049617|12045135|FG003|STARTED|Overall Study||3
10879286|NCT04049617|12045136|FG004|STARTED|Overall Study||2
10879287|NCT04049617|12045137|FG005|STARTED|Overall Study||1
10879288|NCT04049617|12045132|FG000|COMPLETED|Overall Study||3
10879289|NCT04049617|12045133|FG001|COMPLETED|Overall Study||3
10879290|NCT04049617|12045134|FG002|COMPLETED|Overall Study||5
10879291|NCT04049617|12045135|FG003|COMPLETED|Overall Study||1
10879292|NCT04049617|12045136|FG004|COMPLETED|Overall Study||2
10879293|NCT04049617|12045137|FG005|COMPLETED|Overall Study||0
10879294|NCT04049617|12045132|FG000|NOT COMPLETED|Overall Study||0
10879295|NCT04049617|12045133|FG001|NOT COMPLETED|Overall Study||0
10879296|NCT04049617|12045134|FG002|NOT COMPLETED|Overall Study||1
10879297|NCT04049617|12045135|FG003|NOT COMPLETED|Overall Study||2
10879298|NCT04049617|12045136|FG004|NOT COMPLETED|Overall Study||0
10879299|NCT04049617|12045137|FG005|NOT COMPLETED|Overall Study||1
10879300|NCT04048863|12045156|FG000|STARTED|Overall Study||43
10879301|NCT04048863|12045157|FG001|STARTED|Overall Study||0
10879302|NCT04048863|12045158|FG002|STARTED|Overall Study||0
10879303|NCT04048863|12045159|FG003|STARTED|Overall Study||0
10879304|NCT04048863|12045156|FG000|COMPLETED|Overall Study||43
10879305|NCT04048863|12045157|FG001|COMPLETED|Overall Study||0
10879306|NCT04048863|12045158|FG002|COMPLETED|Overall Study||0
10879307|NCT04048863|12045159|FG003|COMPLETED|Overall Study||0
10879308|NCT04048863|12045156|FG000|NOT COMPLETED|Overall Study||0
10879309|NCT04048863|12045157|FG001|NOT COMPLETED|Overall Study||0
10879310|NCT04048863|12045158|FG002|NOT COMPLETED|Overall Study||0
10879311|NCT04048863|12045159|FG003|NOT COMPLETED|Overall Study||0
10879312|NCT04047446|12045171|FG000|STARTED|Overall Study||56
10879313|NCT04047446|12045172|FG001|STARTED|Overall Study||56
10879314|NCT04047446|12045171|FG000|COMPLETED|Overall Study||55
10879315|NCT04047446|12045172|FG001|COMPLETED|Overall Study||56
10879316|NCT04047446|12045171|FG000|NOT COMPLETED|Overall Study||1
10879317|NCT04047446|12045172|FG001|NOT COMPLETED|Overall Study||0
10879318|NCT04046263|12045178|FG000|STARTED|Overall Study||17
10879319|NCT04046263|12045178|FG000|COMPLETED|Overall Study||12
10879320|NCT04046263|12045178|FG000|NOT COMPLETED|Overall Study||5
10879321|NCT04041869|12045182|FG000|STARTED|Overall Study||68
10879322|NCT04041869|12045182|FG000|COMPLETED|Overall Study||54
10879323|NCT04041869|12045182|FG000|NOT COMPLETED|Overall Study||14
10879324|NCT04040621|12045187|FG000|STARTED|Overall Study||4
10879325|NCT04040621|12045187|FG000|COMPLETED|Overall Study||4
10879326|NCT04040621|12045187|FG000|NOT COMPLETED|Overall Study||0
10879327|NCT04030598|12045194|FG000|STARTED|Overall Study||6
10879328|NCT04030598|12045195|FG001|STARTED|Overall Study||14
10879329|NCT04030598|12045196|FG002|STARTED|Overall Study||3
10879330|NCT04030598|12045194|FG000|COMPLETED|Overall Study||6
10879331|NCT04030598|12045195|FG001|COMPLETED|Overall Study||13
10879332|NCT04030598|12045196|FG002|COMPLETED|Overall Study||3
10879333|NCT04030598|12045194|FG000|NOT COMPLETED|Overall Study||0
10879334|NCT04030598|12045195|FG001|NOT COMPLETED|Overall Study||1
10879335|NCT04030598|12045196|FG002|NOT COMPLETED|Overall Study||0
10879336|NCT04027439|12045210|FG000|STARTED|Part A (R, PC, PG) Single Dose||6
10879337|NCT04027439|12045211|FG001|STARTED|Part A (R, PC, PG) Single Dose||6
10879338|NCT04027439|12045212|FG002|STARTED|Part A (R, PC, PG) Single Dose||7
10879339|NCT04027439|12045213|FG003|STARTED|Part A (R, PC, PG) Single Dose||6
10879340|NCT04027439|12045214|FG004|STARTED|Part A (R, PC, PG) Single Dose||6
10879341|NCT04027439|12045215|FG005|STARTED|Part A (R, PC, PG) Single Dose||6
10879342|NCT04027439|12045216|FG006|STARTED|Part A (R, PC, PG) Single Dose||0
10879343|NCT04027439|12045217|FG007|STARTED|Part A (R, PC, PG) Single Dose||0
10879344|NCT04027439|12045218|FG008|STARTED|Part A (R, PC, PG) Single Dose||0
10879345|NCT04027439|12045219|FG009|STARTED|Part A (R, PC, PG) Single Dose||0
10879346|NCT04027439|12045220|FG010|STARTED|Part A (R, PC, PG) Single Dose||0
10879347|NCT04027439|12045221|FG011|STARTED|Part A (R, PC, PG) Single Dose||0
10879348|NCT04027439|12045222|FG012|STARTED|Part A (R, PC, PG) Single Dose||0
10879349|NCT04027439|12045223|FG013|STARTED|Part A (R, PC, PG) Single Dose||0
10879350|NCT04027439|12045224|FG014|STARTED|Part A (R, PC, PG) Single Dose||0
10879351|NCT04027439|12045225|FG015|STARTED|Part A (R, PC, PG) Single Dose||0
10879352|NCT04027439|12045210|FG000|COMPLETED|Part A (R, PC, PG) Single Dose||6
10879353|NCT04027439|12045211|FG001|COMPLETED|Part A (R, PC, PG) Single Dose||6
10879354|NCT04027439|12045212|FG002|COMPLETED|Part A (R, PC, PG) Single Dose||7
10879355|NCT04027439|12045213|FG003|COMPLETED|Part A (R, PC, PG) Single Dose||6
10879356|NCT04027439|12045214|FG004|COMPLETED|Part A (R, PC, PG) Single Dose||6
10879357|NCT04027439|12045215|FG005|COMPLETED|Part A (R, PC, PG) Single Dose||6
10879358|NCT04027439|12045216|FG006|COMPLETED|Part A (R, PC, PG) Single Dose||0
10879359|NCT04027439|12045217|FG007|COMPLETED|Part A (R, PC, PG) Single Dose||0
10879360|NCT04027439|12045218|FG008|COMPLETED|Part A (R, PC, PG) Single Dose||0
10879361|NCT04027439|12045219|FG009|COMPLETED|Part A (R, PC, PG) Single Dose||0
10879362|NCT04027439|12045220|FG010|COMPLETED|Part A (R, PC, PG) Single Dose||0
10879363|NCT04027439|12045221|FG011|COMPLETED|Part A (R, PC, PG) Single Dose||0
10879364|NCT04027439|12045222|FG012|COMPLETED|Part A (R, PC, PG) Single Dose||0
10879365|NCT04027439|12045223|FG013|COMPLETED|Part A (R, PC, PG) Single Dose||0
10879366|NCT04027439|12045224|FG014|COMPLETED|Part A (R, PC, PG) Single Dose||0
10879367|NCT04027439|12045225|FG015|COMPLETED|Part A (R, PC, PG) Single Dose||0
10879368|NCT04027439|12045210|FG000|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879369|NCT04027439|12045211|FG001|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879370|NCT04027439|12045212|FG002|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879371|NCT04027439|12045213|FG003|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879372|NCT04027439|12045214|FG004|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879373|NCT04027439|12045215|FG005|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879374|NCT04027439|12045216|FG006|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879375|NCT04027439|12045217|FG007|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879376|NCT04027439|12045218|FG008|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879377|NCT04027439|12045219|FG009|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879378|NCT04027439|12045220|FG010|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879379|NCT04027439|12045221|FG011|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879380|NCT04027439|12045222|FG012|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879381|NCT04027439|12045223|FG013|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879382|NCT04027439|12045224|FG014|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879383|NCT04027439|12045225|FG015|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879384|NCT04027439|12045210|FG000|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879385|NCT04027439|12045211|FG001|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879386|NCT04027439|12045212|FG002|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879387|NCT04027439|12045213|FG003|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879388|NCT04027439|12045214|FG004|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879389|NCT04027439|12045215|FG005|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879390|NCT04027439|12045216|FG006|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4
10879391|NCT04027439|12045217|FG007|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3
10879392|NCT04027439|12045218|FG008|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4
10879393|NCT04027439|12045219|FG009|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3
10879394|NCT04027439|12045220|FG010|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4
10879395|NCT04027439|12045221|FG011|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3
10879396|NCT04027439|12045222|FG012|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3
10879397|NCT04027439|12045223|FG013|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4
10879398|NCT04027439|12045224|FG014|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4
10879399|NCT04027439|12045225|FG015|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3
10879400|NCT04027439|12045210|FG000|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879401|NCT04027439|12045211|FG001|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879402|NCT04027439|12045212|FG002|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879403|NCT04027439|12045213|FG003|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879404|NCT04027439|12045214|FG004|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879405|NCT04027439|12045215|FG005|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879406|NCT04027439|12045216|FG006|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4
10879407|NCT04027439|12045217|FG007|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day|1 patient discontinued in part b/period 2 and another in part b/period 3.|1
10879408|NCT04027439|12045218|FG008|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4
10879409|NCT04027439|12045219|FG009|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||3
10879410|NCT04027439|12045220|FG010|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4
10879411|NCT04027439|12045221|FG011|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||3
10879412|NCT04027439|12045222|FG012|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||3
10879413|NCT04027439|12045223|FG013|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4
10879414|NCT04027439|12045224|FG014|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4
10879415|NCT04027439|12045225|FG015|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||3
10879416|NCT04027439|12045210|FG000|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879417|NCT04027439|12045211|FG001|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879418|NCT04027439|12045212|FG002|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879419|NCT04027439|12045213|FG003|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879420|NCT04027439|12045214|FG004|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879421|NCT04027439|12045215|FG005|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879422|NCT04027439|12045216|FG006|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879423|NCT04027439|12045217|FG007|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||2
10879424|NCT04027439|12045218|FG008|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879425|NCT04027439|12045219|FG009|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879426|NCT04027439|12045220|FG010|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879427|NCT04027439|12045221|FG011|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879428|NCT04027439|12045222|FG012|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879429|NCT04027439|12045223|FG013|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879430|NCT04027439|12045224|FG014|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879431|NCT04027439|12045225|FG015|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879432|NCT04026568|12045251|FG000|STARTED|Overall Study||0
10879433|NCT04026568|12045252|FG001|STARTED|Overall Study||1
10879434|NCT04026568|12045251|FG000|COMPLETED|Overall Study||0
10879435|NCT04026568|12045252|FG001|COMPLETED|Overall Study||0
10879436|NCT04026568|12045251|FG000|NOT COMPLETED|Overall Study||0
10879437|NCT04026568|12045252|FG001|NOT COMPLETED|Overall Study||1
10879438|NCT04025632|12045260|FG000|STARTED|Overall Study||15
10879439|NCT04025632|12045261|FG001|STARTED|Overall Study||12
10879440|NCT04025632|12045260|FG000|Completed Main Portion|Overall Study||15
10879441|NCT04025632|12045261|FG001|Completed Main Portion|Overall Study||12
10879442|NCT04025632|12045260|FG000|Started Main Portion Safety Follow-up|Overall Study||2
10879443|NCT04025632|12045261|FG001|Started Main Portion Safety Follow-up|Overall Study||0
10879444|NCT04025632|12045260|FG000|Completed Main Portion Safety Follow-up|Overall Study||0
10879445|NCT04025632|12045261|FG001|Completed Main Portion Safety Follow-up|Overall Study||0
10879446|NCT04025632|12045260|FG000|Started Extension Portion|Overall Study||13
10879447|NCT04025632|12045261|FG001|Started Extension Portion|Overall Study||12
10879448|NCT04025632|12045260|FG000|COMPLETED|Overall Study||0
10879449|NCT04025632|12045261|FG001|COMPLETED|Overall Study||0
10879450|NCT04025632|12045260|FG000|NOT COMPLETED|Overall Study||15
10879451|NCT04025632|12045261|FG001|NOT COMPLETED|Overall Study||12
10879452|NCT04024891|12045272|FG000|STARTED|Overall Study||16
10879453|NCT04024891|12045273|FG001|STARTED|Overall Study||16
10879454|NCT04024891|12045272|FG000|COMPLETED|Overall Study||16
10879455|NCT04024891|12045273|FG001|COMPLETED|Overall Study||15
10879456|NCT04024891|12045272|FG000|NOT COMPLETED|Overall Study||0
10879457|NCT04024891|12045273|FG001|NOT COMPLETED|Overall Study||1
10879458|NCT04019561|12045282|FG000|STARTED|Overall Study||25
10879459|NCT04019561|12045283|FG001|STARTED|Overall Study||25
10879460|NCT04019561|12045284|FG002|STARTED|Overall Study||24
10879461|NCT04019561|12045282|FG000|COMPLETED|Overall Study||21
10879462|NCT04019561|12045283|FG001|COMPLETED|Overall Study||23
10879463|NCT04019561|12045284|FG002|COMPLETED|Overall Study||19
10879464|NCT04019561|12045282|FG000|NOT COMPLETED|Overall Study||4
10879465|NCT04019561|12045283|FG001|NOT COMPLETED|Overall Study||2
10879466|NCT04019561|12045284|FG002|NOT COMPLETED|Overall Study||5
10879467|NCT04015518|12045297|FG000|STARTED|Overall Study||43
10879468|NCT04015518|12045298|FG001|STARTED|Overall Study||22
10879469|NCT04015518|12045299|FG002|STARTED|Overall Study||21
10879470|NCT04015518|12045300|FG003|STARTED|Overall Study||22
10879471|NCT04015518|12045301|FG004|STARTED|Overall Study||44
10879472|NCT04015518|12045297|FG000|Full Analysis Set (FAS)|Overall Study||43
10879473|NCT04015518|12045298|FG001|Full Analysis Set (FAS)|Overall Study||22
10879474|NCT04015518|12045299|FG002|Full Analysis Set (FAS)|Overall Study||21
10879475|NCT04015518|12045300|FG003|Full Analysis Set (FAS)|Overall Study||22
10879476|NCT04015518|12045301|FG004|Full Analysis Set (FAS)|Overall Study||44
10879477|NCT04015518|12045297|FG000|COMPLETED|Overall Study||32
10879478|NCT04015518|12045298|FG001|COMPLETED|Overall Study||19
10879479|NCT04015518|12045299|FG002|COMPLETED|Overall Study||18
10879480|NCT04015518|12045300|FG003|COMPLETED|Overall Study||17
10879481|NCT04015518|12045301|FG004|COMPLETED|Overall Study||32
10879482|NCT04015518|12045297|FG000|NOT COMPLETED|Overall Study||11
10879483|NCT04015518|12045298|FG001|NOT COMPLETED|Overall Study||3
10879484|NCT04015518|12045299|FG002|NOT COMPLETED|Overall Study||3
10879485|NCT04015518|12045300|FG003|NOT COMPLETED|Overall Study||5
10879486|NCT04015518|12045301|FG004|NOT COMPLETED|Overall Study||12
10879487|NCT04014075|12045316|FG000|STARTED|Overall Study||79
10879488|NCT04014075|12045316|FG000|COMPLETED|Overall Study||23
10879489|NCT04014075|12045316|FG000|NOT COMPLETED|Overall Study||56
10879490|NCT04005859|12045322|FG000|STARTED|Overall Study||32
10879491|NCT04005859|12045323|FG001|STARTED|Overall Study||29
10879492|NCT04005859|12045322|FG000|COMPLETED|Overall Study||28
10879493|NCT04005859|12045323|FG001|COMPLETED|Overall Study||25
10879494|NCT04005859|12045322|FG000|NOT COMPLETED|Overall Study||4
10879495|NCT04005859|12045323|FG001|NOT COMPLETED|Overall Study||4
10879496|NCT04003155|12045332|FG000|STARTED|Double-Blind (DB) Period (12 Weeks)||175
10879497|NCT04003155|12045333|FG001|STARTED|Double-Blind (DB) Period (12 Weeks)||176
10879498|NCT04003155|12045334|FG002|STARTED|Double-Blind (DB) Period (12 Weeks)||176
10879499|NCT04003155|12045335|FG003|STARTED|Double-Blind (DB) Period (12 Weeks)||0
10879500|NCT04003155|12045336|FG004|STARTED|Double-Blind (DB) Period (12 Weeks)||0
10879501|NCT04003155|12045332|FG000|Full Analysis Set|Double-Blind (DB) Period (12 Weeks)||175
10879502|NCT04003155|12045333|FG001|Full Analysis Set|Double-Blind (DB) Period (12 Weeks)||173
10879576|NCT03976401|12045404|FG003|COMPLETED|Overall Study||19
10879503|NCT04003155|12045334|FG002|Full Analysis Set|Double-Blind (DB) Period (12 Weeks)||174
10879504|NCT04003155|12045335|FG003|Full Analysis Set|Double-Blind (DB) Period (12 Weeks)||0
10879505|NCT04003155|12045336|FG004|Full Analysis Set|Double-Blind (DB) Period (12 Weeks)||0
10879506|NCT04003155|12045332|FG000|Safety Analysis Set|Double-Blind (DB) Period (12 Weeks)||175
10879507|NCT04003155|12045333|FG001|Safety Analysis Set|Double-Blind (DB) Period (12 Weeks)|1 participant who was randomized to fezolinetant 45 mg received fezolinetant 30 mg during the 12-week study period. This participant was included in the fezolinetant 30 mg group for the Safety Analysis Set|174
10879508|NCT04003155|12045334|FG002|Safety Analysis Set|Double-Blind (DB) Period (12 Weeks)||173
10879509|NCT04003155|12045335|FG003|Safety Analysis Set|Double-Blind (DB) Period (12 Weeks)||0
10879510|NCT04003155|12045336|FG004|Safety Analysis Set|Double-Blind (DB) Period (12 Weeks)||0
10879511|NCT04003155|12045332|FG000|Treated|Double-Blind (DB) Period (12 Weeks)||175
10879512|NCT04003155|12045333|FG001|Treated|Double-Blind (DB) Period (12 Weeks)||173
10879513|NCT04003155|12045334|FG002|Treated|Double-Blind (DB) Period (12 Weeks)|1 participant who was randomized in this arm actually received 30mg fezolinetant.|174
10879514|NCT04003155|12045335|FG003|Treated|Double-Blind (DB) Period (12 Weeks)||0
10879515|NCT04003155|12045336|FG004|Treated|Double-Blind (DB) Period (12 Weeks)||0
10879516|NCT04003155|12045332|FG000|COMPLETED|Double-Blind (DB) Period (12 Weeks)||152
10879517|NCT04003155|12045333|FG001|COMPLETED|Double-Blind (DB) Period (12 Weeks)||142
10879518|NCT04003155|12045334|FG002|COMPLETED|Double-Blind (DB) Period (12 Weeks)||161
10879519|NCT04003155|12045335|FG003|COMPLETED|Double-Blind (DB) Period (12 Weeks)||0
10879520|NCT04003155|12045336|FG004|COMPLETED|Double-Blind (DB) Period (12 Weeks)||0
10879521|NCT04003155|12045332|FG000|NOT COMPLETED|Double-Blind (DB) Period (12 Weeks)||23
10879522|NCT04003155|12045333|FG001|NOT COMPLETED|Double-Blind (DB) Period (12 Weeks)||34
10879523|NCT04003155|12045334|FG002|NOT COMPLETED|Double-Blind (DB) Period (12 Weeks)||15
10879524|NCT04003155|12045335|FG003|NOT COMPLETED|Double-Blind (DB) Period (12 Weeks)||0
10879525|NCT04003155|12045336|FG004|NOT COMPLETED|Double-Blind (DB) Period (12 Weeks)||0
10879526|NCT04003155|12045332|FG000|STARTED|Extension Period (EP) (40 Weeks)|Participants who received placebo in double-blind period were moved to fezolinetant 30/45 mg arms in extension treatment period|0
10879527|NCT04003155|12045333|FG001|STARTED|Extension Period (EP) (40 Weeks)|"1 participant who completed DB discontinued study before entering EP.~1 participant who was randomized to 45 mg but received 30 mg in DB, was then moved to 30mg in EP."|142
10879528|NCT04003155|12045334|FG002|STARTED|Extension Period (EP) (40 Weeks)|Two participants who completed double-blind period discontinued the study before entering the extension treatment period|158
10879529|NCT04003155|12045335|FG003|STARTED|Extension Period (EP) (40 Weeks)|Participants who received placebo in double-blind period were randomized to fezolinetant 30 mg arms|76
10879530|NCT04003155|12045336|FG004|STARTED|Extension Period (EP) (40 Weeks)|Participants who received placebo in double-blind period were randomized to fezolinetant 45 mg arms|76
10879531|NCT04003155|12045332|FG000|COMPLETED|Extension Period (EP) (40 Weeks)||0
10879532|NCT04003155|12045333|FG001|COMPLETED|Extension Period (EP) (40 Weeks)||124
10879533|NCT04003155|12045334|FG002|COMPLETED|Extension Period (EP) (40 Weeks)||143
10879534|NCT04003155|12045335|FG003|COMPLETED|Extension Period (EP) (40 Weeks)||62
10879535|NCT04003155|12045336|FG004|COMPLETED|Extension Period (EP) (40 Weeks)||67
10879536|NCT04003155|12045332|FG000|NOT COMPLETED|Extension Period (EP) (40 Weeks)||0
10879537|NCT04003155|12045333|FG001|NOT COMPLETED|Extension Period (EP) (40 Weeks)||18
10879538|NCT04003155|12045334|FG002|NOT COMPLETED|Extension Period (EP) (40 Weeks)||15
10879539|NCT04003155|12045335|FG003|NOT COMPLETED|Extension Period (EP) (40 Weeks)||14
10879540|NCT04003155|12045336|FG004|NOT COMPLETED|Extension Period (EP) (40 Weeks)||9
10879541|NCT04000399|12045356|FG000|STARTED|Overall Study||38
10879542|NCT04000399|12045357|FG001|STARTED|Overall Study||5
10879543|NCT04000399|12045356|FG000|COMPLETED|Overall Study||38
10879544|NCT04000399|12045357|FG001|COMPLETED|Overall Study||5
10879545|NCT04000399|12045356|FG000|NOT COMPLETED|Overall Study||0
10879546|NCT04000399|12045357|FG001|NOT COMPLETED|Overall Study||0
10879547|NCT03999892|12045366|FG000|STARTED|Overall Study||17
10879548|NCT03999892|12045366|FG000|COMPLETED|Overall Study||16
10879549|NCT03999892|12045366|FG000|NOT COMPLETED|Overall Study||1
10879550|NCT03988166|12045370|FG000|STARTED|Overall Study||150
10879551|NCT03988166|12045370|FG000|COMPLETED|Overall Study||147
10879552|NCT03988166|12045370|FG000|NOT COMPLETED|Overall Study||3
10879553|NCT03980808|12045379|FG000|STARTED|Overall Study||24
10879554|NCT03980808|12045380|FG001|STARTED|Overall Study||17
10879555|NCT03980808|12045379|FG000|Phase 2 - 30-day Follow-up|Overall Study||24
10879556|NCT03980808|12045380|FG001|Phase 2 - 30-day Follow-up|Overall Study||17
10879557|NCT03980808|12045379|FG000|COMPLETED|Overall Study||22
10879558|NCT03980808|12045380|FG001|COMPLETED|Overall Study||15
10879559|NCT03980808|12045379|FG000|NOT COMPLETED|Overall Study||2
10879560|NCT03980808|12045380|FG001|NOT COMPLETED|Overall Study||2
10879561|NCT03977454|12045388|FG000|STARTED|Overall Study||97
10879562|NCT03977454|12045389|FG001|STARTED|Overall Study||95
10879563|NCT03977454|12045388|FG000|COMPLETED|Overall Study||95
10879564|NCT03977454|12045389|FG001|COMPLETED|Overall Study||93
10879565|NCT03977454|12045388|FG000|NOT COMPLETED|Overall Study||2
10879566|NCT03977454|12045389|FG001|NOT COMPLETED|Overall Study||2
10879567|NCT03976401|12045401|FG000|STARTED|Overall Study||19
10879568|NCT03976401|12045402|FG001|STARTED|Overall Study||20
10879569|NCT03976401|12045403|FG002|STARTED|Overall Study||20
10879570|NCT03976401|12045404|FG003|STARTED|Overall Study||21
10879571|NCT03976401|12045405|FG004|STARTED|Overall Study||20
10879572|NCT03976401|12045406|FG005|STARTED|Overall Study||10
10879573|NCT03976401|12045401|FG000|COMPLETED|Overall Study||16
10879574|NCT03976401|12045402|FG001|COMPLETED|Overall Study||16
10879575|NCT03976401|12045403|FG002|COMPLETED|Overall Study||15
10879577|NCT03976401|12045405|FG004|COMPLETED|Overall Study||19
10879578|NCT03976401|12045406|FG005|COMPLETED|Overall Study||9
10879579|NCT03976401|12045401|FG000|NOT COMPLETED|Overall Study||3
10879580|NCT03976401|12045402|FG001|NOT COMPLETED|Overall Study||4
10879581|NCT03976401|12045403|FG002|NOT COMPLETED|Overall Study||5
10879582|NCT03976401|12045404|FG003|NOT COMPLETED|Overall Study||2
10879583|NCT03976401|12045405|FG004|NOT COMPLETED|Overall Study||1
10879584|NCT03976401|12045406|FG005|NOT COMPLETED|Overall Study||1
10879585|NCT03967444|12045422|FG000|STARTED|Overall Study||19
10879586|NCT03967444|12045423|FG001|STARTED|Overall Study||40
10879587|NCT03967444|12045422|FG000|COMPLETED|Overall Study||18
10879588|NCT03967444|12045423|FG001|COMPLETED|Overall Study||38
10879589|NCT03967444|12045422|FG000|NOT COMPLETED|Overall Study||1
10879590|NCT03967444|12045423|FG001|NOT COMPLETED|Overall Study||2
10879591|NCT03966885|12045431|FG000|STARTED|Overall Study||78
10879592|NCT03966885|12045432|FG001|STARTED|Overall Study||82
10879593|NCT03966885|12045431|FG000|COMPLETED|Overall Study||56
10879594|NCT03966885|12045432|FG001|COMPLETED|Overall Study||62
10879595|NCT03966885|12045431|FG000|NOT COMPLETED|Overall Study||22
10879596|NCT03966885|12045432|FG001|NOT COMPLETED|Overall Study||20
10879597|NCT03964974|12045441|FG000|STARTED|Overall Study||30
10879598|NCT03964974|12045442|FG001|STARTED|Overall Study||27
10879599|NCT03964974|12045441|FG000|Assigned and Received Intervention|Overall Study||26
10879600|NCT03964974|12045442|FG001|Assigned and Received Intervention|Overall Study||21
10879601|NCT03964974|12045441|FG000|8 Week Follow Up|Overall Study||26
10879602|NCT03964974|12045442|FG001|8 Week Follow Up|Overall Study||22
10879603|NCT03964974|12045441|FG000|16 Week Follow Up|Overall Study||27
10879604|NCT03964974|12045442|FG001|16 Week Follow Up|Overall Study||22
10879605|NCT03964974|12045441|FG000|COMPLETED|Overall Study||27
10879606|NCT03964974|12045442|FG001|COMPLETED|Overall Study||22
10879607|NCT03964974|12045441|FG000|NOT COMPLETED|Overall Study||3
10879608|NCT03964974|12045442|FG001|NOT COMPLETED|Overall Study||5
10879609|NCT03963232|12045450|FG000|STARTED|Overall Study||259
10879610|NCT03963232|12045451|FG001|STARTED|Overall Study||261
10879611|NCT03963232|12045450|FG000|Received at Least One Dose of Study Drug|Overall Study||259
10879612|NCT03963232|12045451|FG001|Received at Least One Dose of Study Drug|Overall Study||261
10879613|NCT03963232|12045450|FG000|COMPLETED|Overall Study||242
10879614|NCT03963232|12045451|FG001|COMPLETED|Overall Study||245
10879615|NCT03963232|12045450|FG000|NOT COMPLETED|Overall Study||17
10879616|NCT03963232|12045451|FG001|NOT COMPLETED|Overall Study||16
10879617|NCT03960957|12045460|FG000|STARTED|Overall Study||224
10879618|NCT03960957|12045461|FG001|STARTED|Overall Study||77
10879619|NCT03960957|12045460|FG000|COMPLETED|Overall Study||216
10879620|NCT03960957|12045461|FG001|COMPLETED|Overall Study||71
10879621|NCT03960957|12045460|FG000|NOT COMPLETED|Overall Study||8
10879622|NCT03960957|12045461|FG001|NOT COMPLETED|Overall Study||6
10879623|NCT03958331|12045470|FG000|STARTED|Overall Study||21
10879624|NCT03958331|12045471|FG001|STARTED|Overall Study||19
10879625|NCT03958331|12045472|FG002|STARTED|Overall Study||64
10879626|NCT03958331|12045470|FG000|COMPLETED|Overall Study||14
10879627|NCT03958331|12045471|FG001|COMPLETED|Overall Study||17
10879628|NCT03958331|12045472|FG002|COMPLETED|Overall Study||47
10879629|NCT03958331|12045470|FG000|NOT COMPLETED|Overall Study||7
10879630|NCT03958331|12045471|FG001|NOT COMPLETED|Overall Study||2
10879631|NCT03958331|12045472|FG002|NOT COMPLETED|Overall Study||17
10879632|NCT03955471|12045478|FG000|STARTED|Overall Study||41
10879633|NCT03955471|12045478|FG000|COMPLETED|Overall Study||1
10879634|NCT03955471|12045478|FG000|NOT COMPLETED|Overall Study||40
10879635|NCT03950674|12045484|FG000|STARTED|Overall Study||25
10879636|NCT03950674|12045485|FG001|STARTED|Overall Study||15
10879637|NCT03950674|12045484|FG000|Treated|Overall Study||25
10879638|NCT03950674|12045485|FG001|Treated|Overall Study||15
10879639|NCT03950674|12045484|FG000|Switched to Pembrolizumab|Overall Study||0
10879640|NCT03950674|12045485|FG001|Switched to Pembrolizumab|Overall Study||4
10879641|NCT03950674|12045484|FG000|COMPLETED|Overall Study||0
10879642|NCT03950674|12045485|FG001|COMPLETED|Overall Study||0
10879643|NCT03950674|12045484|FG000|NOT COMPLETED|Overall Study||25
10879644|NCT03950674|12045485|FG001|NOT COMPLETED|Overall Study||15
10879645|NCT03948698|12045492|FG000|STARTED|Overall Study||4749072
10879646|NCT03948698|12045492|FG000|COMPLETED|Overall Study||4749072
10879647|NCT03948698|12045492|FG000|NOT COMPLETED|Overall Study||0
10879648|NCT03948581|12045498|FG000|STARTED|Overall Study||51
10879649|NCT03948581|12045499|FG001|STARTED|Overall Study||51
10879650|NCT03948581|12045498|FG000|COMPLETED|Overall Study||51
10879651|NCT03948581|12045499|FG001|COMPLETED|Overall Study||50
10879652|NCT03948581|12045498|FG000|NOT COMPLETED|Overall Study||0
10879653|NCT03948581|12045499|FG001|NOT COMPLETED|Overall Study||1
10879654|NCT03943290|12045514|FG000|STARTED|Overall Study||7
10879655|NCT03943290|12045515|FG001|STARTED|Overall Study||1
10879656|NCT03943290|12045516|FG002|STARTED|Overall Study||13
10879657|NCT03943290|12045517|FG003|STARTED|Overall Study||6
10879658|NCT03943290|12045518|FG004|STARTED|Overall Study||7
10879659|NCT03943290|12045519|FG005|STARTED|Overall Study||6
10879660|NCT03943290|12045520|FG006|STARTED|Overall Study||6
10879661|NCT03943290|12045521|FG007|STARTED|Overall Study||8
10879662|NCT03943290|12045522|FG008|STARTED|Overall Study||8
10879663|NCT03943290|12045514|FG000|COMPLETED|Overall Study||0
10879664|NCT03943290|12045515|FG001|COMPLETED|Overall Study||0
10879665|NCT03943290|12045516|FG002|COMPLETED|Overall Study||0
10879666|NCT03943290|12045517|FG003|COMPLETED|Overall Study||0
10879667|NCT03943290|12045518|FG004|COMPLETED|Overall Study||0
10879668|NCT03943290|12045519|FG005|COMPLETED|Overall Study||0
10879669|NCT03943290|12045520|FG006|COMPLETED|Overall Study||0
10879670|NCT03943290|12045521|FG007|COMPLETED|Overall Study||0
10879671|NCT03943290|12045522|FG008|COMPLETED|Overall Study||0
10879672|NCT03943290|12045514|FG000|NOT COMPLETED|Overall Study||7
10879673|NCT03943290|12045515|FG001|NOT COMPLETED|Overall Study||1
10879674|NCT03943290|12045516|FG002|NOT COMPLETED|Overall Study||13
10879675|NCT03943290|12045517|FG003|NOT COMPLETED|Overall Study||6
10879676|NCT03943290|12045518|FG004|NOT COMPLETED|Overall Study||7
10879677|NCT03943290|12045519|FG005|NOT COMPLETED|Overall Study||6
10879678|NCT03943290|12045520|FG006|NOT COMPLETED|Overall Study||6
10879679|NCT03943290|12045521|FG007|NOT COMPLETED|Overall Study||8
10879680|NCT03943290|12045522|FG008|NOT COMPLETED|Overall Study||8
10879681|NCT03938545|12045559|FG000|STARTED|Overall Study||18
10879682|NCT03938545|12045560|FG001|STARTED|Overall Study||19
10879683|NCT03938545|12045561|FG002|STARTED|Overall Study||10
10879684|NCT03938545|12045562|FG003|STARTED|Overall Study||18
10879685|NCT03938545|12045559|FG000|COMPLETED|Overall Study||10
10879686|NCT03938545|12045560|FG001|COMPLETED|Overall Study||14
10879687|NCT03938545|12045561|FG002|COMPLETED|Overall Study||7
10879688|NCT03938545|12045562|FG003|COMPLETED|Overall Study||13
10879689|NCT03938545|12045559|FG000|NOT COMPLETED|Overall Study||8
10879690|NCT03938545|12045560|FG001|NOT COMPLETED|Overall Study||5
10879691|NCT03938545|12045561|FG002|NOT COMPLETED|Overall Study||3
10879692|NCT03938545|12045562|FG003|NOT COMPLETED|Overall Study||5
10879693|NCT03933449|12045574|FG000|STARTED|Overall Study||62
10879694|NCT03933449|12045575|FG001|STARTED|Overall Study||61
10879695|NCT03933449|12045574|FG000|Treated|Overall Study||62
10879696|NCT03933449|12045575|FG001|Treated|Overall Study||59
10879697|NCT03933449|12045574|FG000|COMPLETED|Overall Study||0
10879698|NCT03933449|12045575|FG001|COMPLETED|Overall Study||0
10879699|NCT03933449|12045574|FG000|NOT COMPLETED|Overall Study||62
10879700|NCT03933449|12045575|FG001|NOT COMPLETED|Overall Study||61
10879701|NCT03930771|12045581|FG000|STARTED|Overall Study||1
10879702|NCT03930771|12045581|FG000|COMPLETED|Overall Study||1
10879703|NCT03930771|12045581|FG000|NOT COMPLETED|Overall Study||0
10879704|NCT03929224|12045587|FG000|STARTED|Overall Study||8
10879705|NCT03929224|12045588|FG001|STARTED|Overall Study||9
10879706|NCT03929224|12045587|FG000|COMPLETED|Overall Study||8
10879707|NCT03929224|12045588|FG001|COMPLETED|Overall Study||9
10879708|NCT03929224|12045587|FG000|NOT COMPLETED|Overall Study||0
10879709|NCT03929224|12045588|FG001|NOT COMPLETED|Overall Study||0
10879710|NCT03927482|12045598|FG000|STARTED|Overall Study||118
10879711|NCT03927482|12045599|FG001|STARTED|Overall Study||121
10879712|NCT03927482|12045598|FG000|COMPLETED|Overall Study||110
10879713|NCT03927482|12045599|FG001|COMPLETED|Overall Study||115
10879714|NCT03927482|12045598|FG000|NOT COMPLETED|Overall Study||8
10879715|NCT03927482|12045599|FG001|NOT COMPLETED|Overall Study||6
10879716|NCT03926169|12045608|FG000|STARTED|Period A||82
10879717|NCT03926169|12045609|FG001|STARTED|Period A||80
10879718|NCT03926169|12045610|FG002|STARTED|Period A||81
10879719|NCT03926169|12045608|FG000|Never Received Study Drug|Period A||0
10879720|NCT03926169|12045609|FG001|Never Received Study Drug|Period A||0
10879721|NCT03926169|12045610|FG002|Never Received Study Drug|Period A||1
10879722|NCT03926169|12045608|FG000|COMPLETED|Period A||74
10879723|NCT03926169|12045609|FG001|COMPLETED|Period A||70
10879724|NCT03926169|12045610|FG002|COMPLETED|Period A||75
10879725|NCT03926169|12045608|FG000|NOT COMPLETED|Period A||8
10879726|NCT03926169|12045609|FG001|NOT COMPLETED|Period A||10
10879727|NCT03926169|12045610|FG002|NOT COMPLETED|Period A||6
10879728|NCT03926169|12045608|FG000|STARTED|Period B||74
10879729|NCT03926169|12045609|FG001|STARTED|Period B||70
10879730|NCT03926169|12045610|FG002|STARTED|Period B||75
10879731|NCT03926169|12045608|FG000|Entered Period B and Received Study Drug|Period B||74
10879732|NCT03926169|12045609|FG001|Entered Period B and Received Study Drug|Period B||70
10879733|NCT03926169|12045610|FG002|Entered Period B and Received Study Drug|Period B||74
10879734|NCT03926169|12045608|FG000|COMPLETED|Period B||4
10879735|NCT03926169|12045609|FG001|COMPLETED|Period B||7
10879736|NCT03926169|12045610|FG002|COMPLETED|Period B||4
10879737|NCT03926169|12045608|FG000|NOT COMPLETED|Period B||70
10879738|NCT03926169|12045609|FG001|NOT COMPLETED|Period B||63
10879739|NCT03926169|12045610|FG002|NOT COMPLETED|Period B||71
10879740|NCT03922945|12045624|FG000|STARTED|Overall Study||56
10879741|NCT03922945|12045625|FG001|STARTED|Overall Study||54
10879742|NCT03922945|12045626|FG002|STARTED|Overall Study||113
10879743|NCT03922945|12045624|FG000|COMPLETED|Overall Study||29
10879744|NCT03922945|12045625|FG001|COMPLETED|Overall Study||37
10879745|NCT03922945|12045626|FG002|COMPLETED|Overall Study||73
10879746|NCT03922945|12045624|FG000|NOT COMPLETED|Overall Study||27
10879747|NCT03922945|12045625|FG001|NOT COMPLETED|Overall Study||17
10879748|NCT03922945|12045626|FG002|NOT COMPLETED|Overall Study||40
10879749|NCT03920280|12045639|FG000|STARTED|Overall Study||41
10879750|NCT03920280|12045640|FG001|STARTED|Overall Study||78
10879751|NCT03920280|12045639|FG000|COMPLETED|Overall Study||38
10879752|NCT03920280|12045640|FG001|COMPLETED|Overall Study||72
10879753|NCT03920280|12045639|FG000|NOT COMPLETED|Overall Study||3
10879754|NCT03920280|12045640|FG001|NOT COMPLETED|Overall Study||6
10879755|NCT03917654|12045661|FG000|STARTED|Year 1||15
10879756|NCT03917654|12045662|FG001|STARTED|Year 1||15
10879757|NCT03917654|12045663|FG002|STARTED|Year 1||15
10879758|NCT03917654|12045664|FG003|STARTED|Year 1||15
10879759|NCT03917654|12045665|FG004|STARTED|Year 1||99
10879760|NCT03917654|12045666|FG005|STARTED|Year 1||87
10879761|NCT03917654|12045667|FG006|STARTED|Year 1||192
10879762|NCT03917654|12045668|FG007|STARTED|Year 1||177
10879763|NCT03917654|12045669|FG008|STARTED|Year 1||227
10879764|NCT03917654|12045670|FG009|STARTED|Year 1||267
10879765|NCT03917654|12045671|FG010|STARTED|Year 1||97
10879766|NCT03917654|12045672|FG011|STARTED|Year 1||95
10879767|NCT03917654|12045661|FG000|COMPLETED|Year 1||14
10879768|NCT03917654|12045662|FG001|COMPLETED|Year 1||13
10879769|NCT03917654|12045663|FG002|COMPLETED|Year 1||13
10879770|NCT03917654|12045664|FG003|COMPLETED|Year 1||15
10879771|NCT03917654|12045665|FG004|COMPLETED|Year 1||94
10879772|NCT03917654|12045666|FG005|COMPLETED|Year 1||82
10879773|NCT03917654|12045667|FG006|COMPLETED|Year 1||173
10879774|NCT03917654|12045668|FG007|COMPLETED|Year 1||162
10879775|NCT03917654|12045669|FG008|COMPLETED|Year 1||218
10879776|NCT03917654|12045670|FG009|COMPLETED|Year 1||257
10879777|NCT03917654|12045671|FG010|COMPLETED|Year 1||92
10879778|NCT03917654|12045672|FG011|COMPLETED|Year 1||87
10879779|NCT03917654|12045661|FG000|NOT COMPLETED|Year 1||1
10879780|NCT03917654|12045662|FG001|NOT COMPLETED|Year 1||2
10879781|NCT03917654|12045663|FG002|NOT COMPLETED|Year 1||2
10879782|NCT03917654|12045664|FG003|NOT COMPLETED|Year 1||0
10879783|NCT03917654|12045665|FG004|NOT COMPLETED|Year 1||5
10879784|NCT03917654|12045666|FG005|NOT COMPLETED|Year 1||5
10879785|NCT03917654|12045667|FG006|NOT COMPLETED|Year 1||19
10879786|NCT03917654|12045668|FG007|NOT COMPLETED|Year 1||15
10879787|NCT03917654|12045669|FG008|NOT COMPLETED|Year 1||9
10879788|NCT03917654|12045670|FG009|NOT COMPLETED|Year 1||10
10879789|NCT03917654|12045671|FG010|NOT COMPLETED|Year 1||5
10879790|NCT03917654|12045672|FG011|NOT COMPLETED|Year 1||8
10879791|NCT03917654|12045661|FG000|STARTED|Year 2||13
10879792|NCT03917654|12045662|FG001|STARTED|Year 2||10
10879793|NCT03917654|12045663|FG002|STARTED|Year 2||13
10879794|NCT03917654|12045664|FG003|STARTED|Year 2||14
10879795|NCT03917654|12045665|FG004|STARTED|Year 2||86
10879796|NCT03917654|12045666|FG005|STARTED|Year 2||77
10879797|NCT03917654|12045667|FG006|STARTED|Year 2||152
10879798|NCT03917654|12045668|FG007|STARTED|Year 2||147
10879799|NCT03917654|12045669|FG008|STARTED|Year 2||199
10879800|NCT03917654|12045670|FG009|STARTED|Year 2||238
10879801|NCT03917654|12045671|FG010|STARTED|Year 2||90
10879802|NCT03917654|12045672|FG011|STARTED|Year 2||87
10879803|NCT03917654|12045661|FG000|Did Not Rescreen|Year 2||1
10879804|NCT03917654|12045662|FG001|Did Not Rescreen|Year 2||3
10879805|NCT03917654|12045663|FG002|Did Not Rescreen|Year 2||0
10879806|NCT03917654|12045664|FG003|Did Not Rescreen|Year 2||1
10879807|NCT03917654|12045665|FG004|Did Not Rescreen|Year 2||8
10879808|NCT03917654|12045666|FG005|Did Not Rescreen|Year 2||5
10879809|NCT03917654|12045667|FG006|Did Not Rescreen|Year 2||21
10879810|NCT03917654|12045668|FG007|Did Not Rescreen|Year 2||15
10879811|NCT03917654|12045669|FG008|Did Not Rescreen|Year 2||19
10879812|NCT03917654|12045670|FG009|Did Not Rescreen|Year 2||19
10879813|NCT03917654|12045671|FG010|Did Not Rescreen|Year 2||2
10879814|NCT03917654|12045672|FG011|Did Not Rescreen|Year 2||0
10879815|NCT03917654|12045661|FG000|COMPLETED|Year 2||10
10879816|NCT03917654|12045662|FG001|COMPLETED|Year 2||9
10879817|NCT03917654|12045663|FG002|COMPLETED|Year 2||13
10879818|NCT03917654|12045664|FG003|COMPLETED|Year 2||14
10879819|NCT03917654|12045665|FG004|COMPLETED|Year 2||82
10879820|NCT03917654|12045666|FG005|COMPLETED|Year 2||75
10879821|NCT03917654|12045667|FG006|COMPLETED|Year 2||138
10879822|NCT03917654|12045668|FG007|COMPLETED|Year 2||139
10879823|NCT03917654|12045669|FG008|COMPLETED|Year 2||185
10879824|NCT03917654|12045670|FG009|COMPLETED|Year 2||226
10879825|NCT03917654|12045671|FG010|COMPLETED|Year 2||89
10879826|NCT03917654|12045672|FG011|COMPLETED|Year 2||83
10879827|NCT03917654|12045661|FG000|NOT COMPLETED|Year 2||3
10879828|NCT03917654|12045662|FG001|NOT COMPLETED|Year 2||1
10879829|NCT03917654|12045663|FG002|NOT COMPLETED|Year 2||0
10879830|NCT03917654|12045664|FG003|NOT COMPLETED|Year 2||0
10879831|NCT03917654|12045665|FG004|NOT COMPLETED|Year 2||4
10879832|NCT03917654|12045666|FG005|NOT COMPLETED|Year 2||2
10879833|NCT03917654|12045667|FG006|NOT COMPLETED|Year 2||14
10879834|NCT03917654|12045668|FG007|NOT COMPLETED|Year 2||8
10879835|NCT03917654|12045669|FG008|NOT COMPLETED|Year 2||14
10879836|NCT03917654|12045670|FG009|NOT COMPLETED|Year 2||12
10879837|NCT03917654|12045671|FG010|NOT COMPLETED|Year 2||1
10879838|NCT03917654|12045672|FG011|NOT COMPLETED|Year 2||4
10879839|NCT03917472|12045700|FG000|STARTED|Overall Study||346
10879840|NCT03917472|12045701|FG001|STARTED|Overall Study||171
10879841|NCT03917472|12045700|FG000|COMPLETED|Overall Study||311
10879842|NCT03917472|12045701|FG001|COMPLETED|Overall Study||156
10879843|NCT03917472|12045700|FG000|NOT COMPLETED|Overall Study||35
10879844|NCT03917472|12045701|FG001|NOT COMPLETED|Overall Study||15
10879845|NCT03912805|12045710|FG000|STARTED|Overall Study||19
10879846|NCT03912805|12045711|FG001|STARTED|Overall Study||19
10879847|NCT03912805|12045710|FG000|COMPLETED|Overall Study||19
10879848|NCT03912805|12045711|FG001|COMPLETED|Overall Study||19
10879849|NCT03912805|12045710|FG000|NOT COMPLETED|Overall Study||0
10879850|NCT03912805|12045711|FG001|NOT COMPLETED|Overall Study||0
10879851|NCT03912584|12045717|FG000|STARTED|Overall Study||10
10879852|NCT03912584|12045717|FG000|COMPLETED|Overall Study||10
10879853|NCT03912584|12045717|FG000|NOT COMPLETED|Overall Study||0
10879854|NCT03911154|12045724|FG000|STARTED|Overall Study||9
10879855|NCT03911154|12045724|FG000|Continuous Fixed Interval|Overall Study||9
10879856|NCT03911154|12045724|FG000|Block|Overall Study||9
10879857|NCT03911154|12045724|FG000|In-Phase Adjustable|Overall Study||9
10879858|NCT03911154|12045724|FG000|SHAM|Overall Study||9
10879859|NCT03911154|12045724|FG000|COMPLETED|Overall Study||8
10879860|NCT03911154|12045724|FG000|NOT COMPLETED|Overall Study||1
10879861|NCT03905694|12045731|FG000|STARTED|Primary Analysis Period||18
10879862|NCT03905694|12045731|FG000|COMPLETED|Primary Analysis Period||18
10879863|NCT03905694|12045731|FG000|NOT COMPLETED|Primary Analysis Period||0
10879864|NCT03905694|12045731|FG000|STARTED|Long-term Extension Period||18
10879865|NCT03905694|12045731|FG000|COMPLETED|Long-term Extension Period||0
10879866|NCT03905694|12045731|FG000|NOT COMPLETED|Long-term Extension Period||18
10879867|NCT03905135|12045737|FG000|STARTED|Dose Escalation||6
10879868|NCT03905135|12045738|FG001|STARTED|Dose Escalation||2
10879869|NCT03905135|12045737|FG000|COMPLETED|Dose Escalation||1
10879870|NCT03905135|12045738|FG001|COMPLETED|Dose Escalation||0
10879871|NCT03905135|12045737|FG000|NOT COMPLETED|Dose Escalation||5
10879872|NCT03905135|12045738|FG001|NOT COMPLETED|Dose Escalation||2
10879873|NCT03905135|12045737|FG000|STARTED|Dose Expansion||0
10879874|NCT03905135|12045738|FG001|STARTED|Dose Expansion||0
10879875|NCT03905135|12045737|FG000|COMPLETED|Dose Expansion||0
10879876|NCT03905135|12045738|FG001|COMPLETED|Dose Expansion||0
10879877|NCT03905135|12045737|FG000|NOT COMPLETED|Dose Expansion||0
10879878|NCT03905135|12045738|FG001|NOT COMPLETED|Dose Expansion||0
10879879|NCT03904446|12045748|FG000|STARTED|Overall Study||80
10879880|NCT03904446|12045749|FG001|STARTED|Overall Study||80
10879881|NCT03904446|12045748|FG000|COMPLETED|Overall Study||80
10879882|NCT03904446|12045749|FG001|COMPLETED|Overall Study||80
10879883|NCT03904446|12045748|FG000|NOT COMPLETED|Overall Study||0
10879884|NCT03904446|12045749|FG001|NOT COMPLETED|Overall Study||0
10879885|NCT03901300|12045757|FG000|STARTED|Overall Study|Children were enrolled study participants. Parents were not study participants.|35
10879886|NCT03901300|12045758|FG001|STARTED|Overall Study||37
10879887|NCT03901300|12045757|FG000|COMPLETED|Overall Study||32
10879888|NCT03901300|12045758|FG001|COMPLETED|Overall Study||37
10879889|NCT03901300|12045757|FG000|NOT COMPLETED|Overall Study||3
10879890|NCT03901300|12045758|FG001|NOT COMPLETED|Overall Study||0
10879891|NCT03900624|12045766|FG000|STARTED|Overall Study||61
10879892|NCT03900624|12045767|FG001|STARTED|Overall Study||31
10879893|NCT03900624|12045766|FG000|COMPLETED|Overall Study||61
10879894|NCT03900624|12045767|FG001|COMPLETED|Overall Study||31
10879895|NCT03900624|12045766|FG000|NOT COMPLETED|Overall Study||0
10879896|NCT03900624|12045767|FG001|NOT COMPLETED|Overall Study||0
10879897|NCT03895801|12045778|FG000|STARTED|Overall Study||18
10879898|NCT03895801|12045779|FG001|STARTED|Overall Study||24
10879899|NCT03895801|12045780|FG002|STARTED|Overall Study||15
10879900|NCT03895801|12045778|FG000|COMPLETED|Overall Study||16
10879901|NCT03895801|12045779|FG001|COMPLETED|Overall Study||22
10879902|NCT03895801|12045780|FG002|COMPLETED|Overall Study||13
10879903|NCT03895801|12045778|FG000|NOT COMPLETED|Overall Study||2
10879904|NCT03895801|12045779|FG001|NOT COMPLETED|Overall Study||2
10879905|NCT03895801|12045780|FG002|NOT COMPLETED|Overall Study||2
10879906|NCT03894540|12045794|FG000|STARTED|Overall Study||1
10879907|NCT03894540|12045795|FG001|STARTED|Overall Study||1
10879908|NCT03894540|12045796|FG002|STARTED|Overall Study||1
10879909|NCT03894540|12045797|FG003|STARTED|Overall Study||4
10879910|NCT03894540|12045798|FG004|STARTED|Overall Study||11
10879911|NCT03894540|12045799|FG005|STARTED|Overall Study||4
10879912|NCT03894540|12045794|FG000|COMPLETED|Overall Study||0
10879913|NCT03894540|12045795|FG001|COMPLETED|Overall Study||0
10879914|NCT03894540|12045796|FG002|COMPLETED|Overall Study||0
10879915|NCT03894540|12045797|FG003|COMPLETED|Overall Study||0
10879916|NCT03894540|12045798|FG004|COMPLETED|Overall Study||0
10879917|NCT03894540|12045799|FG005|COMPLETED|Overall Study||0
10879918|NCT03894540|12045794|FG000|NOT COMPLETED|Overall Study||1
10879919|NCT03894540|12045795|FG001|NOT COMPLETED|Overall Study||1
10879920|NCT03894540|12045796|FG002|NOT COMPLETED|Overall Study||1
10879921|NCT03894540|12045797|FG003|NOT COMPLETED|Overall Study||4
10879922|NCT03894540|12045798|FG004|NOT COMPLETED|Overall Study||11
10879923|NCT03894540|12045799|FG005|NOT COMPLETED|Overall Study||4
10879924|NCT03889886|12045821|FG000|STARTED|Overall Study||76
10879925|NCT03889886|12045822|FG001|STARTED|Overall Study||77
10879926|NCT03889886|12045823|FG002|STARTED|Overall Study||76
10879927|NCT03889886|12045824|FG003|STARTED|Overall Study||76
10879928|NCT03889886|12045821|FG000|COMPLETED|Overall Study||76
10879929|NCT03889886|12045822|FG001|COMPLETED|Overall Study||76
10879930|NCT03889886|12045823|FG002|COMPLETED|Overall Study||75
10879931|NCT03889886|12045824|FG003|COMPLETED|Overall Study||69
10879932|NCT03889886|12045821|FG000|NOT COMPLETED|Overall Study||0
10879933|NCT03889886|12045822|FG001|NOT COMPLETED|Overall Study||1
10879934|NCT03889886|12045823|FG002|NOT COMPLETED|Overall Study||1
10879935|NCT03889886|12045824|FG003|NOT COMPLETED|Overall Study||7
10879936|NCT03887533|12045836|FG000|STARTED|Overall Study||1
10879937|NCT03887533|12045837|FG001|STARTED|Overall Study||1
10879938|NCT03887533|12045836|FG000|COMPLETED|Overall Study||1
10879939|NCT03887533|12045837|FG001|COMPLETED|Overall Study||1
10879940|NCT03887533|12045836|FG000|NOT COMPLETED|Overall Study||0
10879941|NCT03887533|12045837|FG001|NOT COMPLETED|Overall Study||0
10879942|NCT03875664|12045845|FG000|STARTED|Overall Study||37
10879943|NCT03875664|12045846|FG001|STARTED|Overall Study||35
10879944|NCT03875664|12045845|FG000|COMPLETED|Overall Study|vaginal surgery n=18; vaginal + abdominal surgery n=19|37
10879945|NCT03875664|12045846|FG001|COMPLETED|Overall Study|Vaginal surgery n=18; vaginal + abdominal surgery n=17|35
10879946|NCT03875664|12045845|FG000|NOT COMPLETED|Overall Study||0
10879947|NCT03875664|12045846|FG001|NOT COMPLETED|Overall Study||0
10879948|NCT03875092|12045854|FG000|STARTED|Overall Study||65
10879949|NCT03875092|12045855|FG001|STARTED|Overall Study||60
10879950|NCT03875092|12045854|FG000|Treated|Overall Study||65
10879951|NCT03875092|12045855|FG001|Treated|Overall Study||60
10879952|NCT03875092|12045854|FG000|Switched to Pembrolizumab+Chemotherapy|Overall Study||0
10880043|NCT03848832|12045981|FG001|STARTED|Overall Study||9
10879953|NCT03875092|12045855|FG001|Switched to Pembrolizumab+Chemotherapy|Overall Study||38
10879954|NCT03875092|12045854|FG000|COMPLETED|Overall Study||0
10879955|NCT03875092|12045855|FG001|COMPLETED|Overall Study||0
10879956|NCT03875092|12045854|FG000|NOT COMPLETED|Overall Study||65
10879957|NCT03875092|12045855|FG001|NOT COMPLETED|Overall Study||60
10879958|NCT03874754|12045863|FG000|STARTED|Overall Study||22
10879959|NCT03874754|12045864|FG001|STARTED|Overall Study||12
10879960|NCT03874754|12045863|FG000|COMPLETED|Overall Study||14
10879961|NCT03874754|12045864|FG001|COMPLETED|Overall Study||6
10879962|NCT03874754|12045863|FG000|NOT COMPLETED|Overall Study||8
10879963|NCT03874754|12045864|FG001|NOT COMPLETED|Overall Study||6
10879964|NCT03873337|12045871|FG000|STARTED|Overall Study||34
10879965|NCT03873337|12045871|FG000|COMPLETED|Overall Study||22
10879966|NCT03873337|12045871|FG000|NOT COMPLETED|Overall Study||12
10879967|NCT03870048|12045875|FG000|STARTED|SHAM Effects on Pain and Fatigue||6
10879968|NCT03870048|12045875|FG000|COMPLETED|SHAM Effects on Pain and Fatigue||6
10879969|NCT03870048|12045875|FG000|NOT COMPLETED|SHAM Effects on Pain and Fatigue||0
10879970|NCT03870048|12045875|FG000|STARTED|tDCS Effects on Pain and Fatigue||6
10879971|NCT03870048|12045875|FG000|COMPLETED|tDCS Effects on Pain and Fatigue||6
10879972|NCT03870048|12045875|FG000|NOT COMPLETED|tDCS Effects on Pain and Fatigue||0
10879973|NCT03869450|12045884|FG000|STARTED|Overall Study||31
10879974|NCT03869450|12045885|FG001|STARTED|Overall Study||25
10879975|NCT03869450|12045886|FG002|STARTED|Overall Study||34
10879976|NCT03869450|12045884|FG000|COMPLETED|Overall Study||30
10879977|NCT03869450|12045885|FG001|COMPLETED|Overall Study||23
10879978|NCT03869450|12045886|FG002|COMPLETED|Overall Study||34
10879979|NCT03869450|12045884|FG000|NOT COMPLETED|Overall Study||1
10879980|NCT03869450|12045885|FG001|NOT COMPLETED|Overall Study||2
10879981|NCT03869450|12045886|FG002|NOT COMPLETED|Overall Study||0
10879982|NCT03866538|12045896|FG000|STARTED|Overall Study||0
10879983|NCT03866538|12045897|FG001|STARTED|Overall Study||1
10879984|NCT03866538|12045896|FG000|COMPLETED|Overall Study||0
10879985|NCT03866538|12045897|FG001|COMPLETED|Overall Study||1
10879986|NCT03866538|12045896|FG000|NOT COMPLETED|Overall Study||0
10879987|NCT03866538|12045897|FG001|NOT COMPLETED|Overall Study||0
10879988|NCT03866473|12045905|FG000|STARTED|Phase 1||69
10879989|NCT03866473|12045906|FG001|STARTED|Phase 1||66
10879990|NCT03866473|12045905|FG000|COMPLETED|Phase 1||68
10879991|NCT03866473|12045906|FG001|COMPLETED|Phase 1||66
10879992|NCT03866473|12045905|FG000|NOT COMPLETED|Phase 1||1
10879993|NCT03866473|12045906|FG001|NOT COMPLETED|Phase 1||0
10879994|NCT03866473|12045905|FG000|STARTED|Phase 2|Three participants completed the study by receiving alternate treatment for diabetic macular edema in phase 1 and 3 were dropped.|62
10879995|NCT03866473|12045906|FG001|STARTED|Phase 2||61
10879996|NCT03866473|12045905|FG000|COMPLETED|Phase 2||60
10879997|NCT03866473|12045906|FG001|COMPLETED|Phase 2|One participant completed the study by receiving alternate treatment for diabetic macular edema in Phase 1 and 4 participants were dropped.|58
10879998|NCT03866473|12045905|FG000|NOT COMPLETED|Phase 2||2
10879999|NCT03866473|12045906|FG001|NOT COMPLETED|Phase 2||3
10880000|NCT03865732|12045918|FG000|STARTED|Overall Study||11
10880001|NCT03865732|12045919|FG001|STARTED|Overall Study||10
10880002|NCT03865732|12045918|FG000|COMPLETED|Overall Study||11
10880003|NCT03865732|12045919|FG001|COMPLETED|Overall Study||9
10880004|NCT03865732|12045918|FG000|NOT COMPLETED|Overall Study||0
10880005|NCT03865732|12045919|FG001|NOT COMPLETED|Overall Study||1
10880006|NCT03865654|12045926|FG000|STARTED|Overall Study||45
10880007|NCT03865654|12045926|FG000|COMPLETED|Overall Study||40
10880008|NCT03865654|12045926|FG000|NOT COMPLETED|Overall Study||5
10880009|NCT03864341|12045930|FG000|STARTED|Overall Study||40
10880010|NCT03864341|12045930|FG000|COMPLETED|Overall Study||39
10880011|NCT03864341|12045930|FG000|NOT COMPLETED|Overall Study||1
10880012|NCT03863834|12045934|FG000|STARTED|Overall Study||12
10880013|NCT03863834|12045934|FG000|COMPLETED|Overall Study||9
10880014|NCT03863834|12045934|FG000|NOT COMPLETED|Overall Study||3
10880015|NCT03860974|12045940|FG000|STARTED|Overall Study||49
10880016|NCT03860974|12045941|FG001|STARTED|Overall Study||51
10880017|NCT03860974|12045940|FG000|COMPLETED|Overall Study||49
10880018|NCT03860974|12045941|FG001|COMPLETED|Overall Study||51
10880019|NCT03860974|12045940|FG000|NOT COMPLETED|Overall Study||0
10880020|NCT03860974|12045941|FG001|NOT COMPLETED|Overall Study||0
10880021|NCT03853148|12045951|FG000|STARTED|Overall Study||10
10880022|NCT03853148|12045952|FG001|STARTED|Overall Study||10
10880023|NCT03853148|12045953|FG002|STARTED|Overall Study||10
10880024|NCT03853148|12045954|FG003|STARTED|Overall Study||20
10880025|NCT03853148|12045951|FG000|COMPLETED|Overall Study||5
10880026|NCT03853148|12045952|FG001|COMPLETED|Overall Study||2
10880027|NCT03853148|12045953|FG002|COMPLETED|Overall Study||2
10880028|NCT03853148|12045954|FG003|COMPLETED|Overall Study||15
10880029|NCT03853148|12045951|FG000|NOT COMPLETED|Overall Study||5
10880030|NCT03853148|12045952|FG001|NOT COMPLETED|Overall Study||8
10880031|NCT03853148|12045953|FG002|NOT COMPLETED|Overall Study||8
10880032|NCT03853148|12045954|FG003|NOT COMPLETED|Overall Study||5
10880033|NCT03852901|12045964|FG000|STARTED|Overall Study||21
10880034|NCT03852901|12045964|FG000|COMPLETED|Overall Study||20
10880035|NCT03852901|12045964|FG000|NOT COMPLETED|Overall Study||1
10880036|NCT03850444|12045970|FG000|STARTED|Overall Study||128
10880037|NCT03850444|12045971|FG001|STARTED|Overall Study||134
10880038|NCT03850444|12045970|FG000|COMPLETED|Overall Study||0
10880039|NCT03850444|12045971|FG001|COMPLETED|Overall Study||0
10880040|NCT03850444|12045970|FG000|NOT COMPLETED|Overall Study||128
10880041|NCT03850444|12045971|FG001|NOT COMPLETED|Overall Study||134
10880042|NCT03848832|12045980|FG000|STARTED|Overall Study||10
10880044|NCT03848832|12045982|FG002|STARTED|Overall Study||10
10880045|NCT03848832|12045980|FG000|COMPLETED|Overall Study||7
10880046|NCT03848832|12045981|FG001|COMPLETED|Overall Study||6
10880047|NCT03848832|12045982|FG002|COMPLETED|Overall Study||4
10880048|NCT03848832|12045980|FG000|NOT COMPLETED|Overall Study||3
10880049|NCT03848832|12045981|FG001|NOT COMPLETED|Overall Study||3
10880050|NCT03848832|12045982|FG002|NOT COMPLETED|Overall Study||6
10880051|NCT03844386|12045996|FG000|STARTED|Overall Study||7
10880052|NCT03844386|12045997|FG001|STARTED|Overall Study||7
10880053|NCT03844386|12045998|FG002|STARTED|Overall Study||8
10880054|NCT03844386|12045999|FG003|STARTED|Overall Study||4
10880055|NCT03844386|12045996|FG000|Completed Day 28|Overall Study||7
10880056|NCT03844386|12045997|FG001|Completed Day 28|Overall Study||7
10880057|NCT03844386|12045998|FG002|Completed Day 28|Overall Study||8
10880058|NCT03844386|12045999|FG003|Completed Day 28|Overall Study||3
10880059|NCT03844386|12045996|FG000|COMPLETED|Overall Study||7
10880060|NCT03844386|12045997|FG001|COMPLETED|Overall Study||7
10880061|NCT03844386|12045998|FG002|COMPLETED|Overall Study||7
10880062|NCT03844386|12045999|FG003|COMPLETED|Overall Study||3
10880063|NCT03844386|12045996|FG000|NOT COMPLETED|Overall Study||0
10880064|NCT03844386|12045997|FG001|NOT COMPLETED|Overall Study||0
10880065|NCT03844386|12045998|FG002|NOT COMPLETED|Overall Study||1
10880066|NCT03844386|12045999|FG003|NOT COMPLETED|Overall Study||1
10880067|NCT03839940|12046011|FG000|STARTED|Overall Study||20
10880068|NCT03839940|12046012|FG001|STARTED|Overall Study||19
10880069|NCT03839940|12046011|FG000|COMPLETED|Overall Study||16
10880070|NCT03839940|12046012|FG001|COMPLETED|Overall Study||17
10880071|NCT03839940|12046011|FG000|NOT COMPLETED|Overall Study||4
10880072|NCT03839940|12046012|FG001|NOT COMPLETED|Overall Study||2
10880073|NCT03839693|12046023|FG000|STARTED|Overall Study||25
10880074|NCT03839693|12046024|FG001|STARTED|Overall Study||30
10880075|NCT03839693|12046025|FG002|STARTED|Overall Study||20
10880076|NCT03839693|12046023|FG000|COMPLETED|Overall Study||23
10880077|NCT03839693|12046024|FG001|COMPLETED|Overall Study||28
10880078|NCT03839693|12046025|FG002|COMPLETED|Overall Study||16
10880079|NCT03839693|12046023|FG000|NOT COMPLETED|Overall Study||2
10880080|NCT03839693|12046024|FG001|NOT COMPLETED|Overall Study||2
10880081|NCT03839693|12046025|FG002|NOT COMPLETED|Overall Study||4
10880082|NCT03837743|12046035|FG000|STARTED|Overall Study||25
10880083|NCT03837743|12046035|FG000|DUR-928 Topical Solution Lesion|Overall Study||25
10880084|NCT03837743|12046035|FG000|Vehicle Topical Solution Lesion|Overall Study||25
10880085|NCT03837743|12046035|FG000|COMPLETED|Overall Study||22
10880086|NCT03837743|12046035|FG000|NOT COMPLETED|Overall Study||3
10880087|NCT03837184|12046043|FG000|STARTED|Overall Study||2
10880088|NCT03837184|12046043|FG000|COMPLETED|Overall Study||2
10880089|NCT03837184|12046043|FG000|NOT COMPLETED|Overall Study||0
10880090|NCT03834623|12046049|FG000|STARTED|Overall Study||11
10880091|NCT03834623|12046050|FG001|STARTED|Overall Study||12
10880092|NCT03834623|12046049|FG000|COMPLETED|Overall Study||11
10880093|NCT03834623|12046050|FG001|COMPLETED|Overall Study||11
10880094|NCT03834623|12046049|FG000|NOT COMPLETED|Overall Study||0
10880095|NCT03834623|12046050|FG001|NOT COMPLETED|Overall Study||1
10880096|NCT03834168|12046058|FG000|STARTED|Overall Study||19
10880097|NCT03834168|12046059|FG001|STARTED|Overall Study||23
10880098|NCT03834168|12046058|FG000|Total Participant Screened for the Purpose of Eligibility|Overall Study||22
10880099|NCT03834168|12046059|FG001|Total Participant Screened for the Purpose of Eligibility|Overall Study||30
10880100|NCT03834168|12046058|FG000|Ineligible Participants|Overall Study||3
10880101|NCT03834168|12046059|FG001|Ineligible Participants|Overall Study||7
10880102|NCT03834168|12046058|FG000|Unable to Complete the Protocol|Overall Study||0
10880103|NCT03834168|12046059|FG001|Unable to Complete the Protocol|Overall Study||1
10880104|NCT03834168|12046058|FG000|Study Dropouts|Overall Study||1
10880105|NCT03834168|12046059|FG001|Study Dropouts|Overall Study||0
10880106|NCT03834168|12046058|FG000|Participants Received 5 Days of Standardized Meals|Overall Study||19
10880107|NCT03834168|12046059|FG001|Participants Received 5 Days of Standardized Meals|Overall Study||23
10880108|NCT03834168|12046058|FG000|Participants Returned for the 24-h Inpatient Protocol|Overall Study||18
10880109|NCT03834168|12046059|FG001|Participants Returned for the 24-h Inpatient Protocol|Overall Study||23
10880110|NCT03834168|12046058|FG000|COMPLETED|Overall Study||18
10880111|NCT03834168|12046059|FG001|COMPLETED|Overall Study||22
10880112|NCT03834168|12046058|FG000|NOT COMPLETED|Overall Study||1
10880113|NCT03834168|12046059|FG001|NOT COMPLETED|Overall Study||1
10880114|NCT03834142|12046067|FG000|STARTED|Overall Study||10
10880115|NCT03834142|12046068|FG001|STARTED|Overall Study||10
10880116|NCT03834142|12046067|FG000|COMPLETED|Overall Study||10
10880117|NCT03834142|12046068|FG001|COMPLETED|Overall Study||10
10880118|NCT03834142|12046067|FG000|NOT COMPLETED|Overall Study||0
10880119|NCT03834142|12046068|FG001|NOT COMPLETED|Overall Study||0
10880120|NCT03833817|12046079|FG000|STARTED|Overall Study||14
10880121|NCT03833817|12046080|FG001|STARTED|Overall Study||14
10880122|NCT03833817|12046079|FG000|COMPLETED|Overall Study|*Note: Whereas 8 patients completed the study, 1 additional patient was able to be included in the analysis of most patient outcome measures as they completed the applicable assessments for those measures prior to being lost to follow-up.|8
10880123|NCT03833817|12046080|FG001|COMPLETED|Overall Study||8
10880124|NCT03833817|12046079|FG000|NOT COMPLETED|Overall Study||6
10880125|NCT03833817|12046080|FG001|NOT COMPLETED|Overall Study||6
10880126|NCT03832114|12046088|FG000|STARTED|Run-in Phase||16
10880127|NCT03832114|12046089|FG001|STARTED|Run-in Phase||11
10880128|NCT03832114|12046090|FG002|STARTED|Run-in Phase||0
10880129|NCT03832114|12046091|FG003|STARTED|Run-in Phase||0
10880130|NCT03832114|12046088|FG000|COMPLETED|Run-in Phase||16
10880131|NCT03832114|12046089|FG001|COMPLETED|Run-in Phase||11
10880132|NCT03832114|12046090|FG002|COMPLETED|Run-in Phase||0
10880133|NCT03832114|12046091|FG003|COMPLETED|Run-in Phase||0
10880134|NCT03832114|12046088|FG000|NOT COMPLETED|Run-in Phase||0
10880135|NCT03832114|12046089|FG001|NOT COMPLETED|Run-in Phase||0
10880136|NCT03832114|12046090|FG002|NOT COMPLETED|Run-in Phase||0
10880137|NCT03832114|12046091|FG003|NOT COMPLETED|Run-in Phase||0
10880138|NCT03832114|12046088|FG000|STARTED|Dose Escalation/200mg b.i.d Treatment||0
10880139|NCT03832114|12046089|FG001|STARTED|Dose Escalation/200mg b.i.d Treatment||0
10880140|NCT03832114|12046090|FG002|STARTED|Dose Escalation/200mg b.i.d Treatment||16
10880141|NCT03832114|12046091|FG003|STARTED|Dose Escalation/200mg b.i.d Treatment||11
10880142|NCT03832114|12046088|FG000|COMPLETED|Dose Escalation/200mg b.i.d Treatment||0
10880143|NCT03832114|12046089|FG001|COMPLETED|Dose Escalation/200mg b.i.d Treatment||0
10880144|NCT03832114|12046090|FG002|COMPLETED|Dose Escalation/200mg b.i.d Treatment||16
10880145|NCT03832114|12046091|FG003|COMPLETED|Dose Escalation/200mg b.i.d Treatment||11
10880146|NCT03832114|12046088|FG000|NOT COMPLETED|Dose Escalation/200mg b.i.d Treatment||0
10880147|NCT03832114|12046089|FG001|NOT COMPLETED|Dose Escalation/200mg b.i.d Treatment||0
10880148|NCT03832114|12046090|FG002|NOT COMPLETED|Dose Escalation/200mg b.i.d Treatment||0
10880149|NCT03832114|12046091|FG003|NOT COMPLETED|Dose Escalation/200mg b.i.d Treatment||0
10880150|NCT03824405|12046104|FG000|STARTED|Overall Study||100
10880151|NCT03824405|12046105|FG001|STARTED|Overall Study||100
10880152|NCT03824405|12046104|FG000|COMPLETED|Overall Study||65
10880153|NCT03824405|12046105|FG001|COMPLETED|Overall Study||55
10880154|NCT03824405|12046104|FG000|NOT COMPLETED|Overall Study||35
10880155|NCT03824405|12046105|FG001|NOT COMPLETED|Overall Study||45
10880156|NCT03823703|12046114|FG000|STARTED|Overall Study||3
10880157|NCT03823703|12046115|FG001|STARTED|Overall Study||5
10880158|NCT03823703|12046116|FG002|STARTED|Overall Study||4
10880159|NCT03823703|12046114|FG000|Treated|Overall Study||3
10880160|NCT03823703|12046115|FG001|Treated|Overall Study||5
10880161|NCT03823703|12046116|FG002|Treated|Overall Study||4
10880162|NCT03823703|12046114|FG000|COMPLETED|Overall Study||0
10880163|NCT03823703|12046115|FG001|COMPLETED|Overall Study||0
10880164|NCT03823703|12046116|FG002|COMPLETED|Overall Study||0
10880165|NCT03823703|12046114|FG000|NOT COMPLETED|Overall Study||3
10880166|NCT03823703|12046115|FG001|NOT COMPLETED|Overall Study||5
10880167|NCT03823703|12046116|FG002|NOT COMPLETED|Overall Study||4
10880168|NCT03823300|12046126|FG000|STARTED|Overall Study||331
10880169|NCT03823300|12046127|FG001|STARTED|Overall Study||327
10880170|NCT03823300|12046126|FG000|Received at Least One Dose of Study Drug|Overall Study||331
10880171|NCT03823300|12046127|FG001|Received at Least One Dose of Study Drug|Overall Study||326
10880172|NCT03823300|12046126|FG000|Completed up to Week 48|Overall Study||321
10880173|NCT03823300|12046127|FG001|Completed up to Week 48|Overall Study||309
10880174|NCT03823300|12046126|FG000|COMPLETED|Overall Study||0
10880175|NCT03823300|12046127|FG001|COMPLETED|Overall Study||0
10880176|NCT03823300|12046126|FG000|NOT COMPLETED|Overall Study||331
10880177|NCT03823300|12046127|FG001|NOT COMPLETED|Overall Study||327
10880178|NCT03817853|12046133|FG000|STARTED|Induction Phase||113
10880179|NCT03817853|12046134|FG001|STARTED|Induction Phase||0
10880180|NCT03817853|12046135|FG002|STARTED|Induction Phase||0
10880181|NCT03817853|12046133|FG000|COMPLETED|Induction Phase||62
10880182|NCT03817853|12046134|FG001|COMPLETED|Induction Phase||0
10880183|NCT03817853|12046135|FG002|COMPLETED|Induction Phase||0
10880184|NCT03817853|12046133|FG000|NOT COMPLETED|Induction Phase||51
10880185|NCT03817853|12046134|FG001|NOT COMPLETED|Induction Phase||0
10880186|NCT03817853|12046135|FG002|NOT COMPLETED|Induction Phase||0
10880187|NCT03817853|12046133|FG000|STARTED|Maintenance/ Follow-up Phase||0
10880188|NCT03817853|12046134|FG001|STARTED|Maintenance/ Follow-up Phase||56
10880189|NCT03817853|12046135|FG002|STARTED|Maintenance/ Follow-up Phase||17
10880190|NCT03817853|12046133|FG000|COMPLETED|Maintenance/ Follow-up Phase||0
10880191|NCT03817853|12046134|FG001|COMPLETED|Maintenance/ Follow-up Phase||0
10880192|NCT03817853|12046135|FG002|COMPLETED|Maintenance/ Follow-up Phase||11
10880193|NCT03817853|12046133|FG000|NOT COMPLETED|Maintenance/ Follow-up Phase||0
10880194|NCT03817853|12046134|FG001|NOT COMPLETED|Maintenance/ Follow-up Phase||56
10880195|NCT03817853|12046135|FG002|NOT COMPLETED|Maintenance/ Follow-up Phase||6
10880196|NCT03814590|12046157|FG000|STARTED|Overall Study||12
10880197|NCT03814590|12046158|FG001|STARTED|Overall Study||12
10880198|NCT03814590|12046159|FG002|STARTED|Overall Study||12
10880199|NCT03814590|12046160|FG003|STARTED|Overall Study||12
10880200|NCT03814590|12046161|FG004|STARTED|Overall Study||101
10880201|NCT03814590|12046162|FG005|STARTED|Overall Study||97
10880202|NCT03814590|12046163|FG006|STARTED|Overall Study||100
10880203|NCT03814590|12046164|FG007|STARTED|Overall Study||101
10880204|NCT03814590|12046165|FG008|STARTED|Overall Study||101
10880205|NCT03814590|12046166|FG009|STARTED|Overall Study||100
10880206|NCT03814590|12046167|FG010|STARTED|Overall Study||103
10880207|NCT03814590|12046168|FG011|STARTED|Overall Study||100
10880208|NCT03814590|12046169|FG012|STARTED|Overall Study||101
10880209|NCT03814590|12046170|FG013|STARTED|Overall Study||101
10880210|NCT03814590|12046157|FG000|COMPLETED|Overall Study||12
10880211|NCT03814590|12046158|FG001|COMPLETED|Overall Study||10
10880212|NCT03814590|12046159|FG002|COMPLETED|Overall Study||11
10880213|NCT03814590|12046160|FG003|COMPLETED|Overall Study||12
10880214|NCT03814590|12046161|FG004|COMPLETED|Overall Study||100
10880215|NCT03814590|12046162|FG005|COMPLETED|Overall Study||92
10880216|NCT03814590|12046163|FG006|COMPLETED|Overall Study||97
10880217|NCT03814590|12046164|FG007|COMPLETED|Overall Study||95
10880218|NCT03814590|12046165|FG008|COMPLETED|Overall Study||101
10880219|NCT03814590|12046166|FG009|COMPLETED|Overall Study||95
10880220|NCT03814590|12046167|FG010|COMPLETED|Overall Study||100
10880221|NCT03814590|12046168|FG011|COMPLETED|Overall Study||100
10880222|NCT03814590|12046169|FG012|COMPLETED|Overall Study||97
10880223|NCT03814590|12046170|FG013|COMPLETED|Overall Study||98
10880224|NCT03814590|12046157|FG000|NOT COMPLETED|Overall Study||0
10880225|NCT03814590|12046158|FG001|NOT COMPLETED|Overall Study||2
10880226|NCT03814590|12046159|FG002|NOT COMPLETED|Overall Study||1
10880227|NCT03814590|12046160|FG003|NOT COMPLETED|Overall Study||0
10880228|NCT03814590|12046161|FG004|NOT COMPLETED|Overall Study||1
10880229|NCT03814590|12046162|FG005|NOT COMPLETED|Overall Study||5
10880230|NCT03814590|12046163|FG006|NOT COMPLETED|Overall Study||3
10880231|NCT03814590|12046164|FG007|NOT COMPLETED|Overall Study||6
10880232|NCT03814590|12046165|FG008|NOT COMPLETED|Overall Study||0
10880233|NCT03814590|12046166|FG009|NOT COMPLETED|Overall Study||5
10880234|NCT03814590|12046167|FG010|NOT COMPLETED|Overall Study||3
10880235|NCT03814590|12046168|FG011|NOT COMPLETED|Overall Study||0
10880236|NCT03814590|12046169|FG012|NOT COMPLETED|Overall Study||4
10880237|NCT03814590|12046170|FG013|NOT COMPLETED|Overall Study||3
10880238|NCT03813121|12046212|FG000|STARTED|Overall Study||4
10880239|NCT03813121|12046213|FG001|STARTED|Overall Study||6
10880240|NCT03813121|12046212|FG000|COMPLETED|Overall Study||4
10880241|NCT03813121|12046213|FG001|COMPLETED|Overall Study||6
10880242|NCT03813121|12046212|FG000|NOT COMPLETED|Overall Study||0
10880243|NCT03813121|12046213|FG001|NOT COMPLETED|Overall Study||0
10880244|NCT03812380|12046221|FG000|STARTED|Overall Study||22
10880245|NCT03812380|12046222|FG001|STARTED|Overall Study||22
10880246|NCT03812380|12046221|FG000|COMPLETED|Overall Study||0
10880247|NCT03812380|12046222|FG001|COMPLETED|Overall Study||1
10880248|NCT03812380|12046221|FG000|NOT COMPLETED|Overall Study||22
10880249|NCT03812380|12046222|FG001|NOT COMPLETED|Overall Study||21
10880250|NCT03812224|12046230|FG000|STARTED|Double-blind Treatment Period||131
10880251|NCT03812224|12046231|FG001|STARTED|Double-blind Treatment Period||130
10880252|NCT03812224|12046230|FG000|COMPLETED|Double-blind Treatment Period||127
10880253|NCT03812224|12046231|FG001|COMPLETED|Double-blind Treatment Period||127
10880254|NCT03812224|12046230|FG000|NOT COMPLETED|Double-blind Treatment Period||4
10880255|NCT03812224|12046231|FG001|NOT COMPLETED|Double-blind Treatment Period||3
10880256|NCT03812224|12046230|FG000|STARTED|Open-label Treatment Period||127
10880257|NCT03812224|12046231|FG001|STARTED|Open-label Treatment Period||127
10880258|NCT03812224|12046230|FG000|COMPLETED|Open-label Treatment Period||125
10880259|NCT03812224|12046231|FG001|COMPLETED|Open-label Treatment Period||124
10880260|NCT03812224|12046230|FG000|NOT COMPLETED|Open-label Treatment Period||2
10880261|NCT03812224|12046231|FG001|NOT COMPLETED|Open-label Treatment Period||3
10880262|NCT03811093|12046240|FG000|STARTED|Overall Study||20
10880263|NCT03811093|12046241|FG001|STARTED|Overall Study||19
10880264|NCT03811093|12046240|FG000|COMPLETED|Overall Study||18
10880265|NCT03811093|12046241|FG001|COMPLETED|Overall Study||15
10880266|NCT03811093|12046240|FG000|NOT COMPLETED|Overall Study||2
10880267|NCT03811093|12046241|FG001|NOT COMPLETED|Overall Study||4
10880268|NCT03810534|12046254|FG000|STARTED|Standard of Care (5-10 Months)||40
10880269|NCT03810534|12046255|FG001|STARTED|Standard of Care (5-10 Months)||46
10880270|NCT03810534|12046256|FG002|STARTED|Standard of Care (5-10 Months)||54
10880271|NCT03810534|12046257|FG003|STARTED|Standard of Care (5-10 Months)||62
10880272|NCT03810534|12046258|FG004|STARTED|Standard of Care (5-10 Months)||34
10880273|NCT03810534|12046259|FG005|STARTED|Standard of Care (5-10 Months)||88
10880274|NCT03810534|12046254|FG000|Patients Started|Standard of Care (5-10 Months)||20
10880275|NCT03810534|12046255|FG001|Patients Started|Standard of Care (5-10 Months)||23
10880276|NCT03810534|12046256|FG002|Patients Started|Standard of Care (5-10 Months)||27
10880277|NCT03810534|12046257|FG003|Patients Started|Standard of Care (5-10 Months)||31
10880278|NCT03810534|12046258|FG004|Patients Started|Standard of Care (5-10 Months)||17
10880279|NCT03810534|12046259|FG005|Patients Started|Standard of Care (5-10 Months)||44
10880280|NCT03810534|12046254|FG000|Caregivers Started|Standard of Care (5-10 Months)||20
10880281|NCT03810534|12046255|FG001|Caregivers Started|Standard of Care (5-10 Months)||23
10880282|NCT03810534|12046256|FG002|Caregivers Started|Standard of Care (5-10 Months)||27
10880283|NCT03810534|12046257|FG003|Caregivers Started|Standard of Care (5-10 Months)||31
10880284|NCT03810534|12046258|FG004|Caregivers Started|Standard of Care (5-10 Months)||17
10880285|NCT03810534|12046259|FG005|Caregivers Started|Standard of Care (5-10 Months)||44
10880286|NCT03810534|12046254|FG000|Completed 7-day (Patients)|Standard of Care (5-10 Months)||16
10880287|NCT03810534|12046255|FG001|Completed 7-day (Patients)|Standard of Care (5-10 Months)||20
10880288|NCT03810534|12046256|FG002|Completed 7-day (Patients)|Standard of Care (5-10 Months)||23
10880289|NCT03810534|12046257|FG003|Completed 7-day (Patients)|Standard of Care (5-10 Months)||29
10880290|NCT03810534|12046258|FG004|Completed 7-day (Patients)|Standard of Care (5-10 Months)||13
10880291|NCT03810534|12046259|FG005|Completed 7-day (Patients)|Standard of Care (5-10 Months)||40
10880292|NCT03810534|12046254|FG000|Completed 7-Day (Caregivers)|Standard of Care (5-10 Months)||18
10880293|NCT03810534|12046255|FG001|Completed 7-Day (Caregivers)|Standard of Care (5-10 Months)||21
10880294|NCT03810534|12046256|FG002|Completed 7-Day (Caregivers)|Standard of Care (5-10 Months)||23
10880295|NCT03810534|12046257|FG003|Completed 7-Day (Caregivers)|Standard of Care (5-10 Months)||29
10880296|NCT03810534|12046258|FG004|Completed 7-Day (Caregivers)|Standard of Care (5-10 Months)||13
10880297|NCT03810534|12046259|FG005|Completed 7-Day (Caregivers)|Standard of Care (5-10 Months)||38
10880298|NCT03810534|12046254|FG000|Completed 30-day (Patients)|Standard of Care (5-10 Months)||14
10880299|NCT03810534|12046255|FG001|Completed 30-day (Patients)|Standard of Care (5-10 Months)||16
10880300|NCT03810534|12046256|FG002|Completed 30-day (Patients)|Standard of Care (5-10 Months)||21
10880301|NCT03810534|12046257|FG003|Completed 30-day (Patients)|Standard of Care (5-10 Months)||23
10880302|NCT03810534|12046258|FG004|Completed 30-day (Patients)|Standard of Care (5-10 Months)||12
10880303|NCT03810534|12046259|FG005|Completed 30-day (Patients)|Standard of Care (5-10 Months)||38
10880304|NCT03810534|12046254|FG000|Completed 30-Day (Caregivers)|Standard of Care (5-10 Months)||14
10880305|NCT03810534|12046255|FG001|Completed 30-Day (Caregivers)|Standard of Care (5-10 Months)||16
10880306|NCT03810534|12046256|FG002|Completed 30-Day (Caregivers)|Standard of Care (5-10 Months)||21
10880307|NCT03810534|12046257|FG003|Completed 30-Day (Caregivers)|Standard of Care (5-10 Months)||23
10880308|NCT03810534|12046258|FG004|Completed 30-Day (Caregivers)|Standard of Care (5-10 Months)||10
10880309|NCT03810534|12046259|FG005|Completed 30-Day (Caregivers)|Standard of Care (5-10 Months)||32
10880310|NCT03810534|12046254|FG000|Completed 60-Day (Patients)|Standard of Care (5-10 Months)||10
10880311|NCT03810534|12046255|FG001|Completed 60-Day (Patients)|Standard of Care (5-10 Months)||16
10880312|NCT03810534|12046256|FG002|Completed 60-Day (Patients)|Standard of Care (5-10 Months)||17
10880313|NCT03810534|12046257|FG003|Completed 60-Day (Patients)|Standard of Care (5-10 Months)||20
10880314|NCT03810534|12046258|FG004|Completed 60-Day (Patients)|Standard of Care (5-10 Months)||10
10880315|NCT03810534|12046259|FG005|Completed 60-Day (Patients)|Standard of Care (5-10 Months)||32
10880316|NCT03810534|12046254|FG000|Completed 60-Day (Caregivers)|Standard of Care (5-10 Months)||10
10880317|NCT03810534|12046255|FG001|Completed 60-Day (Caregivers)|Standard of Care (5-10 Months)||16
10880318|NCT03810534|12046256|FG002|Completed 60-Day (Caregivers)|Standard of Care (5-10 Months)||15
10880319|NCT03810534|12046257|FG003|Completed 60-Day (Caregivers)|Standard of Care (5-10 Months)||20
10880320|NCT03810534|12046258|FG004|Completed 60-Day (Caregivers)|Standard of Care (5-10 Months)||9
10880321|NCT03810534|12046259|FG005|Completed 60-Day (Caregivers)|Standard of Care (5-10 Months)||31
10880322|NCT03810534|12046254|FG000|COMPLETED|Standard of Care (5-10 Months)||20
10880323|NCT03810534|12046255|FG001|COMPLETED|Standard of Care (5-10 Months)||32
10880324|NCT03810534|12046256|FG002|COMPLETED|Standard of Care (5-10 Months)||32
10880325|NCT03810534|12046257|FG003|COMPLETED|Standard of Care (5-10 Months)||40
10880326|NCT03810534|12046258|FG004|COMPLETED|Standard of Care (5-10 Months)||19
10880327|NCT03810534|12046259|FG005|COMPLETED|Standard of Care (5-10 Months)||63
10880328|NCT03810534|12046254|FG000|NOT COMPLETED|Standard of Care (5-10 Months)||20
10880329|NCT03810534|12046255|FG001|NOT COMPLETED|Standard of Care (5-10 Months)||14
10880330|NCT03810534|12046256|FG002|NOT COMPLETED|Standard of Care (5-10 Months)||22
10880331|NCT03810534|12046257|FG003|NOT COMPLETED|Standard of Care (5-10 Months)||22
10880332|NCT03810534|12046258|FG004|NOT COMPLETED|Standard of Care (5-10 Months)||15
10880333|NCT03810534|12046259|FG005|NOT COMPLETED|Standard of Care (5-10 Months)||25
10880334|NCT03810534|12046254|FG000|STARTED|Pre-Implementation Phase (2 Months)||0
10880335|NCT03810534|12046255|FG001|STARTED|Pre-Implementation Phase (2 Months)||0
10880336|NCT03810534|12046256|FG002|STARTED|Pre-Implementation Phase (2 Months)||0
10880337|NCT03810534|12046257|FG003|STARTED|Pre-Implementation Phase (2 Months)||0
10880338|NCT03810534|12046258|FG004|STARTED|Pre-Implementation Phase (2 Months)||0
10880339|NCT03810534|12046259|FG005|STARTED|Pre-Implementation Phase (2 Months)||0
10880340|NCT03810534|12046254|FG000|Patients Started|Pre-Implementation Phase (2 Months)||0
10880341|NCT03810534|12046255|FG001|Patients Started|Pre-Implementation Phase (2 Months)||0
10880342|NCT03810534|12046256|FG002|Patients Started|Pre-Implementation Phase (2 Months)||0
10880343|NCT03810534|12046257|FG003|Patients Started|Pre-Implementation Phase (2 Months)||0
10880344|NCT03810534|12046258|FG004|Patients Started|Pre-Implementation Phase (2 Months)||0
10880345|NCT03810534|12046259|FG005|Patients Started|Pre-Implementation Phase (2 Months)||0
10880346|NCT03810534|12046254|FG000|Caregivers Started|Pre-Implementation Phase (2 Months)||0
10880347|NCT03810534|12046255|FG001|Caregivers Started|Pre-Implementation Phase (2 Months)||0
10880348|NCT03810534|12046256|FG002|Caregivers Started|Pre-Implementation Phase (2 Months)||0
10880349|NCT03810534|12046257|FG003|Caregivers Started|Pre-Implementation Phase (2 Months)||0
10880350|NCT03810534|12046258|FG004|Caregivers Started|Pre-Implementation Phase (2 Months)||0
10880351|NCT03810534|12046259|FG005|Caregivers Started|Pre-Implementation Phase (2 Months)||0
10880352|NCT03810534|12046254|FG000|Completed 7-Day (Patients)|Pre-Implementation Phase (2 Months)||0
10880353|NCT03810534|12046255|FG001|Completed 7-Day (Patients)|Pre-Implementation Phase (2 Months)||0
10880354|NCT03810534|12046256|FG002|Completed 7-Day (Patients)|Pre-Implementation Phase (2 Months)||0
10880355|NCT03810534|12046257|FG003|Completed 7-Day (Patients)|Pre-Implementation Phase (2 Months)||0
10880356|NCT03810534|12046258|FG004|Completed 7-Day (Patients)|Pre-Implementation Phase (2 Months)||0
10880357|NCT03810534|12046259|FG005|Completed 7-Day (Patients)|Pre-Implementation Phase (2 Months)||0
10880358|NCT03810534|12046254|FG000|Completed 7-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0
10880359|NCT03810534|12046255|FG001|Completed 7-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0
10880360|NCT03810534|12046256|FG002|Completed 7-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0
10880361|NCT03810534|12046257|FG003|Completed 7-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0
10880362|NCT03810534|12046258|FG004|Completed 7-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0
10880363|NCT03810534|12046259|FG005|Completed 7-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0
10880364|NCT03810534|12046254|FG000|Completed 30-Day (Patients)|Pre-Implementation Phase (2 Months)||0
10880365|NCT03810534|12046255|FG001|Completed 30-Day (Patients)|Pre-Implementation Phase (2 Months)||0
10880366|NCT03810534|12046256|FG002|Completed 30-Day (Patients)|Pre-Implementation Phase (2 Months)||0
10880367|NCT03810534|12046257|FG003|Completed 30-Day (Patients)|Pre-Implementation Phase (2 Months)||0
10880368|NCT03810534|12046258|FG004|Completed 30-Day (Patients)|Pre-Implementation Phase (2 Months)||0
10880369|NCT03810534|12046259|FG005|Completed 30-Day (Patients)|Pre-Implementation Phase (2 Months)||0
10880370|NCT03810534|12046254|FG000|Completed 30-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0
10880371|NCT03810534|12046255|FG001|Completed 30-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0
10880372|NCT03810534|12046256|FG002|Completed 30-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0
10880373|NCT03810534|12046257|FG003|Completed 30-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0
10880374|NCT03810534|12046258|FG004|Completed 30-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0
10880375|NCT03810534|12046259|FG005|Completed 30-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0
10880376|NCT03810534|12046254|FG000|Completed 60-Day (Patients)|Pre-Implementation Phase (2 Months)||0
10880377|NCT03810534|12046255|FG001|Completed 60-Day (Patients)|Pre-Implementation Phase (2 Months)||0
10880378|NCT03810534|12046256|FG002|Completed 60-Day (Patients)|Pre-Implementation Phase (2 Months)||0
10880379|NCT03810534|12046257|FG003|Completed 60-Day (Patients)|Pre-Implementation Phase (2 Months)||0
10880380|NCT03810534|12046258|FG004|Completed 60-Day (Patients)|Pre-Implementation Phase (2 Months)||0
10880381|NCT03810534|12046259|FG005|Completed 60-Day (Patients)|Pre-Implementation Phase (2 Months)||0
10880382|NCT03810534|12046254|FG000|Completed 60-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0
10880383|NCT03810534|12046255|FG001|Completed 60-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0
10880384|NCT03810534|12046256|FG002|Completed 60-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0
10880385|NCT03810534|12046257|FG003|Completed 60-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0
10880386|NCT03810534|12046258|FG004|Completed 60-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0
10880387|NCT03810534|12046259|FG005|Completed 60-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0
10880388|NCT03810534|12046254|FG000|COMPLETED|Pre-Implementation Phase (2 Months)||0
10880389|NCT03810534|12046255|FG001|COMPLETED|Pre-Implementation Phase (2 Months)||0
10880390|NCT03810534|12046256|FG002|COMPLETED|Pre-Implementation Phase (2 Months)||0
10880391|NCT03810534|12046257|FG003|COMPLETED|Pre-Implementation Phase (2 Months)||0
10880392|NCT03810534|12046258|FG004|COMPLETED|Pre-Implementation Phase (2 Months)||0
10880393|NCT03810534|12046259|FG005|COMPLETED|Pre-Implementation Phase (2 Months)||0
10880394|NCT03810534|12046254|FG000|NOT COMPLETED|Pre-Implementation Phase (2 Months)||0
10880395|NCT03810534|12046255|FG001|NOT COMPLETED|Pre-Implementation Phase (2 Months)||0
10880396|NCT03810534|12046256|FG002|NOT COMPLETED|Pre-Implementation Phase (2 Months)||0
10880397|NCT03810534|12046257|FG003|NOT COMPLETED|Pre-Implementation Phase (2 Months)||0
10880398|NCT03810534|12046258|FG004|NOT COMPLETED|Pre-Implementation Phase (2 Months)||0
10880399|NCT03810534|12046259|FG005|NOT COMPLETED|Pre-Implementation Phase (2 Months)||0
10880400|NCT03810534|12046254|FG000|STARTED|Connect-Home (5-10 Months)||82
10880401|NCT03810534|12046255|FG001|STARTED|Connect-Home (5-10 Months)||80
10880402|NCT03810534|12046256|FG002|STARTED|Connect-Home (5-10 Months)||66
10880403|NCT03810534|12046257|FG003|STARTED|Connect-Home (5-10 Months)||54
10880404|NCT03810534|12046258|FG004|STARTED|Connect-Home (5-10 Months)||10
10880405|NCT03810534|12046259|FG005|STARTED|Connect-Home (5-10 Months)||38
10880406|NCT03810534|12046254|FG000|Patients Started|Connect-Home (5-10 Months)||41
10880407|NCT03810534|12046255|FG001|Patients Started|Connect-Home (5-10 Months)||40
10880408|NCT03810534|12046256|FG002|Patients Started|Connect-Home (5-10 Months)||33
10880409|NCT03810534|12046257|FG003|Patients Started|Connect-Home (5-10 Months)||27
10880410|NCT03810534|12046258|FG004|Patients Started|Connect-Home (5-10 Months)||5
10880411|NCT03810534|12046259|FG005|Patients Started|Connect-Home (5-10 Months)||19
10880412|NCT03810534|12046254|FG000|Caregivers Started|Connect-Home (5-10 Months)||41
10880413|NCT03810534|12046255|FG001|Caregivers Started|Connect-Home (5-10 Months)||40
10880414|NCT03810534|12046256|FG002|Caregivers Started|Connect-Home (5-10 Months)||33
10880415|NCT03810534|12046257|FG003|Caregivers Started|Connect-Home (5-10 Months)||27
10880416|NCT03810534|12046258|FG004|Caregivers Started|Connect-Home (5-10 Months)||5
10880417|NCT03810534|12046259|FG005|Caregivers Started|Connect-Home (5-10 Months)||19
10880418|NCT03810534|12046254|FG000|Completed 7-Day (Patients)|Connect-Home (5-10 Months)||38
10880419|NCT03810534|12046255|FG001|Completed 7-Day (Patients)|Connect-Home (5-10 Months)||35
10880420|NCT03810534|12046256|FG002|Completed 7-Day (Patients)|Connect-Home (5-10 Months)||27
10880421|NCT03810534|12046257|FG003|Completed 7-Day (Patients)|Connect-Home (5-10 Months)||23
10880422|NCT03810534|12046258|FG004|Completed 7-Day (Patients)|Connect-Home (5-10 Months)||4
10880423|NCT03810534|12046259|FG005|Completed 7-Day (Patients)|Connect-Home (5-10 Months)||14
10880424|NCT03810534|12046254|FG000|Completed 7-Day (Caregivers)|Connect-Home (5-10 Months)||35
10880425|NCT03810534|12046255|FG001|Completed 7-Day (Caregivers)|Connect-Home (5-10 Months)||34
10880426|NCT03810534|12046256|FG002|Completed 7-Day (Caregivers)|Connect-Home (5-10 Months)||29
10880427|NCT03810534|12046257|FG003|Completed 7-Day (Caregivers)|Connect-Home (5-10 Months)||24
10880428|NCT03810534|12046258|FG004|Completed 7-Day (Caregivers)|Connect-Home (5-10 Months)||4
10880429|NCT03810534|12046259|FG005|Completed 7-Day (Caregivers)|Connect-Home (5-10 Months)||13
10880430|NCT03810534|12046254|FG000|Completed 30-Day (Patients)|Connect-Home (5-10 Months)||35
10880431|NCT03810534|12046255|FG001|Completed 30-Day (Patients)|Connect-Home (5-10 Months)||31
10880432|NCT03810534|12046256|FG002|Completed 30-Day (Patients)|Connect-Home (5-10 Months)||25
10880433|NCT03810534|12046257|FG003|Completed 30-Day (Patients)|Connect-Home (5-10 Months)||19
10880434|NCT03810534|12046258|FG004|Completed 30-Day (Patients)|Connect-Home (5-10 Months)||3
10880435|NCT03810534|12046259|FG005|Completed 30-Day (Patients)|Connect-Home (5-10 Months)||12
10880436|NCT03810534|12046254|FG000|Completed 30-Day (Caregivers)|Connect-Home (5-10 Months)||34
10880437|NCT03810534|12046255|FG001|Completed 30-Day (Caregivers)|Connect-Home (5-10 Months)||30
10880438|NCT03810534|12046256|FG002|Completed 30-Day (Caregivers)|Connect-Home (5-10 Months)||25
10880439|NCT03810534|12046257|FG003|Completed 30-Day (Caregivers)|Connect-Home (5-10 Months)||21
10880440|NCT03810534|12046258|FG004|Completed 30-Day (Caregivers)|Connect-Home (5-10 Months)||2
10880441|NCT03810534|12046259|FG005|Completed 30-Day (Caregivers)|Connect-Home (5-10 Months)||10
10880442|NCT03810534|12046254|FG000|Completed 60-Day (Patients)|Connect-Home (5-10 Months)||30
10880443|NCT03810534|12046255|FG001|Completed 60-Day (Patients)|Connect-Home (5-10 Months)||25
10880444|NCT03810534|12046256|FG002|Completed 60-Day (Patients)|Connect-Home (5-10 Months)||23
10880445|NCT03810534|12046257|FG003|Completed 60-Day (Patients)|Connect-Home (5-10 Months)||19
10880446|NCT03810534|12046258|FG004|Completed 60-Day (Patients)|Connect-Home (5-10 Months)||2
10880447|NCT03810534|12046259|FG005|Completed 60-Day (Patients)|Connect-Home (5-10 Months)||10
10880448|NCT03810534|12046254|FG000|Completed 60-Day (Caregivers)|Connect-Home (5-10 Months)||32
10880449|NCT03810534|12046255|FG001|Completed 60-Day (Caregivers)|Connect-Home (5-10 Months)||27
10880450|NCT03810534|12046256|FG002|Completed 60-Day (Caregivers)|Connect-Home (5-10 Months)||21
10880451|NCT03810534|12046257|FG003|Completed 60-Day (Caregivers)|Connect-Home (5-10 Months)||19
10880452|NCT03810534|12046258|FG004|Completed 60-Day (Caregivers)|Connect-Home (5-10 Months)||2
10880453|NCT03810534|12046259|FG005|Completed 60-Day (Caregivers)|Connect-Home (5-10 Months)||9
10880454|NCT03810534|12046254|FG000|COMPLETED|Connect-Home (5-10 Months)||62
10880455|NCT03810534|12046255|FG001|COMPLETED|Connect-Home (5-10 Months)||52
10880456|NCT03810534|12046256|FG002|COMPLETED|Connect-Home (5-10 Months)||44
10880457|NCT03810534|12046257|FG003|COMPLETED|Connect-Home (5-10 Months)||38
10880458|NCT03810534|12046258|FG004|COMPLETED|Connect-Home (5-10 Months)||4
10880459|NCT03810534|12046259|FG005|COMPLETED|Connect-Home (5-10 Months)||19
10880460|NCT03810534|12046254|FG000|NOT COMPLETED|Connect-Home (5-10 Months)||20
10880461|NCT03810534|12046255|FG001|NOT COMPLETED|Connect-Home (5-10 Months)||28
10880462|NCT03810534|12046256|FG002|NOT COMPLETED|Connect-Home (5-10 Months)||22
10880463|NCT03810534|12046257|FG003|NOT COMPLETED|Connect-Home (5-10 Months)||16
10880464|NCT03810534|12046258|FG004|NOT COMPLETED|Connect-Home (5-10 Months)||6
10880465|NCT03810534|12046259|FG005|NOT COMPLETED|Connect-Home (5-10 Months)||19
10880466|NCT03810495|12046268|FG000|STARTED|Overall Study||20
10880467|NCT03810495|12046268|FG000|COMPLETED|Overall Study||17
10880468|NCT03810495|12046268|FG000|NOT COMPLETED|Overall Study||3
10880469|NCT03810313|12046274|FG000|STARTED|Overall Study||247
10880470|NCT03810313|12046275|FG001|STARTED|Overall Study||246
10880471|NCT03810313|12046274|FG000|COMPLETED|Overall Study||66
10880472|NCT03810313|12046275|FG001|COMPLETED|Overall Study||70
10880473|NCT03810313|12046274|FG000|NOT COMPLETED|Overall Study||181
10880474|NCT03810313|12046275|FG001|NOT COMPLETED|Overall Study||176
10880475|NCT03807843|12046284|FG000|STARTED|Overall Study||21
10880476|NCT03807843|12046285|FG001|STARTED|Overall Study||20
10880477|NCT03807843|12046284|FG000|COMPLETED|Overall Study||20
10880478|NCT03807843|12046285|FG001|COMPLETED|Overall Study||20
10880479|NCT03807843|12046284|FG000|NOT COMPLETED|Overall Study||1
10880480|NCT03807843|12046285|FG001|NOT COMPLETED|Overall Study||0
10880481|NCT03804879|12046293|FG000|STARTED|Overall Study||41
10880482|NCT03804879|12046294|FG001|STARTED|Overall Study||42
10880483|NCT03804879|12046293|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study||41
10880484|NCT03804879|12046294|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study||0
10880485|NCT03804879|12046293|FG000|Pharmacodynamics (PD) Analysis Set|Overall Study||41
10880486|NCT03804879|12046294|FG001|Pharmacodynamics (PD) Analysis Set|Overall Study||41
10880487|NCT03804879|12046293|FG000|COMPLETED|Overall Study||25
10880488|NCT03804879|12046294|FG001|COMPLETED|Overall Study||29
10880489|NCT03804879|12046293|FG000|NOT COMPLETED|Overall Study||16
10880490|NCT03804879|12046294|FG001|NOT COMPLETED|Overall Study||13
10880491|NCT03802630|12046303|FG000|STARTED|Overall Study||226
10880492|NCT03802630|12046304|FG001|STARTED|Overall Study||224
10880493|NCT03802630|12046303|FG000|COMPLETED|Overall Study||73
10880494|NCT03802630|12046304|FG001|COMPLETED|Overall Study||76
10880495|NCT03802630|12046303|FG000|NOT COMPLETED|Overall Study||153
10880496|NCT03802630|12046304|FG001|NOT COMPLETED|Overall Study||148
10880497|NCT03794882|12046313|FG000|STARTED|Overall Study||8
10880498|NCT03794882|12046314|FG001|STARTED|Overall Study||6
10880499|NCT03794882|12046313|FG000|COMPLETED|Overall Study||8
10880500|NCT03794882|12046314|FG001|COMPLETED|Overall Study||6
10880501|NCT03794882|12046313|FG000|NOT COMPLETED|Overall Study||0
10880502|NCT03794882|12046314|FG001|NOT COMPLETED|Overall Study||0
10880503|NCT03794700|12046323|FG000|STARTED|Overall Study||43
10880504|NCT03794700|12046324|FG001|STARTED|Overall Study||88
10880505|NCT03794700|12046323|FG000|COMPLETED|Overall Study||43
10880506|NCT03794700|12046324|FG001|COMPLETED|Overall Study||88
10880507|NCT03794700|12046323|FG000|NOT COMPLETED|Overall Study||0
10880508|NCT03794700|12046324|FG001|NOT COMPLETED|Overall Study||0
10880509|NCT03789214|12046333|FG000|STARTED|Overall Study||12
10880510|NCT03789214|12046334|FG001|STARTED|Overall Study||14
10880511|NCT03789214|12046335|FG002|STARTED|Overall Study||12
10880512|NCT03789214|12046333|FG000|COMPLETED|Overall Study||8
10880513|NCT03789214|12046334|FG001|COMPLETED|Overall Study||9
10880514|NCT03789214|12046335|FG002|COMPLETED|Overall Study||9
10880515|NCT03789214|12046333|FG000|NOT COMPLETED|Overall Study||4
10880516|NCT03789214|12046334|FG001|NOT COMPLETED|Overall Study||5
10880517|NCT03789214|12046335|FG002|NOT COMPLETED|Overall Study||3
10880518|NCT03789110|12046344|FG000|STARTED|Overall Study||30
10880519|NCT03789110|12046344|FG000|COMPLETED|Overall Study||0
10880520|NCT03789110|12046344|FG000|NOT COMPLETED|Overall Study||30
10880521|NCT03783533|12046348|FG000|STARTED|Overall Study||11
10880522|NCT03783533|12046348|FG000|COMPLETED|Overall Study||7
10880523|NCT03783533|12046348|FG000|NOT COMPLETED|Overall Study||4
10880524|NCT03782064|12046352|FG000|STARTED|Overall Study||5
10880525|NCT03782064|12046352|FG000|Initiated Treatment|Overall Study||2
10880526|NCT03782064|12046352|FG000|COMPLETED|Overall Study||0
10880527|NCT03782064|12046352|FG000|NOT COMPLETED|Overall Study||5
10880528|NCT03777917|12046358|FG000|STARTED|Overall Study||43
10880529|NCT03777917|12046359|FG001|STARTED|Overall Study||23
10880530|NCT03777917|12046358|FG000|Safety Population|Overall Study||43
10880531|NCT03777917|12046359|FG001|Safety Population|Overall Study||22
10880532|NCT03777917|12046358|FG000|COMPLETED|Overall Study||34
10880533|NCT03777917|12046359|FG001|COMPLETED|Overall Study||21
10880534|NCT03777917|12046358|FG000|NOT COMPLETED|Overall Study||9
10880535|NCT03777917|12046359|FG001|NOT COMPLETED|Overall Study||2
10880536|NCT03774875|12046368|FG000|STARTED|Placebo-controlled Period (Week 1-16)||92
10880537|NCT03774875|12046369|FG001|STARTED|Placebo-controlled Period (Week 1-16)||185
10880538|NCT03774875|12046368|FG000|Received Study Drug|Placebo-controlled Period (Week 1-16)||91
10880539|NCT03774875|12046369|FG001|Received Study Drug|Placebo-controlled Period (Week 1-16)||185
10880540|NCT03774875|12046368|FG000|COMPLETED|Placebo-controlled Period (Week 1-16)||69
10880541|NCT03774875|12046369|FG001|COMPLETED|Placebo-controlled Period (Week 1-16)||152
10880542|NCT03774875|12046368|FG000|NOT COMPLETED|Placebo-controlled Period (Week 1-16)||23
10880543|NCT03774875|12046369|FG001|NOT COMPLETED|Placebo-controlled Period (Week 1-16)||33
10880544|NCT03774875|12046368|FG000|STARTED|Apremilast Extension Period (Week 16-52)||69
10880545|NCT03774875|12046369|FG001|STARTED|Apremilast Extension Period (Week 16-52)||152
10880546|NCT03774875|12046368|FG000|COMPLETED|Apremilast Extension Period (Week 16-52)||53
10880547|NCT03774875|12046369|FG001|COMPLETED|Apremilast Extension Period (Week 16-52)||105
10880548|NCT03774875|12046368|FG000|NOT COMPLETED|Apremilast Extension Period (Week 16-52)||16
10880549|NCT03774875|12046369|FG001|NOT COMPLETED|Apremilast Extension Period (Week 16-52)||47
10880550|NCT03774407|12046380|FG000|STARTED|Overall Study||21
10880551|NCT03774407|12046380|FG000|COMPLETED|Overall Study||12
10880552|NCT03774407|12046380|FG000|NOT COMPLETED|Overall Study||9
10880553|NCT03773484|12046386|FG000|STARTED|Pre-intervention||41
10880554|NCT03773484|12046386|FG000|COMPLETED|Pre-intervention||41
10880555|NCT03773484|12046386|FG000|NOT COMPLETED|Pre-intervention||0
10880556|NCT03773484|12046386|FG000|STARTED|Post-intervention||41
10880557|NCT03773484|12046386|FG000|COMPLETED|Post-intervention||36
10880558|NCT03773484|12046386|FG000|NOT COMPLETED|Post-intervention||5
10880559|NCT03773133|12046390|FG000|STARTED|Overall Study||8
10880560|NCT03773133|12046390|FG000|Received the Screening IIP|Overall Study||8
10880561|NCT03773133|12046390|FG000|Received the Therapeutic IRPP|Overall Study||0
10880562|NCT03773133|12046390|FG000|COMPLETED|Overall Study||0
10880563|NCT03773133|12046390|FG000|NOT COMPLETED|Overall Study||8
10880564|NCT03769753|12046395|FG000|STARTED|Overall Study||8
10880565|NCT03769753|12046395|FG000|COMPLETED|Overall Study||1
10880566|NCT03769753|12046395|FG000|NOT COMPLETED|Overall Study||7
10880567|NCT03769090|12046402|FG000|STARTED|Overall Study||1016
10880568|NCT03769090|12046403|FG001|STARTED|Overall Study||1057
10880569|NCT03769090|12046404|FG002|STARTED|Overall Study||1059
10880570|NCT03769090|12046402|FG000|COMPLETED|Overall Study||915
10880571|NCT03769090|12046403|FG001|COMPLETED|Overall Study||933
10880572|NCT03769090|12046404|FG002|COMPLETED|Overall Study||916
10880573|NCT03769090|12046402|FG000|NOT COMPLETED|Overall Study||101
10880574|NCT03769090|12046403|FG001|NOT COMPLETED|Overall Study||124
10880575|NCT03769090|12046404|FG002|NOT COMPLETED|Overall Study||143
10880576|NCT03764475|12046417|FG000|STARTED|Overall Study||230
10880577|NCT03764475|12046418|FG001|STARTED|Overall Study||102
10880578|NCT03764475|12046417|FG000|COMPLETED|Overall Study||164
10880579|NCT03764475|12046418|FG001|COMPLETED|Overall Study||80
10880580|NCT03764475|12046417|FG000|NOT COMPLETED|Overall Study||66
10880581|NCT03764475|12046418|FG001|NOT COMPLETED|Overall Study||22
10880582|NCT03762265|12046430|FG000|STARTED|BT Period: Weeks 1 to 37||66
10880583|NCT03762265|12046431|FG001|STARTED|BT Period: Weeks 1 to 37||65
10880584|NCT03762265|12046430|FG000|COMPLETED|BT Period: Weeks 1 to 37||51
10880585|NCT03762265|12046431|FG001|COMPLETED|BT Period: Weeks 1 to 37||62
10880586|NCT03762265|12046430|FG000|NOT COMPLETED|BT Period: Weeks 1 to 37||15
10880587|NCT03762265|12046431|FG001|NOT COMPLETED|BT Period: Weeks 1 to 37||3
10880588|NCT03762265|12046430|FG000|STARTED|OLE Period: Weeks 37 to 61||51
10880589|NCT03762265|12046431|FG001|STARTED|OLE Period: Weeks 37 to 61|One participant did not enter OLE Period.|61
10880590|NCT03762265|12046430|FG000|COMPLETED|OLE Period: Weeks 37 to 61||35
10880591|NCT03762265|12046431|FG001|COMPLETED|OLE Period: Weeks 37 to 61||45
10880592|NCT03762265|12046430|FG000|NOT COMPLETED|OLE Period: Weeks 37 to 61||16
10880593|NCT03762265|12046431|FG001|NOT COMPLETED|OLE Period: Weeks 37 to 61||16
10880594|NCT03762265|12046430|FG000|STARTED|LTE Period: Weeks 61 to 109||35
10880595|NCT03762265|12046431|FG001|STARTED|LTE Period: Weeks 61 to 109|11 participants did not enter LTE Period.|34
10880596|NCT03762265|12046430|FG000|COMPLETED|LTE Period: Weeks 61 to 109||6
10880597|NCT03762265|12046431|FG001|COMPLETED|LTE Period: Weeks 61 to 109||6
10880598|NCT03762265|12046430|FG000|NOT COMPLETED|LTE Period: Weeks 61 to 109||29
10880599|NCT03762265|12046431|FG001|NOT COMPLETED|LTE Period: Weeks 61 to 109||28
10880600|NCT03760666|12046456|FG000|STARTED|Overall Study||5
10880601|NCT03760666|12046457|FG001|STARTED|Overall Study||11
10880602|NCT03760666|12046458|FG002|STARTED|Overall Study||1
10880603|NCT03760666|12046456|FG000|COMPLETED|Overall Study||0
10880604|NCT03760666|12046457|FG001|COMPLETED|Overall Study||0
10880605|NCT03760666|12046458|FG002|COMPLETED|Overall Study||0
10880606|NCT03760666|12046456|FG000|NOT COMPLETED|Overall Study||5
10880607|NCT03760666|12046457|FG001|NOT COMPLETED|Overall Study||11
10880608|NCT03760666|12046458|FG002|NOT COMPLETED|Overall Study||1
10880609|NCT03759379|12046472|FG000|STARTED|Treatment Period||122
10880610|NCT03759379|12046473|FG001|STARTED|Treatment Period||42
10880611|NCT03759379|12046472|FG000|COMPLETED|Treatment Period||0
10880612|NCT03759379|12046473|FG001|COMPLETED|Treatment Period||0
10880613|NCT03759379|12046472|FG000|NOT COMPLETED|Treatment Period||122
10880614|NCT03759379|12046473|FG001|NOT COMPLETED|Treatment Period||42
10880615|NCT03759379|12046472|FG000|STARTED|Randomized Treatment Extension Period||0
10880616|NCT03759379|12046473|FG001|STARTED|Randomized Treatment Extension Period||0
10880617|NCT03759379|12046472|FG000|COMPLETED|Randomized Treatment Extension Period||0
10880618|NCT03759379|12046473|FG001|COMPLETED|Randomized Treatment Extension Period||0
10880619|NCT03759379|12046472|FG000|NOT COMPLETED|Randomized Treatment Extension Period||0
10880620|NCT03759379|12046473|FG001|NOT COMPLETED|Randomized Treatment Extension Period||0
10880621|NCT03759366|12046479|FG000|STARTED|Primary Evaluation Period (26 Weeks)||11
10880622|NCT03759366|12046479|FG000|COMPLETED|Primary Evaluation Period (26 Weeks)||10
10880623|NCT03759366|12046479|FG000|NOT COMPLETED|Primary Evaluation Period (26 Weeks)||1
10880624|NCT03759366|12046479|FG000|STARTED|Extension Period (Up to 208 Weeks)||10
10880625|NCT03759366|12046479|FG000|COMPLETED|Extension Period (Up to 208 Weeks)||0
10880626|NCT03759366|12046479|FG000|NOT COMPLETED|Extension Period (Up to 208 Weeks)||10
10880627|NCT03759041|12046486|FG000|STARTED|Overall Study||69
10880628|NCT03759041|12046487|FG001|STARTED|Overall Study||68
10880629|NCT03759041|12046488|FG002|STARTED|Overall Study||66
10880630|NCT03759041|12046486|FG000|COMPLETED|Overall Study||42
10880631|NCT03759041|12046487|FG001|COMPLETED|Overall Study||34
10880632|NCT03759041|12046488|FG002|COMPLETED|Overall Study||38
10880633|NCT03759041|12046486|FG000|NOT COMPLETED|Overall Study||27
10880634|NCT03759041|12046487|FG001|NOT COMPLETED|Overall Study||34
10880635|NCT03759041|12046488|FG002|NOT COMPLETED|Overall Study||28
10880636|NCT03757715|12046498|FG000|STARTED|Overall Study||21
10880637|NCT03757715|12046499|FG001|STARTED|Overall Study||25
10880638|NCT03757715|12046498|FG000|COMPLETED|Overall Study||16
10880639|NCT03757715|12046499|FG001|COMPLETED|Overall Study||15
10880640|NCT03757715|12046498|FG000|NOT COMPLETED|Overall Study||5
10880641|NCT03757715|12046499|FG001|NOT COMPLETED|Overall Study||10
10880642|NCT03753542|12046507|FG000|STARTED|Overall Study|Actual Calculated Sample size was 30 Sample, 100 was taken to restore lost to follow up|50
10880643|NCT03753542|12046508|FG001|STARTED|Overall Study|Actual Calculated Sample size was 30 Sample, 100 was taken to restore lost to follow up|50
10880644|NCT03753542|12046507|FG000|COMPLETED|Overall Study|In spite of having lost to follow up the power of study was not lost|41
10880645|NCT03753542|12046508|FG001|COMPLETED|Overall Study|In spite of having lost to follow up the power of study was not lost|36
10880646|NCT03753542|12046507|FG000|NOT COMPLETED|Overall Study||9
10880647|NCT03753542|12046508|FG001|NOT COMPLETED|Overall Study||14
10880648|NCT03750552|12046516|FG000|STARTED|Overall Study||98
10880649|NCT03750552|12046517|FG001|STARTED|Overall Study||97
10880650|NCT03750552|12046516|FG000|Safety Analysis Set|Overall Study||96
10880651|NCT03750552|12046517|FG001|Safety Analysis Set|Overall Study||90
10880652|NCT03750552|12046516|FG000|Full Analysis Set|Overall Study||94
10880653|NCT03750552|12046517|FG001|Full Analysis Set|Overall Study||90
10880654|NCT03750552|12046516|FG000|COMPLETED|Overall Study||90
10880655|NCT03750552|12046517|FG001|COMPLETED|Overall Study||95
10880656|NCT03750552|12046516|FG000|NOT COMPLETED|Overall Study||8
10880657|NCT03750552|12046517|FG001|NOT COMPLETED|Overall Study||2
10880658|NCT03750240|12046524|FG000|STARTED|Overall Study||2
10880659|NCT03750240|12046524|FG000|COMPLETED|Overall Study||0
10880660|NCT03750240|12046524|FG000|NOT COMPLETED|Overall Study||2
10880661|NCT03749109|12046530|FG000|STARTED|Overall Study||35
10880662|NCT03749109|12046531|FG001|STARTED|Overall Study||32
10880663|NCT03749109|12046530|FG000|COMPLETED|Overall Study||33
10880664|NCT03749109|12046531|FG001|COMPLETED|Overall Study||32
10880665|NCT03749109|12046530|FG000|NOT COMPLETED|Overall Study||2
10880666|NCT03749109|12046531|FG001|NOT COMPLETED|Overall Study||0
10880667|NCT03747302|12046540|FG000|STARTED|Overall Study||834
10880668|NCT03747302|12046541|FG001|STARTED|Overall Study||164
10880669|NCT03747302|12046540|FG000|COMPLETED|Overall Study||833
10880670|NCT03747302|12046541|FG001|COMPLETED|Overall Study||162
10880671|NCT03747302|12046540|FG000|NOT COMPLETED|Overall Study||1
10880672|NCT03747302|12046541|FG001|NOT COMPLETED|Overall Study||2
10880673|NCT03744598|12046549|FG000|STARTED|Overall Study||20
10880674|NCT03744598|12046549|FG000|COMPLETED|Overall Study||19
10880675|NCT03744598|12046549|FG000|NOT COMPLETED|Overall Study||1
10880676|NCT03739203|12046556|FG000|STARTED|Double-blind Treatment Period (6 Weeks)||250
10880677|NCT03739203|12046557|FG001|STARTED|Double-blind Treatment Period (6 Weeks)||250
10880678|NCT03739203|12046558|FG002|STARTED|Double-blind Treatment Period (6 Weeks)||251
10880679|NCT03739203|12046556|FG000|Modified Intent-to Treat (mITT) Population|Double-blind Treatment Period (6 Weeks)||249
10880680|NCT03739203|12046557|FG001|Modified Intent-to Treat (mITT) Population|Double-blind Treatment Period (6 Weeks)||250
10880681|NCT03739203|12046558|FG002|Modified Intent-to Treat (mITT) Population|Double-blind Treatment Period (6 Weeks)||251
10880682|NCT03739203|12046556|FG000|COMPLETED|Double-blind Treatment Period (6 Weeks)||235
10880683|NCT03739203|12046557|FG001|COMPLETED|Double-blind Treatment Period (6 Weeks)||233
10880684|NCT03739203|12046558|FG002|COMPLETED|Double-blind Treatment Period (6 Weeks)||226
10880685|NCT03739203|12046556|FG000|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||15
10880686|NCT03739203|12046557|FG001|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||17
10880687|NCT03739203|12046558|FG002|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||25
10880688|NCT03739203|12046556|FG000|STARTED|Safety Follow-Up Period (4 Weeks)||242
10880689|NCT03739203|12046557|FG001|STARTED|Safety Follow-Up Period (4 Weeks)||242
10880690|NCT03739203|12046558|FG002|STARTED|Safety Follow-Up Period (4 Weeks)||242
10880691|NCT03739203|12046556|FG000|COMPLETED|Safety Follow-Up Period (4 Weeks)||240
10880692|NCT03739203|12046557|FG001|COMPLETED|Safety Follow-Up Period (4 Weeks)||240
10880693|NCT03739203|12046558|FG002|COMPLETED|Safety Follow-Up Period (4 Weeks)||238
10880694|NCT03739203|12046556|FG000|NOT COMPLETED|Safety Follow-Up Period (4 Weeks)||2
10880695|NCT03739203|12046557|FG001|NOT COMPLETED|Safety Follow-Up Period (4 Weeks)||2
10880696|NCT03739203|12046558|FG002|NOT COMPLETED|Safety Follow-Up Period (4 Weeks)||4
10880697|NCT03736928|12046571|FG000|STARTED|Overall Study||80
10880698|NCT03736928|12046572|FG001|STARTED|Overall Study||80
10880699|NCT03736928|12046573|FG002|STARTED|Overall Study||80
10880700|NCT03736928|12046574|FG003|STARTED|Overall Study||81
10880701|NCT03736928|12046575|FG004|STARTED|Overall Study||78
10880702|NCT03736928|12046571|FG000|COMPLETED|Overall Study||73
10880703|NCT03736928|12046572|FG001|COMPLETED|Overall Study||78
10880704|NCT03736928|12046573|FG002|COMPLETED|Overall Study||75
10880705|NCT03736928|12046574|FG003|COMPLETED|Overall Study||76
10880706|NCT03736928|12046575|FG004|COMPLETED|Overall Study||67
10880707|NCT03736928|12046571|FG000|NOT COMPLETED|Overall Study||7
10880708|NCT03736928|12046572|FG001|NOT COMPLETED|Overall Study||2
10880709|NCT03736928|12046573|FG002|NOT COMPLETED|Overall Study||5
10880710|NCT03736928|12046574|FG003|NOT COMPLETED|Overall Study||5
10880711|NCT03736928|12046575|FG004|NOT COMPLETED|Overall Study||11
10880712|NCT03733444|12046590|FG000|STARTED|Overall Study||260
10880713|NCT03733444|12046591|FG001|STARTED|Overall Study||262
10880714|NCT03733444|12046592|FG002|STARTED|Overall Study||259
10880715|NCT03733444|12046590|FG000|Treated|Overall Study||259
10880716|NCT03733444|12046591|FG001|Treated|Overall Study||260
10880717|NCT03733444|12046592|FG002|Treated|Overall Study||258
10880718|NCT03733444|12046590|FG000|COMPLETED|Overall Study||0
10880719|NCT03733444|12046591|FG001|COMPLETED|Overall Study||0
10880720|NCT03733444|12046592|FG002|COMPLETED|Overall Study||0
10880721|NCT03733444|12046590|FG000|NOT COMPLETED|Overall Study||260
10880722|NCT03733444|12046591|FG001|NOT COMPLETED|Overall Study||262
10880723|NCT03733444|12046592|FG002|NOT COMPLETED|Overall Study||259
10880724|NCT03730012|12046612|FG000|STARTED|Overall Study||3
10880725|NCT03730012|12046613|FG001|STARTED|Overall Study||8
10880726|NCT03730012|12046612|FG000|COMPLETED|Overall Study||0
10880727|NCT03730012|12046613|FG001|COMPLETED|Overall Study||0
10880728|NCT03730012|12046612|FG000|NOT COMPLETED|Overall Study||3
10880729|NCT03730012|12046613|FG001|NOT COMPLETED|Overall Study||8
10880730|NCT03727841|12046624|FG000|STARTED|Overall Study||3
10880731|NCT03727841|12046625|FG001|STARTED|Overall Study||1
10880732|NCT03727841|12046624|FG000|COMPLETED|Overall Study||0
10880733|NCT03727841|12046625|FG001|COMPLETED|Overall Study||0
10880734|NCT03727841|12046624|FG000|NOT COMPLETED|Overall Study||3
10880735|NCT03727841|12046625|FG001|NOT COMPLETED|Overall Study||1
10880736|NCT03726879|12046633|FG000|STARTED|Overall Study||226
10880737|NCT03726879|12046634|FG001|STARTED|Overall Study||228
10880738|NCT03726879|12046633|FG000|COMPLETED|Overall Study||0
10880739|NCT03726879|12046634|FG001|COMPLETED|Overall Study||0
10880740|NCT03726879|12046633|FG000|NOT COMPLETED|Overall Study||226
10880741|NCT03726879|12046634|FG001|NOT COMPLETED|Overall Study||228
10880742|NCT03724487|12046642|FG000|STARTED|Overall Study||30
10880743|NCT03724487|12046643|FG001|STARTED|Overall Study||30
10880744|NCT03724487|12046642|FG000|COMPLETED|Overall Study||30
10880745|NCT03724487|12046643|FG001|COMPLETED|Overall Study||30
10880746|NCT03724487|12046642|FG000|NOT COMPLETED|Overall Study||0
10880747|NCT03724487|12046643|FG001|NOT COMPLETED|Overall Study||0
10880748|NCT03719287|12046653|FG000|STARTED|Overall Study||100
10880749|NCT03719287|12046654|FG001|STARTED|Overall Study||99
10880750|NCT03719287|12046655|FG002|STARTED|Overall Study||96
10880751|NCT03719287|12046653|FG000|COMPLETED|Overall Study||100
10880752|NCT03719287|12046654|FG001|COMPLETED|Overall Study||99
10880753|NCT03719287|12046655|FG002|COMPLETED|Overall Study||96
10880754|NCT03719287|12046653|FG000|NOT COMPLETED|Overall Study||0
10880755|NCT03719287|12046654|FG001|NOT COMPLETED|Overall Study||0
10880756|NCT03719287|12046655|FG002|NOT COMPLETED|Overall Study||0
10880757|NCT03714620|12046665|FG000|STARTED|Overall Study||49
10880758|NCT03714620|12046666|FG001|STARTED|Overall Study||49
10880759|NCT03714620|12046665|FG000|COMPLETED|Overall Study||49
10880760|NCT03714620|12046666|FG001|COMPLETED|Overall Study||49
10880761|NCT03714620|12046665|FG000|NOT COMPLETED|Overall Study||0
10880762|NCT03714620|12046666|FG001|NOT COMPLETED|Overall Study||0
10880763|NCT03714425|12046674|FG000|STARTED|Overall Study||62
10880764|NCT03714425|12046675|FG001|STARTED|Overall Study||57
10880765|NCT03714425|12046674|FG000|COMPLETED|Overall Study||55
10880766|NCT03714425|12046675|FG001|COMPLETED|Overall Study||46
10880767|NCT03714425|12046674|FG000|NOT COMPLETED|Overall Study||7
10880768|NCT03714425|12046675|FG001|NOT COMPLETED|Overall Study||11
10880769|NCT03712787|12046685|FG000|STARTED|Overall Study||87
10880770|NCT03712787|12046686|FG001|STARTED|Overall Study||97
10880771|NCT03712787|12046687|FG002|STARTED|Overall Study||88
10880772|NCT03712787|12046688|FG003|STARTED|Overall Study||91
10880773|NCT03712787|12046685|FG000|COMPLETED|Overall Study||0
10880774|NCT03712787|12046686|FG001|COMPLETED|Overall Study||0
10880775|NCT03712787|12046687|FG002|COMPLETED|Overall Study||0
10880776|NCT03712787|12046688|FG003|COMPLETED|Overall Study||0
10880777|NCT03712787|12046685|FG000|NOT COMPLETED|Overall Study||87
10880778|NCT03712787|12046686|FG001|NOT COMPLETED|Overall Study||97
10880779|NCT03712787|12046687|FG002|NOT COMPLETED|Overall Study||88
10880780|NCT03712787|12046688|FG003|NOT COMPLETED|Overall Study||91
10880781|NCT03711162|12046701|FG000|STARTED|Overall Study||175
10880782|NCT03711162|12046702|FG001|STARTED|Overall Study||175
10880783|NCT03711162|12046703|FG002|STARTED|Overall Study||175
10880784|NCT03711162|12046701|FG000|Treated|Overall Study||174
10880785|NCT03711162|12046702|FG001|Treated|Overall Study||175
10880786|NCT03711162|12046703|FG002|Treated|Overall Study||174
10880787|NCT03711162|12046701|FG000|COMPLETED|Overall Study||0
10880788|NCT03711162|12046702|FG001|COMPLETED|Overall Study||0
10880789|NCT03711162|12046703|FG002|COMPLETED|Overall Study||0
10880790|NCT03711162|12046701|FG000|NOT COMPLETED|Overall Study||175
10880791|NCT03711162|12046702|FG001|NOT COMPLETED|Overall Study||175
10880792|NCT03711162|12046703|FG002|NOT COMPLETED|Overall Study||175
10880793|NCT03706456|12046717|FG000|STARTED|Overall Study||22
10880794|NCT03706456|12046717|FG000|Started|Overall Study||22
10880795|NCT03706456|12046717|FG000|Completed|Overall Study||0
10880796|NCT03706456|12046717|FG000|COMPLETED|Overall Study||0
10880797|NCT03706456|12046717|FG000|NOT COMPLETED|Overall Study||22
10880798|NCT03705793|12046723|FG000|STARTED|Overall Study||27
10880799|NCT03705793|12046724|FG001|STARTED|Overall Study||26
10880800|NCT03705793|12046723|FG000|COMPLETED|Overall Study||22
10880801|NCT03705793|12046724|FG001|COMPLETED|Overall Study||21
10880802|NCT03705793|12046723|FG000|NOT COMPLETED|Overall Study||5
10880803|NCT03705793|12046724|FG001|NOT COMPLETED|Overall Study||5
10880804|NCT03703466|12046733|FG000|STARTED|Overall Study||24
10880805|NCT03703466|12046734|FG001|STARTED|Overall Study||24
10880806|NCT03703466|12046735|FG002|STARTED|Overall Study||24
10880807|NCT03703466|12046733|FG000|Received at Least One Dose of Study Drug|Overall Study||24
10880808|NCT03703466|12046734|FG001|Received at Least One Dose of Study Drug|Overall Study||23
10880809|NCT03703466|12046735|FG002|Received at Least One Dose of Study Drug|Overall Study||24
10880810|NCT03703466|12046733|FG000|COMPLETED|Overall Study||20
10880811|NCT03703466|12046734|FG001|COMPLETED|Overall Study||18
10880812|NCT03703466|12046735|FG002|COMPLETED|Overall Study||22
10880813|NCT03703466|12046733|FG000|NOT COMPLETED|Overall Study||4
10880814|NCT03703466|12046734|FG001|NOT COMPLETED|Overall Study||6
10880815|NCT03703466|12046735|FG002|NOT COMPLETED|Overall Study||2
10880816|NCT03700047|12046747|FG000|STARTED|Overall Study||142
10880817|NCT03700047|12046748|FG001|STARTED|Overall Study||60
10880818|NCT03700047|12046749|FG002|STARTED|Overall Study||68
10880819|NCT03700047|12046747|FG000|COMPLETED|Overall Study||126
10880820|NCT03700047|12046748|FG001|COMPLETED|Overall Study||50
10880821|NCT03700047|12046749|FG002|COMPLETED|Overall Study||58
10880822|NCT03700047|12046747|FG000|NOT COMPLETED|Overall Study||16
10880823|NCT03700047|12046748|FG001|NOT COMPLETED|Overall Study||10
10880824|NCT03700047|12046749|FG002|NOT COMPLETED|Overall Study||10
10880825|NCT03693612|12046764|FG000|STARTED|Overall Study||1
10880826|NCT03693612|12046765|FG001|STARTED|Overall Study||1
10880827|NCT03693612|12046766|FG002|STARTED|Overall Study||5
10880828|NCT03693612|12046767|FG003|STARTED|Overall Study||3
10880829|NCT03693612|12046768|FG004|STARTED|Overall Study||16
10880830|NCT03693612|12046769|FG005|STARTED|Overall Study||0
10880831|NCT03693612|12046770|FG006|STARTED|Overall Study||0
10880832|NCT03693612|12046764|FG000|COMPLETED|Overall Study||1
10880833|NCT03693612|12046765|FG001|COMPLETED|Overall Study||0
10880834|NCT03693612|12046766|FG002|COMPLETED|Overall Study||4
10880835|NCT03693612|12046767|FG003|COMPLETED|Overall Study||3
10880836|NCT03693612|12046768|FG004|COMPLETED|Overall Study||10
10880837|NCT03693612|12046769|FG005|COMPLETED|Overall Study||0
10880838|NCT03693612|12046770|FG006|COMPLETED|Overall Study||0
10880839|NCT03693612|12046764|FG000|NOT COMPLETED|Overall Study||0
10880840|NCT03693612|12046765|FG001|NOT COMPLETED|Overall Study||1
10880841|NCT03693612|12046766|FG002|NOT COMPLETED|Overall Study||1
10880842|NCT03693612|12046767|FG003|NOT COMPLETED|Overall Study||0
10880843|NCT03693612|12046768|FG004|NOT COMPLETED|Overall Study||6
10880844|NCT03693612|12046769|FG005|NOT COMPLETED|Overall Study||0
10880845|NCT03693612|12046770|FG006|NOT COMPLETED|Overall Study||0
10880846|NCT03693170|12046786|FG000|STARTED|Overall Study||95
10880847|NCT03693170|12046786|FG000|COMPLETED|Overall Study|Participants with study treatment ongoing at the time of cut off date (29JUN2020)|20
10880848|NCT03693170|12046786|FG000|NOT COMPLETED|Overall Study||75
10880849|NCT03692871|12046793|FG000|STARTED|Overall Study||1972
10880850|NCT03692871|12046794|FG001|STARTED|Overall Study||437
10880851|NCT03692871|12046793|FG000|COMPLETED|Overall Study||1847
10880852|NCT03692871|12046794|FG001|COMPLETED|Overall Study||400
10880853|NCT03692871|12046793|FG000|NOT COMPLETED|Overall Study||125
10880854|NCT03692871|12046794|FG001|NOT COMPLETED|Overall Study||37
10880855|NCT03689855|12046800|FG000|STARTED|Overall Study||21
10880856|NCT03689855|12046800|FG000|COMPLETED|Overall Study||17
10880857|NCT03689855|12046800|FG000|NOT COMPLETED|Overall Study||4
10880858|NCT03687736|12046804|FG000|STARTED|Overall Study||120
10880859|NCT03687736|12046804|FG000|COMPLETED|Overall Study||110
10880860|NCT03687736|12046804|FG000|NOT COMPLETED|Overall Study||10
10880861|NCT03684408|12046813|FG000|STARTED|Overall Study||10
10880862|NCT03684408|12046814|FG001|STARTED|Overall Study||16
10880863|NCT03684408|12046815|FG002|STARTED|Overall Study||12
10880864|NCT03684408|12046813|FG000|COMPLETED|Overall Study||9
10880865|NCT03684408|12046814|FG001|COMPLETED|Overall Study||15
10880866|NCT03684408|12046815|FG002|COMPLETED|Overall Study||12
10880867|NCT03684408|12046813|FG000|NOT COMPLETED|Overall Study||1
10880868|NCT03684408|12046814|FG001|NOT COMPLETED|Overall Study||1
10880869|NCT03684408|12046815|FG002|NOT COMPLETED|Overall Study||0
10880870|NCT03682848|12046823|FG000|STARTED|Overall Study||32
10880871|NCT03682848|12046823|FG000|COMPLETED|Overall Study||23
10880872|NCT03682848|12046823|FG000|NOT COMPLETED|Overall Study||9
10880873|NCT03682601|12046830|FG000|STARTED|Overall Study||12
10880874|NCT03682601|12046831|FG001|STARTED|Overall Study||7
10880875|NCT03682601|12046832|FG002|STARTED|Overall Study||13
10880876|NCT03682601|12046830|FG000|COMPLETED|Overall Study||12
10880877|NCT03682601|12046831|FG001|COMPLETED|Overall Study||7
10880878|NCT03682601|12046832|FG002|COMPLETED|Overall Study||13
10880879|NCT03682601|12046830|FG000|NOT COMPLETED|Overall Study||0
10880880|NCT03682601|12046831|FG001|NOT COMPLETED|Overall Study||0
10880881|NCT03682601|12046832|FG002|NOT COMPLETED|Overall Study||0
10880882|NCT03681691|12046845|FG000|STARTED|Overall Study||8
10880883|NCT03681691|12046846|FG001|STARTED|Overall Study||4
10880884|NCT03681691|12046845|FG000|COMPLETED|Overall Study||6
10880885|NCT03681691|12046846|FG001|COMPLETED|Overall Study||3
10880886|NCT03681691|12046845|FG000|NOT COMPLETED|Overall Study||2
10880887|NCT03681691|12046846|FG001|NOT COMPLETED|Overall Study||1
10880888|NCT03681470|12046854|FG000|STARTED|Overall Study||20
10880889|NCT03681470|12046854|FG000|COMPLETED|Overall Study||12
10880890|NCT03681470|12046854|FG000|NOT COMPLETED|Overall Study||8
10880891|NCT03681184|12046860|FG000|STARTED|6-Month Double-Blind Period||13
10880892|NCT03681184|12046861|FG001|STARTED|6-Month Double-Blind Period||26
10880893|NCT03681184|12046860|FG000|COMPLETED|6-Month Double-Blind Period||13
10880894|NCT03681184|12046861|FG001|COMPLETED|6-Month Double-Blind Period||25
10880895|NCT03681184|12046860|FG000|NOT COMPLETED|6-Month Double-Blind Period||0
10880896|NCT03681184|12046861|FG001|NOT COMPLETED|6-Month Double-Blind Period||1
10880897|NCT03681184|12046860|FG000|STARTED|3-Month Blinded Extension Period||13
10880898|NCT03681184|12046861|FG001|STARTED|3-Month Blinded Extension Period|1 participant discontinued study drug and entered safety follow up after the DB period.|24
10880899|NCT03681184|12046860|FG000|COMPLETED|3-Month Blinded Extension Period||1
10880900|NCT03681184|12046861|FG001|COMPLETED|3-Month Blinded Extension Period||1
10880901|NCT03681184|12046860|FG000|NOT COMPLETED|3-Month Blinded Extension Period||12
10880902|NCT03681184|12046861|FG001|NOT COMPLETED|3-Month Blinded Extension Period||23
10880903|NCT03681184|12046860|FG000|STARTED|Open-Label Extension Period||1
10880904|NCT03681184|12046861|FG001|STARTED|Open-Label Extension Period||1
10880905|NCT03681184|12046860|FG000|COMPLETED|Open-Label Extension Period||0
10880906|NCT03681184|12046861|FG001|COMPLETED|Open-Label Extension Period||0
10880907|NCT03681184|12046860|FG000|NOT COMPLETED|Open-Label Extension Period||1
10880908|NCT03681184|12046861|FG001|NOT COMPLETED|Open-Label Extension Period||1
10880909|NCT03679767|12046871|FG000|STARTED|Overall Study||35
10880910|NCT03679767|12046872|FG001|STARTED|Overall Study||23
10880911|NCT03679767|12046873|FG002|STARTED|Overall Study||29
10880912|NCT03679767|12046874|FG003|STARTED|Overall Study||34
10880913|NCT03679767|12046871|FG000|COMPLETED|Overall Study||0
10880914|NCT03679767|12046872|FG001|COMPLETED|Overall Study||0
10880915|NCT03679767|12046873|FG002|COMPLETED|Overall Study||0
10880916|NCT03679767|12046874|FG003|COMPLETED|Overall Study||0
10880917|NCT03679767|12046871|FG000|NOT COMPLETED|Overall Study||35
10880918|NCT03679767|12046872|FG001|NOT COMPLETED|Overall Study||23
10880919|NCT03679767|12046873|FG002|NOT COMPLETED|Overall Study||29
10880920|NCT03679767|12046874|FG003|NOT COMPLETED|Overall Study||34
10880921|NCT03678675|12046888|FG000|STARTED|Overall Study||74
10880922|NCT03678675|12046889|FG001|STARTED|Overall Study||74
10880923|NCT03678675|12046888|FG000|COMPLETED|Overall Study||74
10880924|NCT03678675|12046889|FG001|COMPLETED|Overall Study||74
10880925|NCT03678675|12046888|FG000|NOT COMPLETED|Overall Study||0
10880926|NCT03678675|12046889|FG001|NOT COMPLETED|Overall Study||0
10880927|NCT03677869|12046897|FG000|STARTED|Overall Study||35
10880928|NCT03677869|12046897|FG000|COMPLETED|Overall Study||34
10880929|NCT03677869|12046897|FG000|NOT COMPLETED|Overall Study||1
10880930|NCT03674112|12046903|FG000|STARTED|Overall Study||80
10880931|NCT03674112|12046904|FG001|STARTED|Overall Study||80
10880932|NCT03674112|12046903|FG000|Completed Cross-Over Treatment (Cycles 1 to 6)|Overall Study||80
10880933|NCT03674112|12046904|FG001|Completed Cross-Over Treatment (Cycles 1 to 6)|Overall Study||80
10880934|NCT03674112|12046903|FG000|Completed Continuation Treatment (Cycles 7 up to 18 Total)|Overall Study||34
10880935|NCT03674112|12046904|FG001|Completed Continuation Treatment (Cycles 7 up to 18 Total)|Overall Study||36
10880936|NCT03674112|12046903|FG000|Completed Post-Treatment Follow-Up (Up to 3 Years)|Overall Study||0
10880937|NCT03674112|12046904|FG001|Completed Post-Treatment Follow-Up (Up to 3 Years)|Overall Study||0
10880938|NCT03674112|12046903|FG000|COMPLETED|Overall Study||0
10880939|NCT03674112|12046904|FG001|COMPLETED|Overall Study||0
10880940|NCT03674112|12046903|FG000|NOT COMPLETED|Overall Study||80
10880941|NCT03674112|12046904|FG001|NOT COMPLETED|Overall Study||80
10880942|NCT03673865|12046932|FG000|STARTED|Overall Study||13
10880943|NCT03673865|12046933|FG001|STARTED|Overall Study||12
10880944|NCT03673865|12046932|FG000|COMPLETED|Overall Study||13
10880945|NCT03673865|12046933|FG001|COMPLETED|Overall Study||12
10880946|NCT03673865|12046932|FG000|NOT COMPLETED|Overall Study||0
10880947|NCT03673865|12046933|FG001|NOT COMPLETED|Overall Study||0
10880948|NCT03673046|12046941|FG000|STARTED|Overall Study||40
10880949|NCT03673046|12046942|FG001|STARTED|Overall Study||40
10880950|NCT03673046|12046941|FG000|COMPLETED|Overall Study||31
10880951|NCT03673046|12046942|FG001|COMPLETED|Overall Study||37
10880952|NCT03673046|12046941|FG000|NOT COMPLETED|Overall Study||9
10880953|NCT03673046|12046942|FG001|NOT COMPLETED|Overall Study||3
10880954|NCT03670810|12046954|FG000|STARTED|Main Study||485
10880955|NCT03670810|12046955|FG001|STARTED|Main Study||486
10880956|NCT03670810|12046956|FG002|STARTED|Main Study||249
10880957|NCT03670810|12046957|FG003|STARTED|Main Study||251
10880958|NCT03670810|12046958|FG004|STARTED|Main Study||55
10880959|NCT03670810|12046959|FG005|STARTED|Main Study||53
10880960|NCT03670810|12046960|FG006|STARTED|Main Study||28
10880961|NCT03670810|12046961|FG007|STARTED|Main Study||26
10880962|NCT03670810|12046962|FG008|STARTED|Main Study||0
10880963|NCT03670810|12046954|FG000|Treated at Least One Migraine Attack|Main Study||485
10880964|NCT03670810|12046955|FG001|Treated at Least One Migraine Attack|Main Study||486
10880965|NCT03670810|12046956|FG002|Treated at Least One Migraine Attack|Main Study||249
10880966|NCT03670810|12046957|FG003|Treated at Least One Migraine Attack|Main Study||251
10880967|NCT03670810|12046958|FG004|Treated at Least One Migraine Attack|Main Study||55
10880968|NCT03670810|12046959|FG005|Treated at Least One Migraine Attack|Main Study||53
10880969|NCT03670810|12046960|FG006|Treated at Least One Migraine Attack|Main Study||28
10880970|NCT03670810|12046961|FG007|Treated at Least One Migraine Attack|Main Study||26
10880971|NCT03670810|12046962|FG008|Treated at Least One Migraine Attack|Main Study||0
10880972|NCT03670810|12046954|FG000|COMPLETED|Main Study||403
10880973|NCT03670810|12046955|FG001|COMPLETED|Main Study||394
10880974|NCT03670810|12046956|FG002|COMPLETED|Main Study||219
10880975|NCT03670810|12046957|FG003|COMPLETED|Main Study||223
10880976|NCT03670810|12046958|FG004|COMPLETED|Main Study||45
10880977|NCT03670810|12046959|FG005|COMPLETED|Main Study||46
10880978|NCT03670810|12046960|FG006|COMPLETED|Main Study||26
10880979|NCT03670810|12046961|FG007|COMPLETED|Main Study||23
10880980|NCT03670810|12046962|FG008|COMPLETED|Main Study||0
10880981|NCT03670810|12046954|FG000|NOT COMPLETED|Main Study||82
10880982|NCT03670810|12046955|FG001|NOT COMPLETED|Main Study||92
10880983|NCT03670810|12046956|FG002|NOT COMPLETED|Main Study||30
10880984|NCT03670810|12046957|FG003|NOT COMPLETED|Main Study||28
10880985|NCT03670810|12046958|FG004|NOT COMPLETED|Main Study||10
10880986|NCT03670810|12046959|FG005|NOT COMPLETED|Main Study||7
10880987|NCT03670810|12046960|FG006|NOT COMPLETED|Main Study||2
10880988|NCT03670810|12046961|FG007|NOT COMPLETED|Main Study||3
10880989|NCT03670810|12046962|FG008|NOT COMPLETED|Main Study||0
10880990|NCT03670810|12046954|FG000|STARTED|Open Label Extension|Reported are only those participants who were enrolled in the OLE.|0
10880991|NCT03670810|12046955|FG001|STARTED|Open Label Extension|Reported are only those participants who were enrolled in the OLE.|0
10880992|NCT03670810|12046956|FG002|STARTED|Open Label Extension|Reported are only those participants who were enrolled in the OLE.|0
10880993|NCT03670810|12046957|FG003|STARTED|Open Label Extension|Reported are only those participants who were enrolled in the OLE.|0
10880994|NCT03670810|12046958|FG004|STARTED|Open Label Extension|Reported are only those participants who were enrolled in the OLE.|0
10880995|NCT03670810|12046959|FG005|STARTED|Open Label Extension|Reported are only those participants who were enrolled in the OLE.|0
10880996|NCT03670810|12046960|FG006|STARTED|Open Label Extension|Reported are only those participants who were enrolled in the OLE.|0
10880997|NCT03670810|12046961|FG007|STARTED|Open Label Extension|Reported are only those participants who were enrolled in the OLE.|0
10880998|NCT03670810|12046962|FG008|STARTED|Open Label Extension||477
10880999|NCT03670810|12046954|FG000|Treated at Least One Migraine Attack|Open Label Extension||0
10881000|NCT03670810|12046955|FG001|Treated at Least One Migraine Attack|Open Label Extension||0
10881001|NCT03670810|12046956|FG002|Treated at Least One Migraine Attack|Open Label Extension||0
10881002|NCT03670810|12046957|FG003|Treated at Least One Migraine Attack|Open Label Extension||0
10881003|NCT03670810|12046958|FG004|Treated at Least One Migraine Attack|Open Label Extension||0
10881004|NCT03670810|12046959|FG005|Treated at Least One Migraine Attack|Open Label Extension||0
10881005|NCT03670810|12046960|FG006|Treated at Least One Migraine Attack|Open Label Extension||0
10881006|NCT03670810|12046961|FG007|Treated at Least One Migraine Attack|Open Label Extension||0
10881007|NCT03670810|12046962|FG008|Treated at Least One Migraine Attack|Open Label Extension|One participant signed consent but decided against participating in the OLE period and was not dosed.|476
10881008|NCT03670810|12046954|FG000|COMPLETED|Open Label Extension||0
10881009|NCT03670810|12046955|FG001|COMPLETED|Open Label Extension||0
10881010|NCT03670810|12046956|FG002|COMPLETED|Open Label Extension||0
10881011|NCT03670810|12046957|FG003|COMPLETED|Open Label Extension||0
10881012|NCT03670810|12046958|FG004|COMPLETED|Open Label Extension||0
10881013|NCT03670810|12046959|FG005|COMPLETED|Open Label Extension||0
10881014|NCT03670810|12046960|FG006|COMPLETED|Open Label Extension||0
10881015|NCT03670810|12046961|FG007|COMPLETED|Open Label Extension||0
10881016|NCT03670810|12046962|FG008|COMPLETED|Open Label Extension||324
10881017|NCT03670810|12046954|FG000|NOT COMPLETED|Open Label Extension||0
10881018|NCT03670810|12046955|FG001|NOT COMPLETED|Open Label Extension||0
10881019|NCT03670810|12046956|FG002|NOT COMPLETED|Open Label Extension||0
10881020|NCT03670810|12046957|FG003|NOT COMPLETED|Open Label Extension||0
10881021|NCT03670810|12046958|FG004|NOT COMPLETED|Open Label Extension||0
10881022|NCT03670810|12046959|FG005|NOT COMPLETED|Open Label Extension||0
10881023|NCT03670810|12046960|FG006|NOT COMPLETED|Open Label Extension||0
10881024|NCT03670810|12046961|FG007|NOT COMPLETED|Open Label Extension||0
10881025|NCT03670810|12046962|FG008|NOT COMPLETED|Open Label Extension||153
10881026|NCT03665441|12046978|FG000|STARTED|Overall Study||255
10881027|NCT03665441|12046979|FG001|STARTED|Overall Study||257
10881028|NCT03665441|12046978|FG000|COMPLETED|Overall Study||216
10881029|NCT03665441|12046979|FG001|COMPLETED|Overall Study||240
10881030|NCT03665441|12046978|FG000|NOT COMPLETED|Overall Study||39
10881031|NCT03665441|12046979|FG001|NOT COMPLETED|Overall Study||17
10881032|NCT03665038|12046988|FG000|STARTED|Overall Study||8
10881033|NCT03665038|12046989|FG001|STARTED|Overall Study||8
10881034|NCT03665038|12046990|FG002|STARTED|Overall Study||12
10881035|NCT03665038|12046988|FG000|COMPLETED|Overall Study||8
10881036|NCT03665038|12046989|FG001|COMPLETED|Overall Study||8
10881037|NCT03665038|12046990|FG002|COMPLETED|Overall Study||11
10881038|NCT03665038|12046988|FG000|NOT COMPLETED|Overall Study||0
10881039|NCT03665038|12046989|FG001|NOT COMPLETED|Overall Study||0
10881040|NCT03665038|12046990|FG002|NOT COMPLETED|Overall Study||1
10881041|NCT03664726|12047004|FG000|STARTED|Overall Study||21
10881042|NCT03664726|12047005|FG001|STARTED|Overall Study||20
10881043|NCT03664726|12047006|FG002|STARTED|Overall Study||18
10881044|NCT03664726|12047007|FG003|STARTED|Overall Study||19
10881045|NCT03664726|12047004|FG000|COMPLETED|Overall Study||21
10881046|NCT03664726|12047005|FG001|COMPLETED|Overall Study||20
10881047|NCT03664726|12047006|FG002|COMPLETED|Overall Study||18
10881048|NCT03664726|12047007|FG003|COMPLETED|Overall Study||19
10881049|NCT03664726|12047004|FG000|NOT COMPLETED|Overall Study||0
10881050|NCT03664726|12047005|FG001|NOT COMPLETED|Overall Study||0
10881051|NCT03664726|12047006|FG002|NOT COMPLETED|Overall Study||0
10881052|NCT03664726|12047007|FG003|NOT COMPLETED|Overall Study||0
10881053|NCT03663179|12047025|FG000|STARTED|Overall Study||18
10881054|NCT03663179|12047026|FG001|STARTED|Overall Study||14
10881055|NCT03663179|12047025|FG000|COMPLETED|Overall Study||14
10881056|NCT03663179|12047026|FG001|COMPLETED|Overall Study||13
10881057|NCT03663179|12047025|FG000|NOT COMPLETED|Overall Study||4
10881058|NCT03663179|12047026|FG001|NOT COMPLETED|Overall Study||1
10881059|NCT03662659|12047034|FG000|STARTED|Pre-treatment||138
10881060|NCT03662659|12047035|FG001|STARTED|Pre-treatment||136
10881061|NCT03662659|12047034|FG000|COMPLETED|Pre-treatment||136
10881062|NCT03662659|12047035|FG001|COMPLETED|Pre-treatment||135
10881063|NCT03662659|12047034|FG000|NOT COMPLETED|Pre-treatment||2
10881064|NCT03662659|12047035|FG001|NOT COMPLETED|Pre-treatment||1
10881065|NCT03662659|12047034|FG000|STARTED|Treatment||136
10881066|NCT03662659|12047035|FG001|STARTED|Treatment||135
10881067|NCT03662659|12047034|FG000|COMPLETED|Treatment||21
10881068|NCT03662659|12047035|FG001|COMPLETED|Treatment||29
10881069|NCT03662659|12047034|FG000|NOT COMPLETED|Treatment||115
10881070|NCT03662659|12047035|FG001|NOT COMPLETED|Treatment||106
10881071|NCT03662074|12047041|FG000|STARTED|Overall Study||14
10881072|NCT03662074|12047041|FG000|COMPLETED|Overall Study||14
10881073|NCT03662074|12047041|FG000|NOT COMPLETED|Overall Study||0
10881074|NCT03655756|12047045|FG000|STARTED|Overall Study||7
10881075|NCT03655756|12047045|FG000|COMPLETED|Overall Study||6
10881076|NCT03655756|12047045|FG000|NOT COMPLETED|Overall Study||1
10881077|NCT03655717|12047051|FG000|STARTED|Overall Study||70
10881078|NCT03655717|12047052|FG001|STARTED|Overall Study||68
10881079|NCT03655717|12047053|FG002|STARTED|Overall Study||2
10881080|NCT03655717|12047054|FG003|STARTED|Overall Study||1
10881081|NCT03655717|12047055|FG004|STARTED|Overall Study||0
10881082|NCT03655717|12047056|FG005|STARTED|Overall Study||3
10881083|NCT03655717|12047057|FG006|STARTED|Overall Study||3
10881084|NCT03655717|12047058|FG007|STARTED|Overall Study||3
10881085|NCT03655717|12047059|FG008|STARTED|Overall Study||2
10881086|NCT03655717|12047060|FG009|STARTED|Overall Study||1
10881087|NCT03655717|12047061|FG010|STARTED|Overall Study||1
10881088|NCT03655717|12047062|FG011|STARTED|Overall Study||3
10881089|NCT03655717|12047063|FG012|STARTED|Overall Study||2
10881090|NCT03655717|12047064|FG013|STARTED|Overall Study||3
10881091|NCT03655717|12047065|FG014|STARTED|Overall Study||2
10881092|NCT03655717|12047066|FG015|STARTED|Overall Study||2
10881093|NCT03655717|12047067|FG016|STARTED|Overall Study||2
10881094|NCT03655717|12047068|FG017|STARTED|Overall Study||2
10881095|NCT03655717|12047069|FG018|STARTED|Overall Study||3
10881096|NCT03655717|12047070|FG019|STARTED|Overall Study||3
10881097|NCT03655717|12047071|FG020|STARTED|Overall Study||2
10881098|NCT03655717|12047072|FG021|STARTED|Overall Study||3
10881099|NCT03655717|12047073|FG022|STARTED|Overall Study||2
10881100|NCT03655717|12047074|FG023|STARTED|Overall Study||4
10881101|NCT03655717|12047075|FG024|STARTED|Overall Study||1
10881102|NCT03655717|12047076|FG025|STARTED|Overall Study||2
10881103|NCT03655717|12047051|FG000|COMPLETED|Overall Study||60
10881104|NCT03655717|12047052|FG001|COMPLETED|Overall Study||56
10881105|NCT03655717|12047053|FG002|COMPLETED|Overall Study||1
10881106|NCT03655717|12047054|FG003|COMPLETED|Overall Study||0
10881107|NCT03655717|12047055|FG004|COMPLETED|Overall Study||0
10881108|NCT03655717|12047056|FG005|COMPLETED|Overall Study||1
10881109|NCT03655717|12047057|FG006|COMPLETED|Overall Study||0
10881110|NCT03655717|12047058|FG007|COMPLETED|Overall Study||2
10881111|NCT03655717|12047059|FG008|COMPLETED|Overall Study||0
10881112|NCT03655717|12047060|FG009|COMPLETED|Overall Study||0
10881113|NCT03655717|12047061|FG010|COMPLETED|Overall Study||1
10881114|NCT03655717|12047062|FG011|COMPLETED|Overall Study||1
10881115|NCT03655717|12047063|FG012|COMPLETED|Overall Study||2
10881116|NCT03655717|12047064|FG013|COMPLETED|Overall Study||0
10881117|NCT03655717|12047065|FG014|COMPLETED|Overall Study||2
10881118|NCT03655717|12047066|FG015|COMPLETED|Overall Study||1
10881119|NCT03655717|12047067|FG016|COMPLETED|Overall Study||2
10881120|NCT03655717|12047068|FG017|COMPLETED|Overall Study||2
10881121|NCT03655717|12047069|FG018|COMPLETED|Overall Study||2
10881122|NCT03655717|12047070|FG019|COMPLETED|Overall Study||2
10881123|NCT03655717|12047071|FG020|COMPLETED|Overall Study||2
10881124|NCT03655717|12047072|FG021|COMPLETED|Overall Study||2
10881125|NCT03655717|12047073|FG022|COMPLETED|Overall Study||0
10881126|NCT03655717|12047074|FG023|COMPLETED|Overall Study||2
10881127|NCT03655717|12047075|FG024|COMPLETED|Overall Study||0
10881128|NCT03655717|12047076|FG025|COMPLETED|Overall Study||2
10881129|NCT03655717|12047051|FG000|NOT COMPLETED|Overall Study||10
10881130|NCT03655717|12047052|FG001|NOT COMPLETED|Overall Study||12
10881131|NCT03655717|12047053|FG002|NOT COMPLETED|Overall Study||1
10881132|NCT03655717|12047054|FG003|NOT COMPLETED|Overall Study||1
10881133|NCT03655717|12047055|FG004|NOT COMPLETED|Overall Study||0
10881134|NCT03655717|12047056|FG005|NOT COMPLETED|Overall Study||2
10881135|NCT03655717|12047057|FG006|NOT COMPLETED|Overall Study||3
10881136|NCT03655717|12047058|FG007|NOT COMPLETED|Overall Study||1
10881137|NCT03655717|12047059|FG008|NOT COMPLETED|Overall Study||2
10881138|NCT03655717|12047060|FG009|NOT COMPLETED|Overall Study||1
10881139|NCT03655717|12047061|FG010|NOT COMPLETED|Overall Study||0
10881140|NCT03655717|12047062|FG011|NOT COMPLETED|Overall Study||2
10881141|NCT03655717|12047063|FG012|NOT COMPLETED|Overall Study||0
10881142|NCT03655717|12047064|FG013|NOT COMPLETED|Overall Study||3
10881143|NCT03655717|12047065|FG014|NOT COMPLETED|Overall Study||0
10881144|NCT03655717|12047066|FG015|NOT COMPLETED|Overall Study||1
10881145|NCT03655717|12047067|FG016|NOT COMPLETED|Overall Study||0
10881146|NCT03655717|12047068|FG017|NOT COMPLETED|Overall Study||0
10881147|NCT03655717|12047069|FG018|NOT COMPLETED|Overall Study||1
10881148|NCT03655717|12047070|FG019|NOT COMPLETED|Overall Study||1
10881149|NCT03655717|12047071|FG020|NOT COMPLETED|Overall Study||0
10881150|NCT03655717|12047072|FG021|NOT COMPLETED|Overall Study||1
10881151|NCT03655717|12047073|FG022|NOT COMPLETED|Overall Study||2
10881152|NCT03655717|12047074|FG023|NOT COMPLETED|Overall Study||2
10881153|NCT03655717|12047075|FG024|NOT COMPLETED|Overall Study||1
10881154|NCT03655717|12047076|FG025|NOT COMPLETED|Overall Study||0
10881155|NCT03647267|12047092|FG000|STARTED|Overall Study||24
10881156|NCT03647267|12047093|FG001|STARTED|Overall Study||22
10881157|NCT03647267|12047092|FG000|COMPLETED|Overall Study||23
10881158|NCT03647267|12047093|FG001|COMPLETED|Overall Study||22
10881159|NCT03647267|12047092|FG000|NOT COMPLETED|Overall Study||1
10881160|NCT03647267|12047093|FG001|NOT COMPLETED|Overall Study||0
10881161|NCT03646188|12047106|FG000|STARTED|Overall Study||3
10881162|NCT03646188|12047107|FG001|STARTED|Overall Study||3
10881163|NCT03646188|12047108|FG002|STARTED|Overall Study||3
10881164|NCT03646188|12047109|FG003|STARTED|Overall Study||3
10881165|NCT03646188|12047110|FG004|STARTED|Overall Study||1
10881166|NCT03646188|12047106|FG000|COMPLETED|Overall Study||3
10881167|NCT03646188|12047107|FG001|COMPLETED|Overall Study||3
10881168|NCT03646188|12047108|FG002|COMPLETED|Overall Study||3
10881169|NCT03646188|12047109|FG003|COMPLETED|Overall Study||3
10881170|NCT03646188|12047110|FG004|COMPLETED|Overall Study||1
10881171|NCT03646188|12047106|FG000|NOT COMPLETED|Overall Study||0
10881172|NCT03646188|12047107|FG001|NOT COMPLETED|Overall Study||0
10881173|NCT03646188|12047108|FG002|NOT COMPLETED|Overall Study||0
10881174|NCT03646188|12047109|FG003|NOT COMPLETED|Overall Study||0
10881175|NCT03646188|12047110|FG004|NOT COMPLETED|Overall Study||0
10881176|NCT03645395|12047126|FG000|STARTED|Part 1 (Up to 6 Months)||3
10881177|NCT03645395|12047127|FG001|STARTED|Part 1 (Up to 6 Months)||3
10881178|NCT03645395|12047128|FG002|STARTED|Part 1 (Up to 6 Months)||3
10881179|NCT03645395|12047129|FG003|STARTED|Part 1 (Up to 6 Months)||0
10881180|NCT03645395|12047126|FG000|COMPLETED|Part 1 (Up to 6 Months)||1
10881181|NCT03645395|12047127|FG001|COMPLETED|Part 1 (Up to 6 Months)||0
10881182|NCT03645395|12047128|FG002|COMPLETED|Part 1 (Up to 6 Months)||0
10881183|NCT03645395|12047129|FG003|COMPLETED|Part 1 (Up to 6 Months)||0
10881184|NCT03645395|12047126|FG000|NOT COMPLETED|Part 1 (Up to 6 Months)||2
10881185|NCT03645395|12047127|FG001|NOT COMPLETED|Part 1 (Up to 6 Months)||3
10881186|NCT03645395|12047128|FG002|NOT COMPLETED|Part 1 (Up to 6 Months)||3
10881187|NCT03645395|12047129|FG003|NOT COMPLETED|Part 1 (Up to 6 Months)||0
10881188|NCT03645395|12047126|FG000|STARTED|Part 2 (Up to 6 Months)||0
10881189|NCT03645395|12047127|FG001|STARTED|Part 2 (Up to 6 Months)||0
10881190|NCT03645395|12047128|FG002|STARTED|Part 2 (Up to 6 Months)||0
10881191|NCT03645395|12047129|FG003|STARTED|Part 2 (Up to 6 Months)||0
10881192|NCT03645395|12047126|FG000|COMPLETED|Part 2 (Up to 6 Months)||0
10881193|NCT03645395|12047127|FG001|COMPLETED|Part 2 (Up to 6 Months)||0
10881194|NCT03645395|12047128|FG002|COMPLETED|Part 2 (Up to 6 Months)||0
10881195|NCT03645395|12047129|FG003|COMPLETED|Part 2 (Up to 6 Months)||0
10881196|NCT03645395|12047126|FG000|NOT COMPLETED|Part 2 (Up to 6 Months)||0
10881197|NCT03645395|12047127|FG001|NOT COMPLETED|Part 2 (Up to 6 Months)||0
10881198|NCT03645395|12047128|FG002|NOT COMPLETED|Part 2 (Up to 6 Months)||0
10881199|NCT03645395|12047129|FG003|NOT COMPLETED|Part 2 (Up to 6 Months)||0
10881200|NCT03641651|12047140|FG000|STARTED|Overall Study||15
10881201|NCT03641651|12047140|FG000|COMPLETED|Overall Study||14
10881202|NCT03641651|12047140|FG000|NOT COMPLETED|Overall Study||1
10881203|NCT03638258|12047147|FG000|STARTED|Overall Study||109
10881204|NCT03638258|12047148|FG001|STARTED|Overall Study||113
10881205|NCT03638258|12047149|FG002|STARTED|Overall Study||109
10881206|NCT03638258|12047147|FG000|COMPLETED|Overall Study||102
10881207|NCT03638258|12047148|FG001|COMPLETED|Overall Study||104
10881208|NCT03638258|12047149|FG002|COMPLETED|Overall Study||86
10881209|NCT03638258|12047147|FG000|NOT COMPLETED|Overall Study||7
10881210|NCT03638258|12047148|FG001|NOT COMPLETED|Overall Study||9
10881211|NCT03638258|12047149|FG002|NOT COMPLETED|Overall Study||23
10881212|NCT03637374|12047160|FG000|STARTED|Overall Study||2
10881213|NCT03637374|12047161|FG001|STARTED|Overall Study||0
10881214|NCT03637374|12047160|FG000|COMPLETED|Overall Study||0
10881215|NCT03637374|12047161|FG001|COMPLETED|Overall Study||0
10881216|NCT03637374|12047160|FG000|NOT COMPLETED|Overall Study||2
10881217|NCT03637374|12047161|FG001|NOT COMPLETED|Overall Study||0
10881218|NCT03636906|12047170|FG000|STARTED|Overall Study||65
10881219|NCT03636906|12047171|FG001|STARTED|Overall Study||71
10881220|NCT03636906|12047172|FG002|STARTED|Overall Study||65
10881221|NCT03636906|12047170|FG000|COMPLETED|Overall Study||61
10881222|NCT03636906|12047171|FG001|COMPLETED|Overall Study||71
10881223|NCT03636906|12047172|FG002|COMPLETED|Overall Study||60
10881224|NCT03636906|12047170|FG000|NOT COMPLETED|Overall Study||4
10881225|NCT03636906|12047171|FG001|NOT COMPLETED|Overall Study||0
10881226|NCT03636906|12047172|FG002|NOT COMPLETED|Overall Study||5
10881227|NCT03635099|12047194|FG000|STARTED|Period 1||20
10881228|NCT03635099|12047195|FG001|STARTED|Period 1||40
10881229|NCT03635099|12047196|FG002|STARTED|Period 1||39
10881230|NCT03635099|12047197|FG003|STARTED|Period 1||39
10881231|NCT03635099|12047198|FG004|STARTED|Period 1||40
10881232|NCT03635099|12047199|FG005|STARTED|Period 1||10
10881233|NCT03635099|12047200|FG006|STARTED|Period 1||44
10881234|NCT03635099|12047201|FG007|STARTED|Period 1||42
10881235|NCT03635099|12047194|FG000|Full Analysis Set (FAS)|Period 1||20
10881236|NCT03635099|12047195|FG001|Full Analysis Set (FAS)|Period 1||40
10881237|NCT03635099|12047196|FG002|Full Analysis Set (FAS)|Period 1||39
10881238|NCT03635099|12047197|FG003|Full Analysis Set (FAS)|Period 1||39
10881239|NCT03635099|12047198|FG004|Full Analysis Set (FAS)|Period 1||40
10881240|NCT03635099|12047199|FG005|Full Analysis Set (FAS)|Period 1||10
10881241|NCT03635099|12047200|FG006|Full Analysis Set (FAS)|Period 1||43
10881242|NCT03635099|12047201|FG007|Full Analysis Set (FAS)|Period 1||42
10881243|NCT03635099|12047194|FG000|COMPLETED|Period 1||16
10881244|NCT03635099|12047195|FG001|COMPLETED|Period 1||37
10881245|NCT03635099|12047196|FG002|COMPLETED|Period 1||31
10881246|NCT03635099|12047197|FG003|COMPLETED|Period 1||34
10881247|NCT03635099|12047198|FG004|COMPLETED|Period 1||37
10881248|NCT03635099|12047199|FG005|COMPLETED|Period 1||9
10881249|NCT03635099|12047200|FG006|COMPLETED|Period 1||40
10881250|NCT03635099|12047201|FG007|COMPLETED|Period 1||40
10881251|NCT03635099|12047194|FG000|NOT COMPLETED|Period 1||4
10881252|NCT03635099|12047195|FG001|NOT COMPLETED|Period 1||3
10881253|NCT03635099|12047196|FG002|NOT COMPLETED|Period 1||8
10881254|NCT03635099|12047197|FG003|NOT COMPLETED|Period 1||5
10881255|NCT03635099|12047198|FG004|NOT COMPLETED|Period 1||3
10881256|NCT03635099|12047199|FG005|NOT COMPLETED|Period 1||1
10881257|NCT03635099|12047200|FG006|NOT COMPLETED|Period 1||4
10881258|NCT03635099|12047201|FG007|NOT COMPLETED|Period 1||2
10881259|NCT03635099|12047194|FG000|STARTED|Not Eligible for Period 2||16
10881260|NCT03635099|12047195|FG001|STARTED|Not Eligible for Period 2||37
10881261|NCT03635099|12047196|FG002|STARTED|Not Eligible for Period 2||31
10881262|NCT03635099|12047197|FG003|STARTED|Not Eligible for Period 2||34
10881263|NCT03635099|12047198|FG004|STARTED|Not Eligible for Period 2||37
10881264|NCT03635099|12047199|FG005|STARTED|Not Eligible for Period 2||9
10881265|NCT03635099|12047200|FG006|STARTED|Not Eligible for Period 2||40
10881266|NCT03635099|12047201|FG007|STARTED|Not Eligible for Period 2||40
10881267|NCT03635099|12047194|FG000|COMPLETED|Not Eligible for Period 2||15
10881268|NCT03635099|12047195|FG001|COMPLETED|Not Eligible for Period 2||37
10881269|NCT03635099|12047196|FG002|COMPLETED|Not Eligible for Period 2||31
10881270|NCT03635099|12047197|FG003|COMPLETED|Not Eligible for Period 2||33
10881271|NCT03635099|12047198|FG004|COMPLETED|Not Eligible for Period 2||37
10881272|NCT03635099|12047199|FG005|COMPLETED|Not Eligible for Period 2||0
10881273|NCT03635099|12047200|FG006|COMPLETED|Not Eligible for Period 2||0
10881274|NCT03635099|12047201|FG007|COMPLETED|Not Eligible for Period 2||0
10881275|NCT03635099|12047194|FG000|NOT COMPLETED|Not Eligible for Period 2||1
10881276|NCT03635099|12047195|FG001|NOT COMPLETED|Not Eligible for Period 2||0
10881277|NCT03635099|12047196|FG002|NOT COMPLETED|Not Eligible for Period 2||0
10881278|NCT03635099|12047197|FG003|NOT COMPLETED|Not Eligible for Period 2||1
10881279|NCT03635099|12047198|FG004|NOT COMPLETED|Not Eligible for Period 2||0
10881280|NCT03635099|12047199|FG005|NOT COMPLETED|Not Eligible for Period 2||9
10881281|NCT03635099|12047200|FG006|NOT COMPLETED|Not Eligible for Period 2||40
10881282|NCT03635099|12047201|FG007|NOT COMPLETED|Not Eligible for Period 2||40
10881283|NCT03635099|12047194|FG000|STARTED|Eligible for Period 2||15
10881284|NCT03635099|12047195|FG001|STARTED|Eligible for Period 2||37
10881285|NCT03635099|12047196|FG002|STARTED|Eligible for Period 2||31
10881286|NCT03635099|12047197|FG003|STARTED|Eligible for Period 2||33
10881287|NCT03635099|12047198|FG004|STARTED|Eligible for Period 2||37
10881288|NCT03635099|12047199|FG005|STARTED|Eligible for Period 2||0
10881289|NCT03635099|12047200|FG006|STARTED|Eligible for Period 2||0
10881290|NCT03635099|12047201|FG007|STARTED|Eligible for Period 2||0
10881291|NCT03635099|12047194|FG000|Switching Patients|Eligible for Period 2|Switched to the 'BI 200 mg' dose group.|15
10881292|NCT03635099|12047195|FG001|Switching Patients|Eligible for Period 2|Switched to the 'BI 50 mg' dose group.|35
10881293|NCT03635099|12047196|FG002|Switching Patients|Eligible for Period 2|Switched to the 'BI 100 mg' dose group.|21
10881294|NCT03635099|12047197|FG003|Switching Patients|Eligible for Period 2|Switched to the 'BI 200 mg' dose group.|25
10881295|NCT03635099|12047198|FG004|Switching Patients|Eligible for Period 2||0
10881296|NCT03635099|12047199|FG005|Switching Patients|Eligible for Period 2||0
10881297|NCT03635099|12047200|FG006|Switching Patients|Eligible for Period 2||0
10881298|NCT03635099|12047201|FG007|Switching Patients|Eligible for Period 2||0
10881299|NCT03635099|12047194|FG000|Non Switching Patients|Eligible for Period 2||0
10881300|NCT03635099|12047195|FG001|Non Switching Patients|Eligible for Period 2||2
10881301|NCT03635099|12047196|FG002|Non Switching Patients|Eligible for Period 2||10
10881302|NCT03635099|12047197|FG003|Non Switching Patients|Eligible for Period 2||8
10881303|NCT03635099|12047198|FG004|Non Switching Patients|Eligible for Period 2||37
10881304|NCT03635099|12047199|FG005|Non Switching Patients|Eligible for Period 2||0
10881305|NCT03635099|12047200|FG006|Non Switching Patients|Eligible for Period 2||0
10881306|NCT03635099|12047201|FG007|Non Switching Patients|Eligible for Period 2||0
10881307|NCT03635099|12047194|FG000|COMPLETED|Eligible for Period 2||0
10881308|NCT03635099|12047195|FG001|COMPLETED|Eligible for Period 2||2
10881309|NCT03635099|12047196|FG002|COMPLETED|Eligible for Period 2||10
10881310|NCT03635099|12047197|FG003|COMPLETED|Eligible for Period 2||8
10881311|NCT03635099|12047198|FG004|COMPLETED|Eligible for Period 2||37
10881312|NCT03635099|12047199|FG005|COMPLETED|Eligible for Period 2||0
10881313|NCT03635099|12047200|FG006|COMPLETED|Eligible for Period 2||0
10881314|NCT03635099|12047201|FG007|COMPLETED|Eligible for Period 2||0
10881315|NCT03635099|12047194|FG000|NOT COMPLETED|Eligible for Period 2||15
10881316|NCT03635099|12047195|FG001|NOT COMPLETED|Eligible for Period 2||35
10881317|NCT03635099|12047196|FG002|NOT COMPLETED|Eligible for Period 2||21
10881318|NCT03635099|12047197|FG003|NOT COMPLETED|Eligible for Period 2||25
10881319|NCT03635099|12047198|FG004|NOT COMPLETED|Eligible for Period 2||0
10881320|NCT03635099|12047199|FG005|NOT COMPLETED|Eligible for Period 2||0
10881321|NCT03635099|12047200|FG006|NOT COMPLETED|Eligible for Period 2||0
10881322|NCT03635099|12047201|FG007|NOT COMPLETED|Eligible for Period 2||0
10881323|NCT03635099|12047194|FG000|STARTED|Period 2||0
10881324|NCT03635099|12047195|FG001|STARTED|Period 2||2
10881325|NCT03635099|12047196|FG002|STARTED|Period 2|"Combination of period 1 dose groups: BI 50 mg and switched patients from dose Group BI 25 mg"|45
10881326|NCT03635099|12047197|FG003|STARTED|Period 2|"Combination of period 1 dose groups: BI 100 mg and switched patients from dose Group BI 50 mg"|29
10881327|NCT03635099|12047198|FG004|STARTED|Period 2|"Combination of period 1: BI 200mg, switched patients from dose Group BI 100 mg and Placebo."|77
10881328|NCT03635099|12047199|FG005|STARTED|Period 2||0
10881329|NCT03635099|12047200|FG006|STARTED|Period 2||0
10881330|NCT03635099|12047201|FG007|STARTED|Period 2||0
10881331|NCT03635099|12047194|FG000|COMPLETED|Period 2||0
10881332|NCT03635099|12047195|FG001|COMPLETED|Period 2||2
10881333|NCT03635099|12047196|FG002|COMPLETED|Period 2||36
10881334|NCT03635099|12047197|FG003|COMPLETED|Period 2||25
10881335|NCT03635099|12047198|FG004|COMPLETED|Period 2||65
10881336|NCT03635099|12047199|FG005|COMPLETED|Period 2||0
10881337|NCT03635099|12047200|FG006|COMPLETED|Period 2||0
10881338|NCT03635099|12047201|FG007|COMPLETED|Period 2||0
10881339|NCT03635099|12047194|FG000|NOT COMPLETED|Period 2||0
10881340|NCT03635099|12047195|FG001|NOT COMPLETED|Period 2||0
10881341|NCT03635099|12047196|FG002|NOT COMPLETED|Period 2||9
10881342|NCT03635099|12047197|FG003|NOT COMPLETED|Period 2||4
10881343|NCT03635099|12047198|FG004|NOT COMPLETED|Period 2||12
10881344|NCT03635099|12047199|FG005|NOT COMPLETED|Period 2||0
10881345|NCT03635099|12047200|FG006|NOT COMPLETED|Period 2||0
10881346|NCT03635099|12047201|FG007|NOT COMPLETED|Period 2||0
10881347|NCT03633227|12047229|FG000|STARTED|Double Blind (DB), up to Week 48||12
10881348|NCT03633227|12047230|FG001|STARTED|Double Blind (DB), up to Week 48||10
10881349|NCT03633227|12047229|FG000|COMPLETED|Double Blind (DB), up to Week 48||4
10881350|NCT03633227|12047230|FG001|COMPLETED|Double Blind (DB), up to Week 48||6
10881351|NCT03633227|12047229|FG000|NOT COMPLETED|Double Blind (DB), up to Week 48||8
10881352|NCT03633227|12047230|FG001|NOT COMPLETED|Double Blind (DB), up to Week 48||4
10881353|NCT03633227|12047229|FG000|STARTED|DB Extension, Week 48 up to 3 Years||4
10881354|NCT03633227|12047230|FG001|STARTED|DB Extension, Week 48 up to 3 Years||6
10881355|NCT03633227|12047229|FG000|COMPLETED|DB Extension, Week 48 up to 3 Years||0
10881356|NCT03633227|12047230|FG001|COMPLETED|DB Extension, Week 48 up to 3 Years||0
10881357|NCT03633227|12047229|FG000|NOT COMPLETED|DB Extension, Week 48 up to 3 Years||4
10881358|NCT03633227|12047230|FG001|NOT COMPLETED|DB Extension, Week 48 up to 3 Years||6
10881359|NCT03631550|12047243|FG000|STARTED|Overall Study||94
10881360|NCT03631550|12047244|FG001|STARTED|Overall Study||93
10881361|NCT03631550|12047243|FG000|The ITT Analysis Set|Overall Study||67
10881362|NCT03631550|12047244|FG001|The ITT Analysis Set|Overall Study||64
10881363|NCT03631550|12047243|FG000|The mITT Analysis Set|Overall Study||50
10881364|NCT03631550|12047244|FG001|The mITT Analysis Set|Overall Study||59
10881365|NCT03631550|12047243|FG000|COMPLETED|Overall Study||67
10881366|NCT03631550|12047244|FG001|COMPLETED|Overall Study||64
10881367|NCT03631550|12047243|FG000|NOT COMPLETED|Overall Study||27
10881368|NCT03631550|12047244|FG001|NOT COMPLETED|Overall Study||29
10881369|NCT03628976|12047252|FG000|STARTED|Overall Study||12
10881370|NCT03628976|12047253|FG001|STARTED|Overall Study||12
10881371|NCT03628976|12047252|FG000|COMPLETED|Overall Study||12
10881372|NCT03628976|12047253|FG001|COMPLETED|Overall Study||12
10881373|NCT03628976|12047252|FG000|NOT COMPLETED|Overall Study||0
10881374|NCT03628976|12047253|FG001|NOT COMPLETED|Overall Study||0
10881375|NCT03624881|12047261|FG000|STARTED|Overall Study||283
10881376|NCT03624881|12047262|FG001|STARTED|Overall Study||50
10881377|NCT03624881|12047261|FG000|Safety Set|Overall Study||261
10881378|NCT03624881|12047262|FG001|Safety Set|Overall Study||49
10881379|NCT03624881|12047261|FG000|COMPLETED|Overall Study||237
10881380|NCT03624881|12047262|FG001|COMPLETED|Overall Study||44
10881381|NCT03624881|12047261|FG000|NOT COMPLETED|Overall Study||46
10881382|NCT03624881|12047262|FG001|NOT COMPLETED|Overall Study||6
10881383|NCT03622593|12047271|FG000|STARTED|Overall Study||317
10881384|NCT03622593|12047272|FG001|STARTED|Overall Study||319
10881385|NCT03622593|12047273|FG002|STARTED|Overall Study||315
10881386|NCT03622593|12047271|FG000|Received at Least One Dose of Study Drug|Overall Study||317
10881387|NCT03622593|12047272|FG001|Received at Least One Dose of Study Drug|Overall Study||319
10881388|NCT03622593|12047273|FG002|Received at Least One Dose of Study Drug|Overall Study||314
10881389|NCT03622593|12047271|FG000|Completed up to Week 56|Overall Study||298
10881390|NCT03622593|12047272|FG001|Completed up to Week 56|Overall Study||312
10881391|NCT03622593|12047273|FG002|Completed up to Week 56|Overall Study||299
10881392|NCT03622593|12047271|FG000|COMPLETED|Overall Study||275
10881393|NCT03622593|12047272|FG001|COMPLETED|Overall Study||288
10881394|NCT03622593|12047273|FG002|COMPLETED|Overall Study||267
10881395|NCT03622593|12047271|FG000|NOT COMPLETED|Overall Study||42
10881396|NCT03622593|12047272|FG001|NOT COMPLETED|Overall Study||31
10881397|NCT03622593|12047273|FG002|NOT COMPLETED|Overall Study||48
10881398|NCT03622580|12047285|FG000|STARTED|Overall Study||315
10881399|NCT03622580|12047286|FG001|STARTED|Overall Study||313
10881400|NCT03622580|12047287|FG002|STARTED|Overall Study||312
10881401|NCT03622580|12047285|FG000|Received at Least One Dose of Study Drug|Overall Study||313
10881402|NCT03622580|12047286|FG001|Received at Least One Dose of Study Drug|Overall Study||313
10881403|NCT03622580|12047287|FG002|Received at Least One Dose of Study Drug|Overall Study||311
10881404|NCT03622580|12047285|FG000|Completed up to Week 56|Overall Study||291
10881405|NCT03622580|12047286|FG001|Completed up to Week 56|Overall Study||289
10881406|NCT03622580|12047287|FG002|Completed up to Week 56|Overall Study||292
10881407|NCT03622580|12047285|FG000|COMPLETED|Overall Study||263
10881408|NCT03622580|12047286|FG001|COMPLETED|Overall Study||269
10881409|NCT03622580|12047287|FG002|COMPLETED|Overall Study||260
10881410|NCT03622580|12047285|FG000|NOT COMPLETED|Overall Study||52
10881411|NCT03622580|12047286|FG001|NOT COMPLETED|Overall Study||44
10881412|NCT03622580|12047287|FG002|NOT COMPLETED|Overall Study||52
10881413|NCT03619174|12047298|FG000|STARTED|Overall Study|First subject enrolled 8/8/2018. Last subject, last visit, 7/5/2019|66
10881414|NCT03619174|12047299|FG001|STARTED|Overall Study|First subject enrolled 8/8/2018. Last subject, last visit, 7/5/2019|33
10881415|NCT03619174|12047298|FG000|COMPLETED|Overall Study||57
10881416|NCT03619174|12047299|FG001|COMPLETED|Overall Study||29
10881417|NCT03619174|12047298|FG000|NOT COMPLETED|Overall Study||9
10881418|NCT03619174|12047299|FG001|NOT COMPLETED|Overall Study||4
10881419|NCT03618641|12047305|FG000|STARTED|Overall Study||34
10881420|NCT03618641|12047305|FG000|COMPLETED|Overall Study||34
10881421|NCT03618641|12047305|FG000|NOT COMPLETED|Overall Study||0
10881422|NCT03611101|12047313|FG000|STARTED|Overall Study||32
10881423|NCT03611101|12047314|FG001|STARTED|Overall Study||32
10881424|NCT03611101|12047315|FG002|STARTED|Overall Study||30
10881425|NCT03611101|12047316|FG003|STARTED|Overall Study||30
10881426|NCT03611101|12047313|FG000|COMPLETED|Overall Study||25
10881427|NCT03611101|12047314|FG001|COMPLETED|Overall Study||28
10881428|NCT03611101|12047315|FG002|COMPLETED|Overall Study||27
10881429|NCT03611101|12047316|FG003|COMPLETED|Overall Study||23
10881430|NCT03611101|12047313|FG000|NOT COMPLETED|Overall Study||7
10881431|NCT03611101|12047314|FG001|NOT COMPLETED|Overall Study||4
10881432|NCT03611101|12047315|FG002|NOT COMPLETED|Overall Study||3
10881433|NCT03611101|12047316|FG003|NOT COMPLETED|Overall Study||7
10881434|NCT03607487|12047358|FG000|STARTED|Overall Study||9
10881435|NCT03607487|12047359|FG001|STARTED|Overall Study||9
10881436|NCT03607487|12047360|FG002|STARTED|Overall Study||9
10881437|NCT03607487|12047361|FG003|STARTED|Overall Study||8
10881438|NCT03607487|12047358|FG000|COMPLETED|Overall Study||7
10881439|NCT03607487|12047359|FG001|COMPLETED|Overall Study||9
10881440|NCT03607487|12047360|FG002|COMPLETED|Overall Study||9
10881441|NCT03607487|12047361|FG003|COMPLETED|Overall Study||7
10881442|NCT03607487|12047358|FG000|NOT COMPLETED|Overall Study||2
10881443|NCT03607487|12047359|FG001|NOT COMPLETED|Overall Study||0
10881444|NCT03607487|12047360|FG002|NOT COMPLETED|Overall Study||0
10881445|NCT03607487|12047361|FG003|NOT COMPLETED|Overall Study||1
10881446|NCT03606109|12047375|FG000|STARTED|Overall Study||31
10881447|NCT03606109|12047376|FG001|STARTED|Overall Study||27
10881448|NCT03606109|12047375|FG000|COMPLETED|Overall Study||29
10881449|NCT03606109|12047376|FG001|COMPLETED|Overall Study||26
10881450|NCT03606109|12047375|FG000|NOT COMPLETED|Overall Study||2
10881451|NCT03606109|12047376|FG001|NOT COMPLETED|Overall Study||1
10881452|NCT03602560|12047385|FG000|STARTED|Overall Study||89
10881453|NCT03602560|12047386|FG001|STARTED|Overall Study||89
10881454|NCT03602560|12047387|FG002|STARTED|Overall Study||87
10881455|NCT03602560|12047385|FG000|COMPLETED|Overall Study||1
10881456|NCT03602560|12047386|FG001|COMPLETED|Overall Study||1
10881457|NCT03602560|12047387|FG002|COMPLETED|Overall Study||1
10881458|NCT03602560|12047385|FG000|NOT COMPLETED|Overall Study||88
10881459|NCT03602560|12047386|FG001|NOT COMPLETED|Overall Study||88
10881460|NCT03602560|12047387|FG002|NOT COMPLETED|Overall Study||86
10881461|NCT03595384|12047395|FG000|STARTED|Overall Study||41
10881462|NCT03595384|12047395|FG000|Completed Week 12 Assessment|Overall Study||37
10881463|NCT03595384|12047395|FG000|COMPLETED|Overall Study||25
10881464|NCT03595384|12047395|FG000|NOT COMPLETED|Overall Study||16
10881465|NCT03593629|12047403|FG000|STARTED|Overall Study||166
10881466|NCT03593629|12047404|FG001|STARTED|Overall Study||166
10881467|NCT03593629|12047405|FG002|STARTED|Overall Study||295
10881468|NCT03593629|12047406|FG003|STARTED|Overall Study||163
10881469|NCT03593629|12047403|FG000|COMPLETED|Overall Study||166
10881470|NCT03593629|12047404|FG001|COMPLETED|Overall Study||166
10881471|NCT03593629|12047405|FG002|COMPLETED|Overall Study||295
10881472|NCT03593629|12047406|FG003|COMPLETED|Overall Study||163
10881473|NCT03593629|12047403|FG000|NOT COMPLETED|Overall Study||0
10881474|NCT03593629|12047404|FG001|NOT COMPLETED|Overall Study||0
10881475|NCT03593629|12047405|FG002|NOT COMPLETED|Overall Study||0
10881476|NCT03593629|12047406|FG003|NOT COMPLETED|Overall Study||0
10881477|NCT03592277|12047417|FG000|STARTED|Overall Study||60
10881478|NCT03592277|12047418|FG001|STARTED|Overall Study||60
10881479|NCT03592277|12047417|FG000|Powered For|Overall Study||60
10881480|NCT03592277|12047418|FG001|Powered For|Overall Study||60
10881481|NCT03592277|12047417|FG000|COMPLETED|Overall Study||54
10881482|NCT03592277|12047418|FG001|COMPLETED|Overall Study||52
10881483|NCT03592277|12047417|FG000|NOT COMPLETED|Overall Study||6
10881484|NCT03592277|12047418|FG001|NOT COMPLETED|Overall Study||8
10881485|NCT03591354|12047427|FG000|STARTED|Overall Study||54
10881486|NCT03591354|12047428|FG001|STARTED|Overall Study||55
10881487|NCT03591354|12047429|FG002|STARTED|Overall Study||55
10881488|NCT03591354|12047427|FG000|COMPLETED|Overall Study||54
10881489|NCT03591354|12047428|FG001|COMPLETED|Overall Study||55
10881490|NCT03591354|12047429|FG002|COMPLETED|Overall Study||55
10881491|NCT03591354|12047427|FG000|NOT COMPLETED|Overall Study||0
10881492|NCT03591354|12047428|FG001|NOT COMPLETED|Overall Study||0
10881493|NCT03591354|12047429|FG002|NOT COMPLETED|Overall Study||0
10881494|NCT03590457|12047444|FG000|STARTED|Overall Study||18
10881495|NCT03590457|12047444|FG000|COMPLETED|Overall Study||18
10881496|NCT03590457|12047444|FG000|NOT COMPLETED|Overall Study||0
10881497|NCT03590366|12047450|FG000|STARTED|Overall Study||73
10881498|NCT03590366|12047451|FG001|STARTED|Overall Study||67
10881499|NCT03590366|12047450|FG000|COMPLETED|Overall Study||70
10881500|NCT03590366|12047451|FG001|COMPLETED|Overall Study||59
10881501|NCT03590366|12047450|FG000|NOT COMPLETED|Overall Study||3
10881502|NCT03590366|12047451|FG001|NOT COMPLETED|Overall Study||8
10881503|NCT03589469|12047457|FG000|STARTED|Overall Study||145
10881504|NCT03589469|12047457|FG000|Received Treatment|Overall Study||145
10881505|NCT03589469|12047457|FG000|COMPLETED|Overall Study||0
10881506|NCT03589469|12047457|FG000|NOT COMPLETED|Overall Study||145
10881507|NCT03587584|12047463|FG000|STARTED|Overall Study||37
10881508|NCT03587584|12047464|FG001|STARTED|Overall Study||42
10881509|NCT03587584|12047463|FG000|COMPLETED|Overall Study||33
10881510|NCT03587584|12047464|FG001|COMPLETED|Overall Study||33
10881511|NCT03587584|12047463|FG000|NOT COMPLETED|Overall Study||4
10881512|NCT03587584|12047464|FG001|NOT COMPLETED|Overall Study||9
10881513|NCT03586427|12047475|FG000|STARTED|Overall Study||48
10881514|NCT03586427|12047476|FG001|STARTED|Overall Study||50
10881515|NCT03586427|12047477|FG002|STARTED|Overall Study||52
10881516|NCT03586427|12047478|FG003|STARTED|Overall Study||50
10881517|NCT03586427|12047479|FG004|STARTED|Overall Study||51
10881518|NCT03586427|12047475|FG000|COMPLETED|Overall Study||48
10881519|NCT03586427|12047476|FG001|COMPLETED|Overall Study||46
10881520|NCT03586427|12047477|FG002|COMPLETED|Overall Study||46
10881521|NCT03586427|12047478|FG003|COMPLETED|Overall Study||46
10881522|NCT03586427|12047479|FG004|COMPLETED|Overall Study||46
10881523|NCT03586427|12047475|FG000|NOT COMPLETED|Overall Study||0
10881524|NCT03586427|12047476|FG001|NOT COMPLETED|Overall Study||4
10881525|NCT03586427|12047477|FG002|NOT COMPLETED|Overall Study||6
10881526|NCT03586427|12047478|FG003|NOT COMPLETED|Overall Study||4
10881527|NCT03586427|12047479|FG004|NOT COMPLETED|Overall Study||5
10881528|NCT03586050|12047496|FG000|STARTED|Overall Study||33
10881529|NCT03586050|12047496|FG000|COMPLETED|Overall Study||33
10881530|NCT03586050|12047496|FG000|NOT COMPLETED|Overall Study||0
10881531|NCT03584789|12047503|FG000|STARTED|Overall Study||1739
10881532|NCT03584789|12047504|FG001|STARTED|Overall Study||2297
10881533|NCT03584789|12047505|FG002|STARTED|Overall Study||1686
10881534|NCT03584789|12047503|FG000|COMPLETED|Overall Study||1720
10881535|NCT03584789|12047504|FG001|COMPLETED|Overall Study||2269
10881536|NCT03584789|12047505|FG002|COMPLETED|Overall Study||1660
10881537|NCT03584789|12047503|FG000|NOT COMPLETED|Overall Study||19
10881538|NCT03584789|12047504|FG001|NOT COMPLETED|Overall Study||28
10881539|NCT03584789|12047505|FG002|NOT COMPLETED|Overall Study||26
10881540|NCT03575468|12047515|FG000|STARTED|Overall Study||56
10881541|NCT03575468|12047516|FG001|STARTED|Overall Study||54
10881542|NCT03575468|12047515|FG000|COMPLETED|Overall Study||30
10881543|NCT03575468|12047516|FG001|COMPLETED|Overall Study||33
10881544|NCT03575468|12047515|FG000|NOT COMPLETED|Overall Study||26
10881545|NCT03575468|12047516|FG001|NOT COMPLETED|Overall Study||21
10881546|NCT03575325|12047522|FG000|STARTED|Overall Study||11
10881547|NCT03575325|12047522|FG000|COMPLETED|Overall Study||10
10881548|NCT03575325|12047522|FG000|NOT COMPLETED|Overall Study||1
10881549|NCT03575065|12047530|FG000|STARTED|Overall Study||62
10881550|NCT03575065|12047531|FG001|STARTED|Overall Study||26
10881551|NCT03575065|12047530|FG000|COMPLETED|Overall Study||0
10881552|NCT03575065|12047531|FG001|COMPLETED|Overall Study||0
10881553|NCT03575065|12047530|FG000|NOT COMPLETED|Overall Study||62
10881554|NCT03575065|12047531|FG001|NOT COMPLETED|Overall Study||26
10881555|NCT03571581|12047538|FG000|STARTED|Overall Study||33
10881556|NCT03571581|12047538|FG000|COMPLETED|Overall Study||29
10881557|NCT03571581|12047538|FG000|NOT COMPLETED|Overall Study||4
10881558|NCT03570918|12047553|FG000|STARTED|Period 1||1
10881559|NCT03570918|12047554|FG001|STARTED|Period 1||1
10881560|NCT03570918|12047555|FG002|STARTED|Period 1||4
10881561|NCT03570918|12047556|FG003|STARTED|Period 1||3
10881562|NCT03570918|12047557|FG004|STARTED|Period 1||3
10881563|NCT03570918|12047558|FG005|STARTED|Period 1||3
10881564|NCT03570918|12047559|FG006|STARTED|Period 1||3
10881565|NCT03570918|12047560|FG007|STARTED|Period 1||3
10881566|NCT03570918|12047561|FG008|STARTED|Period 1||0
10881567|NCT03570918|12047553|FG000|COMPLETED|Period 1||1
10881568|NCT03570918|12047554|FG001|COMPLETED|Period 1||1
10881569|NCT03570918|12047555|FG002|COMPLETED|Period 1||4
10881570|NCT03570918|12047556|FG003|COMPLETED|Period 1||3
10881571|NCT03570918|12047557|FG004|COMPLETED|Period 1||3
10881572|NCT03570918|12047558|FG005|COMPLETED|Period 1||3
10881573|NCT03570918|12047559|FG006|COMPLETED|Period 1||3
10881574|NCT03570918|12047560|FG007|COMPLETED|Period 1||3
10881575|NCT03570918|12047561|FG008|COMPLETED|Period 1||0
10881576|NCT03570918|12047553|FG000|NOT COMPLETED|Period 1||0
10881577|NCT03570918|12047554|FG001|NOT COMPLETED|Period 1||0
10881578|NCT03570918|12047555|FG002|NOT COMPLETED|Period 1||0
10881579|NCT03570918|12047556|FG003|NOT COMPLETED|Period 1||0
10881580|NCT03570918|12047557|FG004|NOT COMPLETED|Period 1||0
10881581|NCT03570918|12047558|FG005|NOT COMPLETED|Period 1||0
10881582|NCT03570918|12047559|FG006|NOT COMPLETED|Period 1||0
10881583|NCT03570918|12047560|FG007|NOT COMPLETED|Period 1||0
10881584|NCT03570918|12047561|FG008|NOT COMPLETED|Period 1||0
10881585|NCT03570918|12047553|FG000|STARTED|Period 2||0
10881586|NCT03570918|12047554|FG001|STARTED|Period 2||0
10881587|NCT03570918|12047555|FG002|STARTED|Period 2||0
10881588|NCT03570918|12047556|FG003|STARTED|Period 2||0
10881589|NCT03570918|12047557|FG004|STARTED|Period 2||0
10881590|NCT03570918|12047558|FG005|STARTED|Period 2||0
10881591|NCT03570918|12047559|FG006|STARTED|Period 2||0
10881592|NCT03570918|12047560|FG007|STARTED|Period 2||0
10881593|NCT03570918|12047561|FG008|STARTED|Period 2||3
10881594|NCT03570918|12047553|FG000|COMPLETED|Period 2||0
10881595|NCT03570918|12047554|FG001|COMPLETED|Period 2||0
10881596|NCT03570918|12047555|FG002|COMPLETED|Period 2||0
10881597|NCT03570918|12047556|FG003|COMPLETED|Period 2||0
10881598|NCT03570918|12047557|FG004|COMPLETED|Period 2||0
10881599|NCT03570918|12047558|FG005|COMPLETED|Period 2||0
10881600|NCT03570918|12047559|FG006|COMPLETED|Period 2||0
10881601|NCT03570918|12047560|FG007|COMPLETED|Period 2||0
10881602|NCT03570918|12047561|FG008|COMPLETED|Period 2||3
10881603|NCT03570918|12047553|FG000|NOT COMPLETED|Period 2||0
10881604|NCT03570918|12047554|FG001|NOT COMPLETED|Period 2||0
10881605|NCT03570918|12047555|FG002|NOT COMPLETED|Period 2||0
10881606|NCT03570918|12047556|FG003|NOT COMPLETED|Period 2||0
10881607|NCT03570918|12047557|FG004|NOT COMPLETED|Period 2||0
10881608|NCT03570918|12047558|FG005|NOT COMPLETED|Period 2||0
10881609|NCT03570918|12047559|FG006|NOT COMPLETED|Period 2||0
10881610|NCT03570918|12047560|FG007|NOT COMPLETED|Period 2||0
10881611|NCT03570918|12047561|FG008|NOT COMPLETED|Period 2||0
10881612|NCT03569371|12047590|FG000|STARTED|Overall Study||10
10881613|NCT03569371|12047590|FG000|COMPLETED|Overall Study||7
10881614|NCT03569371|12047590|FG000|NOT COMPLETED|Overall Study||3
10881615|NCT03568643|12047596|FG000|STARTED|Overall Study||161
10881616|NCT03568643|12047597|FG001|STARTED|Overall Study||140
10881617|NCT03568643|12047596|FG000|COMPLETED|Overall Study||161
10881618|NCT03568643|12047597|FG001|COMPLETED|Overall Study||140
10881619|NCT03568643|12047596|FG000|NOT COMPLETED|Overall Study||0
10881620|NCT03568643|12047597|FG001|NOT COMPLETED|Overall Study||0
10881621|NCT03568162|12047609|FG000|STARTED|Overall Study||76
10881622|NCT03568162|12047610|FG001|STARTED|Overall Study||80
10881623|NCT03568162|12047611|FG002|STARTED|Overall Study||77
10881624|NCT03568162|12047612|FG003|STARTED|Overall Study||80
10881625|NCT03568162|12047613|FG004|STARTED|Overall Study||75
10881626|NCT03568162|12047614|FG005|STARTED|Overall Study||74
10881627|NCT03568162|12047609|FG000|COMPLETED|Overall Study||54
10881628|NCT03568162|12047610|FG001|COMPLETED|Overall Study||57
10881629|NCT03568162|12047611|FG002|COMPLETED|Overall Study||42
10881630|NCT03568162|12047612|FG003|COMPLETED|Overall Study||50
10881631|NCT03568162|12047613|FG004|COMPLETED|Overall Study||61
10881632|NCT03568162|12047614|FG005|COMPLETED|Overall Study||60
10881633|NCT03568162|12047609|FG000|NOT COMPLETED|Overall Study||22
10881634|NCT03568162|12047610|FG001|NOT COMPLETED|Overall Study||23
10881635|NCT03568162|12047611|FG002|NOT COMPLETED|Overall Study||35
10881636|NCT03568162|12047612|FG003|NOT COMPLETED|Overall Study||30
10881637|NCT03568162|12047613|FG004|NOT COMPLETED|Overall Study||14
10881638|NCT03568162|12047614|FG005|NOT COMPLETED|Overall Study||14
10881639|NCT03567850|12047633|FG000|STARTED|Overall Study||25
10881640|NCT03567850|12047634|FG001|STARTED|Overall Study||25
10881641|NCT03567850|12047633|FG000|COMPLETED|Overall Study||25
10881642|NCT03567850|12047634|FG001|COMPLETED|Overall Study||25
10881643|NCT03567850|12047633|FG000|NOT COMPLETED|Overall Study||0
10881644|NCT03567850|12047634|FG001|NOT COMPLETED|Overall Study||0
10881645|NCT03565237|12047640|FG000|STARTED|Overall Study||25
10881646|NCT03565237|12047640|FG000|Safety Analysis Set (SAS)|Overall Study||25
10881647|NCT03565237|12047640|FG000|Effectiveness Full Analysis Set (EFAS)|Overall Study||25
10881648|NCT03565237|12047640|FG000|COMPLETED|Overall Study||23
10881649|NCT03565237|12047640|FG000|NOT COMPLETED|Overall Study||2
10881650|NCT03563716|12047646|FG000|STARTED|Overall Study||68
10881651|NCT03563716|12047647|FG001|STARTED|Overall Study||67
10881652|NCT03563716|12047646|FG000|COMPLETED|Overall Study||0
10881653|NCT03563716|12047647|FG001|COMPLETED|Overall Study|"One participant who died had as reason for discontinuation Withdrawal by Subject"|0
10881654|NCT03563716|12047646|FG000|NOT COMPLETED|Overall Study||68
10881655|NCT03563716|12047647|FG001|NOT COMPLETED|Overall Study||67
10881656|NCT03558503|12047653|FG000|STARTED|Overall Study||63
10881657|NCT03558503|12047653|FG000|COMPLETED|Overall Study||60
10881658|NCT03558503|12047653|FG000|NOT COMPLETED|Overall Study||3
10881659|NCT03557151|12047659|FG000|STARTED|Randomization to 3 Months||74
10881660|NCT03557151|12047660|FG001|STARTED|Randomization to 3 Months||134
10881661|NCT03557151|12047659|FG000|Adolescent Participants|Randomization to 3 Months||37
10881662|NCT03557151|12047660|FG001|Adolescent Participants|Randomization to 3 Months||67
10881663|NCT03557151|12047659|FG000|Caregiver Participants|Randomization to 3 Months||37
10881664|NCT03557151|12047660|FG001|Caregiver Participants|Randomization to 3 Months||67
10881665|NCT03557151|12047659|FG000|COMPLETED|Randomization to 3 Months||72
10881666|NCT03557151|12047660|FG001|COMPLETED|Randomization to 3 Months||132
10881667|NCT03557151|12047659|FG000|NOT COMPLETED|Randomization to 3 Months||2
10881668|NCT03557151|12047660|FG001|NOT COMPLETED|Randomization to 3 Months||2
10881669|NCT03557151|12047659|FG000|STARTED|3 to 6 Months||72
10881670|NCT03557151|12047660|FG001|STARTED|3 to 6 Months||132
10881671|NCT03557151|12047659|FG000|Adolescent Participants|3 to 6 Months||36
10881672|NCT03557151|12047660|FG001|Adolescent Participants|3 to 6 Months||66
10881673|NCT03557151|12047659|FG000|Caregiver Participants|3 to 6 Months||36
10881674|NCT03557151|12047660|FG001|Caregiver Participants|3 to 6 Months||66
10881675|NCT03557151|12047659|FG000|COMPLETED|3 to 6 Months||72
10881676|NCT03557151|12047660|FG001|COMPLETED|3 to 6 Months||132
10881677|NCT03557151|12047659|FG000|NOT COMPLETED|3 to 6 Months||0
10881678|NCT03557151|12047660|FG001|NOT COMPLETED|3 to 6 Months||0
10881679|NCT03557151|12047659|FG000|STARTED|6 to 9 Months||72
10881680|NCT03557151|12047660|FG001|STARTED|6 to 9 Months||132
10881681|NCT03557151|12047659|FG000|Adolescent Participants|6 to 9 Months||36
10881682|NCT03557151|12047660|FG001|Adolescent Participants|6 to 9 Months||66
10881683|NCT03557151|12047659|FG000|Caregiver Participants|6 to 9 Months||36
10881684|NCT03557151|12047660|FG001|Caregiver Participants|6 to 9 Months||66
10881685|NCT03557151|12047659|FG000|COMPLETED|6 to 9 Months||70
10881686|NCT03557151|12047660|FG001|COMPLETED|6 to 9 Months||132
10881687|NCT03557151|12047659|FG000|NOT COMPLETED|6 to 9 Months||2
10881688|NCT03557151|12047660|FG001|NOT COMPLETED|6 to 9 Months||0
10881689|NCT03557151|12047659|FG000|STARTED|9 to 12 Months (End of Study)||70
10881690|NCT03557151|12047660|FG001|STARTED|9 to 12 Months (End of Study)||132
10881691|NCT03557151|12047659|FG000|Adolescent Participants|9 to 12 Months (End of Study)||35
10881692|NCT03557151|12047660|FG001|Adolescent Participants|9 to 12 Months (End of Study)||66
10881693|NCT03557151|12047659|FG000|Caregiver Participants|9 to 12 Months (End of Study)||35
10881694|NCT03557151|12047660|FG001|Caregiver Participants|9 to 12 Months (End of Study)||66
10881695|NCT03557151|12047659|FG000|COMPLETED|9 to 12 Months (End of Study)||70
10881696|NCT03557151|12047660|FG001|COMPLETED|9 to 12 Months (End of Study)||130
10881697|NCT03557151|12047659|FG000|NOT COMPLETED|9 to 12 Months (End of Study)||0
10881698|NCT03557151|12047660|FG001|NOT COMPLETED|9 to 12 Months (End of Study)||2
10881699|NCT03552822|12047670|FG000|STARTED|Overall Study||112
10881700|NCT03552822|12047671|FG001|STARTED|Overall Study||429
10881701|NCT03552822|12047670|FG000|COMPLETED|Overall Study||112
10881702|NCT03552822|12047671|FG001|COMPLETED|Overall Study||429
10881703|NCT03552822|12047670|FG000|NOT COMPLETED|Overall Study||0
10881704|NCT03552822|12047671|FG001|NOT COMPLETED|Overall Study||0
10881705|NCT03551522|12047681|FG000|STARTED|DB Phase||53
10881706|NCT03551522|12047682|FG001|STARTED|DB Phase||51
10881707|NCT03551522|12047683|FG002|STARTED|DB Phase||50
10881708|NCT03551522|12047684|FG003|STARTED|DB Phase||27
10881709|NCT03551522|12047685|FG004|STARTED|DB Phase||0
10881710|NCT03551522|12047681|FG000|COMPLETED|DB Phase||27
10881711|NCT03551522|12047682|FG001|COMPLETED|DB Phase||34
10881712|NCT03551522|12047683|FG002|COMPLETED|DB Phase||32
10881713|NCT03551522|12047684|FG003|COMPLETED|DB Phase||17
10881714|NCT03551522|12047685|FG004|COMPLETED|DB Phase||0
10881715|NCT03551522|12047681|FG000|NOT COMPLETED|DB Phase||26
10881716|NCT03551522|12047682|FG001|NOT COMPLETED|DB Phase||17
10881717|NCT03551522|12047683|FG002|NOT COMPLETED|DB Phase||18
10881718|NCT03551522|12047684|FG003|NOT COMPLETED|DB Phase||10
10881719|NCT03551522|12047685|FG004|NOT COMPLETED|DB Phase||0
10881720|NCT03551522|12047681|FG000|STARTED|OLE Phase||0
10881721|NCT03551522|12047682|FG001|STARTED|OLE Phase||0
10881722|NCT03551522|12047683|FG002|STARTED|OLE Phase||0
10881723|NCT03551522|12047684|FG003|STARTED|OLE Phase||0
10881724|NCT03551522|12047685|FG004|STARTED|OLE Phase||12
10881725|NCT03551522|12047681|FG000|COMPLETED|OLE Phase||0
10881726|NCT03551522|12047682|FG001|COMPLETED|OLE Phase||0
10881727|NCT03551522|12047683|FG002|COMPLETED|OLE Phase||0
10881728|NCT03551522|12047684|FG003|COMPLETED|OLE Phase||0
10881729|NCT03551522|12047685|FG004|COMPLETED|OLE Phase||0
10881730|NCT03551522|12047681|FG000|NOT COMPLETED|OLE Phase||0
10881731|NCT03551522|12047682|FG001|NOT COMPLETED|OLE Phase||0
10881732|NCT03551522|12047683|FG002|NOT COMPLETED|OLE Phase||0
10881733|NCT03551522|12047684|FG003|NOT COMPLETED|OLE Phase||0
10881734|NCT03551522|12047685|FG004|NOT COMPLETED|OLE Phase||12
10881735|NCT03547622|12047697|FG000|STARTED|Overall Study||3
10881736|NCT03547622|12047698|FG001|STARTED|Overall Study||3
10881737|NCT03547622|12047697|FG000|COMPLETED|Overall Study||3
10881738|NCT03547622|12047698|FG001|COMPLETED|Overall Study||2
10881739|NCT03547622|12047697|FG000|NOT COMPLETED|Overall Study||0
10881740|NCT03547622|12047698|FG001|NOT COMPLETED|Overall Study||1
10881741|NCT03538951|12047706|FG000|STARTED|Overall Study||41
10881742|NCT03538951|12047707|FG001|STARTED|Overall Study||42
10881743|NCT03538951|12047706|FG000|COMPLETED|Overall Study||40
10881744|NCT03538951|12047707|FG001|COMPLETED|Overall Study||40
10881745|NCT03538951|12047706|FG000|NOT COMPLETED|Overall Study||1
10881746|NCT03538951|12047707|FG001|NOT COMPLETED|Overall Study||2
10881747|NCT03538054|12047713|FG000|STARTED|Baseline Phase (2 Weeks)||19
10881748|NCT03538054|12047713|FG000|COMPLETED|Baseline Phase (2 Weeks)||18
10881749|NCT03538054|12047713|FG000|NOT COMPLETED|Baseline Phase (2 Weeks)||1
10881750|NCT03538054|12047713|FG000|STARTED|Placebo Phase (5 Weeks)||18
10881751|NCT03538054|12047713|FG000|COMPLETED|Placebo Phase (5 Weeks)||16
10881752|NCT03538054|12047713|FG000|NOT COMPLETED|Placebo Phase (5 Weeks)||2
10881753|NCT03538054|12047713|FG000|STARTED|Dextromethorphan Phase (10 Weeks)||16
10881754|NCT03538054|12047713|FG000|COMPLETED|Dextromethorphan Phase (10 Weeks)||14
10881755|NCT03538054|12047713|FG000|NOT COMPLETED|Dextromethorphan Phase (10 Weeks)||2
10881756|NCT03538041|12047721|FG000|STARTED|12-Week Treatment Period||10
10881757|NCT03538041|12047722|FG001|STARTED|12-Week Treatment Period||15
10881758|NCT03538041|12047721|FG000|COMPLETED|12-Week Treatment Period||9
10881759|NCT03538041|12047722|FG001|COMPLETED|12-Week Treatment Period||13
10881760|NCT03538041|12047721|FG000|NOT COMPLETED|12-Week Treatment Period||1
10881761|NCT03538041|12047722|FG001|NOT COMPLETED|12-Week Treatment Period||2
10881762|NCT03538041|12047721|FG000|STARTED|Treatment Extension Period|These participants completed the 24-week Treatment Period and were eligible for an extension of treatment based on their clinical response.|7
10881763|NCT03538041|12047722|FG001|STARTED|Treatment Extension Period|These participants completed the 24-week Treatment Period and were eligible for an extension of treatment based on their clinical response.|10
10881764|NCT03538041|12047721|FG000|COMPLETED|Treatment Extension Period||0
10881765|NCT03538041|12047722|FG001|COMPLETED|Treatment Extension Period||0
10881766|NCT03538041|12047721|FG000|NOT COMPLETED|Treatment Extension Period||7
10881767|NCT03538041|12047722|FG001|NOT COMPLETED|Treatment Extension Period||10
10881768|NCT03525678|12047734|FG000|STARTED|Overall Study||97
10881769|NCT03525678|12047735|FG001|STARTED|Overall Study||99
10881770|NCT03525678|12047736|FG002|STARTED|Overall Study||25
10881771|NCT03525678|12047734|FG000|Received Study Treatment|Overall Study||95
10881772|NCT03525678|12047735|FG001|Received Study Treatment|Overall Study||99
10881773|NCT03525678|12047736|FG002|Received Study Treatment|Overall Study||24
10881774|NCT03525678|12047734|FG000|COMPLETED|Overall Study||0
10881775|NCT03525678|12047735|FG001|COMPLETED|Overall Study||0
10881776|NCT03525678|12047736|FG002|COMPLETED|Overall Study||0
10881777|NCT03525678|12047734|FG000|NOT COMPLETED|Overall Study||97
10881778|NCT03525678|12047735|FG001|NOT COMPLETED|Overall Study||99
10881779|NCT03525678|12047736|FG002|NOT COMPLETED|Overall Study||25
10881780|NCT03525119|12047747|FG000|STARTED|Overall Study||300
10881781|NCT03525119|12047748|FG001|STARTED|Overall Study||300
10881782|NCT03525119|12047749|FG002|STARTED|Overall Study||300
10881783|NCT03525119|12047747|FG000|Safety Population|Overall Study||299
10881784|NCT03525119|12047748|FG001|Safety Population|Overall Study||300
10881785|NCT03525119|12047749|FG002|Safety Population|Overall Study||298
10881786|NCT03525119|12047747|FG000|COMPLETED|Overall Study||260
10881787|NCT03525119|12047748|FG001|COMPLETED|Overall Study||261
10881788|NCT03525119|12047749|FG002|COMPLETED|Overall Study||257
10881789|NCT03525119|12047747|FG000|NOT COMPLETED|Overall Study||40
10881790|NCT03525119|12047748|FG001|NOT COMPLETED|Overall Study||39
10881791|NCT03525119|12047749|FG002|NOT COMPLETED|Overall Study||43
10881792|NCT03521193|12047759|FG000|STARTED|Overall Study|enrolled on the PFO closure hospitalization|78
10881793|NCT03521193|12047760|FG001|STARTED|Overall Study||12
10881794|NCT03521193|12047759|FG000|COMPLETED|Overall Study|8 pts refused to continue the study; 8 patients were non compliant to ASA treatment|62
10881795|NCT03521193|12047760|FG001|COMPLETED|Overall Study||12
10881796|NCT03521193|12047759|FG000|NOT COMPLETED|Overall Study||16
10881797|NCT03521193|12047760|FG001|NOT COMPLETED|Overall Study||0
10881798|NCT03518086|12047769|FG000|STARTED|Overall Study||322
10881799|NCT03518086|12047770|FG001|STARTED|Overall Study||959
10881800|NCT03518086|12047771|FG002|STARTED|Overall Study||0
10881801|NCT03518086|12047772|FG003|STARTED|Overall Study||0
10881802|NCT03518086|12047769|FG000|Received at Least One Dose of Study Drug|Overall Study||321
10881803|NCT03518086|12047770|FG001|Received at Least One Dose of Study Drug|Overall Study||958
10881804|NCT03518086|12047771|FG002|Received at Least One Dose of Study Drug|Overall Study||0
10881805|NCT03518086|12047772|FG003|Received at Least One Dose of Study Drug|Overall Study||0
10881806|NCT03518086|12047769|FG000|COMPLETED|Overall Study||285
10881807|NCT03518086|12047770|FG001|COMPLETED|Overall Study||920
10881808|NCT03518086|12047771|FG002|COMPLETED|Overall Study||0
10881809|NCT03518086|12047772|FG003|COMPLETED|Overall Study||0
10881810|NCT03518086|12047769|FG000|NOT COMPLETED|Overall Study||37
10881811|NCT03518086|12047770|FG001|NOT COMPLETED|Overall Study||39
10881812|NCT03518086|12047771|FG002|NOT COMPLETED|Overall Study||0
10881813|NCT03518086|12047772|FG003|NOT COMPLETED|Overall Study||0
10881814|NCT03518073|12047782|FG000|STARTED|Overall Study||118
10881815|NCT03518073|12047783|FG001|STARTED|Overall Study||126
10881816|NCT03518073|12047784|FG002|STARTED|Overall Study||116
10881817|NCT03518073|12047782|FG000|Received at Least One Dose of Study Drug|Overall Study||118
10881818|NCT03518073|12047783|FG001|Received at Least One Dose of Study Drug|Overall Study||126
10881819|NCT03518073|12047784|FG002|Received at Least One Dose of Study Drug|Overall Study||116
10881820|NCT03518073|12047782|FG000|COMPLETED|Overall Study||74
10881821|NCT03518073|12047783|FG001|COMPLETED|Overall Study||78
10881822|NCT03518073|12047784|FG002|COMPLETED|Overall Study||70
10881823|NCT03518073|12047782|FG000|NOT COMPLETED|Overall Study||44
10881824|NCT03518073|12047783|FG001|NOT COMPLETED|Overall Study||48
10881825|NCT03518073|12047784|FG002|NOT COMPLETED|Overall Study||46
10881826|NCT03514914|12047796|FG000|STARTED|Overall Study||1200
10881827|NCT03514914|12047797|FG001|STARTED|Overall Study||1202
10881828|NCT03514914|12047796|FG000|9 Month Follow-up|Overall Study||1091
10881829|NCT03514914|12047797|FG001|9 Month Follow-up|Overall Study||1114
10881830|NCT03514914|12047796|FG000|COMPLETED|Overall Study||1080
10881831|NCT03514914|12047797|FG001|COMPLETED|Overall Study||1110
10881832|NCT03514914|12047796|FG000|NOT COMPLETED|Overall Study||120
10881833|NCT03514914|12047797|FG001|NOT COMPLETED|Overall Study||92
10881834|NCT03514394|12047806|FG000|STARTED|Overall Study||17
10881835|NCT03514394|12047807|FG001|STARTED|Overall Study||16
10881836|NCT03514394|12047808|FG002|STARTED|Overall Study||11
10881837|NCT03514394|12047806|FG000|COMPLETED|Overall Study||17
10881838|NCT03514394|12047807|FG001|COMPLETED|Overall Study||16
10881839|NCT03514394|12047808|FG002|COMPLETED|Overall Study||10
10881840|NCT03514394|12047806|FG000|NOT COMPLETED|Overall Study||0
10881841|NCT03514394|12047807|FG001|NOT COMPLETED|Overall Study||0
10881842|NCT03514394|12047808|FG002|NOT COMPLETED|Overall Study||1
10881843|NCT03511664|12047818|FG000|STARTED|Overall Study||551
10881844|NCT03511664|12047819|FG001|STARTED|Overall Study||280
10881845|NCT03511664|12047818|FG000|FAS Safety Analysis Set|Overall Study||529
10881846|NCT03511664|12047819|FG001|FAS Safety Analysis Set|Overall Study||205
10881847|NCT03511664|12047818|FG000|Progression-Free Survival (PFS) Full Analysis Set (PFS-FAS)|Overall Study||385
10881848|NCT03511664|12047819|FG001|Progression-Free Survival (PFS) Full Analysis Set (PFS-FAS)|Overall Study||196
10881849|NCT03511664|12047818|FG000|Response Evaluable Analysis Set|Overall Study||319
10881850|NCT03511664|12047819|FG001|Response Evaluable Analysis Set|Overall Study||120
10881851|NCT03511664|12047818|FG000|COMPLETED|Overall Study||329
10881852|NCT03511664|12047819|FG001|COMPLETED|Overall Study||167
10881853|NCT03511664|12047818|FG000|NOT COMPLETED|Overall Study||222
10881854|NCT03511664|12047819|FG001|NOT COMPLETED|Overall Study||113
10881855|NCT03509857|12047827|FG000|STARTED|Overall Study||50
10881856|NCT03509857|12047828|FG001|STARTED|Overall Study||50
10881857|NCT03509857|12047827|FG000|COMPLETED|Overall Study||50
10881858|NCT03509857|12047828|FG001|COMPLETED|Overall Study||50
10881859|NCT03509857|12047827|FG000|NOT COMPLETED|Overall Study||0
10881860|NCT03509857|12047828|FG001|NOT COMPLETED|Overall Study||0
10881861|NCT03505099|12047836|FG000|STARTED|Overall Study||14
10881862|NCT03505099|12047837|FG001|STARTED|Overall Study||15
10881863|NCT03505099|12047836|FG000|Received AVXS-101|Overall Study||14
10881864|NCT03505099|12047837|FG001|Received AVXS-101|Overall Study||15
10881865|NCT03505099|12047836|FG000|COMPLETED|Overall Study||14
10881866|NCT03505099|12047837|FG001|COMPLETED|Overall Study||15
10881867|NCT03505099|12047836|FG000|NOT COMPLETED|Overall Study||0
10881868|NCT03505099|12047837|FG001|NOT COMPLETED|Overall Study||0
10881869|NCT03499821|12047843|FG000|STARTED|Overall Study||35
10881870|NCT03499821|12047843|FG000|COMPLETED|Overall Study||34
10881871|NCT03499821|12047843|FG000|NOT COMPLETED|Overall Study||1
10881872|NCT03498313|12047853|FG000|STARTED|Experimental Period 1||9
10881873|NCT03498313|12047854|FG001|STARTED|Experimental Period 1||8
10881874|NCT03498313|12047855|FG002|STARTED|Experimental Period 1||9
10881875|NCT03498313|12047856|FG003|STARTED|Experimental Period 1||5
10881876|NCT03498313|12047857|FG004|STARTED|Experimental Period 1||9
10881877|NCT03498313|12047858|FG005|STARTED|Experimental Period 1||6
10881878|NCT03498313|12047853|FG000|COMPLETED|Experimental Period 1||8
10881879|NCT03498313|12047854|FG001|COMPLETED|Experimental Period 1||7
10881880|NCT03498313|12047855|FG002|COMPLETED|Experimental Period 1||9
10881881|NCT03498313|12047856|FG003|COMPLETED|Experimental Period 1||4
10881882|NCT03498313|12047857|FG004|COMPLETED|Experimental Period 1||9
10881883|NCT03498313|12047858|FG005|COMPLETED|Experimental Period 1||6
10881884|NCT03498313|12047853|FG000|NOT COMPLETED|Experimental Period 1||1
10881885|NCT03498313|12047854|FG001|NOT COMPLETED|Experimental Period 1||1
10881886|NCT03498313|12047855|FG002|NOT COMPLETED|Experimental Period 1||0
10881887|NCT03498313|12047856|FG003|NOT COMPLETED|Experimental Period 1||1
10881888|NCT03498313|12047857|FG004|NOT COMPLETED|Experimental Period 1||0
10881889|NCT03498313|12047858|FG005|NOT COMPLETED|Experimental Period 1||0
10881890|NCT03498313|12047853|FG000|STARTED|Washout Period 1||8
10881891|NCT03498313|12047854|FG001|STARTED|Washout Period 1||7
10881892|NCT03498313|12047855|FG002|STARTED|Washout Period 1||9
10881893|NCT03498313|12047856|FG003|STARTED|Washout Period 1||4
10881894|NCT03498313|12047857|FG004|STARTED|Washout Period 1||9
10881895|NCT03498313|12047858|FG005|STARTED|Washout Period 1||6
10881896|NCT03498313|12047853|FG000|COMPLETED|Washout Period 1||7
10881897|NCT03498313|12047854|FG001|COMPLETED|Washout Period 1||4
10881898|NCT03498313|12047855|FG002|COMPLETED|Washout Period 1||9
10881899|NCT03498313|12047856|FG003|COMPLETED|Washout Period 1||3
10881900|NCT03498313|12047857|FG004|COMPLETED|Washout Period 1||9
10881901|NCT03498313|12047858|FG005|COMPLETED|Washout Period 1||5
10881902|NCT03498313|12047853|FG000|NOT COMPLETED|Washout Period 1||1
10881903|NCT03498313|12047854|FG001|NOT COMPLETED|Washout Period 1||3
10881904|NCT03498313|12047855|FG002|NOT COMPLETED|Washout Period 1||0
10881905|NCT03498313|12047856|FG003|NOT COMPLETED|Washout Period 1||1
10881906|NCT03498313|12047857|FG004|NOT COMPLETED|Washout Period 1||0
10881907|NCT03498313|12047858|FG005|NOT COMPLETED|Washout Period 1||1
10881908|NCT03498313|12047853|FG000|STARTED|Experimental Period 2||7
10881909|NCT03498313|12047854|FG001|STARTED|Experimental Period 2||4
10881910|NCT03498313|12047855|FG002|STARTED|Experimental Period 2||9
10881911|NCT03498313|12047856|FG003|STARTED|Experimental Period 2||3
10881912|NCT03498313|12047857|FG004|STARTED|Experimental Period 2||9
10881913|NCT03498313|12047858|FG005|STARTED|Experimental Period 2||5
10881914|NCT03498313|12047853|FG000|COMPLETED|Experimental Period 2||7
10881915|NCT03498313|12047854|FG001|COMPLETED|Experimental Period 2||4
10881916|NCT03498313|12047855|FG002|COMPLETED|Experimental Period 2||9
10881917|NCT03498313|12047856|FG003|COMPLETED|Experimental Period 2||3
10881918|NCT03498313|12047857|FG004|COMPLETED|Experimental Period 2||8
10881919|NCT03498313|12047858|FG005|COMPLETED|Experimental Period 2||3
10881920|NCT03498313|12047853|FG000|NOT COMPLETED|Experimental Period 2||0
10881921|NCT03498313|12047854|FG001|NOT COMPLETED|Experimental Period 2||0
10881922|NCT03498313|12047855|FG002|NOT COMPLETED|Experimental Period 2||0
10881923|NCT03498313|12047856|FG003|NOT COMPLETED|Experimental Period 2||0
10881924|NCT03498313|12047857|FG004|NOT COMPLETED|Experimental Period 2||1
10881925|NCT03498313|12047858|FG005|NOT COMPLETED|Experimental Period 2||2
10881926|NCT03498313|12047853|FG000|STARTED|Washout Period 2||7
10881927|NCT03498313|12047854|FG001|STARTED|Washout Period 2||4
10881928|NCT03498313|12047855|FG002|STARTED|Washout Period 2||9
10881929|NCT03498313|12047856|FG003|STARTED|Washout Period 2||3
10881930|NCT03498313|12047857|FG004|STARTED|Washout Period 2||8
10881931|NCT03498313|12047858|FG005|STARTED|Washout Period 2||3
10881932|NCT03498313|12047853|FG000|COMPLETED|Washout Period 2||3
10881933|NCT03498313|12047854|FG001|COMPLETED|Washout Period 2||2
10881934|NCT03498313|12047855|FG002|COMPLETED|Washout Period 2||9
10881935|NCT03498313|12047856|FG003|COMPLETED|Washout Period 2||2
10881936|NCT03498313|12047857|FG004|COMPLETED|Washout Period 2||6
10881937|NCT03498313|12047858|FG005|COMPLETED|Washout Period 2||1
10881938|NCT03498313|12047853|FG000|NOT COMPLETED|Washout Period 2||4
10881939|NCT03498313|12047854|FG001|NOT COMPLETED|Washout Period 2||2
10881940|NCT03498313|12047855|FG002|NOT COMPLETED|Washout Period 2||0
10881941|NCT03498313|12047856|FG003|NOT COMPLETED|Washout Period 2||1
10881942|NCT03498313|12047857|FG004|NOT COMPLETED|Washout Period 2||2
10881943|NCT03498313|12047858|FG005|NOT COMPLETED|Washout Period 2||2
10881944|NCT03498313|12047853|FG000|STARTED|Experimental Period 3||3
10881945|NCT03498313|12047854|FG001|STARTED|Experimental Period 3||2
10881946|NCT03498313|12047855|FG002|STARTED|Experimental Period 3||9
10881947|NCT03498313|12047856|FG003|STARTED|Experimental Period 3||2
10881948|NCT03498313|12047857|FG004|STARTED|Experimental Period 3||6
10881949|NCT03498313|12047858|FG005|STARTED|Experimental Period 3||1
10881950|NCT03498313|12047853|FG000|COMPLETED|Experimental Period 3||3
10881951|NCT03498313|12047854|FG001|COMPLETED|Experimental Period 3||2
10881952|NCT03498313|12047855|FG002|COMPLETED|Experimental Period 3||9
10881953|NCT03498313|12047856|FG003|COMPLETED|Experimental Period 3||2
10881954|NCT03498313|12047857|FG004|COMPLETED|Experimental Period 3||6
10881955|NCT03498313|12047858|FG005|COMPLETED|Experimental Period 3||1
10881956|NCT03498313|12047853|FG000|NOT COMPLETED|Experimental Period 3||0
10881957|NCT03498313|12047854|FG001|NOT COMPLETED|Experimental Period 3||0
10881958|NCT03498313|12047855|FG002|NOT COMPLETED|Experimental Period 3||0
10881959|NCT03498313|12047856|FG003|NOT COMPLETED|Experimental Period 3||0
10881960|NCT03498313|12047857|FG004|NOT COMPLETED|Experimental Period 3||0
10881961|NCT03498313|12047858|FG005|NOT COMPLETED|Experimental Period 3||0
10881962|NCT03497806|12047866|FG000|STARTED|Week 8||132
10881963|NCT03497806|12047866|FG000|COMPLETED|Week 8||123
10881964|NCT03497806|12047866|FG000|NOT COMPLETED|Week 8||9
10881965|NCT03497806|12047866|FG000|STARTED|Week 24||123
10881966|NCT03497806|12047866|FG000|COMPLETED|Week 24||112
10881967|NCT03497806|12047866|FG000|NOT COMPLETED|Week 24||11
10881968|NCT03496844|12047870|FG000|STARTED|Overall Study||15
10881969|NCT03496844|12047870|FG000|COMPLETED|Overall Study||15
10881970|NCT03496844|12047870|FG000|NOT COMPLETED|Overall Study||0
10881971|NCT03495453|12047876|FG000|STARTED|Overall Study||30
10881972|NCT03495453|12047877|FG001|STARTED|Overall Study||30
10881973|NCT03495453|12047876|FG000|COMPLETED|Overall Study||30
10881974|NCT03495453|12047877|FG001|COMPLETED|Overall Study||29
10881975|NCT03495453|12047876|FG000|NOT COMPLETED|Overall Study||0
10881976|NCT03495453|12047877|FG001|NOT COMPLETED|Overall Study||1
10881977|NCT03488251|12047887|FG000|STARTED|Part 1:Dose Escalation (Up to 168 Days)||8
10881978|NCT03488251|12047888|FG001|STARTED|Part 1:Dose Escalation (Up to 168 Days)||0
10881979|NCT03488251|12047889|FG002|STARTED|Part 1:Dose Escalation (Up to 168 Days)||0
10881980|NCT03488251|12047890|FG003|STARTED|Part 1:Dose Escalation (Up to 168 Days)||0
10881981|NCT03488251|12047887|FG000|COMPLETED|Part 1:Dose Escalation (Up to 168 Days)||0
10881982|NCT03488251|12047888|FG001|COMPLETED|Part 1:Dose Escalation (Up to 168 Days)||0
10881983|NCT03488251|12047889|FG002|COMPLETED|Part 1:Dose Escalation (Up to 168 Days)||0
10881984|NCT03488251|12047890|FG003|COMPLETED|Part 1:Dose Escalation (Up to 168 Days)||0
10881985|NCT03488251|12047887|FG000|NOT COMPLETED|Part 1:Dose Escalation (Up to 168 Days)||8
10881986|NCT03488251|12047888|FG001|NOT COMPLETED|Part 1:Dose Escalation (Up to 168 Days)||0
10881987|NCT03488251|12047889|FG002|NOT COMPLETED|Part 1:Dose Escalation (Up to 168 Days)||0
10881988|NCT03488251|12047890|FG003|NOT COMPLETED|Part 1:Dose Escalation (Up to 168 Days)||0
10881989|NCT03488251|12047887|FG000|STARTED|Part 2:Dose Expansion (Up to 168 Days)||0
10881990|NCT03488251|12047888|FG001|STARTED|Part 2:Dose Expansion (Up to 168 Days)||0
10881991|NCT03488251|12047889|FG002|STARTED|Part 2:Dose Expansion (Up to 168 Days)||0
10881992|NCT03488251|12047890|FG003|STARTED|Part 2:Dose Expansion (Up to 168 Days)||0
10881993|NCT03488251|12047887|FG000|COMPLETED|Part 2:Dose Expansion (Up to 168 Days)||0
10881994|NCT03488251|12047888|FG001|COMPLETED|Part 2:Dose Expansion (Up to 168 Days)||0
10881995|NCT03488251|12047889|FG002|COMPLETED|Part 2:Dose Expansion (Up to 168 Days)||0
10881996|NCT03488251|12047890|FG003|COMPLETED|Part 2:Dose Expansion (Up to 168 Days)||0
10881997|NCT03488251|12047887|FG000|NOT COMPLETED|Part 2:Dose Expansion (Up to 168 Days)||0
10881998|NCT03488251|12047888|FG001|NOT COMPLETED|Part 2:Dose Expansion (Up to 168 Days)||0
10881999|NCT03488251|12047889|FG002|NOT COMPLETED|Part 2:Dose Expansion (Up to 168 Days)||0
10882000|NCT03488251|12047890|FG003|NOT COMPLETED|Part 2:Dose Expansion (Up to 168 Days)||0
10882001|NCT03486899|12047905|FG000|STARTED|Overall Study||49
10882002|NCT03486899|12047906|FG001|STARTED|Overall Study||50
10882003|NCT03486899|12047907|FG002|STARTED|Overall Study||49
10882004|NCT03486899|12047908|FG003|STARTED|Overall Study||49
10882005|NCT03486899|12047905|FG000|COMPLETED|Overall Study||41
10882006|NCT03486899|12047906|FG001|COMPLETED|Overall Study||39
10882007|NCT03486899|12047907|FG002|COMPLETED|Overall Study||41
10882008|NCT03486899|12047908|FG003|COMPLETED|Overall Study||39
10882009|NCT03486899|12047905|FG000|NOT COMPLETED|Overall Study||8
10882010|NCT03486899|12047906|FG001|NOT COMPLETED|Overall Study||11
10882011|NCT03486899|12047907|FG002|NOT COMPLETED|Overall Study||8
10882012|NCT03486899|12047908|FG003|NOT COMPLETED|Overall Study||10
10882013|NCT03483077|12047925|FG000|STARTED|Overall Study||12
10882014|NCT03483077|12047926|FG001|STARTED|Overall Study||6
10882015|NCT03483077|12047927|FG002|STARTED|Overall Study||6
10882016|NCT03483077|12047928|FG003|STARTED|Overall Study||6
10882017|NCT03483077|12047929|FG004|STARTED|Overall Study||6
10882018|NCT03483077|12047930|FG005|STARTED|Overall Study||6
10882019|NCT03483077|12047931|FG006|STARTED|Overall Study||6
10882020|NCT03483077|12047925|FG000|COMPLETED|Overall Study||12
10882021|NCT03483077|12047926|FG001|COMPLETED|Overall Study||6
10882022|NCT03483077|12047927|FG002|COMPLETED|Overall Study||6
10882023|NCT03483077|12047928|FG003|COMPLETED|Overall Study||6
10882024|NCT03483077|12047929|FG004|COMPLETED|Overall Study||6
10882025|NCT03483077|12047930|FG005|COMPLETED|Overall Study||6
10882026|NCT03483077|12047931|FG006|COMPLETED|Overall Study||6
10882027|NCT03483077|12047925|FG000|NOT COMPLETED|Overall Study||0
10882028|NCT03483077|12047926|FG001|NOT COMPLETED|Overall Study||0
10882029|NCT03483077|12047927|FG002|NOT COMPLETED|Overall Study||0
10882030|NCT03483077|12047928|FG003|NOT COMPLETED|Overall Study||0
10882031|NCT03483077|12047929|FG004|NOT COMPLETED|Overall Study||0
10882032|NCT03483077|12047930|FG005|NOT COMPLETED|Overall Study||0
10882033|NCT03483077|12047931|FG006|NOT COMPLETED|Overall Study||0
10882034|NCT03475056|12047956|FG000|STARTED|Overall Study||20
10882035|NCT03475056|12047957|FG001|STARTED|Overall Study||20
10882036|NCT03475056|12047956|FG000|Received Product Administration|Overall Study||20
10882037|NCT03475056|12047957|FG001|Received Product Administration|Overall Study||20
10882038|NCT03475056|12047956|FG000|COMPLETED|Overall Study||20
10882039|NCT03475056|12047957|FG001|COMPLETED|Overall Study||17
10882040|NCT03475056|12047956|FG000|NOT COMPLETED|Overall Study||0
10882041|NCT03475056|12047957|FG001|NOT COMPLETED|Overall Study||3
10882042|NCT03474107|12047966|FG000|STARTED|Overall Study||301
10882043|NCT03474107|12047967|FG001|STARTED|Overall Study||307
10882044|NCT03474107|12047966|FG000|Treated|Overall Study||296
10882045|NCT03474107|12047967|FG001|Treated|Overall Study||291
10882046|NCT03474107|12047966|FG000|COMPLETED|Overall Study|Participants still on treatment as of data cut-off date 15-Jul-2020|56
10882047|NCT03474107|12047967|FG001|COMPLETED|Overall Study|Participants still on treatment as of data cut-off date 15-Jul-2020|22
10882048|NCT03474107|12047966|FG000|NOT COMPLETED|Overall Study||245
10882049|NCT03474107|12047967|FG001|NOT COMPLETED|Overall Study||285
10882050|NCT03473340|12047975|FG000|STARTED|Overall Study||13
10882051|NCT03473340|12047976|FG001|STARTED|Overall Study||11
10882052|NCT03473340|12047975|FG000|COMPLETED|Overall Study||8
10882053|NCT03473340|12047976|FG001|COMPLETED|Overall Study||9
10882054|NCT03473340|12047975|FG000|NOT COMPLETED|Overall Study||5
10882055|NCT03473340|12047976|FG001|NOT COMPLETED|Overall Study||2
10882056|NCT03472885|12047982|FG000|STARTED|Overall Study||12
10882057|NCT03472885|12047982|FG000|Safety Population: Received at Least 1 Dose of Study Drug|Overall Study||12
10882058|NCT03472885|12047982|FG000|Efficacy Population: Received Study Drug for at Least 4 Weeks|Overall Study||11
10882059|NCT03472885|12047982|FG000|COMPLETED|Overall Study||11
10882060|NCT03472885|12047982|FG000|NOT COMPLETED|Overall Study||1
10882061|NCT03467152|12047988|FG000|STARTED|Overall Study||100
10882062|NCT03467152|12047989|FG001|STARTED|Overall Study||100
10882063|NCT03467152|12047990|FG002|STARTED|Overall Study|The treatment arms to which these 6 participants were randomized is unknown.|6
10882064|NCT03467152|12047988|FG000|Treated|Overall Study||97
10882065|NCT03467152|12047989|FG001|Treated|Overall Study||99
10882066|NCT03467152|12047990|FG002|Treated|Overall Study||0
10882067|NCT03467152|12047988|FG000|COMPLETED|Overall Study||84
10882068|NCT03467152|12047989|FG001|COMPLETED|Overall Study||89
10882069|NCT03467152|12047990|FG002|COMPLETED|Overall Study||0
10882070|NCT03467152|12047988|FG000|NOT COMPLETED|Overall Study||16
10882071|NCT03467152|12047989|FG001|NOT COMPLETED|Overall Study||11
10882072|NCT03467152|12047990|FG002|NOT COMPLETED|Overall Study||6
10882073|NCT03466918|12047996|FG000|STARTED|Overall Study||58
10882074|NCT03466918|12047996|FG000|Analysis Population|Overall Study||50
10882075|NCT03466918|12047996|FG000|COMPLETED|Overall Study|All 58 patients completed the 30-day primary endpoint.|58
10882076|NCT03466918|12047996|FG000|NOT COMPLETED|Overall Study||0
10882077|NCT03462966|12048001|FG000|STARTED|Overall Study||4
10882078|NCT03462966|12048001|FG000|COMPLETED|Overall Study||4
10882079|NCT03462966|12048001|FG000|NOT COMPLETED|Overall Study||0
10882080|NCT03462719|12048008|FG000|STARTED|Overall Study||106
10882081|NCT03462719|12048009|FG001|STARTED|Overall Study||105
10882082|NCT03462719|12048008|FG000|COMPLETED|Overall Study||11
10882083|NCT03462719|12048009|FG001|COMPLETED|Overall Study||11
10882084|NCT03462719|12048008|FG000|NOT COMPLETED|Overall Study||95
10882085|NCT03462719|12048009|FG001|NOT COMPLETED|Overall Study||94
10882086|NCT03462641|12048017|FG000|STARTED|Visit 1||19
10882087|NCT03462641|12048018|FG001|STARTED|Visit 1||11
10882088|NCT03462641|12048017|FG000|Actually Received Drug or Placebo|Visit 1||18
10882089|NCT03462641|12048018|FG001|Actually Received Drug or Placebo|Visit 1||11
10882090|NCT03462641|12048017|FG000|COMPLETED|Visit 1||18
10882091|NCT03462641|12048018|FG001|COMPLETED|Visit 1||11
10882092|NCT03462641|12048017|FG000|NOT COMPLETED|Visit 1||1
10882093|NCT03462641|12048018|FG001|NOT COMPLETED|Visit 1||0
10882094|NCT03462641|12048017|FG000|STARTED|Visit 2||18
10882095|NCT03462641|12048018|FG001|STARTED|Visit 2||11
10882096|NCT03462641|12048017|FG000|Actually Received Drug or Placebo|Visit 2||18
10882097|NCT03462641|12048018|FG001|Actually Received Drug or Placebo|Visit 2||10
10882098|NCT03462641|12048017|FG000|COMPLETED|Visit 2||18
10882099|NCT03462641|12048018|FG001|COMPLETED|Visit 2||10
10882100|NCT03462641|12048017|FG000|NOT COMPLETED|Visit 2||0
10882101|NCT03462641|12048018|FG001|NOT COMPLETED|Visit 2||1
10882102|NCT03462563|12048028|FG000|STARTED|Overall Study||94
10882103|NCT03462563|12048029|FG001|STARTED|Overall Study||81
10882104|NCT03462563|12048028|FG000|COMPLETED|Overall Study||79
10882105|NCT03462563|12048029|FG001|COMPLETED|Overall Study||64
10882106|NCT03462563|12048028|FG000|NOT COMPLETED|Overall Study||15
10882107|NCT03462563|12048029|FG001|NOT COMPLETED|Overall Study||17
10882108|NCT03461289|12048035|FG000|STARTED|Overall Study||33
10882109|NCT03461289|12048035|FG000|COMPLETED|Overall Study||32
10882110|NCT03461289|12048035|FG000|NOT COMPLETED|Overall Study||1
10882111|NCT03461003|12048041|FG000|STARTED|Overall Study||23
10882112|NCT03461003|12048042|FG001|STARTED|Overall Study||26
10882113|NCT03461003|12048041|FG000|Received Intervention|Overall Study||21
10882114|NCT03461003|12048042|FG001|Received Intervention|Overall Study||22
10882115|NCT03461003|12048041|FG000|Completed 6-month Follow up|Overall Study||18
10882116|NCT03461003|12048042|FG001|Completed 6-month Follow up|Overall Study||23
10882117|NCT03461003|12048041|FG000|COMPLETED|Overall Study||18
10882118|NCT03461003|12048042|FG001|COMPLETED|Overall Study||23
10882119|NCT03461003|12048041|FG000|NOT COMPLETED|Overall Study||5
10882120|NCT03461003|12048042|FG001|NOT COMPLETED|Overall Study||3
10882121|NCT03459443|12048048|FG000|STARTED|Overall Study||22
10882122|NCT03459443|12048048|FG000|Received at Least 1 Dose of Study Drug|Overall Study||22
10882123|NCT03459443|12048048|FG000|COMPLETED|Overall Study||0
10882124|NCT03459443|12048048|FG000|NOT COMPLETED|Overall Study||22
10882125|NCT03457818|12048054|FG000|STARTED|Overall Study||4
10882126|NCT03457818|12048055|FG001|STARTED|Overall Study||4
10882127|NCT03457818|12048054|FG000|COMPLETED|Overall Study|Study terminated|0
10882128|NCT03457818|12048055|FG001|COMPLETED|Overall Study|study terminated|0
10882129|NCT03457818|12048054|FG000|NOT COMPLETED|Overall Study||4
10882130|NCT03457818|12048055|FG001|NOT COMPLETED|Overall Study||4
10882131|NCT03452540|12048061|FG000|STARTED|Overall Study||9
10882132|NCT03452540|12048061|FG000|COMPLETED|Overall Study||5
10882133|NCT03452540|12048061|FG000|NOT COMPLETED|Overall Study||4
10882134|NCT03449199|12048068|FG000|STARTED|Overall Study||42
10882135|NCT03449199|12048069|FG001|STARTED|Overall Study||44
10882136|NCT03449199|12048070|FG002|STARTED|Overall Study||44
10882137|NCT03449199|12048068|FG000|COMPLETED|Overall Study||41
10882138|NCT03449199|12048069|FG001|COMPLETED|Overall Study||43
10882139|NCT03449199|12048070|FG002|COMPLETED|Overall Study||42
10882140|NCT03449199|12048068|FG000|NOT COMPLETED|Overall Study||1
10882141|NCT03449199|12048069|FG001|NOT COMPLETED|Overall Study||1
10882142|NCT03449199|12048070|FG002|NOT COMPLETED|Overall Study||2
10882143|NCT03442985|12048084|FG000|STARTED|Overall Study||62
10882144|NCT03442985|12048085|FG001|STARTED|Overall Study||66
10882145|NCT03442985|12048086|FG002|STARTED|Overall Study||65
10882146|NCT03442985|12048084|FG000|COMPLETED|Overall Study||0
10882147|NCT03442985|12048085|FG001|COMPLETED|Overall Study||0
10882148|NCT03442985|12048086|FG002|COMPLETED|Overall Study||0
10882149|NCT03442985|12048084|FG000|NOT COMPLETED|Overall Study||62
10882150|NCT03442985|12048085|FG001|NOT COMPLETED|Overall Study||66
10882151|NCT03442985|12048086|FG002|NOT COMPLETED|Overall Study||65
10882152|NCT03442764|12048099|FG000|STARTED|Overall Study||19
10882153|NCT03442764|12048100|FG001|STARTED|Overall Study||21
10882154|NCT03442764|12048101|FG002|STARTED|Overall Study||19
10882155|NCT03442764|12048099|FG000|COMPLETED|Overall Study||18
10882156|NCT03442764|12048100|FG001|COMPLETED|Overall Study||21
10882157|NCT03442764|12048101|FG002|COMPLETED|Overall Study||19
10882158|NCT03442764|12048099|FG000|NOT COMPLETED|Overall Study||1
10882159|NCT03442764|12048100|FG001|NOT COMPLETED|Overall Study||0
10882160|NCT03442764|12048101|FG002|NOT COMPLETED|Overall Study||0
10882161|NCT03438396|12048110|FG000|STARTED|Overall Study||102
10882162|NCT03438396|12048110|FG000|Treated|Overall Study||101
10882163|NCT03438396|12048110|FG000|COMPLETED|Overall Study||0
10882164|NCT03438396|12048110|FG000|NOT COMPLETED|Overall Study||102
10882165|NCT03435835|12048114|FG000|STARTED|First Intervention||8
10882166|NCT03435835|12048115|FG001|STARTED|First Intervention||8
10882167|NCT03435835|12048114|FG000|COMPLETED|First Intervention||8
10882168|NCT03435835|12048115|FG001|COMPLETED|First Intervention||8
10882169|NCT03435835|12048114|FG000|NOT COMPLETED|First Intervention||0
10882170|NCT03435835|12048115|FG001|NOT COMPLETED|First Intervention||0
10882171|NCT03435835|12048114|FG000|STARTED|Washout||8
10882172|NCT03435835|12048115|FG001|STARTED|Washout||8
10882173|NCT03435835|12048114|FG000|COMPLETED|Washout||8
10882174|NCT03435835|12048115|FG001|COMPLETED|Washout||8
10882175|NCT03435835|12048114|FG000|NOT COMPLETED|Washout||0
10882176|NCT03435835|12048115|FG001|NOT COMPLETED|Washout||0
10882177|NCT03435835|12048114|FG000|STARTED|Second Intervention||8
10882178|NCT03435835|12048115|FG001|STARTED|Second Intervention||8
10882179|NCT03435835|12048114|FG000|COMPLETED|Second Intervention||8
10882180|NCT03435835|12048115|FG001|COMPLETED|Second Intervention||8
10882181|NCT03435835|12048114|FG000|NOT COMPLETED|Second Intervention||0
10882182|NCT03435835|12048115|FG001|NOT COMPLETED|Second Intervention||0
10882183|NCT03435081|12048124|FG000|STARTED|Week 0 to Week 16||147
10882184|NCT03435081|12048125|FG001|STARTED|Week 0 to Week 16||147
10882185|NCT03435081|12048126|FG002|STARTED|Week 0 to Week 16||146
10882186|NCT03435081|12048124|FG000|Received at Least One Dose of Study Drug|Week 0 to Week 16||147
10882187|NCT03435081|12048125|FG001|Received at Least One Dose of Study Drug|Week 0 to Week 16||147
10882188|NCT03435081|12048126|FG002|Received at Least One Dose of Study Drug|Week 0 to Week 16||146
10882189|NCT03435081|12048124|FG000|Completed Week 16 and Entered JAIX Study|Week 0 to Week 16||111
10882190|NCT03435081|12048125|FG001|Completed Week 16 and Entered JAIX Study|Week 0 to Week 16||112
10882191|NCT03435081|12048126|FG002|Completed Week 16 and Entered JAIX Study|Week 0 to Week 16||96
10882192|NCT03435081|12048124|FG000|COMPLETED|Week 0 to Week 16||126
10882193|NCT03435081|12048125|FG001|COMPLETED|Week 0 to Week 16||131
10882194|NCT03435081|12048126|FG002|COMPLETED|Week 0 to Week 16||127
10882195|NCT03435081|12048124|FG000|NOT COMPLETED|Week 0 to Week 16||21
10882196|NCT03435081|12048125|FG001|NOT COMPLETED|Week 0 to Week 16||16
10882197|NCT03435081|12048126|FG002|NOT COMPLETED|Week 0 to Week 16||19
10882198|NCT03435081|12048124|FG000|STARTED|Week 16 to Week 104|Participants who met IGA 0 or 1 and did not require rescue therapy before Week 16 were allowed to continue in the study beyond 16 weeks.|8
10882199|NCT03435081|12048125|FG001|STARTED|Week 16 to Week 104|Participants who met IGA 0 or 1 and did not require rescue therapy before Week 16 were allowed to continue in the study beyond 16 weeks.|19
10882200|NCT03435081|12048126|FG002|STARTED|Week 16 to Week 104|Participants who met IGA 0 or 1 and did not require rescue therapy before Week 16 were allowed to continue in the study beyond 16 weeks.|35
10882280|NCT03416374|12048200|FG001|STARTED|Treatment Period II||30
10882201|NCT03435081|12048124|FG000|Rolled Over Into the Open-Label Extension Study JAIX.|Week 16 to Week 104|Participants who completed Week 104 and participants who experienced a loss of benefit (IGA score of ≥3) after Week 16, if eligible, had the option to roll over into the Open-Label Extension study JAIX.|6
10882202|NCT03435081|12048125|FG001|Rolled Over Into the Open-Label Extension Study JAIX.|Week 16 to Week 104|Participants who completed Week 104 and participants who experienced a loss of benefit (IGA score of ≥3) after Week 16, if eligible, had the option to roll over into the Open-Label Extension study JAIX.|14
10882203|NCT03435081|12048126|FG002|Rolled Over Into the Open-Label Extension Study JAIX.|Week 16 to Week 104|Participants who completed Week 104 and participants who experienced a loss of benefit (IGA score of ≥3) after Week 16, if eligible, had the option to roll over into the Open-Label Extension study JAIX.|19
10882204|NCT03435081|12048124|FG000|COMPLETED|Week 16 to Week 104||5
10882205|NCT03435081|12048125|FG001|COMPLETED|Week 16 to Week 104||6
10882206|NCT03435081|12048126|FG002|COMPLETED|Week 16 to Week 104||16
10882207|NCT03435081|12048124|FG000|NOT COMPLETED|Week 16 to Week 104||3
10882208|NCT03435081|12048125|FG001|NOT COMPLETED|Week 16 to Week 104||13
10882209|NCT03435081|12048126|FG002|NOT COMPLETED|Week 16 to Week 104||19
10882210|NCT03434379|12048140|FG000|STARTED|Global Period||165
10882211|NCT03434379|12048141|FG001|STARTED|Global Period||336
10882212|NCT03434379|12048142|FG002|STARTED|Global Period||0
10882213|NCT03434379|12048143|FG003|STARTED|Global Period||0
10882214|NCT03434379|12048140|FG000|COMPLETED|Global Period||0
10882215|NCT03434379|12048141|FG001|COMPLETED|Global Period||0
10882216|NCT03434379|12048142|FG002|COMPLETED|Global Period||0
10882217|NCT03434379|12048143|FG003|COMPLETED|Global Period||0
10882218|NCT03434379|12048140|FG000|NOT COMPLETED|Global Period||165
10882219|NCT03434379|12048141|FG001|NOT COMPLETED|Global Period||336
10882220|NCT03434379|12048142|FG002|NOT COMPLETED|Global Period||0
10882221|NCT03434379|12048143|FG003|NOT COMPLETED|Global Period||0
10882222|NCT03434379|12048140|FG000|STARTED|China Extension Period||0
10882223|NCT03434379|12048141|FG001|STARTED|China Extension Period||0
10882224|NCT03434379|12048142|FG002|STARTED|China Extension Period|n=43 Chinese participants from the sorafenib Global population are included in the China population.|61
10882225|NCT03434379|12048143|FG003|STARTED|China Extension Period|n=94 Chinese participants from the Atezolizumab + Bevacizumab Global population are included in the China population.|133
10882226|NCT03434379|12048140|FG000|COMPLETED|China Extension Period||0
10882227|NCT03434379|12048141|FG001|COMPLETED|China Extension Period||0
10882228|NCT03434379|12048142|FG002|COMPLETED|China Extension Period||0
10882229|NCT03434379|12048143|FG003|COMPLETED|China Extension Period||0
10882230|NCT03434379|12048140|FG000|NOT COMPLETED|China Extension Period||0
10882231|NCT03434379|12048141|FG001|NOT COMPLETED|China Extension Period||0
10882232|NCT03434379|12048142|FG002|NOT COMPLETED|China Extension Period||61
10882233|NCT03434379|12048143|FG003|NOT COMPLETED|China Extension Period||133
10882234|NCT03432650|12048157|FG000|STARTED|Overall Study||48
10882235|NCT03432650|12048158|FG001|STARTED|Overall Study||48
10882236|NCT03432650|12048157|FG000|COMPLETED|Overall Study||48
10882237|NCT03432650|12048158|FG001|COMPLETED|Overall Study||48
10882238|NCT03432650|12048157|FG000|NOT COMPLETED|Overall Study||0
10882239|NCT03432650|12048158|FG001|NOT COMPLETED|Overall Study||0
10882240|NCT03431168|12048166|FG000|STARTED|Overall Study||155
10882241|NCT03431168|12048167|FG001|STARTED|Overall Study||153
10882242|NCT03431168|12048166|FG000|COMPLETED|Overall Study||132
10882243|NCT03431168|12048167|FG001|COMPLETED|Overall Study||129
10882244|NCT03431168|12048166|FG000|NOT COMPLETED|Overall Study||23
10882245|NCT03431168|12048167|FG001|NOT COMPLETED|Overall Study||24
10882246|NCT03419364|12048176|FG000|STARTED|Overall Study||11
10882247|NCT03419364|12048177|FG001|STARTED|Overall Study||6
10882248|NCT03419364|12048178|FG002|STARTED|Overall Study||6
10882249|NCT03419364|12048176|FG000|Signed Consent|Overall Study||11
10882250|NCT03419364|12048177|FG001|Signed Consent|Overall Study||6
10882251|NCT03419364|12048178|FG002|Signed Consent|Overall Study||6
10882252|NCT03419364|12048176|FG000|Received Intervention|Overall Study||9
10882253|NCT03419364|12048177|FG001|Received Intervention|Overall Study||6
10882254|NCT03419364|12048178|FG002|Received Intervention|Overall Study||6
10882255|NCT03419364|12048176|FG000|COMPLETED|Overall Study||9
10882256|NCT03419364|12048177|FG001|COMPLETED|Overall Study||6
10882257|NCT03419364|12048178|FG002|COMPLETED|Overall Study||6
10882258|NCT03419364|12048176|FG000|NOT COMPLETED|Overall Study||2
10882259|NCT03419364|12048177|FG001|NOT COMPLETED|Overall Study||0
10882260|NCT03419364|12048178|FG002|NOT COMPLETED|Overall Study||0
10882261|NCT03417570|12048188|FG000|STARTED|Overall Study||50
10882262|NCT03417570|12048189|FG001|STARTED|Overall Study||50
10882263|NCT03417570|12048188|FG000|COMPLETED|Overall Study||50
10882264|NCT03417570|12048189|FG001|COMPLETED|Overall Study||50
10882265|NCT03417570|12048188|FG000|NOT COMPLETED|Overall Study||0
10882266|NCT03417570|12048189|FG001|NOT COMPLETED|Overall Study||0
10882267|NCT03416374|12048199|FG000|STARTED|Treatment Period I||6
10882268|NCT03416374|12048200|FG001|STARTED|Treatment Period I||39
10882269|NCT03416374|12048199|FG000|COMPLETED|Treatment Period I||0
10882270|NCT03416374|12048200|FG001|COMPLETED|Treatment Period I||0
10882271|NCT03416374|12048199|FG000|NOT COMPLETED|Treatment Period I||6
10882272|NCT03416374|12048200|FG001|NOT COMPLETED|Treatment Period I||39
10882273|NCT03416374|12048199|FG000|STARTED|Between Treatment Period I and II||6
10882274|NCT03416374|12048200|FG001|STARTED|Between Treatment Period I and II||39
10882275|NCT03416374|12048199|FG000|COMPLETED|Between Treatment Period I and II||6
10882276|NCT03416374|12048200|FG001|COMPLETED|Between Treatment Period I and II||30
10882277|NCT03416374|12048199|FG000|NOT COMPLETED|Between Treatment Period I and II||0
10882278|NCT03416374|12048200|FG001|NOT COMPLETED|Between Treatment Period I and II||9
10882279|NCT03416374|12048199|FG000|STARTED|Treatment Period II||6
10882281|NCT03416374|12048199|FG000|COMPLETED|Treatment Period II||2
10882282|NCT03416374|12048200|FG001|COMPLETED|Treatment Period II||12
10882283|NCT03416374|12048199|FG000|NOT COMPLETED|Treatment Period II||4
10882284|NCT03416374|12048200|FG001|NOT COMPLETED|Treatment Period II||18
10882285|NCT03414047|12048213|FG000|STARTED|Overall Study||53
10882286|NCT03414047|12048214|FG001|STARTED|Overall Study||46
10882287|NCT03414047|12048215|FG002|STARTED|Overall Study||41
10882288|NCT03414047|12048216|FG003|STARTED|Overall Study||29
10882289|NCT03414047|12048213|FG000|Received at Least One Dose of Study Drug|Overall Study||53
10882290|NCT03414047|12048214|FG001|Received at Least One Dose of Study Drug|Overall Study||46
10882291|NCT03414047|12048215|FG002|Received at Least One Dose of Study Drug|Overall Study||41
10882292|NCT03414047|12048216|FG003|Received at Least One Dose of Study Drug|Overall Study||29
10882293|NCT03414047|12048213|FG000|COMPLETED|Overall Study||51
10882294|NCT03414047|12048214|FG001|COMPLETED|Overall Study||46
10882295|NCT03414047|12048215|FG002|COMPLETED|Overall Study||38
10882296|NCT03414047|12048216|FG003|COMPLETED|Overall Study||27
10882297|NCT03414047|12048213|FG000|NOT COMPLETED|Overall Study||2
10882298|NCT03414047|12048214|FG001|NOT COMPLETED|Overall Study||0
10882299|NCT03414047|12048215|FG002|NOT COMPLETED|Overall Study||3
10882300|NCT03414047|12048216|FG003|NOT COMPLETED|Overall Study||2
10882301|NCT03412630|12048227|FG000|STARTED|Overall Study||1
10882302|NCT03412630|12048227|FG000|COMPLETED|Overall Study||1
10882303|NCT03412630|12048227|FG000|NOT COMPLETED|Overall Study||0
10882304|NCT03412604|12048231|FG000|STARTED|Overall Study||5
10882305|NCT03412604|12048231|FG000|COMPLETED|Overall Study||4
10882306|NCT03412604|12048231|FG000|NOT COMPLETED|Overall Study||1
10882307|NCT03412565|12048239|FG000|STARTED|Overall Study||67
10882308|NCT03412565|12048240|FG001|STARTED|Overall Study||67
10882309|NCT03412565|12048241|FG002|STARTED|Overall Study||65
10882310|NCT03412565|12048242|FG003|STARTED|Overall Study||66
10882311|NCT03412565|12048239|FG000|COMPLETED|Overall Study||66
10882312|NCT03412565|12048240|FG001|COMPLETED|Overall Study||2
10882313|NCT03412565|12048241|FG002|COMPLETED|Overall Study||3
10882314|NCT03412565|12048242|FG003|COMPLETED|Overall Study||12
10882315|NCT03412565|12048239|FG000|NOT COMPLETED|Overall Study||1
10882316|NCT03412565|12048240|FG001|NOT COMPLETED|Overall Study||65
10882317|NCT03412565|12048241|FG002|NOT COMPLETED|Overall Study||62
10882318|NCT03412565|12048242|FG003|NOT COMPLETED|Overall Study||54
10882319|NCT03410693|12048259|FG000|STARTED|Overall Study||87
10882320|NCT03410693|12048260|FG001|STARTED|Overall Study||88
10882321|NCT03410693|12048259|FG000|Started Treatment|Overall Study||86
10882322|NCT03410693|12048260|FG001|Started Treatment|Overall Study||82
10882323|NCT03410693|12048259|FG000|Active Follow-up Performed|Overall Study||61
10882324|NCT03410693|12048260|FG001|Active Follow-up Performed|Overall Study||56
10882325|NCT03410693|12048259|FG000|Entered Long Term Follow-up|Overall Study||56
10882326|NCT03410693|12048260|FG001|Entered Long Term Follow-up|Overall Study||69
10882327|NCT03410693|12048259|FG000|COMPLETED|Overall Study|Completed treatment|0
10882328|NCT03410693|12048260|FG001|COMPLETED|Overall Study|Completed treatment|0
10882329|NCT03410693|12048259|FG000|NOT COMPLETED|Overall Study||87
10882330|NCT03410693|12048260|FG001|NOT COMPLETED|Overall Study||88
10882331|NCT03406702|12048272|FG000|STARTED|Overall Study||7
10882332|NCT03406702|12048272|FG000|COMPLETED|Overall Study||6
10882333|NCT03406702|12048272|FG000|NOT COMPLETED|Overall Study||1
10882334|NCT03406507|12048290|FG000|STARTED|Primary Evaluation Period||5
10882335|NCT03406507|12048291|FG001|STARTED|Primary Evaluation Period||8
10882336|NCT03406507|12048290|FG000|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||5
10882337|NCT03406507|12048291|FG001|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||8
10882338|NCT03406507|12048290|FG000|COMPLETED|Primary Evaluation Period||5
10882339|NCT03406507|12048291|FG001|COMPLETED|Primary Evaluation Period||8
10882340|NCT03406507|12048290|FG000|NOT COMPLETED|Primary Evaluation Period||0
10882341|NCT03406507|12048291|FG001|NOT COMPLETED|Primary Evaluation Period||0
10882342|NCT03406507|12048290|FG000|STARTED|Extension Period||5
10882343|NCT03406507|12048291|FG001|STARTED|Extension Period||8
10882344|NCT03406507|12048290|FG000|Received at Least 1 Dose of Study Drug|Extension Period||5
10882345|NCT03406507|12048291|FG001|Received at Least 1 Dose of Study Drug|Extension Period||8
10882346|NCT03406507|12048290|FG000|COMPLETED|Extension Period||0
10882347|NCT03406507|12048291|FG001|COMPLETED|Extension Period||2
10882348|NCT03406507|12048290|FG000|NOT COMPLETED|Extension Period||5
10882349|NCT03406507|12048291|FG001|NOT COMPLETED|Extension Period||6
10882350|NCT03402230|12048297|FG000|STARTED|Overall Study||25
10882351|NCT03402230|12048298|FG001|STARTED|Overall Study||24
10882352|NCT03402230|12048297|FG000|COMPLETED|Overall Study||25
10882353|NCT03402230|12048298|FG001|COMPLETED|Overall Study||23
10882354|NCT03402230|12048297|FG000|NOT COMPLETED|Overall Study||0
10882355|NCT03402230|12048298|FG001|NOT COMPLETED|Overall Study||1
10882356|NCT03394027|12048306|FG000|STARTED|Overall Study||10
10882357|NCT03394027|12048307|FG001|STARTED|Overall Study||6
10882358|NCT03394027|12048308|FG002|STARTED|Overall Study||14
10882359|NCT03394027|12048306|FG000|COMPLETED|Overall Study||7
10882360|NCT03394027|12048307|FG001|COMPLETED|Overall Study||5
10882361|NCT03394027|12048308|FG002|COMPLETED|Overall Study||10
10882362|NCT03394027|12048306|FG000|NOT COMPLETED|Overall Study||3
10882363|NCT03394027|12048307|FG001|NOT COMPLETED|Overall Study||1
10882364|NCT03394027|12048308|FG002|NOT COMPLETED|Overall Study||4
10882365|NCT03392974|12048334|FG000|STARTED|Overall Study||1
10882366|NCT03392974|12048334|FG000|COMPLETED|Overall Study||1
10882367|NCT03392974|12048334|FG000|NOT COMPLETED|Overall Study||0
10882368|NCT03392753|12048341|FG000|STARTED|Overall Study||83
10882369|NCT03392753|12048342|FG001|STARTED|Overall Study||84
10882370|NCT03392753|12048341|FG000|COMPLETED|Overall Study||47
10882371|NCT03392753|12048342|FG001|COMPLETED|Overall Study||50
10882372|NCT03392753|12048341|FG000|NOT COMPLETED|Overall Study||36
10882373|NCT03392753|12048342|FG001|NOT COMPLETED|Overall Study||34
10882374|NCT03392649|12048350|FG000|STARTED|Overall Study||40
10882375|NCT03392649|12048351|FG001|STARTED|Overall Study||41
10882376|NCT03392649|12048350|FG000|COMPLETED|Overall Study||40
10882377|NCT03392649|12048351|FG001|COMPLETED|Overall Study||41
10882378|NCT03392649|12048350|FG000|NOT COMPLETED|Overall Study||0
10882379|NCT03392649|12048351|FG001|NOT COMPLETED|Overall Study||0
10882380|NCT03392168|12048361|FG000|STARTED|Period 1: Cohort 1||8
10882381|NCT03392168|12048362|FG001|STARTED|Period 1: Cohort 1||0
10882382|NCT03392168|12048363|FG002|STARTED|Period 1: Cohort 1||0
10882383|NCT03392168|12048364|FG003|STARTED|Period 1: Cohort 1||0
10882384|NCT03392168|12048361|FG000|COMPLETED|Period 1: Cohort 1||8
10882385|NCT03392168|12048362|FG001|COMPLETED|Period 1: Cohort 1||0
10882386|NCT03392168|12048363|FG002|COMPLETED|Period 1: Cohort 1||0
10882387|NCT03392168|12048364|FG003|COMPLETED|Period 1: Cohort 1||0
10882388|NCT03392168|12048361|FG000|NOT COMPLETED|Period 1: Cohort 1||0
10882389|NCT03392168|12048362|FG001|NOT COMPLETED|Period 1: Cohort 1||0
10882390|NCT03392168|12048363|FG002|NOT COMPLETED|Period 1: Cohort 1||0
10882391|NCT03392168|12048364|FG003|NOT COMPLETED|Period 1: Cohort 1||0
10882392|NCT03392168|12048361|FG000|STARTED|Period 2: Cohort 2||0
10882393|NCT03392168|12048362|FG001|STARTED|Period 2: Cohort 2|Includes 2 participants from Cohort 1|30
10882394|NCT03392168|12048363|FG002|STARTED|Period 2: Cohort 2|Includes 2 participants from Cohort 1|28
10882395|NCT03392168|12048364|FG003|STARTED|Period 2: Cohort 2|Includes 2 participants from Cohort 1|31
10882396|NCT03392168|12048361|FG000|COMPLETED|Period 2: Cohort 2||0
10882397|NCT03392168|12048362|FG001|COMPLETED|Period 2: Cohort 2||28
10882398|NCT03392168|12048363|FG002|COMPLETED|Period 2: Cohort 2||27
10882399|NCT03392168|12048364|FG003|COMPLETED|Period 2: Cohort 2||30
10882400|NCT03392168|12048361|FG000|NOT COMPLETED|Period 2: Cohort 2||0
10882401|NCT03392168|12048362|FG001|NOT COMPLETED|Period 2: Cohort 2||2
10882402|NCT03392168|12048363|FG002|NOT COMPLETED|Period 2: Cohort 2||1
10882403|NCT03392168|12048364|FG003|NOT COMPLETED|Period 2: Cohort 2||1
10882404|NCT03388008|12048375|FG000|STARTED|Overall Study||14
10882405|NCT03388008|12048376|FG001|STARTED|Overall Study||13
10882406|NCT03388008|12048375|FG000|COMPLETED|Overall Study||14
10882407|NCT03388008|12048376|FG001|COMPLETED|Overall Study||13
10882408|NCT03388008|12048375|FG000|NOT COMPLETED|Overall Study||0
10882409|NCT03388008|12048376|FG001|NOT COMPLETED|Overall Study||0
10882410|NCT03387735|12048384|FG000|STARTED|Overall Study||168
10882411|NCT03387735|12048385|FG001|STARTED|Overall Study||176
10882412|NCT03387735|12048384|FG000|COMPLETED|Overall Study||160
10882413|NCT03387735|12048385|FG001|COMPLETED|Overall Study||160
10882414|NCT03387735|12048384|FG000|NOT COMPLETED|Overall Study||8
10882415|NCT03387735|12048385|FG001|NOT COMPLETED|Overall Study||16
10882416|NCT03387579|12048394|FG000|STARTED|Overall Study||12
10882417|NCT03387579|12048395|FG001|STARTED|Overall Study||12
10882418|NCT03387579|12048396|FG002|STARTED|Overall Study||24
10882419|NCT03387579|12048394|FG000|COMPLETED|Overall Study||12
10882420|NCT03387579|12048395|FG001|COMPLETED|Overall Study||12
10882421|NCT03387579|12048396|FG002|COMPLETED|Overall Study||24
10882422|NCT03387579|12048394|FG000|NOT COMPLETED|Overall Study||0
10882423|NCT03387579|12048395|FG001|NOT COMPLETED|Overall Study||0
10882424|NCT03387579|12048396|FG002|NOT COMPLETED|Overall Study||0
10882425|NCT03386773|12048407|FG000|STARTED|Overall Study||150
10882426|NCT03386773|12048408|FG001|STARTED|Overall Study||150
10882427|NCT03386773|12048407|FG000|COMPLETED|Overall Study||123
10882428|NCT03386773|12048408|FG001|COMPLETED|Overall Study||115
10882429|NCT03386773|12048407|FG000|NOT COMPLETED|Overall Study||27
10882430|NCT03386773|12048408|FG001|NOT COMPLETED|Overall Study||35
10882431|NCT03374631|12048416|FG000|STARTED|First Intervention (20 Minutes)||20
10882432|NCT03374631|12048417|FG001|STARTED|First Intervention (20 Minutes)||20
10882433|NCT03374631|12048416|FG000|COMPLETED|First Intervention (20 Minutes)||20
10882434|NCT03374631|12048417|FG001|COMPLETED|First Intervention (20 Minutes)||20
10882435|NCT03374631|12048416|FG000|NOT COMPLETED|First Intervention (20 Minutes)||0
10882436|NCT03374631|12048417|FG001|NOT COMPLETED|First Intervention (20 Minutes)||0
10882437|NCT03374631|12048416|FG000|STARTED|Washout (1 Week)||20
10882438|NCT03374631|12048417|FG001|STARTED|Washout (1 Week)||20
10882439|NCT03374631|12048416|FG000|COMPLETED|Washout (1 Week)||20
10882440|NCT03374631|12048417|FG001|COMPLETED|Washout (1 Week)||20
10882441|NCT03374631|12048416|FG000|NOT COMPLETED|Washout (1 Week)||0
10882442|NCT03374631|12048417|FG001|NOT COMPLETED|Washout (1 Week)||0
10882443|NCT03374631|12048416|FG000|STARTED|Second Intervention (20 Minutes)||20
10882444|NCT03374631|12048417|FG001|STARTED|Second Intervention (20 Minutes)||20
10882445|NCT03374631|12048416|FG000|COMPLETED|Second Intervention (20 Minutes)||20
10882446|NCT03374631|12048417|FG001|COMPLETED|Second Intervention (20 Minutes)||20
10882447|NCT03374631|12048416|FG000|NOT COMPLETED|Second Intervention (20 Minutes)||0
10882448|NCT03374631|12048417|FG001|NOT COMPLETED|Second Intervention (20 Minutes)||0
10882449|NCT03372161|12048428|FG000|STARTED|Overall Study||202
10882450|NCT03372161|12048429|FG001|STARTED|Overall Study||199
10882451|NCT03372161|12048428|FG000|COMPLETED|Overall Study||193
10882452|NCT03372161|12048429|FG001|COMPLETED|Overall Study||192
10882453|NCT03372161|12048428|FG000|NOT COMPLETED|Overall Study||9
10882454|NCT03372161|12048429|FG001|NOT COMPLETED|Overall Study||7
10882455|NCT03370510|12048437|FG000|STARTED|Overall Study||3
10882456|NCT03370510|12048438|FG001|STARTED|Overall Study||2
10882457|NCT03370510|12048437|FG000|COMPLETED|Overall Study||1
10882458|NCT03370510|12048438|FG001|COMPLETED|Overall Study||2
10882459|NCT03370510|12048437|FG000|NOT COMPLETED|Overall Study||2
10882460|NCT03370510|12048438|FG001|NOT COMPLETED|Overall Study||0
10882461|NCT03370341|12048446|FG000|STARTED|Overall Study||21
10882462|NCT03370341|12048447|FG001|STARTED|Overall Study||20
10882463|NCT03370341|12048446|FG000|COMPLETED|Overall Study||21
10882464|NCT03370341|12048447|FG001|COMPLETED|Overall Study||19
10882465|NCT03370341|12048446|FG000|NOT COMPLETED|Overall Study||0
10882466|NCT03370341|12048447|FG001|NOT COMPLETED|Overall Study||1
10882467|NCT03368781|12048453|FG000|STARTED|Overall Study||128
10882468|NCT03368781|12048453|FG000|Treated Subjects|Overall Study|106 subjects underwent an ablation procedure|106
10882469|NCT03368781|12048453|FG000|COMPLETED|Overall Study||103
10882470|NCT03368781|12048453|FG000|NOT COMPLETED|Overall Study||25
10882471|NCT03368196|12048461|FG000|STARTED|Overall Study||12
10882472|NCT03368196|12048461|FG000|COMPLETED|Overall Study||12
10882473|NCT03368196|12048461|FG000|NOT COMPLETED|Overall Study||0
10882474|NCT03366298|12048465|FG000|STARTED|Overall Study||3
10882475|NCT03366298|12048466|FG001|STARTED|Overall Study||3
10882476|NCT03366298|12048467|FG002|STARTED|Overall Study||3
10882477|NCT03366298|12048468|FG003|STARTED|Overall Study||3
10882478|NCT03366298|12048465|FG000|COMPLETED|Overall Study||3
10882479|NCT03366298|12048466|FG001|COMPLETED|Overall Study||3
10882480|NCT03366298|12048467|FG002|COMPLETED|Overall Study||3
10882481|NCT03366298|12048468|FG003|COMPLETED|Overall Study||3
10882482|NCT03366298|12048465|FG000|NOT COMPLETED|Overall Study||0
10882483|NCT03366298|12048466|FG001|NOT COMPLETED|Overall Study||0
10882484|NCT03366298|12048467|FG002|NOT COMPLETED|Overall Study||0
10882485|NCT03366298|12048468|FG003|NOT COMPLETED|Overall Study||0
10882486|NCT03364270|12048476|FG000|STARTED|Overall Study|First patient to undergo PET-MRI: 10/10/2018|6
10882487|NCT03364270|12048476|FG000|COMPLETED|Overall Study|Last subject scanned: 1/9/2020|6
10882488|NCT03364270|12048476|FG000|NOT COMPLETED|Overall Study||0
10882489|NCT03364036|12048482|FG000|STARTED|Overall Study||270
10882490|NCT03364036|12048482|FG000|Full Analysis Set (FAS)|Overall Study||270
10882491|NCT03364036|12048482|FG000|COMPLETED|Overall Study||264
10882492|NCT03364036|12048482|FG000|NOT COMPLETED|Overall Study||6
10882493|NCT03361306|12048486|FG000|STARTED|Overall Study||15
10882494|NCT03361306|12048486|FG000|COMPLETED|Overall Study||0
10882495|NCT03361306|12048486|FG000|NOT COMPLETED|Overall Study||15
10882496|NCT03360396|12048492|FG000|STARTED|Overall Study||80
10882497|NCT03360396|12048493|FG001|STARTED|Overall Study||40
10882498|NCT03360396|12048492|FG000|COMPLETED|Overall Study||0
10882499|NCT03360396|12048493|FG001|COMPLETED|Overall Study||0
10882500|NCT03360396|12048492|FG000|NOT COMPLETED|Overall Study||80
10882501|NCT03360396|12048493|FG001|NOT COMPLETED|Overall Study||40
10882502|NCT03359356|12048501|FG000|STARTED|Overall Study||20
10882503|NCT03359356|12048502|FG001|STARTED|Overall Study||40
10882504|NCT03359356|12048501|FG000|COMPLETED|Overall Study||20
10882505|NCT03359356|12048502|FG001|COMPLETED|Overall Study||40
10882506|NCT03359356|12048501|FG000|NOT COMPLETED|Overall Study||0
10882507|NCT03359356|12048502|FG001|NOT COMPLETED|Overall Study||0
10882508|NCT03358472|12048515|FG000|STARTED|Overall Study||35
10882509|NCT03358472|12048516|FG001|STARTED|Overall Study||19
10882510|NCT03358472|12048517|FG002|STARTED|Overall Study||35
10882511|NCT03358472|12048515|FG000|Intention-to-Treat (ITT)|Overall Study||35
10882512|NCT03358472|12048516|FG001|Intention-to-Treat (ITT)|Overall Study||19
10882513|NCT03358472|12048517|FG002|Intention-to-Treat (ITT)|Overall Study||35
10882514|NCT03358472|12048515|FG000|All Participants as Treated (APaT)|Overall Study||34
10882515|NCT03358472|12048516|FG001|All Participants as Treated (APaT)|Overall Study||19
10882516|NCT03358472|12048517|FG002|All Participants as Treated (APaT)|Overall Study||34
10882517|NCT03358472|12048515|FG000|COMPLETED|Overall Study||20
10882518|NCT03358472|12048516|FG001|COMPLETED|Overall Study||9
10882519|NCT03358472|12048517|FG002|COMPLETED|Overall Study||19
10882520|NCT03358472|12048515|FG000|NOT COMPLETED|Overall Study||15
10882521|NCT03358472|12048516|FG001|NOT COMPLETED|Overall Study||10
10882522|NCT03358472|12048517|FG002|NOT COMPLETED|Overall Study||16
10882523|NCT03350750|12048527|FG000|STARTED|Overall Study||9
10882524|NCT03350750|12048528|FG001|STARTED|Overall Study||9
10882525|NCT03350750|12048527|FG000|4-month Follow-up (Randomized Evaluation)|Overall Study||8
10882526|NCT03350750|12048528|FG001|4-month Follow-up (Randomized Evaluation)|Overall Study||8
10882527|NCT03350750|12048527|FG000|12-Month Follow-up (Entire Study)|Overall Study||8
10882528|NCT03350750|12048528|FG001|12-Month Follow-up (Entire Study)|Overall Study||8
10882529|NCT03350750|12048527|FG000|COMPLETED|Overall Study||8
10882530|NCT03350750|12048528|FG001|COMPLETED|Overall Study||8
10882531|NCT03350750|12048527|FG000|NOT COMPLETED|Overall Study||1
10882532|NCT03350750|12048528|FG001|NOT COMPLETED|Overall Study||1
10882533|NCT03346434|12048542|FG000|STARTED|Overall Study||10
10882534|NCT03346434|12048543|FG001|STARTED|Overall Study||10
10882535|NCT03346434|12048544|FG002|STARTED|Overall Study||10
10882536|NCT03346434|12048545|FG003|STARTED|Overall Study||10
10882537|NCT03346434|12048546|FG004|STARTED|Overall Study||79
10882538|NCT03346434|12048547|FG005|STARTED|Overall Study||83
10882539|NCT03346434|12048542|FG000|Completed Part A|Overall Study||10
10882540|NCT03346434|12048543|FG001|Completed Part A|Overall Study||10
10882541|NCT03346434|12048544|FG002|Completed Part A|Overall Study||9
10882542|NCT03346434|12048545|FG003|Completed Part A|Overall Study||10
10882543|NCT03346434|12048546|FG004|Completed Part A|Overall Study||0
10882544|NCT03346434|12048547|FG005|Completed Part A|Overall Study||0
10882545|NCT03346434|12048542|FG000|Completed Part B (Week 16)|Overall Study||0
10882546|NCT03346434|12048543|FG001|Completed Part B (Week 16)|Overall Study||0
10882547|NCT03346434|12048544|FG002|Completed Part B (Week 16)|Overall Study||0
10882548|NCT03346434|12048545|FG003|Completed Part B (Week 16)|Overall Study||0
10882549|NCT03346434|12048546|FG004|Completed Part B (Week 16)|Overall Study||76
10882550|NCT03346434|12048547|FG005|Completed Part B (Week 16)|Overall Study||83
10882551|NCT03346434|12048542|FG000|Completed Part B (Week 28)|Overall Study||0
10882552|NCT03346434|12048543|FG001|Completed Part B (Week 28)|Overall Study||0
10882553|NCT03346434|12048544|FG002|Completed Part B (Week 28)|Overall Study||0
10882554|NCT03346434|12048545|FG003|Completed Part B (Week 28)|Overall Study||0
10882555|NCT03346434|12048546|FG004|Completed Part B (Week 28)|Overall Study||1
10882556|NCT03346434|12048547|FG005|Completed Part B (Week 28)|Overall Study||1
10882557|NCT03346434|12048542|FG000|COMPLETED|Overall Study||10
10882558|NCT03346434|12048543|FG001|COMPLETED|Overall Study||10
10882559|NCT03346434|12048544|FG002|COMPLETED|Overall Study||9
10882560|NCT03346434|12048545|FG003|COMPLETED|Overall Study||10
10882561|NCT03346434|12048546|FG004|COMPLETED|Overall Study||1
10882562|NCT03346434|12048547|FG005|COMPLETED|Overall Study||1
10882563|NCT03346434|12048542|FG000|NOT COMPLETED|Overall Study||0
10882564|NCT03346434|12048543|FG001|NOT COMPLETED|Overall Study||0
10882565|NCT03346434|12048544|FG002|NOT COMPLETED|Overall Study||1
10882566|NCT03346434|12048545|FG003|NOT COMPLETED|Overall Study||0
10882567|NCT03346434|12048546|FG004|NOT COMPLETED|Overall Study||78
10882568|NCT03346434|12048547|FG005|NOT COMPLETED|Overall Study||82
10882569|NCT03345836|12048568|FG000|STARTED|Period 1: DB and OL Induction (12 Weeks)||171
10882570|NCT03345836|12048569|FG001|STARTED|Period 1: DB and OL Induction (12 Weeks)||324
10882571|NCT03345836|12048570|FG002|STARTED|Period 1: DB and OL Induction (12 Weeks)||129
10882572|NCT03345836|12048571|FG003|STARTED|Period 1: DB and OL Induction (12 Weeks)||0
10882573|NCT03345836|12048572|FG004|STARTED|Period 1: DB and OL Induction (12 Weeks)||0
10882574|NCT03345836|12048573|FG005|STARTED|Period 1: DB and OL Induction (12 Weeks)||0
10882575|NCT03345836|12048568|FG000|COMPLETED|Period 1: DB and OL Induction (12 Weeks)||149
10882576|NCT03345836|12048569|FG001|COMPLETED|Period 1: DB and OL Induction (12 Weeks)||291
10882577|NCT03345836|12048570|FG002|COMPLETED|Period 1: DB and OL Induction (12 Weeks)||123
10882578|NCT03345836|12048571|FG003|COMPLETED|Period 1: DB and OL Induction (12 Weeks)||0
10882579|NCT03345836|12048572|FG004|COMPLETED|Period 1: DB and OL Induction (12 Weeks)||0
10882580|NCT03345836|12048573|FG005|COMPLETED|Period 1: DB and OL Induction (12 Weeks)||0
10882581|NCT03345836|12048568|FG000|NOT COMPLETED|Period 1: DB and OL Induction (12 Weeks)||22
10882582|NCT03345836|12048569|FG001|NOT COMPLETED|Period 1: DB and OL Induction (12 Weeks)||33
10882583|NCT03345836|12048570|FG002|NOT COMPLETED|Period 1: DB and OL Induction (12 Weeks)||6
10882584|NCT03345836|12048571|FG003|NOT COMPLETED|Period 1: DB and OL Induction (12 Weeks)||0
10882585|NCT03345836|12048572|FG004|NOT COMPLETED|Period 1: DB and OL Induction (12 Weeks)||0
10882586|NCT03345836|12048573|FG005|NOT COMPLETED|Period 1: DB and OL Induction (12 Weeks)||0
10882587|NCT03345836|12048568|FG000|STARTED|Period 2: 12-Week Extended Treatment||0
10882588|NCT03345836|12048569|FG001|STARTED|Period 2: 12-Week Extended Treatment||0
10882589|NCT03345836|12048570|FG002|STARTED|Period 2: 12-Week Extended Treatment||0
10882590|NCT03345836|12048571|FG003|STARTED|Period 2: 12-Week Extended Treatment||78
10882591|NCT03345836|12048572|FG004|STARTED|Period 2: 12-Week Extended Treatment||69
10882592|NCT03345836|12048573|FG005|STARTED|Period 2: 12-Week Extended Treatment||14
10882593|NCT03345836|12048568|FG000|COMPLETED|Period 2: 12-Week Extended Treatment||0
10882594|NCT03345836|12048569|FG001|COMPLETED|Period 2: 12-Week Extended Treatment||0
10882595|NCT03345836|12048570|FG002|COMPLETED|Period 2: 12-Week Extended Treatment||0
10882596|NCT03345836|12048571|FG003|COMPLETED|Period 2: 12-Week Extended Treatment||67
10882597|NCT03345836|12048572|FG004|COMPLETED|Period 2: 12-Week Extended Treatment||51
10882598|NCT03345836|12048573|FG005|COMPLETED|Period 2: 12-Week Extended Treatment||8
10882599|NCT03345836|12048568|FG000|NOT COMPLETED|Period 2: 12-Week Extended Treatment||0
10882600|NCT03345836|12048569|FG001|NOT COMPLETED|Period 2: 12-Week Extended Treatment||0
10882601|NCT03345836|12048570|FG002|NOT COMPLETED|Period 2: 12-Week Extended Treatment||0
10882602|NCT03345836|12048571|FG003|NOT COMPLETED|Period 2: 12-Week Extended Treatment||11
10882603|NCT03345836|12048572|FG004|NOT COMPLETED|Period 2: 12-Week Extended Treatment||18
10882604|NCT03345836|12048573|FG005|NOT COMPLETED|Period 2: 12-Week Extended Treatment||6
10882605|NCT03343054|12048592|FG000|STARTED|Dose Escalation Period (Up to 286 Days)||3
10882606|NCT03343054|12048593|FG001|STARTED|Dose Escalation Period (Up to 286 Days)||6
10882607|NCT03343054|12048594|FG002|STARTED|Dose Escalation Period (Up to 286 Days)|Dose escalation and Dose expansion were separate populations.|0
10882608|NCT03343054|12048592|FG000|COMPLETED|Dose Escalation Period (Up to 286 Days)||0
10882609|NCT03343054|12048593|FG001|COMPLETED|Dose Escalation Period (Up to 286 Days)||0
10882610|NCT03343054|12048594|FG002|COMPLETED|Dose Escalation Period (Up to 286 Days)||0
10882611|NCT03343054|12048592|FG000|NOT COMPLETED|Dose Escalation Period (Up to 286 Days)||3
10882612|NCT03343054|12048593|FG001|NOT COMPLETED|Dose Escalation Period (Up to 286 Days)||6
10882613|NCT03343054|12048594|FG002|NOT COMPLETED|Dose Escalation Period (Up to 286 Days)||0
10882614|NCT03343054|12048592|FG000|STARTED|Dose Expansion Period (Up to 502 Days)||0
10882615|NCT03343054|12048593|FG001|STARTED|Dose Expansion Period (Up to 502 Days)||0
10882616|NCT03343054|12048594|FG002|STARTED|Dose Expansion Period (Up to 502 Days)|Dose escalation and Dose expansion were separate populations.|19
10882617|NCT03343054|12048592|FG000|COMPLETED|Dose Expansion Period (Up to 502 Days)||0
10882618|NCT03343054|12048593|FG001|COMPLETED|Dose Expansion Period (Up to 502 Days)||0
10882619|NCT03343054|12048594|FG002|COMPLETED|Dose Expansion Period (Up to 502 Days)||0
10882620|NCT03343054|12048592|FG000|NOT COMPLETED|Dose Expansion Period (Up to 502 Days)||0
10882621|NCT03343054|12048593|FG001|NOT COMPLETED|Dose Expansion Period (Up to 502 Days)||0
10882622|NCT03343054|12048594|FG002|NOT COMPLETED|Dose Expansion Period (Up to 502 Days)||19
10882623|NCT03342404|12048605|FG000|STARTED|Overall Study||96
10882624|NCT03342404|12048606|FG001|STARTED|Overall Study||49
10882625|NCT03342404|12048605|FG000|COMPLETED|Overall Study||81
10882626|NCT03342404|12048606|FG001|COMPLETED|Overall Study||18
10882627|NCT03342404|12048605|FG000|NOT COMPLETED|Overall Study||15
10882628|NCT03342404|12048606|FG001|NOT COMPLETED|Overall Study||31
10882629|NCT03338998|12048614|FG000|STARTED|Treatment Period||16
10882630|NCT03338998|12048615|FG001|STARTED|Treatment Period||13
10882631|NCT03338998|12048614|FG000|COMPLETED|Treatment Period||8
10882632|NCT03338998|12048615|FG001|COMPLETED|Treatment Period||10
10882633|NCT03338998|12048614|FG000|NOT COMPLETED|Treatment Period||8
10882634|NCT03338998|12048615|FG001|NOT COMPLETED|Treatment Period||3
10882635|NCT03338998|12048614|FG000|STARTED|Safety Follow-Up Period||16
10882636|NCT03338998|12048615|FG001|STARTED|Safety Follow-Up Period||13
10882637|NCT03338998|12048614|FG000|COMPLETED|Safety Follow-Up Period||14
10882638|NCT03338998|12048615|FG001|COMPLETED|Safety Follow-Up Period||12
10882639|NCT03338998|12048614|FG000|NOT COMPLETED|Safety Follow-Up Period||2
10882640|NCT03338998|12048615|FG001|NOT COMPLETED|Safety Follow-Up Period||1
10882641|NCT03338972|12048626|FG000|STARTED|Overall Study||7
10882642|NCT03338972|12048627|FG001|STARTED|Overall Study||8
10882643|NCT03338972|12048628|FG002|STARTED|Overall Study||7
10882644|NCT03338972|12048629|FG003|STARTED|Overall Study||3
10882645|NCT03338972|12048626|FG000|COMPLETED|Overall Study||5
10882646|NCT03338972|12048627|FG001|COMPLETED|Overall Study||7
10882647|NCT03338972|12048628|FG002|COMPLETED|Overall Study||7
10882648|NCT03338972|12048629|FG003|COMPLETED|Overall Study||3
10882649|NCT03338972|12048626|FG000|NOT COMPLETED|Overall Study||2
10882650|NCT03338972|12048627|FG001|NOT COMPLETED|Overall Study||1
10882651|NCT03338972|12048628|FG002|NOT COMPLETED|Overall Study||0
10882652|NCT03338972|12048629|FG003|NOT COMPLETED|Overall Study||0
10882653|NCT03338790|12048643|FG000|STARTED|Overall Study||88
10882654|NCT03338790|12048644|FG001|STARTED|Overall Study||71
10882655|NCT03338790|12048645|FG002|STARTED|Overall Study||84
10882656|NCT03338790|12048646|FG003|STARTED|Overall Study||49
10882657|NCT03338790|12048643|FG000|COMPLETED|Overall Study||4
10882658|NCT03338790|12048644|FG001|COMPLETED|Overall Study||4
10882659|NCT03338790|12048645|FG002|COMPLETED|Overall Study||8
10882660|NCT03338790|12048646|FG003|COMPLETED|Overall Study||4
10882661|NCT03338790|12048643|FG000|NOT COMPLETED|Overall Study||84
10882662|NCT03338790|12048644|FG001|NOT COMPLETED|Overall Study||67
10882663|NCT03338790|12048645|FG002|NOT COMPLETED|Overall Study||76
10882664|NCT03338790|12048646|FG003|NOT COMPLETED|Overall Study||45
10882665|NCT03338244|12048658|FG000|STARTED|Overall Study||33173
10882666|NCT03338244|12048659|FG001|STARTED|Overall Study||33055
10882667|NCT03338244|12048658|FG000|COMPLETED|Overall Study||25995
10882668|NCT03338244|12048659|FG001|COMPLETED|Overall Study||25568
10882669|NCT03338244|12048658|FG000|NOT COMPLETED|Overall Study||7178
10882670|NCT03338244|12048659|FG001|NOT COMPLETED|Overall Study||7487
10882671|NCT03338036|12048669|FG000|STARTED|Overall Study||0
10882672|NCT03338036|12048670|FG001|STARTED|Overall Study||11
10882673|NCT03338036|12048671|FG002|STARTED|Overall Study||12
10882674|NCT03338036|12048672|FG003|STARTED|Overall Study||8
10882675|NCT03338036|12048669|FG000|COMPLETED|Overall Study||0
10882676|NCT03338036|12048670|FG001|COMPLETED|Overall Study||7
10882677|NCT03338036|12048671|FG002|COMPLETED|Overall Study||9
10882678|NCT03338036|12048672|FG003|COMPLETED|Overall Study||8
10882679|NCT03338036|12048669|FG000|NOT COMPLETED|Overall Study||0
10882680|NCT03338036|12048670|FG001|NOT COMPLETED|Overall Study||4
10882681|NCT03338036|12048671|FG002|NOT COMPLETED|Overall Study||3
10882682|NCT03338036|12048672|FG003|NOT COMPLETED|Overall Study||0
10882683|NCT03335774|12048682|FG000|STARTED|Overall Study||51
10882684|NCT03335774|12048683|FG001|STARTED|Overall Study||52
10882685|NCT03335774|12048682|FG000|COMPLETED|Overall Study||50
10882686|NCT03335774|12048683|FG001|COMPLETED|Overall Study||51
10882687|NCT03335774|12048682|FG000|NOT COMPLETED|Overall Study||1
10882688|NCT03335774|12048683|FG001|NOT COMPLETED|Overall Study||1
10882689|NCT03334344|12048691|FG000|STARTED|Overall Study||44
10882690|NCT03334344|12048692|FG001|STARTED|Overall Study||48
10882691|NCT03334344|12048691|FG000|COMPLETED|Overall Study||44
10882692|NCT03334344|12048692|FG001|COMPLETED|Overall Study||48
10882693|NCT03334344|12048691|FG000|NOT COMPLETED|Overall Study||0
10882694|NCT03334344|12048692|FG001|NOT COMPLETED|Overall Study||0
10882695|NCT03333837|12048703|FG000|STARTED|Overall Study||24
10882696|NCT03333837|12048704|FG001|STARTED|Overall Study||25
10882697|NCT03333837|12048705|FG002|STARTED|Overall Study||27
10882698|NCT03333837|12048706|FG003|STARTED|Overall Study||25
10882699|NCT03333837|12048707|FG004|STARTED|Overall Study||3
10882700|NCT03333837|12048703|FG000|COMPLETED|Overall Study||22
10882701|NCT03333837|12048704|FG001|COMPLETED|Overall Study||22
10882702|NCT03333837|12048705|FG002|COMPLETED|Overall Study||22
10882703|NCT03333837|12048706|FG003|COMPLETED|Overall Study||23
10882704|NCT03333837|12048707|FG004|COMPLETED|Overall Study||0
10882705|NCT03333837|12048703|FG000|NOT COMPLETED|Overall Study||2
10882706|NCT03333837|12048704|FG001|NOT COMPLETED|Overall Study||3
10882707|NCT03333837|12048705|FG002|NOT COMPLETED|Overall Study||5
10882708|NCT03333837|12048706|FG003|NOT COMPLETED|Overall Study||2
10882709|NCT03333837|12048707|FG004|NOT COMPLETED|Overall Study||3
10882710|NCT03333590|12048725|FG000|STARTED|Overall Study||1
10882711|NCT03333590|12048726|FG001|STARTED|Overall Study||1
10882712|NCT03333590|12048725|FG000|COMPLETED|Overall Study||1
10882713|NCT03333590|12048726|FG001|COMPLETED|Overall Study||1
10882714|NCT03333590|12048725|FG000|NOT COMPLETED|Overall Study||0
10882715|NCT03333590|12048726|FG001|NOT COMPLETED|Overall Study||0
10882716|NCT03332095|12048736|FG000|STARTED|Overall Study||10
10882717|NCT03332095|12048737|FG001|STARTED|Overall Study||45
10882718|NCT03332095|12048736|FG000|Received at Least One Dose of Study Treatment|Overall Study||9
10882719|NCT03332095|12048737|FG001|Received at Least One Dose of Study Treatment|Overall Study||45
10882720|NCT03332095|12048736|FG000|COMPLETED|Overall Study||9
10882721|NCT03332095|12048737|FG001|COMPLETED|Overall Study||44
10882722|NCT03332095|12048736|FG000|NOT COMPLETED|Overall Study||1
10882723|NCT03332095|12048737|FG001|NOT COMPLETED|Overall Study||1
10882724|NCT03330847|12048746|FG000|STARTED|Overall Study||114
10882725|NCT03330847|12048747|FG001|STARTED|Overall Study||112
10882726|NCT03330847|12048748|FG002|STARTED|Overall Study||47
10882727|NCT03330847|12048746|FG000|COMPLETED|Overall Study||52
10882728|NCT03330847|12048747|FG001|COMPLETED|Overall Study||47
10882729|NCT03330847|12048748|FG002|COMPLETED|Overall Study||32
10882730|NCT03330847|12048746|FG000|NOT COMPLETED|Overall Study||62
10882731|NCT03330847|12048747|FG001|NOT COMPLETED|Overall Study||65
10882732|NCT03330847|12048748|FG002|NOT COMPLETED|Overall Study||15
10882733|NCT03327649|12048760|FG000|STARTED|Overall Study||26
10882734|NCT03327649|12048761|FG001|STARTED|Overall Study||26
10882735|NCT03327649|12048760|FG000|COMPLETED|Overall Study||24
10882736|NCT03327649|12048761|FG001|COMPLETED|Overall Study||24
10882737|NCT03327649|12048760|FG000|NOT COMPLETED|Overall Study||2
10882738|NCT03327649|12048761|FG001|NOT COMPLETED|Overall Study||2
10882739|NCT03325712|12048775|FG000|STARTED|Overall Study||10
10882740|NCT03325712|12048776|FG001|STARTED|Overall Study||2
10882741|NCT03325712|12048777|FG002|STARTED|Overall Study||8
10882742|NCT03325712|12048778|FG003|STARTED|Overall Study||8
10882743|NCT03325712|12048779|FG004|STARTED|Overall Study||8
10882744|NCT03325712|12048780|FG005|STARTED|Overall Study||8
10882745|NCT03325712|12048781|FG006|STARTED|Overall Study||8
10882746|NCT03325712|12048782|FG007|STARTED|Overall Study||8
10882747|NCT03325712|12048775|FG000|COMPLETED|Overall Study||10
10882748|NCT03325712|12048776|FG001|COMPLETED|Overall Study||2
10882749|NCT03325712|12048777|FG002|COMPLETED|Overall Study||8
10882750|NCT03325712|12048778|FG003|COMPLETED|Overall Study||8
10882751|NCT03325712|12048779|FG004|COMPLETED|Overall Study||6
10882752|NCT03325712|12048780|FG005|COMPLETED|Overall Study||8
10882753|NCT03325712|12048781|FG006|COMPLETED|Overall Study||8
10882754|NCT03325712|12048782|FG007|COMPLETED|Overall Study||8
10882755|NCT03325712|12048775|FG000|NOT COMPLETED|Overall Study||0
10882756|NCT03325712|12048776|FG001|NOT COMPLETED|Overall Study||0
10882757|NCT03325712|12048777|FG002|NOT COMPLETED|Overall Study||0
10882758|NCT03325712|12048778|FG003|NOT COMPLETED|Overall Study||0
10882759|NCT03325712|12048779|FG004|NOT COMPLETED|Overall Study||2
10882760|NCT03325712|12048780|FG005|NOT COMPLETED|Overall Study||0
10882761|NCT03325712|12048781|FG006|NOT COMPLETED|Overall Study||0
10882762|NCT03325712|12048782|FG007|NOT COMPLETED|Overall Study||0
10882763|NCT03325166|12048810|FG000|STARTED|Overall Study||2
10882764|NCT03325166|12048810|FG000|COMPLETED|Overall Study||1
10882765|NCT03325166|12048810|FG000|NOT COMPLETED|Overall Study||1
10882766|NCT03323034|12048819|FG000|STARTED|Overall Study||6
10882767|NCT03323034|12048820|FG001|STARTED|Overall Study||6
10882768|NCT03323034|12048821|FG002|STARTED|Overall Study||6
10882769|NCT03323034|12048822|FG003|STARTED|Overall Study||6
10882770|NCT03323034|12048823|FG004|STARTED|Overall Study||6
10882771|NCT03323034|12048819|FG000|COMPLETED|Overall Study||0
10882772|NCT03323034|12048820|FG001|COMPLETED|Overall Study||0
10882773|NCT03323034|12048821|FG002|COMPLETED|Overall Study||0
10882774|NCT03323034|12048822|FG003|COMPLETED|Overall Study||0
10882775|NCT03323034|12048823|FG004|COMPLETED|Overall Study||0
10882776|NCT03323034|12048819|FG000|NOT COMPLETED|Overall Study||6
10882777|NCT03323034|12048820|FG001|NOT COMPLETED|Overall Study||6
10882778|NCT03323034|12048821|FG002|NOT COMPLETED|Overall Study||6
10882779|NCT03323034|12048822|FG003|NOT COMPLETED|Overall Study||6
10882780|NCT03323034|12048823|FG004|NOT COMPLETED|Overall Study||6
10882781|NCT03321526|12048838|FG000|STARTED|Double-blind Treatment Phase (24 Weeks)||54
10882782|NCT03321526|12048839|FG001|STARTED|Double-blind Treatment Phase (24 Weeks)||53
10882783|NCT03321526|12048838|FG000|COMPLETED|Double-blind Treatment Phase (24 Weeks)||30
10882784|NCT03321526|12048839|FG001|COMPLETED|Double-blind Treatment Phase (24 Weeks)||27
10882785|NCT03321526|12048838|FG000|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||24
10882786|NCT03321526|12048839|FG001|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||26
10882787|NCT03321526|12048838|FG000|STARTED|Follow-up Phase (2 Weeks)|All participants that started the double-blind treatment phase were followed-up in follow-up phase.|54
10882788|NCT03321526|12048839|FG001|STARTED|Follow-up Phase (2 Weeks)|All participants that started the double-blind treatment phase were followed-up in follow-up phase except 1 participant as that participant did not received any treatment.|52
10882789|NCT03321526|12048838|FG000|COMPLETED|Follow-up Phase (2 Weeks)||30
10882790|NCT03321526|12048839|FG001|COMPLETED|Follow-up Phase (2 Weeks)||28
10882791|NCT03321526|12048838|FG000|NOT COMPLETED|Follow-up Phase (2 Weeks)||24
10882792|NCT03321526|12048839|FG001|NOT COMPLETED|Follow-up Phase (2 Weeks)||24
10882793|NCT03320824|12048853|FG000|STARTED|Overall Study||184
10882794|NCT03320824|12048854|FG001|STARTED|Overall Study||89
10882795|NCT03320824|12048853|FG000|COMPLETED|Overall Study||166
10882796|NCT03320824|12048854|FG001|COMPLETED|Overall Study||85
10882797|NCT03320824|12048853|FG000|NOT COMPLETED|Overall Study||18
10882798|NCT03320824|12048854|FG001|NOT COMPLETED|Overall Study||4
10882799|NCT03320512|12048863|FG000|STARTED|Overall Study||82
10882800|NCT03320512|12048864|FG001|STARTED|Overall Study||81
10882801|NCT03320512|12048865|FG002|STARTED|Overall Study||83
10882802|NCT03320512|12048863|FG000|Month 3 Survey Started|Overall Study||69
10882803|NCT03320512|12048864|FG001|Month 3 Survey Started|Overall Study||72
10882804|NCT03320512|12048865|FG002|Month 3 Survey Started|Overall Study||71
10882805|NCT03320512|12048863|FG000|Month 3 Survey Completed|Overall Study||69
10882806|NCT03320512|12048864|FG001|Month 3 Survey Completed|Overall Study||72
10882807|NCT03320512|12048865|FG002|Month 3 Survey Completed|Overall Study||68
10882808|NCT03320512|12048863|FG000|Month 3 Lab Sample Collected|Overall Study||51
10882809|NCT03320512|12048864|FG001|Month 3 Lab Sample Collected|Overall Study||54
10882810|NCT03320512|12048865|FG002|Month 3 Lab Sample Collected|Overall Study||51
10882811|NCT03320512|12048863|FG000|Month 6 Survey Started|Overall Study||67
10882812|NCT03320512|12048864|FG001|Month 6 Survey Started|Overall Study||72
10882813|NCT03320512|12048865|FG002|Month 6 Survey Started|Overall Study||69
10882814|NCT03320512|12048863|FG000|Month 6 Survey Completed|Overall Study||65
10882815|NCT03320512|12048864|FG001|Month 6 Survey Completed|Overall Study||71
10882816|NCT03320512|12048865|FG002|Month 6 Survey Completed|Overall Study||68
10882817|NCT03320512|12048863|FG000|Month 6 Lab Sample Collected|Overall Study||53
10882818|NCT03320512|12048864|FG001|Month 6 Lab Sample Collected|Overall Study||59
10882819|NCT03320512|12048865|FG002|Month 6 Lab Sample Collected|Overall Study||51
10882820|NCT03320512|12048863|FG000|COMPLETED|Overall Study||82
10882821|NCT03320512|12048864|FG001|COMPLETED|Overall Study||81
10882822|NCT03320512|12048865|FG002|COMPLETED|Overall Study||83
10882823|NCT03320512|12048863|FG000|NOT COMPLETED|Overall Study||0
10882824|NCT03320512|12048864|FG001|NOT COMPLETED|Overall Study||0
10882825|NCT03320512|12048865|FG002|NOT COMPLETED|Overall Study||0
10882826|NCT03319732|12048873|FG000|STARTED|Overall Study||323
10882827|NCT03319732|12048873|FG000|COMPLETED|Overall Study||218
10882828|NCT03319732|12048873|FG000|NOT COMPLETED|Overall Study||105
10882829|NCT03318861|12048883|FG000|STARTED|Overall Study||3
10882830|NCT03318861|12048884|FG001|STARTED|Overall Study||4
10882831|NCT03318861|12048885|FG002|STARTED|Overall Study||3
10882832|NCT03318861|12048886|FG003|STARTED|Overall Study||4
10882833|NCT03318861|12048887|FG004|STARTED|Overall Study||3
10882834|NCT03318861|12048883|FG000|COMPLETED|Overall Study||0
10882835|NCT03318861|12048884|FG001|COMPLETED|Overall Study||0
10882836|NCT03318861|12048885|FG002|COMPLETED|Overall Study||0
10882837|NCT03318861|12048886|FG003|COMPLETED|Overall Study||0
10882838|NCT03318861|12048887|FG004|COMPLETED|Overall Study||0
10882839|NCT03318861|12048883|FG000|NOT COMPLETED|Overall Study||3
10882840|NCT03318861|12048884|FG001|NOT COMPLETED|Overall Study||4
10882841|NCT03318861|12048885|FG002|NOT COMPLETED|Overall Study||3
10882842|NCT03318861|12048886|FG003|NOT COMPLETED|Overall Study||4
10882843|NCT03318861|12048887|FG004|NOT COMPLETED|Overall Study||3
10882844|NCT03316118|12048901|FG000|STARTED|Overall Study||2
10882845|NCT03316118|12048902|FG001|STARTED|Overall Study||0
10882846|NCT03316118|12048901|FG000|COMPLETED|Overall Study||2
10882847|NCT03316118|12048902|FG001|COMPLETED|Overall Study||0
10882848|NCT03316118|12048901|FG000|NOT COMPLETED|Overall Study||0
10882849|NCT03316118|12048902|FG001|NOT COMPLETED|Overall Study||0
10882850|NCT03315130|12048911|FG000|STARTED|Main Portion (12 Weeks)||15
10882851|NCT03315130|12048912|FG001|STARTED|Main Portion (12 Weeks)||15
10882852|NCT03315130|12048913|FG002|STARTED|Main Portion (12 Weeks)||15
10882853|NCT03315130|12048914|FG003|STARTED|Main Portion (12 Weeks)||0
10882854|NCT03315130|12048911|FG000|COMPLETED|Main Portion (12 Weeks)||15
10882855|NCT03315130|12048912|FG001|COMPLETED|Main Portion (12 Weeks)||13
10882856|NCT03315130|12048913|FG002|COMPLETED|Main Portion (12 Weeks)||15
10882857|NCT03315130|12048914|FG003|COMPLETED|Main Portion (12 Weeks)||0
10882858|NCT03315130|12048911|FG000|NOT COMPLETED|Main Portion (12 Weeks)||0
10882859|NCT03315130|12048912|FG001|NOT COMPLETED|Main Portion (12 Weeks)||2
10882860|NCT03315130|12048913|FG002|NOT COMPLETED|Main Portion (12 Weeks)||0
10882861|NCT03315130|12048914|FG003|NOT COMPLETED|Main Portion (12 Weeks)||0
10882862|NCT03315130|12048911|FG000|STARTED|EP:Before Switch to 0.3 mg/kg(Week13-48)|(15 [who received RA101495 0.1 mg/kg] + 7 [crossover from placebo])|22
10882863|NCT03315130|12048912|FG001|STARTED|EP:Before Switch to 0.3 mg/kg(Week13-48)|(14 [who received RA101495 0.3 mg/kg + 7 [crossover from placebo] + 1 [Subject who withdrew consent in Main Portion rejoined])|21
10882864|NCT03315130|12048913|FG002|STARTED|EP:Before Switch to 0.3 mg/kg(Week13-48)||0
10882865|NCT03315130|12048914|FG003|STARTED|EP:Before Switch to 0.3 mg/kg(Week13-48)||0
10882866|NCT03315130|12048911|FG000|COMPLETED|EP:Before Switch to 0.3 mg/kg(Week13-48)||21
10882867|NCT03315130|12048912|FG001|COMPLETED|EP:Before Switch to 0.3 mg/kg(Week13-48)||21
10882868|NCT03315130|12048913|FG002|COMPLETED|EP:Before Switch to 0.3 mg/kg(Week13-48)||0
10882869|NCT03315130|12048914|FG003|COMPLETED|EP:Before Switch to 0.3 mg/kg(Week13-48)||0
10882870|NCT03315130|12048911|FG000|NOT COMPLETED|EP:Before Switch to 0.3 mg/kg(Week13-48)||1
10882871|NCT03315130|12048912|FG001|NOT COMPLETED|EP:Before Switch to 0.3 mg/kg(Week13-48)||0
10882872|NCT03315130|12048913|FG002|NOT COMPLETED|EP:Before Switch to 0.3 mg/kg(Week13-48)||0
10882873|NCT03315130|12048914|FG003|NOT COMPLETED|EP:Before Switch to 0.3 mg/kg(Week13-48)||0
10882874|NCT03315130|12048911|FG000|STARTED|EP:After Switch to 0.3 mg/kg(Week48-122)||0
10882875|NCT03315130|12048912|FG001|STARTED|EP:After Switch to 0.3 mg/kg(Week48-122)||21
10882876|NCT03315130|12048913|FG002|STARTED|EP:After Switch to 0.3 mg/kg(Week48-122)||0
10882877|NCT03315130|12048914|FG003|STARTED|EP:After Switch to 0.3 mg/kg(Week48-122)||21
10882878|NCT03315130|12048911|FG000|COMPLETED|EP:After Switch to 0.3 mg/kg(Week48-122)||0
10882879|NCT03315130|12048912|FG001|COMPLETED|EP:After Switch to 0.3 mg/kg(Week48-122)||17
10882880|NCT03315130|12048913|FG002|COMPLETED|EP:After Switch to 0.3 mg/kg(Week48-122)||0
10882881|NCT03315130|12048914|FG003|COMPLETED|EP:After Switch to 0.3 mg/kg(Week48-122)||20
10882882|NCT03315130|12048911|FG000|NOT COMPLETED|EP:After Switch to 0.3 mg/kg(Week48-122)||0
10882883|NCT03315130|12048912|FG001|NOT COMPLETED|EP:After Switch to 0.3 mg/kg(Week48-122)||4
10882884|NCT03315130|12048913|FG002|NOT COMPLETED|EP:After Switch to 0.3 mg/kg(Week48-122)||0
10882885|NCT03315130|12048914|FG003|NOT COMPLETED|EP:After Switch to 0.3 mg/kg(Week48-122)||1
10882886|NCT03314857|12048934|FG000|STARTED|Overall Study||67
10882887|NCT03314857|12048934|FG000|Analysis Population|Overall Study||61
10882888|NCT03314857|12048934|FG000|COMPLETED|Overall Study|62/67 patients completed the 30-day primary endpoint visit.|62
10882889|NCT03314857|12048934|FG000|NOT COMPLETED|Overall Study||5
10882890|NCT03308942|12048943|FG000|STARTED|Stage 1 (Up to a Maximum of 45 Months)||17
10882891|NCT03308942|12048944|FG001|STARTED|Stage 1 (Up to a Maximum of 45 Months)||21
10882892|NCT03308942|12048945|FG002|STARTED|Stage 1 (Up to a Maximum of 45 Months)||3
10882893|NCT03308942|12048946|FG003|STARTED|Stage 1 (Up to a Maximum of 45 Months)||0
10882894|NCT03308942|12048947|FG004|STARTED|Stage 1 (Up to a Maximum of 45 Months)||0
10882895|NCT03308942|12048943|FG000|COMPLETED|Stage 1 (Up to a Maximum of 45 Months)||0
10882896|NCT03308942|12048944|FG001|COMPLETED|Stage 1 (Up to a Maximum of 45 Months)||0
10882897|NCT03308942|12048945|FG002|COMPLETED|Stage 1 (Up to a Maximum of 45 Months)||0
10882898|NCT03308942|12048946|FG003|COMPLETED|Stage 1 (Up to a Maximum of 45 Months)||0
10882899|NCT03308942|12048947|FG004|COMPLETED|Stage 1 (Up to a Maximum of 45 Months)||0
10882900|NCT03308942|12048943|FG000|NOT COMPLETED|Stage 1 (Up to a Maximum of 45 Months)||17
10882901|NCT03308942|12048944|FG001|NOT COMPLETED|Stage 1 (Up to a Maximum of 45 Months)||21
10882902|NCT03308942|12048945|FG002|NOT COMPLETED|Stage 1 (Up to a Maximum of 45 Months)||3
10882903|NCT03308942|12048946|FG003|NOT COMPLETED|Stage 1 (Up to a Maximum of 45 Months)||0
10882904|NCT03308942|12048947|FG004|NOT COMPLETED|Stage 1 (Up to a Maximum of 45 Months)||0
10882905|NCT03308942|12048943|FG000|STARTED|Stage 2 (Up to a Maximum of 29 Months)||0
10882906|NCT03308942|12048944|FG001|STARTED|Stage 2 (Up to a Maximum of 29 Months)||0
10882907|NCT03308942|12048945|FG002|STARTED|Stage 2 (Up to a Maximum of 29 Months)||0
10882908|NCT03308942|12048946|FG003|STARTED|Stage 2 (Up to a Maximum of 29 Months)||12
10882909|NCT03308942|12048947|FG004|STARTED|Stage 2 (Up to a Maximum of 29 Months)||0
10882910|NCT03308942|12048943|FG000|COMPLETED|Stage 2 (Up to a Maximum of 29 Months)||0
10882911|NCT03308942|12048944|FG001|COMPLETED|Stage 2 (Up to a Maximum of 29 Months)||0
10882912|NCT03308942|12048945|FG002|COMPLETED|Stage 2 (Up to a Maximum of 29 Months)||0
10882913|NCT03308942|12048946|FG003|COMPLETED|Stage 2 (Up to a Maximum of 29 Months)||0
10882914|NCT03308942|12048947|FG004|COMPLETED|Stage 2 (Up to a Maximum of 29 Months)||0
10882915|NCT03308942|12048943|FG000|NOT COMPLETED|Stage 2 (Up to a Maximum of 29 Months)||0
10882916|NCT03308942|12048944|FG001|NOT COMPLETED|Stage 2 (Up to a Maximum of 29 Months)||0
10882917|NCT03308942|12048945|FG002|NOT COMPLETED|Stage 2 (Up to a Maximum of 29 Months)||0
10882918|NCT03308942|12048946|FG003|NOT COMPLETED|Stage 2 (Up to a Maximum of 29 Months)||12
10882919|NCT03308942|12048947|FG004|NOT COMPLETED|Stage 2 (Up to a Maximum of 29 Months)||0
10882920|NCT03308786|12048960|FG000|STARTED|Overall Study||9
10882921|NCT03308786|12048960|FG000|COMPLETED|Overall Study||0
10882922|NCT03308786|12048960|FG000|NOT COMPLETED|Overall Study||9
10882923|NCT03307785|12048976|FG000|STARTED|Part A: Up to 28.5 Months||16
10882924|NCT03307785|12048977|FG001|STARTED|Part A: Up to 28.5 Months||6
10882925|NCT03307785|12048978|FG002|STARTED|Part A: Up to 28.5 Months||0
10882926|NCT03307785|12048979|FG003|STARTED|Part A: Up to 28.5 Months||0
10882927|NCT03307785|12048980|FG004|STARTED|Part A: Up to 28.5 Months||0
10882928|NCT03307785|12048981|FG005|STARTED|Part A: Up to 28.5 Months||0
10882929|NCT03307785|12048982|FG006|STARTED|Part A: Up to 28.5 Months||0
10882930|NCT03307785|12048983|FG007|STARTED|Part A: Up to 28.5 Months||0
10882931|NCT03307785|12048984|FG008|STARTED|Part A: Up to 28.5 Months||0
10882932|NCT03307785|12048985|FG009|STARTED|Part A: Up to 28.5 Months||0
10882933|NCT03307785|12048986|FG010|STARTED|Part A: Up to 28.5 Months||0
10882934|NCT03307785|12048976|FG000|COMPLETED|Part A: Up to 28.5 Months||0
10882935|NCT03307785|12048977|FG001|COMPLETED|Part A: Up to 28.5 Months||0
10882936|NCT03307785|12048978|FG002|COMPLETED|Part A: Up to 28.5 Months||0
10882937|NCT03307785|12048979|FG003|COMPLETED|Part A: Up to 28.5 Months||0
10882938|NCT03307785|12048980|FG004|COMPLETED|Part A: Up to 28.5 Months||0
10882939|NCT03307785|12048981|FG005|COMPLETED|Part A: Up to 28.5 Months||0
10882940|NCT03307785|12048982|FG006|COMPLETED|Part A: Up to 28.5 Months||0
10882941|NCT03307785|12048983|FG007|COMPLETED|Part A: Up to 28.5 Months||0
10882942|NCT03307785|12048984|FG008|COMPLETED|Part A: Up to 28.5 Months||0
10882943|NCT03307785|12048985|FG009|COMPLETED|Part A: Up to 28.5 Months||0
10882944|NCT03307785|12048986|FG010|COMPLETED|Part A: Up to 28.5 Months||0
10882945|NCT03307785|12048976|FG000|NOT COMPLETED|Part A: Up to 28.5 Months||16
10882946|NCT03307785|12048977|FG001|NOT COMPLETED|Part A: Up to 28.5 Months||6
10882947|NCT03307785|12048978|FG002|NOT COMPLETED|Part A: Up to 28.5 Months||0
10882948|NCT03307785|12048979|FG003|NOT COMPLETED|Part A: Up to 28.5 Months||0
10882949|NCT03307785|12048980|FG004|NOT COMPLETED|Part A: Up to 28.5 Months||0
10882950|NCT03307785|12048981|FG005|NOT COMPLETED|Part A: Up to 28.5 Months||0
10882951|NCT03307785|12048982|FG006|NOT COMPLETED|Part A: Up to 28.5 Months||0
10882952|NCT03307785|12048983|FG007|NOT COMPLETED|Part A: Up to 28.5 Months||0
10882953|NCT03307785|12048984|FG008|NOT COMPLETED|Part A: Up to 28.5 Months||0
10882954|NCT03307785|12048985|FG009|NOT COMPLETED|Part A: Up to 28.5 Months||0
10882955|NCT03307785|12048986|FG010|NOT COMPLETED|Part A: Up to 28.5 Months||0
10882956|NCT03307785|12048976|FG000|STARTED|Part B: Up to 28.5 Months||0
10882957|NCT03307785|12048977|FG001|STARTED|Part B: Up to 28.5 Months||0
10882958|NCT03307785|12048978|FG002|STARTED|Part B: Up to 28.5 Months||14
10882959|NCT03307785|12048979|FG003|STARTED|Part B: Up to 28.5 Months||0
10882960|NCT03307785|12048980|FG004|STARTED|Part B: Up to 28.5 Months||0
10882961|NCT03307785|12048981|FG005|STARTED|Part B: Up to 28.5 Months||0
10882962|NCT03307785|12048982|FG006|STARTED|Part B: Up to 28.5 Months||0
10882963|NCT03307785|12048983|FG007|STARTED|Part B: Up to 28.5 Months||0
10882964|NCT03307785|12048984|FG008|STARTED|Part B: Up to 28.5 Months||0
10882965|NCT03307785|12048985|FG009|STARTED|Part B: Up to 28.5 Months||0
10882966|NCT03307785|12048986|FG010|STARTED|Part B: Up to 28.5 Months||0
10882967|NCT03307785|12048976|FG000|COMPLETED|Part B: Up to 28.5 Months||0
10882968|NCT03307785|12048977|FG001|COMPLETED|Part B: Up to 28.5 Months||0
10882969|NCT03307785|12048978|FG002|COMPLETED|Part B: Up to 28.5 Months||0
10882970|NCT03307785|12048979|FG003|COMPLETED|Part B: Up to 28.5 Months||0
10882971|NCT03307785|12048980|FG004|COMPLETED|Part B: Up to 28.5 Months||0
10882972|NCT03307785|12048981|FG005|COMPLETED|Part B: Up to 28.5 Months||0
10882973|NCT03307785|12048982|FG006|COMPLETED|Part B: Up to 28.5 Months||0
10882974|NCT03307785|12048983|FG007|COMPLETED|Part B: Up to 28.5 Months||0
10882975|NCT03307785|12048984|FG008|COMPLETED|Part B: Up to 28.5 Months||0
10882976|NCT03307785|12048985|FG009|COMPLETED|Part B: Up to 28.5 Months||0
10882977|NCT03307785|12048986|FG010|COMPLETED|Part B: Up to 28.5 Months||0
10882978|NCT03307785|12048976|FG000|NOT COMPLETED|Part B: Up to 28.5 Months||0
10882979|NCT03307785|12048977|FG001|NOT COMPLETED|Part B: Up to 28.5 Months||0
10882980|NCT03307785|12048978|FG002|NOT COMPLETED|Part B: Up to 28.5 Months||14
10882981|NCT03307785|12048979|FG003|NOT COMPLETED|Part B: Up to 28.5 Months||0
10882982|NCT03307785|12048980|FG004|NOT COMPLETED|Part B: Up to 28.5 Months||0
10882983|NCT03307785|12048981|FG005|NOT COMPLETED|Part B: Up to 28.5 Months||0
10882984|NCT03307785|12048982|FG006|NOT COMPLETED|Part B: Up to 28.5 Months||0
10882985|NCT03307785|12048983|FG007|NOT COMPLETED|Part B: Up to 28.5 Months||0
10882986|NCT03307785|12048984|FG008|NOT COMPLETED|Part B: Up to 28.5 Months||0
10882987|NCT03307785|12048985|FG009|NOT COMPLETED|Part B: Up to 28.5 Months||0
10882988|NCT03307785|12048986|FG010|NOT COMPLETED|Part B: Up to 28.5 Months||0
10882989|NCT03307785|12048976|FG000|STARTED|Part C: Up to 22.5 Months||0
10882990|NCT03307785|12048977|FG001|STARTED|Part C: Up to 22.5 Months||0
10882991|NCT03307785|12048978|FG002|STARTED|Part C: Up to 22.5 Months||0
10882992|NCT03307785|12048979|FG003|STARTED|Part C: Up to 22.5 Months||6
10882993|NCT03307785|12048980|FG004|STARTED|Part C: Up to 22.5 Months||7
10882994|NCT03307785|12048981|FG005|STARTED|Part C: Up to 22.5 Months||0
10882995|NCT03307785|12048982|FG006|STARTED|Part C: Up to 22.5 Months||0
10882996|NCT03307785|12048983|FG007|STARTED|Part C: Up to 22.5 Months||0
10882997|NCT03307785|12048984|FG008|STARTED|Part C: Up to 22.5 Months||0
10882998|NCT03307785|12048985|FG009|STARTED|Part C: Up to 22.5 Months||0
10882999|NCT03307785|12048986|FG010|STARTED|Part C: Up to 22.5 Months||0
10883000|NCT03307785|12048976|FG000|COMPLETED|Part C: Up to 22.5 Months||0
10883001|NCT03307785|12048977|FG001|COMPLETED|Part C: Up to 22.5 Months||0
10883002|NCT03307785|12048978|FG002|COMPLETED|Part C: Up to 22.5 Months||0
10883003|NCT03307785|12048979|FG003|COMPLETED|Part C: Up to 22.5 Months||0
10883004|NCT03307785|12048980|FG004|COMPLETED|Part C: Up to 22.5 Months||0
10883005|NCT03307785|12048981|FG005|COMPLETED|Part C: Up to 22.5 Months||0
10883006|NCT03307785|12048982|FG006|COMPLETED|Part C: Up to 22.5 Months||0
10883007|NCT03307785|12048983|FG007|COMPLETED|Part C: Up to 22.5 Months||0
10883008|NCT03307785|12048984|FG008|COMPLETED|Part C: Up to 22.5 Months||0
10883009|NCT03307785|12048985|FG009|COMPLETED|Part C: Up to 22.5 Months||0
10883010|NCT03307785|12048986|FG010|COMPLETED|Part C: Up to 22.5 Months||0
10883011|NCT03307785|12048976|FG000|NOT COMPLETED|Part C: Up to 22.5 Months||0
10883012|NCT03307785|12048977|FG001|NOT COMPLETED|Part C: Up to 22.5 Months||0
10883013|NCT03307785|12048978|FG002|NOT COMPLETED|Part C: Up to 22.5 Months||0
10883014|NCT03307785|12048979|FG003|NOT COMPLETED|Part C: Up to 22.5 Months||6
10883015|NCT03307785|12048980|FG004|NOT COMPLETED|Part C: Up to 22.5 Months||7
10883016|NCT03307785|12048981|FG005|NOT COMPLETED|Part C: Up to 22.5 Months||0
10883017|NCT03307785|12048982|FG006|NOT COMPLETED|Part C: Up to 22.5 Months||0
10883018|NCT03307785|12048983|FG007|NOT COMPLETED|Part C: Up to 22.5 Months||0
10883019|NCT03307785|12048984|FG008|NOT COMPLETED|Part C: Up to 22.5 Months||0
10883020|NCT03307785|12048985|FG009|NOT COMPLETED|Part C: Up to 22.5 Months||0
10883021|NCT03307785|12048986|FG010|NOT COMPLETED|Part C: Up to 22.5 Months||0
10883022|NCT03307785|12048976|FG000|STARTED|Part D: Up to 9.5 Months||0
10883023|NCT03307785|12048977|FG001|STARTED|Part D: Up to 9.5 Months||0
10883024|NCT03307785|12048978|FG002|STARTED|Part D: Up to 9.5 Months||0
10883025|NCT03307785|12048979|FG003|STARTED|Part D: Up to 9.5 Months||0
10883026|NCT03307785|12048980|FG004|STARTED|Part D: Up to 9.5 Months||0
10883027|NCT03307785|12048981|FG005|STARTED|Part D: Up to 9.5 Months||6
10883028|NCT03307785|12048982|FG006|STARTED|Part D: Up to 9.5 Months||0
10883029|NCT03307785|12048983|FG007|STARTED|Part D: Up to 9.5 Months||0
10883030|NCT03307785|12048984|FG008|STARTED|Part D: Up to 9.5 Months||0
10883031|NCT03307785|12048985|FG009|STARTED|Part D: Up to 9.5 Months||0
10883032|NCT03307785|12048986|FG010|STARTED|Part D: Up to 9.5 Months||0
10883033|NCT03307785|12048976|FG000|COMPLETED|Part D: Up to 9.5 Months||0
10883034|NCT03307785|12048977|FG001|COMPLETED|Part D: Up to 9.5 Months||0
10883035|NCT03307785|12048978|FG002|COMPLETED|Part D: Up to 9.5 Months||0
10883036|NCT03307785|12048979|FG003|COMPLETED|Part D: Up to 9.5 Months||0
10883037|NCT03307785|12048980|FG004|COMPLETED|Part D: Up to 9.5 Months||0
10883038|NCT03307785|12048981|FG005|COMPLETED|Part D: Up to 9.5 Months||3
10883039|NCT03307785|12048982|FG006|COMPLETED|Part D: Up to 9.5 Months||0
10883040|NCT03307785|12048983|FG007|COMPLETED|Part D: Up to 9.5 Months||0
10883041|NCT03307785|12048984|FG008|COMPLETED|Part D: Up to 9.5 Months||0
10883042|NCT03307785|12048985|FG009|COMPLETED|Part D: Up to 9.5 Months||0
10883043|NCT03307785|12048986|FG010|COMPLETED|Part D: Up to 9.5 Months||0
10883044|NCT03307785|12048976|FG000|NOT COMPLETED|Part D: Up to 9.5 Months||0
10883045|NCT03307785|12048977|FG001|NOT COMPLETED|Part D: Up to 9.5 Months||0
10883046|NCT03307785|12048978|FG002|NOT COMPLETED|Part D: Up to 9.5 Months||0
10883047|NCT03307785|12048979|FG003|NOT COMPLETED|Part D: Up to 9.5 Months||0
10883048|NCT03307785|12048980|FG004|NOT COMPLETED|Part D: Up to 9.5 Months||0
10883049|NCT03307785|12048981|FG005|NOT COMPLETED|Part D: Up to 9.5 Months||3
10883050|NCT03307785|12048982|FG006|NOT COMPLETED|Part D: Up to 9.5 Months||0
10883051|NCT03307785|12048983|FG007|NOT COMPLETED|Part D: Up to 9.5 Months||0
10883052|NCT03307785|12048984|FG008|NOT COMPLETED|Part D: Up to 9.5 Months||0
10883053|NCT03307785|12048985|FG009|NOT COMPLETED|Part D: Up to 9.5 Months||0
10883054|NCT03307785|12048986|FG010|NOT COMPLETED|Part D: Up to 9.5 Months||0
10883055|NCT03307785|12048976|FG000|STARTED|Part E: Up to 4.4 Months||0
10883056|NCT03307785|12048977|FG001|STARTED|Part E: Up to 4.4 Months||0
10883057|NCT03307785|12048978|FG002|STARTED|Part E: Up to 4.4 Months||0
10883058|NCT03307785|12048979|FG003|STARTED|Part E: Up to 4.4 Months||0
10883059|NCT03307785|12048980|FG004|STARTED|Part E: Up to 4.4 Months||0
10883060|NCT03307785|12048981|FG005|STARTED|Part E: Up to 4.4 Months||0
10883061|NCT03307785|12048982|FG006|STARTED|Part E: Up to 4.4 Months||2
10883062|NCT03307785|12048983|FG007|STARTED|Part E: Up to 4.4 Months||0
10883063|NCT03307785|12048984|FG008|STARTED|Part E: Up to 4.4 Months||0
10883064|NCT03307785|12048985|FG009|STARTED|Part E: Up to 4.4 Months||0
10883065|NCT03307785|12048986|FG010|STARTED|Part E: Up to 4.4 Months||0
10883066|NCT03307785|12048976|FG000|COMPLETED|Part E: Up to 4.4 Months||0
10883067|NCT03307785|12048977|FG001|COMPLETED|Part E: Up to 4.4 Months||0
10883068|NCT03307785|12048978|FG002|COMPLETED|Part E: Up to 4.4 Months||0
10883069|NCT03307785|12048979|FG003|COMPLETED|Part E: Up to 4.4 Months||0
10883070|NCT03307785|12048980|FG004|COMPLETED|Part E: Up to 4.4 Months||0
10883071|NCT03307785|12048981|FG005|COMPLETED|Part E: Up to 4.4 Months||0
10883072|NCT03307785|12048982|FG006|COMPLETED|Part E: Up to 4.4 Months||0
10883073|NCT03307785|12048983|FG007|COMPLETED|Part E: Up to 4.4 Months||0
10883074|NCT03307785|12048984|FG008|COMPLETED|Part E: Up to 4.4 Months||0
10883075|NCT03307785|12048985|FG009|COMPLETED|Part E: Up to 4.4 Months||0
10883076|NCT03307785|12048986|FG010|COMPLETED|Part E: Up to 4.4 Months||0
10883077|NCT03307785|12048976|FG000|NOT COMPLETED|Part E: Up to 4.4 Months||0
10883078|NCT03307785|12048977|FG001|NOT COMPLETED|Part E: Up to 4.4 Months||0
10883079|NCT03307785|12048978|FG002|NOT COMPLETED|Part E: Up to 4.4 Months||0
10883080|NCT03307785|12048979|FG003|NOT COMPLETED|Part E: Up to 4.4 Months||0
10883081|NCT03307785|12048980|FG004|NOT COMPLETED|Part E: Up to 4.4 Months||0
10883082|NCT03307785|12048981|FG005|NOT COMPLETED|Part E: Up to 4.4 Months||0
10883083|NCT03307785|12048982|FG006|NOT COMPLETED|Part E: Up to 4.4 Months||2
10883084|NCT03307785|12048983|FG007|NOT COMPLETED|Part E: Up to 4.4 Months||0
10883085|NCT03307785|12048984|FG008|NOT COMPLETED|Part E: Up to 4.4 Months||0
10883086|NCT03307785|12048985|FG009|NOT COMPLETED|Part E: Up to 4.4 Months||0
10883087|NCT03307785|12048986|FG010|NOT COMPLETED|Part E: Up to 4.4 Months||0
10883088|NCT03307785|12048976|FG000|STARTED|Part F: Up to 3.5 Months||0
10883089|NCT03307785|12048977|FG001|STARTED|Part F: Up to 3.5 Months||0
10883090|NCT03307785|12048978|FG002|STARTED|Part F: Up to 3.5 Months||0
10883091|NCT03307785|12048979|FG003|STARTED|Part F: Up to 3.5 Months||0
10883092|NCT03307785|12048980|FG004|STARTED|Part F: Up to 3.5 Months||0
10883093|NCT03307785|12048981|FG005|STARTED|Part F: Up to 3.5 Months||0
10883094|NCT03307785|12048982|FG006|STARTED|Part F: Up to 3.5 Months||0
10883095|NCT03307785|12048983|FG007|STARTED|Part F: Up to 3.5 Months||1
10883096|NCT03307785|12048984|FG008|STARTED|Part F: Up to 3.5 Months||0
10883097|NCT03307785|12048985|FG009|STARTED|Part F: Up to 3.5 Months||0
10883098|NCT03307785|12048986|FG010|STARTED|Part F: Up to 3.5 Months||0
10883099|NCT03307785|12048976|FG000|COMPLETED|Part F: Up to 3.5 Months||0
10883100|NCT03307785|12048977|FG001|COMPLETED|Part F: Up to 3.5 Months||0
10883101|NCT03307785|12048978|FG002|COMPLETED|Part F: Up to 3.5 Months||0
10883102|NCT03307785|12048979|FG003|COMPLETED|Part F: Up to 3.5 Months||0
10883103|NCT03307785|12048980|FG004|COMPLETED|Part F: Up to 3.5 Months||0
10883104|NCT03307785|12048981|FG005|COMPLETED|Part F: Up to 3.5 Months||0
10883105|NCT03307785|12048982|FG006|COMPLETED|Part F: Up to 3.5 Months||0
10883106|NCT03307785|12048983|FG007|COMPLETED|Part F: Up to 3.5 Months||0
10883107|NCT03307785|12048984|FG008|COMPLETED|Part F: Up to 3.5 Months||0
10883108|NCT03307785|12048985|FG009|COMPLETED|Part F: Up to 3.5 Months||0
10883109|NCT03307785|12048986|FG010|COMPLETED|Part F: Up to 3.5 Months||0
10883110|NCT03307785|12048976|FG000|NOT COMPLETED|Part F: Up to 3.5 Months||0
10883111|NCT03307785|12048977|FG001|NOT COMPLETED|Part F: Up to 3.5 Months||0
10883112|NCT03307785|12048978|FG002|NOT COMPLETED|Part F: Up to 3.5 Months||0
10883113|NCT03307785|12048979|FG003|NOT COMPLETED|Part F: Up to 3.5 Months||0
10883114|NCT03307785|12048980|FG004|NOT COMPLETED|Part F: Up to 3.5 Months||0
10883115|NCT03307785|12048981|FG005|NOT COMPLETED|Part F: Up to 3.5 Months||0
10883116|NCT03307785|12048982|FG006|NOT COMPLETED|Part F: Up to 3.5 Months||0
10883117|NCT03307785|12048983|FG007|NOT COMPLETED|Part F: Up to 3.5 Months||1
10883118|NCT03307785|12048984|FG008|NOT COMPLETED|Part F: Up to 3.5 Months||0
10883119|NCT03307785|12048985|FG009|NOT COMPLETED|Part F: Up to 3.5 Months||0
10883120|NCT03307785|12048986|FG010|NOT COMPLETED|Part F: Up to 3.5 Months||0
10883121|NCT03307785|12048976|FG000|STARTED|Part G: Up to 24 Months||0
10883122|NCT03307785|12048977|FG001|STARTED|Part G: Up to 24 Months||0
10883123|NCT03307785|12048978|FG002|STARTED|Part G: Up to 24 Months||0
10883124|NCT03307785|12048979|FG003|STARTED|Part G: Up to 24 Months||0
10883125|NCT03307785|12048980|FG004|STARTED|Part G: Up to 24 Months||0
10883126|NCT03307785|12048981|FG005|STARTED|Part G: Up to 24 Months||0
10883127|NCT03307785|12048982|FG006|STARTED|Part G: Up to 24 Months||0
10883128|NCT03307785|12048983|FG007|STARTED|Part G: Up to 24 Months||0
10883129|NCT03307785|12048984|FG008|STARTED|Part G: Up to 24 Months||0
10883130|NCT03307785|12048985|FG009|STARTED|Part G: Up to 24 Months||0
10883131|NCT03307785|12048986|FG010|STARTED|Part G: Up to 24 Months||0
10883132|NCT03307785|12048976|FG000|COMPLETED|Part G: Up to 24 Months||0
10883133|NCT03307785|12048977|FG001|COMPLETED|Part G: Up to 24 Months||0
10883134|NCT03307785|12048978|FG002|COMPLETED|Part G: Up to 24 Months||0
10883135|NCT03307785|12048979|FG003|COMPLETED|Part G: Up to 24 Months||0
10883136|NCT03307785|12048980|FG004|COMPLETED|Part G: Up to 24 Months||0
10883137|NCT03307785|12048981|FG005|COMPLETED|Part G: Up to 24 Months||0
10883138|NCT03307785|12048982|FG006|COMPLETED|Part G: Up to 24 Months||0
10883139|NCT03307785|12048983|FG007|COMPLETED|Part G: Up to 24 Months||0
10883140|NCT03307785|12048984|FG008|COMPLETED|Part G: Up to 24 Months||0
10883141|NCT03307785|12048985|FG009|COMPLETED|Part G: Up to 24 Months||0
10883142|NCT03307785|12048986|FG010|COMPLETED|Part G: Up to 24 Months||0
10883143|NCT03307785|12048976|FG000|NOT COMPLETED|Part G: Up to 24 Months||0
10883144|NCT03307785|12048977|FG001|NOT COMPLETED|Part G: Up to 24 Months||0
10883145|NCT03307785|12048978|FG002|NOT COMPLETED|Part G: Up to 24 Months||0
10883146|NCT03307785|12048979|FG003|NOT COMPLETED|Part G: Up to 24 Months||0
10883147|NCT03307785|12048980|FG004|NOT COMPLETED|Part G: Up to 24 Months||0
10883148|NCT03307785|12048981|FG005|NOT COMPLETED|Part G: Up to 24 Months||0
10883149|NCT03307785|12048982|FG006|NOT COMPLETED|Part G: Up to 24 Months||0
10883150|NCT03307785|12048983|FG007|NOT COMPLETED|Part G: Up to 24 Months||0
10883151|NCT03307785|12048984|FG008|NOT COMPLETED|Part G: Up to 24 Months||0
10883152|NCT03307785|12048985|FG009|NOT COMPLETED|Part G: Up to 24 Months||0
10883153|NCT03307785|12048986|FG010|NOT COMPLETED|Part G: Up to 24 Months||0
10883154|NCT03307785|12048976|FG000|STARTED|Part H: Up to 24 Months||0
10883155|NCT03307785|12048977|FG001|STARTED|Part H: Up to 24 Months||0
10883156|NCT03307785|12048978|FG002|STARTED|Part H: Up to 24 Months||0
10883157|NCT03307785|12048979|FG003|STARTED|Part H: Up to 24 Months||0
10883158|NCT03307785|12048980|FG004|STARTED|Part H: Up to 24 Months||0
10883159|NCT03307785|12048981|FG005|STARTED|Part H: Up to 24 Months||0
10883160|NCT03307785|12048982|FG006|STARTED|Part H: Up to 24 Months||0
10883161|NCT03307785|12048983|FG007|STARTED|Part H: Up to 24 Months||0
10883162|NCT03307785|12048984|FG008|STARTED|Part H: Up to 24 Months||0
10883163|NCT03307785|12048985|FG009|STARTED|Part H: Up to 24 Months||0
10883164|NCT03307785|12048986|FG010|STARTED|Part H: Up to 24 Months||0
10883165|NCT03307785|12048976|FG000|COMPLETED|Part H: Up to 24 Months||0
10883166|NCT03307785|12048977|FG001|COMPLETED|Part H: Up to 24 Months||0
10883167|NCT03307785|12048978|FG002|COMPLETED|Part H: Up to 24 Months||0
10883168|NCT03307785|12048979|FG003|COMPLETED|Part H: Up to 24 Months||0
10883169|NCT03307785|12048980|FG004|COMPLETED|Part H: Up to 24 Months||0
10883170|NCT03307785|12048981|FG005|COMPLETED|Part H: Up to 24 Months||0
10883171|NCT03307785|12048982|FG006|COMPLETED|Part H: Up to 24 Months||0
10883172|NCT03307785|12048983|FG007|COMPLETED|Part H: Up to 24 Months||0
10883173|NCT03307785|12048984|FG008|COMPLETED|Part H: Up to 24 Months||0
10883174|NCT03307785|12048985|FG009|COMPLETED|Part H: Up to 24 Months||0
10883175|NCT03307785|12048986|FG010|COMPLETED|Part H: Up to 24 Months||0
10883176|NCT03307785|12048976|FG000|NOT COMPLETED|Part H: Up to 24 Months||0
10883177|NCT03307785|12048977|FG001|NOT COMPLETED|Part H: Up to 24 Months||0
10883178|NCT03307785|12048978|FG002|NOT COMPLETED|Part H: Up to 24 Months||0
10883179|NCT03307785|12048979|FG003|NOT COMPLETED|Part H: Up to 24 Months||0
10883180|NCT03307785|12048980|FG004|NOT COMPLETED|Part H: Up to 24 Months||0
10883181|NCT03307785|12048981|FG005|NOT COMPLETED|Part H: Up to 24 Months||0
10883182|NCT03307785|12048982|FG006|NOT COMPLETED|Part H: Up to 24 Months||0
10883183|NCT03307785|12048983|FG007|NOT COMPLETED|Part H: Up to 24 Months||0
10883184|NCT03307785|12048984|FG008|NOT COMPLETED|Part H: Up to 24 Months||0
10883185|NCT03307785|12048985|FG009|NOT COMPLETED|Part H: Up to 24 Months||0
10883186|NCT03307785|12048986|FG010|NOT COMPLETED|Part H: Up to 24 Months||0
10883187|NCT03307785|12048976|FG000|STARTED|Part I: Up to 24 Months||0
10883188|NCT03307785|12048977|FG001|STARTED|Part I: Up to 24 Months||0
10883189|NCT03307785|12048978|FG002|STARTED|Part I: Up to 24 Months||0
10883190|NCT03307785|12048979|FG003|STARTED|Part I: Up to 24 Months||0
10883191|NCT03307785|12048980|FG004|STARTED|Part I: Up to 24 Months||0
10883192|NCT03307785|12048981|FG005|STARTED|Part I: Up to 24 Months||0
10883193|NCT03307785|12048982|FG006|STARTED|Part I: Up to 24 Months||0
10883194|NCT03307785|12048983|FG007|STARTED|Part I: Up to 24 Months||0
10883195|NCT03307785|12048984|FG008|STARTED|Part I: Up to 24 Months||0
10883196|NCT03307785|12048985|FG009|STARTED|Part I: Up to 24 Months||0
10883197|NCT03307785|12048986|FG010|STARTED|Part I: Up to 24 Months||0
10883198|NCT03307785|12048976|FG000|COMPLETED|Part I: Up to 24 Months||0
10883199|NCT03307785|12048977|FG001|COMPLETED|Part I: Up to 24 Months||0
10883200|NCT03307785|12048978|FG002|COMPLETED|Part I: Up to 24 Months||0
10883201|NCT03307785|12048979|FG003|COMPLETED|Part I: Up to 24 Months||0
10883202|NCT03307785|12048980|FG004|COMPLETED|Part I: Up to 24 Months||0
10883203|NCT03307785|12048981|FG005|COMPLETED|Part I: Up to 24 Months||0
10883204|NCT03307785|12048982|FG006|COMPLETED|Part I: Up to 24 Months||0
10883205|NCT03307785|12048983|FG007|COMPLETED|Part I: Up to 24 Months||0
10883206|NCT03307785|12048984|FG008|COMPLETED|Part I: Up to 24 Months||0
10883207|NCT03307785|12048985|FG009|COMPLETED|Part I: Up to 24 Months||0
10883208|NCT03307785|12048986|FG010|COMPLETED|Part I: Up to 24 Months||0
10883209|NCT03307785|12048976|FG000|NOT COMPLETED|Part I: Up to 24 Months||0
10883210|NCT03307785|12048977|FG001|NOT COMPLETED|Part I: Up to 24 Months||0
10883211|NCT03307785|12048978|FG002|NOT COMPLETED|Part I: Up to 24 Months||0
10883212|NCT03307785|12048979|FG003|NOT COMPLETED|Part I: Up to 24 Months||0
10883213|NCT03307785|12048980|FG004|NOT COMPLETED|Part I: Up to 24 Months||0
10883214|NCT03307785|12048981|FG005|NOT COMPLETED|Part I: Up to 24 Months||0
10883215|NCT03307785|12048982|FG006|NOT COMPLETED|Part I: Up to 24 Months||0
10883216|NCT03307785|12048983|FG007|NOT COMPLETED|Part I: Up to 24 Months||0
10883217|NCT03307785|12048984|FG008|NOT COMPLETED|Part I: Up to 24 Months||0
10883218|NCT03307785|12048985|FG009|NOT COMPLETED|Part I: Up to 24 Months||0
10883219|NCT03307785|12048986|FG010|NOT COMPLETED|Part I: Up to 24 Months||0
10883220|NCT03306277|12049007|FG000|STARTED|Overall Study||22
10883221|NCT03306277|12049007|FG000|COMPLETED|Overall Study||19
10883222|NCT03306277|12049007|FG000|NOT COMPLETED|Overall Study||3
10883223|NCT03303391|12049013|FG000|STARTED|Overall Study||9
10883224|NCT03303391|12049014|FG001|STARTED|Overall Study||3
10883225|NCT03303391|12049013|FG000|COMPLETED|Overall Study||9
10883226|NCT03303391|12049014|FG001|COMPLETED|Overall Study||3
10883227|NCT03303391|12049013|FG000|NOT COMPLETED|Overall Study||0
10883228|NCT03303391|12049014|FG001|NOT COMPLETED|Overall Study||0
10883229|NCT03301636|12049023|FG000|STARTED|Overall Study||7
10883230|NCT03301636|12049024|FG001|STARTED|Overall Study||6
10883231|NCT03301636|12049025|FG002|STARTED|Overall Study||8
10883232|NCT03301636|12049023|FG000|COMPLETED|Overall Study||7
10883233|NCT03301636|12049024|FG001|COMPLETED|Overall Study||6
10883234|NCT03301636|12049025|FG002|COMPLETED|Overall Study||8
10883235|NCT03301636|12049023|FG000|NOT COMPLETED|Overall Study||0
10883236|NCT03301636|12049024|FG001|NOT COMPLETED|Overall Study||0
10883237|NCT03301636|12049025|FG002|NOT COMPLETED|Overall Study||0
10883238|NCT03300466|12049035|FG000|STARTED|Overall Study||10
10883239|NCT03300466|12049036|FG001|STARTED|Overall Study||10
10883240|NCT03300466|12049035|FG000|COMPLETED|Overall Study||9
10883241|NCT03300466|12049036|FG001|COMPLETED|Overall Study||10
10883242|NCT03300466|12049035|FG000|NOT COMPLETED|Overall Study||1
10883243|NCT03300466|12049036|FG001|NOT COMPLETED|Overall Study||0
10883244|NCT03299049|12049044|FG000|STARTED|Overall Study||522
10883245|NCT03299049|12049045|FG001|STARTED|Overall Study||523
10883246|NCT03299049|12049044|FG000|COMPLETED|Overall Study||0
10883247|NCT03299049|12049045|FG001|COMPLETED|Overall Study||0
10883248|NCT03299049|12049044|FG000|NOT COMPLETED|Overall Study||522
10883249|NCT03299049|12049045|FG001|NOT COMPLETED|Overall Study||523
10883250|NCT03293238|12049062|FG000|STARTED|Overall Study||19
10883251|NCT03293238|12049063|FG001|STARTED|Overall Study||16
10883252|NCT03293238|12049064|FG002|STARTED|Overall Study||14
10883253|NCT03293238|12049065|FG003|STARTED|Overall Study||14
10883254|NCT03293238|12049062|FG000|COMPLETED|Overall Study||19
10883255|NCT03293238|12049063|FG001|COMPLETED|Overall Study||16
10883256|NCT03293238|12049064|FG002|COMPLETED|Overall Study||14
10883257|NCT03293238|12049065|FG003|COMPLETED|Overall Study||14
10883258|NCT03293238|12049062|FG000|NOT COMPLETED|Overall Study||0
10883259|NCT03293238|12049063|FG001|NOT COMPLETED|Overall Study||0
10883260|NCT03293238|12049064|FG002|NOT COMPLETED|Overall Study||0
10883261|NCT03293238|12049065|FG003|NOT COMPLETED|Overall Study||0
10883262|NCT03292926|12049077|FG000|STARTED|Overall Study||39
10883263|NCT03292926|12049078|FG001|STARTED|Overall Study||39
10883264|NCT03292926|12049077|FG000|COMPLETED|Overall Study||39
10883265|NCT03292926|12049078|FG001|COMPLETED|Overall Study||39
10883266|NCT03292926|12049077|FG000|NOT COMPLETED|Overall Study||0
10883267|NCT03292926|12049078|FG001|NOT COMPLETED|Overall Study||0
10883268|NCT03292913|12049086|FG000|STARTED|Overall Study||397
10883269|NCT03292913|12049087|FG001|STARTED|Overall Study||402
10883270|NCT03292913|12049086|FG000|COMPLETED|Overall Study||315
10883271|NCT03292913|12049087|FG001|COMPLETED|Overall Study||314
10883272|NCT03292913|12049086|FG000|NOT COMPLETED|Overall Study||82
10883273|NCT03292913|12049087|FG001|NOT COMPLETED|Overall Study||88
10883274|NCT03291808|12049097|FG000|STARTED|Overall Study||43
10883275|NCT03291808|12049097|FG000|COMPLETED|Overall Study||33
10883276|NCT03291808|12049097|FG000|NOT COMPLETED|Overall Study||10
10883277|NCT03290326|12049101|FG000|STARTED|Overall Study||10
10883278|NCT03290326|12049101|FG000|COMPLETED|Overall Study||10
10883279|NCT03290326|12049101|FG000|NOT COMPLETED|Overall Study||0
10883280|NCT03290300|12049107|FG000|STARTED|Overall Study||39
10883281|NCT03290300|12049107|FG000|COMPLETED|Overall Study||36
10883282|NCT03290300|12049107|FG000|NOT COMPLETED|Overall Study||3
10883283|NCT03289052|12049121|FG000|STARTED|Overall Study||20
10883284|NCT03289052|12049122|FG001|STARTED|Overall Study||111
10883285|NCT03289052|12049123|FG002|STARTED|Overall Study||37
10883286|NCT03289052|12049121|FG000|COMPLETED|Overall Study||20
10883287|NCT03289052|12049122|FG001|COMPLETED|Overall Study||108
10883288|NCT03289052|12049123|FG002|COMPLETED|Overall Study||32
10883289|NCT03289052|12049121|FG000|NOT COMPLETED|Overall Study||0
10883290|NCT03289052|12049122|FG001|NOT COMPLETED|Overall Study||3
10883291|NCT03289052|12049123|FG002|NOT COMPLETED|Overall Study||5
10883292|NCT03287947|12049131|FG000|STARTED|Overall Study|Five subjects were enrolled to the study.|5
10883293|NCT03287947|12049131|FG000|COMPLETED|Overall Study|All subjects enrolled discontinued treatment and are now off study.|5
10883294|NCT03287947|12049131|FG000|NOT COMPLETED|Overall Study||0
10883295|NCT03287089|12049137|FG000|STARTED|Overall Study||82
10883296|NCT03287089|12049138|FG001|STARTED|Overall Study||82
10883297|NCT03287089|12049137|FG000|COMPLETED|Overall Study||82
10883298|NCT03287089|12049138|FG001|COMPLETED|Overall Study||76
10883299|NCT03287089|12049137|FG000|NOT COMPLETED|Overall Study||0
10883300|NCT03287089|12049138|FG001|NOT COMPLETED|Overall Study||6
10883301|NCT03286283|12049144|FG000|STARTED|Overall Study||55
10883302|NCT03286283|12049144|FG000|COMPLETED|Overall Study||55
10883303|NCT03286283|12049144|FG000|NOT COMPLETED|Overall Study||0
10883304|NCT03281304|12049150|FG000|STARTED|Overall Study||70
10883305|NCT03281304|12049151|FG001|STARTED|Overall Study||70
10883306|NCT03281304|12049150|FG000|COMPLETED|Overall Study||57
10883307|NCT03281304|12049151|FG001|COMPLETED|Overall Study||58
10883308|NCT03281304|12049150|FG000|NOT COMPLETED|Overall Study||13
10883309|NCT03281304|12049151|FG001|NOT COMPLETED|Overall Study||12
10883310|NCT03279250|12049159|FG000|STARTED|Overall Study||34
10883311|NCT03279250|12049160|FG001|STARTED|Overall Study||34
10883312|NCT03279250|12049159|FG000|COMPLETED|Overall Study||34
10883313|NCT03279250|12049160|FG001|COMPLETED|Overall Study||34
10883314|NCT03279250|12049159|FG000|NOT COMPLETED|Overall Study||0
10883315|NCT03279250|12049160|FG001|NOT COMPLETED|Overall Study||0
10883316|NCT03277105|12049168|FG000|STARTED|Overall Study||259
10883317|NCT03277105|12049169|FG001|STARTED|Overall Study||263
10883318|NCT03277105|12049168|FG000|Safety Analysis Set|Overall Study||258
10883319|NCT03277105|12049169|FG001|Safety Analysis Set|Overall Study||260
10883320|NCT03277105|12049168|FG000|COMPLETED|Overall Study||0
10883321|NCT03277105|12049169|FG001|COMPLETED|Overall Study||0
10883322|NCT03277105|12049168|FG000|NOT COMPLETED|Overall Study||259
10883323|NCT03277105|12049169|FG001|NOT COMPLETED|Overall Study||263
10883324|NCT03276728|12049183|FG000|STARTED|Overall Study||22
10883325|NCT03276728|12049184|FG001|STARTED|Overall Study||66
10883326|NCT03276728|12049185|FG002|STARTED|Overall Study||16
10883327|NCT03276728|12049186|FG003|STARTED|Overall Study||50
10883328|NCT03276728|12049187|FG004|STARTED|Overall Study||7
10883329|NCT03276728|12049188|FG005|STARTED|Overall Study||1
10883330|NCT03276728|12049189|FG006|STARTED|Overall Study||17
10883331|NCT03276728|12049190|FG007|STARTED|Overall Study||3
10883332|NCT03276728|12049183|FG000|Treated Participants|Overall Study||22
10883333|NCT03276728|12049184|FG001|Treated Participants|Overall Study||66
10883334|NCT03276728|12049185|FG002|Treated Participants|Overall Study||16
10883335|NCT03276728|12049186|FG003|Treated Participants|Overall Study||50
10883336|NCT03276728|12049187|FG004|Treated Participants|Overall Study||7
10883337|NCT03276728|12049188|FG005|Treated Participants|Overall Study||1
10883338|NCT03276728|12049189|FG006|Treated Participants|Overall Study||16
10883339|NCT03276728|12049190|FG007|Treated Participants|Overall Study||3
10883340|NCT03276728|12049183|FG000|COMPLETED|Overall Study||22
10883341|NCT03276728|12049184|FG001|COMPLETED|Overall Study||66
10883342|NCT03276728|12049185|FG002|COMPLETED|Overall Study||14
10883343|NCT03276728|12049186|FG003|COMPLETED|Overall Study||45
10883344|NCT03276728|12049187|FG004|COMPLETED|Overall Study||6
10883345|NCT03276728|12049188|FG005|COMPLETED|Overall Study||1
10883346|NCT03276728|12049189|FG006|COMPLETED|Overall Study||15
10883347|NCT03276728|12049190|FG007|COMPLETED|Overall Study||2
10883348|NCT03276728|12049183|FG000|NOT COMPLETED|Overall Study||0
10883349|NCT03276728|12049184|FG001|NOT COMPLETED|Overall Study||0
10883350|NCT03276728|12049185|FG002|NOT COMPLETED|Overall Study||2
10883351|NCT03276728|12049186|FG003|NOT COMPLETED|Overall Study||5
10883352|NCT03276728|12049187|FG004|NOT COMPLETED|Overall Study||1
10883353|NCT03276728|12049188|FG005|NOT COMPLETED|Overall Study||0
10883354|NCT03276728|12049189|FG006|NOT COMPLETED|Overall Study||2
10883355|NCT03276728|12049190|FG007|NOT COMPLETED|Overall Study||1
10883356|NCT03274466|12049212|FG000|STARTED|Overall Study||147
10883357|NCT03274466|12049213|FG001|STARTED|Overall Study||147
10883358|NCT03274466|12049212|FG000|COMPLETED|Overall Study||124
10883359|NCT03274466|12049213|FG001|COMPLETED|Overall Study||118
10883360|NCT03274466|12049212|FG000|NOT COMPLETED|Overall Study||23
10883361|NCT03274466|12049213|FG001|NOT COMPLETED|Overall Study||29
10883362|NCT03273907|12049219|FG000|STARTED|Overall Study||43
10883363|NCT03273907|12049219|FG000|COMPLETED|Overall Study||34
10883364|NCT03273907|12049219|FG000|NOT COMPLETED|Overall Study||9
10883365|NCT03273153|12049227|FG000|STARTED|Overall Study||224
10883366|NCT03273153|12049228|FG001|STARTED|Overall Study||222
10883367|NCT03273153|12049227|FG000|COMPLETED|Overall Study||0
10883368|NCT03273153|12049228|FG001|COMPLETED|Overall Study||0
10883369|NCT03273153|12049227|FG000|NOT COMPLETED|Overall Study||224
10883370|NCT03273153|12049228|FG001|NOT COMPLETED|Overall Study||222
10883371|NCT03268954|12049237|FG000|STARTED|Overall Study||227
10883372|NCT03268954|12049238|FG001|STARTED|Overall Study||227
10883373|NCT03268954|12049237|FG000|Safety Population|Overall Study||220
10883374|NCT03268954|12049238|FG001|Safety Population|Overall Study||223
10883375|NCT03268954|12049237|FG000|COMPLETED|Overall Study||0
10883376|NCT03268954|12049238|FG001|COMPLETED|Overall Study||0
10883377|NCT03268954|12049237|FG000|NOT COMPLETED|Overall Study||227
10883378|NCT03268954|12049238|FG001|NOT COMPLETED|Overall Study||227
10883379|NCT03257631|12049248|FG000|STARTED|Overall Study||11
10883380|NCT03257631|12049249|FG001|STARTED|Overall Study||9
10883381|NCT03257631|12049250|FG002|STARTED|Overall Study||23
10883382|NCT03257631|12049251|FG003|STARTED|Overall Study||10
10883383|NCT03257631|12049248|FG000|Received Study Drug|Overall Study||11
10883384|NCT03257631|12049249|FG001|Received Study Drug|Overall Study||9
10883385|NCT03257631|12049250|FG002|Received Study Drug|Overall Study||22
10883386|NCT03257631|12049251|FG003|Received Study Drug|Overall Study||10
10883387|NCT03257631|12049248|FG000|COMPLETED|Overall Study||0
10883388|NCT03257631|12049249|FG001|COMPLETED|Overall Study||0
10883389|NCT03257631|12049250|FG002|COMPLETED|Overall Study||0
10883390|NCT03257631|12049251|FG003|COMPLETED|Overall Study||0
10883391|NCT03257631|12049248|FG000|NOT COMPLETED|Overall Study||11
10883392|NCT03257631|12049249|FG001|NOT COMPLETED|Overall Study||9
10883393|NCT03257631|12049250|FG002|NOT COMPLETED|Overall Study||23
10883394|NCT03257631|12049251|FG003|NOT COMPLETED|Overall Study||10
10883395|NCT03255629|12049261|FG000|STARTED|Overall Study||8
10883396|NCT03255629|12049262|FG001|STARTED|Overall Study||8
10883475|NCT03253796|12049303|FG002|STARTED|Period 2: Open-Label Retreatment||0
10883476|NCT03253796|12049304|FG003|STARTED|Period 2: Open-Label Retreatment||0
10883397|NCT03255629|12049261|FG000|COMPLETED|Overall Study|"One participant developed intractable nausea and emesis after consuming the mixed meal, and was withdrawn.~Two participants were withdrawn due to not experiencing hypoglycemia during mixed meal testing."|5
10883398|NCT03255629|12049262|FG001|COMPLETED|Overall Study|One participant was withdrawn due to not experiencing hypoglycemia during mixed meal testing.|7
10883399|NCT03255629|12049261|FG000|NOT COMPLETED|Overall Study||3
10883400|NCT03255629|12049262|FG001|NOT COMPLETED|Overall Study||1
10883401|NCT03255187|12049271|FG000|STARTED|Periodfrom Enrollment to First Follow-up||35
10883402|NCT03255187|12049272|FG001|STARTED|Periodfrom Enrollment to First Follow-up||35
10883403|NCT03255187|12049271|FG000|COMPLETED|Periodfrom Enrollment to First Follow-up||34
10883404|NCT03255187|12049272|FG001|COMPLETED|Periodfrom Enrollment to First Follow-up||32
10883405|NCT03255187|12049271|FG000|NOT COMPLETED|Periodfrom Enrollment to First Follow-up||1
10883406|NCT03255187|12049272|FG001|NOT COMPLETED|Periodfrom Enrollment to First Follow-up||3
10883407|NCT03255187|12049271|FG000|STARTED|Period From First to Second Follow-up||34
10883408|NCT03255187|12049272|FG001|STARTED|Period From First to Second Follow-up||32
10883409|NCT03255187|12049271|FG000|COMPLETED|Period From First to Second Follow-up||34
10883410|NCT03255187|12049272|FG001|COMPLETED|Period From First to Second Follow-up||31
10883411|NCT03255187|12049271|FG000|NOT COMPLETED|Period From First to Second Follow-up||0
10883412|NCT03255187|12049272|FG001|NOT COMPLETED|Period From First to Second Follow-up||1
10883413|NCT03255187|12049271|FG000|STARTED|Period From Second to Third Follow-up||34
10883414|NCT03255187|12049272|FG001|STARTED|Period From Second to Third Follow-up||31
10883415|NCT03255187|12049271|FG000|COMPLETED|Period From Second to Third Follow-up||34
10883416|NCT03255187|12049272|FG001|COMPLETED|Period From Second to Third Follow-up||31
10883417|NCT03255187|12049271|FG000|NOT COMPLETED|Period From Second to Third Follow-up||0
10883418|NCT03255187|12049272|FG001|NOT COMPLETED|Period From Second to Third Follow-up||0
10883419|NCT03255187|12049271|FG000|STARTED|Period From Third to Fourth Follow-up||34
10883420|NCT03255187|12049272|FG001|STARTED|Period From Third to Fourth Follow-up||31
10883421|NCT03255187|12049271|FG000|COMPLETED|Period From Third to Fourth Follow-up||34
10883422|NCT03255187|12049272|FG001|COMPLETED|Period From Third to Fourth Follow-up||31
10883423|NCT03255187|12049271|FG000|NOT COMPLETED|Period From Third to Fourth Follow-up||0
10883424|NCT03255187|12049272|FG001|NOT COMPLETED|Period From Third to Fourth Follow-up||0
10883425|NCT03255187|12049271|FG000|STARTED|Period at Fourth Follow-up||34
10883426|NCT03255187|12049272|FG001|STARTED|Period at Fourth Follow-up||31
10883427|NCT03255187|12049271|FG000|COMPLETED|Period at Fourth Follow-up||34
10883428|NCT03255187|12049272|FG001|COMPLETED|Period at Fourth Follow-up||31
10883429|NCT03255187|12049271|FG000|NOT COMPLETED|Period at Fourth Follow-up||0
10883430|NCT03255187|12049272|FG001|NOT COMPLETED|Period at Fourth Follow-up||0
10883431|NCT03254485|12049282|FG000|STARTED|Overall Study||90
10883432|NCT03254485|12049283|FG001|STARTED|Overall Study||7
10883433|NCT03254485|12049284|FG002|STARTED|Overall Study||7
10883434|NCT03254485|12049285|FG003|STARTED|Overall Study||92
10883435|NCT03254485|12049282|FG000|COMPLETED|Overall Study||78
10883436|NCT03254485|12049283|FG001|COMPLETED|Overall Study||7
10883437|NCT03254485|12049284|FG002|COMPLETED|Overall Study||7
10883438|NCT03254485|12049285|FG003|COMPLETED|Overall Study||77
10883439|NCT03254485|12049282|FG000|NOT COMPLETED|Overall Study||12
10883440|NCT03254485|12049283|FG001|NOT COMPLETED|Overall Study||0
10883441|NCT03254485|12049284|FG002|NOT COMPLETED|Overall Study||0
10883442|NCT03254485|12049285|FG003|NOT COMPLETED|Overall Study||15
10883443|NCT03253796|12049301|FG000|STARTED|Period 1: Run-In||323
10883444|NCT03253796|12049302|FG001|STARTED|Period 1: Run-In||0
10883445|NCT03253796|12049303|FG002|STARTED|Period 1: Run-In||0
10883446|NCT03253796|12049304|FG003|STARTED|Period 1: Run-In||0
10883447|NCT03253796|12049305|FG004|STARTED|Period 1: Run-In||0
10883448|NCT03253796|12049301|FG000|COMPLETED|Period 1: Run-In||207
10883449|NCT03253796|12049302|FG001|COMPLETED|Period 1: Run-In||0
10883450|NCT03253796|12049303|FG002|COMPLETED|Period 1: Run-In||0
10883451|NCT03253796|12049304|FG003|COMPLETED|Period 1: Run-In||0
10883452|NCT03253796|12049305|FG004|COMPLETED|Period 1: Run-In||0
10883453|NCT03253796|12049301|FG000|NOT COMPLETED|Period 1: Run-In||116
10883454|NCT03253796|12049302|FG001|NOT COMPLETED|Period 1: Run-In||0
10883455|NCT03253796|12049303|FG002|NOT COMPLETED|Period 1: Run-In||0
10883456|NCT03253796|12049304|FG003|NOT COMPLETED|Period 1: Run-In||0
10883457|NCT03253796|12049305|FG004|NOT COMPLETED|Period 1: Run-In||0
10883458|NCT03253796|12049301|FG000|STARTED|Period 2: Withdrawal vs Continued Tx||0
10883459|NCT03253796|12049302|FG001|STARTED|Period 2: Withdrawal vs Continued Tx||63
10883460|NCT03253796|12049303|FG002|STARTED|Period 2: Withdrawal vs Continued Tx||64
10883461|NCT03253796|12049304|FG003|STARTED|Period 2: Withdrawal vs Continued Tx||62
10883462|NCT03253796|12049305|FG004|STARTED|Period 2: Withdrawal vs Continued Tx||0
10883463|NCT03253796|12049301|FG000|COMPLETED|Period 2: Withdrawal vs Continued Tx||0
10883464|NCT03253796|12049302|FG001|COMPLETED|Period 2: Withdrawal vs Continued Tx||53
10883465|NCT03253796|12049303|FG002|COMPLETED|Period 2: Withdrawal vs Continued Tx||43
10883466|NCT03253796|12049304|FG003|COMPLETED|Period 2: Withdrawal vs Continued Tx||21
10883467|NCT03253796|12049305|FG004|COMPLETED|Period 2: Withdrawal vs Continued Tx||0
10883468|NCT03253796|12049301|FG000|NOT COMPLETED|Period 2: Withdrawal vs Continued Tx||0
10883469|NCT03253796|12049302|FG001|NOT COMPLETED|Period 2: Withdrawal vs Continued Tx||10
10883470|NCT03253796|12049303|FG002|NOT COMPLETED|Period 2: Withdrawal vs Continued Tx||21
10883471|NCT03253796|12049304|FG003|NOT COMPLETED|Period 2: Withdrawal vs Continued Tx||41
10883472|NCT03253796|12049305|FG004|NOT COMPLETED|Period 2: Withdrawal vs Continued Tx||0
10883473|NCT03253796|12049301|FG000|STARTED|Period 2: Open-Label Retreatment||0
10883474|NCT03253796|12049302|FG001|STARTED|Period 2: Open-Label Retreatment||0
10883477|NCT03253796|12049305|FG004|STARTED|Period 2: Open-Label Retreatment||63
10883478|NCT03253796|12049301|FG000|COMPLETED|Period 2: Open-Label Retreatment||0
10883479|NCT03253796|12049302|FG001|COMPLETED|Period 2: Open-Label Retreatment||0
10883480|NCT03253796|12049303|FG002|COMPLETED|Period 2: Open-Label Retreatment||0
10883481|NCT03253796|12049304|FG003|COMPLETED|Period 2: Open-Label Retreatment||0
10883482|NCT03253796|12049305|FG004|COMPLETED|Period 2: Open-Label Retreatment||58
10883483|NCT03253796|12049301|FG000|NOT COMPLETED|Period 2: Open-Label Retreatment||0
10883484|NCT03253796|12049302|FG001|NOT COMPLETED|Period 2: Open-Label Retreatment||0
10883485|NCT03253796|12049303|FG002|NOT COMPLETED|Period 2: Open-Label Retreatment||0
10883486|NCT03253796|12049304|FG003|NOT COMPLETED|Period 2: Open-Label Retreatment||0
10883487|NCT03253796|12049305|FG004|NOT COMPLETED|Period 2: Open-Label Retreatment||5
10883488|NCT03252587|12049324|FG000|STARTED|Overall Study||90
10883489|NCT03252587|12049325|FG001|STARTED|Overall Study||91
10883490|NCT03252587|12049326|FG002|STARTED|Overall Study||93
10883491|NCT03252587|12049327|FG003|STARTED|Overall Study||89
10883492|NCT03252587|12049324|FG000|COMPLETED|Overall Study||66
10883493|NCT03252587|12049325|FG001|COMPLETED|Overall Study||71
10883494|NCT03252587|12049326|FG002|COMPLETED|Overall Study||76
10883495|NCT03252587|12049327|FG003|COMPLETED|Overall Study||62
10883496|NCT03252587|12049324|FG000|NOT COMPLETED|Overall Study||24
10883497|NCT03252587|12049325|FG001|NOT COMPLETED|Overall Study||20
10883498|NCT03252587|12049326|FG002|NOT COMPLETED|Overall Study||17
10883499|NCT03252587|12049327|FG003|NOT COMPLETED|Overall Study||27
10883500|NCT03250273|12049342|FG000|STARTED|Overall Study||13
10883501|NCT03250273|12049343|FG001|STARTED|Overall Study||30
10883502|NCT03250273|12049342|FG000|COMPLETED|Overall Study||11
10883503|NCT03250273|12049343|FG001|COMPLETED|Overall Study||18
10883504|NCT03250273|12049342|FG000|NOT COMPLETED|Overall Study||2
10883505|NCT03250273|12049343|FG001|NOT COMPLETED|Overall Study||12
10883506|NCT03249103|12049349|FG000|STARTED|Overall Study||22
10883507|NCT03249103|12049349|FG000|COMPLETED|Overall Study||20
10883508|NCT03249103|12049349|FG000|NOT COMPLETED|Overall Study||2
10883509|NCT03246061|12049355|FG000|STARTED|Overall Study||66
10883510|NCT03246061|12049356|FG001|STARTED|Overall Study||74
10883511|NCT03246061|12049355|FG000|Interim Analysis|Overall Study||51
10883512|NCT03246061|12049356|FG001|Interim Analysis|Overall Study||53
10883513|NCT03246061|12049355|FG000|COMPLETED|Overall Study||51
10883514|NCT03246061|12049356|FG001|COMPLETED|Overall Study||53
10883515|NCT03246061|12049355|FG000|NOT COMPLETED|Overall Study||15
10883516|NCT03246061|12049356|FG001|NOT COMPLETED|Overall Study||21
10883517|NCT03241173|12049375|FG000|STARTED|Overall Study||4
10883518|NCT03241173|12049376|FG001|STARTED|Overall Study||4
10883519|NCT03241173|12049377|FG002|STARTED|Overall Study||5
10883520|NCT03241173|12049378|FG003|STARTED|Overall Study||5
10883521|NCT03241173|12049379|FG004|STARTED|Overall Study||4
10883522|NCT03241173|12049380|FG005|STARTED|Overall Study||5
10883523|NCT03241173|12049381|FG006|STARTED|Overall Study||4
10883524|NCT03241173|12049382|FG007|STARTED|Overall Study||3
10883525|NCT03241173|12049383|FG008|STARTED|Overall Study|This treatment group did not open for enrollment.|0
10883526|NCT03241173|12049384|FG009|STARTED|Overall Study||6
10883527|NCT03241173|12049385|FG010|STARTED|Overall Study||6
10883528|NCT03241173|12049386|FG011|STARTED|Overall Study||6
10883529|NCT03241173|12049387|FG012|STARTED|Overall Study|This treatment group did not open for enrollment.|0
10883530|NCT03241173|12049388|FG013|STARTED|Overall Study|Phase 2 of the study did not open for enrollment.|0
10883531|NCT03241173|12049389|FG014|STARTED|Overall Study|Phase 2 of the study did not open for enrollment.|0
10883532|NCT03241173|12049375|FG000|COMPLETED|Overall Study||0
10883533|NCT03241173|12049376|FG001|COMPLETED|Overall Study||0
10883534|NCT03241173|12049377|FG002|COMPLETED|Overall Study||0
10883535|NCT03241173|12049378|FG003|COMPLETED|Overall Study||0
10883536|NCT03241173|12049379|FG004|COMPLETED|Overall Study||0
10883537|NCT03241173|12049380|FG005|COMPLETED|Overall Study||0
10883538|NCT03241173|12049381|FG006|COMPLETED|Overall Study||0
10883539|NCT03241173|12049382|FG007|COMPLETED|Overall Study||0
10883540|NCT03241173|12049383|FG008|COMPLETED|Overall Study||0
10883541|NCT03241173|12049384|FG009|COMPLETED|Overall Study||0
10883542|NCT03241173|12049385|FG010|COMPLETED|Overall Study||0
10883543|NCT03241173|12049386|FG011|COMPLETED|Overall Study||0
10883544|NCT03241173|12049387|FG012|COMPLETED|Overall Study||0
10883545|NCT03241173|12049388|FG013|COMPLETED|Overall Study||0
10883546|NCT03241173|12049389|FG014|COMPLETED|Overall Study||0
10883547|NCT03241173|12049375|FG000|NOT COMPLETED|Overall Study||4
10883548|NCT03241173|12049376|FG001|NOT COMPLETED|Overall Study||4
10883549|NCT03241173|12049377|FG002|NOT COMPLETED|Overall Study||5
10883550|NCT03241173|12049378|FG003|NOT COMPLETED|Overall Study||5
10883551|NCT03241173|12049379|FG004|NOT COMPLETED|Overall Study||4
10883552|NCT03241173|12049380|FG005|NOT COMPLETED|Overall Study||5
10883553|NCT03241173|12049381|FG006|NOT COMPLETED|Overall Study||4
10883554|NCT03241173|12049382|FG007|NOT COMPLETED|Overall Study||3
10883555|NCT03241173|12049383|FG008|NOT COMPLETED|Overall Study||0
10883556|NCT03241173|12049384|FG009|NOT COMPLETED|Overall Study||6
10883557|NCT03241173|12049385|FG010|NOT COMPLETED|Overall Study||6
10883558|NCT03241173|12049386|FG011|NOT COMPLETED|Overall Study||6
10883559|NCT03241173|12049387|FG012|NOT COMPLETED|Overall Study||0
10883560|NCT03241173|12049388|FG013|NOT COMPLETED|Overall Study||0
10883561|NCT03241173|12049389|FG014|NOT COMPLETED|Overall Study||0
10883562|NCT03237325|12049419|FG000|STARTED|Overall Study||127
10883563|NCT03237325|12049420|FG001|STARTED|Overall Study||139
10883564|NCT03237325|12049419|FG000|COMPLETED|Overall Study||112
10883565|NCT03237325|12049420|FG001|COMPLETED|Overall Study||114
10883566|NCT03237325|12049419|FG000|NOT COMPLETED|Overall Study||15
10883567|NCT03237325|12049420|FG001|NOT COMPLETED|Overall Study||25
10883568|NCT03234907|12049428|FG000|STARTED|Induction Phase (Week 0 to Week 10)||71
10883569|NCT03234907|12049429|FG001|STARTED|Induction Phase (Week 0 to Week 10)||144
10883570|NCT03234907|12049430|FG002|STARTED|Induction Phase (Week 0 to Week 10)||0
10883571|NCT03234907|12049431|FG003|STARTED|Induction Phase (Week 0 to Week 10)||0
10883572|NCT03234907|12049432|FG004|STARTED|Induction Phase (Week 0 to Week 10)||0
10883573|NCT03234907|12049433|FG005|STARTED|Induction Phase (Week 0 to Week 10)||0
10883574|NCT03234907|12049428|FG000|Treated|Induction Phase (Week 0 to Week 10)||70
10883575|NCT03234907|12049429|FG001|Treated|Induction Phase (Week 0 to Week 10)||144
10883576|NCT03234907|12049430|FG002|Treated|Induction Phase (Week 0 to Week 10)||0
10883577|NCT03234907|12049431|FG003|Treated|Induction Phase (Week 0 to Week 10)||0
10883578|NCT03234907|12049432|FG004|Treated|Induction Phase (Week 0 to Week 10)||0
10883579|NCT03234907|12049433|FG005|Treated|Induction Phase (Week 0 to Week 10)||0
10883580|NCT03234907|12049428|FG000|COMPLETED|Induction Phase (Week 0 to Week 10)||61
10883581|NCT03234907|12049429|FG001|COMPLETED|Induction Phase (Week 0 to Week 10)||138
10883582|NCT03234907|12049430|FG002|COMPLETED|Induction Phase (Week 0 to Week 10)||0
10883583|NCT03234907|12049431|FG003|COMPLETED|Induction Phase (Week 0 to Week 10)||0
10883584|NCT03234907|12049432|FG004|COMPLETED|Induction Phase (Week 0 to Week 10)||0
10883585|NCT03234907|12049433|FG005|COMPLETED|Induction Phase (Week 0 to Week 10)||0
10883586|NCT03234907|12049428|FG000|NOT COMPLETED|Induction Phase (Week 0 to Week 10)||10
10883587|NCT03234907|12049429|FG001|NOT COMPLETED|Induction Phase (Week 0 to Week 10)||6
10883588|NCT03234907|12049430|FG002|NOT COMPLETED|Induction Phase (Week 0 to Week 10)||0
10883589|NCT03234907|12049431|FG003|NOT COMPLETED|Induction Phase (Week 0 to Week 10)||0
10883590|NCT03234907|12049432|FG004|NOT COMPLETED|Induction Phase (Week 0 to Week 10)||0
10883591|NCT03234907|12049433|FG005|NOT COMPLETED|Induction Phase (Week 0 to Week 10)||0
10883592|NCT03234907|12049428|FG000|STARTED|Maintenance Phase (Week 10 to Week 60)||0
10883593|NCT03234907|12049429|FG001|STARTED|Maintenance Phase (Week 10 to Week 60)||0
10883594|NCT03234907|12049430|FG002|STARTED|Maintenance Phase (Week 10 to Week 60)||18
10883595|NCT03234907|12049431|FG003|STARTED|Maintenance Phase (Week 10 to Week 60)||38
10883596|NCT03234907|12049432|FG004|STARTED|Maintenance Phase (Week 10 to Week 60)||46
10883597|NCT03234907|12049433|FG005|STARTED|Maintenance Phase (Week 10 to Week 60)||88
10883598|NCT03234907|12049428|FG000|COMPLETED|Maintenance Phase (Week 10 to Week 60)||0
10883599|NCT03234907|12049429|FG001|COMPLETED|Maintenance Phase (Week 10 to Week 60)||0
10883600|NCT03234907|12049430|FG002|COMPLETED|Maintenance Phase (Week 10 to Week 60)||17
10883601|NCT03234907|12049431|FG003|COMPLETED|Maintenance Phase (Week 10 to Week 60)||27
10883602|NCT03234907|12049432|FG004|COMPLETED|Maintenance Phase (Week 10 to Week 60)||36
10883603|NCT03234907|12049433|FG005|COMPLETED|Maintenance Phase (Week 10 to Week 60)||67
10883604|NCT03234907|12049428|FG000|NOT COMPLETED|Maintenance Phase (Week 10 to Week 60)||0
10883605|NCT03234907|12049429|FG001|NOT COMPLETED|Maintenance Phase (Week 10 to Week 60)||0
10883606|NCT03234907|12049430|FG002|NOT COMPLETED|Maintenance Phase (Week 10 to Week 60)||1
10883607|NCT03234907|12049431|FG003|NOT COMPLETED|Maintenance Phase (Week 10 to Week 60)||11
10883608|NCT03234907|12049432|FG004|NOT COMPLETED|Maintenance Phase (Week 10 to Week 60)||10
10883609|NCT03234907|12049433|FG005|NOT COMPLETED|Maintenance Phase (Week 10 to Week 60)||21
10883610|NCT03230877|12049443|FG000|STARTED|Visit 1||23
10883611|NCT03230877|12049444|FG001|STARTED|Visit 1||15
10883612|NCT03230877|12049443|FG000|COMPLETED|Visit 1||23
10883613|NCT03230877|12049444|FG001|COMPLETED|Visit 1||15
10883614|NCT03230877|12049443|FG000|NOT COMPLETED|Visit 1||0
10883615|NCT03230877|12049444|FG001|NOT COMPLETED|Visit 1||0
10883616|NCT03230877|12049443|FG000|STARTED|Visit 2||23
10883617|NCT03230877|12049444|FG001|STARTED|Visit 2||15
10883618|NCT03230877|12049443|FG000|COMPLETED|Visit 2||23
10883619|NCT03230877|12049444|FG001|COMPLETED|Visit 2||15
10883620|NCT03230877|12049443|FG000|NOT COMPLETED|Visit 2||0
10883621|NCT03230877|12049444|FG001|NOT COMPLETED|Visit 2||0
10883622|NCT03221842|12049453|FG000|STARTED|Period 1 (Open-label)||63
10883623|NCT03221842|12049454|FG001|STARTED|Period 1 (Open-label)||0
10883624|NCT03221842|12049453|FG000|COMPLETED|Period 1 (Open-label)||53
10883625|NCT03221842|12049454|FG001|COMPLETED|Period 1 (Open-label)||0
10883626|NCT03221842|12049453|FG000|NOT COMPLETED|Period 1 (Open-label)||10
10883627|NCT03221842|12049454|FG001|NOT COMPLETED|Period 1 (Open-label)||0
10883628|NCT03221842|12049453|FG000|STARTED|Period 2 (Randomized, Blinded)||7
10883629|NCT03221842|12049454|FG001|STARTED|Period 2 (Randomized, Blinded)||6
10883630|NCT03221842|12049453|FG000|COMPLETED|Period 2 (Randomized, Blinded)||6
10883631|NCT03221842|12049454|FG001|COMPLETED|Period 2 (Randomized, Blinded)||5
10883632|NCT03221842|12049453|FG000|NOT COMPLETED|Period 2 (Randomized, Blinded)||1
10883633|NCT03221842|12049454|FG001|NOT COMPLETED|Period 2 (Randomized, Blinded)||1
10883634|NCT03217591|12049467|FG000|STARTED|Overall Study||54
10883635|NCT03217591|12049468|FG001|STARTED|Overall Study||50
10883636|NCT03217591|12049469|FG002|STARTED|Overall Study||52
10883637|NCT03217591|12049467|FG000|COMPLETED|Overall Study||51
10883638|NCT03217591|12049468|FG001|COMPLETED|Overall Study||47
10883639|NCT03217591|12049469|FG002|COMPLETED|Overall Study||42
10883640|NCT03217591|12049467|FG000|NOT COMPLETED|Overall Study||3
10883641|NCT03217591|12049468|FG001|NOT COMPLETED|Overall Study||3
10883642|NCT03217591|12049469|FG002|NOT COMPLETED|Overall Study||10
10883643|NCT03214250|12049485|FG000|STARTED|Overall Study||7
10883644|NCT03214250|12049486|FG001|STARTED|Overall Study||7
10883645|NCT03214250|12049487|FG002|STARTED|Overall Study||8
10883646|NCT03214250|12049488|FG003|STARTED|Overall Study||8
10883647|NCT03214250|12049489|FG004|STARTED|Overall Study||37
10883648|NCT03214250|12049490|FG005|STARTED|Overall Study||31
10883649|NCT03214250|12049491|FG006|STARTED|Overall Study||31
10883650|NCT03214250|12049485|FG000|COMPLETED|Overall Study||0
10883651|NCT03214250|12049486|FG001|COMPLETED|Overall Study||0
10883652|NCT03214250|12049487|FG002|COMPLETED|Overall Study||0
10883653|NCT03214250|12049488|FG003|COMPLETED|Overall Study||0
10883654|NCT03214250|12049489|FG004|COMPLETED|Overall Study||0
10883655|NCT03214250|12049490|FG005|COMPLETED|Overall Study||0
10883656|NCT03214250|12049491|FG006|COMPLETED|Overall Study||0
10883657|NCT03214250|12049485|FG000|NOT COMPLETED|Overall Study||7
10883658|NCT03214250|12049486|FG001|NOT COMPLETED|Overall Study||7
10883659|NCT03214250|12049487|FG002|NOT COMPLETED|Overall Study||8
10883660|NCT03214250|12049488|FG003|NOT COMPLETED|Overall Study||8
10883661|NCT03214250|12049489|FG004|NOT COMPLETED|Overall Study||37
10883662|NCT03214250|12049490|FG005|NOT COMPLETED|Overall Study||31
10883663|NCT03214250|12049491|FG006|NOT COMPLETED|Overall Study||31
10883664|NCT03213938|12049513|FG000|STARTED|Overall Study||220
10883665|NCT03213938|12049514|FG001|STARTED|Overall Study||220
10883666|NCT03213938|12049513|FG000|COMPLETED|Overall Study||206
10883667|NCT03213938|12049514|FG001|COMPLETED|Overall Study||208
10883668|NCT03213938|12049513|FG000|NOT COMPLETED|Overall Study||14
10883669|NCT03213938|12049514|FG001|NOT COMPLETED|Overall Study||12
10883670|NCT03208127|12049520|FG000|STARTED|Overall Study||24
10883671|NCT03208127|12049520|FG000|COMPLETED|Overall Study||23
10883672|NCT03208127|12049520|FG000|NOT COMPLETED|Overall Study||1
10883673|NCT03207451|12049528|FG000|STARTED|Overall Study||21
10883674|NCT03207451|12049529|FG001|STARTED|Overall Study||8
10883675|NCT03207451|12049530|FG002|STARTED|Overall Study||29
10883676|NCT03207451|12049531|FG003|STARTED|Overall Study||23
10883677|NCT03207451|12049528|FG000|COMPLETED|Overall Study|Scheduling conflict|20
10883678|NCT03207451|12049529|FG001|COMPLETED|Overall Study||8
10883679|NCT03207451|12049530|FG002|COMPLETED|Overall Study|Patients had scheduling issues|27
10883680|NCT03207451|12049531|FG003|COMPLETED|Overall Study|Minor bleeding and scheduling conflicts|20
10883681|NCT03207451|12049528|FG000|NOT COMPLETED|Overall Study||1
10883682|NCT03207451|12049529|FG001|NOT COMPLETED|Overall Study||0
10883683|NCT03207451|12049530|FG002|NOT COMPLETED|Overall Study||2
10883684|NCT03207451|12049531|FG003|NOT COMPLETED|Overall Study||3
10883685|NCT03201965|12049544|FG000|STARTED|Overall Study||28
10883686|NCT03201965|12049545|FG001|STARTED|Overall Study||193
10883687|NCT03201965|12049546|FG002|STARTED|Overall Study||195
10883688|NCT03201965|12049544|FG000|Treated|Overall Study||28
10883689|NCT03201965|12049545|FG001|Treated|Overall Study||188
10883690|NCT03201965|12049546|FG002|Treated|Overall Study||193
10883691|NCT03201965|12049544|FG000|COMPLETED|Overall Study||0
10883692|NCT03201965|12049545|FG001|COMPLETED|Overall Study||0
10883693|NCT03201965|12049546|FG002|COMPLETED|Overall Study||0
10883694|NCT03201965|12049544|FG000|NOT COMPLETED|Overall Study||28
10883695|NCT03201965|12049545|FG001|NOT COMPLETED|Overall Study||193
10883696|NCT03201965|12049546|FG002|NOT COMPLETED|Overall Study||195
10883697|NCT03201562|12049556|FG000|STARTED|Overall Study||18
10883698|NCT03201562|12049557|FG001|STARTED|Overall Study||20
10883699|NCT03201562|12049558|FG002|STARTED|Overall Study||20
10883700|NCT03201562|12049556|FG000|COMPLETED|Overall Study||18
10883701|NCT03201562|12049557|FG001|COMPLETED|Overall Study||19
10883702|NCT03201562|12049558|FG002|COMPLETED|Overall Study||16
10883703|NCT03201562|12049556|FG000|NOT COMPLETED|Overall Study||0
10883704|NCT03201562|12049557|FG001|NOT COMPLETED|Overall Study||1
10883705|NCT03201562|12049558|FG002|NOT COMPLETED|Overall Study||4
10883706|NCT03197935|12049568|FG000|STARTED|Overall Study||168
10883707|NCT03197935|12049569|FG001|STARTED|Overall Study||165
10883708|NCT03197935|12049568|FG000|COMPLETED|Overall Study||0
10883709|NCT03197935|12049569|FG001|COMPLETED|Overall Study||0
10883710|NCT03197935|12049568|FG000|NOT COMPLETED|Overall Study||168
10883711|NCT03197935|12049569|FG001|NOT COMPLETED|Overall Study||165
10883712|NCT03194646|12049580|FG000|STARTED|Overall Study||363
10883713|NCT03194646|12049581|FG001|STARTED|Overall Study||361
10883714|NCT03194646|12049582|FG002|STARTED|Overall Study||183
10883715|NCT03194646|12049583|FG003|STARTED|Overall Study||365
10883716|NCT03194646|12049580|FG000|Treated|Overall Study||349
10883717|NCT03194646|12049581|FG001|Treated|Overall Study||347
10883718|NCT03194646|12049582|FG002|Treated|Overall Study||177
10883719|NCT03194646|12049583|FG003|Treated|Overall Study||365
10883720|NCT03194646|12049580|FG000|COMPLETED|Overall Study||61
10883721|NCT03194646|12049581|FG001|COMPLETED|Overall Study||93
10883722|NCT03194646|12049582|FG002|COMPLETED|Overall Study||44
10883723|NCT03194646|12049583|FG003|COMPLETED|Overall Study||85
10883724|NCT03194646|12049580|FG000|NOT COMPLETED|Overall Study||302
10883725|NCT03194646|12049581|FG001|NOT COMPLETED|Overall Study||268
10883726|NCT03194646|12049582|FG002|NOT COMPLETED|Overall Study||139
10883727|NCT03194646|12049583|FG003|NOT COMPLETED|Overall Study||280
10883728|NCT03192358|12049600|FG000|STARTED|Overall Study||20
10883729|NCT03192358|12049601|FG001|STARTED|Overall Study||20
10883730|NCT03192358|12049600|FG000|COMPLETED|Overall Study||20
10883731|NCT03192358|12049601|FG001|COMPLETED|Overall Study||20
10883732|NCT03192358|12049600|FG000|NOT COMPLETED|Overall Study||0
10883733|NCT03192358|12049601|FG001|NOT COMPLETED|Overall Study||0
10883734|NCT03185949|12049621|FG000|STARTED|ITT Analysis||22
10883735|NCT03185949|12049622|FG001|STARTED|ITT Analysis||22
10883736|NCT03185949|12049621|FG000|COMPLETED|ITT Analysis||18
10883737|NCT03185949|12049622|FG001|COMPLETED|ITT Analysis||19
10883738|NCT03185949|12049621|FG000|NOT COMPLETED|ITT Analysis||4
10883739|NCT03185949|12049622|FG001|NOT COMPLETED|ITT Analysis||3
10883740|NCT03185949|12049621|FG000|STARTED|PP Analysis||18
10883741|NCT03185949|12049622|FG001|STARTED|PP Analysis||19
10883742|NCT03185949|12049621|FG000|COMPLETED|PP Analysis||16
10883743|NCT03185949|12049622|FG001|COMPLETED|PP Analysis||15
10883744|NCT03185949|12049621|FG000|NOT COMPLETED|PP Analysis||2
10883745|NCT03185949|12049622|FG001|NOT COMPLETED|PP Analysis||4
10883746|NCT03185949|12049621|FG000|STARTED|Cross-over at 6 Months||16
10883747|NCT03185949|12049622|FG001|STARTED|Cross-over at 6 Months||0
10883748|NCT03185949|12049621|FG000|COMPLETED|Cross-over at 6 Months||15
10883749|NCT03185949|12049622|FG001|COMPLETED|Cross-over at 6 Months||0
10883750|NCT03185949|12049621|FG000|NOT COMPLETED|Cross-over at 6 Months||1
10883751|NCT03185949|12049622|FG001|NOT COMPLETED|Cross-over at 6 Months||0
10883752|NCT03182686|12049632|FG000|STARTED|Overall Study||144
10883753|NCT03182686|12049633|FG001|STARTED|Overall Study||24
10883754|NCT03182686|12049632|FG000|COMPLETED|Overall Study||137
10883755|NCT03182686|12049633|FG001|COMPLETED|Overall Study||24
10883756|NCT03182686|12049632|FG000|NOT COMPLETED|Overall Study||7
10883757|NCT03182686|12049633|FG001|NOT COMPLETED|Overall Study||0
10883758|NCT03179995|12049641|FG000|STARTED|Overall Study||20
10883759|NCT03179995|12049642|FG001|STARTED|Overall Study||4
10883760|NCT03179995|12049641|FG000|COMPLETED|Overall Study||4
10883761|NCT03179995|12049642|FG001|COMPLETED|Overall Study||1
10883762|NCT03179995|12049641|FG000|NOT COMPLETED|Overall Study||16
10883763|NCT03179995|12049642|FG001|NOT COMPLETED|Overall Study||3
10883764|NCT03179202|12049648|FG000|STARTED|Overall Study||166
10883765|NCT03179202|12049648|FG000|Enrolled/Received Leads|Overall Study||99
10883766|NCT03179202|12049648|FG000|Protocol Population|Overall Study||91
10883767|NCT03179202|12049648|FG000|COMPLETED|Overall Study||75
10883768|NCT03179202|12049648|FG000|NOT COMPLETED|Overall Study||91
10883769|NCT03175549|12049656|FG000|STARTED|Overall Study||26
10883770|NCT03175549|12049657|FG001|STARTED|Overall Study||25
10883771|NCT03175549|12049656|FG000|COMPLETED|Overall Study||22
10883772|NCT03175549|12049657|FG001|COMPLETED|Overall Study||21
10883773|NCT03175549|12049656|FG000|NOT COMPLETED|Overall Study||4
10883774|NCT03175549|12049657|FG001|NOT COMPLETED|Overall Study||4
10883775|NCT03174132|12049665|FG000|STARTED|Overall Study||70
10883776|NCT03174132|12049665|FG000|COMPLETED|Overall Study||70
10883777|NCT03174132|12049665|FG000|NOT COMPLETED|Overall Study||0
10883778|NCT03170349|12049669|FG000|STARTED|At 30 Days Follow-up||124
10883779|NCT03170349|12049669|FG000|COMPLETED|At 30 Days Follow-up||123
10883780|NCT03170349|12049669|FG000|NOT COMPLETED|At 30 Days Follow-up||1
10883781|NCT03170349|12049669|FG000|STARTED|At 6 Months Follow-up||123
10883782|NCT03170349|12049669|FG000|COMPLETED|At 6 Months Follow-up||114
10883783|NCT03170349|12049669|FG000|NOT COMPLETED|At 6 Months Follow-up||9
10883784|NCT03170349|12049669|FG000|STARTED|At 1 Year Follow-up||114
10883785|NCT03170349|12049669|FG000|COMPLETED|At 1 Year Follow-up||106
10883786|NCT03170349|12049669|FG000|NOT COMPLETED|At 1 Year Follow-up||8
10883787|NCT03167619|12049675|FG000|STARTED|Overall Study||23
10883788|NCT03167619|12049676|FG001|STARTED|Overall Study||22
10883789|NCT03167619|12049675|FG000|COMPLETED|Overall Study||11
10883790|NCT03167619|12049676|FG001|COMPLETED|Overall Study||11
10883791|NCT03167619|12049675|FG000|NOT COMPLETED|Overall Study||12
10883792|NCT03167619|12049676|FG001|NOT COMPLETED|Overall Study||11
10883793|NCT03167099|12049684|FG000|STARTED|Overall Study||26
10883794|NCT03167099|12049685|FG001|STARTED|Overall Study||27
10883795|NCT03167099|12049684|FG000|COMPLETED|Overall Study||19
10883796|NCT03167099|12049685|FG001|COMPLETED|Overall Study||19
10883797|NCT03167099|12049684|FG000|NOT COMPLETED|Overall Study||7
10883798|NCT03167099|12049685|FG001|NOT COMPLETED|Overall Study||8
10883799|NCT03164772|12049693|FG000|STARTED|Overall Study||23
10883800|NCT03164772|12049694|FG001|STARTED|Overall Study||34
10883801|NCT03164772|12049693|FG000|COMPLETED|Overall Study||5
10883802|NCT03164772|12049694|FG001|COMPLETED|Overall Study||3
10883803|NCT03164772|12049693|FG000|NOT COMPLETED|Overall Study||18
10883804|NCT03164772|12049694|FG001|NOT COMPLETED|Overall Study||31
10883805|NCT03164616|12049706|FG000|STARTED|Overall Study||338
10883806|NCT03164616|12049707|FG001|STARTED|Overall Study||338
10883807|NCT03164616|12049708|FG002|STARTED|Overall Study||337
10883808|NCT03164616|12049706|FG000|Received Treatment|Overall Study||331
10883809|NCT03164616|12049707|FG001|Received Treatment|Overall Study||335
10883810|NCT03164616|12049708|FG002|Received Treatment|Overall Study||331
10883811|NCT03164616|12049706|FG000|COMPLETED|Overall Study||80
10883812|NCT03164616|12049707|FG001|COMPLETED|Overall Study||65
10883813|NCT03164616|12049708|FG002|COMPLETED|Overall Study||40
10883814|NCT03164616|12049706|FG000|NOT COMPLETED|Overall Study||258
10883815|NCT03164616|12049707|FG001|NOT COMPLETED|Overall Study||273
10883816|NCT03164616|12049708|FG002|NOT COMPLETED|Overall Study||297
10883817|NCT03163992|12049718|FG000|STARTED|Overall Study||60
10883818|NCT03163992|12049718|FG000|COMPLETED|Overall Study||1
10883819|NCT03163992|12049718|FG000|NOT COMPLETED|Overall Study||59
10883820|NCT03163667|12049724|FG000|STARTED|Overall Study||23
10883821|NCT03163667|12049725|FG001|STARTED|Overall Study||46
10883822|NCT03163667|12049724|FG000|COMPLETED|Overall Study||0
10883823|NCT03163667|12049725|FG001|COMPLETED|Overall Study||0
10883824|NCT03163667|12049724|FG000|NOT COMPLETED|Overall Study||23
10883825|NCT03163667|12049725|FG001|NOT COMPLETED|Overall Study||46
10883826|NCT03162224|12049734|FG000|STARTED|Overall Study||15
10883827|NCT03162224|12049735|FG001|STARTED|Overall Study||9
10883828|NCT03162224|12049736|FG002|STARTED|Overall Study||11
10883829|NCT03162224|12049734|FG000|COMPLETED|Overall Study||4
10883830|NCT03162224|12049735|FG001|COMPLETED|Overall Study||1
10883831|NCT03162224|12049736|FG002|COMPLETED|Overall Study||1
10883832|NCT03162224|12049734|FG000|NOT COMPLETED|Overall Study||11
10883833|NCT03162224|12049735|FG001|NOT COMPLETED|Overall Study||8
10883834|NCT03162224|12049736|FG002|NOT COMPLETED|Overall Study||10
10883835|NCT03160716|12049744|FG000|STARTED|Overall Study||60
10883836|NCT03160716|12049744|FG000|COMPLETED|Overall Study||59
10883837|NCT03160716|12049744|FG000|NOT COMPLETED|Overall Study||1
10883838|NCT03158688|12049750|FG000|STARTED|Overall Study||154
10883839|NCT03158688|12049751|FG001|STARTED|Overall Study||312
10883840|NCT03158688|12049750|FG000|Treated|Overall Study||153
10883841|NCT03158688|12049751|FG001|Treated|Overall Study||308
10883842|NCT03158688|12049750|FG000|COMPLETED|Overall Study||0
10883843|NCT03158688|12049751|FG001|COMPLETED|Overall Study||0
10883844|NCT03158688|12049750|FG000|NOT COMPLETED|Overall Study||154
10883845|NCT03158688|12049751|FG001|NOT COMPLETED|Overall Study||312
10883846|NCT03153137|12049759|FG000|STARTED|Overall Study||69
10883847|NCT03153137|12049760|FG001|STARTED|Overall Study||68
10883848|NCT03153137|12049759|FG000|COMPLETED|Overall Study||66
10883849|NCT03153137|12049760|FG001|COMPLETED|Overall Study||64
10883850|NCT03153137|12049759|FG000|NOT COMPLETED|Overall Study||3
10883851|NCT03153137|12049760|FG001|NOT COMPLETED|Overall Study||4
10883852|NCT03151811|12049768|FG000|STARTED|Overall Study||246
10883853|NCT03151811|12049769|FG001|STARTED|Overall Study||249
10883854|NCT03151811|12049768|FG000|COMPLETED|Overall Study|At the time of data entry for primary outcome, there are still patients being treated with melflufen + dexamethasone in the study.|220
10883855|NCT03151811|12049769|FG001|COMPLETED|Overall Study|At the time of data entry for primary outcome, there are still patients being treated with pomalidomide + dexamethasone in the study.|231
10883856|NCT03151811|12049768|FG000|NOT COMPLETED|Overall Study||26
10883857|NCT03151811|12049769|FG001|NOT COMPLETED|Overall Study||18
10883858|NCT03150056|12049781|FG000|STARTED|Overall Study||10
10883859|NCT03150056|12049782|FG001|STARTED|Overall Study||6
10883860|NCT03150056|12049783|FG002|STARTED|Overall Study||4
10883861|NCT03150056|12049784|FG003|STARTED|Overall Study||10
10883862|NCT03150056|12049785|FG004|STARTED|Overall Study||22
10883863|NCT03150056|12049786|FG005|STARTED|Overall Study||21
10883864|NCT03150056|12049781|FG000|COMPLETED|Overall Study||0
10883865|NCT03150056|12049782|FG001|COMPLETED|Overall Study||1
10883866|NCT03150056|12049783|FG002|COMPLETED|Overall Study||1
10883867|NCT03150056|12049784|FG003|COMPLETED|Overall Study||2
10883868|NCT03150056|12049785|FG004|COMPLETED|Overall Study||9
10883869|NCT03150056|12049786|FG005|COMPLETED|Overall Study||3
10883870|NCT03150056|12049781|FG000|NOT COMPLETED|Overall Study||10
10883871|NCT03150056|12049782|FG001|NOT COMPLETED|Overall Study||5
10883872|NCT03150056|12049783|FG002|NOT COMPLETED|Overall Study||3
10883873|NCT03150056|12049784|FG003|NOT COMPLETED|Overall Study||8
10883874|NCT03150056|12049785|FG004|NOT COMPLETED|Overall Study||13
10883875|NCT03150056|12049786|FG005|NOT COMPLETED|Overall Study||18
10883876|NCT03148795|12049803|FG000|STARTED|Overall Study||128
10883877|NCT03148795|12049803|FG000|Treated|Overall Study||127
10883878|NCT03148795|12049803|FG000|COMPLETED|Overall Study||0
10883879|NCT03148795|12049803|FG000|NOT COMPLETED|Overall Study||128
10883880|NCT03144674|12049811|FG000|STARTED|Overall Study||4
10883881|NCT03144674|12049812|FG001|STARTED|Overall Study||6
10883882|NCT03144674|12049813|FG002|STARTED|Overall Study||28
10883883|NCT03144674|12049814|FG003|STARTED|Overall Study||72
10883884|NCT03144674|12049811|FG000|COMPLETED|Overall Study||0
10883885|NCT03144674|12049812|FG001|COMPLETED|Overall Study||0
10883886|NCT03144674|12049813|FG002|COMPLETED|Overall Study||0
10883887|NCT03144674|12049814|FG003|COMPLETED|Overall Study||0
10883888|NCT03144674|12049811|FG000|NOT COMPLETED|Overall Study||4
10883889|NCT03144674|12049812|FG001|NOT COMPLETED|Overall Study||6
10883890|NCT03144674|12049813|FG002|NOT COMPLETED|Overall Study||28
10883891|NCT03144674|12049814|FG003|NOT COMPLETED|Overall Study||72
10883892|NCT03141177|12049832|FG000|STARTED|Overall Study||323
10883893|NCT03141177|12049833|FG001|STARTED|Overall Study||50
10883894|NCT03141177|12049834|FG002|STARTED|Overall Study||328
10883895|NCT03141177|12049832|FG000|Treated|Overall Study||320
10883896|NCT03141177|12049833|FG001|Treated|Overall Study||50
10883897|NCT03141177|12049834|FG002|Treated|Overall Study||320
10883898|NCT03141177|12049832|FG000|COMPLETED|Overall Study||242
10883899|NCT03141177|12049833|FG001|COMPLETED|Overall Study||34
10883900|NCT03141177|12049834|FG002|COMPLETED|Overall Study||210
10883901|NCT03141177|12049832|FG000|NOT COMPLETED|Overall Study||81
10883902|NCT03141177|12049833|FG001|NOT COMPLETED|Overall Study||16
10883903|NCT03141177|12049834|FG002|NOT COMPLETED|Overall Study||118
10883904|NCT03132805|12049846|FG000|STARTED|Overall Study||1629
10883905|NCT03132805|12049847|FG001|STARTED|Overall Study||1792
10883906|NCT03132805|12049848|FG002|STARTED|Overall Study||1812
10883907|NCT03132805|12049846|FG000|Students|Overall Study||1527
10883908|NCT03132805|12049847|FG001|Students|Overall Study||1694
10883909|NCT03132805|12049848|FG002|Students|Overall Study||1702
10883910|NCT03132805|12049846|FG000|Teachers|Overall Study||102
10883911|NCT03132805|12049847|FG001|Teachers|Overall Study||98
10883912|NCT03132805|12049848|FG002|Teachers|Overall Study||110
10883913|NCT03132805|12049846|FG000|Baseline Data Collection (Students)|Overall Study||1442
10883914|NCT03132805|12049847|FG001|Baseline Data Collection (Students)|Overall Study||1603
10883915|NCT03132805|12049848|FG002|Baseline Data Collection (Students)|Overall Study||1617
10883916|NCT03132805|12049846|FG000|Post-test Data Collection (Students)|Overall Study||1395
10883917|NCT03132805|12049847|FG001|Post-test Data Collection (Students)|Overall Study||1564
10883918|NCT03132805|12049848|FG002|Post-test Data Collection (Students)|Overall Study||1609
10883919|NCT03132805|12049846|FG000|Baseline Data Collection (Teachers)|Overall Study||102
10883920|NCT03132805|12049847|FG001|Baseline Data Collection (Teachers)|Overall Study||91
10883921|NCT03132805|12049848|FG002|Baseline Data Collection (Teachers)|Overall Study||99
10883922|NCT03132805|12049846|FG000|Post-test Data Collection (Teachers)|Overall Study||92
10883923|NCT03132805|12049847|FG001|Post-test Data Collection (Teachers)|Overall Study||87
10883924|NCT03132805|12049848|FG002|Post-test Data Collection (Teachers)|Overall Study||90
10883925|NCT03132805|12049846|FG000|COMPLETED|Overall Study||1487
10883926|NCT03132805|12049847|FG001|COMPLETED|Overall Study||1651
10883927|NCT03132805|12049848|FG002|COMPLETED|Overall Study||1699
10883928|NCT03132805|12049846|FG000|NOT COMPLETED|Overall Study||142
10883929|NCT03132805|12049847|FG001|NOT COMPLETED|Overall Study||141
10883930|NCT03132805|12049848|FG002|NOT COMPLETED|Overall Study||113
10883931|NCT03132467|12049856|FG000|STARTED|Overall Study||8
10883932|NCT03132467|12049856|FG000|COMPLETED|Overall Study||4
10883933|NCT03132467|12049856|FG000|NOT COMPLETED|Overall Study||4
10883934|NCT03131219|12049863|FG000|STARTED|Initial Evaluation Period||21
10883935|NCT03131219|12049864|FG001|STARTED|Initial Evaluation Period||10
10883936|NCT03131219|12049863|FG000|Received At Least 1 Dose of Study Drug|Initial Evaluation Period||21
10883937|NCT03131219|12049864|FG001|Received At Least 1 Dose of Study Drug|Initial Evaluation Period||10
10883938|NCT03131219|12049863|FG000|COMPLETED|Initial Evaluation Period||17
10883939|NCT03131219|12049864|FG001|COMPLETED|Initial Evaluation Period||10
10883940|NCT03131219|12049863|FG000|NOT COMPLETED|Initial Evaluation Period||4
10883941|NCT03131219|12049864|FG001|NOT COMPLETED|Initial Evaluation Period||0
10883942|NCT03131219|12049863|FG000|STARTED|Extension Period||17
10883943|NCT03131219|12049864|FG001|STARTED|Extension Period||10
10883944|NCT03131219|12049863|FG000|Received At Least 1 Dose of Study Drug|Extension Period||17
10883945|NCT03131219|12049864|FG001|Received At Least 1 Dose of Study Drug|Extension Period||10
10883946|NCT03131219|12049863|FG000|Ongoing|Extension Period||16
10883947|NCT03131219|12049864|FG001|Ongoing|Extension Period||10
10883948|NCT03131219|12049863|FG000|COMPLETED|Extension Period||0
10883949|NCT03131219|12049864|FG001|COMPLETED|Extension Period||0
10883950|NCT03131219|12049863|FG000|NOT COMPLETED|Extension Period||17
10883951|NCT03131219|12049864|FG001|NOT COMPLETED|Extension Period||10
10883952|NCT03130959|12049880|FG000|STARTED|Overall Study||23
10883953|NCT03130959|12049881|FG001|STARTED|Overall Study||22
10883954|NCT03130959|12049882|FG002|STARTED|Overall Study||16
10883955|NCT03130959|12049883|FG003|STARTED|Overall Study||15
10883956|NCT03130959|12049884|FG004|STARTED|Overall Study||15
10883957|NCT03130959|12049885|FG005|STARTED|Overall Study||15
10883958|NCT03130959|12049886|FG006|STARTED|Overall Study||12
10883959|NCT03130959|12049887|FG007|STARTED|Overall Study||10
10883960|NCT03130959|12049888|FG008|STARTED|Overall Study||19
10883961|NCT03130959|12049889|FG009|STARTED|Overall Study||19
10883962|NCT03130959|12049880|FG000|COMPLETED|Overall Study||0
10883963|NCT03130959|12049881|FG001|COMPLETED|Overall Study||12
10883964|NCT03130959|12049882|FG002|COMPLETED|Overall Study||0
10883965|NCT03130959|12049883|FG003|COMPLETED|Overall Study||1
10883966|NCT03130959|12049884|FG004|COMPLETED|Overall Study||0
10883967|NCT03130959|12049885|FG005|COMPLETED|Overall Study||9
10883968|NCT03130959|12049886|FG006|COMPLETED|Overall Study||0
10883969|NCT03130959|12049887|FG007|COMPLETED|Overall Study||6
10883970|NCT03130959|12049888|FG008|COMPLETED|Overall Study||0
10883971|NCT03130959|12049889|FG009|COMPLETED|Overall Study||4
10883972|NCT03130959|12049880|FG000|NOT COMPLETED|Overall Study||23
10883973|NCT03130959|12049881|FG001|NOT COMPLETED|Overall Study||10
10883974|NCT03130959|12049882|FG002|NOT COMPLETED|Overall Study||16
10883975|NCT03130959|12049883|FG003|NOT COMPLETED|Overall Study||14
10883976|NCT03130959|12049884|FG004|NOT COMPLETED|Overall Study||15
10883977|NCT03130959|12049885|FG005|NOT COMPLETED|Overall Study||6
10883978|NCT03130959|12049886|FG006|NOT COMPLETED|Overall Study||12
10883979|NCT03130959|12049887|FG007|NOT COMPLETED|Overall Study||4
10883980|NCT03130959|12049888|FG008|NOT COMPLETED|Overall Study||19
10883981|NCT03130959|12049889|FG009|NOT COMPLETED|Overall Study||15
10883982|NCT03130439|12049924|FG000|STARTED|Overall Study||27
10883983|NCT03130439|12049924|FG000|COMPLETED|Overall Study||27
10883984|NCT03130439|12049924|FG000|NOT COMPLETED|Overall Study||0
10883985|NCT03128957|12049928|FG000|STARTED|Overall Study||10
10883986|NCT03128957|12049928|FG000|COMPLETED|Overall Study||10
10883987|NCT03128957|12049928|FG000|NOT COMPLETED|Overall Study||0
10883988|NCT03127384|12049932|FG000|STARTED|Overall Study||49
10883989|NCT03127384|12049932|FG000|Completed 3 Month Visit|Overall Study||47
10883990|NCT03127384|12049932|FG000|COMPLETED|Overall Study||43
10883991|NCT03127384|12049932|FG000|NOT COMPLETED|Overall Study||6
10883992|NCT03125902|12049940|FG000|STARTED|Overall Study||220
10883993|NCT03125902|12049941|FG001|STARTED|Overall Study||431
10883994|NCT03125902|12049940|FG000|COMPLETED|Overall Study||0
10883995|NCT03125902|12049941|FG001|COMPLETED|Overall Study||0
10883996|NCT03125902|12049940|FG000|NOT COMPLETED|Overall Study||220
10883997|NCT03125902|12049941|FG001|NOT COMPLETED|Overall Study||431
10883998|NCT03124459|12049954|FG000|STARTED|Part 1-Open Label Dose Escalation||6
10883999|NCT03124459|12049955|FG001|STARTED|Part 1-Open Label Dose Escalation||6
10884000|NCT03124459|12049956|FG002|STARTED|Part 1-Open Label Dose Escalation||6
10884001|NCT03124459|12049957|FG003|STARTED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|0
10884002|NCT03124459|12049958|FG004|STARTED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|0
10884054|NCT03122301|12049974|FG000|COMPLETED|Overall Study||1
10884055|NCT03122301|12049975|FG001|COMPLETED|Overall Study||1
10884056|NCT03122301|12049974|FG000|NOT COMPLETED|Overall Study||0
10884003|NCT03124459|12049959|FG005|STARTED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study. Participants that completed the double-blind portion of the study then moved into this Part 2 open-label portion of the study.|0
10884004|NCT03124459|12049954|FG000|COMPLETED|Part 1-Open Label Dose Escalation||6
10884005|NCT03124459|12049955|FG001|COMPLETED|Part 1-Open Label Dose Escalation||6
10884006|NCT03124459|12049956|FG002|COMPLETED|Part 1-Open Label Dose Escalation||6
10884007|NCT03124459|12049957|FG003|COMPLETED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|0
10884008|NCT03124459|12049958|FG004|COMPLETED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|0
10884009|NCT03124459|12049959|FG005|COMPLETED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study. Participants that completed the double-blind portion of the study then moved into this Part 2 open-label portion of the study.|0
10884010|NCT03124459|12049954|FG000|NOT COMPLETED|Part 1-Open Label Dose Escalation||0
10884011|NCT03124459|12049955|FG001|NOT COMPLETED|Part 1-Open Label Dose Escalation||0
10884012|NCT03124459|12049956|FG002|NOT COMPLETED|Part 1-Open Label Dose Escalation||0
10884013|NCT03124459|12049957|FG003|NOT COMPLETED|Part 1-Open Label Dose Escalation||0
10884014|NCT03124459|12049958|FG004|NOT COMPLETED|Part 1-Open Label Dose Escalation||0
10884015|NCT03124459|12049959|FG005|NOT COMPLETED|Part 1-Open Label Dose Escalation||0
10884016|NCT03124459|12049954|FG000|STARTED|Phase 2- Randomized Doubled-blind|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study.|0
10884017|NCT03124459|12049955|FG001|STARTED|Phase 2- Randomized Doubled-blind|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study.|0
10884018|NCT03124459|12049956|FG002|STARTED|Phase 2- Randomized Doubled-blind|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study.|0
10884019|NCT03124459|12049957|FG003|STARTED|Phase 2- Randomized Doubled-blind|Participants in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|21
10884020|NCT03124459|12049958|FG004|STARTED|Phase 2- Randomized Doubled-blind|Participants in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|24
10884021|NCT03124459|12049959|FG005|STARTED|Phase 2- Randomized Doubled-blind|Participants in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study. Participants that completed the double-blind portion of the study then moved into this Part 2 open-label portion of the study.|0
10884022|NCT03124459|12049954|FG000|COMPLETED|Phase 2- Randomized Doubled-blind||0
10884023|NCT03124459|12049955|FG001|COMPLETED|Phase 2- Randomized Doubled-blind||0
10884024|NCT03124459|12049956|FG002|COMPLETED|Phase 2- Randomized Doubled-blind||0
10884025|NCT03124459|12049957|FG003|COMPLETED|Phase 2- Randomized Doubled-blind||9
10884026|NCT03124459|12049958|FG004|COMPLETED|Phase 2- Randomized Doubled-blind||5
10884027|NCT03124459|12049959|FG005|COMPLETED|Phase 2- Randomized Doubled-blind||0
10884028|NCT03124459|12049954|FG000|NOT COMPLETED|Phase 2- Randomized Doubled-blind||0
10884029|NCT03124459|12049955|FG001|NOT COMPLETED|Phase 2- Randomized Doubled-blind||0
10884030|NCT03124459|12049956|FG002|NOT COMPLETED|Phase 2- Randomized Doubled-blind||0
10884031|NCT03124459|12049957|FG003|NOT COMPLETED|Phase 2- Randomized Doubled-blind||12
10884032|NCT03124459|12049958|FG004|NOT COMPLETED|Phase 2- Randomized Doubled-blind||19
10884033|NCT03124459|12049959|FG005|NOT COMPLETED|Phase 2- Randomized Doubled-blind||0
10884034|NCT03124459|12049954|FG000|STARTED|Part 2- Open Label ACE-083||0
10884035|NCT03124459|12049955|FG001|STARTED|Part 2- Open Label ACE-083||0
10884036|NCT03124459|12049956|FG002|STARTED|Part 2- Open Label ACE-083||0
10884037|NCT03124459|12049957|FG003|STARTED|Part 2- Open Label ACE-083|Participants in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study. Participants that completed the double-blind placebo controlled portion of Part 2, moved into the open-label portion part 2 study.|0
10884038|NCT03124459|12049958|FG004|STARTED|Part 2- Open Label ACE-083|Participants in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study. Participants that completed the double-blind placebo controlled portion of Part 2, moved into the open-label portion part 2 study.|0
10884039|NCT03124459|12049959|FG005|STARTED|Part 2- Open Label ACE-083|The open-label portion of Part 2 are the participants that were enrolled in and completed the double-blind placebo-controlled portion of Part 2.|40
10884040|NCT03124459|12049954|FG000|COMPLETED|Part 2- Open Label ACE-083||0
10884041|NCT03124459|12049955|FG001|COMPLETED|Part 2- Open Label ACE-083||0
10884042|NCT03124459|12049956|FG002|COMPLETED|Part 2- Open Label ACE-083||0
10884043|NCT03124459|12049957|FG003|COMPLETED|Part 2- Open Label ACE-083||0
10884044|NCT03124459|12049958|FG004|COMPLETED|Part 2- Open Label ACE-083||0
10884045|NCT03124459|12049959|FG005|COMPLETED|Part 2- Open Label ACE-083||17
10884046|NCT03124459|12049954|FG000|NOT COMPLETED|Part 2- Open Label ACE-083||0
10884047|NCT03124459|12049955|FG001|NOT COMPLETED|Part 2- Open Label ACE-083||0
10884048|NCT03124459|12049956|FG002|NOT COMPLETED|Part 2- Open Label ACE-083||0
10884049|NCT03124459|12049957|FG003|NOT COMPLETED|Part 2- Open Label ACE-083||0
10884050|NCT03124459|12049958|FG004|NOT COMPLETED|Part 2- Open Label ACE-083||0
10884051|NCT03124459|12049959|FG005|NOT COMPLETED|Part 2- Open Label ACE-083||23
10884052|NCT03122301|12049974|FG000|STARTED|Overall Study||1
10884053|NCT03122301|12049975|FG001|STARTED|Overall Study||1
10884057|NCT03122301|12049975|FG001|NOT COMPLETED|Overall Study||0
10884058|NCT03108924|12049985|FG000|STARTED|Overall Study||6
10884059|NCT03108924|12049986|FG001|STARTED|Overall Study||6
10884060|NCT03108924|12049987|FG002|STARTED|Overall Study||6
10884061|NCT03108924|12049988|FG003|STARTED|Overall Study||6
10884062|NCT03108924|12049985|FG000|COMPLETED|Overall Study||6
10884063|NCT03108924|12049986|FG001|COMPLETED|Overall Study||6
10884064|NCT03108924|12049987|FG002|COMPLETED|Overall Study||6
10884065|NCT03108924|12049988|FG003|COMPLETED|Overall Study||6
10884066|NCT03108924|12049985|FG000|NOT COMPLETED|Overall Study||0
10884067|NCT03108924|12049986|FG001|NOT COMPLETED|Overall Study||0
10884068|NCT03108924|12049987|FG002|NOT COMPLETED|Overall Study||0
10884069|NCT03108924|12049988|FG003|NOT COMPLETED|Overall Study||0
10884070|NCT03106779|12050009|FG000|STARTED|Overall Study||157
10884071|NCT03106779|12050010|FG001|STARTED|Overall Study||76
10884072|NCT03106779|12050009|FG000|Treated|Overall Study||156
10884073|NCT03106779|12050010|FG001|Treated|Overall Study||0
10884074|NCT03106779|12050009|FG000|Not Treated|Overall Study||1
10884075|NCT03106779|12050010|FG001|Not Treated|Overall Study||0
10884076|NCT03106779|12050009|FG000|COMPLETED|Overall Study||97
10884077|NCT03106779|12050010|FG001|COMPLETED|Overall Study||22
10884078|NCT03106779|12050009|FG000|NOT COMPLETED|Overall Study||60
10884079|NCT03106779|12050010|FG001|NOT COMPLETED|Overall Study||54
10884080|NCT03105518|12050016|FG000|STARTED|Overall Study||100
10884081|NCT03105518|12050016|FG000|COMPLETED|Overall Study||100
10884082|NCT03105518|12050016|FG000|NOT COMPLETED|Overall Study||0
10884083|NCT03101930|12050023|FG000|STARTED|Overall Study||46
10884084|NCT03101930|12050024|FG001|STARTED|Overall Study||23
10884085|NCT03101930|12050025|FG002|STARTED|Overall Study||24
10884086|NCT03101930|12050023|FG000|COMPLETED|Overall Study||44
10884087|NCT03101930|12050024|FG001|COMPLETED|Overall Study||22
10884088|NCT03101930|12050025|FG002|COMPLETED|Overall Study||22
10884089|NCT03101930|12050023|FG000|NOT COMPLETED|Overall Study||2
10884090|NCT03101930|12050024|FG001|NOT COMPLETED|Overall Study||1
10884091|NCT03101930|12050025|FG002|NOT COMPLETED|Overall Study||2
10884092|NCT03100149|12050036|FG000|STARTED|Overall Study||105
10884093|NCT03100149|12050037|FG001|STARTED|Overall Study||105
10884094|NCT03100149|12050038|FG002|STARTED|Overall Study||106
10884095|NCT03100149|12050036|FG000|COMPLETED|Overall Study||105
10884096|NCT03100149|12050037|FG001|COMPLETED|Overall Study||101
10884097|NCT03100149|12050038|FG002|COMPLETED|Overall Study||104
10884098|NCT03100149|12050036|FG000|NOT COMPLETED|Overall Study||0
10884099|NCT03100149|12050037|FG001|NOT COMPLETED|Overall Study||4
10884100|NCT03100149|12050038|FG002|NOT COMPLETED|Overall Study||2
10884101|NCT03097783|12050048|FG000|STARTED|Overall Study||132
10884102|NCT03097783|12050049|FG001|STARTED|Overall Study||37
10884103|NCT03097783|12050048|FG000|COMPLETED|Overall Study||123
10884104|NCT03097783|12050049|FG001|COMPLETED|Overall Study||31
10884105|NCT03097783|12050048|FG000|NOT COMPLETED|Overall Study||9
10884106|NCT03097783|12050049|FG001|NOT COMPLETED|Overall Study||6
10884107|NCT03095118|12050055|FG000|STARTED|Overall Study||12
10884108|NCT03095118|12050055|FG000|COMPLETED|Overall Study||10
10884109|NCT03095118|12050055|FG000|NOT COMPLETED|Overall Study||2
10884110|NCT03094637|12050061|FG000|STARTED|Overall Study||17
10884111|NCT03094637|12050062|FG001|STARTED|Overall Study||20
10884112|NCT03094637|12050061|FG000|COMPLETED|Overall Study||17
10884113|NCT03094637|12050062|FG001|COMPLETED|Overall Study||20
10884114|NCT03094637|12050061|FG000|NOT COMPLETED|Overall Study||0
10884115|NCT03094637|12050062|FG001|NOT COMPLETED|Overall Study||0
10884116|NCT03093428|12050071|FG000|STARTED|Overall Study||31
10884117|NCT03093428|12050072|FG001|STARTED|Overall Study||14
10884118|NCT03093428|12050071|FG000|COMPLETED|Overall Study||12
10884119|NCT03093428|12050072|FG001|COMPLETED|Overall Study||8
10884120|NCT03093428|12050071|FG000|NOT COMPLETED|Overall Study||19
10884121|NCT03093428|12050072|FG001|NOT COMPLETED|Overall Study||6
10884122|NCT03091192|12050080|FG000|STARTED|Overall Study||33
10884123|NCT03091192|12050081|FG001|STARTED|Overall Study||27
10884124|NCT03091192|12050080|FG000|COMPLETED|Overall Study||0
10884125|NCT03091192|12050081|FG001|COMPLETED|Overall Study||0
10884126|NCT03091192|12050080|FG000|NOT COMPLETED|Overall Study||33
10884127|NCT03091192|12050081|FG001|NOT COMPLETED|Overall Study||27
10884128|NCT03090152|12050090|FG000|STARTED|Overall Study||60
10884129|NCT03090152|12050091|FG001|STARTED|Overall Study||60
10884130|NCT03090152|12050092|FG002|STARTED|Overall Study||60
10884131|NCT03090152|12050090|FG000|COMPLETED|Overall Study||59
10884132|NCT03090152|12050091|FG001|COMPLETED|Overall Study||56
10884133|NCT03090152|12050092|FG002|COMPLETED|Overall Study||59
10884134|NCT03090152|12050090|FG000|NOT COMPLETED|Overall Study||1
10884135|NCT03090152|12050091|FG001|NOT COMPLETED|Overall Study||4
10884136|NCT03090152|12050092|FG002|NOT COMPLETED|Overall Study||1
10884137|NCT03087708|12050103|FG000|STARTED|Overall Study||17
10884138|NCT03087708|12050104|FG001|STARTED|Overall Study||16
10884139|NCT03087708|12050105|FG002|STARTED|Overall Study||17
10884140|NCT03087708|12050103|FG000|COMPLETED|Overall Study||15
10884141|NCT03087708|12050104|FG001|COMPLETED|Overall Study||15
10884142|NCT03087708|12050105|FG002|COMPLETED|Overall Study||13
10884143|NCT03087708|12050103|FG000|NOT COMPLETED|Overall Study||2
10884144|NCT03087708|12050104|FG001|NOT COMPLETED|Overall Study||1
10884145|NCT03087708|12050105|FG002|NOT COMPLETED|Overall Study||4
10884146|NCT03087058|12050125|FG000|STARTED|Overall Study||14
10884147|NCT03087058|12050126|FG001|STARTED|Overall Study||9
10884235|NCT03060083|12050252|FG001|Attended End of Baseline Study Visit|Overall Study||32
10884236|NCT03060083|12050251|FG000|COMPLETED|Overall Study||31
10884237|NCT03060083|12050252|FG001|COMPLETED|Overall Study||27
10884148|NCT03087058|12050127|FG002|STARTED|Overall Study|Vifor believes the 23 enrolled subjects in Cohort 1 and 2 are representative of patients with hyperkalaemia due to CKD 6 to <18 years of age and that data are sufficient to support assessment of the PD effects, safety, and tolerability of patiromer in this population. The trial was terminated by sponsor decision on the 13 July 2022. The PD and safety of patiromer in the population aged from 0 to <6 will be assessed in a new trial with the protocol number RLY5016-208p.|0
10884149|NCT03087058|12050125|FG000|COMPLETED|Overall Study||12
10884150|NCT03087058|12050126|FG001|COMPLETED|Overall Study||9
10884151|NCT03087058|12050127|FG002|COMPLETED|Overall Study||0
10884152|NCT03087058|12050125|FG000|NOT COMPLETED|Overall Study||2
10884153|NCT03087058|12050126|FG001|NOT COMPLETED|Overall Study||0
10884154|NCT03087058|12050127|FG002|NOT COMPLETED|Overall Study||0
10884155|NCT03087019|12050136|FG000|STARTED|Overall Study||11
10884156|NCT03087019|12050137|FG001|STARTED|Overall Study||10
10884157|NCT03087019|12050136|FG000|COMPLETED|Overall Study||10
10884158|NCT03087019|12050137|FG001|COMPLETED|Overall Study||10
10884159|NCT03087019|12050136|FG000|NOT COMPLETED|Overall Study||1
10884160|NCT03087019|12050137|FG001|NOT COMPLETED|Overall Study||0
10884161|NCT03085914|12050150|FG000|STARTED|Overall Study||9
10884162|NCT03085914|12050151|FG001|STARTED|Overall Study||9
10884163|NCT03085914|12050152|FG002|STARTED|Overall Study||11
10884164|NCT03085914|12050153|FG003|STARTED|Overall Study||9
10884165|NCT03085914|12050154|FG004|STARTED|Overall Study||13
10884166|NCT03085914|12050155|FG005|STARTED|Overall Study||8
10884167|NCT03085914|12050156|FG006|STARTED|Overall Study||11
10884168|NCT03085914|12050150|FG000|COMPLETED|Overall Study||0
10884169|NCT03085914|12050151|FG001|COMPLETED|Overall Study||0
10884170|NCT03085914|12050152|FG002|COMPLETED|Overall Study||0
10884171|NCT03085914|12050153|FG003|COMPLETED|Overall Study||0
10884172|NCT03085914|12050154|FG004|COMPLETED|Overall Study||0
10884173|NCT03085914|12050155|FG005|COMPLETED|Overall Study||0
10884174|NCT03085914|12050156|FG006|COMPLETED|Overall Study||0
10884175|NCT03085914|12050150|FG000|NOT COMPLETED|Overall Study||9
10884176|NCT03085914|12050151|FG001|NOT COMPLETED|Overall Study||9
10884177|NCT03085914|12050152|FG002|NOT COMPLETED|Overall Study||11
10884178|NCT03085914|12050153|FG003|NOT COMPLETED|Overall Study||9
10884179|NCT03085914|12050154|FG004|NOT COMPLETED|Overall Study||13
10884180|NCT03085914|12050155|FG005|NOT COMPLETED|Overall Study||8
10884181|NCT03085914|12050156|FG006|NOT COMPLETED|Overall Study||11
10884182|NCT03084471|12050173|FG000|STARTED|Overall Study||867
10884183|NCT03084471|12050173|FG000|COMPLETED|Overall Study||0
10884184|NCT03084471|12050173|FG000|NOT COMPLETED|Overall Study||867
10884185|NCT03082677|12050180|FG000|STARTED|Overall Study||20
10884186|NCT03082677|12050180|FG000|COMPLETED|Overall Study||18
10884187|NCT03082677|12050180|FG000|NOT COMPLETED|Overall Study||2
10884188|NCT03082664|12050186|FG000|STARTED|Overall Study||75
10884189|NCT03082664|12050187|FG001|STARTED|Overall Study||79
10884190|NCT03082664|12050186|FG000|COMPLETED|Overall Study||75
10884191|NCT03082664|12050187|FG001|COMPLETED|Overall Study||79
10884192|NCT03082664|12050186|FG000|NOT COMPLETED|Overall Study||0
10884193|NCT03082664|12050187|FG001|NOT COMPLETED|Overall Study||0
10884194|NCT03078582|12050195|FG000|STARTED|Overall Study||10
10884195|NCT03078582|12050196|FG001|STARTED|Overall Study||16
10884196|NCT03078582|12050195|FG000|COMPLETED|Overall Study||10
10884197|NCT03078582|12050196|FG001|COMPLETED|Overall Study||8
10884198|NCT03078582|12050195|FG000|NOT COMPLETED|Overall Study||0
10884199|NCT03078582|12050196|FG001|NOT COMPLETED|Overall Study||8
10884200|NCT03075527|12050202|FG000|STARTED|Overall Study||19
10884201|NCT03075527|12050202|FG000|COMPLETED|Overall Study||17
10884202|NCT03075527|12050202|FG000|NOT COMPLETED|Overall Study||2
10884203|NCT03070444|12050208|FG000|STARTED|Overall Study||52
10884204|NCT03070444|12050209|FG001|STARTED|Overall Study||52
10884205|NCT03070444|12050208|FG000|COMPLETED|Overall Study||39
10884206|NCT03070444|12050209|FG001|COMPLETED|Overall Study||35
10884207|NCT03070444|12050208|FG000|NOT COMPLETED|Overall Study||13
10884208|NCT03070444|12050209|FG001|NOT COMPLETED|Overall Study||17
10884209|NCT03070236|12050217|FG000|STARTED|Overall Study||912
10884210|NCT03070236|12050217|FG000|Guideline Concordant Care (GCC) Arm|Overall Study||538
10884211|NCT03070236|12050217|FG000|Active Surveillance (AS) Arm|Overall Study||374
10884212|NCT03070236|12050217|FG000|COMPLETED|Overall Study||912
10884213|NCT03070236|12050217|FG000|NOT COMPLETED|Overall Study||0
10884214|NCT03064126|12050226|FG000|STARTED|Overall Study||278
10884215|NCT03064126|12050227|FG001|STARTED|Overall Study||98
10884216|NCT03064126|12050228|FG002|STARTED|Overall Study||52
10884217|NCT03064126|12050229|FG003|STARTED|Overall Study||12
10884218|NCT03064126|12050226|FG000|COMPLETED|Overall Study||252
10884219|NCT03064126|12050227|FG001|COMPLETED|Overall Study||91
10884220|NCT03064126|12050228|FG002|COMPLETED|Overall Study||49
10884221|NCT03064126|12050229|FG003|COMPLETED|Overall Study||11
10884222|NCT03064126|12050226|FG000|NOT COMPLETED|Overall Study||26
10884223|NCT03064126|12050227|FG001|NOT COMPLETED|Overall Study||7
10884224|NCT03064126|12050228|FG002|NOT COMPLETED|Overall Study||3
10884225|NCT03064126|12050229|FG003|NOT COMPLETED|Overall Study||1
10884226|NCT03063632|12050242|FG000|STARTED|Overall Study||16
10884227|NCT03063632|12050243|FG001|STARTED|Overall Study||12
10884228|NCT03063632|12050242|FG000|COMPLETED|Overall Study||9
10884229|NCT03063632|12050243|FG001|COMPLETED|Overall Study||2
10884230|NCT03063632|12050242|FG000|NOT COMPLETED|Overall Study||7
10884231|NCT03063632|12050243|FG001|NOT COMPLETED|Overall Study||10
10884232|NCT03060083|12050251|FG000|STARTED|Overall Study||39
10884233|NCT03060083|12050252|FG001|STARTED|Overall Study||35
10884234|NCT03060083|12050251|FG000|Attended End of Baseline Study Visit|Overall Study||36
10884238|NCT03060083|12050251|FG000|NOT COMPLETED|Overall Study||8
10884239|NCT03060083|12050252|FG001|NOT COMPLETED|Overall Study||8
10884240|NCT03057600|12050262|FG000|STARTED|Overall Study||9
10884241|NCT03057600|12050263|FG001|STARTED|Overall Study||10
10884242|NCT03057600|12050264|FG002|STARTED|Overall Study||20
10884243|NCT03057600|12050265|FG003|STARTED|Overall Study||13
10884244|NCT03057600|12050262|FG000|COMPLETED|Overall Study||0
10884245|NCT03057600|12050263|FG001|COMPLETED|Overall Study||0
10884246|NCT03057600|12050264|FG002|COMPLETED|Overall Study||0
10884247|NCT03057600|12050265|FG003|COMPLETED|Overall Study||0
10884248|NCT03057600|12050262|FG000|NOT COMPLETED|Overall Study||9
10884249|NCT03057600|12050263|FG001|NOT COMPLETED|Overall Study||10
10884250|NCT03057600|12050264|FG002|NOT COMPLETED|Overall Study||20
10884251|NCT03057600|12050265|FG003|NOT COMPLETED|Overall Study||13
10884252|NCT03055858|12050276|FG000|STARTED|Overall Study||200
10884253|NCT03055858|12050276|FG000|IDE Cohort|Overall Study||50
10884254|NCT03055858|12050276|FG000|CAP Cohort|Overall Study||150
10884255|NCT03055858|12050276|FG000|COMPLETED|Overall Study||194
10884256|NCT03055858|12050276|FG000|NOT COMPLETED|Overall Study||6
10884257|NCT03043872|12050283|FG000|STARTED|Overall Study||329
10884258|NCT03043872|12050284|FG001|STARTED|Overall Study||328
10884259|NCT03043872|12050285|FG002|STARTED|Overall Study||330
10884260|NCT03043872|12050283|FG000|Randomized and Included in Global Cohort Analysis|Overall Study||268
10884261|NCT03043872|12050284|FG001|Randomized and Included in Global Cohort Analysis|Overall Study||268
10884262|NCT03043872|12050285|FG002|Randomized and Included in Global Cohort Analysis|Overall Study||269
10884263|NCT03043872|12050283|FG000|Received Treatment in Global Cohort|Overall Study||266
10884264|NCT03043872|12050284|FG001|Received Treatment in Global Cohort|Overall Study||265
10884265|NCT03043872|12050285|FG002|Received Treatment in Global Cohort|Overall Study||266
10884266|NCT03043872|12050283|FG000|Randomized and Included in China Cohort Analysis|Overall Study||65
10884267|NCT03043872|12050284|FG001|Randomized and Included in China Cohort Analysis|Overall Study||61
10884268|NCT03043872|12050285|FG002|Randomized and Included in China Cohort Analysis|Overall Study||62
10884269|NCT03043872|12050283|FG000|Received Treatment in China Cohort|Overall Study||65
10884270|NCT03043872|12050284|FG001|Received Treatment in China Cohort|Overall Study||61
10884271|NCT03043872|12050285|FG002|Received Treatment in China Cohort|Overall Study||62
10884272|NCT03043872|12050283|FG000|Included in Both Cohorts (Global + China)|Overall Study||4
10884273|NCT03043872|12050284|FG001|Included in Both Cohorts (Global + China)|Overall Study||1
10884274|NCT03043872|12050285|FG002|Included in Both Cohorts (Global + China)|Overall Study||1
10884275|NCT03043872|12050283|FG000|Ongoing Study at Global Cohort Final Analysis Data Cut-off (DCO)|Overall Study||56
10884276|NCT03043872|12050284|FG001|Ongoing Study at Global Cohort Final Analysis Data Cut-off (DCO)|Overall Study||56
10884277|NCT03043872|12050285|FG002|Ongoing Study at Global Cohort Final Analysis Data Cut-off (DCO)|Overall Study||31
10884278|NCT03043872|12050283|FG000|Ongoing Study at China Cohort Second (Final) Analysis DCO|Overall Study||16
10884279|NCT03043872|12050284|FG001|Ongoing Study at China Cohort Second (Final) Analysis DCO|Overall Study||11
10884280|NCT03043872|12050285|FG002|Ongoing Study at China Cohort Second (Final) Analysis DCO|Overall Study||7
10884281|NCT03043872|12050283|FG000|COMPLETED|Overall Study||51
10884282|NCT03043872|12050284|FG001|COMPLETED|Overall Study||52
10884283|NCT03043872|12050285|FG002|COMPLETED|Overall Study||18
10884284|NCT03043872|12050283|FG000|NOT COMPLETED|Overall Study||278
10884285|NCT03043872|12050284|FG001|NOT COMPLETED|Overall Study||276
10884286|NCT03043872|12050285|FG002|NOT COMPLETED|Overall Study||312
10884287|NCT03043664|12050303|FG000|STARTED|Overall Study||22
10884288|NCT03043664|12050303|FG000|COMPLETED|Overall Study||15
10884289|NCT03043664|12050303|FG000|NOT COMPLETED|Overall Study||7
10884290|NCT03043599|12050307|FG000|STARTED|Overall Study||21
10884291|NCT03043599|12050307|FG000|COMPLETED|Overall Study||21
10884292|NCT03043599|12050307|FG000|NOT COMPLETED|Overall Study||0
10884293|NCT03041467|12050313|FG000|STARTED|Overall Study||170
10884294|NCT03041467|12050314|FG001|STARTED|Overall Study||160
10884295|NCT03041467|12050313|FG000|30 Days|Overall Study||159
10884296|NCT03041467|12050314|FG001|30 Days|Overall Study||152
10884297|NCT03041467|12050313|FG000|3 Months|Overall Study||158
10884298|NCT03041467|12050314|FG001|3 Months|Overall Study||151
10884299|NCT03041467|12050313|FG000|6 Months|Overall Study||145
10884300|NCT03041467|12050314|FG001|6 Months|Overall Study||144
10884301|NCT03041467|12050313|FG000|9 Months|Overall Study||138
10884302|NCT03041467|12050314|FG001|9 Months|Overall Study||138
10884303|NCT03041467|12050313|FG000|12 Months|Overall Study||131
10884304|NCT03041467|12050314|FG001|12 Months|Overall Study||121
10884305|NCT03041467|12050313|FG000|18 Months|Overall Study||123
10884306|NCT03041467|12050314|FG001|18 Months|Overall Study||113
10884307|NCT03041467|12050313|FG000|24 Months|Overall Study||110
10884308|NCT03041467|12050314|FG001|24 Months|Overall Study||101
10884309|NCT03041467|12050313|FG000|36 Months|Overall Study||75
10884310|NCT03041467|12050314|FG001|36 Months|Overall Study||58
10884311|NCT03041467|12050313|FG000|COMPLETED|Overall Study||75
10884312|NCT03041467|12050314|FG001|COMPLETED|Overall Study||58
10884313|NCT03041467|12050313|FG000|NOT COMPLETED|Overall Study||95
10884314|NCT03041467|12050314|FG001|NOT COMPLETED|Overall Study||102
10884315|NCT03041415|12050324|FG000|STARTED|Overall Study||140
10884316|NCT03041415|12050325|FG001|STARTED|Overall Study||160
10884317|NCT03041415|12050324|FG000|COMPLETED|Overall Study||123
10884318|NCT03041415|12050325|FG001|COMPLETED|Overall Study||145
10884319|NCT03041415|12050324|FG000|NOT COMPLETED|Overall Study||17
10884320|NCT03041415|12050325|FG001|NOT COMPLETED|Overall Study||15
10884321|NCT03041324|12050334|FG000|STARTED|Overall Study||2
10884322|NCT03041324|12050335|FG001|STARTED|Overall Study||2
10884323|NCT03041324|12050336|FG002|STARTED|Overall Study||5
10884324|NCT03041324|12050334|FG000|COMPLETED|Overall Study||2
10884325|NCT03041324|12050335|FG001|COMPLETED|Overall Study||2
10884326|NCT03041324|12050336|FG002|COMPLETED|Overall Study||5
10884327|NCT03041324|12050334|FG000|NOT COMPLETED|Overall Study||0
10884328|NCT03041324|12050335|FG001|NOT COMPLETED|Overall Study||0
10884329|NCT03041324|12050336|FG002|NOT COMPLETED|Overall Study||0
10884330|NCT03035227|12050349|FG000|STARTED|Overall Study||1
10884331|NCT03035227|12050350|FG001|STARTED|Overall Study||1
10884332|NCT03035227|12050349|FG000|COMPLETED|Overall Study|study stopped due to PI leaving institution|0
10884333|NCT03035227|12050350|FG001|COMPLETED|Overall Study|study stopped due to PI leaving institution|0
10884334|NCT03035227|12050349|FG000|NOT COMPLETED|Overall Study||1
10884335|NCT03035227|12050350|FG001|NOT COMPLETED|Overall Study||1
10884336|NCT03032198|12050358|FG000|STARTED|Overall Study||37
10884337|NCT03032198|12050358|FG000|COMPLETED|Overall Study||36
10884338|NCT03032198|12050358|FG000|NOT COMPLETED|Overall Study||1
10884339|NCT03031847|12050366|FG000|STARTED|Overall Study||22
10884340|NCT03031847|12050367|FG001|STARTED|Overall Study||20
10884341|NCT03031847|12050368|FG002|STARTED|Overall Study||18
10884342|NCT03031847|12050369|FG003|STARTED|Overall Study||42
10884343|NCT03031847|12050366|FG000|COMPLETED|Overall Study||20
10884344|NCT03031847|12050367|FG001|COMPLETED|Overall Study||18
10884345|NCT03031847|12050368|FG002|COMPLETED|Overall Study||14
10884346|NCT03031847|12050369|FG003|COMPLETED|Overall Study||36
10884347|NCT03031847|12050366|FG000|NOT COMPLETED|Overall Study||2
10884348|NCT03031847|12050367|FG001|NOT COMPLETED|Overall Study||2
10884349|NCT03031847|12050368|FG002|NOT COMPLETED|Overall Study||4
10884350|NCT03031847|12050369|FG003|NOT COMPLETED|Overall Study||6
10884351|NCT03031782|12050379|FG000|STARTED|Treatment Period 1||86
10884352|NCT03031782|12050380|FG001|STARTED|Treatment Period 1||0
10884353|NCT03031782|12050381|FG002|STARTED|Treatment Period 1||0
10884354|NCT03031782|12050382|FG003|STARTED|Treatment Period 1||0
10884355|NCT03031782|12050383|FG004|STARTED|Treatment Period 1||0
10884356|NCT03031782|12050379|FG000|COMPLETED|Treatment Period 1||83
10884357|NCT03031782|12050380|FG001|COMPLETED|Treatment Period 1||0
10884358|NCT03031782|12050381|FG002|COMPLETED|Treatment Period 1||0
10884359|NCT03031782|12050382|FG003|COMPLETED|Treatment Period 1||0
10884360|NCT03031782|12050383|FG004|COMPLETED|Treatment Period 1||0
10884361|NCT03031782|12050379|FG000|NOT COMPLETED|Treatment Period 1||3
10884362|NCT03031782|12050380|FG001|NOT COMPLETED|Treatment Period 1||0
10884363|NCT03031782|12050381|FG002|NOT COMPLETED|Treatment Period 1||0
10884364|NCT03031782|12050382|FG003|NOT COMPLETED|Treatment Period 1||0
10884365|NCT03031782|12050383|FG004|NOT COMPLETED|Treatment Period 1||0
10884366|NCT03031782|12050379|FG000|STARTED|Treatment Period 2||0
10884367|NCT03031782|12050380|FG001|STARTED|Treatment Period 2||37
10884368|NCT03031782|12050381|FG002|STARTED|Treatment Period 2||38
10884369|NCT03031782|12050382|FG003|STARTED|Treatment Period 2||0
10884370|NCT03031782|12050383|FG004|STARTED|Treatment Period 2||21
10884371|NCT03031782|12050379|FG000|COMPLETED|Treatment Period 2||0
10884372|NCT03031782|12050380|FG001|COMPLETED|Treatment Period 2||31
10884373|NCT03031782|12050381|FG002|COMPLETED|Treatment Period 2||36
10884374|NCT03031782|12050382|FG003|COMPLETED|Treatment Period 2||0
10884375|NCT03031782|12050383|FG004|COMPLETED|Treatment Period 2||16
10884376|NCT03031782|12050379|FG000|NOT COMPLETED|Treatment Period 2||0
10884377|NCT03031782|12050380|FG001|NOT COMPLETED|Treatment Period 2||6
10884378|NCT03031782|12050381|FG002|NOT COMPLETED|Treatment Period 2||2
10884379|NCT03031782|12050382|FG003|NOT COMPLETED|Treatment Period 2||0
10884380|NCT03031782|12050383|FG004|NOT COMPLETED|Treatment Period 2||5
10884381|NCT03031782|12050379|FG000|STARTED|Treatment Period 3||0
10884382|NCT03031782|12050380|FG001|STARTED|Treatment Period 3||0
10884383|NCT03031782|12050381|FG002|STARTED|Treatment Period 3||0
10884384|NCT03031782|12050382|FG003|STARTED|Treatment Period 3||11
10884385|NCT03031782|12050383|FG004|STARTED|Treatment Period 3||0
10884386|NCT03031782|12050379|FG000|COMPLETED|Treatment Period 3||0
10884387|NCT03031782|12050380|FG001|COMPLETED|Treatment Period 3||0
10884388|NCT03031782|12050381|FG002|COMPLETED|Treatment Period 3||0
10884389|NCT03031782|12050382|FG003|COMPLETED|Treatment Period 3||10
10884390|NCT03031782|12050383|FG004|COMPLETED|Treatment Period 3||0
10884391|NCT03031782|12050379|FG000|NOT COMPLETED|Treatment Period 3||0
10884392|NCT03031782|12050380|FG001|NOT COMPLETED|Treatment Period 3||0
10884393|NCT03031782|12050381|FG002|NOT COMPLETED|Treatment Period 3||0
10884394|NCT03031782|12050382|FG003|NOT COMPLETED|Treatment Period 3||1
10884395|NCT03031782|12050383|FG004|NOT COMPLETED|Treatment Period 3||0
10884396|NCT03030183|12050397|FG000|STARTED|Overall Study||3
10884397|NCT03030183|12050397|FG000|COMPLETED|Overall Study||3
10884398|NCT03030183|12050397|FG000|NOT COMPLETED|Overall Study||0
10884399|NCT03025828|12050401|FG000|STARTED|Overall Study||5
10884400|NCT03025828|12050401|FG000|COMPLETED|Overall Study||4
10884401|NCT03025828|12050401|FG000|NOT COMPLETED|Overall Study||1
10884402|NCT03025542|12050407|FG000|STARTED|Overall Study||32
10884403|NCT03025542|12050408|FG001|STARTED|Overall Study||17
10884404|NCT03025542|12050407|FG000|COMPLETED|Overall Study||30
10884405|NCT03025542|12050408|FG001|COMPLETED|Overall Study||15
10884406|NCT03025542|12050407|FG000|NOT COMPLETED|Overall Study||2
10884407|NCT03025542|12050408|FG001|NOT COMPLETED|Overall Study||2
10884408|NCT03022578|12050418|FG000|STARTED|Overall Study||4
10884409|NCT03022578|12050418|FG000|COMPLETED|Overall Study||0
10884410|NCT03022578|12050418|FG000|NOT COMPLETED|Overall Study||4
10884411|NCT03021642|12050422|FG000|STARTED|Treatment Period 1 (Day 1)||12
10884412|NCT03021642|12050423|FG001|STARTED|Treatment Period 1 (Day 1)||12
10884413|NCT03021642|12050422|FG000|COMPLETED|Treatment Period 1 (Day 1)||12
10884414|NCT03021642|12050423|FG001|COMPLETED|Treatment Period 1 (Day 1)||12
10884415|NCT03021642|12050422|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10884416|NCT03021642|12050423|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10884417|NCT03021642|12050422|FG000|STARTED|Washout Period (21 Days)||12
10884418|NCT03021642|12050423|FG001|STARTED|Washout Period (21 Days)||12
10884419|NCT03021642|12050422|FG000|COMPLETED|Washout Period (21 Days)||11
10884420|NCT03021642|12050423|FG001|COMPLETED|Washout Period (21 Days)||11
10884421|NCT03021642|12050422|FG000|NOT COMPLETED|Washout Period (21 Days)||1
10884422|NCT03021642|12050423|FG001|NOT COMPLETED|Washout Period (21 Days)||1
10884423|NCT03021642|12050422|FG000|STARTED|Treatment Period 2 (Day 22)||11
10884424|NCT03021642|12050423|FG001|STARTED|Treatment Period 2 (Day 22)||11
10884425|NCT03021642|12050422|FG000|COMPLETED|Treatment Period 2 (Day 22)||11
10884426|NCT03021642|12050423|FG001|COMPLETED|Treatment Period 2 (Day 22)||11
10884427|NCT03021642|12050422|FG000|NOT COMPLETED|Treatment Period 2 (Day 22)||0
10884428|NCT03021642|12050423|FG001|NOT COMPLETED|Treatment Period 2 (Day 22)||0
10884429|NCT03021486|12050432|FG000|STARTED|Overall Study||23
10884430|NCT03021486|12050433|FG001|STARTED|Overall Study||22
10884431|NCT03021486|12050434|FG002|STARTED|Overall Study||23
10884432|NCT03021486|12050432|FG000|COMPLETED|Overall Study||15
10884433|NCT03021486|12050433|FG001|COMPLETED|Overall Study||16
10884434|NCT03021486|12050434|FG002|COMPLETED|Overall Study||14
10884435|NCT03021486|12050432|FG000|NOT COMPLETED|Overall Study||8
10884436|NCT03021486|12050433|FG001|NOT COMPLETED|Overall Study||6
10884437|NCT03021486|12050434|FG002|NOT COMPLETED|Overall Study||9
10884438|NCT03020160|12050445|FG000|STARTED|Overall Study||7
10884439|NCT03020160|12050446|FG001|STARTED|Overall Study||41
10884440|NCT03020160|12050445|FG000|Completed 24 Weeks in the Study|Overall Study||7
10884441|NCT03020160|12050446|FG001|Completed 24 Weeks in the Study|Overall Study||41
10884442|NCT03020160|12050445|FG000|COMPLETED|Overall Study||0
10884443|NCT03020160|12050446|FG001|COMPLETED|Overall Study||0
10884444|NCT03020160|12050445|FG000|NOT COMPLETED|Overall Study||7
10884445|NCT03020160|12050446|FG001|NOT COMPLETED|Overall Study||41
10884446|NCT03020017|12050453|FG000|STARTED|NU-0129||8
10884447|NCT03020017|12050453|FG000|COMPLETED|NU-0129||8
10884448|NCT03020017|12050453|FG000|NOT COMPLETED|NU-0129||0
10884449|NCT03020017|12050453|FG000|STARTED|Standard of Care Resection||8
10884450|NCT03020017|12050453|FG000|COMPLETED|Standard of Care Resection||8
10884451|NCT03020017|12050453|FG000|NOT COMPLETED|Standard of Care Resection||0
10884452|NCT03018730|12050457|FG000|STARTED|Overall Study||22
10884453|NCT03018730|12050457|FG000|COMPLETED|Overall Study||20
10884454|NCT03018730|12050457|FG000|NOT COMPLETED|Overall Study||2
10884455|NCT03018392|12050464|FG000|STARTED|Overall Study||20
10884456|NCT03018392|12050464|FG000|COMPLETED|Overall Study||20
10884457|NCT03018392|12050464|FG000|NOT COMPLETED|Overall Study||0
10884458|NCT03016312|12050470|FG000|STARTED|Overall Study||391
10884459|NCT03016312|12050471|FG001|STARTED|Overall Study||380
10884460|NCT03016312|12050470|FG000|COMPLETED|Overall Study||150
10884461|NCT03016312|12050471|FG001|COMPLETED|Overall Study||162
10884462|NCT03016312|12050470|FG000|NOT COMPLETED|Overall Study||241
10884463|NCT03016312|12050471|FG001|NOT COMPLETED|Overall Study||218
10884464|NCT03015259|12050480|FG000|STARTED|Overall Study||613
10884465|NCT03015259|12050481|FG001|STARTED|Overall Study||622
10884466|NCT03015259|12050482|FG002|STARTED|Overall Study||204
10884467|NCT03015259|12050480|FG000|COMPLETED|Overall Study||598
10884468|NCT03015259|12050481|FG001|COMPLETED|Overall Study||604
10884469|NCT03015259|12050482|FG002|COMPLETED|Overall Study||199
10884470|NCT03015259|12050480|FG000|NOT COMPLETED|Overall Study||15
10884471|NCT03015259|12050481|FG001|NOT COMPLETED|Overall Study||18
10884472|NCT03015259|12050482|FG002|NOT COMPLETED|Overall Study||5
10884473|NCT03014362|12050492|FG000|STARTED|Overall Study||59
10884474|NCT03014362|12050493|FG001|STARTED|Overall Study||61
10884475|NCT03014362|12050492|FG000|COMPLETED|Overall Study||41
10884476|NCT03014362|12050493|FG001|COMPLETED|Overall Study||51
10884477|NCT03014362|12050492|FG000|NOT COMPLETED|Overall Study||18
10884478|NCT03014362|12050493|FG001|NOT COMPLETED|Overall Study||10
10884479|NCT03008005|12050502|FG000|STARTED|Overall Study||14
10884480|NCT03008005|12050503|FG001|STARTED|Overall Study||17
10884481|NCT03008005|12050504|FG002|STARTED|Overall Study||15
10884482|NCT03008005|12050502|FG000|COMPLETED|Overall Study||12
10884483|NCT03008005|12050503|FG001|COMPLETED|Overall Study||16
10884484|NCT03008005|12050504|FG002|COMPLETED|Overall Study||15
10884485|NCT03008005|12050502|FG000|NOT COMPLETED|Overall Study||2
10884486|NCT03008005|12050503|FG001|NOT COMPLETED|Overall Study||1
10884487|NCT03008005|12050504|FG002|NOT COMPLETED|Overall Study||0
10884488|NCT03006926|12050514|FG000|STARTED|Overall Study||6
10884489|NCT03006926|12050515|FG001|STARTED|Overall Study||98
10884490|NCT03006926|12050514|FG000|COMPLETED|Overall Study||6
10884491|NCT03006926|12050515|FG001|COMPLETED|Overall Study||0
10884492|NCT03006926|12050514|FG000|NOT COMPLETED|Overall Study||0
10884493|NCT03006926|12050515|FG001|NOT COMPLETED|Overall Study||98
10884494|NCT03006848|12050523|FG000|STARTED|Overall Study||18
10884495|NCT03006848|12050523|FG000|COMPLETED|Overall Study||0
10884496|NCT03006848|12050523|FG000|NOT COMPLETED|Overall Study||18
10884497|NCT03006185|12050534|FG000|STARTED|Overall Study|Since all participants had two test areas each, all participants received both interventions (18 test areas received CO2 and 18 test areas received microdermabrasion)|18
10884498|NCT03006185|12050534|FG000|Number of Test Areas Recieving AFL|Overall Study||18
10884499|NCT03006185|12050534|FG000|Number of Test Areas Receiving MD|Overall Study||18
10884500|NCT03006185|12050534|FG000|COMPLETED|Overall Study||18
10884501|NCT03006185|12050534|FG000|NOT COMPLETED|Overall Study||0
10884502|NCT03004976|12050542|FG000|STARTED|Overall Study||52
10884503|NCT03004976|12050543|FG001|STARTED|Overall Study||27
10884504|NCT03004976|12050542|FG000|COMPLETED|Overall Study||47
10884505|NCT03004976|12050543|FG001|COMPLETED|Overall Study||26
10884506|NCT03004976|12050542|FG000|NOT COMPLETED|Overall Study||5
10884507|NCT03004976|12050543|FG001|NOT COMPLETED|Overall Study||1
10884508|NCT03003520|12050551|FG000|STARTED|Induction||43
10884509|NCT03003520|12050552|FG001|STARTED|Induction||3
10884510|NCT03003520|12050551|FG000|Safety Population|Induction||43
10884511|NCT03003520|12050552|FG001|Safety Population|Induction||3
10884512|NCT03003520|12050551|FG000|Efficacy Evaluable Population|Induction||37
10884513|NCT03003520|12050552|FG001|Efficacy Evaluable Population|Induction||3
10884514|NCT03003520|12050551|FG000|COMPLETED|Induction||30
10884515|NCT03003520|12050552|FG001|COMPLETED|Induction||3
10884516|NCT03003520|12050551|FG000|NOT COMPLETED|Induction||13
10884517|NCT03003520|12050552|FG001|NOT COMPLETED|Induction||0
10884518|NCT03003520|12050551|FG000|STARTED|Consolidation||25
10884519|NCT03003520|12050552|FG001|STARTED|Consolidation||3
10884520|NCT03003520|12050551|FG000|COMPLETED|Consolidation||1
10884521|NCT03003520|12050552|FG001|COMPLETED|Consolidation||2
10884522|NCT03003520|12050551|FG000|NOT COMPLETED|Consolidation||24
10884523|NCT03003520|12050552|FG001|NOT COMPLETED|Consolidation||1
10884524|NCT03003520|12050551|FG000|STARTED|Follow-up||14
10884525|NCT03003520|12050552|FG001|STARTED|Follow-up||3
10884526|NCT03003520|12050551|FG000|COMPLETED|Follow-up||0
10884527|NCT03003520|12050552|FG001|COMPLETED|Follow-up||0
10884528|NCT03003520|12050551|FG000|NOT COMPLETED|Follow-up||14
10884529|NCT03003520|12050552|FG001|NOT COMPLETED|Follow-up||3
10884530|NCT03003130|12050568|FG000|STARTED|Overall Study||88
10884531|NCT03003130|12050569|FG001|STARTED|Overall Study||87
10884532|NCT03003130|12050568|FG000|COMPLETED|Overall Study||80
10884533|NCT03003130|12050569|FG001|COMPLETED|Overall Study||80
10884534|NCT03003130|12050568|FG000|NOT COMPLETED|Overall Study||8
10884535|NCT03003130|12050569|FG001|NOT COMPLETED|Overall Study||7
10884536|NCT02999984|12050575|FG000|STARTED|Overall Study||10
10884537|NCT02999984|12050575|FG000|COMPLETED|Overall Study||9
10884538|NCT02999984|12050575|FG000|NOT COMPLETED|Overall Study||1
10884539|NCT02998840|12050583|FG000|STARTED|Overall Study||33
10884540|NCT02998840|12050584|FG001|STARTED|Overall Study||33
10884541|NCT02998840|12050585|FG002|STARTED|Overall Study||33
10884542|NCT02998840|12050586|FG003|STARTED|Overall Study||33
10884543|NCT02998840|12050583|FG000|COMPLETED|Overall Study||29
10884544|NCT02998840|12050584|FG001|COMPLETED|Overall Study||30
10884545|NCT02998840|12050585|FG002|COMPLETED|Overall Study||31
10884546|NCT02998840|12050586|FG003|COMPLETED|Overall Study||28
10884547|NCT02998840|12050583|FG000|NOT COMPLETED|Overall Study||4
10884548|NCT02998840|12050584|FG001|NOT COMPLETED|Overall Study||3
10884549|NCT02998840|12050585|FG002|NOT COMPLETED|Overall Study||2
10884550|NCT02998840|12050586|FG003|NOT COMPLETED|Overall Study||5
10884551|NCT02998528|12050597|FG000|STARTED|Randomization Period||113
10884552|NCT02998528|12050598|FG001|STARTED|Randomization Period||213
10884553|NCT02998528|12050599|FG002|STARTED|Randomization Period||179
10884554|NCT02998528|12050597|FG000|All Concurrently Randomized Participants in Arms B and C|Randomization Period||0
10884555|NCT02998528|12050598|FG001|All Concurrently Randomized Participants in Arms B and C|Randomization Period||179
10884556|NCT02998528|12050599|FG002|All Concurrently Randomized Participants in Arms B and C|Randomization Period||179
10884557|NCT02998528|12050597|FG000|COMPLETED|Randomization Period||112
10884558|NCT02998528|12050598|FG001|COMPLETED|Randomization Period||207
10884559|NCT02998528|12050599|FG002|COMPLETED|Randomization Period||176
10884560|NCT02998528|12050597|FG000|NOT COMPLETED|Randomization Period||1
10884561|NCT02998528|12050598|FG001|NOT COMPLETED|Randomization Period||6
10884562|NCT02998528|12050599|FG002|NOT COMPLETED|Randomization Period||3
10884563|NCT02998528|12050597|FG000|STARTED|Neoadjuvant Treatment Period||111
10884564|NCT02998528|12050598|FG001|STARTED|Neoadjuvant Treatment Period||208
10884565|NCT02998528|12050599|FG002|STARTED|Neoadjuvant Treatment Period||176
10884566|NCT02998528|12050597|FG000|All Treated Participants From Concurrently Randomized Arms B and C|Neoadjuvant Treatment Period||0
10884567|NCT02998528|12050598|FG001|All Treated Participants From Concurrently Randomized Arms B and C|Neoadjuvant Treatment Period||176
10884568|NCT02998528|12050599|FG002|All Treated Participants From Concurrently Randomized Arms B and C|Neoadjuvant Treatment Period||176
10884569|NCT02998528|12050597|FG000|COMPLETED|Neoadjuvant Treatment Period||101
10884570|NCT02998528|12050598|FG001|COMPLETED|Neoadjuvant Treatment Period||177
10884571|NCT02998528|12050599|FG002|COMPLETED|Neoadjuvant Treatment Period||165
10884572|NCT02998528|12050597|FG000|NOT COMPLETED|Neoadjuvant Treatment Period||10
10884573|NCT02998528|12050598|FG001|NOT COMPLETED|Neoadjuvant Treatment Period||31
10884574|NCT02998528|12050599|FG002|NOT COMPLETED|Neoadjuvant Treatment Period||11
10884575|NCT02998528|12050597|FG000|STARTED|Systemic Adjuvant Treatment Period||37
10884576|NCT02998528|12050598|FG001|STARTED|Systemic Adjuvant Treatment Period||47
10884577|NCT02998528|12050599|FG002|STARTED|Systemic Adjuvant Treatment Period||26
10884578|NCT02998528|12050597|FG000|COMPLETED|Systemic Adjuvant Treatment Period||28
10884579|NCT02998528|12050598|FG001|COMPLETED|Systemic Adjuvant Treatment Period||41
10884580|NCT02998528|12050599|FG002|COMPLETED|Systemic Adjuvant Treatment Period||22
10884581|NCT02998528|12050597|FG000|NOT COMPLETED|Systemic Adjuvant Treatment Period||9
10884582|NCT02998528|12050598|FG001|NOT COMPLETED|Systemic Adjuvant Treatment Period||6
10884583|NCT02998528|12050599|FG002|NOT COMPLETED|Systemic Adjuvant Treatment Period||4
10884584|NCT02994927|12050608|FG000|STARTED|Overall Study||165
10884585|NCT02994927|12050609|FG001|STARTED|Overall Study||166
10884586|NCT02994927|12050608|FG000|COMPLETED|Overall Study||150
10884587|NCT02994927|12050609|FG001|COMPLETED|Overall Study||151
10884588|NCT02994927|12050608|FG000|NOT COMPLETED|Overall Study||15
10884589|NCT02994927|12050609|FG001|NOT COMPLETED|Overall Study||15
10884590|NCT02991482|12050617|FG000|STARTED|Overall Study||73
10884591|NCT02991482|12050618|FG001|STARTED|Overall Study||71
10884592|NCT02991482|12050617|FG000|Crossed-over to Pembrolizumab at Progression|Overall Study||0
10884593|NCT02991482|12050618|FG001|Crossed-over to Pembrolizumab at Progression|Overall Study||45
10884594|NCT02991482|12050617|FG000|COMPLETED|Overall Study||8
10884595|NCT02991482|12050618|FG001|COMPLETED|Overall Study||5
10884596|NCT02991482|12050617|FG000|NOT COMPLETED|Overall Study||65
10884597|NCT02991482|12050618|FG001|NOT COMPLETED|Overall Study||66
10884598|NCT02989194|12050627|FG000|STARTED|Overall Study||50
10884599|NCT02989194|12050628|FG001|STARTED|Overall Study||50
10884600|NCT02989194|12050629|FG002|STARTED|Overall Study||50
10884601|NCT02989194|12050627|FG000|COMPLETED|Overall Study||49
10884602|NCT02989194|12050628|FG001|COMPLETED|Overall Study||48
10884603|NCT02989194|12050629|FG002|COMPLETED|Overall Study||50
10884604|NCT02989194|12050627|FG000|NOT COMPLETED|Overall Study||1
10884605|NCT02989194|12050628|FG001|NOT COMPLETED|Overall Study||2
10884606|NCT02989194|12050629|FG002|NOT COMPLETED|Overall Study||0
10884607|NCT02987543|12050652|FG000|STARTED|Overall Study||162
10884608|NCT02987543|12050653|FG001|STARTED|Overall Study||83
10884609|NCT02987543|12050654|FG002|STARTED|Overall Study||94
10884610|NCT02987543|12050655|FG003|STARTED|Overall Study||48
10884611|NCT02987543|12050652|FG000|COMPLETED|Overall Study||0
10884612|NCT02987543|12050653|FG001|COMPLETED|Overall Study||0
10884613|NCT02987543|12050654|FG002|COMPLETED|Overall Study||0
10884614|NCT02987543|12050655|FG003|COMPLETED|Overall Study||0
10884615|NCT02987543|12050652|FG000|NOT COMPLETED|Overall Study||162
10884616|NCT02987543|12050653|FG001|NOT COMPLETED|Overall Study||83
10884617|NCT02987543|12050654|FG002|NOT COMPLETED|Overall Study||94
10884618|NCT02987543|12050655|FG003|NOT COMPLETED|Overall Study||48
10884619|NCT02984228|12050663|FG000|STARTED|Overall Study||34
10884620|NCT02984228|12050664|FG001|STARTED|Overall Study||36
10884621|NCT02984228|12050663|FG000|COMPLETED|Overall Study||34
10884622|NCT02984228|12050664|FG001|COMPLETED|Overall Study||35
10884623|NCT02984228|12050663|FG000|NOT COMPLETED|Overall Study||0
10884624|NCT02984228|12050664|FG001|NOT COMPLETED|Overall Study||1
10884625|NCT02979587|12050670|FG000|STARTED|Overall Study||50
10884626|NCT02979587|12050670|FG000|Catheterized|Overall Study||50
10884627|NCT02979587|12050670|FG000|Implanted|Overall Study||50
10884628|NCT02979587|12050670|FG000|Implanted > 24 Hours|Overall Study||48
10884629|NCT02979587|12050670|FG000|COMPLETED|Overall Study||48
10884630|NCT02979587|12050670|FG000|NOT COMPLETED|Overall Study||2
10884631|NCT02973425|12050680|FG000|STARTED|Overall Study||220
10884632|NCT02973425|12050681|FG001|STARTED|Overall Study||213
10884633|NCT02973425|12050680|FG000|COMPLETED|Overall Study||171
10884634|NCT02973425|12050681|FG001|COMPLETED|Overall Study||160
10884635|NCT02973425|12050680|FG000|NOT COMPLETED|Overall Study||49
10884636|NCT02973425|12050681|FG001|NOT COMPLETED|Overall Study||53
10884637|NCT02972424|12050690|FG000|STARTED|3 Month Endpoints- Blinded Portion||18
10884638|NCT02972424|12050691|FG001|STARTED|3 Month Endpoints- Blinded Portion||17
10884639|NCT02972424|12050690|FG000|COMPLETED|3 Month Endpoints- Blinded Portion||17
10884640|NCT02972424|12050691|FG001|COMPLETED|3 Month Endpoints- Blinded Portion||12
10884641|NCT02972424|12050690|FG000|NOT COMPLETED|3 Month Endpoints- Blinded Portion||1
10884642|NCT02972424|12050691|FG001|NOT COMPLETED|3 Month Endpoints- Blinded Portion||5
10884643|NCT02972424|12050690|FG000|STARTED|Open Label Extension 3 to 12 Months||17
10884644|NCT02972424|12050691|FG001|STARTED|Open Label Extension 3 to 12 Months||12
10884645|NCT02972424|12050690|FG000|COMPLETED|Open Label Extension 3 to 12 Months||12
10884646|NCT02972424|12050691|FG001|COMPLETED|Open Label Extension 3 to 12 Months||9
10884647|NCT02972424|12050690|FG000|NOT COMPLETED|Open Label Extension 3 to 12 Months||5
10884648|NCT02972424|12050691|FG001|NOT COMPLETED|Open Label Extension 3 to 12 Months||3
10884649|NCT02971683|12050700|FG000|STARTED|Overall Study||75
10884650|NCT02971683|12050701|FG001|STARTED|Overall Study||73
10884651|NCT02971683|12050700|FG000|COMPLETED|Overall Study||69
10884652|NCT02971683|12050701|FG001|COMPLETED|Overall Study||65
10884653|NCT02971683|12050700|FG000|NOT COMPLETED|Overall Study||6
10884654|NCT02971683|12050701|FG001|NOT COMPLETED|Overall Study||8
10884655|NCT02970981|12050707|FG000|STARTED|Overall Study||16
10884656|NCT02970981|12050707|FG000|COMPLETED|Overall Study||16
10884657|NCT02970981|12050707|FG000|NOT COMPLETED|Overall Study||0
10884658|NCT02969356|12050711|FG000|STARTED|Overall Study||157
10884659|NCT02969356|12050711|FG000|Intent-to-Treat (ITT) Population|Overall Study||153
10884660|NCT02969356|12050711|FG000|COMPLETED|Overall Study||134
10884661|NCT02969356|12050711|FG000|NOT COMPLETED|Overall Study||23
10884662|NCT02968004|12050717|FG000|STARTED|Overall Study||109
10884663|NCT02968004|12050718|FG001|STARTED|Overall Study||115
10884664|NCT02968004|12050717|FG000|COMPLETED|Overall Study||108
10884665|NCT02968004|12050718|FG001|COMPLETED|Overall Study||114
10884666|NCT02968004|12050717|FG000|NOT COMPLETED|Overall Study||1
10884667|NCT02968004|12050718|FG001|NOT COMPLETED|Overall Study||1
10884668|NCT02967133|12050726|FG000|STARTED|Overall Study||3
10884669|NCT02967133|12050727|FG001|STARTED|Overall Study||4
10884670|NCT02967133|12050726|FG000|COMPLETED|Overall Study||3
10884671|NCT02967133|12050727|FG001|COMPLETED|Overall Study||4
10884672|NCT02967133|12050726|FG000|NOT COMPLETED|Overall Study||0
10884673|NCT02967133|12050727|FG001|NOT COMPLETED|Overall Study||0
10884674|NCT02965729|12050736|FG000|STARTED|Overall Study||24
10884675|NCT02965729|12050737|FG001|STARTED|Overall Study||25
10884676|NCT02965729|12050738|FG002|STARTED|Overall Study||56
10884677|NCT02965729|12050736|FG000|COMPLETED|Overall Study||17
10884678|NCT02965729|12050737|FG001|COMPLETED|Overall Study||22
10884679|NCT02965729|12050738|FG002|COMPLETED|Overall Study||45
10884680|NCT02965729|12050736|FG000|NOT COMPLETED|Overall Study||7
10884681|NCT02965729|12050737|FG001|NOT COMPLETED|Overall Study||3
10884682|NCT02965729|12050738|FG002|NOT COMPLETED|Overall Study||11
10884683|NCT02964741|12050749|FG000|STARTED|Overall Study||15
10884684|NCT02964741|12050750|FG001|STARTED|Overall Study||13
10884685|NCT02964741|12050751|FG002|STARTED|Overall Study||12
10884686|NCT02964741|12050749|FG000|COMPLETED|Overall Study||13
10884687|NCT02964741|12050750|FG001|COMPLETED|Overall Study||12
10884688|NCT02964741|12050751|FG002|COMPLETED|Overall Study||12
10884689|NCT02964741|12050749|FG000|NOT COMPLETED|Overall Study||2
10884690|NCT02964741|12050750|FG001|NOT COMPLETED|Overall Study||1
10884691|NCT02964741|12050751|FG002|NOT COMPLETED|Overall Study||0
10884692|NCT02963506|12050762|FG000|STARTED|Double-Blind Period||60
10884693|NCT02963506|12050763|FG001|STARTED|Double-Blind Period||61
10884694|NCT02963506|12050764|FG002|STARTED|Double-Blind Period||61
10884695|NCT02963506|12050765|FG003|STARTED|Double-Blind Period||60
10884696|NCT02963506|12050766|FG004|STARTED|Double-Blind Period||61
10884697|NCT02963506|12050767|FG005|STARTED|Double-Blind Period||0
10884698|NCT02963506|12050768|FG006|STARTED|Double-Blind Period||0
10884699|NCT02963506|12050769|FG007|STARTED|Double-Blind Period||0
10884700|NCT02963506|12050770|FG008|STARTED|Double-Blind Period||0
10884701|NCT02963506|12050771|FG009|STARTED|Double-Blind Period||0
10884702|NCT02963506|12050772|FG010|STARTED|Double-Blind Period||0
10884703|NCT02963506|12050773|FG011|STARTED|Double-Blind Period||0
10884704|NCT02963506|12050774|FG012|STARTED|Double-Blind Period||0
10884705|NCT02963506|12050762|FG000|Completed Double-Blind Period|Double-Blind Period||60
10884706|NCT02963506|12050763|FG001|Completed Double-Blind Period|Double-Blind Period||59
10884707|NCT02963506|12050764|FG002|Completed Double-Blind Period|Double-Blind Period||59
10884708|NCT02963506|12050765|FG003|Completed Double-Blind Period|Double-Blind Period||58
10884709|NCT02963506|12050766|FG004|Completed Double-Blind Period|Double-Blind Period||61
10884710|NCT02963506|12050767|FG005|Completed Double-Blind Period|Double-Blind Period||0
10884711|NCT02963506|12050768|FG006|Completed Double-Blind Period|Double-Blind Period||0
10884712|NCT02963506|12050769|FG007|Completed Double-Blind Period|Double-Blind Period||0
10884713|NCT02963506|12050770|FG008|Completed Double-Blind Period|Double-Blind Period||0
10884714|NCT02963506|12050771|FG009|Completed Double-Blind Period|Double-Blind Period||0
10884715|NCT02963506|12050772|FG010|Completed Double-Blind Period|Double-Blind Period||0
10884716|NCT02963506|12050773|FG011|Completed Double-Blind Period|Double-Blind Period||0
10884717|NCT02963506|12050774|FG012|Completed Double-Blind Period|Double-Blind Period||0
10884718|NCT02963506|12050762|FG000|Completed Week 12 - Started Dose-Blind|Double-Blind Period||60
10884719|NCT02963506|12050763|FG001|Completed Week 12 - Started Dose-Blind|Double-Blind Period||58
10884720|NCT02963506|12050764|FG002|Completed Week 12 - Started Dose-Blind|Double-Blind Period||59
10884721|NCT02963506|12050765|FG003|Completed Week 12 - Started Dose-Blind|Double-Blind Period||58
10884722|NCT02963506|12050766|FG004|Completed Week 12 - Started Dose-Blind|Double-Blind Period||61
10884723|NCT02963506|12050767|FG005|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
10884724|NCT02963506|12050768|FG006|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
10884725|NCT02963506|12050769|FG007|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
10884726|NCT02963506|12050770|FG008|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
10884727|NCT02963506|12050771|FG009|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
10884728|NCT02963506|12050772|FG010|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
10884729|NCT02963506|12050773|FG011|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
10884730|NCT02963506|12050774|FG012|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
10884731|NCT02963506|12050762|FG000|COMPLETED|Double-Blind Period||60
10884732|NCT02963506|12050763|FG001|COMPLETED|Double-Blind Period||58
10884733|NCT02963506|12050764|FG002|COMPLETED|Double-Blind Period||59
10884734|NCT02963506|12050765|FG003|COMPLETED|Double-Blind Period||58
10884735|NCT02963506|12050766|FG004|COMPLETED|Double-Blind Period||61
10884736|NCT02963506|12050767|FG005|COMPLETED|Double-Blind Period||0
10884737|NCT02963506|12050768|FG006|COMPLETED|Double-Blind Period||0
10884738|NCT02963506|12050769|FG007|COMPLETED|Double-Blind Period||0
10884739|NCT02963506|12050770|FG008|COMPLETED|Double-Blind Period||0
10884740|NCT02963506|12050771|FG009|COMPLETED|Double-Blind Period||0
10884741|NCT02963506|12050772|FG010|COMPLETED|Double-Blind Period||0
10884742|NCT02963506|12050773|FG011|COMPLETED|Double-Blind Period||0
10884743|NCT02963506|12050774|FG012|COMPLETED|Double-Blind Period||0
10884744|NCT02963506|12050762|FG000|NOT COMPLETED|Double-Blind Period||0
10884745|NCT02963506|12050763|FG001|NOT COMPLETED|Double-Blind Period||3
10884746|NCT02963506|12050764|FG002|NOT COMPLETED|Double-Blind Period||2
10884747|NCT02963506|12050765|FG003|NOT COMPLETED|Double-Blind Period||2
10884748|NCT02963506|12050766|FG004|NOT COMPLETED|Double-Blind Period||0
10884749|NCT02963506|12050767|FG005|NOT COMPLETED|Double-Blind Period||0
10884750|NCT02963506|12050768|FG006|NOT COMPLETED|Double-Blind Period||0
10884751|NCT02963506|12050769|FG007|NOT COMPLETED|Double-Blind Period||0
10884752|NCT02963506|12050770|FG008|NOT COMPLETED|Double-Blind Period||0
10884753|NCT02963506|12050771|FG009|NOT COMPLETED|Double-Blind Period||0
10884754|NCT02963506|12050772|FG010|NOT COMPLETED|Double-Blind Period||0
10884755|NCT02963506|12050773|FG011|NOT COMPLETED|Double-Blind Period||0
10884756|NCT02963506|12050774|FG012|NOT COMPLETED|Double-Blind Period||0
10884757|NCT02963506|12050762|FG000|STARTED|Dose-Blind Period||0
10884758|NCT02963506|12050763|FG001|STARTED|Dose-Blind Period||0
10884759|NCT02963506|12050764|FG002|STARTED|Dose-Blind Period||0
10884760|NCT02963506|12050765|FG003|STARTED|Dose-Blind Period||0
10884761|NCT02963506|12050766|FG004|STARTED|Dose-Blind Period||0
10884762|NCT02963506|12050767|FG005|STARTED|Dose-Blind Period||24
10884763|NCT02963506|12050768|FG006|STARTED|Dose-Blind Period||36
10884764|NCT02963506|12050769|FG007|STARTED|Dose-Blind Period||31
10884765|NCT02963506|12050770|FG008|STARTED|Dose-Blind Period||27
10884766|NCT02963506|12050771|FG009|STARTED|Dose-Blind Period||34
10884767|NCT02963506|12050772|FG010|STARTED|Dose-Blind Period||25
10884768|NCT02963506|12050773|FG011|STARTED|Dose-Blind Period||58
10884769|NCT02963506|12050774|FG012|STARTED|Dose-Blind Period||61
10884770|NCT02963506|12050762|FG000|COMPLETED|Dose-Blind Period||0
10884771|NCT02963506|12050763|FG001|COMPLETED|Dose-Blind Period||0
10884772|NCT02963506|12050764|FG002|COMPLETED|Dose-Blind Period||0
10884773|NCT02963506|12050765|FG003|COMPLETED|Dose-Blind Period||0
10884774|NCT02963506|12050766|FG004|COMPLETED|Dose-Blind Period||0
10884775|NCT02963506|12050767|FG005|COMPLETED|Dose-Blind Period||20
10884776|NCT02963506|12050768|FG006|COMPLETED|Dose-Blind Period||31
10884777|NCT02963506|12050769|FG007|COMPLETED|Dose-Blind Period||26
10884778|NCT02963506|12050770|FG008|COMPLETED|Dose-Blind Period||24
10884779|NCT02963506|12050771|FG009|COMPLETED|Dose-Blind Period||30
10884780|NCT02963506|12050772|FG010|COMPLETED|Dose-Blind Period||24
10884781|NCT02963506|12050773|FG011|COMPLETED|Dose-Blind Period||56
10884782|NCT02963506|12050774|FG012|COMPLETED|Dose-Blind Period||54
10884783|NCT02963506|12050762|FG000|NOT COMPLETED|Dose-Blind Period||0
10884784|NCT02963506|12050763|FG001|NOT COMPLETED|Dose-Blind Period||0
10884785|NCT02963506|12050764|FG002|NOT COMPLETED|Dose-Blind Period||0
10884786|NCT02963506|12050765|FG003|NOT COMPLETED|Dose-Blind Period||0
10884787|NCT02963506|12050766|FG004|NOT COMPLETED|Dose-Blind Period||0
10884788|NCT02963506|12050767|FG005|NOT COMPLETED|Dose-Blind Period||4
10884789|NCT02963506|12050768|FG006|NOT COMPLETED|Dose-Blind Period||5
10884790|NCT02963506|12050769|FG007|NOT COMPLETED|Dose-Blind Period||5
10884791|NCT02963506|12050770|FG008|NOT COMPLETED|Dose-Blind Period||3
10884792|NCT02963506|12050771|FG009|NOT COMPLETED|Dose-Blind Period||4
10884793|NCT02963506|12050772|FG010|NOT COMPLETED|Dose-Blind Period||1
10884794|NCT02963506|12050773|FG011|NOT COMPLETED|Dose-Blind Period||2
10884795|NCT02963506|12050774|FG012|NOT COMPLETED|Dose-Blind Period||7
10884796|NCT02963090|12050794|FG000|STARTED|Overall Study||1
10884797|NCT02963090|12050795|FG001|STARTED|Overall Study||6
10884798|NCT02963090|12050796|FG002|STARTED|Overall Study||2
10884799|NCT02963090|12050794|FG000|COMPLETED|Overall Study||1
10884800|NCT02963090|12050795|FG001|COMPLETED|Overall Study||6
10884801|NCT02963090|12050796|FG002|COMPLETED|Overall Study||2
10884802|NCT02963090|12050794|FG000|NOT COMPLETED|Overall Study||0
10884803|NCT02963090|12050795|FG001|NOT COMPLETED|Overall Study||0
10884804|NCT02963090|12050796|FG002|NOT COMPLETED|Overall Study||0
10884805|NCT02954887|12050803|FG000|STARTED|Overall Study||9
10884806|NCT02954887|12050803|FG000|COMPLETED|Overall Study||2
10884807|NCT02954887|12050803|FG000|NOT COMPLETED|Overall Study||7
10884808|NCT02953548|12050807|FG000|STARTED|Overall Study||5
10884809|NCT02953548|12050808|FG001|STARTED|Overall Study||4
10884810|NCT02953548|12050807|FG000|COMPLETED|Overall Study||5
10884811|NCT02953548|12050808|FG001|COMPLETED|Overall Study||4
10884812|NCT02953548|12050807|FG000|NOT COMPLETED|Overall Study||0
10884813|NCT02953548|12050808|FG001|NOT COMPLETED|Overall Study||0
10884814|NCT02951767|12050815|FG000|STARTED|Overall Study||119
10884815|NCT02951767|12050815|FG000|COMPLETED|Overall Study||0
10884816|NCT02951767|12050815|FG000|NOT COMPLETED|Overall Study||119
10884817|NCT02950818|12050821|FG000|STARTED|Overall Study||228
10884818|NCT02950818|12050822|FG001|STARTED|Overall Study||225
10884819|NCT02950818|12050821|FG000|COMPLETED|Overall Study||161
10884820|NCT02950818|12050822|FG001|COMPLETED|Overall Study||201
10884821|NCT02950818|12050821|FG000|NOT COMPLETED|Overall Study||67
10884822|NCT02950818|12050822|FG001|NOT COMPLETED|Overall Study||24
10884823|NCT02949128|12050829|FG000|STARTED|Initial Evaluation Period||58
10884824|NCT02949128|12050829|FG000|Received At Least 1 Dose of Study Drug|Initial Evaluation Period||58
10884825|NCT02949128|12050829|FG000|COMPLETED|Initial Evaluation Period||49
10884826|NCT02949128|12050829|FG000|NOT COMPLETED|Initial Evaluation Period||9
10884827|NCT02949128|12050829|FG000|STARTED|Extension Period||49
10884828|NCT02949128|12050829|FG000|Received At Least 1 Dose of Study Drug|Extension Period||47
10884829|NCT02949128|12050829|FG000|COMPLETED|Extension Period||0
10884830|NCT02949128|12050829|FG000|NOT COMPLETED|Extension Period||49
10884831|NCT02946931|12050833|FG000|STARTED|Overall Study||1402
10884832|NCT02946931|12050833|FG000|Case Report Forms (CRFs) Collected|Overall Study||814
10884833|NCT02946931|12050833|FG000|CRFs Valid|Overall Study||813
10884834|NCT02946931|12050833|FG000|COMPLETED|Overall Study||571
10884835|NCT02946931|12050833|FG000|NOT COMPLETED|Overall Study||831
10884836|NCT02946463|12050839|FG000|STARTED|Primary Evaluation Period||125
10884837|NCT02946463|12050840|FG001|STARTED|Primary Evaluation Period||121
10884838|NCT02946463|12050839|FG000|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||125
10884839|NCT02946463|12050840|FG001|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||121
10884840|NCT02946463|12050839|FG000|COMPLETED|Primary Evaluation Period||125
10884841|NCT02946463|12050840|FG001|COMPLETED|Primary Evaluation Period||119
10884842|NCT02946463|12050839|FG000|NOT COMPLETED|Primary Evaluation Period||0
10884843|NCT02946463|12050840|FG001|NOT COMPLETED|Primary Evaluation Period||2
10884844|NCT02946463|12050839|FG000|STARTED|Extension Period||124
10884845|NCT02946463|12050840|FG001|STARTED|Extension Period||119
10884846|NCT02946463|12050839|FG000|Received at Least 1 Dose of Ravulizumab|Extension Period||124
10884847|NCT02946463|12050840|FG001|Received at Least 1 Dose of Ravulizumab|Extension Period||119
10884848|NCT02946463|12050839|FG000|COMPLETED|Extension Period||0
10884849|NCT02946463|12050840|FG001|COMPLETED|Extension Period||0
10884850|NCT02946463|12050839|FG000|NOT COMPLETED|Extension Period||124
10884851|NCT02946463|12050840|FG001|NOT COMPLETED|Extension Period||119
10884852|NCT02944071|12050846|FG000|STARTED|Overall Study||123
10884853|NCT02944071|12050846|FG000|COMPLETED|Overall Study||113
10884854|NCT02944071|12050846|FG000|NOT COMPLETED|Overall Study||10
10884855|NCT02938520|12050852|FG000|STARTED|Overall Study||283
10884856|NCT02938520|12050853|FG001|STARTED|Overall Study||283
10884857|NCT02938520|12050852|FG000|COMPLETED|Overall Study||0
10884858|NCT02938520|12050853|FG001|COMPLETED|Overall Study||0
10884859|NCT02938520|12050852|FG000|NOT COMPLETED|Overall Study||283
10884860|NCT02938520|12050853|FG001|NOT COMPLETED|Overall Study||283
10884861|NCT02937818|12050866|FG000|STARTED|Overall Study||21
10884862|NCT02937818|12050867|FG001|STARTED|Overall Study||20
10884863|NCT02937818|12050868|FG002|STARTED|Overall Study||10
10884864|NCT02937818|12050869|FG003|STARTED|Overall Study||21
10884865|NCT02937818|12050866|FG000|COMPLETED|Overall Study||0
10884866|NCT02937818|12050867|FG001|COMPLETED|Overall Study||0
10884867|NCT02937818|12050868|FG002|COMPLETED|Overall Study||0
10884868|NCT02937818|12050869|FG003|COMPLETED|Overall Study||0
10884869|NCT02937818|12050866|FG000|NOT COMPLETED|Overall Study||21
10884870|NCT02937818|12050867|FG001|NOT COMPLETED|Overall Study||20
10884871|NCT02937818|12050868|FG002|NOT COMPLETED|Overall Study||10
10884872|NCT02937818|12050869|FG003|NOT COMPLETED|Overall Study||21
10884873|NCT02933489|12050884|FG000|STARTED|Overall Study||757
10884874|NCT02933489|12050885|FG001|STARTED|Overall Study||759
10884875|NCT02933489|12050884|FG000|DBTperformed|Overall Study||726
10884876|NCT02933489|12050885|FG001|DBTperformed|Overall Study||737
10884877|NCT02933489|12050884|FG000|AB MR Performed|Overall Study||713
10884878|NCT02933489|12050885|FG001|AB MR Performed|Overall Study||733
10884879|NCT02933489|12050884|FG000|COMPLETED|Overall Study||713
10884880|NCT02933489|12050885|FG001|COMPLETED|Overall Study||731
10884881|NCT02933489|12050884|FG000|NOT COMPLETED|Overall Study||44
10884882|NCT02933489|12050885|FG001|NOT COMPLETED|Overall Study||28
10884883|NCT02928224|12050900|FG000|STARTED|Overall Study||37
10884884|NCT02928224|12050901|FG001|STARTED|Overall Study||224
10884885|NCT02928224|12050902|FG002|STARTED|Overall Study||220
10884886|NCT02928224|12050903|FG003|STARTED|Overall Study||221
10884887|NCT02928224|12050900|FG000|COMPLETED|Overall Study||0
10884888|NCT02928224|12050901|FG001|COMPLETED|Overall Study||0
10884889|NCT02928224|12050902|FG002|COMPLETED|Overall Study||0
10884890|NCT02928224|12050903|FG003|COMPLETED|Overall Study||0
10884891|NCT02928224|12050900|FG000|NOT COMPLETED|Overall Study||37
10884892|NCT02928224|12050901|FG001|NOT COMPLETED|Overall Study||224
10884893|NCT02928224|12050902|FG002|NOT COMPLETED|Overall Study||220
10884894|NCT02928224|12050903|FG003|NOT COMPLETED|Overall Study||221
10884895|NCT02927301|12050918|FG000|STARTED|Overall Study||181
10884896|NCT02927301|12050918|FG000|COMPLETED|Overall Study||171
10884897|NCT02927301|12050918|FG000|NOT COMPLETED|Overall Study||10
10884898|NCT02927262|12050924|FG000|STARTED|Overall Study||63
10884899|NCT02927262|12050925|FG001|STARTED|Overall Study||35
10884900|NCT02927262|12050924|FG000|COMPLETED|Overall Study||20
10884901|NCT02927262|12050925|FG001|COMPLETED|Overall Study||12
10884902|NCT02927262|12050924|FG000|NOT COMPLETED|Overall Study||43
10884903|NCT02927262|12050925|FG001|NOT COMPLETED|Overall Study||23
10884904|NCT02927080|12050941|FG000|STARTED|Overall Study||6
10884905|NCT02927080|12050942|FG001|STARTED|Overall Study||6
10884906|NCT02927080|12050943|FG002|STARTED|Overall Study||6
10884907|NCT02927080|12050944|FG003|STARTED|Overall Study||6
10884908|NCT02927080|12050945|FG004|STARTED|Overall Study||7
10884909|NCT02927080|12050946|FG005|STARTED|Overall Study||6
10884910|NCT02927080|12050947|FG006|STARTED|Overall Study||15
10884911|NCT02927080|12050948|FG007|STARTED|Overall Study||14
10884912|NCT02927080|12050949|FG008|STARTED|Overall Study||15
10884913|NCT02927080|12050950|FG009|STARTED|Overall Study||14
10884914|NCT02927080|12050941|FG000|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0
10884915|NCT02927080|12050942|FG001|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0
10884916|NCT02927080|12050943|FG002|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0
10884917|NCT02927080|12050944|FG003|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0
10884918|NCT02927080|12050945|FG004|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0
10884919|NCT02927080|12050946|FG005|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0
10884920|NCT02927080|12050947|FG006|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||14
10884921|NCT02927080|12050948|FG007|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||13
10884922|NCT02927080|12050949|FG008|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||14
10884923|NCT02927080|12050950|FG009|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||12
10884924|NCT02927080|12050941|FG000|COMPLETED|Overall Study||6
10884925|NCT02927080|12050942|FG001|COMPLETED|Overall Study||5
10884926|NCT02927080|12050943|FG002|COMPLETED|Overall Study||6
10884927|NCT02927080|12050944|FG003|COMPLETED|Overall Study||6
10884928|NCT02927080|12050945|FG004|COMPLETED|Overall Study||6
10884929|NCT02927080|12050946|FG005|COMPLETED|Overall Study||6
10884930|NCT02927080|12050947|FG006|COMPLETED|Overall Study||7
10884931|NCT02927080|12050948|FG007|COMPLETED|Overall Study||5
10884932|NCT02927080|12050949|FG008|COMPLETED|Overall Study||12
10884933|NCT02927080|12050950|FG009|COMPLETED|Overall Study||7
10884934|NCT02927080|12050941|FG000|NOT COMPLETED|Overall Study||0
10884935|NCT02927080|12050942|FG001|NOT COMPLETED|Overall Study||1
10884936|NCT02927080|12050943|FG002|NOT COMPLETED|Overall Study||0
10884937|NCT02927080|12050944|FG003|NOT COMPLETED|Overall Study||0
10884938|NCT02927080|12050945|FG004|NOT COMPLETED|Overall Study||1
10884939|NCT02927080|12050946|FG005|NOT COMPLETED|Overall Study||0
10884940|NCT02927080|12050947|FG006|NOT COMPLETED|Overall Study||8
10884941|NCT02927080|12050948|FG007|NOT COMPLETED|Overall Study||9
10884942|NCT02927080|12050949|FG008|NOT COMPLETED|Overall Study||3
10884943|NCT02927080|12050950|FG009|NOT COMPLETED|Overall Study||7
10884944|NCT02923180|12050995|FG000|STARTED|Overall Study||32
10884945|NCT02923180|12050995|FG000|COMPLETED|Overall Study||6
10884946|NCT02923180|12050995|FG000|NOT COMPLETED|Overall Study||26
10884947|NCT02921919|12051001|FG000|STARTED|Overall Study||66
10884948|NCT02921919|12051002|FG001|STARTED|Overall Study||52
10884949|NCT02921919|12051001|FG000|Treated|Overall Study||66
10884950|NCT02921919|12051002|FG001|Treated|Overall Study||52
10884951|NCT02921919|12051001|FG000|COMPLETED|Overall Study||0
10884952|NCT02921919|12051002|FG001|COMPLETED|Overall Study||0
10884953|NCT02921919|12051001|FG000|NOT COMPLETED|Overall Study||66
10884954|NCT02921919|12051002|FG001|NOT COMPLETED|Overall Study||52
10884955|NCT02918721|12051008|FG000|STARTED|Overall Study||70
10884956|NCT02918721|12051008|FG000|COMPLETED|Overall Study||70
10884957|NCT02918721|12051008|FG000|NOT COMPLETED|Overall Study||0
10884958|NCT02918292|12051013|FG000|STARTED|Study Enrollment Prior to Transplant||32
10884959|NCT02918292|12051013|FG000|COMPLETED|Study Enrollment Prior to Transplant||31
10884960|NCT02918292|12051013|FG000|NOT COMPLETED|Study Enrollment Prior to Transplant||1
10884961|NCT02918292|12051013|FG000|STARTED|Study Follow up After Transplant||31
10884962|NCT02918292|12051013|FG000|COMPLETED|Study Follow up After Transplant||25
10884963|NCT02918292|12051013|FG000|NOT COMPLETED|Study Follow up After Transplant||6
10884964|NCT02908685|12051029|FG000|STARTED|Part 1 Exploratory||7
10884965|NCT02908685|12051030|FG001|STARTED|Part 1 Exploratory||7
10884966|NCT02908685|12051031|FG002|STARTED|Part 1 Exploratory||3
10884967|NCT02908685|12051032|FG003|STARTED|Part 1 Exploratory||3
10884968|NCT02908685|12051033|FG004|STARTED|Part 1 Exploratory||7
10884969|NCT02908685|12051034|FG005|STARTED|Part 1 Exploratory||7
10884970|NCT02908685|12051035|FG006|STARTED|Part 1 Exploratory||7
10884971|NCT02908685|12051036|FG007|STARTED|Part 1 Exploratory||3
10884972|NCT02908685|12051037|FG008|STARTED|Part 1 Exploratory||4
10884973|NCT02908685|12051038|FG009|STARTED|Part 1 Exploratory||3
10884974|NCT02908685|12051039|FG010|STARTED|Part 1 Exploratory||0
10884975|NCT02908685|12051040|FG011|STARTED|Part 1 Exploratory||0
10884976|NCT02908685|12051029|FG000|COMPLETED|Part 1 Exploratory||7
10884977|NCT02908685|12051030|FG001|COMPLETED|Part 1 Exploratory||6
10884978|NCT02908685|12051031|FG002|COMPLETED|Part 1 Exploratory||3
10884979|NCT02908685|12051032|FG003|COMPLETED|Part 1 Exploratory||3
10884980|NCT02908685|12051033|FG004|COMPLETED|Part 1 Exploratory||7
10884981|NCT02908685|12051034|FG005|COMPLETED|Part 1 Exploratory||7
10884982|NCT02908685|12051035|FG006|COMPLETED|Part 1 Exploratory||7
10884983|NCT02908685|12051036|FG007|COMPLETED|Part 1 Exploratory||3
10884984|NCT02908685|12051037|FG008|COMPLETED|Part 1 Exploratory||4
10884985|NCT02908685|12051038|FG009|COMPLETED|Part 1 Exploratory||3
10884986|NCT02908685|12051039|FG010|COMPLETED|Part 1 Exploratory||0
10884987|NCT02908685|12051040|FG011|COMPLETED|Part 1 Exploratory||0
10884988|NCT02908685|12051029|FG000|NOT COMPLETED|Part 1 Exploratory||0
10884989|NCT02908685|12051030|FG001|NOT COMPLETED|Part 1 Exploratory||1
10884990|NCT02908685|12051031|FG002|NOT COMPLETED|Part 1 Exploratory||0
10884991|NCT02908685|12051032|FG003|NOT COMPLETED|Part 1 Exploratory||0
10884992|NCT02908685|12051033|FG004|NOT COMPLETED|Part 1 Exploratory||0
10884993|NCT02908685|12051034|FG005|NOT COMPLETED|Part 1 Exploratory||0
10884994|NCT02908685|12051035|FG006|NOT COMPLETED|Part 1 Exploratory||0
10884995|NCT02908685|12051036|FG007|NOT COMPLETED|Part 1 Exploratory||0
10884996|NCT02908685|12051037|FG008|NOT COMPLETED|Part 1 Exploratory||0
10884997|NCT02908685|12051038|FG009|NOT COMPLETED|Part 1 Exploratory||0
10884998|NCT02908685|12051039|FG010|NOT COMPLETED|Part 1 Exploratory||0
10884999|NCT02908685|12051040|FG011|NOT COMPLETED|Part 1 Exploratory||0
10885000|NCT02908685|12051029|FG000|STARTED|Part 2 Confirmatory||0
10885001|NCT02908685|12051030|FG001|STARTED|Part 2 Confirmatory||0
10885002|NCT02908685|12051031|FG002|STARTED|Part 2 Confirmatory||0
10885003|NCT02908685|12051032|FG003|STARTED|Part 2 Confirmatory||0
10885004|NCT02908685|12051033|FG004|STARTED|Part 2 Confirmatory||0
10885005|NCT02908685|12051034|FG005|STARTED|Part 2 Confirmatory||0
10885006|NCT02908685|12051035|FG006|STARTED|Part 2 Confirmatory||0
10885007|NCT02908685|12051036|FG007|STARTED|Part 2 Confirmatory||0
10885008|NCT02908685|12051037|FG008|STARTED|Part 2 Confirmatory||0
10885009|NCT02908685|12051038|FG009|STARTED|Part 2 Confirmatory||0
10885010|NCT02908685|12051039|FG010|STARTED|Part 2 Confirmatory||120
10885011|NCT02908685|12051040|FG011|STARTED|Part 2 Confirmatory||60
10885012|NCT02908685|12051029|FG000|COMPLETED|Part 2 Confirmatory||0
10885013|NCT02908685|12051030|FG001|COMPLETED|Part 2 Confirmatory||0
10885014|NCT02908685|12051031|FG002|COMPLETED|Part 2 Confirmatory||0
10885015|NCT02908685|12051032|FG003|COMPLETED|Part 2 Confirmatory||0
10885016|NCT02908685|12051033|FG004|COMPLETED|Part 2 Confirmatory||0
10885017|NCT02908685|12051034|FG005|COMPLETED|Part 2 Confirmatory||0
10885018|NCT02908685|12051035|FG006|COMPLETED|Part 2 Confirmatory||0
10885019|NCT02908685|12051036|FG007|COMPLETED|Part 2 Confirmatory||0
10885020|NCT02908685|12051037|FG008|COMPLETED|Part 2 Confirmatory||0
10885021|NCT02908685|12051038|FG009|COMPLETED|Part 2 Confirmatory||0
10885022|NCT02908685|12051039|FG010|COMPLETED|Part 2 Confirmatory||117
10885023|NCT02908685|12051040|FG011|COMPLETED|Part 2 Confirmatory||59
10885024|NCT02908685|12051029|FG000|NOT COMPLETED|Part 2 Confirmatory||0
10885025|NCT02908685|12051030|FG001|NOT COMPLETED|Part 2 Confirmatory||0
10885026|NCT02908685|12051031|FG002|NOT COMPLETED|Part 2 Confirmatory||0
10885027|NCT02908685|12051032|FG003|NOT COMPLETED|Part 2 Confirmatory||0
10885028|NCT02908685|12051033|FG004|NOT COMPLETED|Part 2 Confirmatory||0
10885029|NCT02908685|12051034|FG005|NOT COMPLETED|Part 2 Confirmatory||0
10885030|NCT02908685|12051035|FG006|NOT COMPLETED|Part 2 Confirmatory||0
10885031|NCT02908685|12051036|FG007|NOT COMPLETED|Part 2 Confirmatory||0
10885032|NCT02908685|12051037|FG008|NOT COMPLETED|Part 2 Confirmatory||0
10885033|NCT02908685|12051038|FG009|NOT COMPLETED|Part 2 Confirmatory||0
10885034|NCT02908685|12051039|FG010|NOT COMPLETED|Part 2 Confirmatory||3
10885035|NCT02908685|12051040|FG011|NOT COMPLETED|Part 2 Confirmatory||1
10885036|NCT02908672|12051059|FG000|STARTED|Overall Study||258
10885037|NCT02908672|12051060|FG001|STARTED|Overall Study||256
10885038|NCT02908672|12051059|FG000|COMPLETED|Overall Study||0
10885039|NCT02908672|12051060|FG001|COMPLETED|Overall Study||0
10885040|NCT02908672|12051059|FG000|NOT COMPLETED|Overall Study||258
10885041|NCT02908672|12051060|FG001|NOT COMPLETED|Overall Study||256
10885042|NCT02903914|12051074|FG000|STARTED|Overall Study||8
10885043|NCT02903914|12051075|FG001|STARTED|Overall Study||7
10885044|NCT02903914|12051076|FG002|STARTED|Overall Study||85
10885045|NCT02903914|12051077|FG003|STARTED|Overall Study||7
10885046|NCT02903914|12051078|FG004|STARTED|Overall Study||10
10885047|NCT02903914|12051079|FG005|STARTED|Overall Study||14
10885048|NCT02903914|12051080|FG006|STARTED|Overall Study||123
10885049|NCT02903914|12051081|FG007|STARTED|Overall Study||6
10885050|NCT02903914|12051074|FG000|COMPLETED|Overall Study||0
10885051|NCT02903914|12051075|FG001|COMPLETED|Overall Study||0
10885052|NCT02903914|12051076|FG002|COMPLETED|Overall Study||0
10885053|NCT02903914|12051077|FG003|COMPLETED|Overall Study||0
10885054|NCT02903914|12051078|FG004|COMPLETED|Overall Study||0
10885055|NCT02903914|12051079|FG005|COMPLETED|Overall Study||0
10885056|NCT02903914|12051080|FG006|COMPLETED|Overall Study||6
10885057|NCT02903914|12051081|FG007|COMPLETED|Overall Study||1
10885058|NCT02903914|12051074|FG000|NOT COMPLETED|Overall Study||8
10885059|NCT02903914|12051075|FG001|NOT COMPLETED|Overall Study||7
10885060|NCT02903914|12051076|FG002|NOT COMPLETED|Overall Study||85
10885061|NCT02903914|12051077|FG003|NOT COMPLETED|Overall Study||7
10885062|NCT02903914|12051078|FG004|NOT COMPLETED|Overall Study||10
10885063|NCT02903914|12051079|FG005|NOT COMPLETED|Overall Study||14
10885064|NCT02903914|12051080|FG006|NOT COMPLETED|Overall Study||117
10885065|NCT02903914|12051081|FG007|NOT COMPLETED|Overall Study||5
10885066|NCT02901548|12051101|FG000|STARTED|Overall Study||17
10885067|NCT02901548|12051101|FG000|COMPLETED|Overall Study||13
10885068|NCT02901548|12051101|FG000|NOT COMPLETED|Overall Study||4
10885069|NCT02899299|12051107|FG000|STARTED|Pre-treatment||303
10885070|NCT02899299|12051108|FG001|STARTED|Pre-treatment||302
10885071|NCT02899299|12051107|FG000|COMPLETED|Pre-treatment||300
10885072|NCT02899299|12051108|FG001|COMPLETED|Pre-treatment||284
10885073|NCT02899299|12051107|FG000|NOT COMPLETED|Pre-treatment||3
10885074|NCT02899299|12051108|FG001|NOT COMPLETED|Pre-treatment||18
10885075|NCT02899299|12051107|FG000|STARTED|Treatment||300
10885076|NCT02899299|12051108|FG001|STARTED|Treatment||284
10885077|NCT02899299|12051107|FG000|COMPLETED|Treatment||5
10885078|NCT02899299|12051108|FG001|COMPLETED|Treatment||0
10885079|NCT02899299|12051107|FG000|NOT COMPLETED|Treatment||295
10885080|NCT02899299|12051108|FG001|NOT COMPLETED|Treatment||284
10885081|NCT02898259|12051119|FG000|STARTED|Overall Study||3
10885082|NCT02898259|12051120|FG001|STARTED|Overall Study||3
10885083|NCT02898259|12051121|FG002|STARTED|Overall Study||6
10885084|NCT02898259|12051122|FG003|STARTED|Overall Study||7
10885085|NCT02898259|12051123|FG004|STARTED|Overall Study||0
10885086|NCT02898259|12051119|FG000|COMPLETED|Overall Study||2
10885087|NCT02898259|12051120|FG001|COMPLETED|Overall Study||2
10885088|NCT02898259|12051121|FG002|COMPLETED|Overall Study||1
10885089|NCT02898259|12051122|FG003|COMPLETED|Overall Study||6
10885090|NCT02898259|12051123|FG004|COMPLETED|Overall Study||0
10885091|NCT02898259|12051119|FG000|NOT COMPLETED|Overall Study||1
10885092|NCT02898259|12051120|FG001|NOT COMPLETED|Overall Study||1
10885093|NCT02898259|12051121|FG002|NOT COMPLETED|Overall Study||5
10885094|NCT02898259|12051122|FG003|NOT COMPLETED|Overall Study||1
10885095|NCT02898259|12051123|FG004|NOT COMPLETED|Overall Study||0
10885096|NCT02893930|12051136|FG000|STARTED|Overall Study||13
10885097|NCT02893930|12051136|FG000|Eligible and Treated|Overall Study||12
10885098|NCT02893930|12051136|FG000|COMPLETED|Overall Study||0
10885099|NCT02893930|12051136|FG000|NOT COMPLETED|Overall Study||13
10885100|NCT02893423|12051143|FG000|STARTED|Overall Study||17
10885101|NCT02893423|12051144|FG001|STARTED|Overall Study||16
10885102|NCT02893423|12051145|FG002|STARTED|Overall Study||18
10885103|NCT02893423|12051143|FG000|COMPLETED|Overall Study||17
10885104|NCT02893423|12051144|FG001|COMPLETED|Overall Study||16
10885105|NCT02893423|12051145|FG002|COMPLETED|Overall Study||18
10885106|NCT02893423|12051143|FG000|NOT COMPLETED|Overall Study||0
10885107|NCT02893423|12051144|FG001|NOT COMPLETED|Overall Study||0
10885108|NCT02893423|12051145|FG002|NOT COMPLETED|Overall Study||0
10885109|NCT02891226|12051157|FG000|STARTED|Period 1 (Weeks 0 to 12)||64
10885110|NCT02891226|12051158|FG001|STARTED|Period 1 (Weeks 0 to 12)||31
10885111|NCT02891226|12051159|FG002|STARTED|Period 1 (Weeks 0 to 12)||32
10885112|NCT02891226|12051160|FG003|STARTED|Period 1 (Weeks 0 to 12)||64
10885113|NCT02891226|12051161|FG004|STARTED|Period 1 (Weeks 0 to 12)||0
10885114|NCT02891226|12051162|FG005|STARTED|Period 1 (Weeks 0 to 12)||0
10885115|NCT02891226|12051163|FG006|STARTED|Period 1 (Weeks 0 to 12)||0
10885116|NCT02891226|12051164|FG007|STARTED|Period 1 (Weeks 0 to 12)||0
10885117|NCT02891226|12051165|FG008|STARTED|Period 1 (Weeks 0 to 12)||0
10885118|NCT02891226|12051166|FG009|STARTED|Period 1 (Weeks 0 to 12)||0
10885119|NCT02891226|12051167|FG010|STARTED|Period 1 (Weeks 0 to 12)||0
10885120|NCT02891226|12051168|FG011|STARTED|Period 1 (Weeks 0 to 12)||0
10885121|NCT02891226|12051169|FG012|STARTED|Period 1 (Weeks 0 to 12)||0
10885122|NCT02891226|12051170|FG013|STARTED|Period 1 (Weeks 0 to 12)||0
10885123|NCT02891226|12051171|FG014|STARTED|Period 1 (Weeks 0 to 12)||0
10885124|NCT02891226|12051172|FG015|STARTED|Period 1 (Weeks 0 to 12)||0
10885125|NCT02891226|12051157|FG000|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||64
10885126|NCT02891226|12051158|FG001|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||31
10885127|NCT02891226|12051159|FG002|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||32
10885128|NCT02891226|12051160|FG003|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||64
10885129|NCT02891226|12051161|FG004|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
10885130|NCT02891226|12051162|FG005|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
10885131|NCT02891226|12051163|FG006|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
10885132|NCT02891226|12051164|FG007|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
10885133|NCT02891226|12051165|FG008|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
10885134|NCT02891226|12051166|FG009|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
10885135|NCT02891226|12051167|FG010|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
10885136|NCT02891226|12051168|FG011|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
10885137|NCT02891226|12051169|FG012|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
10885138|NCT02891226|12051170|FG013|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
10885139|NCT02891226|12051171|FG014|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
10885140|NCT02891226|12051172|FG015|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
10885141|NCT02891226|12051157|FG000|COMPLETED|Period 1 (Weeks 0 to 12)||59
10885142|NCT02891226|12051158|FG001|COMPLETED|Period 1 (Weeks 0 to 12)||29
10885143|NCT02891226|12051159|FG002|COMPLETED|Period 1 (Weeks 0 to 12)||28
10885144|NCT02891226|12051160|FG003|COMPLETED|Period 1 (Weeks 0 to 12)||60
10885145|NCT02891226|12051161|FG004|COMPLETED|Period 1 (Weeks 0 to 12)||0
10885146|NCT02891226|12051162|FG005|COMPLETED|Period 1 (Weeks 0 to 12)||0
10885147|NCT02891226|12051163|FG006|COMPLETED|Period 1 (Weeks 0 to 12)||0
10885148|NCT02891226|12051164|FG007|COMPLETED|Period 1 (Weeks 0 to 12)||0
10885149|NCT02891226|12051165|FG008|COMPLETED|Period 1 (Weeks 0 to 12)||0
10885150|NCT02891226|12051166|FG009|COMPLETED|Period 1 (Weeks 0 to 12)||0
10885151|NCT02891226|12051167|FG010|COMPLETED|Period 1 (Weeks 0 to 12)||0
10885152|NCT02891226|12051168|FG011|COMPLETED|Period 1 (Weeks 0 to 12)||0
10885153|NCT02891226|12051169|FG012|COMPLETED|Period 1 (Weeks 0 to 12)||0
10885154|NCT02891226|12051170|FG013|COMPLETED|Period 1 (Weeks 0 to 12)||0
10885155|NCT02891226|12051171|FG014|COMPLETED|Period 1 (Weeks 0 to 12)||0
10885156|NCT02891226|12051172|FG015|COMPLETED|Period 1 (Weeks 0 to 12)||0
10885157|NCT02891226|12051157|FG000|NOT COMPLETED|Period 1 (Weeks 0 to 12)||5
10885158|NCT02891226|12051158|FG001|NOT COMPLETED|Period 1 (Weeks 0 to 12)||2
10885159|NCT02891226|12051159|FG002|NOT COMPLETED|Period 1 (Weeks 0 to 12)||4
10885160|NCT02891226|12051160|FG003|NOT COMPLETED|Period 1 (Weeks 0 to 12)||4
10885161|NCT02891226|12051161|FG004|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
10885162|NCT02891226|12051162|FG005|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
10885163|NCT02891226|12051163|FG006|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
10885164|NCT02891226|12051164|FG007|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
10885165|NCT02891226|12051165|FG008|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
10885166|NCT02891226|12051166|FG009|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
10885167|NCT02891226|12051167|FG010|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
10885168|NCT02891226|12051168|FG011|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
10885169|NCT02891226|12051169|FG012|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
10885170|NCT02891226|12051170|FG013|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
10885171|NCT02891226|12051171|FG014|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
10885172|NCT02891226|12051172|FG015|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
10885173|NCT02891226|12051157|FG000|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 1.|0
10885174|NCT02891226|12051158|FG001|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 1.|0
10885175|NCT02891226|12051159|FG002|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 1.|0
10885176|NCT02891226|12051160|FG003|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 1.|0
10885177|NCT02891226|12051161|FG004|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 2.|9
10885178|NCT02891226|12051162|FG005|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 2.|9
10885179|NCT02891226|12051163|FG006|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 2.|23
10885180|NCT02891226|12051164|FG007|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 2.|46
10885181|NCT02891226|12051165|FG008|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 2.|30
10885182|NCT02891226|12051166|FG009|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 2.|59
10885183|NCT02891226|12051167|FG010|STARTED|Period 2 (Weeks 12 to 52)||0
10885184|NCT02891226|12051168|FG011|STARTED|Period 2 (Weeks 12 to 52)||0
10885185|NCT02891226|12051169|FG012|STARTED|Period 2 (Weeks 12 to 52)||0
10885186|NCT02891226|12051170|FG013|STARTED|Period 2 (Weeks 12 to 52)||0
10885187|NCT02891226|12051171|FG014|STARTED|Period 2 (Weeks 12 to 52)||0
10885188|NCT02891226|12051172|FG015|STARTED|Period 2 (Weeks 12 to 52)||0
10885189|NCT02891226|12051157|FG000|COMPLETED|Period 2 (Weeks 12 to 52)||0
10885190|NCT02891226|12051158|FG001|COMPLETED|Period 2 (Weeks 12 to 52)||0
10885191|NCT02891226|12051159|FG002|COMPLETED|Period 2 (Weeks 12 to 52)||0
10885192|NCT02891226|12051160|FG003|COMPLETED|Period 2 (Weeks 12 to 52)||0
10885193|NCT02891226|12051161|FG004|COMPLETED|Period 2 (Weeks 12 to 52)||8
10885194|NCT02891226|12051162|FG005|COMPLETED|Period 2 (Weeks 12 to 52)||8
10885195|NCT02891226|12051163|FG006|COMPLETED|Period 2 (Weeks 12 to 52)||20
10885196|NCT02891226|12051164|FG007|COMPLETED|Period 2 (Weeks 12 to 52)||41
10885197|NCT02891226|12051165|FG008|COMPLETED|Period 2 (Weeks 12 to 52)||24
10885198|NCT02891226|12051166|FG009|COMPLETED|Period 2 (Weeks 12 to 52)||42
10885199|NCT02891226|12051167|FG010|COMPLETED|Period 2 (Weeks 12 to 52)||0
10885200|NCT02891226|12051168|FG011|COMPLETED|Period 2 (Weeks 12 to 52)||0
10885201|NCT02891226|12051169|FG012|COMPLETED|Period 2 (Weeks 12 to 52)||0
10885202|NCT02891226|12051170|FG013|COMPLETED|Period 2 (Weeks 12 to 52)||0
10885203|NCT02891226|12051171|FG014|COMPLETED|Period 2 (Weeks 12 to 52)||0
10885204|NCT02891226|12051172|FG015|COMPLETED|Period 2 (Weeks 12 to 52)||0
10885205|NCT02891226|12051157|FG000|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
10885206|NCT02891226|12051158|FG001|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
10885207|NCT02891226|12051159|FG002|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
10885208|NCT02891226|12051160|FG003|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
10885209|NCT02891226|12051161|FG004|NOT COMPLETED|Period 2 (Weeks 12 to 52)||1
10885210|NCT02891226|12051162|FG005|NOT COMPLETED|Period 2 (Weeks 12 to 52)||1
10885211|NCT02891226|12051163|FG006|NOT COMPLETED|Period 2 (Weeks 12 to 52)||3
10885212|NCT02891226|12051164|FG007|NOT COMPLETED|Period 2 (Weeks 12 to 52)||5
10885213|NCT02891226|12051165|FG008|NOT COMPLETED|Period 2 (Weeks 12 to 52)||6
10885214|NCT02891226|12051166|FG009|NOT COMPLETED|Period 2 (Weeks 12 to 52)||17
10885215|NCT02891226|12051167|FG010|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
10885216|NCT02891226|12051168|FG011|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
10885217|NCT02891226|12051169|FG012|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
10885218|NCT02891226|12051170|FG013|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
10885219|NCT02891226|12051171|FG014|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
10885220|NCT02891226|12051172|FG015|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
10885221|NCT02891226|12051157|FG000|STARTED|Period 3 (Weeks 52 to 208)||0
10885222|NCT02891226|12051158|FG001|STARTED|Period 3 (Weeks 52 to 208)||0
10885223|NCT02891226|12051159|FG002|STARTED|Period 3 (Weeks 52 to 208)||0
10885224|NCT02891226|12051160|FG003|STARTED|Period 3 (Weeks 52 to 208)||0
10885225|NCT02891226|12051161|FG004|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 2.|0
10885226|NCT02891226|12051162|FG005|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 2.|0
10885227|NCT02891226|12051163|FG006|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 2.|0
10885228|NCT02891226|12051164|FG007|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 2.|0
10885229|NCT02891226|12051165|FG008|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 2.|0
10885230|NCT02891226|12051166|FG009|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 2.|0
10885231|NCT02891226|12051167|FG010|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 3.|137
10885232|NCT02891226|12051168|FG011|STARTED|Period 3 (Weeks 52 to 208)||0
10885233|NCT02891226|12051169|FG012|STARTED|Period 3 (Weeks 52 to 208)||0
10885234|NCT02891226|12051170|FG013|STARTED|Period 3 (Weeks 52 to 208)||0
10885235|NCT02891226|12051171|FG014|STARTED|Period 3 (Weeks 52 to 208)||0
10885236|NCT02891226|12051172|FG015|STARTED|Period 3 (Weeks 52 to 208)||0
10885237|NCT02891226|12051157|FG000|COMPLETED|Period 3 (Weeks 52 to 208)||0
10885238|NCT02891226|12051158|FG001|COMPLETED|Period 3 (Weeks 52 to 208)||0
10885239|NCT02891226|12051159|FG002|COMPLETED|Period 3 (Weeks 52 to 208)||0
10885240|NCT02891226|12051160|FG003|COMPLETED|Period 3 (Weeks 52 to 208)||0
10885241|NCT02891226|12051161|FG004|COMPLETED|Period 3 (Weeks 52 to 208)||0
10885242|NCT02891226|12051162|FG005|COMPLETED|Period 3 (Weeks 52 to 208)||0
10885243|NCT02891226|12051163|FG006|COMPLETED|Period 3 (Weeks 52 to 208)||0
10885244|NCT02891226|12051164|FG007|COMPLETED|Period 3 (Weeks 52 to 208)||0
10885245|NCT02891226|12051165|FG008|COMPLETED|Period 3 (Weeks 52 to 208)||0
10885246|NCT02891226|12051166|FG009|COMPLETED|Period 3 (Weeks 52 to 208)||0
10885247|NCT02891226|12051167|FG010|COMPLETED|Period 3 (Weeks 52 to 208)||0
10885248|NCT02891226|12051168|FG011|COMPLETED|Period 3 (Weeks 52 to 208)||0
10885249|NCT02891226|12051169|FG012|COMPLETED|Period 3 (Weeks 52 to 208)||0
10885250|NCT02891226|12051170|FG013|COMPLETED|Period 3 (Weeks 52 to 208)||0
10885251|NCT02891226|12051171|FG014|COMPLETED|Period 3 (Weeks 52 to 208)||0
10885252|NCT02891226|12051172|FG015|COMPLETED|Period 3 (Weeks 52 to 208)||0
10885253|NCT02891226|12051157|FG000|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
10885254|NCT02891226|12051158|FG001|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
10885255|NCT02891226|12051159|FG002|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
10885256|NCT02891226|12051160|FG003|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
10885257|NCT02891226|12051161|FG004|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
10885258|NCT02891226|12051162|FG005|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
10885259|NCT02891226|12051163|FG006|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
10885260|NCT02891226|12051164|FG007|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
10885261|NCT02891226|12051165|FG008|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
10885262|NCT02891226|12051166|FG009|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
10885263|NCT02891226|12051167|FG010|NOT COMPLETED|Period 3 (Weeks 52 to 208)||137
10885264|NCT02891226|12051168|FG011|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
10885265|NCT02891226|12051169|FG012|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
10885266|NCT02891226|12051170|FG013|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
10885267|NCT02891226|12051171|FG014|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
10885268|NCT02891226|12051172|FG015|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
10885269|NCT02891226|12051157|FG000|STARTED|Follow-up Period||0
10885270|NCT02891226|12051158|FG001|STARTED|Follow-up Period||0
10885271|NCT02891226|12051159|FG002|STARTED|Follow-up Period||0
10885272|NCT02891226|12051160|FG003|STARTED|Follow-up Period||0
10885273|NCT02891226|12051161|FG004|STARTED|Follow-up Period||0
10885274|NCT02891226|12051162|FG005|STARTED|Follow-up Period||0
10885275|NCT02891226|12051163|FG006|STARTED|Follow-up Period||0
10885276|NCT02891226|12051164|FG007|STARTED|Follow-up Period||0
10885277|NCT02891226|12051165|FG008|STARTED|Follow-up Period||0
10885278|NCT02891226|12051166|FG009|STARTED|Follow-up Period||0
10885279|NCT02891226|12051167|FG010|STARTED|Follow-up Period||0
10885280|NCT02891226|12051168|FG011|STARTED|Follow-up Period|Participants were assigned to this arm during follow-up period.|1
10885281|NCT02891226|12051169|FG012|STARTED|Follow-up Period|Participants were assigned to this arm during follow-up period.|2
10885282|NCT02891226|12051170|FG013|STARTED|Follow-up Period|Participants were assigned to this arm during follow-up period.|1
10885283|NCT02891226|12051171|FG014|STARTED|Follow-up Period|Participants were assigned to this arm during follow-up period.|1
10885284|NCT02891226|12051172|FG015|STARTED|Follow-up Period|Participants were assigned to this arm during follow-up period.|3
10885285|NCT02891226|12051157|FG000|COMPLETED|Follow-up Period||0
10885286|NCT02891226|12051158|FG001|COMPLETED|Follow-up Period||0
10885287|NCT02891226|12051159|FG002|COMPLETED|Follow-up Period||0
10885288|NCT02891226|12051160|FG003|COMPLETED|Follow-up Period||0
10885289|NCT02891226|12051161|FG004|COMPLETED|Follow-up Period||0
10885290|NCT02891226|12051162|FG005|COMPLETED|Follow-up Period||0
10885291|NCT02891226|12051163|FG006|COMPLETED|Follow-up Period||0
10885292|NCT02891226|12051164|FG007|COMPLETED|Follow-up Period||0
10885293|NCT02891226|12051165|FG008|COMPLETED|Follow-up Period||0
10885294|NCT02891226|12051166|FG009|COMPLETED|Follow-up Period||0
10885295|NCT02891226|12051167|FG010|COMPLETED|Follow-up Period||0
10885296|NCT02891226|12051168|FG011|COMPLETED|Follow-up Period||0
10885297|NCT02891226|12051169|FG012|COMPLETED|Follow-up Period||2
10885298|NCT02891226|12051170|FG013|COMPLETED|Follow-up Period||1
10885299|NCT02891226|12051171|FG014|COMPLETED|Follow-up Period||0
10885300|NCT02891226|12051172|FG015|COMPLETED|Follow-up Period||2
10885301|NCT02891226|12051157|FG000|NOT COMPLETED|Follow-up Period||0
10885302|NCT02891226|12051158|FG001|NOT COMPLETED|Follow-up Period||0
10885303|NCT02891226|12051159|FG002|NOT COMPLETED|Follow-up Period||0
10885304|NCT02891226|12051160|FG003|NOT COMPLETED|Follow-up Period||0
10885305|NCT02891226|12051161|FG004|NOT COMPLETED|Follow-up Period||0
10885306|NCT02891226|12051162|FG005|NOT COMPLETED|Follow-up Period||0
10885307|NCT02891226|12051163|FG006|NOT COMPLETED|Follow-up Period||0
10885308|NCT02891226|12051164|FG007|NOT COMPLETED|Follow-up Period||0
10885309|NCT02891226|12051165|FG008|NOT COMPLETED|Follow-up Period||0
10885310|NCT02891226|12051166|FG009|NOT COMPLETED|Follow-up Period||0
10885311|NCT02891226|12051167|FG010|NOT COMPLETED|Follow-up Period||0
10885312|NCT02891226|12051168|FG011|NOT COMPLETED|Follow-up Period||1
10885313|NCT02891226|12051169|FG012|NOT COMPLETED|Follow-up Period||0
10885314|NCT02891226|12051170|FG013|NOT COMPLETED|Follow-up Period||0
10885315|NCT02891226|12051171|FG014|NOT COMPLETED|Follow-up Period||1
10885316|NCT02891226|12051172|FG015|NOT COMPLETED|Follow-up Period||1
10885317|NCT02890355|12051198|FG000|STARTED|Overall Study||59
10885318|NCT02890355|12051199|FG001|STARTED|Overall Study||58
10885319|NCT02890355|12051198|FG000|Treated & Assessed for AEs|Overall Study||56
10885320|NCT02890355|12051199|FG001|Treated & Assessed for AEs|Overall Study||50
10885321|NCT02890355|12051198|FG000|COMPLETED|Overall Study||0
10885322|NCT02890355|12051199|FG001|COMPLETED|Overall Study||0
10885323|NCT02890355|12051198|FG000|NOT COMPLETED|Overall Study||59
10885324|NCT02890355|12051199|FG001|NOT COMPLETED|Overall Study||58
10885325|NCT02885324|12051207|FG000|STARTED|Overall Study||4
10885326|NCT02885324|12051207|FG000|COMPLETED|Overall Study||4
10885327|NCT02885324|12051207|FG000|NOT COMPLETED|Overall Study||0
10885328|NCT02883673|12051211|FG000|STARTED|Overall Study||107
10885329|NCT02883673|12051211|FG000|COMPLETED|Overall Study||107
10885330|NCT02883673|12051211|FG000|NOT COMPLETED|Overall Study||0
10885331|NCT02880956|12051220|FG000|STARTED|Overall Study||116
10885332|NCT02880956|12051221|FG001|STARTED|Overall Study||108
10885333|NCT02880956|12051222|FG002|STARTED|Overall Study||116
10885334|NCT02880956|12051223|FG003|STARTED|Overall Study||113
10885335|NCT02880956|12051220|FG000|COMPLETED|Overall Study||99
10885336|NCT02880956|12051221|FG001|COMPLETED|Overall Study||93
10885337|NCT02880956|12051222|FG002|COMPLETED|Overall Study||105
10885338|NCT02880956|12051223|FG003|COMPLETED|Overall Study||95
10885339|NCT02880956|12051220|FG000|NOT COMPLETED|Overall Study||17
10885340|NCT02880956|12051221|FG001|NOT COMPLETED|Overall Study||15
10885341|NCT02880956|12051222|FG002|NOT COMPLETED|Overall Study||11
10885342|NCT02880956|12051223|FG003|NOT COMPLETED|Overall Study||18
10885343|NCT02879318|12051238|FG000|STARTED|Overall Study||61
10885344|NCT02879318|12051239|FG001|STARTED|Overall Study||119
10885345|NCT02879318|12051238|FG000|COMPLETED|Overall Study||61
10885346|NCT02879318|12051239|FG001|COMPLETED|Overall Study||119
10885347|NCT02879318|12051238|FG000|NOT COMPLETED|Overall Study||0
10885348|NCT02879318|12051239|FG001|NOT COMPLETED|Overall Study||0
10885349|NCT02876328|12051269|FG000|STARTED|Overall Study||396
10885350|NCT02876328|12051270|FG001|STARTED|Overall Study||221
10885351|NCT02876328|12051271|FG002|STARTED|Overall Study||395
10885352|NCT02876328|12051272|FG003|STARTED|Overall Study||197
10885353|NCT02876328|12051273|FG004|STARTED|Overall Study||191
10885354|NCT02876328|12051274|FG005|STARTED|Overall Study||403
10885355|NCT02876328|12051275|FG006|STARTED|Overall Study||179
10885356|NCT02876328|12051276|FG007|STARTED|Overall Study||407
10885357|NCT02876328|12051277|FG008|STARTED|Overall Study||202
10885358|NCT02876328|12051278|FG009|STARTED|Overall Study||210
10885359|NCT02876328|12051279|FG010|STARTED|Overall Study||187
10885360|NCT02876328|12051280|FG011|STARTED|Overall Study||99
10885361|NCT02876328|12051281|FG012|STARTED|Overall Study||177
10885362|NCT02876328|12051282|FG013|STARTED|Overall Study||99
10885363|NCT02876328|12051283|FG014|STARTED|Overall Study||100
10885364|NCT02876328|12051284|FG015|STARTED|Overall Study||227
10885365|NCT02876328|12051285|FG016|STARTED|Overall Study||107
10885366|NCT02876328|12051286|FG017|STARTED|Overall Study||237
10885367|NCT02876328|12051287|FG018|STARTED|Overall Study||108
10885368|NCT02876328|12051288|FG019|STARTED|Overall Study||107
10885369|NCT02876328|12051289|FG020|STARTED|Overall Study||324
10885370|NCT02876328|12051290|FG021|STARTED|Overall Study||172
10885371|NCT02876328|12051291|FG022|STARTED|Overall Study||34
10885372|NCT02876328|12051292|FG023|STARTED|Overall Study||7
10885373|NCT02876328|12051269|FG000|COMPLETED|Overall Study||379
10885374|NCT02876328|12051270|FG001|COMPLETED|Overall Study||208
10885375|NCT02876328|12051271|FG002|COMPLETED|Overall Study||378
10885376|NCT02876328|12051272|FG003|COMPLETED|Overall Study||188
10885377|NCT02876328|12051273|FG004|COMPLETED|Overall Study||181
10885378|NCT02876328|12051274|FG005|COMPLETED|Overall Study||388
10885379|NCT02876328|12051275|FG006|COMPLETED|Overall Study||175
10885380|NCT02876328|12051276|FG007|COMPLETED|Overall Study||395
10885381|NCT02876328|12051277|FG008|COMPLETED|Overall Study||192
10885382|NCT02876328|12051278|FG009|COMPLETED|Overall Study||202
10885383|NCT02876328|12051279|FG010|COMPLETED|Overall Study||182
10885384|NCT02876328|12051280|FG011|COMPLETED|Overall Study||98
10885385|NCT02876328|12051281|FG012|COMPLETED|Overall Study||172
10885386|NCT02876328|12051282|FG013|COMPLETED|Overall Study||95
10885387|NCT02876328|12051283|FG014|COMPLETED|Overall Study||96
10885388|NCT02876328|12051284|FG015|COMPLETED|Overall Study||223
10885389|NCT02876328|12051285|FG016|COMPLETED|Overall Study||102
10885390|NCT02876328|12051286|FG017|COMPLETED|Overall Study||227
10885391|NCT02876328|12051287|FG018|COMPLETED|Overall Study||106
10885392|NCT02876328|12051288|FG019|COMPLETED|Overall Study||105
10885393|NCT02876328|12051289|FG020|COMPLETED|Overall Study||312
10885394|NCT02876328|12051290|FG021|COMPLETED|Overall Study||164
10885395|NCT02876328|12051291|FG022|COMPLETED|Overall Study||33
10885396|NCT02876328|12051292|FG023|COMPLETED|Overall Study||7
10885397|NCT02876328|12051269|FG000|NOT COMPLETED|Overall Study||17
10885398|NCT02876328|12051270|FG001|NOT COMPLETED|Overall Study||13
10885399|NCT02876328|12051271|FG002|NOT COMPLETED|Overall Study||17
10885400|NCT02876328|12051272|FG003|NOT COMPLETED|Overall Study||9
10885401|NCT02876328|12051273|FG004|NOT COMPLETED|Overall Study||10
10885402|NCT02876328|12051274|FG005|NOT COMPLETED|Overall Study||15
10885403|NCT02876328|12051275|FG006|NOT COMPLETED|Overall Study||4
10885404|NCT02876328|12051276|FG007|NOT COMPLETED|Overall Study||12
10885405|NCT02876328|12051277|FG008|NOT COMPLETED|Overall Study||10
10885406|NCT02876328|12051278|FG009|NOT COMPLETED|Overall Study||8
10885407|NCT02876328|12051279|FG010|NOT COMPLETED|Overall Study||5
10885408|NCT02876328|12051280|FG011|NOT COMPLETED|Overall Study||1
10885409|NCT02876328|12051281|FG012|NOT COMPLETED|Overall Study||5
10885410|NCT02876328|12051282|FG013|NOT COMPLETED|Overall Study||4
10885411|NCT02876328|12051283|FG014|NOT COMPLETED|Overall Study||4
10885412|NCT02876328|12051284|FG015|NOT COMPLETED|Overall Study||4
10885413|NCT02876328|12051285|FG016|NOT COMPLETED|Overall Study||5
10885414|NCT02876328|12051286|FG017|NOT COMPLETED|Overall Study||10
10885415|NCT02876328|12051287|FG018|NOT COMPLETED|Overall Study||2
10885416|NCT02876328|12051288|FG019|NOT COMPLETED|Overall Study||2
10885417|NCT02876328|12051289|FG020|NOT COMPLETED|Overall Study||12
10885418|NCT02876328|12051290|FG021|NOT COMPLETED|Overall Study||8
10885419|NCT02876328|12051291|FG022|NOT COMPLETED|Overall Study||1
10885420|NCT02876328|12051292|FG023|NOT COMPLETED|Overall Study||0
10885421|NCT02873975|12051321|FG000|STARTED|Overall Study||8
10885422|NCT02873975|12051322|FG001|STARTED|Overall Study||10
10885423|NCT02873975|12051323|FG002|STARTED|Overall Study||9
10885424|NCT02873975|12051321|FG000|COMPLETED|Overall Study||8
10885425|NCT02873975|12051322|FG001|COMPLETED|Overall Study||10
10885426|NCT02873975|12051323|FG002|COMPLETED|Overall Study||9
10885427|NCT02873975|12051321|FG000|NOT COMPLETED|Overall Study||0
10885428|NCT02873975|12051322|FG001|NOT COMPLETED|Overall Study||0
10885429|NCT02873975|12051323|FG002|NOT COMPLETED|Overall Study||0
10885430|NCT02872116|12051334|FG000|STARTED|Pre-Treatment||789
10885431|NCT02872116|12051335|FG001|STARTED|Pre-Treatment||833
10885432|NCT02872116|12051336|FG002|STARTED|Pre-Treatment||409
10885433|NCT02872116|12051334|FG000|COMPLETED|Pre-Treatment||782
10885434|NCT02872116|12051335|FG001|COMPLETED|Pre-Treatment||806
10885435|NCT02872116|12051336|FG002|COMPLETED|Pre-Treatment||403
10885436|NCT02872116|12051334|FG000|NOT COMPLETED|Pre-Treatment||7
10885437|NCT02872116|12051335|FG001|NOT COMPLETED|Pre-Treatment||27
10885438|NCT02872116|12051336|FG002|NOT COMPLETED|Pre-Treatment||6
10885439|NCT02872116|12051334|FG000|STARTED|Treatment||782
10885440|NCT02872116|12051335|FG001|STARTED|Treatment||806
10885441|NCT02872116|12051336|FG002|STARTED|Treatment||403
10885442|NCT02872116|12051334|FG000|COMPLETED|Treatment||623
10885443|NCT02872116|12051335|FG001|COMPLETED|Treatment||653
10885444|NCT02872116|12051336|FG002|COMPLETED|Treatment||319
10885445|NCT02872116|12051334|FG000|NOT COMPLETED|Treatment||159
10885446|NCT02872116|12051335|FG001|NOT COMPLETED|Treatment||153
10885447|NCT02872116|12051336|FG002|NOT COMPLETED|Treatment||84
10885448|NCT02871791|12051351|FG000|STARTED|Phase 1b||6
10885449|NCT02871791|12051352|FG001|STARTED|Phase 1b||3
10885450|NCT02871791|12051351|FG000|COMPLETED|Phase 1b||0
10885451|NCT02871791|12051352|FG001|COMPLETED|Phase 1b||0
10885452|NCT02871791|12051351|FG000|NOT COMPLETED|Phase 1b||6
10885453|NCT02871791|12051352|FG001|NOT COMPLETED|Phase 1b||3
10885454|NCT02871791|12051351|FG000|STARTED|Phase 2||32
10885455|NCT02871791|12051352|FG001|STARTED|Phase 2||0
10885456|NCT02871791|12051351|FG000|COMPLETED|Phase 2||29
10885457|NCT02871791|12051352|FG001|COMPLETED|Phase 2||0
10885458|NCT02871791|12051351|FG000|NOT COMPLETED|Phase 2||3
10885459|NCT02871791|12051352|FG001|NOT COMPLETED|Phase 2||0
10885460|NCT02867761|12051360|FG000|STARTED|Overall Study||261
10885461|NCT02867761|12051361|FG001|STARTED|Overall Study||274
10885462|NCT02867761|12051360|FG000|COMPLETED|Overall Study||233
10885463|NCT02867761|12051361|FG001|COMPLETED|Overall Study||248
10885464|NCT02867761|12051360|FG000|NOT COMPLETED|Overall Study||28
10885465|NCT02867761|12051361|FG001|NOT COMPLETED|Overall Study||26
10885466|NCT02865811|12051367|FG000|STARTED|Overall Study||26
10885467|NCT02865811|12051367|FG000|COMPLETED|Overall Study||26
10885468|NCT02865811|12051367|FG000|NOT COMPLETED|Overall Study||0
10885469|NCT02864394|12051374|FG000|STARTED|Overall Study||213
10885470|NCT02864394|12051375|FG001|STARTED|Overall Study||212
10885471|NCT02864394|12051374|FG000|Treated|Overall Study||213
10885472|NCT02864394|12051375|FG001|Treated|Overall Study||198
10885473|NCT02864394|12051374|FG000|COMPLETED|Overall Study||0
10885474|NCT02864394|12051375|FG001|COMPLETED|Overall Study||0
10885475|NCT02864394|12051374|FG000|NOT COMPLETED|Overall Study||213
10885476|NCT02864394|12051375|FG001|NOT COMPLETED|Overall Study||212
10885477|NCT02862457|12051388|FG000|STARTED|Overall Study||3
10885478|NCT02862457|12051389|FG001|STARTED|Overall Study||3
10885479|NCT02862457|12051390|FG002|STARTED|Overall Study||3
10885480|NCT02862457|12051391|FG003|STARTED|Overall Study||6
10885481|NCT02862457|12051392|FG004|STARTED|Overall Study||7
10885482|NCT02862457|12051393|FG005|STARTED|Overall Study||6
10885483|NCT02862457|12051394|FG006|STARTED|Overall Study||6
10885484|NCT02862457|12051388|FG000|COMPLETED|Overall Study||1
10885485|NCT02862457|12051389|FG001|COMPLETED|Overall Study||0
10885486|NCT02862457|12051390|FG002|COMPLETED|Overall Study||0
10885487|NCT02862457|12051391|FG003|COMPLETED|Overall Study||2
10885488|NCT02862457|12051392|FG004|COMPLETED|Overall Study||7
10885489|NCT02862457|12051393|FG005|COMPLETED|Overall Study||3
10885490|NCT02862457|12051394|FG006|COMPLETED|Overall Study||5
10885491|NCT02862457|12051388|FG000|NOT COMPLETED|Overall Study||2
10885492|NCT02862457|12051389|FG001|NOT COMPLETED|Overall Study||3
10885493|NCT02862457|12051390|FG002|NOT COMPLETED|Overall Study||3
10885494|NCT02862457|12051391|FG003|NOT COMPLETED|Overall Study||4
10885495|NCT02862457|12051392|FG004|NOT COMPLETED|Overall Study||0
10885496|NCT02862457|12051393|FG005|NOT COMPLETED|Overall Study||3
10885497|NCT02862457|12051394|FG006|NOT COMPLETED|Overall Study||1
10885498|NCT02856581|12051420|FG000|STARTED|Overall Study||12
10885499|NCT02856581|12051421|FG001|STARTED|Overall Study||11
10885500|NCT02856581|12051420|FG000|COMPLETED|Overall Study||12
10885501|NCT02856581|12051421|FG001|COMPLETED|Overall Study||11
10885502|NCT02856581|12051420|FG000|NOT COMPLETED|Overall Study||0
10885503|NCT02856581|12051421|FG001|NOT COMPLETED|Overall Study||0
10885504|NCT02854436|12051429|FG000|STARTED|Overall Study||289
10885505|NCT02854436|12051429|FG000|Intent to Treat Participants (Breast Cancer Gene [BRCA] and Non-BRCA Participants)|Overall Study|There were 142 BRCA participants and 81 non-BRCA participants.|223
10885506|NCT02854436|12051429|FG000|COMPLETED|Overall Study||0
10885507|NCT02854436|12051429|FG000|NOT COMPLETED|Overall Study||289
10885508|NCT02853344|12051435|FG000|STARTED|Overall Study||110
10885509|NCT02853344|12051436|FG001|STARTED|Overall Study||165
10885510|NCT02853344|12051435|FG000|COMPLETED|Overall Study||0
10885511|NCT02853344|12051436|FG001|COMPLETED|Overall Study||0
10885512|NCT02853344|12051435|FG000|NOT COMPLETED|Overall Study||110
10885513|NCT02853344|12051436|FG001|NOT COMPLETED|Overall Study||165
10885514|NCT02853331|12051446|FG000|STARTED|Overall Study||432
10885515|NCT02853331|12051447|FG001|STARTED|Overall Study||429
10885516|NCT02853331|12051446|FG000|Treated|Overall Study||429
10885517|NCT02853331|12051447|FG001|Treated|Overall Study||425
10885518|NCT02853331|12051446|FG000|COMPLETED|Overall Study||0
10885519|NCT02853331|12051447|FG001|COMPLETED|Overall Study||0
10885520|NCT02853331|12051446|FG000|NOT COMPLETED|Overall Study||432
10885521|NCT02853331|12051447|FG001|NOT COMPLETED|Overall Study||429
10885522|NCT02853305|12051456|FG000|STARTED|Overall Study||351
10885523|NCT02853305|12051457|FG001|STARTED|Overall Study||307
10885524|NCT02853305|12051458|FG002|STARTED|Overall Study||352
10885525|NCT02853305|12051456|FG000|Treated|Overall Study|Includes 2 participants randomized to Pembrolizumab alone|349
10885526|NCT02853305|12051457|FG001|Treated|Overall Study||302
10885527|NCT02853305|12051458|FG002|Treated|Overall Study||342
10885528|NCT02853305|12051456|FG000|COMPLETED|Overall Study||0
10885529|NCT02853305|12051457|FG001|COMPLETED|Overall Study||0
10885530|NCT02853305|12051458|FG002|COMPLETED|Overall Study||0
10885531|NCT02853305|12051456|FG000|NOT COMPLETED|Overall Study||351
10885532|NCT02853305|12051457|FG001|NOT COMPLETED|Overall Study||307
10885533|NCT02853305|12051458|FG002|NOT COMPLETED|Overall Study||352
10885534|NCT02852005|12051471|FG000|STARTED|Overall Study||4
10885535|NCT02852005|12051472|FG001|STARTED|Overall Study||4
10885536|NCT02852005|12051473|FG002|STARTED|Overall Study||6
10885537|NCT02852005|12051474|FG003|STARTED|Overall Study||6
10885538|NCT02852005|12051475|FG004|STARTED|Overall Study||7
10885539|NCT02852005|12051471|FG000|Month 0.5|Overall Study||3
10885540|NCT02852005|12051472|FG001|Month 0.5|Overall Study||4
10885541|NCT02852005|12051473|FG002|Month 0.5|Overall Study||6
10885542|NCT02852005|12051474|FG003|Month 0.5|Overall Study||6
10885543|NCT02852005|12051475|FG004|Month 0.5|Overall Study||7
10885544|NCT02852005|12051471|FG000|Month 4.5|Overall Study||3
10885545|NCT02852005|12051472|FG001|Month 4.5|Overall Study||4
10885546|NCT02852005|12051473|FG002|Month 4.5|Overall Study||6
10885547|NCT02852005|12051474|FG003|Month 4.5|Overall Study||6
10885548|NCT02852005|12051475|FG004|Month 4.5|Overall Study||7
10885549|NCT02852005|12051471|FG000|Month 10|Overall Study||3
10885550|NCT02852005|12051472|FG001|Month 10|Overall Study||3
10885551|NCT02852005|12051473|FG002|Month 10|Overall Study||6
10885552|NCT02852005|12051474|FG003|Month 10|Overall Study||5
10885553|NCT02852005|12051475|FG004|Month 10|Overall Study||7
10885554|NCT02852005|12051471|FG000|COMPLETED|Overall Study||3
10885555|NCT02852005|12051472|FG001|COMPLETED|Overall Study||4
10885556|NCT02852005|12051473|FG002|COMPLETED|Overall Study||6
10885557|NCT02852005|12051474|FG003|COMPLETED|Overall Study||6
10885558|NCT02852005|12051475|FG004|COMPLETED|Overall Study||6
10885559|NCT02852005|12051471|FG000|NOT COMPLETED|Overall Study||1
10885560|NCT02852005|12051472|FG001|NOT COMPLETED|Overall Study||0
10885561|NCT02852005|12051473|FG002|NOT COMPLETED|Overall Study||0
10885562|NCT02852005|12051474|FG003|NOT COMPLETED|Overall Study||0
10885563|NCT02852005|12051475|FG004|NOT COMPLETED|Overall Study||1
10885564|NCT02849639|12051491|FG000|STARTED|Overall Study||44
10885565|NCT02849639|12051492|FG001|STARTED|Overall Study||46
10885566|NCT02849639|12051491|FG000|COMPLETED|Overall Study||41
10885567|NCT02849639|12051492|FG001|COMPLETED|Overall Study||44
10885568|NCT02849639|12051491|FG000|NOT COMPLETED|Overall Study||3
10885569|NCT02849639|12051492|FG001|NOT COMPLETED|Overall Study||2
10885570|NCT02836249|12051500|FG000|STARTED|Overall Study||123
10885571|NCT02836249|12051501|FG001|STARTED|Overall Study||58
10885572|NCT02836249|12051500|FG000|COMPLETED|Overall Study||0
10885573|NCT02836249|12051501|FG001|COMPLETED|Overall Study||0
10885574|NCT02836249|12051500|FG000|NOT COMPLETED|Overall Study||123
10885575|NCT02836249|12051501|FG001|NOT COMPLETED|Overall Study||58
10885576|NCT02832063|12051509|FG000|STARTED|Overall Study||186
10885577|NCT02832063|12051510|FG001|STARTED|Overall Study||186
10885578|NCT02832063|12051509|FG000|COMPLETED|Overall Study||152
10885579|NCT02832063|12051510|FG001|COMPLETED|Overall Study||148
10885580|NCT02832063|12051509|FG000|NOT COMPLETED|Overall Study||34
10885581|NCT02832063|12051510|FG001|NOT COMPLETED|Overall Study||38
10885582|NCT02831764|12051518|FG000|STARTED|Overall Study||360
10885583|NCT02831764|12051519|FG001|STARTED|Overall Study||359
10885584|NCT02831764|12051518|FG000|COMPLETED|Overall Study||0
10885585|NCT02831764|12051519|FG001|COMPLETED|Overall Study||0
10885586|NCT02831764|12051518|FG000|NOT COMPLETED|Overall Study||360
10885587|NCT02831764|12051519|FG001|NOT COMPLETED|Overall Study||359
10885588|NCT02831673|12051527|FG000|STARTED|Overall Study||356
10885589|NCT02831673|12051528|FG001|STARTED|Overall Study||358
10885590|NCT02831673|12051527|FG000|COMPLETED|Overall Study||0
10885591|NCT02831673|12051528|FG001|COMPLETED|Overall Study||0
10885592|NCT02831673|12051527|FG000|NOT COMPLETED|Overall Study||356
10885593|NCT02831673|12051528|FG001|NOT COMPLETED|Overall Study||358
10885594|NCT02829918|12051534|FG000|STARTED|Overall Study||54
10885595|NCT02829918|12051534|FG000|COMPLETED|Overall Study||46
10885596|NCT02829918|12051534|FG000|NOT COMPLETED|Overall Study||8
10885597|NCT02826681|12051540|FG000|STARTED|Overall Study||35
10885598|NCT02826681|12051541|FG001|STARTED|Overall Study||35
10885599|NCT02826681|12051540|FG000|COMPLETED|Overall Study||12
10885600|NCT02826681|12051541|FG001|COMPLETED|Overall Study||13
10885601|NCT02826681|12051540|FG000|NOT COMPLETED|Overall Study||23
10885602|NCT02826681|12051541|FG001|NOT COMPLETED|Overall Study||22
10885603|NCT02824627|12051549|FG000|STARTED|Overall Study||28
10885604|NCT02824627|12051550|FG001|STARTED|Overall Study||30
10885605|NCT02824627|12051549|FG000|COMPLETED|Overall Study||25
10885606|NCT02824627|12051550|FG001|COMPLETED|Overall Study||27
10885607|NCT02824627|12051549|FG000|NOT COMPLETED|Overall Study||3
10885608|NCT02824627|12051550|FG001|NOT COMPLETED|Overall Study||3
10885609|NCT02821000|12051556|FG000|STARTED|Overall Study||103
10885610|NCT02821000|12051556|FG000|Treated|Overall Study||103
10885611|NCT02821000|12051556|FG000|COMPLETED|Overall Study||0
10885612|NCT02821000|12051556|FG000|NOT COMPLETED|Overall Study||103
10885613|NCT02818894|12051562|FG000|STARTED|Overall Study||67
10885614|NCT02818894|12051563|FG001|STARTED|Overall Study||68
10885615|NCT02818894|12051562|FG000|COMPLETED|Overall Study||11
10885616|NCT02818894|12051563|FG001|COMPLETED|Overall Study||12
10885617|NCT02818894|12051562|FG000|NOT COMPLETED|Overall Study||56
10885618|NCT02818894|12051563|FG001|NOT COMPLETED|Overall Study||56
10885619|NCT02816255|12051571|FG000|STARTED|Overall Study||6
10885620|NCT02816255|12051572|FG001|STARTED|Overall Study||5
10885621|NCT02816255|12051571|FG000|COMPLETED|Overall Study||6
10885622|NCT02816255|12051572|FG001|COMPLETED|Overall Study||5
10885623|NCT02816255|12051571|FG000|NOT COMPLETED|Overall Study||0
10885624|NCT02816255|12051572|FG001|NOT COMPLETED|Overall Study||0
10885625|NCT02815540|12051580|FG000|STARTED|Overall Study||2
10885626|NCT02815540|12051580|FG000|COMPLETED|Overall Study||0
10885627|NCT02815540|12051580|FG000|NOT COMPLETED|Overall Study||2
10885628|NCT02808871|12051586|FG000|STARTED|Overall Study||63
10885629|NCT02808871|12051587|FG001|STARTED|Overall Study||60
10885630|NCT02808871|12051586|FG000|COMPLETED|Overall Study||52
10885631|NCT02808871|12051587|FG001|COMPLETED|Overall Study||51
10885632|NCT02808871|12051586|FG000|NOT COMPLETED|Overall Study||11
10885633|NCT02808871|12051587|FG001|NOT COMPLETED|Overall Study||9
10885634|NCT02807493|12051597|FG000|STARTED|Overall Study||174
10885635|NCT02807493|12051598|FG001|STARTED|Overall Study||173
10885636|NCT02807493|12051597|FG000|COMPLETED|Overall Study||87
10885637|NCT02807493|12051598|FG001|COMPLETED|Overall Study||121
10885638|NCT02807493|12051597|FG000|NOT COMPLETED|Overall Study||87
10885639|NCT02807493|12051598|FG001|NOT COMPLETED|Overall Study||52
10885640|NCT02802293|12051607|FG000|STARTED|Overall Study||1
10885641|NCT02802293|12051608|FG001|STARTED|Overall Study||2
10885642|NCT02802293|12051609|FG002|STARTED|Overall Study||3
10885643|NCT02802293|12051607|FG000|COMPLETED|Overall Study||0
10885644|NCT02802293|12051608|FG001|COMPLETED|Overall Study||1
10885645|NCT02802293|12051609|FG002|COMPLETED|Overall Study||1
10885646|NCT02802293|12051607|FG000|NOT COMPLETED|Overall Study||1
10885647|NCT02802293|12051608|FG001|NOT COMPLETED|Overall Study||1
10885648|NCT02802293|12051609|FG002|NOT COMPLETED|Overall Study||2
10885649|NCT02798536|12051620|FG000|STARTED|Overall Study||3
10885650|NCT02798536|12051621|FG001|STARTED|Overall Study||7
10885651|NCT02798536|12051622|FG002|STARTED|Overall Study||11
10885652|NCT02798536|12051620|FG000|COMPLETED|Overall Study||3
10885653|NCT02798536|12051621|FG001|COMPLETED|Overall Study||7
10885654|NCT02798536|12051622|FG002|COMPLETED|Overall Study||11
10885655|NCT02798536|12051620|FG000|NOT COMPLETED|Overall Study||0
10885656|NCT02798536|12051621|FG001|NOT COMPLETED|Overall Study||0
10885657|NCT02798536|12051622|FG002|NOT COMPLETED|Overall Study||0
10885658|NCT02784535|12051636|FG000|STARTED|Overall Study||20
10885659|NCT02784535|12051637|FG001|STARTED|Overall Study||20
10885660|NCT02784535|12051636|FG000|COMPLETED|Overall Study|Randomized ,placebo controlled, crossover phase (days 0-64)|19
10885661|NCT02784535|12051637|FG001|COMPLETED|Overall Study||18
10885662|NCT02784535|12051636|FG000|NOT COMPLETED|Overall Study||1
10885663|NCT02784535|12051637|FG001|NOT COMPLETED|Overall Study||2
10885664|NCT02783950|12051648|FG000|STARTED|Overall Study||182
10885665|NCT02783950|12051649|FG001|STARTED|Overall Study||174
10885666|NCT02783950|12051648|FG000|COMPLETED|Overall Study||175
10885667|NCT02783950|12051649|FG001|COMPLETED|Overall Study||165
10885668|NCT02783950|12051648|FG000|NOT COMPLETED|Overall Study||7
10885669|NCT02783950|12051649|FG001|NOT COMPLETED|Overall Study||9
10885670|NCT02781506|12051655|FG000|STARTED|Overall Study||7
10885671|NCT02781506|12051655|FG000|COMPLETED|Overall Study||2
10885672|NCT02781506|12051655|FG000|NOT COMPLETED|Overall Study||5
10885673|NCT02775903|12051663|FG000|STARTED|Overall Study||42
10885674|NCT02775903|12051664|FG001|STARTED|Overall Study||42
10885675|NCT02775903|12051665|FG002|STARTED|Overall Study||64
10885676|NCT02775903|12051666|FG003|STARTED|Overall Study||65
10885677|NCT02775903|12051663|FG000|Received Study Treatment|Overall Study||38
10885678|NCT02775903|12051664|FG001|Received Study Treatment|Overall Study||41
10885679|NCT02775903|12051665|FG002|Received Study Treatment|Overall Study||64
10885680|NCT02775903|12051666|FG003|Received Study Treatment|Overall Study||62
10885681|NCT02775903|12051663|FG000|COMPLETED|Overall Study||0
10885682|NCT02775903|12051664|FG001|COMPLETED|Overall Study||1
10885683|NCT02775903|12051665|FG002|COMPLETED|Overall Study||0
10885684|NCT02775903|12051666|FG003|COMPLETED|Overall Study||0
10885685|NCT02775903|12051663|FG000|NOT COMPLETED|Overall Study||42
10885686|NCT02775903|12051664|FG001|NOT COMPLETED|Overall Study||41
10885687|NCT02775903|12051665|FG002|NOT COMPLETED|Overall Study||64
10885688|NCT02775903|12051666|FG003|NOT COMPLETED|Overall Study||65
10885689|NCT02775435|12051682|FG000|STARTED|Overall Study||278
10885690|NCT02775435|12051683|FG001|STARTED|Overall Study||281
10885691|NCT02775435|12051682|FG000|Treated|Overall Study||278
10885692|NCT02775435|12051683|FG001|Treated|Overall Study||280
10885693|NCT02775435|12051682|FG000|Switched to Pembrolizumab+Chemotherapy|Overall Study||0
10885694|NCT02775435|12051683|FG001|Switched to Pembrolizumab+Chemotherapy|Overall Study||75
10885695|NCT02775435|12051682|FG000|COMPLETED|Overall Study||0
10885696|NCT02775435|12051683|FG001|COMPLETED|Overall Study||0
10885697|NCT02775435|12051682|FG000|NOT COMPLETED|Overall Study||278
10885698|NCT02775435|12051683|FG001|NOT COMPLETED|Overall Study||281
10885699|NCT02775162|12051691|FG000|STARTED|Overall Study||136
10885700|NCT02775162|12051692|FG001|STARTED|Overall Study||131
10885701|NCT02775162|12051691|FG000|COMPLETED|Overall Study||122
10885702|NCT02775162|12051692|FG001|COMPLETED|Overall Study||121
10885703|NCT02775162|12051691|FG000|NOT COMPLETED|Overall Study||14
10885704|NCT02775162|12051692|FG001|NOT COMPLETED|Overall Study||10
10885705|NCT02773849|12051700|FG000|STARTED|Overall Study||157
10885706|NCT02773849|12051700|FG000|COMPLETED|Overall Study||63
10885707|NCT02773849|12051700|FG000|NOT COMPLETED|Overall Study||94
10885708|NCT02773732|12051710|FG000|STARTED|Ciprofloxacin Dose Level 0||3
10885709|NCT02773732|12051711|FG001|STARTED|Ciprofloxacin Dose Level 0||0
10885710|NCT02773732|12051710|FG000|COMPLETED|Ciprofloxacin Dose Level 0||3
10885711|NCT02773732|12051711|FG001|COMPLETED|Ciprofloxacin Dose Level 0||0
10885712|NCT02773732|12051710|FG000|NOT COMPLETED|Ciprofloxacin Dose Level 0||0
10885713|NCT02773732|12051711|FG001|NOT COMPLETED|Ciprofloxacin Dose Level 0||0
10885714|NCT02773732|12051710|FG000|STARTED|Ciprofloxacin Dose Level +1||0
10885715|NCT02773732|12051711|FG001|STARTED|Ciprofloxacin Dose Level +1||8
10885716|NCT02773732|12051710|FG000|COMPLETED|Ciprofloxacin Dose Level +1||0
10885717|NCT02773732|12051711|FG001|COMPLETED|Ciprofloxacin Dose Level +1||8
10885718|NCT02773732|12051710|FG000|NOT COMPLETED|Ciprofloxacin Dose Level +1||0
10885719|NCT02773732|12051711|FG001|NOT COMPLETED|Ciprofloxacin Dose Level +1||0
10885720|NCT02770716|12051724|FG000|STARTED|Overall Study||199
10885721|NCT02770716|12051725|FG001|STARTED|Overall Study||101
10885722|NCT02770716|12051724|FG000|Intent to Treat (ITT)|Overall Study||199
10885723|NCT02770716|12051725|FG001|Intent to Treat (ITT)|Overall Study||101
10885724|NCT02770716|12051724|FG000|Safety Analysis Set (SAS)|Overall Study|One placebo participant received terlipressin as well, so is included in the terlipressin SAS|200
10885725|NCT02770716|12051725|FG001|Safety Analysis Set (SAS)|Overall Study|One placebo participant did not receive any treatment, so was excluded from the SAS|99
10885726|NCT02770716|12051724|FG000|COMPLETED|Overall Study|ITT Completed Study through Follow-up / Day 90 Visit|87
10885727|NCT02770716|12051725|FG001|COMPLETED|Overall Study|ITT Completed Study through Follow-up / Day 90 Visit|52
10885728|NCT02770716|12051724|FG000|NOT COMPLETED|Overall Study||112
10885729|NCT02770716|12051725|FG001|NOT COMPLETED|Overall Study||49
10885730|NCT02768792|12051731|FG000|STARTED|Overall Study||38
10885731|NCT02768792|12051731|FG000|COMPLETED|Overall Study||37
10885732|NCT02768792|12051731|FG000|NOT COMPLETED|Overall Study||1
10885733|NCT02768701|12051735|FG000|STARTED|Overall Study||40
10885734|NCT02768701|12051735|FG000|COMPLETED|Overall Study||32
10885735|NCT02768701|12051735|FG000|NOT COMPLETED|Overall Study||8
10885736|NCT02766478|12051744|FG000|STARTED|Overall Study||6
10885737|NCT02766478|12051745|FG001|STARTED|Overall Study||4
10885738|NCT02766478|12051744|FG000|COMPLETED|Overall Study||5
10885739|NCT02766478|12051745|FG001|COMPLETED|Overall Study||3
10885740|NCT02766478|12051744|FG000|NOT COMPLETED|Overall Study||1
10885741|NCT02766478|12051745|FG001|NOT COMPLETED|Overall Study||1
10885742|NCT02763566|12051755|FG000|STARTED|Overall Study||207
10885743|NCT02763566|12051756|FG001|STARTED|Overall Study||99
10885744|NCT02763566|12051757|FG002|STARTED|Overall Study||104
10885745|NCT02763566|12051758|FG003|STARTED|Overall Study||53
10885746|NCT02763566|12051755|FG000|COMPLETED|Overall Study||89
10885747|NCT02763566|12051756|FG001|COMPLETED|Overall Study||60
10885748|NCT02763566|12051757|FG002|COMPLETED|Overall Study||50
10885749|NCT02763566|12051758|FG003|COMPLETED|Overall Study||39
10885750|NCT02763566|12051755|FG000|NOT COMPLETED|Overall Study||118
10885751|NCT02763566|12051756|FG001|NOT COMPLETED|Overall Study||39
10885752|NCT02763566|12051757|FG002|NOT COMPLETED|Overall Study||54
10885753|NCT02763566|12051758|FG003|NOT COMPLETED|Overall Study||14
10885754|NCT02761057|12051776|FG000|STARTED|Overall Study||46
10885755|NCT02761057|12051777|FG001|STARTED|Overall Study||44
10885756|NCT02761057|12051778|FG002|STARTED|Overall Study||28
10885757|NCT02761057|12051779|FG003|STARTED|Overall Study||29
10885758|NCT02761057|12051776|FG000|Received Protocol Treatment|Overall Study||45
10885759|NCT02761057|12051777|FG001|Received Protocol Treatment|Overall Study||43
10885760|NCT02761057|12051778|FG002|Received Protocol Treatment|Overall Study||27
10885761|NCT02761057|12051779|FG003|Received Protocol Treatment|Overall Study||28
10885762|NCT02761057|12051776|FG000|COMPLETED|Overall Study||0
10885763|NCT02761057|12051777|FG001|COMPLETED|Overall Study||0
10885764|NCT02761057|12051778|FG002|COMPLETED|Overall Study||0
10885765|NCT02761057|12051779|FG003|COMPLETED|Overall Study||0
10885766|NCT02761057|12051776|FG000|NOT COMPLETED|Overall Study||46
10885767|NCT02761057|12051777|FG001|NOT COMPLETED|Overall Study||44
10885768|NCT02761057|12051778|FG002|NOT COMPLETED|Overall Study||28
10885769|NCT02761057|12051779|FG003|NOT COMPLETED|Overall Study||29
10885770|NCT02759458|12051791|FG000|STARTED|Overall Study||20
10885771|NCT02759458|12051792|FG001|STARTED|Overall Study||20
10885772|NCT02759458|12051791|FG000|COMPLETED|Overall Study||20
10885773|NCT02759458|12051792|FG001|COMPLETED|Overall Study||20
10885774|NCT02759458|12051791|FG000|NOT COMPLETED|Overall Study||0
10885775|NCT02759458|12051792|FG001|NOT COMPLETED|Overall Study||0
10885776|NCT02747927|12051800|FG000|STARTED|Overall Study||6698
10885777|NCT02747927|12051801|FG001|STARTED|Overall Study||13401
10885778|NCT02747927|12051800|FG000|Treated: Safety Set|Overall Study||6687
10885779|NCT02747927|12051801|FG001|Treated: Safety Set|Overall Study||13380
10885780|NCT02747927|12051800|FG000|COMPLETED|Overall Study||6477
10885781|NCT02747927|12051801|FG001|COMPLETED|Overall Study||12943
10885782|NCT02747927|12051800|FG000|NOT COMPLETED|Overall Study||221
10885783|NCT02747927|12051801|FG001|NOT COMPLETED|Overall Study||458
10885784|NCT02747043|12051809|FG000|STARTED|Overall Study||128
10885785|NCT02747043|12051810|FG001|STARTED|Overall Study||128
10885786|NCT02747043|12051809|FG000|Treated|Overall Study||128
10885787|NCT02747043|12051810|FG001|Treated|Overall Study||126
10885788|NCT02747043|12051809|FG000|COMPLETED|Overall Study||118
10885789|NCT02747043|12051810|FG001|COMPLETED|Overall Study||123
10885790|NCT02747043|12051809|FG000|NOT COMPLETED|Overall Study||10
10885791|NCT02747043|12051810|FG001|NOT COMPLETED|Overall Study||5
10885792|NCT02747004|12051819|FG000|STARTED|Overall Study||78
10885793|NCT02747004|12051820|FG001|STARTED|Overall Study||79
10885794|NCT02747004|12051821|FG002|STARTED|Overall Study||77
10885795|NCT02747004|12051819|FG000|Received at Least One Dose of Study Drug|Overall Study||78
10885796|NCT02747004|12051820|FG001|Received at Least One Dose of Study Drug|Overall Study||79
10885797|NCT02747004|12051821|FG002|Received at Least One Dose of Study Drug|Overall Study||77
10885798|NCT02747004|12051819|FG000|COMPLETED|Overall Study||21
10885799|NCT02747004|12051820|FG001|COMPLETED|Overall Study||30
10885800|NCT02747004|12051821|FG002|COMPLETED|Overall Study||30
10885801|NCT02747004|12051819|FG000|NOT COMPLETED|Overall Study||57
10885802|NCT02747004|12051820|FG001|NOT COMPLETED|Overall Study||49
10885803|NCT02747004|12051821|FG002|NOT COMPLETED|Overall Study||47
10885804|NCT02743728|12051829|FG000|STARTED|Overall Study||20
10885805|NCT02743728|12051829|FG000|COMPLETED|Overall Study||20
10885806|NCT02743728|12051829|FG000|NOT COMPLETED|Overall Study||0
10885807|NCT02743494|12051835|FG000|STARTED|Pre-treatment Period||532
10885808|NCT02743494|12051836|FG001|STARTED|Pre-treatment Period||262
10885809|NCT02743494|12051835|FG000|COMPLETED|Pre-treatment Period||532
10885810|NCT02743494|12051836|FG001|COMPLETED|Pre-treatment Period||260
10885811|NCT02743494|12051835|FG000|NOT COMPLETED|Pre-treatment Period||0
10885812|NCT02743494|12051836|FG001|NOT COMPLETED|Pre-treatment Period||2
10885813|NCT02743494|12051835|FG000|STARTED|Treatment Period||532
10885814|NCT02743494|12051836|FG001|STARTED|Treatment Period||260
10885815|NCT02743494|12051835|FG000|COMPLETED|Treatment Period||31
10885816|NCT02743494|12051836|FG001|COMPLETED|Treatment Period||19
10885817|NCT02743494|12051835|FG000|NOT COMPLETED|Treatment Period||501
10885818|NCT02743494|12051836|FG001|NOT COMPLETED|Treatment Period||241
10885819|NCT02741570|12051844|FG000|STARTED|Pre-Treatment Period||472
10885820|NCT02741570|12051845|FG001|STARTED|Pre-Treatment Period||475
10885821|NCT02741570|12051844|FG000|COMPLETED|Pre-Treatment Period||468
10885822|NCT02741570|12051845|FG001|COMPLETED|Pre-Treatment Period||441
10885823|NCT02741570|12051844|FG000|NOT COMPLETED|Pre-Treatment Period||4
10885824|NCT02741570|12051845|FG001|NOT COMPLETED|Pre-Treatment Period||34
10885825|NCT02741570|12051844|FG000|STARTED|Treatment Period||468
10885826|NCT02741570|12051845|FG001|STARTED|Treatment Period||441
10885827|NCT02741570|12051844|FG000|COMPLETED|Treatment Period||0
10885828|NCT02741570|12051845|FG001|COMPLETED|Treatment Period||7
10885829|NCT02741570|12051844|FG000|NOT COMPLETED|Treatment Period||468
10885830|NCT02741570|12051845|FG001|NOT COMPLETED|Treatment Period||434
10885831|NCT02735421|12051851|FG000|STARTED|Part A (Randomized): up to 24 Weeks||67
10885832|NCT02735421|12051851|FG000|COMPLETED|Part A (Randomized): up to 24 Weeks||54
10885833|NCT02735421|12051851|FG000|NOT COMPLETED|Part A (Randomized): up to 24 Weeks||13
10885834|NCT02735421|12051851|FG000|STARTED|Part 2 (Open Label): up to 48 Weeks|Participants who continue treatment with A-BPO Forte gel for up to 24 additional weeks.|45
10885835|NCT02735421|12051851|FG000|COMPLETED|Part 2 (Open Label): up to 48 Weeks||41
10885836|NCT02735421|12051851|FG000|NOT COMPLETED|Part 2 (Open Label): up to 48 Weeks||4
10885837|NCT02730546|12051863|FG000|STARTED|Overall Study||31
10885838|NCT02730546|12051863|FG000|COMPLETED|Overall Study||31
10885839|NCT02730546|12051863|FG000|NOT COMPLETED|Overall Study||0
10885840|NCT02730169|12051871|FG000|STARTED|Overall Study||67
10885841|NCT02730169|12051872|FG001|STARTED|Overall Study||66
10885842|NCT02730169|12051873|FG002|STARTED|Overall Study||67
10885843|NCT02730169|12051874|FG003|STARTED|Overall Study||71
10885844|NCT02730169|12051871|FG000|COMPLETED|Overall Study||53
10885845|NCT02730169|12051872|FG001|COMPLETED|Overall Study||45
10885846|NCT02730169|12051873|FG002|COMPLETED|Overall Study||50
10885847|NCT02730169|12051874|FG003|COMPLETED|Overall Study||55
10885848|NCT02730169|12051871|FG000|NOT COMPLETED|Overall Study||14
10885849|NCT02730169|12051872|FG001|NOT COMPLETED|Overall Study||21
10885850|NCT02730169|12051873|FG002|NOT COMPLETED|Overall Study||17
10885851|NCT02730169|12051874|FG003|NOT COMPLETED|Overall Study||16
10885852|NCT02729025|12051886|FG000|STARTED|Overall Study||64
10885853|NCT02729025|12051887|FG001|STARTED|Overall Study||65
10885854|NCT02729025|12051886|FG000|COMPLETED|Overall Study||64
10885855|NCT02729025|12051887|FG001|COMPLETED|Overall Study||64
10885856|NCT02729025|12051886|FG000|NOT COMPLETED|Overall Study||0
10885857|NCT02729025|12051887|FG001|NOT COMPLETED|Overall Study||1
10885858|NCT02728102|12051896|FG000|STARTED|Overall Study||68
10885859|NCT02728102|12051897|FG001|STARTED|Overall Study||37
10885860|NCT02728102|12051898|FG002|STARTED|Overall Study||35
10885861|NCT02728102|12051896|FG000|COMPLETED|Overall Study||61
10885862|NCT02728102|12051897|FG001|COMPLETED|Overall Study||33
10885863|NCT02728102|12051898|FG002|COMPLETED|Overall Study||30
10885864|NCT02728102|12051896|FG000|NOT COMPLETED|Overall Study||7
10885865|NCT02728102|12051897|FG001|NOT COMPLETED|Overall Study||4
10885866|NCT02728102|12051898|FG002|NOT COMPLETED|Overall Study||5
10885867|NCT02726542|12051909|FG000|STARTED|Overall Study||13
10885868|NCT02726542|12051910|FG001|STARTED|Overall Study||11
10885869|NCT02726542|12051909|FG000|COMPLETED|Overall Study||10
10885870|NCT02726542|12051910|FG001|COMPLETED|Overall Study||10
10885871|NCT02726542|12051909|FG000|NOT COMPLETED|Overall Study||3
10885872|NCT02726542|12051910|FG001|NOT COMPLETED|Overall Study||1
10885873|NCT02723929|12051918|FG000|STARTED|Overall Study||30
10885874|NCT02723929|12051919|FG001|STARTED|Overall Study||34
10885875|NCT02723929|12051918|FG000|COMPLETED|Overall Study||24
10885876|NCT02723929|12051919|FG001|COMPLETED|Overall Study||24
10885877|NCT02723929|12051918|FG000|NOT COMPLETED|Overall Study||6
10885878|NCT02723929|12051919|FG001|NOT COMPLETED|Overall Study||10
10885879|NCT02723162|12051931|FG000|STARTED|Overall Study||18
10885880|NCT02723162|12051932|FG001|STARTED|Overall Study||15
10885881|NCT02723162|12051933|FG002|STARTED|Overall Study||17
10885882|NCT02723162|12051934|FG003|STARTED|Overall Study||17
10885883|NCT02723162|12051931|FG000|Day 10 fMRI Visit|Overall Study||15
10885884|NCT02723162|12051932|FG001|Day 10 fMRI Visit|Overall Study||11
10885885|NCT02723162|12051933|FG002|Day 10 fMRI Visit|Overall Study||14
10885886|NCT02723162|12051934|FG003|Day 10 fMRI Visit|Overall Study||15
10885887|NCT02723162|12051931|FG000|COMPLETED|Overall Study||12
10885888|NCT02723162|12051932|FG001|COMPLETED|Overall Study||10
10885889|NCT02723162|12051933|FG002|COMPLETED|Overall Study||13
10885890|NCT02723162|12051934|FG003|COMPLETED|Overall Study||12
10885891|NCT02723162|12051931|FG000|NOT COMPLETED|Overall Study||6
10885892|NCT02723162|12051932|FG001|NOT COMPLETED|Overall Study||5
10885893|NCT02723162|12051933|FG002|NOT COMPLETED|Overall Study||4
10885894|NCT02723162|12051934|FG003|NOT COMPLETED|Overall Study||5
10885895|NCT02718118|12051946|FG000|STARTED|Overall Study||30
10885896|NCT02718118|12051947|FG001|STARTED|Overall Study||30
10885897|NCT02718118|12051946|FG000|COMPLETED|Overall Study||28
10885898|NCT02718118|12051947|FG001|COMPLETED|Overall Study||29
10885899|NCT02718118|12051946|FG000|NOT COMPLETED|Overall Study||2
10885900|NCT02718118|12051947|FG001|NOT COMPLETED|Overall Study||1
10885901|NCT02718040|12051953|FG000|STARTED|Overall Study||30
10885902|NCT02718040|12051953|FG000|COMPLETED|Overall Study||30
10885903|NCT02718040|12051953|FG000|NOT COMPLETED|Overall Study||0
10885904|NCT02717611|12051957|FG000|STARTED|Overall Study||60
10885905|NCT02717611|12051957|FG000|COMPLETED|Overall Study||0
10885906|NCT02717611|12051957|FG000|NOT COMPLETED|Overall Study||60
10885907|NCT02716974|12051961|FG000|STARTED|Overall Study||26
10885908|NCT02716974|12051961|FG000|COMPLETED|Overall Study||26
10885909|NCT02716974|12051961|FG000|NOT COMPLETED|Overall Study||0
10885910|NCT02714062|12051968|FG000|STARTED|Overall Study||14
10885911|NCT02714062|12051969|FG001|STARTED|Overall Study||15
10885912|NCT02714062|12051970|FG002|STARTED|Overall Study||13
10885913|NCT02714062|12051968|FG000|COMPLETED|Overall Study||13
10885914|NCT02714062|12051969|FG001|COMPLETED|Overall Study||14
10885915|NCT02714062|12051970|FG002|COMPLETED|Overall Study||10
10885916|NCT02714062|12051968|FG000|NOT COMPLETED|Overall Study||1
10885917|NCT02714062|12051969|FG001|NOT COMPLETED|Overall Study||1
10885918|NCT02714062|12051970|FG002|NOT COMPLETED|Overall Study||3
10885919|NCT02713373|12051980|FG000|STARTED|Overall Study||44
10885920|NCT02713373|12051980|FG000|COMPLETED|Overall Study||44
10885921|NCT02713373|12051980|FG000|NOT COMPLETED|Overall Study||0
10885922|NCT02709655|12051984|FG000|STARTED|Single-Blind Phase (4 Weeks)||683
10885923|NCT02709655|12051985|FG001|STARTED|Single-Blind Phase (4 Weeks)||0
10885924|NCT02709655|12051986|FG002|STARTED|Single-Blind Phase (4 Weeks)||0
10885925|NCT02709655|12051987|FG003|STARTED|Single-Blind Phase (4 Weeks)||0
10885926|NCT02709655|12051988|FG004|STARTED|Single-Blind Phase (4 Weeks)||0
10885927|NCT02709655|12051984|FG000|Received at Least 1 Dose of Study Drug|Single-Blind Phase (4 Weeks)||677
10885928|NCT02709655|12051985|FG001|Received at Least 1 Dose of Study Drug|Single-Blind Phase (4 Weeks)||0
10885929|NCT02709655|12051986|FG002|Received at Least 1 Dose of Study Drug|Single-Blind Phase (4 Weeks)||0
10885930|NCT02709655|12051987|FG003|Received at Least 1 Dose of Study Drug|Single-Blind Phase (4 Weeks)||0
10885931|NCT02709655|12051988|FG004|Received at Least 1 Dose of Study Drug|Single-Blind Phase (4 Weeks)||0
10885932|NCT02709655|12051984|FG000|COMPLETED|Single-Blind Phase (4 Weeks)||540
10885933|NCT02709655|12051985|FG001|COMPLETED|Single-Blind Phase (4 Weeks)||0
10885934|NCT02709655|12051986|FG002|COMPLETED|Single-Blind Phase (4 Weeks)||0
10885935|NCT02709655|12051987|FG003|COMPLETED|Single-Blind Phase (4 Weeks)||0
10885936|NCT02709655|12051988|FG004|COMPLETED|Single-Blind Phase (4 Weeks)||0
10885937|NCT02709655|12051984|FG000|NOT COMPLETED|Single-Blind Phase (4 Weeks)||143
10885938|NCT02709655|12051985|FG001|NOT COMPLETED|Single-Blind Phase (4 Weeks)||0
10885939|NCT02709655|12051986|FG002|NOT COMPLETED|Single-Blind Phase (4 Weeks)||0
10885940|NCT02709655|12051987|FG003|NOT COMPLETED|Single-Blind Phase (4 Weeks)||0
10885941|NCT02709655|12051988|FG004|NOT COMPLETED|Single-Blind Phase (4 Weeks)||0
10885942|NCT02709655|12051984|FG000|STARTED|Double-Blind Phase (8 Weeks)||0
10885943|NCT02709655|12051985|FG001|STARTED|Double-Blind Phase (8 Weeks)||153
10885944|NCT02709655|12051986|FG002|STARTED|Double-Blind Phase (8 Weeks)||151
10885945|NCT02709655|12051987|FG003|STARTED|Double-Blind Phase (8 Weeks)||153
10885946|NCT02709655|12051988|FG004|STARTED|Double-Blind Phase (8 Weeks)||83
10885947|NCT02709655|12051984|FG000|Received at Least 1 Dose of Study Drug|Double-Blind Phase (8 Weeks)||0
10885948|NCT02709655|12051985|FG001|Received at Least 1 Dose of Study Drug|Double-Blind Phase (8 Weeks)||153
10885949|NCT02709655|12051986|FG002|Received at Least 1 Dose of Study Drug|Double-Blind Phase (8 Weeks)||151
10885950|NCT02709655|12051987|FG003|Received at Least 1 Dose of Study Drug|Double-Blind Phase (8 Weeks)||153
10885951|NCT02709655|12051988|FG004|Received at Least 1 Dose of Study Drug|Double-Blind Phase (8 Weeks)||83
10885952|NCT02709655|12051984|FG000|Full Analysis Set (FAS)|Double-Blind Phase (8 Weeks)||0
10885953|NCT02709655|12051985|FG001|Full Analysis Set (FAS)|Double-Blind Phase (8 Weeks)||153
10885954|NCT02709655|12051986|FG002|Full Analysis Set (FAS)|Double-Blind Phase (8 Weeks)||148
10885955|NCT02709655|12051987|FG003|Full Analysis Set (FAS)|Double-Blind Phase (8 Weeks)||148
10885956|NCT02709655|12051988|FG004|Full Analysis Set (FAS)|Double-Blind Phase (8 Weeks)||81
10885957|NCT02709655|12051984|FG000|COMPLETED|Double-Blind Phase (8 Weeks)||0
10885958|NCT02709655|12051985|FG001|COMPLETED|Double-Blind Phase (8 Weeks)||138
10885959|NCT02709655|12051986|FG002|COMPLETED|Double-Blind Phase (8 Weeks)||135
10885960|NCT02709655|12051987|FG003|COMPLETED|Double-Blind Phase (8 Weeks)||133
10885961|NCT02709655|12051988|FG004|COMPLETED|Double-Blind Phase (8 Weeks)||78
10885962|NCT02709655|12051984|FG000|NOT COMPLETED|Double-Blind Phase (8 Weeks)||0
10885963|NCT02709655|12051985|FG001|NOT COMPLETED|Double-Blind Phase (8 Weeks)||15
10885964|NCT02709655|12051986|FG002|NOT COMPLETED|Double-Blind Phase (8 Weeks)||16
10885965|NCT02709655|12051987|FG003|NOT COMPLETED|Double-Blind Phase (8 Weeks)||20
10885966|NCT02709655|12051988|FG004|NOT COMPLETED|Double-Blind Phase (8 Weeks)||5
10885967|NCT02707692|12052006|FG000|STARTED|Cycle 1 (30 Days)||9
10885968|NCT02707692|12052007|FG001|STARTED|Cycle 1 (30 Days)||9
10885969|NCT02707692|12052008|FG002|STARTED|Cycle 1 (30 Days)||9
10885970|NCT02707692|12052009|FG003|STARTED|Cycle 1 (30 Days)||9
10885971|NCT02707692|12052010|FG004|STARTED|Cycle 1 (30 Days)||9
10885972|NCT02707692|12052011|FG005|STARTED|Cycle 1 (30 Days)||9
10885973|NCT02707692|12052006|FG000|COMPLETED|Cycle 1 (30 Days)||8
10885974|NCT02707692|12052007|FG001|COMPLETED|Cycle 1 (30 Days)||6
10885975|NCT02707692|12052008|FG002|COMPLETED|Cycle 1 (30 Days)||8
10885976|NCT02707692|12052009|FG003|COMPLETED|Cycle 1 (30 Days)||9
10885977|NCT02707692|12052010|FG004|COMPLETED|Cycle 1 (30 Days)||8
10885978|NCT02707692|12052011|FG005|COMPLETED|Cycle 1 (30 Days)||8
10885979|NCT02707692|12052006|FG000|NOT COMPLETED|Cycle 1 (30 Days)||1
10885980|NCT02707692|12052007|FG001|NOT COMPLETED|Cycle 1 (30 Days)||3
10885981|NCT02707692|12052008|FG002|NOT COMPLETED|Cycle 1 (30 Days)||1
10885982|NCT02707692|12052009|FG003|NOT COMPLETED|Cycle 1 (30 Days)||0
10885983|NCT02707692|12052010|FG004|NOT COMPLETED|Cycle 1 (30 Days)||1
10885984|NCT02707692|12052011|FG005|NOT COMPLETED|Cycle 1 (30 Days)||1
10885985|NCT02707692|12052006|FG000|STARTED|Washout Between Cycles 1 and 2 (>=6 Wks)||8
10885986|NCT02707692|12052007|FG001|STARTED|Washout Between Cycles 1 and 2 (>=6 Wks)||6
10885987|NCT02707692|12052008|FG002|STARTED|Washout Between Cycles 1 and 2 (>=6 Wks)||9
10885988|NCT02707692|12052009|FG003|STARTED|Washout Between Cycles 1 and 2 (>=6 Wks)||9
10885989|NCT02707692|12052010|FG004|STARTED|Washout Between Cycles 1 and 2 (>=6 Wks)||8
10885990|NCT02707692|12052011|FG005|STARTED|Washout Between Cycles 1 and 2 (>=6 Wks)||8
10885991|NCT02707692|12052006|FG000|COMPLETED|Washout Between Cycles 1 and 2 (>=6 Wks)||7
10885992|NCT02707692|12052007|FG001|COMPLETED|Washout Between Cycles 1 and 2 (>=6 Wks)||6
10885993|NCT02707692|12052008|FG002|COMPLETED|Washout Between Cycles 1 and 2 (>=6 Wks)||9
10885994|NCT02707692|12052009|FG003|COMPLETED|Washout Between Cycles 1 and 2 (>=6 Wks)||8
10885995|NCT02707692|12052010|FG004|COMPLETED|Washout Between Cycles 1 and 2 (>=6 Wks)||7
10885996|NCT02707692|12052011|FG005|COMPLETED|Washout Between Cycles 1 and 2 (>=6 Wks)||8
10885997|NCT02707692|12052006|FG000|NOT COMPLETED|Washout Between Cycles 1 and 2 (>=6 Wks)||1
10885998|NCT02707692|12052007|FG001|NOT COMPLETED|Washout Between Cycles 1 and 2 (>=6 Wks)||0
10885999|NCT02707692|12052008|FG002|NOT COMPLETED|Washout Between Cycles 1 and 2 (>=6 Wks)||0
10886000|NCT02707692|12052009|FG003|NOT COMPLETED|Washout Between Cycles 1 and 2 (>=6 Wks)||1
10886001|NCT02707692|12052010|FG004|NOT COMPLETED|Washout Between Cycles 1 and 2 (>=6 Wks)||1
10886002|NCT02707692|12052011|FG005|NOT COMPLETED|Washout Between Cycles 1 and 2 (>=6 Wks)||0
10886003|NCT02707692|12052006|FG000|STARTED|Cycle 2 (30 Days)||7
10886004|NCT02707692|12052007|FG001|STARTED|Cycle 2 (30 Days)||6
10886005|NCT02707692|12052008|FG002|STARTED|Cycle 2 (30 Days)||9
10886006|NCT02707692|12052009|FG003|STARTED|Cycle 2 (30 Days)||8
10886007|NCT02707692|12052010|FG004|STARTED|Cycle 2 (30 Days)||7
10886008|NCT02707692|12052011|FG005|STARTED|Cycle 2 (30 Days)||8
10886009|NCT02707692|12052006|FG000|COMPLETED|Cycle 2 (30 Days)||6
10886010|NCT02707692|12052007|FG001|COMPLETED|Cycle 2 (30 Days)||6
10886011|NCT02707692|12052008|FG002|COMPLETED|Cycle 2 (30 Days)||9
10886012|NCT02707692|12052009|FG003|COMPLETED|Cycle 2 (30 Days)||7
10886013|NCT02707692|12052010|FG004|COMPLETED|Cycle 2 (30 Days)||4
10886014|NCT02707692|12052011|FG005|COMPLETED|Cycle 2 (30 Days)||7
10886015|NCT02707692|12052006|FG000|NOT COMPLETED|Cycle 2 (30 Days)||1
10886016|NCT02707692|12052007|FG001|NOT COMPLETED|Cycle 2 (30 Days)||0
10886017|NCT02707692|12052008|FG002|NOT COMPLETED|Cycle 2 (30 Days)||0
10886018|NCT02707692|12052009|FG003|NOT COMPLETED|Cycle 2 (30 Days)||1
10886019|NCT02707692|12052010|FG004|NOT COMPLETED|Cycle 2 (30 Days)||3
10886020|NCT02707692|12052011|FG005|NOT COMPLETED|Cycle 2 (30 Days)||1
10886021|NCT02707692|12052006|FG000|STARTED|Washout Between Cycles 2 and 3 (>=6 Wks)||7
10886022|NCT02707692|12052007|FG001|STARTED|Washout Between Cycles 2 and 3 (>=6 Wks)||6
10886023|NCT02707692|12052008|FG002|STARTED|Washout Between Cycles 2 and 3 (>=6 Wks)||9
10886024|NCT02707692|12052009|FG003|STARTED|Washout Between Cycles 2 and 3 (>=6 Wks)||7
10886025|NCT02707692|12052010|FG004|STARTED|Washout Between Cycles 2 and 3 (>=6 Wks)||6
10886026|NCT02707692|12052011|FG005|STARTED|Washout Between Cycles 2 and 3 (>=6 Wks)||7
10886027|NCT02707692|12052006|FG000|COMPLETED|Washout Between Cycles 2 and 3 (>=6 Wks)||7
10886028|NCT02707692|12052007|FG001|COMPLETED|Washout Between Cycles 2 and 3 (>=6 Wks)||6
10886029|NCT02707692|12052008|FG002|COMPLETED|Washout Between Cycles 2 and 3 (>=6 Wks)||9
10886030|NCT02707692|12052009|FG003|COMPLETED|Washout Between Cycles 2 and 3 (>=6 Wks)||5
10886031|NCT02707692|12052010|FG004|COMPLETED|Washout Between Cycles 2 and 3 (>=6 Wks)||6
10886032|NCT02707692|12052011|FG005|COMPLETED|Washout Between Cycles 2 and 3 (>=6 Wks)||6
10886033|NCT02707692|12052006|FG000|NOT COMPLETED|Washout Between Cycles 2 and 3 (>=6 Wks)||0
10886034|NCT02707692|12052007|FG001|NOT COMPLETED|Washout Between Cycles 2 and 3 (>=6 Wks)||0
10886035|NCT02707692|12052008|FG002|NOT COMPLETED|Washout Between Cycles 2 and 3 (>=6 Wks)||0
10886036|NCT02707692|12052009|FG003|NOT COMPLETED|Washout Between Cycles 2 and 3 (>=6 Wks)||2
10886037|NCT02707692|12052010|FG004|NOT COMPLETED|Washout Between Cycles 2 and 3 (>=6 Wks)||0
10886038|NCT02707692|12052011|FG005|NOT COMPLETED|Washout Between Cycles 2 and 3 (>=6 Wks)||1
10886039|NCT02707692|12052006|FG000|STARTED|Cycle 3 (30 Days)||7
10886040|NCT02707692|12052007|FG001|STARTED|Cycle 3 (30 Days)||6
10886041|NCT02707692|12052008|FG002|STARTED|Cycle 3 (30 Days)||9
10886042|NCT02707692|12052009|FG003|STARTED|Cycle 3 (30 Days)||5
10886043|NCT02707692|12052010|FG004|STARTED|Cycle 3 (30 Days)||6
10886044|NCT02707692|12052011|FG005|STARTED|Cycle 3 (30 Days)||6
10886045|NCT02707692|12052006|FG000|COMPLETED|Cycle 3 (30 Days)||5
10886046|NCT02707692|12052007|FG001|COMPLETED|Cycle 3 (30 Days)||5
10886047|NCT02707692|12052008|FG002|COMPLETED|Cycle 3 (30 Days)||9
10886048|NCT02707692|12052009|FG003|COMPLETED|Cycle 3 (30 Days)||5
10886049|NCT02707692|12052010|FG004|COMPLETED|Cycle 3 (30 Days)||5
10886050|NCT02707692|12052011|FG005|COMPLETED|Cycle 3 (30 Days)||5
10886051|NCT02707692|12052006|FG000|NOT COMPLETED|Cycle 3 (30 Days)||2
10886052|NCT02707692|12052007|FG001|NOT COMPLETED|Cycle 3 (30 Days)||1
10886053|NCT02707692|12052008|FG002|NOT COMPLETED|Cycle 3 (30 Days)||0
10886054|NCT02707692|12052009|FG003|NOT COMPLETED|Cycle 3 (30 Days)||0
10886055|NCT02707692|12052010|FG004|NOT COMPLETED|Cycle 3 (30 Days)||1
10886056|NCT02707692|12052011|FG005|NOT COMPLETED|Cycle 3 (30 Days)||1
10886057|NCT02706951|12052022|FG000|STARTED|Overall Study||216
10886058|NCT02706951|12052023|FG001|STARTED|Overall Study||217
10886059|NCT02706951|12052024|FG002|STARTED|Overall Study||215
10886060|NCT02706951|12052022|FG000|COMPLETED|Overall Study||202
10886061|NCT02706951|12052023|FG001|COMPLETED|Overall Study||201
10886062|NCT02706951|12052024|FG002|COMPLETED|Overall Study||205
10886063|NCT02706951|12052022|FG000|NOT COMPLETED|Overall Study||14
10886064|NCT02706951|12052023|FG001|NOT COMPLETED|Overall Study||16
10886065|NCT02706951|12052024|FG002|NOT COMPLETED|Overall Study||10
10886066|NCT02706405|12052040|FG000|STARTED|Overall Study||5
10886067|NCT02706405|12052041|FG001|STARTED|Overall Study||3
10886068|NCT02706405|12052042|FG002|STARTED|Overall Study||3
10886069|NCT02706405|12052043|FG003|STARTED|Overall Study||1
10886070|NCT02706405|12052044|FG004|STARTED|Overall Study||1
10886071|NCT02706405|12052045|FG005|STARTED|Overall Study||3
10886072|NCT02706405|12052046|FG006|STARTED|Overall Study||6
10886073|NCT02706405|12052047|FG007|STARTED|Overall Study||7
10886074|NCT02706405|12052040|FG000|COMPLETED|Overall Study||1
10886075|NCT02706405|12052041|FG001|COMPLETED|Overall Study||1
10886076|NCT02706405|12052042|FG002|COMPLETED|Overall Study||3
10886077|NCT02706405|12052043|FG003|COMPLETED|Overall Study||0
10886078|NCT02706405|12052044|FG004|COMPLETED|Overall Study||1
10886079|NCT02706405|12052045|FG005|COMPLETED|Overall Study||2
10886080|NCT02706405|12052046|FG006|COMPLETED|Overall Study||3
10886081|NCT02706405|12052047|FG007|COMPLETED|Overall Study||1
10886082|NCT02706405|12052040|FG000|NOT COMPLETED|Overall Study||4
10886083|NCT02706405|12052041|FG001|NOT COMPLETED|Overall Study||2
10886084|NCT02706405|12052042|FG002|NOT COMPLETED|Overall Study||0
10886085|NCT02706405|12052043|FG003|NOT COMPLETED|Overall Study||1
10886086|NCT02706405|12052044|FG004|NOT COMPLETED|Overall Study||0
10886087|NCT02706405|12052045|FG005|NOT COMPLETED|Overall Study||1
10886088|NCT02706405|12052046|FG006|NOT COMPLETED|Overall Study||3
10886089|NCT02706405|12052047|FG007|NOT COMPLETED|Overall Study||6
10886090|NCT02706392|12052079|FG000|STARTED|Overall Study||2
10886091|NCT02706392|12052080|FG001|STARTED|Overall Study||1
10886092|NCT02706392|12052081|FG002|STARTED|Overall Study||2
10886093|NCT02706392|12052082|FG003|STARTED|Overall Study||3
10886094|NCT02706392|12052083|FG004|STARTED|Overall Study||11
10886095|NCT02706392|12052084|FG005|STARTED|Overall Study||2
10886096|NCT02706392|12052079|FG000|COMPLETED|Overall Study||1
10886097|NCT02706392|12052080|FG001|COMPLETED|Overall Study||1
10886098|NCT02706392|12052081|FG002|COMPLETED|Overall Study||0
10886099|NCT02706392|12052082|FG003|COMPLETED|Overall Study||1
10886100|NCT02706392|12052083|FG004|COMPLETED|Overall Study||6
10886101|NCT02706392|12052084|FG005|COMPLETED|Overall Study||0
10886102|NCT02706392|12052079|FG000|NOT COMPLETED|Overall Study||1
10886103|NCT02706392|12052080|FG001|NOT COMPLETED|Overall Study||0
10886104|NCT02706392|12052081|FG002|NOT COMPLETED|Overall Study||2
10886105|NCT02706392|12052082|FG003|NOT COMPLETED|Overall Study||2
10886106|NCT02706392|12052083|FG004|NOT COMPLETED|Overall Study||5
10886107|NCT02706392|12052084|FG005|NOT COMPLETED|Overall Study||2
10886108|NCT02705755|12052098|FG000|STARTED|Part A (6 Days)||34
10886109|NCT02705755|12052099|FG001|STARTED|Part A (6 Days)||0
10886110|NCT02705755|12052100|FG002|STARTED|Part A (6 Days)||0
10886111|NCT02705755|12052101|FG003|STARTED|Part A (6 Days)||0
10886112|NCT02705755|12052098|FG000|Participants Who Received Placebo|Part A (6 Days)||34
10886113|NCT02705755|12052099|FG001|Participants Who Received Placebo|Part A (6 Days)||0
10886114|NCT02705755|12052100|FG002|Participants Who Received Placebo|Part A (6 Days)||0
10886115|NCT02705755|12052101|FG003|Participants Who Received Placebo|Part A (6 Days)||0
10886116|NCT02705755|12052098|FG000|Participants Who Received 1 mg Study Drug|Part A (6 Days)||17
10886117|NCT02705755|12052099|FG001|Participants Who Received 1 mg Study Drug|Part A (6 Days)||0
10886118|NCT02705755|12052100|FG002|Participants Who Received 1 mg Study Drug|Part A (6 Days)||0
10886119|NCT02705755|12052101|FG003|Participants Who Received 1 mg Study Drug|Part A (6 Days)||0
10886120|NCT02705755|12052098|FG000|Participants Who Received 2.5 mg Study Drug|Part A (6 Days)||31
10886121|NCT02705755|12052099|FG001|Participants Who Received 2.5 mg Study Drug|Part A (6 Days)||0
10886122|NCT02705755|12052100|FG002|Participants Who Received 2.5 mg Study Drug|Part A (6 Days)||0
10886123|NCT02705755|12052101|FG003|Participants Who Received 2.5 mg Study Drug|Part A (6 Days)||0
10886124|NCT02705755|12052098|FG000|Participants Who Received 5 mg Study Drug|Part A (6 Days)||29
10886125|NCT02705755|12052099|FG001|Participants Who Received 5 mg Study Drug|Part A (6 Days)||0
10886126|NCT02705755|12052100|FG002|Participants Who Received 5 mg Study Drug|Part A (6 Days)||0
10886127|NCT02705755|12052101|FG003|Participants Who Received 5 mg Study Drug|Part A (6 Days)||0
10886128|NCT02705755|12052098|FG000|Participants Who Received 10 mg Study Drug|Part A (6 Days)||28
10886129|NCT02705755|12052099|FG001|Participants Who Received 10 mg Study Drug|Part A (6 Days)||0
10886130|NCT02705755|12052100|FG002|Participants Who Received 10 mg Study Drug|Part A (6 Days)||0
10886131|NCT02705755|12052101|FG003|Participants Who Received 10 mg Study Drug|Part A (6 Days)||0
10886132|NCT02705755|12052098|FG000|Participants Who Received 20 mg Study Drug|Part A (6 Days)||13
10886133|NCT02705755|12052099|FG001|Participants Who Received 20 mg Study Drug|Part A (6 Days)||0
10886134|NCT02705755|12052100|FG002|Participants Who Received 20 mg Study Drug|Part A (6 Days)||0
10886135|NCT02705755|12052101|FG003|Participants Who Received 20 mg Study Drug|Part A (6 Days)||0
10886136|NCT02705755|12052098|FG000|Participants Who Rolled to Part B|Part A (6 Days)||10
10886137|NCT02705755|12052099|FG001|Participants Who Rolled to Part B|Part A (6 Days)||0
10886138|NCT02705755|12052100|FG002|Participants Who Rolled to Part B|Part A (6 Days)||0
10886139|NCT02705755|12052101|FG003|Participants Who Rolled to Part B|Part A (6 Days)||0
10886140|NCT02705755|12052098|FG000|Participants Who Rolled to Part C|Part A (6 Days)||21
10886141|NCT02705755|12052099|FG001|Participants Who Rolled to Part C|Part A (6 Days)||0
10886142|NCT02705755|12052100|FG002|Participants Who Rolled to Part C|Part A (6 Days)||0
10886143|NCT02705755|12052101|FG003|Participants Who Rolled to Part C|Part A (6 Days)||0
10886144|NCT02705755|12052098|FG000|COMPLETED|Part A (6 Days)||29
10886145|NCT02705755|12052099|FG001|COMPLETED|Part A (6 Days)||0
10886146|NCT02705755|12052100|FG002|COMPLETED|Part A (6 Days)||0
10886147|NCT02705755|12052101|FG003|COMPLETED|Part A (6 Days)||0
10886148|NCT02705755|12052098|FG000|NOT COMPLETED|Part A (6 Days)||5
10886149|NCT02705755|12052099|FG001|NOT COMPLETED|Part A (6 Days)||0
10886150|NCT02705755|12052100|FG002|NOT COMPLETED|Part A (6 Days)||0
10886151|NCT02705755|12052101|FG003|NOT COMPLETED|Part A (6 Days)||0
10886152|NCT02705755|12052098|FG000|STARTED|Part B (1 Day)||0
10886153|NCT02705755|12052099|FG001|STARTED|Part B (1 Day)||5
10886154|NCT02705755|12052100|FG002|STARTED|Part B (1 Day)|Each participant received their individual maximum tolerated dose from Part A.|5
10886155|NCT02705755|12052101|FG003|STARTED|Part B (1 Day)||0
10886156|NCT02705755|12052098|FG000|Received Study Drug|Part B (1 Day)||0
10886157|NCT02705755|12052099|FG001|Received Study Drug|Part B (1 Day)||5
10886158|NCT02705755|12052100|FG002|Received Study Drug|Part B (1 Day)||5
10886159|NCT02705755|12052101|FG003|Received Study Drug|Part B (1 Day)||0
10886160|NCT02705755|12052098|FG000|COMPLETED|Part B (1 Day)||0
10886161|NCT02705755|12052099|FG001|COMPLETED|Part B (1 Day)||5
10886162|NCT02705755|12052100|FG002|COMPLETED|Part B (1 Day)||5
10886163|NCT02705755|12052101|FG003|COMPLETED|Part B (1 Day)||0
10886164|NCT02705755|12052098|FG000|NOT COMPLETED|Part B (1 Day)||0
10886165|NCT02705755|12052099|FG001|NOT COMPLETED|Part B (1 Day)||0
10886166|NCT02705755|12052100|FG002|NOT COMPLETED|Part B (1 Day)||0
10886167|NCT02705755|12052101|FG003|NOT COMPLETED|Part B (1 Day)||0
10886168|NCT02705755|12052098|FG000|STARTED|Part C (20 Weeks)||0
10886169|NCT02705755|12052099|FG001|STARTED|Part C (20 Weeks)||0
10886170|NCT02705755|12052100|FG002|STARTED|Part C (20 Weeks)||0
10886171|NCT02705755|12052101|FG003|STARTED|Part C (20 Weeks)||21
10886172|NCT02705755|12052098|FG000|Received Study Drug|Part C (20 Weeks)||0
10886173|NCT02705755|12052099|FG001|Received Study Drug|Part C (20 Weeks)||0
10886174|NCT02705755|12052100|FG002|Received Study Drug|Part C (20 Weeks)||0
10886175|NCT02705755|12052101|FG003|Received Study Drug|Part C (20 Weeks)||21
10886176|NCT02705755|12052098|FG000|COMPLETED|Part C (20 Weeks)||0
10886177|NCT02705755|12052099|FG001|COMPLETED|Part C (20 Weeks)||0
10886178|NCT02705755|12052100|FG002|COMPLETED|Part C (20 Weeks)||0
10886179|NCT02705755|12052101|FG003|COMPLETED|Part C (20 Weeks)||11
10886180|NCT02705755|12052098|FG000|NOT COMPLETED|Part C (20 Weeks)||0
10886181|NCT02705755|12052099|FG001|NOT COMPLETED|Part C (20 Weeks)||0
10886182|NCT02705755|12052100|FG002|NOT COMPLETED|Part C (20 Weeks)||0
10886183|NCT02705755|12052101|FG003|NOT COMPLETED|Part C (20 Weeks)||10
10886184|NCT02705105|12052136|FG000|STARTED|Treatment||4
10886185|NCT02705105|12052137|FG001|STARTED|Treatment||110
10886186|NCT02705105|12052136|FG000|Subjects Who Were Replaced|Treatment||1
10886187|NCT02705105|12052137|FG001|Subjects Who Were Replaced|Treatment||0
10886188|NCT02705105|12052136|FG000|D/C From Treatment Phase|Treatment||4
10886189|NCT02705105|12052137|FG001|D/C From Treatment Phase|Treatment||107
10886190|NCT02705105|12052136|FG000|D/C From Follow-Up|Treatment||4
10886191|NCT02705105|12052137|FG001|D/C From Follow-Up|Treatment||110
10886192|NCT02705105|12052136|FG000|COMPLETED|Treatment||0
10886193|NCT02705105|12052137|FG001|COMPLETED|Treatment||1
10886194|NCT02705105|12052136|FG000|NOT COMPLETED|Treatment||4
10886195|NCT02705105|12052137|FG001|NOT COMPLETED|Treatment||109
10886196|NCT02705105|12052136|FG000|STARTED|Follow-Up||4
10886197|NCT02705105|12052137|FG001|STARTED|Follow-Up||110
10886198|NCT02705105|12052136|FG000|COMPLETED|Follow-Up||0
10886199|NCT02705105|12052137|FG001|COMPLETED|Follow-Up||0
10886200|NCT02705105|12052136|FG000|NOT COMPLETED|Follow-Up||4
10886201|NCT02705105|12052137|FG001|NOT COMPLETED|Follow-Up||110
10886202|NCT02703948|12052155|FG000|STARTED|Overall Study||60
10886203|NCT02703948|12052155|FG000|COMPLETED|Overall Study||57
10886204|NCT02703948|12052155|FG000|NOT COMPLETED|Overall Study||3
10886205|NCT02698189|12052161|FG000|STARTED|Overall Study||3
10886206|NCT02698189|12052162|FG001|STARTED|Overall Study||6
10886207|NCT02698189|12052161|FG000|COMPLETED|Overall Study||0
10886208|NCT02698189|12052162|FG001|COMPLETED|Overall Study||0
10886209|NCT02698189|12052161|FG000|NOT COMPLETED|Overall Study||3
10886210|NCT02698189|12052162|FG001|NOT COMPLETED|Overall Study||6
10886211|NCT02697006|12052172|FG000|STARTED|Overall Study||34
10886212|NCT02697006|12052173|FG001|STARTED|Overall Study||13
10886213|NCT02697006|12052172|FG000|COMPLETED|Overall Study||31
10886214|NCT02697006|12052173|FG001|COMPLETED|Overall Study||9
10886215|NCT02697006|12052172|FG000|NOT COMPLETED|Overall Study||3
10886216|NCT02697006|12052173|FG001|NOT COMPLETED|Overall Study||4
10886217|NCT02696096|12052179|FG000|STARTED|Overall Study||21
10886218|NCT02696096|12052179|FG000|Opioid Abstinence During Study Period|Overall Study||11
10886219|NCT02696096|12052179|FG000|COMPLETED|Overall Study||19
10886220|NCT02696096|12052179|FG000|NOT COMPLETED|Overall Study||2
10886221|NCT02689284|12052189|FG000|STARTED|Overall Study||3
10886222|NCT02689284|12052190|FG001|STARTED|Overall Study||92
10886223|NCT02689284|12052189|FG000|COMPLETED|Overall Study||0
10886224|NCT02689284|12052190|FG001|COMPLETED|Overall Study||5
10886225|NCT02689284|12052189|FG000|NOT COMPLETED|Overall Study||3
10886226|NCT02689284|12052190|FG001|NOT COMPLETED|Overall Study||87
10886227|NCT02688647|12052199|FG000|STARTED|Initial Treatment Period (24 Weeks)||52
10886228|NCT02688647|12052200|FG001|STARTED|Initial Treatment Period (24 Weeks)||24
10886229|NCT02688647|12052199|FG000|Treated|Initial Treatment Period (24 Weeks)|1 subject was randomized but did not receive treatment.|51
10886230|NCT02688647|12052200|FG001|Treated|Initial Treatment Period (24 Weeks)||24
10886231|NCT02688647|12052199|FG000|COMPLETED|Initial Treatment Period (24 Weeks)||51
10886232|NCT02688647|12052200|FG001|COMPLETED|Initial Treatment Period (24 Weeks)||18
10886233|NCT02688647|12052199|FG000|NOT COMPLETED|Initial Treatment Period (24 Weeks)||1
10886234|NCT02688647|12052200|FG001|NOT COMPLETED|Initial Treatment Period (24 Weeks)||6
10886235|NCT02688647|12052199|FG000|STARTED|Post Switch Treatment Period (72 Weeks)|51 subjects originally randomized to treatment with belumosudil 400 mg PO QD continued receiving belumosudil 400 mg PO QD.|51
10886236|NCT02688647|12052200|FG001|STARTED|Post Switch Treatment Period (72 Weeks)|17 subjects randomized to treatment with BSC-R cross-overed to treatment with belumosudil 400 mg PO QD.|17
10886237|NCT02688647|12052199|FG000|COMPLETED|Post Switch Treatment Period (72 Weeks)||23
10886238|NCT02688647|12052200|FG001|COMPLETED|Post Switch Treatment Period (72 Weeks)||3
10886239|NCT02688647|12052199|FG000|NOT COMPLETED|Post Switch Treatment Period (72 Weeks)||28
10886240|NCT02688647|12052200|FG001|NOT COMPLETED|Post Switch Treatment Period (72 Weeks)||14
10886241|NCT02688556|12052220|FG000|STARTED|Overall Study||372
10886242|NCT02688556|12052221|FG001|STARTED|Overall Study||373
10886243|NCT02688556|12052220|FG000|COMPLETED|Overall Study||347
10886244|NCT02688556|12052221|FG001|COMPLETED|Overall Study||361
10886245|NCT02688556|12052220|FG000|NOT COMPLETED|Overall Study||25
10886246|NCT02688556|12052221|FG001|NOT COMPLETED|Overall Study||12
10886247|NCT02685826|12052230|FG000|STARTED|Overall Study||25
10886248|NCT02685826|12052231|FG001|STARTED|Overall Study||10
10886249|NCT02685826|12052232|FG002|STARTED|Overall Study||21
10886250|NCT02685826|12052230|FG000|COMPLETED|Overall Study||0
10886251|NCT02685826|12052231|FG001|COMPLETED|Overall Study||0
10886252|NCT02685826|12052232|FG002|COMPLETED|Overall Study||0
10886253|NCT02685826|12052230|FG000|NOT COMPLETED|Overall Study||25
10886254|NCT02685826|12052231|FG001|NOT COMPLETED|Overall Study||10
10886255|NCT02685826|12052232|FG002|NOT COMPLETED|Overall Study||21
10886256|NCT02680587|12052242|FG000|STARTED|Overall Study||18
10886257|NCT02680587|12052243|FG001|STARTED|Overall Study||36
10886258|NCT02680587|12052242|FG000|COMPLETED|Overall Study||17
10886259|NCT02680587|12052243|FG001|COMPLETED|Overall Study||36
10886260|NCT02680587|12052242|FG000|NOT COMPLETED|Overall Study||1
10886261|NCT02680587|12052243|FG001|NOT COMPLETED|Overall Study||0
10886262|NCT02680314|12052255|FG000|STARTED|Overall Study||120
10886263|NCT02680314|12052256|FG001|STARTED|Overall Study||123
10886264|NCT02680314|12052255|FG000|COMPLETED|Overall Study||120
10886265|NCT02680314|12052256|FG001|COMPLETED|Overall Study||123
10886266|NCT02680314|12052255|FG000|NOT COMPLETED|Overall Study||0
10886267|NCT02680314|12052256|FG001|NOT COMPLETED|Overall Study||0
10886268|NCT02679755|12052264|FG000|STARTED|Overall Study||100
10886269|NCT02679755|12052265|FG001|STARTED|Overall Study||152
10886270|NCT02679755|12052264|FG000|COMPLETED|Overall Study||66
10886271|NCT02679755|12052265|FG001|COMPLETED|Overall Study||47
10886272|NCT02679755|12052264|FG000|NOT COMPLETED|Overall Study||34
10886273|NCT02679755|12052265|FG001|NOT COMPLETED|Overall Study||105
10886274|NCT02677896|12052276|FG000|STARTED|Double Blind Period (up to 35 Months)||574
10886275|NCT02677896|12052277|FG001|STARTED|Double Blind Period (up to 35 Months)||576
10886276|NCT02677896|12052276|FG000|Treated|Double Blind Period (up to 35 Months)||572
10886277|NCT02677896|12052277|FG001|Treated|Double Blind Period (up to 35 Months)||574
10886278|NCT02677896|12052276|FG000|COMPLETED|Double Blind Period (up to 35 Months)||0
10886279|NCT02677896|12052277|FG001|COMPLETED|Double Blind Period (up to 35 Months)||0
10886280|NCT02677896|12052276|FG000|NOT COMPLETED|Double Blind Period (up to 35 Months)||574
10886281|NCT02677896|12052277|FG001|NOT COMPLETED|Double Blind Period (up to 35 Months)||576
10886282|NCT02677896|12052276|FG000|STARTED|Open-Label Extension (up to 25 Months)|Eligible participants who provided consent took part in open-label period|365
10886283|NCT02677896|12052277|FG001|STARTED|Open-Label Extension (up to 25 Months)|Eligible participants who provided consent took part in open-label period|180
10886284|NCT02677896|12052276|FG000|COMPLETED|Open-Label Extension (up to 25 Months)||0
10886285|NCT02677896|12052277|FG001|COMPLETED|Open-Label Extension (up to 25 Months)||0
10886286|NCT02677896|12052276|FG000|NOT COMPLETED|Open-Label Extension (up to 25 Months)||365
10886287|NCT02677896|12052277|FG001|NOT COMPLETED|Open-Label Extension (up to 25 Months)||180
10886288|NCT02675231|12052287|FG000|STARTED|Overall Study||79
10886289|NCT02675231|12052288|FG001|STARTED|Overall Study||79
10886290|NCT02675231|12052289|FG002|STARTED|Overall Study||79
10886291|NCT02675231|12052287|FG000|Received at Least One Dose of Drug|Overall Study||78
10886292|NCT02675231|12052288|FG001|Received at Least One Dose of Drug|Overall Study||77
10886293|NCT02675231|12052289|FG002|Received at Least One Dose of Drug|Overall Study||72
10886294|NCT02675231|12052287|FG000|COMPLETED|Overall Study||53
10886295|NCT02675231|12052288|FG001|COMPLETED|Overall Study||43
10886296|NCT02675231|12052289|FG002|COMPLETED|Overall Study||53
10886297|NCT02675231|12052287|FG000|NOT COMPLETED|Overall Study||26
10886298|NCT02675231|12052288|FG001|NOT COMPLETED|Overall Study||36
10886299|NCT02675231|12052289|FG002|NOT COMPLETED|Overall Study||26
10886300|NCT02673697|12052300|FG000|STARTED|Overall Study||453
10886301|NCT02673697|12052301|FG001|STARTED|Overall Study||457
10886302|NCT02673697|12052300|FG000|Implanted|Overall Study||450
10886303|NCT02673697|12052301|FG001|Implanted|Overall Study||446
10886304|NCT02673697|12052300|FG000|Per-Protocol Population|Overall Study||407
10886305|NCT02673697|12052301|FG001|Per-Protocol Population|Overall Study||412
10886306|NCT02673697|12052300|FG000|COMPLETED|Overall Study||0
10886307|NCT02673697|12052301|FG001|COMPLETED|Overall Study||0
10886308|NCT02673697|12052300|FG000|NOT COMPLETED|Overall Study||453
10886309|NCT02673697|12052301|FG001|NOT COMPLETED|Overall Study||457
10886310|NCT02673398|12052307|FG000|STARTED|Overall Study||25
10886311|NCT02673398|12052307|FG000|COMPLETED|Overall Study||25
10886312|NCT02673398|12052307|FG000|NOT COMPLETED|Overall Study||0
10886313|NCT02667587|12052313|FG000|STARTED|Pre-Treatment||358
10886314|NCT02667587|12052314|FG001|STARTED|Pre-Treatment||358
10886315|NCT02667587|12052313|FG000|COMPLETED|Pre-Treatment||354
10886316|NCT02667587|12052314|FG001|COMPLETED|Pre-Treatment||355
10886317|NCT02667587|12052313|FG000|NOT COMPLETED|Pre-Treatment||4
10886318|NCT02667587|12052314|FG001|NOT COMPLETED|Pre-Treatment||3
10886407|NCT02657343|12052421|FG001|NOT COMPLETED|Overall Study||2
10886408|NCT02657343|12052422|FG002|NOT COMPLETED|Overall Study||0
10886319|NCT02667587|12052313|FG000|STARTED|End of Treatment|1 participant was randomized to Radiotherapy, Temozolomide plus Placebo but received Radiotherapy, Temozolomide plus Nivolumab.|355
10886320|NCT02667587|12052314|FG001|STARTED|End of Treatment|1 participant was randomized to Radiotherapy, Temozolomide plus Placebo but received Radiotherapy, Temozolomide plus Nivolumab.|354
10886321|NCT02667587|12052313|FG000|COMPLETED|End of Treatment||37
10886322|NCT02667587|12052314|FG001|COMPLETED|End of Treatment||44
10886323|NCT02667587|12052313|FG000|NOT COMPLETED|End of Treatment||318
10886324|NCT02667587|12052314|FG001|NOT COMPLETED|End of Treatment||310
10886325|NCT02667119|12052322|FG000|STARTED|Overall Study||14
10886326|NCT02667119|12052323|FG001|STARTED|Overall Study||13
10886327|NCT02667119|12052322|FG000|COMPLETED|Overall Study||11
10886328|NCT02667119|12052323|FG001|COMPLETED|Overall Study||13
10886329|NCT02667119|12052322|FG000|NOT COMPLETED|Overall Study||3
10886330|NCT02667119|12052323|FG001|NOT COMPLETED|Overall Study||0
10886331|NCT02666742|12052331|FG000|STARTED|Overall Study||123
10886332|NCT02666742|12052332|FG001|STARTED|Overall Study||123
10886333|NCT02666742|12052331|FG000|COMPLETED|Overall Study||123
10886334|NCT02666742|12052332|FG001|COMPLETED|Overall Study||123
10886335|NCT02666742|12052331|FG000|NOT COMPLETED|Overall Study||0
10886336|NCT02666742|12052332|FG001|NOT COMPLETED|Overall Study||0
10886337|NCT02665481|12052344|FG000|STARTED|Overall Study||150
10886338|NCT02665481|12052345|FG001|STARTED|Overall Study||138
10886339|NCT02665481|12052346|FG002|STARTED|Overall Study||144
10886340|NCT02665481|12052347|FG003|STARTED|Overall Study||153
10886341|NCT02665481|12052344|FG000|COMPLETED|Overall Study||139
10886342|NCT02665481|12052345|FG001|COMPLETED|Overall Study||119
10886343|NCT02665481|12052346|FG002|COMPLETED|Overall Study||106
10886344|NCT02665481|12052347|FG003|COMPLETED|Overall Study||111
10886345|NCT02665481|12052344|FG000|NOT COMPLETED|Overall Study||11
10886346|NCT02665481|12052345|FG001|NOT COMPLETED|Overall Study||19
10886347|NCT02665481|12052346|FG002|NOT COMPLETED|Overall Study||38
10886348|NCT02665481|12052347|FG003|NOT COMPLETED|Overall Study||42
10886349|NCT02665338|12052359|FG000|STARTED|Overall Study||5
10886350|NCT02665338|12052360|FG001|STARTED|Overall Study||6
10886351|NCT02665338|12052359|FG000|COMPLETED|Overall Study||5
10886352|NCT02665338|12052360|FG001|COMPLETED|Overall Study||5
10886353|NCT02665338|12052359|FG000|NOT COMPLETED|Overall Study||0
10886354|NCT02665338|12052360|FG001|NOT COMPLETED|Overall Study||1
10886355|NCT02664181|12052368|FG000|STARTED|Overall Study||8
10886356|NCT02664181|12052369|FG001|STARTED|Overall Study||5
10886357|NCT02664181|12052368|FG000|COMPLETED|Overall Study||8
10886358|NCT02664181|12052369|FG001|COMPLETED|Overall Study||5
10886359|NCT02664181|12052368|FG000|NOT COMPLETED|Overall Study||0
10886360|NCT02664181|12052369|FG001|NOT COMPLETED|Overall Study||0
10886361|NCT02660359|12052378|FG000|STARTED|Overall Study||86
10886362|NCT02660359|12052379|FG001|STARTED|Overall Study||86
10886363|NCT02660359|12052380|FG002|STARTED|Overall Study||85
10886364|NCT02660359|12052378|FG000|Subjects Entered in the Dysport Cycles|Overall Study||56
10886365|NCT02660359|12052379|FG001|Subjects Entered in the Dysport Cycles|Overall Study||86
10886366|NCT02660359|12052380|FG002|Subjects Entered in the Dysport Cycles|Overall Study||85
10886367|NCT02660359|12052378|FG000|COMPLETED|Overall Study||0
10886368|NCT02660359|12052379|FG001|COMPLETED|Overall Study||0
10886369|NCT02660359|12052380|FG002|COMPLETED|Overall Study||1
10886370|NCT02660359|12052378|FG000|NOT COMPLETED|Overall Study||86
10886371|NCT02660359|12052379|FG001|NOT COMPLETED|Overall Study||86
10886372|NCT02660359|12052380|FG002|NOT COMPLETED|Overall Study||84
10886373|NCT02660138|12052391|FG000|STARTED|Overall Study||76
10886374|NCT02660138|12052392|FG001|STARTED|Overall Study||76
10886375|NCT02660138|12052393|FG002|STARTED|Overall Study||75
10886376|NCT02660138|12052391|FG000|Subjects Treated in DBPC Cycle|Overall Study||76
10886377|NCT02660138|12052392|FG001|Subjects Treated in DBPC Cycle|Overall Study||75
10886378|NCT02660138|12052393|FG002|Subjects Treated in DBPC Cycle|Overall Study||75
10886379|NCT02660138|12052391|FG000|Subjects Entered in the Dysport Cycles|Overall Study||49
10886380|NCT02660138|12052392|FG001|Subjects Entered in the Dysport Cycles|Overall Study||75
10886381|NCT02660138|12052393|FG002|Subjects Entered in the Dysport Cycles|Overall Study||75
10886382|NCT02660138|12052391|FG000|COMPLETED|Overall Study||6
10886383|NCT02660138|12052392|FG001|COMPLETED|Overall Study||2
10886384|NCT02660138|12052393|FG002|COMPLETED|Overall Study||3
10886385|NCT02660138|12052391|FG000|NOT COMPLETED|Overall Study||70
10886386|NCT02660138|12052392|FG001|NOT COMPLETED|Overall Study||74
10886387|NCT02660138|12052393|FG002|NOT COMPLETED|Overall Study||72
10886388|NCT02659059|12052406|FG000|STARTED|Overall Study||288
10886389|NCT02659059|12052407|FG001|STARTED|Overall Study||36
10886390|NCT02659059|12052406|FG000|COMPLETED|Overall Study||88
10886391|NCT02659059|12052407|FG001|COMPLETED|Overall Study||4
10886392|NCT02659059|12052406|FG000|NOT COMPLETED|Overall Study||200
10886393|NCT02659059|12052407|FG001|NOT COMPLETED|Overall Study||32
10886394|NCT02657343|12052420|FG000|STARTED|Overall Study||3
10886395|NCT02657343|12052421|FG001|STARTED|Overall Study||3
10886396|NCT02657343|12052422|FG002|STARTED|Overall Study||3
10886397|NCT02657343|12052423|FG003|STARTED|Overall Study||3
10886398|NCT02657343|12052424|FG004|STARTED|Overall Study||13
10886399|NCT02657343|12052425|FG005|STARTED|Overall Study||0
10886400|NCT02657343|12052420|FG000|COMPLETED|Overall Study||2
10886401|NCT02657343|12052421|FG001|COMPLETED|Overall Study||1
10886402|NCT02657343|12052422|FG002|COMPLETED|Overall Study||3
10886403|NCT02657343|12052423|FG003|COMPLETED|Overall Study||3
10886404|NCT02657343|12052424|FG004|COMPLETED|Overall Study||12
10886405|NCT02657343|12052425|FG005|COMPLETED|Overall Study||0
10886406|NCT02657343|12052420|FG000|NOT COMPLETED|Overall Study||1
10886409|NCT02657343|12052423|FG003|NOT COMPLETED|Overall Study||0
10886410|NCT02657343|12052424|FG004|NOT COMPLETED|Overall Study||1
10886411|NCT02657343|12052425|FG005|NOT COMPLETED|Overall Study||0
10886412|NCT02656017|12052441|FG000|STARTED|Overall Study||49
10886413|NCT02656017|12052442|FG001|STARTED|Overall Study||48
10886414|NCT02656017|12052441|FG000|COMPLETED|Overall Study||40
10886415|NCT02656017|12052442|FG001|COMPLETED|Overall Study||42
10886416|NCT02656017|12052441|FG000|NOT COMPLETED|Overall Study||9
10886417|NCT02656017|12052442|FG001|NOT COMPLETED|Overall Study||6
10886418|NCT02652767|12052448|FG000|STARTED|Overall Study||39
10886419|NCT02652767|12052448|FG000|Completed Week 48|Overall Study||38
10886420|NCT02652767|12052448|FG000|COMPLETED|Overall Study||35
10886421|NCT02652767|12052448|FG000|NOT COMPLETED|Overall Study||4
10886422|NCT02652260|12052456|FG000|STARTED|Overall Study||43
10886423|NCT02652260|12052457|FG001|STARTED|Overall Study||43
10886424|NCT02652260|12052456|FG000|COMPLETED|Overall Study||43
10886425|NCT02652260|12052457|FG001|COMPLETED|Overall Study||41
10886426|NCT02652260|12052456|FG000|NOT COMPLETED|Overall Study||0
10886427|NCT02652260|12052457|FG001|NOT COMPLETED|Overall Study||2
10886428|NCT02650921|12052466|FG000|STARTED|Overall Study||92
10886429|NCT02650921|12052466|FG000|COMPLETED|Overall Study||84
10886430|NCT02650921|12052466|FG000|NOT COMPLETED|Overall Study||8
10886431|NCT02644967|12052472|FG000|STARTED|Overall Study|All participants who received at least 1 dose of study treatment (8 mg Tilso/Ipi) including nine rollover participants from the Phase 1 study.|53
10886432|NCT02644967|12052472|FG000|COMPLETED|Overall Study||18
10886433|NCT02644967|12052472|FG000|NOT COMPLETED|Overall Study||35
10886434|NCT02642042|12052476|FG000|STARTED|Overall Study||54
10886435|NCT02642042|12052476|FG000|COMPLETED|Overall Study||0
10886436|NCT02642042|12052476|FG000|NOT COMPLETED|Overall Study||54
10886437|NCT02639546|12052488|FG000|STARTED|Overall Study||6
10886438|NCT02639546|12052489|FG001|STARTED|Overall Study||6
10886439|NCT02639546|12052490|FG002|STARTED|Overall Study||6
10886440|NCT02639546|12052491|FG003|STARTED|Overall Study||6
10886441|NCT02639546|12052492|FG004|STARTED|Overall Study||7
10886442|NCT02639546|12052493|FG005|STARTED|Overall Study||8
10886443|NCT02639546|12052494|FG006|STARTED|Overall Study||5
10886444|NCT02639546|12052495|FG007|STARTED|Overall Study||12
10886445|NCT02639546|12052488|FG000|Tumor Type - Neuroblastoma|Overall Study||0
10886446|NCT02639546|12052489|FG001|Tumor Type - Neuroblastoma|Overall Study||0
10886447|NCT02639546|12052490|FG002|Tumor Type - Neuroblastoma|Overall Study||1
10886448|NCT02639546|12052491|FG003|Tumor Type - Neuroblastoma|Overall Study||0
10886449|NCT02639546|12052492|FG004|Tumor Type - Neuroblastoma|Overall Study||0
10886450|NCT02639546|12052493|FG005|Tumor Type - Neuroblastoma|Overall Study||0
10886451|NCT02639546|12052494|FG006|Tumor Type - Neuroblastoma|Overall Study||0
10886452|NCT02639546|12052495|FG007|Tumor Type - Neuroblastoma|Overall Study||0
10886453|NCT02639546|12052488|FG000|Tumor Type - High-Grade Glioma|Overall Study||3
10886454|NCT02639546|12052489|FG001|Tumor Type - High-Grade Glioma|Overall Study||1
10886455|NCT02639546|12052490|FG002|Tumor Type - High-Grade Glioma|Overall Study||0
10886456|NCT02639546|12052491|FG003|Tumor Type - High-Grade Glioma|Overall Study||0
10886457|NCT02639546|12052492|FG004|Tumor Type - High-Grade Glioma|Overall Study||1
10886458|NCT02639546|12052493|FG005|Tumor Type - High-Grade Glioma|Overall Study||0
10886459|NCT02639546|12052494|FG006|Tumor Type - High-Grade Glioma|Overall Study||0
10886460|NCT02639546|12052495|FG007|Tumor Type - High-Grade Glioma|Overall Study||0
10886461|NCT02639546|12052488|FG000|Tumor Type - Low-Grade Glioma|Overall Study||1
10886462|NCT02639546|12052489|FG001|Tumor Type - Low-Grade Glioma|Overall Study||2
10886463|NCT02639546|12052490|FG002|Tumor Type - Low-Grade Glioma|Overall Study||4
10886464|NCT02639546|12052491|FG003|Tumor Type - Low-Grade Glioma|Overall Study||5
10886465|NCT02639546|12052492|FG004|Tumor Type - Low-Grade Glioma|Overall Study||3
10886466|NCT02639546|12052493|FG005|Tumor Type - Low-Grade Glioma|Overall Study||2
10886467|NCT02639546|12052494|FG006|Tumor Type - Low-Grade Glioma|Overall Study||3
10886468|NCT02639546|12052495|FG007|Tumor Type - Low-Grade Glioma|Overall Study||12
10886469|NCT02639546|12052488|FG000|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
10886470|NCT02639546|12052489|FG001|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
10886471|NCT02639546|12052490|FG002|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
10886472|NCT02639546|12052491|FG003|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
10886473|NCT02639546|12052492|FG004|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
10886474|NCT02639546|12052493|FG005|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
10886475|NCT02639546|12052494|FG006|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||1
10886476|NCT02639546|12052495|FG007|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
10886477|NCT02639546|12052488|FG000|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||0
10886478|NCT02639546|12052489|FG001|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||0
10886479|NCT02639546|12052490|FG002|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||0
10886480|NCT02639546|12052491|FG003|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||0
10886481|NCT02639546|12052492|FG004|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||1
10886482|NCT02639546|12052493|FG005|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||1
10886483|NCT02639546|12052494|FG006|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||0
10886484|NCT02639546|12052495|FG007|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||0
10886485|NCT02639546|12052488|FG000|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||1
10886486|NCT02639546|12052489|FG001|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
10886487|NCT02639546|12052490|FG002|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
10886488|NCT02639546|12052491|FG003|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
10886489|NCT02639546|12052492|FG004|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
10886490|NCT02639546|12052493|FG005|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
10886491|NCT02639546|12052494|FG006|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
10886492|NCT02639546|12052495|FG007|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
10886493|NCT02639546|12052488|FG000|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0
10886494|NCT02639546|12052489|FG001|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||1
10886495|NCT02639546|12052490|FG002|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0
10886496|NCT02639546|12052491|FG003|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0
10886497|NCT02639546|12052492|FG004|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0
10886498|NCT02639546|12052493|FG005|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0
10886499|NCT02639546|12052494|FG006|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0
10886500|NCT02639546|12052495|FG007|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0
10886501|NCT02639546|12052488|FG000|Tumor Type - Plexiform Neurofibroma|Overall Study||1
10886502|NCT02639546|12052489|FG001|Tumor Type - Plexiform Neurofibroma|Overall Study||2
10886503|NCT02639546|12052490|FG002|Tumor Type - Plexiform Neurofibroma|Overall Study||1
10886504|NCT02639546|12052491|FG003|Tumor Type - Plexiform Neurofibroma|Overall Study||1
10886505|NCT02639546|12052492|FG004|Tumor Type - Plexiform Neurofibroma|Overall Study||2
10886506|NCT02639546|12052493|FG005|Tumor Type - Plexiform Neurofibroma|Overall Study||4
10886507|NCT02639546|12052494|FG006|Tumor Type - Plexiform Neurofibroma|Overall Study||1
10886508|NCT02639546|12052495|FG007|Tumor Type - Plexiform Neurofibroma|Overall Study||0
10886509|NCT02639546|12052488|FG000|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0
10886510|NCT02639546|12052489|FG001|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0
10886511|NCT02639546|12052490|FG002|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0
10886512|NCT02639546|12052491|FG003|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0
10886513|NCT02639546|12052492|FG004|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0
10886514|NCT02639546|12052493|FG005|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||1
10886515|NCT02639546|12052494|FG006|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0
10886516|NCT02639546|12052495|FG007|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0
10886517|NCT02639546|12052488|FG000|COMPLETED|Overall Study||0
10886518|NCT02639546|12052489|FG001|COMPLETED|Overall Study||0
10886519|NCT02639546|12052490|FG002|COMPLETED|Overall Study||0
10886520|NCT02639546|12052491|FG003|COMPLETED|Overall Study||0
10886521|NCT02639546|12052492|FG004|COMPLETED|Overall Study||0
10886522|NCT02639546|12052493|FG005|COMPLETED|Overall Study||0
10886523|NCT02639546|12052494|FG006|COMPLETED|Overall Study||0
10886524|NCT02639546|12052495|FG007|COMPLETED|Overall Study||0
10886525|NCT02639546|12052488|FG000|NOT COMPLETED|Overall Study||6
10886526|NCT02639546|12052489|FG001|NOT COMPLETED|Overall Study||6
10886527|NCT02639546|12052490|FG002|NOT COMPLETED|Overall Study||6
10886528|NCT02639546|12052491|FG003|NOT COMPLETED|Overall Study||6
10886529|NCT02639546|12052492|FG004|NOT COMPLETED|Overall Study||7
10886530|NCT02639546|12052493|FG005|NOT COMPLETED|Overall Study||8
10886531|NCT02639546|12052494|FG006|NOT COMPLETED|Overall Study||5
10886532|NCT02639546|12052495|FG007|NOT COMPLETED|Overall Study||12
10886533|NCT02638883|12052527|FG000|STARTED|Overall Study||6
10886534|NCT02638883|12052527|FG000|COMPLETED|Overall Study||6
10886535|NCT02638883|12052527|FG000|NOT COMPLETED|Overall Study||0
10886536|NCT02634333|12052533|FG000|STARTED|Overall Study|Number of Eyes|200
10886537|NCT02634333|12052534|FG001|STARTED|Overall Study|Number of Eyes|199
10886538|NCT02634333|12052533|FG000|COMPLETED|Overall Study|Number of Eyes|160
10886539|NCT02634333|12052534|FG001|COMPLETED|Overall Study|Number of Eyes|167
10886540|NCT02634333|12052533|FG000|NOT COMPLETED|Overall Study||40
10886541|NCT02634333|12052534|FG001|NOT COMPLETED|Overall Study||32
10886542|NCT02633267|12052543|FG000|STARTED|Overall Study||120
10886543|NCT02633267|12052544|FG001|STARTED|Overall Study||130
10886544|NCT02633267|12052543|FG000|COMPLETED|Overall Study||89
10886545|NCT02633267|12052544|FG001|COMPLETED|Overall Study||91
10886546|NCT02633267|12052543|FG000|NOT COMPLETED|Overall Study||31
10886547|NCT02633267|12052544|FG001|NOT COMPLETED|Overall Study||39
10886548|NCT02630459|12052554|FG000|STARTED|Double-Blind Treatment Phase (DBTP)||136
10886549|NCT02630459|12052555|FG001|STARTED|Double-Blind Treatment Phase (DBTP)||67
10886550|NCT02630459|12052556|FG002|STARTED|Double-Blind Treatment Phase (DBTP)||135
10886551|NCT02630459|12052557|FG003|STARTED|Double-Blind Treatment Phase (DBTP)||137
10886552|NCT02630459|12052558|FG004|STARTED|Double-Blind Treatment Phase (DBTP)||0
10886553|NCT02630459|12052559|FG005|STARTED|Double-Blind Treatment Phase (DBTP)||0
10886554|NCT02630459|12052560|FG006|STARTED|Double-Blind Treatment Phase (DBTP)||0
10886555|NCT02630459|12052561|FG007|STARTED|Double-Blind Treatment Phase (DBTP)||0
10886556|NCT02630459|12052554|FG000|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||136
10886557|NCT02630459|12052555|FG001|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||66
10886558|NCT02630459|12052556|FG002|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||135
10886559|NCT02630459|12052557|FG003|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||137
10886560|NCT02630459|12052558|FG004|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||0
10886561|NCT02630459|12052559|FG005|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||0
10886562|NCT02630459|12052560|FG006|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||0
10886563|NCT02630459|12052561|FG007|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||0
10886564|NCT02630459|12052554|FG000|COMPLETED|Double-Blind Treatment Phase (DBTP)||133
10886565|NCT02630459|12052555|FG001|COMPLETED|Double-Blind Treatment Phase (DBTP)||65
10886566|NCT02630459|12052556|FG002|COMPLETED|Double-Blind Treatment Phase (DBTP)||130
10886567|NCT02630459|12052557|FG003|COMPLETED|Double-Blind Treatment Phase (DBTP)||134
10886568|NCT02630459|12052558|FG004|COMPLETED|Double-Blind Treatment Phase (DBTP)||0
10886569|NCT02630459|12052559|FG005|COMPLETED|Double-Blind Treatment Phase (DBTP)||0
10886570|NCT02630459|12052560|FG006|COMPLETED|Double-Blind Treatment Phase (DBTP)||0
10886571|NCT02630459|12052561|FG007|COMPLETED|Double-Blind Treatment Phase (DBTP)||0
10886572|NCT02630459|12052554|FG000|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||3
10886573|NCT02630459|12052555|FG001|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||2
10886574|NCT02630459|12052556|FG002|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||5
10886575|NCT02630459|12052557|FG003|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||3
10886576|NCT02630459|12052558|FG004|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||0
10886577|NCT02630459|12052559|FG005|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||0
10886578|NCT02630459|12052560|FG006|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||0
10886579|NCT02630459|12052561|FG007|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||0
10886580|NCT02630459|12052554|FG000|STARTED|Open-Label Treatment Phase (OLTP)||0
10886581|NCT02630459|12052555|FG001|STARTED|Open-Label Treatment Phase (OLTP)||0
10886582|NCT02630459|12052556|FG002|STARTED|Open-Label Treatment Phase (OLTP)||0
10886583|NCT02630459|12052557|FG003|STARTED|Open-Label Treatment Phase (OLTP)||0
10886584|NCT02630459|12052558|FG004|STARTED|Open-Label Treatment Phase (OLTP)||386
10886585|NCT02630459|12052559|FG005|STARTED|Open-Label Treatment Phase (OLTP)||73
10886586|NCT02630459|12052560|FG006|STARTED|Open-Label Treatment Phase (OLTP)||0
10886587|NCT02630459|12052561|FG007|STARTED|Open-Label Treatment Phase (OLTP)||0
10886588|NCT02630459|12052554|FG000|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10886589|NCT02630459|12052555|FG001|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10886590|NCT02630459|12052556|FG002|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10886591|NCT02630459|12052557|FG003|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10886592|NCT02630459|12052558|FG004|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||270
10886593|NCT02630459|12052559|FG005|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10886594|NCT02630459|12052560|FG006|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10886595|NCT02630459|12052561|FG007|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10886596|NCT02630459|12052554|FG000|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10886597|NCT02630459|12052555|FG001|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10886598|NCT02630459|12052556|FG002|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10886599|NCT02630459|12052557|FG003|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10886600|NCT02630459|12052558|FG004|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10886601|NCT02630459|12052559|FG005|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||73
10886602|NCT02630459|12052560|FG006|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10886603|NCT02630459|12052561|FG007|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10886604|NCT02630459|12052554|FG000|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10886605|NCT02630459|12052555|FG001|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10886606|NCT02630459|12052556|FG002|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10886607|NCT02630459|12052557|FG003|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10886608|NCT02630459|12052558|FG004|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||116
10886609|NCT02630459|12052559|FG005|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10886610|NCT02630459|12052560|FG006|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10886611|NCT02630459|12052561|FG007|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10886612|NCT02630459|12052554|FG000|COMPLETED|Open-Label Treatment Phase (OLTP)||0
10886613|NCT02630459|12052555|FG001|COMPLETED|Open-Label Treatment Phase (OLTP)||0
10886614|NCT02630459|12052556|FG002|COMPLETED|Open-Label Treatment Phase (OLTP)||0
10886615|NCT02630459|12052557|FG003|COMPLETED|Open-Label Treatment Phase (OLTP)||0
10886616|NCT02630459|12052558|FG004|COMPLETED|Open-Label Treatment Phase (OLTP)||357
10886617|NCT02630459|12052559|FG005|COMPLETED|Open-Label Treatment Phase (OLTP)||69
10886618|NCT02630459|12052560|FG006|COMPLETED|Open-Label Treatment Phase (OLTP)||0
10886619|NCT02630459|12052561|FG007|COMPLETED|Open-Label Treatment Phase (OLTP)||0
10886620|NCT02630459|12052554|FG000|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
10886621|NCT02630459|12052555|FG001|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
10886622|NCT02630459|12052556|FG002|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
10886623|NCT02630459|12052557|FG003|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
10886624|NCT02630459|12052558|FG004|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||29
10886625|NCT02630459|12052559|FG005|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||4
10886626|NCT02630459|12052560|FG006|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
10886627|NCT02630459|12052561|FG007|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
10886628|NCT02630459|12052554|FG000|STARTED|Optional CHU Sub-Study (During OLTP)||0
10886790|NCT02594111|12052715|FG001|STARTED|Overall Study||348
10886629|NCT02630459|12052555|FG001|STARTED|Optional CHU Sub-Study (During OLTP)||0
10886630|NCT02630459|12052556|FG002|STARTED|Optional CHU Sub-Study (During OLTP)||0
10886631|NCT02630459|12052557|FG003|STARTED|Optional CHU Sub-Study (During OLTP)||0
10886632|NCT02630459|12052558|FG004|STARTED|Optional CHU Sub-Study (During OLTP)||0
10886633|NCT02630459|12052559|FG005|STARTED|Optional CHU Sub-Study (During OLTP)||0
10886634|NCT02630459|12052560|FG006|STARTED|Optional CHU Sub-Study (During OLTP)||24
10886635|NCT02630459|12052561|FG007|STARTED|Optional CHU Sub-Study (During OLTP)||25
10886636|NCT02630459|12052554|FG000|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
10886637|NCT02630459|12052555|FG001|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
10886638|NCT02630459|12052556|FG002|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
10886639|NCT02630459|12052557|FG003|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
10886640|NCT02630459|12052558|FG004|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
10886641|NCT02630459|12052559|FG005|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
10886642|NCT02630459|12052560|FG006|COMPLETED|Optional CHU Sub-Study (During OLTP)||24
10886643|NCT02630459|12052561|FG007|COMPLETED|Optional CHU Sub-Study (During OLTP)||25
10886644|NCT02630459|12052554|FG000|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
10886645|NCT02630459|12052555|FG001|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
10886646|NCT02630459|12052556|FG002|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
10886647|NCT02630459|12052557|FG003|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
10886648|NCT02630459|12052558|FG004|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
10886649|NCT02630459|12052559|FG005|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
10886650|NCT02630459|12052560|FG006|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
10886651|NCT02630459|12052561|FG007|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
10886652|NCT02630316|12052588|FG000|STARTED|Overall Study||163
10886653|NCT02630316|12052589|FG001|STARTED|Overall Study||163
10886654|NCT02630316|12052588|FG000|COMPLETED|Overall Study||128
10886655|NCT02630316|12052589|FG001|COMPLETED|Overall Study||130
10886656|NCT02630316|12052588|FG000|NOT COMPLETED|Overall Study||35
10886657|NCT02630316|12052589|FG001|NOT COMPLETED|Overall Study||33
10886658|NCT02622386|12052595|FG000|STARTED|First Assignment||12
10886659|NCT02622386|12052596|FG001|STARTED|First Assignment||11
10886660|NCT02622386|12052595|FG000|COMPLETED|First Assignment||9
10886661|NCT02622386|12052596|FG001|COMPLETED|First Assignment||9
10886662|NCT02622386|12052595|FG000|NOT COMPLETED|First Assignment||3
10886663|NCT02622386|12052596|FG001|NOT COMPLETED|First Assignment||2
10886664|NCT02622386|12052595|FG000|STARTED|Washout||9
10886665|NCT02622386|12052596|FG001|STARTED|Washout||9
10886666|NCT02622386|12052595|FG000|COMPLETED|Washout||5
10886667|NCT02622386|12052596|FG001|COMPLETED|Washout||5
10886668|NCT02622386|12052595|FG000|NOT COMPLETED|Washout||4
10886669|NCT02622386|12052596|FG001|NOT COMPLETED|Washout||4
10886670|NCT02622386|12052595|FG000|STARTED|Second Assignment||5
10886671|NCT02622386|12052596|FG001|STARTED|Second Assignment||5
10886672|NCT02622386|12052595|FG000|COMPLETED|Second Assignment||5
10886673|NCT02622386|12052596|FG001|COMPLETED|Second Assignment||3
10886674|NCT02622386|12052595|FG000|NOT COMPLETED|Second Assignment||0
10886675|NCT02622386|12052596|FG001|NOT COMPLETED|Second Assignment||2
10886676|NCT02621606|12052605|FG000|STARTED|Overall Study||3
10886677|NCT02621606|12052606|FG001|STARTED|Overall Study||7
10886678|NCT02621606|12052607|FG002|STARTED|Overall Study||10
10886679|NCT02621606|12052605|FG000|Treated|Overall Study||3
10886680|NCT02621606|12052606|FG001|Treated|Overall Study||7
10886681|NCT02621606|12052607|FG002|Treated|Overall Study||10
10886682|NCT02621606|12052605|FG000|COMPLETED|Overall Study||3
10886683|NCT02621606|12052606|FG001|COMPLETED|Overall Study||6
10886684|NCT02621606|12052607|FG002|COMPLETED|Overall Study||10
10886685|NCT02621606|12052605|FG000|NOT COMPLETED|Overall Study||0
10886686|NCT02621606|12052606|FG001|NOT COMPLETED|Overall Study||1
10886687|NCT02621606|12052607|FG002|NOT COMPLETED|Overall Study||0
10886688|NCT02620761|12052617|FG000|STARTED|Overall Study||1
10886689|NCT02620761|12052618|FG001|STARTED|Overall Study||0
10886690|NCT02620761|12052617|FG000|COMPLETED|Overall Study||1
10886691|NCT02620761|12052618|FG001|COMPLETED|Overall Study||0
10886692|NCT02620761|12052617|FG000|NOT COMPLETED|Overall Study||0
10886693|NCT02620761|12052618|FG001|NOT COMPLETED|Overall Study||0
10886694|NCT02619682|12052624|FG000|STARTED|Overall Study||30
10886695|NCT02619682|12052624|FG000|COMPLETED|Overall Study||16
10886696|NCT02619682|12052624|FG000|NOT COMPLETED|Overall Study||14
10886697|NCT02614794|12052630|FG000|STARTED|Overall Study||410
10886698|NCT02614794|12052631|FG001|STARTED|Overall Study||202
10886699|NCT02614794|12052630|FG000|COMPLETED|Overall Study||0
10886700|NCT02614794|12052631|FG001|COMPLETED|Overall Study||0
10886701|NCT02614794|12052630|FG000|NOT COMPLETED|Overall Study||410
10886702|NCT02614794|12052631|FG001|NOT COMPLETED|Overall Study||202
10886703|NCT02614066|12052641|FG000|STARTED|Overall Study||6
10886704|NCT02614066|12052642|FG001|STARTED|Overall Study||28
10886705|NCT02614066|12052643|FG002|STARTED|Overall Study||20
10886706|NCT02614066|12052644|FG003|STARTED|Overall Study||71
10886707|NCT02614066|12052641|FG000|COMPLETED|Overall Study||0
10886708|NCT02614066|12052642|FG001|COMPLETED|Overall Study||0
10886709|NCT02614066|12052643|FG002|COMPLETED|Overall Study||0
10886710|NCT02614066|12052644|FG003|COMPLETED|Overall Study||0
10886711|NCT02614066|12052641|FG000|NOT COMPLETED|Overall Study||6
10886712|NCT02614066|12052642|FG001|NOT COMPLETED|Overall Study||28
10886713|NCT02614066|12052643|FG002|NOT COMPLETED|Overall Study||20
10886714|NCT02614066|12052644|FG003|NOT COMPLETED|Overall Study||71
10886715|NCT02610777|12052654|FG000|STARTED|Overall Study||62
10886716|NCT02610777|12052655|FG001|STARTED|Overall Study||58
10886717|NCT02610777|12052654|FG000|Response Evaluable Population (REP)|Overall Study||53
10886718|NCT02610777|12052655|FG001|Response Evaluable Population (REP)|Overall Study||55
10886719|NCT02610777|12052654|FG000|COMPLETED|Overall Study||0
10886720|NCT02610777|12052655|FG001|COMPLETED|Overall Study||0
10886721|NCT02610777|12052654|FG000|NOT COMPLETED|Overall Study||62
10886722|NCT02610777|12052655|FG001|NOT COMPLETED|Overall Study||58
10886723|NCT02604511|12052663|FG000|STARTED|Overall Study||31
10886724|NCT02604511|12052663|FG000|COMPLETED|Overall Study||19
10886725|NCT02604511|12052663|FG000|NOT COMPLETED|Overall Study||12
10886726|NCT02603432|12052670|FG000|STARTED|Overall Study||350
10886727|NCT02603432|12052671|FG001|STARTED|Overall Study||350
10886728|NCT02603432|12052670|FG000|COMPLETED|Overall Study||0
10886729|NCT02603432|12052671|FG001|COMPLETED|Overall Study||0
10886730|NCT02603432|12052670|FG000|NOT COMPLETED|Overall Study||350
10886731|NCT02603432|12052671|FG001|NOT COMPLETED|Overall Study||350
10886732|NCT02601209|12052684|FG000|STARTED|Initial Treatment (Up to 4 Months)|Pre-registered|4
10886733|NCT02601209|12052685|FG001|STARTED|Initial Treatment (Up to 4 Months)|Pre-registered|4
10886734|NCT02601209|12052686|FG002|STARTED|Initial Treatment (Up to 4 Months)|Pre-registered|4
10886735|NCT02601209|12052687|FG003|STARTED|Initial Treatment (Up to 4 Months)|Randomized|6
10886736|NCT02601209|12052688|FG004|STARTED|Initial Treatment (Up to 4 Months)|Randomized|13
10886737|NCT02601209|12052689|FG005|STARTED|Initial Treatment (Up to 4 Months)|Randomized|15
10886738|NCT02601209|12052690|FG006|STARTED|Initial Treatment (Up to 4 Months)|Randomized|56
10886739|NCT02601209|12052691|FG007|STARTED|Initial Treatment (Up to 4 Months)|Randomized|6
10886740|NCT02601209|12052692|FG008|STARTED|Initial Treatment (Up to 4 Months)|Randomized|43
10886741|NCT02601209|12052684|FG000|COMPLETED|Initial Treatment (Up to 4 Months)|Registered|3
10886742|NCT02601209|12052685|FG001|COMPLETED|Initial Treatment (Up to 4 Months)|Registered|3
10886743|NCT02601209|12052686|FG002|COMPLETED|Initial Treatment (Up to 4 Months)|Registered|3
10886744|NCT02601209|12052687|FG003|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|6
10886745|NCT02601209|12052688|FG004|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|12
10886746|NCT02601209|12052689|FG005|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|13
10886747|NCT02601209|12052690|FG006|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|55
10886748|NCT02601209|12052691|FG007|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|6
10886749|NCT02601209|12052692|FG008|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|43
10886750|NCT02601209|12052684|FG000|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
10886751|NCT02601209|12052685|FG001|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
10886752|NCT02601209|12052686|FG002|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
10886753|NCT02601209|12052687|FG003|NOT COMPLETED|Initial Treatment (Up to 4 Months)||0
10886754|NCT02601209|12052688|FG004|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
10886755|NCT02601209|12052689|FG005|NOT COMPLETED|Initial Treatment (Up to 4 Months)||2
10886756|NCT02601209|12052690|FG006|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
10886757|NCT02601209|12052691|FG007|NOT COMPLETED|Initial Treatment (Up to 4 Months)||0
10886758|NCT02601209|12052692|FG008|NOT COMPLETED|Initial Treatment (Up to 4 Months)||0
10886759|NCT02601209|12052684|FG000|STARTED|Optional Crossover (Up to 2 Months)||0
10886760|NCT02601209|12052685|FG001|STARTED|Optional Crossover (Up to 2 Months)||0
10886761|NCT02601209|12052686|FG002|STARTED|Optional Crossover (Up to 2 Months)||0
10886762|NCT02601209|12052687|FG003|STARTED|Optional Crossover (Up to 2 Months)||0
10886763|NCT02601209|12052688|FG004|STARTED|Optional Crossover (Up to 2 Months)||0
10886764|NCT02601209|12052689|FG005|STARTED|Optional Crossover (Up to 2 Months)||0
10886765|NCT02601209|12052690|FG006|STARTED|Optional Crossover (Up to 2 Months)||0
10886766|NCT02601209|12052691|FG007|STARTED|Optional Crossover (Up to 2 Months)|PD on pazopanib|6
10886767|NCT02601209|12052692|FG008|STARTED|Optional Crossover (Up to 2 Months)|PD on pazopanib|43
10886768|NCT02601209|12052684|FG000|COMPLETED|Optional Crossover (Up to 2 Months)||0
10886769|NCT02601209|12052685|FG001|COMPLETED|Optional Crossover (Up to 2 Months)||0
10886770|NCT02601209|12052686|FG002|COMPLETED|Optional Crossover (Up to 2 Months)||0
10886771|NCT02601209|12052687|FG003|COMPLETED|Optional Crossover (Up to 2 Months)||0
10886772|NCT02601209|12052688|FG004|COMPLETED|Optional Crossover (Up to 2 Months)||0
10886773|NCT02601209|12052689|FG005|COMPLETED|Optional Crossover (Up to 2 Months)||0
10886774|NCT02601209|12052690|FG006|COMPLETED|Optional Crossover (Up to 2 Months)||0
10886775|NCT02601209|12052691|FG007|COMPLETED|Optional Crossover (Up to 2 Months)|Initiated crossover to MLN0128 following PD on pazopanib|4
10886776|NCT02601209|12052692|FG008|COMPLETED|Optional Crossover (Up to 2 Months)|Initiated crossover to MLN0128 following PD on pazopanib|26
10886777|NCT02601209|12052684|FG000|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
10886778|NCT02601209|12052685|FG001|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
10886779|NCT02601209|12052686|FG002|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
10886780|NCT02601209|12052687|FG003|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
10886781|NCT02601209|12052688|FG004|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
10886782|NCT02601209|12052689|FG005|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
10886783|NCT02601209|12052690|FG006|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
10886784|NCT02601209|12052691|FG007|NOT COMPLETED|Optional Crossover (Up to 2 Months)||2
10886785|NCT02601209|12052692|FG008|NOT COMPLETED|Optional Crossover (Up to 2 Months)||17
10886786|NCT02594735|12052706|FG000|STARTED|Overall Study||10
10886787|NCT02594735|12052706|FG000|COMPLETED|Overall Study|One patient did not receive Abatacept at week 24 due to worsening pre-existing ILD.|9
10886788|NCT02594735|12052706|FG000|NOT COMPLETED|Overall Study||1
10886789|NCT02594111|12052714|FG000|STARTED|Overall Study||366
10886791|NCT02594111|12052714|FG000|COMPLETED|Overall Study||366
10886792|NCT02594111|12052715|FG001|COMPLETED|Overall Study||348
10886793|NCT02594111|12052714|FG000|NOT COMPLETED|Overall Study||0
10886794|NCT02594111|12052715|FG001|NOT COMPLETED|Overall Study||0
10886795|NCT02584634|12052723|FG000|STARTED|Overall Study||12
10886796|NCT02584634|12052724|FG001|STARTED|Overall Study||31
10886797|NCT02584634|12052723|FG000|COMPLETED|Overall Study||0
10886798|NCT02584634|12052724|FG001|COMPLETED|Overall Study||0
10886799|NCT02584634|12052723|FG000|NOT COMPLETED|Overall Study||12
10886800|NCT02584634|12052724|FG001|NOT COMPLETED|Overall Study||31
10886801|NCT02581930|12052733|FG000|STARTED|Overall Study||18
10886802|NCT02581930|12052733|FG000|COMPLETED|Overall Study||16
10886803|NCT02581930|12052733|FG000|NOT COMPLETED|Overall Study||2
10886804|NCT02581137|12052737|FG000|STARTED|Overall Study||26
10886805|NCT02581137|12052737|FG000|COMPLETED|Overall Study||22
10886806|NCT02581137|12052737|FG000|NOT COMPLETED|Overall Study||4
10886807|NCT02580058|12052744|FG000|STARTED|Overall Study||188
10886808|NCT02580058|12052745|FG001|STARTED|Overall Study||188
10886809|NCT02580058|12052746|FG002|STARTED|Overall Study||190
10886810|NCT02580058|12052744|FG000|Treated|Overall Study||187
10886811|NCT02580058|12052745|FG001|Treated|Overall Study||182
10886812|NCT02580058|12052746|FG002|Treated|Overall Study||177
10886813|NCT02580058|12052744|FG000|COMPLETED|Overall Study||109
10886814|NCT02580058|12052745|FG001|COMPLETED|Overall Study||102
10886815|NCT02580058|12052746|FG002|COMPLETED|Overall Study||104
10886816|NCT02580058|12052744|FG000|NOT COMPLETED|Overall Study||79
10886817|NCT02580058|12052745|FG001|NOT COMPLETED|Overall Study||86
10886818|NCT02580058|12052746|FG002|NOT COMPLETED|Overall Study||86
10886819|NCT02579096|12052756|FG000|STARTED|Phase 1, Weeks 0 - 24||468
10886820|NCT02579096|12052757|FG001|STARTED|Phase 1, Weeks 0 - 24||472
10886821|NCT02579096|12052756|FG000|COMPLETED|Phase 1, Weeks 0 - 24||411
10886822|NCT02579096|12052757|FG001|COMPLETED|Phase 1, Weeks 0 - 24||422
10886823|NCT02579096|12052756|FG000|NOT COMPLETED|Phase 1, Weeks 0 - 24||57
10886824|NCT02579096|12052757|FG001|NOT COMPLETED|Phase 1, Weeks 0 - 24||50
10886825|NCT02579096|12052756|FG000|STARTED|Phase 2, Weeks 25 - 48||411
10886826|NCT02579096|12052757|FG001|STARTED|Phase 2, Weeks 25 - 48||422
10886827|NCT02579096|12052756|FG000|COMPLETED|Phase 2, Weeks 25 - 48||389
10886828|NCT02579096|12052757|FG001|COMPLETED|Phase 2, Weeks 25 - 48||391
10886829|NCT02579096|12052756|FG000|NOT COMPLETED|Phase 2, Weeks 25 - 48||22
10886830|NCT02579096|12052757|FG001|NOT COMPLETED|Phase 2, Weeks 25 - 48||31
10886831|NCT02579096|12052756|FG000|STARTED|Phase 3, Weeks 49 - 72||389
10886832|NCT02579096|12052757|FG001|STARTED|Phase 3, Weeks 49 - 72||391
10886833|NCT02579096|12052756|FG000|COMPLETED|Phase 3, Weeks 49 - 72||367
10886834|NCT02579096|12052757|FG001|COMPLETED|Phase 3, Weeks 49 - 72||373
10886835|NCT02579096|12052756|FG000|NOT COMPLETED|Phase 3, Weeks 49 - 72||22
10886836|NCT02579096|12052757|FG001|NOT COMPLETED|Phase 3, Weeks 49 - 72||18
10886837|NCT02578680|12052765|FG000|STARTED|Overall Study||410
10886838|NCT02578680|12052766|FG001|STARTED|Overall Study||206
10886839|NCT02578680|12052765|FG000|Treated|Overall Study||405
10886840|NCT02578680|12052766|FG001|Treated|Overall Study||202
10886841|NCT02578680|12052765|FG000|Switched to Pembrolizumab|Overall Study||0
10886842|NCT02578680|12052766|FG001|Switched to Pembrolizumab|Overall Study||67
10886843|NCT02578680|12052765|FG000|COMPLETED|Overall Study||0
10886844|NCT02578680|12052766|FG001|COMPLETED|Overall Study||0
10886845|NCT02578680|12052765|FG000|NOT COMPLETED|Overall Study||410
10886846|NCT02578680|12052766|FG001|NOT COMPLETED|Overall Study||206
10886847|NCT02577406|12052774|FG000|STARTED|Randomized Period||158
10886848|NCT02577406|12052775|FG001|STARTED|Randomized Period||161
10886849|NCT02577406|12052774|FG000|COMPLETED|Randomized Period||157
10886850|NCT02577406|12052775|FG001|COMPLETED|Randomized Period||141
10886851|NCT02577406|12052774|FG000|NOT COMPLETED|Randomized Period||1
10886852|NCT02577406|12052775|FG001|NOT COMPLETED|Randomized Period||20
10886853|NCT02577406|12052774|FG000|STARTED|Treatment Period||157
10886854|NCT02577406|12052775|FG001|STARTED|Treatment Period||141
10886855|NCT02577406|12052774|FG000|COMPLETED|Treatment Period||10
10886856|NCT02577406|12052775|FG001|COMPLETED|Treatment Period||4
10886857|NCT02577406|12052774|FG000|NOT COMPLETED|Treatment Period||147
10886858|NCT02577406|12052775|FG001|NOT COMPLETED|Treatment Period||137
10886859|NCT02576860|12052787|FG000|STARTED|Overall Study||136
10886860|NCT02576860|12052788|FG001|STARTED|Overall Study||127
10886861|NCT02576860|12052787|FG000|COMPLETED|Overall Study||111
10886862|NCT02576860|12052788|FG001|COMPLETED|Overall Study||103
10886863|NCT02576860|12052787|FG000|NOT COMPLETED|Overall Study||25
10886864|NCT02576860|12052788|FG001|NOT COMPLETED|Overall Study||24
10886865|NCT02576509|12052797|FG000|STARTED|Pre-Treatment Period||371
10886866|NCT02576509|12052798|FG001|STARTED|Pre-Treatment Period||372
10886867|NCT02576509|12052797|FG000|COMPLETED|Pre-Treatment Period||367
10886868|NCT02576509|12052798|FG001|COMPLETED|Pre-Treatment Period||363
10886869|NCT02576509|12052797|FG000|NOT COMPLETED|Pre-Treatment Period||4
10886870|NCT02576509|12052798|FG001|NOT COMPLETED|Pre-Treatment Period||9
10886871|NCT02576509|12052797|FG000|STARTED|Treatment Period||367
10886872|NCT02576509|12052798|FG001|STARTED|Treatment Period||363
10886873|NCT02576509|12052797|FG000|COMPLETED|Treatment Period||38
10886874|NCT02576509|12052798|FG001|COMPLETED|Treatment Period||8
10886875|NCT02576509|12052797|FG000|NOT COMPLETED|Treatment Period||329
10886876|NCT02576509|12052798|FG001|NOT COMPLETED|Treatment Period||355
10886877|NCT02576509|12052797|FG000|STARTED|Follow-up Period||367
10886878|NCT02576509|12052798|FG001|STARTED|Follow-up Period||363
10886879|NCT02576509|12052797|FG000|COMPLETED|Follow-up Period||318
10886880|NCT02576509|12052798|FG001|COMPLETED|Follow-up Period||311
10886881|NCT02576509|12052797|FG000|NOT COMPLETED|Follow-up Period||49
10886882|NCT02576509|12052798|FG001|NOT COMPLETED|Follow-up Period||52
10886883|NCT02574481|12052808|FG000|STARTED|Overall Study||309
10886884|NCT02574481|12052809|FG001|STARTED|Overall Study||156
10886885|NCT02574481|12052810|FG002|STARTED|Overall Study||50
10886886|NCT02574481|12052811|FG003|STARTED|Overall Study||13
10886887|NCT02574481|12052808|FG000|COMPLETED|Overall Study||282
10886888|NCT02574481|12052809|FG001|COMPLETED|Overall Study||142
10886889|NCT02574481|12052810|FG002|COMPLETED|Overall Study||47
10886890|NCT02574481|12052811|FG003|COMPLETED|Overall Study||13
10886891|NCT02574481|12052808|FG000|NOT COMPLETED|Overall Study||27
10886892|NCT02574481|12052809|FG001|NOT COMPLETED|Overall Study||14
10886893|NCT02574481|12052810|FG002|NOT COMPLETED|Overall Study||3
10886894|NCT02574481|12052811|FG003|NOT COMPLETED|Overall Study||0
10886895|NCT02572453|12052827|FG000|STARTED|Overall Study||1
10886896|NCT02572453|12052828|FG001|STARTED|Overall Study||4
10886897|NCT02572453|12052829|FG002|STARTED|Overall Study||20
10886898|NCT02572453|12052827|FG000|COMPLETED|Overall Study||1
10886899|NCT02572453|12052828|FG001|COMPLETED|Overall Study||4
10886900|NCT02572453|12052829|FG002|COMPLETED|Overall Study||20
10886901|NCT02572453|12052827|FG000|NOT COMPLETED|Overall Study||0
10886902|NCT02572453|12052828|FG001|NOT COMPLETED|Overall Study||0
10886903|NCT02572453|12052829|FG002|NOT COMPLETED|Overall Study||0
10886904|NCT02565784|12052837|FG000|STARTED|First Treatment||100
10886905|NCT02565784|12052837|FG000|6 Months Follow-up|First Treatment||99
10886906|NCT02565784|12052837|FG000|12 Months Follow-up|First Treatment||98
10886907|NCT02565784|12052837|FG000|COMPLETED|First Treatment||98
10886908|NCT02565784|12052837|FG000|NOT COMPLETED|First Treatment||2
10886909|NCT02565784|12052837|FG000|STARTED|Second Treatment||98
10886910|NCT02565784|12052837|FG000|6 Months Follow-up|Second Treatment||97
10886911|NCT02565784|12052837|FG000|12 Months Follow-up|Second Treatment||96
10886912|NCT02565784|12052837|FG000|COMPLETED|Second Treatment||96
10886913|NCT02565784|12052837|FG000|NOT COMPLETED|Second Treatment||2
10886914|NCT02565108|12052847|FG000|STARTED|Overall Study||16
10886915|NCT02565108|12052848|FG001|STARTED|Overall Study||4
10886916|NCT02565108|12052847|FG000|Safety Set|Overall Study||16
10886917|NCT02565108|12052848|FG001|Safety Set|Overall Study||4
10886918|NCT02565108|12052847|FG000|Pharmacokinetic (PK) Set|Overall Study||10
10886919|NCT02565108|12052848|FG001|Pharmacokinetic (PK) Set|Overall Study||3
10886920|NCT02565108|12052847|FG000|COMPLETED|Overall Study||14
10886921|NCT02565108|12052848|FG001|COMPLETED|Overall Study||4
10886922|NCT02565108|12052847|FG000|NOT COMPLETED|Overall Study||2
10886923|NCT02565108|12052848|FG001|NOT COMPLETED|Overall Study||0
10886924|NCT02564952|12052854|FG000|STARTED|Overall Study||18
10886925|NCT02564952|12052854|FG000|Received at Least 1 Dose of Study Drug|Overall Study||18
10886926|NCT02564952|12052854|FG000|Completed OLE Titration Period|Overall Study||16
10886927|NCT02564952|12052854|FG000|COMPLETED|Overall Study||7
10886928|NCT02564952|12052854|FG000|NOT COMPLETED|Overall Study||11
10886929|NCT02563925|12052858|FG000|STARTED|Overall Study||28
10886930|NCT02563925|12052858|FG000|COMPLETED|Overall Study||26
10886931|NCT02563925|12052858|FG000|NOT COMPLETED|Overall Study||2
10886932|NCT02563002|12052865|FG000|STARTED|Overall Study||153
10886933|NCT02563002|12052866|FG001|STARTED|Overall Study||154
10886934|NCT02563002|12052865|FG000|Treated|Overall Study||153
10886935|NCT02563002|12052866|FG001|Treated|Overall Study||143
10886936|NCT02563002|12052865|FG000|Received Second Course of Pembrolizumab|Overall Study||8
10886937|NCT02563002|12052866|FG001|Received Second Course of Pembrolizumab|Overall Study||4
10886938|NCT02563002|12052865|FG000|Switched Over to Pembrolizumab|Overall Study||0
10886939|NCT02563002|12052866|FG001|Switched Over to Pembrolizumab|Overall Study||56
10886940|NCT02563002|12052865|FG000|COMPLETED|Overall Study||0
10886941|NCT02563002|12052866|FG001|COMPLETED|Overall Study||0
10886942|NCT02563002|12052865|FG000|NOT COMPLETED|Overall Study||153
10886943|NCT02563002|12052866|FG001|NOT COMPLETED|Overall Study||154
10886944|NCT02562235|12052875|FG000|STARTED|Overall Study||24
10886945|NCT02562235|12052875|FG000|COMPLETED|Overall Study||21
10886946|NCT02562235|12052875|FG000|NOT COMPLETED|Overall Study||3
10886947|NCT02561221|12052886|FG000|STARTED|Overall Study||452
10886948|NCT02561221|12052887|FG001|STARTED|Overall Study||351
10886949|NCT02561221|12052886|FG000|Month 6|Overall Study||386
10886950|NCT02561221|12052887|FG001|Month 6|Overall Study||340
10886951|NCT02561221|12052886|FG000|Month 12|Overall Study||365
10886952|NCT02561221|12052887|FG001|Month 12|Overall Study||326
10886953|NCT02561221|12052886|FG000|Month 18|Overall Study||357
10886954|NCT02561221|12052887|FG001|Month 18|Overall Study||316
10886955|NCT02561221|12052886|FG000|COMPLETED|Overall Study||362
10886956|NCT02561221|12052887|FG001|COMPLETED|Overall Study||308
10886957|NCT02561221|12052886|FG000|NOT COMPLETED|Overall Study||90
10886958|NCT02561221|12052887|FG001|NOT COMPLETED|Overall Study||43
10886959|NCT02560623|12052897|FG000|STARTED|Overall Study||19
10886960|NCT02560623|12052898|FG001|STARTED|Overall Study||22
10886961|NCT02560623|12052899|FG002|STARTED|Overall Study||112
10886962|NCT02560623|12052900|FG003|STARTED|Overall Study||89
10886963|NCT02560623|12052897|FG000|COMPLETED|Overall Study||19
10886964|NCT02560623|12052898|FG001|COMPLETED|Overall Study||20
10886965|NCT02560623|12052899|FG002|COMPLETED|Overall Study||112
10886966|NCT02560623|12052900|FG003|COMPLETED|Overall Study||89
10886967|NCT02560623|12052897|FG000|NOT COMPLETED|Overall Study||0
10886968|NCT02560623|12052898|FG001|NOT COMPLETED|Overall Study||2
10886969|NCT02560623|12052899|FG002|NOT COMPLETED|Overall Study||0
10886970|NCT02560623|12052900|FG003|NOT COMPLETED|Overall Study||0
10886971|NCT02559687|12052910|FG000|STARTED|Overall Study||121
10886972|NCT02559687|12052910|FG000|Received First Course of Pembrolizumab|Overall Study||121
10886973|NCT02559687|12052910|FG000|Received Second Course of Pembrolizumab|Overall Study||1
10886974|NCT02559687|12052910|FG000|COMPLETED|Overall Study||0
10886975|NCT02559687|12052910|FG000|NOT COMPLETED|Overall Study||121
10886976|NCT02556710|12052917|FG000|STARTED|Overall Study||237
10886977|NCT02556710|12052918|FG001|STARTED|Overall Study||243
10886978|NCT02556710|12052917|FG000|COMPLETED|Overall Study||226
10886979|NCT02556710|12052918|FG001|COMPLETED|Overall Study||237
10886980|NCT02556710|12052917|FG000|NOT COMPLETED|Overall Study||11
10886981|NCT02556710|12052918|FG001|NOT COMPLETED|Overall Study||6
10886982|NCT02552212|12052928|FG000|STARTED|Double-Blind Period (Week 0 - 52)||158
10886983|NCT02552212|12052929|FG001|STARTED|Double-Blind Period (Week 0 - 52)||159
10886984|NCT02552212|12052930|FG002|STARTED|Double-Blind Period (Week 0 - 52)||0
10886985|NCT02552212|12052928|FG000|Received OL CZP|Double-Blind Period (Week 0 - 52)||96
10886986|NCT02552212|12052929|FG001|Received OL CZP|Double-Blind Period (Week 0 - 52)||20
10886987|NCT02552212|12052930|FG002|Received OL CZP|Double-Blind Period (Week 0 - 52)||0
10886988|NCT02552212|12052928|FG000|Completed Week 52 Without Starting SFE|Double-Blind Period (Week 0 - 52)||20
10886989|NCT02552212|12052929|FG001|Completed Week 52 Without Starting SFE|Double-Blind Period (Week 0 - 52)||22
10886990|NCT02552212|12052930|FG002|Completed Week 52 Without Starting SFE|Double-Blind Period (Week 0 - 52)||0
10886991|NCT02552212|12052928|FG000|COMPLETED|Double-Blind Period (Week 0 - 52)||143
10886992|NCT02552212|12052929|FG001|COMPLETED|Double-Blind Period (Week 0 - 52)||142
10886993|NCT02552212|12052930|FG002|COMPLETED|Double-Blind Period (Week 0 - 52)||0
10886994|NCT02552212|12052928|FG000|NOT COMPLETED|Double-Blind Period (Week 0 - 52)||15
10886995|NCT02552212|12052929|FG001|NOT COMPLETED|Double-Blind Period (Week 0 - 52)||17
10886996|NCT02552212|12052930|FG002|NOT COMPLETED|Double-Blind Period (Week 0 - 52)||0
10886997|NCT02552212|12052928|FG000|STARTED|SFE Period (Week 52 - 156)||0
10886998|NCT02552212|12052929|FG001|STARTED|SFE Period (Week 52 - 156)||0
10886999|NCT02552212|12052930|FG002|STARTED|SFE Period (Week 52 - 156)|123 subjects from Placebo arm and 120 subjects from CZP 200 mg Q2W arm|243
10887000|NCT02552212|12052928|FG000|COMPLETED|SFE Period (Week 52 - 156)||0
10887001|NCT02552212|12052929|FG001|COMPLETED|SFE Period (Week 52 - 156)||0
10887002|NCT02552212|12052930|FG002|COMPLETED|SFE Period (Week 52 - 156)||206
10887003|NCT02552212|12052928|FG000|NOT COMPLETED|SFE Period (Week 52 - 156)||0
10887004|NCT02552212|12052929|FG001|NOT COMPLETED|SFE Period (Week 52 - 156)||0
10887005|NCT02552212|12052930|FG002|NOT COMPLETED|SFE Period (Week 52 - 156)||37
10887006|NCT02550652|12052948|FG000|STARTED|Overall Study||63
10887007|NCT02550652|12052949|FG001|STARTED|Overall Study||62
10887008|NCT02550652|12052948|FG000|COMPLETED|Overall Study||42
10887009|NCT02550652|12052949|FG001|COMPLETED|Overall Study||41
10887010|NCT02550652|12052948|FG000|NOT COMPLETED|Overall Study||21
10887011|NCT02550652|12052949|FG001|NOT COMPLETED|Overall Study||21
10887012|NCT02547441|12052957|FG000|STARTED|Double-Blind Study Period||235
10887013|NCT02547441|12052958|FG001|STARTED|Double-Blind Study Period||228
10887014|NCT02547441|12052957|FG000|COMPLETED|Double-Blind Study Period||211
10887015|NCT02547441|12052958|FG001|COMPLETED|Double-Blind Study Period||196
10887016|NCT02547441|12052957|FG000|NOT COMPLETED|Double-Blind Study Period||24
10887017|NCT02547441|12052958|FG001|NOT COMPLETED|Double-Blind Study Period||32
10887018|NCT02547441|12052957|FG000|STARTED|Open-Label Study Period||188
10887019|NCT02547441|12052958|FG001|STARTED|Open-Label Study Period||175
10887020|NCT02547441|12052957|FG000|COMPLETED|Open-Label Study Period||66
10887021|NCT02547441|12052958|FG001|COMPLETED|Open-Label Study Period||48
10887022|NCT02547441|12052957|FG000|NOT COMPLETED|Open-Label Study Period||122
10887023|NCT02547441|12052958|FG001|NOT COMPLETED|Open-Label Study Period||127
10887024|NCT02546986|12052967|FG000|STARTED|Treatment Period||51
10887025|NCT02546986|12052968|FG001|STARTED|Treatment Period||49
10887026|NCT02546986|12052967|FG000|COMPLETED|Treatment Period||0
10887027|NCT02546986|12052968|FG001|COMPLETED|Treatment Period||0
10887028|NCT02546986|12052967|FG000|NOT COMPLETED|Treatment Period||51
10887029|NCT02546986|12052968|FG001|NOT COMPLETED|Treatment Period||49
10887030|NCT02546986|12052967|FG000|STARTED|Survival Follow-Up Phase||36
10887031|NCT02546986|12052968|FG001|STARTED|Survival Follow-Up Phase||35
10887032|NCT02546986|12052967|FG000|COMPLETED|Survival Follow-Up Phase||0
10887033|NCT02546986|12052968|FG001|COMPLETED|Survival Follow-Up Phase||0
10887034|NCT02546986|12052967|FG000|NOT COMPLETED|Survival Follow-Up Phase||36
10887035|NCT02546986|12052968|FG001|NOT COMPLETED|Survival Follow-Up Phase||35
10887036|NCT02545608|12052976|FG000|STARTED|Overall Study||9
10887037|NCT02545608|12052977|FG001|STARTED|Overall Study|Split hand study design. Total no. of subjects in Randomised group and No-treatment control is 100.|100
10887038|NCT02545608|12052976|FG000|COMPLETED|Overall Study||9
10887039|NCT02545608|12052977|FG001|COMPLETED|Overall Study||93
10887040|NCT02545608|12052976|FG000|NOT COMPLETED|Overall Study||0
10887041|NCT02545608|12052977|FG001|NOT COMPLETED|Overall Study||7
10887042|NCT02544763|12052987|FG000|STARTED|Overall Study||75
10887043|NCT02544763|12052988|FG001|STARTED|Overall Study||73
10887044|NCT02544763|12052989|FG002|STARTED|Overall Study||76
10887045|NCT02544763|12052987|FG000|COMPLETED|Overall Study||65
10887046|NCT02544763|12052988|FG001|COMPLETED|Overall Study||61
10887047|NCT02544763|12052989|FG002|COMPLETED|Overall Study||75
10887048|NCT02544763|12052987|FG000|NOT COMPLETED|Overall Study||10
10887049|NCT02544763|12052988|FG001|NOT COMPLETED|Overall Study||12
10887050|NCT02544763|12052989|FG002|NOT COMPLETED|Overall Study||1
10887051|NCT02544503|12052999|FG000|STARTED|Overall Study||66
10887052|NCT02544503|12053000|FG001|STARTED|Overall Study||34
10887053|NCT02544503|12052999|FG000|Completed First Study Assessment|Overall Study||42
10887054|NCT02544503|12053000|FG001|Completed First Study Assessment|Overall Study||31
10887055|NCT02544503|12052999|FG000|Stroke Patients Who Completed the 6 Month Post-stroke Assessment|Overall Study||32
10887056|NCT02544503|12053000|FG001|Stroke Patients Who Completed the 6 Month Post-stroke Assessment|Overall Study|Healthy control participants were not assessed at the 6 month time point.|0
10887057|NCT02544503|12052999|FG000|COMPLETED|Overall Study||32
10887058|NCT02544503|12053000|FG001|COMPLETED|Overall Study||31
10887059|NCT02544503|12052999|FG000|NOT COMPLETED|Overall Study||34
10887060|NCT02544503|12053000|FG001|NOT COMPLETED|Overall Study||3
10887061|NCT02544373|12053008|FG000|STARTED|Overall Study||71
10887062|NCT02544373|12053009|FG001|STARTED|Overall Study||40
10887063|NCT02544373|12053008|FG000|COMPLETED|Overall Study||58
10887064|NCT02544373|12053009|FG001|COMPLETED|Overall Study||35
10887065|NCT02544373|12053008|FG000|NOT COMPLETED|Overall Study||13
10887066|NCT02544373|12053009|FG001|NOT COMPLETED|Overall Study||5
10887067|NCT02543944|12053018|FG000|STARTED|Phase 1: GBN/BUP Induction and BUP Detox||60
10887068|NCT02543944|12053019|FG001|STARTED|Phase 1: GBN/BUP Induction and BUP Detox||57
10887069|NCT02543944|12053018|FG000|COMPLETED|Phase 1: GBN/BUP Induction and BUP Detox||41
10887070|NCT02543944|12053019|FG001|COMPLETED|Phase 1: GBN/BUP Induction and BUP Detox||34
10887071|NCT02543944|12053018|FG000|NOT COMPLETED|Phase 1: GBN/BUP Induction and BUP Detox||19
10887072|NCT02543944|12053019|FG001|NOT COMPLETED|Phase 1: GBN/BUP Induction and BUP Detox||23
10887073|NCT02543944|12053018|FG000|STARTED|Phase 2: Transition From BUP to XR-NTX||33
10887074|NCT02543944|12053019|FG001|STARTED|Phase 2: Transition From BUP to XR-NTX||29
10887075|NCT02543944|12053018|FG000|COMPLETED|Phase 2: Transition From BUP to XR-NTX||12
10887076|NCT02543944|12053019|FG001|COMPLETED|Phase 2: Transition From BUP to XR-NTX||12
10887077|NCT02543944|12053018|FG000|NOT COMPLETED|Phase 2: Transition From BUP to XR-NTX||21
10887078|NCT02543944|12053019|FG001|NOT COMPLETED|Phase 2: Transition From BUP to XR-NTX||17
10887079|NCT02543944|12053018|FG000|STARTED|Phase 3: XR-NTX Maintenance||12
10887080|NCT02543944|12053019|FG001|STARTED|Phase 3: XR-NTX Maintenance||12
10887081|NCT02543944|12053018|FG000|COMPLETED|Phase 3: XR-NTX Maintenance||7
10887082|NCT02543944|12053019|FG001|COMPLETED|Phase 3: XR-NTX Maintenance||3
10887083|NCT02543944|12053018|FG000|NOT COMPLETED|Phase 3: XR-NTX Maintenance||5
10887084|NCT02543944|12053019|FG001|NOT COMPLETED|Phase 3: XR-NTX Maintenance||9
10887085|NCT02542293|12053027|FG000|STARTED|Overall Study||474
10887086|NCT02542293|12053028|FG001|STARTED|Overall Study||479
10887087|NCT02542293|12053027|FG000|Randomized in Global Cohort|Overall Study||410
10887088|NCT02542293|12053028|FG001|Randomized in Global Cohort|Overall Study||413
10887089|NCT02542293|12053027|FG000|Received Treatment in Global Cohort|Overall Study||410
10887090|NCT02542293|12053028|FG001|Received Treatment in Global Cohort|Overall Study||399
10887091|NCT02542293|12053027|FG000|Randomized in China Cohort|Overall Study||78
10887092|NCT02542293|12053028|FG001|Randomized in China Cohort|Overall Study||82
10887093|NCT02542293|12053027|FG000|Received Treatment in China Cohort|Overall Study||77
10887094|NCT02542293|12053028|FG001|Received Treatment in China Cohort|Overall Study||78
10887095|NCT02542293|12053027|FG000|Included in Both Cohorts (Global and China)|Overall Study||14
10887096|NCT02542293|12053028|FG001|Included in Both Cohorts (Global and China)|Overall Study||16
10887097|NCT02542293|12053027|FG000|Ongoing in Study at DCO for Final Analysis in Global Cohort|Overall Study||75
10887098|NCT02542293|12053028|FG001|Ongoing in Study at DCO for Final Analysis in Global Cohort|Overall Study||67
10887099|NCT02542293|12053027|FG000|Ongoing in Study at DCO for Final Analysis in China Cohort|Overall Study||27
10887100|NCT02542293|12053028|FG001|Ongoing in Study at DCO for Final Analysis in China Cohort|Overall Study||18
10887101|NCT02542293|12053027|FG000|COMPLETED|Overall Study||99
10887102|NCT02542293|12053028|FG001|COMPLETED|Overall Study||83
10887103|NCT02542293|12053027|FG000|NOT COMPLETED|Overall Study||375
10887104|NCT02542293|12053028|FG001|NOT COMPLETED|Overall Study||396
10887105|NCT02539823|12053044|FG000|STARTED|Overall Study||15
10887106|NCT02539823|12053045|FG001|STARTED|Overall Study||14
10887107|NCT02539823|12053046|FG002|STARTED|Overall Study||13
10887108|NCT02539823|12053044|FG000|COMPLETED|Overall Study||15
10887109|NCT02539823|12053045|FG001|COMPLETED|Overall Study||14
10887110|NCT02539823|12053046|FG002|COMPLETED|Overall Study||13
10887111|NCT02539823|12053044|FG000|NOT COMPLETED|Overall Study||0
10887112|NCT02539823|12053045|FG001|NOT COMPLETED|Overall Study||0
10887113|NCT02539823|12053046|FG002|NOT COMPLETED|Overall Study||0
10887114|NCT02538510|12053056|FG000|STARTED|Overall Study||25
10887115|NCT02538510|12053057|FG001|STARTED|Overall Study||25
10887116|NCT02538510|12053056|FG000|COMPLETED|Overall Study||25
10887117|NCT02538510|12053057|FG001|COMPLETED|Overall Study||25
10887118|NCT02538510|12053056|FG000|NOT COMPLETED|Overall Study||0
10887119|NCT02538510|12053057|FG001|NOT COMPLETED|Overall Study||0
10887120|NCT02533180|12053069|FG000|STARTED|Overall Study||39
10887121|NCT02533180|12053070|FG001|STARTED|Overall Study||61
10887122|NCT02533180|12053069|FG000|COMPLETED|Overall Study||0
10887123|NCT02533180|12053070|FG001|COMPLETED|Overall Study||14
10887124|NCT02533180|12053069|FG000|NOT COMPLETED|Overall Study||39
10887125|NCT02533180|12053070|FG001|NOT COMPLETED|Overall Study||47
10887126|NCT02531308|12053075|FG000|STARTED|Overall Study||5
10887127|NCT02531308|12053075|FG000|COMPLETED|Overall Study||2
10887128|NCT02531308|12053075|FG000|NOT COMPLETED|Overall Study||3
10887129|NCT02527434|12053082|FG000|STARTED|Overall Study||32
10887130|NCT02527434|12053083|FG001|STARTED|Overall Study||12
10887131|NCT02527434|12053084|FG002|STARTED|Overall Study||20
10887132|NCT02527434|12053082|FG000|Started Retreatment Phase (COMBO)|Overall Study||7
10887133|NCT02527434|12053083|FG001|Started Retreatment Phase (COMBO)|Overall Study||5
10887134|NCT02527434|12053084|FG002|Started Retreatment Phase (COMBO)|Overall Study||4
10887135|NCT02527434|12053082|FG000|Started Retreatment Phase (MEDI)|Overall Study||4
10887136|NCT02527434|12053083|FG001|Started Retreatment Phase (MEDI)|Overall Study||0
10887137|NCT02527434|12053084|FG002|Started Retreatment Phase (MEDI)|Overall Study||1
10887138|NCT02527434|12053082|FG000|COMPLETED|Overall Study||4
10887139|NCT02527434|12053083|FG001|COMPLETED|Overall Study||1
10887140|NCT02527434|12053084|FG002|COMPLETED|Overall Study||0
10887141|NCT02527434|12053082|FG000|NOT COMPLETED|Overall Study||28
10887142|NCT02527434|12053083|FG001|NOT COMPLETED|Overall Study||11
10887143|NCT02527434|12053084|FG002|NOT COMPLETED|Overall Study||20
10887144|NCT02526498|12053102|FG000|STARTED|Overall Study||200
10887145|NCT02526498|12053102|FG000|COMPLETED|Overall Study||200
10887146|NCT02526498|12053102|FG000|NOT COMPLETED|Overall Study||0
10887147|NCT02524275|12053106|FG000|STARTED|Overall Study||14
10887148|NCT02524275|12053106|FG000|COMPLETED|Overall Study||9
10887149|NCT02524275|12053106|FG000|NOT COMPLETED|Overall Study||5
10887150|NCT02522845|12053112|FG000|STARTED|Overall Study||100
10887151|NCT02522845|12053113|FG001|STARTED|Overall Study||104
10887152|NCT02522845|12053112|FG000|COMPLETED|Overall Study||63
10887153|NCT02522845|12053113|FG001|COMPLETED|Overall Study||69
10887154|NCT02522845|12053112|FG000|NOT COMPLETED|Overall Study||37
10887155|NCT02522845|12053113|FG001|NOT COMPLETED|Overall Study||35
10887156|NCT02522494|12053121|FG000|STARTED|Overall Study||51
10887157|NCT02522494|12053122|FG001|STARTED|Overall Study||51
10887158|NCT02522494|12053121|FG000|Post-CVT Visit Interview|Overall Study||37
10887159|NCT02522494|12053122|FG001|Post-CVT Visit Interview|Overall Study||48
10887160|NCT02522494|12053121|FG000|4-Week Follow Up|Overall Study||37
10887161|NCT02522494|12053122|FG001|4-Week Follow Up|Overall Study||46
10887162|NCT02522494|12053121|FG000|COMPLETED|Overall Study||37
10887163|NCT02522494|12053122|FG001|COMPLETED|Overall Study||46
10887164|NCT02522494|12053121|FG000|NOT COMPLETED|Overall Study||14
10887165|NCT02522494|12053122|FG001|NOT COMPLETED|Overall Study||5
10887166|NCT02516670|12053130|FG000|STARTED|Overall Study||34
10887167|NCT02516670|12053131|FG001|STARTED|Overall Study||16
10887168|NCT02516670|12053130|FG000|COMPLETED|Overall Study||34
10887169|NCT02516670|12053131|FG001|COMPLETED|Overall Study||16
10887170|NCT02516670|12053130|FG000|NOT COMPLETED|Overall Study||0
10887171|NCT02516670|12053131|FG001|NOT COMPLETED|Overall Study||0
10887172|NCT02513784|12053139|FG000|STARTED|Overall Study||10
10887173|NCT02513784|12053140|FG001|STARTED|Overall Study||10
10887174|NCT02513784|12053139|FG000|COMPLETED|Overall Study||10
10887175|NCT02513784|12053140|FG001|COMPLETED|Overall Study||10
10887176|NCT02513784|12053139|FG000|NOT COMPLETED|Overall Study||0
10887177|NCT02513784|12053140|FG001|NOT COMPLETED|Overall Study||0
10887178|NCT02513485|12053148|FG000|STARTED|Overall Study||28
10887179|NCT02513485|12053149|FG001|STARTED|Overall Study||29
10887180|NCT02513485|12053148|FG000|COMPLETED|Overall Study||27
10887181|NCT02513485|12053149|FG001|COMPLETED|Overall Study||29
10887182|NCT02513485|12053148|FG000|NOT COMPLETED|Overall Study||1
10887183|NCT02513485|12053149|FG001|NOT COMPLETED|Overall Study||0
10887184|NCT02504151|12053157|FG000|STARTED|First Intervention (4 Weeks)||8
10887185|NCT02504151|12053158|FG001|STARTED|First Intervention (4 Weeks)||10
10887186|NCT02504151|12053157|FG000|COMPLETED|First Intervention (4 Weeks)||7
10887187|NCT02504151|12053158|FG001|COMPLETED|First Intervention (4 Weeks)||9
10887188|NCT02504151|12053157|FG000|NOT COMPLETED|First Intervention (4 Weeks)||1
10887189|NCT02504151|12053158|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1
10887190|NCT02504151|12053157|FG000|STARTED|Washout (2 Weeks)||7
10887191|NCT02504151|12053158|FG001|STARTED|Washout (2 Weeks)||9
10887192|NCT02504151|12053157|FG000|COMPLETED|Washout (2 Weeks)||6
10887193|NCT02504151|12053158|FG001|COMPLETED|Washout (2 Weeks)||9
10887194|NCT02504151|12053157|FG000|NOT COMPLETED|Washout (2 Weeks)||1
10887195|NCT02504151|12053158|FG001|NOT COMPLETED|Washout (2 Weeks)||0
10887196|NCT02504151|12053157|FG000|STARTED|Second Intervention (4 Weeks)||6
10887197|NCT02504151|12053158|FG001|STARTED|Second Intervention (4 Weeks)||9
10887198|NCT02504151|12053157|FG000|COMPLETED|Second Intervention (4 Weeks)||4
10887199|NCT02504151|12053158|FG001|COMPLETED|Second Intervention (4 Weeks)||7
10887200|NCT02504151|12053157|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||2
10887201|NCT02504151|12053158|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||2
10887202|NCT02499328|12053183|FG000|STARTED|Overall Study||4
10887203|NCT02499328|12053184|FG001|STARTED|Overall Study||7
10887204|NCT02499328|12053185|FG002|STARTED|Overall Study||10
10887205|NCT02499328|12053186|FG003|STARTED|Overall Study||11
10887206|NCT02499328|12053187|FG004|STARTED|Overall Study||15
10887207|NCT02499328|12053188|FG005|STARTED|Overall Study||9
10887208|NCT02499328|12053189|FG006|STARTED|Overall Study||7
10887209|NCT02499328|12053190|FG007|STARTED|Overall Study||6
10887210|NCT02499328|12053191|FG008|STARTED|Overall Study||14
10887211|NCT02499328|12053192|FG009|STARTED|Overall Study||24
10887212|NCT02499328|12053193|FG010|STARTED|Overall Study||20
10887213|NCT02499328|12053194|FG011|STARTED|Overall Study||54
10887214|NCT02499328|12053195|FG012|STARTED|Overall Study||25
10887215|NCT02499328|12053196|FG013|STARTED|Overall Study||17
10887216|NCT02499328|12053197|FG014|STARTED|Overall Study||10
10887217|NCT02499328|12053198|FG015|STARTED|Overall Study||1
10887218|NCT02499328|12053199|FG016|STARTED|Overall Study||1
10887219|NCT02499328|12053200|FG017|STARTED|Overall Study||55
10887220|NCT02499328|12053201|FG018|STARTED|Overall Study||50
10887221|NCT02499328|12053183|FG000|COMPLETED|Overall Study||0
10887222|NCT02499328|12053184|FG001|COMPLETED|Overall Study||0
10887223|NCT02499328|12053185|FG002|COMPLETED|Overall Study||0
10887224|NCT02499328|12053186|FG003|COMPLETED|Overall Study||0
10887225|NCT02499328|12053187|FG004|COMPLETED|Overall Study||0
10887226|NCT02499328|12053188|FG005|COMPLETED|Overall Study||0
10887227|NCT02499328|12053189|FG006|COMPLETED|Overall Study||0
10887228|NCT02499328|12053190|FG007|COMPLETED|Overall Study||0
10887229|NCT02499328|12053191|FG008|COMPLETED|Overall Study||0
10887230|NCT02499328|12053192|FG009|COMPLETED|Overall Study||0
10887231|NCT02499328|12053193|FG010|COMPLETED|Overall Study||0
10887232|NCT02499328|12053194|FG011|COMPLETED|Overall Study||0
10887233|NCT02499328|12053195|FG012|COMPLETED|Overall Study||0
10887234|NCT02499328|12053196|FG013|COMPLETED|Overall Study||0
10887235|NCT02499328|12053197|FG014|COMPLETED|Overall Study||0
10887236|NCT02499328|12053198|FG015|COMPLETED|Overall Study||0
10887237|NCT02499328|12053199|FG016|COMPLETED|Overall Study||0
10887238|NCT02499328|12053200|FG017|COMPLETED|Overall Study||0
10887239|NCT02499328|12053201|FG018|COMPLETED|Overall Study||1
10887240|NCT02499328|12053183|FG000|NOT COMPLETED|Overall Study||4
10887241|NCT02499328|12053184|FG001|NOT COMPLETED|Overall Study||7
10887242|NCT02499328|12053185|FG002|NOT COMPLETED|Overall Study||10
10887243|NCT02499328|12053186|FG003|NOT COMPLETED|Overall Study||11
10887244|NCT02499328|12053187|FG004|NOT COMPLETED|Overall Study||15
10887245|NCT02499328|12053188|FG005|NOT COMPLETED|Overall Study||9
10887246|NCT02499328|12053189|FG006|NOT COMPLETED|Overall Study||7
10887247|NCT02499328|12053190|FG007|NOT COMPLETED|Overall Study||6
10887248|NCT02499328|12053191|FG008|NOT COMPLETED|Overall Study||14
10887249|NCT02499328|12053192|FG009|NOT COMPLETED|Overall Study||24
10887250|NCT02499328|12053193|FG010|NOT COMPLETED|Overall Study||20
10887251|NCT02499328|12053194|FG011|NOT COMPLETED|Overall Study||54
10887252|NCT02499328|12053195|FG012|NOT COMPLETED|Overall Study||25
10887253|NCT02499328|12053196|FG013|NOT COMPLETED|Overall Study||17
10887254|NCT02499328|12053197|FG014|NOT COMPLETED|Overall Study||10
10887255|NCT02499328|12053198|FG015|NOT COMPLETED|Overall Study||1
10887256|NCT02499328|12053199|FG016|NOT COMPLETED|Overall Study||1
10887257|NCT02499328|12053200|FG017|NOT COMPLETED|Overall Study||55
10887258|NCT02499328|12053201|FG018|NOT COMPLETED|Overall Study||49
10887259|NCT02498600|12053286|FG000|STARTED|Overall Study||49
10887260|NCT02498600|12053287|FG001|STARTED|Overall Study||51
10887261|NCT02498600|12053286|FG000|COMPLETED|Overall Study||49
10887262|NCT02498600|12053287|FG001|COMPLETED|Overall Study||51
10887263|NCT02498600|12053286|FG000|NOT COMPLETED|Overall Study||0
10887264|NCT02498600|12053287|FG001|NOT COMPLETED|Overall Study||0
10887265|NCT02495077|12053295|FG000|STARTED|Overall Study||113
10887266|NCT02495077|12053296|FG001|STARTED|Overall Study||112
10887267|NCT02495077|12053297|FG002|STARTED|Overall Study||17
10887268|NCT02495077|12053298|FG003|STARTED|Overall Study||48
10887269|NCT02495077|12053295|FG000|COMPLETED|Overall Study||93
10887270|NCT02495077|12053296|FG001|COMPLETED|Overall Study||91
10887271|NCT02495077|12053297|FG002|COMPLETED|Overall Study||0
10887272|NCT02495077|12053298|FG003|COMPLETED|Overall Study||0
10887273|NCT02495077|12053295|FG000|NOT COMPLETED|Overall Study||20
10887274|NCT02495077|12053296|FG001|NOT COMPLETED|Overall Study||21
10887275|NCT02495077|12053297|FG002|NOT COMPLETED|Overall Study||17
10887276|NCT02495077|12053298|FG003|NOT COMPLETED|Overall Study||48
10887277|NCT02494921|12053309|FG000|STARTED|Phase 1b, Dose Level I||5
10887278|NCT02494921|12053310|FG001|STARTED|Phase 1b, Dose Level I||0
10887279|NCT02494921|12053311|FG002|STARTED|Phase 1b, Dose Level I||0
10887280|NCT02494921|12053312|FG003|STARTED|Phase 1b, Dose Level I||0
10887281|NCT02494921|12053313|FG004|STARTED|Phase 1b, Dose Level I||0
10887282|NCT02494921|12053309|FG000|COMPLETED|Phase 1b, Dose Level I||3
10887283|NCT02494921|12053310|FG001|COMPLETED|Phase 1b, Dose Level I||0
10887284|NCT02494921|12053311|FG002|COMPLETED|Phase 1b, Dose Level I||0
10887285|NCT02494921|12053312|FG003|COMPLETED|Phase 1b, Dose Level I||0
10887286|NCT02494921|12053313|FG004|COMPLETED|Phase 1b, Dose Level I||0
10887287|NCT02494921|12053309|FG000|NOT COMPLETED|Phase 1b, Dose Level I||2
10887288|NCT02494921|12053310|FG001|NOT COMPLETED|Phase 1b, Dose Level I||0
10887289|NCT02494921|12053311|FG002|NOT COMPLETED|Phase 1b, Dose Level I||0
10887290|NCT02494921|12053312|FG003|NOT COMPLETED|Phase 1b, Dose Level I||0
10887291|NCT02494921|12053313|FG004|NOT COMPLETED|Phase 1b, Dose Level I||0
10887292|NCT02494921|12053309|FG000|STARTED|Phase 1b, Dose Level IA||0
10887293|NCT02494921|12053310|FG001|STARTED|Phase 1b, Dose Level IA||4
10887294|NCT02494921|12053311|FG002|STARTED|Phase 1b, Dose Level IA||0
10887295|NCT02494921|12053312|FG003|STARTED|Phase 1b, Dose Level IA||0
10887296|NCT02494921|12053313|FG004|STARTED|Phase 1b, Dose Level IA||0
10887297|NCT02494921|12053309|FG000|COMPLETED|Phase 1b, Dose Level IA||0
10887298|NCT02494921|12053310|FG001|COMPLETED|Phase 1b, Dose Level IA||3
10887299|NCT02494921|12053311|FG002|COMPLETED|Phase 1b, Dose Level IA||0
10887300|NCT02494921|12053312|FG003|COMPLETED|Phase 1b, Dose Level IA||0
10887301|NCT02494921|12053313|FG004|COMPLETED|Phase 1b, Dose Level IA||0
10887302|NCT02494921|12053309|FG000|NOT COMPLETED|Phase 1b, Dose Level IA||0
10887303|NCT02494921|12053310|FG001|NOT COMPLETED|Phase 1b, Dose Level IA||1
10887304|NCT02494921|12053311|FG002|NOT COMPLETED|Phase 1b, Dose Level IA||0
10887305|NCT02494921|12053312|FG003|NOT COMPLETED|Phase 1b, Dose Level IA||0
10887306|NCT02494921|12053313|FG004|NOT COMPLETED|Phase 1b, Dose Level IA||0
10887307|NCT02494921|12053309|FG000|STARTED|Phase 1b, Dose Level IIC||0
10887308|NCT02494921|12053310|FG001|STARTED|Phase 1b, Dose Level IIC||0
10887309|NCT02494921|12053311|FG002|STARTED|Phase 1b, Dose Level IIC||4
10887310|NCT02494921|12053312|FG003|STARTED|Phase 1b, Dose Level IIC||0
10887311|NCT02494921|12053313|FG004|STARTED|Phase 1b, Dose Level IIC||0
10887312|NCT02494921|12053309|FG000|COMPLETED|Phase 1b, Dose Level IIC||0
10887313|NCT02494921|12053310|FG001|COMPLETED|Phase 1b, Dose Level IIC||0
10887314|NCT02494921|12053311|FG002|COMPLETED|Phase 1b, Dose Level IIC||3
10887315|NCT02494921|12053312|FG003|COMPLETED|Phase 1b, Dose Level IIC||0
10887316|NCT02494921|12053313|FG004|COMPLETED|Phase 1b, Dose Level IIC||0
10887317|NCT02494921|12053309|FG000|NOT COMPLETED|Phase 1b, Dose Level IIC||0
10887318|NCT02494921|12053310|FG001|NOT COMPLETED|Phase 1b, Dose Level IIC||0
10887319|NCT02494921|12053311|FG002|NOT COMPLETED|Phase 1b, Dose Level IIC||1
10887320|NCT02494921|12053312|FG003|NOT COMPLETED|Phase 1b, Dose Level IIC||0
10887321|NCT02494921|12053313|FG004|NOT COMPLETED|Phase 1b, Dose Level IIC||0
10887322|NCT02494921|12053309|FG000|STARTED|Phase 1b, Dose Level IIIC, RP2D||0
10887323|NCT02494921|12053310|FG001|STARTED|Phase 1b, Dose Level IIIC, RP2D||0
10887324|NCT02494921|12053311|FG002|STARTED|Phase 1b, Dose Level IIIC, RP2D||0
10887325|NCT02494921|12053312|FG003|STARTED|Phase 1b, Dose Level IIIC, RP2D||6
10887326|NCT02494921|12053313|FG004|STARTED|Phase 1b, Dose Level IIIC, RP2D||0
10887327|NCT02494921|12053309|FG000|COMPLETED|Phase 1b, Dose Level IIIC, RP2D||0
10887328|NCT02494921|12053310|FG001|COMPLETED|Phase 1b, Dose Level IIIC, RP2D||0
10887329|NCT02494921|12053311|FG002|COMPLETED|Phase 1b, Dose Level IIIC, RP2D||0
10887330|NCT02494921|12053312|FG003|COMPLETED|Phase 1b, Dose Level IIIC, RP2D||6
10887331|NCT02494921|12053313|FG004|COMPLETED|Phase 1b, Dose Level IIIC, RP2D||0
10887332|NCT02494921|12053309|FG000|NOT COMPLETED|Phase 1b, Dose Level IIIC, RP2D||0
10887333|NCT02494921|12053310|FG001|NOT COMPLETED|Phase 1b, Dose Level IIIC, RP2D||0
10887334|NCT02494921|12053311|FG002|NOT COMPLETED|Phase 1b, Dose Level IIIC, RP2D||0
10887335|NCT02494921|12053312|FG003|NOT COMPLETED|Phase 1b, Dose Level IIIC, RP2D||0
10887336|NCT02494921|12053313|FG004|NOT COMPLETED|Phase 1b, Dose Level IIIC, RP2D||0
10887337|NCT02494921|12053309|FG000|STARTED|Phase 2, RP2D||0
10887338|NCT02494921|12053310|FG001|STARTED|Phase 2, RP2D||0
10887339|NCT02494921|12053311|FG002|STARTED|Phase 2, RP2D||0
10887340|NCT02494921|12053312|FG003|STARTED|Phase 2, RP2D||0
10887341|NCT02494921|12053313|FG004|STARTED|Phase 2, RP2D||24
10887342|NCT02494921|12053309|FG000|COMPLETED|Phase 2, RP2D||0
10887343|NCT02494921|12053310|FG001|COMPLETED|Phase 2, RP2D||0
10887344|NCT02494921|12053311|FG002|COMPLETED|Phase 2, RP2D||0
10887345|NCT02494921|12053312|FG003|COMPLETED|Phase 2, RP2D||0
10887346|NCT02494921|12053313|FG004|COMPLETED|Phase 2, RP2D||24
10887347|NCT02494921|12053309|FG000|NOT COMPLETED|Phase 2, RP2D||0
10887348|NCT02494921|12053310|FG001|NOT COMPLETED|Phase 2, RP2D||0
10887349|NCT02494921|12053311|FG002|NOT COMPLETED|Phase 2, RP2D||0
10887350|NCT02494921|12053312|FG003|NOT COMPLETED|Phase 2, RP2D||0
10887351|NCT02494921|12053313|FG004|NOT COMPLETED|Phase 2, RP2D||0
10887352|NCT02494583|12053334|FG000|STARTED|Overall Study||256
10887353|NCT02494583|12053335|FG001|STARTED|Overall Study||257
10887354|NCT02494583|12053336|FG002|STARTED|Overall Study||250
10887355|NCT02494583|12053334|FG000|Treated|Overall Study|1 participant randomized to the pembro combo arm received pembrolizumab monotherapy by mistake.|254
10887356|NCT02494583|12053335|FG001|Treated|Overall Study||250
10887357|NCT02494583|12053336|FG002|Treated|Overall Study||244
10887358|NCT02494583|12053334|FG000|COMPLETED|Overall Study||0
10887359|NCT02494583|12053335|FG001|COMPLETED|Overall Study||0
10887360|NCT02494583|12053336|FG002|COMPLETED|Overall Study||0
10887361|NCT02494583|12053334|FG000|NOT COMPLETED|Overall Study||256
10887362|NCT02494583|12053335|FG001|NOT COMPLETED|Overall Study||257
10887363|NCT02494583|12053336|FG002|NOT COMPLETED|Overall Study||250
10887364|NCT02493946|12053347|FG000|STARTED|DB Period||126
10887365|NCT02493946|12053348|FG001|STARTED|DB Period||64
10887366|NCT02493946|12053349|FG002|STARTED|DB Period||0
10887367|NCT02493946|12053347|FG000|COMPLETED|DB Period||118
10887368|NCT02493946|12053348|FG001|COMPLETED|DB Period||59
10887369|NCT02493946|12053349|FG002|COMPLETED|DB Period||0
10887370|NCT02493946|12053347|FG000|NOT COMPLETED|DB Period||8
10887371|NCT02493946|12053348|FG001|NOT COMPLETED|DB Period||5
10887372|NCT02493946|12053349|FG002|NOT COMPLETED|DB Period||0
10887373|NCT02493946|12053347|FG000|STARTED|Open Label Period|Only the BTX-A-HAC Solution 50 U - LT Analyses arm is applicable for this period.|0
10887374|NCT02493946|12053348|FG001|STARTED|Open Label Period|Only the BTX-A-HAC Solution 50 U - LT Analyses arm is applicable for this period.|0
10887375|NCT02493946|12053349|FG002|STARTED|Open Label Period|The previous period relates to DB period only, this period relates to OL treatment only.|595
10887376|NCT02493946|12053347|FG000|COMPLETED|Open Label Period||0
10887377|NCT02493946|12053348|FG001|COMPLETED|Open Label Period||0
10887378|NCT02493946|12053349|FG002|COMPLETED|Open Label Period||509
10887379|NCT02493946|12053347|FG000|NOT COMPLETED|Open Label Period||0
10887380|NCT02493946|12053348|FG001|NOT COMPLETED|Open Label Period||0
10887381|NCT02493946|12053349|FG002|NOT COMPLETED|Open Label Period||86
10887382|NCT02491632|12053359|FG000|STARTED|Overall Study||38
10887383|NCT02491632|12053360|FG001|STARTED|Overall Study||38
10887384|NCT02491632|12053359|FG000|COMPLETED|Overall Study||31
10887385|NCT02491632|12053360|FG001|COMPLETED|Overall Study||29
10887386|NCT02491632|12053359|FG000|NOT COMPLETED|Overall Study||7
10887387|NCT02491632|12053360|FG001|NOT COMPLETED|Overall Study||9
10887388|NCT02489318|12053368|FG000|STARTED|Randomized||527
10887389|NCT02489318|12053369|FG001|STARTED|Randomized||525
10887390|NCT02489318|12053368|FG000|COMPLETED|Randomized||527
10887391|NCT02489318|12053369|FG001|COMPLETED|Randomized||524
10887392|NCT02489318|12053368|FG000|NOT COMPLETED|Randomized||0
10887393|NCT02489318|12053369|FG001|NOT COMPLETED|Randomized||1
10887394|NCT02489318|12053368|FG000|STARTED|Treated||527
10887395|NCT02489318|12053369|FG001|STARTED|Treated||524
10887396|NCT02489318|12053368|FG000|COMPLETED|Treated|Participants crossed over from placebo to apalutamide after positive results at interim analysis.|208
10887397|NCT02489318|12053369|FG001|COMPLETED|Treated||0
10887398|NCT02489318|12053368|FG000|NOT COMPLETED|Treated||319
10887399|NCT02489318|12053369|FG001|NOT COMPLETED|Treated||524
10887400|NCT02488785|12053378|FG000|STARTED|Overall Study||47
10887401|NCT02488785|12053379|FG001|STARTED|Overall Study||49
10887402|NCT02488785|12053378|FG000|COMPLETED|Overall Study||41
10887403|NCT02488785|12053379|FG001|COMPLETED|Overall Study||38
10887404|NCT02488785|12053378|FG000|NOT COMPLETED|Overall Study||6
10887405|NCT02488785|12053379|FG001|NOT COMPLETED|Overall Study||11
10887406|NCT02488759|12053391|FG000|STARTED|Overall Study||113
10887407|NCT02488759|12053392|FG001|STARTED|Overall Study||195
10887408|NCT02488759|12053393|FG002|STARTED|Overall Study||133
10887409|NCT02488759|12053394|FG003|STARTED|Overall Study||8
10887410|NCT02488759|12053395|FG004|STARTED|Overall Study||6
10887411|NCT02488759|12053396|FG005|STARTED|Overall Study||123
10887412|NCT02488759|12053391|FG000|COMPLETED|Overall Study||2
10887413|NCT02488759|12053392|FG001|COMPLETED|Overall Study||0
10887414|NCT02488759|12053393|FG002|COMPLETED|Overall Study||2
10887415|NCT02488759|12053394|FG003|COMPLETED|Overall Study||0
10887416|NCT02488759|12053395|FG004|COMPLETED|Overall Study||0
10887417|NCT02488759|12053396|FG005|COMPLETED|Overall Study||0
10887418|NCT02488759|12053391|FG000|NOT COMPLETED|Overall Study||111
10887419|NCT02488759|12053392|FG001|NOT COMPLETED|Overall Study||195
10887420|NCT02488759|12053393|FG002|NOT COMPLETED|Overall Study||131
10887421|NCT02488759|12053394|FG003|NOT COMPLETED|Overall Study||8
10887422|NCT02488759|12053395|FG004|NOT COMPLETED|Overall Study||6
10887423|NCT02488759|12053396|FG005|NOT COMPLETED|Overall Study||123
10887424|NCT02488551|12053414|FG000|STARTED|Overall Study||86
10887425|NCT02488551|12053415|FG001|STARTED|Overall Study||49
10887426|NCT02488551|12053416|FG002|STARTED|Overall Study||17
10887427|NCT02488551|12053417|FG003|STARTED|Overall Study||15
10887428|NCT02488551|12053414|FG000|COMPLETED|Overall Study||81
10887429|NCT02488551|12053415|FG001|COMPLETED|Overall Study||41
10887430|NCT02488551|12053416|FG002|COMPLETED|Overall Study||17
10887431|NCT02488551|12053417|FG003|COMPLETED|Overall Study||15
10887432|NCT02488551|12053414|FG000|NOT COMPLETED|Overall Study||5
10887433|NCT02488551|12053415|FG001|NOT COMPLETED|Overall Study||8
10887434|NCT02488551|12053416|FG002|NOT COMPLETED|Overall Study||0
10887435|NCT02488551|12053417|FG003|NOT COMPLETED|Overall Study||0
10887436|NCT02487966|12053431|FG000|STARTED|Overall Study||29
10887437|NCT02487966|12053432|FG001|STARTED|Overall Study||28
10887438|NCT02487966|12053433|FG002|STARTED|Overall Study||28
10887439|NCT02487966|12053434|FG003|STARTED|Overall Study||27
10887440|NCT02487966|12053431|FG000|COMPLETED|Overall Study||28
10887441|NCT02487966|12053432|FG001|COMPLETED|Overall Study||24
10887442|NCT02487966|12053433|FG002|COMPLETED|Overall Study||26
10887443|NCT02487966|12053434|FG003|COMPLETED|Overall Study||25
10887444|NCT02487966|12053431|FG000|NOT COMPLETED|Overall Study||1
10887445|NCT02487966|12053432|FG001|NOT COMPLETED|Overall Study||4
10887446|NCT02487966|12053433|FG002|NOT COMPLETED|Overall Study||2
10887447|NCT02487966|12053434|FG003|NOT COMPLETED|Overall Study||2
10887448|NCT02487745|12053446|FG000|STARTED|Overall Study||47
10887449|NCT02487745|12053447|FG001|STARTED|Overall Study||44
10887450|NCT02487745|12053446|FG000|COMPLETED|Overall Study||47
10887451|NCT02487745|12053447|FG001|COMPLETED|Overall Study||44
10887452|NCT02487745|12053446|FG000|NOT COMPLETED|Overall Study||0
10887453|NCT02487745|12053447|FG001|NOT COMPLETED|Overall Study||0
10887454|NCT02485899|12053455|FG000|STARTED|Overall Study||24
10887455|NCT02485899|12053456|FG001|STARTED|Overall Study|The control group (NH comparator) used for determination of the primary efficacy outcomes of this study was comprised of data from 42 subjects with CLN2 disease from the DEM-CHILD database (NCT04613089).|42
10887456|NCT02485899|12053455|FG000|COMPLETED|Overall Study||17
10887457|NCT02485899|12053456|FG001|COMPLETED|Overall Study|The control group (NH comparator) used for determination of the primary efficacy outcomes of this study was comprised of data from 42 subjects with CLN2 disease from the DEM-CHILD database (NCT04613089).|42
10887458|NCT02485899|12053455|FG000|NOT COMPLETED|Overall Study||7
10887459|NCT02485899|12053456|FG001|NOT COMPLETED|Overall Study||0
10887460|NCT02484443|12053462|FG000|STARTED|Overall Study||41
10887461|NCT02484443|12053462|FG000|COMPLETED|Overall Study||9
10887462|NCT02484443|12053462|FG000|NOT COMPLETED|Overall Study||32
10887463|NCT02477774|12053468|FG000|STARTED|Overall Study||29
10887464|NCT02477774|12053469|FG001|STARTED|Overall Study||26
10887465|NCT02477774|12053468|FG000|COMPLETED|Overall Study||29
10887466|NCT02477774|12053469|FG001|COMPLETED|Overall Study||26
10887467|NCT02477774|12053468|FG000|NOT COMPLETED|Overall Study||0
10887468|NCT02477774|12053469|FG001|NOT COMPLETED|Overall Study||0
10887469|NCT02477696|12053477|FG000|STARTED|Overall Study|3 patients withdrew after being randomized but prior to receiving Acalabrutinib treatment.|268
10887470|NCT02477696|12053478|FG001|STARTED|Overall Study|1 patient withdrew after being randomized but prior to receiving Ibrutinib treatment.|265
10887471|NCT02477696|12053477|FG000|COMPLETED|Overall Study||127
10887472|NCT02477696|12053478|FG001|COMPLETED|Overall Study||110
10887473|NCT02477696|12053477|FG000|NOT COMPLETED|Overall Study||141
10887474|NCT02477696|12053478|FG001|NOT COMPLETED|Overall Study||155
10887475|NCT02476968|12053487|FG000|STARTED|Overall Study||145
10887476|NCT02476968|12053488|FG001|STARTED|Overall Study||33
10887477|NCT02476968|12053489|FG002|STARTED|Overall Study||3
10887478|NCT02476968|12053487|FG000|Received Treatment|Overall Study||143
10887479|NCT02476968|12053488|FG001|Received Treatment|Overall Study||32
10887480|NCT02476968|12053489|FG002|Received Treatment|Overall Study||2
10887481|NCT02476968|12053487|FG000|COMPLETED|Overall Study||50
10887482|NCT02476968|12053488|FG001|COMPLETED|Overall Study||15
10887483|NCT02476968|12053489|FG002|COMPLETED|Overall Study||0
10887484|NCT02476968|12053487|FG000|NOT COMPLETED|Overall Study||95
10887485|NCT02476968|12053488|FG001|NOT COMPLETED|Overall Study||18
10887486|NCT02476968|12053489|FG002|NOT COMPLETED|Overall Study||3
10887487|NCT02476916|12053501|FG000|STARTED|Core Period||27
10887488|NCT02476916|12053502|FG001|STARTED|Core Period||25
10887489|NCT02476916|12053501|FG000|COMPLETED|Core Period||21
10887490|NCT02476916|12053502|FG001|COMPLETED|Core Period||22
10887491|NCT02476916|12053501|FG000|NOT COMPLETED|Core Period||6
10887492|NCT02476916|12053502|FG001|NOT COMPLETED|Core Period||3
10887493|NCT02476916|12053501|FG000|STARTED|Extension Period||18
10887494|NCT02476916|12053502|FG001|STARTED|Extension Period||18
10887495|NCT02476916|12053501|FG000|COMPLETED|Extension Period||0
10887496|NCT02476916|12053502|FG001|COMPLETED|Extension Period||0
10887497|NCT02476916|12053501|FG000|NOT COMPLETED|Extension Period||18
10887498|NCT02476916|12053502|FG001|NOT COMPLETED|Extension Period||18
10887499|NCT02470377|12053512|FG000|STARTED|Overall Study||10
10887500|NCT02470377|12053513|FG001|STARTED|Overall Study||9
10887501|NCT02470377|12053514|FG002|STARTED|Overall Study||5
10887502|NCT02470377|12053512|FG000|COMPLETED|Overall Study||10
10887503|NCT02470377|12053513|FG001|COMPLETED|Overall Study||9
10887504|NCT02470377|12053514|FG002|COMPLETED|Overall Study||5
10887505|NCT02470377|12053512|FG000|NOT COMPLETED|Overall Study||0
10887506|NCT02470377|12053513|FG001|NOT COMPLETED|Overall Study||0
10887507|NCT02470377|12053514|FG002|NOT COMPLETED|Overall Study||0
10887508|NCT02466009|12053522|FG000|STARTED|Overall Study||27
10887509|NCT02466009|12053522|FG000|COMPLETED|Overall Study||27
10887510|NCT02466009|12053522|FG000|NOT COMPLETED|Overall Study||0
10887511|NCT02464410|12053528|FG000|STARTED|Overall Study||147
10887512|NCT02464410|12053529|FG001|STARTED|Overall Study||152
10887513|NCT02464410|12053528|FG000|3-month Follow-up|Overall Study||137
10887514|NCT02464410|12053529|FG001|3-month Follow-up|Overall Study||138
10887515|NCT02464410|12053528|FG000|6-month Follow-up|Overall Study||132
10887516|NCT02464410|12053529|FG001|6-month Follow-up|Overall Study||140
10887517|NCT02464410|12053528|FG000|12-month Follow-up|Overall Study||125
10887518|NCT02464410|12053529|FG001|12-month Follow-up|Overall Study||136
10887519|NCT02464410|12053528|FG000|COMPLETED|Overall Study||125
10887520|NCT02464410|12053529|FG001|COMPLETED|Overall Study||136
10887521|NCT02464410|12053528|FG000|NOT COMPLETED|Overall Study||22
10887522|NCT02464410|12053529|FG001|NOT COMPLETED|Overall Study||16
10887523|NCT02462421|12053539|FG000|STARTED|Overall Study||13
10887524|NCT02462421|12053540|FG001|STARTED|Overall Study||4
10887525|NCT02462421|12053541|FG002|STARTED|Overall Study||6
10887526|NCT02462421|12053542|FG003|STARTED|Overall Study||7
10887527|NCT02462421|12053539|FG000|COMPLETED|Overall Study||13
10887528|NCT02462421|12053540|FG001|COMPLETED|Overall Study||4
10887529|NCT02462421|12053541|FG002|COMPLETED|Overall Study||6
10887530|NCT02462421|12053542|FG003|COMPLETED|Overall Study||7
10887531|NCT02462421|12053539|FG000|NOT COMPLETED|Overall Study||0
10887532|NCT02462421|12053540|FG001|NOT COMPLETED|Overall Study||0
10887533|NCT02462421|12053541|FG002|NOT COMPLETED|Overall Study||0
10887534|NCT02462421|12053542|FG003|NOT COMPLETED|Overall Study||0
10887535|NCT02460874|12053554|FG000|STARTED|Overall Study||1
10887536|NCT02460874|12053555|FG001|STARTED|Overall Study||0
10887537|NCT02460874|12053554|FG000|COMPLETED|Overall Study||1
10887538|NCT02460874|12053555|FG001|COMPLETED|Overall Study||0
10887539|NCT02460874|12053554|FG000|NOT COMPLETED|Overall Study||0
10887540|NCT02460874|12053555|FG001|NOT COMPLETED|Overall Study||0
10887541|NCT02460198|12053563|FG000|STARTED|Overall Study||61
10887542|NCT02460198|12053564|FG001|STARTED|Overall Study||63
10887543|NCT02460198|12053563|FG000|COMPLETED|Overall Study||0
10887544|NCT02460198|12053564|FG001|COMPLETED|Overall Study||0
10887545|NCT02460198|12053563|FG000|NOT COMPLETED|Overall Study||61
10887546|NCT02460198|12053564|FG001|NOT COMPLETED|Overall Study||63
10887547|NCT02457910|12053578|FG000|STARTED|Overall Study||3
10887548|NCT02457910|12053579|FG001|STARTED|Overall Study|In dose escalation, two patients receiving the 4 mg dose of taselisib were removed for toxicities|5
10887549|NCT02457910|12053580|FG002|STARTED|Overall Study||3
10887550|NCT02457910|12053581|FG003|STARTED|Overall Study||2
10887551|NCT02457910|12053582|FG004|STARTED|Overall Study|3 participants crossed over to enzalutamide and taselisib|5
10887552|NCT02457910|12053583|FG005|STARTED|Overall Study||12
10887553|NCT02457910|12053578|FG000|COMPLETED|Overall Study||0
10887554|NCT02457910|12053579|FG001|COMPLETED|Overall Study||0
10887555|NCT02457910|12053580|FG002|COMPLETED|Overall Study||0
10887556|NCT02457910|12053581|FG003|COMPLETED|Overall Study||0
10887557|NCT02457910|12053582|FG004|COMPLETED|Overall Study||0
10887558|NCT02457910|12053583|FG005|COMPLETED|Overall Study||1
10887559|NCT02457910|12053578|FG000|NOT COMPLETED|Overall Study||3
10887560|NCT02457910|12053579|FG001|NOT COMPLETED|Overall Study||5
10887561|NCT02457910|12053580|FG002|NOT COMPLETED|Overall Study||3
10887562|NCT02457910|12053581|FG003|NOT COMPLETED|Overall Study||2
10887563|NCT02457910|12053582|FG004|NOT COMPLETED|Overall Study||5
10887564|NCT02457910|12053583|FG005|NOT COMPLETED|Overall Study||11
10887565|NCT02456740|12053603|FG000|STARTED|Double-blind Treatment Phase (24 Weeks)||319
10887566|NCT02456740|12053604|FG001|STARTED|Double-blind Treatment Phase (24 Weeks)||317
10887567|NCT02456740|12053605|FG002|STARTED|Double-blind Treatment Phase (24 Weeks)||319
10887568|NCT02456740|12053606|FG003|STARTED|Double-blind Treatment Phase (24 Weeks)||0
10887569|NCT02456740|12053607|FG004|STARTED|Double-blind Treatment Phase (24 Weeks)||0
10887570|NCT02456740|12053608|FG005|STARTED|Double-blind Treatment Phase (24 Weeks)||0
10887571|NCT02456740|12053609|FG006|STARTED|Double-blind Treatment Phase (24 Weeks)||0
10887572|NCT02456740|12053610|FG007|STARTED|Double-blind Treatment Phase (24 Weeks)||0
10887573|NCT02456740|12053611|FG008|STARTED|Double-blind Treatment Phase (24 Weeks)||0
10887574|NCT02456740|12053603|FG000|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||319
10887575|NCT02456740|12053604|FG001|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||314
10887576|NCT02456740|12053605|FG002|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||319
10887577|NCT02456740|12053606|FG003|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
10887578|NCT02456740|12053607|FG004|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
10887579|NCT02456740|12053608|FG005|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
10887580|NCT02456740|12053609|FG006|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
10887581|NCT02456740|12053610|FG007|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
10887582|NCT02456740|12053611|FG008|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
10887583|NCT02456740|12053603|FG000|COMPLETED|Double-blind Treatment Phase (24 Weeks)||282
10887584|NCT02456740|12053604|FG001|COMPLETED|Double-blind Treatment Phase (24 Weeks)||284
10887585|NCT02456740|12053605|FG002|COMPLETED|Double-blind Treatment Phase (24 Weeks)||292
10887586|NCT02456740|12053606|FG003|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
10887587|NCT02456740|12053607|FG004|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
10887588|NCT02456740|12053608|FG005|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
10887589|NCT02456740|12053609|FG006|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
10887590|NCT02456740|12053610|FG007|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
10887591|NCT02456740|12053611|FG008|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
10887592|NCT02456740|12053603|FG000|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||37
10887593|NCT02456740|12053604|FG001|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||33
10887594|NCT02456740|12053605|FG002|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||27
10887595|NCT02456740|12053606|FG003|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
10887596|NCT02456740|12053607|FG004|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
10887597|NCT02456740|12053608|FG005|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
10887598|NCT02456740|12053609|FG006|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
10887599|NCT02456740|12053610|FG007|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
10887600|NCT02456740|12053611|FG008|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
10887601|NCT02456740|12053603|FG000|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
10887602|NCT02456740|12053604|FG001|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
10887603|NCT02456740|12053605|FG002|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
10887604|NCT02456740|12053606|FG003|STARTED|Active Treatment Phase (Weeks 24 - 52)||138
10887605|NCT02456740|12053607|FG004|STARTED|Active Treatment Phase (Weeks 24 - 52)||140
10887606|NCT02456740|12053608|FG005|STARTED|Active Treatment Phase (Weeks 24 - 52)||143
10887607|NCT02456740|12053609|FG006|STARTED|Active Treatment Phase (Weeks 24 - 52)||140
10887608|NCT02456740|12053610|FG007|STARTED|Active Treatment Phase (Weeks 24 - 52)||140
10887609|NCT02456740|12053611|FG008|STARTED|Active Treatment Phase (Weeks 24 - 52)||144
10887610|NCT02456740|12053603|FG000|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
10887611|NCT02456740|12053604|FG001|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
10887612|NCT02456740|12053605|FG002|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
10887613|NCT02456740|12053606|FG003|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||124
10887614|NCT02456740|12053607|FG004|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||123
10887615|NCT02456740|12053608|FG005|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||130
10887616|NCT02456740|12053609|FG006|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||131
10887617|NCT02456740|12053610|FG007|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||128
10887618|NCT02456740|12053611|FG008|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||126
10887619|NCT02456740|12053603|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
10887620|NCT02456740|12053604|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
10887621|NCT02456740|12053605|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
10887622|NCT02456740|12053606|FG003|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||14
10887623|NCT02456740|12053607|FG004|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||17
10887624|NCT02456740|12053608|FG005|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||13
10887625|NCT02456740|12053609|FG006|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||9
10887626|NCT02456740|12053610|FG007|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||12
10887627|NCT02456740|12053611|FG008|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||18
10887628|NCT02454933|12053623|FG000|STARTED|Overall Study||17
10887629|NCT02454933|12053624|FG001|STARTED|Overall Study|2 subjects switched to osimertinib monotherapy Cycle 1 Day 1|12
10887630|NCT02454933|12053623|FG000|Treatment Group Randomised to|Overall Study||15
10887631|NCT02454933|12053624|FG001|Treatment Group Randomised to|Overall Study||14
10887632|NCT02454933|12053623|FG000|COMPLETED|Overall Study||9
10887633|NCT02454933|12053624|FG001|COMPLETED|Overall Study||4
10887634|NCT02454933|12053623|FG000|NOT COMPLETED|Overall Study||8
10887635|NCT02454933|12053624|FG001|NOT COMPLETED|Overall Study||8
10887636|NCT02453282|12053632|FG000|STARTED|Overall Study||374
10887637|NCT02453282|12053633|FG001|STARTED|Overall Study||372
10887638|NCT02453282|12053634|FG002|STARTED|Overall Study||372
10887639|NCT02453282|12053632|FG000|Received Treatment|Overall Study||369
10887640|NCT02453282|12053633|FG001|Received Treatment|Overall Study||371
10887641|NCT02453282|12053634|FG002|Received Treatment|Overall Study||352
10887642|NCT02453282|12053632|FG000|COMPLETED|Overall Study||0
10887643|NCT02453282|12053633|FG001|COMPLETED|Overall Study||0
10887644|NCT02453282|12053634|FG002|COMPLETED|Overall Study||0
10887645|NCT02453282|12053632|FG000|NOT COMPLETED|Overall Study||374
10887646|NCT02453282|12053633|FG001|NOT COMPLETED|Overall Study||372
10887647|NCT02453282|12053634|FG002|NOT COMPLETED|Overall Study||372
10887648|NCT02451176|12053646|FG000|STARTED|Overall Study||126
10887649|NCT02451176|12053647|FG001|STARTED|Overall Study||127
10887650|NCT02451176|12053646|FG000|COMPLETED|Overall Study||126
10887651|NCT02451176|12053647|FG001|COMPLETED|Overall Study||127
10887652|NCT02451176|12053646|FG000|NOT COMPLETED|Overall Study||0
10887653|NCT02451176|12053647|FG001|NOT COMPLETED|Overall Study||0
10887654|NCT02448225|12053653|FG000|STARTED|Overall Study||46
10887655|NCT02448225|12053653|FG000|COMPLETED|Overall Study||26
10887656|NCT02448225|12053653|FG000|NOT COMPLETED|Overall Study||20
10887657|NCT02446600|12053664|FG000|STARTED|Overall Study||187
10887658|NCT02446600|12053665|FG001|STARTED|Overall Study|Duplicate enrollment patient has been excluded from all analyses.|190
10887659|NCT02446600|12053666|FG002|STARTED|Overall Study||189
10887660|NCT02446600|12053667|FG003|STARTED|Overall Study||13
10887661|NCT02446600|12053664|FG000|COMPLETED|Overall Study|Completed status includes all clinical reasons for suspending treatment, including disease progression, death and adverse events.|147
10887662|NCT02446600|12053665|FG001|COMPLETED|Overall Study|Completed status includes all clinical reasons for suspending treatment, including disease progression, death and adverse events.|178
10887663|NCT02446600|12053666|FG002|COMPLETED|Overall Study|Completed status includes all clinical reasons for suspending treatment, including disease progression, death and adverse events.|162
10887664|NCT02446600|12053667|FG003|COMPLETED|Overall Study|Completed status includes all clinical reasons for suspending treatment, including disease progression, death and adverse events.|12
10887665|NCT02446600|12053664|FG000|NOT COMPLETED|Overall Study||40
10887666|NCT02446600|12053665|FG001|NOT COMPLETED|Overall Study||12
10887667|NCT02446600|12053666|FG002|NOT COMPLETED|Overall Study||27
10887668|NCT02446600|12053667|FG003|NOT COMPLETED|Overall Study||1
10887669|NCT02442778|12053680|FG000|STARTED|Overall Study||210
10887670|NCT02442778|12053681|FG001|STARTED|Overall Study||151
10887671|NCT02442778|12053682|FG002|STARTED|Overall Study||161
10887672|NCT02442778|12053680|FG000|Safety Population|Overall Study||210
10887673|NCT02442778|12053681|FG001|Safety Population|Overall Study||151
10887674|NCT02442778|12053682|FG002|Safety Population|Overall Study||160
10887675|NCT02442778|12053680|FG000|Modified Intent-to-Treat (mITT) Population|Overall Study||210
10887676|NCT02442778|12053681|FG001|Modified Intent-to-Treat (mITT) Population|Overall Study||150
10887677|NCT02442778|12053682|FG002|Modified Intent-to-Treat (mITT) Population|Overall Study||159
10887678|NCT02442778|12053680|FG000|COMPLETED|Overall Study||192
10887679|NCT02442778|12053681|FG001|COMPLETED|Overall Study||121
10887680|NCT02442778|12053682|FG002|COMPLETED|Overall Study||146
10887681|NCT02442778|12053680|FG000|NOT COMPLETED|Overall Study||18
10887682|NCT02442778|12053681|FG001|NOT COMPLETED|Overall Study||30
10887683|NCT02442778|12053682|FG002|NOT COMPLETED|Overall Study||15
10887684|NCT02439216|12053696|FG000|STARTED|PartA(7 Day Open-Label Treatment Period)||5
10887685|NCT02439216|12053697|FG001|STARTED|PartA(7 Day Open-Label Treatment Period)||6
10887686|NCT02439216|12053698|FG002|STARTED|PartA(7 Day Open-Label Treatment Period)||6
10887687|NCT02439216|12053699|FG003|STARTED|PartA(7 Day Open-Label Treatment Period)||0
10887688|NCT02439216|12053700|FG004|STARTED|PartA(7 Day Open-Label Treatment Period)||0
10887689|NCT02439216|12053701|FG005|STARTED|PartA(7 Day Open-Label Treatment Period)||0
10887690|NCT02439216|12053702|FG006|STARTED|PartA(7 Day Open-Label Treatment Period)||0
10887691|NCT02439216|12053703|FG007|STARTED|PartA(7 Day Open-Label Treatment Period)||0
10887692|NCT02439216|12053704|FG008|STARTED|PartA(7 Day Open-Label Treatment Period)||0
10887693|NCT02439216|12053696|FG000|COMPLETED|PartA(7 Day Open-Label Treatment Period)||4
10887694|NCT02439216|12053697|FG001|COMPLETED|PartA(7 Day Open-Label Treatment Period)||6
10887695|NCT02439216|12053698|FG002|COMPLETED|PartA(7 Day Open-Label Treatment Period)||6
10887696|NCT02439216|12053699|FG003|COMPLETED|PartA(7 Day Open-Label Treatment Period)||0
10887697|NCT02439216|12053700|FG004|COMPLETED|PartA(7 Day Open-Label Treatment Period)||0
10887698|NCT02439216|12053701|FG005|COMPLETED|PartA(7 Day Open-Label Treatment Period)||0
10887699|NCT02439216|12053702|FG006|COMPLETED|PartA(7 Day Open-Label Treatment Period)||0
10887700|NCT02439216|12053703|FG007|COMPLETED|PartA(7 Day Open-Label Treatment Period)||0
10887701|NCT02439216|12053704|FG008|COMPLETED|PartA(7 Day Open-Label Treatment Period)||0
10887702|NCT02439216|12053696|FG000|NOT COMPLETED|PartA(7 Day Open-Label Treatment Period)||1
10887703|NCT02439216|12053697|FG001|NOT COMPLETED|PartA(7 Day Open-Label Treatment Period)||0
10887704|NCT02439216|12053698|FG002|NOT COMPLETED|PartA(7 Day Open-Label Treatment Period)||0
10887705|NCT02439216|12053699|FG003|NOT COMPLETED|PartA(7 Day Open-Label Treatment Period)||0
10887706|NCT02439216|12053700|FG004|NOT COMPLETED|PartA(7 Day Open-Label Treatment Period)||0
10887707|NCT02439216|12053701|FG005|NOT COMPLETED|PartA(7 Day Open-Label Treatment Period)||0
10887708|NCT02439216|12053702|FG006|NOT COMPLETED|PartA(7 Day Open-Label Treatment Period)||0
10887709|NCT02439216|12053703|FG007|NOT COMPLETED|PartA(7 Day Open-Label Treatment Period)||0
10887710|NCT02439216|12053704|FG008|NOT COMPLETED|PartA(7 Day Open-Label Treatment Period)||0
10887711|NCT02439216|12053696|FG000|STARTED|Part B (12-week Double Blind)||0
10887712|NCT02439216|12053697|FG001|STARTED|Part B (12-week Double Blind)||0
10887713|NCT02439216|12053698|FG002|STARTED|Part B (12-week Double Blind)||0
10887714|NCT02439216|12053699|FG003|STARTED|Part B (12-week Double Blind)|4 New subjects plus 6 subjects who completed Part A|10
10887715|NCT02439216|12053700|FG004|STARTED|Part B (12-week Double Blind)|4 New subjects plus 6 subjects who completed Part A|10
10887716|NCT02439216|12053701|FG005|STARTED|Part B (12-week Double Blind)|3 New subjects plus 2 subjects who completed Part A|5
10887717|NCT02439216|12053702|FG006|STARTED|Part B (12-week Double Blind)|4 New subjects plus 2 subjects who completed Part A|6
10887718|NCT02439216|12053703|FG007|STARTED|Part B (12-week Double Blind)||0
10887719|NCT02439216|12053704|FG008|STARTED|Part B (12-week Double Blind)||0
10887720|NCT02439216|12053696|FG000|COMPLETED|Part B (12-week Double Blind)||0
10887721|NCT02439216|12053697|FG001|COMPLETED|Part B (12-week Double Blind)||0
10887722|NCT02439216|12053698|FG002|COMPLETED|Part B (12-week Double Blind)||0
10887723|NCT02439216|12053699|FG003|COMPLETED|Part B (12-week Double Blind)||10
10887724|NCT02439216|12053700|FG004|COMPLETED|Part B (12-week Double Blind)||10
10887725|NCT02439216|12053701|FG005|COMPLETED|Part B (12-week Double Blind)||5
10887726|NCT02439216|12053702|FG006|COMPLETED|Part B (12-week Double Blind)||6
10887727|NCT02439216|12053703|FG007|COMPLETED|Part B (12-week Double Blind)||0
10887728|NCT02439216|12053704|FG008|COMPLETED|Part B (12-week Double Blind)||0
10887729|NCT02439216|12053696|FG000|NOT COMPLETED|Part B (12-week Double Blind)||0
10887730|NCT02439216|12053697|FG001|NOT COMPLETED|Part B (12-week Double Blind)||0
10887731|NCT02439216|12053698|FG002|NOT COMPLETED|Part B (12-week Double Blind)||0
10887732|NCT02439216|12053699|FG003|NOT COMPLETED|Part B (12-week Double Blind)||0
10887733|NCT02439216|12053700|FG004|NOT COMPLETED|Part B (12-week Double Blind)||0
10887734|NCT02439216|12053701|FG005|NOT COMPLETED|Part B (12-week Double Blind)||0
10887735|NCT02439216|12053702|FG006|NOT COMPLETED|Part B (12-week Double Blind)||0
10887736|NCT02439216|12053703|FG007|NOT COMPLETED|Part B (12-week Double Blind)||0
10887737|NCT02439216|12053704|FG008|NOT COMPLETED|Part B (12-week Double Blind)||0
10887738|NCT02439216|12053696|FG000|STARTED|Part C (138-week, Open-label Treatment)||0
10887739|NCT02439216|12053697|FG001|STARTED|Part C (138-week, Open-label Treatment)||0
10887740|NCT02439216|12053698|FG002|STARTED|Part C (138-week, Open-label Treatment)||0
10887741|NCT02439216|12053699|FG003|STARTED|Part C (138-week, Open-label Treatment)||0
10887742|NCT02439216|12053700|FG004|STARTED|Part C (138-week, Open-label Treatment)||0
10887743|NCT02439216|12053701|FG005|STARTED|Part C (138-week, Open-label Treatment)||0
10887744|NCT02439216|12053702|FG006|STARTED|Part C (138-week, Open-label Treatment)||0
10887745|NCT02439216|12053703|FG007|STARTED|Part C (138-week, Open-label Treatment)||15
10887746|NCT02439216|12053704|FG008|STARTED|Part C (138-week, Open-label Treatment)||16
10887747|NCT02439216|12053696|FG000|COMPLETED|Part C (138-week, Open-label Treatment)||0
10887748|NCT02439216|12053697|FG001|COMPLETED|Part C (138-week, Open-label Treatment)||0
10887749|NCT02439216|12053698|FG002|COMPLETED|Part C (138-week, Open-label Treatment)||0
10887750|NCT02439216|12053699|FG003|COMPLETED|Part C (138-week, Open-label Treatment)||0
10887751|NCT02439216|12053700|FG004|COMPLETED|Part C (138-week, Open-label Treatment)||0
10887752|NCT02439216|12053701|FG005|COMPLETED|Part C (138-week, Open-label Treatment)||0
10887753|NCT02439216|12053702|FG006|COMPLETED|Part C (138-week, Open-label Treatment)||0
10887754|NCT02439216|12053703|FG007|COMPLETED|Part C (138-week, Open-label Treatment)||8
10887755|NCT02439216|12053704|FG008|COMPLETED|Part C (138-week, Open-label Treatment)||5
10887756|NCT02439216|12053696|FG000|NOT COMPLETED|Part C (138-week, Open-label Treatment)||0
10887757|NCT02439216|12053697|FG001|NOT COMPLETED|Part C (138-week, Open-label Treatment)||0
10887758|NCT02439216|12053698|FG002|NOT COMPLETED|Part C (138-week, Open-label Treatment)||0
10887759|NCT02439216|12053699|FG003|NOT COMPLETED|Part C (138-week, Open-label Treatment)||0
10887760|NCT02439216|12053700|FG004|NOT COMPLETED|Part C (138-week, Open-label Treatment)||0
10887761|NCT02439216|12053701|FG005|NOT COMPLETED|Part C (138-week, Open-label Treatment)||0
10887762|NCT02439216|12053702|FG006|NOT COMPLETED|Part C (138-week, Open-label Treatment)||0
10887763|NCT02439216|12053703|FG007|NOT COMPLETED|Part C (138-week, Open-label Treatment)||7
10887764|NCT02439216|12053704|FG008|NOT COMPLETED|Part C (138-week, Open-label Treatment)||11
10887765|NCT02437318|12053730|FG000|STARTED|Overall Study||284
10887766|NCT02437318|12053731|FG001|STARTED|Overall Study||288
10887767|NCT02437318|12053730|FG000|End of Treatment (Didn't Complete)|Overall Study||229
10887768|NCT02437318|12053731|FG001|End of Treatment (Didn't Complete)|Overall Study||241
10887769|NCT02437318|12053730|FG000|Untreated (Protocol Deviation)|Overall Study||0
10887770|NCT02437318|12053731|FG001|Untreated (Protocol Deviation)|Overall Study||1
10887771|NCT02437318|12053730|FG000|COMPLETED|Overall Study||55
10887772|NCT02437318|12053731|FG001|COMPLETED|Overall Study||46
10887773|NCT02437318|12053730|FG000|NOT COMPLETED|Overall Study||229
10887774|NCT02437318|12053731|FG001|NOT COMPLETED|Overall Study||242
10887775|NCT02435173|12053740|FG000|STARTED|Overall Study||6
10887776|NCT02435173|12053741|FG001|STARTED|Overall Study||21
10887777|NCT02435173|12053742|FG002|STARTED|Overall Study||10
10887778|NCT02435173|12053740|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study||6
10887779|NCT02435173|12053741|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study||19
10887780|NCT02435173|12053742|FG002|Pharmacokinetics (PK) Analysis Set|Overall Study||0
10887781|NCT02435173|12053740|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||6
10887782|NCT02435173|12053741|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||19
10887783|NCT02435173|12053742|FG002|Pharmacodynamic (PD) Analysis Set|Overall Study||8
10887784|NCT02435173|12053740|FG000|COMPLETED|Overall Study||6
10887785|NCT02435173|12053741|FG001|COMPLETED|Overall Study||21
10887786|NCT02435173|12053742|FG002|COMPLETED|Overall Study||10
10887787|NCT02435173|12053740|FG000|NOT COMPLETED|Overall Study||0
10887788|NCT02435173|12053741|FG001|NOT COMPLETED|Overall Study||0
10887789|NCT02435173|12053742|FG002|NOT COMPLETED|Overall Study||0
10887790|NCT02434081|12053756|FG000|STARTED|Overall Study|Only patients enrolled after protocol amendments 1 (n=43) and 2 (n=36) were analysed (concurrent CRT+Nivo). Patients who received CRT and sequentially Nivo (enrolled under original protocol (n=12) or protocol amendment 1 (n=3)) were not included in the analysis population.|79
10887791|NCT02434081|12053756|FG000|COMPLETED|Overall Study||31
10887792|NCT02434081|12053756|FG000|NOT COMPLETED|Overall Study||48
10887793|NCT02433210|12053763|FG000|STARTED|Overall Study||5
10887794|NCT02433210|12053764|FG001|STARTED|Overall Study||3
10887795|NCT02433210|12053765|FG002|STARTED|Overall Study||3
10887796|NCT02433210|12053763|FG000|COMPLETED|Overall Study||4
10887797|NCT02433210|12053764|FG001|COMPLETED|Overall Study||3
10887798|NCT02433210|12053765|FG002|COMPLETED|Overall Study||3
10887799|NCT02433210|12053763|FG000|NOT COMPLETED|Overall Study||1
10887800|NCT02433210|12053764|FG001|NOT COMPLETED|Overall Study||0
10887801|NCT02433210|12053765|FG002|NOT COMPLETED|Overall Study||0
10887802|NCT02432846|12053857|FG000|STARTED|Overall Study (4 Arms/Strata)||17
10887803|NCT02432846|12053858|FG001|STARTED|Overall Study (4 Arms/Strata)||8
10887804|NCT02432846|12053859|FG002|STARTED|Overall Study (4 Arms/Strata)||41
10887805|NCT02432846|12053860|FG003|STARTED|Overall Study (4 Arms/Strata)||22
10887806|NCT02432846|12053861|FG004|STARTED|Overall Study (4 Arms/Strata)||0
10887807|NCT02432846|12053862|FG005|STARTED|Overall Study (4 Arms/Strata)||0
10887808|NCT02432846|12053857|FG000|COMPLETED|Overall Study (4 Arms/Strata)||2
10887809|NCT02432846|12053858|FG001|COMPLETED|Overall Study (4 Arms/Strata)||0
10887810|NCT02432846|12053859|FG002|COMPLETED|Overall Study (4 Arms/Strata)||17
10887811|NCT02432846|12053860|FG003|COMPLETED|Overall Study (4 Arms/Strata)||8
10887812|NCT02432846|12053861|FG004|COMPLETED|Overall Study (4 Arms/Strata)||0
10887813|NCT02432846|12053862|FG005|COMPLETED|Overall Study (4 Arms/Strata)||0
10887814|NCT02432846|12053857|FG000|NOT COMPLETED|Overall Study (4 Arms/Strata)||15
10887815|NCT02432846|12053858|FG001|NOT COMPLETED|Overall Study (4 Arms/Strata)||8
10887816|NCT02432846|12053859|FG002|NOT COMPLETED|Overall Study (4 Arms/Strata)||24
10887817|NCT02432846|12053860|FG003|NOT COMPLETED|Overall Study (4 Arms/Strata)||14
10887818|NCT02432846|12053861|FG004|NOT COMPLETED|Overall Study (4 Arms/Strata)||0
10887819|NCT02432846|12053862|FG005|NOT COMPLETED|Overall Study (4 Arms/Strata)||0
10887820|NCT02432846|12053857|FG000|STARTED|Overall Study (2 Total/Combined Groups)||0
10887821|NCT02432846|12053858|FG001|STARTED|Overall Study (2 Total/Combined Groups)||0
10887822|NCT02432846|12053859|FG002|STARTED|Overall Study (2 Total/Combined Groups)||0
10887823|NCT02432846|12053860|FG003|STARTED|Overall Study (2 Total/Combined Groups)||0
10887824|NCT02432846|12053861|FG004|STARTED|Overall Study (2 Total/Combined Groups)||58
10887825|NCT02432846|12053862|FG005|STARTED|Overall Study (2 Total/Combined Groups)||30
10887826|NCT02432846|12053857|FG000|COMPLETED|Overall Study (2 Total/Combined Groups)||0
10887827|NCT02432846|12053858|FG001|COMPLETED|Overall Study (2 Total/Combined Groups)||0
10887828|NCT02432846|12053859|FG002|COMPLETED|Overall Study (2 Total/Combined Groups)||0
10887829|NCT02432846|12053860|FG003|COMPLETED|Overall Study (2 Total/Combined Groups)||0
10887830|NCT02432846|12053861|FG004|COMPLETED|Overall Study (2 Total/Combined Groups)||19
10887831|NCT02432846|12053862|FG005|COMPLETED|Overall Study (2 Total/Combined Groups)||8
10887832|NCT02432846|12053857|FG000|NOT COMPLETED|Overall Study (2 Total/Combined Groups)||0
10887833|NCT02432846|12053858|FG001|NOT COMPLETED|Overall Study (2 Total/Combined Groups)||0
10887834|NCT02432846|12053859|FG002|NOT COMPLETED|Overall Study (2 Total/Combined Groups)||0
10887835|NCT02432846|12053860|FG003|NOT COMPLETED|Overall Study (2 Total/Combined Groups)||0
10887836|NCT02432846|12053861|FG004|NOT COMPLETED|Overall Study (2 Total/Combined Groups)||39
10887837|NCT02432846|12053862|FG005|NOT COMPLETED|Overall Study (2 Total/Combined Groups)||22
10887838|NCT02432742|12053875|FG000|STARTED|Overall Study||100
10887839|NCT02432742|12053875|FG000|COMPLETED|Overall Study||95
10887840|NCT02432742|12053875|FG000|NOT COMPLETED|Overall Study||5
10887841|NCT02432690|12053880|FG000|STARTED|Overall Study||13
10887842|NCT02432690|12053880|FG000|COMPLETED|Overall Study||13
10887843|NCT02432690|12053880|FG000|NOT COMPLETED|Overall Study||0
10887844|NCT02432274|12053892|FG000|STARTED|Overall Study||3
10887845|NCT02432274|12053893|FG001|STARTED|Overall Study||9
10887846|NCT02432274|12053894|FG002|STARTED|Overall Study||11
10887847|NCT02432274|12053895|FG003|STARTED|Overall Study||1
10887848|NCT02432274|12053896|FG004|STARTED|Overall Study||31
10887849|NCT02432274|12053897|FG005|STARTED|Overall Study||7
10887850|NCT02432274|12053898|FG006|STARTED|Overall Study||15
10887851|NCT02432274|12053899|FG007|STARTED|Overall Study||20
10887852|NCT02432274|12053892|FG000|Underwent Run-in Period|Overall Study||1
10887853|NCT02432274|12053893|FG001|Underwent Run-in Period|Overall Study||1
10887854|NCT02432274|12053894|FG002|Underwent Run-in Period|Overall Study||0
10887855|NCT02432274|12053895|FG003|Underwent Run-in Period|Overall Study||0
10887856|NCT02432274|12053896|FG004|Underwent Run-in Period|Overall Study||0
10887857|NCT02432274|12053897|FG005|Underwent Run-in Period|Overall Study||0
10887858|NCT02432274|12053898|FG006|Underwent Run-in Period|Overall Study||0
10887859|NCT02432274|12053899|FG007|Underwent Run-in Period|Overall Study||0
10887860|NCT02432274|12053892|FG000|Treated (Safety Population)|Overall Study|2 participants assigned to lenvatinib17mg/m^2 actually received 11mg/m^2 (dose capped at 24 mg/day).|5
10887861|NCT02432274|12053893|FG001|Treated (Safety Population)|Overall Study|2 participants assigned to lenvatinib17mg/m^2 actually received 14mg/m^2 (dose capped at 24 mg/day).|11
10887862|NCT02432274|12053894|FG002|Treated (Safety Population)|Overall Study||7
10887863|NCT02432274|12053895|FG003|Treated (Safety Population)|Overall Study||1
10887864|NCT02432274|12053896|FG004|Treated (Safety Population)|Overall Study||31
10887865|NCT02432274|12053897|FG005|Treated (Safety Population)|Overall Study|4 participants assigned to lenvatinib14mg/m^2 actually received 11mg/m^2 (dose capped at 24 mg/day).|11
10887866|NCT02432274|12053898|FG006|Treated (Safety Population)|Overall Study||11
10887867|NCT02432274|12053899|FG007|Treated (Safety Population)|Overall Study||20
10887868|NCT02432274|12053892|FG000|COMPLETED|Overall Study||0
10887869|NCT02432274|12053893|FG001|COMPLETED|Overall Study||0
10887870|NCT02432274|12053894|FG002|COMPLETED|Overall Study||0
10887871|NCT02432274|12053895|FG003|COMPLETED|Overall Study||0
10887872|NCT02432274|12053896|FG004|COMPLETED|Overall Study||0
10887873|NCT02432274|12053897|FG005|COMPLETED|Overall Study||0
10887874|NCT02432274|12053898|FG006|COMPLETED|Overall Study||0
10887875|NCT02432274|12053899|FG007|COMPLETED|Overall Study||0
10887876|NCT02432274|12053892|FG000|NOT COMPLETED|Overall Study||3
10887877|NCT02432274|12053893|FG001|NOT COMPLETED|Overall Study||9
10887878|NCT02432274|12053894|FG002|NOT COMPLETED|Overall Study||11
10887879|NCT02432274|12053895|FG003|NOT COMPLETED|Overall Study||1
10887880|NCT02432274|12053896|FG004|NOT COMPLETED|Overall Study||31
10887881|NCT02432274|12053897|FG005|NOT COMPLETED|Overall Study||7
10887882|NCT02432274|12053898|FG006|NOT COMPLETED|Overall Study||15
10887883|NCT02432274|12053899|FG007|NOT COMPLETED|Overall Study||20
10887884|NCT02432196|12053929|FG000|STARTED|Overall Study||26
10887885|NCT02432196|12053929|FG000|Implanted With Device|Overall Study||25
10887886|NCT02432196|12053929|FG000|COMPLETED|Overall Study||0
10887887|NCT02432196|12053929|FG000|NOT COMPLETED|Overall Study||26
10887888|NCT02431247|12053935|FG000|STARTED|BL to EOE-Test and BL to Switch- Control||362
10887889|NCT02431247|12053936|FG001|STARTED|BL to EOE-Test and BL to Switch- Control||363
10887890|NCT02431247|12053937|FG002|STARTED|BL to EOE-Test and BL to Switch- Control||0
10887891|NCT02431247|12053935|FG000|COMPLETED|BL to EOE-Test and BL to Switch- Control||296
10887892|NCT02431247|12053936|FG001|COMPLETED|BL to EOE-Test and BL to Switch- Control||322
10887893|NCT02431247|12053937|FG002|COMPLETED|BL to EOE-Test and BL to Switch- Control||0
10887894|NCT02431247|12053935|FG000|NOT COMPLETED|BL to EOE-Test and BL to Switch- Control||66
10887895|NCT02431247|12053936|FG001|NOT COMPLETED|BL to EOE-Test and BL to Switch- Control||41
10887896|NCT02431247|12053937|FG002|NOT COMPLETED|BL to EOE-Test and BL to Switch- Control||0
10887897|NCT02431247|12053935|FG000|STARTED|Switch to D/C/F/TAF (Until EOE)||0
10887898|NCT02431247|12053936|FG001|STARTED|Switch to D/C/F/TAF (Until EOE)|322 participants from DRV/COBI+ FTC/TDF (Control) group switched to D/C/F/TAF (Test) Group|0
10887899|NCT02431247|12053937|FG002|STARTED|Switch to D/C/F/TAF (Until EOE)|322 participants from DRV/COBI+ FTC/TDF (Control) group switched to D/C/F/TAF (Test) Group|322
10887900|NCT02431247|12053935|FG000|COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
10887901|NCT02431247|12053936|FG001|COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
10887902|NCT02431247|12053937|FG002|COMPLETED|Switch to D/C/F/TAF (Until EOE)||289
10887903|NCT02431247|12053935|FG000|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
10887904|NCT02431247|12053936|FG001|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
10887905|NCT02431247|12053937|FG002|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||33
10887906|NCT02429830|12053949|FG000|STARTED|Overall Study||30
10887907|NCT02429830|12053949|FG000|COMPLETED|Overall Study||27
10887908|NCT02429830|12053949|FG000|NOT COMPLETED|Overall Study||3
10887909|NCT02427464|12053955|FG000|STARTED|Overall Study||338
10887910|NCT02427464|12053956|FG001|STARTED|Overall Study||169
10887911|NCT02427464|12053955|FG000|Intent-to-Treat Population|Overall Study||336
10887912|NCT02427464|12053956|FG001|Intent-to-Treat Population|Overall Study||164
10887913|NCT02427464|12053955|FG000|COMPLETED|Overall Study||288
10887914|NCT02427464|12053956|FG001|COMPLETED|Overall Study||145
10887915|NCT02427464|12053955|FG000|NOT COMPLETED|Overall Study||50
10887916|NCT02427464|12053956|FG001|NOT COMPLETED|Overall Study||24
10887917|NCT02426125|12053964|FG000|STARTED|Overall Study||263
10887918|NCT02426125|12053965|FG001|STARTED|Overall Study||267
10887919|NCT02426125|12053964|FG000|Received at Least One Dose of Study Drug|Overall Study||258
10887920|NCT02426125|12053965|FG001|Received at Least One Dose of Study Drug|Overall Study||265
10887921|NCT02426125|12053964|FG000|First Randomized Participants|Overall Study||216
10887922|NCT02426125|12053965|FG001|First Randomized Participants|Overall Study||221
10887923|NCT02426125|12053964|FG000|COMPLETED|Overall Study||234
10887924|NCT02426125|12053965|FG001|COMPLETED|Overall Study||241
10887925|NCT02426125|12053964|FG000|NOT COMPLETED|Overall Study||29
10887926|NCT02426125|12053965|FG001|NOT COMPLETED|Overall Study||26
10887927|NCT02422615|12053975|FG000|STARTED|Overall Study||484
10887928|NCT02422615|12053976|FG001|STARTED|Overall Study||242
10887929|NCT02422615|12053975|FG000|Untreated|Overall Study||1
10887930|NCT02422615|12053976|FG001|Untreated|Overall Study||1
10887931|NCT02422615|12053975|FG000|COMPLETED|Overall Study||204
10887932|NCT02422615|12053976|FG001|COMPLETED|Overall Study||76
10887933|NCT02422615|12053975|FG000|NOT COMPLETED|Overall Study||280
10887934|NCT02422615|12053976|FG001|NOT COMPLETED|Overall Study||166
10887935|NCT02421939|12053984|FG000|STARTED|Overall Study||247
10887936|NCT02421939|12053985|FG001|STARTED|Overall Study||124
10887937|NCT02421939|12053984|FG000|Treated|Overall Study||246
10887938|NCT02421939|12053985|FG001|Treated|Overall Study||109
10887939|NCT02421939|12053984|FG000|COMPLETED|Overall Study||38
10887940|NCT02421939|12053985|FG001|COMPLETED|Overall Study||0
10887941|NCT02421939|12053984|FG000|NOT COMPLETED|Overall Study||209
10887942|NCT02421939|12053985|FG001|NOT COMPLETED|Overall Study||124
10887943|NCT02420119|12053991|FG000|STARTED|Overall Study||53
10887944|NCT02420119|12053991|FG000|COMPLETED|Overall Study||48
10887945|NCT02420119|12053991|FG000|NOT COMPLETED|Overall Study||5
10887946|NCT02418195|12053999|FG000|STARTED|Overall Study|Number subjects screened in this group.|62
10887947|NCT02418195|12054000|FG001|STARTED|Overall Study|Number subjects screened in this group.|63
10887948|NCT02418195|12054001|FG002|STARTED|Overall Study|Number subjects screened in this group.|61
10887949|NCT02418195|12054002|FG003|STARTED|Overall Study|Number subjects screened in this group.|61
10887950|NCT02418195|12053999|FG000|COMPLETED|Overall Study|Number subjects screened in this group.|62
10887951|NCT02418195|12054000|FG001|COMPLETED|Overall Study|Number subjects screened in this group.|63
10887952|NCT02418195|12054001|FG002|COMPLETED|Overall Study|Number subjects screened in this group.|61
10887953|NCT02418195|12054002|FG003|COMPLETED|Overall Study|Number subjects screened in this group.|61
10887954|NCT02418195|12053999|FG000|NOT COMPLETED|Overall Study||0
10887955|NCT02418195|12054000|FG001|NOT COMPLETED|Overall Study||0
10887956|NCT02418195|12054001|FG002|NOT COMPLETED|Overall Study||0
10887957|NCT02418195|12054002|FG003|NOT COMPLETED|Overall Study||0
10887958|NCT02412878|12054014|FG000|STARTED|Overall Study||238
10887959|NCT02412878|12054015|FG001|STARTED|Overall Study||240
10887960|NCT02412878|12054014|FG000|Received Carfilzomib|Overall Study||235
10887961|NCT02412878|12054015|FG001|Received Carfilzomib|Overall Study||238
10887962|NCT02412878|12054014|FG000|COMPLETED|Overall Study||217
10887963|NCT02412878|12054015|FG001|COMPLETED|Overall Study||227
10887964|NCT02412878|12054014|FG000|NOT COMPLETED|Overall Study||21
10887965|NCT02412878|12054015|FG001|NOT COMPLETED|Overall Study||13
10887966|NCT02412670|12054023|FG000|STARTED|Overall Study||30
10887967|NCT02412670|12054024|FG001|STARTED|Overall Study||6
10887968|NCT02412670|12054023|FG000|Eligible and Treated|Overall Study||29
10887969|NCT02412670|12054024|FG001|Eligible and Treated|Overall Study||6
10887970|NCT02412670|12054023|FG000|COMPLETED|Overall Study||23
10887971|NCT02412670|12054024|FG001|COMPLETED|Overall Study||5
10887972|NCT02412670|12054023|FG000|NOT COMPLETED|Overall Study||7
10887973|NCT02412670|12054024|FG001|NOT COMPLETED|Overall Study||1
10887974|NCT02412306|12054035|FG000|STARTED|Overall Study||5
10887975|NCT02412306|12054036|FG001|STARTED|Overall Study||9
10887976|NCT02412306|12054037|FG002|STARTED|Overall Study||21
10887977|NCT02412306|12054038|FG003|STARTED|Overall Study||14
10887978|NCT02412306|12054039|FG004|STARTED|Overall Study||17
10887979|NCT02412306|12054035|FG000|COMPLETED|Overall Study||0
10887980|NCT02412306|12054036|FG001|COMPLETED|Overall Study||1
10887981|NCT02412306|12054037|FG002|COMPLETED|Overall Study||5
10887982|NCT02412306|12054038|FG003|COMPLETED|Overall Study||14
10887983|NCT02412306|12054039|FG004|COMPLETED|Overall Study||15
10887984|NCT02412306|12054035|FG000|NOT COMPLETED|Overall Study||5
10887985|NCT02412306|12054036|FG001|NOT COMPLETED|Overall Study||8
10887986|NCT02412306|12054037|FG002|NOT COMPLETED|Overall Study||16
10887987|NCT02412306|12054038|FG003|NOT COMPLETED|Overall Study||0
10887988|NCT02412306|12054039|FG004|NOT COMPLETED|Overall Study||2
10887989|NCT02408887|12054062|FG000|STARTED|Overall Study||8
10887990|NCT02408887|12054063|FG001|STARTED|Overall Study||6
10887991|NCT02408887|12054062|FG000|COMPLETED|Overall Study||7
10887992|NCT02408887|12054063|FG001|COMPLETED|Overall Study||5
10887993|NCT02408887|12054062|FG000|NOT COMPLETED|Overall Study||1
10887994|NCT02408887|12054063|FG001|NOT COMPLETED|Overall Study||1
10887995|NCT02407236|12054077|FG000|STARTED|Induction Study (8 Weeks)||319
10887996|NCT02407236|12054078|FG001|STARTED|Induction Study (8 Weeks)||320
10887997|NCT02407236|12054079|FG002|STARTED|Induction Study (8 Weeks)||322
10887998|NCT02407236|12054080|FG003|STARTED|Induction Study (8 Weeks)||0
10887999|NCT02407236|12054081|FG004|STARTED|Induction Study (8 Weeks)||0
10888000|NCT02407236|12054082|FG005|STARTED|Induction Study (8 Weeks)||0
10888001|NCT02407236|12054083|FG006|STARTED|Induction Study (8 Weeks)||0
10888002|NCT02407236|12054084|FG007|STARTED|Induction Study (8 Weeks)||0
10888003|NCT02407236|12054077|FG000|Clinical Response at IS Week 8|Induction Study (8 Weeks)||103
10888004|NCT02407236|12054078|FG001|Clinical Response at IS Week 8|Induction Study (8 Weeks)||172
10888005|NCT02407236|12054079|FG002|Clinical Response at IS Week 8|Induction Study (8 Weeks)||208
10888006|NCT02407236|12054080|FG003|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
10888007|NCT02407236|12054081|FG004|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
10888008|NCT02407236|12054082|FG005|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
10888009|NCT02407236|12054083|FG006|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
10888010|NCT02407236|12054084|FG007|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
10888011|NCT02407236|12054077|FG000|Clinical Response at IS Week 16|Induction Study (8 Weeks)||143
10888012|NCT02407236|12054078|FG001|Clinical Response at IS Week 16|Induction Study (8 Weeks)||90
10888013|NCT02407236|12054079|FG002|Clinical Response at IS Week 16|Induction Study (8 Weeks)||67
10888014|NCT02407236|12054080|FG003|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
10888015|NCT02407236|12054081|FG004|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
10888016|NCT02407236|12054082|FG005|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
10888017|NCT02407236|12054083|FG006|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
10888018|NCT02407236|12054084|FG007|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
10888019|NCT02407236|12054077|FG000|Completed Safety Follow-up|Induction Study (8 Weeks)|17 participants from Induction Week (IW)- 8 and 33 participants from IW- 16.|50
10888020|NCT02407236|12054078|FG001|Completed Safety Follow-up|Induction Study (8 Weeks)|10 participants from IW- 8 and 37 from IW- 16.|47
10888021|NCT02407236|12054079|FG002|Completed Safety Follow-up|Induction Study (8 Weeks)|10 participants from IW- 8 and 22 from IW- 16.|32
10888022|NCT02407236|12054080|FG003|Completed Safety Follow-up|Induction Study (8 Weeks)||0
10888023|NCT02407236|12054081|FG004|Completed Safety Follow-up|Induction Study (8 Weeks)||0
10888024|NCT02407236|12054082|FG005|Completed Safety Follow-up|Induction Study (8 Weeks)||0
10888025|NCT02407236|12054083|FG006|Completed Safety Follow-up|Induction Study (8 Weeks)||0
10888026|NCT02407236|12054084|FG007|Completed Safety Follow-up|Induction Study (8 Weeks)||0
10888027|NCT02407236|12054077|FG000|Safety Analysis Set|Induction Study (8 Weeks)||319
10888028|NCT02407236|12054078|FG001|Safety Analysis Set|Induction Study (8 Weeks)|1 participant of ustekinumab 130mg never had drug, 2 participants planned to 6 mg/kg but had 130mg.|321
10888029|NCT02407236|12054079|FG002|Safety Analysis Set|Induction Study (8 Weeks)||320
10888030|NCT02407236|12054080|FG003|Safety Analysis Set|Induction Study (8 Weeks)||0
10888031|NCT02407236|12054081|FG004|Safety Analysis Set|Induction Study (8 Weeks)||0
10888032|NCT02407236|12054082|FG005|Safety Analysis Set|Induction Study (8 Weeks)||0
10888033|NCT02407236|12054083|FG006|Safety Analysis Set|Induction Study (8 Weeks)||0
10888034|NCT02407236|12054084|FG007|Safety Analysis Set|Induction Study (8 Weeks)||0
10888035|NCT02407236|12054077|FG000|Non-responders at Week 8|Induction Study (8 Weeks)||184
10888036|NCT02407236|12054078|FG001|Non-responders at Week 8|Induction Study (8 Weeks)||132
10888037|NCT02407236|12054079|FG002|Non-responders at Week 8|Induction Study (8 Weeks)||101
10888038|NCT02407236|12054080|FG003|Non-responders at Week 8|Induction Study (8 Weeks)||0
10888039|NCT02407236|12054081|FG004|Non-responders at Week 8|Induction Study (8 Weeks)||0
10888040|NCT02407236|12054082|FG005|Non-responders at Week 8|Induction Study (8 Weeks)||0
10888041|NCT02407236|12054083|FG006|Non-responders at Week 8|Induction Study (8 Weeks)||0
10888042|NCT02407236|12054084|FG007|Non-responders at Week 8|Induction Study (8 Weeks)||0
10888043|NCT02407236|12054077|FG000|COMPLETED|Induction Study (8 Weeks)||296
10888044|NCT02407236|12054078|FG001|COMPLETED|Induction Study (8 Weeks)||309
10888045|NCT02407236|12054079|FG002|COMPLETED|Induction Study (8 Weeks)||307
10888046|NCT02407236|12054080|FG003|COMPLETED|Induction Study (8 Weeks)||0
10888047|NCT02407236|12054081|FG004|COMPLETED|Induction Study (8 Weeks)||0
10888048|NCT02407236|12054082|FG005|COMPLETED|Induction Study (8 Weeks)||0
10888049|NCT02407236|12054083|FG006|COMPLETED|Induction Study (8 Weeks)||0
10888050|NCT02407236|12054084|FG007|COMPLETED|Induction Study (8 Weeks)||0
10888051|NCT02407236|12054077|FG000|NOT COMPLETED|Induction Study (8 Weeks)||23
10888052|NCT02407236|12054078|FG001|NOT COMPLETED|Induction Study (8 Weeks)||11
10888053|NCT02407236|12054079|FG002|NOT COMPLETED|Induction Study (8 Weeks)||15
10888054|NCT02407236|12054080|FG003|NOT COMPLETED|Induction Study (8 Weeks)||0
10888055|NCT02407236|12054081|FG004|NOT COMPLETED|Induction Study (8 Weeks)||0
10888056|NCT02407236|12054082|FG005|NOT COMPLETED|Induction Study (8 Weeks)||0
10888057|NCT02407236|12054083|FG006|NOT COMPLETED|Induction Study (8 Weeks)||0
10888058|NCT02407236|12054084|FG007|NOT COMPLETED|Induction Study (8 Weeks)||0
10888059|NCT02407236|12054077|FG000|STARTED|Maintenance Study (44 Weeks)||0
10888060|NCT02407236|12054078|FG001|STARTED|Maintenance Study (44 Weeks)||0
10888061|NCT02407236|12054079|FG002|STARTED|Maintenance Study (44 Weeks)||0
10888062|NCT02407236|12054080|FG003|STARTED|Maintenance Study (44 Weeks)||175
10888063|NCT02407236|12054081|FG004|STARTED|Maintenance Study (44 Weeks)||172
10888064|NCT02407236|12054082|FG005|STARTED|Maintenance Study (44 Weeks)||176
10888065|NCT02407236|12054083|FG006|STARTED|Maintenance Study (44 Weeks)||103
10888066|NCT02407236|12054084|FG007|STARTED|Maintenance Study (44 Weeks)||157
10888067|NCT02407236|12054077|FG000|COMPLETED|Maintenance Study (44 Weeks)||0
10888068|NCT02407236|12054078|FG001|COMPLETED|Maintenance Study (44 Weeks)||0
10888069|NCT02407236|12054079|FG002|COMPLETED|Maintenance Study (44 Weeks)||0
10888070|NCT02407236|12054080|FG003|COMPLETED|Maintenance Study (44 Weeks)||165
10888071|NCT02407236|12054081|FG004|COMPLETED|Maintenance Study (44 Weeks)||161
10888072|NCT02407236|12054082|FG005|COMPLETED|Maintenance Study (44 Weeks)||168
10888073|NCT02407236|12054083|FG006|COMPLETED|Maintenance Study (44 Weeks)||94
10888074|NCT02407236|12054084|FG007|COMPLETED|Maintenance Study (44 Weeks)||149
10888075|NCT02407236|12054077|FG000|NOT COMPLETED|Maintenance Study (44 Weeks)||0
10888076|NCT02407236|12054078|FG001|NOT COMPLETED|Maintenance Study (44 Weeks)||0
10888077|NCT02407236|12054079|FG002|NOT COMPLETED|Maintenance Study (44 Weeks)||0
10888078|NCT02407236|12054080|FG003|NOT COMPLETED|Maintenance Study (44 Weeks)||10
10888079|NCT02407236|12054081|FG004|NOT COMPLETED|Maintenance Study (44 Weeks)||11
10888080|NCT02407236|12054082|FG005|NOT COMPLETED|Maintenance Study (44 Weeks)||8
10888081|NCT02407236|12054083|FG006|NOT COMPLETED|Maintenance Study (44 Weeks)||9
10888082|NCT02407236|12054084|FG007|NOT COMPLETED|Maintenance Study (44 Weeks)||8
10888083|NCT02404441|12054112|FG000|STARTED|Phase 1 Part||16
10888084|NCT02404441|12054113|FG001|STARTED|Phase 1 Part||15
10888085|NCT02404441|12054114|FG002|STARTED|Phase 1 Part||11
10888086|NCT02404441|12054115|FG003|STARTED|Phase 1 Part||6
10888087|NCT02404441|12054116|FG004|STARTED|Phase 1 Part||10
10888088|NCT02404441|12054117|FG005|STARTED|Phase 1 Part||0
10888089|NCT02404441|12054118|FG006|STARTED|Phase 1 Part||0
10888090|NCT02404441|12054119|FG007|STARTED|Phase 1 Part||0
10888091|NCT02404441|12054120|FG008|STARTED|Phase 1 Part||0
10888092|NCT02404441|12054121|FG009|STARTED|Phase 1 Part||0
10888093|NCT02404441|12054112|FG000|COMPLETED|Phase 1 Part||0
10888094|NCT02404441|12054113|FG001|COMPLETED|Phase 1 Part||0
10888095|NCT02404441|12054114|FG002|COMPLETED|Phase 1 Part||0
10888096|NCT02404441|12054115|FG003|COMPLETED|Phase 1 Part||0
10888097|NCT02404441|12054116|FG004|COMPLETED|Phase 1 Part||0
10888098|NCT02404441|12054117|FG005|COMPLETED|Phase 1 Part||0
10888099|NCT02404441|12054118|FG006|COMPLETED|Phase 1 Part||0
10888100|NCT02404441|12054119|FG007|COMPLETED|Phase 1 Part||0
10888101|NCT02404441|12054120|FG008|COMPLETED|Phase 1 Part||0
10888102|NCT02404441|12054121|FG009|COMPLETED|Phase 1 Part||0
10888103|NCT02404441|12054112|FG000|NOT COMPLETED|Phase 1 Part||16
10888104|NCT02404441|12054113|FG001|NOT COMPLETED|Phase 1 Part||15
10888105|NCT02404441|12054114|FG002|NOT COMPLETED|Phase 1 Part||11
10888106|NCT02404441|12054115|FG003|NOT COMPLETED|Phase 1 Part||6
10888107|NCT02404441|12054116|FG004|NOT COMPLETED|Phase 1 Part||10
10888108|NCT02404441|12054117|FG005|NOT COMPLETED|Phase 1 Part||0
10888109|NCT02404441|12054118|FG006|NOT COMPLETED|Phase 1 Part||0
10888110|NCT02404441|12054119|FG007|NOT COMPLETED|Phase 1 Part||0
10888111|NCT02404441|12054120|FG008|NOT COMPLETED|Phase 1 Part||0
10888112|NCT02404441|12054121|FG009|NOT COMPLETED|Phase 1 Part||0
10888113|NCT02404441|12054112|FG000|STARTED|Phase 2 Part||0
10888114|NCT02404441|12054113|FG001|STARTED|Phase 2 Part||0
10888115|NCT02404441|12054114|FG002|STARTED|Phase 2 Part||0
10888116|NCT02404441|12054115|FG003|STARTED|Phase 2 Part||0
10888117|NCT02404441|12054116|FG004|STARTED|Phase 2 Part||0
10888118|NCT02404441|12054117|FG005|STARTED|Phase 2 Part||59
10888119|NCT02404441|12054118|FG006|STARTED|Phase 2 Part||61
10888120|NCT02404441|12054119|FG007|STARTED|Phase 2 Part||40
10888121|NCT02404441|12054120|FG008|STARTED|Phase 2 Part||59
10888122|NCT02404441|12054121|FG009|STARTED|Phase 2 Part||42
10888123|NCT02404441|12054112|FG000|Entered Post-treatment Follow-up|Phase 2 Part||0
10888124|NCT02404441|12054113|FG001|Entered Post-treatment Follow-up|Phase 2 Part||0
10888125|NCT02404441|12054114|FG002|Entered Post-treatment Follow-up|Phase 2 Part||0
10888126|NCT02404441|12054115|FG003|Entered Post-treatment Follow-up|Phase 2 Part||0
10888127|NCT02404441|12054116|FG004|Entered Post-treatment Follow-up|Phase 2 Part||0
10888128|NCT02404441|12054117|FG005|Entered Post-treatment Follow-up|Phase 2 Part||2
10888129|NCT02404441|12054118|FG006|Entered Post-treatment Follow-up|Phase 2 Part||6
10888130|NCT02404441|12054119|FG007|Entered Post-treatment Follow-up|Phase 2 Part||1
10888298|NCT02376790|12054291|FG000|COMPLETED|Overall Study||224
10888131|NCT02404441|12054120|FG008|Entered Post-treatment Follow-up|Phase 2 Part||6
10888132|NCT02404441|12054121|FG009|Entered Post-treatment Follow-up|Phase 2 Part||1
10888133|NCT02404441|12054112|FG000|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||0
10888134|NCT02404441|12054113|FG001|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||0
10888135|NCT02404441|12054114|FG002|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||0
10888136|NCT02404441|12054115|FG003|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||0
10888137|NCT02404441|12054116|FG004|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||0
10888138|NCT02404441|12054117|FG005|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||2
10888139|NCT02404441|12054118|FG006|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||6
10888140|NCT02404441|12054119|FG007|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||1
10888141|NCT02404441|12054120|FG008|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||6
10888142|NCT02404441|12054121|FG009|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||1
10888143|NCT02404441|12054112|FG000|Entered Survival Follow-up|Phase 2 Part||0
10888144|NCT02404441|12054113|FG001|Entered Survival Follow-up|Phase 2 Part||0
10888145|NCT02404441|12054114|FG002|Entered Survival Follow-up|Phase 2 Part||0
10888146|NCT02404441|12054115|FG003|Entered Survival Follow-up|Phase 2 Part||0
10888147|NCT02404441|12054116|FG004|Entered Survival Follow-up|Phase 2 Part||0
10888148|NCT02404441|12054117|FG005|Entered Survival Follow-up|Phase 2 Part||38
10888149|NCT02404441|12054118|FG006|Entered Survival Follow-up|Phase 2 Part||34
10888150|NCT02404441|12054119|FG007|Entered Survival Follow-up|Phase 2 Part||26
10888151|NCT02404441|12054120|FG008|Entered Survival Follow-up|Phase 2 Part||35
10888152|NCT02404441|12054121|FG009|Entered Survival Follow-up|Phase 2 Part||25
10888153|NCT02404441|12054112|FG000|COMPLETED|Phase 2 Part||0
10888154|NCT02404441|12054113|FG001|COMPLETED|Phase 2 Part||0
10888155|NCT02404441|12054114|FG002|COMPLETED|Phase 2 Part||0
10888156|NCT02404441|12054115|FG003|COMPLETED|Phase 2 Part||0
10888157|NCT02404441|12054116|FG004|COMPLETED|Phase 2 Part||0
10888158|NCT02404441|12054117|FG005|COMPLETED|Phase 2 Part||0
10888159|NCT02404441|12054118|FG006|COMPLETED|Phase 2 Part||0
10888160|NCT02404441|12054119|FG007|COMPLETED|Phase 2 Part||0
10888161|NCT02404441|12054120|FG008|COMPLETED|Phase 2 Part||0
10888162|NCT02404441|12054121|FG009|COMPLETED|Phase 2 Part||0
10888163|NCT02404441|12054112|FG000|NOT COMPLETED|Phase 2 Part||0
10888164|NCT02404441|12054113|FG001|NOT COMPLETED|Phase 2 Part||0
10888165|NCT02404441|12054114|FG002|NOT COMPLETED|Phase 2 Part||0
10888166|NCT02404441|12054115|FG003|NOT COMPLETED|Phase 2 Part||0
10888167|NCT02404441|12054116|FG004|NOT COMPLETED|Phase 2 Part||0
10888168|NCT02404441|12054117|FG005|NOT COMPLETED|Phase 2 Part||59
10888169|NCT02404441|12054118|FG006|NOT COMPLETED|Phase 2 Part||61
10888170|NCT02404441|12054119|FG007|NOT COMPLETED|Phase 2 Part||40
10888171|NCT02404441|12054120|FG008|NOT COMPLETED|Phase 2 Part||59
10888172|NCT02404441|12054121|FG009|NOT COMPLETED|Phase 2 Part||42
10888173|NCT02403986|12054167|FG000|STARTED|Overall Study||26
10888174|NCT02403986|12054168|FG001|STARTED|Overall Study||27
10888175|NCT02403986|12054167|FG000|COMPLETED|Overall Study||21
10888176|NCT02403986|12054168|FG001|COMPLETED|Overall Study||23
10888177|NCT02403986|12054167|FG000|NOT COMPLETED|Overall Study||5
10888178|NCT02403986|12054168|FG001|NOT COMPLETED|Overall Study||4
10888179|NCT02403778|12054176|FG000|STARTED|Overall Study||6
10888180|NCT02403778|12054177|FG001|STARTED|Overall Study||4
10888181|NCT02403778|12054176|FG000|COMPLETED|Overall Study||6
10888182|NCT02403778|12054177|FG001|COMPLETED|Overall Study||4
10888183|NCT02403778|12054176|FG000|NOT COMPLETED|Overall Study||0
10888184|NCT02403778|12054177|FG001|NOT COMPLETED|Overall Study||0
10888185|NCT02403674|12054185|FG000|STARTED|Overall Study||368
10888186|NCT02403674|12054186|FG001|STARTED|Overall Study||366
10888187|NCT02403674|12054185|FG000|Treated|Overall Study||364
10888188|NCT02403674|12054186|FG001|Treated|Overall Study||364
10888189|NCT02403674|12054185|FG000|COMPLETED|Overall Study||313
10888190|NCT02403674|12054186|FG001|COMPLETED|Overall Study||303
10888191|NCT02403674|12054185|FG000|NOT COMPLETED|Overall Study||55
10888192|NCT02403674|12054186|FG001|NOT COMPLETED|Overall Study||63
10888193|NCT02399449|12054194|FG000|STARTED|Overall Study||25
10888194|NCT02399449|12054195|FG001|STARTED|Overall Study||32
10888195|NCT02399449|12054194|FG000|COMPLETED|Overall Study||22
10888196|NCT02399449|12054195|FG001|COMPLETED|Overall Study||22
10888197|NCT02399449|12054194|FG000|NOT COMPLETED|Overall Study||3
10888198|NCT02399449|12054195|FG001|NOT COMPLETED|Overall Study||10
10888199|NCT02397096|12054203|FG000|STARTED|Day 1 to Week 24||447
10888200|NCT02397096|12054204|FG001|STARTED|Day 1 to Week 24||223
10888201|NCT02397096|12054203|FG000|COMPLETED|Day 1 to Week 24||427
10888202|NCT02397096|12054204|FG001|COMPLETED|Day 1 to Week 24||209
10888203|NCT02397096|12054203|FG000|NOT COMPLETED|Day 1 to Week 24||20
10888204|NCT02397096|12054204|FG001|NOT COMPLETED|Day 1 to Week 24||14
10888205|NCT02397096|12054203|FG000|STARTED|Week 24 to Week 48||427
10888206|NCT02397096|12054204|FG001|STARTED|Week 24 to Week 48||209
10888207|NCT02397096|12054203|FG000|COMPLETED|Week 24 to Week 48||407
10888208|NCT02397096|12054204|FG001|COMPLETED|Week 24 to Week 48||202
10888209|NCT02397096|12054203|FG000|NOT COMPLETED|Week 24 to Week 48||20
10888210|NCT02397096|12054204|FG001|NOT COMPLETED|Week 24 to Week 48||7
10888211|NCT02397096|12054203|FG000|STARTED|Study Extensions|The extension study is optional; not all eligible participants enrolled.|399
10888212|NCT02397096|12054204|FG001|STARTED|Study Extensions|The extension study is optional; not all eligible participants enrolled.|202
10888213|NCT02397096|12054203|FG000|COMPLETED|Study Extensions|The extension study is ongoing.|0
10888299|NCT02376790|12054292|FG001|COMPLETED|Overall Study||237
10888214|NCT02397096|12054204|FG001|COMPLETED|Study Extensions|The extension study is ongoing.|0
10888215|NCT02397096|12054203|FG000|NOT COMPLETED|Study Extensions||399
10888216|NCT02397096|12054204|FG001|NOT COMPLETED|Study Extensions||202
10888217|NCT02396251|12054216|FG000|STARTED|Overall Study||36
10888218|NCT02396251|12054217|FG001|STARTED|Overall Study||12
10888219|NCT02396251|12054216|FG000|COMPLETED|Overall Study||23
10888220|NCT02396251|12054217|FG001|COMPLETED|Overall Study||7
10888221|NCT02396251|12054216|FG000|NOT COMPLETED|Overall Study||13
10888222|NCT02396251|12054217|FG001|NOT COMPLETED|Overall Study||5
10888223|NCT02394769|12054225|FG000|STARTED|Overall Study||60
10888224|NCT02394769|12054226|FG001|STARTED|Overall Study||60
10888225|NCT02394769|12054227|FG002|STARTED|Overall Study||60
10888226|NCT02394769|12054225|FG000|COMPLETED|Overall Study||58
10888227|NCT02394769|12054226|FG001|COMPLETED|Overall Study||57
10888228|NCT02394769|12054227|FG002|COMPLETED|Overall Study||54
10888229|NCT02394769|12054225|FG000|NOT COMPLETED|Overall Study||2
10888230|NCT02394769|12054226|FG001|NOT COMPLETED|Overall Study||3
10888231|NCT02394769|12054227|FG002|NOT COMPLETED|Overall Study||6
10888232|NCT02393859|12054237|FG000|STARTED|Overall Study||54
10888233|NCT02393859|12054238|FG001|STARTED|Overall Study||54
10888234|NCT02393859|12054237|FG000|COMPLETED|Overall Study||0
10888235|NCT02393859|12054238|FG001|COMPLETED|Overall Study||0
10888236|NCT02393859|12054237|FG000|NOT COMPLETED|Overall Study||54
10888237|NCT02393859|12054238|FG001|NOT COMPLETED|Overall Study||54
10888238|NCT02393690|12054247|FG000|STARTED|Overall Study||29
10888239|NCT02393690|12054248|FG001|STARTED|Overall Study||31
10888240|NCT02393690|12054247|FG000|COMPLETED|Overall Study||29
10888241|NCT02393690|12054248|FG001|COMPLETED|Overall Study||31
10888242|NCT02393690|12054247|FG000|NOT COMPLETED|Overall Study||0
10888243|NCT02393690|12054248|FG001|NOT COMPLETED|Overall Study||0
10888244|NCT02390323|12054254|FG000|STARTED|Overall Study||13
10888245|NCT02390323|12054254|FG000|COMPLETED|Overall Study||13
10888246|NCT02390323|12054254|FG000|NOT COMPLETED|Overall Study||0
10888247|NCT02390245|12054259|FG000|STARTED|Phase I. Telemedicine Screening||906
10888248|NCT02390245|12054260|FG001|STARTED|Phase I. Telemedicine Screening||0
10888249|NCT02390245|12054261|FG002|STARTED|Phase I. Telemedicine Screening||0
10888250|NCT02390245|12054259|FG000|COMPLETED|Phase I. Telemedicine Screening||906
10888251|NCT02390245|12054260|FG001|COMPLETED|Phase I. Telemedicine Screening||0
10888252|NCT02390245|12054261|FG002|COMPLETED|Phase I. Telemedicine Screening||0
10888253|NCT02390245|12054259|FG000|NOT COMPLETED|Phase I. Telemedicine Screening||0
10888254|NCT02390245|12054260|FG001|NOT COMPLETED|Phase I. Telemedicine Screening||0
10888255|NCT02390245|12054261|FG002|NOT COMPLETED|Phase I. Telemedicine Screening||0
10888256|NCT02390245|12054259|FG000|STARTED|Phase 2. Randomization Into 2 Groups|Remaining 355 participants from Phase I Telemedicine Screening had normal eye examinations requiring no further follow-up.|0
10888257|NCT02390245|12054260|FG001|STARTED|Phase 2. Randomization Into 2 Groups||275
10888258|NCT02390245|12054261|FG002|STARTED|Phase 2. Randomization Into 2 Groups||276
10888259|NCT02390245|12054259|FG000|COMPLETED|Phase 2. Randomization Into 2 Groups||0
10888260|NCT02390245|12054260|FG001|COMPLETED|Phase 2. Randomization Into 2 Groups||172
10888261|NCT02390245|12054261|FG002|COMPLETED|Phase 2. Randomization Into 2 Groups||172
10888262|NCT02390245|12054259|FG000|NOT COMPLETED|Phase 2. Randomization Into 2 Groups||0
10888263|NCT02390245|12054260|FG001|NOT COMPLETED|Phase 2. Randomization Into 2 Groups||103
10888264|NCT02390245|12054261|FG002|NOT COMPLETED|Phase 2. Randomization Into 2 Groups||104
10888265|NCT02390245|12054259|FG000|STARTED|Phase 3. Ophthalmic Follow-up Adherence||0
10888266|NCT02390245|12054260|FG001|STARTED|Phase 3. Ophthalmic Follow-up Adherence||172
10888267|NCT02390245|12054261|FG002|STARTED|Phase 3. Ophthalmic Follow-up Adherence||172
10888268|NCT02390245|12054259|FG000|COMPLETED|Phase 3. Ophthalmic Follow-up Adherence||0
10888269|NCT02390245|12054260|FG001|COMPLETED|Phase 3. Ophthalmic Follow-up Adherence||77
10888270|NCT02390245|12054261|FG002|COMPLETED|Phase 3. Ophthalmic Follow-up Adherence||66
10888271|NCT02390245|12054259|FG000|NOT COMPLETED|Phase 3. Ophthalmic Follow-up Adherence||0
10888272|NCT02390245|12054260|FG001|NOT COMPLETED|Phase 3. Ophthalmic Follow-up Adherence||95
10888273|NCT02390245|12054261|FG002|NOT COMPLETED|Phase 3. Ophthalmic Follow-up Adherence||106
10888274|NCT02389946|12054272|FG000|STARTED|Overall Study||884
10888275|NCT02389946|12054273|FG001|STARTED|Overall Study||450
10888276|NCT02389946|12054272|FG000|COMPLETED|Overall Study||860
10888277|NCT02389946|12054273|FG001|COMPLETED|Overall Study||435
10888278|NCT02389946|12054272|FG000|NOT COMPLETED|Overall Study||24
10888279|NCT02389946|12054273|FG001|NOT COMPLETED|Overall Study||15
10888280|NCT02388906|12054281|FG000|STARTED|Pre-Treatment Period||453
10888281|NCT02388906|12054282|FG001|STARTED|Pre-Treatment Period||453
10888282|NCT02388906|12054281|FG000|COMPLETED|Pre-Treatment Period||452
10888283|NCT02388906|12054282|FG001|COMPLETED|Pre-Treatment Period||453
10888284|NCT02388906|12054281|FG000|NOT COMPLETED|Pre-Treatment Period||1
10888285|NCT02388906|12054282|FG001|NOT COMPLETED|Pre-Treatment Period||0
10888286|NCT02388906|12054281|FG000|STARTED|Treatment Period||452
10888287|NCT02388906|12054282|FG001|STARTED|Treatment Period||453
10888288|NCT02388906|12054281|FG000|COMPLETED|Treatment Period||275
10888289|NCT02388906|12054282|FG001|COMPLETED|Treatment Period||122
10888290|NCT02388906|12054281|FG000|NOT COMPLETED|Treatment Period||177
10888291|NCT02388906|12054282|FG001|NOT COMPLETED|Treatment Period||331
10888292|NCT02376790|12054291|FG000|STARTED|Overall Study||284
10888293|NCT02376790|12054292|FG001|STARTED|Overall Study||284
10888294|NCT02376790|12054293|FG002|STARTED|Overall Study||283
10888295|NCT02376790|12054291|FG000|Received Treatment|Overall Study||282
10888296|NCT02376790|12054292|FG001|Received Treatment|Overall Study||284
10888297|NCT02376790|12054293|FG002|Received Treatment|Overall Study||282
10888300|NCT02376790|12054293|FG002|COMPLETED|Overall Study||230
10888301|NCT02376790|12054291|FG000|NOT COMPLETED|Overall Study||60
10888302|NCT02376790|12054292|FG001|NOT COMPLETED|Overall Study||47
10888303|NCT02376790|12054293|FG002|NOT COMPLETED|Overall Study||53
10888304|NCT02372877|12054301|FG000|STARTED|Overall Study||83
10888305|NCT02372877|12054301|FG000|COMPLETED|Overall Study||59
10888306|NCT02372877|12054301|FG000|NOT COMPLETED|Overall Study||24
10888307|NCT02370914|12054305|FG000|STARTED|Overall Study||84
10888308|NCT02370914|12054305|FG000|COMPLETED|Overall Study||82
10888309|NCT02370914|12054305|FG000|NOT COMPLETED|Overall Study||2
10888310|NCT02370238|12054311|FG000|STARTED|Overall Study||62
10888311|NCT02370238|12054312|FG001|STARTED|Overall Study||61
10888312|NCT02370238|12054311|FG000|ITT Population|Overall Study||62
10888313|NCT02370238|12054312|FG001|ITT Population|Overall Study||61
10888314|NCT02370238|12054311|FG000|Safety Population|Overall Study||61
10888315|NCT02370238|12054312|FG001|Safety Population|Overall Study||60
10888316|NCT02370238|12054311|FG000|Responsable-evaluable Population|Overall Study||57
10888317|NCT02370238|12054312|FG001|Responsable-evaluable Population|Overall Study||54
10888318|NCT02370238|12054311|FG000|COMPLETED|Overall Study||15
10888319|NCT02370238|12054312|FG001|COMPLETED|Overall Study||16
10888320|NCT02370238|12054311|FG000|NOT COMPLETED|Overall Study||47
10888321|NCT02370238|12054312|FG001|NOT COMPLETED|Overall Study||45
10888322|NCT02369484|12054322|FG000|STARTED|Overall Study||13
10888323|NCT02369484|12054322|FG000|COMPLETED|Overall Study||13
10888324|NCT02369484|12054322|FG000|NOT COMPLETED|Overall Study||0
10888325|NCT02367040|12054328|FG000|STARTED|Overall Study||307
10888326|NCT02367040|12054329|FG001|STARTED|Overall Study||151
10888327|NCT02367040|12054328|FG000|Received Treatment|Overall Study||304
10888328|NCT02367040|12054329|FG001|Received Treatment|Overall Study||149
10888329|NCT02367040|12054328|FG000|COMPLETED|Overall Study||70
10888330|NCT02367040|12054329|FG001|COMPLETED|Overall Study||29
10888331|NCT02367040|12054328|FG000|NOT COMPLETED|Overall Study||237
10888332|NCT02367040|12054329|FG001|NOT COMPLETED|Overall Study||122
10888333|NCT02362594|12054337|FG000|STARTED|Overall Study||514
10888334|NCT02362594|12054338|FG001|STARTED|Overall Study||505
10888335|NCT02362594|12054337|FG000|Treated|Overall Study||509
10888336|NCT02362594|12054338|FG001|Treated|Overall Study||502
10888337|NCT02362594|12054337|FG000|Continuing Part 1 Adjuvant Therapy|Overall Study||41
10888338|NCT02362594|12054338|FG001|Continuing Part 1 Adjuvant Therapy|Overall Study||21
10888339|NCT02362594|12054337|FG000|COMPLETED|Overall Study||264
10888340|NCT02362594|12054338|FG001|COMPLETED|Overall Study||280
10888341|NCT02362594|12054337|FG000|NOT COMPLETED|Overall Study||250
10888342|NCT02362594|12054338|FG001|NOT COMPLETED|Overall Study||225
10888343|NCT02362503|12054347|FG000|STARTED|Double-blind Period-Up to 8 Days||69
10888344|NCT02362503|12054348|FG001|STARTED|Double-blind Period-Up to 8 Days||203
10888345|NCT02362503|12054349|FG002|STARTED|Double-blind Period-Up to 8 Days||0
10888346|NCT02362503|12054347|FG000|COMPLETED|Double-blind Period-Up to 8 Days||68
10888347|NCT02362503|12054348|FG001|COMPLETED|Double-blind Period-Up to 8 Days||199
10888348|NCT02362503|12054349|FG002|COMPLETED|Double-blind Period-Up to 8 Days||0
10888349|NCT02362503|12054347|FG000|NOT COMPLETED|Double-blind Period-Up to 8 Days||1
10888350|NCT02362503|12054348|FG001|NOT COMPLETED|Double-blind Period-Up to 8 Days||4
10888351|NCT02362503|12054349|FG002|NOT COMPLETED|Double-blind Period-Up to 8 Days||0
10888352|NCT02362503|12054347|FG000|STARTED|Open Label Period-Up to 96 Weeks||68
10888353|NCT02362503|12054348|FG001|STARTED|Open Label Period-Up to 96 Weeks||199
10888354|NCT02362503|12054349|FG002|STARTED|Open Label Period-Up to 96 Weeks||99
10888355|NCT02362503|12054347|FG000|COMPLETED|Open Label Period-Up to 96 Weeks||0
10888356|NCT02362503|12054348|FG001|COMPLETED|Open Label Period-Up to 96 Weeks||0
10888357|NCT02362503|12054349|FG002|COMPLETED|Open Label Period-Up to 96 Weeks||0
10888358|NCT02362503|12054347|FG000|NOT COMPLETED|Open Label Period-Up to 96 Weeks||68
10888359|NCT02362503|12054348|FG001|NOT COMPLETED|Open Label Period-Up to 96 Weeks||199
10888360|NCT02362503|12054349|FG002|NOT COMPLETED|Open Label Period-Up to 96 Weeks||99
10888361|NCT02362464|12054360|FG000|STARTED|Overall Study||14
10888362|NCT02362464|12054360|FG000|COMPLETED|Overall Study||8
10888363|NCT02362464|12054360|FG000|NOT COMPLETED|Overall Study||6
10888364|NCT02361346|12054373|FG000|STARTED|Part 1 and 2 ( Up to Day 112)||3
10888365|NCT02361346|12054374|FG001|STARTED|Part 1 and 2 ( Up to Day 112)||3
10888366|NCT02361346|12054375|FG002|STARTED|Part 1 and 2 ( Up to Day 112)||3
10888367|NCT02361346|12054376|FG003|STARTED|Part 1 and 2 ( Up to Day 112)||4
10888368|NCT02361346|12054377|FG004|STARTED|Part 1 and 2 ( Up to Day 112)||2
10888369|NCT02361346|12054378|FG005|STARTED|Part 1 and 2 ( Up to Day 112)||6
10888370|NCT02361346|12054379|FG006|STARTED|Part 1 and 2 ( Up to Day 112)||6
10888371|NCT02361346|12054380|FG007|STARTED|Part 1 and 2 ( Up to Day 112)||0
10888372|NCT02361346|12054381|FG008|STARTED|Part 1 and 2 ( Up to Day 112)||0
10888373|NCT02361346|12054373|FG000|COMPLETED|Part 1 and 2 ( Up to Day 112)||3
10888374|NCT02361346|12054374|FG001|COMPLETED|Part 1 and 2 ( Up to Day 112)||3
10888375|NCT02361346|12054375|FG002|COMPLETED|Part 1 and 2 ( Up to Day 112)||3
10888376|NCT02361346|12054376|FG003|COMPLETED|Part 1 and 2 ( Up to Day 112)||3
10888377|NCT02361346|12054377|FG004|COMPLETED|Part 1 and 2 ( Up to Day 112)||0
10888378|NCT02361346|12054378|FG005|COMPLETED|Part 1 and 2 ( Up to Day 112)||6
10888379|NCT02361346|12054379|FG006|COMPLETED|Part 1 and 2 ( Up to Day 112)||6
10888380|NCT02361346|12054380|FG007|COMPLETED|Part 1 and 2 ( Up to Day 112)||0
10888381|NCT02361346|12054381|FG008|COMPLETED|Part 1 and 2 ( Up to Day 112)||0
10888382|NCT02361346|12054373|FG000|NOT COMPLETED|Part 1 and 2 ( Up to Day 112)||0
10888383|NCT02361346|12054374|FG001|NOT COMPLETED|Part 1 and 2 ( Up to Day 112)||0
10888384|NCT02361346|12054375|FG002|NOT COMPLETED|Part 1 and 2 ( Up to Day 112)||0
10888385|NCT02361346|12054376|FG003|NOT COMPLETED|Part 1 and 2 ( Up to Day 112)||1
10888386|NCT02361346|12054377|FG004|NOT COMPLETED|Part 1 and 2 ( Up to Day 112)||2
10888387|NCT02361346|12054378|FG005|NOT COMPLETED|Part 1 and 2 ( Up to Day 112)||0
10888388|NCT02361346|12054379|FG006|NOT COMPLETED|Part 1 and 2 ( Up to Day 112)||0
10888389|NCT02361346|12054380|FG007|NOT COMPLETED|Part 1 and 2 ( Up to Day 112)||0
10888390|NCT02361346|12054381|FG008|NOT COMPLETED|Part 1 and 2 ( Up to Day 112)||0
10888391|NCT02361346|12054373|FG000|STARTED|Part 3 (Up to Day 112)||0
10888392|NCT02361346|12054374|FG001|STARTED|Part 3 (Up to Day 112)||0
10888393|NCT02361346|12054375|FG002|STARTED|Part 3 (Up to Day 112)||0
10888394|NCT02361346|12054376|FG003|STARTED|Part 3 (Up to Day 112)||0
10888395|NCT02361346|12054377|FG004|STARTED|Part 3 (Up to Day 112)||0
10888396|NCT02361346|12054378|FG005|STARTED|Part 3 (Up to Day 112)||0
10888397|NCT02361346|12054379|FG006|STARTED|Part 3 (Up to Day 112)||0
10888398|NCT02361346|12054380|FG007|STARTED|Part 3 (Up to Day 112)||11
10888399|NCT02361346|12054381|FG008|STARTED|Part 3 (Up to Day 112)||0
10888400|NCT02361346|12054373|FG000|COMPLETED|Part 3 (Up to Day 112)||0
10888401|NCT02361346|12054374|FG001|COMPLETED|Part 3 (Up to Day 112)||0
10888402|NCT02361346|12054375|FG002|COMPLETED|Part 3 (Up to Day 112)||0
10888403|NCT02361346|12054376|FG003|COMPLETED|Part 3 (Up to Day 112)||0
10888404|NCT02361346|12054377|FG004|COMPLETED|Part 3 (Up to Day 112)||0
10888405|NCT02361346|12054378|FG005|COMPLETED|Part 3 (Up to Day 112)||0
10888406|NCT02361346|12054379|FG006|COMPLETED|Part 3 (Up to Day 112)||0
10888407|NCT02361346|12054380|FG007|COMPLETED|Part 3 (Up to Day 112)||0
10888408|NCT02361346|12054381|FG008|COMPLETED|Part 3 (Up to Day 112)||0
10888409|NCT02361346|12054373|FG000|NOT COMPLETED|Part 3 (Up to Day 112)||0
10888410|NCT02361346|12054374|FG001|NOT COMPLETED|Part 3 (Up to Day 112)||0
10888411|NCT02361346|12054375|FG002|NOT COMPLETED|Part 3 (Up to Day 112)||0
10888412|NCT02361346|12054376|FG003|NOT COMPLETED|Part 3 (Up to Day 112)||0
10888413|NCT02361346|12054377|FG004|NOT COMPLETED|Part 3 (Up to Day 112)||0
10888414|NCT02361346|12054378|FG005|NOT COMPLETED|Part 3 (Up to Day 112)||0
10888415|NCT02361346|12054379|FG006|NOT COMPLETED|Part 3 (Up to Day 112)||0
10888416|NCT02361346|12054380|FG007|NOT COMPLETED|Part 3 (Up to Day 112)||11
10888417|NCT02361346|12054381|FG008|NOT COMPLETED|Part 3 (Up to Day 112)||0
10888418|NCT02361346|12054373|FG000|STARTED|Part 4 (Up to Day 112)||0
10888419|NCT02361346|12054374|FG001|STARTED|Part 4 (Up to Day 112)||0
10888420|NCT02361346|12054375|FG002|STARTED|Part 4 (Up to Day 112)||0
10888421|NCT02361346|12054376|FG003|STARTED|Part 4 (Up to Day 112)||0
10888422|NCT02361346|12054377|FG004|STARTED|Part 4 (Up to Day 112)||0
10888423|NCT02361346|12054378|FG005|STARTED|Part 4 (Up to Day 112)||0
10888424|NCT02361346|12054379|FG006|STARTED|Part 4 (Up to Day 112)||0
10888425|NCT02361346|12054380|FG007|STARTED|Part 4 (Up to Day 112)||0
10888426|NCT02361346|12054381|FG008|STARTED|Part 4 (Up to Day 112)||0
10888427|NCT02361346|12054373|FG000|COMPLETED|Part 4 (Up to Day 112)||0
10888428|NCT02361346|12054374|FG001|COMPLETED|Part 4 (Up to Day 112)||0
10888429|NCT02361346|12054375|FG002|COMPLETED|Part 4 (Up to Day 112)||0
10888430|NCT02361346|12054376|FG003|COMPLETED|Part 4 (Up to Day 112)||0
10888431|NCT02361346|12054377|FG004|COMPLETED|Part 4 (Up to Day 112)||0
10888432|NCT02361346|12054378|FG005|COMPLETED|Part 4 (Up to Day 112)||0
10888433|NCT02361346|12054379|FG006|COMPLETED|Part 4 (Up to Day 112)||0
10888434|NCT02361346|12054380|FG007|COMPLETED|Part 4 (Up to Day 112)||0
10888435|NCT02361346|12054381|FG008|COMPLETED|Part 4 (Up to Day 112)||0
10888436|NCT02361346|12054373|FG000|NOT COMPLETED|Part 4 (Up to Day 112)||0
10888437|NCT02361346|12054374|FG001|NOT COMPLETED|Part 4 (Up to Day 112)||0
10888438|NCT02361346|12054375|FG002|NOT COMPLETED|Part 4 (Up to Day 112)||0
10888439|NCT02361346|12054376|FG003|NOT COMPLETED|Part 4 (Up to Day 112)||0
10888440|NCT02361346|12054377|FG004|NOT COMPLETED|Part 4 (Up to Day 112)||0
10888441|NCT02361346|12054378|FG005|NOT COMPLETED|Part 4 (Up to Day 112)||0
10888442|NCT02361346|12054379|FG006|NOT COMPLETED|Part 4 (Up to Day 112)||0
10888443|NCT02361346|12054380|FG007|NOT COMPLETED|Part 4 (Up to Day 112)||0
10888444|NCT02361346|12054381|FG008|NOT COMPLETED|Part 4 (Up to Day 112)||0
10888445|NCT02358538|12054427|FG000|STARTED|Through Week 26||7
10888446|NCT02358538|12054428|FG001|STARTED|Through Week 26||2
10888447|NCT02358538|12054429|FG002|STARTED|Through Week 26||10
10888448|NCT02358538|12054430|FG003|STARTED|Through Week 26||11
10888449|NCT02358538|12054427|FG000|COMPLETED|Through Week 26||4
10888450|NCT02358538|12054428|FG001|COMPLETED|Through Week 26||0
10888451|NCT02358538|12054429|FG002|COMPLETED|Through Week 26||5
10888452|NCT02358538|12054430|FG003|COMPLETED|Through Week 26||6
10888453|NCT02358538|12054427|FG000|NOT COMPLETED|Through Week 26||3
10888454|NCT02358538|12054428|FG001|NOT COMPLETED|Through Week 26||2
10888455|NCT02358538|12054429|FG002|NOT COMPLETED|Through Week 26||5
10888456|NCT02358538|12054430|FG003|NOT COMPLETED|Through Week 26||5
10888457|NCT02358538|12054427|FG000|STARTED|52 Week Extension Period||4
10888458|NCT02358538|12054428|FG001|STARTED|52 Week Extension Period||0
10888459|NCT02358538|12054429|FG002|STARTED|52 Week Extension Period||4
10888460|NCT02358538|12054430|FG003|STARTED|52 Week Extension Period||6
10888461|NCT02358538|12054427|FG000|COMPLETED|52 Week Extension Period||4
10888462|NCT02358538|12054428|FG001|COMPLETED|52 Week Extension Period||0
10888463|NCT02358538|12054429|FG002|COMPLETED|52 Week Extension Period||2
10888464|NCT02358538|12054430|FG003|COMPLETED|52 Week Extension Period||2
10888465|NCT02358538|12054427|FG000|NOT COMPLETED|52 Week Extension Period||0
10888466|NCT02358538|12054428|FG001|NOT COMPLETED|52 Week Extension Period||0
10888467|NCT02358538|12054429|FG002|NOT COMPLETED|52 Week Extension Period||2
10888468|NCT02358538|12054430|FG003|NOT COMPLETED|52 Week Extension Period||4
10888469|NCT02358031|12054447|FG000|STARTED|Overall Study||301
10888470|NCT02358031|12054448|FG001|STARTED|Overall Study||281
10888471|NCT02358031|12054449|FG002|STARTED|Overall Study||300
10888472|NCT02358031|12054447|FG000|Treated|Overall Study||300
10888473|NCT02358031|12054448|FG001|Treated|Overall Study||276
10888474|NCT02358031|12054449|FG002|Treated|Overall Study||287
10888475|NCT02358031|12054447|FG000|Pembro Mono v Control Efficacy Analyses|Overall Study||301
10888476|NCT02358031|12054448|FG001|Pembro Mono v Control Efficacy Analyses|Overall Study||0
10888477|NCT02358031|12054449|FG002|Pembro Mono v Control Efficacy Analyses|Overall Study||300
10888478|NCT02358031|12054447|FG000|Pembro Combo v Control Efficacy Analyses|Overall Study||0
10888479|NCT02358031|12054448|FG001|Pembro Combo v Control Efficacy Analyses|Overall Study||281
10888480|NCT02358031|12054449|FG002|Pembro Combo v Control Efficacy Analyses|Overall Study||278
10888481|NCT02358031|12054447|FG000|COMPLETED|Overall Study||0
10888482|NCT02358031|12054448|FG001|COMPLETED|Overall Study||0
10888483|NCT02358031|12054449|FG002|COMPLETED|Overall Study||0
10888484|NCT02358031|12054447|FG000|NOT COMPLETED|Overall Study||301
10888485|NCT02358031|12054448|FG001|NOT COMPLETED|Overall Study||281
10888486|NCT02358031|12054449|FG002|NOT COMPLETED|Overall Study||300
10888487|NCT02354820|12054459|FG000|STARTED|Overall Study||9667
10888488|NCT02354820|12054460|FG001|STARTED|Overall Study||6597
10888489|NCT02354820|12054459|FG000|COMPLETED|Overall Study||9667
10888490|NCT02354820|12054460|FG001|COMPLETED|Overall Study||6597
10888491|NCT02354820|12054459|FG000|NOT COMPLETED|Overall Study||0
10888492|NCT02354820|12054460|FG001|NOT COMPLETED|Overall Study||0
10888493|NCT02354586|12054466|FG000|STARTED|Overall Study||463
10888494|NCT02354586|12054466|FG000|COMPLETED|Overall Study||0
10888495|NCT02354586|12054466|FG000|NOT COMPLETED|Overall Study||463
10888496|NCT02354118|12054472|FG000|STARTED|Overall Study||222
10888497|NCT02354118|12054473|FG001|STARTED|Overall Study||214
10888498|NCT02354118|12054472|FG000|COMPLETED|Overall Study||222
10888499|NCT02354118|12054473|FG001|COMPLETED|Overall Study||214
10888500|NCT02354118|12054472|FG000|NOT COMPLETED|Overall Study||0
10888501|NCT02354118|12054473|FG001|NOT COMPLETED|Overall Study||0
10888502|NCT02353871|12054481|FG000|STARTED|Overall Study|Randomised.|125
10888503|NCT02353871|12054482|FG001|STARTED|Overall Study|Randomised. Included a subject who was randomised by mistake (excluded from mITT population).|60
10888504|NCT02353871|12054481|FG000|COMPLETED|Overall Study||122
10888505|NCT02353871|12054482|FG001|COMPLETED|Overall Study||51
10888506|NCT02353871|12054481|FG000|NOT COMPLETED|Overall Study||3
10888507|NCT02353871|12054482|FG001|NOT COMPLETED|Overall Study||9
10888508|NCT02352090|12054491|FG000|STARTED|Overall Study||20
10888509|NCT02352090|12054492|FG001|STARTED|Overall Study||20
10888510|NCT02352090|12054493|FG002|STARTED|Overall Study||19
10888511|NCT02352090|12054491|FG000|COMPLETED|Overall Study||19
10888512|NCT02352090|12054492|FG001|COMPLETED|Overall Study||20
10888513|NCT02352090|12054493|FG002|COMPLETED|Overall Study||17
10888514|NCT02352090|12054491|FG000|NOT COMPLETED|Overall Study||1
10888515|NCT02352090|12054492|FG001|NOT COMPLETED|Overall Study||0
10888516|NCT02352090|12054493|FG002|NOT COMPLETED|Overall Study||2
10888517|NCT02348008|12054503|FG000|STARTED|Overall Study||3
10888518|NCT02348008|12054504|FG001|STARTED|Overall Study||10
10888519|NCT02348008|12054505|FG002|STARTED|Overall Study||48
10888520|NCT02348008|12054503|FG000|COMPLETED|Overall Study||0
10888521|NCT02348008|12054504|FG001|COMPLETED|Overall Study||0
10888522|NCT02348008|12054505|FG002|COMPLETED|Overall Study||29
10888523|NCT02348008|12054503|FG000|NOT COMPLETED|Overall Study||3
10888524|NCT02348008|12054504|FG001|NOT COMPLETED|Overall Study||10
10888525|NCT02348008|12054505|FG002|NOT COMPLETED|Overall Study||19
10888526|NCT02347527|12054515|FG000|STARTED|Overall Study||25
10888527|NCT02347527|12054516|FG001|STARTED|Overall Study||22
10888528|NCT02347527|12054517|FG002|STARTED|Overall Study||23
10888529|NCT02347527|12054518|FG003|STARTED|Overall Study||22
10888530|NCT02347527|12054515|FG000|Completed Intervention|Overall Study||24
10888531|NCT02347527|12054516|FG001|Completed Intervention|Overall Study||21
10888532|NCT02347527|12054517|FG002|Completed Intervention|Overall Study||23
10888533|NCT02347527|12054518|FG003|Completed Intervention|Overall Study||22
10888534|NCT02347527|12054515|FG000|Included in Analyses|Overall Study||22
10888535|NCT02347527|12054516|FG001|Included in Analyses|Overall Study||19
10888536|NCT02347527|12054517|FG002|Included in Analyses|Overall Study||22
10888537|NCT02347527|12054518|FG003|Included in Analyses|Overall Study||20
10888538|NCT02347527|12054515|FG000|COMPLETED|Overall Study||22
10888539|NCT02347527|12054516|FG001|COMPLETED|Overall Study||19
10888540|NCT02347527|12054517|FG002|COMPLETED|Overall Study||22
10888541|NCT02347527|12054518|FG003|COMPLETED|Overall Study||20
10888542|NCT02347527|12054515|FG000|NOT COMPLETED|Overall Study||3
10888543|NCT02347527|12054516|FG001|NOT COMPLETED|Overall Study||3
10888544|NCT02347527|12054517|FG002|NOT COMPLETED|Overall Study||1
10888545|NCT02347527|12054518|FG003|NOT COMPLETED|Overall Study||2
10888546|NCT02341625|12054540|FG000|STARTED|Overall Study||2
10888547|NCT02341625|12054541|FG001|STARTED|Overall Study||2
10888548|NCT02341625|12054542|FG002|STARTED|Overall Study||3
10888549|NCT02341625|12054543|FG003|STARTED|Overall Study||8
10888550|NCT02341625|12054544|FG004|STARTED|Overall Study||8
10888551|NCT02341625|12054545|FG005|STARTED|Overall Study||10
10888552|NCT02341625|12054546|FG006|STARTED|Overall Study||51
10888553|NCT02341625|12054547|FG007|STARTED|Overall Study||8
10888554|NCT02341625|12054548|FG008|STARTED|Overall Study||4
10888555|NCT02341625|12054549|FG009|STARTED|Overall Study||30
10888556|NCT02341625|12054540|FG000|COMPLETED|Overall Study||0
10888557|NCT02341625|12054541|FG001|COMPLETED|Overall Study||0
10888558|NCT02341625|12054542|FG002|COMPLETED|Overall Study||0
10888559|NCT02341625|12054543|FG003|COMPLETED|Overall Study||0
10888560|NCT02341625|12054544|FG004|COMPLETED|Overall Study||0
10888561|NCT02341625|12054545|FG005|COMPLETED|Overall Study||0
10888562|NCT02341625|12054546|FG006|COMPLETED|Overall Study||0
10888563|NCT02341625|12054547|FG007|COMPLETED|Overall Study||0
10888564|NCT02341625|12054548|FG008|COMPLETED|Overall Study||0
10888565|NCT02341625|12054549|FG009|COMPLETED|Overall Study||0
10888566|NCT02341625|12054540|FG000|NOT COMPLETED|Overall Study||2
10888567|NCT02341625|12054541|FG001|NOT COMPLETED|Overall Study||2
10888568|NCT02341625|12054542|FG002|NOT COMPLETED|Overall Study||3
10888569|NCT02341625|12054543|FG003|NOT COMPLETED|Overall Study||8
10888570|NCT02341625|12054544|FG004|NOT COMPLETED|Overall Study||8
10888571|NCT02341625|12054545|FG005|NOT COMPLETED|Overall Study||10
10888572|NCT02341625|12054546|FG006|NOT COMPLETED|Overall Study||51
10888573|NCT02341625|12054547|FG007|NOT COMPLETED|Overall Study||8
10888574|NCT02341625|12054548|FG008|NOT COMPLETED|Overall Study||4
10888575|NCT02341625|12054549|FG009|NOT COMPLETED|Overall Study||30
10888576|NCT02335424|12054594|FG000|STARTED|Overall Study||374
10888577|NCT02335424|12054594|FG000|Treated|Overall Study||370
10888578|NCT02335424|12054594|FG000|COMPLETED|Overall Study||0
10888579|NCT02335424|12054594|FG000|NOT COMPLETED|Overall Study||374
10888580|NCT02335411|12054601|FG000|STARTED|Overall Study||259
10888581|NCT02335411|12054602|FG001|STARTED|Overall Study||25
10888582|NCT02335411|12054603|FG002|STARTED|Overall Study||31
10888583|NCT02335411|12054601|FG000|Second Course Pembrolizumab|Overall Study||3
10888584|NCT02335411|12054602|FG001|Second Course Pembrolizumab|Overall Study||1
10888585|NCT02335411|12054603|FG002|Second Course Pembrolizumab|Overall Study||2
10888586|NCT02335411|12054601|FG000|COMPLETED|Overall Study||0
10888587|NCT02335411|12054602|FG001|COMPLETED|Overall Study||0
10888588|NCT02335411|12054603|FG002|COMPLETED|Overall Study||0
10888589|NCT02335411|12054601|FG000|NOT COMPLETED|Overall Study||259
10888590|NCT02335411|12054602|FG001|NOT COMPLETED|Overall Study||25
10888591|NCT02335411|12054603|FG002|NOT COMPLETED|Overall Study||31
10888592|NCT02328105|12054614|FG000|STARTED|Overall Study||11
10888593|NCT02328105|12054614|FG000|COMPLETED|Overall Study||0
10888594|NCT02328105|12054614|FG000|NOT COMPLETED|Overall Study||11
10888595|NCT02323698|12054618|FG000|STARTED|Overall Study||2
10888596|NCT02323698|12054619|FG001|STARTED|Overall Study||2
10888597|NCT02323698|12054620|FG002|STARTED|Overall Study||2
10888598|NCT02323698|12054621|FG003|STARTED|Overall Study||2
10888599|NCT02323698|12054622|FG004|STARTED|Overall Study||2
10888600|NCT02323698|12054623|FG005|STARTED|Overall Study||2
10888601|NCT02323698|12054618|FG000|Completed First Intervention (5 Days)|Overall Study||2
10888602|NCT02323698|12054619|FG001|Completed First Intervention (5 Days)|Overall Study||2
10888603|NCT02323698|12054620|FG002|Completed First Intervention (5 Days)|Overall Study||2
10888604|NCT02323698|12054621|FG003|Completed First Intervention (5 Days)|Overall Study||2
10888605|NCT02323698|12054622|FG004|Completed First Intervention (5 Days)|Overall Study||2
10888606|NCT02323698|12054623|FG005|Completed First Intervention (5 Days)|Overall Study||2
10888607|NCT02323698|12054618|FG000|Completed Second Intervention (5 Days)|Overall Study||2
10888608|NCT02323698|12054619|FG001|Completed Second Intervention (5 Days)|Overall Study||2
10888609|NCT02323698|12054620|FG002|Completed Second Intervention (5 Days)|Overall Study||1
10888610|NCT02323698|12054621|FG003|Completed Second Intervention (5 Days)|Overall Study||2
10888611|NCT02323698|12054622|FG004|Completed Second Intervention (5 Days)|Overall Study||2
10888612|NCT02323698|12054623|FG005|Completed Second Intervention (5 Days)|Overall Study||2
10888613|NCT02323698|12054618|FG000|Completed Third Intervention (5 Days)|Overall Study||2
10888614|NCT02323698|12054619|FG001|Completed Third Intervention (5 Days)|Overall Study||2
10888615|NCT02323698|12054620|FG002|Completed Third Intervention (5 Days)|Overall Study||0
10888616|NCT02323698|12054621|FG003|Completed Third Intervention (5 Days)|Overall Study||2
10888617|NCT02323698|12054622|FG004|Completed Third Intervention (5 Days)|Overall Study||1
10888618|NCT02323698|12054623|FG005|Completed Third Intervention (5 Days)|Overall Study||2
10888619|NCT02323698|12054618|FG000|COMPLETED|Overall Study||2
10888620|NCT02323698|12054619|FG001|COMPLETED|Overall Study||2
10888621|NCT02323698|12054620|FG002|COMPLETED|Overall Study||0
10888622|NCT02323698|12054621|FG003|COMPLETED|Overall Study||2
10888623|NCT02323698|12054622|FG004|COMPLETED|Overall Study||1
10888624|NCT02323698|12054623|FG005|COMPLETED|Overall Study||2
10888625|NCT02323698|12054618|FG000|NOT COMPLETED|Overall Study||0
10888626|NCT02323698|12054619|FG001|NOT COMPLETED|Overall Study||0
10888627|NCT02323698|12054620|FG002|NOT COMPLETED|Overall Study||2
10888628|NCT02323698|12054621|FG003|NOT COMPLETED|Overall Study||0
10888629|NCT02323698|12054622|FG004|NOT COMPLETED|Overall Study||1
10888630|NCT02323698|12054623|FG005|NOT COMPLETED|Overall Study||0
10888631|NCT02321514|12054631|FG000|STARTED|Overall Study||191
10888632|NCT02321514|12054631|FG000|COMPLETED|Overall Study||166
10888633|NCT02321514|12054631|FG000|NOT COMPLETED|Overall Study||25
10888634|NCT02321436|12054637|FG000|STARTED|Overall Study||28
10888635|NCT02321436|12054638|FG001|STARTED|Overall Study||14
10888636|NCT02321436|12054637|FG000|COMPLETED|Overall Study||27
10888637|NCT02321436|12054638|FG001|COMPLETED|Overall Study||13
10888638|NCT02321436|12054637|FG000|NOT COMPLETED|Overall Study||1
10888639|NCT02321436|12054638|FG001|NOT COMPLETED|Overall Study||1
10888640|NCT02316171|12054647|FG000|STARTED|Overall Study||4
10888641|NCT02316171|12054648|FG001|STARTED|Overall Study||6
10888642|NCT02316171|12054649|FG002|STARTED|Overall Study||3
10888643|NCT02316171|12054650|FG003|STARTED|Overall Study||3
10888644|NCT02316171|12054647|FG000|COMPLETED|Overall Study||3
10888645|NCT02316171|12054648|FG001|COMPLETED|Overall Study||6
10888646|NCT02316171|12054649|FG002|COMPLETED|Overall Study||3
10888647|NCT02316171|12054650|FG003|COMPLETED|Overall Study||3
10888648|NCT02316171|12054647|FG000|NOT COMPLETED|Overall Study||1
10888649|NCT02316171|12054648|FG001|NOT COMPLETED|Overall Study||0
10888650|NCT02316171|12054649|FG002|NOT COMPLETED|Overall Study||0
10888651|NCT02316171|12054650|FG003|NOT COMPLETED|Overall Study||0
10888652|NCT02308488|12054656|FG000|STARTED|Overall Study||97
10888653|NCT02308488|12054656|FG000|COMPLETED|Overall Study||95
10888654|NCT02308488|12054656|FG000|NOT COMPLETED|Overall Study||2
10888655|NCT02307279|12054662|FG000|STARTED|Overall Study||223
10888656|NCT02307279|12054663|FG001|STARTED|Overall Study||213
10888657|NCT02307279|12054662|FG000|COMPLETED|Overall Study||172
10888658|NCT02307279|12054663|FG001|COMPLETED|Overall Study||152
10888659|NCT02307279|12054662|FG000|NOT COMPLETED|Overall Study||51
10888660|NCT02307279|12054663|FG001|NOT COMPLETED|Overall Study||61
10888661|NCT02306161|12054671|FG000|STARTED|Overall Study||157
10888662|NCT02306161|12054672|FG001|STARTED|Overall Study||155
10888663|NCT02306161|12054671|FG000|COMPLETED|Overall Study||93
10888664|NCT02306161|12054672|FG001|COMPLETED|Overall Study||86
10888665|NCT02306161|12054671|FG000|NOT COMPLETED|Overall Study||64
10888666|NCT02306161|12054672|FG001|NOT COMPLETED|Overall Study||69
10888667|NCT02302222|12054680|FG000|STARTED|Overall Study||34
10888668|NCT02302222|12054681|FG001|STARTED|Overall Study||37
10888669|NCT02302222|12054680|FG000|COMPLETED|Overall Study||33
10888670|NCT02302222|12054681|FG001|COMPLETED|Overall Study||31
10888671|NCT02302222|12054680|FG000|NOT COMPLETED|Overall Study||1
10888672|NCT02302222|12054681|FG001|NOT COMPLETED|Overall Study||6
10888673|NCT02297503|12054689|FG000|STARTED|Overall Study||30
10888674|NCT02297503|12054690|FG001|STARTED|Overall Study||31
10888675|NCT02297503|12054689|FG000|Initial Single Treatment|Overall Study||29
10888676|NCT02297503|12054690|FG001|Initial Single Treatment|Overall Study||31
10888677|NCT02297503|12054689|FG000|First Combined Treatment|Overall Study||28
10888678|NCT02297503|12054690|FG001|First Combined Treatment|Overall Study||28
10888679|NCT02297503|12054689|FG000|Second Combined Treatment|Overall Study||28
10888680|NCT02297503|12054690|FG001|Second Combined Treatment|Overall Study||28
10888681|NCT02297503|12054689|FG000|COMPLETED|Overall Study||28
10888682|NCT02297503|12054690|FG001|COMPLETED|Overall Study||27
10888683|NCT02297503|12054689|FG000|NOT COMPLETED|Overall Study||2
10888684|NCT02297503|12054690|FG001|NOT COMPLETED|Overall Study||4
10888685|NCT02296125|12054707|FG000|STARTED|Overall Study||279
10888686|NCT02296125|12054708|FG001|STARTED|Overall Study|183 participant received gefitinib and 93 participants received erlotinib.|277
10888687|NCT02296125|12054709|FG002|STARTED|Overall Study|There were 12 participants who were in both the Global and China Extension Osimertinib Arm.|71
10888688|NCT02296125|12054710|FG003|STARTED|Overall Study|There were 7 participants who were in both the Global and China Extension SoC EGFR-TKI Arm.|65
10888689|NCT02296125|12054707|FG000|COMPLETED|Overall Study||61
10888690|NCT02296125|12054708|FG001|COMPLETED|Overall Study||13
10888691|NCT02296125|12054709|FG002|COMPLETED|Overall Study||15
10888692|NCT02296125|12054710|FG003|COMPLETED|Overall Study||3
10888693|NCT02296125|12054707|FG000|NOT COMPLETED|Overall Study||218
10888694|NCT02296125|12054708|FG001|NOT COMPLETED|Overall Study||264
10888695|NCT02296125|12054709|FG002|NOT COMPLETED|Overall Study||56
10888696|NCT02296125|12054710|FG003|NOT COMPLETED|Overall Study||62
10888697|NCT02294461|12054723|FG000|STARTED|Double-blind Period (up to 29.4 Months)||202
10888698|NCT02294461|12054724|FG001|STARTED|Double-blind Period (up to 29.4 Months)||193
10888699|NCT02294461|12054723|FG000|Treated/Received Study Drug|Double-blind Period (up to 29.4 Months)||202
10888700|NCT02294461|12054724|FG001|Treated/Received Study Drug|Double-blind Period (up to 29.4 Months)||193
10888701|NCT02294461|12054723|FG000|COMPLETED|Double-blind Period (up to 29.4 Months)||84
10888702|NCT02294461|12054724|FG001|COMPLETED|Double-blind Period (up to 29.4 Months)||1
10888703|NCT02294461|12054723|FG000|NOT COMPLETED|Double-blind Period (up to 29.4 Months)||118
10888704|NCT02294461|12054724|FG001|NOT COMPLETED|Double-blind Period (up to 29.4 Months)||192
10888705|NCT02294461|12054723|FG000|STARTED|Open-label Period (up to 54.3 Months)|Eligible participants who provided consent took part in open-label period.|85
10888706|NCT02294461|12054724|FG001|STARTED|Open-label Period (up to 54.3 Months)|Eligible participants who provided consent took part in open-label period.|51
10888707|NCT02294461|12054723|FG000|COMPLETED|Open-label Period (up to 54.3 Months)||0
10888708|NCT02294461|12054724|FG001|COMPLETED|Open-label Period (up to 54.3 Months)||0
10888709|NCT02294461|12054723|FG000|NOT COMPLETED|Open-label Period (up to 54.3 Months)||85
10888710|NCT02294461|12054724|FG001|NOT COMPLETED|Open-label Period (up to 54.3 Months)||51
10888711|NCT02287233|12054745|FG000|STARTED|Overall Study||8
10888712|NCT02287233|12054746|FG001|STARTED|Overall Study||10
10888713|NCT02287233|12054747|FG002|STARTED|Overall Study||76
10888714|NCT02287233|12054745|FG000|Treated|Overall Study||8
10888715|NCT02287233|12054746|FG001|Treated|Overall Study||10
10888716|NCT02287233|12054747|FG002|Treated|Overall Study||74
10888717|NCT02287233|12054745|FG000|COMPLETED|Overall Study||0
10888718|NCT02287233|12054746|FG001|COMPLETED|Overall Study||0
10888719|NCT02287233|12054747|FG002|COMPLETED|Overall Study||0
10888720|NCT02287233|12054745|FG000|NOT COMPLETED|Overall Study||8
10888721|NCT02287233|12054746|FG001|NOT COMPLETED|Overall Study||10
10888722|NCT02287233|12054747|FG002|NOT COMPLETED|Overall Study||76
10888723|NCT02285062|12054760|FG000|STARTED|Overall Study||285
10888724|NCT02285062|12054761|FG001|STARTED|Overall Study||285
10888725|NCT02285062|12054760|FG000|Received Study Treatment|Overall Study||283
10888726|NCT02285062|12054761|FG001|Received Study Treatment|Overall Study||284
10888727|NCT02285062|12054760|FG000|Ongoing Study Treatment|Overall Study||0
10888728|NCT02285062|12054761|FG001|Ongoing Study Treatment|Overall Study||0
10888729|NCT02285062|12054760|FG000|COMPLETED|Overall Study||207
10888730|NCT02285062|12054761|FG001|COMPLETED|Overall Study||201
10888731|NCT02285062|12054760|FG000|NOT COMPLETED|Overall Study||78
10888732|NCT02285062|12054761|FG001|NOT COMPLETED|Overall Study||84
10888733|NCT02281084|12054771|FG000|STARTED|Overall Study||32
10888734|NCT02281084|12054772|FG001|STARTED|Overall Study||22
10888735|NCT02281084|12054773|FG002|STARTED|Overall Study||6
10888736|NCT02281084|12054774|FG003|STARTED|Overall Study||5
10888737|NCT02281084|12054771|FG000|COMPLETED|Overall Study||10
10888738|NCT02281084|12054772|FG001|COMPLETED|Overall Study||4
10888739|NCT02281084|12054773|FG002|COMPLETED|Overall Study||2
10888740|NCT02281084|12054774|FG003|COMPLETED|Overall Study||0
10888741|NCT02281084|12054771|FG000|NOT COMPLETED|Overall Study||22
10888742|NCT02281084|12054772|FG001|NOT COMPLETED|Overall Study||18
10888743|NCT02281084|12054773|FG002|NOT COMPLETED|Overall Study||4
10888744|NCT02281084|12054774|FG003|NOT COMPLETED|Overall Study||5
10888745|NCT02278120|12054786|FG000|STARTED|Overall Study||335
10888746|NCT02278120|12054787|FG001|STARTED|Overall Study||337
10888747|NCT02278120|12054786|FG000|COMPLETED|Overall Study||174
10888748|NCT02278120|12054787|FG001|COMPLETED|Overall Study||121
10888749|NCT02278120|12054786|FG000|NOT COMPLETED|Overall Study||161
10888750|NCT02278120|12054787|FG001|NOT COMPLETED|Overall Study||216
10888751|NCT02277444|12054793|FG000|STARTED|Overall Study||130
10888752|NCT02277444|12054793|FG000|Treated|Overall Study||127
10888753|NCT02277444|12054793|FG000|COMPLETED|Overall Study||0
10888754|NCT02277444|12054793|FG000|NOT COMPLETED|Overall Study||130
10888755|NCT02275780|12054799|FG000|STARTED|Base Study: 96 Weeks||385
10888756|NCT02275780|12054800|FG001|STARTED|Base Study: 96 Weeks||384
10888757|NCT02275780|12054799|FG000|Treated|Base Study: 96 Weeks||383
10888758|NCT02275780|12054800|FG001|Treated|Base Study: 96 Weeks||383
10888759|NCT02275780|12054799|FG000|COMPLETED|Base Study: 96 Weeks||292
10888760|NCT02275780|12054800|FG001|COMPLETED|Base Study: 96 Weeks||273
10888761|NCT02275780|12054799|FG000|NOT COMPLETED|Base Study: 96 Weeks||93
10888762|NCT02275780|12054800|FG001|NOT COMPLETED|Base Study: 96 Weeks||111
10888763|NCT02275780|12054799|FG000|STARTED|Extension Study: up to 192 Weeks|The extension study is optional; not all eligible participants enrolled|260
10888764|NCT02275780|12054800|FG001|STARTED|Extension Study: up to 192 Weeks|The extension study is optional; not all eligible participants enrolled|233
10888765|NCT02275780|12054799|FG000|COMPLETED|Extension Study: up to 192 Weeks|The extension study is ongoing|0
10888766|NCT02275780|12054800|FG001|COMPLETED|Extension Study: up to 192 Weeks|The extension study is ongoing|0
10888767|NCT02275780|12054799|FG000|NOT COMPLETED|Extension Study: up to 192 Weeks||260
10888768|NCT02275780|12054800|FG001|NOT COMPLETED|Extension Study: up to 192 Weeks||233
10888769|NCT02272790|12054812|FG000|STARTED|Overall Study||9
10888770|NCT02272790|12054813|FG001|STARTED|Overall Study||39
10888771|NCT02272790|12054814|FG002|STARTED|Overall Study||23
10888772|NCT02272790|12054815|FG003|STARTED|Overall Study||12
10888773|NCT02272790|12054816|FG004|STARTED|Overall Study||6
10888774|NCT02272790|12054817|FG005|STARTED|Overall Study||6
10888775|NCT02272790|12054812|FG000|COMPLETED|Overall Study||9
10888776|NCT02272790|12054813|FG001|COMPLETED|Overall Study||38
10888777|NCT02272790|12054814|FG002|COMPLETED|Overall Study||23
10888778|NCT02272790|12054815|FG003|COMPLETED|Overall Study||12
10888779|NCT02272790|12054816|FG004|COMPLETED|Overall Study||6
10888780|NCT02272790|12054817|FG005|COMPLETED|Overall Study||6
10888781|NCT02272790|12054812|FG000|NOT COMPLETED|Overall Study||0
10888782|NCT02272790|12054813|FG001|NOT COMPLETED|Overall Study||1
10888783|NCT02272790|12054814|FG002|NOT COMPLETED|Overall Study||0
10888784|NCT02272790|12054815|FG003|NOT COMPLETED|Overall Study||0
10888785|NCT02272790|12054816|FG004|NOT COMPLETED|Overall Study||0
10888786|NCT02272790|12054817|FG005|NOT COMPLETED|Overall Study||0
10888787|NCT02268916|12054839|FG000|STARTED|Overall Study||52
10888788|NCT02268916|12054840|FG001|STARTED|Overall Study||52
10888789|NCT02268916|12054839|FG000|COMPLETED|Overall Study||35
10888790|NCT02268916|12054840|FG001|COMPLETED|Overall Study||42
10888791|NCT02268916|12054839|FG000|NOT COMPLETED|Overall Study||17
10888792|NCT02268916|12054840|FG001|NOT COMPLETED|Overall Study||10
10888793|NCT02268851|12054853|FG000|STARTED|Overall Study||3
10888794|NCT02268851|12054854|FG001|STARTED|Overall Study||3
10888795|NCT02268851|12054855|FG002|STARTED|Overall Study||4
10888796|NCT02268851|12054856|FG003|STARTED|Overall Study||3
10888797|NCT02268851|12054857|FG004|STARTED|Overall Study||15
10888798|NCT02268851|12054858|FG005|STARTED|Overall Study||15
10888799|NCT02268851|12054853|FG000|COMPLETED|Overall Study||2
10888800|NCT02268851|12054854|FG001|COMPLETED|Overall Study||0
10888801|NCT02268851|12054855|FG002|COMPLETED|Overall Study||3
10888802|NCT02268851|12054856|FG003|COMPLETED|Overall Study||0
10888803|NCT02268851|12054857|FG004|COMPLETED|Overall Study||8
10888804|NCT02268851|12054858|FG005|COMPLETED|Overall Study||4
10888805|NCT02268851|12054853|FG000|NOT COMPLETED|Overall Study||1
10888806|NCT02268851|12054854|FG001|NOT COMPLETED|Overall Study||3
10888807|NCT02268851|12054855|FG002|NOT COMPLETED|Overall Study||1
10888808|NCT02268851|12054856|FG003|NOT COMPLETED|Overall Study||3
10888809|NCT02268851|12054857|FG004|NOT COMPLETED|Overall Study||7
10888810|NCT02268851|12054858|FG005|NOT COMPLETED|Overall Study||11
10888811|NCT02268656|12054874|FG000|STARTED|Overall Study||20
10888812|NCT02268656|12054875|FG001|STARTED|Overall Study||20
10888813|NCT02268656|12054874|FG000|COMPLETED|Overall Study||20
10888814|NCT02268656|12054875|FG001|COMPLETED|Overall Study||20
10888815|NCT02268656|12054874|FG000|NOT COMPLETED|Overall Study||0
10888816|NCT02268656|12054875|FG001|NOT COMPLETED|Overall Study||0
10888817|NCT02264977|12054881|FG000|STARTED|Overall Study||9
10888818|NCT02264977|12054881|FG000|COMPLETED|Overall Study||4
10888819|NCT02264977|12054881|FG000|NOT COMPLETED|Overall Study||5
10888820|NCT02258451|12054887|FG000|STARTED|Overall Study||142
10888821|NCT02258451|12054888|FG001|STARTED|Overall Study||141
10888822|NCT02258451|12054887|FG000|COMPLETED|Overall Study||0
10888823|NCT02258451|12054888|FG001|COMPLETED|Overall Study||0
10888824|NCT02258451|12054887|FG000|NOT COMPLETED|Overall Study||142
10888825|NCT02258451|12054888|FG001|NOT COMPLETED|Overall Study||141
10888826|NCT02257736|12054898|FG000|STARTED|Overall Study||490
10888827|NCT02257736|12054899|FG001|STARTED|Overall Study||492
10888828|NCT02257736|12054898|FG000|COMPLETED|Overall Study||39
10888829|NCT02257736|12054899|FG001|COMPLETED|Overall Study||45
10888830|NCT02257736|12054898|FG000|NOT COMPLETED|Overall Study||451
10888831|NCT02257736|12054899|FG001|NOT COMPLETED|Overall Study||447
10888832|NCT02257528|12054905|FG000|STARTED|Overall Study||26
10888833|NCT02257528|12054905|FG000|COMPLETED|Overall Study||25
10888834|NCT02257528|12054905|FG000|NOT COMPLETED|Overall Study||1
10888835|NCT02257489|12054918|FG000|STARTED|Overall Study||6
10888836|NCT02257489|12054919|FG001|STARTED|Overall Study||6
10888837|NCT02257489|12054920|FG002|STARTED|Overall Study||6
10888838|NCT02257489|12054921|FG003|STARTED|Overall Study||6
10888839|NCT02257489|12054922|FG004|STARTED|Overall Study||6
10888840|NCT02257489|12054923|FG005|STARTED|Overall Study||6
10888841|NCT02257489|12054924|FG006|STARTED|Overall Study||6
10888842|NCT02257489|12054925|FG007|STARTED|Overall Study||10
10888843|NCT02257489|12054926|FG008|STARTED|Overall Study||6
10888844|NCT02257489|12054918|FG000|COMPLETED|Overall Study||6
10888845|NCT02257489|12054919|FG001|COMPLETED|Overall Study||6
10888846|NCT02257489|12054920|FG002|COMPLETED|Overall Study||6
10888847|NCT02257489|12054921|FG003|COMPLETED|Overall Study||5
10888848|NCT02257489|12054922|FG004|COMPLETED|Overall Study||6
10888849|NCT02257489|12054923|FG005|COMPLETED|Overall Study||6
10888850|NCT02257489|12054924|FG006|COMPLETED|Overall Study||6
10888851|NCT02257489|12054925|FG007|COMPLETED|Overall Study||10
10888852|NCT02257489|12054926|FG008|COMPLETED|Overall Study||6
10888853|NCT02257489|12054918|FG000|NOT COMPLETED|Overall Study||0
10888854|NCT02257489|12054919|FG001|NOT COMPLETED|Overall Study||0
10888855|NCT02257489|12054920|FG002|NOT COMPLETED|Overall Study||0
10888856|NCT02257489|12054921|FG003|NOT COMPLETED|Overall Study||1
10888857|NCT02257489|12054922|FG004|NOT COMPLETED|Overall Study||0
10888858|NCT02257489|12054923|FG005|NOT COMPLETED|Overall Study||0
10888859|NCT02257489|12054924|FG006|NOT COMPLETED|Overall Study||0
10888860|NCT02257489|12054925|FG007|NOT COMPLETED|Overall Study||0
10888861|NCT02257489|12054926|FG008|NOT COMPLETED|Overall Study||0
10888862|NCT02257138|12054951|FG000|STARTED|Overall Study||5
10888863|NCT02257138|12054952|FG001|STARTED|Overall Study||3
10888864|NCT02257138|12054953|FG002|STARTED|Overall Study||3
10888865|NCT02257138|12054954|FG003|STARTED|Overall Study||3
10888866|NCT02257138|12054955|FG004|STARTED|Overall Study||16
10888867|NCT02257138|12054951|FG000|COMPLETED|Overall Study||5
10888868|NCT02257138|12054952|FG001|COMPLETED|Overall Study||3
10888869|NCT02257138|12054953|FG002|COMPLETED|Overall Study||3
10888870|NCT02257138|12054954|FG003|COMPLETED|Overall Study||3
10888871|NCT02257138|12054955|FG004|COMPLETED|Overall Study||16
10888872|NCT02257138|12054951|FG000|NOT COMPLETED|Overall Study||0
10888873|NCT02257138|12054952|FG001|NOT COMPLETED|Overall Study||0
10888874|NCT02257138|12054953|FG002|NOT COMPLETED|Overall Study||0
10888875|NCT02257138|12054954|FG003|NOT COMPLETED|Overall Study||0
10888876|NCT02257138|12054955|FG004|NOT COMPLETED|Overall Study||0
10888877|NCT02254278|12054966|FG000|STARTED|Overall Study||158
10888878|NCT02254278|12054967|FG001|STARTED|Overall Study||150
10888879|NCT02254278|12054966|FG000|Eligible|Overall Study||157
10888880|NCT02254278|12054967|FG001|Eligible|Overall Study||149
10888881|NCT02254278|12054966|FG000|Started Study Treatment|Overall Study||152
10888882|NCT02254278|12054967|FG001|Started Study Treatment|Overall Study||147
10888883|NCT02254278|12054966|FG000|Negative Post-treatment PET|Overall Study||58
10888884|NCT02254278|12054967|FG001|Negative Post-treatment PET|Overall Study||57
10888885|NCT02254278|12054966|FG000|COMPLETED|Overall Study||157
10888886|NCT02254278|12054967|FG001|COMPLETED|Overall Study||149
10888887|NCT02254278|12054966|FG000|NOT COMPLETED|Overall Study||1
10888888|NCT02254278|12054967|FG001|NOT COMPLETED|Overall Study||1
10888889|NCT02254265|12054979|FG000|STARTED|Overall Study||151
10888890|NCT02254265|12054980|FG001|STARTED|Overall Study||152
10888891|NCT02254265|12054981|FG002|STARTED|Overall Study||152
10888892|NCT02254265|12054979|FG000|COMPLETED|Overall Study||142
10888893|NCT02254265|12054980|FG001|COMPLETED|Overall Study||140
10888894|NCT02254265|12054981|FG002|COMPLETED|Overall Study||144
10888895|NCT02254265|12054979|FG000|NOT COMPLETED|Overall Study||9
10888896|NCT02254265|12054980|FG001|NOT COMPLETED|Overall Study||12
10888897|NCT02254265|12054981|FG002|NOT COMPLETED|Overall Study||8
10888898|NCT02253316|12054989|FG000|STARTED|Consolidation||236
10888899|NCT02253316|12054990|FG001|STARTED|Consolidation||0
10888900|NCT02253316|12054991|FG002|STARTED|Consolidation||0
10888901|NCT02253316|12054989|FG000|COMPLETED|Consolidation||220
10888902|NCT02253316|12054990|FG001|COMPLETED|Consolidation||0
10888903|NCT02253316|12054991|FG002|COMPLETED|Consolidation||0
10888904|NCT02253316|12054989|FG000|NOT COMPLETED|Consolidation||16
10888905|NCT02253316|12054990|FG001|NOT COMPLETED|Consolidation||0
10888906|NCT02253316|12054991|FG002|NOT COMPLETED|Consolidation||0
10888907|NCT02253316|12054989|FG000|STARTED|Maintenance||0
10888908|NCT02253316|12054990|FG001|STARTED|Maintenance||99
10888909|NCT02253316|12054991|FG002|STARTED|Maintenance||116
10888910|NCT02253316|12054989|FG000|COMPLETED|Maintenance||0
10888911|NCT02253316|12054990|FG001|COMPLETED|Maintenance||54
10888912|NCT02253316|12054991|FG002|COMPLETED|Maintenance||50
10888913|NCT02253316|12054989|FG000|NOT COMPLETED|Maintenance||0
10888914|NCT02253316|12054990|FG001|NOT COMPLETED|Maintenance||45
10888915|NCT02253316|12054991|FG002|NOT COMPLETED|Maintenance||66
10888916|NCT02252172|12055001|FG000|STARTED|Overall Study||369
10888917|NCT02252172|12055002|FG001|STARTED|Overall Study||368
10888918|NCT02252172|12055001|FG000|Treated|Overall Study||365
10888919|NCT02252172|12055002|FG001|Treated|Overall Study||364
10888920|NCT02252172|12055001|FG000|COMPLETED|Overall Study||90
10888921|NCT02252172|12055002|FG001|COMPLETED|Overall Study||69
10888922|NCT02252172|12055001|FG000|NOT COMPLETED|Overall Study||279
10888923|NCT02252172|12055002|FG001|NOT COMPLETED|Overall Study||299
10888924|NCT02252042|12055010|FG000|STARTED|Overall Study||247
10888925|NCT02252042|12055011|FG001|STARTED|Overall Study||248
10888926|NCT02252042|12055010|FG000|Treated|Overall Study|1 participant was randomized but did not receive study treatment.|246
10888927|NCT02252042|12055011|FG001|Treated|Overall Study|14 participants were randomized but did not receive study treatment.|234
10888928|NCT02252042|12055010|FG000|COMPLETED|Overall Study||0
10888929|NCT02252042|12055011|FG001|COMPLETED|Overall Study||0
10888930|NCT02252042|12055010|FG000|NOT COMPLETED|Overall Study||247
10888931|NCT02252042|12055011|FG001|NOT COMPLETED|Overall Study||248
10888932|NCT02249104|12055017|FG000|STARTED|Overall Study||28
10888933|NCT02249104|12055017|FG000|COMPLETED|Overall Study||25
10888934|NCT02249104|12055017|FG000|NOT COMPLETED|Overall Study||3
10888935|NCT02249065|12055021|FG000|STARTED|Overall Study||205
10888936|NCT02249065|12055021|FG000|Treated|Overall Study||181
10888937|NCT02249065|12055021|FG000|COMPLETED|Overall Study||176
10888938|NCT02249065|12055021|FG000|NOT COMPLETED|Overall Study||29
10888939|NCT02246621|12055027|FG000|STARTED|Overall Study||328
10888940|NCT02246621|12055028|FG001|STARTED|Overall Study||165
10888941|NCT02246621|12055027|FG000|Received At Least One Dose of Study Drug|Overall Study||327
10888942|NCT02246621|12055028|FG001|Received At Least One Dose of Study Drug|Overall Study||161
10888943|NCT02246621|12055027|FG000|COMPLETED|Overall Study||63
10888944|NCT02246621|12055028|FG001|COMPLETED|Overall Study||30
10888945|NCT02246621|12055027|FG000|NOT COMPLETED|Overall Study||265
10888946|NCT02246621|12055028|FG001|NOT COMPLETED|Overall Study||135
10888947|NCT02243605|12055036|FG000|STARTED|Stage 1 - Interim Analysis Population||23
10888948|NCT02243605|12055037|FG001|STARTED|Stage 1 - Interim Analysis Population||22
10888949|NCT02243605|12055036|FG000|COMPLETED|Stage 1 - Interim Analysis Population||21
10888950|NCT02243605|12055037|FG001|COMPLETED|Stage 1 - Interim Analysis Population||21
10888951|NCT02243605|12055036|FG000|NOT COMPLETED|Stage 1 - Interim Analysis Population||2
10888952|NCT02243605|12055037|FG001|NOT COMPLETED|Stage 1 - Interim Analysis Population||1
10888953|NCT02243605|12055036|FG000|STARTED|Stage 2 - Final Analysis Population||45
10888954|NCT02243605|12055037|FG001|STARTED|Stage 2 - Final Analysis Population||45
10888955|NCT02243605|12055036|FG000|COMPLETED|Stage 2 - Final Analysis Population||39
10888956|NCT02243605|12055037|FG001|COMPLETED|Stage 2 - Final Analysis Population||42
10888957|NCT02243605|12055036|FG000|NOT COMPLETED|Stage 2 - Final Analysis Population||6
10888958|NCT02243605|12055037|FG001|NOT COMPLETED|Stage 2 - Final Analysis Population||3
10888959|NCT02243020|12055045|FG000|STARTED|Overall Study||8
10888960|NCT02243020|12055046|FG001|STARTED|Overall Study||9
10888961|NCT02243020|12055045|FG000|COMPLETED|Overall Study||8
10888962|NCT02243020|12055046|FG001|COMPLETED|Overall Study||9
10888963|NCT02243020|12055045|FG000|NOT COMPLETED|Overall Study||0
10888964|NCT02243020|12055046|FG001|NOT COMPLETED|Overall Study||0
10888965|NCT02242435|12055054|FG000|STARTED|Overall Study||172
10888966|NCT02242435|12055055|FG001|STARTED|Overall Study||170
10888967|NCT02242435|12055054|FG000|COMPLETED|Overall Study||152
10888968|NCT02242435|12055055|FG001|COMPLETED|Overall Study||154
10888969|NCT02242435|12055054|FG000|NOT COMPLETED|Overall Study||20
10888970|NCT02242435|12055055|FG001|NOT COMPLETED|Overall Study||16
10888971|NCT02230189|12055064|FG000|STARTED|Overall Study||22
10888972|NCT02230189|12055065|FG001|STARTED|Overall Study||2
10888973|NCT02230189|12055066|FG002|STARTED|Overall Study||4
10888974|NCT02230189|12055064|FG000|COMPLETED|Overall Study||17
10888975|NCT02230189|12055065|FG001|COMPLETED|Overall Study||2
10888976|NCT02230189|12055066|FG002|COMPLETED|Overall Study||3
10888977|NCT02230189|12055064|FG000|NOT COMPLETED|Overall Study||5
10888978|NCT02230189|12055065|FG001|NOT COMPLETED|Overall Study||0
10888979|NCT02230189|12055066|FG002|NOT COMPLETED|Overall Study||1
10888980|NCT02226159|12055077|FG000|STARTED|Overall Study||33
10888981|NCT02226159|12055078|FG001|STARTED|Overall Study||32
10888982|NCT02226159|12055077|FG000|COMPLETED|Overall Study||27
10888983|NCT02226159|12055078|FG001|COMPLETED|Overall Study||26
10888984|NCT02226159|12055077|FG000|NOT COMPLETED|Overall Study||6
10888985|NCT02226159|12055078|FG001|NOT COMPLETED|Overall Study||6
10888986|NCT02225275|12055084|FG000|STARTED|Overall Study||9
10888987|NCT02225275|12055084|FG000|COMPLETED|Overall Study||9
10888988|NCT02225275|12055084|FG000|NOT COMPLETED|Overall Study||0
10888989|NCT02224703|12055091|FG000|STARTED|Overall Study||67
10888990|NCT02224703|12055092|FG001|STARTED|Overall Study||67
10888991|NCT02224703|12055093|FG002|STARTED|Overall Study||65
10888992|NCT02224703|12055091|FG000|Received at Least 1 Dose of Study Drug|Overall Study||66
10888993|NCT02224703|12055092|FG001|Received at Least 1 Dose of Study Drug|Overall Study||67
10888994|NCT02224703|12055093|FG002|Received at Least 1 Dose of Study Drug|Overall Study||65
10888995|NCT02224703|12055091|FG000|Safety Analysis Set|Overall Study|Two participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group|64
10888996|NCT02224703|12055092|FG001|Safety Analysis Set|Overall Study|Two participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group|69
10888997|NCT02224703|12055093|FG002|Safety Analysis Set|Overall Study||65
10888998|NCT02224703|12055091|FG000|Intent to Treat (ITT) Analysis Set|Overall Study||66
10888999|NCT02224703|12055092|FG001|Intent to Treat (ITT) Analysis Set|Overall Study||67
10889000|NCT02224703|12055093|FG002|Intent to Treat (ITT) Analysis Set|Overall Study||65
10889001|NCT02224703|12055091|FG000|COMPLETED|Overall Study||64
10889002|NCT02224703|12055092|FG001|COMPLETED|Overall Study||61
10889003|NCT02224703|12055093|FG002|COMPLETED|Overall Study||65
10889004|NCT02224703|12055091|FG000|NOT COMPLETED|Overall Study||3
10889005|NCT02224703|12055092|FG001|NOT COMPLETED|Overall Study||6
10889006|NCT02224703|12055093|FG002|NOT COMPLETED|Overall Study||0
10889007|NCT02224690|12055104|FG000|STARTED|Overall Study||86
10889008|NCT02224690|12055105|FG001|STARTED|Overall Study||85
10889009|NCT02224690|12055104|FG000|Safety Analysis Set|Overall Study||86
10889010|NCT02224690|12055105|FG001|Safety Analysis Set|Overall Study||85
10889011|NCT02224690|12055104|FG000|Intent to Treat (ITT) Analysis Set|Overall Study||86
10889012|NCT02224690|12055105|FG001|Intent to Treat (ITT) Analysis Set|Overall Study||85
10889013|NCT02224690|12055104|FG000|COMPLETED|Overall Study||72
10889014|NCT02224690|12055105|FG001|COMPLETED|Overall Study||84
10889015|NCT02224690|12055104|FG000|NOT COMPLETED|Overall Study||14
10889016|NCT02224690|12055105|FG001|NOT COMPLETED|Overall Study||1
10889017|NCT02224560|12055114|FG000|STARTED|Overall Study||76
10889018|NCT02224560|12055115|FG001|STARTED|Overall Study||73
10889019|NCT02224560|12055116|FG002|STARTED|Overall Study||76
10889020|NCT02224560|12055114|FG000|Safety Analysis Set|Overall Study|Six participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group.|82
10889021|NCT02224560|12055115|FG001|Safety Analysis Set|Overall Study|Six participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group.|67
10889022|NCT02224560|12055116|FG002|Safety Analysis Set|Overall Study||76
10889023|NCT02224560|12055114|FG000|Intent to Treat (ITT) Analysis Set|Overall Study||76
10889024|NCT02224560|12055115|FG001|Intent to Treat (ITT) Analysis Set|Overall Study||73
10889025|NCT02224560|12055116|FG002|Intent to Treat (ITT) Analysis Set|Overall Study||76
10889026|NCT02224560|12055114|FG000|COMPLETED|Overall Study||67
10889027|NCT02224560|12055115|FG001|COMPLETED|Overall Study||71
10889028|NCT02224560|12055116|FG002|COMPLETED|Overall Study||74
10889029|NCT02224560|12055114|FG000|NOT COMPLETED|Overall Study||9
10889030|NCT02224560|12055115|FG001|NOT COMPLETED|Overall Study||2
10889031|NCT02224560|12055116|FG002|NOT COMPLETED|Overall Study||2
10889032|NCT02224391|12055126|FG000|STARTED|Overall Study||124
10889033|NCT02224391|12055127|FG001|STARTED|Overall Study||122
10889034|NCT02224391|12055126|FG000|COMPLETED|Overall Study||92
10889035|NCT02224391|12055127|FG001|COMPLETED|Overall Study||98
10889036|NCT02224391|12055126|FG000|NOT COMPLETED|Overall Study||32
10889037|NCT02224391|12055127|FG001|NOT COMPLETED|Overall Study||24
10889038|NCT02220894|12055135|FG000|STARTED|Overall Study|1 additional participant was randomized in error|637
10889039|NCT02220894|12055136|FG001|STARTED|Overall Study||637
10889040|NCT02220894|12055135|FG000|Treated|Overall Study||636
10889041|NCT02220894|12055136|FG001|Treated|Overall Study||615
10889042|NCT02220894|12055135|FG000|COMPLETED|Overall Study||0
10889043|NCT02220894|12055136|FG001|COMPLETED|Overall Study||0
10889044|NCT02220894|12055135|FG000|NOT COMPLETED|Overall Study||637
10889045|NCT02220894|12055136|FG001|NOT COMPLETED|Overall Study||637
10889046|NCT02216851|12055144|FG000|STARTED|Overall Study||98
10889047|NCT02216851|12055145|FG001|STARTED|Overall Study||33
10889048|NCT02216851|12055144|FG000|COMPLETED|Overall Study||96
10889049|NCT02216851|12055145|FG001|COMPLETED|Overall Study||32
10889050|NCT02216851|12055144|FG000|NOT COMPLETED|Overall Study||2
10889051|NCT02216851|12055145|FG001|NOT COMPLETED|Overall Study||1
10889052|NCT02209636|12055153|FG000|STARTED|Main/Parent Study||32
10889053|NCT02209636|12055154|FG001|STARTED|Main/Parent Study||29
10889054|NCT02209636|12055153|FG000|COMPLETED|Main/Parent Study||27
10889055|NCT02209636|12055154|FG001|COMPLETED|Main/Parent Study||27
10889056|NCT02209636|12055153|FG000|NOT COMPLETED|Main/Parent Study||5
10889057|NCT02209636|12055154|FG001|NOT COMPLETED|Main/Parent Study||2
10889058|NCT02209636|12055153|FG000|STARTED|Balance Sub-study||7
10889059|NCT02209636|12055154|FG001|STARTED|Balance Sub-study||8
10889060|NCT02209636|12055153|FG000|COMPLETED|Balance Sub-study||6
10889061|NCT02209636|12055154|FG001|COMPLETED|Balance Sub-study||8
10889062|NCT02209636|12055153|FG000|NOT COMPLETED|Balance Sub-study||1
10889063|NCT02209636|12055154|FG001|NOT COMPLETED|Balance Sub-study||0
10889064|NCT02203513|12055167|FG000|STARTED|Overall Study||22
10889065|NCT02203513|12055168|FG001|STARTED|Overall Study||29
10889066|NCT02203513|12055169|FG002|STARTED|Overall Study||9
10889067|NCT02203513|12055170|FG003|STARTED|Overall Study||2
10889068|NCT02203513|12055171|FG004|STARTED|Overall Study||49
10889069|NCT02203513|12055167|FG000|COMPLETED|Overall Study||16
10889070|NCT02203513|12055168|FG001|COMPLETED|Overall Study||21
10889071|NCT02203513|12055169|FG002|COMPLETED|Overall Study||6
10889072|NCT02203513|12055170|FG003|COMPLETED|Overall Study||1
10889073|NCT02203513|12055171|FG004|COMPLETED|Overall Study||43
10889074|NCT02203513|12055167|FG000|NOT COMPLETED|Overall Study||6
10889075|NCT02203513|12055168|FG001|NOT COMPLETED|Overall Study||8
10889076|NCT02203513|12055169|FG002|NOT COMPLETED|Overall Study||3
10889077|NCT02203513|12055170|FG003|NOT COMPLETED|Overall Study||1
10889078|NCT02203513|12055171|FG004|NOT COMPLETED|Overall Study||6
10889079|NCT02200445|12055188|FG000|STARTED|Overall Study||4
10889080|NCT02200445|12055189|FG001|STARTED|Overall Study||17
10889081|NCT02200445|12055190|FG002|STARTED|Overall Study||5
10889082|NCT02200445|12055188|FG000|COMPLETED|Overall Study||3
10889083|NCT02200445|12055189|FG001|COMPLETED|Overall Study||13
10889084|NCT02200445|12055190|FG002|COMPLETED|Overall Study||3
10889085|NCT02200445|12055188|FG000|NOT COMPLETED|Overall Study||1
10889086|NCT02200445|12055189|FG001|NOT COMPLETED|Overall Study||4
10889087|NCT02200445|12055190|FG002|NOT COMPLETED|Overall Study||2
10889088|NCT02197234|12055198|FG000|STARTED|Part A: Day 1-2 (Simvastatin Alone)||52
10889089|NCT02197234|12055198|FG000|COMPLETED|Part A: Day 1-2 (Simvastatin Alone)||52
10889090|NCT02197234|12055198|FG000|NOT COMPLETED|Part A: Day 1-2 (Simvastatin Alone)||0
10889091|NCT02197234|12055198|FG000|STARTED|Part A: Day 3-30 (AZD9291 Alone)||52
10889092|NCT02197234|12055198|FG000|COMPLETED|Part A: Day 3-30 (AZD9291 Alone)||49
10889093|NCT02197234|12055198|FG000|NOT COMPLETED|Part A: Day 3-30 (AZD9291 Alone)||3
10889094|NCT02197234|12055198|FG000|STARTED|Part A: Day 31-32 (Simvastatin+AZD9291)||49
10889095|NCT02197234|12055198|FG000|COMPLETED|Part A: Day 31-32 (Simvastatin+AZD9291)||49
10889096|NCT02197234|12055198|FG000|NOT COMPLETED|Part A: Day 31-32 (Simvastatin+AZD9291)||0
10889097|NCT02197234|12055198|FG000|STARTED|Part B: Day 33 to End Part B (AZD9291)|49 completed Part A + 1 entered Part B without completing Part A (due to AE) = 50 started Part B|50
10889098|NCT02197234|12055198|FG000|COMPLETED|Part B: Day 33 to End Part B (AZD9291)||20
10889099|NCT02197234|12055198|FG000|NOT COMPLETED|Part B: Day 33 to End Part B (AZD9291)||30
10889100|NCT02195479|12055207|FG000|STARTED|Overall Study||356
10889101|NCT02195479|12055208|FG001|STARTED|Overall Study||350
10889102|NCT02195479|12055207|FG000|Treated|Overall Study||354
10889103|NCT02195479|12055208|FG001|Treated|Overall Study||346
10889104|NCT02195479|12055207|FG000|COMPLETED|Overall Study|None of the participants completed the study as the study is still on-going.|0
10889105|NCT02195479|12055208|FG001|COMPLETED|Overall Study|None of the participants completed the study as the study is still on-going.|0
10889106|NCT02195479|12055207|FG000|NOT COMPLETED|Overall Study||356
10889107|NCT02195479|12055208|FG001|NOT COMPLETED|Overall Study||350
10889108|NCT02186834|12055214|FG000|STARTED|Dose Escalation||6
10889109|NCT02186834|12055215|FG001|STARTED|Dose Escalation||3
10889110|NCT02186834|12055216|FG002|STARTED|Dose Escalation||0
10889111|NCT02186834|12055217|FG003|STARTED|Dose Escalation||7
10889112|NCT02186834|12055218|FG004|STARTED|Dose Escalation||4
10889113|NCT02186834|12055219|FG005|STARTED|Dose Escalation||0
10889114|NCT02186834|12055214|FG000|COMPLETED|Dose Escalation||6
10889115|NCT02186834|12055215|FG001|COMPLETED|Dose Escalation||3
10889116|NCT02186834|12055216|FG002|COMPLETED|Dose Escalation||0
10889117|NCT02186834|12055217|FG003|COMPLETED|Dose Escalation||6
10889118|NCT02186834|12055218|FG004|COMPLETED|Dose Escalation||4
10889119|NCT02186834|12055219|FG005|COMPLETED|Dose Escalation||0
10889120|NCT02186834|12055214|FG000|NOT COMPLETED|Dose Escalation||0
10889121|NCT02186834|12055215|FG001|NOT COMPLETED|Dose Escalation||0
10889122|NCT02186834|12055216|FG002|NOT COMPLETED|Dose Escalation||0
10889123|NCT02186834|12055217|FG003|NOT COMPLETED|Dose Escalation||1
10889124|NCT02186834|12055218|FG004|NOT COMPLETED|Dose Escalation||0
10889125|NCT02186834|12055219|FG005|NOT COMPLETED|Dose Escalation||0
10889126|NCT02186834|12055214|FG000|STARTED|Treatment at RP2D||0
10889127|NCT02186834|12055215|FG001|STARTED|Treatment at RP2D||0
10889128|NCT02186834|12055216|FG002|STARTED|Treatment at RP2D||0
10889129|NCT02186834|12055217|FG003|STARTED|Treatment at RP2D||0
10889130|NCT02186834|12055218|FG004|STARTED|Treatment at RP2D||0
10889131|NCT02186834|12055219|FG005|STARTED|Treatment at RP2D||14
10889132|NCT02186834|12055214|FG000|COMPLETED|Treatment at RP2D||0
10889133|NCT02186834|12055215|FG001|COMPLETED|Treatment at RP2D||0
10889134|NCT02186834|12055216|FG002|COMPLETED|Treatment at RP2D||0
10889135|NCT02186834|12055217|FG003|COMPLETED|Treatment at RP2D||0
10889136|NCT02186834|12055218|FG004|COMPLETED|Treatment at RP2D||0
10889137|NCT02186834|12055219|FG005|COMPLETED|Treatment at RP2D||13
10889138|NCT02186834|12055214|FG000|NOT COMPLETED|Treatment at RP2D||0
10889139|NCT02186834|12055215|FG001|NOT COMPLETED|Treatment at RP2D||0
10889140|NCT02186834|12055216|FG002|NOT COMPLETED|Treatment at RP2D||0
10889141|NCT02186834|12055217|FG003|NOT COMPLETED|Treatment at RP2D||0
10889142|NCT02186834|12055218|FG004|NOT COMPLETED|Treatment at RP2D||0
10889143|NCT02186834|12055219|FG005|NOT COMPLETED|Treatment at RP2D||1
10889144|NCT02184195|12055230|FG000|STARTED|Overall Study||92
10889145|NCT02184195|12055231|FG001|STARTED|Overall Study||62
10889146|NCT02184195|12055230|FG000|COMPLETED|Overall Study||73
10889147|NCT02184195|12055231|FG001|COMPLETED|Overall Study||55
10889148|NCT02184195|12055230|FG000|NOT COMPLETED|Overall Study||19
10889149|NCT02184195|12055231|FG001|NOT COMPLETED|Overall Study||7
10889150|NCT02180867|12055244|FG000|STARTED|Overall Study||10
10889151|NCT02180867|12055245|FG001|STARTED|Overall Study||11
10889152|NCT02180867|12055246|FG002|STARTED|Overall Study||10
10889153|NCT02180867|12055247|FG003|STARTED|Overall Study||49
10889154|NCT02180867|12055248|FG004|STARTED|Overall Study||48
10889155|NCT02180867|12055249|FG005|STARTED|Overall Study||6
10889156|NCT02180867|12055250|FG006|STARTED|Overall Study||6
10889157|NCT02180867|12055244|FG000|Pediatric Patients|Overall Study||6
10889158|NCT02180867|12055245|FG001|Pediatric Patients|Overall Study||4
10889159|NCT02180867|12055246|FG002|Pediatric Patients|Overall Study||3
10889160|NCT02180867|12055247|FG003|Pediatric Patients|Overall Study||18
10889161|NCT02180867|12055248|FG004|Pediatric Patients|Overall Study||19
10889162|NCT02180867|12055249|FG005|Pediatric Patients|Overall Study||1
10889163|NCT02180867|12055250|FG006|Pediatric Patients|Overall Study||0
10889164|NCT02180867|12055244|FG000|Adult Patients|Overall Study||4
10889165|NCT02180867|12055245|FG001|Adult Patients|Overall Study||7
10889166|NCT02180867|12055246|FG002|Adult Patients|Overall Study||7
10889167|NCT02180867|12055247|FG003|Adult Patients|Overall Study||31
10889168|NCT02180867|12055248|FG004|Adult Patients|Overall Study||29
10889169|NCT02180867|12055249|FG005|Adult Patients|Overall Study||5
10889170|NCT02180867|12055250|FG006|Adult Patients|Overall Study||6
10889171|NCT02180867|12055244|FG000|COMPLETED|Overall Study||4
10889172|NCT02180867|12055245|FG001|COMPLETED|Overall Study||0
10889173|NCT02180867|12055246|FG002|COMPLETED|Overall Study||6
10889174|NCT02180867|12055247|FG003|COMPLETED|Overall Study||23
10889175|NCT02180867|12055248|FG004|COMPLETED|Overall Study||21
10889176|NCT02180867|12055249|FG005|COMPLETED|Overall Study||3
10889177|NCT02180867|12055250|FG006|COMPLETED|Overall Study||1
10889178|NCT02180867|12055244|FG000|NOT COMPLETED|Overall Study||6
10889179|NCT02180867|12055245|FG001|NOT COMPLETED|Overall Study||11
10889180|NCT02180867|12055246|FG002|NOT COMPLETED|Overall Study||4
10889181|NCT02180867|12055247|FG003|NOT COMPLETED|Overall Study||26
10889182|NCT02180867|12055248|FG004|NOT COMPLETED|Overall Study||27
10889183|NCT02180867|12055249|FG005|NOT COMPLETED|Overall Study||3
10889184|NCT02180867|12055250|FG006|NOT COMPLETED|Overall Study||5
10889185|NCT02173379|12055280|FG000|STARTED|Overall Study||1296
10889186|NCT02173379|12055281|FG001|STARTED|Overall Study||1308
10889187|NCT02173379|12055280|FG000|COMPLETED|Overall Study||1205
10889188|NCT02173379|12055281|FG001|COMPLETED|Overall Study||1231
10889189|NCT02173379|12055280|FG000|NOT COMPLETED|Overall Study||91
10889190|NCT02173379|12055281|FG001|NOT COMPLETED|Overall Study||77
10889191|NCT02168686|12055291|FG000|STARTED|Overall Study||2
10889192|NCT02168686|12055292|FG001|STARTED|Overall Study||2
10889193|NCT02168686|12055293|FG002|STARTED|Overall Study||2
10889194|NCT02168686|12055291|FG000|COMPLETED|Overall Study||2
10889195|NCT02168686|12055292|FG001|COMPLETED|Overall Study||2
10889196|NCT02168686|12055293|FG002|COMPLETED|Overall Study||2
10889197|NCT02168686|12055291|FG000|NOT COMPLETED|Overall Study||0
10889198|NCT02168686|12055292|FG001|NOT COMPLETED|Overall Study||0
10889199|NCT02168686|12055293|FG002|NOT COMPLETED|Overall Study||0
10889200|NCT02163733|12055312|FG000|STARTED|Part A: Day 1-9 (1st Intervention)||18
10889201|NCT02163733|12055313|FG001|STARTED|Part A: Day 1-9 (1st Intervention)||20
10889202|NCT02163733|12055314|FG002|STARTED|Part A: Day 1-9 (1st Intervention)||0
10889203|NCT02163733|12055312|FG000|COMPLETED|Part A: Day 1-9 (1st Intervention)||18
10889204|NCT02163733|12055313|FG001|COMPLETED|Part A: Day 1-9 (1st Intervention)||20
10889205|NCT02163733|12055314|FG002|COMPLETED|Part A: Day 1-9 (1st Intervention)||0
10889206|NCT02163733|12055312|FG000|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
10889207|NCT02163733|12055313|FG001|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
10889208|NCT02163733|12055314|FG002|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
10889209|NCT02163733|12055312|FG000|STARTED|Part A: Day 10-15 (2nd Intervention)||18
10889210|NCT02163733|12055313|FG001|STARTED|Part A: Day 10-15 (2nd Intervention)||20
10889211|NCT02163733|12055314|FG002|STARTED|Part A: Day 10-15 (2nd Intervention)||0
10889212|NCT02163733|12055312|FG000|COMPLETED|Part A: Day 10-15 (2nd Intervention)||18
10889213|NCT02163733|12055313|FG001|COMPLETED|Part A: Day 10-15 (2nd Intervention)||20
10889214|NCT02163733|12055314|FG002|COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
10889215|NCT02163733|12055312|FG000|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
10889216|NCT02163733|12055313|FG001|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
10889217|NCT02163733|12055314|FG002|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
10889218|NCT02163733|12055312|FG000|STARTED|Part B: Day 15 to End Part B (AZD9291)|Only the AZD9291 once daily (Part B) arm is applicable for this period.|0
10889219|NCT02163733|12055313|FG001|STARTED|Part B: Day 15 to End Part B (AZD9291)|Only the AZD9291 once daily (Part B) arm is applicable for this period.|0
10889220|NCT02163733|12055314|FG002|STARTED|Part B: Day 15 to End Part B (AZD9291)|No patients completed previous period as relates to Part A and arm is applicable only for Part B.|38
10889221|NCT02163733|12055312|FG000|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
10889222|NCT02163733|12055313|FG001|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
10889223|NCT02163733|12055314|FG002|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||14
10889224|NCT02163733|12055312|FG000|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
10889225|NCT02163733|12055313|FG001|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
10889226|NCT02163733|12055314|FG002|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||24
10889227|NCT02162667|12055323|FG000|STARTED|Neoadjuvant Period||278
10889228|NCT02162667|12055324|FG001|STARTED|Neoadjuvant Period||284
10889229|NCT02162667|12055323|FG000|COMPLETED|Neoadjuvant Period||264
10889230|NCT02162667|12055324|FG001|COMPLETED|Neoadjuvant Period||267
10889231|NCT02162667|12055323|FG000|NOT COMPLETED|Neoadjuvant Period||14
10889232|NCT02162667|12055324|FG001|NOT COMPLETED|Neoadjuvant Period||17
10889233|NCT02162667|12055323|FG000|STARTED|Adjuvant Period||260
10889234|NCT02162667|12055324|FG001|STARTED|Adjuvant Period||268
10889235|NCT02162667|12055323|FG000|COMPLETED|Adjuvant Period||248
10889236|NCT02162667|12055324|FG001|COMPLETED|Adjuvant Period||255
10889237|NCT02162667|12055323|FG000|NOT COMPLETED|Adjuvant Period||12
10889238|NCT02162667|12055324|FG001|NOT COMPLETED|Adjuvant Period||13
10889239|NCT02157883|12055334|FG000|STARTED|Part A: Day 1-5 (AZD9291 Alone)||39
10889240|NCT02157883|12055334|FG000|COMPLETED|Part A: Day 1-5 (AZD9291 Alone)||39
10889241|NCT02157883|12055334|FG000|NOT COMPLETED|Part A: Day 1-5 (AZD9291 Alone)||0
10889242|NCT02157883|12055334|FG000|STARTED|Part A: Day 6-18 (AZD9291+Itraconozole)||39
10889243|NCT02157883|12055334|FG000|COMPLETED|Part A: Day 6-18 (AZD9291+Itraconozole)||38
10889244|NCT02157883|12055334|FG000|NOT COMPLETED|Part A: Day 6-18 (AZD9291+Itraconozole)||1
10889245|NCT02157883|12055334|FG000|STARTED|Part B: Day 19 to End Part B (AZD9291)||38
10889246|NCT02157883|12055334|FG000|COMPLETED|Part B: Day 19 to End Part B (AZD9291)||16
10889247|NCT02157883|12055334|FG000|NOT COMPLETED|Part B: Day 19 to End Part B (AZD9291)||22
10889248|NCT02155946|12055345|FG000|STARTED|Overall Study||29
10889249|NCT02155946|12055346|FG001|STARTED|Overall Study||25
10889250|NCT02155946|12055347|FG002|STARTED|Overall Study||29
10889251|NCT02155946|12055348|FG003|STARTED|Overall Study||24
10889252|NCT02155946|12055345|FG000|COMPLETED|Overall Study|number completed at primary endpoint|29
10889253|NCT02155946|12055346|FG001|COMPLETED|Overall Study|number completed at primary endpoint|23
10889254|NCT02155946|12055347|FG002|COMPLETED|Overall Study|number completed at primary endpoint|29
10889255|NCT02155946|12055348|FG003|COMPLETED|Overall Study|number completed at primary endpoint|24
10889256|NCT02155946|12055345|FG000|NOT COMPLETED|Overall Study||0
10889257|NCT02155946|12055346|FG001|NOT COMPLETED|Overall Study||2
10889258|NCT02155946|12055347|FG002|NOT COMPLETED|Overall Study||0
10889259|NCT02155946|12055348|FG003|NOT COMPLETED|Overall Study||0
10889260|NCT02155712|12055362|FG000|STARTED|Primary Objective||319
10889261|NCT02155712|12055363|FG001|STARTED|Primary Objective|Cohort 2 isn't included in primary obj analysis|0
10889262|NCT02155712|12055362|FG000|COMPLETED|Primary Objective||259
10889263|NCT02155712|12055363|FG001|COMPLETED|Primary Objective||0
10889264|NCT02155712|12055362|FG000|NOT COMPLETED|Primary Objective||60
10889265|NCT02155712|12055363|FG001|NOT COMPLETED|Primary Objective||0
10889266|NCT02155712|12055362|FG000|STARTED|Secondary Objectives||319
10889267|NCT02155712|12055363|FG001|STARTED|Secondary Objectives|This period will be updated when posting secondary objective results.|134
10889268|NCT02155712|12055362|FG000|COMPLETED|Secondary Objectives||0
10889269|NCT02155712|12055363|FG001|COMPLETED|Secondary Objectives||0
10889270|NCT02155712|12055362|FG000|NOT COMPLETED|Secondary Objectives||319
10889271|NCT02155712|12055363|FG001|NOT COMPLETED|Secondary Objectives||134
10889272|NCT02152631|12055371|FG000|STARTED|Overall Study||270
10889273|NCT02152631|12055372|FG001|STARTED|Overall Study||183
10889274|NCT02152631|12055371|FG000|Received at Least One Dose of Study Drug|Overall Study||265
10889275|NCT02152631|12055372|FG001|Received at Least One Dose of Study Drug|Overall Study||175
10889276|NCT02152631|12055371|FG000|Off Treatment|Overall Study||246
10889277|NCT02152631|12055372|FG001|Off Treatment|Overall Study||172
10889278|NCT02152631|12055371|FG000|Death Due to Any Cause|Overall Study||30
10889279|NCT02152631|12055372|FG001|Death Due to Any Cause|Overall Study||20
10889280|NCT02152631|12055371|FG000|Progressive Disease|Overall Study||174
10889281|NCT02152631|12055372|FG001|Progressive Disease|Overall Study||137
10889282|NCT02152631|12055371|FG000|COMPLETED|Overall Study||204
10889283|NCT02152631|12055372|FG001|COMPLETED|Overall Study||157
10889284|NCT02152631|12055371|FG000|NOT COMPLETED|Overall Study||66
10889285|NCT02152631|12055372|FG001|NOT COMPLETED|Overall Study||26
10889286|NCT02148263|12055380|FG000|STARTED|Overall Study||12
10889287|NCT02148263|12055381|FG001|STARTED|Overall Study||13
10889288|NCT02148263|12055380|FG000|COMPLETED|Overall Study||9
10889289|NCT02148263|12055381|FG001|COMPLETED|Overall Study||11
10889290|NCT02148263|12055380|FG000|NOT COMPLETED|Overall Study||3
10889291|NCT02148263|12055381|FG001|NOT COMPLETED|Overall Study||2
10889292|NCT02136134|12055389|FG000|STARTED|Overall Study||247
10889293|NCT02136134|12055390|FG001|STARTED|Overall Study||251
10889294|NCT02136134|12055389|FG000|Treated|Overall Study||237
10889295|NCT02136134|12055390|FG001|Treated|Overall Study||243
10889296|NCT02136134|12055389|FG000|COMPLETED|Overall Study||0
10889297|NCT02136134|12055390|FG001|COMPLETED|Overall Study||0
10889298|NCT02136134|12055389|FG000|NOT COMPLETED|Overall Study||247
10889299|NCT02136134|12055390|FG001|NOT COMPLETED|Overall Study||251
10889300|NCT02134925|12055398|FG000|STARTED|Overall Study||54
10889301|NCT02134925|12055399|FG001|STARTED|Overall Study||56
10889302|NCT02134925|12055398|FG000|Received at Least One Dose of Treatment|Overall Study||53
10889303|NCT02134925|12055399|FG001|Received at Least One Dose of Treatment|Overall Study||50
10889304|NCT02134925|12055398|FG000|COMPLETED|Overall Study||52
10889305|NCT02134925|12055399|FG001|COMPLETED|Overall Study||50
10889306|NCT02134925|12055398|FG000|NOT COMPLETED|Overall Study||2
10889307|NCT02134925|12055399|FG001|NOT COMPLETED|Overall Study||6
10889308|NCT02130466|12055419|FG000|STARTED|Overall Study||7
10889309|NCT02130466|12055420|FG001|STARTED|Overall Study||3
10889310|NCT02130466|12055421|FG002|STARTED|Overall Study||2
10889311|NCT02130466|12055422|FG003|STARTED|Overall Study||8
10889312|NCT02130466|12055423|FG004|STARTED|Overall Study||2
10889313|NCT02130466|12055424|FG005|STARTED|Overall Study||60
10889314|NCT02130466|12055425|FG006|STARTED|Overall Study||60
10889315|NCT02130466|12055426|FG007|STARTED|Overall Study||3
10889316|NCT02130466|12055427|FG008|STARTED|Overall Study||4
10889317|NCT02130466|12055428|FG009|STARTED|Overall Study||5
10889318|NCT02130466|12055429|FG010|STARTED|Overall Study||6
10889319|NCT02130466|12055430|FG011|STARTED|Overall Study||3
10889320|NCT02130466|12055431|FG012|STARTED|Overall Study||12
10889321|NCT02130466|12055432|FG013|STARTED|Overall Study||9
10889322|NCT02130466|12055419|FG000|Treated|Overall Study||7
10889323|NCT02130466|12055420|FG001|Treated|Overall Study||3
10889324|NCT02130466|12055421|FG002|Treated|Overall Study||2
10889325|NCT02130466|12055422|FG003|Treated|Overall Study||8
10889326|NCT02130466|12055423|FG004|Treated|Overall Study||2
10889327|NCT02130466|12055424|FG005|Treated|Overall Study||60
10889328|NCT02130466|12055425|FG006|Treated|Overall Study||60
10889329|NCT02130466|12055426|FG007|Treated|Overall Study||3
10889330|NCT02130466|12055427|FG008|Treated|Overall Study||4
10889331|NCT02130466|12055428|FG009|Treated|Overall Study||5
10889332|NCT02130466|12055429|FG010|Treated|Overall Study||6
10889333|NCT02130466|12055430|FG011|Treated|Overall Study||3
10889334|NCT02130466|12055431|FG012|Treated|Overall Study||12
10889335|NCT02130466|12055432|FG013|Treated|Overall Study||9
10889336|NCT02130466|12055419|FG000|COMPLETED|Overall Study||0
10889337|NCT02130466|12055420|FG001|COMPLETED|Overall Study||0
10889338|NCT02130466|12055421|FG002|COMPLETED|Overall Study||0
10889339|NCT02130466|12055422|FG003|COMPLETED|Overall Study||0
10889340|NCT02130466|12055423|FG004|COMPLETED|Overall Study||0
10889341|NCT02130466|12055424|FG005|COMPLETED|Overall Study||0
10889342|NCT02130466|12055425|FG006|COMPLETED|Overall Study||0
10889343|NCT02130466|12055426|FG007|COMPLETED|Overall Study||0
10889344|NCT02130466|12055427|FG008|COMPLETED|Overall Study||0
10889345|NCT02130466|12055428|FG009|COMPLETED|Overall Study||0
10889346|NCT02130466|12055429|FG010|COMPLETED|Overall Study||0
10889347|NCT02130466|12055430|FG011|COMPLETED|Overall Study||0
10889348|NCT02130466|12055431|FG012|COMPLETED|Overall Study||0
10889349|NCT02130466|12055432|FG013|COMPLETED|Overall Study||0
10889350|NCT02130466|12055419|FG000|NOT COMPLETED|Overall Study||7
10889351|NCT02130466|12055420|FG001|NOT COMPLETED|Overall Study||3
10889352|NCT02130466|12055421|FG002|NOT COMPLETED|Overall Study||2
10889353|NCT02130466|12055422|FG003|NOT COMPLETED|Overall Study||8
10889354|NCT02130466|12055423|FG004|NOT COMPLETED|Overall Study||2
10889355|NCT02130466|12055424|FG005|NOT COMPLETED|Overall Study||60
10889356|NCT02130466|12055425|FG006|NOT COMPLETED|Overall Study||60
10889357|NCT02130466|12055426|FG007|NOT COMPLETED|Overall Study||3
10889358|NCT02130466|12055427|FG008|NOT COMPLETED|Overall Study||4
10889359|NCT02130466|12055428|FG009|NOT COMPLETED|Overall Study||5
10889360|NCT02130466|12055429|FG010|NOT COMPLETED|Overall Study||6
10889361|NCT02130466|12055430|FG011|NOT COMPLETED|Overall Study||3
10889362|NCT02130466|12055431|FG012|NOT COMPLETED|Overall Study||12
10889363|NCT02130466|12055432|FG013|NOT COMPLETED|Overall Study||9
10889364|NCT02127723|12055479|FG000|STARTED|Overall Study||20
10889365|NCT02127723|12055479|FG000|COMPLETED|Overall Study||19
10889366|NCT02127723|12055479|FG000|NOT COMPLETED|Overall Study||1
10889367|NCT02126969|12055485|FG000|STARTED|Overall Study||23
10889368|NCT02126969|12055486|FG001|STARTED|Overall Study||22
10889369|NCT02126969|12055485|FG000|COMPLETED|Overall Study||22
10889370|NCT02126969|12055486|FG001|COMPLETED|Overall Study||20
10889371|NCT02126969|12055485|FG000|NOT COMPLETED|Overall Study||1
10889372|NCT02126969|12055486|FG001|NOT COMPLETED|Overall Study||2
10889373|NCT02125461|12055494|FG000|STARTED|Overall Study||476
10889374|NCT02125461|12055495|FG001|STARTED|Overall Study||237
10889375|NCT02125461|12055494|FG000|Full Analysis Set (FAS)|Overall Study||476
10889376|NCT02125461|12055495|FG001|Full Analysis Set (FAS)|Overall Study||237
10889377|NCT02125461|12055494|FG000|Received Treatment|Overall Study||473
10889378|NCT02125461|12055495|FG001|Received Treatment|Overall Study||236
10889379|NCT02125461|12055494|FG000|Safety Analysis Set|Overall Study||475
10889380|NCT02125461|12055495|FG001|Safety Analysis Set|Overall Study||234
10889381|NCT02125461|12055494|FG000|Completed 12 Months of Treatment|Overall Study||232
10889382|NCT02125461|12055495|FG001|Completed 12 Months of Treatment|Overall Study||82
10889383|NCT02125461|12055494|FG000|COMPLETED|Overall Study||178
10889384|NCT02125461|12055495|FG001|COMPLETED|Overall Study||68
10889385|NCT02125461|12055494|FG000|NOT COMPLETED|Overall Study||298
10889386|NCT02125461|12055495|FG001|NOT COMPLETED|Overall Study||169
10889387|NCT02122952|12055503|FG000|STARTED|Overall Study||3
10889388|NCT02122952|12055504|FG001|STARTED|Overall Study||12
10889389|NCT02122952|12055503|FG000|COMPLETED|Overall Study||3
10889390|NCT02122952|12055504|FG001|COMPLETED|Overall Study||12
10889391|NCT02122952|12055503|FG000|NOT COMPLETED|Overall Study||0
10889392|NCT02122952|12055504|FG001|NOT COMPLETED|Overall Study||0
10889393|NCT02120352|12055510|FG000|STARTED|Induction Period (20 Weeks)||309
10889394|NCT02120352|12055511|FG001|STARTED|Induction Period (20 Weeks)||0
10889395|NCT02120352|12055512|FG002|STARTED|Induction Period (20 Weeks)||0
10889396|NCT02120352|12055513|FG003|STARTED|Induction Period (20 Weeks)||0
10889397|NCT02120352|12055510|FG000|COMPLETED|Induction Period (20 Weeks)||288
10889398|NCT02120352|12055511|FG001|COMPLETED|Induction Period (20 Weeks)||0
10889399|NCT02120352|12055512|FG002|COMPLETED|Induction Period (20 Weeks)||0
10889400|NCT02120352|12055513|FG003|COMPLETED|Induction Period (20 Weeks)||0
10889401|NCT02120352|12055510|FG000|NOT COMPLETED|Induction Period (20 Weeks)||21
10889402|NCT02120352|12055511|FG001|NOT COMPLETED|Induction Period (20 Weeks)||0
10889403|NCT02120352|12055512|FG002|NOT COMPLETED|Induction Period (20 Weeks)||0
10889404|NCT02120352|12055513|FG003|NOT COMPLETED|Induction Period (20 Weeks)||0
10889405|NCT02120352|12055510|FG000|STARTED|Maintenance Period (32 Weeks)||0
10889406|NCT02120352|12055511|FG001|STARTED|Maintenance Period (32 Weeks)||115
10889407|NCT02120352|12055512|FG002|STARTED|Maintenance Period (32 Weeks)||115
10889408|NCT02120352|12055513|FG003|STARTED|Maintenance Period (32 Weeks)||56
10889409|NCT02120352|12055510|FG000|COMPLETED|Maintenance Period (32 Weeks)||0
10889410|NCT02120352|12055511|FG001|COMPLETED|Maintenance Period (32 Weeks)||0
10889411|NCT02120352|12055512|FG002|COMPLETED|Maintenance Period (32 Weeks)||0
10889412|NCT02120352|12055513|FG003|COMPLETED|Maintenance Period (32 Weeks)||0
10889413|NCT02120352|12055510|FG000|NOT COMPLETED|Maintenance Period (32 Weeks)||0
10889414|NCT02120352|12055511|FG001|NOT COMPLETED|Maintenance Period (32 Weeks)||115
10889415|NCT02120352|12055512|FG002|NOT COMPLETED|Maintenance Period (32 Weeks)||115
10889416|NCT02120352|12055513|FG003|NOT COMPLETED|Maintenance Period (32 Weeks)||56
10889417|NCT02119416|12055530|FG000|STARTED|Overall Study||32
10889418|NCT02119416|12055531|FG001|STARTED|Overall Study||36
10889419|NCT02119416|12055532|FG002|STARTED|Overall Study||33
10889420|NCT02119416|12055530|FG000|COMPLETED|Overall Study||30
10889421|NCT02119416|12055531|FG001|COMPLETED|Overall Study||35
10889422|NCT02119416|12055532|FG002|COMPLETED|Overall Study||31
10889423|NCT02119416|12055530|FG000|NOT COMPLETED|Overall Study||2
10889424|NCT02119416|12055531|FG001|NOT COMPLETED|Overall Study||1
10889425|NCT02119416|12055532|FG002|NOT COMPLETED|Overall Study||2
10889426|NCT02115373|12055546|FG000|STARTED|Overall Study||4
10889427|NCT02115373|12055547|FG001|STARTED|Overall Study||13
10889428|NCT02115373|12055548|FG002|STARTED|Overall Study||49
10889429|NCT02115373|12055546|FG000|COMPLETED|Overall Study||4
10889430|NCT02115373|12055547|FG001|COMPLETED|Overall Study||13
10889431|NCT02115373|12055548|FG002|COMPLETED|Overall Study||49
10889432|NCT02115373|12055546|FG000|NOT COMPLETED|Overall Study||0
10889433|NCT02115373|12055547|FG001|NOT COMPLETED|Overall Study||0
10889434|NCT02115373|12055548|FG002|NOT COMPLETED|Overall Study||0
10889435|NCT02112526|12055565|FG000|STARTED|Overall Study||11
10889436|NCT02112526|12055566|FG001|STARTED|Overall Study||10
10889437|NCT02112526|12055565|FG000|Enrolled|Overall Study||11
10889438|NCT02112526|12055566|FG001|Enrolled|Overall Study||10
10889439|NCT02112526|12055565|FG000|Received Study Medication|Overall Study||11
10889440|NCT02112526|12055566|FG001|Received Study Medication|Overall Study||10
10889441|NCT02112526|12055565|FG000|Discontinued Study|Overall Study||11
10889442|NCT02112526|12055566|FG001|Discontinued Study|Overall Study||9
10889443|NCT02112526|12055565|FG000|Subjects Continuing Study Medication|Overall Study||0
10889444|NCT02112526|12055566|FG001|Subjects Continuing Study Medication|Overall Study||1
10889445|NCT02112526|12055565|FG000|COMPLETED|Overall Study||0
10889446|NCT02112526|12055566|FG001|COMPLETED|Overall Study||1
10889447|NCT02112526|12055565|FG000|NOT COMPLETED|Overall Study||11
10889448|NCT02112526|12055566|FG001|NOT COMPLETED|Overall Study||9
10889449|NCT02108652|12055572|FG000|STARTED|Overall Study||310
10889450|NCT02108652|12055572|FG000|COMPLETED|Overall Study||0
10889451|NCT02108652|12055572|FG000|NOT COMPLETED|Overall Study||310
10889452|NCT02106351|12055579|FG000|STARTED|Treatment Cycle 1||71
10889453|NCT02106351|12055580|FG001|STARTED|Treatment Cycle 1||70
10889454|NCT02106351|12055581|FG002|STARTED|Treatment Cycle 1||71
10889455|NCT02106351|12055579|FG000|Received Treatment in TC 1|Treatment Cycle 1||70
10889456|NCT02106351|12055580|FG001|Received Treatment in TC 1|Treatment Cycle 1||70
10889457|NCT02106351|12055581|FG002|Received Treatment in TC 1|Treatment Cycle 1||70
10889458|NCT02106351|12055579|FG000|COMPLETED|Treatment Cycle 1||66
10889459|NCT02106351|12055580|FG001|COMPLETED|Treatment Cycle 1||67
10889460|NCT02106351|12055581|FG002|COMPLETED|Treatment Cycle 1||67
10889461|NCT02106351|12055579|FG000|NOT COMPLETED|Treatment Cycle 1||5
10889462|NCT02106351|12055580|FG001|NOT COMPLETED|Treatment Cycle 1||3
10889463|NCT02106351|12055581|FG002|NOT COMPLETED|Treatment Cycle 1||4
10889464|NCT02106351|12055579|FG000|STARTED|Treatment Cycle 2|Subjects who received Dysport 2 U/kg in TC 1 were randomised to receive 8 or 16 U/kg in TCs 2-4.|0
10889465|NCT02106351|12055580|FG001|STARTED|Treatment Cycle 2|Not all subjects who completed TC 1 required retreatment in TC 2.|88
10889466|NCT02106351|12055581|FG002|STARTED|Treatment Cycle 2|Not all subjects who completed TC 1 required retreatment in TC 2.|90
10889467|NCT02106351|12055579|FG000|COMPLETED|Treatment Cycle 2||0
10889468|NCT02106351|12055580|FG001|COMPLETED|Treatment Cycle 2||83
10889469|NCT02106351|12055581|FG002|COMPLETED|Treatment Cycle 2||87
10889470|NCT02106351|12055579|FG000|NOT COMPLETED|Treatment Cycle 2||0
10889471|NCT02106351|12055580|FG001|NOT COMPLETED|Treatment Cycle 2||5
10889472|NCT02106351|12055581|FG002|NOT COMPLETED|Treatment Cycle 2||3
10889473|NCT02106351|12055579|FG000|STARTED|Treatment Cycle 3||0
10889474|NCT02106351|12055580|FG001|STARTED|Treatment Cycle 3|Not all subjects who completed TC 2 required retreatment in TC 3.|49
10889475|NCT02106351|12055581|FG002|STARTED|Treatment Cycle 3|Not all subjects who completed TC 2 required retreatment in TC 3.|58
10889476|NCT02106351|12055579|FG000|COMPLETED|Treatment Cycle 3||0
10889477|NCT02106351|12055580|FG001|COMPLETED|Treatment Cycle 3||45
10889478|NCT02106351|12055581|FG002|COMPLETED|Treatment Cycle 3||53
10889479|NCT02106351|12055579|FG000|NOT COMPLETED|Treatment Cycle 3||0
10889480|NCT02106351|12055580|FG001|NOT COMPLETED|Treatment Cycle 3||4
10889481|NCT02106351|12055581|FG002|NOT COMPLETED|Treatment Cycle 3||5
10889482|NCT02106351|12055579|FG000|STARTED|Treatment Cycle 4||0
10889483|NCT02106351|12055580|FG001|STARTED|Treatment Cycle 4|Not all subjects who completed TC 3 required retreatment in TC 4.|22
10889484|NCT02106351|12055581|FG002|STARTED|Treatment Cycle 4|Not all subjects who completed TC 3 required retreatment in TC 4.|33
10889485|NCT02106351|12055579|FG000|COMPLETED|Treatment Cycle 4||0
10889486|NCT02106351|12055580|FG001|COMPLETED|Treatment Cycle 4||21
10889487|NCT02106351|12055581|FG002|COMPLETED|Treatment Cycle 4||31
10889488|NCT02106351|12055579|FG000|NOT COMPLETED|Treatment Cycle 4||0
10889489|NCT02106351|12055580|FG001|NOT COMPLETED|Treatment Cycle 4||1
10889490|NCT02106351|12055581|FG002|NOT COMPLETED|Treatment Cycle 4||2
10889491|NCT02099864|12055595|FG000|STARTED|Overall Study||36
10889492|NCT02099864|12055595|FG000|COMPLETED|Overall Study||36
10889493|NCT02099864|12055595|FG000|NOT COMPLETED|Overall Study||0
10889494|NCT02098876|12055605|FG000|STARTED|Overall Study||45
10889495|NCT02098876|12055606|FG001|STARTED|Overall Study||41
10889496|NCT02098876|12055605|FG000|COMPLETED|Overall Study||40
10889497|NCT02098876|12055606|FG001|COMPLETED|Overall Study||36
10889498|NCT02098876|12055605|FG000|NOT COMPLETED|Overall Study||5
10889499|NCT02098876|12055606|FG001|NOT COMPLETED|Overall Study||5
10889500|NCT02098343|12055617|FG000|STARTED|Overall Study||9
10889501|NCT02098343|12055618|FG001|STARTED|Overall Study||6
10889502|NCT02098343|12055619|FG002|STARTED|Overall Study||21
10889503|NCT02098343|12055620|FG003|STARTED|Overall Study||105
10889504|NCT02098343|12055621|FG004|STARTED|Overall Study||106
10889505|NCT02098343|12055617|FG000|COMPLETED|Overall Study||9
10889506|NCT02098343|12055618|FG001|COMPLETED|Overall Study||6
10889507|NCT02098343|12055619|FG002|COMPLETED|Overall Study||20
10889508|NCT02098343|12055620|FG003|COMPLETED|Overall Study||105
10889509|NCT02098343|12055621|FG004|COMPLETED|Overall Study||106
10889510|NCT02098343|12055617|FG000|NOT COMPLETED|Overall Study||0
10889511|NCT02098343|12055618|FG001|NOT COMPLETED|Overall Study||0
10889512|NCT02098343|12055619|FG002|NOT COMPLETED|Overall Study||1
10889513|NCT02098343|12055620|FG003|NOT COMPLETED|Overall Study||0
10889514|NCT02098343|12055621|FG004|NOT COMPLETED|Overall Study||0
10889515|NCT02094261|12055634|FG000|STARTED|Overall Study||210
10889516|NCT02094261|12055634|FG000|COMPLETED|Overall Study||0
10889517|NCT02094261|12055634|FG000|NOT COMPLETED|Overall Study||210
10889518|NCT02091960|12055638|FG000|STARTED|Overall Study||103
10889519|NCT02091960|12055638|FG000|Received Treatment|Overall Study||103
10889520|NCT02091960|12055638|FG000|COMPLETED|Overall Study|Completed indicates participants with disease progression|52
10889521|NCT02091960|12055638|FG000|NOT COMPLETED|Overall Study||51
10889522|NCT02091375|12055644|FG000|STARTED|Overall Study||61
10889523|NCT02091375|12055645|FG001|STARTED|Overall Study||59
10889524|NCT02091375|12055644|FG000|Safety Analysis Set|Overall Study||61
10889525|NCT02091375|12055645|FG001|Safety Analysis Set|Overall Study||59
10889526|NCT02091375|12055644|FG000|Intention to Treat (ITT) Analysis Set|Overall Study||61
10889527|NCT02091375|12055645|FG001|Intention to Treat (ITT) Analysis Set|Overall Study||59
10889528|NCT02091375|12055644|FG000|COMPLETED|Overall Study||52
10889529|NCT02091375|12055645|FG001|COMPLETED|Overall Study||56
10889530|NCT02091375|12055644|FG000|NOT COMPLETED|Overall Study||9
10889531|NCT02091375|12055645|FG001|NOT COMPLETED|Overall Study||3
10889532|NCT02091206|12055655|FG000|STARTED|Treatment Period||10
10889533|NCT02091206|12055656|FG001|STARTED|Treatment Period||8
10889534|NCT02091206|12055657|FG002|STARTED|Treatment Period||9
10889535|NCT02091206|12055658|FG003|STARTED|Treatment Period||7
10889536|NCT02091206|12055655|FG000|Safety Analysis Set|Treatment Period||10
10889537|NCT02091206|12055656|FG001|Safety Analysis Set|Treatment Period||8
10889538|NCT02091206|12055657|FG002|Safety Analysis Set|Treatment Period||9
10889539|NCT02091206|12055658|FG003|Safety Analysis Set|Treatment Period||7
10889540|NCT02091206|12055655|FG000|COMPLETED|Treatment Period||10
10889541|NCT02091206|12055656|FG001|COMPLETED|Treatment Period||7
10889542|NCT02091206|12055657|FG002|COMPLETED|Treatment Period||8
10889543|NCT02091206|12055658|FG003|COMPLETED|Treatment Period||7
10889544|NCT02091206|12055655|FG000|NOT COMPLETED|Treatment Period||0
10889545|NCT02091206|12055656|FG001|NOT COMPLETED|Treatment Period||1
10889546|NCT02091206|12055657|FG002|NOT COMPLETED|Treatment Period||1
10889547|NCT02091206|12055658|FG003|NOT COMPLETED|Treatment Period||0
10889548|NCT02091206|12055655|FG000|STARTED|Taper Period||10
10889549|NCT02091206|12055656|FG001|STARTED|Taper Period||7
10889550|NCT02091206|12055657|FG002|STARTED|Taper Period||8
10889551|NCT02091206|12055658|FG003|STARTED|Taper Period||7
10889552|NCT02091206|12055655|FG000|COMPLETED|Taper Period||9
10889553|NCT02091206|12055656|FG001|COMPLETED|Taper Period||7
10889554|NCT02091206|12055657|FG002|COMPLETED|Taper Period||8
10889555|NCT02091206|12055658|FG003|COMPLETED|Taper Period||5
10889556|NCT02091206|12055655|FG000|NOT COMPLETED|Taper Period||1
10889557|NCT02091206|12055656|FG001|NOT COMPLETED|Taper Period||0
10889558|NCT02091206|12055657|FG002|NOT COMPLETED|Taper Period||0
10889559|NCT02091206|12055658|FG003|NOT COMPLETED|Taper Period||2
10889560|NCT02089685|12055674|FG000|STARTED|Overall Study||23
10889561|NCT02089685|12055675|FG001|STARTED|Overall Study||14
10889562|NCT02089685|12055676|FG002|STARTED|Overall Study||3
10889563|NCT02089685|12055677|FG003|STARTED|Overall Study||153
10889564|NCT02089685|12055678|FG004|STARTED|Overall Study||51
10889565|NCT02089685|12055679|FG005|STARTED|Overall Study||51
10889566|NCT02089685|12055674|FG000|Treated|Overall Study||22
10889567|NCT02089685|12055675|FG001|Treated|Overall Study||14
10889568|NCT02089685|12055676|FG002|Treated|Overall Study||3
10889569|NCT02089685|12055677|FG003|Treated|Overall Study||153
10889570|NCT02089685|12055678|FG004|Treated|Overall Study||51
10889571|NCT02089685|12055679|FG005|Treated|Overall Study||51
10889572|NCT02089685|12055674|FG000|COMPLETED|Overall Study||0
10889573|NCT02089685|12055675|FG001|COMPLETED|Overall Study||0
10889574|NCT02089685|12055676|FG002|COMPLETED|Overall Study||0
10889575|NCT02089685|12055677|FG003|COMPLETED|Overall Study||0
10889576|NCT02089685|12055678|FG004|COMPLETED|Overall Study||0
10889577|NCT02089685|12055679|FG005|COMPLETED|Overall Study||0
10889578|NCT02089685|12055674|FG000|NOT COMPLETED|Overall Study||23
10889579|NCT02089685|12055675|FG001|NOT COMPLETED|Overall Study||14
10889580|NCT02089685|12055676|FG002|NOT COMPLETED|Overall Study||3
10889581|NCT02089685|12055677|FG003|NOT COMPLETED|Overall Study||153
10889582|NCT02089685|12055678|FG004|NOT COMPLETED|Overall Study||51
10889583|NCT02089685|12055679|FG005|NOT COMPLETED|Overall Study||51
10889584|NCT02085941|12055705|FG000|STARTED|Overall Study||25
10889585|NCT02085941|12055706|FG001|STARTED|Overall Study||5
10889586|NCT02085941|12055705|FG000|COMPLETED|Overall Study||17
10889587|NCT02085941|12055706|FG001|COMPLETED|Overall Study||2
10889588|NCT02085941|12055705|FG000|NOT COMPLETED|Overall Study||8
10889589|NCT02085941|12055706|FG001|NOT COMPLETED|Overall Study||3
10889590|NCT02080403|12055714|FG000|STARTED|Overall Study||146
10889591|NCT02080403|12055715|FG001|STARTED|Overall Study||144
10889592|NCT02080403|12055714|FG000|COMPLETED|Overall Study||131
10889593|NCT02080403|12055715|FG001|COMPLETED|Overall Study||132
10889594|NCT02080403|12055714|FG000|NOT COMPLETED|Overall Study||15
10889595|NCT02080403|12055715|FG001|NOT COMPLETED|Overall Study||12
10889596|NCT02080221|12055721|FG000|STARTED|Overall Study||50
10889597|NCT02080221|12055721|FG000|COMPLETED|Overall Study||48
10889598|NCT02080221|12055721|FG000|NOT COMPLETED|Overall Study||2
10889599|NCT02076113|12055727|FG000|STARTED|Overall Study||63
10889600|NCT02076113|12055728|FG001|STARTED|Overall Study||100
10889601|NCT02076113|12055727|FG000|Surgery as Randomized|Overall Study|1 patient underwent dorsal fusion surgery|62
10889602|NCT02076113|12055728|FG001|Surgery as Randomized|Overall Study|4 patients underwent ventral fusion surgery|96
10889603|NCT02076113|12055727|FG000|3-Month Follow-up|Overall Study|5 missed follow-up visit; 2 lost to follow-up|56
10889604|NCT02076113|12055728|FG001|3-Month Follow-up|Overall Study|9 missed follow-up appointment; 1 lost to follow-up|90
10889605|NCT02076113|12055727|FG000|6-Month Follow-up|Overall Study|7 missed follow-up visit; 3 lost to follow-up|53
10889606|NCT02076113|12055728|FG001|6-Month Follow-up|Overall Study|7 missed follow-up visit; 1 lost to follow-up; 1 deceased|91
10889607|NCT02076113|12055727|FG000|1-Year Follow-up|Overall Study|3 lost to follow-up|60
10889608|NCT02076113|12055728|FG001|1-Year Follow-up|Overall Study|2 missed follow-up visit; 1 lost to follow-up; 2 deceased|95
10889609|NCT02076113|12055727|FG000|2-Year Follow-up|Overall Study|5 missed follow-up visit; 4 lost to follow-up; 2 withdrew consent; 1 deceased|51
10889610|NCT02076113|12055728|FG001|2-Year Follow-up|Overall Study|14 missed follow-up visit; 1 lost to follow-up; 3 withdrew consent; 3 deceased|79
10889611|NCT02076113|12055727|FG000|COMPLETED|Overall Study||56
10889612|NCT02076113|12055728|FG001|COMPLETED|Overall Study||93
10889613|NCT02076113|12055727|FG000|NOT COMPLETED|Overall Study||7
10889614|NCT02076113|12055728|FG001|NOT COMPLETED|Overall Study||7
10889615|NCT02076009|12055739|FG000|STARTED|Overall Study||283
10889616|NCT02076009|12055740|FG001|STARTED|Overall Study||286
10889617|NCT02076009|12055739|FG000|Treated|Overall Study||281
10889618|NCT02076009|12055740|FG001|Treated|Overall Study||283
10889619|NCT02076009|12055739|FG000|COMPLETED|Overall Study||0
10889620|NCT02076009|12055740|FG001|COMPLETED|Overall Study||0
10889621|NCT02076009|12055739|FG000|NOT COMPLETED|Overall Study||283
10889622|NCT02076009|12055740|FG001|NOT COMPLETED|Overall Study||286
10889623|NCT02075840|12055748|FG000|STARTED|Overall Study||152
10889624|NCT02075840|12055749|FG001|STARTED|Overall Study||151
10889625|NCT02075840|12055748|FG000|COMPLETED|Overall Study||0
10889626|NCT02075840|12055749|FG001|COMPLETED|Overall Study||0
10889627|NCT02075840|12055748|FG000|NOT COMPLETED|Overall Study||152
10889628|NCT02075840|12055749|FG001|NOT COMPLETED|Overall Study||151
10889629|NCT02069366|12055761|FG000|STARTED|Overall Study||13
10889630|NCT02069366|12055762|FG001|STARTED|Overall Study||10
10889631|NCT02069366|12055763|FG002|STARTED|Overall Study||18
10889632|NCT02069366|12055764|FG003|STARTED|Overall Study||17
10889633|NCT02069366|12055765|FG004|STARTED|Overall Study||14
10889634|NCT02069366|12055766|FG005|STARTED|Overall Study||14
10889635|NCT02069366|12055761|FG000|COMPLETED|Overall Study||12
10889636|NCT02069366|12055762|FG001|COMPLETED|Overall Study||10
10889637|NCT02069366|12055763|FG002|COMPLETED|Overall Study||15
10889638|NCT02069366|12055764|FG003|COMPLETED|Overall Study||15
10889639|NCT02069366|12055765|FG004|COMPLETED|Overall Study||14
10889640|NCT02069366|12055766|FG005|COMPLETED|Overall Study||12
10889641|NCT02069366|12055761|FG000|NOT COMPLETED|Overall Study||1
10889642|NCT02069366|12055762|FG001|NOT COMPLETED|Overall Study||0
10889643|NCT02069366|12055763|FG002|NOT COMPLETED|Overall Study||3
10889644|NCT02069366|12055764|FG003|NOT COMPLETED|Overall Study||2
10889645|NCT02069366|12055765|FG004|NOT COMPLETED|Overall Study||0
10889646|NCT02069366|12055766|FG005|NOT COMPLETED|Overall Study||2
10889647|NCT02066415|12055784|FG000|STARTED|Overall Study||286
10889648|NCT02066415|12055785|FG001|STARTED|Overall Study||191
10889649|NCT02066415|12055786|FG002|STARTED|Overall Study||190
10889650|NCT02066415|12055784|FG000|Received Study Drug|Overall Study||282
10889651|NCT02066415|12055785|FG001|Received Study Drug|Overall Study||190
10889652|NCT02066415|12055786|FG002|Received Study Drug|Overall Study||188
10889653|NCT02066415|12055784|FG000|COMPLETED|Overall Study||265
10889654|NCT02066415|12055785|FG001|COMPLETED|Overall Study||184
10889655|NCT02066415|12055786|FG002|COMPLETED|Overall Study||182
10889656|NCT02066415|12055784|FG000|NOT COMPLETED|Overall Study||21
10889657|NCT02066415|12055785|FG001|NOT COMPLETED|Overall Study||7
10889658|NCT02066415|12055786|FG002|NOT COMPLETED|Overall Study||8
10889659|NCT02064296|12055797|FG000|STARTED|Eligibility to Baseline Data Collection||27
10889660|NCT02064296|12055798|FG001|STARTED|Eligibility to Baseline Data Collection||39
10889661|NCT02064296|12055799|FG002|STARTED|Eligibility to Baseline Data Collection||40
10889662|NCT02064296|12055797|FG000|COMPLETED|Eligibility to Baseline Data Collection||26
10889663|NCT02064296|12055798|FG001|COMPLETED|Eligibility to Baseline Data Collection||39
10889664|NCT02064296|12055799|FG002|COMPLETED|Eligibility to Baseline Data Collection||40
10889665|NCT02064296|12055797|FG000|NOT COMPLETED|Eligibility to Baseline Data Collection||1
10889666|NCT02064296|12055798|FG001|NOT COMPLETED|Eligibility to Baseline Data Collection||0
10889667|NCT02064296|12055799|FG002|NOT COMPLETED|Eligibility to Baseline Data Collection||0
10889668|NCT02064296|12055797|FG000|STARTED|Baseline Data Collection|No healthy volunteers were given any treatment as they were used for baseline comparison purposes.|26
10889669|NCT02064296|12055798|FG001|STARTED|Baseline Data Collection||39
10889670|NCT02064296|12055799|FG002|STARTED|Baseline Data Collection||40
10889671|NCT02064296|12055797|FG000|COMPLETED|Baseline Data Collection||26
10889672|NCT02064296|12055798|FG001|COMPLETED|Baseline Data Collection||39
10889673|NCT02064296|12055799|FG002|COMPLETED|Baseline Data Collection||40
10889674|NCT02064296|12055797|FG000|NOT COMPLETED|Baseline Data Collection||0
10889675|NCT02064296|12055798|FG001|NOT COMPLETED|Baseline Data Collection||0
10889676|NCT02064296|12055799|FG002|NOT COMPLETED|Baseline Data Collection||0
10889677|NCT02064296|12055797|FG000|STARTED|Intervention|Healthy controls were never intended to have interventions.|0
10889678|NCT02064296|12055798|FG001|STARTED|Intervention||39
10889679|NCT02064296|12055799|FG002|STARTED|Intervention||40
10889680|NCT02064296|12055797|FG000|COMPLETED|Intervention||0
10889681|NCT02064296|12055798|FG001|COMPLETED|Intervention||38
10889682|NCT02064296|12055799|FG002|COMPLETED|Intervention||38
10889683|NCT02064296|12055797|FG000|NOT COMPLETED|Intervention||0
10889684|NCT02064296|12055798|FG001|NOT COMPLETED|Intervention||1
10889685|NCT02064296|12055799|FG002|NOT COMPLETED|Intervention||2
10889686|NCT02063724|12055809|FG000|STARTED|Overall Study||15
10889687|NCT02063724|12055809|FG000|COMPLETED|Overall Study||14
10889688|NCT02063724|12055809|FG000|NOT COMPLETED|Overall Study||1
10889689|NCT02061358|12055822|FG000|STARTED|Overall Study||6
10889690|NCT02061358|12055823|FG001|STARTED|Overall Study||6
10889691|NCT02061358|12055824|FG002|STARTED|Overall Study||6
10889692|NCT02061358|12055825|FG003|STARTED|Overall Study||6
10889693|NCT02061358|12055826|FG004|STARTED|Overall Study||6
10889694|NCT02061358|12055827|FG005|STARTED|Overall Study||6
10889695|NCT02061358|12055828|FG006|STARTED|Overall Study||6
10889696|NCT02061358|12055829|FG007|STARTED|Overall Study||6
10889697|NCT02061358|12055830|FG008|STARTED|Overall Study||16
10889698|NCT02061358|12055822|FG000|COMPLETED|Overall Study||6
10889699|NCT02061358|12055823|FG001|COMPLETED|Overall Study||6
10889700|NCT02061358|12055824|FG002|COMPLETED|Overall Study||6
10889701|NCT02061358|12055825|FG003|COMPLETED|Overall Study||6
10889702|NCT02061358|12055826|FG004|COMPLETED|Overall Study||6
10889703|NCT02061358|12055827|FG005|COMPLETED|Overall Study||6
10889704|NCT02061358|12055828|FG006|COMPLETED|Overall Study||6
10889705|NCT02061358|12055829|FG007|COMPLETED|Overall Study||6
10889706|NCT02061358|12055830|FG008|COMPLETED|Overall Study||16
10889707|NCT02061358|12055822|FG000|NOT COMPLETED|Overall Study||0
10889708|NCT02061358|12055823|FG001|NOT COMPLETED|Overall Study||0
10889709|NCT02061358|12055824|FG002|NOT COMPLETED|Overall Study||0
10889710|NCT02061358|12055825|FG003|NOT COMPLETED|Overall Study||0
10889711|NCT02061358|12055826|FG004|NOT COMPLETED|Overall Study||0
10889712|NCT02061358|12055827|FG005|NOT COMPLETED|Overall Study||0
10889713|NCT02061358|12055828|FG006|NOT COMPLETED|Overall Study||0
10889714|NCT02061358|12055829|FG007|NOT COMPLETED|Overall Study||0
10889715|NCT02061358|12055830|FG008|NOT COMPLETED|Overall Study||0
10889716|NCT02059265|12055850|FG000|STARTED|Overall Study||32
10889717|NCT02059265|12055850|FG000|COMPLETED|Overall Study||28
10889718|NCT02059265|12055850|FG000|NOT COMPLETED|Overall Study||4
10889719|NCT02053909|12055856|FG000|STARTED|Overall Study||123
10889720|NCT02053909|12055857|FG001|STARTED|Overall Study||127
10889721|NCT02053909|12055856|FG000|COMPLETED|Overall Study||123
10889722|NCT02053909|12055857|FG001|COMPLETED|Overall Study||127
10889723|NCT02053909|12055856|FG000|NOT COMPLETED|Overall Study||0
10889724|NCT02053909|12055857|FG001|NOT COMPLETED|Overall Study||0
10889725|NCT02043678|12055865|FG000|STARTED|Overall Study||401
10889726|NCT02043678|12055866|FG001|STARTED|Overall Study||405
10889727|NCT02043678|12055865|FG000|Treated|Overall Study||390
10889728|NCT02043678|12055866|FG001|Treated|Overall Study||396
10889729|NCT02043678|12055865|FG000|COMPLETED|Overall Study||0
10889730|NCT02043678|12055866|FG001|COMPLETED|Overall Study||0
10889731|NCT02043678|12055865|FG000|NOT COMPLETED|Overall Study||401
10889732|NCT02043678|12055866|FG001|NOT COMPLETED|Overall Study||405
10889733|NCT02032823|12055874|FG000|STARTED|Overall Study||921
10889734|NCT02032823|12055875|FG001|STARTED|Overall Study||915
10889735|NCT02032823|12055874|FG000|COMPLETED|Overall Study||0
10889736|NCT02032823|12055875|FG001|COMPLETED|Overall Study||0
10889737|NCT02032823|12055874|FG000|NOT COMPLETED|Overall Study||921
10889738|NCT02032823|12055875|FG001|NOT COMPLETED|Overall Study||915
10889739|NCT02029443|12055886|FG000|STARTED|Overall Study||134
10889740|NCT02029443|12055887|FG001|STARTED|Overall Study||99
10889741|NCT02029443|12055888|FG002|STARTED|Overall Study||33
10889742|NCT02029443|12055889|FG003|STARTED|Overall Study||29
10889743|NCT02029443|12055890|FG004|STARTED|Overall Study||6
10889744|NCT02029443|12055886|FG000|COMPLETED|Overall Study||41
10889745|NCT02029443|12055887|FG001|COMPLETED|Overall Study||70
10889746|NCT02029443|12055888|FG002|COMPLETED|Overall Study||6
10889747|NCT02029443|12055889|FG003|COMPLETED|Overall Study||3
10889748|NCT02029443|12055890|FG004|COMPLETED|Overall Study||0
10889749|NCT02029443|12055886|FG000|NOT COMPLETED|Overall Study||93
10889750|NCT02029443|12055887|FG001|NOT COMPLETED|Overall Study||29
10889751|NCT02029443|12055888|FG002|NOT COMPLETED|Overall Study||27
10889752|NCT02029443|12055889|FG003|NOT COMPLETED|Overall Study||26
10889753|NCT02029443|12055890|FG004|NOT COMPLETED|Overall Study||6
10889754|NCT02024529|12055926|FG000|STARTED|Overall Study||269
10889755|NCT02024529|12055927|FG001|STARTED|Overall Study||269
10889756|NCT02024529|12055926|FG000|COMPLETED|Overall Study||256
10889757|NCT02024529|12055927|FG001|COMPLETED|Overall Study||244
10889758|NCT02024529|12055926|FG000|NOT COMPLETED|Overall Study||13
10889759|NCT02024529|12055927|FG001|NOT COMPLETED|Overall Study||25
10889760|NCT02024087|12055937|FG000|STARTED|Overall Study||5
10889761|NCT02024087|12055938|FG001|STARTED|Overall Study|Dose change to 0.4 mg/kg and cohort expanded to 16 participants in total at this dose level|16
10889762|NCT02024087|12055937|FG000|COMPLETED|Overall Study||5
10889763|NCT02024087|12055938|FG001|COMPLETED|Overall Study||16
10889764|NCT02024087|12055937|FG000|NOT COMPLETED|Overall Study||0
10889765|NCT02024087|12055938|FG001|NOT COMPLETED|Overall Study||0
10889766|NCT02021812|12055945|FG000|STARTED|Overall Study||31
10889767|NCT02021812|12055945|FG000|COMPLETED|Overall Study||16
10889768|NCT02021812|12055945|FG000|NOT COMPLETED|Overall Study||15
10889769|NCT02016781|12055951|FG000|STARTED|Interim Look for Primary Analysis||260
10889770|NCT02016781|12055952|FG001|STARTED|Interim Look for Primary Analysis||124
10889771|NCT02016781|12055951|FG000|COMPLETED|Interim Look for Primary Analysis||187
10889772|NCT02016781|12055952|FG001|COMPLETED|Interim Look for Primary Analysis||100
10889773|NCT02016781|12055951|FG000|NOT COMPLETED|Interim Look for Primary Analysis||73
10889774|NCT02016781|12055952|FG001|NOT COMPLETED|Interim Look for Primary Analysis||24
10889775|NCT02016781|12055951|FG000|STARTED|Final Database Lock||261
10889776|NCT02016781|12055952|FG001|STARTED|Final Database Lock||123
10889777|NCT02016781|12055951|FG000|COMPLETED|Final Database Lock||248
10889778|NCT02016781|12055952|FG001|COMPLETED|Final Database Lock||115
10889779|NCT02016781|12055951|FG000|NOT COMPLETED|Final Database Lock||13
10889780|NCT02016781|12055952|FG001|NOT COMPLETED|Final Database Lock||8
10889781|NCT02006628|12055960|FG000|STARTED|Overall Study||43
10889782|NCT02006628|12055961|FG001|STARTED|Overall Study||45
10889783|NCT02006628|12055960|FG000|Received at Least 1 Dose of Study Drug|Overall Study||43
10889784|NCT02006628|12055961|FG001|Received at Least 1 Dose of Study Drug|Overall Study||45
10889785|NCT02006628|12055960|FG000|Intention to Treat (ITT) Analysis Set|Overall Study||42
10889786|NCT02006628|12055961|FG001|Intention to Treat (ITT) Analysis Set|Overall Study||44
10889787|NCT02006628|12055960|FG000|COMPLETED|Overall Study||40
10889788|NCT02006628|12055961|FG001|COMPLETED|Overall Study||43
10889789|NCT02006628|12055960|FG000|NOT COMPLETED|Overall Study||3
10889790|NCT02006628|12055961|FG001|NOT COMPLETED|Overall Study||2
10889791|NCT02003144|12055969|FG000|STARTED|Blind Induction Phase||41
10889792|NCT02003144|12055970|FG001|STARTED|Blind Induction Phase||78
10889793|NCT02003144|12055969|FG000|Received at Least 1 Dose of Study Drug|Blind Induction Phase||41
10889794|NCT02003144|12055970|FG001|Received at Least 1 Dose of Study Drug|Blind Induction Phase||78
10889795|NCT02003144|12055969|FG000|COMPLETED|Blind Induction Phase||41
10889796|NCT02003144|12055970|FG001|COMPLETED|Blind Induction Phase||78
10889797|NCT02003144|12055969|FG000|NOT COMPLETED|Blind Induction Phase||0
10889798|NCT02003144|12055970|FG001|NOT COMPLETED|Blind Induction Phase||0
10889799|NCT02003144|12055969|FG000|STARTED|Open Label Maintenance Phase||41
10889800|NCT02003144|12055970|FG001|STARTED|Open Label Maintenance Phase||78
10889801|NCT02003144|12055969|FG000|Received at Least 1 Dose of Study Drug|Open Label Maintenance Phase||41
10889802|NCT02003144|12055970|FG001|Received at Least 1 Dose of Study Drug|Open Label Maintenance Phase||78
10889803|NCT02003144|12055969|FG000|COMPLETED|Open Label Maintenance Phase||32
10889804|NCT02003144|12055970|FG001|COMPLETED|Open Label Maintenance Phase||64
10889805|NCT02003144|12055969|FG000|NOT COMPLETED|Open Label Maintenance Phase||9
10889806|NCT02003144|12055970|FG001|NOT COMPLETED|Open Label Maintenance Phase||14
10889807|NCT02002182|12055979|FG000|STARTED|Overall Study||9
10889808|NCT02002182|12055980|FG001|STARTED|Overall Study||6
10889809|NCT02002182|12055979|FG000|COMPLETED|Overall Study||4
10889810|NCT02002182|12055980|FG001|COMPLETED|Overall Study||5
10889811|NCT02002182|12055979|FG000|NOT COMPLETED|Overall Study||5
10889812|NCT02002182|12055980|FG001|NOT COMPLETED|Overall Study||1
10889813|NCT02000427|12055986|FG000|STARTED|Overall Study||45
10889814|NCT02000427|12055986|FG000|COMPLETED|Overall Study|Indicates participants ongoing in study as of the data cut-off date of 20 May 2015.|23
10889815|NCT02000427|12055986|FG000|NOT COMPLETED|Overall Study||22
10889816|NCT01992393|12055992|FG000|STARTED|Baseline||22
10889817|NCT01992393|12055993|FG001|STARTED|Baseline||22
10889818|NCT01992393|12055992|FG000|COMPLETED|Baseline||21
10889819|NCT01992393|12055993|FG001|COMPLETED|Baseline||22
10889820|NCT01992393|12055992|FG000|NOT COMPLETED|Baseline||1
10889821|NCT01992393|12055993|FG001|NOT COMPLETED|Baseline||0
10889822|NCT01992393|12055992|FG000|STARTED|Week 12 (3 Months)||21
10889823|NCT01992393|12055993|FG001|STARTED|Week 12 (3 Months)||22
10889824|NCT01992393|12055992|FG000|COMPLETED|Week 12 (3 Months)||19
10889825|NCT01992393|12055993|FG001|COMPLETED|Week 12 (3 Months)||18
10889826|NCT01992393|12055992|FG000|NOT COMPLETED|Week 12 (3 Months)||2
10889827|NCT01992393|12055993|FG001|NOT COMPLETED|Week 12 (3 Months)||4
10889828|NCT01992393|12055992|FG000|STARTED|Week 16 (4 Months)||19
10889829|NCT01992393|12055993|FG001|STARTED|Week 16 (4 Months)||18
10889830|NCT01992393|12055992|FG000|COMPLETED|Week 16 (4 Months)||19
10889831|NCT01992393|12055993|FG001|COMPLETED|Week 16 (4 Months)||16
10889832|NCT01992393|12055992|FG000|NOT COMPLETED|Week 16 (4 Months)||0
10889833|NCT01992393|12055993|FG001|NOT COMPLETED|Week 16 (4 Months)||2
10889834|NCT01991457|12055999|FG000|STARTED|Overall Study||19
10889835|NCT01991457|12055999|FG000|COMPLETED|Overall Study||19
10889836|NCT01991457|12055999|FG000|NOT COMPLETED|Overall Study||0
10889837|NCT01988493|12056008|FG000|STARTED|Overall Study||7
10889838|NCT01988493|12056009|FG001|STARTED|Overall Study||14
10889839|NCT01988493|12056010|FG002|STARTED|Overall Study||6
10889840|NCT01988493|12056011|FG003|STARTED|Overall Study||45
10889841|NCT01988493|12056012|FG004|STARTED|Overall Study||45
10889842|NCT01988493|12056008|FG000|Treated|Overall Study||7
10889843|NCT01988493|12056009|FG001|Treated|Overall Study||14
10889844|NCT01988493|12056010|FG002|Treated|Overall Study||6
10889845|NCT01988493|12056011|FG003|Treated|Overall Study||45
10889846|NCT01988493|12056012|FG004|Treated|Overall Study||44
10889847|NCT01988493|12056008|FG000|Safety Population|Overall Study||7
10889848|NCT01988493|12056009|FG001|Safety Population|Overall Study||14
10889849|NCT01988493|12056010|FG002|Safety Population|Overall Study||6
10889850|NCT01988493|12056011|FG003|Safety Population|Overall Study||45
10889851|NCT01988493|12056012|FG004|Safety Population|Overall Study||44
10889852|NCT01988493|12056008|FG000|COMPLETED|Overall Study||7
10889853|NCT01988493|12056009|FG001|COMPLETED|Overall Study||14
10889854|NCT01988493|12056010|FG002|COMPLETED|Overall Study||6
10889855|NCT01988493|12056011|FG003|COMPLETED|Overall Study||45
10889856|NCT01988493|12056012|FG004|COMPLETED|Overall Study||44
10889857|NCT01988493|12056008|FG000|NOT COMPLETED|Overall Study||0
10889858|NCT01988493|12056009|FG001|NOT COMPLETED|Overall Study||0
10889859|NCT01988493|12056010|FG002|NOT COMPLETED|Overall Study||0
10889860|NCT01988493|12056011|FG003|NOT COMPLETED|Overall Study||0
10889861|NCT01988493|12056012|FG004|NOT COMPLETED|Overall Study||1
10889862|NCT01988233|12056026|FG000|STARTED|Overall Study||167
10889863|NCT01988233|12056027|FG001|STARTED|Overall Study||166
10889864|NCT01988233|12056026|FG000|COMPLETED|Overall Study||103
10889865|NCT01988233|12056027|FG001|COMPLETED|Overall Study||115
10889866|NCT01988233|12056026|FG000|NOT COMPLETED|Overall Study||64
10889867|NCT01988233|12056027|FG001|NOT COMPLETED|Overall Study||51
10889868|NCT01986881|12056036|FG000|STARTED|Overall Study||2752
10889869|NCT01986881|12056037|FG001|STARTED|Overall Study||2747
10889870|NCT01986881|12056038|FG002|STARTED|Overall Study||2747
10889871|NCT01986881|12056036|FG000|Treated|Overall Study||2746
10889872|NCT01986881|12056037|FG001|Treated|Overall Study||2747
10889873|NCT01986881|12056038|FG002|Treated|Overall Study||2745
10889874|NCT01986881|12056036|FG000|Participants Enrolled in the Insulin +/- Metformin Glycemic Sub-Study|Overall Study||348
10889875|NCT01986881|12056037|FG001|Participants Enrolled in the Insulin +/- Metformin Glycemic Sub-Study|Overall Study||370
10889876|NCT01986881|12056038|FG002|Participants Enrolled in the Insulin +/- Metformin Glycemic Sub-Study|Overall Study||347
10889877|NCT01986881|12056036|FG000|Participants Enrolled in the Sulfonylurea Monotherapy Glycemic Sub-Study|Overall Study||55
10889878|NCT01986881|12056037|FG001|Participants Enrolled in the Sulfonylurea Monotherapy Glycemic Sub-Study|Overall Study||54
10889879|NCT01986881|12056038|FG002|Participants Enrolled in the Sulfonylurea Monotherapy Glycemic Sub-Study|Overall Study||48
10889880|NCT01986881|12056036|FG000|Participants Enrolled in the Metformin With Sulfonylurea Glycemic Sub-Study|Overall Study||100
10889881|NCT01986881|12056037|FG001|Participants Enrolled in the Metformin With Sulfonylurea Glycemic Sub-Study|Overall Study||113
10889882|NCT01986881|12056038|FG002|Participants Enrolled in the Metformin With Sulfonylurea Glycemic Sub-Study|Overall Study||117
10889883|NCT01986881|12056036|FG000|COMPLETED|Overall Study||2422
10889884|NCT01986881|12056037|FG001|COMPLETED|Overall Study||2401
10889885|NCT01986881|12056038|FG002|COMPLETED|Overall Study||2389
10889886|NCT01986881|12056036|FG000|NOT COMPLETED|Overall Study||330
10889887|NCT01986881|12056037|FG001|NOT COMPLETED|Overall Study||346
10889888|NCT01986881|12056038|FG002|NOT COMPLETED|Overall Study||358
10889889|NCT01982955|12056074|FG000|STARTED|Overall Study||6
10889890|NCT01982955|12056075|FG001|STARTED|Overall Study||12
10889891|NCT01982955|12056076|FG002|STARTED|Overall Study||31
10889892|NCT01982955|12056077|FG003|STARTED|Overall Study||24
10889893|NCT01982955|12056078|FG004|STARTED|Overall Study||15
10889894|NCT01982955|12056074|FG000|Treated|Overall Study||6
10889895|NCT01982955|12056075|FG001|Treated|Overall Study||12
10889896|NCT01982955|12056076|FG002|Treated|Overall Study||31
10889897|NCT01982955|12056077|FG003|Treated|Overall Study||23
10889898|NCT01982955|12056078|FG004|Treated|Overall Study||15
10889899|NCT01982955|12056074|FG000|COMPLETED|Overall Study||6
10889900|NCT01982955|12056075|FG001|COMPLETED|Overall Study||12
10889901|NCT01982955|12056076|FG002|COMPLETED|Overall Study||27
10889902|NCT01982955|12056077|FG003|COMPLETED|Overall Study||23
10889903|NCT01982955|12056078|FG004|COMPLETED|Overall Study||15
10889904|NCT01982955|12056074|FG000|NOT COMPLETED|Overall Study||0
10889905|NCT01982955|12056075|FG001|NOT COMPLETED|Overall Study||0
10889906|NCT01982955|12056076|FG002|NOT COMPLETED|Overall Study||4
10889907|NCT01982955|12056077|FG003|NOT COMPLETED|Overall Study||1
10889908|NCT01982955|12056078|FG004|NOT COMPLETED|Overall Study||0
10889909|NCT01981044|12056091|FG000|STARTED|Overall Study||1
10889910|NCT01981044|12056091|FG000|COMPLETED|Overall Study||1
10889911|NCT01981044|12056091|FG000|NOT COMPLETED|Overall Study||0
10889912|NCT01979536|12056097|FG000|STARTED|Overall Study||68
10889913|NCT01979536|12056098|FG001|STARTED|Overall Study||69
10889914|NCT01979536|12056097|FG000|COMPLETED|Overall Study||66
10889915|NCT01979536|12056098|FG001|COMPLETED|Overall Study||61
10889916|NCT01979536|12056097|FG000|NOT COMPLETED|Overall Study||2
10889917|NCT01979536|12056098|FG001|NOT COMPLETED|Overall Study||8
10889918|NCT01976091|12056111|FG000|STARTED|Overall Study||1
10889919|NCT01976091|12056112|FG001|STARTED|Overall Study||3
10889920|NCT01976091|12056113|FG002|STARTED|Overall Study||2
10889921|NCT01976091|12056111|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1
10889922|NCT01976091|12056112|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
10889923|NCT01976091|12056113|FG002|Received at Least 1 Dose of Study Drug|Overall Study||2
10889924|NCT01976091|12056111|FG000|COMPLETED|Overall Study||1
10889925|NCT01976091|12056112|FG001|COMPLETED|Overall Study||3
10889926|NCT01976091|12056113|FG002|COMPLETED|Overall Study||2
10889927|NCT01976091|12056111|FG000|NOT COMPLETED|Overall Study||0
10889928|NCT01976091|12056112|FG001|NOT COMPLETED|Overall Study||0
10889929|NCT01976091|12056113|FG002|NOT COMPLETED|Overall Study||0
10889930|NCT01975272|12056124|FG000|STARTED|Overall Study||9
10889931|NCT01975272|12056125|FG001|STARTED|Overall Study||10
10889932|NCT01975272|12056126|FG002|STARTED|Overall Study||8
10889933|NCT01975272|12056124|FG000|COMPLETED|Overall Study||8
10889934|NCT01975272|12056125|FG001|COMPLETED|Overall Study||9
10889935|NCT01975272|12056126|FG002|COMPLETED|Overall Study||6
10889936|NCT01975272|12056124|FG000|NOT COMPLETED|Overall Study||1
10889937|NCT01975272|12056125|FG001|NOT COMPLETED|Overall Study||1
10889938|NCT01975272|12056126|FG002|NOT COMPLETED|Overall Study||2
10889939|NCT01972308|12056136|FG000|STARTED|Overall Study||156
10889940|NCT01972308|12056137|FG001|STARTED|Overall Study||156
10889941|NCT01972308|12056136|FG000|COMPLETED|Overall Study||148
10889942|NCT01972308|12056137|FG001|COMPLETED|Overall Study||148
10889943|NCT01972308|12056136|FG000|NOT COMPLETED|Overall Study||8
10889944|NCT01972308|12056137|FG001|NOT COMPLETED|Overall Study||8
10889945|NCT01970501|12056147|FG000|STARTED|Overall Study||134
10889946|NCT01970501|12056148|FG001|STARTED|Overall Study||133
10889947|NCT01970501|12056147|FG000|Randomization (Visit 2)|Overall Study||134
10889948|NCT01970501|12056148|FG001|Randomization (Visit 2)|Overall Study||133
10889949|NCT01970501|12056147|FG000|Initial Dose Level 1|Overall Study||35
10889950|NCT01970501|12056148|FG001|Initial Dose Level 1|Overall Study||45
10889951|NCT01970501|12056147|FG000|Initial Dose Level 2|Overall Study||45
10889952|NCT01970501|12056148|FG001|Initial Dose Level 2|Overall Study||38
10889953|NCT01970501|12056147|FG000|Initial Dose Level 3|Overall Study||51
10889954|NCT01970501|12056148|FG001|Initial Dose Level 3|Overall Study||45
10889955|NCT01970501|12056147|FG000|Initial Dose Level 4|Overall Study||3
10889956|NCT01970501|12056148|FG001|Initial Dose Level 4|Overall Study||5
10889957|NCT01970501|12056147|FG000|Drug Lead-in Period|Overall Study||134
10889958|NCT01970501|12056148|FG001|Drug Lead-in Period|Overall Study||133
10889959|NCT01970501|12056147|FG000|Attained Target Dose|Overall Study||112
10889960|NCT01970501|12056148|FG001|Attained Target Dose|Overall Study||96
10889961|NCT01970501|12056147|FG000|24-Week Follow Up Period|Overall Study||132
10889962|NCT01970501|12056148|FG001|24-Week Follow Up Period|Overall Study||126
10889963|NCT01970501|12056147|FG000|Treatment Extension Period|Overall Study||77
10889964|NCT01970501|12056148|FG001|Treatment Extension Period|Overall Study||64
10889965|NCT01970501|12056147|FG000|COMPLETED|Overall Study||107
10889966|NCT01970501|12056148|FG001|COMPLETED|Overall Study||105
10889967|NCT01970501|12056147|FG000|NOT COMPLETED|Overall Study||27
10889968|NCT01970501|12056148|FG001|NOT COMPLETED|Overall Study||28
10889969|NCT01958021|12056156|FG000|STARTED|Overall Study||334
10889970|NCT01958021|12056157|FG001|STARTED|Overall Study||334
10889971|NCT01958021|12056156|FG000|Patients Untreated|Overall Study||0
10889972|NCT01958021|12056157|FG001|Patients Untreated|Overall Study||4
10889973|NCT01958021|12056156|FG000|Patients Treated|Overall Study||334
10889974|NCT01958021|12056157|FG001|Patients Treated|Overall Study||330
10889975|NCT01958021|12056156|FG000|COMPLETED|Overall Study|Completed = Treatment ongoing|195
10889976|NCT01958021|12056157|FG001|COMPLETED|Overall Study|Completed = Treatment ongoing|154
10889977|NCT01958021|12056156|FG000|NOT COMPLETED|Overall Study||139
10889978|NCT01958021|12056157|FG001|NOT COMPLETED|Overall Study||180
10889979|NCT01952574|12056167|FG000|STARTED|Double-blind Treatment Phase||160
10889980|NCT01952574|12056168|FG001|STARTED|Double-blind Treatment Phase||108
10889981|NCT01952574|12056169|FG002|STARTED|Double-blind Treatment Phase||108
10889982|NCT01952574|12056170|FG003|STARTED|Double-blind Treatment Phase||107
10889983|NCT01952574|12056171|FG004|STARTED|Double-blind Treatment Phase||0
10889984|NCT01952574|12056172|FG005|STARTED|Double-blind Treatment Phase||0
10889985|NCT01952574|12056173|FG006|STARTED|Double-blind Treatment Phase||0
10889986|NCT01952574|12056167|FG000|Received Study Drug|Double-blind Treatment Phase||153
10889987|NCT01952574|12056168|FG001|Received Study Drug|Double-blind Treatment Phase||108
10889988|NCT01952574|12056169|FG002|Received Study Drug|Double-blind Treatment Phase||105
10889989|NCT01952574|12056170|FG003|Received Study Drug|Double-blind Treatment Phase||106
10889990|NCT01952574|12056171|FG004|Received Study Drug|Double-blind Treatment Phase||0
10889991|NCT01952574|12056172|FG005|Received Study Drug|Double-blind Treatment Phase||0
10889992|NCT01952574|12056173|FG006|Received Study Drug|Double-blind Treatment Phase||0
10889993|NCT01952574|12056167|FG000|COMPLETED|Double-blind Treatment Phase||143
10889994|NCT01952574|12056168|FG001|COMPLETED|Double-blind Treatment Phase||105
10889995|NCT01952574|12056169|FG002|COMPLETED|Double-blind Treatment Phase||99
10889996|NCT01952574|12056170|FG003|COMPLETED|Double-blind Treatment Phase||101
10889997|NCT01952574|12056171|FG004|COMPLETED|Double-blind Treatment Phase||0
10889998|NCT01952574|12056172|FG005|COMPLETED|Double-blind Treatment Phase||0
10889999|NCT01952574|12056173|FG006|COMPLETED|Double-blind Treatment Phase||0
10890000|NCT01952574|12056167|FG000|NOT COMPLETED|Double-blind Treatment Phase||17
10890001|NCT01952574|12056168|FG001|NOT COMPLETED|Double-blind Treatment Phase||3
10890002|NCT01952574|12056169|FG002|NOT COMPLETED|Double-blind Treatment Phase||9
10890003|NCT01952574|12056170|FG003|NOT COMPLETED|Double-blind Treatment Phase||6
10890004|NCT01952574|12056171|FG004|NOT COMPLETED|Double-blind Treatment Phase||0
10890005|NCT01952574|12056172|FG005|NOT COMPLETED|Double-blind Treatment Phase||0
10890006|NCT01952574|12056173|FG006|NOT COMPLETED|Double-blind Treatment Phase||0
10890007|NCT01952574|12056167|FG000|STARTED|Open-label Treatment Phase||0
10890008|NCT01952574|12056168|FG001|STARTED|Open-label Treatment Phase||0
10890009|NCT01952574|12056169|FG002|STARTED|Open-label Treatment Phase||0
10890010|NCT01952574|12056170|FG003|STARTED|Open-label Treatment Phase||0
10890011|NCT01952574|12056171|FG004|STARTED|Open-label Treatment Phase||383
10890012|NCT01952574|12056172|FG005|STARTED|Open-label Treatment Phase||0
10890013|NCT01952574|12056173|FG006|STARTED|Open-label Treatment Phase||0
10890014|NCT01952574|12056167|FG000|Received 70 mg Erenumab|Open-label Treatment Phase||0
10890015|NCT01952574|12056168|FG001|Received 70 mg Erenumab|Open-label Treatment Phase||0
10890016|NCT01952574|12056169|FG002|Received 70 mg Erenumab|Open-label Treatment Phase||0
10890017|NCT01952574|12056170|FG003|Received 70 mg Erenumab|Open-label Treatment Phase||0
10890018|NCT01952574|12056171|FG004|Received 70 mg Erenumab|Open-label Treatment Phase||383
10890019|NCT01952574|12056172|FG005|Received 70 mg Erenumab|Open-label Treatment Phase||0
10890020|NCT01952574|12056173|FG006|Received 70 mg Erenumab|Open-label Treatment Phase||0
10890021|NCT01952574|12056167|FG000|Received 140 mg Erenumab|Open-label Treatment Phase||0
10890022|NCT01952574|12056168|FG001|Received 140 mg Erenumab|Open-label Treatment Phase||0
10890023|NCT01952574|12056169|FG002|Received 140 mg Erenumab|Open-label Treatment Phase||0
10890024|NCT01952574|12056170|FG003|Received 140 mg Erenumab|Open-label Treatment Phase||0
10890025|NCT01952574|12056171|FG004|Received 140 mg Erenumab|Open-label Treatment Phase||250
10890026|NCT01952574|12056172|FG005|Received 140 mg Erenumab|Open-label Treatment Phase||0
10890027|NCT01952574|12056173|FG006|Received 140 mg Erenumab|Open-label Treatment Phase||0
10890028|NCT01952574|12056167|FG000|COMPLETED|Open-label Treatment Phase||0
10890029|NCT01952574|12056168|FG001|COMPLETED|Open-label Treatment Phase||0
10890030|NCT01952574|12056169|FG002|COMPLETED|Open-label Treatment Phase||0
10890031|NCT01952574|12056170|FG003|COMPLETED|Open-label Treatment Phase||0
10890032|NCT01952574|12056171|FG004|COMPLETED|Open-label Treatment Phase||221
10890033|NCT01952574|12056172|FG005|COMPLETED|Open-label Treatment Phase||0
10890034|NCT01952574|12056173|FG006|COMPLETED|Open-label Treatment Phase||0
10890035|NCT01952574|12056167|FG000|NOT COMPLETED|Open-label Treatment Phase||0
10890036|NCT01952574|12056168|FG001|NOT COMPLETED|Open-label Treatment Phase||0
10890037|NCT01952574|12056169|FG002|NOT COMPLETED|Open-label Treatment Phase||0
10890038|NCT01952574|12056170|FG003|NOT COMPLETED|Open-label Treatment Phase||0
10890039|NCT01952574|12056171|FG004|NOT COMPLETED|Open-label Treatment Phase||162
10890040|NCT01952574|12056172|FG005|NOT COMPLETED|Open-label Treatment Phase||0
10890041|NCT01952574|12056173|FG006|NOT COMPLETED|Open-label Treatment Phase||0
10890042|NCT01952574|12056167|FG000|STARTED|Clinical Home Use Substudy||0
10890043|NCT01952574|12056168|FG001|STARTED|Clinical Home Use Substudy||0
10890044|NCT01952574|12056169|FG002|STARTED|Clinical Home Use Substudy||0
10890045|NCT01952574|12056170|FG003|STARTED|Clinical Home Use Substudy||0
10890046|NCT01952574|12056171|FG004|STARTED|Clinical Home Use Substudy||0
10890047|NCT01952574|12056172|FG005|STARTED|Clinical Home Use Substudy||42
10890048|NCT01952574|12056173|FG006|STARTED|Clinical Home Use Substudy||41
10890049|NCT01952574|12056167|FG000|COMPLETED|Clinical Home Use Substudy||0
10890050|NCT01952574|12056168|FG001|COMPLETED|Clinical Home Use Substudy||0
10890051|NCT01952574|12056169|FG002|COMPLETED|Clinical Home Use Substudy||0
10890052|NCT01952574|12056170|FG003|COMPLETED|Clinical Home Use Substudy||0
10890053|NCT01952574|12056171|FG004|COMPLETED|Clinical Home Use Substudy||0
10890054|NCT01952574|12056172|FG005|COMPLETED|Clinical Home Use Substudy||39
10890055|NCT01952574|12056173|FG006|COMPLETED|Clinical Home Use Substudy||40
10890056|NCT01952574|12056167|FG000|NOT COMPLETED|Clinical Home Use Substudy||0
10890057|NCT01952574|12056168|FG001|NOT COMPLETED|Clinical Home Use Substudy||0
10890058|NCT01952574|12056169|FG002|NOT COMPLETED|Clinical Home Use Substudy||0
10890059|NCT01952574|12056170|FG003|NOT COMPLETED|Clinical Home Use Substudy||0
10890060|NCT01952574|12056171|FG004|NOT COMPLETED|Clinical Home Use Substudy||0
10890061|NCT01952574|12056172|FG005|NOT COMPLETED|Clinical Home Use Substudy||3
10890062|NCT01952574|12056173|FG006|NOT COMPLETED|Clinical Home Use Substudy||1
10890063|NCT01951417|12056198|FG000|STARTED|Overall Study||81
10890064|NCT01951417|12056198|FG000|COMPLETED|Overall Study||72
10890065|NCT01951417|12056198|FG000|NOT COMPLETED|Overall Study||9
10890066|NCT01949662|12056208|FG000|STARTED|Overall Study||47
10890067|NCT01949662|12056209|FG001|STARTED|Overall Study||43
10890068|NCT01949662|12056208|FG000|COMPLETED|Overall Study||29
10890069|NCT01949662|12056209|FG001|COMPLETED|Overall Study||29
10890070|NCT01949662|12056208|FG000|NOT COMPLETED|Overall Study||18
10890071|NCT01949662|12056209|FG001|NOT COMPLETED|Overall Study||14
10890072|NCT01949337|12056217|FG000|STARTED|Overall Study||657
10890073|NCT01949337|12056218|FG001|STARTED|Overall Study||654
10890074|NCT01949337|12056217|FG000|COMPLETED|Overall Study||657
10890075|NCT01949337|12056218|FG001|COMPLETED|Overall Study||654
10890076|NCT01949337|12056217|FG000|NOT COMPLETED|Overall Study||0
10890077|NCT01949337|12056218|FG001|NOT COMPLETED|Overall Study||0
10890078|NCT01946529|12056227|FG000|STARTED|End of Window Therapy (2 Courses)||1
10890079|NCT01946529|12056228|FG001|STARTED|End of Window Therapy (2 Courses)||17
10890080|NCT01946529|12056229|FG002|STARTED|End of Window Therapy (2 Courses)||6
10890081|NCT01946529|12056227|FG000|COMPLETED|End of Window Therapy (2 Courses)||1
10890082|NCT01946529|12056228|FG001|COMPLETED|End of Window Therapy (2 Courses)||16
10890083|NCT01946529|12056229|FG002|COMPLETED|End of Window Therapy (2 Courses)||6
10890084|NCT01946529|12056227|FG000|NOT COMPLETED|End of Window Therapy (2 Courses)||0
10890085|NCT01946529|12056228|FG001|NOT COMPLETED|End of Window Therapy (2 Courses)||1
10890086|NCT01946529|12056229|FG002|NOT COMPLETED|End of Window Therapy (2 Courses)||0
10890087|NCT01946529|12056227|FG000|STARTED|Completion of All Therapy||1
10890088|NCT01946529|12056228|FG001|STARTED|Completion of All Therapy||16
10890089|NCT01946529|12056229|FG002|STARTED|Completion of All Therapy||6
10890090|NCT01946529|12056227|FG000|COMPLETED|Completion of All Therapy||0
10890091|NCT01946529|12056228|FG001|COMPLETED|Completion of All Therapy||0
10890092|NCT01946529|12056229|FG002|COMPLETED|Completion of All Therapy||0
10890093|NCT01946529|12056227|FG000|NOT COMPLETED|Completion of All Therapy||1
10890094|NCT01946529|12056228|FG001|NOT COMPLETED|Completion of All Therapy||16
10890095|NCT01946529|12056229|FG002|NOT COMPLETED|Completion of All Therapy||6
10890096|NCT01946204|12056238|FG000|STARTED|Overall Study||401
10890097|NCT01946204|12056239|FG001|STARTED|Overall Study||806
10890098|NCT01946204|12056238|FG000|Treated|Overall Study||398
10890099|NCT01946204|12056239|FG001|Treated|Overall Study||803
10890100|NCT01946204|12056238|FG000|COMPLETED|Overall Study||0
10890101|NCT01946204|12056239|FG001|COMPLETED|Overall Study||0
10890102|NCT01946204|12056238|FG000|NOT COMPLETED|Overall Study||401
10890103|NCT01946204|12056239|FG001|NOT COMPLETED|Overall Study||806
10890104|NCT01942694|12056247|FG000|STARTED|Overall Study||1212
10890105|NCT01942694|12056248|FG001|STARTED|Overall Study||1211
10890106|NCT01942694|12056247|FG000|COMPLETED|Overall Study||1211
10890107|NCT01942694|12056248|FG001|COMPLETED|Overall Study||1211
10890108|NCT01942694|12056247|FG000|NOT COMPLETED|Overall Study||1
10890109|NCT01942694|12056248|FG001|NOT COMPLETED|Overall Study||0
10890110|NCT01942135|12056256|FG000|STARTED|Overall Study||347
10890111|NCT01942135|12056257|FG001|STARTED|Overall Study||174
10890112|NCT01942135|12056256|FG000|COMPLETED|Overall Study||0
10890113|NCT01942135|12056257|FG001|COMPLETED|Overall Study||0
10890114|NCT01942135|12056256|FG000|NOT COMPLETED|Overall Study||347
10890115|NCT01942135|12056257|FG001|NOT COMPLETED|Overall Study||174
10890116|NCT01940471|12056265|FG000|STARTED|Double-Blind Phase||582
10890117|NCT01940471|12056266|FG001|STARTED|Double-Blind Phase||293
10890118|NCT01940471|12056265|FG000|COMPLETED|Double-Blind Phase||14
10890119|NCT01940471|12056266|FG001|COMPLETED|Double-Blind Phase||8
10890120|NCT01940471|12056265|FG000|NOT COMPLETED|Double-Blind Phase||568
10890121|NCT01940471|12056266|FG001|NOT COMPLETED|Double-Blind Phase||285
10890122|NCT01940471|12056265|FG000|STARTED|Open-Label Extension||14
10890123|NCT01940471|12056266|FG001|STARTED|Open-Label Extension||8
10890124|NCT01940471|12056265|FG000|COMPLETED|Open-Label Extension||0
10890125|NCT01940471|12056266|FG001|COMPLETED|Open-Label Extension||0
10890126|NCT01940471|12056265|FG000|NOT COMPLETED|Open-Label Extension||14
10890127|NCT01940471|12056266|FG001|NOT COMPLETED|Open-Label Extension||8
10890128|NCT01935934|12056275|FG000|STARTED|Overall Study||70
10890129|NCT01935934|12056276|FG001|STARTED|Overall Study||32
10890130|NCT01935934|12056275|FG000|COMPLETED|Overall Study||70
10890131|NCT01935934|12056276|FG001|COMPLETED|Overall Study||32
10890132|NCT01935934|12056275|FG000|NOT COMPLETED|Overall Study||0
10890133|NCT01935934|12056276|FG001|NOT COMPLETED|Overall Study||0
10890134|NCT01933932|12056287|FG000|STARTED|Overall Study||254
10890135|NCT01933932|12056288|FG001|STARTED|Overall Study||256
10890136|NCT01933932|12056287|FG000|COMPLETED|Overall Study|These were the number of patients who were still ongoing at data cut-off|70
10890137|NCT01933932|12056288|FG001|COMPLETED|Overall Study|These were the number of patients who were still ongoing at data cut-off|78
10890138|NCT01933932|12056287|FG000|NOT COMPLETED|Overall Study||184
10890139|NCT01933932|12056288|FG001|NOT COMPLETED|Overall Study||178
10890140|NCT01930123|12056296|FG000|STARTED|Overall Study||81
10890141|NCT01930123|12056297|FG001|STARTED|Overall Study||37
10890142|NCT01930123|12056296|FG000|COMPLETED|Overall Study||58
10890143|NCT01930123|12056297|FG001|COMPLETED|Overall Study||29
10890144|NCT01930123|12056296|FG000|NOT COMPLETED|Overall Study||23
10890145|NCT01930123|12056297|FG001|NOT COMPLETED|Overall Study||8
10890146|NCT01924533|12056305|FG000|STARTED|Overall Study||263
10890147|NCT01924533|12056306|FG001|STARTED|Overall Study||262
10890148|NCT01924533|12056305|FG000|COMPLETED|Overall Study||74
10890149|NCT01924533|12056306|FG001|COMPLETED|Overall Study||57
10890150|NCT01924533|12056305|FG000|NOT COMPLETED|Overall Study||189
10890151|NCT01924533|12056306|FG001|NOT COMPLETED|Overall Study||205
10890152|NCT01920932|12056312|FG000|STARTED|Overall Study||77
10890153|NCT01920932|12056312|FG000|COMPLETED|Overall Study||75
10890154|NCT01920932|12056312|FG000|NOT COMPLETED|Overall Study||2
10890155|NCT01920061|12056353|FG000|STARTED|Overall Study||4
10890156|NCT01920061|12056354|FG001|STARTED|Overall Study||5
10890157|NCT01920061|12056355|FG002|STARTED|Overall Study||3
10890158|NCT01920061|12056356|FG003|STARTED|Overall Study||4
10890159|NCT01920061|12056357|FG004|STARTED|Overall Study||5
10890160|NCT01920061|12056358|FG005|STARTED|Overall Study||4
10890161|NCT01920061|12056359|FG006|STARTED|Overall Study||3
10890162|NCT01920061|12056360|FG007|STARTED|Overall Study||3
10890163|NCT01920061|12056361|FG008|STARTED|Overall Study||3
10890164|NCT01920061|12056362|FG009|STARTED|Overall Study||3
10890165|NCT01920061|12056363|FG010|STARTED|Overall Study||10
10890166|NCT01920061|12056364|FG011|STARTED|Overall Study||5
10890167|NCT01920061|12056365|FG012|STARTED|Overall Study||3
10890168|NCT01920061|12056366|FG013|STARTED|Overall Study||16
10890169|NCT01920061|12056367|FG014|STARTED|Overall Study||4
10890170|NCT01920061|12056368|FG015|STARTED|Overall Study||7
10890171|NCT01920061|12056369|FG016|STARTED|Overall Study||3
10890172|NCT01920061|12056370|FG017|STARTED|Overall Study||3
10890173|NCT01920061|12056371|FG018|STARTED|Overall Study||10
10890174|NCT01920061|12056372|FG019|STARTED|Overall Study||12
10890175|NCT01920061|12056353|FG000|Received Treatment|Overall Study||4
10890176|NCT01920061|12056354|FG001|Received Treatment|Overall Study||5
10890177|NCT01920061|12056355|FG002|Received Treatment|Overall Study||3
10890178|NCT01920061|12056356|FG003|Received Treatment|Overall Study||3
10890179|NCT01920061|12056357|FG004|Received Treatment|Overall Study||5
10890180|NCT01920061|12056358|FG005|Received Treatment|Overall Study||4
10890181|NCT01920061|12056359|FG006|Received Treatment|Overall Study||3
10890182|NCT01920061|12056360|FG007|Received Treatment|Overall Study||3
10890183|NCT01920061|12056361|FG008|Received Treatment|Overall Study||3
10890184|NCT01920061|12056362|FG009|Received Treatment|Overall Study||3
10890185|NCT01920061|12056363|FG010|Received Treatment|Overall Study||10
10890186|NCT01920061|12056364|FG011|Received Treatment|Overall Study||5
10890187|NCT01920061|12056365|FG012|Received Treatment|Overall Study||2
10890188|NCT01920061|12056366|FG013|Received Treatment|Overall Study||15
10890189|NCT01920061|12056367|FG014|Received Treatment|Overall Study||4
10890190|NCT01920061|12056368|FG015|Received Treatment|Overall Study||7
10890191|NCT01920061|12056369|FG016|Received Treatment|Overall Study||3
10890192|NCT01920061|12056370|FG017|Received Treatment|Overall Study||3
10890193|NCT01920061|12056371|FG018|Received Treatment|Overall Study||10
10890194|NCT01920061|12056372|FG019|Received Treatment|Overall Study||12
10890195|NCT01920061|12056353|FG000|COMPLETED|Overall Study||2
10890196|NCT01920061|12056354|FG001|COMPLETED|Overall Study||1
10890197|NCT01920061|12056355|FG002|COMPLETED|Overall Study||1
10890198|NCT01920061|12056356|FG003|COMPLETED|Overall Study||2
10890199|NCT01920061|12056357|FG004|COMPLETED|Overall Study||3
10890200|NCT01920061|12056358|FG005|COMPLETED|Overall Study||2
10890201|NCT01920061|12056359|FG006|COMPLETED|Overall Study||2
10890202|NCT01920061|12056360|FG007|COMPLETED|Overall Study||2
10890203|NCT01920061|12056361|FG008|COMPLETED|Overall Study||2
10890204|NCT01920061|12056362|FG009|COMPLETED|Overall Study||1
10890205|NCT01920061|12056363|FG010|COMPLETED|Overall Study||5
10890206|NCT01920061|12056364|FG011|COMPLETED|Overall Study||2
10890207|NCT01920061|12056365|FG012|COMPLETED|Overall Study||1
10890208|NCT01920061|12056366|FG013|COMPLETED|Overall Study||10
10890209|NCT01920061|12056367|FG014|COMPLETED|Overall Study||3
10890210|NCT01920061|12056368|FG015|COMPLETED|Overall Study||4
10890211|NCT01920061|12056369|FG016|COMPLETED|Overall Study||1
10890212|NCT01920061|12056370|FG017|COMPLETED|Overall Study||1
10890213|NCT01920061|12056371|FG018|COMPLETED|Overall Study||4
10890214|NCT01920061|12056372|FG019|COMPLETED|Overall Study||8
10890215|NCT01920061|12056353|FG000|NOT COMPLETED|Overall Study||2
10890216|NCT01920061|12056354|FG001|NOT COMPLETED|Overall Study||4
10890217|NCT01920061|12056355|FG002|NOT COMPLETED|Overall Study||2
10890218|NCT01920061|12056356|FG003|NOT COMPLETED|Overall Study||2
10890219|NCT01920061|12056357|FG004|NOT COMPLETED|Overall Study||2
10890220|NCT01920061|12056358|FG005|NOT COMPLETED|Overall Study||2
10890221|NCT01920061|12056359|FG006|NOT COMPLETED|Overall Study||1
10890222|NCT01920061|12056360|FG007|NOT COMPLETED|Overall Study||1
10890223|NCT01920061|12056361|FG008|NOT COMPLETED|Overall Study||1
10890224|NCT01920061|12056362|FG009|NOT COMPLETED|Overall Study||2
10890225|NCT01920061|12056363|FG010|NOT COMPLETED|Overall Study||5
10890226|NCT01920061|12056364|FG011|NOT COMPLETED|Overall Study||3
10890227|NCT01920061|12056365|FG012|NOT COMPLETED|Overall Study||2
10890228|NCT01920061|12056366|FG013|NOT COMPLETED|Overall Study||6
10890229|NCT01920061|12056367|FG014|NOT COMPLETED|Overall Study||1
10890230|NCT01920061|12056368|FG015|NOT COMPLETED|Overall Study||3
10890231|NCT01920061|12056369|FG016|NOT COMPLETED|Overall Study||2
10890232|NCT01920061|12056370|FG017|NOT COMPLETED|Overall Study||2
10890233|NCT01920061|12056371|FG018|NOT COMPLETED|Overall Study||6
10890234|NCT01920061|12056372|FG019|NOT COMPLETED|Overall Study||4
10890235|NCT01910402|12056437|FG000|STARTED|Randomized Phase||248
10890236|NCT01910402|12056438|FG001|STARTED|Randomized Phase||247
10890237|NCT01910402|12056437|FG000|COMPLETED|Randomized Phase||206
10890238|NCT01910402|12056438|FG001|COMPLETED|Randomized Phase||192
10890239|NCT01910402|12056437|FG000|NOT COMPLETED|Randomized Phase||42
10890240|NCT01910402|12056438|FG001|NOT COMPLETED|Randomized Phase||55
10890241|NCT01910402|12056437|FG000|STARTED|Continuation Phase||120
10890242|NCT01910402|12056438|FG001|STARTED|Continuation Phase||0
10890243|NCT01910402|12056437|FG000|COMPLETED|Continuation Phase||30
10890244|NCT01910402|12056438|FG001|COMPLETED|Continuation Phase||0
10890245|NCT01910402|12056437|FG000|NOT COMPLETED|Continuation Phase||90
10890246|NCT01910402|12056438|FG001|NOT COMPLETED|Continuation Phase||0
10890247|NCT01909713|12056446|FG000|STARTED|Overall Study||35
10890248|NCT01909713|12056446|FG000|COMPLETED|Overall Study||35
10890249|NCT01909713|12056446|FG000|NOT COMPLETED|Overall Study||0
10890250|NCT01909479|12056473|FG000|STARTED|From Baseline to Week 26||135
10890251|NCT01909479|12056474|FG001|STARTED|From Baseline to Week 26||67
10890252|NCT01909479|12056473|FG000|COMPLETED|From Baseline to Week 26||129
10890253|NCT01909479|12056474|FG001|COMPLETED|From Baseline to Week 26||58
10890254|NCT01909479|12056473|FG000|NOT COMPLETED|From Baseline to Week 26||6
10890255|NCT01909479|12056474|FG001|NOT COMPLETED|From Baseline to Week 26||9
10890256|NCT01909479|12056473|FG000|STARTED|26 - 52 Weeks||128
10890257|NCT01909479|12056474|FG001|STARTED|26 - 52 Weeks||58
10890258|NCT01909479|12056473|FG000|COMPLETED|26 - 52 Weeks||125
10890259|NCT01909479|12056474|FG001|COMPLETED|26 - 52 Weeks||56
10890260|NCT01909479|12056473|FG000|NOT COMPLETED|26 - 52 Weeks||3
10890261|NCT01909479|12056474|FG001|NOT COMPLETED|26 - 52 Weeks||2
10890262|NCT01909479|12056473|FG000|STARTED|52 Weeks to End of Study|Not all of the participants that completed the previous period continued on in the study|111
10890263|NCT01909479|12056474|FG001|STARTED|52 Weeks to End of Study|Not all of the participants that completed the previous period continued on in the study|50
10890264|NCT01909479|12056473|FG000|COMPLETED|52 Weeks to End of Study||83
10890265|NCT01909479|12056474|FG001|COMPLETED|52 Weeks to End of Study||35
10890266|NCT01909479|12056473|FG000|NOT COMPLETED|52 Weeks to End of Study||28
10890267|NCT01909479|12056474|FG001|NOT COMPLETED|52 Weeks to End of Study||15
10890268|NCT01909453|12056489|FG000|STARTED|Overall Study||192
10890269|NCT01909453|12056490|FG001|STARTED|Overall Study||194
10890270|NCT01909453|12056491|FG002|STARTED|Overall Study||191
10890271|NCT01909453|12056492|FG003|STARTED|Overall Study||258
10890272|NCT01909453|12056493|FG004|STARTED|Overall Study||86
10890273|NCT01909453|12056489|FG000|COMPLETED|Overall Study||0
10890274|NCT01909453|12056490|FG001|COMPLETED|Overall Study||0
10890275|NCT01909453|12056491|FG002|COMPLETED|Overall Study||0
10890276|NCT01909453|12056492|FG003|COMPLETED|Overall Study||0
10890277|NCT01909453|12056493|FG004|COMPLETED|Overall Study||0
10890278|NCT01909453|12056489|FG000|NOT COMPLETED|Overall Study||192
10890279|NCT01909453|12056490|FG001|NOT COMPLETED|Overall Study||194
10890280|NCT01909453|12056491|FG002|NOT COMPLETED|Overall Study||191
10890281|NCT01909453|12056492|FG003|NOT COMPLETED|Overall Study||258
10890282|NCT01909453|12056493|FG004|NOT COMPLETED|Overall Study||86
10890283|NCT01907191|12056513|FG000|STARTED|Overall Study||13
10890284|NCT01907191|12056514|FG001|STARTED|Overall Study||10
10890285|NCT01907191|12056513|FG000|COMPLETED|Overall Study||13
10890286|NCT01907191|12056514|FG001|COMPLETED|Overall Study||10
10890287|NCT01907191|12056513|FG000|NOT COMPLETED|Overall Study||0
10890288|NCT01907191|12056514|FG001|NOT COMPLETED|Overall Study||0
10890289|NCT01902290|12056524|FG000|STARTED|Overall Study||210
10890290|NCT01902290|12056525|FG001|STARTED|Overall Study||211
10890291|NCT01902290|12056524|FG000|Received Study Drug|Overall Study||207
10890292|NCT01902290|12056525|FG001|Received Study Drug|Overall Study||208
10890293|NCT01902290|12056524|FG000|COMPLETED|Overall Study||162
10890294|NCT01902290|12056525|FG001|COMPLETED|Overall Study||158
10890295|NCT01902290|12056524|FG000|NOT COMPLETED|Overall Study||48
10890296|NCT01902290|12056525|FG001|NOT COMPLETED|Overall Study||53
10890297|NCT01902173|12056538|FG000|STARTED|Phase 1 Doublet Regimen Cohort 1||3
10890298|NCT01902173|12056539|FG001|STARTED|Phase 1 Doublet Regimen Cohort 1||0
10890299|NCT01902173|12056540|FG002|STARTED|Phase 1 Doublet Regimen Cohort 1||0
10890300|NCT01902173|12056541|FG003|STARTED|Phase 1 Doublet Regimen Cohort 1||0
10890301|NCT01902173|12056542|FG004|STARTED|Phase 1 Doublet Regimen Cohort 1||0
10890302|NCT01902173|12056543|FG005|STARTED|Phase 1 Doublet Regimen Cohort 1||0
10890303|NCT01902173|12056538|FG000|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
10890304|NCT01902173|12056539|FG001|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
10890305|NCT01902173|12056540|FG002|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
10890306|NCT01902173|12056541|FG003|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
10890307|NCT01902173|12056542|FG004|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
10890308|NCT01902173|12056543|FG005|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
10890309|NCT01902173|12056538|FG000|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||3
10890310|NCT01902173|12056539|FG001|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
10890311|NCT01902173|12056540|FG002|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
10890312|NCT01902173|12056541|FG003|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
10890313|NCT01902173|12056542|FG004|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
10890314|NCT01902173|12056543|FG005|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
10890315|NCT01902173|12056538|FG000|STARTED|Phase 1 Doublet Regimen Cohort 2||0
10890316|NCT01902173|12056539|FG001|STARTED|Phase 1 Doublet Regimen Cohort 2||9
10890317|NCT01902173|12056540|FG002|STARTED|Phase 1 Doublet Regimen Cohort 2||0
10890318|NCT01902173|12056541|FG003|STARTED|Phase 1 Doublet Regimen Cohort 2||0
10890319|NCT01902173|12056542|FG004|STARTED|Phase 1 Doublet Regimen Cohort 2||0
10890320|NCT01902173|12056543|FG005|STARTED|Phase 1 Doublet Regimen Cohort 2||0
10890321|NCT01902173|12056538|FG000|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
10890322|NCT01902173|12056539|FG001|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
10890323|NCT01902173|12056540|FG002|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
10890324|NCT01902173|12056541|FG003|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
10890325|NCT01902173|12056542|FG004|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
10890326|NCT01902173|12056543|FG005|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
10890327|NCT01902173|12056538|FG000|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
10890328|NCT01902173|12056539|FG001|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||9
10890329|NCT01902173|12056540|FG002|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
10890330|NCT01902173|12056541|FG003|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
10890331|NCT01902173|12056542|FG004|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
10890332|NCT01902173|12056543|FG005|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
10890333|NCT01902173|12056538|FG000|STARTED|Phase 1 Triplet Regimen Cohort 1||0
10890334|NCT01902173|12056539|FG001|STARTED|Phase 1 Triplet Regimen Cohort 1||0
10890335|NCT01902173|12056540|FG002|STARTED|Phase 1 Triplet Regimen Cohort 1||4
10890336|NCT01902173|12056541|FG003|STARTED|Phase 1 Triplet Regimen Cohort 1||0
10890337|NCT01902173|12056542|FG004|STARTED|Phase 1 Triplet Regimen Cohort 1||0
10890338|NCT01902173|12056543|FG005|STARTED|Phase 1 Triplet Regimen Cohort 1||0
10890339|NCT01902173|12056538|FG000|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
10890340|NCT01902173|12056539|FG001|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
10890341|NCT01902173|12056540|FG002|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
10890342|NCT01902173|12056541|FG003|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
10890343|NCT01902173|12056542|FG004|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
10890344|NCT01902173|12056543|FG005|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
10890345|NCT01902173|12056538|FG000|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
10890346|NCT01902173|12056539|FG001|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
10890347|NCT01902173|12056540|FG002|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||4
10890348|NCT01902173|12056541|FG003|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
10890349|NCT01902173|12056542|FG004|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
10890350|NCT01902173|12056543|FG005|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
10890351|NCT01902173|12056538|FG000|STARTED|Phase 1 Triplet Regimen Cohort 2||0
10890352|NCT01902173|12056539|FG001|STARTED|Phase 1 Triplet Regimen Cohort 2||0
10890353|NCT01902173|12056540|FG002|STARTED|Phase 1 Triplet Regimen Cohort 2||0
10890354|NCT01902173|12056541|FG003|STARTED|Phase 1 Triplet Regimen Cohort 2||3
10890355|NCT01902173|12056542|FG004|STARTED|Phase 1 Triplet Regimen Cohort 2||0
10890356|NCT01902173|12056543|FG005|STARTED|Phase 1 Triplet Regimen Cohort 2||0
10890357|NCT01902173|12056538|FG000|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
10890358|NCT01902173|12056539|FG001|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
10890359|NCT01902173|12056540|FG002|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
10890360|NCT01902173|12056541|FG003|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
10890361|NCT01902173|12056542|FG004|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
10890362|NCT01902173|12056543|FG005|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
10890363|NCT01902173|12056538|FG000|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
10890364|NCT01902173|12056539|FG001|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
10890365|NCT01902173|12056540|FG002|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
10890366|NCT01902173|12056541|FG003|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||3
10890367|NCT01902173|12056542|FG004|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
10890368|NCT01902173|12056543|FG005|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
10890369|NCT01902173|12056538|FG000|STARTED|Phase 1 Triplet Regimen Cohort 3||0
10890370|NCT01902173|12056539|FG001|STARTED|Phase 1 Triplet Regimen Cohort 3||0
10890371|NCT01902173|12056540|FG002|STARTED|Phase 1 Triplet Regimen Cohort 3||0
10890372|NCT01902173|12056541|FG003|STARTED|Phase 1 Triplet Regimen Cohort 3||0
10890373|NCT01902173|12056542|FG004|STARTED|Phase 1 Triplet Regimen Cohort 3||3
10890374|NCT01902173|12056543|FG005|STARTED|Phase 1 Triplet Regimen Cohort 3||0
10890375|NCT01902173|12056538|FG000|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
10890376|NCT01902173|12056539|FG001|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
10890377|NCT01902173|12056540|FG002|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
10890378|NCT01902173|12056541|FG003|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
10890379|NCT01902173|12056542|FG004|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
10890380|NCT01902173|12056543|FG005|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
10890381|NCT01902173|12056538|FG000|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
10890382|NCT01902173|12056539|FG001|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
10890383|NCT01902173|12056540|FG002|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
10890384|NCT01902173|12056541|FG003|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
10890385|NCT01902173|12056542|FG004|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||3
10890386|NCT01902173|12056543|FG005|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
10890387|NCT01902173|12056538|FG000|STARTED|Phase 1 Triplet Regimen Cohort 4||0
10890388|NCT01902173|12056539|FG001|STARTED|Phase 1 Triplet Regimen Cohort 4||0
10890389|NCT01902173|12056540|FG002|STARTED|Phase 1 Triplet Regimen Cohort 4||0
10890390|NCT01902173|12056541|FG003|STARTED|Phase 1 Triplet Regimen Cohort 4||0
10890391|NCT01902173|12056542|FG004|STARTED|Phase 1 Triplet Regimen Cohort 4||0
10890392|NCT01902173|12056543|FG005|STARTED|Phase 1 Triplet Regimen Cohort 4||5
10890393|NCT01902173|12056538|FG000|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
10890394|NCT01902173|12056539|FG001|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
10890395|NCT01902173|12056540|FG002|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
10890396|NCT01902173|12056541|FG003|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
10890397|NCT01902173|12056542|FG004|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
10890398|NCT01902173|12056543|FG005|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
10890399|NCT01902173|12056538|FG000|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
10890400|NCT01902173|12056539|FG001|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
10890401|NCT01902173|12056540|FG002|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
10890402|NCT01902173|12056541|FG003|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
10890403|NCT01902173|12056542|FG004|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
10890404|NCT01902173|12056543|FG005|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||5
10890405|NCT01902173|12056538|FG000|STARTED|Phase II||0
10890406|NCT01902173|12056539|FG001|STARTED|Phase II||0
10890407|NCT01902173|12056540|FG002|STARTED|Phase II||0
10890408|NCT01902173|12056541|FG003|STARTED|Phase II||0
10890409|NCT01902173|12056542|FG004|STARTED|Phase II||0
10890410|NCT01902173|12056543|FG005|STARTED|Phase II||0
10890411|NCT01902173|12056538|FG000|COMPLETED|Phase II||0
10890412|NCT01902173|12056539|FG001|COMPLETED|Phase II||0
10890413|NCT01902173|12056540|FG002|COMPLETED|Phase II||0
10890414|NCT01902173|12056541|FG003|COMPLETED|Phase II||0
10890415|NCT01902173|12056542|FG004|COMPLETED|Phase II||0
10890416|NCT01902173|12056543|FG005|COMPLETED|Phase II||0
10890417|NCT01902173|12056538|FG000|NOT COMPLETED|Phase II||0
10890418|NCT01902173|12056539|FG001|NOT COMPLETED|Phase II||0
10890419|NCT01902173|12056540|FG002|NOT COMPLETED|Phase II||0
10890420|NCT01902173|12056541|FG003|NOT COMPLETED|Phase II||0
10890421|NCT01902173|12056542|FG004|NOT COMPLETED|Phase II||0
10890422|NCT01902173|12056543|FG005|NOT COMPLETED|Phase II||0
10890423|NCT01900691|12056560|FG000|STARTED|Overall Study||130
10890424|NCT01900691|12056560|FG000|COMPLETED|Overall Study||111
10890425|NCT01900691|12056560|FG000|NOT COMPLETED|Overall Study||19
10890426|NCT01898494|12056569|FG000|STARTED|Step 1 (Arm S - Transoral Surgery)||49
10890427|NCT01898494|12056570|FG001|STARTED|Step 1 (Arm S - Transoral Surgery)||126
10890428|NCT01898494|12056571|FG002|STARTED|Step 1 (Arm S - Transoral Surgery)||132
10890429|NCT01898494|12056572|FG003|STARTED|Step 1 (Arm S - Transoral Surgery)||138
10890430|NCT01898494|12056573|FG004|STARTED|Step 1 (Arm S - Transoral Surgery)||74
10890431|NCT01898494|12056569|FG000|COMPLETED|Step 1 (Arm S - Transoral Surgery)||49
10890432|NCT01898494|12056570|FG001|COMPLETED|Step 1 (Arm S - Transoral Surgery)||126
10890433|NCT01898494|12056571|FG002|COMPLETED|Step 1 (Arm S - Transoral Surgery)||132
10890434|NCT01898494|12056572|FG003|COMPLETED|Step 1 (Arm S - Transoral Surgery)||138
10890435|NCT01898494|12056573|FG004|COMPLETED|Step 1 (Arm S - Transoral Surgery)||50
10890436|NCT01898494|12056569|FG000|NOT COMPLETED|Step 1 (Arm S - Transoral Surgery)||0
10890437|NCT01898494|12056570|FG001|NOT COMPLETED|Step 1 (Arm S - Transoral Surgery)||0
10890438|NCT01898494|12056571|FG002|NOT COMPLETED|Step 1 (Arm S - Transoral Surgery)||0
10890439|NCT01898494|12056572|FG003|NOT COMPLETED|Step 1 (Arm S - Transoral Surgery)||0
10890440|NCT01898494|12056573|FG004|NOT COMPLETED|Step 1 (Arm S - Transoral Surgery)||24
10890441|NCT01898494|12056569|FG000|STARTED|Step 2 (Adjuvant Treatment)||49
10890442|NCT01898494|12056570|FG001|STARTED|Step 2 (Adjuvant Treatment)||126
10890443|NCT01898494|12056571|FG002|STARTED|Step 2 (Adjuvant Treatment)||132
10890444|NCT01898494|12056572|FG003|STARTED|Step 2 (Adjuvant Treatment)||138
10890445|NCT01898494|12056573|FG004|STARTED|Step 2 (Adjuvant Treatment)|This group of patients did not proceed to adjuvant treatment on this study. They either received surgery but did not proceed to adjuvant treatment or did not receive surgery in Step 1.|0
10890446|NCT01898494|12056569|FG000|Treated|Step 2 (Adjuvant Treatment)||49
10890447|NCT01898494|12056570|FG001|Treated|Step 2 (Adjuvant Treatment)||120
10890448|NCT01898494|12056571|FG002|Treated|Step 2 (Adjuvant Treatment)||127
10890449|NCT01898494|12056572|FG003|Treated|Step 2 (Adjuvant Treatment)||134
10890450|NCT01898494|12056573|FG004|Treated|Step 2 (Adjuvant Treatment)||0
10890451|NCT01898494|12056569|FG000|Eligible and Treated|Step 2 (Adjuvant Treatment)||38
10890452|NCT01898494|12056570|FG001|Eligible and Treated|Step 2 (Adjuvant Treatment)||100
10890453|NCT01898494|12056571|FG002|Eligible and Treated|Step 2 (Adjuvant Treatment)||108
10890454|NCT01898494|12056572|FG003|Eligible and Treated|Step 2 (Adjuvant Treatment)||113
10890455|NCT01898494|12056573|FG004|Eligible and Treated|Step 2 (Adjuvant Treatment)||0
10890456|NCT01898494|12056569|FG000|Eligible and Treated Patients With Baseline MDADI Assessed|Step 2 (Adjuvant Treatment)||35
10890457|NCT01898494|12056570|FG001|Eligible and Treated Patients With Baseline MDADI Assessed|Step 2 (Adjuvant Treatment)||91
10890458|NCT01898494|12056571|FG002|Eligible and Treated Patients With Baseline MDADI Assessed|Step 2 (Adjuvant Treatment)||99
10890459|NCT01898494|12056572|FG003|Eligible and Treated Patients With Baseline MDADI Assessed|Step 2 (Adjuvant Treatment)||102
10890460|NCT01898494|12056573|FG004|Eligible and Treated Patients With Baseline MDADI Assessed|Step 2 (Adjuvant Treatment)||0
10890461|NCT01898494|12056569|FG000|Eligible and Treated Patients With Post-surgery MDADI Assessed|Step 2 (Adjuvant Treatment)||31
10890462|NCT01898494|12056570|FG001|Eligible and Treated Patients With Post-surgery MDADI Assessed|Step 2 (Adjuvant Treatment)||83
10890463|NCT01898494|12056571|FG002|Eligible and Treated Patients With Post-surgery MDADI Assessed|Step 2 (Adjuvant Treatment)||88
10890464|NCT01898494|12056572|FG003|Eligible and Treated Patients With Post-surgery MDADI Assessed|Step 2 (Adjuvant Treatment)||94
10890465|NCT01898494|12056573|FG004|Eligible and Treated Patients With Post-surgery MDADI Assessed|Step 2 (Adjuvant Treatment)||0
10890466|NCT01898494|12056569|FG000|Eligible and Treated Patients With FACT-H&N Assessed at 6 Months|Step 2 (Adjuvant Treatment)||21
10890467|NCT01898494|12056570|FG001|Eligible and Treated Patients With FACT-H&N Assessed at 6 Months|Step 2 (Adjuvant Treatment)||75
10890468|NCT01898494|12056571|FG002|Eligible and Treated Patients With FACT-H&N Assessed at 6 Months|Step 2 (Adjuvant Treatment)||80
10890469|NCT01898494|12056572|FG003|Eligible and Treated Patients With FACT-H&N Assessed at 6 Months|Step 2 (Adjuvant Treatment)||77
10890470|NCT01898494|12056573|FG004|Eligible and Treated Patients With FACT-H&N Assessed at 6 Months|Step 2 (Adjuvant Treatment)||0
10890471|NCT01898494|12056569|FG000|COMPLETED|Step 2 (Adjuvant Treatment)||49
10890472|NCT01898494|12056570|FG001|COMPLETED|Step 2 (Adjuvant Treatment)||119
10890473|NCT01898494|12056571|FG002|COMPLETED|Step 2 (Adjuvant Treatment)||118
10890474|NCT01898494|12056572|FG003|COMPLETED|Step 2 (Adjuvant Treatment)||127
10890475|NCT01898494|12056573|FG004|COMPLETED|Step 2 (Adjuvant Treatment)||0
10890476|NCT01898494|12056569|FG000|NOT COMPLETED|Step 2 (Adjuvant Treatment)||0
10890477|NCT01898494|12056570|FG001|NOT COMPLETED|Step 2 (Adjuvant Treatment)||7
10890478|NCT01898494|12056571|FG002|NOT COMPLETED|Step 2 (Adjuvant Treatment)||14
10890479|NCT01898494|12056572|FG003|NOT COMPLETED|Step 2 (Adjuvant Treatment)||11
10890480|NCT01898494|12056573|FG004|NOT COMPLETED|Step 2 (Adjuvant Treatment)||0
10890481|NCT01893567|12056585|FG000|STARTED|Overall Study||28
10890482|NCT01893567|12056585|FG000|COMPLETED|Overall Study||28
10890483|NCT01893567|12056585|FG000|NOT COMPLETED|Overall Study||0
10890484|NCT01892722|12056591|FG000|STARTED|Overall Study||107
10890485|NCT01892722|12056592|FG001|STARTED|Overall Study||108
10890486|NCT01892722|12056591|FG000|Full Analysis Set|Overall Study||107
10890487|NCT01892722|12056592|FG001|Full Analysis Set|Overall Study||107
10890488|NCT01892722|12056591|FG000|COMPLETED|Overall Study||100
10890489|NCT01892722|12056592|FG001|COMPLETED|Overall Study||88
10890490|NCT01892722|12056591|FG000|NOT COMPLETED|Overall Study||7
10890491|NCT01892722|12056592|FG001|NOT COMPLETED|Overall Study||20
10890492|NCT01892657|12056598|FG000|STARTED|Overall Study||128
10890493|NCT01892657|12056598|FG000|COMPLETED|Overall Study||110
10890494|NCT01892657|12056598|FG000|NOT COMPLETED|Overall Study||18
10890495|NCT01890954|12056616|FG000|STARTED|Overall Study||9
10890496|NCT01890954|12056617|FG001|STARTED|Overall Study||8
10890497|NCT01890954|12056616|FG000|COMPLETED|Overall Study||8
10890498|NCT01890954|12056617|FG001|COMPLETED|Overall Study||8
10890499|NCT01890954|12056616|FG000|NOT COMPLETED|Overall Study||1
10890500|NCT01890954|12056617|FG001|NOT COMPLETED|Overall Study||0
10890501|NCT01886872|12056626|FG000|STARTED|Overall Study||183
10890502|NCT01886872|12056627|FG001|STARTED|Overall Study||182
10890503|NCT01886872|12056628|FG002|STARTED|Overall Study||182
10890504|NCT01886872|12056626|FG000|Evaluable for Secondary Endpoints|Overall Study||183
10890505|NCT01886872|12056627|FG001|Evaluable for Secondary Endpoints|Overall Study||182
10890506|NCT01886872|12056628|FG002|Evaluable for Secondary Endpoints|Overall Study||182
10890507|NCT01886872|12056626|FG000|Evaluable for Adverse Events|Overall Study||176
10890508|NCT01886872|12056627|FG001|Evaluable for Adverse Events|Overall Study||180
10890509|NCT01886872|12056628|FG002|Evaluable for Adverse Events|Overall Study||181
10890510|NCT01886872|12056626|FG000|Crossover Cohort|Overall Study||30
10890511|NCT01886872|12056627|FG001|Crossover Cohort|Overall Study||0
10890512|NCT01886872|12056628|FG002|Crossover Cohort|Overall Study||0
10890513|NCT01886872|12056626|FG000|COMPLETED|Overall Study||176
10890514|NCT01886872|12056627|FG001|COMPLETED|Overall Study||178
10890515|NCT01886872|12056628|FG002|COMPLETED|Overall Study||170
10890516|NCT01886872|12056626|FG000|NOT COMPLETED|Overall Study||7
10890517|NCT01886872|12056627|FG001|NOT COMPLETED|Overall Study||4
10890518|NCT01886872|12056628|FG002|NOT COMPLETED|Overall Study||12
10890519|NCT01884740|12056637|FG000|STARTED|Overall Study||13
10890520|NCT01884740|12056637|FG000|COMPLETED|Overall Study||13
10890521|NCT01884740|12056637|FG000|NOT COMPLETED|Overall Study||0
10890522|NCT01879085|12056644|FG000|STARTED|Phase 1b||6
10890523|NCT01879085|12056645|FG001|STARTED|Phase 1b||6
10890524|NCT01879085|12056646|FG002|STARTED|Phase 1b||0
10890525|NCT01879085|12056644|FG000|COMPLETED|Phase 1b||6
10890526|NCT01879085|12056645|FG001|COMPLETED|Phase 1b||6
10890527|NCT01879085|12056646|FG002|COMPLETED|Phase 1b||0
10890528|NCT01879085|12056644|FG000|NOT COMPLETED|Phase 1b||0
10890529|NCT01879085|12056645|FG001|NOT COMPLETED|Phase 1b||0
10890530|NCT01879085|12056646|FG002|NOT COMPLETED|Phase 1b||0
10890531|NCT01879085|12056644|FG000|STARTED|Phase 2||6
10890532|NCT01879085|12056645|FG001|STARTED|Phase 2||0
10890533|NCT01879085|12056646|FG002|STARTED|Phase 2||25
10890534|NCT01879085|12056644|FG000|COMPLETED|Phase 2||6
10890535|NCT01879085|12056645|FG001|COMPLETED|Phase 2||0
10890536|NCT01879085|12056646|FG002|COMPLETED|Phase 2||25
10890537|NCT01879085|12056644|FG000|NOT COMPLETED|Phase 2||0
10890538|NCT01879085|12056645|FG001|NOT COMPLETED|Phase 2||0
10890539|NCT01879085|12056646|FG002|NOT COMPLETED|Phase 2||0
10890540|NCT01872715|12056653|FG000|STARTED|Overall Study||24
10890541|NCT01872715|12056653|FG000|COMPLETED|Overall Study||20
10890542|NCT01872715|12056653|FG000|NOT COMPLETED|Overall Study||4
10890543|NCT01867580|12056669|FG000|STARTED|Overall Study||93
10890544|NCT01867580|12056670|FG001|STARTED|Overall Study||88
10890545|NCT01867580|12056669|FG000|COMPLETED|Overall Study||65
10890546|NCT01867580|12056670|FG001|COMPLETED|Overall Study||64
10890547|NCT01867580|12056669|FG000|NOT COMPLETED|Overall Study||28
10890548|NCT01867580|12056670|FG001|NOT COMPLETED|Overall Study||24
10890549|NCT01865812|12056676|FG000|STARTED|Primary Treatment Phase||27
10890550|NCT01865812|12056677|FG001|STARTED|Primary Treatment Phase||0
10890551|NCT01865812|12056676|FG000|Received at Least 1 Dose of Study Drug|Primary Treatment Phase||27
10890552|NCT01865812|12056677|FG001|Received at Least 1 Dose of Study Drug|Primary Treatment Phase||0
10890553|NCT01865812|12056676|FG000|COMPLETED|Primary Treatment Phase||25
10890554|NCT01865812|12056677|FG001|COMPLETED|Primary Treatment Phase||0
10890555|NCT01865812|12056676|FG000|NOT COMPLETED|Primary Treatment Phase||2
10890556|NCT01865812|12056677|FG001|NOT COMPLETED|Primary Treatment Phase||0
10890557|NCT01865812|12056676|FG000|STARTED|Long-term Safety Extension Phase|Only eligible participants who completed the PTP phase enrolled in the LTSE phase.|0
10890558|NCT01865812|12056677|FG001|STARTED|Long-term Safety Extension Phase|Only eligible participants who completed the PTP phase enrolled in the LTSE phase.|21
10890559|NCT01865812|12056676|FG000|Received at Least 1 Dose of Study Drug|Long-term Safety Extension Phase||0
10890560|NCT01865812|12056677|FG001|Received at Least 1 Dose of Study Drug|Long-term Safety Extension Phase||21
10890561|NCT01865812|12056676|FG000|COMPLETED|Long-term Safety Extension Phase||0
10890562|NCT01865812|12056677|FG001|COMPLETED|Long-term Safety Extension Phase||15
10890563|NCT01865812|12056676|FG000|NOT COMPLETED|Long-term Safety Extension Phase||0
10890564|NCT01865812|12056677|FG001|NOT COMPLETED|Long-term Safety Extension Phase||6
10890565|NCT01864018|12056686|FG000|STARTED|Overall Study||51
10890566|NCT01864018|12056687|FG001|STARTED|Overall Study||36
10890567|NCT01864018|12056686|FG000|Accrued During Phase I|Overall Study||10
10890568|NCT01864018|12056687|FG001|Accrued During Phase I|Overall Study||0
10890569|NCT01864018|12056686|FG000|Accrued During Phase II|Overall Study||41
10890570|NCT01864018|12056687|FG001|Accrued During Phase II|Overall Study||36
10890571|NCT01864018|12056686|FG000|COMPLETED|Overall Study||48
10890572|NCT01864018|12056687|FG001|COMPLETED|Overall Study||35
10890573|NCT01864018|12056686|FG000|NOT COMPLETED|Overall Study||3
10890574|NCT01864018|12056687|FG001|NOT COMPLETED|Overall Study||1
10890575|NCT01856192|12056700|FG000|STARTED|Overall Study||173
10890576|NCT01856192|12056701|FG001|STARTED|Overall Study||176
10890577|NCT01856192|12056700|FG000|Treated Patients|Overall Study||166
10890578|NCT01856192|12056701|FG001|Treated Patients|Overall Study||171
10890579|NCT01856192|12056700|FG000|Evaluable Patients (Eligible and Treated)|Overall Study||145
10890580|NCT01856192|12056701|FG001|Evaluable Patients (Eligible and Treated)|Overall Study||135
10890581|NCT01856192|12056700|FG000|COMPLETED|Overall Study||124
10890582|NCT01856192|12056701|FG001|COMPLETED|Overall Study||116
10890583|NCT01856192|12056700|FG000|NOT COMPLETED|Overall Study||49
10890584|NCT01856192|12056701|FG001|NOT COMPLETED|Overall Study||60
10890585|NCT01853163|12056711|FG000|STARTED|Overall Study||45
10890586|NCT01853163|12056712|FG001|STARTED|Overall Study||29
10890587|NCT01853163|12056713|FG002|STARTED|Overall Study||7
10890588|NCT01853163|12056714|FG003|STARTED|Overall Study||11
10890589|NCT01853163|12056711|FG000|COMPLETED|Overall Study||45
10890590|NCT01853163|12056712|FG001|COMPLETED|Overall Study||29
10890591|NCT01853163|12056713|FG002|COMPLETED|Overall Study||7
10890592|NCT01853163|12056714|FG003|COMPLETED|Overall Study||11
10890593|NCT01853163|12056711|FG000|NOT COMPLETED|Overall Study||0
10890594|NCT01853163|12056712|FG001|NOT COMPLETED|Overall Study||0
10890595|NCT01853163|12056713|FG002|NOT COMPLETED|Overall Study||0
10890596|NCT01853163|12056714|FG003|NOT COMPLETED|Overall Study||0
10890597|NCT01852071|12056728|FG000|STARTED|Overall Study||20
10890598|NCT01852071|12056729|FG001|STARTED|Overall Study||26
10890599|NCT01852071|12056728|FG000|COMPLETED|Overall Study||20
10890600|NCT01852071|12056729|FG001|COMPLETED|Overall Study||26
10890601|NCT01852071|12056728|FG000|NOT COMPLETED|Overall Study||0
10890602|NCT01852071|12056729|FG001|NOT COMPLETED|Overall Study||0
10890603|NCT01850524|12056743|FG000|STARTED|Overall Study||354
10890604|NCT01850524|12056744|FG001|STARTED|Overall Study||351
10890605|NCT01850524|12056743|FG000|Intent-to-Treat (ITT) Population|Overall Study||354
10890606|NCT01850524|12056744|FG001|Intent-to-Treat (ITT) Population|Overall Study||351
10890607|NCT01850524|12056743|FG000|Safety Population|Overall Study|1 participant in this arm who withdrew from the study was not included in the safety population.|349
10890608|NCT01850524|12056744|FG001|Safety Population|Overall Study|Included 4 participants from placebo who received ixazomib; 1 participant who withdrew was excluded.|354
10890609|NCT01850524|12056743|FG000|Participants Completed Study Treatment Per Protocol|Overall Study||270
10890610|NCT01850524|12056744|FG001|Participants Completed Study Treatment Per Protocol|Overall Study||264
10890611|NCT01850524|12056743|FG000|Per Protocol (PP) Population|Overall Study||295
10890612|NCT01850524|12056744|FG001|Per Protocol (PP) Population|Overall Study||298
10890613|NCT01850524|12056743|FG000|Participants With Exposure of ≥ 19 Cycles|Overall Study||189
10890614|NCT01850524|12056744|FG001|Participants With Exposure of ≥ 19 Cycles|Overall Study||191
10890615|NCT01850524|12056743|FG000|COMPLETED|Overall Study||0
10890616|NCT01850524|12056744|FG001|COMPLETED|Overall Study||0
10890617|NCT01850524|12056743|FG000|NOT COMPLETED|Overall Study||354
10890618|NCT01850524|12056744|FG001|NOT COMPLETED|Overall Study||351
10890619|NCT01849575|12056754|FG000|STARTED|Overall Study||1749
10890620|NCT01849575|12056755|FG001|STARTED|Overall Study||1783
10890621|NCT01849575|12056754|FG000|COMPLETED|Overall Study||1599
10890622|NCT01849575|12056755|FG001|COMPLETED|Overall Study||1576
10890623|NCT01849575|12056754|FG000|NOT COMPLETED|Overall Study||150
10890624|NCT01849575|12056755|FG001|NOT COMPLETED|Overall Study||207
10890625|NCT01849263|12056763|FG000|STARTED|Overall Study||40
10890626|NCT01849263|12056763|FG000|COMPLETED|Overall Study||40
10890627|NCT01849263|12056763|FG000|NOT COMPLETED|Overall Study||0
10890628|NCT01844986|12056769|FG000|STARTED|Overall Study||260
10890629|NCT01844986|12056770|FG001|STARTED|Overall Study||131
10890630|NCT01844986|12056769|FG000|COMPLETED|Overall Study||183
10890631|NCT01844986|12056770|FG001|COMPLETED|Overall Study||91
10890632|NCT01844986|12056769|FG000|NOT COMPLETED|Overall Study||77
10890633|NCT01844986|12056770|FG001|NOT COMPLETED|Overall Study||40
10890634|NCT01844518|12056778|FG000|STARTED|Overall Study||173
10890635|NCT01844518|12056779|FG001|STARTED|Overall Study||46
10890636|NCT01844518|12056778|FG000|COMPLETED|Overall Study||132
10890637|NCT01844518|12056779|FG001|COMPLETED|Overall Study||39
10890638|NCT01844518|12056778|FG000|NOT COMPLETED|Overall Study||41
10890639|NCT01844518|12056779|FG001|NOT COMPLETED|Overall Study||7
10890640|NCT01843374|12056790|FG000|STARTED|Overall Study||189
10890641|NCT01843374|12056791|FG001|STARTED|Overall Study||382
10890642|NCT01843374|12056790|FG000|RANDOMIZED|Overall Study||189
10890643|NCT01843374|12056791|FG001|RANDOMIZED|Overall Study||382
10890644|NCT01843374|12056790|FG000|COMPLETED|Overall Study||0
10890645|NCT01843374|12056791|FG001|COMPLETED|Overall Study||3
10890646|NCT01843374|12056790|FG000|NOT COMPLETED|Overall Study||189
10890647|NCT01843374|12056791|FG001|NOT COMPLETED|Overall Study||379
10890648|NCT01841736|12056802|FG000|STARTED|Overall Study||97
10890649|NCT01841736|12056803|FG001|STARTED|Overall Study||74
10890650|NCT01841736|12056802|FG000|Crossover|Overall Study||0
10890651|NCT01841736|12056803|FG001|Crossover|Overall Study||49
10890652|NCT01841736|12056802|FG000|COMPLETED|Overall Study||97
10890653|NCT01841736|12056803|FG001|COMPLETED|Overall Study||74
10890654|NCT01841736|12056802|FG000|NOT COMPLETED|Overall Study||0
10890655|NCT01841736|12056803|FG001|NOT COMPLETED|Overall Study||0
10890656|NCT01839396|12056812|FG000|STARTED|Overall Study||121
10890657|NCT01839396|12056813|FG001|STARTED|Overall Study||39
10890658|NCT01839396|12056812|FG000|COMPLETED|Overall Study||121
10890659|NCT01839396|12056813|FG001|COMPLETED|Overall Study||39
10890660|NCT01839396|12056812|FG000|NOT COMPLETED|Overall Study||0
10890661|NCT01839396|12056813|FG001|NOT COMPLETED|Overall Study||0
10890662|NCT01836445|12056821|FG000|STARTED|Intervention Modules||445
10890663|NCT01836445|12056822|FG001|STARTED|Intervention Modules||456
10890664|NCT01836445|12056821|FG000|COMPLETED|Intervention Modules||375
10890665|NCT01836445|12056822|FG001|COMPLETED|Intervention Modules||434
10890666|NCT01836445|12056821|FG000|NOT COMPLETED|Intervention Modules||70
10890667|NCT01836445|12056822|FG001|NOT COMPLETED|Intervention Modules||22
10890668|NCT01836445|12056821|FG000|STARTED|3 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
10890669|NCT01836445|12056822|FG001|STARTED|3 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|456
10890670|NCT01836445|12056821|FG000|COMPLETED|3 Month Follow-up Assessment||348
10890671|NCT01836445|12056822|FG001|COMPLETED|3 Month Follow-up Assessment||409
10890672|NCT01836445|12056821|FG000|NOT COMPLETED|3 Month Follow-up Assessment||97
10890673|NCT01836445|12056822|FG001|NOT COMPLETED|3 Month Follow-up Assessment||47
10890674|NCT01836445|12056821|FG000|STARTED|6 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
10890675|NCT01836445|12056822|FG001|STARTED|6 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|455
10890676|NCT01836445|12056821|FG000|COMPLETED|6 Month Follow-up Assessment||342
10890677|NCT01836445|12056822|FG001|COMPLETED|6 Month Follow-up Assessment||380
10890678|NCT01836445|12056821|FG000|NOT COMPLETED|6 Month Follow-up Assessment||103
10890679|NCT01836445|12056822|FG001|NOT COMPLETED|6 Month Follow-up Assessment||75
10890680|NCT01836445|12056821|FG000|STARTED|12 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
10890681|NCT01836445|12056822|FG001|STARTED|12 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|455
10890682|NCT01836445|12056821|FG000|COMPLETED|12 Month Follow-up Assessment||370
10890683|NCT01836445|12056822|FG001|COMPLETED|12 Month Follow-up Assessment||391
10890684|NCT01836445|12056821|FG000|NOT COMPLETED|12 Month Follow-up Assessment||75
10890685|NCT01836445|12056822|FG001|NOT COMPLETED|12 Month Follow-up Assessment||64
10890686|NCT01836445|12056821|FG000|STARTED|12 Month STI Testing|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
10890687|NCT01836445|12056822|FG001|STARTED|12 Month STI Testing|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|455
10890688|NCT01836445|12056821|FG000|COMPLETED|12 Month STI Testing||365
10890689|NCT01836445|12056822|FG001|COMPLETED|12 Month STI Testing||378
10890690|NCT01836445|12056821|FG000|NOT COMPLETED|12 Month STI Testing||80
10890691|NCT01836445|12056822|FG001|NOT COMPLETED|12 Month STI Testing||77
10890692|NCT01835145|12056830|FG000|STARTED|Overall Study||32
10890693|NCT01835145|12056831|FG001|STARTED|Overall Study||15
10890694|NCT01835145|12056830|FG000|COMPLETED|Overall Study||31
10890695|NCT01835145|12056831|FG001|COMPLETED|Overall Study||15
10890696|NCT01835145|12056830|FG000|NOT COMPLETED|Overall Study||1
10890697|NCT01835145|12056831|FG001|NOT COMPLETED|Overall Study||0
10890698|NCT01831596|12056839|FG000|STARTED|Overall Study||59
10890699|NCT01831596|12056839|FG000|COMPLETED|Overall Study||51
10890700|NCT01831596|12056839|FG000|NOT COMPLETED|Overall Study||8
10890701|NCT01828099|12056845|FG000|STARTED|Overall Study||189
10890702|NCT01828099|12056846|FG001|STARTED|Overall Study||187
10890703|NCT01828099|12056845|FG000|Untreated Patients|Overall Study||0
10890704|NCT01828099|12056846|FG001|Untreated Patients|Overall Study||12
10890705|NCT01828099|12056845|FG000|Treated|Overall Study|discontinued from treatment phase = Not completed|189
10890706|NCT01828099|12056846|FG001|Treated|Overall Study||175
10890707|NCT01828099|12056845|FG000|Discontinued From Treatment Phase|Overall Study||94
10890708|NCT01828099|12056846|FG001|Discontinued From Treatment Phase|Overall Study||157
10890709|NCT01828099|12056845|FG000|Entered Extension-treatment Phase|Overall Study||0
10890710|NCT01828099|12056846|FG001|Entered Extension-treatment Phase|Overall Study||81
10890711|NCT01828099|12056845|FG000|Entered Post-treatment Follow-up Phase|Overall Study||10
10890712|NCT01828099|12056846|FG001|Entered Post-treatment Follow-up Phase|Overall Study||16
10890713|NCT01828099|12056845|FG000|Entered Survival Follow-up Phase|Overall Study||64
10890714|NCT01828099|12056846|FG001|Entered Survival Follow-up Phase|Overall Study||31
10890715|NCT01828099|12056845|FG000|Discontinued From Study|Overall Study||20
10890716|NCT01828099|12056846|FG001|Discontinued From Study|Overall Study||29
10890717|NCT01828099|12056845|FG000|COMPLETED|Overall Study|Completed = Patients ongoing at the time of data cut-off of 24-Jun-2016|95
10890718|NCT01828099|12056846|FG001|COMPLETED|Overall Study|Completed = Patients ongoing at the time of data cut-off of 24-Jun-2016|30
10890719|NCT01828099|12056845|FG000|NOT COMPLETED|Overall Study||94
10890720|NCT01828099|12056846|FG001|NOT COMPLETED|Overall Study||157
10890721|NCT01818739|12056852|FG000|STARTED|Overall Study||204
10890722|NCT01818739|12056852|FG000|COMPLETED|Overall Study||204
10890723|NCT01818739|12056852|FG000|NOT COMPLETED|Overall Study||0
10890724|NCT01816971|12056857|FG000|STARTED|Overall Study||76
10890725|NCT01816971|12056857|FG000|COMPLETED|Overall Study||64
10890726|NCT01816971|12056857|FG000|NOT COMPLETED|Overall Study||12
10890727|NCT01809691|12056863|FG000|STARTED|Overall Study||638
10890728|NCT01809691|12056864|FG001|STARTED|Overall Study||641
10890729|NCT01809691|12056863|FG000|COMPLETED|Overall Study||0
10890730|NCT01809691|12056864|FG001|COMPLETED|Overall Study||0
10890731|NCT01809691|12056863|FG000|NOT COMPLETED|Overall Study||638
10890732|NCT01809691|12056864|FG001|NOT COMPLETED|Overall Study||641
10890733|NCT01807455|12056870|FG000|STARTED|Overall Study||12
10890734|NCT01807455|12056870|FG000|COMPLETED|Overall Study||12
10890735|NCT01807455|12056870|FG000|NOT COMPLETED|Overall Study||0
10890736|NCT01802632|12056880|FG000|STARTED|Overall Study||201
10890737|NCT01802632|12056881|FG001|STARTED|Overall Study||31
10890738|NCT01802632|12056882|FG002|STARTED|Overall Study||271
10890739|NCT01802632|12056883|FG003|STARTED|Overall Study||60
10890740|NCT01802632|12056884|FG004|STARTED|Overall Study||12
10890741|NCT01802632|12056885|FG005|STARTED|Overall Study||28
10890742|NCT01802632|12056880|FG000|COMPLETED|Overall Study||0
10890743|NCT01802632|12056881|FG001|COMPLETED|Overall Study||0
10890744|NCT01802632|12056882|FG002|COMPLETED|Overall Study||0
10890745|NCT01802632|12056883|FG003|COMPLETED|Overall Study||0
10890746|NCT01802632|12056884|FG004|COMPLETED|Overall Study||0
10890747|NCT01802632|12056885|FG005|COMPLETED|Overall Study||0
10890748|NCT01802632|12056880|FG000|NOT COMPLETED|Overall Study||201
10890749|NCT01802632|12056881|FG001|NOT COMPLETED|Overall Study||31
10890750|NCT01802632|12056882|FG002|NOT COMPLETED|Overall Study||271
10890751|NCT01802632|12056883|FG003|NOT COMPLETED|Overall Study||60
10890752|NCT01802632|12056884|FG004|NOT COMPLETED|Overall Study||12
10890753|NCT01802632|12056885|FG005|NOT COMPLETED|Overall Study||28
10890754|NCT01802281|12056899|FG000|STARTED|Overall Study||93
10890755|NCT01802281|12056900|FG001|STARTED|Overall Study||90
10890756|NCT01802281|12056899|FG000|Eligible and Received Randomized Treatment|Overall Study||88
10890757|NCT01802281|12056900|FG001|Eligible and Received Randomized Treatment|Overall Study||87
10890758|NCT01802281|12056899|FG000|Completed Year 1 Follow-up|Overall Study||88
10890759|NCT01802281|12056900|FG001|Completed Year 1 Follow-up|Overall Study||86
10890760|NCT01802281|12056899|FG000|Completed Year 2 Follow-up|Overall Study||87
10890761|NCT01802281|12056900|FG001|Completed Year 2 Follow-up|Overall Study||84
10890762|NCT01802281|12056899|FG000|COMPLETED|Overall Study||85
10890763|NCT01802281|12056900|FG001|COMPLETED|Overall Study||84
10890764|NCT01802281|12056899|FG000|NOT COMPLETED|Overall Study||8
10890765|NCT01802281|12056900|FG001|NOT COMPLETED|Overall Study||6
10890766|NCT01797458|12056909|FG000|STARTED|Overall Study||52
10890767|NCT01797458|12056910|FG001|STARTED|Overall Study||52
10890768|NCT01797458|12056911|FG002|STARTED|Overall Study||65
10890769|NCT01797458|12056909|FG000|COMPLETED|Overall Study||40
10890770|NCT01797458|12056910|FG001|COMPLETED|Overall Study||43
10890771|NCT01797458|12056911|FG002|COMPLETED|Overall Study||58
10890772|NCT01797458|12056909|FG000|NOT COMPLETED|Overall Study||12
10890773|NCT01797458|12056910|FG001|NOT COMPLETED|Overall Study||9
10890774|NCT01797458|12056911|FG002|NOT COMPLETED|Overall Study||7
10890775|NCT01794338|12056930|FG000|STARTED|Overall Study||8
10890776|NCT01794338|12056931|FG001|STARTED|Overall Study||9
10890777|NCT01794338|12056930|FG000|Screen Failure|Overall Study||3
10890778|NCT01794338|12056931|FG001|Screen Failure|Overall Study||3
10890779|NCT01794338|12056930|FG000|1 Month Follow Up|Overall Study||6
10890780|NCT01794338|12056931|FG001|1 Month Follow Up|Overall Study||9
10890781|NCT01794338|12056930|FG000|6 Month Follow Up|Overall Study||0
10890782|NCT01794338|12056931|FG001|6 Month Follow Up|Overall Study||0
10890783|NCT01794338|12056930|FG000|12 Month Follow Up|Overall Study||0
10890784|NCT01794338|12056931|FG001|12 Month Follow Up|Overall Study||0
10890785|NCT01794338|12056930|FG000|24 Month Follow Up|Overall Study||0
10890786|NCT01794338|12056931|FG001|24 Month Follow Up|Overall Study||0
10890787|NCT01794338|12056930|FG000|36 Month Follow Up|Overall Study||0
10890788|NCT01794338|12056931|FG001|36 Month Follow Up|Overall Study||0
10890789|NCT01794338|12056930|FG000|COMPLETED|Overall Study||0
10890790|NCT01794338|12056931|FG001|COMPLETED|Overall Study||0
10890791|NCT01794338|12056930|FG000|NOT COMPLETED|Overall Study||8
10890792|NCT01794338|12056931|FG001|NOT COMPLETED|Overall Study||9
10890793|NCT01791985|12056937|FG000|STARTED|Overall Study||52
10890794|NCT01791985|12056937|FG000|COMPLETED|Overall Study|Eight patients (8) discontinued study treatment prior to 12 weeks or disease disease progression|44
10890795|NCT01791985|12056937|FG000|NOT COMPLETED|Overall Study||8
10890796|NCT01783223|12056942|FG000|STARTED|Overall Study||668
10890797|NCT01783223|12056942|FG000|COMPLETED|Overall Study||668
10890798|NCT01783223|12056942|FG000|NOT COMPLETED|Overall Study||0
10890799|NCT01783041|12056948|FG000|STARTED|First 2 Weeks of Life||72
10890800|NCT01783041|12056949|FG001|STARTED|First 2 Weeks of Life||72
10890801|NCT01783041|12056948|FG000|COMPLETED|First 2 Weeks of Life||69
10890802|NCT01783041|12056949|FG001|COMPLETED|First 2 Weeks of Life||71
10890803|NCT01783041|12056948|FG000|NOT COMPLETED|First 2 Weeks of Life||3
10890804|NCT01783041|12056949|FG001|NOT COMPLETED|First 2 Weeks of Life||1
10890805|NCT01783041|12056948|FG000|STARTED|NNNS Examination at Term Equivalent Age||69
10890806|NCT01783041|12056949|FG001|STARTED|NNNS Examination at Term Equivalent Age||71
10890807|NCT01783041|12056948|FG000|COMPLETED|NNNS Examination at Term Equivalent Age||60
10890808|NCT01783041|12056949|FG001|COMPLETED|NNNS Examination at Term Equivalent Age||59
10890809|NCT01783041|12056948|FG000|NOT COMPLETED|NNNS Examination at Term Equivalent Age||9
10890810|NCT01783041|12056949|FG001|NOT COMPLETED|NNNS Examination at Term Equivalent Age||12
10890811|NCT01782352|12056959|FG000|STARTED|Overall Study||6463
10890812|NCT01782352|12056960|FG001|STARTED|Overall Study||6464
10890813|NCT01782352|12056961|FG002|STARTED|Overall Study||6470
10890814|NCT01782352|12056962|FG003|STARTED|Overall Study||6474
10890815|NCT01782352|12056959|FG000|COMPLETED|Overall Study||6463
10890816|NCT01782352|12056960|FG001|COMPLETED|Overall Study||6464
10890817|NCT01782352|12056961|FG002|COMPLETED|Overall Study||6470
10890818|NCT01782352|12056962|FG003|COMPLETED|Overall Study||6474
10890819|NCT01782352|12056959|FG000|NOT COMPLETED|Overall Study||0
10890820|NCT01782352|12056960|FG001|NOT COMPLETED|Overall Study||0
10890821|NCT01782352|12056961|FG002|NOT COMPLETED|Overall Study||0
10890822|NCT01782352|12056962|FG003|NOT COMPLETED|Overall Study||0
10890823|NCT01776840|12056974|FG000|STARTED|Overall Study||261
10890824|NCT01776840|12056975|FG001|STARTED|Overall Study||262
10890825|NCT01776840|12056974|FG000|COMPLETED|Overall Study||103
10890826|NCT01776840|12056975|FG001|COMPLETED|Overall Study||107
10890827|NCT01776840|12056974|FG000|NOT COMPLETED|Overall Study||158
10890828|NCT01776840|12056975|FG001|NOT COMPLETED|Overall Study||155
10890829|NCT01776723|12056986|FG000|STARTED|Overall Study||6
10890830|NCT01776723|12056987|FG001|STARTED|Overall Study||4
10890831|NCT01776723|12056988|FG002|STARTED|Overall Study||5
10890832|NCT01776723|12056989|FG003|STARTED|Overall Study||5
10890833|NCT01776723|12056990|FG004|STARTED|Overall Study||30
10890834|NCT01776723|12056986|FG000|COMPLETED|Overall Study||6
10890835|NCT01776723|12056987|FG001|COMPLETED|Overall Study||4
10890836|NCT01776723|12056988|FG002|COMPLETED|Overall Study||5
10890837|NCT01776723|12056989|FG003|COMPLETED|Overall Study||5
10890838|NCT01776723|12056990|FG004|COMPLETED|Overall Study||30
10890839|NCT01776723|12056986|FG000|NOT COMPLETED|Overall Study||0
10890840|NCT01776723|12056987|FG001|NOT COMPLETED|Overall Study||0
10890841|NCT01776723|12056988|FG002|NOT COMPLETED|Overall Study||0
10890842|NCT01776723|12056989|FG003|NOT COMPLETED|Overall Study||0
10890843|NCT01776723|12056990|FG004|NOT COMPLETED|Overall Study||0
10890844|NCT01772472|12057008|FG000|STARTED|Overall Study||743
10890845|NCT01772472|12057009|FG001|STARTED|Overall Study||743
10890846|NCT01772472|12057008|FG000|COMPLETED|Overall Study||0
10890847|NCT01772472|12057009|FG001|COMPLETED|Overall Study||0
10890848|NCT01772472|12057008|FG000|NOT COMPLETED|Overall Study||743
10890849|NCT01772472|12057009|FG001|NOT COMPLETED|Overall Study||743
10890850|NCT01767194|12057017|FG000|STARTED|Overall Study||19
10890851|NCT01767194|12057018|FG001|STARTED|Overall Study||54
10890852|NCT01767194|12057017|FG000|COMPLETED|Overall Study||1
10890853|NCT01767194|12057018|FG001|COMPLETED|Overall Study||11
10890854|NCT01767194|12057017|FG000|NOT COMPLETED|Overall Study||18
10890855|NCT01767194|12057018|FG001|NOT COMPLETED|Overall Study||43
10890856|NCT01760447|12057029|FG000|STARTED|Weeks 0-20|The first randomization for the participant who withdrew and re-randomized is not counted in the 62.|62
10890857|NCT01760447|12057030|FG001|STARTED|Weeks 0-20||62
10890858|NCT01760447|12057031|FG002|STARTED|Weeks 0-20||47
10890859|NCT01760447|12057032|FG003|STARTED|Weeks 0-20||51
10890860|NCT01760447|12057029|FG000|Treated|Weeks 0-20||62
10890861|NCT01760447|12057030|FG001|Treated|Weeks 0-20||62
10890862|NCT01760447|12057031|FG002|Treated|Weeks 0-20||45
10890863|NCT01760447|12057032|FG003|Treated|Weeks 0-20||51
10890864|NCT01760447|12057029|FG000|COMPLETED|Weeks 0-20||59
10890865|NCT01760447|12057030|FG001|COMPLETED|Weeks 0-20||62
10890866|NCT01760447|12057031|FG002|COMPLETED|Weeks 0-20||42
10890867|NCT01760447|12057032|FG003|COMPLETED|Weeks 0-20||47
10890868|NCT01760447|12057029|FG000|NOT COMPLETED|Weeks 0-20||3
10890869|NCT01760447|12057030|FG001|NOT COMPLETED|Weeks 0-20||0
10890870|NCT01760447|12057031|FG002|NOT COMPLETED|Weeks 0-20||5
10890871|NCT01760447|12057032|FG003|NOT COMPLETED|Weeks 0-20||4
10890963|NCT01730118|12057113|FG006|NOT COMPLETED|Dose Expansion||0
10890872|NCT01760447|12057029|FG000|STARTED|Weeks 20-54|MK-0431A-170 added Weeks 20-54 via amendment, but not all participants were eligible for this period|28
10890873|NCT01760447|12057030|FG001|STARTED|Weeks 20-54|MK-0431A-170 added Weeks 20-54 via amendment, but not all participants were eligible for this period|30
10890874|NCT01760447|12057031|FG002|STARTED|Weeks 20-54||42
10890875|NCT01760447|12057032|FG003|STARTED|Weeks 20-54||47
10890876|NCT01760447|12057029|FG000|COMPLETED|Weeks 20-54||25
10890877|NCT01760447|12057030|FG001|COMPLETED|Weeks 20-54||28
10890878|NCT01760447|12057031|FG002|COMPLETED|Weeks 20-54||39
10890879|NCT01760447|12057032|FG003|COMPLETED|Weeks 20-54||43
10890880|NCT01760447|12057029|FG000|NOT COMPLETED|Weeks 20-54||3
10890881|NCT01760447|12057030|FG001|NOT COMPLETED|Weeks 20-54||2
10890882|NCT01760447|12057031|FG002|NOT COMPLETED|Weeks 20-54||3
10890883|NCT01760447|12057032|FG003|NOT COMPLETED|Weeks 20-54||4
10890884|NCT01757535|12057050|FG000|STARTED|Overall Study||238
10890885|NCT01757535|12057051|FG001|STARTED|Overall Study||234
10890886|NCT01757535|12057050|FG000|Received Treatment|Overall Study||236
10890887|NCT01757535|12057051|FG001|Received Treatment|Overall Study||233
10890888|NCT01757535|12057050|FG000|COMPLETED|Overall Study||45
10890889|NCT01757535|12057051|FG001|COMPLETED|Overall Study||26
10890890|NCT01757535|12057050|FG000|NOT COMPLETED|Overall Study||193
10890891|NCT01757535|12057051|FG001|NOT COMPLETED|Overall Study||208
10890892|NCT01753830|12057059|FG000|STARTED|Overall Study||37
10890893|NCT01753830|12057060|FG001|STARTED|Overall Study||38
10890894|NCT01753830|12057059|FG000|COMPLETED|Overall Study||30
10890895|NCT01753830|12057060|FG001|COMPLETED|Overall Study||35
10890896|NCT01753830|12057059|FG000|NOT COMPLETED|Overall Study||7
10890897|NCT01753830|12057060|FG001|NOT COMPLETED|Overall Study||3
10890898|NCT01750281|12057069|FG000|STARTED|Overall Study||43
10890899|NCT01750281|12057070|FG001|STARTED|Overall Study||85
10890900|NCT01750281|12057071|FG002|STARTED|Overall Study||84
10890901|NCT01750281|12057069|FG000|Received Treatment|Overall Study||43
10890902|NCT01750281|12057070|FG001|Received Treatment|Overall Study||84
10890903|NCT01750281|12057071|FG002|Received Treatment|Overall Study||84
10890904|NCT01750281|12057069|FG000|Did Not Receive Treatment|Overall Study||0
10890905|NCT01750281|12057070|FG001|Did Not Receive Treatment|Overall Study||1
10890906|NCT01750281|12057071|FG002|Did Not Receive Treatment|Overall Study||0
10890907|NCT01750281|12057069|FG000|COMPLETED|Overall Study||0
10890908|NCT01750281|12057070|FG001|COMPLETED|Overall Study||0
10890909|NCT01750281|12057071|FG002|COMPLETED|Overall Study||0
10890910|NCT01750281|12057069|FG000|NOT COMPLETED|Overall Study||43
10890911|NCT01750281|12057070|FG001|NOT COMPLETED|Overall Study||85
10890912|NCT01750281|12057071|FG002|NOT COMPLETED|Overall Study||84
10890913|NCT01743872|12057079|FG000|STARTED|Overall Study||23
10890914|NCT01743872|12057079|FG000|COMPLETED|Overall Study||23
10890915|NCT01743872|12057079|FG000|NOT COMPLETED|Overall Study||0
10890916|NCT01740427|12057093|FG000|STARTED|Overall Study||444
10890917|NCT01740427|12057094|FG001|STARTED|Overall Study||222
10890918|NCT01740427|12057093|FG000|COMPLETED|Overall Study||0
10890919|NCT01740427|12057094|FG001|COMPLETED|Overall Study||0
10890920|NCT01740427|12057093|FG000|NOT COMPLETED|Overall Study||444
10890921|NCT01740427|12057094|FG001|NOT COMPLETED|Overall Study||222
10890922|NCT01730118|12057107|FG000|STARTED|Dose Escalation||6
10890923|NCT01730118|12057108|FG001|STARTED|Dose Escalation||7
10890924|NCT01730118|12057109|FG002|STARTED|Dose Escalation||6
10890925|NCT01730118|12057110|FG003|STARTED|Dose Escalation||6
10890926|NCT01730118|12057111|FG004|STARTED|Dose Escalation||0
10890927|NCT01730118|12057112|FG005|STARTED|Dose Escalation||0
10890928|NCT01730118|12057113|FG006|STARTED|Dose Escalation||2
10890929|NCT01730118|12057107|FG000|COMPLETED|Dose Escalation||0
10890930|NCT01730118|12057108|FG001|COMPLETED|Dose Escalation||0
10890931|NCT01730118|12057109|FG002|COMPLETED|Dose Escalation||3
10890932|NCT01730118|12057110|FG003|COMPLETED|Dose Escalation||0
10890933|NCT01730118|12057111|FG004|COMPLETED|Dose Escalation||0
10890934|NCT01730118|12057112|FG005|COMPLETED|Dose Escalation||0
10890935|NCT01730118|12057113|FG006|COMPLETED|Dose Escalation||0
10890936|NCT01730118|12057107|FG000|NOT COMPLETED|Dose Escalation||6
10890937|NCT01730118|12057108|FG001|NOT COMPLETED|Dose Escalation||7
10890938|NCT01730118|12057109|FG002|NOT COMPLETED|Dose Escalation||3
10890939|NCT01730118|12057110|FG003|NOT COMPLETED|Dose Escalation||6
10890940|NCT01730118|12057111|FG004|NOT COMPLETED|Dose Escalation||0
10890941|NCT01730118|12057112|FG005|NOT COMPLETED|Dose Escalation||0
10890942|NCT01730118|12057113|FG006|NOT COMPLETED|Dose Escalation||2
10890943|NCT01730118|12057107|FG000|STARTED|Dose Expansion||0
10890944|NCT01730118|12057108|FG001|STARTED|Dose Expansion||0
10890945|NCT01730118|12057109|FG002|STARTED|Dose Expansion||0
10890946|NCT01730118|12057110|FG003|STARTED|Dose Expansion||0
10890947|NCT01730118|12057111|FG004|STARTED|Dose Expansion||3
10890948|NCT01730118|12057112|FG005|STARTED|Dose Expansion||3
10890949|NCT01730118|12057113|FG006|STARTED|Dose Expansion||0
10890950|NCT01730118|12057107|FG000|COMPLETED|Dose Expansion||0
10890951|NCT01730118|12057108|FG001|COMPLETED|Dose Expansion||0
10890952|NCT01730118|12057109|FG002|COMPLETED|Dose Expansion||0
10890953|NCT01730118|12057110|FG003|COMPLETED|Dose Expansion||0
10890954|NCT01730118|12057111|FG004|COMPLETED|Dose Expansion||0
10890955|NCT01730118|12057112|FG005|COMPLETED|Dose Expansion||0
10890956|NCT01730118|12057113|FG006|COMPLETED|Dose Expansion||0
10890957|NCT01730118|12057107|FG000|NOT COMPLETED|Dose Expansion||0
10890958|NCT01730118|12057108|FG001|NOT COMPLETED|Dose Expansion||0
10890959|NCT01730118|12057109|FG002|NOT COMPLETED|Dose Expansion||0
10890960|NCT01730118|12057110|FG003|NOT COMPLETED|Dose Expansion||0
10890961|NCT01730118|12057111|FG004|NOT COMPLETED|Dose Expansion||3
10890962|NCT01730118|12057112|FG005|NOT COMPLETED|Dose Expansion||3
10890964|NCT01728805|12057132|FG000|STARTED|Randomization Period||186
10890965|NCT01728805|12057133|FG001|STARTED|Randomization Period||186
10890966|NCT01728805|12057134|FG002|STARTED|Randomization Period||0
10890967|NCT01728805|12057132|FG000|COMPLETED|Randomization Period||186
10890968|NCT01728805|12057133|FG001|COMPLETED|Randomization Period||186
10890969|NCT01728805|12057134|FG002|COMPLETED|Randomization Period||0
10890970|NCT01728805|12057132|FG000|NOT COMPLETED|Randomization Period||0
10890971|NCT01728805|12057133|FG001|NOT COMPLETED|Randomization Period||0
10890972|NCT01728805|12057134|FG002|NOT COMPLETED|Randomization Period||0
10890973|NCT01728805|12057132|FG000|STARTED|Crossover Period||0
10890974|NCT01728805|12057133|FG001|STARTED|Crossover Period||0
10890975|NCT01728805|12057134|FG002|STARTED|Crossover Period||136
10890976|NCT01728805|12057132|FG000|COMPLETED|Crossover Period||0
10890977|NCT01728805|12057133|FG001|COMPLETED|Crossover Period||0
10890978|NCT01728805|12057134|FG002|COMPLETED|Crossover Period||136
10890979|NCT01728805|12057132|FG000|NOT COMPLETED|Crossover Period||0
10890980|NCT01728805|12057133|FG001|NOT COMPLETED|Crossover Period||0
10890981|NCT01728805|12057134|FG002|NOT COMPLETED|Crossover Period||0
10890982|NCT01723774|12057144|FG000|STARTED|Neoadjuvant||34
10890983|NCT01723774|12057145|FG001|STARTED|Neoadjuvant||16
10890984|NCT01723774|12057146|FG002|STARTED|Neoadjuvant||34
10890985|NCT01723774|12057147|FG003|STARTED|Neoadjuvant||0
10890986|NCT01723774|12057144|FG000|COMPLETED|Neoadjuvant||27
10890987|NCT01723774|12057145|FG001|COMPLETED|Neoadjuvant||12
10890988|NCT01723774|12057146|FG002|COMPLETED|Neoadjuvant||21
10890989|NCT01723774|12057147|FG003|COMPLETED|Neoadjuvant||0
10890990|NCT01723774|12057144|FG000|NOT COMPLETED|Neoadjuvant||7
10890991|NCT01723774|12057145|FG001|NOT COMPLETED|Neoadjuvant||4
10890992|NCT01723774|12057146|FG002|NOT COMPLETED|Neoadjuvant||13
10890993|NCT01723774|12057147|FG003|NOT COMPLETED|Neoadjuvant||0
10890994|NCT01723774|12057144|FG000|STARTED|Adjuvant||0
10890995|NCT01723774|12057145|FG001|STARTED|Adjuvant||0
10890996|NCT01723774|12057146|FG002|STARTED|Adjuvant||0
10890997|NCT01723774|12057147|FG003|STARTED|Adjuvant||7
10890998|NCT01723774|12057144|FG000|COMPLETED|Adjuvant||0
10890999|NCT01723774|12057145|FG001|COMPLETED|Adjuvant||0
10891000|NCT01723774|12057146|FG002|COMPLETED|Adjuvant||0
10891001|NCT01723774|12057147|FG003|COMPLETED|Adjuvant||6
10891002|NCT01723774|12057144|FG000|NOT COMPLETED|Adjuvant||0
10891003|NCT01723774|12057145|FG001|NOT COMPLETED|Adjuvant||0
10891004|NCT01723774|12057146|FG002|NOT COMPLETED|Adjuvant||0
10891005|NCT01723774|12057147|FG003|NOT COMPLETED|Adjuvant||1
10891006|NCT01719237|12057158|FG000|STARTED|Overall Study||30
10891007|NCT01719237|12057159|FG001|STARTED|Overall Study||30
10891008|NCT01719237|12057158|FG000|COMPLETED|Overall Study||30
10891009|NCT01719237|12057159|FG001|COMPLETED|Overall Study||29
10891010|NCT01719237|12057158|FG000|NOT COMPLETED|Overall Study||0
10891011|NCT01719237|12057159|FG001|NOT COMPLETED|Overall Study||1
10891012|NCT01711541|12057170|FG000|STARTED|Overall Study||4
10891013|NCT01711541|12057171|FG001|STARTED|Overall Study||4
10891014|NCT01711541|12057172|FG002|STARTED|Overall Study||3
10891015|NCT01711541|12057173|FG003|STARTED|Overall Study||6
10891016|NCT01711541|12057174|FG004|STARTED|Overall Study||7
10891017|NCT01711541|12057170|FG000|COMPLETED|Overall Study||4
10891018|NCT01711541|12057171|FG001|COMPLETED|Overall Study||3
10891019|NCT01711541|12057172|FG002|COMPLETED|Overall Study||3
10891020|NCT01711541|12057173|FG003|COMPLETED|Overall Study||5
10891021|NCT01711541|12057174|FG004|COMPLETED|Overall Study||7
10891022|NCT01711541|12057170|FG000|NOT COMPLETED|Overall Study||0
10891023|NCT01711541|12057171|FG001|NOT COMPLETED|Overall Study||1
10891024|NCT01711541|12057172|FG002|NOT COMPLETED|Overall Study||0
10891025|NCT01711541|12057173|FG003|NOT COMPLETED|Overall Study||1
10891026|NCT01711541|12057174|FG004|NOT COMPLETED|Overall Study||0
10891027|NCT01708954|12057194|FG000|STARTED|Step 1||42
10891028|NCT01708954|12057195|FG001|STARTED|Step 1||40
10891029|NCT01708954|12057196|FG002|STARTED|Step 1||43
10891030|NCT01708954|12057194|FG000|Started Protocol Therapy|Step 1||40
10891031|NCT01708954|12057195|FG001|Started Protocol Therapy|Step 1||40
10891032|NCT01708954|12057196|FG002|Started Protocol Therapy|Step 1||39
10891033|NCT01708954|12057194|FG000|Eligible and Treated|Step 1||38
10891034|NCT01708954|12057195|FG001|Eligible and Treated|Step 1||38
10891035|NCT01708954|12057196|FG002|Eligible and Treated|Step 1||35
10891036|NCT01708954|12057194|FG000|Patients With MET Status Data Available|Step 1||30
10891037|NCT01708954|12057195|FG001|Patients With MET Status Data Available|Step 1||32
10891038|NCT01708954|12057196|FG002|Patients With MET Status Data Available|Step 1||24
10891039|NCT01708954|12057194|FG000|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
10891040|NCT01708954|12057195|FG001|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
10891041|NCT01708954|12057196|FG002|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
10891042|NCT01708954|12057194|FG000|NOT COMPLETED|Step 1||42
10891043|NCT01708954|12057195|FG001|NOT COMPLETED|Step 1||40
10891044|NCT01708954|12057196|FG002|NOT COMPLETED|Step 1||43
10891045|NCT01708954|12057194|FG000|STARTED|Step 2|Only patients with disease progression in Step 1 are eligible to register to Step 2.|13
10891046|NCT01708954|12057195|FG001|STARTED|Step 2|Only patients with disease progression in Step 1 are eligible to register to Step 2.|7
10891047|NCT01708954|12057196|FG002|STARTED|Step 2|Only patients with disease progression on Arms A and B were allowed to register to Step 2.|0
10891048|NCT01708954|12057194|FG000|COMPLETED|Step 2|Treatment continued until progressive disease or unacceptable toxicity.|0
10891049|NCT01708954|12057195|FG001|COMPLETED|Step 2|Treatment continued until progressive disease or unacceptable toxicity.|0
10891050|NCT01708954|12057196|FG002|COMPLETED|Step 2||0
10891051|NCT01708954|12057194|FG000|NOT COMPLETED|Step 2||13
10891052|NCT01708954|12057195|FG001|NOT COMPLETED|Step 2||7
10891053|NCT01708954|12057196|FG002|NOT COMPLETED|Step 2||0
10891054|NCT01708941|12057209|FG000|STARTED|Overall Study||21
10891055|NCT01708941|12057210|FG001|STARTED|Overall Study||23
10891056|NCT01708941|12057211|FG002|STARTED|Overall Study||22
10891057|NCT01708941|12057212|FG003|STARTED|Overall Study||22
10891058|NCT01708941|12057209|FG000|Eligible and Started Treatment|Overall Study||18
10891059|NCT01708941|12057210|FG001|Eligible and Started Treatment|Overall Study||22
10891060|NCT01708941|12057211|FG002|Eligible and Started Treatment|Overall Study||19
10891061|NCT01708941|12057212|FG003|Eligible and Started Treatment|Overall Study||22
10891062|NCT01708941|12057209|FG000|COMPLETED|Overall Study||3
10891063|NCT01708941|12057210|FG001|COMPLETED|Overall Study||5
10891064|NCT01708941|12057211|FG002|COMPLETED|Overall Study||3
10891065|NCT01708941|12057212|FG003|COMPLETED|Overall Study||4
10891066|NCT01708941|12057209|FG000|NOT COMPLETED|Overall Study||18
10891067|NCT01708941|12057210|FG001|NOT COMPLETED|Overall Study||18
10891068|NCT01708941|12057211|FG002|NOT COMPLETED|Overall Study||19
10891069|NCT01708941|12057212|FG003|NOT COMPLETED|Overall Study||18
10891070|NCT01706939|12057224|FG000|STARTED|Pre Randomization||23
10891071|NCT01706939|12057225|FG001|STARTED|Pre Randomization||0
10891072|NCT01706939|12057226|FG002|STARTED|Pre Randomization||0
10891073|NCT01706939|12057224|FG000|COMPLETED|Pre Randomization||20
10891074|NCT01706939|12057225|FG001|COMPLETED|Pre Randomization||0
10891075|NCT01706939|12057226|FG002|COMPLETED|Pre Randomization||0
10891076|NCT01706939|12057224|FG000|NOT COMPLETED|Pre Randomization||3
10891077|NCT01706939|12057225|FG001|NOT COMPLETED|Pre Randomization||0
10891078|NCT01706939|12057226|FG002|NOT COMPLETED|Pre Randomization||0
10891079|NCT01706939|12057224|FG000|STARTED|Randomization||0
10891080|NCT01706939|12057225|FG001|STARTED|Randomization||12
10891081|NCT01706939|12057226|FG002|STARTED|Randomization||8
10891082|NCT01706939|12057224|FG000|COMPLETED|Randomization||0
10891083|NCT01706939|12057225|FG001|COMPLETED|Randomization||9
10891084|NCT01706939|12057226|FG002|COMPLETED|Randomization||6
10891085|NCT01706939|12057224|FG000|NOT COMPLETED|Randomization||0
10891086|NCT01706939|12057225|FG001|NOT COMPLETED|Randomization||3
10891087|NCT01706939|12057226|FG002|NOT COMPLETED|Randomization||2
10891088|NCT01700946|12057235|FG000|STARTED|Overall Study||18
10891089|NCT01700946|12057236|FG001|STARTED|Overall Study||24
10891090|NCT01700946|12057235|FG000|COMPLETED|Overall Study||7
10891091|NCT01700946|12057236|FG001|COMPLETED|Overall Study||7
10891092|NCT01700946|12057235|FG000|NOT COMPLETED|Overall Study||11
10891093|NCT01700946|12057236|FG001|NOT COMPLETED|Overall Study||17
10891094|NCT01696994|12057248|FG000|STARTED|Overall Study||39111
10891095|NCT01696994|12057249|FG001|STARTED|Overall Study||39105
10891096|NCT01696994|12057248|FG000|COMPLETED|Overall Study||33919
10891097|NCT01696994|12057249|FG001|COMPLETED|Overall Study||30668
10891098|NCT01696994|12057248|FG000|NOT COMPLETED|Overall Study||5192
10891099|NCT01696994|12057249|FG001|NOT COMPLETED|Overall Study||8437
10891100|NCT01696968|12057259|FG000|STARTED|Overall Study||77456
10891101|NCT01696968|12057260|FG001|STARTED|Overall Study||77445
10891102|NCT01696968|12057259|FG000|COMPLETED|Overall Study||76255
10891103|NCT01696968|12057260|FG001|COMPLETED|Overall Study||70633
10891104|NCT01696968|12057259|FG000|NOT COMPLETED|Overall Study||1201
10891105|NCT01696968|12057260|FG001|NOT COMPLETED|Overall Study||6812
10891106|NCT01682226|12057267|FG000|STARTED|Overall Study||84
10891107|NCT01682226|12057267|FG000|COMPLETED|Overall Study||78
10891108|NCT01682226|12057267|FG000|NOT COMPLETED|Overall Study||6
10891109|NCT01682148|12057273|FG000|STARTED|Overall Study||44
10891110|NCT01682148|12057274|FG001|STARTED|Overall Study||44
10891111|NCT01682148|12057273|FG000|COMPLETED|Overall Study||40
10891112|NCT01682148|12057274|FG001|COMPLETED|Overall Study||41
10891113|NCT01682148|12057273|FG000|NOT COMPLETED|Overall Study||4
10891114|NCT01682148|12057274|FG001|NOT COMPLETED|Overall Study||3
10891115|NCT01682083|12057287|FG000|STARTED|Overall Study||438
10891116|NCT01682083|12057288|FG001|STARTED|Overall Study||432
10891117|NCT01682083|12057287|FG000|COMPLETED|Overall Study|Ongoing patients at the time of data cut-off. 3 patients were untreated|331
10891118|NCT01682083|12057288|FG001|COMPLETED|Overall Study|Ongoing patients at the time of data cut-off.|277
10891119|NCT01682083|12057287|FG000|NOT COMPLETED|Overall Study||107
10891120|NCT01682083|12057288|FG001|NOT COMPLETED|Overall Study||155
10891121|NCT01678131|12057297|FG000|STARTED|Overall Study||10
10891122|NCT01678131|12057298|FG001|STARTED|Overall Study||10
10891123|NCT01678131|12057299|FG002|STARTED|Overall Study||11
10891124|NCT01678131|12057297|FG000|COMPLETED|Overall Study||10
10891125|NCT01678131|12057298|FG001|COMPLETED|Overall Study||9
10891126|NCT01678131|12057299|FG002|COMPLETED|Overall Study||9
10891127|NCT01678131|12057297|FG000|NOT COMPLETED|Overall Study||0
10891128|NCT01678131|12057298|FG001|NOT COMPLETED|Overall Study||1
10891129|NCT01678131|12057299|FG002|NOT COMPLETED|Overall Study||2
10891130|NCT01677858|12057312|FG000|STARTED|Overall Study||3
10891131|NCT01677858|12057313|FG001|STARTED|Overall Study||3
10891132|NCT01677858|12057314|FG002|STARTED|Overall Study||15
10891133|NCT01677858|12057315|FG003|STARTED|Overall Study||6
10891134|NCT01677858|12057316|FG004|STARTED|Overall Study||89
10891135|NCT01677858|12057312|FG000|COMPLETED|Overall Study|Completed indicates participants ongoing in study|0
10891136|NCT01677858|12057313|FG001|COMPLETED|Overall Study|Completed indicates participants ongoing in study|1
10891137|NCT01677858|12057314|FG002|COMPLETED|Overall Study|Completed indicates participants ongoing in study|1
10891138|NCT01677858|12057315|FG003|COMPLETED|Overall Study|Completed indicates participants ongoing in study|0
10891139|NCT01677858|12057316|FG004|COMPLETED|Overall Study|Completed indicates participants ongoing in study|4
10891140|NCT01677858|12057312|FG000|NOT COMPLETED|Overall Study||3
10891141|NCT01677858|12057313|FG001|NOT COMPLETED|Overall Study||2
10891142|NCT01677858|12057314|FG002|NOT COMPLETED|Overall Study||14
10891143|NCT01677858|12057315|FG003|NOT COMPLETED|Overall Study||6
10891144|NCT01677858|12057316|FG004|NOT COMPLETED|Overall Study||85
10891145|NCT01670006|12057333|FG000|STARTED|Overall Study||10
10891146|NCT01670006|12057333|FG000|COMPLETED|Overall Study||10
10891147|NCT01670006|12057333|FG000|NOT COMPLETED|Overall Study||0
10891148|NCT01668784|12057339|FG000|STARTED|Randomized (Pre-treatment)||410
10891149|NCT01668784|12057340|FG001|STARTED|Randomized (Pre-treatment)||411
10891150|NCT01668784|12057339|FG000|COMPLETED|Randomized (Pre-treatment)||406
10891151|NCT01668784|12057340|FG001|COMPLETED|Randomized (Pre-treatment)||397
10891152|NCT01668784|12057339|FG000|NOT COMPLETED|Randomized (Pre-treatment)||4
10891153|NCT01668784|12057340|FG001|NOT COMPLETED|Randomized (Pre-treatment)||14
10891154|NCT01668784|12057339|FG000|STARTED|Treatment Period||406
10891155|NCT01668784|12057340|FG001|STARTED|Treatment Period||397
10891156|NCT01668784|12057339|FG000|COMPLETED|Treatment Period||0
10891157|NCT01668784|12057340|FG001|COMPLETED|Treatment Period||0
10891158|NCT01668784|12057339|FG000|NOT COMPLETED|Treatment Period||406
10891159|NCT01668784|12057340|FG001|NOT COMPLETED|Treatment Period||397
10891160|NCT01665144|12057348|FG000|STARTED|Overall Study||1105
10891161|NCT01665144|12057349|FG001|STARTED|Overall Study||546
10891162|NCT01665144|12057348|FG000|Safety Set|Overall Study||1099
10891163|NCT01665144|12057349|FG001|Safety Set|Overall Study||546
10891164|NCT01665144|12057348|FG000|Full Analysis Set|Overall Study||1099
10891165|NCT01665144|12057349|FG001|Full Analysis Set|Overall Study||546
10891166|NCT01665144|12057348|FG000|COMPLETED|Overall Study||903
10891167|NCT01665144|12057349|FG001|COMPLETED|Overall Study||424
10891168|NCT01665144|12057348|FG000|NOT COMPLETED|Overall Study||202
10891169|NCT01665144|12057349|FG001|NOT COMPLETED|Overall Study||122
10891170|NCT01660451|12057358|FG000|STARTED|Overall Study||33
10891171|NCT01660451|12057359|FG001|STARTED|Overall Study||51
10891172|NCT01660451|12057360|FG002|STARTED|Overall Study||142
10891173|NCT01660451|12057358|FG000|COMPLETED|Overall Study||16
10891174|NCT01660451|12057359|FG001|COMPLETED|Overall Study||34
10891175|NCT01660451|12057360|FG002|COMPLETED|Overall Study||37
10891176|NCT01660451|12057358|FG000|NOT COMPLETED|Overall Study||17
10891177|NCT01660451|12057359|FG001|NOT COMPLETED|Overall Study||17
10891178|NCT01660451|12057360|FG002|NOT COMPLETED|Overall Study||105
10891179|NCT01659853|12057369|FG000|STARTED|Treatment Period 1||35
10891180|NCT01659853|12057370|FG001|STARTED|Treatment Period 1||35
10891181|NCT01659853|12057369|FG000|COMPLETED|Treatment Period 1||35
10891182|NCT01659853|12057370|FG001|COMPLETED|Treatment Period 1||35
10891183|NCT01659853|12057369|FG000|NOT COMPLETED|Treatment Period 1||0
10891184|NCT01659853|12057370|FG001|NOT COMPLETED|Treatment Period 1||0
10891185|NCT01659853|12057369|FG000|STARTED|Washout , 3 to 7 Days||35
10891186|NCT01659853|12057370|FG001|STARTED|Washout , 3 to 7 Days||35
10891187|NCT01659853|12057369|FG000|COMPLETED|Washout , 3 to 7 Days||33
10891188|NCT01659853|12057370|FG001|COMPLETED|Washout , 3 to 7 Days||35
10891189|NCT01659853|12057369|FG000|NOT COMPLETED|Washout , 3 to 7 Days||2
10891190|NCT01659853|12057370|FG001|NOT COMPLETED|Washout , 3 to 7 Days||0
10891191|NCT01659853|12057369|FG000|STARTED|Treatment Period 2||33
10891192|NCT01659853|12057370|FG001|STARTED|Treatment Period 2||35
10891193|NCT01659853|12057369|FG000|COMPLETED|Treatment Period 2||33
10891194|NCT01659853|12057370|FG001|COMPLETED|Treatment Period 2||35
10891195|NCT01659853|12057369|FG000|NOT COMPLETED|Treatment Period 2||0
10891196|NCT01659853|12057370|FG001|NOT COMPLETED|Treatment Period 2||0
10891197|NCT01659541|12057378|FG000|STARTED|Overall Study||12
10891198|NCT01659541|12057378|FG000|COMPLETED|Overall Study||11
10891199|NCT01659541|12057378|FG000|NOT COMPLETED|Overall Study||1
10891200|NCT01652872|12057395|FG000|STARTED|Overall Study||377
10891201|NCT01652872|12057396|FG001|STARTED|Overall Study||379
10891202|NCT01652872|12057395|FG000|Received Investigational Product|Overall Study||377
10891203|NCT01652872|12057396|FG001|Received Investigational Product|Overall Study||377
10891204|NCT01652872|12057395|FG000|COMPLETED|Overall Study||232
10891205|NCT01652872|12057396|FG001|COMPLETED|Overall Study||226
10891206|NCT01652872|12057395|FG000|NOT COMPLETED|Overall Study||145
10891207|NCT01652872|12057396|FG001|NOT COMPLETED|Overall Study||153
10891208|NCT01652469|12057404|FG000|STARTED|Overall Study||38
10891209|NCT01652469|12057405|FG001|STARTED|Overall Study||42
10891210|NCT01652469|12057404|FG000|COMPLETED|Overall Study||37
10891211|NCT01652469|12057405|FG001|COMPLETED|Overall Study||36
10891212|NCT01652469|12057404|FG000|NOT COMPLETED|Overall Study||1
10891213|NCT01652469|12057405|FG001|NOT COMPLETED|Overall Study||6
10891214|NCT01650558|12057414|FG000|STARTED|Overall Study||500
10891215|NCT01650558|12057415|FG001|STARTED|Overall Study||500
10891216|NCT01650558|12057416|FG002|STARTED|Overall Study||499
10891217|NCT01650558|12057414|FG000|COMPLETED|Overall Study||417
10891218|NCT01650558|12057415|FG001|COMPLETED|Overall Study||408
10891219|NCT01650558|12057416|FG002|COMPLETED|Overall Study||424
10891220|NCT01650558|12057414|FG000|NOT COMPLETED|Overall Study||83
10891221|NCT01650558|12057415|FG001|NOT COMPLETED|Overall Study||92
10891222|NCT01650558|12057416|FG002|NOT COMPLETED|Overall Study||75
10891223|NCT01639131|12057425|FG000|STARTED|Overall Study||6
10891224|NCT01639131|12057425|FG000|COMPLETED|Overall Study||0
10891225|NCT01639131|12057425|FG000|NOT COMPLETED|Overall Study||6
10891226|NCT01626079|12057432|FG000|STARTED|Overall Study||302
10891227|NCT01626079|12057433|FG001|STARTED|Overall Study||312
10891228|NCT01626079|12057434|FG002|STARTED|Overall Study||162
10891229|NCT01626079|12057432|FG000|COMPLETED|Overall Study||152
10891230|NCT01626079|12057433|FG001|COMPLETED|Overall Study||111
10891231|NCT01626079|12057434|FG002|COMPLETED|Overall Study||110
10891232|NCT01626079|12057432|FG000|NOT COMPLETED|Overall Study||150
10891233|NCT01626079|12057433|FG001|NOT COMPLETED|Overall Study||201
10891234|NCT01626079|12057434|FG002|NOT COMPLETED|Overall Study||52
10891235|NCT01625611|12057447|FG000|STARTED|Overall Study||55
10891236|NCT01625611|12057448|FG001|STARTED|Overall Study||4
10891237|NCT01625611|12057447|FG000|PET Scan 1|Overall Study||49
10891238|NCT01625611|12057448|FG001|PET Scan 1|Overall Study||4
10891239|NCT01625611|12057447|FG000|Lab 2|Overall Study||48
10891240|NCT01625611|12057448|FG001|Lab 2|Overall Study||0
10891241|NCT01625611|12057447|FG000|PET Scan 2|Overall Study||47
10891242|NCT01625611|12057448|FG001|PET Scan 2|Overall Study||0
10891243|NCT01625611|12057447|FG000|COMPLETED|Overall Study||47
10891244|NCT01625611|12057448|FG001|COMPLETED|Overall Study||4
10891245|NCT01625611|12057447|FG000|NOT COMPLETED|Overall Study||8
10891246|NCT01625611|12057448|FG001|NOT COMPLETED|Overall Study||0
10891247|NCT01625286|12057462|FG000|STARTED|Overall Study||12
10891248|NCT01625286|12057463|FG001|STARTED|Overall Study||8
10891249|NCT01625286|12057464|FG002|STARTED|Overall Study||5
10891250|NCT01625286|12057465|FG003|STARTED|Overall Study||7
10891251|NCT01625286|12057466|FG004|STARTED|Overall Study||6
10891252|NCT01625286|12057467|FG005|STARTED|Overall Study||54
10891253|NCT01625286|12057468|FG006|STARTED|Overall Study||56
10891254|NCT01625286|12057462|FG000|Received AZD5363/Placebo Treatment|Overall Study||12
10891255|NCT01625286|12057463|FG001|Received AZD5363/Placebo Treatment|Overall Study||8
10891256|NCT01625286|12057464|FG002|Received AZD5363/Placebo Treatment|Overall Study||5
10891257|NCT01625286|12057465|FG003|Received AZD5363/Placebo Treatment|Overall Study||7
10891258|NCT01625286|12057466|FG004|Received AZD5363/Placebo Treatment|Overall Study||6
10891259|NCT01625286|12057467|FG005|Received AZD5363/Placebo Treatment|Overall Study||54
10891260|NCT01625286|12057468|FG006|Received AZD5363/Placebo Treatment|Overall Study||55
10891261|NCT01625286|12057462|FG000|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
10891262|NCT01625286|12057463|FG001|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
10891263|NCT01625286|12057464|FG002|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
10891264|NCT01625286|12057465|FG003|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
10891265|NCT01625286|12057466|FG004|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
10891266|NCT01625286|12057467|FG005|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
10891267|NCT01625286|12057468|FG006|Did Not Receive AZD5363/Placebo Trt|Overall Study||1
10891268|NCT01625286|12057462|FG000|COMPLETED|Overall Study||0
10891269|NCT01625286|12057463|FG001|COMPLETED|Overall Study||0
10891270|NCT01625286|12057464|FG002|COMPLETED|Overall Study||0
10891271|NCT01625286|12057465|FG003|COMPLETED|Overall Study||0
10891272|NCT01625286|12057466|FG004|COMPLETED|Overall Study||0
10891273|NCT01625286|12057467|FG005|COMPLETED|Overall Study||0
10891274|NCT01625286|12057468|FG006|COMPLETED|Overall Study||0
10891275|NCT01625286|12057462|FG000|NOT COMPLETED|Overall Study||12
10891276|NCT01625286|12057463|FG001|NOT COMPLETED|Overall Study||8
10891277|NCT01625286|12057464|FG002|NOT COMPLETED|Overall Study||5
10891278|NCT01625286|12057465|FG003|NOT COMPLETED|Overall Study||7
10891279|NCT01625286|12057466|FG004|NOT COMPLETED|Overall Study||6
10891280|NCT01625286|12057467|FG005|NOT COMPLETED|Overall Study||54
10891281|NCT01625286|12057468|FG006|NOT COMPLETED|Overall Study||56
10891282|NCT01621906|12057486|FG000|STARTED|Overall Study||12
10891283|NCT01621906|12057487|FG001|STARTED|Overall Study||5
10891284|NCT01621906|12057486|FG000|COMPLETED|Overall Study||12
10891285|NCT01621906|12057487|FG001|COMPLETED|Overall Study||5
10891286|NCT01621906|12057486|FG000|NOT COMPLETED|Overall Study||0
10891287|NCT01621906|12057487|FG001|NOT COMPLETED|Overall Study||0
10891288|NCT01615887|12057496|FG000|STARTED|Overall Study||41
10891289|NCT01615887|12057497|FG001|STARTED|Overall Study||22
10891290|NCT01615887|12057496|FG000|COMPLETED|Overall Study||29
10891291|NCT01615887|12057497|FG001|COMPLETED|Overall Study||19
10891292|NCT01615887|12057496|FG000|NOT COMPLETED|Overall Study||12
10891293|NCT01615887|12057497|FG001|NOT COMPLETED|Overall Study||3
10891294|NCT01615029|12057508|FG000|STARTED|Overall Study||3
10891295|NCT01615029|12057509|FG001|STARTED|Overall Study||3
10891296|NCT01615029|12057510|FG002|STARTED|Overall Study||4
10891297|NCT01615029|12057511|FG003|STARTED|Overall Study||3
10891298|NCT01615029|12057512|FG004|STARTED|Overall Study||32
10891299|NCT01615029|12057508|FG000|COMPLETED|Overall Study||0
10891300|NCT01615029|12057509|FG001|COMPLETED|Overall Study||0
10891301|NCT01615029|12057510|FG002|COMPLETED|Overall Study||0
10891302|NCT01615029|12057511|FG003|COMPLETED|Overall Study||0
10891303|NCT01615029|12057512|FG004|COMPLETED|Overall Study||0
10891304|NCT01615029|12057508|FG000|NOT COMPLETED|Overall Study||3
10891305|NCT01615029|12057509|FG001|NOT COMPLETED|Overall Study||3
10891306|NCT01615029|12057510|FG002|NOT COMPLETED|Overall Study||4
10891307|NCT01615029|12057511|FG003|NOT COMPLETED|Overall Study||3
10891308|NCT01615029|12057512|FG004|NOT COMPLETED|Overall Study||32
10891309|NCT01613118|12057528|FG000|STARTED|Double-blind||13
10891310|NCT01613118|12057529|FG001|STARTED|Double-blind||26
10891311|NCT01613118|12057530|FG002|STARTED|Double-blind||34
10891312|NCT01613118|12057531|FG003|STARTED|Double-blind||36
10891313|NCT01613118|12057528|FG000|COMPLETED|Double-blind||13
10891314|NCT01613118|12057529|FG001|COMPLETED|Double-blind||23
10891315|NCT01613118|12057530|FG002|COMPLETED|Double-blind||32
10891316|NCT01613118|12057531|FG003|COMPLETED|Double-blind||35
10891317|NCT01613118|12057528|FG000|NOT COMPLETED|Double-blind||0
10891318|NCT01613118|12057529|FG001|NOT COMPLETED|Double-blind||3
10891319|NCT01613118|12057530|FG002|NOT COMPLETED|Double-blind||2
10891320|NCT01613118|12057531|FG003|NOT COMPLETED|Double-blind||1
10891321|NCT01613118|12057528|FG000|STARTED|Open-label Extension|Arm includes subjects from the Irbesartan Arm in the Double-blind period.|21
10891322|NCT01613118|12057529|FG001|STARTED|Open-label Extension|Arm includes subjects from the Irbesartan Arm in the Double-blind period.|42
10891323|NCT01613118|12057530|FG002|STARTED|Open-label Extension|Arm includes subjects from the Irbesartan Arm in the Double-blind period.|40
10891324|NCT01613118|12057531|FG003|STARTED|Open-label Extension||0
10891325|NCT01613118|12057528|FG000|COMPLETED|Open-label Extension|OLE ongoing|0
10891326|NCT01613118|12057529|FG001|COMPLETED|Open-label Extension|OLE ongoing|0
10891327|NCT01613118|12057530|FG002|COMPLETED|Open-label Extension|OLE ongoing|0
10891328|NCT01613118|12057531|FG003|COMPLETED|Open-label Extension||0
10891329|NCT01613118|12057528|FG000|NOT COMPLETED|Open-label Extension||21
10891330|NCT01613118|12057529|FG001|NOT COMPLETED|Open-label Extension||42
10891331|NCT01613118|12057530|FG002|NOT COMPLETED|Open-label Extension||40
10891332|NCT01613118|12057531|FG003|NOT COMPLETED|Open-label Extension||0
10891333|NCT01603407|12057545|FG000|STARTED|Overall Study||65
10891334|NCT01603407|12057546|FG001|STARTED|Overall Study||65
10891335|NCT01603407|12057547|FG002|STARTED|Overall Study||66
10891336|NCT01603407|12057545|FG000|COMPLETED|Overall Study||54
10891337|NCT01603407|12057546|FG001|COMPLETED|Overall Study||54
10891338|NCT01603407|12057547|FG002|COMPLETED|Overall Study||56
10891339|NCT01603407|12057545|FG000|NOT COMPLETED|Overall Study||11
10891340|NCT01603407|12057546|FG001|NOT COMPLETED|Overall Study||11
10891341|NCT01603407|12057547|FG002|NOT COMPLETED|Overall Study||10
10891342|NCT01602380|12057557|FG000|STARTED|Overall Study||230
10891343|NCT01602380|12057558|FG001|STARTED|Overall Study||232
10891344|NCT01602380|12057557|FG000|COMPLETED|Overall Study|Completed: number of patients ongoing in the study at data cut-off for the primary analysis|137
10891345|NCT01602380|12057558|FG001|COMPLETED|Overall Study|Completed: number of patients ongoing in the study at data cut-off for the primary analysis|131
10891346|NCT01602380|12057557|FG000|NOT COMPLETED|Overall Study||93
10891347|NCT01602380|12057558|FG001|NOT COMPLETED|Overall Study||101
10891348|NCT01598311|12057566|FG000|STARTED|Overall Study||303
10891349|NCT01598311|12057567|FG001|STARTED|Overall Study||305
10891350|NCT01598311|12057566|FG000|Treated|Overall Study||294
10891351|NCT01598311|12057567|FG001|Treated|Overall Study||301
10891352|NCT01598311|12057566|FG000|Treated and Confirmed CDAD|Overall Study||285
10891353|NCT01598311|12057567|FG001|Treated and Confirmed CDAD|Overall Study||292
10891354|NCT01598311|12057566|FG000|COMPLETED|Overall Study||256
10891355|NCT01598311|12057567|FG001|COMPLETED|Overall Study||244
10891356|NCT01598311|12057566|FG000|NOT COMPLETED|Overall Study||47
10891357|NCT01598311|12057567|FG001|NOT COMPLETED|Overall Study||61
10891358|NCT01597388|12057582|FG000|STARTED|Overall Study||6
10891359|NCT01597388|12057583|FG001|STARTED|Overall Study||13
10891360|NCT01597388|12057584|FG002|STARTED|Overall Study||14
10891361|NCT01597388|12057585|FG003|STARTED|Overall Study||10
10891362|NCT01597388|12057586|FG004|STARTED|Overall Study||37
10891363|NCT01597388|12057587|FG005|STARTED|Overall Study||4
10891364|NCT01597388|12057588|FG006|STARTED|Overall Study||8
10891365|NCT01597388|12057589|FG007|STARTED|Overall Study||5
10891366|NCT01597388|12057590|FG008|STARTED|Overall Study||2
10891367|NCT01597388|12057582|FG000|COMPLETED|Overall Study||6
10891368|NCT01597388|12057583|FG001|COMPLETED|Overall Study||13
10891369|NCT01597388|12057584|FG002|COMPLETED|Overall Study||14
10891370|NCT01597388|12057585|FG003|COMPLETED|Overall Study||10
10891371|NCT01597388|12057586|FG004|COMPLETED|Overall Study||37
10891372|NCT01597388|12057587|FG005|COMPLETED|Overall Study||4
10891373|NCT01597388|12057588|FG006|COMPLETED|Overall Study||8
10891374|NCT01597388|12057589|FG007|COMPLETED|Overall Study||5
10891375|NCT01597388|12057590|FG008|COMPLETED|Overall Study||2
10891376|NCT01597388|12057582|FG000|NOT COMPLETED|Overall Study||0
10891377|NCT01597388|12057583|FG001|NOT COMPLETED|Overall Study||0
10891378|NCT01597388|12057584|FG002|NOT COMPLETED|Overall Study||0
10891379|NCT01597388|12057585|FG003|NOT COMPLETED|Overall Study||0
10891380|NCT01597388|12057586|FG004|NOT COMPLETED|Overall Study||0
10891381|NCT01597388|12057587|FG005|NOT COMPLETED|Overall Study||0
10891382|NCT01597388|12057588|FG006|NOT COMPLETED|Overall Study||0
10891383|NCT01597388|12057589|FG007|NOT COMPLETED|Overall Study||0
10891384|NCT01597388|12057590|FG008|NOT COMPLETED|Overall Study||0
10891385|NCT01593761|12057627|FG000|STARTED|Overall Study||20
10891386|NCT01593761|12057627|FG000|COMPLETED|Overall Study||12
10891387|NCT01593761|12057627|FG000|NOT COMPLETED|Overall Study||8
10891388|NCT01593254|12057639|FG000|STARTED|Treatment Period||86
10891389|NCT01593254|12057640|FG001|STARTED|Treatment Period||174
10891390|NCT01593254|12057639|FG000|Crossed Over to Dasatinib|Treatment Period||42
10891391|NCT01593254|12057640|FG001|Crossed Over to Dasatinib|Treatment Period||0
10891392|NCT01593254|12057639|FG000|COMPLETED|Treatment Period||72
10891393|NCT01593254|12057640|FG001|COMPLETED|Treatment Period||143
10891394|NCT01593254|12057639|FG000|NOT COMPLETED|Treatment Period||14
10891395|NCT01593254|12057640|FG001|NOT COMPLETED|Treatment Period||31
10891396|NCT01593254|12057639|FG000|STARTED|Follow-Up Period||14
10891397|NCT01593254|12057640|FG001|STARTED|Follow-Up Period||28
10891398|NCT01593254|12057639|FG000|COMPLETED|Follow-Up Period||11
10891399|NCT01593254|12057640|FG001|COMPLETED|Follow-Up Period||17
10891400|NCT01593254|12057639|FG000|NOT COMPLETED|Follow-Up Period||3
10891401|NCT01593254|12057640|FG001|NOT COMPLETED|Follow-Up Period||11
10891402|NCT01592721|12057647|FG000|STARTED|Treatment Period||6
10891403|NCT01592721|12057647|FG000|COMPLETED|Treatment Period||6
10891404|NCT01592721|12057647|FG000|NOT COMPLETED|Treatment Period||0
10891405|NCT01592721|12057647|FG000|STARTED|Long-term Follow-up||6
10891406|NCT01592721|12057647|FG000|COMPLETED|Long-term Follow-up||5
10891407|NCT01592721|12057647|FG000|NOT COMPLETED|Long-term Follow-up||1
10891408|NCT01592370|12057658|FG000|STARTED|Overall Study||105
10891409|NCT01592370|12057659|FG001|STARTED|Overall Study||65
10891410|NCT01592370|12057660|FG002|STARTED|Overall Study||72
10891411|NCT01592370|12057661|FG003|STARTED|Overall Study||6
10891412|NCT01592370|12057662|FG004|STARTED|Overall Study||5
10891413|NCT01592370|12057663|FG005|STARTED|Overall Study||41
10891414|NCT01592370|12057664|FG006|STARTED|Overall Study||22
10891415|NCT01592370|12057658|FG000|COMPLETED|Overall Study||1
10891416|NCT01592370|12057659|FG001|COMPLETED|Overall Study||40
10891417|NCT01592370|12057660|FG002|COMPLETED|Overall Study||0
10891418|NCT01592370|12057661|FG003|COMPLETED|Overall Study||1
10891419|NCT01592370|12057662|FG004|COMPLETED|Overall Study||1
10891420|NCT01592370|12057663|FG005|COMPLETED|Overall Study||7
10891421|NCT01592370|12057664|FG006|COMPLETED|Overall Study||6
10891422|NCT01592370|12057658|FG000|NOT COMPLETED|Overall Study||104
10891423|NCT01592370|12057659|FG001|NOT COMPLETED|Overall Study||25
10891424|NCT01592370|12057660|FG002|NOT COMPLETED|Overall Study||72
10891425|NCT01592370|12057661|FG003|NOT COMPLETED|Overall Study||5
10891426|NCT01592370|12057662|FG004|NOT COMPLETED|Overall Study||4
10891427|NCT01592370|12057663|FG005|NOT COMPLETED|Overall Study||34
10891428|NCT01592370|12057664|FG006|NOT COMPLETED|Overall Study||16
10891429|NCT01590017|12057684|FG000|STARTED|Overall Study||41
10891430|NCT01590017|12057684|FG000|COMPLETED|Overall Study||37
10891431|NCT01590017|12057684|FG000|NOT COMPLETED|Overall Study||4
10891432|NCT01582009|12057688|FG000|STARTED|Overall Study||26
10891433|NCT01582009|12057688|FG000|COMPLETED|Overall Study||24
10891434|NCT01582009|12057688|FG000|NOT COMPLETED|Overall Study||2
10891435|NCT01575834|12057694|FG000|STARTED|Overall Study||3591
10891436|NCT01575834|12057695|FG001|STARTED|Overall Study||3589
10891437|NCT01575834|12057694|FG000|Received Double-blind Treatment|Overall Study|Six participants received a dose of romosozumab in error during the double-blind period.|3582
10891438|NCT01575834|12057695|FG001|Received Double-blind Treatment|Overall Study||3575
10891439|NCT01575834|12057694|FG000|Completed Double-blind Period|Overall Study||3205
10891440|NCT01575834|12057695|FG001|Completed Double-blind Period|Overall Study||3185
10891441|NCT01575834|12057694|FG000|Completed 24-month Study Period|Overall Study||3032
10891442|NCT01575834|12057695|FG001|Completed 24-month Study Period|Overall Study||2994
10891443|NCT01575834|12057694|FG000|COMPLETED|Overall Study|Completed 36-month study period|2892
10891444|NCT01575834|12057695|FG001|COMPLETED|Overall Study|Completed 36-month study period|2851
10891445|NCT01575834|12057694|FG000|NOT COMPLETED|Overall Study||699
10891446|NCT01575834|12057695|FG001|NOT COMPLETED|Overall Study||738
10891447|NCT01574274|12057707|FG000|STARTED|Overall Study||119
10891448|NCT01574274|12057708|FG001|STARTED|Overall Study||121
10891449|NCT01574274|12057707|FG000|Evaluable for Induction Events|Overall Study||115
10891450|NCT01574274|12057708|FG001|Evaluable for Induction Events|Overall Study||115
10891451|NCT01574274|12057707|FG000|Achieved Complete Remission|Overall Study||109
10891452|NCT01574274|12057708|FG001|Achieved Complete Remission|Overall Study||114
10891453|NCT01574274|12057707|FG000|Received Post-induction Asparaginase|Overall Study||109
10891454|NCT01574274|12057708|FG001|Received Post-induction Asparaginase|Overall Study||114
10891455|NCT01574274|12057707|FG000|Eligible|Overall Study||119
10891456|NCT01574274|12057708|FG001|Eligible|Overall Study||120
10891457|NCT01574274|12057707|FG000|COMPLETED|Overall Study||87
10891458|NCT01574274|12057708|FG001|COMPLETED|Overall Study||99
10891459|NCT01574274|12057707|FG000|NOT COMPLETED|Overall Study||32
10891460|NCT01574274|12057708|FG001|NOT COMPLETED|Overall Study||22
10891461|NCT01572480|12057714|FG000|STARTED|Participants Enrolled||55
10891462|NCT01572480|12057714|FG000|COMPLETED|Participants Enrolled||54
10891463|NCT01572480|12057714|FG000|NOT COMPLETED|Participants Enrolled||1
10891464|NCT01572480|12057714|FG000|STARTED|Drug Administration||54
10891465|NCT01572480|12057714|FG000|COMPLETED|Drug Administration|2 participants discontinued drug administration early because of adverse events, thus 1 was taken off study and 1 proceeded to maintenance.|53
10891466|NCT01572480|12057714|FG000|NOT COMPLETED|Drug Administration||1
10891467|NCT01572480|12057714|FG000|STARTED|Initiated Maintenance Therapy||53
10891468|NCT01572480|12057714|FG000|COMPLETED|Initiated Maintenance Therapy||50
10891469|NCT01572480|12057714|FG000|NOT COMPLETED|Initiated Maintenance Therapy||3
10891470|NCT01572480|12057714|FG000|STARTED|Completed Maintenance Therapy||50
10891471|NCT01572480|12057714|FG000|COMPLETED|Completed Maintenance Therapy||30
10891472|NCT01572480|12057714|FG000|NOT COMPLETED|Completed Maintenance Therapy||20
10891473|NCT01568866|12057720|FG000|STARTED|Overall Study||465
10891474|NCT01568866|12057721|FG001|STARTED|Overall Study||464
10891475|NCT01568866|12057720|FG000|Received Treatment|Overall Study||456
10891476|NCT01568866|12057721|FG001|Received Treatment|Overall Study||463
10891477|NCT01568866|12057720|FG000|COMPLETED|Overall Study|Indicates participants still receiving treatment|27
10891478|NCT01568866|12057721|FG001|COMPLETED|Overall Study|Indicates participants still receiving treatment|48
10891479|NCT01568866|12057720|FG000|NOT COMPLETED|Overall Study||438
10891480|NCT01568866|12057721|FG001|NOT COMPLETED|Overall Study||416
10891481|NCT01566695|12057729|FG000|STARTED|Overall Study||107
10891482|NCT01566695|12057730|FG001|STARTED|Overall Study||109
10891483|NCT01566695|12057729|FG000|COMPLETED|Overall Study||12
10891484|NCT01566695|12057730|FG001|COMPLETED|Overall Study||10
10891485|NCT01566695|12057729|FG000|NOT COMPLETED|Overall Study||95
10891486|NCT01566695|12057730|FG001|NOT COMPLETED|Overall Study||99
10891487|NCT01565382|12057736|FG000|STARTED|Overall Study||40
10891488|NCT01565382|12057736|FG000|COMPLETED|Overall Study||40
10891489|NCT01565382|12057736|FG000|NOT COMPLETED|Overall Study||0
10891490|NCT01562028|12057743|FG000|STARTED|Overall Study||37
10891491|NCT01562028|12057744|FG001|STARTED|Overall Study||72
10891492|NCT01562028|12057743|FG000|COMPLETED|Overall Study||34
10891493|NCT01562028|12057744|FG001|COMPLETED|Overall Study||70
10891494|NCT01562028|12057743|FG000|NOT COMPLETED|Overall Study||3
10891495|NCT01562028|12057744|FG001|NOT COMPLETED|Overall Study||2
10891496|NCT01555697|12057758|FG000|STARTED|Overall Study||10
10891497|NCT01555697|12057759|FG001|STARTED|Overall Study||10
10891498|NCT01555697|12057760|FG002|STARTED|Overall Study||10
10891499|NCT01555697|12057761|FG003|STARTED|Overall Study||10
10891500|NCT01555697|12057762|FG004|STARTED|Overall Study||10
10891501|NCT01555697|12057763|FG005|STARTED|Overall Study||10
10891502|NCT01555697|12057764|FG006|STARTED|Overall Study||10
10891503|NCT01555697|12057765|FG007|STARTED|Overall Study||10
10891504|NCT01555697|12057758|FG000|6 Hours Lab Testing Day 1|Overall Study||10
10891505|NCT01555697|12057759|FG001|6 Hours Lab Testing Day 1|Overall Study||10
10891506|NCT01555697|12057760|FG002|6 Hours Lab Testing Day 1|Overall Study||10
10891507|NCT01555697|12057761|FG003|6 Hours Lab Testing Day 1|Overall Study||10
10891508|NCT01555697|12057762|FG004|6 Hours Lab Testing Day 1|Overall Study||10
10891509|NCT01555697|12057763|FG005|6 Hours Lab Testing Day 1|Overall Study||10
10891510|NCT01555697|12057764|FG006|6 Hours Lab Testing Day 1|Overall Study||10
10891511|NCT01555697|12057765|FG007|6 Hours Lab Testing Day 1|Overall Study||10
10891512|NCT01555697|12057758|FG000|Approx 7 Day Washout|Overall Study||10
10891513|NCT01555697|12057759|FG001|Approx 7 Day Washout|Overall Study||10
10891514|NCT01555697|12057760|FG002|Approx 7 Day Washout|Overall Study||10
10891515|NCT01555697|12057761|FG003|Approx 7 Day Washout|Overall Study||10
10891516|NCT01555697|12057762|FG004|Approx 7 Day Washout|Overall Study||10
10891517|NCT01555697|12057763|FG005|Approx 7 Day Washout|Overall Study||10
10891518|NCT01555697|12057764|FG006|Approx 7 Day Washout|Overall Study||10
10891519|NCT01555697|12057765|FG007|Approx 7 Day Washout|Overall Study||10
10891520|NCT01555697|12057758|FG000|6 Hours Lab Testing Day 2|Overall Study||10
10891521|NCT01555697|12057759|FG001|6 Hours Lab Testing Day 2|Overall Study||10
10891522|NCT01555697|12057760|FG002|6 Hours Lab Testing Day 2|Overall Study||10
10891523|NCT01555697|12057761|FG003|6 Hours Lab Testing Day 2|Overall Study||10
10891524|NCT01555697|12057762|FG004|6 Hours Lab Testing Day 2|Overall Study||10
10891525|NCT01555697|12057763|FG005|6 Hours Lab Testing Day 2|Overall Study||10
10891526|NCT01555697|12057764|FG006|6 Hours Lab Testing Day 2|Overall Study||10
10891527|NCT01555697|12057765|FG007|6 Hours Lab Testing Day 2|Overall Study||10
10891528|NCT01555697|12057758|FG000|COMPLETED|Overall Study||10
10891529|NCT01555697|12057759|FG001|COMPLETED|Overall Study||10
10891530|NCT01555697|12057760|FG002|COMPLETED|Overall Study||10
10891531|NCT01555697|12057761|FG003|COMPLETED|Overall Study||10
10891532|NCT01555697|12057762|FG004|COMPLETED|Overall Study||10
10891533|NCT01555697|12057763|FG005|COMPLETED|Overall Study||10
10891534|NCT01555697|12057764|FG006|COMPLETED|Overall Study||10
10891535|NCT01555697|12057765|FG007|COMPLETED|Overall Study||10
10891536|NCT01555697|12057758|FG000|NOT COMPLETED|Overall Study||0
10891537|NCT01555697|12057759|FG001|NOT COMPLETED|Overall Study||0
10891538|NCT01555697|12057760|FG002|NOT COMPLETED|Overall Study||0
10891539|NCT01555697|12057761|FG003|NOT COMPLETED|Overall Study||0
10891540|NCT01555697|12057762|FG004|NOT COMPLETED|Overall Study||0
10891541|NCT01555697|12057763|FG005|NOT COMPLETED|Overall Study||0
10891542|NCT01555697|12057764|FG006|NOT COMPLETED|Overall Study||0
10891543|NCT01555697|12057765|FG007|NOT COMPLETED|Overall Study||0
10891544|NCT01553149|12057779|FG000|STARTED|Overall Study||37
10891545|NCT01553149|12057780|FG001|STARTED|Overall Study||38
10891546|NCT01553149|12057779|FG000|COMPLETED|Overall Study||32
10891547|NCT01553149|12057780|FG001|COMPLETED|Overall Study||18
10891548|NCT01553149|12057779|FG000|NOT COMPLETED|Overall Study||5
10891549|NCT01553149|12057780|FG001|NOT COMPLETED|Overall Study||20
10891550|NCT01535053|12057788|FG000|STARTED|Overall Study||29
10891551|NCT01535053|12057789|FG001|STARTED|Overall Study||28
10891552|NCT01535053|12057788|FG000|COMPLETED|Overall Study|treated for 3 cycles after hCG <5mIU/ml or until biologic,disease progression, unacceptable toxicity|28
10891553|NCT01535053|12057789|FG001|COMPLETED|Overall Study|treated for 3 cycles after hCG <5mIU/ml or until biologic,disease progression, unacceptable toxicity|26
10891554|NCT01535053|12057788|FG000|NOT COMPLETED|Overall Study||1
10891555|NCT01535053|12057789|FG001|NOT COMPLETED|Overall Study||2
10891556|NCT01522976|12057798|FG000|STARTED|Overall Study||97
10891557|NCT01522976|12057799|FG001|STARTED|Overall Study||92
10891558|NCT01522976|12057800|FG002|STARTED|Overall Study||93
10891559|NCT01522976|12057798|FG000|COMPLETED|Overall Study||0
10891560|NCT01522976|12057799|FG001|COMPLETED|Overall Study||0
10891561|NCT01522976|12057800|FG002|COMPLETED|Overall Study||0
10891562|NCT01522976|12057798|FG000|NOT COMPLETED|Overall Study||97
10891563|NCT01522976|12057799|FG001|NOT COMPLETED|Overall Study||92
10891564|NCT01522976|12057800|FG002|NOT COMPLETED|Overall Study||93
10891565|NCT01522456|12057811|FG000|STARTED|Overall Study||73
10891566|NCT01522456|12057811|FG000|COMPLETED|Overall Study||65
10891567|NCT01522456|12057811|FG000|NOT COMPLETED|Overall Study||8
10891568|NCT01522365|12057824|FG000|STARTED|Overall Study||20
10891569|NCT01522365|12057825|FG001|STARTED|Overall Study||20
10891570|NCT01522365|12057824|FG000|Intention-to-Treat|Overall Study||19
10891571|NCT01522365|12057825|FG001|Intention-to-Treat|Overall Study||19
10891572|NCT01522365|12057824|FG000|COMPLETED|Overall Study||18
10891573|NCT01522365|12057825|FG001|COMPLETED|Overall Study||18
10891574|NCT01522365|12057824|FG000|NOT COMPLETED|Overall Study||2
10891575|NCT01522365|12057825|FG001|NOT COMPLETED|Overall Study||2
10891576|NCT01517711|12057834|FG000|STARTED|Overall Study||22
10891577|NCT01517711|12057835|FG001|STARTED|Overall Study||18
10891578|NCT01517711|12057834|FG000|COMPLETED|Overall Study||20
10891579|NCT01517711|12057835|FG001|COMPLETED|Overall Study||15
10891580|NCT01517711|12057834|FG000|NOT COMPLETED|Overall Study||2
10891581|NCT01517711|12057835|FG001|NOT COMPLETED|Overall Study||3
10891582|NCT01496976|12057845|FG000|STARTED|Overall Study||45
10891583|NCT01496976|12057845|FG000|COMPLETED|Overall Study||44
10891584|NCT01496976|12057845|FG000|NOT COMPLETED|Overall Study||1
10891585|NCT01490502|12057851|FG000|STARTED|Overall Study||83
10891586|NCT01490502|12057852|FG001|STARTED|Overall Study||89
10891587|NCT01490502|12057851|FG000|Received Allocated Intervention|Overall Study||83
10891588|NCT01490502|12057852|FG001|Received Allocated Intervention|Overall Study||88
10891589|NCT01490502|12057851|FG000|Attended at Least 1 Follow-up Visit|Overall Study||82
10891590|NCT01490502|12057852|FG001|Attended at Least 1 Follow-up Visit|Overall Study||83
10891591|NCT01490502|12057851|FG000|COMPLETED|Overall Study||68
10891592|NCT01490502|12057852|FG001|COMPLETED|Overall Study||72
10891593|NCT01490502|12057851|FG000|NOT COMPLETED|Overall Study||15
10891594|NCT01490502|12057852|FG001|NOT COMPLETED|Overall Study||17
10891595|NCT01485614|12057862|FG000|STARTED|Randomization||96
10891596|NCT01485614|12057863|FG001|STARTED|Randomization||90
10891597|NCT01485614|12057864|FG002|STARTED|Randomization||9
10891598|NCT01485614|12057865|FG003|STARTED|Randomization||5
10891599|NCT01485614|12057862|FG000|COMPLETED|Randomization||95
10891600|NCT01485614|12057863|FG001|COMPLETED|Randomization||90
10891601|NCT01485614|12057864|FG002|COMPLETED|Randomization||9
10891602|NCT01485614|12057865|FG003|COMPLETED|Randomization||5
10891603|NCT01485614|12057862|FG000|NOT COMPLETED|Randomization||1
10891604|NCT01485614|12057863|FG001|NOT COMPLETED|Randomization||0
10891605|NCT01485614|12057864|FG002|NOT COMPLETED|Randomization||0
10891606|NCT01485614|12057865|FG003|NOT COMPLETED|Randomization||0
10891607|NCT01485614|12057862|FG000|STARTED|Weeks 0-20||95
10891608|NCT01485614|12057863|FG001|STARTED|Weeks 0-20||90
10891609|NCT01485614|12057864|FG002|STARTED|Weeks 0-20||9
10891610|NCT01485614|12057865|FG003|STARTED|Weeks 0-20||5
10891611|NCT01485614|12057862|FG000|Treated|Weeks 0-20||95
10891612|NCT01485614|12057863|FG001|Treated|Weeks 0-20||90
10891613|NCT01485614|12057864|FG002|Treated|Weeks 0-20||9
10891614|NCT01485614|12057865|FG003|Treated|Weeks 0-20||5
10891615|NCT01485614|12057862|FG000|COMPLETED|Weeks 0-20||85
10891616|NCT01485614|12057863|FG001|COMPLETED|Weeks 0-20||86
10891617|NCT01485614|12057864|FG002|COMPLETED|Weeks 0-20||8
10891618|NCT01485614|12057865|FG003|COMPLETED|Weeks 0-20||5
10891619|NCT01485614|12057862|FG000|NOT COMPLETED|Weeks 0-20||10
10891620|NCT01485614|12057863|FG001|NOT COMPLETED|Weeks 0-20||4
10891621|NCT01485614|12057864|FG002|NOT COMPLETED|Weeks 0-20||1
10891622|NCT01485614|12057865|FG003|NOT COMPLETED|Weeks 0-20||0
10891623|NCT01485614|12057862|FG000|STARTED|Weeks 20-54||85
10891624|NCT01485614|12057863|FG001|STARTED|Weeks 20-54||86
10891625|NCT01485614|12057864|FG002|STARTED|Weeks 20-54||8
10891626|NCT01485614|12057865|FG003|STARTED|Weeks 20-54||5
10891627|NCT01485614|12057862|FG000|COMPLETED|Weeks 20-54||74
10891628|NCT01485614|12057863|FG001|COMPLETED|Weeks 20-54||78
10891629|NCT01485614|12057864|FG002|COMPLETED|Weeks 20-54||6
10891630|NCT01485614|12057865|FG003|COMPLETED|Weeks 20-54||5
10891631|NCT01485614|12057862|FG000|NOT COMPLETED|Weeks 20-54||11
10891632|NCT01485614|12057863|FG001|NOT COMPLETED|Weeks 20-54||8
10891633|NCT01485614|12057864|FG002|NOT COMPLETED|Weeks 20-54||2
10891634|NCT01485614|12057865|FG003|NOT COMPLETED|Weeks 20-54||0
10891635|NCT01471522|12057883|FG000|STARTED|Overall Study||2588
10891636|NCT01471522|12057884|FG001|STARTED|Overall Study||2591
10891637|NCT01471522|12057883|FG000|COMPLETED|Overall Study||2524
10891638|NCT01471522|12057884|FG001|COMPLETED|Overall Study||2543
10891639|NCT01471522|12057883|FG000|NOT COMPLETED|Overall Study||64
10891640|NCT01471522|12057884|FG001|NOT COMPLETED|Overall Study||48
10891641|NCT01462630|12057891|FG000|STARTED|Overall Study||29
10891642|NCT01462630|12057891|FG000|COMPLETED|Overall Study||22
10891643|NCT01462630|12057891|FG000|NOT COMPLETED|Overall Study||7
10891644|NCT01458366|12057900|FG000|STARTED|Period 1: 70mg/m^2||5
10891645|NCT01458366|12057901|FG001|STARTED|Period 1: 70mg/m^2||0
10891646|NCT01458366|12057902|FG002|STARTED|Period 1: 70mg/m^2||0
10891647|NCT01458366|12057903|FG003|STARTED|Period 1: 70mg/m^2||0
10891648|NCT01458366|12057904|FG004|STARTED|Period 1: 70mg/m^2||0
10891649|NCT01458366|12057900|FG000|COMPLETED|Period 1: 70mg/m^2||3
10891650|NCT01458366|12057901|FG001|COMPLETED|Period 1: 70mg/m^2||0
10891651|NCT01458366|12057902|FG002|COMPLETED|Period 1: 70mg/m^2||0
10891652|NCT01458366|12057903|FG003|COMPLETED|Period 1: 70mg/m^2||0
10891653|NCT01458366|12057904|FG004|COMPLETED|Period 1: 70mg/m^2||0
10891654|NCT01458366|12057900|FG000|NOT COMPLETED|Period 1: 70mg/m^2||2
10891655|NCT01458366|12057901|FG001|NOT COMPLETED|Period 1: 70mg/m^2||0
10891656|NCT01458366|12057902|FG002|NOT COMPLETED|Period 1: 70mg/m^2||0
10891657|NCT01458366|12057903|FG003|NOT COMPLETED|Period 1: 70mg/m^2||0
10891658|NCT01458366|12057904|FG004|NOT COMPLETED|Period 1: 70mg/m^2||0
10891659|NCT01458366|12057900|FG000|STARTED|Period 2: 50mg/m^2||0
10891660|NCT01458366|12057901|FG001|STARTED|Period 2: 50mg/m^2||0
10891661|NCT01458366|12057902|FG002|STARTED|Period 2: 50mg/m^2||0
10891662|NCT01458366|12057903|FG003|STARTED|Period 2: 50mg/m^2||0
10891663|NCT01458366|12057904|FG004|STARTED|Period 2: 50mg/m^2||0
10891664|NCT01458366|12057900|FG000|COMPLETED|Period 2: 50mg/m^2||0
10891665|NCT01458366|12057901|FG001|COMPLETED|Period 2: 50mg/m^2||0
10891666|NCT01458366|12057902|FG002|COMPLETED|Period 2: 50mg/m^2||0
10891667|NCT01458366|12057903|FG003|COMPLETED|Period 2: 50mg/m^2||0
10891668|NCT01458366|12057904|FG004|COMPLETED|Period 2: 50mg/m^2||0
10891669|NCT01458366|12057900|FG000|NOT COMPLETED|Period 2: 50mg/m^2||0
10891670|NCT01458366|12057901|FG001|NOT COMPLETED|Period 2: 50mg/m^2||0
10891671|NCT01458366|12057902|FG002|NOT COMPLETED|Period 2: 50mg/m^2||0
10891672|NCT01458366|12057903|FG003|NOT COMPLETED|Period 2: 50mg/m^2||0
10891673|NCT01458366|12057904|FG004|NOT COMPLETED|Period 2: 50mg/m^2||0
10891674|NCT01458366|12057900|FG000|STARTED|Period 3: 90mg/m^2||0
10891675|NCT01458366|12057901|FG001|STARTED|Period 3: 90mg/m^2||0
10891676|NCT01458366|12057902|FG002|STARTED|Period 3: 90mg/m^2||3
10891677|NCT01458366|12057903|FG003|STARTED|Period 3: 90mg/m^2||0
10891678|NCT01458366|12057904|FG004|STARTED|Period 3: 90mg/m^2||0
10891679|NCT01458366|12057900|FG000|COMPLETED|Period 3: 90mg/m^2||0
10891680|NCT01458366|12057901|FG001|COMPLETED|Period 3: 90mg/m^2||0
10891681|NCT01458366|12057902|FG002|COMPLETED|Period 3: 90mg/m^2||3
10891682|NCT01458366|12057903|FG003|COMPLETED|Period 3: 90mg/m^2||0
10891683|NCT01458366|12057904|FG004|COMPLETED|Period 3: 90mg/m^2||0
10891684|NCT01458366|12057900|FG000|NOT COMPLETED|Period 3: 90mg/m^2||0
10891685|NCT01458366|12057901|FG001|NOT COMPLETED|Period 3: 90mg/m^2||0
10891686|NCT01458366|12057902|FG002|NOT COMPLETED|Period 3: 90mg/m^2||0
10891687|NCT01458366|12057903|FG003|NOT COMPLETED|Period 3: 90mg/m^2||0
10891688|NCT01458366|12057904|FG004|NOT COMPLETED|Period 3: 90mg/m^2||0
10891689|NCT01458366|12057900|FG000|STARTED|Period 4: 120mg/m^2||0
10891690|NCT01458366|12057901|FG001|STARTED|Period 4: 120mg/m^2||0
10891691|NCT01458366|12057902|FG002|STARTED|Period 4: 120mg/m^2||0
10891692|NCT01458366|12057903|FG003|STARTED|Period 4: 120mg/m^2||3
10891693|NCT01458366|12057904|FG004|STARTED|Period 4: 120mg/m^2||0
10891694|NCT01458366|12057900|FG000|COMPLETED|Period 4: 120mg/m^2||0
10891695|NCT01458366|12057901|FG001|COMPLETED|Period 4: 120mg/m^2||0
10891696|NCT01458366|12057902|FG002|COMPLETED|Period 4: 120mg/m^2||0
10891697|NCT01458366|12057903|FG003|COMPLETED|Period 4: 120mg/m^2||3
10891698|NCT01458366|12057904|FG004|COMPLETED|Period 4: 120mg/m^2||0
10891699|NCT01458366|12057900|FG000|NOT COMPLETED|Period 4: 120mg/m^2||0
10891700|NCT01458366|12057901|FG001|NOT COMPLETED|Period 4: 120mg/m^2||0
10891701|NCT01458366|12057902|FG002|NOT COMPLETED|Period 4: 120mg/m^2||0
10891702|NCT01458366|12057903|FG003|NOT COMPLETED|Period 4: 120mg/m^2||0
10891703|NCT01458366|12057904|FG004|NOT COMPLETED|Period 4: 120mg/m^2||0
10891704|NCT01458366|12057900|FG000|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0
10891705|NCT01458366|12057901|FG001|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0
10891706|NCT01458366|12057902|FG002|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0
10891707|NCT01458366|12057903|FG003|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0
10891708|NCT01458366|12057904|FG004|STARTED|Period 5: Maximum Tolerated Dose (MTD)||27
10891709|NCT01458366|12057900|FG000|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
10891710|NCT01458366|12057901|FG001|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
10891711|NCT01458366|12057902|FG002|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
10891712|NCT01458366|12057903|FG003|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
10891713|NCT01458366|12057904|FG004|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||26
10891714|NCT01458366|12057900|FG000|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
10891715|NCT01458366|12057901|FG001|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
10891716|NCT01458366|12057902|FG002|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
10891717|NCT01458366|12057903|FG003|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
10891718|NCT01458366|12057904|FG004|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||1
10891719|NCT01452919|12057912|FG000|STARTED|Open-Label Treatment|During the open label treatment, all patients received LY2140023 monotherapy (first column); no patients were randomized yet (thus, 0 patients listed in column 2 and 3)|123
10891720|NCT01452919|12057913|FG001|STARTED|Open-Label Treatment||0
10891721|NCT01452919|12057914|FG002|STARTED|Open-Label Treatment||0
10891722|NCT01452919|12057912|FG000|Received at Least 1 Dose of Study Drug|Open-Label Treatment||123
10891723|NCT01452919|12057913|FG001|Received at Least 1 Dose of Study Drug|Open-Label Treatment||0
10891724|NCT01452919|12057914|FG002|Received at Least 1 Dose of Study Drug|Open-Label Treatment||0
10891725|NCT01452919|12057912|FG000|COMPLETED|Open-Label Treatment||103
10891726|NCT01452919|12057913|FG001|COMPLETED|Open-Label Treatment||0
10891727|NCT01452919|12057914|FG002|COMPLETED|Open-Label Treatment||0
10891728|NCT01452919|12057912|FG000|NOT COMPLETED|Open-Label Treatment||20
10891729|NCT01452919|12057913|FG001|NOT COMPLETED|Open-Label Treatment||0
10891730|NCT01452919|12057914|FG002|NOT COMPLETED|Open-Label Treatment||0
10891731|NCT01452919|12057912|FG000|STARTED|Randomization Treatment||0
10891732|NCT01452919|12057913|FG001|STARTED|Randomization Treatment|For randomization treatment, the 103 completers of the open label period above were assigned to placebo (50 patients; column 2) and LY2140023 (randomization) (53 patients) (column 3)|50
10891733|NCT01452919|12057914|FG002|STARTED|Randomization Treatment|For randomization treatment, the 103 completers of the open label period above were assigned to placebo (50 patients; column 2) and LY2140023 (randomization) (53 patients) (column 3)|53
10891734|NCT01452919|12057912|FG000|Received at Least 1 Dose of Study Drug|Randomization Treatment||0
10891735|NCT01452919|12057913|FG001|Received at Least 1 Dose of Study Drug|Randomization Treatment||50
10891736|NCT01452919|12057914|FG002|Received at Least 1 Dose of Study Drug|Randomization Treatment||53
10891737|NCT01452919|12057912|FG000|COMPLETED|Randomization Treatment||0
10891738|NCT01452919|12057913|FG001|COMPLETED|Randomization Treatment||47
10891739|NCT01452919|12057914|FG002|COMPLETED|Randomization Treatment||51
10891740|NCT01452919|12057912|FG000|NOT COMPLETED|Randomization Treatment||0
10891741|NCT01452919|12057913|FG001|NOT COMPLETED|Randomization Treatment||3
10891742|NCT01452919|12057914|FG002|NOT COMPLETED|Randomization Treatment||2
10891743|NCT01450631|12057926|FG000|STARTED|Overall Study||46
10891744|NCT01450631|12057927|FG001|STARTED|Overall Study||46
10891745|NCT01450631|12057926|FG000|COMPLETED|Overall Study||43
10891746|NCT01450631|12057927|FG001|COMPLETED|Overall Study||42
10891747|NCT01450631|12057926|FG000|NOT COMPLETED|Overall Study||3
10891748|NCT01450631|12057927|FG001|NOT COMPLETED|Overall Study||4
10891749|NCT01439880|12057935|FG000|STARTED|SOC-controlled Period (Year 1)||442
10891750|NCT01439880|12057936|FG001|STARTED|SOC-controlled Period (Year 1)||882
10891751|NCT01439880|12057935|FG000|Received Evolocumab|SOC-controlled Period (Year 1)||0
10891752|NCT01439880|12057936|FG001|Received Evolocumab|SOC-controlled Period (Year 1)||881
10891753|NCT01439880|12057935|FG000|COMPLETED|SOC-controlled Period (Year 1)||398
10891754|NCT01439880|12057936|FG001|COMPLETED|SOC-controlled Period (Year 1)||822
10891755|NCT01439880|12057935|FG000|NOT COMPLETED|SOC-controlled Period (Year 1)||44
10891756|NCT01439880|12057936|FG001|NOT COMPLETED|SOC-controlled Period (Year 1)||60
10891757|NCT01439880|12057935|FG000|STARTED|All-IP Period (Years 2 to 5)||398
10891758|NCT01439880|12057936|FG001|STARTED|All-IP Period (Years 2 to 5)||822
10891759|NCT01439880|12057935|FG000|Received Evolocumab|All-IP Period (Years 2 to 5)||374
10891760|NCT01439880|12057936|FG001|Received Evolocumab|All-IP Period (Years 2 to 5)||777
10891761|NCT01439880|12057935|FG000|COMPLETED|All-IP Period (Years 2 to 5)||328
10891762|NCT01439880|12057936|FG001|COMPLETED|All-IP Period (Years 2 to 5)||682
10891763|NCT01439880|12057935|FG000|NOT COMPLETED|All-IP Period (Years 2 to 5)||70
10891764|NCT01439880|12057936|FG001|NOT COMPLETED|All-IP Period (Years 2 to 5)||140
10891765|NCT01431755|12057953|FG000|STARTED|Overall Study||54
10891766|NCT01431755|12057953|FG000|COMPLETED|Overall Study||49
10891767|NCT01431755|12057953|FG000|NOT COMPLETED|Overall Study||5
10891768|NCT01428024|12057961|FG000|STARTED|Overall Study||30
10891769|NCT01428024|12057962|FG001|STARTED|Overall Study||30
10891770|NCT01428024|12057961|FG000|COMPLETED|Overall Study||29
10891771|NCT01428024|12057962|FG001|COMPLETED|Overall Study||29
10891772|NCT01428024|12057961|FG000|NOT COMPLETED|Overall Study||1
10891773|NCT01428024|12057962|FG001|NOT COMPLETED|Overall Study||1
10891774|NCT01426269|12057979|FG000|STARTED|Period 1: 12 Weeks||235
10891775|NCT01426269|12057980|FG001|STARTED|Period 1: 12 Weeks||0
10891776|NCT01426269|12057981|FG002|STARTED|Period 1: 12 Weeks||0
10891777|NCT01426269|12057979|FG000|COMPLETED|Period 1: 12 Weeks||180
10891778|NCT01426269|12057980|FG001|COMPLETED|Period 1: 12 Weeks||0
10891779|NCT01426269|12057981|FG002|COMPLETED|Period 1: 12 Weeks||0
10891780|NCT01426269|12057979|FG000|NOT COMPLETED|Period 1: 12 Weeks||55
10891781|NCT01426269|12057980|FG001|NOT COMPLETED|Period 1: 12 Weeks||0
10891782|NCT01426269|12057981|FG002|NOT COMPLETED|Period 1: 12 Weeks||0
10891783|NCT01426269|12057979|FG000|STARTED|Eligibility for Period 2, Randomization||180
10891784|NCT01426269|12057980|FG001|STARTED|Eligibility for Period 2, Randomization||0
10891785|NCT01426269|12057981|FG002|STARTED|Eligibility for Period 2, Randomization||0
10891786|NCT01426269|12057979|FG000|COMPLETED|Eligibility for Period 2, Randomization||130
10891787|NCT01426269|12057980|FG001|COMPLETED|Eligibility for Period 2, Randomization||0
10891788|NCT01426269|12057981|FG002|COMPLETED|Eligibility for Period 2, Randomization||0
10891789|NCT01426269|12057979|FG000|NOT COMPLETED|Eligibility for Period 2, Randomization||50
10891790|NCT01426269|12057980|FG001|NOT COMPLETED|Eligibility for Period 2, Randomization||0
10891791|NCT01426269|12057981|FG002|NOT COMPLETED|Eligibility for Period 2, Randomization||0
10891792|NCT01426269|12057979|FG000|STARTED|Period 2: 40 Weeks||0
10891793|NCT01426269|12057980|FG001|STARTED|Period 2: 40 Weeks||65
10891794|NCT01426269|12057981|FG002|STARTED|Period 2: 40 Weeks||65
10891795|NCT01426269|12057979|FG000|COMPLETED|Period 2: 40 Weeks||0
10891796|NCT01426269|12057980|FG001|COMPLETED|Period 2: 40 Weeks||27
10891797|NCT01426269|12057981|FG002|COMPLETED|Period 2: 40 Weeks||18
10891798|NCT01426269|12057979|FG000|NOT COMPLETED|Period 2: 40 Weeks||0
10891799|NCT01426269|12057980|FG001|NOT COMPLETED|Period 2: 40 Weeks||38
10891800|NCT01426269|12057981|FG002|NOT COMPLETED|Period 2: 40 Weeks||47
10891801|NCT01420926|12057994|FG000|STARTED|Overall Study||82
10891802|NCT01420926|12057995|FG001|STARTED|Overall Study||81
10891803|NCT01420926|12057994|FG000|COMPLETED|Overall Study||22
10891804|NCT01420926|12057995|FG001|COMPLETED|Overall Study||16
10891805|NCT01420926|12057994|FG000|NOT COMPLETED|Overall Study||60
10891806|NCT01420926|12057995|FG001|NOT COMPLETED|Overall Study||65
10891807|NCT01417234|12058001|FG000|STARTED|Overall Study||30
10891808|NCT01417234|12058001|FG000|COMPLETED|Overall Study||27
10891809|NCT01417234|12058001|FG000|NOT COMPLETED|Overall Study||3
10891810|NCT01415440|12058008|FG000|STARTED|Overall Study||41
10891811|NCT01415440|12058009|FG001|STARTED|Overall Study||29
10891812|NCT01415440|12058010|FG002|STARTED|Overall Study||29
10891813|NCT01415440|12058008|FG000|COMPLETED|Overall Study||37
10891814|NCT01415440|12058009|FG001|COMPLETED|Overall Study||28
10891815|NCT01415440|12058010|FG002|COMPLETED|Overall Study||27
10891816|NCT01415440|12058008|FG000|NOT COMPLETED|Overall Study||4
10891817|NCT01415440|12058009|FG001|NOT COMPLETED|Overall Study||1
10891818|NCT01415440|12058010|FG002|NOT COMPLETED|Overall Study||2
10891819|NCT01393522|12058019|FG000|STARTED|Overall Study||19
10891820|NCT01393522|12058020|FG001|STARTED|Overall Study||18
10891821|NCT01393522|12058019|FG000|COMPLETED|Overall Study||12
10891822|NCT01393522|12058020|FG001|COMPLETED|Overall Study||14
10891823|NCT01393522|12058019|FG000|NOT COMPLETED|Overall Study||7
10891824|NCT01393522|12058020|FG001|NOT COMPLETED|Overall Study||4
10891825|NCT01393314|12058028|FG000|STARTED|Overall Study||54
10891826|NCT01393314|12058029|FG001|STARTED|Overall Study||45
10891827|NCT01393314|12058028|FG000|COMPLETED|Overall Study||54
10891828|NCT01393314|12058029|FG001|COMPLETED|Overall Study||45
10891829|NCT01393314|12058028|FG000|NOT COMPLETED|Overall Study||0
10891830|NCT01393314|12058029|FG001|NOT COMPLETED|Overall Study||0
10891831|NCT01386385|12058041|FG000|STARTED|Phase I 40mg: Concurrent CRT||8
10891832|NCT01386385|12058042|FG001|STARTED|Phase I 40mg: Concurrent CRT||0
10891833|NCT01386385|12058043|FG002|STARTED|Phase I 40mg: Concurrent CRT||0
10891834|NCT01386385|12058044|FG003|STARTED|Phase I 40mg: Concurrent CRT||0
10891835|NCT01386385|12058045|FG004|STARTED|Phase I 40mg: Concurrent CRT||0
10891836|NCT01386385|12058046|FG005|STARTED|Phase I 40mg: Concurrent CRT||0
10891837|NCT01386385|12058047|FG006|STARTED|Phase I 40mg: Concurrent CRT||0
10891838|NCT01386385|12058048|FG007|STARTED|Phase I 40mg: Concurrent CRT||0
10891839|NCT01386385|12058041|FG000|COMPLETED|Phase I 40mg: Concurrent CRT||6
10891840|NCT01386385|12058042|FG001|COMPLETED|Phase I 40mg: Concurrent CRT||0
10891841|NCT01386385|12058043|FG002|COMPLETED|Phase I 40mg: Concurrent CRT||0
10891842|NCT01386385|12058044|FG003|COMPLETED|Phase I 40mg: Concurrent CRT||0
10891843|NCT01386385|12058045|FG004|COMPLETED|Phase I 40mg: Concurrent CRT||0
10891844|NCT01386385|12058046|FG005|COMPLETED|Phase I 40mg: Concurrent CRT||0
10891845|NCT01386385|12058047|FG006|COMPLETED|Phase I 40mg: Concurrent CRT||0
10891846|NCT01386385|12058048|FG007|COMPLETED|Phase I 40mg: Concurrent CRT||0
10891847|NCT01386385|12058041|FG000|NOT COMPLETED|Phase I 40mg: Concurrent CRT||2
10891848|NCT01386385|12058042|FG001|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
10891849|NCT01386385|12058043|FG002|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
10891850|NCT01386385|12058044|FG003|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
10891851|NCT01386385|12058045|FG004|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
10891852|NCT01386385|12058046|FG005|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
10891853|NCT01386385|12058047|FG006|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
10891854|NCT01386385|12058048|FG007|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
10891855|NCT01386385|12058041|FG000|STARTED|Phase I 40mg: Consolidation Therapy||0
10891856|NCT01386385|12058042|FG001|STARTED|Phase I 40mg: Consolidation Therapy||4
10891857|NCT01386385|12058043|FG002|STARTED|Phase I 40mg: Consolidation Therapy||0
10891858|NCT01386385|12058044|FG003|STARTED|Phase I 40mg: Consolidation Therapy||0
10891859|NCT01386385|12058045|FG004|STARTED|Phase I 40mg: Consolidation Therapy||0
10891860|NCT01386385|12058046|FG005|STARTED|Phase I 40mg: Consolidation Therapy||0
10891861|NCT01386385|12058047|FG006|STARTED|Phase I 40mg: Consolidation Therapy||0
10891862|NCT01386385|12058048|FG007|STARTED|Phase I 40mg: Consolidation Therapy||0
10891863|NCT01386385|12058041|FG000|COMPLETED|Phase I 40mg: Consolidation Therapy||0
10891864|NCT01386385|12058042|FG001|COMPLETED|Phase I 40mg: Consolidation Therapy||4
10891865|NCT01386385|12058043|FG002|COMPLETED|Phase I 40mg: Consolidation Therapy||0
10891866|NCT01386385|12058044|FG003|COMPLETED|Phase I 40mg: Consolidation Therapy||0
10891867|NCT01386385|12058045|FG004|COMPLETED|Phase I 40mg: Consolidation Therapy||0
10891868|NCT01386385|12058046|FG005|COMPLETED|Phase I 40mg: Consolidation Therapy||0
10891869|NCT01386385|12058047|FG006|COMPLETED|Phase I 40mg: Consolidation Therapy||0
10891870|NCT01386385|12058048|FG007|COMPLETED|Phase I 40mg: Consolidation Therapy||0
10891871|NCT01386385|12058041|FG000|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
10891872|NCT01386385|12058042|FG001|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
10891873|NCT01386385|12058043|FG002|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
10891874|NCT01386385|12058044|FG003|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
10891875|NCT01386385|12058045|FG004|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
10891876|NCT01386385|12058046|FG005|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
10891877|NCT01386385|12058047|FG006|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
10891878|NCT01386385|12058048|FG007|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
10891879|NCT01386385|12058041|FG000|STARTED|Phase I 80mg: Concurrent CRT||0
10891880|NCT01386385|12058042|FG001|STARTED|Phase I 80mg: Concurrent CRT||0
10891881|NCT01386385|12058043|FG002|STARTED|Phase I 80mg: Concurrent CRT||7
10891882|NCT01386385|12058044|FG003|STARTED|Phase I 80mg: Concurrent CRT||0
10891883|NCT01386385|12058045|FG004|STARTED|Phase I 80mg: Concurrent CRT||0
10891884|NCT01386385|12058046|FG005|STARTED|Phase I 80mg: Concurrent CRT||0
10891885|NCT01386385|12058047|FG006|STARTED|Phase I 80mg: Concurrent CRT||0
10891886|NCT01386385|12058048|FG007|STARTED|Phase I 80mg: Concurrent CRT||0
10891887|NCT01386385|12058041|FG000|COMPLETED|Phase I 80mg: Concurrent CRT||0
10891888|NCT01386385|12058042|FG001|COMPLETED|Phase I 80mg: Concurrent CRT||0
10891889|NCT01386385|12058043|FG002|COMPLETED|Phase I 80mg: Concurrent CRT||5
10891890|NCT01386385|12058044|FG003|COMPLETED|Phase I 80mg: Concurrent CRT||0
10891891|NCT01386385|12058045|FG004|COMPLETED|Phase I 80mg: Concurrent CRT||0
10891892|NCT01386385|12058046|FG005|COMPLETED|Phase I 80mg: Concurrent CRT||0
10891893|NCT01386385|12058047|FG006|COMPLETED|Phase I 80mg: Concurrent CRT||0
10891894|NCT01386385|12058048|FG007|COMPLETED|Phase I 80mg: Concurrent CRT||0
10891895|NCT01386385|12058041|FG000|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
10891896|NCT01386385|12058042|FG001|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
10891897|NCT01386385|12058043|FG002|NOT COMPLETED|Phase I 80mg: Concurrent CRT||2
10891898|NCT01386385|12058044|FG003|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
10891899|NCT01386385|12058045|FG004|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
10891900|NCT01386385|12058046|FG005|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
10891901|NCT01386385|12058047|FG006|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
10891902|NCT01386385|12058048|FG007|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
10891903|NCT01386385|12058041|FG000|STARTED|Phase I 80mg: Consolidation Therapy||0
10891904|NCT01386385|12058042|FG001|STARTED|Phase I 80mg: Consolidation Therapy||0
10891905|NCT01386385|12058043|FG002|STARTED|Phase I 80mg: Consolidation Therapy||0
10891906|NCT01386385|12058044|FG003|STARTED|Phase I 80mg: Consolidation Therapy||5
10891907|NCT01386385|12058045|FG004|STARTED|Phase I 80mg: Consolidation Therapy||0
10891908|NCT01386385|12058046|FG005|STARTED|Phase I 80mg: Consolidation Therapy||0
10891909|NCT01386385|12058047|FG006|STARTED|Phase I 80mg: Consolidation Therapy||0
10891910|NCT01386385|12058048|FG007|STARTED|Phase I 80mg: Consolidation Therapy||0
10891911|NCT01386385|12058041|FG000|COMPLETED|Phase I 80mg: Consolidation Therapy||0
10891912|NCT01386385|12058042|FG001|COMPLETED|Phase I 80mg: Consolidation Therapy||0
10891913|NCT01386385|12058043|FG002|COMPLETED|Phase I 80mg: Consolidation Therapy||0
10891914|NCT01386385|12058044|FG003|COMPLETED|Phase I 80mg: Consolidation Therapy||5
10891915|NCT01386385|12058045|FG004|COMPLETED|Phase I 80mg: Consolidation Therapy||0
10891916|NCT01386385|12058046|FG005|COMPLETED|Phase I 80mg: Consolidation Therapy||0
10891917|NCT01386385|12058047|FG006|COMPLETED|Phase I 80mg: Consolidation Therapy||0
10891918|NCT01386385|12058048|FG007|COMPLETED|Phase I 80mg: Consolidation Therapy||0
10891919|NCT01386385|12058041|FG000|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
10891920|NCT01386385|12058042|FG001|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
10891921|NCT01386385|12058043|FG002|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
10891922|NCT01386385|12058044|FG003|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
10891923|NCT01386385|12058045|FG004|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
10891924|NCT01386385|12058046|FG005|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
10891925|NCT01386385|12058047|FG006|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
10891926|NCT01386385|12058048|FG007|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
10891927|NCT01386385|12058041|FG000|STARTED|Phase I 120mg: Concurrent CRT||0
10891928|NCT01386385|12058042|FG001|STARTED|Phase I 120mg: Concurrent CRT||0
10891929|NCT01386385|12058043|FG002|STARTED|Phase I 120mg: Concurrent CRT||0
10891930|NCT01386385|12058044|FG003|STARTED|Phase I 120mg: Concurrent CRT||0
10891931|NCT01386385|12058045|FG004|STARTED|Phase I 120mg: Concurrent CRT||6
10891932|NCT01386385|12058046|FG005|STARTED|Phase I 120mg: Concurrent CRT||0
10891933|NCT01386385|12058047|FG006|STARTED|Phase I 120mg: Concurrent CRT||0
10891934|NCT01386385|12058048|FG007|STARTED|Phase I 120mg: Concurrent CRT||0
10891935|NCT01386385|12058041|FG000|COMPLETED|Phase I 120mg: Concurrent CRT||0
10891936|NCT01386385|12058042|FG001|COMPLETED|Phase I 120mg: Concurrent CRT||0
10891937|NCT01386385|12058043|FG002|COMPLETED|Phase I 120mg: Concurrent CRT||0
10891938|NCT01386385|12058044|FG003|COMPLETED|Phase I 120mg: Concurrent CRT||0
10891939|NCT01386385|12058045|FG004|COMPLETED|Phase I 120mg: Concurrent CRT||5
10891940|NCT01386385|12058046|FG005|COMPLETED|Phase I 120mg: Concurrent CRT||0
10891941|NCT01386385|12058047|FG006|COMPLETED|Phase I 120mg: Concurrent CRT||0
10891942|NCT01386385|12058048|FG007|COMPLETED|Phase I 120mg: Concurrent CRT||0
10891943|NCT01386385|12058041|FG000|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
10891944|NCT01386385|12058042|FG001|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
10891945|NCT01386385|12058043|FG002|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
10891946|NCT01386385|12058044|FG003|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
10891947|NCT01386385|12058045|FG004|NOT COMPLETED|Phase I 120mg: Concurrent CRT||1
10891948|NCT01386385|12058046|FG005|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
10891949|NCT01386385|12058047|FG006|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
10891950|NCT01386385|12058048|FG007|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
10891951|NCT01386385|12058041|FG000|STARTED|Phase I 120mg: Consolidation Therapy||0
10891952|NCT01386385|12058042|FG001|STARTED|Phase I 120mg: Consolidation Therapy||0
10891953|NCT01386385|12058043|FG002|STARTED|Phase I 120mg: Consolidation Therapy||0
10891954|NCT01386385|12058044|FG003|STARTED|Phase I 120mg: Consolidation Therapy||0
10891955|NCT01386385|12058045|FG004|STARTED|Phase I 120mg: Consolidation Therapy||0
10891956|NCT01386385|12058046|FG005|STARTED|Phase I 120mg: Consolidation Therapy||5
10891957|NCT01386385|12058047|FG006|STARTED|Phase I 120mg: Consolidation Therapy||0
10891958|NCT01386385|12058048|FG007|STARTED|Phase I 120mg: Consolidation Therapy||0
10891959|NCT01386385|12058041|FG000|COMPLETED|Phase I 120mg: Consolidation Therapy||0
10891960|NCT01386385|12058042|FG001|COMPLETED|Phase I 120mg: Consolidation Therapy||0
10891961|NCT01386385|12058043|FG002|COMPLETED|Phase I 120mg: Consolidation Therapy||0
10891962|NCT01386385|12058044|FG003|COMPLETED|Phase I 120mg: Consolidation Therapy||0
10891963|NCT01386385|12058045|FG004|COMPLETED|Phase I 120mg: Consolidation Therapy||0
10891964|NCT01386385|12058046|FG005|COMPLETED|Phase I 120mg: Consolidation Therapy||5
10891965|NCT01386385|12058047|FG006|COMPLETED|Phase I 120mg: Consolidation Therapy||0
10891966|NCT01386385|12058048|FG007|COMPLETED|Phase I 120mg: Consolidation Therapy||0
10891967|NCT01386385|12058041|FG000|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
10891968|NCT01386385|12058042|FG001|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
10891969|NCT01386385|12058043|FG002|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
10891970|NCT01386385|12058044|FG003|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
10891971|NCT01386385|12058045|FG004|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
10891972|NCT01386385|12058046|FG005|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
10891973|NCT01386385|12058047|FG006|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
10891974|NCT01386385|12058048|FG007|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
10891975|NCT01386385|12058041|FG000|STARTED|Phase II Concurrent CRT||0
10891976|NCT01386385|12058042|FG001|STARTED|Phase II Concurrent CRT||0
10891977|NCT01386385|12058043|FG002|STARTED|Phase II Concurrent CRT||0
10891978|NCT01386385|12058044|FG003|STARTED|Phase II Concurrent CRT||0
10891979|NCT01386385|12058045|FG004|STARTED|Phase II Concurrent CRT||0
10891980|NCT01386385|12058046|FG005|STARTED|Phase II Concurrent CRT||0
10891981|NCT01386385|12058047|FG006|STARTED|Phase II Concurrent CRT||18
10891982|NCT01386385|12058048|FG007|STARTED|Phase II Concurrent CRT||13
10891983|NCT01386385|12058041|FG000|COMPLETED|Phase II Concurrent CRT||0
10891984|NCT01386385|12058042|FG001|COMPLETED|Phase II Concurrent CRT||0
10891985|NCT01386385|12058043|FG002|COMPLETED|Phase II Concurrent CRT||0
10891986|NCT01386385|12058044|FG003|COMPLETED|Phase II Concurrent CRT||0
10891987|NCT01386385|12058045|FG004|COMPLETED|Phase II Concurrent CRT||0
10891988|NCT01386385|12058046|FG005|COMPLETED|Phase II Concurrent CRT||0
10891989|NCT01386385|12058047|FG006|COMPLETED|Phase II Concurrent CRT||12
10891990|NCT01386385|12058048|FG007|COMPLETED|Phase II Concurrent CRT||10
10891991|NCT01386385|12058041|FG000|NOT COMPLETED|Phase II Concurrent CRT||0
10891992|NCT01386385|12058042|FG001|NOT COMPLETED|Phase II Concurrent CRT||0
10891993|NCT01386385|12058043|FG002|NOT COMPLETED|Phase II Concurrent CRT||0
10891994|NCT01386385|12058044|FG003|NOT COMPLETED|Phase II Concurrent CRT||0
10891995|NCT01386385|12058045|FG004|NOT COMPLETED|Phase II Concurrent CRT||0
10891996|NCT01386385|12058046|FG005|NOT COMPLETED|Phase II Concurrent CRT||0
10891997|NCT01386385|12058047|FG006|NOT COMPLETED|Phase II Concurrent CRT||6
10891998|NCT01386385|12058048|FG007|NOT COMPLETED|Phase II Concurrent CRT||3
10891999|NCT01386385|12058041|FG000|STARTED|Phase II: Consolidation Therapy||0
10892000|NCT01386385|12058042|FG001|STARTED|Phase II: Consolidation Therapy||0
10892001|NCT01386385|12058043|FG002|STARTED|Phase II: Consolidation Therapy||0
10892002|NCT01386385|12058044|FG003|STARTED|Phase II: Consolidation Therapy||0
10892003|NCT01386385|12058045|FG004|STARTED|Phase II: Consolidation Therapy||0
10892004|NCT01386385|12058046|FG005|STARTED|Phase II: Consolidation Therapy||0
10892005|NCT01386385|12058047|FG006|STARTED|Phase II: Consolidation Therapy||13
10892006|NCT01386385|12058048|FG007|STARTED|Phase II: Consolidation Therapy||10
10892007|NCT01386385|12058041|FG000|COMPLETED|Phase II: Consolidation Therapy||0
10892008|NCT01386385|12058042|FG001|COMPLETED|Phase II: Consolidation Therapy||0
10892009|NCT01386385|12058043|FG002|COMPLETED|Phase II: Consolidation Therapy||0
10892010|NCT01386385|12058044|FG003|COMPLETED|Phase II: Consolidation Therapy||0
10892011|NCT01386385|12058045|FG004|COMPLETED|Phase II: Consolidation Therapy||0
10892012|NCT01386385|12058046|FG005|COMPLETED|Phase II: Consolidation Therapy||0
10892013|NCT01386385|12058047|FG006|COMPLETED|Phase II: Consolidation Therapy||8
10892014|NCT01386385|12058048|FG007|COMPLETED|Phase II: Consolidation Therapy||8
10892015|NCT01386385|12058041|FG000|NOT COMPLETED|Phase II: Consolidation Therapy||0
10892016|NCT01386385|12058042|FG001|NOT COMPLETED|Phase II: Consolidation Therapy||0
10892017|NCT01386385|12058043|FG002|NOT COMPLETED|Phase II: Consolidation Therapy||0
10892018|NCT01386385|12058044|FG003|NOT COMPLETED|Phase II: Consolidation Therapy||0
10892019|NCT01386385|12058045|FG004|NOT COMPLETED|Phase II: Consolidation Therapy||0
10892020|NCT01386385|12058046|FG005|NOT COMPLETED|Phase II: Consolidation Therapy||0
10892021|NCT01386385|12058047|FG006|NOT COMPLETED|Phase II: Consolidation Therapy||5
10892022|NCT01386385|12058048|FG007|NOT COMPLETED|Phase II: Consolidation Therapy||2
10892023|NCT01385176|12058071|FG000|STARTED|Randomization Phase|The randomization phase of the study started after implant of the investigational device system.|63
10892024|NCT01385176|12058072|FG001|STARTED|Randomization Phase|The randomization phase of the study started after implant of the investigational device system.|32
10892025|NCT01385176|12058071|FG000|COMPLETED|Randomization Phase|The study randomization phase ended after all patients have had their 6 month follow-up visit.|62
10892026|NCT01385176|12058072|FG001|COMPLETED|Randomization Phase|The study randomization phase ended after all patients have had their 6 month follow-up visit.|30
10892027|NCT01385176|12058071|FG000|NOT COMPLETED|Randomization Phase||1
10892028|NCT01385176|12058072|FG001|NOT COMPLETED|Randomization Phase||2
10892029|NCT01385176|12058071|FG000|STARTED|6-18 Month All VNS Active|Primary Study Phase ended with completion of the 18 months follow-up visit for the last patient|62
10892030|NCT01385176|12058072|FG001|STARTED|6-18 Month All VNS Active|Primary Study Phase ended with completion of the 18 months follow-up visit for the last patient|30
10892031|NCT01385176|12058071|FG000|COMPLETED|6-18 Month All VNS Active||58
10892032|NCT01385176|12058072|FG001|COMPLETED|6-18 Month All VNS Active||27
10892033|NCT01385176|12058071|FG000|NOT COMPLETED|6-18 Month All VNS Active||4
10892034|NCT01385176|12058072|FG001|NOT COMPLETED|6-18 Month All VNS Active||3
10892035|NCT01372774|12058085|FG000|STARTED|Overall Study||96
10892036|NCT01372774|12058086|FG001|STARTED|Overall Study||98
10892037|NCT01372774|12058085|FG000|COMPLETED|Overall Study||92
10892038|NCT01372774|12058086|FG001|COMPLETED|Overall Study||93
10892039|NCT01372774|12058085|FG000|NOT COMPLETED|Overall Study||4
10892040|NCT01372774|12058086|FG001|NOT COMPLETED|Overall Study||5
10892041|NCT01371981|12058100|FG000|STARTED|Overall Study||580
10892042|NCT01371981|12058101|FG001|STARTED|Overall Study||591
10892043|NCT01371981|12058102|FG002|STARTED|Overall Study||12
10892044|NCT01371981|12058103|FG003|STARTED|Overall Study||33
10892045|NCT01371981|12058104|FG004|STARTED|Overall Study||47
10892046|NCT01371981|12058105|FG005|STARTED|Overall Study||382
10892047|NCT01371981|12058100|FG000|COMPLETED|Overall Study||396
10892048|NCT01371981|12058101|FG001|COMPLETED|Overall Study||399
10892049|NCT01371981|12058102|FG002|COMPLETED|Overall Study||6
10892050|NCT01371981|12058103|FG003|COMPLETED|Overall Study||12
10892051|NCT01371981|12058104|FG004|COMPLETED|Overall Study||15
10892052|NCT01371981|12058105|FG005|COMPLETED|Overall Study||368
10892053|NCT01371981|12058100|FG000|NOT COMPLETED|Overall Study||184
10892054|NCT01371981|12058101|FG001|NOT COMPLETED|Overall Study||192
10892055|NCT01371981|12058102|FG002|NOT COMPLETED|Overall Study||6
10892056|NCT01371981|12058103|FG003|NOT COMPLETED|Overall Study||21
10892057|NCT01371981|12058104|FG004|NOT COMPLETED|Overall Study||32
10892058|NCT01371981|12058105|FG005|NOT COMPLETED|Overall Study||14
10892059|NCT01364597|12058128|FG000|STARTED|Overall Study||36
10892060|NCT01364597|12058129|FG001|STARTED|Overall Study||15
10892061|NCT01364597|12058130|FG002|STARTED|Overall Study||141
10892062|NCT01364597|12058131|FG003|STARTED|Overall Study||65
10892063|NCT01364597|12058128|FG000|Directly Enrolled (DE) Participants|Overall Study||0
10892064|NCT01364597|12058129|FG001|Directly Enrolled (DE) Participants|Overall Study||0
10892065|NCT01364597|12058130|FG002|Directly Enrolled (DE) Participants|Overall Study||85
10892066|NCT01364597|12058131|FG003|Directly Enrolled (DE) Participants|Overall Study||35
10892067|NCT01364597|12058128|FG000|Long-term Follow-up (LTFU) Participants|Overall Study||36
10892068|NCT01364597|12058129|FG001|Long-term Follow-up (LTFU) Participants|Overall Study||15
10892069|NCT01364597|12058130|FG002|Long-term Follow-up (LTFU) Participants|Overall Study||56
10892070|NCT01364597|12058131|FG003|Long-term Follow-up (LTFU) Participants|Overall Study||30
10892071|NCT01364597|12058128|FG000|COMPLETED|Overall Study||18
10892072|NCT01364597|12058129|FG001|COMPLETED|Overall Study||4
10892073|NCT01364597|12058130|FG002|COMPLETED|Overall Study||65
10892074|NCT01364597|12058131|FG003|COMPLETED|Overall Study||37
10892075|NCT01364597|12058128|FG000|NOT COMPLETED|Overall Study||18
10892076|NCT01364597|12058129|FG001|NOT COMPLETED|Overall Study||11
10892077|NCT01364597|12058130|FG002|NOT COMPLETED|Overall Study||76
10892078|NCT01364597|12058131|FG003|NOT COMPLETED|Overall Study||28
10892079|NCT01359592|12058144|FG000|STARTED|Initial Registration||158
10892080|NCT01359592|12058145|FG001|STARTED|Initial Registration||1
10892081|NCT01359592|12058146|FG002|STARTED|Initial Registration||0
10892082|NCT01359592|12058147|FG003|STARTED|Initial Registration||0
10892083|NCT01359592|12058144|FG000|Eligible and Evaluable|Initial Registration||132
10892084|NCT01359592|12058145|FG001|Eligible and Evaluable|Initial Registration||1
10892085|NCT01359592|12058146|FG002|Eligible and Evaluable|Initial Registration||0
10892086|NCT01359592|12058147|FG003|Eligible and Evaluable|Initial Registration||0
10892087|NCT01359592|12058144|FG000|COMPLETED|Initial Registration||129
10892088|NCT01359592|12058145|FG001|COMPLETED|Initial Registration||1
10892089|NCT01359592|12058146|FG002|COMPLETED|Initial Registration||0
10892090|NCT01359592|12058147|FG003|COMPLETED|Initial Registration||0
10892091|NCT01359592|12058144|FG000|NOT COMPLETED|Initial Registration||29
10892092|NCT01359592|12058145|FG001|NOT COMPLETED|Initial Registration||0
10892093|NCT01359592|12058146|FG002|NOT COMPLETED|Initial Registration||0
10892094|NCT01359592|12058147|FG003|NOT COMPLETED|Initial Registration||0
10892095|NCT01359592|12058144|FG000|STARTED|PET-Directed Therapy||0
10892096|NCT01359592|12058145|FG001|STARTED|PET-Directed Therapy||0
10892097|NCT01359592|12058146|FG002|STARTED|PET-Directed Therapy||137
10892098|NCT01359592|12058147|FG003|STARTED|PET-Directed Therapy||12
10892099|NCT01359592|12058144|FG000|Eligible and Evaluable|PET-Directed Therapy||0
10892100|NCT01359592|12058145|FG001|Eligible and Evaluable|PET-Directed Therapy||0
10892101|NCT01359592|12058146|FG002|Eligible and Evaluable|PET-Directed Therapy||113
10892102|NCT01359592|12058147|FG003|Eligible and Evaluable|PET-Directed Therapy||12
10892103|NCT01359592|12058144|FG000|COMPLETED|PET-Directed Therapy||0
10892104|NCT01359592|12058145|FG001|COMPLETED|PET-Directed Therapy||0
10892105|NCT01359592|12058146|FG002|COMPLETED|PET-Directed Therapy||111
10892106|NCT01359592|12058147|FG003|COMPLETED|PET-Directed Therapy||12
10892107|NCT01359592|12058144|FG000|NOT COMPLETED|PET-Directed Therapy||0
10892108|NCT01359592|12058145|FG001|NOT COMPLETED|PET-Directed Therapy||0
10892109|NCT01359592|12058146|FG002|NOT COMPLETED|PET-Directed Therapy||26
10892110|NCT01359592|12058147|FG003|NOT COMPLETED|PET-Directed Therapy||0
10892111|NCT01357980|12058166|FG000|STARTED|Overall Study||16
10892112|NCT01357980|12058167|FG001|STARTED|Overall Study||7
10892113|NCT01357980|12058168|FG002|STARTED|Overall Study||17
10892114|NCT01357980|12058169|FG003|STARTED|Overall Study||7
10892115|NCT01357980|12058166|FG000|COMPLETED|Overall Study||16
10892116|NCT01357980|12058167|FG001|COMPLETED|Overall Study||6
10892117|NCT01357980|12058168|FG002|COMPLETED|Overall Study||16
10892118|NCT01357980|12058169|FG003|COMPLETED|Overall Study||7
10892119|NCT01357980|12058166|FG000|NOT COMPLETED|Overall Study||0
10892120|NCT01357980|12058167|FG001|NOT COMPLETED|Overall Study||1
10892121|NCT01357980|12058168|FG002|NOT COMPLETED|Overall Study||1
10892122|NCT01357980|12058169|FG003|NOT COMPLETED|Overall Study||0
10892123|NCT01354353|12058185|FG000|STARTED|Overall Study||16
10892124|NCT01354353|12058186|FG001|STARTED|Overall Study|Included in this arm are six participants who erroneously received oral 80 mg LY2140023 BID.|12
10892125|NCT01354353|12058187|FG002|STARTED|Overall Study||11
10892126|NCT01354353|12058188|FG003|STARTED|Overall Study||12
10892127|NCT01354353|12058189|FG004|STARTED|Overall Study||12
10892128|NCT01354353|12058190|FG005|STARTED|Overall Study||12
10892129|NCT01354353|12058185|FG000|Received at Least One Dose of Study Drug|Overall Study||16
10892130|NCT01354353|12058186|FG001|Received at Least One Dose of Study Drug|Overall Study||11
10892131|NCT01354353|12058187|FG002|Received at Least One Dose of Study Drug|Overall Study||10
10892132|NCT01354353|12058188|FG003|Received at Least One Dose of Study Drug|Overall Study||11
10892133|NCT01354353|12058189|FG004|Received at Least One Dose of Study Drug|Overall Study||11
10892134|NCT01354353|12058190|FG005|Received at Least One Dose of Study Drug|Overall Study||11
10892135|NCT01354353|12058185|FG000|COMPLETED|Overall Study||13
10892136|NCT01354353|12058186|FG001|COMPLETED|Overall Study||11
10892137|NCT01354353|12058187|FG002|COMPLETED|Overall Study||9
10892138|NCT01354353|12058188|FG003|COMPLETED|Overall Study||7
10892139|NCT01354353|12058189|FG004|COMPLETED|Overall Study||11
10892140|NCT01354353|12058190|FG005|COMPLETED|Overall Study||6
10892141|NCT01354353|12058185|FG000|NOT COMPLETED|Overall Study||3
10892142|NCT01354353|12058186|FG001|NOT COMPLETED|Overall Study||1
10892143|NCT01354353|12058187|FG002|NOT COMPLETED|Overall Study||2
10892144|NCT01354353|12058188|FG003|NOT COMPLETED|Overall Study||5
10892145|NCT01354353|12058189|FG004|NOT COMPLETED|Overall Study||1
10892146|NCT01354353|12058190|FG005|NOT COMPLETED|Overall Study||6
10892147|NCT01353313|12058213|FG000|STARTED|Overall Study||398
10892148|NCT01353313|12058214|FG001|STARTED|Overall Study||402
10892149|NCT01353313|12058213|FG000|Completed Assessment for Neurodevelopmental Impairment|Overall Study||321
10892150|NCT01353313|12058214|FG001|Completed Assessment for Neurodevelopmental Impairment|Overall Study||318
10892151|NCT01353313|12058213|FG000|Died After Discharge|Overall Study||8
10892152|NCT01353313|12058214|FG001|Died After Discharge|Overall Study||6
10892153|NCT01353313|12058213|FG000|Died Before Discharge|Overall Study||35
10892154|NCT01353313|12058214|FG001|Died Before Discharge|Overall Study||40
10892155|NCT01353313|12058213|FG000|Survived to Discharge|Overall Study||363
10892156|NCT01353313|12058214|FG001|Survived to Discharge|Overall Study||362
10892157|NCT01353313|12058213|FG000|COMPLETED|Overall Study||364
10892158|NCT01353313|12058214|FG001|COMPLETED|Overall Study||364
10892159|NCT01353313|12058213|FG000|NOT COMPLETED|Overall Study||34
10892160|NCT01353313|12058214|FG001|NOT COMPLETED|Overall Study||38
10892161|NCT01351805|12058224|FG000|STARTED|Overall Study||6463
10892162|NCT01351805|12058225|FG001|STARTED|Overall Study||6464
10892163|NCT01351805|12058226|FG002|STARTED|Overall Study||6470
10892164|NCT01351805|12058227|FG003|STARTED|Overall Study||6474
10892165|NCT01351805|12058224|FG000|COMPLETED|Overall Study||6463
10892166|NCT01351805|12058225|FG001|COMPLETED|Overall Study||6464
10892167|NCT01351805|12058226|FG002|COMPLETED|Overall Study||6470
10892168|NCT01351805|12058227|FG003|COMPLETED|Overall Study||6474
10892169|NCT01351805|12058224|FG000|NOT COMPLETED|Overall Study||0
10892170|NCT01351805|12058225|FG001|NOT COMPLETED|Overall Study||0
10892171|NCT01351805|12058226|FG002|NOT COMPLETED|Overall Study||0
10892172|NCT01351805|12058227|FG003|NOT COMPLETED|Overall Study||0
10892173|NCT01341444|12058243|FG000|STARTED|Overall Study||31
10892174|NCT01341444|12058244|FG001|STARTED|Overall Study||32
10892175|NCT01341444|12058243|FG000|COMPLETED|Overall Study||26
10892176|NCT01341444|12058244|FG001|COMPLETED|Overall Study||29
10892177|NCT01341444|12058243|FG000|NOT COMPLETED|Overall Study||5
10892178|NCT01341444|12058244|FG001|NOT COMPLETED|Overall Study||3
10892179|NCT01333397|12058255|FG000|STARTED|Overall Study||35
10892180|NCT01333397|12058256|FG001|STARTED|Overall Study||36
10892181|NCT01333397|12058257|FG002|STARTED|Overall Study||35
10892182|NCT01333397|12058258|FG003|STARTED|Overall Study||35
10892183|NCT01333397|12058259|FG004|STARTED|Overall Study||35
10892184|NCT01333397|12058255|FG000|COMPLETED|Overall Study||34
10892185|NCT01333397|12058256|FG001|COMPLETED|Overall Study||36
10892186|NCT01333397|12058257|FG002|COMPLETED|Overall Study||35
10892187|NCT01333397|12058258|FG003|COMPLETED|Overall Study||34
10892188|NCT01333397|12058259|FG004|COMPLETED|Overall Study||35
10892189|NCT01333397|12058255|FG000|NOT COMPLETED|Overall Study||1
10892190|NCT01333397|12058256|FG001|NOT COMPLETED|Overall Study||0
10892191|NCT01333397|12058257|FG002|NOT COMPLETED|Overall Study||0
10892192|NCT01333397|12058258|FG003|NOT COMPLETED|Overall Study||1
10892193|NCT01333397|12058259|FG004|NOT COMPLETED|Overall Study||0
10892194|NCT01332968|12058282|FG000|STARTED|Induction Period||699
10892195|NCT01332968|12058283|FG001|STARTED|Induction Period||702
10892196|NCT01332968|12058284|FG002|STARTED|Induction Period||0
10892197|NCT01332968|12058285|FG003|STARTED|Induction Period||0
10892198|NCT01332968|12058286|FG004|STARTED|Induction Period||0
10892199|NCT01332968|12058287|FG005|STARTED|Induction Period||0
10892200|NCT01332968|12058288|FG006|STARTED|Induction Period||0
10892201|NCT01332968|12058289|FG007|STARTED|Induction Period||0
10892202|NCT01332968|12058282|FG000|COMPLETED|Induction Period||641
10892203|NCT01332968|12058283|FG001|COMPLETED|Induction Period||646
10892204|NCT01332968|12058284|FG002|COMPLETED|Induction Period||0
10892205|NCT01332968|12058285|FG003|COMPLETED|Induction Period||0
10892206|NCT01332968|12058286|FG004|COMPLETED|Induction Period||0
10892207|NCT01332968|12058287|FG005|COMPLETED|Induction Period||0
10892208|NCT01332968|12058288|FG006|COMPLETED|Induction Period||0
10892209|NCT01332968|12058289|FG007|COMPLETED|Induction Period||0
10892210|NCT01332968|12058282|FG000|NOT COMPLETED|Induction Period||58
10892211|NCT01332968|12058283|FG001|NOT COMPLETED|Induction Period||56
10892212|NCT01332968|12058284|FG002|NOT COMPLETED|Induction Period||0
10892213|NCT01332968|12058285|FG003|NOT COMPLETED|Induction Period||0
10892214|NCT01332968|12058286|FG004|NOT COMPLETED|Induction Period||0
10892215|NCT01332968|12058287|FG005|NOT COMPLETED|Induction Period||0
10892216|NCT01332968|12058288|FG006|NOT COMPLETED|Induction Period||0
10892217|NCT01332968|12058289|FG007|NOT COMPLETED|Induction Period||0
10892218|NCT01332968|12058282|FG000|STARTED|Maintenance/Observation Period||0
10892219|NCT01332968|12058283|FG001|STARTED|Maintenance/Observation Period||0
10892220|NCT01332968|12058284|FG002|STARTED|Maintenance/Observation Period||612
10892221|NCT01332968|12058285|FG003|STARTED|Maintenance/Observation Period||624
10892222|NCT01332968|12058286|FG004|STARTED|Maintenance/Observation Period||12
10892223|NCT01332968|12058287|FG005|STARTED|Maintenance/Observation Period||11
10892224|NCT01332968|12058288|FG006|STARTED|Maintenance/Observation Period||0
10892225|NCT01332968|12058289|FG007|STARTED|Maintenance/Observation Period||0
10892226|NCT01332968|12058282|FG000|COMPLETED|Maintenance/Observation Period||0
10892227|NCT01332968|12058283|FG001|COMPLETED|Maintenance/Observation Period||0
10892228|NCT01332968|12058284|FG002|COMPLETED|Maintenance/Observation Period||451
10892229|NCT01332968|12058285|FG003|COMPLETED|Maintenance/Observation Period||475
10892230|NCT01332968|12058286|FG004|COMPLETED|Maintenance/Observation Period||12
10892231|NCT01332968|12058287|FG005|COMPLETED|Maintenance/Observation Period||10
10892232|NCT01332968|12058288|FG006|COMPLETED|Maintenance/Observation Period||0
10892233|NCT01332968|12058289|FG007|COMPLETED|Maintenance/Observation Period||0
10892234|NCT01332968|12058282|FG000|NOT COMPLETED|Maintenance/Observation Period||0
10892235|NCT01332968|12058283|FG001|NOT COMPLETED|Maintenance/Observation Period||0
10892236|NCT01332968|12058284|FG002|NOT COMPLETED|Maintenance/Observation Period||161
10892237|NCT01332968|12058285|FG003|NOT COMPLETED|Maintenance/Observation Period||149
10892238|NCT01332968|12058286|FG004|NOT COMPLETED|Maintenance/Observation Period||0
10892239|NCT01332968|12058287|FG005|NOT COMPLETED|Maintenance/Observation Period||1
10892240|NCT01332968|12058288|FG006|NOT COMPLETED|Maintenance/Observation Period||0
10892241|NCT01332968|12058289|FG007|NOT COMPLETED|Maintenance/Observation Period||0
10892242|NCT01332968|12058282|FG000|STARTED|Follow-Up Period||0
10892243|NCT01332968|12058283|FG001|STARTED|Follow-Up Period||0
10892244|NCT01332968|12058284|FG002|STARTED|Follow-Up Period||0
10892245|NCT01332968|12058285|FG003|STARTED|Follow-Up Period||0
10892246|NCT01332968|12058286|FG004|STARTED|Follow-Up Period||0
10892247|NCT01332968|12058287|FG005|STARTED|Follow-Up Period||0
10892248|NCT01332968|12058288|FG006|STARTED|Follow-Up Period||554
10892249|NCT01332968|12058289|FG007|STARTED|Follow-Up Period||602
10892250|NCT01332968|12058282|FG000|COMPLETED|Follow-Up Period||0
10892251|NCT01332968|12058283|FG001|COMPLETED|Follow-Up Period||0
10892252|NCT01332968|12058284|FG002|COMPLETED|Follow-Up Period||0
10892253|NCT01332968|12058285|FG003|COMPLETED|Follow-Up Period||0
10892254|NCT01332968|12058286|FG004|COMPLETED|Follow-Up Period||0
10892255|NCT01332968|12058287|FG005|COMPLETED|Follow-Up Period||0
10892256|NCT01332968|12058288|FG006|COMPLETED|Follow-Up Period||324
10892257|NCT01332968|12058289|FG007|COMPLETED|Follow-Up Period||367
10892258|NCT01332968|12058282|FG000|NOT COMPLETED|Follow-Up Period||0
10892259|NCT01332968|12058283|FG001|NOT COMPLETED|Follow-Up Period||0
10892260|NCT01332968|12058284|FG002|NOT COMPLETED|Follow-Up Period||0
10892261|NCT01332968|12058285|FG003|NOT COMPLETED|Follow-Up Period||0
10892262|NCT01332968|12058286|FG004|NOT COMPLETED|Follow-Up Period||0
10892263|NCT01332968|12058287|FG005|NOT COMPLETED|Follow-Up Period||0
10892264|NCT01332968|12058288|FG006|NOT COMPLETED|Follow-Up Period||230
10892265|NCT01332968|12058289|FG007|NOT COMPLETED|Follow-Up Period||235
10892266|NCT01331408|12058297|FG000|STARTED|Overall Study||61
10892267|NCT01331408|12058297|FG000|COMPLETED|Overall Study||50
10892268|NCT01331408|12058297|FG000|NOT COMPLETED|Overall Study||11
10892269|NCT01331148|12058303|FG000|STARTED|Overall Study||23
10892270|NCT01331148|12058304|FG001|STARTED|Overall Study||23
10892271|NCT01331148|12058303|FG000|COMPLETED|Overall Study||20
10892272|NCT01331148|12058304|FG001|COMPLETED|Overall Study||19
10892273|NCT01331148|12058303|FG000|NOT COMPLETED|Overall Study||3
10892274|NCT01331148|12058304|FG001|NOT COMPLETED|Overall Study||4
10892275|NCT01328093|12058312|FG000|STARTED|Double-Blind Phase||516
10892276|NCT01328093|12058313|FG001|STARTED|Double-Blind Phase||162
10892277|NCT01328093|12058312|FG000|Received at Least 1 Dose of Study Drug|Double-Blind Phase||514
10892278|NCT01328093|12058313|FG001|Received at Least 1 Dose of Study Drug|Double-Blind Phase||161
10892279|NCT01328093|12058312|FG000|Modified Intent-To-Treat (mITT)|Double-Blind Phase||511
10892280|NCT01328093|12058313|FG001|Modified Intent-To-Treat (mITT)|Double-Blind Phase||161
10892281|NCT01328093|12058312|FG000|COMPLETED|Double-Blind Phase|Not all participants entered Open-Label Treatment Phase.|231
10892282|NCT01328093|12058313|FG001|COMPLETED|Double-Blind Phase|Not all participants entered Open-Label Treatment Phase.|84
10892283|NCT01328093|12058312|FG000|NOT COMPLETED|Double-Blind Phase||285
10892284|NCT01328093|12058313|FG001|NOT COMPLETED|Double-Blind Phase||78
10892285|NCT01328093|12058312|FG000|STARTED|Open-Label Phase||200
10892286|NCT01328093|12058313|FG001|STARTED|Open-Label Phase||73
10892287|NCT01328093|12058312|FG000|Received at Least 1 Dose of Study Drug|Open-Label Phase||198
10892288|NCT01328093|12058313|FG001|Received at Least 1 Dose of Study Drug|Open-Label Phase||73
10892289|NCT01328093|12058312|FG000|Modified Intent-To-Treat (mITT)|Open-Label Phase||197
10892290|NCT01328093|12058313|FG001|Modified Intent-To-Treat (mITT)|Open-Label Phase||73
10892291|NCT01328093|12058312|FG000|COMPLETED|Open-Label Phase||60
10892292|NCT01328093|12058313|FG001|COMPLETED|Open-Label Phase||23
10892293|NCT01328093|12058312|FG000|NOT COMPLETED|Open-Label Phase||140
10892294|NCT01328093|12058313|FG001|NOT COMPLETED|Open-Label Phase||50
10892295|NCT01327651|12058329|FG000|STARTED|Self-administered Dosing Period||60
10892296|NCT01327651|12058330|FG001|STARTED|Self-administered Dosing Period||59
10892297|NCT01327651|12058331|FG002|STARTED|Self-administered Dosing Period||60
10892298|NCT01327651|12058332|FG003|STARTED|Self-administered Dosing Period||60
10892299|NCT01327651|12058333|FG004|STARTED|Self-administered Dosing Period||59
10892300|NCT01327651|12058334|FG005|STARTED|Self-administered Dosing Period||59
10892301|NCT01327651|12058335|FG006|STARTED|Self-administered Dosing Period||59
10892302|NCT01327651|12058336|FG007|STARTED|Self-administered Dosing Period||60
10892303|NCT01327651|12058337|FG008|STARTED|Self-administered Dosing Period||60
10892304|NCT01327651|12058329|FG000|Week 10|Self-administered Dosing Period||59
10892305|NCT01327651|12058330|FG001|Week 10|Self-administered Dosing Period||58
10892306|NCT01327651|12058331|FG002|Week 10|Self-administered Dosing Period||60
10892307|NCT01327651|12058332|FG003|Week 10|Self-administered Dosing Period||60
10892308|NCT01327651|12058333|FG004|Week 10|Self-administered Dosing Period||59
10892309|NCT01327651|12058334|FG005|Week 10|Self-administered Dosing Period||59
10892310|NCT01327651|12058335|FG006|Week 10|Self-administered Dosing Period||57
10892311|NCT01327651|12058336|FG007|Week 10|Self-administered Dosing Period||57
10892312|NCT01327651|12058337|FG008|Week 10|Self-administered Dosing Period||56
10892313|NCT01327651|12058329|FG000|Week 14|Self-administered Dosing Period||59
10892314|NCT01327651|12058330|FG001|Week 14|Self-administered Dosing Period||55
10892315|NCT01327651|12058331|FG002|Week 14|Self-administered Dosing Period||57
10892316|NCT01327651|12058332|FG003|Week 14|Self-administered Dosing Period||60
10892317|NCT01327651|12058333|FG004|Week 14|Self-administered Dosing Period||58
10892318|NCT01327651|12058334|FG005|Week 14|Self-administered Dosing Period||59
10892319|NCT01327651|12058335|FG006|Week 14|Self-administered Dosing Period||54
10892320|NCT01327651|12058336|FG007|Week 14|Self-administered Dosing Period||51
10892321|NCT01327651|12058337|FG008|Week 14|Self-administered Dosing Period||54
10892322|NCT01327651|12058329|FG000|Week 18|Self-administered Dosing Period||57
10892323|NCT01327651|12058330|FG001|Week 18|Self-administered Dosing Period||56
10892324|NCT01327651|12058331|FG002|Week 18|Self-administered Dosing Period||56
10892325|NCT01327651|12058332|FG003|Week 18|Self-administered Dosing Period||60
10892326|NCT01327651|12058333|FG004|Week 18|Self-administered Dosing Period||57
10892327|NCT01327651|12058334|FG005|Week 18|Self-administered Dosing Period||59
10892328|NCT01327651|12058335|FG006|Week 18|Self-administered Dosing Period||53
10892329|NCT01327651|12058336|FG007|Week 18|Self-administered Dosing Period||49
10892330|NCT01327651|12058337|FG008|Week 18|Self-administered Dosing Period||53
10892331|NCT01327651|12058329|FG000|Week 22|Self-administered Dosing Period||59
10892332|NCT01327651|12058330|FG001|Week 22|Self-administered Dosing Period||56
10892333|NCT01327651|12058331|FG002|Week 22|Self-administered Dosing Period||55
10892334|NCT01327651|12058332|FG003|Week 22|Self-administered Dosing Period||58
10892335|NCT01327651|12058333|FG004|Week 22|Self-administered Dosing Period||56
10892336|NCT01327651|12058334|FG005|Week 22|Self-administered Dosing Period||59
10892337|NCT01327651|12058335|FG006|Week 22|Self-administered Dosing Period||50
10892338|NCT01327651|12058336|FG007|Week 22|Self-administered Dosing Period||50
10892339|NCT01327651|12058337|FG008|Week 22|Self-administered Dosing Period||51
10892340|NCT01327651|12058329|FG000|Week 26|Self-administered Dosing Period||58
10892341|NCT01327651|12058330|FG001|Week 26|Self-administered Dosing Period||56
10892342|NCT01327651|12058331|FG002|Week 26|Self-administered Dosing Period||53
10892343|NCT01327651|12058332|FG003|Week 26|Self-administered Dosing Period||57
10892344|NCT01327651|12058333|FG004|Week 26|Self-administered Dosing Period||56
10892345|NCT01327651|12058334|FG005|Week 26|Self-administered Dosing Period||58
10892346|NCT01327651|12058335|FG006|Week 26|Self-administered Dosing Period||50
10892347|NCT01327651|12058336|FG007|Week 26|Self-administered Dosing Period||51
10892348|NCT01327651|12058337|FG008|Week 26|Self-administered Dosing Period||49
10892349|NCT01327651|12058329|FG000|COMPLETED|Self-administered Dosing Period||56
10892350|NCT01327651|12058330|FG001|COMPLETED|Self-administered Dosing Period||56
10892351|NCT01327651|12058331|FG002|COMPLETED|Self-administered Dosing Period||56
10892352|NCT01327651|12058332|FG003|COMPLETED|Self-administered Dosing Period||57
10892353|NCT01327651|12058333|FG004|COMPLETED|Self-administered Dosing Period||56
10892354|NCT01327651|12058334|FG005|COMPLETED|Self-administered Dosing Period||59
10892355|NCT01327651|12058335|FG006|COMPLETED|Self-administered Dosing Period||49
10892356|NCT01327651|12058336|FG007|COMPLETED|Self-administered Dosing Period||50
10892357|NCT01327651|12058337|FG008|COMPLETED|Self-administered Dosing Period||49
10892358|NCT01327651|12058329|FG000|NOT COMPLETED|Self-administered Dosing Period||4
10892359|NCT01327651|12058330|FG001|NOT COMPLETED|Self-administered Dosing Period||3
10892360|NCT01327651|12058331|FG002|NOT COMPLETED|Self-administered Dosing Period||4
10892361|NCT01327651|12058332|FG003|NOT COMPLETED|Self-administered Dosing Period||3
10892362|NCT01327651|12058333|FG004|NOT COMPLETED|Self-administered Dosing Period||3
10892363|NCT01327651|12058334|FG005|NOT COMPLETED|Self-administered Dosing Period||0
10892364|NCT01327651|12058335|FG006|NOT COMPLETED|Self-administered Dosing Period||10
10892365|NCT01327651|12058336|FG007|NOT COMPLETED|Self-administered Dosing Period||10
10892366|NCT01327651|12058337|FG008|NOT COMPLETED|Self-administered Dosing Period||11
10892367|NCT01327651|12058329|FG000|STARTED|Post Study Follow-up||56
10892368|NCT01327651|12058330|FG001|STARTED|Post Study Follow-up||56
10892369|NCT01327651|12058331|FG002|STARTED|Post Study Follow-up||56
10892370|NCT01327651|12058332|FG003|STARTED|Post Study Follow-up||57
10892371|NCT01327651|12058333|FG004|STARTED|Post Study Follow-up||56
10892372|NCT01327651|12058334|FG005|STARTED|Post Study Follow-up||59
10892373|NCT01327651|12058335|FG006|STARTED|Post Study Follow-up||49
10892374|NCT01327651|12058336|FG007|STARTED|Post Study Follow-up||50
10892375|NCT01327651|12058337|FG008|STARTED|Post Study Follow-up||49
10892376|NCT01327651|12058329|FG000|COMPLETED|Post Study Follow-up||56
10892377|NCT01327651|12058330|FG001|COMPLETED|Post Study Follow-up||55
10892378|NCT01327651|12058331|FG002|COMPLETED|Post Study Follow-up||55
10892379|NCT01327651|12058332|FG003|COMPLETED|Post Study Follow-up||57
10892380|NCT01327651|12058333|FG004|COMPLETED|Post Study Follow-up||56
10892381|NCT01327651|12058334|FG005|COMPLETED|Post Study Follow-up||59
10892382|NCT01327651|12058335|FG006|COMPLETED|Post Study Follow-up||45
10892383|NCT01327651|12058336|FG007|COMPLETED|Post Study Follow-up||49
10892384|NCT01327651|12058337|FG008|COMPLETED|Post Study Follow-up||47
10892385|NCT01327651|12058329|FG000|NOT COMPLETED|Post Study Follow-up||0
10892386|NCT01327651|12058330|FG001|NOT COMPLETED|Post Study Follow-up||1
10892387|NCT01327651|12058331|FG002|NOT COMPLETED|Post Study Follow-up||1
10892388|NCT01327651|12058332|FG003|NOT COMPLETED|Post Study Follow-up||0
10892389|NCT01327651|12058333|FG004|NOT COMPLETED|Post Study Follow-up||0
10892390|NCT01327651|12058334|FG005|NOT COMPLETED|Post Study Follow-up||0
10892391|NCT01327651|12058335|FG006|NOT COMPLETED|Post Study Follow-up||4
10892392|NCT01327651|12058336|FG007|NOT COMPLETED|Post Study Follow-up||1
10892393|NCT01327651|12058337|FG008|NOT COMPLETED|Post Study Follow-up||2
10892394|NCT01326455|12058379|FG000|STARTED|Overall Study||25
10892395|NCT01326455|12058380|FG001|STARTED|Overall Study||25
10892396|NCT01326455|12058381|FG002|STARTED|Overall Study||25
10892397|NCT01326455|12058379|FG000|COMPLETED|Overall Study||15
10892398|NCT01326455|12058380|FG001|COMPLETED|Overall Study||20
10892399|NCT01326455|12058381|FG002|COMPLETED|Overall Study||18
10892400|NCT01326455|12058379|FG000|NOT COMPLETED|Overall Study||10
10892401|NCT01326455|12058380|FG001|NOT COMPLETED|Overall Study||5
10892402|NCT01326455|12058381|FG002|NOT COMPLETED|Overall Study||7
10892403|NCT01319981|12058393|FG000|STARTED|Overall Study||15
10892404|NCT01319981|12058394|FG001|STARTED|Overall Study||16
10892405|NCT01319981|12058393|FG000|COMPLETED|Overall Study||15
10892406|NCT01319981|12058394|FG001|COMPLETED|Overall Study||16
10892407|NCT01319981|12058393|FG000|NOT COMPLETED|Overall Study||0
10892408|NCT01319981|12058394|FG001|NOT COMPLETED|Overall Study||0
10892409|NCT01314313|12058404|FG000|STARTED|Overall Study||1011
10892410|NCT01314313|12058405|FG001|STARTED|Overall Study||1021
10892411|NCT01314313|12058404|FG000|As Treated|Overall Study||994
10892412|NCT01314313|12058405|FG001|As Treated|Overall Study||944
10892413|NCT01314313|12058404|FG000|Valve Implanted|Overall Study||974
10892414|NCT01314313|12058405|FG001|Valve Implanted|Overall Study||936
10892415|NCT01314313|12058404|FG000|COMPLETED|Overall Study||784
10892416|NCT01314313|12058405|FG001|COMPLETED|Overall Study||710
10892417|NCT01314313|12058404|FG000|NOT COMPLETED|Overall Study||227
10892418|NCT01314313|12058405|FG001|NOT COMPLETED|Overall Study||311
10892419|NCT01314118|12058413|FG000|STARTED|Overall Study||131
10892420|NCT01314118|12058413|FG000|COMPLETED|Overall Study||0
10892421|NCT01314118|12058413|FG000|NOT COMPLETED|Overall Study||131
10892422|NCT01313312|12058417|FG000|STARTED|Overall Study||258
10892423|NCT01313312|12058417|FG000|Cycle 1|Overall Study||254
10892424|NCT01313312|12058417|FG000|Cycle 2|Overall Study||229
10892425|NCT01313312|12058417|FG000|Cycle 3|Overall Study||175
10892426|NCT01313312|12058417|FG000|Cycle 4|Overall Study||81
10892427|NCT01313312|12058417|FG000|Cycle 5|Overall Study||11
10892428|NCT01313312|12058417|FG000|COMPLETED|Overall Study||222
10892429|NCT01313312|12058417|FG000|NOT COMPLETED|Overall Study||36
10892430|NCT01313299|12058424|FG000|STARTED|Overall Study||81
10892431|NCT01313299|12058425|FG001|STARTED|Overall Study||81
10892432|NCT01313299|12058426|FG002|STARTED|Overall Study||81
10892433|NCT01313299|12058424|FG000|COMPLETED|Overall Study||74
10892434|NCT01313299|12058425|FG001|COMPLETED|Overall Study||78
10892435|NCT01313299|12058426|FG002|COMPLETED|Overall Study||77
10892436|NCT01313299|12058424|FG000|NOT COMPLETED|Overall Study||7
10892437|NCT01313299|12058425|FG001|NOT COMPLETED|Overall Study||3
10892438|NCT01313299|12058426|FG002|NOT COMPLETED|Overall Study||4
10892439|NCT01311115|12058436|FG000|STARTED|Overall Study||132
10892440|NCT01311115|12058437|FG001|STARTED|Overall Study||69
10892441|NCT01311115|12058436|FG000|COMPLETED|Overall Study||132
10892442|NCT01311115|12058437|FG001|COMPLETED|Overall Study||69
10892443|NCT01311115|12058436|FG000|NOT COMPLETED|Overall Study||0
10892444|NCT01311115|12058437|FG001|NOT COMPLETED|Overall Study||0
10892445|NCT01308853|12058443|FG000|STARTED|Overall Study||24
10892446|NCT01308853|12058443|FG000|COMPLETED|Overall Study||20
10892447|NCT01308853|12058443|FG000|NOT COMPLETED|Overall Study||4
10892448|NCT01308619|12058449|FG000|STARTED|Overall Study||84
10892449|NCT01308619|12058450|FG001|STARTED|Overall Study||86
10892450|NCT01308619|12058449|FG000|COMPLETED|Overall Study||77
10892451|NCT01308619|12058450|FG001|COMPLETED|Overall Study||83
10892452|NCT01308619|12058449|FG000|NOT COMPLETED|Overall Study||7
10892453|NCT01308619|12058450|FG001|NOT COMPLETED|Overall Study||3
10892454|NCT01288911|12058460|FG000|STARTED|Double-blind Period||184
10892455|NCT01288911|12058461|FG001|STARTED|Double-blind Period||191
10892456|NCT01288911|12058460|FG000|Received Treatment|Double-blind Period||183
10892457|NCT01288911|12058461|FG001|Received Treatment|Double-blind Period||189
10892458|NCT01288911|12058460|FG000|COMPLETED|Double-blind Period|Indicates participants were still receiving treatment at the data cut-off date of 19 October 2014.|42
10892459|NCT01288911|12058461|FG001|COMPLETED|Double-blind Period|Indicates participants were still receiving treatment at the data cut-off date of 19 October 2014.|9
10892460|NCT01288911|12058460|FG000|NOT COMPLETED|Double-blind Period||142
10892461|NCT01288911|12058461|FG001|NOT COMPLETED|Double-blind Period||182
10892462|NCT01288911|12058460|FG000|STARTED|Open-label Period (All Enzalutamide)||42
10892463|NCT01288911|12058461|FG001|STARTED|Open-label Period (All Enzalutamide)||9
10892464|NCT01288911|12058460|FG000|Received Treatment|Open-label Period (All Enzalutamide)||42
10892465|NCT01288911|12058461|FG001|Received Treatment|Open-label Period (All Enzalutamide)||9
10892466|NCT01288911|12058460|FG000|COMPLETED|Open-label Period (All Enzalutamide)||0
10892467|NCT01288911|12058461|FG001|COMPLETED|Open-label Period (All Enzalutamide)||0
10892468|NCT01288911|12058460|FG000|NOT COMPLETED|Open-label Period (All Enzalutamide)||42
10892469|NCT01288911|12058461|FG001|NOT COMPLETED|Open-label Period (All Enzalutamide)||9
10892470|NCT01286272|12058472|FG000|STARTED|Overall Study||67
10892471|NCT01286272|12058473|FG001|STARTED|Overall Study||65
10892472|NCT01286272|12058472|FG000|COMPLETED|Overall Study||66
10892473|NCT01286272|12058473|FG001|COMPLETED|Overall Study||62
10892474|NCT01286272|12058472|FG000|NOT COMPLETED|Overall Study||1
10892475|NCT01286272|12058473|FG001|NOT COMPLETED|Overall Study||3
10892476|NCT01275677|12058481|FG000|STARTED|Overall Study||1630
10892477|NCT01275677|12058482|FG001|STARTED|Overall Study||1640
10892478|NCT01275677|12058481|FG000|COMPLETED|Overall Study||1602
10892479|NCT01275677|12058482|FG001|COMPLETED|Overall Study||1598
10892480|NCT01275677|12058481|FG000|NOT COMPLETED|Overall Study||28
10892481|NCT01275677|12058482|FG001|NOT COMPLETED|Overall Study||42
10892482|NCT01273610|12058490|FG000|STARTED|Overall Study||30
10892483|NCT01273610|12058491|FG001|STARTED|Overall Study||10
10892484|NCT01273610|12058490|FG000|COMPLETED|Overall Study||30
10892485|NCT01273610|12058491|FG001|COMPLETED|Overall Study||10
10892486|NCT01273610|12058490|FG000|NOT COMPLETED|Overall Study||0
10892487|NCT01273610|12058491|FG001|NOT COMPLETED|Overall Study||0
10892488|NCT01267955|12058498|FG000|STARTED|Stage 1 (6 Months)||20
10892489|NCT01267955|12058498|FG000|COMPLETED|Stage 1 (6 Months)||17
10892490|NCT01267955|12058498|FG000|NOT COMPLETED|Stage 1 (6 Months)||3
10892491|NCT01267955|12058498|FG000|STARTED|Stage 2 (6 Months)||45
10892492|NCT01267955|12058498|FG000|COMPLETED|Stage 2 (6 Months)||39
10892493|NCT01267955|12058498|FG000|NOT COMPLETED|Stage 2 (6 Months)||6
10892494|NCT01265849|12058505|FG000|STARTED|Overall Study||396
10892495|NCT01265849|12058506|FG001|STARTED|Overall Study||398
10892496|NCT01265849|12058507|FG002|STARTED|Overall Study||134
10892497|NCT01265849|12058505|FG000|COMPLETED|Overall Study||350
10892498|NCT01265849|12058506|FG001|COMPLETED|Overall Study||337
10892499|NCT01265849|12058507|FG002|COMPLETED|Overall Study||115
10892500|NCT01265849|12058505|FG000|NOT COMPLETED|Overall Study||46
10892501|NCT01265849|12058506|FG001|NOT COMPLETED|Overall Study||61
10892502|NCT01265849|12058507|FG002|NOT COMPLETED|Overall Study||19
10892503|NCT01265459|12058522|FG000|STARTED|Overall Study||23
10892504|NCT01265459|12058523|FG001|STARTED|Overall Study||23
10892505|NCT01265459|12058524|FG002|STARTED|Overall Study||22
10892506|NCT01265459|12058522|FG000|COMPLETED|Overall Study||23
10892507|NCT01265459|12058523|FG001|COMPLETED|Overall Study||23
10892508|NCT01265459|12058524|FG002|COMPLETED|Overall Study||20
10892509|NCT01265459|12058522|FG000|NOT COMPLETED|Overall Study||0
10892510|NCT01265459|12058523|FG001|NOT COMPLETED|Overall Study||0
10892511|NCT01265459|12058524|FG002|NOT COMPLETED|Overall Study||2
10892512|NCT01263769|12058544|FG000|STARTED|Overall Study||25
10892513|NCT01263769|12058544|FG000|COMPLETED|Overall Study||24
10892514|NCT01263769|12058544|FG000|NOT COMPLETED|Overall Study||1
10892515|NCT01261611|12058551|FG000|STARTED|Treatment Cycle 1||156
10892516|NCT01261611|12058552|FG001|STARTED|Treatment Cycle 1||159
10892517|NCT01261611|12058553|FG002|STARTED|Treatment Cycle 1||54
10892518|NCT01261611|12058551|FG000|COMPLETED|Treatment Cycle 1||152
10892519|NCT01261611|12058552|FG001|COMPLETED|Treatment Cycle 1||156
10892520|NCT01261611|12058553|FG002|COMPLETED|Treatment Cycle 1||52
10892521|NCT01261611|12058551|FG000|NOT COMPLETED|Treatment Cycle 1||4
10892522|NCT01261611|12058552|FG001|NOT COMPLETED|Treatment Cycle 1||3
10892523|NCT01261611|12058553|FG002|NOT COMPLETED|Treatment Cycle 1||2
10892524|NCT01261611|12058551|FG000|STARTED|Treatment Cycle 2|All but 1 who completed DB period entered the open label period. This subject remained at Cycle 1.|359
10892525|NCT01261611|12058552|FG001|STARTED|Treatment Cycle 2||0
10892526|NCT01261611|12058553|FG002|STARTED|Treatment Cycle 2||0
10892527|NCT01261611|12058551|FG000|COMPLETED|Treatment Cycle 2||346
10892528|NCT01261611|12058552|FG001|COMPLETED|Treatment Cycle 2||0
10892529|NCT01261611|12058553|FG002|COMPLETED|Treatment Cycle 2||0
10892530|NCT01261611|12058551|FG000|NOT COMPLETED|Treatment Cycle 2||13
10892531|NCT01261611|12058552|FG001|NOT COMPLETED|Treatment Cycle 2||0
10892532|NCT01261611|12058553|FG002|NOT COMPLETED|Treatment Cycle 2||0
10892533|NCT01261611|12058551|FG000|STARTED|Treatment Cycle 3||346
10892534|NCT01261611|12058552|FG001|STARTED|Treatment Cycle 3||0
10892535|NCT01261611|12058553|FG002|STARTED|Treatment Cycle 3||0
10892536|NCT01261611|12058551|FG000|COMPLETED|Treatment Cycle 3||316
10892537|NCT01261611|12058552|FG001|COMPLETED|Treatment Cycle 3||0
10892538|NCT01261611|12058553|FG002|COMPLETED|Treatment Cycle 3||0
10892539|NCT01261611|12058551|FG000|NOT COMPLETED|Treatment Cycle 3||30
10892540|NCT01261611|12058552|FG001|NOT COMPLETED|Treatment Cycle 3||0
10892541|NCT01261611|12058553|FG002|NOT COMPLETED|Treatment Cycle 3||0
10892542|NCT01261611|12058551|FG000|STARTED|Treatment Cycle 4||316
10892543|NCT01261611|12058552|FG001|STARTED|Treatment Cycle 4||0
10892544|NCT01261611|12058553|FG002|STARTED|Treatment Cycle 4||0
10892545|NCT01261611|12058551|FG000|COMPLETED|Treatment Cycle 4||220
10892546|NCT01261611|12058552|FG001|COMPLETED|Treatment Cycle 4||0
10892547|NCT01261611|12058553|FG002|COMPLETED|Treatment Cycle 4||0
10892548|NCT01261611|12058551|FG000|NOT COMPLETED|Treatment Cycle 4||96
10892549|NCT01261611|12058552|FG001|NOT COMPLETED|Treatment Cycle 4||0
10892550|NCT01261611|12058553|FG002|NOT COMPLETED|Treatment Cycle 4||0
10892551|NCT01261611|12058551|FG000|STARTED|Treatment Cycle 5||220
10892552|NCT01261611|12058552|FG001|STARTED|Treatment Cycle 5||0
10892553|NCT01261611|12058553|FG002|STARTED|Treatment Cycle 5||0
10892554|NCT01261611|12058551|FG000|COMPLETED|Treatment Cycle 5||217
10892555|NCT01261611|12058552|FG001|COMPLETED|Treatment Cycle 5||0
10892556|NCT01261611|12058553|FG002|COMPLETED|Treatment Cycle 5||0
10892557|NCT01261611|12058551|FG000|NOT COMPLETED|Treatment Cycle 5||3
10892558|NCT01261611|12058552|FG001|NOT COMPLETED|Treatment Cycle 5||0
10892559|NCT01261611|12058553|FG002|NOT COMPLETED|Treatment Cycle 5||0
10892560|NCT01256398|12058565|FG000|STARTED|Overall Study||66
10892561|NCT01256398|12058565|FG000|COMPLETED|Overall Study||65
10892562|NCT01256398|12058565|FG000|NOT COMPLETED|Overall Study||1
10892563|NCT01253070|12058569|FG000|STARTED|Overall Study||54
10892564|NCT01253070|12058569|FG000|COMPLETED|Overall Study||54
10892565|NCT01253070|12058569|FG000|NOT COMPLETED|Overall Study||0
10892566|NCT01252719|12058576|FG000|STARTED|Overall Study|Participants Randomized|483
10892567|NCT01252719|12058577|FG001|STARTED|Overall Study|Participants Randomized|485
10892568|NCT01252719|12058576|FG000|Modified Intent to Treat Population|Overall Study||475
10892569|NCT01252719|12058577|FG001|Modified Intent to Treat Population|Overall Study||479
10892570|NCT01252719|12058576|FG000|COMPLETED|Overall Study||433
10892571|NCT01252719|12058577|FG001|COMPLETED|Overall Study||423
10892572|NCT01252719|12058576|FG000|NOT COMPLETED|Overall Study||50
10892573|NCT01252719|12058577|FG001|NOT COMPLETED|Overall Study||62
10892574|NCT01251861|12058585|FG000|STARTED|Overall Study||54
10892575|NCT01251861|12058586|FG001|STARTED|Overall Study||54
10892576|NCT01251861|12058585|FG000|Pts Who Received Protocol Therapy|Overall Study||50
10892577|NCT01251861|12058586|FG001|Pts Who Received Protocol Therapy|Overall Study||53
10892578|NCT01251861|12058585|FG000|Pts w/ Follow-up PSA Lower Than Baseline|Overall Study||49
10892579|NCT01251861|12058586|FG001|Pts w/ Follow-up PSA Lower Than Baseline|Overall Study||47
10892580|NCT01251861|12058585|FG000|Pts With PSA Response|Overall Study||44
10892581|NCT01251861|12058586|FG001|Pts With PSA Response|Overall Study||36
10892582|NCT01251861|12058585|FG000|COMPLETED|Overall Study||36
10892583|NCT01251861|12058586|FG001|COMPLETED|Overall Study||26
10892584|NCT01251861|12058585|FG000|NOT COMPLETED|Overall Study||18
10892585|NCT01251861|12058586|FG001|NOT COMPLETED|Overall Study||28
10892586|NCT01251380|12058592|FG000|STARTED|Overall Study|Safety population.|216
10892587|NCT01251380|12058592|FG000|Cycle 1|Overall Study||207
10892588|NCT01251380|12058592|FG000|Cycle 2|Overall Study||175
10892589|NCT01251380|12058592|FG000|Cycle 3|Overall Study||86
10892590|NCT01251380|12058592|FG000|Cycle 4|Overall Study||11
10892591|NCT01251380|12058592|FG000|COMPLETED|Overall Study||194
10892592|NCT01251380|12058592|FG000|NOT COMPLETED|Overall Study||22
10892593|NCT01251367|12058601|FG000|STARTED|Overall Study||345
10892594|NCT01251367|12058601|FG000|Cycle 1|Overall Study||345
10892595|NCT01251367|12058601|FG000|Cycle 2|Overall Study||297
10892596|NCT01251367|12058601|FG000|Cycle 3|Overall Study||224
10892597|NCT01251367|12058601|FG000|Cycle 4|Overall Study||139
10892598|NCT01251367|12058601|FG000|COMPLETED|Overall Study||269
10892599|NCT01251367|12058601|FG000|NOT COMPLETED|Overall Study||76
10892600|NCT01251276|12058607|FG000|STARTED|Overall Study|Not all Base Study completers enrolled in the Challenge Dose Study|96
10892601|NCT01251276|12058608|FG001|STARTED|Overall Study|Not all Base Study completers enrolled in the Challenge Dose Study|108
10892602|NCT01251276|12058607|FG000|Vaccinated|Overall Study||96
10892603|NCT01251276|12058608|FG001|Vaccinated|Overall Study||108
10892604|NCT01251276|12058607|FG000|COMPLETED|Overall Study||95
10892605|NCT01251276|12058608|FG001|COMPLETED|Overall Study||107
10892606|NCT01251276|12058607|FG000|NOT COMPLETED|Overall Study||1
10892607|NCT01251276|12058608|FG001|NOT COMPLETED|Overall Study||1
10892608|NCT01249417|12058617|FG000|STARTED|Randomised Population||80
10892609|NCT01249417|12058618|FG001|STARTED|Randomised Population||80
10892610|NCT01249417|12058619|FG002|STARTED|Randomised Population||81
10892611|NCT01249417|12058617|FG000|Treated|Randomised Population||80
10892612|NCT01249417|12058618|FG001|Treated|Randomised Population||80
10892613|NCT01249417|12058619|FG002|Treated|Randomised Population||79
10892614|NCT01249417|12058617|FG000|COMPLETED|Randomised Population||79
10892615|NCT01249417|12058618|FG001|COMPLETED|Randomised Population||79
10892616|NCT01249417|12058619|FG002|COMPLETED|Randomised Population||77
10892617|NCT01249417|12058617|FG000|NOT COMPLETED|Randomised Population||1
10892618|NCT01249417|12058618|FG001|NOT COMPLETED|Randomised Population||1
10892619|NCT01249417|12058619|FG002|NOT COMPLETED|Randomised Population||4
10892620|NCT01249417|12058617|FG000|STARTED|Treatment Phase - ITT Population||79
10892621|NCT01249417|12058618|FG001|STARTED|Treatment Phase - ITT Population||79
10892622|NCT01249417|12058619|FG002|STARTED|Treatment Phase - ITT Population||77
10892623|NCT01249417|12058617|FG000|COMPLETED|Treatment Phase - ITT Population||78
10892624|NCT01249417|12058618|FG001|COMPLETED|Treatment Phase - ITT Population||75
10892625|NCT01249417|12058619|FG002|COMPLETED|Treatment Phase - ITT Population||73
10892626|NCT01249417|12058617|FG000|NOT COMPLETED|Treatment Phase - ITT Population||1
10892627|NCT01249417|12058618|FG001|NOT COMPLETED|Treatment Phase - ITT Population||4
10892628|NCT01249417|12058619|FG002|NOT COMPLETED|Treatment Phase - ITT Population||4
10892629|NCT01249404|12058630|FG000|STARTED|Overall Study||127
10892630|NCT01249404|12058631|FG001|STARTED|Overall Study||129
10892631|NCT01249404|12058632|FG002|STARTED|Overall Study||132
10892632|NCT01249404|12058630|FG000|COMPLETED|Overall Study||120
10892633|NCT01249404|12058631|FG001|COMPLETED|Overall Study||121
10892634|NCT01249404|12058632|FG002|COMPLETED|Overall Study||125
10892635|NCT01249404|12058630|FG000|NOT COMPLETED|Overall Study||7
10892636|NCT01249404|12058631|FG001|NOT COMPLETED|Overall Study||8
10892637|NCT01249404|12058632|FG002|NOT COMPLETED|Overall Study||7
10892638|NCT01238211|12058640|FG000|STARTED|Overall Study||61
10892639|NCT01238211|12058640|FG000|COMPLETED|Overall Study||3
10892640|NCT01238211|12058640|FG000|NOT COMPLETED|Overall Study||58
10892641|NCT01236560|12058650|FG000|STARTED|Overall Study||6
10892642|NCT01236560|12058651|FG001|STARTED|Overall Study||32
10892643|NCT01236560|12058652|FG002|STARTED|Overall Study||31
10892644|NCT01236560|12058653|FG003|STARTED|Overall Study||32
10892645|NCT01236560|12058654|FG004|STARTED|Overall Study||0
10892646|NCT01236560|12058655|FG005|STARTED|Overall Study||0
10892647|NCT01236560|12058650|FG000|COMPLETED|Overall Study||1
10892648|NCT01236560|12058651|FG001|COMPLETED|Overall Study||8
10892649|NCT01236560|12058652|FG002|COMPLETED|Overall Study||11
10892650|NCT01236560|12058653|FG003|COMPLETED|Overall Study||10
10892651|NCT01236560|12058654|FG004|COMPLETED|Overall Study||0
10892652|NCT01236560|12058655|FG005|COMPLETED|Overall Study||0
10892653|NCT01236560|12058650|FG000|NOT COMPLETED|Overall Study||5
10892654|NCT01236560|12058651|FG001|NOT COMPLETED|Overall Study||24
10892655|NCT01236560|12058652|FG002|NOT COMPLETED|Overall Study||20
10892656|NCT01236560|12058653|FG003|NOT COMPLETED|Overall Study||22
10892657|NCT01236560|12058654|FG004|NOT COMPLETED|Overall Study||0
10892658|NCT01236560|12058655|FG005|NOT COMPLETED|Overall Study||0
10892659|NCT01230411|12058667|FG000|STARTED|Overall Study||21
10892660|NCT01230411|12058668|FG001|STARTED|Overall Study||23
10892661|NCT01230411|12058667|FG000|COMPLETED|Overall Study||21
10892662|NCT01230411|12058668|FG001|COMPLETED|Overall Study||23
10892663|NCT01230411|12058667|FG000|NOT COMPLETED|Overall Study||0
10892664|NCT01230411|12058668|FG001|NOT COMPLETED|Overall Study||0
10892665|NCT01229943|12058676|FG000|STARTED|Overall Study||75
10892666|NCT01229943|12058677|FG001|STARTED|Overall Study||75
10892667|NCT01229943|12058676|FG000|COMPLETED|Overall Study||57
10892668|NCT01229943|12058677|FG001|COMPLETED|Overall Study||58
10892669|NCT01229943|12058676|FG000|NOT COMPLETED|Overall Study||18
10892670|NCT01229943|12058677|FG001|NOT COMPLETED|Overall Study||17
10892671|NCT01223963|12058685|FG000|STARTED|Overall Study|All subjects treated between May 1 2008 and Dec 31 2009 in selected clinics were to be asked.|93
10892672|NCT01223963|12058685|FG000|COMPLETED|Overall Study||93
10892673|NCT01223963|12058685|FG000|NOT COMPLETED|Overall Study||0
10892674|NCT01212822|12058690|FG000|STARTED|Overall Study||20
10892675|NCT01212822|12058690|FG000|COMPLETED|Overall Study||20
10892676|NCT01212822|12058690|FG000|NOT COMPLETED|Overall Study||0
10892677|NCT01209949|12058694|FG000|STARTED|Overall Study||30
10892678|NCT01209949|12058694|FG000|COMPLETED|Overall Study||27
10892679|NCT01209949|12058694|FG000|NOT COMPLETED|Overall Study||3
10892680|NCT01207492|12058698|FG000|STARTED|Overall Study||17
10892681|NCT01207492|12058698|FG000|COMPLETED|Overall Study||2
10892682|NCT01207492|12058698|FG000|NOT COMPLETED|Overall Study||15
10892683|NCT01197950|12058705|FG000|STARTED|Overall Study||99
10892684|NCT01197950|12058706|FG001|STARTED|Overall Study||103
10892685|NCT01197950|12058707|FG002|STARTED|Overall Study||101
10892686|NCT01197950|12058705|FG000|COMPLETED|Overall Study|women's request (9), high workload (3), returned home (1), partus in one hour (1), other (2)|83
10892687|NCT01197950|12058706|FG001|COMPLETED|Overall Study|women's request (11) high workload (4) returned to home (1)|87
10892688|NCT01197950|12058707|FG002|COMPLETED|Overall Study|woman's request (11) high workload (1) returned to home (2) other (4)|83
10892689|NCT01197950|12058705|FG000|NOT COMPLETED|Overall Study||16
10892690|NCT01197950|12058706|FG001|NOT COMPLETED|Overall Study||16
10892691|NCT01197950|12058707|FG002|NOT COMPLETED|Overall Study||18
10892692|NCT01196390|12058717|FG000|STARTED|Overall Study||102
10892693|NCT01196390|12058718|FG001|STARTED|Overall Study||101
10892694|NCT01196390|12058717|FG000|Eligible|Overall Study||98
10892695|NCT01196390|12058718|FG001|Eligible|Overall Study||96
10892696|NCT01196390|12058717|FG000|Eligible and Started Study Treatment|Overall Study||95
10892697|NCT01196390|12058718|FG001|Eligible and Started Study Treatment|Overall Study||96
10892698|NCT01196390|12058717|FG000|Eligible and Had Surgery|Overall Study||82
10892699|NCT01196390|12058718|FG001|Eligible and Had Surgery|Overall Study||78
10892700|NCT01196390|12058717|FG000|COMPLETED|Overall Study||98
10892701|NCT01196390|12058718|FG001|COMPLETED|Overall Study||96
10892702|NCT01196390|12058717|FG000|NOT COMPLETED|Overall Study||4
10892703|NCT01196390|12058718|FG001|NOT COMPLETED|Overall Study||5
10892704|NCT01171898|12058730|FG000|STARTED|Overall Study||30
10892705|NCT01171898|12058731|FG001|STARTED|Overall Study||51
10892706|NCT01171898|12058732|FG002|STARTED|Overall Study||25
10892707|NCT01171898|12058733|FG003|STARTED|Overall Study||21
10892708|NCT01171898|12058730|FG000|COMPLETED|Overall Study||26
10892709|NCT01171898|12058731|FG001|COMPLETED|Overall Study||32
10892710|NCT01171898|12058732|FG002|COMPLETED|Overall Study||13
10892711|NCT01171898|12058733|FG003|COMPLETED|Overall Study||15
10892712|NCT01171898|12058730|FG000|NOT COMPLETED|Overall Study||4
10892713|NCT01171898|12058731|FG001|NOT COMPLETED|Overall Study||19
10892714|NCT01171898|12058732|FG002|NOT COMPLETED|Overall Study||12
10892715|NCT01171898|12058733|FG003|NOT COMPLETED|Overall Study||6
10892716|NCT01168219|12058746|FG000|STARTED|Overall Study||68
10892717|NCT01168219|12058746|FG000|COMPLETED|Overall Study||63
10892718|NCT01168219|12058746|FG000|NOT COMPLETED|Overall Study||5
10892719|NCT01167712|12058752|FG000|STARTED|Overall Study||346
10892720|NCT01167712|12058753|FG001|STARTED|Overall Study||346
10892721|NCT01167712|12058752|FG000|COMPLETED|Overall Study||346
10892722|NCT01167712|12058753|FG001|COMPLETED|Overall Study||346
10892723|NCT01167712|12058752|FG000|NOT COMPLETED|Overall Study||0
10892724|NCT01167712|12058753|FG001|NOT COMPLETED|Overall Study||0
10892725|NCT01146275|12058759|FG000|STARTED|Overall Study||6
10892726|NCT01146275|12058759|FG000|COMPLETED|Overall Study||6
10892727|NCT01146275|12058759|FG000|NOT COMPLETED|Overall Study||0
10892728|NCT01145495|12058764|FG000|STARTED|Overall Study||63
10892729|NCT01145495|12058764|FG000|COMPLETED|Overall Study||51
10892730|NCT01145495|12058764|FG000|NOT COMPLETED|Overall Study||12
10892731|NCT01145209|12058770|FG000|STARTED|Overall Study||13
10892732|NCT01145209|12058771|FG001|STARTED|Overall Study||19
10892733|NCT01145209|12058770|FG000|COMPLETED|Overall Study||10
10892734|NCT01145209|12058771|FG001|COMPLETED|Overall Study||18
10892735|NCT01145209|12058770|FG000|NOT COMPLETED|Overall Study||3
10892736|NCT01145209|12058771|FG001|NOT COMPLETED|Overall Study||1
10892737|NCT01143038|12058785|FG000|STARTED|Overall Study||75
10892738|NCT01143038|12058785|FG000|COMPLETED|Overall Study|Defined as completion of romiplostim treatment|59
10892739|NCT01143038|12058785|FG000|NOT COMPLETED|Overall Study||16
10892740|NCT01142388|12058791|FG000|STARTED|Overall Study||47
10892741|NCT01142388|12058792|FG001|STARTED|Overall Study||47
10892742|NCT01142388|12058791|FG000|Eligible|Overall Study||43
10892743|NCT01142388|12058792|FG001|Eligible|Overall Study||44
10892744|NCT01142388|12058791|FG000|Treated|Overall Study||40
10892745|NCT01142388|12058792|FG001|Treated|Overall Study||44
10892746|NCT01142388|12058791|FG000|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.|0
10892747|NCT01142388|12058792|FG001|COMPLETED|Overall Study||0
10892748|NCT01142388|12058791|FG000|NOT COMPLETED|Overall Study||47
10892749|NCT01142388|12058792|FG001|NOT COMPLETED|Overall Study||47
10892750|NCT01139047|12058798|FG000|STARTED|Overall Study||77
10892751|NCT01139047|12058798|FG000|COMPLETED|Overall Study||76
10892752|NCT01139047|12058798|FG000|NOT COMPLETED|Overall Study||1
10892753|NCT01139008|12058805|FG000|STARTED|Overall Study||80
10892754|NCT01139008|12058805|FG000|COMPLETED|Overall Study||74
10892755|NCT01139008|12058805|FG000|NOT COMPLETED|Overall Study||6
10892756|NCT01134614|12058814|FG000|STARTED|Overall Study||123
10892757|NCT01134614|12058815|FG001|STARTED|Overall Study||122
10892758|NCT01134614|12058814|FG000|Treated|Overall Study||119
10892759|NCT01134614|12058815|FG001|Treated|Overall Study||121
10892760|NCT01134614|12058814|FG000|Treated and Toxicity Assessed|Overall Study||118
10892761|NCT01134614|12058815|FG001|Treated and Toxicity Assessed|Overall Study||120
10892762|NCT01134614|12058814|FG000|COMPLETED|Overall Study|Treatment continues until disease progression or unacceptable toxicity.|0
10892763|NCT01134614|12058815|FG001|COMPLETED|Overall Study|Treatment continues until disease progression or unacceptable toxicities|0
10892764|NCT01134614|12058814|FG000|NOT COMPLETED|Overall Study||123
10892765|NCT01134614|12058815|FG001|NOT COMPLETED|Overall Study||122
10892766|NCT01131182|12058823|FG000|STARTED|Overall Study||529
10892767|NCT01131182|12058824|FG001|STARTED|Overall Study||537
10892768|NCT01131182|12058823|FG000|COMPLETED|Overall Study||513
10892769|NCT01131182|12058824|FG001|COMPLETED|Overall Study||521
10892770|NCT01131182|12058823|FG000|NOT COMPLETED|Overall Study||16
10892771|NCT01131182|12058824|FG001|NOT COMPLETED|Overall Study||16
10892772|NCT01126736|12058835|FG000|STARTED|Overall Study||4
10892773|NCT01126736|12058836|FG001|STARTED|Overall Study||6
10892774|NCT01126736|12058837|FG002|STARTED|Overall Study||5
10892775|NCT01126736|12058838|FG003|STARTED|Overall Study||42
10892776|NCT01126736|12058839|FG004|STARTED|Overall Study||41
10892777|NCT01126736|12058835|FG000|Safety Population|Overall Study||4
10892778|NCT01126736|12058836|FG001|Safety Population|Overall Study||6
10892779|NCT01126736|12058837|FG002|Safety Population|Overall Study||5
10892780|NCT01126736|12058838|FG003|Safety Population|Overall Study||41
10892781|NCT01126736|12058839|FG004|Safety Population|Overall Study||39
10892782|NCT01126736|12058835|FG000|Modified Intent-to-treat (MITT)|Overall Study||4
10892783|NCT01126736|12058836|FG001|Modified Intent-to-treat (MITT)|Overall Study||6
10892784|NCT01126736|12058837|FG002|Modified Intent-to-treat (MITT)|Overall Study||5
10892785|NCT01126736|12058838|FG003|Modified Intent-to-treat (MITT)|Overall Study||39
10892786|NCT01126736|12058839|FG004|Modified Intent-to-treat (MITT)|Overall Study||39
10892787|NCT01126736|12058835|FG000|COMPLETED|Overall Study||0
10892788|NCT01126736|12058836|FG001|COMPLETED|Overall Study||0
10892789|NCT01126736|12058837|FG002|COMPLETED|Overall Study||0
10892790|NCT01126736|12058838|FG003|COMPLETED|Overall Study||0
10892791|NCT01126736|12058839|FG004|COMPLETED|Overall Study||0
10892792|NCT01126736|12058835|FG000|NOT COMPLETED|Overall Study||4
10892793|NCT01126736|12058836|FG001|NOT COMPLETED|Overall Study||6
10892794|NCT01126736|12058837|FG002|NOT COMPLETED|Overall Study||5
10892795|NCT01126736|12058838|FG003|NOT COMPLETED|Overall Study||42
10892796|NCT01126736|12058839|FG004|NOT COMPLETED|Overall Study||41
10892797|NCT01125436|12058853|FG000|STARTED|Overall Study||31
10892798|NCT01125436|12058854|FG001|STARTED|Overall Study||33
10892799|NCT01125436|12058853|FG000|COMPLETED|Overall Study||19
10892800|NCT01125436|12058854|FG001|COMPLETED|Overall Study||21
10892801|NCT01125436|12058853|FG000|NOT COMPLETED|Overall Study||12
10892802|NCT01125436|12058854|FG001|NOT COMPLETED|Overall Study||12
10892803|NCT01120964|12058862|FG000|STARTED|Overall Study||11
10892804|NCT01120964|12058863|FG001|STARTED|Overall Study||11
10892805|NCT01120964|12058862|FG000|COMPLETED|Overall Study||10
10892806|NCT01120964|12058863|FG001|COMPLETED|Overall Study||11
10892807|NCT01120964|12058862|FG000|NOT COMPLETED|Overall Study||1
10892808|NCT01120964|12058863|FG001|NOT COMPLETED|Overall Study||0
10892809|NCT01119066|12058873|FG000|STARTED|Overall Study||132
10892810|NCT01119066|12058874|FG001|STARTED|Overall Study||227
10892811|NCT01119066|12058875|FG002|STARTED|Overall Study||52
10892812|NCT01119066|12058876|FG003|STARTED|Overall Study||11
10892813|NCT01119066|12058873|FG000|COMPLETED|Overall Study||125
10892814|NCT01119066|12058874|FG001|COMPLETED|Overall Study||213
10892815|NCT01119066|12058875|FG002|COMPLETED|Overall Study||52
10892816|NCT01119066|12058876|FG003|COMPLETED|Overall Study||11
10892817|NCT01119066|12058873|FG000|NOT COMPLETED|Overall Study||7
10892818|NCT01119066|12058874|FG001|NOT COMPLETED|Overall Study||14
10892819|NCT01119066|12058875|FG002|NOT COMPLETED|Overall Study||0
10892820|NCT01119066|12058876|FG003|NOT COMPLETED|Overall Study||0
10892821|NCT01112306|12058886|FG000|STARTED|Overall Study||709
10892822|NCT01112306|12058886|FG000|COMPLETED|Overall Study||424
10892823|NCT01112306|12058886|FG000|NOT COMPLETED|Overall Study||285
10892824|NCT01110681|12058890|FG000|STARTED|Overall Study||115
10892825|NCT01110681|12058890|FG000|COMPLETED|Overall Study||83
10892826|NCT01110681|12058890|FG000|NOT COMPLETED|Overall Study||32
10892827|NCT01081678|12058898|FG000|STARTED|Overall Study||89
10892828|NCT01081678|12058899|FG001|STARTED|Overall Study||60
10892829|NCT01081678|12058900|FG002|STARTED|Overall Study||93
10892830|NCT01081678|12058901|FG003|STARTED|Overall Study||90
10892831|NCT01081678|12058898|FG000|Received Study Drug|Overall Study||87
10892832|NCT01081678|12058899|FG001|Received Study Drug|Overall Study||60
10892833|NCT01081678|12058900|FG002|Received Study Drug|Overall Study||89
10892834|NCT01081678|12058901|FG003|Received Study Drug|Overall Study||89
10892835|NCT01081678|12058898|FG000|Completed 24 Weeks of Study|Overall Study||73
10892836|NCT01081678|12058899|FG001|Completed 24 Weeks of Study|Overall Study||50
10892837|NCT01081678|12058900|FG002|Completed 24 Weeks of Study|Overall Study||72
10892838|NCT01081678|12058901|FG003|Completed 24 Weeks of Study|Overall Study||68
10892839|NCT01081678|12058898|FG000|COMPLETED|Overall Study||62
10892840|NCT01081678|12058899|FG001|COMPLETED|Overall Study||44
10892841|NCT01081678|12058900|FG002|COMPLETED|Overall Study||62
10892842|NCT01081678|12058901|FG003|COMPLETED|Overall Study||61
10892843|NCT01081678|12058898|FG000|NOT COMPLETED|Overall Study||27
10892844|NCT01081678|12058899|FG001|NOT COMPLETED|Overall Study||16
10892845|NCT01081678|12058900|FG002|NOT COMPLETED|Overall Study||31
10892846|NCT01081678|12058901|FG003|NOT COMPLETED|Overall Study||29
10892847|NCT01081262|12058915|FG000|STARTED|Overall Study||13
10892848|NCT01081262|12058916|FG001|STARTED|Overall Study||13
10892849|NCT01081262|12058917|FG002|STARTED|Overall Study||13
10892850|NCT01081262|12058918|FG003|STARTED|Overall Study||11
10892851|NCT01081262|12058915|FG000|COMPLETED|Overall Study||13
10892852|NCT01081262|12058916|FG001|COMPLETED|Overall Study||13
10892853|NCT01081262|12058917|FG002|COMPLETED|Overall Study||13
10892854|NCT01081262|12058918|FG003|COMPLETED|Overall Study||11
10892855|NCT01081262|12058915|FG000|NOT COMPLETED|Overall Study||0
10892856|NCT01081262|12058916|FG001|NOT COMPLETED|Overall Study||0
10892857|NCT01081262|12058917|FG002|NOT COMPLETED|Overall Study||0
10892858|NCT01081262|12058918|FG003|NOT COMPLETED|Overall Study||0
10892859|NCT01080391|12058930|FG000|STARTED|Overall Study||396
10892860|NCT01080391|12058931|FG001|STARTED|Overall Study||396
10892861|NCT01080391|12058930|FG000|Treated|Overall Study||389
10892862|NCT01080391|12058931|FG001|Treated|Overall Study||392
10892863|NCT01080391|12058930|FG000|COMPLETED|Overall Study||389
10892864|NCT01080391|12058931|FG001|COMPLETED|Overall Study||392
10892865|NCT01080391|12058930|FG000|NOT COMPLETED|Overall Study||7
10892866|NCT01080391|12058931|FG001|NOT COMPLETED|Overall Study||4
10892867|NCT01077856|12058940|FG000|STARTED|Overall Study||22199
10892868|NCT01077856|12058941|FG001|STARTED|Overall Study||16604
10892869|NCT01077856|12058942|FG002|STARTED|Overall Study||15713
10892870|NCT01077856|12058940|FG000|COMPLETED|Overall Study||22199
10892871|NCT01077856|12058941|FG001|COMPLETED|Overall Study||16604
10892872|NCT01077856|12058942|FG002|COMPLETED|Overall Study||15713
10892873|NCT01077856|12058940|FG000|NOT COMPLETED|Overall Study||0
10892874|NCT01077856|12058941|FG001|NOT COMPLETED|Overall Study||0
10892875|NCT01077856|12058942|FG002|NOT COMPLETED|Overall Study||0
10892876|NCT01065454|12058986|FG000|STARTED|Treatment||67
10892877|NCT01065454|12058987|FG001|STARTED|Treatment||33
10892878|NCT01065454|12058988|FG002|STARTED|Treatment||32
10892879|NCT01065454|12058989|FG003|STARTED|Treatment||69
10892880|NCT01065454|12058986|FG000|COMPLETED|Treatment||54
10892881|NCT01065454|12058987|FG001|COMPLETED|Treatment||28
10892882|NCT01065454|12058988|FG002|COMPLETED|Treatment||23
10892883|NCT01065454|12058989|FG003|COMPLETED|Treatment||57
10892884|NCT01065454|12058986|FG000|NOT COMPLETED|Treatment||13
10892885|NCT01065454|12058987|FG001|NOT COMPLETED|Treatment||5
10892886|NCT01065454|12058988|FG002|NOT COMPLETED|Treatment||9
10892887|NCT01065454|12058989|FG003|NOT COMPLETED|Treatment||12
10892888|NCT01065454|12058986|FG000|STARTED|Follow up||54
10892889|NCT01065454|12058987|FG001|STARTED|Follow up||28
10892890|NCT01065454|12058988|FG002|STARTED|Follow up||23
10892891|NCT01065454|12058989|FG003|STARTED|Follow up||57
10892892|NCT01065454|12058986|FG000|Entering Follow-up|Follow up||49
10892893|NCT01065454|12058987|FG001|Entering Follow-up|Follow up||27
10892894|NCT01065454|12058988|FG002|Entering Follow-up|Follow up||23
10892895|NCT01065454|12058989|FG003|Entering Follow-up|Follow up||51
10892896|NCT01065454|12058986|FG000|COMPLETED|Follow up||15
10892897|NCT01065454|12058987|FG001|COMPLETED|Follow up||4
10892898|NCT01065454|12058988|FG002|COMPLETED|Follow up||6
10892899|NCT01065454|12058989|FG003|COMPLETED|Follow up||13
10892900|NCT01065454|12058986|FG000|NOT COMPLETED|Follow up||39
10892901|NCT01065454|12058987|FG001|NOT COMPLETED|Follow up||24
10892902|NCT01065454|12058988|FG002|NOT COMPLETED|Follow up||17
10892903|NCT01065454|12058989|FG003|NOT COMPLETED|Follow up||44
10892904|NCT01064648|12059002|FG000|STARTED|Phase I Cohort1: Dose Level 1||7
10892905|NCT01064648|12059003|FG001|STARTED|Phase I Cohort1: Dose Level 1||0
10892906|NCT01064648|12059004|FG002|STARTED|Phase I Cohort1: Dose Level 1||0
10892907|NCT01064648|12059005|FG003|STARTED|Phase I Cohort1: Dose Level 1||0
10892908|NCT01064648|12059002|FG000|COMPLETED|Phase I Cohort1: Dose Level 1||0
10892909|NCT01064648|12059003|FG001|COMPLETED|Phase I Cohort1: Dose Level 1||0
10892910|NCT01064648|12059004|FG002|COMPLETED|Phase I Cohort1: Dose Level 1||0
10892911|NCT01064648|12059005|FG003|COMPLETED|Phase I Cohort1: Dose Level 1||0
10892912|NCT01064648|12059002|FG000|NOT COMPLETED|Phase I Cohort1: Dose Level 1||7
10892913|NCT01064648|12059003|FG001|NOT COMPLETED|Phase I Cohort1: Dose Level 1||0
10892914|NCT01064648|12059004|FG002|NOT COMPLETED|Phase I Cohort1: Dose Level 1||0
10892915|NCT01064648|12059005|FG003|NOT COMPLETED|Phase I Cohort1: Dose Level 1||0
10892916|NCT01064648|12059002|FG000|STARTED|Phase I Cohort 2: Dose Level 2||0
10892917|NCT01064648|12059003|FG001|STARTED|Phase I Cohort 2: Dose Level 2||13
10892918|NCT01064648|12059004|FG002|STARTED|Phase I Cohort 2: Dose Level 2||0
10892919|NCT01064648|12059005|FG003|STARTED|Phase I Cohort 2: Dose Level 2||0
10892920|NCT01064648|12059002|FG000|COMPLETED|Phase I Cohort 2: Dose Level 2||0
10892921|NCT01064648|12059003|FG001|COMPLETED|Phase I Cohort 2: Dose Level 2||0
10892922|NCT01064648|12059004|FG002|COMPLETED|Phase I Cohort 2: Dose Level 2||0
10892923|NCT01064648|12059005|FG003|COMPLETED|Phase I Cohort 2: Dose Level 2||0
10892924|NCT01064648|12059002|FG000|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||0
10892925|NCT01064648|12059003|FG001|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||13
10892926|NCT01064648|12059004|FG002|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||0
10892927|NCT01064648|12059005|FG003|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||0
10892928|NCT01064648|12059002|FG000|STARTED|Phase II||0
10892929|NCT01064648|12059003|FG001|STARTED|Phase II||0
10892930|NCT01064648|12059004|FG002|STARTED|Phase II||49
10892931|NCT01064648|12059005|FG003|STARTED|Phase II||48
10892932|NCT01064648|12059002|FG000|COMPLETED|Phase II||0
10892933|NCT01064648|12059003|FG001|COMPLETED|Phase II||0
10892934|NCT01064648|12059004|FG002|COMPLETED|Phase II||0
10892935|NCT01064648|12059005|FG003|COMPLETED|Phase II||0
10892936|NCT01064648|12059002|FG000|NOT COMPLETED|Phase II||0
10892937|NCT01064648|12059003|FG001|NOT COMPLETED|Phase II||0
10892938|NCT01064648|12059004|FG002|NOT COMPLETED|Phase II||49
10892939|NCT01064648|12059005|FG003|NOT COMPLETED|Phase II||48
10892940|NCT01064479|12059020|FG000|STARTED|Overall Study||60
10892941|NCT01064479|12059021|FG001|STARTED|Overall Study||59
10892942|NCT01064479|12059020|FG000|COMPLETED|Overall Study||45
10892943|NCT01064479|12059021|FG001|COMPLETED|Overall Study||42
10892944|NCT01064479|12059020|FG000|NOT COMPLETED|Overall Study||15
10892945|NCT01064479|12059021|FG001|NOT COMPLETED|Overall Study||17
10892946|NCT01063517|12059029|FG000|STARTED|Overall Study||62
10892947|NCT01063517|12059030|FG001|STARTED|Overall Study||62
10892948|NCT01063517|12059029|FG000|Received Randomised Treatment|Overall Study||61
10892949|NCT01063517|12059030|FG001|Received Randomised Treatment|Overall Study||62
10892950|NCT01063517|12059029|FG000|COMPLETED|Overall Study||4
10892951|NCT01063517|12059030|FG001|COMPLETED|Overall Study||2
10892952|NCT01063517|12059029|FG000|NOT COMPLETED|Overall Study||58
10892953|NCT01063517|12059030|FG001|NOT COMPLETED|Overall Study||60
10892954|NCT01052103|12059038|FG000|STARTED|Overall Study||84
10892955|NCT01052103|12059039|FG001|STARTED|Overall Study||83
10892956|NCT01052103|12059038|FG000|Received at Least 1 Dose of Study Drug|Overall Study||82
10892957|NCT01052103|12059039|FG001|Received at Least 1 Dose of Study Drug|Overall Study||82
10892958|NCT01052103|12059038|FG000|COMPLETED|Overall Study||50
10892959|NCT01052103|12059039|FG001|COMPLETED|Overall Study||60
10892960|NCT01052103|12059038|FG000|NOT COMPLETED|Overall Study||34
10892961|NCT01052103|12059039|FG001|NOT COMPLETED|Overall Study||23
10892962|NCT01046565|12059046|FG000|STARTED|Overall Study||75
10892963|NCT01046565|12059046|FG000|COMPLETED|Overall Study||66
10892964|NCT01046565|12059046|FG000|NOT COMPLETED|Overall Study||9
10892965|NCT01046396|12059055|FG000|STARTED|Overall Study||69
10892966|NCT01046396|12059055|FG000|COMPLETED|Overall Study||64
10892967|NCT01046396|12059055|FG000|NOT COMPLETED|Overall Study||5
10892968|NCT01036087|12059062|FG000|STARTED|Overall Study||40
10892969|NCT01036087|12059062|FG000|COMPLETED|Overall Study||37
10892970|NCT01036087|12059062|FG000|NOT COMPLETED|Overall Study||3
10892971|NCT01026012|12059066|FG000|STARTED|Overall Study||40
10892972|NCT01026012|12059066|FG000|COMPLETED|Overall Study||40
10892973|NCT01026012|12059066|FG000|NOT COMPLETED|Overall Study||0
10892974|NCT01016353|12059072|FG000|STARTED|Overall Study||180
10892975|NCT01016353|12059073|FG001|STARTED|Overall Study||103
10892976|NCT01016353|12059072|FG000|COMPLETED|Overall Study||178
10892977|NCT01016353|12059073|FG001|COMPLETED|Overall Study||102
10892978|NCT01016353|12059072|FG000|NOT COMPLETED|Overall Study||2
10892979|NCT01016353|12059073|FG001|NOT COMPLETED|Overall Study||1
10892980|NCT01015833|12059081|FG000|STARTED|Overall Study||180
10892981|NCT01015833|12059082|FG001|STARTED|Overall Study||176
10892982|NCT01015833|12059081|FG000|COMPLETED|Overall Study||167
10892983|NCT01015833|12059082|FG001|COMPLETED|Overall Study||171
10892984|NCT01015833|12059081|FG000|NOT COMPLETED|Overall Study||13
10892985|NCT01015833|12059082|FG001|NOT COMPLETED|Overall Study||5
10892986|NCT01014936|12059091|FG000|STARTED|Overall Study||42
10892987|NCT01014936|12059092|FG001|STARTED|Overall Study||45
10892988|NCT01014936|12059093|FG002|STARTED|Overall Study||62
10892989|NCT01014936|12059091|FG000|COMPLETED|Overall Study||42
10892990|NCT01014936|12059092|FG001|COMPLETED|Overall Study||45
10892991|NCT01014936|12059093|FG002|COMPLETED|Overall Study||62
10892992|NCT01014936|12059091|FG000|NOT COMPLETED|Overall Study||0
10892993|NCT01014936|12059092|FG001|NOT COMPLETED|Overall Study||0
10892994|NCT01014936|12059093|FG002|NOT COMPLETED|Overall Study||0
10892995|NCT01005745|12059159|FG000|STARTED|Overall Study||19
10892996|NCT01005745|12059159|FG000|COMPLETED|Overall Study||13
10892997|NCT01005745|12059159|FG000|NOT COMPLETED|Overall Study||6
10892998|NCT01002820|12059163|FG000|STARTED|Overall Study||11
10892999|NCT01002820|12059163|FG000|COMPLETED|Overall Study||7
10893000|NCT01002820|12059163|FG000|NOT COMPLETED|Overall Study||4
10893001|NCT01001377|12059169|FG000|STARTED|Overall Study||504
10893002|NCT01001377|12059170|FG001|STARTED|Overall Study||506
10893003|NCT01001377|12059169|FG000|Received Treatment|Overall Study||500
10893004|NCT01001377|12059170|FG001|Received Treatment|Overall Study||499
10893005|NCT01001377|12059169|FG000|COMPLETED|Overall Study|Indicates participants continuing in study|78
10893006|NCT01001377|12059170|FG001|COMPLETED|Overall Study|Indicates participants continuing in study|85
10893007|NCT01001377|12059169|FG000|NOT COMPLETED|Overall Study||426
10893008|NCT01001377|12059170|FG001|NOT COMPLETED|Overall Study||421
10893009|NCT00994162|12059178|FG000|STARTED|Overall Study||153
10893010|NCT00994162|12059178|FG000|Participants Receiving Treatment|Overall Study||152
10893011|NCT00994162|12059178|FG000|COMPLETED|Overall Study||125
10893012|NCT00994162|12059178|FG000|NOT COMPLETED|Overall Study||28
10893013|NCT00988637|12059185|FG000|STARTED|Overall Study||70
10893014|NCT00988637|12059186|FG001|STARTED|Overall Study||68
10893015|NCT00988637|12059185|FG000|COMPLETED|Overall Study||67
10893016|NCT00988637|12059186|FG001|COMPLETED|Overall Study||65
10893017|NCT00988637|12059185|FG000|NOT COMPLETED|Overall Study||3
10893018|NCT00988637|12059186|FG001|NOT COMPLETED|Overall Study||3
10893019|NCT00980538|12059192|FG000|STARTED|Overall Study||180
10893020|NCT00980538|12059192|FG000|COMPLETED|Overall Study||0
10893021|NCT00980538|12059192|FG000|NOT COMPLETED|Overall Study||180
10893022|NCT00980460|12059201|FG000|STARTED|Overall Study||8
10893023|NCT00980460|12059202|FG001|STARTED|Overall Study||51
10893024|NCT00980460|12059203|FG002|STARTED|Overall Study||105
10893025|NCT00980460|12059204|FG003|STARTED|Overall Study||32
10893026|NCT00980460|12059205|FG004|STARTED|Overall Study||40
10893027|NCT00980460|12059201|FG000|COMPLETED|Overall Study||8
10893028|NCT00980460|12059202|FG001|COMPLETED|Overall Study||47
10893029|NCT00980460|12059203|FG002|COMPLETED|Overall Study||70
10893030|NCT00980460|12059204|FG003|COMPLETED|Overall Study||14
10893031|NCT00980460|12059205|FG004|COMPLETED|Overall Study||24
10893032|NCT00980460|12059201|FG000|NOT COMPLETED|Overall Study||0
10893033|NCT00980460|12059202|FG001|NOT COMPLETED|Overall Study||4
10893034|NCT00980460|12059203|FG002|NOT COMPLETED|Overall Study||35
10893035|NCT00980460|12059204|FG003|NOT COMPLETED|Overall Study||18
10893036|NCT00980460|12059205|FG004|NOT COMPLETED|Overall Study||16
10893037|NCT00978562|12059224|FG000|STARTED|Overall Study||14
10893038|NCT00978562|12059224|FG000|COMPLETED|Overall Study||12
10893039|NCT00978562|12059224|FG000|NOT COMPLETED|Overall Study||2
10893040|NCT00977574|12059233|FG000|STARTED|Overall Study||116
10893041|NCT00977574|12059234|FG001|STARTED|Overall Study||115
10893042|NCT00977574|12059235|FG002|STARTED|Overall Study||118
10893043|NCT00977574|12059233|FG000|COMPLETED|Overall Study||112
10893044|NCT00977574|12059234|FG001|COMPLETED|Overall Study||113
10893045|NCT00977574|12059235|FG002|COMPLETED|Overall Study||114
10893046|NCT00977574|12059233|FG000|NOT COMPLETED|Overall Study||4
10893047|NCT00977574|12059234|FG001|NOT COMPLETED|Overall Study||2
10893048|NCT00977574|12059235|FG002|NOT COMPLETED|Overall Study||4
10893049|NCT00972478|12059245|FG000|STARTED|Overall Study||11
10893050|NCT00972478|12059246|FG001|STARTED|Overall Study||72
10893051|NCT00972478|12059245|FG000|Eligible and Began Protocol Therapy|Overall Study||9
10893052|NCT00972478|12059246|FG001|Eligible and Began Protocol Therapy|Overall Study||63
10893053|NCT00972478|12059245|FG000|COMPLETED|Overall Study||4
10893054|NCT00972478|12059246|FG001|COMPLETED|Overall Study||34
10893055|NCT00972478|12059245|FG000|NOT COMPLETED|Overall Study||7
10893056|NCT00972478|12059246|FG001|NOT COMPLETED|Overall Study||38
10893057|NCT00972179|12059260|FG000|STARTED|Overall Study||6
10893058|NCT00972179|12059261|FG001|STARTED|Overall Study||6
10893059|NCT00972179|12059262|FG002|STARTED|Overall Study||6
10893060|NCT00972179|12059263|FG003|STARTED|Overall Study||6
10893061|NCT00972179|12059264|FG004|STARTED|Overall Study||7
10893062|NCT00972179|12059265|FG005|STARTED|Overall Study||6
10893063|NCT00972179|12059266|FG006|STARTED|Overall Study||12
10893064|NCT00972179|12059260|FG000|COMPLETED|Overall Study||5
10893065|NCT00972179|12059261|FG001|COMPLETED|Overall Study||3
10893066|NCT00972179|12059262|FG002|COMPLETED|Overall Study||5
10893067|NCT00972179|12059263|FG003|COMPLETED|Overall Study||5
10893068|NCT00972179|12059264|FG004|COMPLETED|Overall Study||5
10893069|NCT00972179|12059265|FG005|COMPLETED|Overall Study||3
10893070|NCT00972179|12059266|FG006|COMPLETED|Overall Study||8
10893071|NCT00972179|12059260|FG000|NOT COMPLETED|Overall Study||1
10893072|NCT00972179|12059261|FG001|NOT COMPLETED|Overall Study||3
10893073|NCT00972179|12059262|FG002|NOT COMPLETED|Overall Study||1
10893074|NCT00972179|12059263|FG003|NOT COMPLETED|Overall Study||1
10893075|NCT00972179|12059264|FG004|NOT COMPLETED|Overall Study||2
10893076|NCT00972179|12059265|FG005|NOT COMPLETED|Overall Study||3
10893077|NCT00972179|12059266|FG006|NOT COMPLETED|Overall Study||4
10893078|NCT00970684|12059286|FG000|STARTED|Overall Study||13
10893079|NCT00970684|12059286|FG000|COMPLETED|Overall Study||3
10893080|NCT00970684|12059286|FG000|NOT COMPLETED|Overall Study||10
10893081|NCT00961064|12059290|FG000|STARTED|Initial Treatment (Weeks 1 - 20)||30
10893082|NCT00961064|12059290|FG000|COMPLETED|Initial Treatment (Weeks 1 - 20)||14
10893083|NCT00961064|12059290|FG000|NOT COMPLETED|Initial Treatment (Weeks 1 - 20)||16
10893084|NCT00961064|12059290|FG000|STARTED|Extended Access: Week 20 to Up to Year 5||14
10893085|NCT00961064|12059290|FG000|COMPLETED|Extended Access: Week 20 to Up to Year 5||7
10893086|NCT00961064|12059290|FG000|NOT COMPLETED|Extended Access: Week 20 to Up to Year 5||7
10893087|NCT00951080|12059296|FG000|STARTED|Overall Study||64
10893088|NCT00951080|12059297|FG001|STARTED|Overall Study||68
10893089|NCT00951080|12059296|FG000|COMPLETED|Overall Study||38
10893090|NCT00951080|12059297|FG001|COMPLETED|Overall Study||41
10893091|NCT00951080|12059296|FG000|NOT COMPLETED|Overall Study||26
10893092|NCT00951080|12059297|FG001|NOT COMPLETED|Overall Study||27
10893093|NCT00942331|12059305|FG000|STARTED|Overall Study||252
10893094|NCT00942331|12059306|FG001|STARTED|Overall Study||254
10893095|NCT00942331|12059305|FG000|COMPLETED|Overall Study||237
10893096|NCT00942331|12059306|FG001|COMPLETED|Overall Study||232
10893097|NCT00942331|12059305|FG000|NOT COMPLETED|Overall Study||15
10893098|NCT00942331|12059306|FG001|NOT COMPLETED|Overall Study||22
10893099|NCT00937937|12059312|FG000|STARTED|Overall Study||72
10893100|NCT00937937|12059312|FG000|COMPLETED|Overall Study||0
10893101|NCT00937937|12059312|FG000|NOT COMPLETED|Overall Study||72
10893102|NCT00931268|12059317|FG000|STARTED|Overall Study||10
10893103|NCT00931268|12059317|FG000|COMPLETED|Overall Study||4
10893104|NCT00931268|12059317|FG000|NOT COMPLETED|Overall Study||6
10893105|NCT00907478|12059324|FG000|STARTED|Overall Study||50
10893106|NCT00907478|12059325|FG001|STARTED|Overall Study||50
10893107|NCT00907478|12059326|FG002|STARTED|Overall Study||69
10893108|NCT00907478|12059324|FG000|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|23
10893109|NCT00907478|12059325|FG001|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|33
10893110|NCT00907478|12059326|FG002|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|47
10893111|NCT00907478|12059324|FG000|NOT COMPLETED|Overall Study||27
10893112|NCT00907478|12059325|FG001|NOT COMPLETED|Overall Study||17
10893113|NCT00907478|12059326|FG002|NOT COMPLETED|Overall Study||22
10893114|NCT00907296|12059346|FG000|STARTED|Overall Study||103
10893115|NCT00907296|12059347|FG001|STARTED|Overall Study||34
10893116|NCT00907296|12059348|FG002|STARTED|Overall Study||34
10893117|NCT00907296|12059349|FG003|STARTED|Overall Study||33
10893118|NCT00907296|12059350|FG004|STARTED|Overall Study||33
10893119|NCT00907296|12059351|FG005|STARTED|Overall Study||33
10893120|NCT00907296|12059352|FG006|STARTED|Overall Study||33
10893121|NCT00907296|12059353|FG007|STARTED|Overall Study||33
10893122|NCT00907296|12059354|FG008|STARTED|Overall Study||31
10893123|NCT00907296|12059355|FG009|STARTED|Overall Study||35
10893124|NCT00907296|12059346|FG000|Received Treatment|Overall Study||100
10893125|NCT00907296|12059347|FG001|Received Treatment|Overall Study||34
10893126|NCT00907296|12059348|FG002|Received Treatment|Overall Study||34
10893127|NCT00907296|12059349|FG003|Received Treatment|Overall Study||32
10893128|NCT00907296|12059350|FG004|Received Treatment|Overall Study||33
10893129|NCT00907296|12059351|FG005|Received Treatment|Overall Study||32
10893130|NCT00907296|12059352|FG006|Received Treatment|Overall Study||31
10893131|NCT00907296|12059353|FG007|Received Treatment|Overall Study||32
10893132|NCT00907296|12059354|FG008|Received Treatment|Overall Study||30
10893133|NCT00907296|12059355|FG009|Received Treatment|Overall Study||35
10893134|NCT00907296|12059346|FG000|COMPLETED|Overall Study||83
10893135|NCT00907296|12059347|FG001|COMPLETED|Overall Study||29
10893136|NCT00907296|12059348|FG002|COMPLETED|Overall Study||32
10893137|NCT00907296|12059349|FG003|COMPLETED|Overall Study||29
10893138|NCT00907296|12059350|FG004|COMPLETED|Overall Study||32
10893139|NCT00907296|12059351|FG005|COMPLETED|Overall Study||24
10893140|NCT00907296|12059352|FG006|COMPLETED|Overall Study||27
10893141|NCT00907296|12059353|FG007|COMPLETED|Overall Study||26
10893142|NCT00907296|12059354|FG008|COMPLETED|Overall Study||27
10893143|NCT00907296|12059355|FG009|COMPLETED|Overall Study||28
10893144|NCT00907296|12059346|FG000|NOT COMPLETED|Overall Study||20
10893145|NCT00907296|12059347|FG001|NOT COMPLETED|Overall Study||5
10893146|NCT00907296|12059348|FG002|NOT COMPLETED|Overall Study||2
10893147|NCT00907296|12059349|FG003|NOT COMPLETED|Overall Study||4
10893148|NCT00907296|12059350|FG004|NOT COMPLETED|Overall Study||1
10893149|NCT00907296|12059351|FG005|NOT COMPLETED|Overall Study||9
10893150|NCT00907296|12059352|FG006|NOT COMPLETED|Overall Study||6
10893151|NCT00907296|12059353|FG007|NOT COMPLETED|Overall Study||7
10893152|NCT00907296|12059354|FG008|NOT COMPLETED|Overall Study||4
10893153|NCT00907296|12059355|FG009|NOT COMPLETED|Overall Study||7
10893154|NCT00907101|12059377|FG000|STARTED|Overall Study||30
10893155|NCT00907101|12059377|FG000|COMPLETED|Overall Study||30
10893156|NCT00907101|12059377|FG000|NOT COMPLETED|Overall Study||0
10893157|NCT00896532|12059389|FG000|STARTED|Months 1-24: Romosozumab Treatment Phase||52
10893158|NCT00896532|12059390|FG001|STARTED|Months 1-24: Romosozumab Treatment Phase||51
10893159|NCT00896532|12059391|FG002|STARTED|Months 1-24: Romosozumab Treatment Phase||55
10893160|NCT00896532|12059392|FG003|STARTED|Months 1-24: Romosozumab Treatment Phase||51
10893161|NCT00896532|12059393|FG004|STARTED|Months 1-24: Romosozumab Treatment Phase||54
10893162|NCT00896532|12059394|FG005|STARTED|Months 1-24: Romosozumab Treatment Phase||51
10893163|NCT00896532|12059395|FG006|STARTED|Months 1-24: Romosozumab Treatment Phase||53
10893164|NCT00896532|12059396|FG007|STARTED|Months 1-24: Romosozumab Treatment Phase||52
10893165|NCT00896532|12059397|FG008|STARTED|Months 1-24: Romosozumab Treatment Phase||0
10893166|NCT00896532|12059398|FG009|STARTED|Months 1-24: Romosozumab Treatment Phase||0
10893167|NCT00896532|12059399|FG010|STARTED|Months 1-24: Romosozumab Treatment Phase||0
10893168|NCT00896532|12059400|FG011|STARTED|Months 1-24: Romosozumab Treatment Phase||0
10893169|NCT00896532|12059401|FG012|STARTED|Months 1-24: Romosozumab Treatment Phase||0
10893170|NCT00896532|12059402|FG013|STARTED|Months 1-24: Romosozumab Treatment Phase||0
10893171|NCT00896532|12059403|FG014|STARTED|Months 1-24: Romosozumab Treatment Phase||0
10893172|NCT00896532|12059404|FG015|STARTED|Months 1-24: Romosozumab Treatment Phase||0
10893173|NCT00896532|12059405|FG016|STARTED|Months 1-24: Romosozumab Treatment Phase||0
10893174|NCT00896532|12059406|FG017|STARTED|Months 1-24: Romosozumab Treatment Phase||0
10893175|NCT00896532|12059407|FG018|STARTED|Months 1-24: Romosozumab Treatment Phase||0
10893176|NCT00896532|12059408|FG019|STARTED|Months 1-24: Romosozumab Treatment Phase||0
10893177|NCT00896532|12059409|FG020|STARTED|Months 1-24: Romosozumab Treatment Phase||0
10893178|NCT00896532|12059410|FG021|STARTED|Months 1-24: Romosozumab Treatment Phase||0
10893179|NCT00896532|12059411|FG022|STARTED|Months 1-24: Romosozumab Treatment Phase||0
10893180|NCT00896532|12059389|FG000|Received Treatment|Months 1-24: Romosozumab Treatment Phase|One participant received 1 dose of romosozumab 70 mg in error|51
10893181|NCT00896532|12059390|FG001|Received Treatment|Months 1-24: Romosozumab Treatment Phase||51
10893182|NCT00896532|12059391|FG002|Received Treatment|Months 1-24: Romosozumab Treatment Phase||54
10893183|NCT00896532|12059392|FG003|Received Treatment|Months 1-24: Romosozumab Treatment Phase||49
10893184|NCT00896532|12059393|FG004|Received Treatment|Months 1-24: Romosozumab Treatment Phase||53
10893185|NCT00896532|12059394|FG005|Received Treatment|Months 1-24: Romosozumab Treatment Phase||48
10893186|NCT00896532|12059395|FG006|Received Treatment|Months 1-24: Romosozumab Treatment Phase||53
10893187|NCT00896532|12059396|FG007|Received Treatment|Months 1-24: Romosozumab Treatment Phase||51
10893188|NCT00896532|12059397|FG008|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
10893189|NCT00896532|12059398|FG009|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
10893190|NCT00896532|12059399|FG010|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
10893191|NCT00896532|12059400|FG011|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
10893192|NCT00896532|12059401|FG012|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
10893193|NCT00896532|12059402|FG013|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
10893194|NCT00896532|12059403|FG014|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
10893195|NCT00896532|12059404|FG015|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
10893196|NCT00896532|12059405|FG016|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
10893197|NCT00896532|12059406|FG017|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
10893198|NCT00896532|12059407|FG018|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
10893199|NCT00896532|12059408|FG019|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
10893200|NCT00896532|12059409|FG020|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
10893201|NCT00896532|12059410|FG021|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
10893202|NCT00896532|12059411|FG022|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
10893203|NCT00896532|12059389|FG000|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||47
10893204|NCT00896532|12059390|FG001|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||49
10893205|NCT00896532|12059391|FG002|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||46
10893206|NCT00896532|12059392|FG003|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||45
10893207|NCT00896532|12059393|FG004|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||50
10893208|NCT00896532|12059394|FG005|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||46
10893209|NCT00896532|12059395|FG006|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||51
10893210|NCT00896532|12059396|FG007|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||49
10893211|NCT00896532|12059397|FG008|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
10893212|NCT00896532|12059398|FG009|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
10893213|NCT00896532|12059399|FG010|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
10893214|NCT00896532|12059400|FG011|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
10893215|NCT00896532|12059401|FG012|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
10893216|NCT00896532|12059402|FG013|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
10893217|NCT00896532|12059403|FG014|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
10893218|NCT00896532|12059404|FG015|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
10893219|NCT00896532|12059405|FG016|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
10893220|NCT00896532|12059406|FG017|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
10893221|NCT00896532|12059407|FG018|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
10893222|NCT00896532|12059408|FG019|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
10893223|NCT00896532|12059409|FG020|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
10893224|NCT00896532|12059410|FG021|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
10893225|NCT00896532|12059411|FG022|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
10893226|NCT00896532|12059389|FG000|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46
10893227|NCT00896532|12059390|FG001|COMPLETED|Months 1-24: Romosozumab Treatment Phase||45
10893228|NCT00896532|12059391|FG002|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46
10893229|NCT00896532|12059392|FG003|COMPLETED|Months 1-24: Romosozumab Treatment Phase||39
10893230|NCT00896532|12059393|FG004|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46
10893231|NCT00896532|12059394|FG005|COMPLETED|Months 1-24: Romosozumab Treatment Phase||43
10893232|NCT00896532|12059395|FG006|COMPLETED|Months 1-24: Romosozumab Treatment Phase||48
10893233|NCT00896532|12059396|FG007|COMPLETED|Months 1-24: Romosozumab Treatment Phase||48
10893234|NCT00896532|12059397|FG008|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893235|NCT00896532|12059398|FG009|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893236|NCT00896532|12059399|FG010|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893237|NCT00896532|12059400|FG011|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893238|NCT00896532|12059401|FG012|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893239|NCT00896532|12059402|FG013|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893240|NCT00896532|12059403|FG014|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893241|NCT00896532|12059404|FG015|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893242|NCT00896532|12059405|FG016|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893243|NCT00896532|12059406|FG017|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893244|NCT00896532|12059407|FG018|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893245|NCT00896532|12059408|FG019|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893246|NCT00896532|12059409|FG020|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893247|NCT00896532|12059410|FG021|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893248|NCT00896532|12059411|FG022|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893249|NCT00896532|12059389|FG000|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||6
10893250|NCT00896532|12059390|FG001|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||6
10893251|NCT00896532|12059391|FG002|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||9
10893252|NCT00896532|12059392|FG003|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||12
10893253|NCT00896532|12059393|FG004|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||8
10893254|NCT00896532|12059394|FG005|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||8
10893255|NCT00896532|12059395|FG006|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||5
10893256|NCT00896532|12059396|FG007|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||4
10893257|NCT00896532|12059397|FG008|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893258|NCT00896532|12059398|FG009|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893259|NCT00896532|12059399|FG010|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893260|NCT00896532|12059400|FG011|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893261|NCT00896532|12059401|FG012|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893262|NCT00896532|12059402|FG013|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893263|NCT00896532|12059403|FG014|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893264|NCT00896532|12059404|FG015|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893265|NCT00896532|12059405|FG016|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893266|NCT00896532|12059406|FG017|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893267|NCT00896532|12059407|FG018|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893268|NCT00896532|12059408|FG019|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893269|NCT00896532|12059409|FG020|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893270|NCT00896532|12059410|FG021|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893271|NCT00896532|12059411|FG022|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893272|NCT00896532|12059389|FG000|STARTED|Months 24-36: Denosumab Extension Phase||0
10893273|NCT00896532|12059390|FG001|STARTED|Months 24-36: Denosumab Extension Phase||0
10893274|NCT00896532|12059391|FG002|STARTED|Months 24-36: Denosumab Extension Phase||0
10893275|NCT00896532|12059392|FG003|STARTED|Months 24-36: Denosumab Extension Phase||0
10893276|NCT00896532|12059393|FG004|STARTED|Months 24-36: Denosumab Extension Phase||0
10893277|NCT00896532|12059394|FG005|STARTED|Months 24-36: Denosumab Extension Phase||0
10893278|NCT00896532|12059395|FG006|STARTED|Months 24-36: Denosumab Extension Phase||0
10893279|NCT00896532|12059396|FG007|STARTED|Months 24-36: Denosumab Extension Phase||0
10893280|NCT00896532|12059397|FG008|STARTED|Months 24-36: Denosumab Extension Phase||18
10893281|NCT00896532|12059398|FG009|STARTED|Months 24-36: Denosumab Extension Phase||18
10893282|NCT00896532|12059399|FG010|STARTED|Months 24-36: Denosumab Extension Phase||20
10893283|NCT00896532|12059400|FG011|STARTED|Months 24-36: Denosumab Extension Phase||21
10893284|NCT00896532|12059401|FG012|STARTED|Months 24-36: Denosumab Extension Phase||93
10893285|NCT00896532|12059402|FG013|STARTED|Months 24-36: Denosumab Extension Phase||90
10893286|NCT00896532|12059403|FG014|STARTED|Months 24-36: Denosumab Extension Phase||0
10893287|NCT00896532|12059404|FG015|STARTED|Months 24-36: Denosumab Extension Phase||0
10893288|NCT00896532|12059405|FG016|STARTED|Months 24-36: Denosumab Extension Phase||0
10893289|NCT00896532|12059406|FG017|STARTED|Months 24-36: Denosumab Extension Phase||0
10893290|NCT00896532|12059407|FG018|STARTED|Months 24-36: Denosumab Extension Phase||0
10893291|NCT00896532|12059408|FG019|STARTED|Months 24-36: Denosumab Extension Phase||0
10893292|NCT00896532|12059409|FG020|STARTED|Months 24-36: Denosumab Extension Phase||0
10893293|NCT00896532|12059410|FG021|STARTED|Months 24-36: Denosumab Extension Phase||0
10893294|NCT00896532|12059411|FG022|STARTED|Months 24-36: Denosumab Extension Phase||0
10893295|NCT00896532|12059389|FG000|Received Treatment|Months 24-36: Denosumab Extension Phase||0
10893296|NCT00896532|12059390|FG001|Received Treatment|Months 24-36: Denosumab Extension Phase||0
10893297|NCT00896532|12059391|FG002|Received Treatment|Months 24-36: Denosumab Extension Phase||0
10893298|NCT00896532|12059392|FG003|Received Treatment|Months 24-36: Denosumab Extension Phase||0
10893299|NCT00896532|12059393|FG004|Received Treatment|Months 24-36: Denosumab Extension Phase||0
10893300|NCT00896532|12059394|FG005|Received Treatment|Months 24-36: Denosumab Extension Phase||0
10893301|NCT00896532|12059395|FG006|Received Treatment|Months 24-36: Denosumab Extension Phase||0
10893302|NCT00896532|12059396|FG007|Received Treatment|Months 24-36: Denosumab Extension Phase||0
10893303|NCT00896532|12059397|FG008|Received Treatment|Months 24-36: Denosumab Extension Phase||18
10893304|NCT00896532|12059398|FG009|Received Treatment|Months 24-36: Denosumab Extension Phase|Includes one participant who received 1 dose of romosozumab 70 mg in error in first 12 months|18
10893305|NCT00896532|12059399|FG010|Received Treatment|Months 24-36: Denosumab Extension Phase||19
10893306|NCT00896532|12059400|FG011|Received Treatment|Months 24-36: Denosumab Extension Phase||19
10893307|NCT00896532|12059401|FG012|Received Treatment|Months 24-36: Denosumab Extension Phase||90
10893308|NCT00896532|12059402|FG013|Received Treatment|Months 24-36: Denosumab Extension Phase||88
10893309|NCT00896532|12059403|FG014|Received Treatment|Months 24-36: Denosumab Extension Phase||0
10893310|NCT00896532|12059404|FG015|Received Treatment|Months 24-36: Denosumab Extension Phase||0
10893311|NCT00896532|12059405|FG016|Received Treatment|Months 24-36: Denosumab Extension Phase||0
10893312|NCT00896532|12059406|FG017|Received Treatment|Months 24-36: Denosumab Extension Phase||0
10893313|NCT00896532|12059407|FG018|Received Treatment|Months 24-36: Denosumab Extension Phase||0
10893314|NCT00896532|12059408|FG019|Received Treatment|Months 24-36: Denosumab Extension Phase||0
10893315|NCT00896532|12059409|FG020|Received Treatment|Months 24-36: Denosumab Extension Phase||0
10893316|NCT00896532|12059410|FG021|Received Treatment|Months 24-36: Denosumab Extension Phase||0
10893317|NCT00896532|12059411|FG022|Received Treatment|Months 24-36: Denosumab Extension Phase||0
10893318|NCT00896532|12059389|FG000|COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893319|NCT00896532|12059390|FG001|COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893320|NCT00896532|12059391|FG002|COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893321|NCT00896532|12059392|FG003|COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893322|NCT00896532|12059393|FG004|COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893323|NCT00896532|12059394|FG005|COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893324|NCT00896532|12059395|FG006|COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893325|NCT00896532|12059396|FG007|COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893326|NCT00896532|12059397|FG008|COMPLETED|Months 24-36: Denosumab Extension Phase||17
10893327|NCT00896532|12059398|FG009|COMPLETED|Months 24-36: Denosumab Extension Phase||18
10893328|NCT00896532|12059399|FG010|COMPLETED|Months 24-36: Denosumab Extension Phase||18
10893329|NCT00896532|12059400|FG011|COMPLETED|Months 24-36: Denosumab Extension Phase||19
10893330|NCT00896532|12059401|FG012|COMPLETED|Months 24-36: Denosumab Extension Phase||88
10893331|NCT00896532|12059402|FG013|COMPLETED|Months 24-36: Denosumab Extension Phase||88
10893332|NCT00896532|12059403|FG014|COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893333|NCT00896532|12059404|FG015|COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893334|NCT00896532|12059405|FG016|COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893335|NCT00896532|12059406|FG017|COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893336|NCT00896532|12059407|FG018|COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893337|NCT00896532|12059408|FG019|COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893338|NCT00896532|12059409|FG020|COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893339|NCT00896532|12059410|FG021|COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893340|NCT00896532|12059411|FG022|COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893341|NCT00896532|12059389|FG000|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893342|NCT00896532|12059390|FG001|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893343|NCT00896532|12059391|FG002|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893344|NCT00896532|12059392|FG003|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893345|NCT00896532|12059393|FG004|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893346|NCT00896532|12059394|FG005|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893347|NCT00896532|12059395|FG006|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893348|NCT00896532|12059396|FG007|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893349|NCT00896532|12059397|FG008|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||1
10893350|NCT00896532|12059398|FG009|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893351|NCT00896532|12059399|FG010|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2
10893352|NCT00896532|12059400|FG011|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2
10893353|NCT00896532|12059401|FG012|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||5
10893354|NCT00896532|12059402|FG013|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2
10893355|NCT00896532|12059403|FG014|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893356|NCT00896532|12059404|FG015|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893357|NCT00896532|12059405|FG016|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893358|NCT00896532|12059406|FG017|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893359|NCT00896532|12059407|FG018|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893360|NCT00896532|12059408|FG019|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893361|NCT00896532|12059409|FG020|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893362|NCT00896532|12059410|FG021|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893363|NCT00896532|12059411|FG022|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893364|NCT00896532|12059389|FG000|STARTED|Months 36-48: Romosozumab Retreatment||0
10893365|NCT00896532|12059390|FG001|STARTED|Months 36-48: Romosozumab Retreatment||0
10893366|NCT00896532|12059391|FG002|STARTED|Months 36-48: Romosozumab Retreatment||0
10893367|NCT00896532|12059392|FG003|STARTED|Months 36-48: Romosozumab Retreatment||0
10893368|NCT00896532|12059393|FG004|STARTED|Months 36-48: Romosozumab Retreatment||0
10893369|NCT00896532|12059394|FG005|STARTED|Months 36-48: Romosozumab Retreatment||0
10893370|NCT00896532|12059395|FG006|STARTED|Months 36-48: Romosozumab Retreatment||0
10893371|NCT00896532|12059396|FG007|STARTED|Months 36-48: Romosozumab Retreatment||0
10893372|NCT00896532|12059397|FG008|STARTED|Months 36-48: Romosozumab Retreatment||0
10893373|NCT00896532|12059398|FG009|STARTED|Months 36-48: Romosozumab Retreatment||0
10893374|NCT00896532|12059399|FG010|STARTED|Months 36-48: Romosozumab Retreatment||0
10893375|NCT00896532|12059400|FG011|STARTED|Months 36-48: Romosozumab Retreatment||0
10893376|NCT00896532|12059401|FG012|STARTED|Months 36-48: Romosozumab Retreatment||0
10893377|NCT00896532|12059402|FG013|STARTED|Months 36-48: Romosozumab Retreatment||0
10893378|NCT00896532|12059403|FG014|STARTED|Months 36-48: Romosozumab Retreatment||12
10893379|NCT00896532|12059404|FG015|STARTED|Months 36-48: Romosozumab Retreatment||16
10893380|NCT00896532|12059405|FG016|STARTED|Months 36-48: Romosozumab Retreatment||72
10893381|NCT00896532|12059406|FG017|STARTED|Months 36-48: Romosozumab Retreatment||67
10893382|NCT00896532|12059407|FG018|STARTED|Months 36-48: Romosozumab Retreatment||0
10893383|NCT00896532|12059408|FG019|STARTED|Months 36-48: Romosozumab Retreatment||0
10893384|NCT00896532|12059409|FG020|STARTED|Months 36-48: Romosozumab Retreatment||0
10893385|NCT00896532|12059410|FG021|STARTED|Months 36-48: Romosozumab Retreatment||0
10893386|NCT00896532|12059411|FG022|STARTED|Months 36-48: Romosozumab Retreatment||0
10893387|NCT00896532|12059389|FG000|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
10893388|NCT00896532|12059390|FG001|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
10893389|NCT00896532|12059391|FG002|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
10893390|NCT00896532|12059392|FG003|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
10893391|NCT00896532|12059393|FG004|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
10893392|NCT00896532|12059394|FG005|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
10893393|NCT00896532|12059395|FG006|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
10893394|NCT00896532|12059396|FG007|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
10893395|NCT00896532|12059397|FG008|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
10893396|NCT00896532|12059398|FG009|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
10893397|NCT00896532|12059399|FG010|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
10893398|NCT00896532|12059400|FG011|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
10893399|NCT00896532|12059401|FG012|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
10893400|NCT00896532|12059402|FG013|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
10893401|NCT00896532|12059403|FG014|Received Romosozumab|Months 36-48: Romosozumab Retreatment||12
10893402|NCT00896532|12059404|FG015|Received Romosozumab|Months 36-48: Romosozumab Retreatment|Includes one participant who received 1 dose of romosozumab 70 mg in error in first 12 months|16
10893403|NCT00896532|12059405|FG016|Received Romosozumab|Months 36-48: Romosozumab Retreatment||72
10893404|NCT00896532|12059406|FG017|Received Romosozumab|Months 36-48: Romosozumab Retreatment||67
10893405|NCT00896532|12059407|FG018|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
10893406|NCT00896532|12059408|FG019|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
10893407|NCT00896532|12059409|FG020|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
10893561|NCT00881868|12059484|FG001|STARTED|Overall Study||40
10893408|NCT00896532|12059410|FG021|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
10893409|NCT00896532|12059411|FG022|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
10893410|NCT00896532|12059389|FG000|COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893411|NCT00896532|12059390|FG001|COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893412|NCT00896532|12059391|FG002|COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893413|NCT00896532|12059392|FG003|COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893414|NCT00896532|12059393|FG004|COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893415|NCT00896532|12059394|FG005|COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893416|NCT00896532|12059395|FG006|COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893417|NCT00896532|12059396|FG007|COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893418|NCT00896532|12059397|FG008|COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893419|NCT00896532|12059398|FG009|COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893420|NCT00896532|12059399|FG010|COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893421|NCT00896532|12059400|FG011|COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893422|NCT00896532|12059401|FG012|COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893423|NCT00896532|12059402|FG013|COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893424|NCT00896532|12059403|FG014|COMPLETED|Months 36-48: Romosozumab Retreatment||12
10893425|NCT00896532|12059404|FG015|COMPLETED|Months 36-48: Romosozumab Retreatment||14
10893426|NCT00896532|12059405|FG016|COMPLETED|Months 36-48: Romosozumab Retreatment||65
10893427|NCT00896532|12059406|FG017|COMPLETED|Months 36-48: Romosozumab Retreatment||64
10893428|NCT00896532|12059407|FG018|COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893429|NCT00896532|12059408|FG019|COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893430|NCT00896532|12059409|FG020|COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893431|NCT00896532|12059410|FG021|COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893432|NCT00896532|12059411|FG022|COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893433|NCT00896532|12059389|FG000|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893434|NCT00896532|12059390|FG001|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893435|NCT00896532|12059391|FG002|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893436|NCT00896532|12059392|FG003|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893437|NCT00896532|12059393|FG004|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893438|NCT00896532|12059394|FG005|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893439|NCT00896532|12059395|FG006|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893440|NCT00896532|12059396|FG007|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893441|NCT00896532|12059397|FG008|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893442|NCT00896532|12059398|FG009|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893443|NCT00896532|12059399|FG010|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893444|NCT00896532|12059400|FG011|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893445|NCT00896532|12059401|FG012|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893446|NCT00896532|12059402|FG013|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893447|NCT00896532|12059403|FG014|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893448|NCT00896532|12059404|FG015|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||2
10893449|NCT00896532|12059405|FG016|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||7
10893450|NCT00896532|12059406|FG017|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||3
10893451|NCT00896532|12059407|FG018|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893452|NCT00896532|12059408|FG019|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893453|NCT00896532|12059409|FG020|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893454|NCT00896532|12059410|FG021|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893455|NCT00896532|12059411|FG022|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893456|NCT00896532|12059389|FG000|STARTED|Months 48-72: Follow-on Phase||0
10893457|NCT00896532|12059390|FG001|STARTED|Months 48-72: Follow-on Phase||0
10893458|NCT00896532|12059391|FG002|STARTED|Months 48-72: Follow-on Phase||0
10893459|NCT00896532|12059392|FG003|STARTED|Months 48-72: Follow-on Phase||0
10893460|NCT00896532|12059393|FG004|STARTED|Months 48-72: Follow-on Phase||0
10893461|NCT00896532|12059394|FG005|STARTED|Months 48-72: Follow-on Phase||0
10893462|NCT00896532|12059395|FG006|STARTED|Months 48-72: Follow-on Phase||0
10893463|NCT00896532|12059396|FG007|STARTED|Months 48-72: Follow-on Phase||0
10893464|NCT00896532|12059397|FG008|STARTED|Months 48-72: Follow-on Phase||0
10893465|NCT00896532|12059398|FG009|STARTED|Months 48-72: Follow-on Phase||0
10893466|NCT00896532|12059399|FG010|STARTED|Months 48-72: Follow-on Phase||0
10893467|NCT00896532|12059400|FG011|STARTED|Months 48-72: Follow-on Phase||0
10893468|NCT00896532|12059401|FG012|STARTED|Months 48-72: Follow-on Phase||0
10893469|NCT00896532|12059402|FG013|STARTED|Months 48-72: Follow-on Phase||0
10893470|NCT00896532|12059403|FG014|STARTED|Months 48-72: Follow-on Phase||0
10893471|NCT00896532|12059404|FG015|STARTED|Months 48-72: Follow-on Phase||0
10893472|NCT00896532|12059405|FG016|STARTED|Months 48-72: Follow-on Phase||0
10893473|NCT00896532|12059406|FG017|STARTED|Months 48-72: Follow-on Phase||0
10893474|NCT00896532|12059407|FG018|STARTED|Months 48-72: Follow-on Phase||51
10893475|NCT00896532|12059408|FG019|STARTED|Months 48-72: Follow-on Phase||11
10893476|NCT00896532|12059409|FG020|STARTED|Months 48-72: Follow-on Phase||12
10893477|NCT00896532|12059410|FG021|STARTED|Months 48-72: Follow-on Phase||59
10893478|NCT00896532|12059411|FG022|STARTED|Months 48-72: Follow-on Phase||8
10893479|NCT00896532|12059389|FG000|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
10893480|NCT00896532|12059390|FG001|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
10893481|NCT00896532|12059391|FG002|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
10893482|NCT00896532|12059392|FG003|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
10893483|NCT00896532|12059393|FG004|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
10893484|NCT00896532|12059394|FG005|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
10893485|NCT00896532|12059395|FG006|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
10893486|NCT00896532|12059396|FG007|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
10893487|NCT00896532|12059397|FG008|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
10893488|NCT00896532|12059398|FG009|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
10893489|NCT00896532|12059399|FG010|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
10893490|NCT00896532|12059400|FG011|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
10893491|NCT00896532|12059401|FG012|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
10893492|NCT00896532|12059402|FG013|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
10893493|NCT00896532|12059403|FG014|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
10893494|NCT00896532|12059404|FG015|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
10893495|NCT00896532|12059405|FG016|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
10893496|NCT00896532|12059406|FG017|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
10893497|NCT00896532|12059407|FG018|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
10893498|NCT00896532|12059408|FG019|Received Zoledronic Acid|Months 48-72: Follow-on Phase||11
10893499|NCT00896532|12059409|FG020|Received Zoledronic Acid|Months 48-72: Follow-on Phase||12
10893500|NCT00896532|12059410|FG021|Received Zoledronic Acid|Months 48-72: Follow-on Phase||56
10893501|NCT00896532|12059411|FG022|Received Zoledronic Acid|Months 48-72: Follow-on Phase||8
10893502|NCT00896532|12059389|FG000|COMPLETED|Months 48-72: Follow-on Phase||0
10893503|NCT00896532|12059390|FG001|COMPLETED|Months 48-72: Follow-on Phase||0
10893504|NCT00896532|12059391|FG002|COMPLETED|Months 48-72: Follow-on Phase||0
10893505|NCT00896532|12059392|FG003|COMPLETED|Months 48-72: Follow-on Phase||0
10893506|NCT00896532|12059393|FG004|COMPLETED|Months 48-72: Follow-on Phase||0
10893507|NCT00896532|12059394|FG005|COMPLETED|Months 48-72: Follow-on Phase||0
10893508|NCT00896532|12059395|FG006|COMPLETED|Months 48-72: Follow-on Phase||0
10893509|NCT00896532|12059396|FG007|COMPLETED|Months 48-72: Follow-on Phase||0
10893510|NCT00896532|12059397|FG008|COMPLETED|Months 48-72: Follow-on Phase||0
10893511|NCT00896532|12059398|FG009|COMPLETED|Months 48-72: Follow-on Phase||0
10893512|NCT00896532|12059399|FG010|COMPLETED|Months 48-72: Follow-on Phase||0
10893513|NCT00896532|12059400|FG011|COMPLETED|Months 48-72: Follow-on Phase||0
10893514|NCT00896532|12059401|FG012|COMPLETED|Months 48-72: Follow-on Phase||0
10893515|NCT00896532|12059402|FG013|COMPLETED|Months 48-72: Follow-on Phase||0
10893516|NCT00896532|12059403|FG014|COMPLETED|Months 48-72: Follow-on Phase||0
10893517|NCT00896532|12059404|FG015|COMPLETED|Months 48-72: Follow-on Phase||0
10893518|NCT00896532|12059405|FG016|COMPLETED|Months 48-72: Follow-on Phase||0
10893519|NCT00896532|12059406|FG017|COMPLETED|Months 48-72: Follow-on Phase||0
10893520|NCT00896532|12059407|FG018|COMPLETED|Months 48-72: Follow-on Phase||50
10893521|NCT00896532|12059408|FG019|COMPLETED|Months 48-72: Follow-on Phase||11
10893522|NCT00896532|12059409|FG020|COMPLETED|Months 48-72: Follow-on Phase||12
10893523|NCT00896532|12059410|FG021|COMPLETED|Months 48-72: Follow-on Phase||57
10893524|NCT00896532|12059411|FG022|COMPLETED|Months 48-72: Follow-on Phase||8
10893525|NCT00896532|12059389|FG000|NOT COMPLETED|Months 48-72: Follow-on Phase||0
10893526|NCT00896532|12059390|FG001|NOT COMPLETED|Months 48-72: Follow-on Phase||0
10893527|NCT00896532|12059391|FG002|NOT COMPLETED|Months 48-72: Follow-on Phase||0
10893528|NCT00896532|12059392|FG003|NOT COMPLETED|Months 48-72: Follow-on Phase||0
10893529|NCT00896532|12059393|FG004|NOT COMPLETED|Months 48-72: Follow-on Phase||0
10893530|NCT00896532|12059394|FG005|NOT COMPLETED|Months 48-72: Follow-on Phase||0
10893531|NCT00896532|12059395|FG006|NOT COMPLETED|Months 48-72: Follow-on Phase||0
10893532|NCT00896532|12059396|FG007|NOT COMPLETED|Months 48-72: Follow-on Phase||0
10893533|NCT00896532|12059397|FG008|NOT COMPLETED|Months 48-72: Follow-on Phase||0
10893534|NCT00896532|12059398|FG009|NOT COMPLETED|Months 48-72: Follow-on Phase||0
10893535|NCT00896532|12059399|FG010|NOT COMPLETED|Months 48-72: Follow-on Phase||0
10893536|NCT00896532|12059400|FG011|NOT COMPLETED|Months 48-72: Follow-on Phase||0
10893537|NCT00896532|12059401|FG012|NOT COMPLETED|Months 48-72: Follow-on Phase||0
10893538|NCT00896532|12059402|FG013|NOT COMPLETED|Months 48-72: Follow-on Phase||0
10893539|NCT00896532|12059403|FG014|NOT COMPLETED|Months 48-72: Follow-on Phase||0
10893540|NCT00896532|12059404|FG015|NOT COMPLETED|Months 48-72: Follow-on Phase||0
10893541|NCT00896532|12059405|FG016|NOT COMPLETED|Months 48-72: Follow-on Phase||0
10893542|NCT00896532|12059406|FG017|NOT COMPLETED|Months 48-72: Follow-on Phase||0
10893543|NCT00896532|12059407|FG018|NOT COMPLETED|Months 48-72: Follow-on Phase||1
10893544|NCT00896532|12059408|FG019|NOT COMPLETED|Months 48-72: Follow-on Phase||0
10893545|NCT00896532|12059409|FG020|NOT COMPLETED|Months 48-72: Follow-on Phase||0
10893546|NCT00896532|12059410|FG021|NOT COMPLETED|Months 48-72: Follow-on Phase||2
10893547|NCT00896532|12059411|FG022|NOT COMPLETED|Months 48-72: Follow-on Phase||0
10893548|NCT00892281|12059460|FG000|STARTED|Overall Study||1197
10893549|NCT00892281|12059461|FG001|STARTED|Overall Study||224
10893550|NCT00892281|12059460|FG000|COMPLETED|Overall Study||930
10893551|NCT00892281|12059461|FG001|COMPLETED|Overall Study||187
10893552|NCT00892281|12059460|FG000|NOT COMPLETED|Overall Study||267
10893553|NCT00892281|12059461|FG001|NOT COMPLETED|Overall Study||37
10893554|NCT00888290|12059467|FG000|STARTED|Overall Study||20
10893555|NCT00888290|12059467|FG000|COMPLETED|Overall Study||20
10893556|NCT00888290|12059467|FG000|NOT COMPLETED|Overall Study||0
10893557|NCT00885664|12059475|FG000|STARTED|Overall Study||60
10893558|NCT00885664|12059475|FG000|COMPLETED|Overall Study||48
10893559|NCT00885664|12059475|FG000|NOT COMPLETED|Overall Study||12
10893560|NCT00881868|12059483|FG000|STARTED|Overall Study||41
10893562|NCT00881868|12059483|FG000|COMPLETED|Overall Study||33
10893563|NCT00881868|12059484|FG001|COMPLETED|Overall Study||38
10893564|NCT00881868|12059483|FG000|NOT COMPLETED|Overall Study||8
10893565|NCT00881868|12059484|FG001|NOT COMPLETED|Overall Study||2
10893566|NCT00866840|12059490|FG000|STARTED|Overall Study||13
10893567|NCT00866840|12059490|FG000|COMPLETED|Overall Study||13
10893568|NCT00866840|12059490|FG000|NOT COMPLETED|Overall Study||0
10893569|NCT00861705|12059498|FG000|STARTED|Overall Study||115
10893570|NCT00861705|12059499|FG001|STARTED|Overall Study||113
10893571|NCT00861705|12059500|FG002|STARTED|Overall Study||113
10893572|NCT00861705|12059501|FG003|STARTED|Overall Study||113
10893573|NCT00861705|12059498|FG000|COMPLETED|Overall Study||108
10893574|NCT00861705|12059499|FG001|COMPLETED|Overall Study||110
10893575|NCT00861705|12059500|FG002|COMPLETED|Overall Study||113
10893576|NCT00861705|12059501|FG003|COMPLETED|Overall Study||112
10893577|NCT00861705|12059498|FG000|NOT COMPLETED|Overall Study||7
10893578|NCT00861705|12059499|FG001|NOT COMPLETED|Overall Study||3
10893579|NCT00861705|12059500|FG002|NOT COMPLETED|Overall Study||0
10893580|NCT00861705|12059501|FG003|NOT COMPLETED|Overall Study||1
10893581|NCT00847730|12059519|FG000|STARTED|Overall Study||33
10893582|NCT00847730|12059519|FG000|COMPLETED|Overall Study||25
10893583|NCT00847730|12059519|FG000|NOT COMPLETED|Overall Study||8
10893584|NCT00846742|12059523|FG000|STARTED|Overall Study||85
10893585|NCT00846742|12059523|FG000|With Radiation Therapy (RT)|Overall Study||17
10893586|NCT00846742|12059523|FG000|Without Radiation Therapy (RT)|Overall Study||68
10893587|NCT00846742|12059523|FG000|COMPLETED|Overall Study||84
10893588|NCT00846742|12059523|FG000|NOT COMPLETED|Overall Study||1
10893589|NCT00845026|12059530|FG000|STARTED|Study Period III||130
10893590|NCT00845026|12059531|FG001|STARTED|Study Period III||131
10893591|NCT00845026|12059530|FG000|COMPLETED|Study Period III|7 completed, left study; 28 completed, entered Study Phase IV.|35
10893592|NCT00845026|12059531|FG001|COMPLETED|Study Period III|9 completed, left study; 50 completed, entered Study Phase IV.|59
10893593|NCT00845026|12059530|FG000|NOT COMPLETED|Study Period III||95
10893594|NCT00845026|12059531|FG001|NOT COMPLETED|Study Period III||72
10893595|NCT00845026|12059530|FG000|STARTED|Study Period IV|7 completed period III but left study; 28 completed period III AND entered period IV.|28
10893596|NCT00845026|12059531|FG001|STARTED|Study Period IV|9 completed period III, left study; 50 completed period III AND entered period IV.|50
10893597|NCT00845026|12059530|FG000|COMPLETED|Study Period IV||12
10893598|NCT00845026|12059531|FG001|COMPLETED|Study Period IV||46
10893599|NCT00845026|12059530|FG000|NOT COMPLETED|Study Period IV||16
10893600|NCT00845026|12059531|FG001|NOT COMPLETED|Study Period IV||4
10893601|NCT00843882|12059542|FG000|STARTED|Step 1||38
10893602|NCT00843882|12059543|FG001|STARTED|Step 1||103
10893603|NCT00843882|12059544|FG002|STARTED|Step 1||106
10893604|NCT00843882|12059542|FG000|Treated Patients|Step 1||36
10893605|NCT00843882|12059543|FG001|Treated Patients|Step 1||103
10893606|NCT00843882|12059544|FG002|Treated Patients|Step 1||106
10893607|NCT00843882|12059542|FG000|Evaluable Patients Included in Primary Analysis|Step 1||0
10893608|NCT00843882|12059543|FG001|Evaluable Patients Included in Primary Analysis|Step 1||96
10893609|NCT00843882|12059544|FG002|Evaluable Patients Included in Primary Analysis|Step 1||99
10893610|NCT00843882|12059542|FG000|Patients With Cytogenetic Response Data Available|Step 1||0
10893611|NCT00843882|12059543|FG001|Patients With Cytogenetic Response Data Available|Step 1||55
10893612|NCT00843882|12059544|FG002|Patients With Cytogenetic Response Data Available|Step 1||51
10893613|NCT00843882|12059542|FG000|COMPLETED|Step 1||6
10893614|NCT00843882|12059543|FG001|COMPLETED|Step 1||48
10893615|NCT00843882|12059544|FG002|COMPLETED|Step 1||41
10893616|NCT00843882|12059542|FG000|NOT COMPLETED|Step 1||32
10893617|NCT00843882|12059543|FG001|NOT COMPLETED|Step 1||55
10893618|NCT00843882|12059544|FG002|NOT COMPLETED|Step 1||65
10893619|NCT00843882|12059542|FG000|STARTED|Step 2 (Cross-over to Arm B)|All patients in Arm A that did not achieve major erythroid response (MER) were offered to receive combined treatment in Step 2.|7
10893620|NCT00843882|12059543|FG001|STARTED|Step 2 (Cross-over to Arm B)|All patients in Arm A that did not achieve major erythroid response (MER) were offered to receive combined treatment in Step 2.|46
10893621|NCT00843882|12059544|FG002|STARTED|Step 2 (Cross-over to Arm B)|Only patients in Arm A that did not achieve major erythroid response (MER) were offered to receive combined treatment in Step 2.|0
10893622|NCT00843882|12059542|FG000|Evaluable Patients Included in Primary Analysis|Step 2 (Cross-over to Arm B)||7
10893623|NCT00843882|12059543|FG001|Evaluable Patients Included in Primary Analysis|Step 2 (Cross-over to Arm B)||37
10893624|NCT00843882|12059544|FG002|Evaluable Patients Included in Primary Analysis|Step 2 (Cross-over to Arm B)||0
10893625|NCT00843882|12059542|FG000|COMPLETED|Step 2 (Cross-over to Arm B)||3
10893626|NCT00843882|12059543|FG001|COMPLETED|Step 2 (Cross-over to Arm B)||20
10893627|NCT00843882|12059544|FG002|COMPLETED|Step 2 (Cross-over to Arm B)||0
10893628|NCT00843882|12059542|FG000|NOT COMPLETED|Step 2 (Cross-over to Arm B)||4
10893629|NCT00843882|12059543|FG001|NOT COMPLETED|Step 2 (Cross-over to Arm B)||26
10893630|NCT00843882|12059544|FG002|NOT COMPLETED|Step 2 (Cross-over to Arm B)||0
10893631|NCT00838383|12059560|FG000|STARTED|Overall Study||9
10893632|NCT00838383|12059561|FG001|STARTED|Overall Study||10
10893633|NCT00838383|12059562|FG002|STARTED|Overall Study||10
10893634|NCT00838383|12059560|FG000|COMPLETED|Overall Study||9
10893635|NCT00838383|12059561|FG001|COMPLETED|Overall Study||10
10893636|NCT00838383|12059562|FG002|COMPLETED|Overall Study||10
10893637|NCT00838383|12059560|FG000|NOT COMPLETED|Overall Study||0
10893638|NCT00838383|12059561|FG001|NOT COMPLETED|Overall Study||0
10893639|NCT00838383|12059562|FG002|NOT COMPLETED|Overall Study||0
10893640|NCT00837096|12059572|FG000|STARTED|Overall Study||10
10893641|NCT00837096|12059573|FG001|STARTED|Overall Study||9
10893642|NCT00837096|12059572|FG000|COMPLETED|Overall Study||0
10893643|NCT00837096|12059573|FG001|COMPLETED|Overall Study||0
10893644|NCT00837096|12059572|FG000|NOT COMPLETED|Overall Study||10
10893645|NCT00837096|12059573|FG001|NOT COMPLETED|Overall Study||9
10893646|NCT00836810|12059581|FG000|STARTED|Overall Study||5
10893647|NCT00836810|12059582|FG001|STARTED|Overall Study||6
10893648|NCT00836810|12059581|FG000|COMPLETED|Overall Study|1 patient was subsequently diagnosed with SLE and, per protocol, was not included.|4
10893649|NCT00836810|12059582|FG001|COMPLETED|Overall Study||6
10893650|NCT00836810|12059581|FG000|NOT COMPLETED|Overall Study||1
10893651|NCT00836810|12059582|FG001|NOT COMPLETED|Overall Study||0
10893652|NCT00822120|12059590|FG000|STARTED|Initial Registration||358
10893653|NCT00822120|12059591|FG001|STARTED|Initial Registration||13
10893654|NCT00822120|12059592|FG002|STARTED|Initial Registration||0
10893655|NCT00822120|12059593|FG003|STARTED|Initial Registration||0
10893656|NCT00822120|12059594|FG004|STARTED|Initial Registration||0
10893657|NCT00822120|12059595|FG005|STARTED|Initial Registration||0
10893658|NCT00822120|12059590|FG000|Eligible and Evaluable Patients|Initial Registration||336
10893659|NCT00822120|12059591|FG001|Eligible and Evaluable Patients|Initial Registration||12
10893660|NCT00822120|12059592|FG002|Eligible and Evaluable Patients|Initial Registration||0
10893661|NCT00822120|12059593|FG003|Eligible and Evaluable Patients|Initial Registration||0
10893662|NCT00822120|12059594|FG004|Eligible and Evaluable Patients|Initial Registration||0
10893663|NCT00822120|12059595|FG005|Eligible and Evaluable Patients|Initial Registration||0
10893664|NCT00822120|12059590|FG000|COMPLETED|Initial Registration||332
10893665|NCT00822120|12059591|FG001|COMPLETED|Initial Registration||12
10893666|NCT00822120|12059592|FG002|COMPLETED|Initial Registration||0
10893667|NCT00822120|12059593|FG003|COMPLETED|Initial Registration||0
10893668|NCT00822120|12059594|FG004|COMPLETED|Initial Registration||0
10893669|NCT00822120|12059595|FG005|COMPLETED|Initial Registration||0
10893670|NCT00822120|12059590|FG000|NOT COMPLETED|Initial Registration||26
10893671|NCT00822120|12059591|FG001|NOT COMPLETED|Initial Registration||1
10893672|NCT00822120|12059592|FG002|NOT COMPLETED|Initial Registration||0
10893673|NCT00822120|12059593|FG003|NOT COMPLETED|Initial Registration||0
10893674|NCT00822120|12059594|FG004|NOT COMPLETED|Initial Registration||0
10893675|NCT00822120|12059595|FG005|NOT COMPLETED|Initial Registration||0
10893676|NCT00822120|12059590|FG000|STARTED|PET-directed Therapy||0
10893677|NCT00822120|12059591|FG001|STARTED|PET-directed Therapy||0
10893678|NCT00822120|12059592|FG002|STARTED|PET-directed Therapy||270
10893679|NCT00822120|12059593|FG003|STARTED|PET-directed Therapy||55
10893680|NCT00822120|12059594|FG004|STARTED|PET-directed Therapy||10
10893681|NCT00822120|12059595|FG005|STARTED|PET-directed Therapy||1
10893682|NCT00822120|12059590|FG000|Eligibile and Evaluable Patients|PET-directed Therapy||0
10893683|NCT00822120|12059591|FG001|Eligibile and Evaluable Patients|PET-directed Therapy||0
10893684|NCT00822120|12059592|FG002|Eligibile and Evaluable Patients|PET-directed Therapy||270
10893685|NCT00822120|12059593|FG003|Eligibile and Evaluable Patients|PET-directed Therapy||55
10893686|NCT00822120|12059594|FG004|Eligibile and Evaluable Patients|PET-directed Therapy||10
10893687|NCT00822120|12059595|FG005|Eligibile and Evaluable Patients|PET-directed Therapy||1
10893688|NCT00822120|12059590|FG000|COMPLETED|PET-directed Therapy||0
10893689|NCT00822120|12059591|FG001|COMPLETED|PET-directed Therapy||0
10893690|NCT00822120|12059592|FG002|COMPLETED|PET-directed Therapy||270
10893691|NCT00822120|12059593|FG003|COMPLETED|PET-directed Therapy||45
10893692|NCT00822120|12059594|FG004|COMPLETED|PET-directed Therapy||10
10893693|NCT00822120|12059595|FG005|COMPLETED|PET-directed Therapy||1
10893694|NCT00822120|12059590|FG000|NOT COMPLETED|PET-directed Therapy||0
10893695|NCT00822120|12059591|FG001|NOT COMPLETED|PET-directed Therapy||0
10893696|NCT00822120|12059592|FG002|NOT COMPLETED|PET-directed Therapy||0
10893697|NCT00822120|12059593|FG003|NOT COMPLETED|PET-directed Therapy||10
10893698|NCT00822120|12059594|FG004|NOT COMPLETED|PET-directed Therapy||0
10893699|NCT00822120|12059595|FG005|NOT COMPLETED|PET-directed Therapy||0
10893700|NCT00819780|12059618|FG000|STARTED|Overall Study||142
10893701|NCT00819780|12059619|FG001|STARTED|Overall Study||143
10893702|NCT00819780|12059618|FG000|Received Study Treatment|Overall Study||139
10893703|NCT00819780|12059619|FG001|Received Study Treatment|Overall Study||139
10893704|NCT00819780|12059618|FG000|COMPLETED|Overall Study|Indicates participants who ended study treatment|114
10893705|NCT00819780|12059619|FG001|COMPLETED|Overall Study|Indicates participants who ended study treatment|122
10893706|NCT00819780|12059618|FG000|NOT COMPLETED|Overall Study||28
10893707|NCT00819780|12059619|FG001|NOT COMPLETED|Overall Study||21
10893708|NCT00792948|12059625|FG000|STARTED|Overall Study|Patients registered to induction/consolidation step|97
10893709|NCT00792948|12059625|FG000|COMPLETED|Overall Study|Patients who completed induction/consolidation step|69
10893710|NCT00792948|12059625|FG000|NOT COMPLETED|Overall Study||28
10893711|NCT00789399|12059634|FG000|STARTED|Overall Study||41
10893712|NCT00789399|12059635|FG001|STARTED|Overall Study||37
10893713|NCT00789399|12059634|FG000|COMPLETED|Overall Study||39
10893714|NCT00789399|12059635|FG001|COMPLETED|Overall Study||37
10893715|NCT00789399|12059634|FG000|NOT COMPLETED|Overall Study||2
10893716|NCT00789399|12059635|FG001|NOT COMPLETED|Overall Study||0
10893717|NCT00785291|12059644|FG000|STARTED|Overall Study||283
10893718|NCT00785291|12059645|FG001|STARTED|Overall Study||271
10893719|NCT00785291|12059646|FG002|STARTED|Overall Study||245
10893720|NCT00785291|12059644|FG000|COMPLETED|Overall Study||147
10893721|NCT00785291|12059645|FG001|COMPLETED|Overall Study||122
10893722|NCT00785291|12059646|FG002|COMPLETED|Overall Study||139
10893723|NCT00785291|12059644|FG000|NOT COMPLETED|Overall Study||136
10893724|NCT00785291|12059645|FG001|NOT COMPLETED|Overall Study||149
10893725|NCT00785291|12059646|FG002|NOT COMPLETED|Overall Study||106
10893726|NCT00784823|12059658|FG000|STARTED|Overall Study||6
10893727|NCT00784823|12059659|FG001|STARTED|Overall Study||3
10893728|NCT00784823|12059660|FG002|STARTED|Overall Study||3
10893729|NCT00784823|12059661|FG003|STARTED|Overall Study||20
10893730|NCT00784823|12059658|FG000|COMPLETED|Overall Study||6
10893731|NCT00784823|12059659|FG001|COMPLETED|Overall Study||3
10893732|NCT00784823|12059660|FG002|COMPLETED|Overall Study||3
10893733|NCT00784823|12059661|FG003|COMPLETED|Overall Study||20
10893734|NCT00784823|12059658|FG000|NOT COMPLETED|Overall Study||0
10893735|NCT00784823|12059659|FG001|NOT COMPLETED|Overall Study||0
10893736|NCT00784823|12059660|FG002|NOT COMPLETED|Overall Study||0
10893737|NCT00784823|12059661|FG003|NOT COMPLETED|Overall Study||0
10893738|NCT00773357|12059668|FG000|STARTED|Overall Study||50
10893739|NCT00773357|12059669|FG001|STARTED|Overall Study||50
10893740|NCT00773357|12059668|FG000|COMPLETED|Overall Study||50
10893741|NCT00773357|12059669|FG001|COMPLETED|Overall Study||50
10893742|NCT00773357|12059668|FG000|NOT COMPLETED|Overall Study||0
10893743|NCT00773357|12059669|FG001|NOT COMPLETED|Overall Study||0
10893744|NCT00770809|12059678|FG000|STARTED|Overall Study||118
10893745|NCT00770809|12059679|FG001|STARTED|Overall Study||120
10893746|NCT00770809|12059680|FG002|STARTED|Overall Study||67
10893747|NCT00770809|12059678|FG000|COMPLETED|Overall Study||101
10893748|NCT00770809|12059679|FG001|COMPLETED|Overall Study||110
10893749|NCT00770809|12059680|FG002|COMPLETED|Overall Study||44
10893750|NCT00770809|12059678|FG000|NOT COMPLETED|Overall Study||17
10893751|NCT00770809|12059679|FG001|NOT COMPLETED|Overall Study||10
10893752|NCT00770809|12059680|FG002|NOT COMPLETED|Overall Study||23
10893753|NCT00769379|12059690|FG000|STARTED|Overall Study||1008
10893754|NCT00769379|12059691|FG001|STARTED|Overall Study||1006
10893755|NCT00769379|12059690|FG000|COMPLETED|Overall Study||1005
10893756|NCT00769379|12059691|FG001|COMPLETED|Overall Study||993
10893757|NCT00769379|12059690|FG000|NOT COMPLETED|Overall Study||3
10893758|NCT00769379|12059691|FG001|NOT COMPLETED|Overall Study||13
10893759|NCT00763555|12059699|FG000|STARTED|Overall Study||44
10893760|NCT00763555|12059700|FG001|STARTED|Overall Study||44
10893761|NCT00763555|12059699|FG000|COMPLETED|Overall Study||40
10893762|NCT00763555|12059700|FG001|COMPLETED|Overall Study||34
10893763|NCT00763555|12059699|FG000|NOT COMPLETED|Overall Study||4
10893764|NCT00763555|12059700|FG001|NOT COMPLETED|Overall Study||10
10893765|NCT00757042|12059717|FG000|STARTED|Overall Study||6
10893766|NCT00757042|12059718|FG001|STARTED|Overall Study||6
10893767|NCT00757042|12059719|FG002|STARTED|Overall Study||6
10893768|NCT00757042|12059720|FG003|STARTED|Overall Study||6
10893769|NCT00757042|12059721|FG004|STARTED|Overall Study||6
10893770|NCT00757042|12059722|FG005|STARTED|Overall Study||6
10893771|NCT00757042|12059723|FG006|STARTED|Overall Study||6
10893772|NCT00757042|12059724|FG007|STARTED|Overall Study||6
10893773|NCT00757042|12059725|FG008|STARTED|Overall Study||16
10893774|NCT00757042|12059726|FG009|STARTED|Overall Study||10
10893775|NCT00757042|12059727|FG010|STARTED|Overall Study||4
10893776|NCT00757042|12059717|FG000|Received Study Drug|Overall Study||6
10893777|NCT00757042|12059718|FG001|Received Study Drug|Overall Study||6
10893778|NCT00757042|12059719|FG002|Received Study Drug|Overall Study||6
10893779|NCT00757042|12059720|FG003|Received Study Drug|Overall Study||6
10893780|NCT00757042|12059721|FG004|Received Study Drug|Overall Study||6
10893781|NCT00757042|12059722|FG005|Received Study Drug|Overall Study||6
10893782|NCT00757042|12059723|FG006|Received Study Drug|Overall Study||6
10893783|NCT00757042|12059724|FG007|Received Study Drug|Overall Study||6
10893784|NCT00757042|12059725|FG008|Received Study Drug|Overall Study||16
10893785|NCT00757042|12059726|FG009|Received Study Drug|Overall Study||9
10893786|NCT00757042|12059727|FG010|Received Study Drug|Overall Study||3
10893787|NCT00757042|12059717|FG000|COMPLETED|Overall Study||6
10893788|NCT00757042|12059718|FG001|COMPLETED|Overall Study||6
10893789|NCT00757042|12059719|FG002|COMPLETED|Overall Study||6
10893790|NCT00757042|12059720|FG003|COMPLETED|Overall Study||6
10893791|NCT00757042|12059721|FG004|COMPLETED|Overall Study||6
10893792|NCT00757042|12059722|FG005|COMPLETED|Overall Study||6
10893793|NCT00757042|12059723|FG006|COMPLETED|Overall Study||6
10893794|NCT00757042|12059724|FG007|COMPLETED|Overall Study||6
10893795|NCT00757042|12059725|FG008|COMPLETED|Overall Study||15
10893796|NCT00757042|12059726|FG009|COMPLETED|Overall Study||9
10893797|NCT00757042|12059727|FG010|COMPLETED|Overall Study||3
10893798|NCT00757042|12059717|FG000|NOT COMPLETED|Overall Study||0
10893799|NCT00757042|12059718|FG001|NOT COMPLETED|Overall Study||0
10893800|NCT00757042|12059719|FG002|NOT COMPLETED|Overall Study||0
10893801|NCT00757042|12059720|FG003|NOT COMPLETED|Overall Study||0
10893802|NCT00757042|12059721|FG004|NOT COMPLETED|Overall Study||0
10893803|NCT00757042|12059722|FG005|NOT COMPLETED|Overall Study||0
10893804|NCT00757042|12059723|FG006|NOT COMPLETED|Overall Study||0
10893805|NCT00757042|12059724|FG007|NOT COMPLETED|Overall Study||0
10893806|NCT00757042|12059725|FG008|NOT COMPLETED|Overall Study||1
10893807|NCT00757042|12059726|FG009|NOT COMPLETED|Overall Study||1
10893808|NCT00757042|12059727|FG010|NOT COMPLETED|Overall Study||1
10893809|NCT00738920|12059761|FG000|STARTED|Baseline to 2-Week Follow-Up||145
10893810|NCT00738920|12059762|FG001|STARTED|Baseline to 2-Week Follow-Up||146
10893811|NCT00738920|12059763|FG002|STARTED|Baseline to 2-Week Follow-Up||145
10893812|NCT00738920|12059761|FG000|COMPLETED|Baseline to 2-Week Follow-Up||129
10893813|NCT00738920|12059762|FG001|COMPLETED|Baseline to 2-Week Follow-Up||123
10893814|NCT00738920|12059763|FG002|COMPLETED|Baseline to 2-Week Follow-Up||130
10893815|NCT00738920|12059761|FG000|NOT COMPLETED|Baseline to 2-Week Follow-Up||16
10893816|NCT00738920|12059762|FG001|NOT COMPLETED|Baseline to 2-Week Follow-Up||23
10893896|NCT00725049|12059813|FG001|COMPLETED|Overall Study||20
10893817|NCT00738920|12059763|FG002|NOT COMPLETED|Baseline to 2-Week Follow-Up||15
10893818|NCT00738920|12059761|FG000|STARTED|2-Week Follow-Up to 3-Month Follow-Up||129
10893819|NCT00738920|12059762|FG001|STARTED|2-Week Follow-Up to 3-Month Follow-Up||123
10893820|NCT00738920|12059763|FG002|STARTED|2-Week Follow-Up to 3-Month Follow-Up||130
10893821|NCT00738920|12059761|FG000|COMPLETED|2-Week Follow-Up to 3-Month Follow-Up||121
10893822|NCT00738920|12059762|FG001|COMPLETED|2-Week Follow-Up to 3-Month Follow-Up||111
10893823|NCT00738920|12059763|FG002|COMPLETED|2-Week Follow-Up to 3-Month Follow-Up||118
10893824|NCT00738920|12059761|FG000|NOT COMPLETED|2-Week Follow-Up to 3-Month Follow-Up||8
10893825|NCT00738920|12059762|FG001|NOT COMPLETED|2-Week Follow-Up to 3-Month Follow-Up||12
10893826|NCT00738920|12059763|FG002|NOT COMPLETED|2-Week Follow-Up to 3-Month Follow-Up||12
10893827|NCT00738920|12059761|FG000|STARTED|3-Month Follow-Up to 6-Month Follow-Up||121
10893828|NCT00738920|12059762|FG001|STARTED|3-Month Follow-Up to 6-Month Follow-Up||111
10893829|NCT00738920|12059763|FG002|STARTED|3-Month Follow-Up to 6-Month Follow-Up||118
10893830|NCT00738920|12059761|FG000|COMPLETED|3-Month Follow-Up to 6-Month Follow-Up||117
10893831|NCT00738920|12059762|FG001|COMPLETED|3-Month Follow-Up to 6-Month Follow-Up||111
10893832|NCT00738920|12059763|FG002|COMPLETED|3-Month Follow-Up to 6-Month Follow-Up||115
10893833|NCT00738920|12059761|FG000|NOT COMPLETED|3-Month Follow-Up to 6-Month Follow-Up||4
10893834|NCT00738920|12059762|FG001|NOT COMPLETED|3-Month Follow-Up to 6-Month Follow-Up||0
10893835|NCT00738920|12059763|FG002|NOT COMPLETED|3-Month Follow-Up to 6-Month Follow-Up||3
10893836|NCT00738920|12059761|FG000|STARTED|6-Month Follow-Up to 9-Month Follow-Up||117
10893837|NCT00738920|12059762|FG001|STARTED|6-Month Follow-Up to 9-Month Follow-Up||111
10893838|NCT00738920|12059763|FG002|STARTED|6-Month Follow-Up to 9-Month Follow-Up||115
10893839|NCT00738920|12059761|FG000|COMPLETED|6-Month Follow-Up to 9-Month Follow-Up||113
10893840|NCT00738920|12059762|FG001|COMPLETED|6-Month Follow-Up to 9-Month Follow-Up||104
10893841|NCT00738920|12059763|FG002|COMPLETED|6-Month Follow-Up to 9-Month Follow-Up||103
10893842|NCT00738920|12059761|FG000|NOT COMPLETED|6-Month Follow-Up to 9-Month Follow-Up||4
10893843|NCT00738920|12059762|FG001|NOT COMPLETED|6-Month Follow-Up to 9-Month Follow-Up||7
10893844|NCT00738920|12059763|FG002|NOT COMPLETED|6-Month Follow-Up to 9-Month Follow-Up||12
10893845|NCT00738920|12059761|FG000|STARTED|9-Month Follow-Up to 12-Month Follow-Up||113
10893846|NCT00738920|12059762|FG001|STARTED|9-Month Follow-Up to 12-Month Follow-Up||104
10893847|NCT00738920|12059763|FG002|STARTED|9-Month Follow-Up to 12-Month Follow-Up||103
10893848|NCT00738920|12059761|FG000|COMPLETED|9-Month Follow-Up to 12-Month Follow-Up||112
10893849|NCT00738920|12059762|FG001|COMPLETED|9-Month Follow-Up to 12-Month Follow-Up||103
10893850|NCT00738920|12059763|FG002|COMPLETED|9-Month Follow-Up to 12-Month Follow-Up||102
10893851|NCT00738920|12059761|FG000|NOT COMPLETED|9-Month Follow-Up to 12-Month Follow-Up||1
10893852|NCT00738920|12059762|FG001|NOT COMPLETED|9-Month Follow-Up to 12-Month Follow-Up||1
10893853|NCT00738920|12059763|FG002|NOT COMPLETED|9-Month Follow-Up to 12-Month Follow-Up||1
10893854|NCT00738582|12059771|FG000|STARTED|Combination Therapy||89
10893855|NCT00738582|12059772|FG001|STARTED|Combination Therapy||0
10893856|NCT00738582|12059771|FG000|COMPLETED|Combination Therapy||56
10893857|NCT00738582|12059772|FG001|COMPLETED|Combination Therapy||0
10893858|NCT00738582|12059771|FG000|NOT COMPLETED|Combination Therapy||33
10893859|NCT00738582|12059772|FG001|NOT COMPLETED|Combination Therapy||0
10893860|NCT00738582|12059771|FG000|STARTED|Maintenance Therapy|This arm ended once all participants entered into the Maintenance Therapy phase of the study.|0
10893861|NCT00738582|12059772|FG001|STARTED|Maintenance Therapy|Only eligible participants entered into this phase of the study.|56
10893862|NCT00738582|12059771|FG000|COMPLETED|Maintenance Therapy||0
10893863|NCT00738582|12059772|FG001|COMPLETED|Maintenance Therapy||0
10893864|NCT00738582|12059771|FG000|NOT COMPLETED|Maintenance Therapy||0
10893865|NCT00738582|12059772|FG001|NOT COMPLETED|Maintenance Therapy||56
10893866|NCT00733954|12059781|FG000|STARTED|Overall Study||124
10893867|NCT00733954|12059782|FG001|STARTED|Overall Study||125
10893868|NCT00733954|12059781|FG000|COMPLETED|Overall Study||116
10893869|NCT00733954|12059782|FG001|COMPLETED|Overall Study||123
10893870|NCT00733954|12059781|FG000|NOT COMPLETED|Overall Study||8
10893871|NCT00733954|12059782|FG001|NOT COMPLETED|Overall Study||2
10893872|NCT00731731|12059791|FG000|STARTED|Overall Study||12
10893873|NCT00731731|12059792|FG001|STARTED|Overall Study||3
10893874|NCT00731731|12059793|FG002|STARTED|Overall Study||110
10893875|NCT00731731|12059791|FG000|COMPLETED|Overall Study||12
10893876|NCT00731731|12059792|FG001|COMPLETED|Overall Study||3
10893877|NCT00731731|12059793|FG002|COMPLETED|Overall Study||107
10893878|NCT00731731|12059791|FG000|NOT COMPLETED|Overall Study||0
10893879|NCT00731731|12059792|FG001|NOT COMPLETED|Overall Study||0
10893880|NCT00731731|12059793|FG002|NOT COMPLETED|Overall Study||3
10893881|NCT00728884|12059806|FG000|STARTED|Implant Placement Surgery||162
10893882|NCT00728884|12059806|FG000|COMPLETED|Implant Placement Surgery||162
10893883|NCT00728884|12059806|FG000|NOT COMPLETED|Implant Placement Surgery||0
10893884|NCT00728884|12059806|FG000|STARTED|Permanent Prosthesis Placement||162
10893885|NCT00728884|12059806|FG000|COMPLETED|Permanent Prosthesis Placement||149
10893886|NCT00728884|12059806|FG000|NOT COMPLETED|Permanent Prosthesis Placement||13
10893887|NCT00728884|12059806|FG000|STARTED|One Year Post Placement Follow-up||149
10893888|NCT00728884|12059806|FG000|COMPLETED|One Year Post Placement Follow-up||145
10893889|NCT00728884|12059806|FG000|NOT COMPLETED|One Year Post Placement Follow-up||4
10893890|NCT00728884|12059806|FG000|STARTED|Two Year Post Placement Follow-up||145
10893891|NCT00728884|12059806|FG000|COMPLETED|Two Year Post Placement Follow-up||145
10893892|NCT00728884|12059806|FG000|NOT COMPLETED|Two Year Post Placement Follow-up||0
10893893|NCT00725049|12059812|FG000|STARTED|Overall Study||17
10893894|NCT00725049|12059813|FG001|STARTED|Overall Study||20
10893895|NCT00725049|12059812|FG000|COMPLETED|Overall Study||17
10893897|NCT00725049|12059812|FG000|NOT COMPLETED|Overall Study||0
10893898|NCT00725049|12059813|FG001|NOT COMPLETED|Overall Study||0
10893899|NCT00716443|12059819|FG000|STARTED|Overall Study||51
10893900|NCT00716443|12059819|FG000|COMPLETED|Overall Study||51
10893901|NCT00716443|12059819|FG000|NOT COMPLETED|Overall Study||0
10893902|NCT00680992|12059827|FG000|STARTED|Overall Study||268
10893903|NCT00680992|12059828|FG001|STARTED|Overall Study||252
10893904|NCT00680992|12059829|FG002|STARTED|Overall Study||12
10893905|NCT00680992|12059827|FG000|Safety Analysis Set|Overall Study||265
10893906|NCT00680992|12059828|FG001|Safety Analysis Set|Overall Study||249
10893907|NCT00680992|12059829|FG002|Safety Analysis Set|Overall Study||12
10893908|NCT00680992|12059827|FG000|Efficacy Analysis Set|Overall Study||260
10893909|NCT00680992|12059828|FG001|Efficacy Analysis Set|Overall Study||242
10893910|NCT00680992|12059829|FG002|Efficacy Analysis Set|Overall Study||11
10893911|NCT00680992|12059827|FG000|COMPLETED|Overall Study||0
10893912|NCT00680992|12059828|FG001|COMPLETED|Overall Study||0
10893913|NCT00680992|12059829|FG002|COMPLETED|Overall Study||0
10893914|NCT00680992|12059827|FG000|NOT COMPLETED|Overall Study||268
10893915|NCT00680992|12059828|FG001|NOT COMPLETED|Overall Study||252
10893916|NCT00680992|12059829|FG002|NOT COMPLETED|Overall Study||12
10893917|NCT00679783|12059845|FG000|STARTED|Overall Study|Gave Informed consent and passed screening|4
10893918|NCT00679783|12059846|FG001|STARTED|Overall Study|Gave Informed consent and passed screening|13
10893919|NCT00679783|12059847|FG002|STARTED|Overall Study|Gave Informed consent and passed screening|3
10893920|NCT00679783|12059848|FG003|STARTED|Overall Study|Gave Informed consent and passed screening|45
10893921|NCT00679783|12059849|FG004|STARTED|Overall Study|Gave Informed consent and passed screening|5
10893922|NCT00679783|12059850|FG005|STARTED|Overall Study|Gave Informed consent and passed screening|5
10893923|NCT00679783|12059851|FG006|STARTED|Overall Study|Gave Informed consent and passed screening|16
10893924|NCT00679783|12059845|FG000|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|2
10893925|NCT00679783|12059846|FG001|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|10
10893926|NCT00679783|12059847|FG002|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|2
10893927|NCT00679783|12059848|FG003|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|25
10893928|NCT00679783|12059849|FG004|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|4
10893929|NCT00679783|12059850|FG005|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|5
10893930|NCT00679783|12059851|FG006|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|15
10893931|NCT00679783|12059845|FG000|NOT COMPLETED|Overall Study||2
10893932|NCT00679783|12059846|FG001|NOT COMPLETED|Overall Study||3
10893933|NCT00679783|12059847|FG002|NOT COMPLETED|Overall Study||1
10893934|NCT00679783|12059848|FG003|NOT COMPLETED|Overall Study||20
10893935|NCT00679783|12059849|FG004|NOT COMPLETED|Overall Study||1
10893936|NCT00679783|12059850|FG005|NOT COMPLETED|Overall Study||0
10893937|NCT00679783|12059851|FG006|NOT COMPLETED|Overall Study||1
10893938|NCT00679042|12059867|FG000|STARTED|Transplant + 1 Year Follow Up||21
10893939|NCT00679042|12059867|FG000|COMPLETED|Transplant + 1 Year Follow Up||19
10893940|NCT00679042|12059867|FG000|NOT COMPLETED|Transplant + 1 Year Follow Up||2
10893941|NCT00679042|12059867|FG000|STARTED|5-Year Follow Up||19
10893942|NCT00679042|12059867|FG000|COMPLETED|5-Year Follow Up||5
10893943|NCT00679042|12059867|FG000|NOT COMPLETED|5-Year Follow Up||14
10893944|NCT00679042|12059867|FG000|STARTED|10-Year Follow Up||5
10893945|NCT00679042|12059867|FG000|COMPLETED|10-Year Follow Up||0
10893946|NCT00679042|12059867|FG000|NOT COMPLETED|10-Year Follow Up||5
10893947|NCT00671749|12059871|FG000|STARTED|Overall Study||100
10893948|NCT00671749|12059871|FG000|COMPLETED|Overall Study||92
10893949|NCT00671749|12059871|FG000|NOT COMPLETED|Overall Study||8
10893950|NCT00669071|12059875|FG000|STARTED|Overall Study||56
10893951|NCT00669071|12059875|FG000|COMPLETED|Overall Study||52
10893952|NCT00669071|12059875|FG000|NOT COMPLETED|Overall Study||4
10893953|NCT00667251|12059883|FG000|STARTED|Overall Study||326
10893954|NCT00667251|12059884|FG001|STARTED|Overall Study||326
10893955|NCT00667251|12059883|FG000|Combination Rx|Overall Study||322
10893956|NCT00667251|12059884|FG001|Combination Rx|Overall Study||325
10893957|NCT00667251|12059883|FG000|Monotherapy|Overall Study||225
10893958|NCT00667251|12059884|FG001|Monotherapy|Overall Study||232
10893959|NCT00667251|12059883|FG000|Not Started|Overall Study||4
10893960|NCT00667251|12059884|FG001|Not Started|Overall Study||1
10893961|NCT00667251|12059883|FG000|COMPLETED|Overall Study||256
10893962|NCT00667251|12059884|FG001|COMPLETED|Overall Study||231
10893963|NCT00667251|12059883|FG000|NOT COMPLETED|Overall Study||70
10893964|NCT00667251|12059884|FG001|NOT COMPLETED|Overall Study||95
10893965|NCT00658814|12059892|FG000|STARTED|Remission Induction Chemotherapy||83
10893966|NCT00658814|12059893|FG001|STARTED|Remission Induction Chemotherapy||59
10893967|NCT00658814|12059892|FG000|Eligible|Remission Induction Chemotherapy||82
10893968|NCT00658814|12059893|FG001|Eligible|Remission Induction Chemotherapy||57
10893969|NCT00658814|12059892|FG000|Eligible and Began Protocol Therapy|Remission Induction Chemotherapy||79
10893970|NCT00658814|12059893|FG001|Eligible and Began Protocol Therapy|Remission Induction Chemotherapy||54
10893971|NCT00658814|12059892|FG000|COMPLETED|Remission Induction Chemotherapy||75
10893972|NCT00658814|12059893|FG001|COMPLETED|Remission Induction Chemotherapy||41
10893973|NCT00658814|12059892|FG000|NOT COMPLETED|Remission Induction Chemotherapy||8
10893974|NCT00658814|12059893|FG001|NOT COMPLETED|Remission Induction Chemotherapy||18
10893975|NCT00658814|12059892|FG000|STARTED|Consolidation Therapy||24
10893976|NCT00658814|12059893|FG001|STARTED|Consolidation Therapy||13
10893977|NCT00658814|12059892|FG000|Eligible|Consolidation Therapy||22
10893978|NCT00658814|12059893|FG001|Eligible|Consolidation Therapy||11
10893979|NCT00658814|12059892|FG000|COMPLETED|Consolidation Therapy||22
10893980|NCT00658814|12059893|FG001|COMPLETED|Consolidation Therapy||10
10893981|NCT00658814|12059892|FG000|NOT COMPLETED|Consolidation Therapy||2
10893982|NCT00658814|12059893|FG001|NOT COMPLETED|Consolidation Therapy||3
10893983|NCT00658814|12059892|FG000|STARTED|Maintenance Therapy||20
10893984|NCT00658814|12059893|FG001|STARTED|Maintenance Therapy||8
10893985|NCT00658814|12059892|FG000|Eligible|Maintenance Therapy||19
10893986|NCT00658814|12059893|FG001|Eligible|Maintenance Therapy||8
10893987|NCT00658814|12059892|FG000|COMPLETED|Maintenance Therapy||17
10893988|NCT00658814|12059893|FG001|COMPLETED|Maintenance Therapy||7
10893989|NCT00658814|12059892|FG000|NOT COMPLETED|Maintenance Therapy||3
10893990|NCT00658814|12059893|FG001|NOT COMPLETED|Maintenance Therapy||1
10893991|NCT00658788|12059903|FG000|STARTED|Overall Study||305
10893992|NCT00658788|12059903|FG000|COMPLETED|Overall Study||231
10893993|NCT00658788|12059903|FG000|NOT COMPLETED|Overall Study||74
10893994|NCT00647556|12059918|FG000|STARTED|Overall Study||15
10893995|NCT00647556|12059919|FG001|STARTED|Overall Study||15
10893996|NCT00647556|12059918|FG000|COMPLETED|Overall Study||12
10893997|NCT00647556|12059919|FG001|COMPLETED|Overall Study||13
10893998|NCT00647556|12059918|FG000|NOT COMPLETED|Overall Study||3
10893999|NCT00647556|12059919|FG001|NOT COMPLETED|Overall Study||2
10894000|NCT00644280|12059927|FG000|STARTED|Overall Study||6
10894001|NCT00644280|12059928|FG001|STARTED|Overall Study||5
10894002|NCT00644280|12059927|FG000|COMPLETED|Overall Study||6
10894003|NCT00644280|12059928|FG001|COMPLETED|Overall Study||5
10894004|NCT00644280|12059927|FG000|NOT COMPLETED|Overall Study||0
10894005|NCT00644280|12059928|FG001|NOT COMPLETED|Overall Study||0
10894006|NCT00641186|12059934|FG000|STARTED|Overall Study||30
10894007|NCT00641186|12059934|FG000|COMPLETED|Overall Study||27
10894008|NCT00641186|12059934|FG000|NOT COMPLETED|Overall Study||3
10894009|NCT00635700|12059940|FG000|STARTED|Overall Study||24
10894010|NCT00635700|12059941|FG001|STARTED|Overall Study||27
10894011|NCT00635700|12059940|FG000|COMPLETED|Overall Study||9
10894012|NCT00635700|12059941|FG001|COMPLETED|Overall Study||13
10894013|NCT00635700|12059940|FG000|NOT COMPLETED|Overall Study||15
10894014|NCT00635700|12059941|FG001|NOT COMPLETED|Overall Study||14
10894015|NCT00625378|12059949|FG000|STARTED|Overall Study||205
10894016|NCT00625378|12059950|FG001|STARTED|Overall Study||1
10894017|NCT00625378|12059949|FG000|Treated in STEP|Overall Study||203
10894018|NCT00625378|12059950|FG001|Treated in STEP|Overall Study||1
10894019|NCT00625378|12059949|FG000|COMPLETED|Overall Study||0
10894020|NCT00625378|12059950|FG001|COMPLETED|Overall Study||0
10894021|NCT00625378|12059949|FG000|NOT COMPLETED|Overall Study||205
10894022|NCT00625378|12059950|FG001|NOT COMPLETED|Overall Study||1
10894023|NCT00609791|12059956|FG000|STARTED|Overall Study||40
10894024|NCT00609791|12059956|FG000|COMPLETED|Overall Study||39
10894025|NCT00609791|12059956|FG000|NOT COMPLETED|Overall Study||1
10894026|NCT00605189|12059963|FG000|STARTED|Overall Study||20
10894027|NCT00605189|12059964|FG001|STARTED|Overall Study||21
10894028|NCT00605189|12059965|FG002|STARTED|Overall Study||9
10894029|NCT00605189|12059963|FG000|COMPLETED|Overall Study||17
10894030|NCT00605189|12059964|FG001|COMPLETED|Overall Study||19
10894031|NCT00605189|12059965|FG002|COMPLETED|Overall Study||9
10894032|NCT00605189|12059963|FG000|NOT COMPLETED|Overall Study||3
10894033|NCT00605189|12059964|FG001|NOT COMPLETED|Overall Study||2
10894034|NCT00605189|12059965|FG002|NOT COMPLETED|Overall Study||0
10894035|NCT00602641|12059975|FG000|STARTED|Overall Study||154
10894036|NCT00602641|12059976|FG001|STARTED|Overall Study||152
10894037|NCT00602641|12059975|FG000|Started Protocol Therapy|Overall Study||148
10894038|NCT00602641|12059976|FG001|Started Protocol Therapy|Overall Study||150
10894039|NCT00602641|12059975|FG000|COMPLETED|Overall Study|Treatment continued until progression of disease, unacceptable toxicity or patient withdrawal.|0
10894040|NCT00602641|12059976|FG001|COMPLETED|Overall Study|Treatment continued until progression of disease, unacceptable toxicity or patient withdrawal.|0
10894041|NCT00602641|12059975|FG000|NOT COMPLETED|Overall Study||154
10894042|NCT00602641|12059976|FG001|NOT COMPLETED|Overall Study||152
10894043|NCT00602459|12059986|FG000|STARTED|Initial Registration/Randomization||138
10894044|NCT00602459|12059987|FG001|STARTED|Initial Registration/Randomization||140
10894045|NCT00602459|12059988|FG002|STARTED|Initial Registration/Randomization||140
10894046|NCT00602459|12059989|FG003|STARTED|Initial Registration/Randomization||0
10894047|NCT00602459|12059986|FG000|COMPLETED|Initial Registration/Randomization||133
10894048|NCT00602459|12059987|FG001|COMPLETED|Initial Registration/Randomization||130
10894049|NCT00602459|12059988|FG002|COMPLETED|Initial Registration/Randomization||137
10894050|NCT00602459|12059989|FG003|COMPLETED|Initial Registration/Randomization||0
10894051|NCT00602459|12059986|FG000|NOT COMPLETED|Initial Registration/Randomization||5
10894052|NCT00602459|12059987|FG001|NOT COMPLETED|Initial Registration/Randomization||10
10894053|NCT00602459|12059988|FG002|NOT COMPLETED|Initial Registration/Randomization||3
10894054|NCT00602459|12059989|FG003|NOT COMPLETED|Initial Registration/Randomization||0
10894055|NCT00602459|12059986|FG000|STARTED|Re-assignment After Del(11q22.3) Testing||123
10894056|NCT00602459|12059987|FG001|STARTED|Re-assignment After Del(11q22.3) Testing||109
10894057|NCT00602459|12059988|FG002|STARTED|Re-assignment After Del(11q22.3) Testing||137
10894058|NCT00602459|12059989|FG003|STARTED|Re-assignment After Del(11q22.3) Testing||31
10894059|NCT00602459|12059986|FG000|COMPLETED|Re-assignment After Del(11q22.3) Testing||123
10894060|NCT00602459|12059987|FG001|COMPLETED|Re-assignment After Del(11q22.3) Testing||109
10894061|NCT00602459|12059988|FG002|COMPLETED|Re-assignment After Del(11q22.3) Testing||137
10894062|NCT00602459|12059989|FG003|COMPLETED|Re-assignment After Del(11q22.3) Testing||31
10894063|NCT00602459|12059986|FG000|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
10894064|NCT00602459|12059987|FG001|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
10894065|NCT00602459|12059988|FG002|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
10894066|NCT00602459|12059989|FG003|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
10894067|NCT00602030|12060009|FG000|STARTED|Lead-in Phase||3
10894068|NCT00602030|12060010|FG001|STARTED|Lead-in Phase||6
10894069|NCT00602030|12060011|FG002|STARTED|Lead-in Phase||0
10894070|NCT00602030|12060012|FG003|STARTED|Lead-in Phase||0
10894071|NCT00602030|12060013|FG004|STARTED|Lead-in Phase||0
10894072|NCT00602030|12060009|FG000|COMPLETED|Lead-in Phase||1
10894073|NCT00602030|12060010|FG001|COMPLETED|Lead-in Phase||1
10894074|NCT00602030|12060011|FG002|COMPLETED|Lead-in Phase||0
10894075|NCT00602030|12060012|FG003|COMPLETED|Lead-in Phase||0
10894076|NCT00602030|12060013|FG004|COMPLETED|Lead-in Phase||0
10894077|NCT00602030|12060009|FG000|NOT COMPLETED|Lead-in Phase||2
10894078|NCT00602030|12060010|FG001|NOT COMPLETED|Lead-in Phase||5
10894079|NCT00602030|12060011|FG002|NOT COMPLETED|Lead-in Phase||0
10894080|NCT00602030|12060012|FG003|NOT COMPLETED|Lead-in Phase||0
10894081|NCT00602030|12060013|FG004|NOT COMPLETED|Lead-in Phase||0
10894082|NCT00602030|12060009|FG000|STARTED|Double-blind Phase||0
10894083|NCT00602030|12060010|FG001|STARTED|Double-blind Phase||0
10894084|NCT00602030|12060011|FG002|STARTED|Double-blind Phase||65
10894085|NCT00602030|12060012|FG003|STARTED|Double-blind Phase||67
10894086|NCT00602030|12060013|FG004|STARTED|Double-blind Phase||0
10894087|NCT00602030|12060009|FG000|Received Treatment|Double-blind Phase||0
10894088|NCT00602030|12060010|FG001|Received Treatment|Double-blind Phase||0
10894089|NCT00602030|12060011|FG002|Received Treatment|Double-blind Phase||63
10894090|NCT00602030|12060012|FG003|Received Treatment|Double-blind Phase||65
10894091|NCT00602030|12060013|FG004|Received Treatment|Double-blind Phase||0
10894092|NCT00602030|12060009|FG000|COMPLETED|Double-blind Phase||0
10894093|NCT00602030|12060010|FG001|COMPLETED|Double-blind Phase||0
10894094|NCT00602030|12060011|FG002|COMPLETED|Double-blind Phase||11
10894095|NCT00602030|12060012|FG003|COMPLETED|Double-blind Phase||8
10894096|NCT00602030|12060013|FG004|COMPLETED|Double-blind Phase||0
10894097|NCT00602030|12060009|FG000|NOT COMPLETED|Double-blind Phase||0
10894098|NCT00602030|12060010|FG001|NOT COMPLETED|Double-blind Phase||0
10894099|NCT00602030|12060011|FG002|NOT COMPLETED|Double-blind Phase||54
10894100|NCT00602030|12060012|FG003|NOT COMPLETED|Double-blind Phase||59
10894101|NCT00602030|12060013|FG004|NOT COMPLETED|Double-blind Phase||0
10894102|NCT00602030|12060009|FG000|STARTED|Crossover Phase||0
10894103|NCT00602030|12060010|FG001|STARTED|Crossover Phase||0
10894104|NCT00602030|12060011|FG002|STARTED|Crossover Phase||0
10894105|NCT00602030|12060012|FG003|STARTED|Crossover Phase||0
10894106|NCT00602030|12060013|FG004|STARTED|Crossover Phase||16
10894107|NCT00602030|12060009|FG000|COMPLETED|Crossover Phase||0
10894108|NCT00602030|12060010|FG001|COMPLETED|Crossover Phase||0
10894109|NCT00602030|12060011|FG002|COMPLETED|Crossover Phase||0
10894110|NCT00602030|12060012|FG003|COMPLETED|Crossover Phase||0
10894111|NCT00602030|12060013|FG004|COMPLETED|Crossover Phase||0
10894112|NCT00602030|12060009|FG000|NOT COMPLETED|Crossover Phase||0
10894113|NCT00602030|12060010|FG001|NOT COMPLETED|Crossover Phase||0
10894114|NCT00602030|12060011|FG002|NOT COMPLETED|Crossover Phase||0
10894115|NCT00602030|12060012|FG003|NOT COMPLETED|Crossover Phase||0
10894116|NCT00602030|12060013|FG004|NOT COMPLETED|Crossover Phase||16
10894117|NCT00601900|12060027|FG000|STARTED|Overall Study||195
10894118|NCT00601900|12060028|FG001|STARTED|Overall Study||199
10894119|NCT00601900|12060027|FG000|COMPLETED|Overall Study||195
10894120|NCT00601900|12060028|FG001|COMPLETED|Overall Study||196
10894121|NCT00601900|12060027|FG000|NOT COMPLETED|Overall Study||0
10894122|NCT00601900|12060028|FG001|NOT COMPLETED|Overall Study||3
10894123|NCT00597012|12060036|FG000|STARTED|Overall Study||174
10894124|NCT00597012|12060037|FG001|STARTED|Overall Study||177
10894125|NCT00597012|12060036|FG000|COMPLETED|Overall Study||161
10894126|NCT00597012|12060037|FG001|COMPLETED|Overall Study||169
10894127|NCT00597012|12060036|FG000|NOT COMPLETED|Overall Study||13
10894128|NCT00597012|12060037|FG001|NOT COMPLETED|Overall Study||8
10894129|NCT00588770|12060047|FG000|STARTED|Overall Study||200
10894130|NCT00588770|12060048|FG001|STARTED|Overall Study||203
10894131|NCT00588770|12060047|FG000|Eligible|Overall Study||188
10894132|NCT00588770|12060048|FG001|Eligible|Overall Study||183
10894133|NCT00588770|12060047|FG000|Start Protocol Therapy|Overall Study||200
10894134|NCT00588770|12060048|FG001|Start Protocol Therapy|Overall Study||194
10894135|NCT00588770|12060047|FG000|COMPLETED|Overall Study||41
10894136|NCT00588770|12060048|FG001|COMPLETED|Overall Study||3
10894137|NCT00588770|12060047|FG000|NOT COMPLETED|Overall Study||159
10894138|NCT00588770|12060048|FG001|NOT COMPLETED|Overall Study||200
10894139|NCT00580489|12060056|FG000|STARTED|Overall Study||104
10894140|NCT00580489|12060057|FG001|STARTED|Overall Study||100
10894141|NCT00580489|12060056|FG000|COMPLETED|Overall Study||104
10894142|NCT00580489|12060057|FG001|COMPLETED|Overall Study||100
10894143|NCT00580489|12060056|FG000|NOT COMPLETED|Overall Study||0
10894144|NCT00580489|12060057|FG001|NOT COMPLETED|Overall Study||0
10894145|NCT00569127|12060067|FG000|STARTED|Overall Study||214
10894146|NCT00569127|12060068|FG001|STARTED|Overall Study||213
10894147|NCT00569127|12060067|FG000|Eligible|Overall Study||200
10894148|NCT00569127|12060068|FG001|Eligible|Overall Study||202
10894149|NCT00569127|12060067|FG000|COMPLETED|Overall Study||0
10894150|NCT00569127|12060068|FG001|COMPLETED|Overall Study||0
10894151|NCT00569127|12060067|FG000|NOT COMPLETED|Overall Study||214
10894152|NCT00569127|12060068|FG001|NOT COMPLETED|Overall Study||213
10894153|NCT00565851|12060082|FG000|STARTED|Surgical Assignment||316
10894154|NCT00565851|12060083|FG001|STARTED|Surgical Assignment||456
10894155|NCT00565851|12060084|FG002|STARTED|Surgical Assignment||33
10894156|NCT00565851|12060085|FG003|STARTED|Surgical Assignment||165
10894157|NCT00565851|12060086|FG004|STARTED|Surgical Assignment||6
10894158|NCT00565851|12060087|FG005|STARTED|Surgical Assignment||34
10894159|NCT00565851|12060088|FG006|STARTED|Surgical Assignment||5
10894160|NCT00565851|12060089|FG007|STARTED|Surgical Assignment||37
10894161|NCT00565851|12060082|FG000|Randomized - Yes Surgery|Surgical Assignment||0
10894162|NCT00565851|12060083|FG001|Randomized - Yes Surgery|Surgical Assignment||0
10894163|NCT00565851|12060084|FG002|Randomized - Yes Surgery|Surgical Assignment||33
10894164|NCT00565851|12060085|FG003|Randomized - Yes Surgery|Surgical Assignment||165
10894165|NCT00565851|12060086|FG004|Randomized - Yes Surgery|Surgical Assignment||0
10894166|NCT00565851|12060087|FG005|Randomized - Yes Surgery|Surgical Assignment||0
10894167|NCT00565851|12060088|FG006|Randomized - Yes Surgery|Surgical Assignment||5
10894168|NCT00565851|12060089|FG007|Randomized - Yes Surgery|Surgical Assignment||37
10894169|NCT00565851|12060082|FG000|Randomized - no Surgery|Surgical Assignment||33
10894170|NCT00565851|12060083|FG001|Randomized - no Surgery|Surgical Assignment||172
10894171|NCT00565851|12060084|FG002|Randomized - no Surgery|Surgical Assignment||0
10894172|NCT00565851|12060085|FG003|Randomized - no Surgery|Surgical Assignment||0
10894173|NCT00565851|12060086|FG004|Randomized - no Surgery|Surgical Assignment||6
10894174|NCT00565851|12060087|FG005|Randomized - no Surgery|Surgical Assignment||34
10894175|NCT00565851|12060088|FG006|Randomized - no Surgery|Surgical Assignment||0
10894176|NCT00565851|12060089|FG007|Randomized - no Surgery|Surgical Assignment||0
10894177|NCT00565851|12060082|FG000|Not Surgical Candidate|Surgical Assignment||283
10894178|NCT00565851|12060083|FG001|Not Surgical Candidate|Surgical Assignment||284
10894179|NCT00565851|12060084|FG002|Not Surgical Candidate|Surgical Assignment||0
10894180|NCT00565851|12060085|FG003|Not Surgical Candidate|Surgical Assignment||0
10894181|NCT00565851|12060086|FG004|Not Surgical Candidate|Surgical Assignment||0
10894182|NCT00565851|12060087|FG005|Not Surgical Candidate|Surgical Assignment||0
10894183|NCT00565851|12060088|FG006|Not Surgical Candidate|Surgical Assignment||0
10894184|NCT00565851|12060089|FG007|Not Surgical Candidate|Surgical Assignment||0
10894185|NCT00565851|12060082|FG000|COMPLETED|Surgical Assignment||313
10894186|NCT00565851|12060083|FG001|COMPLETED|Surgical Assignment||454
10894187|NCT00565851|12060084|FG002|COMPLETED|Surgical Assignment||31
10894188|NCT00565851|12060085|FG003|COMPLETED|Surgical Assignment||154
10894189|NCT00565851|12060086|FG004|COMPLETED|Surgical Assignment||6
10894190|NCT00565851|12060087|FG005|COMPLETED|Surgical Assignment||34
10894191|NCT00565851|12060088|FG006|COMPLETED|Surgical Assignment||5
10894192|NCT00565851|12060089|FG007|COMPLETED|Surgical Assignment||35
10894193|NCT00565851|12060082|FG000|NOT COMPLETED|Surgical Assignment||3
10894194|NCT00565851|12060083|FG001|NOT COMPLETED|Surgical Assignment||2
10894195|NCT00565851|12060084|FG002|NOT COMPLETED|Surgical Assignment||2
10894196|NCT00565851|12060085|FG003|NOT COMPLETED|Surgical Assignment||11
10894197|NCT00565851|12060086|FG004|NOT COMPLETED|Surgical Assignment||0
10894198|NCT00565851|12060087|FG005|NOT COMPLETED|Surgical Assignment||0
10894199|NCT00565851|12060088|FG006|NOT COMPLETED|Surgical Assignment||0
10894200|NCT00565851|12060089|FG007|NOT COMPLETED|Surgical Assignment||2
10894201|NCT00565851|12060082|FG000|STARTED|Chemotherapy Assignment||316
10894202|NCT00565851|12060083|FG001|STARTED|Chemotherapy Assignment||456
10894203|NCT00565851|12060084|FG002|STARTED|Chemotherapy Assignment||33
10894204|NCT00565851|12060085|FG003|STARTED|Chemotherapy Assignment||165
10894205|NCT00565851|12060086|FG004|STARTED|Chemotherapy Assignment||6
10894206|NCT00565851|12060087|FG005|STARTED|Chemotherapy Assignment||34
10894207|NCT00565851|12060088|FG006|STARTED|Chemotherapy Assignment||5
10894208|NCT00565851|12060089|FG007|STARTED|Chemotherapy Assignment||37
10894209|NCT00565851|12060082|FG000|Randomized to Chemo|Chemotherapy Assignment||310
10894210|NCT00565851|12060083|FG001|Randomized to Chemo|Chemotherapy Assignment||311
10894211|NCT00565851|12060084|FG002|Randomized to Chemo|Chemotherapy Assignment||27
10894212|NCT00565851|12060085|FG003|Randomized to Chemo|Chemotherapy Assignment||26
10894213|NCT00565851|12060086|FG004|Randomized to Chemo|Chemotherapy Assignment||0
10894214|NCT00565851|12060087|FG005|Randomized to Chemo|Chemotherapy Assignment||0
10894215|NCT00565851|12060088|FG006|Randomized to Chemo|Chemotherapy Assignment||0
10894216|NCT00565851|12060089|FG007|Randomized to Chemo|Chemotherapy Assignment||0
10894217|NCT00565851|12060082|FG000|Pre-specified Chemo|Chemotherapy Assignment||6
10894218|NCT00565851|12060083|FG001|Pre-specified Chemo|Chemotherapy Assignment||145
10894219|NCT00565851|12060084|FG002|Pre-specified Chemo|Chemotherapy Assignment||6
10894220|NCT00565851|12060085|FG003|Pre-specified Chemo|Chemotherapy Assignment||139
10894221|NCT00565851|12060086|FG004|Pre-specified Chemo|Chemotherapy Assignment||6
10894222|NCT00565851|12060087|FG005|Pre-specified Chemo|Chemotherapy Assignment||34
10894223|NCT00565851|12060088|FG006|Pre-specified Chemo|Chemotherapy Assignment||5
10894224|NCT00565851|12060089|FG007|Pre-specified Chemo|Chemotherapy Assignment||37
10894225|NCT00565851|12060082|FG000|COMPLETED|Chemotherapy Assignment||307
10894226|NCT00565851|12060083|FG001|COMPLETED|Chemotherapy Assignment||433
10894227|NCT00565851|12060084|FG002|COMPLETED|Chemotherapy Assignment||30
10894228|NCT00565851|12060085|FG003|COMPLETED|Chemotherapy Assignment||129
10894229|NCT00565851|12060086|FG004|COMPLETED|Chemotherapy Assignment||6
10894230|NCT00565851|12060087|FG005|COMPLETED|Chemotherapy Assignment||31
10894231|NCT00565851|12060088|FG006|COMPLETED|Chemotherapy Assignment||5
10894232|NCT00565851|12060089|FG007|COMPLETED|Chemotherapy Assignment||34
10894233|NCT00565851|12060082|FG000|NOT COMPLETED|Chemotherapy Assignment||9
10894234|NCT00565851|12060083|FG001|NOT COMPLETED|Chemotherapy Assignment||23
10894235|NCT00565851|12060084|FG002|NOT COMPLETED|Chemotherapy Assignment||3
10894236|NCT00565851|12060085|FG003|NOT COMPLETED|Chemotherapy Assignment||36
10894237|NCT00565851|12060086|FG004|NOT COMPLETED|Chemotherapy Assignment||0
10894238|NCT00565851|12060087|FG005|NOT COMPLETED|Chemotherapy Assignment||3
10894239|NCT00565851|12060088|FG006|NOT COMPLETED|Chemotherapy Assignment||0
10894240|NCT00565851|12060089|FG007|NOT COMPLETED|Chemotherapy Assignment||3
10894241|NCT00557193|12060111|FG000|STARTED|Induction||218
10894242|NCT00557193|12060112|FG001|STARTED|Induction||0
10894243|NCT00557193|12060113|FG002|STARTED|Induction||0
10894244|NCT00557193|12060114|FG003|STARTED|Induction||0
10894245|NCT00557193|12060115|FG004|STARTED|Induction||0
10894246|NCT00557193|12060116|FG005|STARTED|Induction||0
10894247|NCT00557193|12060111|FG000|COMPLETED|Induction||192
10894248|NCT00557193|12060112|FG001|COMPLETED|Induction||0
10894249|NCT00557193|12060113|FG002|COMPLETED|Induction||0
10894250|NCT00557193|12060114|FG003|COMPLETED|Induction||0
10894251|NCT00557193|12060115|FG004|COMPLETED|Induction||0
10894252|NCT00557193|12060116|FG005|COMPLETED|Induction||0
10894253|NCT00557193|12060111|FG000|NOT COMPLETED|Induction||26
10894254|NCT00557193|12060112|FG001|NOT COMPLETED|Induction||0
10894255|NCT00557193|12060113|FG002|NOT COMPLETED|Induction||0
10894256|NCT00557193|12060114|FG003|NOT COMPLETED|Induction||0
10894257|NCT00557193|12060115|FG004|NOT COMPLETED|Induction||0
10894258|NCT00557193|12060116|FG005|NOT COMPLETED|Induction||0
10894259|NCT00557193|12060111|FG000|STARTED|Post Induction Therapy by Tx Assignment||0
10894260|NCT00557193|12060112|FG001|STARTED|Post Induction Therapy by Tx Assignment||60
10894261|NCT00557193|12060113|FG002|STARTED|Post Induction Therapy by Tx Assignment||54
10894262|NCT00557193|12060114|FG003|STARTED|Post Induction Therapy by Tx Assignment||11
10894263|NCT00557193|12060115|FG004|STARTED|Post Induction Therapy by Tx Assignment||11
10894264|NCT00557193|12060116|FG005|STARTED|Post Induction Therapy by Tx Assignment||56
10894265|NCT00557193|12060111|FG000|COMPLETED|Post Induction Therapy by Tx Assignment||0
10894266|NCT00557193|12060112|FG001|COMPLETED|Post Induction Therapy by Tx Assignment||50
10894267|NCT00557193|12060113|FG002|COMPLETED|Post Induction Therapy by Tx Assignment||22
10894268|NCT00557193|12060114|FG003|COMPLETED|Post Induction Therapy by Tx Assignment||4
10894269|NCT00557193|12060115|FG004|COMPLETED|Post Induction Therapy by Tx Assignment||4
10894270|NCT00557193|12060116|FG005|COMPLETED|Post Induction Therapy by Tx Assignment||19
10894271|NCT00557193|12060111|FG000|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0
10894272|NCT00557193|12060112|FG001|NOT COMPLETED|Post Induction Therapy by Tx Assignment||10
10894273|NCT00557193|12060113|FG002|NOT COMPLETED|Post Induction Therapy by Tx Assignment||32
10894274|NCT00557193|12060114|FG003|NOT COMPLETED|Post Induction Therapy by Tx Assignment||7
10894275|NCT00557193|12060115|FG004|NOT COMPLETED|Post Induction Therapy by Tx Assignment||7
10894276|NCT00557193|12060116|FG005|NOT COMPLETED|Post Induction Therapy by Tx Assignment||37
10894277|NCT00556374|12060143|FG000|STARTED|Overall Study||1709
10894278|NCT00556374|12060144|FG001|STARTED|Overall Study||1711
10894279|NCT00556374|12060143|FG000|Received Study Drug|Overall Study||1699
10894280|NCT00556374|12060144|FG001|Received Study Drug|Overall Study||1700
10894281|NCT00556374|12060143|FG000|COMPLETED|Overall Study|Indicates participants continuing study|1462
10894282|NCT00556374|12060144|FG001|COMPLETED|Overall Study|Indicates participants continuing study|1491
10894283|NCT00556374|12060143|FG000|NOT COMPLETED|Overall Study||247
10894284|NCT00556374|12060144|FG001|NOT COMPLETED|Overall Study||220
10894285|NCT00549848|12060153|FG000|STARTED|Overall Study||206
10894286|NCT00549848|12060154|FG001|STARTED|Overall Study||208
10894287|NCT00549848|12060155|FG002|STARTED|Overall Study||184
10894288|NCT00549848|12060153|FG000|COMPLETED|Overall Study||194
10894289|NCT00549848|12060154|FG001|COMPLETED|Overall Study||188
10894290|NCT00549848|12060155|FG002|COMPLETED|Overall Study||133
10894291|NCT00549848|12060153|FG000|NOT COMPLETED|Overall Study||12
10894292|NCT00549848|12060154|FG001|NOT COMPLETED|Overall Study||20
10894293|NCT00549848|12060155|FG002|NOT COMPLETED|Overall Study||51
10894294|NCT00530062|12060171|FG000|STARTED|Overall Study||49
10894295|NCT00530062|12060171|FG000|Received at Least 1 Dose of Study Drug|Overall Study||49
10894296|NCT00530062|12060171|FG000|COMPLETED|Overall Study||49
10894297|NCT00530062|12060171|FG000|NOT COMPLETED|Overall Study||0
10894298|NCT00523341|12060179|FG000|STARTED|Overall Study||2207
10894299|NCT00523341|12060180|FG001|STARTED|Overall Study||2343
10894300|NCT00523341|12060179|FG000|Received Treatment|Overall Study||2206
10894301|NCT00523341|12060180|FG001|Received Treatment|Overall Study||2343
10894302|NCT00523341|12060179|FG000|COMPLETED|Overall Study||1283
10894303|NCT00523341|12060180|FG001|COMPLETED|Overall Study||1343
10894304|NCT00523341|12060179|FG000|NOT COMPLETED|Overall Study||924
10894305|NCT00523341|12060180|FG001|NOT COMPLETED|Overall Study||1000
10894306|NCT00520767|12060186|FG000|STARTED|Overall Study||35
10894307|NCT00520767|12060186|FG000|COMPLETED|Overall Study||33
10894308|NCT00520767|12060186|FG000|NOT COMPLETED|Overall Study||2
10894309|NCT00508820|12060192|FG000|STARTED|Overall Study||168
10894310|NCT00508820|12060193|FG001|STARTED|Overall Study||239
10894311|NCT00508820|12060192|FG000|COMPLETED|Overall Study||113
10894312|NCT00508820|12060193|FG001|COMPLETED|Overall Study||175
10894313|NCT00508820|12060192|FG000|NOT COMPLETED|Overall Study||55
10894314|NCT00508820|12060193|FG001|NOT COMPLETED|Overall Study||64
10894315|NCT00493467|12060199|FG000|STARTED|Overall Study||31
10894316|NCT00493467|12060199|FG000|COMPLETED|Overall Study||30
10894317|NCT00493467|12060199|FG000|NOT COMPLETED|Overall Study||1
10894318|NCT00486889|12060203|FG000|STARTED|Overall Study||12
10894319|NCT00486889|12060203|FG000|COMPLETED|Overall Study||1
10894320|NCT00486889|12060203|FG000|NOT COMPLETED|Overall Study||11
10894321|NCT00472212|12060209|FG000|STARTED|Overall Study||31
10894322|NCT00472212|12060210|FG001|STARTED|Overall Study||27
10894323|NCT00472212|12060209|FG000|COMPLETED|Overall Study||25
10894324|NCT00472212|12060210|FG001|COMPLETED|Overall Study||23
10894325|NCT00472212|12060209|FG000|NOT COMPLETED|Overall Study||6
10894326|NCT00472212|12060210|FG001|NOT COMPLETED|Overall Study||4
10894327|NCT00470704|12060218|FG000|STARTED|Overall Study||41
10894328|NCT00470704|12060219|FG001|STARTED|Overall Study||46
10894329|NCT00470704|12060218|FG000|Safety Population|Overall Study||41
10894330|NCT00470704|12060219|FG001|Safety Population|Overall Study||45
10894331|NCT00470704|12060218|FG000|Treated|Overall Study||40
10894332|NCT00470704|12060219|FG001|Treated|Overall Study||45
10894333|NCT00470704|12060218|FG000|COMPLETED|Overall Study||0
10894334|NCT00470704|12060219|FG001|COMPLETED|Overall Study||0
10894335|NCT00470704|12060218|FG000|NOT COMPLETED|Overall Study||41
10894336|NCT00470704|12060219|FG001|NOT COMPLETED|Overall Study||46
10894337|NCT00468715|12060225|FG000|STARTED|Overall Study||28
10894338|NCT00468715|12060225|FG000|COMPLETED|Overall Study||28
10894339|NCT00468715|12060225|FG000|NOT COMPLETED|Overall Study||0
10894340|NCT00436566|12060229|FG000|STARTED|Overall Study||112
10894341|NCT00436566|12060229|FG000|COMPLETED|Overall Study||109
10894342|NCT00436566|12060229|FG000|NOT COMPLETED|Overall Study||3
10894343|NCT00433511|12060236|FG000|STARTED|Step 1||1000
10894344|NCT00433511|12060237|FG001|STARTED|Step 1||1986
10894345|NCT00433511|12060238|FG002|STARTED|Step 1||2008
10894346|NCT00433511|12060236|FG000|Patients Who Received Treatment|Step 1||972
10894347|NCT00433511|12060237|FG001|Patients Who Received Treatment|Step 1||1922
10894348|NCT00433511|12060238|FG002|Patients Who Received Treatment|Step 1||1942
10894349|NCT00433511|12060236|FG000|Patients in Genetic Ancestry Analysis|Step 1||575
10894350|NCT00433511|12060237|FG001|Patients in Genetic Ancestry Analysis|Step 1||1126
10894351|NCT00433511|12060238|FG002|Patients in Genetic Ancestry Analysis|Step 1||1158
10894352|NCT00433511|12060236|FG000|COMPLETED|Step 1||864
10894353|NCT00433511|12060237|FG001|COMPLETED|Step 1||1601
10894354|NCT00433511|12060238|FG002|COMPLETED|Step 1||1618
10894355|NCT00433511|12060236|FG000|NOT COMPLETED|Step 1||136
10894356|NCT00433511|12060237|FG001|NOT COMPLETED|Step 1||385
10894357|NCT00433511|12060238|FG002|NOT COMPLETED|Step 1||390
10894358|NCT00433511|12060236|FG000|STARTED|Step 2 (Arm D)|Only Arm C patients at Step 1 who did not end protocol therapy early were eligible for Step 2, Arm D|0
10894359|NCT00433511|12060237|FG001|STARTED|Step 2 (Arm D)|Only Arm C patients at Step 1 who did not end protocol therapy early were eligible for Step 2, Arm D|0
10894360|NCT00433511|12060238|FG002|STARTED|Step 2 (Arm D)|Only Arm C patients at Step 1 who did not end protocol therapy early were eligible for Step 2, Arm D|1316
10894361|NCT00433511|12060236|FG000|Patients Who Received Treatment|Step 2 (Arm D)||0
10894362|NCT00433511|12060237|FG001|Patients Who Received Treatment|Step 2 (Arm D)||0
10894363|NCT00433511|12060238|FG002|Patients Who Received Treatment|Step 2 (Arm D)||1168
10894364|NCT00433511|12060236|FG000|COMPLETED|Step 2 (Arm D)||0
10894365|NCT00433511|12060237|FG001|COMPLETED|Step 2 (Arm D)||0
10894366|NCT00433511|12060238|FG002|COMPLETED|Step 2 (Arm D)||825
10894367|NCT00433511|12060236|FG000|NOT COMPLETED|Step 2 (Arm D)||0
10894368|NCT00433511|12060237|FG001|NOT COMPLETED|Step 2 (Arm D)||0
10894369|NCT00433511|12060238|FG002|NOT COMPLETED|Step 2 (Arm D)||491
10894370|NCT00432965|12060251|FG000|STARTED|Overall Study||169
10894371|NCT00432965|12060252|FG001|STARTED|Overall Study||166
10894372|NCT00432965|12060251|FG000|COMPLETED|Overall Study||75
10894373|NCT00432965|12060252|FG001|COMPLETED|Overall Study||80
10894374|NCT00432965|12060251|FG000|NOT COMPLETED|Overall Study||94
10894375|NCT00432965|12060252|FG001|NOT COMPLETED|Overall Study||86
10894376|NCT00415532|12060260|FG000|STARTED|Treatment Period||77
10894377|NCT00415532|12060261|FG001|STARTED|Treatment Period||157
10894378|NCT00415532|12060260|FG000|Received Treatment|Treatment Period||75
10894379|NCT00415532|12060261|FG001|Received Treatment|Treatment Period||154
10894380|NCT00415532|12060260|FG000|Switched to Romiplostim Group|Treatment Period||2
10894381|NCT00415532|12060261|FG001|Switched to Romiplostim Group|Treatment Period||0
10894382|NCT00415532|12060260|FG000|COMPLETED|Treatment Period||60
10894383|NCT00415532|12060261|FG001|COMPLETED|Treatment Period||142
10894384|NCT00415532|12060260|FG000|NOT COMPLETED|Treatment Period||17
10894385|NCT00415532|12060261|FG001|NOT COMPLETED|Treatment Period||15
10894386|NCT00415532|12060260|FG000|STARTED|Safety Follow Up Period|Participants who completed the treatment period were not required to participate in this follow-up|43
10894387|NCT00415532|12060261|FG001|STARTED|Safety Follow Up Period|Participants who completed the treatment period were not required to participate in this follow-up|30
10894388|NCT00415532|12060260|FG000|COMPLETED|Safety Follow Up Period||34
10894389|NCT00415532|12060261|FG001|COMPLETED|Safety Follow Up Period||18
10894390|NCT00415532|12060260|FG000|NOT COMPLETED|Safety Follow Up Period||9
10894391|NCT00415532|12060261|FG001|NOT COMPLETED|Safety Follow Up Period||12
10894392|NCT00408005|12060269|FG000|STARTED|Induction||1596
10894393|NCT00408005|12060270|FG001|STARTED|Induction||299
10894394|NCT00408005|12060271|FG002|STARTED|Induction||0
10894395|NCT00408005|12060272|FG003|STARTED|Induction||0
10894396|NCT00408005|12060273|FG004|STARTED|Induction||0
10894397|NCT00408005|12060274|FG005|STARTED|Induction||0
10894398|NCT00408005|12060275|FG006|STARTED|Induction||0
10894399|NCT00408005|12060276|FG007|STARTED|Induction||0
10894400|NCT00408005|12060269|FG000|COMPLETED|Induction||1189
10894401|NCT00408005|12060270|FG001|COMPLETED|Induction||205
10894402|NCT00408005|12060271|FG002|COMPLETED|Induction||0
10894403|NCT00408005|12060272|FG003|COMPLETED|Induction||0
10894404|NCT00408005|12060273|FG004|COMPLETED|Induction||0
10894405|NCT00408005|12060274|FG005|COMPLETED|Induction||0
10894406|NCT00408005|12060275|FG006|COMPLETED|Induction||0
10894407|NCT00408005|12060276|FG007|COMPLETED|Induction||0
10894408|NCT00408005|12060269|FG000|NOT COMPLETED|Induction||407
10894409|NCT00408005|12060270|FG001|NOT COMPLETED|Induction||94
10894410|NCT00408005|12060271|FG002|NOT COMPLETED|Induction||0
10894411|NCT00408005|12060272|FG003|NOT COMPLETED|Induction||0
10894412|NCT00408005|12060273|FG004|NOT COMPLETED|Induction||0
10894413|NCT00408005|12060274|FG005|NOT COMPLETED|Induction||0
10894414|NCT00408005|12060275|FG006|NOT COMPLETED|Induction||0
10894415|NCT00408005|12060276|FG007|NOT COMPLETED|Induction||0
10894416|NCT00408005|12060269|FG000|STARTED|Post Induction Therapy by Tx Assignment||0
10894417|NCT00408005|12060270|FG001|STARTED|Post Induction Therapy by Tx Assignment||0
10894418|NCT00408005|12060271|FG002|STARTED|Post Induction Therapy by Tx Assignment||372
10894419|NCT00408005|12060272|FG003|STARTED|Post Induction Therapy by Tx Assignment||147
10894420|NCT00408005|12060273|FG004|STARTED|Post Induction Therapy by Tx Assignment||451
10894421|NCT00408005|12060274|FG005|STARTED|Post Induction Therapy by Tx Assignment||219
10894422|NCT00408005|12060275|FG006|STARTED|Post Induction Therapy by Tx Assignment||143
10894423|NCT00408005|12060276|FG007|STARTED|Post Induction Therapy by Tx Assignment||62
10894424|NCT00408005|12060269|FG000|Low Risk|Post Induction Therapy by Tx Assignment||0
10894425|NCT00408005|12060270|FG001|Low Risk|Post Induction Therapy by Tx Assignment||0
10894426|NCT00408005|12060271|FG002|Low Risk|Post Induction Therapy by Tx Assignment||217
10894427|NCT00408005|12060272|FG003|Low Risk|Post Induction Therapy by Tx Assignment||0
10894428|NCT00408005|12060273|FG004|Low Risk|Post Induction Therapy by Tx Assignment||55
10894429|NCT00408005|12060274|FG005|Low Risk|Post Induction Therapy by Tx Assignment||0
10894430|NCT00408005|12060275|FG006|Low Risk|Post Induction Therapy by Tx Assignment||0
10894431|NCT00408005|12060276|FG007|Low Risk|Post Induction Therapy by Tx Assignment||0
10894432|NCT00408005|12060269|FG000|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
10894433|NCT00408005|12060270|FG001|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
10894434|NCT00408005|12060271|FG002|Intermediate Risk|Post Induction Therapy by Tx Assignment||99
10894435|NCT00408005|12060272|FG003|Intermediate Risk|Post Induction Therapy by Tx Assignment||95
10894436|NCT00408005|12060273|FG004|Intermediate Risk|Post Induction Therapy by Tx Assignment||257
10894437|NCT00408005|12060274|FG005|Intermediate Risk|Post Induction Therapy by Tx Assignment||93
10894438|NCT00408005|12060275|FG006|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
10894439|NCT00408005|12060276|FG007|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
10894440|NCT00408005|12060269|FG000|High Risk|Post Induction Therapy by Tx Assignment||0
10894441|NCT00408005|12060270|FG001|High Risk|Post Induction Therapy by Tx Assignment||0
10894442|NCT00408005|12060271|FG002|High Risk|Post Induction Therapy by Tx Assignment||56
10894443|NCT00408005|12060272|FG003|High Risk|Post Induction Therapy by Tx Assignment||52
10894444|NCT00408005|12060273|FG004|High Risk|Post Induction Therapy by Tx Assignment||55
10894445|NCT00408005|12060274|FG005|High Risk|Post Induction Therapy by Tx Assignment||52
10894446|NCT00408005|12060275|FG006|High Risk|Post Induction Therapy by Tx Assignment||0
10894447|NCT00408005|12060276|FG007|High Risk|Post Induction Therapy by Tx Assignment||0
10894448|NCT00408005|12060269|FG000|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
10894449|NCT00408005|12060270|FG001|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
10894450|NCT00408005|12060271|FG002|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
10894451|NCT00408005|12060272|FG003|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
10894452|NCT00408005|12060273|FG004|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||84
10894453|NCT00408005|12060274|FG005|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||31
10894454|NCT00408005|12060275|FG006|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
10894455|NCT00408005|12060276|FG007|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
10894456|NCT00408005|12060269|FG000|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
10894457|NCT00408005|12060270|FG001|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
10894458|NCT00408005|12060271|FG002|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
10894459|NCT00408005|12060272|FG003|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
10894460|NCT00408005|12060273|FG004|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
10894461|NCT00408005|12060274|FG005|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||43
10894462|NCT00408005|12060275|FG006|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
10894463|NCT00408005|12060276|FG007|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
10894464|NCT00408005|12060269|FG000|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
10894465|NCT00408005|12060270|FG001|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
10894466|NCT00408005|12060271|FG002|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
10894467|NCT00408005|12060272|FG003|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
10894468|NCT00408005|12060273|FG004|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
10894469|NCT00408005|12060274|FG005|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
10894470|NCT00408005|12060275|FG006|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||82
10894471|NCT00408005|12060276|FG007|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
10894472|NCT00408005|12060269|FG000|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
10894473|NCT00408005|12060270|FG001|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
10894474|NCT00408005|12060271|FG002|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
10894475|NCT00408005|12060272|FG003|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
10894476|NCT00408005|12060273|FG004|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
10894477|NCT00408005|12060274|FG005|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
10894478|NCT00408005|12060275|FG006|T-LLy High Risk|Post Induction Therapy by Tx Assignment||61
10894479|NCT00408005|12060276|FG007|T-LLy High Risk|Post Induction Therapy by Tx Assignment||60
10894480|NCT00408005|12060269|FG000|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
10894481|NCT00408005|12060270|FG001|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
10894482|NCT00408005|12060271|FG002|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
10894483|NCT00408005|12060272|FG003|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
10894484|NCT00408005|12060273|FG004|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
10894485|NCT00408005|12060274|FG005|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
10894486|NCT00408005|12060275|FG006|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
10894487|NCT00408005|12060276|FG007|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||2
10894488|NCT00408005|12060269|FG000|COMPLETED|Post Induction Therapy by Tx Assignment||0
10894489|NCT00408005|12060270|FG001|COMPLETED|Post Induction Therapy by Tx Assignment||0
10894490|NCT00408005|12060271|FG002|COMPLETED|Post Induction Therapy by Tx Assignment||287
10894491|NCT00408005|12060272|FG003|COMPLETED|Post Induction Therapy by Tx Assignment||103
10894492|NCT00408005|12060273|FG004|COMPLETED|Post Induction Therapy by Tx Assignment||319
10894493|NCT00408005|12060274|FG005|COMPLETED|Post Induction Therapy by Tx Assignment||118
10894494|NCT00408005|12060275|FG006|COMPLETED|Post Induction Therapy by Tx Assignment||115
10894495|NCT00408005|12060276|FG007|COMPLETED|Post Induction Therapy by Tx Assignment||48
10894496|NCT00408005|12060269|FG000|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0
10894497|NCT00408005|12060270|FG001|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0
10894498|NCT00408005|12060271|FG002|NOT COMPLETED|Post Induction Therapy by Tx Assignment||85
10894499|NCT00408005|12060272|FG003|NOT COMPLETED|Post Induction Therapy by Tx Assignment||44
10894500|NCT00408005|12060273|FG004|NOT COMPLETED|Post Induction Therapy by Tx Assignment||132
10894501|NCT00408005|12060274|FG005|NOT COMPLETED|Post Induction Therapy by Tx Assignment||101
10894502|NCT00408005|12060275|FG006|NOT COMPLETED|Post Induction Therapy by Tx Assignment||28
10894503|NCT00408005|12060276|FG007|NOT COMPLETED|Post Induction Therapy by Tx Assignment||14
10894504|NCT00394147|12060296|FG000|STARTED|Overall Study||17
10894505|NCT00394147|12060296|FG000|COMPLETED|Overall Study||17
10894506|NCT00394147|12060296|FG000|NOT COMPLETED|Overall Study||0
10894507|NCT00389610|12060302|FG000|STARTED|Overall Study||11
10894508|NCT00389610|12060303|FG001|STARTED|Overall Study||45
10894509|NCT00389610|12060302|FG000|COMPLETED|Overall Study||11
10894510|NCT00389610|12060303|FG001|COMPLETED|Overall Study|milestone period is defined as receiving at least one booster vaccine|23
10894511|NCT00389610|12060302|FG000|NOT COMPLETED|Overall Study||0
10894512|NCT00389610|12060303|FG001|NOT COMPLETED|Overall Study||22
10894513|NCT00383708|12060309|FG000|STARTED|Enrolment Through Start Treatment||125
10894514|NCT00383708|12060309|FG000|COMPLETED|Enrolment Through Start Treatment||92
10894515|NCT00383708|12060309|FG000|NOT COMPLETED|Enrolment Through Start Treatment||33
10894516|NCT00383708|12060309|FG000|STARTED|Run-in Period||92
10894517|NCT00383708|12060309|FG000|COMPLETED|Run-in Period||85
10894518|NCT00383708|12060309|FG000|NOT COMPLETED|Run-in Period||7
10894519|NCT00383708|12060309|FG000|STARTED|Co-administration Period||57
10894520|NCT00383708|12060309|FG000|COMPLETED|Co-administration Period||52
10894521|NCT00383708|12060309|FG000|NOT COMPLETED|Co-administration Period||5
10894522|NCT00377156|12060316|FG000|STARTED|Overall Study||111
10894523|NCT00377156|12060317|FG001|STARTED|Overall Study||102
10894524|NCT00377156|12060316|FG000|COMPLETED|Overall Study||63
10894525|NCT00377156|12060317|FG001|COMPLETED|Overall Study||48
10894526|NCT00377156|12060316|FG000|NOT COMPLETED|Overall Study||48
10894527|NCT00377156|12060317|FG001|NOT COMPLETED|Overall Study||54
10894528|NCT00373217|12060327|FG000|STARTED|Overall Study||3
10894529|NCT00373217|12060328|FG001|STARTED|Overall Study||3
10894530|NCT00373217|12060327|FG000|COMPLETED|Overall Study||2
10894531|NCT00373217|12060328|FG001|COMPLETED|Overall Study||3
10894532|NCT00373217|12060327|FG000|NOT COMPLETED|Overall Study||1
10894533|NCT00373217|12060328|FG001|NOT COMPLETED|Overall Study||0
10894534|NCT00364013|12060336|FG000|STARTED|Overall Study||593
10894535|NCT00364013|12060337|FG001|STARTED|Overall Study||590
10894536|NCT00364013|12060336|FG000|Received Study Drug|Overall Study|One participant randomized to this group did not receive any panitumumab|586
10894537|NCT00364013|12060337|FG001|Received Study Drug|Overall Study||583
10894538|NCT00364013|12060336|FG000|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|492
10894539|NCT00364013|12060337|FG001|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|495
10894540|NCT00364013|12060336|FG000|NOT COMPLETED|Overall Study||101
10894541|NCT00364013|12060337|FG001|NOT COMPLETED|Overall Study||95
10894542|NCT00345839|12060349|FG000|STARTED|Overall Study|Randomized to cinacalcet|1948
10894543|NCT00345839|12060350|FG001|STARTED|Overall Study|Randomized to placebo|1935
10894544|NCT00345839|12060349|FG000|COMPLETED|Overall Study|Participants who completed study includes those with ended study due to death.|1799
10894545|NCT00345839|12060350|FG001|COMPLETED|Overall Study|Participants who completed study includes those with ended study due to death.|1776
10894546|NCT00345839|12060349|FG000|NOT COMPLETED|Overall Study||149
10894547|NCT00345839|12060350|FG001|NOT COMPLETED|Overall Study||159
10894548|NCT00339183|12060358|FG000|STARTED|Overall Study||591
10894549|NCT00339183|12060359|FG001|STARTED|Overall Study||595
10894550|NCT00339183|12060358|FG000|Received Study Drug|Overall Study|Includes one participant who received FOLFIRI Alone|588
10894551|NCT00339183|12060359|FG001|Received Study Drug|Overall Study||593
10894552|NCT00339183|12060358|FG000|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|470
10894638|NCT00278915|12060448|FG000|COMPLETED|Overall Study||29
10894553|NCT00339183|12060359|FG001|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|490
10894554|NCT00339183|12060358|FG000|NOT COMPLETED|Overall Study||121
10894555|NCT00339183|12060359|FG001|NOT COMPLETED|Overall Study||105
10894556|NCT00332605|12060372|FG000|STARTED|Overall Study||14
10894557|NCT00332605|12060373|FG001|STARTED|Overall Study||14
10894558|NCT00332605|12060374|FG002|STARTED|Overall Study||17
10894559|NCT00332605|12060372|FG000|COMPLETED|Overall Study||12
10894560|NCT00332605|12060373|FG001|COMPLETED|Overall Study||12
10894561|NCT00332605|12060374|FG002|COMPLETED|Overall Study||9
10894562|NCT00332605|12060372|FG000|NOT COMPLETED|Overall Study||2
10894563|NCT00332605|12060373|FG001|NOT COMPLETED|Overall Study||2
10894564|NCT00332605|12060374|FG002|NOT COMPLETED|Overall Study||8
10894565|NCT00326625|12060384|FG000|STARTED|Overall Study||184
10894566|NCT00326625|12060385|FG001|STARTED|Overall Study||182
10894567|NCT00326625|12060384|FG000|COMPLETED|Overall Study||130
10894568|NCT00326625|12060385|FG001|COMPLETED|Overall Study||144
10894569|NCT00326625|12060384|FG000|NOT COMPLETED|Overall Study||54
10894570|NCT00326625|12060385|FG001|NOT COMPLETED|Overall Study||38
10894571|NCT00324805|12060393|FG000|STARTED|Overall Study||749
10894572|NCT00324805|12060394|FG001|STARTED|Overall Study||752
10894573|NCT00324805|12060393|FG000|Started Assigned Therapy|Overall Study||737
10894574|NCT00324805|12060394|FG001|Started Assigned Therapy|Overall Study||735
10894575|NCT00324805|12060393|FG000|COMPLETED|Overall Study||599
10894576|NCT00324805|12060394|FG001|COMPLETED|Overall Study||269
10894577|NCT00324805|12060393|FG000|NOT COMPLETED|Overall Study||150
10894578|NCT00324805|12060394|FG001|NOT COMPLETED|Overall Study||483
10894579|NCT00323063|12060402|FG000|STARTED|Overall Study||26
10894580|NCT00323063|12060403|FG001|STARTED|Overall Study||23
10894581|NCT00323063|12060402|FG000|COMPLETED|Overall Study||24
10894582|NCT00323063|12060403|FG001|COMPLETED|Overall Study||23
10894583|NCT00323063|12060402|FG000|NOT COMPLETED|Overall Study||2
10894584|NCT00323063|12060403|FG001|NOT COMPLETED|Overall Study||0
10894585|NCT00310180|12060413|FG000|STARTED|Overall Study||1629
10894586|NCT00310180|12060414|FG001|STARTED|Overall Study||3458
10894587|NCT00310180|12060415|FG002|STARTED|Overall Study||3449
10894588|NCT00310180|12060416|FG003|STARTED|Overall Study||1737
10894589|NCT00310180|12060413|FG000|No On-study Data|Overall Study||0
10894590|NCT00310180|12060414|FG001|No On-study Data|Overall Study||2
10894591|NCT00310180|12060415|FG002|No On-study Data|Overall Study||10
10894592|NCT00310180|12060416|FG003|No On-study Data|Overall Study||172
10894593|NCT00310180|12060413|FG000|Ineligible|Overall Study||3
10894594|NCT00310180|12060414|FG001|Ineligible|Overall Study||4
10894595|NCT00310180|12060415|FG002|Ineligible|Overall Study||6
10894596|NCT00310180|12060416|FG003|Ineligible|Overall Study||7
10894597|NCT00310180|12060413|FG000|No Follow-up Data|Overall Study||7
10894598|NCT00310180|12060414|FG001|No Follow-up Data|Overall Study||55
10894599|NCT00310180|12060415|FG002|No Follow-up Data|Overall Study||131
10894600|NCT00310180|12060416|FG003|No Follow-up Data|Overall Study||245
10894601|NCT00310180|12060413|FG000|COMPLETED|Overall Study||1619
10894602|NCT00310180|12060414|FG001|COMPLETED|Overall Study||3399
10894603|NCT00310180|12060415|FG002|COMPLETED|Overall Study||3312
10894604|NCT00310180|12060416|FG003|COMPLETED|Overall Study||1389
10894605|NCT00310180|12060413|FG000|NOT COMPLETED|Overall Study||10
10894606|NCT00310180|12060414|FG001|NOT COMPLETED|Overall Study||59
10894607|NCT00310180|12060415|FG002|NOT COMPLETED|Overall Study||137
10894608|NCT00310180|12060416|FG003|NOT COMPLETED|Overall Study||348
10894609|NCT00302952|12060428|FG000|STARTED|Overall Study||34
10894610|NCT00302952|12060429|FG001|STARTED|Overall Study||30
10894611|NCT00302952|12060428|FG000|Started Intent-to-Treat (ITT)|Overall Study||34
10894612|NCT00302952|12060429|FG001|Started Intent-to-Treat (ITT)|Overall Study||30
10894613|NCT00302952|12060428|FG000|Completed Intent-to-Treat (ITT)|Overall Study||34
10894614|NCT00302952|12060429|FG001|Completed Intent-to-Treat (ITT)|Overall Study|One participant did not have a baseline C-reactive Protein and was excluded from the ITT population.|29
10894615|NCT00302952|12060428|FG000|COMPLETED|Overall Study||31
10894616|NCT00302952|12060429|FG001|COMPLETED|Overall Study||25
10894617|NCT00302952|12060428|FG000|NOT COMPLETED|Overall Study||3
10894618|NCT00302952|12060429|FG001|NOT COMPLETED|Overall Study||5
10894619|NCT00289094|12060437|FG000|STARTED|Overall Study||50
10894620|NCT00289094|12060438|FG001|STARTED|Overall Study||49
10894621|NCT00289094|12060437|FG000|COMPLETED|Overall Study||3
10894622|NCT00289094|12060438|FG001|COMPLETED|Overall Study||2
10894623|NCT00289094|12060437|FG000|NOT COMPLETED|Overall Study||47
10894624|NCT00289094|12060438|FG001|NOT COMPLETED|Overall Study||47
10894625|NCT00288509|12060444|FG000|STARTED|Treatment Cycle 1||108
10894626|NCT00288509|12060444|FG000|COMPLETED|Treatment Cycle 1||102
10894627|NCT00288509|12060444|FG000|NOT COMPLETED|Treatment Cycle 1||6
10894628|NCT00288509|12060444|FG000|STARTED|Treatment Cycle 2|2 subjects completed Cycle 1 but withdrew before Cycle 2 due to insufficient clinical response|100
10894629|NCT00288509|12060444|FG000|COMPLETED|Treatment Cycle 2||97
10894630|NCT00288509|12060444|FG000|NOT COMPLETED|Treatment Cycle 2||3
10894631|NCT00288509|12060444|FG000|STARTED|Treatment Cycle 3|One subject completed Cycle 2 but withdrew before Cycle 3 due to insufficient clinical response|96
10894632|NCT00288509|12060444|FG000|COMPLETED|Treatment Cycle 3||91
10894633|NCT00288509|12060444|FG000|NOT COMPLETED|Treatment Cycle 3||5
10894634|NCT00288509|12060444|FG000|STARTED|Treatment Cycle 4|3 subjects completed Cycle 3 but withdrew before Cycle 4, treatment stopped according to protocol|88
10894635|NCT00288509|12060444|FG000|COMPLETED|Treatment Cycle 4||80
10894636|NCT00288509|12060444|FG000|NOT COMPLETED|Treatment Cycle 4||8
10894637|NCT00278915|12060448|FG000|STARTED|Overall Study|First 6 patients were dosed at 2mg/kg then increased to 4 mg/kg. Remaining 24 were dosed at 4mg/kg.|30
10894639|NCT00278915|12060448|FG000|NOT COMPLETED|Overall Study||1
10894640|NCT00257660|12060454|FG000|STARTED|Overall Study||55
10894641|NCT00257660|12060455|FG001|STARTED|Overall Study||61
10894642|NCT00257660|12060454|FG000|COMPLETED|Overall Study||45
10894643|NCT00257660|12060455|FG001|COMPLETED|Overall Study||38
10894644|NCT00257660|12060454|FG000|NOT COMPLETED|Overall Study||10
10894645|NCT00257660|12060455|FG001|NOT COMPLETED|Overall Study||23
10894646|NCT00136695|12060463|FG000|STARTED|Overall Study||45
10894647|NCT00136695|12060464|FG001|STARTED|Overall Study||43
10894648|NCT00136695|12060463|FG000|COMPLETED|Overall Study||34
10894649|NCT00136695|12060464|FG001|COMPLETED|Overall Study||35
10894650|NCT00136695|12060463|FG000|NOT COMPLETED|Overall Study||11
10894651|NCT00136695|12060464|FG001|NOT COMPLETED|Overall Study||8
10894652|NCT00127127|12060474|FG000|STARTED|Overall Study||3
10894653|NCT00127127|12060475|FG001|STARTED|Overall Study||6
10894654|NCT00127127|12060476|FG002|STARTED|Overall Study||3
10894655|NCT00127127|12060477|FG003|STARTED|Overall Study||6
10894656|NCT00127127|12060474|FG000|COMPLETED|Overall Study||2
10894657|NCT00127127|12060475|FG001|COMPLETED|Overall Study||1
10894658|NCT00127127|12060476|FG002|COMPLETED|Overall Study||3
10894659|NCT00127127|12060477|FG003|COMPLETED|Overall Study||3
10894660|NCT00127127|12060474|FG000|NOT COMPLETED|Overall Study||1
10894661|NCT00127127|12060475|FG001|NOT COMPLETED|Overall Study||5
10894662|NCT00127127|12060476|FG002|NOT COMPLETED|Overall Study||0
10894663|NCT00127127|12060477|FG003|NOT COMPLETED|Overall Study||3
10894664|NCT00119366|12060519|FG000|STARTED|Overall Study||1
10894665|NCT00119366|12060520|FG001|STARTED|Overall Study||2
10894666|NCT00119366|12060521|FG002|STARTED|Overall Study||3
10894667|NCT00119366|12060522|FG003|STARTED|Overall Study||2
10894668|NCT00119366|12060523|FG004|STARTED|Overall Study||8
10894669|NCT00119366|12060519|FG000|COMPLETED|Overall Study||1
10894670|NCT00119366|12060520|FG001|COMPLETED|Overall Study||2
10894671|NCT00119366|12060521|FG002|COMPLETED|Overall Study||3
10894672|NCT00119366|12060522|FG003|COMPLETED|Overall Study||2
10894673|NCT00119366|12060523|FG004|COMPLETED|Overall Study||8
10894674|NCT00119366|12060519|FG000|NOT COMPLETED|Overall Study||0
10894675|NCT00119366|12060520|FG001|NOT COMPLETED|Overall Study||0
10894676|NCT00119366|12060521|FG002|NOT COMPLETED|Overall Study||0
10894677|NCT00119366|12060522|FG003|NOT COMPLETED|Overall Study||0
10894678|NCT00119366|12060523|FG004|NOT COMPLETED|Overall Study||0
10894679|NCT00114101|12060545|FG000|STARTED|Overall Study||231
10894680|NCT00114101|12060546|FG001|STARTED|Overall Study||229
10894681|NCT00114101|12060545|FG000|COMPLETED|Overall Study||231
10894682|NCT00114101|12060546|FG001|COMPLETED|Overall Study||229
10894683|NCT00114101|12060545|FG000|NOT COMPLETED|Overall Study||0
10894684|NCT00114101|12060546|FG001|NOT COMPLETED|Overall Study||0
10894685|NCT00113763|12060556|FG000|STARTED|Overall Study||231
10894686|NCT00113763|12060557|FG001|STARTED|Overall Study||232
10894687|NCT00113763|12060556|FG000|Received Study Drug|Overall Study||229
10894688|NCT00113763|12060557|FG001|Received Study Drug|Overall Study||0
10894689|NCT00113763|12060556|FG000|COMPLETED|Overall Study|Defined as participants who completed safety follow-up visit or who died.|158
10894690|NCT00113763|12060557|FG001|COMPLETED|Overall Study|Defined as participants who completed safety follow-up visit or who died.|206
10894691|NCT00113763|12060556|FG000|NOT COMPLETED|Overall Study||73
10894692|NCT00113763|12060557|FG001|NOT COMPLETED|Overall Study||26
10894693|NCT00101101|12060564|FG000|STARTED|Overall Study||43
10894694|NCT00101101|12060564|FG000|COMPLETED|Overall Study|Participants who received at least one vaccine injection.|23
10894695|NCT00101101|12060564|FG000|NOT COMPLETED|Overall Study||20
10894696|NCT00099437|12060570|FG000|STARTED|Overall Study|randomised patients|374
10894697|NCT00099437|12060571|FG001|STARTED|Overall Study|randomised patients|362
10894698|NCT00099437|12060570|FG000|COMPLETED|Overall Study|ongoing study treatment at survival follow-up data cut-off|8
10894699|NCT00099437|12060571|FG001|COMPLETED|Overall Study|ongoing study treatment at survival follow-up data cut-off|13
10894700|NCT00099437|12060570|FG000|NOT COMPLETED|Overall Study||366
10894701|NCT00099437|12060571|FG001|NOT COMPLETED|Overall Study||349
10894702|NCT00098475|12060579|FG000|STARTED|Step 1||223
10894703|NCT00098475|12060580|FG001|STARTED|Step 1||222
10894704|NCT00098475|12060581|FG002|STARTED|Step 1||4
10894705|NCT00098475|12060582|FG003|STARTED|Step 1||3
10894706|NCT00098475|12060579|FG000|Treated|Step 1||223
10894707|NCT00098475|12060580|FG001|Treated|Step 1||220
10894708|NCT00098475|12060581|FG002|Treated|Step 1||4
10894709|NCT00098475|12060582|FG003|Treated|Step 1||3
10894710|NCT00098475|12060579|FG000|Eligible|Step 1|Some patients were considered eligible at registration but found ineligible in the analysis.|214
10894711|NCT00098475|12060580|FG001|Eligible|Step 1|Some patients were considered eligible at registration but found ineligible in the analysis.|208
10894712|NCT00098475|12060581|FG002|Eligible|Step 1||4
10894713|NCT00098475|12060582|FG003|Eligible|Step 1||3
10894714|NCT00098475|12060579|FG000|COMPLETED|Step 1||52
10894715|NCT00098475|12060580|FG001|COMPLETED|Step 1||49
10894716|NCT00098475|12060581|FG002|COMPLETED|Step 1||0
10894717|NCT00098475|12060582|FG003|COMPLETED|Step 1||0
10894718|NCT00098475|12060579|FG000|NOT COMPLETED|Step 1||171
10894719|NCT00098475|12060580|FG001|NOT COMPLETED|Step 1||173
10894720|NCT00098475|12060581|FG002|NOT COMPLETED|Step 1||4
10894721|NCT00098475|12060582|FG003|NOT COMPLETED|Step 1||3
10894722|NCT00098475|12060579|FG000|STARTED|Step 2|Step 2 treatment was an option but not required for patients who ended step 1 treatment.|5
10894723|NCT00098475|12060580|FG001|STARTED|Step 2|Step 2 treatment was an option but not required for patients who ended step 1 treatment.|15
10894724|NCT00098475|12060581|FG002|STARTED|Step 2||0
10894725|NCT00098475|12060582|FG003|STARTED|Step 2||0
10894726|NCT00098475|12060579|FG000|Treated|Step 2||4
10894727|NCT00098475|12060580|FG001|Treated|Step 2||14
10894728|NCT00098475|12060581|FG002|Treated|Step 2||0
10894729|NCT00098475|12060582|FG003|Treated|Step 2||0
10894730|NCT00098475|12060579|FG000|Eligible|Step 2|Some patients were considered eligible at registration but found ineligible in the analysis.|2
10894731|NCT00098475|12060580|FG001|Eligible|Step 2|Some patients were considered eligible at registration but found ineligible in the analysis.|9
10894732|NCT00098475|12060581|FG002|Eligible|Step 2||0
10894733|NCT00098475|12060582|FG003|Eligible|Step 2||0
10894734|NCT00098475|12060579|FG000|COMPLETED|Step 2||0
10894735|NCT00098475|12060580|FG001|COMPLETED|Step 2||5
10894736|NCT00098475|12060581|FG002|COMPLETED|Step 2||0
10894737|NCT00098475|12060582|FG003|COMPLETED|Step 2||0
10894738|NCT00098475|12060579|FG000|NOT COMPLETED|Step 2||5
10894739|NCT00098475|12060580|FG001|NOT COMPLETED|Step 2||10
10894740|NCT00098475|12060581|FG002|NOT COMPLETED|Step 2||0
10894741|NCT00098475|12060582|FG003|NOT COMPLETED|Step 2||0
10894742|NCT00093015|12060594|FG000|STARTED|Overall Study||2026
10894743|NCT00093015|12060595|FG001|STARTED|Overall Study||2012
10894744|NCT00093015|12060594|FG000|Received Study Medication|Overall Study||2019
10894745|NCT00093015|12060595|FG001|Received Study Medication|Overall Study||2004
10894746|NCT00093015|12060594|FG000|COMPLETED|Overall Study||1361
10894747|NCT00093015|12060595|FG001|COMPLETED|Overall Study||1348
10894748|NCT00093015|12060594|FG000|NOT COMPLETED|Overall Study||665
10894749|NCT00093015|12060595|FG001|NOT COMPLETED|Overall Study||664
10894750|NCT00092534|12060603|FG000|STARTED|Base Study Vaccination Period||6087
10894751|NCT00092534|12060604|FG001|STARTED|Base Study Vaccination Period||6080
10894752|NCT00092534|12060605|FG002|STARTED|Base Study Vaccination Period||0
10894753|NCT00092534|12060606|FG003|STARTED|Base Study Vaccination Period||0
10894754|NCT00092534|12060607|FG004|STARTED|Base Study Vaccination Period||0
10894755|NCT00092534|12060603|FG000|COMPLETED|Base Study Vaccination Period||5916
10894756|NCT00092534|12060604|FG001|COMPLETED|Base Study Vaccination Period||5954
10894757|NCT00092534|12060605|FG002|COMPLETED|Base Study Vaccination Period||0
10894758|NCT00092534|12060606|FG003|COMPLETED|Base Study Vaccination Period||0
10894759|NCT00092534|12060607|FG004|COMPLETED|Base Study Vaccination Period||0
10894760|NCT00092534|12060603|FG000|NOT COMPLETED|Base Study Vaccination Period||171
10894761|NCT00092534|12060604|FG001|NOT COMPLETED|Base Study Vaccination Period||126
10894762|NCT00092534|12060605|FG002|NOT COMPLETED|Base Study Vaccination Period||0
10894763|NCT00092534|12060606|FG003|NOT COMPLETED|Base Study Vaccination Period||0
10894764|NCT00092534|12060607|FG004|NOT COMPLETED|Base Study Vaccination Period||0
10894765|NCT00092534|12060603|FG000|STARTED|Base Study Follow-Up Period|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up.|5942
10894766|NCT00092534|12060604|FG001|STARTED|Base Study Follow-Up Period|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up.|5971
10894767|NCT00092534|12060605|FG002|STARTED|Base Study Follow-Up Period||0
10894768|NCT00092534|12060606|FG003|STARTED|Base Study Follow-Up Period||0
10894769|NCT00092534|12060607|FG004|STARTED|Base Study Follow-Up Period||0
10894770|NCT00092534|12060603|FG000|COMPLETED|Base Study Follow-Up Period||5626
10894771|NCT00092534|12060604|FG001|COMPLETED|Base Study Follow-Up Period||5277
10894772|NCT00092534|12060605|FG002|COMPLETED|Base Study Follow-Up Period||0
10894773|NCT00092534|12060606|FG003|COMPLETED|Base Study Follow-Up Period||0
10894774|NCT00092534|12060607|FG004|COMPLETED|Base Study Follow-Up Period||0
10894775|NCT00092534|12060603|FG000|NOT COMPLETED|Base Study Follow-Up Period||316
10894776|NCT00092534|12060604|FG001|NOT COMPLETED|Base Study Follow-Up Period||694
10894777|NCT00092534|12060605|FG002|NOT COMPLETED|Base Study Follow-Up Period||0
10894778|NCT00092534|12060606|FG003|NOT COMPLETED|Base Study Follow-Up Period||0
10894779|NCT00092534|12060607|FG004|NOT COMPLETED|Base Study Follow-Up Period||0
10894780|NCT00092534|12060603|FG000|STARTED|Base Study EXT||0
10894781|NCT00092534|12060604|FG001|STARTED|Base Study EXT||0
10894782|NCT00092534|12060605|FG002|STARTED|Base Study EXT||594
10894783|NCT00092534|12060606|FG003|STARTED|Base Study EXT||0
10894784|NCT00092534|12060607|FG004|STARTED|Base Study EXT||0
10894785|NCT00092534|12060603|FG000|COMPLETED|Base Study EXT||0
10894786|NCT00092534|12060604|FG001|COMPLETED|Base Study EXT||0
10894787|NCT00092534|12060605|FG002|COMPLETED|Base Study EXT||449
10894788|NCT00092534|12060606|FG003|COMPLETED|Base Study EXT||0
10894789|NCT00092534|12060607|FG004|COMPLETED|Base Study EXT||0
10894790|NCT00092534|12060603|FG000|NOT COMPLETED|Base Study EXT||0
10894791|NCT00092534|12060604|FG001|NOT COMPLETED|Base Study EXT||0
10894792|NCT00092534|12060605|FG002|NOT COMPLETED|Base Study EXT||145
10894793|NCT00092534|12060606|FG003|NOT COMPLETED|Base Study EXT||0
10894794|NCT00092534|12060607|FG004|NOT COMPLETED|Base Study EXT||0
10894795|NCT00092534|12060603|FG000|STARTED|Long-Term Follow-Up (LTFU) Study||0
10894796|NCT00092534|12060604|FG001|STARTED|Long-Term Follow-Up (LTFU) Study||0
10894797|NCT00092534|12060605|FG002|STARTED|Long-Term Follow-Up (LTFU) Study||0
10894798|NCT00092534|12060606|FG003|STARTED|Long-Term Follow-Up (LTFU) Study|Some Base Study participants did not consent for inclusion in the LTFU.|2750
10894799|NCT00092534|12060607|FG004|STARTED|Long-Term Follow-Up (LTFU) Study|Some Base Study participants did not consent for inclusion in the LTFU.|2097
10894800|NCT00092534|12060603|FG000|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||0
10894801|NCT00092534|12060604|FG001|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||0
10894802|NCT00092534|12060605|FG002|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||0
10894803|NCT00092534|12060606|FG003|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||2650
10894804|NCT00092534|12060607|FG004|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||2050
10894805|NCT00092534|12060603|FG000|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||0
10894806|NCT00092534|12060604|FG001|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||0
10894807|NCT00092534|12060605|FG002|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||0
10894808|NCT00092534|12060606|FG003|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||2385
10894809|NCT00092534|12060607|FG004|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||1849
10894810|NCT00092534|12060603|FG000|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||0
10894811|NCT00092534|12060604|FG001|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||0
10894812|NCT00092534|12060605|FG002|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||0
10894813|NCT00092534|12060606|FG003|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||2448
10894814|NCT00092534|12060607|FG004|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||1888
10894815|NCT00092534|12060603|FG000|COMPLETED|Long-Term Follow-Up (LTFU) Study||0
10894816|NCT00092534|12060604|FG001|COMPLETED|Long-Term Follow-Up (LTFU) Study||0
10894817|NCT00092534|12060605|FG002|COMPLETED|Long-Term Follow-Up (LTFU) Study||0
10894818|NCT00092534|12060606|FG003|COMPLETED|Long-Term Follow-Up (LTFU) Study||2749
10894819|NCT00092534|12060607|FG004|COMPLETED|Long-Term Follow-Up (LTFU) Study||2097
10894820|NCT00092534|12060603|FG000|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
10894821|NCT00092534|12060604|FG001|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
10894822|NCT00092534|12060605|FG002|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
10894823|NCT00092534|12060606|FG003|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||1
10894824|NCT00092534|12060607|FG004|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
10894825|NCT00089791|12060619|FG000|STARTED|Overall Study||3906
10894826|NCT00089791|12060620|FG001|STARTED|Overall Study||3902
10894827|NCT00089791|12060619|FG000|Received Study Medication|Overall Study||3883
10894828|NCT00089791|12060620|FG001|Received Study Medication|Overall Study||3879
10894829|NCT00089791|12060619|FG000|Safety Analysis Set|Overall Study|7 participants in the placebo arm received ≥1 dose of denosumab & were analyzed in the denosumab arm|3876
10894830|NCT00089791|12060620|FG001|Safety Analysis Set|Overall Study||3886
10894831|NCT00089791|12060619|FG000|COMPLETED|Overall Study||3206
10894832|NCT00089791|12060620|FG001|COMPLETED|Overall Study||3272
10894833|NCT00089791|12060619|FG000|NOT COMPLETED|Overall Study||700
10894834|NCT00089791|12060620|FG001|NOT COMPLETED|Overall Study||630
10894835|NCT00087178|12060628|FG000|STARTED|Overall Study||1361
10894836|NCT00087178|12060629|FG001|STARTED|Overall Study||1361
10894837|NCT00087178|12060628|FG000|COMPLETED|Overall Study||1355
10894838|NCT00087178|12060629|FG001|COMPLETED|Overall Study||1343
10894839|NCT00087178|12060628|FG000|NOT COMPLETED|Overall Study||6
10894840|NCT00087178|12060629|FG001|NOT COMPLETED|Overall Study||18
10894841|NCT00074412|12060637|FG000|STARTED|Overall Study|Number of infants randomized at 6 weeks.|763
10894842|NCT00074412|12060638|FG001|STARTED|Overall Study|Number of infants randomized at 6 weeks.|759
10894843|NCT00074412|12060637|FG000|Week 8 Visit|Overall Study||759
10894844|NCT00074412|12060638|FG001|Week 8 Visit|Overall Study||759
10894845|NCT00074412|12060637|FG000|Month 3 Visit|Overall Study||759
10894846|NCT00074412|12060638|FG001|Month 3 Visit|Overall Study||755
10894847|NCT00074412|12060637|FG000|Month 4 Visit|Overall Study||758
10894848|NCT00074412|12060638|FG001|Month 4 Visit|Overall Study||752
10894849|NCT00074412|12060637|FG000|Month 5 Visit|Overall Study||756
10894850|NCT00074412|12060638|FG001|Month 5 Visit|Overall Study||750
10894851|NCT00074412|12060637|FG000|Month 6 Visit|Overall Study||748
10894852|NCT00074412|12060638|FG001|Month 6 Visit|Overall Study||748
10894853|NCT00074412|12060637|FG000|Month 9 Visit|Overall Study||741
10894854|NCT00074412|12060638|FG001|Month 9 Visit|Overall Study||741
10894855|NCT00074412|12060637|FG000|Month 12 Visit|Overall Study||733
10894856|NCT00074412|12060638|FG001|Month 12 Visit|Overall Study||735
10894857|NCT00074412|12060637|FG000|COMPLETED|Overall Study|Number of infants who completed final 18 month visit: out of 733 infants who were expected.|681
10894858|NCT00074412|12060638|FG001|COMPLETED|Overall Study|Number of infants who completed final 18 month visit: out of 733 infants who were expected.|675
10894859|NCT00074412|12060637|FG000|NOT COMPLETED|Overall Study||82
10894860|NCT00074412|12060638|FG001|NOT COMPLETED|Overall Study||84
10894861|NCT00070499|12060649|FG000|STARTED|Overall Study||75
10894862|NCT00070499|12060650|FG001|STARTED|Overall Study||78
10894863|NCT00070499|12060651|FG002|STARTED|Overall Study||126
10894864|NCT00070499|12060652|FG003|STARTED|Overall Study||127
10894865|NCT00070499|12060649|FG000|Eligible|Overall Study||73
10894866|NCT00070499|12060650|FG001|Eligible|Overall Study||73
10894867|NCT00070499|12060651|FG002|Eligible|Overall Study||123
10894868|NCT00070499|12060652|FG003|Eligible|Overall Study||125
10894869|NCT00070499|12060649|FG000|Eligible and Treated|Overall Study||72
10894870|NCT00070499|12060650|FG001|Eligible and Treated|Overall Study||73
10894871|NCT00070499|12060651|FG002|Eligible and Treated|Overall Study||123
10894872|NCT00070499|12060652|FG003|Eligible and Treated|Overall Study||123
10894873|NCT00070499|12060649|FG000|COMPLETED|Overall Study||37
10894874|NCT00070499|12060650|FG001|COMPLETED|Overall Study||52
10894875|NCT00070499|12060651|FG002|COMPLETED|Overall Study||6
10894876|NCT00070499|12060652|FG003|COMPLETED|Overall Study||17
10894877|NCT00070499|12060649|FG000|NOT COMPLETED|Overall Study||38
10894878|NCT00070499|12060650|FG001|NOT COMPLETED|Overall Study||26
10894879|NCT00070499|12060651|FG002|NOT COMPLETED|Overall Study||120
10894880|NCT00070499|12060652|FG003|NOT COMPLETED|Overall Study||110
10894881|NCT00026312|12060672|FG000|STARTED|Overall Study||116
10894882|NCT00026312|12060673|FG001|STARTED|Overall Study||1333
10894883|NCT00026312|12060672|FG000|COMPLETED|Overall Study||82
10894884|NCT00026312|12060673|FG001|COMPLETED|Overall Study||1064
10894885|NCT00026312|12060672|FG000|NOT COMPLETED|Overall Study||34
10894886|NCT00026312|12060673|FG001|NOT COMPLETED|Overall Study||269
10894887|NCT00006721|12060686|FG000|STARTED|Overall Study||17
10894888|NCT00006721|12060687|FG001|STARTED|Overall Study||279
10894889|NCT00006721|12060688|FG002|STARTED|Overall Study||275
10894890|NCT00006721|12060686|FG000|Eligible|Overall Study||15
10894891|NCT00006721|12060687|FG001|Eligible|Overall Study||267
10894892|NCT00006721|12060688|FG002|Eligible|Overall Study||265
10894893|NCT00006721|12060686|FG000|Eligible and Began Protocol Therapy|Overall Study||14
10894894|NCT00006721|12060687|FG001|Eligible and Began Protocol Therapy|Overall Study||267
10894895|NCT00006721|12060688|FG002|Eligible and Began Protocol Therapy|Overall Study||265
10894896|NCT00006721|12060686|FG000|COMPLETED|Overall Study||13
10894897|NCT00006721|12060687|FG001|COMPLETED|Overall Study||254
10894898|NCT00006721|12060688|FG002|COMPLETED|Overall Study||242
10894899|NCT00006721|12060686|FG000|NOT COMPLETED|Overall Study||4
10894900|NCT00006721|12060687|FG001|NOT COMPLETED|Overall Study||25
10894901|NCT00006721|12060688|FG002|NOT COMPLETED|Overall Study||33
10894902|NCT00006436|12060698|FG000|STARTED|Overall Study||68
10894903|NCT00006436|12060698|FG000|COMPLETED|Overall Study||65
10894904|NCT00006436|12060698|FG000|NOT COMPLETED|Overall Study||3
10894905|NCT00002540|12060707|FG000|STARTED|Overall Study||38345
10894906|NCT00002540|12060708|FG001|STARTED|Overall Study||38340
10894907|NCT00002540|12060707|FG000|COMPLETED|Overall Study||37544
10894908|NCT00002540|12060708|FG001|COMPLETED|Overall Study||35876
10894909|NCT00002540|12060707|FG000|NOT COMPLETED|Overall Study||801
10894910|NCT00002540|12060708|FG001|NOT COMPLETED|Overall Study||2464
